id|nct_id|name|downcase_name
5046574|NCT03708172|Imaging|imaging
5047694|NCT03700944|Yoga|yoga
5428241|NCT01595555|online|online
5049778|NCT03687021|progesterone|progesterone
5050093|NCT03684850|RCT|rct
5103879|NCT03347994|AML|aml
5730908|NCT00390962|Adh|adh
5051493|NCT03676322|M5049|m5049
5053157|NCT03666351|LVM|lvm
5053346|NCT03665285|PK|pk
5053465|NCT03664531|challenge|challenge
5054165|NCT03659643|MCI|mci
5054264|NCT03659058|HCV|hcv
5054490|NCT03657576|GBM|gbm
5054701|NCT03656198|Rabies|rabies
5932793|NCT03219957|HCV|hcv
5056488|NCT03645915|glut1|glut1
5056599|NCT03645408|alcohol craving|alcohol craving
5056844|NCT03643939|NIV|niv
5058185|NCT03635255|CAD|cad
5058364|NCT03634254|AAC|aac
5058792|NCT03631498|smoking|smoking
5059015|NCT03630120|DTC|dtc
5059539|NCT03626857|ACL|acl
5059885|NCT03624556|Homocysteine|homocysteine
5060133|NCT03623100|ERP|erp
5061034|NCT03617497|EEG|eeg
5062074|NCT03611062|children|children
5062456|NCT03608774|MSM|msm
5062606|NCT03607890|MSI|msi
5063920|NCT03599830|Cancer|cancer
5064066|NCT03598790|PSO|pso
5064909|NCT03593356|Poverty|poverty
5065396|NCT03590340|CHMI|chmi
5065964|NCT03586492|CZT|czt
5066827|NCT03581201|glucose profiles|glucose profiles
5067087|NCT03579576|HIV|hiv
4977402|NCT04133649|AAV|aav
5069087|NCT03567499|SAP|sap
5069825|NCT03562689|ICU|icu
5939224|NCT01301183|Estrogen|estrogen
5939226|NCT01301183|IGF-1|igf-1
4980539|NCT04114500|FET|fet
5073204|NCT03541356|ON|on
5073788|NCT03537898|acetate|acetate
5074024|NCT03536494|Mirabegron|mirabegron
5076279|NCT03522246|HRD|hrd
5076466|NCT03521245|NGS|ngs
5077832|NCT03513068|POC|poc
5078194|NCT03511105|Placebo|placebo
5079600|NCT03501719|HIV|hiv
5080455|NCT03496207|PAH|pah
5080867|NCT03493646|AML|aml
5081304|NCT03490903|VR|vr
5900468|NCT02010203|BCG|bcg
5081934|NCT03486587|afatinib|afatinib
5082368|NCT03483792|AMH|amh
5082766|NCT03481166|pilot|pilot
5342880|NCT01981681|Topical|topical
5083482|NCT03476473|Asthma|asthma
5898151|NCT02705846|BRCA1|brca1
5695667|NCT00515632|Oedema|oedema
5085618|NCT03463564|CSII|csii
5144727|NCT03087097|SAM|sam
5086179|NCT03459456|OCD|ocd
4956374|NCT04261621|Sepsis|sepsis
4956722|NCT04259190|values|values
5086622|NCT03456856|Black|black
4957080|NCT04257084|chromoendoscopy|chromoendoscopy
4957401|NCT04255030|Coping|coping
5087684|NCT03449979|EEG|eeg
4958834|NCT04245943|Fatigue|fatigue
5088816|NCT03443063|E2006|e2006
5088896|NCT03442504|FES PET/CT|fes pet/ct
4998977|NCT04001010|QoL|qol
5089453|NCT03439202|EEG|eeg
5089951|NCT03436303|progestin|progestin
5090091|NCT03435419|RDT|rdt
5090210|NCT03434639|Spectroscopy|spectroscopy
5091132|NCT03428932|MRI|mri
4961667|NCT04229290|HIV|hiv
5092624|NCT03419819|PKU|pku
5092812|NCT03418740|FA|fa
5092877|NCT03418272|ICU|icu
5093290|NCT03415802|S-1|s-1
5003846|NCT03972202|TMS|tms
4983021|NCT04098315|HIV|hiv
5004294|NCT03969394|MRI|mri
5094429|NCT03408587|eye|eye
4965252|NCT04206943|ALL|all
4965457|NCT04205591|RCT|rct
5095217|NCT03403725|NHL|nhl
4965971|NCT04202029|TIM|tim
4966099|NCT04201418|T60A|t60a
5095935|NCT03398538|DFU|dfu
5096474|NCT03395340|cGVHD|cgvhd
5006732|NCT03954522|ICU|icu
5096951|NCT03392545|gliomas|gliomas
5097110|NCT03391765|PSP|psp
5098304|NCT03383926|Longo|longo
5098531|NCT03382457|TR|tr
5099512|NCT03376334|SEBT|sebt
4970251|NCT04176276|DKD|dkd
5099834|NCT03374150|Obesity|obesity
5100909|NCT03367546|SCD|scd
5101544|NCT03363724|HaGuide|haguide
5099506|NCT03376360|MRI|mri
5102793|NCT03355573|AS|as
5103007|NCT03353948|Obesity|obesity
5103372|NCT03351270|CNM|cnm
5103949|NCT03347630|MRI|mri
5104118|NCT03346499|HIV|hiv
5104539|NCT03344029|Flu|flu
5104895|NCT03341429|obesity|obesity
5105527|NCT03337620|chronic|chronic
5167596|NCT02944578|HIV|hiv
5105794|NCT03336177|gynecology|gynecology
5105969|NCT03335059|BCG|bcg
5106184|NCT03333993|Fatigue|fatigue
4977775|NCT04131231|MPE|mpe
4977953|NCT04129827|Knee|knee
5107176|NCT03327883|Treatment Responses|treatment responses
5108281|NCT03321188|HIPEC|hipec
5108718|NCT03318575|PCI|pci
5109399|NCT03314441|yoga|yoga
5109734|NCT03312023|Hepatitis B|hepatitis b
5110129|NCT03309540|Pain|pain
4978733|NCT04124991|HCC|hcc
5110612|NCT03306368|OUD|oud
5110979|NCT03304093|IFCT|ifct
5111515|NCT03300427|LVEF|lvef
5111869|NCT03298178|TAVR|tavr
5112005|NCT03297125|MRI|mri
5112441|NCT03294304|UC|uc
5024472|NCT03845101|RCT|rct
4980947|NCT04111770|PCI|pci
5113144|NCT03289611|pregnancy|pregnancy
5113444|NCT03287869|Bipolar|bipolar
5113568|NCT03287245|MPN|mpn
5113735|NCT03285854|CKD|ckd
5113804|NCT03285490|Actinic Keratoses|actinic keratoses
5114045|NCT03283787|ACell|acell
5114598|NCT03280589|EEG|eeg
5115106|NCT03277053|ERP|erp
5115487|NCT03274440|CBD|cbd
5116675|NCT03266640|CMV|cmv
5117010|NCT03264313|TMS|tms
5118609|NCT03254485|HFpEF|hfpef
5118977|NCT03252041|PCS|pcs
5119039|NCT03251716|Female|female
5119175|NCT03250728|CDG|cdg
5119265|NCT03250117|Dyskinesia|dyskinesia
5119694|NCT03247439|CMC Joint|cmc joint
4988148|NCT04065477|TBI|tbi
5120526|NCT03241459|PTA|pta
4992280|NCT04041323|KDIGO|kdigo
4992415|NCT04040699|KN026|kn026
4988560|NCT04063085|gel|gel
4993013|NCT04037371|winter|winter
5121441|NCT03236142|DS|ds
5121636|NCT03235310|HIV|hiv
5121657|NCT03235063|registry|registry
4994248|NCT04030013|renal|renal
5035202|NCT03779204|Hope|hope
5123620|NCT03222752|CES|ces
5124106|NCT03219359|Colitis|colitis
5124600|NCT03215927|ILD|ild
5124811|NCT03214679|HCV|hcv
5125038|NCT03213184|asthma|asthma
5037996|NCT03761381|MCI|mci
5125556|NCT03209830|stroke|stroke
5356838|NCT01917799|Heparin|heparin
5126161|NCT03205891|TAK228|tak228
5127120|NCT03199807|NRT|nrt
4999168|NCT04000022|TBS|tbs
5127923|NCT03194737|BPH|bph
5128089|NCT03193775|HBsAg|hbsag
5128891|NCT03188731|Dengue|dengue
5129125|NCT03187522|AAA|aaa
5129473|NCT03185208|MCI|mci
5043457|NCT03727672|markers|markers
5130715|NCT03177486|Frank sign|frank sign
5131035|NCT03175276|Delirium|delirium
5131223|NCT03173924|PSA|psa
4998481|NCT04003974|FSHD, FSHD1|fshd, fshd1
5131472|NCT03172156|ctDNA|ctdna
5131576|NCT03171376|Coronal leakage|coronal leakage
5131751|NCT03170063|Parkinson's Disease|parkinson's disease
5132227|NCT03166878|CAR-T|car-t
5020167|NCT03871127|PCI|pci
5133636|NCT03157830|MS|ms
5133872|NCT03157128|MTC|mtc
5135687|NCT03145129|IOP|iop
5135895|NCT03143829|gerontology|gerontology
5050077|NCT03685045|OST|ost
5137857|NCT03129854|metastatic|metastatic
5138024|NCT03128502|saliva|saliva
5005251|NCT03963661|SIGHT|sight
5138652|NCT03124160|IUD|iud
5010707|NCT03929666|HER2|her2
5139352|NCT03119792|Prevention|prevention
5011338|NCT03925298|outcome|outcome
5139586|NCT03118271|lumbar traction|lumbar traction
5139696|NCT03117608|OA|oa
5140099|NCT03114917|CBT|cbt
5140216|NCT03114189|Kneipp|kneipp
5007588|NCT03949062|iR2|ir2
5141146|NCT03108872|Stroke|stroke
5141252|NCT03108157|IVF|ivf
5141609|NCT03105973|CBT|cbt
5013898|NCT03910036|PRP|prp
5142390|NCT03100981|Anxiety|anxiety
5014764|NCT03904602|CVI|cvi
5144214|NCT03090230|DTA|dta
5145411|NCT03082534|Pembrolizumab|pembrolizumab
5017545|NCT03887039|ADHD|adhd
5145618|NCT03081494|PDR001|pdr001
5145818|NCT03080207|Physiotherapy|physiotherapy
5145951|NCT03079674|biomarker|biomarker
5146070|NCT03078946|delirium|delirium
5146204|NCT03078179|Child|child
5019819|NCT03873116|BCX7353|bcx7353
5063030|NCT03605147|HMB|hmb
5149050|NCT03061435|HPV|hpv
5219971|NCT02624050|ARB|arb
5150167|NCT03053791|MLR|mlr
5150398|NCT03052283|Gut|gut
5022689|NCT03855735|App|app
5023480|NCT03850704|MM|mm
5073390|NCT03540134|DBS|dbs
5153673|NCT03031574|Phase 1|phase 1
5154345|NCT03027635|PleurX|pleurx
5026865|NCT03830918|SCLC|sclc
5070506|NCT03558568|DBS|dbs
5155900|NCT03017443|Obesity|obesity
5718618|NCT00436488|Obesity|obesity
5156696|NCT03012854|POEM|poem
5029167|NCT03816995|cleancision|cleancision
5029296|NCT03816007|PTSD|ptsd
5023314|NCT03851900|VAS|vas
5157111|NCT03009981|Lupron|lupron
5030664|NCT03807544|AUD|aud
5158841|NCT02999282|TMS|tms
5031772|NCT03800628|QOL|qol
5159669|NCT02993627|BMI|bmi
5032242|NCT03797534|gene|gene
5032352|NCT03796923|Elderly|elderly
5160052|NCT02991118|LDL|ldl
5032710|NCT03794791|HBV|hbv
5033043|NCT03792412|obesity|obesity
5160835|NCT02986334|MRI|mri
5161323|NCT02983097|relapse|relapse
5161606|NCT02981602|HBV|hbv
5027978|NCT03824067|LMIC|lmic
5161860|NCT02980250|domperidone|domperidone
5162733|NCT02975349|M2951|m2951
5163746|NCT02969395|3T|3t
5163989|NCT02967484|RCT|rct
5164258|NCT02965742|DXA|dxa
5164666|NCT02963051|Copper|copper
5031756|NCT03800719|IM|im
5038145|NCT03760705|CHF|chf
5165403|NCT02958241|MRI|mri
5165826|NCT02955849|rural|rural
5166252|NCT02953496|SFA|sfa
5166915|NCT02949089|safety|safety
5039961|NCT03748966|XLH|xlh
5053722|NCT03662750|PET|pet
5033843|NCT03787498|AML|aml
5167557|NCT02944773|newborn|newborn
5167972|NCT02942238|D3|d3
5086649|NCT03456622|G7|g7
5169067|NCT02934776|MRI|mri
5042614|NCT03732859|IPF|ipf
5036107|NCT03773523|MRI|mri
5044095|NCT03723837|IPV|ipv
5171076|NCT02922790|tobacco|tobacco
5171430|NCT02920996|MET|met
5172364|NCT02915367|SMS|sms
5172562|NCT02914366|GBA1|gba1
5174198|NCT02903472|SCI|sci
5174219|NCT02903342|Fever|fever
5174321|NCT02902822|mole|mole
5041363|NCT03740412|old|old
5049275|NCT03690661|face|face
5042939|NCT03730805|Qat|qat
5176381|NCT02889315|LenusPro|lenuspro
5050482|NCT03682458|iPS|ips
5177018|NCT02884648|Avastin|avastin
5043903|NCT03724890|M3814|m3814
5177250|NCT02883114|GSM|gsm
5177382|NCT02882503|Endoscopic ultrasound|endoscopic ultrasound
5177587|NCT02881060|Glucagon|glucagon
5178168|NCT02877212|ITP|itp
5178578|NCT02874183|HF|hf
5178675|NCT02873559|men|men
5178953|NCT02871752|couples|couples
5099636|NCT03375593|RCT|rct
5054440|NCT03657966|Vaccine|vaccine
5180482|NCT02862210|Lithium|lithium
5055416|NCT03652142|DDR|ddr
5048499|NCT03695588|QLB|qlb
5181766|NCT02853929|Tetanus|tetanus
5048772|NCT03694067|JAK|jak
5182073|NCT02851940|Pain|pain
5182431|NCT02849470|PRP|prp
5182451|NCT02849392|Satiety|satiety
5182885|NCT02847026|IPV|ipv
5185562|NCT02830087|walking|walking
5053152|NCT03666390|suicide|suicide
5186090|NCT02826811|kidney|kidney
5107131|NCT03328130|AAV|aav
5174451|NCT02901951|HBV|hbv
5187651|NCT02817451|Tetanus|tetanus
5062920|NCT03605927|HCT|hct
5188711|NCT02811185|PET|pet
5189771|NCT02804724|HIV|hiv
5065962|NCT03586492|CFR|cfr
5066083|NCT03585686|LCH|lch
5179743|NCT02866227|Gel|gel
5191223|NCT02796716|KPC|kpc
5066817|NCT03581266|Rye|rye
5191957|NCT02792569|POI|poi
5068321|NCT03572231|YM178|ym178
5060545|NCT03620487|NGS|ngs
5193210|NCT02785237|OCT|oct
5193276|NCT02784834|CLL|cll
5193354|NCT02784288|HPV|hpv
5193682|NCT02782637|Counseling|counseling
5069483|NCT03564873|Omacetaxine|omacetaxine
5194529|NCT02777853|tea|tea
5194603|NCT02777437|T4|t4
5063645|NCT03601819|MCL|mcl
5195606|NCT02771626|MEL|mel
5195853|NCT02770118|obesity|obesity
5118869|NCT03252873|copd|copd
5197257|NCT02761369|PAS|pas
5073198|NCT03541382|HIV|hiv
5073566|NCT03539068|War|war
5074688|NCT03531957|eczema|eczema
5198850|NCT02751528|Vaccine|vaccine
5199175|NCT02749565|OSA|osa
5067105|NCT03579485|naive|naive
5124458|NCT03217188|17-300|17-300
5200801|NCT02739347|EEG|eeg
5201948|NCT02732119|CDK|cdk
5202528|NCT02728401|sepsis|sepsis
5202634|NCT02727582|MDR|mdr
5202839|NCT02726360|Use|use
5202970|NCT02725580|NCL|ncl
5203220|NCT02724254|AGW|agw
5071771|NCT03550352|CBD|cbd
5071996|NCT03549312|HIV|hiv
5072157|NCT03548324|RDS|rds
5205454|NCT02710864|Cytomegalovirus|cytomegalovirus
5082362|NCT03483805|nutrition|nutrition
5082537|NCT03482661|MCE|mce
5083572|NCT03475953|GIST|gist
5207252|NCT02699476|TBI|tbi
5084898|NCT03468101|FEV1|fev1
5085468|NCT03464422|MSM|msm
5086343|NCT03458533|MRI|mri
5209122|NCT02688712|IIA|iia
5077566|NCT03514628|SVT|svt
5086719|NCT03455881|TEF|tef
5209557|NCT02685787|Dementia|dementia
5209862|NCT02684019|propofol|propofol
5078229|NCT03510897|AKI|aki
5087613|NCT03450824|Knee Varus|knee varus
5078586|NCT03508297|RCM|rcm
5136641|NCT03138395|PCR|pcr
5088369|NCT03445533|PD1|pd1
5211217|NCT02674958|aspirin|aspirin
5211432|NCT02673593|Safety|safety
5212009|NCT02669485|ICG|icg
5212032|NCT02669342|Infection|infection
5089668|NCT03437863|mHealth|mhealth
5212321|NCT02667483|DMD|dmd
5212663|NCT02665234|Dry Eye|dry eye
5213358|NCT02661425|IBS-D|ibs-d
5091419|NCT03427333|VT|vt
5092619|NCT03419819|GMP|gmp
5141636|NCT03105778|BNP|bnp
5215203|NCT02650908|Lesion|lesion
5215297|NCT02650401|ALK|alk
5104697|NCT03342976|ICT|ict
5215922|NCT02646878|Type 2 Diabetes|type 2 diabetes
5216318|NCT02644161|CAI|cai
5095023|NCT03404895|DFU|dfu
5217072|NCT02639702|Dosing|dosing
5106435|NCT03332537|IBS|ibs
5217890|NCT02635048|Safety|safety
5096245|NCT03396575|CNS|cns
5218508|NCT02631993|UVA|uva
5218934|NCT02629497|DHA|dha
5088178|NCT03446768|OSA|osa
5219761|NCT02625298|MTA|mta
5219823|NCT02624947|RSV|rsv
5220572|NCT02620501|EGD|egd
5098912|NCT03380026|CTCL|ctcl
5099510|NCT03376347|HPI|hpi
5090381|NCT03434067|PTH|pth
5221814|NCT02612350|ctDNA|ctdna
5100387|NCT03370614|PET|pet
5150422|NCT03052114|EIT|eit
5091318|NCT03427814|BGB-290|bgb-290
5101376|NCT03364634|icp|icp
5163058|NCT02973542|IBS|ibs
5112690|NCT03292874|MRI|mri
5092644|NCT03419663|cereal|cereal
5102295|NCT03358836|FIX|fix
5224240|NCT02597530|TEAS|teas
5102876|NCT03354949|Wheelchair|wheelchair
5224537|NCT02595684|Obesity|obesity
5224554|NCT02595619|AKI|aki
5230747|NCT02560233|EEG|eeg
5224734|NCT02594566|Vaccine|vaccine
5224940|NCT02593305|hypoxia|hypoxia
5225623|NCT02589470|memory|memory
5225722|NCT02589028|glucose level|glucose level
5225973|NCT02587442|ARS|ars
5226215|NCT02585973|HNSCC|hnscc
5226932|NCT02581371|stroke|stroke
5227468|NCT02578511|ALL|all
5227562|NCT02577913|safety|safety
5227782|NCT02576782|femoral|femoral
5227908|NCT02576275|SLL|sll
5228142|NCT02574806|BNP|bnp
5228219|NCT02574468|MTA|mta
5228892|NCT02571036|KIT|kit
5098317|NCT03383783|Caries|caries
5229781|NCT02565888|HIV|hiv
5230784|NCT02560012|RCC|rcc
5110208|NCT03309020|OCT|oct
5231373|NCT02556346|MT-3724|mt-3724
5111207|NCT03302481|Obesity surgery|obesity surgery
5232315|NCT02550548|GIP|gip
5232497|NCT02549573|PD|pd
5103009|NCT03353948|IVF|ivf
5103741|NCT03348891|TNF|tnf
5103825|NCT03348423|Pain|pain
5114261|NCT03282565|ACL|acl
5114741|NCT03279614|ORR|orr
5115737|NCT03272594|Sucrose|sucrose
5236871|NCT02521844|RSPO fusions|rspo fusions
5236981|NCT02521116|Oxymap T1|oxymap t1
5237297|NCT02519140|EMR|emr
5237408|NCT02518503|Statins|statins
5237610|NCT02517151|IBD|ibd
5107534|NCT03325855|FMT|fmt
5170228|NCT02927808|LDL-C|ldl-c
5118702|NCT03254082|sorghum health|sorghum health
5108416|NCT03320304|TRD|trd
5108501|NCT03319771|walking|walking
5239150|NCT02508181|I-gel|i-gel
5239379|NCT02506361|TOP2α|top2α
5120276|NCT03243396|Youth|youth
5240700|NCT02499276|PAV|pav
5241532|NCT02494726|TEG|teg
5241596|NCT02494427|Crowns|crowns
5242473|NCT02488720|biomarkers|biomarkers
5054827|NCT03655262|unconscious fear conditioning|unconscious fear conditioning
5054828|NCT03655262|anxiety disorders|anxiety disorders
5323487|NCT02068950|LBM|lbm
5243410|NCT02483689|Appendicitis|appendicitis
5113495|NCT03287596|MRI|mri
5243954|NCT02480400|Placebo|placebo
5244056|NCT02479607|Breast Cancer|breast cancer
5244158|NCT02479126|Computed Tomography|computed tomography
5054829|NCT03655262|decoded neuro-reinforcement|decoded neuro-reinforcement
5244578|NCT02476864|safety|safety
5054830|NCT03655249|Multiple breath washout|multiple breath washout
5244906|NCT02474719|peritoneal dialysis|peritoneal dialysis
5245169|NCT02473341|mDF|mdf
5125471|NCT03210415|China|china
5245210|NCT02473094|Neoadjuvant|neoadjuvant
5245317|NCT02472691|CMML|cmml
5125687|NCT03208972|IVF|ivf
5233337|NCT02544373|OSA|osa
5245643|NCT02470806|dfu|dfu
5115346|NCT03275428|THRIVE|thrive
5245729|NCT02470234|ADHD|adhd
5126107|NCT03206190|at risk|at risk
5245823|NCT02469792|Stem cells|stem cells
5245939|NCT02469246|HIV|hiv
5054831|NCT03655249|Electrical impedance tomography|electrical impedance tomography
5342495|NCT01983293|QLV|qlv
5126562|NCT03203447|RVO|rvo
5054832|NCT03655249|Lung clearance index|lung clearance index
5054833|NCT03655249|Chest physiotherapy|chest physiotherapy
5054834|NCT03655249|Autogenic drainage|autogenic drainage
5116401|NCT03268434|CBT|cbt
5054835|NCT03655249|Cystic fibrosis|cystic fibrosis
5116505|NCT03267823|INR|inr
5127417|NCT03197792|TEE|tee
5181363|NCT02855944|CO-338|co-338
5128105|NCT03193671|HE4|he4
5181878|NCT02853214|MGUS|mgus
5960951|NCT04290156|quality of life|quality of life
5117739|NCT03259568|TMS|tms
5182290|NCT02850146|tau|tau
5248384|NCT02455102|Prevention|prevention
5128942|NCT03188380|nec|nec
5129042|NCT03187899|clavicle fracture|clavicle fracture
5182874|NCT02847091|ASP1941|asp1941
5054836|NCT03655223|Newborn Screening|newborn screening
5249009|NCT02451189|Overweight|overweight
5054837|NCT03655223|Rare Disorders|rare disorders
5054838|NCT03655223|Genetic Counseling|genetic counseling
5054839|NCT03655223|Families|families
5054840|NCT03655223|Development|development
5054841|NCT03655223|Risk|risk
5054842|NCT03655197|Microbiome|microbiome
5054843|NCT03655197|Lipidome|lipidome
5249813|NCT02445989|HIV|hiv
5054844|NCT03655184|melatonin|melatonin
5130701|NCT03177538|IVF|ivf
5250222|NCT02443636|Suicide|suicide
5054845|NCT03655184|medication Overuse Headache|medication overuse headache
5054858|NCT03655119|Adoelscent|adoelscent
5250788|NCT02440893|Metformin|metformin
5120476|NCT03241797|AIP|aip
5251088|NCT02439216|DMD|dmd
5120997|NCT03238872|CBT|cbt
5121181|NCT03237858|ICD|icd
5132322|NCT03166020|Stroke|stroke
5251800|NCT02434796|HIV|hiv
5132580|NCT03164252|Laser;|laser;
5252100|NCT02433041|NSE|nse
5132802|NCT03162900|QTc|qtc
5252225|NCT02432287|aging|aging
5121939|NCT03233516|MxA|mxa
5252434|NCT02431351|Selinexor|selinexor
5252567|NCT02430714|Lenvima|lenvima
5133354|NCT03159598|A-BR|a-br
5122329|NCT03230721|BPH|bph
5133588|NCT03158038|Vaccine|vaccine
5054859|NCT03655119|Crisis Intervention|crisis intervention
5134262|NCT03154268|China|china
5134619|NCT03152357|TKA|tka
5253825|NCT02423798|CGM|cgm
5123538|NCT03223285|Pain|pain
5254196|NCT02422108|RANKL|rankl
5135047|NCT03149575|GBM|gbm
5254521|NCT02420379|DMD|dmd
5254611|NCT02419859|Insulin|insulin
5190113|NCT02802501|ACT|act
5254736|NCT02419287|ALK|alk
5135526|NCT03146260|TESE|tese
5255241|NCT02416713|DriveID|driveid
5054860|NCT03655106|Ultrasound guided intravenous access|ultrasound guided intravenous access
5125107|NCT03212716|Flu|flu
5255802|NCT02413593|HCV|hcv
5054861|NCT03655106|vascular access|vascular access
5136591|NCT03138811|safety|safety
5136696|NCT03137875|TB|tb
5054862|NCT03655106|extended dwell catheter|extended dwell catheter
5054863|NCT03655106|IV survival|iv survival
5256318|NCT02410655|Oxytocin|oxytocin
5125989|NCT03206931|NTRK1|ntrk1
5054864|NCT03655093|Multiple sclerosis|multiple sclerosis
5256724|NCT02408224|ACS|acs
5126467|NCT03203837|Y90|y90
5257372|NCT02404402|Cognition|cognition
5054865|NCT03655093|Self-questionnaire|self-questionnaire
5127078|NCT03199976|wheeze|wheeze
5257778|NCT02402361|Diabetic Neuropathy|diabetic neuropathy
5257900|NCT02401607|stress|stress
5258232|NCT02399449|iron|iron
5139137|NCT03121027|BMI|bmi
5054866|NCT03655093|Measurement tools|measurement tools
5054867|NCT03655041|Physiological Phenomena|physiological phenomena
5258624|NCT02396927|3D|3d
5258654|NCT02396771|Uterine|uterine
5258774|NCT02396095|female|female
5054868|NCT03655028|COPD|copd
5054869|NCT03655028|Exercise|exercise
5054870|NCT03655028|Rehabilitation|rehabilitation
5128890|NCT03188731|ZIKA|zika
5140518|NCT03112421|IVD|ivd
5054871|NCT03654989|Iontophoresis|iontophoresis
5140969|NCT03110133|C. diff|c. diff
5129907|NCT03182686|OA|oa
5054872|NCT03654989|Treprostinil|treprostinil
5129932|NCT03182478|SPD|spd
5054873|NCT03654989|Diabetic|diabetic
5141412|NCT03107208|DKA|dka
5141588|NCT03106103|urodynamics|urodynamics
5261032|NCT02382783|Flare|flare
5261130|NCT02382120|ventilation|ventilation
5261255|NCT02381392|infrared|infrared
5142386|NCT03100981|Breast cancer|breast cancer
5261460|NCT02380508|BCG study|bcg study
5198229|NCT02755740|female|female
5142718|NCT03098927|Motor Imagery|motor imagery
5261781|NCT02378701|MDS|mds
5143033|NCT03097250|PKU|pku
5143256|NCT03096132|Obesity|obesity
5054876|NCT03654976|Allergic asthma, allergic rhinitis, HDM, pediatric|allergic asthma, allergic rhinitis, hdm, pediatric
5263297|NCT02369965|HIV-1|hiv-1
5132917|NCT03162432|IBD|ibd
5054877|NCT03654963|medication reconciliation|medication reconciliation
5263832|NCT02366975|TRT|trt
5054878|NCT03654963|safe pharmacotherapy|safe pharmacotherapy
5263959|NCT02366195|T-VEC|t-vec
5264058|NCT02365597|JNJ-42756493|jnj-42756493
5264176|NCT02364778|CAD|cad
5054879|NCT03654937|Influenza vaccination|influenza vaccination
5054880|NCT03654937|elite athletes|elite athletes
5201517|NCT02734602|PET|pet
5054881|NCT03654937|Immune response|immune response
5054882|NCT03654937|Side effects|side effects
5054884|NCT03654924|Leak|leak
5264812|NCT02361073|ERP|erp
5054885|NCT03654924|Sore Throat|sore throat
5054896|NCT03654872|Hong Kong|hong kong
5265116|NCT02359318|Icon|icon
5265218|NCT02358928|Obesity|obesity
5146284|NCT03077841|XRT|xrt
5265454|NCT02357719|Polysomnography|polysomnography
5146513|NCT03076528|balance|balance
5054897|NCT03654872|virulence mechanism|virulence mechanism
5054898|NCT03654859|OHCA|ohca
5202909|NCT02725970|DGA|dga
5146717|NCT03075254|Pain|pain
5054899|NCT03654859|cardiac arrest|cardiac arrest
5147158|NCT03072381|PRP|prp
5147539|NCT03070418|DHS|dhs
5266666|NCT02350309|Insomnia Disorder|insomnia disorder
5266771|NCT02349789|tDCS|tdcs
5266868|NCT02349217|Standard of care|standard of care
5266987|NCT02348489|SGI-110|sgi-110
5054900|NCT03654859|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5054901|NCT03654833|Drug: multi-arm|drug: multi-arm
5054902|NCT03654833|Phase IIa|phase iia
5054903|NCT03654794|Tacrolimus|tacrolimus
5054904|NCT03654794|Pharmacokinetics|pharmacokinetics
5267709|NCT02344589|ACB|acb
5267792|NCT02343965|leukemia|leukemia
5137230|NCT03134183|D&E|d&e
5268447|NCT02340481|Placebo|placebo
5149698|NCT03056755|HR+|hr+
5054905|NCT03654781|periodontal treatment|periodontal treatment
5054906|NCT03654781|Initial periodontal therapy|initial periodontal therapy
5054907|NCT03654781|H. pylori|h. pylori
5054908|NCT03654755|eczema|eczema
5054909|NCT03654742|tonsil surgery|tonsil surgery
5207657|NCT02697097|FAI|fai
5269921|NCT02331173|RS1|rs1
5054910|NCT03654742|tonsillectomy|tonsillectomy
5139443|NCT03119246|HD|hd
5208308|NCT02693379|HPV|hpv
5054911|NCT03654742|intracapsular|intracapsular
5139579|NCT03118323|WTP|wtp
5054912|NCT03654742|microdebrider|microdebrider
5151432|NCT03045419|MRI|mri
5054913|NCT03654742|coblation|coblation
5151495|NCT03045107|costs|costs
5151725|NCT03043729|Aflibercept|aflibercept
5270945|NCT02325427|TMS|tms
5054914|NCT03654742|extracapsular|extracapsular
5054915|NCT03654742|electrosurgery|electrosurgery
5209294|NCT02687529|TB|tb
5054916|NCT03654742|electrocautery|electrocautery
5054927|NCT03654716|Lymphoma|lymphoma
5054928|NCT03654716|TP53|tp53
5054929|NCT03654716|p53|p53
5054930|NCT03654716|MDM2|mdm2
5054931|NCT03654716|MDMX|mdmx
5054932|NCT03654716|PPM1D|ppm1d
5210336|NCT02680821|ALL|all
5272096|NCT02319538|FSS|fss
5054933|NCT03654703|HSCT, AML， R-AML|hsct, aml， r-aml
5210684|NCT02678520|RT|rt
5054934|NCT03654677|Hepatitis A Vaccine|hepatitis a vaccine
5210849|NCT02677324|WM|wm
5272620|NCT02316691|Rituximab|rituximab
5054935|NCT03654664|Hepatitis A vaccine|hepatitis a vaccine
5054936|NCT03654625|Worry|worry
5054937|NCT03654625|Anxiety|anxiety
5153842|NCT03030482|Anxiety|anxiety
5142143|NCT03102463|Obesity|obesity
5211556|NCT02672748|BMI|bmi
5154096|NCT03029078|CRE|cre
5270298|NCT02328885|DLI|dli
5273362|NCT02312687|FGF23|fgf23
5154510|NCT03026712|tDCS|tdcs
5273444|NCT02312115|DGF|dgf
5154749|NCT03025321|craving|craving
5273642|NCT02310945|pain|pain
5212413|NCT02666846|PK|pk
5273855|NCT02309879|Pain|pain
5273989|NCT02308969|LSD|lsd
5274191|NCT02307721|Pharmacology|pharmacology
5279155|NCT02279875|TB|tb
5155454|NCT03020537|Young adults|young adults
5274490|NCT02306252|Older Adult|older adult
5274585|NCT02305836|Randomized controlled trial|randomized controlled trial
5274819|NCT02304328|SAH|sah
5274938|NCT02303509|Subjects|subjects
5275145|NCT02302417|Asthma|asthma
5054938|NCT03654625|Generalized Anxiety Disorder|generalized anxiety disorder
5156437|NCT03014310|AS03|as03
5054939|NCT03654625|Written Exposure|written exposure
5156618|NCT03013296|GIP|gip
5275568|NCT02300051|Hypersexual behavior|hypersexual behavior
5144882|NCT03086122|OSA|osa
5156890|NCT03011372|8p11|8p11
5156944|NCT03011060|Capecitabine|capecitabine
5276003|NCT02297776|NSE|nse
5054940|NCT03654599|Digital Storytelling|digital storytelling
5054941|NCT03654599|Narrative|narrative
5276570|NCT02294409|CRT|crt
5145879|NCT03079960|DBS|dbs
5276842|NCT02292979|HL|hl
5276946|NCT02292498|feasibility|feasibility
5277057|NCT02291991|Immunogenecity|immunogenecity
5158252|NCT03002727|Microsatellite|microsatellite
5054942|NCT03654599|Cancer patients|cancer patients
5054943|NCT03654599|Psychosocial health|psychosocial health
5158572|NCT03000751|CT scan|ct scan
5054944|NCT03654599|bone marrow transplant|bone marrow transplant
5277642|NCT02288884|Wound|wound
5382202|NCT01802918|HIV|hiv
5054945|NCT03654534|gastric cancer|gastric cancer
5278718|NCT02281994|IDE|ide
5148009|NCT03067441|LDL|ldl
5054946|NCT03654534|chemothrapy|chemothrapy
5218687|NCT02630992|infants|infants
5278994|NCT02280525|CLL|cll
5279055|NCT02280252|breast|breast
5054947|NCT03654534|oral nutritional supplements|oral nutritional supplements
5279305|NCT02279095|FOP|fop
5054948|NCT03654534|malnutrition|malnutrition
5148746|NCT03063385|STD|std
5054949|NCT03654508|long-acting beta2-agonist|long-acting beta2-agonist
5160891|NCT02986100|CO-338|co-338
5280071|NCT02274480|MRI|mri
5161706|NCT02980874|RVO|rvo
5280580|NCT02271724|MMN|mmn
5280670|NCT02271126|ECMO|ecmo
5162004|NCT02979249|EPP|epp
5281370|NCT02267278|MF|mf
5162713|NCT02975557|MGD|mgd
5281773|NCT02264873|Relapse|relapse
5151274|NCT03046667|Barley|barley
5163727|NCT02969525|PsA|psa
5283699|NCT02253238|XRT|xrt
5224739|NCT02594553|GP|gp
5054950|NCT03654508|pharmacogenetics|pharmacogenetics
5054956|NCT03654456|outcome|outcome
5284241|NCT02250534|Women|women
5054957|NCT03654456|prognosis|prognosis
5165878|NCT02955563|Anxiety|anxiety
5154092|NCT03029078|XDR|xdr
5166557|NCT02951234|aspirin|aspirin
5285869|NCT02242955|Relapse|relapse
5286458|NCT02239900|XRT|xrt
5286790|NCT02238496|Glioma|glioma
5168529|NCT02938520|TMC278|tmc278
5287362|NCT02235779|ILD|ild
5287782|NCT02233803|safety|safety
5288335|NCT02231229|Fast-TB|fast-tb
5170745|NCT02924402|NHL|nhl
5171474|NCT02920645|ICH|ich
5290290|NCT02223052|MM|mm
5173459|NCT02908256|PVI|pvi
5779265|NCT00200863|arousal|arousal
5779267|NCT00200850|Allergy|allergy
5175301|NCT02895555|ODI|odi
5163818|NCT02968849|HIV|hiv
5177829|NCT02879682|glioma|glioma
5296362|NCT02194816|CAM|cam
5054958|NCT03654456|sleep-disordered breathing|sleep-disordered breathing
5054959|NCT03654430|Left ventricular Twist|left ventricular twist
5296507|NCT02194231|MPM|mpm
5296596|NCT02193815|plaque|plaque
5054960|NCT03654430|2D-speckle-tracking|2d-speckle-tracking
5054961|NCT03654430|Postnatal adaptation|postnatal adaptation
5297262|NCT02190981|Ultrasound|ultrasound
5297356|NCT02190539|homeopathy|homeopathy
5054962|NCT03654417|vulvar biopsy|vulvar biopsy
5179242|NCT02869802|PDAC|pdac
5179440|NCT02868489|Microbiota|microbiota
5297915|NCT02188420|TMS|tms
5167678|NCT02944162|AML|aml
5298246|NCT02187003|SCD|scd
5179935|NCT02865356|eczema|eczema
5167846|NCT02943213|Cycle|cycle
5298538|NCT02185807|video-assisted|video-assisted
5298646|NCT02185469|vitrectomy|vitrectomy
5180393|NCT02862717|ICER|icer
5169185|NCT02934178|Gastroenteritis|gastroenteritis
5299936|NCT02178098|LDL|ldl
5300050|NCT02177526|MRI|mri
5300178|NCT02176408|MDD|mdd
5300379|NCT02175446|MBC|mbc
5300854|NCT02172872|AML|aml
5301022|NCT02171273|Genetic|genetic
5303869|NCT02158078|Insulin|insulin
5173099|NCT02910284|HSV|hsv
5304082|NCT02157038|MRI|mri
5304157|NCT02156609|PCI|pci
5185404|NCT02830971|Nurse|nurse
5304920|NCT02152956|AML|aml
5174948|NCT02898116|ALK Inhibitor|alk inhibitor
5306122|NCT02147418|HPV|hpv
5175563|NCT02893995|PAH|pah
5306869|NCT02144077|PDT|pdt
5307502|NCT02141022|Gilenya|gilenya
5188818|NCT02810587|topical antibiotics|topical antibiotics
5176797|NCT02886156|CPAP|cpap
5307900|NCT02139176|HIV|hiv
5308153|NCT02138162|Phase 1|phase 1
5308300|NCT02137369|MDD|mdd
5189553|NCT02806193|MRI|mri
5308711|NCT02135198|AZD7325|azd7325
5308799|NCT02134730|school children|school children
5308950|NCT02134210|PsO|pso
5309421|NCT02132052|PD|pd
5190241|NCT02801864|chronic|chronic
5309774|NCT02130466|PD1|pd1
5190729|NCT02799017|Writing|writing
5310027|NCT02129543|SCT|sct
5311311|NCT02123498|LPR|lpr
5311452|NCT02122926|RCT|rct
5192313|NCT02790463|Allopurinol|allopurinol
5311809|NCT02121197|Ozurdex|ozurdex
5312047|NCT02120287|Brain Tumor|brain tumor
5424730|NCT01609933|HCV|hcv
5312345|NCT02119117|mtDNA|mtdna
5193576|NCT02783261|Y90|y90
5317471|NCT02097095|TB|tb
5181928|NCT02852915|T4|t4
5182099|NCT02851706|Glioma|glioma
5313734|NCT02113293|safety|safety
5314468|NCT02110238|Supartz|supartz
5314662|NCT02109367|HE4|he4
5314929|NCT02108223|rLH|rlh
5312953|NCT02116335|BMI|bmi
5317056|NCT02098954|TKI|tki
5198751|NCT02752178|MDD|mdd
5266931|NCT02348788|RCT|rct
5318786|NCT02090985|Stoma|stoma
5199744|NCT02745678|Enema|enema
5319378|NCT02087956|Navigation|navigation
5319489|NCT02087384|HIV|hiv
5188136|NCT02814578|OCT|oct
5319703|NCT02086162|Smoking|smoking
5188274|NCT02813720|HR-pQCT|hr-pqct
5268943|NCT02337322|HIV|hiv
5200895|NCT02738619|allergic rhinitis|allergic rhinitis
5320843|NCT02081105|compliance,|compliance,
5320945|NCT02080715|Sleep-wake|sleep-wake
5321314|NCT02078843|NET|net
5201998|NCT02731755|FMD|fmd
5322047|NCT02075658|AirSeal® IFS|airseal® ifs
5437460|NCT01555892|LMP|lmp
5322632|NCT02072980|DT1|dt1
5191609|NCT02794519|ACQ|acq
5323792|NCT02067494|Bandages|bandages
5204949|NCT02714036|ALS|als
5326563|NCT02055131|PFA-100|pfa-100
5326838|NCT02053883|SCI|sci
5327041|NCT02052947|CSF|csf
5327228|NCT02052141|HAE|hae
5314112|NCT02111824|ICG|icg
5327596|NCT02050477|Surgery|surgery
5196262|NCT02767258|Dry eye|dry eye
5328415|NCT02047006|AUC|auc
5328447|NCT02046863|Kinesia|kinesia
5208548|NCT02692183|EEG|eeg
5328694|NCT02045888|Grade|grade
5328807|NCT02045381|MRI|mri
5329413|NCT02042976|Anxiety|anxiety
5329550|NCT02042274|EPA|epa
5209665|NCT02685098|BKA|bka
5329849|NCT02041065|Safety|safety
5330642|NCT02037425|Botox|botox
5330747|NCT02036931|Joint|joint
5330835|NCT02036619|IADPSG|iadpsg
5211429|NCT02673619|Topical|topical
5331710|NCT02032459|Preeclampsia|preeclampsia
5331799|NCT02032004|Stem Cells|stem cells
5331928|NCT02031198|tau|tau
5332009|NCT02030769|Pronase|pronase
5212562|NCT02665975|CBT|cbt
5213290|NCT02661919|GTC|gtc
5213458|NCT02661035|SLL|sll
5335470|NCT02015156|Phase 1|phase 1
5336765|NCT02009462|HIV|hiv
5337395|NCT02006875|leg|leg
5217130|NCT02639312|Microsomia|microsomia
5337740|NCT02005237|Neuroimaging|neuroimaging
5217400|NCT02637687|NTRK1|ntrk1
5338046|NCT02003729|ESS|ess
5338190|NCT02002910|iFR|ifr
5217849|NCT02635230|Aspirin|aspirin
5339464|NCT01997372|SAA|saa
5219317|NCT02627677|CML|cml
5339952|NCT01995279|low back pain|low back pain
5340449|NCT01992744|pregnancy|pregnancy
5341207|NCT01989026|BCG|bcg
5208643|NCT02691494|ABT-620|abt-620
5341347|NCT01988402|gout|gout
5208846|NCT02690233|surgery|surgery
5343262|NCT01979692|CLM|clm
5222521|NCT02607930|HIV|hiv
5343526|NCT01978314|AKI|aki
5222896|NCT02605421|PBSC|pbsc
5223388|NCT02602561|HMB|hmb
5344481|NCT01974219|HIV|hiv
5344743|NCT01973140|Tolvaptan|tolvaptan
5345054|NCT01971710|HIV|hiv
5345458|NCT01969903|dexmedetomidine|dexmedetomidine
5346312|NCT01966445|HER3|her3
5346401|NCT01966133|HCC|hcc
5346815|NCT01964209|ICISS|iciss
5347109|NCT01962857|Fitness|fitness
5214664|NCT02654249|THD|thd
5347913|NCT01959308|Adult|adult
5348128|NCT01958125|VNS|vns
5227206|NCT02579889|Stroke|stroke
5349078|NCT01953575|EoE|eoe
5349435|NCT01951807|Coping|coping
5216498|NCT02643134|ESWL|eswl
5304887|NCT02153177|RCT|rct
5349836|NCT01949844|MRI|mri
5350049|NCT01948817|Thalassemia|thalassemia
5229427|NCT02568111|MS|ms
5229987|NCT02564601|aging|aging
5218154|NCT02633696|Phase I|phase i
5351516|NCT01942031|TIA|tia
5351936|NCT01940094|GPA|gpa
5352219|NCT01938859|lithium|lithium
5352594|NCT01937091|HIV|hiv
5352682|NCT01936519|Zortress|zortress
5231741|NCT02553915|EPA|epa
5231893|NCT02552927|PDA|pda
5353172|NCT01934153|topical|topical
5353694|NCT01931956|REALISM|realism
5354554|NCT01927809|Colon|colon
5354740|NCT01927055|PAF|paf
5233890|NCT02540850|SEPT9|sept9
5355407|NCT01924169|CLL|cll
5222516|NCT02607956|HIV|hiv
5234780|NCT02534909|PNH|pnh
5235441|NCT02530892|IVF|ivf
5223823|NCT02599935|MNA|mna
5225647|NCT02589275|bedtime|bedtime
5316958|NCT02099487|HGG|hgg
5359769|NCT01903395|Supportive Care Needs|supportive care needs
5226507|NCT02583802|MHD|mhd
5360254|NCT01901237|Terminal|terminal
5360777|NCT01898715|ACC|acc
5240028|NCT02503098|App|app
5361628|NCT01894555|Aspirin|aspirin
5240367|NCT02501200|CKD-391|ckd-391
5320684|NCT02081820|DCI|dci
5362675|NCT01890304|TBI|tbi
5363190|NCT01887834|gas|gas
5363640|NCT01885702|Vaccines|vaccines
5230441|NCT02561949|War|war
5364830|NCT01880827|obesity|obesity
5369171|NCT01861002|ALL|all
5365699|NCT01876992|bmi|bmi
5366650|NCT01872780|Korean|korean
5366860|NCT01871792|Statin|statin
5367605|NCT01868165|Ageing|ageing
5371490|NCT01851551|NHL|nhl
5368232|NCT01865097|Imagery|imagery
5235077|NCT02533102|E7050|e7050
5368875|NCT01862458|tPA|tpa
5328935|NCT02044822|CLL|cll
5964537|NCT04129970|Binge Eating|binge eating
5964538|NCT04129970|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5964540|NCT04129970|Neuromodulation|neuromodulation
5964658|NCT04112186|Inhibitory Control|inhibitory control
5964659|NCT04112186|Salience Attribution|salience attribution
5964661|NCT04111848|Ketamine|ketamine
5964782|NCT04099797|Glioma|glioma
5964902|NCT04087174|Castration Resistant|castration resistant
5964903|NCT04087174|Prostate Cancer|prostate cancer
5964904|NCT04086953|Exercise Test|exercise test
5964905|NCT04086953|Walking Test|walking test
5964906|NCT04086953|Chronic Disease|chronic disease
5965018|NCT04072107|Treatment adaptation|treatment adaptation
5965019|NCT04071158|Respiratory tract infection|respiratory tract infection
5965020|NCT04071158|Respiratory Syncytial Virus|respiratory syncytial virus
5965021|NCT04071158|RSV|rsv
5965022|NCT04071158|Tdap|tdap
5965023|NCT04071158|Tetanus|tetanus
5965024|NCT04071158|Diphtheria|diphtheria
5965025|NCT04071158|Acellular Pertussis|acellular pertussis
5965026|NCT04071158|Vaccine|vaccine
5965027|NCT04070287|HIV Prevention|hiv prevention
5965028|NCT04070287|HIV self-testing|hiv self-testing
5965029|NCT04070287|young people|young people
5965030|NCT04070287|Nigeria|nigeria
5965031|NCT04070157|Opioid Withdrawal Syndrome|opioid withdrawal syndrome
5965032|NCT04070157|OWS|ows
5965033|NCT04070157|Opioid taper|opioid taper
5965049|NCT04068610|MSS-CRC|mss-crc
5965121|NCT04064697|Valganciclovir|valganciclovir
5965122|NCT04064697|Anti-TNF|anti-tnf
5965123|NCT04064697|Mayo score|mayo score
5965124|NCT04064476|schizophrenia|schizophrenia
5965125|NCT04064476|violence risk|violence risk
5965127|NCT04064060|ACE-536|ace-536
5965241|NCT04052997|Camidanlumab Tesirine; Relapsed or Refractory Hodgkins Lymphoma; Classical Hodgkins Lymphoma; Lymphoma|camidanlumab tesirine; relapsed or refractory hodgkins lymphoma; classical hodgkins lymphoma; lymphoma
5965356|NCT04044352|Live virus|live virus
5965729|NCT03998163|CKD-associated pruritus|ckd-associated pruritus
5965730|NCT03998163|CKD-aP|ckd-ap
5965731|NCT03998163|ESRD (end stage renal disease)|esrd (end stage renal disease)
5965732|NCT03998163|difelikefalin|difelikefalin
5965858|NCT03976869|Asthma|asthma
5966230|NCT03935269|Stress|stress
5966352|NCT03917901|Obesity|obesity
5966478|NCT03900455|polyurethane foam|polyurethane foam
5966479|NCT03900455|pressure ulcer|pressure ulcer
5966480|NCT03900104|Endometrial Cancer|endometrial cancer
5966481|NCT03900104|Sentinel Lymph Node|sentinel lymph node
5966484|NCT03899545|pectoral I block|pectoral i block
5966596|NCT03875378|Bone mineral density|bone mineral density
5966597|NCT03875378|Estrogen|estrogen
5966599|NCT03875235|Durvalumab|durvalumab
5966717|NCT03850171|Heart failure|heart failure
5966718|NCT03850171|Breast disease|breast disease
5966719|NCT03850171|Exercise rehabilitation|exercise rehabilitation
5966720|NCT03850171|Lymphoma|lymphoma
5966957|NCT03821233|Breast cancer|breast cancer
5966958|NCT03821233|Ovarian cancer|ovarian cancer
5966959|NCT03821233|Non-small cell lung cancer|non-small cell lung cancer
5966960|NCT03821233|Colorectal cancer|colorectal cancer
5967014|NCT03814746|SCA|sca
5967203|NCT03795987|Veteran|veteran
5967204|NCT03795987|Digital therapeutic|digital therapeutic
5967205|NCT03795987|Digital medicine|digital medicine
5967206|NCT03795233|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
5967207|NCT03795233|Vancomycin|vancomycin
5967208|NCT03795233|Dysbiosis|dysbiosis
5967321|NCT03773965|Juvenile psoriatic arthritis (JPsA)|juvenile psoriatic arthritis (jpsa)
5967322|NCT03773965|Enthesitis‑related juvenile idiopathic arthritis (ERA)|enthesitis‑related juvenile idiopathic arthritis (era)
5967323|NCT03773965|Systemic JIA with and without systemic features|systemic jia with and without systemic features
5967324|NCT03772717|Pediatrics|pediatrics
5967325|NCT03772717|Vagus nerve stimulation|vagus nerve stimulation
5967326|NCT03771833|breast|breast
5967681|NCT03721172|Scalp|scalp
5967682|NCT03721172|Nail|nail
5967683|NCT03721172|Itch|itch
5967684|NCT03720470|atopic dermatitis|atopic dermatitis
5967685|NCT03720470|atopic eczema|atopic eczema
5967686|NCT03720470|eczema|eczema
5967687|NCT03720470|JAK|jak
5967688|NCT03720470|janus kinase|janus kinase
5967690|NCT03719599|Malaria|malaria
5967795|NCT03701763|Apremilast|apremilast
5967918|NCT03677596|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5967919|NCT03677596|ACUTE LYMPHOBLASTIC leukemia|acute lymphoblastic leukemia
5967920|NCT03677596|inotuzumab ozogamicin|inotuzumab ozogamicin
5967921|NCT03677596|Besponsa|besponsa
5967922|NCT03677596|transplant|transplant
5967923|NCT03677284|Intervention study|intervention study
5967924|NCT03677284|Assistive products|assistive products
5968030|NCT03663933|Autoimmunity|autoimmunity
5968287|NCT03630250|GMO|gmo
5968409|NCT03615326|Gastric Cancer|gastric cancer
5968410|NCT03614728|Acute myeloid leukaemia|acute myeloid leukaemia
5968411|NCT03614728|Myelodysplastic syndrome|myelodysplastic syndrome
5968412|NCT03614728|GSK3326595|gsk3326595
5968413|NCT03614676|third trimester|third trimester
5968414|NCT03614676|Respiratory Syncytial Virus (RSV) illness|respiratory syncytial virus (rsv) illness
5968415|NCT03614676|Pregnancy|pregnancy
5968416|NCT03614676|Maternal Immunization|maternal immunization
5968417|NCT03614676|Pregnant Women|pregnant women
5968649|NCT03575351|B-cell NHL|b-cell nhl
5968776|NCT03553940|Pediatric|pediatric
5968777|NCT03553940|QIV|qiv
5968901|NCT03532542|Duchenne|duchenne
5968902|NCT03532308|Fermented Soy|fermented soy
5968903|NCT03529669|Cancer|cancer
5969148|NCT03492983|Body composition|body composition
5969149|NCT03492983|Quality of life|quality of life
5969150|NCT03492983|Cognitive performance|cognitive performance
5969151|NCT03492983|Postmenopausal women|postmenopausal women
5969185|NCT03486873|PD1|pd1
5969649|NCT03425773|Colorectal cancer|colorectal cancer
5969650|NCT03425773|Pancreatic cancer|pancreatic cancer
5969651|NCT03425747|calcium carbonate|calcium carbonate
5969652|NCT03425747|calcium citrate|calcium citrate
5969653|NCT03425747|quality of life|quality of life
5969655|NCT03425747|hypocalcemia|hypocalcemia
5969892|NCT03385330|BPD|bpd
5970013|NCT03359421|trauma|trauma
5970138|NCT03330067|laparoscope|laparoscope
5970139|NCT03329521|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5970140|NCT03329521|Kidney Transplant|kidney transplant
5970141|NCT03329521|Living Kidney Donation|living kidney donation
5970142|NCT03329521|Kidney Disease|kidney disease
5970143|NCT03329092|Complicated intra-abdominal infection|complicated intra-abdominal infection
5970163|NCT03324503|FRI|fri
5970508|NCT03260322|Pembrolizumab|pembrolizumab
5970754|NCT03206060|Hypertension|hypertension
5970755|NCT03206060|Catecholamine|catecholamine
5970756|NCT03206060|Familial Syndromes|familial syndromes
5970757|NCT03206060|Somatostatin Receptors|somatostatin receptors
5970758|NCT03206060|Ionizing Radiation|ionizing radiation
5970759|NCT03204331|Endometriosis|endometriosis
5970760|NCT03204331|Pain|pain
5970761|NCT03204331|Dysmenorrhea|dysmenorrhea
5970762|NCT03204318|Endometriosis|endometriosis
5970987|NCT03137394|spinal cord injury|spinal cord injury
5970988|NCT03137394|shoulder pain|shoulder pain
5970989|NCT03137394|psychosocial|psychosocial
5970990|NCT03136744|Sedentary behaviour|sedentary behaviour
5971105|NCT03109522|lymphedema|lymphedema
5971484|NCT03036280|Alzheimer's Disease|alzheimer's disease
5971606|NCT03015181|HIV-1|hiv-1
5971607|NCT03015181|Immune Response|immune response
5971608|NCT03009539|Prevention with Hispanic youth|prevention with hispanic youth
5971609|NCT03009539|eHealth preventive intervention in primary care|ehealth preventive intervention in primary care
5971610|NCT03009539|Hispanic adolescent|hispanic adolescent
5971611|NCT03009539|Familias Unidas|familias unidas
5971724|NCT02973789|Tumor Treating Fields|tumor treating fields
5971848|NCT02947230|Physical Activity|physical activity
5972091|NCT02882542|heart rate variability|heart rate variability
5972092|NCT02882542|blood pressure|blood pressure
5972093|NCT02882542|affect|affect
5972094|NCT02882542|mood|mood
5972095|NCT02882542|respiration|respiration
5972716|NCT02688140|APL|apl
5972839|NCT02640014|Oral immunotherapy (OIT)|oral immunotherapy (oit)
5972842|NCT02639325|Brain Tumor|brain tumor
5972963|NCT02612662|AZD4076|azd4076
5972964|NCT02612662|Healthy male subjects|healthy male subjects
5972977|NCT02611960|PD1|pd1
5973121|NCT02564991|MRI|mri
5973339|NCT02485639|memory B cells|memory b cells
5973340|NCT02482506|African American|african american
5973341|NCT02482506|Overweight|overweight
5973342|NCT02482506|Adults|adults
5973462|NCT02448589|Dose Escalation|dose escalation
5973463|NCT02448589|Dose Expansion|dose expansion
5973464|NCT02448589|MTD|mtd
5973465|NCT02448589|TAS-119|tas-119
5973466|NCT02448589|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
5973467|NCT02445248|Diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
5973468|NCT02445248|DLBCL,|dlbcl,
5973478|NCT02435849|ALL|all
5973588|NCT02399124|RCC|rcc
5973706|NCT02352974|rhGAD65|rhgad65
5973828|NCT02317367|Construct Validity|construct validity
5973829|NCT02317367|Self-Affirmation|self-affirmation
5973830|NCT02317367|Alcohol Consumption|alcohol consumption
5973831|NCT02317367|Breast Cancer|breast cancer
5973832|NCT02313428|Diabetic Foot Ulcer|diabetic foot ulcer
5973834|NCT02313428|Medicaid Recipients|medicaid recipients
5973946|NCT02276547|Heart valve|heart valve
5973947|NCT02276547|Transcatheter|transcatheter
5973948|NCT02276547|Transapical|transapical
5973949|NCT02276547|Functional|functional
5973950|NCT02276547|Degenerative|degenerative
5973952|NCT02276027|adenocarcinoma lung cancer,squamous cell lung carcinoma, NSCLC|adenocarcinoma lung cancer,squamous cell lung carcinoma, nsclc
5974185|NCT02165397|Lymphoma|lymphoma
5974187|NCT02165397|WM|wm
5974317|NCT02127710|AZD6094|azd6094
5974571|NCT02026388|PH|ph
5974693|NCT01976715|Treatment Failure|treatment failure
5974813|NCT01940081|Exercise Test|exercise test
5974814|NCT01937858|HbA1c|hba1c
5974815|NCT01937858|glycated hemoglobin|glycated hemoglobin
5974816|NCT01937858|correlation|correlation
5974817|NCT01937858|diabetes|diabetes
5974818|NCT01937858|renal failure|renal failure
5974883|NCT01900730|VPA|vpa
5974929|NCT01871727|E7777|e7777
5975064|NCT01809288|Women|women
5975181|NCT01752426|CLL|cll
5975431|NCT01627756|Immune System|immune system
5975432|NCT01626586|Youth|youth
5975433|NCT01626586|Family|family
5975555|NCT01568697|Periodontitis|periodontitis
5975556|NCT01568697|Oral Mucosal Immunity|oral mucosal immunity
5975557|NCT01568697|Oral Infection|oral infection
5975560|NCT01568697|Gum Disease|gum disease
5975803|NCT01418313|PET/CT|pet/ct
5975816|NCT01411267|ALL|all
5976058|NCT01289457|Acute Myelogenous Leukemia|acute myelogenous leukemia
5976059|NCT01289457|AML|aml
5976060|NCT01289457|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5976061|NCT01289457|MDS|mds
5976062|NCT01289457|Relapsed|relapsed
5976063|NCT01289457|Refractory|refractory
5976064|NCT01289457|Clofarabine|clofarabine
5976065|NCT01289457|Clofarex|clofarex
5976177|NCT01238250|genetic mutation|genetic mutation
5976180|NCT01238250|autism|autism
5976449|NCT01061684|NASH|nash
5976670|NCT00898638|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5976767|NCT00862433|HV|hv
5976888|NCT00788125|recurrent osteosarcoma|recurrent osteosarcoma
5976988|NCT00775853|PD|pd
5977346|NCT00451022|Long Term Survivor|long term survivor
5977347|NCT00451022|Research Specimen|research specimen
5977348|NCT00450788|Etiology|etiology
5977473|NCT00352573|Microallocation|microallocation
5978105|NCT00047853|Unpredictability|unpredictability
5978233|NCT00027183|Lung Injury|lung injury
5978362|NCT00006518|Tumor|tumor
5054963|NCT03654404|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5054964|NCT03654404|Positive Psychology|positive psychology
5054965|NCT03654404|Hematologic malignancy|hematologic malignancy
5054966|NCT03654404|Positive Psychological Intervention|positive psychological intervention
5054967|NCT03654391|Astragalus and Notoginseng extrats|astragalus and notoginseng extrats
5054968|NCT03654391|Body weight|body weight
5054969|NCT03654391|BMI|bmi
5054970|NCT03654391|Triglyceride|triglyceride
5054971|NCT03654391|obese|obese
5054975|NCT03654365|preventative screening|preventative screening
5054976|NCT03654365|electronic health records|electronic health records
5054977|NCT03654365|personal health records|personal health records
5960952|NCT04290156|randomized controlled trial|randomized controlled trial
5960953|NCT04290143|medical water|medical water
5054978|NCT03654365|population health tools|population health tools
5054979|NCT03654352|lung|lung
5054980|NCT03654352|ceramide|ceramide
5054981|NCT03654352|sphingolipid|sphingolipid
5054982|NCT03654352|inflammation|inflammation
5054983|NCT03654352|pulmonary|pulmonary
5054984|NCT03654352|ARDS|ards
5054985|NCT03654352|ALI|ali
5054986|NCT03654313|Atherosclerosis|atherosclerosis
5045089|NCT03717298|Advanced Pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
5045090|NCT03717298|Ocoxin-Viusid|ocoxin-viusid
5045091|NCT03717298|Oxidative stress|oxidative stress
5045092|NCT03717298|Antioxidant|antioxidant
5045093|NCT03717285|RIRS|rirs
5045094|NCT03717285|Renal stones|renal stones
5045095|NCT03717285|ureteral access sheath|ureteral access sheath
5045096|NCT03717285|ureteral injury|ureteral injury
5045097|NCT03717272|AEF0117|aef0117
5045098|NCT03717272|Cannabis-related Use Disorder|cannabis-related use disorder
5045099|NCT03717272|Cannabis subjective effects|cannabis subjective effects
5045100|NCT03717272|Cannabis self-administration|cannabis self-administration
5045101|NCT03717272|cannabis-induced analgesia|cannabis-induced analgesia
5045102|NCT03717272|cannabis-related cognitive disorder|cannabis-related cognitive disorder
5045103|NCT03717259|Renal Donation|renal donation
5045104|NCT03717259|Renal Transplant|renal transplant
5045105|NCT03717259|Open Nephrectomy|open nephrectomy
5045106|NCT03717259|Laparoscopic Nephrectomy|laparoscopic nephrectomy
5045107|NCT03717259|Hand Assisted|hand assisted
5045108|NCT03717259|Surgical Morbidity|surgical morbidity
5045109|NCT03717246|sleep hygiene|sleep hygiene
5045110|NCT03717246|Latino Children|latino children
5045111|NCT03717246|middle school|middle school
5045112|NCT03717246|educational intervention|educational intervention
5045113|NCT03717220|soft-tissue defects|soft-tissue defects
5045114|NCT03717220|dorsal branch of the digital artery|dorsal branch of the digital artery
5045115|NCT03717220|regional flap|regional flap
5045116|NCT03717194|type 2 diabetes|type 2 diabetes
5045117|NCT03717194|heart failure|heart failure
5045118|NCT03717194|ertugliflozin|ertugliflozin
5045119|NCT03717194|Global longitudinal strain (GLS)|global longitudinal strain (gls)
5045120|NCT03717168|recombinant growth hormone|recombinant growth hormone
5045121|NCT03717168|Difficult ventilator weaning|difficult ventilator weaning
5045122|NCT03717168|postoperative complications|postoperative complications
5045123|NCT03717155|Avelumab|avelumab
5045124|NCT03717155|Cetuximab|cetuximab
5045125|NCT03717155|Cisplatin|cisplatin
5045126|NCT03717155|Gemcitabine|gemcitabine
5045127|NCT03717155|Non-Small Cell Lung Cancer|non-small cell lung cancer
5045128|NCT03717142|Fluorescence|fluorescence
5045129|NCT03717142|Brain|brain
5045130|NCT03717142|Cancer detection|cancer detection
5045142|NCT03717038|modotuximab|modotuximab
5045144|NCT03717038|Trifluridine|trifluridine
5045145|NCT03717038|Tipiracil|tipiracil
5045146|NCT03717038|Lonsurf|lonsurf
5045147|NCT03717025|ACRAL|acral
5045148|NCT03716999|palliative|palliative
5045149|NCT03716999|starlight|starlight
5045150|NCT03716999|end-of-life symptoms|end-of-life symptoms
5045151|NCT03716999|non-pharmacological|non-pharmacological
5045152|NCT03716986|MRI|mri
5045153|NCT03716986|Hypoxia|hypoxia
5045154|NCT03716986|O2 saturation|o2 saturation
5045155|NCT03716986|FMISO PET|fmiso pet
5045156|NCT03716986|Glioma|glioma
5045157|NCT03716973|spinal cord stimulation|spinal cord stimulation
5045158|NCT03716973|paraesthesia-free|paraesthesia-free
5045159|NCT03716947|Clinical outcome|clinical outcome
5045160|NCT03716947|Mobility|mobility
5045161|NCT03716947|Facet-joints|facet-joints
5045162|NCT03716921|Septic Arthritis of native joint|septic arthritis of native joint
5045167|NCT03716895|Lactate clearance|lactate clearance
5045168|NCT03716895|Acute Kidney Injury|acute kidney injury
5045169|NCT03716895|Days alive and free|days alive and free
5045170|NCT03716895|Ventilation-free days|ventilation-free days
5045171|NCT03716895|Vasopressor-free days|vasopressor-free days
5045173|NCT03716882|Principal Component 1 (PC1)|principal component 1 (pc1)
5045174|NCT03716882|Principal Component 2 (PC2)|principal component 2 (pc2)
5045175|NCT03716882|Song Meter 4|song meter 4
5045176|NCT03716882|Acoustic structures crying|acoustic structures crying
5045177|NCT03716882|PRAAT software|praat software
5045178|NCT03716869|adolescent; mental health; depression; suicide|adolescent; mental health; depression; suicide
5045179|NCT03716843|Dynamic Pressure Monitoring|dynamic pressure monitoring
5045180|NCT03716817|Crown|crown
5045181|NCT03716817|Ceramic|ceramic
5045182|NCT03716817|CAD/CAM|cad/cam
5045183|NCT03716778|Heart failure|heart failure
5045184|NCT03716778|eccentric|eccentric
5045185|NCT03716778|exercise|exercise
5045186|NCT03716778|rehabilitation program|rehabilitation program
5045187|NCT03716778|exercise testing|exercise testing
5045188|NCT03716778|6 min. walk test|6 min. walk test
5045189|NCT03716752|connective tissue wall technique|connective tissue wall technique
5045190|NCT03716752|modified connective tissue wall technique with a wing|modified connective tissue wall technique with a wing
5045191|NCT03716752|recession defects in posterior teeth|recession defects in posterior teeth
5342944|NCT01981421|Quantitative imaging|quantitative imaging
5045192|NCT03716752|recession defects with infrabony defects|recession defects with infrabony defects
5045197|NCT03716687|negative pressure wound closure|negative pressure wound closure
5045198|NCT03716687|surgical site infection|surgical site infection
5045199|NCT03716687|cost effectiveness|cost effectiveness
5045200|NCT03716674|Parkinson's Disease|parkinson's disease
5045201|NCT03716674|rhythmic auditory stimulation|rhythmic auditory stimulation
5960890|NCT04290403|Urinary Incontinence|urinary incontinence
5045202|NCT03716674|cueing|cueing
5045203|NCT03716674|Long-Range Autocorrelations|long-range autocorrelations
5045204|NCT03716622|Helicobacter Pylori|helicobacter pylori
5045205|NCT03716622|furazolidone|furazolidone
5045206|NCT03716622|clarithromycin|clarithromycin
5045207|NCT03716622|bismuth-containing quadruple regimen|bismuth-containing quadruple regimen
5045208|NCT03716596|pancreatic cancer|pancreatic cancer
5045209|NCT03716596|Second-line Chemotherapy resistant|second-line chemotherapy resistant
5045210|NCT03716596|immune therapy|immune therapy
5045211|NCT03716596|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5045213|NCT03716557|spinal cord stimulation|spinal cord stimulation
5045214|NCT03716557|high frequency stimulation|high frequency stimulation
5045215|NCT03716557|paraesthesia-free|paraesthesia-free
5045216|NCT03716544|Tinnitus|tinnitus
5045217|NCT03716544|Hearing Loss|hearing loss
5045218|NCT03716544|Amplification|amplification
5045219|NCT03716544|Sound Therapy|sound therapy
5045220|NCT03716531|Pancreatic Cancer|pancreatic cancer
5045221|NCT03716518|Colon Cancer|colon cancer
5045222|NCT03716518|Traditional Chinese Medicine|traditional chinese medicine
5045223|NCT03716518|Adverse Effect of Chemotherapy|adverse effect of chemotherapy
5045224|NCT03716518|Chemotherapy|chemotherapy
5046106|NCT03711045|saccade|saccade
5045230|NCT03716401|Ultrasound Imaging|ultrasound imaging
5045231|NCT03716401|Biomarkers|biomarkers
5045232|NCT03716401|Prognosis|prognosis
5045233|NCT03716388|Fecal Microbiota Transplantation|fecal microbiota transplantation
5045234|NCT03716388|Ulcerative Colitis|ulcerative colitis
5045235|NCT03716388|Induction of Remission|induction of remission
5045236|NCT03716375|Pleural empyema, urokinase|pleural empyema, urokinase
5045237|NCT03716336|resistive exercises|resistive exercises
5045238|NCT03716336|aerobic exercises|aerobic exercises
5045239|NCT03716336|diet|diet
5045240|NCT03716336|insulin resistance|insulin resistance
5045241|NCT03716336|premenopausal|premenopausal
5045242|NCT03716284|electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
5045243|NCT03716284|peripheral pulmonary nodules|peripheral pulmonary nodules
5045244|NCT03716284|diagnostic yield|diagnostic yield
5045245|NCT03716271|presbyopia compensation|presbyopia compensation
5045246|NCT03716271|EDF|edf
5045247|NCT03716271|Light Sword Lens|light sword lens
5045248|NCT03716258|Parkinson Disease|parkinson disease
5045249|NCT03716258|Biomarkers|biomarkers
5045250|NCT03716258|Inflammation|inflammation
5045251|NCT03716245|breast cancer|breast cancer
5045252|NCT03716245|supraclavicular lymph node|supraclavicular lymph node
5045253|NCT03716245|dissection|dissection
5045254|NCT03716245|radiotherpy|radiotherpy
5045255|NCT03716245|prognosis|prognosis
5045256|NCT03716206|Shoulder Pain|shoulder pain
5045258|NCT03716206|Motor function|motor function
5045259|NCT03716180|Breast Cancer|breast cancer
5045260|NCT03716167|laser|laser
5045261|NCT03716167|ulcer|ulcer
5045262|NCT03716167|wound|wound
5045263|NCT03716089|GIST|gist
5045264|NCT03716089|laparoscopic resection|laparoscopic resection
5045265|NCT03716089|early complication|early complication
5045266|NCT03716089|mortality|mortality
5045267|NCT03716089|tumor sites|tumor sites
5045268|NCT03716076|Carbetocin|carbetocin
5045269|NCT03716076|Myocardial repolarization|myocardial repolarization
5045270|NCT03716063|colorectal cancer|colorectal cancer
5045271|NCT03716063|traditional Chinese medicine|traditional chinese medicine
5045272|NCT03716050|breast reconstruction|breast reconstruction
5045273|NCT03716050|Breast Cancer|breast cancer
5045274|NCT03716050|Implant Complication|implant complication
5045275|NCT03716037|physical activity|physical activity
5045276|NCT03716037|exercise|exercise
5045277|NCT03716037|depression|depression
5045278|NCT03716037|anxiety|anxiety
5045279|NCT03716037|stress|stress
5045280|NCT03716024|CSSSI|csssi
5045281|NCT03715972|cerebrovascular reserve|cerebrovascular reserve
5045282|NCT03715972|white matter disease in patients with chronic anemia|white matter disease in patients with chronic anemia
5045283|NCT03715946|Phase II|phase ii
5045284|NCT03715946|Oropharynx Cancer|oropharynx cancer
5045286|NCT03715946|Nivolumab|nivolumab
5045287|NCT03715946|Adjuvant therapy|adjuvant therapy
5045288|NCT03715946|De-Escalated Radiation|de-escalated radiation
5045289|NCT03715946|Squamous cell carcinoma|squamous cell carcinoma
5045290|NCT03715946|P16+|p16+
5045291|NCT03715946|Head and Neck cancer|head and neck cancer
5045292|NCT03715946|Oropharynx Squamous Cell Carcinoma|oropharynx squamous cell carcinoma
5045293|NCT03715946|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
5045294|NCT03715946|Transoral surgery|transoral surgery
5045295|NCT03715946|Radiotherapy|radiotherapy
5045296|NCT03715933|Phase 1|phase 1
5045297|NCT03715933|Phase 1 Clinical Trial|phase 1 clinical trial
5045298|NCT03715933|Solid Tumors|solid tumors
5045299|NCT03715933|Sarcoma|sarcoma
5045300|NCT03715933|Pleural Mesothelioma|pleural mesothelioma
5045301|NCT03715933|Stomach Cancer|stomach cancer
5045302|NCT03715933|Colorectal Cancer|colorectal cancer
5045303|NCT03715933|Colon Cancer|colon cancer
5045304|NCT03715933|Rectal Cancer|rectal cancer
5960891|NCT04290403|Dementia|dementia
5045305|NCT03715933|DR5|dr5
5045306|NCT03715933|Gastric Adenocarcinoma|gastric adenocarcinoma
5045307|NCT03715933|Colorectal Adenocarcinoma|colorectal adenocarcinoma
5045308|NCT03715920|Quadriceps femoris|quadriceps femoris
5045309|NCT03715920|isometric form|isometric form
5045310|NCT03715920|exercise|exercise
5045311|NCT03715907|Professional Practice Gaps|professional practice gaps
5045312|NCT03715894|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5045313|NCT03715894|Pacemaker|pacemaker
5045314|NCT03715894|Aortic valve calcification|aortic valve calcification
5045327|NCT03715777|BoNTA|bonta
5045328|NCT03715777|Electromyography|electromyography
5045329|NCT03715777|EMG|emg
5045330|NCT03715777|Pelvic Pain|pelvic pain
5045331|NCT03715777|Pelvic Pain Syndrome|pelvic pain syndrome
5045332|NCT03715764|Knee osteoarthritis|knee osteoarthritis
5045333|NCT03715764|Physical Therapist|physical therapist
5045334|NCT03715764|Primary assessor|primary assessor
5045335|NCT03715764|Primary care|primary care
5045340|NCT03715751|Transpulmonary Pressure|transpulmonary pressure
5045341|NCT03715686|Neoplasm, Breast|neoplasm, breast
5045342|NCT03715686|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5045343|NCT03715686|Lymph Node Metastases|lymph node metastases
5045344|NCT03715686|response|response
5045345|NCT03715660|Non muscle invasive bladder cancer, recurrence, progression|non muscle invasive bladder cancer, recurrence, progression
5045346|NCT03715621|Acute Myeloid Leukemia|acute myeloid leukemia
5045347|NCT03715621|next generation sequencing|next generation sequencing
5045348|NCT03715621|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5045349|NCT03715595|treat-to-target|treat-to-target
5045350|NCT03715595|smart system of disease management|smart system of disease management
5045351|NCT03715595|drug use|drug use
5045352|NCT03715517|Injections, Spinal|injections, spinal
5045353|NCT03715517|Analgesia, Epidural|analgesia, epidural
5045354|NCT03715517|Anesthesia, Spinal|anesthesia, spinal
5045355|NCT03715517|Patient Reported Outcome Measures|patient reported outcome measures
5045357|NCT03715504|Tolero|tolero
5045358|NCT03715504|Solid Tumor|solid tumor
5045359|NCT03715504|Advanced Malignancy|advanced malignancy
5045360|NCT03715504|First in Human|first in human
5045361|NCT03715504|Phase 1|phase 1
5045362|NCT03715504|Cancer|cancer
5045363|NCT03715413|pulsed radiofrequency, non-cyclic mastalgia|pulsed radiofrequency, non-cyclic mastalgia
5045364|NCT03715400|Virtual Reality|virtual reality
5045365|NCT03715400|Depression|depression
5045366|NCT03715400|Stress|stress
5045367|NCT03715400|Anxiety|anxiety
5045368|NCT03715400|Treatment|treatment
5045369|NCT03715374|Platelet rich fibrin|platelet rich fibrin
5045370|NCT03715374|bone graft|bone graft
5045371|NCT03715374|non inferiority trial|non inferiority trial
5045372|NCT03715361|ECG measurement|ecg measurement
5045373|NCT03715361|AF-Stroke|af-stroke
5045374|NCT03715361|Germany|germany
5045375|NCT03715361|Electrocardiogram|electrocardiogram
5045376|NCT03715348|fresh frozen plasma|fresh frozen plasma
5045377|NCT03715348|prothrombin complex concentrate|prothrombin complex concentrate
5045378|NCT03715348|cardiac surgery|cardiac surgery
5045379|NCT03715335|Screening|screening
5045380|NCT03715335|Emergency Department|emergency department
5045381|NCT03715335|Adolescents|adolescents
5045382|NCT03715335|Sexually Transmitted Infections|sexually transmitted infections
5045383|NCT03715335|Sexually Transmitted Diseases|sexually transmitted diseases
5045384|NCT03715335|Cost Effectiveness|cost effectiveness
5045385|NCT03715335|Pragmatic Trial|pragmatic trial
5045386|NCT03715322|bronchiectasis|bronchiectasis
5045387|NCT03715322|Pseudomonas aeruginosa|pseudomonas aeruginosa
5045388|NCT03715322|tobramycin|tobramycin
5045389|NCT03715322|nebulization|nebulization
5045390|NCT03715322|bacterial load|bacterial load
5045391|NCT03715322|quality of life|quality of life
5045392|NCT03715283|MUNIX|munix
5045393|NCT03715257|Advanced extubation|advanced extubation
5045394|NCT03715205|programmed cell death 1 (PD-1, PD1 )|programmed cell death 1 (pd-1, pd1 )
5045395|NCT03715205|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5045396|NCT03715205|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5045398|NCT03715127|Depression|depression
5045399|NCT03715127|5HT-2A|5ht-2a
5045400|NCT03715127|Psilocybin|psilocybin
5045401|NCT03715127|clinical efficacy|clinical efficacy
5045402|NCT03715127|self|self
5045405|NCT03715127|proof-of-concept|proof-of-concept
5045406|NCT03715088|Irisin|irisin
5045407|NCT03715088|Obesity|obesity
5045408|NCT03715088|Resistance Training|resistance training
5045409|NCT03715088|Older Adults|older adults
5045410|NCT03715088|Younger Adults|younger adults
5045411|NCT03715088|Myokines|myokines
5045412|NCT03715075|Intra-epidermal|intra-epidermal
5045413|NCT03715075|nerve fibre density|nerve fibre density
5045414|NCT03715062|Long-term care facility|long-term care facility
5045415|NCT03715062|ISBAR|isbar
5045416|NCT03715062|Communication|communication
5045417|NCT03715062|Antibiotics|antibiotics
5045418|NCT03715062|Antibiotic stewardship|antibiotic stewardship
5045419|NCT03715049|upper lip wrinkles|upper lip wrinkles
5045420|NCT03715023|RSV infection|rsv infection
5960892|NCT04290403|Randomised Cross Over Trial|randomised cross over trial
5045421|NCT03715023|Hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
5045422|NCT03714984|Prostatectomy|prostatectomy
5045423|NCT03714984|Pelvic Floor Disorders|pelvic floor disorders
5045424|NCT03714984|Robotic Surgical Procedures|robotic surgical procedures
5045425|NCT03714984|rehabilitation|rehabilitation
5045426|NCT03714971|Whatsapp|whatsapp
5045427|NCT03714971|smoking cessation|smoking cessation
5045428|NCT03714971|cessation service|cessation service
5045429|NCT03714945|Allergic Rhinitis|allergic rhinitis
5045430|NCT03714945|Children|children
5045431|NCT03714945|Cognitive Ability|cognitive ability
5428235|NCT01595568|Substance Use Problems|substance use problems
5045432|NCT03714932|Arch analysis, Mixed dentition,Tanaka & Johnston|arch analysis, mixed dentition,tanaka & johnston
5045433|NCT03714906|head and neck cancer|head and neck cancer
5045434|NCT03714906|pain|pain
5045435|NCT03714906|analgesia|analgesia
5045436|NCT03714867|head and neck cancer|head and neck cancer
5045437|NCT03714867|analgesia|analgesia
5045438|NCT03714867|pregabalin|pregabalin
5045439|NCT03714841|C reactive protein|c reactive protein
5045440|NCT03714841|randomized controlled trial|randomized controlled trial
5045441|NCT03714841|Blood culture|blood culture
5045442|NCT03714828|Skin cancer|skin cancer
5045443|NCT03714828|Squamous cell|squamous cell
5045444|NCT03714828|Squamous Cell Carcinoma|squamous cell carcinoma
5045445|NCT03714828|Skin lesion|skin lesion
5045446|NCT03714828|Keratoacanthoma|keratoacanthoma
5045447|NCT03714828|talimogene laherparepvec|talimogene laherparepvec
5045448|NCT03714815|pulmonary vascular disease|pulmonary vascular disease
5045449|NCT03714815|macitentan|macitentan
5045450|NCT03714815|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5045451|NCT03714802|bifurcation lesion|bifurcation lesion
5045452|NCT03714802|percutaneous coronary intervention|percutaneous coronary intervention
5045453|NCT03714802|Szabo|szabo
5045454|NCT03714802|T-stenting|t-stenting
5045462|NCT03714776|Blood Pressure|blood pressure
5045463|NCT03714776|High Blood Pressure|high blood pressure
5045464|NCT03714763|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
5045465|NCT03714763|Dopamine Agonist|dopamine agonist
5045466|NCT03714763|Dopamine D2 Receptors|dopamine d2 receptors
5045467|NCT03714763|PET-MR|pet-mr
5045468|NCT03714750|bifurcation coronary lesions|bifurcation coronary lesions
5045469|NCT03714750|interventional technique of coronary lesions|interventional technique of coronary lesions
5045470|NCT03714750|Double kissing and crush|double kissing and crush
5045471|NCT03714750|DK crush|dk crush
5045472|NCT03714750|Reverse TAP|reverse tap
5045473|NCT03714750|reverse T-and-protrusion|reverse t-and-protrusion
5045474|NCT03714724|Critically ill patients|critically ill patients
5045475|NCT03714724|intraabdominal pressure|intraabdominal pressure
5045476|NCT03714724|hemodynamics|hemodynamics
5045477|NCT03714724|positive end-expiratory pressure|positive end-expiratory pressure
5045478|NCT03714711|total hip replacement|total hip replacement
5045479|NCT03714711|total knee replacement|total knee replacement
5045480|NCT03714698|Pilates exercise|pilates exercise
5045481|NCT03714672|Wisdom tooth removal|wisdom tooth removal
5045482|NCT03714672|Dental pain|dental pain
5045483|NCT03714633|cognitive development|cognitive development
5045484|NCT03714633|motor development|motor development
5045485|NCT03714633|parent-child interaction|parent-child interaction
5045486|NCT03714633|parental mental health|parental mental health
5045487|NCT03714633|strength-based intervention|strength-based intervention
5045488|NCT03714633|prematurity|prematurity
5045495|NCT03714477|Worsening hypertension|worsening hypertension
5045496|NCT03714477|Renal stone|renal stone
5045497|NCT03714464|Gastrointestinal physiology|gastrointestinal physiology
5045498|NCT03714464|Gastrointestinal response to sugars|gastrointestinal response to sugars
5045499|NCT03714464|gastrointestinal|gastrointestinal
5045500|NCT03714464|MRI|mri
5045501|NCT03714464|stomach|stomach
5045502|NCT03714464|small bowel|small bowel
5045503|NCT03714464|sorbitol|sorbitol
5045504|NCT03714464|excess fructose|excess fructose
5045505|NCT03714464|FODMAPs|fodmaps
5045506|NCT03714464|colon|colon
5045507|NCT03714438|Medicago sativa|medicago sativa
5045508|NCT03714438|Insulin secretion|insulin secretion
5045509|NCT03714438|Insulin Sensitivity|insulin sensitivity
5423348|NCT01616069|Heart Function|heart function
5045513|NCT03714399|Ultrasound (US)|ultrasound (us)
5045514|NCT03714399|Cardiac Surgery|cardiac surgery
5045515|NCT03714399|Rectus Femoris Cross Sectional Area (RFcsa)|rectus femoris cross sectional area (rfcsa)
5045516|NCT03714373|PWS|pws
5045517|NCT03714373|Prader-Willi Syndrome|prader-willi syndrome
5045518|NCT03714360|TXA;decompression; discectomy; operative time; blood loss|txa;decompression; discectomy; operative time; blood loss
5045519|NCT03714347|cerebral oxygen monitoring|cerebral oxygen monitoring
5045520|NCT03714347|intracranial surgery|intracranial surgery
5045521|NCT03714347|general anesthesia|general anesthesia
5045522|NCT03714334|Recurrent Glioblastoma|recurrent glioblastoma
5045523|NCT03714334|oncolytic virus|oncolytic virus
5045524|NCT03714334|immunotherapy|immunotherapy
5045525|NCT03714321|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
5960893|NCT04290403|continence products|continence products
5960894|NCT04290390|rifampin|rifampin
5045526|NCT03714308|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5045527|NCT03714282|Spinal cord stimulation|spinal cord stimulation
5045528|NCT03714282|electrical stimulation|electrical stimulation
5045529|NCT03714282|locomotion|locomotion
5045530|NCT03714269|children|children
5045531|NCT03714269|medial gastrocnemius muscle|medial gastrocnemius muscle
5045532|NCT03714256|Pediatric|pediatric
5045533|NCT03714230|Functional status, Symptoms, Cognitive functioning, QOL|functional status, symptoms, cognitive functioning, qol
5045534|NCT03714217|Spinal Cord Injury|spinal cord injury
5045535|NCT03714217|Obesity|obesity
5045536|NCT03714217|Telenutrition|telenutrition
5045537|NCT03714204|academic physician burnout|academic physician burnout
5045538|NCT03714204|physician burnout|physician burnout
5428236|NCT01595568|Prevention|prevention
5045539|NCT03714204|Intervention to reduce physician burnout|intervention to reduce physician burnout
5045540|NCT03714204|physician depression|physician depression
5045541|NCT03714204|physician insomnia|physician insomnia
5045542|NCT03714204|physician stress|physician stress
5045543|NCT03714204|Transcendental Meditation|transcendental meditation
5045545|NCT03714165|Alpha defensin|alpha defensin
5045546|NCT03714165|16S rRNA gene|16s rrna gene
5045564|NCT03714009|fasting|fasting
5045565|NCT03713996|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
5045566|NCT03713996|Self-Care|self-care
5045567|NCT03713996|Fatigue|fatigue
5045568|NCT03713996|Diabetes|diabetes
5045569|NCT03713996|Glycemic Control|glycemic control
5045570|NCT03713983|behavior, addictive|behavior, addictive
5045571|NCT03713983|addiction medicine|addiction medicine
5045572|NCT03713983|substance-related disorders|substance-related disorders
5045573|NCT03713983|abuse, narcotic|abuse, narcotic
5045574|NCT03713983|addiction, narcotic|addiction, narcotic
5045575|NCT03713983|analgesics, narcotic|analgesics, narcotic
5045576|NCT03713983|opioid-related disorders|opioid-related disorders
5045577|NCT03713983|benzodiazepines|benzodiazepines
5045578|NCT03713983|prescription drugs|prescription drugs
5045579|NCT03713970|cetra duo press,e.max press,clinical performance|cetra duo press,e.max press,clinical performance
5045580|NCT03713957|Brain Diseases|brain diseases
5045581|NCT03713957|Central Nervous System Diseases|central nervous system diseases
5045582|NCT03713957|Nervous System Diseases|nervous system diseases
5045583|NCT03713957|Neurodegenerative Diseases|neurodegenerative diseases
5045584|NCT03713957|Neurocognitive Disorders|neurocognitive disorders
5045585|NCT03713957|Mental Disorders|mental disorders
5045586|NCT03713957|Parkinson's Disease|parkinson's disease
5045587|NCT03713957|Dementia|dementia
5045588|NCT03713879|post ERCP panceatitis|post ercp panceatitis
5045589|NCT03713879|rectal indomethacin|rectal indomethacin
5045590|NCT03713879|pancreatic stents|pancreatic stents
5045591|NCT03713853|Total hip replacement|total hip replacement
5045592|NCT03713853|Total hip arthroplasty|total hip arthroplasty
5045593|NCT03713853|Open Reduction internal Fixation|open reduction internal fixation
5045594|NCT03713853|Hip fixation|hip fixation
5045595|NCT03713840|nutrition|nutrition
5045596|NCT03713840|child care|child care
5045597|NCT03713840|obesity|obesity
5045598|NCT03713827|glass hybrids|glass hybrids
5045599|NCT03713827|bruxism|bruxism
5045600|NCT03713827|Non carious cervical lesions|non carious cervical lesions
5045601|NCT03713814|Electromyography|electromyography
5045602|NCT03713814|Exercise therapy|exercise therapy
5045603|NCT03713814|Muscle Strength Dynamometer|muscle strength dynamometer
5045604|NCT03713814|Pilots|pilots
5045605|NCT03713814|Back Pain|back pain
5045606|NCT03713788|Stretch tolerance|stretch tolerance
5045607|NCT03713788|Range of Motion|range of motion
5045608|NCT03713762|Peribulbar block|peribulbar block
5045609|NCT03713749|Robotic esophagectomy|robotic esophagectomy
5045610|NCT03713749|Video-assisted thoracoscopic esophagectomy|video-assisted thoracoscopic esophagectomy
5045611|NCT03713749|Recurrent laryngeal nerve lymh node|recurrent laryngeal nerve lymh node
5356792|NCT01918007|Respiratory Sounds|respiratory sounds
5045612|NCT03713749|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5045613|NCT03713736|HPV infection|hpv infection
5045614|NCT03713736|Spondyloarthritis|spondyloarthritis
5045615|NCT03713736|Rhumatoid Arthritis|rhumatoid arthritis
5045616|NCT03713736|Cervical smear|cervical smear
5045617|NCT03713736|cervical cancer screening|cervical cancer screening
5045618|NCT03713710|self-sampling for HPV testing|self-sampling for hpv testing
5045619|NCT03713697|self-collection for HPV testing|self-collection for hpv testing
5045620|NCT03713671|Primary Hyperparathyroidism|primary hyperparathyroidism
5045621|NCT03713671|Spatio-Temporal Parameters of Gait|spatio-temporal parameters of gait
5045622|NCT03713671|Gait Symmetry|gait symmetry
5045623|NCT03713671|Balance|balance
5045624|NCT03713632|acne inversa|acne inversa
5045625|NCT03713632|Hidradenitis suppurativa|hidradenitis suppurativa
5045626|NCT03713632|maladie de Verneuil|maladie de verneuil
5045627|NCT03713632|inflammatory disease|inflammatory disease
5045628|NCT03713632|AIN457|ain457
5045629|NCT03713632|AIN457M|ain457m
5045636|NCT03713606|Portal hypertension|portal hypertension
5960895|NCT04290390|itraconazole|itraconazole
5960896|NCT04290390|CYP3A|cyp3a
5960897|NCT04290377|Neural plasticity|neural plasticity
5045637|NCT03713606|serum biomarker|serum biomarker
5045638|NCT03713606|diagnosis|diagnosis
5045643|NCT03713580|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
5045644|NCT03713580|Venetoclax|venetoclax
5045645|NCT03713567|Aggressive Periodontitis|aggressive periodontitis
5045646|NCT03713567|Biomarkers|biomarkers
5045647|NCT03713567|Microbiota|microbiota
5045648|NCT03713567|Dental Implants|dental implants
5045649|NCT03713554|SSD, unilateral hearing loss|ssd, unilateral hearing loss
5045650|NCT03713541|Anorexia nervosa [MeSH]|anorexia nervosa [mesh]
5045651|NCT03713541|Feeding and Eating Disorders [MeSH]|feeding and eating disorders [mesh]
5045652|NCT03713541|women|women
5045653|NCT03713541|youth|youth
5045654|NCT03713541|adolescent|adolescent
5045655|NCT03713541|duration of untreated illness (DUI)|duration of untreated illness (dui)
5045656|NCT03713541|time-to-treatment [MeSH]|time-to-treatment [mesh]
5045657|NCT03713541|facilitators|facilitators
5045663|NCT03713502|Diabetes|diabetes
5045665|NCT03713502|Enteropathy|enteropathy
5045666|NCT03713502|Inflammation|inflammation
5045667|NCT03713502|Microbial translocation|microbial translocation
5045668|NCT03713502|Endotoxin translocation|endotoxin translocation
5045669|NCT03713502|Insulin resistance|insulin resistance
5045670|NCT03713502|Visceral obesity|visceral obesity
5045671|NCT03713502|Incretin hormones|incretin hormones
5045672|NCT03713502|GLP-1|glp-1
5045673|NCT03713502|GLP-2|glp-2
5045674|NCT03713502|GIP|gip
5045675|NCT03713489|acute-on-chronic liver failure|acute-on-chronic liver failure
5045676|NCT03713489|platelet|platelet
5045677|NCT03713489|Hepatitis B|hepatitis b
5045678|NCT03713450|Radiation|radiation
5045679|NCT03713450|Contrast|contrast
5045680|NCT03713450|Endovascular|endovascular
5045681|NCT03713450|Fusion imaging guidance|fusion imaging guidance
5045682|NCT03713450|Iliac|iliac
5045683|NCT03713372|Head and Neck Cancer|head and neck cancer
5045684|NCT03713372|Epidermal growth factor receptor|epidermal growth factor receptor
5045685|NCT03713372|EGFR|egfr
5045686|NCT03713372|SCT200|sct200
5045687|NCT03713359|MRVAC vaccine, fever, rash|mrvac vaccine, fever, rash
5045688|NCT03713346|lactose intolerance, dairy intolerance|lactose intolerance, dairy intolerance
5045689|NCT03713333|digital health|digital health
5045690|NCT03713333|handheld ultrasound|handheld ultrasound
5045691|NCT03713333|smartphone ECG|smartphone ecg
5045692|NCT03713333|mobile health|mobile health
5045693|NCT03713333|point of care genomics|point of care genomics
5045694|NCT03713333|big data|big data
5045695|NCT03713333|artificial intelligence|artificial intelligence
5045696|NCT03713333|learning health system|learning health system
5045697|NCT03713320|SOLAR|solar
5045698|NCT03713320|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5045699|NCT03713320|CTCL|ctcl
5045700|NCT03713320|Mycosis Fungoides|mycosis fungoides
5045701|NCT03713320|Lymphoma|lymphoma
5045702|NCT03713320|Lymphoma, T-cell|lymphoma, t-cell
5045703|NCT03713320|Lymphoma, T-cell, cutaneous|lymphoma, t-cell, cutaneous
5045704|NCT03713320|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5045705|NCT03713320|Lymphoproliferative Disorders|lymphoproliferative disorders
5045706|NCT03713320|Lymphatic Diseases|lymphatic diseases
5045707|NCT03713320|Immunoproliferative Disorders|immunoproliferative disorders
5045708|NCT03713320|Immune System Diseases|immune system diseases
5045709|NCT03713320|Neoplasms|neoplasms
5045710|NCT03713320|MicroRNAs|micrornas
5045711|NCT03713320|Vorinostat|vorinostat
5045712|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5045713|NCT03713307|Septic shock|septic shock
5045714|NCT03713307|acute kidney injury|acute kidney injury
5045715|NCT03713307|haemodynamic monitoring|haemodynamic monitoring
5045716|NCT03713307|microcirculation|microcirculation
5045717|NCT03713294|multiple myeloma|multiple myeloma
5045718|NCT03713268|Microscope Integrated optical coherence tomography|microscope integrated optical coherence tomography
5045719|NCT03713268|MIOCT|mioct
5045731|NCT03713229|men who have sex with men|men who have sex with men
5045732|NCT03713229|HIV infection|hiv infection
5045733|NCT03713229|diagnostic performance|diagnostic performance
5045734|NCT03713203|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5045735|NCT03713203|Medical Device|medical device
5045736|NCT03713203|Paget Disease|paget disease
5045738|NCT03713151|Telemedicine, Feasibility, Exercise|telemedicine, feasibility, exercise
5045739|NCT03713138|Follicle stimulating hormone|follicle stimulating hormone
5045740|NCT03713138|Leutinizing hormone|leutinizing hormone
5045741|NCT03713138|Sex hormone binding globulin|sex hormone binding globulin
5045742|NCT03713138|Serum Prolactin|serum prolactin
5045743|NCT03713138|Flaxseed sachets|flaxseed sachets
5045744|NCT03713138|Lipid profile|lipid profile
5045745|NCT03713112|deprescribe|deprescribe
5045746|NCT03713112|multi-disciplinary|multi-disciplinary
5045747|NCT03713112|open label|open label
5045748|NCT03713112|rounds|rounds
5045749|NCT03713112|randomised controlled trial|randomised controlled trial
5045750|NCT03713099|Microwave Ablation|microwave ablation
5045751|NCT03713086|Rabies|rabies
5045752|NCT03713086|Vaccine|vaccine
5045753|NCT03713086|Safety|safety
5960898|NCT04290377|Brain Machine Interface|brain machine interface
5960899|NCT04290377|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
5045754|NCT03713086|Ractogenicity|ractogenicity
5045755|NCT03713086|Immunogenicity|immunogenicity
5045756|NCT03713060|Pregnancy|pregnancy
5045757|NCT03713060|Gastric bypass|gastric bypass
5045758|NCT03713060|Hypoglycemia|hypoglycemia
5045759|NCT03713060|Gestational weight gain|gestational weight gain
5045760|NCT03713060|Fetal growth|fetal growth
5045761|NCT03713047|Questionnaire|questionnaire
5045762|NCT03713047|Long term follow up|long term follow up
5045763|NCT03713047|Surgical Procedure|surgical procedure
5045764|NCT03713047|Groin hernia repair|groin hernia repair
5045768|NCT03713047|ADL-functions|adl-functions
5045769|NCT03713047|Psychometrics|psychometrics
5045770|NCT03713047|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
5045771|NCT03713034|HIV testing and counseling (HTC)|hiv testing and counseling (htc)
5045772|NCT03713008|Fluid Responsiveness, Anesthesia, Surgery, Stroke Volume Variation, Fluid status,|fluid responsiveness, anesthesia, surgery, stroke volume variation, fluid status,
5045773|NCT03712995|Cutler-Beard|cutler-beard
5045774|NCT03712995|tarsoconjunctival graft|tarsoconjunctival graft
5045775|NCT03712995|upper eyelid|upper eyelid
5045776|NCT03712982|Infertility|infertility
5045777|NCT03712982|Fertility|fertility
5045778|NCT03712982|Mindfulness|mindfulness
5045779|NCT03712982|Ellen Langer|ellen langer
5045780|NCT03712982|Wellbeing|wellbeing
5045781|NCT03712982|Attention to Variability|attention to variability
5045782|NCT03712956|early breast cancer|early breast cancer
5045783|NCT03712956|luminal B|luminal b
5045784|NCT03712956|adjuvant chemotherapy|adjuvant chemotherapy
5045785|NCT03712943|colon cancer|colon cancer
5045786|NCT03712943|colorectal|colorectal
5045788|NCT03712943|Mismatch Repair|mismatch repair
5045789|NCT03712917|Migraine|migraine
5045790|NCT03712917|Greater Occipital Nerve Block|greater occipital nerve block
5045791|NCT03712917|Topiramate|topiramate
5045792|NCT03712917|Flunarizine|flunarizine
5045793|NCT03712891|PACU length of stay|pacu length of stay
5045794|NCT03712891|coffee|coffee
5045795|NCT03712865|embolic stroke|embolic stroke
5045796|NCT03712865|cryptogenic|cryptogenic
5045797|NCT03712865|atrial fibrillation|atrial fibrillation
5045798|NCT03712865|long term cardiac rhythm monitoring|long term cardiac rhythm monitoring
5045799|NCT03712852|Platelet rich fibrin|platelet rich fibrin
5045800|NCT03712852|sub-epithelial connective tissue|sub-epithelial connective tissue
5045801|NCT03712852|coronally advanced flap|coronally advanced flap
5045802|NCT03712839|Activities of Daily Living (ADL)|activities of daily living (adl)
5045803|NCT03712839|Executive Deficit|executive deficit
5045815|NCT03712800|Anthroposophic Medicine|anthroposophic medicine
5045816|NCT03712800|HRV Biofeedback|hrv biofeedback
5045817|NCT03712774|quality of life|quality of life
5045818|NCT03712774|neoadjuvant|neoadjuvant
5045819|NCT03712774|definitive|definitive
5045820|NCT03712774|chemoradiation|chemoradiation
5045821|NCT03712774|esophageal cancer|esophageal cancer
5045822|NCT03712761|Dietary Protein Supplementation|dietary protein supplementation
5045823|NCT03712735|Labor analgesia|labor analgesia
5045824|NCT03712735|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5045825|NCT03712683|Unexplained Infertility, pregnancy rate,hypothyroidism|unexplained infertility, pregnancy rate,hypothyroidism
5045826|NCT03712657|ERAS|eras
5045827|NCT03712657|Pediatric surgery|pediatric surgery
5045828|NCT03712657|Emergency|emergency
5045829|NCT03712657|Both of systolic and diastolic will be measured|both of systolic and diastolic will be measured
5045830|NCT03712644|Critical limb ischemia|critical limb ischemia
5045831|NCT03712644|Coronary artery disease|coronary artery disease
5045832|NCT03712644|Fractional flow reserve-guided coronary revascularization|fractional flow reserve-guided coronary revascularization
5045833|NCT03712631|tunneling technique|tunneling technique
5039095|NCT03754127|RCT|rct
5045834|NCT03712631|collagen membrane|collagen membrane
5045835|NCT03712631|tunnel|tunnel
5045836|NCT03712631|augmentation|augmentation
5045837|NCT03712631|horizontal ridge augmentation|horizontal ridge augmentation
5045838|NCT03712631|bone graft|bone graft
5045839|NCT03712631|ridge augmentation|ridge augmentation
5045840|NCT03712631|posterior mandible|posterior mandible
5045841|NCT03712618|Platelet Transfusion Refractoriness|platelet transfusion refractoriness
5045842|NCT03712618|Continuous Platelet Transfusion|continuous platelet transfusion
5045843|NCT03712566|Liquid Biopsy|liquid biopsy
5045844|NCT03712566|Circulating Tumor DNA|circulating tumor dna
5045845|NCT03712566|Molecular Profiling|molecular profiling
5045846|NCT03712566|Immune Analysis|immune analysis
5045847|NCT03712566|Epigenetics|epigenetics
5045848|NCT03712566|Radiomics|radiomics
5045849|NCT03712553|Behavioral Economics|behavioral economics
5045850|NCT03712553|Screening|screening
5045851|NCT03712553|Outreach|outreach
5045852|NCT03712527|Active discopathy|active discopathy
5045853|NCT03712488|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
5045854|NCT03712475|Pharmacokinetic|pharmacokinetic
5045855|NCT03712462|Eating Disorder|eating disorder
5045856|NCT03712462|Binge Eating|binge eating
5045857|NCT03712462|Binge Eating Disorder|binge eating disorder
5045858|NCT03712462|Weight Loss|weight loss
5045859|NCT03712436|Palliative Care|palliative care
5045860|NCT03712436|Supportive Care|supportive care
5045861|NCT03712436|Low Income Setting|low income setting
5045862|NCT03712436|LMIC|lmic
5045863|NCT03712436|Africa|africa
5045864|NCT03712423|Nanoparticles|nanoparticles
5045865|NCT03712423|Positron-Emission Tomography|positron-emission tomography
5045866|NCT03712423|Docetaxel|docetaxel
5045868|NCT03712423|Quantification|quantification
5045869|NCT03712384|Recovery|recovery
5045870|NCT03712384|Qualitative research|qualitative research
5045871|NCT03712384|Personal narratives|personal narratives
5045877|NCT03712332|Distress tolerance|distress tolerance
5045878|NCT03712332|transdiagnostic|transdiagnostic
5045879|NCT03712319|mindfulness|mindfulness
5045880|NCT03712319|mobile application|mobile application
5045881|NCT03712319|students|students
5045882|NCT03712319|anxiety|anxiety
5045883|NCT03712319|depression|depression
5045884|NCT03712319|self-compassion|self-compassion
5045885|NCT03712319|empathy|empathy
5045886|NCT03712319|burnout|burnout
5045887|NCT03712254|acute pain, fosphenytoin|acute pain, fosphenytoin
5045888|NCT03712215|Mechanical Ventilation|mechanical ventilation
5045889|NCT03712215|Electrical Stimulation|electrical stimulation
5045890|NCT03712215|Diaphragm|diaphragm
5045891|NCT03712215|Ventilometry|ventilometry
5045892|NCT03712215|Physiotherapy|physiotherapy
5045893|NCT03712085|Functional magnetic resonance imaging（fMRI）|functional magnetic resonance imaging（fmri）
5045894|NCT03712085|Surface electromyography （sEMG）|surface electromyography （semg）
5059227|NCT03628560|Oximetry|oximetry
5045897|NCT03712085|Effects and mechanism|effects and mechanism
5045898|NCT03712059|Colorectal cancer sreening|colorectal cancer sreening
5045900|NCT03712059|Artificial intelligence|artificial intelligence
5045901|NCT03712033|Hypertension management|hypertension management
5045902|NCT03712033|Stroke|stroke
5045903|NCT03712033|Secondary Prevention|secondary prevention
5045904|NCT03712033|Modifiable stroke risk factor|modifiable stroke risk factor
5342945|NCT01981395|fenobam|fenobam
5045905|NCT03712033|Home blood pressure monitoring system|home blood pressure monitoring system
5045906|NCT03712033|Telehealth|telehealth
5045907|NCT03712033|Telus Health|telus health
5045908|NCT03712033|Telemonitoring|telemonitoring
5045909|NCT03712033|Systolic hypertension|systolic hypertension
5045910|NCT03712033|Cerebrovascular Accident|cerebrovascular accident
5045911|NCT03712033|TIA|tia
5045912|NCT03712007|Orthodontic Anchorage Procedures|orthodontic anchorage procedures
5045913|NCT03712007|Malocclusion, Angle Class III|malocclusion, angle class iii
5045914|NCT03712007|Palatal Expansion Technique.|palatal expansion technique.
5045915|NCT03712007|Cone-Beam Computed Tomography|cone-beam computed tomography
5045916|NCT03712007|Dental Models|dental models
5045917|NCT03711981|laparascopic, surgery, anesthesia|laparascopic, surgery, anesthesia
5045918|NCT03711968|Interoception|interoception
5045919|NCT03711968|Sense of movement|sense of movement
5045920|NCT03711968|Posture|posture
5045921|NCT03711968|body scheme|body scheme
5045922|NCT03711942|Root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
5045923|NCT03711916|Breast cancer|breast cancer
5045924|NCT03711916|Mastectomy|mastectomy
5045925|NCT03711916|Perfusion|perfusion
5045926|NCT03711916|Hemostasis|hemostasis
5045927|NCT03711877|alopecia|alopecia
5045928|NCT03711877|scalp cooling system|scalp cooling system
5045929|NCT03711877|cold cap|cold cap
5045930|NCT03711851|Chronic pain|chronic pain
5045931|NCT03711851|Self-help|self-help
5045932|NCT03711851|Bibliotherapy|bibliotherapy
5045933|NCT03711851|Web-based interventions|web-based interventions
5045934|NCT03711851|Acceptance and commitment therapy|acceptance and commitment therapy
5045943|NCT03711799|Autism Services|autism services
5045944|NCT03711799|Mind the Gap|mind the gap
5045945|NCT03711799|Peer Coach|peer coach
5045946|NCT03711773|joint pain|joint pain
5045947|NCT03711773|osteoarthritis|osteoarthritis
5045948|NCT03711773|hip pain|hip pain
5045949|NCT03711773|knee pain|knee pain
5045950|NCT03711773|ankle pain|ankle pain
5045951|NCT03711760|telepsychology|telepsychology
5045952|NCT03711760|spinal cord injuries|spinal cord injuries
5045953|NCT03711760|depression|depression
5045954|NCT03711760|cognitive behavioral therapy|cognitive behavioral therapy
5045955|NCT03711747|Ankle|ankle
5045956|NCT03711747|Ankle Pain|ankle pain
5045957|NCT03711747|Joint Pain|joint pain
5045958|NCT03711747|Ankle Osteoarthritis|ankle osteoarthritis
5045960|NCT03711695|ibeat|ibeat
5045961|NCT03711695|wrist watch|wrist watch
5045962|NCT03711695|digital health|digital health
5045963|NCT03711695|Arrythmia|arrythmia
5045964|NCT03711682|Type 2 diabetes mellitus|type 2 diabetes mellitus
5045965|NCT03711682|Glucose|glucose
5045966|NCT03711682|Cinnamomum verum|cinnamomum verum
5045967|NCT03711682|Cinnamomum zeylanicum|cinnamomum zeylanicum
5045968|NCT03711682|Cinnamon|cinnamon
5045969|NCT03711682|HbA1c|hba1c
5045970|NCT03711682|Blood Pressure|blood pressure
5045971|NCT03711682|Glycated Hemoglobin|glycated hemoglobin
5045972|NCT03711682|Diastolic Pressure|diastolic pressure
5045973|NCT03711682|Systolic Pressure|systolic pressure
5045974|NCT03711682|Body Mass Index|body mass index
5045975|NCT03711682|BMI|bmi
5045976|NCT03711682|Metformin|metformin
5045977|NCT03711682|Waist Circumference|waist circumference
5045978|NCT03711669|autoimmune hepatitis|autoimmune hepatitis
5045979|NCT03711669|disease flare|disease flare
5045980|NCT03711669|treatment withdrawal|treatment withdrawal
5045981|NCT03711656|Type 1 diabetes|type 1 diabetes
5045982|NCT03711656|intermittent continuous glucose monitoring|intermittent continuous glucose monitoring
5045983|NCT03711656|hypoglycemia|hypoglycemia
5045984|NCT03711656|machine learning|machine learning
5045985|NCT03711643|prostatic biopsies echo-guided|prostatic biopsies echo-guided
5045986|NCT03711643|Pain measurement|pain measurement
5045987|NCT03711643|Anxiety assessment|anxiety assessment
5045988|NCT03711617|chronic kidney disease|chronic kidney disease
5045989|NCT03711617|uremic toxin|uremic toxin
5045990|NCT03711617|prognosis|prognosis
5045991|NCT03711604|Hematological Malignancies|hematological malignancies
5045992|NCT03711604|Tenalisib|tenalisib
5045993|NCT03711604|RP6530|rp6530
5045994|NCT03711604|Compassionate Use|compassionate use
5045999|NCT03711578|Non-Hodgkin lymphoma,|non-hodgkin lymphoma,
5046000|NCT03711578|Tenalisib|tenalisib
5046001|NCT03711578|RP6530|rp6530
5046002|NCT03711565|Nasal CPAP|nasal cpap
5046003|NCT03711565|High Frequency NCPAP|high frequency ncpap
5046011|NCT03711539|Endurance Exercise|endurance exercise
5046012|NCT03711539|Coronary Artery Disease|coronary artery disease
5046013|NCT03711539|Atrial Fibrillation|atrial fibrillation
5046014|NCT03711539|Myocardial Fibrosis|myocardial fibrosis
5046015|NCT03711539|Coronary CT|coronary ct
5046016|NCT03711500|plasticity|plasticity
5046017|NCT03711487|Colorectal surgery|colorectal surgery
5046018|NCT03711487|Foeniculum|foeniculum
5046019|NCT03711487|Ileus|ileus
5046023|NCT03711409|Frozen Shoulder|frozen shoulder
5046024|NCT03711409|Manual therapy|manual therapy
5046025|NCT03711409|Soft tissue mobilization|soft tissue mobilization
5046026|NCT03711396|Advance Care Planning|advance care planning
5046027|NCT03711370|infant feeding|infant feeding
5046028|NCT03711370|feeding interactions|feeding interactions
5046029|NCT03711370|maternal feeding practices|maternal feeding practices
5046030|NCT03711370|bottle-feeding|bottle-feeding
5046031|NCT03711370|opaque bottles|opaque bottles
5046032|NCT03711344|Cognitive Behavioral Therapy|cognitive behavioral therapy
5046033|NCT03711344|Cultural Adaptation|cultural adaptation
5046034|NCT03711344|East Asian Youth|east asian youth
5046035|NCT03711331|Ventilator-associated pneumonia|ventilator-associated pneumonia
5046036|NCT03711331|Hospital-acquired pneumonia|hospital-acquired pneumonia
5046040|NCT03711331|Antibiotics stewardship|antibiotics stewardship
5046041|NCT03711292|Emergency Department|emergency department
5046043|NCT03711292|Behavioral Sciences|behavioral sciences
5046044|NCT03711279|Sarcoma|sarcoma
5046045|NCT03711279|SHR-1210|shr-1210
5046046|NCT03711279|Apatinib|apatinib
5046047|NCT03711253|acute hiv infection|acute hiv infection
5046048|NCT03711253|emergency department|emergency department
5046049|NCT03711253|antiretroviral therapy|antiretroviral therapy
5046050|NCT03711240|colorectal liver metastases|colorectal liver metastases
5046051|NCT03711240|FOLFOXIRI|folfoxiri
5046052|NCT03711240|bevacizumab|bevacizumab
5046053|NCT03711227|Serial Procalcitonin, Admitted Pneumonia, qSOFA, Sepsis|serial procalcitonin, admitted pneumonia, qsofa, sepsis
5046054|NCT03711201|Hypertensive patients|hypertensive patients
5046055|NCT03711201|Introduction of operating room|introduction of operating room
5046056|NCT03711201|Anxiety|anxiety
5046057|NCT03711201|Blood pressure|blood pressure
5046058|NCT03711175|Sub-scapularis repair|sub-scapularis repair
5046059|NCT03711149|Ambulation|ambulation
5046060|NCT03711149|Length of stay|length of stay
5046061|NCT03711149|Patient Satisfaction|patient satisfaction
5046062|NCT03711149|Activity Monitor|activity monitor
5046063|NCT03711149|Digital Health|digital health
5046064|NCT03711123|metacognitive therapy, psychotherapy|metacognitive therapy, psychotherapy
5046065|NCT03711110|Cardiotoxicity|cardiotoxicity
5046066|NCT03711110|Elderly|elderly
5046067|NCT03711110|Antineoplastic agents|antineoplastic agents
5046068|NCT03711110|Cardiovascular monitoring|cardiovascular monitoring
5046069|NCT03711110|Cardioprotection|cardioprotection
5046070|NCT03711110|Cardio-oncology|cardio-oncology
5046071|NCT03711110|Chemically-Induced Disorders|chemically-induced disorders
5046072|NCT03711110|Radiation Injuries|radiation injuries
5046073|NCT03711110|Drug-Related Side Effects and Adverse Reactions.|drug-related side effects and adverse reactions.
5046074|NCT03711110|Primary prevention|primary prevention
5046075|NCT03711110|Secondary prevention.|secondary prevention.
5046076|NCT03711110|Mortality|mortality
5046077|NCT03711084|non-nutritive sweeteners|non-nutritive sweeteners
5046078|NCT03711084|sucrose|sucrose
5046079|NCT03711084|food-cue responses|food-cue responses
5046080|NCT03711084|appetite|appetite
5046081|NCT03711084|blood glucose|blood glucose
5046082|NCT03711084|energy intake|energy intake
5046083|NCT03711071|patient-centered-communication|patient-centered-communication
5046084|NCT03711071|Primary Care|primary care
5046085|NCT03711071|over investigation|over investigation
5046086|NCT03711071|communication|communication
5046087|NCT03711071|consultation|consultation
5960900|NCT04290377|Stroke|stroke
5960901|NCT04290377|Upper extremity|upper extremity
5046088|NCT03711071|shared-decision making|shared-decision making
5046089|NCT03711071|medical education|medical education
5046090|NCT03711071|low back pain|low back pain
5046091|NCT03711058|Immunotherapy|immunotherapy
5046092|NCT03711058|Nivolumab|nivolumab
5046093|NCT03711058|Copanlisib|copanlisib
5046094|NCT03711058|Unresectable|unresectable
5046095|NCT03711058|Metastatic|metastatic
5046096|NCT03711058|PD-1|pd-1
5046127|NCT03710915|Dose escalation|dose escalation
5046128|NCT03710915|HG146|hg146
5046129|NCT03710889|BA058|ba058
5046130|NCT03710889|abaloparatide|abaloparatide
5046131|NCT03710889|TYMLOS®|tymlos®
5046132|NCT03710889|Bone metabolism|bone metabolism
5046137|NCT03710850|Diabetes|diabetes
5046138|NCT03710850|Inulin|inulin
5046139|NCT03710850|Microbiome|microbiome
5046140|NCT03710837|Education|education
5046141|NCT03710837|Healthcare professional students|healthcare professional students
5046142|NCT03710811|insulin|insulin
5046143|NCT03710811|drug naive|drug naive
5046144|NCT03710798|Diet, ketogenic|diet, ketogenic
5046145|NCT03710798|Pain|pain
5046146|NCT03710798|Quality of Life|quality of life
5046147|NCT03710798|Body Composition|body composition
5046148|NCT03710798|Body Fat Distribution|body fat distribution
5046149|NCT03710785|8 Channel Surface Electromyography|8 channel surface electromyography
5046150|NCT03710785|Forward Neck Posture Syndrome|forward neck posture syndrome
5046151|NCT03710759|Pneumonia|pneumonia
5046152|NCT03710759|Drainage|drainage
5046153|NCT03710759|Autogenic Drainage|autogenic drainage
5046154|NCT03710746|obesity|obesity
5046155|NCT03710746|overweight|overweight
5046156|NCT03710746|prevention|prevention
5046157|NCT03710746|adolescence|adolescence
5046158|NCT03710746|dissonance|dissonance
5046163|NCT03710707|LRRK2|lrrk2
5046164|NCT03710707|Parkinson's Disease|parkinson's disease
5046165|NCT03710707|Movement Disorders|movement disorders
5046166|NCT03710681|SHR-1314 Phase 1|shr-1314 phase 1
5046167|NCT03710655|QOL and pain|qol and pain
5046168|NCT03710642|Dementia|dementia
5046169|NCT03710642|Agitation|agitation
5046170|NCT03710642|PEACE-AD|peace-ad
5046171|NCT03710629|Non-small cell lung cancer, gene mutations|non-small cell lung cancer, gene mutations
5046172|NCT03710616|early-stage NSCLC, real-world evidences, patient survivals|early-stage nsclc, real-world evidences, patient survivals
5046173|NCT03710564|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5046174|NCT03710564|nAMD|namd
5046175|NCT03710564|intravitreal injection|intravitreal injection
5046176|NCT03710564|IVT|ivt
5046177|NCT03710564|anti-VEGF|anti-vegf
5046178|NCT03710564|brolucizumab|brolucizumab
5046179|NCT03710564|aflibercept|aflibercept
5046180|NCT03710564|EYLEA|eylea
5046181|NCT03710564|double-masked|double-masked
5046182|NCT03710564|MERLIN|merlin
5046183|NCT03710564|BEOVU|beovu
5046184|NCT03710538|glycemia|glycemia
5046185|NCT03710512|hydroset|hydroset
5046186|NCT03710499|Acromegaly|acromegaly
5046187|NCT03710499|Rehabilitation|rehabilitation
5046188|NCT03710499|Physiotherapy|physiotherapy
5046189|NCT03710486|Drug Therapy|drug therapy
5046190|NCT03710473|Hypertension|hypertension
5046191|NCT03710473|Non-invasive blood pressure Monitoring|non-invasive blood pressure monitoring
5046192|NCT03710473|Photoplethysmography|photoplethysmography
5046194|NCT03710460|Dapagliflozin|dapagliflozin
5046195|NCT03710460|Metformin XR|metformin xr
5046196|NCT03710460|Visceral adiposity|visceral adiposity
5046197|NCT03710447|Cardiometabolic Health|cardiometabolic health
5046198|NCT03710447|Cardiorespiratory Fitness|cardiorespiratory fitness
5046199|NCT03710447|Muscular Strength|muscular strength
5046200|NCT03710447|Body Composition|body composition
5046201|NCT03710447|Inflammation|inflammation
5046202|NCT03710447|Aerobic Exercise|aerobic exercise
5046203|NCT03710447|Resistance Exercise|resistance exercise
5046204|NCT03710434|Phase 1, healthy, bioavailability, pharmacokinetics|phase 1, healthy, bioavailability, pharmacokinetics
5046205|NCT03710408|Hypodermoclysis|hypodermoclysis
5046206|NCT03710408|Older adults|older adults
5046207|NCT03710408|Geriatric patient|geriatric patient
5046208|NCT03710408|Hydration therapy|hydration therapy
5059524|NCT03626935|3d printing|3d printing
5046213|NCT03710343|Pediatric|pediatric
5428237|NCT01595555|stress|stress
5046226|NCT03710317|carbetocin|carbetocin
5046227|NCT03710304|cesarean section|cesarean section
5046228|NCT03710304|tranexamic acid|tranexamic acid
5046229|NCT03710304|postpartum hemorrhage|postpartum hemorrhage
5046230|NCT03710304|buccal misoprostol|buccal misoprostol
5046231|NCT03710291|serum bicarbonate|serum bicarbonate
5046232|NCT03710291|renal outcomes|renal outcomes
5046233|NCT03710291|TRC101|trc101
5046234|NCT03710291|eGFR|egfr
5046235|NCT03710265|SHR-1701|shr-1701
5046236|NCT03710265|Solid tumor|solid tumor
5046239|NCT03710226|plateletcrit|plateletcrit
5046240|NCT03710226|platelet distribution width|platelet distribution width
5342946|NCT01981395|heat|heat
5046242|NCT03710161|end stage renal disease|end stage renal disease
5046243|NCT03710148|Iodine|iodine
5046244|NCT03710148|Estimated Average Requirement|estimated average requirement
5960902|NCT04290377|Function|function
5046245|NCT03710148|Recommended Nutritent Intake|recommended nutritent intake
5046246|NCT03710148|Tolerable Upper Intake Level|tolerable upper intake level
5046247|NCT03710148|Pregnant Women|pregnant women
5046248|NCT03710148|Pregnancy|pregnancy
5046249|NCT03710148|EAR|ear
5046250|NCT03710148|RNI|rni
5046251|NCT03710148|UL|ul
5046252|NCT03710109|Concussion|concussion
5046253|NCT03710109|Sports Concussion|sports concussion
5046254|NCT03710109|Sports Medicine|sports medicine
5046255|NCT03710109|Electroencephalography|electroencephalography
5046256|NCT03710109|Steady state visual evoked potential|steady state visual evoked potential
5046257|NCT03710109|Evoked Potential|evoked potential
5046258|NCT03710096|Mac Grath|mac grath
5046259|NCT03710096|Double lumen tube|double lumen tube
5046260|NCT03710083|Diabetes Type I Type II|diabetes type i type ii
5046261|NCT03710070|Collateral Flow Index|collateral flow index
5046262|NCT03710070|Permanent Internal Mammary Artery Occlusion|permanent internal mammary artery occlusion
5046263|NCT03710057|Ivabradine|ivabradine
5046264|NCT03710057|Heart Rate|heart rate
5046265|NCT03710057|Health Related Quality of Life|health related quality of life
5046266|NCT03710057|Safety|safety
5046267|NCT03710057|Chronic Heart Failure Patient|chronic heart failure patient
5046268|NCT03710044|atopic dermatitis|atopic dermatitis
5046269|NCT03710044|cyclosporine A|cyclosporine a
5046270|NCT03710044|atopic dermatitis pathophysiology|atopic dermatitis pathophysiology
5046271|NCT03710031|psychoneurological symptoms (PNS)|psychoneurological symptoms (pns)
5046272|NCT03710031|quality of life (QOL)|quality of life (qol)
5046273|NCT03710031|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5046274|NCT03710031|microbiota gut-brain axis|microbiota gut-brain axis
5046275|NCT03710031|inflammation|inflammation
5046276|NCT03710018|Breast conservative surgery, tumor bed irradiation|breast conservative surgery, tumor bed irradiation
5046281|NCT03709979|video laryngoscopy|video laryngoscopy
5046282|NCT03709979|Pediatric patient|pediatric patient
5046283|NCT03709979|Position|position
5046284|NCT03709966|Portable monitoring device|portable monitoring device
5046285|NCT03709953|apatinib|apatinib
5046286|NCT03709953|pulmonary lymphoepithelioid carcinoma|pulmonary lymphoepithelioid carcinoma
5046287|NCT03709940|longitudinal study|longitudinal study
5046288|NCT03709940|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5046289|NCT03709940|brain connectivity|brain connectivity
5046290|NCT03709940|biomarker|biomarker
5046291|NCT03709940|treatment response|treatment response
5046292|NCT03709940|methylphenidate|methylphenidate
5046293|NCT03709940|stimulant medication|stimulant medication
5046294|NCT03709914|Pediatric PK|pediatric pk
5046295|NCT03709901|Chronic Lumbar Back Pain|chronic lumbar back pain
5046296|NCT03709901|Low Back Pain|low back pain
5046297|NCT03709901|Back Pain|back pain
5046298|NCT03709901|Degenerative Disc Disease|degenerative disc disease
5046299|NCT03709901|Intervertebral Disc Degeneration|intervertebral disc degeneration
5046300|NCT03709875|Telerehabilitation|telerehabilitation
5046301|NCT03709875|Motor outcomes|motor outcomes
5046302|NCT03709875|Cognitive dysfunction|cognitive dysfunction
5046303|NCT03709849|Anovulatory Infertility|anovulatory infertility
5046304|NCT03709849|Bushen Culuan Decoction|bushen culuan decoction
5046305|NCT03709836|Coronary artery disease|coronary artery disease
5046306|NCT03709836|Coronary bifurcation lesion|coronary bifurcation lesion
5046310|NCT03709797|Spinal Cord Injury|spinal cord injury
5046311|NCT03709797|Shoulder Pain|shoulder pain
5046312|NCT03709797|Myofascial Pain Syndrome|myofascial pain syndrome
5046313|NCT03709797|Dry Needling|dry needling
5046314|NCT03709758|Acute Myeloid Leukemia|acute myeloid leukemia
5046315|NCT03709732|Quality of Life|quality of life
5046316|NCT03709732|Registries|registries
5046317|NCT03709732|Norway|norway
5046318|NCT03709732|Caregivers|caregivers
5046319|NCT03709732|Employment|employment
5046320|NCT03709706|GSK3377794|gsk3377794
5046321|NCT03709706|Pembrolizumab|pembrolizumab
5046322|NCT03709706|T Cell Receptors|t cell receptors
5046323|NCT03709706|Adoptive T-cell therapy|adoptive t-cell therapy
5046324|NCT03709706|Non-Small Cell Lung Cancer|non-small cell lung cancer
5046325|NCT03709693|sternotomy|sternotomy
5046326|NCT03709693|rigid fixation|rigid fixation
5046327|NCT03709693|sternal fixation|sternal fixation
5046328|NCT03709693|sternal plating|sternal plating
5046431|NCT03708952|Dietary factors|dietary factors
5046632|NCT03707691|Hearing|hearing
5046337|NCT03709654|zit|zit
5046338|NCT03709654|probiotic|probiotic
5046339|NCT03709641|Dry Eye Disease|dry eye disease
5046340|NCT03709641|Restyalne Defyne|restyalne defyne
5046341|NCT03709615|Social anxiety disorder|social anxiety disorder
5046342|NCT03709615|iCBT|icbt
5046343|NCT03709615|Therapeutic processes|therapeutic processes
5046344|NCT03709602|HPV|hpv
5046345|NCT03709602|adolescents|adolescents
5046346|NCT03709602|HPV Vaccine|hpv vaccine
5046347|NCT03709602|social determinants|social determinants
5046348|NCT03709589|Mortality|mortality
5046349|NCT03709589|High Dependency Unit|high dependency unit
5046350|NCT03709589|Modified Early Warning Score|modified early warning score
5046351|NCT03709511|Heart valve surgery|heart valve surgery
5046352|NCT03709511|Rehabilitation|rehabilitation
5046353|NCT03709511|Physical exercise|physical exercise
5046354|NCT03709511|Psycho-education|psycho-education
5046355|NCT03709498|Diet|diet
5046356|NCT03709498|Nutritional Status|nutritional status
5046357|NCT03709498|Acute Exacerbation|acute exacerbation
5046358|NCT03709498|Phase Angle|phase angle
5046359|NCT03709485|microbiome|microbiome
5046360|NCT03709485|prostate cancer|prostate cancer
5046361|NCT03709485|sequencing|sequencing
5046363|NCT03709446|Breast Neoplasms|breast neoplasms
5046364|NCT03709446|Breast Diseases|breast diseases
5046365|NCT03709446|Leflunomide|leflunomide
5046366|NCT03709446|Teriflunomide|teriflunomide
5046367|NCT03709446|Phosphatase and tensin homolog|phosphatase and tensin homolog
5046368|NCT03709420|Hydroxysteroid (17B) dehydrogenase|hydroxysteroid (17b) dehydrogenase
5046369|NCT03709420|HSD17B1|hsd17b1
5046370|NCT03709394|ultrasound|ultrasound
5046371|NCT03709394|peripheral venous catheter|peripheral venous catheter
5046372|NCT03709381|steroid-induced adrenal suppression|steroid-induced adrenal suppression
5046373|NCT03709381|vascular endothelial growth factor|vascular endothelial growth factor
5046374|NCT03709381|adrenocorticotropic hormone|adrenocorticotropic hormone
5046375|NCT03709381|osteopenia|osteopenia
5046376|NCT03709368|Hand washing|hand washing
5046377|NCT03709368|WASH|wash
5046378|NCT03709368|RANAS|ranas
5046379|NCT03709368|Behavior change|behavior change
5046380|NCT03709355|HIV-1|hiv-1
5046381|NCT03709329|End-effector|end-effector
5046382|NCT03709329|Robot Assisted Gait Therapy|robot assisted gait therapy
5046383|NCT03709329|Gait Pattern|gait pattern
5046384|NCT03709329|Energy Consumption|energy consumption
5046385|NCT03709329|Chronic stroke|chronic stroke
5046386|NCT03709329|Hemiplegia|hemiplegia
5046387|NCT03709303|Informed Consent|informed consent
5046388|NCT03709303|Stem Cell Transplantation|stem cell transplantation
5046389|NCT03709303|Understanding|understanding
5046390|NCT03709303|Optimism|optimism
5046391|NCT03709303|Sickle Cell Disease|sickle cell disease
5046392|NCT03709277|Specialty|specialty
5046393|NCT03709277|Pharmacist Intervention|pharmacist intervention
5046394|NCT03709264|kidney protection|kidney protection
5046395|NCT03709264|acute kidney injury|acute kidney injury
5046396|NCT03709264|cardiac surgery|cardiac surgery
5046397|NCT03709264|amino acids|amino acids
5046398|NCT03709264|mortality|mortality
5046399|NCT03709264|ICU|icu
5046400|NCT03709238|Pain|pain
5091414|NCT03427346|ESD|esd
5046401|NCT03709238|Alzheimers disease|alzheimers disease
5046402|NCT03709225|Anxiety|anxiety
5046403|NCT03709225|Music Therapy|music therapy
5046404|NCT03709225|Oncology|oncology
5046405|NCT03709225|Adolescent and Young Adults|adolescent and young adults
5046410|NCT03709147|LKB1-inactive adenocarcinoma|lkb1-inactive adenocarcinoma
5046411|NCT03709147|Cisplatin-pemetrexed|cisplatin-pemetrexed
5046412|NCT03709147|Metformin|metformin
5046413|NCT03709147|Fasting-mimicking diet (FMD)|fasting-mimicking diet (fmd)
5046414|NCT03709147|Progression-free survival|progression-free survival
5046415|NCT03709134|Circulating tumor cells|circulating tumor cells
5046416|NCT03709134|CTC|ctc
5046417|NCT03709121|reproxalap|reproxalap
5046418|NCT03709121|ADX-102|adx-102
5046419|NCT03709121|allergic conjunctivitis|allergic conjunctivitis
5046424|NCT03709095|Sprint interval training|sprint interval training
5046426|NCT03709095|Spinal Cord Injury|spinal cord injury
5046427|NCT03709082|palbociclib|palbociclib
5046428|NCT03709004|Pacifier|pacifier
5046429|NCT03708991|IVF|ivf
5046430|NCT03708991|ICSI|icsi
5046432|NCT03708952|Precursor lesions of colorectal cancer|precursor lesions of colorectal cancer
5046433|NCT03708952|Lifestyle|lifestyle
5046434|NCT03708952|Polyps|polyps
5046435|NCT03708926|degenerative disc disease|degenerative disc disease
5046436|NCT03708926|low back pain|low back pain
5046437|NCT03708926|PTH|pth
5046438|NCT03708926|abaloparatide|abaloparatide
5046439|NCT03708900|Cushing's disease (CD)|cushing's disease (cd)
5046440|NCT03708900|LCI699|lci699
5046441|NCT03708900|osilodrostat|osilodrostat
5046442|NCT03708900|Pituitary Gland|pituitary gland
5046443|NCT03708900|Adrenocorticotropic Hormone (ACTH)|adrenocorticotropic hormone (acth)
5046444|NCT03708900|Urinary Free Cortisol (UFC)|urinary free cortisol (ufc)
5046445|NCT03708900|mean Urinary Free Cortisol (mUFC)|mean urinary free cortisol (mufc)
5046446|NCT03708887|Type 2 diabetes|type 2 diabetes
5046447|NCT03708887|Obesity|obesity
5046448|NCT03708887|Omega-3 fatty acids|omega-3 fatty acids
5046449|NCT03708861|maraviroc, atazanavir/ritonavir|maraviroc, atazanavir/ritonavir
5046450|NCT03708848|Helicobacter pylori|helicobacter pylori
5046451|NCT03708848|Tailored therapy|tailored therapy
5046452|NCT03708848|Penicillin allergy|penicillin allergy
5046453|NCT03708848|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
5046454|NCT03708835|Stroke patient|stroke patient
5046455|NCT03708835|home care|home care
5046456|NCT03708835|family caregiver|family caregiver
5046457|NCT03708835|transitional care model|transitional care model
5046458|NCT03708835|caregiving competence|caregiving competence
5046459|NCT03708835|health literacy|health literacy
5046460|NCT03708835|burnout|burnout
5046461|NCT03708809|IUD, contraception, levonogestral|iud, contraception, levonogestral
5046462|NCT03708796|ED|ed
5046463|NCT03708796|ER|er
5046464|NCT03708796|qSOFA|qsofa
5046465|NCT03708796|SOFA|sofa
5046466|NCT03708796|RETTS|retts
5046467|NCT03708796|NEWS|news
5046468|NCT03708796|SIRS|sirs
5046469|NCT03708796|triage|triage
5046470|NCT03708757|Cerebral palsy|cerebral palsy
5046471|NCT03708757|Post Isometric Relaxation|post isometric relaxation
5046472|NCT03708757|Hamstring Spasticity|hamstring spasticity
5046473|NCT03708744|Healthy|healthy
5046474|NCT03708744|Volunteer|volunteer
5046475|NCT03708744|Pharmacokinetics|pharmacokinetics
5046476|NCT03708731|Sickle Cell Disease|sickle cell disease
5046477|NCT03708731|Youth|youth
5046478|NCT03708731|Hydroxyurea|hydroxyurea
5046479|NCT03708731|Non-Adherence|non-adherence
5046480|NCT03708731|Electronic Adherence Monitoring|electronic adherence monitoring
5046481|NCT03708731|AdhereTech smart bottle|adheretech smart bottle
5046482|NCT03708718|Diffuse cutaneous systemic sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
5046483|NCT03708718|Prednisolone|prednisolone
5046484|NCT03708718|Randomised Controlled Trial|randomised controlled trial
5046485|NCT03708718|Disability|disability
5046486|NCT03708718|Pain|pain
5046487|NCT03708718|Fatigue|fatigue
5046488|NCT03708692|General Anesthesia|general anesthesia
5046489|NCT03708692|Recovery|recovery
5046490|NCT03708692|Cognitive Function|cognitive function
5046491|NCT03708692|Menstrual Cycle phase|menstrual cycle phase
5046492|NCT03708640|Frailty|frailty
5046493|NCT03708640|Physical Activity|physical activity
5046494|NCT03708640|HIV|hiv
5046495|NCT03708640|Aging|aging
5046496|NCT03708640|Exercise|exercise
5046497|NCT03708640|mHealth|mhealth
5046498|NCT03708640|smartphone|smartphone
5046499|NCT03708640|activity tracker|activity tracker
5046500|NCT03708640|pedometer|pedometer
5046501|NCT03708640|text messaging|text messaging
5046502|NCT03708640|Short Message Service (SMS)|short message service (sms)
5046503|NCT03708614|Autism Spectrum Disorder|autism spectrum disorder
5046504|NCT03708614|Atypical antipsychotic medication|atypical antipsychotic medication
5046505|NCT03708614|Psychotropic medication|psychotropic medication
5046506|NCT03708614|Psychotropic-induced weight gain|psychotropic-induced weight gain
5046507|NCT03708614|Controlled energy intake with elevated protein|controlled energy intake with elevated protein
5046508|NCT03708614|Dietary intervention|dietary intervention
5046509|NCT03708614|Acceptability|acceptability
5046510|NCT03708614|Feasibility|feasibility
5046511|NCT03708588|Ticagrelor|ticagrelor
5046512|NCT03708588|Stent|stent
5046513|NCT03708549|Berberine|berberine
5046514|NCT03708549|Metformin|metformin
5046515|NCT03708549|Metabolic syndrome|metabolic syndrome
5428238|NCT01595555|relaxation|relaxation
5046523|NCT03708497|tranexamic acid|tranexamic acid
5046524|NCT03708497|postpartum hemorrhage|postpartum hemorrhage
5046525|NCT03708497|buccal misoprostol|buccal misoprostol
5046526|NCT03708484|Aerobic Interval training|aerobic interval training
5046527|NCT03708484|Ejection Fraction|ejection fraction
5046528|NCT03708484|Myocardial Infarction|myocardial infarction
5046529|NCT03708484|Resistive Interval Training|resistive interval training
5046530|NCT03708471|Atrial fibrillation|atrial fibrillation
5046531|NCT03708471|Hybrid ablation|hybrid ablation
5046532|NCT03708471|Surgical ablation|surgical ablation
5046538|NCT03708445|cytology|cytology
5046539|NCT03708445|aminoacyl-tRNA synthetases|aminoacyl-trna synthetases
5046540|NCT03708419|Insulin resistance|insulin resistance
5046541|NCT03708419|Personalized nutrition|personalized nutrition
5046542|NCT03708406|cleft palate|cleft palate
5046543|NCT03708406|Eustachian dysfunction|eustachian dysfunction
5046544|NCT03708406|Obstructive ventilation|obstructive ventilation
5046545|NCT03708354|skeletal muscle strength|skeletal muscle strength
5046546|NCT03708341|melatonin|melatonin
5046547|NCT03708341|Sleep Deprivation|sleep deprivation
5046548|NCT03708341|Intensive Care Psychosis|intensive care psychosis
5046549|NCT03708302|breast reduction surgery|breast reduction surgery
5046550|NCT03708302|serratus plane block|serratus plane block
5046551|NCT03708302|parasternal infrapectoral block|parasternal infrapectoral block
5046552|NCT03708276|Self-management|self-management
5046553|NCT03708276|Web-based program|web-based program
5046554|NCT03708263|532 nm green Laser|532 nm green laser
5046555|NCT03708263|585 nm yellow laser|585 nm yellow laser
5046557|NCT03708263|telangiectasis score|telangiectasis score
5046558|NCT03708263|skin disease|skin disease
5046559|NCT03708250|button battery|button battery
5046560|NCT03708250|intoxication|intoxication
5046561|NCT03708250|oesophageal necrosis|oesophageal necrosis
5046562|NCT03708250|Poison Control Centre|poison control centre
5046563|NCT03708250|Poisoning|poisoning
5046564|NCT03708224|Cancer|cancer
5046565|NCT03708224|Non-Virally Associated Squamous Cell Carcinoma|non-virally associated squamous cell carcinoma
5046566|NCT03708224|Head and Neck|head and neck
5046567|NCT03708211|Drug therapy|drug therapy
5046568|NCT03708172|rTMS|rtms
5046569|NCT03708172|Depression|depression
5046570|NCT03708172|Youth|youth
5046571|NCT03708172|TBS|tbs
5046572|NCT03708172|Brain Stimulation|brain stimulation
5960903|NCT04290377|Recovery|recovery
5960904|NCT04290364|Palliative care|palliative care
5046573|NCT03708172|Electrophysiology|electrophysiology
5046575|NCT03708159|tDCS|tdcs
5046576|NCT03708159|Mindfulness meditation|mindfulness meditation
5046577|NCT03708159|Home-based tDCS|home-based tdcs
5046578|NCT03708159|rTMS|rtms
5046579|NCT03708133|New formulation|new formulation
5046580|NCT03708107|galvanic current|galvanic current
5046581|NCT03708107|electrolysis|electrolysis
5046582|NCT03708107|myofascial trigger point|myofascial trigger point
5046583|NCT03708107|percutaneous microelectrolysis|percutaneous microelectrolysis
5046584|NCT03708107|dry needling|dry needling
5046585|NCT03708107|ischemic compression|ischemic compression
5046589|NCT03708068|Exclusive|exclusive
5046590|NCT03708068|Enteral Nutrition|enteral nutrition
5046591|NCT03708068|Preterm Infant|preterm infant
5046592|NCT03708042|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
5046593|NCT03708042|Definitive Chemoradiation|definitive chemoradiation
5046594|NCT03708042|Clinical complete response|clinical complete response
5046599|NCT03707977|broadly neutralizing antibodies|broadly neutralizing antibodies
5046600|NCT03707977|HIV suppression|hiv suppression
5046601|NCT03707964|Medical Education|medical education
5046602|NCT03707964|Simulation|simulation
5046603|NCT03707964|Crisis Resource Management|crisis resource management
5046604|NCT03707951|alcohol|alcohol
5046605|NCT03707951|youth|youth
5046606|NCT03707951|adolescent|adolescent
5046607|NCT03707951|pharmacotherapy|pharmacotherapy
5046608|NCT03707951|medication|medication
5046609|NCT03707951|N-acetylcysteine|n-acetylcysteine
5046610|NCT03707886|chronic pain|chronic pain
5046611|NCT03707886|shared medical appointment|shared medical appointment
5046612|NCT03707886|veterans|veterans
5046613|NCT03707873|Education|education
5046614|NCT03707847|crizotinib|crizotinib
5046615|NCT03707847|etoposide|etoposide
5046616|NCT03707847|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5046617|NCT03707847|ORR|orr
5046618|NCT03707847|OS|os
5046619|NCT03707847|PFS|pfs
5046620|NCT03707847|adverse events|adverse events
5046621|NCT03707808|solid tumors|solid tumors
5046622|NCT03707756|DFNA9|dfna9
5046648|NCT03707613|double guidewire technique|double guidewire technique
5046655|NCT03707587|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5046656|NCT03707587|Monoclonal Antibody|monoclonal antibody
5046657|NCT03707587|PD-L1 Expression|pd-l1 expression
5046658|NCT03707548|body psychotherapy|body psychotherapy
5046659|NCT03707548|smartphone-triggered interventions|smartphone-triggered interventions
5046660|NCT03707548|psychosocial impairments related to cancer|psychosocial impairments related to cancer
5046661|NCT03707548|cancer-related disturbances in bodily wellbeing|cancer-related disturbances in bodily wellbeing
5046662|NCT03707548|Body Image Scale|body image scale
5046663|NCT03707548|group psychotherapy|group psychotherapy
5046664|NCT03707548|bodily disturbances in post-treatment cancer patients|bodily disturbances in post-treatment cancer patients
5046665|NCT03707509|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5046666|NCT03707509|PD-1 Antibody|pd-1 antibody
5046667|NCT03707509|Cisplatin|cisplatin
5046668|NCT03707509|Gemcitabine|gemcitabine
5046669|NCT03707496|De Winter Syndrome|de winter syndrome
5046670|NCT03707470|exercise induced muscle damage|exercise induced muscle damage
5046671|NCT03707470|recovery|recovery
5046672|NCT03707470|rugby|rugby
5046673|NCT03707431|Adolescent|adolescent
5046674|NCT03707431|Pancreatitis|pancreatitis
5046675|NCT03707431|Pain|pain
5046676|NCT03707431|Internet Intervention|internet intervention
5046677|NCT03707431|Behavioral Intervention|behavioral intervention
5046678|NCT03707392|stoma education|stoma education
5046679|NCT03707379|Diabetes mellitus|diabetes mellitus
5046680|NCT03707379|Diabetic management|diabetic management
5046681|NCT03707379|Share care|share care
5046682|NCT03707366|Mentoring|mentoring
5046683|NCT03707366|Positive Youth Development|positive youth development
5046684|NCT03707366|Skills training|skills training
5046685|NCT03707366|Relationships|relationships
5046686|NCT03707366|Child Welfare|child welfare
5046687|NCT03707340|tamoxifen|tamoxifen
5046688|NCT03707340|Flibanserin|flibanserin
5046689|NCT03707340|hyposexual desire disorder|hyposexual desire disorder
5046690|NCT03707327|pain|pain
5046691|NCT03707327|knee|knee
5046692|NCT03707327|cryotherapy|cryotherapy
5046693|NCT03707314|NSTEMI|nstemi
5046694|NCT03707301|Cancer|cancer
5046695|NCT03707301|Sophrology|sophrology
5046696|NCT03707301|Anxiety|anxiety
5046697|NCT03707301|Hospital Anxiety and Depression scale|hospital anxiety and depression scale
5046698|NCT03707275|Clinical trial|clinical trial
5046699|NCT03707275|Patient-centered outcomes|patient-centered outcomes
5046700|NCT03707275|Treatment of heart failure|treatment of heart failure
5046701|NCT03707275|Technology in heart failure|technology in heart failure
5046702|NCT03707262|Tolerance|tolerance
5046703|NCT03707262|Kidney Transplant|kidney transplant
5046704|NCT03707236|Isotretinoin|isotretinoin
5046705|NCT03707223|career development, people with disabilities|career development, people with disabilities
5046706|NCT03707210|virtual reality|virtual reality
5046707|NCT03707210|chemotherapy|chemotherapy
5046708|NCT03707171|Type 2 diabetes mellitus|type 2 diabetes mellitus
5046709|NCT03707171|Cognitive function|cognitive function
5046710|NCT03707171|Liraglutide|liraglutide
5046711|NCT03707158|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5046712|NCT03707158|Face to face CBT|face to face cbt
5046713|NCT03707158|Online CBT|online cbt
5046714|NCT03707158|Telehealth|telehealth
5046715|NCT03707158|Anxiety|anxiety
5046716|NCT03707158|Child|child
5046717|NCT03707145|well-being|well-being
5046718|NCT03707145|exercise|exercise
5046719|NCT03707145|physical activity|physical activity
5046728|NCT03707106|virtual reality|virtual reality
5046734|NCT03707067|elite athlete|elite athlete
5046737|NCT03707041|PfSPZ Challenge|pfspz challenge
5046738|NCT03707041|chemoprotection|chemoprotection
5046739|NCT03707015|Retinal Detachment; internal limiting membrane flap; retinal paracentral breaks|retinal detachment; internal limiting membrane flap; retinal paracentral breaks
5046740|NCT03706989|EEG|eeg
5046741|NCT03706989|Cognitive reserve|cognitive reserve
5046742|NCT03706989|Neuroinflammation|neuroinflammation
5046747|NCT03706937|Care pathways|care pathways
5046748|NCT03706937|Motivational attitude|motivational attitude
5046749|NCT03706937|Motivational interviewing|motivational interviewing
5046750|NCT03706937|Nursing|nursing
5046751|NCT03706924|HIV -1|hiv -1
5046752|NCT03706924|elsulfavirine fixed-dose combination|elsulfavirine fixed-dose combination
5046753|NCT03706911|HIV-1|hiv-1
5046754|NCT03706872|pregnant women|pregnant women
5046755|NCT03706872|obesity|obesity
5046756|NCT03706872|Mobile Applications|mobile applications
5046757|NCT03706872|weight gain|weight gain
5046758|NCT03706872|physical activity|physical activity
5046759|NCT03706846|Cirrhosis|cirrhosis
5046760|NCT03706846|Upper digestive endoscopy|upper digestive endoscopy
5046761|NCT03706846|fasting|fasting
5046762|NCT03706846|esophageal cancer|esophageal cancer
5046763|NCT03706846|Superficial neoplastic lesions|superficial neoplastic lesions
5046764|NCT03706846|Esophageal mucosa|esophageal mucosa
5046765|NCT03706846|Gastric mucosa|gastric mucosa
5046766|NCT03706807|Mindfulness|mindfulness
5046767|NCT03706807|Older people|older people
5046768|NCT03706807|Quality of Life|quality of life
5046769|NCT03706807|Cognitive Function|cognitive function
5046770|NCT03706781|Phase I|phase i
5046771|NCT03706781|Local tolerability|local tolerability
5046772|NCT03706781|Systemic Availability|systemic availability
5046773|NCT03706781|Cetylpyridinium chloride 0.05%|cetylpyridinium chloride 0.05%
5046774|NCT03706781|Benzydamine hydrochloride 0.15%|benzydamine hydrochloride 0.15%
5046775|NCT03706781|Mucoadhesive polymer|mucoadhesive polymer
5046776|NCT03706781|Tantum Verde Bocca|tantum verde bocca
5046777|NCT03706755|spinal anesthesia|spinal anesthesia
5046778|NCT03706755|blood pressure|blood pressure
5046779|NCT03706755|norepinephrine|norepinephrine
5046780|NCT03706755|Cesarean Section|cesarean section
5046781|NCT03706729|Ankle injury|ankle injury
5046782|NCT03706729|Joint instability|joint instability
5046783|NCT03706729|Prevention and control|prevention and control
5046784|NCT03706729|Elite athletes|elite athletes
5046785|NCT03706729|Indoor Sports|indoor sports
5046786|NCT03706729|Ligamentous sprain|ligamentous sprain
5046787|NCT03706729|Fear of re-injury|fear of re-injury
5046788|NCT03706716|shared decision making|shared decision making
5046789|NCT03706690|NSCLC|nsclc
5046790|NCT03706690|Double-Blind|double-blind
5046791|NCT03706690|PD-L1|pd-l1
5046792|NCT03706690|MEDI4736|medi4736
5046793|NCT03706690|Durvalumab|durvalumab
5046794|NCT03706690|PFS|pfs
5046795|NCT03706690|OS|os
5046799|NCT03706638|Iron Deficiency Anemia|iron deficiency anemia
5046800|NCT03706638|Pregnancy|pregnancy
5046801|NCT03706638|Side Effects|side effects
5046802|NCT03706625|Non Hodgkin Lymphoma|non hodgkin lymphoma
5046803|NCT03706625|glioma|glioma
5046804|NCT03706625|lung cancer|lung cancer
5046805|NCT03706625|HIV|hiv
5046806|NCT03706625|transplantation|transplantation
5046807|NCT03706625|brain|brain
5046808|NCT03706586|Delivery Room|delivery room
5046809|NCT03706586|Resuscitation|resuscitation
5046810|NCT03706573|byl719,adult,breast cancer,HR+ advanced cancer, HR+ metastic cancer, resistant, refractory|byl719,adult,breast cancer,hr+ advanced cancer, hr+ metastic cancer, resistant, refractory
5046811|NCT03706560|workers|workers
5046812|NCT03706560|eye injuries|eye injuries
5046813|NCT03706560|work abilities|work abilities
5046814|NCT03706534|Breast cancer|breast cancer
5046815|NCT03706534|Breast Imaging|breast imaging
5046816|NCT03706521|SM04690|sm04690
5046817|NCT03706521|Wnt pathway inhibitor|wnt pathway inhibitor
5046818|NCT03706521|osteoarthritis|osteoarthritis
5046819|NCT03706521|Samumed|samumed
5046820|NCT03706508|Robot-assisted prostatectomy|robot-assisted prostatectomy
5046821|NCT03706508|Pentafecta|pentafecta
5046822|NCT03706508|Biochemical failure|biochemical failure
5046823|NCT03706508|Surgical margin|surgical margin
5046838|NCT03706391|ALS Reversal|als reversal
5046839|NCT03706391|PMA Reversal|pma reversal
5046842|NCT03706352|Cancer patients, Epidural analgesia, Postoperative pain, tunneling|cancer patients, epidural analgesia, postoperative pain, tunneling
5046843|NCT03706339|cesarean section|cesarean section
5046844|NCT03706339|tranexamic acid|tranexamic acid
5046845|NCT03706339|postpartum hemorrhage|postpartum hemorrhage
5046846|NCT03706326|Esophageal cancer|esophageal cancer
5046847|NCT03706326|Neoplasms, Esophageal|neoplasms, esophageal
5046848|NCT03706326|Cancer of Esophagus|cancer of esophagus
5046849|NCT03706326|Solid tumor|solid tumor
5046850|NCT03706313|Total knee replacement|total knee replacement
5046851|NCT03706287|non small cell lung cancer|non small cell lung cancer
5046852|NCT03706287|anlotinib|anlotinib
5046854|NCT03706287|T790M negative|t790m negative
5046856|NCT03706261|Amyloid|amyloid
5046857|NCT03706261|MK-6240|mk-6240
5046858|NCT03706261|Florbetaben|florbetaben
5046859|NCT03706261|Racial/Ethnic Minority|racial/ethnic minority
5046860|NCT03706261|Alzheimer's disease|alzheimer's disease
5046861|NCT03706209|moderate to severe|moderate to severe
5046862|NCT03706209|chronic|chronic
5046863|NCT03706209|plaque psoriasis|plaque psoriasis
5046864|NCT03706196|dental exposome|dental exposome
5046865|NCT03706170|Persistent Vegetative State|persistent vegetative state
5046866|NCT03706170|minimally conscious state|minimally conscious state
5046867|NCT03706170|Emotions|emotions
5046868|NCT03706170|Awareness|awareness
5046869|NCT03706170|electrodermal activity|electrodermal activity
5046870|NCT03706170|Electroencephalography|electroencephalography
5046871|NCT03706157|Conventional transarterial chemoembolization (c-TACE)|conventional transarterial chemoembolization (c-tace)
5046872|NCT03706157|Doxorubicin|doxorubicin
5046873|NCT03706157|Kinetics of distribution|kinetics of distribution
5046874|NCT03706131|multiple sclerosis|multiple sclerosis
5046875|NCT03706131|cervical region|cervical region
5046876|NCT03706131|balance|balance
5046877|NCT03706131|spasticity|spasticity
5046878|NCT03706131|mobilisation|mobilisation
5046879|NCT03706118|Multiple Sclerosis|multiple sclerosis
5046880|NCT03706118|Spinal Cord Atrophy|spinal cord atrophy
5046881|NCT03706092|iatrogenic|iatrogenic
5046882|NCT03706092|surgery ICU|surgery icu
5046883|NCT03706092|quality of life|quality of life
5046884|NCT03706092|disability|disability
5046885|NCT03706092|inappropriate medications|inappropriate medications
5046887|NCT03706040|Atopic dermatitis|atopic dermatitis
5046888|NCT03706040|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
5046889|NCT03706014|siblings|siblings
5046890|NCT03706014|family|family
5046891|NCT03706014|Latinos|latinos
5046892|NCT03706014|social emotional competencies|social emotional competencies
5046893|NCT03706014|parenting|parenting
5046894|NCT03706014|middle childhood|middle childhood
5046895|NCT03706014|late childhood|late childhood
5046896|NCT03705988|Tic disorders|tic disorders
5046897|NCT03705988|Tourette Syndrome|tourette syndrome
5046898|NCT03705988|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
5046899|NCT03705988|CES|ces
5046900|NCT03705936|Non-invasive brain stimulation|non-invasive brain stimulation
5046901|NCT03705936|Swallowing|swallowing
5046902|NCT03705936|Metaplasticity|metaplasticity
5046903|NCT03705910|proprioception|proprioception
5046904|NCT03705910|manual therapies|manual therapies
5046905|NCT03705910|pain|pain
5046906|NCT03705910|health status|health status
5046907|NCT03705910|posture|posture
5046908|NCT03705910|sleep|sleep
5046909|NCT03705910|fatigue|fatigue
5046910|NCT03705910|depression|depression
5046911|NCT03705871|Palatal Expansion Technique|palatal expansion technique
5046912|NCT03705871|Cone-Beam Computed Tomography|cone-beam computed tomography
5046913|NCT03705871|Dental Models|dental models
5046914|NCT03705858|Acute Myeloid Leukemia|acute myeloid leukemia
5046915|NCT03705858|Actinium-225|actinium-225
5046916|NCT03705858|Lintuzumab|lintuzumab
5046917|NCT03705858|Columbia|columbia
5046918|NCT03705858|Post-remission|post-remission
5046919|NCT03705858|Phase I|phase i
5046920|NCT03705832|Ginger|ginger
5046921|NCT03705832|Dietary supplement|dietary supplement
5046922|NCT03705819|[11C]-NOP46|[11c]-nop46
5046923|NCT03705793|mometasone irrigation, mometasone spray, chronic rhinosinusitis|mometasone irrigation, mometasone spray, chronic rhinosinusitis
5046924|NCT03705780|fentanyl|fentanyl
5046925|NCT03705780|OSAS screening scale|osas screening scale
5046926|NCT03705780|adenotonsillectomy|adenotonsillectomy
5047780|NCT03700333|S-1|s-1
5046931|NCT03705741|randomized controlled trial|randomized controlled trial
5046932|NCT03705728|anesthesia, general|anesthesia, general
5046933|NCT03705728|postoperative delirium|postoperative delirium
5046934|NCT03705728|postoperative nausea and vomiting|postoperative nausea and vomiting
5046936|NCT03705728|total intravenous anesthesia|total intravenous anesthesia
5046937|NCT03705728|closed-loop anesthesia|closed-loop anesthesia
5046938|NCT03705728|EEG monitoring|eeg monitoring
5046939|NCT03705728|propofol|propofol
5046940|NCT03705728|remifentanil|remifentanil
5046941|NCT03705728|sevoflurane|sevoflurane
5046942|NCT03705715|Microglial activation|microglial activation
5046943|NCT03705715|Immune activation|immune activation
5046944|NCT03705715|PET neuroimaging|pet neuroimaging
5046945|NCT03705702|Physical activity|physical activity
5046946|NCT03705702|Behavioral intervention|behavioral intervention
5046947|NCT03705702|Asthma clinical control|asthma clinical control
5046948|NCT03705676|Sensorimotor control|sensorimotor control
5960905|NCT04290312|mastiha oil, bioavailability|mastiha oil, bioavailability
5046949|NCT03705676|Event-related potentials|event-related potentials
5046955|NCT03705650|primary care|primary care
5046956|NCT03705650|limited echocardiogram|limited echocardiogram
5046963|NCT03705611|Secondary distribution|secondary distribution
5046964|NCT03705611|HIV self-testing|hiv self-testing
5046965|NCT03705611|Malawi|malawi
5046966|NCT03705572|Milk|milk
5046967|NCT03705572|Lacprodan PL20|lacprodan pl20
5046968|NCT03705572|Glycerophospholipids|glycerophospholipids
5046969|NCT03705572|Cognition|cognition
5046970|NCT03705559|marijuana|marijuana
5046971|NCT03705559|opioid|opioid
5046972|NCT03705559|opiate|opiate
5046973|NCT03705559|cannabis|cannabis
5046974|NCT03705533|telmisartan|telmisartan
5046975|NCT03705533|bioequivalence|bioequivalence
5046976|NCT03705533|Micardis|micardis
5046977|NCT03705520|PD|pd
5046978|NCT03705520|Parkinson's|parkinson's
5046979|NCT03705520|Parkinson's Disease|parkinson's disease
5046980|NCT03705520|Microbiome|microbiome
5046981|NCT03705494|Breastfeeding|breastfeeding
5046982|NCT03705494|Peer counsellor|peer counsellor
5046983|NCT03705468|Less Invasive Surfactant Administration (LISA)|less invasive surfactant administration (lisa)
5046984|NCT03705468|Sedation|sedation
5046985|NCT03705468|RDS treated by CPAP requiring surfactant|rds treated by cpap requiring surfactant
5046986|NCT03705468|Sedation during intra tracheal surfactant administration by the LISA method|sedation during intra tracheal surfactant administration by the lisa method
5046987|NCT03705468|Available intravenous line|available intravenous line
5046988|NCT03705416|GERD|gerd
5046989|NCT03705416|Bariatric surgery|bariatric surgery
5046990|NCT03705416|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
5046991|NCT03705416|Sleeve gastrectomy|sleeve gastrectomy
5046992|NCT03705416|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5046993|NCT03705390|ILB|ilb
5046994|NCT03705390|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5046995|NCT03705390|Motor Neuron Disease|motor neuron disease
5046996|NCT03705390|ALS|als
5046997|NCT03705377|child care|child care
5046998|NCT03705377|child development|child development
5046999|NCT03705377|child health|child health
5047000|NCT03705377|child nutrition|child nutrition
5047001|NCT03705377|child rearing|child rearing
5047002|NCT03705377|children|children
5047003|NCT03705377|curriculum|curriculum
5047004|NCT03705377|early childhood education|early childhood education
5047005|NCT03705377|families|families
5047006|NCT03705377|Head Start|head start
5047007|NCT03705377|parenting skills|parenting skills
5047008|NCT03705377|parents|parents
5047009|NCT03705377|school readiness|school readiness
5047010|NCT03705364|wheelchair|wheelchair
5047011|NCT03705364|non-ambulatory|non-ambulatory
5047012|NCT03705351|temozolomide|temozolomide
5047013|NCT03705351|tumor treating fields|tumor treating fields
5047014|NCT03705351|optune|optune
5047015|NCT03705351|novocure|novocure
5047016|NCT03705351|glioblastoma|glioblastoma
5047017|NCT03705351|brain tumor|brain tumor
5047018|NCT03705338|Anesthesia|anesthesia
5047019|NCT03705338|Children|children
5047020|NCT03705338|Electroencephalography|electroencephalography
5047021|NCT03705338|Propofol|propofol
5047022|NCT03705312|mitral regurgitation|mitral regurgitation
5047023|NCT03705312|transcatheter mitral valve repair|transcatheter mitral valve repair
5047024|NCT03705286|Pneumonia|pneumonia
5047025|NCT03705286|Endotracheal intubation|endotracheal intubation
5047026|NCT03705247|Dental Implants|dental implants
5047027|NCT03705234|Inclisiran|inclisiran
5047028|NCT03705234|PCSK9|pcsk9
5047029|NCT03705234|Cardiovascular|cardiovascular
5047030|NCT03705234|LDL Cholesterol|ldl cholesterol
5047031|NCT03705234|Cholesterol|cholesterol
5047032|NCT03705234|Lipid|lipid
5047033|NCT03705234|RNA interference|rna interference
5047034|NCT03705182|fluorescence|fluorescence
5047035|NCT03705182|dermal assessment|dermal assessment
5047036|NCT03705182|skin exposure|skin exposure
5047037|NCT03705169|HIV|hiv
5047038|NCT03705169|pharmacokinetics|pharmacokinetics
5047055|NCT03705104|Chronic Pain|chronic pain
5047056|NCT03705104|Self-management|self-management
5047058|NCT03705104|Appication|appication
5047060|NCT03705104|Intervention|intervention
5047073|NCT03705078|type 2 gastro-esophageal varices|type 2 gastro-esophageal varices
5047074|NCT03705078|isolated gastric varices|isolated gastric varices
5047075|NCT03705078|transjugular intra-hepatic porto systemic shunt (TIPS)|transjugular intra-hepatic porto systemic shunt (tips)
5047076|NCT03705078|portal hypertension|portal hypertension
5047077|NCT03705078|glue obliteration|glue obliteration
5047078|NCT03705078|tissue adhesive|tissue adhesive
5047079|NCT03705065|augmentation mammoplasty|augmentation mammoplasty
5047080|NCT03705052|Art therapy|art therapy
5047081|NCT03705052|surveys and questionnaires|surveys and questionnaires
5047082|NCT03705052|patient|patient
5047083|NCT03705052|caregiver|caregiver
5047084|NCT03705039|knee osteoarthritis|knee osteoarthritis
5047085|NCT03705039|ultrasonography|ultrasonography
5047086|NCT03705039|ultrasound treatment|ultrasound treatment
5342947|NCT01981395|capsaicin|capsaicin
5099982|NCT03373097|CAR T|car t
5047087|NCT03705026|postoperative nausea and vomiting|postoperative nausea and vomiting
5047088|NCT03705026|general anesthesia|general anesthesia
5047089|NCT03705026|breast surgery|breast surgery
5047090|NCT03705026|single nucleotide polymorphism|single nucleotide polymorphism
5047091|NCT03705013|Cologuard|cologuard
5047092|NCT03704987|Klinefelter|klinefelter
5047093|NCT03704987|Osteoporosis|osteoporosis
5047094|NCT03704987|dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
5047095|NCT03704974|Child Health Services|child health services
5047096|NCT03704974|Pediatric Health Service Utilization|pediatric health service utilization
5047097|NCT03704974|Incredible Years|incredible years
5047098|NCT03704948|Depression|depression
5047099|NCT03704948|Listening Visits|listening visits
5047100|NCT03704948|Nurses|nurses
5047101|NCT03704948|Hospitalized newborns|hospitalized newborns
5047102|NCT03704935|Pulmonary rehabilitation|pulmonary rehabilitation
5047103|NCT03704935|Maintenance program|maintenance program
5047104|NCT03704935|Cohort|cohort
5047105|NCT03704935|Microenvironment|microenvironment
5047106|NCT03704935|Long-term benefits|long-term benefits
5047107|NCT03704922|Transfusion|transfusion
5047108|NCT03704909|Epinephrine, Ephedrine, cesarean section, spinal anesthesia|epinephrine, ephedrine, cesarean section, spinal anesthesia
5047109|NCT03704883|Cycling|cycling
5047110|NCT03704883|Endurance|endurance
5047111|NCT03704883|Pain|pain
5047112|NCT03704883|Injury|injury
5047113|NCT03704857|Root canal Preparation|root canal preparation
5047114|NCT03704857|Postoperative symptoms|postoperative symptoms
5047115|NCT03704857|Apical repair|apical repair
5047116|NCT03704857|Oral health-related quality of life|oral health-related quality of life
5047117|NCT03704857|PDT|pdt
5047118|NCT03704857|Passive ultrassonic irrigation|passive ultrassonic irrigation
5047119|NCT03704857|Irrigating solutions|irrigating solutions
5047120|NCT03704857|Filling materials|filling materials
5047121|NCT03704857|Foraminal enlargement|foraminal enlargement
5047122|NCT03704831|Locoregional anesthesia|locoregional anesthesia
5047123|NCT03704831|IPACK block|ipack block
5047124|NCT03704831|surgical infiltration|surgical infiltration
5047125|NCT03704831|Total knee arthroplasty|total knee arthroplasty
5047126|NCT03704779|Mindfulness|mindfulness
5047132|NCT03704753|Cardiac Surgery|cardiac surgery
5047133|NCT03704753|Thoracic Surgery|thoracic surgery
5047134|NCT03704753|Nerve block|nerve block
5047135|NCT03704688|trametinib|trametinib
5047136|NCT03704688|Ponatinib|ponatinib
5047140|NCT03704662|resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
5047141|NCT03704662|borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
5047142|NCT03704662|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5047160|NCT03704584|orthopedic disorders|orthopedic disorders
5047161|NCT03704584|corticosteroids(CS)|corticosteroids(cs)
5047162|NCT03704584|Lidocaine|lidocaine
5047163|NCT03704584|Injections|injections
5047165|NCT03704571|bowel preparation|bowel preparation
5047166|NCT03704571|colonoscopy|colonoscopy
5047167|NCT03704571|predictive model|predictive model
5047168|NCT03704571|randomized controlled trial|randomized controlled trial
5047169|NCT03704532|achilles tendon rupture|achilles tendon rupture
5047170|NCT03704532|nonoperative treatment|nonoperative treatment
5047171|NCT03704532|functional rehabilitation|functional rehabilitation
5047172|NCT03704532|operative treatment|operative treatment
5047173|NCT03704532|biomechanical measurements|biomechanical measurements
5047174|NCT03704519|Healthy volunteers|healthy volunteers
5047175|NCT03704519|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5047176|NCT03704506|Reyanning mixture|reyanning mixture
5047177|NCT03704506|efficacy|efficacy
5047178|NCT03704506|safety|safety
5047179|NCT03704506|randomized|randomized
5047180|NCT03704506|double-blind|double-blind
5047181|NCT03704506|placebo-controlled|placebo-controlled
5047182|NCT03704506|multicenter|multicenter
5047183|NCT03704506|antibiotics|antibiotics
5047184|NCT03704493|Exercise testing|exercise testing
5047185|NCT03704493|coronary artery disease|coronary artery disease
5047186|NCT03704493|virtual group motivation|virtual group motivation
5047187|NCT03704480|Immunotherapy|immunotherapy
5047188|NCT03704467|Avelumab|avelumab
5047189|NCT03704467|Carboplatin|carboplatin
5047190|NCT03704467|Primary Peritoneal Cancer|primary peritoneal cancer
5047191|NCT03704467|Fallopian Tube Cancer|fallopian tube cancer
5047192|NCT03704467|Platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5047193|NCT03704467|Deoxy ribonucleic acid (DNA)-damage response inhibition|deoxy ribonucleic acid (dna)-damage response inhibition
5047194|NCT03704441|Spinal anesthesia in old age|spinal anesthesia in old age
5047195|NCT03704428|SHR1314|shr1314
5047196|NCT03704389|Geriatrics|geriatrics
5047197|NCT03704389|Clinical decision support|clinical decision support
5047198|NCT03704389|Behavioral Economics|behavioral economics
5047199|NCT03704376|Femoral Nerve Block|femoral nerve block
5047200|NCT03704376|Adductor Canal Block|adductor canal block
5047201|NCT03704363|Modic changes|modic changes
5047202|NCT03704363|biomarkers|biomarkers
5047203|NCT03704363|treatment|treatment
5047204|NCT03704363|infliximab|infliximab
5047205|NCT03704363|chronic low back pain|chronic low back pain
5047206|NCT03704324|Incidence and profile|incidence and profile
5960906|NCT04290273|erythema|erythema
5047207|NCT03704324|Risk factors|risk factors
5047208|NCT03704324|Prediction model|prediction model
5047209|NCT03704285|anesthesia|anesthesia
5047210|NCT03704285|burned|burned
5047211|NCT03704285|TIVA|tiva
5047212|NCT03704285|propofol|propofol
5047213|NCT03704233|Transbrochial cryobiopsy|transbrochial cryobiopsy
5047214|NCT03704233|Diffuse parenchymal lung diseases|diffuse parenchymal lung diseases
5047215|NCT03704233|Diagnosis|diagnosis
5047216|NCT03704220|Single anti-thrombotic therapy|single anti-thrombotic therapy
5047217|NCT03704220|Mechanical circulatory support|mechanical circulatory support
5047218|NCT03704194|falls|falls
5047219|NCT03704194|exercise program|exercise program
5047220|NCT03704194|medically underserved|medically underserved
5047221|NCT03704181|fibrosis|fibrosis
5047222|NCT03704181|Inflammation|inflammation
5047223|NCT03704129|Diaphragm Ultrasound|diaphragm ultrasound
5047224|NCT03704129|Educational Programme|educational programme
5047225|NCT03704116|chronic traumatic brain injury|chronic traumatic brain injury
5047226|NCT03704116|cognition|cognition
5047227|NCT03704116|executive function|executive function
5047228|NCT03704090|Postoperative Delirium|postoperative delirium
5047229|NCT03704090|Prevention Measure|prevention measure
5047230|NCT03704090|Non-pharmacological|non-pharmacological
5047231|NCT03704090|Subsyndromal Delirium|subsyndromal delirium
5047232|NCT03704064|Weight Loss|weight loss
5047233|NCT03704064|Weight Stigma|weight stigma
5047234|NCT03704064|Physical Activity|physical activity
5047235|NCT03704064|Cardiovascular Risk Factor|cardiovascular risk factor
5047236|NCT03704051|infant feeding|infant feeding
5047237|NCT03704051|feeding interactions|feeding interactions
5047238|NCT03704051|maternal feeding practices|maternal feeding practices
5047239|NCT03704051|breastfeeding|breastfeeding
5047240|NCT03704051|bottle-feeding|bottle-feeding
5047241|NCT03704038|PEEP|peep
5047242|NCT03704038|Electrical impedance tomography|electrical impedance tomography
5047245|NCT03704025|Heart rate variability|heart rate variability
5047246|NCT03704025|Baroreflex sensitivity|baroreflex sensitivity
5047247|NCT03704012|Premature Infant|premature infant
5047249|NCT03704012|Tactile Kinesthetic Stimulation|tactile kinesthetic stimulation
5047250|NCT03703999|flash glucose monitoring|flash glucose monitoring
5047251|NCT03703999|HbA1c|hba1c
5047252|NCT03703986|deterioration|deterioration
5047253|NCT03703986|risk factors|risk factors
5047254|NCT03703986|predictors|predictors
5047255|NCT03703973|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5047256|NCT03703973|Leukocyte Telomere Length|leukocyte telomere length
5047257|NCT03703947|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5047258|NCT03703947|Biomarkers|biomarkers
5047259|NCT03703934|Pain phenotyping|pain phenotyping
5047260|NCT03703934|Quantitative sensory testing|quantitative sensory testing
5047261|NCT03703921|Intensive interdisciplinary pain treatment|intensive interdisciplinary pain treatment
5047262|NCT03703921|fMRI|fmri
5047263|NCT03703921|fear of pain|fear of pain
5047264|NCT03703908|FSGS|fsgs
5047265|NCT03703908|Glomerulosclerosis|glomerulosclerosis
5047266|NCT03703908|Proteinuria|proteinuria
5047267|NCT03703882|Muscular Dystrophies|muscular dystrophies
5047268|NCT03703882|Musculoskeletal Diseases|musculoskeletal diseases
5047269|NCT03703882|Neuromuscular Diseases|neuromuscular diseases
5047270|NCT03703882|Duchenne muscular dystrophy|duchenne muscular dystrophy
5047272|NCT03703882|dystrophin|dystrophin
5047273|NCT03703882|dystrophy|dystrophy
5047274|NCT03703882|Duchenne|duchenne
5047275|NCT03703856|Alzheimer's Disease|alzheimer's disease
5047276|NCT03703856|Alzheimer Disease|alzheimer disease
5047277|NCT03703856|Alzheimer|alzheimer
5047279|NCT03703856|Alzheimer's|alzheimer's
5047280|NCT03703843|AUS|aus
5047281|NCT03703843|Artificial Urinary Sphincter|artificial urinary sphincter
5047282|NCT03703830|Cerebellum|cerebellum
5047283|NCT03703830|Transcranial direct current stimulation|transcranial direct current stimulation
5047284|NCT03703830|Gait ataxia|gait ataxia
5047285|NCT03703791|AR101|ar101
5729823|NCT00395135|Obesity|obesity
5047286|NCT03703791|Characterized Peanut Allergen CPNA|characterized peanut allergen cpna
5047287|NCT03703791|(Characterized Peanut Allergen) OIT|(characterized peanut allergen) oit
5047288|NCT03703791|Peanut Allergy|peanut allergy
5047289|NCT03703791|Allergy|allergy
5047290|NCT03703791|Peanut-Allergic Children|peanut-allergic children
5047291|NCT03703791|Peanut-Allergic Adolescents|peanut-allergic adolescents
5047292|NCT03703791|Desensitization|desensitization
5047293|NCT03703791|Quality of Life|quality of life
5047294|NCT03703791|OIT (oral immunotherapy)|oit (oral immunotherapy)
5054987|NCT03654313|Cardiovascular Disease|cardiovascular disease
5047295|NCT03703791|CODIT (TM) Characterized Oral Desensitization Immunotherapy (TM)|codit (tm) characterized oral desensitization immunotherapy (tm)
5047296|NCT03703778|Prostate Cancer|prostate cancer
5047297|NCT03703778|Androgen deprivation therapy|androgen deprivation therapy
5047298|NCT03703765|Volume|volume
5047299|NCT03703765|veins|veins
5047300|NCT03703765|lower limb|lower limb
5047301|NCT03703765|imaging|imaging
5047302|NCT03703739|Iron deficiency|iron deficiency
5047303|NCT03703739|iron fortified rice|iron fortified rice
5047304|NCT03703739|extruded rice|extruded rice
5047305|NCT03703726|Iron deficiency|iron deficiency
5047306|NCT03703726|iron fortified rice|iron fortified rice
5047307|NCT03703726|extruded rice|extruded rice
5047308|NCT03703700|IVF-ET|ivf-et
5047309|NCT03703700|infertility|infertility
5047310|NCT03703700|aged|aged
5047311|NCT03703700|women|women
5047312|NCT03703687|palliative care|palliative care
5047313|NCT03703687|gratitude|gratitude
5047314|NCT03703687|positive psychology|positive psychology
5047315|NCT03703661|negative pressure wound therapy|negative pressure wound therapy
5047316|NCT03703648|Dental caries|dental caries
5047317|NCT03703648|Periodontal disease|periodontal disease
5047318|NCT03703648|Head and neck cancer|head and neck cancer
5047319|NCT03703648|Radiotherapy|radiotherapy
5047320|NCT03703648|Micro-costings study|micro-costings study
5047321|NCT03703648|Dental health|dental health
5047322|NCT03703635|ICAD|icad
5047627|NCT03701542|vitrectomy|vitrectomy
5047328|NCT03703622|HBB knowledge and skills attainment and retention|hbb knowledge and skills attainment and retention
5047330|NCT03703622|Skills, knowledge, Birth attendants|skills, knowledge, birth attendants
5047331|NCT03703609|yoga|yoga
5047332|NCT03703609|rehabilitation|rehabilitation
5047333|NCT03703609|physical activity|physical activity
5047334|NCT03703609|quality of life|quality of life
5047335|NCT03703609|anxiety|anxiety
5047336|NCT03703609|depression|depression
5047337|NCT03703557|Breast|breast
5047350|NCT03703375|Angioimmunoblastic|angioimmunoblastic
5047352|NCT03703375|Lymphoma|lymphoma
5047353|NCT03703362|Resistance training|resistance training
5047354|NCT03703362|Feasibility|feasibility
5047355|NCT03703349|Coronary artery surgery|coronary artery surgery
5047356|NCT03703349|oral magnesium|oral magnesium
5047357|NCT03703349|atrial fibrillation|atrial fibrillation
5047365|NCT03703310|Nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5047367|NCT03703310|Hedgehog|hedgehog
5047368|NCT03703310|Surgically eligible basal cell carcinomas|surgically eligible basal cell carcinomas
5047369|NCT03703310|Patidegib|patidegib
5047370|NCT03703297|Small Cell Lung Cancer|small cell lung cancer
5047371|NCT03703297|SCLC|sclc
5047372|NCT03703297|LS-SCLC|ls-sclc
5047373|NCT03703297|Limited Stage|limited stage
5047374|NCT03703297|Carcinoma|carcinoma
5047375|NCT03703297|Lung Cancer|lung cancer
5047376|NCT03703284|mechanism,|mechanism,
5047377|NCT03703284|cerebral edema,|cerebral edema,
5047378|NCT03703284|large hemispheric infarction|large hemispheric infarction
5047379|NCT03703271|postmolar|postmolar
5047380|NCT03703271|Gestational Trophoblastic Neoplasia|gestational trophoblastic neoplasia
5047381|NCT03703271|hysteroscopic|hysteroscopic
5047382|NCT03703271|repeat curettage|repeat curettage
5047383|NCT03703271|methotrexate|methotrexate
5047384|NCT03703245|Plaque Accumulation|plaque accumulation
5047385|NCT03703232|prosthesis|prosthesis
5047386|NCT03703232|prosthetic|prosthetic
5047387|NCT03703232|foot|foot
5047388|NCT03703232|ankle|ankle
5047389|NCT03703232|mobility|mobility
5047390|NCT03703232|amputee|amputee
5047391|NCT03703167|Ibrutinib|ibrutinib
5047392|NCT03703167|Rituximab|rituximab
5047393|NCT03703167|Lenalidomide|lenalidomide
5047394|NCT03703167|relapsed/refractory PCNSL|relapsed/refractory pcnsl
5047395|NCT03703167|relapsed/refractory SCNSL|relapsed/refractory scnsl
5047396|NCT03703167|18-432|18-432
5047397|NCT03703154|End Stage Renal Disease|end stage renal disease
5047398|NCT03703141|sucralose|sucralose
5047399|NCT03703141|insulin|insulin
5047400|NCT03703141|AUC|auc
5047401|NCT03703141|young|young
5047402|NCT03703141|inflammatory markers|inflammatory markers
5047403|NCT03703141|intolerance|intolerance
5047404|NCT03703128|psychological autopsy|psychological autopsy
5047405|NCT03703128|prevention|prevention
5047406|NCT03703115|ICSI|icsi
5047407|NCT03703115|Polycystic ovary syndrome|polycystic ovary syndrome
5047408|NCT03703115|Infertility|infertility
5047409|NCT03703115|Fasting|fasting
5047410|NCT03703102|AD|ad
5047411|NCT03703102|eczema|eczema
5047412|NCT03703102|skin diseases|skin diseases
5047413|NCT03703102|biologics|biologics
5047414|NCT03703089|Positive Peritoneal Cytology|positive peritoneal cytology
5047415|NCT03703063|Pancreatic cancer|pancreatic cancer
5047416|NCT03703063|nal-IRI|nal-iri
5047417|NCT03703063|NAPOLI|napoli
5047418|NCT03703037|Late term pregnancy|late term pregnancy
5047419|NCT03703037|Doppler|doppler
5047420|NCT03703011|geriatrics|geriatrics
5047421|NCT03703011|discharge|discharge
5047422|NCT03703011|Accelerometers|accelerometers
5047423|NCT03702985|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
5047424|NCT03702985|amifostine|amifostine
5047425|NCT03702985|irinotecan|irinotecan
5047426|NCT03702985|capecitabine|capecitabine
5047427|NCT03702972|Burn|burn
5047428|NCT03702972|Pediatry|pediatry
5047430|NCT03702972|Depth determination|depth determination
5047431|NCT03702907|Frontotemporal Dementia|frontotemporal dementia
5047432|NCT03702907|Lewy Body Dementia|lewy body dementia
5047433|NCT03702907|Aging|aging
5047434|NCT03702907|Vascular Dementia|vascular dementia
5047435|NCT03702894|bioequivalence|bioequivalence
5047436|NCT03702894|amoxicillin|amoxicillin
5047437|NCT03702894|clavulanic acid|clavulanic acid
5047438|NCT03702894|Augmentin|augmentin
5047439|NCT03702881|Open Bite|open bite
5047440|NCT03702881|Orthodontic appliance|orthodontic appliance
5047441|NCT03702881|Cephalometry|cephalometry
5047442|NCT03702881|Dental models|dental models
5047443|NCT03702842|walking|walking
5047444|NCT03702842|locomotor training|locomotor training
5047445|NCT03702842|rehabilitation|rehabilitation
5060724|NCT03619421|supplement|supplement
5047450|NCT03702816|neuroinflammation|neuroinflammation
5047451|NCT03702803|Phytopharmaceutical|phytopharmaceutical
5047452|NCT03702803|Anxiety|anxiety
5047453|NCT03702803|Outpatients|outpatients
5047456|NCT03702764|coronary plaque eccentricity|coronary plaque eccentricity
5047457|NCT03702764|vulnerable coronary plaque|vulnerable coronary plaque
5047458|NCT03702764|coronary artery disease|coronary artery disease
5047459|NCT03702764|myocardial infarction|myocardial infarction
5428239|NCT01595555|mindfulness|mindfulness
5047460|NCT03702764|coronary computed tomography angiography|coronary computed tomography angiography
5047461|NCT03702764|major adverse cardiac events|major adverse cardiac events
5047462|NCT03702738|Host-directed therapy|host-directed therapy
5047463|NCT03702738|N-acetylcysteine|n-acetylcysteine
5047464|NCT03702738|Glutathione|glutathione
5047465|NCT03702725|Myeloma|myeloma
5047466|NCT03702725|Multiple Myeloma|multiple myeloma
5047467|NCT03702725|Refractory Multiple Myeloma|refractory multiple myeloma
5047468|NCT03702725|Ibrutinib|ibrutinib
5047469|NCT03702712|Survivorship|survivorship
5047470|NCT03702712|Fatigue|fatigue
5047471|NCT03702712|Relax|relax
5047472|NCT03702712|Cognition|cognition
5047473|NCT03702712|Exercise|exercise
5047474|NCT03702699|auricular point detection|auricular point detection
5047475|NCT03702699|knee osteoarthritis|knee osteoarthritis
5047476|NCT03702699|pain|pain
5047477|NCT03702686|breastfeeding, pre-term infant, NICU|breastfeeding, pre-term infant, nicu
5047478|NCT03702647|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5047479|NCT03702647|Ropivacaine|ropivacaine
5047480|NCT03702647|Post-procedure pain control|post-procedure pain control
5047481|NCT03702595|Hip Osteoarthritis|hip osteoarthritis
5047482|NCT03702595|Manual therapy|manual therapy
5047483|NCT03702595|physiotherapy|physiotherapy
5047484|NCT03702582|Atrial Fibrillation|atrial fibrillation
5047485|NCT03702582|Rivaroxaban|rivaroxaban
5047486|NCT03702582|Warfarin|warfarin
5047487|NCT03702582|Stroke|stroke
5047488|NCT03702582|Anticoagulation|anticoagulation
5047489|NCT03702582|Bleeding|bleeding
5047490|NCT03702569|Volume Expansion|volume expansion
5047491|NCT03702569|Intensive Care Unit|intensive care unit
5047492|NCT03702569|Left Ventricular Contractility|left ventricular contractility
5047493|NCT03702569|Speckle Tracking|speckle tracking
5047494|NCT03702569|STRAIN|strain
5047495|NCT03702517|lateral stair walking|lateral stair walking
5047496|NCT03702517|range of motion|range of motion
5047497|NCT03702517|muscle strength|muscle strength
5047498|NCT03702478|Quality of life|quality of life
5047499|NCT03702478|hernia|hernia
5047500|NCT03702478|parastomal bulging|parastomal bulging
5047501|NCT03702478|stoma|stoma
5047502|NCT03702478|cross-sectional|cross-sectional
5729824|NCT00395135|Weight loss|weight loss
5047503|NCT03702465|Type 2 Diabetes|type 2 diabetes
5047504|NCT03702465|DNA-based diet|dna-based diet
5047506|NCT03702413|Acute cerebral infarction due to large vessel occlusion|acute cerebral infarction due to large vessel occlusion
5047507|NCT03702413|Mechanical thrombectomy|mechanical thrombectomy
5047508|NCT03702413|Ischemic stroke|ischemic stroke
5047509|NCT03702400|phenylephrine|phenylephrine
5047510|NCT03702400|norepinephrine|norepinephrine
5047511|NCT03702400|cesarean delivery under spinal anesthesia|cesarean delivery under spinal anesthesia
5047512|NCT03702387|IVRA|ivra
5047513|NCT03702387|Bier Block|bier block
5047514|NCT03702387|Esmarch Bandage|esmarch bandage
5047515|NCT03702374|diabetic retinopathy|diabetic retinopathy
5047516|NCT03702374|oxidative stress|oxidative stress
5047517|NCT03702374|mitochondrial dysfunction|mitochondrial dysfunction
5047518|NCT03702374|oxidative markers|oxidative markers
5047519|NCT03702374|diabetes|diabetes
5047520|NCT03702374|antioxidant therapy|antioxidant therapy
5047521|NCT03702335|Older adults|older adults
5047522|NCT03702335|Dietary consultation|dietary consultation
5047523|NCT03702335|Mental health|mental health
5047524|NCT03702335|Sleep quality|sleep quality
5047525|NCT03702335|Dietary quality|dietary quality
5047526|NCT03702335|Cardio-metabolic health|cardio-metabolic health
5047527|NCT03702309|High Risk|high risk
5047528|NCT03702309|Liquid Biopsy|liquid biopsy
5047537|NCT03702231|Acalabrutinib|acalabrutinib
5047538|NCT03702231|Shingles|shingles
5047539|NCT03702231|Herpes|herpes
5047540|NCT03702218|Transplantation|transplantation
5047541|NCT03702218|Hepatitis C|hepatitis c
5047542|NCT03702192|heart failure|heart failure
5047543|NCT03702179|localized muscle invasive bladder cancer|localized muscle invasive bladder cancer
5047544|NCT03702179|bladder preservation|bladder preservation
5047545|NCT03702179|durvalumab|durvalumab
5047546|NCT03702179|tremelimumab|tremelimumab
5047547|NCT03702179|radiotherapy|radiotherapy
5047563|NCT03702088|Multi-parametric flow cytometry|multi-parametric flow cytometry
5047564|NCT03702088|Hevylite®|hevylite®
5047565|NCT03702075|chronic neck pain|chronic neck pain
5047566|NCT03702036|Nuclear protein in testis (NUT)|nuclear protein in testis (nut)
5047567|NCT03702036|NUT Midline Carcinoma (NMC)|nut midline carcinoma (nmc)
5047568|NCT03702010|Spinal cord stimulation|spinal cord stimulation
5047569|NCT03702010|Back surgery|back surgery
5047570|NCT03702010|Chronic pain|chronic pain
5047571|NCT03701945|microbiota|microbiota
5047572|NCT03701945|pulmonary rehabilitation|pulmonary rehabilitation
5047573|NCT03701932|Depression, Transcranial Magnetic Stimulation (TMS)|depression, transcranial magnetic stimulation (tms)
5047574|NCT03701880|Decompensated Heart Failure|decompensated heart failure
5047575|NCT03701880|Ivabradine|ivabradine
5047576|NCT03701880|ST2 Biomarker|st2 biomarker
5047577|NCT03701854|heart failure|heart failure
5047578|NCT03701854|pacemaker|pacemaker
5047579|NCT03701854|exercise test|exercise test
5047580|NCT03701854|muscle strength|muscle strength
5047581|NCT03701854|dyspnea|dyspnea
5047582|NCT03701854|fatigue|fatigue
5047583|NCT03701815|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5047584|NCT03701815|exercise|exercise
5047585|NCT03701815|BDNF|bdnf
5047586|NCT03701815|lifestyle medicine|lifestyle medicine
5047587|NCT03701802|HIV prevention|hiv prevention
5047588|NCT03701802|Tenofovir Disoproxil Fumarate (TDF)/Emtricitabine (FTC)|tenofovir disoproxil fumarate (tdf)/emtricitabine (ftc)
5047589|NCT03701802|PrEP|prep
5047590|NCT03701776|Ataxia, exercise, spinocerebellar disease, neuroimaging|ataxia, exercise, spinocerebellar disease, neuroimaging
5047602|NCT03701750|pregnancy|pregnancy
5047603|NCT03701750|LMWH|lmwh
5047604|NCT03701750|Low Molecular Weight Heparin|low molecular weight heparin
5047605|NCT03701750|Assisted Reproductive Technology|assisted reproductive technology
5047606|NCT03701750|Implantation|implantation
5047607|NCT03701724|Major Depressive Disorder|major depressive disorder
5047608|NCT03701724|Unipolar depression|unipolar depression
5047609|NCT03701724|Chronic depression|chronic depression
5047610|NCT03701724|Recurrent depression|recurrent depression
5047611|NCT03701724|Depressive disorder|depressive disorder
5047612|NCT03701724|Magnetic stimulation|magnetic stimulation
5047613|NCT03701724|Non-invasive brain stimulation|non-invasive brain stimulation
5047614|NCT03701724|1 Hertz (Hz) rTMS|1 hertz (hz) rtms
5047615|NCT03701724|Maintenance rTMS|maintenance rtms
5047616|NCT03701724|Cost-utility|cost-utility
5047617|NCT03701724|Efficiency|efficiency
5047618|NCT03701724|Medico-economic|medico-economic
5047619|NCT03701724|Antidepressants|antidepressants
5047620|NCT03701711|Lenalidomide|lenalidomide
5047621|NCT03701685|nerve flap|nerve flap
5047622|NCT03701685|sensory reconstruction|sensory reconstruction
5047623|NCT03701685|nerve repair|nerve repair
5047624|NCT03701568|myopathy, muscle weakness, hypotonia, dysphagia, ptosis|myopathy, muscle weakness, hypotonia, dysphagia, ptosis
5047625|NCT03701542|macular hole|macular hole
5047626|NCT03701542|microperymetry|microperymetry
5047637|NCT03701464|Cholecystitis|cholecystitis
5047638|NCT03701451|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5047639|NCT03701451|Decitabine|decitabine
5047640|NCT03701451|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5047641|NCT03701451|Induced chemotherapy|induced chemotherapy
5047642|NCT03701399|Ataxia, SCA, Spinocerebellar Ataxia|ataxia, sca, spinocerebellar ataxia
5047643|NCT03701386|cesarean section|cesarean section
5047644|NCT03701386|placenta accreta spectrum|placenta accreta spectrum
5047645|NCT03701386|N&H sandwich technique|n&h sandwich technique
5047653|NCT03701347|Learning effectiveness|learning effectiveness
5047660|NCT03701269|Fracture|fracture
5047661|NCT03701256|TAP block|tap block
5047662|NCT03701256|curare|curare
5047663|NCT03701256|laparoscopy|laparoscopy
5047664|NCT03701256|gynecology surgery|gynecology surgery
5047665|NCT03701256|abdominal compliance|abdominal compliance
5047666|NCT03701230|low temperature|low temperature
5047667|NCT03701230|rota-flush solution|rota-flush solution
5047668|NCT03701230|RA-related myocardial injury|ra-related myocardial injury
5047669|NCT03701230|severe calcified lesion|severe calcified lesion
5047670|NCT03701191|gingival recession, periosteum, autogenous graft|gingival recession, periosteum, autogenous graft
5047671|NCT03701139|phacoemulsification|phacoemulsification
5047672|NCT03701139|cataract|cataract
5047673|NCT03701139|primary posterior capsule opacification|primary posterior capsule opacification
5047674|NCT03701139|posterior capsulotomy|posterior capsulotomy
5047675|NCT03701139|randomized controlled trial|randomized controlled trial
5047676|NCT03701139|Nd:YAG laser capsulotomy|nd:yag laser capsulotomy
5047677|NCT03701113|Osteoporosis|osteoporosis
5047678|NCT03701113|Postmenopausal|postmenopausal
5047679|NCT03701113|Bone Turnover Markers|bone turnover markers
5047680|NCT03701113|Dairy Products|dairy products
5047681|NCT03701074|patent ductus arteriosus|patent ductus arteriosus
5047682|NCT03701074|acetaminophen|acetaminophen
5047683|NCT03701074|ibuprofen|ibuprofen
5047684|NCT03701074|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5047685|NCT03701074|mechanical ventilation|mechanical ventilation
5047686|NCT03701061|immune response|immune response
5047687|NCT03701009|ERCP|ercp
5960907|NCT04290273|photobiology|photobiology
5960908|NCT04290273|photomedicine|photomedicine
5960909|NCT04290273|phototherapy|phototherapy
5047688|NCT03701009|Common bile duct stone|common bile duct stone
5047689|NCT03701009|Cholangitis|cholangitis
5047690|NCT03701009|Residual stone|residual stone
5047691|NCT03701009|Irrigation|irrigation
5047693|NCT03700944|Allergic Rhinitis|allergic rhinitis
5047695|NCT03700944|Cytokines|cytokines
5047696|NCT03700944|Rhinitis symptoms|rhinitis symptoms
5047697|NCT03700931|Episodic memory|episodic memory
5047698|NCT03700931|Eating episodes|eating episodes
5047699|NCT03700931|Fruit and vegetable intake|fruit and vegetable intake
5047700|NCT03700892|e-cig|e-cig
5047701|NCT03700892|E-cigarette|e-cigarette
5047702|NCT03700892|Electronic cigarette|electronic cigarette
5047703|NCT03700892|Vaping|vaping
5047704|NCT03700866|luxation injury|luxation injury
5047705|NCT03700866|splinting time|splinting time
5047706|NCT03700866|crown-root fracture|crown-root fracture
5047707|NCT03700866|surgical extrusion|surgical extrusion
5047708|NCT03700840|Oral biofilm|oral biofilm
5047709|NCT03700840|Microbiota|microbiota
5047710|NCT03700840|Adolescent|adolescent
5047711|NCT03700840|Dental carie|dental carie
5047720|NCT03700801|Weight control|weight control
5047721|NCT03700801|Safety|safety
5047722|NCT03700775|Hypertension|hypertension
5047723|NCT03700775|Telemedicine|telemedicine
5047724|NCT03700762|Thyroid Nodule|thyroid nodule
5047725|NCT03700762|differential diagnosis|differential diagnosis
5047747|NCT03700567|low temperature|low temperature
5047748|NCT03700567|contrast|contrast
5047749|NCT03700567|PCI-related myocardial injury|pci-related myocardial injury
5047754|NCT03700541|Perioperative analgesia|perioperative analgesia
5047755|NCT03700541|Colorectal Cancer|colorectal cancer
5047756|NCT03700541|Circulating Tumor Cell|circulating tumor cell
5047758|NCT03700502|resting state functional MRI|resting state functional mri
5047759|NCT03700502|painful diabetic neuropathy|painful diabetic neuropathy
5047760|NCT03700450|Without detection of deletion 17p or translocation 4;14;|without detection of deletion 17p or translocation 4;14;
5047761|NCT03700450|Post Cyclophosphamide|post cyclophosphamide
5047762|NCT03700450|GvHD Prophylaxis|gvhd prophylaxis
5047763|NCT03700450|Allogeneic SCT|allogeneic sct
5047764|NCT03700437|fasting|fasting
5047765|NCT03700437|diet|diet
5047766|NCT03700437|chemo-immunotherapy|chemo-immunotherapy
5047767|NCT03700437|lung cancer|lung cancer
5047768|NCT03700437|circulating tumor cells|circulating tumor cells
5047773|NCT03700411|Perioperative analgesia|perioperative analgesia
5047779|NCT03700333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5047781|NCT03700333|Pemetrexed|pemetrexed
5047782|NCT03700333|maintenance therapy|maintenance therapy
5047783|NCT03700268|Deafness|deafness
5047784|NCT03700268|cochlear implant|cochlear implant
5047785|NCT03700268|Artificial Intelligence|artificial intelligence
5047786|NCT03700216|limb Fracture|limb fracture
5047787|NCT03700216|limb blood circulation|limb blood circulation
5047788|NCT03700216|early-warning model|early-warning model
5047789|NCT03700216|Children|children
5047790|NCT03700203|Cardiac Arrest|cardiac arrest
5047791|NCT03700190|autism|autism
5047792|NCT03700190|activity and participation|activity and participation
5047793|NCT03700190|sensory perception|sensory perception
5047794|NCT03700190|facial expression|facial expression
5047795|NCT03700190|developmental functions|developmental functions
5047796|NCT03700190|predictors|predictors
5047797|NCT03700190|follow-up study|follow-up study
5047798|NCT03700164|Cold Exposure|cold exposure
5047799|NCT03700164|Glucose Tolerance|glucose tolerance
5047800|NCT03700125|Advanced life support (ALS)|advanced life support (als)
5047801|NCT03700125|Extra-corporeal Membrane Oxygenation Resuscitation (ECMO)|extra-corporeal membrane oxygenation resuscitation (ecmo)
5047802|NCT03700112|Electronic Nicotine Delivery System|electronic nicotine delivery system
5047803|NCT03700112|Combustible Cigarettes|combustible cigarettes
5047804|NCT03700112|Nicotine|nicotine
5047805|NCT03700086|negative pressure wound therapy|negative pressure wound therapy
5047806|NCT03700086|wound infection|wound infection
5047807|NCT03700086|pancreaticoduodenectomy|pancreaticoduodenectomy
5047808|NCT03700086|total pancreatectomy|total pancreatectomy
5047809|NCT03700086|surgical palliation of pancreatic cancer|surgical palliation of pancreatic cancer
5047810|NCT03700073|physiological cost index|physiological cost index
5047811|NCT03700073|health-related quality of life|health-related quality of life
5047812|NCT03700073|gait deviation index|gait deviation index
5047813|NCT03700073|gait analysis|gait analysis
5047814|NCT03700073|cerebral palsy|cerebral palsy
5047815|NCT03700034|Antenatal care|antenatal care
5054988|NCT03654313|CAD|cad
5047816|NCT03700034|Pregnancy care|pregnancy care
5047817|NCT03700034|Pregnancy complications|pregnancy complications
5047818|NCT03700034|Pregnancy Induced Hypertension|pregnancy induced hypertension
5047819|NCT03700034|Gestational Diabetes Mellitus|gestational diabetes mellitus
5047820|NCT03700034|Anemia|anemia
5047821|NCT03700008|Mental Disorder|mental disorder
5047822|NCT03700008|Treatment planning|treatment planning
5047835|NCT03699930|transcranial direct current stimulation|transcranial direct current stimulation
5047837|NCT03699917|gastric emptying|gastric emptying
5047838|NCT03699917|pancreatic leak|pancreatic leak
5047839|NCT03699917|pancreaticoduodenectomy|pancreaticoduodenectomy
5047840|NCT03699917|stroke volume variation|stroke volume variation
5047841|NCT03699904|COPD|copd
5047843|NCT03699865|low nicotine|low nicotine
5047844|NCT03699865|smoking behaviors|smoking behaviors
5047845|NCT03699865|risk perceptions|risk perceptions
5047846|NCT03699839|Vaccination|vaccination
5047847|NCT03699839|Adjuvanted vaccine|adjuvanted vaccine
5047848|NCT03699839|High-dose vaccine|high-dose vaccine
5047849|NCT03699826|transcranial magnetic stimulation|transcranial magnetic stimulation
5047851|NCT03699813|ROTEM, PT, aPTT|rotem, pt, aptt
5047852|NCT03699800|Graphomotor intervention program|graphomotor intervention program
5047853|NCT03699800|Second grade children|second grade children
5047854|NCT03699800|Prevention and early identification|prevention and early identification
5047855|NCT03699800|Process and product of handwriting|process and product of handwriting
5047856|NCT03699800|Quality and speed of handwriting|quality and speed of handwriting
5047857|NCT03699787|Graphomotor intervention program|graphomotor intervention program
5047858|NCT03699787|Preschool children|preschool children
5047859|NCT03699787|Graphomotor competences|graphomotor competences
5047860|NCT03699787|Prevention|prevention
5047861|NCT03699761|Anastomotic leakage|anastomotic leakage
5047862|NCT03699761|Sexual Dysfunction|sexual dysfunction
5047863|NCT03699761|low anterior resection syndrome|low anterior resection syndrome
5047864|NCT03699761|Pelvic Peritonization|pelvic peritonization
5047865|NCT03699748|cancer|cancer
5047866|NCT03699748|end of life|end of life
5047867|NCT03699748|patient-centered|patient-centered
5047868|NCT03699722|women|women
5047870|NCT03699722|PrEP|prep
5047871|NCT03699722|intervention|intervention
5047874|NCT03699696|acute kidney injury|acute kidney injury
5047875|NCT03699696|hypotension|hypotension
5047879|NCT03699670|Resuscitation|resuscitation
5047880|NCT03699670|Wounds and Injuries|wounds and injuries
5047881|NCT03699670|Ultrasonography|ultrasonography
5047882|NCT03699670|Radiography|radiography
5047883|NCT03699670|Diagnostic Imaging|diagnostic imaging
5047884|NCT03699657|RFA|rfa
5047885|NCT03699644|FTD|ftd
5047886|NCT03699644|Dementia|dementia
5047887|NCT03699644|Retina|retina
5047890|NCT03699605|Stroke|stroke
5047891|NCT03699605|Aphasia|aphasia
5047892|NCT03699605|Broca Aphasia|broca aphasia
5047893|NCT03699605|communication skills|communication skills
5047894|NCT03699605|Verbal expressive skill management programme|verbal expressive skill management programme
5047895|NCT03699579|advanced or metastatic renal cell carcinoma (RCC)|advanced or metastatic renal cell carcinoma (rcc)
5047896|NCT03699566|Trunk muscle endurance|trunk muscle endurance
5047897|NCT03699566|respiratory muscle strength|respiratory muscle strength
5047898|NCT03699566|respiratory functions|respiratory functions
5047899|NCT03699553|online intervention|online intervention
5047900|NCT03699553|chronic pain|chronic pain
5047901|NCT03699553|positive emotion|positive emotion
5047902|NCT03699553|affective science|affective science
5047903|NCT03699540|simulated driving, outpatient|simulated driving, outpatient
5047904|NCT03699527|medical cannabis|medical cannabis
5047905|NCT03699514|Brain Network Activation (BNA™)|brain network activation (bna™)
5047906|NCT03699514|EEG|eeg
5047907|NCT03699514|Cognitive Tasks|cognitive tasks
5047908|NCT03699488|technology|technology
5047909|NCT03699488|messaging psychotherapy|messaging psychotherapy
5047910|NCT03699488|depression|depression
5047911|NCT03699488|anxiety|anxiety
5047912|NCT03699488|telehealth|telehealth
5047913|NCT03699462|Endothelial Glycocalyx (EG)|endothelial glycocalyx (eg)
5047914|NCT03699462|5% albumin|5% albumin
5047915|NCT03699462|off-pump coronary artery bypass surgery (OPCAB)|off-pump coronary artery bypass surgery (opcab)
5047916|NCT03699436|Vascular alterations|vascular alterations
5047917|NCT03699436|Galvanic current|galvanic current
5047918|NCT03699436|Pain|pain
5047919|NCT03699436|Peripheral blow flow|peripheral blow flow
5047920|NCT03699436|Temperature|temperature
5047921|NCT03699436|Upper limb functionality|upper limb functionality
5047931|NCT03699384|Avelumab|avelumab
5047932|NCT03699384|18-012|18-012
5047933|NCT03699371|early parenteral nutrition|early parenteral nutrition
5047934|NCT03699371|supplemental nutrition|supplemental nutrition
5047935|NCT03699371|quality of life|quality of life
5047936|NCT03699371|oncological surgery|oncological surgery
5047937|NCT03699371|critical care|critical care
5047938|NCT03699358|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5047939|NCT03699358|respiratory function test|respiratory function test
5047940|NCT03699358|respiratory muscles|respiratory muscles
5047941|NCT03699358|muscle strength|muscle strength
5047942|NCT03699358|exercise|exercise
5047943|NCT03699358|walk test|walk test
5047944|NCT03699358|quality of life|quality of life
5047945|NCT03699345|CENTERA|centera
5047946|NCT03699345|THV|thv
5047947|NCT03699345|Transcatheter Heart Valve|transcatheter heart valve
5047948|NCT03699332|image guided surgery|image guided surgery
5047949|NCT03699332|CRS|crs
5047950|NCT03699332|HIPEC|hipec
5047951|NCT03699332|Fluorescence|fluorescence
5047952|NCT03699332|Antibodies, monoclonal|antibodies, monoclonal
5047953|NCT03699319|FOLFIRINOX|folfirinox
5047954|NCT03699319|CPI-613|cpi-613
5960910|NCT04290260|Cardiovascular nursing|cardiovascular nursing
5047955|NCT03699280|virtual reality, hysteroscopy, acute pain, distraction technique|virtual reality, hysteroscopy, acute pain, distraction technique
5047956|NCT03699254|Lung transplantation|lung transplantation
5047957|NCT03699254|Cytomegalovirus infection|cytomegalovirus infection
5047958|NCT03699254|Specific immunity|specific immunity
5428240|NCT01595555|web-based|web-based
5047959|NCT03699228|Bone mineral density, quantitative computed tomography, Osteoporosis, obesity, liver steatosis|bone mineral density, quantitative computed tomography, osteoporosis, obesity, liver steatosis
5047962|NCT03699189|education programme|education programme
5047963|NCT03699189|quality of life|quality of life
5047964|NCT03699189|dietary freedom|dietary freedom
5047965|NCT03699189|patient empowerment|patient empowerment
5047966|NCT03699163|Volatile organic compounds|volatile organic compounds
5047967|NCT03699163|Mass spectrometry|mass spectrometry
5047968|NCT03699163|Early detection|early detection
5047969|NCT03699137|Acute coronary syndrome|acute coronary syndrome
5047970|NCT03699137|Emergency Medical Services|emergency medical services
5047971|NCT03699137|Electrocardiogram|electrocardiogram
5047972|NCT03699137|Outcomes|outcomes
5047973|NCT03699098|hypothyroidism|hypothyroidism
5047974|NCT03699098|radiotherapy|radiotherapy
5047975|NCT03699098|head and neck cancer|head and neck cancer
5047979|NCT03699059|Kidney transplant|kidney transplant
5047980|NCT03699059|Weight gain|weight gain
5047981|NCT03699059|Physical activity|physical activity
5047982|NCT03699059|Weight management|weight management
5047983|NCT03699046|Bone Marrow Lesion|bone marrow lesion
5048002|NCT03699020|Older Adults|older adults
5048003|NCT03698981|HIV|hiv
5048004|NCT03698981|Stigma|stigma
5048005|NCT03698968|surgical complication|surgical complication
5048006|NCT03698968|NPWT|npwt
5048007|NCT03698968|negative pressure|negative pressure
5048008|NCT03698968|knee arthroplasty|knee arthroplasty
5048009|NCT03698968|abdominal incision|abdominal incision
5048010|NCT03698968|skin graft|skin graft
5048011|NCT03698968|infection|infection
5048012|NCT03698968|dehisced|dehisced
5048020|NCT03698942|Breast Screening|breast screening
5048021|NCT03698942|Breast Imaging|breast imaging
5048022|NCT03698942|SoftVue|softvue
5048023|NCT03698942|Mammography|mammography
5048024|NCT03698942|Ultrasound|ultrasound
5048025|NCT03698942|Reader Study|reader study
5048026|NCT03698942|ROC AUC|roc auc
5048027|NCT03698942|Breast Cancer Detection|breast cancer detection
5048028|NCT03698942|Dense Breasts|dense breasts
5048029|NCT03698942|Breast Density|breast density
5048030|NCT03698942|Dense Breast Tissue|dense breast tissue
5048031|NCT03698942|Dense Breast Parenchyma|dense breast parenchyma
5048032|NCT03698929|dietary cholesterol|dietary cholesterol
5048034|NCT03698929|nutrition|nutrition
5048035|NCT03698929|egg yolks|egg yolks
5048036|NCT03698929|eggs|eggs
5048037|NCT03698903|Intervention|intervention
5048038|NCT03698903|Sedentary Behavior|sedentary behavior
5048039|NCT03698903|Overweight or obese adults|overweight or obese adults
5048040|NCT03698890|Hypertension|hypertension
5048041|NCT03698890|Telehealth|telehealth
5048042|NCT03698890|Primary care|primary care
5048043|NCT03698890|Teamlet|teamlet
5048044|NCT03698851|Peri-Implantitis lesion|peri-implantitis lesion
5048045|NCT03698851|Dental Implants|dental implants
5048046|NCT03698812|Ulcerative Colitis|ulcerative colitis
5048047|NCT03698812|Mucosal Healing|mucosal healing
5048048|NCT03698812|Histological Remission|histological remission
5048049|NCT03698812|Prospective Study|prospective study
5048050|NCT03698799|Adherence|adherence
5048051|NCT03698799|Intensive Care Unit|intensive care unit
5048052|NCT03698799|Lung Protective Strategy|lung protective strategy
5048053|NCT03698799|Mechanical Ventilation|mechanical ventilation
5048054|NCT03698799|Perioperative Critical Care|perioperative critical care
5048055|NCT03698799|Surgical|surgical
5048056|NCT03698721|Tissue engineering|tissue engineering
5048057|NCT03698721|Collagen scaffold|collagen scaffold
5048058|NCT03698721|Alginate scaffold|alginate scaffold
5048059|NCT03698721|Urothelial cells|urothelial cells
5048060|NCT03698669|Depression|depression
5048061|NCT03698669|Pain|pain
5048062|NCT03698669|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5048063|NCT03698669|Buprenorphine|buprenorphine
5048064|NCT03698669|Behavioral health specialist (BHS)|behavioral health specialist (bhs)
5048065|NCT03698669|Primary care provider (PCP)|primary care provider (pcp)
5048066|NCT03698656|Spiritual dimension|spiritual dimension
5048067|NCT03698656|Hematologic cancer|hematologic cancer
5048068|NCT03698656|Acute leukemia|acute leukemia
5048069|NCT03698656|Lymphoma|lymphoma
5048070|NCT03698656|Nurse interview|nurse interview
5048071|NCT03698656|Quality of life|quality of life
5048072|NCT03698630|Asthma|asthma
5048073|NCT03698630|Pediatric|pediatric
5048074|NCT03698630|Corticosteroid|corticosteroid
5048075|NCT03698630|Emergency department|emergency department
5048076|NCT03698565|Pain Postoperative|pain postoperative
5048077|NCT03698565|Tonsillectomy|tonsillectomy
5061340|NCT03615599|vegetarian|vegetarian
5048083|NCT03698500|Ulcerative Colitis|ulcerative colitis
5048084|NCT03698500|Crohn`s disease|crohn`s disease
5048085|NCT03698500|miRNA|mirna
5048086|NCT03698448|Oligosaccharide|oligosaccharide
5048087|NCT03698435|ganciclovir|ganciclovir
5048088|NCT03698435|valganciclovir|valganciclovir
5048089|NCT03698435|therapeutic drug monitoring|therapeutic drug monitoring
5048098|NCT03698357|interactive video balance-based exercise|interactive video balance-based exercise
5048099|NCT03698357|conventional physiotherapy|conventional physiotherapy
5048100|NCT03698344|air pollution|air pollution
5048101|NCT03698344|microneurography|microneurography
5048102|NCT03698344|MNSA|mnsa
5048103|NCT03698344|Biodiesel|biodiesel
5048105|NCT03698318|Ginger|ginger
5048106|NCT03698318|Pharmacokinetics|pharmacokinetics
5048107|NCT03698318|Shogaols|shogaols
5048108|NCT03698318|Gingerols|gingerols
5048109|NCT03698318|Bioavailability|bioavailability
5048110|NCT03698305|Tolerability|tolerability
5048111|NCT03698305|Pharmacokinetics|pharmacokinetics
5048112|NCT03698305|Safety|safety
5048113|NCT03698305|ASP5354|asp5354
5048114|NCT03698266|Needle Knife Fistulotomy|needle knife fistulotomy
5048115|NCT03698266|Sphincterotomy|sphincterotomy
5048116|NCT03698266|Post-ERCP pancreatitis|post-ercp pancreatitis
5048117|NCT03698253|EGFR|egfr
5048118|NCT03698253|KRAS|kras
5048119|NCT03698253|tumor sideness|tumor sideness
5048120|NCT03698253|FOLFIRI|folfiri
5048121|NCT03698253|regorafenib|regorafenib
5048122|NCT03698253|metastatic colorectal cancer|metastatic colorectal cancer
5048123|NCT03698240|Mindfulness|mindfulness
5048124|NCT03698240|ADHD|adhd
5048125|NCT03698240|Oppositional Defiant Disorder|oppositional defiant disorder
5048126|NCT03698227|Soft tissue sarcoma|soft tissue sarcoma
5048127|NCT03698214|systolic blood pressure|systolic blood pressure
5048128|NCT03698214|reversed shock index|reversed shock index
5048129|NCT03698214|traumatic brain injury|traumatic brain injury
5048130|NCT03698214|mortality|mortality
5048131|NCT03698175|Emotion|emotion
5048132|NCT03698175|Cognition|cognition
5048133|NCT03698175|Positive psychology|positive psychology
5048134|NCT03698136|tetraplegia|tetraplegia
5048135|NCT03698136|denervated muscles|denervated muscles
5048136|NCT03698136|electrical stimulation|electrical stimulation
5048137|NCT03698123|Nutrition|nutrition
5048138|NCT03698123|Physician well-being|physician well-being
5048139|NCT03698123|Cognitive performance|cognitive performance
5048140|NCT03698123|Sleepiness|sleepiness
5048141|NCT03698123|Shift-work|shift-work
5048142|NCT03698097|quality management|quality management
5048143|NCT03698097|paper questionnaires|paper questionnaires
5048144|NCT03698097|satisfaction surveys|satisfaction surveys
5048145|NCT03698097|survey technique|survey technique
5048146|NCT03698097|online questionnaires|online questionnaires
5048147|NCT03698071|ANCA associated vasculitis|anca associated vasculitis
5048148|NCT03698071|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5048149|NCT03698071|microscopic polyangiitis|microscopic polyangiitis
5048150|NCT03698071|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
5048151|NCT03698071|soluble-CD95-Ligand|soluble-cd95-ligand
5048152|NCT03698058|Nutrition|nutrition
5048153|NCT03698058|Toddlers|toddlers
5048154|NCT03698058|A2|a2
5048155|NCT03698058|B-casein|b-casein
5048156|NCT03698058|Gut comfort|gut comfort
5048157|NCT03698058|Growing up milk|growing up milk
5048158|NCT03698045|PRO-143|pro-143
5048159|NCT03698045|Topical antibiotic|topical antibiotic
5048160|NCT03698045|Ophthalmic antibiotic|ophthalmic antibiotic
5048161|NCT03698045|External bacterial infections|external bacterial infections
5048162|NCT03697993|Fosfomycin|fosfomycin
5048163|NCT03697993|levofloxacin|levofloxacin
5048164|NCT03697993|Open-label|open-label
5048165|NCT03697993|Phase IV|phase iv
5048166|NCT03697993|UTI|uti
5048167|NCT03697967|Delayed cord clamping|delayed cord clamping
5048168|NCT03697928|Acetylcarnitine kinetic|acetylcarnitine kinetic
5048169|NCT03697928|Phosphocreatine (PCr) kinetic|phosphocreatine (pcr) kinetic
5048170|NCT03697915|Lift system|lift system
5048171|NCT03697915|Early mobilization|early mobilization
5048172|NCT03697915|Immobilization|immobilization
5048173|NCT03697902|Cisterna magna length|cisterna magna length
5048174|NCT03697902|ultrasound|ultrasound
5048175|NCT03697889|Bioequivalence|bioequivalence
5048176|NCT03697876|PRO-165|pro-165
5048179|NCT03697863|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5048181|NCT03697824|Synovial Sarcoma|synovial sarcoma
5048182|NCT03697824|pembrolizumab|pembrolizumab
5048183|NCT03697824|NY-ESO-1|ny-eso-1
5048184|NCT03697824|GSK3377794|gsk3377794
5048185|NCT03697824|LAGE-1a|lage-1a
5048186|NCT03697785|weaning|weaning
5101235|NCT03365440|ECG|ecg
5048187|NCT03697785|cardiothoracic|cardiothoracic
5048188|NCT03697785|mechanical ventilation|mechanical ventilation
5048190|NCT03697785|critical care|critical care
5048191|NCT03697785|beacon caresystem|beacon caresystem
5048192|NCT03697772|continuity of care|continuity of care
5048193|NCT03697772|primary care|primary care
5048194|NCT03697772|multimorbidity|multimorbidity
5048195|NCT03697772|quality of life|quality of life
5048196|NCT03697759|Digital Decision Support System|digital decision support system
5048197|NCT03697759|App|app
5048198|NCT03697759|Self-management|self-management
5048199|NCT03697720|cross-organ sensitivity|cross-organ sensitivity
5048200|NCT03697720|bladder pain|bladder pain
5048201|NCT03697720|NSAID|nsaid
5048202|NCT03697720|visceral pain|visceral pain
5048203|NCT03697707|AML in CR1 or CRi|aml in cr1 or cri
5048204|NCT03697707|DCOne|dcone
5048205|NCT03697707|DCP-001|dcp-001
5048206|NCT03697707|Minimal Residual Disease|minimal residual disease
5048207|NCT03697668|Imatinib Mesylate|imatinib mesylate
5048208|NCT03697668|piperaquine phosphate|piperaquine phosphate
5048209|NCT03697668|dihydroartemisinin|dihydroartemisinin
5048210|NCT03697629|Multiple Myeloma|multiple myeloma
5048211|NCT03697629|Relapse|relapse
5048212|NCT03697629|Refractory|refractory
5048213|NCT03697629|Daratumumab|daratumumab
5048214|NCT03697629|Accelerated Infusion|accelerated infusion
5048215|NCT03697577|cyclin-dependent kinase (CDK) 4/6 inhibitors|cyclin-dependent kinase (cdk) 4/6 inhibitors
5048216|NCT03697577|Body composition|body composition
5048217|NCT03697577|body fat mass|body fat mass
5048218|NCT03697577|metastatic ER+/HER2- breast cancer|metastatic er+/her2- breast cancer
5048219|NCT03697564|Pancreating Cancer|pancreating cancer
5048220|NCT03697564|Cancer|cancer
5048221|NCT03697564|Stage IV|stage iv
5048222|NCT03697564|gemcitabine|gemcitabine
5048223|NCT03697564|nivolumab|nivolumab
5048224|NCT03697564|cabiralizumab|cabiralizumab
5048225|NCT03697564|BMS-986227|bms-986227
5048226|NCT03697564|FPA008|fpa008
5048227|NCT03697564|GemCaN|gemcan
5048229|NCT03697525|repetitive muscle vibration (rMV)|repetitive muscle vibration (rmv)
5048230|NCT03697525|acute stroke|acute stroke
5048231|NCT03697525|motor recovery|motor recovery
5048232|NCT03697525|nonpharmacological therapy|nonpharmacological therapy
5048233|NCT03697525|bedside intervention|bedside intervention
5048234|NCT03697499|ozone exposure|ozone exposure
5048235|NCT03697499|fish oil|fish oil
5048236|NCT03697499|2*2 factorial design|2*2 factorial design
5048237|NCT03697486|PYY|pyy
5048238|NCT03697486|ghrelin|ghrelin
5048239|NCT03697486|ad libitum intake|ad libitum intake
5048240|NCT03697486|high protein diet|high protein diet
5048241|NCT03697486|moderately protein diet|moderately protein diet
5048242|NCT03697486|low protein diet|low protein diet
5048243|NCT03697486|breakfast|breakfast
5048244|NCT03697486|obesity|obesity
5048245|NCT03697473|Hamstring strength|hamstring strength
5048246|NCT03697473|Isokinetics|isokinetics
5048247|NCT03697473|Nordic hamstring exercise|nordic hamstring exercise
5048248|NCT03697473|Eccentric strength|eccentric strength
5048249|NCT03697473|Hip extension exercise|hip extension exercise
5048250|NCT03697421|parenting|parenting
5048251|NCT03697421|relationships|relationships
5048252|NCT03697421|relationship education|relationship education
5048253|NCT03697421|couples|couples
5048254|NCT03697421|marriage|marriage
5048255|NCT03697330|liberal, restrictive, fluid, RIFLE|liberal, restrictive, fluid, rifle
5048256|NCT03697291|Self invented iECG wire|self invented iecg wire
5048257|NCT03697291|PS wire|ps wire
5048258|NCT03697291|Certodyn|certodyn
5048259|NCT03697291|intracavitary ECG|intracavitary ecg
5048260|NCT03697291|PICC line|picc line
5048261|NCT03697291|giant P wave|giant p wave
5048262|NCT03697278|pain|pain
5048263|NCT03697278|postoperative|postoperative
5048265|NCT03697239|metastatic pancreatic cancer|metastatic pancreatic cancer
5048266|NCT03697239|cancer|cancer
5048267|NCT03697239|pancreatic|pancreatic
5048268|NCT03697239|Vitamin C|vitamin c
5048269|NCT03697239|Ascorbic Acid|ascorbic acid
5048270|NCT03697239|Nanoparticle Paclitaxel Protein Bound|nanoparticle paclitaxel protein bound
5048271|NCT03697239|cisplatin|cisplatin
5048272|NCT03697239|gemcitabine|gemcitabine
5048273|NCT03697239|pancreas|pancreas
5048274|NCT03697213|Surprise Question|surprise question
5048275|NCT03697213|Prognostication|prognostication
5048276|NCT03697200|Breast Cancer Survivors|breast cancer survivors
5048277|NCT03697200|Aromatase Inhibitor|aromatase inhibitor
5048286|NCT03697122|Cardiopulmonary bypass|cardiopulmonary bypass
5048288|NCT03697122|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5048289|NCT03697122|Heated Humidified Breathing Circuit|heated humidified breathing circuit
5048290|NCT03697109|Cushing syndrome|cushing syndrome
5048291|NCT03697109|Cushing disease|cushing disease
5048292|NCT03697109|Hypercortisolemia|hypercortisolemia
5048293|NCT03697109|Cushingoid|cushingoid
5048294|NCT03697109|Type 2 Diabetes|type 2 diabetes
5048295|NCT03697109|Impaired Glucose Intolerance|impaired glucose intolerance
5048296|NCT03697109|Hypertension|hypertension
5048297|NCT03697109|Adrenocorticotropic hormone|adrenocorticotropic hormone
5048298|NCT03697109|Primary Pigmented Nodular Adrenal Disease|primary pigmented nodular adrenal disease
5048299|NCT03697109|Moon Facies|moon facies
5048303|NCT03697109|Cortisol|cortisol
5048304|NCT03697109|Cushing|cushing
5048305|NCT03697096|UTI|uti
5048306|NCT03697096|CPOE|cpoe
5048307|NCT03697096|Empiric Therapy|empiric therapy
5048308|NCT03697070|PNA|pna
5048309|NCT03697070|CPOE|cpoe
5048310|NCT03697070|Empiric Therapy|empiric therapy
5048311|NCT03697057|postoperative recovery|postoperative recovery
5048312|NCT03697057|psychomotor function|psychomotor function
5048313|NCT03697057|measurement|measurement
5925459|NCT04192227|Partner|partner
5048314|NCT03696992|colonoscopy|colonoscopy
5048315|NCT03696966|weight management|weight management
5048316|NCT03696966|obesity|obesity
5048317|NCT03696966|very-low calorie diet|very-low calorie diet
5048318|NCT03696966|intermittent diet|intermittent diet
5048319|NCT03696953|Probiotics|probiotics
5048320|NCT03696953|Pregnancy|pregnancy
5048321|NCT03696953|Group B Streptococcus|group b streptococcus
5048322|NCT03696953|Gastrointestinal symptoms|gastrointestinal symptoms
5048323|NCT03696914|eosinophil|eosinophil
5048324|NCT03696914|phenotype|phenotype
5048325|NCT03696914|cluster|cluster
5048326|NCT03696914|asthma severity|asthma severity
5048327|NCT03696901|Dalbavancine|dalbavancine
5048328|NCT03696901|Xydalba|xydalba
5048329|NCT03696888|Randomized Controlled Trial|randomized controlled trial
5048330|NCT03696888|Internet|internet
5048331|NCT03696888|Mobile phone|mobile phone
5048332|NCT03696888|Smartphone|smartphone
5048333|NCT03696888|App|app
5048334|NCT03696888|Alcohol|alcohol
5048335|NCT03696888|Substance use|substance use
5048336|NCT03696875|Discharge Planning|discharge planning
5048337|NCT03696875|Emergency Department|emergency department
5048338|NCT03696875|Heart failure|heart failure
5048339|NCT03696875|Older|older
5048340|NCT03696875|Frail|frail
5048341|NCT03696797|Iron Reduction|iron reduction
5048342|NCT03696797|Phlebotomy|phlebotomy
5048343|NCT03696784|CAR T cells|car t cells
5048344|NCT03696784|CD19|cd19
5048345|NCT03696784|Lymphoma|lymphoma
5048346|NCT03696784|AP1903|ap1903
5048347|NCT03696784|Cytokine Release Syndrome|cytokine release syndrome
5048348|NCT03696784|Neurotoxicity|neurotoxicity
5048349|NCT03696771|Phase I, NJH395, HER2+, ISAC, TLR7|phase i, njh395, her2+, isac, tlr7
5048350|NCT03696758|premature adults|premature adults
5048351|NCT03696758|premature|premature
5048352|NCT03696758|premature cardiac function|premature cardiac function
5048353|NCT03696758|MRI|mri
5048354|NCT03696758|sildenafil|sildenafil
5048355|NCT03696758|metoprolol|metoprolol
5048356|NCT03696758|CMR|cmr
5048357|NCT03696745|Autologous Umbilical Cord Blood Stem Cells|autologous umbilical cord blood stem cells
5048358|NCT03696745|Safety|safety
5048359|NCT03696745|Effect|effect
5048360|NCT03696745|brain injury|brain injury
5048361|NCT03696680|hemorrhagic|hemorrhagic
5048362|NCT03696680|brain metastases|brain metastases
5048363|NCT03696680|FSRT|fsrt
5048364|NCT03696680|Stereotactic radiation therapy|stereotactic radiation therapy
5048365|NCT03696628|Cardiomyocytes|cardiomyocytes
5048366|NCT03696628|Induced pluripotent stem cells|induced pluripotent stem cells
5048367|NCT03696628|Genetic cardiomyopathy|genetic cardiomyopathy
5048368|NCT03696615|high-intensity|high-intensity
5048369|NCT03696602|airway smooth muscle, asthma, bronchial test, lung function|airway smooth muscle, asthma, bronchial test, lung function
5048370|NCT03696563|prehospital|prehospital
5048371|NCT03696563|oxygen therapy|oxygen therapy
5048372|NCT03696563|automation|automation
5048373|NCT03696563|trauma|trauma
5048374|NCT03696563|COPD|copd
5048375|NCT03696537|Radiation|radiation
5048376|NCT03696537|Total Marrow Irradiation|total marrow irradiation
5048377|NCT03696537|Fludarabine|fludarabine
5048378|NCT03696537|Bone Marrow Transplantation|bone marrow transplantation
5048379|NCT03696524|congestive heart failure|congestive heart failure
5048380|NCT03696524|pleural effusion|pleural effusion
5048381|NCT03696524|shortness of breath|shortness of breath
5048382|NCT03696524|tunneled pleural catheter|tunneled pleural catheter
5048383|NCT03696524|thoracentesis|thoracentesis
5048384|NCT03696511|Miniscrew|miniscrew
5048385|NCT03696498|Partial excavation|partial excavation
5048386|NCT03696498|Deep dentin caries|deep dentin caries
5048388|NCT03696485|Secondary Progressive Multiple Sclerosis (SPMS), safety|secondary progressive multiple sclerosis (spms), safety
5048389|NCT03696446|Cardiac Rehabilitation|cardiac rehabilitation
5729825|NCT00395135|lorcaserin|lorcaserin
5048390|NCT03696446|Patient Activation|patient activation
5048391|NCT03696433|salt sensitive, blood pressure, obesity, magnetic resonance imaging|salt sensitive, blood pressure, obesity, magnetic resonance imaging
5048392|NCT03696420|Probabilistic targeting|probabilistic targeting
5048394|NCT03696420|Machine-learning|machine-learning
5048395|NCT03696420|Essential Tremor|essential tremor
5048396|NCT03696381|computerized cognitive rehabilitation|computerized cognitive rehabilitation
5048397|NCT03696381|trns|trns
5048398|NCT03696381|traumatic brain injury|traumatic brain injury
5048399|NCT03696381|tbi|tbi
5048401|NCT03696355|Anaplastic Astrocytoma|anaplastic astrocytoma
5048402|NCT03696355|Atypical Brainstem Glioma|atypical brainstem glioma
5048403|NCT03696355|Brain Cancer|brain cancer
5048404|NCT03696355|Brain Stem Glioma|brain stem glioma
5048405|NCT03696355|Brain Tumors in Children|brain tumors in children
5048406|NCT03696355|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5048407|NCT03696355|Diffuse Midline Glioma|diffuse midline glioma
5048408|NCT03696355|Glioblastoma|glioblastoma
5048409|NCT03696355|H3 K27M mutant|h3 k27m mutant
5048410|NCT03696355|Newly Diagnosed|newly diagnosed
5048411|NCT03696355|Non-brainstem Midline Glioma|non-brainstem midline glioma
5960911|NCT04290260|Bra|bra
5960912|NCT04290260|Dehiscence|dehiscence
5048412|NCT03696355|Pediatric Brain Tumor|pediatric brain tumor
5048413|NCT03696355|Radiation Therapy|radiation therapy
5048414|NCT03696355|St. Jude Brain Tumor Studies|st. jude brain tumor studies
5048415|NCT03696355|St. Jude Studies|st. jude studies
5048416|NCT03696355|St. Jude Treatment|st. jude treatment
5048417|NCT03696342|pazufloxacin|pazufloxacin
5048418|NCT03696342|PRO-157|pro-157
5048419|NCT03696342|Fluoroquinolones|fluoroquinolones
5048420|NCT03696303|Streptococcus pneumoniae|streptococcus pneumoniae
5048421|NCT03696303|Pneumonia|pneumonia
5048422|NCT03696303|Community-acquired|community-acquired
5048423|NCT03696303|Pediatric|pediatric
5048424|NCT03696303|Urine antigen|urine antigen
5048425|NCT03696290|Bronchiectasis|bronchiectasis
5048426|NCT03696277|Stereotactic, Radiotherapy,|stereotactic, radiotherapy,
5048427|NCT03696264|Protein Requirements|protein requirements
5048428|NCT03696225|PTSD|ptsd
5048725|NCT03694288|Lisfranc|lisfranc
5048430|NCT03696186|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5048432|NCT03696186|Chemotherapy|chemotherapy
5048433|NCT03696186|Target Therapy|target therapy
5048435|NCT03696095|total knee arthroplasty|total knee arthroplasty
5048436|NCT03696095|postoperative pain|postoperative pain
5048437|NCT03696095|programmed intermittent bolus|programmed intermittent bolus
5048438|NCT03696095|Continuous femoral nerve block|continuous femoral nerve block
5048439|NCT03696043|intracranial pressure|intracranial pressure
5048440|NCT03696043|external ventricular drain|external ventricular drain
5048441|NCT03696043|cerebrospinal fluid|cerebrospinal fluid
5048442|NCT03696017|Opioid Abuse|opioid abuse
5048443|NCT03696017|Benzodiazepine abuse|benzodiazepine abuse
5048444|NCT03695939|xenograft, allograft, burns, severe burns, temporary coverage, porcine.|xenograft, allograft, burns, severe burns, temporary coverage, porcine.
5048445|NCT03695926|HV|hv
5048446|NCT03695913|Pre-diabetes, low carbohydrate diet|pre-diabetes, low carbohydrate diet
5048447|NCT03695887|burns, pain, dressing change, nitrous oxide|burns, pain, dressing change, nitrous oxide
5048448|NCT03695861|Endocarditis Infectious|endocarditis infectious
5048449|NCT03695861|Native valve|native valve
5048450|NCT03695861|ESC 2015 modified diagnostic criteria|esc 2015 modified diagnostic criteria
5048451|NCT03695861|18F-FDG PET-CT|18f-fdg pet-ct
5048452|NCT03695861|Detection of peripheral emboli|detection of peripheral emboli
5048453|NCT03695848|Cervical Myelopathy，Prognostication，Diffusion Tensor Imaging, fMRI|cervical myelopathy，prognostication，diffusion tensor imaging, fmri
5048454|NCT03695835|prostate cancer|prostate cancer
5048455|NCT03695835|lung cancer|lung cancer
5048456|NCT03695835|pancreatic cancer|pancreatic cancer
5048457|NCT03695835|colorectal cancer|colorectal cancer
5048458|NCT03695835|bladder cancer|bladder cancer
5048459|NCT03695796|patients with a NAFLD proven by liver biopsy|patients with a nafld proven by liver biopsy
5048460|NCT03695757|Immunoglobulin G|immunoglobulin g
5048461|NCT03695757|Treatment|treatment
5048462|NCT03695757|Immunostimulatory effect|immunostimulatory effect
5048463|NCT03695757|Tumor|tumor
5048464|NCT03695757|Solid tumor|solid tumor
5048465|NCT03695744|Myeloma|myeloma
5048466|NCT03695744|Daratumumab|daratumumab
5048467|NCT03695744|Non-Transplant Eligible|non-transplant eligible
5048468|NCT03695731|diabetes|diabetes
5048469|NCT03695731|brown adipose tissue|brown adipose tissue
5048470|NCT03695731|energy expenditure|energy expenditure
5048471|NCT03695731|glycemic control|glycemic control
5048472|NCT03695731|neuropathy|neuropathy
5048473|NCT03695731|18F-FDG PET-RMI|18f-fdg pet-rmi
5048474|NCT03695705|Norfloxacin,Rifaximin,Prophylaxis|norfloxacin,rifaximin,prophylaxis
5048475|NCT03695679|computer-assisted instruction/methods|computer-assisted instruction/methods
5048476|NCT03695679|safe sex|safe sex
5048477|NCT03695679|students|students
5048478|NCT03695679|universities|universities
5048479|NCT03695653|Drinking|drinking
5048480|NCT03695653|Alcohol Problems|alcohol problems
5048481|NCT03695653|Moderation-Oriented Treatment|moderation-oriented treatment
5048482|NCT03695653|Controlled Drinking|controlled drinking
5048483|NCT03695653|Reduced Drinking|reduced drinking
5048484|NCT03695653|Problem Drinking|problem drinking
5048485|NCT03695653|Text Message|text message
5048486|NCT03695653|Mobile Phone|mobile phone
5048487|NCT03695653|Technology|technology
5048488|NCT03695640|total knee arthroplasty|total knee arthroplasty
5048489|NCT03695640|postoperative pain|postoperative pain
5048490|NCT03695640|continuous femoral nerve block|continuous femoral nerve block
5049255|NCT03690700|Tetraplegia|tetraplegia
5048505|NCT03695575|Listening Effort|listening effort
5048506|NCT03695575|Speech in Noise|speech in noise
5048507|NCT03695562|vitamin D|vitamin d
5048508|NCT03695562|implant stability|implant stability
5048509|NCT03695562|sequential drilling|sequential drilling
5048510|NCT03695562|single drilling|single drilling
5048511|NCT03695549|advanced platelet rich fibrin,A-PRF|advanced platelet rich fibrin,a-prf
5048512|NCT03695523|Physical activity|physical activity
5048513|NCT03695523|Children|children
5048514|NCT03695523|Child care|child care
5048515|NCT03695523|Policy|policy
5048516|NCT03695523|Accelerometer|accelerometer
5048517|NCT03695510|head and neck cancer,Immunotherapy|head and neck cancer,immunotherapy
5960913|NCT04290260|Sternotomy|sternotomy
5048518|NCT03695497|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5048519|NCT03695497|Orthopedic procedures|orthopedic procedures
5048921|NCT03693027|gum disease|gum disease
5048544|NCT03695354|gait|gait
5048545|NCT03695354|muscle|muscle
5048546|NCT03695354|rehabilitation|rehabilitation
5048547|NCT03695341|Endocrine Therapy|endocrine therapy
5048548|NCT03695341|Fulvestrant|fulvestrant
5048549|NCT03695341|Everolimus|everolimus
5048550|NCT03695315|Obstructive Sleep Apnea|obstructive sleep apnea
5048551|NCT03695315|Hypoxia|hypoxia
5048552|NCT03695315|Insulin Resistance|insulin resistance
5048553|NCT03695302|knowledge/attitude/practice/questionnaire/post-exposure|knowledge/attitude/practice/questionnaire/post-exposure
5048554|NCT03695289|Antipsychotics|antipsychotics
5048559|NCT03695237|Central Precocious Puberty (CPP)|central precocious puberty (cpp)
5048560|NCT03695237|Leuprolide Acetate (LA)|leuprolide acetate (la)
5048561|NCT03695224|Topological perception|topological perception
5048562|NCT03695224|Glaucoma|glaucoma
5048563|NCT03695211|great auricular nerve|great auricular nerve
5048564|NCT03695211|sternocleidomastoid muscle|sternocleidomastoid muscle
5048565|NCT03695211|ultrasound guidance|ultrasound guidance
5048568|NCT03695159|anti-thrombotic drugs|anti-thrombotic drugs
5048569|NCT03695159|cardiac intervention|cardiac intervention
5048570|NCT03695159|Non-cardiac intervention|non-cardiac intervention
5048571|NCT03695146|High blood pressure|high blood pressure
5048572|NCT03695146|HIV|hiv
5048574|NCT03695133|elderly|elderly
5048575|NCT03695133|integrative nursing|integrative nursing
5048576|NCT03695133|omaha system|omaha system
5048577|NCT03695120|ACEI (Angiotensin-Converting-Enzyme Inhibitor)|acei (angiotensin-converting-enzyme inhibitor)
5048578|NCT03695120|ARB (Angiotensin II Receptor Blocker)|arb (angiotensin ii receptor blocker)
5048579|NCT03695120|CHF (Congestive Heart Failure)|chf (congestive heart failure)
5048580|NCT03695120|RAAS (Renin Angiotensin Aldosterone System)|raas (renin angiotensin aldosterone system)
5048581|NCT03695094|Epilepsy|epilepsy
5048582|NCT03695094|Phase 1|phase 1
5048583|NCT03695094|padsevonil|padsevonil
5048602|NCT03695068|Learning Disabilities|learning disabilities
5048603|NCT03695068|Dyslexia|dyslexia
5048604|NCT03695068|Reading|reading
5048605|NCT03695003|Sage|sage
5048606|NCT03695003|Terpene|terpene
5048607|NCT03695003|Polyphenol|polyphenol
5048608|NCT03695003|Cognition|cognition
5048609|NCT03695003|Mood|mood
5048610|NCT03694977|Gastric Cancer|gastric cancer
5048619|NCT03694938|Brain metastasis|brain metastasis
5048620|NCT03694938|Magnetic resonance imaging|magnetic resonance imaging
5048624|NCT03694860|crush induction, RSI|crush induction, rsi
5048625|NCT03694847|asthma|asthma
5048626|NCT03694847|chronic rhinosinusitis|chronic rhinosinusitis
5048627|NCT03694847|nasal polyposis|nasal polyposis
5048628|NCT03694834|Endometrial Cancer|endometrial cancer
5048629|NCT03694834|Uterus|uterus
5048630|NCT03694834|Endometrioid|endometrioid
5048635|NCT03694808|Flu|flu
5048636|NCT03694808|Vaccine|vaccine
5048637|NCT03694782|diet|diet
5048638|NCT03694782|food prices|food prices
5048639|NCT03694782|environment|environment
5049368|NCT03690076|Obesity|obesity
5048646|NCT03694769|functional neurological symptoms|functional neurological symptoms
5048647|NCT03694756|TMEM;|tmem;
5048648|NCT03694756|Magnetic resonance imaging (MRI);|magnetic resonance imaging (mri);
5048649|NCT03694756|breast cancer.|breast cancer.
5048650|NCT03694743|mandibular molars|mandibular molars
5048651|NCT03694730|Tendinopathy|tendinopathy
5048652|NCT03694730|Tendinitis|tendinitis
5048653|NCT03694730|Tendinosis|tendinosis
5048654|NCT03694730|Rehabilitation|rehabilitation
5048655|NCT03694730|Exercise Treatment|exercise treatment
5048656|NCT03694730|Activity Modification|activity modification
5048657|NCT03694717|shock|shock
5048658|NCT03694717|fluid expansion|fluid expansion
5048659|NCT03694717|fluid responsiveness|fluid responsiveness
5048660|NCT03694704|cochlear implant|cochlear implant
5048661|NCT03694704|stimulation strategy|stimulation strategy
5048662|NCT03694704|sound coding strategy|sound coding strategy
5048663|NCT03694678|Psychiatry|psychiatry
5048664|NCT03694678|Dyads|dyads
5048665|NCT03694678|Patients|patients
5048666|NCT03694678|Caregivers|caregivers
5048667|NCT03694678|Psychosocial|psychosocial
5048668|NCT03694665|airways pressure|airways pressure
5048669|NCT03694665|mechanical ventilation|mechanical ventilation
5048670|NCT03694665|Atelectasis|atelectasis
5048671|NCT03694652|Text messaging|text messaging
5048672|NCT03694652|PAD|pad
5048673|NCT03694613|Preterm Infant|preterm infant
5048674|NCT03694613|Early-Onset Neonatal Sepsis|early-onset neonatal sepsis
5048675|NCT03694613|Umbilical Cord|umbilical cord
5048676|NCT03694613|Complete Cell Count|complete cell count
5048677|NCT03694613|Placenta|placenta
5048678|NCT03694613|Blood Culture|blood culture
5048679|NCT03694561|Pompe disease|pompe disease
5048680|NCT03694561|Glycogen Storage Disease Type II|glycogen storage disease type ii
5048681|NCT03694561|Acid Maltase Deficiency|acid maltase deficiency
5048682|NCT03694561|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
5048683|NCT03694561|Alglucosidase alfa|alglucosidase alfa
5048684|NCT03694561|Newborn Screening|newborn screening
5048685|NCT03694548|Yoga|yoga
5048686|NCT03694548|Behavioral/Social|behavioral/social
5048687|NCT03694548|Pediatrics|pediatrics
5048688|NCT03694535|Thermochemotherapy|thermochemotherapy
5048689|NCT03694535|bladder|bladder
5048690|NCT03694535|cancer|cancer
5048691|NCT03694509|Gastric emptying|gastric emptying
5048692|NCT03694509|tea|tea
5048693|NCT03694509|milk|milk
5048694|NCT03694509|pregnancy|pregnancy
5048695|NCT03694509|gastric ultrasound|gastric ultrasound
5048696|NCT03694509|ultrasound|ultrasound
5048697|NCT03694509|gastric antrum|gastric antrum
5048698|NCT03694483|prostasomes,|prostasomes,
5048699|NCT03694483|prostate cancer,|prostate cancer,
5048700|NCT03694483|biomarkers|biomarkers
5048701|NCT03694457|Prospective|prospective
5048702|NCT03694457|Randomized study|randomized study
5048703|NCT03694457|Proximal humerus fracture|proximal humerus fracture
5048704|NCT03694457|Surgical treatment|surgical treatment
5048705|NCT03694405|MenACWY|menacwy
5048706|NCT03694405|Neisseria meningitidis|neisseria meningitidis
5048707|NCT03694405|adolescents|adolescents
5048708|NCT03694392|influenza|influenza
5048709|NCT03694392|vaccine effectiveness|vaccine effectiveness
5048710|NCT03694379|Apneic Oxygenation|apneic oxygenation
5048711|NCT03694379|Endotracheal intubation|endotracheal intubation
5048712|NCT03694379|Airway Management|airway management
5048713|NCT03694379|Emergency Department|emergency department
5048715|NCT03694366|Reproductive, Maternal, Newborn, and Child Health|reproductive, maternal, newborn, and child health
5048716|NCT03694366|Community Health Workers|community health workers
5048717|NCT03694366|Implementation Research|implementation research
5048718|NCT03694366|Health Systems Strengthening|health systems strengthening
5048719|NCT03694314|Omega-3 fatty acids|omega-3 fatty acids
5048720|NCT03694314|Sleep|sleep
5048721|NCT03694314|Behavior|behavior
5048722|NCT03694314|Parenting|parenting
5048723|NCT03694301|Monitoring, Intraoperative|monitoring, intraoperative
5048724|NCT03694301|Pulse Wave Analysis|pulse wave analysis
5048726|NCT03694275|Drug Therapy|drug therapy
5048727|NCT03694275|15q Duplication Syndrome|15q duplication syndrome
5048728|NCT03694275|CDKL5 Deficiency Disease|cdkl5 deficiency disease
5048729|NCT03694275|Brain Diseases|brain diseases
5048730|NCT03694275|Epilepsy|epilepsy
5048731|NCT03694275|Central Nervous System Diseases|central nervous system diseases
5048732|NCT03694275|Autism|autism
5048733|NCT03694275|Infantile spams|infantile spams
5048734|NCT03694275|Cholesterol 24S-hydroxylase inhibitor|cholesterol 24s-hydroxylase inhibitor
5048735|NCT03694275|Anti-epilepsy drug|anti-epilepsy drug
5048736|NCT03694275|Anticonvulsants|anticonvulsants
5048740|NCT03694262|recurrent endometrial cancer|recurrent endometrial cancer
5048741|NCT03694262|Bevacizumab|bevacizumab
5048742|NCT03694262|Atezolizumab|atezolizumab
5048743|NCT03694262|Rucaparib|rucaparib
5048744|NCT03694236|NSCLC|nsclc
5048745|NCT03694236|Durvalumab|durvalumab
5048746|NCT03694236|medi4736|medi4736
5048747|NCT03694223|FODMAP|fodmap
5048748|NCT03694223|DIET|diet
5048749|NCT03694223|BLOATING|bloating
5048750|NCT03694210|Direct Endoscopic Necrosectomy|direct endoscopic necrosectomy
5048751|NCT03694210|Walled Off Necrosis|walled off necrosis
5048752|NCT03694210|Walled Off Pancreatic Necrosis|walled off pancreatic necrosis
5048753|NCT03694171|Elderly|elderly
5048754|NCT03694171|Cancer|cancer
5048755|NCT03694171|Cohort study|cohort study
5048756|NCT03694171|Cancer registry|cancer registry
5048757|NCT03694171|Access to care|access to care
5048758|NCT03694171|Cancer stage|cancer stage
5048759|NCT03694171|Cancer treatment|cancer treatment
5048760|NCT03694171|Prognosis|prognosis
5048761|NCT03694171|Functional decline|functional decline
5048762|NCT03694171|Survival|survival
5048763|NCT03694132|Brain excitability|brain excitability
5048764|NCT03694132|Brain connectivity|brain connectivity
5048765|NCT03694132|Motor cortex|motor cortex
5048766|NCT03694132|Somatosensory cortex|somatosensory cortex
5048767|NCT03694119|Healthy Volunteer|healthy volunteer
5048768|NCT03694119|Ozanimod|ozanimod
5048769|NCT03694119|Oral Tyramine|oral tyramine
5048770|NCT03694067|Androgenetic|androgenetic
5048771|NCT03694067|Alopecia|alopecia
5048773|NCT03694067|STAT|stat
5048774|NCT03694054|Care Coordination|care coordination
5048775|NCT03694054|Oncology Care|oncology care
5048776|NCT03694054|Lung Cancer|lung cancer
5048777|NCT03694028|biomechanical|biomechanical
5048778|NCT03694028|kinematic|kinematic
5048779|NCT03694028|muscle coactivation|muscle coactivation
5048780|NCT03694028|torque|torque
5048781|NCT03693989|corticosteroid|corticosteroid
5048782|NCT03693989|anti-inflammatory steroid|anti-inflammatory steroid
5048783|NCT03693989|phacoemulsification|phacoemulsification
5048784|NCT03693911|gamification|gamification
5048785|NCT03693911|Acceptance and Commitment Therapy|acceptance and commitment therapy
5048786|NCT03693911|digitalized intervention|digitalized intervention
5048787|NCT03693885|caesarean section|caesarean section
5048788|NCT03693885|Oxytocin challenge test|oxytocin challenge test
5048789|NCT03693872|Parkinson|parkinson
5048790|NCT03693872|Nonmotor symptomatology|nonmotor symptomatology
5048791|NCT03693833|Cannabidiol|cannabidiol
5048792|NCT03693833|Cannabis|cannabis
5048793|NCT03693833|Osteoarthritis|osteoarthritis
5048794|NCT03693833|Psoriatic arthritis|psoriatic arthritis
5048795|NCT03693820|cholecystectomy;|cholecystectomy;
5048796|NCT03693820|analgesia;|analgesia;
5048797|NCT03693820|gallbladder;|gallbladder;
5048798|NCT03693820|infiltration;|infiltration;
5048799|NCT03693820|visceral pain|visceral pain
5048800|NCT03693807|Medtronic Pump|medtronic pump
5048801|NCT03693807|Codman Catheter|codman catheter
5048802|NCT03693807|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
5048803|NCT03693807|Floxuridine (FUDR)|floxuridine (fudr)
5048804|NCT03693807|Gemcitabine|gemcitabine
5048805|NCT03693807|Oxaliplatin|oxaliplatin
5048806|NCT03693807|Irinotecan (CPT-11)|irinotecan (cpt-11)
5048807|NCT03693807|Fluorouracil|fluorouracil
5048808|NCT03693807|Leucovorin Calcium (Folinic Acid)|leucovorin calcium (folinic acid)
5048809|NCT03693807|Dexamethasone|dexamethasone
5048810|NCT03693807|18-343|18-343
5048811|NCT03693794|psychosocial/rehabilitative interventions|psychosocial/rehabilitative interventions
5048812|NCT03693794|Schizophrenia|schizophrenia
5062029|NCT03611283|Xerostomia|xerostomia
5048814|NCT03693794|long acting injection antipsychotic|long acting injection antipsychotic
5048815|NCT03693794|functional outcome|functional outcome
5048816|NCT03693781|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5048817|NCT03693781|stress granules|stress granules
5048819|NCT03693781|protein quality control|protein quality control
5048820|NCT03693781|colchicine|colchicine
5048821|NCT03693781|ALSFRS-r|alsfrs-r
5048822|NCT03693781|survival|survival
5048823|NCT03693781|safety|safety
5048824|NCT03693729|memory|memory
5048825|NCT03693729|metacognition|metacognition
5048826|NCT03693729|metamemory|metamemory
5048922|NCT03693014|Radiation|radiation
5048841|NCT03693638|spinal anesthesia|spinal anesthesia
5048842|NCT03693638|pregnancy-induced hypertension|pregnancy-induced hypertension
5048843|NCT03693638|Cesarean section|cesarean section
5048858|NCT03693534|Long Antagonist|long antagonist
5048859|NCT03693534|Long agonist|long agonist
5048860|NCT03693534|clinical pregnancy rate|clinical pregnancy rate
5048861|NCT03693534|live birth rate|live birth rate
5048862|NCT03693534|ovarian stimulation|ovarian stimulation
5048864|NCT03693469|Virtual Reality|virtual reality
5048867|NCT03693443|knowledge|knowledge
5048868|NCT03693443|behaviors|behaviors
5048869|NCT03693443|Early childhood caries|early childhood caries
5048870|NCT03693417|pharyngitis|pharyngitis
5048871|NCT03693417|intubation|intubation
5048873|NCT03693378|high-risk familial|high-risk familial
5048874|NCT03693378|screening program|screening program
5048875|NCT03693378|pancreatic cancer|pancreatic cancer
5048876|NCT03693365|Carbon dioxide|carbon dioxide
5048877|NCT03693365|Pulmonary blood flow|pulmonary blood flow
5048878|NCT03693365|Ventilation|ventilation
5048879|NCT03693313|ASD, Autism Spectrum Disorder|asd, autism spectrum disorder
5048880|NCT03693300|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
5048881|NCT03693300|Durvalumab|durvalumab
5048882|NCT03693300|IV infusion immunoglobulin G (IgG)|iv infusion immunoglobulin g (igg)
5048883|NCT03693300|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
5048884|NCT03693300|Complement-dependent cytotoxicity|complement-dependent cytotoxicity
5048885|NCT03693300|Monotherapy|monotherapy
5048886|NCT03693287|Preterm|preterm
5048887|NCT03693287|Infant|infant
5048888|NCT03693287|Parenteral Nutrition|parenteral nutrition
5048889|NCT03693287|Growth|growth
5048890|NCT03693261|epicardial fat|epicardial fat
5048891|NCT03693248|advanced ovarian cancer|advanced ovarian cancer
5048892|NCT03693248|advanced fallopian cancer|advanced fallopian cancer
5048893|NCT03693248|advanced peritoneal cancer|advanced peritoneal cancer
5048894|NCT03693248|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5048895|NCT03693248|cycles of chemotherapy|cycles of chemotherapy
5048896|NCT03693248|survival|survival
5048897|NCT03693235|Tracheal Intubation|tracheal intubation
5048898|NCT03693235|Lightwand|lightwand
5048899|NCT03693222|Quadratus lumborum block, abdominal trunk block|quadratus lumborum block, abdominal trunk block
5048900|NCT03693209|Implementation intentions|implementation intentions
5048901|NCT03693209|Volitional Help Sheet|volitional help sheet
5048902|NCT03693209|Adolescent|adolescent
5048903|NCT03693196|Dental implant|dental implant
5048904|NCT03693196|Immunology|immunology
5048905|NCT03693196|Microbiology|microbiology
5048906|NCT03693196|Surface characteristic|surface characteristic
5048907|NCT03693183|Dry Eye|dry eye
5048908|NCT03693170|Metastatic Colorectal Cancer|metastatic colorectal cancer
5048909|NCT03693118|manual therapy; multiple sclerosis; rehabilitation; motor cortex; neuroplasticity|manual therapy; multiple sclerosis; rehabilitation; motor cortex; neuroplasticity
5048910|NCT03693079|heavy metal|heavy metal
5048911|NCT03693079|wet cupping therapy|wet cupping therapy
5048912|NCT03693079|steel industry worker|steel industry worker
5048913|NCT03693066|stepwise excavation|stepwise excavation
5048914|NCT03693066|indirect pulp capping|indirect pulp capping
5048915|NCT03693066|ozone|ozone
5048916|NCT03693066|deep caries|deep caries
5048917|NCT03693027|Older adults|older adults
5048918|NCT03693027|microbiome|microbiome
5960914|NCT04290247|Pediatric|pediatric
5048919|NCT03693027|gum health|gum health
5048920|NCT03693027|gingivitis|gingivitis
5048923|NCT03693014|Immunotherapy/Checkpoint Inhibitors|immunotherapy/checkpoint inhibitors
5048925|NCT03692988|Psychotherapy|psychotherapy
5048926|NCT03692988|Dignity|dignity
5048927|NCT03692988|Family|family
5048928|NCT03692975|Clinically Isolated Syndrome|clinically isolated syndrome
5048929|NCT03692975|NODDI|noddi
5048930|NCT03692975|Hippocampus|hippocampus
5048931|NCT03692975|episodic memory function|episodic memory function
5048932|NCT03692975|dentate gyrus|dentate gyrus
5048933|NCT03692975|MRI|mri
5048934|NCT03692884|diabetes mellitus|diabetes mellitus
5048935|NCT03692884|risk factors|risk factors
5048936|NCT03692884|biomarkers|biomarkers
5048937|NCT03692884|chronic diabetes complications|chronic diabetes complications
5048938|NCT03692858|arthroplasty|arthroplasty
5048939|NCT03692858|replacement|replacement
5048940|NCT03692858|knee|knee
5048947|NCT03692793|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5048948|NCT03692793|Minimal Clinically Important Difference|minimal clinically important difference
5048950|NCT03692793|Rehabilitation|rehabilitation
5048951|NCT03692793|Disability Evaluation|disability evaluation
5048952|NCT03692793|Activities of Daily Living|activities of daily living
5048953|NCT03692793|Motivation|motivation
5048954|NCT03692793|Self-efficacy|self-efficacy
5048955|NCT03692754|Immune Thrombocytopenia|immune thrombocytopenia
5048956|NCT03692728|congenital cataract|congenital cataract
5048957|NCT03692728|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5048958|NCT03692728|Conners'Parent Rating Scale-48|conners'parent rating scale-48
5342948|NCT01981395|hyperalgesia|hyperalgesia
5048959|NCT03692715|ureteral stones; ureteral calculi; shockwave lithotripsy|ureteral stones; ureteral calculi; shockwave lithotripsy
5048960|NCT03692689|Triple Negative Breast Neoplasms|triple negative breast neoplasms
5048961|NCT03692689|Breast Neoplasms|breast neoplasms
5048962|NCT03692689|Neoplasms by Site|neoplasms by site
5048963|NCT03692689|Neoplasms|neoplasms
5048964|NCT03692689|Epidermal growth factor receptor|epidermal growth factor receptor
5048965|NCT03692689|EGFR|egfr
5048966|NCT03692689|SCT200|sct200
5048977|NCT03692585|Patient Involvement|patient involvement
5048978|NCT03692585|eHealth Literacy|ehealth literacy
5048979|NCT03692572|Neural control|neural control
5048980|NCT03692572|Cardiovascular function|cardiovascular function
5048981|NCT03692572|Inorganic nitrate supplementation|inorganic nitrate supplementation
5048982|NCT03692559|CRBSI|crbsi
5048983|NCT03692559|CLABSI|clabsi
5048984|NCT03692533|Geminin, prognosis|geminin, prognosis
5048985|NCT03692520|Neoplasms|neoplasms
5048986|NCT03692520|Solid Tumors|solid tumors
5048987|NCT03692520|Epidermal growth factor receptor|epidermal growth factor receptor
5048988|NCT03692520|EGFR|egfr
5048989|NCT03692520|SCT200|sct200
5048990|NCT03692507|HMB: β-hydroxy β-methylbutyrate|hmb: β-hydroxy β-methylbutyrate
5048991|NCT03692507|MNA: Mini Nutrition Assessment|mna: mini nutrition assessment
5048992|NCT03692507|GMS: Graz Malnutrition Screening|gms: graz malnutrition screening
5048993|NCT03692507|MUST: Malnutrition Universal Screening Tool|must: malnutrition universal screening tool
5048994|NCT03692507|MST: Malnutrition Screening Tool|mst: malnutrition screening tool
5048995|NCT03692507|SGA: Subjective Global Assessment|sga: subjective global assessment
5048996|NCT03692507|REE: Resting Energy Expenditure|ree: resting energy expenditure
5048997|NCT03692507|IC: Indirect calorimetry|ic: indirect calorimetry
5048998|NCT03692481|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5048999|NCT03692481|18FDG uptake|18fdg uptake
5049000|NCT03692481|prognosis|prognosis
5049001|NCT03692455|GERD|gerd
5049002|NCT03692455|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5049003|NCT03692455|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
5049005|NCT03692442|cytokine|cytokine
5049006|NCT03692442|efficacy|efficacy
5049007|NCT03692442|side effect|side effect
5049008|NCT03692429|unresectable metastatic colorectal cancer|unresectable metastatic colorectal cancer
5049009|NCT03692416|C3,C4, C5a & ANCA|c3,c4, c5a & anca
5049010|NCT03692390|Virtual Reality|virtual reality
5049011|NCT03692390|Heart Rate|heart rate
5049012|NCT03692390|Blood Pressure|blood pressure
5049013|NCT03692377|Virtual Reality|virtual reality
5049014|NCT03692364|biomaterials|biomaterials
5049015|NCT03692364|Implant wear|implant wear
5049016|NCT03692364|hip arthroplasty|hip arthroplasty
5049017|NCT03692364|osteolysis|osteolysis
5049040|NCT03692299|Saccaromyces boulardii|saccaromyces boulardii
5049041|NCT03692247|pain|pain
5049042|NCT03692247|music|music
5049043|NCT03692234|homoarginine|homoarginine
5049044|NCT03692221|Back pain|back pain
5049045|NCT03692208|Geriatrics|geriatrics
5049046|NCT03692195|sleep|sleep
5049047|NCT03692195|healthy volunteers|healthy volunteers
5049048|NCT03692195|sleep study|sleep study
5049049|NCT03692182|Antipsychotic|antipsychotic
5049051|NCT03692169|Central serous chorioretinopathy|central serous chorioretinopathy
5049052|NCT03692156|sternocleidomastoid muscle|sternocleidomastoid muscle
5049053|NCT03692156|Superficial Cervical Plexus block|superficial cervical plexus block
5049054|NCT03692156|ultrasound|ultrasound
5049055|NCT03692130|Acceptance|acceptance
5049056|NCT03692130|Mindfulness|mindfulness
5049057|NCT03692130|Commitment|commitment
5049058|NCT03692130|Group-Psychotherapy|group-psychotherapy
5049059|NCT03692117|COPD Exacerbation|copd exacerbation
5049060|NCT03692117|Severe|severe
5049061|NCT03692117|ECCO2R|ecco2r
5049062|NCT03692117|invasive mechanical ventilation|invasive mechanical ventilation
5049063|NCT03692104|prostate cancer|prostate cancer
5049064|NCT03692104|brachytherapy|brachytherapy
5049065|NCT03692104|Quality assurance|quality assurance
5049066|NCT03692065|Cancer|cancer
5049067|NCT03692065|VTE|vte
5049068|NCT03692065|Apixaban|apixaban
5049069|NCT03692065|Thrombosis|thrombosis
5049070|NCT03692026|post-extraction implant, dental implant|post-extraction implant, dental implant
5049071|NCT03692026|melatonin|melatonin
5049072|NCT03692026|Hyaluronic acid|hyaluronic acid
5049073|NCT03692013|Nocturnal hypertension,Peritoneal dialysis,Losartan|nocturnal hypertension,peritoneal dialysis,losartan
5049074|NCT03692000|eHealth Literacy|ehealth literacy
5049075|NCT03692000|Health Literacy|health literacy
5049076|NCT03692000|Computer Literacy|computer literacy
5049077|NCT03692000|Software Design|software design
5049079|NCT03692000|Health Behavior|health behavior
5049080|NCT03691987|fecal transplantation|fecal transplantation
5049081|NCT03691987|bacterio therapy|bacterio therapy
5049082|NCT03691987|fatigue|fatigue
5049083|NCT03691987|fecal microbiota transplantation|fecal microbiota transplantation
5049084|NCT03691935|kidney|kidney
5049085|NCT03691935|surgery|surgery
5049086|NCT03691935|analgesia|analgesia
5049087|NCT03691935|surgical incision|surgical incision
5049088|NCT03691935|opioid sparing|opioid sparing
5049089|NCT03691935|flank pain|flank pain
5049090|NCT03691935|local anesthesia|local anesthesia
5049091|NCT03691922|Shoulder|shoulder
5049092|NCT03691922|Pain|pain
5049093|NCT03691922|Erector Spinae Plane block|erector spinae plane block
5049094|NCT03691922|Surgery|surgery
5049095|NCT03691922|Arthroscopy|arthroscopy
5049096|NCT03691922|Periarticular infiltration|periarticular infiltration
5049097|NCT03691922|Post-Anesthesia Care Unit|post-anesthesia care unit
5049098|NCT03691922|Day Surgery Unit|day surgery unit
5049099|NCT03691922|Regional anesthesia|regional anesthesia
5049100|NCT03691922|Analgesia|analgesia
5049101|NCT03691909|arthritis|arthritis
5049102|NCT03691909|stem cells|stem cells
5049103|NCT03691909|MSCs|mscs
5049104|NCT03691909|adipose MSCs|adipose mscs
5049105|NCT03691896|premature|premature
5049106|NCT03691896|osteopenia|osteopenia
5049107|NCT03691896|Vit. D|vit. d
5049108|NCT03691896|LBW (low birth weight)|lbw (low birth weight)
5049109|NCT03691896|25OHD|25ohd
5049110|NCT03691883|tuberculosis, infectious diseases|tuberculosis, infectious diseases
5049111|NCT03691870|brain arteriovenous malformation|brain arteriovenous malformation
5049112|NCT03691870|Arteriovenous malformations|arteriovenous malformations
5049114|NCT03691870|BAVM|bavm
5049115|NCT03691870|stroke|stroke
5049116|NCT03691870|intracranial hemorrhage|intracranial hemorrhage
5049117|NCT03691870|congenital abnormalities|congenital abnormalities
5049118|NCT03691870|aneurysm|aneurysm
5049119|NCT03691870|vascular malformations|vascular malformations
5049121|NCT03691870|cardiovascular diseases|cardiovascular diseases
5049122|NCT03691870|vascular diseases|vascular diseases
5049124|NCT03691805|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5049125|NCT03691792|cognitive-behavioral therapy|cognitive-behavioral therapy
5049126|NCT03691792|light therapy|light therapy
5049127|NCT03691792|biomarkers|biomarkers
5049128|NCT03691792|treatment mechanisms|treatment mechanisms
5049131|NCT03691740|circadian, melatonin, preterm labor|circadian, melatonin, preterm labor
5049132|NCT03691688|aspirin; coronary artery disease, uric acid|aspirin; coronary artery disease, uric acid
5049133|NCT03691675|Drug-coated balloon|drug-coated balloon
5049134|NCT03691675|restenosis|restenosis
5049135|NCT03691675|dissection|dissection
5049136|NCT03691623|challenge study|challenge study
5049137|NCT03691623|RSV|rsv
5049138|NCT03691623|antiviral|antiviral
5049139|NCT03691623|RSV-A Memphis 37b|rsv-a memphis 37b
5049140|NCT03691558|ketogenic diet|ketogenic diet
5049141|NCT03691558|triathlon|triathlon
5049142|NCT03691558|VO2max|vo2max
5049143|NCT03691558|PPO|ppo
5049144|NCT03691545|physical activity|physical activity
5049145|NCT03691545|fruit and vegetable consumption|fruit and vegetable consumption
5049146|NCT03691545|telehealth|telehealth
5049147|NCT03691545|young adult cancer survivors|young adult cancer survivors
5049148|NCT03691545|rural-dwelling|rural-dwelling
5049149|NCT03691532|lipemia|lipemia
5049150|NCT03691532|feeding|feeding
5049151|NCT03691532|paraplegia|paraplegia
5049152|NCT03691532|tetraplegia|tetraplegia
5049153|NCT03691532|physical activity|physical activity
5049154|NCT03691532|macronutrient metabolism|macronutrient metabolism
5049158|NCT03691506|Cerebral Palsy|cerebral palsy
5049159|NCT03691506|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5049160|NCT03691467|immediate dental implant|immediate dental implant
5049161|NCT03691467|immediate implant|immediate implant
5049162|NCT03691467|hyaluronic acid|hyaluronic acid
5049163|NCT03691467|gengigel|gengigel
5960915|NCT04290247|Ultrasound|ultrasound
5049164|NCT03691454|gastric adenocarcinoma|gastric adenocarcinoma
5049165|NCT03691454|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5049166|NCT03691454|locally advanced|locally advanced
5049167|NCT03691454|Oxaliplatin|oxaliplatin
5049168|NCT03691454|S-1|s-1
5049169|NCT03691454|Docetaxel|docetaxel
5049170|NCT03691441|locally advanced|locally advanced
5049171|NCT03691441|transorally resectable|transorally resectable
5049172|NCT03691415|Double Chin Fat Reduction|double chin fat reduction
5049173|NCT03691363|child|child
5049174|NCT03691363|Adolescent|adolescent
5049175|NCT03691363|exercise|exercise
5049176|NCT03691363|rehabilitation|rehabilitation
5049177|NCT03691363|physical activity|physical activity
5049178|NCT03691363|virtual|virtual
5049179|NCT03691363|mobile health|mobile health
5049180|NCT03691311|rank|rank
5049181|NCT03691311|rankl|rankl
5049182|NCT03691311|denosumab|denosumab
5049183|NCT03691298|Suturefix|suturefix
5049184|NCT03691298|hip instability|hip instability
5049888|NCT03686098|Soy|soy
5049194|NCT03691220|Intervention|intervention
5049195|NCT03691220|Adherence|adherence
5049196|NCT03691181|Outpatient ventilator support|outpatient ventilator support
5049197|NCT03691168|Inherited retinal dystrophies, Gene screen|inherited retinal dystrophies, gene screen
5049198|NCT03691116|Mental Health|mental health
5049199|NCT03691116|Digital Intervention|digital intervention
5049200|NCT03691116|Alcohol|alcohol
5049201|NCT03691116|Tobacco|tobacco
5049202|NCT03691116|Diet|diet
5049203|NCT03691116|Physical Activity|physical activity
5049204|NCT03691116|Primary Health Care|primary health care
5049205|NCT03691090|PD-1Antibody|pd-1antibody
5049206|NCT03691090|advanced esophageal cancer|advanced esophageal cancer
5049207|NCT03691090|paclitaxel|paclitaxel
5049208|NCT03691090|cisplatin|cisplatin
5049209|NCT03691077|Multiple Sclerosis|multiple sclerosis
5049210|NCT03691077|Ocrelizumab|ocrelizumab
5049211|NCT03691077|Microglial cells Activation|microglial cells activation
5049212|NCT03691077|PET-IRM|pet-irm
5049213|NCT03691077|18F-DPA714|18f-dpa714
5049214|NCT03691064|Gastroenteropancreatic neuroendocrine tumours|gastroenteropancreatic neuroendocrine tumours
5049215|NCT03691025|robot assisted laparoscopic prostatectomy|robot assisted laparoscopic prostatectomy
5049216|NCT03691025|optic nerve sheath diameter|optic nerve sheath diameter
5049217|NCT03690973|Bone graft|bone graft
5049218|NCT03690973|Immediate dental implant|immediate dental implant
5049219|NCT03690973|Flap|flap
5049220|NCT03690973|Flapless|flapless
5049222|NCT03690869|Newly Diagnosed|newly diagnosed
5049223|NCT03690869|Recurrent|recurrent
5049224|NCT03690869|Refractory|refractory
5049225|NCT03690843|motor development|motor development
5049226|NCT03690843|toddler|toddler
5049227|NCT03690843|prediction|prediction
5049228|NCT03690830|Metabolomic|metabolomic
5049229|NCT03690830|Endometrial biomarkers|endometrial biomarkers
5049230|NCT03690830|Infertility|infertility
5049231|NCT03690804|kangaroo care|kangaroo care
5049232|NCT03690804|neonatal intensive care units|neonatal intensive care units
5049233|NCT03690804|autonomic co-regulation|autonomic co-regulation
5049234|NCT03690765|endometriosis|endometriosis
5049235|NCT03690765|dydrogesterone|dydrogesterone
5049236|NCT03690765|Duphaston®|duphaston®
5049237|NCT03690765|progestogens|progestogens
5049238|NCT03690765|pelvic pain|pelvic pain
5049239|NCT03690752|Obesity|obesity
5049240|NCT03690752|Alter-G Anti-Gravity Treadmill|alter-g anti-gravity treadmill
5049241|NCT03690752|6-minute walk test|6-minute walk test
5049242|NCT03690752|timed up and go test|timed up and go test
5049243|NCT03690752|physical activity enjoyment|physical activity enjoyment
5049244|NCT03690752|pain|pain
5049246|NCT03690713|fractional flow reserve|fractional flow reserve
5049247|NCT03690713|myocardial ischemia|myocardial ischemia
5049248|NCT03690713|coronary artery disease|coronary artery disease
5049249|NCT03690713|coronary flow reserve|coronary flow reserve
5049250|NCT03690713|index of microcirculatory resistance|index of microcirculatory resistance
5049251|NCT03690713|prognosis|prognosis
5049252|NCT03690713|percutaneous coronary intervention|percutaneous coronary intervention
5049253|NCT03690700|BFR Exercise|bfr exercise
5049254|NCT03690700|Spinal Cord Injury|spinal cord injury
5049256|NCT03690700|Neuromuscular Recovery|neuromuscular recovery
5049257|NCT03690700|Randomized controlled study|randomized controlled study
5049258|NCT03690700|Physical Function|physical function
5049259|NCT03690700|Quality of Life|quality of life
5049260|NCT03690687|Surgical Anastomosis|surgical anastomosis
5049261|NCT03690687|Enterostomy|enterostomy
5049262|NCT03690687|Mortality|mortality
5049263|NCT03690687|Morbidity|morbidity
5049264|NCT03690687|Abdominal Closure Techniques|abdominal closure techniques
5049265|NCT03690687|APACHE II|apache ii
5049266|NCT03690687|Secondary Peritonitis|secondary peritonitis
5049267|NCT03690687|Delayed Anastomosis|delayed anastomosis
5049268|NCT03690687|Primary Anastomosis|primary anastomosis
5049269|NCT03690687|Mannheim Peritonitis Index|mannheim peritonitis index
5049271|NCT03690674|Physical Activity|physical activity
5049272|NCT03690674|Behavioral Management Training|behavioral management training
5049273|NCT03690674|Mobile Health|mobile health
5960916|NCT04290247|X-ray|x-ray
5960917|NCT04290247|Fracture|fracture
5049274|NCT03690661|adolescent|adolescent
5049276|NCT03690661|social skills|social skills
5049277|NCT03690661|video game|video game
5049278|NCT03690635|treatment of gingival recession|treatment of gingival recession
5049279|NCT03690635|root coverage|root coverage
5049289|NCT03690583|Respiratory bacteria|respiratory bacteria
5049290|NCT03690570|Glioma|glioma
5049291|NCT03690570|Children|children
5049292|NCT03690570|Chemotherapy|chemotherapy
5049293|NCT03690570|treatment toxicitT|treatment toxicitt
5049294|NCT03690570|Survival|survival
5049295|NCT03690557|Delivery of Health Care|delivery of health care
5049296|NCT03690557|Rural Health|rural health
5049297|NCT03690557|Primary Health Care|primary health care
5049298|NCT03690557|Outcomes and Process Assessment (Health Care)|outcomes and process assessment (health care)
5049299|NCT03690518|cardiac rehabilitation|cardiac rehabilitation
5049300|NCT03690518|Congenital heart diseases|congenital heart diseases
5049301|NCT03690518|Heart defects, congenital|heart defects, congenital
5049302|NCT03690518|Adolescent|adolescent
5049303|NCT03690518|Young adult|young adult
5049304|NCT03690518|Physical activity|physical activity
5049305|NCT03690518|Cardio-pulmonary exercice test|cardio-pulmonary exercice test
5049306|NCT03690518|Oxygen uptake|oxygen uptake
5049307|NCT03690518|Muscular deconditioning|muscular deconditioning
5049308|NCT03690518|Patient education as topic|patient education as topic
5049309|NCT03690518|Quality of life|quality of life
5049310|NCT03690518|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5049311|NCT03690440|Borderline Ovarian Tumor (BOT)|borderline ovarian tumor (bot)
5049312|NCT03690440|Fertility-sparing surgery|fertility-sparing surgery
5049313|NCT03690440|Gynecology|gynecology
5049314|NCT03690440|Oncology|oncology
5049315|NCT03690414|Myopia control|myopia control
5049316|NCT03690414|Atropine eye drops|atropine eye drops
5049317|NCT03690414|Caffeine eye drops|caffeine eye drops
5049318|NCT03690414|Pupillary diameter|pupillary diameter
5049337|NCT03690375|elastin|elastin
5049338|NCT03690375|RNA|rna
5049339|NCT03690349|severe asthma exacerbation|severe asthma exacerbation
5049340|NCT03690349|Mold sensitization|mold sensitization
5049341|NCT03690323|Pancreatic cancer|pancreatic cancer
5049342|NCT03690323|Pancreatic neoplasms|pancreatic neoplasms
5049343|NCT03690323|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5049344|NCT03690323|Radiofrequency ablation|radiofrequency ablation
5049345|NCT03690323|Chemotherapy|chemotherapy
5049346|NCT03690297|adenoma detection rate|adenoma detection rate
5049347|NCT03690297|Linked Color Imaging|linked color imaging
5049348|NCT03690297|colonoscopy|colonoscopy
5049349|NCT03690258|muscle function; muscle fibers; systolic blood pressure|muscle function; muscle fibers; systolic blood pressure
5049350|NCT03690245|Congenital Heart Defect|congenital heart defect
5049351|NCT03690245|Newborn|newborn
5049352|NCT03690193|Ketogenic Diet|ketogenic diet
5049353|NCT03690193|Alzheimer's disease|alzheimer's disease
5049354|NCT03690141|Prostate Cancer|prostate cancer
5049355|NCT03690141|Castrate-resistant Prostate Cancer|castrate-resistant prostate cancer
5049356|NCT03690141|CRPC|crpc
5049357|NCT03690141|eFT508|eft508
5049358|NCT03690141|eFT508-0009|eft508-0009
5049359|NCT03690141|tomivosertib|tomivosertib
5049360|NCT03690128|Clinical deterioration|clinical deterioration
5049361|NCT03690128|Risk stratification|risk stratification
5049362|NCT03690128|Patient Safety|patient safety
5049363|NCT03690128|Early Warning Score|early warning score
5049364|NCT03690128|Monitoring|monitoring
5049365|NCT03690128|Clinical assessment|clinical assessment
5049366|NCT03690076|Heart|heart
5049367|NCT03690076|Mitochondria|mitochondria
5049381|NCT03689959|flexion deformity|flexion deformity
5049382|NCT03689959|hemiepiphysiodesis|hemiepiphysiodesis
5049383|NCT03689959|eight plate|eight plate
5049384|NCT03689959|children|children
5049385|NCT03689881|Sacroiliitis|sacroiliitis
5049386|NCT03689881|SI joint|si joint
5049387|NCT03689881|tomosynthesis|tomosynthesis
5049388|NCT03689881|CT|ct
5049389|NCT03689881|Xray|xray
5049390|NCT03689868|virtual reality|virtual reality
5049391|NCT03689751|multimedia|multimedia
5049392|NCT03689738|Resistant Starch|resistant starch
5049393|NCT03689738|Free Fatty Acids|free fatty acids
5049394|NCT03689738|Potato|potato
5049395|NCT03689738|Insulin sensitivity|insulin sensitivity
5049396|NCT03689738|Lipid Metabolism|lipid metabolism
5049410|NCT03689699|Immunotherapy|immunotherapy
5049411|NCT03689699|Nivolumab|nivolumab
5049412|NCT03689699|BMS-986253|bms-986253
5049413|NCT03689699|Degarelix|degarelix
5049414|NCT03689699|HuMax IL-8|humax il-8
5049415|NCT03689686|Noninvasive ventilation|noninvasive ventilation
5049416|NCT03689660|motivation|motivation
5049417|NCT03689660|neuromuscular disease|neuromuscular disease
5049418|NCT03689660|duchenne muscular dystrophy|duchenne muscular dystrophy
5049419|NCT03689660|spinal Muscular Atrophy|spinal muscular atrophy
5049421|NCT03689660|biofeedback training|biofeedback training
5049422|NCT03689608|intermittent fasting|intermittent fasting
5049423|NCT03689608|calorie restriction|calorie restriction
5049424|NCT03689608|prediabetes|prediabetes
5960918|NCT04290247|Diagnosis|diagnosis
5960919|NCT04290234|cognitive fear|cognitive fear
5960920|NCT04290234|fMRI|fmri
5049425|NCT03689595|Multiple Myeloma|multiple myeloma
5049426|NCT03689569|microbiome|microbiome
5049427|NCT03689569|inflammation|inflammation
5049428|NCT03689569|resistant starch|resistant starch
5049429|NCT03689569|exercise training|exercise training
5049430|NCT03689556|FLT PET/CT|flt pet/ct
5049431|NCT03689556|carbon ion radiation therapy|carbon ion radiation therapy
5049432|NCT03689556|re-irradiation|re-irradiation
5049433|NCT03689543|Perimenopause-related depression|perimenopause-related depression
5049434|NCT03689530|peer support|peer support
5049435|NCT03689504|Guatemala|guatemala
5049436|NCT03689504|indigenous|indigenous
5049437|NCT03689504|dietary diversity|dietary diversity
5049438|NCT03689504|chronic malnutrition|chronic malnutrition
5049439|NCT03689504|Maya|maya
5049440|NCT03689504|agriculture|agriculture
5049441|NCT03689504|behavior change|behavior change
5049442|NCT03689504|food insecurity|food insecurity
5049443|NCT03689491|rTMS|rtms
5049444|NCT03689491|visual feedback|visual feedback
5049445|NCT03689491|gait|gait
5049446|NCT03689478|Hyperthermic intravesical chemotherapy|hyperthermic intravesical chemotherapy
5049447|NCT03689478|Bladder cancer|bladder cancer
5049448|NCT03689465|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5049449|NCT03689465|posttransplantation cyclophosphamide|posttransplantation cyclophosphamide
5049450|NCT03689465|antithymocyte globulin|antithymocyte globulin
5049451|NCT03689465|viral infection|viral infection
5049452|NCT03689465|graft-versus-host disease|graft-versus-host disease
5049453|NCT03689426|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
5049454|NCT03689426|Tissue Characterisation|tissue characterisation
5049455|NCT03689426|Wearable Technology|wearable technology
5049456|NCT03689426|Prognosis|prognosis
5049457|NCT03689426|Response to Therapy|response to therapy
5049458|NCT03689413|neuromonitoring|neuromonitoring
5049459|NCT03689413|thyroid surgery|thyroid surgery
5049460|NCT03689387|cerebral vascular stroke|cerebral vascular stroke
5049461|NCT03689387|activity practice|activity practice
5049462|NCT03689361|migraine aura|migraine aura
5049463|NCT03689322|aging|aging
5049464|NCT03689322|whole body vibration|whole body vibration
5049465|NCT03689322|respiratory muscle training|respiratory muscle training
5049466|NCT03689309|Spontaneous breathing Trial|spontaneous breathing trial
5049472|NCT03689257|Crohn´s disease|crohn´s disease
5049473|NCT03689257|epidemiology|epidemiology
5049474|NCT03689257|incidence|incidence
5049475|NCT03689257|omics|omics
5049478|NCT03689192|Arginase 1|arginase 1
5049479|NCT03689166|Probiotics|probiotics
5049480|NCT03689166|Preterm birth|preterm birth
5049481|NCT03689166|Threatened preterm labour|threatened preterm labour
5049482|NCT03689140|mHealth|mhealth
5049483|NCT03689140|Mobile health|mobile health
5049484|NCT03689140|Telehealth|telehealth
5049485|NCT03689140|Pregnancy|pregnancy
5049486|NCT03689140|Tobacco|tobacco
5049487|NCT03689140|Cessation|cessation
5049488|NCT03689127|intubation|intubation
5049489|NCT03689127|pharyngitis|pharyngitis
5049490|NCT03689114|epilepsy|epilepsy
5049491|NCT03689114|antiepileptic drugs|antiepileptic drugs
5049492|NCT03689114|low dose|low dose
5049493|NCT03689114|standard dose|standard dose
5049494|NCT03689114|new diagnosis|new diagnosis
5049495|NCT03689049|Polypharmacy|polypharmacy
5049496|NCT03689049|Deprescribing|deprescribing
5049497|NCT03689049|Aged Adult|aged adult
5049498|NCT03689049|Elderly Patient|elderly patient
5049499|NCT03689049|Primary Health Care|primary health care
5049500|NCT03689049|Quality Improvement|quality improvement
5049501|NCT03689049|Practice Facilitation|practice facilitation
5049502|NCT03689049|Learning Collaborative|learning collaborative
5049503|NCT03689049|Electronic Medical Records (EMR)|electronic medical records (emr)
5049504|NCT03689036|malaria|malaria
5049505|NCT03689036|transmission|transmission
5049506|NCT03689036|Asymptomatic infeccion|asymptomatic infeccion
5049507|NCT03689036|malaria elimination|malaria elimination
5049508|NCT03689036|residual malaria|residual malaria
5049509|NCT03689036|Amazon|amazon
5049510|NCT03689023|Cardiovascular Diseases|cardiovascular diseases
5049511|NCT03689023|Health Promotion|health promotion
5049512|NCT03688997|simulator|simulator
5049513|NCT03688997|knot tying|knot tying
5049514|NCT03688997|vessel ligation|vessel ligation
5049515|NCT03688997|surgical training|surgical training
5049516|NCT03688932|aging|aging
5049517|NCT03688932|functional capacity|functional capacity
5049518|NCT03688932|muscle metabolism|muscle metabolism
5049519|NCT03688919|adolescents|adolescents
5049520|NCT03688919|Type 1 Diabetes|type 1 diabetes
5049542|NCT03688828|Saccharomyces Boulardii|saccharomyces boulardii
5049543|NCT03688828|Standard Quadruple Therapy|standard quadruple therapy
5049544|NCT03688763|insomnia|insomnia
5049546|NCT03688763|PTSD|ptsd
5049547|NCT03688750|heel height|heel height
5049548|NCT03688750|spinal configuration|spinal configuration
5049549|NCT03688750|phases of menstrual cycle|phases of menstrual cycle
5049550|NCT03688737|low level laser , cleft palate , healing|low level laser , cleft palate , healing
5049551|NCT03688711|glucagon|glucagon
5049552|NCT03688685|ET|et
5960921|NCT04290234|reactive fear|reactive fear
5049553|NCT03688685|Essential Tremor|essential tremor
5049554|NCT03688672|contact lens|contact lens
5049555|NCT03688672|soft contact lens|soft contact lens
5049556|NCT03688672|feasibility|feasibility
5049557|NCT03688620|Pilot study|pilot study
5049558|NCT03688620|Safety surveillance|safety surveillance
5049559|NCT03688620|Quadrivalent seasonal influenza vaccine|quadrivalent seasonal influenza vaccine
5049560|NCT03688620|Influenza|influenza
5049561|NCT03688607|NICU|nicu
5049562|NCT03688607|POKE|poke
5049563|NCT03688607|Length of Stay|length of stay
5049564|NCT03688607|Infection|infection
5049565|NCT03688607|Neonates|neonates
5049566|NCT03688581|Abortion|abortion
5049567|NCT03688581|Emergency contraception|emergency contraception
5049568|NCT03688581|Emergency pill|emergency pill
5049569|NCT03688581|Perception of pregnancy risk|perception of pregnancy risk
5049570|NCT03688581|Contraceptive failure|contraceptive failure
5049571|NCT03688542|Deprescribing|deprescribing
5049572|NCT03688542|Inappropriate Medication|inappropriate medication
5049573|NCT03688542|Nursing Homes|nursing homes
5049575|NCT03688516|memory|memory
5049576|NCT03688516|Williams-Beuren syndrome|williams-beuren syndrome
5049577|NCT03688490|aquagenic pruritus|aquagenic pruritus
5049578|NCT03688425|Intraocular Lens|intraocular lens
5049579|NCT03688425|trifocal|trifocal
5049580|NCT03688425|hydrophobic|hydrophobic
5049581|NCT03688412|Cardiac pacing, artificial|cardiac pacing, artificial
5049582|NCT03688412|Cardiac Resynchronizaton Therapy Devices|cardiac resynchronizaton therapy devices
5049586|NCT03688399|cataract|cataract
5049587|NCT03688399|PhysIOL|physiol
5049588|NCT03688386|Language intervention|language intervention
5049589|NCT03688386|Preterm reading|preterm reading
5049590|NCT03688386|Heart rate variability|heart rate variability
5049591|NCT03688386|Mother-infant interaction|mother-infant interaction
5049592|NCT03688386|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
5049593|NCT03688386|LENA|lena
5049594|NCT03688321|Probiotics|probiotics
5049595|NCT03688321|Group B Streptococcus|group b streptococcus
5049596|NCT03688321|Infection|infection
5049597|NCT03688321|Prevention|prevention
5049598|NCT03688308|Bone marrow aspirate|bone marrow aspirate
5049599|NCT03688308|Biologics|biologics
5049600|NCT03688295|complicated acute appendicitis|complicated acute appendicitis
5049601|NCT03688295|post-operative antibiotic therapy|post-operative antibiotic therapy
5049602|NCT03688269|regional anesthesia|regional anesthesia
5049603|NCT03688269|dexamethasone|dexamethasone
5049604|NCT03688269|ropivacaine|ropivacaine
5049606|NCT03688243|early AMD|early amd
5049607|NCT03688243|intermediate AMD|intermediate amd
5049608|NCT03688243|Geographic Atrophy|geographic atrophy
5049609|NCT03688243|nascent GA|nascent ga
5049610|NCT03688217|exclusive breastfeeding|exclusive breastfeeding
5049611|NCT03688217|health education|health education
5049612|NCT03688217|entertainment-education|entertainment-education
5049613|NCT03688217|low- and middle-income countries|low- and middle-income countries
5049614|NCT03688217|video-based|video-based
5049615|NCT03688217|narrative|narrative
5049616|NCT03688217|community-based|community-based
5049617|NCT03688204|Breast Cancer|breast cancer
5049618|NCT03688204|Breast Neoplasm|breast neoplasm
5049619|NCT03688204|Genetic Testing|genetic testing
5049620|NCT03688204|Breast Cancer Risk|breast cancer risk
5049621|NCT03688204|Cancer Risk|cancer risk
5049622|NCT03688204|Risk Score|risk score
5049623|NCT03688204|Genetic Risk Score|genetic risk score
5050019|NCT03685370|LOS|los
5049629|NCT03688178|Glioblastoma|glioblastoma
5049630|NCT03688178|Dendritic cells|dendritic cells
5049631|NCT03688178|Temozolomide|temozolomide
5049632|NCT03688178|Duke University|duke university
5049633|NCT03688178|Varlilumab|varlilumab
5049634|NCT03688165|Stroke|stroke
5049635|NCT03688165|End-effector|end-effector
5049636|NCT03688165|Exoskeleton|exoskeleton
5049637|NCT03688165|Treadmill-based gait training|treadmill-based gait training
5049638|NCT03688165|Over-ground gait training|over-ground gait training
5049639|NCT03688165|Rehabilitation|rehabilitation
5049644|NCT03688152|DLBCL|dlbcl
5049645|NCT03688152|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5049646|NCT03688152|phosphatidylinositol 3-kinase delta inhibitor|phosphatidylinositol 3-kinase delta inhibitor
5049647|NCT03688152|PI3Kδ|pi3kδ
5049648|NCT03688152|PIM kinases|pim kinases
5049649|NCT03688139|depression|depression
5049650|NCT03688139|major depressive disorder|major depressive disorder
5049651|NCT03688139|mental health|mental health
5049652|NCT03688139|mood disorder|mood disorder
5049653|NCT03688139|geriatric|geriatric
5049654|NCT03688139|late-life|late-life
5049655|NCT03688126|cognitive decline|cognitive decline
5049656|NCT03688126|dementia|dementia
5049657|NCT03688126|cognitive function|cognitive function
5049658|NCT03688074|Asthma|asthma
5049659|NCT03688074|Uncontrolled asthma|uncontrolled asthma
5049660|NCT03688074|Severe uncontrolled asthma|severe uncontrolled asthma
5049661|NCT03688061|Hepatitis|hepatitis
5049662|NCT03688061|Vaccine|vaccine
5049663|NCT03688061|Adenoviral-vector|adenoviral-vector
5049664|NCT03688061|human invariant chain|human invariant chain
5960922|NCT04290221|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
5926818|NCT04007770|19-179|19-179
5049665|NCT03688022|Relative Bioavailability and DDI study with MT-7117 and a proton pump inhibitor|relative bioavailability and ddi study with mt-7117 and a proton pump inhibitor
5049671|NCT03687983|GoldenFlow Peripheral Stent System|goldenflow peripheral stent system
5049672|NCT03687970|CIPN|cipn
5049673|NCT03687970|Neuropathic pain|neuropathic pain
5049674|NCT03687970|DLss|dlss
5049675|NCT03687970|Peripheral neuropathy|peripheral neuropathy
5049676|NCT03687944|Rheumatoid Arthritis|rheumatoid arthritis
5049677|NCT03687944|Unsupported Upper Limb Exercise Test|unsupported upper limb exercise test
5049678|NCT03687944|Validity|validity
5049679|NCT03687892|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5049680|NCT03687892|functional MRI|functional mri
5049681|NCT03687892|Theta Burst Stimulation|theta burst stimulation
5049682|NCT03687866|NIPT|nipt
5049683|NCT03687866|digital PCR|digital pcr
5049684|NCT03687866|trisomy 21|trisomy 21
5049685|NCT03687866|prenatal diagnosis|prenatal diagnosis
5062838|NCT03606369|Breast Neoplasm|breast neoplasm
5049687|NCT03687853|arterial infusion chemotherapy|arterial infusion chemotherapy
5049688|NCT03687853|liver metastases|liver metastases
5049689|NCT03687840|Diabetic Polyneuropathy|diabetic polyneuropathy
5049690|NCT03687840|Lower Extremity Burn Injury|lower extremity burn injury
5049691|NCT03687840|Spatio-Temporal Parameters of Gait|spatio-temporal parameters of gait
5049692|NCT03687840|Gait Symmetry|gait symmetry
5049693|NCT03687801|audiologic rehabilitation|audiologic rehabilitation
5049694|NCT03687801|hearing loss|hearing loss
5049695|NCT03687801|patient education|patient education
5049696|NCT03687801|patient participation|patient participation
5049697|NCT03687801|structured rehabilitation|structured rehabilitation
5049698|NCT03687801|internet interventions|internet interventions
5049699|NCT03687801|counseling|counseling
5049700|NCT03687788|Laughter therapy; Loneliness; Life Satisfaction; Older adults; Nursing|laughter therapy; loneliness; life satisfaction; older adults; nursing
5049701|NCT03687762|chronic pain|chronic pain
5049702|NCT03687762|mechanisms|mechanisms
5049703|NCT03687762|cognitive therapy|cognitive therapy
5049704|NCT03687762|mindfulness meditation|mindfulness meditation
5049705|NCT03687762|activation skills|activation skills
5049707|NCT03687606|Gonadotropin treatment|gonadotropin treatment
5049708|NCT03687606|human chorionic gonadotropin|human chorionic gonadotropin
5049709|NCT03687606|human menopausal gonadotropin|human menopausal gonadotropin
5049710|NCT03687580|Photobiomodulation|photobiomodulation
5049711|NCT03687580|Low-Level Laser Therapy|low-level laser therapy
5049712|NCT03687580|over the counter|over the counter
5049713|NCT03687541|In-hospital falls|in-hospital falls
5049714|NCT03687541|fall-related bleeding|fall-related bleeding
5049715|NCT03687541|anticoagulant-related bleeding|anticoagulant-related bleeding
5342950|NCT01981395|mood|mood
5049716|NCT03687541|antiplatelet-related bleeding|antiplatelet-related bleeding
5049722|NCT03687489|Abdominal Aortic Aneurysm Stent Graft System|abdominal aortic aneurysm stent graft system
5049725|NCT03687463|Decitabine|decitabine
5049726|NCT03687463|JMML|jmml
5049727|NCT03687450|yoga|yoga
5049728|NCT03687450|mindfulness|mindfulness
5049729|NCT03687450|meditation|meditation
5049730|NCT03687450|resident|resident
5049731|NCT03687450|residency|residency
5049732|NCT03687437|Oral lichen planus, mean platelet volume|oral lichen planus, mean platelet volume
5049733|NCT03687424|"Noninvasive Ventilation[Mesh]"|"noninvasive ventilation[mesh]"
5049734|NCT03687424|"Obesity[Mesh]"|"obesity[mesh]"
5049735|NCT03687424|"Deep Sedation[Mesh]"|"deep sedation[mesh]"
5049736|NCT03687424|"Hypoxia[Mesh]"|"hypoxia[mesh]"
5049737|NCT03687424|"Adult[Mesh]"|"adult[mesh]"
5049738|NCT03687424|"Airway management[Mesh]"|"airway management[mesh]"
5049746|NCT03687398|copy number|copy number
5049747|NCT03687385|"Noninvasive Ventilation[Mesh]"|"noninvasive ventilation[mesh]"
5049748|NCT03687385|"Airway management[Mesh]"|"airway management[mesh]"
5049749|NCT03687385|"Adult[Mesh]"|"adult[mesh]"
5049750|NCT03687385|"Colonoscopy[Mesh]"|"colonoscopy[mesh]"
5049751|NCT03687385|"Deep Sedation[Mesh]"|"deep sedation[mesh]"
5049752|NCT03687385|"Hypoxia[Mesh]"|"hypoxia[mesh]"
5049753|NCT03687372|common warts|common warts
5049755|NCT03687346|Eating disorder|eating disorder
5049756|NCT03687346|adolescent|adolescent
5049760|NCT03687307|class II,|class ii,
5049761|NCT03687307|soft tissue changes|soft tissue changes
5049762|NCT03687307|CBCT|cbct
5049763|NCT03687229|micro ribonucleic acid-122|micro ribonucleic acid-122
5049764|NCT03687229|insulin|insulin
5049765|NCT03687203|Activity of daily living function|activity of daily living function
5049766|NCT03687203|Cognitive impairment|cognitive impairment
5049767|NCT03687203|Parkinson's disease dementia|parkinson's disease dementia
5049768|NCT03687099|Glioblastoma|glioblastoma
5049769|NCT03687099|CD45|cd45
5049770|NCT03687099|Lymphocytes|lymphocytes
5049771|NCT03687099|Microglia|microglia
5049772|NCT03687099|Macrophage|macrophage
5049773|NCT03687047|DENTADURES|dentadures
5049774|NCT03687047|EDENTULOUS|edentulous
5049775|NCT03687047|MASTIGATORY PERFORMANCE|mastigatory performance
5049776|NCT03687021|endometrial receptivity|endometrial receptivity
5960923|NCT04290221|Trigger points|trigger points
5960924|NCT04290221|Lumbar nerve root|lumbar nerve root
5049779|NCT03687008|Cognition|cognition
5049780|NCT03687008|Working Memory|working memory
5049781|NCT03687008|Magnetic Resonance Imaging|magnetic resonance imaging
5049782|NCT03687008|Cogmed|cogmed
5049783|NCT03686943|Elderly|elderly
5049784|NCT03686943|Iatrogenic drug risk|iatrogenic drug risk
5049785|NCT03686943|Family pharmacy|family pharmacy
5049786|NCT03686917|diabetes|diabetes
5049787|NCT03686917|type 2 diabetes|type 2 diabetes
5049788|NCT03686917|diabetes mellitus|diabetes mellitus
5049789|NCT03686917|type 2 diabetes mellitus|type 2 diabetes mellitus
5049790|NCT03686917|outpatient|outpatient
5049791|NCT03686878|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5049792|NCT03686878|Dry Eye Disease|dry eye disease
5049793|NCT03686878|Eye Dryness|eye dryness
5049802|NCT03686826|multimodal evoked potentials (mmEP)|multimodal evoked potentials (mmep)
5049804|NCT03686787|melasma|melasma
5049805|NCT03686787|chloasma|chloasma
5049806|NCT03686787|tranexamic acid|tranexamic acid
5049807|NCT03686787|nonablative laser resurfacing|nonablative laser resurfacing
5049808|NCT03686787|sunscreen|sunscreen
5049809|NCT03686787|hyperpigmentation|hyperpigmentation
5049810|NCT03686774|Memantine|memantine
5049811|NCT03686774|post-mastectomy|post-mastectomy
5049812|NCT03686774|prophylaxis|prophylaxis
5049813|NCT03686774|Neuropathic pain|neuropathic pain
5049814|NCT03686774|Cognitive-emotional parameters|cognitive-emotional parameters
5049815|NCT03686761|Inflammation|inflammation
5049816|NCT03686761|Healing|healing
5049821|NCT03686696|Treatment|treatment
5049822|NCT03686696|ACE inhibitors|ace inhibitors
5049823|NCT03686696|Angiotensin receptor blockade|angiotensin receptor blockade
5049824|NCT03686696|Beta blockers|beta blockers
5049825|NCT03686683|ISUP Grade Group 1 or 2|isup grade group 1 or 2
5049826|NCT03686683|Number biopsies 1 or >1 (≤12 months of Screening)|number biopsies 1 or >1 (≤12 months of screening)
5049827|NCT03686657|Diabetes|diabetes
5049829|NCT03686657|FPG|fpg
5049830|NCT03686657|Beta cell function index|beta cell function index
5049831|NCT03686657|HbA1c|hba1c
5103100|NCT03353194|Canada|canada
5049832|NCT03686657|Atherogenic index|atherogenic index
5049833|NCT03686644|night splinting|night splinting
5049834|NCT03686644|stiffness|stiffness
5049835|NCT03686644|ankle foot orthoses|ankle foot orthoses
5049836|NCT03686644|teenager|teenager
5049837|NCT03686631|respiratory therapy|respiratory therapy
5049838|NCT03686631|Pulmonary Atelectasis|pulmonary atelectasis
5049839|NCT03686631|perioperative medicine|perioperative medicine
5049840|NCT03686631|incentive spirometry|incentive spirometry
5049841|NCT03686631|smartphone|smartphone
5049842|NCT03686592|Pancreatic cancer|pancreatic cancer
5049843|NCT03686592|body awareness|body awareness
5049844|NCT03686592|post-traumatic stress|post-traumatic stress
5049845|NCT03686514|Flu vaccine|flu vaccine
5049846|NCT03686514|Influenza vaccine|influenza vaccine
5049847|NCT03686514|Immune response|immune response
5049848|NCT03686514|Influenza strain|influenza strain
5049850|NCT03686475|Pulpotomy, Primary molars, Biodentine, MTA.|pulpotomy, primary molars, biodentine, mta.
5049851|NCT03686436|unrecognized condition|unrecognized condition
5049852|NCT03686423|Exercise|exercise
5049853|NCT03686410|Fibromyalgia|fibromyalgia
5049854|NCT03686410|Therapeutic Patient Education|therapeutic patient education
5049855|NCT03686410|Educational Technology|educational technology
5049856|NCT03686410|Mixed Methods Research|mixed methods research
5049860|NCT03686345|Chemotherapy|chemotherapy
5049861|NCT03686345|Relapse Incidence|relapse incidence
5049862|NCT03686345|Overall Survival|overall survival
5049863|NCT03686345|Disease Free Survival|disease free survival
5049864|NCT03686345|Minimal Residual Disease monitoring|minimal residual disease monitoring
5049865|NCT03686332|Radiotherapy|radiotherapy
5049866|NCT03686332|Immunotherapy|immunotherapy
5049873|NCT03686267|implants- titanium abutments- all ceramic crowns- lithium disilicate- color measurements- pink and white aesthetics|implants- titanium abutments- all ceramic crowns- lithium disilicate- color measurements- pink and white aesthetics
5049877|NCT03686215|breast cancer surgery|breast cancer surgery
5049879|NCT03686189|Iliac Bifurcation Stent Graft System|iliac bifurcation stent graft system
5049880|NCT03686163|Acute Ischemic stroke|acute ischemic stroke
5049881|NCT03686163|Nerve Growth Factor|nerve growth factor
5049882|NCT03686163|Intranasal|intranasal
5049883|NCT03686163|Neurological Function|neurological function
5049884|NCT03686150|pediatric obesity|pediatric obesity
5049889|NCT03686098|Prevention|prevention
5049891|NCT03686098|Breast Cancer|breast cancer
5049892|NCT03686098|Mammographic Density|mammographic density
5049893|NCT03686098|Isoflavones|isoflavones
5049894|NCT03686046|Hearing aid|hearing aid
5049902|NCT03686020|Oral potentially malignant lesions|oral potentially malignant lesions
5049903|NCT03686020|Oral cancer|oral cancer
5049904|NCT03686020|salivary CYFRA21-1|salivary cyfra21-1
5049905|NCT03686020|serum CYFRA21-1|serum cyfra21-1
5049906|NCT03685942|light therapy|light therapy
5049907|NCT03685929|Pressure ulcer|pressure ulcer
5049908|NCT03685929|Incontinence-associated dermatitis|incontinence-associated dermatitis
5049909|NCT03685929|Histopathology|histopathology
5049910|NCT03685929|Ischemia|ischemia
5049911|NCT03685929|Irritation|irritation
5049912|NCT03685929|Prevention|prevention
5049914|NCT03685929|Skin|skin
5049915|NCT03685838|mechano-chemical ablation|mechano-chemical ablation
5050315|NCT03683290|Embryo|embryo
5049919|NCT03685812|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5049921|NCT03685812|position sense|position sense
5049922|NCT03685812|validity|validity
5049923|NCT03685812|reliability|reliability
5049924|NCT03685799|Barretts Esophagus|barretts esophagus
5049925|NCT03685799|Dysplasia|dysplasia
5049926|NCT03685773|diabetes|diabetes
5049927|NCT03685773|type 2 diabetes|type 2 diabetes
5049928|NCT03685773|diazoxide|diazoxide
5049929|NCT03685773|insulin resistance|insulin resistance
5049930|NCT03685773|MRI|mri
5049931|NCT03685773|liver transplant|liver transplant
5049932|NCT03685760|Mechanically Ventilated Older Adults|mechanically ventilated older adults
5049933|NCT03685760|Reiki|reiki
5049934|NCT03685760|Pain|pain
5049935|NCT03685760|Agitation|agitation
5049936|NCT03685760|Delirium|delirium
5049937|NCT03685747|Vancomycin|vancomycin
5049938|NCT03685747|Pharmacokinetics|pharmacokinetics
5049939|NCT03685747|Pharmacodynamics|pharmacodynamics
5049940|NCT03685747|Automated Peritoneal Dialysis|automated peritoneal dialysis
5049941|NCT03685734|DSAEK|dsaek
5049942|NCT03685721|ATP|atp
5049943|NCT03685721|Trait|trait
5049944|NCT03685721|GDP|gdp
5049945|NCT03685721|Genetics|genetics
5049946|NCT03685708|Ibrutinib|ibrutinib
5049947|NCT03685708|Acalabrutinib|acalabrutinib
5049948|NCT03685708|Immunology|immunology
5049949|NCT03685669|DNA methylation|dna methylation
5049950|NCT03685669|ctDNA|ctdna
5049951|NCT03685656|Overweight|overweight
5049952|NCT03685656|Obesity|obesity
5049953|NCT03685656|Slimming gel|slimming gel
5049954|NCT03685656|Cosmetic product|cosmetic product
5049955|NCT03685656|Waist circumference|waist circumference
5049956|NCT03685656|Thigh circumference|thigh circumference
5049957|NCT03685643|Peer-led, dating applications, young adults, sexual behavior|peer-led, dating applications, young adults, sexual behavior
5049958|NCT03685630|Brivaracetam|brivaracetam
5049959|NCT03685630|Epilepsy|epilepsy
5049960|NCT03685630|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
5049961|NCT03685630|Japanese subjects|japanese subjects
5049962|NCT03685604|chlorhexidine in alcoholic solution|chlorhexidine in alcoholic solution
5049963|NCT03685604|PVP iodine in alcoholic solution|pvp iodine in alcoholic solution
5049964|NCT03685604|preoperative skin antisepsis|preoperative skin antisepsis
5049965|NCT03685591|efficacy|efficacy
5049966|NCT03685591|safety|safety
5049967|NCT03685591|pharmacokinetics|pharmacokinetics
5049968|NCT03685591|dose escalation|dose escalation
5049969|NCT03685591|dose expansion|dose expansion
5049970|NCT03685591|open-label|open-label
5049971|NCT03685591|TGFb|tgfb
5049972|NCT03685591|transforming growth factor beta|transforming growth factor beta
5049973|NCT03685591|breast cancer|breast cancer
5049974|NCT03685591|prostate cancer|prostate cancer
5049976|NCT03685591|HER2 negative|her2 negative
5049977|NCT03685591|CRPC|crpc
5049978|NCT03685591|metastatic|metastatic
5049980|NCT03685591|adenocarcinoma|adenocarcinoma
5049981|NCT03685578|Mechanical thrombectomy, EmboTrap|mechanical thrombectomy, embotrap
5049982|NCT03685565|facial laceration|facial laceration
5049983|NCT03685565|pediatric|pediatric
5049984|NCT03685565|dermabond|dermabond
5049985|NCT03685565|skin glue|skin glue
5049986|NCT03685565|steristrips|steristrips
5049987|NCT03685565|skin adhesive|skin adhesive
5049988|NCT03685565|scar|scar
5049989|NCT03685565|cosmesis|cosmesis
5049990|NCT03685487|decolonization|decolonization
5049991|NCT03685487|mupirocin|mupirocin
5049992|NCT03685487|cardiac surgery|cardiac surgery
5050001|NCT03685435|Gastric volume|gastric volume
5050007|NCT03685396|Connective tissue graft|connective tissue graft
5050008|NCT03685396|Platelet concentrates|platelet concentrates
5050010|NCT03685396|Mucogingival surgery|mucogingival surgery
5050011|NCT03685383|Extracorporeal Circulation|extracorporeal circulation
5050012|NCT03685383|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5050013|NCT03685383|Cytokine Adsorption|cytokine adsorption
5050014|NCT03685383|Post-Cardiac Arrest Syndrome|post-cardiac arrest syndrome
5050015|NCT03685383|Cardiac Arrest|cardiac arrest
5050016|NCT03685383|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
5050017|NCT03685370|Epidural catheter|epidural catheter
5050018|NCT03685370|postoperative pain|postoperative pain
5050026|NCT03685253|neuropathy|neuropathy
5050027|NCT03685253|treatment|treatment
5050028|NCT03685253|drug|drug
5050029|NCT03685227|Yoga Nidra|yoga nidra
5050030|NCT03685227|Electroencephalography|electroencephalography
5050031|NCT03685227|Electrocardiography|electrocardiography
5050032|NCT03685227|Respiratory rate|respiratory rate
5050033|NCT03685214|sepsis|sepsis
5050034|NCT03685214|intensive care unit|intensive care unit
5050035|NCT03685214|acetated Ringer's solution|acetated ringer's solution
5050036|NCT03685214|AKI|aki
5050037|NCT03685214|normal saline|normal saline
5960925|NCT04290221|Randomized clinical trial|randomized clinical trial
5960926|NCT04290208|Humans|humans
5050038|NCT03685214|prognosis|prognosis
5050039|NCT03685214|continuous renal replacement therapy|continuous renal replacement therapy
5050040|NCT03685201|orange pomace fiber|orange pomace fiber
5050041|NCT03685201|glycemic response|glycemic response
5050042|NCT03685201|Orange|orange
5050043|NCT03685175|Magnetic Resonance Imaging|magnetic resonance imaging
5050044|NCT03685175|Doxorubicin|doxorubicin
5050050|NCT03685149|arrhythmogenic right ventricular cardiomyopathy|arrhythmogenic right ventricular cardiomyopathy
5050051|NCT03685149|ARVC|arvc
5050052|NCT03685149|Flecainide|flecainide
5050053|NCT03685149|ventricualr arrhythmias|ventricualr arrhythmias
5050054|NCT03685149|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5050055|NCT03685123|Exercise training|exercise training
5050056|NCT03685123|Insulin resistance|insulin resistance
5050057|NCT03685123|Lipids|lipids
5050058|NCT03685123|Arterial stiffness|arterial stiffness
5050059|NCT03685123|Fitness|fitness
5050060|NCT03685123|Weight maintenance|weight maintenance
5050061|NCT03685123|Body composition|body composition
5050062|NCT03685123|Energy expenditure|energy expenditure
5050063|NCT03685123|Weight loss|weight loss
5050064|NCT03685110|Hip Arthroplasty|hip arthroplasty
5050065|NCT03685110|Hip Prosthesis|hip prosthesis
5050066|NCT03685058|Initial caries treatment|initial caries treatment
5050067|NCT03685058|Non-cavitated caries treatment|non-cavitated caries treatment
5050068|NCT03685058|Incipient caries treatment|incipient caries treatment
5050069|NCT03685058|Proximal caries|proximal caries
5050070|NCT03685058|Primary teeth|primary teeth
5050071|NCT03685058|Light curable resin modified glass ionomer varnish|light curable resin modified glass ionomer varnish
5050072|NCT03685058|Vanish XT varnish|vanish xt varnish
5050073|NCT03685058|Clinpro XT varnish|clinpro xt varnish
5050074|NCT03685058|Dental white spot lesions|dental white spot lesions
5050075|NCT03685045|hepatitis c|hepatitis c
5050076|NCT03685045|opioid substitution settings|opioid substitution settings
5050078|NCT03685045|people who inject drugs|people who inject drugs
5050079|NCT03685045|direct-acting antiviral treatment|direct-acting antiviral treatment
5050080|NCT03684980|Voraxaze (glucarpidase)|voraxaze (glucarpidase)
5050081|NCT03684980|B-cell non-Hodgkin‟s lymphoma involving the brain|b-cell non-hodgkin‟s lymphoma involving the brain
5050082|NCT03684980|B-cell non-Hodgkin‟s lymphoma involving spinal cord, and/or leptomeningeal space|b-cell non-hodgkin‟s lymphoma involving spinal cord, and/or leptomeningeal space
5050083|NCT03684915|Rotary instrumentation|rotary instrumentation
5050084|NCT03684915|pulpectomy|pulpectomy
5050085|NCT03684915|primary teeth|primary teeth
5050087|NCT03684876|cardiac surgery|cardiac surgery
5050088|NCT03684876|venous congestion|venous congestion
5050089|NCT03684876|diuretic depletion|diuretic depletion
5050090|NCT03684850|Knee brace|knee brace
5050091|NCT03684850|biomechanical footwear|biomechanical footwear
5050092|NCT03684850|exercise|exercise
5050094|NCT03684798|MCII|mcii
5050095|NCT03684798|Alcohol Use Disorder|alcohol use disorder
5050096|NCT03684798|Motivation|motivation
5050097|NCT03684798|Mental Contrasting|mental contrasting
5050107|NCT03684733|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5050108|NCT03684733|X-ray mammography (XRM)|x-ray mammography (xrm)
5428242|NCT01595555|social media|social media
5050129|NCT03684577|Hypnosis|hypnosis
5050130|NCT03684577|Wait-list|wait-list
5050131|NCT03684551|Community Health Worker|community health worker
5050132|NCT03684551|Health worker supervision|health worker supervision
5050133|NCT03684551|Mali|mali
5050134|NCT03684551|Randomized controlled trial|randomized controlled trial
5050135|NCT03684525|Mesioangular displaced canines|mesioangular displaced canines
5050136|NCT03684525|Interceptive treatment|interceptive treatment
5050137|NCT03684486|bronchial cancer|bronchial cancer
5050138|NCT03684486|rehabilitation|rehabilitation
5050139|NCT03684473|Yoga|yoga
5050140|NCT03684473|Mindfulness Meditation|mindfulness meditation
5050141|NCT03684473|Online|online
5050142|NCT03684473|Posttraumatic Stress Disorder|posttraumatic stress disorder
5050143|NCT03684473|Young Adulthood|young adulthood
5050144|NCT03684460|circadian misalignment|circadian misalignment
5050145|NCT03684460|bright light|bright light
5050146|NCT03684460|entrainment|entrainment
5050147|NCT03684460|zeitgeber|zeitgeber
5050148|NCT03684460|critical illness|critical illness
5050149|NCT03684460|delirium|delirium
5050150|NCT03684460|actigraphy|actigraphy
5050151|NCT03684434|Anxiety|anxiety
5050152|NCT03684434|Depression|depression
5050153|NCT03684434|Internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5050154|NCT03684434|Motivational Interviewing|motivational interviewing
5050155|NCT03684434|Randomized controlled trial|randomized controlled trial
5050156|NCT03684434|Pre-treatment|pre-treatment
5050157|NCT03684434|Mental health system|mental health system
5050158|NCT03684421|Long Antagonist|long antagonist
5050159|NCT03684421|Classical Antagonist|classical antagonist
5050160|NCT03684421|live birth rate|live birth rate
5050161|NCT03684421|clinical pregnancy rate|clinical pregnancy rate
5050162|NCT03684421|ovarian stimulation|ovarian stimulation
5050163|NCT03684421|IVF|ivf
5050164|NCT03684382|anticipatory grief intervention|anticipatory grief intervention
5050165|NCT03684382|randomized controlled trial|randomized controlled trial
5050166|NCT03684382|narrative therapy|narrative therapy
5050167|NCT03684382|therapist-facilitated e-counselling|therapist-facilitated e-counselling
5050168|NCT03684369|walking|walking
5050169|NCT03684369|balance|balance
5050170|NCT03684369|fatigue|fatigue
5050171|NCT03684317|Pharmacology|pharmacology
5050172|NCT03684317|Psychiatry|psychiatry
5050173|NCT03684291|Mechanical ventilation|mechanical ventilation
5050174|NCT03684291|Laparoscopic surgery|laparoscopic surgery
5050175|NCT03684291|Hemodynamics|hemodynamics
5050176|NCT03684252|Self-stigma|self-stigma
5050177|NCT03684252|Drug Use Disorders|drug use disorders
5050178|NCT03684252|HIV|hiv
5050179|NCT03684213|Racial Differences|racial differences
5050180|NCT03684213|Oxidative Stress|oxidative stress
5050181|NCT03684213|Antioxidant|antioxidant
5050182|NCT03684213|Microvasculature|microvasculature
5050183|NCT03684174|Tonometry|tonometry
5050184|NCT03684161|Congenital Heart Disease|congenital heart disease
5050185|NCT03684161|Ventricular Septal Defect|ventricular septal defect
5050186|NCT03684161|Long-term Outcome|long-term outcome
5050187|NCT03684161|Cardiopulmonary Function|cardiopulmonary function
5050188|NCT03684148|osteoarthritis|osteoarthritis
5050189|NCT03684148|muscle voluntary activation|muscle voluntary activation
5050190|NCT03684148|knee replacement|knee replacement
5050191|NCT03684148|cognitive training|cognitive training
5050192|NCT03684148|functional performance|functional performance
5050193|NCT03684148|randomized controlled trial|randomized controlled trial
5050194|NCT03684135|Breast cancer|breast cancer
5050195|NCT03684135|Cosmetics|cosmetics
5050196|NCT03684135|Satisfaction|satisfaction
5050197|NCT03684135|Chemotherapy|chemotherapy
5050198|NCT03684135|Thermal cure|thermal cure
5050199|NCT03684122|Umbilical cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5050200|NCT03684122|Parkinson Disease|parkinson disease
5050201|NCT03684122|Neurodegenerative|neurodegenerative
5050202|NCT03684122|allogeneic|allogeneic
5050212|NCT03684070|Older adults|older adults
5050213|NCT03684070|Asian Americans|asian americans
5050214|NCT03684070|Chinese|chinese
5050215|NCT03684070|behavior change|behavior change
5050216|NCT03684057|Worry|worry
5050217|NCT03684031|Reactive Aggression|reactive aggression
5050218|NCT03684031|Anger|anger
5050219|NCT03684031|Cognitive Control Training|cognitive control training
5050220|NCT03684031|Anger Rumination|anger rumination
5050221|NCT03683979|Reactive aggression|reactive aggression
5050222|NCT03683979|High trait anger|high trait anger
5050232|NCT03683953|BPD|bpd
5050233|NCT03683940|Pilot Study|pilot study
5050234|NCT03683940|High Risk|high risk
5050235|NCT03683940|Prospective|prospective
5050236|NCT03683940|Screening|screening
5050237|NCT03683927|Respiratory infections|respiratory infections
5050238|NCT03683927|Probiotics|probiotics
5050239|NCT03683927|Microbiome|microbiome
5050240|NCT03683927|Viruses|viruses
5050241|NCT03683927|Children|children
5050242|NCT03683901|Electrical stimulation therapy|electrical stimulation therapy
5050243|NCT03683901|TENS|tens
5235482|NCT02530658|DNA|dna
5050244|NCT03683901|t-NMES|t-nmes
5050245|NCT03683901|Stroke|stroke
5050246|NCT03683888|epicardial fat|epicardial fat
5050247|NCT03683862|hawley|hawley
5050248|NCT03683862|thermoplastic|thermoplastic
5050249|NCT03683862|orthodontic retention|orthodontic retention
5050250|NCT03683862|compliance|compliance
5050251|NCT03683862|vacuum- formed|vacuum- formed
5050252|NCT03683810|hemoglobin|hemoglobin
5050253|NCT03683810|quality of life|quality of life
5050254|NCT03683758|football|football
5050255|NCT03683758|soccer|soccer
5050256|NCT03683758|warm-up|warm-up
5050257|NCT03683758|FIFA|fifa
5050258|NCT03683758|11+|11+
5050259|NCT03683758|performance|performance
5050260|NCT03683758|speed|speed
5050261|NCT03683758|agility|agility
5050262|NCT03683758|jump|jump
5050263|NCT03683745|disease burden|disease burden
5050264|NCT03683693|procalcitonin|procalcitonin
5050265|NCT03683693|antibiotic stewardship in ICU|antibiotic stewardship in icu
5050266|NCT03683693|Multidrug resistance|multidrug resistance
5050267|NCT03683693|neurocritical care|neurocritical care
5050268|NCT03683680|Mesothelioma|mesothelioma
5050269|NCT03683667|linear growth|linear growth
5050270|NCT03683667|infant feeding|infant feeding
5050271|NCT03683667|environmental enteric dysfunction|environmental enteric dysfunction
5729826|NCT00395135|APD356|apd356
5050272|NCT03683641|Insertional Achilles Tendinopathy|insertional achilles tendinopathy
5050273|NCT03683641|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5050274|NCT03683641|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
5050275|NCT03683615|Resorbable, blow out fractures|resorbable, blow out fractures
5050276|NCT03683602|PNF, manual therapy, neck pain|pnf, manual therapy, neck pain
5050277|NCT03683576|GB001|gb001
5050278|NCT03683576|eosinophilic asthma|eosinophilic asthma
5050279|NCT03683576|moderate asthma|moderate asthma
5050280|NCT03683576|severe asthma|severe asthma
5050281|NCT03683563|Dialysis catheters|dialysis catheters
5050282|NCT03683563|Citrate|citrate
5050283|NCT03683563|Locking solution|locking solution
5050284|NCT03683550|SLNE|slne
5050285|NCT03683550|SPECT/CT|spect/ct
5050286|NCT03683524|Simplification strategy|simplification strategy
5050287|NCT03683524|Multidrug resistant|multidrug resistant
5050288|NCT03683524|Dolutegravir|dolutegravir
5050289|NCT03683524|Darunavir/cobicistat|darunavir/cobicistat
5050290|NCT03683524|Bitherapy|bitherapy
5050291|NCT03683511|amikacin|amikacin
5050292|NCT03683498|Ruxolitinib|ruxolitinib
5050293|NCT03683498|T cells|t cells
5050294|NCT03683485|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5050295|NCT03683472|Anxiety, worry, mindfulness, meditation|anxiety, worry, mindfulness, meditation
5050296|NCT03683459|FemFlow|femflow
5050297|NCT03683459|Drug-eluting peripheral balloon catheter|drug-eluting peripheral balloon catheter
5050298|NCT03683446|Colorectal Cancer|colorectal cancer
5050299|NCT03683446|Colorectal|colorectal
5050300|NCT03683446|Colorectal surgery|colorectal surgery
5050301|NCT03683446|Surgical complications|surgical complications
5050302|NCT03683446|Rectal|rectal
5050303|NCT03683446|Rectal Cancer|rectal cancer
5050328|NCT03683199|Correction|correction
5050329|NCT03683199|Objective|objective
5050330|NCT03683199|Assessment|assessment
5050337|NCT03683173|Physical Activity|physical activity
5050338|NCT03683173|Rural|rural
5050339|NCT03683173|Cancer Prevention|cancer prevention
5050340|NCT03683160|Stroke, mobility, cognitive strategy training|stroke, mobility, cognitive strategy training
5050341|NCT03683134|Cardiovascular Disease|cardiovascular disease
5050342|NCT03683134|Mediterranean Diet|mediterranean diet
5050343|NCT03683134|Nutrition education|nutrition education
5050344|NCT03683121|Esophagogastric variceal hemorrhage|esophagogastric variceal hemorrhage
5050345|NCT03683121|cirrhosis|cirrhosis
5050346|NCT03683121|secondary prevention|secondary prevention
5050347|NCT03683121|Non-selective beta blocker|non-selective beta blocker
5050348|NCT03683121|compliance|compliance
5050349|NCT03683095|Lymphedema|lymphedema
5050350|NCT03683095|Lymphovenous bypass|lymphovenous bypass
5095672|NCT03400397|CBT|cbt
5050351|NCT03683056|Prevention|prevention
5050352|NCT03683056|Promotion|promotion
5050353|NCT03683056|Mental Health|mental health
5050354|NCT03683030|Interventional|interventional
5050355|NCT03683030|Radiofrequency Ablation|radiofrequency ablation
5050367|NCT03682978|Social Function|social function
5050369|NCT03682978|Safety|safety
5050370|NCT03682978|Tolerability|tolerability
5050371|NCT03682978|Children|children
5050372|NCT03682978|Adolescents|adolescents
5050373|NCT03682978|ASD|asd
5050374|NCT03682965|Mountain Cedar|mountain cedar
5050375|NCT03682965|Juniperus Ashei|juniperus ashei
5050376|NCT03682965|Pollinosis|pollinosis
5050377|NCT03682965|Intra-lymphatic|intra-lymphatic
5050378|NCT03682952|Chronic Renal Disease|chronic renal disease
5050379|NCT03682952|Nail fold microcirculation|nail fold microcirculation
5050380|NCT03682952|Interventional therapy|interventional therapy
5349331|NCT01952236|web|web
5369104|NCT01861366|Nursing home|nursing home
5050381|NCT03682939|vaccination|vaccination
5050382|NCT03682939|HIV|hiv
5050383|NCT03682939|meningitis|meningitis
5050384|NCT03682939|Vaccine|vaccine
5050385|NCT03682939|Immunogenicity|immunogenicity
5050386|NCT03682939|Safety|safety
5050387|NCT03682939|Bexsero|bexsero
5050388|NCT03682939|Menveo|menveo
5050389|NCT03682939|co-administration|co-administration
5729827|NCT00395135|BLOOM|bloom
5050394|NCT03682887|Atrial fibrillation|atrial fibrillation
5050395|NCT03682887|Cryoballoon|cryoballoon
5050396|NCT03682887|Linear ablation|linear ablation
5050397|NCT03682848|Viral load|viral load
5050398|NCT03682848|Dolutegravir|dolutegravir
5050399|NCT03682848|Lamivudine|lamivudine
5050400|NCT03682848|HIV-1|hiv-1
5050401|NCT03682848|Fixed dose combination|fixed dose combination
5050402|NCT03682848|DOVATO|dovato
5050403|NCT03682835|gastric motility|gastric motility
5050404|NCT03682835|gastric emptying|gastric emptying
5050405|NCT03682835|nutrient volume tolerance|nutrient volume tolerance
5050406|NCT03682835|peppermint oil|peppermint oil
5050407|NCT03682835|caraway oil|caraway oil
5050408|NCT03682822|Pregnancy|pregnancy
5050409|NCT03682822|labor induction|labor induction
5050410|NCT03682822|preterm|preterm
5050411|NCT03682809|Artificial Tears|artificial tears
5050412|NCT03682809|Systane Complete|systane complete
5050413|NCT03682809|Contact Lens Discomfort|contact lens discomfort
5050414|NCT03682809|Dry Eye|dry eye
5050415|NCT03682809|Daily Disposable Contact Lenses|daily disposable contact lenses
5050416|NCT03682796|Antibody-Drug Conjugate|antibody-drug conjugate
5050417|NCT03682796|ADC|adc
5050418|NCT03682796|CD22|cd22
5050419|NCT03682796|SMARTag™ technology|smartag™ technology
5050420|NCT03682796|TRPH-222|trph-222
5050421|NCT03682783|Artificial Intelligence; Glaucoma|artificial intelligence; glaucoma
5050436|NCT03682666|constraint induced movement therapy|constraint induced movement therapy
5050437|NCT03682666|sonography|sonography
5050438|NCT03682653|childhood mortality|childhood mortality
5050439|NCT03682653|neonates|neonates
5050440|NCT03682653|azithromycin|azithromycin
5050441|NCT03682653|mass drug administration|mass drug administration
5063595|NCT03601962|pH|ph
5050446|NCT03682601|Sexual Pain|sexual pain
5050447|NCT03682601|Postmenopausal Symptoms|postmenopausal symptoms
5050448|NCT03682601|Vulvovaginal Atrophy|vulvovaginal atrophy
5050449|NCT03682601|Vulvodynia|vulvodynia
5050450|NCT03682601|Dyspareunia|dyspareunia
5050451|NCT03682601|Vestibulodynia|vestibulodynia
5050452|NCT03682601|Female Sexual Dysfunction|female sexual dysfunction
5050453|NCT03682601|Arousal Disorders, Sexual|arousal disorders, sexual
5050454|NCT03682588|Fibromyalgia|fibromyalgia
5050455|NCT03682588|Treatment|treatment
5050456|NCT03682588|Exercise|exercise
5050465|NCT03682523|Hospitalization|hospitalization
5050466|NCT03682523|Acute care|acute care
5050467|NCT03682523|older adults|older adults
5050468|NCT03682523|intervention|intervention
5050469|NCT03682510|placenta previa|placenta previa
5050470|NCT03682510|transverse b lynch suture|transverse b lynch suture
5050471|NCT03682510|N&H sandwich technique|n&h sandwich technique
5050472|NCT03682497|Heart failure.|heart failure.
5050473|NCT03682497|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
5051097|NCT03679000|cohort study|cohort study
5050474|NCT03682497|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
5050476|NCT03682484|MA-0211|ma-0211
5050477|NCT03682484|Single Ascending Dose|single ascending dose
5050478|NCT03682484|Healthy Volunteer|healthy volunteer
5050479|NCT03682484|Multiple Ascending Dose|multiple ascending dose
5050480|NCT03682484|Pharmacodynamics|pharmacodynamics
5050481|NCT03682471|submental fat reduction|submental fat reduction
5050483|NCT03682458|genetic mutations|genetic mutations
5050484|NCT03682458|neurodegenerative diseases|neurodegenerative diseases
5050485|NCT03682458|experimental therapeutic approaches|experimental therapeutic approaches
5050486|NCT03682458|molecular processes|molecular processes
5050487|NCT03682445|Type 2 diabetes mellitus|type 2 diabetes mellitus
5050488|NCT03682445|exercise|exercise
5050489|NCT03682445|aerobic|aerobic
5050490|NCT03682445|interval|interval
5050491|NCT03682445|continuous|continuous
5050492|NCT03682393|postoperative|postoperative
5050493|NCT03682393|atrial fibrillation|atrial fibrillation
5050494|NCT03682393|post cardiac surgery|post cardiac surgery
5050495|NCT03682393|corticosteroid|corticosteroid
5050496|NCT03682367|Gabapentin|gabapentin
5050497|NCT03682367|Narcotic|narcotic
5050498|NCT03682367|Cancer|cancer
5050499|NCT03682367|Placebo|placebo
5050500|NCT03682354|Erector spinae plane block|erector spinae plane block
5050501|NCT03682354|Video-assisted thoracic surgery;|video-assisted thoracic surgery;
5050502|NCT03682354|Intercostal nerve block|intercostal nerve block
5050503|NCT03682354|Patient-controlled intravenous analgesia|patient-controlled intravenous analgesia
5050504|NCT03682328|Vertebroplasty|vertebroplasty
5050505|NCT03682328|Kyphoplasty|kyphoplasty
5050506|NCT03682328|Osteoporosis|osteoporosis
5251958|NCT02433964|LED|led
5369105|NCT01861327|Carbon dioxide|carbon dioxide
5050507|NCT03682328|Vertebral fractures|vertebral fractures
5050508|NCT03682315|Maxillary sinus augmentation|maxillary sinus augmentation
5050509|NCT03682315|Sinus lift|sinus lift
5050510|NCT03682315|Biomaterial|biomaterial
5050511|NCT03682315|Anorganic bovine bone|anorganic bovine bone
5730228|NCT00393458|indacaterol|indacaterol
5050512|NCT03682315|Phicogenic biomaterial|phicogenic biomaterial
5050513|NCT03682315|Implant Dentistry|implant dentistry
5050514|NCT03682302|Pediatric|pediatric
5050515|NCT03682237|Hyperglycemia|hyperglycemia
5050516|NCT03682237|Hypoglycemia|hypoglycemia
5050517|NCT03682237|Carbohydrate counting|carbohydrate counting
5050518|NCT03682237|Automated bolus calculation|automated bolus calculation
5050539|NCT03682172|Gallbladder Motility|gallbladder motility
5050540|NCT03682172|Gallbladder Emptying|gallbladder emptying
5050541|NCT03682172|Glucagon-Like Peptide 2|glucagon-like peptide 2
5050543|NCT03682146|Robot Assisted|robot assisted
5050544|NCT03682146|Prostatectomy|prostatectomy
5050545|NCT03682146|Laparoscopy|laparoscopy
5050546|NCT03682146|Continence|continence
5050547|NCT03682133|Prehabilitation|prehabilitation
5050548|NCT03682133|Preoperative care|preoperative care
5050564|NCT03682094|probiotics|probiotics
5050565|NCT03682094|oral microbiome|oral microbiome
5050566|NCT03682094|dysphagia|dysphagia
5050567|NCT03682081|dementia|dementia
5050568|NCT03682081|dysphagia|dysphagia
5050569|NCT03682068|renal pelvis|renal pelvis
5050570|NCT03682068|ureters|ureters
5050571|NCT03682068|urinary bladder|urinary bladder
5050572|NCT03682068|urethra|urethra
5050573|NCT03682068|bladder cancer|bladder cancer
5050702|NCT03681366|myopia control|myopia control
5050582|NCT03682029|Clonal Cytopenia of Undetermined Significance|clonal cytopenia of undetermined significance
5050583|NCT03682029|Myelodysplastic Syndromes|myelodysplastic syndromes
5050588|NCT03682029|TET2|tet2
5050589|NCT03682029|Randomized, Placebo-Controlled Trial|randomized, placebo-controlled trial
5050590|NCT03682029|Clinical Study|clinical study
5050591|NCT03681990|surgical skin prep|surgical skin prep
5050592|NCT03681990|CHG|chg
5050593|NCT03681990|IPA|ipa
5050594|NCT03681977|Total Knee Arthroplasty|total knee arthroplasty
5050595|NCT03681977|Medial Pivot Knee Implant Design|medial pivot knee implant design
5050596|NCT03681977|Knee Joint Mechanics|knee joint mechanics
5050597|NCT03681951|Anticancer Agents|anticancer agents
5050598|NCT03681951|FTIH|ftih
5050599|NCT03681951|Pembrolizumab|pembrolizumab
5050600|NCT03681951|Rip1K|rip1k
5050601|NCT03681951|GSK3145095|gsk3145095
5050602|NCT03681951|Dose Escalation|dose escalation
5050603|NCT03681951|Immunotherapy resistance|immunotherapy resistance
5050604|NCT03681951|Dose Expansion|dose expansion
5050605|NCT03681951|RECIST 1.1|recist 1.1
5050606|NCT03681951|Advanced solid tumors|advanced solid tumors
5050607|NCT03681951|Innate immunity|innate immunity
5050608|NCT03681925|Patient-centered care|patient-centered care
5050609|NCT03681925|Dietitian|dietitian
5050610|NCT03681925|Nutrition literacy|nutrition literacy
5050611|NCT03681912|Implementation Science|implementation science
5050612|NCT03681912|Motivational Interviewing|motivational interviewing
5050613|NCT03681912|Youth Living with HIV|youth living with hiv
5050614|NCT03681899|Rupture of galenic|rupture of galenic
5050615|NCT03681899|Ederly patients|ederly patients
5050616|NCT03681899|Geriatry|geriatry
5050617|NCT03681899|Drug class|drug class
5050618|NCT03681860|BCG|bcg
5050633|NCT03681769|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5050634|NCT03681769|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5050635|NCT03681769|Medial Prefrontal Cortex|medial prefrontal cortex
5050636|NCT03681769|Brain Stimulation|brain stimulation
5050637|NCT03681743|Virtual Reality|virtual reality
5050638|NCT03681743|Pain|pain
5050639|NCT03681743|Anxiety|anxiety
5050640|NCT03681730|Virtual Reality|virtual reality
5050641|NCT03681730|Pain|pain
5050642|NCT03681730|Anxiety|anxiety
5050643|NCT03681717|Virtual Reality|virtual reality
5050644|NCT03681717|Pain|pain
5050645|NCT03681717|Anxiety|anxiety
5050646|NCT03681704|Diabetic Kidney Disease，Traditional Chinese medicine|diabetic kidney disease，traditional chinese medicine
5050647|NCT03681691|women's health|women's health
5050648|NCT03681691|estradiol|estradiol
5050649|NCT03681691|postmenopausal|postmenopausal
5050650|NCT03681678|Laser Therapy|laser therapy
5050651|NCT03681639|Hip resurfacing|hip resurfacing
5050652|NCT03681639|Medical Device|medical device
5050653|NCT03681639|Safety|safety
5050654|NCT03681639|Hip prosthesis|hip prosthesis
5050655|NCT03681626|critically ill patient|critically ill patient
5050656|NCT03681626|extubation|extubation
5050657|NCT03681626|tracheal suction|tracheal suction
5050658|NCT03681626|intensive care unit|intensive care unit
5050665|NCT03681574|pediatric|pediatric
5050666|NCT03681574|gabapentin|gabapentin
5104024|NCT03347162|PRO|pro
5050667|NCT03681574|agitation|agitation
5050668|NCT03681574|induction|induction
5050669|NCT03681548|liposomal doxorubicin injection|liposomal doxorubicin injection
5236079|NCT02526888|interaction|interaction
5264767|NCT02361346|NHL|nhl
5050670|NCT03681548|bioequivalence study|bioequivalence study
5050671|NCT03681548|ovarian cancer|ovarian cancer
5050672|NCT03681535|DLBCL|dlbcl
5050673|NCT03681535|Reduce radiation dose|reduce radiation dose
5050674|NCT03681522|local anesthesia|local anesthesia
5050675|NCT03681522|prostate, biopsy|prostate, biopsy
5050676|NCT03681522|transrectal|transrectal
5050677|NCT03681509|Pramipexole|pramipexole
5050678|NCT03681483|RO5126766 (CH5126766)|ro5126766 (ch5126766)
5050679|NCT03681483|KRAS-Mutant|kras-mutant
5050680|NCT03681483|18-285|18-285
5050681|NCT03681470|skin of color|skin of color
5050682|NCT03681470|acne|acne
5050683|NCT03681470|skin diseases|skin diseases
5050684|NCT03681457|LJN452, tropifexor, PK, safety, healthy subjects, hepatically impaired|ljn452, tropifexor, pk, safety, healthy subjects, hepatically impaired
5050685|NCT03681431|Pharmacokinetic|pharmacokinetic
5050686|NCT03681431|Ceftriaxone|ceftriaxone
5050687|NCT03681431|Enterococcus faecalis|enterococcus faecalis
5050688|NCT03681431|Infectious Endocarditis|infectious endocarditis
5050689|NCT03681418|Axillary Lymph Node Biopsy in Breast Cancer|axillary lymph node biopsy in breast cancer
5050690|NCT03681392|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5050691|NCT03681392|Erectile Dysfunction|erectile dysfunction
5050693|NCT03681392|Prostatism|prostatism
5050694|NCT03681392|Lower Urinary Tract Symptoms, male|lower urinary tract symptoms, male
5050695|NCT03681379|Levosimendan|levosimendan
5050696|NCT03681379|pharmacokinetics|pharmacokinetics
5050697|NCT03681379|children|children
5050698|NCT03681379|acute heart failure|acute heart failure
5050699|NCT03681366|myopia|myopia
5050700|NCT03681366|Myopic Defocus|myopic defocus
5050701|NCT03681366|contact lens|contact lens
5050703|NCT03681288|PTSD|ptsd
5050704|NCT03681288|substance use disorder|substance use disorder
5050705|NCT03681288|moral injury|moral injury
5050706|NCT03681288|self-compassion|self-compassion
5050707|NCT03681288|mindfulness|mindfulness
5050708|NCT03681288|Veterans|veterans
5050709|NCT03681275|Ventilator-induced Diaphragm Dysfunction|ventilator-induced diaphragm dysfunction
5050711|NCT03681236|Alveolar recruitment, laparoscopic surgery|alveolar recruitment, laparoscopic surgery
5050712|NCT03681210|Heart Failure|heart failure
5050713|NCT03681210|Heart Diseases|heart diseases
5050714|NCT03681210|Cardiovascular Diseases|cardiovascular diseases
5050715|NCT03681197|metformin,unexplained infertility|metformin,unexplained infertility
5050716|NCT03681184|PH1|ph1
5050717|NCT03681184|Primary Hyperoxaluria|primary hyperoxaluria
5050718|NCT03681184|RNAi therapeutic|rnai therapeutic
5960927|NCT04290208|Female|female
5050719|NCT03681184|siRNA|sirna
5050720|NCT03681184|AGT|agt
5050721|NCT03681145|Young Adults|young adults
5050725|NCT03681106|Total Knee Arthroplasty|total knee arthroplasty
5050726|NCT03681106|Kinesiotaping|kinesiotaping
5050727|NCT03681106|Neuro taping|neuro taping
5050728|NCT03681106|Rehabilitation|rehabilitation
5050730|NCT03681093|Nasal Polyposis|nasal polyposis
5050736|NCT03681067|Crohn's disease|crohn's disease
5050737|NCT03681067|CDAID|cdaid
5050738|NCT03681067|CDAI|cdai
5050739|NCT03681067|GSK1070806|gsk1070806
5050740|NCT03681054|Nutrition|nutrition
5050741|NCT03681054|Dietary Counseling|dietary counseling
5050742|NCT03681054|Diet|diet
5050743|NCT03681054|Pregnancy|pregnancy
5050744|NCT03681041|Pancreatic injury|pancreatic injury
5050745|NCT03681028|Glioblastoma|glioblastoma
5050746|NCT03681028|Adult Glioblastoma|adult glioblastoma
5050747|NCT03681028|Glioma|glioma
5050748|NCT03681028|Precision Medicine|precision medicine
5050749|NCT03681028|Specialized Tumor Board|specialized tumor board
5050750|NCT03680976|Asthma|asthma
5050751|NCT03680976|Obesity|obesity
5050752|NCT03680976|Nitrated fatty acids|nitrated fatty acids
5050753|NCT03680937|Vitrification|vitrification
5050754|NCT03680937|In vitro maturation|in vitro maturation
5050755|NCT03680937|time lapse|time lapse
5050756|NCT03680937|High resolution imaging|high resolution imaging
5050757|NCT03680937|quantitative molecular analysis|quantitative molecular analysis
5050758|NCT03680924|PTEN|pten
5050759|NCT03680924|phosphatase and tensin homology mutation|phosphatase and tensin homology mutation
5050760|NCT03680898|Carbapenem|carbapenem
5050761|NCT03680898|rectal swab|rectal swab
5050762|NCT03680898|infectious disease|infectious disease
5050763|NCT03680898|infection|infection
5050764|NCT03680885|Lidocaine ineffectiveness|lidocaine ineffectiveness
5050765|NCT03680885|ADHD|adhd
5050766|NCT03680885|ADD|add
5050767|NCT03680872|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
5050768|NCT03680872|Biomedical Engineering|biomedical engineering
5050769|NCT03680872|Paralysis|paralysis
5050770|NCT03680872|Tetraplegia|tetraplegia
5050771|NCT03680872|Quadriplegia|quadriplegia
5050772|NCT03680872|Movement Restoration|movement restoration
5050773|NCT03680872|Muscle Stimulation|muscle stimulation
5050774|NCT03680872|Tactile Sensation|tactile sensation
5050775|NCT03680807|Knee osteoarthritis|knee osteoarthritis
5050776|NCT03680807|power production|power production
5248312|NCT02455596|Carcinoid Tumor|carcinoid tumor
5264941|NCT02360436|ROS|ros
5248417|NCT02454920|Strabismus|strabismus
5236462|NCT02524509|Chonodron|chonodron
5050777|NCT03680807|functional capacity|functional capacity
5050782|NCT03680755|dental avoidance|dental avoidance
5050783|NCT03680755|dental phobia|dental phobia
5050784|NCT03680755|pain sensitivity|pain sensitivity
5050785|NCT03680729|Prevention|prevention
5050786|NCT03680729|HIV/AIDS|hiv/aids
5050787|NCT03680729|MSM|msm
5050788|NCT03680729|Alabama|alabama
5050789|NCT03680664|Mild Cognitive Impairment|mild cognitive impairment
5050790|NCT03680664|Dementia|dementia
5050791|NCT03680664|Mindfulness|mindfulness
5050792|NCT03680638|Racial Differences|racial differences
5050793|NCT03680638|Oxidative Stress|oxidative stress
5050794|NCT03680638|Obesity|obesity
5050795|NCT03680638|Local Heating|local heating
5050796|NCT03680625|Virtual reality|virtual reality
5050797|NCT03680625|Immersive distraction|immersive distraction
5050798|NCT03680625|Virtual world|virtual world
5050799|NCT03680625|Virtual environment|virtual environment
5050800|NCT03680625|Passive distraction|passive distraction
5050801|NCT03680625|Procedural pain|procedural pain
5050802|NCT03680625|Procedural anxiety|procedural anxiety
5050803|NCT03680625|Acute pain|acute pain
5050804|NCT03680625|Pain management|pain management
5050806|NCT03680625|Children, Child|children, child
5050807|NCT03680625|Kid, Kids|kid, kids
5050808|NCT03680625|Pediatric, Pediatrics|pediatric, pediatrics
5050809|NCT03680625|Young children|young children
5050810|NCT03680625|Orthopedics|orthopedics
5050811|NCT03680625|Kirschner wire, K pin|kirschner wire, k pin
5050812|NCT03680625|Bone wires|bone wires
5050813|NCT03680625|Percutaneous pins|percutaneous pins
5050814|NCT03680625|Non-pharmacological|non-pharmacological
5050815|NCT03680625|Clinical Research|clinical research
5050816|NCT03680625|Nursing Practice|nursing practice
5050817|NCT03680625|User-computer interface|user-computer interface
5050818|NCT03680625|Pediatric Nursing|pediatric nursing
5050819|NCT03680625|Hospital, Pediatric|hospital, pediatric
5050820|NCT03680625|Sutures|sutures
5050821|NCT03680573|Racial Differences|racial differences
5050822|NCT03680573|Oxidative Stress|oxidative stress
5050823|NCT03680560|HER2|her2
5050824|NCT03680560|ACTR|actr
5050825|NCT03680560|ACTR087|actr087
5050826|NCT03680560|ACTR707|actr707
5050827|NCT03680560|T cell|t cell
5050828|NCT03680560|T cell product|t cell product
5050829|NCT03680560|adoptive T cells|adoptive t cells
5050830|NCT03680560|gene therapy|gene therapy
5050831|NCT03680560|breast cancer|breast cancer
5050832|NCT03680560|gastric cancer|gastric cancer
5050833|NCT03680560|gastro esophageal cancer|gastro esophageal cancer
5050834|NCT03680560|immunotherapy|immunotherapy
5050835|NCT03680560|solid tumor|solid tumor
5050839|NCT03680534|3D reconstruction|3d reconstruction
5050840|NCT03680521|ccRCC|ccrcc
5050841|NCT03680521|MGCD516|mgcd516
5050842|NCT03680521|Antineoplastic Agents|antineoplastic agents
5050843|NCT03680521|Immunologic factors|immunologic factors
5050844|NCT03680521|nivolumab|nivolumab
5050845|NCT03680521|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5050846|NCT03680521|VEGFR|vegfr
5050847|NCT03680521|TAM RTKs|tam rtks
5050848|NCT03680521|PD-1|pd-1
5050849|NCT03680521|PD-L1|pd-l1
5050850|NCT03680508|immunotherapy|immunotherapy
5050851|NCT03680508|PD-1|pd-1
5050852|NCT03680508|TIM-3|tim-3
5050853|NCT03680495|COPD|copd
5050854|NCT03680495|Steroid Resistance|steroid resistance
5050855|NCT03680482|High-Intensity Sweeteners|high-intensity sweeteners
5050856|NCT03680482|insulin|insulin
5050857|NCT03680482|ghrelin|ghrelin
5050858|NCT03680482|Glucagon-Like Peptide 1|glucagon-like peptide 1
5050859|NCT03680482|Non-Nutritive Sweeteners|non-nutritive sweeteners
5050860|NCT03680482|Stevia rebaudiana|stevia rebaudiana
5050861|NCT03680469|Ischemic Stroke|ischemic stroke
5050862|NCT03680469|Acute|acute
5050863|NCT03680469|Early intervention|early intervention
5050864|NCT03680469|Mobilization|mobilization
5050865|NCT03680456|Anemia|anemia
5050866|NCT03680456|Ferric carboxymaltose|ferric carboxymaltose
5050867|NCT03680456|intravenous iron|intravenous iron
5050868|NCT03680456|intraoperative blood loss|intraoperative blood loss
5050869|NCT03680456|patient blood management|patient blood management
5050870|NCT03680456|Red blood cell transfusion|red blood cell transfusion
5050871|NCT03680456|postoperative iron replacement|postoperative iron replacement
5050872|NCT03680443|revision|revision
5050873|NCT03680443|reinforcement|reinforcement
5050874|NCT03680430|adaptive image guided radiation therapy|adaptive image guided radiation therapy
5050875|NCT03680430|limb soft tissues sarcomas|limb soft tissues sarcomas
5050876|NCT03680417|Measles-Rubella|measles-rubella
5050877|NCT03680417|Vaccine|vaccine
5050878|NCT03680417|Safety|safety
5050879|NCT03680417|Immunogenicity|immunogenicity
5050880|NCT03680417|Reactogenicity|reactogenicity
5050881|NCT03680417|Protectivity|protectivity
5050882|NCT03680404|Racial Differences|racial differences
5248717|NCT02453178|brain|brain
5050883|NCT03680404|Oxidative Stress|oxidative stress
5050884|NCT03680378|bronchial epithelial lining fluid|bronchial epithelial lining fluid
5050885|NCT03680365|Duchenne, DMD|duchenne, dmd
5050886|NCT03680313|Cardio-ankle vascular index (CAVI)|cardio-ankle vascular index (cavi)
5050887|NCT03680300|agility run test|agility run test
5050888|NCT03680300|vertical jump test|vertical jump test
5050889|NCT03680300|100 meter sprint|100 meter sprint
5050890|NCT03680300|nordic lower test|nordic lower test
5050891|NCT03680300|ymca sit and reach box|ymca sit and reach box
5050892|NCT03680300|active knee extension|active knee extension
5050893|NCT03680300|passive knee extension|passive knee extension
5050894|NCT03680300|post isometric relaxation|post isometric relaxation
5050895|NCT03680300|post facilitation stretch|post facilitation stretch
5050896|NCT03680300|muscle energy technique|muscle energy technique
5050897|NCT03680300|friction massage|friction massage
5050898|NCT03680300|sports medicine|sports medicine
5050899|NCT03680300|physical therapy|physical therapy
5050900|NCT03680300|young athlete|young athlete
5050901|NCT03680300|pakistan|pakistan
5050902|NCT03680261|Gastric Cancer|gastric cancer
5050903|NCT03680261|Chemoradiotherapy|chemoradiotherapy
5050904|NCT03680261|Chemotherapy|chemotherapy
5050913|NCT03680222|external branches of superior laryngeal nerve|external branches of superior laryngeal nerve
5050914|NCT03680222|thyroidectomy|thyroidectomy
5050915|NCT03680222|thyroid cancer|thyroid cancer
5050916|NCT03680209|Task trainning|task trainning
5050917|NCT03680209|Procedural simulation|procedural simulation
5050918|NCT03680196|hip dislocation|hip dislocation
5050919|NCT03680196|GMFCS level 3,4,5|gmfcs level 3,4,5
5050920|NCT03680183|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5050921|NCT03680183|pharmacokinetics|pharmacokinetics
5050922|NCT03680183|Hepatitis B|hepatitis b
5050923|NCT03680170|Cognitive rehabilitation|cognitive rehabilitation
5050924|NCT03680170|Working memory|working memory
5050925|NCT03680170|Randomized controlled trial|randomized controlled trial
5050926|NCT03680170|Placebo control|placebo control
5050927|NCT03680157|Martha G. Welch|martha g. welch
5050928|NCT03680157|emotional connection|emotional connection
5050929|NCT03680157|child development|child development
5050930|NCT03680157|premature birth|premature birth
5050931|NCT03680092|cancer|cancer
5050932|NCT03680092|Graft-Versus-Host Disease|graft-versus-host disease
5050933|NCT03680092|Hematologic Neoplasms|hematologic neoplasms
5050934|NCT03680092|Abatacept|abatacept
5050935|NCT03680092|Cyclophosphamide|cyclophosphamide
5050936|NCT03680092|GVHD prophylaxis|gvhd prophylaxis
5051476|NCT03676400|NGF-574H|ngf-574h
5050938|NCT03680092|High risk hematologic malignancy|high risk hematologic malignancy
5050939|NCT03680092|hematologic malignancy|hematologic malignancy
5050940|NCT03680092|Allogeneic Hematopoetic Stem Cell Transplantation|allogeneic hematopoetic stem cell transplantation
5050941|NCT03680092|GVHD|gvhd
5050942|NCT03680079|social media|social media
5050943|NCT03680079|noncompliance|noncompliance
5960928|NCT04290208|Pregnancy|pregnancy
5960929|NCT04290208|Acetaminophen|acetaminophen
5050944|NCT03680079|youth|youth
5050945|NCT03680079|group education|group education
5050946|NCT03680066|Peanut allergy|peanut allergy
5050947|NCT03680066|Tree Nut allergy|tree nut allergy
5050948|NCT03680066|Precautionary allergen labeling|precautionary allergen labeling
5050949|NCT03680066|May contain traces|may contain traces
5050950|NCT03680066|Allergen threshold|allergen threshold
5050951|NCT03680027|Serum lipids|serum lipids
5050952|NCT03680027|Hyperlipidemia|hyperlipidemia
5050953|NCT03680027|Walnut|walnut
5050954|NCT03680001|emotional connection|emotional connection
5050955|NCT03680001|Martha G. Welch|martha g. welch
5050956|NCT03680001|nursing education|nursing education
5050957|NCT03679988|oral health status|oral health status
5050958|NCT03679988|oral findings|oral findings
5050959|NCT03679988|oral manifestations|oral manifestations
5050960|NCT03679988|patient with mucocutaneous ocular disorders|patient with mucocutaneous ocular disorders
5050961|NCT03679988|mucocutaneous ocular disorders|mucocutaneous ocular disorders
5050962|NCT03679962|Bright Light Therapy|bright light therapy
5050963|NCT03679962|Sleep Deprivation|sleep deprivation
5050964|NCT03679962|Adolescent|adolescent
5050965|NCT03679962|Depression|depression
5050966|NCT03679962|Suicidal Ideation|suicidal ideation
5050967|NCT03679949|experimental pain|experimental pain
5050968|NCT03679949|Cannabis|cannabis
5050969|NCT03679949|Cannabidiol|cannabidiol
5050971|NCT03679923|exercise-induced|exercise-induced
5050972|NCT03679923|joint pain|joint pain
5050973|NCT03679923|joint stiffness|joint stiffness
5050974|NCT03679923|cartilage turnover|cartilage turnover
5050975|NCT03679923|CTX-II|ctx-ii
5050976|NCT03679910|CA 19-9|ca 19-9
5050977|NCT03679910|CEA|cea
5050978|NCT03679819|multiparametric MRI|multiparametric mri
5050979|NCT03679819|ExactVu ultrasound scanner|exactvu ultrasound scanner
5050980|NCT03679819|prostatectomy|prostatectomy
5350861|NCT01945008|HCV|hcv
5050981|NCT03679806|aquatic therapy|aquatic therapy
5050982|NCT03679806|Limits of stability|limits of stability
5050983|NCT03679806|Halliwick|halliwick
5050984|NCT03679806|aquatic plyometric exercises|aquatic plyometric exercises
5050985|NCT03679793|Trigger Finger Disorder|trigger finger disorder
5050986|NCT03679793|Trigger Thumb|trigger thumb
5050987|NCT03679793|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5050988|NCT03679793|Orthopedics|orthopedics
5050989|NCT03679780|Racial Differences|racial differences
5050990|NCT03679780|Oxidative Stress|oxidative stress
5050991|NCT03679767|PD-1inhibitor|pd-1inhibitor
5050992|NCT03679767|non-small cell lung cancer|non-small cell lung cancer
5050993|NCT03679767|urothelial cancer|urothelial cancer
5050994|NCT03679767|melanoma|melanoma
5064034|NCT03599024|pain relief|pain relief
5050999|NCT03679715|Community-dwellers|community-dwellers
5051000|NCT03679715|older adults|older adults
5051001|NCT03679715|museum|museum
5051002|NCT03679715|art|art
5051003|NCT03679689|Non-Nutritive sweeteners|non-nutritive sweeteners
5051004|NCT03679689|Artificially sweeteners|artificially sweeteners
5051005|NCT03679689|obesity|obesity
5051006|NCT03679689|overweight|overweight
5051007|NCT03679676|Food Allergy|food allergy
5051008|NCT03679676|Hypersensitivity, Peanut|hypersensitivity, peanut
5051009|NCT03679676|Food Hypersensitivity|food hypersensitivity
5051010|NCT03679676|Allergy, Food|allergy, food
5051011|NCT03679663|ultrasound|ultrasound
5051012|NCT03679650|AML|aml
5051013|NCT03679624|treatment naive|treatment naive
5051014|NCT03679624|relapsed|relapsed
5051015|NCT03679624|frontline|frontline
5051016|NCT03679624|refractory|refractory
5051017|NCT03679624|daratumumab|daratumumab
5051018|NCT03679624|ibrutinib|ibrutinib
5051019|NCT03679611|Recovery time|recovery time
5051020|NCT03679611|reversal of neuromuscular blockers|reversal of neuromuscular blockers
5051021|NCT03679611|obstructive sleep apnea|obstructive sleep apnea
5051022|NCT03679611|morbid obesity|morbid obesity
5051023|NCT03679611|bariatric surgery|bariatric surgery
5051024|NCT03679572|partial nephrectomy|partial nephrectomy
5051025|NCT03679572|robot-assisted|robot-assisted
5051026|NCT03679572|surgery|surgery
5051027|NCT03679572|near-infrared fluorescence|near-infrared fluorescence
5051031|NCT03679533|Nutrition|nutrition
5051032|NCT03679533|Microbiome|microbiome
5051033|NCT03679533|Flavonoids|flavonoids
5051034|NCT03679520|Prenatal education|prenatal education
5051035|NCT03679520|Parents|parents
5051036|NCT03679520|Randomized controlled trial|randomized controlled trial
5051037|NCT03679520|Self Efficacy|self efficacy
5051038|NCT03679520|Depression, postpartum|depression, postpartum
5051039|NCT03679442|macrophage activation, N-acetylcysteine, acetaminophen|macrophage activation, n-acetylcysteine, acetaminophen
5051040|NCT03679429|Colonoscopy|colonoscopy
5051594|NCT03675646|nephrectomy|nephrectomy
5051051|NCT03679364|lyophilized|lyophilized
5051052|NCT03679364|injectable|injectable
5051053|NCT03679299|Flow-mediated dilation (FMD)|flow-mediated dilation (fmd)
5051054|NCT03679299|arterial stiffness|arterial stiffness
5051055|NCT03679299|pulse wave velocity (PWV)|pulse wave velocity (pwv)
5051056|NCT03679299|cardiovascular risk and asthma|cardiovascular risk and asthma
5051057|NCT03679299|endothelial function|endothelial function
5051058|NCT03679299|systemic inflammation|systemic inflammation
5928190|NCT03826589|Axitinib|axitinib
5096400|NCT03395860|ATG|atg
5051059|NCT03679299|C-reactive protein (CRP)|c-reactive protein (crp)
5051060|NCT03679299|eosinophils|eosinophils
5051061|NCT03679299|neutrophils|neutrophils
5051062|NCT03679299|asthma exacerbation|asthma exacerbation
5051063|NCT03679286|Coagulation|coagulation
5051064|NCT03679260|Prostate Cancer|prostate cancer
5051065|NCT03679260|Prostate Adenocarcinoma|prostate adenocarcinoma
5051066|NCT03679260|Active Surveillance|active surveillance
5051067|NCT03679260|Diet|diet
5051068|NCT03679260|Weight Loss|weight loss
5051069|NCT03679260|low carb|low carb
5051070|NCT03679260|Ketogenic Diet|ketogenic diet
5051071|NCT03679260|Ketogenic|ketogenic
5051073|NCT03679130|Pregnancy|pregnancy
5051074|NCT03679130|Physical activity|physical activity
5051075|NCT03679130|Healthy|healthy
5051076|NCT03679130|Epigenetics|epigenetics
5051077|NCT03679130|Process evaluation|process evaluation
5051078|NCT03679130|Doubly labeled water|doubly labeled water
5051079|NCT03679117|mindfulness|mindfulness
5051080|NCT03679117|pregnancy|pregnancy
5051081|NCT03679117|hypertension|hypertension
5051082|NCT03679104|Gastric Per-oral Endoscopic Pyloromyotomy|gastric per-oral endoscopic pyloromyotomy
5051083|NCT03679091|Ticagrelor|ticagrelor
5051084|NCT03679091|clopidogrel|clopidogrel
5051085|NCT03679091|coronary artery disease|coronary artery disease
5051086|NCT03679091|platelet reactivity|platelet reactivity
5051087|NCT03679039|colorectal cancer|colorectal cancer
5051088|NCT03679039|liver metastases|liver metastases
5051089|NCT03679039|conversion therapy|conversion therapy
5051090|NCT03679013|cardiac|cardiac
5051091|NCT03679013|surgery|surgery
5051092|NCT03679013|pain|pain
5249022|NCT02451059|low-income|low-income
5249218|NCT02449850|Allergy|allergy
5943415|NCT04276974|polyphenols|polyphenols
5943416|NCT04276974|pesticides|pesticides
5943417|NCT04276974|plant based food|plant based food
5943418|NCT04276974|organic|organic
5943419|NCT04276974|microbiome|microbiome
5943420|NCT04276974|vascular function|vascular function
5943421|NCT04276948|dietary supplement|dietary supplement
5943422|NCT04276909|Primary Pancreatic Cancer|primary pancreatic cancer
5943423|NCT04276909|Peritoneal Invasion|peritoneal invasion
5943424|NCT04276896|LV-DC vaccine|lv-dc vaccine
5943425|NCT04276896|SARS-CoV-2 CTL|sars-cov-2 ctl
5943426|NCT04276844|Diaphragmatic paralysis|diaphragmatic paralysis
5943427|NCT04276844|Respiratory complications|respiratory complications
5943428|NCT04276831|Intubation|intubation
5943429|NCT04276831|Cardiovascular response|cardiovascular response
5943430|NCT04276831|Laryngoscope|laryngoscope
5943431|NCT04276818|PRP|prp
5943432|NCT04276818|Burn|burn
5943433|NCT04276766|nitrates|nitrates
5943434|NCT04276766|beetroot|beetroot
5943435|NCT04276766|nutrition|nutrition
5943436|NCT04276766|microcirculation|microcirculation
5943437|NCT04276766|nitrites|nitrites
5943438|NCT04276727|CIPN|cipn
5237202|NCT02519634|SMP|smp
5943439|NCT04276727|Peripheral neuropathy|peripheral neuropathy
5943440|NCT04276727|Chemotherapy|chemotherapy
5943441|NCT04276727|Neuropathic pain|neuropathic pain
5943442|NCT04276714|residual limbs|residual limbs
5943443|NCT04276714|pain|pain
5943444|NCT04276714|adjustable socket|adjustable socket
5943445|NCT04276701|Immune mediators|immune mediators
5943446|NCT04276701|Immune metabolites|immune metabolites
5943447|NCT04276701|cardio vascular diseases|cardio vascular diseases
5943448|NCT04276701|Systemic Lupus Erythematosus|systemic lupus erythematosus
5943452|NCT04276662|Hepatic Impairment|hepatic impairment
5943453|NCT04276662|DS-3201b|ds-3201b
5943454|NCT04276662|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
5943455|NCT04276623|Dupilumab|dupilumab
5943456|NCT04276623|Dupixent|dupixent
5253630|NCT02424903|hip|hip
5943457|NCT04276623|Conjunctivitis|conjunctivitis
5943458|NCT04276623|Bioday|bioday
5943459|NCT04276584|abdominal surgery|abdominal surgery
5943460|NCT04276584|hypoxia|hypoxia
5943461|NCT04276584|lung function|lung function
5943462|NCT04276584|ventilation|ventilation
5943463|NCT04276584|Carbon dioxide partial pressure|carbon dioxide partial pressure
5943464|NCT04276584|oxygen situation|oxygen situation
5943465|NCT04276584|Postoperative|postoperative
5943474|NCT04276506|Music|music
5943475|NCT04276506|Visual Information|visual information
5943476|NCT04276480|Fecal carriage|fecal carriage
5943477|NCT04276480|Ventilator-associated pneumonia|ventilator-associated pneumonia
5943478|NCT04276480|Piperacillin-tazobactam|piperacillin-tazobactam
5943482|NCT04276415|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5943483|NCT04276415|DS-6157a|ds-6157a
5943484|NCT04276415|Anti-drug antibody conjugate|anti-drug antibody conjugate
5943485|NCT04276415|G-protein coupled receptor 20 (GPR20)|g-protein coupled receptor 20 (gpr20)
5943486|NCT04276350|Acupuncture|acupuncture
5943487|NCT04276350|Faecal Incontinence|faecal incontinence
5943488|NCT04276350|Traditional Chinese Medicine|traditional chinese medicine
5943489|NCT04276272|PET/CT|pet/ct
5943490|NCT04276246|Partial Edentulism|partial edentulism
5943491|NCT04276246|Kennedy Class 1|kennedy class 1
5943559|NCT04275830|Digital Storytelling|digital storytelling
5943560|NCT04275830|Narrative|narrative
5943561|NCT04275830|Cancer patients|cancer patients
5943562|NCT04275830|Bone marrow transplant|bone marrow transplant
5943563|NCT04275830|Psychosocial health|psychosocial health
5943564|NCT04275830|Heart rate variability biofeedback|heart rate variability biofeedback
5943565|NCT04275804|Vibration|vibration
5943566|NCT04275804|Whole Body Vibration|whole body vibration
5943567|NCT04275804|Low Magnitude High Frequency Vibration|low magnitude high frequency vibration
5943568|NCT04275804|Biophysical Intervention|biophysical intervention
5943569|NCT04275791|Advanced Trauma Life Support Care|advanced trauma life support care
5943570|NCT04275791|Trauma Severity Indices|trauma severity indices
5943571|NCT04275791|Trauma Centers|trauma centers
5943572|NCT04275791|Triage|triage
5943573|NCT04275778|APS|aps
5943574|NCT04275778|Anticoagulants|anticoagulants
5943575|NCT04275778|Pregancy|pregancy
5943576|NCT04275778|Heparin Low-Molecular-Weight|heparin low-molecular-weight
5943577|NCT04275778|Aspirin|aspirin
5943590|NCT04275570|pregnancy|pregnancy
5943650|NCT04275167|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
5943651|NCT04275167|Optical Coherence Tomography|optical coherence tomography
5943652|NCT04275167|EED|eed
5943653|NCT04275167|Pakistan|pakistan
5943654|NCT04275167|Intestinal Disorder|intestinal disorder
5943655|NCT04275128|genicular ablation|genicular ablation
5943656|NCT04275128|cooled radiofrequency|cooled radiofrequency
5943657|NCT04275128|chronic knee pain|chronic knee pain
5943658|NCT04275128|cooled RF|cooled rf
5943659|NCT04275128|radiofrequency ablation|radiofrequency ablation
5943660|NCT04275063|ASC|asc
5943661|NCT04275063|Sport and physical activity|sport and physical activity
5943662|NCT04275063|Parent perceptions|parent perceptions
5943663|NCT04275037|Isometric Handgrip Training|isometric handgrip training
5943664|NCT04275037|Elderly|elderly
5943665|NCT04275037|Pre-Hypertension|pre-hypertension
5943666|NCT04275037|Hypertension|hypertension
5943667|NCT04275011|Exercise|exercise
5943668|NCT04275011|Progressive Resistance Training|progressive resistance training
5943669|NCT04275011|Impact Exercise|impact exercise
5943670|NCT04275011|Anti-resorptive medication|anti-resorptive medication
5943671|NCT04274946|breast|breast
5943672|NCT04274946|sentinel lymph node|sentinel lymph node
5943673|NCT04274946|patent blue|patent blue
5943674|NCT04274946|indocyanine green|indocyanine green
5943675|NCT04274881|Surface landmarks|surface landmarks
5943676|NCT04274881|C-length|c-length
5943677|NCT04274881|Central venous catheterization|central venous catheterization
5943678|NCT04274881|Internal jugular vein|internal jugular vein
5943679|NCT04274881|Prediction|prediction
5943680|NCT04274881|Accuracy|accuracy
5943698|NCT04273607|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5943699|NCT04273607|Anticoagulation|anticoagulation
5943700|NCT04273607|Thrombosis|thrombosis
5943701|NCT04273607|Hemorrhage|hemorrhage
5943719|NCT04272957|HMPL-306|hmpl-306
5943720|NCT04272957|IDH1 Mutation|idh1 mutation
5943721|NCT04272957|IDH2 Mutation|idh2 mutation
5943722|NCT04272957|Acute myeloid leukemia|acute myeloid leukemia
5943723|NCT04272957|Myelodysplastic symdrome|myelodysplastic symdrome
5943724|NCT04272957|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5943725|NCT04272957|Myeloid Leukemia/Neoplasms|myeloid leukemia/neoplasms
5943729|NCT04272892|Sleep|sleep
5943730|NCT04272892|Rehabilitation|rehabilitation
5943731|NCT04272892|Digital|digital
5943732|NCT04272892|Cognitive Behavioural Therapy for Insomnia|cognitive behavioural therapy for insomnia
5943736|NCT04272372|lymphedema|lymphedema
5051093|NCT03679000|environmental exposure|environmental exposure
5051094|NCT03679000|epigenetic process|epigenetic process
5051095|NCT03679000|embryo development|embryo development
5051096|NCT03679000|infertility|infertility
5051107|NCT03678922|children|children
5051108|NCT03678922|prognosis|prognosis
5051109|NCT03678922|general practice|general practice
5051110|NCT03678922|bio-psycho-social|bio-psycho-social
5051111|NCT03678909|Troponin|troponin
5051112|NCT03678909|BNP|bnp
5051113|NCT03678909|Biomarkers|biomarkers
5051114|NCT03678909|Hypoplastic Left Heart|hypoplastic left heart
5051115|NCT03678909|Norwood|norwood
5051116|NCT03678909|DKS|dks
5051117|NCT03678896|Type II Diabetes|type ii diabetes
5051118|NCT03678896|Educational methods|educational methods
5051119|NCT03678896|Disease self-management|disease self-management
5051120|NCT03678883|Refractory cancers|refractory cancers
5051121|NCT03678883|9-ING-41|9-ing-41
5051122|NCT03678883|Glycogen Synthase Kinase|glycogen synthase kinase
5051123|NCT03678883|GSK-3β|gsk-3β
5051124|NCT03678883|NF-κβ|nf-κβ
5051125|NCT03678883|Apoptosis|apoptosis
5051126|NCT03678883|Chemoresistance|chemoresistance
5051127|NCT03678883|DNA damage response DDR|dna damage response ddr
5051128|NCT03678883|Ataxia telangiectasia mutated and Rad3 related ATR|ataxia telangiectasia mutated and rad3 related atr
5051129|NCT03678883|Checkpoint kinase 1 CHK1|checkpoint kinase 1 chk1
5051130|NCT03678857|creatine, hypertrophy, strength|creatine, hypertrophy, strength
5051131|NCT03678831|Osteoarthritis|osteoarthritis
5051132|NCT03678831|prosthetic surgery of the knee|prosthetic surgery of the knee
5051133|NCT03678831|obesity|obesity
5051134|NCT03678831|type 2 diabetes|type 2 diabetes
5051135|NCT03678831|bone marrow fat|bone marrow fat
5051136|NCT03678779|child nutrition|child nutrition
5051137|NCT03678779|nutrition education|nutrition education
5051138|NCT03678779|parent intervention|parent intervention
5051139|NCT03678766|Overweight|overweight
5051140|NCT03678766|Obesity|obesity
5051705|NCT03674983|MSM|msm
5051144|NCT03678766|Weight|weight
5051145|NCT03678766|Treatment|treatment
5051146|NCT03678766|Intervention|intervention
5051147|NCT03678766|Behavioral Treatment|behavioral treatment
5051148|NCT03678753|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
5051149|NCT03678753|PGTC|pgtc
5051150|NCT03678753|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
5051151|NCT03678753|Generalized Tonic-Clonic Seizures|generalized tonic-clonic seizures
5051152|NCT03678714|polycystic ovary syndrome|polycystic ovary syndrome
5051153|NCT03678714|exercise|exercise
5051154|NCT03678714|physical activity|physical activity
5051155|NCT03678714|cardiovascular disease|cardiovascular disease
5051156|NCT03678714|low-density lipoprotein|low-density lipoprotein
5051157|NCT03678714|metabolism|metabolism
5051158|NCT03678701|whey protein|whey protein
5051159|NCT03678701|Obesity|obesity
5051160|NCT03678675|ketorolac|ketorolac
5051161|NCT03678675|opiate|opiate
5051162|NCT03678675|cesarean section|cesarean section
5051163|NCT03678662|Exercise-induced hypoalgesia, expectation, pain sensitivity|exercise-induced hypoalgesia, expectation, pain sensitivity
5051164|NCT03678649|Head and Neck Neoplasms;Capecitabine|head and neck neoplasms;capecitabine
5051165|NCT03678623|Musculoskeletal Pain|musculoskeletal pain
5051166|NCT03678623|Occupational Exposure|occupational exposure
5051167|NCT03678623|Predictive value of tests|predictive value of tests
5051168|NCT03678623|Back muscles|back muscles
5960930|NCT04290208|Narcotics|narcotics
5960931|NCT04290208|Patient Satisfaction|patient satisfaction
5051169|NCT03678532|sedation|sedation
5051170|NCT03678532|COPD|copd
5051171|NCT03678532|critically ill|critically ill
5051172|NCT03678532|intensive care|intensive care
5051173|NCT03678506|Venous thromboembolism|venous thromboembolism
5051174|NCT03678506|D-Dimer|d-dimer
5051175|NCT03678506|Apixaban|apixaban
5051176|NCT03678506|Extended treatment|extended treatment
5051177|NCT03678493|AML|aml
5051178|NCT03678493|Allo-HCT|allo-hct
5051179|NCT03678467|tissue engineering, tissue engineered product, mesenchymal stem cells|tissue engineering, tissue engineered product, mesenchymal stem cells
5051180|NCT03678454|Chronic myeloid leukemia|chronic myeloid leukemia
5051181|NCT03678454|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5051183|NCT03678454|ponatinib|ponatinib
5051184|NCT03678415|Depression, anxiety and stress|depression, anxiety and stress
5051185|NCT03678402|falling|falling
5051186|NCT03678402|inpatient|inpatient
5051187|NCT03678389|Pituitary Adenoma|pituitary adenoma
5051188|NCT03678389|pituitary surgery|pituitary surgery
5051189|NCT03678389|Transsphenoidal Surgery|transsphenoidal surgery
5051190|NCT03678389|Pituitary Tumors|pituitary tumors
5051191|NCT03678376|Diagnostic strategy|diagnostic strategy
5051192|NCT03678376|Neurocognitive disorders|neurocognitive disorders
5051193|NCT03678376|Primary Care|primary care
5051194|NCT03678363|Rheumatoid Arthritis|rheumatoid arthritis
5051195|NCT03678363|Tai chi chuan|tai chi chuan
5051196|NCT03678363|Physical Activity|physical activity
5051197|NCT03678324|fabry|fabry
5051198|NCT03678324|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
5051199|NCT03678324|Fabry brain lesions|fabry brain lesions
5051200|NCT03678285|High intensity exercise|high intensity exercise
5051201|NCT03678285|Proenkephalin-A|proenkephalin-a
5051202|NCT03678272|Inguinal hernia|inguinal hernia
5051203|NCT03678272|Chronic postoperative inguinal pain|chronic postoperative inguinal pain
5051204|NCT03678272|Glue mesh|glue mesh
5051205|NCT03678272|Suture mesh|suture mesh
5051206|NCT03678259|Amyloidosis, AL, ATTR, ALect2|amyloidosis, al, attr, alect2
5051207|NCT03678233|hypermetabolism|hypermetabolism
5051208|NCT03678233|hypogonadism|hypogonadism
5051209|NCT03678233|testosterone|testosterone
5051210|NCT03678220|Laparoscopic Ultrasound|laparoscopic ultrasound
5051211|NCT03678194|Depression|depression
5051212|NCT03678194|Smartphone|smartphone
5051213|NCT03678194|Relapse prevention|relapse prevention
5051214|NCT03678194|Mobile support system|mobile support system
5051215|NCT03678194|eHealth|ehealth
5051216|NCT03678194|Ecological|ecological
5051217|NCT03678194|Randomized|randomized
5051218|NCT03678194|Multicentric|multicentric
5051219|NCT03678181|Prevention|prevention
5051220|NCT03678181|Internet|internet
5051221|NCT03678181|Adolescence|adolescence
5051222|NCT03678181|LGBT|lgbt
5051223|NCT03678181|Sexuality|sexuality
5051224|NCT03678181|Young Adulthood|young adulthood
5051231|NCT03678116|caffeine|caffeine
5051232|NCT03678116|metabolism|metabolism
5051233|NCT03678064|physical therapy|physical therapy
5051235|NCT03678064|pediatric rehabilitation|pediatric rehabilitation
5051236|NCT03678064|gross motor function|gross motor function
5051237|NCT03678064|participation|participation
5051238|NCT03678038|adhesive capsulitis|adhesive capsulitis
5051239|NCT03677947|overvalued ideation|overvalued ideation
5051240|NCT03677947|treatment acceptability|treatment acceptability
5051241|NCT03677947|treatment adherence|treatment adherence
5051242|NCT03677947|treatment outcome|treatment outcome
5051799|NCT03674489|median nerve|median nerve
5051249|NCT03677908|Temporoparietal Areas|temporoparietal areas
5051250|NCT03677908|Neural Biomarker|neural biomarker
5051251|NCT03677895|rotator cuff disorder|rotator cuff disorder
5051252|NCT03677882|mind body bridging|mind body bridging
5051253|NCT03677882|mindfulness|mindfulness
5051254|NCT03677882|suicidal ideation|suicidal ideation
5051255|NCT03677882|suicide related behaviors|suicide related behaviors
5051256|NCT03677869|Pneumatic Vitreolysis|pneumatic vitreolysis
5051257|NCT03677856|Paravertebral block|paravertebral block
5051258|NCT03677856|Thoracic epidural block|thoracic epidural block
5051259|NCT03677856|Thoracotomy|thoracotomy
5051260|NCT03677843|hip dislocation|hip dislocation
5051261|NCT03677843|GMFCS level 3,4,5|gmfcs level 3,4,5
5051262|NCT03677843|scoliosis|scoliosis
5051263|NCT03677817|thoracoscopic surgery|thoracoscopic surgery
5051264|NCT03677817|Perioperative intravenous lidocaine administration|perioperative intravenous lidocaine administration
5051265|NCT03677817|Lidocaine|lidocaine
5051266|NCT03677804|aortic valve reconstruction|aortic valve reconstruction
5051267|NCT03677804|OZAKI technique|ozaki technique
5051268|NCT03677804|autologous pericardium|autologous pericardium
5051269|NCT03677791|counselling|counselling
5051270|NCT03677791|computed tomography|computed tomography
5051271|NCT03677791|coronary|coronary
5051272|NCT03677791|CT|ct
5051273|NCT03677791|virtual|virtual
5943963|NCT04255862|UCB4940|ucb4940
5943964|NCT04255862|Bimekizumab|bimekizumab
5943965|NCT04255862|Bioequivalence|bioequivalence
5943966|NCT04255862|Auto-injector|auto-injector
5943967|NCT04255862|Healthy study participants|healthy study participants
5943968|NCT04255862|Safety-syringe|safety-syringe
5943969|NCT04255823|Proton pump inhibitors|proton pump inhibitors
5943970|NCT04255823|Deprescription|deprescription
5943971|NCT04255823|Multi-faceted intervention|multi-faceted intervention
5943972|NCT04255823|Patient-centered|patient-centered
5943973|NCT04255823|Primary health care|primary health care
5943974|NCT04255823|Pharmacoepidemiology|pharmacoepidemiology
5944031|NCT04251442|Osteoarthritis|osteoarthritis
5944032|NCT04251442|Total knee repalcement|total knee repalcement
5051274|NCT03677791|360|360
5051275|NCT03677791|anxiety|anxiety
5051276|NCT03677765|subclavian venous catheterization|subclavian venous catheterization
5051277|NCT03677752|Intervention|intervention
5051278|NCT03677752|Maternal sensitivity|maternal sensitivity
5960932|NCT04290208|Cesarean Section|cesarean section
5051279|NCT03677752|Neurodevelopment|neurodevelopment
5051280|NCT03677752|Maternal stress|maternal stress
5051281|NCT03677752|Maternal anxiety|maternal anxiety
5051282|NCT03677752|Neonatal intensive care unit|neonatal intensive care unit
5051283|NCT03677726|Insomnia|insomnia
5051284|NCT03677726|Cognitive aging|cognitive aging
5051285|NCT03677726|Mindfulness|mindfulness
5051286|NCT03677713|endoscopic|endoscopic
5051287|NCT03677713|endonasal|endonasal
5051295|NCT03677687|Mindfulness|mindfulness
5051296|NCT03677661|Concussion|concussion
5051297|NCT03677661|Physical therapy|physical therapy
5051298|NCT03677661|Vestibular rehabilitation|vestibular rehabilitation
5051299|NCT03677661|Mild traumatic brain injury|mild traumatic brain injury
5051300|NCT03677635|Negative Symptoms|negative symptoms
5051301|NCT03677635|Autobiographical Memory|autobiographical memory
5051302|NCT03677622|Restricted fluid therapy|restricted fluid therapy
5051303|NCT03677622|Goal directed fluid therapy|goal directed fluid therapy
5051304|NCT03677622|Colorectal surgery|colorectal surgery
5051305|NCT03677622|Surgery|surgery
5051306|NCT03677622|Enhanced recovery|enhanced recovery
5051307|NCT03677622|Fluid therapy|fluid therapy
5051314|NCT03677544|radical systectomy|radical systectomy
5051315|NCT03677544|Ureteral frozen section|ureteral frozen section
5051316|NCT03677518|total knee arthroplasty|total knee arthroplasty
5051317|NCT03677518|medial-pivot knee system|medial-pivot knee system
5051318|NCT03677518|kinematics|kinematics
5051319|NCT03677518|survivorship|survivorship
5051320|NCT03677505|double lumen intubation|double lumen intubation
5051321|NCT03677505|videolaryngoscope|videolaryngoscope
5051322|NCT03677479|bone grafts|bone grafts
5051323|NCT03677479|xenograft|xenograft
5051324|NCT03677466|Intramyocardial haemorrhage|intramyocardial haemorrhage
5051325|NCT03677466|Myocardial Infarction|myocardial infarction
5051326|NCT03677466|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5051327|NCT03677466|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5051328|NCT03677466|Pharmaco invasive strategy|pharmaco invasive strategy
5051329|NCT03677466|Fibrinolytic therapy|fibrinolytic therapy
5051330|NCT03677466|Global longitudinal strain|global longitudinal strain
5051331|NCT03677466|Myocardial Necrosis|myocardial necrosis
5051332|NCT03677466|Coronary Artery Disease|coronary artery disease
5051333|NCT03677414|circulating-tumor DNA ctDNA|circulating-tumor dna ctdna
5051334|NCT03677349|Oral cancer|oral cancer
5051335|NCT03677349|Free Flap|free flap
5051336|NCT03677349|Neurrorhaphy|neurrorhaphy
5051337|NCT03677349|Quality of life|quality of life
5051338|NCT03677323|virtual reality|virtual reality
5051339|NCT03677323|pain|pain
5051340|NCT03677323|anxiety|anxiety
5051341|NCT03677297|Intervention Study|intervention study
5051342|NCT03677297|Rosuvastatin|rosuvastatin
5051343|NCT03677297|Periodontitis|periodontitis
5051347|NCT03677258|Collagen|collagen
5051930|NCT03673592|Mosaicism|mosaicism
5051351|NCT03677232|Congenital Heart Disease, Hong Kong, Adolescent|congenital heart disease, hong kong, adolescent
5051352|NCT03677219|consent|consent
5051353|NCT03677219|lumbar puncture|lumbar puncture
5051354|NCT03677219|pediatric|pediatric
5051355|NCT03677219|video|video
5051356|NCT03677180|Cardiogenic shock|cardiogenic shock
5051357|NCT03677180|Mechanical circulatory support|mechanical circulatory support
5051358|NCT03677180|National Cardiogenic Shock Initiative|national cardiogenic shock initiative
5051359|NCT03677180|Myocardial infarction|myocardial infarction
5051360|NCT03677180|Heart attack|heart attack
5051361|NCT03677180|Acute MI|acute mi
5051362|NCT03677180|NCSI|ncsi
5051363|NCT03677180|National CSI|national csi
5051364|NCT03677180|Impella|impella
5051365|NCT03677180|Shock|shock
5051366|NCT03677180|Hemodynamic Support|hemodynamic support
5051367|NCT03677167|chronic plantar heel pain|chronic plantar heel pain
5051368|NCT03677167|barefoot|barefoot
5051369|NCT03677167|treadmill|treadmill
5051370|NCT03677167|Plantar Fascitis|plantar fascitis
5051371|NCT03677128|Digital Health|digital health
5051372|NCT03677128|Pediatric Cancer|pediatric cancer
5051373|NCT03677128|Low and middle-income country|low and middle-income country
5051374|NCT03677128|Tanzania|tanzania
5051375|NCT03677128|Healthcare provider decision support|healthcare provider decision support
5051376|NCT03677128|Protocol-driven treatment|protocol-driven treatment
5051377|NCT03677128|Burkitt lymphoma|burkitt lymphoma
5051378|NCT03677128|Retinoblastoma|retinoblastoma
5944074|NCT04246437|FDOPA|fdopa
5944147|NCT04241380|Total anomalous pulmonary venous connection (TAPVC)|total anomalous pulmonary venous connection (tapvc)
5944148|NCT04241380|Anticoagulant management|anticoagulant management
5944149|NCT04241380|Pulmonary venous obstruction (PVO)|pulmonary venous obstruction (pvo)
5944150|NCT04241380|outcomes|outcomes
5944159|NCT04238819|CDK4|cdk4
5944160|NCT04238819|CDK6|cdk6
5944161|NCT04238819|Ewing's sarcoma|ewing's sarcoma
5944162|NCT04238819|neuroblastoma|neuroblastoma
5944163|NCT04238819|malignant rhabdoid tumor|malignant rhabdoid tumor
5944164|NCT04238819|rhabdomyosarcoma|rhabdomyosarcoma
5944165|NCT04238819|osteosarcoma|osteosarcoma
5944166|NCT04238819|brain tumor|brain tumor
5944167|NCT04238819|glioblastoma|glioblastoma
5944168|NCT04238819|malignant glioma|malignant glioma
5944169|NCT04238819|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5944170|NCT04238819|medulloblastoma|medulloblastoma
5944171|NCT04238819|ependymoma|ependymoma
5944172|NCT04238819|solid tumor|solid tumor
5944188|NCT04238104|Saturation|saturation
5944189|NCT04238104|Cut-off value|cut-off value
5944190|NCT04238104|Neonates|neonates
5944191|NCT04238104|Altitude|altitude
5944192|NCT04238104|POX|pox
5944193|NCT04238104|major CHD|major chd
5944200|NCT04237727|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5944201|NCT04237727|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5944202|NCT04237727|Respiration, Artificial|respiration, artificial
5944206|NCT04237194|Assessment of nerve fiber excitability|assessment of nerve fiber excitability
5944220|NCT04235478|cervical disc herniation|cervical disc herniation
5944221|NCT04235478|epidural injection|epidural injection
5944222|NCT04235478|radicular pain|radicular pain
5944223|NCT04235478|neuropathic pain|neuropathic pain
5944242|NCT04232345|Randomized|randomized
5944243|NCT04232345|Single-blind|single-blind
5944244|NCT04232345|Placebo-controlled|placebo-controlled
5944245|NCT04232345|Multiple-ascending dose|multiple-ascending dose
5944246|NCT04232345|AZD4831 oral suspension|azd4831 oral suspension
5944254|NCT04231097|Mindfulness|mindfulness
5944255|NCT04231097|Acute Coronary Syndrome|acute coronary syndrome
5944256|NCT04231097|Videoconferencing|videoconferencing
5944257|NCT04231097|Depression|depression
5944258|NCT04231058|COPD|copd
5944259|NCT04231058|acupuncture|acupuncture
5944260|NCT04231058|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5944264|NCT04230408|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
5944265|NCT04230408|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
5944266|NCT04230408|Durvalumab|durvalumab
5944267|NCT04230408|MEDI4736|medi4736
5944285|NCT04227561|penile nerve block|penile nerve block
5944286|NCT04227561|pudendal nerve block|pudendal nerve block
5944287|NCT04227340|Adolescents|adolescents
5944288|NCT04227340|Autologous Transplant|autologous transplant
5944289|NCT04227340|Chemotherapy|chemotherapy
5944290|NCT04227340|Children|children
5944291|NCT04227340|Extra-oral Photobiomodulation Therapy|extra-oral photobiomodulation therapy
5944292|NCT04227340|HCT|hct
5944293|NCT04227340|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5944294|NCT04227340|Low Level Light therapy|low level light therapy
5944295|NCT04227340|Oral Mucositis|oral mucositis
5944296|NCT04227340|PBM|pbm
5944297|NCT04227340|Photobiomodulation Therapy|photobiomodulation therapy
5944319|NCT04224740|Penile Neoplasms pembrolizumab cisplatin carboplatin 5- fluorouracil|penile neoplasms pembrolizumab cisplatin carboplatin 5- fluorouracil
5944320|NCT04223960|EA1080|ea1080
5944321|NCT04223960|Pharmacokinetics|pharmacokinetics
5944322|NCT04223960|Food effect study|food effect study
5944323|NCT04223960|Pharmacodynamics|pharmacodynamics
5944340|NCT04222569|Intensive Care Unit|intensive care unit
5944341|NCT04222569|Critical Care|critical care
5944342|NCT04222569|Mechanical Ventilation Weaning|mechanical ventilation weaning
5944343|NCT04222569|Spontaneous Breath Trial|spontaneous breath trial
5944344|NCT04222569|Rehabilitation|rehabilitation
5944365|NCT04217174|HIV|hiv
5944366|NCT04217174|adherence|adherence
5944367|NCT04217174|retention in care|retention in care
5944368|NCT04217174|avatar|avatar
5944369|NCT04217174|mobile phone application|mobile phone application
5944370|NCT04217174|food safety|food safety
5944392|NCT04214886|Leukemia|leukemia
5944393|NCT04214886|Lymphoma|lymphoma
5944394|NCT04214886|CAR T|car t
5944395|NCT04214886|Chimeric|chimeric
5944396|NCT04214886|CD19|cd19
5944416|NCT04212013|Ibrutinib|ibrutinib
5944417|NCT04212013|Rituximab|rituximab
5944418|NCT04212013|Treatment Naïve|treatment naïve
5944419|NCT04212013|19-243|19-243
5267228|NCT02346955|Bladder|bladder
5944505|NCT04202822|real-time polymerase chain reaction|real-time polymerase chain reaction
5944506|NCT04202822|early wound healing|early wound healing
5944507|NCT04202822|gingiva|gingiva
5944508|NCT04202822|oral mucosa|oral mucosa
5944553|NCT04199728|Opiate treatment|opiate treatment
5944554|NCT04199728|Opioid treatment|opioid treatment
5944555|NCT04199728|Glucagon-Like Peptide-1 Agonist|glucagon-like peptide-1 agonist
5944556|NCT04199728|Opioid use disorder|opioid use disorder
5944557|NCT04199728|Liraglutide|liraglutide
5944584|NCT04197154|Nocebo|nocebo
5944585|NCT04197154|Pain|pain
5944586|NCT04197154|Fear|fear
5944587|NCT04197154|Conditioning|conditioning
5944588|NCT04197154|Negative suggestions|negative suggestions
5944589|NCT04197154|Extinction|extinction
5944598|NCT04194255|iron-deficiency|iron-deficiency
5944599|NCT04194255|Prebiotics|prebiotics
5944600|NCT04194255|galacto-oligosaccharides|galacto-oligosaccharides
5944643|NCT04191122|Primary care|primary care
5944644|NCT04191122|Community settings|community settings
5944668|NCT04187989|Social Media|social media
5944724|NCT04182204|Lymphoma|lymphoma
5944725|NCT04182204|Large B-Cell|large b-cell
5944726|NCT04182204|Diffuse|diffuse
5944732|NCT04180033|Colonoscopy surveillance|colonoscopy surveillance
5944747|NCT04177108|Breast Neoplasms|breast neoplasms
5944748|NCT04177108|Triple Negative Breast Neoplasms|triple negative breast neoplasms
5944749|NCT04177108|Neoplasms by Site|neoplasms by site
5944750|NCT04177108|Neoplasms|neoplasms
5944751|NCT04177108|Breast Diseases|breast diseases
5944752|NCT04177108|Skin Diseases|skin diseases
5944753|NCT04177108|Paclitaxel|paclitaxel
5944754|NCT04177108|Atezolizumab|atezolizumab
5944755|NCT04177108|Ipatasertib|ipatasertib
5944756|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal
5944757|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5944758|NCT04177108|Antineoplastic Agents|antineoplastic agents
5944759|NCT04177108|Tubulin Modulators|tubulin modulators
5944760|NCT04177108|Antimitotic Agents|antimitotic agents
5944761|NCT04177108|Mitosis Modulators|mitosis modulators
5944870|NCT04167527|Immediate Mechanical Thrombectomy|immediate mechanical thrombectomy
5944871|NCT04167527|Initial medical management|initial medical management
5944872|NCT04167527|Large vessel occlusion|large vessel occlusion
5944873|NCT04167527|Efficacy|efficacy
5944874|NCT04167527|Safety|safety
5944883|NCT04167228|ceftazidime / avibactam|ceftazidime / avibactam
5944884|NCT04167228|carbapenem resistant enterobacteria|carbapenem resistant enterobacteria
5944890|NCT04166747|virtual reality|virtual reality
5944891|NCT04166747|older population|older population
5944892|NCT04166747|functional fitness|functional fitness
5944893|NCT04166747|quality of life|quality of life
5944894|NCT04166747|happiness|happiness
5944905|NCT04165967|Tumor-infiltrating Lymphocyte (TIL) Transfer|tumor-infiltrating lymphocyte (til) transfer
5944906|NCT04165967|Nivolumab|nivolumab
5944907|NCT04165967|metastatic melanoma|metastatic melanoma
5944908|NCT04165967|anti-PD-1 therapy|anti-pd-1 therapy
5944909|NCT04165967|failed immunotherapy|failed immunotherapy
5944910|NCT04165967|personalized Investigational Medicinal Product (IMP)|personalized investigational medicinal product (imp)
5944973|NCT04162080|kayak polo|kayak polo
5944997|NCT04160234|elderly|elderly
5944998|NCT04160234|surgery|surgery
5944999|NCT04160234|preoperative risk|preoperative risk
5250666|NCT02441413|FRI|fri
5945021|NCT04158700|TGF-beta|tgf-beta
5945022|NCT04158700|Urothelial carcinoma|urothelial carcinoma
5945023|NCT04158700|Hepatocellular carcinoma|hepatocellular carcinoma
5945024|NCT04158700|Non-small cell lung cancer|non-small cell lung cancer
5945025|NCT04158700|TGF- beta receptor type I inhibitor|tgf- beta receptor type i inhibitor
5945028|NCT04158336|Solid tumor|solid tumor
5051379|NCT03677128|Treatment abandonment|treatment abandonment
5051380|NCT03677128|Client health records|client health records
5051381|NCT03677089|ASD|asd
5051382|NCT03677089|Autism|autism
5051383|NCT03677089|Telehealth|telehealth
5051384|NCT03677089|Primary Care Providers|primary care providers
5051385|NCT03677063|peritoneal dialysis|peritoneal dialysis
5051386|NCT03677063|dressing|dressing
5044403|NCT03721627|HCV|hcv
5051387|NCT03677063|exit-site|exit-site
5051388|NCT03677063|catheter|catheter
5051389|NCT03677063|infection|infection
5051394|NCT03677037|mentalization-based therapy|mentalization-based therapy
5051395|NCT03677037|borderline personality disorder|borderline personality disorder
5960933|NCT04290208|Pain|pain
5960934|NCT04290208|Postoperative Period|postoperative period
5051396|NCT03677037|randomized clinical trial|randomized clinical trial
5051397|NCT03677037|psychotherapy research|psychotherapy research
5051398|NCT03677037|treatment intensity|treatment intensity
5051399|NCT03677024|Sentinel lymph node policy|sentinel lymph node policy
5051400|NCT03677011|myo-inositol|myo-inositol
5051401|NCT03677011|fertilization rate|fertilization rate
5051402|NCT03677011|infertility|infertility
5051403|NCT03677011|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
5051405|NCT03676998|Prolonged weaning|prolonged weaning
5051406|NCT03676998|Diaphragm dysfunction|diaphragm dysfunction
5051407|NCT03676998|Liberation from mechanical|liberation from mechanical
5051408|NCT03676920|financial toxicity, cancer, treatment cost, patient-provider communication|financial toxicity, cancer, treatment cost, patient-provider communication
5051409|NCT03676907|cesarean scar defect|cesarean scar defect
5051410|NCT03676907|single suturation technique|single suturation technique
5051411|NCT03676907|double suturation technique|double suturation technique
5051412|NCT03676907|myometrial thickness|myometrial thickness
5051413|NCT03676907|uterine scar|uterine scar
5051414|NCT03676816|Chlamydia|chlamydia
5051415|NCT03676816|Gonorrhea|gonorrhea
5051416|NCT03676790|Osteoarthritis, Knee|osteoarthritis, knee
5051417|NCT03676790|Ultrasonic Therapy|ultrasonic therapy
5051418|NCT03676790|Exercise Therapy|exercise therapy
5051419|NCT03676790|Randomized controlled trial.|randomized controlled trial.
5051420|NCT03676777|Bacterial infection|bacterial infection
5051421|NCT03676777|Fungal infection|fungal infection
5051422|NCT03676777|Cirrhosis|cirrhosis
5051423|NCT03676777|Multi-drug resistance|multi-drug resistance
5051424|NCT03676777|Antibiotic treatment|antibiotic treatment
5051425|NCT03676777|Clinical outcome|clinical outcome
5051426|NCT03676777|Organ failure|organ failure
5051427|NCT03676777|Acute-on-chronic liver failure|acute-on-chronic liver failure
5051428|NCT03676777|Decompensated cirrhosis|decompensated cirrhosis
5051429|NCT03676777|Complications of cirrhosis|complications of cirrhosis
5051430|NCT03676777|Acute kidney injury|acute kidney injury
5051431|NCT03676764|Childhood mortality|childhood mortality
5051432|NCT03676764|Azithromycin|azithromycin
5051433|NCT03676764|Mass treatment|mass treatment
5051434|NCT03676764|Vaccine Visit targeted treatment|vaccine visit targeted treatment
5051435|NCT03676751|azithromycin|azithromycin
5051436|NCT03676751|mass drug administration|mass drug administration
5051437|NCT03676751|childhood mortality|childhood mortality
5051438|NCT03676738|Anesthesia, Risk Factors, Age|anesthesia, risk factors, age
5051439|NCT03676699|Extravascular lung water, inferior vena cava collapsibility|extravascular lung water, inferior vena cava collapsibility
5051440|NCT03676582|swallowing disorders|swallowing disorders
5051441|NCT03676582|instrumental swallow assessment|instrumental swallow assessment
5051442|NCT03676582|acoustic analysis|acoustic analysis
5051445|NCT03676569|refractory epilepsy|refractory epilepsy
5051447|NCT03676569|mezenchymal stem cells|mezenchymal stem cells
5051448|NCT03676569|anti-neuronal antibody|anti-neuronal antibody
5051449|NCT03676569|Rasmussen encephality|rasmussen encephality
5051450|NCT03676569|adipose derived regenerative stem cells|adipose derived regenerative stem cells
5051451|NCT03676556|wound treatment|wound treatment
5051452|NCT03676556|lidocaine|lidocaine
5051453|NCT03676556|pain reduction|pain reduction
5051454|NCT03676556|local anesthetic|local anesthetic
5051455|NCT03676491|unipolar|unipolar
5051456|NCT03676491|sleep disturbances|sleep disturbances
5051457|NCT03676465|Type 1 Diabetes Mellitus (T1D)|type 1 diabetes mellitus (t1d)
5051458|NCT03676465|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5051459|NCT03676465|Activity Monitor (i.e. Fitbit)|activity monitor (i.e. fitbit)
5051460|NCT03676465|Hemoglobin A1c (HbA1c)|hemoglobin a1c (hba1c)
5051461|NCT03676465|Companion Medical inPen|companion medical inpen
5051462|NCT03676465|Insulin Pump|insulin pump
5051463|NCT03676465|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
5051464|NCT03676439|Lateral Cord Stimulation|lateral cord stimulation
5051465|NCT03676439|Disability|disability
5051466|NCT03676439|Magnetic Stimulation|magnetic stimulation
5051467|NCT03676439|Spasticity|spasticity
5051468|NCT03676439|Spinal Cord Stimulation|spinal cord stimulation
5051469|NCT03676413|asthma|asthma
5051470|NCT03676413|therapeutic equivalence|therapeutic equivalence
5945137|NCT04150653|Abdominal aortic aneurysm rupture prevention|abdominal aortic aneurysm rupture prevention
5945138|NCT04150653|Non-invasive vascular elastography by ultrasound|non-invasive vascular elastography by ultrasound
5945139|NCT04150653|3D mapping of AAA strain|3d mapping of aaa strain
5945140|NCT04150653|Vascular vulnerability assessment|vascular vulnerability assessment
5945179|NCT04148352|Food allergy|food allergy
5945180|NCT04148352|Milk allergy|milk allergy
5945181|NCT04148352|Oral Immunotherapy|oral immunotherapy
5945232|NCT04145804|Time in range|time in range
5945233|NCT04145804|Hybrid closed loop system|hybrid closed loop system
5945234|NCT04145804|Multiple daily insulin injection|multiple daily insulin injection
5945246|NCT04144556|Stroke|stroke
5945247|NCT04144556|virtual reality|virtual reality
5945248|NCT04144556|physical therapy|physical therapy
5945284|NCT04141670|RYR1|ryr1
5945285|NCT04141670|Myopathy|myopathy
5945325|NCT04138199|Lopinavir/ritonavir (LPV/r)|lopinavir/ritonavir (lpv/r)
5945326|NCT04138199|Kaletra|kaletra
5945327|NCT04138199|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5945328|NCT04138199|Generic Product|generic product
5945329|NCT04138199|Highly Active Anti-Retroviral Therapy (HAART)|highly active anti-retroviral therapy (haart)
5945348|NCT04136340|Telemedicine|telemedicine
5945349|NCT04136340|Virtual Visits|virtual visits
5945350|NCT04136340|19-382|19-382
5945380|NCT04132362|music|music
5945381|NCT04132362|dementia|dementia
5945382|NCT04132362|emotional responses|emotional responses
5945391|NCT04130958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5945392|NCT04130958|Intermittent Theta Burst|intermittent theta burst
5369106|NCT01861327|aortic aneurysm|aortic aneurysm
5945436|NCT04126200|a(OX40)|a(ox40)
5945437|NCT04126200|a(ICOS)|a(icos)
5945438|NCT04126200|Belantamab mafodotin|belantamab mafodotin
5945439|NCT04126200|gamma-secretase inhibitor|gamma-secretase inhibitor
5945440|NCT04126200|GSK2857916|gsk2857916
5945441|NCT04126200|GSK3174998|gsk3174998
5945442|NCT04126200|GSK3359609|gsk3359609
5945443|NCT04126200|nirogacestat|nirogacestat
5945444|NCT04126200|Platform study|platform study
5945445|NCT04126200|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5945451|NCT04125329|Human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
5945452|NCT04125329|Diabetic nephropathy|diabetic nephropathy
5945467|NCT04123327|Symptom preoccupation|symptom preoccupation
5945468|NCT04123327|Atrial fibrillation|atrial fibrillation
5945469|NCT04123327|Quality of Life|quality of life
5945470|NCT04123327|Cardiac anxiety|cardiac anxiety
5945484|NCT04121676|Solid tumors|solid tumors
5945485|NCT04121676|Anti-CD137|anti-cd137
5945486|NCT04121676|Advanced Cancer|advanced cancer
5945487|NCT04121676|Open-Label|open-label
5945488|NCT04121676|Dose Escalation|dose escalation
5945489|NCT04121676|Monotherapy|monotherapy
5945500|NCT04120233|cognitive disorder|cognitive disorder
5945501|NCT04120233|pharmacokinetics|pharmacokinetics
5945502|NCT04120233|MW151|mw151
5945503|NCT04120233|MW01-2-151SRM|mw01-2-151srm
5945504|NCT04120233|PK|pk
5945505|NCT04120233|dose escalation|dose escalation
5945600|NCT04107948|sedentary time|sedentary time
5945601|NCT04107948|therapeutic education sessions|therapeutic education sessions
5945727|NCT04093752|T2DM|t2dm
5945728|NCT04093492|gestational age|gestational age
5945729|NCT04093492|multi-media|multi-media
5945730|NCT04093492|mobile application|mobile application
5945731|NCT04093492|anxiety|anxiety
5945732|NCT04093492|clinical trial|clinical trial
5945733|NCT04093492|random allocation|random allocation
5251192|NCT02438462|Imaging|imaging
5945800|NCT04089033|Retinal detachment|retinal detachment
5945801|NCT04089033|Metamorphopsia|metamorphopsia
5945802|NCT04089033|Aniseikonia|aniseikonia
5945803|NCT04089033|Retinal displacement|retinal displacement
5945805|NCT04088396|Systemic|systemic
5945806|NCT04088396|Fever|fever
5945807|NCT04088396|Flare|flare
5945808|NCT04088396|sJIA|sjia
5945809|NCT04088396|JIA|jia
5945922|NCT04073433|Mood|mood
5945923|NCT04073433|Subjective Effects|subjective effects
5945924|NCT04073433|MDMA|mdma
5333710|NCT02023242|PXG|pxg
5051471|NCT03676413|bioequivalence|bioequivalence
5051472|NCT03676413|fluticasone propionate|fluticasone propionate
5051474|NCT03676400|mesenchymal stem cells|mesenchymal stem cells
5051475|NCT03676400|conditioned media|conditioned media
5051480|NCT03676400|umbilical cord blood|umbilical cord blood
5051481|NCT03676387|pediatric|pediatric
5051482|NCT03676387|endotracheal tube|endotracheal tube
5051483|NCT03676387|ultrasonography|ultrasonography
5096883|NCT03393013|lupus|lupus
5051484|NCT03676361|Kidney Damage|kidney damage
5946022|NCT04066504|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
5946023|NCT04066504|laBCC|labcc
5946030|NCT04065256|music therapy|music therapy
5946031|NCT04065256|intensive care unit|intensive care unit
5946032|NCT04065256|delirium|delirium
5946081|NCT04058288|stroke|stroke
5946082|NCT04058288|HD-tDCS|hd-tdcs
5946083|NCT04058288|musicglove|musicglove
5946084|NCT04058288|Upper-limb rehab|upper-limb rehab
5051485|NCT03676348|quality of life|quality of life
5051486|NCT03676348|health related quality of life|health related quality of life
5051487|NCT03676348|thyroid cancer|thyroid cancer
5051488|NCT03676348|thyroid nodule|thyroid nodule
5051489|NCT03676348|thyroid neoplasm|thyroid neoplasm
5051490|NCT03676348|thyroid surgery|thyroid surgery
5051491|NCT03676348|patient reported outcome measurements|patient reported outcome measurements
5051492|NCT03676322|Pharmacokinetics|pharmacokinetics
5051494|NCT03676296|Puerarin|puerarin
5051495|NCT03676296|Lipids|lipids
5051496|NCT03676296|Testosterone|testosterone
5051497|NCT03676270|Cancer|cancer
5051498|NCT03676270|Phase I trials|phase i trials
5051499|NCT03676270|Review|review
5051500|NCT03676257|Metastatic breast cancer|metastatic breast cancer
5051501|NCT03676257|Real world data|real world data
5051502|NCT03676257|Surrogate|surrogate
5051503|NCT03676218|Cancer|cancer
5051504|NCT03676218|Elderly|elderly
5051505|NCT03676218|Randomized controlled trial|randomized controlled trial
5051506|NCT03676218|Endpoint|endpoint
5051507|NCT03676218|Consensus|consensus
5051508|NCT03676205|Platelet-Rich Plasma|platelet-rich plasma
5051509|NCT03676205|hamstrings|hamstrings
5051510|NCT03676205|cuadriceps|cuadriceps
5051511|NCT03676205|football players|football players
5051512|NCT03676166|Cannabis|cannabis
5051513|NCT03676166|Toxicology|toxicology
5051514|NCT03676166|Intoxication|intoxication
5051614|NCT03675451|Imaging|imaging
5051527|NCT03676075|colorectal cancer|colorectal cancer
5051528|NCT03676075|early diagnosis|early diagnosis
5051529|NCT03676075|5-hydroxymethylcytosine|5-hydroxymethylcytosine
5051530|NCT03676062|exercise, pain, yoga|exercise, pain, yoga
5051531|NCT03676049|Children, Epilepsy, Cannabidiol|children, epilepsy, cannabidiol
5051532|NCT03676023|mapca|mapca
5051533|NCT03676023|tranexamic acid|tranexamic acid
5051535|NCT03676023|pulmonary hemorrhage|pulmonary hemorrhage
5051536|NCT03676010|Cancer|cancer
5051537|NCT03676010|Randomized controlled trial|randomized controlled trial
5051538|NCT03676010|Endpoint|endpoint
5051539|NCT03676010|Consensus|consensus
5051540|NCT03675997|Autograft|autograft
5051541|NCT03675997|Anxiety|anxiety
5051542|NCT03675997|Protected environment|protected environment
5051543|NCT03675984|surface EMG, cobb angle, exercise, Spinal Curvatures|surface emg, cobb angle, exercise, spinal curvatures
5051544|NCT03675971|Pain Management; Analgesics, Opioid; Cannabis|pain management; analgesics, opioid; cannabis
5051545|NCT03675958|H Reflex|h reflex
5051546|NCT03675958|Johnstone's Pressure Splint|johnstone's pressure splint
5051547|NCT03675958|Stretching|stretching
5051548|NCT03675958|Functional Reach|functional reach
5051549|NCT03675958|Spasticity|spasticity
5051550|NCT03675919|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5051551|NCT03675906|hypoalbuminemia|hypoalbuminemia
5051552|NCT03675906|Acute Kidney Failure|acute kidney failure
5051553|NCT03675906|older age|older age
5051554|NCT03675906|hip fracture|hip fracture
5051570|NCT03675763|Skull|skull
5051571|NCT03675763|Osteopathic Manipulation|osteopathic manipulation
5051572|NCT03675763|Infantile Colic|infantile colic
5051573|NCT03675763|Clinical Trial|clinical trial
5051574|NCT03675763|Massage|massage
5051575|NCT03675763|Infant|infant
5051576|NCT03675763|Osteopathic Medicine|osteopathic medicine
5051577|NCT03675750|antipsychotic drugs|antipsychotic drugs
5051578|NCT03675750|hyperprolactinemia|hyperprolactinemia
5051579|NCT03675750|bone metabolism|bone metabolism
5051587|NCT03675698|Nasotracheal tube size based on radiological images of nose.|nasotracheal tube size based on radiological images of nose.
5051588|NCT03675685|Cellulite|cellulite
5051589|NCT03675685|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
5051590|NCT03675685|EFP|efp
5051591|NCT03675659|tmj pain|tmj pain
5051592|NCT03675646|morphine spinal|morphine spinal
5051593|NCT03675646|prostatectomy|prostatectomy
5051595|NCT03675607|Infant Nutritional Physiological Phenomena|infant nutritional physiological phenomena
5051596|NCT03675607|Complementary feeding|complementary feeding
5051597|NCT03675607|Feeding Behavior|feeding behavior
5051598|NCT03675607|Food Preferences|food preferences
5051600|NCT03675607|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5051601|NCT03675594|Dislodgement force|dislodgement force
5051602|NCT03675594|Digital denture|digital denture
5051603|NCT03675594|CAD/CAM metallic dentures|cad/cam metallic dentures
5051604|NCT03675529|prostate neoplasm|prostate neoplasm
5051605|NCT03675529|exercise|exercise
5051606|NCT03675529|high intensity interval training|high intensity interval training
5051607|NCT03675529|tumor hypoxia|tumor hypoxia
5051608|NCT03675529|immune cells|immune cells
5051609|NCT03675503|Fall Prevention|fall prevention
5051610|NCT03675503|Hospital Acquired Conditions|hospital acquired conditions
5051611|NCT03675503|Nurse Education|nurse education
5051612|NCT03675503|Assistive Devices|assistive devices
5051613|NCT03675451|PET/CT|pet/ct
5051619|NCT03675412|Primary Open Angle Glaucoma (POAG)|primary open angle glaucoma (poag)
5946207|NCT04049383|ALL, B-cell, CAR-T|all, b-cell, car-t
5946228|NCT04047719|Pneumonia|pneumonia
5946229|NCT04047719|NGS|ngs
5946230|NCT04047719|cell free DNA|cell free dna
5946231|NCT04047719|microbial cell free DNA|microbial cell free dna
5946232|NCT04047719|immunocompromised|immunocompromised
5946235|NCT04046419|validity, reliability, Turkish version, HC-PAIRS|validity, reliability, turkish version, hc-pairs
5946404|NCT04027751|tropisetron|tropisetron
5946405|NCT04027751|emergence delirium|emergence delirium
5946406|NCT04027751|postoperative delirium|postoperative delirium
5946408|NCT04026204|TAVR|tavr
5946409|NCT04026204|Coronary cannulation|coronary cannulation
5946410|NCT04026204|Transcatheter aortic prosthesis|transcatheter aortic prosthesis
5946458|NCT04019184|Cardiac surgery|cardiac surgery
5946459|NCT04019184|glutamine|glutamine
5355476|NCT01923818|TIA|tia
5369107|NCT01861327|angioplasty|angioplasty
5369108|NCT01861327|Critical lower limb ischemia|critical lower limb ischemia
5369109|NCT01861288|Inflammatory Bowel Disease|inflammatory bowel disease
5946526|NCT04012164|microbiome|microbiome
5946527|NCT04012164|virome|virome
5946528|NCT04012164|zoonotic disease|zoonotic disease
5946529|NCT04012164|ecological gradient|ecological gradient
5946530|NCT04012164|human-animal relations|human-animal relations
5946531|NCT04012164|anthropology|anthropology
5946532|NCT04012164|social sciences|social sciences
5946576|NCT04007432|nocturnal hypoxia|nocturnal hypoxia
5946577|NCT04007432|delirum developpement|delirum developpement
5946593|NCT04004611|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
5946594|NCT04004611|IL-23p19|il-23p19
5946595|NCT04004611|Pediatric|pediatric
5946644|NCT04001153|Hall Technique|hall technique
5946645|NCT04001153|Primary Molar|primary molar
5946646|NCT04001153|Vertical Dimension|vertical dimension
5355732|NCT01922648|RSV|rsv
5946670|NCT03998618|psychotherapy|psychotherapy
5946671|NCT03998618|fatigue|fatigue
5946672|NCT03998618|quality of life|quality of life
5946696|NCT03997266|premature birth|premature birth
5946697|NCT03997266|human microbiome|human microbiome
5946698|NCT03997266|antibiotics|antibiotics
5946707|NCT03994926|cannabis|cannabis
5946711|NCT03994731|gout|gout
5946712|NCT03994731|uncontrolled gout|uncontrolled gout
5946739|NCT03990896|Breast Cancer|breast cancer
5946758|NCT03987919|T2DM|t2dm
5946759|NCT03987919|GLP-1 RA|glp-1 ra
5946760|NCT03987919|Glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
5946761|NCT03987919|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5946762|NCT03987919|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
5946822|NCT03977688|sepsis|sepsis
5946823|NCT03977688|septic shock|septic shock
5946824|NCT03977688|cytokin adsorption|cytokin adsorption
5239901|NCT02503683|AAT|aat
5946886|NCT03969719|Non-alcoholic steatohepatitis; Type 2 Diabetes Mellitus|non-alcoholic steatohepatitis; type 2 diabetes mellitus
5946922|NCT03965403|stroke|stroke
5946923|NCT03965403|hemiparesis|hemiparesis
5946924|NCT03965403|Robotic|robotic
5334713|NCT02018393|FEIBA®|feiba®
5054989|NCT03654313|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
5054990|NCT03654287|sepsis|sepsis
5054991|NCT03654287|CRRT|crrt
5054992|NCT03654287|ECMO|ecmo
5054993|NCT03654287|CELS|cels
5054994|NCT03654274|Endometriosis|endometriosis
5054995|NCT03654274|Dysmenorrhea|dysmenorrhea
5054996|NCT03654274|Pain|pain
5054997|NCT03654274|Dypareunia|dypareunia
5054998|NCT03654261|Cognitive Therapy|cognitive therapy
5054999|NCT03654261|Workshop|workshop
5055000|NCT03654261|Postpartum Depression|postpartum depression
5055004|NCT03654209|Argon Plasma Coagulation|argon plasma coagulation
5055005|NCT03654209|Snare Tip Soft Coagulation|snare tip soft coagulation
5055017|NCT03654105|Diet|diet
5055018|NCT03654105|Physical Activity|physical activity
5055019|NCT03654105|CRP|crp
5055020|NCT03654092|Exercise|exercise
5055021|NCT03654092|Minimal equipment|minimal equipment
5055022|NCT03654092|Home-based|home-based
5055023|NCT03654092|COPD|copd
5055024|NCT03654092|Exercise training intervention|exercise training intervention
5055025|NCT03654092|Randomized controlled trial|randomized controlled trial
5055026|NCT03654079|Simulation|simulation
5055027|NCT03654079|Pregnancy|pregnancy
5055028|NCT03654079|Labor and Delivery|labor and delivery
5055037|NCT03654014|Neurologic outcome|neurologic outcome
5055038|NCT03654014|Cerebrospinal fluid biomarkers|cerebrospinal fluid biomarkers
5055039|NCT03654014|serum biomarkers|serum biomarkers
5055040|NCT03654001|Septic Shock|septic shock
5055041|NCT03654001|Albumin|albumin
5055042|NCT03654001|Balanced crystalloids|balanced crystalloids
5055043|NCT03653988|Nerve block|nerve block
5055044|NCT03653988|Pectoralis nerve blocks|pectoralis nerve blocks
5055045|NCT03653988|PECS I|pecs i
5055046|NCT03653988|PECS II|pecs ii
5055047|NCT03653988|Mastectomy|mastectomy
5055048|NCT03653975|Nodding Syndrome|nodding syndrome
5055049|NCT03653975|Head Nodding|head nodding
5055050|NCT03653975|Epilepsy|epilepsy
5055051|NCT03653975|Onchocerciasis|onchocerciasis
5055052|NCT03653975|Cognitive impairment|cognitive impairment
5055053|NCT03653975|Mahenge|mahenge
5055054|NCT03653962|Multimedia|multimedia
5055055|NCT03653962|informed consent|informed consent
5055056|NCT03653962|metabolic surgery|metabolic surgery
5055057|NCT03653962|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5055058|NCT03653949|Cystic fibrosis|cystic fibrosis
5055059|NCT03653949|Insulin Resistance|insulin resistance
5055060|NCT03653949|Aerobic Exercise|aerobic exercise
5055061|NCT03653949|Child|child
5055062|NCT03653949|Adolescents|adolescents
5067943|NCT03574467|stroke|stroke
5055067|NCT03653897|Ingestible sensor|ingestible sensor
5055068|NCT03653897|Medication adherence|medication adherence
5055069|NCT03653897|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
5055074|NCT03653858|Deep Brain Stimulation|deep brain stimulation
5055075|NCT03653858|Treatment-resistant depression|treatment-resistant depression
5055076|NCT03653858|Medial forebrain bundle|medial forebrain bundle
5055077|NCT03653845|Hypertension|hypertension
5055078|NCT03653845|Primary Aldosteronism|primary aldosteronism
5055079|NCT03653845|Ablation|ablation
5055080|NCT03653845|Adrenal Gland|adrenal gland
5055081|NCT03653832|Sedation|sedation
5055082|NCT03653832|Ventilation|ventilation
5055083|NCT03653819|Compression Stockings|compression stockings
5055084|NCT03653819|Feasibility Study|feasibility study
5055085|NCT03653819|Physical Activity|physical activity
5055086|NCT03653819|High Intensity Interval Training|high intensity interval training
5055087|NCT03653819|Cross over trial|cross over trial
5055090|NCT03653780|Wearable Exoskeleton|wearable exoskeleton
5055091|NCT03653780|Stroke|stroke
5055092|NCT03653780|Oxygen Consumption|oxygen consumption
5055093|NCT03653780|Cardiorespiratory Responses|cardiorespiratory responses
5055094|NCT03653767|classroom ergonomics|classroom ergonomics
5055095|NCT03653767|sedentary behavior|sedentary behavior
5055096|NCT03653767|school interventions|school interventions
5055097|NCT03653767|physical activity|physical activity
5055098|NCT03653754|growth|growth
5055099|NCT03653754|Body Composition|body composition
5055100|NCT03653728|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion|non-invasive monitoring; near-infrared spectroscopy; traumatic brain injury; cerebral contusion
5055101|NCT03653715|Refractive Errors|refractive errors
5055102|NCT03653715|Myopia|myopia
5055103|NCT03653715|Hyperopia|hyperopia
5055104|NCT03653715|Astigmatism|astigmatism
5055105|NCT03653689|IBS|ibs
5055106|NCT03653689|metabotype|metabotype
5055107|NCT03653689|FODMAP|fodmap
5055108|NCT03653689|gluten|gluten
5960954|NCT04290143|healing water|healing water
5960955|NCT04290143|placebo|placebo
5947100|NCT03947333|Diabetes|diabetes
5947101|NCT03947333|Patient Activation|patient activation
5947102|NCT03947333|Patient Web Portals|patient web portals
5947103|NCT03947333|Health Information Technology|health information technology
5947143|NCT03942211|selexipag, sarcoidosis, pulmonary hypertension|selexipag, sarcoidosis, pulmonary hypertension
5947173|NCT03940196|Platinum Resistant Ovarian Cancer|platinum resistant ovarian cancer
5947174|NCT03940196|PROC|proc
5947175|NCT03940196|TTFields|ttfields
5947176|NCT03940196|Paclitaxel|paclitaxel
5947177|NCT03940196|Minimal toxicity|minimal toxicity
5947178|NCT03940196|TTF|ttf
5947179|NCT03940196|Tumor Treating Fields|tumor treating fields
5947180|NCT03940196|Novocure|novocure
5252386|NCT02431559|PLD|pld
5947245|NCT03933215|Multiple Sclerosis|multiple sclerosis
5947246|NCT03933215|Cladribine Tablets|cladribine tablets
5947247|NCT03933215|Observational|observational
5947248|NCT03933215|Mavenclad|mavenclad
5947249|NCT03933202|Multiple Sclerosis|multiple sclerosis
5947250|NCT03933202|Cladribine Tablets|cladribine tablets
5947251|NCT03933202|Observational|observational
5947252|NCT03933202|Mavenclad|mavenclad
5947309|NCT03923478|Phase 1B|phase 1b
5947310|NCT03923478|Randomized|randomized
5947311|NCT03923478|Placebo Controlled|placebo controlled
5947336|NCT03919448|Bevacizumab|bevacizumab
5947337|NCT03919448|Biosimilar|biosimilar
5947338|NCT03919448|Antineoplasic Agents|antineoplasic agents
5947339|NCT03919448|Bioequivalence|bioequivalence
5947340|NCT03919448|Inmunogenicity|inmunogenicity
5947341|NCT03919448|safety|safety
5947342|NCT03919448|healthy male volunteers|healthy male volunteers
5947351|NCT03919266|Acute chest syndrome|acute chest syndrome
5947352|NCT03919266|SCD|scd
5947353|NCT03919266|PCR multiplex|pcr multiplex
5947354|NCT03919266|antibiotic treatment|antibiotic treatment
5947442|NCT03907514|Technology Assessment, Health|technology assessment, health
5947443|NCT03907514|Dental anxiety|dental anxiety
5947444|NCT03907514|Adolescent|adolescent
5947445|NCT03907514|Clinical Trial|clinical trial
5947484|NCT03904693|tadalafil|tadalafil
5947485|NCT03904693|fixed dose combination therapy|fixed dose combination therapy
5947567|NCT03887715|VNS|vns
5947568|NCT03887715|Depression|depression
5947569|NCT03887715|TRD|trd
5947571|NCT03886909|Exercise|exercise
5947572|NCT03886909|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5947573|NCT03886909|Physical function|physical function
5051620|NCT03675412|Optical Coherence Tomography Angiography (OCTA)|optical coherence tomography angiography (octa)
5051621|NCT03675412|Caffeine|caffeine
5051622|NCT03675412|Macular Blood Flow|macular blood flow
5051623|NCT03675412|Peripapillary Blood Flow|peripapillary blood flow
5051624|NCT03675399|isometric exercise|isometric exercise
5051625|NCT03675399|rotator cuff|rotator cuff
5051626|NCT03675399|pain threshold|pain threshold
5051627|NCT03675373|chat-based intervention|chat-based intervention
5051628|NCT03675373|alcohol brief intervention|alcohol brief intervention
5051629|NCT03675373|high-risk drinking|high-risk drinking
5051630|NCT03675373|university students|university students
5051631|NCT03675373|AUDIT|audit
5051632|NCT03675373|instant messaging|instant messaging
5051633|NCT03675373|WhatsApp|whatsapp
5051637|NCT03675334|clinical trial|clinical trial
5051638|NCT03675334|root coverage|root coverage
5051639|NCT03675334|biomaterials|biomaterials
5051640|NCT03675334|collagen matrix|collagen matrix
5051641|NCT03675334|coronally advanced flap|coronally advanced flap
5051645|NCT03675282|PET Scan|pet scan
5051646|NCT03675243|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5051647|NCT03675243|TEM|tem
5051648|NCT03675243|QoL|qol
5051649|NCT03675243|quality of life|quality of life
5051650|NCT03675243|rectal cancer|rectal cancer
5051651|NCT03675243|rectal surgery|rectal surgery
5051652|NCT03675243|rectal neoplasm|rectal neoplasm
5051653|NCT03675230|TOMO irradiation|tomo irradiation
5051654|NCT03675178|Anerning particle|anerning particle
5051655|NCT03675178|Clinical endpoint antibiotic application frequency|clinical endpoint antibiotic application frequency
5051656|NCT03675178|efficacy and safety|efficacy and safety
5051657|NCT03675178|randomized|randomized
5051658|NCT03675178|double blind|double blind
5051659|NCT03675165|Prevention|prevention
5051660|NCT03675165|Psychology|psychology
5051661|NCT03675165|Self-Management|self-management
5051675|NCT03675113|maximal exercise capacity|maximal exercise capacity
5051677|NCT03675113|quality of life|quality of life
5051678|NCT03675113|dyspnea|dyspnea
5051679|NCT03675113|pulmonary function|pulmonary function
5051680|NCT03675113|fatigue|fatigue
5051681|NCT03675113|anxiety|anxiety
5051682|NCT03675113|depression|depression
5051683|NCT03675100|Irritable bowel syndrome|irritable bowel syndrome
5051684|NCT03675100|Subtype|subtype
5051685|NCT03675100|Tight junction|tight junction
5051686|NCT03675100|Sex|sex
5051687|NCT03675087|Work Capacity Evaluation|work capacity evaluation
5051688|NCT03675087|Fatigue Syndrome,Chronic|fatigue syndrome,chronic
5051689|NCT03675087|Exercise Tests|exercise tests
5051690|NCT03675048|Gut Microbiota|gut microbiota
5051691|NCT03675048|Cesarean Section|cesarean section
5051692|NCT03675048|Dysbiosis|dysbiosis
5051693|NCT03675009|Child Day Care Centers|child day care centers
5051694|NCT03675009|Indoor Air Quality|indoor air quality
5051695|NCT03675009|Educational Intervention|educational intervention
5051696|NCT03674996|Prostatectomy|prostatectomy
5051697|NCT03674996|Patient satisfaction|patient satisfaction
5051698|NCT03674996|Questionnaire|questionnaire
5051699|NCT03674983|adherence|adherence
5051700|NCT03674983|AIDS prevention|aids prevention
5064749|NCT03594136|ICP|icp
5051712|NCT03674944|Overweight|overweight
5051713|NCT03674944|Obesity|obesity
5051714|NCT03674944|Overeating|overeating
5051715|NCT03674944|Treatment|treatment
5051718|NCT03674944|Behavioral Treatment|behavioral treatment
5051719|NCT03674944|Dialectical Behavior Therapy|dialectical behavior therapy
5051720|NCT03674944|Emotion Regulation|emotion regulation
5051721|NCT03674931|countervail age-related cognitive and cerebral decline|countervail age-related cognitive and cerebral decline
5051722|NCT03674931|healthy elderly|healthy elderly
5051723|NCT03674931|musical training|musical training
5051724|NCT03674931|neuroimagery and brain plasticity|neuroimagery and brain plasticity
5051725|NCT03674931|psychometrics|psychometrics
5051726|NCT03674931|executive function|executive function
5051727|NCT03674931|mental health|mental health
5051729|NCT03674931|sensorimotor function|sensorimotor function
5051730|NCT03674892|Intranasal Neurostimulation|intranasal neurostimulation
5051731|NCT03674879|Follow Up|follow up
5051732|NCT03674879|Text Messaging|text messaging
5051733|NCT03674840|Multifocal Intraocular Lenses|multifocal intraocular lenses
5051734|NCT03674840|visual acuity|visual acuity
5051735|NCT03674840|kappa angle|kappa angle
5051736|NCT03674814|prostate cancer|prostate cancer
5051737|NCT03674814|Enzalutamide|enzalutamide
5051738|NCT03674814|Relacorilant|relacorilant
5051739|NCT03674801|Superficial esophageal cancer|superficial esophageal cancer
5051740|NCT03674801|Endoscopic mucosectomy|endoscopic mucosectomy
5051741|NCT03674801|Submucosal dissection|submucosal dissection
5051742|NCT03674801|therapeutic strategy|therapeutic strategy
5947673|NCT03864068|Polycystic Ovary Syndrome|polycystic ovary syndrome
5947674|NCT03864068|Anovulation|anovulation
5947675|NCT03864068|Hyperandrogenism|hyperandrogenism
5947676|NCT03864068|Insulin Resistance|insulin resistance
5947677|NCT03864068|Glucose Intolerance|glucose intolerance
5947678|NCT03864068|Metabolic Complication|metabolic complication
5947739|NCT03853551|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
5947770|NCT03848819|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5947771|NCT03848819|Dynamic Hyperinflation|dynamic hyperinflation
5947798|NCT03843268|Automated Mechanical Peripheral Stimulation (AMPS)|automated mechanical peripheral stimulation (amps)
5947799|NCT03843268|Gait Disorders|gait disorders
5947897|NCT03831191|eczema|eczema
5947898|NCT03831191|atopic eczema|atopic eczema
5252999|NCT02428491|Tetanus|tetanus
5932440|NCT03272165|Tolerability|tolerability
5055109|NCT03653676|Sickle Cell Anemia|sickle cell anemia
5055110|NCT03653676|Sickle Cell Disease|sickle cell disease
5055111|NCT03653676|Exercise|exercise
5055112|NCT03653676|Fitness|fitness
5055113|NCT03653676|Asthma|asthma
5055123|NCT03653611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5055124|NCT03653598|Atrial Fibrillation|atrial fibrillation
5055125|NCT03653585|Multiple Sclerosis|multiple sclerosis
5055126|NCT03653585|Magnetic Resonance Imaging|magnetic resonance imaging
5055136|NCT03653546|Central Nervous System Metastases|central nervous system metastases
5055137|NCT03653546|Respiratory Tract Diseases|respiratory tract diseases
5055139|NCT03653546|Exon 19Del|exon 19del
5055140|NCT03653546|L858R|l858r
5055141|NCT03653546|Lung Neoplasm|lung neoplasm
5055142|NCT03653546|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5055143|NCT03653546|Neoplasms|neoplasms
5055155|NCT03653494|non-intubated general anaesthesia|non-intubated general anaesthesia
5055156|NCT03653494|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5055159|NCT03653481|inulin|inulin
5055160|NCT03653481|prebiotic|prebiotic
5055162|NCT03653481|Inflammatory Bowel Disease|inflammatory bowel disease
5055163|NCT03653455|Shoulder|shoulder
5055164|NCT03653455|Arthroscopy|arthroscopy
5055165|NCT03653455|sub-acromial decompression|sub-acromial decompression
5055166|NCT03653455|distal clavicle resection|distal clavicle resection
5055167|NCT03653455|biceps tenodesis|biceps tenodesis
5055168|NCT03653455|rotator cuff repair|rotator cuff repair
5055169|NCT03653455|Patient reported outcomes|patient reported outcomes
5055170|NCT03653442|Induced hypotension|induced hypotension
5055171|NCT03653442|Spinal Anaesthesia|spinal anaesthesia
5055172|NCT03653442|Elective Caesarean section|elective caesarean section
5055173|NCT03653442|non-invasive haemodynamic parameters|non-invasive haemodynamic parameters
5055174|NCT03653429|foot and ankle surgeries|foot and ankle surgeries
5731484|NCT00388804|Zoladex|zoladex
5055175|NCT03653429|tranexamic acid|tranexamic acid
5055176|NCT03653429|wound healing|wound healing
5055177|NCT03653429|blood loss|blood loss
5055178|NCT03653416|Total knee arthroplasty|total knee arthroplasty
5055179|NCT03653416|Peri articular infiltration|peri articular infiltration
5055180|NCT03653416|Pack block|pack block
5055181|NCT03653416|Adductor canal catheter|adductor canal catheter
5055182|NCT03653390|health promotion intervention|health promotion intervention
5055183|NCT03653390|community participation|community participation
5055184|NCT03653390|quality of life|quality of life
5055185|NCT03653390|middle age|middle age
5055186|NCT03653390|multiple sclerosis|multiple sclerosis
5055187|NCT03653390|spinal cord injury|spinal cord injury
5055188|NCT03653390|muscular dystrophy|muscular dystrophy
5055189|NCT03653390|post-polio syndrome|post-polio syndrome
5055190|NCT03653377|mucoviscidosis|mucoviscidosis
5055191|NCT03653377|Human Papilloma Virus|human papilloma virus
5055192|NCT03653377|Vaccination|vaccination
5055193|NCT03653377|Young girl|young girl
5055194|NCT03653338|Sickle Cell|sickle cell
5055195|NCT03653338|Diamond-Blackfan|diamond-blackfan
5055196|NCT03653338|Beta-thalassemia|beta-thalassemia
5055197|NCT03653338|Anemia|anemia
5055198|NCT03653338|Stem cell transplantation|stem cell transplantation
5055199|NCT03653338|Unrelated Donor|unrelated donor
5055200|NCT03653338|haploidentical|haploidentical
5055201|NCT03653338|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5055202|NCT03653338|bone marrow transplant (BMT)|bone marrow transplant (bmt)
5055203|NCT03653338|mismatched|mismatched
5055204|NCT03653338|t-cell depletion|t-cell depletion
5055205|NCT03653325|hyperoxia|hyperoxia
5055206|NCT03653325|post rosc|post rosc
5055207|NCT03653325|oxygen reserve index|oxygen reserve index
5055208|NCT03653325|Fi02 titration|fi02 titration
5055209|NCT03653325|post cardiac arrest care|post cardiac arrest care
5055210|NCT03653325|oxygen|oxygen
5055211|NCT03653312|Ischemic Stroke|ischemic stroke
5055212|NCT03653312|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5055213|NCT03653312|Activities of daily living|activities of daily living
5055214|NCT03653312|Patient reported outcome|patient reported outcome
5055215|NCT03653312|Neuroplasticity|neuroplasticity
5055216|NCT03653312|Transcranial magnetic stimulation|transcranial magnetic stimulation
5055217|NCT03653312|Fugl Meyer|fugl meyer
5055218|NCT03653299|stroke|stroke
5055219|NCT03653299|phototherapy|phototherapy
5055220|NCT03653299|gait|gait
5055221|NCT03653299|balance|balance
5055222|NCT03653299|functional mobility|functional mobility
5055223|NCT03653286|Neuromuscular Eletrical Stimulation|neuromuscular eletrical stimulation
5055224|NCT03653286|Torque|torque
5055225|NCT03653286|Runners|runners
5055228|NCT03653273|disease modifying treatment|disease modifying treatment
5055229|NCT03653273|medico economic impact|medico economic impact
5055230|NCT03653273|treatment withdrawal|treatment withdrawal
5055231|NCT03653247|Intervention: Genetic: BIVV003|intervention: genetic: bivv003
5055235|NCT03653234|active and assisted living|active and assisted living
5948058|NCT03815175|High Bleeding Risk (HBR)|high bleeding risk (hbr)
5948059|NCT03815175|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
5948060|NCT03815175|Drug eluting stent (DES)|drug eluting stent (des)
5948061|NCT03815175|XIENCE|xience
5948062|NCT03815175|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5948063|NCT03815175|Coronary Artery Disease|coronary artery disease
5055236|NCT03653234|assistive technology|assistive technology
5055238|NCT03653234|remote consultations|remote consultations
5960956|NCT04290117|Sleep Hygiene|sleep hygiene
5960957|NCT04290117|Morning Light|morning light
5055239|NCT03653234|informal caregivers|informal caregivers
5055240|NCT03653234|quality of life|quality of life
5055241|NCT03653195|concussion|concussion
5055242|NCT03653195|biomarker|biomarker
5055243|NCT03653195|metabolomic|metabolomic
5055244|NCT03653195|urine|urine
5055245|NCT03653195|NMR spectroscopy|nmr spectroscopy
5055247|NCT03653143|Behavioral regulation|behavioral regulation
5055248|NCT03653143|Emotional regulation|emotional regulation
5055249|NCT03653143|Social communication|social communication
5055250|NCT03653143|Development|development
5055251|NCT03653130|homeless|homeless
5055252|NCT03653130|recreational therapy|recreational therapy
5055253|NCT03653130|community integration|community integration
5047998|NCT03699020|HIV|hiv
5055254|NCT03653130|reintegration|reintegration
5055255|NCT03653130|Veteran|veteran
5055256|NCT03653130|housing insecurity|housing insecurity
5055257|NCT03653130|Domiciliary|domiciliary
5055258|NCT03653130|Human Occupation|human occupation
5055259|NCT03653130|Occupational therapy|occupational therapy
5055260|NCT03653130|Music|music
5055261|NCT03653117|Transperineal laser ablation|transperineal laser ablation
5055262|NCT03653117|LUTS|luts
5055264|NCT03653117|Laser ablation|laser ablation
5055265|NCT03653104|Melodica|melodica
5055266|NCT03653104|pursed lip breathing|pursed lip breathing
5055267|NCT03653104|breathing exercise|breathing exercise
5055268|NCT03653104|Music|music
5055269|NCT03653091|Type 2 diabetes|type 2 diabetes
5055270|NCT03653091|Diabetes Mellitus|diabetes mellitus
5055271|NCT03653091|Noninsulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes mellitus
5055272|NCT03653091|Glucose Metabolism Disorders|glucose metabolism disorders
5055273|NCT03653091|Metabolic Diseases|metabolic diseases
5731485|NCT00388804|Flutamide|flutamide
5055274|NCT03653091|Endocrine System Diseases|endocrine system diseases
5055275|NCT03653091|Revita System|revita system
5055276|NCT03653091|Anti-diabetic medications|anti-diabetic medications
5055277|NCT03653091|Duodenal Mucosal Resurfacing|duodenal mucosal resurfacing
5055278|NCT03653078|Surgical guide|surgical guide
5055279|NCT03653078|Surgical stent|surgical stent
5055280|NCT03653078|orthodontic mini screw|orthodontic mini screw
5055281|NCT03653078|temporary anchorage device|temporary anchorage device
5055282|NCT03653026|Upadacitinib|upadacitinib
5055286|NCT03653000|Ultrasound guided brachial plexus blockade|ultrasound guided brachial plexus blockade
5055287|NCT03653000|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
5055288|NCT03652987|PCOS|pcos
5055289|NCT03652987|Hyperandrogenemia|hyperandrogenemia
5055290|NCT03652987|Rotterdam Criteria|rotterdam criteria
5055291|NCT03652987|Insulin sensitivity|insulin sensitivity
5055292|NCT03652987|BMI|bmi
5055293|NCT03652987|Antral follicle count|antral follicle count
5055294|NCT03652974|Schizophrenia， clozapine， valproate， ECT|schizophrenia， clozapine， valproate， ect
5055295|NCT03652948|mobile app|mobile app
5055296|NCT03652948|middle age adults|middle age adults
5055297|NCT03652948|older adults|older adults
5055298|NCT03652935|Breast cancer, mindfulness, immune, stress|breast cancer, mindfulness, immune, stress
5055299|NCT03652896|hepatocellular carcinoma|hepatocellular carcinoma
5055300|NCT03652896|anatomical liver resection|anatomical liver resection
5055301|NCT03652883|Implementation|implementation
5055302|NCT03652883|Tailored implementation strategies|tailored implementation strategies
5055303|NCT03652883|iCBT|icbt
5055304|NCT03652883|Common mental disorders|common mental disorders
5055305|NCT03652870|Parkinson's Disease|parkinson's disease
5055308|NCT03652831|Cervical radiculopathy,|cervical radiculopathy,
5055309|NCT03652831|Soft tissue mobilization,|soft tissue mobilization,
5055310|NCT03652831|Neural mobilization|neural mobilization
5055311|NCT03652766|Overweight|overweight
5055312|NCT03652766|Obesity|obesity
5055313|NCT03652766|e-Health|e-health
5055314|NCT03652766|Gestational Weight Gain|gestational weight gain
5055315|NCT03652766|Pregnancy|pregnancy
5055316|NCT03652766|Women's Health|women's health
5055317|NCT03652766|Prevention|prevention
5055318|NCT03652740|over-the-counter|over-the-counter
5055319|NCT03652740|prescription medication|prescription medication
5055320|NCT03652740|subjective effects|subjective effects
5055321|NCT03652727|PICC|picc
5055322|NCT03652727|PIC Line|pic line
5055336|NCT03652649|BMI|bmi
5055337|NCT03652623|Transgender|transgender
5055338|NCT03652623|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5055339|NCT03652623|HIV Prevention|hiv prevention
5055340|NCT03652623|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
5948185|NCT03804853|Rehabilitiation|rehabilitiation
5948270|NCT03794999|asthma|asthma
5948271|NCT03794999|pregnancy|pregnancy
5948272|NCT03794999|benralizumab|benralizumab
5948273|NCT03794999|infant|infant
5948274|NCT03794999|teratogenic|teratogenic
5241108|NCT02496832|PET|pet
5055341|NCT03652623|Cross-sex Hormone Therapy|cross-sex hormone therapy
5055342|NCT03652623|Adherence|adherence
5055350|NCT03652597|Heart-brain pathway|heart-brain pathway
5055351|NCT03652597|Depression|depression
5055352|NCT03652597|Neuromodulation|neuromodulation
5055353|NCT03652597|DLPFC|dlpfc
5055354|NCT03652597|Heart rate|heart rate
5055355|NCT03652584|postmenopause|postmenopause
5055356|NCT03652584|diet|diet
5055357|NCT03652584|Skeletal muscle mass|skeletal muscle mass
5055358|NCT03652519|Exercise|exercise
5960958|NCT04290117|Acceptance and Commitment Training|acceptance and commitment training
5960959|NCT04290104|cholecystectomy|cholecystectomy
5960960|NCT04290104|antibiotic|antibiotic
5055359|NCT03652519|Immune Signalling|immune signalling
5055360|NCT03652519|Cognition|cognition
5055361|NCT03652519|Health-related Quality of Life|health-related quality of life
5055364|NCT03652480|shoulder pain|shoulder pain
5055365|NCT03652480|type 2 diabetes|type 2 diabetes
5055366|NCT03652480|subacromial corticosteroid injection|subacromial corticosteroid injection
5055367|NCT03652480|glycemia|glycemia
5055368|NCT03652480|efficacy|efficacy
5055369|NCT03652480|safety|safety
5055370|NCT03652467|Deferoxamine|deferoxamine
5055371|NCT03652467|Transarterial chemoembolization|transarterial chemoembolization
5055372|NCT03652467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5055373|NCT03652454|regional acceleratory phenomenon|regional acceleratory phenomenon
5055374|NCT03652454|micro-osteoperforation|micro-osteoperforation
5055375|NCT03652454|orthodontic alignment|orthodontic alignment
5055376|NCT03652428|LAPC|lapc
5055377|NCT03652428|Nab-paclitaxel +Gemcitabine|nab-paclitaxel +gemcitabine
5055378|NCT03652428|Proton Therapy|proton therapy
5055379|NCT03652402|Kidney|kidney
5055380|NCT03652402|Allogenic transplantation|allogenic transplantation
5055381|NCT03652402|Cohort study|cohort study
5055382|NCT03652402|Rejection|rejection
5055383|NCT03652402|Biomarkers|biomarkers
5055384|NCT03652402|Response to treatment|response to treatment
5055385|NCT03652402|Integrative medicine|integrative medicine
5055386|NCT03652324|coil treatment|coil treatment
5055387|NCT03652324|general anesthesia|general anesthesia
5055388|NCT03652324|deep sedation|deep sedation
5055389|NCT03652311|opiate use disorder|opiate use disorder
5055390|NCT03652311|neuromodulation|neuromodulation
5055391|NCT03652311|caloric vestibular stimulation|caloric vestibular stimulation
5055392|NCT03652311|adjunct therapy|adjunct therapy
5055393|NCT03652298|PTSD|ptsd
5055394|NCT03652298|Memory Structuring Intervention (MSI)|memory structuring intervention (msi)
5055395|NCT03652298|Cancer|cancer
5055396|NCT03652298|Vagal breathing|vagal breathing
5068238|NCT03572634|First in human|first in human
5055399|NCT03652272|electronic health record|electronic health record
5055400|NCT03652259|limb girdle muscular dystrophy|limb girdle muscular dystrophy
5055402|NCT03652259|beta-sarcoglycan|beta-sarcoglycan
5055403|NCT03652259|gene transfer|gene transfer
5055404|NCT03652259|adeno-associated virus|adeno-associated virus
5055405|NCT03652181|CCM (Cerebral Cavernous Malformations)|ccm (cerebral cavernous malformations)
5055406|NCT03652181|Dynamic Contrast Enhanced Quantitative Perfusion (DCEQP)|dynamic contrast enhanced quantitative perfusion (dceqp)
5055407|NCT03652181|Quantitative Susceptibility Mapping (QSM)|quantitative susceptibility mapping (qsm)
5055408|NCT03652181|Cerebral Cavernous Malformation|cerebral cavernous malformation
5055409|NCT03652181|Cavernoma|cavernoma
5055410|NCT03652181|Cavernous Angioma|cavernous angioma
5055411|NCT03652168|stress|stress
5055412|NCT03652168|health|health
5055413|NCT03652168|mindfulness|mindfulness
5055414|NCT03652168|employees|employees
5055415|NCT03652142|HNSCC|hnscc
5055417|NCT03652142|DNA damage|dna damage
5055418|NCT03652142|DNA damage repair|dna damage repair
5055419|NCT03652142|PD-L1|pd-l1
5055420|NCT03652142|PD-1|pd-1
5055421|NCT03652142|NIVOLUMAB|nivolumab
5055422|NCT03652142|Head and Neck cancer|head and neck cancer
5055430|NCT03652038|Multiple ascending dose|multiple ascending dose
5055431|NCT03652038|MAD|mad
5055432|NCT03652038|Phase 1|phase 1
5055433|NCT03652038|first-in-human|first-in-human
5055434|NCT03652038|TD-8236|td-8236
5055435|NCT03652038|asthma|asthma
5055436|NCT03652012|Mild Cognitive Impairment|mild cognitive impairment
5051743|NCT03674762|submerged two-stage, nonsubmerged one-stage, dental implants, marginal bone loss|submerged two-stage, nonsubmerged one-stage, dental implants, marginal bone loss
5051744|NCT03674736|Healthy|healthy
5051745|NCT03674736|Men|men
5051746|NCT03674736|Adults|adults
5051747|NCT03674736|Methionine|methionine
5051748|NCT03674736|Lysine|lysine
5051749|NCT03674723|Healthy|healthy
5051750|NCT03674723|Men|men
5051751|NCT03674723|Adults|adults
5051752|NCT03674723|Methionine|methionine
5051753|NCT03674710|EUS-FNA|eus-fna
5051754|NCT03674684|hydroxyethyl starch, gelatin, ROTEM, coagulation|hydroxyethyl starch, gelatin, rotem, coagulation
5051755|NCT03674671|Depression|depression
5051756|NCT03674671|MDD|mdd
5051757|NCT03674671|neuroimaging|neuroimaging
5051758|NCT03674671|biomarkers|biomarkers
5051764|NCT03674645|Optimization|optimization
5051765|NCT03674632|breastfeeding|breastfeeding
5960935|NCT04290195|myopic choroidal neovascularisation|myopic choroidal neovascularisation
5051766|NCT03674632|maternal stress|maternal stress
5051767|NCT03674632|infant behavior|infant behavior
5051768|NCT03674632|infant development|infant development
5051769|NCT03674632|relaxation|relaxation
5051770|NCT03674606|Pre-eclampsia|pre-eclampsia
5051771|NCT03674606|Fetal Medicine Foundation|fetal medicine foundation
5051772|NCT03674606|FMF screening|fmf screening
5051773|NCT03674606|First trimester|first trimester
5051774|NCT03674606|Aspirin|aspirin
5051775|NCT03674606|Placental disease|placental disease
5051776|NCT03674606|nulliparous|nulliparous
5051777|NCT03674606|LDA|lda
5051778|NCT03674606|low-dose aspirin|low-dose aspirin
5051779|NCT03674606|fetal growth restriction|fetal growth restriction
5051780|NCT03674606|trans-abdominal uterine artery doppler examination|trans-abdominal uterine artery doppler examination
5051786|NCT03674580|suicidal patients;psychiatry|suicidal patients;psychiatry
5051787|NCT03674567|Non-small Cell Lung Cancer|non-small cell lung cancer
5051788|NCT03674567|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5051789|NCT03674567|Breast Cancer|breast cancer
5051790|NCT03674567|Urothelial Carcinoma|urothelial carcinoma
5051791|NCT03674567|Gastric Cancer|gastric cancer
5051792|NCT03674528|MRI|mri
5051793|NCT03674528|MRE|mre
5051794|NCT03674528|Liver Disease|liver disease
5051795|NCT03674528|Liver Fibrosis|liver fibrosis
5051796|NCT03674489|neurodynamics|neurodynamics
5064820|NCT03593824|Adversity|adversity
5051797|NCT03674489|neurodynamic mobilization|neurodynamic mobilization
5051798|NCT03674489|quantitative sensory testing|quantitative sensory testing
5051800|NCT03674489|pressure pain threshold|pressure pain threshold
5051801|NCT03674489|thermal pain threshold|thermal pain threshold
5051802|NCT03674489|thermal pain tolerance|thermal pain tolerance
5051806|NCT03674411|AML|aml
5051807|NCT03674411|ALL|all
5051808|NCT03674411|CML|cml
5051809|NCT03674411|MCL|mcl
5051810|NCT03674398|post-concussion|post-concussion
5051811|NCT03674398|Mild Traumatic Brain Injury|mild traumatic brain injury
5051812|NCT03674398|head injury|head injury
5051813|NCT03674398|headache|headache
5051814|NCT03674398|aerobic exercise|aerobic exercise
5051832|NCT03674281|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
5051833|NCT03674281|Insulin Pump|insulin pump
5051834|NCT03674281|Artificial Pancreas (AP)|artificial pancreas (ap)
5051835|NCT03674281|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5051845|NCT03674216|peripherally inserted central venous catheter|peripherally inserted central venous catheter
5051846|NCT03674216|midline catheter|midline catheter
5051847|NCT03674216|thrombosis|thrombosis
5051848|NCT03674216|blood stream infection|blood stream infection
5051849|NCT03674203|Platelet-rich plasma|platelet-rich plasma
5051850|NCT03674177|Vaccines|vaccines
5051851|NCT03674177|Safety|safety
5051852|NCT03674177|Immunogenicity|immunogenicity
5051853|NCT03674177|Reactogenicity|reactogenicity
5051854|NCT03674177|Respiratory Syncytial Viruses|respiratory syncytial viruses
5051855|NCT03674151|split-skin|split-skin
5051856|NCT03674151|burn wound|burn wound
5051857|NCT03674151|wound dressing|wound dressing
5051858|NCT03674151|comparison|comparison
5051859|NCT03674151|silver|silver
5051860|NCT03674151|honey|honey
5051861|NCT03674151|PVP-Iod|pvp-iod
5051862|NCT03674151|hydrogel|hydrogel
5051863|NCT03674125|Hepatitis C Virus|hepatitis c virus
5051864|NCT03674125|HCV|hcv
5051865|NCT03674125|Vaccine|vaccine
5051866|NCT03674125|DNA|dna
5051870|NCT03674073|Neoantigen|neoantigen
5051871|NCT03674073|Vaccine|vaccine
5051872|NCT03674073|Dendritic Cell|dendritic cell
5051873|NCT03674073|Personalized|personalized
5051874|NCT03674073|Liver cancer|liver cancer
5051875|NCT03674060|Healthy Male Volunteers|healthy male volunteers
5051876|NCT03674060|Evaluation of the Pharmacokinetic Property|evaluation of the pharmacokinetic property
5051877|NCT03674060|A Dose-block Randomized, Active-controlled, Open-label|a dose-block randomized, active-controlled, open-label
5051878|NCT03674047|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5051879|NCT03674034|MRI images|mri images
5051880|NCT03674034|CTscan|ctscan
5051881|NCT03674008|Sedation anesthesia gastrointestinal endoscopy|sedation anesthesia gastrointestinal endoscopy
5051882|NCT03673969|Mini Gastric Bypass|mini gastric bypass
5051883|NCT03673969|Roux En-Y Gastric Bypass|roux en-y gastric bypass
5051884|NCT03673969|Bariatric surgery|bariatric surgery
5051885|NCT03673969|Type 2 diabetes|type 2 diabetes
5051886|NCT03673930|NIRS|nirs
5051887|NCT03673930|mood|mood
5051888|NCT03673930|cognitive performance|cognitive performance
5051889|NCT03673930|Zanthozylum armatum|zanthozylum armatum
5051890|NCT03673930|Nepalese pepper|nepalese pepper
5051891|NCT03673865|3D Printer|3d printer
5051892|NCT03673865|orbital implants|orbital implants
5051901|NCT03673774|pulmonary hypertension|pulmonary hypertension
5051902|NCT03673774|impedancemetry|impedancemetry
5051903|NCT03673774|cardiac output|cardiac output
5051904|NCT03673761|muscle weakness|muscle weakness
5051905|NCT03673761|myopathy|myopathy
5051906|NCT03673748|Lupus Erythematosus|lupus erythematosus
5051907|NCT03673748|Lupus Nephritis|lupus nephritis
5960936|NCT04290182|Vocal fold scar|vocal fold scar
5960937|NCT04290182|MSC|msc
5960938|NCT04290182|dysphonia|dysphonia
5051908|NCT03673748|Stem Cell|stem cell
5051909|NCT03673748|Mesenchymal Stem Cells|mesenchymal stem cells
5051910|NCT03673748|Autoimmune diseases|autoimmune diseases
5051911|NCT03673748|Systemic Lupus Erythematosus|systemic lupus erythematosus
5051912|NCT03673722|Mediterranean Diet|mediterranean diet
5051913|NCT03673722|Physical Activity|physical activity
5051915|NCT03673722|Alzheimer Disease|alzheimer disease
5051916|NCT03673722|Cognition|cognition
5051917|NCT03673683|Invasive Mechanical Ventilation|invasive mechanical ventilation
5051918|NCT03673670|COPD|copd
5051919|NCT03673670|Bronchodilation|bronchodilation
5051920|NCT03673670|FEV1|fev1
5051921|NCT03673657|Local Advanced Non-small Cell Lung Cancer|local advanced non-small cell lung cancer
5051922|NCT03673657|Chemoradiotherapy|chemoradiotherapy
5051923|NCT03673657|Oral Nutritional Supplements|oral nutritional supplements
5051924|NCT03673631|non-invasive ventilation|non-invasive ventilation
5051925|NCT03673631|nasal high flow humidified canula oxygenation|nasal high flow humidified canula oxygenation
5051926|NCT03673631|palliative|palliative
5051934|NCT03673592|Preimplantation genetics|preimplantation genetics
5051936|NCT03673579|Developmental care|developmental care
5051937|NCT03673579|Neuroprotective|neuroprotective
5051938|NCT03673579|Technology|technology
5051939|NCT03673566|NICU|nicu
5051940|NCT03673566|Developmental care|developmental care
5051941|NCT03673566|Neuroprotective|neuroprotective
5051942|NCT03673566|Technology|technology
5051943|NCT03673553|fibromyalgia|fibromyalgia
5051944|NCT03673553|pain|pain
5051945|NCT03673553|quality of life|quality of life
5051946|NCT03673553|multidomal treatment|multidomal treatment
5051947|NCT03673540|Bulimia Nervosa|bulimia nervosa
5051948|NCT03673540|Eating Disorder|eating disorder
5051949|NCT03673540|Binge Eating|binge eating
5051950|NCT03673540|Bulimia|bulimia
5051951|NCT03673540|Purging|purging
5051952|NCT03673527|open-label|open-label
5051953|NCT03673527|multiple-dose|multiple-dose
5051954|NCT03673527|non-randomised|non-randomised
5051955|NCT03673527|non-comparative|non-comparative
5948698|NCT03733028|anger|anger
5253695|NCT02424474|cell free fetal DNA|cell free fetal dna
5948821|NCT03718156|delirium|delirium
5948822|NCT03718156|dementia|dementia
5948823|NCT03718156|long-term care|long-term care
5948824|NCT03718156|cluster randomized trial|cluster randomized trial
5948825|NCT03718156|nursing|nursing
5948826|NCT03718156|geriatrics|geriatrics
5369110|NCT01861288|Fecal Calprotectin|fecal calprotectin
5948832|NCT03715140|Osteoarthritis, Crucumin, Flowcytometry|osteoarthritis, crucumin, flowcytometry
5948833|NCT03714490|rectal cancer|rectal cancer
5948834|NCT03714490|short-term radiotherapy|short-term radiotherapy
5948835|NCT03714490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5948836|NCT03714490|total mesorectal excision|total mesorectal excision
5948837|NCT03714490|MRI-simulation|mri-simulation
5948838|NCT03714490|boost|boost
5948898|NCT03706079|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
5948932|NCT03700593|Single port robotic surgery|single port robotic surgery
5948933|NCT03700593|Minimally invasive colectomy|minimally invasive colectomy
5948934|NCT03700593|Single port robotic colectomy|single port robotic colectomy
5948935|NCT03700593|Single port robotic TEM|single port robotic tem
5948936|NCT03700554|Pneumothorax|pneumothorax
5948937|NCT03700554|Iatrogenic|iatrogenic
5948938|NCT03700554|Chest tube|chest tube
5948939|NCT03700554|Pleuralvent|pleuralvent
5948940|NCT03700424|Acute Coronary Syndrome|acute coronary syndrome
5948941|NCT03700424|Trehalose|trehalose
5948942|NCT03700424|Arterial inflammation|arterial inflammation
5948943|NCT03700424|Autophagy|autophagy
5948944|NCT03699618|NVAMD|nvamd
5948945|NCT03699618|Anti-VEGF|anti-vegf
5948949|NCT03698955|Plant-based diet|plant-based diet
5948950|NCT03698955|Mediterranean diet|mediterranean diet
5948951|NCT03698955|Vegan diet|vegan diet
5948952|NCT03698955|Metabolism|metabolism
5948953|NCT03698955|Insulin sensitivity|insulin sensitivity
5948954|NCT03698955|Cholesterol|cholesterol
5948955|NCT03698955|Advanced glycation end-products|advanced glycation end-products
5948995|NCT03689244|CTEPH|cteph
5948996|NCT03689244|selexipag|selexipag
5949000|NCT03687320|Photobiomodulation|photobiomodulation
5949001|NCT03687320|Low-Level Light Therapy|low-level light therapy
5949002|NCT03687320|Low-Level Laser Therapy|low-level laser therapy
5253922|NCT02423252|RCT|rct
5051956|NCT03673514|Direct anterior approach|direct anterior approach
5051957|NCT03673514|posterior approach|posterior approach
5051958|NCT03673488|Incontinence|incontinence
5051959|NCT03673449|peripheral nerve injury|peripheral nerve injury
5051960|NCT03673449|nerve guide|nerve guide
5051961|NCT03673449|silk fibroin|silk fibroin
5051962|NCT03673449|silk|silk
5051963|NCT03673449|nerve regeneration|nerve regeneration
5051964|NCT03673423|Resectability Status|resectability status
5051965|NCT03673423|NCCN criteria|nccn criteria
5051966|NCT03673397|Exercise|exercise
5051967|NCT03673397|Sleep|sleep
5051968|NCT03673397|Depression|depression
5051969|NCT03673397|Heart rate variability|heart rate variability
5051970|NCT03673397|Blood pressure|blood pressure
5051971|NCT03673397|randomized controlled trial|randomized controlled trial
5051972|NCT03673397|polysomnography|polysomnography
5051973|NCT03673384|far-infrared radiation|far-infrared radiation
5051974|NCT03673384|allergic rhinitis|allergic rhinitis
5051975|NCT03673384|IgE|ige
5051976|NCT03673384|eosinophil cationic protein|eosinophil cationic protein
5051977|NCT03673384|Taiwanese version of the 20-item Sinonasal Outcome Test|taiwanese version of the 20-item sinonasal outcome test
5051978|NCT03673384|WHOQOL-BREF|whoqol-bref
5051979|NCT03673371|Limb Prosthesis|limb prosthesis
5051980|NCT03673371|Shoe|shoe
5051981|NCT03673371|Self Concepts|self concepts
5051982|NCT03673345|B Cell|b cell
5051983|NCT03673345|Children|children
5051984|NCT03673345|Influenza|influenza
5051985|NCT03673345|T Cell|t cell
5051986|NCT03673345|Vaccination|vaccination
5051987|NCT03673332|Elderly cancer patients|elderly cancer patients
5051988|NCT03673332|Immunotherapies|immunotherapies
5051989|NCT03673306|Breast cancer|breast cancer
5051990|NCT03673306|BRCA|brca
5051991|NCT03673306|Young|young
5051992|NCT03673306|Survivorship|survivorship
5051993|NCT03673293|Total Joint Arthroplasty|total joint arthroplasty
5051997|NCT03673280|intrathecal morphine|intrathecal morphine
5051998|NCT03673280|quadratus lumborum block|quadratus lumborum block
5051999|NCT03673280|cesarean c-section|cesarean c-section
5052000|NCT03673280|postoperative pain|postoperative pain
5052001|NCT03673280|chronic pain|chronic pain
5052002|NCT03673267|health literacy|health literacy
5052003|NCT03673267|nutrition literacy|nutrition literacy
5052004|NCT03673267|parenting|parenting
5052005|NCT03673254|rotational atherectomy device,|rotational atherectomy device,
5052006|NCT03673241|Ischemic Stroke|ischemic stroke
5052007|NCT03673241|Motor Recovery|motor recovery
5052008|NCT03673241|Length of Stay Reduction|length of stay reduction
5052009|NCT03673189|Sensors|sensors
5052010|NCT03673189|Health Recording|health recording
5052011|NCT03673163|chronic postoperative pain|chronic postoperative pain
5052012|NCT03673163|lidocaine infusion|lidocaine infusion
5052015|NCT03673137|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5052016|NCT03673137|Irreversible electroporation|irreversible electroporation
5052017|NCT03673137|overall survival time|overall survival time
5052019|NCT03673124|peritoneum|peritoneum
5052020|NCT03673124|fallopian tube|fallopian tube
5052021|NCT03673098|Resilience|resilience
5052022|NCT03673098|Women|women
5052023|NCT03673098|HIV/AIDS|hiv/aids
5052024|NCT03673059|Microbiome|microbiome
5052025|NCT03673059|Eczema|eczema
5052026|NCT03673059|Itching|itching
5052029|NCT03673033|Transplantation, Hepatic, Cirrhosis, Bile duct|transplantation, hepatic, cirrhosis, bile duct
5052031|NCT03673020|Solid Tumor|solid tumor
5052035|NCT03672994|Acute Breathlessness|acute breathlessness
5052036|NCT03672994|Breathomics|breathomics
5052037|NCT03672968|Heredity Optic Atrophy|heredity optic atrophy
5052038|NCT03672968|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5052039|NCT03672968|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5052040|NCT03672968|LHON|lhon
5052041|NCT03672968|Eye Diseases|eye diseases
5052042|NCT03672968|Hereditary Eye Diseases|hereditary eye diseases
5949074|NCT03682055|NPC|npc
5949120|NCT03674372|tracheal occlusion|tracheal occlusion
5949121|NCT03674372|FETO|feto
5949122|NCT03674372|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5254041|NCT02422732|Children|children
5254042|NCT02422732|Reading disability|reading disability
5254043|NCT02422732|Morphological and functional MRI|morphological and functional mri
5949270|NCT03653871|Alzheimer Disease|alzheimer disease
5949271|NCT03653871|Dementia|dementia
5949272|NCT03653871|Caregiver|caregiver
5949273|NCT03653871|Performing Arts|performing arts
5259785|NCT02389608|balance|balance
5949366|NCT03645512|Resilience|resilience
5949367|NCT03645512|High Performance|high performance
5949368|NCT03645512|Critical Care Nurse|critical care nurse
5055437|NCT03651986|Circulating Tumor DNA (ctDNA)|circulating tumor dna (ctdna)
5055438|NCT03651986|DNA Methylation Analysis|dna methylation analysis
5055439|NCT03651986|Next-Generation Sequencing (NGS)|next-generation sequencing (ngs)
5055440|NCT03651986|Low-Dose Computed Tomography (LDCT)|low-dose computed tomography (ldct)
5055441|NCT03651973|Self massages and self stretching|self massages and self stretching
5055442|NCT03651973|Workshops for self massages and stretching learning|workshops for self massages and stretching learning
5055443|NCT03651921|Breast Cancer|breast cancer
5055444|NCT03651921|Self-Management|self-management
5055445|NCT03651921|Cancer Survivorship|cancer survivorship
5055446|NCT03651895|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5055447|NCT03651869|Smoking|smoking
5055448|NCT03651843|high risk|high risk
5055449|NCT03651843|pregnant women|pregnant women
5055450|NCT03651843|occupational hazard|occupational hazard
5055452|NCT03651830|Amputation|amputation
5055453|NCT03651830|Rehabilitation|rehabilitation
5055454|NCT03651830|Prescriptions|prescriptions
5055455|NCT03651830|Emulator|emulator
5055456|NCT03651830|Prosthetics|prosthetics
5055458|NCT03651778|gamma-Hydroxybutyric acid|gamma-hydroxybutyric acid
5055459|NCT03651778|Substances of abuse|substances of abuse
5055460|NCT03651778|Poisoning induced by others|poisoning induced by others
5055461|NCT03651778|Recreational drugs|recreational drugs
5055462|NCT03651778|Poisoning|poisoning
5055463|NCT03651778|Intoxication|intoxication
5055464|NCT03651765|setmelanotide|setmelanotide
5055465|NCT03651765|RM-493|rm-493
5055466|NCT03651765|obesity|obesity
5932899|NCT03200717|RCC|rcc
5055467|NCT03651765|leptin-melanocortin|leptin-melanocortin
5055468|NCT03651765|melanocortin 4 receptor|melanocortin 4 receptor
5055469|NCT03651739|Rehabilitation|rehabilitation
5055470|NCT03651713|exercise|exercise
5055471|NCT03651713|glucose|glucose
5055472|NCT03651713|vascular function|vascular function
5055473|NCT03651687|Head circumference|head circumference
5055474|NCT03651687|Neurodevelopment|neurodevelopment
5055475|NCT03651687|Newborn|newborn
5055476|NCT03651687|Infant|infant
5055477|NCT03651687|Surveillance|surveillance
5055478|NCT03651687|Prediction|prediction
5055479|NCT03651648|apnea; prematurity; kinesthetic stimulation|apnea; prematurity; kinesthetic stimulation
5055480|NCT03651635|ICU|icu
5055481|NCT03651635|Biomarkers|biomarkers
5055482|NCT03651622|Type 1 diabetes|type 1 diabetes
5055483|NCT03651622|T1D|t1d
5055484|NCT03651622|Type 1 diabetes mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5055485|NCT03651622|weight management|weight management
5055486|NCT03651622|overweight|overweight
5055487|NCT03651622|obese|obese
5055488|NCT03651609|Ulnar neuropathy at the elbow|ulnar neuropathy at the elbow
5055489|NCT03651609|Electromyography|electromyography
5055490|NCT03651609|Ultrasonography|ultrasonography
5055491|NCT03651609|Treatment|treatment
5055492|NCT03651609|Surgery|surgery
5055493|NCT03651609|Conservative treatment|conservative treatment
5055494|NCT03651596|Adherence|adherence
5055495|NCT03651596|Adolescence|adolescence
5055496|NCT03651596|mHealth|mhealth
5055497|NCT03651583|Migraine|migraine
5055499|NCT03651583|Qigong|qigong
5055500|NCT03651583|Relaxation|relaxation
5055501|NCT03651583|Exercise|exercise
5055502|NCT03651557|Neu2000KWL|neu2000kwl
5423362|NCT01615939|Continuous Nerve Block|continuous nerve block
5055512|NCT03651544|vector vaccine|vector vaccine
5055514|NCT03651518|Personalized treatment|personalized treatment
5055515|NCT03651518|Inflammatory diseases|inflammatory diseases
5055516|NCT03651518|auto-inflammatory diseases|auto-inflammatory diseases
5055517|NCT03651518|auto-immune diseases|auto-immune diseases
5055518|NCT03651518|Targeted treatments|targeted treatments
5055519|NCT03651518|skin|skin
5055520|NCT03651505|X-linked Hypophosphatemia|x-linked hypophosphatemia
5055521|NCT03651505|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
5055528|NCT03651492|nocturnal hypertension|nocturnal hypertension
5055529|NCT03651492|renal transplantation|renal transplantation
5055531|NCT03651479|virtual reality|virtual reality
5055532|NCT03651479|boxing|boxing
5055533|NCT03651479|upper extremity function|upper extremity function
5055534|NCT03651479|cognitive function|cognitive function
5055535|NCT03651479|balance|balance
5055536|NCT03651440|Disc herniation|disc herniation
5055537|NCT03651440|Endurance|endurance
5055538|NCT03651440|Lumbar stabilization exercise|lumbar stabilization exercise
5055539|NCT03651440|PNF|pnf
5055540|NCT03651440|Strength|strength
5055541|NCT03651427|Estradiol;|estradiol;
5055542|NCT03651427|Brain|brain
5055543|NCT03651427|glutamate|glutamate
5055544|NCT03651427|spectroscopy|spectroscopy
5055545|NCT03651427|hypogonadism|hypogonadism
5055547|NCT03651375|Dose Hypofractionation|dose hypofractionation
5055548|NCT03651375|Neoadjuvant Therapy|neoadjuvant therapy
5055549|NCT03651375|Chemoradiotherapy|chemoradiotherapy
5055550|NCT03651375|Sarcoma|sarcoma
5055551|NCT03651375|Dose Fractionation|dose fractionation
5055552|NCT03651375|Dose-Response Relationship|dose-response relationship
5055553|NCT03651375|Antineoplastic Agents|antineoplastic agents
5055554|NCT03651375|Drug Therapy|drug therapy
5055555|NCT03651375|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5055556|NCT03651362|optic neuritis|optic neuritis
5055557|NCT03651362|DIR|dir
5055558|NCT03651362|visual disability|visual disability
5055559|NCT03651362|CIS|cis
5055560|NCT03651362|multiple sclerosis|multiple sclerosis
5055561|NCT03651362|NMOSD|nmosd
5055562|NCT03651336|POAG|poag
5055563|NCT03651336|Primary Open Angle Glaucoma|primary open angle glaucoma
5055564|NCT03651336|Cataract|cataract
5055565|NCT03651336|Intraocular Pressure|intraocular pressure
5055566|NCT03651336|Intraocular Pressure Sensor System|intraocular pressure sensor system
5055567|NCT03651336|IOP|iop
5055568|NCT03651336|Self-monitoring of intraocular pressure|self-monitoring of intraocular pressure
5055569|NCT03651323|Atrial fibrillation|atrial fibrillation
5055570|NCT03651323|Left atrial appendage|left atrial appendage
5055582|NCT03651284|video game|video game
5055583|NCT03651284|sedentary activity|sedentary activity
5055584|NCT03651258|Feeding Behavior|feeding behavior
5055587|NCT03651219|SCLC|sclc
5055588|NCT03651219|apatinib|apatinib
5055589|NCT03651219|Irinotecan|irinotecan
5055590|NCT03651206|Malignant mixed Mullerian tumors|malignant mixed mullerian tumors
5055591|NCT03651206|Metastatic ovarian carcinosarcoma|metastatic ovarian carcinosarcoma
5055592|NCT03651206|Recurrent ovarian carcinosarcoma|recurrent ovarian carcinosarcoma
5055593|NCT03651206|Metastatic endometrial carcinosarcoma|metastatic endometrial carcinosarcoma
5055594|NCT03651206|Recurrent endometrial carcinosarcoma|recurrent endometrial carcinosarcoma
5055595|NCT03651206|Niraparib|niraparib
5960961|NCT04290065|Hamstring muscle|hamstring muscle
5932989|NCT03186898|HCC|hcc
5055596|NCT03651206|TSR-042 (Dostarlimab)|tsr-042 (dostarlimab)
5055597|NCT03651193|Adult Onset Still's Disease|adult onset still's disease
5055598|NCT03651193|Chinese population|chinese population
5055599|NCT03651180|Polymer free drug eluting stent|polymer free drug eluting stent
5055610|NCT03651128|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5055611|NCT03651128|High Risk Multiple Myeloma|high risk multiple myeloma
5055612|NCT03651102|Thalidomide|thalidomide
5055613|NCT03651102|Thalassemia|thalassemia
5055614|NCT03651089|acute myocardial infarction|acute myocardial infarction
5055615|NCT03651089|inflammation|inflammation
5055616|NCT03651063|rehabilitation; social robots|rehabilitation; social robots
5055617|NCT03651037|cancer|cancer
5055618|NCT03651037|bone health|bone health
5055619|NCT03651037|physical activity|physical activity
5055620|NCT03651037|technology platfrom|technology platfrom
5055822|NCT03649958|concussion|concussion
5055621|NCT03651011|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5055622|NCT03651011|Navigated laser photocoagulation|navigated laser photocoagulation
5055623|NCT03651011|Macular Edema|macular edema
5055624|NCT03651011|Oximetry|oximetry
5055625|NCT03651011|Retinal vascular caliber measurements|retinal vascular caliber measurements
5055626|NCT03651011|Microperimetry|microperimetry
5055627|NCT03650998|nerve block|nerve block
5055628|NCT03650998|ultrasound|ultrasound
5055629|NCT03650998|opioids|opioids
5055630|NCT03650998|hysterectomy|hysterectomy
5055631|NCT03650946|Prostate cancer|prostate cancer
5055632|NCT03650946|Ga-68 PSMA PET|ga-68 psma pet
5055633|NCT03650933|GB241|gb241
5055634|NCT03650933|Rituximab|rituximab
5055635|NCT03650933|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5055636|NCT03650933|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5055638|NCT03650894|Breast Cancer|breast cancer
5055639|NCT03650894|Her2 negative breast cancer|her2 negative breast cancer
5055640|NCT03650894|Immunotherapy|immunotherapy
5055641|NCT03650894|Opdivo|opdivo
5055642|NCT03650894|Nivolumab|nivolumab
5055643|NCT03650894|Yervoy|yervoy
5055644|NCT03650894|Ipilimumab|ipilimumab
5055645|NCT03650894|Bicalutamide|bicalutamide
5055646|NCT03650894|Casodex|casodex
5055647|NCT03650868|Thoracal Paravertebral Block|thoracal paravertebral block
5055648|NCT03650868|Breast Surgery|breast surgery
5055649|NCT03650868|Seroma Reduction|seroma reduction
5055650|NCT03650855|degenerative spine disease|degenerative spine disease
5055651|NCT03650855|screw loosening|screw loosening
5055652|NCT03650855|Quantitative CT scan|quantitative ct scan
5055653|NCT03650855|vertebral bone density|vertebral bone density
5055655|NCT03650829|Offspring|offspring
5055656|NCT03650829|Development|development
5055657|NCT03650829|Cohort|cohort
5055658|NCT03650816|Alzheimer Disease|alzheimer disease
5055659|NCT03650816|Subjective cognitive impairment|subjective cognitive impairment
5052043|NCT03672968|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
5052044|NCT03672968|Inborn Genetic Disease|inborn genetic disease
5052045|NCT03672968|Gene Therapy|gene therapy
5052046|NCT03672968|Intravitreal Injections|intravitreal injections
5052047|NCT03672968|Mitochondrial Disease|mitochondrial disease
5052048|NCT03672968|AAV2 Vectors|aav2 vectors
5052049|NCT03672968|Neurodegenerative Disease|neurodegenerative disease
5052050|NCT03672968|Atrophy|atrophy
5052051|NCT03672942|intimate partner violence|intimate partner violence
5052052|NCT03672942|aggression|aggression
5052053|NCT03672942|batterers intervention|batterers intervention
5052054|NCT03672942|mindfulness|mindfulness
5052055|NCT03672942|communication skills|communication skills
5052056|NCT03672942|couples|couples
5052057|NCT03672929|Total hip arthroplasty|total hip arthroplasty
5052058|NCT03672929|Medical Device|medical device
5052059|NCT03672929|Safety|safety
5052060|NCT03672929|Hip prosthesis|hip prosthesis
5052061|NCT03672916|Total hip arthroplasty|total hip arthroplasty
5052062|NCT03672916|Medical Device|medical device
5052063|NCT03672916|Safety|safety
5052064|NCT03672916|Hip prosthesis|hip prosthesis
5052065|NCT03672903|obesity|obesity
5052066|NCT03672903|weight vest|weight vest
5052067|NCT03672903|gravitostat|gravitostat
5052068|NCT03672903|appetite|appetite
5052069|NCT03672903|obesity treatment|obesity treatment
5052070|NCT03672903|leptin|leptin
5052071|NCT03672903|body weight|body weight
5052072|NCT03672903|weight loss|weight loss
5052073|NCT03672903|diet-induced obesity|diet-induced obesity
5052074|NCT03672903|osteocytes|osteocytes
5052075|NCT03672903|glucose metabolism|glucose metabolism
5052076|NCT03672890|Telestroke|telestroke
5052077|NCT03672890|Telemedicine|telemedicine
5052078|NCT03672890|Stroke|stroke
5052079|NCT03672890|Secondary stroke prevention|secondary stroke prevention
5052080|NCT03672877|Physical Therapy|physical therapy
5052081|NCT03672877|Rehabilitation|rehabilitation
5052083|NCT03672864|Walking|walking
5052084|NCT03672864|Intensive exercise|intensive exercise
5052085|NCT03672864|Rehabilitation|rehabilitation
5052086|NCT03672864|Cerebral Palsy|cerebral palsy
5052087|NCT03672864|Early intervention|early intervention
5052088|NCT03672812|liraglutide|liraglutide
5052089|NCT03672812|brain death|brain death
5052090|NCT03672812|inflammation|inflammation
5052091|NCT03672799|Head and neck cancer|head and neck cancer
5052092|NCT03672799|Rehabilitation|rehabilitation
5052093|NCT03672799|Rehabilitation planning consult|rehabilitation planning consult
5052094|NCT03672799|Self-management|self-management
5052095|NCT03672786|Gene Expression|gene expression
5052096|NCT03672786|Athletes|athletes
5052097|NCT03672786|Micronutrient Intervention|micronutrient intervention
5052098|NCT03672786|Whole Blood|whole blood
5052099|NCT03672773|Small Cell Lung Cancer|small cell lung cancer
5052100|NCT03672773|PARP Inhibitor|parp inhibitor
5052101|NCT03672734|pH gastric contents|ph gastric contents
5052105|NCT03672682|DLBCL|dlbcl
5052106|NCT03672682|chemosensitivity|chemosensitivity
5052107|NCT03672682|chemoresistance|chemoresistance
5052108|NCT03672669|Leukocyte- and platelet rich fibrin|leukocyte- and platelet rich fibrin
5052109|NCT03672669|Advanced platelet rich fibrin|advanced platelet rich fibrin
5052110|NCT03672669|Impacted mandibular third molar surgery|impacted mandibular third molar surgery
5052111|NCT03672656|diabetic retinopathy|diabetic retinopathy
5052112|NCT03672656|patterns|patterns
5052113|NCT03672656|low time of impulse|low time of impulse
5052114|NCT03672656|Pascal|pascal
5052115|NCT03672643|NSCLC|nsclc
5052129|NCT03672565|Exposure and Response prevention ERP|exposure and response prevention erp
5052130|NCT03672565|Cognitive-behavioural therapy|cognitive-behavioural therapy
5052131|NCT03672565|Pediatric OCD|pediatric ocd
5052132|NCT03672565|Childhood-onset OCD|childhood-onset ocd
5052133|NCT03672552|Aspiration pneumonia|aspiration pneumonia
5052134|NCT03672552|Dementia|dementia
5052135|NCT03672552|Dysphagia|dysphagia
5052136|NCT03672552|Oral hygiene|oral hygiene
5052137|NCT03672552|Long-term care|long-term care
5052138|NCT03672552|Frazier Free Water|frazier free water
5052139|NCT03672513|Menopuase|menopuase
5052140|NCT03672513|Zinc|zinc
5052141|NCT03672513|Magnesium|magnesium
5052142|NCT03672513|Antioxidant|antioxidant
5052143|NCT03672513|Bone loss|bone loss
5052144|NCT03672513|Nutritional intervention|nutritional intervention
5052145|NCT03672487|Congenital Transmission|congenital transmission
5052146|NCT03672487|Trypanosoma cruzi|trypanosoma cruzi
5052147|NCT03672487|Benznidazole|benznidazole
5052148|NCT03672474|Alzheimer's Disease|alzheimer's disease
5052149|NCT03672474|Photobiomodulation|photobiomodulation
5052150|NCT03672474|Innovative Therapy|innovative therapy
5052151|NCT03672448|dementia|dementia
5052152|NCT03672448|depression|depression
5949663|NCT03606538|MDMA|mdma
5949753|NCT03592069|H. Pylori Infection|h. pylori infection
5949754|NCT03592069|Gastritis|gastritis
5949755|NCT03592069|H.Pylori treatment|h.pylori treatment
5949756|NCT03592069|Treatment Resistance|treatment resistance
5052153|NCT03672448|cohort study|cohort study
5052154|NCT03672448|sample bank|sample bank
5052155|NCT03672448|precision diagnosis|precision diagnosis
5052156|NCT03672448|brain imaging|brain imaging
5052157|NCT03672435|post operative recovery|post operative recovery
5052158|NCT03672435|oculocardiac reflex|oculocardiac reflex
5052159|NCT03672435|extra ocular muscle|extra ocular muscle
5052160|NCT03672435|conjunctiva|conjunctiva
5052161|NCT03672435|numbing drop|numbing drop
5052162|NCT03672435|heart rate|heart rate
5052163|NCT03672422|Pediatric|pediatric
5052164|NCT03672422|Pancreatitis|pancreatitis
5052165|NCT03672422|Chronic|chronic
5052166|NCT03672422|Acute|acute
5052167|NCT03672422|Recurrent|recurrent
5052168|NCT03672422|ARP|arp
5052169|NCT03672422|CP|cp
5052170|NCT03672422|Pancreas|pancreas
5052171|NCT03672422|Children|children
5052172|NCT03672409|Knowledge in Type 2 diabetes,|knowledge in type 2 diabetes,
5052173|NCT03672409|Training program|training program
5052174|NCT03672409|Primary health care|primary health care
5052175|NCT03672396|exercise|exercise
5052176|NCT03672396|hormone therapy|hormone therapy
5052177|NCT03672370|Total hip arthroplasty|total hip arthroplasty
5052178|NCT03672370|Medical device|medical device
5052179|NCT03672370|Performance|performance
5052180|NCT03672370|Safety|safety
5052181|NCT03672370|Hip prosthesis|hip prosthesis
5052182|NCT03672357|Liver resection|liver resection
5052183|NCT03672357|Laparoscopic surgery|laparoscopic surgery
5052184|NCT03672357|fast recovery|fast recovery
5052185|NCT03672331|standard breast screening - risk-based screening program|standard breast screening - risk-based screening program
5052186|NCT03672318|CAR T cells|car t cells
5052187|NCT03672318|CD138|cd138
5052188|NCT03672318|Multiple Myeloma|multiple myeloma
5052189|NCT03672292|Aspergillosis|aspergillosis
5052190|NCT03672292|SCY-078|scy-078
5052191|NCT03672292|Ibrexafungerp|ibrexafungerp
5052192|NCT03672292|Coadministration|coadministration
5052193|NCT03672240|Urinary Bladder Neoplasms|urinary bladder neoplasms
5052194|NCT03672240|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5052195|NCT03672240|Oral Antineoplastic Agent|oral antineoplastic agent
5052196|NCT03672227|Head Start|head start
5052197|NCT03672227|Family Style Dining|family style dining
5052198|NCT03672201|Aggression|aggression
5052199|NCT03672201|Agitation|agitation
5052200|NCT03672201|Alzheimer's disease|alzheimer's disease
5052201|NCT03672201|Integrated Care Pathway|integrated care pathway
5052202|NCT03672201|StaN|stan
5052203|NCT03672201|Dementia|dementia
5052204|NCT03672188|Hepatitis B Virus|hepatitis b virus
5052205|NCT03672188|Chronic Hepatitis B|chronic hepatitis b
5052206|NCT03672188|HBV|hbv
5052207|NCT03672188|Hepatitis|hepatitis
5052208|NCT03672097|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5052209|NCT03672097|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
5052210|NCT03672097|Non-ST elevation myocardial infarction [NSTEMI]|non-st elevation myocardial infarction [nstemi]
5052798|NCT03668613|plaque psoriasis|plaque psoriasis
5052228|NCT03671993|intravesical instillation|intravesical instillation
5052230|NCT03671967|bacteremia|bacteremia
5052231|NCT03671967|enterobacteriaceae|enterobacteriaceae
5052232|NCT03671967|extended spectrum beta-lactamase|extended spectrum beta-lactamase
5052233|NCT03671967|meropenem|meropenem
5052234|NCT03671967|piperacillin tazobactam|piperacillin tazobactam
5052238|NCT03671915|artificial pancreas|artificial pancreas
5052239|NCT03671902|Phonocardiogram|phonocardiogram
5052240|NCT03671889|Alzheimer Disease|alzheimer disease
5052241|NCT03671889|Alzheimer Syndrome|alzheimer syndrome
5052242|NCT03671889|Magnetic Resonance guided Focal Ultrasound (MRgFUS)|magnetic resonance guided focal ultrasound (mrgfus)
5052243|NCT03671889|Blood-Brain Barrier|blood-brain barrier
5052244|NCT03671889|ExAblate|exablate
5052245|NCT03671876|Stroke|stroke
5052246|NCT03671876|Sub-acute|sub-acute
5052247|NCT03671876|Mobility|mobility
5052248|NCT03671876|Movement therapy|movement therapy
5052249|NCT03671876|Exercise|exercise
5052250|NCT03671863|Ultrasound|ultrasound
5052251|NCT03671863|Prenatal diagnosis|prenatal diagnosis
5052252|NCT03671863|Congenital deformities|congenital deformities
5052253|NCT03671863|Perinatal outcome|perinatal outcome
5052272|NCT03671707|active referral|active referral
5052273|NCT03671707|nicotine replacement therapy|nicotine replacement therapy
5052274|NCT03671707|pregnancy|pregnancy
5052275|NCT03671707|family health|family health
5052276|NCT03671707|Chinese|chinese
5052277|NCT03671694|laser treatment|laser treatment
5052278|NCT03671681|Chronic Migraine|chronic migraine
5052279|NCT03671681|Medication Overuse Headache|medication overuse headache
5052280|NCT03671681|Mindfulness|mindfulness
5052281|NCT03671681|Pharmacological Prophylaxis|pharmacological prophylaxis
5052282|NCT03671681|Neuroimaging|neuroimaging
5052283|NCT03671681|Neuroinflammation|neuroinflammation
5052284|NCT03671681|Disability|disability
5052285|NCT03671681|Quality of Life|quality of life
5052286|NCT03671681|Depression|depression
5052287|NCT03671681|Anxiety|anxiety
5052288|NCT03671655|Superficial femoral artery|superficial femoral artery
5052289|NCT03671655|chronic total occlusion|chronic total occlusion
5052290|NCT03671642|perfusion|perfusion
5052291|NCT03671642|indocyanine green angiography|indocyanine green angiography
5052292|NCT03671642|feasibility study|feasibility study
5052293|NCT03671629|Clinical pharmacist|clinical pharmacist
5052294|NCT03671629|Elderly|elderly
5052295|NCT03671629|Adherence|adherence
5052296|NCT03671629|Drug-related readmission|drug-related readmission
5052297|NCT03671564|Oncology|oncology
5052298|NCT03671564|MDM2|mdm2
5052299|NCT03671564|Escalation with overdose control (EWOC)|escalation with overdose control (ewoc)
5052300|NCT03671551|Eating Disorders in Children|eating disorders in children
5052301|NCT03671551|Psychomotor Development Impaired|psychomotor development impaired
5052302|NCT03671499|sedentary behavior|sedentary behavior
5052303|NCT03671499|physical activity|physical activity
5052304|NCT03671473|Carpal Tunnel Syndrome|carpal tunnel syndrome
5052305|NCT03671473|Extracorporeal shock wave|extracorporeal shock wave
5052306|NCT03671460|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
5052307|NCT03671460|CD19 CAR-T|cd19 car-t
5052308|NCT03671447|intensive care medicine|intensive care medicine
5052309|NCT03671447|critical illness|critical illness
5052310|NCT03671447|post intensive care syndrome|post intensive care syndrome
5052311|NCT03671447|e-health|e-health
5052312|NCT03671447|tele-ICU|tele-icu
5052313|NCT03671447|quality indicators (QIs) in intensive care medicine|quality indicators (qis) in intensive care medicine
5052314|NCT03671447|German Innovation Fund|german innovation fund
5052315|NCT03671434|Research|research
5052329|NCT03671421|hamstring|hamstring
5052330|NCT03671421|quadriceps tendon|quadriceps tendon
5052331|NCT03671408|heart transplant|heart transplant
5052332|NCT03671408|periodontitis|periodontitis
5052333|NCT03671408|hsCRP|hscrp
5052334|NCT03671395|Running Injuries|running injuries
5052335|NCT03671395|Motion Analysis|motion analysis
5052336|NCT03671395|Biomechanics|biomechanics
5052337|NCT03671395|Inertial Measurement Unit|inertial measurement unit
5052338|NCT03671395|Sensor Technology|sensor technology
5052339|NCT03671395|Kinetic|kinetic
5052340|NCT03671395|Kinematic|kinematic
5052341|NCT03671395|Injury|injury
5052342|NCT03671382|Cancer|cancer
5052344|NCT03671369|Adverse events after vaccination|adverse events after vaccination
5052345|NCT03671369|Safety|safety
5052346|NCT03671369|Serious adverse events after vaccination|serious adverse events after vaccination
5052347|NCT03671356|risk score|risk score
5052348|NCT03671356|risk management|risk management
5052349|NCT03671356|NCDR|ncdr
5052350|NCT03671356|interventional cardiology|interventional cardiology
5052351|NCT03671343|sarcopenia|sarcopenia
5052352|NCT03671343|chronic kidney disease|chronic kidney disease
5052353|NCT03671343|older|older
5052379|NCT03671291|VIH|vih
5052380|NCT03671291|PrEP|prep
5052381|NCT03671291|risk factors|risk factors
5052382|NCT03671291|Prevention|prevention
5052383|NCT03671291|Access to care|access to care
5052384|NCT03671278|low back pain|low back pain
5052385|NCT03671278|emergency|emergency
5052386|NCT03671278|feasibility|feasibility
5052387|NCT03671278|implementation|implementation
5052388|NCT03671265|Esophageal Cancer|esophageal cancer
5052389|NCT03671265|Concurrent chemoradiation|concurrent chemoradiation
5052390|NCT03671265|Immunotherapy|immunotherapy
5052391|NCT03671265|SHR-1210|shr-1210
5052392|NCT03671265|Apatinib|apatinib
5052393|NCT03671239|Acceptability|acceptability
5052394|NCT03671239|Rectal microbicide|rectal microbicide
5052395|NCT03671200|Primary teeth|primary teeth
5052396|NCT03671200|Permanent first molar|permanent first molar
5052397|NCT03671200|Caries|caries
5052398|NCT03671161|Diabetes Type 1|diabetes type 1
5052399|NCT03671161|Insulin Pump|insulin pump
5052400|NCT03671161|flash glucose monitoring|flash glucose monitoring
5052401|NCT03671161|hypoglycemia|hypoglycemia
5052402|NCT03671161|ketoacidocetosis|ketoacidocetosis
5052403|NCT03671161|DTSQ|dtsq
5052404|NCT03671161|HFS|hfs
5052405|NCT03671148|KEEPsAKE 2|keepsake 2
5052406|NCT03671148|KEEPsAKE2|keepsake2
5052407|NCT03671135|Intrastromal|intrastromal
5052408|NCT03671135|Corneal Inlay|corneal inlay
5052409|NCT03671109|Malaria|malaria
5052410|NCT03671109|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5052411|NCT03671109|HIV|hiv
5052412|NCT03671109|Pregnancy|pregnancy
5052413|NCT03671109|Treatment|treatment
5052414|NCT03671109|Prevention|prevention
5052415|NCT03671096|Intrastromal|intrastromal
5052416|NCT03671096|Corneal|corneal
5052417|NCT03671096|Allograft|allograft
5052418|NCT03671083|Concussion|concussion
5052419|NCT03671083|Sports Related Concussion|sports related concussion
5052420|NCT03671083|Mild Traumatic Brain Injury|mild traumatic brain injury
5960939|NCT04290169|Cerebral palsy|cerebral palsy
5960940|NCT04290169|Cognition|cognition
5052431|NCT03670992|robotic surgery|robotic surgery
5052432|NCT03670992|pancreatic metastases|pancreatic metastases
5052433|NCT03670992|quality of life|quality of life
5052441|NCT03670914|Sleep Disorder Breathing|sleep disorder breathing
5052442|NCT03670914|Central Sleep Apnea|central sleep apnea
5052443|NCT03670914|Narcotics|narcotics
5052444|NCT03670914|Home Sleep Apnea Testing Device|home sleep apnea testing device
5052445|NCT03670914|WatchPAT 200|watchpat 200
5052446|NCT03670914|In-Lab Polysomnography|in-lab polysomnography
5052447|NCT03670914|Comparison|comparison
5052448|NCT03670914|Accuracy|accuracy
5052449|NCT03670914|Efficacy|efficacy
5052450|NCT03670875|Children, obesity, agave-inulin, curcumin, O3FA|children, obesity, agave-inulin, curcumin, o3fa
5052451|NCT03670862|Ischemic stroke|ischemic stroke
5052452|NCT03670862|CTP|ctp
5052453|NCT03670862|CTA|cta
5052454|NCT03670849|Laparoscopic Ultrasound|laparoscopic ultrasound
5052455|NCT03670836|Misoprostol|misoprostol
5052456|NCT03670836|Dilapan|dilapan
5052457|NCT03670836|Induction of labor|induction of labor
5052458|NCT03670836|Aquacryl hydrogel|aquacryl hydrogel
5052459|NCT03670823|Major Depression|major depression
5052460|NCT03670823|EEG|eeg
5052461|NCT03670823|Eye Tracker|eye tracker
5052462|NCT03670823|fMRI|fmri
5052463|NCT03670823|MRI|mri
5052464|NCT03670823|Resting State Connectivity|resting state connectivity
5052465|NCT03670823|Cognition|cognition
5065426|NCT03590145|Hip-related|hip-related
5052473|NCT03670797|patients with diabetes|patients with diabetes
5052474|NCT03670784|Ectopic pregnancy|ectopic pregnancy
5052475|NCT03670784|Electronic medical records|electronic medical records
5052476|NCT03670784|Chart Review|chart review
5052477|NCT03670784|Intrauterine device (IUD)|intrauterine device (iud)
5052478|NCT03670732|Continuous positive airway pressure|continuous positive airway pressure
5052479|NCT03670732|Nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
5052480|NCT03670732|Mean airway pressure|mean airway pressure
5052482|NCT03670732|Bradycardia|bradycardia
5052483|NCT03670732|Prematurity|prematurity
5052489|NCT03670680|Menorrhagia|menorrhagia
5052490|NCT03670680|Lina LibrataTM|lina libratatm
5052491|NCT03670680|efficiency|efficiency
5052492|NCT03670680|menometrorrhagia|menometrorrhagia
5052493|NCT03670654|Asthma|asthma
5052494|NCT03670654|Exercise|exercise
5052495|NCT03670654|Pilates|pilates
5052496|NCT03670654|Quality of life|quality of life
5052497|NCT03670654|Clinical control|clinical control
5052498|NCT03670641|Insulin therapy|insulin therapy
5052499|NCT03670641|Continuous glucose monitor|continuous glucose monitor
5052500|NCT03670615|Alzheimer disease|alzheimer disease
5052501|NCT03670615|cognition|cognition
5052502|NCT03670615|transcranial direct current stimulation|transcranial direct current stimulation
5052503|NCT03670615|exercise|exercise
5052504|NCT03670615|mild cognitive impairment|mild cognitive impairment
5052505|NCT03670589|vestibular schwannoma|vestibular schwannoma
5052506|NCT03670589|gammaknife radiosurgery|gammaknife radiosurgery
5052507|NCT03670589|vestibular evaluation|vestibular evaluation
5052508|NCT03670563|Therapeutic exercise|therapeutic exercise
5052509|NCT03670537|Iron deficiency, Non-anemic|iron deficiency, non-anemic
5052510|NCT03670537|Pregnancy|pregnancy
5052511|NCT03670498|stroke|stroke
5052512|NCT03670498|cervical spinal cord injury|cervical spinal cord injury
5052513|NCT03670485|stroke|stroke
5052514|NCT03670485|cervical spinal cord injury|cervical spinal cord injury
5052515|NCT03670472|Cystic fibrosis|cystic fibrosis
5052516|NCT03670472|nonsense mutations|nonsense mutations
5052517|NCT03670472|CFTR gene|cftr gene
5052518|NCT03670472|nasal epithelial cells|nasal epithelial cells
5052539|NCT03670212|nicotine seeking|nicotine seeking
5052540|NCT03670212|relapse|relapse
5052541|NCT03670212|excitatory neural activity|excitatory neural activity
5052542|NCT03670212|glutamate|glutamate
5052543|NCT03670212|negative affect|negative affect
5052544|NCT03670173|Multiple myeloma, Osalmid|multiple myeloma, osalmid
5052545|NCT03670134|Laser Endomicroscopy|laser endomicroscopy
5052546|NCT03670134|Intestinal Metaplasia|intestinal metaplasia
5055660|NCT03650816|Cognitive Dysfunction|cognitive dysfunction
5950114|NCT03534063|Arthroplasty Surgery|arthroplasty surgery
5950115|NCT03534063|Genotype-Guided Pain Management|genotype-guided pain management
5950164|NCT03523247|Cholesterol|cholesterol
5950165|NCT03523247|LDL|ldl
5950166|NCT03523247|HDL|hdl
5950167|NCT03523247|triglycerides|triglycerides
5950168|NCT03523247|c-reactive protein|c-reactive protein
5950169|NCT03523247|whole food diet|whole food diet
5950170|NCT03523247|plant based diet|plant based diet
5950171|NCT03523247|community based enrollment|community based enrollment
5950184|NCT03520751|scAAV1.tMCK.NTF3|scaav1.tmck.ntf3
5950185|NCT03520751|NTF3|ntf3
5950200|NCT03518073|Memory problems|memory problems
5950201|NCT03518073|Cognitive impairment|cognitive impairment
5950202|NCT03518073|PERISCOPE-ALZ|periscope-alz
5950203|NCT03518073|Dementia|dementia
5950204|NCT03518073|Tauopathy|tauopathy
5950205|NCT03518073|Neurofibrillary tangles|neurofibrillary tangles
5950212|NCT03518047|Plaque Psoriasis|plaque psoriasis
5950217|NCT03517631|HIV|hiv
5950218|NCT03517631|AIDS|aids
5950219|NCT03517631|Lentivirus|lentivirus
5950220|NCT03517631|shRNA|shrna
5950221|NCT03517631|Multiplex|multiplex
5950222|NCT03517631|Gene therapy|gene therapy
5255041|NCT02417506|VAS|vas
5950303|NCT03510104|MerTK|mertk
5950320|NCT03507452|Malignant Mesothelioma|malignant mesothelioma
5950321|NCT03507452|Malignant Pleural Epithelioid Mesothelioma|malignant pleural epithelioid mesothelioma
5950322|NCT03507452|Malignant Peritoneal Epithelioid Mesothelioma|malignant peritoneal epithelioid mesothelioma
5950334|NCT03505073|ASCVD|ascvd
5950368|NCT03498430|Indolent Non-Hodgkin's Lymphoma (iNHL) (excluding CLL)|indolent non-hodgkin's lymphoma (inhl) (excluding cll)
5242767|NCT02487199|IFN|ifn
5950396|NCT03493269|Psoriasis|psoriasis
5052547|NCT03670121|COPD, Emphysema, Homogenous, Collateral Ventilation|copd, emphysema, homogenous, collateral ventilation
5052548|NCT03670121|vapor|vapor
5052549|NCT03670121|ablation|ablation
5052550|NCT03670056|combination immunotherapy|combination immunotherapy
5052551|NCT03670056|platinum-based chemotherapy|platinum-based chemotherapy
5052552|NCT03670004|Artifical Limbs|artifical limbs
5052553|NCT03670004|Amputation|amputation
5052554|NCT03670004|Accidental Falls|accidental falls
5052555|NCT03670004|Stability|stability
5052556|NCT03670004|Balance|balance
5052557|NCT03670004|Gait|gait
5052558|NCT03670004|Electromyography|electromyography
5052559|NCT03669978|Occlusive arthritis|occlusive arthritis
5052560|NCT03669978|bone panorama|bone panorama
5052561|NCT03669978|arterial panorama|arterial panorama
5052562|NCT03669952|Breast cancer|breast cancer
5052563|NCT03669952|Ductal carcinoma in situ|ductal carcinoma in situ
5052564|NCT03669952|Invasive ductal carcinoma|invasive ductal carcinoma
5052565|NCT03669952|Prognosis factors|prognosis factors
5052566|NCT03669939|Center for Disease Control Guidelines|center for disease control guidelines
5052567|NCT03669939|Opioids for chronic pain|opioids for chronic pain
5052568|NCT03669939|communication strategies|communication strategies
5052578|NCT03669913|sexuality|sexuality
5052579|NCT03669913|education|education
5052580|NCT03669913|adolescents|adolescents
5052581|NCT03669900|SERI|seri
5052582|NCT03669900|correction surgery|correction surgery
5052583|NCT03669900|Complications|complications
5052584|NCT03669900|radiological|radiological
5052585|NCT03669900|outcomes|outcomes
5052586|NCT03669887|Gestational diabetes|gestational diabetes
5052587|NCT03669887|Diabetes|diabetes
5052588|NCT03669887|Lifestyle|lifestyle
5052589|NCT03669887|Diet Modification|diet modification
5052590|NCT03669887|Childhood Obesity|childhood obesity
5052591|NCT03669887|Diabetes Mellitus|diabetes mellitus
5052592|NCT03669848|carbon monoxide poisoning|carbon monoxide poisoning
5052593|NCT03669848|e-cigarette user|e-cigarette user
5052594|NCT03669848|transcutaneous saturation measurements|transcutaneous saturation measurements
5052598|NCT03669822|Ulcerative colitis|ulcerative colitis
5052599|NCT03669822|Inflammatory bowel disease|inflammatory bowel disease
5052609|NCT03669796|Aged|aged
5052610|NCT03669770|Lipohypertrophy|lipohypertrophy
5052611|NCT03669770|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5052612|NCT03669770|Ultrasound|ultrasound
5052613|NCT03669770|Glucose variability|glucose variability
5052614|NCT03669770|Glycaemic control|glycaemic control
5052615|NCT03669744|chronic pain|chronic pain
5052616|NCT03669744|trigeminal neuralgia|trigeminal neuralgia
5052618|NCT03669744|trigeminal nerve block|trigeminal nerve block
5052619|NCT03669731|Obesity|obesity
5052620|NCT03669731|Protein|protein
5052621|NCT03669731|Pregnancy|pregnancy
5052622|NCT03669731|bariatric surgery|bariatric surgery
5052623|NCT03669705|Axillary Surgery|axillary surgery
5052624|NCT03669692|Prostate|prostate
5052625|NCT03669692|Caloric Restriction|caloric restriction
5052626|NCT03669692|Metabolic Syndrome|metabolic syndrome
5052627|NCT03669692|Heart Rate Variability|heart rate variability
5052628|NCT03669679|breast reduction|breast reduction
5052629|NCT03669679|mammaplasty|mammaplasty
5052630|NCT03669679|breast-q|breast-q
5052631|NCT03669679|patient satisfaction|patient satisfaction
5052632|NCT03669679|patient reported outcome measures|patient reported outcome measures
5052633|NCT03669679|superomedial pedicle|superomedial pedicle
5731108|NCT00390195|Randomize|randomize
5052634|NCT03669679|inferior pedicle|inferior pedicle
5052635|NCT03669666|valvular heart disease|valvular heart disease
5052636|NCT03669666|ejection fraction|ejection fraction
5052637|NCT03669627|infants|infants
5052638|NCT03669627|priming|priming
5052646|NCT03669536|cognitive impairment|cognitive impairment
5052648|NCT03669536|geriatrics|geriatrics
5052649|NCT03669497|Palliative Radiotherapy|palliative radiotherapy
5052650|NCT03669497|Hypo-fractionated Radiotherapy|hypo-fractionated radiotherapy
5052651|NCT03669497|Simultaneous integrated boost|simultaneous integrated boost
5052652|NCT03669484|anaesthesia|anaesthesia
5052653|NCT03669484|surgery|surgery
5052654|NCT03669445|Newly Diagnosed Multiple myeloma|newly diagnosed multiple myeloma
5052655|NCT03669445|Daratumumab|daratumumab
5052656|NCT03669445|Lenalidomide|lenalidomide
5052657|NCT03669445|Ixazomib|ixazomib
5052658|NCT03669445|Dexamethasone|dexamethasone
5052659|NCT03669432|locally advanced thyroid cancers, IMRT, toxicity|locally advanced thyroid cancers, imrt, toxicity
5052660|NCT03669419|Outcome|outcome
5052661|NCT03669419|Postoperative Complications|postoperative complications
5052662|NCT03669419|Failure to rescue|failure to rescue
5052663|NCT03669419|QoR-9|qor-9
5950555|NCT03477344|Cardiac Surgery|cardiac surgery
5950556|NCT03477344|Delirium|delirium
5950557|NCT03477344|Sleep deprivation|sleep deprivation
5950642|NCT03461900|Septic shock|septic shock
5950643|NCT03461900|Fluid optimisation|fluid optimisation
5950644|NCT03461900|Minifluid challenge|minifluid challenge
5950645|NCT03461900|Fluid overload|fluid overload
5950730|NCT03450980|Double Vision, Amblyopia|double vision, amblyopia
5950839|NCT03437512|tDCS|tdcs
5950840|NCT03437512|MRI|mri
5950841|NCT03437512|Speech|speech
5950842|NCT03437512|fluency|fluency
5950848|NCT03436251|hyperthermia|hyperthermia
5950849|NCT03436251|human papillomavirus virus|human papillomavirus virus
5950850|NCT03436251|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5255474|NCT02415582|Aging|aging
5950909|NCT03427593|CVID|cvid
5950910|NCT03427593|Neutropenia|neutropenia
5950911|NCT03427593|Autoimmunity|autoimmunity
5950912|NCT03427593|Lymphoproliferation|lymphoproliferation
5950953|NCT03424239|Roux-en-Y gastric bypass, sleeve gastrectomy|roux-en-y gastric bypass, sleeve gastrectomy
5951021|NCT03416634|Health promotion|health promotion
5951022|NCT03416634|Behavioral research|behavioral research
5951023|NCT03416634|Preventive medicine|preventive medicine
5951024|NCT03416634|Obesity|obesity
5951025|NCT03416634|Cardiovascular disease|cardiovascular disease
5951035|NCT03409978|Infants, newborn|infants, newborn
5951036|NCT03409978|General Movements|general movements
5951037|NCT03409978|Video Recording|video recording
5951038|NCT03409978|Mobile Applications|mobile applications
5951039|NCT03409978|Prognosis|prognosis
5951040|NCT03409978|Parents|parents
5951046|NCT03409536|SSEP Monitoring|ssep monitoring
5951047|NCT03409536|Diagnostic threshold|diagnostic threshold
5261644|NCT02379520|HPV|hpv
5052664|NCT03669419|patient-centred questionnaire|patient-centred questionnaire
5052665|NCT03669406|Healed pelvic eschar|healed pelvic eschar
5052666|NCT03669406|Paraplegic patient|paraplegic patient
5052667|NCT03669406|Fat autograft|fat autograft
5052668|NCT03669354|Prescription Drugs|prescription drugs
5052669|NCT03669354|Spinal Manipulation|spinal manipulation
5052670|NCT03669341|breath hold|breath hold
5052671|NCT03669341|DIBH|dibh
5052672|NCT03669341|HFPV|hfpv
5052674|NCT03669328|Surgery|surgery
5052675|NCT03669328|cancer|cancer
5052676|NCT03669328|anesthesia|anesthesia
5052677|NCT03669328|pain|pain
5052678|NCT03669328|outcome patient|outcome patient
5052679|NCT03669328|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5052680|NCT03669315|Gambling Disorder|gambling disorder
5052681|NCT03669315|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5052682|NCT03669302|locomotor training|locomotor training
5052683|NCT03669302|transcutaneous spinal cord stimulation|transcutaneous spinal cord stimulation
5052684|NCT03669302|Lokomat|lokomat
5052685|NCT03669302|brain stimulation|brain stimulation
5052686|NCT03669302|peripheral nerve stimulation|peripheral nerve stimulation
5052687|NCT03669302|H-reflex|h-reflex
5052688|NCT03669302|spinal neural circuits|spinal neural circuits
5052689|NCT03669302|neuroplasticity|neuroplasticity
5052690|NCT03669302|recovery|recovery
5052691|NCT03669263|Painkyl®|painkyl®
5052692|NCT03669263|fentanyl buccal soluble film|fentanyl buccal soluble film
5052693|NCT03669263|dose titration|dose titration
5052695|NCT03669250|EEG|eeg
5052696|NCT03669250|P50|p50
5052700|NCT03669237|Bowel Function|bowel function
5052701|NCT03669237|Sphincter Preservation Surgery|sphincter preservation surgery
5052702|NCT03669237|Reconstruction Method|reconstruction method
5052703|NCT03669224|marginal adptation|marginal adptation
5052704|NCT03669224|marginal staining|marginal staining
5052705|NCT03669224|post operative sensitivity|post operative sensitivity
5052706|NCT03669224|recurrent caries|recurrent caries
5052707|NCT03669211|Therapeutic education|therapeutic education
5052708|NCT03669211|Cardiac stress test|cardiac stress test
5052709|NCT03669198|Acute Heart Failure|acute heart failure
5052710|NCT03669198|Cost|cost
5052711|NCT03669198|NT-pro BNP|nt-pro bnp
5052712|NCT03669185|PETN|petn
5052713|NCT03669146|Emmetropization|emmetropization
5052714|NCT03669146|Refractive Error|refractive error
5052715|NCT03669146|Glasses|glasses
5052716|NCT03669146|Accommodation|accommodation
5052717|NCT03669133|Fatty liver|fatty liver
5052718|NCT03669133|NAFLD|nafld
5052719|NCT03669133|NASH|nash
5052720|NCT03669133|HIV|hiv
5052722|NCT03669081|live kidney donor|live kidney donor
5052723|NCT03669081|donor nephrectomy|donor nephrectomy
5052724|NCT03669068|Gastrointestinal endoscopy|gastrointestinal endoscopy
5052727|NCT03669068|Cardiovascular event|cardiovascular event
5052728|NCT03669055|aortic dissection|aortic dissection
5052729|NCT03669055|hemodynamic|hemodynamic
5052730|NCT03669055|4D flow phase contrast MRI|4d flow phase contrast mri
5052731|NCT03669029|Golimumab|golimumab
5052732|NCT03669029|Inflammatory Bowel Disease|inflammatory bowel disease
5052733|NCT03669029|Optimization|optimization
5052734|NCT03669029|Drug levels|drug levels
5052735|NCT03669029|Anti-drug antibody levels|anti-drug antibody levels
5052736|NCT03669016|well-being|well-being
5052737|NCT03669016|functional ability|functional ability
5052738|NCT03669016|stress|stress
5052739|NCT03669016|mindfulness|mindfulness
5052740|NCT03669016|undergaduate students|undergaduate students
5052741|NCT03669003|lung biopsy|lung biopsy
5052742|NCT03669003|gelfoam|gelfoam
5052743|NCT03668964|Intestinal microbiota|intestinal microbiota
5052747|NCT03668938|Occupational Therapy|occupational therapy
5053182|NCT03666247|AIDS|aids
5052748|NCT03668938|Complex Patient|complex patient
5052749|NCT03668938|Randomized Control Trial|randomized control trial
5052750|NCT03668938|Social Reintegration|social reintegration
5052751|NCT03668925|spondyloarthritis|spondyloarthritis
5052752|NCT03668925|hidrosadenitis suppurativa|hidrosadenitis suppurativa
5052753|NCT03668925|inflammation|inflammation
5255856|NCT02413242|ICU|icu
5951281|NCT03366714|Noninvasive ventilation, respiratory distress syndrome|noninvasive ventilation, respiratory distress syndrome
5274431|NCT02306434|postnatal care|postnatal care
5951311|NCT03361995|STEMI|stemi
5951328|NCT03358563|Prostate Cancer|prostate cancer
5951329|NCT03358563|Prostatectomy|prostatectomy
5951330|NCT03358563|Chemohormonal therapy|chemohormonal therapy
5951331|NCT03358563|Androgen deprivation therapy|androgen deprivation therapy
5951332|NCT03358563|docetaxel chemotherapy|docetaxel chemotherapy
5951346|NCT03349775|Pulmonary Hypertension|pulmonary hypertension
5951347|NCT03349775|BMI|bmi
5951348|NCT03349775|Echocardiography|echocardiography
5951349|NCT03349775|CPET|cpet
5951350|NCT03349775|6-minute walk test|6-minute walk test
5951351|NCT03349775|Cardio Metabolic disease|cardio metabolic disease
5255924|NCT02412813|arthroplasty|arthroplasty
5951379|NCT03342287|gut microbiome|gut microbiome
5951380|NCT03342287|anxiety|anxiety
5951381|NCT03342287|depression|depression
5951382|NCT03342287|cognition|cognition
5951392|NCT03340415|Hallux Valgus|hallux valgus
5951393|NCT03340415|Bunion|bunion
5951394|NCT03340415|Post-operative|post-operative
5951395|NCT03340415|Rehabilitation|rehabilitation
5951396|NCT03340415|Weight Bearing Status|weight bearing status
5951404|NCT03339973|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5951405|NCT03339973|ABCB5|abcb5
5951406|NCT03339973|allogeneic|allogeneic
5951407|NCT03339973|mesenchymal stem cells|mesenchymal stem cells
5951408|NCT03339973|advanced therapy medicinal product|advanced therapy medicinal product
5951409|NCT03339973|somatic cell therapy|somatic cell therapy
5951410|NCT03339973|phase I/IIa|phase i/iia
5951411|NCT03339973|non-healing ulcers|non-healing ulcers
5951412|NCT03339024|Oxytocin|oxytocin
5951413|NCT03339024|Administration, Intranasal|administration, intranasal
5951414|NCT03339024|Ethanol|ethanol
5951415|NCT03339024|Follow-up Studies|follow-up studies
5951433|NCT03338023|Insulin Glargine|insulin glargine
5951435|NCT03337750|Combat|combat
5951436|NCT03337750|Psychological Treatment|psychological treatment
5951437|NCT03337750|Military|military
5951438|NCT03337750|Psychotherapy|psychotherapy
5951439|NCT03337750|Trauma|trauma
5951440|NCT03337750|Posttraumatic Stress|posttraumatic stress
5951441|NCT03337750|Posttraumatic Stress Disorder|posttraumatic stress disorder
5369111|NCT01861288|Clinical IBD score (SCCAI, PUCAI, aPCDAI)|clinical ibd score (sccai, pucai, apcdai)
5369112|NCT01861288|Endoscopic deep remission|endoscopic deep remission
5369113|NCT01861288|Histopathologic deep remission|histopathologic deep remission
5369114|NCT01861288|Immunological deep remission|immunological deep remission
5951489|NCT03330171|Immunogenicity|immunogenicity
5951490|NCT03330171|Safety|safety
5951491|NCT03330171|Vaccine|vaccine
5951513|NCT03325816|nivolumab|nivolumab
5951514|NCT03325816|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
5951515|NCT03325816|Lutathera|lutathera
5951609|NCT03305731|Rehabilitation|rehabilitation
5951610|NCT03305731|Disability|disability
5951658|NCT03298997|Hemorrhoids|hemorrhoids
5951659|NCT03298997|Ligation|ligation
5951660|NCT03298997|Ultrasound|ultrasound
5951661|NCT03298997|Prospective|prospective
5951662|NCT03298997|Randomized Controlled Trial|randomized controlled trial
5951664|NCT03298243|stroke|stroke
5951665|NCT03298243|proprioception|proprioception
5951666|NCT03298243|sensory substitution|sensory substitution
5951679|NCT03293407|Pulmonary arterial hypertension|pulmonary arterial hypertension
5951680|NCT03293407|PAH|pah
5052754|NCT03668925|magnetic resonance imaging|magnetic resonance imaging
5052755|NCT03668873|Parent Training|parent training
5052756|NCT03668873|Telehealth|telehealth
5052757|NCT03668873|Sleep Problems|sleep problems
5052758|NCT03668860|Antenatal Corticosteroids|antenatal corticosteroids
5052759|NCT03668860|Betamethasone|betamethasone
5052760|NCT03668860|Dexamethasone|dexamethasone
5052761|NCT03668821|Vascular Diseases|vascular diseases
5052762|NCT03668821|Peripheral Artery Disease|peripheral artery disease
5052763|NCT03668808|Insulin Degludec|insulin degludec
5052764|NCT03668808|Insulin Glargine|insulin glargine
5052765|NCT03668808|Air Travel|air travel
5052766|NCT03668808|Continuous Glucose Monitor|continuous glucose monitor
5052767|NCT03668743|risk factor|risk factor
5052768|NCT03668730|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5052769|NCT03668730|IMRT|imrt
5052770|NCT03668730|Radiation dose|radiation dose
5052771|NCT03668730|induction chemotherapy|induction chemotherapy
5052772|NCT03668717|osteoarthritis|osteoarthritis
5052773|NCT03668717|medial|medial
5052774|NCT03668717|unicompartmental|unicompartmental
5052775|NCT03668704|osteoarthritis|osteoarthritis
5052776|NCT03668704|medial|medial
5052777|NCT03668704|bicompartmental|bicompartmental
5052778|NCT03668704|patellofemoral|patellofemoral
5052779|NCT03668691|osteoarthritis|osteoarthritis
5052780|NCT03668691|medial unicompartmental|medial unicompartmental
5052781|NCT03668691|lateral unicompartmental|lateral unicompartmental
5052782|NCT03668691|bicompartmental|bicompartmental
5052783|NCT03668691|patellofemoral|patellofemoral
5052784|NCT03668678|Obesity|obesity
5052785|NCT03668678|Physical Activity|physical activity
5052786|NCT03668678|Nutrition|nutrition
5052787|NCT03668678|Curriculum|curriculum
5052788|NCT03668678|Preschool|preschool
5052789|NCT03668678|Literacy|literacy
5052790|NCT03668665|Split Skin Removal|split skin removal
5052791|NCT03668665|Hyaloronic acid|hyaloronic acid
5052792|NCT03668665|Split Wound Design|split wound design
5052793|NCT03668652|Prostate Cancer|prostate cancer
5052794|NCT03668652|HIFU Focal Treatment|hifu focal treatment
5052795|NCT03668652|Radical prostatectomy|radical prostatectomy
5052796|NCT03668613|pediatric|pediatric
5052797|NCT03668613|secukinumab|secukinumab
5052802|NCT03668574|Low back pain|low back pain
5052803|NCT03668561|stroke|stroke
5052804|NCT03668561|hemiplegia|hemiplegia
5052805|NCT03668535|Urinary|urinary
5052806|NCT03668535|Bladder|bladder
5052807|NCT03668535|Injury|injury
5052808|NCT03668535|Cesarean|cesarean
5052809|NCT03668522|H3F3AK27M|h3f3ak27m
5052810|NCT03668509|SHR1459|shr1459
5960941|NCT04290169|Spasticity|spasticity
5052811|NCT03668509|Phase 1|phase 1
5052812|NCT03668483|rehabilitation|rehabilitation
5052813|NCT03668483|exercise|exercise
5052814|NCT03668483|maximal inspiratory pressure|maximal inspiratory pressure
5052815|NCT03668483|walk test|walk test
5052816|NCT03668483|muscle strength|muscle strength
5052817|NCT03668483|dyspnea|dyspnea
5052818|NCT03668483|lung transplantation|lung transplantation
5052819|NCT03668470|type 1 diabetes|type 1 diabetes
5052820|NCT03668470|insulin microsecretion|insulin microsecretion
5052821|NCT03668470|dulaglutide|dulaglutide
5052822|NCT03668470|randomized|randomized
5052823|NCT03668470|double-blind placebo-controlled trial|double-blind placebo-controlled trial
5052824|NCT03668457|Depression|depression
5052825|NCT03668457|Medication adherence|medication adherence
5052826|NCT03668457|Multicomponent intervention|multicomponent intervention
5052827|NCT03668444|Text Messaging|text messaging
5052828|NCT03668431|Metastatic colorectal cancer|metastatic colorectal cancer
5052829|NCT03668379|Depression|depression
5052831|NCT03668379|Latinos|latinos
5098335|NCT03383692|ADC|adc
5052832|NCT03668379|Sequential multiple assignment randomized trial designs|sequential multiple assignment randomized trial designs
5052833|NCT03668379|Mobile health|mobile health
5052834|NCT03668379|Cognitive-behavioral therapy|cognitive-behavioral therapy
5052835|NCT03668366|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5052836|NCT03668366|IMRT|imrt
5052837|NCT03668366|S-1|s-1
5052838|NCT03668340|Uterine Cancer|uterine cancer
5052839|NCT03668327|Preterm|preterm
5052840|NCT03668327|Cohort|cohort
5052841|NCT03668327|Early development|early development
5052842|NCT03668327|Child|child
5052843|NCT03668288|IVIG|ivig
5052844|NCT03668288|PID|pid
5052845|NCT03668288|home infusion|home infusion
5052846|NCT03668288|hyaluronidase|hyaluronidase
5052847|NCT03668288|immunoglobulin|immunoglobulin
5052848|NCT03668288|secondary and primary immunodeficiency disease|secondary and primary immunodeficiency disease
5052849|NCT03668288|tolerance|tolerance
5052850|NCT03668249|Drug therapy|drug therapy
5052851|NCT03668236|Fluid resuscitation|fluid resuscitation
5052852|NCT03668236|Critical care|critical care
5052853|NCT03668236|Intensive care|intensive care
5052854|NCT03668236|Crystalloid|crystalloid
5052855|NCT03668236|IV fluid therapy|iv fluid therapy
5052856|NCT03668210|Anterior cruciate ligament|anterior cruciate ligament
5052857|NCT03668210|ligamentoplasty|ligamentoplasty
5052858|NCT03668210|isokinetics|isokinetics
5052859|NCT03668171|Acute-On-Chronic Liver Failure, mesenchymal stem cell,|acute-on-chronic liver failure, mesenchymal stem cell,
5052860|NCT03668145|Primary Biliary Cirrhosis (now termed as primary biliary cholangitis), mesenchymal stem cell,|primary biliary cirrhosis (now termed as primary biliary cholangitis), mesenchymal stem cell,
5052861|NCT03668132|Aphasia|aphasia
5052862|NCT03668132|Functional magnetic resonance imaging|functional magnetic resonance imaging
5052863|NCT03668132|Subcortical aphasia|subcortical aphasia
5052864|NCT03668132|Post-stroke aphasia|post-stroke aphasia
5052865|NCT03668132|Cortical activation|cortical activation
5052866|NCT03668119|TMB-H|tmb-h
5052867|NCT03668093|caries prevention|caries prevention
5052868|NCT03668093|caries management|caries management
5052869|NCT03668080|burnout|burnout
5052870|NCT03668080|residents|residents
5052871|NCT03668080|surgical residents|surgical residents
5052872|NCT03668015|caries|caries
5052873|NCT03668015|bacteria|bacteria
5052874|NCT03668015|saliva|saliva
5052875|NCT03668015|plaque|plaque
5052876|NCT03668015|microbial ecology|microbial ecology
5052877|NCT03668002|Fistula vs. Graft|fistula vs. graft
5052878|NCT03667989|SPECT|spect
5052879|NCT03667989|123I-MIBG|123i-mibg
5052880|NCT03667989|Chronic heart failure|chronic heart failure
5052881|NCT03667989|Cardiac resynchronization therapy|cardiac resynchronization therapy
5052883|NCT03667976|cardiovascular disease|cardiovascular disease
5052884|NCT03667976|South Asian|south asian
5052885|NCT03667976|physical activity|physical activity
5052886|NCT03667976|peer support|peer support
5052887|NCT03667976|pedometer|pedometer
5052888|NCT03667950|anastomotic perfusion, tissue oxygen saturation|anastomotic perfusion, tissue oxygen saturation
5052889|NCT03667937|Venous Ulcer|venous ulcer
5052890|NCT03667937|Leg Injuries|leg injuries
5052891|NCT03667937|Bacterial Infections|bacterial infections
5052892|NCT03667924|Caregiving|caregiving
5052893|NCT03667924|Community-based care|community-based care
5052894|NCT03667924|Long-term services and supports|long-term services and supports
5052895|NCT03667924|Volunteer|volunteer
5052904|NCT03667885|biomarkers|biomarkers
5052905|NCT03667872|Deep Brain Stimulation|deep brain stimulation
5052906|NCT03667872|Habenula|habenula
5052907|NCT03667872|Functional magnetic resonance imaging|functional magnetic resonance imaging
5052908|NCT03667833|Shoulder Brace|shoulder brace
5052909|NCT03667768|Dentition, Permanent|dentition, permanent
5052910|NCT03667768|Glass Ionomer Cements|glass ionomer cements
5052911|NCT03667755|pre-operation whey protein infused carbohydrate loading|pre-operation whey protein infused carbohydrate loading
5052912|NCT03667755|early oral feeding post-operation|early oral feeding post-operation
5052913|NCT03667742|sweat protein markers in tuberculosis|sweat protein markers in tuberculosis
5960942|NCT04290169|BoNT-A|bont-a
5930062|NCT03575611|RCC|rcc
5052914|NCT03667729|PMR, anxiety, psychotic syndrome, quality of life|pmr, anxiety, psychotic syndrome, quality of life
5052915|NCT03667716|PVRIG|pvrig
5052916|NCT03667716|advanced cancer|advanced cancer
5052917|NCT03667716|checkpoint inhibitor|checkpoint inhibitor
5052918|NCT03667716|DNAM (DNAX Accessory molecule 1)|dnam (dnax accessory molecule 1)
5052919|NCT03667716|PD-1 inhibitor|pd-1 inhibitor
5052920|NCT03667716|CD112|cd112
5052921|NCT03667716|CD 112R|cd 112r
5052922|NCT03667716|Poliovirus receptor-related immunoglobulin|poliovirus receptor-related immunoglobulin
5052923|NCT03667716|PVRL2|pvrl2
5052924|NCT03667716|Nivolumab|nivolumab
5052925|NCT03667716|opdivo|opdivo
5052926|NCT03667690|Mycoses|mycoses
5052927|NCT03667690|Candidiasis|candidiasis
5052928|NCT03667690|Candidiasis, Invasive|candidiasis, invasive
5052929|NCT03667690|Candidemia|candidemia
5052930|NCT03667690|Fungemia|fungemia
5052931|NCT03667690|Sepsis|sepsis
5052932|NCT03667690|Invasive Fungal Infections|invasive fungal infections
5052933|NCT03667690|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5052934|NCT03667690|Pathologic Processes|pathologic processes
5052935|NCT03667690|Fluconazole|fluconazole
5052936|NCT03667690|Caspofungin|caspofungin
5951923|NCT03257098|Chronic Venous Ulcer|chronic venous ulcer
5951924|NCT03257098|ABCB5|abcb5
5951925|NCT03257098|Allogeneic|allogeneic
5951926|NCT03257098|Mesenchymal stem cells|mesenchymal stem cells
5951927|NCT03257098|varicose ulcer|varicose ulcer
5951928|NCT03257098|skin ulcer|skin ulcer
5951929|NCT03257098|advanced therapy medicinal product|advanced therapy medicinal product
5951930|NCT03257098|somatic cell therapy|somatic cell therapy
5951931|NCT03257098|phase I/IIa|phase i/iia
5951957|NCT03244514|cardiac surgery|cardiac surgery
5951958|NCT03244514|KDIGO-Guideline|kdigo-guideline
5951961|NCT03242057|NAVA|nava
5951962|NCT03242057|Extubation|extubation
5951963|NCT03242057|NIPPV|nippv
5951973|NCT03240237|HFpEF|hfpef
5256458|NCT02409914|PET|pet
5952062|NCT03225391|Residents|residents
5952063|NCT03225391|Naps|naps
5952064|NCT03225391|decision making|decision making
5952081|NCT03223272|hypertension|hypertension
5952082|NCT03223272|sympathetic tone|sympathetic tone
5952083|NCT03223272|resperpine|resperpine
5952120|NCT03219775|tailored immuno therapy|tailored immuno therapy
5952121|NCT03219775|Nivolumab|nivolumab
5256526|NCT02409576|EWS|ews
5952122|NCT03219775|Ipilimumab|ipilimumab
5952123|NCT03219775|boost|boost
5952135|NCT03218683|relapsed|relapsed
5952136|NCT03218683|refractory|refractory
5952137|NCT03218683|AZD5991|azd5991
5952138|NCT03218683|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5952139|NCT03218683|Richter syndrome|richter syndrome
5952140|NCT03218683|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5952141|NCT03218683|Small lymphocytic lymphoma|small lymphocytic lymphoma
5952142|NCT03218683|T-cell lymphoma, Multiple myeloma|t-cell lymphoma, multiple myeloma
5952143|NCT03218683|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5952144|NCT03218683|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5952145|NCT03218683|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5952166|NCT03210103|Transoral Surgery|transoral surgery
5952167|NCT03210103|Head and Neck Cancer|head and neck cancer
5952171|NCT03208010|health disparities|health disparities
5952172|NCT03208010|lifestyle behaviors|lifestyle behaviors
5952173|NCT03208010|diabetes prevention|diabetes prevention
5952174|NCT03208010|Hispanic health|hispanic health
5952195|NCT03204240|Spinal Cord Injury|spinal cord injury
5952196|NCT03204240|Skeletal Muscle|skeletal muscle
5952197|NCT03204240|Functional Electrical Stimulation|functional electrical stimulation
5952198|NCT03204240|Diabetes|diabetes
5952200|NCT03200860|heart failure|heart failure
5952201|NCT03200860|diuretic response|diuretic response
5952202|NCT03200860|empagliflozin|empagliflozin
5952203|NCT03200834|Right colon cancer|right colon cancer
5952204|NCT03200834|D3 dissection|d3 dissection
5952205|NCT03200834|complete mesocolic excision|complete mesocolic excision
5952206|NCT03200834|Hemicolectomy|hemicolectomy
5952210|NCT03200574|Perceval|perceval
5952211|NCT03199534|Pelvic Pain|pelvic pain
5952212|NCT03199534|Dyspareunia|dyspareunia
5952213|NCT03199534|Pelvic Floor Dysfunction|pelvic floor dysfunction
5952214|NCT03199534|Pelvic Floor Physical Therapy|pelvic floor physical therapy
5952215|NCT03199534|Chemodenervation|chemodenervation
5952216|NCT03199534|Botulinum Toxin A|botulinum toxin a
5952217|NCT03199534|Vaginismus|vaginismus
5952218|NCT03199053|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5952220|NCT03197194|Central retinal artery occlusion|central retinal artery occlusion
5952221|NCT03197194|visual acuity|visual acuity
5952222|NCT03197194|visual field|visual field
5952223|NCT03197194|mRs|mrs
5952224|NCT03197194|NEI-VFQ-25|nei-vfq-25
5952250|NCT03193437|Thymus|thymus
5952251|NCT03193437|Selinexor|selinexor
5952252|NCT03193437|KPT-330|kpt-330
5275493|NCT02300610|Ureter|ureter
5952276|NCT03187639|Coronary artery disease|coronary artery disease
5952277|NCT03187639|CT coronary angiography|ct coronary angiography
5952278|NCT03187639|FFRct|ffrct
5952279|NCT03187639|Rapid access chest pain clinic|rapid access chest pain clinic
5952280|NCT03187639|Stable chest pain|stable chest pain
5952281|NCT03187639|Resource utilisation|resource utilisation
5952282|NCT03187639|Quality of life|quality of life
5952289|NCT03186677|ISU304|isu304
5952290|NCT03186677|previously treated hemophilia B patients|previously treated hemophilia b patients
5952291|NCT03186677|FIX|fix
5952292|NCT03186677|Factor IX|factor ix
5952293|NCT03186677|CB2679d|cb2679d
5952302|NCT03181763|MDMA|mdma
5952303|NCT03181763|Startle response|startle response
5952304|NCT03181763|sleep|sleep
5952305|NCT03181763|Oxytocin|oxytocin
5244351|NCT02477995|Safety|safety
5952382|NCT03164772|mRNA Vaccine|mrna vaccine
5952383|NCT03164772|Durvalumab|durvalumab
5952384|NCT03164772|MEDI4736|medi4736
5952385|NCT03164772|anti-PD-L1|anti-pd-l1
5952386|NCT03164772|tremelimumab|tremelimumab
5952388|NCT03164772|BI 1361849|bi 1361849
5952424|NCT03155997|early stage breast cancer|early stage breast cancer
5952425|NCT03155997|cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
5952426|NCT03155243|Humira®|humira®
5952427|NCT03155243|Adalimumab|adalimumab
5952428|NCT03155243|Ocular inflammation|ocular inflammation
5952429|NCT03155243|Active non-infectious intermediate, posterior and panuveitis|active non-infectious intermediate, posterior and panuveitis
5952477|NCT03136861|axial spondyloarthritis|axial spondyloarthritis
5952478|NCT03136861|ankylosing spondylitis|ankylosing spondylitis
5952479|NCT03136861|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
5952480|NCT03136861|inflammatory back pain|inflammatory back pain
5952481|NCT03136861|spinal pain|spinal pain
5952482|NCT03136861|secukinumab|secukinumab
5952483|NCT03136861|AIN457|ain457
5952497|NCT03136263|Attention|attention
5952498|NCT03136263|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
5952499|NCT03136263|Cognitive control|cognitive control
5952500|NCT03136263|Executive control|executive control
5952501|NCT03136263|Executive functions|executive functions
5952502|NCT03136263|Impulse control|impulse control
5952503|NCT03136263|Impulsivity|impulsivity
5952504|NCT03136263|Oxytocin|oxytocin
5952775|NCT03084471|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
5952776|NCT03084471|Cytotoxic T-lymphocyte antigen-4 (CTLA-4)|cytotoxic t-lymphocyte antigen-4 (ctla-4)
5952777|NCT03084471|Durvalumab in combination with tremelimumab|durvalumab in combination with tremelimumab
5244726|NCT02475824|ERCP|ercp
5952889|NCT03061812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5952890|NCT03061812|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
5952891|NCT03061812|rovalpituzumab tesirine|rovalpituzumab tesirine
5952892|NCT03061812|topotecan|topotecan
5952893|NCT03061812|metastatic|metastatic
5952898|NCT03060434|pentoxifylline|pentoxifylline
5952899|NCT03060434|Disc hernia|disc hernia
5952900|NCT03060434|sciatica|sciatica
5952901|NCT03060434|lumbar radiculopathy|lumbar radiculopathy
5952923|NCT03052920|cochlear implant|cochlear implant
5952924|NCT03052920|asymmetric hearing loss|asymmetric hearing loss
5952969|NCT03041532|retroflexion proximal|retroflexion proximal
5952970|NCT03041532|colorectal cancer screening programme|colorectal cancer screening programme
5952971|NCT03041532|adenoma detection rate|adenoma detection rate
5952972|NCT03041532|right colon|right colon
5244860|NCT02474992|HIV|hiv
5953035|NCT03035266|blood flow restriction|blood flow restriction
5953036|NCT03035266|strength|strength
5953037|NCT03035266|muscle atrophy|muscle atrophy
5953038|NCT03035266|post-operative therapy|post-operative therapy
5953039|NCT03035266|knee|knee
5953050|NCT03031639|endoscopic|endoscopic
5953051|NCT03031639|thyroidectomy|thyroidectomy
5953073|NCT03027284|Neoplasm|neoplasm
5953113|NCT03016884|Herpes Zoster|herpes zoster
5953114|NCT03016884|anti TNF alpha|anti tnf alpha
5953115|NCT03016884|tofacitinib|tofacitinib
5953116|NCT03016884|Rheumatoid Arthritis|rheumatoid arthritis
5953135|NCT03015610|Personalized Medicine|personalized medicine
5953136|NCT03015610|CYP2C19|cyp2c19
5953137|NCT03015610|Lansoprazole|lansoprazole
5953138|NCT03015610|Pharmacokinetics|pharmacokinetics
5953204|NCT02989805|Emergency Medicine|emergency medicine
5953205|NCT02989805|Psychiatry|psychiatry
5953206|NCT02989805|Health Promotion|health promotion
5953207|NCT02989805|Public Health|public health
5052937|NCT03667690|Echinocandins|echinocandins
5052938|NCT03667690|Antifungal Agents|antifungal agents
5052939|NCT03667690|Anti-infective Agents|anti-infective agents
5052940|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
5052941|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors
5052942|NCT03667690|Enzyme Inhibitors|enzyme inhibitors
5052943|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5052944|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors
5052945|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs
5052946|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors
5052947|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors
5052948|NCT03667677|Hypertension|hypertension
5052949|NCT03667677|Anxiety|anxiety
5052950|NCT03667677|Tandospirone|tandospirone
5052951|NCT03667677|Amlodipine|amlodipine
5052952|NCT03667664|Autonomy|autonomy
5052953|NCT03667664|Elderly|elderly
5052954|NCT03667664|Physical exercise|physical exercise
5053391|NCT03664960|EG|eg
5052965|NCT03667573|aging|aging
5052966|NCT03667573|walking|walking
5052967|NCT03667573|spinal cord|spinal cord
5052968|NCT03667573|electrical stimulation|electrical stimulation
5052969|NCT03667560|Mastectomy|mastectomy
5052970|NCT03667560|Breast Reconstruction|breast reconstruction
5052971|NCT03667560|Acellular dermal matrix|acellular dermal matrix
5052972|NCT03667534|cholestasis|cholestasis
5052973|NCT03667534|new born screening|new born screening
5052974|NCT03667534|dry blood spot|dry blood spot
5052975|NCT03667534|biliary atresia|biliary atresia
5052976|NCT03667495|microbiota|microbiota
5052977|NCT03667495|colorectal cancer|colorectal cancer
5052978|NCT03667495|recurrence|recurrence
5052979|NCT03667482|Cabozantinib|cabozantinib
5052980|NCT03667482|Cetuximab|cetuximab
5052981|NCT03667482|18-303|18-303
5052982|NCT03667469|Obesity|obesity
5052983|NCT03667469|Bariatric surgery|bariatric surgery
5052984|NCT03667469|Ospanov's procedure|ospanov's procedure
5052986|NCT03667469|Band-separated gastric bypass|band-separated gastric bypass
5052987|NCT03667469|Weight loss therapy|weight loss therapy
5052988|NCT03667469|Metabolic syndrom|metabolic syndrom
5052989|NCT03667469|Life expectancy|life expectancy
5052990|NCT03667469|Telomere lenght|telomere lenght
5052991|NCT03667469|Hypocaloric diet|hypocaloric diet
5052992|NCT03667456|Parkinson|parkinson
5052993|NCT03667456|Serious Game|serious game
5052994|NCT03667456|Self management|self management
5052995|NCT03667456|Rehabilitation|rehabilitation
5052996|NCT03667456|Telemedicine|telemedicine
5052997|NCT03667443|myo-inositol|myo-inositol
5052998|NCT03667443|alpha-lactalbumin|alpha-lactalbumin
5052999|NCT03667443|polycystic ovary syndrome|polycystic ovary syndrome
5053000|NCT03667443|anovulation|anovulation
5053001|NCT03667443|infertility|infertility
5053002|NCT03667417|BRCA gene mutation|brca gene mutation
5053003|NCT03667404|Resistant maltodextrin|resistant maltodextrin
5053004|NCT03667404|dietary fiber|dietary fiber
5053005|NCT03667404|gut microbiome|gut microbiome
5053006|NCT03667404|Parkinson's disease|parkinson's disease
5053007|NCT03667391|Chronic ThromboEmbolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5053008|NCT03667378|Quality of Life|quality of life
5053009|NCT03667378|Supportive Care|supportive care
5053010|NCT03667378|18-363|18-363
5053011|NCT03667365|severe aortic valve stenosis|severe aortic valve stenosis
5053012|NCT03667365|low gradient|low gradient
5053013|NCT03667365|preserved left ventricular ejection fraction|preserved left ventricular ejection fraction
5053014|NCT03667365|symptomatic patients|symptomatic patients
5053015|NCT03667352|Scalp block|scalp block
5053016|NCT03667352|Transversus abdominis plane block|transversus abdominis plane block
5053017|NCT03667352|Ropivacaine|ropivacaine
5053018|NCT03667352|Clonidine|clonidine
5053019|NCT03667326|Aspirin|aspirin
5960943|NCT04290169|Botulinum Toxin A|botulinum toxin a
5053020|NCT03667313|in-stent restenosis; sirolimus-; paclitaxel-eluting balloon|in-stent restenosis; sirolimus-; paclitaxel-eluting balloon
5053021|NCT03667300|Type2 Diabetes Mellitus|type2 diabetes mellitus
5053022|NCT03667300|Intervention|intervention
5053023|NCT03667300|Albuminuria|albuminuria
5053024|NCT03667274|aortic valve replacement|aortic valve replacement
5053025|NCT03667274|mitral valve reconstruction|mitral valve reconstruction
5053026|NCT03667274|mitral valve replacement|mitral valve replacement
5053027|NCT03667248|PERCEVAL® sutureless aortic valve prosthesis|perceval® sutureless aortic valve prosthesis
5053028|NCT03667248|aortic valve stenosis|aortic valve stenosis
5053029|NCT03667248|aortic valve replacement|aortic valve replacement
5953311|NCT02962414|Everolimus|everolimus
5953481|NCT02928055|Stroke|stroke
5953482|NCT02928055|Shoulder Pain|shoulder pain
5953483|NCT02928055|Electrical stimulation|electrical stimulation
5953484|NCT02928055|Neuromuscular stimulation|neuromuscular stimulation
5953485|NCT02928055|Intramuscular stimulation|intramuscular stimulation
5953511|NCT02925871|stroke|stroke
5953512|NCT02925871|rehabilitation|rehabilitation
5953513|NCT02925871|interdisciplinary health team|interdisciplinary health team
5953514|NCT02925871|patient-centered care|patient-centered care
5953515|NCT02925871|care transition|care transition
5953525|NCT02923726|Antitachycardia Pacing Therapy|antitachycardia pacing therapy
5953526|NCT02923726|Shock Therapy|shock therapy
5953527|NCT02923726|Primary Prevention|primary prevention
5276868|NCT02292823|PCI|pci
5953567|NCT02918305|denervation|denervation
5953568|NCT02918305|resistant hypertension|resistant hypertension
5953569|NCT02917954|eHealth/mHealth solutions|ehealth/mhealth solutions
5953570|NCT02917954|complex care needs|complex care needs
5953571|NCT02917954|seniors|seniors
5953572|NCT02917954|patient-centred care|patient-centred care
5953573|NCT02917954|goal-oriented care|goal-oriented care
5953574|NCT02917954|primary health care|primary health care
5953575|NCT02917954|implementation|implementation
5953576|NCT02917954|pragmatic trial|pragmatic trial
5953577|NCT02917954|health outcomes|health outcomes
5953578|NCT02917954|cost-effectiveness analysis|cost-effectiveness analysis
5257858|NCT02401802|Diet|diet
5953585|NCT02917031|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5953586|NCT02917031|Heart Failure|heart failure
5953587|NCT02917031|Saxagliptin|saxagliptin
5953588|NCT02917031|Sitagliptin|sitagliptin
5953620|NCT02901925|ABY-029|aby-029
5953621|NCT02901925|Affibody|affibody
5953622|NCT02901925|Molecular Fluorescence-Guided Surgery|molecular fluorescence-guided surgery
5953623|NCT02901925|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5369115|NCT01861288|Treatment algorithm|treatment algorithm
5369116|NCT01861275|osa|osa
5369117|NCT01861275|cerebral palsy|cerebral palsy
5953653|NCT02898077|Second line|second line
5953654|NCT02898077|Angiogenesis|angiogenesis
5953655|NCT02898077|Vascular endothelial growth factor receptor 2|vascular endothelial growth factor receptor 2
5953663|NCT02890615|Survivors|survivors
5953664|NCT02890615|Self Care|self care
5953672|NCT02888067|Neuromuscular Blockade|neuromuscular blockade
5380417|NCT01810614|PKD|pkd
5953762|NCT02867020|apalutamide|apalutamide
5953763|NCT02867020|abiraterone|abiraterone
5953764|NCT02867020|prostate cancer|prostate cancer
5953813|NCT02855554|myocardial tissue characterization|myocardial tissue characterization
5257986|NCT02401061|ITP|itp
5953849|NCT02837458|Electric current|electric current
5953850|NCT02837458|Nerve block|nerve block
5953851|NCT02837458|somatosensory evaluation|somatosensory evaluation
5953857|NCT02833207|blood flow|blood flow
5953858|NCT02833207|vasodilation|vasodilation
5953859|NCT02833207|Doppler Ultrasound|doppler ultrasound
5953860|NCT02833207|endothelium dependent dilation|endothelium dependent dilation
5953907|NCT02817802|Registry|registry
5953908|NCT02817802|Magmaris|magmaris
5953909|NCT02817802|Coronary Artery Disease|coronary artery disease
5953910|NCT02817802|PCI|pci
5953928|NCT02808780|Ulcerative Colitis|ulcerative colitis
5953929|NCT02808780|Simponi (Golimumab)|simponi (golimumab)
5953930|NCT02808780|Thiopurines|thiopurines
5953931|NCT02808780|Lymphoma|lymphoma
5953932|NCT02808780|Malignancies|malignancies
5258061|NCT02400515|Exercise|exercise
5953964|NCT02798458|Fabry's Disease|fabry's disease
5953965|NCT02798458|Fabry|fabry
5258196|NCT02399657|implant|implant
5954080|NCT02766881|Ductal Carcinoma in Situ|ductal carcinoma in situ
5954081|NCT02766881|DSC|dsc
5954082|NCT02766881|Breast Conserving Surgery|breast conserving surgery
5277463|NCT02289716|Pain|pain
5055661|NCT03650816|Neurodegenerative Diseases|neurodegenerative diseases
5055662|NCT03650816|Cerebrovascular reactivity|cerebrovascular reactivity
5055663|NCT03650816|Doppler ultrasonography|doppler ultrasonography
5055664|NCT03650816|Biomarker|biomarker
5055665|NCT03650816|Endothelin-1|endothelin-1
5055666|NCT03650816|Big-Endothelin-1|big-endothelin-1
5055667|NCT03650816|ADMA|adma
5055668|NCT03650816|Renin|renin
5055669|NCT03650803|3D MR Fingerprinting|3d mr fingerprinting
5056049|NCT03648502|dementia|dementia
5055671|NCT03650790|CTRP|ctrp
5055672|NCT03650790|Adipocytokines|adipocytokines
5055673|NCT03650790|pre-eclampsia|pre-eclampsia
5055674|NCT03650751|stroke；nursing assessment；condition of a patient；deterioration；|stroke；nursing assessment；condition of a patient；deterioration；
5055675|NCT03650725|Colonoscopy|colonoscopy
5055676|NCT03650725|bowel preparation|bowel preparation
5055677|NCT03650712|cystic fibrosis|cystic fibrosis
5055678|NCT03650712|insulin|insulin
5055679|NCT03650712|glucose|glucose
5055680|NCT03650712|children|children
5055681|NCT03650712|abnormal glucose tolerance|abnormal glucose tolerance
5055682|NCT03650712|impaired glucose tolerance|impaired glucose tolerance
5055683|NCT03650712|indeterminate glycemia|indeterminate glycemia
5055684|NCT03650712|diabetes|diabetes
5055685|NCT03650699|Oral Cavity Squamous Cell Carcinoma|oral cavity squamous cell carcinoma
5055686|NCT03650699|Biofeedback|biofeedback
5055687|NCT03650699|Rehabilitation|rehabilitation
5055688|NCT03650699|Head and Neck Cancer|head and neck cancer
5055689|NCT03650699|electropalatography|electropalatography
5055690|NCT03650699|EPG|epg
5055691|NCT03650673|Hand osteoarthritis|hand osteoarthritis
5055692|NCT03650673|Prospective cohort|prospective cohort
5055693|NCT03650673|Cartilage|cartilage
5055694|NCT03650673|Mobility|mobility
5055695|NCT03650647|Dental caries|dental caries
5055696|NCT03650647|Dentin|dentin
5055697|NCT03650647|Pulp exposure prevention|pulp exposure prevention
5055698|NCT03650647|Deep caries lesion|deep caries lesion
5055699|NCT03650647|Conservative Treatment|conservative treatment
5055705|NCT03650595|Focal Laser Ablation|focal laser ablation
5055706|NCT03650595|MR-Guided Focal Laser Ablation|mr-guided focal laser ablation
5960962|NCT04290065|Soccer|soccer
5960963|NCT04290065|Flexibility|flexibility
5055707|NCT03650582|food intake|food intake
5055708|NCT03650582|energy expenditure|energy expenditure
5055709|NCT03650582|central nervous system|central nervous system
5055710|NCT03650582|appetite|appetite
5055711|NCT03650569|Angelman Syndrome|angelman syndrome
5055712|NCT03650569|Caregivers|caregivers
5055713|NCT03650569|Parents|parents
5055714|NCT03650569|Rare diseases|rare diseases
5055715|NCT03650569|Registries|registries
5055716|NCT03650530|Family-centred intervention|family-centred intervention
5055717|NCT03650530|Support program|support program
5055718|NCT03650530|The Family Talk Intervention|the family talk intervention
5055719|NCT03650517|Laparoscopic|laparoscopic
5055720|NCT03650517|Robotic|robotic
5055721|NCT03650517|Right colon tumor|right colon tumor
5055722|NCT03650517|Anastomosis|anastomosis
5055767|NCT03650348|CD137|cd137
5055768|NCT03650348|HER2|her2
5055769|NCT03650348|Atezolizumab|atezolizumab
5055770|NCT03650335|erector spine plan block|erector spine plan block
5055771|NCT03650335|postoperative opioid consumption|postoperative opioid consumption
5055772|NCT03650335|thoracotomy|thoracotomy
5055773|NCT03650335|analgesia|analgesia
5055774|NCT03650335|anesthesia|anesthesia
5055775|NCT03650309|Deep Brain Stimulation|deep brain stimulation
5055776|NCT03650309|Functional Neurosurgery|functional neurosurgery
5055777|NCT03650309|Neuromodulation|neuromodulation
5055778|NCT03650309|Bariatrics|bariatrics
5055779|NCT03650309|Weight Loss|weight loss
5055780|NCT03650309|Addiction|addiction
5055781|NCT03650257|supratentorial glioma|supratentorial glioma
5954121|NCT02750319|Amiodarone|amiodarone
5954230|NCT02722746|Epidural Analgesia|epidural analgesia
5954277|NCT02706951|Musculoskeletal Disease|musculoskeletal disease
5954278|NCT02706951|Arthritis|arthritis
5954279|NCT02706951|Joint Disease|joint disease
5954280|NCT02706951|anti-inflammatory agents|anti-inflammatory agents
5954281|NCT02706951|antirheumatic agents|antirheumatic agents
5954305|NCT02699645|Blood Pressure (BP)|blood pressure (bp)
5954306|NCT02699645|Stroke|stroke
5954368|NCT02687009|colon cancer|colon cancer
5954369|NCT02687009|Wnt pathway|wnt pathway
5954370|NCT02687009|Frizzled|frizzled
5954380|NCT02680834|venous stasis ulcer|venous stasis ulcer
5954381|NCT02680834|wound|wound
5954382|NCT02680834|chronic venous insufficiency|chronic venous insufficiency
5954393|NCT02677896|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
5954394|NCT02677896|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
5954395|NCT02677896|Xtandi|xtandi
5954396|NCT02677896|Enzalutamide|enzalutamide
5954401|NCT02675426|Musculoskeletal Disease|musculoskeletal disease
5954402|NCT02675426|Arthritis|arthritis
5954403|NCT02675426|Joint Disease|joint disease
5954404|NCT02675426|Anti-inflammatory agents|anti-inflammatory agents
5954405|NCT02675426|Antirheumatic agents|antirheumatic agents
5954406|NCT02675426|Upadacitinib|upadacitinib
5954407|NCT02671071|Cervix Cancer|cervix cancer
5954412|NCT02669966|Kidney Transplantation|kidney transplantation
5954413|NCT02669589|CRRT|crrt
5954414|NCT02669589|AKI|aki
5954415|NCT02669589|anticoagulation|anticoagulation
5954416|NCT02669589|KDIGO|kdigo
5258465|NCT02398032|sleep apnea|sleep apnea
5258466|NCT02398032|hypertension|hypertension
5954464|NCT02648737|Parkinson's disease|parkinson's disease
5954465|NCT02648737|Cognitive Behavioural therapy|cognitive behavioural therapy
5954466|NCT02648737|generalized anxiety disorder|generalized anxiety disorder
5954467|NCT02648737|social phobia|social phobia
5954468|NCT02648737|cerebral connectivity|cerebral connectivity
5954578|NCT02625389|scheduled for selective transarterial catheterization|scheduled for selective transarterial catheterization
5954604|NCT02616484|Sodium Dichloroacetate|sodium dichloroacetate
5954605|NCT02616484|Treatment of PDCD with Dichloroacetate|treatment of pdcd with dichloroacetate
5053030|NCT03667248|preoperative CT scan of the heart|preoperative ct scan of the heart
5053031|NCT03667235|OZAKI technique|ozaki technique
5053032|NCT03667170|MSI-H|msi-h
5053033|NCT03667170|dMMR|dmmr
5053034|NCT03667170|Colorectal cancer|colorectal cancer
5053035|NCT03667170|Non-Colorectal Cancers|non-colorectal cancers
5053036|NCT03667157|Graves Disease|graves disease
5053037|NCT03667157|Graves Ophthalmopathy|graves ophthalmopathy
5053038|NCT03667157|Dysthyroid Orbitopathy|dysthyroid orbitopathy
5053039|NCT03667157|Liver Failure|liver failure
5053040|NCT03667157|Liver Injury|liver injury
5053041|NCT03667157|Acute Liver Failure|acute liver failure
5053042|NCT03667157|Acute Liver Injury|acute liver injury
5053043|NCT03667157|Methylprednisolone|methylprednisolone
5053044|NCT03667157|Glucocorticoids|glucocorticoids
5053045|NCT03667157|Glucocorticoids Toxicity|glucocorticoids toxicity
5053047|NCT03667157|Side effects|side effects
5053048|NCT03667157|Adverse effects|adverse effects
5053049|NCT03667157|Aminotransferase|aminotransferase
5053050|NCT03667144|Double inlet left ventricle without Fontan circulation|double inlet left ventricle without fontan circulation
5053051|NCT03667131|arterial stiffness|arterial stiffness
5053052|NCT03667131|enalapril maleate|enalapril maleate
5053053|NCT03667092|Lu-177 Dotatate|lu-177 dotatate
5053054|NCT03667092|transcript analysis and variation|transcript analysis and variation
5053055|NCT03667092|molecular biomarkers|molecular biomarkers
5053056|NCT03667092|midgut neuroendocrine tumors|midgut neuroendocrine tumors
5053057|NCT03667053|Glucagon|glucagon
5053058|NCT03667027|Diaphragm Dysfunction|diaphragm dysfunction
5053059|NCT03667027|Acute Respiratory Failure|acute respiratory failure
5053060|NCT03667027|Mechanical Ventilation|mechanical ventilation
5053061|NCT03667014|atopic dermatitis|atopic dermatitis
5053062|NCT03667014|eczema|eczema
5053063|NCT03667014|dupilumab|dupilumab
5053064|NCT03667001|systemic lidocain|systemic lidocain
5053065|NCT03666988|Dose-escalation|dose-escalation
5053066|NCT03666988|First time in humans|first time in humans
5053067|NCT03666988|Solid tumors|solid tumors
5053068|NCT03666988|GSK3368715|gsk3368715
5053069|NCT03666988|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5053070|NCT03666975|Low intensity vibration|low intensity vibration
5053071|NCT03666975|Paediatric bone growth|paediatric bone growth
5053072|NCT03666949|chronic subdural hematoma|chronic subdural hematoma
5053073|NCT03666949|general anesthesia|general anesthesia
5053074|NCT03666949|locoregional anesthesia|locoregional anesthesia
5053075|NCT03666949|length of stay|length of stay
5053076|NCT03666936|Cancer survivors|cancer survivors
5053077|NCT03666936|Return to work|return to work
5053078|NCT03666936|Italy|italy
5053079|NCT03666936|Occupational Therapy|occupational therapy
5053080|NCT03666936|Comprehensive Health Care|comprehensive health care
5053081|NCT03666936|Neoplasm|neoplasm
5053082|NCT03666884|dry eye|dry eye
5053083|NCT03666884|autologous serum|autologous serum
5053084|NCT03666884|cyclosporine ophthalmic emulsion|cyclosporine ophthalmic emulsion
5053085|NCT03666858|Drug Therapy|drug therapy
5053086|NCT03666806|Sickle cell anaemia, stroke, preventing, children, Uganda|sickle cell anaemia, stroke, preventing, children, uganda
5053088|NCT03666793|Medication Reconciliation|medication reconciliation
5053089|NCT03666793|Patient Readmission|patient readmission
5053090|NCT03666780|Left atrial appendage occluder|left atrial appendage occluder
5053091|NCT03666754|Venous Leg Ulcer|venous leg ulcer
5053092|NCT03666754|Glue embolization|glue embolization
5053093|NCT03666754|saphenous vein reflux|saphenous vein reflux
5053094|NCT03666741|Heart Valve Diseases|heart valve diseases
5053095|NCT03666741|Heart Diseases|heart diseases
5053096|NCT03666741|Cardiovascular Diseases|cardiovascular diseases
5053097|NCT03666741|Surgical valve|surgical valve
5053098|NCT03666702|upper limb|upper limb
5053099|NCT03666702|physiotherapy|physiotherapy
5053100|NCT03666702|web-based|web-based
5053101|NCT03666637|Adult|adult
5053102|NCT03666637|avascular necrosis|avascular necrosis
5053103|NCT03666637|Complications|complications
5053104|NCT03666637|Delayed fixation|delayed fixation
5053105|NCT03666637|nonunion|nonunion
5053106|NCT03666637|Surgical timing|surgical timing
5053107|NCT03666637|Pauwels|pauwels
5053108|NCT03666624|LGBT|lgbt
5053109|NCT03666611|Dementia|dementia
5053110|NCT03666611|End of Life|end of life
5053111|NCT03666611|Palliative|palliative
5053112|NCT03666598|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5053113|NCT03666598|Tourniquets|tourniquets
5053114|NCT03666598|Pain, postoperative|pain, postoperative
5053411|NCT03664843|lung cancer|lung cancer
5053126|NCT03666546|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5053127|NCT03666546|Lactulose|lactulose
5053128|NCT03666546|Constipation|constipation
5053129|NCT03666546|Oral intake|oral intake
5053130|NCT03666533|Gait therapy|gait therapy
5053131|NCT03666533|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5954717|NCT02588651|Lymphoma|lymphoma
5954718|NCT02588651|Leukemia|leukemia
5954719|NCT02588651|Brentuximab Vedotin|brentuximab vedotin
5954727|NCT02582957|ARDS|ards
5954728|NCT02582957|Shock Lung|shock lung
5954729|NCT02582957|Acute Chest Syndrome|acute chest syndrome
5954730|NCT02582957|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5954731|NCT02582957|Respiratory insufficiency|respiratory insufficiency
5954732|NCT02582957|Trauma|trauma
5954784|NCT02572687|metastatic|metastatic
5954785|NCT02572687|advanced|advanced
5954786|NCT02572687|immuno-oncology|immuno-oncology
5954787|NCT02572687|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5954788|NCT02572687|angiogenesis|angiogenesis
5954789|NCT02572687|PD-1|pd-1
5954790|NCT02572687|PD-L1|pd-l1
5954813|NCT02564432|amputee|amputee
5954814|NCT02564198|relapsed pediatric solid tumors|relapsed pediatric solid tumors
5954815|NCT02564198|unspecified childhood solid tumor|unspecified childhood solid tumor
5954816|NCT02564198|brain and central nervous system tumors|brain and central nervous system tumors
5258775|NCT02396095|cancer|cancer
5954877|NCT02545049|Type 2 Diabetes|type 2 diabetes
5954878|NCT02545049|Kidney diseases|kidney diseases
5954879|NCT02544880|HNSCC|hnscc
5954880|NCT02544880|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5954881|NCT02544880|Tadalafil|tadalafil
5954882|NCT02544880|PDE5 Inhibition|pde5 inhibition
5954883|NCT02544880|Anti-MUC1 Vaccine|anti-muc1 vaccine
5954884|NCT02544880|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
5954885|NCT02544880|Recurrent HNSCC|recurrent hnscc
5954886|NCT02544880|Second primary site disease stage III|second primary site disease stage iii
5954887|NCT02544880|Second primary site disease stage IV|second primary site disease stage iv
5954888|NCT02544880|Anti-Influenza Vaccine|anti-influenza vaccine
5954932|NCT02530073|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5954933|NCT02530073|FETO|feto
5954934|NCT02530073|tracheal occlusion|tracheal occlusion
5258878|NCT02395341|cancer survivors|cancer survivors
5954969|NCT02517723|Borderline Personality Disorder|borderline personality disorder
5954970|NCT02517723|comorbid Posttraumatic Stress Disorder|comorbid posttraumatic stress disorder
5954971|NCT02517723|Narrative Exposure Therapy|narrative exposure therapy
5954972|NCT02517723|Dialectical-Behavioral Therapy|dialectical-behavioral therapy
5955007|NCT02508454|Prevention|prevention
5955008|NCT02508454|Screening|screening
5955009|NCT02508454|Biobanking|biobanking
5265797|NCT02355457|AMI|ami
5955044|NCT02487654|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5955045|NCT02487654|Pulmonary vein isolation|pulmonary vein isolation
5955046|NCT02487654|Ganglionated plexus|ganglionated plexus
5955047|NCT02487654|Radiofrequency ablation|radiofrequency ablation
5955048|NCT02487654|Pulmonary vein ectopy|pulmonary vein ectopy
5955049|NCT02487654|High frequency stimulation|high frequency stimulation
5955050|NCT02487654|autonomic nervous system|autonomic nervous system
5955051|NCT02487654|Ganglionated plexi|ganglionated plexi
5955052|NCT02487654|atrial fibrillation|atrial fibrillation
5955058|NCT02485860|pilonidal cysts|pilonidal cysts
5955059|NCT02485860|Cavity wound|cavity wound
5955060|NCT02485860|long healing|long healing
5955061|NCT02485860|honey|honey
5955068|NCT02485600|Cadence|cadence
5955069|NCT02485600|Duodopa|duodopa
5955070|NCT02485600|Parkinson's disease|parkinson's disease
5955071|NCT02485600|LCIG|lcig
5955072|NCT02485600|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5955073|NCT02485600|Observational|observational
5955195|NCT02451111|Rituximab|rituximab
5955196|NCT02451111|Ibrutinib|ibrutinib
5955197|NCT02451111|Follicular Lymphoma|follicular lymphoma
5955214|NCT02443324|immuno-oncology|immuno-oncology
5955215|NCT02443324|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5955216|NCT02443324|angiogenesis|angiogenesis
5955217|NCT02443324|PD-1|pd-1
5955218|NCT02443324|carcinoma of the bladder|carcinoma of the bladder
5955219|NCT02443324|carcinoma of the urethra|carcinoma of the urethra
5955220|NCT02443324|carcinoma of the ureter|carcinoma of the ureter
5955221|NCT02443324|carcinoma of the renal pelvis|carcinoma of the renal pelvis
5955222|NCT02443324|carcinoma of the biliary tract|carcinoma of the biliary tract
5955241|NCT02428985|Riociguat|riociguat
5955242|NCT02428985|Adempas|adempas
5955243|NCT02428985|soluble guanylate cyclase (sGC) stimulator|soluble guanylate cyclase (sgc) stimulator
5955244|NCT02428985|Pulmonary arterial hypertension|pulmonary arterial hypertension
5955245|NCT02428985|Japan|japan
5955246|NCT02428985|Post-marketing surveillance|post-marketing surveillance
5053132|NCT03666533|Neuroplasticity|neuroplasticity
5053133|NCT03666533|walking ability|walking ability
5053134|NCT03666533|brain stimulation|brain stimulation
5053135|NCT03666533|virtual reality|virtual reality
5053136|NCT03666520|medication administration, IV to PO conversion|medication administration, iv to po conversion
5053137|NCT03666520|IV to PO conversion|iv to po conversion
5053138|NCT03666481|Sleeve gastrectomy|sleeve gastrectomy
5053139|NCT03666481|Accelerometer|accelerometer
5053140|NCT03666481|Exercise|exercise
5053141|NCT03666481|Self-determination theory|self-determination theory
5053142|NCT03666481|Morbid obesity|morbid obesity
5053143|NCT03666442|rectal cancer；|rectal cancer；
5053144|NCT03666442|neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5053145|NCT03666403|airway pressure|airway pressure
5053146|NCT03666403|bronchomalacia|bronchomalacia
5053147|NCT03666403|tracheomalacia|tracheomalacia
5053148|NCT03666403|positive pressure ventilation|positive pressure ventilation
5053155|NCT03666351|Aortic Regurgitation|aortic regurgitation
5053156|NCT03666351|Hypertension|hypertension
5053158|NCT03666351|Left Ventricular Hypertrophy|left ventricular hypertrophy
5053159|NCT03666338|early mobilization|early mobilization
5053160|NCT03666325|metastatic squamous cell cancer of the skin|metastatic squamous cell cancer of the skin
5053161|NCT03666325|skin neoplasm|skin neoplasm
5053162|NCT03666325|locally advanced squamous cell cancer of the skin|locally advanced squamous cell cancer of the skin
5053163|NCT03666325|immunotherapy|immunotherapy
5053164|NCT03666325|pembrolizumab|pembrolizumab
5053165|NCT03666325|cetuximab|cetuximab
5053166|NCT03666312|Enteric microbiome|enteric microbiome
5053167|NCT03666312|Liver transplantation|liver transplantation
5053168|NCT03666299|postthoracotomy pain syndrome|postthoracotomy pain syndrome
5053169|NCT03666299|chronic pain|chronic pain
5053170|NCT03666299|lidocaine|lidocaine
5053171|NCT03666286|early mobilization, intensive care, longterm outcomes|early mobilization, intensive care, longterm outcomes
5053172|NCT03666273|Neoplasm|neoplasm
5053173|NCT03666273|Immuno oncology drug|immuno oncology drug
5053174|NCT03666273|Urothelial cancer|urothelial cancer
5053175|NCT03666273|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5053176|NCT03666273|Cervical cancer|cervical cancer
5053177|NCT03666273|Gastric/ Gastroesophageal junction adenocarcinoma|gastric/ gastroesophageal junction adenocarcinoma
5053178|NCT03666260|Total hip replacement surgery|total hip replacement surgery
5053179|NCT03666260|post operative pain|post operative pain
5053180|NCT03666260|quadratus lumborum block|quadratus lumborum block
5053181|NCT03666260|femoral block|femoral block
5053187|NCT03666234|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5053188|NCT03666234|Epidemiology|epidemiology
5053189|NCT03666234|Nature History|nature history
5053190|NCT03666221|Nimotuzumab|nimotuzumab
5053191|NCT03666221|IMRT|imrt
5053192|NCT03666221|Radiation|radiation
5053193|NCT03666221|Recurrent|recurrent
5053194|NCT03666221|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5053195|NCT03666195|Nanoparticles|nanoparticles
5053196|NCT03666195|Titanium dioxide|titanium dioxide
5053197|NCT03666195|biofilm|biofilm
5053198|NCT03666195|self cleansing|self cleansing
5053199|NCT03666195|denture plaque|denture plaque
5053200|NCT03666195|anti microbial|anti microbial
5053201|NCT03666091|ESPOIR cohort Rheumatoid arthritis Early arthritis Undifferentiated arthritis|espoir cohort rheumatoid arthritis early arthritis undifferentiated arthritis
5053202|NCT03666052|children and adolescent|children and adolescent
5053203|NCT03666052|high myopia|high myopia
5053204|NCT03666052|prospective study|prospective study
5053205|NCT03666026|Reminder Recall (R/R)|reminder recall (r/r)
5053206|NCT03666026|Influenza Vaccine|influenza vaccine
5053207|NCT03666026|Electronic Health Record|electronic health record
5053208|NCT03666013|Mitochondrial health|mitochondrial health
5053211|NCT03665974|Pregnancy, deficinecy, vitamin D, diabetes, gestational|pregnancy, deficinecy, vitamin d, diabetes, gestational
5053213|NCT03665961|metabolic syndrome|metabolic syndrome
5053214|NCT03665961|ethnicity|ethnicity
5053215|NCT03665961|dietary components|dietary components
5053216|NCT03665948|Sports Nutrition|sports nutrition
5053217|NCT03665948|Ketogenic Diet|ketogenic diet
5053218|NCT03665948|Low Glycemic Index Diet|low glycemic index diet
5053219|NCT03665948|Crossfit|crossfit
5053220|NCT03665948|Physical capacity|physical capacity
5053221|NCT03665948|Performance|performance
5053222|NCT03665948|Exercise metabolism|exercise metabolism
5053223|NCT03665948|Training support|training support
5053224|NCT03665922|prostatectomy|prostatectomy
5053225|NCT03665896|double-lumen endotracheal tube|double-lumen endotracheal tube
5259184|NCT02393222|ESRD|esrd
5955425|NCT02369549|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5955426|NCT02369549|Micro-particle curcumin|micro-particle curcumin
5955427|NCT02369549|Albuminuria|albuminuria
5955430|NCT02365467|TEVAR|tevar
5955431|NCT02365467|Thoracic Aneurysm|thoracic aneurysm
5955432|NCT02365467|Endovascular Aortic Repair|endovascular aortic repair
5955433|NCT02365467|Type B Dissection|type b dissection
5259273|NCT02392767|vitamin B|vitamin b
5955503|NCT02344004|ALIS|alis
5955504|NCT02344004|ARIKAYCE|arikayce
5955567|NCT02328287|Spinal Fusion|spinal fusion
5955568|NCT02328287|Revision Surgery|revision surgery
5955569|NCT02328287|Pseudarthrosis|pseudarthrosis
5955570|NCT02328287|Cell Therapy|cell therapy
5955571|NCT02328287|Bone Graft|bone graft
5259400|NCT02392039|Placebo|placebo
5053226|NCT03665896|VivaSight double-lumen tube|vivasight double-lumen tube
5053227|NCT03665870|Telehealth|telehealth
5053228|NCT03665870|Emergency Medicine|emergency medicine
5053229|NCT03665870|Paramedicine|paramedicine
5053230|NCT03665870|Diabetes|diabetes
5053231|NCT03665870|Hypoglycemia|hypoglycemia
5053232|NCT03665870|Telecoaching|telecoaching
5053233|NCT03665831|dTMS|dtms
5053234|NCT03665831|depression|depression
5053235|NCT03665831|magnetic|magnetic
5053236|NCT03665831|iTBS|itbs
5053237|NCT03665805|Muscle Relaxation|muscle relaxation
5053238|NCT03665740|Gulf War Illness|gulf war illness
5053239|NCT03665740|Chronic Multisymptom Illness|chronic multisymptom illness
5053240|NCT03665740|Antioxidants|antioxidants
5053241|NCT03665740|Resveratrol|resveratrol
5053242|NCT03665740|Gulf War Syndrome|gulf war syndrome
5053243|NCT03665688|Cervical ripening|cervical ripening
5053244|NCT03665688|Labor induction|labor induction
5053245|NCT03665688|Outpatient|outpatient
5053246|NCT03665688|Mechanical|mechanical
5053249|NCT03665649|Bone marrow-derived stem cells|bone marrow-derived stem cells
5053250|NCT03665649|Endometrial regeneration|endometrial regeneration
5053251|NCT03665649|Assisted reproduction techniques|assisted reproduction techniques
5053252|NCT03665649|Endometrial physiopathology|endometrial physiopathology
5053253|NCT03665649|CD133+|cd133+
5053254|NCT03665649|Endometrial atrophy|endometrial atrophy
5053255|NCT03665649|Endometrial thickness|endometrial thickness
5053256|NCT03665636|Glycogen Storage Disease Type I|glycogen storage disease type i
5053257|NCT03665636|GSD I|gsd i
5053258|NCT03665636|Anaplerosis|anaplerosis
5053259|NCT03665636|Triheptanoin|triheptanoin
5053260|NCT03665636|Hypoglycemia|hypoglycemia
5053261|NCT03665623|prediction|prediction
5053262|NCT03665623|early pregnancy|early pregnancy
5053263|NCT03665623|preeclampsia|preeclampsia
5053264|NCT03665623|multiple markers|multiple markers
5053265|NCT03665610|Pharmacodynamics|pharmacodynamics
5053266|NCT03665610|Pharmacokinetics|pharmacokinetics
5053267|NCT03665610|Ozanimod|ozanimod
5053268|NCT03665610|Safety|safety
5053269|NCT03665610|Healthy Subjects|healthy subjects
5053276|NCT03665584|Lichen Sclerosus|lichen sclerosus
5053277|NCT03665584|MonaLisa Touch|monalisa touch
5053278|NCT03665558|Ventricular contractility|ventricular contractility
5053279|NCT03665558|Pacing|pacing
5053280|NCT03665558|Ventricular dP/dt|ventricular dp/dt
5053281|NCT03665558|Aortic dP/dt|aortic dp/dt
5053282|NCT03665545|glioblastoma|glioblastoma
5053286|NCT03665506|mCRC|mcrc
5053287|NCT03665506|Trifluridin/Tipiracil|trifluridin/tipiracil
5053288|NCT03665493|Levodopa medication|levodopa medication
5053289|NCT03665493|stop signal task|stop signal task
5053290|NCT03665493|inhibitory control|inhibitory control
5053291|NCT03665493|Parkinson's Disease|parkinson's disease
5053292|NCT03665493|stop signal reaction time|stop signal reaction time
5053293|NCT03665493|proactive inhibition|proactive inhibition
5053294|NCT03665454|Parkinson's Disease|parkinson's disease
5053295|NCT03665454|Parkinson Disease|parkinson disease
5053296|NCT03665454|End-Stage|end-stage
5053297|NCT03665454|Progressed|progressed
5053298|NCT03665454|Advanced Parkinson's Disease|advanced parkinson's disease
5053299|NCT03665454|End-Stage Parkinson's Disease|end-stage parkinson's disease
5053300|NCT03665454|Clinical intervention|clinical intervention
5053301|NCT03665454|Double-blind, randomized|double-blind, randomized
5053302|NCT03665441|pancreatic|pancreatic
5053303|NCT03665441|cancer|cancer
5053304|NCT03665441|asparaginase|asparaginase
5053305|NCT03665441|gemcitabine|gemcitabine
5053306|NCT03665441|Abraxane|abraxane
5053307|NCT03665441|asparagine depletion|asparagine depletion
5053308|NCT03665441|onivyde|onivyde
5053309|NCT03665441|nab-paclitaxel|nab-paclitaxel
5053310|NCT03665441|folinic acid|folinic acid
5053311|NCT03665441|fluorouracil|fluorouracil
5053312|NCT03665441|irinotecan|irinotecan
5053313|NCT03665441|leucovorin|leucovorin
5053314|NCT03665441|amino acid|amino acid
5259505|NCT02391441|MRI|mri
5955780|NCT02244632|Colorectal cancer|colorectal cancer
5955781|NCT02244632|Colorectal carcinoma|colorectal carcinoma
5955782|NCT02244632|Colorectal tumors|colorectal tumors
5955783|NCT02244632|Intestinal Neoplasm|intestinal neoplasm
5955784|NCT02244632|Gastrointestinal Neoplasm|gastrointestinal neoplasm
5955785|NCT02244632|Gastrointestinal disease|gastrointestinal disease
5955786|NCT02244632|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
5955787|NCT02244632|Tetrahydrofolates|tetrahydrofolates
5955788|NCT02244632|Therapeutic uses|therapeutic uses
5955789|NCT02244632|Pharmacokinetics|pharmacokinetics
5955790|NCT02244632|Pharmacodynamics|pharmacodynamics
5955791|NCT02244632|Safety assessments|safety assessments
5955802|NCT02240459|crossover study|crossover study
5955803|NCT02240459|placebo controlled|placebo controlled
5955804|NCT02240459|double blind|double blind
5955805|NCT02240459|overactive bladder|overactive bladder
5955807|NCT02234128|Ex Vivo Lung Perfusion|ex vivo lung perfusion
5955808|NCT02234128|EVLP|evlp
5955809|NCT02234128|Lung Transplant|lung transplant
5955810|NCT02234128|Lung Transplantation|lung transplantation
5955811|NCT02234128|Toronto EVLP System™|toronto evlp system™
5955812|NCT02234128|PERFUSIX|perfusix
5259597|NCT02390908|CD4|cd4
5955872|NCT02216643|Stroke|stroke
5955873|NCT02216643|Ischemic Stroke|ischemic stroke
5955874|NCT02216643|Thrombectomy|thrombectomy
5955875|NCT02216643|Reperfusion Therapy|reperfusion therapy
5955876|NCT02216643|Treatment|treatment
5955900|NCT02205138|Spinal Fusion|spinal fusion
5955901|NCT02205138|Lumbar Interbody Fusion|lumbar interbody fusion
5955902|NCT02205138|Degenerative Disc Disease|degenerative disc disease
5955903|NCT02205138|Cell Therapy|cell therapy
5955904|NCT02205138|Bone Graft|bone graft
5955911|NCT02201251|Epilepsy|epilepsy
5955912|NCT02201251|Topiramate|topiramate
5955913|NCT02201251|Levetiracetam|levetiracetam
5955914|NCT02201251|Pediatric|pediatric
5259702|NCT02390206|Stroke|stroke
5955967|NCT02185560|Sorafenib|sorafenib
5955968|NCT02185560|Differentiated Thyroid Carcinoma,|differentiated thyroid carcinoma,
5955969|NCT02185560|Japan|japan
5955970|NCT02185560|Post Marketing Surveillance|post marketing surveillance
5955971|NCT02185560|Drug Use Investigation|drug use investigation
5247493|NCT02460731|PSP|psp
5053315|NCT03665441|RECIST 1.1|recist 1.1
5053316|NCT03665428|helicobacter pylori infection|helicobacter pylori infection
5053317|NCT03665428|Drug Resistance, Microbial|drug resistance, microbial
5053318|NCT03665389|FFRct|ffrct
5053319|NCT03665389|aortic stenosis|aortic stenosis
5053320|NCT03665363|Young adults|young adults
5053321|NCT03665363|Psychoeducation|psychoeducation
5053322|NCT03665363|Internet-based intervention|internet-based intervention
5053323|NCT03665363|Adolescents|adolescents
5053324|NCT03665350|Heart Failure|heart failure
5053325|NCT03665350|Type 2 diabetes mellitus|type 2 diabetes mellitus
5053326|NCT03665350|Insulin|insulin
5053327|NCT03665350|Older adults|older adults
5053328|NCT03665324|Supraventricular arrhythmias|supraventricular arrhythmias
5053329|NCT03665324|veteran athlete|veteran athlete
5053331|NCT03665324|ETT|ett
5053332|NCT03665311|Albumin|albumin
5053333|NCT03665311|Normal Saline|normal saline
5053334|NCT03665311|Dialysis|dialysis
5053335|NCT03665311|Intensive Care Unit|intensive care unit
5053336|NCT03665285|Advanced Cancer|advanced cancer
5053337|NCT03665285|Metastatic Cancer|metastatic cancer
5053338|NCT03665285|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5053339|NCT03665285|Non Small Cell Lung Cancer|non small cell lung cancer
5960944|NCT04290169|video game|video game
5960945|NCT04290169|balance|balance
5053340|NCT03665285|Ovarian Cancer|ovarian cancer
5053341|NCT03665285|NC318|nc318
5053342|NCT03665285|Immunotherapy|immunotherapy
5053343|NCT03665285|PD-L1|pd-l1
5053344|NCT03665285|dose escalation|dose escalation
5053345|NCT03665285|biomarker|biomarker
5053347|NCT03665285|cohort expansion|cohort expansion
5053348|NCT03665285|Solid Tumor|solid tumor
5053349|NCT03665285|Triple Negative Breast Cancer|triple negative breast cancer
5053350|NCT03665259|Oxygen|oxygen
5053351|NCT03665259|Perioperative medicine|perioperative medicine
5053352|NCT03665259|General anesthesia|general anesthesia
5053353|NCT03665259|Preoxygenation|preoxygenation
5053354|NCT03665246|ECD|ecd
5053355|NCT03665246|maternal mental health|maternal mental health
5053356|NCT03665246|early childhood development|early childhood development
5053363|NCT03665181|Radioprotection|radioprotection
5053364|NCT03665181|dosimetry|dosimetry
5053365|NCT03665181|tomodensitometry|tomodensitometry
5053366|NCT03665181|pediatrics|pediatrics
5053367|NCT03665155|89Zr-DFO-daratumumab|89zr-dfo-daratumumab
5053368|NCT03665155|CD38-targeting monoclonal antibody|cd38-targeting monoclonal antibody
5053369|NCT03665155|CT|ct
5053370|NCT03665155|MR|mr
5053371|NCT03665155|FDG PET/CT|fdg pet/ct
5053372|NCT03665155|18-267|18-267
5053373|NCT03665142|Tension-Type Headache|tension-type headache
5053374|NCT03665142|Kinesio Tape|kinesio tape
5053375|NCT03665142|Pain|pain
5053376|NCT03665116|Gene expression|gene expression
5053377|NCT03665116|Molecular phenotype|molecular phenotype
5053378|NCT03665116|Osteoarthritis severity grading|osteoarthritis severity grading
5053379|NCT03665077|Aromatase Inhibitor Induced Musculoskeletal Syndrome|aromatase inhibitor induced musculoskeletal syndrome
5053380|NCT03665077|AIMSS|aimss
5053381|NCT03665077|Breast Cancer|breast cancer
5053382|NCT03665077|Biomarkers|biomarkers
5053383|NCT03665077|Oxylipin|oxylipin
5053384|NCT03665064|Pituitary tumor|pituitary tumor
5053385|NCT03665064|Acromegaly|acromegaly
5053386|NCT03665064|Cushing|cushing
5053387|NCT03665064|Prolactinoma|prolactinoma
5053388|NCT03664960|Eosinophilic Gastritis|eosinophilic gastritis
5053389|NCT03664960|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5053390|NCT03664960|Eosinophil|eosinophil
5053392|NCT03664960|EGE|ege
5053393|NCT03664960|EGID|egid
5053394|NCT03664960|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
5053395|NCT03664947|exercise|exercise
5053396|NCT03664947|sleep problems|sleep problems
5053397|NCT03664947|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5053398|NCT03664934|Neck pain, Rehabilitation, Muscles, Clinical Trial,|neck pain, rehabilitation, muscles, clinical trial,
5053399|NCT03664934|Diagnostics|diagnostics
5053400|NCT03664921|Analgesia|analgesia
5053401|NCT03664908|Lupus nephritis|lupus nephritis
5053402|NCT03664908|systemic lupus erythematosus|systemic lupus erythematosus
5053403|NCT03664908|anti-glomerular basement membrane disease anti-GBM antiboby|anti-glomerular basement membrane disease anti-gbm antiboby
5053404|NCT03664895|premenopausal women, MMG density, Ovary function suppression|premenopausal women, mmg density, ovary function suppression
5053405|NCT03664869|bladder cancer|bladder cancer
5053406|NCT03664869|recurrence|recurrence
5053407|NCT03664869|BCG|bcg
5053408|NCT03664869|mitomycin C|mitomycin c
5053409|NCT03664869|electromotive drug administration|electromotive drug administration
5053410|NCT03664843|circulating tumor DNA|circulating tumor dna
5053421|NCT03664817|Social Capital|social capital
5053422|NCT03664765|OSA|osa
5053423|NCT03664765|SCI/D|sci/d
5053424|NCT03664765|RMT|rmt
5053425|NCT03664765|Upper airway exercise|upper airway exercise
5055782|NCT03650231|Epstein-barr virus|epstein-barr virus
5055783|NCT03650231|infectious mononucleosis|infectious mononucleosis
5055784|NCT03650179|urine stream interruption exercise|urine stream interruption exercise
5055785|NCT03650179|voiding function|voiding function
5055786|NCT03650179|pelvic floor muscles exercise|pelvic floor muscles exercise
5055787|NCT03650166|mhealth|mhealth
5055788|NCT03650166|short-messaging system|short-messaging system
5055789|NCT03650166|self-management|self-management
5055790|NCT03650166|home blood pressure monitoring|home blood pressure monitoring
5055791|NCT03650166|health literacy|health literacy
5055792|NCT03650140|Gout|gout
5055793|NCT03650140|Tart Cherry|tart cherry
5055794|NCT03650140|Pharmacokinetics|pharmacokinetics
5055795|NCT03650127|Genetic risk score|genetic risk score
5055796|NCT03650127|metabolic risk score|metabolic risk score
5055797|NCT03650127|health promotion|health promotion
5055798|NCT03650127|web-based|web-based
5055799|NCT03650127|intervention|intervention
5055800|NCT03650114|ofatumumab|ofatumumab
5055801|NCT03650114|relapsing multiple sclerosis|relapsing multiple sclerosis
5055802|NCT03650101|Hydrocephalus|hydrocephalus
5055803|NCT03650062|Patient Reported Outcome Measures|patient reported outcome measures
5055804|NCT03650062|Follow-Up Studies|follow-up studies
5055805|NCT03650062|Patient Outcome Assessment|patient outcome assessment
5055806|NCT03650062|Treatment Outcome|treatment outcome
5055807|NCT03650062|Pancreatitis, Acute Necrotizing|pancreatitis, acute necrotizing
5055808|NCT03650036|Primary teeth|primary teeth
5055809|NCT03650036|Dental Pulp Necrosis|dental pulp necrosis
5055810|NCT03650036|Root Canal Obturation|root canal obturation
5055811|NCT03650023|Chitosan Oligosaccharide|chitosan oligosaccharide
5055812|NCT03650023|diabetes mellitus|diabetes mellitus
5055813|NCT03650023|blood glucose|blood glucose
5055814|NCT03650023|fasting blood sugar|fasting blood sugar
5055815|NCT03650023|normal blood glucose|normal blood glucose
5055818|NCT03649984|Symptom-management|symptom-management
5055819|NCT03649984|Outpatients|outpatients
5055820|NCT03649984|Nurse-led intervention|nurse-led intervention
5055821|NCT03649984|Implementation|implementation
5055827|NCT03649958|anxiety|anxiety
5055828|NCT03649958|pain|pain
5055829|NCT03649958|depression|depression
5055830|NCT03649958|sleep|sleep
5055831|NCT03649932|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5055832|NCT03649932|Pulmonary hypertension|pulmonary hypertension
5055833|NCT03649932|Citrulline|citrulline
5055834|NCT03649906|Micro-coil|micro-coil
5055835|NCT03649906|CT-guided locate|ct-guided locate
5055836|NCT03649893|sedentary behavior|sedentary behavior
5055837|NCT03649893|phyical activity|phyical activity
5055838|NCT03649893|workplace interventions|workplace interventions
5055839|NCT03649893|active breaks|active breaks
5055840|NCT03649893|workplace ergonomics|workplace ergonomics
5055841|NCT03649854|TAPSE|tapse
5055842|NCT03649854|Right heart function|right heart function
5055843|NCT03649841|Prostate Cancer|prostate cancer
5055844|NCT03649828|kefir|kefir
5055848|NCT03649828|Hypertension|hypertension
5055849|NCT03649815|schizophrenia|schizophrenia
5055850|NCT03649815|psychosis|psychosis
5055852|NCT03649815|digital health|digital health
5055853|NCT03649789|healing|healing
5055854|NCT03649789|biomarkers|biomarkers
5731486|NCT00388804|EBRT|ebrt
5055855|NCT03649789|sanative therapy|sanative therapy
5055856|NCT03649789|nutritional supplements|nutritional supplements
5055857|NCT03649789|medications|medications
5055858|NCT03649789|salivary flow|salivary flow
5055859|NCT03649776|Disparities|disparities
5960964|NCT04290065|Hip joint|hip joint
5055860|NCT03649711|P2Y12 inhibitors|p2y12 inhibitors
5055861|NCT03649711|Platelet aggregation|platelet aggregation
5055862|NCT03649711|ticagrelor|ticagrelor
5055863|NCT03649711|clopidogrel|clopidogrel
5055864|NCT03649711|chronic kidney disease|chronic kidney disease
5055865|NCT03649698|Sarcopenia|sarcopenia
5055866|NCT03649698|Nutrition|nutrition
5055867|NCT03649698|Protein|protein
5055868|NCT03649698|Vitamin D|vitamin d
5055869|NCT03649698|Exercise|exercise
5055870|NCT03649698|Older people|older people
5055871|NCT03649698|Frailty|frailty
5055872|NCT03649672|Tof Watch, rocuronium|tof watch, rocuronium
5055873|NCT03649646|Hypertension|hypertension
5055874|NCT03649646|Fimasartan|fimasartan
5055875|NCT03649633|Shock, Septic|shock, septic
5055876|NCT03649633|Cerebrovascular Circulation|cerebrovascular circulation
5055877|NCT03649633|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5055878|NCT03649633|Patient Reported Outcome Measure|patient reported outcome measure
5055879|NCT03649620|cholesterol|cholesterol
5247566|NCT02460367|IDO|ido
5055880|NCT03649620|Bokbunja|bokbunja
5055881|NCT03649620|Clinical Trial|clinical trial
5055882|NCT03649529|HLA-A2|hla-a2
5055883|NCT03649529|gp100|gp100
5055884|NCT03649516|mHealth|mhealth
5055885|NCT03649516|Mobile application|mobile application
5055886|NCT03649516|Chronic Kidney Diseases|chronic kidney diseases
5055887|NCT03649503|Brain Health|brain health
5055888|NCT03649503|Brain Research|brain research
5055889|NCT03649503|parkinsonism|parkinsonism
5055890|NCT03649503|prospective cohort study|prospective cohort study
5055891|NCT03649503|large sample size|large sample size
5055895|NCT03649464|recurrent high-grade glioma|recurrent high-grade glioma
5055896|NCT03649451|Reference dose levels|reference dose levels
5055897|NCT03649451|Surgery|surgery
5055898|NCT03649451|C-arm|c-arm
5055899|NCT03649451|Orthopedic|orthopedic
5055900|NCT03649451|Urology|urology
5055901|NCT03649451|Vascular|vascular
5055902|NCT03649451|Neurosurgery|neurosurgery
5055903|NCT03649451|Cardiology|cardiology
5055904|NCT03649451|Digestive|digestive
5055905|NCT03649451|Fluoroscopy|fluoroscopy
5055906|NCT03649451|Patient radiation protection|patient radiation protection
5055907|NCT03649451|X-ray|x-ray
5055908|NCT03649451|Interventional radiology|interventional radiology
5055909|NCT03649451|Optimization|optimization
5055910|NCT03649451|Kerma Area Product|kerma area product
5055911|NCT03649425|infection|infection
5055912|NCT03649425|pin site|pin site
5055913|NCT03649425|external fixator|external fixator
5055914|NCT03649425|hydroxyapatite coated|hydroxyapatite coated
5055915|NCT03649412|Tablet formulation|tablet formulation
5055916|NCT03649412|Sequence|sequence
5055917|NCT03649412|Immediate release|immediate release
5055918|NCT03649412|Pharmacokinetic|pharmacokinetic
5055919|NCT03649373|Shoulder|shoulder
5055920|NCT03649373|Dislocation|dislocation
5055921|NCT03649373|Noergaard|noergaard
5055922|NCT03649373|Reduction|reduction
5055923|NCT03649360|Knee pain|knee pain
5055924|NCT03649360|Intramedullary tibial nail|intramedullary tibial nail
5055925|NCT03649360|KOOS|koos
5055926|NCT03649347|Exposure therapy|exposure therapy
5055927|NCT03649347|Technology|technology
5055928|NCT03649347|Telemedicine|telemedicine
5055929|NCT03649308|Negative pressure wound therapy|negative pressure wound therapy
5055940|NCT03649256|conventional suture, barbed suture, niche, scar, cesarean section|conventional suture, barbed suture, niche, scar, cesarean section
5055941|NCT03649243|Diabetes|diabetes
5055942|NCT03649243|Foot wounds|foot wounds
5055943|NCT03649243|oxidative stress|oxidative stress
5055944|NCT03649243|inflammation|inflammation
5055945|NCT03649243|propolis|propolis
5055946|NCT03649204|PAD|pad
5055947|NCT03649191|Advance Care Planning|advance care planning
5055949|NCT03649191|Sustainability|sustainability
5055950|NCT03649191|Scalability|scalability
5055951|NCT03649165|MEK Inhibitor|mek inhibitor
5055952|NCT03649165|Selumetinib capsule|selumetinib capsule
5055953|NCT03649165|Selumetinib granule|selumetinib granule
5055954|NCT03649165|PK|pk
5055955|NCT03649165|Bioavailibilty|bioavailibilty
5055956|NCT03649165|Crossover study|crossover study
5055957|NCT03649165|Open-label|open-label
5055958|NCT03649165|Food effect|food effect
5055959|NCT03649126|standardized structured reporting|standardized structured reporting
5731592|NCT00388336|PROCRIT|procrit
5110096|NCT03309774|Pain|pain
5055960|NCT03649126|treatment decisions|treatment decisions
5055961|NCT03649126|multidisciplinary team|multidisciplinary team
5055962|NCT03649126|pathology|pathology
5055963|NCT03649126|implementation tools|implementation tools
5055964|NCT03649100|Dental implants|dental implants
5055965|NCT03649100|Implant stability|implant stability
5055966|NCT03649100|Osseointegration|osseointegration
5055967|NCT03649100|ISQ measurement|isq measurement
5055968|NCT03649074|ADHD|adhd
5055969|NCT03649061|COBRA-Slim|cobra-slim
5055970|NCT03649061|Accelerated access to anti-TNF|accelerated access to anti-tnf
5055971|NCT03649061|treat to target|treat to target
5055972|NCT03649061|remission induction|remission induction
5055973|NCT03649009|Thiamine|thiamine
5055974|NCT03649009|Lactate|lactate
5055975|NCT03649009|Septic shock|septic shock
5055976|NCT03648996|arterial stiffness|arterial stiffness
5055977|NCT03648996|endothelial dysfunction|endothelial dysfunction
5055978|NCT03648996|type 2 diabetes|type 2 diabetes
5055979|NCT03648996|hyperuricemia|hyperuricemia
5055980|NCT03648983|Enhanced Lymphedema|enhanced lymphedema
5055981|NCT03648970|Preeclampsia|preeclampsia
5055982|NCT03648970|Pravastatin|pravastatin
5055983|NCT03648970|Maternal morbidity|maternal morbidity
5055984|NCT03648970|Neonatal mortality|neonatal mortality
5055985|NCT03648970|Neonatal morbidity|neonatal morbidity
5055986|NCT03648944|Rehabilitation Outcome|rehabilitation outcome
5055987|NCT03648918|Family|family
5055988|NCT03648918|Healthy Controls|healthy controls
5055989|NCT03648905|Autonomic Failure|autonomic failure
5055990|NCT03648905|Parkinson's Disease|parkinson's disease
5055991|NCT03648905|Multiple System Atrophy|multiple system atrophy
5055992|NCT03648905|Lewy Body|lewy body
5055993|NCT03648905|Catecholamines|catecholamines
5055994|NCT03648892|Dopamine Response|dopamine response
5055995|NCT03648892|Energy Expenditure|energy expenditure
5055996|NCT03648892|Neurocognitive Function|neurocognitive function
5055997|NCT03648892|Obesity|obesity
5055998|NCT03648879|Diagnostic|diagnostic
5055999|NCT03648879|Diagnosis|diagnosis
5056000|NCT03648879|EGD|egd
5056001|NCT03648879|Examination of Stomach|examination of stomach
5056002|NCT03648853|photoplethysmography|photoplethysmography
5056003|NCT03648853|stress response|stress response
5056004|NCT03648814|Neovascular glaucoma|neovascular glaucoma
5056005|NCT03648775|Osteosynthesis|osteosynthesis
5056006|NCT03648775|Prophylactic consolidation|prophylactic consolidation
5056007|NCT03648775|Proximal femur|proximal femur
5056008|NCT03648762|Heart failure|heart failure
5056009|NCT03648762|Exercise|exercise
5056010|NCT03648762|Cardiopulmonary|cardiopulmonary
5056011|NCT03648736|FGF23, TASH|fgf23, tash
5056012|NCT03648710|Sickle Cell Disease|sickle cell disease
5056013|NCT03648684|Nonmedical prescription stimulant use|nonmedical prescription stimulant use
5056014|NCT03648684|Expectancy challenge|expectancy challenge
5056015|NCT03648684|College students|college students
5056016|NCT03648671|Safinamide|safinamide
5056017|NCT03648671|Pain|pain
5056018|NCT03648671|Parkinson|parkinson
5056019|NCT03648645|Pregnancy|pregnancy
5056367|NCT03646604|ABT-494|abt-494
5056035|NCT03648567|Common variable immunodeficiency|common variable immunodeficiency
5056036|NCT03648567|children|children
5056037|NCT03648528|Vitamin D Deficiency|vitamin d deficiency
5056038|NCT03648528|hyperparathyroidism|hyperparathyroidism
5056039|NCT03648528|hemodialysis|hemodialysis
5056040|NCT03648515|Validity|validity
5056041|NCT03648515|Reliability|reliability
5056042|NCT03648515|Reproducibility|reproducibility
5056043|NCT03648515|Intra-oral images|intra-oral images
5056044|NCT03648515|Plaster models|plaster models
5056045|NCT03648515|Digital images|digital images
5056046|NCT03648515|Little's index of irregularity|little's index of irregularity
5056047|NCT03648515|Bolton's analysis|bolton's analysis
5056060|NCT03648437|acetaminophen|acetaminophen
5056061|NCT03648437|ibuprofen|ibuprofen
5056062|NCT03648437|preterm infant|preterm infant
5056063|NCT03648437|near infra-red spectroscopy|near infra-red spectroscopy
5056064|NCT03648424|Linagliptin|linagliptin
5056065|NCT03648424|Cardiovascular Death|cardiovascular death
5056066|NCT03648424|Stroke|stroke
5056067|NCT03648424|Myocardial Infarction|myocardial infarction
5056068|NCT03648424|Hospitalization for Unstable Angina|hospitalization for unstable angina
5056069|NCT03648424|Type 2 diabetes mellitus|type 2 diabetes mellitus
5056070|NCT03648424|Glimepiride|glimepiride
5056071|NCT03648411|malaria|malaria
5056072|NCT03648411|falciparum|falciparum
5056073|NCT03648411|vivax|vivax
5056074|NCT03648411|Myanmar|myanmar
5056075|NCT03648411|migrant workers|migrant workers
5056076|NCT03648411|asymptomatic infection|asymptomatic infection
5056077|NCT03648411|drug resistance|drug resistance
5056078|NCT03648398|Therapeutic education program|therapeutic education program
5056079|NCT03648398|Online|online
5056080|NCT03648372|Drug therapy|drug therapy
5056081|NCT03648359|Prostate biopsy|prostate biopsy
5056082|NCT03648359|Prostate cancer|prostate cancer
5056083|NCT03648359|Magnetic resonance imaging|magnetic resonance imaging
5056084|NCT03648359|Neoplasm staging|neoplasm staging
5056085|NCT03648333|amlodipine|amlodipine
5056086|NCT03648333|valsartan|valsartan
5056087|NCT03648333|hypertension|hypertension
5056088|NCT03648320|IgE mediated peanut allergy|ige mediated peanut allergy
5056089|NCT03648320|Oral immunotherapy|oral immunotherapy
5056090|NCT03648320|Desensitisation|desensitisation
5056091|NCT03648320|GUPI|gupi
5056092|NCT03648307|Splenectomy|splenectomy
5056093|NCT03648307|metabolism|metabolism
5056094|NCT03648307|diabetes|diabetes
5056095|NCT03648307|stem cells|stem cells
5056096|NCT03648307|trauma surgery|trauma surgery
5056097|NCT03648294|blood pressure|blood pressure
5056098|NCT03648268|brain|brain
5056099|NCT03648268|networks|networks
5056100|NCT03648268|schizophrenia|schizophrenia
5956382|NCT02047994|Gastric cancer|gastric cancer
5056101|NCT03648242|pediatric obesity|pediatric obesity
5056102|NCT03648242|electronic health record|electronic health record
5960965|NCT04290065|Suboccipital muscles|suboccipital muscles
5056103|NCT03648242|clinical decision support|clinical decision support
5056104|NCT03648229|glaucoma|glaucoma
5056105|NCT03648229|laser|laser
5056106|NCT03648229|Africa|africa
5056107|NCT03648216|Sedentary Behaviour|sedentary behaviour
5056108|NCT03648216|Subjective Well-Being|subjective well-being
5056109|NCT03648216|University Students|university students
5056110|NCT03648203|asthma|asthma
5056111|NCT03648203|quality of life|quality of life
5056112|NCT03648203|self-care|self-care
5056113|NCT03648203|healthcare utilization|healthcare utilization
5056115|NCT03648190|CD|cd
5056116|NCT03648177|Behavioral Intervention|behavioral intervention
5056117|NCT03648177|Medication Adherence|medication adherence
5056118|NCT03648177|Psychosocial Treatment|psychosocial treatment
5056119|NCT03648164|well-being|well-being
5056120|NCT03648164|health behavior|health behavior
5056121|NCT03648164|choice|choice
5056126|NCT03648164|interpersonal relationships|interpersonal relationships
5056128|NCT03648164|nutrition|nutrition
5056129|NCT03648164|survey|survey
5056130|NCT03648164|student|student
5056131|NCT03648164|college|college
5056132|NCT03648164|university|university
5056133|NCT03648151|Radomic feature|radomic feature
5056134|NCT03648151|PET|pet
5056135|NCT03648151|CT|ct
5056136|NCT03648125|young elite rowers|young elite rowers
5056137|NCT03648112|dietary fibres|dietary fibres
5056138|NCT03648112|ß-glucan|ß-glucan
5056330|NCT03647007|small-sided games|small-sided games
5056139|NCT03648112|low-density-lipoprotein-cholesterol|low-density-lipoprotein-cholesterol
5056140|NCT03648112|insulin|insulin
5056141|NCT03648112|fasting glucose|fasting glucose
5056142|NCT03648112|microbiota|microbiota
5056143|NCT03648099|Labor Pain|labor pain
5056144|NCT03648099|Labor dance|labor dance
5056145|NCT03648099|Music|music
5056146|NCT03648099|Fear of childbirth|fear of childbirth
5056147|NCT03648086|NAFLD|nafld
5056148|NCT03647995|Probiotics|probiotics
5056149|NCT03647995|Diarrhea|diarrhea
5056150|NCT03647995|Clostridium difficile|clostridium difficile
5056151|NCT03647995|Antibiotics|antibiotics
5056152|NCT03647995|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
5056153|NCT03647995|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5056154|NCT03647995|Microbial flora|microbial flora
5056155|NCT03647956|Atezolizumab|atezolizumab
5056156|NCT03647956|Bevacizumab|bevacizumab
5056157|NCT03647956|Carboplatin|carboplatin
5056158|NCT03647956|Pemetrexed|pemetrexed
5056159|NCT03647956|EGFR-mutant metastatic NSCLC|egfr-mutant metastatic nsclc
5056160|NCT03647904|Employment|employment
5056161|NCT03647904|Self efficacy|self efficacy
5056162|NCT03647891|obstructive sleep apnea|obstructive sleep apnea
5056163|NCT03647891|CPAP|cpap
5056164|NCT03647891|hospital readmission|hospital readmission
5056165|NCT03647891|heart failure|heart failure
5056166|NCT03647891|myocardial infarction|myocardial infarction
5056167|NCT03647891|cardiac arrhythmia|cardiac arrhythmia
5056168|NCT03647865|Computer Guided,|computer guided,
5056169|NCT03647865|Osseous Genioplasty|osseous genioplasty
5056170|NCT03647865|Custom Made Titanium Plates|custom made titanium plates
5056171|NCT03647865|Orthognathic Surgery|orthognathic surgery
5056172|NCT03647865|Genioplasty|genioplasty
5056173|NCT03647865|patient Specific device|patient specific device
5056174|NCT03647852|severe gastrointestinal involvement|severe gastrointestinal involvement
5056175|NCT03647839|Microsatellite stable tumour|microsatellite stable tumour
5056176|NCT03647839|Refractory colorectal cancer|refractory colorectal cancer
5056177|NCT03647839|Tumour microenvironment|tumour microenvironment
5056178|NCT03647839|Vascular Disrupting Agent|vascular disrupting agent
5056179|NCT03647839|STAT3 inhibitors|stat3 inhibitors
5056181|NCT03647839|Unresectable colorectal cancer|unresectable colorectal cancer
5056182|NCT03647839|nivolumab|nivolumab
5056183|NCT03647839|BNC105|bnc105
5056184|NCT03647839|BBI-608|bbi-608
5056185|NCT03647826|youth mental health|youth mental health
5056186|NCT03647826|mental health prevention|mental health prevention
5056187|NCT03647826|empowerment|empowerment
5056188|NCT03647800|APVO436|apvo436
5056189|NCT03647774|Extended release naltrexone|extended release naltrexone
5056190|NCT03647774|Opioid dependence|opioid dependence
5056191|NCT03647774|Recovery|recovery
5056192|NCT03647774|Health economics|health economics
5056193|NCT03647761|Tetra-grip|tetra-grip
5056194|NCT03647761|Assisting Hand Assessment|assisting hand assessment
5056195|NCT03647696|respiratory depression, opioid-induced sedation|respiratory depression, opioid-induced sedation
5056196|NCT03647670|PF-04965842|pf-04965842
5056197|NCT03647657|Calcitonin|calcitonin
5056198|NCT03647657|Medullary thyroid carcinoma|medullary thyroid carcinoma
5056199|NCT03647657|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
5056200|NCT03647657|Gastrin|gastrin
5056201|NCT03647657|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
5056202|NCT03647644|Cardiac Surgery|cardiac surgery
5056203|NCT03647644|Bleeding|bleeding
5056204|NCT03647644|Transfusion|transfusion
5056205|NCT03647644|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
5056206|NCT03647605|vr|vr
5056207|NCT03647605|virtual reality|virtual reality
5056208|NCT03647605|social phobia|social phobia
5056209|NCT03647605|vret|vret
5056210|NCT03647605|virtual reality exposure therapy|virtual reality exposure therapy
5056211|NCT03647592|Non-small Cell Lung Cancer|non-small cell lung cancer
5056212|NCT03647592|Bevacizumab|bevacizumab
5056213|NCT03647592|Erlotinib/Gefitinib|erlotinib/gefitinib
5056214|NCT03647592|EGFR mutation positive|egfr mutation positive
5056215|NCT03647566|sodium fluoride|sodium fluoride
5056216|NCT03647566|positron emission tomography|positron emission tomography
5056217|NCT03647566|computed tomography|computed tomography
5056218|NCT03647566|acute aortic syndrome|acute aortic syndrome
5056219|NCT03647566|aortic dissection|aortic dissection
5056220|NCT03647566|intramural haematoma|intramural haematoma
5056221|NCT03647566|penetrating aortic ulcer|penetrating aortic ulcer
5056222|NCT03647540|fluorescence laparoscopy|fluorescence laparoscopy
5056223|NCT03647540|adenocarcinoma of the esophagogastric junction (AEG)|adenocarcinoma of the esophagogastric junction (aeg)
5056224|NCT03647527|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5056225|NCT03647527|acute radiation oral mucositis|acute radiation oral mucositis
5056226|NCT03647527|intensity modulated radiotherapy|intensity modulated radiotherapy
5056227|NCT03647527|tomography radiotherapy|tomography radiotherapy
5056228|NCT03647514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5056229|NCT03647514|Abraxane|abraxane
5056230|NCT03647514|Xeloda|xeloda
5056231|NCT03647501|lumbar spinal arthrodesis|lumbar spinal arthrodesis
5056232|NCT03647501|interbody cage|interbody cage
5056233|NCT03647501|3D-printing|3d-printing
5056530|NCT03645694|Caregiving|caregiving
5056244|NCT03647488|docetaxel|docetaxel
5056245|NCT03647462|obstructive sleep apnea|obstructive sleep apnea
5056246|NCT03647462|chronic obstructive sleep apnea|chronic obstructive sleep apnea
5423363|NCT01615926|dyspnea|dyspnea
5056250|NCT03647397|environmental intervention|environmental intervention
5056251|NCT03647397|respiratory distress|respiratory distress
5056252|NCT03647397|pediatric hospitalization|pediatric hospitalization
5056253|NCT03647397|pneumonia|pneumonia
5056254|NCT03647397|bronchiolitis|bronchiolitis
5056255|NCT03647384|Traditional Chinese medicine|traditional chinese medicine
5056256|NCT03647384|Randomized clinical trial|randomized clinical trial
5056257|NCT03647384|Mild-to-moderate cognitive impairment|mild-to-moderate cognitive impairment
5056258|NCT03647371|Difficult Intubation|difficult intubation
5056259|NCT03647371|Thyromental Height Test|thyromental height test
5056260|NCT03647371|Videolaryngoscopy|videolaryngoscopy
5056261|NCT03647358|Iodine-124|iodine-124
5056262|NCT03647358|PET Scan|pet scan
5056263|NCT03647358|18-253|18-253
5056264|NCT03647345|Noninvasive brain stimulation|noninvasive brain stimulation
5056265|NCT03647345|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5056266|NCT03647345|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5056267|NCT03647319|Noninvasive Brain Stimulation|noninvasive brain stimulation
5056268|NCT03647319|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5056269|NCT03647319|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5056270|NCT03647306|peripheral circadian clock|peripheral circadian clock
5056271|NCT03647306|central circadian clocks|central circadian clocks
5056272|NCT03647306|chronotype|chronotype
5056273|NCT03647306|diet|diet
5056274|NCT03647293|Central Catheter|central catheter
5056275|NCT03647293|Central Line|central line
5056276|NCT03647293|Internal Jugular Vein|internal jugular vein
5056277|NCT03647293|Neonate|neonate
5056278|NCT03647293|Peripherally Inserted Central Line|peripherally inserted central line
5056279|NCT03647293|Ultrasound Guided|ultrasound guided
5056280|NCT03647293|Pain Score|pain score
5056281|NCT03647280|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5056282|NCT03647280|Abraxane|abraxane
5056283|NCT03647280|Epirubicin|epirubicin
5056284|NCT03647254|Anticoagulants|anticoagulants
5056285|NCT03647254|Warfarin|warfarin
5056288|NCT03647215|Chronic myeloid leukemia|chronic myeloid leukemia
5056289|NCT03647215|chronic phase|chronic phase
5956758|NCT01896102|Adrenoleukodystrophy|adrenoleukodystrophy
5956759|NCT01896102|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
5956760|NCT01896102|Gene therapy|gene therapy
5956761|NCT01896102|Hematopoietic stem cell|hematopoietic stem cell
5956914|NCT01815359|ICARuS|icarus
5956915|NCT01815359|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
5956916|NCT01815359|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5956917|NCT01815359|Optimal Surgical Debulking|optimal surgical debulking
5956918|NCT01815359|Leucovorin|leucovorin
5956919|NCT01815359|Floxuridine (FUDR)|floxuridine (fudr)
5956920|NCT01815359|Mitomycin|mitomycin
5956921|NCT01815359|12-289|12-289
5956944|NCT01808794|membranes|membranes
5260553|NCT02385409|Patient Blood Management|patient blood management
5260554|NCT02385409|Preoperative anemia|preoperative anemia
5260555|NCT02385409|Hip replacement|hip replacement
5260556|NCT02385409|Knee replacement|knee replacement
5260558|NCT02385396|Infertility|infertility
5956945|NCT01808794|Mucograft|mucograft
5956946|NCT01808794|Dynamatrixw|dynamatrixw
5956947|NCT01808794|ridge|ridge
5956948|NCT01808794|preservation|preservation
5956949|NCT01808794|bone|bone
5956950|NCT01808794|allograft|allograft
5956951|NCT01808794|extraction|extraction
5956952|NCT01808794|site|site
5956953|NCT01808794|healing|healing
5957015|NCT01774409|all advanced malignant tumor|all advanced malignant tumor
5053426|NCT03664726|Delay Discounting, Episodic Future Thinking|delay discounting, episodic future thinking
5053427|NCT03664713|Severe Mental Disorder|severe mental disorder
5053428|NCT03664713|Psychological Trauma|psychological trauma
5053429|NCT03664713|Eye Movement Desensitization and Reprocessing Therapy|eye movement desensitization and reprocessing therapy
5053430|NCT03664700|Supraglottic airway device|supraglottic airway device
5053431|NCT03664700|LMA Protector|lma protector
5053432|NCT03664687|Adjuvant Zoledronate|adjuvant zoledronate
5053439|NCT03664648|Pregnant|pregnant
5053440|NCT03664648|Conceived|conceived
5053441|NCT03664648|HBV Vaccine|hbv vaccine
5053442|NCT03664648|Hepatitis B|hepatitis b
5053443|NCT03664648|Hepatitis B vaccine|hepatitis b vaccine
5053444|NCT03664648|HBV|hbv
5053445|NCT03664648|Hepatitis|hepatitis
5053446|NCT03664648|Registry|registry
5053447|NCT03664648|Prevention|prevention
5053448|NCT03664648|Female volunteers|female volunteers
5053452|NCT03664583|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5053453|NCT03664583|Comorbidity|comorbidity
5053454|NCT03664583|Aged|aged
5053455|NCT03664583|Health Services|health services
5053456|NCT03664570|Gastric motility|gastric motility
5053457|NCT03664557|Resuscitation|resuscitation
5053458|NCT03664557|REBOA|reboa
5053459|NCT03664544|Severe Hepatic Impairment|severe hepatic impairment
5053460|NCT03664544|Healthy|healthy
5053461|NCT03664531|crossover|crossover
5053462|NCT03664531|gluten|gluten
5053463|NCT03664531|amylase trypsin inhibitors|amylase trypsin inhibitors
5053464|NCT03664531|diet|diet
5053466|NCT03664492|Communication about weight|communication about weight
5053467|NCT03664492|education|education
5053468|NCT03664492|parents|parents
5053469|NCT03664492|health care professionals|health care professionals
5053470|NCT03664479|stroke|stroke
5053471|NCT03664479|cervical spinal cord injury|cervical spinal cord injury
5053472|NCT03664453|omaveloxolone|omaveloxolone
5053473|NCT03664453|omaveloxolone capsules|omaveloxolone capsules
5053475|NCT03664440|rilpivirine switch therapy|rilpivirine switch therapy
5053476|NCT03664414|oxidative stress|oxidative stress
5053477|NCT03664414|fibrosis|fibrosis
5053478|NCT03664414|inflammation|inflammation
5053479|NCT03664414|quality of life|quality of life
5053480|NCT03664388|Acute Coronary Syndrome; Bleeding; Dual antiplatelet therapy|acute coronary syndrome; bleeding; dual antiplatelet therapy
5053481|NCT03664375|Dystonia Task-specific training Botulinum toxin type A|dystonia task-specific training botulinum toxin type a
5053482|NCT03664336|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5053483|NCT03664336|refractory|refractory
5053484|NCT03664336|rituximab|rituximab
5053485|NCT03664323|Immunotherapy|immunotherapy
5053486|NCT03664323|chemotherapy|chemotherapy
5053487|NCT03664323|anti-PD1|anti-pd1
5053488|NCT03664323|re-sensibilization|re-sensibilization
5053489|NCT03664297|replased/refractory mature B cell neoplasms|replased/refractory mature b cell neoplasms
5053490|NCT03664297|BTK inhibitor|btk inhibitor
5053491|NCT03664271|atopic dermatitis|atopic dermatitis
5053492|NCT03664271|eczema|eczema
5053493|NCT03664206|Treshold Tracking Transcranial Magnetic Stimulation|treshold tracking transcranial magnetic stimulation
5053494|NCT03664206|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5053495|NCT03664206|Inter-rater agreement|inter-rater agreement
5053496|NCT03664206|Reproducibililty of Results|reproducibililty of results
5053497|NCT03664206|Case-control Studies|case-control studies
5053498|NCT03664206|Biomarkers|biomarkers
5053499|NCT03664206|Intra-rater agreement|intra-rater agreement
5053500|NCT03664180|anticoagulantion|anticoagulantion
5053501|NCT03664180|post-procedure|post-procedure
5053502|NCT03664180|STEMI|stemi
5053503|NCT03664167|gout|gout
5053504|NCT03664167|Obesity|obesity
5053505|NCT03664167|arthritis|arthritis
5053521|NCT03664024|Programmed Cell Death 1|programmed cell death 1
5053522|NCT03664024|PD1|pd1
5053523|NCT03664024|PD-1|pd-1
5053524|NCT03664024|Programmed Cell Death Ligand 1|programmed cell death ligand 1
5053525|NCT03664024|PDL1|pdl1
5053526|NCT03664024|PD-L1|pd-l1
5053527|NCT03663998|Antibody|antibody
5053528|NCT03663998|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
5053529|NCT03663998|Investigational Medicinal Product|investigational medicinal product
5053530|NCT03663998|neutralizing antibody responses|neutralizing antibody responses
5053531|NCT03663985|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5053532|NCT03663985|surgery|surgery
5053533|NCT03663985|anthropology|anthropology
5260765|NCT02384408|Bcl-2|bcl-2
5957216|NCT01693523|Pancreatic Cancer|pancreatic cancer
5957217|NCT01693523|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5957218|NCT01693523|Locally advanced|locally advanced
5957219|NCT01693523|Metastatic disease|metastatic disease
5957220|NCT01693523|Symptom reduction|symptom reduction
5957221|NCT01693523|Minocycline|minocycline
5957222|NCT01693523|Dynacin|dynacin
5957223|NCT01693523|Minocin|minocin
5957224|NCT01693523|Minocin PAC|minocin pac
5957225|NCT01693523|Myrac|myrac
5957226|NCT01693523|Solodyn|solodyn
5957227|NCT01693523|Placebo|placebo
5957228|NCT01693523|Sugar Pill|sugar pill
5957229|NCT01693523|Questionnaires|questionnaires
5957230|NCT01693523|Surveys|surveys
5957241|NCT01678586|Pain|pain
5957242|NCT01678586|Pain management|pain management
5053534|NCT03663985|sociology|sociology
5053535|NCT03663972|treatment|treatment
5053536|NCT03663972|efficacy|efficacy
5053537|NCT03663972|efficiency|efficiency
5053538|NCT03663972|late-acquired sounds|late-acquired sounds
5053539|NCT03663959|Outcomes|outcomes
5053540|NCT03663959|Pectopexy|pectopexy
5053541|NCT03663959|Sacrospinous ligament fixation|sacrospinous ligament fixation
5053542|NCT03663959|Prolapse surgery|prolapse surgery
5053548|NCT03663920|Viral Load|viral load
5053549|NCT03663920|CD4|cd4
5053550|NCT03663920|Mortality|mortality
5053551|NCT03663920|Disease Progression|disease progression
5053552|NCT03663907|Telemedicine|telemedicine
5053553|NCT03663907|Telemonitoring|telemonitoring
5053554|NCT03663907|Disease Management|disease management
5053555|NCT03663907|Chronic Care Model|chronic care model
5053556|NCT03663907|Transitional Care|transitional care
5053557|NCT03663894|Autologous stem cell transplantation|autologous stem cell transplantation
5053558|NCT03663894|rituximab|rituximab
5053559|NCT03663894|Follicular Lymphoma|follicular lymphoma
5053560|NCT03663894|prognosis|prognosis
5053561|NCT03663881|Polyphenols|polyphenols
5053562|NCT03663881|Safety|safety
5053563|NCT03663881|Herbal Extract|herbal extract
5053564|NCT03663842|Lumbosacral Plexus|lumbosacral plexus
5053565|NCT03663842|Physical Therapy Modalities|physical therapy modalities
5053566|NCT03663842|Manual Therapies|manual therapies
5053567|NCT03663842|Disability Evaluation.|disability evaluation.
5053568|NCT03663816|shoe insert|shoe insert
5053569|NCT03663816|orthotics|orthotics
5053570|NCT03663816|sway|sway
5053571|NCT03663790|osteoarthritis|osteoarthritis
5053572|NCT03663790|biomechanics|biomechanics
5053573|NCT03663790|gait retraining|gait retraining
5053574|NCT03663790|real-time biofeedback|real-time biofeedback
5053575|NCT03663790|knee|knee
5053576|NCT03663764|Unresectable Thymoma and Thymic Carcinoma|unresectable thymoma and thymic carcinoma
5053577|NCT03663764|Chemoradiotherapy|chemoradiotherapy
5053578|NCT03663764|Thymosin a1|thymosin a1
5053579|NCT03663751|donor chimerism,|donor chimerism,
5053580|NCT03663751|decitabine,|decitabine,
5053581|NCT03663751|allo-HSCT|allo-hsct
5053582|NCT03663725|temozolomide|temozolomide
5053583|NCT03663725|Stupp protocol|stupp protocol
5053584|NCT03663699|Exercise Therapy|exercise therapy
5053585|NCT03663699|Physical Fitness|physical fitness
5053586|NCT03663699|Games, Recreational|games, recreational
5053587|NCT03663699|Children|children
5053588|NCT03663699|Adolescents|adolescents
5053589|NCT03663699|Healthy Lifestyle|healthy lifestyle
5053590|NCT03663699|Exercise Test|exercise test
5053592|NCT03663673|pediatric patients|pediatric patients
5053593|NCT03663673|Atopic Dermatitis|atopic dermatitis
5053594|NCT03663660|Bronchiolitis|bronchiolitis
5053595|NCT03663660|Health care|health care
5053596|NCT03663660|Organizational change|organizational change
5053597|NCT03663660|children|children
5053598|NCT03663660|Epidemic|epidemic
5053599|NCT03663660|cost|cost
5053600|NCT03663595|Patellofemoral pain|patellofemoral pain
5053601|NCT03663595|Etiology|etiology
5053602|NCT03663595|Multiarticular rehabilitation|multiarticular rehabilitation
5053603|NCT03663595|Local factors|local factors
5053604|NCT03663595|Nonlocal factors|nonlocal factors
5053605|NCT03663556|intestinal microbiota|intestinal microbiota
5053606|NCT03663556|preterm infants|preterm infants
5053607|NCT03663556|breast milk|breast milk
5053608|NCT03663556|donor human milk|donor human milk
5053609|NCT03663556|formula|formula
5053610|NCT03663530|Food intake|food intake
5053611|NCT03663530|Energy expenditure|energy expenditure
5053612|NCT03663530|Body composition|body composition
5053613|NCT03663530|Meal timing|meal timing
5053614|NCT03663517|Thyroid|thyroid
5053615|NCT03663517|Reference values|reference values
5053616|NCT03663517|Pregnancy|pregnancy
5053617|NCT03663504|Oral Antibiotics|oral antibiotics
5053618|NCT03663504|Preoperative Mechanical Bowel Preparation|preoperative mechanical bowel preparation
5053619|NCT03663504|Surgical Site Infection|surgical site infection
5053620|NCT03663504|C. difficile|c. difficile
5053621|NCT03663491|Gastroscopy|gastroscopy
5053622|NCT03663491|Transnasal Endoscopy|transnasal endoscopy
5053623|NCT03663491|Sedation|sedation
5053624|NCT03663465|Hawthorn|hawthorn
5053625|NCT03663465|TG/HDL ratio|tg/hdl ratio
5053626|NCT03663465|dyslipidemia|dyslipidemia
5053627|NCT03663465|schizophrenia|schizophrenia
5053628|NCT03663465|antipsychotics|antipsychotics
5053629|NCT03663439|anterior augmentation,shell technique,onlay bone graft|anterior augmentation,shell technique,onlay bone graft
5053630|NCT03663374|alcohol dependence|alcohol dependence
5053631|NCT03663374|abstinence|abstinence
5053632|NCT03663374|alcohol abuse|alcohol abuse
5053633|NCT03663374|LY2196044|ly2196044
5053634|NCT03663374|ondelopran|ondelopran
5053635|NCT03663361|ankle sprain, sensorimotor, rehabilitation, osteoarthritis|ankle sprain, sensorimotor, rehabilitation, osteoarthritis
5056290|NCT03647215|accelerated phase|accelerated phase
5056291|NCT03647215|blast phase|blast phase
5056292|NCT03647215|Philadelphia chromosome-positive acute lymphoblastic leukemia|philadelphia chromosome-positive acute lymphoblastic leukemia
5056293|NCT03647215|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5056294|NCT03647176|Cold snare polypectomy|cold snare polypectomy
5056295|NCT03647176|Colorectal polyps|colorectal polyps
5056296|NCT03647176|CARE Study|care study
5056297|NCT03647137|freezing of gait|freezing of gait
5056298|NCT03647137|amyloid|amyloid
5056299|NCT03647137|cholinergic|cholinergic
5056300|NCT03647137|mobility|mobility
5056302|NCT03647137|imaging|imaging
5056315|NCT03647111|Non-small Cell Lung Cancer|non-small cell lung cancer
5056316|NCT03647111|ALK rearranged|alk rearranged
5056317|NCT03647111|Crizotinib|crizotinib
5056318|NCT03647085|atrial fibrillation|atrial fibrillation
5056319|NCT03647085|atrial flutter|atrial flutter
5056320|NCT03647085|arrhythmia|arrhythmia
5056321|NCT03647046|Keratoconus, scleral lens|keratoconus, scleral lens
5056322|NCT03647033|istent|istent
5056323|NCT03647033|primary angle closure|primary angle closure
5056324|NCT03647020|oocyte|oocyte
5056325|NCT03647020|ovarian stimulation|ovarian stimulation
5056326|NCT03647020|dysmorphic cytoplasm|dysmorphic cytoplasm
5056327|NCT03647007|fat percentage|fat percentage
5056328|NCT03647007|physical fitness|physical fitness
5056329|NCT03647007|well-being|well-being
5056336|NCT03646981|RDT|rdt
5056337|NCT03646981|Eastern Africa|eastern africa
5056338|NCT03646968|Anlotinib Combined With Docetaxel|anlotinib combined with docetaxel
5056339|NCT03646929|facilitation technique|facilitation technique
5056340|NCT03646929|multimodal evoked potentials (mmEP) in multiple sclerosis|multimodal evoked potentials (mmep) in multiple sclerosis
5428243|NCT01595555|discussion board|discussion board
5056341|NCT03646929|motor evoked potential (MEP) in multiple sclerosis|motor evoked potential (mep) in multiple sclerosis
5056342|NCT03646890|Epidemiology|epidemiology
5056343|NCT03646890|Clinical features|clinical features
5056344|NCT03646890|Etiology|etiology
5056345|NCT03646890|Tertiary center|tertiary center
5056346|NCT03646838|International adoption|international adoption
5056347|NCT03646838|Family experiences|family experiences
5056348|NCT03646838|Adolescents|adolescents
5056349|NCT03646838|France|france
5056350|NCT03646747|head and neck|head and neck
5056351|NCT03646747|radiotherapy|radiotherapy
5056352|NCT03646747|magnetic resonance imaging|magnetic resonance imaging
5056358|NCT03646656|cardiovascular disease|cardiovascular disease
5056359|NCT03646656|social support|social support
5056360|NCT03646643|Atrial fibrillation|atrial fibrillation
5056361|NCT03646643|Coronary sinus-left atrium connection|coronary sinus-left atrium connection
5056362|NCT03646643|Ablation|ablation
5056363|NCT03646630|lower abdominal surgeries|lower abdominal surgeries
5056374|NCT03646526|Amitriptyline hydrochloride|amitriptyline hydrochloride
5056375|NCT03646513|THA|tha
5056376|NCT03646487|pregnancy|pregnancy
5056377|NCT03646487|iron status|iron status
5056378|NCT03646487|structural violence|structural violence
5056379|NCT03646461|oropharyngeal|oropharyngeal
5056380|NCT03646448|Internet Use Disorders|internet use disorders
5056381|NCT03646448|Brief Intervention|brief intervention
5110606|NCT03306381|IBS|ibs
5056382|NCT03646448|Motivational Interviewing|motivational interviewing
5056383|NCT03646448|CBT|cbt
5056384|NCT03646448|Proactive|proactive
5056385|NCT03646435|inpatients|inpatients
5056386|NCT03646435|wearables|wearables
5056387|NCT03646435|continuous monitoring|continuous monitoring
5056388|NCT03646383|benign thyroid nodule|benign thyroid nodule
5056389|NCT03646383|radiofrequency|radiofrequency
5056390|NCT03646383|symptomatic thyroid nodule|symptomatic thyroid nodule
5056391|NCT03646357|Infarction|infarction
5056392|NCT03646357|Myocardial Infarction|myocardial infarction
5056393|NCT03646357|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5056394|NCT03646357|Non-ST Elevated Myocardial Infarction|non-st elevated myocardial infarction
5056395|NCT03646357|Ischemia|ischemia
5056396|NCT03646357|Myocardial Ischemia|myocardial ischemia
5056397|NCT03646357|Heart Diseases|heart diseases
5056398|NCT03646357|Cardiovascular Diseases|cardiovascular diseases
5056399|NCT03646357|Metoprolol|metoprolol
5056400|NCT03646357|Bisoprolol|bisoprolol
5056401|NCT03646357|Betablocker|betablocker
5056402|NCT03646357|Anti-Arrhythmia Agents|anti-arrhythmia agents
5056403|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs
5056404|NCT03646357|Beta-blocker|beta-blocker
5056405|NCT03646357|Beta blocker|beta blocker
5056406|NCT03646344|Deceased donor renal transplantation|deceased donor renal transplantation
5056407|NCT03646344|Heme Arginate|heme arginate
5056408|NCT03646344|Delayed graft function|delayed graft function
5056409|NCT03646253|Proximal humerus fracture|proximal humerus fracture
5356793|NCT01917981|Intermittent cardiac monitoring|intermittent cardiac monitoring
5056420|NCT03646201|portion size|portion size
5056421|NCT03646201|behavioral|behavioral
5056422|NCT03646201|environmental|environmental
5056423|NCT03646201|feeding practices|feeding practices
5957622|NCT01461005|Spondylolisthesis|spondylolisthesis
5957623|NCT01461005|Neurologic impairment|neurologic impairment
5957624|NCT01461005|Kyphosis|kyphosis
5957625|NCT01461005|Pseudarthrosis|pseudarthrosis
5056424|NCT03646175|Choline|choline
5056425|NCT03646175|Trimethylamine N-Oxide|trimethylamine n-oxide
5056426|NCT03646175|Vascular health|vascular health
5056427|NCT03646149|Social Skills|social skills
5056428|NCT03646149|Housing|housing
5056434|NCT03646110|esophageal cancer|esophageal cancer
5056435|NCT03646110|Minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
5056436|NCT03646110|single-incision Minimally invasive esophagectomy (SIMIE)|single-incision minimally invasive esophagectomy (simie)
5056438|NCT03646097|Co-Registration|co-registration
5056439|NCT03646097|Stent|stent
5056440|NCT03646097|PCI|pci
5056441|NCT03646097|Geographical mismatch|geographical mismatch
5056442|NCT03646097|Edge Dissection|edge dissection
5056443|NCT03646084|pain|pain
5056444|NCT03646084|sleep|sleep
5056445|NCT03646084|circadian rhythm|circadian rhythm
5056446|NCT03646071|Locally Advanced|locally advanced
5056447|NCT03646071|Metastatic|metastatic
5056448|NCT03646071|Solid Tumor|solid tumor
5056449|NCT03646058|Treatment|treatment
5056450|NCT03646058|Suicidal ideas|suicidal ideas
5056451|NCT03646058|Depression|depression
5056452|NCT03646058|Buprenorphine|buprenorphine
5056453|NCT03646058|Opioid agonist|opioid agonist
5056454|NCT03646058|Mental pain|mental pain
5960966|NCT04290052|Cryptogenic|cryptogenic
5960967|NCT04290000|CAR T-Cell|car t-cell
5056455|NCT03646032|Mobile dating simulation game|mobile dating simulation game
5056470|NCT03645954|Femoral nerve block|femoral nerve block
5056471|NCT03645954|Primary total knee arthroplasty|primary total knee arthroplasty
5056472|NCT03645954|Pain management|pain management
5056473|NCT03645954|Functional recovery|functional recovery
5056474|NCT03645941|Social Media|social media
5056475|NCT03645941|Alaska Native|alaska native
5056489|NCT03645915|biomarkers|biomarkers
5056490|NCT03645915|diagnosis|diagnosis
5056491|NCT03645902|Acute stroke|acute stroke
5056492|NCT03645902|Susceptibility-weighted imaging|susceptibility-weighted imaging
5056493|NCT03645902|Arterial occlusion|arterial occlusion
5056494|NCT03645902|Time of flight|time of flight
5056501|NCT03645824|Pacritinib|pacritinib
5056502|NCT03645824|JAK2 inhibitor|jak2 inhibitor
5056503|NCT03645824|Myelofibrosis|myelofibrosis
5056504|NCT03645811|anxiety|anxiety
5056505|NCT03645811|OSCE|osce
5056506|NCT03645811|EFT|eft
5056507|NCT03645811|breath|breath
5056508|NCT03645811|music|music
5056509|NCT03645798|burnout|burnout
5056510|NCT03645798|turnover intention|turnover intention
5056511|NCT03645798|job performance|job performance
5056512|NCT03645798|job satisfaction|job satisfaction
5056513|NCT03645798|resilience|resilience
5056514|NCT03645798|self-efficacy|self-efficacy
5056515|NCT03645798|coping style|coping style
5056516|NCT03645798|cortisol|cortisol
5056517|NCT03645798|nurse|nurse
5056518|NCT03645759|behavioral treatment|behavioral treatment
5056519|NCT03645759|telehealth|telehealth
5056520|NCT03645759|stroke self-management|stroke self-management
5056521|NCT03645759|psychological distress|psychological distress
5056522|NCT03645759|social integration|social integration
5056523|NCT03645733|Haemodialysis|haemodialysis
5056524|NCT03645733|Kidney Disease|kidney disease
5056525|NCT03645733|Mental Health|mental health
5056526|NCT03645733|Cognitive Impairment|cognitive impairment
5056527|NCT03645707|Critical Care Nurse|critical care nurse
5056528|NCT03645707|Resilience|resilience
5056529|NCT03645707|Stress Mindset|stress mindset
5056540|NCT03645681|Cannulation|cannulation
5056541|NCT03645681|Quick Sealing dialysis graft|quick sealing dialysis graft
5056542|NCT03645668|sepsis，meropenem，2 steps administration|sepsis，meropenem，2 steps administration
5056543|NCT03645655|hepatoblastoma|hepatoblastoma
5056544|NCT03645655|Hepatic Hemangioendothelioma|hepatic hemangioendothelioma
5056545|NCT03645655|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
5056546|NCT03645655|Alpha-fetoprotein|alpha-fetoprotein
5056547|NCT03645655|infant|infant
5056548|NCT03645655|Differential diagnosis|differential diagnosis
5056549|NCT03645616|Musculoskeletal disease|musculoskeletal disease
5056550|NCT03645616|Stress test|stress test
5056554|NCT03645603|dexmedetomidine|dexmedetomidine
5056556|NCT03645603|sedation|sedation
5056557|NCT03645603|pediatric intensive care unit|pediatric intensive care unit
5056558|NCT03645603|abstinence syndrome|abstinence syndrome
5056559|NCT03645603|assessment tool|assessment tool
5056560|NCT03645577|Pulmonary vein isolation|pulmonary vein isolation
5056561|NCT03645577|Phrenic nerve palsy|phrenic nerve palsy
5056562|NCT03645577|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5056563|NCT03645577|Persistent atrial fibrillation|persistent atrial fibrillation
5056564|NCT03645564|Stroke|stroke
5056565|NCT03645564|Anti-vitamin K|anti-vitamin k
5053636|NCT03663335|Renal transplantation, CFZ533, CNI-free immunosuppression, transplant rejection, allograft rejection.|renal transplantation, cfz533, cni-free immunosuppression, transplant rejection, allograft rejection.
5053637|NCT03663270|goal directed management|goal directed management
5053638|NCT03663257|Interventional Neurology|interventional neurology
5053639|NCT03663257|Aneurysm|aneurysm
5053640|NCT03663257|Neurology|neurology
5053641|NCT03663257|Radiology|radiology
5053642|NCT03663257|AneurysmFlow|aneurysmflow
5053643|NCT03663192|Shock, Septic|shock, septic
5053644|NCT03663192|Echocardiography|echocardiography
5053645|NCT03663192|speckle tracking|speckle tracking
5957738|NCT01404754|MDMA|mdma
5957739|NCT01404754|mood|mood
5957740|NCT01404754|subjective effects|subjective effects
5957741|NCT01404754|interpersonal closeness|interpersonal closeness
5957755|NCT01380535|Extracorporeal photopheresis therapy|extracorporeal photopheresis therapy
5957756|NCT01380535|Methoxsalen|methoxsalen
5957757|NCT01380535|cGVHD|cgvhd
5957758|NCT01380535|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5957759|NCT01380353|Women undergoing total mastectomy|women undergoing total mastectomy
5957760|NCT01380353|Breast cancer prevention|breast cancer prevention
5957793|NCT01359761|Suicide|suicide
5957794|NCT01359761|Cognitive Therapy|cognitive therapy
5957795|NCT01359761|Inpatient|inpatient
5957796|NCT01359761|Military|military
5281245|NCT02268006|SIB|sib
5957863|NCT01346410|pancreatic cancer|pancreatic cancer
5261407|NCT02380755|Obesity|obesity
5958034|NCT01272050|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5958035|NCT01272050|recurrent prostate cancer|recurrent prostate cancer
5958036|NCT01272050|stage IIA prostate cancer|stage iia prostate cancer
5958037|NCT01272050|stage IIB prostate cancer|stage iib prostate cancer
5958038|NCT01272050|stage III prostate cancer|stage iii prostate cancer
5958046|NCT01266603|Metastatic Melanoma|metastatic melanoma
5958047|NCT01266603|Unresectable Melanoma|unresectable melanoma
5958048|NCT01266603|HDIL-2|hdil-2
5958049|NCT01266603|Interleukin-2|interleukin-2
5958050|NCT01266603|IL-2|il-2
5958051|NCT01266603|Aldesleukin|aldesleukin
5958052|NCT01266603|Proleukin|proleukin
5958053|NCT01266603|recMAGE-A3 + AS15|recmage-a3 + as15
5958054|NCT01266603|ASCI|asci
5958055|NCT01266603|recMAGE-A3|recmage-a3
5958056|NCT01266603|Recombinant MAGE-A3 protein|recombinant mage-a3 protein
5958057|NCT01266603|recMAGE-A3 + AS15 ASCI|recmage-a3 + as15 asci
5958058|NCT01266603|MAGE-A3|mage-a3
5958059|NCT01266603|MAGE-A3 ASCI|mage-a3 asci
5261497|NCT02380365|QTc interval|qtc interval
5261498|NCT02380365|arrhythmia|arrhythmia
5261502|NCT02380313|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5053646|NCT03663192|strain|strain
5053647|NCT03663179|ADHD|adhd
5053648|NCT03663179|TMS|tms
5053649|NCT03663166|Lung|lung
5053650|NCT03663166|Unresectable NSCLC|unresectable nsclc
5053651|NCT03663166|Radiation|radiation
5053652|NCT03663127|gamma-aminobutyric acid|gamma-aminobutyric acid
5053653|NCT03663127|blood pressure|blood pressure
5053654|NCT03663127|clinical trial|clinical trial
5053655|NCT03663127|angiotensin converting enzyme|angiotensin converting enzyme
5053656|NCT03663127|Beauty Drink|beauty drink
5053657|NCT03663114|Hepatocellular Carcinoma|hepatocellular carcinoma
5053658|NCT03663114|Lenvima|lenvima
5053659|NCT03663114|Post-marketing surveillance|post-marketing surveillance
5053660|NCT03663114|LEN02T|len02t
5053661|NCT03663114|Lenvatinib Mesilate|lenvatinib mesilate
5053662|NCT03663088|Physiotherapy|physiotherapy
5053663|NCT03663088|Global postural re-education|global postural re-education
5053664|NCT03663088|Cobb angle|cobb angle
5053665|NCT03663088|Posture|posture
5053666|NCT03663088|Back pain|back pain
5053667|NCT03663088|Participation|participation
5053668|NCT03663062|colorectal adenoma|colorectal adenoma
5053669|NCT03663062|colorectal cancer|colorectal cancer
5053670|NCT03663062|Obesity|obesity
5053671|NCT03663062|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5053672|NCT03663062|Metabolic syndrome|metabolic syndrome
5053673|NCT03663062|Liver Fibrosis|liver fibrosis
5053674|NCT03663036|Arthroscopic Superior Capsular Reconstruction|arthroscopic superior capsular reconstruction
5053675|NCT03663036|Fascia Lata|fascia lata
5053676|NCT03663036|Autograft|autograft
5053677|NCT03663036|Donor Site Morbidity|donor site morbidity
5053678|NCT03663036|Rotator Cuff Tear|rotator cuff tear
5053679|NCT03662997|Chronic wound|chronic wound
5053680|NCT03662997|Venous Leg Ulcer|venous leg ulcer
5053681|NCT03662997|Diabetic Foot Ulcer|diabetic foot ulcer
5053682|NCT03662997|Wound dressing|wound dressing
5053683|NCT03662932|Abdominal surgery|abdominal surgery
5053684|NCT03662932|Early mobilization|early mobilization
5053685|NCT03662932|Feasibility|feasibility
5053686|NCT03662906|Chronic urinary retention|chronic urinary retention
5053688|NCT03662906|Urinary function|urinary function
5053689|NCT03662906|Randomized controlled trial|randomized controlled trial
5053690|NCT03662893|overactive bladder|overactive bladder
5053691|NCT03662893|behavioural therapy|behavioural therapy
5053692|NCT03662893|adherence|adherence
5053693|NCT03662893|drug persistence|drug persistence
5053694|NCT03662867|mindfulness training|mindfulness training
5053695|NCT03662867|economically disadvantaged families|economically disadvantaged families
5053696|NCT03662867|family-based interventions|family-based interventions
5053697|NCT03662828|Kaposi's disease|kaposi's disease
5053698|NCT03662828|HHV8|hhv8
5053699|NCT03662828|Prevalence|prevalence
5053700|NCT03662815|Neoantigen|neoantigen
5053701|NCT03662815|iNeo-Vac-P01|ineo-vac-p01
5053702|NCT03662815|Peptide Vaccine|peptide vaccine
5053703|NCT03662802|artificial intelligence|artificial intelligence
5053704|NCT03662802|machine learning|machine learning
5053710|NCT03662789|Iron deficiency|iron deficiency
5053711|NCT03662789|Intravenous iron supplement|intravenous iron supplement
5053712|NCT03662789|Peak oxygen consumption|peak oxygen consumption
5053713|NCT03662789|Cardiopulmonary exercise test|cardiopulmonary exercise test
5053714|NCT03662789|Cognitive function|cognitive function
5053715|NCT03662789|Muscle strength|muscle strength
5053716|NCT03662776|Quality of Life|quality of life
5053717|NCT03662776|physical health|physical health
5053718|NCT03662776|emotional health|emotional health
5053719|NCT03662776|18-397|18-397
5053720|NCT03662750|TSPO|tspo
5053723|NCT03662750|Stroke|stroke
5053724|NCT03662750|Brain inflammation|brain inflammation
5053725|NCT03662737|Visuomotor task|visuomotor task
5053726|NCT03662724|Relapsed/refractory adult acute myeloid leukemia (AML)|relapsed/refractory adult acute myeloid leukemia (aml)
5053727|NCT03662711|adult|adult
5053728|NCT03662711|drug therapy|drug therapy
5053729|NCT03662711|combination|combination
5053730|NCT03662711|bronchodilator agents|bronchodilator agents
5053731|NCT03662711|male|male
5053732|NCT03662711|female|female
5053733|NCT03662698|Radiotherapy|radiotherapy
5053734|NCT03662698|Guided Imagery|guided imagery
5053735|NCT03662698|Therapy|therapy
5053736|NCT03662698|Distress|distress
5053737|NCT03662698|Anxiety|anxiety
5053738|NCT03662698|Depression|depression
5053739|NCT03662685|goeckerman|goeckerman
5053740|NCT03662685|phototherapy|phototherapy
5053741|NCT03662685|psoriasis|psoriasis
5053742|NCT03662607|preprocedure|preprocedure
5053743|NCT03662607|anxiety|anxiety
5053744|NCT03662607|cardiac catheterization|cardiac catheterization
5053745|NCT03662594|Anticoagulation|anticoagulation
5958249|NCT01180881|Proton Radiation|proton radiation
5958250|NCT01180881|CNS tumors|cns tumors
5958251|NCT01180881|Brain Tumors|brain tumors
5958252|NCT01180881|Neurobehavioral functioning|neurobehavioral functioning
5958326|NCT01129440|Children|children
5958327|NCT01129440|Fluoride varnish|fluoride varnish
5346254|NCT01966757|NCL|ncl
5958328|NCT01129440|Glass ionomer sealant|glass ionomer sealant
5958329|NCT01129440|Prevention|prevention
5958354|NCT01112306|Open-label|open-label
5958355|NCT01112306|PAH|pah
5958356|NCT01112306|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5053746|NCT03662581|Generalized anxiety disorder|generalized anxiety disorder
5053747|NCT03662581|Mental health|mental health
5053748|NCT03662581|Mindfulness|mindfulness
5053749|NCT03662581|Group-based therapy|group-based therapy
5053750|NCT03662516|PF-04965842|pf-04965842
5053751|NCT03662451|Return-to-work|return-to-work
5053752|NCT03662451|Cosmesis|cosmesis
5053753|NCT03662451|Visual analogue pain score|visual analogue pain score
5053754|NCT03662438|Exercise|exercise
5053755|NCT03662438|Physical Activity|physical activity
5053756|NCT03662438|Respiratory Failure|respiratory failure
5053757|NCT03662438|Oxygen Inhalation Therapy|oxygen inhalation therapy
5053758|NCT03662425|schizophrenia|schizophrenia
5053759|NCT03662425|negative symptoms|negative symptoms
5053760|NCT03662425|Oxytocin|oxytocin
5731109|NCT00390195|Phase I|phase i
5053761|NCT03662386|hereditary retinal dystrophies|hereditary retinal dystrophies
5053762|NCT03662373|on line monitoring|on line monitoring
5053763|NCT03662373|PET in beam|pet in beam
5053764|NCT03662373|Hadrontherapy|hadrontherapy
5053765|NCT03662360|BPSD (behavioral and psycological symptoms of dementia)|bpsd (behavioral and psycological symptoms of dementia)
5053766|NCT03662360|aromatherapy|aromatherapy
5053767|NCT03662360|elderly|elderly
5053768|NCT03662334|Diabetes|diabetes
5053769|NCT03662334|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5053770|NCT03662334|Type 1 Diabetes|type 1 diabetes
5053771|NCT03662334|T1DM|t1dm
5053772|NCT03662334|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5053773|NCT03662334|CSII|csii
5053774|NCT03662334|Insulin pump|insulin pump
5053775|NCT03662334|Insulin|insulin
5053776|NCT03662334|rHuPH20|rhuph20
5053777|NCT03662334|Hylenex|hylenex
5053778|NCT03662334|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
5053779|NCT03662334|Recombinant hyaluronidase|recombinant hyaluronidase
5053780|NCT03662321|teenager|teenager
5053781|NCT03662321|sexuality|sexuality
5053782|NCT03662321|internet|internet
5053783|NCT03662308|Hypothermia|hypothermia
5053784|NCT03662308|Body Temperature Regulation|body temperature regulation
5053785|NCT03662308|Cognition|cognition
5960946|NCT04290169|Upper extremity function|upper extremity function
5960947|NCT04290156|inflammatory bowel disease|inflammatory bowel disease
5053786|NCT03662295|Cognitive Impairment|cognitive impairment
5053787|NCT03662282|Omegaven|omegaven
5053788|NCT03662282|parenteral nutrition|parenteral nutrition
5053789|NCT03662282|Liver disease|liver disease
5053790|NCT03662282|Cholestasis|cholestasis
5053791|NCT03662256|hearing loss|hearing loss
5053792|NCT03662256|deafness|deafness
5053793|NCT03662256|hearing disorders|hearing disorders
5053794|NCT03662256|ear diseases|ear diseases
5053795|NCT03662256|otorhinolaryngologic diseases|otorhinolaryngologic diseases
5053796|NCT03662256|child, preschool|child, preschool
5053797|NCT03662230|war wounds|war wounds
5053798|NCT03662230|intensive care unit|intensive care unit
5053799|NCT03662217|Diabetes Type 2|diabetes type 2
5053800|NCT03662204|blood draw|blood draw
5053801|NCT03662204|sample collection|sample collection
5053802|NCT03662165|HIV testing|hiv testing
5053803|NCT03662165|Truck drivers|truck drivers
5053805|NCT03662152|foam roller|foam roller
5053806|NCT03662152|vibration foam roller|vibration foam roller
5053807|NCT03662152|pressure pain threshold|pressure pain threshold
5053808|NCT03662152|oxygen saturation|oxygen saturation
5053809|NCT03662152|countermovement jump|countermovement jump
5053810|NCT03662152|soreness|soreness
5053811|NCT03662113|domperidone|domperidone
5053812|NCT03661996|Osteoarthritis|osteoarthritis
5053813|NCT03661996|Knee Pain|knee pain
5053814|NCT03661996|non opioid|non opioid
5053820|NCT03661944|return to play|return to play
5053821|NCT03661944|overhead athletes|overhead athletes
5053822|NCT03661918|Parent, adolescent, coaching, weight loss|parent, adolescent, coaching, weight loss
5053823|NCT03661905|Treatment acceptability|treatment acceptability
5053824|NCT03661905|Cognitive therapy|cognitive therapy
5053825|NCT03661905|Anxiety disorders|anxiety disorders
5053826|NCT03661892|Breast Cancer|breast cancer
5053827|NCT03661892|Bone Metastases|bone metastases
5053830|NCT03661892|Syndros|syndros
5053831|NCT03661892|Bone pain|bone pain
5053837|NCT03661840|Acceptance and Commitment Therapy|acceptance and commitment therapy
5053838|NCT03661840|Cancer|cancer
5053839|NCT03661840|Survivor|survivor
5053840|NCT03661840|Group Based|group based
5053841|NCT03661840|Pain Management|pain management
5053842|NCT03661814|Negative Pressure Wound Therapy|negative pressure wound therapy
5958528|NCT00939653|relapsed|relapsed
5053843|NCT03661814|Colorectal Surgery|colorectal surgery
5053844|NCT03661814|Prevena|prevena
5053845|NCT03661814|Surgical Site Infection|surgical site infection
5053846|NCT03661801|Respiratory|respiratory
5053847|NCT03661801|Pleural Effusion|pleural effusion
5053848|NCT03661788|Atomoxetin|atomoxetin
5053849|NCT03661788|fMRT|fmrt
5053850|NCT03661762|eye movements|eye movements
5053851|NCT03661762|electronystagmography|electronystagmography
5053852|NCT03661762|nystagmus|nystagmus
5053853|NCT03661762|electrooculogram|electrooculogram
5053854|NCT03661762|vestibular assessment|vestibular assessment
5053855|NCT03661723|Glioblastoma|glioblastoma
5053856|NCT03661697|skin|skin
5053857|NCT03661697|sun damage|sun damage
5053858|NCT03661697|photoaging of face|photoaging of face
5053859|NCT03661697|skin care|skin care
5053860|NCT03661697|laser therapy|laser therapy
5053861|NCT03661684|Diabetes|diabetes
5053862|NCT03661684|Glucocorticoids|glucocorticoids
5053863|NCT03661684|Hyperglycemia|hyperglycemia
5053864|NCT03661671|Linked-color imaging|linked-color imaging
5053865|NCT03661671|Detection|detection
5053866|NCT03661645|Glucocorticoids(GS)|glucocorticoids(gs)
5053867|NCT03661645|injection|injection
5053868|NCT03661619|Gingival recession|gingival recession
5053869|NCT03661619|Root coverage|root coverage
5053870|NCT03661619|Periodontal plastic surgery|periodontal plastic surgery
5053871|NCT03661619|Subepithelial connective tissue graft|subepithelial connective tissue graft
5053872|NCT03661567|methylprednisolone|methylprednisolone
5053873|NCT03661567|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5053874|NCT03661567|Radiation-induced Pulmonary Injury|radiation-induced pulmonary injury
5053875|NCT03661541|Squaric Acid|squaric acid
5053876|NCT03661528|thrombosis|thrombosis
5053877|NCT03661528|anticoagulant|anticoagulant
5053878|NCT03661528|acute intracranial hemorrhage|acute intracranial hemorrhage
5053879|NCT03661515|Acute Myeloid Leukemia|acute myeloid leukemia
5053880|NCT03661515|Relapsed|relapsed
5053881|NCT03661515|Refractory|refractory
5053882|NCT03661515|Selinexor|selinexor
5053883|NCT03661489|remimazolam|remimazolam
5053884|NCT03661476|Intermittent Exotropia|intermittent exotropia
5053885|NCT03661476|Oculo-Motor Exercises|oculo-motor exercises
5053886|NCT03661476|Physiotherapy|physiotherapy
5053887|NCT03661476|Intermittent Exotropia Survey|intermittent exotropia survey
5053888|NCT03661463|Aspirin|aspirin
5053889|NCT03661463|Magnetic Resonance Vessel Wall Imaging|magnetic resonance vessel wall imaging
5053890|NCT03661450|Clinical Decision-Support System|clinical decision-support system
5053891|NCT03661424|Metastatic Breast Cancer|metastatic breast cancer
5053892|NCT03661424|Adoptive Cell Therapy|adoptive cell therapy
5053893|NCT03661424|Armed Activated T-cells|armed activated t-cells
5053894|NCT03661424|Bispecific Antibodies|bispecific antibodies
5053895|NCT03661424|Immunotherapy|immunotherapy
5053896|NCT03661398|Percutaneous mitral valve replacement|percutaneous mitral valve replacement
5053897|NCT03661398|Trans-septal mitral valve replacement|trans-septal mitral valve replacement
5053898|NCT03661398|Transcatheter mitral valve replacement|transcatheter mitral valve replacement
5053899|NCT03661398|TMVR|tmvr
5053900|NCT03661398|Primary MR|primary mr
5053901|NCT03661398|Secondary MR|secondary mr
5053902|NCT03661398|Structural Heart Disease|structural heart disease
5053903|NCT03661398|Heart Failure|heart failure
5053905|NCT03661398|Functional Mitral Valve Disease|functional mitral valve disease
5053906|NCT03661385|Cardiopulmonary bypass|cardiopulmonary bypass
5053907|NCT03661385|Congenital heart disease|congenital heart disease
5053908|NCT03661385|Low cardiac output syndrome|low cardiac output syndrome
5053909|NCT03661385|Nitric oxide|nitric oxide
5053927|NCT03661151|Gastroesophageal reflux disease|gastroesophageal reflux disease
5053928|NCT03661151|Antireflux surgery|antireflux surgery
5053929|NCT03661138|Upadacitinib|upadacitinib
5053930|NCT03661138|Topical Corticosteroids|topical corticosteroids
5053931|NCT03661138|Atopic Dermatitis|atopic dermatitis
5053932|NCT03661112|blood pressure|blood pressure
5053933|NCT03661112|mobile device|mobile device
5053934|NCT03661086|closed-loop|closed-loop
5053935|NCT03661086|oxygen treatment|oxygen treatment
5053936|NCT03661060|Acute Heart Failure|acute heart failure
5053937|NCT03661060|Chronic Heart Failure|chronic heart failure
5053938|NCT03661060|Guideline adherence|guideline adherence
5053939|NCT03661060|Clinical registry|clinical registry
5053946|NCT03661034|Dementia|dementia
5053947|NCT03661034|Alzheimer's Disease|alzheimer's disease
5053948|NCT03661034|Memory Loss|memory loss
5053949|NCT03661021|Functional movement disorder|functional movement disorder
5053950|NCT03661021|Functional neurological disorder|functional neurological disorder
5053951|NCT03661021|FMD|fmd
5053952|NCT03661021|Psychogenic movement disorder|psychogenic movement disorder
5053953|NCT03661021|Movement Disorders|movement disorders
5053954|NCT03660995|Slow language impairment|slow language impairment
5053955|NCT03660995|semantic|semantic
5053956|NCT03660995|pragmatic|pragmatic
5053957|NCT03660995|procedural learning|procedural learning
5053958|NCT03660995|genotype|genotype
5053959|NCT03660969|troponin|troponin
5053960|NCT03660943|Osteoarthritis|osteoarthritis
5053961|NCT03660943|Knee Pain|knee pain
5053962|NCT03660904|vitrification|vitrification
5053963|NCT03660904|blastocysts|blastocysts
5053964|NCT03660904|home-made media|home-made media
5053965|NCT03660865|Light Adjustable Lens|light adjustable lens
5053966|NCT03660865|Intraocular lens|intraocular lens
5053967|NCT03660865|LAL|lal
5053968|NCT03660813|oocyte, double triggering, follicle size|oocyte, double triggering, follicle size
5053969|NCT03660787|Adhesion|adhesion
5053970|NCT03660787|Efficacy|efficacy
5053971|NCT03660748|human microbiota|human microbiota
5053972|NCT03660735|Immune Profiling|immune profiling
5053973|NCT03660735|Pre-IVF|pre-ivf
5053974|NCT03660709|Unprotected anal intercourse|unprotected anal intercourse
5053975|NCT03660709|HIV retesting|hiv retesting
5053976|NCT03660709|Risk perception|risk perception
5053977|NCT03660683|saxagliptin dapagliflozin diabetes cardiovascular diseases EPC|saxagliptin dapagliflozin diabetes cardiovascular diseases epc
5053978|NCT03660670|Oral chemotherapy|oral chemotherapy
5053979|NCT03660670|cancer outpatient|cancer outpatient
5053980|NCT03660670|ONCORAL|oncoral
5053981|NCT03660670|medico-economic|medico-economic
5053982|NCT03660670|Health related program|health related program
5053983|NCT03660670|multidisciplinary|multidisciplinary
5053984|NCT03660670|therapeutic education|therapeutic education
5053985|NCT03660657|complementary and integrative medicine|complementary and integrative medicine
5053986|NCT03660657|cost-effectiveness ratio|cost-effectiveness ratio
5053987|NCT03660657|ischemic heart disease|ischemic heart disease
5053988|NCT03660657|heart failure|heart failure
5053989|NCT03660657|ozone therapy|ozone therapy
5053990|NCT03660657|quality of life related to health|quality of life related to health
5053991|NCT03660657|shared decision-making tool|shared decision-making tool
5053995|NCT03660618|perfusion|perfusion
5053996|NCT03660618|inflammatory|inflammatory
5053997|NCT03660618|ischemia|ischemia
5053998|NCT03660618|lesions|lesions
5053999|NCT03660618|neuropathy|neuropathy
5054000|NCT03660618|burns|burns
5054001|NCT03660618|cancer|cancer
5054002|NCT03660618|stroke|stroke
5054003|NCT03660605|gait|gait
5054004|NCT03660605|balance|balance
5054005|NCT03660605|auditory cues|auditory cues
5054009|NCT03660579|Physical fitness|physical fitness
5054011|NCT03660579|Stress|stress
5054012|NCT03660579|Training|training
5054013|NCT03660579|HIIT|hiit
5054014|NCT03660579|Beer|beer
5054015|NCT03660566|Platelet-Rich Fibrin|platelet-rich fibrin
5054016|NCT03660566|Dental Implant|dental implant
5054017|NCT03660553|Diabetes|diabetes
5054018|NCT03660553|Elderly|elderly
5054019|NCT03660553|Insulin treatment|insulin treatment
5054020|NCT03660553|Quality of life|quality of life
5054021|NCT03660527|hemoglobin, vitamin D, vitamin A, TC, TG, HDLC|hemoglobin, vitamin d, vitamin a, tc, tg, hdlc
5054022|NCT03660514|Reproductive Coercion|reproductive coercion
5054023|NCT03660514|Gender-based violence|gender-based violence
5054024|NCT03660514|Contraception|contraception
5054025|NCT03660514|Clinic-based screening for IPV|clinic-based screening for ipv
5054026|NCT03660514|Clinic-based counseling|clinic-based counseling
5054027|NCT03660501|Continuous monitoring|continuous monitoring
5054028|NCT03660488|syphilis|syphilis
5054029|NCT03660488|cefixime|cefixime
5054030|NCT03660488|penicillin|penicillin
5054035|NCT03660449|Hypofractionated Conformal Radiation|hypofractionated conformal radiation
5054036|NCT03660449|S-1|s-1
5054037|NCT03660423|Dance|dance
5054038|NCT03660410|indians, south american|indians, south american
5054039|NCT03660410|periodontal disease|periodontal disease
5054040|NCT03660410|dental caries|dental caries
5054041|NCT03660397|Uncontrolled Hypertension|uncontrolled hypertension
5054042|NCT03660397|Resistant hypertension|resistant hypertension
5054043|NCT03660397|Aldosterone|aldosterone
5054044|NCT03660397|Ablation|ablation
5054045|NCT03660397|Adrenal Gland|adrenal gland
5054046|NCT03660358|preterm infants|preterm infants
5054047|NCT03660358|kinesiotape|kinesiotape
5054048|NCT03660358|ventilation|ventilation
5054049|NCT03660358|respiratory muscles|respiratory muscles
5054050|NCT03660319|music therapy|music therapy
5054051|NCT03660319|EMT|emt
5054052|NCT03660319|environmental music therapy|environmental music therapy
5054053|NCT03660319|radiation oncology|radiation oncology
5054054|NCT03660319|anxiety|anxiety
5054055|NCT03660319|waiting room|waiting room
5054056|NCT03660280|Inflammation|inflammation
5054057|NCT03660267|Benign Gynecologic Operation|benign gynecologic operation
5054058|NCT03660267|Coffee Ingestion|coffee ingestion
5054059|NCT03660267|Recovery of Bowel Function|recovery of bowel function
5054060|NCT03660228|MDS|mds
5054061|NCT03660228|Myelodysplastic Syndromes|myelodysplastic syndromes
5054062|NCT03660228|Quality of life|quality of life
5054063|NCT03660228|Tranfusion-dependent|tranfusion-dependent
5054064|NCT03660202|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5054065|NCT03660189|intravenous fluids|intravenous fluids
5054066|NCT03660189|adults|adults
5054067|NCT03660189|two bag system|two bag system
5054068|NCT03660137|Non-palpable lesion|non-palpable lesion
5054069|NCT03660137|Localization|localization
5054070|NCT03660137|Lumpectomy|lumpectomy
5054071|NCT03660137|Breast-Conserving Surgery|breast-conserving surgery
5054072|NCT03660137|Breast Cancer|breast cancer
5054073|NCT03660098|FMD|fmd
5054074|NCT03660098|functional movement disorder|functional movement disorder
5054075|NCT03660098|functional neurological disorder|functional neurological disorder
5054076|NCT03660098|functional tremor|functional tremor
5054077|NCT03660098|psychogenic tremor|psychogenic tremor
5054078|NCT03660085|Prostate Cancer|prostate cancer
5054079|NCT03660085|Radical Prostatectomy|radical prostatectomy
5054080|NCT03660085|Urological Symptoms|urological symptoms
5054081|NCT03660085|Radiation Therapy|radiation therapy
5054082|NCT03660085|Mental Health|mental health
5054083|NCT03660085|Pre-Habilitation|pre-habilitation
5054084|NCT03660085|Exercise|exercise
5054085|NCT03660085|Pelvic floor exercises|pelvic floor exercises
5054086|NCT03660085|Intimacy and Connection|intimacy and connection
5054087|NCT03660085|Social connection|social connection
5054088|NCT03660085|Meditation|meditation
5054089|NCT03660085|Stress reduction|stress reduction
5054090|NCT03660059|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5054091|NCT03660059|efficacy|efficacy
5054092|NCT03660059|ASP015K|asp015k
5054093|NCT03660059|Peficitinib|peficitinib
5054094|NCT03660059|safety|safety
5054095|NCT03660046|Human immunodeficiency virus|human immunodeficiency virus
5054096|NCT03660046|Sexually Transmitted Diseases|sexually transmitted diseases
5054097|NCT03660046|Contraceptives|contraceptives
5054098|NCT03660033|Simulation|simulation
5054099|NCT03660033|NRP|nrp
5054100|NCT03660033|Resuscitation|resuscitation
5054101|NCT03660033|ECG|ecg
5054102|NCT03660033|Electrocardiogram|electrocardiogram
5054103|NCT03660007|In vitro fertilization|in vitro fertilization
5054104|NCT03660007|Assisted Reproductive Techniques|assisted reproductive techniques
5054105|NCT03660007|Pulmonary embolism|pulmonary embolism
5054106|NCT03660007|Venous Thromboembolism|venous thromboembolism
5054107|NCT03660007|Pregnancy|pregnancy
5054108|NCT03659994|Facial Hair|facial hair
5054109|NCT03659955|Dry eye|dry eye
5054110|NCT03659955|Ocular surface|ocular surface
5054111|NCT03659955|Autologous blood|autologous blood
5054112|NCT03659916|Pediatric|pediatric
5054113|NCT03659916|Cholestasis|cholestasis
5054114|NCT03659903|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5054115|NCT03659903|pancreaticoduodenectomy|pancreaticoduodenectomy
5054116|NCT03659877|Physical Activity|physical activity
5054117|NCT03659877|Accelerometer|accelerometer
5054118|NCT03659864|nanoparticles|nanoparticles
5054119|NCT03659864|pollution|pollution
5054120|NCT03659851|Heart failure|heart failure
5054121|NCT03659851|Left ventricular dysfunction|left ventricular dysfunction
5054122|NCT03659838|Asthma|asthma
5054123|NCT03659838|Wheeze|wheeze
5054124|NCT03659838|Cough|cough
5054125|NCT03659838|Snoring|snoring
5054126|NCT03659838|Bronchial obstruction|bronchial obstruction
5054127|NCT03659838|Air pollution|air pollution
5960948|NCT04290156|transitional care|transitional care
5054128|NCT03659812|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
5054133|NCT03659773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5054134|NCT03659773|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5054136|NCT03659773|vaccines|vaccines
5054137|NCT03659773|immune function|immune function
5054138|NCT03659760|Melatonin|melatonin
5054139|NCT03659760|Interleukin|interleukin
5054140|NCT03659760|Transcranial|transcranial
5054141|NCT03659760|Surgery|surgery
5054142|NCT03659760|Intensive care|intensive care
5054143|NCT03659747|Lactose maldigestion|lactose maldigestion
5054144|NCT03659747|gastrointestinal|gastrointestinal
5054145|NCT03659747|Single-nucleotide polymorphism|single-nucleotide polymorphism
5054146|NCT03659747|probiotic|probiotic
5054147|NCT03659721|Pregnant|pregnant
5054148|NCT03659721|Infant|infant
5054149|NCT03659721|Parent|parent
5054150|NCT03659721|Family|family
5054151|NCT03659721|Mother|mother
5054152|NCT03659721|Support|support
5054153|NCT03659708|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
5054154|NCT03659708|Lyon VTE-score|lyon vte-score
5054155|NCT03659708|pregnancy|pregnancy
5054156|NCT03659708|thromboprophylaxis|thromboprophylaxis
5054157|NCT03659708|venous thromboembolism|venous thromboembolism
5054158|NCT03659708|quality of life|quality of life
5054159|NCT03659708|cost utility|cost utility
5054160|NCT03659682|GLP1R, neuroprotection, inflammation|glp1r, neuroprotection, inflammation
5054161|NCT03659669|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5054162|NCT03659669|Cancer|cancer
5054163|NCT03659669|venetoclax|venetoclax
5054164|NCT03659669|observation|observation
5054166|NCT03659643|Alzheimer´s disease|alzheimer´s disease
5054167|NCT03659643|Lewy Body Dementia|lewy body dementia
5054168|NCT03659643|EEG|eeg
5249641|NCT02447094|robot|robot
5282398|NCT02260570|MRI|mri
5958982|NCT00734019|Arthroplasty, Replacement, Knee, TKR, PFC Sigma|arthroplasty, replacement, knee, tkr, pfc sigma
5958983|NCT00732212|UGI Bleeding|ugi bleeding
5958984|NCT00732212|Ulcer or variceal hemorrhage|ulcer or variceal hemorrhage
5958985|NCT00732212|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
5958986|NCT00732212|Endoscopy|endoscopy
5958987|NCT00732212|Randomized Controlled Trial|randomized controlled trial
5958988|NCT00732212|Non-variceal UGI hemorrhage|non-variceal ugi hemorrhage
5958989|NCT00732212|Variceal hemorrhage|variceal hemorrhage
5054169|NCT03659617|alveolar bone|alveolar bone
5054170|NCT03659617|alveolar ridge|alveolar ridge
5054171|NCT03659617|bone resorption|bone resorption
5054172|NCT03659617|bone grafting|bone grafting
5054173|NCT03659617|barrier membrane|barrier membrane
5054174|NCT03659604|physical activity|physical activity
5054175|NCT03659604|sedentary behavior|sedentary behavior
5054176|NCT03659604|serious game|serious game
5054177|NCT03659604|exergame|exergame
5054178|NCT03659604|behaviour change techniques|behaviour change techniques
5054179|NCT03659604|tailored feedback|tailored feedback
5054180|NCT03659591|Cognitive Behaviour Therapy|cognitive behaviour therapy
5054181|NCT03659591|Community Mental Health|community mental health
5054182|NCT03659591|Adaptive Psychological Training|adaptive psychological training
5054183|NCT03659591|Quality of Life|quality of life
5054184|NCT03659591|Wellbeing|wellbeing
5054185|NCT03659591|Treatment|treatment
5731110|NCT00390195|Phase II|phase ii
5054186|NCT03659578|Non-small Cell Lung Cancer|non-small cell lung cancer
5054187|NCT03659578|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5054188|NCT03659578|Thymosin a1|thymosin a1
5054189|NCT03659539|propofol|propofol
5054190|NCT03659539|desflurane|desflurane
5054191|NCT03659539|robotic|robotic
5054192|NCT03659539|recovery|recovery
5054193|NCT03659526|Myocardial velocity imaging|myocardial velocity imaging
5054194|NCT03659526|Strain|strain
5054195|NCT03659526|Strain rate|strain rate
5054196|NCT03659526|Speckle tracking|speckle tracking
5054197|NCT03659526|Deformation|deformation
5054198|NCT03659526|Quantitative|quantitative
5054199|NCT03659526|Echocardiography|echocardiography
5054200|NCT03659526|Machine learning|machine learning
5054201|NCT03659513|Hypoxia|hypoxia
5054202|NCT03659513|ECMO|ecmo
5054203|NCT03659513|Antibiotics|antibiotics
5054204|NCT03659513|Pharmacokinetics|pharmacokinetics
5054205|NCT03659474|skin temperature|skin temperature
5054206|NCT03659474|postural control|postural control
5054207|NCT03659474|ankle|ankle
5054208|NCT03659448|Fluorescence|fluorescence
5054209|NCT03659448|Cancer|cancer
5054210|NCT03659448|SGM-101|sgm-101
5054211|NCT03659448|Surgery|surgery
5054212|NCT03659448|Colorectal|colorectal
5054213|NCT03659409|Mindfulness|mindfulness
5054214|NCT03659409|Stroke Survivors|stroke survivors
5054215|NCT03659409|Caregivers|caregivers
5054216|NCT03659370|Osteoarthritis|osteoarthritis
5054217|NCT03659370|Knee|knee
5054218|NCT03659370|Fumigation|fumigation
5054219|NCT03659370|Acupuncture|acupuncture
5054220|NCT03659344|sutures|sutures
5054221|NCT03659344|Surgical Wound Infection|surgical wound infection
5054223|NCT03659305|Bevacizumab|bevacizumab
5054224|NCT03659305|oncology|oncology
5054225|NCT03659305|VEGF receptor|vegf receptor
5054226|NCT03659292|Epidural block|epidural block
5054241|NCT03659227|sampling|sampling
5054242|NCT03659227|collection|collection
5054243|NCT03659214|Cystic Fibrosis|cystic fibrosis
5054245|NCT03659214|Adherence|adherence
5054246|NCT03659214|Adolescent|adolescent
5054247|NCT03659214|Anxiety|anxiety
5054248|NCT03659214|Depression|depression
5054249|NCT03659214|Psychology|psychology
5054250|NCT03659149|Hypertension|hypertension
5054251|NCT03659149|Dyslipidemias|dyslipidemias
5054252|NCT03659149|CKD-333|ckd-333
5054253|NCT03659123|Elderly|elderly
5054254|NCT03659123|Prehabilitation|prehabilitation
5054255|NCT03659123|Cancer|cancer
5054256|NCT03659123|Surgery|surgery
5054257|NCT03659110|vaccine|vaccine
5054258|NCT03659110|safety|safety
5054259|NCT03659084|Acute myeloid leukaemia|acute myeloid leukaemia
5054260|NCT03659084|Myelodysplastic syndrome|myelodysplastic syndrome
5054261|NCT03659084|Iron Chelation Therapy (Exjade)|iron chelation therapy (exjade)
5054262|NCT03659084|allogeneic Hematopoietic Stem Cell transplantation (Allo-HSCT)|allogeneic hematopoietic stem cell transplantation (allo-hsct)
5054263|NCT03659058|fibrosis|fibrosis
5054265|NCT03659058|Reversal|reversal
5054266|NCT03659058|sustained virological response|sustained virological response
5054267|NCT03659032|Manual Therapy|manual therapy
5054268|NCT03659032|Cranial assymetry|cranial assymetry
5054269|NCT03659032|Cranial deformation|cranial deformation
5054270|NCT03659032|Physical Therapy|physical therapy
5054271|NCT03659006|inflammatory Biomarkers, Traumatic brain injury, multimodal MRI, tertiary lesion|inflammatory biomarkers, traumatic brain injury, multimodal mri, tertiary lesion
5054272|NCT03658993|Microscopic colitis|microscopic colitis
5054273|NCT03658993|Diarrhoea|diarrhoea
5054274|NCT03658993|Microbiome|microbiome
5054275|NCT03658993|Rifaxamine|rifaxamine
5054276|NCT03658980|Diabetes Mellitus|diabetes mellitus
5054277|NCT03658980|Diabetic Retinopathy|diabetic retinopathy
5054278|NCT03658980|Referral|referral
5054279|NCT03658967|Lymphedema|lymphedema
5054280|NCT03658967|Breast cancer|breast cancer
5054281|NCT03658967|Adenoviral vector|adenoviral vector
5054282|NCT03658954|Sleep Disorders|sleep disorders
5054283|NCT03658954|Self-Management|self-management
5054284|NCT03658954|Telemedicine|telemedicine
5262614|NCT02374099|ER+|er+
5959233|NCT00508547|Methotrexate|methotrexate
5959234|NCT00508547|Acitretin|acitretin
5959235|NCT00508547|Cyclosporine|cyclosporine
5959236|NCT00508547|Systemic PUVA|systemic puva
5959237|NCT00508547|Infliximab|infliximab
5959238|NCT00508547|Adalimumab|adalimumab
5959239|NCT00508547|Alefacept|alefacept
5959240|NCT00508547|Efalizumab|efalizumab
5959241|NCT00508547|Etanercept|etanercept
5959242|NCT00508547|Psoriasis|psoriasis
5959243|NCT00508547|Psoriatic arthritis|psoriatic arthritis
5959244|NCT00508547|Skin disease|skin disease
5959245|NCT00508547|Cosentyx|cosentyx
5959309|NCT00486889|Glycogenesis 2|glycogenesis 2
5250150|NCT02444091|CFS|cfs
5959364|NCT00440726|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5959365|NCT00440726|Pediatrics|pediatrics
5959366|NCT00440726|Relapsed|relapsed
5959367|NCT00440726|Recurrence|recurrence
5959368|NCT00440726|Bortezomib|bortezomib
5959369|NCT00440726|Velcade|velcade
5959370|NCT00440726|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
5959371|NCT00440726|Investigational|investigational
5959372|NCT00440726|Childhood|childhood
5959373|NCT00440726|ALL|all
5959374|NCT00440726|Relapsed ALL|relapsed all
5959375|NCT00440726|Refractory ALL|refractory all
5959376|NCT00440726|Relapsed pediatric ALL|relapsed pediatric all
5959377|NCT00440726|Refractory pediatric ALL|refractory pediatric all
5959378|NCT00440726|TACL|tacl
5959379|NCT00440726|Recurrent Pediatric ALL|recurrent pediatric all
5959380|NCT00432796|Anticoagulation|anticoagulation
5959381|NCT00432796|Prosthetic heart valves|prosthetic heart valves
5959382|NCT00432796|Atrial fibrillation|atrial fibrillation
5959383|NCT00432796|Bridging Therapy|bridging therapy
5959384|NCT00432796|Thromboembolism|thromboembolism
5959385|NCT00432796|Warfarin|warfarin
5959386|NCT00432796|Low Molecular Weight Heparin|low molecular weight heparin
5959422|NCT00390104|Neuromuscular Disease|neuromuscular disease
5959423|NCT00390104|Muscle weakness|muscle weakness
5959424|NCT00390104|Muscle atrophy|muscle atrophy
5959425|NCT00389142|pelvic pain|pelvic pain
5959426|NCT00389142|urinary frequency|urinary frequency
5959427|NCT00389142|painful bladder|painful bladder
5959428|NCT00389142|urinary urgency|urinary urgency
5959460|NCT00365586|Pain|pain
5959461|NCT00365586|Osteoarthritis|osteoarthritis
5959462|NCT00365586|Knee|knee
5959463|NCT00365586|NSAID|nsaid
5959497|NCT00352625|Tendonitis|tendonitis
5959498|NCT00352625|Bursitis|bursitis
5959499|NCT00352625|Pain|pain
5959500|NCT00352625|Shoulder Pain|shoulder pain
5959501|NCT00352625|Elbow Pain|elbow pain
5959502|NCT00352625|Knee Pain|knee pain
5959503|NCT00352625|Tendon Injury|tendon injury
5959504|NCT00352625|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5959510|NCT00351104|Sprain|sprain
5959511|NCT00351104|Strain|strain
5959512|NCT00351104|Pain|pain
5959513|NCT00351104|Ankle Pain|ankle pain
5959514|NCT00351104|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5054285|NCT03658954|Health Education|health education
5054286|NCT03658954|Wearable Electronic Devices|wearable electronic devices
5054287|NCT03658941|craniotomy|craniotomy
5731483|NCT00388804|Goserelin|goserelin
5054288|NCT03658941|dural tenting suture|dural tenting suture
5054289|NCT03658941|epidural hematoma|epidural hematoma
5054290|NCT03658915|Position sense|position sense
5054291|NCT03658915|Smartphone|smartphone
5054292|NCT03658915|Validity|validity
5054293|NCT03658915|Reliability|reliability
5054294|NCT03658915|Knee osteoarthritis|knee osteoarthritis
5054295|NCT03658902|Botulism|botulism
5054296|NCT03658902|Intensive Care|intensive care
5054297|NCT03658876|Hemodialysis|hemodialysis
5054298|NCT03658863|choledocholithiasis|choledocholithiasis
5054299|NCT03658863|endoscopic ultrasound|endoscopic ultrasound
5054300|NCT03658863|ERCP|ercp
5054301|NCT03658863|intraoperative cholangiography|intraoperative cholangiography
5054302|NCT03658863|common bile duct stone|common bile duct stone
5054303|NCT03658863|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5054304|NCT03658863|gallstone disease|gallstone disease
5054305|NCT03658863|cholelithiasis|cholelithiasis
5054306|NCT03658863|bile duct obstruction|bile duct obstruction
5054307|NCT03658863|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5054308|NCT03658850|hypernatremia|hypernatremia
5054762|NCT03655704|Open-label|open-label
5054324|NCT03658772|checkpoint inhibitor|checkpoint inhibitor
5054326|NCT03658759|Extra corporeal Life support|extra corporeal life support
5054327|NCT03658759|extracorporeal cardiopulmonary resuscitation|extracorporeal cardiopulmonary resuscitation
5054328|NCT03658759|refractory out-of-hospital cardiac arrest|refractory out-of-hospital cardiac arrest
5054329|NCT03658759|extra corporeal membrane oxygenation|extra corporeal membrane oxygenation
5054330|NCT03658759|mechanical circulatory support|mechanical circulatory support
5054331|NCT03658759|mechanical chest compressions|mechanical chest compressions
5054332|NCT03658746|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
5054334|NCT03658733|Sequential therapy|sequential therapy
5054335|NCT03658733|Rescue treatment|rescue treatment
5054336|NCT03658707|Functional shoulder score|functional shoulder score
5054337|NCT03658707|questionnaire|questionnaire
5054338|NCT03658707|subacromial impingement syndrome|subacromial impingement syndrome
5054339|NCT03658694|fibromyalgia|fibromyalgia
5054340|NCT03658694|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5054341|NCT03658681|Fat quality|fat quality
5054342|NCT03658681|Blood glucose|blood glucose
5054343|NCT03658681|Gut microbiota|gut microbiota
5054344|NCT03658681|Satiety|satiety
5054345|NCT03658681|Dietary intervention|dietary intervention
5054346|NCT03658642|Opioid Use Disorder|opioid use disorder
5054347|NCT03658642|Buprenorphine|buprenorphine
5054348|NCT03658642|Opioid-use Disorder|opioid-use disorder
5054349|NCT03658642|Health IT|health it
5054350|NCT03658616|Excessive sweating|excessive sweating
5054351|NCT03658577|Actue Coronary Syndrome|actue coronary syndrome
5054352|NCT03658577|Beta-Blocker|beta-blocker
5054353|NCT03658577|Percutaneous Coronary Intervention|percutaneous coronary intervention
5054354|NCT03658564|Insulin resistance|insulin resistance
5054355|NCT03658564|Diabetes mellitus|diabetes mellitus
5054356|NCT03658564|Carbohydrate|carbohydrate
5054357|NCT03658551|Portal hypertension|portal hypertension
5054358|NCT03658551|Intestinal permeability|intestinal permeability
5931688|NCT03391778|Genetically engineered|genetically engineered
5054359|NCT03658551|Liver cirrhosis|liver cirrhosis
5054360|NCT03658551|bacterial translocation|bacterial translocation
5054361|NCT03658551|confocal endoscopy|confocal endoscopy
5054362|NCT03658525|MR GUIDED RADIOTHERAPY|mr guided radiotherapy
5054363|NCT03658499|intimate partner violence|intimate partner violence
5054364|NCT03658499|Domestic Violence|domestic violence
5054365|NCT03658499|Treatment adjuncts|treatment adjuncts
5054366|NCT03658499|Dialectical behavior therapy|dialectical behavior therapy
5054367|NCT03658486|Exercise|exercise
5054368|NCT03658486|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
5054369|NCT03658473|gastroprotection|gastroprotection
5054370|NCT03658473|rebamipide|rebamipide
5054371|NCT03658473|rabeprazole|rabeprazole
5054372|NCT03658473|naproxeno|naproxeno
5054373|NCT03658460|immunotherapy|immunotherapy
5054374|NCT03658460|immune checkpoint inhibitors|immune checkpoint inhibitors
5054375|NCT03658460|biomarkers|biomarkers
5054376|NCT03658460|sequencing|sequencing
5054377|NCT03658421|femoral nerve blockade|femoral nerve blockade
5054378|NCT03658421|dexmedetomidine|dexmedetomidine
5054379|NCT03658421|ropivacaine|ropivacaine
5054380|NCT03658421|anesthesia|anesthesia
5054381|NCT03658395|Vaginal, Prolapse, laparoscopic, sacrocolpopexy|vaginal, prolapse, laparoscopic, sacrocolpopexy
5054382|NCT03658343|soft tissue sarcoma|soft tissue sarcoma
5054383|NCT03658330|Ketamine|ketamine
5054384|NCT03658330|Naltrexone|naltrexone
5054385|NCT03658330|Depression|depression
5108395|NCT03320512|app|app
5054386|NCT03658330|Alcohol|alcohol
5263032|NCT02371590|CLL|cll
5959755|NCT00308204|discoid lupus|discoid lupus
5959756|NCT00308204|lupus|lupus
5959757|NCT00308204|discoid lupus erythematosus|discoid lupus erythematosus
5959758|NCT00308204|lupus of the scalp|lupus of the scalp
5959759|NCT00305760|stage III pancreatic cancer|stage iii pancreatic cancer
5959760|NCT00305760|recurrent pancreatic cancer|recurrent pancreatic cancer
5959761|NCT00305760|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5959762|NCT00305760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5959763|NCT00305760|stage IV pancreatic cancer|stage iv pancreatic cancer
5959776|NCT00278109|stage I breast cancer|stage i breast cancer
5959777|NCT00278109|stage II breast cancer|stage ii breast cancer
5283323|NCT02255331|MRI|mri
5283494|NCT02254629|Probiotic|probiotic
5263167|NCT02370719|Hb A1c|hb a1c
5054387|NCT03658291|Sanjin tablets|sanjin tablets
5054388|NCT03658291|efficacy and safety|efficacy and safety
5054389|NCT03658291|recurrence rate|recurrence rate
5054390|NCT03658291|randomized|randomized
5054391|NCT03658291|double blind|double blind
5054392|NCT03658291|parallel control|parallel control
5054393|NCT03658291|multi-center clinical study|multi-center clinical study
5054394|NCT03658265|breast cancer modified radical mastectomy|breast cancer modified radical mastectomy
5054395|NCT03658265|shoulder dysfunction|shoulder dysfunction
5054396|NCT03658265|Rehabilitation Training|rehabilitation training
5054855|NCT03655132|ACT|act
5054408|NCT03658213|Goserelin acetate|goserelin acetate
5054409|NCT03658213|Estrogen suppression|estrogen suppression
5054414|NCT03658200|Image quality|image quality
5054415|NCT03658200|Contrast media|contrast media
5054416|NCT03658174|Nitrate|nitrate
5054417|NCT03658148|Acute Kidney Injury|acute kidney injury
5054418|NCT03658148|Cardiac Surgery|cardiac surgery
5054419|NCT03658148|Cardiopulmonary Bypass|cardiopulmonary bypass
5054420|NCT03658148|Congenital Heart Disease|congenital heart disease
5054421|NCT03658148|Biomarkers|biomarkers
5054422|NCT03658135|CBS, CBD, nfvPPA, FTD, sMAPT, TES|cbs, cbd, nfvppa, ftd, smapt, tes
5054423|NCT03658122|Parent-Child Care|parent-child care
5054424|NCT03658122|Parent-Child Relationship|parent-child relationship
5054425|NCT03658122|Disruptive Behavior|disruptive behavior
5054426|NCT03658122|Brief Intervention|brief intervention
5054427|NCT03658083|exercise|exercise
5054428|NCT03658083|physical activity|physical activity
5054429|NCT03658083|quality of life|quality of life
5054430|NCT03658083|qualitative|qualitative
5054431|NCT03658083|recovery|recovery
5054432|NCT03658005|Ticagrelor|ticagrelor
5054433|NCT03658005|acute coronary syndrome|acute coronary syndrome
5054434|NCT03658005|anti-platelet drug|anti-platelet drug
5054435|NCT03657979|analgesia|analgesia
5054436|NCT03657979|TAP-block|tap-block
5054437|NCT03657966|Immunotherapy|immunotherapy
5054439|NCT03657966|Biologic|biologic
5054441|NCT03657966|Ovarian cancer|ovarian cancer
5054442|NCT03657966|Fallopian Tube cancer|fallopian tube cancer
5054443|NCT03657966|Primary peritoneal cancer|primary peritoneal cancer
5054444|NCT03657966|dendritic cells|dendritic cells
5054445|NCT03657966|chemotherapy|chemotherapy
5054446|NCT03657966|leukapheresis|leukapheresis
5054447|NCT03657966|FIGO III|figo iii
5054448|NCT03657966|FIGO IV|figo iv
5054449|NCT03657953|Total Hip Arthroplasty|total hip arthroplasty
5054450|NCT03657953|minimally invasive|minimally invasive
5054451|NCT03657953|Patient-relevant outcomes|patient-relevant outcomes
5054452|NCT03657940|Exercise therapy|exercise therapy
5054453|NCT03657927|Morbidly Obese|morbidly obese
5054454|NCT03657927|Difficult Airway Management|difficult airway management
5054455|NCT03657927|Videolaryngoscopy|videolaryngoscopy
5054456|NCT03657888|Family|family
5054457|NCT03657888|Vulnerable|vulnerable
5054458|NCT03657888|Volunteer|volunteer
5054459|NCT03657888|Child|child
5054460|NCT03657888|Civil society|civil society
5054461|NCT03657888|Intervention|intervention
5054466|NCT03657810|Pain|pain
5054467|NCT03657810|Nausea|nausea
5054468|NCT03657810|Vomiting|vomiting
5054469|NCT03657771|Esophagitis|esophagitis
5054470|NCT03657771|Diet|diet
5054471|NCT03657758|eicosapentaenoic acid|eicosapentaenoic acid
5054472|NCT03657758|OCT|oct
5054473|NCT03657758|neoatherosclerosis|neoatherosclerosis
5054474|NCT03657745|Alzheimer Disease|alzheimer disease
5054475|NCT03657745|Alzheimer's|alzheimer's
5960949|NCT04290156|adolescents|adolescents
5960950|NCT04290156|chronic illness|chronic illness
5054476|NCT03657745|Dementia|dementia
5054477|NCT03657732|Alzheimer's Disease|alzheimer's disease
5054478|NCT03657654|Thyroidectomy|thyroidectomy
5054479|NCT03657654|Laryngeal Nerves|laryngeal nerves
5054480|NCT03657654|Voice problems|voice problems
5054481|NCT03657628|Breast Cancer|breast cancer
5054482|NCT03657615|hearing loss|hearing loss
5054483|NCT03657615|tinnitus|tinnitus
5054484|NCT03657615|neuroimaging|neuroimaging
5054485|NCT03657615|hearing aids|hearing aids
5054486|NCT03657615|Positron emission Tomography - PET|positron emission tomography - pet
5054487|NCT03657576|oncolytic virus|oncolytic virus
5054488|NCT03657576|glioma|glioma
5054489|NCT03657576|glioblastoma|glioblastoma
5054491|NCT03657576|HSV|hsv
5054492|NCT03657576|immunotherapy|immunotherapy
5054493|NCT03657511|Smoking|smoking
5054494|NCT03657498|Tooth color changes|tooth color changes
5054495|NCT03657498|Orthognathic surgery|orthognathic surgery
5054496|NCT03657498|Spectrophotometer|spectrophotometer
5054497|NCT03657459|video education|video education
5054498|NCT03657459|self care management|self care management
5054499|NCT03657459|symptom recognition|symptom recognition
5054500|NCT03657420|Multiple Myeloma|multiple myeloma
5054501|NCT03657329|Automated Sleep Staging|automated sleep staging
5054502|NCT03657329|Automated Apnea Detection|automated apnea detection
5054503|NCT03657303|Joint Diseases|joint diseases
5263429|NCT02369029|HCC|hcc
5251059|NCT02439385|Avastin|avastin
5264312|NCT02363998|buprenorphine step down|buprenorphine step down
5264313|NCT02363998|opioid withdrawal syndrome|opioid withdrawal syndrome
5264314|NCT02363959|Hyperbaric Oxygen|hyperbaric oxygen
5264320|NCT02363959|Airway Ischemia|airway ischemia
5350258|NCT01947907|hGH|hgh
5265769|NCT02355587|cutaneous melanoma|cutaneous melanoma
5265770|NCT02355587|DecisionDx-Melanoma|decisiondx-melanoma
5266317|NCT02352402|Patency|patency
5054504|NCT03657303|Musculoskeletal Diseases|musculoskeletal diseases
5928614|NCT03777046|PPD|ppd
5054505|NCT03657303|Arthritis|arthritis
5054506|NCT03657290|Vadadustat|vadadustat
5272404|NCT02317848|ECG|ecg
5054507|NCT03657290|healthy volunteers|healthy volunteers
5289887|NCT02224703|CBD|cbd
5272816|NCT02315612|ALL|all
5272912|NCT02315066|tumors|tumors
5054508|NCT03657290|bioequivalence|bioequivalence
5273047|NCT02314481|ALK|alk
5285586|NCT02244164|Lipasemia|lipasemia
5054509|NCT03657290|pharmacokinetics|pharmacokinetics
4956368|NCT04261647|pelvic floor exercise|pelvic floor exercise
5286418|NCT02240082|Stress|stress
5273997|NCT02308917|IBD|ibd
5274198|NCT02307682|AMD|amd
5054510|NCT03657277|Peer Reviewed Research|peer reviewed research
5274302|NCT02307318|Angiography|angiography
5054515|NCT03657225|miniaturized|miniaturized
4963458|NCT04218331|PROMPT|prompt
5054516|NCT03657225|cardiopulmonary bypass|cardiopulmonary bypass
5054518|NCT03657186|Microbiome|microbiome
5377551|NCT01823770|HTA|hta
5054519|NCT03657186|Microbiota|microbiota
5054520|NCT03657186|Hafnia alvei|hafnia alvei
5054521|NCT03657186|Overweight|overweight
5054522|NCT03657186|Food intake|food intake
5054523|NCT03657186|Appetite regulation|appetite regulation
5054524|NCT03657186|Satiety|satiety
5054525|NCT03657186|Weight loss|weight loss
5054526|NCT03657186|Glucose Metabolism|glucose metabolism
5054527|NCT03657186|Glycemia|glycemia
5054528|NCT03657186|Enterobacteriaceae|enterobacteriaceae
5054529|NCT03657186|Gut-brain axis|gut-brain axis
5054530|NCT03657186|Molecular mimicry|molecular mimicry
4958456|NCT04248465|ALS|als
4958589|NCT04247464|Toxicity|toxicity
5287835|NCT02233582|ibuprofen|ibuprofen
4958842|NCT04245839|JCAR017|jcar017
4958965|NCT04245345|Micra|micra
5288184|NCT02231853|CMV|cmv
5054531|NCT03657160|Drug Therapy|drug therapy
5054532|NCT03657121|Prognosis|prognosis
5054533|NCT03657121|Palliative Care|palliative care
5378936|NCT01817257|Cancer|cancer
5054534|NCT03657121|End Stage|end stage
5054535|NCT03657121|Mortality|mortality
5054536|NCT03657121|Palliative|palliative
4959752|NCT04240795|Gel|gel
4959843|NCT04240002|AML|aml
5054537|NCT03657121|Advance Care Planning|advance care planning
5054538|NCT03657121|Symptom|symptom
5288973|NCT02228655|CKD|ckd
5054539|NCT03657121|Exacerbation|exacerbation
4960352|NCT04236804|TMC-CP01|tmc-cp01
4960608|NCT04235348|Muc-2|muc-2
5289361|NCT02226848|Angiogenesis|angiogenesis
4961155|NCT04232436|Prematurity|prematurity
5054540|NCT03657108|brachytherapy|brachytherapy
4961501|NCT04230512|Leg|leg
4961625|NCT04229537|SCT-I10A|sct-i10a
5277703|NCT02288481|TB|tb
5054541|NCT03657108|prostatectomy|prostatectomy
4961973|NCT04227522|BRCA negative|brca negative
4962097|NCT04226768|Palliative care|palliative care
5054542|NCT03657108|radiation therapy|radiation therapy
5054543|NCT03657108|surgery|surgery
5054544|NCT03657095|Hypertension|hypertension
5056566|NCT03645564|Direct anti-coagulant|direct anti-coagulant
5054545|NCT03657095|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
5054546|NCT03657095|Hypertension, Pulmonary|hypertension, pulmonary
5054550|NCT03657095|Respiratory Tract Diseases|respiratory tract diseases
5054551|NCT03657095|Prostacyclin|prostacyclin
5054552|NCT03657095|Beraprost|beraprost
5054553|NCT03657095|Epoprostenol|epoprostenol
5054554|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5054555|NCT03657095|Vasodilator Agents|vasodilator agents
5054556|NCT03657095|Antihypertensive Agents|antihypertensive agents
5291305|NCT02218502|RMI|rmi
5054557|NCT03657056|Epilepsy|epilepsy
5054558|NCT03657056|Ultrasound|ultrasound
5056567|NCT03645564|Nurse|nurse
5383058|NCT01799044|CRLM|crlm
5054563|NCT03657030|Healthy Volunteers|healthy volunteers
5056568|NCT03645551|dentistry|dentistry
5279551|NCT02277912|ICH|ich
4964393|NCT04212026|nivolumab|nivolumab
5054564|NCT03656978|vascular access|vascular access
4964640|NCT04210362|counseling|counseling
4964785|NCT04209426|revision|revision
4964913|NCT04208880|Intervention|intervention
5054565|NCT03656978|vascular catheterization|vascular catheterization
5054566|NCT03656978|ultrasound-guided|ultrasound-guided
5297642|NCT02189447|Ectasia|ectasia
4965493|NCT04205344|Pregnant|pregnant
4965634|NCT04204434|Cancer|cancer
4965753|NCT04203511|unresectable|unresectable
4966036|NCT04201704|Diuretics|diuretics
5293618|NCT02207608|BCG|bcg
5293628|NCT02207543|home|home
4966469|NCT04199182|Physical performance|physical performance
5054567|NCT03656978|ultrasonography|ultrasonography
4985400|NCT04083066|ORR|orr
5054568|NCT03656978|perioperative|perioperative
5054569|NCT03656978|anesthesia|anesthesia
5056569|NCT03645551|laminate veneer|laminate veneer
5294286|NCT02204579|ADH|adh
5054570|NCT03656978|cardiovascular abnormalities|cardiovascular abnormalities
5386315|NCT01784055|MR|mr
5294574|NCT02203214|Ligamys|ligamys
5386688|NCT01782365|MCI|mci
4968075|NCT04189471|SAH|sah
5295003|NCT02201381|AML|aml
5054572|NCT03656965|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5054573|NCT03656952|PF-06700841|pf-06700841
5054574|NCT03656952|QT effect|qt effect
5054575|NCT03656952|concentration-QTc analysis|concentration-qtc analysis
4966488|NCT04199078|HPV|hpv
5054576|NCT03656913|Kidney Stone|kidney stone
5054577|NCT03656913|Renal|renal
5054578|NCT03656913|Renal Stone|renal stone
4969327|NCT04181190|IgE|ige
4969546|NCT04179929|ALL|all
5056570|NCT03645551|existing restoration|existing restoration
5056571|NCT03645551|survival|survival
5054579|NCT03656874|Decision Support Systems, Clinical|decision support systems, clinical
5054580|NCT03656874|Smoking reduction|smoking reduction
5010191|NCT03933046|osa|osa
5054581|NCT03656874|Smoking cessation|smoking cessation
5054582|NCT03656874|Smoking, Tobacco|smoking, tobacco
5054583|NCT03656861|Aortic Valve|aortic valve
5389616|NCT01769248|EUS|eus
5054584|NCT03656861|Sinus of Valsalva|sinus of valsalva
4970962|NCT04171947|Tea|tea
4971167|NCT04170959|Metformin|metformin
5390083|NCT01767376|Tetanus|tetanus
4971559|NCT04168463|Companion robots|companion robots
5054585|NCT03656861|Echocardiography|echocardiography
5297791|NCT02188901|HCC|hcc
5297871|NCT02188667|Headache Pain|headache pain
5298390|NCT02186301|cancer|cancer
4972862|NCT04161586|Prilocaine|prilocaine
4972997|NCT04160767|Celiac disease|celiac disease
5298911|NCT02184377|lexical tone|lexical tone
4973588|NCT04156659|China|china
4973745|NCT04155853|fascia lata|fascia lata
5299435|NCT02180711|MZL|mzl
5054586|NCT03656861|Sudden cardiac death|sudden cardiac death
5056572|NCT03645538|Parkinson's disease|parkinson's disease
5054587|NCT03656848|Quantitative Coronary Angiography|quantitative coronary angiography
4974817|NCT04149639|Dr. Bredesen|dr. bredesen
4975097|NCT04147741|Fatigue|fatigue
5054588|NCT03656848|Quantitative Flow Ratio|quantitative flow ratio
4975395|NCT04145700|soft tissue sarcoma|soft tissue sarcoma
5054589|NCT03656848|Coronary Artery Disease|coronary artery disease
5300578|NCT02174471|T1 Mapping|t1 mapping
4975815|NCT04143139|Calcium|calcium
5287840|NCT02233569|IPOM|ipom
5287970|NCT02232984|CRT-D|crt-d
5054590|NCT03656848|Myocardial Ischaemia|myocardial ischaemia
5056573|NCT03645538|Healthy subjects|healthy subjects
5301340|NCT02169583|Safety|safety
5301531|NCT02168816|Diabetes|diabetes
5301641|NCT02168244|pain|pain
5288844|NCT02229201|Interleukin 6|interleukin 6
5288961|NCT02228694|ADC|adc
5289045|NCT02228356|ITV|itv
4977486|NCT04133246|parenthood|parenthood
5054591|NCT03656848|Percutaneous Coronary Intervention|percutaneous coronary intervention
4977639|NCT04132245|diet|diet
5054592|NCT03656848|Coronary Circulation|coronary circulation
5054594|NCT03656796|Auditory cueing|auditory cueing
5054595|NCT03656796|TMS|tms
4978199|NCT04128293|Safety|safety
5054596|NCT03656757|Cardiac Power|cardiac power
5302829|NCT02162628|POP|pop
5054597|NCT03656757|Oscillatory Power|oscillatory power
4978803|NCT04124601|Ipilimumab|ipilimumab
4979339|NCT04121468|metformin|metformin
4979356|NCT04121403|ms|ms
4979863|NCT04118543|Exercise|exercise
4979985|NCT04117854|pediatric|pediatric
5291075|NCT02219490|Naive|naive
5398210|NCT01729793|IL6|il6
4980212|NCT04116541|Ribociclib|ribociclib
4980306|NCT04115995|Breast reconstruction|breast reconstruction
5291548|NCT02217371|PSG|psg
4980660|NCT04113655|TDA202|tda202
5054598|NCT03656757|Coronary Artery Bypass Graft|coronary artery bypass graft
5304757|NCT02153775|Craving|craving
5054599|NCT03656757|Arterioventricular Coupling|arterioventricular coupling
5054600|NCT03656731|exercise|exercise
5054601|NCT03656731|older|older
5399763|NCT01722786|PCC|pcc
5054602|NCT03656731|resistance training|resistance training
5054603|NCT03656731|breast cancer|breast cancer
5054604|NCT03656666|apremilast|apremilast
4982092|NCT04104347|metacognitive training|metacognitive training
5054605|NCT03656666|genital erosive lichen planus|genital erosive lichen planus
5054606|NCT03656627|Autoimmune Diseases|autoimmune diseases
5292749|NCT02211742|dapagliflozin|dapagliflozin
5054607|NCT03656627|Non-small Cell Lung Cancer|non-small cell lung cancer
5305944|NCT02148094|HIV|hiv
5054608|NCT03656627|Ulcerative Colitis|ulcerative colitis
5054609|NCT03656627|Multiple Sclerosis|multiple sclerosis
5306171|NCT02147184|DXA|dxa
5054610|NCT03656627|Crohn Disease|crohn disease
5054611|NCT03656627|Systemic Lupus Erythematosus|systemic lupus erythematosus
4983372|NCT04095910|Prevention|prevention
5054612|NCT03656627|Polymyalgia Rheumatica|polymyalgia rheumatica
5054613|NCT03656627|Giant Cell Arteritis|giant cell arteritis
5293873|NCT02206360|MRI|mri
5054614|NCT03656627|Psoriasis|psoriasis
5054618|NCT03656614|sugammadex neostigmine|sugammadex neostigmine
5054619|NCT03656601|3D ultrasound|3d ultrasound
4984764|NCT04087239|HBV|hbv
5054620|NCT03656601|pelvic floor|pelvic floor
5054622|NCT03656601|quality of life|quality of life
5294837|NCT02201953|SOF/VEL|sof/vel
5307995|NCT02138786|Karyopharm|karyopharm
5308198|NCT02137889|CLL|cll
5403400|NCT01706705|CT|ct
4985446|NCT04082858|ECT|ect
4985586|NCT04081753|AML|aml
4985669|NCT04081077|Linezolid|linezolid
4985791|NCT04080219|cardiopulmonary bypass|cardiopulmonary bypass
5054623|NCT03656562|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5054624|NCT03656562|Anti-CD40|anti-cd40
5296056|NCT02196155|RCT|rct
5054625|NCT03656562|anti-BAFF-receptor|anti-baff-receptor
5054626|NCT03656562|B-cell depletion|b-cell depletion
5054627|NCT03656562|BAFF-receptor blockade|baff-receptor blockade
5054628|NCT03656562|ianalumab|ianalumab
5054629|NCT03656562|VAY736|vay736
5054630|NCT03656562|iscalimab|iscalimab
5054631|NCT03656562|CFZ533|cfz533
5054632|NCT03656536|Cholangiocarcinoma|cholangiocarcinoma
4987921|NCT04066881|HIV|hiv
5310418|NCT02127892|MUD|mud
5297448|NCT02190136|obesity|obesity
4988312|NCT04064632|HIV|hiv
5297545|NCT02189785|social|social
4988583|NCT04062890|Hyperinsulinism|hyperinsulinism
4988640|NCT04062591|VAS|vas
5310808|NCT02126007|fatigue|fatigue
5311050|NCT02124733|AK|ak
5054633|NCT03656536|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
5054634|NCT03656536|FGFR|fgfr
5315815|NCT02104700|HIV|hiv
5054635|NCT03656536|FGFR rearrangement|fgfr rearrangement
5311448|NCT02122952|SMN|smn
4989643|NCT04056286|GIP|gip
5054636|NCT03656523|Acute Coronary Syndrome|acute coronary syndrome
5054637|NCT03656523|Atrial Fibrillation|atrial fibrillation
5054638|NCT03656523|Percutaneous Coronary Intervention|percutaneous coronary intervention
5054639|NCT03656497|genetic mutations, voltage gated sodium channels, phenotype,|genetic mutations, voltage gated sodium channels, phenotype,
5054640|NCT03656484|Melatonin|melatonin
5054641|NCT03656484|Hyaluronic Acid|hyaluronic acid
5054642|NCT03656484|Tetracycline|tetracycline
5054643|NCT03656484|Metronidazole|metronidazole
5054644|NCT03656484|topic paste|topic paste
5054645|NCT03656484|chronic periodontitis|chronic periodontitis
5054646|NCT03656458|Impaired Balance|impaired balance
5054647|NCT03656458|Geriatrics|geriatrics
5054648|NCT03656458|Balance Training|balance training
5054654|NCT03656445|total knee arthroplasty|total knee arthroplasty
4991190|NCT04047277|Trauma|trauma
5299878|NCT02178475|NHL|nhl
5054655|NCT03656445|tranexamic acid|tranexamic acid
5054656|NCT03656445|without tourniquet|without tourniquet
5054657|NCT03656445|blood loss|blood loss
5054658|NCT03656445|function|function
5054659|NCT03656445|multiple doses|multiple doses
5054660|NCT03656432|CPP-ACP pastes|cpp-acp pastes
5054661|NCT03656432|CPP_ACPF|cpp_acpf
4991977|NCT04042922|Gamma|gamma
5300413|NCT02175251|rTMS|rtms
5054662|NCT03656432|Fluoride release|fluoride release
5054663|NCT03656432|early carious lesion|early carious lesion
5054664|NCT03656419|Halitosis|halitosis
4993015|NCT04037345|Knee Osteoarthritis|knee osteoarthritis
4993158|NCT04036357|NAFLD|nafld
5301360|NCT02169505|HL|hl
5054665|NCT03656419|Photodynamic Therapy|photodynamic therapy
5054666|NCT03656419|qPCR|qpcr
5314582|NCT02109770|XXY|xxy
5314681|NCT02109263|Saccharose|saccharose
5315031|NCT02107794|Aid|aid
4994259|NCT04029896|CP|cp
5302136|NCT02165852|adenoma|adenoma
4994372|NCT04029116|RVVC|rvvc
5302379|NCT02164604|ROP|rop
5412500|NCT01666990|HIV|hiv
4994697|NCT04026880|Androgens|androgens
5315635|NCT02105545|CAF|caf
5412711|NCT01665833|PCI|pci
5302792|NCT02162849|NRT|nrt
4995182|NCT04023916|TP53|tp53
4995360|NCT04022863|TEP|tep
5413246|NCT01663168|HIV|hiv
4995423|NCT04022460|Pediatric|pediatric
4995679|NCT04020731|MEG|meg
4995846|NCT04019795|LED|led
5303475|NCT02159872|Leukemia|leukemia
4996176|NCT04017923|Age|age
4992544|NCT04039971|ACL|acl
4996687|NCT04014647|Risk|risk
5414726|NCT01656070|HIV|hiv
5317474|NCT02097095|TB-018|tb-018
5304496|NCT02155062|Rye|rye
4997214|NCT04011644|mHealth|mhealth
5415114|NCT01654263|elderly|elderly
5415222|NCT01653782|LPB|lpb
5304810|NCT02153567|Anxiety|anxiety
4997588|NCT04009291|PTH(1-34)|pth(1-34)
4997757|NCT04008290|MMC|mmc
5054667|NCT03656406|Double-lumen endotracheal tube|double-lumen endotracheal tube
5415604|NCT01651975|DSS|dss
5054668|NCT03656406|Cuff pressure|cuff pressure
5054669|NCT03656393|EGFR|egfr
5054670|NCT03656393|NSCLC|nsclc
4998118|NCT04005924|fiber|fiber
5318570|NCT02091934|PRK|prk
5305651|NCT02149498|BNA|bna
5054671|NCT03656393|Carboplatin|carboplatin
5416992|NCT01645176|OA|oa
4999359|NCT03998761|FET|fet
5054672|NCT03656393|vinorelbine|vinorelbine
5054673|NCT03656393|Gefitinib|gefitinib
5054674|NCT03656367|glycaemia|glycaemia
4999924|NCT03995368|EEG|eeg
5054675|NCT03656367|insulinemia|insulinemia
5417741|NCT01641796|CL|cl
5000139|NCT03994133|kt/V|kt/v
5054676|NCT03656367|lipaemia|lipaemia
5054677|NCT03656367|appetite|appetite
5418322|NCT01639352|HCC|hcc
5307406|NCT02141516|asplenia|asplenia
5001186|NCT03988036|PAM50|pam50
5001314|NCT03987243|Wheelchair User|wheelchair user
5307909|NCT02139163|fever|fever
5001564|NCT03985709|Microbiota|microbiota
5054678|NCT03656354|seismocardiography|seismocardiography
5321340|NCT02078752|ADC|adc
5054679|NCT03656341|foot care|foot care
5054680|NCT03656341|older adults|older adults
5002139|NCT03982485|Apatinib|apatinib
5054681|NCT03656341|senior center|senior center
5054682|NCT03656341|self-management|self-management
5054683|NCT03656341|self-care|self-care
5054684|NCT03656328|probiotics|probiotics
5054685|NCT03656328|inflammation markers|inflammation markers
5054686|NCT03656315|Difficult airway|difficult airway
5309239|NCT02133001|Esketamine|esketamine
5003303|NCT03975543|RHO|rho
5054687|NCT03656315|Cricothyroid membrane|cricothyroid membrane
5322522|NCT02073604|SMA|sma
5054688|NCT03656315|Assessment|assessment
5054689|NCT03656302|Bipolar disorder|bipolar disorder
5054690|NCT03656302|Circadian Rhythm Disorders|circadian rhythm disorders
5004155|NCT03970278|AAV|aav
5004376|NCT03969030|HIV|hiv
5323548|NCT02068729|DDD|ddd
5054691|NCT03656302|High-risk offspring|high-risk offspring
5054692|NCT03656302|Endophenotypes|endophenotypes
5004845|NCT03966248|Massage|massage
5054693|NCT03656289|Contraception|contraception
5323885|NCT02066948|DXA|dxa
5054694|NCT03656289|Etonogestrel implant|etonogestrel implant
5054698|NCT03656211|Uterine AVM|uterine avm
5005590|NCT03961763|DHA|dha
5005831|NCT03960307|PBR|pbr
5324680|NCT02063503|chronic|chronic
5324807|NCT02062840|EEG|eeg
5311903|NCT02120859|PCI|pci
5312036|NCT02120339|PAH|pah
5325475|NCT02060006|TB|tb
5006996|NCT03952624|Fatigue|fatigue
5325560|NCT02059590|BAL8728|bal8728
5007254|NCT03951103|rFVIIIFc|rfviiifc
5054699|NCT03656198|Non-Specific Effects of Vaccines|non-specific effects of vaccines
5054700|NCT03656198|Heterologous Immunity|heterologous immunity
5326176|NCT02056873|DBS|dbs
5425570|NCT01606696|CAD|cad
5008074|NCT03946046|CDIP58|cdip58
5054702|NCT03656198|Patient Reported Outcome Measures|patient reported outcome measures
5326590|NCT02055118|MPS2|mps2
5313664|NCT02113540|CIN|cin
5008708|NCT03942146|surgery|surgery
5313716|NCT02113371|Safety|safety
5327184|NCT02052310|Anemia|anemia
5054703|NCT03656172|Anemia by functional martial deficiency|anemia by functional martial deficiency
5054704|NCT03656172|RET-He|ret-he
5054705|NCT03656159|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
5327594|NCT02050477|Obesity|obesity
5054706|NCT03656159|Psychological Intervention|psychological intervention
5328335|NCT02047344|NSCLC|nsclc
5328584|NCT02046304|XRT|xrt
5011190|NCT03926364|function|function
5011343|NCT03925259|ACT|act
5054707|NCT03656159|Older adults|older adults
5011514|NCT03924336|OFD|ofd
5054708|NCT03656159|Caregivers|caregivers
5012154|NCT03920202|Rectal cancer|rectal cancer
5316328|NCT02102282|Surgery|surgery
5012314|NCT03919227|RIRS|rirs
5316538|NCT02101398|tDCS|tdcs
5330139|NCT02039674|Paclitaxel|paclitaxel
5013021|NCT03915288|Force|force
5330484|NCT02038049|Multiple Sclerosis|multiple sclerosis
5330618|NCT02037490|Infants|infants
5317340|NCT02097693|DBS|dbs
5331194|NCT02034760|Frailty|frailty
5014089|NCT03908840|Liver|liver
5331289|NCT02034266|supplementation|supplementation
5317913|NCT02095015|MPS I|mps i
5054709|NCT03656146|social determinants of health|social determinants of health
5054710|NCT03656146|food insecurity|food insecurity
5331857|NCT02031666|Healthy|healthy
5054711|NCT03656146|screening|screening
5017830|NCT03885297|miRNA|mirna
5054712|NCT03656146|pediatrics|pediatrics
5319273|NCT02088541|AML|aml
5054713|NCT03656133|HPV|hpv
5332780|NCT02027506|ECG|ecg
5054714|NCT03656133|Radiotherapy Fractionation|radiotherapy fractionation
5054719|NCT03656120|thienorphine hydrochloride|thienorphine hydrochloride
5054720|NCT03656055|MRI|mri
5054721|NCT03656055|axonal loss|axonal loss
5054722|NCT03656055|MS|ms
5054723|NCT03656055|OCT|oct
5054724|NCT03656042|Dementia|dementia
5333802|NCT02022787|RCC|rcc
5939747|NCT01005745|skin|skin
5333939|NCT02022176|Nitrate|nitrate
5017554|NCT03886974|Transition of care|transition of care
5017680|NCT03886220|ABT-620|abt-620
5054725|NCT03656042|Alzheimer's disease|alzheimer's disease
5334580|NCT02018926|Azacitidine|azacitidine
5435687|NCT01563575|HPH|hph
5334685|NCT02018497|Hypotension|hypotension
5334780|NCT02018042|AA|aa
5018396|NCT03881852|EDS|eds
5334897|NCT02017522|PET|pet
5321430|NCT02078310|Healthy|healthy
5018711|NCT03879993|Exercise|exercise
5018996|NCT03877939|miRNA|mirna
5436578|NCT01559636|OPV|opv
5054726|NCT03656042|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5335830|NCT02013635|clinical evolution|clinical evolution
5019874|NCT03872739|CIN|cin
5019925|NCT03872479|p.Cys998X|p.cys998x
5454600|NCT01483560|REMOVAL|removal
5020390|NCT03869879|falls|falls
5336636|NCT02010034|TPN|tpn
5323109|NCT02070744|CF|cf
5054727|NCT03655990|Dentures Implant|dentures implant
5054728|NCT03655977|Cervical cancer|cervical cancer
5054729|NCT03655977|Treatment planning|treatment planning
5054730|NCT03655977|PET/MRI imaging|pet/mri imaging
5054731|NCT03655912|Amblyopia|amblyopia
5439224|NCT01548599|HIV|hiv
5054735|NCT03655899|systems biology|systems biology
5054736|NCT03655899|Sepsis|sepsis
5054737|NCT03655886|metastatic|metastatic
5054738|NCT03655886|prostate cancer|prostate cancer
5338013|NCT02003859|IBD|ibd
5054739|NCT03655886|local|local
5017025|NCT03889899|SCC|scc
5054740|NCT03655886|cytoreductive|cytoreductive
5054741|NCT03655808|Bronchiectasis|bronchiectasis
5338486|NCT02001649|SNP|snp
5324913|NCT02062359|Gene Therapy|gene therapy
5325030|NCT02061917|Tobacco|tobacco
5054742|NCT03655808|Bronchial basal cells|bronchial basal cells
5054743|NCT03655808|Autologous transplantation|autologous transplantation
5054749|NCT03655730|Depression|depression
5441109|NCT01540786|OAB|oab
5023596|NCT03850080|Joint|joint
5054750|NCT03655730|suicidal risk|suicidal risk
5339283|NCT01998048|Bankart|bankart
5024234|NCT03846492|TMS|tms
5024326|NCT03845985|trauma|trauma
5024433|NCT03845270|IFCT|ifct
5024554|NCT03844516|pacing|pacing
5054751|NCT03655730|self-harm behavior|self-harm behavior
5024808|NCT03843073|Prostate cancer|prostate cancer
5024943|NCT03842163|HCM|hcm
5054752|NCT03655730|young people|young people
5039702|NCT03750552|145|145
5054753|NCT03655717|fNIRS|fnirs
5327146|NCT02052453|ICD|icd
5054754|NCT03655717|THC|thc
5054755|NCT03655717|Intoxication|intoxication
5340876|NCT01990612|39 weeks gestation|39 weeks gestation
5054756|NCT03655704|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5054757|NCT03655704|Apabetalone|apabetalone
5067631|NCT03576313|reduction|reduction
5054773|NCT03655613|PD-1 inhibitor|pd-1 inhibitor
5327629|NCT02050386|MRI|mri
5054774|NCT03655613|c-Met inhibitor|c-met inhibitor
5444208|NCT01527292|VAP|vap
5341606|NCT01987102|Methotrexate|methotrexate
5026895|NCT03830775|PRP|prp
5054775|NCT03655574|Brief intervention|brief intervention
5027599|NCT03826264|TAVI|tavi
5342322|NCT01983969|Busulfex|busulfex
5445510|NCT01521416|UK|uk
5445731|NCT01520519|CLL|cll
5343068|NCT01980771|prevention|prevention
5054776|NCT03655574|Behavioral intervention|behavioral intervention
5054784|NCT03655535|BTI320|bti320
5446090|NCT01519089|safety|safety
5054785|NCT03655535|Sugardown|sugardown
5329844|NCT02041078|CUSA|cusa
5029174|NCT03816956|VAP|vap
5029362|NCT03815617|IBS|ibs
5446858|NCT01516021|CBF|cbf
5344104|NCT01976208|IgE|ige
5029701|NCT03813550|PXE|pxe
5029809|NCT03812809|EGFR|egfr
5344354|NCT01974804|MRI|mri
5054786|NCT03655535|Post-prandial glucose excursions|post-prandial glucose excursions
5054787|NCT03655496|patient centred|patient centred
5054788|NCT03655496|m-health|m-health
5030729|NCT03807219|NLC|nlc
5054789|NCT03655496|e-health|e-health
5345120|NCT01971437|OAB|oab
5054790|NCT03655496|home-based|home-based
5031208|NCT03804060|Cooling|cooling
5031306|NCT03803605|Agent|agent
5054791|NCT03655496|self-care|self-care
5054792|NCT03655470|suicidal behavior|suicidal behavior
5054793|NCT03655470|nonsuicidal self injury|nonsuicidal self injury
5054794|NCT03655470|adolescents|adolescents
5054795|NCT03655457|Lung|lung
5054797|NCT03655457|Surfaktant|surfaktant
5346072|NCT01967225|Bacteremia,|bacteremia,
5332509|NCT02028559|stones|stones
5332629|NCT02028039|ALL|all
5054798|NCT03655431|multiple sclerosis|multiple sclerosis
5054799|NCT03655431|rehabilitation|rehabilitation
5054800|NCT03655431|telerehabilitation|telerehabilitation
5054801|NCT03655431|telehealth|telehealth
5054802|NCT03655431|veteran health|veteran health
5033313|NCT03790917|AF|af
5450834|NCT01499342|SFA|sfa
5033501|NCT03789786|Outcomes|outcomes
5054803|NCT03655431|physical therapy|physical therapy
5054804|NCT03655405|Deprescribing|deprescribing
5054805|NCT03655405|Nursing Home|nursing home
5452081|NCT01493999|HPR|hpr
5348273|NCT01957436|cancer|cancer
5034760|NCT03781895|COPD|copd
5348369|NCT01956942|LASER|laser
5348466|NCT01956448|DES|des
5035003|NCT03780543|CHB|chb
5054806|NCT03655405|Potentially Inappropriate Medication|potentially inappropriate medication
5035285|NCT03778892|MSM|msm
5054807|NCT03655392|asthma|asthma
5452968|NCT01490411|SIT|sit
5335226|NCT02016131|AAA|aaa
5029727|NCT03813381|Diet|diet
5349425|NCT01951911|Ketamine|ketamine
5335863|NCT02013544|DHEA|dhea
5349736|NCT01950286|chemotherapy|chemotherapy
5454210|NCT01485276|PD|pd
5350042|NCT01948856|laryngitis|laryngitis
5336313|NCT02011295|OLT|olt
5350234|NCT01947972|preterm neonate|preterm neonate
5037301|NCT03766035|PSC|psc
5054808|NCT03655392|inflammation|inflammation
5054809|NCT03655392|patients education|patients education
5054810|NCT03655392|spirometry|spirometry
5054811|NCT03655379|Preterm birth|preterm birth
5054812|NCT03655379|Fetal nasal Doppler|fetal nasal doppler
5350716|NCT01945762|MTC|mtc
5350815|NCT01945164|XL999|xl999
5351067|NCT01944072|FCM|fcm
5351220|NCT01943461|Phase 1|phase 1
5038541|NCT03757923|PCO|pco
5038657|NCT03757039|glasses|glasses
5054813|NCT03655379|Fetal breathing|fetal breathing
5351599|NCT01941693|anxiety|anxiety
5054814|NCT03655366|epilepsy|epilepsy
5054815|NCT03655366|seizures|seizures
5039243|NCT03753113|Baldness|baldness
5352130|NCT01939262|Pain|pain
5054816|NCT03655366|seizure alert dogs|seizure alert dogs
5039940|NCT03749148|exercise|exercise
5457742|NCT01470794|AOD|aod
5054817|NCT03655366|seizure response dogs|seizure response dogs
5352844|NCT01935674|HIV|hiv
5352925|NCT01935323|obesity|obesity
5353124|NCT01934387|Prevention|prevention
5040839|NCT03743675|Overweight|overweight
5034621|NCT03782909|BMI|bmi
5353532|NCT01932580|gastric|gastric
5339831|NCT01995942|CRM|crm
5054818|NCT03655366|assistance dogs|assistance dogs
5054822|NCT03655340|Hemorrhagic Disorder|hemorrhagic disorder
5041655|NCT03738943|PLP|plp
5054823|NCT03655340|Genetic Diseases, Inborn|genetic diseases, inborn
5055522|NCT03651505|KRN23|krn23
5054824|NCT03655327|stroke rehabilitation|stroke rehabilitation
5354529|NCT01927965|GI tumors|gi tumors
5042649|NCT03732625|Raltegravir|raltegravir
5042774|NCT03731754|Traditional closure|traditional closure
5056579|NCT03645486|Chronic granulomatous disease|chronic granulomatous disease
5056580|NCT03645486|Lentiviral vector|lentiviral vector
5341418|NCT01988129|rls|rls
5355330|NCT01924481|MRI|mri
5460999|NCT01457222|Stress|stress
5355385|NCT01924286|Prednisone|prednisone
5043767|NCT03725904|IVF|ivf
5355678|NCT01922973|ghrelin|ghrelin
5461514|NCT01454921|HIV|hiv
5355975|NCT01921361|Shivering|shivering
5044339|NCT03721978|CIN 2|cin 2
5054826|NCT03655275|subluxation , platelet rich plasma (PRP), prolotherapy.|subluxation , platelet rich plasma (prp), prolotherapy.
5356403|NCT01919723|PCI|pci
5044732|NCT03719573|exercise|exercise
5342605|NCT01982851|pain|pain
5117472|NCT03261323|Mastectomy|mastectomy
5117473|NCT03261310|acetaminophen|acetaminophen
5117474|NCT03261310|pain|pain
5369618|NCT01859052|obesity|obesity
5117475|NCT03261310|laminectomy|laminectomy
5117476|NCT03261310|craniotomy|craniotomy
5117477|NCT03261284|D-dimer|d-dimer
5369943|NCT01857622|oral|oral
5370028|NCT01857245|arm|arm
5002871|NCT03978078|stomach|stomach
5344147|NCT01976013|PT|pt
5370530|NCT01855282|Overweight,|overweight,
5002872|NCT03978078|oesophagus|oesophagus
5370631|NCT01854892|muscle|muscle
5002873|NCT03978078|bile duct|bile duct
5344816|NCT01972802|HEAD AND NECK|head and neck
5002874|NCT03978078|small intestine|small intestine
5465161|NCT01440231|SLE|sle
5371266|NCT01852604|HCV|hcv
5117478|NCT03261284|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5117479|NCT03261284|Direct thrombin inhibitor|direct thrombin inhibitor
5359297|NCT01905592|BRCA|brca
5371779|NCT01850433|CBT|cbt
5117481|NCT03261193|quadratus lumborum block|quadratus lumborum block
5359982|NCT01902329|APL|apl
5117482|NCT03261193|post-operative pain|post-operative pain
5117483|NCT03261193|cesarean section pain|cesarean section pain
5117484|NCT03261193|analgesia|analgesia
5117485|NCT03261193|nerve block|nerve block
5117486|NCT03261167|Botulinum toxin A|botulinum toxin a
5346723|NCT01964560|Vimpat|vimpat
5117487|NCT03261167|Safety|safety
5117494|NCT03261154|Phosphate|phosphate
5117495|NCT03261128|cancer|cancer
5117496|NCT03261128|chemotherapy|chemotherapy
5360993|NCT01897636|vaccination|vaccination
5373551|NCT01842087|BUN|bun
5347297|NCT01962350|H1-Coil;|h1-coil;
5361298|NCT01895842|MDS|mds
5373685|NCT01841437|iStent|istent
5374335|NCT01838590|HCV|hcv
5117497|NCT03261115|Pain, Benzocaine, Clinical trial|pain, benzocaine, clinical trial
5117499|NCT03261102|Crohn|crohn
5117500|NCT03261102|adalimumab|adalimumab
5117501|NCT03261102|ADAL|adal
5348787|NCT01954797|MRI|mri
5375136|NCT01834599|NIRS|nirs
5470039|NCT01420939|TBI|tbi
5117502|NCT03261089|coma, prognosis, cardiac arrest|coma, prognosis, cardiac arrest
5117510|NCT03261050|Eating disorder|eating disorder
5375540|NCT01832909|walnuts|walnuts
5470533|NCT01419028|HPP|hpp
5375784|NCT01831921|obesity|obesity
5376015|NCT01830920|AKI|aki
5376074|NCT01830673|IL10|il10
5363751|NCT01885299|Lung|lung
5471401|NCT01415271|A1c|a1c
5350146|NCT01948323|Maternal health|maternal health
5117511|NCT03261050|Counter attitudinal therapy|counter attitudinal therapy
5117512|NCT03261050|fMRI|fmri
5376699|NCT01827813|needle biopsy|needle biopsy
5350436|NCT01947075|HIV|hiv
5364446|NCT01882205|DALM|dalm
5364548|NCT01881815|pressure sores|pressure sores
5377030|NCT01826474|DMD|dmd
5377113|NCT01826071|Sever's disease|sever's disease
5002877|NCT03978052|Dietary supplement|dietary supplement
5364975|NCT01880216|DVT|dvt
5490469|NCT01335230|HIV|hiv
5365159|NCT01879410|vilanterol (VI)|vilanterol (vi)
5473043|NCT01408732|HHT|hht
5377711|NCT01823094|computed tomography|computed tomography
5377824|NCT01822626|BMI|bmi
5002878|NCT03978052|personalized medicine,|personalized medicine,
5473540|NCT01406834|PTSD|ptsd
5378258|NCT01820637|SFA|sfa
5117513|NCT03261024|En-masse retraction , Class I bimaxillary protrusion|en-masse retraction , class i bimaxillary protrusion
5117514|NCT03261011|immunotherapy|immunotherapy
5352038|NCT01939665|IRE|ire
5352207|NCT01938963|Older Adults|older adults
5117515|NCT03261011|immuno-oncology|immuno-oncology
5117516|NCT03261011|advanced solid tumors|advanced solid tumors
5117521|NCT03260907|Overactive bladder|overactive bladder
5117522|NCT03260907|menopause|menopause
5117523|NCT03260907|Postmenopausal overactive bladder|postmenopausal overactive bladder
5127516|NCT03197285|pain|pain
5117536|NCT03260829|vitamin C|vitamin c
5117538|NCT03260829|intraepidermal injection|intraepidermal injection
5117539|NCT03260816|Preschoolers|preschoolers
5367518|NCT01868490|Cholangiocarcinoma|cholangiocarcinoma
5380084|NCT01812239|premature birth|premature birth
5367784|NCT01867359|DNA|dna
5367956|NCT01866397|HCMV|hcmv
5117540|NCT03260816|Developmental Delay|developmental delay
5117541|NCT03260816|Disruptive Behavior|disruptive behavior
5381068|NCT01807611|NK cell|nk cell
5002885|NCT03978026|Nap|nap
5117542|NCT03260816|Early Intervention|early intervention
5002887|NCT03978026|cognition|cognition
5117543|NCT03260816|Parent-Child Interaction Therapy (PCIT)|parent-child interaction therapy (pcit)
5117544|NCT03260816|Telehealth|telehealth
5117545|NCT03260816|Telemental Health|telemental health
5355082|NCT01925417|C diff|c diff
5117546|NCT03260816|Telepsychiatry|telepsychiatry
5117547|NCT03260803|osteopenia|osteopenia
5117548|NCT03260803|oligopin|oligopin
5117549|NCT03260803|postmenopause|postmenopause
5117550|NCT03260803|antioxidant|antioxidant
5117551|NCT03260803|bone|bone
5382089|NCT01803386|ALS|als
5117552|NCT03260790|Vaccine|vaccine
5478454|NCT01385670|PFO|pfo
5355682|NCT01922960|trauma|trauma
5117553|NCT03260790|Pneumococcal|pneumococcal
5117554|NCT03260790|Pneumonia|pneumonia
5002901|NCT03977909|Cognition|cognition
5117555|NCT03260764|Multifocal Contact Lenses|multifocal contact lenses
5117556|NCT03260764|Bifocal Spectacles|bifocal spectacles
5382993|NCT01799265|PAP|pap
5383183|NCT01798394|pregnant|pregnant
5002904|NCT03977896|11C-MET|11c-met
5117557|NCT03260764|Congenital Cataracts|congenital cataracts
5383614|NCT01796470|CLL|cll
5117558|NCT03260738|Chronic Low Back Pain|chronic low back pain
5117559|NCT03260738|Rehabilitation|rehabilitation
5117560|NCT03260738|Robot Poppy|robot poppy
5117561|NCT03260712|biliary tract cancer|biliary tract cancer
5371557|NCT01851330|HCV|hcv
5117562|NCT03260712|metastitic cancer|metastitic cancer
5117563|NCT03260712|advanced cancer|advanced cancer
5384330|NCT01793194|DVT|dvt
5384394|NCT01793090|VEP|vep
5384501|NCT01792726|Intrabeam|intrabeam
5117564|NCT03260712|pembrolizumab|pembrolizumab
5117565|NCT03260712|cisplatin|cisplatin
5117566|NCT03260712|gemcitabine|gemcitabine
5117567|NCT03260712|gallbladder cancer|gallbladder cancer
5117568|NCT03260673|cataract|cataract
5384902|NCT01790555|THC|thc
5372718|NCT01846234|Salt|salt
5358641|NCT01909141|PCOS|pcos
5117569|NCT03260673|phacoemulsification|phacoemulsification
5385607|NCT01787357|Healthy|healthy
5373193|NCT01844011|pregnancy|pregnancy
5117570|NCT03260673|type 2 diabetes mellitus|type 2 diabetes mellitus
5359242|NCT01905917|Stroke|stroke
5117571|NCT03260673|corneal endothelial cells|corneal endothelial cells
5483267|NCT01365377|ICU|icu
5373600|NCT01841840|Stroke|stroke
5117572|NCT03260634|voriconazole|voriconazole
5386286|NCT01784172|efficacy|efficacy
5373920|NCT01840397|NSE|nse
5386503|NCT01783054|SURGERY|surgery
5117573|NCT03260634|therapeutic drug monitoring|therapeutic drug monitoring
5002914|NCT03977857|Hepatitis B|hepatitis b
5484339|NCT01360905|PTL|ptl
5360323|NCT01900912|health|health
5374627|NCT01837251|PLD|pld
5117574|NCT03260608|dementia, deficits, burden, caregivers, telemedicine.|dementia, deficits, burden, caregivers, telemedicine.
5117575|NCT03260582|cardiac rehabilitation|cardiac rehabilitation
5117576|NCT03260582|eHealth|ehealth
5002916|NCT03977857|liver volume|liver volume
5361515|NCT01895101|tranexamix acid|tranexamix acid
5117577|NCT03260582|smartphone application|smartphone application
5056581|NCT03645460|Adenosine deaminase severe combined immunodeficiency lentiviral vector|adenosine deaminase severe combined immunodeficiency lentiviral vector
5056582|NCT03645447|Depression|depression
5376169|NCT01830192|HE4|he4
5388887|NCT01772641|craving|craving
5056583|NCT03645447|Diagnostic aid|diagnostic aid
5056584|NCT03645447|Taste|taste
5056585|NCT03645434|Moderate to severe COPD|moderate to severe copd
5389485|NCT01769924|Blood pressure|blood pressure
5056586|NCT03645434|Muscarinic receptor antagonist|muscarinic receptor antagonist
5389592|NCT01769391|NSCLC|nsclc
5117578|NCT03260569|Mechanical ventilation|mechanical ventilation
5117579|NCT03260569|Inhaled nitric oxide|inhaled nitric oxide
5377394|NCT01824589|ITPR|itpr
5753922|NCT00305149|Gallium|gallium
5363267|NCT01887483|IBS|ibs
5117580|NCT03260556|pulmonary fibrosis|pulmonary fibrosis
5363490|NCT01886404|Sustiva|sustiva
5390496|NCT01765491|colonoscopy|colonoscopy
5488917|NCT01341639|Hib|hib
5056587|NCT03645434|β2 adrenoceptor agonist (MABA)|β2 adrenoceptor agonist (maba)
5364006|NCT01883973|PD|pd
5364184|NCT01883362|AML|aml
5378619|NCT01818843|safety|safety
5117581|NCT03260543|ginseng powder|ginseng powder
5117582|NCT03260543|Fatty Liver|fatty liver
5379124|NCT01816412|Arms|arms
5056588|NCT03645434|Long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
5379535|NCT01814826|MLN4924|mln4924
5392125|NCT01757847|Obesity|obesity
5117583|NCT03260543|Clinical Trial|clinical trial
5490982|NCT01333046|CTL|ctl
5392324|NCT01756807|Combo Stent|combo stent
5380058|NCT01812330|CR|cr
5365879|NCT01876134|Cyr-61|cyr-61
5056589|NCT03645434|Long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
5733057|NCT00382616|impulsive|impulsive
5393344|NCT01751945|EmONC|emonc
5366611|NCT01872923|PCI|pci
5393438|NCT01751464|youth|youth
5366669|NCT01872715|Oracea|oracea
5056590|NCT03645434|Inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
5393743|NCT01749800|TBI|tbi
5393842|NCT01749358|arm therapy|arm therapy
5393936|NCT01748929|Global Health|global health
5117609|NCT03260400|Regenerative Peripheral Nerve Interface|regenerative peripheral nerve interface
5117616|NCT03260335|Challenging behaviour|challenging behaviour
5117617|NCT03260335|Biofeedback|biofeedback
5394343|NCT01747148|Antisense|antisense
5381882|NCT01804127|DLBCL|dlbcl
5382188|NCT01802983|Prognosis|prognosis
5394886|NCT01744587|EBV|ebv
5395007|NCT01744067|Inflammation|inflammation
5382595|NCT01801254|EEG|eeg
5117618|NCT03260335|Anxiety management|anxiety management
5961997|NCT04283591|anxiety|anxiety
5117624|NCT03260296|smartphones addiction|smartphones addiction
5117625|NCT03260283|pethidine|pethidine
5117747|NCT03259529|Rituximab|rituximab
5395734|NCT01740934|anatabine|anatabine
5117626|NCT03260257|Neurofeedback, Gamma band response|neurofeedback, gamma band response
5368996|NCT01861964|XOS|xos
5117627|NCT03260244|atrial fibrillation|atrial fibrillation
5383714|NCT01796093|Economics|economics
5056591|NCT03645434|Small airways disease (obstructive bronchiolitis)|small airways disease (obstructive bronchiolitis)
5117628|NCT03260244|atrial flutter|atrial flutter
5396785|NCT01736683|ACE-011|ace-011
5056592|NCT03645434|Parenchymal destruction (emphysema),|parenchymal destruction (emphysema),
5056593|NCT03645421|Diabetes|diabetes
5056594|NCT03645421|MEDI0382|medi0382
5397137|NCT01735240|safety|safety
5056595|NCT03645421|D5674C00001|d5674c00001
5056596|NCT03645421|T2DM|t2dm
5496917|NCT01308502|LPR|lpr
5397653|NCT01732653|elderly,|elderly,
5497404|NCT01306643|NHL|nhl
5056597|NCT03645421|Type 2 Diabetes|type 2 diabetes
5056598|NCT03645408|exenatide|exenatide
5398074|NCT01730495|CFS|cfs
5960968|NCT04290000|lymphoma|lymphoma
5056600|NCT03645408|alcohol consumption|alcohol consumption
5398413|NCT01729013|fat|fat
5398540|NCT01728545|HLA|hla
5056601|NCT03645382|overweight|overweight
5056602|NCT03645382|body fat|body fat
5056603|NCT03645382|diabetic,|diabetic,
5056607|NCT03645382|glycemic|glycemic
5386027|NCT01785355|CKD|ckd
5398906|NCT01726751|Abdominal pain|abdominal pain
5372116|NCT01848886|ERAH|erah
5372224|NCT01848457|Cancer|cancer
5056608|NCT03645369|subcutaneous heparin|subcutaneous heparin
5372515|NCT01847196|VTE|vte
5399835|NCT01722448|rhabdomyolysis|rhabdomyolysis
5399946|NCT01721798|IU International units|iu international units
5387206|NCT01779700|psychosis|psychosis
5400142|NCT01721109|HIV-1|hiv-1
5373110|NCT01844414|HIV|hiv
5056609|NCT03645369|injection pain|injection pain
5056610|NCT03645369|ecchymosis|ecchymosis
5387723|NCT01777503|elderly|elderly
5400656|NCT01718730|MRS|mrs
5400781|NCT01718054|Growth|growth
5056611|NCT03645330|Atezolizumab|atezolizumab
5056612|NCT03645291|insect sting allergy|insect sting allergy
5002936|NCT03977714|metal-free|metal-free
5056613|NCT03645291|Hymenoptera allergy|hymenoptera allergy
5401199|NCT01716546|DCF|dcf
5401302|NCT01715922|Burundi|burundi
5056614|NCT03645291|local insect allergen extracts|local insect allergen extracts
5056615|NCT03645265|speech rhythm|speech rhythm
5374517|NCT01837732|elderly|elderly
5401841|NCT01713738|ITP|itp
5402214|NCT01711892|Prostate Cancer|prostate cancer
5402346|NCT01711294|PCL|pcl
5056616|NCT03645265|speech therapy|speech therapy
5402432|NCT01710904|Oxycodone|oxycodone
5056620|NCT03645226|Idiopathic REM sleep|idiopathic rem sleep
5056621|NCT03645226|Parkinson's disease|parkinson's disease
5056622|NCT03645226|Gut microbiota|gut microbiota
5056623|NCT03645226|Syncleinpathy|syncleinpathy
5403056|NCT01708239|Pregnancy|pregnancy
5375915|NCT01831388|Dyspnea|dyspnea
5056624|NCT03645213|School-age children|school-age children
5056625|NCT03645213|pain|pain
5056626|NCT03645213|fear|fear
5056635|NCT03645174|Laryngeal mask airway|laryngeal mask airway
5056636|NCT03645174|fiberoptic|fiberoptic
5504406|NCT01277107|PSG|psg
5390841|NCT01763853|Hypovolemia|hypovolemia
5504744|NCT01275625|hiv|hiv
5403859|NCT01704729|Myopia|myopia
5403960|NCT01704352|CBT-I|cbt-i
5117629|NCT03260244|supraventricular tachycardia|supraventricular tachycardia
5376926|NCT01827046|ICH|ich
5391339|NCT01761578|Bioresorbable|bioresorbable
5117630|NCT03260244|ventricular tachycardia|ventricular tachycardia
5117631|NCT03260244|premature ventricular contractions|premature ventricular contractions
5391823|NCT01759160|propofol|propofol
5404999|NCT01699997|RCT|rct
5392336|NCT01756768|PD-0332991|pd-0332991
5405404|NCT01698255|Depression|depression
5405633|NCT01696916|COPD|copd
5117632|NCT03260244|cardiac mapping system|cardiac mapping system
5117633|NCT03260218|postoperative delirium|postoperative delirium
5117634|NCT03260218|elderly|elderly
5405927|NCT01695408|Steroids|steroids
5117635|NCT03260218|total joint replacement|total joint replacement
5117636|NCT03260218|risk factors for delirium|risk factors for delirium
5379148|NCT01816308|AF|af
5117637|NCT03260218|postoperative confusion|postoperative confusion
5117639|NCT03260205|Lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
5117640|NCT03260205|ADHD|adhd
5056637|NCT03645148|Neoantigen, Pancreatic Cancer, iNeo-Vac-P01,Peptide Vaccine|neoantigen, pancreatic cancer, ineo-vac-p01,peptide vaccine
5056643|NCT03645096|Depression|depression
5407153|NCT01690312|Apolipoprotein B|apolipoprotein b
5508755|NCT01258790|TS|ts
5056644|NCT03645096|Pregnenolone|pregnenolone
5056645|NCT03645096|Women|women
5394551|NCT01746160|healing|healing
5056646|NCT03645070|atrial-esophageal fistula|atrial-esophageal fistula
5056647|NCT03645070|radiofrequency ablation|radiofrequency ablation
5407774|NCT01687556|EGCG|egcg
5509543|NCT01255072|TMS|tms
5395089|NCT01743664|Anxiety|anxiety
5002953|NCT03977610|Treatment response|treatment response
5395424|NCT01742364|BCG|bcg
5056648|NCT03645070|Atrial Fibrillation ablation|atrial fibrillation ablation
5395728|NCT01740960|THC|thc
5408691|NCT01683448|cardiac surgery|cardiac surgery
5056649|NCT03645044|HBV sAg loss/seroconversion|hbv sag loss/seroconversion
5381582|NCT01805258|India|india
5408979|NCT01682226|FLUDARABINE|fludarabine
5381826|NCT01804296|TMS|tms
5117641|NCT03260205|hyperactivity|hyperactivity
5117646|NCT03260166|lupus erythematosus|lupus erythematosus
5117647|NCT03260153|Intracerebral Hemorrhage|intracerebral hemorrhage
5117648|NCT03260153|Perihematomal edema|perihematomal edema
5396956|NCT01735994|prevention|prevention
5056650|NCT03645044|"HBV e antigen (eAg) loss/seroconversion"|"hbv e antigen (eag) loss/seroconversion"
5056651|NCT03645044|antiretroviral therapy|antiretroviral therapy
5398384|NCT01729117|Low-income|low-income
5410481|NCT01675492|error|error
5056652|NCT03645031|acute intermittent hypoxia (AIH)|acute intermittent hypoxia (aih)
5397874|NCT01731587|L-BLP25|l-blp25
5056653|NCT03645031|respiratory motor function|respiratory motor function
5410894|NCT01673698|obesity|obesity
5056654|NCT03645031|hypoxia|hypoxia
5056655|NCT03645031|normoxia|normoxia
5056656|NCT03645031|EMG (electromyography)|emg (electromyography)
5056657|NCT03645018|lung|lung
5056658|NCT03645018|cancer|cancer
5398693|NCT01727882|Stress|stress
5411652|NCT01670526|TBI|tbi
5056659|NCT03645018|early diagnosis|early diagnosis
5056660|NCT03645018|DTS|dts
5384455|NCT01792973|HIV|hiv
5056661|NCT03645005|eHealth|ehealth
5514665|NCT01232634|MRI|mri
5384845|NCT01790880|Aphasia|aphasia
5412297|NCT01667731|HCV|hcv
5385128|NCT01789320|SCS|scs
5412484|NCT01667003|Multicenter|multicenter
5412594|NCT01666392|Fish oil|fish oil
5399956|NCT01721733|EPI743|epi743
5412803|NCT01665469|Ox-LDL|ox-ldl
5413005|NCT01664273|muscle|muscle
5400224|NCT01720680|COPD|copd
5056662|NCT03645005|Health Related Quality of Life|health related quality of life
5056663|NCT03645005|Symptom Burden|symptom burden
5413425|NCT01662362|Chagas Disease|chagas disease
5056664|NCT03645005|Breast Cancer|breast cancer
5056665|NCT03645005|Hispanic|hispanic
5413619|NCT01661439|aps|aps
5056666|NCT03644966|Probiotics|probiotics
5413808|NCT01660490|Femoral Fractures|femoral fractures
5413902|NCT01660022|Healthy|healthy
5414016|NCT01659398|ophthalmic blood flow|ophthalmic blood flow
5401260|NCT01716195|HPV|hpv
5056667|NCT03644966|multi-drug resistant UTI|multi-drug resistant uti
5401487|NCT01715246|HMO|hmo
5401621|NCT01714635|IOL|iol
5056668|NCT03644966|recurrent UTI|recurrent uti
5401809|NCT01713855|ITP|itp
5056669|NCT03644953|Hydroxyurea|hydroxyurea
5056670|NCT03644953|Transfusion|transfusion
5056671|NCT03644940|Dascena|dascena
5415131|NCT01654172|Diabetes|diabetes
5387910|NCT01776853|MRI|mri
5056672|NCT03644940|patient mortality|patient mortality
5056673|NCT03644940|machine learning|machine learning
5415771|NCT01651325|DXM|dxm
5056674|NCT03644940|algorithm|algorithm
5056675|NCT03644940|diagnostic|diagnostic
5056676|NCT03644927|Veterans|veterans
5056677|NCT03644927|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5056678|NCT03644927|Exercise maintenance|exercise maintenance
5056679|NCT03644927|Neuropeptide Y (NPY)|neuropeptide y (npy)
5002970|NCT03977558|Fatty Acids|fatty acids
5403890|NCT01704651|Ovary|ovary
5416901|NCT01645865|SMS|sms
5056680|NCT03644927|Exercise-related intrinsic motivation|exercise-related intrinsic motivation
5056681|NCT03644927|Exercise Self efficacy|exercise self efficacy
5417393|NCT01643577|Idiopathic|idiopathic
5389935|NCT01767987|ACS|acs
5417687|NCT01642212|EoE|eoe
5417799|NCT01641588|posture|posture
5056682|NCT03644927|Transtheoretical Model (TTM)|transtheoretical model (ttm)
5405420|NCT01698177|Cancer|cancer
5418592|NCT01637844|Telbivudine|telbivudine
5391123|NCT01762579|Gluten|gluten
5056683|NCT03644927|Self-Determination Theory (SDT)|self-determination theory (sdt)
5056684|NCT03644914|Reading|reading
5418886|NCT01636453|ICA|ica
5056685|NCT03644914|1st grade|1st grade
5056686|NCT03644914|Literacy|literacy
5056687|NCT03644888|COPD|copd
5056688|NCT03644888|Vibration|vibration
5056689|NCT03644888|Rehabilitation|rehabilitation
5056690|NCT03644849|Leg Ulcer|leg ulcer
5419467|NCT01633632|Yoga|yoga
5406836|NCT01691625|DC-CIK|dc-cik
5406990|NCT01691092|PET|pet
5056691|NCT03644849|Lower extremity ulcer|lower extremity ulcer
5056692|NCT03644849|carbon dioxide laser|carbon dioxide laser
5056693|NCT03644849|CO2 Laser|co2 laser
5419965|NCT01631279|solid tumors|solid tumors
5392612|NCT01755520|CABG|cabg
5056694|NCT03644849|Ablative fractional carbon dioxide lasers|ablative fractional carbon dioxide lasers
5524762|NCT01189344|LT4|lt4
5056697|NCT03644758|Firefighter|firefighter
5420597|NCT01628055|CVA|cva
5056698|NCT03644758|Sleep|sleep
5407950|NCT01686685|CXCR4|cxcr4
5420984|NCT01626313|OEF|oef
5056699|NCT03644758|Sleep disorders|sleep disorders
5525672|NCT01185457|HRV|hrv
5421096|NCT01625962|ECI|eci
5408361|NCT01684826|X-rays|x-rays
5416275|NCT01648933|PET|pet
5421375|NCT01624792|EPA|epa
5408662|NCT01683591|Dysphagia|dysphagia
5408773|NCT01683019|EEG|eeg
5421676|NCT01623297|Laparoscopy|laparoscopy
5408953|NCT01682395|Malawi|malawi
5409049|NCT01681979|asthma|asthma
5394461|NCT01746628|FloSeal|floseal
5056700|NCT03644758|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
5056701|NCT03644758|Epworth Sleepiness Scale|epworth sleepiness scale
5394866|NCT01744652|Metastatic|metastatic
5422495|NCT01619605|tryptases|tryptases
5002973|NCT03977519|manual acupuncture|manual acupuncture
5422692|NCT01618903|Chinese healthy volunteers|chinese healthy volunteers
5395287|NCT01742897|Durogesic|durogesic
5422802|NCT01618526|Colon|colon
5410062|NCT01677442|VATS|vats
5395682|NCT01741181|25(OH)Vitamin D|25(oh)vitamin d
5056702|NCT03644758|Insomnia Severity Index (ISI)|insomnia severity index (isi)
5056703|NCT03644758|stop-BANG questionnaire|stop-bang questionnaire
5056704|NCT03644745|Aging|aging
5056705|NCT03644732|Cognition|cognition
5423910|NCT01613586|ASP3652|asp3652
5056706|NCT03644719|Substance Abuse|substance abuse
5056707|NCT03644719|Cognitive behavioral treatment|cognitive behavioral treatment
5056708|NCT03644719|Ketamine|ketamine
5411275|NCT01672346|PAF|paf
5396805|NCT01736631|bipolar disorder|bipolar disorder
5411715|NCT01670266|OHT|oht
5397126|NCT01735266|Colonoscopy|colonoscopy
5530123|NCT01167608|Anxiety|anxiety
5424962|NCT01609361|Morbidity|morbidity
5425064|NCT01608724|Type 2 DM|type 2 dm
5397585|NCT01732926|LPL|lpl
5425359|NCT01607736|falls|falls
5397927|NCT01731327|CP-690|cp-690
5425762|NCT01605760|elderly|elderly
5412938|NCT01664767|COPD|copd
5056709|NCT03644719|Stage of Change|stage of change
5398344|NCT01729325|Resilience|resilience
5413135|NCT01663649|Depression|depression
5056710|NCT03644693|Angelman Syndrome|angelman syndrome
5056711|NCT03644693|Ketosis|ketosis
5056712|NCT03644693|Children|children
5398982|NCT01726517|HCV|hcv
5056713|NCT03644667|heart transplant recipients|heart transplant recipients
5426698|NCT01601678|LHM|lhm
5056714|NCT03644667|alloimmunity|alloimmunity
5056715|NCT03644667|anti-inflammatory|anti-inflammatory
5056716|NCT03644667|tocilizumab|tocilizumab
5934055|NCT02987166|pembrolizumab|pembrolizumab
5399344|NCT01724918|EEG|eeg
5414152|NCT01658618|ulcer|ulcer
5056717|NCT03644667|efficacy clinical trial|efficacy clinical trial
5414255|NCT01658111|EMG|emg
5427149|NCT01599793|CRPC|crpc
5427251|NCT01599585|Behavioral Activation|behavioral activation
5117649|NCT03260153|Deproteinised Calf Blood Serum Injection|deproteinised calf blood serum injection
5117655|NCT03260127|PTSD|ptsd
5414768|NCT01655966|hcv|hcv
5400158|NCT01721018|MPM|mpm
5117656|NCT03260127|treatment|treatment
5400361|NCT01720160|HFrEF|hfref
5534013|NCT01150942|JEV|jev
5428098|NCT01596127|CNS|cns
5534144|NCT01150370|HIV|hiv
5428137|NCT01595958|Cardiac arrest|cardiac arrest
5400653|NCT01718730|Glutamate|glutamate
5428308|NCT01595295|MDS|mds
5117657|NCT03260127|posttraumatic stress disorder|posttraumatic stress disorder
5117658|NCT03260127|therapy|therapy
5056719|NCT03644654|fluid responsiveness, haemodynamical monitoring, ClearSight|fluid responsiveness, haemodynamical monitoring, clearsight
5056720|NCT03644641|Desflurane|desflurane
5428802|NCT01593241|RT|rt
5117659|NCT03260127|cognition|cognition
5117660|NCT03260127|thinking|thinking
5429394|NCT01590615|Hepatitis B|hepatitis b
5429592|NCT01589757|"Breast Milk"|"breast milk"
5429797|NCT01588704|bevacizumab|bevacizumab
5056721|NCT03644641|Near-infrared spectroscopy|near-infrared spectroscopy
5056722|NCT03644641|Propofol|propofol
5056723|NCT03644641|Spinal surgery|spinal surgery
5056724|NCT03644641|Prone position|prone position
5430222|NCT01586533|UC|uc
5430414|NCT01585753|maraviroc|maraviroc
5056725|NCT03644641|Visual acuity|visual acuity
5056728|NCT03644615|Mindfulness|mindfulness
5056729|NCT03644615|MBSR|mbsr
5430618|NCT01584882|Tobacco|tobacco
5056730|NCT03644602|low FODMAPs diet|low fodmaps diet
5056731|NCT03644602|Adherence|adherence
5403385|NCT01706731|CBT|cbt
5056732|NCT03644602|Inflammatory Bowel Diseases|inflammatory bowel diseases
5056733|NCT03644602|Irritable Bowel Syndrome|irritable bowel syndrome
5431232|NCT01582555|QOL|qol
5056734|NCT03644602|Coeliac Disease|coeliac disease
5056735|NCT03644589|Cisplatin|cisplatin
5056736|NCT03644589|Pembrolizumab|pembrolizumab
5431644|NCT01580709|ERCP|ercp
5418928|NCT01636245|HFMD|hfmd
5056737|NCT03644589|Keytruda|keytruda
5056738|NCT03644589|Triple Negative Breast Cancer|triple negative breast cancer
5404419|NCT01702506|fed|fed
5404522|NCT01702064|CML|cml
5432381|NCT01577589|AUC|auc
5419392|NCT01633996|Acupuncture|acupuncture
5056739|NCT03644589|Immune-Checkpoint Inhibitor|immune-checkpoint inhibitor
5419612|NCT01632969|12-136|12-136
5419910|NCT01631539|DC Bead™|dc bead™
5420084|NCT01630889|Kidney|kidney
5433342|NCT01573481|SLEEP|sleep
5056740|NCT03644589|Metastatic Breast Cancer|metastatic breast cancer
5433551|NCT01572662|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5420708|NCT01627717|HIV|hiv
5420796|NCT01627340|adults|adults
5433994|NCT01570920|walking|walking
5434183|NCT01570218|fatigue|fatigue
5680268|NCT00578422|PAD|pad
5056741|NCT03644589|Breast Carcinoma|breast carcinoma
5421402|NCT01624636|AMD|amd
5056742|NCT03644589|Recurrent Breast Cancer|recurrent breast cancer
5056743|NCT03644576|Ozanimod|ozanimod
5434660|NCT01568073|PD|pd
5056744|NCT03644576|Pseudoephedrine|pseudoephedrine
5056745|NCT03644576|Healthy Adult Subjects|healthy adult subjects
5056746|NCT03644563|Oral HPV|oral hpv
5056747|NCT03644563|Persistent infection|persistent infection
5056748|NCT03644563|Oropharyngeal cancer (OPC)|oropharyngeal cancer (opc)
5056749|NCT03644563|HPV antibody|hpv antibody
5435414|NCT01564758|non-comparative|non-comparative
5056750|NCT03644563|HPV Screening Study|hpv screening study
5056753|NCT03644524|heat therapy|heat therapy
5056754|NCT03644524|blood pressure|blood pressure
5436232|NCT01561040|tear film deficiency|tear film deficiency
5423410|NCT01615757|AML|aml
5436438|NCT01560247|Neurothrombectomy|neurothrombectomy
5056755|NCT03644524|oral glucose tolerance test|oral glucose tolerance test
5056756|NCT03644524|adipose tissue|adipose tissue
5436844|NCT01558492|CRPC|crpc
5436951|NCT01557985|children|children
5117661|NCT03260127|executive function|executive function
5117662|NCT03260127|computer|computer
5117663|NCT03260127|training|training
5437678|NCT01554943|HEC|hec
5424930|NCT01609465|CVD|cvd
5437999|NCT01553682|STDs|stds
5117664|NCT03260114|Physical activity|physical activity
5117665|NCT03260114|Body weight|body weight
5117666|NCT03260114|Obesity|obesity
5117667|NCT03260062|cochlear implants|cochlear implants
5410806|NCT01674179|qEEG|qeeg
5056757|NCT03644524|muscle sympathetic nerve activity|muscle sympathetic nerve activity
5056758|NCT03644511|HCC|hcc
5056760|NCT03644511|Live cell carcinoma|live cell carcinoma
5425740|NCT01605864|CAP|cap
5056761|NCT03644498|influenza|influenza
5056762|NCT03644498|myositis|myositis
5439232|NCT01548586|TMS|tms
5056763|NCT03644498|myocarditis|myocarditis
5056764|NCT03644498|rhabdomyolysis|rhabdomyolysis
5056765|NCT03644498|checkpoint inhibitors|checkpoint inhibitors
5426528|NCT01602354|EAA|eaa
5426730|NCT01601418|YF476|yf476
5056766|NCT03644485|kidney transplant|kidney transplant
5427219|NCT01599637|CIU|ciu
5056767|NCT03644485|Tacrolimus|tacrolimus
5056768|NCT03644485|Prograf|prograf
5056769|NCT03644485|Advagraf|advagraf
5056770|NCT03644485|FK506|fk506
5440582|NCT01543048|CIN3|cin3
5435735|NCT01563276|PSP|psp
5117668|NCT03260062|language development|language development
5441268|NCT01539915|Psoriasis|psoriasis
5549912|NCT01087411|DXA|dxa
5117669|NCT03260062|parenting intervention|parenting intervention
5056771|NCT03644472|dietary nitrate supplementation|dietary nitrate supplementation
5056772|NCT03644472|beetroot juice|beetroot juice
5441708|NCT01538368|EUS|eus
5056773|NCT03644459|Tolerability|tolerability
5056774|NCT03644459|Safety|safety
5414254|NCT01658111|EEG|eeg
5117670|NCT03260062|maternal sensitivity|maternal sensitivity
5414425|NCT01657305|STSG|stsg
5414525|NCT01656915|response|response
5442270|NCT01535677|λz|λz
5056775|NCT03644459|Humanized Anti-VEGF Monoclonal Antibody|humanized anti-vegf monoclonal antibody
5056776|NCT03644459|autocrine loops|autocrine loops
5429396|NCT01590615|OLT|olt
5056777|NCT03644459|LYN00101|lyn00101
5056778|NCT03644446|Bisoprolol|bisoprolol
5415027|NCT01654679|surgery|surgery
5415183|NCT01653977|GDT|gdt
5056779|NCT03644420|Osteoarthritis|osteoarthritis
5443260|NCT01531296|MRI|mri
5056780|NCT03644420|Knee|knee
5056781|NCT03644420|Bone|bone
5056782|NCT03644420|Bone Marrow|bone marrow
5416259|NCT01649011|ODI|odi
5444195|NCT01527344|CAV|cav
5416747|NCT01646411|SLE|sle
5444576|NCT01525667|THA|tha
5416885|NCT01645904|Survey|survey
5056783|NCT03644420|Magnetic Resonance Imaging|magnetic resonance imaging
5056784|NCT03644407|registry|registry
5056785|NCT03644407|scoliosis|scoliosis
5554506|NCT01068847|opioid|opioid
5417622|NCT01642485|Fed|fed
5056786|NCT03644407|disc disease|disc disease
5554991|NCT01066663|CLL|cll
5056787|NCT03644407|spinal fracture|spinal fracture
5056788|NCT03644407|spinal fusion|spinal fusion
5445733|NCT01520519|SLL|sll
5056789|NCT03644407|spine surgery|spine surgery
5056790|NCT03644368|cervical phlegmon|cervical phlegmon
5445975|NCT01519544|Actigraphy|actigraphy
5056791|NCT03644368|tonsillar abscesses|tonsillar abscesses
5555743|NCT01063660|ATG|atg
5433101|NCT01574352|BMI|bmi
5433296|NCT01573637|schizophrenia|schizophrenia
5446467|NCT01517685|EPA|epa
5446575|NCT01517152|Translation|translation
5433590|NCT01572545|sclerostin|sclerostin
5446727|NCT01516619|NHL|nhl
5418942|NCT01636193|Safety|safety
5446800|NCT01516294|AMD|amd
5433810|NCT01571661|safety|safety
5056792|NCT03644368|retropharyngeal or parapharyngeal abscesses|retropharyngeal or parapharyngeal abscesses
5434079|NCT01570582|ECG|ecg
5447285|NCT01514084|suture|suture
5434324|NCT01569503|VNS|vns
5447586|NCT01512602|Suicide prevention|suicide prevention
5434643|NCT01568177|MCD|mcd
5557852|NCT01054664|RNA|rna
5448040|NCT01511068|PAP|pap
5056793|NCT03644368|medical and chirurgical treatment|medical and chirurgical treatment
5420269|NCT01629940|HED|hed
5558237|NCT01053143|Adults|adults
5435114|NCT01566045|Biopsy|biopsy
5558345|NCT01052779|IDA|ida
5448385|NCT01509469|Sucrose|sucrose
5420634|NCT01627938|MS|ms
5056794|NCT03644368|Bacteria in deep neck infections|bacteria in deep neck infections
5056795|NCT03644342|cervical cancer|cervical cancer
5421231|NCT01625338|HCV|hcv
5056796|NCT03644342|Niraparib|niraparib
5056797|NCT03644342|radiotherapy|radiotherapy
5056798|NCT03644342|carcinoma of the cervix|carcinoma of the cervix
5421541|NCT01624064|ACEI|acei
5449499|NCT01504893|ventilation|ventilation
5436525|NCT01559844|HCC|hcc
5421829|NCT01622595|CONS|cons
5846727|NCT00043654|HV|hv
5437337|NCT01556347|memory|memory
5056799|NCT03644329|Breast Cancer Survivors|breast cancer survivors
5056800|NCT03644329|resistance Training|resistance training
5561356|NCT01042275|TVT|tvt
5056801|NCT03644329|fatigability|fatigability
5056802|NCT03644329|Body Composition|body composition
5056803|NCT03644329|Functional capacity|functional capacity
5450966|NCT01498692|DES|des
5056804|NCT03644290|vascular ischemic lesion|vascular ischemic lesion
5056805|NCT03644264|Chronic Kidney Disease|chronic kidney disease
5451290|NCT01497353|Delivery room|delivery room
5056806|NCT03644264|Hyperphosphatemia|hyperphosphatemia
5056807|NCT03644264|Dialysis|dialysis
5056808|NCT03644212|Polycystic Ovary Syndrome|polycystic ovary syndrome
5056809|NCT03644212|Vitamin D|vitamin d
5438685|NCT01550783|HPV|hpv
5056810|NCT03644212|Anti Mullerian Hormone|anti mullerian hormone
5452204|NCT01493323|Genetic|genetic
5424541|NCT01610583|Latino|latino
5452418|NCT01492361|Fish|fish
5439556|NCT01547299|neoadjuvant|neoadjuvant
5439655|NCT01546883|MRI|mri
5056811|NCT03644212|Soluble receptor for Advanced Glycation End Products|soluble receptor for advanced glycation end products
5424903|NCT01609634|Healthy|healthy
5439960|NCT01545648|breast|breast
5056812|NCT03644199|Gastric emptying|gastric emptying
5440109|NCT01545141|HIPEC|hipec
5425381|NCT01607619|CRP|crp
5440365|NCT01544036|AKI|aki
5425544|NCT01606852|anxiety|anxiety
5453643|NCT01487733|recurrent salivary gland cancer|recurrent salivary gland cancer
5453810|NCT01487044|DME|dme
5440703|NCT01542671|primary care|primary care
5454000|NCT01486056|ECG|ecg
5454132|NCT01485653|Block|block
5056813|NCT03644199|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
5454225|NCT01485198|knee|knee
5056814|NCT03644199|Incretins|incretins
5441280|NCT01539837|Iron chelation|iron chelation
5566030|NCT01022892|CT|ct
5454635|NCT01483456|aged|aged
5454741|NCT01482884|tralokinumab|tralokinumab
5426901|NCT01600872|TOS|tos
5566564|NCT01020695|EEG|eeg
5441875|NCT01537549|glutathione|glutathione
5427223|NCT01599637|IgE|ige
5442162|NCT01536145|CP-751871|cp-751871
5442268|NCT01535677|AUC|auc
5455486|NCT01479868|RBV|rbv
5442574|NCT01534455|GBG|gbg
5427802|NCT01597193|MDV3100|mdv3100
5455950|NCT01478178|bevacizumab refractory|bevacizumab refractory
5442869|NCT01533051|Korea|korea
5456117|NCT01477476|DKA|dka
5456163|NCT01477294|Dilution Techniques|dilution techniques
5428295|NCT01595334|rLH|rlh
5456560|NCT01475474|BM|bm
5443403|NCT01530672|HIV|hiv
5056815|NCT03644186|hormone receptor positive early breast cancer|hormone receptor positive early breast cancer
5443673|NCT01529593|DLT|dlt
5443822|NCT01529008|Hip|hip
5457102|NCT01473264|RDS|rds
5960969|NCT04290000|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5960970|NCT04289974|Palbociclib|palbociclib
5444168|NCT01527448|PPD|ppd
5457372|NCT01472172|safety|safety
5429382|NCT01590654|HBV|hbv
5457478|NCT01471379|IBS|ibs
5457578|NCT01471262|Liver|liver
5444564|NCT01525719|RAD001|rad001
5457827|NCT01470352|CPM|cpm
5457926|NCT01469897|QOL|qol
5444889|NCT01524172|yoga|yoga
5458235|NCT01468545|PAH|pah
5458316|NCT01468246|Breast Cancer|breast cancer
5458417|NCT01467869|abnormal semen|abnormal semen
5056816|NCT03644186|HER2 receptor positive early breast cancer|her2 receptor positive early breast cancer
5056817|NCT03644173|integrative medicine|integrative medicine
5056819|NCT03644160|Physical activity|physical activity
5056820|NCT03644160|Behaviour Change|behaviour change
5459171|NCT01464840|Pregnancy|pregnancy
5056821|NCT03644160|Physiotherapy|physiotherapy
5446258|NCT01518439|cough|cough
5459703|NCT01462669|Retigabine|retigabine
5056916|NCT03643341|Healthy Weights|healthy weights
5056827|NCT03644017|Dialysis|dialysis
5056828|NCT03644017|Venous Stenosis|venous stenosis
5446856|NCT01516021|insula|insula
5056829|NCT03644017|Venous Occlusion|venous occlusion
5056830|NCT03644017|Stent Graft|stent graft
5056831|NCT03643991|Agitation|agitation
5460527|NCT01459263|GSV|gsv
5056832|NCT03643991|Dementia|dementia
5056833|NCT03643991|Inpatient|inpatient
5432560|NCT01576744|HE4|he4
5056834|NCT03643978|Decision aids|decision aids
5461068|NCT01456884|Infants|infants
5461166|NCT01456572|stomach|stomach
5056835|NCT03643965|IgA Nephropathy|iga nephropathy
5461262|NCT01456143|Neoplasia|neoplasia
5433139|NCT01574209|IBS|ibs
5056836|NCT03643952|methicillin-resistant S. aureus (MRSA) infections|methicillin-resistant s. aureus (mrsa) infections
5574491|NCT00989495|AIS|ais
5433446|NCT01573078|IBS|ibs
5448355|NCT01509586|smoking|smoking
5117671|NCT03260062|facilitative language techniques|facilitative language techniques
5461942|NCT01453114|CBT|cbt
5461978|NCT01452971|lung cancer|lung cancer
5117672|NCT03260036|Urea synthesis|urea synthesis
5117673|NCT03260036|Ammonia|ammonia
5575373|NCT00986089|IUD|iud
5462478|NCT01451021|Hair Loss|hair loss
5434316|NCT01569568|MRI|mri
5449569|NCT01504698|Effect|effect
5434727|NCT01567826|CHD|chd
5117674|NCT03260036|Bariatric surgery|bariatric surgery
5117675|NCT03260023|Avelumab|avelumab
5117676|NCT03260023|Cancer|cancer
5463479|NCT01446939|Diagnosis|diagnosis
5117683|NCT03259919|Pregnancy outcome|pregnancy outcome
5117684|NCT03259919|Androgens|androgens
5463739|NCT01445769|PMF|pmf
5450511|NCT01500733|Leukemia|leukemia
5450623|NCT01500226|Rolapitant|rolapitant
5435835|NCT01562730|iECG|iecg
5464327|NCT01443468|Screening|screening
5903964|NCT00092222|HIV|hiv
5436213|NCT01561092|Stroke|stroke
5578152|NCT00975442|Elbow|elbow
5451236|NCT01497639|GPi|gpi
5437119|NCT01557400|DBMD|dbmd
5578444|NCT00974402|OEF|oef
5464856|NCT01441245|BNP|bnp
5465034|NCT01440621|Modafinil|modafinil
5436816|NCT01558648|12-003|12-003
5578895|NCT00973011|GA|ga
5437116|NCT01557400|DMD|dmd
5452044|NCT01494168|Obesity|obesity
5452236|NCT01493154|HPV|hpv
5056837|NCT03643952|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
5465763|NCT01437930|TAG|tag
5056838|NCT03643939|respiratory insufficiency|respiratory insufficiency
5437677|NCT01554943|CMF|cmf
5437722|NCT01554852|vorinostat|vorinostat
5056839|NCT03643939|respiratory failure|respiratory failure
5437837|NCT01554410|Cervical|cervical
5452873|NCT01490723|Rituxan|rituxan
5614226|NCT00841022|RCT|rct
5438151|NCT01553136|Chantix|chantix
5056840|NCT03643939|non-invasive ventilation|non-invasive ventilation
5466816|NCT01433523|AIT|ait
5056841|NCT03643939|high flow nasal cannula|high flow nasal cannula
5056842|NCT03643939|nasal high flow|nasal high flow
5581089|NCT00964132|RXR|rxr
5056843|NCT03643939|trans-nasal insufflation|trans-nasal insufflation
5056845|NCT03643939|HFNC|hfnc
5056846|NCT03643926|ankle|ankle
5056847|NCT03643926|instability|instability
5056848|NCT03643926|brostrom|brostrom
5056849|NCT03643926|open|open
5581907|NCT00961155|EBC|ebc
5582028|NCT00960726|MDS|mds
5056850|NCT03643926|arthroscopic|arthroscopic
5467996|NCT01429090|Reflex, Pupillary|reflex, pupillary
5439945|NCT01545674|Aneuploidy|aneuploidy
5468400|NCT01427335|OHSS|ohss
5455060|NCT01481636|AHI|ahi
5455153|NCT01481246|aging|aging
5468600|NCT01426620|polyphenol|polyphenol
5056851|NCT03643874|Single-dose disposable dry powder inhaler|single-dose disposable dry powder inhaler
5440484|NCT01543555|statin|statin
5056852|NCT03643861|SBRT|sbrt
5463715|NCT01445873|Thelin|thelin
5056853|NCT03643861|Breast cancer|breast cancer
5469346|NCT01423500|ALL|all
5056854|NCT03643861|Early stage|early stage
5469483|NCT01422915|EPP|epp
5456056|NCT01477749|PSA|psa
5441159|NCT01540461|HCC|hcc
5056855|NCT03643861|Radiation therapy|radiation therapy
5469949|NCT01421212|HBV|hbv
5470044|NCT01420939|HV|hv
5441667|NCT01538459|Adult|adult
5056856|NCT03643822|ACB adjuncts|acb adjuncts
5056857|NCT03643822|Dexamethasone|dexamethasone
5442124|NCT01536288|AMS|ams
5056858|NCT03643822|Dexmedetomidine|dexmedetomidine
5457255|NCT01472666|Type 2 diabetes|type 2 diabetes
5056859|NCT03643822|post operative analgesia|post operative analgesia
5457473|NCT01471418|TMJ|tmj
5457571|NCT01471288|Carum Carvi|carum carvi
5471128|NCT01416233|fat|fat
5442644|NCT01534104|fMRI|fmri
5585968|NCT00946647|MDS|mds
5471352|NCT01415440|ADD|add
5442937|NCT01532661|HAEMORRHAGIC|haemorrhagic
5586240|NCT00945880|HCV|hcv
5458209|NCT01468636|HPV|hpv
5471662|NCT01414062|Nutrition|nutrition
5458295|NCT01468337|CSC|csc
5471764|NCT01413581|rhBSSL|rhbssl
5471966|NCT01412840|Pain|pain
5056860|NCT03643809|Systemic autoinflammatory diseases (SAIDs)|systemic autoinflammatory diseases (saids)
5903979|NCT00086567|Blood|blood
5056861|NCT03643783|Bariatric Surgery|bariatric surgery
5056862|NCT03643783|Prorenin|prorenin
5587606|NCT00940537|MRS|mrs
5472878|NCT01409187|Melanoma|melanoma
5056863|NCT03643783|Hypertension|hypertension
5056864|NCT03643783|Obesity|obesity
5056865|NCT03643770|hypoxia|hypoxia
5056866|NCT03643757|Blood gas analysis|blood gas analysis
5444898|NCT01524146|PDT|pdt
5056867|NCT03643757|Epidural analgesia|epidural analgesia
5056868|NCT03643757|Lung cancer|lung cancer
5445032|NCT01523626|TBCT|tbct
5056869|NCT03643757|Respiratory function tests|respiratory function tests
5056876|NCT03643692|Diabetes Mellitus|diabetes mellitus
5460600|NCT01459029|D-serine|d-serine
5460810|NCT01457976|cancer|cancer
5056877|NCT03643692|blood glucose|blood glucose
5056878|NCT03643692|environmental case parameters|environmental case parameters
5461741|NCT01453803|ASC|asc
5056879|NCT03643653|Bronchiectasis|bronchiectasis
5056880|NCT03643653|multi-centered registry|multi-centered registry
5447212|NCT01514409|Low mood|low mood
5475850|NCT01396863|MRI|mri
5462500|NCT01450943|Dermagraft|dermagraft
5056881|NCT03643614|adipose derived stromal cells|adipose derived stromal cells
5447611|NCT01512576|treatment|treatment
5056882|NCT03643614|stromal vascular fraction|stromal vascular fraction
5056883|NCT03643614|mesenchymal stem cells|mesenchymal stem cells
5056884|NCT03643614|rectovaginal fistula|rectovaginal fistula
5447903|NCT01511510|safety|safety
5476505|NCT01393847|HV|hv
5592377|NCT00921531|TACE|tace
5463299|NCT01447537|Muscle mass|muscle mass
5477012|NCT01391819|Incidence|incidence
5448496|NCT01508793|Sleep|sleep
5056885|NCT03643601|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5477393|NCT01390246|Bupropion SR|bupropion sr
5477526|NCT01389557|DHP|dhp
5464160|NCT01444196|ACU|acu
5464254|NCT01443767|esCCO|escco
5056886|NCT03643601|chronic kidney disease associated anemia|chronic kidney disease associated anemia
5478022|NCT01387477|ICU|icu
5478113|NCT01387113|stroke|stroke
5056887|NCT03643601|ASP1517|asp1517
5056888|NCT03643588|Hyaluronan|hyaluronan
5478506|NCT01385319|Bare metal stent|bare metal stent
5056889|NCT03643588|synovial fluid supplement|synovial fluid supplement
5056893|NCT03643549|Temozolomide|temozolomide
5056894|NCT03643549|Bortezomib|bortezomib
5478994|NCT01383161|Supplement|supplement
5450451|NCT01500915|AMD|amd
5465762|NCT01437930|human|human
5056895|NCT03643549|Recurrent disease|recurrent disease
5595852|NCT00907478|ITP|itp
5466081|NCT01436500|HRS|hrs
5479901|NCT01379443|Children|children
5451360|NCT01497093|Myeloma|myeloma
5479996|NCT01379053|Gas chromatography|gas chromatography
5480196|NCT01378260|PAD Study|pad study
5466884|NCT01433302|Lymphedema|lymphedema
5480299|NCT01377818|COPD|copd
5451871|NCT01494896|COPD|copd
5480608|NCT01376674|radiotherapy|radiotherapy
5480609|NCT01376674|immunology|immunology
5465638|NCT01438385|Biliary|biliary
5480817|NCT01375764|Cholesterol|cholesterol
5480929|NCT01375335|Inotropes|inotropes
5481080|NCT01374698|PCI|pci
5481135|NCT01374451|Pasireotide|pasireotide
5481136|NCT01374451|Everolimus|everolimus
5481236|NCT01374022|Randomized Controlled Trial|randomized controlled trial
5467884|NCT01429467|Cortisol|cortisol
5453022|NCT01490203|MRI|mri
5468492|NCT01427062|balance|balance
5468579|NCT01426685|sudden death|sudden death
5468678|NCT01426217|stopcock contamination|stopcock contamination
5468781|NCT01425775|vitamin D|vitamin d
5482476|NCT01368666|Biological valve|biological valve
5469278|NCT01423747|ALL|all
5469536|NCT01422603|AML|aml
5483119|NCT01365897|Attention|attention
5454666|NCT01483274|AML|aml
5599929|NCT00897715|CKD|ckd
5483443|NCT01364480|Tetraplegia|tetraplegia
5455046|NCT01481675|PYY|pyy
5455154|NCT01481246|MCI|mci
5483972|NCT01362439|Paliperidone|paliperidone
5484085|NCT01361984|Brovana|brovana
5484281|NCT01361204|pharmacy training|pharmacy training
5484407|NCT01360671|PPHN|pphn
5484670|NCT01359670|tadalafil|tadalafil
5484855|NCT01358786|Quilting suture|quilting suture
5471400|NCT01415271|diabetes|diabetes
5484956|NCT01358370|Wolman Phenotype|wolman phenotype
5485055|NCT01357954|Gross motor function|gross motor function
5472226|NCT01411943|Pain|pain
5485806|NCT01354574|lipoproteins|lipoproteins
5457096|NCT01473264|BPD|bpd
5457176|NCT01472991|ADHD|adhd
5472530|NCT01410643|metabolism|metabolism
5472639|NCT01410318|Stroke|stroke
5486293|NCT01352520|LyP|lyp
5457534|NCT01471444|AML|aml
5603306|NCT00885313|NAFLD|nafld
5473403|NCT01407393|overweight|overweight
5473614|NCT01406587|Burning|burning
5487341|NCT01348139|Asthma|asthma
5604460|NCT00880334|TCC|tcc
5487838|NCT01346345|Recession|recession
5487920|NCT01346046|Type 2 Diabetes|type 2 diabetes
5488035|NCT01345487|legumes|legumes
5488036|NCT01345487|meat|meat
5605381|NCT00876863|NGF|ngf
5474842|NCT01401465|PAR|par
5488792|NCT01342237|etoposide|etoposide
5488892|NCT01341717|Sitagliptin|sitagliptin
5489002|NCT01341184|rifabutin|rifabutin
5489541|NCT01338987|FLT|flt
5489713|NCT01338324|Simvastatin|simvastatin
5489951|NCT01337362|Hypoglycaemia-associated autonomic failure|hypoglycaemia-associated autonomic failure
5461118|NCT01456754|Insulin|insulin
5461219|NCT01456403|MRI|mri
5476581|NCT01393470|HPV|hpv
5461572|NCT01454700|CGM|cgm
5476738|NCT01392820|MAD|mad
5461705|NCT01454011|hsCRP|hscrp
5490845|NCT01333696|Pemetrexed|pemetrexed
5608678|NCT00863811|IOP|iop
5490944|NCT01333241|Obesity|obesity
5056896|NCT03643536|left ventricular ejection fraction; quality of life|left ventricular ejection fraction; quality of life
5461991|NCT01452906|PA21|pa21
5609145|NCT00861861|CAD|cad
5491301|NCT01331603|MDS|mds
5477525|NCT01389557|malaria|malaria
5462482|NCT01451008|Colon|colon
5462638|NCT01450332|ACL|acl
5462780|NCT01449695|PAD|pad
5478025|NCT01387464|Bromday|bromday
5609919|NCT00858364|NSCLC|nsclc
5478122|NCT01387113|CTA|cta
5463084|NCT01448434|MSC|msc
5610541|NCT00855907|IBD|ibd
5478721|NCT01384383|GS 9451|gs 9451
5492818|NCT01325246|repair|repair
5479070|NCT01382719|FSD|fsd
5479227|NCT01382056|PAD|pad
5611767|NCT00851136|CRC|crc
5479712|NCT01380249|Phase I|phase i
5493728|NCT01321411|Near Infrared Spectroscopy|near infrared spectroscopy
5493731|NCT01321398|HFO|hfo
5479915|NCT01379391|TPO|tpo
5493832|NCT01321047|opioid|opioid
5493923|NCT01320748|MRI Scans|mri scans
5494112|NCT01319981|Cytarabine|cytarabine
5612622|NCT00847561|Anxiety|anxiety
5480405|NCT01377454|mTBI|mtbi
5480524|NCT01377064|HIV|hiv
5494508|NCT01318096|efficacy|efficacy
5494530|NCT01318044|MRI|mri
5494605|NCT01317615|Large cell carcinoma,|large cell carcinoma,
5494717|NCT01317225|Progesterone|progesterone
5494823|NCT01316809|Glioblastoma Multiforme|glioblastoma multiforme
5465872|NCT01437475|HBV|hbv
5495023|NCT01316614|Stylet|stylet
5495028|NCT01316588|microbial sealant|microbial sealant
5495240|NCT01315860|Low Back Pain|low back pain
5614097|NCT00841529|LAA|laa
5671461|NCT00615927|GBM|gbm
5495540|NCT01314547|life event|life event
5117685|NCT03259893|Proctor Conceptual Model of Implementation Research|proctor conceptual model of implementation research
5117686|NCT03259893|Prevention|prevention
5496042|NCT01312363|Patch|patch
5496141|NCT01311856|Exercise|exercise
5117687|NCT03259893|Safety net hospital|safety net hospital
5117688|NCT03259893|Diverse inner city patients|diverse inner city patients
5467458|NCT01431235|SUD|sud
5496667|NCT01309659|old|old
5496743|NCT01309334|MRI|mri
5117689|NCT03259880|evaluation|evaluation
5117690|NCT03259867|Hepatocellular carcinoma|hepatocellular carcinoma
5468097|NCT01428804|tDCS|tdcs
5497232|NCT01307228|Policymakers|policymakers
5497364|NCT01306799|Bone|bone
5483727|NCT01363401|MND|mnd
5468504|NCT01427023|APTIMA|aptima
5117691|NCT03259867|Colorectal cancer|colorectal cancer
5117692|NCT03259867|Immune checkpoint inhibitor|immune checkpoint inhibitor
5117693|NCT03259867|Gastric cancer|gastric cancer
5468939|NCT01425086|PCM|pcm
5117694|NCT03259867|Non-small cell lung cancer|non-small cell lung cancer
5498167|NCT01303640|Coronary stent|coronary stent
5484540|NCT01360190|MDD|mdd
5117695|NCT03259828|Sigmoid colon cancer|sigmoid colon cancer
5498768|NCT01301105|social stress|social stress
5485090|NCT01357837|Pain|pain
5117696|NCT03259828|Internal organ motion|internal organ motion
5485395|NCT01356290|Relapse|relapse
5485634|NCT01355354|Phase 1|phase 1
5117697|NCT03259828|Radiotherapy|radiotherapy
5117698|NCT03259815|FFR Targeted PCI|ffr targeted pci
5499594|NCT01297530|Phase I|phase i
5486057|NCT01353391|Metformin in Women|metformin in women
5117699|NCT03259815|Post-PCI FFR|post-pci ffr
5486291|NCT01352520|ALCL|alcl
5499951|NCT01295944|Malignancy|malignancy
5500069|NCT01295541|Deconditioning|deconditioning
5117700|NCT03259815|Physiology-guided PCI Optimisation|physiology-guided pci optimisation
5117701|NCT03259776|Intensive Care|intensive care
5620474|NCT00816855|NPC|npc
5500677|NCT01293175|polyphenols|polyphenols
5487199|NCT01348763|HIV|hiv
5500778|NCT01292824|Entry|entry
5620858|NCT00815711|IPF|ipf
5500974|NCT01291992|Postop|postop
5501062|NCT01291654|PDA|pda
5501168|NCT01291329|stem cell|stem cell
5501175|NCT01291290|TEG|teg
5117702|NCT03259776|Patient- and Family-Centred Care|patient- and family-centred care
5487839|NCT01346319|dose escalating|dose escalating
5117703|NCT03259776|Patient and Public Involvement|patient and public involvement
5472507|NCT01410721|TBI|tbi
5117704|NCT03259776|South West London Major Trauma Network|south west london major trauma network
5117705|NCT03259776|Service Improvement|service improvement
5472901|NCT01409174|Ipilimumab|ipilimumab
5117706|NCT03259776|Survey Questionnaire|survey questionnaire
5117707|NCT03259776|Visitor Experiences|visitor experiences
5117708|NCT03259763|Gastroenterostomy|gastroenterostomy
5488949|NCT01341483|erection|erection
5117709|NCT03259763|Gastric Outlet Obstruction|gastric outlet obstruction
5117711|NCT03259763|Endosonography|endosonography
5502834|NCT01284257|MMF|mmf
5473786|NCT01405976|CPAP|cpap
5489380|NCT01339702|TBI|tbi
5503036|NCT01283191|drug use|drug use
5503133|NCT01282749|Faith based|faith based
5117712|NCT03259750|Self-reported outcome instrument|self-reported outcome instrument
5503261|NCT01282047|HIV|hiv
5117713|NCT03259750|Sport|sport
5117714|NCT03259750|Ankle and foot|ankle and foot
5117715|NCT03259750|Injury|injury
5489971|NCT01337271|weaning|weaning
5117716|NCT03259711|Cardiotoxicity|cardiotoxicity
5503714|NCT01279889|blood pressure|blood pressure
5503802|NCT01279473|CML|cml
5490384|NCT01335672|CALIBER|caliber
5117717|NCT03259711|selective estrogen receptor modulators|selective estrogen receptor modulators
5504626|NCT01276119|CDP6038|cdp6038
5117718|NCT03259711|aromatase inhibitors|aromatase inhibitors
5117719|NCT03259711|hormone replacement therapy|hormone replacement therapy
5117720|NCT03259711|estrogen|estrogen
5117724|NCT03259672|intubation|intubation
5117725|NCT03259672|pharyngitis|pharyngitis
5117726|NCT03259672|remifentanil|remifentanil
5117727|NCT03259633|Neurofibromatosis type1,|neurofibromatosis type1,
5117728|NCT03259633|Plexiform Neurofibromas|plexiform neurofibromas
5491888|NCT01329094|evaluation|evaluation
5492082|NCT01328288|depression|depression
5476736|NCT01392820|PK|pk
5492178|NCT01327872|TLD|tld
5505828|NCT01271582|Irinotecan|irinotecan
5492380|NCT01327053|skin cancer|skin cancer
5506058|NCT01270529|CKD|ckd
5477009|NCT01391832|CPT|cpt
5492618|NCT01326195|Females|females
5506330|NCT01269450|late abortion|late abortion
5477323|NCT01390441|RA|ra
5477387|NCT01390272|Veterans|veterans
5506721|NCT01267630|Disorientation|disorientation
5506722|NCT01267617|hemodialysis|hemodialysis
5477792|NCT01388387|tacrolimus|tacrolimus
5493482|NCT01322555|ASD|asd
5507063|NCT01266187|liver metastasis|liver metastasis
5628313|NCT00786773|PPI|ppi
5507374|NCT01264744|Urine sample|urine sample
5507375|NCT01264731|melanoma|melanoma
5493825|NCT01321086|PAD|pad
5507578|NCT01263782|Nonsquamous cell|nonsquamous cell
5507681|NCT01263418|Arzerra|arzerra
5507985|NCT01262144|PET CT|pet ct
5508104|NCT01261624|poly JIA|poly jia
5494496|NCT01318148|Aspergillosis|aspergillosis
5494592|NCT01317693|LI-ESWT|li-eswt
5494809|NCT01316822|M-CSF|m-csf
5629992|NCT00779857|laa|laa
5495011|NCT01316679|HCC|hcc
5479657|NCT01380483|bioequivalence|bioequivalence
5495336|NCT01315379|CBT|cbt
5479964|NCT01379183|Healthy|healthy
5480105|NCT01378637|Leg|leg
5509315|NCT01256099|CBT|cbt
5495597|NCT01314300|Plaster|plaster
5495699|NCT01313767|spasticity|spasticity
5480868|NCT01375569|CD105|cd105
5496284|NCT01311154|AMR|amr
5510125|NCT01252550|IBS|ibs
5631963|NCT00771394|BPH|bph
5481077|NCT01374711|Sepsis|sepsis
5481284|NCT01373827|MC1|mc1
5510590|NCT01250314|men|men
5510846|NCT01249105|GBM|gbm
5496984|NCT01308138|pathology|pathology
5511009|NCT01248416|GH|gh
5481769|NCT01371578|HCV|hcv
5497385|NCT01306708|SPADI|spadi
5511392|NCT01246752|Tx|tx
5482290|NCT01369407|HF|hf
5482421|NCT01368939|MBI|mbi
5511675|NCT01245335|CLI|cli
5497907|NCT01304693|AMD|amd
5482576|NCT01368250|Valve|valve
5514772|NCT01232140|CRP|crp
5498136|NCT01303796|AML|aml
5482871|NCT01366937|egg|egg
5512254|NCT01242657|Tobacco Use Cessation|tobacco use cessation
5512450|NCT01241773|TMC435-TiDP16-C123|tmc435-tidp16-c123
5512552|NCT01241396|survey|survey
5512844|NCT01240291|trauma|trauma
5635408|NCT00756522|COPD|copd
5513197|NCT01238575|PDD|pdd
5499776|NCT01296763|Irinotecan|irinotecan
5484492|NCT01360359|RCT|rct
5484582|NCT01360073|MI|mi
5636369|NCT00752843|DDI|ddi
5500176|NCT01295216|mHealth|mhealth
5636657|NCT00751842|GAD|gad
5484948|NCT01358383|Pharmacokinetics|pharmacokinetics
5514553|NCT01233180|massage|massage
5501094|NCT01291563|TBC|tbc
5514644|NCT01232712|Multiple Myeloma|multiple myeloma
5514645|NCT01232699|obesity|obesity
5514747|NCT01232244|Glucagon|glucagon
5500886|NCT01292317|CIN|cin
5514852|NCT01231711|functional status|functional status
5514961|NCT01231347|jaundice|jaundice
5501082|NCT01291589|MSM|msm
5515068|NCT01230827|GO KIDS|go kids
5515252|NCT01229891|yogurt drink|yogurt drink
5501509|NCT01289912|TSC|tsc
5515621|NCT01228084|prostate cancer|prostate cancer
5515709|NCT01227694|Osteoarthritis|osteoarthritis
5486668|NCT01350804|ACR|acr
5515900|NCT01226693|PH-797804|ph-797804
5656350|NCT00677014|HF|hf
5516619|NCT01223248|IGIMRT|igimrt
5516820|NCT01222390|Expander Profile|expander profile
5639876|NCT00740441|rcc|rcc
5516917|NCT01222039|Adipose tissue|adipose tissue
5503148|NCT01282645|PSI|psi
5640130|NCT00739414|LBH589|lbh589
5488086|NCT01345253|PGA|pga
5640513|NCT00738062|NOH|noh
5517392|NCT01220128|breast cancer|breast cancer
5517483|NCT01219712|non-cardiac surgery|non-cardiac surgery
5640750|NCT00737308|crowns|crowns
5517581|NCT01219426|French|french
5517690|NCT01218867|Metastatic Melanoma|metastatic melanoma
5488648|NCT01342978|HPV|hpv
5503894|NCT01279044|MSM|msm
5504027|NCT01278524|ICU|icu
5517891|NCT01217931|RCC|rcc
5504107|NCT01278225|EEG|eeg
5660554|NCT00661141|ethanol|ethanol
5518208|NCT01216644|ECF|ecf
5518271|NCT01216306|Obesity|obesity
5504466|NCT01276860|OSA|osa
5489269|NCT01340040|Phase I|phase i
5504669|NCT01275950|students|students
5518765|NCT01214096|rhNRG-1|rhnrg-1
5518863|NCT01213628|warming|warming
5642533|NCT00730704|HPV|hpv
5505089|NCT01274351|Ph+|ph+
5518958|NCT01213238|HAI|hai
5519129|NCT01212718|biopsy|biopsy
5519160|NCT01212562|cryosurgery|cryosurgery
5490043|NCT01337024|HRV|hrv
5490163|NCT01336569|IOP|iop
5519376|NCT01211652|France|france
5519491|NCT01211184|Glucose|glucose
5505661|NCT01272271|Cornea|cornea
5490470|NCT01335230|HCV|hcv
5519681|NCT01210430|POTS|pots
5505971|NCT01270906|CHIR258|chir258
5519879|NCT01209429|STATb5|statb5
5520067|NCT01208701|Nephrology|nephrology
5491133|NCT01332370|Sitagliptin|sitagliptin
5520361|NCT01207375|cognition|cognition
5491262|NCT01331811|HIV|hiv
5506580|NCT01268306|SPK|spk
5520457|NCT01206894|lung cancer|lung cancer
5491448|NCT01331044|RUTF|rutf
5491549|NCT01330615|EMLA|emla
5506869|NCT01266954|PET|pet
5507107|NCT01266057|Vorinostat|vorinostat
5507216|NCT01265537|Transplant|transplant
5491938|NCT01328860|Spinal Cord Injury|spinal cord injury
5492060|NCT01328392|LPR|lpr
5507426|NCT01264575|epinephrine|epinephrine
5521233|NCT01203787|HCC|hcc
5492172|NCT01327898|MSM|msm
5507724|NCT01263249|Femoral|femoral
5521531|NCT01202734|Male|male
5507822|NCT01262807|radius|radius
5521642|NCT01202266|Phase 1|phase 1
5492581|NCT01326403|hip|hip
5508013|NCT01262053|Patient Safety|patient safety
5521856|NCT01201330|ONJ|onj
5508117|NCT01261585|SUV|suv
5521932|NCT01200979|Infection|infection
5492956|NCT01324726|Bacterial colonization|bacterial colonization
5508436|NCT01260129|BPH|bph
5508502|NCT01259856|Hydroxyurea|hydroxyurea
5522341|NCT01199575|CLL|cll
5493267|NCT01323374|FMS|fms
5522523|NCT01198730|DM|dm
5508792|NCT01258569|colon|colon
5522736|NCT01197677|Register|register
5522737|NCT01197677|CAD|cad
5493708|NCT01321541|NHL|nhl
5522830|NCT01197248|cystocele|cystocele
5522927|NCT01196897|TIA|tia
5056897|NCT03643523|anastomitic leak, infectious complications, colorectal surgery|anastomitic leak, infectious complications, colorectal surgery
5509199|NCT01256645|weaning|weaning
5523122|NCT01196117|Apnea|apnea
5523218|NCT01195558|Nap|nap
5056902|NCT03643484|Lung Diseases, Interstitial|lung diseases, interstitial
5056903|NCT03643484|Radiation Pneumonitis|radiation pneumonitis
5523423|NCT01194661|TMS|tms
5056904|NCT03643458|NIRS|nirs
5523522|NCT01194232|CF|cf
5056905|NCT03643458|TANEC|tanec
5648202|NCT00710112|CLD|cld
5056906|NCT03643458|splanchnic oxygenation|splanchnic oxygenation
5056907|NCT03643458|enteral feeding|enteral feeding
5056908|NCT03643458|preterm infants|preterm infants
5523986|NCT01192425|AA|aa
5510173|NCT01252407|heart rate|heart rate
5495009|NCT01316718|IBS|ibs
5524398|NCT01190800|Decision-making assessment|decision-making assessment
5649302|NCT00705497|RFA|rfa
5524525|NCT01190423|AN|an
5510840|NCT01249157|PEM|pem
5524594|NCT01190111|HIV|hiv
5511031|NCT01248273|QS-21|qs-21
5511151|NCT01247701|UCB|ucb
5524928|NCT01188564|HAE|hae
5525449|NCT01186380|TEE|tee
5496294|NCT01311076|Insulin|insulin
5056909|NCT03643445|motivational Interviewing; motivation|motivational interviewing; motivation
5496660|NCT01309659|UAE|uae
5496700|NCT01309451|DME|dme
5512217|NCT01242852|IVF|ivf
5512413|NCT01241955|CPR|cpr
5526176|NCT01183572|folate|folate
5497189|NCT01307384|THA|tha
5529362|NCT01170624|PhD|phd
5512871|NCT01240148|paresthesia|paresthesia
5526692|NCT01181440|Dermagraft|dermagraft
5512961|NCT01239784|Heart Defects|heart defects
5526794|NCT01181076|Adult|adult
5497576|NCT01306006|Mortality|mortality
5513054|NCT01239212|neonate|neonate
5513150|NCT01238757|Prevalence|prevalence
5056910|NCT03643445|psychoeducation; psychoeducational-oriented treatment|psychoeducation; psychoeducational-oriented treatment
5056911|NCT03643367|Sepsis|sepsis
5056912|NCT03643367|Septic Shock|septic shock
5527594|NCT01177514|PRK|prk
5513997|NCT01235806|MRI|mri
5056913|NCT03643367|Sevoflurane Conditioning|sevoflurane conditioning
5528512|NCT01173913|DLT|dlt
5528187|NCT01175278|fracture|fracture
5056914|NCT03643341|Family-based|family-based
5056915|NCT03643341|Community-based|community-based
5528457|NCT01174212|hip|hip
5528607|NCT01173510|HIV|hiv
5056928|NCT03643276|Immunotherapy|immunotherapy
5056929|NCT03643276|Blinatumomab|blinatumomab
5056930|NCT03643276|Proteasome Inhibitor|proteasome inhibitor
5528882|NCT01172340|exercise|exercise
5056937|NCT03643237|active aging|active aging
5056938|NCT03643237|health promotion|health promotion
5500063|NCT01295567|CABG|cabg
5529462|NCT01170286|Safety|safety
5056939|NCT03643237|study protocol|study protocol
5056941|NCT03643224|electrophysiology|electrophysiology
5056942|NCT03643224|atrial fibrillation|atrial fibrillation
5056943|NCT03643224|catheter|catheter
5056944|NCT03643224|persistent|persistent
5056949|NCT03643185|cytokine|cytokine
5056950|NCT03643185|ABPA|abpa
5056951|NCT03643159|Digital Medicine System|digital medicine system
5056952|NCT03643133|Bone|bone
5530799|NCT01164579|Joint Structure|joint structure
5056953|NCT03643133|Neoplasm, bone tissue|neoplasm, bone tissue
5501819|NCT01288755|HIV|hiv
5530969|NCT01164020|aging|aging
5517325|NCT01220401|Suicide|suicide
5693450|NCT00524472|Outcome|outcome
5502074|NCT01287598|Phase I|phase i
5658051|NCT00670761|MVA|mva
5502252|NCT01286935|PD|pd
5531569|NCT01161264|Immunogenicity|immunogenicity
5056954|NCT03643133|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
5056955|NCT03643107|Drug Response Prediction (DRP)|drug response prediction (drp)
5056956|NCT03643055|medullary thyroid cancer|medullary thyroid cancer
5056957|NCT03643055|imaging|imaging
5056958|NCT03643055|hybrid-imaging|hybrid-imaging
5531922|NCT01159886|IBD|ibd
5056959|NCT03643055|18F-choline|18f-choline
5532014|NCT01159379|Ertapenem|ertapenem
5502848|NCT01284192|ASP3026|asp3026
5532161|NCT01158729|Pediatrics|pediatrics
5532271|NCT01158196|laser|laser
5056960|NCT03643055|18F-fluorocholine|18f-fluorocholine
5056961|NCT03643055|PET|pet
5056962|NCT03643055|PET/CT|pet/ct
5056967|NCT03643003|music|music
5503440|NCT01281267|VCA|vca
5518994|NCT01213147|Buserelin|buserelin
5503625|NCT01280240|CIA|cia
5519415|NCT01211496|knee|knee
5533167|NCT01154556|failed NNRTI regime|failed nnrti regime
5056968|NCT03643003|music therapy|music therapy
5056969|NCT03642990|paclitaxel|paclitaxel
5504616|NCT01276184|SMS|sms
5504854|NCT01275196|CML-CP|cml-cp
5534188|NCT01150214|af|af
5056970|NCT03642990|nicotinamide riboside|nicotinamide riboside
5056971|NCT03642990|NIAGEN|niagen
5056972|NCT03642990|nab-paclitaxel|nab-paclitaxel
5505406|NCT01273155|Solid Tumor|solid tumor
5520967|NCT01204788|Infection|infection
5662336|NCT00654147|HIV|hiv
5056973|NCT03642977|Longitudinal study|longitudinal study
5056974|NCT03642977|Real time PCR|real time pcr
5056975|NCT03642951|magnetic|magnetic
5056976|NCT03642951|brain|brain
5056977|NCT03642951|stimulation|stimulation
5056978|NCT03642938|Exercise|exercise
5662895|NCT00651755|AD|ad
5056979|NCT03642938|Dose|dose
5056980|NCT03642938|Analgesia|analgesia
5506471|NCT01268800|AML|aml
5522057|NCT01200511|toric|toric
5056981|NCT03642925|Meal replacement|meal replacement
5522259|NCT01199861|MS|ms
5056982|NCT03642925|calorie restriction|calorie restriction
5056983|NCT03642925|body weight|body weight
5522652|NCT01198132|Rebif|rebif
5522774|NCT01197443|BMI|bmi
5056988|NCT03642782|electroretinogram pattern|electroretinogram pattern
5507602|NCT01263756|Adults|adults
5523332|NCT01195077|HIV|hiv
5056989|NCT03642769|Pancreatitis|pancreatitis
5056990|NCT03642769|Fluids|fluids
5056991|NCT03642769|SIRS|sirs
5523617|NCT01193777|Shock|shock
5056992|NCT03642769|Management|management
5056993|NCT03642769|Lactated Ringer|lactated ringer
5524081|NCT01192100|PYY|pyy
5056996|NCT03642743|minimally invasive surgery|minimally invasive surgery
5508788|NCT01258582|HIV|hiv
5056998|NCT03642743|satisfaction|satisfaction
5056999|NCT03642730|echocardiography|echocardiography
5524383|NCT01190904|DM|dm
5057000|NCT03642730|training|training
5508996|NCT01257594|GBM|gbm
5057001|NCT03642730|follow-up|follow-up
5057002|NCT03642704|PMTCT|pmtct
5524628|NCT01189955|RLN|rln
5509463|NCT01255371|HIV|hiv
5057003|NCT03642704|HIV early diagnosis|hiv early diagnosis
5509787|NCT01254123|MRI|mri
5057004|NCT03642704|HIV preventive therapy|hiv preventive therapy
5667499|NCT00630942|PSC|psc
5525389|NCT01186575|Coitus|coitus
5538797|NCT01132534|NBI|nbi
5510134|NCT01252537|Tuberculosis|tuberculosis
5538959|NCT01131611|Rehabilitation|rehabilitation
5525675|NCT01185444|Hyaluronate|hyaluronate
5525775|NCT01185080|AZD8848|azd8848
5539150|NCT01130909|Healthy|healthy
5539264|NCT01130402|age|age
5510535|NCT01250561|phn|phn
5526107|NCT01183780|CRC|crc
5668558|NCT00626938|HLA|hla
5526171|NCT01183611|safety|safety
5510998|NCT01248455|SMM|smm
5539763|NCT01128153|Saxagliptin|saxagliptin
5526580|NCT01181830|metabolic syndrome|metabolic syndrome
5511339|NCT01246960|stomach|stomach
5526832|NCT01180907|PET|pet
5526899|NCT01180660|Pain|pain
5526993|NCT01180270|SVV|svv
5511721|NCT01245062|Cancer|cancer
5540626|NCT01124422|tiotropium|tiotropium
5511915|NCT01244204|immunity|immunity
5512017|NCT01243658|BPD|bpd
5527488|NCT01178073|PAH|pah
5512107|NCT01243216|Pregnancy|pregnancy
5512300|NCT01242436|therapy|therapy
5541143|NCT01122251|valsartan|valsartan
5527857|NCT01176500|PET Imaging|pet imaging
5541340|NCT01121445|CPAP|cpap
5528089|NCT01175694|APBI|apbi
5541428|NCT01120925|Stem Cells|stem cells
5528261|NCT01175018|Heart Failure|heart failure
5541838|NCT01119053|VNS|vns
5541948|NCT01118767|Surveys|surveys
5542036|NCT01118481|iFR|ifr
5513433|NCT01237925|Gel|gel
5528887|NCT01172301|CF|cf
5529072|NCT01171820|myocardial ischemia|myocardial ischemia
5542501|NCT01116947|Dietary Phosphorus Binding (DPB)|dietary phosphorus binding (dpb)
5529227|NCT01171300|rectum|rectum
5529363|NCT01170624|EGM|egm
5057005|NCT03642704|prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
5672650|NCT00611325|GBM|gbm
5057006|NCT03642678|Prediction Model|prediction model
5529899|NCT01168635|Asthma|asthma
5532668|NCT01156480|NEC|nec
5057007|NCT03642678|Malnutrition|malnutrition
5057008|NCT03642678|Hemodialysis|hemodialysis
5514889|NCT01231620|H1N1|h1n1
5673489|NCT00608023|HIV|hiv
5543597|NCT01113086|Parkinson|parkinson
5543694|NCT01112774|Brain excitability|brain excitability
5543803|NCT01112215|SLE|sle
5057013|NCT03642613|COPD, RWE, Physical Activity|copd, rwe, physical activity
5543995|NCT01111305|Post-Treatment Reactions|post-treatment reactions
5544091|NCT01110889|Major Depressive Disorder|major depressive disorder
5674256|NCT00604279|R092670|r092670
5674376|NCT00603811|M2e|m2e
5544285|NCT01110148|skin biopsy|skin biopsy
5531027|NCT01163864|smoking|smoking
5544478|NCT01109394|Sarcoma|sarcoma
5515902|NCT01226680|Dry Eye|dry eye
5544674|NCT01108601|lactate|lactate
5544774|NCT01108133|Traumatic Memories|traumatic memories
5675075|NCT00600938|LVEF|lvef
5544882|NCT01107613|COPD|copd
5057014|NCT03642574|Preimplantation Methylome Screening|preimplantation methylome screening
5516282|NCT01224847|AMD|amd
5531726|NCT01160653|stroke|stroke
5545065|NCT01106742|IBD|ibd
5516477|NCT01223833|BMI|bmi
5531937|NCT01159821|CYP2D6 inhibitor|cyp2d6 inhibitor
5545358|NCT01105585|IOL|iol
5532217|NCT01158352|Growth|growth
5545564|NCT01104701|Amylin|amylin
5676069|NCT00596700|IBD|ibd
5057015|NCT03642574|Preimplantation Genetic Screening|preimplantation genetic screening
5057016|NCT03642574|single embryo transfer|single embryo transfer
5545917|NCT01103115|AIS|ais
5546028|NCT01102608|sarcoma|sarcoma
5057017|NCT03642574|cumulative live birth rate|cumulative live birth rate
5057018|NCT03642548|NSCLC|nsclc
5057019|NCT03642548|Bifico|bifico
5057020|NCT03642548|gut-lung axis|gut-lung axis
5533267|NCT01154192|LH|lh
5533304|NCT01154010|PEMF|pemf
5677581|NCT00589836|HCM|hcm
5546809|NCT01099800|CAM|cam
5057021|NCT03642535|Photodynamic Therapy|photodynamic therapy
5546908|NCT01099358|Sarcoma|sarcoma
5057026|NCT03642522|biomarker|biomarker
5057027|NCT03642522|treatment-resistant|treatment-resistant
5534078|NCT01150617|Normoglycemia|normoglycemia
5534174|NCT01150266|stroke|stroke
5547628|NCT01096407|arthralgia|arthralgia
5057028|NCT03642509|Left atrial appendage occlusion|left atrial appendage occlusion
5534467|NCT01149070|Gonal-f|gonal-f
5057029|NCT03642509|Novel oral anticoagulation|novel oral anticoagulation
5057030|NCT03642483|type 1 diabetes|type 1 diabetes
5057031|NCT03642483|metabolic control|metabolic control
5057032|NCT03642483|psychosocial risk factors|psychosocial risk factors
5057033|NCT03642483|FEPB|fepb
5057034|NCT03642483|children|children
5057035|NCT03642483|adolescents|adolescents
5535059|NCT01146847|insulin|insulin
5057036|NCT03642470|type 1 diabetes|type 1 diabetes
5548449|NCT01093443|IVF|ivf
5057037|NCT03642470|metabolic control|metabolic control
5548634|NCT01092793|Krill|krill
5733058|NCT00382616|hyperactive|hyperactive
5057038|NCT03642470|psychosocial risk factors|psychosocial risk factors
5057039|NCT03642470|cortisol|cortisol
5057040|NCT03642470|children|children
5057041|NCT03642470|adolescents|adolescents
5549300|NCT01089829|CKD|ckd
5057042|NCT03642457|Video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
5520963|NCT01204788|AML|aml
5681199|NCT00574353|07-151|07-151
5681353|NCT00573703|Surgery|surgery
5549860|NCT01087567|insulin|insulin
5536873|NCT01139151|AML|aml
5057043|NCT03642457|Serratus plane block|serratus plane block
5057044|NCT03642457|local infiltration|local infiltration
5057045|NCT03642444|stroke|stroke
5057046|NCT03642444|hemiplegia|hemiplegia
5671584|NCT00615407|Asthma, alcohol|asthma, alcohol
5522227|NCT01200004|Azacitidine|azacitidine
5550836|NCT01083667|ALS|als
5550855|NCT01083589|Metastatic NSCLC|metastatic nsclc
5537590|NCT01137643|aplastic anemia|aplastic anemia
5551557|NCT01081119|alcohol|alcohol
5522822|NCT01197274|allergy|allergy
5551461|NCT01081431|IPSS|ipss
5551750|NCT01080157|Diabetes|diabetes
5538360|NCT01133951|Incidence|incidence
5523409|NCT01194713|Abeta|abeta
5552004|NCT01079026|hnp|hnp
5523504|NCT01194310|glaucoma|glaucoma
5538668|NCT01132547|mixed osteosarcoma|mixed osteosarcoma
5428254|NCT01595503|Schizophrenia, auditory hallucination|schizophrenia, auditory hallucination
5057303|NCT03640936|allergy|allergy
5523923|NCT01192685|TMS|tms
5538978|NCT01131520|SBIRT|sbirt
5539169|NCT01130792|rotavirus|rotavirus
5552847|NCT01075672|OCD|ocd
5539377|NCT01129817|Subclassification|subclassification
5552861|NCT01075659|VAS|vas
5524479|NCT01190566|chemotherapy|chemotherapy
5539483|NCT01129258|PK|pk
5524668|NCT01189773|pain control|pain control
5539866|NCT01127737|SSE|sse
5553472|NCT01073423|sleep|sleep
5525052|NCT01187992|Atorvastatin|atorvastatin
5540169|NCT01126320|VAP|vap
5540246|NCT01125956|Diabetes|diabetes
5553843|NCT01071707|IPF|ipf
5540564|NCT01124656|HbA1c|hba1c
5554010|NCT01070940|augmentation index|augmentation index
5554011|NCT01070940|dose-response|dose-response
5540643|NCT01124370|Sleep Apnea|sleep apnea
5525737|NCT01185184|550|550
5554309|NCT01069575|vaccine|vaccine
5554310|NCT01069575|HLA-A*2402|hla-a*2402
5543641|NCT01112930|DHA|dha
5526034|NCT01184053|UNC|unc
5541250|NCT01121861|stability|stability
5541761|NCT01119391|IVF|ivf
5555470|NCT01064778|Intake Regulation|intake regulation
5555471|NCT01064778|Weight Loss|weight loss
5555472|NCT01064778|Hunger|hunger
5555567|NCT01064388|Safety|safety
5527333|NCT01178593|hypnosis|hypnosis
5555791|NCT01063465|Tendon|tendon
5527434|NCT01178294|hemophilia A|hemophilia a
5555880|NCT01062958|Neevo DHA|neevo dha
5555983|NCT01062633|dietary supplements|dietary supplements
5556082|NCT01062152|MDS|mds
5556084|NCT01062152|Low risk MDS|low risk mds
5542709|NCT01116232|prolymphocytic leukemia|prolymphocytic leukemia
5542825|NCT01116232|intraocular lymphoma|intraocular lymphoma
5543002|NCT01115335|Gomco|gomco
5543233|NCT01114477|TMS|tms
5556972|NCT01058512|hepatitis C|hepatitis c
5556978|NCT01058499|COPD|copd
5528638|NCT01173406|Adherence|adherence
5557061|NCT01058096|Bipolar I Disorder|bipolar i disorder
5528819|NCT01172600|epidural block|epidural block
5690723|NCT00535223|War|war
5543905|NCT01111760|CT scan|ct scan
5544010|NCT01111240|Humira|humira
5557627|NCT01055704|Colonic transit|colonic transit
5544293|NCT01110122|Soccer|soccer
5557835|NCT01054729|GT1|gt1
5544437|NCT01109498|AAV|aav
5529580|NCT01169636|ICE|ice
5558015|NCT01054131|chronic disease|chronic disease
5558016|NCT01054118|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5558122|NCT01053611|pain|pain
5529760|NCT01169129|surgery|surgery
5558265|NCT01053065|Statin|statin
5691981|NCT00529880|AML|aml
5558503|NCT01052233|Sham-surgery|sham-surgery
5545058|NCT01106755|kinematic|kinematic
5558696|NCT01051440|vyvanse|vyvanse
5545248|NCT01105962|traumatic|traumatic
5558789|NCT01051076|ITI|iti
5558895|NCT01050660|PNAC|pnac
5545431|NCT01105299|anastrozole|anastrozole
5559003|NCT01050140|diet|diet
5530633|NCT01165242|Adult|adult
5559087|NCT01049841|pediatric|pediatric
5559192|NCT01049503|Nails|nails
5530811|NCT01164449|glucose control|glucose control
5530919|NCT01164163|polycythemia vera|polycythemia vera
5530983|NCT01163968|Rural|rural
5531139|NCT01163240|HBV|hbv
5546017|NCT01102673|PK|pk
5546096|NCT01102257|DED|ded
5546197|NCT01101815|Substance Abuse|substance abuse
5559777|NCT01047735|Malignant Tumor|malignant tumor
5553987|NCT01071083|MS|ms
5546346|NCT01101412|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5546423|NCT01101412|intraocular lymphoma|intraocular lymphoma
5560134|NCT01047163|Men|men
5546489|NCT01101191|Healthy subjects|healthy subjects
5560170|NCT01047033|Peru|peru
5531810|NCT01160354|AML|aml
5546683|NCT01100346|Gonal-f|gonal-f
5532080|NCT01159132|HIV|hiv
5731291|NCT00389493|OCD|ocd
5547099|NCT01098708|DMD|dmd
5560750|NCT01044732|Neoplasms|neoplasms
5561138|NCT01043185|pH|ph
5532641|NCT01156584|GBM|gbm
5561358|NCT01042275|TOT|tot
5532938|NCT01155388|CKD|ckd
5547845|NCT01095757|Myeloma|myeloma
5548049|NCT01095146|SoJIA|sojia
5561936|NCT01040039|HCV|hcv
5548334|NCT01093937|Champix|champix
5533612|NCT01152567|ACE|ace
5696919|NCT00511368|HIV|hiv
5533946|NCT01151189|HIV|hiv
5562528|NCT01037751|Cancer|cancer
5548899|NCT01091662|Seizures|seizures
5534178|NCT01150266|tPA|tpa
5534305|NCT01149785|crizotinib|crizotinib
5549205|NCT01090258|weaning|weaning
5563002|NCT01035255|outcome study|outcome study
5563003|NCT01035255|BNP|bnp
5534510|NCT01148862|X54|x54
5549477|NCT01089127|COPD|copd
5563199|NCT01034319|genetics|genetics
5549565|NCT01088737|melanoma|melanoma
5563382|NCT01033409|pneumonia|pneumonia
5563489|NCT01032967|chemoradiotherapy|chemoradiotherapy
5563583|NCT01032616|isotopes|isotopes
5535097|NCT01146626|SVR|svr
5563675|NCT01032317|Arrhythmia|arrhythmia
5563686|NCT01032291|Erbitux|erbitux
5535287|NCT01145794|SHS|shs
5535390|NCT01145209|Arzerra|arzerra
5699139|NCT00504140|IFN-|ifn-
5564086|NCT01030991|Epidemiology|epidemiology
5564174|NCT01030640|healthy volunteers|healthy volunteers
5564175|NCT01030627|Eclampsia|eclampsia
5550547|NCT01084980|tacrolimus|tacrolimus
5550637|NCT01084525|Vertigo episodes|vertigo episodes
5550732|NCT01084200|Female patients|female patients
5536082|NCT01142375|AML|aml
5564684|NCT01028638|PET|pet
5564766|NCT01028157|HIV|hiv
5536264|NCT01141738|caregiver|caregiver
5564841|NCT01027845|Immunogenicity|immunogenicity
5565101|NCT01026727|HIV|hiv
5565248|NCT01025999|DM|dm
5566833|NCT01019447|SSI|ssi
5565416|NCT01025310|environment|environment
5565444|NCT01025206|safety|safety
5700869|NCT00499239|MM|mm
5565523|NCT01024959|PCA3|pca3
5565615|NCT01024478|Magnetic Resonance Angiography|magnetic resonance angiography
5701412|NCT00497107|PSK|psk
5566006|NCT01022957|extra renal damages|extra renal damages
5701703|NCT00496132|CLL|cll
5566104|NCT01022515|pheochromocytoma|pheochromocytoma
5566105|NCT01022515|paraganglioma|paraganglioma
5566209|NCT01022125|HCV|hcv
5701883|NCT00495417|AD|ad
5566306|NCT01021683|Fever|fever
5566395|NCT01021319|magnetic resonance imaging|magnetic resonance imaging
5566667|NCT01020201|Chinese female patient|chinese female patient
5702519|NCT00493077|Safety|safety
5566778|NCT01019733|Ischemia|ischemia
5566779|NCT01019733|Brain|brain
5702645|NCT00492609|ACL|acl
5566982|NCT01018732|ACWY|acwy
5538561|NCT01132885|Healthy Volunteer|healthy volunteer
5567361|NCT01016873|Oraya|oraya
5553663|NCT01072474|Safety|safety
5567561|NCT01016054|Combination Drug Therapy|combination drug therapy
5567563|NCT01016054|safety|safety
5567672|NCT01015924|TEN|ten
5553999|NCT01071031|CD4|cd4
5567799|NCT01015495|CNV|cnv
5567901|NCT01015092|HAART|haart
5554377|NCT01069341|PDR|pdr
5568105|NCT01014234|Regulatory T cells|regulatory t cells
5568495|NCT01012583|Drug eluting stent|drug eluting stent
5562555|NCT01037686|PD|pd
5568575|NCT01012232|total knee arthroplasty|total knee arthroplasty
5568704|NCT01011595|staging|staging
5539985|NCT01127204|HIV|hiv
5705321|NCT00482313|ADHD|adhd
5569026|NCT01010217|MMF|mmf
5555313|NCT01065467|LBH589|lbh589
5569189|NCT01009528|Quality of care|quality of care
5569192|NCT01009515|metastatic|metastatic
5540516|NCT01124799|HCV|hcv
5705952|NCT00479856|MBC|mbc
5555804|NCT01063348|Picking|picking
5569792|NCT01007461|STEMI|stemi
5569794|NCT01007448|CTCL|ctcl
5541115|NCT01122368|mycoses|mycoses
5570102|NCT01006109|MEG|meg
5572848|NCT00995527|HV|hv
5541713|NCT01119547|Arthritis|arthritis
5570628|NCT01004016|SCD|scd
5542126|NCT01118117|SFA|sfa
5571158|NCT01001858|OSA|osa
5542477|NCT01117064|OSA|osa
5571445|NCT01000597|fluticasone furoate|fluticasone furoate
5571447|NCT01000584|vaccine|vaccine
5542669|NCT01116323|Adverse events|adverse events
5571543|NCT01000142|Manipulation|manipulation
5571641|NCT00999778|Autism|autism
5571645|NCT00999778|ASD|asd
5571821|NCT00999167|HE|he
5571822|NCT00999167|HPN-100|hpn-100
5571823|NCT00999167|GT4P|gt4p
5571934|NCT00998712|pregnancy|pregnancy
5572033|NCT00998322|gemcitabine|gemcitabine
5572039|NCT00998270|MM|mm
5572135|NCT00997945|PK|pk
5558783|NCT01051115|CLL|cll
5671992|NCT00613275|PNRP|pnrp
5543668|NCT01112865|Dyads|dyads
5572603|NCT00996320|Guideline Adherence|guideline adherence
5543876|NCT01111838|colon|colon
5572782|NCT00995774|arm|arm
5559115|NCT01049750|male|male
5559214|NCT01049425|taxane|taxane
5559316|NCT01049074|RCT|rct
5544279|NCT01110161|CT|ct
5710877|NCT00461864|hip|hip
5005921|NCT03959722|Endurance athletes|endurance athletes
5544630|NCT01108783|Tearing|tearing
5559803|NCT01047735|Outcome|outcome
5573503|NCT00993460|Obesity|obesity
5005922|NCT03959722|probiotics|probiotics
5573673|NCT00992758|anti-B1 antibody|anti-b1 antibody
5005923|NCT03959722|endurance exercise|endurance exercise
5711618|NCT00458952|MIBG|mibg
5560399|NCT01046240|emesis|emesis
5545301|NCT01105806|Video|video
5545476|NCT01105117|PAH|pah
5545479|NCT01105091|PAH|pah
5560771|NCT01044628|COPD|copd
5574543|NCT00989300|Clopidogrel|clopidogrel
5561170|NCT01042990|Stroke|stroke
5574943|NCT00987662|obesity|obesity
5574945|NCT00987662|new onset diabetes|new onset diabetes
5575039|NCT00987389|ANCA-Positive|anca-positive
5575058|NCT00987298|DXA|dxa
5575241|NCT00986531|early phase trials|early phase trials
5575247|NCT00986505|lidocaine|lidocaine
5713461|NCT00452660|MDS|mds
5575430|NCT00985842|Artificial limbs|artificial limbs
5575638|NCT00984997|Multimodality Treatment|multimodality treatment
5546738|NCT01100086|Opioid|opioid
5575739|NCT00984581|Wound healing|wound healing
5546854|NCT01099462|fever|fever
5575848|NCT00984191|preoperative|preoperative
5546934|NCT01099267|MDS|mds
5714515|NCT00448396|EPO|epo
5576243|NCT00983008|Signs and Symptoms|signs and symptoms
5576245|NCT00983008|Fatigue|fatigue
5576350|NCT00982514|ALL|all
5576434|NCT00982150|Open-Label Study|open-label study
5547620|NCT01096433|CPAP|cpap
5576544|NCT00981721|PK|pk
5547797|NCT01095926|ALL|all
5715257|NCT00446082|SOM230|som230
5547976|NCT01095393|CZP|czp
5577010|NCT00979914|osteoarthritis|osteoarthritis
5577038|NCT00979797|CHW|chw
5563500|NCT01032941|Probiotics|probiotics
5005925|NCT03959696|Patient Reported Outcomes|patient reported outcomes
5577212|NCT00979134|Cancer|cancer
5715909|NCT00445341|MCL|mcl
5715968|NCT00445081|WLQ|wlq
5716349|NCT00443651|Rituxan|rituxan
5577926|NCT00976313|thoracic epidural analgesia|thoracic epidural analgesia
5006014|NCT03959033|EORTC QLQc-30|eortc qlqc-30
5549102|NCT01090674|mobility|mobility
5578124|NCT00975572|Flu|flu
5549192|NCT01090297|Blood pressure|blood pressure
5578299|NCT00974883|GCA|gca
5549573|NCT01088698|311-nm|311-nm
5565056|NCT01026844|tarceva|tarceva
5549859|NCT01087567|diabetes|diabetes
5717812|NCT00439361|Mesna|mesna
5565330|NCT01025661|pain|pain
5578917|NCT00972946|MRI|mri
5718014|NCT00438854|CLL|cll
5579033|NCT00972348|HIV|hiv
5550268|NCT01086059|adalimumab|adalimumab
5550363|NCT01085747|SEMS|sems
5579287|NCT00971178|Analgesia|analgesia
5550453|NCT01085409|Quality of life|quality of life
5579384|NCT00970879|cotrimoxazole|cotrimoxazole
5550549|NCT01084967|obesity|obesity
5565908|NCT01023321|Safety|safety
5579684|NCT00969423|VATS|vats
5566217|NCT01022099|Navigation|navigation
5550962|NCT01083251|HBV|hbv
5566312|NCT01021670|Priligy|priligy
5566417|NCT01021215|Smoking|smoking
5719571|NCT00433316|pain|pain
5580309|NCT00967226|hemangioma|hemangioma
5551506|NCT01081275|CAM|cam
5566888|NCT01019252|ADHD|adhd
5719907|NCT00432055|Adult|adult
5580790|NCT00965185|HIV|hiv
5580926|NCT00964821|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5552193|NCT01078376|Drug Therapy|drug therapy
5581133|NCT00964015|surgery|surgery
5581204|NCT00963846|cognition|cognition
5581292|NCT00963495|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
5552483|NCT01077401|DME|dme
5581374|NCT00963300|stage I prostate cancer|stage i prostate cancer
5581625|NCT00962442|oxidative stress|oxidative stress
5581627|NCT00962429|neuropathy, lipoic acid|neuropathy, lipoic acid
5721494|NCT00426374|HIV|hiv
5568196|NCT01013922|VC|vc
5568380|NCT01013168|sTNF-R2|stnf-r2
5581925|NCT00961103|spinal muscular atrophy|spinal muscular atrophy
5568561|NCT01012284|Tuberculosis|tuberculosis
5568894|NCT01010737|safety|safety
5582481|NCT00958815|HIV|hiv
5553777|NCT01072032|EEG|eeg
5576783|NCT00980798|Quality of life|quality of life
5006016|NCT03959007|Transplant|transplant
5002974|NCT03977519|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5569685|NCT01007942|bolero|bolero
5583229|NCT00956449|flu|flu
5742950|NCT00346762|HIV|hiv
5570067|NCT01006395|Bone Health|bone health
5570270|NCT01005407|HBV|hbv
5583739|NCT00954460|human|human
5555031|NCT01066533|MTA|mta
5583835|NCT00953771|TTP|ttp
5002975|NCT03977519|randomized controlled trial|randomized controlled trial
5583932|NCT00953290|Thigh|thigh
5570649|NCT01003912|MLD|mld
5006017|NCT03959007|Well-being|well-being
5006018|NCT03959007|Anxiety|anxiety
5584420|NCT00951756|Dietary fat|dietary fat
5002976|NCT03977506|driving capacity|driving capacity
5002977|NCT03977506|cerebrovascular accident|cerebrovascular accident
5002978|NCT03977506|grid|grid
5584670|NCT00951106|Peru|peru
5556109|NCT01062100|MRI|mri
5584758|NCT00950846|Busulfan|busulfan
5002979|NCT03977467|atezolizumab|atezolizumab
5584849|NCT00950443|endoscopy|endoscopy
5002980|NCT03977467|NSCLC|nsclc
5556300|NCT01061242|Sleep quality|sleep quality
5585045|NCT00949754|pain|pain
5571904|NCT00998842|ECG|ecg
5572113|NCT00998036|TNBC|tnbc
5585387|NCT00948961|sarcoma|sarcoma
5556971|NCT01058538|L19|l19
5585664|NCT00947895|ACTH|acth
5557164|NCT01057628|ASP1941|asp1941
5585759|NCT00947544|UCD|ucd
5557341|NCT01056900|ACI|aci
5557498|NCT01056185|flu|flu
5557541|NCT01056081|COPD|copd
5586156|NCT00946231|BNP|bnp
5573140|NCT00994331|Magnetic Navigation|magnetic navigation
5573286|NCT00993811|HIV|hiv
5002981|NCT03977467|Non-Small Cell Lung Cancer|non-small cell lung cancer
5586478|NCT00944944|OVARY|ovary
5558018|NCT01054105|genes|genes
5586600|NCT00944476|MRI|mri
5558541|NCT01052116|Soy|soy
5558678|NCT01051544|ITI|iti
5558795|NCT01051063|WT1|wt1
5558940|NCT01050465|HIV|hiv
5002982|NCT03977467|advanced solid tumors|advanced solid tumors
5587703|NCT00940212|Safety|safety
5574509|NCT00989404|pk|pk
5587787|NCT00939757|YM178|ym178
5574933|NCT00987688|trauma|trauma
5559681|NCT01047735|Address|address
5588547|NCT00936611|WM|wm
5588824|NCT00935454|liver cirrhosis|liver cirrhosis
5575803|NCT00984360|A118G|a118g
5583335|NCT00956085|OCD|ocd
5575973|NCT00984061|healthy|healthy
5002983|NCT03977415|Interstitial Lung Disease|interstitial lung disease
5576039|NCT00983879|GLD|gld
5589525|NCT00932854|EBUS|ebus
5002985|NCT03977415|Pulmonary Fibrosis|pulmonary fibrosis
5002986|NCT03977415|Rheumatoid Arthritis|rheumatoid arthritis
5589807|NCT00931580|White|white
5589905|NCT00931086|RA|ra
5002987|NCT03977415|RA|ra
5578173|NCT00975403|exercise|exercise
5732532|NCT00385034|IPV|ipv
5577103|NCT00979563|MTD|mtd
5590325|NCT00929370|CSF|csf
5590397|NCT00929110|NVA237|nva237
5577277|NCT00978848|trichomonas|trichomonas
5733415|NCT00381433|HCV|hcv
5590890|NCT00927199|Lipids|lipids
5562503|NCT01037907|TNF alpha|tnf alpha
5577929|NCT00976300|SLE|sle
5002988|NCT03977415|Rheumatology|rheumatology
5591168|NCT00925925|CD19|cd19
5006022|NCT03958929|satisfaction|satisfaction
5591290|NCT00925444|Humans|humans
5578266|NCT00975000|Cinacalcet|cinacalcet
5006023|NCT03958929|rural|rural
5591594|NCT00924365|HIV|hiv
5563186|NCT01034358|Crohn disease|crohn disease
5591683|NCT00924066|Cervical Cancer|cervical cancer
5591893|NCT00923403|soymilk|soymilk
5002994|NCT03977376|Comunication instrument|comunication instrument
5592016|NCT00923052|Surgery|surgery
5592120|NCT00922558|children|children
5592226|NCT00922103|functional results|functional results
5002995|NCT03977376|Patients|patients
5002996|NCT03977363|Anticoagulation|anticoagulation
5002997|NCT03977363|Anticoagulants|anticoagulants
5564085|NCT01030991|Genetics|genetics
5564193|NCT01030562|HPV|hpv
5002998|NCT03977363|Vitamin K antagonists|vitamin k antagonists
5587008|NCT00942799|Top1|top1
5002999|NCT03977363|Warfarin|warfarin
5579851|NCT00968773|inguinal hernia|inguinal hernia
5593243|NCT00918411|YM060|ym060
5003000|NCT03977363|Low molecular weight heparin|low molecular weight heparin
5593547|NCT00917059|EEG|eeg
5565246|NCT01025999|RYGB|rygb
5593763|NCT00916253|MWT|mwt
5580547|NCT00966160|treatment naive|treatment naive
5565413|NCT01025310|visual|visual
5003001|NCT03977363|Direct oral anticoagulants|direct oral anticoagulants
5594035|NCT00915096|Follicular Lymphoma|follicular lymphoma
5594161|NCT00914628|GvL|gvl
5754954|NCT00301886|pain|pain
5003002|NCT03977363|dabigatran|dabigatran
5003003|NCT03977363|rivaroxaban|rivaroxaban
5594643|NCT00912483|VTE|vte
5003004|NCT03977363|apixaban|apixaban
5594927|NCT00911222|emesis|emesis
5595454|NCT00909272|block|block
5582290|NCT00959621|ASA|asa
5003005|NCT03977363|edoxaban|edoxaban
5595841|NCT00907543|surgery|surgery
5739586|NCT00359385|PTH|pth
5003006|NCT03977363|Atrial Fibrillation|atrial fibrillation
5003007|NCT03977363|Thromboembolism|thromboembolism
5006026|NCT03958903|Neuropace RNS|neuropace rns
5582909|NCT00957398|Motility|motility
5567860|NCT01015261|ALL|all
5596697|NCT00904436|Dyspnea|dyspnea
5596862|NCT00903591|Breast|breast
5003008|NCT03977363|Venous Thromboembolism|venous thromboembolism
5003009|NCT03977363|Heart Valve Diseases|heart valve diseases
5597236|NCT00902096|IgE|ige
5003010|NCT03977363|Arrhythmia|arrhythmia
5583779|NCT00954148|PET/CT|pet/ct
5568976|NCT01010399|HIV|hiv
5597998|NCT00900159|SWSD|swsd
5584338|NCT00952159|CYP2D6|cyp2d6
5584416|NCT00951795|HIV|hiv
5587040|NCT00942669|SAS|sas
5742558|NCT00348686|LVH|lvh
5798750|NCT00111176|Descending|descending
5003011|NCT03977363|Heart Diseases|heart diseases
5584914|NCT00950248|MS|ms
5743234|NCT00345839|CKD|ckd
5598559|NCT00899821|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5598666|NCT00899717|Limited mouth opening|limited mouth opening
5598675|NCT00899717|TMD|tmd
5570595|NCT01004094|parents|parents
5585498|NCT00948532|XLIF|xlif
5570786|NCT01003275|Placebo|placebo
5598902|NCT00899132|skin cancer|skin cancer
5599039|NCT00898781|ovarian sarcoma|ovarian sarcoma
5599273|NCT00898612|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5599339|NCT00898508|stage IV breast cancer|stage iv breast cancer
5680437|NCT00577798|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5599503|NCT00898235|primary systemic amyloidosis|primary systemic amyloidosis
5571755|NCT00999388|Elderly|elderly
5599686|NCT00897897|Fibroids|fibroids
5599759|NCT00897793|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5572581|NCT00996346|3066K1|3066k1
5003012|NCT03977363|Cardiovascular Diseases|cardiovascular diseases
5746573|NCT00333632|Sleep|sleep
5600413|NCT00896285|cancer|cancer
5746669|NCT00333138|MS|ms
5587823|NCT00939601|OSA|osa
5600532|NCT00895700|Anxiety|anxiety
5003013|NCT03977363|Vascular Diseases|vascular diseases
5003014|NCT03977363|Embolism and Thrombosis|embolism and thrombosis
5003015|NCT03977324|CTG|ctg
5018909|NCT03878615|IFABP|ifabp
5601251|NCT00892762|OAG|oag
5573689|NCT00992693|LF|lf
5003018|NCT03977324|horizontal defect|horizontal defect
5601517|NCT00891735|AMD|amd
5601702|NCT00891163|Analgesia|analgesia
5601801|NCT00891085|ali|ali
5003019|NCT03977324|keratinised tissue|keratinised tissue
5003020|NCT03977298|peri-implantitis|peri-implantitis
5601997|NCT00890344|BIA|bia
5574454|NCT00989664|NHL|nhl
5602071|NCT00890071|Ultrasound|ultrasound
5602169|NCT00889785|Adolescents|adolescents
5003022|NCT03977298|Chlorhexidine|chlorhexidine
5589540|NCT00932750|Diet|diet
5602358|NCT00889148|hip|hip
5003023|NCT03977298|surgical treatment|surgical treatment
5575045|NCT00987350|Vaccine|vaccine
5575137|NCT00987025|hypertension|hypertension
5590011|NCT00930670|clopidogrel|clopidogrel
5603080|NCT00886249|Vision|vision
5575723|NCT00984659|Dyspnea|dyspnea
5590806|NCT00927576|memory|memory
5787506|NCT00158314|CBT|cbt
5590887|NCT00927199|Alpha Linolenic Acid|alpha linolenic acid
5003024|NCT03977298|Keratinised tissue|keratinised tissue
5603787|NCT00883324|fFN|ffn
5576346|NCT00982527|fenoldopam|fenoldopam
5604124|NCT00881920|B Cell|b cell
5591369|NCT00925249|quantiferon|quantiferon
5591484|NCT00924820|NM|nm
5591576|NCT00924443|evoltra|evoltra
5604369|NCT00880711|Fiona|fiona
5591799|NCT00923741|NSCLC|nsclc
5577165|NCT00979303|SVT|svt
5003025|NCT03977285|peri-implantitis|peri-implantitis
5752474|NCT00310401|hypoxia|hypoxia
5592335|NCT00921700|Paracetamol|paracetamol
5752717|NCT00309738|KRE|kre
5605186|NCT00877552|MRI|mri
5752935|NCT00308633|CAD|cad
5003026|NCT03977285|surgical treatment|surgical treatment
5003027|NCT03977285|Er:Yag laser|er:yag laser
5003028|NCT03977285|Air-flow|air-flow
5753563|NCT00306124|MCI|mci
5600014|NCT00897299|PgR|pgr
5606072|NCT00874042|PK|pk
5593343|NCT00917904|Healthy|healthy
5593444|NCT00917384|IMC-1121B|imc-1121b
5606251|NCT00873327|presumed sepsis|presumed sepsis
5593546|NCT00917059|SSRI|ssri
5606366|NCT00872846|Overweight|overweight
5754709|NCT00302341|Dyspnea|dyspnea
5003029|NCT03977285|chlorhexidine|chlorhexidine
5594266|NCT00914225|HIV|hiv
5607064|NCT00870324|ICD|icd
5594434|NCT00913354|ivf|ivf
5607257|NCT00869557|HIV|hiv
5594632|NCT00912522|TMS|tms
5607378|NCT00869102|IGT|igt
5594634|NCT00912522|Motivation|motivation
5594824|NCT00911638|Joint replacement|joint replacement
5003030|NCT03977272|Pancreatic Cancer|pancreatic cancer
5707065|NCT00475800|knee|knee
5595139|NCT00910429|PH|ph
5607953|NCT00866671|T-ALL|t-all
5608189|NCT00866008|IVF|ivf
5003031|NCT03977272|Anti-PD-1 Antibody|anti-pd-1 antibody
5608356|NCT00865332|Methylphenidate|methylphenidate
5595631|NCT00908427|KTP laser|ktp laser
5608765|NCT00863408|Malaria|malaria
5581013|NCT00964600|cesarean|cesarean
5003032|NCT03977233|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
5608962|NCT00862732|RCT|rct
5596207|NCT00905957|relief|relief
5609125|NCT00861991|empathy|empathy
5581293|NCT00963482|Smoking|smoking
5596450|NCT00905034|ALL|all
5609290|NCT00861328|Phase 1|phase 1
5581452|NCT00963079|IVF|ivf
5596497|NCT00904943|Bioequivalence|bioequivalence
5596613|NCT00904514|prolymphocytic leukemia|prolymphocytic leukemia
5609490|NCT00860509|diet|diet
5609585|NCT00860054|deuterium|deuterium
5581728|NCT00962078|6 MWD|6 mwd
5596747|NCT00904228|sepsis|sepsis
5609689|NCT00859586|AML|aml
5596951|NCT00903292|EGFR|egfr
5609886|NCT00858520|DNA|dna
5610004|NCT00858065|Choice|choice
5610096|NCT00857623|PDN|pdn
5610361|NCT00856570|DDI|ddi
5758847|NCT00288587|CHF|chf
5610389|NCT00856479|Infuse|infuse
5582521|NCT00958542|children|children
5597658|NCT00900692|CVA|cva
5597874|NCT00900302|stage IV anal cancer|stage iv anal cancer
5610868|NCT00854464|Inflammatory Factors|inflammatory factors
5611067|NCT00853710|Cancer|cancer
5611195|NCT00853203|QOL|qol
5611280|NCT00852839|Dry mouth|dry mouth
5598215|NCT00900094|stage I breast cancer|stage i breast cancer
5611373|NCT00852462|SAMI|sami
5583451|NCT00955630|OHS|ohs
5611577|NCT00851695|COPD|copd
5599727|NCT00897819|stage IV rectal cancer|stage iv rectal cancer
5611673|NCT00851318|Rheumatoid Arthritis|rheumatoid arthritis
5003033|NCT03977233|Pancreatic Cancer Non-resectable|pancreatic cancer non-resectable
5598586|NCT00899821|recurrent salivary gland cancer|recurrent salivary gland cancer
5612349|NCT00848783|capecitabine|capecitabine
5584336|NCT00952172|Actigraphy|actigraphy
5612575|NCT00847743|aging|aging
5612778|NCT00847015|Bladder|bladder
5612779|NCT00847015|Urinary|urinary
5599317|NCT00898560|Partial|partial
5003034|NCT03977233|Pancreatic Cancer Resectable|pancreatic cancer resectable
5612987|NCT00846183|IVF|ivf
5761990|NCT00276159|IRM|irm
5613082|NCT00845819|oral mucositis|oral mucositis
5599515|NCT00898170|myoma|myoma
5613198|NCT00845312|Age|age
5003035|NCT03977233|neoadjuvant FOLFIRNOX|neoadjuvant folfirnox
5613273|NCT00844987|Strategies in ACS|strategies in acs
5003036|NCT03977233|FOLFIRINOX|folfirinox
5585039|NCT00949780|ABR|abr
5613368|NCT00844532|PAD|pad
5599685|NCT00897897|Uterine Leiomyomas|uterine leiomyomas
5613642|NCT00843297|Hypothermia|hypothermia
5003037|NCT03977233|Pancreatic Cancer, Adult|pancreatic cancer, adult
5613641|NCT00843297|Sudden Cardiac Arrest|sudden cardiac arrest
5585380|NCT00948961|NYESO1|nyeso1
5003038|NCT03977194|IFCT|ifct
5003039|NCT03977194|ELDERLY|elderly
5003040|NCT03977194|NSCLC|nsclc
5613978|NCT00842023|BNP|bnp
5614162|NCT00841256|SIT|sit
5585987|NCT00946556|HIV|hiv
5614308|NCT00840775|catheterization|catheterization
5614411|NCT00840268|Dry Eye|dry eye
5600364|NCT00896467|stage IV gastric cancer|stage iv gastric cancer
5614589|NCT00839371|midazolam|midazolam
5003041|NCT03977194|immunotherapy|immunotherapy
5614909|NCT00838318|CRCS|crcs
5615002|NCT00837954|PTFE Graft|ptfe graft
5601267|NCT00892710|NSCLC|nsclc
5587093|NCT00942461|CRP|crp
5615606|NCT00835406|Bioequivalence|bioequivalence
5003042|NCT03977194|chemotherapy|chemotherapy
5003043|NCT03977181|PrEP|prep
5003044|NCT03977181|HIV Prevention|hiv prevention
5587565|NCT00940693|Duloxetine|duloxetine
5616026|NCT00833430|AVN|avn
5003045|NCT03977181|Adherence Support|adherence support
5616196|NCT00832702|Cardiac|cardiac
5616303|NCT00832325|09-001|09-001
5003046|NCT03977181|Adolescence|adolescence
5003047|NCT03977181|South Africa|south africa
5616508|NCT00831363|THA|tha
5602321|NCT00889278|APBSCT|apbsct
5588258|NCT00937534|Fimasartan|fimasartan
5616802|NCT00830245|Lung cancer|lung cancer
5003048|NCT03977155|Irritable Bowel Sydrome|irritable bowel sydrome
5602724|NCT00887484|Acne|acne
5617029|NCT00829335|HCC|hcc
5588624|NCT00936273|SAS|sas
5003049|NCT03977155|diarrhea|diarrhea
5617450|NCT00827736|ISDN|isdn
5003050|NCT03977155|BOS-589|bos-589
5589391|NCT00933400|CTA|cta
5603762|NCT00883441|AEDES|aedes
5589621|NCT00932373|MBC|mbc
5618215|NCT00824941|Brain|brain
5604190|NCT00881660|FETO|feto
5604249|NCT00881335|geriatric|geriatric
5618511|NCT00823758|OTC|otc
5618664|NCT00823511|HPV|hpv
5590261|NCT00929630|seton|seton
5618989|NCT00822315|HIV|hiv
5619060|NCT00822068|stroke|stroke
5590651|NCT00928161|RIX|rix
5604933|NCT00878540|depression|depression
5619163|NCT00821600|Long-acting Injectable|long-acting injectable
5605032|NCT00878098|DDT|ddt
5605146|NCT00877695|HIV|hiv
5789826|NCT00146796|RDT|rdt
5619562|NCT00819975|Casein|casein
5619780|NCT00819195|MS|ms
5619924|NCT00818870|GERD|gerd
5605837|NCT00874952|HDL|hdl
5605970|NCT00874354|PCI|pci
5606041|NCT00874172|Anemia|anemia
5591963|NCT00923182|CLL|cll
5620404|NCT00817193|Aging|aging
5592052|NCT00922883|SAA|saa
5592261|NCT00921986|syncope|syncope
5606541|NCT00872261|HIV|hiv
5592590|NCT00920777|CBT|cbt
5620970|NCT00815256|CXL|cxl
5592656|NCT00920621|Asthma|asthma
5771945|NCT00236678|Anemia|anemia
5607017|NCT00870454|Carisbamate|carisbamate
5592925|NCT00919516|Ischemia|ischemia
5593090|NCT00918983|BPH|bph
5621516|NCT00813436|ToM|tom
5621750|NCT00812708|photophobia|photophobia
5772885|NCT00231972|HIV|hiv
5621842|NCT00812214|migraine|migraine
5607999|NCT00866593|innovator|innovator
5608165|NCT00866073|AML|aml
5622219|NCT00810732|B1321005|b1321005
5622228|NCT00810693|PH|ph
5622319|NCT00810368|GWI|gwi
5622409|NCT00810056|Child abuse and neglect|child abuse and neglect
5622410|NCT00810056|Out-of-home care|out-of-home care
5622454|NCT00809835|CBT|cbt
5773730|NCT00228202|PCR|pcr
5622601|NCT00809237|Non-small cell lung cancer|non-small cell lung cancer
5622602|NCT00809237|Gefitinib|gefitinib
5616837|NCT00830063|OA|oa
5622868|NCT00808405|HSV shedding|hsv shedding
5622869|NCT00808405|women|women
5622876|NCT00808353|CVD|cvd
5609018|NCT00862472|ocular hypertension|ocular hypertension
5622971|NCT00807885|rHuPH20|rhuph20
5623168|NCT00807053|SAR|sar
5609322|NCT00861172|3T MRI|3t mri
5595031|NCT00910871|TB|tb
5609519|NCT00860353|Safety|safety
5595243|NCT00910104|PNALD|pnald
5609711|NCT00859391|Celiac Disease|celiac disease
5595448|NCT00909285|TMS|tms
5623706|NCT00804908|MM|mm
5623790|NCT00804544|99mTc-sestMIBI|99mtc-sestmibi
5623974|NCT00803842|erlotinib|erlotinib
5610323|NCT00856791|Ovarian|ovarian
5596006|NCT00906893|Hypoxia|hypoxia
5610405|NCT00856440|SCI|sci
5624347|NCT00802217|Pharmacokinetics|pharmacokinetics
5624348|NCT00802217|Safety|safety
5596301|NCT00905645|Breast Augmentation|breast augmentation
5610784|NCT00854854|NKCell|nkcell
5610877|NCT00854438|elderly|elderly
5624719|NCT00800670|adenovirus|adenovirus
5624728|NCT00800644|Cervix|cervix
5624891|NCT00800150|intraocular lymphoma|intraocular lymphoma
5625074|NCT00799565|echography|echography
5597029|NCT00903006|MK-0646|mk-0646
5625493|NCT00797823|glucagon|glucagon
5625494|NCT00797823|insulin|insulin
5614320|NCT00840736|VBG|vbg
5777947|NCT00208091|Tremor|tremor
5625683|NCT00797017|Fentanyl Matrix|fentanyl matrix
5611928|NCT00850551|Cystic Fibrosis|cystic fibrosis
5625882|NCT00796185|Schizophrenia|schizophrenia
5625978|NCT00795756|Adults|adults
5612277|NCT00849043|OSA|osa
5626074|NCT00795353|Amevive|amevive
5778588|NCT00204308|HIV|hiv
5778723|NCT00203749|HIV|hiv
5612551|NCT00847847|ALS|als
5626395|NCT00793910|PRK|prk
5612627|NCT00847548|drug abuse|drug abuse
5626571|NCT00793052|trismus|trismus
5612829|NCT00846859|varenicline|varenicline
5612963|NCT00846287|COPD|copd
5626955|NCT00791336|nelfinavir|nelfinavir
5627145|NCT00790582|Lithium|lithium
5627349|NCT00789945|type 1 diabetes|type 1 diabetes
5627439|NCT00789581|Adjuvant|adjuvant
5613901|NCT00842387|PPI|ppi
5627885|NCT00788060|Sutent|sutent
5672497|NCT00611676|activity limitation|activity limitation
5614178|NCT00841191|CNTO 328|cnto 328
5628143|NCT00787488|recurrent|recurrent
5628152|NCT00787462|Pain|pain
5614311|NCT00840762|HIV|hiv
5614369|NCT00840554|HGG|hgg
5628341|NCT00786695|noncardiac chest pain|noncardiac chest pain
5628435|NCT00786370|blood pressure|blood pressure
5628474|NCT00786201|IPF|ipf
5628543|NCT00785980|male|male
5614646|NCT00839176|Rexahn|rexahn
5628744|NCT00785122|cancer vaccine|cancer vaccine
5614831|NCT00838578|Rectal Diseases|rectal diseases
5628827|NCT00784914|adult craniopharyngioma|adult craniopharyngioma
5628930|NCT00784485|Asthma|asthma
5615306|NCT00836719|NAA|naa
5615431|NCT00836212|HIV|hiv
5629425|NCT00782366|predictive genomics|predictive genomics
5615523|NCT00835835|gait|gait
5629647|NCT00781482|Eszopiclone|eszopiclone
5615812|NCT00834405|Bioequivalence|bioequivalence
5629857|NCT00780468|Diet|diet
5629950|NCT00780052|c-myb|c-myb
5616197|NCT00832702|MRI|mri
5630409|NCT00777738|Safety|safety
5630410|NCT00777738|Efficacy|efficacy
5630507|NCT00777322|keratoconus|keratoconus
5630607|NCT00777010|mild cognitive impairment|mild cognitive impairment
5616816|NCT00830180|NGF|ngf
5630807|NCT00775944|Counselling|counselling
5630809|NCT00775944|Telephone|telephone
5631091|NCT00774839|Colon|colon
5617353|NCT00828126|CT|ct
5601820|NCT00890994|MBI|mbi
5631537|NCT00773045|ICU|icu
5631673|NCT00772486|Refractory|refractory
5631756|NCT00772161|ADHD|adhd
5631855|NCT00771836|pediatric|pediatric
5786087|NCT00164840|GERD|gerd
5632133|NCT00770575|Carotid Artery, Common|carotid artery, common
5618293|NCT00824707|anti-virus therapy|anti-virus therapy
5618399|NCT00824252|HNC|hnc
5632270|NCT00770198|liver|liver
5632271|NCT00770198|alcohol|alcohol
5632365|NCT00769834|disc edema|disc edema
5680378|NCT00577993|Rituximab|rituximab
5618927|NCT00822601|Randomized|randomized
5603398|NCT00884949|LSD|lsd
5632947|NCT00767494|OAG|oag
5633159|NCT00766506|PCA|pca
5619520|NCT00820170|08-122|08-122
5633419|NCT00765453|autologous|autologous
5619729|NCT00819351|EFS|efs
5633490|NCT00765232|laparoscopic|laparoscopic
5633586|NCT00764621|Liver|liver
5633686|NCT00764127|adolescent|adolescent
5604767|NCT00879177|smoking|smoking
5634321|NCT00761410|Knee|knee
5634417|NCT00761020|Malaria|malaria
5634459|NCT00760877|CML|cml
5634513|NCT00760669|Remicade|remicade
5620691|NCT00816374|SSE|sse
5634712|NCT00759811|Methotrexate|methotrexate
5620976|NCT00815243|bone|bone
5635106|NCT00757718|Gestational Hypertension|gestational hypertension
5635383|NCT00756626|Bottle Weaning|bottle weaning
5606032|NCT00874198|outcome|outcome
5621607|NCT00813124|CML|cml
5672489|NCT00611702|RT-PCR|rt-pcr
5621895|NCT00812019|Safety|safety
5606717|NCT00871585|PSA|psa
5622276|NCT00810576|PS-341|ps-341
5622462|NCT00809770|stimulant abuse|stimulant abuse
5622652|NCT00809029|GIP|gip
5607295|NCT00869427|UVI|uvi
5622820|NCT00808522|Hcg|hcg
5636756|NCT00751621|PID|pid
5622920|NCT00808080|AML|aml
5636825|NCT00751348|mumps|mumps
5623100|NCT00807378|PCR|pcr
5623297|NCT00806741|Optic Disk|optic disk
5608011|NCT00866593|SDS|sds
5793207|NCT00131235|STI|sti
5623537|NCT00805649|combined therapy|combined therapy
5637612|NCT00748839|HIT|hit
5623834|NCT00804388|Hip|hip
5637687|NCT00748501|ALS,|als,
5637780|NCT00748137|Type 1 Diabetes|type 1 diabetes
5608702|NCT00863681|PH|ph
5637888|NCT00747708|autologous|autologous
5637980|NCT00747435|ski slope audiogram|ski slope audiogram
5624223|NCT00802724|spine|spine
5638084|NCT00746941|HIV|hiv
5624303|NCT00802412|alcoholism|alcoholism
5624486|NCT00801632|mixed chimerism|mixed chimerism
5624643|NCT00800995|SOD|sod
5638488|NCT00745355|Questionnaires|questionnaires
5624928|NCT00800033|lipids|lipids
5638981|NCT00743457|lethargy|lethargy
5638982|NCT00743457|VPS failure|vps failure
5638983|NCT00743444|GERD|gerd
5639102|NCT00742989|OLT|olt
5639178|NCT00742690|cirrhosis|cirrhosis
5639282|NCT00742365|Psychiatric Disorder|psychiatric disorder
5639307|NCT00742300|SLE|sle
5610194|NCT00857259|AMD|amd
5625535|NCT00797641|ulcer|ulcer
5639593|NCT00741390|Lancets|lancets
5639700|NCT00741013|endotoxin|endotoxin
5610611|NCT00855491|PCO|pco
5796333|NCT00119483|Men|men
5626019|NCT00795613|PET|pet
5626618|NCT00792805|COPD|copd
5640666|NCT00737607|outcome|outcome
5640780|NCT00737204|HIV|hiv
5640888|NCT00736840|Breath|breath
5627096|NCT00790855|MDS|mds
5641073|NCT00736203|fMRI|fmri
5797927|NCT00114088|DUB|dub
5641172|NCT00735735|chronic|chronic
5612194|NCT00849381|HPV|hpv
5641533|NCT00734747|GERD|gerd
5627699|NCT00788554|TEP|tep
5641632|NCT00734383|diabetes|diabetes
5628243|NCT00787059|AC6|ac6
5628391|NCT00786487|diabetes|diabetes
5642338|NCT00731601|rebleeding|rebleeding
5642442|NCT00731211|Metastatic|metastatic
5642534|NCT00730704|Gardasil|gardasil
5613438|NCT00844311|hCG|hcg
5642817|NCT00729521|Fall injury hospitalization|fall injury hospitalization
5642925|NCT00729092|PET SCAN|pet scan
5629268|NCT00782873|obesity|obesity
5643120|NCT00728468|Phase 1|phase 1
5629353|NCT00782574|BRCA1|brca1
5643219|NCT00728091|aquaretic|aquaretic
5643418|NCT00727363|nosocomial infection|nosocomial infection
5614263|NCT00840853|CTL|ctl
5614348|NCT00840658|STIs|stis
5643673|NCT00726713|vitamin B6|vitamin b6
5630265|NCT00778453|predictors|predictors
5644135|NCT00725049|crestal bone level|crestal bone level
5614999|NCT00837980|IMRT|imrt
5630444|NCT00777595|QTc|qtc
5644346|NCT00724035|Anesthesia|anesthesia
5630651|NCT00776737|HV|hv
5644538|NCT00723047|Patients|patients
5630737|NCT00776321|dyslipidemia|dyslipidemia
5644940|NCT00721461|Assess|assess
5645016|NCT00721071|Expectorated Sputum|expectorated sputum
5645041|NCT00721006|PAD|pad
5645112|NCT00720850|Lenalidomide|lenalidomide
5631321|NCT00773942|Pharmacist|pharmacist
5802999|NCT00096694|IUD|iud
5645357|NCT00719979|Internet|internet
5631778|NCT00772122|G-CSF|g-csf
5632025|NCT00771082|OA|oa
5616795|NCT00830271|suture|suture
5616900|NCT00829829|Gout|gout
5645949|NCT00718432|Frailty|frailty
5616992|NCT00829439|L-dopa|l-dopa
5646094|NCT00717795|NED|ned
5646260|NCT00717119|Treated|treated
5646421|NCT00716755|Dopamine|dopamine
5646422|NCT00716755|D2 receptor|d2 receptor
5646523|NCT00716235|ADHD|adhd
5646728|NCT00715533|acute|acute
5646835|NCT00715130|Worksite|worksite
5618179|NCT00825045|D2|d2
5633361|NCT00765674|aliskiren|aliskiren
5647360|NCT00713089|Eczema|eczema
5633483|NCT00765284|RCT|rct
5647535|NCT00712543|lactulose|lactulose
5633720|NCT00763997|ibuprofen|ibuprofen
5806163|NCT00089596|ALL|all
5648215|NCT00710060|HIV|hiv
5648248|NCT00709982|Folic Acid|folic acid
5619124|NCT00821795|therapy|therapy
5619218|NCT00821275|Leiomyoma|leiomyoma
5648673|NCT00708318|AeroLEF|aerolef
5619507|NCT00820222|HER2 positive|her2 positive
5648777|NCT00707915|posture|posture
5619686|NCT00819546|AML|aml
5648906|NCT00707330|mda|mda
5619719|NCT00819403|low hdl|low hdl
5649162|NCT00706147|Superoxide dismutase|superoxide dismutase
5649167|NCT00706134|aliskiren|aliskiren
5635208|NCT00757315|AKN|akn
5649352|NCT00705094|VO2peak|vo2peak
5649507|NCT00704093|pacing|pacing
5620253|NCT00817726|RBD|rbd
5649717|NCT00703131|fistula|fistula
5620487|NCT00816816|NPC|npc
5649798|NCT00702845|Active-controlled|active-controlled
5646073|NCT00717925|NHL|nhl
5650005|NCT00702052|Lymphoma|lymphoma
5620687|NCT00816374|CMM|cmm
5650140|NCT00701545|ivr|ivr
5636113|NCT00753714|ZD6474|zd6474
5650302|NCT00700739|Disc|disc
5650604|NCT00699504|ECG|ecg
5808687|NCT00087529|MS|ms
5650854|NCT00698399|LTx|ltx
5636749|NCT00751647|CF|cf
5637033|NCT00750412|Social Work|social work
5651336|NCT00696371|PET Imaging|pet imaging
5651580|NCT00695396|Anemia|anemia
5651643|NCT00695136|Autism|autism
5651732|NCT00694772|Tonsillotomy|tonsillotomy
5672656|NCT00611325|Bortezomib|bortezomib
5809851|NCT00085696|NHL|nhl
5652111|NCT00693173|IMRT|imrt
5652214|NCT00692796|Dyspnea|dyspnea
5637793|NCT00748098|RLS|rls
5652314|NCT00692432|MIF|mif
5652316|NCT00692432|CPB|cpb
5623131|NCT00807222|ADHD|adhd
5638301|NCT00746109|abscess|abscess
5638398|NCT00745693|Endothelin|endothelin
5638497|NCT00745316|Congestive Heart Failure|congestive heart failure
5638597|NCT00744770|TMC278-TiDP6-C121|tmc278-tidp6-c121
5638786|NCT00744198|Sling|sling
5653280|NCT00689039|AZD1305|azd1305
5653377|NCT00688792|Adherence|adherence
5653584|NCT00688012|Hepatitis C|hepatitis c
5639296|NCT00742326|HIV|hiv
5639397|NCT00742001|recovery|recovery
5653900|NCT00686556|MDS|mds
5624265|NCT00802555|HCC|hcc
5639520|NCT00741637|Diarrhea|diarrhea
5654004|NCT00686192|Obesity|obesity
5654198|NCT00685464|PCI|pci
5639811|NCT00740558|LF|lf
5624622|NCT00801060|CLL|cll
5639885|NCT00740389|TMC125-C187|tmc125-c187
5654704|NCT00683358|VEGFR1|vegfr1
5654918|NCT00682513|RDP|rdp
5655044|NCT00682058|fat|fat
5812899|NCT00082329|CXCR4|cxcr4
5640596|NCT00737854|OLP|olp
5640674|NCT00737581|cord|cord
5640740|NCT00737334|BIS|bis
5640786|NCT00737191|pain|pain
5655300|NCT00681135|orthodontics|orthodontics
5655414|NCT00680641|COPD|copd
5655715|NCT00679458|pain|pain
5625953|NCT00795886|ALL|all
5655845|NCT00678860|HV|hv
5003051|NCT03977038|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5655923|NCT00678587|platelets|platelets
5626145|NCT00794924|elderly|elderly
5626348|NCT00794105|Gas|gas
5656287|NCT00677261|Anesthesia|anesthesia
5003052|NCT03977038|Hot Cognition|hot cognition
5626541|NCT00793143|LSG|lsg
5656506|NCT00676338|Byetta|byetta
5003053|NCT03977038|Cold Cognition|cold cognition
5642146|NCT00732485|PPAR|ppar
5626956|NCT00791336|NFV|nfv
5656985|NCT00674622|Tennis elbow|tennis elbow
5642546|NCT00730626|Immunity|immunity
5627340|NCT00789971|cmo|cmo
5657361|NCT00673179|AD|ad
5642833|NCT00729469|Vaginal atrophy|vaginal atrophy
5657861|NCT00671346|Myocardial infarction|myocardial infarction
5643242|NCT00728026|Table test,|table test,
5658156|NCT00670306|BPH|bph
5658276|NCT00669643|MDT|mdt
5658618|NCT00668070|NASH|nash
5003054|NCT03977038|Attentional Imaging|attentional imaging
5628650|NCT00785434|MDD|mdd
5672499|NCT00611676|depression|depression
5629017|NCT00784147|resistance|resistance
5644476|NCT00723411|GAD|gad
5680409|NCT00577915|Breast cancer|breast cancer
5003055|NCT03977038|Eye tracking|eye tracking
5644688|NCT00722462|IVF|ivf
5629467|NCT00782158|Hepatitis B|hepatitis b
5645110|NCT00720850|MDS|mds
5817567|NCT00080093|Condom|condom
5003056|NCT03977038|Cognitive impairment|cognitive impairment
5003057|NCT03977038|Cognition|cognition
5660149|NCT00662402|K|k
5003058|NCT03976999|Biological Specimen Banks|biological specimen banks
5003059|NCT03976999|Cancer|cancer
5660377|NCT00661999|anemia|anemia
5630412|NCT00777712|diabetes|diabetes
5818468|NCT00079612|RCC|rcc
5646033|NCT00718094|IBD|ibd
5630910|NCT00775515|chronic|chronic
5671727|NCT00614653|Xeloda|xeloda
5631148|NCT00774683|HIV|hiv
5646381|NCT00716898|Condition|condition
5661119|NCT00658957|Foot Ulcer|foot ulcer
5646443|NCT00716703|time factors|time factors
5646749|NCT00715442|Clear cell|clear cell
5661704|NCT00656409|Vaccine|vaccine
4998647|NCT04003077|traditional Chinese medicine|traditional chinese medicine
5647210|NCT00713700|PDA|pda
5662092|NCT00654784|DMD|dmd
5647549|NCT00712491|CNV|cnv
5662348|NCT00654043|fed|fed
5003060|NCT03976999|Gynecology|gynecology
5662696|NCT00652613|3DCRT|3dcrt
5648149|NCT00710346|Uterus|uterus
5003061|NCT03976986|Infants|infants
5632772|NCT00768443|PPI|ppi
5632959|NCT00767429|fall risk|fall risk
5663129|NCT00651105|Adults|adults
5663227|NCT00650546|NASH|nash
5633150|NCT00766558|anorexia|anorexia
5663326|NCT00649337|mammography|mammography
5821380|NCT00075998|IPF|ipf
5648771|NCT00707941|PCR|pcr
5663431|NCT00648245|COPD|copd
5663526|NCT00647439|Immune Mediated|immune mediated
5633505|NCT00765128|Percutaneous|percutaneous
5649067|NCT00706576|HCC|hcc
5649153|NCT00706160|HV|hv
5847691|NCT00038532|HIV|hiv
5649903|NCT00702520|Follow-up|follow-up
5634377|NCT00761189|Paliperidone|paliperidone
5650084|NCT00701805|paricalcitol|paricalcitol
5664774|NCT00641849|Fat|fat
5664789|NCT00641745|Lurasidone|lurasidone
5634668|NCT00759967|Randomized|randomized
5664984|NCT00641173|PTSD|ptsd
5634858|NCT00759148|conjunctivitis|conjunctivitis
5650538|NCT00699790|NOS|nos
5634972|NCT00758511|pain|pain
5665344|NCT00639561|Diet|diet
5635340|NCT00756756|G-CSF|g-csf
5665550|NCT00638664|cardiac|cardiac
5665687|NCT00638040|pH|ph
5635591|NCT00755742|TNF|tnf
5665750|NCT00637806|Megestrol acetate|megestrol acetate
5635642|NCT00755560|Pediatrics|pediatrics
5651431|NCT00695942|VTE|vte
5651527|NCT00695487|THC|thc
5665990|NCT00637104|stents|stents
5651703|NCT00694863|ACTH|acth
5666204|NCT00636285|Safety|safety
5636068|NCT00753870|current|current
5651903|NCT00694018|randomized trial|randomized trial
5666385|NCT00635440|proteasome|proteasome
5652002|NCT00693615|HPV, Vaccine|hpv, vaccine
5636432|NCT00752544|HCV|hcv
5652380|NCT00692159|Anti-folate|anti-folate
5652486|NCT00691639|Open-angle glaucoma|open-angle glaucoma
5652560|NCT00691392|MDR TB|mdr tb
5652729|NCT00690989|Headache|headache
5667361|NCT00631384|HIV|hiv
5653132|NCT00689533|TIS|tis
5667550|NCT00630734|HIV|hiv
5653290|NCT00689026|PEG|peg
5667643|NCT00630409|Gemcitabine|gemcitabine
5667748|NCT00629993|HPV vaccine|hpv vaccine
5667933|NCT00629252|P50|p50
5003062|NCT03976986|Hypoxia Altitude Simulation Test|hypoxia altitude simulation test
5653855|NCT00686829|HIV|hiv
5003063|NCT03976986|Oxygen Delivery Device|oxygen delivery device
5668488|NCT00627172|MDCT|mdct
5668962|NCT00625443|ITP|itp
5669190|NCT00624585|MDS|mds
5669339|NCT00623896|Nehb|nehb
5639216|NCT00742586|RNA|rna
5669443|NCT00623506|TBI|tbi
5828206|NCT00061568|SCA|sca
5653769|NCT00687245|GERD|gerd
5669605|NCT00622960|obesity|obesity
5655445|NCT00680472|Pain|pain
5639569|NCT00741494|HBA|hba
5655528|NCT00680082|France|france
5669812|NCT00622128|Dementia|dementia
5639887|NCT00740389|HIV|hiv
5670114|NCT00621023|MDS|mds
5655937|NCT00678522|Renal function|renal function
5656039|NCT00678158|Bone|bone
5640133|NCT00739401|AAA|aaa
5640379|NCT00738660|ARB|arb
5670542|NCT00619476|PHN|phn
5656554|NCT00676156|LA|la
5670731|NCT00618683|AVNRT|avnrt
5656872|NCT00675064|safety|safety
5670992|NCT00617747|ZOMIG|zomig
5657090|NCT00674323|vision|vision
5641174|NCT00735722|AF|af
5657311|NCT00673400|ODS|ods
4957309|NCT04255693|influence|influence
4959364|NCT04243018|Shame|shame
5657607|NCT00672243|GBM|gbm
5830726|NCT00056914|HV|hv
5680404|NCT00577954|TBI|tbi
4966599|NCT04198311|sleep|sleep
5641893|NCT00733356|ADD|add
5660455|NCT00661661|550|550
4970358|NCT04175743|Plasma|plasma
4971552|NCT04168476|Median Nerve|median nerve
5658376|NCT00669214|Raptiva|raptiva
5658664|NCT00667888|HIMRT|himrt
5658878|NCT00667212|anger|anger
5658974|NCT00666887|Minocycline|minocycline
5643159|NCT00728273|Vietnam|vietnam
5659293|NCT00666094|RCT|rct
4990185|NCT04053166|MRI|mri
4991644|NCT04044911|Cup of tea|cup of tea
5659562|NCT00664885|clinics|clinics
5643708|NCT00726687|Cancer|cancer
5659957|NCT00663156|harvest|harvest
5644155|NCT00724971|NHL|nhl
5008748|NCT03941873|HCC|hcc
5003064|NCT03976986|Portable Oxygen Concentrator|portable oxygen concentrator
5010719|NCT03929666|Cisplatin|cisplatin
5014414|NCT03906669|prometrium|prometrium
5003065|NCT03976986|Hypoxic Challenge Testing|hypoxic challenge testing
5019210|NCT03876834|leukemia|leukemia
5003066|NCT03976960|cancer|cancer
5027312|NCT03827980|Outcome|outcome
5003067|NCT03976960|colon|colon
5661495|NCT00657202|NF1|nf1
5035352|NCT03778515|MRI|mri
5661533|NCT00657007|SLE|sle
5039353|NCT03752567|ecg|ecg
5003069|NCT03976960|colic|colic
5043228|NCT03728933|RLS|rls
5044574|NCT03720496|NHL|nhl
5645904|NCT00718588|RA|ra
5047325|NCT03703635|TIA|tia
5646003|NCT00718172|HCV|hcv
5646404|NCT00716807|TMD|tmd
5055729|NCT03650465|GAD|gad
5646382|NCT00716898|Cancer|cancer
5646576|NCT00716053|COPD|copd
5646661|NCT00715793|Melanoma|melanoma
5070037|NCT03561168|Anesthesia|anesthesia
5003070|NCT03976947|Driving pressure|driving pressure
5647065|NCT00714337|Formulation|formulation
5663164|NCT00650962|CPR|cpr
5663265|NCT00650091|NAC|nac
5077049|NCT03517618|S-1|s-1
5079105|NCT03504904|Chronic pain|chronic pain
5647402|NCT00712933|SLE|sle
5663541|NCT00647387|septal|septal
5083114|NCT03478761|CYP24A1|cyp24a1
5663629|NCT00647088|Genetic|genetic
5087560|NCT03451331|carboplatin|carboplatin
5647726|NCT00711906|HIV|hiv
5664038|NCT00645411|Flu|flu
5003071|NCT03976947|Postoperative pulmonary complications|postoperative pulmonary complications
5096191|NCT03396731|VLU|vlu
5003072|NCT03976934|open inguinal hernia repair|open inguinal hernia repair
5098035|NCT03385590|healthy|healthy
5664589|NCT00642499|HIV|hiv
5664788|NCT00641758|Nitric oxide|nitric oxide
5664932|NCT00641329|ADD|add
5118608|NCT03254485|HF|hf
5648988|NCT00706901|MI|mi
5003073|NCT03976934|spinal anaesthesia|spinal anaesthesia
5132778|NCT03163082|Coercion theory|coercion theory
5003074|NCT03976934|urinary retention|urinary retention
5003075|NCT03976934|elective alpha blockers|elective alpha blockers
5144626|NCT03087812|stone|stone
5147816|NCT03068676|Depression|depression
5665874|NCT00637637|tongue cancer|tongue cancer
5650131|NCT00701584|Lignans|lignans
5666183|NCT00636350|xanthophylls|xanthophylls
5198771|NCT02752035|AML|aml
5650533|NCT00699842|MDS|mds
5258542|NCT02397655|atherosclerosis|atherosclerosis
5650742|NCT00698932|HBA1c|hba1c
5270345|NCT02328638|ASD|asd
5003076|NCT03976921|Computed Tomography Perfusion|computed tomography perfusion
5651034|NCT00697645|Stroke,|stroke,
5285459|NCT02244866|IVF|ivf
5667064|NCT00632658|cGVHD|cgvhd
5308919|NCT02134288|Belatacept|belatacept
5667352|NCT00631410|Phase 1|phase 1
5352699|NCT01936467|EUS|eus
5363696|NCT01885442|cycle ergometry|cycle ergometry
5380386|NCT01810809|Hip|hip
5388236|NCT01775371|Emergency|emergency
5003077|NCT03976921|Cardiovascular Outcomes|cardiovascular outcomes
5652960|NCT00690144|simulation|simulation
5463809|NCT01445548|AMD|amd
5472348|NCT01411410|phase I|phase i
5653181|NCT00689338|ICU|icu
5486215|NCT01352858|RA|ra
5669188|NCT00624611|CPB|cpb
5653512|NCT00688311|HIV|hiv
5003078|NCT03976921|Cost-effectiveness|cost-effectiveness
5003079|NCT03976908|Tinnitus|tinnitus
5547749|NCT01096095|SCA|sca
5003080|NCT03976908|Deep Brain Stimulation|deep brain stimulation
5669615|NCT00622947|saliva cortisol|saliva cortisol
5595048|NCT00910806|TMC207-C110|tmc207-c110
5605955|NCT00874380|FFQ|ffq
5003081|NCT03976895|viral bronchiolitis|viral bronchiolitis
5003082|NCT03976895|Prone position|prone position
5662417|NCT00653783|MSA|msa
5003083|NCT03976895|high flow nasal cannula|high flow nasal cannula
5680844|NCT00576043|Safety|safety
5654540|NCT00684008|infection|infection
5003084|NCT03976895|noninvasive ventilation|noninvasive ventilation
5671405|NCT00616135|ADRC|adrc
5672908|NCT00610168|booster|booster
5671538|NCT00615602|FEC|fec
5654846|NCT00682877|GI|gi
5844189|NCT00050492|Ocular|ocular
5671890|NCT00613808|leg|leg
5670823|NCT00618293|aortic stenosis|aortic stenosis
5672072|NCT00613054|GBM|gbm
5670986|NCT00617786|urgency|urgency
5672239|NCT00612677|recurrent|recurrent
5671097|NCT00617305|PAH|pah
5672342|NCT00612287|Pain|pain
5003085|NCT03976895|Randomized controlled trial|randomized controlled trial
5672646|NCT00611325|Glioblastoma|glioblastoma
5003102|NCT03976778|Well-child|well-child
5672802|NCT00610571|Malignant Gliomas|malignant gliomas
5672830|NCT00610493|MRI|mri
5845616|NCT00050271|Biopsy|biopsy
5673010|NCT00609778|CPR|cpr
5656235|NCT00677443|S-1|s-1
5656336|NCT00677079|BRCA-1|brca-1
5673399|NCT00608400|CLA|cla
5673443|NCT00608179|epinephrine|epinephrine
5673553|NCT00607815|PCT|pct
5846528|NCT00044239|OCD|ocd
5005946|NCT03959566|Safety|safety
5003103|NCT03976778|Pediatric health maintenance|pediatric health maintenance
5003104|NCT03976778|Health supervision for children|health supervision for children
5003105|NCT03976752|HIV|hiv
5003106|NCT03976752|MSM|msm
5003107|NCT03976752|Anti-retrovirals|anti-retrovirals
4970857|NCT04172506|Anti-PD-1|anti-pd-1
4970858|NCT04172506|immunotherapy|immunotherapy
4970862|NCT04172454|Bispecific|bispecific
5003108|NCT03976752|Pharmacokinetics|pharmacokinetics
5673913|NCT00606164|pharmacodynamics|pharmacodynamics
5003109|NCT03976752|Peri-exposure HIV prophylaxis|peri-exposure hiv prophylaxis
4973641|NCT04156438|ARDS|ards
5674008|NCT00605566|sorafenib|sorafenib
5657659|NCT00672035|LT|lt
4974547|NCT04151446|Presbyopia|presbyopia
5674097|NCT00605059|Alzheimer|alzheimer
5657754|NCT00671697|MDS|mds
4977442|NCT04133480|cognition|cognition
5676145|NCT00596362|Eye|eye
5888688|NCT04157296|anxious|anxious
5674691|NCT00602355|Postpartum|postpartum
5674758|NCT00602082|gastrinoma|gastrinoma
5889761|NCT04059588|metastases|metastases
4994226|NCT04030143|Gluteal Muscle|gluteal muscle
5849216|NCT00030966|MS|ms
4998297|NCT04005027|QT interval|qt interval
5659273|NCT00666172|Obesity|obesity
5005379|NCT03963011|NEC|nec
5659287|NCT00666107|HPV|hpv
5008936|NCT03940625|MRI|mri
5675619|NCT00598364|thyroid|thyroid
5659620|NCT00664716|RA|ra
5891293|NCT03909971|NSCLC|nsclc
5675846|NCT00597493|GBM|gbm
5891768|NCT03845998|airway|airway
5891954|NCT03829657|nOH|noh
5660096|NCT00662597|VDA|vda
5026408|NCT03833531|CPD|cpd
5027213|NCT03828656|Nightmares|nightmares
5030373|NCT03809416|PRP|prp
5660577|NCT00661011|Surgery|surgery
5893562|NCT03548051|Placebo|placebo
5852004|NCT00002405|VX 478|vx 478
5038525|NCT03758105|tDCS|tdcs
5040102|NCT03748199|CF|cf
5894313|NCT03454451|CRC|crc
5661134|NCT00658918|PAR|par
5050520|NCT03682224|clinical trial|clinical trial
5894918|NCT03380754|Nausea|nausea
5052424|NCT03671044|Docetaxel|docetaxel
5055133|NCT03653585|7 Tesla|7 tesla
5677236|NCT00591305|PDL|pdl
5661712|NCT00656370|Hylenex|hylenex
5059132|NCT03629301|Online|online
5677401|NCT00590564|SST|sst
5661948|NCT00655395|MDS|mds
5061143|NCT03616847|Tourniquet|tourniquet
5662058|NCT00654927|MS|ms
5895903|NCT03215810|NSCLC|nsclc
5065629|NCT03589092|NGS|ngs
5662209|NCT00654433|MLD|mld
5071938|NCT03549546|CD4|cd4
5662419|NCT00653783|PSP|psp
5073915|NCT03537183|PCWP|pcwp
5662494|NCT00653549|fasting|fasting
5076224|NCT03522506|Drug Therapy|drug therapy
4969075|NCT04182906|Trauma|trauma
5662908|NCT00651755|NHL|nhl
5083681|NCT03475394|Gel|gel
5087858|NCT03448796|Tomofix|tomofix
5663210|NCT00650715|IGF-1|igf-1
5091856|NCT03424538|posture|posture
5096197|NCT03396718|postoperative|postoperative
5101187|NCT03365778|SLT|slt
5104943|NCT03341195|SMS|sms
5106739|NCT03330652|mRS|mrs
5109883|NCT03311087|high flow nasal oxygen|high flow nasal oxygen
5678838|NCT00584714|perfusion|perfusion
5664123|NCT00644904|Safety|safety
5117872|NCT03258840|Paraoxonase 1|paraoxonase 1
5679131|NCT00583362|SLE|sle
5902277|NCT01189851|breast|breast
5664421|NCT00643422|normal eyes|normal eyes
5126415|NCT03204188|Complex Cytogenics|complex cytogenics
5129122|NCT03187548|WSL|wsl
5679365|NCT00582348|Lung|lung
5664836|NCT00641563|midazolam|midazolam
5138439|NCT03125889|BPH|bph
5664919|NCT00641381|HIV Infections|hiv infections
5143744|NCT03093324|DMF|dmf
5665101|NCT00640692|Imatinib|imatinib
5680030|NCT00579475|leiomyomas|leiomyomas
5873108|NCT03749044|SLE|sle
5057047|NCT03642418|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management|asthma, children, spirometry, lung function, asthma action plan, asthma exacerbation, self management
5057048|NCT03642392|Achilles tendon|achilles tendon
5057049|NCT03642392|Patellar tendon|patellar tendon
4955932|NCT04264455|ICD|icd
5665767|NCT00637754|ICD|icd
5255658|NCT02414373|urination|urination
5057050|NCT03642392|Inflammation|inflammation
5057051|NCT03642366|Low Intensity Shockwave Therapy|low intensity shockwave therapy
5057052|NCT03642353|plaque control|plaque control
5057053|NCT03642353|bacteria|bacteria
5273417|NCT02312219|HIV|hiv
5057054|NCT03642353|inflammation|inflammation
5666203|NCT00636285|A110|a110
5288656|NCT02229981|HIV|hiv
5057055|NCT03642353|familial aggregation|familial aggregation
5057056|NCT03642353|prevention|prevention
5057057|NCT03642327|Child Abuse Prevention|child abuse prevention
5326466|NCT02055573|Low Income|low income
4976705|NCT04138030|Adenoma|adenoma
5336529|NCT02010463|obese|obese
5347479|NCT01961414|Exudative|exudative
5057058|NCT03642327|Primary Care|primary care
5667276|NCT00631644|HV|hv
5667353|NCT00631410|CRC|crc
5057059|NCT03642327|Professional Education in Primary Care|professional education in primary care
5396599|NCT01737450|BKM120|bkm120
5057060|NCT03642314|pre exposure prophylaxis|pre exposure prophylaxis
5667932|NCT00629252|PPI|ppi
5057061|NCT03642314|men who have sex with men|men who have sex with men
5668237|NCT00628238|CLL|cll
5483825|NCT01362920|PCT|pct
5009878|NCT03934905|nrf2|nrf2
5510939|NCT01248754|FDOPA|fdopa
5960971|NCT04289974|endocrinotherapy|endocrinotherapy
5014019|NCT03909178|Osteoarthritis|osteoarthritis
5668848|NCT00625807|meditation|meditation
5562159|NCT01039311|tomography|tomography
5669120|NCT00624871|HIE|hie
5609003|NCT00862550|Acupuncture|acupuncture
5669233|NCT00624416|fat|fat
5645971|NCT00718328|Statins|statins
5027425|NCT03827304|Qualitative|qualitative
5669508|NCT00623155|season|season
5668847|NCT00625807|Stress|stress
5057062|NCT03642301|Hemoglobin adducts from o-toluidine in blood|hemoglobin adducts from o-toluidine in blood
5669582|NCT00623051|HIV|hiv
5671316|NCT00616564|GM-CSF|gm-csf
5057063|NCT03642301|Urinary o-toluidine|urinary o-toluidine
5036360|NCT03771690|FTO|fto
5057064|NCT03642301|Intrathecal anesthesia|intrathecal anesthesia
5671667|NCT00614926|ALS|als
5041809|NCT03737864|readmission|readmission
5671894|NCT00613795|probiotics|probiotics
5057065|NCT03642301|Hyperbaric prilocaine|hyperbaric prilocaine
5672176|NCT00612742|Menopause|menopause
5049605|NCT03688243|AMD|amd
5672429|NCT00611949|Neuropathy|neuropathy
5056457|NCT03646032|HIV|hiv
5058919|NCT03630718|Female|female
5672710|NCT00611078|environment|environment
5057066|NCT03642301|Ambulatory surgery|ambulatory surgery
5057067|NCT03642275|heart failure|heart failure
5057068|NCT03642275|mHealth|mhealth
5057069|NCT03642275|smartphone|smartphone
5057070|NCT03642275|wearable electronic devices|wearable electronic devices
5674032|NCT00605449|GSK376501|gsk376501
5057071|NCT03642275|text messaging|text messaging
5057072|NCT03642275|self-management|self-management
5057073|NCT03642275|self-care|self-care
5057074|NCT03642249|delirium|delirium
5057075|NCT03642249|knowledge translation|knowledge translation
5057076|NCT03642249|Objective Structured Clinical Examination|objective structured clinical examination
5057077|NCT03642249|evidence-based practice|evidence-based practice
5057078|NCT03642197|Bariatric Surgery|bariatric surgery
5057079|NCT03642197|Obesity|obesity
5057080|NCT03642197|Social Support|social support
5057081|NCT03642197|Health Behavior|health behavior
5057082|NCT03642184|empagliflozin|empagliflozin
5057083|NCT03642184|linagliptin|linagliptin
5057084|NCT03642184|diabetes|diabetes
5057085|NCT03642184|kidney transplantation|kidney transplantation
5057086|NCT03642171|Contraception|contraception
5057087|NCT03642171|Intrauterine Device|intrauterine device
5057088|NCT03642171|UT380|ut380
5057089|NCT03642132|untreated epithelial ovarian cancer|untreated epithelial ovarian cancer
5057090|NCT03642132|fallopian tube carncer|fallopian tube carncer
5057091|NCT03642132|primary peritoneal cancer|primary peritoneal cancer
5057092|NCT03642106|Adolescent|adolescent
5057094|NCT03642106|Immigrant|immigrant
5057095|NCT03642093|Frailty|frailty
5057096|NCT03642093|Prehabilitation|prehabilitation
5057097|NCT03642067|Relatlimab|relatlimab
5057098|NCT03642067|Nivolumab|nivolumab
5057099|NCT03642067|Immunotherapy|immunotherapy
5057100|NCT03642067|Anti-PD-1|anti-pd-1
5057101|NCT03642067|Anti-LAG-3|anti-lag-3
5057102|NCT03642067|Antibody|antibody
5057103|NCT03642067|MSS|mss
5057104|NCT03642067|PD-L1|pd-l1
5057105|NCT03642067|Microsatellite stability|microsatellite stability
5057106|NCT03642067|Colorectal cancer|colorectal cancer
5057107|NCT03642067|Colon cancer|colon cancer
5057108|NCT03642067|Rectal cancer|rectal cancer
5057109|NCT03642041|Smoking|smoking
5057110|NCT03642041|Lung cancer|lung cancer
5057111|NCT03642041|Survival|survival
5057112|NCT03642041|Quality of life|quality of life
5057117|NCT03642015|music|music
5057118|NCT03642015|anxiety|anxiety
5057119|NCT03642015|digestive tract endoscopy|digestive tract endoscopy
5057130|NCT03641924|Posttraumatic Stress Disorder|posttraumatic stress disorder
5057132|NCT03641924|Neuropsychology|neuropsychology
5057133|NCT03641911|incidence|incidence
5057134|NCT03641911|surgical ICU|surgical icu
5057135|NCT03641898|Fractional flow reserve|fractional flow reserve
5057136|NCT03641898|Intravascular ultrasound|intravascular ultrasound
5057137|NCT03641898|Major adverse cardiovascular events|major adverse cardiovascular events
5057138|NCT03641898|Non-ST-segment acute coronary syndrome|non-st-segment acute coronary syndrome
5057139|NCT03641898|Percutaneous coronary intervention|percutaneous coronary intervention
5057140|NCT03641872|acute-on-chronic liver disease|acute-on-chronic liver disease
5057141|NCT03641872|acute decompensation|acute decompensation
5057142|NCT03641872|multiple organ failures|multiple organ failures
5057143|NCT03641872|acute-on-chronic liver failure|acute-on-chronic liver failure
5057144|NCT03641859|pain|pain
5057145|NCT03641859|anxiety|anxiety
5057146|NCT03641833|cardiac|cardiac
5057147|NCT03641833|surgery|surgery
5057148|NCT03641833|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5057149|NCT03641833|bypass|bypass
5057150|NCT03641833|brain biomarkers|brain biomarkers
5057151|NCT03641833|transcranial Doppler|transcranial doppler
5057152|NCT03641781|Isokinetic, Isometric, Agility|isokinetic, isometric, agility
5057153|NCT03641781|Athletic Single Leg Stability,|athletic single leg stability,
5057154|NCT03641781|Vertical Jump Biodex, Knee Pain|vertical jump biodex, knee pain
5057155|NCT03641768|Alzheimer Dementia|alzheimer dementia
5057156|NCT03641768|PTSD|ptsd
5057157|NCT03641768|MRI|mri
5057158|NCT03641755|Breast Cancer|breast cancer
5057165|NCT03641716|early childhood, family, occupational therapy|early childhood, family, occupational therapy
5057167|NCT03641690|mortality|mortality
5057168|NCT03641690|ICU|icu
5057169|NCT03641677|EVLP|evlp
5057170|NCT03641677|ex vivo lung perfusion|ex vivo lung perfusion
5057171|NCT03641677|organ perfusion|organ perfusion
5057172|NCT03641677|CLES|cles
5057173|NCT03641677|centralized lung evaluation system|centralized lung evaluation system
5057174|NCT03641677|united therapeutics|united therapeutics
5057175|NCT03641638|Postpartum thyroiditis|postpartum thyroiditis
5057176|NCT03641638|PPT|ppt
5057177|NCT03641638|TPOAb|tpoab
5057178|NCT03641625|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5057179|NCT03641625|Laparoscopic Hysterectomy|laparoscopic hysterectomy
5057180|NCT03641625|Muscular Tissue Oxygen Saturation|muscular tissue oxygen saturation
5960972|NCT04289974|resistance|resistance
5960973|NCT04289961|Circulating Tumour Cells (CTCs)|circulating tumour cells (ctcs)
5057181|NCT03641625|Hemodynamic Management|hemodynamic management
5057182|NCT03641612|rotary instruments|rotary instruments
5057183|NCT03641612|endotoxins|endotoxins
5057184|NCT03641599|RV systolic function|rv systolic function
5057185|NCT03641599|HFpEF|hfpef
5057186|NCT03641599|HFmrEF|hfmref
5057187|NCT03641599|HFrEF|hfref
5057188|NCT03641586|Dose Escalation|dose escalation
5057189|NCT03641586|Dose Expansion|dose expansion
5057190|NCT03641586|BGB-283|bgb-283
5057191|NCT03641560|Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC)|progressive metastatic castration-resistant prostate cancer (mcrpc)
5057192|NCT03641560|Enzalutamide|enzalutamide
5057193|NCT03641560|Xtandi|xtandi
5057194|NCT03641560|MDV3100|mdv3100
5057195|NCT03641547|Oesophageal cancer|oesophageal cancer
5057196|NCT03641534|Perfusion|perfusion
5057197|NCT03641534|Lung congestion|lung congestion
5057198|NCT03641521|child vegetable intake|child vegetable intake
5057199|NCT03641521|behavioral strategy|behavioral strategy
5057200|NCT03641521|intervention|intervention
5057201|NCT03641508|trigger finger|trigger finger
5057202|NCT03641495|fibromyalgia|fibromyalgia
5057203|NCT03641495|therapeutic exercise|therapeutic exercise
5057204|NCT03641495|physiotherapy|physiotherapy
5057205|NCT03641482|third molar surgery|third molar surgery
5057206|NCT03641482|oral surgery|oral surgery
5057207|NCT03641482|propolis|propolis
5057221|NCT03641417|Gut hormones|gut hormones
5049849|NCT03686501|HV|hv
5057222|NCT03641417|Adipokines|adipokines
5057223|NCT03641404|ergothioneine|ergothioneine
5057224|NCT03641404|mild cognitive impairment|mild cognitive impairment
5057225|NCT03641404|dementia|dementia
5057226|NCT03641404|dietary antioxidant|dietary antioxidant
5057227|NCT03641391|Awake surgery|awake surgery
5057228|NCT03641391|Direct cortical stimulation|direct cortical stimulation
5057229|NCT03641391|Language mapping|language mapping
5057231|NCT03641378|Cancer Care|cancer care
5057232|NCT03641365|Intraoral scanner|intraoral scanner
5057233|NCT03641365|Guided surgery|guided surgery
5057234|NCT03641365|Implant accuracy|implant accuracy
5057235|NCT03641365|Dental implants|dental implants
5057236|NCT03641339|Mosquito|mosquito
5057237|NCT03641339|Saliva|saliva
5057238|NCT03641339|Immune Response|immune response
5057239|NCT03641339|Sand Fly|sand fly
5057240|NCT03641339|Biopsy|biopsy
5057241|NCT03641326|Gliosarcoma|gliosarcoma
5057242|NCT03641326|Brain Tumor|brain tumor
5057243|NCT03641326|MDASI|mdasi
5057244|NCT03641300|Magnetic Seizure Therapy|magnetic seizure therapy
5057245|NCT03641300|Electroconvulsive Therapy|electroconvulsive therapy
5057246|NCT03641300|Bipolar Disorder|bipolar disorder
5057247|NCT03641300|Depression|depression
5057248|NCT03641300|Suicidal Ideation|suicidal ideation
5057249|NCT03641274|Vulnerable populations|vulnerable populations
5057250|NCT03641274|Emergency department|emergency department
5733059|NCT00382616|children|children
5057251|NCT03641261|Hereditary ichthyosis|hereditary ichthyosis
5057252|NCT03641235|pulmonary microbiota|pulmonary microbiota
5057253|NCT03641235|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5057254|NCT03641222|Acupuncture|acupuncture
5057255|NCT03641222|Group|group
5057256|NCT03641222|Community Based|community based
5057257|NCT03641222|Individual|individual
5057258|NCT03641222|Randomized|randomized
5057259|NCT03641209|acetaminophen|acetaminophen
5057260|NCT03641209|ductus arteriosus|ductus arteriosus
5057261|NCT03641209|NIRS|nirs
5057262|NCT03641209|intravenous|intravenous
5057263|NCT03641196|Orthodontic Appliances|orthodontic appliances
5057264|NCT03641196|Dentition, Mixed|dentition, mixed
5057265|NCT03641157|Difficult intubation|difficult intubation
5057266|NCT03641157|Pediatrics|pediatrics
5057267|NCT03641157|predictive tests|predictive tests
5057268|NCT03641144|Diabetic Macular Edema|diabetic macular edema
5057269|NCT03641144|navigation laser|navigation laser
5057270|NCT03641144|laser photocoagulation|laser photocoagulation
5057271|NCT03641118|cancer|cancer
5057272|NCT03641118|sarcopenia|sarcopenia
5057273|NCT03641118|surgery|surgery
5057274|NCT03641118|chemotherapy|chemotherapy
5057275|NCT03641092|School readiness|school readiness
5057276|NCT03641092|Child development|child development
5057277|NCT03641092|Child behavior|child behavior
5057278|NCT03641092|Parenting behavior|parenting behavior
5057279|NCT03641092|CenteringParenting|centeringparenting
5057280|NCT03641066|ankle|ankle
5057281|NCT03641066|biomechanics|biomechanics
5057282|NCT03641053|honey|honey
5057283|NCT03641053|povidone-iodine|povidone-iodine
5057284|NCT03641053|randomized control trial|randomized control trial
5057285|NCT03641053|wound healing|wound healing
5057286|NCT03641040|Video-oculography|video-oculography
5057287|NCT03641040|Intermittent exotropia|intermittent exotropia
5057288|NCT03641040|ocular deviation|ocular deviation
5057289|NCT03641027|Obesity|obesity
5057290|NCT03641027|Physical Activity|physical activity
5057291|NCT03641001|Intervention|intervention
5057292|NCT03641001|Food voucher|food voucher
5057293|NCT03641001|Child feeding|child feeding
5057294|NCT03641001|Growth|growth
5057295|NCT03641001|WASH|wash
5057296|NCT03640975|eosinophilic esophagitis|eosinophilic esophagitis
5057297|NCT03640975|children|children
5057298|NCT03640975|innate immunity|innate immunity
5057299|NCT03640962|Postmenopause|postmenopause
5057300|NCT03640962|Low back pain|low back pain
5057301|NCT03640962|Woman|woman
5057302|NCT03640936|asthma|asthma
5057310|NCT03640897|Oleocalcareous liniment|oleocalcareous liniment
5057315|NCT03640780|surgical timing|surgical timing
5057316|NCT03640780|cataract extraction|cataract extraction
5057317|NCT03640780|IOL implantation|iol implantation
5057318|NCT03640780|childhood cataract|childhood cataract
5057319|NCT03640780|real-world data|real-world data
5057320|NCT03640767|Rehabilitation|rehabilitation
5057527|NCT03639402|Practice|practice
5057337|NCT03640663|Midwifery-led continuity of care|midwifery-led continuity of care
5057338|NCT03640663|Birth complications|birth complications
5057339|NCT03640650|Sequential bilateral cataract surgery|sequential bilateral cataract surgery
5057340|NCT03640637|Positron emission tomography|positron emission tomography
5057341|NCT03640637|Magnetic resonance imaging|magnetic resonance imaging
5057342|NCT03640624|Physical Therapy Modalities|physical therapy modalities
5057343|NCT03640611|cerebral palsy, activity, participation, environmental factors, ICF-CY|cerebral palsy, activity, participation, environmental factors, icf-cy
5057344|NCT03640585|Cerebral palsy|cerebral palsy
5057345|NCT03640585|Music therapy|music therapy
5057346|NCT03640585|Gross motor function|gross motor function
5057347|NCT03640559|Adhesion|adhesion
5057348|NCT03640559|Safety|safety
5057349|NCT03640507|vaginal preparation|vaginal preparation
5057350|NCT03640507|antisepsis|antisepsis
5057351|NCT03640507|C-section|c-section
5057352|NCT03640494|Optical Coherence Tomography|optical coherence tomography
5057353|NCT03640494|Newborn|newborn
5057354|NCT03640494|Infant|infant
5057355|NCT03640416|night on call|night on call
5057356|NCT03640416|sleep deprivation|sleep deprivation
5057357|NCT03640416|fitbit®|fitbit®
5057358|NCT03640416|smart watch|smart watch
5057359|NCT03640416|stress|stress
5057360|NCT03640403|Malaria|malaria
5057361|NCT03640403|school children|school children
5057362|NCT03640403|randomized controlled trial|randomized controlled trial
5057363|NCT03640403|safety|safety
5057364|NCT03640403|effectiveness|effectiveness
5057365|NCT03640403|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5057366|NCT03640403|cognitive|cognitive
5057367|NCT03640403|Artesunate-amodiaquine|artesunate-amodiaquine
5057368|NCT03640403|malaria serology|malaria serology
5057369|NCT03640403|drug resistance|drug resistance
5733772|NCT00379730|biomarkers|biomarkers
5057370|NCT03640364|pelvic organ prolapse|pelvic organ prolapse
5057371|NCT03640364|incontinence|incontinence
5057372|NCT03640364|minimally invasive|minimally invasive
5057373|NCT03640364|vaginal surgery|vaginal surgery
5057374|NCT03640364|macroporous|macroporous
5057375|NCT03640364|lightweight|lightweight
5057376|NCT03640364|mesh|mesh
5057377|NCT03640364|polypropylene|polypropylene
5057379|NCT03640364|urge|urge
5057380|NCT03640351|Dry eye|dry eye
5057381|NCT03640351|Cataract surgery|cataract surgery
5057382|NCT03640351|Diquas|diquas
5057383|NCT03640351|preservative free|preservative free
5057384|NCT03640312|Hypertension|hypertension
5057385|NCT03640312|Blood Pressure|blood pressure
5057386|NCT03640299|Gynecologic Cancer|gynecologic cancer
5057387|NCT03640299|Enhanced Recovery After Surgery|enhanced recovery after surgery
5057388|NCT03640299|Laparoscopic surgery|laparoscopic surgery
5057395|NCT03640273|Loratadine|loratadine
5057396|NCT03640273|Prapchompoothaweep|prapchompoothaweep
5057397|NCT03640273|Allergic rhinitis|allergic rhinitis
5057398|NCT03640247|Thyroidectomy|thyroidectomy
5057399|NCT03640247|Parathryoidectomy|parathryoidectomy
5057400|NCT03640221|Hypertension|hypertension
5057401|NCT03640221|Diabetes|diabetes
5057402|NCT03640208|health disparities|health disparities
5057403|NCT03640208|African American|african american
5057404|NCT03640208|risk assessment|risk assessment
5057405|NCT03640208|secondary prevention|secondary prevention
5057406|NCT03640182|Health Management Model|health management model
5057407|NCT03640182|Chinese Medicine|chinese medicine
5057408|NCT03640182|Preventive Medicine|preventive medicine
5057409|NCT03640182|Body Constitution|body constitution
5057410|NCT03640182|Health Promotion|health promotion
5057411|NCT03640169|Health Management Model|health management model
5057412|NCT03640169|Chinese Medicine|chinese medicine
5057413|NCT03640169|Preventive Medicine|preventive medicine
5057414|NCT03640169|Body Constitution|body constitution
5057415|NCT03640169|Health Promotion|health promotion
5057416|NCT03640156|Oxytocin|oxytocin
5057417|NCT03640156|Eye Contact|eye contact
5057418|NCT03640156|Mirror System|mirror system
5057419|NCT03640156|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5057431|NCT03639961|Integrated|integrated
5057433|NCT03639961|managing|managing
5057434|NCT03639961|governing|governing
5057435|NCT03639961|practices|practices
5057436|NCT03639948|Pembrolizumab|pembrolizumab
5057437|NCT03639948|Carboplatin|carboplatin
5057438|NCT03639948|Docetaxel|docetaxel
5057439|NCT03639948|Pegfilgrastim|pegfilgrastim
5057440|NCT03639948|breast cancer|breast cancer
5057441|NCT03639935|Metastatic|metastatic
5057442|NCT03639935|Platinum|platinum
5057443|NCT03639935|Rucaparib|rucaparib
5057444|NCT03639935|Nivolumab|nivolumab
5057445|NCT03639935|PARP Inhibitor|parp inhibitor
5057446|NCT03639935|Anti-PD-1 Antibody|anti-pd-1 antibody
5057447|NCT03639922|acute ischaemic stroke|acute ischaemic stroke
5057448|NCT03639922|Imatinib|imatinib
5057449|NCT03639922|blood-brain-barrier|blood-brain-barrier
5057450|NCT03639922|trombectomy|trombectomy
5057451|NCT03639922|iv trombolysis|iv trombolysis
5057452|NCT03639909|sweat gland|sweat gland
5057453|NCT03639883|wound healing|wound healing
5057454|NCT03639870|refractory|refractory
5057455|NCT03639831|Mood|mood
5057456|NCT03639831|Anxiety|anxiety
5057457|NCT03639831|Stress|stress
5057458|NCT03639831|Dietary supplement|dietary supplement
5057459|NCT03639831|Botanical|botanical
5057460|NCT03639792|gastric cancer|gastric cancer
5057461|NCT03639792|postoperative complication|postoperative complication
5057462|NCT03639792|octogenarian|octogenarian
5057463|NCT03639779|Calcinosis cutis|calcinosis cutis
5057464|NCT03639779|sodium thiosulfate|sodium thiosulfate
5057465|NCT03639779|sodium chloride|sodium chloride
5057466|NCT03639766|Raynaud Phenomenon|raynaud phenomenon
5057467|NCT03639766|AbobotulinumtoxinA|abobotulinumtoxina
5057468|NCT03639753|teen driver safety|teen driver safety
5057469|NCT03639753|injury prevention|injury prevention
5057470|NCT03639727|cough|cough
5057471|NCT03639727|cough provocation test|cough provocation test
5057472|NCT03639727|mannitol|mannitol
5057473|NCT03639727|citric acid|citric acid
5057483|NCT03639701|Thymidine|thymidine
5057484|NCT03639701|Deoxycytidine|deoxycytidine
5057485|NCT03639636|periodontitis|periodontitis
5057486|NCT03639636|sclerostin|sclerostin
5057487|NCT03639636|periodontal surgery|periodontal surgery
5057488|NCT03639636|scaling and root planing|scaling and root planing
5057489|NCT03639623|Peroxisome proliferator-activated receptors|peroxisome proliferator-activated receptors
5057490|NCT03639623|NAFLD|nafld
5057491|NCT03639623|NASH|nash
5057492|NCT03639623|Post Transplant Metabolic Syndrome|post transplant metabolic syndrome
5057493|NCT03639597|ablation|ablation
5057494|NCT03639597|ultrasound|ultrasound
5057495|NCT03639597|automation|automation
5057496|NCT03639597|catheter|catheter
5057499|NCT03639506|repetition failure|repetition failure
5057500|NCT03639506|autologous mitochondria transplantation|autologous mitochondria transplantation
5903508|NCT00357214|bone turnover|bone turnover
5057501|NCT03639506|embryo quality|embryo quality
5057502|NCT03639506|live birth rate|live birth rate
5057503|NCT03639467|anlotinib|anlotinib
5057504|NCT03639467|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5057505|NCT03639467|gemcitabine|gemcitabine
5057506|NCT03639467|cisplatin|cisplatin
5057507|NCT03639454|dry needling|dry needling
5057508|NCT03639454|myofascial trigger point|myofascial trigger point
5057509|NCT03639454|muscle tone|muscle tone
5057510|NCT03639441|dry needling|dry needling
5057511|NCT03639441|myofascial trigger point|myofascial trigger point
5057512|NCT03639441|muscle tone|muscle tone
5057513|NCT03639428|pharmacokinetics|pharmacokinetics
5057514|NCT03639428|child|child
5057515|NCT03639428|cyclodextrin|cyclodextrin
5057516|NCT03639428|moderate sedation|moderate sedation
5057517|NCT03639415|Opioid|opioid
5057518|NCT03639415|Refractory Pain|refractory pain
5057519|NCT03639415|dose frequency|dose frequency
5057520|NCT03639415|nausea|nausea
5057521|NCT03639415|vomit|vomit
5057522|NCT03639415|dizziness|dizziness
5057523|NCT03639402|Diet|diet
5428255|NCT01595451|Acupuncture|acupuncture
5057541|NCT03639376|Saliva|saliva
5057542|NCT03639363|4% chlorhexidine gluconate|4% chlorhexidine gluconate
5057543|NCT03639363|infection control|infection control
5057544|NCT03639350|intermittent energy restriction|intermittent energy restriction
5057545|NCT03639350|Randomized Controlled Trial|randomized controlled trial
5057546|NCT03639350|Adiposity|adiposity
5057547|NCT03639337|Probiotic|probiotic
5057548|NCT03639337|Food allergy|food allergy
5057549|NCT03639324|venetoclax|venetoclax
5057550|NCT03639324|idelalisib|idelalisib
5057552|NCT03639311|ART|art
5057553|NCT03639311|maintenance|maintenance
5057554|NCT03639311|Long acting|long acting
5057555|NCT03639311|LATTE|latte
5057556|NCT03639298|premature children|premature children
5057557|NCT03639298|processing speed|processing speed
5057558|NCT03639298|executive functions|executive functions
5057559|NCT03639272|talar fractures|talar fractures
5057560|NCT03639272|talar neck fractures;|talar neck fractures;
5057561|NCT03639272|talar body fractures;|talar body fractures;
5057570|NCT03639194|Cancer|cancer
5057571|NCT03639194|Small Cell Lung Cancer|small cell lung cancer
5057572|NCT03639194|Small Cell Lung Carcinoma|small cell lung carcinoma
5057573|NCT03639181|B-NHL|b-nhl
5057574|NCT03639155|vadadustat|vadadustat
5057575|NCT03639155|AKB-6548|akb-6548
5057576|NCT03639155|hypoxia-inducible factor|hypoxia-inducible factor
5057577|NCT03639155|HIF|hif
5057578|NCT03639155|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5057579|NCT03639155|HIF-PHI|hif-phi
5057580|NCT03639142|constipation, prunes, children|constipation, prunes, children
5057581|NCT03639116|Spike timing-dependent plasticity|spike timing-dependent plasticity
5057582|NCT03639116|cerebrovascular accident|cerebrovascular accident
5057583|NCT03639116|stroke|stroke
5057584|NCT03639116|paralysis|paralysis
5057585|NCT03639116|hemiparesis|hemiparesis
5057586|NCT03639090|chemotherapy, mass spectrometry|chemotherapy, mass spectrometry
5057587|NCT03639077|Bone graft|bone graft
5057588|NCT03639077|Lateral window approach|lateral window approach
5057589|NCT03639077|Sinus augmentation|sinus augmentation
5057590|NCT03639077|Volumetric change|volumetric change
5057591|NCT03638960|peripheral nerve block|peripheral nerve block
5057592|NCT03638960|interscalene|interscalene
5057593|NCT03638960|arthroscopic shoulder surgery|arthroscopic shoulder surgery
5057594|NCT03638960|liposomal bupivacaine|liposomal bupivacaine
5057595|NCT03638934|Advance care planning|advance care planning
5057596|NCT03638895|weight management|weight management
5057597|NCT03638895|obesity|obesity
5057598|NCT03638895|severe obesity|severe obesity
5057599|NCT03638895|structured dietary intervention|structured dietary intervention
5057600|NCT03638895|calorie restriction|calorie restriction
5057601|NCT03638895|indirect calorimetry|indirect calorimetry
5057602|NCT03638895|resting energy expenditure|resting energy expenditure
5057603|NCT03638895|resting metabolic rate|resting metabolic rate
5057604|NCT03638895|respiratory quotient|respiratory quotient
5057605|NCT03638895|substrate oxidation|substrate oxidation
5057606|NCT03638895|glycemic variability|glycemic variability
5057607|NCT03638895|insulin sensitivity|insulin sensitivity
5057608|NCT03638895|peripheral neuropathy|peripheral neuropathy
5057609|NCT03638856|Cervical priming|cervical priming
5057610|NCT03638856|Diagnosis hysteroscopy|diagnosis hysteroscopy
5057611|NCT03638856|Oral Misoprostal|oral misoprostal
5057612|NCT03638856|Premenopause|premenopause
5057613|NCT03638843|bariatric endoscopy|bariatric endoscopy
5057614|NCT03638843|obesity|obesity
5057615|NCT03638843|metabolic syndrome|metabolic syndrome
5057616|NCT03638843|gastric mucosal devitalization|gastric mucosal devitalization
5057617|NCT03638843|Endoscopic bariatric therapies|endoscopic bariatric therapies
5057618|NCT03638830|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5057619|NCT03638830|antibiotic resistance|antibiotic resistance
5057620|NCT03638830|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
5057621|NCT03638830|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
5057622|NCT03638830|Pseudomonas Infections|pseudomonas infections
5057623|NCT03638830|Urinary Tract Infections|urinary tract infections
5057624|NCT03638817|Inherited thrombocytopenias (IT)|inherited thrombocytopenias (it)
5057630|NCT03638817|Rare disease|rare disease
5057631|NCT03638817|Thrombopoietin mimetic|thrombopoietin mimetic
5057632|NCT03638804|89Zr|89zr
5057633|NCT03638804|PD-L1|pd-l1
5057634|NCT03638804|KN035|kn035
5057635|NCT03638804|PET|pet
5057636|NCT03638765|immunotherapy|immunotherapy
5057637|NCT03638765|dendritic cells|dendritic cells
5057638|NCT03638765|brain metastases|brain metastases
5057639|NCT03638726|intraoperative mydriasis|intraoperative mydriasis
5057640|NCT03638726|subconjunctival atropine|subconjunctival atropine
5057641|NCT03638726|intracameral epinephrine|intracameral epinephrine
5057642|NCT03638726|cataract surgery|cataract surgery
5057643|NCT03638713|water exchange|water exchange
5057644|NCT03638713|colonoscopy|colonoscopy
5057645|NCT03638713|cecal insertion time|cecal insertion time
5057646|NCT03638713|bidirectional endoscopy|bidirectional endoscopy
5057647|NCT03638700|stenosis|stenosis
5057648|NCT03638700|bile duct|bile duct
5057649|NCT03638700|guidewire|guidewire
5057650|NCT03638700|ercp|ercp
5057651|NCT03638687|Pregnancy|pregnancy
5057652|NCT03638687|Postpartum|postpartum
5057653|NCT03638648|breast cancer|breast cancer
5057654|NCT03638648|neoadjuvant|neoadjuvant
5057655|NCT03638648|multiple gene detection|multiple gene detection
5057656|NCT03638635|Bupivacaine|bupivacaine
5057657|NCT03638635|Exparel|exparel
5057658|NCT03638635|TAP Block|tap block
5057659|NCT03638635|Opioids|opioids
5057660|NCT03638635|Narcotics|narcotics
5057661|NCT03638635|ERAS|eras
5057663|NCT03638609|IABP|iabp
5057664|NCT03638609|Post-Cardiac Arrest Syndrome|post-cardiac arrest syndrome
5057665|NCT03638609|Beclin-1|beclin-1
5057666|NCT03638609|Caspase-3|caspase-3
5057667|NCT03638609|Mortality|mortality
5057668|NCT03638596|Alcohol Impaired Driving|alcohol impaired driving
5057669|NCT03638596|Driving While Intoxicated|driving while intoxicated
5057670|NCT03638596|Driving Under the Influence|driving under the influence
5057671|NCT03638596|Driving While Impaired|driving while impaired
5057672|NCT03638583|Alzheimer's|alzheimer's
5057673|NCT03638583|Prevention|prevention
5057674|NCT03638583|Web-Based|web-based
5057675|NCT03638531|tDCS|tdcs
5057676|NCT03638531|cortical excitability|cortical excitability
5057677|NCT03638531|motor cortex|motor cortex
5057678|NCT03638531|motor learning|motor learning
5057679|NCT03638531|handwriting|handwriting
5057680|NCT03638531|micrographia|micrographia
5057681|NCT03638518|rehabilitation|rehabilitation
5057682|NCT03638518|balance|balance
5057683|NCT03638518|functional capacity|functional capacity
5057684|NCT03638492|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
5057685|NCT03638492|Randomized Controlled Trials as Topic|randomized controlled trials as topic
5057686|NCT03638492|Survival|survival
5057687|NCT03638492|Margin|margin
5057688|NCT03638453|Pedi Care|pedi care
5057689|NCT03638440|Opioid Induced Constipation|opioid induced constipation
5057690|NCT03638440|Naloxegol|naloxegol
5057691|NCT03638440|Peripherally Acting Mu-Opioids Receptor Antagonist (PAMORA)|peripherally acting mu-opioids receptor antagonist (pamora)
5057692|NCT03638427|menstrual blood, high risk HPV|menstrual blood, high risk hpv
5057693|NCT03638375|Metastatic melanoma|metastatic melanoma
5057694|NCT03638375|anti-PD1|anti-pd1
5057695|NCT03638375|TIL|til
5057696|NCT03638375|interferon-alpha|interferon-alpha
5057697|NCT03638375|adoptive cell therapy|adoptive cell therapy
5057698|NCT03638375|nivolumab|nivolumab
5057699|NCT03638362|obese|obese
5057700|NCT03638362|overweight|overweight
5057701|NCT03638362|tart cherry juice|tart cherry juice
5057707|NCT03638284|Dementia|dementia
5057708|NCT03638284|neuropsychiatric symptoms|neuropsychiatric symptoms
5057709|NCT03638284|tDCS|tdcs
5057710|NCT03638284|Transcranial direct current stimulation|transcranial direct current stimulation
5057711|NCT03638284|Alzheimer Disease|alzheimer disease
5057712|NCT03638284|Mixed Dementia|mixed dementia
5057713|NCT03638284|agitation in dementia|agitation in dementia
5057714|NCT03638284|non-invasive brain stimulation|non-invasive brain stimulation
5057715|NCT03638232|Drug consumption|drug consumption
5057716|NCT03638232|Response to treatment|response to treatment
5057717|NCT03638232|Non optimal drug use|non optimal drug use
5057720|NCT03638141|HCC|hcc
5057721|NCT03638141|Durvalumab|durvalumab
5057722|NCT03638141|Tremelimumab|tremelimumab
5057723|NCT03638141|Immunotherapy|immunotherapy
5057724|NCT03638141|PD-L1|pd-l1
5057725|NCT03638141|Antibodies|antibodies
5057726|NCT03638141|Hepatocellular Carcinoma|hepatocellular carcinoma
5057734|NCT03638063|Capsaicin|capsaicin
5057735|NCT03638063|cough provocation test|cough provocation test
5057736|NCT03638011|Cesarean Section|cesarean section
5057737|NCT03638011|Pregnancy|pregnancy
5057738|NCT03637998|Gene expression|gene expression
5057739|NCT03637998|Quantitative Sensory Testing|quantitative sensory testing
5057740|NCT03637998|Genotyping|genotyping
5057741|NCT03637985|resistive exercises|resistive exercises
5057742|NCT03637985|aerobic|aerobic
5057743|NCT03637985|Menopause|menopause
5057744|NCT03637985|hypertension|hypertension
5057745|NCT03637946|Resin composite|resin composite
5057746|NCT03637946|clinical trial|clinical trial
5057747|NCT03637946|biocompatibility|biocompatibility
5057748|NCT03637946|cytokines|cytokines
5057749|NCT03637920|Transmen|transmen
5057750|NCT03637920|Sexuality|sexuality
5057751|NCT03637920|Sexual behavior|sexual behavior
5057752|NCT03637920|Body Image|body image
5057753|NCT03637920|Trassexualism|trassexualism
5057754|NCT03637894|Newborns|newborns
5057755|NCT03637894|Fermented milk|fermented milk
5057756|NCT03637894|Innate immunity|innate immunity
5057757|NCT03637881|Milk|milk
5057758|NCT03637881|Consumer choice|consumer choice
5057759|NCT03637868|HER2-negative breast cancer|her2-negative breast cancer
5057763|NCT03637829|Healthy adults|healthy adults
5057764|NCT03637829|Cognitive performance|cognitive performance
5057765|NCT03637829|Chocolate|chocolate
5057766|NCT03637829|Food intake|food intake
5057767|NCT03637829|Glycemic response|glycemic response
5057775|NCT03637738|Intrabeam®|intrabeam®
5057776|NCT03637738|intraoperative radiation therapy|intraoperative radiation therapy
5057777|NCT03637738|conventional external radiotherapy|conventional external radiotherapy
5057778|NCT03637738|conservative surgery|conservative surgery
5057779|NCT03637699|Positive Psychology|positive psychology
5057780|NCT03637699|Positive Affect|positive affect
5057781|NCT03637686|Colorectal cancer|colorectal cancer
5057782|NCT03637686|Circulating tumor DNA|circulating tumor dna
5057783|NCT03637660|Benzathine penicillin G|benzathine penicillin g
5057784|NCT03637660|Early Syphillis|early syphillis
5057786|NCT03637660|Phase 4|phase 4
5057787|NCT03637647|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5057788|NCT03637647|oesophagogastric|oesophagogastric
5057789|NCT03637647|surgery|surgery
5057790|NCT03637647|chemotherapy|chemotherapy
5057791|NCT03637634|children and adolescents|children and adolescents
5057792|NCT03637582|voiding efficiency|voiding efficiency
5057793|NCT03637582|detrusor underactivity|detrusor underactivity
5057794|NCT03637582|urodynamics|urodynamics
5057795|NCT03637556|thalassemia|thalassemia
5057796|NCT03637556|iron|iron
5057797|NCT03637556|chelation|chelation
5057798|NCT03637556|deferasirox|deferasirox
5057799|NCT03637556|DST-0509|dst-0509
5057800|NCT03637556|transfusion|transfusion
5057801|NCT03637543|Prostate Cancer|prostate cancer
5057802|NCT03637504|Feasibility|feasibility
5057803|NCT03637504|Mobile Medication Plan Application|mobile medication plan application
5057804|NCT03637504|Patient Care|patient care
5057805|NCT03637504|Nebulized Medications|nebulized medications
5960974|NCT04289961|CTC clusters|ctc clusters
5057806|NCT03637504|Oral Medications|oral medications
5057807|NCT03637504|MedActionPlan|medactionplan
5057808|NCT03637504|eTrack Nebulizer|etrack nebulizer
5057809|NCT03637504|AdhereTech Pill Bottles|adheretech pill bottles
5057814|NCT03637465|hydration|hydration
5057815|NCT03637465|water intake|water intake
5057816|NCT03637465|sugar sweetened beverages|sugar sweetened beverages
5057817|NCT03637465|youth|youth
5057818|NCT03637465|children|children
5057819|NCT03637452|e-cigarettes|e-cigarettes
5057820|NCT03637452|juul brand e-cigarette|juul brand e-cigarette
5057821|NCT03637452|njoy brand e-cigarette|njoy brand e-cigarette
5057822|NCT03637452|evolv/mirage DNA 75c brand e-cigarette|evolv/mirage dna 75c brand e-cigarette
5057823|NCT03637426|nano-hydroxyapatite|nano-hydroxyapatite
5057825|NCT03637426|desensitizing|desensitizing
5057826|NCT03637413|preterm infants|preterm infants
5057827|NCT03637413|hindmilk|hindmilk
5057828|NCT03637387|TGN|tgn
5057829|NCT03637387|TN|tn
5057830|NCT03637374|aortic aneurysm|aortic aneurysm
5057831|NCT03637335|irradiation|irradiation
5057832|NCT03637335|placebo|placebo
5057833|NCT03637335|carboplatin|carboplatin
5057834|NCT03637257|Capnography|capnography
5057835|NCT03637257|Pediatric|pediatric
5057836|NCT03637257|nasal cannula|nasal cannula
5057837|NCT03637257|Guedel airway|guedel airway
5057838|NCT03637244|HIV PrEP Decision support African Caribbean Black Canadians|hiv prep decision support african caribbean black canadians
5057839|NCT03637218|High Altitude|high altitude
5057840|NCT03637218|non-invasive cardiac output|non-invasive cardiac output
5057841|NCT03637218|Finapres|finapres
5057842|NCT03637192|High Altitude|high altitude
5057843|NCT03637192|cognitive function|cognitive function
5057844|NCT03637179|High Altitude|high altitude
5057845|NCT03637179|Pulmonary artery pressure|pulmonary artery pressure
5057846|NCT03637179|Echocardiography|echocardiography
5057847|NCT03637179|Right heart function|right heart function
5057848|NCT03637179|exercise|exercise
5057849|NCT03637166|High Altitude|high altitude
5057850|NCT03637166|Pulmonary artery pressure|pulmonary artery pressure
5057851|NCT03637166|Echocardiography|echocardiography
5057852|NCT03637166|Right heart function|right heart function
5057853|NCT03637153|exercise capacity|exercise capacity
5057854|NCT03637153|High Altitude|high altitude
5057855|NCT03637153|contant loaded exercise test|contant loaded exercise test
5057856|NCT03637140|Simulated altitude|simulated altitude
5057857|NCT03637140|Pulmonary artery pressure|pulmonary artery pressure
5057858|NCT03637140|Echocardiography|echocardiography
5057859|NCT03637140|Right heart function|right heart function
5057860|NCT03637140|exercise|exercise
5057861|NCT03637127|Simulated altitude|simulated altitude
5057862|NCT03637127|cognitive function|cognitive function
5057863|NCT03637114|Simulated altitude|simulated altitude
5057864|NCT03637114|arterial blood gas analysis|arterial blood gas analysis
5057865|NCT03637114|near infrared spectroscopy|near infrared spectroscopy
5057866|NCT03637101|Ischemia modified albumin|ischemia modified albumin
5057867|NCT03637101|Traumatic brain injury|traumatic brain injury
5057868|NCT03637101|Troponin|troponin
5057869|NCT03637101|Conscious Level|conscious level
5057870|NCT03637101|Poor outcome|poor outcome
5057871|NCT03637088|Simulated altitude|simulated altitude
5057872|NCT03637088|Pulmonary artery pressure|pulmonary artery pressure
5057873|NCT03637088|Echocardiography|echocardiography
5057874|NCT03637088|Right heart function|right heart function
5057878|NCT03637075|dopamine signalling|dopamine signalling
5057880|NCT03637049|drug-drug interaction|drug-drug interaction
5057881|NCT03637049|CYP3A|cyp3a
5057882|NCT03637049|midazolam|midazolam
5057883|NCT03637049|healthy subjects|healthy subjects
5057884|NCT03637023|fMRI|fmri
5057885|NCT03637023|Virtual Reality Therapy|virtual reality therapy
5057886|NCT03637023|Exercise Therapy|exercise therapy
5057887|NCT03636906|Safety|safety
5057888|NCT03636906|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5057889|NCT03636906|Vaccine|vaccine
5057890|NCT03636906|Reactogenicity|reactogenicity
5057891|NCT03636906|Immunogenicity|immunogenicity
5057892|NCT03636906|Infants|infants
5057893|NCT03636893|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5057894|NCT03636893|perioperative chemotherapy|perioperative chemotherapy
5057895|NCT03636893|Systemic chemotherapy|systemic chemotherapy
5057896|NCT03636893|FLOT|flot
5057898|NCT03636893|Gastric cancer|gastric cancer
5057899|NCT03636880|heart failure|heart failure
5057900|NCT03636880|insomnia|insomnia
5057901|NCT03636880|anxiety|anxiety
5057902|NCT03636880|depression|depression
5057903|NCT03636880|memory|memory
5057904|NCT03636880|attention|attention
5057905|NCT03636880|executive functioning|executive functioning
5057906|NCT03636880|decision making|decision making
5057907|NCT03636880|self-care|self-care
5057908|NCT03636880|quality of life|quality of life
5057909|NCT03636880|functional status|functional status
5057910|NCT03636880|walk test|walk test
5057911|NCT03636880|sleep monitoring|sleep monitoring
5057912|NCT03636854|Eccentric|eccentric
5057913|NCT03636854|Concentric|concentric
5057914|NCT03636854|Strength|strength
5960975|NCT04289961|EUS-FNA|eus-fna
5057915|NCT03636854|Balance|balance
5057916|NCT03636854|Thickness|thickness
5057917|NCT03636815|Left ventricular assist device|left ventricular assist device
5057918|NCT03636815|Physical therapy|physical therapy
5057919|NCT03636776|Quality of Life|quality of life
5057920|NCT03636776|Psychological vulnerability|psychological vulnerability
5057921|NCT03636724|E-health intervention|e-health intervention
5057922|NCT03636724|multiple health behavior change|multiple health behavior change
5057923|NCT03636724|Health Action Process Approach Model|health action process approach model
5057924|NCT03636724|Cardiac patients|cardiac patients
5057925|NCT03636685|Anlotinib|anlotinib
5057926|NCT03636685|NSCLC|nsclc
5057927|NCT03636685|platinum-based chemotherapy|platinum-based chemotherapy
5057928|NCT03636672|falls|falls
5057929|NCT03636672|Balance control|balance control
5057930|NCT03636672|Aging|aging
5057931|NCT03636672|Balance reactions|balance reactions
5057932|NCT03636672|Perturbation|perturbation
5057947|NCT03636568|pituitary surgery|pituitary surgery
5057948|NCT03636568|pituitary|pituitary
5057949|NCT03636555|Oxytocin|oxytocin
5057950|NCT03636555|Heavy drinking|heavy drinking
5057951|NCT03636555|Moderate drinking|moderate drinking
5057953|NCT03636529|overweight|overweight
5057954|NCT03636529|tart cherry juice|tart cherry juice
5057955|NCT03636503|Lymphoma|lymphoma
5057956|NCT03636490|Non-Dipping Blood Pressure|non-dipping blood pressure
5057957|NCT03636464|Pharmacokinetics|pharmacokinetics
5057958|NCT03636464|antibiotics|antibiotics
5057959|NCT03636464|RRT|rrt
5057960|NCT03636451|Dilation & curettage|dilation & curettage
5057961|NCT03636451|Paracervical block|paracervical block
5057962|NCT03636438|gene therapy|gene therapy
5057963|NCT03636438|OTC Deficiency|otc deficiency
5057964|NCT03636438|Urea Cycle Disorder|urea cycle disorder
5057965|NCT03636425|Running|running
5057966|NCT03636425|Resistance Training|resistance training
5057967|NCT03636425|Mountain|mountain
5057968|NCT03636425|Physiotherapy|physiotherapy
5057969|NCT03636412|lung transplant|lung transplant
5057970|NCT03636412|frailty|frailty
5057971|NCT03636399|adults|adults
5057972|NCT03636399|rehabilitation|rehabilitation
5057973|NCT03636399|social communication disorder|social communication disorder
5057974|NCT03636399|cognitive communication disorder|cognitive communication disorder
5057975|NCT03636399|groups|groups
5057976|NCT03636399|evidence-based|evidence-based
5057977|NCT03636386|Electrotherapy|electrotherapy
5057978|NCT03636386|Electrolysis|electrolysis
5057979|NCT03636386|Myofascial Pain Syndromes|myofascial pain syndromes
5057980|NCT03636386|Pain Threshold|pain threshold
5057981|NCT03636386|Visual Analog Pain Scale|visual analog pain scale
5057982|NCT03636347|PiZZ or Null genotype|pizz or null genotype
5057983|NCT03636347|Neutrophil elastase inhibitor|neutrophil elastase inhibitor
5057984|NCT03636347|Alpha-1|alpha-1
5057985|NCT03636347|Alvelestat|alvelestat
5057986|NCT03636347|AZD9668|azd9668
5057987|NCT03636347|MPH966|mph966
5070636|NCT03557710|eating|eating
5057988|NCT03636334|Hypertension|hypertension
5057989|NCT03636334|Decision support system|decision support system
5058224|NCT03635021|FOLFIRI|folfiri
5057997|NCT03636308|gemcitabine|gemcitabine
5057998|NCT03636295|Mechanical valve replacement|mechanical valve replacement
5057999|NCT03636295|Vitamin K antagonist|vitamin k antagonist
5058000|NCT03636295|INR targets|inr targets
5058001|NCT03636295|Bleeding|bleeding
5058002|NCT03636295|Thromboembolism|thromboembolism
5058003|NCT03636282|Chronic disease|chronic disease
5058004|NCT03636282|Men's health|men's health
5058005|NCT03636282|Health promotion|health promotion
5058006|NCT03636282|Exercise|exercise
5058007|NCT03636282|Healthy diet|healthy diet
5058008|NCT03636282|Health Technology|health technology
5058009|NCT03636282|Weight loss|weight loss
5058029|NCT03636256|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5058030|NCT03636256|muscle invasive bladder cancer|muscle invasive bladder cancer
5058031|NCT03636256|high-risk bladder cancer|high-risk bladder cancer
5058032|NCT03636256|BCG-unresponsive bladder cancer|bcg-unresponsive bladder cancer
5058033|NCT03636256|BCG failure|bcg failure
5058046|NCT03636165|Ropivacaine|ropivacaine
5058047|NCT03636165|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
5058048|NCT03636165|Child|child
5058049|NCT03636152|chronic kidney disease|chronic kidney disease
5058050|NCT03636152|cardiovascular disease|cardiovascular disease
5058051|NCT03636152|Inflammation|inflammation
5058052|NCT03636152|Atherosclerosis|atherosclerosis
5058053|NCT03636152|Vascular stiffness|vascular stiffness
5058054|NCT03636100|Atrial fibrillation|atrial fibrillation
5058055|NCT03636100|Catheter ablation|catheter ablation
5058056|NCT03636100|Cryoballon ablation|cryoballon ablation
5058057|NCT03636100|Acetylcholine|acetylcholine
5058058|NCT03636100|Ganglionated plexus|ganglionated plexus
5058059|NCT03636100|Pulmonary veins|pulmonary veins
5058060|NCT03636100|Pulmonary vein isolation|pulmonary vein isolation
5058065|NCT03636009|cervical radiculopathy|cervical radiculopathy
5058066|NCT03636009|neck pain|neck pain
5058067|NCT03636009|neuromobilizations|neuromobilizations
5356794|NCT01917981|Implantable device|implantable device
5960976|NCT04289961|Portal Vein|portal vein
5058068|NCT03635996|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5058069|NCT03635996|cardiac monitoring|cardiac monitoring
5058070|NCT03635996|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
5058071|NCT03635996|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
5058072|NCT03635996|calcium channel blocker|calcium channel blocker
5058073|NCT03635996|conversion rate|conversion rate
5058077|NCT03635957|gout|gout
5058078|NCT03635957|uncontrolled gout|uncontrolled gout
5058079|NCT03635944|growth|growth
5058080|NCT03635944|small for gestational age|small for gestational age
5058081|NCT03635944|prematurity|prematurity
5058082|NCT03635944|breastfeeding|breastfeeding
5058083|NCT03635944|fortification|fortification
5058084|NCT03635944|parenteral nutrition|parenteral nutrition
5058085|NCT03635944|nutrition|nutrition
5058086|NCT03635931|CGF|cgf
5058087|NCT03635931|lost interdental papilla|lost interdental papilla
5058088|NCT03635905|abortion|abortion
5058089|NCT03635905|gabapentin|gabapentin
5058090|NCT03635905|Neurontin|neurontin
5058091|NCT03635905|Dilation and evacuation|dilation and evacuation
5058092|NCT03635892|Nivolumab|nivolumab
5058093|NCT03635892|Cabozantinib|cabozantinib
5058094|NCT03635892|18-254|18-254
5058095|NCT03635840|IABP|iabp
5058096|NCT03635840|Cardiogenic Shock|cardiogenic shock
5058097|NCT03635840|Myocardial Infarction|myocardial infarction
5058098|NCT03635814|Clinicaltrial, DME, DR, AMD, imatinib mesylate|clinicaltrial, dme, dr, amd, imatinib mesylate
5058099|NCT03635775|non-invasive brain stimulation|non-invasive brain stimulation
5058100|NCT03635775|rehabilitation|rehabilitation
5058101|NCT03635775|pediatrics|pediatrics
5058102|NCT03635762|Nutrition|nutrition
5058103|NCT03635762|Behavioral Intervention|behavioral intervention
5058104|NCT03635749|Acute Stroke|acute stroke
5058105|NCT03635749|Transient Ischemic Attack|transient ischemic attack
5058106|NCT03635749|Antiplatelet Therapy|antiplatelet therapy
5058107|NCT03635749|Randomized Controlled Trial|randomized controlled trial
5058108|NCT03635749|Double Blind Study|double blind study
5058109|NCT03635749|Multicenter Study|multicenter study
5428256|NCT01595451|Back Pain|back pain
5058122|NCT03635697|Mindfulness|mindfulness
5058123|NCT03635697|Anxiety|anxiety
5058124|NCT03635697|Depression|depression
5058125|NCT03635697|NST|nst
5058126|NCT03635697|Non-stress test|non-stress test
5058130|NCT03635684|Treatment Outcome|treatment outcome
5058131|NCT03635684|Geriatrics|geriatrics
5058132|NCT03635684|Gerontology|gerontology
5058133|NCT03635671|Imaging|imaging
5058134|NCT03635671|Diabetes|diabetes
5058135|NCT03635671|OCTA|octa
5058136|NCT03635632|Gene Therapy|gene therapy
5058137|NCT03635632|CAR T-cells|car t-cells
5058138|NCT03635632|Neuroblastoma|neuroblastoma
5058139|NCT03635632|chimeric antigen receptor|chimeric antigen receptor
5058140|NCT03635632|Immunotherapy|immunotherapy
5058141|NCT03635632|Sarcoma|sarcoma
5058142|NCT03635632|Uveal Melanoma|uveal melanoma
5924385|NCT04272112|all ceramic|all ceramic
5058143|NCT03635632|Breast cancer|breast cancer
5058144|NCT03635632|GD2 positive cancer|gd2 positive cancer
5058145|NCT03635619|Esophageal Cancer|esophageal cancer
5058146|NCT03635619|Magnetic Resonance Imaging|magnetic resonance imaging
5058147|NCT03635619|Prognosis|prognosis
5058148|NCT03635619|neoplasm staging|neoplasm staging
5058149|NCT03635567|Programmed Cell Death 1|programmed cell death 1
5058150|NCT03635567|PD1|pd1
5058151|NCT03635567|PD-1|pd-1
5058152|NCT03635567|Programmed Cell Death Ligand 1|programmed cell death ligand 1
5058153|NCT03635567|PDL1|pdl1
5058154|NCT03635567|PD-L1|pd-l1
5058155|NCT03635554|Aphasia|aphasia
5058156|NCT03635541|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5058157|NCT03635541|non alcoholic steatohepatitis|non alcoholic steatohepatitis
5058158|NCT03635541|steatosis|steatosis
5058159|NCT03635541|fibrosis|fibrosis
5058160|NCT03635541|progression|progression
5058161|NCT03635541|risk factors|risk factors
5058162|NCT03635476|Stroke Rehabilitation|stroke rehabilitation
5058163|NCT03635476|Personalized Nutrition|personalized nutrition
5058164|NCT03635476|Mobile-Health|mobile-health
5058165|NCT03635476|Stroke|stroke
5058166|NCT03635450|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5058167|NCT03635450|newborn infants|newborn infants
5058168|NCT03635450|therapeutic hypothermia|therapeutic hypothermia
5058169|NCT03635450|hCT-MSC, an Umbilical Cord Tissue-Derived Mesenchymal Stromal Cell Product|hct-msc, an umbilical cord tissue-derived mesenchymal stromal cell product
5058170|NCT03635437|Remygen|remygen
5058171|NCT03635437|GABA|gaba
5058172|NCT03635372|Dyspepsia|dyspepsia
5058173|NCT03635372|Emergency Department|emergency department
5058174|NCT03635372|Antacid|antacid
5058175|NCT03635372|Viscous Lidocaine|viscous lidocaine
5058176|NCT03635359|fetal|fetal
5058177|NCT03635359|screening test|screening test
5058178|NCT03635359|trisomy|trisomy
5058179|NCT03635359|aneuploidy|aneuploidy
5058180|NCT03635359|copy number variant|copy number variant
5058181|NCT03635307|Blood Volume expansion|blood volume expansion
5058182|NCT03635307|Fluid responsiveness|fluid responsiveness
5058183|NCT03635307|Stroke volume|stroke volume
5960977|NCT04289961|Biomarkers|biomarkers
5935553|NCT02628067|SCLC|sclc
5058184|NCT03635307|Perioperative optimization|perioperative optimization
5058186|NCT03635255|miRNA|mirna
5058187|NCT03635242|postural control|postural control
5058188|NCT03635242|Chronic Low Back Pain|chronic low back pain
5058189|NCT03635242|therapeutic excercise|therapeutic excercise
5112601|NCT03293368|PRP|prp
5058190|NCT03635242|healed patients|healed patients
5058191|NCT03635229|cardiac surgery|cardiac surgery
5058192|NCT03635229|perioperative care|perioperative care
5058193|NCT03635229|postoperative delirium|postoperative delirium
5058194|NCT03635229|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5058195|NCT03635216|Cervical cancer|cervical cancer
5058196|NCT03635216|Biomarker|biomarker
5058197|NCT03635216|Recurrence|recurrence
5058198|NCT03635203|C-shaped root canal / C-shaped canals|c-shaped root canal / c-shaped canals
5058199|NCT03635190|Peripheral Arterial Diseases|peripheral arterial diseases
5058200|NCT03635190|Peripheral Artery Diseases|peripheral artery diseases
5058201|NCT03635190|Arterial Occlusive Diseases|arterial occlusive diseases
5058202|NCT03635190|Peripheral Vascular Diseases|peripheral vascular diseases
5058203|NCT03635164|HPV Negative|hpv negative
5058204|NCT03635164|Durvalumab|durvalumab
5058205|NCT03635164|Surgical Resection|surgical resection
5058206|NCT03635164|Neoadjuvant|neoadjuvant
5058207|NCT03635164|Radiation|radiation
5058208|NCT03635151|Clinical trial|clinical trial
5058209|NCT03635112|TD-1473|td-1473
5058210|NCT03635112|Janus kinase inhibitor|janus kinase inhibitor
5058211|NCT03635112|JAK inhibitor|jak inhibitor
5058212|NCT03635112|Inflammatory Bowel Disease|inflammatory bowel disease
5058222|NCT03635021|colorectal cancer|colorectal cancer
5058223|NCT03635021|FOLFOX|folfox
5058225|NCT03635021|panitumumab|panitumumab
5058226|NCT03635021|bevacizumab|bevacizumab
5058227|NCT03635021|wild-type RAS|wild-type ras
5058228|NCT03635021|primary left-sided|primary left-sided
5058229|NCT03634982|SHP2|shp2
5058230|NCT03634982|PTPN11|ptpn11
5058231|NCT03634982|NSCLC|nsclc
5058232|NCT03634982|EGFR|egfr
5058233|NCT03634982|RTK|rtk
5058234|NCT03634982|KRAS G12|kras g12
5058235|NCT03634982|BRAF Class 3|braf class 3
5058236|NCT03634982|NF1 LOF|nf1 lof
5058237|NCT03634982|advanced solid tumor|advanced solid tumor
5058238|NCT03634982|advanced solid malignancies|advanced solid malignancies
5058239|NCT03634982|melanoma|melanoma
5058240|NCT03634982|skin cancer|skin cancer
5058241|NCT03634982|ovarian cancer|ovarian cancer
5058242|NCT03634982|pancreatic cancer|pancreatic cancer
5058243|NCT03634982|endometrium/uterus cancer|endometrium/uterus cancer
5058244|NCT03634982|bladder cancer|bladder cancer
5058245|NCT03634982|cervical cancer|cervical cancer
5058246|NCT03634982|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5058247|NCT03634982|Neoplasms, Squamous Cell|neoplasms, squamous cell
5058248|NCT03634982|Carcinoma, Squamous Cell|carcinoma, squamous cell
5058249|NCT03634982|Esophageal Neoplasms|esophageal neoplasms
5058250|NCT03634982|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5058251|NCT03634982|Bronchial Neoplasms|bronchial neoplasms
5058252|NCT03634982|Lung Neoplasms|lung neoplasms
5058253|NCT03634982|Respiratory Tract Neoplasms|respiratory tract neoplasms
5058254|NCT03634982|Thoracic Neoplasms|thoracic neoplasms
5058255|NCT03634982|Neoplasms by Site|neoplasms by site
5058256|NCT03634982|Neoplasms|neoplasms
5058257|NCT03634982|Lung Diseases|lung diseases
5058258|NCT03634982|Respiratory Tract Diseases|respiratory tract diseases
5058259|NCT03634982|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5058260|NCT03634982|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5058261|NCT03634982|Digestive System Neoplasms|digestive system neoplasms
5058262|NCT03634982|Head and Neck Neoplasms|head and neck neoplasms
5058263|NCT03634982|Digestive System Diseases|digestive system diseases
5058264|NCT03634982|Esophageal Diseases|esophageal diseases
5058265|NCT03634982|Gastrointestinal Diseases|gastrointestinal diseases
5058266|NCT03634956|multinoduler goitre|multinoduler goitre
5058267|NCT03634956|thyroid cancer|thyroid cancer
5058268|NCT03634956|sugammadex sodium|sugammadex sodium
5058269|NCT03634956|intraoperative nerve monitorization|intraoperative nerve monitorization
5058270|NCT03634943|Clinical Practice Guidelines|clinical practice guidelines
5058271|NCT03634930|Breast Feeding, Exclusive versus Formula Feeding, Exclusive|breast feeding, exclusive versus formula feeding, exclusive
5058272|NCT03634930|satiety cues|satiety cues
5058273|NCT03634930|childhood obesity|childhood obesity
5058274|NCT03634930|biomarker|biomarker
5356795|NCT01917968|POP|pop
5058275|NCT03634930|nutritional status|nutritional status
5058276|NCT03634930|infant body composition|infant body composition
5058277|NCT03634930|infant weight gain velocity|infant weight gain velocity
5058278|NCT03634930|metabolic programming|metabolic programming
5058279|NCT03634930|inflammation|inflammation
5058280|NCT03634917|Acamprosate|acamprosate
5058281|NCT03634917|Calcium|calcium
5058282|NCT03634917|alcohol self-administration|alcohol self-administration
5058283|NCT03634904|antibiotic dosing|antibiotic dosing
5903509|NCT00357214|calcium excretion|calcium excretion
5058284|NCT03634904|pharmacokinetics|pharmacokinetics
5960978|NCT04289948|Diabetes|diabetes
5058285|NCT03634904|pharmacodynamics|pharmacodynamics
5058286|NCT03634904|hemodialysis|hemodialysis
5058287|NCT03634865|Bone trauma-fracture|bone trauma-fracture
5058288|NCT03634865|Radius|radius
5058289|NCT03634865|CT-scan|ct-scan
5058290|NCT03634865|Internal fixation|internal fixation
5058291|NCT03634852|IC Moxifloxacin hydrochloride|ic moxifloxacin hydrochloride
5058292|NCT03634852|SC triamcinolone acetonide|sc triamcinolone acetonide
5058293|NCT03634826|circulating tumor DNA|circulating tumor dna
5058294|NCT03634826|ctDNA methylation|ctdna methylation
5058295|NCT03634826|lung cancer|lung cancer
5058296|NCT03634826|surveillance|surveillance
5058297|NCT03634787|Heat Shock Proteins, early diagnosis|heat shock proteins, early diagnosis
5058298|NCT03634774|meals|meals
5058299|NCT03634774|staff training|staff training
5058305|NCT03634735|Thiamine|thiamine
5058306|NCT03634735|Vitamin B1|vitamin b1
5058307|NCT03634722|transcutaneous electrical nerve stimulation;|transcutaneous electrical nerve stimulation;
5058308|NCT03634696|Late-stage|late-stage
5058309|NCT03634696|Palliative care|palliative care
5058310|NCT03634696|Novel technology|novel technology
5058311|NCT03634696|Communication|communication
5058312|NCT03634683|recurrent hepatocellular carcinoma|recurrent hepatocellular carcinoma
5058313|NCT03634683|hepatitis B virus-related|hepatitis b virus-related
5058314|NCT03634683|post liver transplantation|post liver transplantation
5058316|NCT03634657|Scattered radiation|scattered radiation
5058317|NCT03634657|X-ray protection|x-ray protection
5058318|NCT03634657|Radiation in cath lab|radiation in cath lab
5058327|NCT03634605|Pleurodesis|pleurodesis
5058328|NCT03634579|Cancer/Carcinogenesis|cancer/carcinogenesis
5058329|NCT03634579|Laser Treatment|laser treatment
5058430|NCT03633721|cognition|cognition
5058330|NCT03634579|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5058331|NCT03634579|Radiology|radiology
5058332|NCT03634488|sickle cell disease|sickle cell disease
5058333|NCT03634488|sub-Saharan Africa|sub-saharan africa
5058334|NCT03634488|malnutrition|malnutrition
5058335|NCT03634488|low-income settings|low-income settings
5058336|NCT03634488|severe acute malnutrition|severe acute malnutrition
5058337|NCT03634488|sickle cell anemia|sickle cell anemia
5058339|NCT03634462|lipedema|lipedema
5058340|NCT03634462|lymphedema|lymphedema
5058341|NCT03634462|therapy|therapy
5058342|NCT03634462|sodium|sodium
5058343|NCT03634462|swelling|swelling
5058344|NCT03634436|SHR-1209 Phase 1|shr-1209 phase 1
5058345|NCT03634423|Interest in exercising more|interest in exercising more
5058346|NCT03634384|Myocardial Infarction|myocardial infarction
5058347|NCT03634384|Chest Pain|chest pain
5058348|NCT03634358|bipolar|bipolar
5058349|NCT03634358|scalpel|scalpel
5058350|NCT03634358|foreskin|foreskin
5058351|NCT03634358|prepuce|prepuce
5058352|NCT03634345|Atopic dermatitis|atopic dermatitis
5058353|NCT03634332|pancreatic|pancreatic
5058354|NCT03634332|pancreas|pancreas
5058355|NCT03634332|cancer|cancer
5058356|NCT03634332|adenocarcinoma|adenocarcinoma
5058357|NCT03634306|Visual clearing System Laparoscopic Hysterectomy Myomectomy|visual clearing system laparoscopic hysterectomy myomectomy
5058358|NCT03634293|sepsis|sepsis
5058359|NCT03634293|septic shock|septic shock
5058360|NCT03634293|PCSK9 INHIBITOR|pcsk9 inhibitor
5058361|NCT03634280|Ankle Sprains|ankle sprains
5058362|NCT03634280|Kinesio Tape|kinesio tape
5058363|NCT03634280|Splint|splint
5058365|NCT03634254|Satisfaction level of communication quality|satisfaction level of communication quality
5058366|NCT03634202|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5058367|NCT03634202|Simultaneous Integrated Boost|simultaneous integrated boost
5058368|NCT03634202|Low and middle Rectal carcinoma|low and middle rectal carcinoma
5058369|NCT03634189|Cannabidiol|cannabidiol
5058370|NCT03634189|Heart Failure|heart failure
5058371|NCT03634189|AHA/ACC stage A-C|aha/acc stage a-c
5058372|NCT03634163|disability|disability
5058373|NCT03634137|Afamelanotide|afamelanotide
5058374|NCT03634137|Nontherapeutic Human Experimentation in healthy volunteers|nontherapeutic human experimentation in healthy volunteers
5058375|NCT03634111|transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
5058376|NCT03634111|postoperative analgesia|postoperative analgesia
5058377|NCT03634111|cesarean section|cesarean section
5058378|NCT03634098|Patients|patients
5058379|NCT03634085|safety|safety
5058380|NCT03634085|tolerability|tolerability
5058381|NCT03634085|pharmacokinetics|pharmacokinetics
5058382|NCT03634046|Lumbar Disc Herniation|lumbar disc herniation
5058383|NCT03634046|Low Back Pain|low back pain
5058384|NCT03634046|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
5058385|NCT03634046|Radiofrequency Ablation|radiofrequency ablation
5058386|NCT03634033|Implementation Science|implementation science
5058387|NCT03634033|Adoption|adoption
5058388|NCT03634033|Sustainability|sustainability
5058389|NCT03633994|Randomized controlled trial|randomized controlled trial
5058390|NCT03633994|Heparin instillation|heparin instillation
5058391|NCT03633968|sinus augmentation,lifting|sinus augmentation,lifting
5058392|NCT03633955|FLT|flt
5058393|NCT03633916|adolescents|adolescents
5058394|NCT03633916|urban|urban
5058395|NCT03633916|school|school
5058396|NCT03633916|demand for mental health care|demand for mental health care
5058397|NCT03633903|Early life stress|early life stress
5058398|NCT03633903|Adolescent|adolescent
5058399|NCT03633903|Mindfulness|mindfulness
5058400|NCT03633903|Neurobiological|neurobiological
5058401|NCT03633903|Stress|stress
5058419|NCT03633773|CAR-T|car-t
5058420|NCT03633773|Immunotherapy|immunotherapy
5058421|NCT03633747|hepatic hemangioma|hepatic hemangioma
5058422|NCT03633747|propranolol|propranolol
5058423|NCT03633734|Pancreatic cancer|pancreatic cancer
5058424|NCT03633734|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5058425|NCT03633734|Gemcitabine|gemcitabine
5058426|NCT03633734|Nab-paclitaxel|nab-paclitaxel
5058427|NCT03633734|Modified Folfirinox|modified folfirinox
5058428|NCT03633734|Sequential treatment|sequential treatment
5058429|NCT03633721|mobility|mobility
5058441|NCT03633630|Emblica officinalis|emblica officinalis
5058442|NCT03633630|Metabolic Syndrome|metabolic syndrome
5058443|NCT03633630|Insulin Secretion|insulin secretion
5058444|NCT03633630|Insulin Sensitivity|insulin sensitivity
5058445|NCT03633604|Hematologic Diseases|hematologic diseases
5058446|NCT03633604|Blood Substitutes|blood substitutes
5058447|NCT03633552|Glioblastoma Multiforme|glioblastoma multiforme
5058448|NCT03633552|Anaplastic Astrocytoma|anaplastic astrocytoma
5058449|NCT03633552|Adjuvant treatment|adjuvant treatment
5058450|NCT03633552|Extended chemotherapy|extended chemotherapy
5058451|NCT03633539|SILS|sils
5058452|NCT03633539|colorectal cancer|colorectal cancer
5058453|NCT03633513|Immune System|immune system
5058454|NCT03633513|Immunology|immunology
5058455|NCT03633513|Neuroinflammation|neuroinflammation
5058456|NCT03633513|Inflammation|inflammation
5058457|NCT03633513|Neuroprotection|neuroprotection
5058458|NCT03633500|Colostrum|colostrum
5058459|NCT03633500|Oral immune therapy|oral immune therapy
5058460|NCT03633500|Preterm|preterm
5058461|NCT03633500|Oral feeding|oral feeding
5058462|NCT03633500|Sepsis|sepsis
5058463|NCT03633474|Healthy volunteer|healthy volunteer
5058464|NCT03633474|Human Challenge study|human challenge study
5058465|NCT03633422|Rehabilitation|rehabilitation
5058466|NCT03633422|Screening|screening
5058467|NCT03633422|Enrollment|enrollment
5058468|NCT03633409|IBD|ibd
5058469|NCT03633409|EBI2|ebi2
5058470|NCT03633409|G protein coupled receptor|g protein coupled receptor
5058471|NCT03633409|FACS|facs
5058472|NCT03633409|UBAC2|ubac2
5058473|NCT03633409|lymphocyte migration|lymphocyte migration
5058474|NCT03633409|single nucleotide polymorphism|single nucleotide polymorphism
5058475|NCT03633396|PPP|ppp
5058476|NCT03633370|Cardiac Arrest|cardiac arrest
5058477|NCT03633370|Dispatcher|dispatcher
5058478|NCT03633370|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5058479|NCT03633357|Bipolar Disorder|bipolar disorder
5058480|NCT03633357|Cognitive Impairment|cognitive impairment
5058481|NCT03633344|Diarrhoea|diarrhoea
5058482|NCT03633344|Carbowhite|carbowhite
5058483|NCT03633344|Colloidal silicon dioxide|colloidal silicon dioxide
5058484|NCT03633318|electrical impedance myography|electrical impedance myography
5058485|NCT03633318|EIM|eim
5058486|NCT03633305|Insomnia|insomnia
5058487|NCT03633305|Pragmatic Clinical Trial|pragmatic clinical trial
5058488|NCT03633305|Drug Therapy|drug therapy
5058489|NCT03633305|Cognitive Behavior Therapy|cognitive behavior therapy
5058490|NCT03633305|Primary Care|primary care
5733868|NCT00379353|Anorexia|anorexia
5058497|NCT03633214|Prostatic neoplasms|prostatic neoplasms
5058498|NCT03633214|Mass screening|mass screening
5058499|NCT03633214|General practitioners|general practitioners
5058500|NCT03633214|Primary health care|primary health care
5104478|NCT03344341|T2DM|t2dm
5058501|NCT03633214|Clinical trial|clinical trial
5058502|NCT03633188|Bone and Joint Infections (BJI)|bone and joint infections (bji)
5058503|NCT03633188|gut dysbiosis|gut dysbiosis
5058504|NCT03633188|antimicrobial resistance|antimicrobial resistance
5058505|NCT03633188|antibiotic resistance gene|antibiotic resistance gene
5058506|NCT03633188|mobile genetic elements|mobile genetic elements
5058507|NCT03633162|Maternal Grandmother|maternal grandmother
5058508|NCT03633162|Genes|genes
5058509|NCT03633162|Immune|immune
5058510|NCT03633162|Cohort|cohort
5058511|NCT03633162|Child development|child development
5058512|NCT03633149|prenatal alcohol exposure|prenatal alcohol exposure
5058513|NCT03633149|marijuana|marijuana
5058526|NCT03633110|Immunotherapy|immunotherapy
5058527|NCT03633110|Solid Tumor|solid tumor
5058528|NCT03633110|Personal|personal
5058530|NCT03633110|Lung|lung
5058531|NCT03633110|Cancer|cancer
5058532|NCT03633110|Bladder|bladder
5058533|NCT03633110|Kidney|kidney
5058534|NCT03633110|Melanoma|melanoma
5058535|NCT03633110|Carcinoma|carcinoma
5058536|NCT03633058|MECP2|mecp2
5058537|NCT03633058|RTT|rtt
5058538|NCT03633058|Retts|retts
5058539|NCT03633058|ketamine|ketamine
5058540|NCT03633045|CLL, chronic lymphocytic leukemia, ibrutinib|cll, chronic lymphocytic leukemia, ibrutinib
5960979|NCT04289948|Diabetic Foot Disease|diabetic foot disease
5960980|NCT04289948|Diabetic Foot Ulcer|diabetic foot ulcer
5058541|NCT03633032|bone imaging; MRI; UTE; radiation-free; ultrashort echo time ; anatomy|bone imaging; mri; ute; radiation-free; ultrashort echo time ; anatomy
5058542|NCT03633019|thrombocytopenia|thrombocytopenia
5058543|NCT03633019|rhTPO|rhtpo
5058544|NCT03633019|real-world study|real-world study
5058545|NCT03633019|safety|safety
5058546|NCT03633019|efficacy|efficacy
5058547|NCT03632993|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
5058548|NCT03632993|Cellulite|cellulite
5058549|NCT03632993|Collagenase Clostridium Histolyticum|collagenase clostridium histolyticum
5058550|NCT03632980|HIFU|hifu
5058551|NCT03632980|Localized Prostate cancer|localized prostate cancer
5058552|NCT03632980|MRI|mri
5058553|NCT03632980|PSA nadir|psa nadir
5058554|NCT03632980|Biopsy|biopsy
5924758|NCT04249765|Hand function|hand function
5058555|NCT03632980|High Intensity Focused Ultrasound|high intensity focused ultrasound
5058556|NCT03632980|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5058557|NCT03632954|Wounds|wounds
5058558|NCT03632954|ACell|acell
5058559|NCT03632954|ACell MicroMatrix®|acell micromatrix®
5058560|NCT03632954|ACell Cytal® Wound Matrix|acell cytal® wound matrix
5058561|NCT03632954|Extracellular Matrix|extracellular matrix
5058562|NCT03632954|Urinary Bladder Matrix|urinary bladder matrix
5058563|NCT03632941|Cancer|cancer
5058564|NCT03632941|Immunotherapy|immunotherapy
5058565|NCT03632941|PD-1 Antibody|pd-1 antibody
5058566|NCT03632941|HER2|her2
5058567|NCT03632941|T cell|t cell
5058568|NCT03632928|Ultrasound elastography|ultrasound elastography
5058569|NCT03632928|Pressure pain threshold|pressure pain threshold
5058570|NCT03632928|variation|variation
5058571|NCT03632915|Antiepileptics|antiepileptics
5058572|NCT03632915|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5058573|NCT03632902|supraglottic devices|supraglottic devices
5058574|NCT03632876|Retinol|retinol
5058575|NCT03632876|Stable isotope dilution|stable isotope dilution
5058576|NCT03632876|DXA|dxa
5058577|NCT03632876|retinyl palmitate|retinyl palmitate
5058578|NCT03632863|Pregnancy|pregnancy
5058579|NCT03632863|Depression|depression
5058580|NCT03632863|Antidepressant Use|antidepressant use
5058581|NCT03632863|Decision Aid|decision aid
5058582|NCT03632850|pancreatic cancer|pancreatic cancer
5058583|NCT03632850|shared decision-making|shared decision-making
5058584|NCT03632850|decision aids|decision aids
5058585|NCT03632850|web-based decision tool|web-based decision tool
5058586|NCT03632850|mixed methods|mixed methods
5058587|NCT03632837|extracorporal circulation|extracorporal circulation
5058588|NCT03632837|hemoadsorption|hemoadsorption
5058589|NCT03632837|post resuscitation syndrome|post resuscitation syndrome
5058590|NCT03632824|Antepartum bleeding|antepartum bleeding
5058591|NCT03632824|Perinatal morbidity|perinatal morbidity
5058592|NCT03632824|Perinatal mortality|perinatal mortality
5058593|NCT03632824|Preterm labor|preterm labor
5058594|NCT03632811|cutaneous mastocytosis|cutaneous mastocytosis
5113107|NCT03289832|Skin|skin
5058595|NCT03632811|indolent systemic mastocytosis|indolent systemic mastocytosis
5058596|NCT03632811|quality of life questionnaire in mastocytosis patient|quality of life questionnaire in mastocytosis patient
5058597|NCT03632798|ChemoID|chemoid
5058598|NCT03632798|cancer stem cells|cancer stem cells
5058599|NCT03632798|drug response assay|drug response assay
5058600|NCT03632798|ovarian cancer|ovarian cancer
5058601|NCT03632785|Platelet|platelet
5058602|NCT03632785|Coronary stenosis|coronary stenosis
5058603|NCT03632785|Coronary angiography|coronary angiography
5058604|NCT03632772|Overactive bladder|overactive bladder
5058605|NCT03632772|Transurethral Resection of the Prostate|transurethral resection of the prostate
5058606|NCT03632772|Pharmacotherapy|pharmacotherapy
5058607|NCT03632772|Mirabegron|mirabegron
5058613|NCT03632694|mHealth|mhealth
5058614|NCT03632694|Jawbone|jawbone
5058615|NCT03632681|Cognitive processes|cognitive processes
5058616|NCT03632681|Reward processes|reward processes
5058617|NCT03632681|fMRI|fmri
5058618|NCT03632681|Insulin|insulin
5058619|NCT03632629|cognitive training|cognitive training
5058620|NCT03632629|developmental delay|developmental delay
5058621|NCT03632629|children|children
5058622|NCT03632629|therapeutic effect|therapeutic effect
5058634|NCT03632551|Cochlear implant|cochlear implant
5058635|NCT03632551|Asymmetrical hearing loss|asymmetrical hearing loss
5058636|NCT03632551|Spatial hearing|spatial hearing
5058637|NCT03632551|Binaural hearing|binaural hearing
5058638|NCT03632551|Localization|localization
5058639|NCT03632538|Acute Kidney Injury|acute kidney injury
5058640|NCT03632538|Cardiac Surgery|cardiac surgery
5058641|NCT03632512|Hericium erinaceus|hericium erinaceus
5058642|NCT03632512|Hearing|hearing
5058643|NCT03632486|Ultrasound|ultrasound
5058644|NCT03632486|Dengue|dengue
5058645|NCT03632473|Multimodal Evoked potentials|multimodal evoked potentials
5058646|NCT03632473|Visual evoked potentials|visual evoked potentials
5058647|NCT03632473|Somato-sensory evoked potentials|somato-sensory evoked potentials
5058648|NCT03632473|Motor evoked potentials|motor evoked potentials
5058649|NCT03632473|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
5960981|NCT04289935|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5960982|NCT04289935|VISION I|vision i
5960983|NCT04289935|breast cancer|breast cancer
5058650|NCT03632447|Digital Health|digital health
5058651|NCT03632447|Female|female
5058652|NCT03632395|gastric cancer|gastric cancer
5058653|NCT03632395|postoperative complication|postoperative complication
5058654|NCT03632395|anastomotic leak|anastomotic leak
5058655|NCT03632395|oral contrast agent|oral contrast agent
5058656|NCT03632395|computed tomography|computed tomography
5058657|NCT03632382|Sleep apnea diagnosis|sleep apnea diagnosis
5058658|NCT03632382|3D acquisition|3d acquisition
5058659|NCT03632369|MRI|mri
5058660|NCT03632369|Hyperpolarized|hyperpolarized
5058661|NCT03632369|xenon-129|xenon-129
5058662|NCT03632343|self-management|self-management
5058663|NCT03632343|pain|pain
5058664|NCT03632343|adolescents|adolescents
5058665|NCT03632343|mHealth|mhealth
5058666|NCT03632317|H3.1K27M|h3.1k27m
5058667|NCT03632317|H3.3K27M|h3.3k27m
5058668|NCT03632317|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5058669|NCT03632317|DIPG|dipg
5058670|NCT03632317|high-grade glioma|high-grade glioma
5058671|NCT03632317|pediatric glioma|pediatric glioma
5058672|NCT03632317|H3K27M|h3k27m
5058673|NCT03632317|panobinostat|panobinostat
5058674|NCT03632304|hand surgery|hand surgery
5058675|NCT03632304|quality of recovery|quality of recovery
5058676|NCT03632304|local anesthesia|local anesthesia
5058677|NCT03632304|regional anesthesia|regional anesthesia
5058678|NCT03632304|QoR-15|qor-15
5058679|NCT03632291|UB-221|ub-221
5058680|NCT03632291|anti-IgE monoclonal antibody|anti-ige monoclonal antibody
5058681|NCT03632291|chronic spontaneous urticaria (CSU)|chronic spontaneous urticaria (csu)
5058682|NCT03632239|Resource|resource
5058683|NCT03632239|Variant|variant
5058684|NCT03632239|Sequencing|sequencing
5058685|NCT03632239|Genome|genome
5058686|NCT03632239|Phenotype|phenotype
5058687|NCT03632226|PET Imaging|pet imaging
5058688|NCT03632226|Neurodegeneration|neurodegeneration
5058689|NCT03632213|Mucopolysaccharidoses|mucopolysaccharidoses
5058690|NCT03632213|Losartan|losartan
5058691|NCT03632213|Aortic root dilatation|aortic root dilatation
5058692|NCT03632213|Echocardiogram|echocardiogram
5903510|NCT00357214|nitrogen excretion|nitrogen excretion
5113278|NCT03288714|TMS|tms
5058693|NCT03632213|MPS IV|mps iv
5058694|NCT03632213|MPS VI|mps vi
5058695|NCT03632174|Probiotic|probiotic
5058696|NCT03632174|Atopic Dermatitis|atopic dermatitis
5058697|NCT03632174|Lactobacillus reuteri|lactobacillus reuteri
5058698|NCT03632135|ChemoID|chemoid
5058699|NCT03632135|Cancer stem cells|cancer stem cells
5058700|NCT03632135|Drug response assay|drug response assay
5058701|NCT03632135|Glioblastoma|glioblastoma
5058702|NCT03632135|Brain Cancer|brain cancer
5058703|NCT03632122|comorbidity|comorbidity
5058704|NCT03632122|pain|pain
5058716|NCT03632031|diabetic ulcer|diabetic ulcer
5058717|NCT03632018|cardiac rehabilitation|cardiac rehabilitation
5058718|NCT03632018|physical activity|physical activity
5058719|NCT03632005|Surgical Site Infection|surgical site infection
5058720|NCT03631992|Children|children
5058721|NCT03631992|Sugar|sugar
5058723|NCT03631992|Snacking|snacking
5058724|NCT03631992|Biomarker|biomarker
5058726|NCT03631940|Umbilical Cord Milking|umbilical cord milking
5058727|NCT03631940|Immediate Cord Clamping|immediate cord clamping
5058728|NCT03631940|Resuscitation|resuscitation
5058729|NCT03631927|critical care unit|critical care unit
5058730|NCT03631901|Melatonin|melatonin
5058731|NCT03631901|Diazepam|diazepam
5058732|NCT03631901|recurrence|recurrence
5058733|NCT03631901|prophylaxis|prophylaxis
5058734|NCT03631901|Febrile convulsions|febrile convulsions
5058735|NCT03631862|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5058736|NCT03631862|Apatinib|apatinib
5058749|NCT03631784|PDL1|pdl1
5058750|NCT03631784|PD-L1|pd-l1
5058751|NCT03631771|Hypothyroidism|hypothyroidism
5058752|NCT03631771|Child|child
5058753|NCT03631771|Iodine|iodine
5058754|NCT03631771|Iodinated contrast medium (ICM)|iodinated contrast medium (icm)
5058755|NCT03631771|Thyroid function test (TFT)|thyroid function test (tft)
5058756|NCT03631771|Iodixanol|iodixanol
5058757|NCT03631771|Iohexol|iohexol
5058758|NCT03631771|Iopromide|iopromide
5058759|NCT03631771|Ioversol|ioversol
5058763|NCT03631745|mental health literacy|mental health literacy
5058764|NCT03631745|stigma|stigma
5058765|NCT03631745|help-seeking|help-seeking
5058766|NCT03631745|Latino|latino
5058767|NCT03631745|faith-based|faith-based
5058768|NCT03631745|religious congregations|religious congregations
5058769|NCT03631745|contact-based interventions|contact-based interventions
5058770|NCT03631719|Wolbachia|wolbachia
5058771|NCT03631719|Colombia|colombia
5058772|NCT03631719|Dengue|dengue
5058773|NCT03631719|Zika|zika
5058774|NCT03631719|Chikungunya|chikungunya
5058775|NCT03631719|Arboviral diseases|arboviral diseases
5058776|NCT03631719|Disease surveillance|disease surveillance
5058777|NCT03631706|M7824|m7824
5058778|NCT03631706|Pembrolizumab|pembrolizumab
5058779|NCT03631706|PD-L1-tumor Expression|pd-l1-tumor expression
5058780|NCT03631706|INTR@PID Lung 037|intr@pid lung 037
5058781|NCT03631706|Bintrafusp alfa|bintrafusp alfa
5960984|NCT04289935|Vacuum assisted biopsy|vacuum assisted biopsy
5058782|NCT03631693|postoperative healing|postoperative healing
5058783|NCT03631667|Benzo[a]pyrene|benzo[a]pyrene
5058784|NCT03631667|Accelerator Mass Spectrometry|accelerator mass spectrometry
5058785|NCT03631667|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
5058786|NCT03631667|Phenanthrene|phenanthrene
5058787|NCT03631615|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5058788|NCT03631615|PD-1 antibody(SHR-1210)|pd-1 antibody(shr-1210)
5058789|NCT03631615|locally advanced proximal stomach adenocarcinoma|locally advanced proximal stomach adenocarcinoma
5058790|NCT03631524|deconditioning, isolation precautions, telerehabilitation|deconditioning, isolation precautions, telerehabilitation
5058791|NCT03631511|direct pulp capping, RetroMTA, histological evaluation|direct pulp capping, retromta, histological evaluation
5058793|NCT03631498|hypoxia|hypoxia
5058794|NCT03631498|apoptosis|apoptosis
5058795|NCT03631498|chronic periodontitis|chronic periodontitis
5058796|NCT03631459|Kanglaita Injection/Capsule|kanglaita injection/capsule
5058797|NCT03631459|Cancer cachexia|cancer cachexia
5058798|NCT03631459|Real-world evidences|real-world evidences
5058799|NCT03631459|Overall survival|overall survival
5058804|NCT03631342|Ventilator Hyperinflation|ventilator hyperinflation
5058805|NCT03631342|Physical Therapy|physical therapy
5058806|NCT03631342|Mechanical Ventilation|mechanical ventilation
5058807|NCT03631316|valganciclovir|valganciclovir
5058808|NCT03631316|kidney transplantation|kidney transplantation
5058809|NCT03631316|pharmacokinetics|pharmacokinetics
5058810|NCT03631303|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5903511|NCT00357214|potassium bicarbonate|potassium bicarbonate
5058811|NCT03631303|Post-extrasystolic Potentiation|post-extrasystolic potentiation
5058813|NCT03631290|kidney failure, chronic|kidney failure, chronic
5058815|NCT03631290|aged|aged
5058816|NCT03631290|inappropriate prescribing|inappropriate prescribing
5058817|NCT03631290|preliminary data|preliminary data
5058818|NCT03631277|Indirect pulp treatment|indirect pulp treatment
5058819|NCT03631277|Photo-activated oral disinfection|photo-activated oral disinfection
5058820|NCT03631277|Calcium Hydroxide|calcium hydroxide
5058821|NCT03631264|preterm infants|preterm infants
5058822|NCT03631264|kinesiotape|kinesiotape
5058823|NCT03631264|swallowing|swallowing
5058824|NCT03631238|Cholesterol|cholesterol
5058825|NCT03631238|Dementia|dementia
5058826|NCT03631238|Homocysteine|homocysteine
5058827|NCT03631238|Cognitive dysfunctions|cognitive dysfunctions
5058831|NCT03631212|virtual humans|virtual humans
5058832|NCT03631212|smoking cessation|smoking cessation
5058835|NCT03631212|Acceptance and Commitment Therapy|acceptance and commitment therapy
5058836|NCT03631199|ACZ885|acz885
5058837|NCT03631199|canakinumab|canakinumab
5058838|NCT03631199|pembrolizumab|pembrolizumab
5058839|NCT03631199|carboplatin|carboplatin
5058840|NCT03631199|cisplatin|cisplatin
5058841|NCT03631199|paclitaxel|paclitaxel
5058842|NCT03631199|nab-paclitaxel|nab-paclitaxel
5058843|NCT03631199|pemetrexed|pemetrexed
5058844|NCT03631199|NSCLC|nsclc
5058845|NCT03631199|non-small cell lung cancer|non-small cell lung cancer
5058846|NCT03631199|non small cell lung cancer|non small cell lung cancer
5058847|NCT03631199|squamous|squamous
5058858|NCT03631173|Pancreaticoduodenectomy|pancreaticoduodenectomy
5058859|NCT03631173|Pancreatectomy|pancreatectomy
5058860|NCT03631173|Anastomosis, Surgical|anastomosis, surgical
5058861|NCT03631160|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5058862|NCT03631160|Transcutaneous Acupoint Electrical Stimulation|transcutaneous acupoint electrical stimulation
5058863|NCT03631160|Postoperative spontaneous voiding|postoperative spontaneous voiding
5058864|NCT03631160|Postoperative Dysuria|postoperative dysuria
5058865|NCT03631108|Iris Vessel|iris vessel
5058866|NCT03631108|OCTA|octa
5058867|NCT03631082|effects|effects
5058868|NCT03631082|slump stretching|slump stretching
5058869|NCT03631082|lumbar mobilization|lumbar mobilization
5058870|NCT03631082|non radiculating|non radiculating
5058871|NCT03631082|Low back pain|low back pain
5058872|NCT03631082|exercises|exercises
5058873|NCT03631082|quality of life|quality of life
5058874|NCT03631082|modified oswestry low back pain disability|modified oswestry low back pain disability
5058875|NCT03631082|numeric pain rating scale|numeric pain rating scale
5058876|NCT03631082|fear avoidance beliefs|fear avoidance beliefs
5058877|NCT03631030|Cooled radiofrequency ablation|cooled radiofrequency ablation
5058879|NCT03631017|Radiation Dosimetry of [18F]PARPi|radiation dosimetry of [18f]parpi
5058880|NCT03631017|PET/CT scans|pet/ct scans
5058881|NCT03631004|nausea and vomiting|nausea and vomiting
5058882|NCT03630978|hepatocellular carcinoma|hepatocellular carcinoma
5058883|NCT03630978|colorectal liver metastases|colorectal liver metastases
5058884|NCT03630978|non-colorectal liver metastases|non-colorectal liver metastases
5058885|NCT03630978|focal nodular hyperplasia|focal nodular hyperplasia
5058886|NCT03630978|liver hemangioma|liver hemangioma
5058887|NCT03630978|liver cysts|liver cysts
5058888|NCT03630978|surgical morbidity|surgical morbidity
5058889|NCT03630978|surgical mortality|surgical mortality
5058890|NCT03630978|sarcopenia|sarcopenia
5058891|NCT03630926|NV-VPAC1 Prostate Cancer Urine Diagnostic test|nv-vpac1 prostate cancer urine diagnostic test
5058892|NCT03630913|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5058893|NCT03630913|Sentinel lymph node|sentinel lymph node
5058894|NCT03630913|Axillary lymphadenectomy|axillary lymphadenectomy
5058895|NCT03630913|Tagged axillary metastatic node|tagged axillary metastatic node
5058896|NCT03630887|Prewarming|prewarming
5058897|NCT03630887|Tympanic temperature|tympanic temperature
5058898|NCT03630887|Transurethral Resection|transurethral resection
5058899|NCT03630861|MicroRNAs|micrornas
5058900|NCT03630861|Glioblastoma|glioblastoma
5058901|NCT03630861|nonglial tumors|nonglial tumors
5058902|NCT03630861|stroke|stroke
5058903|NCT03630861|diagnosis|diagnosis
5058904|NCT03630835|Complicated carotid atherosclerotic plaques|complicated carotid atherosclerotic plaques
5058905|NCT03630835|Endarterectomy|endarterectomy
5058906|NCT03630835|99mTc-ANNexin-V-128|99mtc-annexin-v-128
5058907|NCT03630809|nonmetastatic|nonmetastatic
5058908|NCT03630809|classic HER2|classic her2
5058909|NCT03630809|Nonmetastatic classic HER2|nonmetastatic classic her2
5058910|NCT03630757|Fibromyalgia syndrome|fibromyalgia syndrome
5058911|NCT03630757|Manual Therapies|manual therapies
5058924|NCT03630692|oral drug|oral drug
5058925|NCT03630692|safety|safety
5058926|NCT03630692|adherence|adherence
5058928|NCT03630653|Neoplasm Staging|neoplasm staging
5058929|NCT03630653|Neoplasm Recurrence|neoplasm recurrence
5059225|NCT03628573|Biomarkers|biomarkers
5058934|NCT03630614|electronic cigarette|electronic cigarette
5058935|NCT03630614|nicotine|nicotine
5058936|NCT03630614|varenicline|varenicline
5058937|NCT03630614|randomized|randomized
5058938|NCT03630614|double blind|double blind
5058939|NCT03630614|double dummy|double dummy
5058940|NCT03630588|probiotics|probiotics
5058941|NCT03630588|visceral fat|visceral fat
5058942|NCT03630588|abdominal obesity|abdominal obesity
5058949|NCT03630523|PHTS|phts
5058950|NCT03630523|PTEN|pten
5058951|NCT03630523|Vaccination|vaccination
5058952|NCT03630510|Physical Therapy Modalities,|physical therapy modalities,
5058953|NCT03630510|Respiration Artificial,|respiration artificial,
5058954|NCT03630510|Respiratory Care Units,|respiratory care units,
5058955|NCT03630510|Respiratory Mechanics,|respiratory mechanics,
5058956|NCT03630510|Positive-Pressure Respiration|positive-pressure respiration
5058962|NCT03630484|Physical Therapy|physical therapy
5058963|NCT03630484|Mechanical Ventilation|mechanical ventilation
5058964|NCT03630471|Adolescents|adolescents
5058965|NCT03630432|Severe|severe
5058966|NCT03630432|Difficult|difficult
5058967|NCT03630432|Overweight and obese|overweight and obese
5058968|NCT03630393|Prostatectomy|prostatectomy
5058969|NCT03630393|Robotic|robotic
5058970|NCT03630393|Urology|urology
5058971|NCT03630328|Cogni.Q|cogni.q
5058972|NCT03630328|immune enhancement|immune enhancement
5058973|NCT03630328|natural killer cells|natural killer cells
5058974|NCT03630328|NK cells|nk cells
5058975|NCT03630328|Korean Angelica gigas|korean angelica gigas
5058977|NCT03630289|tissue autograft|tissue autograft
5058978|NCT03630289|blood brain barrier|blood brain barrier
5058979|NCT03630263|Gastric emptying|gastric emptying
5058980|NCT03630263|Postprandial blood glucose|postprandial blood glucose
5058983|NCT03630224|Severe trauma|severe trauma
5058984|NCT03630224|Acute kidney injury|acute kidney injury
5058985|NCT03630224|Fluid resuscitation|fluid resuscitation
5058986|NCT03630224|Sodium chloride|sodium chloride
5058987|NCT03630224|Plasmalyte|plasmalyte
5058988|NCT03630211|Stem Cell Transplantation|stem cell transplantation
5058989|NCT03630211|Systemic Sclerosis|systemic sclerosis
5058990|NCT03630211|Scleroderma|scleroderma
5058991|NCT03630211|Interstitial Lung Disease|interstitial lung disease
5058992|NCT03630211|ILD (Interstitial Lung Disease)|ild (interstitial lung disease)
5058993|NCT03630211|Pulmonary Hypertension|pulmonary hypertension
5058994|NCT03630211|BMT ( bone marrow transplantation)|bmt ( bone marrow transplantation)
5058995|NCT03630211|Autologous|autologous
5058996|NCT03630198|corticosteroid|corticosteroid
5058997|NCT03630198|local anesthetic|local anesthetic
5058998|NCT03630172|low back pain|low back pain
5058999|NCT03630172|dry needling|dry needling
5059000|NCT03630172|flexibility|flexibility
5059001|NCT03630172|sympathetic nervous system|sympathetic nervous system
5059011|NCT03630120|Thyroid disease|thyroid disease
5059012|NCT03630120|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5059014|NCT03630120|Medullary thyroid cancer|medullary thyroid cancer
5059016|NCT03630120|Advanced thyroid cancer|advanced thyroid cancer
5059017|NCT03630120|Progressive thyroid cancer|progressive thyroid cancer
5059018|NCT03630120|MTC|mtc
5059019|NCT03630107|itchy scalp|itchy scalp
5059020|NCT03630107|chronic pruritus|chronic pruritus
5059021|NCT03630068|Liver Neoplasms|liver neoplasms
5059022|NCT03630068|Hepatocellular Carcinoma|hepatocellular carcinoma
5059023|NCT03630068|Ablation Techniques|ablation techniques
5059024|NCT03630068|Stereotaxic Techniques|stereotaxic techniques
5059025|NCT03630068|Computer-Assisted Therapy|computer-assisted therapy
5059026|NCT03630068|Computer-Assisted Surgery|computer-assisted surgery
5059027|NCT03630068|Interventional Radiology|interventional radiology
5059028|NCT03630055|Direct oral anticoagulants|direct oral anticoagulants
5059029|NCT03630055|Transradial access|transradial access
5059030|NCT03630055|Percutaneous coronary intervention|percutaneous coronary intervention
5059031|NCT03630042|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5059032|NCT03630042|Relapsed|relapsed
5059033|NCT03630042|Refractory|refractory
5059034|NCT03630042|Rituximab|rituximab
5059035|NCT03630042|Pembrolizumab|pembrolizumab
5059037|NCT03630003|critical care|critical care
5059038|NCT03630003|alternative communication|alternative communication
5059039|NCT03630003|augmentative communication|augmentative communication
5059040|NCT03629938|Feiss line|feiss line
5059041|NCT03629938|Medial longitudinal arch|medial longitudinal arch
5059042|NCT03629938|Navicular drop|navicular drop
5059043|NCT03629938|Pes planus|pes planus
5059044|NCT03629899|Retinitis Pigmentosa|retinitis pigmentosa
5059045|NCT03629899|Inherited Retinal Degeneration|inherited retinal degeneration
5059046|NCT03629899|Retina Implant|retina implant
5059047|NCT03629899|Retinal Prosthesis|retinal prosthesis
5059048|NCT03629899|Artificial Vision|artificial vision
5059049|NCT03629886|Adults|adults
5059050|NCT03629886|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5059051|NCT03629886|Cervical cancer|cervical cancer
5059052|NCT03629886|Safety|safety
5059053|NCT03629860|Atrophic, augmetation, bone regeneration|atrophic, augmetation, bone regeneration
5059054|NCT03629847|NETs, MTD, Everolimus.|nets, mtd, everolimus.
5059055|NCT03629821|Postural Balance|postural balance
5059056|NCT03629821|Dance Therapy|dance therapy
5059057|NCT03629821|Exercise Therapy|exercise therapy
5059240|NCT03628521|combination|combination
5059063|NCT03629769|Proxelan|proxelan
5059064|NCT03629730|coordination|coordination
5059065|NCT03629717|Mammographic density|mammographic density
5059066|NCT03629717|Premenopausal|premenopausal
5059067|NCT03629717|Breast cancer|breast cancer
5059068|NCT03629717|Chemoprevention|chemoprevention
5059069|NCT03629717|Denosumab|denosumab
5059070|NCT03629691|Cavitation|cavitation
5059073|NCT03629665|chronic aphasia|chronic aphasia
5059074|NCT03629665|rehabilitation|rehabilitation
5059075|NCT03629665|randomized controlled trial (RCT)|randomized controlled trial (rct)
5059076|NCT03629652|head-down position|head-down position
5059077|NCT03629652|ischemic stroke|ischemic stroke
5059078|NCT03629652|rehabilitation|rehabilitation
5059079|NCT03629639|Psoriasis|psoriasis
5059080|NCT03629639|Metformin|metformin
5059081|NCT03629639|Gut microbiota|gut microbiota
5059082|NCT03629626|preoperative / intraoperative/ postoperative management|preoperative / intraoperative/ postoperative management
5059083|NCT03629561|"Paraproteinemias[Mesh]"|"paraproteinemias[mesh]"
5059084|NCT03629561|"Kidney Diseases[Mesh]"|"kidney diseases[mesh]"
5059085|NCT03629548|dinoprostone|dinoprostone
5059086|NCT03629548|early amniotomy|early amniotomy
5059087|NCT03629548|labor induction|labor induction
5059088|NCT03629548|foley bulb|foley bulb
5059089|NCT03629509|decision aid|decision aid
5059090|NCT03629509|breast cancer|breast cancer
5059091|NCT03629509|young females|young females
5059092|NCT03629509|implementation|implementation
5059093|NCT03629509|stepped wedge trial|stepped wedge trial
5059094|NCT03629483|Elderly|elderly
5059095|NCT03629483|Knee Arthroplasty|knee arthroplasty
5059096|NCT03629483|Nerve Block|nerve block
5059097|NCT03629483|Dexmedetomidine|dexmedetomidine
5059098|NCT03629483|Postoperative Delirium|postoperative delirium
5059099|NCT03629483|Long-term Outcome|long-term outcome
5059100|NCT03629431|ARISCAT|ariscat
5059101|NCT03629431|complications|complications
5059102|NCT03629431|postoperative|postoperative
5059103|NCT03629418|Coronary Artery Bypass, Off-Pump|coronary artery bypass, off-pump
5059104|NCT03629418|Intraoperative Hypotension|intraoperative hypotension
5059105|NCT03629418|Acute Kidney Injury|acute kidney injury
5059106|NCT03629418|Preventive Medicine|preventive medicine
5059107|NCT03629418|Intraoperative Care|intraoperative care
5059108|NCT03629405|pH of the skin|ph of the skin
5059109|NCT03629405|SDS|sds
5059110|NCT03629405|Lipbarvis|lipbarvis
5059111|NCT03629405|TEWL|tewl
5059112|NCT03629405|Skin hydration|skin hydration
5059113|NCT03629392|Methionine|methionine
5059114|NCT03629392|Cysteine|cysteine
5059115|NCT03629392|Energy metabolism|energy metabolism
5059116|NCT03629392|Sulfur amino acids|sulfur amino acids
5059117|NCT03629366|Refugees|refugees
5059118|NCT03629366|Supported Employment|supported employment
5059119|NCT03629366|Individual Placement and Support|individual placement and support
5059120|NCT03629366|Employment|employment
5059121|NCT03629366|Vocational Rehabilitation|vocational rehabilitation
5059122|NCT03629366|Mental Health|mental health
5071767|NCT03550352|HIV|hiv
5059153|NCT03629223|Bioequivalence|bioequivalence
5059154|NCT03629197|primary care|primary care
5059155|NCT03629197|chronic pain|chronic pain
5059156|NCT03629197|patient-physician communication|patient-physician communication
5059157|NCT03629197|opioid analgesics|opioid analgesics
5059158|NCT03629197|standardized patients|standardized patients
5059159|NCT03629158|Behavioral Medicine|behavioral medicine
5059160|NCT03629158|Clinical Trial|clinical trial
5059161|NCT03629158|Cardiology|cardiology
5059162|NCT03629158|Health Behavior|health behavior
5059163|NCT03629158|Healthy Lifestyle|healthy lifestyle
5059164|NCT03629158|Self Efficacy|self efficacy
5059165|NCT03629106|Bipolar Disorder|bipolar disorder
5059166|NCT03629106|Cannabis Use Disorder|cannabis use disorder
5059167|NCT03629106|Cognitive Function|cognitive function
5059168|NCT03629093|General anesthesia|general anesthesia
5059169|NCT03629093|Infant|infant
5059170|NCT03629093|Neurodevelopment|neurodevelopment
5059171|NCT03629093|Postoperative|postoperative
5059172|NCT03629093|the Gesell Developmental Inventory|the gesell developmental inventory
5059173|NCT03629080|solid organ transplantation|solid organ transplantation
5059174|NCT03629080|vaccine|vaccine
5059175|NCT03629067|Hypertension|hypertension
5059176|NCT03629028|uterine closure; uterine scar defect; niche; cesarean;|uterine closure; uterine scar defect; niche; cesarean;
5059177|NCT03628976|tVNS, training, neuromotor adaptation|tvns, training, neuromotor adaptation
5059178|NCT03628963|Diabetes|diabetes
5059179|NCT03628963|hypertension|hypertension
5059180|NCT03628963|dyslipidemia|dyslipidemia
5059181|NCT03628950|Interscalene block|interscalene block
5105252|NCT03339154|Men|men
5059195|NCT03628859|Predictive biomarkers|predictive biomarkers
5059196|NCT03628859|Translational study|translational study
5059204|NCT03628807|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
5059205|NCT03628807|non-invasive assessments|non-invasive assessments
5059206|NCT03628807|Transthoracic echocardiography (TTE) with Speckle-tracking|transthoracic echocardiography (tte) with speckle-tracking
5059207|NCT03628807|Computer tomography scan (CT-scan)|computer tomography scan (ct-scan)
5059208|NCT03628807|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5059209|NCT03628807|circulating biomarkers|circulating biomarkers
5059210|NCT03628807|Electroencephalography (EEG)|electroencephalography (eeg)
5059211|NCT03628781|Behavioral intervention|behavioral intervention
5059212|NCT03628755|Fluency shaping therapy|fluency shaping therapy
5059213|NCT03628755|Digital Manipulation|digital manipulation
5059214|NCT03628755|Stuttering|stuttering
5059215|NCT03628755|communication|communication
5059216|NCT03628742|periodontal probe|periodontal probe
5059217|NCT03628742|gingival thickness|gingival thickness
5059218|NCT03628742|gingival biotype|gingival biotype
5059219|NCT03628599|Symptomatic|symptomatic
5059220|NCT03628586|acute coronary syndrome; biomarkers, HS troponins|acute coronary syndrome; biomarkers, hs troponins
5059221|NCT03628573|rTMS|rtms
5059222|NCT03628573|Depression|depression
5059223|NCT03628573|Theta Burst Stimulation|theta burst stimulation
5059224|NCT03628573|Inpatients|inpatients
5059232|NCT03628547|psychosocial problems|psychosocial problems
5059234|NCT03628534|Cardiac Arrhythmia|cardiac arrhythmia
5059235|NCT03628534|Ventricular Tachycardia|ventricular tachycardia
5059236|NCT03628534|Arrhythmia|arrhythmia
5059237|NCT03628534|Pathological processes|pathological processes
5059238|NCT03628521|lung cancer|lung cancer
5059239|NCT03628521|first-line|first-line
5071828|NCT03550144|Aging|aging
5059248|NCT03628443|CKD|ckd
5059249|NCT03628443|HFrEF|hfref
5059250|NCT03628443|HFpEF|hfpef
5059251|NCT03628443|FGF23|fgf23
5059252|NCT03628443|Dialysis|dialysis
5059253|NCT03628443|Atherosclerosis|atherosclerosis
5059254|NCT03628443|Coronary Artery Disease|coronary artery disease
5059255|NCT03628430|Anesthesia;|anesthesia;
5059256|NCT03628430|lidocaine;|lidocaine;
5059257|NCT03628430|patient experience|patient experience
5059258|NCT03628430|patient pain|patient pain
5059259|NCT03628430|sodium bicarbonate|sodium bicarbonate
5059260|NCT03628430|Vascular Access Devices|vascular access devices
5059261|NCT03628417|cutaneous metastases|cutaneous metastases
5059262|NCT03628417|calcium electroporation|calcium electroporation
5925410|NCT04196491|BB2121|bb2121
5059263|NCT03628417|bleomycin electroporation|bleomycin electroporation
5059264|NCT03628404|Alzheimer disease|alzheimer disease
5059265|NCT03628404|Dementia|dementia
5059266|NCT03628404|Faroe Islands|faroe islands
5059267|NCT03628404|Isolated population|isolated population
5059268|NCT03628404|Environmental exposure|environmental exposure
5059269|NCT03628391|delirium|delirium
5059270|NCT03628391|intensive care unit|intensive care unit
5059271|NCT03628391|critical illness|critical illness
5059272|NCT03628391|cognitive impairment|cognitive impairment
5059273|NCT03628365|Body composition|body composition
5059274|NCT03628365|muscle mass|muscle mass
5059275|NCT03628365|protein metabolism|protein metabolism
5059276|NCT03628365|enteral nutrition|enteral nutrition
5059278|NCT03628339|Tepotinib|tepotinib
5059279|NCT03628339|Midazolam|midazolam
5059280|NCT03628339|Cytochrome P450|cytochrome p450
5059281|NCT03628339|Pharmacokinetics|pharmacokinetics
5059282|NCT03628326|Pulmonary artery|pulmonary artery
5059283|NCT03628326|3D reconstruction|3d reconstruction
5059448|NCT03627494|FTIH|ftih
5059284|NCT03628326|Video-assisted thoracic surgery lobectomy|video-assisted thoracic surgery lobectomy
5059285|NCT03628326|CT angiography|ct angiography
5059286|NCT03628326|Anatomic variation|anatomic variation
5059287|NCT03628313|Echoacrdiography|echoacrdiography
5059288|NCT03628313|EchoDoppler|echodoppler
5059289|NCT03628313|Aortic valve stenosis|aortic valve stenosis
5059290|NCT03628313|Prognosis|prognosis
5960985|NCT04289909|relapsing remitting Multiple sclerosis|relapsing remitting multiple sclerosis
5960986|NCT04289909|Progressive Multiple Sclerosis|progressive multiple sclerosis
5059291|NCT03628300|neurotoxicity|neurotoxicity
5059292|NCT03628287|viral load suppression|viral load suppression
5059293|NCT03628287|medical case management|medical case management
5059301|NCT03628222|Lung lesion|lung lesion
5059302|NCT03628222|Electromagnetic navigation bronchoscopy (ENB)|electromagnetic navigation bronchoscopy (enb)
5059303|NCT03628222|Transbronchial lung biopsy(TBLB)|transbronchial lung biopsy(tblb)
5059304|NCT03628222|bronchoscopy|bronchoscopy
5059305|NCT03628209|resectable osteosarcoma|resectable osteosarcoma
5059306|NCT03628144|Immunonutrition|immunonutrition
5059307|NCT03628144|Radiotherapy|radiotherapy
5059308|NCT03628144|Unresectable|unresectable
5059309|NCT03628144|Stage IIIA-B|stage iiia-b
5059310|NCT03628144|Lung cancer|lung cancer
5059311|NCT03628144|Radiation oncology|radiation oncology
5059312|NCT03628144|Thoracic oncology|thoracic oncology
5059313|NCT03628144|Epidemiology|epidemiology
5059314|NCT03628144|Nutrition|nutrition
5059315|NCT03628105|Anxiety|anxiety
5059316|NCT03628105|Specific Phobia|specific phobia
5059317|NCT03628105|Claustrophobia|claustrophobia
5059318|NCT03628105|Exposure|exposure
5059319|NCT03628105|Cognitive therapy|cognitive therapy
5059320|NCT03628105|Cognitive restructuring|cognitive restructuring
5059321|NCT03628105|Consolidation|consolidation
5059322|NCT03628105|Inhibitory learning|inhibitory learning
5059323|NCT03628105|Expectancy violation|expectancy violation
5059324|NCT03628105|Expectancy|expectancy
5059325|NCT03628105|Exposure therapy|exposure therapy
5059326|NCT03628105|Anxiety disorder|anxiety disorder
5059327|NCT03628092|genitourinary symptoms of menopause|genitourinary symptoms of menopause
5059328|NCT03628092|CO2 fractional ablative laser|co2 fractional ablative laser
5059332|NCT03628092|Dyspareunia|dyspareunia
5059333|NCT03628092|Vaginal itch|vaginal itch
5059335|NCT03628066|Ovarian Suppression|ovarian suppression
5059336|NCT03628066|Neoadjuvant|neoadjuvant
5059337|NCT03628066|Premenopausal|premenopausal
5059338|NCT03628066|Estrogen-Receptor Positive|estrogen-receptor positive
5059339|NCT03628066|HER2-Negative|her2-negative
5059340|NCT03628066|Primary|primary
5059341|NCT03628066|Palbociclib|palbociclib
5059342|NCT03628066|Letrozole|letrozole
5059343|NCT03628066|Goserelin|goserelin
5059344|NCT03628066|Ki67|ki67
5423364|NCT01615926|shortness of breath|shortness of breath
5059348|NCT03628053|tisagenlecleucel|tisagenlecleucel
5059349|NCT03628053|intouzumab|intouzumab
5059350|NCT03628053|blinatumomab|blinatumomab
5059351|NCT03628053|CAR-T|car-t
5059352|NCT03628053|CTL019|ctl019
5059353|NCT03628027|Major Depressive Disorder|major depressive disorder
5059354|NCT03628027|Antidepressant Medication|antidepressant medication
5059355|NCT03628027|Digital Health|digital health
5733869|NCT00379353|Fatigue|fatigue
5059356|NCT03628027|Computerised Decision Support Tool|computerised decision support tool
5059357|NCT03628014|older, hospital, program|older, hospital, program
5059358|NCT03628001|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
5059359|NCT03628001|Distal malignant bile duct obstruction|distal malignant bile duct obstruction
5059360|NCT03628001|Sphincterotomy|sphincterotomy
5059361|NCT03627988|Breast Cancer Invasive|breast cancer invasive
5059362|NCT03627988|TomoTherapy|tomotherapy
5059363|NCT03627988|Immediate prosthetic breast reconstruction|immediate prosthetic breast reconstruction
5059364|NCT03627975|revascularization|revascularization
5059365|NCT03627975|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
5059366|NCT03627962|gaze-directed oculomotor training, reading in Chinese|gaze-directed oculomotor training, reading in chinese
5059367|NCT03627949|Web-based intervention|web-based intervention
5059368|NCT03627949|Health behavior change|health behavior change
5059369|NCT03627949|University students|university students
5059370|NCT03627949|Health Action Process Approach Model|health action process approach model
5059371|NCT03627936|Lorcaserin|lorcaserin
5059372|NCT03627936|Bioequivalence|bioequivalence
5059373|NCT03627936|Extended release|extended release
5059374|NCT03627936|Tablets|tablets
5059375|NCT03627936|Phase 1|phase 1
5059376|NCT03627936|Healthy|healthy
5059377|NCT03627923|Postprandial glucose response|postprandial glucose response
5059378|NCT03627923|Mediterranean diet|mediterranean diet
5059379|NCT03627923|Personalized nutrition|personalized nutrition
5059380|NCT03627910|gut microbiota|gut microbiota
5059381|NCT03627910|Iatrogenic malnutrition|iatrogenic malnutrition
5059382|NCT03627910|pressure ulcer|pressure ulcer
5059383|NCT03627884|Central Venous Catheters|central venous catheters
5059384|NCT03627884|End Stage Renal Disease|end stage renal disease
5059385|NCT03627884|Hemodialysis|hemodialysis
5059386|NCT03627884|Catheter-related infection|catheter-related infection
5059387|NCT03627884|Catheter loss due to clot formation|catheter loss due to clot formation
5059388|NCT03627884|Acute Renal Failure|acute renal failure
5059389|NCT03627871|exercise|exercise
5059390|NCT03627871|social norms|social norms
5059392|NCT03627832|alcohol|alcohol
5059393|NCT03627832|drinking|drinking
5059394|NCT03627832|sleep|sleep
5059395|NCT03627832|insomnia|insomnia
5059396|NCT03627832|young adult|young adult
5059397|NCT03627819|Plant sterols|plant sterols
5059398|NCT03627819|Plant stanols|plant stanols
5059399|NCT03627819|Liver inflammation|liver inflammation
5059400|NCT03627806|Disparities|disparities
5059401|NCT03627806|Florida-Puerto Rico Stroke Registry|florida-puerto rico stroke registry
5059402|NCT03627793|frailty|frailty
5059403|NCT03627793|exercise|exercise
5059404|NCT03627793|resistance training|resistance training
5059405|NCT03627793|strength|strength
5059406|NCT03627793|older adults|older adults
5059412|NCT03627754|Glasdegib|glasdegib
5059413|NCT03627754|PF-04449913|pf-04449913
5059414|NCT03627754|Pharmacokinetics|pharmacokinetics
5059415|NCT03627754|Hepatic Impairment|hepatic impairment
5059416|NCT03627689|asthma|asthma
5059417|NCT03627689|environmental intervention|environmental intervention
5059418|NCT03627689|allergies|allergies
5059419|NCT03627689|air purifier|air purifier
5059420|NCT03627676|Nodules of endometriosis|nodules of endometriosis
5059421|NCT03627676|Cryoablation|cryoablation
5059422|NCT03627650|burn|burn
5059423|NCT03627650|scar|scar
5059424|NCT03627650|fat|fat
5059425|NCT03627650|grafting|grafting
5059426|NCT03627624|MCID|mcid
5059427|NCT03627624|30 STS test|30 sts test
5059428|NCT03627624|Pulmonary rehabilitation|pulmonary rehabilitation
5059429|NCT03627611|Thyroxine|thyroxine
5059436|NCT03627585|left ventricular dysfunction|left ventricular dysfunction
5059437|NCT03627585|bradycardia|bradycardia
5059438|NCT03627585|remodelling|remodelling
5059439|NCT03627572|RESCEU (consortium)|resceu (consortium)
5059440|NCT03627572|Burden of Disease|burden of disease
5059441|NCT03627559|Pancreaticoduodenectomy|pancreaticoduodenectomy
5059442|NCT03627559|Pancreatectomy|pancreatectomy
5059443|NCT03627546|PWID|pwid
5059444|NCT03627507|Hepatitis B, Seroconversion, Seroprotection, Vaccine|hepatitis b, seroconversion, seroprotection, vaccine
5059445|NCT03627494|Dose proportionality|dose proportionality
5059446|NCT03627494|Food effect|food effect
5059447|NCT03627494|Pharmacokinetics|pharmacokinetics
5059461|NCT03627390|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
5059462|NCT03627390|BP-C1|bp-c1
5059463|NCT03627390|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
5059464|NCT03627390|Platinum analogue|platinum analogue
5059465|NCT03627390|Metronomic chemotherapy|metronomic chemotherapy
5059466|NCT03627390|Cisplatin|cisplatin
5059467|NCT03627390|Pancreatic cancer|pancreatic cancer
5059468|NCT03627390|BP-C2|bp-c2
5059469|NCT03627390|molybdenum salts of benzene-polycarboxylic acids|molybdenum salts of benzene-polycarboxylic acids
5059470|NCT03627377|Schizophrenia|schizophrenia
5059471|NCT03627377|Serious mental illness|serious mental illness
5059472|NCT03627377|Obesity|obesity
5059473|NCT03627377|Diabetes|diabetes
5059474|NCT03627377|Lifestyle Risk Reduction|lifestyle risk reduction
5059475|NCT03627351|Taste|taste
5059476|NCT03627351|Odor|odor
5059477|NCT03627351|Sensory Panel|sensory panel
5059478|NCT03627351|Flavor|flavor
5059479|NCT03627351|Genes|genes
5059480|NCT03627351|Pediatric Medicines|pediatric medicines
5059481|NCT03627247|cognitive behavioral|cognitive behavioral
5059482|NCT03627247|stress management|stress management
5059483|NCT03627247|pregnancy|pregnancy
5059484|NCT03627247|cortisol|cortisol
5059485|NCT03627221|social network|social network
5059486|NCT03627221|nursing students|nursing students
5059487|NCT03627221|sleep|sleep
5059488|NCT03627221|music care|music care
5059493|NCT03627195|Schizophrenia|schizophrenia
5059494|NCT03627156|Guided counseling|guided counseling
5059495|NCT03627156|nutrition outcome|nutrition outcome
5059496|NCT03627156|Ethiopia|ethiopia
5059497|NCT03627156|Community trial|community trial
5059498|NCT03627130|Percutaneous Coronary Intervention|percutaneous coronary intervention
5059499|NCT03627130|Nitric Oxide|nitric oxide
5059500|NCT03627130|Nitrite|nitrite
5059501|NCT03627130|Acute Kidney Injury|acute kidney injury
5059502|NCT03627130|Acute Coronary Syndrome|acute coronary syndrome
5059503|NCT03627091|Crohn's disease|crohn's disease
5059504|NCT03627078|traumatic memories|traumatic memories
5059505|NCT03627078|post traumatic stress disorder|post traumatic stress disorder
5059506|NCT03627078|motor interference therapy|motor interference therapy
5059507|NCT03627078|non pharmacological therapy|non pharmacological therapy
5059508|NCT03627078|trauma related disorders|trauma related disorders
5059511|NCT03627052|Inflammatory bowel disease|inflammatory bowel disease
5059512|NCT03627052|ulcerative colitis|ulcerative colitis
5059513|NCT03627052|Janus kinase inhibitor|janus kinase inhibitor
5059514|NCT03627052|JAK1|jak1
5059515|NCT03627026|Melanoma|melanoma
5059516|NCT03627026|Sphingolipids|sphingolipids
5059517|NCT03627026|Immune checkpoints|immune checkpoints
5059518|NCT03627026|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
5059519|NCT03627026|Immunosuppressive cytokines|immunosuppressive cytokines
5059520|NCT03627026|Circulating leukocytes|circulating leukocytes
5059521|NCT03626961|NEWS|news
5059522|NCT03626935|ankle joint|ankle joint
5059523|NCT03626935|arthrodesis|arthrodesis
5081461|NCT03490045|Incentives|incentives
5059535|NCT03626896|Focused Ultrasound|focused ultrasound
5960987|NCT04289909|Optic neuritis|optic neuritis
5059537|NCT03626883|arthroscopy|arthroscopy
5059538|NCT03626857|Knee|knee
5059540|NCT03626857|Reconstruction|reconstruction
5059541|NCT03626857|Rehabilitation|rehabilitation
5059542|NCT03626857|Eccentric Exercise|eccentric exercise
5059543|NCT03626857|Electrical Stimulation|electrical stimulation
5059544|NCT03626844|Manual Lysis, Postpartum Hemorrhage, Third Stage of Delivery.|manual lysis, postpartum hemorrhage, third stage of delivery.
5059549|NCT03626818|WBRT|wbrt
5059550|NCT03626818|NCT|nct
5059551|NCT03626792|Pilates|pilates
5059552|NCT03626792|Blood Pressure|blood pressure
5059553|NCT03626792|Postmenopausal women|postmenopausal women
5059554|NCT03626753|Pain|pain
5059555|NCT03626753|multimodal|multimodal
5059556|NCT03626753|analgesia|analgesia
5059557|NCT03626753|postoperative|postoperative
5059558|NCT03626753|cesarean section|cesarean section
5059559|NCT03626753|obstetric|obstetric
5059560|NCT03626753|Agents|agents
5059561|NCT03626753|Physiological effects of drugs|physiological effects of drugs
5059562|NCT03626753|opioid|opioid
5059563|NCT03626753|Paracetamol|paracetamol
5059564|NCT03626753|NSAIDs|nsaids
5059565|NCT03626740|dental pulp|dental pulp
5059566|NCT03626740|deep carious lesions|deep carious lesions
5059567|NCT03626740|treatment effect|treatment effect
5059568|NCT03626727|Excessive Daytime Sleepiness|excessive daytime sleepiness
5059569|NCT03626727|Prolonged sleep|prolonged sleep
5059570|NCT03626727|Traumatic Brain Injury|traumatic brain injury
5059571|NCT03626714|Tacrolimus|tacrolimus
5059572|NCT03626714|Immunosuppressant|immunosuppressant
5059573|NCT03626714|Sustained-release|sustained-release
5059574|NCT03626714|Plexis|plexis
5059575|NCT03626701|Pediatric|pediatric
5059576|NCT03626701|Burns|burns
5059577|NCT03626701|Partial-thickness|partial-thickness
5059584|NCT03626623|Diabetes|diabetes
5059585|NCT03626623|Foot Ulcer|foot ulcer
5059586|NCT03626610|Prehabilitation|prehabilitation
5059587|NCT03626610|Exercise|exercise
5059588|NCT03626610|Cancer|cancer
5059589|NCT03626610|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5059590|NCT03626545|ACZ885|acz885
5059591|NCT03626545|canakinumab|canakinumab
5059592|NCT03626545|docetaxel|docetaxel
5059593|NCT03626545|NSCLC|nsclc
5059594|NCT03626545|Non Small Cell Lung Cancer|non small cell lung cancer
5059595|NCT03626545|Carcinoma|carcinoma
5059596|NCT03626545|IL-1β|il-1β
5059597|NCT03626545|PD-(L)1|pd-(l)1
5059598|NCT03626545|CANOPY|canopy
5059599|NCT03626545|CANOPY-2|canopy-2
5059600|NCT03626545|second or third line therapy|second or third line therapy
5059601|NCT03626545|PD-(L)1 inhibitors|pd-(l)1 inhibitors
5059602|NCT03626545|platinum-based chemotherapy|platinum-based chemotherapy
5059603|NCT03626532|Mindfulness-based stress reduction|mindfulness-based stress reduction
5059604|NCT03626532|Cognitive function|cognitive function
5059605|NCT03626532|Emotion regulation|emotion regulation
5059606|NCT03626532|Lifestyle education|lifestyle education
5059607|NCT03626532|Attentional control|attentional control
5059608|NCT03626532|Mindfulness training|mindfulness training
5059609|NCT03626532|Aging|aging
5059610|NCT03626532|Older adults|older adults
5059611|NCT03626532|Mind-wandering|mind-wandering
5059612|NCT03626532|Functional connectivity|functional connectivity
5059613|NCT03626532|Randomized controlled trial|randomized controlled trial
5059614|NCT03626519|COPD|copd
5059615|NCT03626519|Menthol|menthol
5059616|NCT03626519|Exercise|exercise
5059617|NCT03626519|Dyspnea|dyspnea
5059618|NCT03626506|spironolactone|spironolactone
5059619|NCT03626506|Indapamide|indapamide
5059620|NCT03626506|Obesity|obesity
5059621|NCT03626506|Hypertension|hypertension
5059622|NCT03626506|Target organ damage|target organ damage
5059623|NCT03626480|Surgery|surgery
5059624|NCT03626480|Nutritional outcome|nutritional outcome
5059625|NCT03626480|Infants|infants
5059626|NCT03626454|Norepinephrine, hypotension, spinal, caesarean section|norepinephrine, hypotension, spinal, caesarean section
5059627|NCT03626441|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5059628|NCT03626441|Ginger|ginger
5059629|NCT03626428|EEG|eeg
5059633|NCT03626402|advanced cancer|advanced cancer
5059634|NCT03626402|African American|african american
5059635|NCT03626389|physiotherapy|physiotherapy
5059636|NCT03626389|primary health care setting|primary health care setting
5059637|NCT03626324|Spinal Cord Injury (SCI)|spinal cord injury (sci)
5059638|NCT03626324|Neurogenic Lower Urinary Tract Dysfunction (NLUTD)|neurogenic lower urinary tract dysfunction (nlutd)
5059639|NCT03626324|Catheter associated Urinary Tract Infection (CAUTI)|catheter associated urinary tract infection (cauti)
5059640|NCT03626324|Urinary Catheters|urinary catheters
5059641|NCT03626324|Dementia|dementia
5059643|NCT03626324|Diabetes|diabetes
5059644|NCT03626324|Parkinson's|parkinson's
5059645|NCT03626311|Lupus|lupus
5059646|NCT03626311|SLE|sle
5059647|NCT03626259|hypertension|hypertension
5059660|NCT03626155|continuous glucose monitoring|continuous glucose monitoring
5059661|NCT03626129|Haemostasis|haemostasis
5059662|NCT03626129|Trans radial band|trans radial band
5059663|NCT03626129|Coronary angiography|coronary angiography
5960988|NCT04289909|multiple sclerosis|multiple sclerosis
5059664|NCT03626129|Radial artery occlusion|radial artery occlusion
5059665|NCT03626129|Percutaneous coronary intervention|percutaneous coronary intervention
5059666|NCT03626103|depression|depression
5059667|NCT03626103|violence|violence
5059668|NCT03626103|emergency department|emergency department
5059670|NCT03626103|text message|text message
5059671|NCT03626090|Liver|liver
5059672|NCT03626090|Cirrhosis|cirrhosis
5059673|NCT03626090|Child B|child b
5059674|NCT03626090|Child C|child c
5059675|NCT03626090|Advance|advance
5059676|NCT03626090|Advanced|advanced
5059677|NCT03626090|Singapore|singapore
5059679|NCT03626090|Mesenchymal|mesenchymal
5059680|NCT03626090|Stem Cell|stem cell
5059681|NCT03626090|Cell Therapy|cell therapy
5059682|NCT03626090|MSC Therapy|msc therapy
5059683|NCT03626090|Treatment|treatment
5059684|NCT03626077|Biofeedback|biofeedback
5059685|NCT03626077|Visual-Motor Integration|visual-motor integration
5059686|NCT03626077|Visual Perception|visual perception
5059687|NCT03626051|ankle taping|ankle taping
5059688|NCT03626038|Trauma|trauma
5059689|NCT03626038|Medical Device|medical device
5059690|NCT03626038|Performance|performance
5059691|NCT03626038|Safety|safety
5059692|NCT03626038|Proximal Humeral Fracture|proximal humeral fracture
5059693|NCT03625999|Auditory attention|auditory attention
5059698|NCT03625973|Dementia|dementia
5059699|NCT03625973|Memory, Episodic|memory, episodic
5059700|NCT03625973|Printing, Three-Dimensional|printing, three-dimensional
5059701|NCT03625960|warts|warts
5059702|NCT03625960|trichloroacetic acid|trichloroacetic acid
5059703|NCT03625947|Hemoptysis|hemoptysis
5059704|NCT03625947|Lung cancer|lung cancer
5059705|NCT03625921|Physical Therapy|physical therapy
5059706|NCT03625921|Powered Prosthesis|powered prosthesis
5059707|NCT03625921|Biomechanical outcomes|biomechanical outcomes
5059708|NCT03625908|Coronary artery disease|coronary artery disease
5059709|NCT03625908|Optical coherence tomography|optical coherence tomography
5059710|NCT03625908|antiplatelet therapy|antiplatelet therapy
5059711|NCT03625843|urodynamics|urodynamics
5059712|NCT03625804|Electrical Stimulation|electrical stimulation
5059713|NCT03625804|Cortical Excitability|cortical excitability
5059714|NCT03625804|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5059715|NCT03625791|sarcoma|sarcoma
5059716|NCT03625791|genetic|genetic
5059717|NCT03625778|Obesity|obesity
5059718|NCT03625778|MEDI0382|medi0382
5059719|NCT03625778|Overweight|overweight
5059720|NCT03625765|Indocyanine green|indocyanine green
5059721|NCT03625765|SmartGoggles|smartgoggles
5059722|NCT03625726|cirrhosis|cirrhosis
5059723|NCT03625726|hypercoagulability|hypercoagulability
5059724|NCT03625726|thrombin generation assay|thrombin generation assay
5059725|NCT03625726|soluble Endothelial Protein C Receptor|soluble endothelial protein c receptor
5059726|NCT03625687|Lung disease|lung disease
5059727|NCT03625687|Lung Transplant|lung transplant
5059728|NCT03625687|HCV|hcv
5059729|NCT03625687|Hepatitis C|hepatitis c
5059730|NCT03625661|Treatment Related Cancer,iron deficiency|treatment related cancer,iron deficiency
5059731|NCT03625648|Diabetic Kidney disease|diabetic kidney disease
5059732|NCT03625648|pentoxifylline|pentoxifylline
5059733|NCT03625635|primary noninvasive breast cancer|primary noninvasive breast cancer
5059734|NCT03625635|sarcopenic obesity prevention|sarcopenic obesity prevention
5059735|NCT03625635|individualized nutrition intervention|individualized nutrition intervention
5059736|NCT03625635|food-based intervention|food-based intervention
5059737|NCT03625622|Alzheimer's disease|alzheimer's disease
5059738|NCT03625570|muscle weakness|muscle weakness
5059739|NCT03625570|muscle power|muscle power
5059740|NCT03625570|resistance training|resistance training
5059751|NCT03625531|Fixed protocol|fixed protocol
5059752|NCT03625531|Letrozole|letrozole
5059753|NCT03625505|Cancer|cancer
5059754|NCT03625505|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5059755|NCT03625505|Relapsed or Refractory AML|relapsed or refractory aml
5059756|NCT03625505|Pharmacokinetics|pharmacokinetics
5059757|NCT03625505|venetoclax|venetoclax
5059758|NCT03625505|gilteritinib|gilteritinib
5059759|NCT03625492|artificial sweeteners|artificial sweeteners
5059760|NCT03625492|caffeine|caffeine
5059761|NCT03625492|alcohol drinking|alcohol drinking
5059762|NCT03625492|urinary urgency|urinary urgency
5059763|NCT03625492|overactive bladder|overactive bladder
5059764|NCT03625492|urinary incontinence, urge|urinary incontinence, urge
5059765|NCT03625492|lower urinary tract symptoms|lower urinary tract symptoms
5059766|NCT03625453|Tourette Syndrome|tourette syndrome
5059767|NCT03625453|Chronic Motor Tic Disorder|chronic motor tic disorder
5059768|NCT03625440|cognitive tests|cognitive tests
5059769|NCT03625440|carboxyhemoglobin|carboxyhemoglobin
5059770|NCT03625440|nicotine|nicotine
5059771|NCT03625427|palmitoleic acid|palmitoleic acid
5059772|NCT03625427|monounsaturated fatty acid|monounsaturated fatty acid
5059773|NCT03625427|chronic inflammation|chronic inflammation
5059774|NCT03625401|mild to moderate|mild to moderate
5059775|NCT03625388|Leukemia, Myeloid, Philadelphia Positive|leukemia, myeloid, philadelphia positive
5059776|NCT03625388|Dasatinib|dasatinib
5960989|NCT04289909|adaptive optics|adaptive optics
5059777|NCT03625388|Generic Dasatinib|generic dasatinib
5059778|NCT03625388|Dasatinib 50 mg once daily|dasatinib 50 mg once daily
5059779|NCT03625388|Early chronic phase chronic myeloid leukemia|early chronic phase chronic myeloid leukemia
5059780|NCT03625375|exercise|exercise
5059781|NCT03625336|prostate|prostate
5059782|NCT03625336|calcification|calcification
5059784|NCT03625284|fucoxanthin|fucoxanthin
5059785|NCT03625284|microalgae|microalgae
5059786|NCT03625284|non alcoholic fatty liver|non alcoholic fatty liver
5059787|NCT03625271|Electroencephalogram|electroencephalogram
5059788|NCT03625271|data base|data base
5059789|NCT03625271|machine learning|machine learning
5059790|NCT03625258|mutations|mutations
5059791|NCT03625258|infected patients|infected patients
5059792|NCT03625245|Satiety|satiety
5059793|NCT03625245|Vegetable protein|vegetable protein
5059794|NCT03625245|Yogurt|yogurt
5059795|NCT03625245|Fiber|fiber
5059796|NCT03625245|Visual Analogue Scale|visual analogue scale
5059797|NCT03625245|Cross-over|cross-over
5059798|NCT03625193|Sit-to-stand test|sit-to-stand test
5059799|NCT03625193|Psychometric properties|psychometric properties
5059800|NCT03625180|nanofractured autologous matrix-induced chondrogenesis|nanofractured autologous matrix-induced chondrogenesis
5059801|NCT03625167|skin ageing|skin ageing
5059802|NCT03625167|suction blister|suction blister
5059803|NCT03625167|dermo-epidermal junction|dermo-epidermal junction
5059804|NCT03625115|Early Intervention|early intervention
5059805|NCT03625115|Developmental outcomes|developmental outcomes
5059806|NCT03625115|Health disparities|health disparities
5059807|NCT03625115|Early Childhood|early childhood
5059808|NCT03625102|Antroquinonol|antroquinonol
5059809|NCT03625102|Hocena|hocena
5059810|NCT03625089|Carotid Atherosclerosis|carotid atherosclerosis
5059811|NCT03625089|Arterial Stiffness|arterial stiffness
5059812|NCT03625089|Cardiovascular Risk|cardiovascular risk
5059813|NCT03625063|exercise capacity|exercise capacity
5059814|NCT03625063|physical activity|physical activity
5059815|NCT03625063|respiratory muscle strength|respiratory muscle strength
5059816|NCT03625063|respiratory muscle endurance|respiratory muscle endurance
5059817|NCT03625011|Pain Relief|pain relief
5059818|NCT03625011|Non-Narcotic Pain relief|non-narcotic pain relief
5059819|NCT03624985|lidocaine|lidocaine
5059820|NCT03624985|lumbar spine surgery|lumbar spine surgery
5059821|NCT03624985|postoperative pain|postoperative pain
5059822|NCT03624985|opioid reduction|opioid reduction
5059823|NCT03624972|communication|communication
5059824|NCT03624972|sexual health|sexual health
5059825|NCT03624972|menopausal health|menopausal health
5059826|NCT03624959|Healthy Volunteer|healthy volunteer
5059827|NCT03624959|Cytochrome P450 (CYP)|cytochrome p450 (cyp)
5059828|NCT03624959|ozanimod|ozanimod
5059829|NCT03624946|Zika virus|zika virus
5059830|NCT03624946|Human immune globulin|human immune globulin
5059831|NCT03624946|Hyperimmune|hyperimmune
5059832|NCT03624946|Polyclonal antibodies|polyclonal antibodies
5059833|NCT03624933|Depression|depression
5059834|NCT03624933|Cognitive Functioning|cognitive functioning
5059835|NCT03624933|Cannabis Use Disorder|cannabis use disorder
5059836|NCT03624907|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5059837|NCT03624894|oral impressions|oral impressions
5059838|NCT03624894|glassionomer cements|glassionomer cements
5059839|NCT03624894|dental restorations|dental restorations
5059840|NCT03624894|dental wear|dental wear
5059841|NCT03624868|Tai Chi|tai chi
5059842|NCT03624868|Older Veterans|older veterans
5059843|NCT03624868|Physical activity|physical activity
5059844|NCT03624868|PTSD|ptsd
5059845|NCT03624764|promontofixation|promontofixation
5059846|NCT03624764|prolapse surgery|prolapse surgery
5059847|NCT03624738|Femoro-femoral bypass|femoro-femoral bypass
5059848|NCT03624725|Gastric cancer|gastric cancer
5059849|NCT03624725|Quality of life|quality of life
5059850|NCT03624699|glaucoma|glaucoma
5059851|NCT03624699|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
5059852|NCT03624686|Acute Lymphoblastic Leukemia,Immunotherapy,chimeric antigen receptor,non-Hodgkin's lymphoma|acute lymphoblastic leukemia,immunotherapy,chimeric antigen receptor,non-hodgkin's lymphoma
5059853|NCT03624660|High-risk|high-risk
5059854|NCT03624660|Prostate cancer|prostate cancer
5059855|NCT03624660|Proton Radiation|proton radiation
5059856|NCT03624660|Dose-escalated|dose-escalated
5059857|NCT03624660|Hypofractionation|hypofractionation
5059858|NCT03624660|Simultaneous Integrated Boost (SIB)|simultaneous integrated boost (sib)
5059859|NCT03624660|Intraprostatic Tumor (IPT)|intraprostatic tumor (ipt)
5059860|NCT03624660|Proton Therapy (PT)|proton therapy (pt)
5059861|NCT03624660|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
5059862|NCT03624660|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5059875|NCT03624582|Physical activity|physical activity
5059876|NCT03624582|Decision-making|decision-making
5059877|NCT03624582|Cardiometabolic risk factors|cardiometabolic risk factors
5059878|NCT03624556|Down Syndrome (DS)|down syndrome (ds)
5059879|NCT03624556|Fragile X Syndrome (FXS)|fragile x syndrome (fxs)
5059880|NCT03624556|Intellectual Development Disorder (IDD)|intellectual development disorder (idd)
5059882|NCT03624556|EGCG|egcg
5960990|NCT04289909|eye disease|eye disease
5059883|NCT03624556|Epigallocatechin gallate|epigallocatechin gallate
5059884|NCT03624556|Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A)|dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a)
5059886|NCT03624556|Dietary supplement|dietary supplement
5059887|NCT03624556|Green tea|green tea
5059888|NCT03624556|IMIM|imim
5059889|NCT03624556|PERSEUS|perseus
5059890|NCT03624504|Transcatheter Pacing System|transcatheter pacing system
5059891|NCT03624504|Micra Implantable Device|micra implantable device
5059892|NCT03624504|Transfermoral Catheter Delivery System|transfermoral catheter delivery system
5059893|NCT03624439|double-lumen tube|double-lumen tube
5059894|NCT03624439|ETView|etview
5059895|NCT03624439|medical simulation|medical simulation
5059896|NCT03624439|anesthesiologist|anesthesiologist
5059897|NCT03624439|difficult airway|difficult airway
5059898|NCT03624426|nerve monitoring|nerve monitoring
5059899|NCT03624426|automated somatosensory evoked potential|automated somatosensory evoked potential
5059900|NCT03624426|nerve injury|nerve injury
5059901|NCT03624413|adolescent|adolescent
5059902|NCT03624413|HIV|hiv
5059903|NCT03624413|transition care|transition care
5059904|NCT03624413|mobile health|mobile health
5059905|NCT03624413|Social media|social media
5059906|NCT03624413|South Africa|south africa
5059907|NCT03624400|Autism spectrum disorder|autism spectrum disorder
5059908|NCT03624400|Sleep|sleep
5059909|NCT03624400|Cognitive-behavioral treatment|cognitive-behavioral treatment
5059910|NCT03624400|Internet delivered treatment|internet delivered treatment
5059911|NCT03624387|older adults, cognitive impairment, art therapy, hospital|older adults, cognitive impairment, art therapy, hospital
5059912|NCT03624374|Natural History Study|natural history study
5059913|NCT03624374|Kennedy Krieger Institute|kennedy krieger institute
5059914|NCT03624374|Virtual assessment|virtual assessment
5059915|NCT03624374|DARS2|dars2
5059916|NCT03624374|Johns Hopkins Hospital|johns hopkins hospital
5059917|NCT03624361|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
5059918|NCT03624361|Glaucoma Implant|glaucoma implant
5059919|NCT03624361|Lower IOP|lower iop
5059920|NCT03624361|IOP|iop
5059921|NCT03624361|Intraocular Pressure|intraocular pressure
5059922|NCT03624348|stress|stress
5059923|NCT03624348|mindfulness|mindfulness
5059924|NCT03624348|work related stress|work related stress
5059925|NCT03624348|health|health
5059926|NCT03624348|meditation|meditation
5059927|NCT03624335|Umbilical cord clamping|umbilical cord clamping
5059928|NCT03624335|Anemia Neonatal|anemia neonatal
5059929|NCT03624335|Iron metabolism disorders|iron metabolism disorders
5059930|NCT03624322|Agitation|agitation
5059931|NCT03624322|Schizophrenia|schizophrenia
5059932|NCT03624322|Bipolar I disorder|bipolar i disorder
5059933|NCT03624322|OLZ|olz
5059934|NCT03624322|Olanzapine|olanzapine
5059935|NCT03624322|Zyprexa|zyprexa
5059939|NCT03624257|Laser treatment|laser treatment
5059940|NCT03624257|surgical treatment|surgical treatment
5059941|NCT03624257|patient reported outcomes|patient reported outcomes
5059942|NCT03624257|microbiology|microbiology
5059943|NCT03624257|immunology|immunology
5059944|NCT03624257|radiological examination|radiological examination
5059945|NCT03624244|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
5059955|NCT03624114|pituitary adenoma surgery|pituitary adenoma surgery
5059956|NCT03624114|endoscopic transsphenoidal surgery|endoscopic transsphenoidal surgery
5059957|NCT03624114|sphenoid septation|sphenoid septation
5059958|NCT03624088|Breast Cancer Prevention|breast cancer prevention
5059959|NCT03624088|Genetic Testing|genetic testing
5059960|NCT03624088|Orthodox Jewish|orthodox jewish
5059961|NCT03624088|Community-Based Participatory Research|community-based participatory research
5059962|NCT03624088|BRCA|brca
5059963|NCT03624088|Decision Support|decision support
5059965|NCT03623984|Gallium-DOTATATE (68)|gallium-dotatate (68)
5059966|NCT03623984|Neuroendocrine Tumors|neuroendocrine tumors
5059967|NCT03623984|Pancreatic neuroendocrine Tumors|pancreatic neuroendocrine tumors
5059968|NCT03623984|Molecular|molecular
5059969|NCT03623984|Surgery|surgery
5059970|NCT03623984|Carcinoid|carcinoid
5059971|NCT03623971|Cataract|cataract
5059972|NCT03623971|Artificial Intelligence|artificial intelligence
5059973|NCT03623971|Medical Referral Pattern|medical referral pattern
5059974|NCT03623958|image guided|image guided
5059975|NCT03623958|lung nodule|lung nodule
5059976|NCT03623958|lung cancer|lung cancer
5059977|NCT03623958|lung mass|lung mass
5059978|NCT03623893|Metachronous contralateral inguinal hernia|metachronous contralateral inguinal hernia
5059979|NCT03623893|Hernia repair|hernia repair
5059980|NCT03623893|Contralateral exploration|contralateral exploration
5059981|NCT03623893|Cost-effectiveness|cost-effectiveness
5059983|NCT03623841|Executive function|executive function
5059987|NCT03623828|minimally conscious state|minimally conscious state
5059989|NCT03623828|crs-r|crs-r
5059990|NCT03623802|Chronic low back pain|chronic low back pain
5059991|NCT03623802|Movement therapy|movement therapy
5059992|NCT03623802|Supervised training|supervised training
5059993|NCT03623789|Total hip arthroplasty|total hip arthroplasty
5059994|NCT03623789|Tranexamic acid|tranexamic acid
5059995|NCT03623789|Floseal|floseal
5059996|NCT03623789|postoperative blood loss|postoperative blood loss
5059997|NCT03623789|Thrombin|thrombin
5059998|NCT03623776|Non-Small Cell Lung Cancer|non-small cell lung cancer
5059999|NCT03623776|Neoadjuvant|neoadjuvant
5060000|NCT03623776|Programmed Death-1|programmed death-1
5060001|NCT03623763|vitamin D|vitamin d
5060002|NCT03623763|water sport|water sport
5060003|NCT03623763|IL-4|il-4
5060004|NCT03623763|IL-6|il-6
5060005|NCT03623763|TNF-a|tnf-a
5060006|NCT03623763|IFN-gamma|ifn-gamma
5060007|NCT03623763|athletes|athletes
5060008|NCT03623763|respiratory infection|respiratory infection
5060009|NCT03623724|Major Depression|major depression
5060010|NCT03623724|Blended Therapy|blended therapy
5060011|NCT03623724|Randomized Clinical Trials|randomized clinical trials
5060012|NCT03623724|e-Mental Health|e-mental health
5060013|NCT03623724|Routine Practice|routine practice
5060014|NCT03623711|major depressive disorder|major depressive disorder
5060015|NCT03623711|Magnetic Resonance Imaging|magnetic resonance imaging
5060016|NCT03623711|Antidepressant Treatment|antidepressant treatment
5060017|NCT03623698|Hypertonic saline|hypertonic saline
5060018|NCT03623698|nebulised|nebulised
5060019|NCT03623698|children|children
5060020|NCT03623698|young people|young people
5060024|NCT03623685|preterm labor|preterm labor
5060025|NCT03623672|sleep|sleep
5060027|NCT03623672|rapid eye movement|rapid eye movement
5060028|NCT03623672|parkinson|parkinson
5060029|NCT03623672|lewy body disease|lewy body disease
5060030|NCT03623672|dementia with lewy bodies|dementia with lewy bodies
5060031|NCT03623672|Multiple System Atrophy|multiple system atrophy
5060032|NCT03623672|parasomnia|parasomnia
5060033|NCT03623672|synuclein|synuclein
5060034|NCT03623672|synucleinopathy|synucleinopathy
5060035|NCT03623659|Assisted hatching|assisted hatching
5060036|NCT03623659|Zona pellucida|zona pellucida
5060037|NCT03623659|Implantation failure|implantation failure
5060038|NCT03623659|Blastocyst|blastocyst
5060039|NCT03623659|Cryopreservation|cryopreservation
5060040|NCT03623646|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5060041|NCT03623646|Anti PD-L1|anti pd-l1
5060042|NCT03623646|Durvalumab|durvalumab
5060043|NCT03623646|Radiation therapy|radiation therapy
5060044|NCT03623646|Cisplatin|cisplatin
5060045|NCT03623646|Human Papilloma Virus|human papilloma virus
5060046|NCT03623620|Depression|depression
5060047|NCT03623620|Pregnancy|pregnancy
5060048|NCT03623620|Antidepressants|antidepressants
5060050|NCT03623620|Medication use during pregnancy|medication use during pregnancy
5060051|NCT03623620|Depression Relapse|depression relapse
5060052|NCT03623581|ASPS|asps
5060054|NCT03623568|HCV|hcv
5060055|NCT03623568|Hepatitis C|hepatitis c
5060056|NCT03623568|Transplant|transplant
5060057|NCT03623555|Stress regulation|stress regulation
5060058|NCT03623555|Depression|depression
5060059|NCT03623555|Intimate partner violence|intimate partner violence
5060060|NCT03623555|Resilience|resilience
5060061|NCT03623555|Psychophysiology|psychophysiology
5060062|NCT03623555|Endocrine response|endocrine response
5060063|NCT03623555|Risk factor|risk factor
5060064|NCT03623542|Dementia|dementia
5060065|NCT03623542|alzheimer dementia|alzheimer dementia
5060066|NCT03623516|Thyroid neoplasms; Thyroid gland; ;|thyroid neoplasms; thyroid gland; ;
5060067|NCT03623516|Thyroid gland|thyroid gland
5060068|NCT03623516|Incidence|incidence
5060069|NCT03623516|Overdiagnosis|overdiagnosis
5060070|NCT03623503|newborn|newborn
5060071|NCT03623503|neonatal spesis|neonatal spesis
5060072|NCT03623503|clinical sriteria|clinical sriteria
5060073|NCT03623490|kidney cancer|kidney cancer
5060074|NCT03623490|breast cancer|breast cancer
5060075|NCT03623490|oral therapy|oral therapy
5060076|NCT03623490|managment|managment
5060081|NCT03623399|postoperative pain|postoperative pain
5060082|NCT03623399|Intraabdominal laparoscopic gas pressure|intraabdominal laparoscopic gas pressure
5060083|NCT03623360|Gadoxetate disodium|gadoxetate disodium
5060084|NCT03623347|bully glioblastoma|bully glioblastoma
5060085|NCT03623347|multifocal glioblastoma|multifocal glioblastoma
5060086|NCT03623347|bevacizumab|bevacizumab
5060087|NCT03623347|temozolomide|temozolomide
5060088|NCT03623282|Synatura|synatura
5060089|NCT03623282|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5060090|NCT03623282|Ahn Gook Pharmaceuticals|ahn gook pharmaceuticals
5060092|NCT03623230|Femoral nerve block|femoral nerve block
5060093|NCT03623230|peripheral nerve block|peripheral nerve block
5060094|NCT03623230|Concentration|concentration
5060095|NCT03623230|volume|volume
5060096|NCT03623230|bupivacaine|bupivacaine
5060097|NCT03623230|post operative analgesia|post operative analgesia
5060098|NCT03623230|total knee arthroplasty|total knee arthroplasty
5060099|NCT03623217|Behavioral|behavioral
5060100|NCT03623217|Questionnaire development|questionnaire development
5060101|NCT03623217|Questionnaire|questionnaire
5060102|NCT03623217|Interview with patients|interview with patients
5960991|NCT04289909|peripheral nervous system disease|peripheral nervous system disease
5960992|NCT04289896|Football, Youth players|football, youth players
5060103|NCT03623217|Observational|observational
5060104|NCT03623217|Tacrolimus|tacrolimus
5060105|NCT03623217|Patient reported outcome tool|patient reported outcome tool
5060106|NCT03623217|Validation|validation
5060107|NCT03623217|Kidney transplantation|kidney transplantation
5060108|NCT03623204|Obesity|obesity
5060109|NCT03623204|Dyspnea|dyspnea
5060110|NCT03623204|Bariatric Surgery|bariatric surgery
5060111|NCT03623191|Erosive pustular dermatosis of the leg|erosive pustular dermatosis of the leg
5060112|NCT03623191|Erosive pustular dermatosis of the scalp|erosive pustular dermatosis of the scalp
5060113|NCT03623191|Venous insufficiency|venous insufficiency
5060114|NCT03623178|Substance Use Disorders|substance use disorders
5060115|NCT03623178|Assertive Community Treatment|assertive community treatment
5060116|NCT03623178|Community Treatment|community treatment
5060117|NCT03623178|Treatment engagement|treatment engagement
5060118|NCT03623178|Service Use|service use
5060119|NCT03623165|Heart Failure|heart failure
5060123|NCT03623139|diet|diet
5060124|NCT03623139|type 2 diabetes|type 2 diabetes
5060125|NCT03623113|Carbohydrate counting|carbohydrate counting
5060126|NCT03623113|Basic carbohydrate counting|basic carbohydrate counting
5060127|NCT03623113|Advanced carbohydrate counting|advanced carbohydrate counting
5060128|NCT03623113|Carbohydrates|carbohydrates
5060129|NCT03623113|Diet|diet
5060130|NCT03623100|Children|children
5060131|NCT03623100|Phonology|phonology
5060134|NCT03623100|ABR|abr
5060135|NCT03623100|FFR|ffr
5060136|NCT03623074|Myopia|myopia
5060137|NCT03623035|Lumbar Plexus block|lumbar plexus block
5060138|NCT03623035|total hip arthroplasty|total hip arthroplasty
5060139|NCT03623035|Arthroplasty, direct anterior approach|arthroplasty, direct anterior approach
5060140|NCT03623035|Pain|pain
5060141|NCT03623022|healthy|healthy
5060142|NCT03622944|neck pain|neck pain
5060143|NCT03622944|physiotherapy|physiotherapy
5060144|NCT03622944|rehabilitation|rehabilitation
5060145|NCT03622931|ovarian|ovarian
5060146|NCT03622931|cancer|cancer
5060151|NCT03622879|Mirror therapy|mirror therapy
5060152|NCT03622879|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5060153|NCT03622879|Rehabilitation|rehabilitation
5060154|NCT03622853|adhesive capsulitis|adhesive capsulitis
5060155|NCT03622840|Cognitive Remediation|cognitive remediation
5060156|NCT03622827|Adjuvant therapy|adjuvant therapy
5060157|NCT03622827|chemoradiotherapy|chemoradiotherapy
5060158|NCT03622827|Uterine Cervical Neoplasms|uterine cervical neoplasms
5060160|NCT03622827|Endostar|endostar
5060161|NCT03622814|caregiving|caregiving
5060162|NCT03622814|mealtimes|mealtimes
5060173|NCT03622736|rheumatoid arthritis|rheumatoid arthritis
5060175|NCT03622723|viscosupplementation|viscosupplementation
5060176|NCT03622723|hyaluronic acid|hyaluronic acid
5060177|NCT03622723|metartarsophalangeal joint|metartarsophalangeal joint
5060178|NCT03622723|foot arthritis|foot arthritis
5060179|NCT03622723|osteoarthritis of the big toe|osteoarthritis of the big toe
5060180|NCT03622710|Rehabilitation|rehabilitation
5060181|NCT03622710|Surfaces|surfaces
5060182|NCT03622710|Walking|walking
5060183|NCT03622710|Spinal cord injury|spinal cord injury
5060184|NCT03622697|mindfulness|mindfulness
5060185|NCT03622697|meditation|meditation
5060186|NCT03622697|facial paralysis|facial paralysis
5060187|NCT03622697|quality of life|quality of life
5060188|NCT03622697|social functioning|social functioning
5733870|NCT00379353|Thalidomide|thalidomide
5060189|NCT03622684|TMJ- temporomandibular joint-disorder|tmj- temporomandibular joint-disorder
5060190|NCT03622684|Muscle relaxation|muscle relaxation
5060191|NCT03622684|Psychoemotional factor|psychoemotional factor
5060193|NCT03622671|Coronary Artery By-pass Grafting|coronary artery by-pass grafting
5060194|NCT03622671|CABG|cabg
5060195|NCT03622671|Fibrin|fibrin
5060196|NCT03622671|Clot Lysis Time|clot lysis time
5060197|NCT03622671|CLT|clt
5060198|NCT03622671|Bleeding|bleeding
5060199|NCT03622671|Drainage|drainage
5060200|NCT03622671|Rethoracotomy|rethoracotomy
5060201|NCT03622645|Range of motion|range of motion
5060202|NCT03622645|Wrist|wrist
5060203|NCT03622645|Hand|hand
5060204|NCT03622645|Finger|finger
5060205|NCT03622645|Measurement|measurement
5060208|NCT03622606|Right hemispheric Stroke|right hemispheric stroke
5060209|NCT03622606|Crossed aphasia|crossed aphasia
5060210|NCT03622606|Acute phase|acute phase
5060211|NCT03622502|dexmedetomidine|dexmedetomidine
5060212|NCT03622502|remifentanil|remifentanil
5060213|NCT03622502|extubation|extubation
5060214|NCT03622476|Hemophilia A，pharmacokinetics|hemophilia a，pharmacokinetics
5060215|NCT03622463|Antroquinonol|antroquinonol
5060216|NCT03622463|Hocena|hocena
5060217|NCT03622437|Aftercare|aftercare
5060218|NCT03622437|Follow-up|follow-up
5060219|NCT03622437|Patient Involvement|patient involvement
5060220|NCT03622437|Patient-reported Outcomes (PRO)|patient-reported outcomes (pro)
5060221|NCT03622398|total knee arthroplasty|total knee arthroplasty
5060222|NCT03622398|highly cross-linked polyethylene|highly cross-linked polyethylene
5960993|NCT04289896|Plyometric exercises|plyometric exercises
5960994|NCT04289896|Strength|strength
5060223|NCT03622385|DNA Methylation|dna methylation
5060224|NCT03622385|DNA Biomarkers|dna biomarkers
5060225|NCT03622385|Pelvic Mass|pelvic mass
5060226|NCT03622372|FLEXOR TENDON|flexor tendon
5060227|NCT03622372|ZONE 2|zone 2
5060228|NCT03622359|Radionuclide imaging|radionuclide imaging
5060229|NCT03622359|Perfusion imaging|perfusion imaging
5060230|NCT03622346|Echinococcosis, Hydatidosis, TKR, Fracture|echinococcosis, hydatidosis, tkr, fracture
5060231|NCT03622333|Neuroendocrine tumors|neuroendocrine tumors
5060232|NCT03622333|carcinoid tumors|carcinoid tumors
5060233|NCT03622333|midgut|midgut
5060234|NCT03622333|small intestine|small intestine
5060235|NCT03622333|genetic predisposition|genetic predisposition
5060236|NCT03622333|hereditary|hereditary
5060237|NCT03622320|insulin resistance|insulin resistance
5060238|NCT03622307|Subcutaneous ICD Therapy|subcutaneous icd therapy
5060239|NCT03622307|VT Ablation|vt ablation
5060240|NCT03622268|indirect calorimetry|indirect calorimetry
5060241|NCT03622268|energy expenditure assessment|energy expenditure assessment
5060242|NCT03622268|intensive care unit|intensive care unit
5060243|NCT03622255|Intrabony defects|intrabony defects
5060244|NCT03622255|Minimally invasive non-surgical technique|minimally invasive non-surgical technique
5072828|NCT03543865|Resilience|resilience
5060245|NCT03622255|Enamel Matrix Derivative|enamel matrix derivative
5060246|NCT03622229|pancreatic cancer, endoscopic ultrasound, fine needle biopsy|pancreatic cancer, endoscopic ultrasound, fine needle biopsy
5060253|NCT03622151|Housing First|housing first
5060254|NCT03622151|homeless|homeless
5060255|NCT03622138|Evidence-based Prevention Programs|evidence-based prevention programs
5060256|NCT03622138|Youth Prevention Programs|youth prevention programs
5060257|NCT03622138|Outcomes Data|outcomes data
5060258|NCT03622138|Continuous Quality Improvement|continuous quality improvement
5060259|NCT03622112|Inhaled non-steroidal glucocorticoid receptor modulator|inhaled non-steroidal glucocorticoid receptor modulator
5060260|NCT03622112|Asthma|asthma
5060261|NCT03622112|Inhaled corticosteroids.|inhaled corticosteroids.
5060262|NCT03622112|Glucocorticoid receptor (GA) agonists.|glucocorticoid receptor (ga) agonists.
5060263|NCT03622112|Chronic obstructive pulmonary disease.|chronic obstructive pulmonary disease.
5060264|NCT03622112|Short-acting B2 agonist.|short-acting b2 agonist.
5060265|NCT03622112|Fluticasone furoate.|fluticasone furoate.
5060266|NCT03622073|Post abortion care|post abortion care
5060267|NCT03622073|Misoprostol|misoprostol
5060268|NCT03622073|Second trimester|second trimester
5060269|NCT03622047|Labor, Analgesia, Dexmedetomidine, Sufentanil|labor, analgesia, dexmedetomidine, sufentanil
5060270|NCT03622034|knee features|knee features
5060271|NCT03622034|ethnic changes|ethnic changes
5060272|NCT03621982|Camidanlumab tesirine|camidanlumab tesirine
5060273|NCT03621969|Vagus Nerve Stimulation|vagus nerve stimulation
5060274|NCT03621956|Near-Infrared Spectroscopy|near-infrared spectroscopy
5060275|NCT03621943|Neurodevelopmental impairment|neurodevelopmental impairment
5060276|NCT03621943|Disability|disability
5060277|NCT03621943|Umbilical cord milking|umbilical cord milking
5060278|NCT03621943|Early Cord Clamping|early cord clamping
5060279|NCT03621930|RESCEU (consortium)|resceu (consortium)
5060280|NCT03621930|RSV|rsv
5060281|NCT03621930|Respiratory Syncytial Virus|respiratory syncytial virus
5060282|NCT03621917|near infrared spectroscopy|near infrared spectroscopy
5060283|NCT03621917|acute ischemic stroke|acute ischemic stroke
5060284|NCT03621917|thrombolytic therapy|thrombolytic therapy
5060285|NCT03621904|Hormonal therapy|hormonal therapy
5060286|NCT03621904|Endocrine therapy|endocrine therapy
5060287|NCT03621904|Translational research|translational research
5060288|NCT03621904|Tumor factors|tumor factors
5060289|NCT03621891|hyper-occlusion|hyper-occlusion
5060290|NCT03621891|hypoxia|hypoxia
5060291|NCT03621891|occlusal trauma|occlusal trauma
5060292|NCT03621891|periodontitis|periodontitis
5060293|NCT03621891|subgingival microbiota|subgingival microbiota
5060294|NCT03621878|Lumbosacral radiculopathy|lumbosacral radiculopathy
5060295|NCT03621878|peripheral sensitization|peripheral sensitization
5060296|NCT03621878|Neural mobilization|neural mobilization
5060297|NCT03621878|radicular LBP|radicular lbp
5060298|NCT03621878|slider|slider
5060299|NCT03621878|tensioner|tensioner
5060300|NCT03621865|bioavailability|bioavailability
5060301|NCT03621865|pharmacokinetic study|pharmacokinetic study
5060302|NCT03621865|curcuminoids|curcuminoids
5060303|NCT03621865|curcumin|curcumin
5060304|NCT03621865|healthy volunteers|healthy volunteers
5060305|NCT03621852|Endosonography|endosonography
5060306|NCT03621852|fine needle biopsy|fine needle biopsy
5060307|NCT03621826|sickle cell anemia|sickle cell anemia
5060308|NCT03621826|TCD|tcd
5060309|NCT03621826|screening|screening
5060310|NCT03621826|dissemination|dissemination
5060311|NCT03621826|implementation|implementation
5060312|NCT03621813|Neuropathic Pain|neuropathic pain
5060313|NCT03621813|Exercise|exercise
5060314|NCT03621813|Lung Cancer|lung cancer
5060315|NCT03621800|Thirst|thirst
5060316|NCT03621800|Elderly|elderly
5060317|NCT03621800|Postoperative Period|postoperative period
5060318|NCT03621800|Surgical Patient|surgical patient
5060319|NCT03621800|Menthol|menthol
5060320|NCT03621800|Ice|ice
5960995|NCT04289896|Running speed|running speed
5060321|NCT03621800|Randomized Controlled Trial|randomized controlled trial
5060322|NCT03621774|Schizophrenia|schizophrenia
5060323|NCT03621774|CBT|cbt
5060324|NCT03621774|Mobile CBT|mobile cbt
5060325|NCT03621774|Negative Symptoms|negative symptoms
5060326|NCT03621761|cognitive behavioral therapy|cognitive behavioral therapy
5060327|NCT03621761|modafinil|modafinil
5060328|NCT03621761|Provigil|provigil
5060329|NCT03621761|fatigue|fatigue
5060330|NCT03621761|MS|ms
5060331|NCT03621748|craniotomy|craniotomy
5060332|NCT03621748|awake craniotomy|awake craniotomy
5060333|NCT03621735|Tinnitus|tinnitus
5060334|NCT03621735|Ringing in the ear|ringing in the ear
5060335|NCT03621709|TAVR|tavr
5060336|NCT03621709|TAVI|tavi
5060337|NCT03621709|Aortic valve stenosis|aortic valve stenosis
5060338|NCT03621670|Meningitis|meningitis
5060339|NCT03621670|Immune response|immune response
5060340|NCT03621670|Sufficiency|sufficiency
5060356|NCT03621540|schizophrenia|schizophrenia
5060357|NCT03621540|cognitive deficits|cognitive deficits
5060358|NCT03621540|working memory training|working memory training
5060359|NCT03621514|Painless indwelling urethral catheter|painless indwelling urethral catheter
5060360|NCT03621514|uniportal video-assisted thoracoscopic surgery|uniportal video-assisted thoracoscopic surgery
5060361|NCT03621514|Lobectomy|lobectomy
5060362|NCT03621514|Lung cancer|lung cancer
5060363|NCT03621501|Percutaneous coronary intervention|percutaneous coronary intervention
5060364|NCT03621501|Multivessel disease|multivessel disease
5060365|NCT03621488|Behavioral Activation|behavioral activation
5060366|NCT03621488|Virtual reality|virtual reality
5060367|NCT03621488|Depression|depression
5060368|NCT03621449|passive leg raising|passive leg raising
5060369|NCT03621449|fluid responsiveness|fluid responsiveness
5060370|NCT03621449|pulse contour analysis|pulse contour analysis
5060371|NCT03621449|transthoracic ultrasound|transthoracic ultrasound
5060372|NCT03621449|velocity time integral|velocity time integral
5060373|NCT03621397|Spanish-speakers|spanish-speakers
5060374|NCT03621397|Subarachnoid hemorrhage|subarachnoid hemorrhage
5060375|NCT03621397|Cognitive Intervention|cognitive intervention
5060376|NCT03621384|BsmI|bsmi
5060377|NCT03621384|Diabetic kidney disease|diabetic kidney disease
5060378|NCT03621384|Polymorphisms|polymorphisms
5060379|NCT03621384|Vitamin D receptor gene|vitamin d receptor gene
5060380|NCT03621358|Satiety|satiety
5060381|NCT03621358|Encapsulated flavour|encapsulated flavour
5060382|NCT03621358|Gummies|gummies
5060383|NCT03621358|Visual Analogue Scale|visual analogue scale
5060384|NCT03621358|Cross-over|cross-over
5060385|NCT03621319|Hybrid argon plasma coagulation|hybrid argon plasma coagulation
5060386|NCT03621319|Submucosal injection|submucosal injection
5060387|NCT03621293|Long term outcome|long term outcome
5060388|NCT03621293|Brain|brain
5060389|NCT03621293|Lung|lung
5060390|NCT03621293|Oxygen strategies|oxygen strategies
5060391|NCT03621254|Functional Electrical Stimulation|functional electrical stimulation
5060392|NCT03621254|Exercise Training|exercise training
5060393|NCT03621254|Aerobic Fitness|aerobic fitness
5060394|NCT03621254|Muscle Strength|muscle strength
5060395|NCT03621228|Delirium|delirium
5060396|NCT03621228|Hyperactive|hyperactive
5060397|NCT03621228|Aggression|aggression
5060398|NCT03621228|Anxiety|anxiety
5060399|NCT03621228|Digital therapy|digital therapy
5060400|NCT03621215|tart cherries|tart cherries
5060401|NCT03621215|gout|gout
5060402|NCT03621215|cardiovascular disease risk|cardiovascular disease risk
5060403|NCT03621215|gout attack|gout attack
5060404|NCT03621215|gout flare|gout flare
5060405|NCT03621202|large bore|large bore
5060406|NCT03621202|femoral access|femoral access
5060407|NCT03621202|internal bleeding|internal bleeding
5060408|NCT03621202|retroperitoneal hematoma|retroperitoneal hematoma
5060409|NCT03621202|bleeding complications|bleeding complications
5060410|NCT03621176|Exercise|exercise
5060411|NCT03621176|Health-related quality of life|health-related quality of life
5060412|NCT03621176|Physical function|physical function
5060413|NCT03621176|Hemodialysis|hemodialysis
5060414|NCT03621176|Peritoneal dialysis|peritoneal dialysis
5060415|NCT03621163|bleaching agent|bleaching agent
5060416|NCT03621150|mri|mri
5060417|NCT03621150|musculoskeletal ultrasound|musculoskeletal ultrasound
5060418|NCT03621150|tendinopathy|tendinopathy
5060419|NCT03621137|Atopic Eczema|atopic eczema
5060433|NCT03621111|Antiplatelet therapy|antiplatelet therapy
5060435|NCT03621111|Lipid-lowering therapy|lipid-lowering therapy
5060436|NCT03621111|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
5060441|NCT03621072|Bioequivalence|bioequivalence
5060442|NCT03621072|Phase I|phase i
5060443|NCT03621072|Chinese|chinese
5060444|NCT03621072|Healthy Subjects|healthy subjects
5060445|NCT03621059|Tourette syndrome|tourette syndrome
5060446|NCT03621059|behavior therapy|behavior therapy
5060447|NCT03621059|children and adolescents|children and adolescents
5060448|NCT03621046|motor;|motor;
5060449|NCT03621046|cognition|cognition
5060453|NCT03621007|POMC|pomc
5060454|NCT03621007|LEPR|lepr
5060455|NCT03621007|PCSK1|pcsk1
5060456|NCT03621007|Bi-Allelic Loss|bi-allelic loss
5060457|NCT03621007|Obesity|obesity
5937905|NCT01893372|MDS|mds
5060458|NCT03620994|Irritable Bowel Syndrome|irritable bowel syndrome
5060459|NCT03620994|alarm symptoms|alarm symptoms
5060460|NCT03620994|Roman IV|roman iv
5060461|NCT03620968|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5060462|NCT03620968|Cognitive training|cognitive training
5060463|NCT03620968|Anaesthesia in Non-cardiac surgery|anaesthesia in non-cardiac surgery
5060464|NCT03620968|Elderly adult|elderly adult
5060465|NCT03620968|Perioperative management.|perioperative management.
5060469|NCT03620929|estradiol|estradiol
5060470|NCT03620916|liver resection|liver resection
5060471|NCT03620916|analgesia|analgesia
5060472|NCT03620916|pain|pain
5060473|NCT03620916|postoperative recovery|postoperative recovery
5060475|NCT03620890|Pregnancy|pregnancy
5926469|NCT04047238|Elderly|elderly
5060476|NCT03620851|enhanced recovery program|enhanced recovery program
5060477|NCT03620851|colorectal surgery|colorectal surgery
5060478|NCT03620851|elderly|elderly
5060479|NCT03620812|rapeseed, protein, postprandial, glucose|rapeseed, protein, postprandial, glucose
5060480|NCT03620799|Roller intervention|roller intervention
5060481|NCT03620799|Knee pain|knee pain
5060482|NCT03620799|Algometry|algometry
5060483|NCT03620760|Unstable Angina|unstable angina
5060484|NCT03620760|Stent|stent
5060485|NCT03620760|Ticagrelor|ticagrelor
5060486|NCT03620760|Platelet aggregation|platelet aggregation
5060487|NCT03620760|Percutaneous Coronary Intervention|percutaneous coronary intervention
5060488|NCT03620760|Coronary Artery Disease|coronary artery disease
5926552|NCT04040894|Autoimmune Thyroid Disease|autoimmune thyroid disease
5086419|NCT03458208|AUC|auc
5060489|NCT03620760|Major Adverse Cardiovascular and Cerebrovascular Events|major adverse cardiovascular and cerebrovascular events
5060490|NCT03620760|Bleeding Events|bleeding events
5060491|NCT03620708|tobacco|tobacco
5060492|NCT03620708|smoking|smoking
5060493|NCT03620708|cigarette|cigarette
5060494|NCT03620669|Lung cancer|lung cancer
5060495|NCT03620669|Durvalumab|durvalumab
5060496|NCT03620669|PD-L1|pd-l1
5060497|NCT03620669|NSCLC|nsclc
5060498|NCT03620669|Phase II|phase ii
5060499|NCT03620669|PS 2|ps 2
5060500|NCT03620656|Atrial Fibrillation|atrial fibrillation
5060501|NCT03620656|FibriCheck|fibricheck
5060502|NCT03620656|Validation|validation
5060503|NCT03620656|Smartphone|smartphone
5060504|NCT03620656|Smartwatch|smartwatch
5733871|NCT00379353|Placebo|placebo
5060505|NCT03620643|Advanced E-cadherin negative gastric cancer|advanced e-cadherin negative gastric cancer
5060506|NCT03620643|Oestrogen receptor positive lobular breast cancer|oestrogen receptor positive lobular breast cancer
5060507|NCT03620643|Crizotinib|crizotinib
5060508|NCT03620643|Fulvestrant|fulvestrant
5060511|NCT03620604|single incision sling|single incision sling
5060512|NCT03620604|safety|safety
5060513|NCT03620604|efficacy|efficacy
5060530|NCT03620565|Native tissue|native tissue
5060531|NCT03620565|Tape|tape
5060532|NCT03620565|Complication|complication
5060533|NCT03620565|the CTS coding|the cts coding
5060534|NCT03620552|18F-S16|18f-s16
5060535|NCT03620552|Neurodegenerative Dementia|neurodegenerative dementia
5060536|NCT03620552|PET/CT|pet/ct
5060537|NCT03620539|flow-mediated dilation|flow-mediated dilation
5060538|NCT03620539|sauna|sauna
5060539|NCT03620539|vascular|vascular
5060540|NCT03620539|heat|heat
5060541|NCT03620526|Iloprost|iloprost
5060542|NCT03620526|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5060543|NCT03620526|hemodynamic|hemodynamic
5060544|NCT03620526|Pulmonary wedge pressure|pulmonary wedge pressure
5060546|NCT03620487|Sequencing|sequencing
5060550|NCT03620461|metastatic pancreatic cancer|metastatic pancreatic cancer
5060551|NCT03620461|real world data|real world data
5060552|NCT03620461|gemcitabine|gemcitabine
5060553|NCT03620461|nabpaclitaxel|nabpaclitaxel
5060555|NCT03620461|safety|safety
5060563|NCT03620383|Transradial access|transradial access
5060564|NCT03620383|Radial artery|radial artery
5060565|NCT03620383|Vasodilation|vasodilation
5060566|NCT03620383|Heat|heat
5060567|NCT03620370|Normobaric hyperoxia;|normobaric hyperoxia;
5060568|NCT03620370|Acute ischemic stroke;|acute ischemic stroke;
5060569|NCT03620370|vascular recanalization;|vascular recanalization;
5060570|NCT03620370|Endovascular treatment;|endovascular treatment;
5060571|NCT03620370|reperfusion therapy|reperfusion therapy
5060572|NCT03620318|Compassionate use|compassionate use
5060574|NCT03620266|acute myocardial infarction|acute myocardial infarction
5060575|NCT03620266|diet therapy|diet therapy
5060576|NCT03620266|anthocyanin|anthocyanin
5060577|NCT03620266|bilberry bush|bilberry bush
5060578|NCT03620266|exercise capacity|exercise capacity
5060579|NCT03620266|cholesterol|cholesterol
5060580|NCT03620266|beta glucans|beta glucans
5060581|NCT03620253|modafinil|modafinil
5060582|NCT03620253|remitted depression|remitted depression
5060583|NCT03620253|cognition|cognition
5060584|NCT03620227|Combined Exercise|combined exercise
5060585|NCT03620227|Beetroot juice|beetroot juice
5060586|NCT03620227|Women health|women health
5060587|NCT03620214|CHILD|child
5060588|NCT03620214|GROWTH|growth
5060589|NCT03620214|PHYSIOLOGICAL PARAMETERS|physiological parameters
5060590|NCT03620214|FACE|face
5060591|NCT03620214|MAXILLARY|maxillary
5960996|NCT04289896|Muscular extensibility|muscular extensibility
5060592|NCT03620188|Patient treatment goals|patient treatment goals
5060593|NCT03620175|Healthy Participants|healthy participants
5060594|NCT03620175|Skin|skin
5060595|NCT03620175|Dermal|dermal
5060596|NCT03620175|Biopsy|biopsy
5060597|NCT03620149|denosumab|denosumab
5060598|NCT03620149|Giant cell tumor of bone|giant cell tumor of bone
5060599|NCT03620136|Total knee prosthesis|total knee prosthesis
5060600|NCT03620136|Adductor canal block|adductor canal block
5060601|NCT03620136|Local peri-articular infiltrations|local peri-articular infiltrations
5060602|NCT03620136|Postoperative analgesia|postoperative analgesia
5060603|NCT03620136|Early rehabilitation|early rehabilitation
5060604|NCT03620136|Patient Controlled Analgesia|patient controlled analgesia
5060605|NCT03620123|SCCHN|scchn
5060606|NCT03620123|Nivolumab|nivolumab
5060607|NCT03620123|Ipilimumab|ipilimumab
5060608|NCT03620097|Autism Spectrum Disorders|autism spectrum disorders
5060609|NCT03620097|ASD|asd
5060610|NCT03620097|Children|children
5060611|NCT03620097|Autism|autism
5060612|NCT03620097|Docosahexaenoic acid|docosahexaenoic acid
5060613|NCT03620097|Inflammation|inflammation
5060614|NCT03620097|Oxidative stress|oxidative stress
5060615|NCT03620097|Intestinal microbiota|intestinal microbiota
5060616|NCT03620097|heavy metals|heavy metals
5926589|NCT04036968|Analgesia|analgesia
5060617|NCT03620071|complex chronic condition|complex chronic condition
5060618|NCT03620071|care coordination|care coordination
5060619|NCT03620071|shared decision making|shared decision making
5060620|NCT03620071|health literacy|health literacy
5060621|NCT03620019|Denosumab|denosumab
5060622|NCT03620019|Pembrolizumab|pembrolizumab
5060623|NCT03620019|Melanoma|melanoma
5060624|NCT03620019|Unresectable|unresectable
5060625|NCT03620019|Cutaneous|cutaneous
5060626|NCT03620019|Nivolumab|nivolumab
5060627|NCT03619993|R-CHOP|r-chop
5060628|NCT03619993|G-CSF|g-csf
5060629|NCT03619993|Early breast cancer|early breast cancer
5060630|NCT03619993|Anthracycline/cyclophosphamide|anthracycline/cyclophosphamide
5060631|NCT03619993|1st line|1st line
5060632|NCT03619993|immunochemotherapy|immunochemotherapy
5060633|NCT03619993|taxane|taxane
5115525|NCT03274206|HPV|hpv
5060634|NCT03619980|Prostate Cancer|prostate cancer
5060635|NCT03619980|Non interventional|non interventional
5060636|NCT03619980|Registry|registry
5060637|NCT03619967|breast cancer|breast cancer
5060638|NCT03619967|sentynel lymph node|sentynel lymph node
5060639|NCT03619967|fluorescence imaging|fluorescence imaging
5060640|NCT03619954|NK cell infusion|nk cell infusion
5060641|NCT03619941|Montmorency Tart Cherry|montmorency tart cherry
5060642|NCT03619941|Anthocyanins|anthocyanins
5060643|NCT03619941|Polyphenols|polyphenols
5060644|NCT03619941|Metabolic Syndrome|metabolic syndrome
5060645|NCT03619941|Insulin Resistance|insulin resistance
5060646|NCT03619941|Hypertension|hypertension
5060647|NCT03619941|Lipid Profile|lipid profile
5060648|NCT03619941|Prediabetes|prediabetes
5060649|NCT03619928|Dry needling|dry needling
5060650|NCT03619928|Massotherapy|massotherapy
5060651|NCT03619928|Delayed onset muscle soreness|delayed onset muscle soreness
5060652|NCT03619902|GPP|gpp
5060653|NCT03619889|Chronic Pain|chronic pain
5060654|NCT03619889|Physical Therapy modalities|physical therapy modalities
5060655|NCT03619876|CTLA4-Ig|ctla4-ig
5060656|NCT03619876|Abatacept|abatacept
5060657|NCT03619876|Myocarditis|myocarditis
5060658|NCT03619876|RA|ra
5060659|NCT03619863|Hemophilia|hemophilia
5060660|NCT03619863|Non-Factor Products|non-factor products
5060661|NCT03619863|Bypassing Agents|bypassing agents
5060662|NCT03619863|Clotting Factor Replacement Products|clotting factor replacement products
5060663|NCT03619850|Iron Deficiency Anemia, IDA, Chronic Kidney Disease, CKD, pediatrics, ferumoxytol, iron sucrose, Feraheme, Venofer|iron deficiency anemia, ida, chronic kidney disease, ckd, pediatrics, ferumoxytol, iron sucrose, feraheme, venofer
5060664|NCT03619811|esophageal disorders|esophageal disorders
5060665|NCT03619785|Nerve Block|nerve block
5060666|NCT03619785|Serratus Anterior Plane Block|serratus anterior plane block
5060667|NCT03619785|Ultrasound|ultrasound
5060668|NCT03619785|Emergency Department|emergency department
5060669|NCT03619772|hand|hand
5060670|NCT03619772|stroke|stroke
5060671|NCT03619772|therapy|therapy
5060672|NCT03619772|rehabilitation|rehabilitation
5060673|NCT03619759|Sugammadex|sugammadex
5060674|NCT03619759|Colorectal surgery|colorectal surgery
5060675|NCT03619759|postoperative complication|postoperative complication
5060676|NCT03619746|infection|infection
5060677|NCT03619733|HEART score, troponins|heart score, troponins
5060678|NCT03619720|Emotions, Respiratory Rate, Phonation|emotions, respiratory rate, phonation
5060679|NCT03619707|Luteal Phase Support|luteal phase support
5060680|NCT03619707|Cryo-warmed Embryo Transfer|cryo-warmed embryo transfer
5060681|NCT03619707|Assisted Reproductive Technology|assisted reproductive technology
5060682|NCT03619668|Effect of radiotherapy|effect of radiotherapy
5060683|NCT03619655|J1835|j1835
5060684|NCT03619655|SPECT CT|spect ct
5060685|NCT03619655|PSMA|psma
5060686|NCT03619655|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
5060687|NCT03619655|WB-MRI|wb-mri
5060688|NCT03619655|NaF|naf
5060689|NCT03619629|Kinesio-taping|kinesio-taping
5060690|NCT03619629|Mulligan|mulligan
5060691|NCT03619629|Mobilization|mobilization
5060692|NCT03619629|balance|balance
5060693|NCT03619629|ankle|ankle
5060694|NCT03619590|Teratogenicity|teratogenicity
5060695|NCT03619590|Pregnancy|pregnancy
5060696|NCT03619590|Hepatitis B|hepatitis b
5060697|NCT03619590|Twinrix|twinrix
5060698|NCT03619590|Prenatal exposure|prenatal exposure
5060699|NCT03619590|Hepatitis A|hepatitis a
5060700|NCT03619577|Mild Cognitive Impairment|mild cognitive impairment
5060701|NCT03619577|cognitive training|cognitive training
5060702|NCT03619577|exercise|exercise
5060703|NCT03619512|Richter Syndrome|richter syndrome
5060704|NCT03619512|Genomics|genomics
5060705|NCT03619512|Proteomics|proteomics
5060706|NCT03619512|Chemotherapy resistance|chemotherapy resistance
5060707|NCT03619486|Low Energy Shock Wave (LESW)|low energy shock wave (lesw)
5060708|NCT03619486|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5060709|NCT03619486|interstitial cystitis/bladder pain syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
5428257|NCT01595451|Lower Back Pain|lower back pain
5060710|NCT03619473|standard motorcycle child safety helmet|standard motorcycle child safety helmet
5060712|NCT03619473|toy/game helmet|toy/game helmet
5060713|NCT03619460|wisdom teeth|wisdom teeth
5060714|NCT03619460|extraction|extraction
5060715|NCT03619460|piezoelectric technique|piezoelectric technique
5060716|NCT03619434|Femtolaser|femtolaser
5060717|NCT03619434|Corneal Transplant|corneal transplant
5060718|NCT03619434|Keratoplasty|keratoplasty
5060719|NCT03619434|Corneal Graft|corneal graft
5060720|NCT03619434|Laser|laser
5060721|NCT03619434|Trephine|trephine
5060722|NCT03619421|zinc|zinc
5060723|NCT03619421|nutrition|nutrition
5060730|NCT03619408|PPI|ppi
5060731|NCT03619395|Cardiovascular Secondary prevention|cardiovascular secondary prevention
5060732|NCT03619395|Cardiovascular risk factors control|cardiovascular risk factors control
5060733|NCT03619382|ankle|ankle
5060734|NCT03619356|hemoglobin|hemoglobin
5060735|NCT03619356|oxygenation concentration|oxygenation concentration
5060736|NCT03619317|Heartdisease|heartdisease
5903512|NCT00357214|muscle loss|muscle loss
5115633|NCT03273257|PEA|pea
5060737|NCT03619317|Radiation|radiation
5060738|NCT03619317|Chemoradiotherapy|chemoradiotherapy
5060739|NCT03619317|cardiovascular disease|cardiovascular disease
5060740|NCT03619304|coffee, oral squamous cell carcinoma|coffee, oral squamous cell carcinoma
5060741|NCT03619278|HIV|hiv
5060742|NCT03619239|Phase 1b/2a|phase 1b/2a
5060743|NCT03619200|Primary prevention|primary prevention
5060744|NCT03619200|Adults|adults
5060745|NCT03619200|Pressure platform|pressure platform
5060746|NCT03619200|Inertial Sensors|inertial sensors
5060747|NCT03619200|Clinical Protocol|clinical protocol
5060748|NCT03619174|incontinence|incontinence
5060749|NCT03619174|urine|urine
5060750|NCT03619174|urinary|urinary
5060751|NCT03619174|pee|pee
5060752|NCT03619174|leak|leak
5060753|NCT03619174|SUI|sui
5060754|NCT03619161|atopic dermatitis|atopic dermatitis
5060755|NCT03619161|eczema|eczema
5060756|NCT03619161|bleach bath|bleach bath
5060757|NCT03619161|bacteria|bacteria
5060758|NCT03619161|bathroom|bathroom
5060759|NCT03619161|cleaning|cleaning
5060760|NCT03619135|Pain|pain
5060761|NCT03619135|Anxiety|anxiety
5060762|NCT03619135|intravenous access|intravenous access
5060763|NCT03619109|C-Reactive Protein|c-reactive protein
5060765|NCT03619109|Procalcitonin|procalcitonin
5060766|NCT03619109|Lactate|lactate
5060767|NCT03619109|In Vitro Diagnostic Product|in vitro diagnostic product
5060768|NCT03619109|IVD|ivd
5060769|NCT03619096|Gingival recession|gingival recession
5060770|NCT03619096|porcine collagen matrix|porcine collagen matrix
5060771|NCT03619096|multiple gingival recessions|multiple gingival recessions
5060772|NCT03619096|tunnel technique|tunnel technique
5060773|NCT03619083|Assessments|assessments
5060774|NCT03619083|Sensory Gating|sensory gating
5060775|NCT03619083|Attention|attention
5060776|NCT03619083|Executive Control|executive control
5060777|NCT03619083|18-240|18-240
5060778|NCT03619070|Fatigability|fatigability
5060779|NCT03619070|Postmenopausal Woman|postmenopausal woman
5060780|NCT03619070|Resistance training|resistance training
5060781|NCT03619070|Physical performance|physical performance
5060782|NCT03619070|Older adults|older adults
5060783|NCT03619044|Metastatic breast cancer|metastatic breast cancer
5060784|NCT03619044|FES-PET|fes-pet
5060785|NCT03619044|HER2-positive Breast Cancer|her2-positive breast cancer
5060786|NCT03619031|type 1 diabetes|type 1 diabetes
5060787|NCT03619031|postprandial glycemia|postprandial glycemia
5060788|NCT03619031|pizza leavening|pizza leavening
5060789|NCT03619005|Prasterone|prasterone
5060790|NCT03619005|DHEA|dhea
5060791|NCT03619005|Menopause|menopause
5060792|NCT03619005|Sexual Disorder|sexual disorder
5060793|NCT03619005|HSDD|hsdd
5060794|NCT03618992|Valley Fever|valley fever
5060795|NCT03618992|Coccidioidomycosis|coccidioidomycosis
5060796|NCT03618979|regenerative medicine|regenerative medicine
5060797|NCT03618979|low back pain|low back pain
5960997|NCT04289896|Youth players|youth players
5960998|NCT04289883|Satiety|satiety
5060798|NCT03618979|multifidus|multifidus
5060799|NCT03618979|platelet rich plasma|platelet rich plasma
5060800|NCT03618966|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5060801|NCT03618966|Muscle disease|muscle disease
5060802|NCT03618966|Neuromuscular magnetic stimulation|neuromuscular magnetic stimulation
5060803|NCT03618940|fire|fire
5060804|NCT03618940|burn injury|burn injury
5060805|NCT03618940|children|children
5060806|NCT03618940|scalds|scalds
5060807|NCT03618927|intervention|intervention
5060808|NCT03618927|health policy|health policy
5060809|NCT03618927|psychosocial health|psychosocial health
5060810|NCT03618927|education|education
5060811|NCT03618888|Out-of-Hospital Cardiac arrest|out-of-hospital cardiac arrest
5060812|NCT03618888|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5060813|NCT03618888|Automated External Defibrillator|automated external defibrillator
5060814|NCT03618888|Self-learning|self-learning
5060815|NCT03618888|Basic Life Support|basic life support
5060821|NCT03618836|Bacterial vaginosis|bacterial vaginosis
5060822|NCT03618836|Vaginal microbiota|vaginal microbiota
5060823|NCT03618836|Molecular methods|molecular methods
5060840|NCT03618771|Osteoarthritis|osteoarthritis
5060841|NCT03618771|Stability|stability
5060842|NCT03618771|Knee|knee
5060843|NCT03618771|Functional Outcome|functional outcome
5060844|NCT03618771|Gait|gait
5060845|NCT03618771|Biomechanics|biomechanics
5060846|NCT03618758|Gastric cancer|gastric cancer
5060847|NCT03618758|Peritoneal carcinomatosis|peritoneal carcinomatosis
5060848|NCT03618758|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5060849|NCT03618758|Paclitaxel|paclitaxel
5903513|NCT00357214|muscle atrophy|muscle atrophy
5060850|NCT03618758|FOLFOX|folfox
5060851|NCT03618732|stroke|stroke
5060852|NCT03618732|upper limb|upper limb
5060853|NCT03618732|motor control|motor control
5060854|NCT03618732|function|function
5060855|NCT03618732|bilateral movement|bilateral movement
5060856|NCT03618732|virtual reality|virtual reality
5060857|NCT03618719|obstructive sleep apnea|obstructive sleep apnea
5060858|NCT03618719|intermittent hypoxia|intermittent hypoxia
5060859|NCT03618719|granulocyte function|granulocyte function
5060860|NCT03618719|continuous positive airway pressure (CPAP) therapy|continuous positive airway pressure (cpap) therapy
5060861|NCT03618693|prostatectomy|prostatectomy
5060862|NCT03618693|pain|pain
5060863|NCT03618693|recovery|recovery
5060864|NCT03618680|Sleep|sleep
5060865|NCT03618641|Stage IIIB/C/D|stage iiib/c/d
5060866|NCT03618563|daily function|daily function
5060867|NCT03618563|executive functions|executive functions
5060868|NCT03618550|Pembrolizumab|pembrolizumab
5060869|NCT03618550|GVD|gvd
5060870|NCT03618550|18-160|18-160
5060871|NCT03618537|Ixazomib|ixazomib
5060872|NCT03618537|18-069|18-069
5060873|NCT03618524|heat stress|heat stress
5060874|NCT03618524|endothelial function|endothelial function
5060875|NCT03618524|hot water immersion|hot water immersion
5060876|NCT03618524|arterial stiffness|arterial stiffness
5060877|NCT03618498|macular hole|macular hole
5060878|NCT03618498|retinal detachment|retinal detachment
5060879|NCT03618498|PDR|pdr
5060880|NCT03618459|Breast surgery|breast surgery
5060881|NCT03618459|Paravertebral block|paravertebral block
5060882|NCT03618459|Pain Control|pain control
5060883|NCT03618446|Pelvic fractures|pelvic fractures
5060884|NCT03618446|mortality|mortality
5060885|NCT03618446|predictors|predictors
5060886|NCT03618446|trauma registry|trauma registry
5060887|NCT03618433|kinect|kinect
5060888|NCT03618433|breast cancer|breast cancer
5060889|NCT03618433|mastectomy|mastectomy
5060890|NCT03618433|upper extremity dysfunction|upper extremity dysfunction
5060891|NCT03618407|Influenza|influenza
5060892|NCT03618407|Antiviral Treatment|antiviral treatment
5060893|NCT03618407|Cough|cough
5060894|NCT03618407|Oseltamivir capsule|oseltamivir capsule
5060895|NCT03618407|Lotus Clear Capsule|lotus clear capsule
5060896|NCT03618394|preterms|preterms
5060897|NCT03618394|parenteral|parenteral
5060898|NCT03618394|lipid|lipid
5060899|NCT03618381|CAR T cell|car t cell
5060900|NCT03618381|Pediatric|pediatric
5060901|NCT03618381|Young Adults|young adults
5060902|NCT03618381|Non-CNS solid tumor|non-cns solid tumor
5060903|NCT03618329|COLON CANCER|colon cancer
5060904|NCT03618329|ERAS|eras
5060905|NCT03618329|NUTRITION|nutrition
5060906|NCT03618316|pharmacokinetics|pharmacokinetics
5060907|NCT03618316|Drug-drug interaction|drug-drug interaction
5060908|NCT03618290|Acute ischemic stroke|acute ischemic stroke
5060909|NCT03618290|plasma free fatty acid|plasma free fatty acid
5060915|NCT03618238|anlotinib|anlotinib
5060916|NCT03618238|L-asparaginase resistant|l-asparaginase resistant
5060917|NCT03618199|Caloric testing|caloric testing
5060918|NCT03618199|vestibular nystagmography|vestibular nystagmography
5060919|NCT03618199|VNG|vng
5060920|NCT03618199|Videonystagmography|videonystagmography
5060921|NCT03618186|African Americans|african americans
5060922|NCT03618186|neurological exam|neurological exam
5060923|NCT03618186|Dementia|dementia
5060924|NCT03618186|Alzheimer's Disease|alzheimer's disease
5060925|NCT03618173|dexamethasone|dexamethasone
5060926|NCT03618173|analgesia|analgesia
5060927|NCT03618173|lower limb blockade|lower limb blockade
5060928|NCT03618173|children|children
5060929|NCT03618173|pediatric|pediatric
5060930|NCT03618121|Videogames|videogames
5060931|NCT03618121|Commercial biofeedback device|commercial biofeedback device
5060932|NCT03618082|prospective|prospective
5060933|NCT03618082|single blind|single blind
5060949|NCT03617978|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5060951|NCT03617978|medical simulation|medical simulation
5060952|NCT03617978|leg elevation|leg elevation
5060953|NCT03617952|Cookstoves|cookstoves
5060954|NCT03617952|Household Air Pollution|household air pollution
5060955|NCT03617952|Behavior Change|behavior change
5060956|NCT03617952|Global Health|global health
5060957|NCT03617939|Tissue Repository|tissue repository
5060958|NCT03617939|Blood Samples|blood samples
5060959|NCT03617939|Biological Samples|biological samples
5060960|NCT03617939|Surveys|surveys
5060961|NCT03617939|Early Detection|early detection
5060962|NCT03617939|Risk Assessment|risk assessment
5060963|NCT03617900|ginger extract|ginger extract
5060964|NCT03617900|pain relief|pain relief
5060965|NCT03617900|postpartum women|postpartum women
5060966|NCT03617887|Core|core
5060967|NCT03617887|Isometric abdominal|isometric abdominal
5060968|NCT03617887|Gluteus medius|gluteus medius
5060969|NCT03617887|Adductor|adductor
5060970|NCT03617887|Lumbo-pelvic stability|lumbo-pelvic stability
5060971|NCT03617874|Pre-exposure prophylaxis|pre-exposure prophylaxis
5060972|NCT03617874|Human Immunodeficiency Virus|human immunodeficiency virus
5060973|NCT03617874|PrEP|prep
5060974|NCT03617874|Risk for HIV acquisition|risk for hiv acquisition
5060975|NCT03617874|PrEP candidacy|prep candidacy
5060976|NCT03617848|HFpEF|hfpef
5060977|NCT03617809|Prewarming|prewarming
5060978|NCT03617809|Perioperative hypothermia|perioperative hypothermia
5060979|NCT03617809|Esophageal thermometer|esophageal thermometer
5060980|NCT03617796|markers CD64|markers cd64
5060981|NCT03617770|type 1 diabetes|type 1 diabetes
5060982|NCT03617770|glycemic control|glycemic control
5060983|NCT03617770|sleep|sleep
5060984|NCT03617770|diabetes distress|diabetes distress
5060985|NCT03617757|Chinese|chinese
5060986|NCT03617757|Diabetes Mellitus|diabetes mellitus
5060987|NCT03617757|Impaired fasting glucose|impaired fasting glucose
5060988|NCT03617757|Incidence|incidence
5060989|NCT03617757|Progression|progression
5060990|NCT03617757|Risk factors|risk factors
5060991|NCT03617705|alcohol consumption|alcohol consumption
5060992|NCT03617692|Stage III|stage iii
5060993|NCT03617692|Stage IV|stage iv
5060994|NCT03617692|Cannabis|cannabis
5060995|NCT03617692|Lung Cancer|lung cancer
5060996|NCT03617692|Tumors|tumors
5060997|NCT03617692|Observational Study|observational study
5060998|NCT03617679|Rucaparib|rucaparib
5060999|NCT03617679|Placebo|placebo
5061000|NCT03617679|Randomized|randomized
5061001|NCT03617679|Double Blind|double blind
5061002|NCT03617679|Stage III/IV|stage iii/iv
5061006|NCT03617640|Nervous cells|nervous cells
5061007|NCT03617640|Microbiom|microbiom
5061008|NCT03617627|chronic pain|chronic pain
5061010|NCT03617627|self-management|self-management
5061011|NCT03617549|neonatal intensive care|neonatal intensive care
5061029|NCT03617510|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
5061030|NCT03617497|Alzheimer Disease|alzheimer disease
5061031|NCT03617497|Alzheimer dementia|alzheimer dementia
5061032|NCT03617497|Epilepsy|epilepsy
5061033|NCT03617497|Sleep Wake Disorders|sleep wake disorders
5061035|NCT03617497|Polysomnography|polysomnography
5061036|NCT03617497|Foramen ovale electrodes|foramen ovale electrodes
5061061|NCT03617328|polyICLC|polyiclc
5061062|NCT03617328|varlilumab|varlilumab
5061063|NCT03617328|CDX-1127|cdx-1127
5061064|NCT03617328|Montanide ISA-51|montanide isa-51
5061065|NCT03617315|Crosslinked Hyaluronic Acid|crosslinked hyaluronic acid
5061066|NCT03617315|Meibomian Gland Disfunction|meibomian gland disfunction
5061067|NCT03617315|Lubricants|lubricants
5061068|NCT03617315|Contact Lens|contact lens
5061069|NCT03617315|Dry Eye|dry eye
5061070|NCT03617302|Carotid artery stiffness|carotid artery stiffness
5061071|NCT03617302|Cerebrovascular function|cerebrovascular function
5061072|NCT03617302|Cerebral blood flow|cerebral blood flow
5061073|NCT03617302|Pulsatility|pulsatility
5061074|NCT03617302|Beetroot juice|beetroot juice
5061075|NCT03617302|Dietary Inorganic Nitrate Supplementation|dietary inorganic nitrate supplementation
5061076|NCT03617302|Cerebral Small Vessel Disease|cerebral small vessel disease
5061077|NCT03617302|Cerebrovascular Reserve|cerebrovascular reserve
5061078|NCT03617302|Neurovascular Coupling|neurovascular coupling
5061082|NCT03617224|Mycosis Fungoides (MF), Sezary Syndrome (SS), Pembrolizumab, Total Skin Electron Beam Therapy (TSEBT)|mycosis fungoides (mf), sezary syndrome (ss), pembrolizumab, total skin electron beam therapy (tsebt)
5061083|NCT03617211|pelvic reconstructive surgery|pelvic reconstructive surgery
5061084|NCT03617211|mesh|mesh
5061085|NCT03617211|native tissue|native tissue
5061086|NCT03617211|tape|tape
5960999|NCT04289883|Appetite|appetite
5961000|NCT04289883|Food structure|food structure
5061087|NCT03617211|complications|complications
5061088|NCT03617211|Category-time-site (CTS) coding|category-time-site (cts) coding
5061089|NCT03617185|Metabolic syndrome|metabolic syndrome
5061090|NCT03617185|Exercise|exercise
5061220|NCT03616366|VTE|vte
5061104|NCT03617120|3D body scanning|3d body scanning
5061105|NCT03617120|Surface topography|surface topography
5061107|NCT03617120|Quality of Life|quality of life
5061108|NCT03617094|Vertebral fracture|vertebral fracture
5061109|NCT03617094|Early Percutaneous Vertebroplasty|early percutaneous vertebroplasty
5061110|NCT03617094|Standard Conservative Treatment|standard conservative treatment
5061111|NCT03617094|Kyphosis angle|kyphosis angle
5061112|NCT03617055|kidney injury, asphyxia,cystatin c|kidney injury, asphyxia,cystatin c
5061113|NCT03617029|Deep-seated|deep-seated
5061114|NCT03617029|Needle localization|needle localization
5061115|NCT03617029|CT-guided|ct-guided
5061116|NCT03617029|Thoracoscopy|thoracoscopy
5061117|NCT03617029|Fiducial marker|fiducial marker
5061121|NCT03616990|Recidivism|recidivism
5061122|NCT03616990|Substance use|substance use
5061123|NCT03616990|Jail|jail
5061124|NCT03616990|Mental health|mental health
5061125|NCT03616990|Continuity of care|continuity of care
5061126|NCT03616990|Chicago|chicago
5061127|NCT03616990|Needs Assessment|needs assessment
5061128|NCT03616964|SLE|sle
5061129|NCT03616938|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5061130|NCT03616938|chest compression|chest compression
5061131|NCT03616938|medical simulation|medical simulation
5061132|NCT03616938|randomization|randomization
5061133|NCT03616938|quality|quality
5061135|NCT03616886|Breast cancer|breast cancer
5061136|NCT03616886|Triple negative|triple negative
5061137|NCT03616886|Metastatic|metastatic
5061144|NCT03616847|Foot volume|foot volume
5073624|NCT03538795|arm|arm
5061149|NCT03616769|Uric Acid Serum; Prospective;|uric acid serum; prospective;
5061150|NCT03616756|Nurse leader|nurse leader
5061151|NCT03616756|Resilience|resilience
5061152|NCT03616756|Parenting|parenting
5061154|NCT03616756|Depression|depression
5061155|NCT03616730|Non-invasive cardiac output monitor|non-invasive cardiac output monitor
5061156|NCT03616730|Cardiac output|cardiac output
5061157|NCT03616704|ARDS|ards
5061158|NCT03616704|strain|strain
5061159|NCT03616704|stress|stress
5061160|NCT03616704|Mechanical Power|mechanical power
5061161|NCT03616665|persistent depressive disorder|persistent depressive disorder
5061162|NCT03616665|psychotherapy|psychotherapy
5061163|NCT03616665|cognitive behavioral therapy|cognitive behavioral therapy
5061164|NCT03616665|inpatient treatment|inpatient treatment
5061165|NCT03616665|childhood maltreatment|childhood maltreatment
5061166|NCT03616665|treatment-resistance|treatment-resistance
5061167|NCT03616665|randomized controlled trial|randomized controlled trial
5061168|NCT03616665|clinical effectiveness|clinical effectiveness
5061169|NCT03616665|personalized psychotherapy|personalized psychotherapy
5061170|NCT03616665|comorbidity|comorbidity
5061171|NCT03616665|cognitive behavioral analysis system of psychotherapy|cognitive behavioral analysis system of psychotherapy
5061172|NCT03616626|Breast Cancer|breast cancer
5061173|NCT03616626|Accelerated partial Breast Irradiation|accelerated partial breast irradiation
5061174|NCT03616626|Breast cosmesis|breast cosmesis
5061175|NCT03616626|radiation Toxicity|radiation toxicity
5061176|NCT03616600|Myopia|myopia
5061177|NCT03616600|Orthokeratology|orthokeratology
5061178|NCT03616587|Breast Cancer|breast cancer
5061179|NCT03616587|Phase 1|phase 1
5061180|NCT03616587|Safety|safety
5061181|NCT03616587|Tolerability|tolerability
5061182|NCT03616587|Pharmacokinetics|pharmacokinetics
5061183|NCT03616587|ER Positive|er positive
5061184|NCT03616587|HER2 Negative|her2 negative
5061253|NCT03615989|Bone Health|bone health
5061192|NCT03616548|narrow band imaging|narrow band imaging
5061194|NCT03616509|Functional Magnetic Resonance|functional magnetic resonance
5061195|NCT03616509|Strength|strength
5061196|NCT03616509|Body composition|body composition
5061197|NCT03616496|PET imaging|pet imaging
5061198|NCT03616496|Cardiac Amyloidosis|cardiac amyloidosis
5061199|NCT03616496|Florbetaben|florbetaben
5061200|NCT03616496|Heart failure|heart failure
5112996|NCT03290534|Pd-103|pd-103
5061201|NCT03616496|Cardiology|cardiology
5061202|NCT03616483|Multiple myeloma|multiple myeloma
5061203|NCT03616483|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5061204|NCT03616483|Plasmacytoma|plasmacytoma
5061205|NCT03616483|Smoldering multiple myeloma|smoldering multiple myeloma
5114028|NCT03283826|Autoimmunity|autoimmunity
5061210|NCT03616457|Screening Diagnostic|screening diagnostic
5061211|NCT03616444|colorectal adenomatous polyps|colorectal adenomatous polyps
5061212|NCT03616444|Clinical curative effect|clinical curative effect
5061213|NCT03616431|Pancreatic malignancy|pancreatic malignancy
5061214|NCT03616431|Pancreatic enzyme insufficiency|pancreatic enzyme insufficiency
5061215|NCT03616431|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5061216|NCT03616431|Pancreo-kit breath test|pancreo-kit breath test
5061217|NCT03616405|Sequential Therapy|sequential therapy
5061218|NCT03616405|Rescue Treatment|rescue treatment
5061219|NCT03616392|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5061221|NCT03616366|SNP|snp
5061222|NCT03616366|biomarkers|biomarkers
5061223|NCT03616301|bioequivalence|bioequivalence
5061224|NCT03616301|amoxicillin|amoxicillin
5061225|NCT03616301|clavulanic acid|clavulanic acid
5061226|NCT03616301|Augmentin|augmentin
5061227|NCT03616223|Intratympanic Administration|intratympanic administration
5061228|NCT03616223|Hearing Restoration|hearing restoration
5061229|NCT03616210|mechanical ventilation|mechanical ventilation
5061230|NCT03616210|protective ventilation|protective ventilation
5061231|NCT03616210|vascular surgery|vascular surgery
5061232|NCT03616210|postoperative pulmonary complications|postoperative pulmonary complications
5061233|NCT03616197|gingival biotype of adjacent teeth|gingival biotype of adjacent teeth
5061236|NCT03616171|Sleep Behavior|sleep behavior
5061237|NCT03616171|Insulin resistance|insulin resistance
5061238|NCT03616158|Rheumatoid arthritis|rheumatoid arthritis
5061239|NCT03616158|Interstitial Lung Disease|interstitial lung disease
5061240|NCT03616158|RA|ra
5061241|NCT03616158|ILD|ild
5061242|NCT03616145|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5061243|NCT03616119|gastoesophageal reflux disease|gastoesophageal reflux disease
5061244|NCT03616119|prevalence|prevalence
5061245|NCT03616119|Azerbaijan|azerbaijan
5061246|NCT03616106|Information Visualization|information visualization
5061247|NCT03616080|cerebral palsy|cerebral palsy
5061248|NCT03616054|Airway management|airway management
5061249|NCT03616041|Severe hematochezia|severe hematochezia
5061250|NCT03616015|HSCT|hsct
5061277|NCT03615885|Polyphenols|polyphenols
5061278|NCT03615885|Metabolic Syndrome|metabolic syndrome
5061279|NCT03615885|Insulin Resistance|insulin resistance
5061280|NCT03615885|Hypertension|hypertension
5061281|NCT03615885|Lipid Profile|lipid profile
5061284|NCT03615859|Glucocorticoids|glucocorticoids
5061285|NCT03615859|Hydrocortisone|hydrocortisone
5061286|NCT03615859|Prednisolone|prednisolone
5061287|NCT03615833|peripheral artery disease|peripheral artery disease
5061288|NCT03615833|Vitamin D|vitamin d
5061289|NCT03615820|Nanovesicles|nanovesicles
5061290|NCT03615820|Aphthous ulcer|aphthous ulcer
5061291|NCT03615807|diabetic foot infections|diabetic foot infections
5061292|NCT03615807|antibiotic reduction|antibiotic reduction
5061293|NCT03615807|osteomyelitis|osteomyelitis
5061294|NCT03615807|soft tissue infections|soft tissue infections
5061295|NCT03615781|septic arthritis|septic arthritis
5061296|NCT03615781|surgery|surgery
5061297|NCT03615781|antibiotic duration|antibiotic duration
5061298|NCT03615781|remission|remission
5061299|NCT03615781|sequelae|sequelae
5061300|NCT03615755|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5061301|NCT03615755|Diabetic Foot Ulcer|diabetic foot ulcer
5061302|NCT03615755|HbA1c|hba1c
5061303|NCT03615755|Leukocyte|leukocyte
5061304|NCT03615755|Serum creatinine|serum creatinine
5061305|NCT03615742|Diesel Exhaust|diesel exhaust
5061306|NCT03615742|Air Pollution|air pollution
5061307|NCT03615742|Inhaled Corticosteroids|inhaled corticosteroids
5061308|NCT03615742|Gene Expression|gene expression
5061311|NCT03615729|Rheumatoid arthritis|rheumatoid arthritis
5061312|NCT03615729|Genetic polymorphism|genetic polymorphism
5061313|NCT03615729|RORc2 protein|rorc2 protein
5061315|NCT03615716|violence|violence
5061316|NCT03615716|adolescence|adolescence
5061317|NCT03615690|ulcerative colitis|ulcerative colitis
5061318|NCT03615690|IBD|ibd
5061319|NCT03615690|diet|diet
5061320|NCT03615690|fasting|fasting
5061321|NCT03615690|fasting mimicking diet|fasting mimicking diet
5061322|NCT03615690|UC|uc
5061323|NCT03615690|intermittent fasting|intermittent fasting
5061324|NCT03615664|Lymphoma|lymphoma
5061325|NCT03615664|Immunochemotherapy|immunochemotherapy
5061326|NCT03615664|Salvage therapy|salvage therapy
5061327|NCT03615664|Bendamustine|bendamustine
5061328|NCT03615664|Gemcitabine|gemcitabine
5061329|NCT03615664|Dexamethasone|dexamethasone
5061330|NCT03615664|Hodgkin's Lymphoma|hodgkin's lymphoma
5061331|NCT03615664|ASCT|asct
5061332|NCT03615638|Fall prevention|fall prevention
5061333|NCT03615638|Total knee arthroplasty|total knee arthroplasty
5061334|NCT03615638|Commnuity-based|commnuity-based
5061335|NCT03615625|Exercise|exercise
5061336|NCT03615625|Aging|aging
5061438|NCT03615131|Gleason score|gleason score
5061354|NCT03615534|Fenofibrate|fenofibrate
5061355|NCT03615534|treatment|treatment
5061356|NCT03615534|Obesity|obesity
5061357|NCT03615534|Atherogenic Dyslipidemia|atherogenic dyslipidemia
5061358|NCT03615508|Alpha blockers|alpha blockers
5061359|NCT03615508|Tamsulosin|tamsulosin
5061370|NCT03615404|glioblastoma|glioblastoma
5061371|NCT03615404|medulloblastoma|medulloblastoma
5061372|NCT03615404|glioma|glioma
5061373|NCT03615404|pediatric|pediatric
5061374|NCT03615404|recurrent|recurrent
5061375|NCT03615404|newly diagnosed|newly diagnosed
5061385|NCT03615352|ovarian reserve|ovarian reserve
5061386|NCT03615352|pelvic pain|pelvic pain
5061387|NCT03615339|Food supplement, Fermented food, Whey|food supplement, fermented food, whey
5061394|NCT03615313|mesothelin, PD-1, CAR T cells, solid tumor|mesothelin, pd-1, car t cells, solid tumor
5061395|NCT03615274|childhood obesity|childhood obesity
5061396|NCT03615274|cognitive training|cognitive training
5961001|NCT04289870|Tricuspid Valve|tricuspid valve
5061397|NCT03615274|executive function|executive function
5061398|NCT03615274|quality of life|quality of life
5061399|NCT03615274|neuroimaging|neuroimaging
5061400|NCT03615274|magnetic resonance|magnetic resonance
5061401|NCT03615274|connectivity|connectivity
5061402|NCT03615274|decision making|decision making
5061403|NCT03615261|prenatal maternal stress|prenatal maternal stress
5061404|NCT03615261|mindfulness|mindfulness
5061405|NCT03615261|stress reduction|stress reduction
5061406|NCT03615261|health sensing|health sensing
5061407|NCT03615261|mhealth|mhealth
5061408|NCT03615235|Apolopoprotein L1 gene (APOL1)|apolopoprotein l1 gene (apol1)
5061409|NCT03615235|Kidney Transplantation|kidney transplantation
5121180|NCT03237858|CRT-D|crt-d
5061410|NCT03615235|Kidney Donor|kidney donor
5061411|NCT03615235|United Network for Organ Sharing (UNOS)|united network for organ sharing (unos)
5061412|NCT03615235|Association of Organ Procurement Organizations (AOPO)|association of organ procurement organizations (aopo)
5061413|NCT03615235|Kidney Transplantation Outcomes Network|kidney transplantation outcomes network
5061414|NCT03615222|functional impairment|functional impairment
5061415|NCT03615222|quality of life|quality of life
5061416|NCT03615222|Veterans|veterans
5061417|NCT03615222|mindfulness|mindfulness
5061418|NCT03615222|Acceptance and Commitment Therapy|acceptance and commitment therapy
5061419|NCT03615196|NorLeu3-A(1-7)|norleu3-a(1-7)
5061420|NCT03615196|USB005|usb005
5061421|NCT03615196|aclerastide|aclerastide
5061422|NCT03615196|corneal repair|corneal repair
5061423|NCT03615196|corneal injury|corneal injury
5061432|NCT03615144|Clofarabine|clofarabine
5061433|NCT03615144|Fludarabine|fludarabine
5061434|NCT03615144|17-596|17-596
5061435|NCT03615131|Prostate cancer|prostate cancer
5061436|NCT03615131|mpMRI-TRUS fusion biopsy|mpmri-trus fusion biopsy
5061437|NCT03615131|PIRADS|pirads
5061442|NCT03615092|Acellular dermal matrix graft|acellular dermal matrix graft
5061444|NCT03615092|Root coverage|root coverage
5061445|NCT03615092|Noncarious cervical lesion|noncarious cervical lesion
5061446|NCT03615053|pharmacokinetics|pharmacokinetics
5061447|NCT03615053|popPK|poppk
5061449|NCT03615053|Hemophilia|hemophilia
5061450|NCT03615040|COPD|copd
5061451|NCT03615040|Exacerbations|exacerbations
5061452|NCT03615040|ST2 MAb|st2 mab
5061453|NCT03615040|RG6149|rg6149
5061454|NCT03615040|MSTT1041A|mstt1041a
5061455|NCT03615040|Anti-ST2|anti-st2
5061456|NCT03615040|Phase IIa|phase iia
5061457|NCT03615040|Placebo controlled|placebo controlled
5061458|NCT03614988|Polypharmacy|polypharmacy
5061459|NCT03614988|Elderly|elderly
5061460|NCT03614975|inactivated|inactivated
5061461|NCT03614975|influenza|influenza
5061462|NCT03614975|vaccine|vaccine
5733873|NCT00379327|Acupuncture|acupuncture
5061463|NCT03614962|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5061472|NCT03614910|Nanoknife|nanoknife
5061473|NCT03614884|gambling|gambling
5061474|NCT03614884|smoking|smoking
5061475|NCT03614884|online intervention|online intervention
5675005|NCT00601237|HIV|hiv
5061476|NCT03614884|Cognitive Behavioural Therapy|cognitive behavioural therapy
5061477|NCT03614884|Motivational Interviewing|motivational interviewing
5061478|NCT03614884|Randomized Controlled Trial|randomized controlled trial
5061479|NCT03614871|Tobacco|tobacco
5061480|NCT03614871|Calculus|calculus
5061484|NCT03614871|Biofilm|biofilm
5061485|NCT03614858|CD19|cd19
5061486|NCT03614858|CD22|cd22
5061487|NCT03614845|postoperative atelectasis|postoperative atelectasis
5061488|NCT03614845|mechanical ventilation|mechanical ventilation
5061489|NCT03614845|laparoscopic surgery|laparoscopic surgery
5126061|NCT03206580|functionality|functionality
5061490|NCT03614845|lung ultrasonography|lung ultrasonography
5061491|NCT03614845|volume controlled ventilation|volume controlled ventilation
5061492|NCT03614845|pressure controlled|pressure controlled
5061493|NCT03614832|ticagrelor|ticagrelor
5061494|NCT03614832|clopidogrel|clopidogrel
5061495|NCT03614832|platelet reactivity|platelet reactivity
5061496|NCT03614819|Lasers|lasers
5061497|NCT03614819|Dental enamel hypoplasia|dental enamel hypoplasia
5061498|NCT03614819|Preventive dentistry|preventive dentistry
5061499|NCT03614819|Dental caries|dental caries
5061500|NCT03614780|rurality|rurality
5061504|NCT03614702|bOPV|bopv
5061505|NCT03614702|IPV|ipv
5061506|NCT03614702|sequential immunization|sequential immunization
5061507|NCT03614702|immunogenecity|immunogenecity
5061508|NCT03614702|safety|safety
5061516|NCT03614650|immunotherapyT cellGI cancergene therapy|immunotherapyt cellgi cancergene therapy
5061518|NCT03614624|Healthy subject|healthy subject
5061519|NCT03614624|Echocardiography|echocardiography
5061520|NCT03614624|2D and 3D Strain|2d and 3d strain
5061521|NCT03614624|General Electric|general electric
5061522|NCT03614624|Philips|philips
5061523|NCT03614611|pessaries|pessaries
5061524|NCT03614611|Urinary Incontinence/therapy|urinary incontinence/therapy
5061525|NCT03614611|Patient Satisfaction|patient satisfaction
5061526|NCT03614611|Female|female
5061527|NCT03614611|Surveys and Questionnaires|surveys and questionnaires
5061528|NCT03614611|Treatment Outcome|treatment outcome
5061529|NCT03614585|Stroke|stroke
5061530|NCT03614585|Rehabilitation|rehabilitation
5061531|NCT03614585|Neurosciences|neurosciences
5061532|NCT03614585|Exercise|exercise
5061533|NCT03614585|Neurorecovery|neurorecovery
5061534|NCT03614585|Cardiovascular health|cardiovascular health
5061535|NCT03614585|High-intensity interval training|high-intensity interval training
5061536|NCT03614585|Moderate-intensity continuous training|moderate-intensity continuous training
5061537|NCT03614572|Sleep deprivation|sleep deprivation
5061538|NCT03614572|Motivational Interviewing|motivational interviewing
5061539|NCT03614572|Text reminders|text reminders
5061542|NCT03614546|radiotherapy|radiotherapy
5061543|NCT03614546|transarterial chemoembolization|transarterial chemoembolization
5061544|NCT03614533|Typhoid in Burkina Faso|typhoid in burkina faso
5061545|NCT03614533|Typhoid Conjugate Vaccine|typhoid conjugate vaccine
5061546|NCT03614507|oxygen dependent|oxygen dependent
5061547|NCT03614507|Infant Between 1 Month and 12 Months Old|infant between 1 month and 12 months old
5061548|NCT03614494|Piroxicam|piroxicam
5061549|NCT03614494|Levonorgestrel|levonorgestrel
5061550|NCT03614494|Placebo|placebo
5061551|NCT03614494|Randomised controlled control|randomised controlled control
5061552|NCT03614494|Emergency contraception|emergency contraception
5061553|NCT03614468|Infant Formula|infant formula
5061554|NCT03614429|Penile Prosthesis|penile prosthesis
5061555|NCT03614429|Urethral injury|urethral injury
5061556|NCT03614429|Urethral sterilization|urethral sterilization
5061560|NCT03614273|nebulization|nebulization
5061561|NCT03614273|adrenaline|adrenaline
5061562|NCT03614273|hypertonic saline|hypertonic saline
5061563|NCT03614273|bronchiolitis|bronchiolitis
5061564|NCT03614260|Denervation|denervation
5061565|NCT03614260|Resistant Hypertension|resistant hypertension
5061566|NCT03614260|Essential Hypertension|essential hypertension
5061567|NCT03614260|Uncontrolled Hypertension|uncontrolled hypertension
5734667|NCT00377091|thrombosis|thrombosis
5061568|NCT03614247|Lower calyceal stone|lower calyceal stone
5061569|NCT03614247|cost-effectiveness|cost-effectiveness
5061570|NCT03614247|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5061584|NCT03614208|Exercise capacity|exercise capacity
5061578|NCT03614221|Indigo naturalis|indigo naturalis
5061579|NCT03614221|Tacrolimus|tacrolimus
5061580|NCT03614208|Systemic sclerosis|systemic sclerosis
5061581|NCT03614208|Home based rehabilitation|home based rehabilitation
5061582|NCT03614208|Quality of life|quality of life
5061583|NCT03614208|Hand mobility|hand mobility
5061591|NCT03614091|Modified radical mastectomy|modified radical mastectomy
5061593|NCT03614039|diosmectite|diosmectite
5061594|NCT03614039|nutraceuticals|nutraceuticals
5061595|NCT03614039|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5061596|NCT03614039|probiotics|probiotics
5061597|NCT03614039|Lactobacillus|lactobacillus
5061598|NCT03614039|Bifidobacterium|bifidobacterium
5061599|NCT03614039|Propionibacterium|propionibacterium
5061600|NCT03613974|foot and ankle|foot and ankle
5061601|NCT03613974|day case surgery|day case surgery
5061602|NCT03613922|manual therapy|manual therapy
5061603|NCT03613922|radius fracture|radius fracture
5061604|NCT03613922|function|function
5061605|NCT03613922|disability|disability
5061606|NCT03613922|physiotherapy|physiotherapy
5061607|NCT03613883|aneurysm|aneurysm
5061608|NCT03613883|embolization|embolization
5061609|NCT03613883|stent graft|stent graft
5061610|NCT03613870|PermeaDerm, Mepilex Ag, partial thickness burn wounds|permeaderm, mepilex ag, partial thickness burn wounds
5061611|NCT03613844|Alzheimer's disease|alzheimer's disease
5128746|NCT03189758|MRI|mri
5061612|NCT03613844|Docosahexaenoic Acids|docosahexaenoic acids
5061613|NCT03613844|Apolipoprotein E4|apolipoprotein e4
5061614|NCT03613792|dynamic|dynamic
5061615|NCT03613792|flexible|flexible
5061616|NCT03613779|Lung ultrasound|lung ultrasound
5061617|NCT03613779|Heart failure|heart failure
5061618|NCT03613779|Management|management
5061619|NCT03613753|relapsed|relapsed
5061620|NCT03613740|Insulin Sensitivity|insulin sensitivity
5061621|NCT03613740|Metabolic Syndrome|metabolic syndrome
5061622|NCT03613740|Fucoxanthin|fucoxanthin
5061623|NCT03613740|Insulin Secretion|insulin secretion
5061624|NCT03613727|Vitamin C|vitamin c
5061625|NCT03613727|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
5061626|NCT03613727|Non-relapse mortality|non-relapse mortality
5061627|NCT03613727|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
5061628|NCT03613701|Moyamoya disease|moyamoya disease
5061629|NCT03613701|Endothelial progenitor cells|endothelial progenitor cells
5061630|NCT03613701|revascularization|revascularization
5061631|NCT03613675|video games|video games
5061632|NCT03613662|lumbosacral radicular pain|lumbosacral radicular pain
5061633|NCT03613662|sciatica|sciatica
5061634|NCT03613662|leg pain|leg pain
5061635|NCT03613649|AZD0914|azd0914
5061636|NCT03613649|Cardiac|cardiac
5061637|NCT03613649|ETX0914|etx0914
5061652|NCT03613519|Sleep hygiene|sleep hygiene
5061653|NCT03613519|Sleep Healthy Using the Internet (SHUTi)|sleep healthy using the internet (shuti)
5927385|NCT03941652|Gestational Diabetes|gestational diabetes
5061654|NCT03613519|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
5061655|NCT03613519|Black Women's Health Study|black women's health study
5061657|NCT03613493|self-sampling|self-sampling
5061658|NCT03613493|culture|culture
5061662|NCT03613467|Vedio-assisted thoracoscopic lobectomy|vedio-assisted thoracoscopic lobectomy
5061663|NCT03613467|Thoracotomy lobectomy|thoracotomy lobectomy
5061664|NCT03613467|Real-world evidences;|real-world evidences;
5061665|NCT03613467|pN2 NSCLC|pn2 nsclc
5061666|NCT03613441|Mindfulness|mindfulness
5061667|NCT03613441|Residency training|residency training
5061668|NCT03613376|Varicose veins|varicose veins
5061669|NCT03613376|Compression stockings|compression stockings
5061670|NCT03613376|Sclerotherapy|sclerotherapy
5061671|NCT03613376|Radiofrequency ablation|radiofrequency ablation
5061672|NCT03613350|Cystocele|cystocele
5061673|NCT03613350|Urodynamic stress incontinence|urodynamic stress incontinence
5061674|NCT03613350|Detrusor overactivity|detrusor overactivity
5061675|NCT03613350|Pad test|pad test
5061676|NCT03613350|Urodynamic study|urodynamic study
5061677|NCT03613324|Cystocele|cystocele
5061678|NCT03613324|Bladder outlet obstruction|bladder outlet obstruction
5116621|NCT03266952|stroke|stroke
5061679|NCT03613324|Detrusor underactivity|detrusor underactivity
5061680|NCT03613324|Urodynamic study|urodynamic study
5061681|NCT03613311|Cystocele|cystocele
5061682|NCT03613311|Urodynamic stress incontinence|urodynamic stress incontinence
5061683|NCT03613311|Pad test|pad test
5061684|NCT03613311|Urodynamic study|urodynamic study
5061685|NCT03613298|HIFU|hifu
5061686|NCT03613298|High Intensity Focused Ultrasound|high intensity focused ultrasound
5061697|NCT03613272|elevation of the sternum|elevation of the sternum
5061698|NCT03613272|curative effect|curative effect
5061700|NCT03613246|Aortic valve stenosis|aortic valve stenosis
5061701|NCT03613246|ALLEGRA|allegra
5061702|NCT03613233|MIGS|migs
5061703|NCT03613233|canaloplasty|canaloplasty
5061704|NCT03613233|glaucoma|glaucoma
5061705|NCT03613233|glaucoma surgery|glaucoma surgery
5061706|NCT03613233|glaucoma implant|glaucoma implant
5061707|NCT03613233|deep sclerectomy|deep sclerectomy
5061708|NCT03613233|iridencleisis|iridencleisis
5061709|NCT03613233|QoL|qol
5061710|NCT03613233|quality of life|quality of life
5061711|NCT03613233|NEI VFQ 25|nei vfq 25
5061712|NCT03613220|advanced HR+ HER2 breast cancer|advanced hr+ her2 breast cancer
5061713|NCT03613220|breast cancer|breast cancer
5061714|NCT03613220|proteomic analysis|proteomic analysis
5061715|NCT03613220|protein expression|protein expression
5061716|NCT03613220|ctDNA Analysis|ctdna analysis
5061717|NCT03613220|adult|adult
5061718|NCT03613220|LEE011|lee011
5061719|NCT03613207|Dermal open flow microperfusion|dermal open flow microperfusion
5061720|NCT03613207|dOFM|dofm
5061721|NCT03613181|ANG1005|ang1005
5061722|NCT03613181|Leptomeningeal carcinomatosis|leptomeningeal carcinomatosis
5061723|NCT03613181|Leptomeningeal disease|leptomeningeal disease
5061724|NCT03613181|Leptomeningeal metastases|leptomeningeal metastases
5061725|NCT03613181|Brain metastases|brain metastases
5061726|NCT03613181|HER2-negative|her2-negative
5061727|NCT03613181|Breast cancer|breast cancer
5061728|NCT03613181|Targeted therapy|targeted therapy
5061729|NCT03613168|Cholangiocarcinoma|cholangiocarcinoma
5061730|NCT03613168|Biliary Tract Cancer|biliary tract cancer
5061731|NCT03613168|Trastuzumab|trastuzumab
5061732|NCT03613155|Emergency|emergency
5061733|NCT03613142|Double tract|double tract
5061734|NCT03613142|Esophagogastrostomy|esophagogastrostomy
5061735|NCT03613142|Gastric cancer|gastric cancer
5061736|NCT03613142|GastroEsophageal Cancer|gastroesophageal cancer
5061737|NCT03613129|myalgic encephalomyelitis|myalgic encephalomyelitis
5061738|NCT03613129|chronic fatigue syndrome|chronic fatigue syndrome
5061739|NCT03613129|corticotropin releasing-factor receptor subtype 2 (CRF2)|corticotropin releasing-factor receptor subtype 2 (crf2)
5061740|NCT03613129|corticotropin releasing-hormone receptor subtype 2 (CRH2)|corticotropin releasing-hormone receptor subtype 2 (crh2)
5061741|NCT03613116|vitamin D|vitamin d
5061742|NCT03613116|cognitive decline|cognitive decline
5061743|NCT03613103|video laryngoscopy|video laryngoscopy
5061744|NCT03613103|airway|airway
5061745|NCT03613103|injury|injury
5061746|NCT03613103|direct laryngoscopy|direct laryngoscopy
5061747|NCT03613103|intubation|intubation
5061748|NCT03613103|endotracheal|endotracheal
5061749|NCT03613077|Survival rate|survival rate
5061750|NCT03613077|Success rate|success rate
5061751|NCT03613077|Straumann® BLX Implant Roxolid® SLActive®,|straumann® blx implant roxolid® slactive®,
5061752|NCT03613038|Dysarthria|dysarthria
5061753|NCT03613038|Speech motor performance|speech motor performance
5061754|NCT03613038|Speech motor control|speech motor control
5061755|NCT03613038|Speech kinematics|speech kinematics
5061756|NCT03613012|Pain assessment|pain assessment
5061757|NCT03613012|electroencephalographic|electroencephalographic
5061758|NCT03613012|numerical rating scale|numerical rating scale
5061759|NCT03613012|pain index|pain index
5061767|NCT03612934|life quality|life quality
5061768|NCT03612934|performance status|performance status
5061770|NCT03612921|oral amantadine|oral amantadine
5061771|NCT03612921|IV amantadine|iv amantadine
5061772|NCT03612921|tracheal intubation|tracheal intubation
5061773|NCT03612908|Hyperthyroidism|hyperthyroidism
5061774|NCT03612908|Polymorphism|polymorphism
5061775|NCT03612908|TSHβX1|tshβx1
5903514|NCT00357214|bone loss|bone loss
5961002|NCT04289870|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
5356698|NCT01918384|NPC-14|npc-14
5061776|NCT03612908|D2 THR92ALA|d2 thr92ala
5061777|NCT03612908|Hypothyroidism|hypothyroidism
5061778|NCT03612882|Sedentary Behaviour|sedentary behaviour
5061779|NCT03612882|Subjective Well-Being|subjective well-being
5061782|NCT03612869|Sanfilippo syndrome Type A|sanfilippo syndrome type a
5061783|NCT03612869|Mucopolysaccharidosis Type IIIA|mucopolysaccharidosis type iiia
5061784|NCT03612869|Lysosomal Storage Disease|lysosomal storage disease
5061785|NCT03612856|Hemodialysis|hemodialysis
5061786|NCT03612843|dry needling|dry needling
5061787|NCT03612843|adverse event|adverse event
5061788|NCT03612843|physical therapy|physical therapy
5061789|NCT03612830|The Third Space|the third space
5061790|NCT03612817|tafluprost/timolol fixed combination, 24-hour IOP control|tafluprost/timolol fixed combination, 24-hour iop control
5061791|NCT03612804|smoking cessation|smoking cessation
5061792|NCT03612804|lung cancer screening|lung cancer screening
5061793|NCT03612804|telephone counseling|telephone counseling
5061794|NCT03612804|quitline|quitline
5061795|NCT03612778|nutrition|nutrition
5061796|NCT03612778|dyslipidemia|dyslipidemia
5061797|NCT03612778|insulin resistance|insulin resistance
5061798|NCT03612778|inflammation|inflammation
5061799|NCT03612765|heart failure|heart failure
5061800|NCT03612765|self-care|self-care
5061801|NCT03612765|behavio*|behavio*
5061802|NCT03612765|intervention|intervention
5061803|NCT03612765|randomized controlled trial|randomized controlled trial
5061804|NCT03612752|Chicken essence, cognitive function|chicken essence, cognitive function
5061805|NCT03612739|CAR-T Cells|car-t cells
5061806|NCT03612739|NKR-2|nkr-2
5061808|NCT03612739|Epigenetic drug therapy|epigenetic drug therapy
5061809|NCT03612700|Cyclopropane fatty acids|cyclopropane fatty acids
5061810|NCT03612700|GC-MS|gc-ms
5061811|NCT03612687|Hemodynamic Monitoring|hemodynamic monitoring
5061812|NCT03612687|Perioperative Fluid Management|perioperative fluid management
5061813|NCT03612687|Hepatobiliary and Pancreas Surgery|hepatobiliary and pancreas surgery
5061814|NCT03612674|Mass screening|mass screening
5061815|NCT03612674|Adenoma detection rate|adenoma detection rate
5061816|NCT03612674|ARC Endocuff Vision|arc endocuff vision
5061817|NCT03612674|Colonoscopy|colonoscopy
5061818|NCT03612661|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias|disordered eating, body image, intuitive eating, undergraduates, college, unhealthy weight control behaviors, eating disorders, weight stigma, weight bias
5061819|NCT03612622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5061820|NCT03612622|Magnetic Resonance Imaging|magnetic resonance imaging
5061821|NCT03612622|Alzheimer Disease|alzheimer disease
5061822|NCT03612609|Dengue virus|dengue virus
5061823|NCT03612609|Semen|semen
5061824|NCT03612596|wearable|wearable
5061825|NCT03612596|mobile app|mobile app
5061826|NCT03612596|physical activity|physical activity
5061827|NCT03612596|survivorship|survivorship
5061828|NCT03612596|narrative|narrative
5061829|NCT03612596|identity|identity
5061830|NCT03612583|Diaphragm Dysfunction|diaphragm dysfunction
5061831|NCT03612583|Acute Respiratory Failure|acute respiratory failure
5061832|NCT03612583|Sedation|sedation
5061833|NCT03612583|Mechanical Ventilation|mechanical ventilation
5061834|NCT03612583|Lung Stress|lung stress
5061835|NCT03612570|Nano-Pulse Stimulation|nano-pulse stimulation
5061836|NCT03612570|NPS|nps
5061837|NCT03612557|Benzathine benzylpenicillin|benzathine benzylpenicillin
5061838|NCT03612557|penicillin G benzathine|penicillin g benzathine
5061839|NCT03612518|postpartum family planning|postpartum family planning
5061840|NCT03612518|RCT|rct
5061841|NCT03612518|mhealth|mhealth
5061842|NCT03612492|esmolol|esmolol
5061843|NCT03612492|lidocaine|lidocaine
5061844|NCT03612492|intubation|intubation
5061845|NCT03612492|hemodynamic response|hemodynamic response
5061846|NCT03612466|dosimetry|dosimetry
5061847|NCT03612466|radiopharmaceutical|radiopharmaceutical
5061848|NCT03612466|radiotherapy|radiotherapy
5061849|NCT03612466|Maximally tolerated dose|maximally tolerated dose
5061850|NCT03612466|MTD|mtd
5061851|NCT03612466|tumor|tumor
5061852|NCT03612466|myelosuppression|myelosuppression
5061853|NCT03612440|dexmedetomidine|dexmedetomidine
5061854|NCT03612440|oxygenation index|oxygenation index
5961003|NCT04289870|Tricuspid Regurgitation|tricuspid regurgitation
5961004|NCT04289857|Gymnastics trampoline|gymnastics trampoline
5961005|NCT04289857|Neurodynamics|neurodynamics
5961006|NCT04289857|Jump|jump
5961007|NCT04289857|Range of motion|range of motion
5961008|NCT04289857|Randomized clinical trial|randomized clinical trial
5961009|NCT04289844|Active mobilizations|active mobilizations
5961010|NCT04289844|Strength|strength
5961011|NCT04289844|Endurance|endurance
5961012|NCT04289844|Vertical Jump|vertical jump
5961013|NCT04289844|Physiotherapy|physiotherapy
5961014|NCT04289818|Diabetes Mellitus|diabetes mellitus
5961015|NCT04289818|Health coaching|health coaching
5961016|NCT04289805|Fertility preservation|fertility preservation
5961017|NCT04289805|Letrozole|letrozole
5961018|NCT04289805|Ovarian stimulation|ovarian stimulation
5961019|NCT04289779|muscle invasive|muscle invasive
5961020|NCT04289753|Geriatrics|geriatrics
5961021|NCT04289753|Quality of care|quality of care
5961022|NCT04289740|emotional disorders|emotional disorders
5961023|NCT04289740|cognitive behavioural therapy|cognitive behavioural therapy
5961024|NCT04289740|adolescents|adolescents
5961025|NCT04289714|Asthma|asthma
5139717|NCT03117504|SUI|sui
5356760|NCT01918059|Laceration|laceration
5061855|NCT03612440|respiratory index|respiratory index
5061856|NCT03612440|inflammatory factors|inflammatory factors
5061857|NCT03612414|xerostomia|xerostomia
5061858|NCT03612414|pH|ph
5061859|NCT03612414|Carnosine|carnosine
5061860|NCT03612414|karkadé|karkadé
5061861|NCT03612414|Aqualief|aqualief
5061862|NCT03612414|Mucoadhesive|mucoadhesive
5061863|NCT03612401|Spinal cord injury|spinal cord injury
5061864|NCT03612401|SCI|sci
5061865|NCT03612401|Neurogenic bladder|neurogenic bladder
5061866|NCT03612401|Overactive bladder|overactive bladder
5061867|NCT03612401|anticholinergic|anticholinergic
5061868|NCT03612401|mirabegron|mirabegron
5061869|NCT03612401|cognitive|cognitive
5061870|NCT03612401|cognition|cognition
5061871|NCT03612401|NGB|ngb
5061872|NCT03612401|OAB|oab
5735644|NCT00374205|Coartem|coartem
5061873|NCT03612362|Acute Respiratory Infection, Household Air Pollution|acute respiratory infection, household air pollution
5061874|NCT03612349|cigarettes|cigarettes
5061875|NCT03612349|smoking|smoking
5061876|NCT03612297|Antimicrobial resistance|antimicrobial resistance
5061877|NCT03612297|Antimicrobial stewardship|antimicrobial stewardship
5061878|NCT03612297|Selective reporting antimicrobial susceptibility tests|selective reporting antimicrobial susceptibility tests
5061879|NCT03612297|Escherichia coli|escherichia coli
5061880|NCT03612284|Contact lens solution|contact lens solution
5061881|NCT03612271|Hypertension|hypertension
5061882|NCT03612271|mHealth|mhealth
5061883|NCT03612258|Fibromyalgia|fibromyalgia
5061884|NCT03612258|Pain|pain
5061885|NCT03612258|Neuroimaging|neuroimaging
5061886|NCT03612258|Sensory sensitivity|sensory sensitivity
5061887|NCT03612258|Fatigue|fatigue
5061888|NCT03612232|adrenal cancer|adrenal cancer
5061889|NCT03612232|adrenal cortex neoplasm|adrenal cortex neoplasm
5061890|NCT03612232|adrenal cortical carcinoma|adrenal cortical carcinoma
5061891|NCT03612232|cabozantinib|cabozantinib
5061892|NCT03612232|c-MET|c-met
5061893|NCT03612219|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5061894|NCT03612219|Apatinib|apatinib
5061895|NCT03612219|Adjuvant treatment|adjuvant treatment
5061896|NCT03612219|Progression-free survival|progression-free survival
5061897|NCT03612141|Severe stroke|severe stroke
5061903|NCT03612128|upper extremity|upper extremity
5061904|NCT03612128|daily life activities|daily life activities
5061905|NCT03612128|functional motor capacity|functional motor capacity
5061906|NCT03612128|motor functions|motor functions
5061907|NCT03612102|Selective Mutism|selective mutism
5061908|NCT03612102|Treatment|treatment
5061909|NCT03612102|Anxiety|anxiety
5061910|NCT03612102|Intensive Treatment|intensive treatment
5061912|NCT03612102|Group Treatment|group treatment
5061913|NCT03612076|prosthetic joint infection|prosthetic joint infection
5061914|NCT03612050|Palliative care|palliative care
5061915|NCT03612050|Despair|despair
5061916|NCT03612050|Spiritual well-being|spiritual well-being
5061917|NCT03612037|pre-diabetes|pre-diabetes
5061918|NCT03612037|glucose|glucose
5061919|NCT03612037|insulin|insulin
5061920|NCT03612037|blood lipids|blood lipids
5061921|NCT03612037|alpha lipoic acid|alpha lipoic acid
5061922|NCT03612011|Hand Foot Syndrome Grade 2|hand foot syndrome grade 2
5061923|NCT03612011|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
5061924|NCT03612011|Oncology|oncology
5061925|NCT03612011|Repair Cream|repair cream
5061926|NCT03612011|Cutaneous events|cutaneous events
5061927|NCT03612011|Palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
5061928|NCT03612011|Targeted Therapies or Conventional Chemotherapy|targeted therapies or conventional chemotherapy
5061929|NCT03611998|Sex trafficking|sex trafficking
5061930|NCT03611998|Occupational therapy|occupational therapy
5927624|NCT03913650|IL-6|il-6
5142272|NCT03101618|allergen|allergen
5061931|NCT03611998|Occupation-based programming|occupation-based programming
5061941|NCT03611933|vascular complications|vascular complications
5061942|NCT03611933|vital signs|vital signs
5061943|NCT03611894|RMI|rmi
5061944|NCT03611881|lung screening|lung screening
5061945|NCT03611855|Brain-Computer Interface|brain-computer interface
5891020|NCT03938545|IMVT-1401|imvt-1401
5061946|NCT03611855|Motor Rehabilitation|motor rehabilitation
5061947|NCT03611855|Electroencephalography|electroencephalography
5061948|NCT03611855|Magnetic Resonance Imaging|magnetic resonance imaging
5061949|NCT03611829|emotional eating|emotional eating
5061950|NCT03611803|Robotic-assisted gait training|robotic-assisted gait training
5061951|NCT03611803|SCI|sci
5061952|NCT03611803|Ambulatory activity|ambulatory activity
5061953|NCT03611738|Advanced NSCLC|advanced nsclc
5061954|NCT03611738|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5061955|NCT03611738|anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
5061956|NCT03611738|ALK-negative|alk-negative
5061957|NCT03611738|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5061958|NCT03611738|wild-type (WT)|wild-type (wt)
5927691|NCT03907293|Exercise|exercise
5061959|NCT03611725|Distal radial approach|distal radial approach
5061960|NCT03611725|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5061961|NCT03611712|Cancer-related Fatigue|cancer-related fatigue
5061962|NCT03611712|Tumor response|tumor response
5961026|NCT04289714|Children|children
5061963|NCT03611712|Survival|survival
5061964|NCT03611712|Chemoradiation|chemoradiation
5061965|NCT03611712|esophageal cancer|esophageal cancer
5061966|NCT03611673|sense of smell|sense of smell
5061967|NCT03611673|smell test|smell test
5061968|NCT03611673|at-home smell test|at-home smell test
5061969|NCT03611673|essential oil|essential oil
5061970|NCT03611673|olfactory loss|olfactory loss
5061971|NCT03611660|pediatric obesity, stress|pediatric obesity, stress
5061972|NCT03611647|Microbiome|microbiome
5061973|NCT03611647|Probiotic|probiotic
5061974|NCT03611634|gut microbiote, bone and joint infection, antibiotics|gut microbiote, bone and joint infection, antibiotics
5061975|NCT03611595|13-cis-Retinoic Acid|13-cis-retinoic acid
5061976|NCT03611595|Children|children
5061977|NCT03611595|Relapsed Solid Tumors|relapsed solid tumors
5061978|NCT03611595|Refractory Solid Tumors|refractory solid tumors
5061979|NCT03611595|Solid Tumors|solid tumors
5061985|NCT03611556|pancreatic cancer|pancreatic cancer
5061986|NCT03611556|durvalumab|durvalumab
5061987|NCT03611543|Breast Cancer|breast cancer
5061988|NCT03611543|Tomosynthesis|tomosynthesis
5061989|NCT03611543|3D Mammogram|3d mammogram
5061990|NCT03611543|Diagnostic Mammogram|diagnostic mammogram
5062000|NCT03611504|Hemospray, Gastrointestinal bleeding, Gastrointestinal hemorrhage, Hemostatic powder|hemospray, gastrointestinal bleeding, gastrointestinal hemorrhage, hemostatic powder
5062001|NCT03611465|Sudden cardiac death|sudden cardiac death
5062002|NCT03611465|Electrophisiologic exploration|electrophisiologic exploration
5062003|NCT03611465|Myocardial infarction|myocardial infarction
5062004|NCT03611426|Serine protease|serine protease
5062005|NCT03611426|Tolerance|tolerance
5062006|NCT03611426|Immunogenicity|immunogenicity
5062007|NCT03611426|Safety|safety
5062008|NCT03611413|COLON PERFORATION SURGERY|colon perforation surgery
5062009|NCT03611400|Probiotic|probiotic
5061980|NCT03611595|cancer|cancer
5062013|NCT03611387|Artificial Intelligence|artificial intelligence
5062014|NCT03611361|peripheral arterial disease|peripheral arterial disease
5062015|NCT03611361|re-amputation|re-amputation
5062016|NCT03611361|optical imaging|optical imaging
5062017|NCT03611361|Computer Assisted Detection (CADe)|computer assisted detection (cade)
5062018|NCT03611348|acrofacal vitiligo, latanoprost, microneedling|acrofacal vitiligo, latanoprost, microneedling
5062019|NCT03611309|Pancreatic Cancer|pancreatic cancer
5062020|NCT03611309|Hepatocellular Cancer|hepatocellular cancer
5062021|NCT03611309|Esophageal Cancer|esophageal cancer
5062022|NCT03611309|Gastric Cancer|gastric cancer
5062023|NCT03611309|Cholangio carcinomas|cholangio carcinomas
5062024|NCT03611296|Cardiorespiratory fitness|cardiorespiratory fitness
5062025|NCT03611296|Inhibitory control|inhibitory control
5062026|NCT03611296|Motivation|motivation
5062027|NCT03611296|Food intake|food intake
5062028|NCT03611296|Body composition|body composition
5062030|NCT03611283|Sjögren's syndrome|sjögren's syndrome
5062031|NCT03611283|Topical dry mouth products|topical dry mouth products
5062032|NCT03611283|Olive Oil|olive oil
5062033|NCT03611283|Oral Health Impact Profile|oral health impact profile
5062034|NCT03611257|Bacteremia|bacteremia
5062035|NCT03611257|Optimal targeted antibiotics|optimal targeted antibiotics
5062036|NCT03611257|Antibiotic susceptibility test|antibiotic susceptibility test
5062037|NCT03611257|Antimicrobial stewardship|antimicrobial stewardship
5062038|NCT03611218|Hemodialysis|hemodialysis
5062039|NCT03611218|Hemodiafiltration|hemodiafiltration
5062040|NCT03611218|Renal replacement therapy|renal replacement therapy
5062041|NCT03611205|Oropharyngeal|oropharyngeal
5062042|NCT03611205|Squamous Cell Carcinoma|squamous cell carcinoma
5062044|NCT03611192|Multicomponent Exercise|multicomponent exercise
5062045|NCT03611192|Executive Function|executive function
5062046|NCT03611192|Balance|balance
5062047|NCT03611192|Pre-frail|pre-frail
5062048|NCT03611179|advanced ovarian cancer|advanced ovarian cancer
5062049|NCT03611179|upfront treatment|upfront treatment
5062050|NCT03611179|bevacizumab|bevacizumab
5062051|NCT03611166|proteomics|proteomics
5062052|NCT03611166|plasma|plasma
5062053|NCT03611166|chronic disorder of consciousness|chronic disorder of consciousness
5062054|NCT03611153|Heart Failure|heart failure
5062055|NCT03611153|Ejection Fraction|ejection fraction
5062056|NCT03611153|Preserved|preserved
5151426|NCT03045445|CT|ct
5062057|NCT03611153|Myeloperoxidase Inhibitor|myeloperoxidase inhibitor
5062058|NCT03611153|Exercise|exercise
5062059|NCT03611140|metabolic syndrome|metabolic syndrome
5062060|NCT03611140|gut microbiota|gut microbiota
5062061|NCT03611140|metabolic endotoxemia|metabolic endotoxemia
5062062|NCT03611140|functional foods|functional foods
5062063|NCT03611114|endothelial function|endothelial function
5062064|NCT03611114|flow mediated dilation|flow mediated dilation
5062065|NCT03611114|lipid profile|lipid profile
5062066|NCT03611114|blood pressure|blood pressure
5062067|NCT03611114|flavanones|flavanones
5062068|NCT03611114|Caucasian|caucasian
5062069|NCT03611088|Child Development|child development
5062070|NCT03611088|Kangaroo Mother Care Method|kangaroo mother care method
5062071|NCT03611088|Electromyography|electromyography
5062072|NCT03611088|Microcirculation|microcirculation
5062073|NCT03611088|Premature|premature
5961027|NCT04289714|Adherence|adherence
5062075|NCT03611062|executive function|executive function
5062077|NCT03611062|traumatic brain injury|traumatic brain injury
5062078|NCT03610971|CP-CML|cp-cml
5062079|NCT03610971|Chronic Myeloid Leukemia|chronic myeloid leukemia
5062080|NCT03610971|CML|cml
5062081|NCT03610971|combination therapy|combination therapy
5062085|NCT03610945|drug-drug interaction|drug-drug interaction
5062087|NCT03610919|oxytocin|oxytocin
5062088|NCT03610919|genotype|genotype
5062089|NCT03610919|autism trait|autism trait
5062090|NCT03610906|Pilot Study|pilot study
5062091|NCT03610906|Biological Targets|biological targets
5062092|NCT03610906|CTNNB1|ctnnb1
5062093|NCT03610906|Tumor|tumor
5062094|NCT03610893|nerve block adjuvants|nerve block adjuvants
5062095|NCT03610893|dexamethasone|dexamethasone
5062096|NCT03610893|dexmedetomidine|dexmedetomidine
5062097|NCT03610893|nerve block duration|nerve block duration
5062098|NCT03610880|healthy Chinese volunteers|healthy chinese volunteers
5062099|NCT03610880|TG-2349|tg-2349
5062100|NCT03610880|DAG181|dag181
5062101|NCT03610880|pharmacokinetics|pharmacokinetics
5062102|NCT03610880|safety|safety
5062103|NCT03610880|multiple ascending oral doses|multiple ascending oral doses
5062104|NCT03610867|safety|safety
5062105|NCT03610867|tolerability|tolerability
5062106|NCT03610867|PK|pk
5062107|NCT03610867|single ascending oral dose|single ascending oral dose
5062108|NCT03610867|multiple ascending oral doses|multiple ascending oral doses
5062109|NCT03610828|Vegetarian Diet|vegetarian diet
5062110|NCT03610828|Vegan Diet|vegan diet
5062082|NCT03610971|BCR-ABL oncogene|bcr-abl oncogene
5062111|NCT03610828|Systematic Reviews and Meta-Analysis|systematic reviews and meta-analysis
5062112|NCT03610828|Clinical practice guidelines|clinical practice guidelines
5062113|NCT03610828|Prospective cohort studies|prospective cohort studies
5062114|NCT03610828|Cardiovascular disease|cardiovascular disease
5062115|NCT03610828|Coronary heart disease|coronary heart disease
5062116|NCT03610828|Stroke|stroke
5062117|NCT03610828|Cardiovascular mortality|cardiovascular mortality
5062118|NCT03610828|Coronary heart disease mortality|coronary heart disease mortality
5062119|NCT03610828|Stroke mortality|stroke mortality
5062120|NCT03610815|Alcohol|alcohol
5062121|NCT03610815|SBIRT|sbirt
5062122|NCT03610815|Mobile Technology|mobile technology
5062123|NCT03610815|Implementation Science|implementation science
5062124|NCT03610815|Dissemination Research|dissemination research
5062125|NCT03610815|Hybrid Effectiveness-Implementation Design|hybrid effectiveness-implementation design
5062126|NCT03610802|Immunophenotyping|immunophenotyping
5062128|NCT03610802|Repository|repository
5062129|NCT03610802|HLA-Typing|hla-typing
5062130|NCT03610802|Next Generation Sequencing|next generation sequencing
5062131|NCT03610776|Portion control plate|portion control plate
5062132|NCT03610776|Visual attention|visual attention
5062133|NCT03610776|Eating rate|eating rate
5062134|NCT03610776|Cephalic satiety response|cephalic satiety response
5062135|NCT03610763|Rehabilitation Neuroscience|rehabilitation neuroscience
5062136|NCT03610763|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5062137|NCT03610763|Rehabilitation Therapy|rehabilitation therapy
5062138|NCT03610763|Neuroplasticity|neuroplasticity
5062139|NCT03610763|Transplantation|transplantation
5062140|NCT03610763|Hand Therapy|hand therapy
5062141|NCT03610763|Constraint Induced Movement Therapy|constraint induced movement therapy
5062142|NCT03610763|Peripheral Nerve Injuries|peripheral nerve injuries
5062144|NCT03610763|CIMT|cimt
5062145|NCT03610750|Community Mental Health Care|community mental health care
5062146|NCT03610750|Task-shifting|task-shifting
5062147|NCT03610724|Tisagenlecleucel|tisagenlecleucel
5062148|NCT03610724|relapsed/refractory B-cell non-Hodgkin lymphoma|relapsed/refractory b-cell non-hodgkin lymphoma
5062149|NCT03610724|pediatric patients|pediatric patients
5062150|NCT03610724|Burkitt's lymphoma (BL)|burkitt's lymphoma (bl)
5062151|NCT03610724|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5062152|NCT03610724|primary mediastinal large B-cell lymphoma (PMBCL)|primary mediastinal large b-cell lymphoma (pmbcl)
5062153|NCT03610724|gray zone lymphoma (GZL)|gray zone lymphoma (gzl)
5062154|NCT03610724|follicular lymphoma (FL)|follicular lymphoma (fl)
5062155|NCT03610724|leukapheresis|leukapheresis
5062156|NCT03610724|lymphodepleting chemotherapy (LD)|lymphodepleting chemotherapy (ld)
5062157|NCT03610724|NHL|nhl
5062158|NCT03610698|caregiving|caregiving
5062159|NCT03610698|psychological well-being|psychological well-being
5062160|NCT03610698|alzheimer's|alzheimer's
5062161|NCT03610698|positive emotion|positive emotion
5062162|NCT03610685|Severe asthma|severe asthma
5062163|NCT03610685|Mepolizumab|mepolizumab
5062164|NCT03610685|IL5|il5
5062165|NCT03610685|Steroid resistance|steroid resistance
5062166|NCT03610685|Eosinophilic asthma|eosinophilic asthma
5062167|NCT03610685|Type 2 inflammation|type 2 inflammation
5062168|NCT03610659|COPD|copd
5062169|NCT03610659|Burden of disease|burden of disease
5062170|NCT03610646|Diabetic Macular Edema,|diabetic macular edema,
5062171|NCT03610646|BCVA,|bcva,
5062172|NCT03610646|ETDRS Letters.|etdrs letters.
5062173|NCT03610620|Basal cell carcinoma|basal cell carcinoma
5062174|NCT03610620|Mohs surgery|mohs surgery
5423196|NCT01616745|NTM Lung disease patients enrolled in SNUH|ntm lung disease patients enrolled in snuh
5062175|NCT03610620|Vivascope 2500 ex-vivo fluorescent confocal microscope|vivascope 2500 ex-vivo fluorescent confocal microscope
5062176|NCT03610620|Frozen section Mohs histology|frozen section mohs histology
5062177|NCT03610568|Gender Norms|gender norms
5062178|NCT03610568|Gender-Based Violence|gender-based violence
5062179|NCT03610568|Mental Health|mental health
5062180|NCT03610568|Sexual & Reproductive Health|sexual & reproductive health
5062181|NCT03610568|Adolescent Health|adolescent health
5062182|NCT03610542|Test Anxiety|test anxiety
5062183|NCT03610542|Wellbeing|wellbeing
5062184|NCT03610529|ECG Monitoring|ecg monitoring
5062185|NCT03610529|Controlled|controlled
5062186|NCT03610529|Comparative|comparative
5062187|NCT03610529|Clinical trial|clinical trial
5062188|NCT03610516|anti-CD40|anti-cd40
5062189|NCT03610516|CFZ533|cfz533
5062190|NCT03610516|moderately active lupus nephritis|moderately active lupus nephritis
5062191|NCT03610477|Microbiome|microbiome
5062192|NCT03610451|Anorexia nervosa|anorexia nervosa
5062193|NCT03610451|Floatation therapy|floatation therapy
5062194|NCT03610438|Acute Lymphoid Leukemia|acute lymphoid leukemia
5062195|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin
5062196|NCT03610412|Diabetes Mellitus Type 2|diabetes mellitus type 2
5062197|NCT03610412|IGF1|igf1
5062198|NCT03610412|Cinnamomum cassia|cinnamomum cassia
5062199|NCT03610412|Metabolic control|metabolic control
5062200|NCT03610412|Metformin|metformin
5062201|NCT03610399|treatment response|treatment response
5062202|NCT03610399|efficacy|efficacy
5062203|NCT03610399|primaquine|primaquine
5062204|NCT03610399|chloroquine|chloroquine
5062238|NCT03610204|Manual therapy|manual therapy
5062239|NCT03610204|Myofascial|myofascial
5062240|NCT03610191|biomarkers|biomarkers
5062242|NCT03610191|Cystatin C|cystatin c
5062243|NCT03610191|DNA methylation markers|dna methylation markers
5062244|NCT03610191|SNP mutations in CTNNA2 gene|snp mutations in ctnna2 gene
5062245|NCT03610139|cognitive performance|cognitive performance
5062246|NCT03610139|vitamin D3 replacement|vitamin d3 replacement
5062247|NCT03610139|Lebanon|lebanon
5062248|NCT03610126|BASKA mask|baska mask
5062249|NCT03610126|controlled ventilation|controlled ventilation
5927877|NCT03875365|POPE|pope
5062250|NCT03610113|Conservative treatment|conservative treatment
5062251|NCT03610113|Reverse shoulder arthroplasty|reverse shoulder arthroplasty
5062252|NCT03610113|Proximal humeral fractures|proximal humeral fractures
5062253|NCT03610100|Pancreatic|pancreatic
5062254|NCT03610100|Neoplasms|neoplasms
5062255|NCT03610100|Metastatic|metastatic
5062256|NCT03610100|Gemcitabine|gemcitabine
5062257|NCT03610100|Gemzar|gemzar
5062258|NCT03610100|Phosphoramidate|phosphoramidate
5062259|NCT03610100|Cytidine Aminohydrolase|cytidine aminohydrolase
5062260|NCT03610100|Deoxycytidine Kinase|deoxycytidine kinase
5062261|NCT03610100|Nucleoside Transport Proteins|nucleoside transport proteins
5062262|NCT03610100|hENT1 protein, human|hent1 protein, human
5062263|NCT03610074|thirst|thirst
5062264|NCT03610074|mouth|mouth
5062265|NCT03610074|critical care|critical care
5062266|NCT03610074|water deprivation|water deprivation
5062267|NCT03610048|Alkermes|alkermes
5062268|NCT03610048|Major depressive disorder|major depressive disorder
5062269|NCT03610048|Depression|depression
5062270|NCT03610048|ALKS 5461|alks 5461
5062271|NCT03610022|Vismodegib|vismodegib
5062272|NCT03610022|Pharmacokinetic|pharmacokinetic
5062273|NCT03610022|LC-MS/MS-MRM|lc-ms/ms-mrm
5062274|NCT03610022|Human plasma concentrations|human plasma concentrations
5062275|NCT03610022|Adverse events|adverse events
5062276|NCT03609970|Vitamin D|vitamin d
5062278|NCT03609970|Immune system|immune system
5062279|NCT03609944|ERCP|ercp
5062280|NCT03609944|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5062281|NCT03609944|pancreatitis|pancreatitis
5062282|NCT03609931|Mitral Valve|mitral valve
5062283|NCT03609918|Chinese NSCLC|chinese nsclc
5062284|NCT03609918|next-generation sequencing|next-generation sequencing
5062285|NCT03609905|ulcerative colitis (UC)|ulcerative colitis (uc)
5062286|NCT03609905|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
5062287|NCT03609879|cervical collar|cervical collar
5062288|NCT03609879|sonography|sonography
5062289|NCT03609879|adult patients|adult patients
5062290|NCT03609879|Optic nerve sheath diameter|optic nerve sheath diameter
5062291|NCT03609879|Ultrasonography|ultrasonography
5423197|NCT01616693|rotavirus|rotavirus
5062321|NCT03609697|Cardio-metabolic risks|cardio-metabolic risks
5062323|NCT03609697|Lifestyle intervention|lifestyle intervention
5062324|NCT03609697|Community-based|community-based
5062325|NCT03609684|core stabilization|core stabilization
5062326|NCT03609684|endurance|endurance
5062328|NCT03609684|children|children
5062329|NCT03609671|Breast Cancer|breast cancer
5062330|NCT03609671|Emotions Immunology|emotions immunology
5062331|NCT03609658|Vulnerable Older Adults|vulnerable older adults
5062332|NCT03609658|Nurse Navigator|nurse navigator
5062333|NCT03609658|Usual Care|usual care
5961028|NCT04289714|Electronic Monitoring devices (EMD)|electronic monitoring devices (emd)
5961029|NCT04289714|Inhalers|inhalers
5062334|NCT03609658|Family|family
5062335|NCT03609658|Multimorbid patients|multimorbid patients
5062336|NCT03609645|Fascia Iliaca Block|fascia iliaca block
5062337|NCT03609645|Femoral and Obturator Articular Branch Block|femoral and obturator articular branch block
5062338|NCT03609632|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
5062339|NCT03609632|Hypoglycaemia|hypoglycaemia
5062341|NCT03609632|Glucose|glucose
5062342|NCT03609632|Incretins|incretins
5062343|NCT03609632|Stable isotope|stable isotope
5062344|NCT03609606|Dyslipidemia|dyslipidemia
5062345|NCT03609606|Hypertension|hypertension
5062346|NCT03609606|CKD-386|ckd-386
5062347|NCT03609606|Drug-Drug Interaction|drug-drug interaction
5062348|NCT03609593|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5062349|NCT03609593|Leukemia|leukemia
5062350|NCT03609593|Bendamustine|bendamustine
5062351|NCT03609593|Rituximab|rituximab
5062352|NCT03609593|Venetoclax|venetoclax
5062353|NCT03609580|post operative urinary retention|post operative urinary retention
5062354|NCT03609580|inability to urinate|inability to urinate
5062355|NCT03609580|urinary retentions|urinary retentions
5062356|NCT03609580|lung cancer|lung cancer
5062357|NCT03609580|VATs|vats
5062358|NCT03609580|Robotic Lung Surgery|robotic lung surgery
5062359|NCT03609580|lung resections|lung resections
5062360|NCT03609554|trunk flexor endurance|trunk flexor endurance
5062361|NCT03609554|trunk extensor endurance|trunk extensor endurance
5062362|NCT03609554|hamstring extensibility|hamstring extensibility
5062363|NCT03609502|sleep|sleep
5062364|NCT03609502|memory consolidation|memory consolidation
5062365|NCT03609502|speech perception|speech perception
5062366|NCT03609489|Biliary cancer|biliary cancer
5062367|NCT03609489|adjuvant therapy|adjuvant therapy
5062368|NCT03609489|apatinib|apatinib
5062369|NCT03609489|capecitabine|capecitabine
5062370|NCT03609463|diabetes|diabetes
5062371|NCT03609463|overweight|overweight
5062372|NCT03609463|obesity|obesity
5062373|NCT03609463|well-being|well-being
5062374|NCT03609463|behavioral|behavioral
5062375|NCT03609463|small change|small change
5062376|NCT03609463|weight loss|weight loss
5062377|NCT03609437|Embolic stroke|embolic stroke
5062378|NCT03609437|Arterial stiffness|arterial stiffness
5062379|NCT03609437|Endothelial function|endothelial function
5062380|NCT03609437|Endothelial glycocalyx|endothelial glycocalyx
5062381|NCT03609437|Left ventricular function|left ventricular function
5062382|NCT03609437|Oxidative stress|oxidative stress
5062384|NCT03609385|troponin|troponin
5062385|NCT03609385|acute coronary syndrome|acute coronary syndrome
5062386|NCT03609385|culprit lesion|culprit lesion
5062387|NCT03609372|HPV|hpv
5062388|NCT03609372|Vaccination|vaccination
5062389|NCT03609372|Practice Based Research|practice based research
5062390|NCT03609359|lenvatinib, pembrolizumab, phase II, gastric cancer|lenvatinib, pembrolizumab, phase ii, gastric cancer
5062391|NCT03609346|STEMI|stemi
5062392|NCT03609320|HPV|hpv
5062393|NCT03609320|Vaccination|vaccination
5062394|NCT03609320|Practice Based Intervention|practice based intervention
5062395|NCT03609294|Fimasartan|fimasartan
5062396|NCT03609294|Linagliptin|linagliptin
5062397|NCT03609268|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
5062398|NCT03609268|Microwave ablation|microwave ablation
5062399|NCT03609268|Stereotactic body radiotherapy|stereotactic body radiotherapy
5062400|NCT03609268|Small liver cancer|small liver cancer
5062401|NCT03609242|HPV|hpv
5062402|NCT03609242|Vaccination|vaccination
5155472|NCT03020433|CVA|cva
5062403|NCT03609242|Practice Based Intervention|practice based intervention
5062405|NCT03609164|arthroscopic surgery|arthroscopic surgery
5062406|NCT03609164|massive rotator cuff repair|massive rotator cuff repair
5062407|NCT03609164|single-row repair|single-row repair
5062408|NCT03609164|suture-spanning augmentation|suture-spanning augmentation
5062409|NCT03609151|Hepatocellular carcinoma|hepatocellular carcinoma
5062410|NCT03609151|Early-stage liver cancer|early-stage liver cancer
5062411|NCT03609151|Hepatectomy|hepatectomy
5062412|NCT03609151|Stereotactic body radiotherapy|stereotactic body radiotherapy
5062413|NCT03609125|cord blood|cord blood
5062414|NCT03609125|neuroprotection|neuroprotection
5062415|NCT03609125|growth factors|growth factors
5062416|NCT03609073|endoscopy|endoscopy
5062417|NCT03609073|mini invasive|mini invasive
5062418|NCT03609060|Elderly patients|elderly patients
5062419|NCT03609047|Breast cancer|breast cancer
5062420|NCT03609047|elderly patients|elderly patients
5062421|NCT03609047|CDK4/6 inhibitor|cdk4/6 inhibitor
5062422|NCT03608995|preterm labor|preterm labor
5062423|NCT03608995|biomarkers|biomarkers
5062424|NCT03608995|Preterm delivery threat|preterm delivery threat
5062425|NCT03608982|First aid|first aid
5062426|NCT03608982|Simulated patient|simulated patient
5062427|NCT03608982|Laypeople|laypeople
5062431|NCT03608969|Quality of Life|quality of life
5062432|NCT03608956|regional oximetry|regional oximetry
5062433|NCT03608956|cerebral oximetry|cerebral oximetry
5062434|NCT03608943|glucocorticoids|glucocorticoids
5062435|NCT03608943|prednisolone|prednisolone
5062436|NCT03608943|hydrocortisone|hydrocortisone
5062437|NCT03608917|Vitiligo|vitiligo
5961030|NCT04289714|Inhaled medication|inhaled medication
5062438|NCT03608917|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
5062439|NCT03608917|narrow-band ultraviolet B (NB-UVB)|narrow-band ultraviolet b (nb-uvb)
5062446|NCT03608839|Intravitreal dexamethasone solution|intravitreal dexamethasone solution
5062447|NCT03608839|Short term treament|short term treament
5062449|NCT03608787|Alcohol Intoxication|alcohol intoxication
5062450|NCT03608787|Alcohol Overservice|alcohol overservice
5062451|NCT03608787|Prevention|prevention
5062452|NCT03608787|Alcohol Serving Establishments|alcohol serving establishments
5062453|NCT03608774|Azithromycin|azithromycin
5062454|NCT03608774|Doxycycline|doxycycline
5062455|NCT03608774|Efficacy|efficacy
5062457|NCT03608774|Phase 4|phase 4
5062458|NCT03608774|Rectal Chlamydia|rectal chlamydia
5062459|NCT03608761|dry eye|dry eye
5062460|NCT03608761|Sjögren syndrome|sjögren syndrome
5062461|NCT03608761|Rebamipida 2%|rebamipida 2%
5062462|NCT03608761|autologous serum|autologous serum
5062463|NCT03608748|Nafld Score|nafld score
5062464|NCT03608748|Elastography|elastography
5062465|NCT03608709|Accidental falls|accidental falls
5062466|NCT03608709|Prediction model|prediction model
5062467|NCT03608696|buprenorphine|buprenorphine
5062468|NCT03608696|pharmacometrics|pharmacometrics
5062469|NCT03608657|Psoriatic Arthritis|psoriatic arthritis
5062470|NCT03608657|Canada|canada
5062471|NCT03608657|CC-10004|cc-10004
5062472|NCT03608657|Apremilast|apremilast
5062473|NCT03608657|APPRAISE|appraise
5062474|NCT03608657|Safety|safety
5062475|NCT03608657|Non-interventional|non-interventional
5062476|NCT03608657|Observation|observation
5062477|NCT03608657|DMARDs|dmards
5062478|NCT03608618|platinum resistant|platinum resistant
5062479|NCT03608618|high grade serous adenocarcinoma|high grade serous adenocarcinoma
5062480|NCT03608618|recurrence after chemotherapy|recurrence after chemotherapy
5062481|NCT03608618|intraperitoneal|intraperitoneal
5423198|NCT01616693|polio|polio
5062488|NCT03608553|Blood Brain Barrier Disruption|blood brain barrier disruption
5062489|NCT03608527|Upper limb motor rehabilitation|upper limb motor rehabilitation
5062490|NCT03608527|Voluntary movements|voluntary movements
5062491|NCT03608527|functional magnetic resonance imaging|functional magnetic resonance imaging
5062492|NCT03608501|Drug therapy|drug therapy
5062497|NCT03608462|first episode schizophrenia|first episode schizophrenia
5062498|NCT03608462|rTMS|rtms
5735645|NCT00374205|Arsucam|arsucam
5062499|NCT03608462|hippocampal neurogenesis|hippocampal neurogenesis
5062500|NCT03608462|MRS|mrs
5062501|NCT03608462|cognitive function|cognitive function
5062502|NCT03608436|Quality of recovery|quality of recovery
5062503|NCT03608436|Laparoscopic surgery|laparoscopic surgery
5062504|NCT03608436|Deep neuromuscular block|deep neuromuscular block
5062505|NCT03608436|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
5062506|NCT03608423|Intracerebral Hemorrhage|intracerebral hemorrhage
5062507|NCT03608423|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5928092|NCT03836716|ALS|als
5062508|NCT03608423|Surgical Procedures, Endoscopic|surgical procedures, endoscopic
5062509|NCT03608410|Patient reported outcomes|patient reported outcomes
5062510|NCT03608410|Internet|internet
5062511|NCT03608410|TelePRO|telepro
5062516|NCT03608358|DPP-4 inhibitor|dpp-4 inhibitor
5062517|NCT03608358|HbA1c|hba1c
5062518|NCT03608358|Incretin|incretin
5062519|NCT03608358|Dapagliflozin|dapagliflozin
5062520|NCT03608345|oral health|oral health
5062521|NCT03608345|dental plaque|dental plaque
5062522|NCT03608345|space maintenance|space maintenance
5062523|NCT03608306|Clinical Performance|clinical performance
5062524|NCT03608306|Bioactive Restorative Material|bioactive restorative material
5062525|NCT03608306|Glass Hybrid Restorative|glass hybrid restorative
5062526|NCT03608280|orbital reconstruction|orbital reconstruction
5062527|NCT03608280|3D-printed patient specific porous titanium implant|3d-printed patient specific porous titanium implant
5062529|NCT03608280|medico-economic study|medico-economic study
5062530|NCT03608267|endoscopy|endoscopy
5062531|NCT03608267|mini invasive|mini invasive
5062532|NCT03608241|female|female
5062533|NCT03608241|post-menopausal|post-menopausal
5062534|NCT03608241|healthy|healthy
5062535|NCT03608241|oral contraceptive|oral contraceptive
5675917|NCT00597285|HHV-6B|hhv-6b
5062536|NCT03608215|Dysmenorrhea|dysmenorrhea
5062537|NCT03608215|Neuromodulation|neuromodulation
5062538|NCT03608215|Transcranial direct current stimulation|transcranial direct current stimulation
5062539|NCT03608215|Neuroplasticity|neuroplasticity
5062540|NCT03608215|Neuroimaging|neuroimaging
5062541|NCT03608202|Intensive Care|intensive care
5062542|NCT03608202|Point-of-Care Ultrasound|point-of-care ultrasound
5062543|NCT03608202|Thoracic Ultrasound|thoracic ultrasound
5062544|NCT03608202|Diagnostic Techniques and procedures.|diagnostic techniques and procedures.
5062545|NCT03608189|Osteoarthritis|osteoarthritis
5062551|NCT03608176|Lifestyle Intervention|lifestyle intervention
5062552|NCT03608176|Plants|plants
5062553|NCT03608176|Water|water
5062554|NCT03608176|Weight loss|weight loss
5062555|NCT03608176|Diet|diet
5062556|NCT03608176|Overweight|overweight
5062557|NCT03608163|diabetes|diabetes
5062558|NCT03608163|hypoglycemia|hypoglycemia
5062559|NCT03608163|diazoxide|diazoxide
5062560|NCT03608163|naloxone|naloxone
5062561|NCT03608163|healthy subjects|healthy subjects
5062562|NCT03608163|low blood sugar|low blood sugar
5062563|NCT03608137|Schizophrenia ; Cannabis|schizophrenia ; cannabis
5062564|NCT03608098|Basketing|basketing
5062565|NCT03608098|Dusting|dusting
5062566|NCT03608098|Holmium Laser|holmium laser
5062567|NCT03608098|Laser Lithotripsy|laser lithotripsy
5062568|NCT03608098|Intracorporeal Lithotripsy|intracorporeal lithotripsy
5062569|NCT03608098|Urolithiasis|urolithiasis
5062571|NCT03608059|PTCy|ptcy
5062572|NCT03608059|haplo-PBSCT|haplo-pbsct
5062573|NCT03608059|GVHD|gvhd
5062574|NCT03608007|ROS1 NSCLC|ros1 nsclc
5062575|NCT03608007|X-396|x-396
5062576|NCT03607994|Neurotechnology|neurotechnology
5062577|NCT03607994|Autonomic Dysregulation|autonomic dysregulation
5062578|NCT03607994|Hyperarousal|hyperarousal
5062579|NCT03607994|Brain Electrical Activity|brain electrical activity
5062580|NCT03607994|Closed-loop|closed-loop
5062581|NCT03607994|Acoustic Stimulation|acoustic stimulation
5062582|NCT03607994|Allostasis|allostasis
5062583|NCT03607994|Insomnia|insomnia
5062588|NCT03607968|Urodynamic stress incontinence|urodynamic stress incontinence
5062590|NCT03607929|deshydration|deshydration
5062591|NCT03607929|adverse events|adverse events
5062592|NCT03607929|cesarean|cesarean
5062593|NCT03607929|fever|fever
5062594|NCT03607916|Scheduled cesarean delivery,spinal anesthesia,local anesthesia|scheduled cesarean delivery,spinal anesthesia,local anesthesia
5062595|NCT03607903|intradermal|intradermal
5062596|NCT03607903|adalimumab|adalimumab
5062597|NCT03607903|microneedle|microneedle
5062598|NCT03607903|subcutaneous|subcutaneous
5062599|NCT03607903|healthy volunteers|healthy volunteers
5062600|NCT03607890|Relatlimab|relatlimab
5062601|NCT03607890|Nivolumab|nivolumab
5062602|NCT03607890|Immunotherapy|immunotherapy
5062603|NCT03607890|Anti - PD-1|anti - pd-1
5062604|NCT03607890|Anti - LAG-3|anti - lag-3
5062605|NCT03607890|Antibodies|antibodies
5062607|NCT03607890|MMR deficient|mmr deficient
5062608|NCT03607890|Microsatellite instability|microsatellite instability
5062609|NCT03607877|Positive education|positive education
5062610|NCT03607877|Walking exercise|walking exercise
5062611|NCT03607877|Well-being|well-being
5062612|NCT03607877|Pedometer|pedometer
5062613|NCT03607877|Cardiovascular fitness|cardiovascular fitness
5062614|NCT03607838|Lumbar disc herniation|lumbar disc herniation
5062615|NCT03607838|Radiculopathy|radiculopathy
5062616|NCT03607838|Sciatica|sciatica
5062617|NCT03607838|Intradiscal injection|intradiscal injection
5062618|NCT03607838|Chemonucleolysis|chemonucleolysis
5062620|NCT03607812|Hypertension|hypertension
5062621|NCT03607812|ABPM|abpm
5062622|NCT03607799|South Asian|south asian
5062623|NCT03607799|diet|diet
5062624|NCT03607773|Multiple Sclerosis|multiple sclerosis
5062625|NCT03607773|Mindfulness|mindfulness
5062626|NCT03607747|Arterial Stiffness|arterial stiffness
5062627|NCT03607747|Pulse Wave Velocity|pulse wave velocity
5062628|NCT03607747|Peritoneal Dialysis|peritoneal dialysis
5062629|NCT03607721|deep brain stimulation|deep brain stimulation
5062630|NCT03607721|kinematics|kinematics
5062631|NCT03607721|markerless|markerless
5062632|NCT03607721|body motion evaluation|body motion evaluation
5062636|NCT03607695|cognition|cognition
5062637|NCT03607695|genetics|genetics
5062638|NCT03607630|Imagery rescripting|imagery rescripting
5062639|NCT03607630|case series|case series
5062640|NCT03607630|ImRs|imrs
5062641|NCT03607630|Psychosis|psychosis
5062642|NCT03607617|social determinants of health|social determinants of health
5062643|NCT03607617|community health clinic|community health clinic
5062644|NCT03607617|primary care|primary care
5062645|NCT03607617|electronic medical record|electronic medical record
5062646|NCT03607604|MODY|mody
5062647|NCT03607604|Diabetes Mellitus|diabetes mellitus
5062648|NCT03607604|UCPCR|ucpcr
5062649|NCT03607604|Monogenic Diabetes|monogenic diabetes
5062650|NCT03607591|rTMS|rtms
5062651|NCT03607591|Craving|craving
5062652|NCT03607591|Mood and cognitive behavior|mood and cognitive behavior
5062653|NCT03607591|Substance-Related Disorders|substance-related disorders
5062654|NCT03607578|Prevention|prevention
5062655|NCT03607552|Supplemental Screening|supplemental screening
5062661|NCT03607487|Hidradenitis suppurativa|hidradenitis suppurativa
5062662|NCT03607487|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5062663|NCT03607487|skin disease|skin disease
5062667|NCT03607383|statins|statins
5062668|NCT03607383|red rice yeast|red rice yeast
5062669|NCT03607383|adverse effects|adverse effects
5062670|NCT03607383|cholesterol, LDL|cholesterol, ldl
5062671|NCT03607383|treatment outcome|treatment outcome
5062672|NCT03607383|tolerability|tolerability
5062673|NCT03607370|Rectal cancer|rectal cancer
5062674|NCT03607370|Chemoradiotherapy|chemoradiotherapy
5961031|NCT04289701|Hypertension|hypertension
5062675|NCT03607370|Surgery|surgery
5062676|NCT03607357|High Flow Nasal Oxygen|high flow nasal oxygen
5062677|NCT03607357|Non-invasive Ventilation|non-invasive ventilation
5062678|NCT03607357|Acute Left Heart Failure|acute left heart failure
5062679|NCT03607344|Sacrocolpopexy|sacrocolpopexy
5062680|NCT03607344|Day case surgery|day case surgery
5062681|NCT03607344|Laparoscopic|laparoscopic
5062682|NCT03607331|depression|depression
5062683|NCT03607331|electro-acupuncture|electro-acupuncture
5062684|NCT03607331|auricular concha|auricular concha
5062685|NCT03607318|alcohol|alcohol
5062686|NCT03607318|suicide|suicide
5062687|NCT03607318|adolescents|adolescents
5062688|NCT03607292|Sciatic Nerve Blocks|sciatic nerve blocks
5062694|NCT03607266|Preemptive analgesia|preemptive analgesia
5062695|NCT03607266|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5062696|NCT03607266|preemptive|preemptive
5062697|NCT03607253|medial longitudinal arch|medial longitudinal arch
5062699|NCT03607227|microsurgical free flaps|microsurgical free flaps
5062700|NCT03607227|popliteal nerve block|popliteal nerve block
5062701|NCT03607227|head and neck cancer|head and neck cancer
5062702|NCT03607227|postoperative pain|postoperative pain
5062703|NCT03607201|acute coronary syndrome|acute coronary syndrome
5062704|NCT03607201|diabetes|diabetes
5062705|NCT03607201|heart failure|heart failure
5062706|NCT03607201|acute pulmonary edema|acute pulmonary edema
5062707|NCT03607201|malignant arrhythmia|malignant arrhythmia
5062708|NCT03607162|Bacteriemia|bacteriemia
5062709|NCT03607162|meningitis|meningitis
5062710|NCT03607162|Urinary tract infection|urinary tract infection
5062711|NCT03607162|antibiotic treatment|antibiotic treatment
5062712|NCT03607149|Pemetrexed|pemetrexed
5062713|NCT03607149|Non-small cell lung cancer|non-small cell lung cancer
5062714|NCT03607149|Clearance of creatine|clearance of creatine
5062715|NCT03607136|early detection|early detection
5062716|NCT03607136|health promotion|health promotion
5062717|NCT03607136|community-dwelling|community-dwelling
5062718|NCT03607136|elderly|elderly
5062719|NCT03607097|secondary prevention|secondary prevention
5062720|NCT03607097|pharmaceutical care|pharmaceutical care
5062721|NCT03607097|drug related problems|drug related problems
5062722|NCT03607097|emergency department|emergency department
5062723|NCT03607084|school-aged children|school-aged children
5062724|NCT03607084|school-based health program|school-based health program
5062725|NCT03607084|Zambia|zambia
5062726|NCT03607084|child and adolescent health|child and adolescent health
5062727|NCT03607045|Boxer's Fracture|boxer's fracture
5062728|NCT03607019|Intensive care|intensive care
5062729|NCT03607019|Critical care|critical care
5062730|NCT03607019|Poverty|poverty
5062731|NCT03607019|inequalities|inequalities
5062732|NCT03607006|Anterior maxillary region|anterior maxillary region
5062733|NCT03607006|Patient specific|patient specific
5062741|NCT03606902|Epidural, Fentanyl, Kidney, Continuous, nephrotoxic.|epidural, fentanyl, kidney, continuous, nephrotoxic.
5062742|NCT03606850|cortical excitability|cortical excitability
5062743|NCT03606850|marker of response|marker of response
5062744|NCT03606837|Prostate Cancer|prostate cancer
5062745|NCT03606837|68Ga-RM2|68ga-rm2
5062746|NCT03606837|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
5062747|NCT03606837|PET/CT|pet/ct
5062748|NCT03606837|Prostate cancer imaging|prostate cancer imaging
5062749|NCT03606824|Thyroid Hormone Replacement|thyroid hormone replacement
5062750|NCT03606824|Subclinical Hypothyroidism|subclinical hypothyroidism
5062751|NCT03606824|Dyslipidemia|dyslipidemia
5062752|NCT03606824|ASCVD|ascvd
5062753|NCT03606824|Statin|statin
5062754|NCT03606798|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5062755|NCT03606798|Behavioral disorders|behavioral disorders
5062756|NCT03606785|colorectal,blood, transfusion,haemorrhage,tranexamic acid.|colorectal,blood, transfusion,haemorrhage,tranexamic acid.
5062757|NCT03606759|Addiction|addiction
5062758|NCT03606759|High-risk relapse situation|high-risk relapse situation
5062759|NCT03606759|Craving|craving
5062760|NCT03606759|Individual cues|individual cues
5062761|NCT03606759|Individually tailored treatment|individually tailored treatment
5062762|NCT03606746|Kidney Transplant|kidney transplant
5062763|NCT03606746|Kidney Failure|kidney failure
5062764|NCT03606746|Anti-rejection therapy|anti-rejection therapy
5062765|NCT03606746|Living Donor|living donor
5062766|NCT03606746|HLA-matched|hla-matched
5062767|NCT03606746|Hematopoietic Stem Cells (HSC)|hematopoietic stem cells (hsc)
5062768|NCT03606746|CD34+|cd34+
5062769|NCT03606746|CD3+|cd3+
5062770|NCT03606746|T cells|t cells
5062771|NCT03606746|Cellular Therapy|cellular therapy
5062772|NCT03606746|Immunotherapy|immunotherapy
5062773|NCT03606746|Immunosuppression|immunosuppression
5062774|NCT03606720|Pelvic Girdle Pain|pelvic girdle pain
5062775|NCT03606720|low level laser therapy|low level laser therapy
5062776|NCT03606720|pelvic stabilization exercises|pelvic stabilization exercises
5062777|NCT03606720|postpartum pain|postpartum pain
5062778|NCT03606694|dihydromyricetin|dihydromyricetin
5062779|NCT03606694|metformin|metformin
5062780|NCT03606694|type 2 diabetes mellitus|type 2 diabetes mellitus
5062781|NCT03606681|Dental Pulp|dental pulp
5062782|NCT03606681|calcium hydroxide|calcium hydroxide
5062783|NCT03606681|Dental Pulp Capping|dental pulp capping
5062784|NCT03606655|kava|kava
5062785|NCT03606655|tobacco|tobacco
5062786|NCT03606655|cessation|cessation
5062787|NCT03606655|cancer|cancer
5062788|NCT03606655|nicotine|nicotine
5062790|NCT03606655|metabolism|metabolism
5062791|NCT03606655|carcinogen|carcinogen
5062792|NCT03606642|Cardiovascular disease|cardiovascular disease
5062793|NCT03606642|peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
5062794|NCT03606642|Ischemia|ischemia
5062795|NCT03606616|ACOSOG Z0011|acosog z0011
5062796|NCT03606616|Chinese breast cancer|chinese breast cancer
5062797|NCT03606616|sentinel lymph node|sentinel lymph node
5062798|NCT03606616|overall survival|overall survival
5062799|NCT03606616|disease-free survival|disease-free survival
5062800|NCT03606603|nutritional status|nutritional status
5062801|NCT03606603|malnutrition|malnutrition
5062802|NCT03606603|energy intake|energy intake
5062803|NCT03606603|protein intake|protein intake
5062804|NCT03606603|ICU|icu
5062805|NCT03606603|surgical ward|surgical ward
5062806|NCT03606603|hospital|hospital
5062807|NCT03606603|enteral nutrition|enteral nutrition
5062808|NCT03606603|parenteral nutrition|parenteral nutrition
5062809|NCT03606603|nutrition|nutrition
5062810|NCT03606590|Hepatocellular Carcinoma|hepatocellular carcinoma
5062811|NCT03606590|Treatment|treatment
5062812|NCT03606590|Minimal toxicity|minimal toxicity
5062813|NCT03606590|TTFields|ttfields
5062814|NCT03606590|Tumor Treating Fields|tumor treating fields
5062815|NCT03606590|Novocure|novocure
5062816|NCT03606590|Sorafenib|sorafenib
5062817|NCT03606590|Nexavar|nexavar
5735646|NCT00374192|Menopause|menopause
5062818|NCT03606577|Multiple Myeloma|multiple myeloma
5062819|NCT03606577|Newly Diagnosed|newly diagnosed
5062820|NCT03606577|High Risk|high risk
5062821|NCT03606577|Revlimid|revlimid
5062822|NCT03606577|Carfilzomib|carfilzomib
5062823|NCT03606577|Daratumumab|daratumumab
5062824|NCT03606577|Dexaméthasone|dexaméthasone
5062825|NCT03606564|compliance|compliance
5062826|NCT03606564|fasting guidelines|fasting guidelines
5062827|NCT03606551|Self-ligating|self-ligating
5062828|NCT03606551|Orthodontic|orthodontic
5062829|NCT03606551|Esthetic|esthetic
5062833|NCT03606473|prenatal exposure|prenatal exposure
5062842|NCT03606369|Ondansetron|ondansetron
5062843|NCT03606330|coronary artery disease|coronary artery disease
5062844|NCT03606330|myocardial infarction|myocardial infarction
5062845|NCT03606330|cardiac imaging techniques|cardiac imaging techniques
5062846|NCT03606330|major adverse cardiovascular events|major adverse cardiovascular events
5062847|NCT03606330|vulnerable coronary plaques|vulnerable coronary plaques
5062848|NCT03606330|serum biomarkers|serum biomarkers
5062849|NCT03606330|coronary shear stress|coronary shear stress
5062850|NCT03606317|Lung and Pancreatic Cancer|lung and pancreatic cancer
5062851|NCT03606304|self-care|self-care
5062852|NCT03606304|quality of life|quality of life
5062853|NCT03606291|isotoxic|isotoxic
5062854|NCT03606291|hypofractionation|hypofractionation
5226131|NCT02586597|PAS|pas
5062855|NCT03606291|Non-Small-Cell Lung|non-small-cell lung
5062856|NCT03606278|Debriefing|debriefing
5062857|NCT03606252|Pneumocystis jirovecii|pneumocystis jirovecii
5062858|NCT03606252|Pneumonia|pneumonia
5062859|NCT03606252|Specialized Proresolving Mediators|specialized proresolving mediators
5062860|NCT03606252|Inflammation|inflammation
5062861|NCT03606252|prognosis|prognosis
5062862|NCT03606239|isotoxic|isotoxic
5062863|NCT03606239|hypofractionated radiotherapy|hypofractionated radiotherapy
5062864|NCT03606239|Non-Small-Cell Lung|non-small-cell lung
5062865|NCT03606213|HIV Vaccine|hiv vaccine
5062866|NCT03606213|Electroporation|electroporation
5062867|NCT03606187|Back Pain, Spinal Cord Stimulation|back pain, spinal cord stimulation
5062868|NCT03606174|MGCD516|mgcd516
5062869|NCT03606174|Antineoplastic Agents|antineoplastic agents
5062870|NCT03606174|Immunologic Factors|immunologic factors
5062871|NCT03606174|Nivolumab|nivolumab
5062872|NCT03606174|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5062873|NCT03606174|VEGFR|vegfr
5062874|NCT03606174|TAM RTKs|tam rtks
5062875|NCT03606174|PD-1|pd-1
5062883|NCT03606109|Tranexamic acid (TXA)|tranexamic acid (txa)
5062884|NCT03606096|immune response|immune response
5062885|NCT03606096|impact of acellular pertussis vaccination|impact of acellular pertussis vaccination
5062886|NCT03606083|aorto-iliac|aorto-iliac
5062887|NCT03606083|iliac|iliac
5062888|NCT03606083|aneurysm|aneurysm
5062889|NCT03606018|Pharmacokinetics|pharmacokinetics
5062890|NCT03606018|Pharmacodynamics|pharmacodynamics
5062891|NCT03606018|Insulin Lispro|insulin lispro
5062892|NCT03606005|stem cell transplantation|stem cell transplantation
5062893|NCT03606005|Pulmonary Functions|pulmonary functions
5062894|NCT03606005|exercise capacity|exercise capacity
5062895|NCT03606005|dyspnea|dyspnea
5062896|NCT03606005|Quality of Life|quality of life
5062897|NCT03606005|physical activity|physical activity
5062898|NCT03605992|Rehabilitation|rehabilitation
5246595|NCT02465840|rehabilitation|rehabilitation
5062899|NCT03605992|Coronary artery disease|coronary artery disease
5062900|NCT03605992|Home-based|home-based
5062907|NCT03605979|Low glucose suspend|low glucose suspend
5062908|NCT03605966|analgesia|analgesia
5062909|NCT03605966|pain|pain
5062910|NCT03605966|nociception|nociception
5062911|NCT03605966|pupillometry|pupillometry
5961032|NCT04289701|Blood Pressure Control|blood pressure control
5961033|NCT04289688|DR Congo|dr congo
5062912|NCT03605966|analgesic|analgesic
5062913|NCT03605966|opioid|opioid
5062914|NCT03605953|Cell therapy|cell therapy
5062915|NCT03605953|immuno-modulation|immuno-modulation
5062916|NCT03605953|immunotherapy|immunotherapy
5062917|NCT03605953|Hematology|hematology
5062918|NCT03605940|Acute-graft-versus-host Disease|acute-graft-versus-host disease
5062919|NCT03605940|Extracorporal Photopheresis|extracorporal photopheresis
5062921|NCT03605927|hematopoietic cell transplantation|hematopoietic cell transplantation
5062922|NCT03605927|antibody therapy|antibody therapy
5062923|NCT03605901|Post-operative pain|post-operative pain
5062924|NCT03605901|Spine surgery|spine surgery
5062925|NCT03605901|Methadone|methadone
5062926|NCT03605901|Opioid|opioid
5062927|NCT03605888|Nutrition|nutrition
5118124|NCT03257475|R-V|r-v
5062928|NCT03605862|Enterovirus|enterovirus
5062929|NCT03605862|Rhinovirus|rhinovirus
5062930|NCT03605849|Centanafadine|centanafadine
5062931|NCT03605849|ADD|add
5062932|NCT03605849|ADHD|adhd
5062933|NCT03605836|Centanafadine|centanafadine
5062934|NCT03605836|ADD|add
5062935|NCT03605836|ADHD|adhd
5062937|NCT03605810|Renal function, eGRF, Atrial fibrillation, Coronary artery disease, Type 2 diabetes mellitus, Machine learning, Prognostic modeling|renal function, egrf, atrial fibrillation, coronary artery disease, type 2 diabetes mellitus, machine learning, prognostic modeling
5062938|NCT03605758|Ivermectin|ivermectin
5062939|NCT03605758|S. stercoralis|s. stercoralis
5062940|NCT03605758|parasite|parasite
5062941|NCT03605758|helminth|helminth
5062942|NCT03605758|Filariform|filariform
5062943|NCT03605758|larvae|larvae
5062944|NCT03605758|Baermann technique|baermann technique
5062945|NCT03605745|BPH|bph
5062946|NCT03605745|Minimally Invasive|minimally invasive
5062947|NCT03605745|Water Vapor Therapy|water vapor therapy
5062948|NCT03605745|Rezum|rezum
5062949|NCT03605680|Centanafadine|centanafadine
5062950|NCT03605680|ADHD|adhd
5062951|NCT03605680|ADD|add
5062952|NCT03605641|E-Cigarettes|e-cigarettes
5062953|NCT03605641|Conventional Cigarettes|conventional cigarettes
5062954|NCT03605641|JUUL|juul
5062955|NCT03605641|VUSE|vuse
5062956|NCT03605615|vaginal delivery|vaginal delivery
5062957|NCT03605615|perineal tear|perineal tear
5062958|NCT03605615|randomized controled trial|randomized controled trial
5062959|NCT03605589|Blinatumomab|blinatumomab
5062960|NCT03605589|Pembrolizumab|pembrolizumab
5062961|NCT03605589|CD19 positive|cd19 positive
5062962|NCT03605589|Relapsed|relapsed
5062963|NCT03605589|Refractory|refractory
5062964|NCT03605576|Fu's subcutaneous needle|fu's subcutaneous needle
5062965|NCT03605576|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5062966|NCT03605563|Fu's subcutaneous needling (FSN)|fu's subcutaneous needling (fsn)
5062967|NCT03605563|Myofascial trigger point|myofascial trigger point
5062970|NCT03605524|Sensory training|sensory training
5062971|NCT03605524|Depression|depression
5062972|NCT03605524|Olfaction|olfaction
5062973|NCT03605524|Emotion|emotion
5062974|NCT03605524|Perception|perception
5062975|NCT03605472|primary hyperparathyroidism|primary hyperparathyroidism
5062976|NCT03605472|cervical ultrasound|cervical ultrasound
5062977|NCT03605472|echoscintigraphy|echoscintigraphy
5062978|NCT03605394|Maxillary sinus|maxillary sinus
5062979|NCT03605394|sinus septa|sinus septa
5062993|NCT03605329|Sleep Apnea, Obstructive|sleep apnea, obstructive
5062994|NCT03605329|diabetes|diabetes
5062995|NCT03605316|Deep brain stimulation|deep brain stimulation
5062996|NCT03605316|obsessive-compulsive disorder|obsessive-compulsive disorder
5062997|NCT03605316|neuromodulation|neuromodulation
5062998|NCT03605316|psychiatry|psychiatry
5063014|NCT03605225|intraoperative|intraoperative
5063015|NCT03605212|TLS|tls
5063016|NCT03605212|FLO-02|flo-02
5063017|NCT03605212|Hematological Malignancies|hematological malignancies
5063018|NCT03605199|denosumab|denosumab
5063019|NCT03605199|giant cell rich tumor of bone|giant cell rich tumor of bone
5063020|NCT03605186|chamomile cryotherapy|chamomile cryotherapy
5063021|NCT03605186|cryotherapy|cryotherapy
5063022|NCT03605186|cancer|cancer
5063023|NCT03605186|children|children
5063024|NCT03605186|pediatric|pediatric
5063025|NCT03605186|chemotherapy|chemotherapy
5063026|NCT03605160|cataract surgery|cataract surgery
5063027|NCT03605160|polish|polish
5063028|NCT03605160|residual lens fibers|residual lens fibers
5063029|NCT03605160|fluid-jet|fluid-jet
5063031|NCT03605147|sarcopenia|sarcopenia
5063032|NCT03605147|liver cirrhosis|liver cirrhosis
5735647|NCT00374192|Insomnia|insomnia
5063033|NCT03605147|chronic liver disease|chronic liver disease
5063034|NCT03605147|malnutrition|malnutrition
5063035|NCT03605147|muscle wasting|muscle wasting
5063036|NCT03605134|troponin|troponin
5063037|NCT03605134|diastolic function|diastolic function
5063038|NCT03605121|waist circumference|waist circumference
5063061|NCT03605030|Percutaneous Coronary Intervention|percutaneous coronary intervention
5063062|NCT03605030|Radiation|radiation
5063063|NCT03605030|Lead Shielding|lead shielding
5063064|NCT03605017|cognitive rehabilitation|cognitive rehabilitation
5063065|NCT03605017|attention|attention
5961034|NCT04289688|Three delays model|three delays model
5063066|NCT03605017|executive function|executive function
5063067|NCT03605004|Genetic Testing|genetic testing
5063068|NCT03605004|Variant of Uncertain Significance|variant of uncertain significance
5063069|NCT03605004|Uncertainty|uncertainty
5063070|NCT03605004|Qualitative|qualitative
5063071|NCT03604952|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5063072|NCT03604952|Ramadan observance|ramadan observance
5063073|NCT03604952|pulmonary variables|pulmonary variables
5063074|NCT03604952|postural balance|postural balance
5063075|NCT03604952|exercise performance|exercise performance
5063076|NCT03604939|cardio-vascular disease|cardio-vascular disease
5063077|NCT03604939|stroke cancer|stroke cancer
5254620|NCT02419833|PCI|pci
5063078|NCT03604939|breast cancer|breast cancer
5063079|NCT03604939|oral cancer|oral cancer
5063080|NCT03604939|cervical cancer|cervical cancer
5063081|NCT03604913|Valve sparing aortic root replacement|valve sparing aortic root replacement
5063082|NCT03604861|Opioid recovery|opioid recovery
5063083|NCT03604861|Recovery|recovery
5063084|NCT03604861|Opioid-related disorders|opioid-related disorders
5063085|NCT03604861|Substance-related disorders|substance-related disorders
5063086|NCT03604861|Heroin dependence|heroin dependence
5063087|NCT03604861|Opioid dependence|opioid dependence
5063088|NCT03604861|Addiction|addiction
5063089|NCT03604861|Buprenorphine|buprenorphine
5063090|NCT03604861|Opiate substitution treatment|opiate substitution treatment
5063091|NCT03604861|Analgesics|analgesics
5063092|NCT03604861|Opioid|opioid
5063093|NCT03604861|Narcotics|narcotics
5063094|NCT03604861|Patient outcome assessment|patient outcome assessment
5063095|NCT03604861|Patient-centered care|patient-centered care
5063096|NCT03604861|Cost of illness|cost of illness
5063097|NCT03604861|Employment|employment
5063098|NCT03604861|Health-related quality-of-life|health-related quality-of-life
5063099|NCT03604861|Family relations|family relations
5063100|NCT03604861|Lifestyle|lifestyle
5063101|NCT03604861|Citizenship|citizenship
5063102|NCT03604848|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
5063103|NCT03604848|next generation sequencing|next generation sequencing
5063104|NCT03604848|drug susceptibility test|drug susceptibility test
5063105|NCT03604848|precision treatment|precision treatment
5063106|NCT03604835|UX003|ux003
5063107|NCT03604835|Mepsevii|mepsevii
5063108|NCT03604835|vestronidase alfa-vjbk|vestronidase alfa-vjbk
5063109|NCT03604835|vestronidase alfa|vestronidase alfa
5063110|NCT03604835|recombinant human beta-glucuronidase|recombinant human beta-glucuronidase
5063111|NCT03604822|Music Therapy|music therapy
5075528|NCT03526978|poliomyelitis|poliomyelitis
5063112|NCT03604822|Neurologic Music Therapy|neurologic music therapy
5063113|NCT03604822|Rehabilitation|rehabilitation
5063114|NCT03604822|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5063115|NCT03604822|ALS|als
5063116|NCT03604796|acetaminophen|acetaminophen
5063117|NCT03604783|Tolero|tolero
5063118|NCT03604783|Phase 1|phase 1
5063119|NCT03604783|First in human|first in human
5063120|NCT03604783|Advanced Malignancy|advanced malignancy
5063121|NCT03604783|Cancer|cancer
5063122|NCT03604783|Metastatic|metastatic
5063123|NCT03604783|Progressive|progressive
5063124|NCT03604770|Caloric Intake|caloric intake
5063125|NCT03604770|Anti-mullerian hormone (AMH)|anti-mullerian hormone (amh)
5063126|NCT03604770|Antral follicles (AFC)|antral follicles (afc)
5063127|NCT03604770|Infertility|infertility
5063128|NCT03604770|Fertility|fertility
5063129|NCT03604770|Diet|diet
5063130|NCT03604770|Ovarian Reserve|ovarian reserve
5063131|NCT03604770|Obesity|obesity
5063132|NCT03604770|Nutrition|nutrition
5063133|NCT03604757|Prostate Cancer|prostate cancer
5063134|NCT03604757|68Ga-RM2|68ga-rm2
5063135|NCT03604757|bombesin|bombesin
5063136|NCT03604757|GRP-R|grp-r
5063137|NCT03604757|68Ga-Prostate Specific Membrane Antigen|68ga-prostate specific membrane antigen
5063138|NCT03604757|PSMA|psma
5063139|NCT03604757|PET/CT|pet/ct
5063141|NCT03604692|cGVHD|cgvhd
5063142|NCT03604666|Breast Cancer|breast cancer
5063143|NCT03604666|Skin cancer|skin cancer
5063144|NCT03604666|Surgery|surgery
5063145|NCT03604666|Ambulatory|ambulatory
5063146|NCT03604653|HIPEC|hipec
5063147|NCT03604653|Stomach cancer|stomach cancer
5063148|NCT03604653|colorectal cancer|colorectal cancer
5063149|NCT03604653|appendiceal cancer|appendiceal cancer
5063150|NCT03604653|ovarian cancer|ovarian cancer
5063151|NCT03604653|uterine cancer|uterine cancer
5063152|NCT03604653|cervical cancer|cervical cancer
5063153|NCT03604653|fallopian tube cancer|fallopian tube cancer
5063154|NCT03604653|primary peritoneal carcinoma|primary peritoneal carcinoma
5063155|NCT03604653|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5063156|NCT03604640|Functional impairment|functional impairment
5063157|NCT03604640|Hospital associated disability|hospital associated disability
5063158|NCT03604614|peritoneal metastatis|peritoneal metastatis
5063159|NCT03604614|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5063160|NCT03604614|Advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
5063161|NCT03604601|salvage surgery|salvage surgery
5961035|NCT04289688|Health care seeking|health care seeking
5893148|NCT03608397|DAXI|daxi
5961036|NCT04289688|Health itinerary|health itinerary
5063162|NCT03604601|recurrent laryngeal carcinoma|recurrent laryngeal carcinoma
5063163|NCT03604601|experience|experience
5063164|NCT03604575|Pharmacokinetics|pharmacokinetics
5063165|NCT03604575|Pharmacodynamics|pharmacodynamics
5063166|NCT03604575|Insulin Lispro|insulin lispro
5063167|NCT03604536|Adherence|adherence
5063169|NCT03604536|Aminosalicylate|aminosalicylate
5063170|NCT03604458|Universal Health Coverage, Surgery in resource limited settings|universal health coverage, surgery in resource limited settings
5063171|NCT03604406|Shingles|shingles
5063172|NCT03604406|abatacept|abatacept
5063173|NCT03604406|Varicella Zoster Vaccine|varicella zoster vaccine
5063174|NCT03604393|Immunization|immunization
5063175|NCT03604367|fMRI|fmri
5063176|NCT03604367|BOLD Signal|bold signal
5063177|NCT03604367|Rehabilitation|rehabilitation
5063178|NCT03604354|osteoarthritis knee,pre-emptive analgesia,TKA,Opioids,gabapentinoids|osteoarthritis knee,pre-emptive analgesia,tka,opioids,gabapentinoids
5063179|NCT03604341|Medical Abortion|medical abortion
5063180|NCT03604341|Pain|pain
5063181|NCT03604341|Cannabis|cannabis
5063182|NCT03604302|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5063183|NCT03604302|18-331|18-331
5063184|NCT03604289|angiotensin-1-7|angiotensin-1-7
5063185|NCT03604276|Headache|headache
5063186|NCT03604276|Subarachnoid hemorrhage|subarachnoid hemorrhage
5063187|NCT03604276|Neuroinflammation|neuroinflammation
5063188|NCT03604237|forceps biopsy|forceps biopsy
5063189|NCT03604237|colorectal tumors|colorectal tumors
5063190|NCT03604198|Cushing Syndrome|cushing syndrome
5063191|NCT03604198|Cushing Disease|cushing disease
5063192|NCT03604198|Cushing|cushing
5063193|NCT03604198|Hypercortisolemia|hypercortisolemia
5063194|NCT03604198|Cushingoid|cushingoid
5063195|NCT03604198|Type 2 Diabetes|type 2 diabetes
5063196|NCT03604198|Impaired Glucose Intolerance|impaired glucose intolerance
5063197|NCT03604198|Hypertension|hypertension
5063198|NCT03604198|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
5063199|NCT03604198|Adrenocortical Carcinoma|adrenocortical carcinoma
5063200|NCT03604198|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
5063201|NCT03604198|Moon Facies|moon facies
5063202|NCT03604198|Dorsocervical Fat Pad|dorsocervical fat pad
5063203|NCT03604198|Adrenal Adenoma|adrenal adenoma
5063204|NCT03604198|Adrenal Carcinoma|adrenal carcinoma
5063205|NCT03604198|Adrenal Autonomy|adrenal autonomy
5063207|NCT03604185|Hearing Loss|hearing loss
5063208|NCT03604185|Auditory Processing|auditory processing
5063209|NCT03604185|Aging|aging
5063210|NCT03604185|Speech Perception in Noise (SIN)|speech perception in noise (sin)
5063211|NCT03604185|Pitch Discrimination|pitch discrimination
5063212|NCT03604185|Frequency Following Response (FFR)|frequency following response (ffr)
5063213|NCT03604185|Choir Singing|choir singing
5063214|NCT03604185|Musical Training|musical training
5063215|NCT03604172|binge eating disorder|binge eating disorder
5063216|NCT03604172|obesity|obesity
5055498|NCT03651583|Kiko|kiko
5063217|NCT03604172|cognitive behavioral therapy|cognitive behavioral therapy
5063218|NCT03604159|Opioid dependence|opioid dependence
5063219|NCT03604159|Buprenorphine|buprenorphine
5063220|NCT03604159|primary care treatment|primary care treatment
5063221|NCT03604159|extended-release buprenorphine|extended-release buprenorphine
5063222|NCT03604146|COPD|copd
5063223|NCT03604146|Quality Control|quality control
5063224|NCT03604120|Preoxygenation|preoxygenation
5063225|NCT03604120|High flow nasal cannula|high flow nasal cannula
5063227|NCT03604081|Constraint Induced Movement Therapy|constraint induced movement therapy
5063228|NCT03604068|Caesarean section|caesarean section
5063229|NCT03604055|Hamartoma, Cryotherapy|hamartoma, cryotherapy
5063230|NCT03604029|ACS|acs
5063231|NCT03604003|CKD, bedtime dosing, isolated nocturnal hypertension|ckd, bedtime dosing, isolated nocturnal hypertension
5063232|NCT03603990|Edema|edema
5063241|NCT03603977|Real World Study|real world study
5063242|NCT03603977|HIV-1-infected patients|hiv-1-infected patients
5063243|NCT03603964|Guadecitabine|guadecitabine
5063244|NCT03603951|SHR2554|shr2554
5063245|NCT03603951|EZH2 inhibitor|ezh2 inhibitor
5063246|NCT03603951|phase 1|phase 1
5063247|NCT03603951|mature lymphoid neoplasm|mature lymphoid neoplasm
5063248|NCT03603938|potassium losartan, CKD, nondipping BP pattern|potassium losartan, ckd, nondipping bp pattern
5063249|NCT03603925|Computed tomography|computed tomography
5063250|NCT03603925|standardized update values|standardized update values
5063251|NCT03603873|Anxiety|anxiety
5063252|NCT03603873|Premedication|premedication
5063253|NCT03603873|general anaesthetic|general anaesthetic
5063254|NCT03603860|vital signs|vital signs
5063255|NCT03603860|blood pressure|blood pressure
5063256|NCT03603860|cardiac surgery|cardiac surgery
5063257|NCT03603860|non-invasive monitoring|non-invasive monitoring
5063258|NCT03603834|Neoadjuvant|neoadjuvant
5063259|NCT03603834|Potentially resectable|potentially resectable
5063260|NCT03603834|Chemotherapy|chemotherapy
5063261|NCT03603834|Bile duct cancer|bile duct cancer
5063262|NCT03603821|LUTS|luts
5063263|NCT03603821|QUESTIONNAIRE|questionnaire
5063264|NCT03603821|IPSS|ipss
5063265|NCT03603743|exercise training|exercise training
5063266|NCT03603743|chronic heart failure|chronic heart failure
5063267|NCT03603743|parasympathetic|parasympathetic
5063268|NCT03603743|autonomic nervous system|autonomic nervous system
5063269|NCT03603743|cardiorespiratory fitness|cardiorespiratory fitness
5063270|NCT03603743|cardiac rehabilitation|cardiac rehabilitation
5063273|NCT03603717|insomnia|insomnia
5063274|NCT03603717|suicidal ideation|suicidal ideation
5063275|NCT03603717|depression|depression
5063276|NCT03603717|posttraumatic stress disorder|posttraumatic stress disorder
5063277|NCT03603717|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5063278|NCT03603717|sleep|sleep
5063279|NCT03603717|suicide|suicide
5063280|NCT03603678|Obstructive sleep apnea|obstructive sleep apnea
5063281|NCT03603678|Potassium channel blocker|potassium channel blocker
5063282|NCT03603678|Polysomnography|polysomnography
5063283|NCT03603678|PSG|psg
5063284|NCT03603665|Botulism|botulism
5063285|NCT03603665|Dose Escalation|dose escalation
5063286|NCT03603665|Double-Blind|double-blind
5063287|NCT03603665|NTM-1633|ntm-1633
5063288|NCT03603665|Pharmacokinetics|pharmacokinetics
5063289|NCT03603665|Phase I|phase i
5063290|NCT03603665|Safety|safety
5063291|NCT03603652|Lung Lesions; Soft Tissue- Lung|lung lesions; soft tissue- lung
5063298|NCT03603626|Endoscopic ear surgery|endoscopic ear surgery
5063299|NCT03603626|Myringoplasty|myringoplasty
5063300|NCT03603626|Pregabalin|pregabalin
5063301|NCT03603626|Preemptive analgesia|preemptive analgesia
5063302|NCT03603587|biologic markers|biologic markers
5063303|NCT03603587|skin cancer|skin cancer
5063304|NCT03603587|solar aging of skin|solar aging of skin
5063305|NCT03603587|alopecic scalp|alopecic scalp
5063306|NCT03603574|Abdomen/surgery|abdomen/surgery
5063307|NCT03603574|Thoracic Surgery|thoracic surgery
5063308|NCT03603561|bipolar depression|bipolar depression
5063309|NCT03603561|TMS|tms
5063310|NCT03603561|transcranial magnetic stimulation|transcranial magnetic stimulation
5063311|NCT03603561|add-on treatment|add-on treatment
5063314|NCT03603522|Cough|cough
5063315|NCT03603522|Capsaicin|capsaicin
5063316|NCT03603522|Probiotics|probiotics
5063317|NCT03603522|TRPV1|trpv1
5063318|NCT03603509|Fluad, MF59, Fluzone, HDFlu, Influenza, Vaccine|fluad, mf59, fluzone, hdflu, influenza, vaccine
5063319|NCT03603496|Tobacco|tobacco
5063320|NCT03603496|Cessation|cessation
5063321|NCT03603496|Hospitalization|hospitalization
5063322|NCT03603496|eReferral|ereferral
5055609|NCT03651128|bb2121|bb2121
5063345|NCT03603197|cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
5063347|NCT03603197|Metastatic Breast Cancer|metastatic breast cancer
5063348|NCT03603197|Platinum analogue|platinum analogue
5063349|NCT03603197|Metronomic chemotherapy|metronomic chemotherapy
5063350|NCT03603197|Breast cancer|breast cancer
5063351|NCT03603197|Cisplatin|cisplatin
5063352|NCT03603184|endometrial cancer|endometrial cancer
5063353|NCT03603184|neoplasm|neoplasm
5063354|NCT03603184|immunotherapy|immunotherapy
5063361|NCT03603158|KCNH2|kcnh2
5063362|NCT03603158|METHADONE|methadone
5063363|NCT03603158|OPIOID|opioid
5063364|NCT03603119|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5063365|NCT03603119|Dexamethasone|dexamethasone
5063366|NCT03603119|Ondansetron|ondansetron
5063367|NCT03603119|Midazolam|midazolam
5063368|NCT03603119|Laparoscopy|laparoscopy
5063369|NCT03603119|High risk|high risk
5063370|NCT03603093|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5063371|NCT03603093|Paediatric|paediatric
5063372|NCT03603067|monophthalmos|monophthalmos
5063373|NCT03603067|social psychology|social psychology
5063374|NCT03603067|ocular surgery|ocular surgery
5063375|NCT03603054|Neck pain|neck pain
5063376|NCT03603054|Neural mobilization|neural mobilization
5063377|NCT03603054|Myofascial trigger point|myofascial trigger point
5063378|NCT03603054|Sciatic nerve|sciatic nerve
5063380|NCT03603028|Exercise|exercise
5063381|NCT03603028|Exergaming|exergaming
5063382|NCT03603015|bladder|bladder
5063383|NCT03603015|urinary tract|urinary tract
5063384|NCT03603015|symptoms|symptoms
5063385|NCT03603015|contractility|contractility
5063386|NCT03603015|urodynamics|urodynamics
5063387|NCT03603015|penile cuff test|penile cuff test
5063388|NCT03602976|hepatic sarcoidosis|hepatic sarcoidosis
5063389|NCT03602976|elevated alp|elevated alp
5063395|NCT03602937|Acceptability|acceptability
5063396|NCT03602937|Renal|renal
5063397|NCT03602937|CKD|ckd
5063398|NCT03602937|Kidney|kidney
5063399|NCT03602937|Vitaflo|vitaflo
5063400|NCT03602937|High energy, low volume|high energy, low volume
5063401|NCT03602937|Low potassium|low potassium
5063402|NCT03602937|Low phosphorus|low phosphorus
5063403|NCT03602937|Low vitamin A|low vitamin a
5063404|NCT03602924|levodopa infusion|levodopa infusion
5063405|NCT03602885|Gastrointestinal Cancer|gastrointestinal cancer
5063406|NCT03602885|cancer|cancer
5063407|NCT03602885|palliative|palliative
5063408|NCT03602885|chemotherapy|chemotherapy
5063409|NCT03602885|metastatic|metastatic
5063410|NCT03602885|colorectal|colorectal
5063411|NCT03602885|pancreatic|pancreatic
5063412|NCT03602885|communication|communication
5063413|NCT03602885|informed consent|informed consent
5063414|NCT03602885|video|video
5063415|NCT03602885|education|education
5063416|NCT03602885|oncology|oncology
5063417|NCT03602885|patient-centered|patient-centered
5063418|NCT03602885|outcomes research|outcomes research
5063419|NCT03602872|Knee osteoarthritis, safety, MSCs|knee osteoarthritis, safety, mscs
5063420|NCT03602859|FIRST|first
5063421|NCT03602859|FIRST trial|first trial
5063422|NCT03602859|Niraparib|niraparib
5063423|NCT03602859|Dostarlimab (TSR-042)|dostarlimab (tsr-042)
5063424|NCT03602846|diabetes mellitus in pregnancy|diabetes mellitus in pregnancy
5063425|NCT03602846|gestational diabetes|gestational diabetes
5063426|NCT03602846|pregnancy outcomes|pregnancy outcomes
5929093|NCT03717051|intervention|intervention
5063427|NCT03602820|Leber congenital amaurosis, retinitis pigmentosa|leber congenital amaurosis, retinitis pigmentosa
5063428|NCT03602781|PAH|pah
5063429|NCT03602781|Inhaled Nitric Oxide|inhaled nitric oxide
5063430|NCT03602781|iNO|ino
5063431|NCT03602781|Long Term Oxygen Therapy|long term oxygen therapy
5063432|NCT03602781|Oxygen therapy|oxygen therapy
5063433|NCT03602768|Healthy aging|healthy aging
5063434|NCT03602768|executive functions|executive functions
5063435|NCT03602768|memory|memory
5063436|NCT03602768|cognitive training|cognitive training
5063437|NCT03602768|cognitive intervention|cognitive intervention
5063438|NCT03602768|subjective cognitive impairment|subjective cognitive impairment
5063455|NCT03602703|Direct acting antiviral drugs immune responses|direct acting antiviral drugs immune responses
5063456|NCT03602690|Third-line regimen|third-line regimen
5063458|NCT03602690|Darunavir|darunavir
5063459|NCT03602690|Cambodia|cambodia
5063460|NCT03602677|Colorectal surgery|colorectal surgery
5063461|NCT03602677|Anastomosis|anastomosis
5063462|NCT03602677|Anastomosis leak|anastomosis leak
5063463|NCT03602677|Fluorescence imaging|fluorescence imaging
5063464|NCT03602625|Premature birth; Risk factors|premature birth; risk factors
5063469|NCT03602599|Mouth|mouth
5063470|NCT03602599|Alloimmunity|alloimmunity
5063471|NCT03602599|Autoimmunity|autoimmunity
5063472|NCT03602599|Salivary Gland|salivary gland
5063473|NCT03602599|Ulcer|ulcer
5063474|NCT03602573|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5063475|NCT03602573|Liver fibrosis|liver fibrosis
5063476|NCT03602573|Menopause|menopause
5063477|NCT03602573|Hormone|hormone
5063478|NCT03602560|PBC|pbc
5063479|NCT03602560|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
5063480|NCT03602534|acne vulgaris|acne vulgaris
5271999|NCT02320084|HT-1|ht-1
5063481|NCT03602534|thyroid dysfunction|thyroid dysfunction
5063482|NCT03602521|Psychiatry|psychiatry
5063483|NCT03602521|Suicidal Behavior|suicidal behavior
5063484|NCT03602521|Borderline Personality Disorder|borderline personality disorder
5063485|NCT03602521|Interpersonal Relations|interpersonal relations
5063486|NCT03602521|Social Stress|social stress
5063487|NCT03602521|Oxytocin|oxytocin
5063488|NCT03602521|Neuropeptide|neuropeptide
5063489|NCT03602508|darifenacin|darifenacin
5063490|NCT03602508|fesoterodine|fesoterodine
5063491|NCT03602508|trospium|trospium
5063492|NCT03602508|solifenacin|solifenacin
5063493|NCT03602508|oxybutynin|oxybutynin
5063494|NCT03602508|tolterodine|tolterodine
5063495|NCT03602508|Betmiga|betmiga
5063496|NCT03602508|YM178|ym178
5063497|NCT03602508|mirabegron|mirabegron
5063498|NCT03602508|Overactive bladder|overactive bladder
5063499|NCT03602508|propiverine|propiverine
5063500|NCT03602508|antimuscarinics|antimuscarinics
5063501|NCT03602508|OAB|oab
5063502|NCT03602508|imidafenacin|imidafenacin
5063503|NCT03602482|postural tachycardia syndrome|postural tachycardia syndrome
5063504|NCT03602482|cognition|cognition
5063505|NCT03602443|Upper Extremity Hemiparesis|upper extremity hemiparesis
5063506|NCT03602417|colorectal cancer|colorectal cancer
5063507|NCT03602417|stent|stent
5063508|NCT03602404|Iodine|iodine
5063509|NCT03602378|Parents|parents
5063510|NCT03602378|Quality of life|quality of life
5063511|NCT03602378|Stress|stress
5063512|NCT03602378|Children with developmental disability|children with developmental disability
5063513|NCT03602378|Children with chronic disease|children with chronic disease
5063514|NCT03602378|Cortisol|cortisol
5063515|NCT03602378|Heart rate variability|heart rate variability
5063516|NCT03602378|Advanced glycation end products|advanced glycation end products
5063517|NCT03602378|Sleep quality|sleep quality
5063518|NCT03602378|Family cohesion|family cohesion
5063519|NCT03602378|Stigma|stigma
5063520|NCT03602378|Resilience|resilience
5063521|NCT03602378|Anxiety|anxiety
5063522|NCT03602378|Depression|depression
5063523|NCT03602378|Self Esteem|self esteem
5063524|NCT03602365|Oxygen Consumption|oxygen consumption
5063525|NCT03602365|Physical Activity|physical activity
5063526|NCT03602365|Passive Motion|passive motion
5063527|NCT03602352|Cohort|cohort
5063528|NCT03602352|Surgery|surgery
5063529|NCT03602352|Adhesive Small Bowel Obstruction|adhesive small bowel obstruction
5063530|NCT03602352|Cost|cost
5063531|NCT03602339|Gadolinium|gadolinium
5063532|NCT03602339|Contrast enhancement|contrast enhancement
5063533|NCT03602339|Central nervous system lesion|central nervous system lesion
5342797|NCT01981954|Safety|safety
5063534|NCT03602326|Stroke|stroke
5063535|NCT03602326|Early term|early term
5063536|NCT03602326|Bobath|bobath
5063537|NCT03602326|Neurodevelopmental treatment|neurodevelopmental treatment
5063544|NCT03602274|APAP|apap
5063545|NCT03602274|malnutrition|malnutrition
5063546|NCT03602274|biomarker|biomarker
5063547|NCT03602274|liver toxicity|liver toxicity
5063560|NCT03602170|High-Intensity Interval Training|high-intensity interval training
5063561|NCT03602170|Exercise|exercise
5063562|NCT03602170|Cardiovascular Health|cardiovascular health
5063563|NCT03602170|Blood Pressure|blood pressure
5063564|NCT03602157|CAR T cells|car t cells
5063566|NCT03602157|CCR4|ccr4
5063585|NCT03602014|Northera|northera
5063586|NCT03602014|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5063587|NCT03602001|attentive eating|attentive eating
5063588|NCT03602001|e-health|e-health
5063589|NCT03602001|weight loss|weight loss
5063590|NCT03602001|food intake|food intake
5063591|NCT03601988|gastric cancer|gastric cancer
5063592|NCT03601988|radiotherapy|radiotherapy
5063593|NCT03601988|postoperative|postoperative
5063594|NCT03601962|Xerostomia|xerostomia
5063596|NCT03601962|Saliva|saliva
5063597|NCT03601962|Aqualief|aqualief
5063598|NCT03601962|Carnosine|carnosine
5063619|NCT03601858|hyperactivity disorder|hyperactivity disorder
5063620|NCT03601858|Adult|adult
5063621|NCT03601858|Epidemiology|epidemiology
5063622|NCT03601858|Evolution|evolution
5063623|NCT03601858|treatment|treatment
5063624|NCT03601845|Magnetic resonance elastography|magnetic resonance elastography
5063625|NCT03601845|Intrinsic activation|intrinsic activation
5063626|NCT03601845|Liver disease|liver disease
5063627|NCT03601845|Cerebral function|cerebral function
5063628|NCT03601832|scar-related|scar-related
5063629|NCT03601832|ventricular tachycardia|ventricular tachycardia
5063630|NCT03601832|substrate ablation|substrate ablation
5063631|NCT03601832|stereotactic radiosurgery|stereotactic radiosurgery
5063632|NCT03601832|functional radiosurgery|functional radiosurgery
5063633|NCT03601832|4D navigation|4d navigation
5063634|NCT03601819|Relapsed|relapsed
5063635|NCT03601819|Refractory|refractory
5063636|NCT03601819|MyD88|myd88
5063637|NCT03601819|JAK2|jak2
5063638|NCT03601819|JAK3|jak3
5063639|NCT03601819|TYK2|tyk2
5063640|NCT03601819|IRAK1|irak1
5063641|NCT03601819|CLL|cll
5063642|NCT03601819|SMZL|smzl
5063643|NCT03601819|LPL|lpl
5063644|NCT03601819|WM|wm
5063651|NCT03601715|Diathermy|diathermy
5063652|NCT03601715|Short-Wave Therapy|short-wave therapy
5063653|NCT03601715|Body temperature|body temperature
5063654|NCT03601715|Skin Temperature|skin temperature
5063659|NCT03601689|Low rectal cancer|low rectal cancer
5063660|NCT03601689|Neoadjuvant treatment|neoadjuvant treatment
5929242|NCT03692312|Tideglusib|tideglusib
5063661|NCT03601689|Complete pathological response|complete pathological response
5063663|NCT03601689|disease free survival|disease free survival
5063664|NCT03601689|Predictive factors|predictive factors
5063665|NCT03601663|physical activity|physical activity
5063666|NCT03601663|obesity|obesity
5063667|NCT03601663|pilot study|pilot study
5063668|NCT03601663|randomized controlled trial|randomized controlled trial
5063669|NCT03601663|women|women
5063670|NCT03601663|eHealth|ehealth
5063671|NCT03601624|Multiple Myeloma|multiple myeloma
5063672|NCT03601624|Relapse|relapse
5063673|NCT03601624|Progression|progression
5063674|NCT03601624|Pomalidomide|pomalidomide
5063675|NCT03601559|gut-brain axis, cognitve demand battery, probiotics|gut-brain axis, cognitve demand battery, probiotics
5063676|NCT03601494|Diabetic Neuropathies|diabetic neuropathies
5063677|NCT03601494|Chronic pain|chronic pain
5063678|NCT03601481|telemedicine|telemedicine
5063679|NCT03601481|cardiac images|cardiac images
5063698|NCT03601416|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
5063699|NCT03601416|moderate and severe bronchopulmonary dysplasia|moderate and severe bronchopulmonary dysplasia
5063700|NCT03601403|Education|education
5063701|NCT03601403|Dry Powder Inhalers|dry powder inhalers
5063702|NCT03601403|Metered Dose Inhalers|metered dose inhalers
5063703|NCT03601403|Pulmonary Disease|pulmonary disease
5063704|NCT03601403|Chronic Obstructive|chronic obstructive
5063705|NCT03601390|PET/CT|pet/ct
5063706|NCT03601390|EBV DNA|ebv dna
5063707|NCT03601390|predicting predicting|predicting predicting
5063708|NCT03601377|attention bias|attention bias
5063709|NCT03601377|treatment predictors|treatment predictors
5063710|NCT03601364|peep, tidal volume, cardiopulmonary bypass, oxidative stress|peep, tidal volume, cardiopulmonary bypass, oxidative stress
5961037|NCT04289688|Reaching health care|reaching health care
5961038|NCT04289688|Severe febrile Illness|severe febrile illness
5961039|NCT04289688|Children under 5|children under 5
5961040|NCT04289688|Malaria|malaria
5961041|NCT04289688|sub-Saharan Africa|sub-saharan africa
5961042|NCT04289636|self-compassion|self-compassion
5961043|NCT04289636|exercise|exercise
5961044|NCT04289636|nutrition|nutrition
5961045|NCT04289636|physical activity|physical activity
5961046|NCT04289623|Prospect theory|prospect theory
5961047|NCT04289623|Social norms|social norms
5961048|NCT04289610|Shoulder Pain|shoulder pain
5961049|NCT04289610|Transcutaneous radiofrequency treatment|transcutaneous radiofrequency treatment
5342878|NCT01981681|Safety|safety
5342879|NCT01981681|PK|pk
5063711|NCT03601351|CANCER, COLON, OPIOIDS, MOR-1|cancer, colon, opioids, mor-1
5063712|NCT03601338|Unexplained stillbirth|unexplained stillbirth
5356798|NCT01917968|Repair Augmented with Mesh|repair augmented with mesh
5063713|NCT03601338|Low molecular Weight Heparin|low molecular weight heparin
5063714|NCT03601338|Umbilical artery|umbilical artery
5063715|NCT03601338|Doppler Ultrasound|doppler ultrasound
5063716|NCT03601338|Antenatal care|antenatal care
5063717|NCT03601325|pancreatitis|pancreatitis
5063718|NCT03601273|left gastric artery embolization|left gastric artery embolization
5063719|NCT03601273|bariatric embolization|bariatric embolization
5063720|NCT03601273|interventional radiology|interventional radiology
5063721|NCT03601273|obesity|obesity
5063722|NCT03601273|morbid obesity|morbid obesity
5063723|NCT03601273|weight loss|weight loss
5063724|NCT03601234|Gastric stromal tumors|gastric stromal tumors
5063725|NCT03601195|Sonoelastography|sonoelastography
5063726|NCT03601169|cognition|cognition
5063727|NCT03601169|mood|mood
5063728|NCT03601169|sleep|sleep
5063729|NCT03601156|rectal cancer|rectal cancer
5063730|NCT03601156|intraarterial chemoembolization|intraarterial chemoembolization
5063731|NCT03601156|radiotherpy|radiotherpy
5063732|NCT03601156|Oxaliplatin|oxaliplatin
5063733|NCT03601156|Tegafur Gimeracil and Oteracil Porassium Capsule|tegafur gimeracil and oteracil porassium capsule
5063734|NCT03601130|osteotomy|osteotomy
5063735|NCT03601130|osteoarthritis|osteoarthritis
5063736|NCT03601130|bone graft substitute|bone graft substitute
5063737|NCT03601104|Eccentric Training|eccentric training
5063738|NCT03601104|Resistance Training|resistance training
5063739|NCT03601091|dexmedetomidine|dexmedetomidine
5063740|NCT03601091|coronary artery bypass graft|coronary artery bypass graft
5063741|NCT03601091|heart rate variability|heart rate variability
5063742|NCT03601078|Multiple Myeloma|multiple myeloma
5063743|NCT03601078|bb2121|bb2121
5064232|NCT03597802|Workplace|workplace
5063746|NCT03601052|Keloid|keloid
5063747|NCT03601052|MicroRNAs|micrornas
5063748|NCT03601052|Wound healing|wound healing
5929319|NCT03682679|sonoelastography|sonoelastography
5063749|NCT03601039|Absnow Absorbable Occluder|absnow absorbable occluder
5063750|NCT03601039|ASD Occluder|asd occluder
5063751|NCT03601026|Severe mental illness|severe mental illness
5063752|NCT03601026|Developmental psychopathology|developmental psychopathology
5063753|NCT03601026|Trial-within-cohort|trial-within-cohort
5063754|NCT03601026|Genetic counselling|genetic counselling
5063755|NCT03601026|Cannabis use|cannabis use
5063756|NCT03601026|Prevention|prevention
5063757|NCT03601000|amnestic|amnestic
5063765|NCT03600909|Blood Stem Cell Transplant|blood stem cell transplant
5063766|NCT03600909|busulfan|busulfan
5063767|NCT03600909|cyclophosphamide|cyclophosphamide
5063768|NCT03600909|fludarabine|fludarabine
5063769|NCT03600909|17-498|17-498
5063770|NCT03600896|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5063771|NCT03600896|Recombinant human interleukin-7|recombinant human interleukin-7
5063772|NCT03600896|CYT107|cyt107
5290541|NCT02221791|Cocoa|cocoa
5063773|NCT03600896|T-Cell Recovery after Cord Blood Transplantation|t-cell recovery after cord blood transplantation
5063774|NCT03600896|CBT|cbt
5063775|NCT03600857|medical abortion|medical abortion
5063776|NCT03600857|mifepristone|mifepristone
5063777|NCT03600857|misoprostol|misoprostol
5063778|NCT03600857|home use|home use
5063779|NCT03600831|esophageal neoplasma|esophageal neoplasma
5063780|NCT03600831|adjuvant therapy|adjuvant therapy
5063781|NCT03600831|chemotherapy|chemotherapy
5063782|NCT03600831|radiotherapy|radiotherapy
5063783|NCT03600792|Agenesis of the corpus callosum|agenesis of the corpus callosum
5063784|NCT03600792|whole exome sequencing|whole exome sequencing
5063785|NCT03600792|prenatal diagnosis|prenatal diagnosis
5063786|NCT03600740|Parkinson Disease|parkinson disease
5063787|NCT03600740|Deep Brain Stimulation|deep brain stimulation
5063788|NCT03600740|Diffusion Tensor Imaging|diffusion tensor imaging
5063792|NCT03600675|Body composition|body composition
5063793|NCT03600675|Abdominal fat|abdominal fat
5063794|NCT03600675|Inflammatory cytokines|inflammatory cytokines
5063795|NCT03600675|Bone markers|bone markers
5063796|NCT03600675|Bone mineral density|bone mineral density
5063797|NCT03600662|aortic stenosis|aortic stenosis
5063798|NCT03600662|aortic regurgitation|aortic regurgitation
5063799|NCT03600662|Trileaflet reconstruction of the aortic valve|trileaflet reconstruction of the aortic valve
5063800|NCT03600662|Biological aortic valve prosthesis|biological aortic valve prosthesis
5063801|NCT03600662|Effective orifice area|effective orifice area
5063802|NCT03600623|advanced pancreatic cancer|advanced pancreatic cancer
5063803|NCT03600623|inoperable pancreatic cancer|inoperable pancreatic cancer
5063804|NCT03600623|Folfirinox|folfirinox
5063805|NCT03600623|Gemcitabine-Abraxane|gemcitabine-abraxane
5063806|NCT03600623|Gemcitabine-nab-Paclitaxel|gemcitabine-nab-paclitaxel
5063807|NCT03600623|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5063808|NCT03600571|Viscosupplementation|viscosupplementation
5063809|NCT03600571|Hyaluronate|hyaluronate
5961050|NCT04289610|Ultrasound|ultrasound
5961051|NCT04289597|difficult mask, difficult laryngoscopy, difficult intubation|difficult mask, difficult laryngoscopy, difficult intubation
5961052|NCT04289584|Taekwondo|taekwondo
5063810|NCT03600571|Distribution|distribution
5063811|NCT03600571|Knee osteoarthritis|knee osteoarthritis
5063812|NCT03600571|Injection approach|injection approach
5063813|NCT03600558|FLAG|flag
5063822|NCT03600428|live attenuated influenza vaccine|live attenuated influenza vaccine
5063823|NCT03600415|High Altitude|high altitude
5063824|NCT03600415|arterial blood gas analysis|arterial blood gas analysis
5063825|NCT03600415|near infrared spectroscopy|near infrared spectroscopy
5063826|NCT03600402|ROM|rom
5063827|NCT03600402|Manual Therapy|manual therapy
5063828|NCT03600402|Mobilization|mobilization
5063829|NCT03600402|Ankle|ankle
5063830|NCT03600389|Patient Health Priorities|patient health priorities
5063831|NCT03600389|Health Outcome Goals|health outcome goals
5063832|NCT03600389|Healthcare Preferences|healthcare preferences
5063833|NCT03600324|mild traumatic brain injury|mild traumatic brain injury
5063834|NCT03600324|vestibular impairment|vestibular impairment
5063835|NCT03600324|vestibular rehabilitation|vestibular rehabilitation
5063836|NCT03600285|VIVIAN|vivian
5063837|NCT03600272|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
5063838|NCT03600272|Epidural analgesia|epidural analgesia
5063839|NCT03600272|Labor duration|labor duration
5063840|NCT03600259|Myocardial Infarction|myocardial infarction
5063841|NCT03600259|Coronary Disease|coronary disease
5063842|NCT03600259|Coronary Artery Disease|coronary artery disease
5063843|NCT03600259|Myocardial Ischemia|myocardial ischemia
5063844|NCT03600233|Oncology|oncology
5063845|NCT03600233|Neuroendocrine Tumors|neuroendocrine tumors
5063847|NCT03600233|Vasculogenic mimicry|vasculogenic mimicry
5063848|NCT03600220|acupuncture, hypertension, elderly, home health care|acupuncture, hypertension, elderly, home health care
5063849|NCT03600207|Low Back Pain|low back pain
5063850|NCT03600207|Diaphragm|diaphragm
5063851|NCT03600181|Preoxygenation|preoxygenation
5063852|NCT03600181|Hypoxemia|hypoxemia
5063853|NCT03600181|ICU|icu
5063854|NCT03600181|ORI|ori
5063855|NCT03600181|Orotracheal intubation|orotracheal intubation
5063856|NCT03600142|Stigma|stigma
5063857|NCT03600142|HIV|hiv
5063858|NCT03600142|Counseling|counseling
5063859|NCT03600142|Tanzania|tanzania
5063860|NCT03600142|Pregnancy|pregnancy
5063861|NCT03600142|Cognitive-behavioral therapy|cognitive-behavioral therapy
5063862|NCT03600142|Retention in care|retention in care
5063863|NCT03600142|Prevention of mother to child transmission|prevention of mother to child transmission
5063864|NCT03600129|regional anesthesia|regional anesthesia
5063865|NCT03600129|quadratus lumborum block|quadratus lumborum block
5063866|NCT03600129|patient controlled anesthesia|patient controlled anesthesia
5063867|NCT03600129|laparoscopic prostatectomy|laparoscopic prostatectomy
5063868|NCT03600103|adolescent|adolescent
5063869|NCT03600103|community health nursing|community health nursing
5063870|NCT03600103|text messaging|text messaging
5063871|NCT03600103|mobile health|mobile health
5063872|NCT03600090|Breast Cancer|breast cancer
5063873|NCT03600038|Smoking cessation|smoking cessation
5063874|NCT03600038|App for quitting smoking|app for quitting smoking
5063875|NCT03600038|Cancer|cancer
5063876|NCT03600038|Oncology|oncology
5063877|NCT03600012|Diplegic Cerebral Palsy|diplegic cerebral palsy
5063878|NCT03600012|Cycling With Functional Electrical Stimulation|cycling with functional electrical stimulation
5063879|NCT03600012|Gait Analysis|gait analysis
5063880|NCT03600012|Functional Strenght Training|functional strenght training
5063881|NCT03600012|Quality of Life|quality of life
5063882|NCT03600012|Qxygen Consumption|qxygen consumption
5063883|NCT03599986|RA|ra
5063884|NCT03599973|Rehydration Solutions|rehydration solutions
5063885|NCT03599947|colorectal cancer|colorectal cancer
5063886|NCT03599947|early diagnosis|early diagnosis
5063887|NCT03599947|5-hydroxymethylcytosine|5-hydroxymethylcytosine
5063888|NCT03599934|Elderly|elderly
5063889|NCT03599934|Exercise|exercise
5063890|NCT03599934|Fall|fall
5063891|NCT03599934|Home safety|home safety
5063892|NCT03599921|Family-based Treatment|family-based treatment
5063893|NCT03599921|Enhanced Cognitive Behavioral Therapy|enhanced cognitive behavioral therapy
5063894|NCT03599921|Anorexia Nervosa|anorexia nervosa
5063895|NCT03599921|Other Specified Feeding or Eating Disorder|other specified feeding or eating disorder
5063896|NCT03599921|Bulimia Nervosa|bulimia nervosa
5063897|NCT03599921|Unspecified Feeding or Eating Disorder|unspecified feeding or eating disorder
5063898|NCT03599921|Avoidant/Restrictive Food Intake Disorder|avoidant/restrictive food intake disorder
5428258|NCT01595451|Brigham and Women's Hospital|brigham and women's hospital
5428259|NCT01595451|Massachusetts General Hospital|massachusetts general hospital
5063899|NCT03599921|Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents|unified protocol for the transdiagnostic treatment of emotional disorders in children and adolescents
5063901|NCT03599908|skin prick tests|skin prick tests
5063902|NCT03599908|diagnosis|diagnosis
5063903|NCT03599908|rhinitis|rhinitis
5063904|NCT03599908|asthma|asthma
5301752|NCT02167763|IUD|iud
5063905|NCT03599908|allergy|allergy
5063906|NCT03599908|laboratory|laboratory
5063907|NCT03599895|3D printing technology|3d printing technology
5063908|NCT03599882|human immunodeficiency virus|human immunodeficiency virus
5063909|NCT03599882|liver steatosis|liver steatosis
5961053|NCT04289584|Strength|strength
5063910|NCT03599882|liver fibrosis|liver fibrosis
5063911|NCT03599882|controlled attenuation parameter|controlled attenuation parameter
5063912|NCT03599882|transient elastography|transient elastography
5063913|NCT03599856|Checklist|checklist
5063914|NCT03599856|Intensive Care Unit|intensive care unit
5063915|NCT03599856|Clinical decision support systems|clinical decision support systems
5063916|NCT03599856|Medical errors|medical errors
5063917|NCT03599856|Patient safety|patient safety
5063918|NCT03599830|Immunotherapy|immunotherapy
5063919|NCT03599830|Cognition|cognition
5063921|NCT03599804|Vestibular|vestibular
5063922|NCT03599804|Cochlear|cochlear
5063923|NCT03599804|Implant|implant
5063924|NCT03599804|Hearing|hearing
5063925|NCT03599804|Child|child
5063926|NCT03599791|Allergic Rhinitis|allergic rhinitis
5063927|NCT03599791|hayfever|hayfever
5063928|NCT03599791|rhinoconjunctivitis|rhinoconjunctivitis
5063929|NCT03599791|azelastine|azelastine
5063930|NCT03599791|fluticasone|fluticasone
5063931|NCT03599791|nasal spray|nasal spray
5063932|NCT03599791|seasonal|seasonal
5063933|NCT03599791|perennial|perennial
5063934|NCT03599791|TNSS|tnss
5063935|NCT03599791|TOSS|toss
5063936|NCT03599778|apatinib|apatinib
5063937|NCT03599778|Gastric Carcinoma|gastric carcinoma
5063938|NCT03599778|post-operative chemotherapy|post-operative chemotherapy
5063939|NCT03599739|Influenza|influenza
5063940|NCT03599739|Vaccine|vaccine
5063941|NCT03599739|Vaccination|vaccination
5063942|NCT03599739|Nursing Home|nursing home
5063943|NCT03599739|Respiratory-Related Hospitalizations|respiratory-related hospitalizations
5063947|NCT03599713|INCMGA00012|incmga00012
5063948|NCT03599700|thrombosis|thrombosis
5063949|NCT03599700|myeloproliferative neoplasms|myeloproliferative neoplasms
5063950|NCT03599661|Cancer|cancer
5063951|NCT03599661|Fertility|fertility
5063952|NCT03599661|Preservation|preservation
5063953|NCT03599648|intervention|intervention
5063954|NCT03599648|behavioral parent training|behavioral parent training
5063955|NCT03599648|mindfulness-based stress reduction|mindfulness-based stress reduction
5063957|NCT03599583|Vaccination|vaccination
5063958|NCT03599583|Practice based intervention|practice based intervention
5063959|NCT03599570|HPV|hpv
5063960|NCT03599570|Vaccination|vaccination
5063961|NCT03599570|Practice based intervention|practice based intervention
5063962|NCT03599557|HPV|hpv
5063963|NCT03599557|Vaccination|vaccination
5063964|NCT03599557|Practice based intervention|practice based intervention
5063965|NCT03599544|Upper limb function|upper limb function
5063966|NCT03599544|Arm and hand weakness|arm and hand weakness
5063967|NCT03599505|intraoperative ultrasonographic localization|intraoperative ultrasonographic localization
5063968|NCT03599505|pulmonary nodules|pulmonary nodules
5063969|NCT03599505|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5063970|NCT03599492|Gut Microflora|gut microflora
5063971|NCT03599492|Transjugular Intraheptic Portosystemic Shunting|transjugular intraheptic portosystemic shunting
5063972|NCT03599479|Virtual reality|virtual reality
5063973|NCT03599479|Acute pain|acute pain
5063974|NCT03599479|Anxiety|anxiety
5063975|NCT03599440|cardiac output|cardiac output
5063976|NCT03599440|pulse contour analysis|pulse contour analysis
5063977|NCT03599440|stroke volume|stroke volume
5063978|NCT03599440|hemodynamic monitoring|hemodynamic monitoring
5063979|NCT03599427|postoperative analgesia|postoperative analgesia
5063980|NCT03599427|knee surgery|knee surgery
5063981|NCT03599427|intravenous lidocaine|intravenous lidocaine
5063982|NCT03599414|sarcoidosis|sarcoidosis
5063983|NCT03599414|cardiac|cardiac
5063984|NCT03599414|MRI|mri
5063985|NCT03599414|Echocardiography|echocardiography
5063986|NCT03599414|pulmonary|pulmonary
5063987|NCT03599414|cytokine|cytokine
5063988|NCT03599375|Chimeric Antigen Receptor-Modified T Cells|chimeric antigen receptor-modified t cells
5063989|NCT03599375|CART|cart
5063990|NCT03599375|Recurrent B Cell Acute Lymphoblastic Leukemia|recurrent b cell acute lymphoblastic leukemia
5063991|NCT03599375|refractory B Cell Acute Lymphoblastic Leukemia|refractory b cell acute lymphoblastic leukemia
5063992|NCT03599375|ALL|all
5063993|NCT03599310|Advance care planning|advance care planning
5063994|NCT03599310|Communication|communication
5063995|NCT03599310|Nurse|nurse
5063996|NCT03599310|End-of-life|end-of-life
5063997|NCT03599232|formative assessment|formative assessment
5063998|NCT03599232|objective structured clinical examination (OSCE)|objective structured clinical examination (osce)
5063999|NCT03599232|Iraq|iraq
5064000|NCT03599232|impact|impact
5064001|NCT03599232|feedback|feedback
5064006|NCT03599180|Sensitized Acupoints|sensitized acupoints
5064008|NCT03599180|High performance liquid chromatography（HPLC）|high performance liquid chromatography（hplc）
5064009|NCT03599167|red blood cell transfusion|red blood cell transfusion
5064010|NCT03599167|preterm infant|preterm infant
5064011|NCT03599167|HAS guideline|has guideline
5064012|NCT03599167|transfusion guidelines|transfusion guidelines
5064013|NCT03599167|kappa agreement test application|kappa agreement test application
5064014|NCT03599154|Gemcitabine|gemcitabine
5064015|NCT03599141|adolescent|adolescent
5064016|NCT03599141|parent|parent
5064017|NCT03599115|inhibitory control training|inhibitory control training
5064018|NCT03599115|food|food
5064019|NCT03599115|event-related potentials|event-related potentials
5064020|NCT03599115|weight reduction|weight reduction
5064021|NCT03599037|ICOUGH Recovery App|icough recovery app
5064022|NCT03599037|Length of stay|length of stay
5064023|NCT03599037|Care coach|care coach
5064024|NCT03599037|Incentive spirometry|incentive spirometry
5064025|NCT03599037|Coughing|coughing
5064026|NCT03599037|Post operative ambulation|post operative ambulation
5064027|NCT03599037|Deep breathing|deep breathing
5064028|NCT03599037|Smartphone|smartphone
5064029|NCT03599024|patient-controlled analgesia|patient-controlled analgesia
5064030|NCT03599024|epidural analgesia|epidural analgesia
5064031|NCT03599024|analgesics|analgesics
5064032|NCT03599024|drug consumption|drug consumption
5064233|NCT03597802|Exercise|exercise
5064041|NCT03598933|botulinum toxin|botulinum toxin
5064042|NCT03598933|Cricopharyngeal dysfunction|cricopharyngeal dysfunction
5064053|NCT03598907|point of care|point of care
5064054|NCT03598907|coagulopathy|coagulopathy
5064055|NCT03598907|lung transplantation|lung transplantation
5064056|NCT03598907|primary graft dysfunction|primary graft dysfunction
5064057|NCT03598868|Bipolar Disorder|bipolar disorder
5064058|NCT03598868|Depression, Bipolar|depression, bipolar
5064059|NCT03598868|vortioxetine|vortioxetine
5064060|NCT03598842|blood signature of Tb risk|blood signature of tb risk
5064061|NCT03598842|anti Mtb immunity|anti mtb immunity
5064062|NCT03598842|RNA biomarkers|rna biomarkers
5064063|NCT03598842|RePORT Study|report study
5064064|NCT03598842|India|india
5064065|NCT03598790|Bimekizumab|bimekizumab
5064067|NCT03598790|Psoriasis|psoriasis
5064068|NCT03598738|Esomeprazole|esomeprazole
5064069|NCT03598738|Gastrin|gastrin
5064070|NCT03598738|HbA1c|hba1c
5064071|NCT03598738|Glycaemic Regulation|glycaemic regulation
5064072|NCT03598686|HIV|hiv
5064073|NCT03598686|HIV/AIDS|hiv/aids
5064074|NCT03598686|self-testing|self-testing
5064075|NCT03598686|HIVST|hivst
5064076|NCT03598686|home-based|home-based
5064077|NCT03598686|community-based|community-based
5064078|NCT03598686|lesotho|lesotho
5064079|NCT03598686|oraquick|oraquick
5064080|NCT03598686|testing coverage|testing coverage
5064081|NCT03598686|htc campaign|htc campaign
5064082|NCT03598660|Breast cancer, SORCIN, Annexin A3|breast cancer, sorcin, annexin a3
5064083|NCT03598647|exercise|exercise
5064084|NCT03598647|physical activity|physical activity
5064085|NCT03598647|obesity|obesity
5064086|NCT03598647|weight loss|weight loss
5064087|NCT03598634|cross-linking|cross-linking
5064091|NCT03598582|myelodysplastic syndromes|myelodysplastic syndromes
5064092|NCT03598582|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5064093|NCT03598582|factors of response|factors of response
5064094|NCT03598556|China|china
5064095|NCT03598556|Anti-retroviral Therapy|anti-retroviral therapy
5064096|NCT03598556|Vitamin D|vitamin d
5064097|NCT03598556|Tenofovir|tenofovir
5064098|NCT03598556|Efavirenz|efavirenz
5064099|NCT03598556|Lamivudine|lamivudine
5064100|NCT03598530|Fracture fixation|fracture fixation
5064101|NCT03598530|Surgical treatment|surgical treatment
5064102|NCT03598530|Fracture reduction|fracture reduction
5064103|NCT03598504|SCI|sci
5064104|NCT03598504|Spasms|spasms
5064105|NCT03598504|Vibration|vibration
5064106|NCT03598465|Post-hepatectomy liver failure|post-hepatectomy liver failure
5064107|NCT03598465|Sphingolipids metabolism|sphingolipids metabolism
5064108|NCT03598452|Cytomegalovirus retinopathy|cytomegalovirus retinopathy
5064109|NCT03598452|High-dose|high-dose
5064110|NCT03598452|Ganciclovir|ganciclovir
5064111|NCT03598452|Intravitreal injection|intravitreal injection
5064115|NCT03598413|enhanced recovery|enhanced recovery
5326469|NCT02055560|MyCare|mycare
5064116|NCT03598413|perioperative nutrition|perioperative nutrition
5064117|NCT03598413|macrophages|macrophages
5064118|NCT03598413|omega 3 fatty acids|omega 3 fatty acids
5064119|NCT03598387|acute kidney injury|acute kidney injury
5064120|NCT03598387|automated peritoneal dialysis|automated peritoneal dialysis
5064130|NCT03598348|advanced gastric cancer, apatinib, capecitabine, maintenance|advanced gastric cancer, apatinib, capecitabine, maintenance
5064132|NCT03598309|Lung nodule|lung nodule
5064136|NCT03598296|Video-assisted thoracoscope lobectomy|video-assisted thoracoscope lobectomy
5064137|NCT03598296|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5064138|NCT03598296|Chest tube|chest tube
5064139|NCT03598270|Ovarian|ovarian
5064140|NCT03598270|Atezolizumab|atezolizumab
5064141|NCT03598270|Niraparib|niraparib
5076535|NCT03520907|children|children
5064146|NCT03598218|initial distant metastases|initial distant metastases
5064147|NCT03598218|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5064148|NCT03598205|Therapy for diabetic macular edema|therapy for diabetic macular edema
5064149|NCT03598205|Curcumin formulation (DIABEC)|curcumin formulation (diabec)
5064150|NCT03598192|Hepatectomy|hepatectomy
5064151|NCT03598192|Transversus abdominis plane block (TAP block)|transversus abdominis plane block (tap block)
5064152|NCT03598192|Paravertebral block|paravertebral block
5961054|NCT04289584|Balance|balance
5064153|NCT03598192|Postoperative analgesia|postoperative analgesia
5064154|NCT03598192|Liver resection|liver resection
5064155|NCT03598166|colorectal cancer screening|colorectal cancer screening
5064156|NCT03598166|septin 9|septin 9
5064157|NCT03598153|Waist and knee pain|waist and knee pain
5064158|NCT03598153|sciatica|sciatica
5064159|NCT03598140|Sildenafil|sildenafil
5064160|NCT03598140|Concussion|concussion
5064161|NCT03598140|CBF|cbf
5064162|NCT03598140|CVR|cvr
5064163|NCT03598127|Vitamin A|vitamin a
5064164|NCT03598127|status|status
5064165|NCT03598127|sepsis|sepsis
5064166|NCT03598127|illness severity|illness severity
5064167|NCT03598049|Implants|implants
5064168|NCT03598049|Stability|stability
5064169|NCT03598049|Bone loss|bone loss
5064170|NCT03598049|Success|success
5064171|NCT03598036|calcineurin inhibitors|calcineurin inhibitors
5064172|NCT03598036|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5064173|NCT03598023|ACell|acell
5064174|NCT03598023|Hand|hand
5064175|NCT03598023|Burn|burn
5064176|NCT03598023|ACell Cytal Burn Matrix®|acell cytal burn matrix®
5064177|NCT03598023|Extracellular Matrix|extracellular matrix
5064178|NCT03598023|Urinary Bladder Matrix|urinary bladder matrix
5064179|NCT03598023|Wound|wound
5064180|NCT03598023|Partial-Thickness|partial-thickness
5064181|NCT03598023|Burn Management|burn management
5064182|NCT03597997|Postoperative pain|postoperative pain
5064183|NCT03597997|Total intravenous anaesthesia|total intravenous anaesthesia
5064184|NCT03597997|TIVA|tiva
5064185|NCT03597997|Propofol|propofol
5064186|NCT03597997|Hepatectomy|hepatectomy
5064187|NCT03597958|Familial Hypercholesterolemia|familial hypercholesterolemia
5064188|NCT03597958|Hypercholesterolemia|hypercholesterolemia
5064189|NCT03597958|Cascade Screening|cascade screening
5064190|NCT03597958|Novel FH Genes|novel fh genes
5064191|NCT03597958|Novel FH Mutations|novel fh mutations
5064192|NCT03597958|Next generation sequencing|next generation sequencing
5064193|NCT03597945|Magnesium sulfate|magnesium sulfate
5064194|NCT03597945|lidocaine|lidocaine
5064195|NCT03597945|femoral nerve block|femoral nerve block
5064196|NCT03597945|prehospital|prehospital
5064197|NCT03597945|pain|pain
5064198|NCT03597932|major surgery|major surgery
5064199|NCT03597932|ansethesia care|ansethesia care
5064200|NCT03597932|postoperative complication|postoperative complication
5064201|NCT03597932|handover checklist|handover checklist
5064202|NCT03597932|anesthesiologist burnout|anesthesiologist burnout
5064203|NCT03597919|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
5064204|NCT03597919|Sabin strain|sabin strain
5064205|NCT03597906|Topography guided ablation|topography guided ablation
5064206|NCT03597906|Astigmatism|astigmatism
5064207|NCT03597906|LASIK|lasik
5064208|NCT03597893|intranasal oxytocin|intranasal oxytocin
5064209|NCT03597893|stress|stress
5064210|NCT03597893|belief updating|belief updating
5064211|NCT03597880|difficult airway, obese patient,|difficult airway, obese patient,
5064212|NCT03597867|vitreoretinal surgery|vitreoretinal surgery
5064213|NCT03597867|epiretinal membrane|epiretinal membrane
5064214|NCT03597867|macular hole|macular hole
5064216|NCT03597867|prostaglandin E2|prostaglandin e2
5064217|NCT03597854|Acute kidney disease|acute kidney disease
5064218|NCT03597854|critically ill|critically ill
5064219|NCT03597841|Monotherapy|monotherapy
5064220|NCT03597841|Combination therapy|combination therapy
5064221|NCT03597841|Colistin-resistant|colistin-resistant
5064222|NCT03597841|Klebsiella Pneumonia|klebsiella pneumonia
5064223|NCT03597841|Bacteremia|bacteremia
5064224|NCT03597841|Blood stream infection|blood stream infection
5064225|NCT03597828|Monitored Anesthesia Care|monitored anesthesia care
5064226|NCT03597828|Pleuroscopy|pleuroscopy
5064227|NCT03597828|dexmedetomidine|dexmedetomidine
5064228|NCT03597828|fentanyl|fentanyl
5064229|NCT03597828|midazolam|midazolam
5064230|NCT03597828|sedation|sedation
5064231|NCT03597802|Ergonomics|ergonomics
5064244|NCT03597750|Alternating-pressure devices|alternating-pressure devices
5064247|NCT03597750|Prevention|prevention
5064248|NCT03597711|Peripheral Intravenous cannulation|peripheral intravenous cannulation
5064249|NCT03597698|job loss|job loss
5064250|NCT03597698|unfit for a job|unfit for a job
5064251|NCT03597672|Gastric carcinoma|gastric carcinoma
5064252|NCT03597672|Early diagnosis|early diagnosis
5064253|NCT03597672|screening stragety|screening stragety
5064254|NCT03597672|health population cohort|health population cohort
5064255|NCT03597646|Kinesio Taping|kinesio taping
5076629|NCT03520413|Rural Health|rural health
5064256|NCT03597646|inspiratory muscle training|inspiratory muscle training
5064257|NCT03597646|respiratory|respiratory
5064258|NCT03597607|Smoking cessation|smoking cessation
5064259|NCT03597607|pharmacist|pharmacist
5064260|NCT03597607|self-efficacy|self-efficacy
5064267|NCT03597581|SLC6a8|slc6a8
5064268|NCT03597581|Creatine transporter|creatine transporter
5064269|NCT03597581|FOLFIRI|folfiri
5064270|NCT03597568|Resveratrol|resveratrol
5064271|NCT03597568|Kidney Diseases|kidney diseases
5064272|NCT03597568|Renal Insufficiency|renal insufficiency
5064273|NCT03597568|Diabetes|diabetes
5064274|NCT03597568|Oxidative stress|oxidative stress
5064275|NCT03597568|Endothelial dysfunction|endothelial dysfunction
5064276|NCT03597555|Idiopathic Hypersomnia|idiopathic hypersomnia
5064277|NCT03597542|Children|children
5064278|NCT03597542|Inflammation|inflammation
5064279|NCT03597542|Obesity|obesity
5064280|NCT03597516|Lactose Intolerance|lactose intolerance
5064655|NCT03594864|Graft survival|graft survival
5064281|NCT03597490|Partial Thickness Rotator Cuff Tear|partial thickness rotator cuff tear
5064282|NCT03597490|Physical Therapy|physical therapy
5064283|NCT03597477|Autism Spectrum Disorder|autism spectrum disorder
5064284|NCT03597477|Dexmedetomidine|dexmedetomidine
5064285|NCT03597464|lupus nephritis|lupus nephritis
5064286|NCT03597464|calcineurin inhibitors|calcineurin inhibitors
5064287|NCT03597464|voclosporin|voclosporin
5064288|NCT03597451|strength|strength
5064289|NCT03597451|walking|walking
5064290|NCT03597451|sit-to-stand|sit-to-stand
5064291|NCT03597425|Cardiac arrest|cardiac arrest
5064292|NCT03597425|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5064293|NCT03597425|Survival|survival
5064294|NCT03597425|Prediction|prediction
5064295|NCT03597399|Leber Congenital Amaurosis (LCA)|leber congenital amaurosis (lca)
5064296|NCT03597399|Inherited Retinal Dystrophy|inherited retinal dystrophy
5064297|NCT03597399|RPE65|rpe65
5064298|NCT03597399|Retinitis Pigmentosa (RP)|retinitis pigmentosa (rp)
5064299|NCT03597373|Prediction|prediction
5064300|NCT03597373|Myasthenia gravis|myasthenia gravis
5064301|NCT03597373|Reintubation|reintubation
5064302|NCT03597347|Nontuberculosis mycobacterial (NTM) infection|nontuberculosis mycobacterial (ntm) infection
5064303|NCT03597347|Cystic Fibrosis (CF)|cystic fibrosis (cf)
5064304|NCT03597347|M. avium complex (MAC)|m. avium complex (mac)
5064305|NCT03597347|M. abscessus complex (MABSC)|m. abscessus complex (mabsc)
5064306|NCT03597347|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
5064307|NCT03597334|administration,inhalation|administration,inhalation
5064308|NCT03597334|metered dose inhalers|metered dose inhalers
5064309|NCT03597334|nebulizers and vaporizers|nebulizers and vaporizers
5064310|NCT03597334|bronchodilator agents|bronchodilator agents
5064311|NCT03597334|anti-bacterial agents|anti-bacterial agents
5064312|NCT03597321|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5064313|NCT03597321|donor lymphocyte infusion|donor lymphocyte infusion
5064318|NCT03597282|Checkpoint Inhibitor|checkpoint inhibitor
5064319|NCT03597282|Immunotherapy|immunotherapy
5064320|NCT03597282|Personalized Vaccine|personalized vaccine
5064321|NCT03597282|Neoantigen|neoantigen
5064322|NCT03597282|POLY-ICLC|poly-iclc
5064323|NCT03597282|Peptide|peptide
5064324|NCT03597256|Hyaluronic acid|hyaluronic acid
5064325|NCT03597256|Chin Retrusion|chin retrusion
5064326|NCT03597243|Cash transfer|cash transfer
5064327|NCT03597243|HIV|hiv
5064328|NCT03597243|adolescent girls|adolescent girls
5064330|NCT03597217|PF-05221304, PK, Japanese, NASH, ACC inhibitor|pf-05221304, pk, japanese, nash, acc inhibitor
5064331|NCT03597191|Y-balance test|y-balance test
5064332|NCT03597191|Functional Movement Screen|functional movement screen
5064333|NCT03597191|Spinal stabilization exercises|spinal stabilization exercises
5064334|NCT03597191|Dynamic balance|dynamic balance
5064335|NCT03597191|Postural control|postural control
5064336|NCT03597191|Physical performance|physical performance
5064337|NCT03597165|Incidental Findings|incidental findings
5735648|NCT00374192|Depression|depression
5064338|NCT03597165|Genomic Sequencing|genomic sequencing
5064339|NCT03597165|Randomized Controlled Trial|randomized controlled trial
5064340|NCT03597165|Clinical Utility|clinical utility
5064341|NCT03597165|Personal Utility|personal utility
5064342|NCT03597152|uncomplicated recurrent urinary tract infection|uncomplicated recurrent urinary tract infection
5337648|NCT02005653|DEC|dec
5064343|NCT03597139|Dry Eye|dry eye
5064344|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors
5064345|NCT03597126|Robotic|robotic
5064346|NCT03597126|Intersphincteric Resection|intersphincteric resection
5064347|NCT03597126|rectal cancer|rectal cancer
5064348|NCT03597126|pelvic autonomic nerve anal function|pelvic autonomic nerve anal function
5064349|NCT03597087|Anesthesia, Bladder cancer, Recurrence rate, Transurethral resection of bladder mass|anesthesia, bladder cancer, recurrence rate, transurethral resection of bladder mass
5064350|NCT03597074|ICU|icu
5064351|NCT03597074|Renal Resistive Index|renal resistive index
5064352|NCT03597074|Acute Kidney Injury|acute kidney injury
5064353|NCT03597074|Sepsis|sepsis
5064354|NCT03597061|obesity prevention|obesity prevention
5064355|NCT03597061|infant|infant
5064356|NCT03597061|complementary feeding|complementary feeding
5064357|NCT03597061|diet variety|diet variety
5064358|NCT03597061|weight-for-length|weight-for-length
5064359|NCT03597061|food responsiveness|food responsiveness
5064360|NCT03597061|satiety responsiveness|satiety responsiveness
5064361|NCT03597048|stigma intervention|stigma intervention
5064362|NCT03597022|Subcutaneous|subcutaneous
5064363|NCT03597022|Prophylaxis|prophylaxis
5064364|NCT03597022|Non-Inhibitors|non-inhibitors
5064365|NCT03597022|Inhibitors|inhibitors
5064366|NCT03597009|talimogene laherparepvec|talimogene laherparepvec
5064367|NCT03597009|Nivolumab|nivolumab
5064369|NCT03596983|Short Sleeping|short sleeping
5064370|NCT03596970|Open-label|open-label
5064371|NCT03596970|randomized|randomized
5064372|NCT03596970|calcineurin-inhibitor|calcineurin-inhibitor
5064373|NCT03596970|CNI|cni
5064374|NCT03596970|tacrolimus|tacrolimus
5064375|NCT03596970|MMF|mmf
5064376|NCT03596970|maintenance liver transplant|maintenance liver transplant
5064377|NCT03596970|RAD001H|rad001h
5064378|NCT03596970|CRAD001H|crad001h
5064379|NCT03596970|liver transplant|liver transplant
5064380|NCT03596970|transplantation|transplantation
5064381|NCT03596944|acute coronary syndrome|acute coronary syndrome
5064382|NCT03596944|statin|statin
5064383|NCT03596944|mortality|mortality
5064384|NCT03596944|GRACE score|grace score
5064385|NCT03596944|TIMI score|timi score
5064386|NCT03596931|acute coronary syndrome|acute coronary syndrome
5064387|NCT03596931|statin|statin
5064388|NCT03596931|acute pulmonary edema|acute pulmonary edema
5064389|NCT03596931|malignant arrhythmia|malignant arrhythmia
5064390|NCT03596931|heart failure|heart failure
5064391|NCT03596879|insomnia|insomnia
5064392|NCT03596879|post partum depression (PPD)|post partum depression (ppd)
5064393|NCT03596879|digital CBTI (dCBTI)|digital cbti (dcbti)
5064394|NCT03596879|online CBTI|online cbti
5064395|NCT03596879|rumination|rumination
5064397|NCT03596840|Hypertension|hypertension
5064398|NCT03596840|Microalbuminuria|microalbuminuria
5064399|NCT03596840|Effectiveness|effectiveness
5064400|NCT03596840|Antihypertensive medications|antihypertensive medications
5064401|NCT03596827|Diarrhea|diarrhea
5064402|NCT03596827|Gastroenteritis|gastroenteritis
5064403|NCT03596827|Bacterial Infections|bacterial infections
5064404|NCT03596827|Escherichia Coli Infections|escherichia coli infections
5064405|NCT03596827|E.coli|e.coli
5064406|NCT03596814|Hemophilia A|hemophilia a
5064407|NCT03596814|Hemophilia B|hemophilia b
5064408|NCT03596814|Research database|research database
5064409|NCT03596814|Clotting Factors|clotting factors
5064410|NCT03596814|Regimen of Treatment|regimen of treatment
5064411|NCT03596814|Impact Budget Analysis|impact budget analysis
5064412|NCT03596736|Distal Humerus Fracture|distal humerus fracture
5064413|NCT03596736|Arthroplasty, Replacement, Elbow|arthroplasty, replacement, elbow
5064414|NCT03596697|CRV431|crv431
5064415|NCT03596697|Hepatitis B Virus|hepatitis b virus
5064416|NCT03596697|Hepatitis Virus|hepatitis virus
5064417|NCT03596684|Carbohydrate Metabolism|carbohydrate metabolism
5064418|NCT03596684|Citrulline|citrulline
5064419|NCT03596684|Statine|statine
5064420|NCT03596619|plum-blossom needling|plum-blossom needling
5064421|NCT03596619|Photodynamic Therapy|photodynamic therapy
5064422|NCT03596619|Actinic Keratoses|actinic keratoses
5064423|NCT03596606|Chronic Facial Pain|chronic facial pain
5064424|NCT03596606|Osteopathic Manual treatment|osteopathic manual treatment
5064425|NCT03596606|Therapeutic Exercise|therapeutic exercise
5064426|NCT03596593|Solid tumor|solid tumor
5064431|NCT03596567|Glasdegib|glasdegib
5064432|NCT03596567|PF-04449913|pf-04449913
5064433|NCT03596567|Pharmacokinetics|pharmacokinetics
5064434|NCT03596567|Renal Impairment|renal impairment
5064435|NCT03596541|Telemedicina|telemedicina
5064436|NCT03596541|Respiratory sounds|respiratory sounds
5064437|NCT03596541|Tele-stethoscopy|tele-stethoscopy
5064439|NCT03596541|Real-time|real-time
5064440|NCT03596541|e-health|e-health
5064441|NCT03596541|Heart sounds|heart sounds
5064442|NCT03596528|Interstitial lung disease, cryobiopsy, surgical biopsy|interstitial lung disease, cryobiopsy, surgical biopsy
5064443|NCT03596502|Direct oral anticoagulants|direct oral anticoagulants
5064444|NCT03596502|Safety|safety
5064445|NCT03596502|Atrial fibrillation|atrial fibrillation
5064446|NCT03596502|Ischemic stroke|ischemic stroke
5064447|NCT03596502|Systemic embolization|systemic embolization
5064448|NCT03596476|Gastro-esophageal reflux|gastro-esophageal reflux
5064449|NCT03596476|High resolution Impedance Manometry|high resolution impedance manometry
5064450|NCT03596476|Resistance to proton pump inhibitors (PPI)|resistance to proton pump inhibitors (ppi)
5064451|NCT03596437|Fibromuscular dysplasia|fibromuscular dysplasia
5064452|NCT03596437|Vascular Ehler-Danlos Syndrome|vascular ehler-danlos syndrome
5064453|NCT03596437|Ultrasound|ultrasound
5064454|NCT03596398|Fabry disease|fabry disease
5064455|NCT03596398|Young stroke|young stroke
5064456|NCT03596372|First-in-human|first-in-human
5064457|NCT03596372|Immuno-oncology|immuno-oncology
5064459|NCT03596372|Checkpoint inhibition|checkpoint inhibition
5064460|NCT03596359|Self Care|self care
5064461|NCT03596359|Heart Failure|heart failure
5064462|NCT03596359|Quality of Life|quality of life
5064463|NCT03596359|Teach-Back|teach-back
5064481|NCT03596177|MEDI0382|medi0382
5064482|NCT03596151|Chlamydia trachomatis|chlamydia trachomatis
5064483|NCT03596151|device|device
5064484|NCT03596151|diagnostic|diagnostic
5064485|NCT03596151|molecular|molecular
5064486|NCT03596151|Neisseria gonorrhoeae|neisseria gonorrhoeae
5064487|NCT03596151|Trichomonas vaginalis|trichomonas vaginalis
5064488|NCT03596138|angle measurement|angle measurement
5064489|NCT03596138|automated|automated
5064490|NCT03596138|strabismus|strabismus
5064491|NCT03596125|Glutathione|glutathione
5961055|NCT04289584|Theraband|theraband
5064492|NCT03596125|Antioxidant|antioxidant
5961056|NCT04289584|Proprioception|proprioception
5064493|NCT03596125|Oxidative stress|oxidative stress
5064494|NCT03596125|Preterm|preterm
5064495|NCT03596099|Prehypertension|prehypertension
5064496|NCT03596099|Rice vinegar|rice vinegar
5064497|NCT03596099|vinegar|vinegar
5064498|NCT03596099|acetic acid|acetic acid
5064499|NCT03596086|GBM|gbm
5064500|NCT03596086|glioblastoma|glioblastoma
5064501|NCT03596086|Astrocytoma|astrocytoma
5064502|NCT03596073|Breast Cancer|breast cancer
5064504|NCT03596047|radial wave therapy|radial wave therapy
5064505|NCT03596034|Electronic Nicotine Delivery System (ENDS)|electronic nicotine delivery system (ends)
5064506|NCT03596034|ENDS|ends
5064507|NCT03596034|Puff Topography|puff topography
5064508|NCT03596021|exercise|exercise
5064509|NCT03596021|toe walking|toe walking
5064510|NCT03596021|scale|scale
5064511|NCT03596021|reliability|reliability
5064512|NCT03596021|validity|validity
5064513|NCT03596008|strawberry|strawberry
5064514|NCT03596008|monocytes|monocytes
5064515|NCT03596008|endothelial function|endothelial function
5064516|NCT03595982|chronic hypertension|chronic hypertension
5064517|NCT03595982|postpartum hypertension|postpartum hypertension
5064518|NCT03595982|preeclampsia|preeclampsia
5064519|NCT03595982|treatment|treatment
5064520|NCT03595982|Procardia XL|procardia xl
5064521|NCT03595969|mitochondrial DNA|mitochondrial dna
5064522|NCT03595956|Transgender|transgender
5064523|NCT03595956|HIV/AIDS|hiv/aids
5064524|NCT03595956|Gender affirmation|gender affirmation
5064525|NCT03595956|PrEP|prep
5064526|NCT03595930|ARNUITY|arnuity
5064527|NCT03595930|Effectiveness|effectiveness
5064528|NCT03595930|Asthma|asthma
5064529|NCT03595930|Post-marketing surveillance|post-marketing surveillance
5064530|NCT03595930|Safety|safety
5064533|NCT03595917|Philadelphia chromosome positive Acute Lymphoblastic Leukemia (Ph+ ALL).|philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all).
5064535|NCT03595904|colonoscopy|colonoscopy
5064536|NCT03595904|African Americans|african americans
5064537|NCT03595904|Telemedicine|telemedicine
5064539|NCT03595826|ADHD/ADD DCD Exercises Neurostimulant Drugs|adhd/add dcd exercises neurostimulant drugs
5064540|NCT03595813|Immune check point blockade|immune check point blockade
5064541|NCT03595813|biomarkers|biomarkers
5064542|NCT03595813|immunomonitoring|immunomonitoring
5064543|NCT03595787|prehabilitation|prehabilitation
5064544|NCT03595787|coaching|coaching
5064545|NCT03595787|nutritional support|nutritional support
5064546|NCT03595787|physical activity|physical activity
5064547|NCT03595787|allogeneic stem cells transplantation|allogeneic stem cells transplantation
5064549|NCT03595761|cerebral vasculitis|cerebral vasculitis
5064550|NCT03595748|Hospitalizations|hospitalizations
5064551|NCT03595748|Dialysis patients|dialysis patients
5677391|NCT00590642|OCD|ocd
5064552|NCT03595748|Peer mentorship|peer mentorship
5064553|NCT03595722|Pelvic cancer|pelvic cancer
5064554|NCT03595722|rectal cancer|rectal cancer
5064555|NCT03595722|HIFU|hifu
5064556|NCT03595722|QoL|qol
5064557|NCT03595722|complications|complications
5064558|NCT03595709|Efavirenz|efavirenz
5064594|NCT03595319|Elderly|elderly
5064595|NCT03595293|Prescription Opioid Use Disorder|prescription opioid use disorder
5064368|NCT03597009|PleurX|pleurx
5064611|NCT03595150|Pancreatitis|pancreatitis
5064612|NCT03595150|Diclofenac|diclofenac
5064613|NCT03595111|Cardiac Protection|cardiac protection
5064614|NCT03595111|Pediatric|pediatric
5064615|NCT03595111|Myocardial biopsy|myocardial biopsy
5064616|NCT03595111|Cardiopulmonary Bypass|cardiopulmonary bypass
5064617|NCT03595098|OCD|ocd
5349781|NCT01950091|app|app
5064618|NCT03595059|Cancer|cancer
5064619|NCT03595059|Advanced Solid Tumors|advanced solid tumors
5064620|NCT03595059|Relapsed and/or Refractory Solid Tumors|relapsed and/or refractory solid tumors
5064621|NCT03595059|ABBV-155|abbv-155
5064622|NCT03595059|Taxane|taxane
5064623|NCT03595059|Paclitaxel|paclitaxel
5064624|NCT03595059|Docetaxel|docetaxel
5064625|NCT03595059|breast cancer|breast cancer
5064626|NCT03595059|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5077022|NCT03517826|COPD|copd
5064635|NCT03594916|Neuromodulation|neuromodulation
5064636|NCT03594916|Transcranial direct current stimulation|transcranial direct current stimulation
5064637|NCT03594916|Neuroimaging|neuroimaging
5064638|NCT03594916|Neuroplasticity|neuroplasticity
5064639|NCT03594903|therapy expectation|therapy expectation
5064640|NCT03594903|therapy motivation|therapy motivation
5064641|NCT03594903|critical attitudes towards psychotherapy|critical attitudes towards psychotherapy
5064642|NCT03594903|expectation violation|expectation violation
5064643|NCT03594903|Violex model|violex model
5064644|NCT03594903|psychological online-experiment|psychological online-experiment
5064645|NCT03594890|influenza|influenza
5064646|NCT03594890|vaccine|vaccine
5064647|NCT03594890|nucleoprotein|nucleoprotein
5064652|NCT03594864|Liver|liver
5064653|NCT03594864|Transplantation|transplantation
5064654|NCT03594864|Hyper-reduction|hyper-reduction
5356458|NCT01919528|ultrasonography|ultrasonography
5064656|NCT03594864|Overall survival|overall survival
5064657|NCT03594851|quality of sleep|quality of sleep
5120109|NCT03244449|myokine|myokine
5064658|NCT03594851|elderly|elderly
5064659|NCT03594851|health education|health education
5961057|NCT04289571|Cone-Rod Degeneration|cone-rod degeneration
5886614|NCT04272671|Opioid|opioid
5064660|NCT03594851|quantity of sleep|quantity of sleep
5064661|NCT03594851|caregiver's burden|caregiver's burden
5064662|NCT03594838|HCV viremia testing|hcv viremia testing
5064663|NCT03594825|Nocturnal Hypertension; Hemodialysis; Valsartan|nocturnal hypertension; hemodialysis; valsartan
5064664|NCT03594799|Simulated Microgravity|simulated microgravity
5064665|NCT03594799|Weightlessness|weightlessness
5064666|NCT03594799|Countermeasure|countermeasure
5064667|NCT03594799|Bedrest|bedrest
5064668|NCT03594734|Traumatic Brain Injury|traumatic brain injury
5064669|NCT03594734|Group Lifestyle Balance|group lifestyle balance
5064670|NCT03594734|Weight-Loss|weight-loss
5064671|NCT03594695|cesarean section, anesthesia, hs-CRP, NLR|cesarean section, anesthesia, hs-crp, nlr
5064672|NCT03594682|Apatinib,NSCLC,Dose titration|apatinib,nsclc,dose titration
5064673|NCT03594656|Parkinson's disease|parkinson's disease
5064674|NCT03594656|Lingzhi|lingzhi
5064675|NCT03594656|Traditional Chinese Medicine|traditional chinese medicine
5064676|NCT03594643|electronic|electronic
5064677|NCT03594643|surgery|surgery
5064678|NCT03594643|outcome|outcome
5064679|NCT03594643|anesthesia|anesthesia
5064680|NCT03594643|cigarette|cigarette
5064681|NCT03594604|norethindrone|norethindrone
5064682|NCT03594552|Autism Spectrum Disorder|autism spectrum disorder
5064683|NCT03594552|Arbaclofen|arbaclofen
5064684|NCT03594552|E-I balance|e-i balance
5064685|NCT03594552|pharmacological imaging|pharmacological imaging
5064686|NCT03594552|GABA|gaba
5064687|NCT03594539|ESRD|esrd
5064688|NCT03594539|Microvascular|microvascular
5064689|NCT03594539|Hyperphosphatemia|hyperphosphatemia
5064690|NCT03594539|LDF|ldf
5064691|NCT03594526|Nursing Care|nursing care
5064474|NCT03596242|SMS|sms
5064725|NCT03594253|oppositional defiant disorder|oppositional defiant disorder
5077116|NCT03517410|Smart phone|smart phone
5064728|NCT03594253|psychodynamic psychotherapy|psychodynamic psychotherapy
5064730|NCT03594214|vitamin d|vitamin d
5064731|NCT03594214|prognosis|prognosis
5064732|NCT03594201|ICSI, progressive sperm count, embryo|icsi, progressive sperm count, embryo
5064733|NCT03594175|CVAD|cvad
5064734|NCT03594175|CUSA-081|cusa-081
5064735|NCT03594175|reteplase|reteplase
5064736|NCT03594175|alteplase|alteplase
5064737|NCT03594175|occluded catheters|occluded catheters
5064738|NCT03594175|catheter|catheter
5064739|NCT03594175|occlusion|occlusion
5064740|NCT03594175|thrombosis|thrombosis
5064741|NCT03594175|thrombotic occlusion|thrombotic occlusion
5064742|NCT03594162|CAR T cells|car t cells
5064743|NCT03594162|CD19|cd19
5064744|NCT03594162|Leukemia|leukemia
5064745|NCT03594162|T Lymphocytes|t lymphocytes
5064746|NCT03594162|AP1903|ap1903
5064747|NCT03594149|levofloxacin, antibacterial prophylaxis, febrile episode|levofloxacin, antibacterial prophylaxis, febrile episode
5064748|NCT03594136|Intracranial pressure|intracranial pressure
5064750|NCT03594136|Normal value|normal value
5064751|NCT03594136|Reference value|reference value
5064752|NCT03594136|Hydrocephalus|hydrocephalus
5064753|NCT03594123|Agitation|agitation
5064754|NCT03594084|Malaria|malaria
5064755|NCT03594084|Malaria imported cases|malaria imported cases
5064756|NCT03594084|Recurrent malaria|recurrent malaria
5064757|NCT03594084|Endemic malaria areas|endemic malaria areas
5064758|NCT03594084|Biological diagnosis|biological diagnosis
5064759|NCT03594084|Hospital vs private laboratory diagnosis|hospital vs private laboratory diagnosis
5064760|NCT03594058|overactive bladder|overactive bladder
5064769|NCT03594019|immediate implant placement|immediate implant placement
5064770|NCT03594019|connective tissue graft|connective tissue graft
5064771|NCT03594019|samll dehiscence|samll dehiscence
5064772|NCT03594006|Active Therapy|active therapy
5064773|NCT03593980|Gastric Ultrasound|gastric ultrasound
5064774|NCT03593967|wellbeing|wellbeing
5064775|NCT03593967|intergenerational arts|intergenerational arts
5064776|NCT03593967|aspiration|aspiration
5064777|NCT03593967|resilience|resilience
5064778|NCT03593967|storytelling|storytelling
5064779|NCT03593967|art making|art making
5064780|NCT03593967|seniors|seniors
5064781|NCT03593967|youth|youth
5064782|NCT03593941|Ageing|ageing
5064783|NCT03593941|Gut Microbiota|gut microbiota
5064784|NCT03593941|Challenging behaviour|challenging behaviour
5064785|NCT03593941|Dementia|dementia
5064786|NCT03593928|biomarker|biomarker
5064787|NCT03593928|plaque morphology|plaque morphology
5064788|NCT03593915|Previously untreated MDS|previously untreated mds
5064789|NCT03593915|MDS who have received <6 cycles of treatment with hypomethylating agents (HMAs)|mds who have received <6 cycles of treatment with hypomethylating agents (hmas)
5064790|NCT03593915|De novo or secondary MDS (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant|de novo or secondary mds (treatment-related) who are not eligible for intensive induction chemotherapy or stem cell transplant
5064791|NCT03593915|FAB subtypes: refractory anemia [RA], RA w/ ringed sideroblasts, RA w/ excess blasts, RA w/ excess blasts in transformation or chronic myelomonocytic leukemia|fab subtypes: refractory anemia [ra], ra w/ ringed sideroblasts, ra w/ excess blasts, ra w/ excess blasts in transformation or chronic myelomonocytic leukemia
5961058|NCT04289571|Rod-Cone Degeneration|rod-cone degeneration
5961059|NCT04289571|Eye|eye
5961060|NCT04289571|BCVA|bcva
5961061|NCT04289571|OCT|oct
5064792|NCT03593915|Intermediate and above per the Revised International Prognostic Scoring System (IPSS-R) groups|intermediate and above per the revised international prognostic scoring system (ipss-r) groups
5064793|NCT03593915|Tolero|tolero
5064794|NCT03593915|Cancer|cancer
5064795|NCT03593915|Phase 1b/2|phase 1b/2
5064796|NCT03593902|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5064797|NCT03593902|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5064798|NCT03593889|Collaborative stepped care|collaborative stepped care
5064799|NCT03593889|Peer support|peer support
5064800|NCT03593889|Early identification|early identification
5064801|NCT03593889|Selective prevention|selective prevention
5064802|NCT03593889|Indicated prevention|indicated prevention
5064803|NCT03593876|Stroke|stroke
5064804|NCT03593876|Aphasia|aphasia
5064805|NCT03593876|Rehabilitation|rehabilitation
5064806|NCT03593876|Cognition|cognition
5064807|NCT03593876|Disability|disability
5064808|NCT03593863|Brain structure and function|brain structure and function
5064809|NCT03593863|Adolescents|adolescents
5064810|NCT03593863|Physical activity|physical activity
5064811|NCT03593863|Cognitive function|cognitive function
5064812|NCT03593863|Mental health|mental health
5064813|NCT03593863|Fitness|fitness
5064814|NCT03593850|Pain management|pain management
5064815|NCT03593850|Pain|pain
5064816|NCT03593850|Primary dysmenorrhea|primary dysmenorrhea
5064817|NCT03593850|Music|music
5064818|NCT03593850|Music Therapy|music therapy
5064831|NCT03593746|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5064832|NCT03593746|Functional Capacity|functional capacity
5064833|NCT03593746|Photobiomodulation Therapy|photobiomodulation therapy
5064834|NCT03593720|hypaspadias|hypaspadias
5064835|NCT03593707|PF-06865571|pf-06865571
5064836|NCT03593707|Metformin|metformin
5064837|NCT03593707|Drug-drug interaction|drug-drug interaction
5064838|NCT03593707|Pharmacokinetics|pharmacokinetics
5064839|NCT03593681|salpingo-oophorectomy|salpingo-oophorectomy
5064840|NCT03593681|salpingectomy|salpingectomy
5064841|NCT03593681|ovarian cancer|ovarian cancer
5064842|NCT03593681|fallopian tube cancer|fallopian tube cancer
5064843|NCT03593681|high grade serous carcinoma|high grade serous carcinoma
5064844|NCT03593681|hysteroscopic biopsy|hysteroscopic biopsy
5930354|NCT03551691|fat absorption|fat absorption
5064845|NCT03593681|fallopian tube cell collection|fallopian tube cell collection
5064846|NCT03593681|peritoneal cancer|peritoneal cancer
5064847|NCT03593668|Metformin|metformin
5064848|NCT03593668|Benaglutide|benaglutide
5064851|NCT03593629|PrEP|prep
5064852|NCT03593629|Truvada|truvada
5064853|NCT03593629|Public Health|public health
5064854|NCT03593629|Global Health|global health
5064855|NCT03593629|Infectious Disease|infectious disease
5064856|NCT03593629|Self-Testing|self-testing
5064857|NCT03593629|Kenya|kenya
5064858|NCT03593629|Africa|africa
5064859|NCT03593629|Low and/or Middle Income Countries (LMIC)|low and/or middle income countries (lmic)
5064860|NCT03593629|Cost-Effectiveness|cost-effectiveness
5064861|NCT03593577|Schwannoma|schwannoma
5064863|NCT03593577|endolymphatic hydrops|endolymphatic hydrops
5064864|NCT03593577|magnetic resonnance imaging|magnetic resonnance imaging
5064866|NCT03593564|Randomized Controlled Trial|randomized controlled trial
5064867|NCT03593564|Cognitive Behavioral Therapy|cognitive behavioral therapy
5064868|NCT03593564|Intervention Study|intervention study
5064869|NCT03593551|stress|stress
5064870|NCT03593551|anxiety|anxiety
5064871|NCT03593551|breastfeeding|breastfeeding
5064872|NCT03593551|relaxation|relaxation
5064873|NCT03593551|meditation|meditation
5064874|NCT03593551|music|music
5064875|NCT03593525|Pediatric Oncology|pediatric oncology
5064876|NCT03593525|Randomized Control Trial|randomized control trial
5064877|NCT03593525|Symptom Screening|symptom screening
5064878|NCT03593525|Quality of Life|quality of life
5064879|NCT03593512|multiple system atrophy|multiple system atrophy
5064880|NCT03593512|autonomic|autonomic
5064881|NCT03593499|melanoma|melanoma
5064882|NCT03593499|omaveloxolone|omaveloxolone
5064883|NCT03593499|expanded access|expanded access
5064884|NCT03593473|Oxytocin|oxytocin
5064885|NCT03593473|Hypothalamic-pituitary-adrenal axis (HPA)|hypothalamic-pituitary-adrenal axis (hpa)
5064886|NCT03593447|Chronic hepatics C virus (HCV) genotype 1|chronic hepatics c virus (hcv) genotype 1
5064887|NCT03593447|treatment naïve|treatment naïve
5064888|NCT03593447|non-cirrhotic|non-cirrhotic
5064889|NCT03593447|cirrhotic|cirrhotic
5064890|NCT03593447|efficacy|efficacy
5064891|NCT03593447|safety|safety
5064892|NCT03593447|TG-2349|tg-2349
5064893|NCT03593447|DAG181|dag181
5064894|NCT03593447|Ribavirin|ribavirin
5064895|NCT03593395|Transition|transition
5064896|NCT03593395|Emerging Adults|emerging adults
5064897|NCT03593395|Peer Mentoring|peer mentoring
5064898|NCT03593382|Female endurance athletes|female endurance athletes
5064899|NCT03593382|Energy Availability|energy availability
5064900|NCT03593382|Nutrient Availability|nutrient availability
5064901|NCT03593382|Bone Mineral Density|bone mineral density
5064902|NCT03593382|Menstrual dysfunction|menstrual dysfunction
5064903|NCT03593382|Female athlete triad|female athlete triad
5961062|NCT04289558|falciparum malaria|falciparum malaria
5961063|NCT04289558|malaria|malaria
5064904|NCT03593382|Energy metabolism|energy metabolism
5064905|NCT03593382|Recovery after exercise|recovery after exercise
5064906|NCT03593382|Endothelial function|endothelial function
5064907|NCT03593382|Eating disorders|eating disorders
5064908|NCT03593382|Performance|performance
5064910|NCT03593356|Income|income
5064911|NCT03593356|Child Development|child development
5064912|NCT03593356|Brain Development|brain development
5064913|NCT03593330|Transitional Care|transitional care
5064914|NCT03593330|Discharge Planning|discharge planning
5064915|NCT03593330|Readmission|readmission
5064916|NCT03593330|Elective Neurosurgery|elective neurosurgery
5064917|NCT03593330|Elective Spinal Surgery|elective spinal surgery
5064918|NCT03593330|Elective Brain Surgery|elective brain surgery
5064919|NCT03593330|Transitional Care Program|transitional care program
5064920|NCT03593330|TCP|tcp
5064922|NCT03593317|Right ventricle|right ventricle
5064923|NCT03593291|Stroke, VTE prophylaxis, Anti Xa|stroke, vte prophylaxis, anti xa
5064924|NCT03593239|Electronic Nicotine Delivery System|electronic nicotine delivery system
5064925|NCT03593239|Combustible Cigarettes|combustible cigarettes
5064926|NCT03593239|Nicotine|nicotine
5064935|NCT03593161|supportive care|supportive care
5064936|NCT03593135|vinegar|vinegar
5064937|NCT03593135|diabetes|diabetes
5064938|NCT03593135|hyperglycemia|hyperglycemia
5064939|NCT03593135|hypercholesterolemia|hypercholesterolemia
5064940|NCT03593135|nutraceutical|nutraceutical
5064941|NCT03593122|Vulvovaginal Dryness|vulvovaginal dryness
4966194|NCT04200963|AHRi|ahri
5064942|NCT03593109|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
5064943|NCT03593109|CD19 and CD22|cd19 and cd22
5064944|NCT03593096|High Altitude|high altitude
5064945|NCT03593096|Exercise|exercise
5064946|NCT03593096|Ventilation|ventilation
5064947|NCT03593096|Heart rate|heart rate
5064948|NCT03593083|High Altitude|high altitude
5064949|NCT03593083|Exercise|exercise
5064950|NCT03593083|Electrocardiography|electrocardiography
5064951|NCT03593083|Non-invasive Blood Pressure|non-invasive blood pressure
5064952|NCT03593083|Finapres|finapres
5064953|NCT03593070|online group intervention|online group intervention
5064954|NCT03593057|dysmenorrhoea|dysmenorrhoea
5064955|NCT03593057|manual therapy|manual therapy
5064956|NCT03593044|atropine|atropine
5064957|NCT03593044|photophobia|photophobia
5064958|NCT03593044|pupil|pupil
5064959|NCT03593044|reading speed|reading speed
5064960|NCT03593044|myopia|myopia
5064961|NCT03593044|Surveys and Questionnaires|surveys and questionnaires
5064962|NCT03593018|oral azacitidine|oral azacitidine
5064963|NCT03593005|High Altitude|high altitude
5930476|NCT03534453|ovarian cancer|ovarian cancer
5064964|NCT03593005|Altitude related symptoms|altitude related symptoms
5064965|NCT03592979|Simulated altitude|simulated altitude
5064966|NCT03592979|exercise|exercise
5064967|NCT03592979|ventilation|ventilation
5064968|NCT03592979|heart rate|heart rate
5064969|NCT03592966|(Poly)phenols|(poly)phenols
5064970|NCT03592966|Blueberries|blueberries
5064974|NCT03592953|Serious game|serious game
5064975|NCT03592953|Post partum hemorrhage|post partum hemorrhage
5064976|NCT03592953|Non technical skills|non technical skills
5064977|NCT03592927|exercise capacity|exercise capacity
5064978|NCT03592927|simulated altitude|simulated altitude
5064979|NCT03592888|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5064980|NCT03592888|Cancer vaccine|cancer vaccine
5064981|NCT03592888|Dendritic cell vaccine|dendritic cell vaccine
5064982|NCT03592888|Mutant KRAS|mutant kras
5064983|NCT03592849|thin endometrium|thin endometrium
5064984|NCT03592849|infertility|infertility
5064985|NCT03592797|Low-level laser therapy|low-level laser therapy
5064986|NCT03592797|Laser acupuncture|laser acupuncture
5064987|NCT03592797|Sequelae of Bell's palsy|sequelae of bell's palsy
5064988|NCT03592797|Randomized controlled trial|randomized controlled trial
5064989|NCT03592745|Transcutaneous vagus nerve stimulation (tVNS)|transcutaneous vagus nerve stimulation (tvns)
5064990|NCT03592745|VNS|vns
5064991|NCT03592745|robotic therapy|robotic therapy
5064992|NCT03592745|occupational therapy|occupational therapy
5064993|NCT03592745|motor rehabilitation|motor rehabilitation
5064994|NCT03592719|HIV Prevention|hiv prevention
5064995|NCT03592719|PrEP|prep
5064996|NCT03592719|Black|black
5064997|NCT03592719|African American|african american
5064998|NCT03592719|Women|women
5064999|NCT03592719|Motivational Interviewing|motivational interviewing
5065000|NCT03592706|HepatoCellular Carcinoma|hepatocellular carcinoma
5065001|NCT03592706|Liver Cancer|liver cancer
5065002|NCT03592706|Immune Killer Cells|immune killer cells
5065003|NCT03592706|IKC|ikc
5065004|NCT03592706|Immune Therapy|immune therapy
5065005|NCT03592706|Immunotherapy|immunotherapy
5065006|NCT03592706|Cell Therapy|cell therapy
5065007|NCT03592706|IVY|ivy
5065008|NCT03592706|IVY02|ivy02
5065009|NCT03592693|Shock, Septic|shock, septic
5065010|NCT03592693|Vitamin C|vitamin c
5065011|NCT03592693|Hydrocortisone|hydrocortisone
5065012|NCT03592680|Post-operative atrial fibrillation|post-operative atrial fibrillation
5065013|NCT03592680|Ascorbic Acid|ascorbic acid
5065014|NCT03592680|Vitamin C|vitamin c
5065015|NCT03592680|antioxidant|antioxidant
5065016|NCT03592680|Cardiac surgery|cardiac surgery
5065017|NCT03592667|Stage I Hypertension|stage i hypertension
5065018|NCT03592667|Without type 2 diabetes mellitus|without type 2 diabetes mellitus
5065019|NCT03592667|Variability of blood pressure|variability of blood pressure
5065020|NCT03592667|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
5065021|NCT03592667|Dapagliflozin|dapagliflozin
5065029|NCT03592576|Pre-approval Access|pre-approval access
5065031|NCT03592576|Special Access Program|special access program
5065032|NCT03592576|Named Patient Basis|named patient basis
5065033|NCT03592576|Special Access Scheme|special access scheme
5065034|NCT03592563|stroke|stroke
5065035|NCT03592563|dementia|dementia
5065036|NCT03592563|Alzheimer disease|alzheimer disease
5065037|NCT03592563|Health Brain|health brain
5065038|NCT03592563|Health knowledge|health knowledge
5065039|NCT03592537|Fentanyl versus midazolam|fentanyl versus midazolam
5065040|NCT03592511|Intervention study|intervention study
5065041|NCT03592511|Functional food|functional food
5065042|NCT03592511|Grape pomace|grape pomace
5065043|NCT03592498|Burns|burns
5065044|NCT03592498|Wounds and Injuries|wounds and injuries
5065045|NCT03592498|Biocompatible Materials|biocompatible materials
5065046|NCT03592498|Nile Tilapia|nile tilapia
5065047|NCT03592498|Oreochromis niloticus.|oreochromis niloticus.
5065048|NCT03592485|Erector Spinae Plane blockade|erector spinae plane blockade
5065049|NCT03592485|Pectoral Fascia block|pectoral fascia block
5065050|NCT03592485|patient control anlagesia|patient control anlagesia
5065051|NCT03592485|mitral valve replacement|mitral valve replacement
5065052|NCT03592472|Renal Cell Carcinoma|renal cell carcinoma
5065053|NCT03592472|Progression-free survival|progression-free survival
5065054|NCT03592472|Abexinostat|abexinostat
5065055|NCT03592472|Pazopanib|pazopanib
5065056|NCT03592472|RECIST|recist
5065057|NCT03592472|Cancer therapy|cancer therapy
5065058|NCT03592433|Decision Making|decision making
5065059|NCT03592433|Decision Support|decision support
5930527|NCT03524612|Immune|immune
5065060|NCT03592433|Health Literacy|health literacy
5065061|NCT03592420|Accidental falls|accidental falls
5065062|NCT03592420|Clinical trial|clinical trial
5065063|NCT03592420|Aged|aged
5065064|NCT03592420|Parkinson's Disease|parkinson's disease
5065065|NCT03592420|Stroke|stroke
5065066|NCT03592420|Exercise|exercise
5065067|NCT03592420|Education|education
5065068|NCT03592355|virtual care|virtual care
5065069|NCT03592355|virtual visit|virtual visit
5065070|NCT03592355|telemedicine|telemedicine
5065071|NCT03592342|Patch|patch
5065072|NCT03592342|Rivelin-Clo Patch|rivelin-clo patch
5065073|NCT03592342|Oral Lichen Planus|oral lichen planus
5065074|NCT03592342|Ulcerative|ulcerative
5065075|NCT03592342|Erythematous|erythematous
5065084|NCT03592277|Septic Shock|septic shock
5065085|NCT03592277|Vitamin C|vitamin c
5065086|NCT03592277|Thiamine|thiamine
5065091|NCT03592212|Asthma|asthma
5065092|NCT03592212|Salbutamol response|salbutamol response
5065093|NCT03592212|Phosphodiesterase 4 variant|phosphodiesterase 4 variant
5065094|NCT03592212|lung function|lung function
5065095|NCT03592212|airflow limitation|airflow limitation
5065096|NCT03592199|biomarker|biomarker
5065097|NCT03592199|metastatic|metastatic
5065098|NCT03592199|sunitinib|sunitinib
5065099|NCT03592199|axitinib|axitinib
5065100|NCT03592199|next generation sequencing|next generation sequencing
5065101|NCT03592199|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5065102|NCT03592186|adolescent|adolescent
5065103|NCT03592186|substance use|substance use
5065104|NCT03592147|Meditation|meditation
5065105|NCT03592147|Music|music
5065106|NCT03592147|Relaxation|relaxation
5065107|NCT03592147|Light Therapy|light therapy
5065108|NCT03592147|Stress|stress
5065109|NCT03592121|Nipple Neuropathy, Cancer Survivor|nipple neuropathy, cancer survivor
5065110|NCT03592108|Obstructive sleep apnea (OAS)|obstructive sleep apnea (oas)
5065111|NCT03592108|Cheyne-Stokes respiration (CSR)|cheyne-stokes respiration (csr)
5065112|NCT03592108|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5065113|NCT03592108|Telemedicine|telemedicine
5065114|NCT03592108|Heart failure|heart failure
5065115|NCT03592095|Dry needling|dry needling
5065116|NCT03592095|Placebo|placebo
5065117|NCT03592095|Myofascial pain sindrome|myofascial pain sindrome
5065118|NCT03592095|Masking|masking
5065123|NCT03592056|hemidiaphragmatic paralysis|hemidiaphragmatic paralysis
5065320|NCT03590717|vegetables|vegetables
5065126|NCT03592056|diluted local anesthetic infusion|diluted local anesthetic infusion
5065127|NCT03592056|ambulatory regional analgesia|ambulatory regional analgesia
5065128|NCT03592056|ambulatory continuous nerve block|ambulatory continuous nerve block
5065129|NCT03592056|continuous local anesthetic infusion|continuous local anesthetic infusion
5065130|NCT03592043|MitraClip|mitraclip
5065131|NCT03592043|Degenerative Mitral Regurgitation|degenerative mitral regurgitation
5065132|NCT03592030|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5065133|NCT03592030|Minimal change diseases|minimal change diseases
5065134|NCT03592030|Primitive FSGS|primitive fsgs
5065135|NCT03591991|Empagliflozin|empagliflozin
5065136|NCT03591991|Percutaneous coronary intervention|percutaneous coronary intervention
5077520|NCT03515083|apixaban|apixaban
5065147|NCT03591926|nebulized|nebulized
5065148|NCT03591926|inhalation|inhalation
5065149|NCT03591900|early diabetes|early diabetes
5065150|NCT03591900|prediabetes|prediabetes
5065151|NCT03591900|continuous glucose monitoring system|continuous glucose monitoring system
5065152|NCT03591900|detection|detection
5065153|NCT03591874|ogvhd|ogvhd
5065154|NCT03591874|ocular graft vs host|ocular graft vs host
5065155|NCT03591874|Ocular Surface Disease|ocular surface disease
5065156|NCT03591874|Ocular Graft vs Host Disease|ocular graft vs host disease
5065157|NCT03591874|Brimonidine Tartrate|brimonidine tartrate
5065158|NCT03591874|Lubricant Eye Drops|lubricant eye drops
5065159|NCT03591874|Ophthalmic Solutions|ophthalmic solutions
5065160|NCT03591874|Graft vs Host Disease|graft vs host disease
5065161|NCT03591848|Breast cancer|breast cancer
5065162|NCT03591848|Preservation of fertility|preservation of fertility
5065163|NCT03591848|Online support decision tool|online support decision tool
5065164|NCT03591835|Nasal septum-tragus length; newborn|nasal septum-tragus length; newborn
5065166|NCT03591822|Pain|pain
5065167|NCT03591822|Nursing care|nursing care
5065168|NCT03591822|Psychosocial intervention|psychosocial intervention
5065169|NCT03591822|Robot-assisted therapy|robot-assisted therapy
5065170|NCT03591822|paro robot|paro robot
5065171|NCT03591809|cognitive function|cognitive function
5065172|NCT03591809|fatigue|fatigue
5065173|NCT03591809|quality of life|quality of life
5376423|NCT01828879|Dermatitis, Atopic|dermatitis, atopic
5065174|NCT03591809|Functional exercise capacity|functional exercise capacity
5065175|NCT03591770|Shingrix vaccine|shingrix vaccine
5065176|NCT03591770|tofacitinib monotherapy|tofacitinib monotherapy
5065177|NCT03591770|anti-TNF monotherapy|anti-tnf monotherapy
5065178|NCT03591770|anti-TNF agent|anti-tnf agent
5065179|NCT03591770|thiopurine|thiopurine
5065180|NCT03591770|aminosalicylates|aminosalicylates
5065181|NCT03591757|Tolcapone|tolcapone
5065182|NCT03591757|Transthyretin (TTR)|transthyretin (ttr)
5065183|NCT03591757|Mutant TTR|mutant ttr
5065184|NCT03591757|Plasma TTR|plasma ttr
5065185|NCT03591757|CSF TTR|csf ttr
5065186|NCT03591757|Tetramer stability|tetramer stability
5065188|NCT03591757|Amyloidosis|amyloidosis
5065190|NCT03591731|NIPINEC|nipinec
5065191|NCT03591731|Neuroendocrine|neuroendocrine
5065192|NCT03591731|FFCD|ffcd
5065193|NCT03591731|GERCOR|gercor
5065194|NCT03591666|head and neck adenocarcinoma|head and neck adenocarcinoma
5065195|NCT03591666|Anlotinib|anlotinib
5065196|NCT03591627|Atrial fibrillation|atrial fibrillation
5065197|NCT03591627|Atrial Flutter|atrial flutter
5065198|NCT03591627|Transesophageal echocardiography|transesophageal echocardiography
5065199|NCT03591627|Ablation|ablation
5065200|NCT03591627|Cardioversion|cardioversion
5065201|NCT03591627|Thrombus; Embolism|thrombus; embolism
5065202|NCT03591614|Vaccine|vaccine
5065203|NCT03591614|DKK1|dkk1
5065206|NCT03591575|thalassemia|thalassemia
5065207|NCT03591575|iron overload|iron overload
5065208|NCT03591575|chelation|chelation
5065209|NCT03591575|deferiprone|deferiprone
5065210|NCT03591575|Ferriprox|ferriprox
5065211|NCT03591562|MRI|mri
5065212|NCT03591562|COPD|copd
5065213|NCT03591562|Disease Progression|disease progression
5065214|NCT03591523|cerebrovascular circulation|cerebrovascular circulation
5065215|NCT03591523|arterial blood flow|arterial blood flow
5065216|NCT03591523|magnetic resonance|magnetic resonance
5065217|NCT03591523|duplex sonography|duplex sonography
5065218|NCT03591510|PKC412|pkc412
5065219|NCT03591510|Acute Myeloid Leukemia|acute myeloid leukemia
5065220|NCT03591510|AML|aml
5065221|NCT03591510|FLT3-mutated|flt3-mutated
5065222|NCT03591510|pediatric population|pediatric population
5065223|NCT03591510|midostaurin|midostaurin
5065224|NCT03591510|midostaurin combined with standard chemotherapy|midostaurin combined with standard chemotherapy
5065225|NCT03591510|single agent post-consolidation therapy|single agent post-consolidation therapy
5065226|NCT03591510|untreated FLT3-mutated AML|untreated flt3-mutated aml
5065227|NCT03591497|Myelopathy|myelopathy
5065228|NCT03591497|Virtual Reality|virtual reality
5065229|NCT03591497|Rehabilitation|rehabilitation
5065230|NCT03591497|Balance|balance
5065231|NCT03591484|Halitosis|halitosis
5065235|NCT03591471|Henoch-Schönlein Purpura Nephritis|henoch-schönlein purpura nephritis
5065236|NCT03591471|Integrated and Stepped Treatment in TCM|integrated and stepped treatment in tcm
5065237|NCT03591380|Donor Specific Antibody|donor specific antibody
5065239|NCT03591380|Allograft Tolerance|allograft tolerance
5065240|NCT03591354|Artificial Pancreas (AP)|artificial pancreas (ap)
5065241|NCT03591354|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5065242|NCT03591354|Insulin Pump|insulin pump
5065243|NCT03591354|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5065244|NCT03591354|Closed Loop Control (CLC)|closed loop control (clc)
5065245|NCT03591354|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
5065246|NCT03591341|melatonin|melatonin
5065247|NCT03591341|breast milk|breast milk
5065248|NCT03591328|Acute myocardial infarction|acute myocardial infarction
5961064|NCT04289558|Africa|africa
5065249|NCT03591328|Unstable angina|unstable angina
5065250|NCT03591328|Acute coronary syndrome|acute coronary syndrome
5961065|NCT04289558|Duke|duke
5961066|NCT04289558|Tanzania|tanzania
5065251|NCT03591328|Computational fluid dynamics|computational fluid dynamics
5065252|NCT03591328|Coronary computed tomography angiography|coronary computed tomography angiography
5065253|NCT03591328|Fractional flow reserve|fractional flow reserve
5065254|NCT03591315|visual pathway|visual pathway
5065255|NCT03591315|functional magnetic resonance imaging|functional magnetic resonance imaging
5065256|NCT03591315|pituitary adenoma|pituitary adenoma
5065257|NCT03591302|Kidney Transplantation|kidney transplantation
5065258|NCT03591302|Blood Stem Cell Transplantation|blood stem cell transplantation
5065259|NCT03591289|Robotic Surgery|robotic surgery
5065260|NCT03591276|metastatic breast cancer|metastatic breast cancer
5065261|NCT03591276|immune check point inhibitors|immune check point inhibitors
5065262|NCT03591276|chemotherapy|chemotherapy
5065263|NCT03591276|liposomal doxorubicin|liposomal doxorubicin
5065264|NCT03591276|pharmacokinetics|pharmacokinetics
5065265|NCT03591276|Anti-PD1 antibodies|anti-pd1 antibodies
5065266|NCT03591250|Healthcare renunciation|healthcare renunciation
5065267|NCT03591250|Continuous positive airway pressure|continuous positive airway pressure
5065268|NCT03591250|Non-invasive ventilation|non-invasive ventilation
5065269|NCT03591250|Oxygen therapy|oxygen therapy
5065270|NCT03591237|cancer|cancer
5065271|NCT03591237|late effects|late effects
5065272|NCT03591237|pain|pain
5065273|NCT03591224|pharmacogenetics|pharmacogenetics
5065274|NCT03591224|pharmacogenomics|pharmacogenomics
5065275|NCT03591224|antidepressants|antidepressants
5065276|NCT03591224|pharmacy|pharmacy
5065277|NCT03591224|pharmacist|pharmacist
5065278|NCT03591224|community|community
5065279|NCT03591185|Accidental Falls|accidental falls
5065280|NCT03591185|Primary prevention|primary prevention
5065281|NCT03591185|Pressure platform|pressure platform
5065282|NCT03591185|Inertial Sensor|inertial sensor
5065283|NCT03591146|Postsurgical Pain Management|postsurgical pain management
5065284|NCT03591081|Diabetic foot|diabetic foot
5065285|NCT03591055|Frail elderly|frail elderly
5065286|NCT03591055|Clinical Trial|clinical trial
5065287|NCT03590977|Streptococcus Mutans|streptococcus mutans
5065288|NCT03590977|licorice|licorice
5065297|NCT03590847|Time Restricted Feeding|time restricted feeding
5065298|NCT03590808|Influenza|influenza
5065299|NCT03590808|vaccine|vaccine
5065300|NCT03590808|solid carcinoma|solid carcinoma
5065301|NCT03590808|immune checkpoint|immune checkpoint
5065302|NCT03590808|efficacy|efficacy
5065303|NCT03590808|safety|safety
5065304|NCT03590769|Peripheral Arterial Disease|peripheral arterial disease
5065305|NCT03590769|PAD|pad
5065306|NCT03590769|Claudication, Intermittent|claudication, intermittent
5065307|NCT03590769|Claudication|claudication
5065308|NCT03590769|SFA Occlusion|sfa occlusion
5065309|NCT03590769|Arterial Occlusion|arterial occlusion
5065310|NCT03590769|Iliac Artery Occlusion|iliac artery occlusion
5065311|NCT03590769|Vascular Calcification|vascular calcification
5065312|NCT03590756|Skin Health|skin health
5065313|NCT03590756|Skin Wrinkle|skin wrinkle
5065314|NCT03590756|Skin Redness|skin redness
5065315|NCT03590756|Carotenoid|carotenoid
5065316|NCT03590756|Mango|mango
5065317|NCT03590717|dietary diversity|dietary diversity
5065318|NCT03590717|minimum acceptable diet|minimum acceptable diet
5065319|NCT03590717|fruits|fruits
5065332|NCT03590652|Pomalidomide|pomalidomide
5065333|NCT03590652|Ixazomib|ixazomib
5065334|NCT03590652|Dexamethasone|dexamethasone
5065336|NCT03590652|Phase 2|phase 2
5065337|NCT03590652|Darzalex|darzalex
5065338|NCT03590652|Pomalyst|pomalyst
5404496|NCT01702168|EBT|ebt
5065360|NCT03590600|Phase 1|phase 1
5065361|NCT03590600|Anti-Bacterial Agents|anti-bacterial agents
5931054|NCT03467516|Uveal Diseases|uveal diseases
5065362|NCT03590600|Respiratory Tract Infections|respiratory tract infections
5065367|NCT03590522|pathogenesis of heart failure|pathogenesis of heart failure
5065368|NCT03590522|cardiac ryanodine Receptor 2|cardiac ryanodine receptor 2
5065369|NCT03590522|Amino acids|amino acids
5065370|NCT03590509|Telemedicine|telemedicine
5065371|NCT03590496|propionate|propionate
5065372|NCT03590483|Twins|twins
5065373|NCT03590483|ART|art
5065374|NCT03590483|Induction of Ovulation|induction of ovulation
5065375|NCT03590483|Perinatal mortality|perinatal mortality
5065376|NCT03590470|avoidable hospitalisations|avoidable hospitalisations
5065377|NCT03590470|quality of care|quality of care
5065378|NCT03590470|nursing homes|nursing homes
5065379|NCT03590470|implementation science|implementation science
5065380|NCT03590470|quality improvement|quality improvement
5065381|NCT03590431|iodine|iodine
5065382|NCT03590431|bioavailability|bioavailability
5065383|NCT03590431|milk|milk
5065384|NCT03590418|Intestinal failure|intestinal failure
5065385|NCT03590418|Microbiota|microbiota
5065386|NCT03590405|uterus|uterus
5065387|NCT03590405|infertility|infertility
5065388|NCT03590405|transplantation|transplantation
5065389|NCT03590392|Vaccine|vaccine
5065390|NCT03590392|Chikungunya Virus|chikungunya virus
5065391|NCT03590392|Chikungunya Fever|chikungunya fever
5065392|NCT03590366|Type 1 erythematotelangiectatic rosacea|type 1 erythematotelangiectatic rosacea
5065393|NCT03590340|Plasmodium falciparum|plasmodium falciparum
5065394|NCT03590340|PfSPZ Vaccine|pfspz vaccine
5065395|NCT03590340|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
5065397|NCT03590314|Stroke|stroke
5065398|NCT03590314|Upper limb|upper limb
5065399|NCT03590314|Recovery|recovery
5065400|NCT03590288|Liver cirrhosis|liver cirrhosis
5065401|NCT03590288|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5065402|NCT03590288|Pressure gradient|pressure gradient
5065403|NCT03590288|Outcome prediction|outcome prediction
5065404|NCT03590275|pancreatic cancer|pancreatic cancer
5065405|NCT03590275|chemotherapy|chemotherapy
5065413|NCT03590197|Neuron-specific Enolase|neuron-specific enolase
5065415|NCT03590184|Abdominal wall repair|abdominal wall repair
5065416|NCT03590184|Infection|infection
5065417|NCT03590184|Biologic mesh|biologic mesh
5065418|NCT03590184|Biosynthetic mesh|biosynthetic mesh
5065419|NCT03590184|Cost-effectiveness|cost-effectiveness
5065420|NCT03590171|ALL|all
5065421|NCT03590145|Groin pain|groin pain
5065827|NCT03587779|sevoflurane|sevoflurane
5065437|NCT03590080|Graves' Ophthalmopathy|graves' ophthalmopathy
5065438|NCT03590080|Hypertension|hypertension
5065439|NCT03590080|Blood Pressure|blood pressure
5065440|NCT03590080|Methylprednisolone|methylprednisolone
5065441|NCT03590080|Glucocorticoids|glucocorticoids
5065442|NCT03590067|End stage renal disease|end stage renal disease
5065447|NCT03590067|oral finding|oral finding
5065448|NCT03590067|oral manifestation|oral manifestation
5065449|NCT03590041|Diabetes Mellitus Type 2, Comparative Effectiveness Trial|diabetes mellitus type 2, comparative effectiveness trial
5065450|NCT03590015|Recruitment|recruitment
5065451|NCT03590015|Invitation Letter|invitation letter
5065452|NCT03590015|patients|patients
5065463|NCT03589950|anlotinib|anlotinib
5065464|NCT03589950|docetaxel|docetaxel
5065465|NCT03589950|pemetrexed|pemetrexed
5065466|NCT03589937|refractive error|refractive error
5065467|NCT03589937|ocular structural parameters|ocular structural parameters
5065468|NCT03589924|Immediate implant reconstruction|immediate implant reconstruction
5065469|NCT03589924|TiLoop® Bra|tiloop® bra
5065470|NCT03589898|magnetic resonance imaging|magnetic resonance imaging
5065471|NCT03589898|spectroscopy|spectroscopy
5065473|NCT03589898|glutamate|glutamate
5065474|NCT03589898|social cognition|social cognition
5065476|NCT03589872|hand function, dual task, Parkinson disease, activities of daily living|hand function, dual task, parkinson disease, activities of daily living
5065477|NCT03589859|neurologic rehabilitation|neurologic rehabilitation
5065478|NCT03589859|computer games|computer games
5065479|NCT03589833|Rheumatoid Arthritis|rheumatoid arthritis
5065480|NCT03589833|Methotrexate|methotrexate
5065481|NCT03589833|Tripterygium|tripterygium
5065482|NCT03589833|TNF inhibitor|tnf inhibitor
5065483|NCT03589820|Wilson Disease|wilson disease
5065484|NCT03589820|Liver Failure|liver failure
5065485|NCT03589820|plasma exchange|plasma exchange
5065486|NCT03589820|continuous hemodiafiltration|continuous hemodiafiltration
5065496|NCT03589794|AP 10-602 [GLA-LSQ]|ap 10-602 [gla-lsq]
5065497|NCT03589794|Challenge|challenge
5065498|NCT03589794|Healthy adults|healthy adults
5065499|NCT03589794|Malaria|malaria
5065500|NCT03589794|P. falciparum|p. falciparum
5065501|NCT03589794|rCSP|rcsp
5065502|NCT03589794|Vaccine|vaccine
5065511|NCT03589755|mindfulness|mindfulness
5065512|NCT03589755|meditation|meditation
5065513|NCT03589755|anxiety|anxiety
5065514|NCT03589755|depression|depression
5065515|NCT03589742|Atrial Fibrillation|atrial fibrillation
5065516|NCT03589742|Atrial Flutter|atrial flutter
5065517|NCT03589742|Radiofrequency Ablation|radiofrequency ablation
5065518|NCT03589742|Pulmonary Vein Isolation|pulmonary vein isolation
5065519|NCT03589742|Catheter|catheter
5065520|NCT03589742|AblaView Ablation Catheter|ablaview ablation catheter
5065521|NCT03589742|Atrioventricular node|atrioventricular node
5065522|NCT03589716|Vital Signs|vital signs
5065527|NCT03589690|Metabolic Syndrome|metabolic syndrome
5065528|NCT03589690|Thioctic Acid|thioctic acid
5065529|NCT03589690|Inflammation|inflammation
5065530|NCT03589690|Insulin Resistance|insulin resistance
5065531|NCT03589677|DM1|dm1
5065532|NCT03589677|Brain|brain
5065533|NCT03589677|MRI|mri
5065534|NCT03589651|Solid tumors|solid tumors
5065535|NCT03589651|locally advanced unresectable tumor|locally advanced unresectable tumor
5065536|NCT03589651|metastatic solid tumors|metastatic solid tumors
5065537|NCT03589638|tracheal intubation|tracheal intubation
5065538|NCT03589638|videolaryngoscopy|videolaryngoscopy
5065539|NCT03589638|hemodynamics|hemodynamics
5065540|NCT03589638|intraocular pressure|intraocular pressure
5065541|NCT03589625|electricity and health|electricity and health
5065542|NCT03589625|maternal health|maternal health
5065543|NCT03589625|quality of care|quality of care
5065544|NCT03589625|solar power|solar power
5065545|NCT03589612|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5065546|NCT03589612|performance|performance
5065547|NCT03589612|hamstring flexibility|hamstring flexibility
5065548|NCT03589612|regression|regression
5065549|NCT03589573|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5065550|NCT03589573|muscle strength|muscle strength
5065551|NCT03589573|hamstring flexibility|hamstring flexibility
5065552|NCT03589573|back muscle|back muscle
5065553|NCT03589573|lower extremity|lower extremity
5065554|NCT03589560|revascularization|revascularization
5065555|NCT03589560|necrotic|necrotic
5065556|NCT03589560|immature|immature
5065557|NCT03589560|coronal plug|coronal plug
5065558|NCT03589547|Lung cancer|lung cancer
5065560|NCT03589547|Stage III|stage iii
5065561|NCT03589547|Post chemoradiation|post chemoradiation
5065562|NCT03589521|Veterans|veterans
5065563|NCT03589521|Cognitive Therapy|cognitive therapy
5065564|NCT03589521|Couple Therapy|couple therapy
5065565|NCT03589508|National Guard|national guard
5065566|NCT03589508|Telehealth|telehealth
5065567|NCT03589508|Prevention|prevention
5065568|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine
5065573|NCT03589391|Epidural injection|epidural injection
5065574|NCT03589391|loss of resistance detection|loss of resistance detection
5065578|NCT03589352|breast cancer|breast cancer
5065579|NCT03589352|cervix cancer|cervix cancer
5065594|NCT03589326|Bcr-abl fusion proteins|bcr-abl fusion proteins
5065595|NCT03589326|Iclusig|iclusig
5065596|NCT03589326|Gleevec|gleevec
5065597|NCT03589287|Intra-articular (IA), Allogeneic, MSC, OA|intra-articular (ia), allogeneic, msc, oa
5065598|NCT03589274|alcohol use disorder|alcohol use disorder
5065599|NCT03589274|women|women
5065600|NCT03589274|female specific therapy|female specific therapy
5065601|NCT03589274|cognitive behavior therapy|cognitive behavior therapy
5065602|NCT03589274|group therapy|group therapy
5065603|NCT03589235|autografts|autografts
5065604|NCT03589235|gingival recession|gingival recession
5065605|NCT03589235|free gingival graft|free gingival graft
5065606|NCT03589235|Attached gingival width|attached gingival width
5065607|NCT03589235|Platelet-Rich Fibrin dressing|platelet-rich fibrin dressing
5065608|NCT03589209|Round window visibility|round window visibility
5065609|NCT03589209|Cochlear implantation|cochlear implantation
5065610|NCT03589183|Gut Microbiome|gut microbiome
5065611|NCT03589183|Ulcerative colitis|ulcerative colitis
5065612|NCT03589183|Crohn disease|crohn disease
5065613|NCT03589183|Multi-omics|multi-omics
5065614|NCT03589183|Psychometrics|psychometrics
5065615|NCT03589183|anxiety|anxiety
5065616|NCT03589183|depression|depression
5065617|NCT03589170|Atrial fibrillation|atrial fibrillation
5065618|NCT03589170|Opportunistic screening|opportunistic screening
5065619|NCT03589170|ischaemic stroke|ischaemic stroke
5065620|NCT03589118|Substance Addiction|substance addiction
5065621|NCT03589118|Craving|craving
5065622|NCT03589118|Chinese Medecine|chinese medecine
5065623|NCT03589118|Qi Gong|qi gong
5065624|NCT03589118|Psychology|psychology
5065625|NCT03589092|GDM|gdm
5065626|NCT03589092|MODY|mody
5065635|NCT03589066|rotigotine|rotigotine
5065636|NCT03589066|parkinson|parkinson
5065637|NCT03589066|parkinsons|parkinsons
5065638|NCT03589066|intramuscular injection|intramuscular injection
5065639|NCT03589066|UPDRS|updrs
5065640|NCT03589053|Limb remote ischemic conditioning|limb remote ischemic conditioning
5065641|NCT03589053|Cerebrovascular reserve|cerebrovascular reserve
5065642|NCT03589014|Cerebral Cavernous Malformation|cerebral cavernous malformation
5065643|NCT03589014|Propranolol|propranolol
5065644|NCT03589014|Magnetic Resonance Imaging|magnetic resonance imaging
5342951|NCT01981395|cognitive function|cognitive function
5065645|NCT03588962|allergy to metals, restenosis, in-stent restenosis|allergy to metals, restenosis, in-stent restenosis
5065646|NCT03588962|coronary artery disease|coronary artery disease
5065647|NCT03588923|HCV|hcv
5065648|NCT03588923|NS5B|ns5b
5065649|NCT03588923|SH229|sh229
5065650|NCT03588910|ambulatory|ambulatory
5065651|NCT03588910|narcotics|narcotics
5065652|NCT03588910|opioids|opioids
5065653|NCT03588910|postoperative|postoperative
5065654|NCT03588910|gynecology|gynecology
5931328|NCT03434262|MEK|mek
5065655|NCT03588910|laparoscopy|laparoscopy
5065656|NCT03588910|pain|pain
5065657|NCT03588910|surgery|surgery
5065658|NCT03588897|nutritional status|nutritional status
5065659|NCT03588897|Nutridrink|nutridrink
5065660|NCT03588897|elderly nutrition|elderly nutrition
5065661|NCT03588871|Tooth bleaching|tooth bleaching
5065662|NCT03588871|Quality of life|quality of life
5065663|NCT03588832|Stroke|stroke
5065664|NCT03588832|Spasticity|spasticity
5065665|NCT03588832|Upper Extremity|upper extremity
5065666|NCT03588832|Quality of Life|quality of life
5065667|NCT03588806|Abuse-deterrent opioid drugs|abuse-deterrent opioid drugs
5065668|NCT03588806|Xtampza ER|xtampza er
5065669|NCT03588780|acute stroke|acute stroke
5065670|NCT03588780|thrombectomy|thrombectomy
5065671|NCT03588780|tandem lesions|tandem lesions
5065672|NCT03588767|polytrauma|polytrauma
5065673|NCT03588767|endocrine response|endocrine response
5065674|NCT03588767|metabolic response|metabolic response
5065675|NCT03588767|bone metabolism|bone metabolism
5065676|NCT03588767|anabolic substance|anabolic substance
5065677|NCT03588767|vitamin D|vitamin d
5065679|NCT03588728|Smoking|smoking
5065680|NCT03588728|Schizophrenia|schizophrenia
5065689|NCT03588702|radiofrequency|radiofrequency
5065690|NCT03588702|pulsed electro-magnetic fields|pulsed electro-magnetic fields
5065691|NCT03588702|liposuction|liposuction
5065692|NCT03588689|hip fracture|hip fracture
5065693|NCT03588689|fascia iliaca block|fascia iliaca block
5065694|NCT03588689|continuous fascia iliaca block|continuous fascia iliaca block
5065695|NCT03588689|neuromuscular blockade|neuromuscular blockade
5065697|NCT03588676|High Altitude|high altitude
5065698|NCT03588676|Melatonin|melatonin
5065699|NCT03588676|Neurocognitive|neurocognitive
5065700|NCT03588663|Robotics|robotics
5065701|NCT03588663|Walking|walking
5065702|NCT03588663|Balance|balance
5065703|NCT03588611|bivalirudin|bivalirudin
5065704|NCT03588611|bolus injection|bolus injection
5065705|NCT03588611|activated clotting time|activated clotting time
5065706|NCT03588611|Renal insufficiency|renal insufficiency
5065707|NCT03588598|CLL|cll
5065708|NCT03588598|SLL|sll
5065709|NCT03588598|NHL|nhl
5065710|NCT03588598|SHC014748M|shc014748m
5065711|NCT03588598|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5065712|NCT03588572|Behavioural evaluation|behavioural evaluation
5065713|NCT03588572|Functional magnetic resonance imaging|functional magnetic resonance imaging
5065714|NCT03588572|Venlafaxine|venlafaxine
5065715|NCT03588559|Monitors, Blood Pressure|monitors, blood pressure
5065717|NCT03588533|HER-2 Positive|her-2 positive
5065718|NCT03588533|Gastric or gastroesophageal adenocarcinoma|gastric or gastroesophageal adenocarcinoma
5065719|NCT03588533|Herzuma|herzuma
5065720|NCT03588520|Hypertension|hypertension
5065721|NCT03588520|Chronic Kidney Disease|chronic kidney disease
5065722|NCT03588520|Home Blood Pressure Monitoring|home blood pressure monitoring
5065723|NCT03588520|Blood Pressure Management|blood pressure management
5065724|NCT03588520|Masked Hypertension|masked hypertension
5065725|NCT03588520|White Coat Hypertension|white coat hypertension
5065726|NCT03588520|Renal Insufficiency|renal insufficiency
5065727|NCT03588520|Cardiovascular Risk|cardiovascular risk
5065728|NCT03588507|papilla preservation|papilla preservation
5065731|NCT03588507|nanocrystalline hydroxyapetite|nanocrystalline hydroxyapetite
5065732|NCT03588507|nanobone graft|nanobone graft
5065733|NCT03588494|Recombinant human endostatin|recombinant human endostatin
5065734|NCT03588494|NSCLC|nsclc
5065735|NCT03588494|chemoradiotherapy|chemoradiotherapy
5065736|NCT03588481|PCI|pci
5065737|NCT03588481|DES|des
5065738|NCT03588481|real world|real world
5065739|NCT03588429|Sevoflurane|sevoflurane
5065740|NCT03588429|Isoflurane|isoflurane
5065741|NCT03588416|pT1|pt1
5065742|NCT03588416|Polypectomy|polypectomy
5065743|NCT03588416|Lymph node metastasis|lymph node metastasis
5065744|NCT03588416|Colorectal neoplasm|colorectal neoplasm
5065745|NCT03588364|osteopathic manipulation|osteopathic manipulation
5065746|NCT03588338|PONV|ponv
5065747|NCT03588338|Paracetamol|paracetamol
5065748|NCT03588325|MDW|mdw
5065749|NCT03588325|Sepsis|sepsis
5065750|NCT03588312|Aortic arch hypoplasia|aortic arch hypoplasia
5065751|NCT03588312|Glutaraldehyde treated autologous pericardium|glutaraldehyde treated autologous pericardium
5065752|NCT03588312|Single stage repair|single stage repair
5065753|NCT03588312|Congenital heart defects|congenital heart defects
5065754|NCT03588312|Newborns|newborns
5065757|NCT03588273|Bariatric surgery|bariatric surgery
5065758|NCT03588273|Pharmacokinetics|pharmacokinetics
5065759|NCT03588273|Amoxicillin|amoxicillin
5065761|NCT03588260|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5065762|NCT03588260|respiratory muscle strength|respiratory muscle strength
5065763|NCT03588260|physical activity|physical activity
5065764|NCT03588260|quality of life|quality of life
5065765|NCT03588260|dyspnea|dyspnea
5065766|NCT03588260|fatigue severity|fatigue severity
5065767|NCT03588260|exercise capacity|exercise capacity
5065768|NCT03588208|Fibromyalgia|fibromyalgia
5065769|NCT03588208|Pain|pain
5065770|NCT03588208|Function|function
5065771|NCT03588208|Quality of life|quality of life
5065772|NCT03588195|Education|education
5065773|NCT03588195|Pain|pain
5065774|NCT03588195|Function|function
5065775|NCT03588195|Quality of life|quality of life
5065776|NCT03588182|Virtual Reality (VR)|virtual reality (vr)
5065777|NCT03588156|Healthy Subject|healthy subject
5065778|NCT03588156|PK Study|pk study
5065779|NCT03588156|Tolerability|tolerability
5065780|NCT03588156|Safety Evaluation|safety evaluation
5065781|NCT03588143|Subacromial pain|subacromial pain
5065782|NCT03588143|Joint range of motion|joint range of motion
5065783|NCT03588143|Electrotherapy|electrotherapy
5065784|NCT03588143|Physiotherapy|physiotherapy
5065785|NCT03588143|Impingement|impingement
5065786|NCT03588130|Debridement|debridement
5065787|NCT03588117|Metabolic Syndrome|metabolic syndrome
5931607|NCT03405870|lipids|lipids
5065788|NCT03588104|Electronic Health (eHealth)|electronic health (ehealth)
5065792|NCT03588052|Vestibular incision subperiosteal tunnel access, Subepithelial connective tissue graft, Platelets rich fibrin, Multiple gingival recessions|vestibular incision subperiosteal tunnel access, subepithelial connective tissue graft, platelets rich fibrin, multiple gingival recessions
5065793|NCT03587935|Colon Adenoma|colon adenoma
5065795|NCT03587935|Adenoma detection rate|adenoma detection rate
5065796|NCT03587935|Magnetic Endoscopy Imaging|magnetic endoscopy imaging
5065797|NCT03587909|FLACS|flacs
5065798|NCT03587909|Phaco|phaco
5065799|NCT03587909|Shallow Anterior Chamber|shallow anterior chamber
5065800|NCT03587896|distress|distress
5065801|NCT03587896|post-traumatic stress disorder|post-traumatic stress disorder
5065802|NCT03587896|prevention|prevention
5065803|NCT03587896|refugees|refugees
5065804|NCT03587896|Self Help Plus|self help plus
5065805|NCT03587896|Turkey|turkey
5065806|NCT03587883|flavanol|flavanol
5065807|NCT03587883|cocoa flavanols|cocoa flavanols
5065808|NCT03587883|arterial stiffness|arterial stiffness
5065809|NCT03587883|blood pressure|blood pressure
5065810|NCT03587883|step test|step test
5065811|NCT03587870|intensive care unit|intensive care unit
5065812|NCT03587870|intermittent enteral nutrition|intermittent enteral nutrition
5931699|NCT03391778|NY-ESO-1|ny-eso-1
5065813|NCT03587870|continuous enteral nutrition|continuous enteral nutrition
5065814|NCT03587870|muscle wasting|muscle wasting
5065815|NCT03587857|Health Disparity|health disparity
5065816|NCT03587844|Brentuximab Vedotin|brentuximab vedotin
5065817|NCT03587844|18-147|18-147
5065818|NCT03587818|Patient-Centered Care|patient-centered care
5065819|NCT03587818|Health Communication|health communication
5065820|NCT03587818|Clinical trial|clinical trial
5065821|NCT03587818|Colorectal neoplasms|colorectal neoplasms
5065822|NCT03587818|Colorectal surgery|colorectal surgery
5065823|NCT03587818|Continuity of patient care|continuity of patient care
5065824|NCT03587818|Medical-surgical nursing|medical-surgical nursing
5931872|NCT03361241|Stroke|stroke
5065825|NCT03587818|Qualitative Research|qualitative research
5065826|NCT03587779|patient state index|patient state index
5065830|NCT03587766|Trypanosoma cruzi Infection|trypanosoma cruzi infection
5065832|NCT03587766|Trypanosomiasis, South American|trypanosomiasis, south american
5065833|NCT03587766|American Trypanosomiasis|american trypanosomiasis
5065834|NCT03587766|Kissing bug|kissing bug
5065835|NCT03587740|Breast Cancer|breast cancer
5065839|NCT03587649|AD|ad
5065840|NCT03587649|PD|pd
5065841|NCT03587649|HV|hv
5065842|NCT03587610|vaccination coverage|vaccination coverage
5065843|NCT03587558|carvedilol|carvedilol
5065844|NCT03587558|SOICR|soicr
5065845|NCT03587558|triggered activity|triggered activity
5065846|NCT03587558|outflow tract PVC/VT|outflow tract pvc/vt
5065847|NCT03587532|esophagectomy|esophagectomy
5065848|NCT03587532|indocyanine green|indocyanine green
5065849|NCT03587532|near infrared fluorescence|near infrared fluorescence
5065850|NCT03587506|Generalized epilepsy, idiopathic, periodic limb movement|generalized epilepsy, idiopathic, periodic limb movement
5065851|NCT03587480|Low rectal cancer|low rectal cancer
5065852|NCT03587480|Total Mesorectal Excision (TME)|total mesorectal excision (tme)
5065853|NCT03587480|neoadjuvant Chemo-radiotherapy (nCRT)|neoadjuvant chemo-radiotherapy (ncrt)
5065854|NCT03587480|lateral lymph node dissection (LLND)|lateral lymph node dissection (llnd)
5065855|NCT03587454|teleglaucoma|teleglaucoma
5065856|NCT03587454|teleophthalmology|teleophthalmology
5065857|NCT03587441|postural headache|postural headache
5898097|NCT02711137|AML|aml
5931905|NCT03353220|Overweight|overweight
5065858|NCT03587441|intrathecal neostigmine for prevention of PDPH|intrathecal neostigmine for prevention of pdph
5065859|NCT03587415|amylin; obesity; polycystic ovarian syndrome; preptin|amylin; obesity; polycystic ovarian syndrome; preptin
5065860|NCT03587389|Rotavirus|rotavirus
5065861|NCT03587389|Vaccine|vaccine
5065862|NCT03587389|Diarrhea|diarrhea
5065863|NCT03587389|Host genetics|host genetics
5065864|NCT03587337|Per-Oral Endoscopy Myotomy|per-oral endoscopy myotomy
5065865|NCT03587337|Microbial Translocation|microbial translocation
5065866|NCT03587298|ShearWave Elastography|shearwave elastography
5065867|NCT03587285|prostate cancer|prostate cancer
5454859|NCT01482338|PMS|pms
5065868|NCT03587285|central memory T cell|central memory t cell
5065869|NCT03587259|breast cancer screening|breast cancer screening
5065870|NCT03587259|tomosynthesis|tomosynthesis
5065871|NCT03587259|digital mammography|digital mammography
5065872|NCT03587233|Weight status|weight status
5065873|NCT03587233|Body mass index|body mass index
5065874|NCT03587233|Physical activity level|physical activity level
5065875|NCT03587233|Lifestyle behaviour|lifestyle behaviour
5065876|NCT03587207|Meningitis|meningitis
5065877|NCT03587207|Concomitantly|concomitantly
5065878|NCT03587207|Adolescent|adolescent
5065879|NCT03587207|Neisseria meningitidis|neisseria meningitidis
5065880|NCT03587207|Healthy subjects|healthy subjects
5065881|NCT03587207|Adult|adult
5065882|NCT03587181|Cryoballoon, Cryoablation, biobanking, Loop recorder, biopsy|cryoballoon, cryoablation, biobanking, loop recorder, biopsy
5065883|NCT03587168|Parkinson's Disease|parkinson's disease
5065575|NCT03589391|mechatronic device|mechatronic device
5065884|NCT03587168|The Timed 360° Turn Test|the timed 360° turn test
5065885|NCT03587168|Validity|validity
5065886|NCT03587168|Reliability|reliability
5065887|NCT03587155|ASNS, single cell RNA seq, Neurodevelopmental Dysplasia,|asns, single cell rna seq, neurodevelopmental dysplasia,
5065888|NCT03587142|gastroparesis|gastroparesis
5065889|NCT03587142|early satiety|early satiety
5065891|NCT03587142|buspirone|buspirone
5065892|NCT03587142|5-HT 1a receptor agonist|5-ht 1a receptor agonist
5065893|NCT03587129|epithelial ovarian cancer|epithelial ovarian cancer
5065894|NCT03587129|ovarian cancer|ovarian cancer
5065895|NCT03587129|platinum-resistant|platinum-resistant
5065897|NCT03587064|CRT-D|crt-d
5065898|NCT03587064|CRT-DX|crt-dx
5065899|NCT03587064|Atrial pacing|atrial pacing
5065900|NCT03587025|amitryptyline|amitryptyline
5065901|NCT03587025|Analgesia|analgesia
5065902|NCT03587025|Hysterectomy|hysterectomy
5065903|NCT03587025|Pain, Postoperative|pain, postoperative
5356761|NCT01918059|Tissue adhesive|tissue adhesive
5065904|NCT03586999|Nivolumab|nivolumab
5065905|NCT03586999|First Line Treatment|first line treatment
5065906|NCT03586999|EPOCH|epoch
5065907|NCT03586999|Standard of Care|standard of care
5065908|NCT03586986|First degree relative|first degree relative
5065909|NCT03586856|Continuous positive airway pressure|continuous positive airway pressure
5065910|NCT03586856|Air Leakage|air leakage
5065911|NCT03586856|Work of breathing|work of breathing
5065912|NCT03586804|menstrual|menstrual
5065913|NCT03586804|postural sway|postural sway
5065914|NCT03586804|dual task|dual task
5065915|NCT03586778|Back Pain|back pain
5065916|NCT03586778|Dry Needling|dry needling
5065917|NCT03586765|incontinence|incontinence
5065918|NCT03586765|female|female
5065919|NCT03586765|observational study|observational study
5065920|NCT03586765|self filled survey|self filled survey
5065921|NCT03586765|epidemiology|epidemiology
5065922|NCT03586752|HQCPR between standard and on-line program|hqcpr between standard and on-line program
5065923|NCT03586752|Education|education
5065933|NCT03586700|placebo|placebo
5065934|NCT03586687|Ultrasound guided injection|ultrasound guided injection
5065935|NCT03586674|pediatric cholestasis, Fibrate|pediatric cholestasis, fibrate
5065936|NCT03586622|Home monitoring|home monitoring
5065937|NCT03586622|Irritable Bowel Syndrome|irritable bowel syndrome
5065947|NCT03586557|Optic Neuritis|optic neuritis
5065948|NCT03586557|aquaporin4-IgG|aquaporin4-igg
5065949|NCT03586557|Treatment|treatment
5065950|NCT03586544|pediatric|pediatric
5065951|NCT03586544|bronchoconstriction|bronchoconstriction
5065952|NCT03586531|renal biopsy|renal biopsy
5065953|NCT03586518|Cardiac MRI|cardiac mri
5065954|NCT03586518|Hemodialysis|hemodialysis
5065955|NCT03586518|Myocardial Fibrosis|myocardial fibrosis
5065956|NCT03586518|Myocardial Inflammation|myocardial inflammation
5065957|NCT03586505|Keratitis|keratitis
5065958|NCT03586505|Eye Infection|eye infection
5065959|NCT03586505|Photophobia|photophobia
5065960|NCT03586505|Red light|red light
5065961|NCT03586505|Infrared light|infrared light
5065963|NCT03586492|SPECT|spect
5065965|NCT03586492|Coronary|coronary
5065966|NCT03586492|Calcium score|calcium score
5065967|NCT03586492|Scintigraphy|scintigraphy
5065968|NCT03586492|Myocardial perfusion|myocardial perfusion
5065969|NCT03586479|Vocabulary|vocabulary
5065970|NCT03586466|opioid abuse|opioid abuse
5065971|NCT03586466|opioid dependence|opioid dependence
5065972|NCT03586466|medication assisted treatment|medication assisted treatment
5065973|NCT03586466|opioids|opioids
5065974|NCT03586466|buprenorphine|buprenorphine
5065975|NCT03586466|buprenorphine/naloxone|buprenorphine/naloxone
5065976|NCT03586466|MedicaSafe|medicasafe
5342952|NCT01981382|low back pain|low back pain
5065977|NCT03586453|Non-Small Cell Lung Cancer (NSCLC) with an Epidermal Growth Factor Receptor (EGFR) mutation|non-small cell lung cancer (nsclc) with an epidermal growth factor receptor (egfr) mutation
5065978|NCT03586440|RS-FHRSP-grip strength|rs-fhrsp-grip strength
5065979|NCT03586414|MitoQ|mitoq
5932175|NCT03311633|Radius Fracture Distal|radius fracture distal
5065980|NCT03586401|Children who have been treated for cancer|children who have been treated for cancer
5065981|NCT03586401|Qualification of health|qualification of health
5065982|NCT03586401|Physical insolvency|physical insolvency
5065983|NCT03586401|Late toxic effects|late toxic effects
5065984|NCT03586401|Physical therapy|physical therapy
5065985|NCT03586401|Physical activity|physical activity
5065986|NCT03586401|Systems for decision making support|systems for decision making support
5065987|NCT03586388|Hypersensitivity, Milk|hypersensitivity, milk
5065988|NCT03586388|Cow's Milk|cow's milk
5065989|NCT03586388|Immunotherapy|immunotherapy
5065990|NCT03586388|Infant|infant
5065991|NCT03586362|Vancomycin|vancomycin
5065992|NCT03586362|MRSA nasal swab|mrsa nasal swab
5065993|NCT03586362|Pneumonia|pneumonia
5065994|NCT03586297|BCRF|bcrf
5065995|NCT03586297|Microbiome|microbiome
5065996|NCT03586297|Intratumoal microbiota|intratumoal microbiota
5065997|NCT03586284|Cytomegalovirus uveitis|cytomegalovirus uveitis
5065998|NCT03586284|Cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
5065999|NCT03586284|Cytomegalovirus keratouveitis|cytomegalovirus keratouveitis
5066000|NCT03586284|Cytomegalovirus iridocyclitis|cytomegalovirus iridocyclitis
5065696|NCT03588676|Hypoxia|hypoxia
5066001|NCT03586258|Neuropsychological study|neuropsychological study
5066002|NCT03586258|Brain imaging|brain imaging
5066003|NCT03586245|Iron Bioavailability|iron bioavailability
5066004|NCT03586245|Iron Fortification|iron fortification
5066005|NCT03586245|ferrous sulfate|ferrous sulfate
5066006|NCT03586245|ferric pyrophosphate|ferric pyrophosphate
5066007|NCT03586245|aspergillus oryzae|aspergillus oryzae
5066008|NCT03586245|stable isotope|stable isotope
5066009|NCT03586232|Rhinoplasty|rhinoplasty
5066010|NCT03586232|Arnica Montana|arnica montana
5066020|NCT03586206|toxins|toxins
5066021|NCT03586206|serum|serum
5066022|NCT03586206|infection|infection
5066122|NCT03585439|vertebral fusion|vertebral fusion
5066023|NCT03586154|Ketamine; pain; platelet rich plasma; mastectomy; shoulder|ketamine; pain; platelet rich plasma; mastectomy; shoulder
5961067|NCT04289558|sodium nitrite|sodium nitrite
5961068|NCT04289558|Phase I|phase i
5066024|NCT03586102|Protein supplementation|protein supplementation
5066025|NCT03586102|Human milk fortification|human milk fortification
5066026|NCT03586089|Phenobarbital|phenobarbital
5066027|NCT03586089|Alcohol|alcohol
5066028|NCT03586089|Withdrawal|withdrawal
5066029|NCT03586050|Hepatocellular Carcinoma; liver cancer; cancer; liver|hepatocellular carcinoma; liver cancer; cancer; liver
5066030|NCT03586011|Physical activity on prescription|physical activity on prescription
5066031|NCT03586011|Correlate of physical activity|correlate of physical activity
5066032|NCT03586011|Predicting factor|predicting factor
5066033|NCT03585933|Myocardial fibrosis|myocardial fibrosis
5066034|NCT03585933|Severe aortic stenosis|severe aortic stenosis
5066035|NCT03585933|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
5066036|NCT03585933|Scintigraphy|scintigraphy
5066037|NCT03585933|SAVR/TAVI|savr/tavi
5066039|NCT03585920|Oral sensitivity|oral sensitivity
5066040|NCT03585920|Appetite|appetite
5066041|NCT03585920|Metabolism|metabolism
5066042|NCT03585868|flavonoids|flavonoids
5066043|NCT03585842|Scale Translation|scale translation
5066044|NCT03585842|Substance Use Disorder|substance use disorder
5066045|NCT03585842|Comorbidities psychiatric|comorbidities psychiatric
5066046|NCT03585829|treatment|treatment
5066047|NCT03585829|quality of life|quality of life
5066048|NCT03585829|hypoglycemia|hypoglycemia
5066049|NCT03585816|Pneumoperitoneum|pneumoperitoneum
5066050|NCT03585816|Exhaust gas|exhaust gas
5066051|NCT03585816|chromatographic study|chromatographic study
5066052|NCT03585816|Nitrous oxide|nitrous oxide
5066053|NCT03585816|Nitrogen dioxide|nitrogen dioxide
5066054|NCT03585790|Eye Fatigue|eye fatigue
5066055|NCT03585751|non vital|non vital
5066056|NCT03585751|deciduous|deciduous
5066057|NCT03585751|3mixstatin|3mixstatin
5066058|NCT03585751|simvastatin|simvastatin
5066059|NCT03585751|triple antibiotic mix|triple antibiotic mix
5066060|NCT03585751|3 mix|3 mix
5066061|NCT03585738|Inositol|inositol
5066062|NCT03585738|Polycystic ovarian syndrome|polycystic ovarian syndrome
5066063|NCT03585738|Pregnancy|pregnancy
5066064|NCT03585738|Obstetrics outcomes|obstetrics outcomes
5066065|NCT03585738|Gestational diabetes|gestational diabetes
5066066|NCT03585738|Preeclampsia|preeclampsia
5066067|NCT03585725|Ribavirin|ribavirin
5066068|NCT03585725|Follicular Lymphoma|follicular lymphoma
5066069|NCT03585725|Mantle Cell Lymphoma|mantle cell lymphoma
5066070|NCT03585725|Lymphoma|lymphoma
5066071|NCT03585725|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5066072|NCT03585725|Indolent Lymphoma|indolent lymphoma
5066073|NCT03585712|Birth Control|birth control
5066074|NCT03585712|Progestin Only Pill|progestin only pill
5066075|NCT03585712|Estrogen Free Pill|estrogen free pill
5066076|NCT03585712|Norgestrel|norgestrel
5066077|NCT03585712|Oral Contraception|oral contraception
5066078|NCT03585712|Female Contraception|female contraception
5066079|NCT03585712|Cervical Mucus|cervical mucus
5898636|NCT02567357|autism|autism
5066080|NCT03585712|Ovarian Activity|ovarian activity
5066081|NCT03585699|spinal biopsy|spinal biopsy
5066082|NCT03585699|prospective randomizd trial|prospective randomizd trial
5066084|NCT03585686|Langerhans|langerhans
5066085|NCT03585686|histiocytosis|histiocytosis
5066086|NCT03585686|vemurafenib|vemurafenib
5066087|NCT03585686|BRAF|braf
5066088|NCT03585673|esophageal cancer|esophageal cancer
5066089|NCT03585673|metastatic|metastatic
5066090|NCT03585673|inoperable|inoperable
5066091|NCT03585673|relapsed|relapsed
5066092|NCT03585647|General anesthesia|general anesthesia
5066093|NCT03585647|Regional anesthesia|regional anesthesia
5066094|NCT03585647|Integrated anesthesia|integrated anesthesia
5066095|NCT03585647|Hip arthroplasty|hip arthroplasty
5066096|NCT03585647|Toxicological gene expression|toxicological gene expression
5066097|NCT03585634|Fathers|fathers
5066098|NCT03585634|Masculinity|masculinity
5066099|NCT03585634|Gender role|gender role
5066100|NCT03585634|Health Behaviour|health behaviour
5066102|NCT03585595|Antihypertensive treatment|antihypertensive treatment
5066103|NCT03585582|Respiratory Health|respiratory health
5066104|NCT03585556|Wet Age-related Macular Degeneration|wet age-related macular degeneration
5066105|NCT03585556|Gene therapy|gene therapy
5066106|NCT03585556|Wet AMD|wet amd
5066107|NCT03585530|Esophageal neoplasma|esophageal neoplasma
5066108|NCT03585530|adjuvant therapy|adjuvant therapy
5066109|NCT03585530|raltitrexed|raltitrexed
5066110|NCT03585530|radiotherapy|radiotherapy
5066111|NCT03585504|Implanon|implanon
5066113|NCT03585504|Contraceptive Implant|contraceptive implant
5066114|NCT03585504|Adolescent Pregnancy Prevention|adolescent pregnancy prevention
5066115|NCT03585504|Post Partum Insertion of Implanon|post partum insertion of implanon
5066116|NCT03585478|Celiac|celiac
5066117|NCT03585452|dexmedetomidine|dexmedetomidine
5066118|NCT03585452|cardiac surgery|cardiac surgery
5066119|NCT03585452|brain injury biomarkers|brain injury biomarkers
5066120|NCT03585452|cognitive examination|cognitive examination
5066121|NCT03585439|Isthmic spondylolisthesis|isthmic spondylolisthesis
5066123|NCT03585439|combined approach|combined approach
5066124|NCT03585439|circumferential fusion|circumferential fusion
5066125|NCT03585439|ALIF|alif
5066126|NCT03585439|posterior fusion|posterior fusion
5066127|NCT03585413|Bariatric surgery|bariatric surgery
5066128|NCT03585413|Obesity|obesity
5066129|NCT03585413|NAFLD|nafld
5066130|NCT03585413|Micronutrient supplementation|micronutrient supplementation
5066131|NCT03585413|Probiotic supplementation|probiotic supplementation
5066132|NCT03585400|Neuromuscular Blockade Agents|neuromuscular blockade agents
5066133|NCT03585400|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
5066134|NCT03585400|Perioperative Care|perioperative care
5066135|NCT03585400|Quality Improvement|quality improvement
5066136|NCT03585400|Respiratory Complication|respiratory complication
5066137|NCT03585374|pain|pain
5066138|NCT03585374|methoxyflurane|methoxyflurane
5066139|NCT03585374|Penthrox|penthrox
5066140|NCT03585361|Contraceptive Usage|contraceptive usage
5066141|NCT03585361|Pregnancy|pregnancy
5066142|NCT03585361|Postpartum Family Planning|postpartum family planning
5066143|NCT03585361|Contraception|contraception
5066144|NCT03585361|Prenatal Care|prenatal care
5066145|NCT03585361|Postnatal Care|postnatal care
5066146|NCT03585361|Postpartum Care|postpartum care
5066147|NCT03585361|Family Planning|family planning
5066148|NCT03585361|Ethiopia|ethiopia
5066149|NCT03585361|Community Health Workers|community health workers
5066150|NCT03585361|Community Based Care|community based care
5066151|NCT03585361|Health Extension Workers|health extension workers
5066152|NCT03585348|Neuromuscular Blockade Agents|neuromuscular blockade agents
5066153|NCT03585348|Provider Variability|provider variability
5066154|NCT03585348|Quality Improvement|quality improvement
5066155|NCT03585348|Perioperative Care|perioperative care
5066156|NCT03585348|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
5066157|NCT03585335|Cardiorespiratory Fitness Score|cardiorespiratory fitness score
5066159|NCT03585283|Myofascial Release|myofascial release
5066160|NCT03585283|Manual Therapies|manual therapies
5066538|NCT03583047|Prognosis|prognosis
5066161|NCT03585257|covert hepatic encephalopathy|covert hepatic encephalopathy
5066162|NCT03585257|inflammation|inflammation
5066163|NCT03585257|cognition|cognition
5066164|NCT03585257|quality of life|quality of life
5066166|NCT03585231|Chatbot|chatbot
5066167|NCT03585231|Conversational agent|conversational agent
5066168|NCT03585231|Chatbot for quitting smoking|chatbot for quitting smoking
5066169|NCT03585231|Messaging|messaging
5066170|NCT03585231|Text messaging|text messaging
5066171|NCT03585231|SMS|sms
5066172|NCT03585218|Quality of Life|quality of life
5066173|NCT03585218|Breast Cancer|breast cancer
5066174|NCT03585218|Essentials Oils|essentials oils
5066175|NCT03585218|Adjuvant Chemotherapy|adjuvant chemotherapy
5066176|NCT03585218|Salivary cortisol|salivary cortisol
5066177|NCT03585218|Neuropsychophysiology|neuropsychophysiology
5066178|NCT03585205|Stress response|stress response
5066179|NCT03585205|Cognitive Load|cognitive load
5066180|NCT03585179|Melasma|melasma
5066181|NCT03585179|Chloasma|chloasma
5066182|NCT03585179|Melanosis|melanosis
5066183|NCT03585179|Tranexamic acid|tranexamic acid
5066184|NCT03585179|Hydroquinone|hydroquinone
5066185|NCT03585179|Therapeutics|therapeutics
5066186|NCT03585166|Liver Cancer|liver cancer
5066187|NCT03585166|laparoscopic hepatectomy|laparoscopic hepatectomy
5066188|NCT03585166|open hepatectomy|open hepatectomy
5066189|NCT03585140|Acne Vulgaris|acne vulgaris
5066190|NCT03585140|Low Glycemic Diet|low glycemic diet
5066191|NCT03585140|Doxycycline|doxycycline
5066192|NCT03585140|Adapalene|adapalene
5066193|NCT03585127|Auditory verbal hallucinations|auditory verbal hallucinations
5066194|NCT03585127|Schizophrenia|schizophrenia
5066195|NCT03585127|Treatment-resistant|treatment-resistant
5066196|NCT03585127|Psychotherapy|psychotherapy
5066197|NCT03585127|Cognitive Behavioral Therapy|cognitive behavioral therapy
5066198|NCT03585127|Avatar Therapy|avatar therapy
5066211|NCT03584971|estradiol|estradiol
5066212|NCT03584971|cooperation|cooperation
5066213|NCT03584971|competitiveness|competitiveness
5066214|NCT03584971|risk preferences|risk preferences
5066215|NCT03584958|glaucoma surgery|glaucoma surgery
5066216|NCT03584958|MIGS, minimally invasive glaucoma surgery|migs, minimally invasive glaucoma surgery
5066217|NCT03584958|refractive outcomes|refractive outcomes
5066218|NCT03584958|visual outcomes|visual outcomes
5066219|NCT03584932|Youth,|youth,
5066220|NCT03584932|Criminal justice|criminal justice
5065932|NCT03586700|RCT|rct
5066231|NCT03584867|Basic life support|basic life support
5066232|NCT03584867|CPR skills|cpr skills
5066233|NCT03584867|Training|training
5066234|NCT03584867|High quality CPR|high quality cpr
5066235|NCT03584828|Cardiac Rehabilitation|cardiac rehabilitation
5066236|NCT03584828|exercise|exercise
5066237|NCT03584802|severe acute exacerbation of idiopathic pulmonary fibrosis|severe acute exacerbation of idiopathic pulmonary fibrosis
5066241|NCT03584776|Virtual reality|virtual reality
5066242|NCT03584750|Somatic and psychological factors|somatic and psychological factors
5066243|NCT03584737|acute sinusitis|acute sinusitis
5066244|NCT03584737|bacterial sinusitis|bacterial sinusitis
5066245|NCT03584737|point-of-care|point-of-care
5066246|NCT03584737|in vitro diagnostic device (IVD)|in vitro diagnostic device (ivd)
5961069|NCT04289558|infectious disease|infectious disease
5961070|NCT04289558|hematology|hematology
5066247|NCT03584724|HLA-B27|hla-b27
5066248|NCT03584724|relapses|relapses
5066249|NCT03584724|curcumin|curcumin
5066250|NCT03584711|Stop and Go strategy|stop and go strategy
5066251|NCT03584711|RAS Wild-type|ras wild-type
5066252|NCT03584672|Multiple Sclerosis|multiple sclerosis
5066253|NCT03584672|Static Balance Test|static balance test
5066254|NCT03584672|Balance|balance
5066255|NCT03584672|Reliability|reliability
5066256|NCT03584672|Validity|validity
5066257|NCT03584659|Patient-reported outcomes|patient-reported outcomes
5932600|NCT03248128|Fluticasone furoate|fluticasone furoate
5066258|NCT03584659|Electronic reporting of symptoms|electronic reporting of symptoms
5066259|NCT03584659|Immunotherapy|immunotherapy
5066260|NCT03584659|Chemotherapy|chemotherapy
5066261|NCT03584646|liver transplantation|liver transplantation
5066262|NCT03584646|malnutrition|malnutrition
5066263|NCT03584646|exercise|exercise
5066264|NCT03584646|prehabilitation|prehabilitation
5066265|NCT03584646|nutrition|nutrition
5066266|NCT03584646|sarcopenia|sarcopenia
5066267|NCT03584633|Indocyanine Green|indocyanine green
5066268|NCT03584633|Indocyanine Green Lymphography|indocyanine green lymphography
5066269|NCT03584633|Exercise|exercise
5066270|NCT03584620|lung transplantation|lung transplantation
5066271|NCT03584620|inspiratory muscle training|inspiratory muscle training
5066272|NCT03584620|pulmonary rehabilitation|pulmonary rehabilitation
5066273|NCT03584620|quality of life|quality of life
5066274|NCT03584620|physical activity|physical activity
5066275|NCT03584594|presepsin|presepsin
5066276|NCT03584594|biomarkers|biomarkers
5066277|NCT03584594|sepsis|sepsis
5066278|NCT03584594|diagnosis|diagnosis
5066279|NCT03584568|Caregiving|caregiving
5066280|NCT03584568|Intergeneration|intergeneration
5898910|NCT02507544|Advanced Solid Malignancy|advanced solid malignancy
5066281|NCT03584568|Reappraisal through perspective taking|reappraisal through perspective taking
5066282|NCT03584555|Small incision lenticule extraction|small incision lenticule extraction
5066283|NCT03584555|Cap thickness|cap thickness
5066284|NCT03584542|Zolpidem|zolpidem
5066285|NCT03584542|hypnotics and sedatives|hypnotics and sedatives
5066286|NCT03584542|Drug and narcotic control|drug and narcotic control
5066287|NCT03584542|Drug prescription|drug prescription
5066292|NCT03584516|Janus kinase inhibitor|janus kinase inhibitor
5066293|NCT03584516|corticosteroids|corticosteroids
5066294|NCT03584503|general anesthesia|general anesthesia
5066295|NCT03584503|laryngospasm|laryngospasm
5066296|NCT03584503|postoperative complications|postoperative complications
5066298|NCT03584503|Suction Above Cuff Endotracheal Tube|suction above cuff endotracheal tube
5066299|NCT03584477|Stroke|stroke
5066300|NCT03584477|Robot,|robot,
5066301|NCT03584477|Rehabilitation|rehabilitation
5066302|NCT03584477|Hemiparesis|hemiparesis
5066303|NCT03584477|Upper limb|upper limb
5066304|NCT03584477|Function|function
5066305|NCT03584477|Motor control|motor control
5066306|NCT03584438|TMS|tms
5066307|NCT03584438|Motor Cortex|motor cortex
5066308|NCT03584438|Excitability|excitability
5066309|NCT03584438|LTP|ltp
5066310|NCT03584438|LTD|ltd
5066311|NCT03584425|BOLD Signal|bold signal
5066312|NCT03584425|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5066313|NCT03584425|MR Spectroscopy|mr spectroscopy
5066314|NCT03584425|Anatomical Imaging|anatomical imaging
5066315|NCT03584425|Kinematics|kinematics
5066316|NCT03584386|Suicidality|suicidality
5066317|NCT03584386|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
5066318|NCT03584386|CAMS|cams
5066014|NCT03586219|Surgery|surgery
5066320|NCT03584386|Emergency Department|emergency department
5066321|NCT03584386|Suicide Intervention|suicide intervention
5066322|NCT03584386|Suicide Assessment|suicide assessment
5066323|NCT03584386|Suicide Prevention|suicide prevention
5066324|NCT03584373|Pain Outcomes|pain outcomes
5066325|NCT03584373|Ureteroscopy|ureteroscopy
5066326|NCT03584373|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
5066328|NCT03584321|Non-Obstructive Coronary Artery Disease|non-obstructive coronary artery disease
5961071|NCT04289532|Breast cancer, integrin α6, first-in-human, SPECT, 99mTc|breast cancer, integrin α6, first-in-human, spect, 99mtc
5961072|NCT04289493|Rehabilitation|rehabilitation
5961073|NCT04289493|Word dubbing|word dubbing
5961074|NCT04289493|Functional communication|functional communication
5961075|NCT04289480|intracranial aneurysms, Neurovascular|intracranial aneurysms, neurovascular
5961076|NCT04289428|Hepatitis B|hepatitis b
5961077|NCT04289428|Diagnostics|diagnostics
5961078|NCT04289428|HBV DNA|hbv dna
5961079|NCT04289428|ALT|alt
5961080|NCT04289428|Point of care|point of care
5961081|NCT04289428|Dried blood spot|dried blood spot
5961082|NCT04289402|Aging|aging
5961083|NCT04289389|Prevalence|prevalence
5961084|NCT04289389|Epidemiology|epidemiology
5961085|NCT04289389|Alzheimer`s disease|alzheimer`s disease
5961086|NCT04289376|Sports|sports
5961087|NCT04289298|depression|depression
5961088|NCT04289298|geriatric|geriatric
5961089|NCT04289298|psychotherapy|psychotherapy
5961090|NCT04289298|group|group
5961091|NCT04289272|body image|body image
5961092|NCT04289272|school|school
5961093|NCT04289272|intervention|intervention
5961094|NCT04289272|adolescence|adolescence
5961095|NCT04289272|self-esteem|self-esteem
5961096|NCT04289259|Tumor mutational burden|tumor mutational burden
5961097|NCT04289259|Cancer gene panel|cancer gene panel
5961098|NCT04289259|Whole-exome sequencing|whole-exome sequencing
5066329|NCT03584321|Coronary Angiography|coronary angiography
5066330|NCT03584308|Papillomavirus|papillomavirus
5066331|NCT03584308|Viusid|viusid
5066332|NCT03584308|Glizigen|glizigen
5066333|NCT03584308|Papilloma virus Esophageal|papilloma virus esophageal
5066334|NCT03584308|Antioxidant|antioxidant
5066335|NCT03584282|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5066336|NCT03584282|Methamphetamine|methamphetamine
5066337|NCT03584269|COPD|copd
5066338|NCT03584269|Oxygenation Long term|oxygenation long term
5066339|NCT03584269|Non invasive Ventilation|non invasive ventilation
5066340|NCT03584269|Nocturnal Hypoventilation|nocturnal hypoventilation
5066341|NCT03584243|collagen crosslinking|collagen crosslinking
5066342|NCT03584243|transepithelial crosslinking|transepithelial crosslinking
5066343|NCT03584178|ACTH-axis|acth-axis
5066344|NCT03584178|Budesonide|budesonide
5066345|NCT03584178|MAD|mad
5066346|NCT03584178|INSI|insi
5066347|NCT03584178|Intraocular pressure|intraocular pressure
5066348|NCT03584178|Bone density|bone density
5066349|NCT03584165|NightstaRx|nightstarx
5066350|NCT03584165|NSR-REP1|nsr-rep1
5066351|NCT03584165|Choroideremia|choroideremia
5066352|NCT03584165|CHM|chm
5066353|NCT03584165|Gene Therapy|gene therapy
5066354|NCT03584165|AAV|aav
5066355|NCT03584165|REP1|rep1
5677977|NCT00588848|OSA|osa
5066356|NCT03584152|Postoperative pain|postoperative pain
5066357|NCT03584152|Rhinoplasty|rhinoplasty
5066358|NCT03584087|Terlipressin, Variceal Haemorrhage, EVL|terlipressin, variceal haemorrhage, evl
5066359|NCT03584074|Pregabalin|pregabalin
5066360|NCT03584074|Selective COX-2 inhibitor|selective cox-2 inhibitor
5066361|NCT03584061|Chronic Pain|chronic pain
5066362|NCT03584061|Herpes Zoster|herpes zoster
5066363|NCT03584061|Pain|pain
5066364|NCT03584035|sensory motor integration exercise|sensory motor integration exercise
5066365|NCT03583983|Physical Activity|physical activity
5066366|NCT03583983|Dietary Habits|dietary habits
5066367|NCT03583983|Genetic Scores|genetic scores
5066368|NCT03583983|Cardiovascular Health|cardiovascular health
5066369|NCT03583970|Left Ventricular Assist Device|left ventricular assist device
5066370|NCT03583970|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5066371|NCT03583970|Refractory Cardiogenic Shock|refractory cardiogenic shock
5066372|NCT03583970|Heart Failure|heart failure
5066373|NCT03583970|Cardiovascular diseases|cardiovascular diseases
5066374|NCT03583970|Myocardial Infarction|myocardial infarction
5066375|NCT03583970|Myocardial Ischemia|myocardial ischemia
5066376|NCT03583970|Shock|shock
5066377|NCT03583944|E7389|e7389
5066378|NCT03583944|Tumors, Breast|tumors, breast
5066379|NCT03583944|Breast Cancer|breast cancer
5066380|NCT03583944|Breast Carcinoma|breast carcinoma
5066381|NCT03583944|Neoplasms, Breast|neoplasms, breast
5066382|NCT03583931|VATS Decortication|vats decortication
5066383|NCT03583931|Surgical Pleural Decortication|surgical pleural decortication
5066384|NCT03583931|Fibrinolytic Therapy|fibrinolytic therapy
5066385|NCT03583931|Pneumonia|pneumonia
5066386|NCT03583931|Thoracostomy|thoracostomy
5066387|NCT03583918|facial wrinkles|facial wrinkles
5066388|NCT03583918|skin laxity|skin laxity
5066389|NCT03583918|sagging skin|sagging skin
5066390|NCT03583892|Gabapentin, laparoscopic cholecystectomy, postoperative pain|gabapentin, laparoscopic cholecystectomy, postoperative pain
5066391|NCT03583879|Exoskeleton|exoskeleton
5066392|NCT03583879|Functional exercise|functional exercise
5066393|NCT03583866|blood pressure|blood pressure
5066394|NCT03583866|microdialysis|microdialysis
5066395|NCT03583840|men's health|men's health
5066396|NCT03583840|internet|internet
5066397|NCT03583840|telemedicine|telemedicine
5066398|NCT03583840|mass screening|mass screening
5066399|NCT03583840|health behavior|health behavior
5066400|NCT03583827|Cerebrovascular disorders|cerebrovascular disorders
5066401|NCT03583827|Upper extremity|upper extremity
5066402|NCT03583827|Paresis|paresis
5066403|NCT03583827|Electroencephalography|electroencephalography
5066404|NCT03583827|Psychomotor Performance|psychomotor performance
5066405|NCT03583801|Perioperative Anxiety|perioperative anxiety
5066406|NCT03583801|Aromatherapy|aromatherapy
5066407|NCT03583801|Surgery|surgery
5066408|NCT03583801|Loco-regional Anesthesia|loco-regional anesthesia
5066409|NCT03583801|Ambulatory|ambulatory
5066410|NCT03583762|Microarray Assay Technique|microarray assay technique
5066411|NCT03583762|Mass Spectrometry Technique|mass spectrometry technique
5066412|NCT03583762|Time to appropriate antibiotic|time to appropriate antibiotic
5066413|NCT03583749|Antimicrobial agents|antimicrobial agents
5066414|NCT03583749|subcutaneous administration|subcutaneous administration
5066415|NCT03583749|safety|safety
5066428|NCT03583697|Genetic Diseases, Inborn|genetic diseases, inborn
5066429|NCT03583697|Osteochondrodysplasias|osteochondrodysplasias
5066430|NCT03583684|Pivotal Response Treatment|pivotal response treatment
5066431|NCT03583684|Imaging|imaging
5066432|NCT03583671|Molar Incisor Hypomineralization , enamel defects.|molar incisor hypomineralization , enamel defects.
5066433|NCT03583645|Adolescence|adolescence
5066434|NCT03583645|Prevention|prevention
5066435|NCT03583645|Aggressive behavior|aggressive behavior
5066436|NCT03583645|Dating Violence|dating violence
5066437|NCT03583606|Adenovirus vector|adenovirus vector
5066438|NCT03583606|Ebola Virus|ebola virus
5066439|NCT03583606|Immunogenicity|immunogenicity
5066440|NCT03583606|Non-Human Primates Vaccination/Challenge Studies|non-human primates vaccination/challenge studies
5066441|NCT03583606|Phase 1|phase 1
5066442|NCT03583606|Reactogenicity|reactogenicity
5066443|NCT03583606|Safety|safety
5066444|NCT03583606|Zaire ebolavirus vaccine|zaire ebolavirus vaccine
5066445|NCT03583593|Diabetes|diabetes
5066446|NCT03583593|Insulin|insulin
5066447|NCT03583593|Diabetic Foot|diabetic foot
5066448|NCT03583593|Nutritional supplement|nutritional supplement
5066449|NCT03583593|Diamel|diamel
5066450|NCT03583580|Breast conserving surgery|breast conserving surgery
5066451|NCT03583580|Accelerate partial breast irradiation|accelerate partial breast irradiation
5066452|NCT03583580|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5066453|NCT03583580|phase II|phase ii
5066454|NCT03583567|protamine|protamine
5066455|NCT03583567|antihistamine|antihistamine
5066456|NCT03583554|Suicide|suicide
5066457|NCT03583554|Kynurenine|kynurenine
5066458|NCT03583554|metabolic pathway|metabolic pathway
5066459|NCT03583554|Veterans|veterans
5066460|NCT03583554|OEF/OIF/OND|oef/oif/ond
5066461|NCT03583554|electrophysiology|electrophysiology
5066462|NCT03583554|NMDA receptor|nmda receptor
5066463|NCT03583554|suicidal ideation|suicidal ideation
5066464|NCT03583541|Vulnerable women|vulnerable women
5066465|NCT03583541|Female sex workers|female sex workers
5066466|NCT03583541|Combination interventions|combination interventions
5066467|NCT03583541|Economic empowerment|economic empowerment
5066468|NCT03583541|HIV/AIDS|hiv/aids
5066469|NCT03583541|Sexually transmitted infections|sexually transmitted infections
5066470|NCT03583541|Sub-Saharan Africa|sub-saharan africa
5066471|NCT03583541|Uganda|uganda
5066472|NCT03583502|LCPUFA|lcpufa
5066473|NCT03583502|DHA|dha
5066474|NCT03583502|krill oil|krill oil
5066475|NCT03583502|supplementation|supplementation
5066476|NCT03583502|breast milk|breast milk
5066477|NCT03583476|Helicobacter pylori|helicobacter pylori
5066478|NCT03583476|Resistance|resistance
5066479|NCT03583476|Minimal inhibitory concentration|minimal inhibitory concentration
5066480|NCT03583476|Treatment efficacy|treatment efficacy
5066481|NCT03583411|thrombocytopenia|thrombocytopenia
5066482|NCT03583411|thrombocytosis|thrombocytosis
5066483|NCT03583398|TAVI|tavi
5066484|NCT03583398|quality of life|quality of life
5066485|NCT03583398|SAVR|savr
5066486|NCT03583372|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
5066487|NCT03583372|incontinence|incontinence
5066488|NCT03583372|OAB|oab
5066489|NCT03583372|vibegron|vibegron
5066490|NCT03583372|urge urinary incontinence|urge urinary incontinence
5066491|NCT03583372|Urinary bladder, overactive|urinary bladder, overactive
5066492|NCT03583372|Urologic Diseases|urologic diseases
5066493|NCT03583372|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5066494|NCT03583372|Urological Agents|urological agents
5066495|NCT03583346|M6495|m6495
5066496|NCT03583346|Anti-ADAMTS-5 Nanobody|anti-adamts-5 nanobody
5066497|NCT03583346|Osteoarthritis|osteoarthritis
5066498|NCT03583307|Sirolimus|sirolimus
5066499|NCT03583307|Vascular anomalies|vascular anomalies
5066500|NCT03583268|Type 1 diabetes|type 1 diabetes
5066501|NCT03583268|Physical activity|physical activity
5066507|NCT03583203|schizophrenia|schizophrenia
5066508|NCT03583203|bipolar disorder|bipolar disorder
5066509|NCT03583203|tobacco|tobacco
5066510|NCT03583203|COPD|copd
5066511|NCT03583190|Neck pain|neck pain
5066512|NCT03583190|Headache|headache
5066513|NCT03583190|Dry needling|dry needling
5066514|NCT03583190|manual therapy|manual therapy
5066515|NCT03583177|Proteolysis|proteolysis
5066516|NCT03583177|Muscle|muscle
5066517|NCT03583177|Cachexia|cachexia
5066518|NCT03583164|Anti fungal|anti fungal
5066519|NCT03583164|Invasive aspergillosis|invasive aspergillosis
5066520|NCT03583164|Rare moulds|rare moulds
5066531|NCT03583125|hepatocellular carcinoma|hepatocellular carcinoma
5066533|NCT03583073|clinical high risk|clinical high risk
5066534|NCT03583047|MACE|mace
5066535|NCT03583047|EPCs|epcs
5066536|NCT03583047|Cardiovascular risk|cardiovascular risk
5932918|NCT03198702|physiotherapy|physiotherapy
5066537|NCT03583047|Endothelial dysfunction|endothelial dysfunction
5066539|NCT03583034|HoLEP|holep
5066540|NCT03583034|Prostate|prostate
5066541|NCT03582982|resistance exercise|resistance exercise
5066542|NCT03582982|muscle fatigue|muscle fatigue
5066543|NCT03582982|physical function|physical function
5066544|NCT03582969|IBD|ibd
5066545|NCT03582969|UC|uc
5066546|NCT03582969|fecal-transplantation|fecal-transplantation
5066547|NCT03582969|capsules|capsules
5066548|NCT03582969|microbiota|microbiota
5066549|NCT03582969|microbiome|microbiome
5066550|NCT03582969|colitis|colitis
5066551|NCT03582969|pediatric|pediatric
5066552|NCT03582943|remote ischemic conditioning, motor learning|remote ischemic conditioning, motor learning
5066553|NCT03582930|Infasurf|infasurf
5066554|NCT03582930|Surfactant|surfactant
5066555|NCT03582930|RDS|rds
5066556|NCT03582930|Respiratory Distress Syndrome|respiratory distress syndrome
5066557|NCT03582930|Aerosolized|aerosolized
5066558|NCT03582930|Nebulized|nebulized
5066559|NCT03582930|Inhaled|inhaled
5066560|NCT03582930|Pre-term|pre-term
5066561|NCT03582930|Premature|premature
5066562|NCT03582904|motor learning|motor learning
5066563|NCT03582904|tDCS|tdcs
5066564|NCT03582904|locomotion|locomotion
5066565|NCT03582865|Breast cancer|breast cancer
5066566|NCT03582865|Genotyping|genotyping
5066567|NCT03582865|Tamoxifen|tamoxifen
5066576|NCT03582813|self-directed care|self-directed care
5066577|NCT03582813|mental health services|mental health services
5066578|NCT03582813|mental health recovery|mental health recovery
5066579|NCT03582813|behavioral health service financing|behavioral health service financing
5066580|NCT03582800|Sodium thiosulfate|sodium thiosulfate
5066581|NCT03582800|Ectopic calcification|ectopic calcification
5066582|NCT03582800|Ectopic Ossification|ectopic ossification
5066583|NCT03582735|Carpal Tunnel Syndrome|carpal tunnel syndrome
5066584|NCT03582735|Ultrasound Imaging|ultrasound imaging
5066585|NCT03582735|Preoperative Care|preoperative care
5066586|NCT03582735|Exercise Therapy|exercise therapy
5066587|NCT03582722|Polybrominated Biphenyl Exposure|polybrominated biphenyl exposure
5066588|NCT03582722|Gastrointestinal lipase inhibitor|gastrointestinal lipase inhibitor
5066589|NCT03582683|Self-Management Programs|self-management programs
5066590|NCT03582683|Behavioral Health|behavioral health
5066591|NCT03582670|Prospective Memory|prospective memory
5066592|NCT03582670|Occupational Therapy|occupational therapy
5066593|NCT03582657|nanostructured-implant|nanostructured-implant
5066594|NCT03582657|titanium implant|titanium implant
5066595|NCT03582657|nano-roughness surface|nano-roughness surface
5066596|NCT03582657|hydrophilic surface|hydrophilic surface
5066597|NCT03582657|KONTACT N|kontact n
5066598|NCT03582657|BIOTECH DENTAL|biotech dental
5066599|NCT03582644|Osteoarthritis, Knee|osteoarthritis, knee
5066600|NCT03582644|Cryotherapy|cryotherapy
5066601|NCT03582644|Physiotherapy|physiotherapy
5066602|NCT03582644|Physical Agent|physical agent
5066622|NCT03582527|refractory to chemotherapy|refractory to chemotherapy
5066623|NCT03582527|unresectable|unresectable
5066624|NCT03582527|PD-L1|pd-l1
5066625|NCT03582527|VENTANA PD-L1 (SP263)|ventana pd-l1 (sp263)
5066626|NCT03582514|Radiotherapy|radiotherapy
5066627|NCT03582514|Preoperative single fraction|preoperative single fraction
5066628|NCT03582514|3+3 design|3+3 design
5066629|NCT03582462|IONIS FXI-L|ionis fxi-l
5066630|NCT03582462|Factor XI|factor xi
5066631|NCT03582449|Hunter syndrome (Mucopolysaccharydosis II)|hunter syndrome (mucopolysaccharydosis ii)
5066632|NCT03582436|Kidney|kidney
5066633|NCT03582436|Allogeneic transplantation|allogeneic transplantation
5066634|NCT03582436|Cohort study|cohort study
5066635|NCT03582436|Rejection|rejection
5066636|NCT03582436|Biomarkers|biomarkers
5066637|NCT03582436|Integrative medicine|integrative medicine
5066638|NCT03582371|Parkinson's Disease|parkinson's disease
5066639|NCT03582371|Rehabilitation|rehabilitation
5066640|NCT03582371|Balance|balance
5066641|NCT03582371|Aquatic therapy|aquatic therapy
5066642|NCT03582371|Stand Up Paddle|stand up paddle
5066643|NCT03582306|colon cancer|colon cancer
5066644|NCT03582306|dietary intervention|dietary intervention
5066645|NCT03582306|vegetables|vegetables
5066646|NCT03582306|microbiota|microbiota
5066647|NCT03582293|Tranexamic Acid|tranexamic acid
5066648|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents
5066649|NCT03582241|Acute myeloid leukemia|acute myeloid leukemia
5066650|NCT03582241|Relapse|relapse
5066651|NCT03582241|Mutations|mutations
5066652|NCT03582228|Virtual Environments|virtual environments
5932992|NCT03186898|Liver cancer|liver cancer
5066653|NCT03582228|Social Communication|social communication
5066654|NCT03582215|Sunscreen|sunscreen
5066655|NCT03582215|Pharmacokinetics|pharmacokinetics
5066656|NCT03582202|dietitic service, organization of service|dietitic service, organization of service
5066657|NCT03582189|Liver Cancer|liver cancer
5066658|NCT03582189|Pancreatic Cancer|pancreatic cancer
5066659|NCT03582189|Radiation|radiation
5066660|NCT03582176|Acute elbow fractures and/or dislocations|acute elbow fractures and/or dislocations
5066661|NCT03582163|Deep Brain Stimulation|deep brain stimulation
5066662|NCT03582163|Longitudinal Outcomes|longitudinal outcomes
5066663|NCT03582163|Subthalamic Nucleus|subthalamic nucleus
5066664|NCT03582163|Globus Pallidus Interna|globus pallidus interna
5066796|NCT03581409|cerebral aneurysm|cerebral aneurysm
5066665|NCT03582150|Ambulatory alcohol detoxification|ambulatory alcohol detoxification
5066666|NCT03582150|alcohol withdrawal|alcohol withdrawal
5066667|NCT03582150|remote monitoring with breathalyzer|remote monitoring with breathalyzer
5066668|NCT03582137|Parkinson's Disease|parkinson's disease
5066669|NCT03582137|Motor symptoms|motor symptoms
5066670|NCT03582137|Tremor|tremor
5066671|NCT03582137|tolerability|tolerability
5066672|NCT03582137|safety|safety
5066673|NCT03582137|cognition|cognition
5066674|NCT03582137|anxiety|anxiety
5066675|NCT03582137|psychosis|psychosis
5066676|NCT03582137|mood|mood
5066677|NCT03582137|dyskinesia|dyskinesia
5066678|NCT03582137|sleep|sleep
5066679|NCT03582137|cannabidiol|cannabidiol
5066680|NCT03582137|cannabis|cannabis
5066681|NCT03582137|efficacy|efficacy
5066682|NCT03582137|non-motor symptoms|non-motor symptoms
5066683|NCT03582137|quality of life|quality of life
5066684|NCT03582137|seborrhea|seborrhea
5066685|NCT03582111|Ultrasound|ultrasound
5066686|NCT03582111|Pregnancy|pregnancy
5066687|NCT03582111|Diagnosis|diagnosis
5066688|NCT03582098|Idelalisib|idelalisib
5066689|NCT03582098|Zydelig|zydelig
5066690|NCT03582085|Fibromyalgia|fibromyalgia
5066697|NCT03582020|vegetarians|vegetarians
5066698|NCT03582020|vegans|vegans
5066699|NCT03582020|flexitarians|flexitarians
5066700|NCT03582020|western diet|western diet
5066718|NCT03581942|Recurrent/ Refractory|recurrent/ refractory
5066720|NCT03581942|Brain lymphoma|brain lymphoma
5066721|NCT03581942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
5066722|NCT03581942|BTK|btk
5066723|NCT03581942|PI3K|pi3k
5066724|NCT03581929|Mild Cognitive Impairment|mild cognitive impairment
5066725|NCT03581929|Dementia|dementia
5066726|NCT03581929|Memormax|memormax
5066727|NCT03581929|Food Supplement|food supplement
5066728|NCT03581929|Microbiota|microbiota
5066729|NCT03581890|Colorectal cancer|colorectal cancer
5066730|NCT03581890|Socioeconomic position|socioeconomic position
5066735|NCT03581864|aphakia|aphakia
5066736|NCT03581864|black diaphragmintraocular lens|black diaphragmintraocular lens
5066737|NCT03581864|eye rupture|eye rupture
5066738|NCT03581864|aniridia|aniridia
5066739|NCT03581851|simulated altitude|simulated altitude
5066740|NCT03581851|exercise|exercise
5066741|NCT03581851|electrocardiography|electrocardiography
5066742|NCT03581851|non- invasive blood pressure|non- invasive blood pressure
5066743|NCT03581838|EoE|eoe
5066744|NCT03581838|Dysphagia|dysphagia
5066745|NCT03581812|Gut Microbiota|gut microbiota
5066746|NCT03581812|Microbiome|microbiome
5066747|NCT03581812|Gut Health|gut health
5066748|NCT03581812|Snack|snack
5066749|NCT03581799|Child|child
5066750|NCT03581760|cycling exercise|cycling exercise
5066751|NCT03581760|mechanically ventilated patient|mechanically ventilated patient
5066752|NCT03581760|muscle strength assessment|muscle strength assessment
5066753|NCT03581760|muscle weakness|muscle weakness
5066754|NCT03581747|Atopic dermatis|atopic dermatis
5066755|NCT03581747|Epithelial barrier|epithelial barrier
5066756|NCT03581747|Electrical impedance spectroscopy|electrical impedance spectroscopy
5066757|NCT03581747|Allergy|allergy
5066758|NCT03581734|Oral Polio Vaccine|oral polio vaccine
5066759|NCT03581734|Oral Cholera Vaccine|oral cholera vaccine
5066760|NCT03581734|Co-administration|co-administration
5066761|NCT03581734|Immunogenecity|immunogenecity
5066762|NCT03581721|Postoperative hypothermia|postoperative hypothermia
5066763|NCT03581721|caesarean section|caesarean section
5066764|NCT03581721|IV fluids warming|iv fluids warming
5066765|NCT03581708|lung cancer|lung cancer
5066766|NCT03581708|Venous Thromboembolism|venous thromboembolism
5066767|NCT03581656|Degenerative Mitral Leaflet Prolapse|degenerative mitral leaflet prolapse
5066768|NCT03581656|Heart Disease|heart disease
5066769|NCT03581656|Minimally Invasive|minimally invasive
5066770|NCT03581643|Montreal Cognitive Assessment|montreal cognitive assessment
5066771|NCT03581643|Sensitivity|sensitivity
5066772|NCT03581643|Specificity|specificity
5066773|NCT03581643|Validation Study|validation study
5066774|NCT03581617|Infertility|infertility
5066775|NCT03581617|NK cells|nk cells
5066776|NCT03581617|HLA-G|hla-g
5066777|NCT03581604|Penicillin/b-lactams|penicillin/b-lactams
5066778|NCT03581578|Troponin|troponin
5066779|NCT03581565|cementation|cementation
5066782|NCT03581565|periimplantitis|periimplantitis
5066783|NCT03581552|Post Menopausal|post menopausal
5066784|NCT03581552|ER positive|er positive
5066785|NCT03581552|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
5066786|NCT03581552|Breast Cancer|breast cancer
5066787|NCT03581539|Laparoscopic Nephrectomy,|laparoscopic nephrectomy,
5066788|NCT03581539|Simple Nephrectomy|simple nephrectomy
5066789|NCT03581539|Partial Nephrectomy|partial nephrectomy
5066790|NCT03581539|Pain,acute|pain,acute
5066791|NCT03581539|Pain,postoperative|pain,postoperative
5066792|NCT03581461|Trauma|trauma
5066793|NCT03581461|Yoga|yoga
5066794|NCT03581461|Mindfulness|mindfulness
5066799|NCT03581396|schwannoma intralabyrinth|schwannoma intralabyrinth
5066800|NCT03581383|Hepatitis C|hepatitis c
5066801|NCT03581383|Hep C|hep c
5066802|NCT03581383|CARE-C|care-c
5066803|NCT03581383|Kentucky|kentucky
5066804|NCT03581370|Pneumonia|pneumonia
5066805|NCT03581370|Pseudomonas aeruginosa|pseudomonas aeruginosa
5066806|NCT03581370|pharmacokinetics|pharmacokinetics
5066807|NCT03581357|Previous diagnosis of cancer, completed primary treatment of cancer|previous diagnosis of cancer, completed primary treatment of cancer
5066808|NCT03581344|Conservative Treatment|conservative treatment
5066809|NCT03581344|Neoadjuvant Therapy|neoadjuvant therapy
5066810|NCT03581344|Radiotherapy|radiotherapy
5066818|NCT03581266|Wheat|wheat
5066819|NCT03581266|Rye factor|rye factor
5066820|NCT03581266|Glucose kinetics|glucose kinetics
5066821|NCT03581227|CAPTURE, COPD|capture, copd
5066822|NCT03581201|intestinal microbiome|intestinal microbiome
5066823|NCT03581201|oral contraceptives|oral contraceptives
5066824|NCT03581201|estrogens|estrogens
5066825|NCT03581201|bacterial population|bacterial population
5066826|NCT03581201|hormone status|hormone status
5066828|NCT03581201|lipid parameters|lipid parameters
5066829|NCT03581201|body composition|body composition
5066830|NCT03581123|acute/subacute low back pain|acute/subacute low back pain
5066831|NCT03581123|randomized clinical trial|randomized clinical trial
5066832|NCT03581123|self-management|self-management
5066833|NCT03581123|behavioral modification|behavioral modification
5066834|NCT03581123|spinal manipulation therapy|spinal manipulation therapy
5066835|NCT03581123|standard medical care|standard medical care
5066836|NCT03581123|secondary prevention|secondary prevention
5066837|NCT03581110|COPD|copd
5066838|NCT03581110|Computed tomography|computed tomography
5066839|NCT03581110|Expiration|expiration
5066840|NCT03581110|organ specific radiation dose|organ specific radiation dose
5066841|NCT03581097|Anxiety disorders|anxiety disorders
5066842|NCT03581097|hand surgery|hand surgery
5066843|NCT03581097|Educational Video|educational video
5066844|NCT03581071|Dialysis, CKD|dialysis, ckd
5066845|NCT03581058|MRI|mri
5066846|NCT03581058|Cannabis|cannabis
5066847|NCT03581058|Driving|driving
5066848|NCT03581045|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5066849|NCT03581045|ALL|all
5066850|NCT03581045|Survivors|survivors
5066851|NCT03581045|Cognitive performance|cognitive performance
5066852|NCT03581045|Postural control|postural control
5066853|NCT03581019|infertility, uterus, transplantation, MRKH|infertility, uterus, transplantation, mrkh
5066854|NCT03581006|World Trade Center|world trade center
5066855|NCT03581006|Firefighters|firefighters
5066856|NCT03581006|FDNY|fdny
5066857|NCT03581006|9/11|9/11
5066858|NCT03581006|Metabolomics|metabolomics
5066859|NCT03581006|FIREHOUSE|firehouse
5066860|NCT03580993|Critical Illness|critical illness
5066861|NCT03580993|Ultrasonography|ultrasonography
5066862|NCT03580967|Type 2 Diabetes|type 2 diabetes
5066863|NCT03580967|Major Depressive Disorder|major depressive disorder
5066864|NCT03580967|Vortioxetine|vortioxetine
5066865|NCT03580941|Pregnancy|pregnancy
5066866|NCT03580941|Hemolytic-Uremic Syndrome|hemolytic-uremic syndrome
5066867|NCT03580928|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5066868|NCT03580915|functional literacy|functional literacy
5066869|NCT03580915|homelessness|homelessness
5066870|NCT03580915|daily life activities|daily life activities
5066871|NCT03580863|Pediatric|pediatric
5066872|NCT03580863|emergency surgical and medical service|emergency surgical and medical service
5066873|NCT03580863|Liberal doctor|liberal doctor
5066874|NCT03580863|complaint|complaint
5066875|NCT03580850|intra labyrinthine schwannoma|intra labyrinthine schwannoma
5066876|NCT03580850|schwannoma|schwannoma
5066877|NCT03580850|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5066878|NCT03580850|gadolinium|gadolinium
5066900|NCT03580694|Anti-CTLA-4|anti-ctla-4
5066901|NCT03580694|Immunotherapy|immunotherapy
5066902|NCT03580681|Rheumatoid Arthritis|rheumatoid arthritis
5066903|NCT03580681|Diet|diet
5066904|NCT03580681|Fat-Restricted|fat-restricted
5066905|NCT03580681|Vegeterian|vegeterian
5066906|NCT03580668|Observational|observational
5066907|NCT03580629|Live Donor Liver Transplant|live donor liver transplant
5066908|NCT03580629|Education|education
5066909|NCT03580629|Advocacy|advocacy
5066910|NCT03580629|Live Donor Champion|live donor champion
5066911|NCT03580551|Veterans|veterans
5066912|NCT03580551|Sedentary|sedentary
5066913|NCT03580551|Chronic illness|chronic illness
5066914|NCT03580486|Parkinson's Disease|parkinson's disease
5066915|NCT03580486|Hand Function|hand function
5066916|NCT03580486|Squares Test|squares test
5066917|NCT03580421|Endometrial Cancer|endometrial cancer
5066918|NCT03580421|Health-economics analysis|health-economics analysis
5066919|NCT03580421|Ambulatory surgery|ambulatory surgery
5066920|NCT03580421|QALY|qaly
5066921|NCT03580421|discrete choice experiment|discrete choice experiment
5066922|NCT03580408|Nivolumab|nivolumab
5066923|NCT03580408|Lymphoma|lymphoma
5066924|NCT03580408|Anti-PD1|anti-pd1
5066925|NCT03580395|apatinib|apatinib
5066926|NCT03580395|neoadjuvant therapy|neoadjuvant therapy
5066927|NCT03580395|breast cancer|breast cancer
5066928|NCT03580369|Anti-IgE, CSU (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticarial), hives severity score, itch severity score, urticaria activity score
5067029|NCT03579901|Breast Surgery|breast surgery
5067030|NCT03579901|Breast Augmentation|breast augmentation
5067031|NCT03579901|Breast Reconstruction|breast reconstruction
5066932|NCT03580330|diabetes mellitus|diabetes mellitus
5066933|NCT03580330|telemedicine|telemedicine
5066934|NCT03580330|mobile health|mobile health
5066935|NCT03580330|rural health|rural health
5066936|NCT03580330|refugees|refugees
5066940|NCT03580304|Fatigue Mental|fatigue mental
5066941|NCT03580304|Fatigue Signs and Symptoms|fatigue signs and symptoms
5066942|NCT03580304|Behavioral Symptoms|behavioral symptoms
5066943|NCT03580304|Industrial work|industrial work
5066944|NCT03580304|physical effort|physical effort
5066945|NCT03580304|mental effort|mental effort
5066946|NCT03580304|questionnaires|questionnaires
5961099|NCT04289259|FoundationOne CDx assay panel|foundationone cdx assay panel
5961100|NCT04289259|RNA-sequencing|rna-sequencing
5961101|NCT04289246|older adult|older adult
5961102|NCT04289246|frail elderly|frail elderly
5961103|NCT04289246|mobile health|mobile health
5961104|NCT04289194|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5961105|NCT04289194|mesenchymal stem cells|mesenchymal stem cells
5961106|NCT04289194|anti-inflammation|anti-inflammation
5961107|NCT04289194|allogenic|allogenic
5961108|NCT04289194|ARDS|ards
5961109|NCT04289194|acute lung injury|acute lung injury
5961110|NCT04289194|cell therapy|cell therapy
5961111|NCT04289129|Muscle tone|muscle tone
5961112|NCT04289129|viscoelastic properties|viscoelastic properties
5961113|NCT04289129|aging|aging
5961114|NCT04289077|Health-related quality of life|health-related quality of life
5961115|NCT04289077|Quality of life|quality of life
5961116|NCT04289038|itch|itch
5961117|NCT04289038|pruritus|pruritus
5961118|NCT04289038|nursing|nursing
5961119|NCT04289038|virtual reality|virtual reality
5961120|NCT04289025|Arthroplasty|arthroplasty
5961121|NCT04289025|Replacement Rehabilitation|replacement rehabilitation
5961122|NCT04289012|Acute myocardial infarction|acute myocardial infarction
5961123|NCT04289012|Non-ST Segment Elevation MI|non-st segment elevation mi
5961124|NCT04289012|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5066947|NCT03580304|ergonomic evaluation|ergonomic evaluation
5066948|NCT03580291|Lupus Nephritis|lupus nephritis
5066949|NCT03580291|Mesenchymal stem cell|mesenchymal stem cell
5066950|NCT03580252|preterm|preterm
5066951|NCT03580252|Child Development Disorders|child development disorders
5066952|NCT03580252|Hammersmith|hammersmith
5066953|NCT03580252|neurological outcomes|neurological outcomes
5066954|NCT03580252|epidemiology|epidemiology
5066955|NCT03580239|CRPC|crpc
5066956|NCT03580239|Everolimus|everolimus
5066957|NCT03580239|mTOR|mtor
5066958|NCT03580226|Diabetes mellitus|diabetes mellitus
5066959|NCT03580226|Glycemic control|glycemic control
5066960|NCT03580226|Lipid profile|lipid profile
5066961|NCT03580226|Kidney profile|kidney profile
5066962|NCT03580226|Uric acid|uric acid
5066963|NCT03580213|Occupational Therapy|occupational therapy
5066964|NCT03580213|Physical Therapy|physical therapy
5066965|NCT03580213|Hand Therapy|hand therapy
5066967|NCT03580213|COPM|copm
5066968|NCT03580213|URAM|uram
5066969|NCT03580213|ROM|rom
5066970|NCT03580213|Hand exercise|hand exercise
5066971|NCT03580213|Scar|scar
5066972|NCT03580213|Oedema|oedema
5066973|NCT03580213|Splint|splint
5066974|NCT03580213|Orthosis|orthosis
5066975|NCT03580200|Latent Trigger Point|latent trigger point
5066976|NCT03580200|Myofascial Trigger Point|myofascial trigger point
5066991|NCT03580148|glenohumeral joint|glenohumeral joint
5067006|NCT03580044|Serious bacterial infection|serious bacterial infection
5067007|NCT03580044|cIAI|ciai
5067008|NCT03580044|HAP/(VAP|hap/(vap
5067009|NCT03580044|cUTI|cuti
5067011|NCT03580044|MBL|mbl
5067012|NCT03580031|LUF|luf
5067013|NCT03580031|HCG|hcg
5067014|NCT03580031|Booster dose|booster dose
5067015|NCT03580031|Ovulation rate|ovulation rate
5067016|NCT03580031|pregnancy rate|pregnancy rate
5067017|NCT03580018|Anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid|anterior cruciate ligament reconstruction, knee, hemarthrosis, tranexamic acid
5067018|NCT03579979|Near-infrared fluorescence|near-infrared fluorescence
5067019|NCT03579979|Image guided surgery|image guided surgery
5067020|NCT03579979|Sentinel lymph node biopsy|sentinel lymph node biopsy
5067021|NCT03579979|Indocyanine green|indocyanine green
5067022|NCT03579979|Methylene blue|methylene blue
5067023|NCT03579953|Brain Stimulation|brain stimulation
5067024|NCT03579914|Anterior Myocardial Infarction|anterior myocardial infarction
5067025|NCT03579914|Intravenous Metoprolol|intravenous metoprolol
5067026|NCT03579914|RIPC|ripc
5067027|NCT03579914|Myocardial Protection|myocardial protection
5067028|NCT03579901|Breast Implants|breast implants
5067032|NCT03579836|Pancreatic Cancer|pancreatic cancer
5067033|NCT03579810|Behavioral Modification|behavioral modification
5067034|NCT03579810|Health Community|health community
5067035|NCT03579810|Community Intervention|community intervention
5067036|NCT03579810|Prevention|prevention
5067037|NCT03579810|Education Intervention|education intervention
5067038|NCT03579810|Cardiovascular Health|cardiovascular health
5067039|NCT03579810|Colombia|colombia
5067040|NCT03579797|diabetic eye diseases|diabetic eye diseases
5067041|NCT03579797|diabetic retinopathy|diabetic retinopathy
5067042|NCT03579745|lingual orthodontics|lingual orthodontics
5067043|NCT03579745|Lever arm|lever arm
5067044|NCT03579745|En masse retraction|en masse retraction
5067045|NCT03579732|Low-dose aspirin,|low-dose aspirin,
5067046|NCT03579732|Cancer prevention|cancer prevention
5067047|NCT03579693|Mitochondria|mitochondria
5067048|NCT03579693|Antioxidants|antioxidants
5067049|NCT03579693|CoQ10|coq10
5067050|NCT03579693|Nicotinamide riboside|nicotinamide riboside
5067051|NCT03579693|Ergometry|ergometry
5961125|NCT04289012|Dual antiplatelet therapy|dual antiplatelet therapy
5961126|NCT04289012|Helicobacter pylori|helicobacter pylori
5067052|NCT03579693|Fatigue|fatigue
5961127|NCT04289012|Screening|screening
5961128|NCT04289012|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5961129|NCT04289012|Urea breath test|urea breath test
5961130|NCT04288999|Rectal cancer|rectal cancer
5067053|NCT03579693|Aerobic capacity|aerobic capacity
5067054|NCT03579680|Prostatic Neoplasms|prostatic neoplasms
5067055|NCT03579680|De-implementation|de-implementation
5067056|NCT03579680|androgen deprivation therapy|androgen deprivation therapy
5067057|NCT03579680|Provider Preferences|provider preferences
5067058|NCT03579654|Prostate Specific Antigen|prostate specific antigen
5067059|NCT03579654|Immunotherapy|immunotherapy
5067060|NCT03579641|Heart Failure|heart failure
5067061|NCT03579641|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5067062|NCT03579641|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
5067063|NCT03579641|Heart Failure Sensor Data|heart failure sensor data
5067064|NCT03579641|30-day Heart Failure Readmission|30-day heart failure readmission
5067065|NCT03579641|Ventricular Tachycardia/Ventricular Fibrillation Therapy|ventricular tachycardia/ventricular fibrillation therapy
5067066|NCT03579641|Non-Heart Failure Hospitalization|non-heart failure hospitalization
5067067|NCT03579641|HeartLogic Feature|heartlogic feature
5067068|NCT03579641|Latitude Remote Patient Monitor|latitude remote patient monitor
5067069|NCT03579641|Data Linkage|data linkage
5067070|NCT03579641|Sleep Incline Sensor|sleep incline sensor
5067071|NCT03579641|Respiratory Sensor|respiratory sensor
5067072|NCT03579641|Decongestive Intravenous therapy|decongestive intravenous therapy
5067073|NCT03579641|Decompensation|decompensation
5067074|NCT03579602|Tumor Paint|tumor paint
5066708|NCT03581955|diet|diet
5067079|NCT03579602|brain cancer|brain cancer
5067080|NCT03579602|pediatrics|pediatrics
5067081|NCT03579602|fluorescence guided surgery|fluorescence guided surgery
5067082|NCT03579589|Neuromuscular Blockade Reversal|neuromuscular blockade reversal
5067083|NCT03579589|Outpatient Surgery|outpatient surgery
5067084|NCT03579576|PWID|pwid
5067088|NCT03579563|Presbycusis|presbycusis
5067089|NCT03579563|Hearing aid|hearing aid
5423199|NCT01616693|zinc supplement|zinc supplement
5067090|NCT03579550|dysmorphic uterus, metroplasty, hysteroscopy|dysmorphic uterus, metroplasty, hysteroscopy
5067091|NCT03579537|Hemodialysis|hemodialysis
5067092|NCT03579537|Klotho Protein|klotho protein
5067094|NCT03579537|Lifestyle condition|lifestyle condition
5067095|NCT03579524|Erector Spinae Plane Block|erector spinae plane block
5067096|NCT03579524|Serratus Anterior Plane Block|serratus anterior plane block
5067097|NCT03579498|Cardiac arrest|cardiac arrest
5067098|NCT03579498|Cognitive impairment|cognitive impairment
5067099|NCT03579498|Depression|depression
5067100|NCT03579498|Anxiety|anxiety
5067101|NCT03579498|PTSD|ptsd
5067102|NCT03579498|Health- related quality of life|health- related quality of life
5067103|NCT03579498|functional MRI|functional mri
5067104|NCT03579485|raltegravir|raltegravir
5067106|NCT03579485|Aging|aging
5067107|NCT03579459|Clostridium Difficile|clostridium difficile
5067108|NCT03579459|vaccine|vaccine
5067109|NCT03579407|osteoarthritis|osteoarthritis
5067110|NCT03579407|cell therapy|cell therapy
5067111|NCT03579407|stem cells|stem cells
5067112|NCT03579407|needle|needle
5067113|NCT03579407|bone marrow aspiration|bone marrow aspiration
5067114|NCT03579394|ovarian cancer|ovarian cancer
5067115|NCT03579394|retarded surgery|retarded surgery
5067116|NCT03579394|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5067117|NCT03579368|Cataract|cataract
5067118|NCT03579368|IOL|iol
5067119|NCT03579368|Presbyopia Correcting IOL|presbyopia correcting iol
5067120|NCT03579368|Patient Satisfaction|patient satisfaction
5067121|NCT03579368|Spectacle Independence|spectacle independence
5067122|NCT03579329|sarcopenia|sarcopenia
5067123|NCT03579329|Osteoarthritis|osteoarthritis
5933469|NCT03096847|LEE011|lee011
5067124|NCT03579329|Total Knee Arthroplasty|total knee arthroplasty
5067125|NCT03579303|Homoeopathy|homoeopathy
5067126|NCT03579303|Yoga|yoga
5067127|NCT03579277|Radial Forearm Free Flap|radial forearm free flap
5067128|NCT03579277|Ulnar Forearm Free Flap|ulnar forearm free flap
5067129|NCT03579277|Free Tissue Transfer|free tissue transfer
5067130|NCT03579212|Osteosynthesis|osteosynthesis
5067131|NCT03579212|Prophylactic consolidation|prophylactic consolidation
5067132|NCT03579212|Proximal femur|proximal femur
5067133|NCT03579199|hepatic tumor|hepatic tumor
5067134|NCT03579199|liver|liver
5067135|NCT03579199|ICG|icg
5067136|NCT03579199|ICG camera|icg camera
5067137|NCT03579199|laparoscopy|laparoscopy
5067138|NCT03579173|Nutritional Status|nutritional status
5067139|NCT03579173|Infant Pulmonary Function Testing|infant pulmonary function testing
5067140|NCT03579173|Lung Clearance Index|lung clearance index
5067141|NCT03579173|Multiple Breath Washout|multiple breath washout
5067142|NCT03579121|pharmacogenomics|pharmacogenomics
5067143|NCT03579121|preoperative evaluation|preoperative evaluation
5067144|NCT03579121|perioperative opioid use|perioperative opioid use
5067145|NCT03579108|Hypertension|hypertension
5067146|NCT03579082|Decitabine|decitabine
5067147|NCT03579082|ORR|orr
5067148|NCT03579082|TTP|ttp
5067149|NCT03579082|OS|os
5067150|NCT03579082|PFS|pfs
5067151|NCT03579069|Ductus venosus Doppler|ductus venosus doppler
5067152|NCT03579030|RTA 1701|rta 1701
5067153|NCT03579030|RTA 1701 capsules|rta 1701 capsules
5067154|NCT03579017|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5067155|NCT03579017|Cognitive|cognitive
5067156|NCT03579017|Screening|screening
5067157|NCT03579017|Validation|validation
5067158|NCT03579004|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5067159|NCT03579004|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5067160|NCT03579004|preoperative chemotherapy|preoperative chemotherapy
5067161|NCT03578991|Type 2 diabetes mellitus|type 2 diabetes mellitus
5067162|NCT03578991|Mild cognitive impairment|mild cognitive impairment
5067163|NCT03578991|Alzheimer disease|alzheimer disease
5067164|NCT03578991|Intervention|intervention
5067165|NCT03578991|Clinical trial|clinical trial
5067166|NCT03578991|mHealth|mhealth
5067167|NCT03578991|Smart electronic pillbox|smart electronic pillbox
5067168|NCT03578991|Interactive digital platform|interactive digital platform
5067169|NCT03578952|TAVR|tavr
5067170|NCT03578952|TAVI|tavi
5067171|NCT03578952|Pure AR|pure ar
5067172|NCT03578913|PFM implant supported restoration|pfm implant supported restoration
5067173|NCT03578913|Clinical assessment|clinical assessment
5067174|NCT03578913|radiographic assessment|radiographic assessment
5067175|NCT03578900|Xerostomia|xerostomia
5067179|NCT03578887|Obesity, Gliosis, Weight-Loss, Roux-en-Y Gastric Bypass, Type 2 Diabetes Mellitus|obesity, gliosis, weight-loss, roux-en-y gastric bypass, type 2 diabetes mellitus
5067181|NCT03578848|sphygmomanometer|sphygmomanometer
5067183|NCT03578835|SF-36|sf-36
5067184|NCT03578835|Clinical Outcome|clinical outcome
5067185|NCT03578835|Whole Genome Sequencing|whole genome sequencing
5067186|NCT03578835|Predictive Score|predictive score
5067187|NCT03578835|Bloodstream Infection|bloodstream infection
5067188|NCT03578835|Septic Shock|septic shock
5067189|NCT03578835|Multi-resistant Bacteria|multi-resistant bacteria
5067190|NCT03578796|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5067191|NCT03578796|Cognitive|cognitive
5067192|NCT03578796|Predictor|predictor
5067193|NCT03578757|stress|stress
5067194|NCT03578757|prevention|prevention
5067195|NCT03578757|obesity|obesity
5067197|NCT03578757|psychology|psychology
5067198|NCT03578757|biomarkers|biomarkers
5067200|NCT03578705|Orthopedic trauma|orthopedic trauma
5067201|NCT03578692|acute severe ulcerative colitis|acute severe ulcerative colitis
5067202|NCT03578692|predictive indicator|predictive indicator
5067203|NCT03578692|surgery|surgery
5067204|NCT03578666|recovery intervention|recovery intervention
5067205|NCT03578666|fatigue|fatigue
5067206|NCT03578666|running|running
5067207|NCT03578666|cryotherapy|cryotherapy
5067208|NCT03578666|running economy|running economy
5067209|NCT03578640|Hepatitis C Virus|hepatitis c virus
5067210|NCT03578640|Chronic Hepatitis C|chronic hepatitis c
5067211|NCT03578640|Genotype 4|genotype 4
5067212|NCT03578640|Treatment-naive|treatment-naive
5067213|NCT03578640|Non-cirrhotic|non-cirrhotic
5067214|NCT03578614|Vascular cognitive impairment|vascular cognitive impairment
5570124|NCT01006005|HIV|hiv
4970926|NCT04172129|THA|tha
5067215|NCT03578614|Physical Activity|physical activity
5067216|NCT03578614|Randomized Clinical Trial|randomized clinical trial
5067217|NCT03578614|Stroke|stroke
5067218|NCT03578614|TIA|tia
5067219|NCT03578614|Small Vessel Disease|small vessel disease
5067220|NCT03578601|Intubation|intubation
5067221|NCT03578601|Difficult|difficult
5067222|NCT03578601|thyroid|thyroid
5067223|NCT03578588|single dose|single dose
5067224|NCT03578588|multiple dose|multiple dose
5067225|NCT03578588|Pharmacokinetic|pharmacokinetic
5067226|NCT03578588|Tolerability|tolerability
5067227|NCT03578588|Healthy Subject|healthy subject
5067228|NCT03578588|Benapenem|benapenem
5067229|NCT03578575|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5067230|NCT03578575|Concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
5067231|NCT03578562|Femoroacetabular Impingement|femoroacetabular impingement
5067232|NCT03578562|Anterior Pelvic Tilt|anterior pelvic tilt
5067233|NCT03578549|Dental Pulp Test|dental pulp test
5067234|NCT03578549|Vitality Testing|vitality testing
5067235|NCT03578549|Pulpal Blood Flow Measure|pulpal blood flow measure
5067237|NCT03578536|Therapy, Occupational|therapy, occupational
5067238|NCT03578536|Hemiplegia|hemiplegia
5067239|NCT03578510|Hemodialysis, sodium, endothelium, sympathetic activity, vasopressin|hemodialysis, sodium, endothelium, sympathetic activity, vasopressin
5067240|NCT03578497|Interleukin-1 receptor antagonism|interleukin-1 receptor antagonism
5067241|NCT03578497|Kineret/Anakinra|kineret/anakinra
5067242|NCT03578497|testosteron|testosteron
5067243|NCT03578484|Breast Aesthetics|breast aesthetics
5067244|NCT03578484|3D scanning|3d scanning
5067245|NCT03578484|Aesthetic rating|aesthetic rating
5067246|NCT03578484|Cultural Differences Aesthetics|cultural differences aesthetics
5067247|NCT03578484|Mammometrics|mammometrics
5067248|NCT03578445|EUS|eus
5067249|NCT03578445|EUS-FNA|eus-fna
5067250|NCT03578445|microbiopsy|microbiopsy
5067251|NCT03578432|Xerostomia|xerostomia
5067252|NCT03578432|Dry Mouth|dry mouth
5067253|NCT03578432|Salivary Gland Dysfunction|salivary gland dysfunction
5067254|NCT03578432|Head and Neck Cancer|head and neck cancer
5067255|NCT03578432|Mouth Cancer|mouth cancer
5067256|NCT03578432|Everolimus|everolimus
5067257|NCT03578432|Rapamycin|rapamycin
5067258|NCT03578432|Neck Cancer|neck cancer
5067259|NCT03578432|Saliva|saliva
5067260|NCT03578419|Anemia|anemia
5067261|NCT03578419|Blood transfusion|blood transfusion
5067262|NCT03578419|Intensive Care Unit|intensive care unit
5067263|NCT03578419|Blood sampling|blood sampling
5067264|NCT03578419|Stepped wedge|stepped wedge
5067265|NCT03578419|Red blood cells|red blood cells
5067266|NCT03578393|Preanesthetic visit|preanesthetic visit
5067267|NCT03578380|Lymphovenous bypass|lymphovenous bypass
5067268|NCT03578380|Lymphovenous anastomosis|lymphovenous anastomosis
5067269|NCT03578380|Supermicrosurgery|supermicrosurgery
5067270|NCT03578380|Lymphangiography|lymphangiography
5067271|NCT03578380|MD Anderson Lymphedema Stage|md anderson lymphedema stage
5067272|NCT03578367|CML|cml
5066895|NCT03580720|Intensive Care|intensive care
5067280|NCT03578367|deep molecular response|deep molecular response
5067282|NCT03578367|Ph+ CML|ph+ cml
5067283|NCT03578367|chronic phase|chronic phase
5067284|NCT03578367|cancer of the white blood cells|cancer of the white blood cells
5067285|NCT03578367|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5067286|NCT03578367|leukemia, myeloid|leukemia, myeloid
5067287|NCT03578367|leukemia|leukemia
5067288|NCT03578341|Immunoglobulins A, G and M|immunoglobulins a, g and m
5067289|NCT03578341|Neonatal Sepsis|neonatal sepsis
5067290|NCT03578341|Human Milk|human milk
5067291|NCT03578341|Orally Colostrum|orally colostrum
5067292|NCT03578315|Solar Lentigo|solar lentigo
5067296|NCT03578289|Parents of children with disabilities|parents of children with disabilities
5067297|NCT03578289|emotional functioning|emotional functioning
5067299|NCT03578276|Prophylaxis|prophylaxis
5067300|NCT03578263|cesarean section|cesarean section
5067301|NCT03578263|post-partum hemorrhage|post-partum hemorrhage
5067302|NCT03578263|multiple pregnancy|multiple pregnancy
5067303|NCT03578250|Stroke|stroke
5067304|NCT03578250|Error augmentation|error augmentation
5067305|NCT03578250|Rehabilitation|rehabilitation
5067306|NCT03578250|Cerebellum|cerebellum
5067307|NCT03578250|Motor learning|motor learning
5587610|NCT00940524|ALL|all
5067308|NCT03578250|Adaptation|adaptation
5067309|NCT03578133|pneumonia|pneumonia
5067311|NCT03578133|Myanmar|myanmar
5067312|NCT03578133|diagnosis|diagnosis
5678434|NCT00586846|03-074|03-074
5067313|NCT03578107|acute ischemic stroke|acute ischemic stroke
5067314|NCT03578107|IV-tPA|iv-tpa
5067315|NCT03578107|endovascular treatment|endovascular treatment
5067316|NCT03578107|intervention|intervention
5067317|NCT03578094|cohort|cohort
5067318|NCT03578094|Noncommunicable diseases|noncommunicable diseases
5067319|NCT03578094|pregnancy|pregnancy
5067320|NCT03578094|infant|infant
5067321|NCT03578094|cognition|cognition
5067322|NCT03578094|United Arab Emirates|united arab emirates
5067323|NCT03578094|gestational diabetes|gestational diabetes
5067324|NCT03578068|Quality of Recovery|quality of recovery
5067325|NCT03578068|Postoperative|postoperative
5067326|NCT03578068|Surgery|surgery
5067327|NCT03578068|French|french
5067328|NCT03578068|Translation|translation
5067329|NCT03578068|Validation|validation
5067330|NCT03578029|Epidermolysis Bullosa|epidermolysis bullosa
5067331|NCT03578016|attachment|attachment
5067332|NCT03578016|parent|parent
5067333|NCT03578016|training|training
5067334|NCT03578016|sensitivity|sensitivity
5067335|NCT03578003|Sleep|sleep
5067336|NCT03578003|Bright Light|bright light
5067337|NCT03577990|hypertension, Black women, self-management, coaching|hypertension, black women, self-management, coaching
5933647|NCT03069703|Vaccine|vaccine
5597119|NCT00902720|Ovarian|ovarian
5067338|NCT03577977|Multiple sclerosis (MS), Betaseron, Betaferon|multiple sclerosis (ms), betaseron, betaferon
5067339|NCT03577964|Pneumonia|pneumonia
5067340|NCT03577964|Glucose|glucose
5067341|NCT03577964|Infections|infections
5067342|NCT03577964|Respiratory Tract Infection|respiratory tract infection
5067343|NCT03577964|Hyperglycemia|hyperglycemia
5067344|NCT03577964|Critical Care|critical care
5067345|NCT03577938|Liver Failure|liver failure
5067346|NCT03577938|traditional Chinese medicine|traditional chinese medicine
5067347|NCT03577938|Hepatitis B|hepatitis b
5067348|NCT03577912|ERAS|eras
5067349|NCT03577912|transversus_abdominis_plane_block|transversus_abdominis_plane_block
5067350|NCT03577912|postoperative_pain|postoperative_pain
5067351|NCT03577873|gallbladder stones|gallbladder stones
5067352|NCT03577873|common bile duct stones|common bile duct stones
5067353|NCT03577873|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5067354|NCT03577847|Stroke, Thrombolysis, Rural CT|stroke, thrombolysis, rural ct
5067355|NCT03577834|randomized clinical trial|randomized clinical trial
5067356|NCT03577834|vinegar|vinegar
5067357|NCT03577834|adiposity|adiposity
5067358|NCT03577834|insulin resistance|insulin resistance
5067359|NCT03577795|COPD, ACO, RWE|copd, aco, rwe
5067360|NCT03577782|HIV|hiv
5067361|NCT03577782|CD4+|cd4+
5067362|NCT03577782|T-cell|t-cell
5067363|NCT03577782|Reservoir|reservoir
5067364|NCT03577782|Cure|cure
5067365|NCT03577782|Antiretroviral therapy|antiretroviral therapy
5067366|NCT03577782|Vedolizumab|vedolizumab
5067367|NCT03577782|Gut|gut
5067368|NCT03577782|Alpha4Beta7|alpha4beta7
5067369|NCT03577782|gp120|gp120
5067370|NCT03577782|Interruption|interruption
5067371|NCT03577769|Health care associated urinary tract infection|health care associated urinary tract infection
5067373|NCT03577769|Elderly|elderly
5067374|NCT03577769|Geriatrics|geriatrics
5067375|NCT03577769|Antimicrobial resistance|antimicrobial resistance
5067376|NCT03577769|Multi-resistant bacteria|multi-resistant bacteria
5067377|NCT03577756|cystic fibrosis|cystic fibrosis
5067378|NCT03577756|neurodevelopment|neurodevelopment
5067379|NCT03577756|early rehabilitation|early rehabilitation
5067380|NCT03577743|antiangiogenesis|antiangiogenesis
5067381|NCT03577743|taxanes and carboplatin|taxanes and carboplatin
5067382|NCT03577743|metastatic TNBC|metastatic tnbc
5067383|NCT03577730|Opioid Use|opioid use
5067384|NCT03577730|Opioid Dependence|opioid dependence
5067385|NCT03577730|Opioid-Related Disorders|opioid-related disorders
5067386|NCT03577730|Opioid Abuse|opioid abuse
5067387|NCT03577730|Opioid-use Disorder|opioid-use disorder
5067388|NCT03577730|Pain|pain
5067389|NCT03577730|Pain, Postoperative|pain, postoperative
5079695|NCT03501160|Caregiving distress|caregiving distress
5067401|NCT03577665|Liver Metastasis, Curative Proton Beam Therapy|liver metastasis, curative proton beam therapy
5067403|NCT03577652|Clopidogrel|clopidogrel
5067404|NCT03577652|Switching strategy|switching strategy
5067405|NCT03577613|radical hysterectomy|radical hysterectomy
5067406|NCT03577613|minimally invasive surgery|minimally invasive surgery
5067407|NCT03577600|Recurrent Ependymoma|recurrent ependymoma
5067408|NCT03577600|Brainstem Gliomas|brainstem gliomas
5067409|NCT03577600|Rotational Field Quantum Magnetic Resonance (RFQMR)|rotational field quantum magnetic resonance (rfqmr)
5067410|NCT03577600|Cytotron®|cytotron®
5067411|NCT03577600|High Grade Gliomas|high grade gliomas
5067412|NCT03577600|Quantum Magnetic Resonance Therapy (QMRT)|quantum magnetic resonance therapy (qmrt)
5067413|NCT03577600|Brain Tumor Recurrence|brain tumor recurrence
5067414|NCT03577587|galactagogue|galactagogue
5067415|NCT03577587|milk thistle|milk thistle
5067416|NCT03577587|silymarin|silymarin
5067417|NCT03577587|Silitidil|silitidil
5067418|NCT03577535|Oral Mucositis|oral mucositis
5067419|NCT03577535|Nutritional supplement|nutritional supplement
5067420|NCT03577535|Chemotherapy|chemotherapy
5067421|NCT03577535|Radiotherapy|radiotherapy
5067422|NCT03577535|Ocoxin / Oncoxin|ocoxin / oncoxin
5067423|NCT03577457|oxytocin|oxytocin
5067424|NCT03577457|serotonin|serotonin
5067425|NCT03577457|social reward|social reward
5067426|NCT03577457|decision making|decision making
5067427|NCT03577444|gene polymorphism|gene polymorphism
5067428|NCT03577444|stroke|stroke
5067429|NCT03577444|dysphagia|dysphagia
5067430|NCT03577444|poststroke recovery|poststroke recovery
5067431|NCT03577431|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
5067432|NCT03577431|immunosuppression|immunosuppression
5067433|NCT03577431|operational tolerance|operational tolerance
5067434|NCT03577405|Critical Illness|critical illness
5067435|NCT03577405|Acute Disease|acute disease
5067436|NCT03577405|Shock|shock
5067437|NCT03577405|Acute Kidney Injury|acute kidney injury
5067438|NCT03577405|Ultrasonography|ultrasonography
5067439|NCT03577379|Rotator cuff repair, whole blood fibrin clot|rotator cuff repair, whole blood fibrin clot
5067440|NCT03577366|Bacteremia|bacteremia
5067441|NCT03577366|Sepsis|sepsis
5067442|NCT03577366|Diagnostic Error|diagnostic error
5067443|NCT03577301|HIV|hiv
5067444|NCT03577301|Intervention|intervention
5067445|NCT03577301|Men Who Have Sex with Men (MSM)|men who have sex with men (msm)
5067446|NCT03577301|PrEP|prep
5067447|NCT03577301|YMHP|ymhp
5067448|NCT03577301|YMSM|ymsm
5067449|NCT03577288|Feelings|feelings
5067450|NCT03577288|Emotions|emotions
5067451|NCT03577288|Virtual Reality|virtual reality
5067452|NCT03577288|Young Adult|young adult
5067453|NCT03577288|Child|child
5067454|NCT03577223|Egg|egg
5067455|NCT03577223|HDL|hdl
5067456|NCT03577223|Inflammation|inflammation
5067457|NCT03577210|chin deficiency|chin deficiency
5067458|NCT03577210|chin asymmetry|chin asymmetry
5067459|NCT03577197|Breast neoplasms|breast neoplasms
5067460|NCT03577197|Neoplasm Metastasis|neoplasm metastasis
5067461|NCT03577197|Registry|registry
5067462|NCT03577184|GRIP, DM|grip, dm
5067463|NCT03577171|CHB|chb
5067464|NCT03577171|HBV|hbv
5067465|NCT03577171|HBeAg-positive|hbeag-positive
5067466|NCT03577171|hepatitis B|hepatitis b
5067467|NCT03577158|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5067468|NCT03577158|Insulin|insulin
5067469|NCT03577158|Exercise|exercise
5067470|NCT03577158|Closed-loop|closed-loop
5067471|NCT03577158|Artificial Pancreas|artificial pancreas
5067472|NCT03577145|Bioavailability|bioavailability
5067473|NCT03577145|Polyphenols|polyphenols
5067474|NCT03577145|Dietary fibre|dietary fibre
5067475|NCT03577145|Phenolic acids|phenolic acids
5067476|NCT03577132|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5067477|NCT03577132|atezolizumab|atezolizumab
5067478|NCT03577119|Prediabetes|prediabetes
5067479|NCT03577119|Glucose Tolerance|glucose tolerance
5067483|NCT03577119|Milk fat|milk fat
5067484|NCT03577119|Lipid metabolism|lipid metabolism
5067485|NCT03577119|Inflammation markers|inflammation markers
5067486|NCT03577119|Fecal microbiota composition|fecal microbiota composition
5067487|NCT03577119|Dairy|dairy
5067488|NCT03577106|transcranial magnetic stimulation|transcranial magnetic stimulation
5067490|NCT03577106|MRI|mri
5961131|NCT04288999|Locally recurrent rectal cancer|locally recurrent rectal cancer
5067491|NCT03577106|magnetic resonance imaging|magnetic resonance imaging
5067492|NCT03577106|fMRI|fmri
5067493|NCT03577106|functional magnetic resonance imaging|functional magnetic resonance imaging
5067494|NCT03577106|sleep|sleep
5067495|NCT03577106|intermittent theta burst stimulation|intermittent theta burst stimulation
5067496|NCT03577106|iTBS|itbs
5067497|NCT03577093|stroke, miR-494, neuroprotection, CDK|stroke, mir-494, neuroprotection, cdk
5067498|NCT03577080|COPD, Exercise training|copd, exercise training
5067499|NCT03577054|Helping Babies Breathe|helping babies breathe
5067500|NCT03577054|newborn resuscitation|newborn resuscitation
5067501|NCT03577054|skills retention|skills retention
5067502|NCT03577054|mobile health|mobile health
5067503|NCT03577054|user-centred design|user-centred design
5067504|NCT03577041|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5067505|NCT03577041|Bevacizumab|bevacizumab
5067506|NCT03577041|Cost-Effective|cost-effective
5067507|NCT03577041|Quality of life|quality of life
5067508|NCT03577015|disseminated intravascular coagulation|disseminated intravascular coagulation
5067509|NCT03577015|sepsis|sepsis
5067510|NCT03577015|trauma|trauma
5067511|NCT03577015|pancreatitis|pancreatitis
5067512|NCT03577015|malignancy|malignancy
5067513|NCT03577015|obstetric complication|obstetric complication
5067514|NCT03577002|Advance care planning|advance care planning
5067515|NCT03577002|Patient-provider communications|patient-provider communications
5067516|NCT03577002|Interdisciplinary teams|interdisciplinary teams
5067517|NCT03577002|Practice-based research networks|practice-based research networks
5067518|NCT03577002|Cluster-randomized controlled trial|cluster-randomized controlled trial
5067519|NCT03577002|Primary care|primary care
5067520|NCT03576989|leg ulcer, fish oil, wounds|leg ulcer, fish oil, wounds
5067521|NCT03576976|Cognitive Remediation|cognitive remediation
5067522|NCT03576950|Uterine rupture|uterine rupture
5067523|NCT03576950|Cesarean section|cesarean section
5067524|NCT03576950|Labour|labour
5067525|NCT03576950|Myomectomy|myomectomy
5067526|NCT03576950|Delivery|delivery
5067527|NCT03576924|Physical activity adherence|physical activity adherence
5067528|NCT03576924|Exercise motivation|exercise motivation
5609913|NCT00858364|Aranesp|aranesp
5067529|NCT03576924|Exercise enjoyment|exercise enjoyment
5067530|NCT03576924|Prediabetes|prediabetes
5067531|NCT03576872|Gastro Intestinal Cancer|gastro intestinal cancer
5067532|NCT03576846|neck pain|neck pain
5067834|NCT03575169|Monitoring|monitoring
5067533|NCT03576846|spinal manipulative therapy|spinal manipulative therapy
5067534|NCT03576846|heart rate variability|heart rate variability
5067535|NCT03576846|conditioned pain modulation|conditioned pain modulation
5067536|NCT03576820|pediatrics|pediatrics
5067537|NCT03576820|intranasal lidocaine|intranasal lidocaine
5067538|NCT03576820|migraine|migraine
5067539|NCT03576820|headache|headache
5067540|NCT03576820|emergency department|emergency department
5067541|NCT03576820|pain|pain
5067542|NCT03576807|B-cell leukemia|b-cell leukemia
5067543|NCT03576794|PMR RCT|pmr rct
5067544|NCT03576794|Leflunomide|leflunomide
5067545|NCT03576781|Brain Stimulation|brain stimulation
5067546|NCT03576781|Treatment|treatment
5067547|NCT03576768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5067548|NCT03576768|Brain Stimulation|brain stimulation
5067549|NCT03576768|Treatment|treatment
5067550|NCT03576768|Neuroimaging|neuroimaging
5067551|NCT03576742|pancytopenia|pancytopenia
5067552|NCT03576742|aplastic anemia|aplastic anemia
5067553|NCT03576742|myelodysplastic syndrome|myelodysplastic syndrome
5067554|NCT03576742|primary immunodeficiency|primary immunodeficiency
5067555|NCT03576742|immune dysregulation|immune dysregulation
5067556|NCT03576742|autoimmune cytopenia|autoimmune cytopenia
5067557|NCT03576729|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
5067558|NCT03576729|MPS I|mps i
5067559|NCT03576729|MPS IH|mps ih
5067560|NCT03576729|MPS IHS|mps ihs
5067561|NCT03576729|MPS IS|mps is
5067562|NCT03576729|Mucopolysaccharidosis I|mucopolysaccharidosis i
5067563|NCT03576716|chronic kidney disease|chronic kidney disease
5067564|NCT03576716|vitamin d catabolism|vitamin d catabolism
5067565|NCT03576703|metabolic syndrome|metabolic syndrome
5067566|NCT03576703|inflammation|inflammation
5067567|NCT03576703|insulin sensitivity|insulin sensitivity
5067568|NCT03576703|metabolic flexibility|metabolic flexibility
5067569|NCT03576703|overweight/obese|overweight/obese
5067570|NCT03576690|Positive Ebola Virus (EBOV) diagnostic test|positive ebola virus (ebov) diagnostic test
5067571|NCT03576690|symptomatic|symptomatic
5079887|NCT03499912|Genetic mutations|genetic mutations
5067572|NCT03576677|Advanced chronic heart failure|advanced chronic heart failure
5067574|NCT03576677|Exercise hemodynamics|exercise hemodynamics
5067575|NCT03576677|Levosimendan|levosimendan
5067576|NCT03576664|carvedilol|carvedilol
5067577|NCT03576664|adrenergic antagonists|adrenergic antagonists
5067578|NCT03576664|glymphatic system|glymphatic system
5067579|NCT03576664|volunteers|volunteers
5067580|NCT03576664|Molecular Mechanisms of Pharmacological|molecular mechanisms of pharmacological
5067581|NCT03576625|Buglossoides arvensis|buglossoides arvensis
5067585|NCT03576612|glioblastoma, newly diagnosed, GMCI, Checkpoint inhibitor|glioblastoma, newly diagnosed, gmci, checkpoint inhibitor
5067587|NCT03576573|Avascular necrosis|avascular necrosis
5067589|NCT03576573|Protrusio acetabuli|protrusio acetabuli
5067590|NCT03576573|Painful hip dysplasia|painful hip dysplasia
5067591|NCT03576573|Rheumatoid arthritis|rheumatoid arthritis
5067592|NCT03576573|Correction of functional deformity|correction of functional deformity
5067593|NCT03576521|breast cancer|breast cancer
5067594|NCT03576521|chemotherapy toxicity|chemotherapy toxicity
5067595|NCT03576521|Oxidative Stress|oxidative stress
5067596|NCT03576521|Nutritional supplement|nutritional supplement
5067597|NCT03576521|Ocoxin Viusid|ocoxin viusid
5067598|NCT03576508|Osteoarthritis|osteoarthritis
5067599|NCT03576508|Knee|knee
5067600|NCT03576495|Medical education|medical education
5067601|NCT03576495|Patient-reported Satisfaction|patient-reported satisfaction
5067602|NCT03576495|Patient-reported outcomes|patient-reported outcomes
5067603|NCT03576495|Cultural dexterity|cultural dexterity
5067604|NCT03576495|Cross cultural care|cross cultural care
5067605|NCT03576495|Resident physician education|resident physician education
5067606|NCT03576482|Anxiety disorders|anxiety disorders
5067607|NCT03576482|Depression|depression
5067608|NCT03576482|Transport to operating room|transport to operating room
5067609|NCT03576469|Intravenous Immunoglobulin|intravenous immunoglobulin
5067610|NCT03576469|C1-esterase inhibitor|c1-esterase inhibitor
5067611|NCT03576469|Adverse drug reaction (ADR)|adverse drug reaction (adr)
5067612|NCT03576456|coronary angiography|coronary angiography
5067613|NCT03576456|premedication|premedication
5067614|NCT03576456|pain|pain
5067615|NCT03576456|anxiety|anxiety
5067616|NCT03576391|Sensorimotor control|sensorimotor control
5067617|NCT03576391|Feedforward|feedforward
5067618|NCT03576391|Physical Fatigue|physical fatigue
5067619|NCT03576391|Cognitive Fatigue|cognitive fatigue
5067620|NCT03576391|Event-related potentials|event-related potentials
5067621|NCT03576365|Perceived Control|perceived control
5067622|NCT03576365|Distress|distress
5067623|NCT03576339|Wound Healing|wound healing
5067624|NCT03576339|Electrical Stimulation|electrical stimulation
5067625|NCT03576339|Palatal|palatal
5067626|NCT03576326|Preventive Dentistry|preventive dentistry
5067627|NCT03576326|Health Disparities|health disparities
5067628|NCT03576326|Health Behavior|health behavior
5067635|NCT03576274|Exercise|exercise
5067636|NCT03576274|biomarkers|biomarkers
5067637|NCT03576261|hemodynamics|hemodynamics
5067638|NCT03576261|venous return|venous return
5067639|NCT03576261|heart failure|heart failure
5067640|NCT03576261|anesthesia|anesthesia
5067641|NCT03576248|State of consciousness|state of consciousness
5067642|NCT03576248|tACS|tacs
5067643|NCT03576248|tDCS|tdcs
5067644|NCT03576248|Global neuronal workspace|global neuronal workspace
5067645|NCT03576248|Brain injury|brain injury
5067646|NCT03576235|Uremic pruritus|uremic pruritus
5067647|NCT03576235|Hemodialysis|hemodialysis
5067648|NCT03576222|PICO; incisional hernia; surgical site occurrences|pico; incisional hernia; surgical site occurrences
5067649|NCT03576209|Physical activity|physical activity
5067650|NCT03576209|sedentary behaviour|sedentary behaviour
5067651|NCT03576209|sleep|sleep
5678728|NCT00585312|FAP|fap
5067652|NCT03576209|Quality of life|quality of life
5067653|NCT03576209|functional ability|functional ability
5067654|NCT03576209|well-being|well-being
5067655|NCT03576209|Social identity and leadership|social identity and leadership
5067656|NCT03576209|social support and motivation|social support and motivation
5067657|NCT03576209|Aged, older adults|aged, older adults
5067658|NCT03576196|physical therapy|physical therapy
5067659|NCT03576196|Pain|pain
5067660|NCT03576196|disability|disability
5067661|NCT03576196|kinesiophobia.|kinesiophobia.
5067662|NCT03576157|mobile health, Pregnant and postpartum women, Frontline health workers, India|mobile health, pregnant and postpartum women, frontline health workers, india
5067667|NCT03576105|third molar|third molar
5067668|NCT03576105|pericoronitis|pericoronitis
5067669|NCT03576105|photodynamic therapy|photodynamic therapy
5067670|NCT03576105|microbiological analysis|microbiological analysis
5067671|NCT03576105|laser|laser
5067672|NCT03576105|randomized controlled clinical study|randomized controlled clinical study
5067673|NCT03576079|laser therapy|laser therapy
5067674|NCT03576079|anterior re-positioning splint|anterior re-positioning splint
5067675|NCT03576066|CHB|chb
5067679|NCT03576066|HBeAg-negative|hbeag-negative
5067680|NCT03576040|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
5067681|NCT03576040|whole body dynamic acquisition|whole body dynamic acquisition
5067682|NCT03576040|Gallium 68|gallium 68
5067683|NCT03576014|CMV|cmv
5067684|NCT03576014|BKV|bkv
5067685|NCT03576014|CMV Reactivation|cmv reactivation
5067698|NCT03575962|2-period|2-period
5067699|NCT03575962|Pharmacokinetics|pharmacokinetics
5067700|NCT03575962|FTIH|ftih
5067701|NCT03575962|GSK3640254|gsk3640254
5067702|NCT03575962|healthy subject|healthy subject
5067703|NCT03575962|bioavailability|bioavailability
5735650|NCT00374192|Sleep|sleep
5067704|NCT03575936|Pharmacists Intervention|pharmacists intervention
5067705|NCT03575923|Physical activity|physical activity
5067706|NCT03575923|Wellbeing|wellbeing
5961132|NCT04288999|Chemoradiotherapy|chemoradiotherapy
5067707|NCT03575923|Urban green space|urban green space
5067708|NCT03575923|Older adults|older adults
5067709|NCT03575923|Natural experiment|natural experiment
5067710|NCT03575923|Protocol|protocol
5067711|NCT03575923|GHIA|ghia
5067712|NCT03575910|Heart|heart
5067713|NCT03575910|Transplantation|transplantation
5067714|NCT03575910|Acute cardiac rejection|acute cardiac rejection
5067715|NCT03575910|Biomarkers|biomarkers
5067716|NCT03575910|Genomics|genomics
5067719|NCT03575871|atopic dermatitis|atopic dermatitis
5067720|NCT03575871|atopic eczema|atopic eczema
5067721|NCT03575871|eczema|eczema
5067723|NCT03575871|janus kinase|janus kinase
5067724|NCT03575858|Single dental implants|single dental implants
5067725|NCT03575858|Barrel Shaped Interdental toothbrush|barrel shaped interdental toothbrush
5067726|NCT03575858|Tapered Interdental toothbrush|tapered interdental toothbrush
5067727|NCT03575858|peri-implant mucositis and gingivitis|peri-implant mucositis and gingivitis
5067728|NCT03575845|Yoga|yoga
5067744|NCT03575728|Support Patient Self-Care|support patient self-care
5067745|NCT03575715|endobronchial ultrasound|endobronchial ultrasound
5067746|NCT03575715|peripheral pulmonary lesions|peripheral pulmonary lesions
5067747|NCT03575715|image features|image features
5067748|NCT03575702|overactive bladder|overactive bladder
5067749|NCT03575702|urinary incontinence|urinary incontinence
5067750|NCT03575702|frequent urination|frequent urination
5067751|NCT03575702|urge incontinence|urge incontinence
5067752|NCT03575702|urgency episodes|urgency episodes
5067753|NCT03575689|Nasal Splint|nasal splint
5067754|NCT03575689|Septum deviation|septum deviation
5067756|NCT03575676|Huntington|huntington
5067757|NCT03575676|Chorea|chorea
5067758|NCT03575676|SOM3355|som3355
5067759|NCT03575663|Breathomics|breathomics
5067760|NCT03575663|Metabolomics|metabolomics
5067761|NCT03575663|Exhaled breath test|exhaled breath test
5067762|NCT03575663|Biomarker|biomarker
5067763|NCT03575637|Olanzapine|olanzapine
5067764|NCT03575637|Gastric Cancer|gastric cancer
5067765|NCT03575637|Tolerance|tolerance
5067773|NCT03575585|HIV|hiv
5067774|NCT03575585|Counselor Skills Training|counselor skills training
5067775|NCT03575585|Behavioral Intervention|behavioral intervention
5067776|NCT03575585|Personalized Feedback Report|personalized feedback report
5067777|NCT03575572|Fontan|fontan
5067778|NCT03575572|Colchicine|colchicine
5067779|NCT03575572|heart surgery|heart surgery
5067780|NCT03575520|breast cancer|breast cancer
5067781|NCT03575520|dose-dense chemotherapy|dose-dense chemotherapy
5067782|NCT03575520|pegfilgrastim|pegfilgrastim
5067783|NCT03575468|e-cigarette|e-cigarette
5067784|NCT03575468|vaping|vaping
5067785|NCT03575468|electronic nicotine delivery system (ENDS)|electronic nicotine delivery system (ends)
5067786|NCT03575468|smoking cessation|smoking cessation
5067787|NCT03575455|concussion|concussion
5067788|NCT03575455|aerobic exercise|aerobic exercise
5067789|NCT03575455|sub-acute|sub-acute
5067790|NCT03575429|Pediatrics|pediatrics
5067791|NCT03575429|Social Communication|social communication
5067792|NCT03575429|Family Navigators|family navigators
5067795|NCT03575364|ClotTriever|clottriever
5067796|NCT03575364|Thrombectomy|thrombectomy
5067807|NCT03575338|scarf|scarf
5067808|NCT03575338|minimally invasive surgery|minimally invasive surgery
5067809|NCT03575338|hallux valgus|hallux valgus
5067810|NCT03575325|T-cell acute lymphoblastic leukemia|t-cell acute lymphoblastic leukemia
5067391|NCT03577730|Delirium|delirium
5067819|NCT03575273|opioid dependence|opioid dependence
5067820|NCT03575273|obesity|obesity
5067821|NCT03575273|food reward|food reward
5067822|NCT03575273|olfactory|olfactory
5067823|NCT03575260|Fulvestrant|fulvestrant
5067824|NCT03575260|Exemestane|exemestane
5067825|NCT03575221|Osteogenesis Imperfecta|osteogenesis imperfecta
5067826|NCT03575221|Collagen|collagen
5067827|NCT03575221|Short Stature|short stature
5067828|NCT03575208|Hepatitis B|hepatitis b
5067829|NCT03575208|Immune Response|immune response
5067830|NCT03575208|HBsAg Loss|hbsag loss
5067831|NCT03575208|Hepatitis B Virus|hepatitis b virus
5067832|NCT03575208|Interferon|interferon
5067833|NCT03575169|Bispectral index|bispectral index
5067846|NCT03575143|Obstructive Sleep Apnea|obstructive sleep apnea
5067847|NCT03575143|Human Immunodeficiency Virus|human immunodeficiency virus
5067848|NCT03575143|CPAP|cpap
5067849|NCT03575091|Infant|infant
5067850|NCT03575091|Respiration|respiration
5067851|NCT03575026|Early dementia|early dementia
5067852|NCT03575026|Caregiver|caregiver
5067853|NCT03575026|Anxiety|anxiety
5067854|NCT03575026|Well-being|well-being
5067855|NCT03574987|Physical Activity|physical activity
5961133|NCT04288999|Surgery|surgery
5067856|NCT03574987|Nutrition|nutrition
5067857|NCT03574987|Carbohydrates|carbohydrates
5067859|NCT03574987|Energy Balance|energy balance
5067860|NCT03574974|PTSD|ptsd
5067861|NCT03574974|Neurofeedback|neurofeedback
5067862|NCT03574961|depression|depression
5067863|NCT03574961|social isolation|social isolation
5067864|NCT03574935|"Qing-Hua-Bu"|"qing-hua-bu"
5067865|NCT03574935|Dynamic sequential treatment|dynamic sequential treatment
5067866|NCT03574935|Clinical evaluation|clinical evaluation
5067867|NCT03574935|Generalized application|generalized application
5067868|NCT03574883|Conscious access|conscious access
5067869|NCT03574883|transcranial electric stimulation|transcranial electric stimulation
5067870|NCT03574883|tACS|tacs
5067871|NCT03574883|Global neuronal workspace|global neuronal workspace
5067872|NCT03574883|Masking paradigm|masking paradigm
5067873|NCT03574883|tDCS|tdcs
5067874|NCT03574857|Loop diuretics|loop diuretics
5067875|NCT03574857|Heart failure|heart failure
5067876|NCT03574857|Diuretic resistance|diuretic resistance
5067877|NCT03574857|Thiazide diuretics|thiazide diuretics
5067878|NCT03574831|GERD|gerd
5067879|NCT03574831|Radiofrequency ablation|radiofrequency ablation
5067880|NCT03574831|efficiency|efficiency
5067881|NCT03574831|safety|safety
5067883|NCT03574805|Asthma|asthma
5067884|NCT03574805|Anticalin|anticalin
5067885|NCT03574805|PRS-060|prs-060
5067886|NCT03574805|Pieris|pieris
5059982|NCT03623893|Infants|infants
5067887|NCT03574805|IL-4 receptor alpha|il-4 receptor alpha
5067888|NCT03574805|IL-13|il-13
5067889|NCT03574805|IL-4|il-4
5067890|NCT03574779|PARP Inhibitor|parp inhibitor
5067891|NCT03574779|OPAL|opal
5067892|NCT03574779|OPAL Clinical Trial|opal clinical trial
5067893|NCT03574779|OPAL Study|opal study
5067894|NCT03574701|olfactory|olfactory
5067895|NCT03574701|Vitamin A|vitamin a
5067896|NCT03574701|Olfactory training|olfactory training
5067898|NCT03574688|Hydration|hydration
5067899|NCT03574688|Water|water
5067900|NCT03574688|Vasopressin|vasopressin
5067901|NCT03574688|Copeptin|copeptin
5067902|NCT03574688|Glucose|glucose
5067903|NCT03574675|simulated altitude|simulated altitude
5067904|NCT03574675|exercise|exercise
5067905|NCT03574675|non-invasive cardiac output|non-invasive cardiac output
5067906|NCT03574662|frailty|frailty
5067907|NCT03574662|advanced|advanced
5067908|NCT03574623|stroke|stroke
5067909|NCT03574623|rehabilitation|rehabilitation
5067910|NCT03574623|therapy|therapy
5067911|NCT03574623|electrical stimulation|electrical stimulation
5067912|NCT03574623|hand|hand
5628136|NCT00787501|Depression|depression
5067913|NCT03574610|Neurogenic bladder|neurogenic bladder
5067914|NCT03574610|Functional Neuroimaging|functional neuroimaging
5067915|NCT03574610|Transcranial Rotating Permanent Magnet Stimulator (TRPMS)|transcranial rotating permanent magnet stimulator (trpms)
5067921|NCT03574558|Pump therapy|pump therapy
5067922|NCT03574558|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
5067923|NCT03574558|Decision Support System (DSS)|decision support system (dss)
5067924|NCT03574545|Rheumatoid Arthritis|rheumatoid arthritis
5067925|NCT03574545|VAY736|vay736
5067926|NCT03574545|Ianalumab|ianalumab
5067927|NCT03574506|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5067928|NCT03574506|Pregnancy|pregnancy
5067929|NCT03574493|laparotomy|laparotomy
5067930|NCT03574493|laparoscopy|laparoscopy
5067931|NCT03574493|low anterior resection|low anterior resection
5067932|NCT03574493|rectal cancer|rectal cancer
5067933|NCT03574493|robot assisted surgery|robot assisted surgery
5067934|NCT03574493|total mesorectal excision|total mesorectal excision
5067935|NCT03574493|transanal surgery|transanal surgery
5067945|NCT03574454|Whole Body Diffusion Weighted|whole body diffusion weighted
5067946|NCT03574454|Magnetic Resonance Imaging|magnetic resonance imaging
5067948|NCT03574454|Reading Time|reading time
5067949|NCT03574454|Convolutional Neural Network|convolutional neural network
5067950|NCT03574454|Algorithm|algorithm
5067951|NCT03574454|Diagnostic performance|diagnostic performance
5067953|NCT03574402|advanced stage|advanced stage
5067954|NCT03574402|high throughput sequencing|high throughput sequencing
5067955|NCT03574402|targeted therapy|targeted therapy
5067956|NCT03574402|immunotherapy|immunotherapy
5067957|NCT03574376|Rib trauma, intercostal nerve block, liposomal bupivacaine|rib trauma, intercostal nerve block, liposomal bupivacaine
5067958|NCT03574363|Chronic Kidney Disease|chronic kidney disease
5067959|NCT03574363|Hypertension|hypertension
5067960|NCT03574350|Kangaroo position|kangaroo position
5067961|NCT03574350|Kinesthetic Stimulation|kinesthetic stimulation
5067962|NCT03574350|Kangaroo Mother Care|kangaroo mother care
5067963|NCT03574350|Bonding|bonding
5067964|NCT03574337|Residual neuromuscular blockade|residual neuromuscular blockade
5067965|NCT03574337|Reversal|reversal
5067966|NCT03574337|Cardiac surgery|cardiac surgery
5067967|NCT03574311|CABG|cabg
5067968|NCT03574311|cardiac surgery|cardiac surgery
5067969|NCT03574311|blood transfusion|blood transfusion
5067970|NCT03574311|intravenous iron|intravenous iron
5067971|NCT03574311|postoperative infection|postoperative infection
5067972|NCT03574298|Radical prostatectomy|radical prostatectomy
5067973|NCT03574298|urinary incontinence|urinary incontinence
5067974|NCT03574298|pelvic floor muscle|pelvic floor muscle
5067975|NCT03574298|reaction time|reaction time
5067976|NCT03574272|mobile IoT technology|mobile iot technology
5067977|NCT03574272|Patient Transfer Monitoring System|patient transfer monitoring system
5067981|NCT03574181|Wrist watch blood alcohol level|wrist watch blood alcohol level
5067982|NCT03574181|Blood alcohol|blood alcohol
5067983|NCT03574181|Objective alcohol measure|objective alcohol measure
5961134|NCT04288999|Chemotherapy|chemotherapy
5961135|NCT04288986|Autism spectrum condition|autism spectrum condition
5067984|NCT03574155|Gynecological cancer|gynecological cancer
5067985|NCT03574155|Anxiety|anxiety
5067986|NCT03574155|Pre-operative counseling|pre-operative counseling
5067987|NCT03574142|Pharmacokinetics|pharmacokinetics
5067988|NCT03574142|Safety|safety
5067989|NCT03574142|Tolerability|tolerability
5067990|NCT03574142|Epanova|epanova
5067991|NCT03574142|Omega-3 carboxylic acids|omega-3 carboxylic acids
5067992|NCT03574142|Chinese|chinese
5067993|NCT03574116|Sarcopenia|sarcopenia
5067994|NCT03574116|jejunostomy|jejunostomy
5067995|NCT03574116|oesogastric adenocarcinoma|oesogastric adenocarcinoma
5067996|NCT03574116|scanography|scanography
5067997|NCT03574103|Obesity|obesity
5067998|NCT03574103|Overweight|overweight
5067999|NCT03574103|Weight loss|weight loss
5068000|NCT03574103|Fasting|fasting
5068001|NCT03574090|topical antibiotic|topical antibiotic
5068002|NCT03574090|surgical wound infection|surgical wound infection
5068003|NCT03574090|prevention of surgical wound infection|prevention of surgical wound infection
5068004|NCT03574051|oral microbiota|oral microbiota
5068005|NCT03574051|16S rRNA gene|16s rrna gene
5068006|NCT03574051|thyroid cancer|thyroid cancer
5934156|NCT02964507|mTPI|mtpi
5068007|NCT03574051|iodine 131 treatment|iodine 131 treatment
5068008|NCT03574051|fecal microbiota|fecal microbiota
5068009|NCT03574051|radiotherapy|radiotherapy
5068010|NCT03574025|Observational, Paediatric, Cardiac Arrest, PICU,|observational, paediatric, cardiac arrest, picu,
5068011|NCT03573999|mannitol|mannitol
5068012|NCT03573999|hypertonic saline|hypertonic saline
5068013|NCT03573999|brain metabolism|brain metabolism
5068014|NCT03573999|brain oxygenation|brain oxygenation
5068015|NCT03573973|Dietary inequalities|dietary inequalities
5068016|NCT03573973|Public Health|public health
5068017|NCT03573973|Choice architecture|choice architecture
5068018|NCT03573973|Supermarkets|supermarkets
5068019|NCT03573960|Lenvatinib, E7080, Refractory Differentiated Thyroid Cancer|lenvatinib, e7080, refractory differentiated thyroid cancer
5068020|NCT03573947|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5068021|NCT03573947|nivolumab|nivolumab
5068022|NCT03573947|ipilimumab|ipilimumab
5068023|NCT03573947|paclitaxel|paclitaxel
5068024|NCT03573947|immunotherapy|immunotherapy
5068025|NCT03573921|Paediatrics|paediatrics
5068026|NCT03573921|Gastrografin|gastrografin
5668544|NCT00626964|APO B|apo b
5068027|NCT03573882|Open Label Extension|open label extension
5068028|NCT03573843|Delirium|delirium
5068029|NCT03573843|Prevention|prevention
5068030|NCT03573843|Cognitive stimulation|cognitive stimulation
5068031|NCT03573830|Child Passenger Injury|child passenger injury
5068032|NCT03573830|Child Restraint Systems|child restraint systems
5068033|NCT03573830|Traffic Accidents|traffic accidents
5068034|NCT03573817|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5068035|NCT03573817|Pulmonary Function|pulmonary function
5068037|NCT03573817|Performist|performist
5068236|NCT03572634|Tolero|tolero
5068042|NCT03573778|health promotion|health promotion
5068043|NCT03573778|intimate partner violence|intimate partner violence
5068049|NCT03573765|upper limb|upper limb
5068050|NCT03573765|hand surgery|hand surgery
5068051|NCT03573765|wrist surgery|wrist surgery
5068052|NCT03573765|shoulder surgery|shoulder surgery
5068053|NCT03573765|elbow surgery|elbow surgery
5068056|NCT03573765|revision surgery|revision surgery
5068057|NCT03573752|Laparoscopic Promontofixation|laparoscopic promontofixation
5068058|NCT03573752|Outpatient management|outpatient management
5068059|NCT03573713|Hygiene practices|hygiene practices
5068060|NCT03573713|Sanitation|sanitation
5068061|NCT03573713|Nutrition|nutrition
5068062|NCT03573713|Interpersonal Psychotherapy|interpersonal psychotherapy
5068063|NCT03573713|Maternal depression|maternal depression
5068064|NCT03573713|clustered randomized controlled trial|clustered randomized controlled trial
5068065|NCT03573700|Leukemia|leukemia
5068066|NCT03573700|Leukemia, lymphoid|leukemia, lymphoid
5068067|NCT03573700|Leukemia, B-cell|leukemia, b-cell
5068068|NCT03573700|Relapsed|relapsed
5068069|NCT03573700|Refractory|refractory
5068070|NCT03573700|Pediatric|pediatric
5068071|NCT03573700|Chimeric antigen receptor|chimeric antigen receptor
5068073|NCT03573700|CAR T cell|car t cell
5068074|NCT03573700|Anti-CD19|anti-cd19
5068075|NCT03573700|CD19|cd19
5068076|NCT03573687|protein|protein
5068077|NCT03573687|lipolysis|lipolysis
5068078|NCT03573687|fat oxidation|fat oxidation
5068079|NCT03573687|resistance training|resistance training
5068080|NCT03573687|nutrient timing|nutrient timing
5068081|NCT03573674|Working conditions,|working conditions,
5068082|NCT03573674|cognitive load|cognitive load
5068083|NCT03573674|disruptions|disruptions
5068084|NCT03573674|interruptions|interruptions
5068085|NCT03573674|information overload|information overload
5068086|NCT03573674|Mental contrasting with implementation intentions MCII|mental contrasting with implementation intentions mcii
5068087|NCT03573674|Cognitive ergonomics|cognitive ergonomics
5068088|NCT03573661|Breast Conserving Surgery|breast conserving surgery
5068089|NCT03573661|Breast Imaging|breast imaging
5068090|NCT03573661|Breast Cancer Locator|breast cancer locator
5068091|NCT03573661|Supine MRI|supine mri
5068092|NCT03573596|CML|cml
5068093|NCT03573596|second stop|second stop
5068094|NCT03573596|dasatinib|dasatinib
5068095|NCT03573583|muscle mass|muscle mass
5068096|NCT03573583|muscle loss|muscle loss
5068097|NCT03573583|Deuterated creatine (D3Cr) dilution|deuterated creatine (d3cr) dilution
5068098|NCT03573583|older adults|older adults
5068099|NCT03573583|resistance training|resistance training
5068100|NCT03573583|physical function|physical function
5068101|NCT03573544|mAbs|mabs
5068102|NCT03573544|monoclonal antibodies|monoclonal antibodies
5068103|NCT03573531|donor human milk|donor human milk
5068104|NCT03573531|lipid peroxidation|lipid peroxidation
5068105|NCT03573531|neonate|neonate
5068106|NCT03573531|omega-3 fatty acids|omega-3 fatty acids
5068113|NCT03573479|critical care|critical care
5068114|NCT03573479|child health|child health
5068115|NCT03573479|quality improvement|quality improvement
5068117|NCT03573466|Motor Neuron|motor neuron
5068118|NCT03573466|Neuromuscular Junction|neuromuscular junction
5068123|NCT03573414|Cardiovascular system|cardiovascular system
5068124|NCT03573414|Polyphenols|polyphenols
5068125|NCT03573401|ALA-PDT|ala-pdt
5068126|NCT03573388|Intermediate coronary lesions|intermediate coronary lesions
5068127|NCT03573388|Fractional flow reserve|fractional flow reserve
5068128|NCT03573388|Optical coherence tomography|optical coherence tomography
5068129|NCT03573375|Questionnaires|questionnaires
5068130|NCT03573375|Surveys|surveys
5068131|NCT03573362|sarcoidosis|sarcoidosis
5068132|NCT03573362|ebus|ebus
5068133|NCT03573362|endobronchial ultrasound|endobronchial ultrasound
5068237|NCT03572634|Phase 1/2|phase 1/2
5068142|NCT03573284|cough variant asthma|cough variant asthma
5068143|NCT03573284|chronic cough|chronic cough
5068144|NCT03573284|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5068145|NCT03573284|impulse oscillometry|impulse oscillometry
5068146|NCT03573284|forced mid-expiratory flow|forced mid-expiratory flow
5068147|NCT03573271|facial wrinkles|facial wrinkles
5068157|NCT03573219|Non-invasive pain model|non-invasive pain model
5068158|NCT03573206|vessel closure|vessel closure
5068159|NCT03573206|venous access site|venous access site
5068160|NCT03573206|femoral venotomy|femoral venotomy
5068161|NCT03573206|medium bore|medium bore
5068162|NCT03573206|multiple access sites|multiple access sites
5068163|NCT03573193|xenograft bone|xenograft bone
5068164|NCT03573193|synthetic bone substitutes|synthetic bone substitutes
5068165|NCT03573180|CAST index, prevalence of caries, primary dentition caries|cast index, prevalence of caries, primary dentition caries
5068166|NCT03573154|nicotine|nicotine
5068167|NCT03573154|e-cigarette|e-cigarette
5068168|NCT03573154|exhaled breath|exhaled breath
5068169|NCT03573154|pharmacokinetic model|pharmacokinetic model
5068170|NCT03573115|Optical Coherence Tomography|optical coherence tomography
5068171|NCT03573115|Reflectance Confocal Microscopy|reflectance confocal microscopy
5068172|NCT03573115|Gold microparticles|gold microparticles
5068173|NCT03573115|Adapalene|adapalene
5068174|NCT03573115|Benzoyl Peroxide|benzoyl peroxide
5068175|NCT03573102|proteinuria , SGLT2 inhibitors , diabetes|proteinuria , sglt2 inhibitors , diabetes
5068176|NCT03573089|Renal dialysis|renal dialysis
5068182|NCT03573089|Hyperphosphatemia|hyperphosphatemia
5068183|NCT03573063|starvation|starvation
5068184|NCT03573063|androgens|androgens
5068185|NCT03573063|healthy women|healthy women
5068186|NCT03573063|PCOS|pcos
5068187|NCT03573024|Venetoclax|venetoclax
5068188|NCT03573024|Azacitidine|azacitidine
5068189|NCT03573024|Non-Elderly|non-elderly
5068190|NCT03573024|Previously Untreated|previously untreated
5068191|NCT03573011|prostate cancer|prostate cancer
5068192|NCT03573011|biochemical recurrence|biochemical recurrence
5068193|NCT03573011|18F-PET imaging|18f-pet imaging
5068194|NCT03572933|refractory seizures|refractory seizures
5068195|NCT03572933|genetic pediatric encephalopathies|genetic pediatric encephalopathies
5068196|NCT03572933|epilepsy in children|epilepsy in children
5068197|NCT03572933|seizure disorder|seizure disorder
5068198|NCT03572920|Sleep|sleep
5068199|NCT03572920|Actigraphy|actigraphy
5068200|NCT03572920|Pain|pain
5068201|NCT03572920|Patients|patients
5068202|NCT03572920|Hospitalization|hospitalization
5068203|NCT03572920|Hip Replacement|hip replacement
5068204|NCT03572920|Knee Replacement|knee replacement
5068205|NCT03572920|Arthroplasty|arthroplasty
5068206|NCT03572881|Brugada syndrome|brugada syndrome
5068207|NCT03572881|ventricular arrhythmia|ventricular arrhythmia
5068208|NCT03572881|sudden death|sudden death
5068209|NCT03572803|ntratissue Percutaneous Electrolysis|ntratissue percutaneous electrolysis
5068210|NCT03572803|Dry needling|dry needling
5068211|NCT03572803|Eccentric exercise|eccentric exercise
5068212|NCT03572803|Lateral epicondyle|lateral epicondyle
5068213|NCT03572790|5-HT4|5-ht4
5068214|NCT03572790|Prucalopride|prucalopride
5068215|NCT03572790|Resolor|resolor
5356799|NCT01917968|Pelvic Organ Prolapse|pelvic organ prolapse
5068216|NCT03572790|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5068217|NCT03572790|Emotional Processing|emotional processing
5068218|NCT03572790|Healthy Volunteers|healthy volunteers
5068219|NCT03572777|Helicobacter pylori, eradication, hybrid therapy, concomitant therapy|helicobacter pylori, eradication, hybrid therapy, concomitant therapy
5068220|NCT03572751|Sensor|sensor
5356764|NCT01918059|octyl-2-cyanoacrylate|octyl-2-cyanoacrylate
5356765|NCT01918046|biomarker|biomarker
5356766|NCT01918046|MIOX|miox
5068221|NCT03572751|Wearable|wearable
5068222|NCT03572738|acne inversa|acne inversa
5068223|NCT03572738|HS|hs
5068224|NCT03572738|Verneuil's Disease|verneuil's disease
5068225|NCT03572712|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5068226|NCT03572712|Non Invasive Ventilation|non invasive ventilation
5068227|NCT03572712|Transcutaneous capnography|transcutaneous capnography
5068228|NCT03572686|supraclavicular nerve block|supraclavicular nerve block
5068229|NCT03572686|dexamethasone|dexamethasone
5068230|NCT03572686|Ropivacaine|ropivacaine
5068231|NCT03572660|stem cell|stem cell
5068232|NCT03572660|circulatory support|circulatory support
5068233|NCT03572647|Erythropoeitin|erythropoeitin
5080484|NCT03496025|facial nerve palsy|facial nerve palsy
5068234|NCT03572647|Chronic Kidney Disease|chronic kidney disease
5068240|NCT03572634|Previously treated Small Lymphocytic Lymphoma (SLL)|previously treated small lymphocytic lymphoma (sll)
5068241|NCT03572634|AXL inhibitor|axl inhibitor
5068242|NCT03572634|Cancer|cancer
5068243|NCT03572634|Advanced Cancer|advanced cancer
5068244|NCT03572634|Relapsed / Refractory CLL|relapsed / refractory cll
5068245|NCT03572621|Prostatectomy|prostatectomy
5068246|NCT03572608|acupuncture|acupuncture
5068247|NCT03572608|infertility|infertility
5068248|NCT03572608|pregnancy|pregnancy
5068249|NCT03572595|FDG-PET/CT|fdg-pet/ct
5068250|NCT03572595|Staging and restaging|staging and restaging
5068251|NCT03572569|Pediatrics|pediatrics
5068252|NCT03572569|Cardiomyopathy|cardiomyopathy
5068253|NCT03572569|Heart failure|heart failure
5068254|NCT03572569|Risk stratification|risk stratification
5068255|NCT03572569|Family screening|family screening
5068256|NCT03572569|Genetics|genetics
5068257|NCT03572517|Delirium|delirium
5068258|NCT03572517|Anesthesia|anesthesia
5068259|NCT03572517|Surgical Oncology|surgical oncology
5068260|NCT03572465|Chronic liver disease|chronic liver disease
5068261|NCT03572465|Fibrosis|fibrosis
5068262|NCT03572465|Elastography|elastography
5068263|NCT03572465|Ultrasound|ultrasound
5068264|NCT03572465|Magnetic resonance elastography|magnetic resonance elastography
5068265|NCT03572465|Diagnostic performance|diagnostic performance
5068266|NCT03572465|Sensitivity and specificity|sensitivity and specificity
5068267|NCT03572439|epidural|epidural
5068268|NCT03572439|sensory block level|sensory block level
5068269|NCT03572439|dermatome|dermatome
5068270|NCT03572413|Laparoscopic surgery|laparoscopic surgery
5068271|NCT03572413|Deep neuromuscular block|deep neuromuscular block
5068272|NCT03572413|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
5068273|NCT03572413|Postoperative immune suppression|postoperative immune suppression
5068274|NCT03572400|pancreatic cancer|pancreatic cancer
5068275|NCT03572400|pancreas cancer|pancreas cancer
5068276|NCT03572387|Prostate Neoplasms|prostate neoplasms
5068277|NCT03572387|Prostatic Neoplasms|prostatic neoplasms
5068278|NCT03572387|5-Azacitidine|5-azacitidine
5068279|NCT03572387|all-trans retinoic acid|all-trans retinoic acid
5068280|NCT03572387|PSA|psa
5068281|NCT03572374|Workforce|workforce
5068282|NCT03572374|Employers|employers
5068283|NCT03572374|Talking to Employers and Medical Staff About Work (TEAMWork)|talking to employers and medical staff about work (teamwork)
5068284|NCT03572374|18-217|18-217
5068285|NCT03572348|urethral stricture|urethral stricture
5068286|NCT03572348|urethroplasty|urethroplasty
5068287|NCT03572348|bulbar urethra|bulbar urethra
5068288|NCT03572348|reconstructive surgery|reconstructive surgery
5068289|NCT03572348|lower urinary tract symptoms|lower urinary tract symptoms
5068290|NCT03572348|erectile function|erectile function
5068291|NCT03572335|HIV|hiv
5068292|NCT03572335|emphysema|emphysema
5068293|NCT03572335|diffusing capacity|diffusing capacity
5068294|NCT03572335|chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
5068298|NCT03572296|Blackcurrant|blackcurrant
5068299|NCT03572296|Polyphenols|polyphenols
5068300|NCT03572296|Pulp|pulp
5068301|NCT03572296|Fibre|fibre
5068302|NCT03572296|Glucose|glucose
5068303|NCT03572296|Postprandial|postprandial
5934407|NCT02922049|BORN|born
5068304|NCT03572296|Metabolism|metabolism
5068305|NCT03572296|Cognition|cognition
5068306|NCT03572283|Pancreas|pancreas
5068307|NCT03572283|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5068308|NCT03572283|adenocarcinoma|adenocarcinoma
5068309|NCT03572283|bethanechol|bethanechol
5068310|NCT03572283|parasympathetic|parasympathetic
5068311|NCT03572270|HIV|hiv
5068312|NCT03572270|Ovarian reserve|ovarian reserve
5068313|NCT03572270|Fertility preservation|fertility preservation
5068314|NCT03572270|Anti HIV agents|anti hiv agents
5068315|NCT03572244|Laser-Lok|laser-lok
5068316|NCT03572244|Crevicular fluid|crevicular fluid
5068317|NCT03572244|Machined|machined
5068318|NCT03572244|Abutment|abutment
5961136|NCT04288986|Autism|autism
5961137|NCT04288986|Sport|sport
5961138|NCT04288986|Wellbeing|wellbeing
5068319|NCT03572231|Betmiga|betmiga
5068320|NCT03572231|OAB|oab
5068322|NCT03572231|Overactive Bladder|overactive bladder
5068323|NCT03572231|mirabegron|mirabegron
5961139|NCT04288986|Self-image|self-image
5342885|NCT01981655|Heart|heart
5068324|NCT03572205|Nutrigenetics|nutrigenetics
5068325|NCT03572179|3d printed positioning tray|3d printed positioning tray
5068327|NCT03572153|Hot Flashes|hot flashes
5068328|NCT03572153|Postmenopausal Symptoms|postmenopausal symptoms
5068329|NCT03572153|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
5068330|NCT03572153|Mind Body|mind body
5068331|NCT03572153|Hypnosis|hypnosis
5068332|NCT03572140|HCV|hcv
5068333|NCT03572140|Sofosbuvir|sofosbuvir
5068334|NCT03572140|Safety|safety
5068335|NCT03572140|RAVs|ravs
5068336|NCT03572140|Daclatasvir|daclatasvir
5068337|NCT03572127|Protein|protein
5068338|NCT03572127|Resistance Exercise|resistance exercise
5068339|NCT03572127|Skeletal Muscle|skeletal muscle
5068340|NCT03572127|Mycoprotein|mycoprotein
5068344|NCT03572101|patients|patients
5068345|NCT03572101|caregivers|caregivers
5068346|NCT03572101|quality of life|quality of life
5068347|NCT03572062|Respiratory tract infection, RSV, Adjuvant, vaccine|respiratory tract infection, rsv, adjuvant, vaccine
5068351|NCT03572023|Non-obstructive coronary artery atherosclerosis|non-obstructive coronary artery atherosclerosis
5068352|NCT03572023|MINOCA|minoca
5068353|NCT03572023|Myocardial infarction|myocardial infarction
5068354|NCT03572023|Proinflammatory interleukins|proinflammatory interleukins
5068355|NCT03572023|Thrombophilia|thrombophilia
5068356|NCT03572023|Genetic testing|genetic testing
5068357|NCT03572023|SPECT|spect
5068358|NCT03572023|MSCT|msct
5068359|NCT03572023|MRI|mri
5068360|NCT03571984|Breast cancer|breast cancer
5068361|NCT03571984|depression|depression
5068362|NCT03571984|Moving on ABC Plus|moving on abc plus
5068363|NCT03571984|Pakistan|pakistan
5068364|NCT03571919|Lidocaine infusion|lidocaine infusion
5068365|NCT03571906|Rehabilitation|rehabilitation
5068366|NCT03571867|Adenotonsillectomy|adenotonsillectomy
5068367|NCT03571867|Severity of Agitation|severity of agitation
5068368|NCT03571867|Sugammadex|sugammadex
5068369|NCT03571841|Breast Cancer Survivors|breast cancer survivors
5068370|NCT03571841|Sexual Function Disturbances|sexual function disturbances
5068371|NCT03571841|Ovarian Suppression Treatment|ovarian suppression treatment
5068372|NCT03571815|Fluoride varnish|fluoride varnish
5068373|NCT03571815|clinical trial|clinical trial
5068374|NCT03571815|dental caries|dental caries
5068375|NCT03571802|pharmacokinetics|pharmacokinetics
5068376|NCT03571802|simvastatin|simvastatin
5068377|NCT03571802|bariatric surgery|bariatric surgery
5068378|NCT03571802|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5068379|NCT03571789|AF|af
5068380|NCT03571763|Cerebral Hemorrhage|cerebral hemorrhage
5068381|NCT03571763|anti-thrombosis|anti-thrombosis
5068382|NCT03571750|Suicide|suicide
5068383|NCT03571750|Prevention|prevention
5068384|NCT03571750|Risk Factor|risk factor
5068385|NCT03571750|Intervention|intervention
5068386|NCT03571750|Military|military
5068391|NCT03571737|emergency department|emergency department
5068392|NCT03571724|Very Low Nicotine|very low nicotine
5068394|NCT03571724|VLN|vln
5068395|NCT03571698|Knee Osteoarthritis|knee osteoarthritis
5068396|NCT03571698|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5068397|NCT03571698|Exercise|exercise
5068398|NCT03571698|Pain|pain
5068399|NCT03571698|Function|function
5068400|NCT03571672|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5068401|NCT03571672|DEFINITY|definity
5068402|NCT03571672|Enhanced Echocardiogram|enhanced echocardiogram
5068403|NCT03571672|Cardiac Magnetic Resonance|cardiac magnetic resonance
5068404|NCT03571633|Pegfilgrastim|pegfilgrastim
5068405|NCT03571633|Trastuzumab/Paclitaxel|trastuzumab/paclitaxel
5068406|NCT03571633|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
5068410|NCT03571555|HIV|hiv
5068411|NCT03571555|perinatal|perinatal
5068412|NCT03571555|adolescent|adolescent
5068413|NCT03571555|camp|camp
5068414|NCT03571555|psychosocial|psychosocial
5068415|NCT03571542|Children|children
5068416|NCT03571542|transplanted|transplanted
5068417|NCT03571542|kidney transplantation|kidney transplantation
5068418|NCT03571542|respiratory function|respiratory function
5068419|NCT03571542|pulmonary function tests|pulmonary function tests
5068420|NCT03571542|respiratory disease|respiratory disease
5068421|NCT03571542|immunosuppression|immunosuppression
5068422|NCT03571529|EMG driven exoskeleton|emg driven exoskeleton
5068423|NCT03571529|hand rehabilitation|hand rehabilitation
5068424|NCT03571529|hand function|hand function
5068425|NCT03571529|upper extremity outcome|upper extremity outcome
5068426|NCT03571516|Short bowel syndrome|short bowel syndrome
5068427|NCT03571516|Teduglutide|teduglutide
5068428|NCT03571503|Complementary Therapies|complementary therapies
5068429|NCT03571503|Exercise|exercise
5068430|NCT03571503|Acupuncture|acupuncture
5068431|NCT03571477|Sleep apnea diagnosis|sleep apnea diagnosis
5068432|NCT03571477|Sleep apnea monitoring|sleep apnea monitoring
5961140|NCT04288973|mother-infant relationship|mother-infant relationship
5068433|NCT03571464|obsessive compulsive disorder|obsessive compulsive disorder
5068434|NCT03571464|cognitive therapy|cognitive therapy
5068435|NCT03571464|maladaptive beliefs|maladaptive beliefs
5068436|NCT03571464|mobile app|mobile app
5068437|NCT03571451|peritoneal dialysis|peritoneal dialysis
5068438|NCT03571451|survival rate|survival rate
5068439|NCT03571451|technique survival rate|technique survival rate
5068440|NCT03571451|risk factors|risk factors
5068452|NCT03571347|asylum seekers|asylum seekers
5068453|NCT03571347|refugees|refugees
5068454|NCT03571347|Self Help Plus|self help plus
5068455|NCT03571347|Europe|europe
5068456|NCT03571308|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
5068457|NCT03571308|Acalabrunitib|acalabrunitib
5068458|NCT03571308|Bruton Tyrosine Kinase|bruton tyrosine kinase
5068467|NCT03571282|effectiveness|effectiveness
5068468|NCT03571230|Helicobacter Pylori Infection|helicobacter pylori infection
5903351|NCT00455325|Atherosclerosis|atherosclerosis
5068469|NCT03571230|Antimicrobial Susceptibility testing(AST)|antimicrobial susceptibility testing(ast)
5068470|NCT03571217|Type 2 diabetes mellitus|type 2 diabetes mellitus
5068471|NCT03571217|diabetic retinopathy|diabetic retinopathy
5068472|NCT03571217|visual impairment|visual impairment
5068473|NCT03571217|diabetic choroidopathy|diabetic choroidopathy
5068474|NCT03571204|Treatment Interruption|treatment interruption
5068475|NCT03571204|Neutralizing Monoclonal Antibody|neutralizing monoclonal antibody
5068476|NCT03571191|Bone Diseases|bone diseases
5068477|NCT03571191|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
5068478|NCT03571191|Bone Turnover|bone turnover
5068479|NCT03571165|carers|carers
5068480|NCT03571165|quality of life|quality of life
5068481|NCT03571165|dementia|dementia
5068482|NCT03571165|web-based intervention|web-based intervention
5068483|NCT03571152|Caregivers|caregivers
5068484|NCT03571152|Educational videos|educational videos
5068485|NCT03571152|Subacute phase|subacute phase
5068486|NCT03571139|OCT angiography|oct angiography
5068487|NCT03571139|Diabetic retinopathy|diabetic retinopathy
5068488|NCT03571139|Cataract surgery|cataract surgery
5068489|NCT03571113|cardiac arrest, OHCA survival score, predicting survival, German Resuscitation Registry|cardiac arrest, ohca survival score, predicting survival, german resuscitation registry
5068490|NCT03571061|water-aided colonoscopy; difficult colonoscopy|water-aided colonoscopy; difficult colonoscopy
5068491|NCT03571035|Mandibular deviation|mandibular deviation
5068492|NCT03571035|mandibular movement recording|mandibular movement recording
5735651|NCT00374192|Lunesta|lunesta
5068493|NCT03570996|esophageal cancer|esophageal cancer
5068494|NCT03570996|transversus abdominis plane catheter|transversus abdominis plane catheter
5068495|NCT03570996|epidural|epidural
5068496|NCT03570996|pain, postoperative|pain, postoperative
5068497|NCT03570944|Postoperative Complications|postoperative complications
5068498|NCT03570931|INAD|inad
5068516|NCT03570866|Endometrial cancer|endometrial cancer
5068517|NCT03570866|Positron emission tomography|positron emission tomography
5068519|NCT03570840|pediatric metabolic syndrome|pediatric metabolic syndrome
5068520|NCT03570801|Lumbar Spondylolisthesis|lumbar spondylolisthesis
5068521|NCT03570801|Grade 1 Spondylolisthesis|grade 1 spondylolisthesis
5068522|NCT03570801|Lumbar Spinal Stenosis|lumbar spinal stenosis
5068523|NCT03570801|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5068524|NCT03570775|hyperbilirubinemia|hyperbilirubinemia
5068525|NCT03570775|treatment|treatment
5068526|NCT03570775|devices|devices
5068527|NCT03570775|newborn|newborn
5068528|NCT03570775|phototherapy|phototherapy
5068529|NCT03570762|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5068530|NCT03570710|cesarean section|cesarean section
5068531|NCT03570710|placenta accreta spectrum|placenta accreta spectrum
5068532|NCT03570710|tranexamic acid|tranexamic acid
5068634|NCT03570099|prevention|prevention
5068537|NCT03570697|Cardiovascular events|cardiovascular events
5068538|NCT03570697|Coronary atherosclerotic plaques|coronary atherosclerotic plaques
5068539|NCT03570697|Lipid-lowering therapy|lipid-lowering therapy
5068540|NCT03570697|Statin|statin
5068541|NCT03570697|Maximally tolerated statin therapy|maximally tolerated statin therapy
5068542|NCT03570671|MDCTA|mdcta
5068543|NCT03570671|Coronary artery spasm|coronary artery spasm
5068549|NCT03570580|Sleep Apnea, Obstructive, Mass Screening|sleep apnea, obstructive, mass screening
5068550|NCT03570541|Colon cancer|colon cancer
5068551|NCT03570541|nerve block|nerve block
5068552|NCT03570541|ultra-sound|ultra-sound
5068553|NCT03570541|opioids|opioids
5068554|NCT03570541|surgical stress|surgical stress
5068555|NCT03570489|Cardiovascular fitness, refractory epilepsy,|cardiovascular fitness, refractory epilepsy,
5068556|NCT03570450|Cell therapy|cell therapy
5068571|NCT03570424|Adaptation, Physiological|adaptation, physiological
5068573|NCT03570424|Protein Hydrolysates|protein hydrolysates
5068574|NCT03570372|Life quality|life quality
5068575|NCT03570372|ASD|asd
5934646|NCT02869659|obesity|obesity
5068576|NCT03570372|Internet based treatment|internet based treatment
5068577|NCT03570372|Autism|autism
5068578|NCT03570372|ICBT|icbt
5068579|NCT03570359|COPD|copd
5068580|NCT03570333|gingival recession|gingival recession
5068581|NCT03570333|gingival graft|gingival graft
5068582|NCT03570333|Palate|palate
5068583|NCT03570333|Gingival mesenchymal stem cells|gingival mesenchymal stem cells
5068584|NCT03570333|molar|molar
5068585|NCT03570333|premolar|premolar
5068586|NCT03570320|opioid|opioid
5068587|NCT03570320|narcotic|narcotic
5068588|NCT03570320|postoperative|postoperative
5068589|NCT03570320|prescription|prescription
5068590|NCT03570320|refill|refill
5068591|NCT03570320|upper extremity surgery|upper extremity surgery
5068592|NCT03570307|MISCARRAGE, CURATTAGE MISOPROSTOL|miscarrage, curattage misoprostol
5068593|NCT03570281|cancer-related stroke|cancer-related stroke
5068594|NCT03570281|coagulopathy|coagulopathy
5068595|NCT03570281|D-dimer|d-dimer
5068596|NCT03570281|Edoxaban|edoxaban
5068597|NCT03570281|enoxaparine|enoxaparine
5068598|NCT03570268|Falls prevention|falls prevention
5068599|NCT03570268|Education|education
5068600|NCT03570268|Neurological disease|neurological disease
5068601|NCT03570242|gynecologic cancer|gynecologic cancer
5068602|NCT03570242|WB-EMS|wb-ems
5068603|NCT03570242|whole-body electromyostimulation|whole-body electromyostimulation
5068604|NCT03570242|nutrition|nutrition
5068605|NCT03570242|protein|protein
5068606|NCT03570242|exercise|exercise
5068607|NCT03570242|cancer cachexia|cancer cachexia
5068608|NCT03570229|Quality of life (QOL)|quality of life (qol)
5342953|NCT01981382|pain sensitivity|pain sensitivity
5068609|NCT03570229|Hyperbaric oxygen treatment (HBOT)|hyperbaric oxygen treatment (hbot)
5068610|NCT03570229|Late radiation tissue injury (LRTI)|late radiation tissue injury (lrti)
5068611|NCT03570229|Longitudinal|longitudinal
5068612|NCT03570229|Mixed methods|mixed methods
5068613|NCT03570229|Patient experiences|patient experiences
5068618|NCT03570203|Hyponatremia|hyponatremia
5068619|NCT03570203|Dysnatremia|dysnatremia
5068620|NCT03570203|Neurosurgery|neurosurgery
5068621|NCT03570203|Neurointensive Care|neurointensive care
5068622|NCT03570177|osteoporotic fractures|osteoporotic fractures
5068624|NCT03570177|BND|bnd
5068625|NCT03570177|automatic measurement|automatic measurement
5068626|NCT03570138|Freestyle libre|freestyle libre
5068627|NCT03570138|Type 2 diabetes|type 2 diabetes
5068628|NCT03570138|Hypoglycemia-induced cardiac arrhythmias|hypoglycemia-induced cardiac arrhythmias
5068629|NCT03570138|Flash Continuous Glucose Monitoring|flash continuous glucose monitoring
5068630|NCT03570099|opioid overdose|opioid overdose
5068631|NCT03570099|mortality|mortality
5068632|NCT03570099|naloxone|naloxone
5068633|NCT03570099|substance use disorder|substance use disorder
5068639|NCT03570008|spa bath|spa bath
5068645|NCT03569969|amniotic membrane|amniotic membrane
5068646|NCT03569969|Tympanic Membrane Perforation|tympanic membrane perforation
5068647|NCT03569956|Razor bumps|razor bumps
5068648|NCT03569956|Skin Irritation|skin irritation
5068649|NCT03569956|Shaving|shaving
5068650|NCT03569943|Robot based procedure|robot based procedure
5068651|NCT03569943|RobOtol|robotol
5068652|NCT03569943|Tympanic drain|tympanic drain
5068653|NCT03569930|Flavonoid-based supplements|flavonoid-based supplements
5068654|NCT03569930|Centella asiatica|centella asiatica
5068655|NCT03569930|Hemorrhoids|hemorrhoids
5068656|NCT03569930|defecation|defecation
5068657|NCT03569930|bleeding|bleeding
5068658|NCT03569930|pain|pain
5068659|NCT03569904|Cystic fibrosis|cystic fibrosis
5068660|NCT03569904|Pulmonary Dysbiosis|pulmonary dysbiosis
5068661|NCT03569904|pulmonary exacerbation|pulmonary exacerbation
5068662|NCT03569904|Fungal bacterial pulmonary dysbiosis|fungal bacterial pulmonary dysbiosis
5068664|NCT03569904|Microbiota|microbiota
5068665|NCT03569891|Gene therapy|gene therapy
5068666|NCT03569891|FIX|fix
5068667|NCT03569891|factor IX|factor ix
5068668|NCT03569891|Bleeding|bleeding
5068669|NCT03569891|Viral vector|viral vector
5068670|NCT03569891|Padua|padua
5068671|NCT03569891|hemophilia|hemophilia
5068672|NCT03569891|AAV (adeno-associated virus)|aav (adeno-associated virus)
5068673|NCT03569891|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
5068674|NCT03569891|serotype 5|serotype 5
5068675|NCT03569878|PTSD|ptsd
5068676|NCT03569878|Physical Injury|physical injury
5068677|NCT03569878|Patient Concerns|patient concerns
5356800|NCT01917955|MRI|mri
5068678|NCT03569878|Emergency Department Utilization|emergency department utilization
5068679|NCT03569813|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5068680|NCT03569813|Home-based monitoring|home-based monitoring
5068681|NCT03569800|Levothyrox®|levothyrox®
5068682|NCT03569800|thyroid hormones|thyroid hormones
5068683|NCT03569800|bioequivalent|bioequivalent
5068684|NCT03569761|colorectal cancer screening|colorectal cancer screening
5068685|NCT03569761|decision aids|decision aids
5068686|NCT03569761|American Indians|american indians
5068687|NCT03569748|smoking|smoking
5068688|NCT03569748|harm reduction|harm reduction
5068689|NCT03569748|electronic cigarette|electronic cigarette
5068690|NCT03569748|heated tobacco product|heated tobacco product
5068691|NCT03569735|Prospective Cohort Study|prospective cohort study
5068692|NCT03569735|Nutrition|nutrition
5068693|NCT03569735|Chronic diseases|chronic diseases
5068694|NCT03569735|Nanshan|nanshan
5068695|NCT03569735|Chinese|chinese
5068696|NCT03569722|Cognitive screen|cognitive screen
5068697|NCT03569670|cost|cost
5068698|NCT03569670|total knee replacement|total knee replacement
5068699|NCT03569670|arthroplasty|arthroplasty
5068700|NCT03569670|posterior stabilized|posterior stabilized
5068701|NCT03569670|cruciate retaining|cruciate retaining
5068702|NCT03569670|all-polyethylene|all-polyethylene
5068703|NCT03569657|Caregivers|caregivers
5068704|NCT03569631|Phosphodiesterase Type 4D|phosphodiesterase type 4d
5068705|NCT03569631|PDE4D|pde4d
5068706|NCT03569631|Cognitive Dysfunction|cognitive dysfunction
5068707|NCT03569631|Neurocognitive Disorders|neurocognitive disorders
5068708|NCT03569631|Fragile X Syndrome|fragile x syndrome
5068709|NCT03569631|Fragile X|fragile x
5068710|NCT03569631|FXS|fxs
5068711|NCT03569631|Brain Diseases|brain diseases
5068712|NCT03569631|Central Nervous System Diseases|central nervous system diseases
5068713|NCT03569631|Nervous System Diseases|nervous system diseases
5068714|NCT03569631|Mental Disorders|mental disorders
5068715|NCT03569631|Cognition Disorders|cognition disorders
5068716|NCT03569631|Enzyme Inhibitors|enzyme inhibitors
5068717|NCT03569631|Nootropic Agents|nootropic agents
5068718|NCT03569631|Developmental Disorder|developmental disorder
5068719|NCT03569631|Autism|autism
5068720|NCT03569631|Autistic Spectrum Disorder|autistic spectrum disorder
5068721|NCT03569631|Genetic Disease|genetic disease
5068722|NCT03569631|Behavioral Disorder|behavioral disorder
5068723|NCT03569631|Learning Disorder|learning disorder
5068724|NCT03569605|young adult|young adult
5068725|NCT03569605|cancer survivor|cancer survivor
5068726|NCT03569592|HIV/AIDS|hiv/aids
5068727|NCT03569592|naloxone|naloxone
5068728|NCT03569592|incarceration|incarceration
5068729|NCT03569566|Age|age
5068730|NCT03569566|Genes|genes
5068731|NCT03569566|Training volume|training volume
5068732|NCT03569566|Training intensity|training intensity
5068733|NCT03569566|Tick-bourne disease|tick-bourne disease
5068734|NCT03569566|Endurance performance|endurance performance
5068742|NCT03569553|Anthrax immune globulin|anthrax immune globulin
5068743|NCT03569553|Anti toxin|anti toxin
5068744|NCT03569553|Poluclonal antibodies|poluclonal antibodies
5068745|NCT03569540|Subarachnoid hemorrhage|subarachnoid hemorrhage
5068746|NCT03569540|Glibenclamide|glibenclamide
5068747|NCT03569527|Kiwifruit|kiwifruit
5068748|NCT03569514|Anthrax|anthrax
5068749|NCT03569514|Bacillus anthracis|bacillus anthracis
5068750|NCT03569514|Bacterial infection|bacterial infection
5068751|NCT03569514|AIGIV|aigiv
5068752|NCT03569514|Anthrax immune globulin|anthrax immune globulin
5068753|NCT03569514|Anti toxin|anti toxin
5068754|NCT03569514|Polyclonal antibodies|polyclonal antibodies
5068755|NCT03569501|gestational diabetes mellitus|gestational diabetes mellitus
5068756|NCT03569501|oat|oat
5068757|NCT03569501|docosahexaenoic acid|docosahexaenoic acid
5068758|NCT03569501|glycemic control|glycemic control
5068759|NCT03569501|intestinal flora|intestinal flora
5068760|NCT03569501|newborn|newborn
5068761|NCT03569501|leptin|leptin
5068762|NCT03569488|quality of life|quality of life
5068763|NCT03569488|sphincter-sparing surgery|sphincter-sparing surgery
5068764|NCT03569488|LARS score|lars score
5068765|NCT03569462|HIV self-testing|hiv self-testing
5068766|NCT03569462|Mobile Health|mobile health
5068774|NCT03569449|Family Resource Scale|family resource scale
5068775|NCT03569449|Federally qualified community health center|federally qualified community health center
5068777|NCT03569410|albumin|albumin
5068778|NCT03569410|end stage renal disease|end stage renal disease
5068779|NCT03569371|Hidradenitis suppurativa (HS)|hidradenitis suppurativa (hs)
5068780|NCT03569371|Janus kinase (JAK)|janus kinase (jak)
5068781|NCT03569371|Janus kinase 1 (JAK1) inhibitor|janus kinase 1 (jak1) inhibitor
5068782|NCT03569358|Randomised Controlled Study|randomised controlled study
5068783|NCT03569358|Unblinded|unblinded
5068784|NCT03569358|Electroencephalogram|electroencephalogram
5068785|NCT03569358|Feasibility|feasibility
5068786|NCT03569332|Incentive Spirometer|incentive spirometer
5068787|NCT03569319|Mediterranean Diet|mediterranean diet
5068789|NCT03569306|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
5068790|NCT03569306|peripheral pulmonary nodules|peripheral pulmonary nodules
5068791|NCT03569306|diagnostic yield|diagnostic yield
5068794|NCT03569280|KPG-121|kpg-121
5068795|NCT03569280|Enzalutamide|enzalutamide
5068796|NCT03569280|Abiraterone|abiraterone
5068797|NCT03569280|Apalutamide|apalutamide
5068798|NCT03569280|Non-metastatic and Metastatic Prostate Cancer|non-metastatic and metastatic prostate cancer
5068799|NCT03569254|infant, newborn|infant, newborn
5068800|NCT03569254|devices|devices
5068801|NCT03569254|treatment|treatment
5068802|NCT03569254|hyperbilirubinemia|hyperbilirubinemia
5068803|NCT03569241|Radiotherapy|radiotherapy
5068804|NCT03569241|metastasis-directed therapy|metastasis-directed therapy
5068805|NCT03569228|hearing loss|hearing loss
5068806|NCT03569228|hearing aids|hearing aids
5068807|NCT03569202|Lubricant Eye Drops|lubricant eye drops
5068808|NCT03569202|Moderate or Severe Dry Eye|moderate or severe dry eye
5068809|NCT03569202|Hyaluronic Acid|hyaluronic acid
5068810|NCT03569202|Trehalose|trehalose
5068811|NCT03569202|Disaccharides|disaccharides
5068812|NCT03569202|Polysaccharides|polysaccharides
5068813|NCT03569202|Fatty Acids, Omega-3|fatty acids, omega-3
5068814|NCT03569202|Tears|tears
5068815|NCT03569202|Osmolar Concentration|osmolar concentration
5068816|NCT03569202|Anterior Eye Segment|anterior eye segment
5068817|NCT03569202|Severity of Illness Index|severity of illness index
5342954|NCT01981382|genes|genes
5068818|NCT03569176|mobile health, autism, ASD, mobile therapy, digital, wearable computing, technology|mobile health, autism, asd, mobile therapy, digital, wearable computing, technology
5068819|NCT03569150|palliative care|palliative care
5068820|NCT03569150|end-of-life care|end-of-life care
5068821|NCT03569150|advance care planning|advance care planning
5068822|NCT03569150|communication|communication
5068823|NCT03569150|health literacy|health literacy
5068824|NCT03569150|serious life-limiting illness|serious life-limiting illness
5068825|NCT03569137|Gut Microbiome|gut microbiome
5068826|NCT03569137|hematologic malignancies B|hematologic malignancies b
5068827|NCT03569137|biomarkers|biomarkers
5068828|NCT03569137|targeted therapy|targeted therapy
5068829|NCT03569137|Gut microbiota|gut microbiota
5068834|NCT03569059|Virtual Environment|virtual environment
5068835|NCT03569059|Robotics|robotics
5068836|NCT03569059|Upper Extremity|upper extremity
5068838|NCT03569059|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5068840|NCT03569020|Nutrition|nutrition
5068841|NCT03569020|DASH|dash
5068842|NCT03569020|Gout|gout
5068843|NCT03569020|Hyperuricemia|hyperuricemia
5068844|NCT03569020|Potassium|potassium
5068845|NCT03569020|Uric acid|uric acid
5068846|NCT03569020|Trial|trial
5068847|NCT03569020|Blood pressure|blood pressure
5068848|NCT03569020|Glucose|glucose
5068849|NCT03569020|Lipid|lipid
5068860|NCT03568968|Parkinson's Disease|parkinson's disease
5068861|NCT03568968|NAD metabolism|nad metabolism
5068873|NCT03568942|urinary tract infections|urinary tract infections
5068874|NCT03568916|Direct oral anticoagulants|direct oral anticoagulants
5068876|NCT03568916|Atrial fibrillation|atrial fibrillation
5068877|NCT03568916|Ischemic stroke|ischemic stroke
5068878|NCT03568916|Systemic embolization|systemic embolization
5068879|NCT03568903|Parkinson Disease|parkinson disease
5068880|NCT03568903|Gait|gait
5068881|NCT03568903|Physical therapy|physical therapy
5068882|NCT03568903|functional performance|functional performance
5068883|NCT03568903|group therapy|group therapy
5068884|NCT03568890|Left Atrial Appendage Closure|left atrial appendage closure
5068885|NCT03568890|Anticoagulation therapy|anticoagulation therapy
5068886|NCT03568890|Antiplatelet therapy|antiplatelet therapy
5068887|NCT03568825|Two-dimensional randomized response surface pathway design|two-dimensional randomized response surface pathway design
5068888|NCT03568825|Osteopathic Manual Therapy|osteopathic manual therapy
5068889|NCT03568825|OMT in treatment of GERD|omt in treatment of gerd
5068890|NCT03568825|Dose-response|dose-response
5068891|NCT03568812|HIV|hiv
5068892|NCT03568812|immunological non responder|immunological non responder
5068893|NCT03568812|gut inflammation|gut inflammation
5068894|NCT03568786|end-inspiratory pause|end-inspiratory pause
5068895|NCT03568786|lung protection|lung protection
5068896|NCT03568786|intraoperative ventilation|intraoperative ventilation
5068897|NCT03568786|lung compliance|lung compliance
5068898|NCT03568760|Anomia|anomia
5068899|NCT03568734|microbiome|microbiome
5068900|NCT03568734|transplant|transplant
5068901|NCT03568734|infant|infant
5068902|NCT03568734|newborn|newborn
5068903|NCT03568721|pain|pain
5068904|NCT03568721|orthodontics|orthodontics
5068905|NCT03568708|Primary Ovarian Insufficiency|primary ovarian insufficiency
5068906|NCT03568708|Hormone Replacement Therapy|hormone replacement therapy
5068907|NCT03568708|Estrogen Deficiency|estrogen deficiency
5068908|NCT03568695|pooled analysis|pooled analysis
5068909|NCT03568695|sensitivity|sensitivity
5068910|NCT03568695|men who have sex with men|men who have sex with men
5068911|NCT03568682|food insecurity|food insecurity
5068912|NCT03568682|nutrition|nutrition
5068913|NCT03568682|treatment adherence|treatment adherence
5068914|NCT03568669|NIH Toolbox|nih toolbox
5068915|NCT03568669|Toolbox|toolbox
5068916|NCT03568669|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
5068917|NCT03568669|CCHS|cchs
5068918|NCT03568669|Autonomic Nervous System Dysregulation|autonomic nervous system dysregulation
5068919|NCT03568669|PHOX2B|phox2b
5068920|NCT03568617|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5068921|NCT03568617|Migraine Disorders|migraine disorders
5068922|NCT03568617|Prophylaxis|prophylaxis
5068923|NCT03568617|Treatment Outcome|treatment outcome
5068924|NCT03568617|Brain|brain
5068925|NCT03568604|vulvovaginal atrophy|vulvovaginal atrophy
5068926|NCT03568604|dyspareunia|dyspareunia
5068927|NCT03568604|prasterone|prasterone
5068928|NCT03568604|vulvoscopy|vulvoscopy
5068929|NCT03568591|Psychosensory Therapy|psychosensory therapy
5068930|NCT03568591|Trauma, Psychological|trauma, psychological
5068931|NCT03568591|DS14|ds14
5068932|NCT03568591|CD-RISC|cd-risc
5068933|NCT03568591|Resilience|resilience
5068934|NCT03568591|Psychosomatic Medicine|psychosomatic medicine
5068935|NCT03568591|Type D Personality|type d personality
5068945|NCT03568552|Patient Decision Aid|patient decision aid
5068946|NCT03568552|Medication Treatment for Opioid Use Disorder (MOUD)|medication treatment for opioid use disorder (moud)
5068947|NCT03568539|Advanced/metastatic solid malignancies, TMB high|advanced/metastatic solid malignancies, tmb high
5068948|NCT03568513|Curcumin|curcumin
5961141|NCT04288973|technologies|technologies
5068949|NCT03568513|IBS and microbiota|ibs and microbiota
5068950|NCT03568500|Digital Medicine System|digital medicine system
5068951|NCT03568487|scapular dyskinesis|scapular dyskinesis
5068952|NCT03568487|EMG biofeedback|emg biofeedback
5068953|NCT03568487|scapulometer|scapulometer
5068961|NCT03568448|HER2 negative breast cancer|her2 negative breast cancer
5068962|NCT03568396|Nociceptive stimulation|nociceptive stimulation
5068963|NCT03568383|Tuberculosis|tuberculosis
5068967|NCT03568357|tetralogy of Fallot|tetralogy of fallot
5068968|NCT03568344|Severe malaria|severe malaria
5068969|NCT03568344|Mortality|mortality
5068970|NCT03568344|Referral|referral
5068971|NCT03568344|Rectal artesunate|rectal artesunate
5068982|NCT03568253|Cambra application (Caries management by risk assessment)|cambra application (caries management by risk assessment)
5068985|NCT03568227|Neurophysiology|neurophysiology
5068986|NCT03568227|fMRI|fmri
5068987|NCT03568227|Resting-State|resting-state
5068988|NCT03568227|Hypnotic Sub-States|hypnotic sub-states
5068989|NCT03568214|Primary Prevention|primary prevention
5068990|NCT03568201|Diagnosis|diagnosis
5068991|NCT03568201|Peripheral artery disease|peripheral artery disease
5068992|NCT03568201|Sports|sports
5068993|NCT03568188|prostate cancer|prostate cancer
5068994|NCT03568188|HIFU focal|hifu focal
5068995|NCT03568188|adverse effect|adverse effect
5068996|NCT03568188|intermediate risk|intermediate risk
5068997|NCT03568162|ISB 830 for the treatment of moderate to severe atopic dermatitis|isb 830 for the treatment of moderate to severe atopic dermatitis
5068998|NCT03568136|neurodermatitis|neurodermatitis
5068999|NCT03568136|moderate to severe inflammatory reaction of the skin|moderate to severe inflammatory reaction of the skin
5069000|NCT03568136|Skin and Connective Tissue Diseases|skin and connective tissue diseases
5069005|NCT03568058|immunotherapy|immunotherapy
5069006|NCT03568058|personalized cancer vaccine|personalized cancer vaccine
5069007|NCT03568058|personalized immunotherapy|personalized immunotherapy
5069008|NCT03568058|pembrolizumab|pembrolizumab
5069009|NCT03568058|Keytruda|keytruda
5069010|NCT03568058|cancer|cancer
5069011|NCT03568058|neoantigen|neoantigen
5069012|NCT03568058|solid tumor|solid tumor
5069013|NCT03568058|vaccine|vaccine
5069014|NCT03568045|circadian misalignment|circadian misalignment
5069015|NCT03568045|entrainment|entrainment
5069016|NCT03568045|zeitgeber|zeitgeber
5069017|NCT03568045|bright light|bright light
5069018|NCT03568045|critical illness|critical illness
5069019|NCT03568032|intima media thickness|intima media thickness
5069020|NCT03568006|subacromial impingement|subacromial impingement
5069021|NCT03568006|pain|pain
5069022|NCT03568006|shoulder|shoulder
5069023|NCT03568006|passive mobilization|passive mobilization
5069024|NCT03567993|mhealth|mhealth
5069025|NCT03567993|Tobacco cessation|tobacco cessation
5069026|NCT03567993|Vietnam|vietnam
5069027|NCT03567993|Smoking cessation|smoking cessation
5069028|NCT03567967|nutrition|nutrition
5069029|NCT03567967|fruits and vegetables|fruits and vegetables
5069030|NCT03567967|sugar-sweetened beverages|sugar-sweetened beverages
5069031|NCT03567954|Diagnostic ultrasound|diagnostic ultrasound
5069032|NCT03567902|C-MAC|c-mac
5069338|NCT03565614|reablement|reablement
5069033|NCT03567876|Mantle cell lymphoma|mantle cell lymphoma
5069034|NCT03567876|Elderly patients|elderly patients
5069035|NCT03567876|First line|first line
5069036|NCT03567785|Therapy adherence|therapy adherence
5069037|NCT03567772|Video-game assisted rehabilitation|video-game assisted rehabilitation
5069038|NCT03567772|COPD|copd
5069039|NCT03567772|Exercise tolerance|exercise tolerance
5069040|NCT03567746|Colonic Polyp|colonic polyp
5069041|NCT03567746|Endoscopic mucosal resection|endoscopic mucosal resection
5069042|NCT03567733|Dual antiplatelet treatment|dual antiplatelet treatment
5069043|NCT03567733|Elderly patients|elderly patients
5069044|NCT03567720|Metastatic|metastatic
5069045|NCT03567720|Inoperable Locally Advanced|inoperable locally advanced
5069047|NCT03567720|pIL-12|pil-12
5069048|NCT03567720|tavokinogene telseplasmid|tavokinogene telseplasmid
5069049|NCT03567720|pembrolizumab|pembrolizumab
5069050|NCT03567707|Vaginal seeding|vaginal seeding
5069051|NCT03567707|Immune responses|immune responses
5069052|NCT03567707|Allergen sensitization|allergen sensitization
5069053|NCT03567694|asthma, allergic rhinitis, HA115, CRTH2 antagonists|asthma, allergic rhinitis, ha115, crth2 antagonists
5069054|NCT03567694|CT133|ct133
5069055|NCT03567655|medroxyprogestrone acetate|medroxyprogestrone acetate
5069056|NCT03567642|Osimertinib|osimertinib
5069057|NCT03567642|Platinum|platinum
5069058|NCT03567642|Etoposide|etoposide
5069059|NCT03567642|EGFR Mutant|egfr mutant
5069060|NCT03567642|18-211|18-211
5069061|NCT03567629|Irinotecan|irinotecan
5069062|NCT03567629|Oxaliplatin|oxaliplatin
5069063|NCT03567629|refractory|refractory
5069064|NCT03567629|mCRC|mcrc
5069065|NCT03567616|Cancer|cancer
5069066|NCT03567616|Multiple Myeloma (MM)|multiple myeloma (mm)
5081292|NCT03490916|Acetazolamide|acetazolamide
5935017|NCT02767427|Infection Control|infection control
5069067|NCT03567616|Relapsed or Refractory (R/R)|relapsed or refractory (r/r)
5069071|NCT03567590|Cluster Headache, pulsed radiofrequency|cluster headache, pulsed radiofrequency
5069072|NCT03567577|Peptide|peptide
5069073|NCT03567564|abdominal muscles|abdominal muscles
5069074|NCT03567564|spontaneous breathing trial|spontaneous breathing trial
5069075|NCT03567564|critically ill patients|critically ill patients
5069076|NCT03567551|Preeclampsia|preeclampsia
5069077|NCT03567551|Pregnancy|pregnancy
5069078|NCT03567551|Complications|complications
5069079|NCT03567551|Eclampsia|eclampsia
5069080|NCT03567551|Aquaporin|aquaporin
5069081|NCT03567551|Aquaporin 4|aquaporin 4
5069082|NCT03567538|Thoracic surgery|thoracic surgery
5069083|NCT03567538|Lung surgery|lung surgery
5069084|NCT03567538|Epidemiologic Methods|epidemiologic methods
5069085|NCT03567499|Pro-arrhythmic|pro-arrhythmic
5069086|NCT03567499|Holter ECG|holter ecg
5069088|NCT03567499|Cardiac telemetry|cardiac telemetry
5069089|NCT03567499|Benign arrhythmic|benign arrhythmic
5069090|NCT03567447|Parkinsons Disease|parkinsons disease
5069091|NCT03567447|PD|pd
5069092|NCT03567447|Patient Falls|patient falls
5069093|NCT03567447|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5069094|NCT03567421|stone disease|stone disease
5069095|NCT03567421|ureteral stent|ureteral stent
5069096|NCT03567421|stenting|stenting
5069097|NCT03567421|ureteroscopy treatment|ureteroscopy treatment
5069098|NCT03567421|stent placement|stent placement
5069099|NCT03567421|postoperative ureteral stenting|postoperative ureteral stenting
5069100|NCT03567421|Société Internationale d'Urologie|société internationale d'urologie
5069101|NCT03567421|uCARE|ucare
5069102|NCT03567369|Third molar|third molar
5069103|NCT03567369|Surgery|surgery
5069104|NCT03567369|Swelling|swelling
5069105|NCT03567343|sleep|sleep
5069106|NCT03567317|CPAP|cpap
5069107|NCT03567317|Weight Gain|weight gain
5069108|NCT03567317|obstructive sleep apnea|obstructive sleep apnea
5069109|NCT03567304|HIV|hiv
5069110|NCT03567304|Neurocognitive disorder|neurocognitive disorder
5069111|NCT03567304|Efavirenz|efavirenz
5069112|NCT03567304|Rilpivirine|rilpivirine
5069113|NCT03567291|adolescents|adolescents
5069114|NCT03567291|children|children
5069115|NCT03567278|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
5069116|NCT03567252|Appalachia|appalachia
5069117|NCT03567252|Exercise|exercise
5069118|NCT03567239|Rehabilitation Engineering|rehabilitation engineering
5069119|NCT03567239|Adaptive Devices|adaptive devices
5069120|NCT03567239|Assistive Technology|assistive technology
5069121|NCT03567213|Tetraplegia|tetraplegia
5069122|NCT03567213|ALS|als
5069123|NCT03567213|Locked-in Syndrome|locked-in syndrome
5069124|NCT03567213|Brainstem stroke|brainstem stroke
5069125|NCT03567213|Brain Computer Interface|brain computer interface
5069126|NCT03567213|Rehabilitation|rehabilitation
5069127|NCT03567213|Stroke|stroke
5069128|NCT03567213|Hopkins|hopkins
5069129|NCT03567187|Cryoneurolysis|cryoneurolysis
5069130|NCT03567187|iovera|iovera
5069131|NCT03567187|Superficial nerves treatment|superficial nerves treatment
5069132|NCT03567187|Deep Fibular Nerve|deep fibular nerve
5069133|NCT03567174|hepatitis C|hepatitis c
5069134|NCT03567148|Graft|graft
5069135|NCT03567148|Pain|pain
5069136|NCT03567148|Palate|palate
5069137|NCT03567148|Wound healing|wound healing
5069138|NCT03567135|Temozolomide|temozolomide
5069139|NCT03567135|Apatinib|apatinib
5069140|NCT03567135|Radiotherapy|radiotherapy
5069141|NCT03567122|Cranio-cervical|cranio-cervical
5069142|NCT03567122|Motor Control|motor control
5069143|NCT03567122|Deep Flexor muscles|deep flexor muscles
5069144|NCT03567096|Cardiac resynchronization therapy|cardiac resynchronization therapy
4993243|NCT04035876|HCC|hcc
5069145|NCT03567096|MultiPoint Pacing|multipoint pacing
5069146|NCT03567083|Refugees|refugees
5069147|NCT03567083|Mental Health Problems|mental health problems
5069148|NCT03567031|Pediatric Anesthesia|pediatric anesthesia
5069149|NCT03567031|Near-Infrared Spectroscopy|near-infrared spectroscopy
5069150|NCT03567031|End-Tidal CO2|end-tidal co2
5069151|NCT03567031|Cerebral Blood Flow|cerebral blood flow
5069152|NCT03566966|hepatitis C virus infection|hepatitis c virus infection
5069153|NCT03566966|non-organ-specific antibodies|non-organ-specific antibodies
5069154|NCT03566966|prognostic value|prognostic value
5069155|NCT03566966|sustained virological response|sustained virological response
5069156|NCT03566953|Dental Decay|dental decay
5069157|NCT03566927|Arteriovenous Fistula|arteriovenous fistula
5069158|NCT03566927|Vascular Fistula|vascular fistula
5069159|NCT03566927|Scoring|scoring
5069160|NCT03566927|Fistula|fistula
5069161|NCT03566927|Cardiovascular Disease|cardiovascular disease
5069162|NCT03566901|Balance, Gait, Rehabilitation, Stroke, Robotics, Postural|balance, gait, rehabilitation, stroke, robotics, postural
5069163|NCT03566875|TKA robot assisted with the Stryker's MAKO™ system|tka robot assisted with the stryker's mako™ system
5069164|NCT03566875|surgery precision|surgery precision
5069165|NCT03566849|Volleyball|volleyball
5069166|NCT03566849|Shoulder impingement|shoulder impingement
5069172|NCT03566836|Cardioversion|cardioversion
5069182|NCT03566771|Self-Monitoring|self-monitoring
5069183|NCT03566771|Behavioural Treatment|behavioural treatment
5069184|NCT03566732|questionnaire survey|questionnaire survey
5069185|NCT03566732|care for dying patients|care for dying patients
5069186|NCT03566719|Prevention|prevention
5069187|NCT03566719|Active Ageing|active ageing
5069188|NCT03566719|Fall|fall
5069189|NCT03566719|Fall Risk|fall risk
5069190|NCT03566719|Exercise Programs|exercise programs
5069191|NCT03566667|Beta-blockers|beta-blockers
5069192|NCT03566654|remote ischemic conditioning|remote ischemic conditioning
5069193|NCT03566628|Cerebral Angiography|cerebral angiography
5069194|NCT03566628|Shivering|shivering
5069195|NCT03566628|Anaesthesia|anaesthesia
5069196|NCT03566628|Warmed solutions|warmed solutions
5069197|NCT03566615|colonoscopy|colonoscopy
5069198|NCT03566615|adenoma detection rate|adenoma detection rate
5069199|NCT03566615|caps|caps
5069200|NCT03566563|Community Screening|community screening
5069201|NCT03566563|Halfway house|halfway house
5069202|NCT03566563|People who inject drugs|people who inject drugs
5069203|NCT03566563|Substance users|substance users
5069204|NCT03566563|Released prisoners|released prisoners
5069205|NCT03566511|diabetes|diabetes
5069206|NCT03566511|type 2 diabetes|type 2 diabetes
5069207|NCT03566511|insulin resistance|insulin resistance
5069208|NCT03566511|diazoxide|diazoxide
5069210|NCT03566459|Opioid Use Disorder (OUD)|opioid use disorder (oud)
5069211|NCT03566459|Medication Assisted Treatment (MAT)|medication assisted treatment (mat)
5069212|NCT03566459|Telemedicine|telemedicine
5069213|NCT03566459|Veteran|veteran
5069214|NCT03566446|CALR mutation|calr mutation
5069215|NCT03566381|Wearable sensor, sweat sensor|wearable sensor, sweat sensor
5069216|NCT03566368|Cardiac Dysfunction|cardiac dysfunction
5069217|NCT03566368|Traumatic Brain Injury|traumatic brain injury
5069218|NCT03566355|Lung Metastasis, Curative Proton Beam Therapy|lung metastasis, curative proton beam therapy
5069219|NCT03566329|craniotomy- Emergence- hypertension|craniotomy- emergence- hypertension
5069220|NCT03566303|Valve Heart Disease|valve heart disease
5069221|NCT03566303|Rivaroxaban|rivaroxaban
5069222|NCT03566303|Warfarin|warfarin
5069223|NCT03566251|Multiple Sclerosis|multiple sclerosis
5069224|NCT03566251|Balance|balance
5069225|NCT03566251|Core Stability|core stability
5069226|NCT03566251|Proprioception|proprioception
5069227|NCT03566251|Functional Mobility|functional mobility
5069228|NCT03566238|Pediatric|pediatric
5069229|NCT03566238|Cholestasis|cholestasis
5069230|NCT03566212|Anxiety|anxiety
5069231|NCT03566212|Camouflaged syringe|camouflaged syringe
5069232|NCT03566212|Conventional syringe|conventional syringe
5069233|NCT03566186|Photobiomodulation|photobiomodulation
5069434|NCT03565172|ankle|ankle
5069239|NCT03566160|Biopsy|biopsy
5069241|NCT03566160|Endoscopy|endoscopy
5069242|NCT03566160|Cryobiopsy|cryobiopsy
5069243|NCT03566160|OCT|oct
5069244|NCT03566108|Gingival phenotype|gingival phenotype
5069245|NCT03566108|Keratinized gingiva|keratinized gingiva
5069246|NCT03566108|Gingival recession|gingival recession
5069247|NCT03566108|Soft tissue recession|soft tissue recession
5069248|NCT03566095|Rural|rural
5069249|NCT03566095|Food Policy Councils|food policy councils
5069250|NCT03566095|Food Pantry|food pantry
5069251|NCT03566095|Community Coaching|community coaching
5069252|NCT03566069|Oxytocin|oxytocin
5069253|NCT03566069|Psychotherapy|psychotherapy
5069254|NCT03566069|Depression|depression
5069255|NCT03566069|Anxiety|anxiety
5069256|NCT03566069|Therapeutic working Alliance|therapeutic working alliance
5069257|NCT03566043|MPS II|mps ii
5069258|NCT03566043|gene therapy|gene therapy
5069259|NCT03566043|Hunter|hunter
5069260|NCT03566030|Hepatitis B|hepatitis b
5069261|NCT03566030|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5069262|NCT03566030|Tenofovir Alafenamide|tenofovir alafenamide
5069263|NCT03566030|Switch|switch
5069264|NCT03566017|Glomerular filtration rate|glomerular filtration rate
5069265|NCT03566017|Proteinuria|proteinuria
5069266|NCT03566017|PRX-102|prx-102
5069267|NCT03566017|pegunigalsidase alfa|pegunigalsidase alfa
5069268|NCT03566017|Fabry disease|fabry disease
5069269|NCT03565991|BRCA, ATM|brca, atm
5068768|NCT03569462|China|china
5069282|NCT03565939|Anti inflammatory|anti inflammatory
5069283|NCT03565939|Hygiene Hypothesis|hygiene hypothesis
5069284|NCT03565939|Helminths|helminths
5069285|NCT03565939|Microbiome|microbiome
5069286|NCT03565939|MAYO|mayo
5069287|NCT03565926|low back pain|low back pain
5069288|NCT03565926|manual therapy|manual therapy
5069289|NCT03565926|hypopressive therapeutic exercises|hypopressive therapeutic exercises
5069290|NCT03565848|Laparoscopy|laparoscopy
5069291|NCT03565848|Colorectal resection|colorectal resection
5069292|NCT03565848|Deep infiltrating endometriosis|deep infiltrating endometriosis
5069293|NCT03565848|Constipation|constipation
5069294|NCT03565835|abiraterone|abiraterone
5069295|NCT03565835|prostate cancer|prostate cancer
5069296|NCT03565835|androgen deprivation therapy|androgen deprivation therapy
5069297|NCT03565822|Oesophageal Atresia|oesophageal atresia
5069298|NCT03565822|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5069299|NCT03565822|Short Bowel Syndrome|short bowel syndrome
5069300|NCT03565809|Diabetes mellitus|diabetes mellitus
5069301|NCT03565809|Alzheimer Disease or related disorders|alzheimer disease or related disorders
5069308|NCT03565770|child|child
5069309|NCT03565770|coaching|coaching
5961142|NCT04288973|disability|disability
5356767|NCT01918033|Rhinitis|rhinitis
5069310|NCT03565770|telemedicine|telemedicine
5069311|NCT03565770|nurses|nurses
5069312|NCT03565770|individual follow-up|individual follow-up
5069313|NCT03565757|Stress Management|stress management
5069314|NCT03565757|Resilience|resilience
5069315|NCT03565744|obesity|obesity
5069316|NCT03565744|adolescents|adolescents
5069317|NCT03565744|school-based|school-based
5069318|NCT03565744|weight management|weight management
5069319|NCT03565744|wellness|wellness
5069320|NCT03565692|Microbiome|microbiome
5069321|NCT03565692|Microbiota|microbiota
5069322|NCT03565692|Mycobiota|mycobiota
5069323|NCT03565692|Mycobiome|mycobiome
5069324|NCT03565692|Deep-Sequencing|deep-sequencing
5069325|NCT03565692|Cystic Fibrosis|cystic fibrosis
5069326|NCT03565666|bionic pancreas|bionic pancreas
5069327|NCT03565666|closed loop|closed loop
5069328|NCT03565666|insulin|insulin
5069329|NCT03565666|continuous glucose monitor|continuous glucose monitor
5069330|NCT03565640|Buttock pain|buttock pain
5069331|NCT03565640|Thigh pain|thigh pain
5069332|NCT03565640|Sacrospinous ligament fixation|sacrospinous ligament fixation
5069333|NCT03565627|mHealth|mhealth
5069334|NCT03565627|digital health|digital health
5069335|NCT03565627|behavior change|behavior change
5069336|NCT03565627|physical activity|physical activity
5069337|NCT03565627|mobile apps|mobile apps
5069352|NCT03565562|Suicide and attempted suicide|suicide and attempted suicide
5069354|NCT03565562|Psychological Distress|psychological distress
5069355|NCT03565549|Brain|brain
5069356|NCT03565549|Trauma|trauma
5069357|NCT03565549|Medical education|medical education
5069358|NCT03565549|Emergency department|emergency department
5069359|NCT03565536|Nexavar|nexavar
5069360|NCT03565536|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5069361|NCT03565536|Neoadjuvant Treatment|neoadjuvant treatment
5069362|NCT03565510|High-protein diet|high-protein diet
5069363|NCT03565510|Energy metabolism|energy metabolism
5069364|NCT03565484|Antimicrobial Susceptibility Testing|antimicrobial susceptibility testing
5069365|NCT03565484|Rescue Therapy|rescue therapy
5069366|NCT03565471|Atrial Septal Defect|atrial septal defect
5069367|NCT03565471|Exercise Capacity|exercise capacity
5069368|NCT03565471|Pulmonary Hypertension|pulmonary hypertension
5069369|NCT03565471|Heart Rate Variability|heart rate variability
5682873|NCT00567242|language|language
5069370|NCT03565471|Congenital Heart Disease|congenital heart disease
5069382|NCT03565432|work disability|work disability
5069383|NCT03565432|quality of life|quality of life
5069384|NCT03565432|psychosocial distress|psychosocial distress
5069389|NCT03565380|Tai Chi|tai chi
5069390|NCT03565380|Fall|fall
5069391|NCT03565380|Balance|balance
5069392|NCT03565380|Post operative|post operative
5069393|NCT03565380|Elderly|elderly
5069394|NCT03565354|Patient blood management|patient blood management
5069395|NCT03565328|Mitochondrial bioenergetic dysfunction|mitochondrial bioenergetic dysfunction
5069397|NCT03565328|Hyperacetylation of mitochondrial bioenergetic enzymes|hyperacetylation of mitochondrial bioenergetic enzymes
5069398|NCT03565328|NAD+ dependent sirtuin enzymes|nad+ dependent sirtuin enzymes
5069400|NCT03565315|HIV Prevention|hiv prevention
5069401|NCT03565315|Broadly Neutralizing Monoclonal Antibodies|broadly neutralizing monoclonal antibodies
5069402|NCT03565315|First in Human Study|first in human study
5069403|NCT03565315|Anti-Drug Antibody Response to 10E8VLS or VRC07-523LS|anti-drug antibody response to 10e8vls or vrc07-523ls
5069406|NCT03565302|Muscle function|muscle function
5069407|NCT03565302|Exercise performance|exercise performance
5069408|NCT03565302|Skeletal muscle|skeletal muscle
5069409|NCT03565302|Doping|doping
5069410|NCT03565302|Anti-Doping|anti-doping
5069411|NCT03565302|Enantiomeric analysis|enantiomeric analysis
5069412|NCT03565276|Post partum hemorrhage|post partum hemorrhage
5069413|NCT03565276|Tranexamic acid|tranexamic acid
5069414|NCT03565276|TXA|txa
5069415|NCT03565276|Dose-finding|dose-finding
5069416|NCT03565276|Prevention|prevention
5069417|NCT03565250|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5069418|NCT03565250|Self concept|self concept
5069419|NCT03565250|Child|child
5069420|NCT03565250|Neuropsychology|neuropsychology
5069421|NCT03565224|Cervical vertebrae|cervical vertebrae
5069422|NCT03565224|Postoperative complications|postoperative complications
5069423|NCT03565224|Radiography|radiography
5069424|NCT03565224|Spinal fusion|spinal fusion
5069425|NCT03565224|Coating|coating
5069426|NCT03565211|Progesterone vaginal ring (PVR)|progesterone vaginal ring (pvr)
5069427|NCT03565211|Vaginal progesterone ring|vaginal progesterone ring
5069428|NCT03565211|Assisted reproductive technology (ART)|assisted reproductive technology (art)
5069429|NCT03565211|Infertility|infertility
5069430|NCT03565172|cerebral palsy|cerebral palsy
5069431|NCT03565172|stretching|stretching
5069432|NCT03565172|isokinetic dynamometer|isokinetic dynamometer
5069433|NCT03565172|ultrasound|ultrasound
5069439|NCT03565107|Methylation pattern|methylation pattern
5069440|NCT03565081|Prader-Willi Syndrome|prader-willi syndrome
5069441|NCT03565081|Resistance Training|resistance training
5069442|NCT03565081|Body Composition|body composition
5069443|NCT03565042|Arthritis, Psoriatic|arthritis, psoriatic
5961143|NCT04288960|stroke|stroke
5961144|NCT04288960|validity|validity
5069444|NCT03565042|Mechanism of Action|mechanism of action
5069445|NCT03565042|Ustekinumab|ustekinumab
5069446|NCT03565042|anti-p40|anti-p40
5069447|NCT03565042|anti-IL23/Il12 p40|anti-il23/il12 p40
5069448|NCT03565029|rectal cancer|rectal cancer
5069449|NCT03565029|neoadjuvant|neoadjuvant
5069450|NCT03565029|non operative management|non operative management
5069451|NCT03565016|Alcohol use disorders|alcohol use disorders
5069452|NCT03565016|agitation|agitation
5069453|NCT03565016|intensive care unit|intensive care unit
5069454|NCT03565016|restlessness|restlessness
5069455|NCT03565016|alcohol withdrawal syndrome|alcohol withdrawal syndrome
5069456|NCT03565016|alcohol-dependence|alcohol-dependence
5069457|NCT03565016|heavy drinking|heavy drinking
5069458|NCT03565003|JAB-3068|jab-3068
5069459|NCT03565003|SHP2|shp2
5069460|NCT03565003|PTPN11|ptpn11
5069461|NCT03565003|ESCC|escc
5069462|NCT03565003|NSCLC|nsclc
5069463|NCT03565003|HNSCC|hnscc
5069464|NCT03565003|Colorectal cancer (CRC)|colorectal cancer (crc)
5069465|NCT03565003|EGFR|egfr
5069466|NCT03564977|CAR-T|car-t
5069467|NCT03564977|minimal residual disease|minimal residual disease
5069468|NCT03564977|B cell maliganacy|b cell maliganacy
5069469|NCT03564964|SUVN-502|suvn-502
5069470|NCT03564964|Expanded Access|expanded access
5069471|NCT03564938|metastatic colorectal cancer|metastatic colorectal cancer
5069472|NCT03564938|mCRC|mcrc
5069473|NCT03564925|Atrial Fibrillation|atrial fibrillation
5069474|NCT03564925|CryoAblation|cryoablation
5069475|NCT03564925|pulmonary vein isolation|pulmonary vein isolation
5069476|NCT03564925|wide area circumferential ablation|wide area circumferential ablation
5069477|NCT03564925|contact force|contact force
5069478|NCT03564899|Breast cancer|breast cancer
5069479|NCT03564899|Survivorship|survivorship
5069480|NCT03564899|Physical activity intervention|physical activity intervention
5069481|NCT03564899|Activity trackers|activity trackers
5069482|NCT03564899|Sedentary time|sedentary time
5069484|NCT03564873|Azacitidine|azacitidine
5069485|NCT03564873|Previously Untreated|previously untreated
5069486|NCT03564873|Phase I/II|phase i/ii
5069487|NCT03564873|Dose Escalation|dose escalation
5069488|NCT03564873|Maximum Tolerated Dose|maximum tolerated dose
5069489|NCT03564847|Learning Through Play Plus|learning through play plus
5069490|NCT03564847|Cognitive Behavior Therapy|cognitive behavior therapy
5069491|NCT03564847|Parenting Intervention|parenting intervention
5069492|NCT03564847|Low and middle-income country|low and middle-income country
5069493|NCT03564834|Elderly patients|elderly patients
5069494|NCT03564834|Open gastrectomy|open gastrectomy
5069495|NCT03564834|Laparoscopic gastrectomy|laparoscopic gastrectomy
5069496|NCT03564821|myeloid neoplasms|myeloid neoplasms
5069497|NCT03564808|Contour defects, Pigmentation, Enriched fat grafting|contour defects, pigmentation, enriched fat grafting
5069499|NCT03564795|Keratin|keratin
5069500|NCT03564795|Hydrogel|hydrogel
5069501|NCT03564795|Burn Dressing|burn dressing
5069502|NCT03564782|PVSRIPO|pvsripo
5069503|NCT03564782|Invasive Breast Cancer|invasive breast cancer
5069504|NCT03564769|screening|screening
5069505|NCT03564756|Anemia|anemia
5069506|NCT03564756|Pregnancy|pregnancy
5069507|NCT03564756|Iron|iron
5069508|NCT03564756|Vitamin C|vitamin c
5069509|NCT03564743|Spondyloarthritis|spondyloarthritis
5069510|NCT03564743|ASAS criteria|asas criteria
5069511|NCT03564743|Diagnosis criteria|diagnosis criteria
5069512|NCT03564743|Classification criteria|classification criteria
5069513|NCT03564730|Bilateral, staged, simultaneous|bilateral, staged, simultaneous
5069519|NCT03564613|Dolutegravir|dolutegravir
5069520|NCT03564613|Europe|europe
5069521|NCT03564613|NEAT ID|neat id
5069522|NCT03564613|pregnancy|pregnancy
5069523|NCT03564613|Safety|safety
5069524|NCT03564613|Antiretroviral|antiretroviral
5069525|NCT03564600|low back pain|low back pain
5069526|NCT03564587|Cancer Survivors|cancer survivors
5069527|NCT03564587|Adolescent|adolescent
5069528|NCT03564587|Achieving Wellness After Kancer in Early Life|achieving wellness after kancer in early life
5069529|NCT03564587|AWAKE|awake
5069530|NCT03564587|Health-Promoting Behaviors|health-promoting behaviors
5069531|NCT03564561|glycogen storage disease type II, adult|glycogen storage disease type ii, adult
5069532|NCT03564561|Pompe disease|pompe disease
5069533|NCT03564561|clinical evolution|clinical evolution
5069534|NCT03564561|molecular evolution|molecular evolution
5069535|NCT03564561|follow-up|follow-up
5069536|NCT03564561|c.-32-13T>G mutation|c.-32-13t>g mutation
5069537|NCT03564561|antisense oligonucleotide treatment|antisense oligonucleotide treatment
5069538|NCT03564561|in vitro|in vitro
5069539|NCT03564535|Adult|adult
5069540|NCT03564535|Inguinal hernia|inguinal hernia
5069541|NCT03564535|Inflammatory|inflammatory
5069542|NCT03564535|Surgical Mesh|surgical mesh
5069543|NCT03564535|Laparoscopy/Methods|laparoscopy/methods
5069544|NCT03564535|Postoperative pain|postoperative pain
5069545|NCT03564535|Recurrence|recurrence
5069546|NCT03564535|Randomized Controlled Trials|randomized controlled trials
5069547|NCT03564535|Double-Blind Method|double-blind method
5069548|NCT03564535|Pain|pain
5069549|NCT03564535|Chronic pain|chronic pain
5069550|NCT03564535|Seroma|seroma
5342886|NCT01981655|Failure|failure
5069551|NCT03564535|Total extraperitoneal repair|total extraperitoneal repair
5069552|NCT03564535|Tacker|tacker
5069553|NCT03564535|Mesh fixation|mesh fixation
5069554|NCT03564535|Self gripping|self gripping
5069555|NCT03564509|Human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
5069556|NCT03564509|Recombinant Human Chorionic Gonadotropin (rhCG)|recombinant human chorionic gonadotropin (rhcg)
5069557|NCT03564509|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
5069558|NCT03564509|Assisted Reproductive Technologies (ART)|assisted reproductive technologies (art)
5069559|NCT03564496|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
5069560|NCT03564470|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5069561|NCT03564470|Ph-like|ph-like
5069562|NCT03564470|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5069563|NCT03564470|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5069564|NCT03564444|Bivalent.|bivalent.
5069565|NCT03564444|Influenza.|influenza.
5069566|NCT03564444|FluMist Quadrivalent.|flumist quadrivalent.
5069567|NCT03564444|Vaccine Prevention in Healthy Adults.|vaccine prevention in healthy adults.
5069568|NCT03564353|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5069569|NCT03564353|memory|memory
5069570|NCT03564314|Acute kidney injury|acute kidney injury
5069571|NCT03564314|Major surgery|major surgery
5069572|NCT03564314|Clinical decision support|clinical decision support
5069573|NCT03564301|Peri-implantitis|peri-implantitis
5069574|NCT03564301|antibiotics|antibiotics
5069575|NCT03564301|Metronidazole|metronidazole
5069576|NCT03564301|non- surgical treatment|non- surgical treatment
5069578|NCT03564275|Proton Therapy|proton therapy
5069579|NCT03564223|Adolescent|adolescent
5069580|NCT03564223|Parental concerns|parental concerns
5069581|NCT03564223|Child Health|child health
5069582|NCT03564223|Paediatrician Concerns|paediatrician concerns
5069583|NCT03564210|screen time|screen time
5069584|NCT03564197|EGFR WT|egfr wt
5069585|NCT03564197|negative EML4-ALK fusion|negative eml4-alk fusion
5069586|NCT03564197|eligible for first line chemo-immunotherapy or 2nd line and beyond PD-(L)1 immunotherapy monotherapy|eligible for first line chemo-immunotherapy or 2nd line and beyond pd-(l)1 immunotherapy monotherapy
5069587|NCT03564184|Parent-infant bonding|parent-infant bonding
5069588|NCT03564184|Music therapy|music therapy
5069589|NCT03564132|Yigansan|yigansan
5069590|NCT03564132|YGTSS|ygtss
5069591|NCT03564119|papulopustular rosacea|papulopustular rosacea
5069592|NCT03564106|chronic sacroilitis,radiofrequancy,intraarticular steroids injection|chronic sacroilitis,radiofrequancy,intraarticular steroids injection
5069593|NCT03564093|pediatrics|pediatrics
5069594|NCT03564093|sedation|sedation
5069600|NCT03564093|pediatric|pediatric
5069601|NCT03564093|pediatric sedation|pediatric sedation
5069602|NCT03564080|exercise rehabilitation|exercise rehabilitation
5069603|NCT03564080|supervised exercise programmes|supervised exercise programmes
5069608|NCT03564054|non small cell lung cancer|non small cell lung cancer
5069609|NCT03564054|photodynamic therapy|photodynamic therapy
5069610|NCT03564054|argon plasma coagulation|argon plasma coagulation
5069611|NCT03564054|endobronchial obstruction|endobronchial obstruction
5069612|NCT03564041|depression|depression
5069613|NCT03564041|late-life|late-life
5069614|NCT03564041|executive functioning|executive functioning
5069615|NCT03564041|sahaj samadhi|sahaj samadhi
5069616|NCT03564041|meditation|meditation
5069617|NCT03564041|treatment-resistant|treatment-resistant
5069618|NCT03564028|COPD|copd
5069619|NCT03564028|daily activity|daily activity
5069620|NCT03564028|stair climbing|stair climbing
5069621|NCT03564028|rehabilitation|rehabilitation
5069622|NCT03563989|Chronic total occlusion|chronic total occlusion
5069623|NCT03563989|Self-expandable stent|self-expandable stent
5069624|NCT03563989|Percutaneous coronary intervention|percutaneous coronary intervention
5069625|NCT03563989|Coronary artery disease|coronary artery disease
5069626|NCT03563976|Early Stage Lung Cancer|early stage lung cancer
5069627|NCT03563872|hypertension|hypertension
5069628|NCT03563872|team-based|team-based
5069629|NCT03563872|guidelines|guidelines
5070325|NCT03559569|Infection|infection
5069630|NCT03563872|implementation|implementation
5069631|NCT03563833|Minimal Flow Anesthesia|minimal flow anesthesia
5069632|NCT03563833|Thiol/disulfide balance|thiol/disulfide balance
5069633|NCT03563833|Tissue oxygen saturation|tissue oxygen saturation
5069634|NCT03563833|hypotensive anesthesia|hypotensive anesthesia
5069635|NCT03563820|Positive Psychology|positive psychology
5069636|NCT03563820|Resilience|resilience
5069637|NCT03563820|Well-Being|well-being
5069638|NCT03563781|ovarian cancer|ovarian cancer
5069639|NCT03563781|laparoscopy|laparoscopy
5069640|NCT03563781|sentinel node|sentinel node
5069641|NCT03563781|lymphadenectomy|lymphadenectomy
5069642|NCT03563768|coronary artery disease|coronary artery disease
5069643|NCT03563768|aortic atherosclerotic disease|aortic atherosclerotic disease
5069644|NCT03563768|one-stop|one-stop
5069645|NCT03563768|endovascular aortic repair|endovascular aortic repair
5069646|NCT03563768|percutaneous coronary intervention|percutaneous coronary intervention
5069647|NCT03563742|Treatment-naive|treatment-naive
5961145|NCT04288960|gait|gait
5961146|NCT04288947|Disrespect and Abuse|disrespect and abuse
5069648|NCT03563742|rilpivirine|rilpivirine
5069649|NCT03563742|India|india
5069650|NCT03563729|Immune therapy|immune therapy
5069651|NCT03563729|checkpoint inhibitor|checkpoint inhibitor
5069652|NCT03563729|pembrolizumab|pembrolizumab
5069653|NCT03563729|ipilimumab|ipilimumab
5069654|NCT03563729|nivolumab|nivolumab
5069655|NCT03563729|steroid|steroid
5069656|NCT03563729|brain metastasis|brain metastasis
5069657|NCT03563703|Catheterization, Peripheral|catheterization, peripheral
5069658|NCT03563703|Ultrasound|ultrasound
5935589|NCT02622035|Child Feeding|child feeding
5069659|NCT03563703|Near Infrared Light|near infrared light
5069660|NCT03563690|KOA|koa
5069661|NCT03563690|Acupuncture treatment|acupuncture treatment
5069662|NCT03563690|Multi-center RCT|multi-center rct
5069663|NCT03563677|psychosomatic|psychosomatic
5069664|NCT03563677|unclear diagnosis|unclear diagnosis
5935695|NCT02598752|15-274|15-274
5069665|NCT03563625|Local anesthetic|local anesthetic
5069666|NCT03563625|Hernioraphy|hernioraphy
5069667|NCT03563625|Wound healing|wound healing
5069668|NCT03563612|one lung ventilation|one lung ventilation
5069669|NCT03563612|continuous positive airway pressure|continuous positive airway pressure
5069670|NCT03563612|differential lung ventilation|differential lung ventilation
5069671|NCT03563586|oral antibiotic|oral antibiotic
5736308|NCT00371878|Lung|lung
5069675|NCT03563573|Conditions in which lidocaine is ineffective|conditions in which lidocaine is ineffective
5069679|NCT03563547|LDL-Cholesterol|ldl-cholesterol
5069680|NCT03563547|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5069681|NCT03563547|Paediatrics|paediatrics
5069682|NCT03563547|Dietary Treatment|dietary treatment
5069683|NCT03563534|Silver diamine fluoride, dental caries children|silver diamine fluoride, dental caries children
5069684|NCT03563521|severe asthma|severe asthma
5069685|NCT03563521|inflammatory phenotypes|inflammatory phenotypes
5069686|NCT03563521|serum cytokines|serum cytokines
5069687|NCT03563521|eosinophilia|eosinophilia
5069688|NCT03563521|atopy|atopy
5069689|NCT03563521|chronic rhinosinusitis with nasal polyposis|chronic rhinosinusitis with nasal polyposis
5069690|NCT03563508|cone beam computed tomography|cone beam computed tomography
5069691|NCT03563508|maxillary premolars|maxillary premolars
5069692|NCT03563508|root canal anatomy|root canal anatomy
5069693|NCT03563508|root canal morphology|root canal morphology
5069695|NCT03563495|tissue engineering.|tissue engineering.
5069701|NCT03563456|interval training|interval training
5069702|NCT03563456|resistance training|resistance training
5069703|NCT03563456|oxydative stress|oxydative stress
5069704|NCT03563456|physical fitness|physical fitness
5069705|NCT03563443|Bladder Cancer|bladder cancer
5069706|NCT03563443|Genomic imprinting|genomic imprinting
5069707|NCT03563443|Urine biomarker|urine biomarker
5069708|NCT03563443|Diagnosis|diagnosis
5069709|NCT03563443|Surveillance|surveillance
5069710|NCT03563430|foam roller|foam roller
5069711|NCT03563430|electrical stimulation|electrical stimulation
5069712|NCT03563430|low intensity aerobic training|low intensity aerobic training
5069713|NCT03563430|lactate removal|lactate removal
5069714|NCT03563326|Epithelial Cell Adhesion Molecule|epithelial cell adhesion molecule
5069715|NCT03563326|Chimeric Antigen Receptor-modified T cell|chimeric antigen receptor-modified t cell
5069716|NCT03563326|Gastric carcinoma|gastric carcinoma
5069717|NCT03563326|Peritoneal metastasis|peritoneal metastasis
5069718|NCT03563313|Artificial Pancreas (AP)|artificial pancreas (ap)
5069719|NCT03563313|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5069720|NCT03563313|Insulin Pump|insulin pump
5069721|NCT03563313|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5069722|NCT03563313|Closed Loop Control (CLC)|closed loop control (clc)
5069723|NCT03563313|Sensor-Augmented Pump (SAP)|sensor-augmented pump (sap)
5069726|NCT03563261|Collagen supplementation|collagen supplementation
5069727|NCT03563261|Locomotor behaviour|locomotor behaviour
5069728|NCT03563248|Pancreatic Cancer|pancreatic cancer
5069729|NCT03563235|Osteoporosis|osteoporosis
5069730|NCT03563235|kidney deficiency and blood stasis syndrome|kidney deficiency and blood stasis syndrome
5069731|NCT03563235|Xuling Jiangu Granules|xuling jiangu granules
5069732|NCT03563222|Parenteral nutrition|parenteral nutrition
5069733|NCT03563222|Pediatrics|pediatrics
5069734|NCT03563222|Malnutrition|malnutrition
5069735|NCT03563222|Nutritional needs|nutritional needs
5069736|NCT03563209|Elbow spasticity|elbow spasticity
5069738|NCT03563183|immunogenicity|immunogenicity
5069739|NCT03563183|Herpes Zoster|herpes zoster
5069740|NCT03563183|efficacy|efficacy
5069741|NCT03563183|safety|safety
5069742|NCT03563183|frailty|frailty
5069743|NCT03563183|Shingles vaccine|shingles vaccine
5069745|NCT03563157|Colorectal Cancer|colorectal cancer
5069746|NCT03563157|Metastatic Colorectal Cancer|metastatic colorectal cancer
5069747|NCT03563131|Osteoarthritis|osteoarthritis
5069748|NCT03563131|Knee|knee
5069749|NCT03563131|Arthroplasties|arthroplasties
5069750|NCT03563118|Prolidase Activity|prolidase activity
5069751|NCT03563118|Obstructive Sleep-Apnea Syndrome|obstructive sleep-apnea syndrome
5069752|NCT03563105|tissue oxygen saturation|tissue oxygen saturation
5069753|NCT03563092|Complete Inguinal Hernia|complete inguinal hernia
5069754|NCT03563092|Inguinoscrotal Hernia|inguinoscrotal hernia
5961147|NCT04288947|Childbirth|childbirth
5342887|NCT01981655|Perfusion|perfusion
5939223|NCT01301183|Anorexia Nervosa|anorexia nervosa
5069755|NCT03563092|Laparoscopic hernia repair|laparoscopic hernia repair
5069756|NCT03563079|Handling, Musculoskeletal|handling, musculoskeletal
5069757|NCT03563079|Tissue, Subcutaneous|tissue, subcutaneous
5069758|NCT03563079|Myofascial Release|myofascial release
5069759|NCT03563079|Instrument-Mobilized Soft Tissue Mobilization|instrument-mobilized soft tissue mobilization
5069760|NCT03563066|Skin Lesions|skin lesions
5069761|NCT03563066|Benralizumab|benralizumab
5069762|NCT03563066|Eosinophils|eosinophils
5069763|NCT03563066|Intra-dermal challenge|intra-dermal challenge
5069764|NCT03563066|Anti-inflammatory agents|anti-inflammatory agents
5069765|NCT03563066|Physiological Effects of Drugs|physiological effects of drugs
5069770|NCT03563014|Radium-223|radium-223
5069771|NCT03563014|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5069772|NCT03563014|CRPC|crpc
5069773|NCT03563014|Phase IV|phase iv
5069774|NCT03563001|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5069775|NCT03563001|asthma-chronic obstructive pulmonary disease overlap|asthma-chronic obstructive pulmonary disease overlap
5069776|NCT03563001|small airway|small airway
5069777|NCT03563001|quality of life|quality of life
5069778|NCT03562962|Functional Analytic Psychotherapy|functional analytic psychotherapy
5069779|NCT03562962|Process-Outcome Psychotherapies|process-outcome psychotherapies
5069780|NCT03562962|Mechanism of change|mechanism of change
5069781|NCT03562962|Interpersonal Functioning|interpersonal functioning
5069782|NCT03562962|Psychological Distress|psychological distress
5069783|NCT03562962|Contingencies of reinforcement|contingencies of reinforcement
5069784|NCT03562936|LSS,DS|lss,ds
5069785|NCT03562897|Dietary supplements|dietary supplements
5069786|NCT03562897|Ocoxin-Viusid|ocoxin-viusid
5069787|NCT03562897|Nutritional supplement|nutritional supplement
5069788|NCT03562897|Ovarian Cancer|ovarian cancer
5069799|NCT03562871|Keytruda|keytruda
5069800|NCT03562832|PARP inhibitor|parp inhibitor
5069801|NCT03562832|Drug Response Prediction (DRP)|drug response prediction (drp)
5069802|NCT03562832|Tankyrase 1/2 inhibitor|tankyrase 1/2 inhibitor
5069803|NCT03562832|mRNA biomarker|mrna biomarker
5069804|NCT03562819|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5069805|NCT03562793|pain|pain
5069809|NCT03562767|Family Practice|family practice
5069810|NCT03562767|Diabetes|diabetes
5069811|NCT03562728|Transplant|transplant
5069812|NCT03562728|ECMO|ecmo
5069813|NCT03562728|Sarcopenia|sarcopenia
5069814|NCT03562728|Deconditioning|deconditioning
5069815|NCT03562728|Physical therapy|physical therapy
5069816|NCT03562715|microRNAs|micrornas
5069817|NCT03562715|exosomes|exosomes
5069818|NCT03562715|preeclampsia|preeclampsia
5070532|NCT03558503|Local|local
5069821|NCT03562702|diarrhea|diarrhea
5069823|NCT03562689|Encephalopathy|encephalopathy
5069824|NCT03562689|Delirium|delirium
5069826|NCT03562689|EEG|eeg
5069827|NCT03562689|MRI|mri
5069828|NCT03562689|Cognitive tests|cognitive tests
5069829|NCT03562663|robotics|robotics
5069830|NCT03562663|transcranial direct current stimulation|transcranial direct current stimulation
5069831|NCT03562663|neurorehabilitation|neurorehabilitation
5069832|NCT03562663|transcranial magnetic stimulation|transcranial magnetic stimulation
5069833|NCT03562637|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5069834|NCT03562637|Adjuvant chemotherapy|adjuvant chemotherapy
5069835|NCT03562637|TNBC|tnbc
5069836|NCT03562611|postoperative pain|postoperative pain
5069837|NCT03562611|general anesthesia|general anesthesia
5069838|NCT03562611|postoperative discomfort|postoperative discomfort
5069839|NCT03562585|Chronic hepatitis B|chronic hepatitis b
5069840|NCT03562585|Alanine Aminotransferase|alanine aminotransferase
5069841|NCT03562585|Aspartate Aminotransferase|aspartate aminotransferase
5069842|NCT03562559|Total Knee Arthroplasty|total knee arthroplasty
5069843|NCT03562559|Adductor Canal Block|adductor canal block
5069844|NCT03562546|CVI|cvi
5069845|NCT03562546|Calf Muscle Pump Function|calf muscle pump function
5069846|NCT03562546|Structured Exercise|structured exercise
5069847|NCT03562546|Varicose Veins|varicose veins
5069848|NCT03562520|Aerobic fitness|aerobic fitness
5069849|NCT03562520|Aerobic exercise|aerobic exercise
5069850|NCT03562520|Behavior change counseling|behavior change counseling
5069851|NCT03562507|ESK981|esk981
5069852|NCT03562494|PD, Parkinson's disease|pd, parkinson's disease
5069853|NCT03562494|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
5069854|NCT03562494|AADC|aadc
5069855|NCT03562494|AAV2-AADC|aav2-aadc
5069856|NCT03562494|AAV2|aav2
5069857|NCT03562494|VY-AADC|vy-aadc
5069858|NCT03562494|AAV2-hAADC|aav2-haadc
5069859|NCT03562481|Healthy pediatric volunteers|healthy pediatric volunteers
5069860|NCT03562468|Nicotinamide riboside|nicotinamide riboside
5069861|NCT03562468|NAD|nad
5069862|NCT03562468|TRU NIAGEN|tru niagen
5069863|NCT03562455|Virtual Reality|virtual reality
5069864|NCT03562455|Wheelchairs|wheelchairs
5069865|NCT03562403|deep brain stimulation|deep brain stimulation
5961148|NCT04288947|Maternity Care|maternity care
5961149|NCT04288934|Spinal cord injuries|spinal cord injuries
5939225|NCT01301183|Teenagers|teenagers
4978450|NCT04126681|CML|cml
5069866|NCT03562364|anti-gravity|anti-gravity
5069867|NCT03562338|chronic nonspecific neck pain|chronic nonspecific neck pain
5069868|NCT03562338|disability|disability
5069869|NCT03562338|predictive model|predictive model
5069870|NCT03562338|rehabilitation|rehabilitation
5069871|NCT03562338|pain intensity|pain intensity
5069872|NCT03562312|MPA|mpa
5069873|NCT03562312|Music Performance Anxiety|music performance anxiety
5069874|NCT03562312|HIIT|hiit
5069875|NCT03562312|Exercise|exercise
5069876|NCT03562312|Cortisol|cortisol
5069877|NCT03562312|HRV|hrv
5069878|NCT03562312|Heart Rate|heart rate
5069879|NCT03562286|Open spina bifida|open spina bifida
5069880|NCT03562286|spinal dysraphism|spinal dysraphism
5069881|NCT03562273|Breast Nomogram|breast nomogram
5069882|NCT03562273|Breast Cancer Quality of Life|breast cancer quality of life
5069883|NCT03562273|GammaPod Registry|gammapod registry
5069884|NCT03562234|Colorectal Cancer|colorectal cancer
5069914|NCT03562052|Occupational carcinogens|occupational carcinogens
5069915|NCT03562052|Tobacco smoking|tobacco smoking
5069916|NCT03562052|Screening|screening
5069917|NCT03562052|Chest CT Scan|chest ct scan
5069918|NCT03562052|Asbestos|asbestos
5069919|NCT03562000|ICU|icu
5069920|NCT03562000|Cough|cough
5069921|NCT03562000|Randomised study|randomised study
5069922|NCT03562000|Cough assistance|cough assistance
5069923|NCT03562000|Medical device|medical device
5069924|NCT03562000|Physiotherapy|physiotherapy
5069925|NCT03561987|ADIPOSE TISSUE, CARDIOVASCULAR, OBESE PATIENTS|adipose tissue, cardiovascular, obese patients
5069926|NCT03561948|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5069927|NCT03561948|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5069928|NCT03561948|Colonic Diseases|colonic diseases
5069929|NCT03561922|Retinal Degeneration|retinal degeneration
5069930|NCT03561922|Artificial Vision|artificial vision
5069931|NCT03561922|Retinal Prosthesis|retinal prosthesis
5069932|NCT03561922|Subretinal Implant|subretinal implant
5069933|NCT03561922|Inherited Retinal Dystrophy|inherited retinal dystrophy
5069934|NCT03561922|Vision Restoration|vision restoration
5069935|NCT03561922|Bionic Eye|bionic eye
5069936|NCT03561922|Bionic Vision|bionic vision
5069937|NCT03561922|Retinitis Pigmentosa|retinitis pigmentosa
5069938|NCT03561922|Artificial Retina|artificial retina
5069939|NCT03561922|Retina Implant|retina implant
5069940|NCT03561922|Cone-Rod Dystrophy|cone-rod dystrophy
5069941|NCT03561922|Choroideremia|choroideremia
5069942|NCT03561922|Retinopathia Pigmentosa|retinopathia pigmentosa
5069943|NCT03561896|Radation therapy|radation therapy
5069944|NCT03561896|sterotactic radiosurgery|sterotactic radiosurgery
5069945|NCT03561896|quality of life|quality of life
5069946|NCT03561896|solid cancer|solid cancer
5069947|NCT03561896|palliation|palliation
5069948|NCT03561896|neurologic functionning|neurologic functionning
5069949|NCT03561883|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5069950|NCT03561883|GERD|gerd
5069951|NCT03561883|Proton Pump Inhibitor|proton pump inhibitor
5069952|NCT03561883|IW-3718|iw-3718
5069953|NCT03561870|IDH-mutant|idh-mutant
5069954|NCT03561870|recurrent|recurrent
5069955|NCT03561870|glioma|glioma
5069956|NCT03561805|TAVI|tavi
5069957|NCT03561805|ECG monitoring|ecg monitoring
5069958|NCT03561779|Osteoarthritis|osteoarthritis
5069959|NCT03561753|Tuberculosis|tuberculosis
5069960|NCT03561740|breast cancer|breast cancer
5069961|NCT03561740|HER2-positive|her2-positive
5069962|NCT03561740|metronomic chemotherapy|metronomic chemotherapy
5069963|NCT03561740|capecitabine|capecitabine
5069964|NCT03561740|high-risk|high-risk
5069965|NCT03561727|incisional hernia|incisional hernia
5069966|NCT03561727|malignancy|malignancy
5069967|NCT03561727|transverse incision|transverse incision
5069968|NCT03561727|abdominal closure|abdominal closure
5069969|NCT03561727|surgical technique|surgical technique
5069970|NCT03561727|insicion|insicion
5069971|NCT03561727|surgery|surgery
5069972|NCT03561688|Biomechanics|biomechanics
5069973|NCT03561688|Pain|pain
5069974|NCT03561688|Gait|gait
5069975|NCT03561688|Foot orthotics|foot orthotics
5069976|NCT03561688|Rheumatoid Arthritis|rheumatoid arthritis
5069977|NCT03561675|healthy participants older than 40 years|healthy participants older than 40 years
5069978|NCT03561675|altitude|altitude
5069979|NCT03561675|prevention|prevention
5069980|NCT03561675|acetazolamide|acetazolamide
5069981|NCT03561662|soya|soya
5069982|NCT03561662|menopause|menopause
5069983|NCT03561662|cognitive function|cognitive function
5069984|NCT03561662|isoflavones|isoflavones
5069985|NCT03561649|TNF inhibitor|tnf inhibitor
5069986|NCT03561649|Adalimumab|adalimumab
5069987|NCT03561649|Spondyloarthritis|spondyloarthritis
5961150|NCT04288934|Mesenchymal Stem Cells|mesenchymal stem cells
5069988|NCT03561649|Biomarkers analysis|biomarkers analysis
5069989|NCT03561649|Personalized medicine|personalized medicine
5069990|NCT03561636|Health literacy|health literacy
5069991|NCT03561610|cancer cachexia|cancer cachexia
5961151|NCT04288934|Allogenic|allogenic
5069992|NCT03561610|malnutrition|malnutrition
5069993|NCT03561610|nutritional supplement|nutritional supplement
5069994|NCT03561610|sip feed|sip feed
5069995|NCT03561610|nutritional risk|nutritional risk
5069996|NCT03561597|stepped care|stepped care
5069997|NCT03561597|mobile application|mobile application
5069998|NCT03561584|Sclerosing|sclerosing
5069999|NCT03561584|Cholangitis|cholangitis
5070000|NCT03561571|chylomicrons|chylomicrons
5070001|NCT03561571|Very Low Density Lipoprotein|very low density lipoprotein
5070002|NCT03561571|saturated fat|saturated fat
5070003|NCT03561571|platelet function|platelet function
5070004|NCT03561571|type 2 diabetes|type 2 diabetes
5070005|NCT03561571|post prandial phase|post prandial phase
5070006|NCT03561558|Bioequivalence|bioequivalence
5070007|NCT03561441|Endoscopic retrograde pancreatocholangiography|endoscopic retrograde pancreatocholangiography
5070008|NCT03561441|Pancreatitis|pancreatitis
5070009|NCT03561441|Lactate ringer's solution|lactate ringer's solution
5070010|NCT03561441|Tailored therapy|tailored therapy
5070011|NCT03561428|lichen sclerosus|lichen sclerosus
5070012|NCT03561415|Lung transplant, prophylaxis, pre-emptive|lung transplant, prophylaxis, pre-emptive
5070014|NCT03561402|teriflunomide|teriflunomide
5070015|NCT03561402|activity|activity
5070016|NCT03561376|Scar|scar
5070017|NCT03561363|insulin sensitivity|insulin sensitivity
5070018|NCT03561363|high-fat diet|high-fat diet
5070019|NCT03561350|Microsatellite Instability|microsatellite instability
5070020|NCT03561350|Circulating Tumor DNA|circulating tumor dna
5070021|NCT03561350|Colorectal Neoplasms|colorectal neoplasms
5070022|NCT03561298|Pharmacokinetics|pharmacokinetics
5070038|NCT03561168|Anesthetic Neurotoxicity|anesthetic neurotoxicity
5070039|NCT03561168|MRI Diagnostic Yield|mri diagnostic yield
5070040|NCT03561155|Upper Extremity|upper extremity
5070041|NCT03561155|Recovery|recovery
5070042|NCT03561116|Metabolic Syndrome|metabolic syndrome
5070043|NCT03561116|Xanthohumol|xanthohumol
5070044|NCT03561116|Glucose metabolism|glucose metabolism
5070045|NCT03561116|DNA damage|dna damage
5070046|NCT03561090|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5070047|NCT03561090|GERD|gerd
5070048|NCT03561090|Proton Pump Inhibitors|proton pump inhibitors
5070049|NCT03561090|IW-3718|iw-3718
5070050|NCT03561077|Pain|pain
5070051|NCT03561077|Pediatrics|pediatrics
5070056|NCT03561064|CBT|cbt
5070057|NCT03561064|CBT-I|cbt-i
5070058|NCT03561064|cognitive behavioral therapy|cognitive behavioral therapy
5070059|NCT03561051|T-MACS|t-macs
5070060|NCT03561051|Pre-hospital environment|pre-hospital environment
5070061|NCT03561025|Diagnostic Imaging|diagnostic imaging
5070062|NCT03561025|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
5070063|NCT03561025|Magnetic Resonance Imaging|magnetic resonance imaging
5070064|NCT03561012|health|health
5070065|NCT03561012|nutrition|nutrition
5070066|NCT03561012|pregnancy|pregnancy
5070067|NCT03561012|infant|infant
5070068|NCT03561012|child|child
5070069|NCT03560986|Neridronic Acid|neridronic acid
5070070|NCT03560986|Neridronate|neridronate
5070071|NCT03560986|CRPS|crps
5070072|NCT03560986|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
5070080|NCT03560947|chronic nonspecific neck pain|chronic nonspecific neck pain
5070081|NCT03560947|exercise|exercise
5070082|NCT03560947|manual therapy|manual therapy
5070083|NCT03560921|biomarkers|biomarkers
5070084|NCT03560908|leukemia,myeloid, acute|leukemia,myeloid, acute
5070085|NCT03560908|relapse|relapse
5070086|NCT03560908|mutation|mutation
5070087|NCT03560908|KIT|kit
5070095|NCT03560817|Cost-utility analysis|cost-utility analysis
5070096|NCT03560817|Time-trade-off method|time-trade-off method
5070097|NCT03560817|Discrete choice experiment method|discrete choice experiment method
5070099|NCT03560804|chlorthalidone|chlorthalidone
5070100|NCT03560804|hemodynamics|hemodynamics
5070101|NCT03560778|Urinary Bladder, Overactive|urinary bladder, overactive
5070102|NCT03560778|Urinary Incontinence, Urge|urinary incontinence, urge
5070103|NCT03560778|Urodynamics|urodynamics
5070104|NCT03560765|Rehabilitation|rehabilitation
5070105|NCT03560765|Assistive technology|assistive technology
5070106|NCT03560739|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5070107|NCT03560739|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5070108|NCT03560739|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5070109|NCT03560739|Bioequivalence|bioequivalence
5070110|NCT03560739|Pharmacokinetics|pharmacokinetics
5070111|NCT03560739|Neurofilament light chain|neurofilament light chain
5070112|NCT03560739|Pre-filled Syringe|pre-filled syringe
5070113|NCT03560739|Auto-injector|auto-injector
5070114|NCT03560687|Anemia|anemia
5070115|NCT03560687|Heart Surgery|heart surgery
5070116|NCT03560687|Iron Supplementation|iron supplementation
5070117|NCT03560674|Dental trauma|dental trauma
5070118|NCT03560674|emergency management|emergency management
5070119|NCT03560674|traumatic injures.|traumatic injures.
5070120|NCT03560661|Acoustic and perceptual markers|acoustic and perceptual markers
5070121|NCT03560661|Dysarthria|dysarthria
5070122|NCT03560661|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5070123|NCT03560661|Primitive lateral sclerosis|primitive lateral sclerosis
5070130|NCT03560635|body composition|body composition
5070131|NCT03560635|metabolic rate|metabolic rate
5070132|NCT03560635|dietary adherence|dietary adherence
5070133|NCT03560635|resting energy expenditure|resting energy expenditure
5070134|NCT03560635|weight loss|weight loss
5070135|NCT03560635|weight regain|weight regain
5070136|NCT03560622|focused ultrasound|focused ultrasound
5070137|NCT03560622|fMRI|fmri
5070138|NCT03560596|Latino|latino
5070139|NCT03560570|stroke-like|stroke-like
5070140|NCT03560570|thrombosis|thrombosis
5070141|NCT03560570|haemorrhages|haemorrhages
5070142|NCT03560557|Pharmacokinetics|pharmacokinetics
5070143|NCT03560557|Meropenem|meropenem
5070144|NCT03560557|Critical illness|critical illness
5070145|NCT03560557|Capillary leak|capillary leak
5070146|NCT03560557|Augmented renal clearance|augmented renal clearance
5070147|NCT03560531|Estrogen receptor|estrogen receptor
5070148|NCT03560531|Hormone receptor|hormone receptor
5070149|NCT03560531|Selective estrogen receptor degrader|selective estrogen receptor degrader
5070150|NCT03560531|Hormone sensitive|hormone sensitive
5070151|NCT03560531|Phase 1 Dose Escalation|phase 1 dose escalation
5070152|NCT03560531|Phase 2 Combination|phase 2 combination
5070153|NCT03560518|Depression|depression
5070154|NCT03560505|Ultrasound reference material|ultrasound reference material
5070155|NCT03560505|Sensitivity|sensitivity
5070156|NCT03560505|Specificity|specificity
5070157|NCT03560505|Common fibular compression neuropathy|common fibular compression neuropathy
5070158|NCT03560505|Type 2 diabetes polyneuropathy|type 2 diabetes polyneuropathy
5070159|NCT03560505|Intra-rater reliability|intra-rater reliability
5936689|NCT02308111|PBC|pbc
5070160|NCT03560505|Inter-rater reliability|inter-rater reliability
5070161|NCT03560492|posture|posture
5070162|NCT03560492|cervical pain|cervical pain
5070163|NCT03560492|exercise|exercise
5070164|NCT03560479|First-in human|first-in human
5070165|NCT03560479|Phase 1|phase 1
5070166|NCT03560479|Phase 2|phase 2
5070167|NCT03560479|Safety|safety
5070168|NCT03560479|Tolerability|tolerability
5070176|NCT03560479|Urothelial|urothelial
5070177|NCT03560479|Malignant|malignant
5070178|NCT03560479|Papillary|papillary
5070179|NCT03560479|Transurethral|transurethral
5070180|NCT03560479|Non-muscle invasive|non-muscle invasive
5070181|NCT03560479|Instillation|instillation
5070182|NCT03560479|Intravesical|intravesical
5070183|NCT03560453|Autism|autism
5070184|NCT03560453|ASD|asd
5070185|NCT03560453|Competitive Integrated Employment|competitive integrated employment
5070186|NCT03560453|Project SEARCH|project search
5070187|NCT03560453|Outcomes|outcomes
5070190|NCT03560440|Pharmacokinetics|pharmacokinetics
5070191|NCT03560440|Trough level|trough level
5070192|NCT03560440|Pediatric|pediatric
5070193|NCT03560401|Bracing; transforaminal lumbar interbody fusion (TLIF); outcome; fusion rate|bracing; transforaminal lumbar interbody fusion (tlif); outcome; fusion rate
5070201|NCT03560375|Weight loss; Diabetes; Frailty; Sarcopenia|weight loss; diabetes; frailty; sarcopenia
5070202|NCT03560362|bupivacaine|bupivacaine
5070203|NCT03560362|lipossomal extended release bupivacaine|lipossomal extended release bupivacaine
5070204|NCT03560362|Intercostal nerve block|intercostal nerve block
5070205|NCT03560362|thoracic surgery|thoracic surgery
5070206|NCT03560362|minimally invasive surgery|minimally invasive surgery
5070207|NCT03560323|Ketone Body Metabolism|ketone body metabolism
5070208|NCT03560323|Myocardial Glucose Uptake|myocardial glucose uptake
5070209|NCT03560323|Positron Emission Tomography|positron emission tomography
5070210|NCT03560323|Myocardial Function|myocardial function
5070211|NCT03560310|Coronary Bypass Grafting|coronary bypass grafting
5070212|NCT03560310|Antiplatelet treatment|antiplatelet treatment
5070213|NCT03560284|Marathon|marathon
5070214|NCT03560284|Half Marathon|half marathon
5070215|NCT03560284|Runners|runners
5070216|NCT03560284|Ederly|ederly
5070217|NCT03560284|Aging process|aging process
5070218|NCT03560284|Sport Addiction|sport addiction
5070219|NCT03560232|Open Fracture|open fracture
5070220|NCT03560232|Wound Infection|wound infection
5070221|NCT03560232|Antimicrobial Prophylaxis|antimicrobial prophylaxis
5070222|NCT03560232|Cefazolin|cefazolin
5070223|NCT03560232|Gentamicin|gentamicin
5070224|NCT03560232|Ceftriaxone|ceftriaxone
5070225|NCT03560232|Ampicillin/Sulbactam|ampicillin/sulbactam
5070226|NCT03560232|Clindamycin|clindamycin
5070227|NCT03560232|Piperacillin/tazobactam|piperacillin/tazobactam
5070228|NCT03560219|Atrial Fibrillation|atrial fibrillation
5070229|NCT03560219|Atrial Fibrosis|atrial fibrosis
5070230|NCT03560219|Genome Wide Association Studies|genome wide association studies
5070231|NCT03560219|Biomarkers|biomarkers
5070232|NCT03560219|Echocardiography|echocardiography
5070233|NCT03560219|Magnetic Resonance Imaging|magnetic resonance imaging
5070234|NCT03560219|Flow Mediated Dilatation|flow mediated dilatation
5070235|NCT03560219|Thrombogenic Substrate|thrombogenic substrate
5070236|NCT03560206|Diet, low-sodium|diet, low-sodium
5070237|NCT03560206|caregivers|caregivers
5070238|NCT03560193|Skin antisepsis|skin antisepsis
5070239|NCT03560193|Chlorhexidine|chlorhexidine
5070240|NCT03560193|Povidone Iodine|povidone iodine
5070241|NCT03560193|Surgical site infection|surgical site infection
5070242|NCT03560180|Anastomotic Leak|anastomotic leak
5070243|NCT03560180|Colorectal Surgery|colorectal surgery
5070244|NCT03560154|Pulmonary Function Test|pulmonary function test
5070245|NCT03560154|Peripheral Muscle strength|peripheral muscle strength
5070246|NCT03560154|Postural balance|postural balance
5070247|NCT03560154|Dyspnea|dyspnea
5070248|NCT03560154|Pulmonary Muscle Strength|pulmonary muscle strength
5070249|NCT03560154|Functional Capacity|functional capacity
5070250|NCT03560154|Fatigue|fatigue
5070251|NCT03560154|Quality of Life|quality of life
5070252|NCT03560128|Colonoscopy|colonoscopy
5070253|NCT03560115|Children|children
5070254|NCT03560115|Heel|heel
5070255|NCT03560115|Reliability|reliability
5070256|NCT03560089|Parkinson's disease|parkinson's disease
5070257|NCT03560089|Gait|gait
5070258|NCT03560089|Rehabilitation|rehabilitation
5070259|NCT03560089|Serious game|serious game
5070260|NCT03560076|Acute Care|acute care
5070261|NCT03560076|SBIRT|sbirt
5070262|NCT03560076|Substance Use|substance use
5070263|NCT03560076|Alcohol|alcohol
5070264|NCT03560076|Opioid|opioid
5070265|NCT03560076|Tobacco|tobacco
5070266|NCT03560076|Nurse|nurse
5070267|NCT03560076|Toolkit|toolkit
5070268|NCT03560076|Implementation|implementation
5070269|NCT03560063|arthroplasty|arthroplasty
5070270|NCT03560063|dislocation|dislocation
5070271|NCT03560063|templating|templating
5070272|NCT03560050|early childhood education|early childhood education
5070273|NCT03560050|family child care home|family child care home
5070284|NCT03559985|Neuropathic pain|neuropathic pain
5070285|NCT03559985|Analgesic effect|analgesic effect
5070286|NCT03559985|Pharmacogenetics|pharmacogenetics
5070287|NCT03559985|Biological parameters|biological parameters
5070288|NCT03559985|Cognitivo-emotional parameters|cognitivo-emotional parameters
5070289|NCT03559946|Overactive Bladder Syndrome|overactive bladder syndrome
5937027|NCT02193152|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5070290|NCT03559946|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
5070291|NCT03559907|prevention|prevention
5070292|NCT03559907|nutrition|nutrition
5070295|NCT03559907|underserved|underserved
5937138|NCT02159521|deep vein thrombosis|deep vein thrombosis
5683874|NCT00562848|safety|safety
5070296|NCT03559881|Skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer|skeletal muscle mass, muscle strength, dairy products, high protein diet, cancer treatment, lung cancer
5070297|NCT03559816|Episiotomy|episiotomy
5070298|NCT03559816|Vaginal delivery|vaginal delivery
5070299|NCT03559816|Perineal trauma|perineal trauma
5070300|NCT03559816|Laceration|laceration
5070301|NCT03559816|Classification of second-degree laceration|classification of second-degree laceration
5070302|NCT03559803|Cervical Cancer|cervical cancer
5070303|NCT03559803|PD-L1|pd-l1
5070304|NCT03559803|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5738157|NCT00364949|PCOS|pcos
5070305|NCT03559790|chronic hepatitis B|chronic hepatitis b
5070306|NCT03559790|tenofovir alafenamide|tenofovir alafenamide
5070307|NCT03559790|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5070308|NCT03559790|Safety|safety
5070309|NCT03559790|Efficacy|efficacy
5070310|NCT03559777|closed sinus lifiting|closed sinus lifiting
5070311|NCT03559777|implant stability|implant stability
5070312|NCT03559777|osteotome|osteotome
5070313|NCT03559777|densah bur|densah bur
5070314|NCT03559751|Abuse liability|abuse liability
5070315|NCT03559725|Abuse liability|abuse liability
5070316|NCT03559712|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5070317|NCT03559712|Collaborative Care|collaborative care
5070318|NCT03559712|Telemedecine|telemedecine
5070319|NCT03559712|Telemental Health|telemental health
5070320|NCT03559608|arterial hypertension|arterial hypertension
5070321|NCT03559608|male health|male health
5070322|NCT03559608|Warmia-Masuria region|warmia-masuria region
5070323|NCT03559569|Shock|shock
5070324|NCT03559569|Cardiovascular Diseases|cardiovascular diseases
5070332|NCT03559530|Acinetobacter baumannii|acinetobacter baumannii
5070333|NCT03559530|Anti-Infective Agents|anti-infective agents
5070334|NCT03559504|electroencephalography|electroencephalography
5070335|NCT03559504|general anesthesia|general anesthesia
5070337|NCT03559491|steroid|steroid
5070338|NCT03559491|retinal vein occlusion|retinal vein occlusion
5070339|NCT03559491|macular edema|macular edema
5070340|NCT03559465|systemic sclerosis|systemic sclerosis
5070341|NCT03559465|B lymphocyte|b lymphocyte
5070342|NCT03559452|Muscle damage|muscle damage
5070343|NCT03559452|Inflammation|inflammation
5070344|NCT03559452|Immobilisation|immobilisation
5070345|NCT03559426|antipsychotics|antipsychotics
5070346|NCT03559426|schizophrenia|schizophrenia
5070347|NCT03559426|reduction|reduction
5070348|NCT03559413|Individualized peptide vaccination|individualized peptide vaccination
5070349|NCT03559413|Immunotherapy|immunotherapy
5070350|NCT03559413|Tumor-specific mutations|tumor-specific mutations
5070351|NCT03559413|Neoantigens|neoantigens
5070352|NCT03559374|Vanadis NIPT system|vanadis nipt system
5070353|NCT03559348|in Elderly Patients|in elderly patients
5070354|NCT03559335|Colorectal cancer|colorectal cancer
5070355|NCT03559335|Biomarkers|biomarkers
5961152|NCT04288934|Bone marrow derived Mesenchymal stem cells|bone marrow derived mesenchymal stem cells
5961153|NCT04288934|American Spinal Injury Association Impairment Scale|american spinal injury association impairment scale
5070356|NCT03559335|Neutrophil CD64|neutrophil cd64
5070357|NCT03559335|Monocyte Human Leukocyte Antigen - DR|monocyte human leukocyte antigen - dr
5070358|NCT03559335|Postoperative Infectious Complications|postoperative infectious complications
5070360|NCT03559335|Procalcitonin (PCT)|procalcitonin (pct)
5070362|NCT03559296|assessment|assessment
5070363|NCT03559296|edema|edema
5070364|NCT03559296|dermis|dermis
5070365|NCT03559296|postmastectomy Lymphedema|postmastectomy lymphedema
5070366|NCT03559296|reliability|reliability
5070367|NCT03559296|ultrasound|ultrasound
5070368|NCT03559296|grade|grade
5070369|NCT03559283|stroke, dual-task, gait parameters, fNIRS|stroke, dual-task, gait parameters, fnirs
5070372|NCT03559257|prevention|prevention
5070373|NCT03559257|prophylaxis|prophylaxis
5070374|NCT03559257|headache|headache
5069789|NCT03562897|Metastasis|metastasis
5070417|NCT03559075|atopic dermatitis|atopic dermatitis
5070419|NCT03559075|children|children
5070420|NCT03559036|Locomotor Training|locomotor training
5070421|NCT03559036|Urodynamics|urodynamics
5070422|NCT03559023|Thoracic epidural|thoracic epidural
5070423|NCT03559010|Daily birth control|daily birth control
5070424|NCT03558984|Cardiac|cardiac
5070425|NCT03558984|Surgery|surgery
5070426|NCT03558984|Sternotomy|sternotomy
5070427|NCT03558984|Heart|heart
5070428|NCT03558984|CABG|cabg
5070429|NCT03558984|Valve-replacement|valve-replacement
5070430|NCT03558984|Aorta-replacement|aorta-replacement
5070431|NCT03558971|Cortisol|cortisol
5070432|NCT03558945|pancreatic tumor|pancreatic tumor
5070433|NCT03558945|neoantigen|neoantigen
5070434|NCT03558945|vaccine|vaccine
5070435|NCT03558906|Periodontal disease|periodontal disease
5070436|NCT03558906|Hypoxia|hypoxia
5070437|NCT03558906|Cytokines|cytokines
5070438|NCT03558906|Gingival crevicular fluid|gingival crevicular fluid
5070439|NCT03558906|Saliva|saliva
5070440|NCT03558893|circadian rhythm|circadian rhythm
5070441|NCT03558867|Pre Diabetes|pre diabetes
5070442|NCT03558867|Insulin resistance|insulin resistance
5070443|NCT03558867|Metformin|metformin
5070444|NCT03558867|Gut microbiota|gut microbiota
5070445|NCT03558867|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5070446|NCT03558854|Systemic sclerosis|systemic sclerosis
5070447|NCT03558854|Acetylsalicylic acid|acetylsalicylic acid
5070448|NCT03558854|Vascular dysfunction|vascular dysfunction
5070449|NCT03558841|gait|gait
5070450|NCT03558841|mobility|mobility
5070451|NCT03558841|geriatric|geriatric
5070452|NCT03558841|rehabilitation|rehabilitation
5070453|NCT03558841|inpatient|inpatient
5070454|NCT03558828|physical activity|physical activity
5070455|NCT03558828|women|women
5070456|NCT03558828|sedentary|sedentary
5070457|NCT03558828|accelerometer|accelerometer
5070458|NCT03558828|text message|text message
5070459|NCT03558828|group meeting|group meeting
5070460|NCT03558828|personal call|personal call
5070461|NCT03558828|workplace|workplace
5070462|NCT03558828|cost-effectiveness|cost-effectiveness
5070463|NCT03558828|Sequential Multiple Assignment Randomized Trial|sequential multiple assignment randomized trial
5070464|NCT03558828|adaptive intervention|adaptive intervention
5070465|NCT03558828|Actigraph|actigraph
5070466|NCT03558828|Fitbit|fitbit
5070467|NCT03558828|iCardia|icardia
5070468|NCT03558815|intellectual disability|intellectual disability
5070469|NCT03558815|psychotropic medication|psychotropic medication
5070470|NCT03558815|mental health services evaluation|mental health services evaluation
5937616|NCT02002741|patent ductus arteriosus|patent ductus arteriosus
5937756|NCT01953081|Enteral feeding|enteral feeding
5070471|NCT03558776|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid|alpha linolenic acid, linseed oil, eicosapentaenoic acid, docosahexaenoic acid
5070473|NCT03558737|non-invasive high frequency ventilation (nHFJV)|non-invasive high frequency ventilation (nhfjv)
5070474|NCT03558737|nasal intermittent positive pressure ventilation (NIPPV)|nasal intermittent positive pressure ventilation (nippv)
5070475|NCT03558724|Fluorescence|fluorescence
5070476|NCT03558724|Endoscopy|endoscopy
5070477|NCT03558724|Bevacizumab-800CW|bevacizumab-800cw
5070478|NCT03558724|Locally advanced esophageal cancer|locally advanced esophageal cancer
5070479|NCT03558711|prostate cancer|prostate cancer
5070480|NCT03558711|biochemical recurrence|biochemical recurrence
5070481|NCT03558711|18F-PET imaging|18f-pet imaging
5070482|NCT03558698|cognition|cognition
5070483|NCT03558698|sleep|sleep
5070484|NCT03558698|carbon dioxide|carbon dioxide
5070485|NCT03558698|bio effluents|bio effluents
5070486|NCT03558672|Flexitouch|flexitouch
5070487|NCT03558659|Stroke|stroke
5070488|NCT03558659|Obstructive sleep apnea|obstructive sleep apnea
5070489|NCT03558659|Positional therapy|positional therapy
5070490|NCT03558646|Smoke inhalation injury|smoke inhalation injury
5070491|NCT03558646|Acute kidney injury|acute kidney injury
5070492|NCT03558646|Intensive care unit|intensive care unit
5070493|NCT03558646|Burns|burns
5070494|NCT03558646|Prognosis|prognosis
5070495|NCT03558646|Hydroxocobalamin|hydroxocobalamin
5070496|NCT03558633|Cricoid pressure|cricoid pressure
5070509|NCT03558568|Facial expressions|facial expressions
5070511|NCT03558555|Acetaminophen|acetaminophen
5070512|NCT03558555|Tylenol|tylenol
5070513|NCT03558555|Intravenous versus oral|intravenous versus oral
5070514|NCT03558529|relapse|relapse
5070515|NCT03558529|early signs|early signs
5070516|NCT03558529|basic symptoms|basic symptoms
5070517|NCT03558529|smartphone app|smartphone app
5070518|NCT03558529|mhealth|mhealth
5070519|NCT03558516|Meningioma|meningioma
5070520|NCT03558516|Magnesium sulphate|magnesium sulphate
5342955|NCT01981382|gene expression,|gene expression,
5070521|NCT03558516|Montreal cognitive assessment|montreal cognitive assessment
5070522|NCT03558516|Intraoperative blood loss|intraoperative blood loss
5070523|NCT03558503|UGN-102|ugn-102
5070524|NCT03558503|UG-1 gel|ug-1 gel
5070525|NCT03558503|Bladder cancer|bladder cancer
5070526|NCT03558503|Gel|gel
5070527|NCT03558503|Slow Release|slow release
5070528|NCT03558503|Non Muscle Invasive Bladder Cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
5070529|NCT03558503|Low grade (LG)|low grade (lg)
5070530|NCT03558503|Prolonged Release|prolonged release
5070531|NCT03558503|Mitomycin C|mitomycin c
5070533|NCT03558503|Intravesical|intravesical
5070534|NCT03558503|Ta|ta
5070535|NCT03558503|T1|t1
5070536|NCT03558503|MMC|mmc
5070537|NCT03558451|Primary health care|primary health care
5070538|NCT03558425|CKD-381|ckd-381
5070539|NCT03558425|D026|d026
5070540|NCT03558412|Decitabine|decitabine
5070541|NCT03558412|RR|rr
5070542|NCT03558412|TTP|ttp
5070543|NCT03558412|OS|os
5070544|NCT03558412|MST|mst
5070545|NCT03558399|Endometrial receptivity analysis|endometrial receptivity analysis
5070546|NCT03558399|Window of implantation|window of implantation
5070547|NCT03558399|Euploid|euploid
5070548|NCT03558399|Infertility, Female|infertility, female
5070549|NCT03558399|Implantation failure|implantation failure
5070550|NCT03558399|Frozen embryo transfer FET|frozen embryo transfer fet
5070551|NCT03558399|ERA|era
5070552|NCT03558399|WOI|woi
5070553|NCT03558399|FET|fet
5070554|NCT03558399|Synchrony|synchrony
5070555|NCT03558373|adherence|adherence
5070556|NCT03558373|tacrolimus|tacrolimus
5070557|NCT03558373|once-daily|once-daily
5070558|NCT03558360|lean body mass|lean body mass
5070559|NCT03558360|bariatric surgery|bariatric surgery
5070560|NCT03558334|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5070561|NCT03558334|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
5070562|NCT03558295|Percutaneous coronary intervention (PCI), oral anticoagulants, atrial fibrillation, DOAC.|percutaneous coronary intervention (pci), oral anticoagulants, atrial fibrillation, doac.
5070563|NCT03558269|Autologous Umbilical cord blood infusion|autologous umbilical cord blood infusion
5070564|NCT03558269|Congenital Heart Disease|congenital heart disease
5070565|NCT03558269|Brain Injuries|brain injuries
5070566|NCT03558269|Low Cardiac Output Syndrome|low cardiac output syndrome
5070567|NCT03558269|Neonatal Disorder|neonatal disorder
5070568|NCT03558256|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5070569|NCT03558243|radial artery occlusion|radial artery occlusion
5070570|NCT03558243|prevention|prevention
5070571|NCT03558243|patent hemostasis|patent hemostasis
5070572|NCT03558243|transradial intervention|transradial intervention
5070573|NCT03558243|ulnar compression|ulnar compression
5070574|NCT03558230|pediatric|pediatric
5070575|NCT03558230|hemiplegic|hemiplegic
5070576|NCT03558230|hand function|hand function
5070577|NCT03558217|total hip arthroplasty|total hip arthroplasty
5070578|NCT03558217|collarless femoral implant|collarless femoral implant
5070579|NCT03558217|collared femoral implant|collared femoral implant
5070586|NCT03558126|POAG|poag
5070595|NCT03558048|Prostate Specific Antigen|prostate specific antigen
5070596|NCT03558048|IBD|ibd
5070597|NCT03558048|PSA|psa
5070598|NCT03558035|Hypopharyngeal carcinoma|hypopharyngeal carcinoma
5070599|NCT03558035|Locally advanced|locally advanced
5070600|NCT03558035|Multi-disciplinary treatment|multi-disciplinary treatment
5070601|NCT03558035|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5070602|NCT03558035|Prognosis|prognosis
5070603|NCT03558009|Hereditary Angioedema|hereditary angioedema
5070604|NCT03558009|DBS-based biochemical and genetic assay for HAE type I/II|dbs-based biochemical and genetic assay for hae type i/ii
5070605|NCT03557931|aripiprazole|aripiprazole
5070606|NCT03557931|ziprasidone|ziprasidone
5070607|NCT03557931|lurasidone|lurasidone
5070608|NCT03557931|schizophrenia|schizophrenia
5070609|NCT03557931|ASP4345|asp4345
5070610|NCT03557931|quetiapine|quetiapine
5070611|NCT03557931|olanzapine|olanzapine
5070612|NCT03557931|brexpiprazole|brexpiprazole
5070613|NCT03557931|risperidone|risperidone
5070614|NCT03557931|paliperidone|paliperidone
5070615|NCT03557879|Hearing impairment|hearing impairment
5070616|NCT03557879|familial|familial
5070617|NCT03557866|foot posture|foot posture
5070618|NCT03557866|running|running
5070619|NCT03557866|foot index|foot index
5070620|NCT03557840|temocillin|temocillin
5070621|NCT03557840|free concentration|free concentration
5070622|NCT03557840|total concentration|total concentration
5070623|NCT03557840|pharmacokinetics|pharmacokinetics
5070624|NCT03557840|pharmacodynamic|pharmacodynamic
5070625|NCT03557840|probability of target attainment|probability of target attainment
5070626|NCT03557840|non-ICU|non-icu
5070627|NCT03557827|periodontitis|periodontitis
5070628|NCT03557827|photodynamic therapy|photodynamic therapy
5070629|NCT03557814|chronic periodontitis|chronic periodontitis
5070630|NCT03557814|light-emitting diodes|light-emitting diodes
5070631|NCT03557788|Rifaximin|rifaximin
5070632|NCT03557762|Cancer survivors|cancer survivors
5070633|NCT03557762|Smartphone app|smartphone app
5070639|NCT03557710|cancer risk|cancer risk
5070640|NCT03557710|translational neuroscience|translational neuroscience
5070641|NCT03557710|cognitive reappraisal|cognitive reappraisal
5070642|NCT03557710|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5070643|NCT03557710|vmPFC|vmpfc
5070644|NCT03557710|inhibitory control|inhibitory control
5070645|NCT03557710|valuation|valuation
5070646|NCT03557697|Chinese Americans|chinese americans
5070647|NCT03557697|SMS intervention|sms intervention
5070648|NCT03557645|mechanical ventilation|mechanical ventilation
5070649|NCT03557645|physiotherapy|physiotherapy
5070650|NCT03557645|ventilator hyperinflation|ventilator hyperinflation
5070651|NCT03557645|airway clearance technique|airway clearance technique
5070652|NCT03557632|Opioid Dependence|opioid dependence
5070653|NCT03557632|Injection Drug Use|injection drug use
5070654|NCT03557632|Hispanics|hispanics
5070655|NCT03557632|Mexican Americans|mexican americans
5070656|NCT03557632|Virtual Reality Cue Exposure|virtual reality cue exposure
5070657|NCT03557619|Cancer|cancer
5070658|NCT03557619|Hematologic Malignancies, venetoclax|hematologic malignancies, venetoclax
5070659|NCT03557619|ethinyl estradiol|ethinyl estradiol
5070660|NCT03557619|relapsed or refractory non-Hodgkin's lymphoma|relapsed or refractory non-hodgkin's lymphoma
5070661|NCT03557619|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5070662|NCT03557606|CCJ|ccj
5070663|NCT03557606|Bone Marrow Concentrate|bone marrow concentrate
5070664|NCT03557606|Stem Cell Therapy|stem cell therapy
5070665|NCT03557606|Alar Ligament|alar ligament
5070666|NCT03557606|Transverse Ligament|transverse ligament
5070667|NCT03557593|Antipsychotic|antipsychotic
5070668|NCT03557593|Nursing home|nursing home
5070669|NCT03557593|Long-term care|long-term care
5070670|NCT03557554|Massage|massage
5070671|NCT03557554|Breast Cancer|breast cancer
5070672|NCT03557554|Neuropathy|neuropathy
5070673|NCT03557541|diabetes|diabetes
5070674|NCT03557541|T2D|t2d
5070675|NCT03557541|diet|diet
5070676|NCT03557541|nutrition|nutrition
5070677|NCT03557541|prediabetes|prediabetes
5070678|NCT03557541|sardine|sardine
5070679|NCT03557541|elderly|elderly
5070680|NCT03557515|Depression|depression
5070681|NCT03557515|Cognitive Behavioral Therapy|cognitive behavioral therapy
5070682|NCT03557515|Coping|coping
5070683|NCT03557515|Meditation|meditation
5070684|NCT03557515|Anxiety|anxiety
5070685|NCT03557502|Stage 1 hypertension|stage 1 hypertension
5070688|NCT03557476|Taekwondo|taekwondo
5070697|NCT03557411|SHR-1210,radiotherapy,Oligometastases,NSCLC|shr-1210,radiotherapy,oligometastases,nsclc
5070698|NCT03557398|Hyaluronic acid|hyaluronic acid
5070699|NCT03557398|Post-menopause|post-menopause
5070700|NCT03557385|Fractional Flow Reserve|fractional flow reserve
5070701|NCT03557372|Recurrent glioblastoma|recurrent glioblastoma
5070702|NCT03557372|Radiation Therapy|radiation therapy
5070703|NCT03557359|Recurrent|recurrent
5070704|NCT03557359|Progressive|progressive
5070705|NCT03557359|High Grade Glioma|high grade glioma
5070706|NCT03557359|IDH Mutant|idh mutant
5070707|NCT03557320|environment|environment
5070708|NCT03557320|pressure|pressure
5070709|NCT03557320|temperature|temperature
5070710|NCT03557320|case-crossover|case-crossover
5070712|NCT03557307|Severe Asthma|severe asthma
5070713|NCT03557307|Oral Corticosteroids|oral corticosteroids
5070719|NCT03557229|Oxidative Stress|oxidative stress
5070720|NCT03557229|Sepsis|sepsis
5070721|NCT03557229|Treatment|treatment
5070722|NCT03557229|Antioxidant therapy|antioxidant therapy
5070723|NCT03557216|Diverticulitis|diverticulitis
5070724|NCT03557216|Advanced colonic neoplasm|advanced colonic neoplasm
5070725|NCT03557216|Colonoscopy|colonoscopy
5070726|NCT03557203|Vernal Keratoconjunctivitis|vernal keratoconjunctivitis
5070727|NCT03557203|Atopic Keratoconjunctivitis|atopic keratoconjunctivitis
5070728|NCT03557203|tacrolimus|tacrolimus
5070729|NCT03557190|VEGF inhibitors|vegf inhibitors
5070730|NCT03557190|hypertension|hypertension
5738158|NCT00364949|Pregnant|pregnant
5070731|NCT03557190|endothelial function|endothelial function
5070732|NCT03557190|thrombosis|thrombosis
5070733|NCT03557190|venous occlusion plethysmography|venous occlusion plethysmography
5070734|NCT03557177|cisplatin|cisplatin
5070735|NCT03557177|flow mediated dilatation|flow mediated dilatation
5070736|NCT03557138|SGLT2 inhibitor|sglt2 inhibitor
5070737|NCT03557138|18F-FDG|18f-fdg
5070738|NCT03557138|alpha-Methyl-4-18F-FDG|alpha-methyl-4-18f-fdg
5070739|NCT03557112|Locally Advanced Nasopharyngeal Carcinoma|locally advanced nasopharyngeal carcinoma
5070740|NCT03557112|nimotuzumab|nimotuzumab
5070741|NCT03557112|chemoradiotherapy|chemoradiotherapy
5070742|NCT03557112|cisplatin|cisplatin
5070743|NCT03557099|SAA|saa
5070744|NCT03557073|Hand injuries|hand injuries
5070745|NCT03557073|Hand trauma|hand trauma
5070746|NCT03557073|Patient reported outcomes|patient reported outcomes
5070747|NCT03557060|Nucala|nucala
5070748|NCT03557060|Drug use investigation|drug use investigation
5070749|NCT03557060|EGPA|egpa
5070750|NCT03557060|Long-term|long-term
5070751|NCT03557034|pulmonary vein isolation|pulmonary vein isolation
5070752|NCT03557034|atrial fibrillation|atrial fibrillation
5070753|NCT03557034|remote monitoring|remote monitoring
5070754|NCT03557034|heart rhythm monitor|heart rhythm monitor
5070755|NCT03557008|Rabies Vaccine|rabies vaccine
5070756|NCT03557008|Antibiotics|antibiotics
5070757|NCT03557008|Biopsy|biopsy
5070758|NCT03556982|Acute Myeloid Leukemia|acute myeloid leukemia
5070759|NCT03556982|Relapsed|relapsed
5070760|NCT03556982|Refractory|refractory
5070761|NCT03556930|Non-sedated radiotherapy treatment|non-sedated radiotherapy treatment
5070762|NCT03556878|Circadian rhythm disorders|circadian rhythm disorders
5070763|NCT03556878|Sleep disorders|sleep disorders
5070764|NCT03556878|Acceptability|acceptability
5070765|NCT03556878|Adaptation|adaptation
5070766|NCT03556878|Feasibility|feasibility
5070767|NCT03556839|Cervix|cervix
5070768|NCT03556839|Carcinoma|carcinoma
5070769|NCT03556839|Atezolizumab|atezolizumab
5070770|NCT03556813|Patient information|patient information
5070771|NCT03556813|Natural Language Processing|natural language processing
5070772|NCT03556813|Conversational agent|conversational agent
5070773|NCT03556813|Chatbot|chatbot
5070774|NCT03556800|Hypoestrogenism|hypoestrogenism
5070775|NCT03556800|Menopausal hormone therapy|menopausal hormone therapy
5070776|NCT03556761|Furosemide|furosemide
5070777|NCT03556761|Postpartum|postpartum
5070778|NCT03556761|Hypertension|hypertension
5070779|NCT03556748|hematological malignancies|hematological malignancies
5070780|NCT03556748|leukemia|leukemia
5070781|NCT03556748|myeloma|myeloma
5070782|NCT03556748|lymphoma|lymphoma
5070783|NCT03556748|exercise|exercise
5070784|NCT03556748|nutrition|nutrition
5070785|NCT03556748|protein|protein
5070786|NCT03556748|WB-EMS|wb-ems
5070802|NCT03556683|asthma, hypertonic saline|asthma, hypertonic saline
5070804|NCT03556657|Sickle Cell Disease|sickle cell disease
5070805|NCT03556657|Quality of Life|quality of life
5070806|NCT03556657|Chronic Pain|chronic pain
5070807|NCT03556644|Near Infrared Spectroscopy|near infrared spectroscopy
5070808|NCT03556644|Computed Tomography Coronary Angiography|computed tomography coronary angiography
5070809|NCT03556644|Atherosclerosis|atherosclerosis
5070810|NCT03556644|Endothelial Shear Stress|endothelial shear stress
5070811|NCT03556566|ovary|ovary
5070812|NCT03556566|ovarian|ovarian
5070813|NCT03556566|immunotherapy|immunotherapy
5070814|NCT03556566|cancer|cancer
5070815|NCT03556553|composite resin|composite resin
5070817|NCT03556540|Chronic Kidney Disease|chronic kidney disease
5070819|NCT03556540|Exercise|exercise
5070820|NCT03556527|osteotomy|osteotomy
5070821|NCT03556527|reverse oblique sigmoid notch|reverse oblique sigmoid notch
5938141|NCT01808820|HGG|hgg
5070822|NCT03556527|ulnar impaction syndrome|ulnar impaction syndrome
5070823|NCT03556527|ulnar shortening|ulnar shortening
5070824|NCT03556514|Locking Plate Fixaion|locking plate fixaion
5070825|NCT03556488|Chest ultrasound|chest ultrasound
5070826|NCT03556488|Pediatric community acquired pneumonia|pediatric community acquired pneumonia
5070827|NCT03556488|Air bronchogram|air bronchogram
5070828|NCT03556449|scapula/innervation*|scapula/innervation*
5070829|NCT03556449|Thoracic Nerves/injuries*|thoracic nerves/injuries*
5070830|NCT03556449|Peripheral Nerve Injuries|peripheral nerve injuries
5070831|NCT03556449|Shoulder|shoulder
5070837|NCT03556423|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5070838|NCT03556423|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5070839|NCT03556423|Conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
5070840|NCT03556423|Clinical measures|clinical measures
5070841|NCT03556423|Knee osteoarthritis|knee osteoarthritis
5070842|NCT03556410|Sleep|sleep
5070843|NCT03556410|Obesity|obesity
5070844|NCT03556410|Metabolic Syndrome|metabolic syndrome
5070845|NCT03556410|Physical Activity|physical activity
5938369|NCT01729455|Lupus|lupus
5070846|NCT03556397|breast cancer|breast cancer
5070847|NCT03556397|neoadjuvant therapy|neoadjuvant therapy
5070848|NCT03556397|sentinel lymph node biopsy|sentinel lymph node biopsy
5684606|NCT00559663|hsCRP|hscrp
5070849|NCT03556397|axillary dissection|axillary dissection
5070850|NCT03556384|cancer|cancer
5070851|NCT03556384|Temozolomide|temozolomide
5070852|NCT03556384|GIST|gist
5938509|NCT01662466|DHEA|dhea
5070853|NCT03556384|SDH-Mutant/Deficient|sdh-mutant/deficient
5070854|NCT03556384|SDH|sdh
5070855|NCT03556384|Succinate Dehydrogenase|succinate dehydrogenase
5070856|NCT03556371|Cocaine|cocaine
5070857|NCT03556371|Coca Paste|coca paste
5070858|NCT03556371|N-Acetylcysteine|n-acetylcysteine
5070859|NCT03556371|Craving|craving
5070860|NCT03556371|Abstinence|abstinence
5070861|NCT03556358|trastuzumab|trastuzumab
5070862|NCT03556358|Herceptin|herceptin
5070863|NCT03556345|RC48-ADC|rc48-adc
5070864|NCT03556345|HER2 overexpression|her2 overexpression
5070865|NCT03556345|Gastric cancer|gastric cancer
5070866|NCT03556332|Carfilzomib|carfilzomib
5070867|NCT03556332|Lenalidomide|lenalidomide
5083107|NCT03478826|ILD|ild
5070893|NCT03556176|Physical activity|physical activity
5961154|NCT04288869|cerebral perfusion|cerebral perfusion
5961155|NCT04288869|general anesthesia|general anesthesia
5961156|NCT04288869|hypotension|hypotension
5961157|NCT04288869|transcranial Doppler|transcranial doppler
5070894|NCT03556176|Polymorphisms|polymorphisms
5070895|NCT03556163|Chronic periodontitis|chronic periodontitis
5070896|NCT03556163|Modified Widman flap surgery|modified widman flap surgery
5070897|NCT03556163|Suturing technique|suturing technique
5070898|NCT03556137|PET/MRI|pet/mri
5070899|NCT03556137|Chronic Pain|chronic pain
5070900|NCT03556124|Transcranial direct current stimulation|transcranial direct current stimulation
5070901|NCT03556124|major depression|major depression
5070902|NCT03556124|MRI|mri
5070903|NCT03556111|implant , sticky bone|implant , sticky bone
5070904|NCT03556098|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5070905|NCT03556098|Hypoglycemia|hypoglycemia
5070906|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5070907|NCT03556098|Glucagon|glucagon
5070908|NCT03556098|Incretin|incretin
5070909|NCT03556085|idiopathic intracranial hypertension|idiopathic intracranial hypertension
5070910|NCT03556085|venous sinus stenting|venous sinus stenting
5070911|NCT03556072|ERCP|ercp
5070912|NCT03556072|periampullary diverticula|periampullary diverticula
5070913|NCT03556072|difficulty cannulation|difficulty cannulation
5070914|NCT03556072|complication|complication
5070915|NCT03556072|biliary disorder|biliary disorder
5070916|NCT03556059|EOSS|eoss
5070917|NCT03556059|Obesity and metabolic surgery|obesity and metabolic surgery
5070918|NCT03556059|postoperative outcome|postoperative outcome
5070919|NCT03556059|procedure selection|procedure selection
5070920|NCT03556046|Clear Cell Renal Carcinoma|clear cell renal carcinoma
5070921|NCT03556007|T regulatory cells|t regulatory cells
5070923|NCT03555968|THC|thc
5070924|NCT03555968|Alcohol|alcohol
5070925|NCT03555968|Driving|driving
5070926|NCT03555968|Dronabinol|dronabinol
5070927|NCT03555929|Axillary block|axillary block
5070928|NCT03555929|Dexamethasone|dexamethasone
5070929|NCT03555929|anesthesia|anesthesia
5070930|NCT03555916|BOTOX®-Allergan|botox®-allergan
5070931|NCT03555916|PPTTN|ppttn
5070932|NCT03555916|Pain measurements|pain measurements
5738159|NCT00364949|Cord Blood|cord blood
5127460|NCT03197532|healthy|healthy
5070933|NCT03555890|Oral disintegrating tablet|oral disintegrating tablet
5070934|NCT03555890|Levocetirizine|levocetirizine
5070935|NCT03555890|Immediate release tablet|immediate release tablet
5070936|NCT03555890|Bioequivalence|bioequivalence
5070937|NCT03555890|Japanese subjects|japanese subjects
5070938|NCT03555877|Ribociclib|ribociclib
5070939|NCT03555877|Anti-hormonal maintainance treatment|anti-hormonal maintainance treatment
5070940|NCT03555877|HR-positive|hr-positive
5070941|NCT03555877|HER2-negative|her2-negative
5070956|NCT03555734|Cardiovascular disease|cardiovascular disease
5070957|NCT03555734|Coronary heart disease|coronary heart disease
5070958|NCT03555734|Stroke|stroke
5070959|NCT03555734|Diabetes|diabetes
5070960|NCT03555734|Hypertension|hypertension
5070961|NCT03555734|Obesity|obesity
5070962|NCT03555734|Prospective cohort studies|prospective cohort studies
5070963|NCT03555734|Umbrella review|umbrella review
5070964|NCT03555734|Systematic review and meta-analysis|systematic review and meta-analysis
5070965|NCT03555708|Gait Training|gait training
5070966|NCT03555708|Power Training|power training
5070967|NCT03555708|Action-Perception Training|action-perception training
5070968|NCT03555708|Brain Imaging|brain imaging
5070969|NCT03555708|Mobility|mobility
5070970|NCT03555695|karate|karate
5070971|NCT03555695|exercise|exercise
5070972|NCT03555682|Multiple Dosage|multiple dosage
5070973|NCT03555669|Implementation Science|implementation science
5070974|NCT03555669|Malawi|malawi
5070976|NCT03555643|Stroke|stroke
5070977|NCT03555643|Ischemia|ischemia
5070978|NCT03555643|MRI|mri
5070979|NCT03555643|FLAIR|flair
5070980|NCT03555643|hyperintense acute reperfusion marker|hyperintense acute reperfusion marker
5070981|NCT03555617|healthy volunteers|healthy volunteers
5070982|NCT03555617|drug-drug interaction|drug-drug interaction
5070983|NCT03555617|itraconazole|itraconazole
5070984|NCT03555617|CYP3A|cyp3a
5070985|NCT03555617|P-gp|p-gp
5070986|NCT03555617|Inflammatory Bowel Disease|inflammatory bowel disease
5070987|NCT03555617|IBD|ibd
4959742|NCT04240834|PCI|pci
5070988|NCT03555617|Irritable Bowel Syndrome|irritable bowel syndrome
5070989|NCT03555617|IBS|ibs
5070990|NCT03555539|Hepatic Impairment|hepatic impairment
5070991|NCT03555539|ACH-0144471|ach-0144471
5070992|NCT03555500|Fasting|fasting
5070993|NCT03555500|Non fasting|non fasting
5070994|NCT03555500|Cardiac catheterization|cardiac catheterization
5070995|NCT03555487|Hyperparathyroidism|hyperparathyroidism
5070996|NCT03555487|18F choline|18f choline
5070997|NCT03555487|PET|pet
5070998|NCT03555487|Tc-99m sestaMIBI|tc-99m sestamibi
5070999|NCT03555487|SPECT|spect
5071000|NCT03555448|Immunosuppression|immunosuppression
5071001|NCT03555435|Problem-solving|problem-solving
5071002|NCT03555435|Stigma reduction|stigma reduction
5071003|NCT03555435|Peer support|peer support
5071004|NCT03555435|Online mental health program|online mental health program
5071005|NCT03555422|Endometrial Neoplasms|endometrial neoplasms
5071006|NCT03555422|Uterine Neoplasms|uterine neoplasms
5071007|NCT03555422|Genital Neoplasms|genital neoplasms
5071008|NCT03555422|Neoplasms by Site|neoplasms by site
5071009|NCT03555422|Neoplasms|neoplasms
5071010|NCT03555422|Uterine Diseases|uterine diseases
5071011|NCT03555422|Genital Diseases|genital diseases
5071012|NCT03555422|Female|female
5071013|NCT03555383|bloodless transplantation|bloodless transplantation
5071014|NCT03555383|hemostasis reserve capacity|hemostasis reserve capacity
5071015|NCT03555383|surgery|surgery
5071016|NCT03555370|adolescent|adolescent
5071017|NCT03555370|concussion|concussion
5071018|NCT03555357|Abdomen|abdomen
5071019|NCT03555357|Abdominoplasty|abdominoplasty
5071020|NCT03555357|Scar Therapy|scar therapy
5071021|NCT03555357|Scar|scar
5071022|NCT03555331|responsive parenting|responsive parenting
5071023|NCT03555318|Heart failure|heart failure
5071024|NCT03555318|Frailty|frailty
5071025|NCT03555318|Outcome|outcome
5071026|NCT03555318|Hospitalization|hospitalization
5071027|NCT03555318|Mortality|mortality
5071028|NCT03555292|11C-PIB|11c-pib
5071029|NCT03555292|Parkinson's disease|parkinson's disease
5071030|NCT03555292|dementia|dementia
5071031|NCT03555292|mild cognitive impairment|mild cognitive impairment
5071032|NCT03555279|HIV Prevention|hiv prevention
5071033|NCT03555279|Juvenile Justice|juvenile justice
5071034|NCT03555279|Sexual Health|sexual health
5071035|NCT03555279|Evidence Based Intervention|evidence based intervention
5071045|NCT03555227|pecs2 blocks|pecs2 blocks
5071047|NCT03555214|migraine|migraine
5071048|NCT03555214|manual therapy|manual therapy
5071049|NCT03555188|Diarrhoea|diarrhoea
5071052|NCT03555162|neuroimaging|neuroimaging
5071053|NCT03555162|Evolution|evolution
5071054|NCT03555110|EMDR Therapy|emdr therapy
5071055|NCT03555110|Bariatric Surgery|bariatric surgery
5071066|NCT03555019|Brain maturation|brain maturation
5071067|NCT03555019|Postnatal growth|postnatal growth
5071071|NCT03554967|Oral Squamous Cell Carcinoma|oral squamous cell carcinoma
5071072|NCT03554967|Toluidine Blue|toluidine blue
5071073|NCT03554967|Frozen Section|frozen section
5071074|NCT03554967|Tumor margin assessment|tumor margin assessment
5071075|NCT03554954|Nutrients|nutrients
5071076|NCT03554954|Diet|diet
5071077|NCT03554954|Sleep Quality|sleep quality
5071078|NCT03554954|Middle-aged adults|middle-aged adults
5071079|NCT03554954|Older adults|older adults
5071080|NCT03554915|Agitation, Ketamine, Midazolam, Emergency Medical Services|agitation, ketamine, midazolam, emergency medical services
5071081|NCT03554902|Endoscopic gastric tubulization|endoscopic gastric tubulization
5071082|NCT03554902|Weight loss|weight loss
5071083|NCT03554902|Quality of life|quality of life
5071084|NCT03554876|Biofilm|biofilm
5071085|NCT03554876|peri-implantitis|peri-implantitis
5071086|NCT03554876|metagenomic analysis|metagenomic analysis
5071087|NCT03554876|abutment|abutment
5071088|NCT03554863|Anesthesia genral, Oxygen|anesthesia genral, oxygen
5071089|NCT03554837|safety|safety
5071090|NCT03554837|effectiveness|effectiveness
5071091|NCT03554837|low dose|low dose
5071092|NCT03554759|Chronic Liver Disease|chronic liver disease
5071093|NCT03554759|Low Platelet Count|low platelet count
5071094|NCT03554733|self efficacy|self efficacy
5071095|NCT03554733|participation|participation
5071096|NCT03554733|satisfaction with life|satisfaction with life
5071097|NCT03554707|Childhood CNS tumor|childhood cns tumor
5071098|NCT03554707|Recurrent CNS malignancies|recurrent cns malignancies
5071099|NCT03554707|Progressive CNS malignancies|progressive cns malignancies
5071100|NCT03554707|Refractory CNS malignancies|refractory cns malignancies
5071101|NCT03554681|Bayes Model|bayes model
5071108|NCT03554616|Malaria|malaria
5071109|NCT03554616|Vector Control|vector control
5071110|NCT03554616|Long lasting Insecticidal Net|long lasting insecticidal net
5071113|NCT03554590|carbohydrate counting|carbohydrate counting
5071114|NCT03554590|insulin therapy|insulin therapy
5684871|NCT00558558|Haelan|haelan
5071115|NCT03554564|peripheral artery disease|peripheral artery disease
5071116|NCT03554564|claudication|claudication
5071117|NCT03554564|supervised exercise therapy|supervised exercise therapy
5071118|NCT03554564|walking|walking
5071119|NCT03554564|quality of life|quality of life
5071120|NCT03554551|Parasympathetic|parasympathetic
5071121|NCT03554538|Shoulder impingement syndrome|shoulder impingement syndrome
5071122|NCT03554538|Exercise web app|exercise web app
5071123|NCT03554538|Efficacy|efficacy
5071124|NCT03554525|Obesity|obesity
5071125|NCT03554525|Overweight|overweight
5071126|NCT03554525|Weight Loss|weight loss
5071127|NCT03554525|Body weight maintenance|body weight maintenance
5071128|NCT03554525|Weight Change, Body|weight change, body
5071129|NCT03554525|Saccharomyces Cerevisiae|saccharomyces cerevisiae
5071130|NCT03554525|Beta-glucans|beta-glucans
5071131|NCT03554512|Neonatal Intensive Care|neonatal intensive care
5071132|NCT03554512|Telehealth|telehealth
5071133|NCT03554512|Anxiety|anxiety
5071134|NCT03554512|Self Efficacy|self efficacy
5071135|NCT03554512|Parenting/psychology|parenting/psychology
5071142|NCT03554473|Checkpoint Inhibitors|checkpoint inhibitors
5071143|NCT03554447|Pentoxifylline|pentoxifylline
5071144|NCT03554447|Anti-inflammatory|anti-inflammatory
5961158|NCT04288869|Bispectral Index|bispectral index
5961159|NCT04288869|Near-infrared spectroscopy|near-infrared spectroscopy
5071145|NCT03554447|MDD|mdd
5961160|NCT04288843|Endometrial dating|endometrial dating
5071146|NCT03554447|phosphodiastrase inhibitors|phosphodiastrase inhibitors
5071147|NCT03554421|Key Words: Anal Fissure, tibial nerve stimulation|key words: anal fissure, tibial nerve stimulation
5071148|NCT03554408|10-1074-LS|10-1074-ls
5071149|NCT03554408|3BNC117-LS|3bnc117-ls
5071150|NCT03554408|First in Human|first in human
5071151|NCT03554408|Dose Escalation|dose escalation
5071152|NCT03554395|PD-1 activated CIK|pd-1 activated cik
5071153|NCT03554395|MUC1|muc1
5071154|NCT03554395|bispecific antibody|bispecific antibody
5071155|NCT03554395|gastric cancer|gastric cancer
5071156|NCT03554382|person-centred care (PCC)|person-centred care (pcc)
5071157|NCT03554382|self-efficacy|self-efficacy
5071158|NCT03554369|Prostate|prostate
5071163|NCT03554330|pulmonary arterial hypertension|pulmonary arterial hypertension
5071165|NCT03554330|radiofrequency catheter ablation|radiofrequency catheter ablation
5071166|NCT03554330|spontaneous closure|spontaneous closure
5071167|NCT03554317|Bipolar Androgen Therapy|bipolar androgen therapy
5071168|NCT03554317|Testosterone|testosterone
5071169|NCT03554317|Nivolumab|nivolumab
5071170|NCT03554291|famotidine|famotidine
5071171|NCT03554291|H2 blocker|h2 blocker
5071172|NCT03554291|H2 antagonist|h2 antagonist
5071173|NCT03554278|NEC|nec
5071174|NCT03554278|transfusion|transfusion
5071175|NCT03554278|microbiome|microbiome
5071176|NCT03554278|premature|premature
5071177|NCT03554265|growth hormone|growth hormone
5071178|NCT03554265|Traumatic Brain injury|traumatic brain injury
5071179|NCT03554265|concussion|concussion
5071180|NCT03554265|mTBI|mtbi
5071181|NCT03554265|fatigue|fatigue
5071182|NCT03554265|cognitive impairment|cognitive impairment
5071183|NCT03554265|BIAFAC|biafac
5071184|NCT03554239|Genotyping techniques|genotyping techniques
5071185|NCT03554239|Fungal infection|fungal infection
5071186|NCT03554226|agitation|agitation
5071187|NCT03554226|aggressivity|aggressivity
5071188|NCT03554200|Empagliflozin|empagliflozin
5071189|NCT03554200|acute heart failure|acute heart failure
5063168|NCT03604536|eHealth|ehealth
5071190|NCT03554200|cardiac output|cardiac output
5071191|NCT03554200|left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
5071192|NCT03554200|exercise capacity|exercise capacity
5071193|NCT03554174|psilocybin|psilocybin
5071194|NCT03554161|Tocilizumab|tocilizumab
5071195|NCT03554161|Refractory uveitis|refractory uveitis
5071196|NCT03554109|TNBC|tnbc
5071197|NCT03554096|Multiple Dosage|multiple dosage
5071198|NCT03554070|Prostate|prostate
5071199|NCT03554070|BPH|bph
5071200|NCT03554070|Laser|laser
5071201|NCT03554070|Endoscopic Enucleation of the Prostate|endoscopic enucleation of the prostate
5071202|NCT03554070|Thulium|thulium
5071203|NCT03554070|Thulium Fiber Laser|thulium fiber laser
5071204|NCT03554057|Angiogram, Coronary Computed Tomographic Angiography|angiogram, coronary computed tomographic angiography
5071205|NCT03553992|Tobacco|tobacco
5071206|NCT03553992|Gender Identity Minority|gender identity minority
5071207|NCT03553992|Sexual Identity Minority|sexual identity minority
5071208|NCT03553992|Cessation|cessation
5071209|NCT03553992|Intervention|intervention
5071210|NCT03553992|Young Adults|young adults
5071211|NCT03553992|Social Media|social media
5071212|NCT03553992|Internet|internet
5071213|NCT03553992|Cigarette|cigarette
5071214|NCT03553979|stress management|stress management
5071215|NCT03553979|stress intervention|stress intervention
5071216|NCT03553979|smoking intervention|smoking intervention
5071217|NCT03553979|lower SES|lower ses
5071218|NCT03553979|lower income|lower income
5071219|NCT03553966|Dental caries|dental caries
5071220|NCT03553966|Toothpaste|toothpaste
5071221|NCT03553966|Fluoride|fluoride
5071222|NCT03553966|Hydroxyapatite|hydroxyapatite
5071223|NCT03553953|Anesthesia|anesthesia
5071224|NCT03553953|Bispectral index (BIS™)|bispectral index (bis™)
5071232|NCT03553927|Male Infertility|male infertility
5071233|NCT03553927|Obesity|obesity
5071234|NCT03553888|Hidradenitis Suppurativa|hidradenitis suppurativa
5071235|NCT03553888|Periodontal diseases|periodontal diseases
5071236|NCT03553888|Multicenter cross-sectional study|multicenter cross-sectional study
5071252|NCT03553732|active surveillance|active surveillance
5071253|NCT03553732|health information technology|health information technology
5071254|NCT03553732|patient safety|patient safety
5071255|NCT03553732|adherence|adherence
5071256|NCT03553732|ambulatory|ambulatory
5071257|NCT03553732|outpatient|outpatient
5071258|NCT03553732|human factors|human factors
5071259|NCT03553732|systems engineering|systems engineering
5071260|NCT03553732|vulnerable populations|vulnerable populations
5071261|NCT03553732|chronic disease|chronic disease
5071262|NCT03553706|growth restriction, nutritive status, comorbide disorders, Down Syndrome|growth restriction, nutritive status, comorbide disorders, down syndrome
5071263|NCT03553693|HIV|hiv
5071264|NCT03553693|Viral Load|viral load
5071265|NCT03553693|Counseling|counseling
5961161|NCT04288817|wart|wart
5071266|NCT03553693|Costs and Costs Analysis|costs and costs analysis
5071267|NCT03553693|Point-Of-Care Systems|point-of-care systems
5961162|NCT04288817|Intralesional tuberculin PPD|intralesional tuberculin ppd
5071268|NCT03553667|Hemodynamic Monitoring|hemodynamic monitoring
5071269|NCT03553667|Perioperative Care|perioperative care
5071270|NCT03553667|Outcome Assessment|outcome assessment
5071271|NCT03553641|capacity|capacity
5071272|NCT03553641|clinical ethics|clinical ethics
5071285|NCT03553602|Salvage Radiotherapy|salvage radiotherapy
5071286|NCT03553589|metabolomics|metabolomics
5071287|NCT03553589|proteomics|proteomics
5071288|NCT03553589|early diagnosis|early diagnosis
5071289|NCT03553589|prognosis|prognosis
5071290|NCT03553576|Labor pain|labor pain
5071291|NCT03553576|Epidural|epidural
5071292|NCT03553576|Obstetric|obstetric
5071293|NCT03553576|Labor Analgesia|labor analgesia
5071294|NCT03553563|D961H|d961h
5071295|NCT03553563|paediatric|paediatric
5071296|NCT03553563|reflux esophagitis|reflux esophagitis
5071297|NCT03553563|gastric ulcer|gastric ulcer
5071298|NCT03553537|Peripheral T-cell Lymphoma, decitabine|peripheral t-cell lymphoma, decitabine
5071299|NCT03553524|Type 2 Diabetes|type 2 diabetes
5071300|NCT03553524|Insulin independent|insulin independent
5071301|NCT03553524|HIIT|hiit
5071302|NCT03553524|CGM-based blood glucose|cgm-based blood glucose
5071303|NCT03553511|Laparoscopy|laparoscopy
5071304|NCT03553511|Hysterectomy|hysterectomy
5071305|NCT03553511|Uterosacral ligaments suspension|uterosacral ligaments suspension
5071306|NCT03553511|McCall culdoplasty|mccall culdoplasty
5071307|NCT03553511|Post-hysterectomy vault prolapse|post-hysterectomy vault prolapse
5071308|NCT03553498|pain|pain
5071309|NCT03553498|opioid analgesics|opioid analgesics
5071310|NCT03553498|Emergency Department|emergency department
5071311|NCT03553498|randomized controlled trial|randomized controlled trial
5071313|NCT03553498|hydromorphone|hydromorphone
5071314|NCT03553459|fluid responsiveness|fluid responsiveness
5071315|NCT03553459|trendelenburg|trendelenburg
5071316|NCT03553459|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5071317|NCT03553446|Sevoflurane|sevoflurane
5071318|NCT03553446|Motion|motion
5071319|NCT03553446|Botulinum toxins|botulinum toxins
5071320|NCT03553446|Cerebral palsy|cerebral palsy
5071321|NCT03553433|apremilast|apremilast
5071322|NCT03553433|quality of life|quality of life
5071323|NCT03553433|pruritus|pruritus
5071324|NCT03553433|oral drug|oral drug
5071325|NCT03553433|placebo|placebo
5071326|NCT03553420|lipodystrophy|lipodystrophy
5071327|NCT03553407|Low level laser|low level laser
5071328|NCT03553407|Pulpitis|pulpitis
5071329|NCT03553407|Mandibular molars|mandibular molars
5071330|NCT03553368|lung nodules|lung nodules
5071331|NCT03553355|infrared laser moxibustion|infrared laser moxibustion
5071332|NCT03553355|cancer-related fatigue|cancer-related fatigue
5071333|NCT03553355|breast cancer|breast cancer
5071334|NCT03553290|Dentistry|dentistry
5071335|NCT03553290|Dentinal Hypersensitivity|dentinal hypersensitivity
5071341|NCT03553277|transfluthrin|transfluthrin
5071342|NCT03553251|Hypersensitivity|hypersensitivity
5071343|NCT03553251|Beta Lactam Adverse Reaction|beta lactam adverse reaction
5908853|NCT04152551|OI|oi
5071344|NCT03553238|Early T-cell Precursor|early t-cell precursor
5071345|NCT03553238|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5071346|NCT03553238|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5071347|NCT03553238|Chidamide|chidamide
5071348|NCT03553225|vascular function|vascular function
5071349|NCT03553225|endothelial function|endothelial function
5071350|NCT03553225|polyphenols|polyphenols
5071351|NCT03553225|Concord Grape|concord grape
5071352|NCT03553212|Prostate cancer|prostate cancer
5071353|NCT03553212|organ-confined|organ-confined
5071354|NCT03553212|external beam Radiotherapy|external beam radiotherapy
5071355|NCT03553212|Image-guided tomotherapy|image-guided tomotherapy
5071356|NCT03553199|Tissue Retraction System|tissue retraction system
5071357|NCT03553199|Colorectal polyps|colorectal polyps
5071358|NCT03553173|Smoking Cessation|smoking cessation
5071360|NCT03553173|Decision Support System|decision support system
5071361|NCT03553147|denutrition screening tool|denutrition screening tool
5071362|NCT03553147|SARC-F score|sarc-f score
5071363|NCT03553147|denutrition in geriatric population|denutrition in geriatric population
5071364|NCT03553147|sarc-f score associated with denutrition|sarc-f score associated with denutrition
5071365|NCT03553121|gynecologic cancer|gynecologic cancer
5071366|NCT03553121|postoperative bowel function|postoperative bowel function
5071391|NCT03552965|Robust photon radiotherapy|robust photon radiotherapy
5071392|NCT03552965|Margin based radiotherapy|margin based radiotherapy
5071393|NCT03552939|microbiota|microbiota
5071394|NCT03552939|breast milk|breast milk
5071409|NCT03552887|Physiotherapy|physiotherapy
5071410|NCT03552887|Cardiac Surgery|cardiac surgery
5071411|NCT03552861|Parkinson's disease|parkinson's disease
5071412|NCT03552861|rTMS|rtms
5071413|NCT03552861|Dorsal prefrontal cortex|dorsal prefrontal cortex
5071414|NCT03552861|Depression|depression
5071415|NCT03552861|Cognitive impairment|cognitive impairment
5071416|NCT03552835|no caries removal|no caries removal
5071417|NCT03552835|partial caries removal upto soft dentin|partial caries removal upto soft dentin
5071418|NCT03552835|partial caries removal upto firm dentin|partial caries removal upto firm dentin
5961163|NCT04288804|Parkinson's Disease|parkinson's disease
5071419|NCT03552783|fathers|fathers
5071420|NCT03552783|parenting|parenting
5071421|NCT03552783|African American|african american
5071422|NCT03552770|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5071423|NCT03552770|bevacizumab|bevacizumab
5071424|NCT03552770|pro-re-nata regimens|pro-re-nata regimens
5071425|NCT03552770|clinical governance|clinical governance
5071426|NCT03552718|solid tumors|solid tumors
5071427|NCT03552692|BCL-2 positive|bcl-2 positive
5071428|NCT03552692|PTCL-NOS|ptcl-nos
5071429|NCT03552692|angioimmunoblastic T-cell lymphoma (AITL)|angioimmunoblastic t-cell lymphoma (aitl)
5071430|NCT03552692|T-follicular helper origin (TFH)|t-follicular helper origin (tfh)
5071431|NCT03552692|Venetoclax|venetoclax
5071930|NCT03549585|Emergency|emergency
5071442|NCT03552627|hyperoxia|hyperoxia
5071445|NCT03552627|perioperative|perioperative
5071449|NCT03552575|sacubritil|sacubritil
5071450|NCT03552575|valsartan|valsartan
5071451|NCT03552575|left ventricular remodelling|left ventricular remodelling
5071452|NCT03552575|asymptomatic left ventricular systolic dysfunction|asymptomatic left ventricular systolic dysfunction
5071453|NCT03552575|myocardial infarction|myocardial infarction
5071454|NCT03552523|bionic pancreas|bionic pancreas
5071455|NCT03552523|CGM|cgm
5071456|NCT03552497|Radiomics|radiomics
5071457|NCT03552497|Bosniak classification|bosniak classification
5071458|NCT03552497|Renal cell carcinoma|renal cell carcinoma
5071459|NCT03552497|Medical imaging|medical imaging
5071460|NCT03552458|oral mucositis|oral mucositis
5071461|NCT03552458|probiotics|probiotics
5071462|NCT03552458|anti-neoplastic chemotherapy|anti-neoplastic chemotherapy
5071463|NCT03552432|alirocumab|alirocumab
5071464|NCT03552432|Thin-cap fIbroatheroma (TCFA)|thin-cap fibroatheroma (tcfa)
5071465|NCT03552432|vulnerable plaque|vulnerable plaque
5071466|NCT03552432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
5071467|NCT03552419|Operating room leveling|operating room leveling
5071468|NCT03552419|Obstetric anesthesia|obstetric anesthesia
5071469|NCT03552419|Time to incision|time to incision
5071473|NCT03552367|Obesity|obesity
5071474|NCT03552367|Children|children
5071475|NCT03552367|Non-alcoholic fatty acid liver disease|non-alcoholic fatty acid liver disease
5071476|NCT03552367|Exercise|exercise
5071477|NCT03552367|Metabolic syndrome|metabolic syndrome
5071478|NCT03552367|Cardiovascular risk|cardiovascular risk
5071479|NCT03552341|Iodine|iodine
5071480|NCT03552341|Cognitive function|cognitive function
5071481|NCT03552341|Birth outcomes|birth outcomes
5071518|NCT03552068|Clonidine|clonidine
5071519|NCT03552068|Noradrenergic system|noradrenergic system
5071520|NCT03552055|placental proteins|placental proteins
5071525|NCT03552016|Myopia|myopia
5071526|NCT03552016|Axial Myopia|axial myopia
5071527|NCT03552016|Children|children
5071528|NCT03552016|Refractive Error|refractive error
5071529|NCT03552016|Riboflavin|riboflavin
5071530|NCT03552016|Vitamin B2|vitamin b2
5071531|NCT03552003|Hodgkin|hodgkin
5071532|NCT03552003|Elderly patients|elderly patients
5071533|NCT03552003|CGA|cga
5071535|NCT03551990|WB-EMS|wb-ems
5071536|NCT03551990|Cancer|cancer
5071537|NCT03551990|Muscle atrophy|muscle atrophy
5071538|NCT03551990|Muscle protein|muscle protein
5071539|NCT03551990|Exercise|exercise
5071540|NCT03551990|Muscle fiber|muscle fiber
5071541|NCT03551964|Acute myocardial infarction|acute myocardial infarction
5071542|NCT03551964|Cardiogenic shock|cardiogenic shock
5071543|NCT03551964|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5071544|NCT03551964|Dual antiplatelet therapy|dual antiplatelet therapy
5071545|NCT03551964|Cangrelor|cangrelor
5071546|NCT03551964|Ticagrelor|ticagrelor
5071547|NCT03551938|HIV, telehealth, HIV testing, YMSM, couples|hiv, telehealth, hiv testing, ymsm, couples
5071548|NCT03551873|Breast milk|breast milk
5071549|NCT03551873|Lactating|lactating
5071550|NCT03551860|Total hip replacement|total hip replacement
5071551|NCT03551860|Motor block post-operatively|motor block post-operatively
5071552|NCT03551860|Morphine consumption post-operatively|morphine consumption post-operatively
5071553|NCT03551860|Transmuscular Quadratus Nerve Block|transmuscular quadratus nerve block
5071554|NCT03551860|Fascia Iliaca Nerve Block|fascia iliaca nerve block
5071555|NCT03551704|Smoking|smoking
5071556|NCT03551704|Substance addiction|substance addiction
5071557|NCT03551704|Cocaine|cocaine
5071558|NCT03551704|Alcohol|alcohol
5071559|NCT03551704|Behavioral treatment|behavioral treatment
5071562|NCT03551665|Multiple Sclerosis|multiple sclerosis
5071563|NCT03551665|Falls|falls
5071564|NCT03551665|Posture|posture
5071565|NCT03551665|Rehabilitation|rehabilitation
5071566|NCT03551665|Cognition|cognition
5071567|NCT03551665|Neuroimaging|neuroimaging
5071568|NCT03551626|dabrafenib|dabrafenib
5071569|NCT03551626|trametinib|trametinib
5071570|NCT03551626|adjuvant|adjuvant
5071571|NCT03551626|melanoma|melanoma
5071572|NCT03551626|combination treatment|combination treatment
5071573|NCT03551626|pyrexia|pyrexia
5071574|NCT03551600|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5071575|NCT03551600|renal oxygen saturations|renal oxygen saturations
5961164|NCT04288804|Dysphonia|dysphonia
5071576|NCT03551600|splanchnic oxygen saturations|splanchnic oxygen saturations
5961165|NCT04288804|Tremor|tremor
5071577|NCT03551561|Chlorhexidine|chlorhexidine
5071578|NCT03551561|Infection|infection
5071579|NCT03551561|Orthopedics|orthopedics
5071580|NCT03551561|Surgical rooms|surgical rooms
5071581|NCT03551561|Antisepsis|antisepsis
5071599|NCT03551470|colorectal and synchronous liver metastases|colorectal and synchronous liver metastases
5738366|NCT00364013|Oncology|oncology
5071600|NCT03551470|simultaneous surgery|simultaneous surgery
5071601|NCT03551457|Patient Derived Xenograft|patient derived xenograft
5071602|NCT03551457|Treatment Response Phenotype|treatment response phenotype
5071603|NCT03551457|Personalised|personalised
5071604|NCT03551392|Cognitive Aging|cognitive aging
5071605|NCT03551392|Photobiomodulation|photobiomodulation
5071606|NCT03551392|Low Level Light Therapy|low level light therapy
5071607|NCT03551392|Near Infrared (NIR) Light|near infrared (nir) light
5071608|NCT03551392|Neuromodulation|neuromodulation
5071609|NCT03551379|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5071610|NCT03551366|Physical Activity|physical activity
5071611|NCT03551366|Physical Education|physical education
5071612|NCT03551366|Children|children
5071613|NCT03551366|Pedagogy|pedagogy
5071614|NCT03551366|Motor Competence|motor competence
5071615|NCT03551366|Perceived Motor Competence|perceived motor competence
5071616|NCT03551366|Self-perception|self-perception
5071617|NCT03551366|Cognition|cognition
5071618|NCT03551366|Fundamental Movement Skills|fundamental movement skills
5071619|NCT03551353|video feedback|video feedback
5071620|NCT03551353|checkout prosedures|checkout prosedures
5071621|NCT03551340|Gastroenteritis, panel by PCR, antibiotic use|gastroenteritis, panel by pcr, antibiotic use
5071622|NCT03551327|Post-stroke fatigue|post-stroke fatigue
5071623|NCT03551314|Non-invasive ventilation|non-invasive ventilation
5071624|NCT03551314|Preterm infant|preterm infant
5071625|NCT03551314|Breathing pattern|breathing pattern
5071626|NCT03551301|Substance Use Disorders|substance use disorders
5071627|NCT03551301|Case Management|case management
5071628|NCT03551301|Community Treatment|community treatment
5071629|NCT03551301|Hospital discharge|hospital discharge
5071630|NCT03551288|SUVN-911|suvn-911
5071631|NCT03551288|Depression|depression
5071632|NCT03551288|alpha4 beta2 receptor|alpha4 beta2 receptor
5071634|NCT03551275|Multiple Sclerosis|multiple sclerosis
5071635|NCT03551275|anti-CD20|anti-cd20
5071636|NCT03551210|nemonoxacin|nemonoxacin
5071637|NCT03551210|community-acquired pneumonia|community-acquired pneumonia
5071638|NCT03551210|quinolones|quinolones
5071639|NCT03551197|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5071640|NCT03551197|exercise|exercise
5071641|NCT03551197|lung function|lung function
4968364|NCT04187443|DME|dme
5071642|NCT03551197|quality of life|quality of life
5071643|NCT03551184|Sickness behavior|sickness behavior
5071644|NCT03551184|Endotoxin|endotoxin
5071645|NCT03551184|Lipopolysaccharide|lipopolysaccharide
5071646|NCT03551184|Psychoneuroimmunology|psychoneuroimmunology
5071647|NCT03551171|PARP inhibitor|parp inhibitor
5071648|NCT03551171|BRCA mutation|brca mutation
5071649|NCT03551132|elderly|elderly
5071650|NCT03551132|resistance training|resistance training
5071651|NCT03551132|health|health
5071652|NCT03551106|e-learning|e-learning
5071653|NCT03551106|web based learning module|web based learning module
5071654|NCT03551093|Ischemic Stroke|ischemic stroke
5071655|NCT03551093|Mild Acute Ischemic Stroke|mild acute ischemic stroke
5071656|NCT03551093|Safety|safety
5071657|NCT03551093|Signal of Efficacy|signal of efficacy
5071658|NCT03551080|Sickness behavior|sickness behavior
5071659|NCT03551080|Cytokines|cytokines
5071660|NCT03551080|Psychoneuroimmunology|psychoneuroimmunology
5071661|NCT03551067|Dexmedetomidine|dexmedetomidine
5071662|NCT03551067|Adenotonsillectomy|adenotonsillectomy
5071663|NCT03551067|Parental Separation|parental separation
5071664|NCT03551067|Face Mask Acceptance|face mask acceptance
5071665|NCT03551041|depression, self-referential, neural representation|depression, self-referential, neural representation
5071666|NCT03551015|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5071667|NCT03551015|Median sternotomy|median sternotomy
5071668|NCT03551015|Post-operative outpatient review|post-operative outpatient review
5071669|NCT03551015|Cardiac rehabilitation|cardiac rehabilitation
5071670|NCT03551015|Quality of life|quality of life
5071672|NCT03551002|Hepatitis C|hepatitis c
5083867|NCT03474315|Machine learning|machine learning
5071676|NCT03550989|Environmental Tobacco Smoke|environmental tobacco smoke
5071677|NCT03550989|Indoor Air Quality|indoor air quality
5071678|NCT03550898|Dynamic Ultrasonography|dynamic ultrasonography
5071679|NCT03550898|Spinal Dysraphism|spinal dysraphism
5071680|NCT03550885|microbiome, human|microbiome, human
5071682|NCT03550885|diet, western|diet, western
5071683|NCT03550872|heart failure, atrial fibrillation and exercise training|heart failure, atrial fibrillation and exercise training
5071684|NCT03550846|Spinal Fusion|spinal fusion
5071685|NCT03550833|Rheumatoid arthritis|rheumatoid arthritis
5071686|NCT03550833|Stress|stress
5071687|NCT03550820|pulmonary MAC|pulmonary mac
5071688|NCT03550820|energy metabolism|energy metabolism
5071689|NCT03550781|Takayasu Arteritis|takayasu arteritis
5071690|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents
5961166|NCT04288804|Neurological Disorder|neurological disorder
5071691|NCT03550781|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
5071692|NCT03550768|ERCP|ercp
5128339|NCT03192020|Xiapex|xiapex
5071693|NCT03550768|anatomy of major duodenal papilla|anatomy of major duodenal papilla
5071694|NCT03550755|cervix|cervix
5071695|NCT03550755|uterus|uterus
5071696|NCT03550742|Human Milk Oligosaccharides|human milk oligosaccharides
5071697|NCT03550742|IBS-C|ibs-c
5071698|NCT03550742|IBS-D|ibs-d
5071699|NCT03550742|IBS-M|ibs-m
5071700|NCT03550729|Exercise training|exercise training
5071701|NCT03550729|Biomarkers|biomarkers
5071702|NCT03550716|azoospermia|azoospermia
5071703|NCT03550716|microdissection testicular sperm extraction|microdissection testicular sperm extraction
5071704|NCT03550716|testicular sperm aspiration|testicular sperm aspiration
5071705|NCT03550716|male infertility|male infertility
5071706|NCT03550716|surgical sperm retrieval|surgical sperm retrieval
5071707|NCT03550677|Ankle nerve block|ankle nerve block
5071708|NCT03550677|post operative analgesia|post operative analgesia
5071709|NCT03550677|patient satisfaction|patient satisfaction
5071710|NCT03550677|foot surgery|foot surgery
5071711|NCT03550651|Plaque|plaque
5071712|NCT03550651|Plaque regrowth|plaque regrowth
5071713|NCT03550651|Licorice extract|licorice extract
5071714|NCT03550651|Mouthrinse|mouthrinse
5071715|NCT03550651|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
5071716|NCT03550651|Hypertonic salt solution|hypertonic salt solution
5071717|NCT03550651|Essential oils|essential oils
5071718|NCT03550573|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5071719|NCT03550573|sudden death|sudden death
5071720|NCT03550573|3D mapping|3d mapping
5071721|NCT03550560|Endoscopic Ultrasound-Guided|endoscopic ultrasound-guided
5071722|NCT03550560|EUS-Guided|eus-guided
5071723|NCT03550560|Transgastric plastic prostheses|transgastric plastic prostheses
5071724|NCT03550547|Physical Activity|physical activity
5071725|NCT03550547|Education|education
5071726|NCT03550547|Dietary|dietary
5071727|NCT03550547|Self-management|self-management
5071728|NCT03550534|Calcium carbonate|calcium carbonate
5071729|NCT03550534|Chronic kidney disease|chronic kidney disease
5071730|NCT03550534|Normophosphatemia|normophosphatemia
5071731|NCT03550534|FGF23|fgf23
5071732|NCT03550534|Phosphate binder|phosphate binder
5071733|NCT03550508|JMT103 in Patients with Bone Metastases from Tumors|jmt103 in patients with bone metastases from tumors
5071734|NCT03550495|ICU delirium|icu delirium
5071735|NCT03550495|prevention|prevention
5071736|NCT03550495|psychiatry|psychiatry
5071737|NCT03550482|Oncoxin|oncoxin
5071738|NCT03550482|Nutritional supplement|nutritional supplement
5071739|NCT03550482|Chemotherapy|chemotherapy
5071740|NCT03550482|Oxidative stress|oxidative stress
5071741|NCT03550482|Antioxidant|antioxidant
5071742|NCT03550469|hyperoxia|hyperoxia
5071743|NCT03550469|hypoxia|hypoxia
5071744|NCT03550456|Exercise Induced Asthma (EIA)|exercise induced asthma (eia)
5071745|NCT03550456|Exercise Induced Laryngeal Obstruction (EILO)|exercise induced laryngeal obstruction (eilo)
5071746|NCT03550456|Quality of life|quality of life
5071747|NCT03550456|Exercise challenge in cold chamber (ECC)|exercise challenge in cold chamber (ecc)
5071748|NCT03550456|Continous laryngoscopy while exercising (CLE)|continous laryngoscopy while exercising (cle)
5071749|NCT03550443|Bardoxolone Methyl|bardoxolone methyl
5071750|NCT03550443|Diabetic Kidney Disease|diabetic kidney disease
5071751|NCT03550443|Diabetes Mellitus|diabetes mellitus
5071752|NCT03550443|Kidney Diseases|kidney diseases
5071753|NCT03550430|tinnitus distress|tinnitus distress
5071754|NCT03550430|tinnitus intrusiveness|tinnitus intrusiveness
5071755|NCT03550430|synchronization by loss of inhibition model (SLIM)|synchronization by loss of inhibition model (slim)
5071756|NCT03550430|neurofeedback|neurofeedback
5071757|NCT03550430|alpha/delta neurofeedback|alpha/delta neurofeedback
5071758|NCT03550430|beta/theta neurofeedback|beta/theta neurofeedback
5071759|NCT03550430|electroencephalography (EEG)|electroencephalography (eeg)
5083970|NCT03473834|Turning|turning
5071773|NCT03550352|Inflammation|inflammation
5071774|NCT03550352|Immune activation|immune activation
5071775|NCT03550339|obesity|obesity
5071776|NCT03550339|appetite|appetite
5071777|NCT03550339|food reward|food reward
5071778|NCT03550339|hormonal responses|hormonal responses
5071779|NCT03550339|psychophysiological responses|psychophysiological responses
5071780|NCT03550339|implicit measures|implicit measures
5071781|NCT03550339|explicit measures|explicit measures
5071782|NCT03550326|anesthesia|anesthesia
5071783|NCT03550326|difficult airway|difficult airway
5071784|NCT03550326|supraglottic airway device|supraglottic airway device
5071785|NCT03550326|difficult intubation|difficult intubation
5071786|NCT03550326|airway complications|airway complications
5071787|NCT03550274|Acute lateral ankle sprain|acute lateral ankle sprain
5071788|NCT03550274|Acute ankle injury|acute ankle injury
5071789|NCT03550274|Ankle sprain|ankle sprain
5071790|NCT03550274|Exercise therapy|exercise therapy
5071791|NCT03550274|App-based rehabilitation|app-based rehabilitation
5071792|NCT03550274|Mixed-method|mixed-method
5071793|NCT03550274|Pilot Study|pilot study
5071795|NCT03550261|Salt-wasting|salt-wasting
5961167|NCT04288804|Web-based|web-based
5071797|NCT03550261|plasma and urine steroid profile|plasma and urine steroid profile
5071798|NCT03550261|Fludrocortisone|fludrocortisone
5071799|NCT03550248|Healthy Weights|healthy weights
5071800|NCT03550248|Health Promotion|health promotion
5071801|NCT03550248|Scale-up|scale-up
5071802|NCT03550248|Family Health|family health
5071803|NCT03550248|Prevention|prevention
5071804|NCT03550248|Childhood Obesity|childhood obesity
5071805|NCT03550248|Physical Activity|physical activity
5071806|NCT03550248|Cooking Activity|cooking activity
5071807|NCT03550248|Family education model|family education model
5071808|NCT03550235|Heart failure|heart failure
5071809|NCT03550235|dyspnea|dyspnea
5071810|NCT03550235|stress test|stress test
5071811|NCT03550222|Diaphragmatic dysfunction|diaphragmatic dysfunction
5071812|NCT03550222|Mechanical Ventilation|mechanical ventilation
5071813|NCT03550222|ICU acquired weakness|icu acquired weakness
5071814|NCT03550222|Weaning|weaning
5071815|NCT03550222|Skeletal muscles|skeletal muscles
5071816|NCT03550222|Respiratory muscles|respiratory muscles
5071817|NCT03550170|Fatigue|fatigue
5071818|NCT03550170|Wellness|wellness
5071819|NCT03550170|Multiple Sclerosis|multiple sclerosis
5071820|NCT03550170|Quality of life|quality of life
5071821|NCT03550157|Cellulite|cellulite
5071822|NCT03550157|Cutaneous ultrasound|cutaneous ultrasound
5071823|NCT03550157|PnKCelulitis® program|pnkcelulitis® program
5071825|NCT03550144|Compassion|compassion
5071826|NCT03550144|Anxiety|anxiety
5071838|NCT03550105|Muscle Strength|muscle strength
5071839|NCT03550105|Muscle Endurance|muscle endurance
5071840|NCT03550105|Hypertension|hypertension
5071841|NCT03550105|Physical Inactivity|physical inactivity
5071842|NCT03550092|aphasia|aphasia
5071843|NCT03550092|treatment|treatment
5071844|NCT03550092|therapy|therapy
5071845|NCT03550092|anomia|anomia
5071846|NCT03550092|fMRI|fmri
5071847|NCT03550092|neuroimaging|neuroimaging
5071848|NCT03550092|semantics|semantics
5071849|NCT03550066|Diabetes, gestational|diabetes, gestational
5071850|NCT03550066|Diabetes Mellitus|diabetes mellitus
5071851|NCT03550040|radical prostatectomy|radical prostatectomy
5071852|NCT03550040|laparoscopic prostatectomy|laparoscopic prostatectomy
5071853|NCT03550040|robot assisted prostatectomy|robot assisted prostatectomy
5071854|NCT03550014|Low Back Pain|low back pain
5071855|NCT03550014|Hip|hip
5071856|NCT03550014|Physical Therapy|physical therapy
5071857|NCT03550001|locally advanced rectal cancer|locally advanced rectal cancer
5071858|NCT03550001|lymph node yeild|lymph node yeild
5071859|NCT03550001|lymph node tracer|lymph node tracer
5071860|NCT03550001|stage shift|stage shift
5071861|NCT03550001|prognosis|prognosis
5071862|NCT03549988|Ulcerative colitis|ulcerative colitis
5071863|NCT03549988|Fecal calprotectin|fecal calprotectin
5071866|NCT03549975|botulinum toxin|botulinum toxin
5071867|NCT03549975|functional electrical stimulation|functional electrical stimulation
5071868|NCT03549962|Preoperative|preoperative
5071869|NCT03549962|Nutritional Status|nutritional status
5071870|NCT03549962|Arthroplasty|arthroplasty
5071871|NCT03549962|Replacement|replacement
5071872|NCT03549962|Osteoarthritis|osteoarthritis
5071873|NCT03549962|Knee|knee
5071874|NCT03549949|pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
5071875|NCT03549936|NAS, low lactose formula|nas, low lactose formula
5071876|NCT03549923|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5071877|NCT03549923|renal replacement therapy|renal replacement therapy
5071878|NCT03549923|beta-blocker|beta-blocker
5071879|NCT03549884|Early cord Clamping|early cord clamping
5071880|NCT03549884|Delayed cord clamping|delayed cord clamping
5071881|NCT03549884|Full term infant|full term infant
5071882|NCT03549884|Elective cesarean section|elective cesarean section
5071883|NCT03549884|Hematocrit|hematocrit
5071884|NCT03549884|Postnatal adaptation|postnatal adaptation
5071892|NCT03549832|HCV|hcv
5071893|NCT03549832|DAAs|daas
5071894|NCT03549832|Non-responder|non-responder
5071895|NCT03549819|Anxiety Disorders|anxiety disorders
5071896|NCT03549819|Cannabidiol|cannabidiol
5071897|NCT03549819|Cannabis|cannabis
5071898|NCT03549806|Atrium, tachyarrhythmias|atrium, tachyarrhythmias
5071899|NCT03549780|Brooke Ileostomy|brooke ileostomy
5071900|NCT03549780|stoma|stoma
5071901|NCT03549780|ileostomy|ileostomy
5071906|NCT03549728|endometriosis|endometriosis
5071907|NCT03549728|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5071908|NCT03549728|recurrent implantation failure|recurrent implantation failure
5071909|NCT03549676|FMT|fmt
5071910|NCT03549676|GVHD|gvhd
5071911|NCT03549676|HSCT|hsct
5071912|NCT03549650|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
5071914|NCT03549637|Psychiatry, hypobetalipoproteinemia, LDL-Cholesterol|psychiatry, hypobetalipoproteinemia, ldl-cholesterol
5071915|NCT03549611|ureteroscopy|ureteroscopy
5071916|NCT03549611|opioids|opioids
5071917|NCT03549611|narcotics|narcotics
5071918|NCT03549611|text messaging|text messaging
5071919|NCT03549611|real time data acquisition|real time data acquisition
5071920|NCT03549611|ecologic momentary assessments|ecologic momentary assessments
5071921|NCT03549611|pre-emptive analgesia|pre-emptive analgesia
5071922|NCT03549611|gabapentin|gabapentin
5071923|NCT03549611|meloxicam|meloxicam
5071924|NCT03549611|tamsulosin|tamsulosin
5071925|NCT03549611|kidney stones|kidney stones
5071926|NCT03549611|lithotripsy|lithotripsy
5071927|NCT03549611|nephrolithiasis|nephrolithiasis
5071928|NCT03549585|End of life|end of life
5071929|NCT03549585|Spotting|spotting
5071940|NCT03549533|Aluminum|aluminum
5071941|NCT03549533|Sperm|sperm
5071942|NCT03549533|DNA methylation|dna methylation
5071943|NCT03549533|DNA fragmentation|dna fragmentation
5071944|NCT03549533|Seminal plasma|seminal plasma
5071945|NCT03549520|Ultrasound|ultrasound
5071946|NCT03549520|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5071947|NCT03549507|Ultrasound|ultrasound
5071948|NCT03549507|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5071949|NCT03549481|risk score|risk score
5071950|NCT03549481|acute coronary syndrome|acute coronary syndrome
5071951|NCT03549481|left ventricular remodelng|left ventricular remodelng
5071952|NCT03549468|ischemic cardiomyopathy; neuromodulation; repolarization alternans|ischemic cardiomyopathy; neuromodulation; repolarization alternans
5071953|NCT03549455|anxious|anxious
5071954|NCT03549455|anxiety|anxiety
5071955|NCT03549442|Multiple Myeloma|multiple myeloma
5071956|NCT03549442|BCMA CART|bcma cart
5071957|NCT03549442|huCART19|hucart19
5071958|NCT03549416|Atopic dermatitis|atopic dermatitis
5071959|NCT03549416|Dupilumab|dupilumab
5071960|NCT03549416|Dupixent|dupixent
5071961|NCT03549416|BioDay|bioday
5071962|NCT03549416|Daily practice|daily practice
5071963|NCT03549416|Real world|real world
5071964|NCT03549416|Atopic Diseases Registry|atopic diseases registry
5071965|NCT03549416|Registry|registry
5071966|NCT03549416|Multi center|multi center
5071967|NCT03549403|Telephone education|telephone education
5071968|NCT03549403|Effectiveness|effectiveness
5071969|NCT03549403|Health|health
5071970|NCT03549403|Cost|cost
5071971|NCT03549403|Day surgery|day surgery
5071972|NCT03549403|Adult patient|adult patient
5071973|NCT03549390|Type 2 diabetes|type 2 diabetes
5071974|NCT03549390|ethnicity|ethnicity
5071975|NCT03549390|physical activity|physical activity
5071976|NCT03549390|yoga|yoga
5071977|NCT03549377|Sleep|sleep
5071978|NCT03549377|Academic functioning|academic functioning
5071979|NCT03549377|Problem behaviors|problem behaviors
5071980|NCT03549377|College age youth|college age youth
5071981|NCT03549377|Self-regulation|self-regulation
5071982|NCT03549351|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5071983|NCT03549351|measurable residual disease|measurable residual disease
5071984|NCT03549351|surrogate endpoint|surrogate endpoint
5072000|NCT03549312|Opioid Substitution Therapy|opioid substitution therapy
5072001|NCT03549312|Buprenorphine/Naloxone|buprenorphine/naloxone
5072010|NCT03549286|Pregnancy|pregnancy
5072011|NCT03549286|Down's syndrome|down's syndrome
5072012|NCT03549286|non invasive prenatal testing|non invasive prenatal testing
5072013|NCT03549273|carcinoma|carcinoma
5072014|NCT03549273|intraepithelial cervix lesions|intraepithelial cervix lesions
5072015|NCT03549273|Oxidative Stress|oxidative stress
5072016|NCT03549273|Ocoxin Viusid|ocoxin viusid
5072017|NCT03549273|Glizigen Spray|glizigen spray
5072018|NCT03549260|low density lipoprotein cholesterol|low density lipoprotein cholesterol
5072019|NCT03549260|PCSK9|pcsk9
5072020|NCT03549247|OHIP-14|ohip-14
5072021|NCT03549247|Periodontitis|periodontitis
5072022|NCT03549234|Regional anesthesia|regional anesthesia
5072023|NCT03549234|Paravertebral|paravertebral
5072024|NCT03549234|Erector spinae|erector spinae
5072025|NCT03549234|Nerve block|nerve block
5072026|NCT03549221|total knee arthroplasty|total knee arthroplasty
5072027|NCT03549221|multimodal anesthetic cocktail|multimodal anesthetic cocktail
5072028|NCT03549221|adrenaline|adrenaline
5072029|NCT03549221|morphine consumption|morphine consumption
5072030|NCT03549221|blood loss|blood loss
5072031|NCT03549221|Levobupivacaine|levobupivacaine
5072032|NCT03549182|acute tryptophan depletion|acute tryptophan depletion
5072033|NCT03549182|tryptophan hydroxylase 2 gene|tryptophan hydroxylase 2 gene
5072034|NCT03549182|emotion|emotion
5072039|NCT03549156|Moderate Acute Malnutrition, Malnutrition|moderate acute malnutrition, malnutrition
5072040|NCT03549143|IBS; Irritable Bowel Syndrome; spasmolytics; mebeverine; Duspatalin|ibs; irritable bowel syndrome; spasmolytics; mebeverine; duspatalin
5072041|NCT03549104|fear of hypoglycemia|fear of hypoglycemia
5072042|NCT03549104|glycemic control|glycemic control
5072043|NCT03549104|glycemic variability|glycemic variability
5072044|NCT03549104|self-management behavior|self-management behavior
5072045|NCT03549065|Brain stimulation|brain stimulation
5071359|NCT03553173|App|app
5072060|NCT03549000|A2aR|a2ar
5072061|NCT03549000|Adenosine|adenosine
5072062|NCT03548974|Multiple Sclerosis|multiple sclerosis
5072063|NCT03548974|Spasticity|spasticity
5072064|NCT03548974|MOTOmed training|motomed training
5072065|NCT03548974|internet|internet
5072066|NCT03548922|Risser|risser
5072067|NCT03548922|Tanner|tanner
5072068|NCT03548922|pressure of correction|pressure of correction
5072069|NCT03548909|NT-proBNP|nt-probnp
5072070|NCT03548896|implant|implant
5072071|NCT03548857|Muscle dysfunction|muscle dysfunction
5072072|NCT03548857|Cardiovascular regulation|cardiovascular regulation
5072073|NCT03548857|Lung transplantation (LTx)|lung transplantation (ltx)
5072074|NCT03548831|Minilaparotomy|minilaparotomy
5072075|NCT03548831|Hysterectomy|hysterectomy
5072076|NCT03548831|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
5072077|NCT03548831|Benign|benign
5072078|NCT03548831|Gynaecology|gynaecology
5072079|NCT03548792|Arthroplasty Knee|arthroplasty knee
5072081|NCT03548753|Chest pain|chest pain
5072082|NCT03548753|Diagnostic tests|diagnostic tests
5072093|NCT03548714|Ethanol use|ethanol use
5072094|NCT03548701|Thromboelastometry|thromboelastometry
5072095|NCT03548701|Vaginal Bleeding|vaginal bleeding
5072096|NCT03548701|Early Pregnancy|early pregnancy
5072097|NCT03548688|Bladder Cancer|bladder cancer
5072098|NCT03548688|Haematuria|haematuria
5072099|NCT03548688|Collaborative study|collaborative study
5072100|NCT03548675|Pharmacogenetics|pharmacogenetics
5072101|NCT03548675|Antidepressive Agents|antidepressive agents
5072102|NCT03548662|Rotator Cuff Tear|rotator cuff tear
5072103|NCT03548662|Platelet Rich Plasma|platelet rich plasma
5072104|NCT03548662|Ultrasound|ultrasound
5072105|NCT03548662|Exercise|exercise
5072106|NCT03548662|Hyaluronic Acid|hyaluronic acid
5072107|NCT03548649|spinal cord injury|spinal cord injury
5072108|NCT03548649|complete spinal cord injury|complete spinal cord injury
5072109|NCT03548649|incomplete spinal cord injury|incomplete spinal cord injury
5072110|NCT03548649|exoskeleton robot|exoskeleton robot
5072111|NCT03548649|gait training|gait training
5072112|NCT03548649|security testing|security testing
5072113|NCT03548649|functional testing|functional testing
5072118|NCT03548610|nanofat|nanofat
5072119|NCT03548610|tumor defect|tumor defect
5072120|NCT03548584|Agitation|agitation
5072121|NCT03548558|Early Childhood Development|early childhood development
5072122|NCT03548558|Parenting Behaviors|parenting behaviors
5072123|NCT03548558|Group-based curriculum|group-based curriculum
5072124|NCT03548558|Kenya|kenya
5072125|NCT03548558|Child Outcomes|child outcomes
5072126|NCT03548558|Community Health Volunteers|community health volunteers
5072127|NCT03548545|MDD|mdd
5072128|NCT03548545|CBT|cbt
5072129|NCT03548545|tDCS|tdcs
5072130|NCT03548532|temperature|temperature
5072131|NCT03548506|STN|stn
5072132|NCT03548506|DBS|dbs
5072133|NCT03548506|steering|steering
5072134|NCT03548506|segmented electrode leads|segmented electrode leads
5072135|NCT03548493|Magnesium sulphate|magnesium sulphate
5072136|NCT03548493|Fentanyl|fentanyl
5072137|NCT03548493|Conscious sedation|conscious sedation
5072151|NCT03548376|postural control|postural control
5072153|NCT03548376|gross-motor function|gross-motor function
5072154|NCT03548376|quality of life|quality of life
5072155|NCT03548376|hippotherapy|hippotherapy
5072156|NCT03548324|Feeding Tolerance|feeding tolerance
5072158|NCT03548324|HFNC|hfnc
5072159|NCT03548324|NCPAP|ncpap
5072160|NCT03548324|Preterm|preterm
5072161|NCT03548324|NEC|nec
5072162|NCT03548324|Enteral Nutrition|enteral nutrition
5072163|NCT03548324|Non Invasive Respiratory Support|non invasive respiratory support
5428260|NCT01595451|Effects of Acupuncture|effects of acupuncture
5072177|NCT03548155|schizophrenia；berberine；symptoms；inflammation|schizophrenia；berberine；symptoms；inflammation
5072179|NCT03548142|advanced dementia|advanced dementia
5072180|NCT03548142|life-prolonging treatment|life-prolonging treatment
5072181|NCT03548142|patient will|patient will
5072182|NCT03548142|advanced care planning|advanced care planning
5072183|NCT03548116|Healthy Volunteer|healthy volunteer
5072184|NCT03548116|Ultrasound|ultrasound
5072185|NCT03548116|Insonification|insonification
5072186|NCT03548116|Spleen|spleen
5072187|NCT03548090|stroke rehabilitation|stroke rehabilitation
5072188|NCT03548090|walking limitations|walking limitations
5072189|NCT03548090|gait rehabilitation|gait rehabilitation
5072204|NCT03548038|taste perception|taste perception
5072205|NCT03548038|bariatric surgery|bariatric surgery
5072206|NCT03548038|taste preference|taste preference
5072207|NCT03548038|weight loss surgery|weight loss surgery
5072210|NCT03548012|Intervention|intervention
5072211|NCT03548012|Randomised controlled trial|randomised controlled trial
5072212|NCT03547999|CV301 Vaccination|cv301 vaccination
5072213|NCT03547999|mFOLFOX6|mfolfox6
5072214|NCT03547999|Fowlpox (FP)-CV301|fowlpox (fp)-cv301
5072215|NCT03547999|nivolumab|nivolumab
5072216|NCT03547999|MVA-BN-CV301|mva-bn-cv301
5072217|NCT03547986|flow-limiting dissection|flow-limiting dissection
5072218|NCT03547986|residual stenosis|residual stenosis
5072219|NCT03547960|Gestational diabetes|gestational diabetes
5072220|NCT03547934|Abdominal fat|abdominal fat
5072221|NCT03547882|Opioid|opioid
5072222|NCT03547882|Buprenorphine|buprenorphine
5072223|NCT03547882|Naltrexone|naltrexone
5961168|NCT04288804|Neurological Disease|neurological disease
5072224|NCT03547882|methadone|methadone
5072225|NCT03547869|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5072226|NCT03547869|Gulf War Illness|gulf war illness
5072227|NCT03547869|Pain modulation|pain modulation
5961169|NCT04288765|Newly diagnosed|newly diagnosed
5072228|NCT03547843|Behavior therapy|behavior therapy
5072229|NCT03547843|Peer groups|peer groups
5072230|NCT03547843|Patient satisfaction|patient satisfaction
5072231|NCT03547843|Feasibility studies|feasibility studies
5072232|NCT03547830|chronic granulomatous disease|chronic granulomatous disease
5072233|NCT03547830|graft failure|graft failure
5072234|NCT03547830|stem cell transplantation|stem cell transplantation
5072235|NCT03547830|plerixafor|plerixafor
5072236|NCT03547830|conditioning regimen|conditioning regimen
5072237|NCT03547791|Antenatal corticosteroid|antenatal corticosteroid
5072238|NCT03547791|Twin pregnancies|twin pregnancies
5072239|NCT03547791|Respiratory morbidity|respiratory morbidity
5072240|NCT03547791|Randomized controlled trial|randomized controlled trial
5072241|NCT03547765|Obesity|obesity
5072242|NCT03547765|Sexual Dysfunction|sexual dysfunction
5072243|NCT03547752|motor imaginery|motor imaginery
5072244|NCT03547752|mental training|mental training
5072245|NCT03547687|Electrical stimulation|electrical stimulation
5072246|NCT03547687|Intubation|intubation
5072247|NCT03547687|ICU discharge|icu discharge
5072248|NCT03547661|Premenstrual Syndrome|premenstrual syndrome
5072249|NCT03547661|Open-Label Placebo Effect|open-label placebo effect
5072250|NCT03547661|randomized controlled trial|randomized controlled trial
5072251|NCT03547609|Kabuki Syndrome|kabuki syndrome
5072252|NCT03547609|Intellectual Profile|intellectual profile
5072253|NCT03547609|Memory|memory
5072254|NCT03547596|Lower urinary tract symptoms|lower urinary tract symptoms
5072255|NCT03547596|Erectile dysfunction|erectile dysfunction
5072256|NCT03547596|Obstructive Sleep Apneas Syndrom|obstructive sleep apneas syndrom
5072257|NCT03547570|Joint instability|joint instability
5072258|NCT03547570|Hypermobility|hypermobility
5072259|NCT03547570|Shoulder|shoulder
5887185|NCT04268641|Stroke|stroke
5072260|NCT03547570|Strength training|strength training
5072271|NCT03547505|ProGlider|proglider
5072272|NCT03547492|language|language
5072273|NCT03547492|LENA|lena
5072274|NCT03547492|adolescent|adolescent
5072275|NCT03547453|Menstrual cycles|menstrual cycles
5072276|NCT03547453|Ultrasound|ultrasound
5072277|NCT03547453|Ovary|ovary
5072278|NCT03547453|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5072279|NCT03547440|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5072280|NCT03547440|immigrant|immigrant
5072281|NCT03547440|microbiota|microbiota
5072282|NCT03547440|bioindicator|bioindicator
5072283|NCT03547440|Methanobrevibacter smithii|methanobrevibacter smithii
5072284|NCT03547427|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5072285|NCT03547427|Pramlintide|pramlintide
5072286|NCT03547427|Lispro Insulin|lispro insulin
5072287|NCT03547427|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5072288|NCT03547427|Acetaminophen|acetaminophen
5072289|NCT03547427|Hypoglycemia|hypoglycemia
5072290|NCT03547427|Exercise|exercise
5072291|NCT03547388|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5072292|NCT03547388|hyperthermia|hyperthermia
5072293|NCT03547388|hypoxia|hypoxia
5072294|NCT03547388|18f-fluoromisonidazole|18f-fluoromisonidazole
5072295|NCT03547388|positron emission tomography|positron emission tomography
5072296|NCT03547388|FMISO|fmiso
5072298|NCT03547388|whole body hyperthermia|whole body hyperthermia
5072299|NCT03547388|local recurrence|local recurrence
5072300|NCT03547388|lymph node recurrence|lymph node recurrence
5072301|NCT03547388|radiochemotherapy|radiochemotherapy
5072302|NCT03547362|Amino acids|amino acids
5072303|NCT03547362|Dairy proteins|dairy proteins
5072304|NCT03547362|Postprandial|postprandial
5072305|NCT03547362|Older adults|older adults
5072306|NCT03547349|respiratory therapy|respiratory therapy
5072312|NCT03547310|Neuromuscular rehabilitation|neuromuscular rehabilitation
5072313|NCT03547310|Games for health|games for health
5072314|NCT03547297|Acute Hepatic Porphyria|acute hepatic porphyria
5072315|NCT03547297|Hepatic Porphyrias|hepatic porphyrias
5072316|NCT03547297|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
5072317|NCT03547297|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
5072318|NCT03547297|Variegate Porphyria (VP)|variegate porphyria (vp)
5072319|NCT03547297|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
5072320|NCT03547297|Porphyria Acute|porphyria acute
5072321|NCT03547271|Meningococcal meningitis|meningococcal meningitis
5072322|NCT03547271|MenACYW conjugate vaccine|menacyw conjugate vaccine
5072323|NCT03547271|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
5072325|NCT03547258|Italian observational study|italian observational study
5072326|NCT03547258|FLT3-ITD Mutation|flt3-itd mutation
5072327|NCT03547258|FLT3-TKD Mutation|flt3-tkd mutation
5072328|NCT03547232|Acute pancreatitis|acute pancreatitis
5072329|NCT03547232|Indomethacin|indomethacin
5072330|NCT03547232|Prognosis|prognosis
5072331|NCT03547232|Organ dysfunction|organ dysfunction
5072332|NCT03547219|Depression|depression
5072333|NCT03547219|Adolescent|adolescent
5072334|NCT03547219|Biomarker|biomarker
5072335|NCT03547219|Inflammation|inflammation
5072336|NCT03547219|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
5961170|NCT04288739|AML|aml
5072337|NCT03547219|Functional MRI|functional mri
5072338|NCT03547219|Antidepressant|antidepressant
5072339|NCT03547219|Machine learning|machine learning
5072340|NCT03547206|NAION|naion
5072341|NCT03547206|ischemic optic neuropathy|ischemic optic neuropathy
5072342|NCT03547193|difficult laringoscopy|difficult laringoscopy
5072343|NCT03547193|difficult airway|difficult airway
5072344|NCT03547193|airway management|airway management
5072345|NCT03547180|Respiration panic|respiration panic
5072346|NCT03547180|Cognitions|cognitions
5072347|NCT03547180|Panic|panic
5072348|NCT03547180|Treatment|treatment
5072349|NCT03547180|Mediators|mediators
5072350|NCT03547180|Moderators|moderators
5072351|NCT03547128|fluoride|fluoride
5072352|NCT03547128|genetics|genetics
5072353|NCT03547128|physical activity|physical activity
5072354|NCT03547128|diet|diet
5072355|NCT03547115|B-Cell Malignancies, AML, Voruciclib, Cyclin Dependent Kinase Inhibitor|b-cell malignancies, aml, voruciclib, cyclin dependent kinase inhibitor
5071590|NCT03551509|ECM|ecm
5072359|NCT03547076|Nurse|nurse
5072360|NCT03547076|Focused cardiac ultrasound|focused cardiac ultrasound
5072361|NCT03547076|FoCUS|focus
5072362|NCT03547076|Telemedicine|telemedicine
5072363|NCT03547076|Support|support
5072364|NCT03547063|Obesity, appetite, taste, fMRI|obesity, appetite, taste, fmri
5072365|NCT03547050|Epilepsy|epilepsy
5072366|NCT03547050|Rolandic|rolandic
5072367|NCT03547050|Genetics|genetics
5072368|NCT03547050|Genomewide Association Study|genomewide association study
5072370|NCT03547050|Neurology|neurology
5072371|NCT03547050|Pediatrics|pediatrics
5072372|NCT03546998|epidermoid carcinoma|epidermoid carcinoma
5072373|NCT03546998|esophageal achalasia|esophageal achalasia
5072374|NCT03546998|risk factors|risk factors
5072375|NCT03546959|stroke|stroke
5072376|NCT03546959|spasticity|spasticity
5072377|NCT03546959|lycra|lycra
5072378|NCT03546959|orthosis|orthosis
5072379|NCT03546959|splint|splint
5072380|NCT03546959|treatment|treatment
5072381|NCT03546959|upper extremity|upper extremity
5072382|NCT03546946|Attention|attention
5072383|NCT03546946|Anxiety|anxiety
5072384|NCT03546946|Adolescence|adolescence
5072385|NCT03546894|Drug Therapy|drug therapy
5072386|NCT03546881|PAOD|paod
5072387|NCT03546881|endovascular|endovascular
5072388|NCT03546881|fusion|fusion
5072389|NCT03546881|radiation|radiation
5072390|NCT03546881|exposure|exposure
5072391|NCT03546790|Cannabis|cannabis
5072392|NCT03546777|Shoulder pain, coracoacromial ligament thickness|shoulder pain, coracoacromial ligament thickness
5072393|NCT03546764|Percutatneous catheter|percutatneous catheter
5072394|NCT03546764|chest tube|chest tube
5072395|NCT03546764|trauma|trauma
5072396|NCT03546764|hemothorax|hemothorax
5072397|NCT03546751|Endothelial Dysfunction|endothelial dysfunction
5072398|NCT03546751|Micro RNA|micro rna
5072399|NCT03546738|Lumbar Vertebrae|lumbar vertebrae
5072400|NCT03546738|Surgery|surgery
5072401|NCT03546738|Postoperational Complications|postoperational complications
5072402|NCT03546738|Spinal Cord Stimulation|spinal cord stimulation
5072403|NCT03546712|Acuity|acuity
5072404|NCT03546712|children|children
5072405|NCT03546712|forearm|forearm
5072406|NCT03546712|perception|perception
5072407|NCT03546712|touch location|touch location
5072408|NCT03546686|Hormone Receptor Negative|hormone receptor negative
5072409|NCT03546686|Her2- Negative|her2- negative
5072410|NCT03546686|Resectable Breast Cancer|resectable breast cancer
5072411|NCT03546686|breast cancer|breast cancer
5072412|NCT03546686|immunotherapy|immunotherapy
5072413|NCT03546686|Ipilimumab|ipilimumab
5072414|NCT03546686|Nivolumab|nivolumab
5072415|NCT03546686|Cryoablation|cryoablation
5072416|NCT03546673|Chinese breast cancer survivors expressive writing|chinese breast cancer survivors expressive writing
5072418|NCT03546660|Eosinophilic Esophagitis|eosinophilic esophagitis
5072419|NCT03546660|Barrett's Esophagus|barrett's esophagus
5072420|NCT03546660|Capsule|capsule
5072421|NCT03546660|SECM|secm
5072422|NCT03546660|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
5072423|NCT03546634|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
5072424|NCT03546634|Sabin strain|sabin strain
5072425|NCT03546621|Hepatitis D|hepatitis d
5072426|NCT03546608|Hepatic Impairment|hepatic impairment
5072427|NCT03546608|Tepotinib|tepotinib
5072428|NCT03546608|Pharmacokinetics|pharmacokinetics
5072429|NCT03546595|Polycystic Ovary Syndrome|polycystic ovary syndrome
5072430|NCT03546595|Insulin Resistance|insulin resistance
5072431|NCT03546582|HNSCC|hnscc
5072432|NCT03546582|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5072433|NCT03546582|KEYSTROKE|keystroke
5961171|NCT04288726|CD30-Positive Lymphoma|cd30-positive lymphoma
5072434|NCT03546517|myofascial trigger point|myofascial trigger point
5072435|NCT03546517|dry needling|dry needling
5072436|NCT03546517|spasticity|spasticity
5072437|NCT03546517|stroke|stroke
5072438|NCT03546504|child|child
5072439|NCT03546504|dental|dental
5072440|NCT03546504|oral health|oral health
5072441|NCT03546504|sensory desensitization|sensory desensitization
5072442|NCT03546504|sensory processing|sensory processing
5961172|NCT04288726|Hodgkin lymphoma|hodgkin lymphoma
5961173|NCT04288726|non-Hodgkin lymphoma|non-hodgkin lymphoma
5892855|NCT03643562|NPC|npc
5072443|NCT03546504|occupational therapy|occupational therapy
5072444|NCT03546478|SPECT/CT|spect/ct
5072445|NCT03546478|HER2 imaging|her2 imaging
5072446|NCT03546452|NSCLC|nsclc
5072447|NCT03546452|malignant hydrothorax|malignant hydrothorax
5072448|NCT03546452|prospective study|prospective study
5072449|NCT03546439|atrial fibrillation|atrial fibrillation
5072450|NCT03546439|vascular closure|vascular closure
5072451|NCT03546426|Mesothelioma, Malignant|mesothelioma, malignant
5072452|NCT03546426|PDL-1 negative|pdl-1 negative
5072453|NCT03546426|advanced disease|advanced disease
5072454|NCT03546426|progressive disease|progressive disease
5072455|NCT03546413|food|food
5072456|NCT03546413|peanut|peanut
5072457|NCT03546413|allergy|allergy
5072469|NCT03546322|chronic disease|chronic disease
5072470|NCT03546309|pediatric moyamoya disease|pediatric moyamoya disease
5072471|NCT03546309|remote ischemic conditioning|remote ischemic conditioning
5072472|NCT03546309|revascularization therapy|revascularization therapy
5072473|NCT03546296|Dietary Exposure|dietary exposure
5072474|NCT03546296|gallbladder carcinoma|gallbladder carcinoma
5072475|NCT03546270|Swimming|swimming
5072476|NCT03546270|Arterial Stiffness|arterial stiffness
5901836|NCT01375530|HV|hv
5072477|NCT03546270|Blood Pressure|blood pressure
5072478|NCT03546270|Muscular Strength|muscular strength
5072479|NCT03546270|Cardiorespiratory Endurance|cardiorespiratory endurance
5072482|NCT03546257|Narrow band imaging|narrow band imaging
5072483|NCT03546257|Endoscopic ultrasonography|endoscopic ultrasonography
5072484|NCT03546231|Tricuspid regurgitation|tricuspid regurgitation
5072485|NCT03546231|tricuspid valve|tricuspid valve
5072486|NCT03546231|surgery|surgery
5072487|NCT03546231|outcome|outcome
5072488|NCT03546231|prognosis|prognosis
5072489|NCT03546231|mortality|mortality
5072490|NCT03546231|right ventricle|right ventricle
5072491|NCT03546231|asymptomatic|asymptomatic
5072492|NCT03546192|Influenza|influenza
5072493|NCT03546192|Influenza virus vaccine|influenza virus vaccine
5072494|NCT03546192|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
5072495|NCT03546179|PVI, Tidal volume challenge|pvi, tidal volume challenge
5072496|NCT03546166|basal cell carcinoma|basal cell carcinoma
5072497|NCT03546127|Next Generation Sequencing|next generation sequencing
5072498|NCT03546127|Exome|exome
5072499|NCT03546127|RNA sequencing|rna sequencing
5072500|NCT03546127|Soft-tissue sarcoma|soft-tissue sarcoma
5072501|NCT03546127|Colorectal carcinoma|colorectal carcinoma
5072502|NCT03546114|Gender|gender
5072506|NCT03546088|awake intubation|awake intubation
5072507|NCT03546088|nasal fiberscope|nasal fiberscope
5072508|NCT03546088|topical anesthesia|topical anesthesia
5072509|NCT03546075|Cognition|cognition
5072510|NCT03546075|Resveratrol|resveratrol
5072511|NCT03546075|Whole body metabolism|whole body metabolism
5072512|NCT03546049|ultrasound-guided percutaneous transhepatic biliary drainage|ultrasound-guided percutaneous transhepatic biliary drainage
5072513|NCT03546049|endoscopic ultrasound-guided antegrade biliary drainage|endoscopic ultrasound-guided antegrade biliary drainage
5072514|NCT03546049|endoscopic ultrasound-guided transhepatic biliary drainage|endoscopic ultrasound-guided transhepatic biliary drainage
5072515|NCT03546049|endoscopic ultrasound-guided choledochal biliary drainage|endoscopic ultrasound-guided choledochal biliary drainage
5072516|NCT03546049|self-expandable metal stent|self-expandable metal stent
5072517|NCT03546049|malignant bile duct obstruction|malignant bile duct obstruction
5072518|NCT03546023|Chronic cancer pain|chronic cancer pain
5072519|NCT03546023|pain clinic|pain clinic
5072520|NCT03546023|Brief Pain Inventory|brief pain inventory
5072521|NCT03545997|Montelukast|montelukast
5072522|NCT03545997|leukotriene pathway|leukotriene pathway
5072523|NCT03545997|endothelial function|endothelial function
5072524|NCT03545997|flux-mediated dilation|flux-mediated dilation
5072525|NCT03545958|Older adults|older adults
5072526|NCT03545958|Community-based|community-based
5072527|NCT03545958|High-intensity interval training (HIT)|high-intensity interval training (hit)
5072528|NCT03545958|Mind-motor training|mind-motor training
5072529|NCT03545932|Hydrogymnastics|hydrogymnastics
5072530|NCT03545932|Physical Condition|physical condition
5072531|NCT03545932|Physical Activity and Health|physical activity and health
5072546|NCT03545763|Social Determinants of Health|social determinants of health
5072547|NCT03545763|Health Insurance|health insurance
5072548|NCT03545763|Medicaid|medicaid
5072549|NCT03545763|Affordable Care Act|affordable care act
5072550|NCT03545750|Acute kidney injury|acute kidney injury
5072551|NCT03545750|Continuous renal replacement therapy|continuous renal replacement therapy
5072553|NCT03545750|Heparin|heparin
5072554|NCT03545672|Primary Biliary Cholangitis|primary biliary cholangitis
5072555|NCT03545672|Cardiac impairment|cardiac impairment
5072556|NCT03545672|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5071765|NCT03550378|MEDI0382|medi0382
5072558|NCT03545633|Abdominal tissues|abdominal tissues
5072559|NCT03545620|difficult airway|difficult airway
5072560|NCT03545620|difficult intubation|difficult intubation
5072561|NCT03545620|videolaryngoscope|videolaryngoscope
5072562|NCT03545620|exchange catheter|exchange catheter
5961174|NCT04288726|CD30 CAR|cd30 car
5961175|NCT04288713|Coronavirus|coronavirus
5356768|NCT01918033|Allergic Rhinitis|allergic rhinitis
5072563|NCT03545620|fiberoptic bronchoscope|fiberoptic bronchoscope
5072564|NCT03545620|Laryngeal subglottic airway device|laryngeal subglottic airway device
5072565|NCT03545620|tracheostomy|tracheostomy
5072574|NCT03545581|Uric acid|uric acid
5072575|NCT03545581|Glucose homeostasis|glucose homeostasis
5072576|NCT03545568|Sialic acid|sialic acid
5072577|NCT03545568|Monosaccharide|monosaccharide
5072579|NCT03545555|antioxidant capacity|antioxidant capacity
5072580|NCT03545555|cholesterol|cholesterol
5072581|NCT03545555|lipid status|lipid status
5072585|NCT03545516|Wound infiltration|wound infiltration
5072586|NCT03545516|Post Cesarean|post cesarean
5072587|NCT03545516|Pain management|pain management
5072588|NCT03545516|bupivacaine|bupivacaine
5072589|NCT03545516|dexmedetomidine|dexmedetomidine
5072590|NCT03545516|postoperative pain|postoperative pain
5072591|NCT03545503|Rapid Sequence Intubation|rapid sequence intubation
5072592|NCT03545503|Hemodynamics|hemodynamics
5072593|NCT03545503|Etomidate|etomidate
5072594|NCT03545503|Ketamine|ketamine
5072595|NCT03545477|gait rehabilitation|gait rehabilitation
5072596|NCT03545477|curved walking training|curved walking training
5072597|NCT03545477|lower limb|lower limb
5072598|NCT03545464|Acute urticaria|acute urticaria
5072599|NCT03545451|EEG, neurofeedback, fMRI, ALS, surgery, upper limbs|eeg, neurofeedback, fmri, als, surgery, upper limbs
5072603|NCT03545373|antimicrobial resistance|antimicrobial resistance
5072604|NCT03545373|TB|tb
5072605|NCT03545373|Cough|cough
5072606|NCT03545373|antibiotics|antibiotics
5072607|NCT03545373|anti-infective agents|anti-infective agents
5072608|NCT03545347|Rehabilitation|rehabilitation
5072609|NCT03545347|Physiotherapy|physiotherapy
5072610|NCT03545347|Strength training|strength training
5072611|NCT03545347|Anabolic steroids|anabolic steroids
5072612|NCT03545347|Nutritional supplement|nutritional supplement
5072614|NCT03545321|Naloxone|naloxone
5072615|NCT03545321|Community pharmacies|community pharmacies
5072616|NCT03545321|Academic detailing|academic detailing
5072617|NCT03545321|MOON|moon
5072618|NCT03545321|MOON+|moon+
5072619|NCT03545321|RESPOND|respond
5072620|NCT03545308|Neuromuscular|neuromuscular
5072621|NCT03545308|Deep Anesthesia|deep anesthesia
5072622|NCT03545308|Rocuronium|rocuronium
5072623|NCT03545282|Mental Health|mental health
5072624|NCT03545282|Minority Health|minority health
5072625|NCT03545282|Latina|latina
5072626|NCT03545269|Degenerative Arthritis|degenerative arthritis
5072627|NCT03545269|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5072628|NCT03545269|Cartilage defects|cartilage defects
5072629|NCT03545269|Cartilage lesion|cartilage lesion
5072630|NCT03545269|Arthritis|arthritis
5072631|NCT03545256|Outpatient|outpatient
5072640|NCT03545204|Neonatal Mortality & Neurodevelopment of an Infant.|neonatal mortality & neurodevelopment of an infant.
5072642|NCT03545178|continuous glucose monitoring|continuous glucose monitoring
5072643|NCT03545178|flash glucose monitoring|flash glucose monitoring
5072644|NCT03545178|hypoglycemia prediction|hypoglycemia prediction
5072645|NCT03545178|deep learning algorithm|deep learning algorithm
5072649|NCT03545126|Tauopathies|tauopathies
5072650|NCT03545113|graft|graft
5072651|NCT03545113|fistula|fistula
5072652|NCT03545113|hemodialysis|hemodialysis
5072653|NCT03545113|Vascular access|vascular access
5072654|NCT03545100|oral cancer|oral cancer
5072655|NCT03545100|shoulder dysfunction|shoulder dysfunction
5072656|NCT03545100|quality of life|quality of life
5072657|NCT03545100|motor control|motor control
5072658|NCT03545100|strengthening exercise|strengthening exercise
5072659|NCT03545074|mindfulness|mindfulness
5072660|NCT03545074|depression|depression
5072661|NCT03545074|Spanish|spanish
5072662|NCT03545048|web-based exercises|web-based exercises
5072663|NCT03545048|Digital health|digital health
5072664|NCT03545048|knee exercises|knee exercises
5072665|NCT03545035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5072666|NCT03545035|Idelalisib|idelalisib
5072667|NCT03545035|Rituximab|rituximab
5072668|NCT03545022|third molar|third molar
5072669|NCT03545022|acupuncture|acupuncture
5072670|NCT03545022|pain|pain
5072671|NCT03545022|edema|edema
5072672|NCT03545022|trismus|trismus
5072673|NCT03545022|anxiety|anxiety
5072674|NCT03544996|Insulin, needle-less, transdermal|insulin, needle-less, transdermal
5072675|NCT03544983|Breast Cancer|breast cancer
5072676|NCT03544983|Ovarian Cancer|ovarian cancer
5072677|NCT03544983|Prostate Cancer|prostate cancer
5072678|NCT03544983|BRCA1|brca1
5072679|NCT03544983|BRCA2|brca2
5072680|NCT03544970|fetal MRI|fetal mri
5072681|NCT03544970|Posterior fossa|posterior fossa
5072682|NCT03544957|Screening instrument|screening instrument
5072683|NCT03544944|bowel preparation|bowel preparation
5072684|NCT03544892|Low carbohydrate diet|low carbohydrate diet
5072705|NCT03544671|Nutritional deficiencies|nutritional deficiencies
5072706|NCT03544671|Miconutrients|miconutrients
5072707|NCT03544671|Children|children
5072709|NCT03544658|Tooth extrinsic stain|tooth extrinsic stain
5961176|NCT04288713|Soliris|soliris
5072710|NCT03544658|Tooth color|tooth color
5961177|NCT04288713|Eculizumab|eculizumab
5939268|NCT01281813|TMC114IFD3001|tmc114ifd3001
5939269|NCT01281813|TMC114|tmc114
5939270|NCT01281813|HIV|hiv
5939271|NCT01281813|Darunavir|darunavir
5939272|NCT01281813|PREZISTA|prezista
5872770|NCT03786198|early breast cancer|early breast cancer
5872771|NCT03786198|aromatase inhibitor therapy|aromatase inhibitor therapy
5872772|NCT03786198|activity program|activity program
5872773|NCT03786198|physical activity|physical activity
5872774|NCT03786198|activity tracker|activity tracker
5872775|NCT03786198|pedometer|pedometer
5872776|NCT03786198|stepcounter|stepcounter
5872777|NCT03786185|Neuroplasticity|neuroplasticity
5872778|NCT03786185|Computerized training|computerized training
5872779|NCT03786185|Music reading|music reading
5872780|NCT03786185|Multisensory training|multisensory training
5072711|NCT03544658|Dental prophylaxis|dental prophylaxis
5072712|NCT03544658|Visual shade guide|visual shade guide
5072713|NCT03544658|Dental spectrophotometer|dental spectrophotometer
5072714|NCT03544645|Diabetic Education|diabetic education
5072715|NCT03544645|audiovisual material|audiovisual material
5072716|NCT03544645|Manual material|manual material
5072717|NCT03544632|adipose-derived extracellular matrix (ECM)|adipose-derived extracellular matrix (ecm)
5072718|NCT03544632|acellular adipose tissue (AAT)|acellular adipose tissue (aat)
5072719|NCT03544580|dentin|dentin
5072720|NCT03544580|immediate implant|immediate implant
5072721|NCT03544580|buccal bone resorption|buccal bone resorption
5072723|NCT03544554|Overactive bladder|overactive bladder
5072724|NCT03544554|healthy lifestyle behaviors|healthy lifestyle behaviors
5072725|NCT03544554|quality of life|quality of life
5072726|NCT03544515|peri-implantitis|peri-implantitis
5072727|NCT03544515|laser treatment|laser treatment
5072728|NCT03544515|Biolase|biolase
5072729|NCT03544515|Er,Cr:YSGG|er,cr:ysgg
5072730|NCT03544502|music, anesthesia, surgery|music, anesthesia, surgery
5072731|NCT03544476|mobile Health|mobile health
5072732|NCT03544437|lymph node dissection|lymph node dissection
5072733|NCT03544437|upper tract urothelial carcinoma|upper tract urothelial carcinoma
5072734|NCT03544437|nephroureterectomy|nephroureterectomy
5072735|NCT03544411|Olive oil|olive oil
5072736|NCT03544411|Bran oil|bran oil
5072737|NCT03544411|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5072738|NCT03544411|Antioxidant|antioxidant
5961178|NCT04288713|Covid-19|covid-19
5961179|NCT04288713|Complement|complement
5961180|NCT04288713|Immunomodulation|immunomodulation
5961181|NCT04288661|perianastomotic drain|perianastomotic drain
5961182|NCT04288661|gastrectomy|gastrectomy
5961183|NCT04288661|complication detection|complication detection
5961184|NCT04288635|mitochondrial dysfunction|mitochondrial dysfunction
5961185|NCT04288622|Experience Sampling Method|experience sampling method
5961186|NCT04288622|At risk|at risk
5961187|NCT04288622|Depression|depression
5961188|NCT04288622|Women|women
5961189|NCT04288622|Randomized Controlled Trials|randomized controlled trials
5961190|NCT04288622|Feedback|feedback
5961191|NCT04288609|affective disorder|affective disorder
5961192|NCT04288583|Wearable sensors|wearable sensors
5961193|NCT04288583|Falls|falls
5961194|NCT04288583|Physical activity|physical activity
5961195|NCT04288583|Parkinson's disease|parkinson's disease
5961196|NCT04288544|eicosapentaenoic acid, Nutrition, micronutrients, anti-inflammatory foods, omega-3 fatty acids, microalgae|eicosapentaenoic acid, nutrition, micronutrients, anti-inflammatory foods, omega-3 fatty acids, microalgae
5961197|NCT04288531|Iodine|iodine
5961198|NCT04288531|Human milk|human milk
5961199|NCT04288531|Maternal health|maternal health
5961200|NCT04288531|Nutritional assessment|nutritional assessment
5961201|NCT04288531|Thyroid hormones|thyroid hormones
5961202|NCT04288531|Pregnancy|pregnancy
5961203|NCT04288531|Population health|population health
5961204|NCT04288531|Congenital hypothyroidism|congenital hypothyroidism
5961205|NCT04288531|Psychomotor development|psychomotor development
5961206|NCT04288518|99mTc-1-thio-D-glucose|99mtc-1-thio-d-glucose
5961207|NCT04288518|Brain|brain
5961208|NCT04288518|Neoplasms|neoplasms
5961209|NCT04288518|SPECT|spect
5961210|NCT04288492|Respiratory biofeedback|respiratory biofeedback
5961211|NCT04288492|Postpoerative Pain|postpoerative pain
5961212|NCT04288492|Preoperative Anxiety|preoperative anxiety
5961213|NCT04288479|Exercise|exercise
5961214|NCT04288479|High Intensity Interval Training|high intensity interval training
5961215|NCT04288479|Pregnancy Outcome|pregnancy outcome
5961216|NCT04288479|Placental Circulation|placental circulation
5961217|NCT04288479|Fetal Blood|fetal blood
5961218|NCT04288479|Heart Rate, Fetal|heart rate, fetal
5961219|NCT04288453|participation|participation
5961220|NCT04288453|environmental barriers|environmental barriers
5961221|NCT04288453|youth|youth
5961222|NCT04288453|disabilities|disabilities
5961223|NCT04288453|body functions|body functions
5961224|NCT04288427|Finasteride|finasteride
5961225|NCT04288427|5 Alpha Reductase|5 alpha reductase
5961226|NCT04288375|Postoperative Radiation|postoperative radiation
5961227|NCT04288375|Soft Tissue Sarcoma of extremity|soft tissue sarcoma of extremity
5961228|NCT04288375|20-064|20-064
5961229|NCT04288362|Diabetes|diabetes
5961230|NCT04288362|Long term conditions|long term conditions
5961231|NCT04288362|Chronic disease management|chronic disease management
5961232|NCT04288362|Patient engagement|patient engagement
5961233|NCT04288362|Patient empowerment|patient empowerment
5961234|NCT04288362|Self-management|self-management
5961235|NCT04288362|Care Planning|care planning
5961236|NCT04288349|perineal block|perineal block
5961237|NCT04288349|hemorrhoidectomy|hemorrhoidectomy
5961238|NCT04288349|hemorrhoids|hemorrhoids
5961239|NCT04288349|hemorrhoids treatment|hemorrhoids treatment
5961240|NCT04288349|pudendal nerve|pudendal nerve
5961241|NCT04288284|Complicated colorectal cancer|complicated colorectal cancer
5961242|NCT04288284|Curative resection|curative resection
5961243|NCT04288284|Surgical and oncologic outcomes|surgical and oncologic outcomes
5072739|NCT03544411|glycemic control|glycemic control
5072740|NCT03544411|lipid profile|lipid profile
5072745|NCT03544333|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5072747|NCT03544333|medication-free|medication-free
5072748|NCT03544320|Pre-diabetes|pre-diabetes
5072749|NCT03544320|diabetes|diabetes
5072750|NCT03544320|wearable devices|wearable devices
4955703|NCT04265768|imaging|imaging
5072751|NCT03544320|mobile health|mobile health
5072752|NCT03544307|Taekwondo|taekwondo
5072753|NCT03544307|Menopause|menopause
5072754|NCT03544307|Hypertension|hypertension
5072755|NCT03544307|Arterial Stiffness|arterial stiffness
5072756|NCT03544307|Blood Catecholamines|blood catecholamines
5072757|NCT03544281|Relapsed / Refractory Multiple Myeloma|relapsed / refractory multiple myeloma
5072758|NCT03544281|Dose escalation|dose escalation
5072759|NCT03544281|Antibody-Drug Conjugate|antibody-drug conjugate
5072760|NCT03544281|Dose expansion|dose expansion
5072761|NCT03544268|ultrasound|ultrasound
5072762|NCT03544268|breast|breast
5072763|NCT03544268|angiography|angiography
5072764|NCT03544255|pancreatic cancer|pancreatic cancer
5072765|NCT03544255|EUS-FNA|eus-fna
5072766|NCT03544255|organoid|organoid
5072767|NCT03544242|Diabetes|diabetes
5072768|NCT03544242|Insulin Resistance|insulin resistance
5072769|NCT03544242|Nitrite|nitrite
5072770|NCT03544242|Pancreatic islet cells|pancreatic islet cells
5072771|NCT03544242|Autotransplantation|autotransplantation
5072772|NCT03544242|Ischemia reperfusion injury|ischemia reperfusion injury
5072773|NCT03544242|Mitigation|mitigation
5072774|NCT03544242|Cure|cure
5072775|NCT03544242|Nitric oxide|nitric oxide
5072776|NCT03544242|Sodium nitrite|sodium nitrite
5072777|NCT03544242|Islet cell|islet cell
5072778|NCT03544242|Survival|survival
5072779|NCT03544242|Pancreas|pancreas
5072780|NCT03544242|Liver|liver
5072782|NCT03544216|Contact Lens|contact lens
5072783|NCT03544216|Multifocal|multifocal
5072784|NCT03544216|Accommodation|accommodation
5072794|NCT03544073|in-vitro fertilization|in-vitro fertilization
5072795|NCT03544060|Familial Chylomicronemia|familial chylomicronemia
5072796|NCT03544060|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
5072797|NCT03544060|Hyperlipoproteinemias|hyperlipoproteinemias
5072798|NCT03544060|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
5072799|NCT03544060|Hyperlipoproteinemia Type 1|hyperlipoproteinemia type 1
5072800|NCT03544060|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
5072801|NCT03544060|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
5072802|NCT03544060|Hyperlipidemias|hyperlipidemias
5072803|NCT03544060|Dyslipidemias|dyslipidemias
5072804|NCT03544060|Lipid Metabolism Disorders|lipid metabolism disorders
5072805|NCT03544060|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5072806|NCT03544060|Metabolic Diseases|metabolic diseases
5072807|NCT03544060|Metabolism, Inborn Errors|metabolism, inborn errors
5072808|NCT03544060|Genetic Diseases, Inborn|genetic diseases, inborn
5072809|NCT03544021|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5072810|NCT03544021|Relapsed|relapsed
5072811|NCT03544021|Refractory|refractory
5072812|NCT03543995|lower urinary tract symptoms|lower urinary tract symptoms
5072813|NCT03543995|nocturnal enuresis|nocturnal enuresis
5072814|NCT03543995|spina bifida occulta|spina bifida occulta
5072815|NCT03543995|treatment response|treatment response
5072816|NCT03543956|Silica|silica
5072817|NCT03543956|Organic Solvents|organic solvents
5072818|NCT03543956|Toxic substances exposure|toxic substances exposure
5072819|NCT03543904|Abdomen|abdomen
5072820|NCT03543904|Children|children
5072821|NCT03543904|Chest physical therapy|chest physical therapy
5072822|NCT03543904|Surgery|surgery
5072823|NCT03543891|Gut microbiota|gut microbiota
5072824|NCT03543891|16S rRNA gene|16s rrna gene
5072825|NCT03543891|Thyroid cancer|thyroid cancer
5072831|NCT03543852|Health promotion|health promotion
5072832|NCT03543852|Health education|health education
5072839|NCT03543826|rocuronium|rocuronium
5072840|NCT03543826|neuromuscular blocking agents|neuromuscular blocking agents
5072841|NCT03543813|cancer|cancer
5072842|NCT03543813|solid tumor|solid tumor
5072843|NCT03543813|DLBCL|dlbcl
5072844|NCT03543813|CX-2029|cx-2029
5072845|NCT03543813|PROBODY™ Therapeutic|probody™ therapeutic
5072846|NCT03543813|Drug Conjugate|drug conjugate
5072847|NCT03543813|Antibody drug conjugate|antibody drug conjugate
5072848|NCT03543813|CD71|cd71
5072849|NCT03543813|Transferrin receptor 1|transferrin receptor 1
5072850|NCT03543787|Referral networks|referral networks
5072851|NCT03543787|low and middle income countries|low and middle income countries
5072852|NCT03543787|PRECEDE-PROCEED|precede-proceed
5072853|NCT03543787|implementation research|implementation research
5072854|NCT03543787|hypertension|hypertension
5072855|NCT03543787|cardiovascular disease|cardiovascular disease
5072856|NCT03543787|process evaluation|process evaluation
5072857|NCT03543774|Chronic kidney disease|chronic kidney disease
5072858|NCT03543774|Lipid lowering therapy|lipid lowering therapy
5072859|NCT03543774|Hypercholesterolemia|hypercholesterolemia
5072860|NCT03543748|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5072861|NCT03543748|cognitive impairment|cognitive impairment
5893229|NCT03597594|Transplant|transplant
5072862|NCT03543722|Veterans|veterans
5072863|NCT03543722|Disability|disability
5072864|NCT03543722|Employment|employment
5072865|NCT03543722|Vocational Rehabilitation|vocational rehabilitation
5072866|NCT03543722|Supported Employment|supported employment
5072867|NCT03543709|Behcet's disease|behcet's disease
5072868|NCT03543709|Fibromyalgia|fibromyalgia
5072869|NCT03543709|Disease activity|disease activity
5072870|NCT03543683|Non-Small Cell Lung Cancer|non-small cell lung cancer
5072871|NCT03543683|Aspirin|aspirin
5072872|NCT03543683|Osimertinib|osimertinib
5072873|NCT03543683|EGFR-TKI|egfr-tki
5072874|NCT03543683|T790M|t790m
5072875|NCT03543644|Microbiome|microbiome
5072876|NCT03543644|Sugar Sweetened Beverages|sugar sweetened beverages
5072877|NCT03543644|Diet Beverages|diet beverages
5072878|NCT03543644|Non-Nutritive Sweetened Beverages|non-nutritive sweetened beverages
5072879|NCT03543644|Glucose response|glucose response
5072880|NCT03543618|dental implant|dental implant
5072881|NCT03543618|edentulous ridge|edentulous ridge
5072884|NCT03543592|power doppler|power doppler
5072885|NCT03543592|endometrium|endometrium
5072886|NCT03543579|multiple myeloma|multiple myeloma
5072887|NCT03543579|Carfilzomib|carfilzomib
5072888|NCT03543579|Proteasome inhibition|proteasome inhibition
5072889|NCT03543566|antimuscarinic medication|antimuscarinic medication
5072890|NCT03543566|medical management|medical management
5072891|NCT03543566|dual incontinence|dual incontinence
5072892|NCT03543566|darifenacin|darifenacin
5072893|NCT03543566|quality of life|quality of life
5072894|NCT03543566|bowel diary|bowel diary
5072895|NCT03543514|colon cancer, rectal cancer, prehabilitation|colon cancer, rectal cancer, prehabilitation
5072896|NCT03543462|Ovarian Cancer|ovarian cancer
5072897|NCT03543462|Diaphragm|diaphragm
5072898|NCT03543462|Chest Drain|chest drain
5072899|NCT03543462|Diaphragmatic Resection|diaphragmatic resection
5072900|NCT03543462|Pleural Effusion|pleural effusion
5072901|NCT03543436|Non-inferiority study|non-inferiority study
5072902|NCT03543436|Temocillin|temocillin
5072903|NCT03543436|Carbapenem|carbapenem
5072904|NCT03543436|ESBL infection|esbl infection
5072905|NCT03543436|Urinary tract infection|urinary tract infection
5072906|NCT03543423|Gut hormone secretion|gut hormone secretion
5072907|NCT03543423|Glucose absorption|glucose absorption
5072908|NCT03543423|early meal phase|early meal phase
5072909|NCT03543423|Insulin and glucagon secretion|insulin and glucagon secretion
5072910|NCT03543410|Depression, Depressive episode, Bipolar, Bipolar 1, Bipolar 1 depression|depression, depressive episode, bipolar, bipolar 1, bipolar 1 depression
5072911|NCT03543397|ductal carcinomas|ductal carcinomas
5072912|NCT03543397|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
5072913|NCT03543397|MRI|mri
5072914|NCT03543384|facial neuritis|facial neuritis
5072915|NCT03543384|T2 weighted gradient-echo|t2 weighted gradient-echo
5072916|NCT03543384|fast imaging employing steady state acquisition (FIESTA-C)|fast imaging employing steady state acquisition (fiesta-c)
5072917|NCT03543384|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5072918|NCT03543371|Neuropsychology|neuropsychology
5072919|NCT03543358|rovalpituzumab tesirine|rovalpituzumab tesirine
5072920|NCT03543358|rollover study|rollover study
5072921|NCT03543358|cancer|cancer
5072922|NCT03543345|RCA|rca
5072923|NCT03543345|PCI|pci
5072924|NCT03543345|right ventricular function|right ventricular function
5072925|NCT03543332|Physical training|physical training
5072926|NCT03543332|Kinesiophobia|kinesiophobia
5072927|NCT03543293|perilymphatic fistulas|perilymphatic fistulas
5085067|NCT03466892|Chronic pain|chronic pain
5072928|NCT03543293|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5072930|NCT03543293|round window|round window
5072932|NCT03543293|tinnitus|tinnitus
5072933|NCT03543293|cophosis|cophosis
5072934|NCT03543280|fatigability post stroke|fatigability post stroke
5072935|NCT03543280|post stroke|post stroke
5072936|NCT03543280|high-speed CT|high-speed ct
5072938|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a
5072939|NCT03543254|Injections|injections
5072940|NCT03543254|Cranial Sutures|cranial sutures
5072941|NCT03543254|Head|head
5072942|NCT03543241|Strain|strain
5072943|NCT03543228|Strain|strain
5072944|NCT03543215|MRI|mri
5072945|NCT03543215|Radiomics|radiomics
5072946|NCT03543215|Texture features|texture features
5072947|NCT03543215|Prognostication|prognostication
5072948|NCT03543215|Endometrial cancer|endometrial cancer
5072949|NCT03543202|Unilateral transversus abdominal plane block|unilateral transversus abdominal plane block
5072950|NCT03543202|Local infiltration anesthesia|local infiltration anesthesia
5072951|NCT03543202|Cholecystectomy|cholecystectomy
5072952|NCT03543202|Postoperative analgesia|postoperative analgesia
5072953|NCT03543189|Gleason Group 5|gleason group 5
5072954|NCT03543189|PCa|pca
5072955|NCT03543189|Advanced Stage Prostate Cancer|advanced stage prostate cancer
5072956|NCT03543189|Immunotherapy|immunotherapy
5072957|NCT03543189|Oligometastaic Disease|oligometastaic disease
5072958|NCT03543189|Brachytherapy|brachytherapy
5961244|NCT04288271|pediatric|pediatric
5072959|NCT03543189|Androgen Deprivation Therapy|androgen deprivation therapy
5961245|NCT04288271|adolescent|adolescent
5072960|NCT03543176|Cohort|cohort
5072961|NCT03543176|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5072962|NCT03543176|Observational|observational
5072963|NCT03543176|GOLD|gold
5072964|NCT03543176|Claims|claims
5072965|NCT03543176|Health plan recruitment|health plan recruitment
5072966|NCT03543163|buccal fat pad graft|buccal fat pad graft
5072967|NCT03543163|sub-epithelial connective tissue graft|sub-epithelial connective tissue graft
5072968|NCT03543150|Spasmodic Dysphonia|spasmodic dysphonia
5072969|NCT03543150|VHI-10 scores|vhi-10 scores
5072970|NCT03543150|BOTOX|botox
5072971|NCT03543150|Drug use investigation|drug use investigation
5072972|NCT03543124|colonoscopy|colonoscopy
5072973|NCT03543124|pain|pain
5072974|NCT03543124|water exchange|water exchange
5072975|NCT03543124|cap|cap
5072976|NCT03543098|Knee Injury|knee injury
5072977|NCT03543098|Knee Injuries|knee injuries
5072978|NCT03543098|Knee Surgery|knee surgery
5072979|NCT03543098|Rehabilitation|rehabilitation
5072984|NCT03543020|radiation induced alopecia|radiation induced alopecia
5072985|NCT03543020|whole brain radiation|whole brain radiation
5072986|NCT03543020|partial brain radiation|partial brain radiation
5072987|NCT03543020|radiotherapy|radiotherapy
5072988|NCT03542981|pain|pain
5072989|NCT03542981|surgery|surgery
5072990|NCT03542981|interferential current|interferential current
5072991|NCT03542981|total knee arthroplasty|total knee arthroplasty
5072992|NCT03542968|Congenital heart disease|congenital heart disease
5072993|NCT03542968|Tetralogy of Fallot|tetralogy of fallot
5072994|NCT03542968|Imaging by 4D Flow,|imaging by 4d flow,
5072995|NCT03542968|Magnetic resonance imaging|magnetic resonance imaging
5072996|NCT03542968|Prevention of ventricular dysfunction|prevention of ventricular dysfunction
5072997|NCT03542942|locally advanced|locally advanced
5072998|NCT03542942|radiotherapy|radiotherapy
5072999|NCT03542942|DW-MRI|dw-mri
5073000|NCT03542942|target volume|target volume
5073001|NCT03542890|Anesthesia, General|anesthesia, general
5073002|NCT03542890|Baska|baska
5073003|NCT03542890|I-gel|i-gel
5073004|NCT03542877|Cabozantinib|cabozantinib
5073005|NCT03542877|Progression Free Survival|progression free survival
5073006|NCT03542877|Metastatic Colorectal Cancer|metastatic colorectal cancer
5073007|NCT03542877|Tumor|tumor
5073008|NCT03542864|obesity|obesity
5073009|NCT03542864|overweight|overweight
5073010|NCT03542864|fat percentage|fat percentage
5073011|NCT03542864|body fat|body fat
5073012|NCT03542864|enteral feeding|enteral feeding
5073013|NCT03542864|fat loss|fat loss
5073014|NCT03542825|Iron|iron
5073015|NCT03542825|Deficiency|deficiency
5073016|NCT03542812|L-citrulline|l-citrulline
5073017|NCT03542812|Nitric oxide|nitric oxide
5073018|NCT03542786|HIV-1|hiv-1
5073019|NCT03542760|Methylene Blue|methylene blue
5073020|NCT03542747|Airway|airway
5073021|NCT03542747|extraglottic|extraglottic
5073022|NCT03542747|simulation|simulation
5073023|NCT03542747|laryngeal mask|laryngeal mask
5073024|NCT03542721|chronic fatigue symptom|chronic fatigue symptom
5073025|NCT03542721|blood circulation|blood circulation
5073026|NCT03542656|Stroke|stroke
5073027|NCT03542656|intracerebral hemorrhage|intracerebral hemorrhage
5073049|NCT03542396|Mental disorders|mental disorders
5073053|NCT03542383|High Definition Transcranial Direct Current Stimulation|high definition transcranial direct current stimulation
5073054|NCT03542383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5073055|NCT03542370|dietary approaches to stop hypertension|dietary approaches to stop hypertension
5073056|NCT03542370|DASH|dash
5073057|NCT03542370|cardiometabolic health|cardiometabolic health
5073058|NCT03542370|Umbrella Review|umbrella review
5073059|NCT03542370|GRADE|grade
5073060|NCT03542370|Systematic review and meta-analysis|systematic review and meta-analysis
5073061|NCT03542318|Pulmonary Rehabilitation|pulmonary rehabilitation
5073062|NCT03542318|Functional outcomes|functional outcomes
5073063|NCT03542318|Health Status|health status
5073064|NCT03542318|Exercise|exercise
5073065|NCT03542279|Autoimmune encephalitis, Plasma exchange, Immunotherapy, Outcome|autoimmune encephalitis, plasma exchange, immunotherapy, outcome
5073066|NCT03542266|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5073067|NCT03542266|Azacitidine|azacitidine
5073068|NCT03542266|Lymphoma|lymphoma
5073069|NCT03542253|Early lung cancer,ground-glass nodule,CT,exosome|early lung cancer,ground-glass nodule,ct,exosome
5073078|NCT03542188|Large Vessel Occlusion|large vessel occlusion
5073079|NCT03542188|Stroke|stroke
5073080|NCT03542188|EVT|evt
5073081|NCT03542175|Rucaparib|rucaparib
5073082|NCT03542175|Radiotherapy|radiotherapy
5073083|NCT03542175|Triple Negative Breast Cancer|triple negative breast cancer
5073084|NCT03542175|18-002|18-002
5073085|NCT03542162|Healaflow|healaflow
5073086|NCT03542162|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5073087|NCT03542162|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
5073088|NCT03542162|Minimally invasive surgery|minimally invasive surgery
5073089|NCT03542162|Complications|complications
5369132|NCT01861184|Lower respiratory tract infection|lower respiratory tract infection
5369133|NCT01861184|LRTI|lrti
5369134|NCT01861184|Pneumococcal carriage|pneumococcal carriage
5073093|NCT03542123|Electrical Stimulation Therapy; Electrodes; Parasympathetic Nervous System; Sympathetic Fibers, Post Ganglionic; Congestive Heart Failure; Heart Failure|electrical stimulation therapy; electrodes; parasympathetic nervous system; sympathetic fibers, post ganglionic; congestive heart failure; heart failure
5073094|NCT03542097|Ewing Sarcoma|ewing sarcoma
5073095|NCT03542032|i-gel|i-gel
5073096|NCT03542032|jaw-thrust|jaw-thrust
5073097|NCT03541993|Resveratrol|resveratrol
5073098|NCT03541993|Cerebral blood flow|cerebral blood flow
5073099|NCT03541993|Cognition|cognition
5073100|NCT03541993|Hypoxia|hypoxia
5073101|NCT03541993|Polyphenols|polyphenols
5073105|NCT03541967|bone conduction|bone conduction
5073106|NCT03541954|sensitization|sensitization
5073108|NCT03541941|Liposomal Bupivacaine|liposomal bupivacaine
5073109|NCT03541941|Exparel|exparel
5073110|NCT03541941|Transversus Abdominis Plane block|transversus abdominis plane block
5073111|NCT03541941|Hernia|hernia
5073112|NCT03541928|gene therapy|gene therapy
5073113|NCT03541928|untreated prostate cancer|untreated prostate cancer
5073114|NCT03541902|Malignant Neoplasms of Urinary Tract|malignant neoplasms of urinary tract
5073115|NCT03541902|Renal cell carcinoma|renal cell carcinoma
5073116|NCT03541902|Cabozantinib|cabozantinib
5073117|NCT03541902|XL-184|xl-184
5073118|NCT03541902|XL184|xl184
5073119|NCT03541902|Sunitinib|sunitinib
5073120|NCT03541902|Sunitinib Malate|sunitinib malate
5073121|NCT03541902|SU011248|su011248
5073122|NCT03541902|Sutent|sutent
5073127|NCT03541863|Progression|progression
5073128|NCT03541863|Endocrine sensitivity|endocrine sensitivity
5073129|NCT03541837|Bilateral ESP Catheter|bilateral esp catheter
5073130|NCT03541837|Open heart surgery|open heart surgery
5073131|NCT03541837|opioid free post op analgesia|opioid free post op analgesia
5073132|NCT03541811|gait|gait
5073133|NCT03541811|motion capture|motion capture
5073134|NCT03541811|hemophilia joint health score|hemophilia joint health score
5073135|NCT03541811|physical activity|physical activity
5073136|NCT03541811|body composition|body composition
5073137|NCT03541811|gait deviation index|gait deviation index
5073138|NCT03541811|hemophilia|hemophilia
5073139|NCT03541798|traditional sitting position|traditional sitting position
5073140|NCT03541798|combine spinal-epidural anesthesia|combine spinal-epidural anesthesia
5073141|NCT03541798|orthopedic surgery|orthopedic surgery
5073142|NCT03541785|NGAL|ngal
5073143|NCT03541785|Renal Angina Index|renal angina index
5073144|NCT03541772|Head Carcinoma|head carcinoma
5073145|NCT03541772|Neck Carcinoma|neck carcinoma
5073146|NCT03541772|Chemotherapy|chemotherapy
5073147|NCT03541772|Radiotherapy|radiotherapy
5073148|NCT03541772|Oncoxin Viusid|oncoxin viusid
5073149|NCT03541772|Nutritional supplement|nutritional supplement
5073150|NCT03541759|Elective shoulder surgery, hydromorphone, piritramide|elective shoulder surgery, hydromorphone, piritramide
5073151|NCT03541733|magnetic resonance enterography|magnetic resonance enterography
5073152|NCT03541733|bowel preparation|bowel preparation
5073154|NCT03541707|EEG|eeg
5073155|NCT03541707|Depression|depression
5073156|NCT03541707|adolescents|adolescents
5073157|NCT03541694|Yellow fever|yellow fever
5073158|NCT03541694|Stamaril®|stamaril®
5073159|NCT03541681|Epidural Steroid Injections|epidural steroid injections
5423200|NCT01616693|probiotic supplement|probiotic supplement
5073160|NCT03541681|Cervical Epidural Injections|cervical epidural injections
5073161|NCT03541681|Transforaminal Epidural Injections|transforaminal epidural injections
5073162|NCT03541681|Steroids|steroids
5073163|NCT03541681|Local Anesthetic|local anesthetic
5073164|NCT03541655|total knee replacement|total knee replacement
5073165|NCT03541655|pain|pain
5073166|NCT03541655|celecoxib|celecoxib
5073167|NCT03541655|intra-articular|intra-articular
5073168|NCT03541603|PH-HFpEF|ph-hfpef
5073169|NCT03541590|percutaneous biliary drainage|percutaneous biliary drainage
5073170|NCT03541538|joint manipulation|joint manipulation
5073171|NCT03541538|cervical|cervical
5073172|NCT03541538|pressure pain|pressure pain
5073173|NCT03541538|manual therapy|manual therapy
5073174|NCT03541512|Mindfulness therapy|mindfulness therapy
5073175|NCT03541512|Vulvodynia|vulvodynia
5073176|NCT03541512|Vulvar pain|vulvar pain
5073181|NCT03541486|ascorbic acid|ascorbic acid
5073182|NCT03541486|ascorbate|ascorbate
5073183|NCT03541486|sodium ascorbate|sodium ascorbate
5073184|NCT03541486|radiotherapy|radiotherapy
5073185|NCT03541486|radiotherapy, image-guided|radiotherapy, image-guided
5073186|NCT03541486|gemcitabine|gemcitabine
5073187|NCT03541460|centenarians|centenarians
5073188|NCT03541460|epigenome|epigenome
5073189|NCT03541460|longevity|longevity
5073190|NCT03541460|healthy aging|healthy aging
5073191|NCT03541460|epigenetic|epigenetic
5073192|NCT03541447|ADPKD, Tolvaptan, Octrotide LAR|adpkd, tolvaptan, octrotide lar
5073193|NCT03541434|obstructive sleep apnea|obstructive sleep apnea
5073194|NCT03541434|tonsillitis|tonsillitis
5073195|NCT03541434|middle ear effusion|middle ear effusion
5073196|NCT03541434|pathophysiology|pathophysiology
5073197|NCT03541434|score|score
5073199|NCT03541382|HIV Self-Testing|hiv self-testing
5073200|NCT03541382|Malawi|malawi
5073201|NCT03541356|Parkinsons|parkinsons
5073202|NCT03541356|L-dopa|l-dopa
5073203|NCT03541356|levodopa|levodopa
5073205|NCT03541356|OFF|off
5073206|NCT03541356|PD|pd
5073207|NCT03541356|POD device|pod device
5073208|NCT03541356|I231|i231
5073209|NCT03541356|benserazide|benserazide
5073210|NCT03541356|Precision olfactory delivery|precision olfactory delivery
5073211|NCT03541356|MDS-UPDRS|mds-updrs
5073212|NCT03541356|Carbidopa|carbidopa
5073213|NCT03541356|DCI|dci
5073214|NCT03541356|Decarboxylase Inhibitor|decarboxylase inhibitor
5073215|NCT03541330|Siblings|siblings
5073216|NCT03541330|information|information
5073217|NCT03541330|malignant haemopathy|malignant haemopathy
5073221|NCT03541317|School mental health|school mental health
5073222|NCT03541317|Implementation intervention|implementation intervention
5073223|NCT03541304|high dose radiotherapy|high dose radiotherapy
5073224|NCT03541304|rectal cancer|rectal cancer
5073225|NCT03541278|Breast Cancer|breast cancer
5073226|NCT03541278|Internal Mammary Lymph Node|internal mammary lymph node
5073227|NCT03541278|Internal Mammary Sentinel Lymph Node Biopsy|internal mammary sentinel lymph node biopsy
5073228|NCT03541278|Detection Rate|detection rate
5073229|NCT03541265|liposomal bupivacaine|liposomal bupivacaine
5073230|NCT03541265|total knee arthroplasty|total knee arthroplasty
5073231|NCT03541213|ferric carboxymaltose|ferric carboxymaltose
5073232|NCT03541213|mitochondrial metabolism|mitochondrial metabolism
5073233|NCT03541213|cardiomyocyte|cardiomyocyte
5073234|NCT03541187|cockroach|cockroach
5073235|NCT03541187|immunotherapy|immunotherapy
5073236|NCT03541187|inner city asthma|inner city asthma
5073237|NCT03541187|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
5073238|NCT03541187|Nasal Allergen Challenge (NAC)|nasal allergen challenge (nac)
5073239|NCT03541161|Early rehabilitation|early rehabilitation
5073240|NCT03541161|Conventional protocol|conventional protocol
5073241|NCT03541161|Tissue expander insertion|tissue expander insertion
5073242|NCT03541148|Cutaneous malignant melanoma|cutaneous malignant melanoma
5073243|NCT03541148|Nutritional supplement|nutritional supplement
5073244|NCT03541148|survival|survival
5073245|NCT03541148|Green tea|green tea
5073246|NCT03541135|Cardiovascular health|cardiovascular health
5073247|NCT03541135|Diet|diet
5073248|NCT03541135|Functional limitations|functional limitations
5073249|NCT03541135|Frailty|frailty
5073250|NCT03541135|Older Adults|older adults
5073251|NCT03541109|Cardiovascular disease|cardiovascular disease
5073252|NCT03541109|fixed dose combination therapy|fixed dose combination therapy
5073253|NCT03541109|cost effectiveness|cost effectiveness
5073254|NCT03541070|kinesiology taping|kinesiology taping
5073255|NCT03541070|balance|balance
5073256|NCT03541070|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5073257|NCT03541018|TRV Reposition Chair|trv reposition chair
5073258|NCT03541018|Epley Maneuvre|epley maneuvre
5073259|NCT03541005|Overweight|overweight
5073260|NCT03541005|Obesity|obesity
5065076|NCT03592342|OLP|olp
5073261|NCT03541005|Nutritional supplement|nutritional supplement
5073262|NCT03541005|Weight loss|weight loss
5073263|NCT03541005|waist|waist
5073264|NCT03540953|Endoscopic injection of Mitomycin C|endoscopic injection of mitomycin c
5073265|NCT03540927|Well-being|well-being
5073267|NCT03540927|Conflict affected settings|conflict affected settings
5073268|NCT03540927|Psychosocial intervention|psychosocial intervention
5073269|NCT03540927|Psychological Capital|psychological capital
5073270|NCT03540914|healthy participants older than 40 years|healthy participants older than 40 years
5073271|NCT03540914|right heart function|right heart function
5073272|NCT03540914|prevention|prevention
5073273|NCT03540914|acetazolamide|acetazolamide
5073274|NCT03540901|prevention|prevention
5073275|NCT03540901|acetazolamide|acetazolamide
5073276|NCT03540901|obstructive airway disease|obstructive airway disease
5073277|NCT03540901|lung water|lung water
5073278|NCT03540888|Dynamic Stretching|dynamic stretching
5073279|NCT03540888|Static Stretching|static stretching
5073280|NCT03540888|Manual Therapy|manual therapy
5073281|NCT03540875|Anesthesia, general|anesthesia, general
5073282|NCT03540875|Total intravenous anesthesia|total intravenous anesthesia
5073283|NCT03540875|Closed loop anesthesia|closed loop anesthesia
5073284|NCT03540875|Conox|conox
5073285|NCT03540875|EEG monitoring|eeg monitoring
5073286|NCT03540875|qCon|qcon
5073287|NCT03540875|qNox|qnox
5073288|NCT03540862|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5073289|NCT03540862|Maintenance Negative Pressure Ventilation- assisted pulmonary rehabilitation|maintenance negative pressure ventilation- assisted pulmonary rehabilitation
5073290|NCT03540862|Six minute walk test|six minute walk test
5073291|NCT03540862|Overall survival|overall survival
5073292|NCT03540810|antiphospholipid syndrome|antiphospholipid syndrome
5073293|NCT03540810|thrombosis|thrombosis
5073294|NCT03540810|hydroxychloroquine|hydroxychloroquine
5073295|NCT03540784|muscle weakness|muscle weakness
5073296|NCT03540784|muscle mass|muscle mass
5073297|NCT03540784|whole-body electromyostimulation|whole-body electromyostimulation
5073298|NCT03540784|WB-EMS|wb-ems
5073299|NCT03540784|nutrition|nutrition
5073300|NCT03540784|protein|protein
5073301|NCT03540784|crohn's disease|crohn's disease
5073302|NCT03540784|ulcerative colitis|ulcerative colitis
5073303|NCT03540771|palliative care|palliative care
5073304|NCT03540771|hepatology|hepatology
5073305|NCT03540758|type 2 diabetes|type 2 diabetes
5073306|NCT03540758|diabetes|diabetes
5073307|NCT03540758|insulin resistance|insulin resistance
5073308|NCT03540758|diazoxide|diazoxide
5073309|NCT03540719|classification|classification
5073310|NCT03540719|questionnaires|questionnaires
5073313|NCT03540706|Respiratory Infections|respiratory infections
5073314|NCT03540706|C-reactive protein|c-reactive protein
5073315|NCT03540706|antibiotic prescription|antibiotic prescription
5073316|NCT03540693|Bariatric surgery|bariatric surgery
5073317|NCT03540693|gastric bypass surgery|gastric bypass surgery
5073318|NCT03540693|sleeve gastrectomy|sleeve gastrectomy
5073319|NCT03540693|laparoscopic gastric banding|laparoscopic gastric banding
5073320|NCT03540693|food preferences|food preferences
5073321|NCT03540693|flavor perception|flavor perception
5073622|NCT03538795|hemiplegia|hemiplegia
5073322|NCT03540667|Total hip arthroplasty|total hip arthroplasty
5738367|NCT00364013|Cancer|cancer
5073323|NCT03540667|Total knee arthroplasty|total knee arthroplasty
5073324|NCT03540667|Total joint arthroplasty|total joint arthroplasty
5073325|NCT03540667|Low middle income country|low middle income country
5073326|NCT03540667|Enhanced recovery pathway|enhanced recovery pathway
5073327|NCT03540641|Binge Eating Disorder|binge eating disorder
5073328|NCT03540641|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5073329|NCT03540641|Food Craving|food craving
5073330|NCT03540602|Polyphenol rich supplementation|polyphenol rich supplementation
5073331|NCT03540602|Tart cherry|tart cherry
5073332|NCT03540602|Lifting|lifting
5073333|NCT03540602|Recovery|recovery
5073334|NCT03540563|ctDNA|ctdna
5073335|NCT03540511|cardiac surgery|cardiac surgery
5073336|NCT03540511|troponin|troponin
5073337|NCT03540511|mortality|mortality
5073338|NCT03540498|Oral health|oral health
5073339|NCT03540498|Probiotics|probiotics
5073340|NCT03540498|L. plantarum|l. plantarum
5073341|NCT03540498|L. brevis|l. brevis
5073342|NCT03540498|Periodontics|periodontics
5073343|NCT03540498|Dental plaque|dental plaque
5073344|NCT03540472|tacrolimus|tacrolimus
5073345|NCT03540472|refractory pure red cell aplasia|refractory pure red cell aplasia
5073346|NCT03540472|prospective study|prospective study
5073347|NCT03540446|First Relief|first relief
5073348|NCT03540446|Diebetes|diebetes
5073349|NCT03540446|Pheripheral Neuropathy|pheripheral neuropathy
5073350|NCT03540446|Pain Releif|pain releif
5073351|NCT03540420|Atezolizumab|atezolizumab
5073352|NCT03540420|Chemoradiotherapy|chemoradiotherapy
5073353|NCT03540420|Immunotherapy|immunotherapy
5073354|NCT03540407|Cervical carcinoma|cervical carcinoma
5073355|NCT03540407|Endometrial adenocarcinoma|endometrial adenocarcinoma
5073357|NCT03540407|Nutritional supplement|nutritional supplement
5073358|NCT03540407|Antioxidant|antioxidant
5073359|NCT03540381|Neoatherosclerosis|neoatherosclerosis
5073360|NCT03540381|Cholesterol Uptake Capacity|cholesterol uptake capacity
5073364|NCT03540342|coronary artery disease|coronary artery disease
5073365|NCT03540342|aortic atherosclerotic disease|aortic atherosclerotic disease
5073366|NCT03540342|one-stop|one-stop
5073367|NCT03540342|percutaneous coronary intervention|percutaneous coronary intervention
5073368|NCT03540342|endovascular aortic repair|endovascular aortic repair
5073369|NCT03540329|osteogenesis|osteogenesis
5073370|NCT03540329|distraction|distraction
5073371|NCT03540329|Lower face asymmetry|lower face asymmetry
5073372|NCT03540303|relapsed/refractory, B cell, lymphoma, CAR|relapsed/refractory, b cell, lymphoma, car
5073373|NCT03540277|prevention program|prevention program
5073374|NCT03540277|body-image|body-image
5073375|NCT03540277|self-esteem|self-esteem
5073376|NCT03540277|parents|parents
5073377|NCT03540277|adolescents|adolescents
5073378|NCT03540238|sedation|sedation
5073379|NCT03540238|endoscopy|endoscopy
5073380|NCT03540238|anesthesia|anesthesia
5073381|NCT03540238|gastroenterologist|gastroenterologist
5073382|NCT03540225|Progesterone|progesterone
5073383|NCT03540199|activated CIK|activated cik
5073384|NCT03540199|MUC1|muc1
5073385|NCT03540199|bispecific antibody|bispecific antibody
5073386|NCT03540199|kidney cancer|kidney cancer
5073387|NCT03540147|blood flow restriction|blood flow restriction
5073388|NCT03540147|blood pressure|blood pressure
5073389|NCT03540147|yoga|yoga
5073391|NCT03540121|video|video
5073392|NCT03540121|contract|contract
5073393|NCT03540121|patient education|patient education
5073394|NCT03540108|hypercholesterolemia|hypercholesterolemia
5073395|NCT03540108|bile acid synthesis|bile acid synthesis
5073396|NCT03540108|cholesterol|cholesterol
5073397|NCT03540108|bile salt hydrolysis|bile salt hydrolysis
5073398|NCT03540108|vitamin D|vitamin d
5073399|NCT03540108|probiotic L plantarum LPLDL®|probiotic l plantarum lpldl®
5073400|NCT03540082|Aging|aging
5073401|NCT03540082|Older Adults|older adults
5073402|NCT03540082|Fall prevention|fall prevention
5073403|NCT03540082|Fall safety|fall safety
5073404|NCT03540082|Safe landing|safe landing
5073405|NCT03540056|varicocele|varicocele
5073406|NCT03540056|testicular growth|testicular growth
5073407|NCT03540043|Mild moderate atopic dermatitis|mild moderate atopic dermatitis
5073408|NCT03540030|Primary Total Shoulder Arthroplasty|primary total shoulder arthroplasty
5073409|NCT03540030|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5073410|NCT03540017|Ovarian Cancer|ovarian cancer
5073419|NCT03539965|PD-L2|pd-l2
5073420|NCT03539939|Gingival crevicular fluid|gingival crevicular fluid
5073623|NCT03538795|hemiparesis|hemiparesis
5073421|NCT03539939|Gingival recession|gingival recession
5073422|NCT03539939|Saliva|saliva
5073423|NCT03539939|Smoking|smoking
5073424|NCT03539939|Wound healing|wound healing
5073425|NCT03539926|Cystinuria|cystinuria
5073426|NCT03539926|pH Control|ph control
5073427|NCT03539887|Ketamine|ketamine
5073428|NCT03539887|Depression|depression
5073429|NCT03539887|Suicidal Ideation|suicidal ideation
5073430|NCT03539887|Alcohol Abuse|alcohol abuse
5073431|NCT03539861|End Stage Renal Disease|end stage renal disease
5073432|NCT03539861|Hemodialysis|hemodialysis
5073433|NCT03539861|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
5073435|NCT03539848|Community Setting|community setting
5073436|NCT03539848|Mild TBI|mild tbi
5073437|NCT03539835|Breast Cancer Survivors|breast cancer survivors
5073438|NCT03539835|Resistance Training|resistance training
5073439|NCT03539835|Fatigue|fatigue
5073440|NCT03539835|Physical Function|physical function
5073441|NCT03539835|Behavioral Function|behavioral function
5073442|NCT03539835|Kynurenine metabolism|kynurenine metabolism
5073443|NCT03539822|Cabozantinib|cabozantinib
5073444|NCT03539822|Durvalumab|durvalumab
5073445|NCT03539822|MEDI4736|medi4736
5073446|NCT03539809|Branched Chain Amino Acids|branched chain amino acids
5073447|NCT03539809|Direct Amino Acid Oxidation|direct amino acid oxidation
5073448|NCT03539809|Stable isotopes|stable isotopes
5073449|NCT03539796|dural puncture epidurals|dural puncture epidurals
5073450|NCT03539796|DPE|dpe
4956557|NCT04260152|Fibro-Gide|fibro-gide
5073451|NCT03539796|combined-spinal epidural|combined-spinal epidural
5073452|NCT03539796|CSE|cse
5073453|NCT03539796|cesarean section|cesarean section
5073454|NCT03539796|patient satisfaction|patient satisfaction
5073455|NCT03539783|Endotype|endotype
5073458|NCT03539783|Transcriptomics|transcriptomics
5073459|NCT03539770|Lung Development|lung development
5073460|NCT03539770|Lung Regeneration|lung regeneration
5073461|NCT03539770|Hyperpolarized Helium|hyperpolarized helium
5073466|NCT03539744|Cancer|cancer
5073467|NCT03539744|Multiple Myeloma (MM)|multiple myeloma (mm)
5073468|NCT03539744|Relapsed or Refractory Multiple Myeloma (R/R MM)|relapsed or refractory multiple myeloma (r/r mm)
5073469|NCT03539744|pharmacokinetics|pharmacokinetics
5073470|NCT03539679|Exercise, sickness absences, health, military fitness|exercise, sickness absences, health, military fitness
5073471|NCT03539640|PEEP|peep
5073472|NCT03539640|Diaphragm|diaphragm
5073473|NCT03539627|diabetes mellitus|diabetes mellitus
5073474|NCT03539627|Edarbi|edarbi
5073475|NCT03539627|hypertension|hypertension
5073476|NCT03539614|Prazosin|prazosin
5073477|NCT03539614|Nightmares|nightmares
5073478|NCT03539614|N-of-1|n-of-1
5073479|NCT03539601|Atopic Dermatitis, Crisaborole ointment 2%, TCS, TCI|atopic dermatitis, crisaborole ointment 2%, tcs, tci
5073480|NCT03539588|dry needling|dry needling
5073481|NCT03539588|electrical stimulation|electrical stimulation
5073482|NCT03539588|E-Stim|e-stim
5073483|NCT03539588|LBP|lbp
5073484|NCT03539588|low back pain|low back pain
5073485|NCT03539588|trigger point|trigger point
5073486|NCT03539588|chronic|chronic
5073487|NCT03539588|subacute|subacute
5073488|NCT03539575|K2|k2
5073489|NCT03539575|Spice|spice
5073490|NCT03539575|Synthetic Marijuana|synthetic marijuana
5073491|NCT03539536|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5073492|NCT03539536|Cancer|cancer
5073493|NCT03539536|Telisotuzumab vedotin|telisotuzumab vedotin
5073494|NCT03539536|ABBV-399|abbv-399
5073495|NCT03539536|c-Met, c-Met overexpression|c-met, c-met overexpression
5073496|NCT03539536|metastatic|metastatic
5073497|NCT03539536|MET gene amplification|met gene amplification
5073498|NCT03539523|L test|l test
5073499|NCT03539523|cerebral palsy|cerebral palsy
5073500|NCT03539523|children|children
5073501|NCT03539523|validity|validity
5073502|NCT03539523|reliability|reliability
5073503|NCT03539497|biomarker|biomarker
5073504|NCT03539445|AIS|ais
5073505|NCT03539445|butylphthalide|butylphthalide
5073506|NCT03539445|mechanical thrombectomy|mechanical thrombectomy
5073507|NCT03539445|iv-rtPA|iv-rtpa
5073510|NCT03539419|Plaque Psoriasis|plaque psoriasis
5073511|NCT03539419|Apremilast|apremilast
5073512|NCT03539419|CC-10004|cc-10004
5073513|NCT03539367|healthy participants older than 40 years|healthy participants older than 40 years
5073514|NCT03539367|lung water|lung water
5073515|NCT03539367|prevention|prevention
5073516|NCT03539367|acetazolamide|acetazolamide
5073517|NCT03539354|Atrial fibrillation|atrial fibrillation
5073518|NCT03539354|Spinal cord stimulatoin|spinal cord stimulatoin
5073519|NCT03539354|Coronary artery bypass grafting|coronary artery bypass grafting
5073520|NCT03539302|Inhaled Flecainide|inhaled flecainide
5073521|NCT03539289|IPF|ipf
5130470|NCT03179163|Skin|skin
5369135|NCT01861158|Parenting|parenting
5873495|NCT03701334|early breast cancer (EBC)|early breast cancer (ebc)
5873496|NCT03701334|HR+/HER2-|hr+/her2-
5873497|NCT03701334|adjuvant|adjuvant
5873498|NCT03701334|LEE011|lee011
5873499|NCT03701334|ribociclib|ribociclib
5873500|NCT03701334|CDK4/6 inhibitor|cdk4/6 inhibitor
5873517|NCT03699956|RRx-001|rrx-001
5873518|NCT03699956|Lung Cancer|lung cancer
5873519|NCT03699956|Lung Neoplasms|lung neoplasms
5873520|NCT03699956|Phase 3|phase 3
5873521|NCT03699956|Immunotherapy|immunotherapy
5873522|NCT03699956|Small Cell Carcinoma|small cell carcinoma
5873523|NCT03699709|diet|diet
5873524|NCT03699709|cooking skills|cooking skills
5073522|NCT03539289|Mitigating Adverse Events|mitigating adverse events
5073523|NCT03539276|quality improvement|quality improvement
5073524|NCT03539276|long term care|long term care
5073525|NCT03539276|polypharmacy|polypharmacy
5073526|NCT03539250|Radiation-induced temporal lobe injury;NPC|radiation-induced temporal lobe injury;npc
5073527|NCT03539250|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5073528|NCT03539250|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5073529|NCT03539237|Video demonstration|video demonstration
5073530|NCT03539237|Intensity levels|intensity levels
5073531|NCT03539237|Physical activity|physical activity
5073532|NCT03539237|Self-report|self-report
5073533|NCT03539237|Accelerometer|accelerometer
5073534|NCT03539185|Airtraq|airtraq
5073535|NCT03539185|Fiberoptic|fiberoptic
5073536|NCT03539185|Awake|awake
5073537|NCT03539185|Tracheal intubation|tracheal intubation
5073538|NCT03539185|laryngeal nerve blocks|laryngeal nerve blocks
5073539|NCT03539185|sedation|sedation
5073540|NCT03539185|remifentanil|remifentanil
5073541|NCT03539159|Allogeneic serum eye drops|allogeneic serum eye drops
5073542|NCT03539159|Micro eye drops|micro eye drops
5073543|NCT03539159|Cross-over multicenter trial|cross-over multicenter trial
5073544|NCT03539159|Ocular Surface Disease Index (OSDI)|ocular surface disease index (osdi)
5073545|NCT03539146|byproducts|byproducts
5073546|NCT03539146|functional yogurt|functional yogurt
5073547|NCT03539146|satiety|satiety
5073548|NCT03539146|sensory analysis|sensory analysis
5073549|NCT03539146|sustainable health|sustainable health
5073550|NCT03539146|novel food ingredient|novel food ingredient
5073551|NCT03539133|STEMI|stemi
5073552|NCT03539133|infarction|infarction
5073553|NCT03539133|coronary artery disease|coronary artery disease
5073554|NCT03539133|comorbidities|comorbidities
5073555|NCT03539133|diabetes|diabetes
5961246|NCT04288271|renal|renal
5961247|NCT04288271|allograft|allograft
5961248|NCT04288271|immunosuppressive|immunosuppressive
5961249|NCT04288271|immunosuppression|immunosuppression
5961250|NCT04288271|adherence|adherence
5961251|NCT04288271|medication|medication
5961252|NCT04288271|young adult|young adult
5961253|NCT04288271|mobile health|mobile health
5961254|NCT04288245|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
5961255|NCT04288245|Rehabilitation|rehabilitation
5961256|NCT04288245|Targeted Plasticity Therapy|targeted plasticity therapy
5961257|NCT04288232|anti-VEGF|anti-vegf
5961258|NCT04288232|intravitreal aflibercept|intravitreal aflibercept
5961259|NCT04288232|diabetic macular edema|diabetic macular edema
5961260|NCT04288232|Treat-and-Extend regimen|treat-and-extend regimen
5961261|NCT04288206|antibiotic stewardship|antibiotic stewardship
5961262|NCT04288206|post operative infection|post operative infection
5961263|NCT04288206|pediatric|pediatric
5961264|NCT04288206|cefazolin|cefazolin
5961265|NCT04288193|sleep|sleep
5961266|NCT04288193|antipsychotic|antipsychotic
5961267|NCT04288193|bpsd|bpsd
5961268|NCT04288193|deprescribing|deprescribing
5961269|NCT04288141|FLIM-FRET|flim-fret
5961270|NCT04288141|HER2-HER3 dimer|her2-her3 dimer
5961271|NCT04288141|Exosomes|exosomes
5961272|NCT04288141|Predictive biomarkers|predictive biomarkers
5961273|NCT04288128|spinocerebellar ataxia, multimodal approach, biomarker, Antisense oligonucleotides (ASOs) therapy|spinocerebellar ataxia, multimodal approach, biomarker, antisense oligonucleotides (asos) therapy
5961274|NCT04288089|H3B-6545|h3b-6545
5961275|NCT04288089|Palbociclib|palbociclib
5961276|NCT04288089|Metastatic Estrogen Receptor-Positive|metastatic estrogen receptor-positive
5961277|NCT04288089|HER2-Negative Breast Cancer|her2-negative breast cancer
5961278|NCT04288050|continuous glucose monitoring system|continuous glucose monitoring system
5961279|NCT04288050|haemodialysis|haemodialysis
5961280|NCT04288050|peritoneal dialysis|peritoneal dialysis
5961281|NCT04288024|Parkinson|parkinson
5961282|NCT04288024|dual-task training|dual-task training
5961283|NCT04288024|attention|attention
5961284|NCT04288024|electroencephalogram (EEG)|electroencephalogram (eeg)
5961285|NCT04288011|MS|ms
5961286|NCT04288011|mobile app|mobile app
5961287|NCT04288011|machine learning|machine learning
5961288|NCT04288011|EDSS|edss
5961289|NCT04288011|BeCare|becare
5961290|NCT04287998|MXRA5|mxra5
5961291|NCT04287998|ANXA4|anxa4
5961292|NCT04287998|Syndecan1|syndecan1
5961293|NCT04287998|TIMP1|timp1
5961294|NCT04287998|lead|lead
5961295|NCT04287998|arsenic|arsenic
5961296|NCT04287985|VIS649|vis649
5961297|NCT04287985|Kidney Diseases|kidney diseases
5961298|NCT04287985|Glomerulonephritis, IGA|glomerulonephritis, iga
5961299|NCT04287985|Glomerulonephritis|glomerulonephritis
5961300|NCT04287985|Nephritis|nephritis
5961301|NCT04287985|Autoimmune Diseases|autoimmune diseases
5961302|NCT04287985|Immune System Diseases|immune system diseases
5961303|NCT04287985|Immunoglobulins|immunoglobulins
5961304|NCT04287985|Antibodies|antibodies
5961305|NCT04287985|Immunoglobulin A|immunoglobulin a
5961306|NCT04287985|Immunologic Factors|immunologic factors
5961307|NCT04287985|Physiological Effects of Drugs|physiological effects of drugs
5961308|NCT04287985|Proteinuria|proteinuria
5073556|NCT03539133|anemia|anemia
5073557|NCT03539094|Multiple Sclerosis|multiple sclerosis
5073563|NCT03539081|Blood Flow|blood flow
5073564|NCT03539068|Veteran|veteran
5073565|NCT03539068|Mental Health|mental health
5073567|NCT03539068|Shared decision-making|shared decision-making
5073568|NCT03539068|Access to care|access to care
5073569|NCT03539055|DRT|drt
5073570|NCT03539055|Device related thrombus|device related thrombus
5073571|NCT03539055|Dabigatran etexilate|dabigatran etexilate
5073572|NCT03539055|Aspirin|aspirin
5073573|NCT03539055|Watchman|watchman
5073574|NCT03539042|DNA methylation|dna methylation
5073575|NCT03539042|Physical activity|physical activity
5073576|NCT03539042|Exercise capacity|exercise capacity
5073577|NCT03539016|Chronic hepatitis B, Mother-to-child transmission|chronic hepatitis b, mother-to-child transmission
5073578|NCT03538990|Nutrition|nutrition
5073579|NCT03538990|Dietary Approaches to Stop Hypertension|dietary approaches to stop hypertension
5073580|NCT03538990|Cardiometabolic Outcomes|cardiometabolic outcomes
5073581|NCT03538990|Pulmonary Artery Pressure|pulmonary artery pressure
5073582|NCT03538990|CardioMEMS|cardiomems
5073583|NCT03538977|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5073584|NCT03538977|Hydrotherapy|hydrotherapy
5073585|NCT03538977|Electromyography|electromyography
5073586|NCT03538977|Pain|pain
5073587|NCT03538977|Prematurity|prematurity
5073588|NCT03538964|Cataract|cataract
5073589|NCT03538964|Low Astigmatism|low astigmatism
5073590|NCT03538951|actinic keratosis|actinic keratosis
5073591|NCT03538951|efficacy|efficacy
5073592|NCT03538951|safety|safety
5073593|NCT03538951|VDA-1102|vda-1102
5073594|NCT03538938|Smoking|smoking
5073595|NCT03538938|Smoking cessation|smoking cessation
5073596|NCT03538938|Quitline|quitline
5073597|NCT03538938|Nicotine Replacement Therapy|nicotine replacement therapy
5073598|NCT03538938|SmokefreeTXT text messages|smokefreetxt text messages
5073599|NCT03538938|Financial incentives|financial incentives
5073600|NCT03538912|empirical antifungal therapy|empirical antifungal therapy
5073601|NCT03538912|invasive candidiasis|invasive candidiasis
5073602|NCT03538912|biomarkers|biomarkers
5073603|NCT03538912|de-escalation|de-escalation
5073604|NCT03538912|ICU|icu
5073605|NCT03538899|Artemis-deficient Severe Combined Immunodeficiency|artemis-deficient severe combined immunodeficiency
5073606|NCT03538899|gene therapy|gene therapy
5073607|NCT03538899|autologous stem cell transplant|autologous stem cell transplant
5073608|NCT03538886|Coronary revascularization|coronary revascularization
5072826|NCT03543891|Metabonomics|metabonomics
5073609|NCT03538873|Subsyndromic symptoms of depression|subsyndromic symptoms of depression
5073610|NCT03538873|Subsyndromic symptoms of anxiety|subsyndromic symptoms of anxiety
5073612|NCT03538873|Physical activity|physical activity
5073613|NCT03538873|Population-based study|population-based study
5073614|NCT03538860|Telepsychiatry|telepsychiatry
5073615|NCT03538860|AsynchronousTelepsychiatry|asynchronoustelepsychiatry
5073616|NCT03538860|Automated Translation|automated translation
5073617|NCT03538847|postoperative pain|postoperative pain
5073618|NCT03538847|eye surgery|eye surgery
5073619|NCT03538847|vitrectomy|vitrectomy
5073620|NCT03538847|pain control protocol|pain control protocol
5073621|NCT03538795|stroke|stroke
5073634|NCT03538756|Neuropathy|neuropathy
5073635|NCT03538743|Type 2 diabetes mellitus|type 2 diabetes mellitus
5073636|NCT03538717|Axitinib,|axitinib,
5073637|NCT03538717|Renal Carcinoma,|renal carcinoma,
5073638|NCT03538717|Long responders|long responders
5073639|NCT03538704|Endometrial cancer|endometrial cancer
5073640|NCT03538704|Atypical hyperplasia|atypical hyperplasia
5073641|NCT03538704|Fertility-preserving|fertility-preserving
5073642|NCT03538704|Remission time|remission time
5073643|NCT03538704|Recurrence|recurrence
5073644|NCT03538704|Pregnancy|pregnancy
5073645|NCT03538704|Progesterone receptor|progesterone receptor
5073646|NCT03538691|Brexpiprazole|brexpiprazole
5073658|NCT03538639|Etiology of Rare and Orphan Diseases with Vascular Phenotype|etiology of rare and orphan diseases with vascular phenotype
5073659|NCT03538639|Natural History of Rare and Orphan Diseases with Vascular Phenotype|natural history of rare and orphan diseases with vascular phenotype
5073660|NCT03538639|Pathophysiology of Uncommon Vascular Diseases|pathophysiology of uncommon vascular diseases
5073661|NCT03538639|Undiagnosed Diseases|undiagnosed diseases
5073662|NCT03538639|Rare Human Diseases with Vascular Features|rare human diseases with vascular features
5073663|NCT03538626|Immune Cells|immune cells
5073664|NCT03538626|bNAb|bnab
5073665|NCT03538626|Plasma Cell|plasma cell
5073666|NCT03538626|HIV|hiv
5073667|NCT03538626|Immunotherapy|immunotherapy
5073668|NCT03538613|Adoptive Cell Therapy|adoptive cell therapy
5073669|NCT03538613|Immunotherapy|immunotherapy
5073680|NCT03538587|Quality of Life|quality of life
5073681|NCT03538548|Cocaine Abuse|cocaine abuse
5073682|NCT03538548|Cocaine Use Disorder|cocaine use disorder
5073683|NCT03538548|Substance-Related Disorders|substance-related disorders
5073684|NCT03538535|reinforcement learning|reinforcement learning
5073685|NCT03538535|computational models|computational models
5073686|NCT03538535|neuroimaging|neuroimaging
5961309|NCT04287907|end tidal carbon dioxide|end tidal carbon dioxide
5961310|NCT04287907|mask ventilation|mask ventilation
5073687|NCT03538457|Bariatric surgery|bariatric surgery
5073688|NCT03538457|Gastrointestinal tract|gastrointestinal tract
5073689|NCT03538457|Biological availability|biological availability
5073690|NCT03538457|Pharmacokinetics|pharmacokinetics
5073691|NCT03538457|Acetaminophen|acetaminophen
5073692|NCT03538431|Autism Spectrum Disorder|autism spectrum disorder
5073693|NCT03538431|ASD|asd
5073694|NCT03538431|Anxiety|anxiety
5073695|NCT03538418|Frailty|frailty
5073696|NCT03538418|Wearable technology|wearable technology
5073697|NCT03538418|Physical activity|physical activity
5073698|NCT03538418|Behaviour change|behaviour change
5073699|NCT03538405|harmonic techniques|harmonic techniques
5073700|NCT03538405|supporting cushions|supporting cushions
5073701|NCT03538405|intervention|intervention
5073702|NCT03538379|Tourniquets|tourniquets
5073703|NCT03538379|Bleeding Control Basic (B-Con) Course|bleeding control basic (b-con) course
5073704|NCT03538379|Layperson training|layperson training
5073705|NCT03538366|Ulcerative Colitis|ulcerative colitis
5073706|NCT03538366|Inflammatory bowel disease|inflammatory bowel disease
5073707|NCT03538366|Pouchitis|pouchitis
5073708|NCT03538366|Fecal microbiota transplant|fecal microbiota transplant
5073709|NCT03538366|Fecal microbiota treatment|fecal microbiota treatment
5073710|NCT03538340|Thoracotomy|thoracotomy
5073711|NCT03538340|Cryoanalgesia|cryoanalgesia
5073712|NCT03538340|Pain|pain
5073713|NCT03538327|essential hypertension|essential hypertension
5073714|NCT03538327|insulin resistance|insulin resistance
5073715|NCT03538327|silybin|silybin
5073716|NCT03538262|SURE-PD3|sure-pd3
5073717|NCT03538262|STEADY-PD III|steady-pd iii
5073718|NCT03538262|Parkinson disease|parkinson disease
5073719|NCT03538262|PD|pd
5073720|NCT03538262|Parkinson Study Group (PSG)|parkinson study group (psg)
5073721|NCT03538262|Telemedicine|telemedicine
5073722|NCT03538262|Smartphone|smartphone
5073723|NCT03538262|Disease progression|disease progression
5073724|NCT03538262|Televisits|televisits
5073725|NCT03538262|Patient-reported outcomes|patient-reported outcomes
5073726|NCT03538249|Heart Failure|heart failure
5073727|NCT03538249|Aerobic Exercise|aerobic exercise
5073728|NCT03538249|Respiratory Muscle Training|respiratory muscle training
5073729|NCT03538249|Strength Training|strength training
5073730|NCT03538223|Music listening|music listening
5073731|NCT03538223|Radiotherapy|radiotherapy
5073732|NCT03538223|Breast cancer|breast cancer
5073733|NCT03538223|Psychological rehabilitation|psychological rehabilitation
5673174|NCT00609050|lung function|lung function
5072931|NCT03543293|vertigo|vertigo
5862705|NCT00001543|Corticotropin Releasing Hormone Binding Protein|corticotropin releasing hormone binding protein
5073734|NCT03538210|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis|obesity, bariatric surgery, gastrointestinal functions, adipose tissu, steatohepatitis
5073735|NCT03538197|suicide attempt|suicide attempt
5073736|NCT03538197|suicide re attempt|suicide re attempt
5073737|NCT03538158|Older adults|older adults
5073738|NCT03538158|Physical well-being|physical well-being
5073739|NCT03538158|Quality of life|quality of life
5073740|NCT03538119|Cardiac Rehabilitation|cardiac rehabilitation
5073741|NCT03538119|High Intensity Interval Training|high intensity interval training
5073742|NCT03538119|Exercise-based Rehabilitation|exercise-based rehabilitation
5073743|NCT03538119|Secondary prevention|secondary prevention
5073744|NCT03538119|Sedentary Behavior|sedentary behavior
5073745|NCT03538106|Cesrean delivery|cesrean delivery
5073746|NCT03538106|Risks factors|risks factors
5073747|NCT03538106|Diabetes Type 1|diabetes type 1
5073748|NCT03538093|arthrodesis|arthrodesis
5073749|NCT03538093|core stabilization|core stabilization
5073750|NCT03538093|physical therapy|physical therapy
5073751|NCT03538080|venous disease|venous disease
5073752|NCT03538080|peripheral vascular disease|peripheral vascular disease
5073753|NCT03538080|vascular surgery|vascular surgery
5073754|NCT03538080|ultrasound imaging|ultrasound imaging
5085861|NCT03461666|Primary insomnia|primary insomnia
5073759|NCT03538067|intravascular ultrasound|intravascular ultrasound
5073760|NCT03538054|Fibromyalgia|fibromyalgia
5073761|NCT03538041|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5073762|NCT03538041|phosphatidylinositol 3-kinase (PI3K) inhibitor|phosphatidylinositol 3-kinase (pi3k) inhibitor
5073763|NCT03538028|lymphocyte activation gene (LAG)|lymphocyte activation gene (lag)
5073765|NCT03538028|advanced solid tumor|advanced solid tumor
5073766|NCT03538028|metastatic solid tumor|metastatic solid tumor
5073767|NCT03538028|relapsed/refractory DLCBL|relapsed/refractory dlcbl
5073768|NCT03538015|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5073770|NCT03538002|blue light filtering spectacle lens|blue light filtering spectacle lens
5073771|NCT03537989|fluid therapy|fluid therapy
5073772|NCT03537989|Restricted fluid therapy|restricted fluid therapy
5073773|NCT03537989|saline|saline
5073774|NCT03537963|HCT survivors|hct survivors
5073775|NCT03537963|hematopoietic stem cell transplant (HCT)|hematopoietic stem cell transplant (hct)
5073776|NCT03537963|survivors of hematopoietic stem cell transplant|survivors of hematopoietic stem cell transplant
5073777|NCT03537950|Cannabidiol|cannabidiol
5073778|NCT03537950|Cannabidivarin|cannabidivarin
5073779|NCT03537950|E-I balance|e-i balance
5961311|NCT04287907|neonatal resuscitation|neonatal resuscitation
5073780|NCT03537950|pharmacological imaging|pharmacological imaging
5073781|NCT03537924|healthy participants older than 40 years|healthy participants older than 40 years
5073782|NCT03537924|right heart function during exercise|right heart function during exercise
5073783|NCT03537924|prevention|prevention
5073784|NCT03537924|acetazolamide|acetazolamide
5073785|NCT03537898|balanced crystalloid|balanced crystalloid
5073786|NCT03537898|crystalloid|crystalloid
5073787|NCT03537898|isotonic|isotonic
5073789|NCT03537898|non-acetate|non-acetate
5073790|NCT03537898|lactated Ringer's|lactated ringer's
5073791|NCT03537898|Normosol|normosol
5073792|NCT03537859|hospitalized child|hospitalized child
5073793|NCT03537859|salivary cortisol|salivary cortisol
5073794|NCT03537859|augmented reality|augmented reality
5073795|NCT03537807|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5073796|NCT03537807|ALS|als
5073797|NCT03537807|Lou Gehrig Disease|lou gehrig disease
5073798|NCT03537807|Lou Gehrig's Disease|lou gehrig's disease
5073799|NCT03537807|Lou-Gehrigs Disease|lou-gehrigs disease
5073800|NCT03537807|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
5073801|NCT03537807|Riluzole|riluzole
5073802|NCT03537807|Rilutek®|rilutek®
5073803|NCT03537807|Sublingual|sublingual
5073804|NCT03537807|Oral formulation|oral formulation
5073805|NCT03537807|Neuroprotective Agents|neuroprotective agents
5073806|NCT03537807|Administration, Sublingual|administration, sublingual
5073807|NCT03537807|Administration, Oral|administration, oral
5073808|NCT03537807|Biological Availability|biological availability
5073809|NCT03537781|food choice, food labels|food choice, food labels
5073810|NCT03537742|Heart Transplant|heart transplant
5073811|NCT03537729|Alzheimer's disease|alzheimer's disease
5073812|NCT03537729|Age related memory disorders|age related memory disorders
5073911|NCT03537196|Vietnam|vietnam
5073821|NCT03537664|Periapical Periodontitis|periapical periodontitis
5073822|NCT03537664|Bacterial Infections|bacterial infections
5073823|NCT03537664|Root Canal Preparation|root canal preparation
5073824|NCT03537664|Calcium Hydroxide|calcium hydroxide
5073825|NCT03537664|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
5073826|NCT03537664|RNA-Directed DNA Polymerase|rna-directed dna polymerase
5073827|NCT03537638|Lupus|lupus
5073828|NCT03537638|Quality of life|quality of life
5073829|NCT03537638|Multicomponent intervention|multicomponent intervention
5130854|NCT03176485|cancer|cancer
5073830|NCT03537638|Clinical Practice Guideline|clinical practice guideline
5073831|NCT03537638|Computerized clinical decision support system|computerized clinical decision support system
5073832|NCT03537638|Activity|activity
5073833|NCT03537612|Post-operative pain|post-operative pain
5073834|NCT03537573|Pragmatic clinical trial|pragmatic clinical trial
5073835|NCT03537573|Primary care|primary care
5073836|NCT03537573|Provider-targeted|provider-targeted
5073837|NCT03537573|Behavioral intervention|behavioral intervention
5073838|NCT03537573|Electronic health record|electronic health record
5073844|NCT03537521|severe bleeding|severe bleeding
5073845|NCT03537521|dabigatran|dabigatran
5073846|NCT03537521|rivaroxaban|rivaroxaban
5073847|NCT03537521|apixaban|apixaban
5073848|NCT03537521|edoxaban|edoxaban
5073849|NCT03537521|PCC|pcc
5073850|NCT03537521|aPCC|apcc
5073851|NCT03537521|rVIIa|rviia
5073852|NCT03537521|hemodialysis|hemodialysis
5073853|NCT03537521|antidots|antidots
5073854|NCT03537521|idarucizumab|idarucizumab
5085963|NCT03460964|Sensor|sensor
5073862|NCT03537495|pharmacokinetic study|pharmacokinetic study
5073863|NCT03537456|Dermal Filler|dermal filler
5073864|NCT03537456|Hyaluronic Acid|hyaluronic acid
5073866|NCT03537443|Vitamin D|vitamin d
5073867|NCT03537443|Bone mineral density|bone mineral density
5073868|NCT03537443|Bone mineral content|bone mineral content
5073869|NCT03537430|TNT (Totally no tube)|tnt (totally no tube)
5073870|NCT03537430|uniportal VATS|uniportal vats
5073871|NCT03537430|mediastinal tumor|mediastinal tumor
5073872|NCT03537404|hepatitis C|hepatitis c
5073873|NCT03537404|chronic|chronic
5073874|NCT03537404|pharmacokinetics|pharmacokinetics
5073875|NCT03537404|HIV|hiv
5073876|NCT03537404|coinfection|coinfection
5073877|NCT03537404|concomitant therapy|concomitant therapy
5073878|NCT03537391|prostate cancer|prostate cancer
5073879|NCT03537391|imaging of prostate cancer|imaging of prostate cancer
5073880|NCT03537391|staging of prostate cancer|staging of prostate cancer
5073881|NCT03537391|prostate specific membrane antigen (PSMA)|prostate specific membrane antigen (psma)
5073882|NCT03537391|positron emission tomography|positron emission tomography
5073883|NCT03537391|bone scintigraphy|bone scintigraphy
5073884|NCT03537391|whole body magnetic resonance imaging|whole body magnetic resonance imaging
5073885|NCT03537391|whole body computer tomography|whole body computer tomography
5073886|NCT03537391|single photon emission tomography (SPECT)|single photon emission tomography (spect)
5073887|NCT03537378|Hybrid APC,Early Central Lung Neoplasms,|hybrid apc,early central lung neoplasms,
5073888|NCT03537365|Human Milk Fortification|human milk fortification
5073889|NCT03537365|Bovine Colostrum|bovine colostrum
5073890|NCT03537365|Very Preterm Infants|very preterm infants
5073891|NCT03537365|Enteral feeding|enteral feeding
5073892|NCT03537365|Human Milk|human milk
5073895|NCT03537326|doping|doping
5073896|NCT03537261|Parent Training|parent training
5073897|NCT03537261|Aggressive Behavior|aggressive behavior
5073898|NCT03537235|Libramed|libramed
5073899|NCT03537235|Policaptil Gel retard|policaptil gel retard
5073900|NCT03537235|Overweigth|overweigth
5073901|NCT03537235|Obesity|obesity
5073902|NCT03537235|Medical Device|medical device
5073903|NCT03537235|glycemic profile|glycemic profile
5073904|NCT03537235|incretin|incretin
5073905|NCT03537222|quality of life|quality of life
5073906|NCT03537222|psychometrics|psychometrics
5073907|NCT03537196|People who inject drugs|people who inject drugs
5073908|NCT03537196|Hepatitis C|hepatitis c
5073909|NCT03537196|Direct Acting Antiviral|direct acting antiviral
5073910|NCT03537196|HCV Elimination|hcv elimination
5073919|NCT03537144|indomethacin|indomethacin
5073920|NCT03537131|diabetes|diabetes
5073921|NCT03537131|dapagliflozin|dapagliflozin
5073922|NCT03537131|exercise|exercise
5073923|NCT03537131|hypoglycemia|hypoglycemia
5073924|NCT03537105|cytokine|cytokine
5073925|NCT03537105|skin inflammation|skin inflammation
5073926|NCT03537079|hypoxia|hypoxia
5073927|NCT03537079|exercise training|exercise training
5073928|NCT03537079|heart failure|heart failure
5073929|NCT03537079|cardiac remodeling|cardiac remodeling
5073930|NCT03537053|Sedentary Lifestyle|sedentary lifestyle
5073931|NCT03537027|vitamin D3|vitamin d3
5073932|NCT03537027|cholecalciferol|cholecalciferol
5073933|NCT03537027|calcidiol|calcidiol
5073934|NCT03537027|25-hydroxyvitamin D|25-hydroxyvitamin d
5073935|NCT03537027|gene expression|gene expression
5073936|NCT03537027|vitamin D receptor|vitamin d receptor
5073937|NCT03537027|adults|adults
5073938|NCT03537027|clinical trial|clinical trial
5073939|NCT03537001|Methoxyflurane|methoxyflurane
5073940|NCT03537001|Penthrox|penthrox
5073941|NCT03537001|anesthetic|anesthetic
5073942|NCT03537001|analgesia|analgesia
5073943|NCT03537001|acute|acute
5073944|NCT03537001|traumatic|traumatic
5073945|NCT03537001|pain|pain
5073946|NCT03537001|prehospital setting|prehospital setting
5073947|NCT03537001|visual numeric scale|visual numeric scale
5073948|NCT03536988|Ulcerative Colitiis|ulcerative colitiis
5073949|NCT03536988|Ileal pouch anal anastomosis|ileal pouch anal anastomosis
5073950|NCT03536988|Transanal Minimally Invasive Surgery|transanal minimally invasive surgery
5073951|NCT03536988|Postoperative Outcome|postoperative outcome
5073952|NCT03536975|Dementia|dementia
5073953|NCT03536975|Mild Dementia|mild dementia
5073954|NCT03536975|Cognitive Impairment|cognitive impairment
5073955|NCT03536923|Female|female
5073956|NCT03536910|copeptin levels|copeptin levels
5073957|NCT03536910|Cesarean section|cesarean section
5073958|NCT03536910|general anesthesia|general anesthesia
5073977|NCT03536728|DFMO|dfmo
5073978|NCT03536728|AMXT 1501|amxt 1501
5073979|NCT03536689|Amniotic fluid index|amniotic fluid index
5073980|NCT03536676|Breakfast|breakfast
5073981|NCT03536676|Obesity|obesity
5073982|NCT03536676|Mood|mood
5073983|NCT03536676|Eating Behavior|eating behavior
5073984|NCT03536676|Cognitive Function|cognitive function
5073985|NCT03536650|Metabolic diseases|metabolic diseases
5073986|NCT03536624|prevention|prevention
5073987|NCT03536624|biomarkers|biomarkers
5073988|NCT03536624|stress|stress
5073989|NCT03536624|burn out|burn out
5073990|NCT03536624|occupation|occupation
5073991|NCT03536624|work|work
5073992|NCT03536624|spa bath|spa bath
5073993|NCT03536611|dabigatran|dabigatran
5073994|NCT03536611|warfarin|warfarin
5073995|NCT03536611|non-valve atrial fibrillation|non-valve atrial fibrillation
5073996|NCT03536611|percutaneous coronary intervention|percutaneous coronary intervention
5073997|NCT03536572|Sleep Apnea Syndromes|sleep apnea syndromes
5073998|NCT03536572|Chronic Disease|chronic disease
5073999|NCT03536572|Adherence|adherence
5074000|NCT03536572|Self-Care|self-care
5074001|NCT03536572|Patient Outcomes|patient outcomes
5074002|NCT03536559|gold|gold
5074003|NCT03536559|nanocrystal|nanocrystal
5074004|NCT03536559|multifocal visual evoked potential|multifocal visual evoked potential
5074005|NCT03536559|full field visual evoked potential|full field visual evoked potential
5074006|NCT03536559|low contrast vision|low contrast vision
5074007|NCT03536559|low contrast letter acuity|low contrast letter acuity
5074008|NCT03536559|remyelination|remyelination
5074009|NCT03536559|demyelination|demyelination
5074010|NCT03536546|Veterans Health|veterans health
5074011|NCT03536546|Intervention, Brief|intervention, brief
5074012|NCT03536546|Peer|peer
5074013|NCT03536520|healthy participants older than 40 years|healthy participants older than 40 years
5074016|NCT03536520|prevention|prevention
5074017|NCT03536520|acetazolamide|acetazolamide
5356801|NCT01917942|Radiotherapy|radiotherapy
5074018|NCT03536507|healthy participants older than 40 years|healthy participants older than 40 years
5074019|NCT03536507|sleep disordered breathing|sleep disordered breathing
5074020|NCT03536507|periodic breathing|periodic breathing
5074021|NCT03536507|prevention|prevention
5074022|NCT03536507|acetazolamide|acetazolamide
5074023|NCT03536494|Overactive bladder|overactive bladder
5074025|NCT03536494|Persistence|persistence
5074026|NCT03536494|Patient-Centered Care|patient-centered care
5074027|NCT03536494|Inappropriate prescribing|inappropriate prescribing
5074028|NCT03536494|Discontinuation|discontinuation
5074029|NCT03536468|Tooth loss, edentulousness, psychology, oral health-related|tooth loss, edentulousness, psychology, oral health-related
5074030|NCT03536455|healthy participants older than 40 years|healthy participants older than 40 years
5074031|NCT03536455|exercise performance|exercise performance
5074032|NCT03536455|prevention|prevention
5074033|NCT03536455|acetazolamide|acetazolamide
5074034|NCT03536442|antenatal|antenatal
5074035|NCT03536442|postpartum|postpartum
5074036|NCT03536442|mental health|mental health
5074037|NCT03536429|healthy participants older than 40 years|healthy participants older than 40 years
5074038|NCT03536429|postural control|postural control
5074039|NCT03536429|prevention|prevention
5074040|NCT03536429|acetazolamide|acetazolamide
5074041|NCT03536416|Self-management|self-management
5074042|NCT03536416|Children and young people|children and young people
5074044|NCT03536377|Diabetes Mellitus Remission|diabetes mellitus remission
5074045|NCT03536377|Prediabetic State|prediabetic state
5074046|NCT03536377|caloric restriction|caloric restriction
5074047|NCT03536377|weight loss|weight loss
5074048|NCT03536377|diet|diet
5074049|NCT03536377|Barbados|barbados
5074050|NCT03536351|social skills|social skills
5074051|NCT03536351|child|child
5074052|NCT03536351|theory of mind|theory of mind
5074053|NCT03536351|drama|drama
5074054|NCT03536351|occupational therapy|occupational therapy
5074055|NCT03536351|speech-language pathology|speech-language pathology
5074056|NCT03536351|neural activation|neural activation
5074057|NCT03536338|Sit-to-stand; Spinal Stimulation; transcutaneous|sit-to-stand; spinal stimulation; transcutaneous
5074058|NCT03536299|Physical therapy|physical therapy
5074059|NCT03536299|Gait training|gait training
5074060|NCT03536299|Cognitive-motor interference|cognitive-motor interference
5074061|NCT03536299|Rehabilitation|rehabilitation
5074062|NCT03536273|sedentary|sedentary
5074068|NCT03536247|choledocholithiasis|choledocholithiasis
5074069|NCT03536247|ERCP|ercp
5074070|NCT03536247|endoscopic retrograde cholangiopancreatograhy|endoscopic retrograde cholangiopancreatograhy
5074071|NCT03536195|renal replacement therapy|renal replacement therapy
5074072|NCT03536195|acute renal failure|acute renal failure
5074073|NCT03536195|coagulation|coagulation
5074074|NCT03536195|bleeding|bleeding
5074077|NCT03536156|Dental implant|dental implant
5074078|NCT03536156|Implant Emergence Profile|implant emergence profile
5074079|NCT03536143|bullosa|bullosa
5074085|NCT03536143|telserpavec|telserpavec
5074086|NCT03536143|KB103|kb103
5074087|NCT03536143|HSV-COL7A1|hsv-col7a1
5074088|NCT03536130|chest tube, lung resection, air leakage|chest tube, lung resection, air leakage
5074089|NCT03536078|home phototherapy|home phototherapy
5074090|NCT03536078|parental bonding|parental bonding
5074091|NCT03536039|CNS lymphoma|cns lymphoma
5074092|NCT03536039|BBB permeabilization|bbb permeabilization
5074093|NCT03536039|R-CHOP|r-chop
5074094|NCT03536039|TNF|tnf
5074095|NCT03536000|Cardiac function|cardiac function
5074096|NCT03536000|Fetal|fetal
5074097|NCT03536000|Strain|strain
5074098|NCT03535935|Chinese medicine|chinese medicine
5074099|NCT03535935|Astragalus|astragalus
5074100|NCT03535935|Pragmatic trial|pragmatic trial
5074101|NCT03535922|Hemodialysis|hemodialysis
5074102|NCT03535922|Chronic Kidney Disease|chronic kidney disease
5074103|NCT03535909|CHF|chf
5074104|NCT03535909|central venous pressure|central venous pressure
5074105|NCT03535909|noninvasive|noninvasive
5074106|NCT03535909|ADHF|adhf
5074107|NCT03535909|stroke volume|stroke volume
5074108|NCT03535857|overactive bladder|overactive bladder
5074109|NCT03535857|OAB|oab
5074110|NCT03535857|urge urinary incontinence|urge urinary incontinence
5074111|NCT03535857|PTNS|ptns
5074112|NCT03535844|Wolfberry (Goji berry)|wolfberry (goji berry)
5074113|NCT03535844|Healthy diet|healthy diet
5074114|NCT03535844|Cardiovascular diseases|cardiovascular diseases
5074122|NCT03535805|Community Health Care|community health care
5074123|NCT03535805|Early Intervention|early intervention
5074124|NCT03535740|Drug Therapy|drug therapy
5074125|NCT03535714|Treatment|treatment
5074126|NCT03535714|Psychotherapy|psychotherapy
5074127|NCT03535714|Young Adult|young adult
5074128|NCT03535714|Adolescence|adolescence
5074129|NCT03535688|Chronic Pain|chronic pain
5074130|NCT03535688|Low Back Pain|low back pain
5074131|NCT03535688|D-cycloserine|d-cycloserine
5074133|NCT03535636|Polysomnography|polysomnography
5074134|NCT03535636|Refugees|refugees
5074135|NCT03535623|remote ischemic preconditioning|remote ischemic preconditioning
5074136|NCT03535623|free flap reconstruction|free flap reconstruction
5074137|NCT03535623|preoperative radiotherapy|preoperative radiotherapy
5074138|NCT03535610|Embolization|embolization
5961312|NCT04287894|No prior radiotherapy to the thorax.|no prior radiotherapy to the thorax.
5961313|NCT04287894|undergoing EBUS and/or mediastinoscopy.|undergoing ebus and/or mediastinoscopy.
5074139|NCT03535610|Uterine Leiomyoma|uterine leiomyoma
5074140|NCT03535610|Embospheres|embospheres
5074141|NCT03535610|Microspheres|microspheres
5074142|NCT03535597|Transradial Access|transradial access
5074143|NCT03535597|Hemostasis|hemostasis
5074144|NCT03535571|Energy increase|energy increase
5074145|NCT03535571|Energy|energy
5074146|NCT03535571|Healthy|healthy
5074147|NCT03535571|anti-inflammatory|anti-inflammatory
5074148|NCT03535571|Open-label|open-label
5074149|NCT03535571|Salmon protein|salmon protein
5074150|NCT03535571|Natural health product|natural health product
5074151|NCT03535571|Dietary supplement|dietary supplement
5074152|NCT03535545|PET Imaging|pet imaging
5074153|NCT03535545|Molecular Imaging|molecular imaging
5074154|NCT03535532|resistant hypertension|resistant hypertension
5074155|NCT03535532|Adrenal Disease|adrenal disease
5074156|NCT03535532|medical treatment|medical treatment
5074157|NCT03535532|laparoscopic adrenalectomy|laparoscopic adrenalectomy
5074158|NCT03535506|Breast Cancer|breast cancer
5074159|NCT03535506|DCIS|dcis
5074160|NCT03535506|Ductal Carcinoma In Situ|ductal carcinoma in situ
5074161|NCT03535506|Palbociclib|palbociclib
5074162|NCT03535480|ovarian reserve|ovarian reserve
5074163|NCT03535467|Caregivers|caregivers
5074164|NCT03535467|Exoskeleton Device|exoskeleton device
5074165|NCT03535467|Stroke Rehabilitation|stroke rehabilitation
5074166|NCT03535454|Fibromyalgia|fibromyalgia
5074167|NCT03535454|Musculoskeletal Diseases|musculoskeletal diseases
5074168|NCT03535454|Work|work
5074169|NCT03535441|hemorrhagic shock|hemorrhagic shock
5074170|NCT03535441|HMGB1|hmgb1
5074171|NCT03535376|Bariatric surgery|bariatric surgery
5074172|NCT03535376|Gastrointestinal tract|gastrointestinal tract
5074173|NCT03535376|Biological availability|biological availability
5074174|NCT03535376|Pharmacokinetics|pharmacokinetics
5074175|NCT03535376|Valsartan|valsartan
5074176|NCT03535363|Osimertinib|osimertinib
5074177|NCT03535350|ibrutinib|ibrutinib
5074178|NCT03535350|temozolomide|temozolomide
5074179|NCT03535350|brain cancer|brain cancer
5074180|NCT03535337|Interventions|interventions
5074181|NCT03535337|youth living with HIV|youth living with hiv
5074182|NCT03535337|mHealth|mhealth
5074183|NCT03535337|ART adherence|art adherence
5074184|NCT03535337|adaptive intervention|adaptive intervention
5074185|NCT03535337|cell phone|cell phone
5074186|NCT03535337|text messaging|text messaging
5074187|NCT03535285|periodontal ligament|periodontal ligament
5074188|NCT03535285|dentoalveolar|dentoalveolar
5074189|NCT03535285|distraction|distraction
5074190|NCT03535285|orthodontic|orthodontic
5074191|NCT03535259|hepatocellular carcinoma|hepatocellular carcinoma
5074192|NCT03535259|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5074193|NCT03535259|sorafenib|sorafenib
5074194|NCT03535259|portal vein thrombosis|portal vein thrombosis
5074195|NCT03535259|lymph node metastasis|lymph node metastasis
5074196|NCT03535246|immunotherapy|immunotherapy
5074197|NCT03535246|T cell|t cell
5074198|NCT03535246|Cancer|cancer
5074199|NCT03535246|Gene therapy|gene therapy
5074200|NCT03535233|Alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, IL-23, TGFβ-1|alopecia areata, intralesional corticosteroid, minoxidil, clobetasol propionate, il-23, tgfβ-1
5074201|NCT03535220|Multiple Myeloma|multiple myeloma
5074202|NCT03535220|Sickle Cell Disease|sickle cell disease
5074204|NCT03535168|Healthy volunteers|healthy volunteers
5074211|NCT03535090|Graves' Disease|graves' disease
5074212|NCT03535090|Graves Ophthalmopathy|graves ophthalmopathy
5074219|NCT03535077|Atypical Nevi|atypical nevi
5074220|NCT03535064|HAND HYGIENE, HAND WASHING, INFLUENZA, SCHOOL ABSENCE, SCHOOL CHILDREN, UPPER RESPIRATORY INFECTIONS|hand hygiene, hand washing, influenza, school absence, school children, upper respiratory infections
5074222|NCT03535051|fractional carbon dioxide laser|fractional carbon dioxide laser
5074223|NCT03535051|tacrolimus|tacrolimus
5074224|NCT03535051|drug delivery|drug delivery
5074225|NCT03535038|Intravascular volume|intravascular volume
5074226|NCT03535038|Inferior vena cava diameter|inferior vena cava diameter
5074227|NCT03535038|Ultrasonography|ultrasonography
5074228|NCT03535038|Vascular Pedicle Width|vascular pedicle width
5074229|NCT03535038|Chest x-ray|chest x-ray
5074230|NCT03534999|TENS,|tens,
5074231|NCT03534999|VAS,|vas,
5074232|NCT03534999|Oxford-Hip-score,|oxford-hip-score,
5074233|NCT03534999|Hip-arthroplasthy,|hip-arthroplasthy,
5074234|NCT03534999|Pain-intensity|pain-intensity
5074235|NCT03534973|Cataract|cataract
5074236|NCT03534973|Caffeine|caffeine
5074237|NCT03534947|Neoadjuvant|neoadjuvant
5074238|NCT03534947|Sonidegib|sonidegib
5074239|NCT03534934|COPD|copd
5074240|NCT03534934|Osteoporosis|osteoporosis
5074241|NCT03534921|Diabetes mellitus|diabetes mellitus
5074242|NCT03534921|Schizophrenia|schizophrenia
5074247|NCT03534895|ambulatory surgery|ambulatory surgery
5074248|NCT03534882|anti-glaucoma medications|anti-glaucoma medications
5074249|NCT03534882|glaucoma|glaucoma
5074250|NCT03534882|prostaglandin analogues|prostaglandin analogues
5074251|NCT03534882|medication washout|medication washout
5074252|NCT03534869|auricular acupuncture|auricular acupuncture
5961314|NCT04287881|Methylenetetrahydrofolate reductase (MTHFR) deficiency|methylenetetrahydrofolate reductase (mthfr) deficiency
5961315|NCT04287881|Ischemic Stroke|ischemic stroke
5961316|NCT04287881|Epileptic seizures|epileptic seizures
5074253|NCT03534869|episiotomy|episiotomy
5074254|NCT03534869|acupuncture|acupuncture
5074255|NCT03534869|pain relief|pain relief
5074256|NCT03534869|analgesic therapy|analgesic therapy
5074257|NCT03534843|Spontaneous rupture|spontaneous rupture
5074258|NCT03534843|survival|survival
5074259|NCT03534843|hepatocellular carcinoma|hepatocellular carcinoma
5074260|NCT03534843|Child-Pugh|child-pugh
5074261|NCT03534843|Albumin-bilirubin|albumin-bilirubin
5074262|NCT03534817|Cardiac Rehabilitation|cardiac rehabilitation
5074263|NCT03534817|Early Access Cardiac Rehabilitation|early access cardiac rehabilitation
5074264|NCT03534817|Cardiac Rehabilitation Adherence|cardiac rehabilitation adherence
5074265|NCT03534817|Myocardial Infarction|myocardial infarction
5074266|NCT03534817|Ventricular Remodeling|ventricular remodeling
5074267|NCT03534765|Laparotomy|laparotomy
5074268|NCT03534765|Frailty|frailty
5074269|NCT03534765|Sacropenia|sacropenia
5074270|NCT03534752|Inborn errors of Metabolism|inborn errors of metabolism
5074271|NCT03534752|Adulthood|adulthood
5074272|NCT03534752|Clinical characteristics|clinical characteristics
5738862|NCT00361803|recurrent|recurrent
5074273|NCT03534739|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
5074274|NCT03534739|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
5074275|NCT03534739|massage|massage
5074276|NCT03534739|hypoalgesia|hypoalgesia
5074277|NCT03534713|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5074278|NCT03534713|Cervical Cancer|cervical cancer
5074279|NCT03534713|Paraaortic Lymph Node Involvement|paraaortic lymph node involvement
5074280|NCT03534713|Carboplatin|carboplatin
5074298|NCT03534544|adherence|adherence
5074299|NCT03534505|Inguinal Herniorrhaphy|inguinal herniorrhaphy
5074300|NCT03534505|Analgesic Effects of Local Wound|analgesic effects of local wound
5074301|NCT03534492|urothelial|urothelial
5074302|NCT03534492|bladder cancer|bladder cancer
5074303|NCT03534492|olaparib|olaparib
5074304|NCT03534492|durvalumab|durvalumab
5074312|NCT03534440|Diastolic Dysfunction|diastolic dysfunction
5074315|NCT03534440|Postoperative care|postoperative care
5074316|NCT03534440|TEVAR|tevar
5074317|NCT03534427|arterial stiffness|arterial stiffness
5074318|NCT03534427|endothelin-1|endothelin-1
5074319|NCT03534427|c-reactive protein|c-reactive protein
5074320|NCT03534427|adiposity|adiposity
5074321|NCT03534427|exercise|exercise
5074322|NCT03534427|jump rope|jump rope
5074323|NCT03534414|dietary portfolio|dietary portfolio
5074324|NCT03534414|plant sterols|plant sterols
5074325|NCT03534414|plant protein|plant protein
5074326|NCT03534414|viscous fibre|viscous fibre
5074327|NCT03534414|nuts|nuts
5074328|NCT03534401|Reproductive Coercion|reproductive coercion
5074329|NCT03534401|Gender-based violence|gender-based violence
5074335|NCT03534349|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5074336|NCT03534349|lower limb flexibility|lower limb flexibility
5074338|NCT03534336|Weight Reduction|weight reduction
5074339|NCT03534336|Health Literacy|health literacy
5074340|NCT03534336|Financial Incentives|financial incentives
5074341|NCT03534336|Lifestyle Change|lifestyle change
5074342|NCT03534323|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5074343|NCT03534323|Richter's Syndrome|richter's syndrome
5074344|NCT03534323|Richter's Transformation|richter's transformation
5074345|NCT03534310|obesity|obesity
5074346|NCT03534310|sleeve-gastrectomy|sleeve-gastrectomy
5074347|NCT03534310|liraglutide|liraglutide
5074348|NCT03534310|Weight-loss|weight-loss
5074349|NCT03534297|heart failure|heart failure
5074350|NCT03534297|systolic heart failure|systolic heart failure
5074351|NCT03534284|Hemodialysis|hemodialysis
5074352|NCT03534284|Kidney disease|kidney disease
5074353|NCT03534284|Trazodone|trazodone
5074354|NCT03534284|Cognitive behavioral therapy|cognitive behavioral therapy
5074360|NCT03534219|Earpopper|earpopper
5074361|NCT03534219|Prophylaxis|prophylaxis
5074362|NCT03534219|Randomized controlled trial|randomized controlled trial
5074363|NCT03534167|depression|depression
5074364|NCT03534167|anxiety|anxiety
5074365|NCT03534167|gay|gay
5074366|NCT03534167|youth|youth
5074367|NCT03534167|Cognitive Behavior Therapy|cognitive behavior therapy
5074368|NCT03534141|Hypothermia|hypothermia
5074369|NCT03534141|NGAL - Neutrophil Gelatinase-associated Lipocalin|ngal - neutrophil gelatinase-associated lipocalin
5074370|NCT03534128|Traumatic Brain Injury|traumatic brain injury
5074371|NCT03534128|Spatial navigation|spatial navigation
5074372|NCT03534128|Virtual Reality|virtual reality
5074373|NCT03534128|Cues|cues
5074374|NCT03534115|bleaching, toxicity, NAC|bleaching, toxicity, nac
5074375|NCT03534102|Total Hip Arthroplasty|total hip arthroplasty
5074376|NCT03534102|Total Knee Arthroplasty|total knee arthroplasty
5074377|NCT03534102|Opioid Dependence|opioid dependence
5074378|NCT03534102|Opioid Tapering|opioid tapering
5074381|NCT03534050|Glioma|glioma
5074382|NCT03534050|Low-Grade Glioma (LGG)|low-grade glioma (lgg)
5074383|NCT03534050|Neurobehavioral Assessments|neurobehavioral assessments
5074384|NCT03534050|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
5074385|NCT03534050|Radiation Therapy (RT)|radiation therapy (rt)
5074386|NCT03534050|Hippocampus|hippocampus
5369136|NCT01861158|Adolescence|adolescence
5894628|NCT03420209|posture|posture
5074387|NCT03534050|Progression-Free Survival (PFS)|progression-free survival (pfs)
5074388|NCT03534037|Serum uric acid|serum uric acid
5074389|NCT03534037|Metabolic syndrome|metabolic syndrome
5074390|NCT03534037|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5074391|NCT03534037|Febuxostat|febuxostat
5074392|NCT03534037|Benzbromarone|benzbromarone
5074393|NCT03534011|Balloon occlusion|balloon occlusion
5074394|NCT03534011|Air ambulances|air ambulances
5074395|NCT03534011|Aorta|aorta
5074396|NCT03534011|Resuscitation|resuscitation
5074397|NCT03533985|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5074398|NCT03533985|Music therapy|music therapy
5074399|NCT03533985|Attachment|attachment
5074400|NCT03533985|Music medicine|music medicine
5074401|NCT03533985|Multi-modal stimulation|multi-modal stimulation
5074402|NCT03533959|in-stent neoatherosclerosis|in-stent neoatherosclerosis
5074403|NCT03533959|alirocumab|alirocumab
5074404|NCT03533933|collagen matrix|collagen matrix
5074405|NCT03533933|connective tissue graft|connective tissue graft
5074406|NCT03533933|histometry|histometry
5074407|NCT03533933|xenograft|xenograft
5074408|NCT03533933|periodontal regeneration|periodontal regeneration
5074409|NCT03533933|biometry|biometry
5074410|NCT03533881|collagen|collagen
5074411|NCT03533881|volatile oils|volatile oils
5074412|NCT03533881|metabolic syndrome|metabolic syndrome
5074413|NCT03533881|insulin resistance|insulin resistance
5074414|NCT03533868|Point-of-care|point-of-care
5074415|NCT03533868|Viral load monitoring|viral load monitoring
5074416|NCT03533868|Nigeria|nigeria
5074417|NCT03533842|Triage|triage
5074418|NCT03533842|Algorithms|algorithms
5074419|NCT03533842|Emergencies|emergencies
5074420|NCT03533842|Eyes emergencies|eyes emergencies
5074421|NCT03533842|Ophtalmology|ophtalmology
5074422|NCT03533829|vaccination|vaccination
5074423|NCT03533829|pre-syncope|pre-syncope
5074424|NCT03533829|syncope prevention|syncope prevention
5074425|NCT03533816|Gamma delta T-cells|gamma delta t-cells
5074426|NCT03533816|Hematopoietic Stem Cell Transplantation (HCT)|hematopoietic stem cell transplantation (hct)
5074427|NCT03533816|Post-transplant Cyclophosphamide (PTCy)|post-transplant cyclophosphamide (ptcy)
5074428|NCT03533816|Expanded/Activated gamma delta (EAGD)|expanded/activated gamma delta (eagd)
5074438|NCT03533647|high myopia|high myopia
5074439|NCT03533647|ocular biometric parameters|ocular biometric parameters
5074440|NCT03533647|adolescent|adolescent
5074441|NCT03533647|children|children
5074442|NCT03533634|midshaft clavicle fracture|midshaft clavicle fracture
5074443|NCT03533634|functional outcome|functional outcome
5074444|NCT03533634|anteroinferior plate|anteroinferior plate
5074445|NCT03533634|superior plate|superior plate
5074446|NCT03533634|reconstruction plate|reconstruction plate
5074447|NCT03533608|PTSD|ptsd
5074448|NCT03533608|Prolonged Exposure|prolonged exposure
5074449|NCT03533608|Group Therapy|group therapy
5074450|NCT03533569|pain|pain
5074451|NCT03533569|inflammation|inflammation
5074452|NCT03533543|Myocardial infarction|myocardial infarction
5074453|NCT03533543|New-onset atrial fibrillation|new-onset atrial fibrillation
5074454|NCT03533543|Retrospective|retrospective
5074455|NCT03533543|Prognosis|prognosis
5074456|NCT03533530|Electrical source imaging|electrical source imaging
5074457|NCT03533504|pharmacokinetics|pharmacokinetics
5074458|NCT03533504|hemophilia|hemophilia
5074459|NCT03533504|factor VII|factor vii
5074460|NCT03533504|factor IX|factor ix
5074461|NCT03533504|population pharmacokinetics|population pharmacokinetics
5074462|NCT03533478|Nutritional supplement|nutritional supplement
5074463|NCT03533478|Diabetic Macular Edema|diabetic macular edema
5074464|NCT03533478|Diabetes|diabetes
5074465|NCT03533478|Alzer|alzer
5074466|NCT03533478|Oxidative Stress|oxidative stress
5074467|NCT03533478|Diamel|diamel
5074468|NCT03533400|respiratory therapy|respiratory therapy
5074469|NCT03533400|videogaming therapy|videogaming therapy
5074470|NCT03533400|incentive spirometry|incentive spirometry
5074471|NCT03533374|Accuracy|accuracy
5074472|NCT03533374|Inter-ictal EEG Discharges|inter-ictal eeg discharges
5074473|NCT03533374|Inter-rater agreement|inter-rater agreement
5074474|NCT03533374|Long Term Monitoring|long term monitoring
5074475|NCT03533374|Sensitivity|sensitivity
5074476|NCT03533374|Sharp transients|sharp transients
5074477|NCT03533374|Specificity|specificity
5074478|NCT03533374|Source Space|source space
5074479|NCT03533374|Voltage maps|voltage maps
5074480|NCT03533361|expanded access program|expanded access program
5074481|NCT03533361|radioiodine refractory|radioiodine refractory
5074482|NCT03533361|differentiated|differentiated
5074483|NCT03533361|lenvatinib|lenvatinib
5074484|NCT03533335|Oral Hygiene|oral hygiene
5074485|NCT03533335|Oral Sprays|oral sprays
5074486|NCT03533335|Oral Health|oral health
5074487|NCT03533335|Frail Elderly|frail elderly
5074488|NCT03533335|Nursing Homes|nursing homes
5074489|NCT03533335|Chlorhexidine|chlorhexidine
5074490|NCT03533335|Chlorine Dioxide|chlorine dioxide
5961317|NCT04287881|Adult patients|adult patients
5074491|NCT03533309|horizontal defect, Anterior maxillary|horizontal defect, anterior maxillary
5074492|NCT03533244|Hyperemia|hyperemia
5074493|NCT03533231|Pulp regeneration, intracanal medication|pulp regeneration, intracanal medication
5074494|NCT03533218|endotracheal tube, point of care ultrasound|endotracheal tube, point of care ultrasound
5074495|NCT03533179|Glucagon|glucagon
5074496|NCT03533179|Beta-adrenergic antagonist|beta-adrenergic antagonist
5074497|NCT03533179|poisoning|poisoning
5074498|NCT03533166|Peri-implant mucositis|peri-implant mucositis
5074499|NCT03533166|Chlorhexidine|chlorhexidine
5074500|NCT03533166|CPC|cpc
5074501|NCT03533166|Treatment|treatment
5074502|NCT03533153|MSC|msc
5074503|NCT03533101|Tocilizumab|tocilizumab
5074504|NCT03533101|Haploidentical|haploidentical
5074505|NCT03533101|Peripheral blood|peripheral blood
5074506|NCT03533088|shoulder|shoulder
5074507|NCT03533088|rotator cuff|rotator cuff
5074508|NCT03533088|scapula|scapula
5074509|NCT03533062|OAB , Botox , anticholinergics , quality of life|oab , botox , anticholinergics , quality of life
5074510|NCT03533036|Virtual Reality|virtual reality
5074511|NCT03533036|Anxiety|anxiety
5074516|NCT03533023|Shift Workers|shift workers
5074517|NCT03533023|Time-Restricted Eating|time-restricted eating
5074518|NCT03533023|Fasting|fasting
5074519|NCT03533010|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5074520|NCT03533010|Bone Health|bone health
5074521|NCT03533010|Treatment|treatment
5074527|NCT03532932|Drug therapy|drug therapy
5074528|NCT03532893|COPD incidence|copd incidence
5074529|NCT03532893|Decline in FEV1|decline in fev1
5074530|NCT03532893|Inflammatory biomarkers|inflammatory biomarkers
5074532|NCT03532893|microRNA-23a|microrna-23a
5074533|NCT03532880|Olaparib|olaparib
5074534|NCT03532880|Radiation therapy|radiation therapy
5074535|NCT03532880|18-195|18-195
5074536|NCT03532880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5074537|NCT03532867|Exercise Test|exercise test
5074538|NCT03532867|Blood Pressure|blood pressure
5074539|NCT03532867|Choroid|choroid
5074540|NCT03532815|Cardiovascular Diseases, Framingham risk score, Life style modification, Randomized Controlled Trial|cardiovascular diseases, framingham risk score, life style modification, randomized controlled trial
5074541|NCT03532802|metoprolol|metoprolol
5074542|NCT03532802|heart diseases|heart diseases
5074543|NCT03532802|cardiovascular diseases|cardiovascular diseases
5074544|NCT03532802|ventricular outflow obstruction|ventricular outflow obstruction
5074545|NCT03532802|hemodynamics|hemodynamics
5074546|NCT03532763|Inflammation|inflammation
5074547|NCT03532763|Tocotrienols|tocotrienols
5074548|NCT03532763|Cardiovascular disease|cardiovascular disease
5074549|NCT03532737|head and neck cancer|head and neck cancer
5074550|NCT03532737|check point inhibitor|check point inhibitor
5074551|NCT03532737|Pembrolizumab|pembrolizumab
5074552|NCT03532737|Chemoradiation|chemoradiation
5074553|NCT03532724|Patient Self-management, Acenocoumarol, Warfarin|patient self-management, acenocoumarol, warfarin
5074554|NCT03532698|lung cancer|lung cancer
5074555|NCT03532698|Aspirin|aspirin
5074556|NCT03532698|Osimertinib|osimertinib
5074557|NCT03532698|EGFR-TKI|egfr-tki
5074558|NCT03532698|resistance|resistance
5074559|NCT03532685|Asthma|asthma
5074560|NCT03532685|severity|severity
5074561|NCT03532685|follow up|follow up
5074562|NCT03532685|obesity|obesity
5074563|NCT03532685|bariatric surgery|bariatric surgery
5074564|NCT03532672|Acute fasting|acute fasting
5074565|NCT03532672|Inflammatory response|inflammatory response
5074566|NCT03532672|Energy Expenditure|energy expenditure
5122084|NCT03232411|biobank|biobank
5074567|NCT03532659|adolescents|adolescents
5074568|NCT03532659|obesity|obesity
5074569|NCT03532659|lung function|lung function
5074570|NCT03532659|microcirculation|microcirculation
5074571|NCT03532659|intima media thickness|intima media thickness
5074572|NCT03532633|infant|infant
5074573|NCT03532633|cord|cord
5074574|NCT03532633|micronutrients|micronutrients
5074575|NCT03532633|purine|purine
5074576|NCT03532633|pyrimidine|pyrimidine
5074577|NCT03532620|Pitavastatin|pitavastatin
5074578|NCT03532620|Prediabetic State|prediabetic state
5074579|NCT03532620|Hypertension|hypertension
5074580|NCT03532620|Dyslipidemias|dyslipidemias
5074581|NCT03532620|Cardiovascular Disease|cardiovascular disease
5074595|NCT03532503|foley catheter|foley catheter
5074596|NCT03532477|Bariatric surgery|bariatric surgery
5074597|NCT03532477|Gastrointestinal tract|gastrointestinal tract
5074598|NCT03532477|Biological availability|biological availability
5074599|NCT03532477|Pharmacokinetics|pharmacokinetics
5074600|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride
5074601|NCT03532464|Chlamydia Trachomatis|chlamydia trachomatis
5074602|NCT03532464|Infection|infection
5074604|NCT03532464|Anal|anal
5074605|NCT03532451|Muscle-Invasive|muscle-invasive
5074606|NCT03532451|Cisplatin-Ineligible|cisplatin-ineligible
5074607|NCT03532451|Nivolumab|nivolumab
5074608|NCT03532451|Lirilumab|lirilumab
5074609|NCT03532412|Polysomnography, Sleep apnea, Central sleep apnea|polysomnography, sleep apnea, central sleep apnea
5074610|NCT03532399|Bivalirudin|bivalirudin
5074611|NCT03532386|Infertility|infertility
5074612|NCT03532386|male factor infertility|male factor infertility
5074613|NCT03532386|oligoasthenospermia|oligoasthenospermia
5074617|NCT03532321|Stress|stress
5074618|NCT03532321|occupational risks|occupational risks
5074619|NCT03532321|hospital organization|hospital organization
5074620|NCT03532321|longitudinal|longitudinal
5074622|NCT03532269|sleep|sleep
5074623|NCT03532269|nightmare|nightmare
5074625|NCT03532256|Quality Improvement|quality improvement
5074626|NCT03532256|Prescription Use|prescription use
5074627|NCT03532256|Patient Experience|patient experience
5074628|NCT03532256|SMS Messaging|sms messaging
5074629|NCT03532256|Crowd Sourcing|crowd sourcing
5074630|NCT03532243|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5074631|NCT03532243|inspiratory muscle training|inspiratory muscle training
5074632|NCT03532243|Central Drive|central drive
5074633|NCT03532230|Chronic Low Back Pain|chronic low back pain
5073756|NCT03538067|stent apposition|stent apposition
5074640|NCT03532178|Electroconvulsive Therapy, Neuromuscular Blockade|electroconvulsive therapy, neuromuscular blockade
5074641|NCT03532152|VR|vr
5074642|NCT03532152|moderate stress|moderate stress
5074643|NCT03532139|Ovarian Cancer|ovarian cancer
5074644|NCT03532113|Cognitive intervention|cognitive intervention
5074645|NCT03532113|Cognitive training|cognitive training
5074646|NCT03532113|Aging|aging
5074647|NCT03532113|Working memory|working memory
5074648|NCT03532113|Cognitive reserve|cognitive reserve
5074649|NCT03532113|Brain imaging|brain imaging
5074650|NCT03532113|Brain plasticity|brain plasticity
5074651|NCT03532113|Polymorphisms|polymorphisms
5074652|NCT03532113|Transfer|transfer
5074653|NCT03532113|Inhibition|inhibition
5074654|NCT03532113|Updating|updating
5074655|NCT03532100|lower limb prosthesis|lower limb prosthesis
5074656|NCT03532100|transtibial amputation|transtibial amputation
5074657|NCT03532100|below knee amputation|below knee amputation
5074658|NCT03532100|biomechanics|biomechanics
5074659|NCT03532100|gait|gait
5074660|NCT03532087|Breast cancer|breast cancer
5074661|NCT03532087|Denosumab|denosumab
5074662|NCT03532087|Chemotherapy|chemotherapy
5074663|NCT03532087|Immunity|immunity
5074664|NCT03532087|Immune system|immune system
5074665|NCT03532087|PERIDENO|perideno
5074666|NCT03532061|Familial Caregiver|familial caregiver
5074667|NCT03532061|Cancer|cancer
5074668|NCT03532061|Symptom Management|symptom management
5074669|NCT03532061|COPE Principles|cope principles
5074670|NCT03532061|Problem-solving Skills Training Program|problem-solving skills training program
5074671|NCT03532048|Hispanic|hispanic
5074672|NCT03532048|Fathers|fathers
5074673|NCT03532048|Child|child
5074674|NCT03532048|Obesity Prevention|obesity prevention
5074675|NCT03532048|Cultural adaptation|cultural adaptation
5074676|NCT03532048|Weight Loss|weight loss
5074680|NCT03531996|Pulmonary Surfactant|pulmonary surfactant
5074681|NCT03531996|Rare Lung Disease|rare lung disease
5074682|NCT03531996|Registry|registry
5074683|NCT03531983|gamma nail|gamma nail
5074684|NCT03531970|inferior alveolar nerve block|inferior alveolar nerve block
5074685|NCT03531970|irreversible pulpitis|irreversible pulpitis
5074686|NCT03531970|local anesthesia|local anesthesia
5074687|NCT03531970|dexamethasone|dexamethasone
5074707|NCT03531814|Plexiform Neurofibromas|plexiform neurofibromas
5074708|NCT03531814|Medication Event Monitoring Systems|medication event monitoring systems
5074709|NCT03531814|Oral Medication|oral medication
5074710|NCT03531801|Referred pain|referred pain
5074711|NCT03531801|pressure algometry|pressure algometry
5074712|NCT03531801|pain mapping|pain mapping
5074713|NCT03531788|dynamic arm support|dynamic arm support
5074714|NCT03531788|mobile arm support|mobile arm support
5074715|NCT03531788|rehabilitation|rehabilitation
5074716|NCT03531788|occupational therapy|occupational therapy
5074717|NCT03531775|upright MRI|upright mri
5074718|NCT03531775|COPD with hyperinflation|copd with hyperinflation
5074719|NCT03531775|Diaphragmatic weakness|diaphragmatic weakness
5074720|NCT03531762|Proton Pump Inhibitor|proton pump inhibitor
5074721|NCT03531762|Omeprazole|omeprazole
5074722|NCT03531762|Tepotinib|tepotinib
5074723|NCT03531762|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5074724|NCT03531762|Pharmacokinetics|pharmacokinetics
5074725|NCT03531736|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5074726|NCT03531736|intensity conditioning regimen|intensity conditioning regimen
5074727|NCT03531736|17-639|17-639
5074728|NCT03531723|external ventricular derivation|external ventricular derivation
5074729|NCT03531697|Loteprednol Etabonate|loteprednol etabonate
5074730|NCT03531645|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5074731|NCT03531645|Advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas|advanced low grade serous ovarian, primary peritoneal, or fallopian tube carcinomas
5074732|NCT03531645|Fulvestrant|fulvestrant
5074733|NCT03531645|Faslodex|faslodex
5074734|NCT03531645|Abemaciclib|abemaciclib
5074735|NCT03531645|PD-0332991|pd-0332991
5074736|NCT03531645|Ibrance|ibrance
5074737|NCT03531619|posturography|posturography
5074738|NCT03531619|quality of life|quality of life
5074739|NCT03531619|pressure algometry|pressure algometry
5074740|NCT03531619|cervicogenic dizziness|cervicogenic dizziness
5074742|NCT03531593|IBD|ibd
5074743|NCT03531593|US Elastography|us elastography
5074744|NCT03531593|Liver Fibrosis|liver fibrosis
5074745|NCT03531567|Upper Extremity Hemiparesis|upper extremity hemiparesis
5074746|NCT03531567|Virtual Reality (VR)|virtual reality (vr)
5073861|NCT03537495|linezolid|linezolid
5074753|NCT03531502|tachycardia|tachycardia
5074754|NCT03531502|defibrillator|defibrillator
5074755|NCT03531502|arrythmia|arrythmia
5074756|NCT03531476|Mindfulness|mindfulness
5074757|NCT03531476|Chronic Pain|chronic pain
5074758|NCT03531476|Disability|disability
5074759|NCT03531476|Quality of Life|quality of life
5074761|NCT03531463|Displaced|displaced
5074762|NCT03531463|Non-Operative treatment|non-operative treatment
5074763|NCT03531463|Reversed Total Shoulder Prosthesis|reversed total shoulder prosthesis
5074764|NCT03531450|Gastroparesis|gastroparesis
5074765|NCT03531424|Coronary Stenosis|coronary stenosis
5074766|NCT03531424|Percutaneous Coronary Intervention|percutaneous coronary intervention
5074767|NCT03531424|Stents|stents
5074768|NCT03531424|Computed Tomography Angiography|computed tomography angiography
5074769|NCT03531424|Augmented Reality|augmented reality
5074773|NCT03531385|Sleep disturbance|sleep disturbance
5074774|NCT03531346|Tear film|tear film
5074775|NCT03531346|Tear osmolarity|tear osmolarity
5074776|NCT03531346|Contact lenses|contact lenses
5074777|NCT03531333|Glioma, intraoperative ultrasound, gross total resection, quality of life|glioma, intraoperative ultrasound, gross total resection, quality of life
5074778|NCT03531307|Lactate|lactate
5074779|NCT03531307|Ki-67|ki-67
5074780|NCT03531307|Mitotic index|mitotic index
5074781|NCT03531307|Brain tumor|brain tumor
5074782|NCT03531268|Pharmacogenomic Analysis|pharmacogenomic analysis
5074783|NCT03531268|Clinical Utility|clinical utility
5074784|NCT03531268|Outcomes|outcomes
5074785|NCT03531203|soursop|soursop
5074786|NCT03531203|supplementation|supplementation
5074787|NCT03531203|prehypertension|prehypertension
5074788|NCT03531203|uric acid|uric acid
5074789|NCT03531203|randomized controlled trial|randomized controlled trial
5074790|NCT03531190|Head and neck cancer|head and neck cancer
5074791|NCT03531190|wound healing|wound healing
5074792|NCT03531190|pre and post-surgical nutrition|pre and post-surgical nutrition
5074793|NCT03531190|zinc, arginine, vitamin C, protein, oral supplements|zinc, arginine, vitamin c, protein, oral supplements
5074794|NCT03531177|type 2 diabetes|type 2 diabetes
5074795|NCT03531177|Ethnicity|ethnicity
5074796|NCT03531177|African-caribbean|african-caribbean
5074797|NCT03531177|Education|education
5074798|NCT03531177|Self-management|self-management
5074799|NCT03531164|spinal cord injuries|spinal cord injuries
5074800|NCT03531164|kayak|kayak
5074801|NCT03531164|trunk control|trunk control
5074802|NCT03531138|performance test|performance test
5066611|NCT03582605|TADs|tads
5074803|NCT03531138|exercise capacity|exercise capacity
5074804|NCT03531138|rehabilitation outcome|rehabilitation outcome
5074805|NCT03531138|pulmonary rehabilitation|pulmonary rehabilitation
5074806|NCT03531099|Prostate cancer|prostate cancer
5074807|NCT03531099|HIFU focal|hifu focal
5074808|NCT03531099|adverse effect|adverse effect
5074809|NCT03531099|low risk|low risk
5074810|NCT03531086|dopamine transporter binding|dopamine transporter binding
5074811|NCT03531073|treat to target|treat to target
5074812|NCT03531047|progressive|progressive
5074829|NCT03530891|surgery computer assisted|surgery computer assisted
5074830|NCT03530865|mandibular molars|mandibular molars
5074831|NCT03530865|extra root|extra root
5074832|NCT03530865|extra root canal|extra root canal
5074833|NCT03530865|root morphology|root morphology
5074834|NCT03530865|cbct endodontics|cbct endodontics
5074835|NCT03530839|lesser toe deformity|lesser toe deformity
5074836|NCT03530839|claw toe|claw toe
5074837|NCT03530839|PIP joint|pip joint
5074838|NCT03530839|arthrodesis|arthrodesis
5074839|NCT03530839|resection arthroplasty|resection arthroplasty
5074840|NCT03530813|School|school
5074841|NCT03530813|Management|management
5074842|NCT03530813|Technology|technology
5074843|NCT03530813|Asthma Education|asthma education
5074844|NCT03530787|Ginger|ginger
5074845|NCT03530787|Curcumin|curcumin
5074846|NCT03530787|Zingerone|zingerone
5074847|NCT03530774|physical performance battery|physical performance battery
5074848|NCT03530774|24-hour dietary recalls|24-hour dietary recalls
5074849|NCT03530774|dual-energy X-ray absorptimetry|dual-energy x-ray absorptimetry
5074850|NCT03530774|dietary supplement|dietary supplement
5074851|NCT03530774|protein|protein
5074852|NCT03530735|Fingerprick Autologous Blood|fingerprick autologous blood
5074853|NCT03530696|Breast Cancer|breast cancer
5074854|NCT03530696|HER2-positive|her2-positive
5074855|NCT03530696|T-DM1|t-dm1
5074856|NCT03530696|HER2-positive Breast Cancer|her2-positive breast cancer
5074857|NCT03530696|Recurrent Breast Cancer|recurrent breast cancer
5074864|NCT03530579|Diabetes Prevention|diabetes prevention
5074865|NCT03530566|PnK Method|pnk method
5074866|NCT03530566|obesity|obesity
5074867|NCT03530566|very low calorie ketogenic diet|very low calorie ketogenic diet
5074868|NCT03530566|Comorbidity|comorbidity
5074869|NCT03530566|Bariatric Surgery|bariatric surgery
5074870|NCT03530566|weight loss|weight loss
5074871|NCT03530527|ERCP|ercp
5961318|NCT04287868|HPV Cancers|hpv cancers
5356769|NCT01918033|Nose Diseases|nose diseases
5074872|NCT03530527|Endoscopic ultrasound (EUS) guided biliary drainage|endoscopic ultrasound (eus) guided biliary drainage
5074873|NCT03530501|microbiota|microbiota
5074874|NCT03530501|obesity|obesity
5074875|NCT03530462|episodic memory|episodic memory
5074876|NCT03530462|executive control|executive control
5074877|NCT03530462|fMRI|fmri
5074878|NCT03530436|Bioavailability|bioavailability
5074879|NCT03530436|Pharmacokinetics|pharmacokinetics
5074880|NCT03530436|Curcumin|curcumin
5074881|NCT03530436|Demethoxycurcumin|demethoxycurcumin
5074882|NCT03530436|Bisdemethoxycurcumin|bisdemethoxycurcumin
5074900|NCT03530358|Muscle Synergies|muscle synergies
5074902|NCT03530358|Virtual Reality|virtual reality
5074903|NCT03530358|Robotics|robotics
5074904|NCT03530345|Neridronic Acid|neridronic acid
5074905|NCT03530345|Neridronate|neridronate
5074906|NCT03530345|CRPS|crps
5074907|NCT03530345|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
5074911|NCT03530319|Mycoplasma pneumoniae|mycoplasma pneumoniae
5074912|NCT03530319|Macrolide-resistance|macrolide-resistance
5074913|NCT03530319|Children|children
5074914|NCT03530280|pregabalin|pregabalin
5074915|NCT03530280|adductor canal block|adductor canal block
5074916|NCT03530280|postoperative pain|postoperative pain
5074917|NCT03530267|colorectal cancer|colorectal cancer
5074918|NCT03530267|5-FU|5-fu
5074919|NCT03530267|Aflibercept|aflibercept
5074920|NCT03530267|Oxaliplatin|oxaliplatin
5074921|NCT03530254|Endometrial receptivity|endometrial receptivity
5074922|NCT03530254|Preimplantation Genetic Diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
4958268|NCT04249609|Energy intake|energy intake
5074923|NCT03530254|Preimplantation Genetic Testing for Aneuploidy (PGT-A)|preimplantation genetic testing for aneuploidy (pgt-a)
5074924|NCT03530254|Embryo Transfer (ET)|embryo transfer (et)
5074925|NCT03530254|Endometrial Receptivity Analysis (ERA)|endometrial receptivity analysis (era)
5074926|NCT03530254|Endometrial Diagnosis|endometrial diagnosis
5074927|NCT03530254|Live Newborn Rate (LBR)|live newborn rate (lbr)
5074928|NCT03530241|fluorescence|fluorescence
5738863|NCT00361803|refractory|refractory
5074929|NCT03530241|cholangiography|cholangiography
5074930|NCT03530241|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
5074931|NCT03530215|Cardiotoxicity|cardiotoxicity
5074932|NCT03530215|Antineoplastic and immunomodulating agents|antineoplastic and immunomodulating agents
5074933|NCT03530202|muscle thickness|muscle thickness
5074934|NCT03530202|strength|strength
5074935|NCT03530202|power|power
5074936|NCT03530202|functionality|functionality
5074937|NCT03530189|Hyperglycemia;|hyperglycemia;
5074938|NCT03530189|Hypoglycemia;|hypoglycemia;
5074939|NCT03530189|Neurodevelopment;|neurodevelopment;
5074940|NCT03530189|Prematurity|prematurity
5074941|NCT03530163|Exercise|exercise
5074942|NCT03530163|Aerobic|aerobic
5074943|NCT03530163|Cognitive Function|cognitive function
5074944|NCT03530150|Burns|burns
5074945|NCT03530150|Partial-thickness burn wounds|partial-thickness burn wounds
5074946|NCT03530150|Re-epithelization|re-epithelization
5074947|NCT03530150|Second-Degree Wound|second-degree wound
5074948|NCT03530150|Pirfenidone|pirfenidone
5074949|NCT03530150|Wound Healing|wound healing
5074950|NCT03530137|homelessness|homelessness
5074951|NCT03530137|homeless children|homeless children
5074952|NCT03530137|homeless families|homeless families
5074953|NCT03530124|apnea following vaccination|apnea following vaccination
5074954|NCT03530111|Adipose tissue|adipose tissue
5074955|NCT03530111|Adipose turnover|adipose turnover
5074956|NCT03530111|Adipose kinetics|adipose kinetics
5074957|NCT03530111|Exercise|exercise
5074958|NCT03530111|Deuterium|deuterium
5074959|NCT03530098|Age Determination by Skeleton|age determination by skeleton
5074960|NCT03530098|Machine Learning|machine learning
5074961|NCT03530098|Deep Learning|deep learning
5074962|NCT03530098|Artificial Intelligence|artificial intelligence
5074963|NCT03530098|Prospective|prospective
5074964|NCT03530098|Clinical Validation|clinical validation
5074965|NCT03530059|Home-based training program|home-based training program
5074966|NCT03530020|monolithic zirconia|monolithic zirconia
5074967|NCT03530020|tooth wear|tooth wear
5074968|NCT03530020|all ceramic crown|all ceramic crown
5074969|NCT03529981|PTSD|ptsd
5074970|NCT03529968|esophageal adenocarcinoma|esophageal adenocarcinoma
5074971|NCT03529968|staging|staging
5074973|NCT03529968|PET-CT|pet-ct
5074974|NCT03529968|EUS|eus
5074975|NCT03529955|dermatomyositis|dermatomyositis
5074976|NCT03529955|apremilast|apremilast
5074977|NCT03529955|recalcitrant cutaneous disease|recalcitrant cutaneous disease
5074978|NCT03529942|Osteoarthritis|osteoarthritis
5074979|NCT03529942|Knee|knee
5074980|NCT03529942|Pain|pain
5074981|NCT03529942|Intra-articular|intra-articular
5074982|NCT03529942|Injection|injection
5074983|NCT03529942|Corticosteroid|corticosteroid
5074984|NCT03529929|glucocorticoids|glucocorticoids
5074985|NCT03529929|aging|aging
5074986|NCT03529929|NFKB|nfkb
5961319|NCT04287868|HPV Associated Malignancies|hpv associated malignancies
5074987|NCT03529929|Medrol|medrol
5074988|NCT03529929|methylprednisolone|methylprednisolone
5074989|NCT03529903|behavior change|behavior change
5074990|NCT03529903|health coaching|health coaching
5074991|NCT03529903|wearable activity tracker|wearable activity tracker
5074992|NCT03529903|text messaging|text messaging
5074993|NCT03529903|lifestyle-related chronic diseases|lifestyle-related chronic diseases
5074994|NCT03529890|locally advanced urothelial carcinoma|locally advanced urothelial carcinoma
5074995|NCT03529890|immunotherapy|immunotherapy
5074996|NCT03529890|cystectomy|cystectomy
5074997|NCT03529890|radiation|radiation
5074998|NCT03529890|nivolumab|nivolumab
5074999|NCT03529877|Epidermolysis Bullosa|epidermolysis bullosa
5075000|NCT03529877|Epidermolysis Bullosa Dystrophica|epidermolysis bullosa dystrophica
5075001|NCT03529877|Skin Abnormalities|skin abnormalities
5075002|NCT03529877|Congenital Abnormalities|congenital abnormalities
5075005|NCT03529877|Mesenchymal Stem Cells|mesenchymal stem cells
5075006|NCT03529877|ABCB5|abcb5
5075007|NCT03529877|Allogeneic|allogeneic
5075008|NCT03529851|Patient reported outcomes|patient reported outcomes
5075009|NCT03529851|Symptom monitoring|symptom monitoring
5075010|NCT03529851|Follow-up|follow-up
5075011|NCT03529838|Combined Exercise|combined exercise
5075012|NCT03529838|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
5075013|NCT03529838|Blood analysis|blood analysis
5075014|NCT03529838|Salivary analysis|salivary analysis
5075017|NCT03529825|Microbiome|microbiome
5075018|NCT03529825|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5075019|NCT03529825|Blood stream infections|blood stream infections
5075020|NCT03529825|Acute graft versus host disease|acute graft versus host disease
5075021|NCT03529812|Behavioral intervention|behavioral intervention
5075022|NCT03529812|Social intervention|social intervention
5075023|NCT03529799|mTBI|mtbi
5075025|NCT03529799|brain injury|brain injury
5075026|NCT03529799|concussion|concussion
5075027|NCT03529786|Hunter Syndrome|hunter syndrome
5075028|NCT03529786|Natural History|natural history
5075029|NCT03529786|Iduronate-2-sulfatase|iduronate-2-sulfatase
5075030|NCT03529786|glycosaminoglycans|glycosaminoglycans
5738864|NCT00361803|research|research
5075031|NCT03529773|Respiratory tract infections, RSV, vaccine|respiratory tract infections, rsv, vaccine
5075032|NCT03529760|Leukemia, occult hepatitis B virus infection|leukemia, occult hepatitis b virus infection
5075033|NCT03529734|Anticipatory postural adjustments|anticipatory postural adjustments
5075034|NCT03529734|Trunk muscles reflex responses|trunk muscles reflex responses
5075035|NCT03529734|Sitting balance|sitting balance
5075036|NCT03529734|Kinesthesia|kinesthesia
5075037|NCT03529695|obesity|obesity
5075038|NCT03529695|childhood obesity|childhood obesity
5075039|NCT03529695|maternal and child health|maternal and child health
5075040|NCT03529695|health disparities|health disparities
5075041|NCT03529695|prevention|prevention
5075042|NCT03529695|low-income|low-income
5075043|NCT03529695|social network|social network
5075044|NCT03529695|home environment|home environment
5075045|NCT03529682|Circuit Exercise|circuit exercise
5075046|NCT03529682|Trunk Control|trunk control
5075047|NCT03529682|Functional Strength Training|functional strength training
5075051|NCT03529656|Liver transplantation|liver transplantation
5075052|NCT03529656|rehabilitation|rehabilitation
5075053|NCT03529656|ICU acquired weakness|icu acquired weakness
5075054|NCT03529604|Oral Cancer|oral cancer
5075055|NCT03529604|Potentially Malignant Oral Disorders|potentially malignant oral disorders
5075056|NCT03529604|Saliva|saliva
5075057|NCT03529604|Squamous cell carcinoma antigen 1|squamous cell carcinoma antigen 1
5075058|NCT03529604|Squamous cell carcinoma antigen 2|squamous cell carcinoma antigen 2
5075059|NCT03529604|Trophoblast cell surface antigen|trophoblast cell surface antigen
5075060|NCT03529604|Diadenosine tetraphosphate|diadenosine tetraphosphate
5075061|NCT03529578|Pressure Ulcer, Decubitus Ulcer|pressure ulcer, decubitus ulcer
5075062|NCT03529539|Cancer|cancer
5075063|NCT03529500|dental caries|dental caries
5075064|NCT03529500|saliva|saliva
5075065|NCT03529500|child|child
5075066|NCT03529461|severe obesity|severe obesity
5075067|NCT03529461|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5075068|NCT03529461|endoscopy|endoscopy
5075069|NCT03529461|hypoxia|hypoxia
5075070|NCT03529461|bariatric surgery|bariatric surgery
5075071|NCT03529461|sedation|sedation
5075072|NCT03529461|adverse events|adverse events
5075073|NCT03529461|BMI|bmi
5075074|NCT03529461|anesthesia|anesthesia
5075090|NCT03529422|Head and Neck|head and neck
5075091|NCT03529422|Larynx|larynx
5075092|NCT03529422|Lip|lip
5075093|NCT03529422|Oral Cancer|oral cancer
5075094|NCT03529409|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5075095|NCT03529409|Substance Use|substance use
5075096|NCT03529409|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5075097|NCT03529409|Immune System Diseases|immune system diseases
5075098|NCT03529409|Behavioral Symptoms|behavioral symptoms
5075099|NCT03529409|RNA Virus Infections|rna virus infections
5075100|NCT03529409|HIV Infections|hiv infections
5075101|NCT03529409|Alcohol Use|alcohol use
5075109|NCT03529396|Weekly chloroquine|weekly chloroquine
5075110|NCT03529396|Brazilian Amazon|brazilian amazon
5075111|NCT03529396|Oxidative stress|oxidative stress
5961320|NCT04287868|Vaccine|vaccine
5961321|NCT04287868|Immunotherapy|immunotherapy
5075112|NCT03529383|Localized breast cancer|localized breast cancer
5075118|NCT03529383|Therapeutic education|therapeutic education
5075119|NCT03529383|Obesity|obesity
4958478|NCT04248205|ketamine|ketamine
5075120|NCT03529357|Biological Age|biological age
5075121|NCT03529357|Motivation|motivation
5075122|NCT03529331|Pain Medications, Analgesia, Emergency Medicine|pain medications, analgesia, emergency medicine
5075123|NCT03529305|Stroke|stroke
5075124|NCT03529305|rTMS|rtms
5075125|NCT03529305|MRI|mri
5075126|NCT03529253|Alirocumab|alirocumab
5075127|NCT03529253|NIRS-IVUS|nirs-ivus
5075128|NCT03529253|LCBI|lcbi
5075129|NCT03529240|kinesiology taping|kinesiology taping
5075130|NCT03529240|performance|performance
5075131|NCT03529240|energy consumption|energy consumption
5075132|NCT03529240|gait|gait
5075133|NCT03529240|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5075134|NCT03529227|chlorambucil|chlorambucil
5075135|NCT03529227|obinutuzumab|obinutuzumab
5075136|NCT03529214|Quality Improvement|quality improvement
5075137|NCT03529214|Program Evaluation|program evaluation
5075138|NCT03529214|Quality Assurance|quality assurance
5075139|NCT03529214|Feasibility|feasibility
5075140|NCT03529214|Acceptability|acceptability
5075141|NCT03529188|Diabetes type 1|diabetes type 1
5075142|NCT03529188|Child ans teenager|child ans teenager
5075143|NCT03529188|Fear of Hypoglycaemia|fear of hypoglycaemia
5075144|NCT03529162|Biceps Tendinitis|biceps tendinitis
5075145|NCT03529162|Subpectoral biceps tenodesis|subpectoral biceps tenodesis
5075146|NCT03529162|Biceps tendon disorder|biceps tendon disorder
5075147|NCT03529136|Mesenchymal Stem Cell|mesenchymal stem cell
5075148|NCT03529136|MSC|msc
5075149|NCT03529110|Breast Cancer|breast cancer
5075150|NCT03529110|Metastatic breast cancer|metastatic breast cancer
5075151|NCT03529110|DS-8201a|ds-8201a
5075152|NCT03529110|DESTINY - Breast 03|destiny - breast 03
5075153|NCT03529084|Non small cell lung cancer|non small cell lung cancer
5075154|NCT03529084|NSCLC|nsclc
5075155|NCT03529084|EGFR mutation|egfr mutation
5075156|NCT03529084|EGF816|egf816
5075157|NCT03529084|nazartinib|nazartinib
5075158|NCT03529084|erlotinib|erlotinib
5075159|NCT03529084|gefitinib|gefitinib
5075160|NCT03529071|communication|communication
5075161|NCT03529071|patient activation|patient activation
5075162|NCT03529045|VNS|vns
5075163|NCT03529045|VNS Therapy|vns therapy
5075164|NCT03529045|Vagus Nerve Stimulation|vagus nerve stimulation
5075165|NCT03529032|methadone|methadone
5075166|NCT03529032|postoperative pain|postoperative pain
5075167|NCT03529032|acute pain therapy|acute pain therapy
5075168|NCT03529032|postoperative pain therapy|postoperative pain therapy
5075169|NCT03529019|Enhanced Recovery After Surgery Protocol|enhanced recovery after surgery protocol
5075170|NCT03529006|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5075171|NCT03529006|drug eluting balloon|drug eluting balloon
5075172|NCT03528993|stroke, hippotherapy, balance, postural control, gait|stroke, hippotherapy, balance, postural control, gait
5075174|NCT03528980|bariatric surgery|bariatric surgery
5075175|NCT03528954|Emergence agitation|emergence agitation
5075176|NCT03528954|Propofol|propofol
5075177|NCT03528954|General anesthesia|general anesthesia
5075178|NCT03528941|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
5075179|NCT03528941|Hepatitis B|hepatitis b
5075180|NCT03528941|Ibrutinib|ibrutinib
5075181|NCT03528928|pelvic floor|pelvic floor
5075182|NCT03528928|electrical stimulation|electrical stimulation
5075183|NCT03528928|bladder|bladder
5075184|NCT03528928|ultrasound|ultrasound
5075185|NCT03528915|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's|neonate, infant; eyewash; delivery room; prophylaxis; risk factor's
5075186|NCT03528876|gastric cancer|gastric cancer
5075187|NCT03528876|esophageal cancer|esophageal cancer
5075188|NCT03528876|adnocarcinoma|adnocarcinoma
5075189|NCT03528876|FOLFIRI|folfiri
5075190|NCT03528876|FOLFOX|folfox
5075191|NCT03528876|Metastatic cancer|metastatic cancer
5075192|NCT03528811|Diabetes|diabetes
5075193|NCT03528811|Peripheral Vascular Disease|peripheral vascular disease
5075194|NCT03528811|Microcirculation|microcirculation
5075195|NCT03528785|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5075196|NCT03528785|Liposomial IrinoTecan|liposomial irinotecan
5075197|NCT03528785|nal-IRI|nal-iri
5075198|NCT03528785|Resectable pancreatic cancer|resectable pancreatic cancer
5423201|NCT01616693|rotavirus vaccine shedding|rotavirus vaccine shedding
5075199|NCT03528772|anal fissure, minoxidil, glycreyl trinitrate|anal fissure, minoxidil, glycreyl trinitrate
5075200|NCT03528746|Patellar tendinopathy|patellar tendinopathy
5075201|NCT03528720|Tomography, Optical Coherence|tomography, optical coherence
5075202|NCT03528720|Fluorescein Angiography|fluorescein angiography
5075203|NCT03528720|Fundus photographs|fundus photographs
5075211|NCT03528655|separation care|separation care
5075212|NCT03528655|rooming-in care|rooming-in care
5075319|NCT03528057|Kidney|kidney
5075218|NCT03528629|safety|safety
5075219|NCT03528629|ASP8951|asp8951
5075220|NCT03528629|immunogenicity|immunogenicity
5075221|NCT03528603|platelet, aggregation, phenolic, olive oil, oleocanthal|platelet, aggregation, phenolic, olive oil, oleocanthal
5075222|NCT03528590|laryngeal mask airway|laryngeal mask airway
5075223|NCT03528590|breast surgery|breast surgery
5075224|NCT03528564|Preoperative Anemia|preoperative anemia
5075225|NCT03528564|Intravenous Iron|intravenous iron
5075226|NCT03528564|Erythropoietin|erythropoietin
5075227|NCT03528538|Fenugreek|fenugreek
5075228|NCT03528538|Aging Male Symptoms|aging male symptoms
5075229|NCT03528538|Testosterone|testosterone
5075230|NCT03528538|Supplementation|supplementation
5075231|NCT03528538|Double Blind|double blind
5075232|NCT03528538|Body Composition|body composition
5075233|NCT03528525|Diseases|diseases
5075234|NCT03528525|Children|children
5075235|NCT03528525|Respiratory|respiratory
5075236|NCT03528525|Monogenic diseases|monogenic diseases
5075237|NCT03528525|China|china
5075238|NCT03528512|Pediatric|pediatric
5075239|NCT03528512|analgesia|analgesia
5075240|NCT03528512|pain control|pain control
5075241|NCT03528512|sedation|sedation
5075242|NCT03528512|intranasal ketamine|intranasal ketamine
5075243|NCT03528512|intranasal midazolam|intranasal midazolam
5075244|NCT03528512|intranasal fentanyl|intranasal fentanyl
5075245|NCT03528499|Scapula|scapula
5075246|NCT03528499|Physical Therapy|physical therapy
5075247|NCT03528499|Movement|movement
5075248|NCT03528499|Rehabilitation|rehabilitation
5075249|NCT03528460|Parkinson Disease|parkinson disease
5075250|NCT03528460|Deep Brain Stimulation|deep brain stimulation
5075251|NCT03528460|Subthalamic Nucleus|subthalamic nucleus
5075252|NCT03528460|Predictive factors|predictive factors
5075253|NCT03528447|lung transplantation|lung transplantation
5075254|NCT03528447|cognition|cognition
5075255|NCT03528447|MOCA|moca
5075256|NCT03528447|exercise|exercise
5075257|NCT03528447|pulmonary rehabilitation|pulmonary rehabilitation
5075258|NCT03528434|Zinc|zinc
5075259|NCT03528421|CAR-T|car-t
5075260|NCT03528395|Balance|balance
5075261|NCT03528395|Baropodometry|baropodometry
5075262|NCT03528395|Video games|video games
5075263|NCT03528395|Virtual reality|virtual reality
5075264|NCT03528343|appendicitis|appendicitis
5075265|NCT03528343|postoperative pain|postoperative pain
5075266|NCT03528343|patient satisfaction|patient satisfaction
5075267|NCT03528343|children|children
5075268|NCT03528343|pediatric|pediatric
5075269|NCT03528343|narcotic|narcotic
5075270|NCT03528343|pain control|pain control
5075271|NCT03528304|Obesity|obesity
5075272|NCT03528304|Overweight|overweight
5075273|NCT03528304|Current smoker|current smoker
5075274|NCT03528304|American Indian/Alaska Native|american indian/alaska native
5075275|NCT03528291|Human,|human,
5075276|NCT03528291|adult,|adult,
5075277|NCT03528291|intensive care unit,|intensive care unit,
5075278|NCT03528291|cardiogenic shock,|cardiogenic shock,
5075279|NCT03528291|Transient circulatory support,|transient circulatory support,
5075280|NCT03528291|extra corporeal life support|extra corporeal life support
5075281|NCT03528291|Impella|impella
5075282|NCT03528265|lateral flow immunoassay|lateral flow immunoassay
5075284|NCT03528252|cholesterol|cholesterol
5075285|NCT03528252|LDL cholesterol|ldl cholesterol
5075286|NCT03528252|Triglycerides|triglycerides
5075287|NCT03528252|Diet|diet
5075288|NCT03528252|Food|food
5075289|NCT03528252|Lipoproteins|lipoproteins
5075290|NCT03528226|Type 1 diabetes|type 1 diabetes
5075291|NCT03528226|endothelial function|endothelial function
5075292|NCT03528226|exercise training|exercise training
5075293|NCT03528226|physical activity|physical activity
5075294|NCT03528213|sepsis|sepsis
5075295|NCT03528213|fluid balance|fluid balance
5075296|NCT03528213|metabolism|metabolism
5075297|NCT03528213|ischemia-reperfusion|ischemia-reperfusion
5075298|NCT03528213|treatment|treatment
5075299|NCT03528161|hypersensitive troponin|hypersensitive troponin
5075300|NCT03528161|risk of serious adverse events|risk of serious adverse events
5075301|NCT03528161|emergency|emergency
5075302|NCT03528148|Post stroke|post stroke
5075303|NCT03528148|Gait|gait
5075304|NCT03528148|Elliptical cross bike.|elliptical cross bike.
5075305|NCT03528148|Postural control|postural control
5075306|NCT03528148|Balance|balance
5075312|NCT03528083|Bronchiolitis|bronchiolitis
5075313|NCT03528083|Children|children
5075314|NCT03528083|Hospital|hospital
5075315|NCT03528070|Sarcoidosis|sarcoidosis
5075316|NCT03528070|Tranilast|tranilast
5075317|NCT03528070|skin|skin
5075318|NCT03528070|lung|lung
5075320|NCT03528044|Bariatric surgery|bariatric surgery
5075332|NCT03528018|Physical therapy|physical therapy
5075333|NCT03528005|Integrated Health Care Systems|integrated health care systems
5075335|NCT03528005|Multi-domain intervention|multi-domain intervention
5075336|NCT03528005|Clinical Trials, Randomized|clinical trials, randomized
5075337|NCT03527992|Randomized Therapeutic trial|randomized therapeutic trial
5075338|NCT03527992|Hypoxemic pneumonia|hypoxemic pneumonia
5075339|NCT03527992|Automated oxygen therapy|automated oxygen therapy
5075340|NCT03527992|Length of stay|length of stay
5075341|NCT03527992|medico-economic cost|medico-economic cost
5961322|NCT04287868|Immuno-oncology|immuno-oncology
5075342|NCT03527953|bulk-fill restorative resins, dental caries|bulk-fill restorative resins, dental caries
5075343|NCT03527927|COPD|copd
5075344|NCT03527914|Depression|depression
5075345|NCT03527914|Psychosis|psychosis
5961323|NCT04287842|desflurane|desflurane
5075346|NCT03527914|Personality Disorder|personality disorder
5075347|NCT03527914|Substance Abuse|substance abuse
5075348|NCT03527901|aggressive periodontitis|aggressive periodontitis
5075349|NCT03527901|healthy peri-implant|healthy peri-implant
5075350|NCT03527901|chairside test|chairside test
5075351|NCT03527901|chronic periodontitis|chronic periodontitis
5075352|NCT03527849|Osteoarthritis|osteoarthritis
5075353|NCT03527849|Knee Osteoarthritis|knee osteoarthritis
5075354|NCT03527849|Knee Pain|knee pain
5075355|NCT03527823|Fertilization in Vitro|fertilization in vitro
5075356|NCT03527823|Granulosa Cells|granulosa cells
5075357|NCT03527823|Apoptosis|apoptosis
5075358|NCT03527810|sleeve gastrectomy|sleeve gastrectomy
5075359|NCT03527810|hiatal interrogation|hiatal interrogation
5075360|NCT03527810|GERD|gerd
5075361|NCT03527797|Critical illness associated diaphragm weakness|critical illness associated diaphragm weakness
5075362|NCT03527797|Mechanical ventilation|mechanical ventilation
5075363|NCT03527797|Critical illness|critical illness
5075364|NCT03527797|Respiratory muscle dysfunction|respiratory muscle dysfunction
5075365|NCT03527784|rectal adenocarcinoma|rectal adenocarcinoma
5075366|NCT03527784|abdominoperineal resection|abdominoperineal resection
5075367|NCT03527784|hernia prophylaxis|hernia prophylaxis
5075368|NCT03527758|Biomarkers|biomarkers
5075369|NCT03527758|Hypotension|hypotension
5075370|NCT03527758|Organ Protection|organ protection
5075371|NCT03527758|Intraoperative|intraoperative
5075372|NCT03527719|Hypertension|hypertension
5075373|NCT03527719|Stroke|stroke
5075374|NCT03527719|China|china
5075375|NCT03527719|Protocol-based treatment|protocol-based treatment
5075380|NCT03527602|Apical patency|apical patency
5075381|NCT03527602|Endodontics|endodontics
5075382|NCT03527589|Prostatic Artery Embolization|prostatic artery embolization
5075383|NCT03527589|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5075384|NCT03527589|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5075386|NCT03527589|BPH|bph
5075387|NCT03527589|LUTS|luts
5075388|NCT03527589|Embolization|embolization
5075389|NCT03527589|Embolic|embolic
5075390|NCT03527589|Embosphere Microsphere|embosphere microsphere
5075391|NCT03527563|Hypertension|hypertension
5075392|NCT03527550|impulsivity|impulsivity
5075393|NCT03527550|Inhibition (Psychology)|inhibition (psychology)
5075394|NCT03527550|Working memory|working memory
5075395|NCT03527550|Cognitive Remediation|cognitive remediation
5075396|NCT03527524|exercise|exercise
5075397|NCT03527472|cognitive dysfunction|cognitive dysfunction
5075398|NCT03527472|memantine|memantine
5075399|NCT03527472|lupus|lupus
5075400|NCT03527446|Metabolic flexibility|metabolic flexibility
5075401|NCT03527446|Insulin sensitivity|insulin sensitivity
5075402|NCT03527446|Sprint interval training|sprint interval training
5075403|NCT03527446|Obesity|obesity
5075404|NCT03527446|Exercise intensity|exercise intensity
5075428|NCT03527381|Nitric Oxide|nitric oxide
5075429|NCT03527381|Kidney Function Tests|kidney function tests
5075430|NCT03527381|Renal Insufficiency|renal insufficiency
5075431|NCT03527381|Protective Agents|protective agents
5075432|NCT03527381|Coronary Artery Bypass|coronary artery bypass
5075433|NCT03527381|Cardiac Surgery|cardiac surgery
5075435|NCT03527355|Vi-DT|vi-dt
5075436|NCT03527355|Conjugate vaccine|conjugate vaccine
5075437|NCT03527355|First in human|first in human
5075438|NCT03527355|New vaccine|new vaccine
5075439|NCT03527329|Prewarming|prewarming
5075440|NCT03527329|Tympanic temperature|tympanic temperature
5075441|NCT03527303|stress|stress
5075442|NCT03527303|health|health
5075443|NCT03527303|meditation|meditation
5075444|NCT03527303|mindfulness|mindfulness
5075445|NCT03527303|employees|employees
5075446|NCT03527303|job strain|job strain
5075447|NCT03527303|burnout|burnout
5075448|NCT03527303|work|work
5075449|NCT03527303|mood|mood
5075450|NCT03527303|affect|affect
5075451|NCT03527303|work related stress|work related stress
5075452|NCT03527277|orange juice|orange juice
5075453|NCT03527277|sugar-sweetened beverage|sugar-sweetened beverage
5075454|NCT03527277|triglyceride|triglyceride
5075455|NCT03527277|low density lipoprotein cholesterol|low density lipoprotein cholesterol
5075456|NCT03527277|apolipoprotein B|apolipoprotein b
5075457|NCT03527277|uric acid|uric acid
5075458|NCT03527277|de novo lipogenesis|de novo lipogenesis
5075459|NCT03527277|hepatic triglyceride|hepatic triglyceride
5075460|NCT03527277|hepatic glucose production|hepatic glucose production
5075461|NCT03527277|whole body insulin sensitivity|whole body insulin sensitivity
5075462|NCT03527264|cervical cancer|cervical cancer
5075463|NCT03527264|Stage IB|stage ib
5075464|NCT03527264|Stage IIA|stage iia
5075465|NCT03527264|Stage IIB|stage iib
5075466|NCT03527264|Stage IIIA|stage iiia
5075467|NCT03527264|Stage IIIB|stage iiib
5075468|NCT03527264|Stage IVA|stage iva
5075469|NCT03527251|clinical trial, phase I|clinical trial, phase i
5075470|NCT03527251|CTLA-4 antibody|ctla-4 antibody
5075471|NCT03527251|PD-1 antibody|pd-1 antibody
5075472|NCT03527251|non-small cell lung cancer|non-small cell lung cancer
5075473|NCT03527238|Phenotypic Precision Medicine (PPM)|phenotypic precision medicine (ppm)
5075474|NCT03527238|Tacrolimus|tacrolimus
5075475|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors
5075482|NCT03527212|Dry Eye Disease|dry eye disease
5075483|NCT03527212|Corneal Epithelial Disorders|corneal epithelial disorders
5075484|NCT03527212|Re-Epithelialization|re-epithelialization
5075485|NCT03527173|Challenge|challenge
5075486|NCT03527173|Efficacy|efficacy
5075487|NCT03527173|Shigellosis|shigellosis
5075488|NCT03527173|Vaccination|vaccination
5075490|NCT03527160|NGAL|ngal
5075509|NCT03527095|Cystic Fibrosis|cystic fibrosis
5075510|NCT03527082|mesh|mesh
5075511|NCT03527082|erosion|erosion
5075512|NCT03527082|transvaginal|transvaginal
5075513|NCT03527082|prolapse|prolapse
5075514|NCT03527082|laparoscopic|laparoscopic
5075515|NCT03527082|tension free tape|tension free tape
5075516|NCT03527056|CRE|cre
5075517|NCT03527030|Tobacco Use|tobacco use
5075518|NCT03527030|IQOS|iqos
5075519|NCT03527017|Tobacco Use|tobacco use
5075520|NCT03527017|IQOS|iqos
5075521|NCT03527004|Tobacco Use|tobacco use
5075522|NCT03527004|IQOS|iqos
5075526|NCT03526978|Sabin strain|sabin strain
5075534|NCT03526939|Hepatitis C|hepatitis c
5075535|NCT03526939|Vietnam|vietnam
5075536|NCT03526939|Behavioral Intervention|behavioral intervention
5075537|NCT03526926|newly-diagnosed t-AML or AML-MRC|newly-diagnosed t-aml or aml-mrc
5075538|NCT03526913|chronic leg ulcers, PRP|chronic leg ulcers, prp
5075539|NCT03526913|split-thickness skin graft|split-thickness skin graft
5075540|NCT03526913|platelet-rich plasma|platelet-rich plasma
5075541|NCT03526874|Pain|pain
5075542|NCT03526874|Chronic Migraine|chronic migraine
5075543|NCT03526874|Episodic Migraine|episodic migraine
5075544|NCT03526874|Headache|headache
5075545|NCT03526874|Nerve Block|nerve block
5075546|NCT03526848|3BNC117|3bnc117
5075547|NCT03526848|10-1074|10-1074
5075548|NCT03526848|Broadly Neutralizing Antibody|broadly neutralizing antibody
5075549|NCT03526835|Bispecific antibody|bispecific antibody
5075550|NCT03526835|First-in-human|first-in-human
5075551|NCT03526835|MCLA-158|mcla-158
5075552|NCT03526835|Antibodies|antibodies
5075553|NCT03526835|Bispecific|bispecific
5075554|NCT03526835|immunologic factors|immunologic factors
5075571|NCT03526757|Elderly|elderly
5075579|NCT03526692|Mild cognitive impairment|mild cognitive impairment
5075580|NCT03526692|Neurofeedback|neurofeedback
5075581|NCT03526692|electroencephalography|electroencephalography
5075582|NCT03526692|attention|attention
5075583|NCT03526692|memory|memory
5075584|NCT03526679|soft tissue sarcoma|soft tissue sarcoma
5075585|NCT03526679|phase Ib/II|phase ib/ii
5075586|NCT03526679|advanced cancer|advanced cancer
5075587|NCT03526666|Vitamin C|vitamin c
5075588|NCT03526666|Ascorbic Acid|ascorbic acid
5075589|NCT03526666|Epigenetics|epigenetics
5075590|NCT03526666|5-hydroxymethylcytosine|5-hydroxymethylcytosine
5075591|NCT03526666|5-methylcytosine|5-methylcytosine
5075592|NCT03526627|advanced care management, advanced heart failure|advanced care management, advanced heart failure
5075593|NCT03526601|heart failure|heart failure
5075594|NCT03526601|prevalence|prevalence
5075595|NCT03526588|CDH|cdh
5075596|NCT03526523|Mindfulness based stress reduction|mindfulness based stress reduction
5075597|NCT03526523|Perimenopausal depression|perimenopausal depression
5075598|NCT03526523|Menopause transition|menopause transition
5075599|NCT03526510|High Risk Prostate Cancer|high risk prostate cancer
5075600|NCT03526510|Radiotherapy|radiotherapy
4958906|NCT04245540|painful menstruation|painful menstruation
5075601|NCT03526497|Catheterization, Peripheral/methods|catheterization, peripheral/methods
5075602|NCT03526497|Humans|humans
5075603|NCT03526497|Acute Disease|acute disease
5075604|NCT03526497|Aged|aged
5075605|NCT03526497|Female|female
5075606|NCT03526497|Male|male
5075607|NCT03526497|Follow-Up Studies|follow-up studies
5075608|NCT03526497|Heart Failure/physiopathology|heart failure/physiopathology
5075609|NCT03526497|Prospective Studies|prospective studies
5075610|NCT03526497|Stroke Volume/physiology|stroke volume/physiology
5075611|NCT03526497|Venous Pressure/physiology|venous pressure/physiology
5075612|NCT03526484|UTI|uti
5075613|NCT03526484|Urinalysis|urinalysis
5075614|NCT03526484|Urine Culture|urine culture
5075615|NCT03526484|Cystoscopy|cystoscopy
5075616|NCT03526484|BCG treatment|bcg treatment
5075617|NCT03526484|Prostate Biopsy|prostate biopsy
5075618|NCT03526471|Left Atrial Appendage|left atrial appendage
5075619|NCT03526471|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5075620|NCT03526458|Holmium Laser|holmium laser
5075621|NCT03526458|Laser setting|laser setting
5075622|NCT03526458|Stone fragmentation|stone fragmentation
5075623|NCT03526445|Glucagon|glucagon
5075624|NCT03526445|Stable isotope|stable isotope
5075625|NCT03526445|Energy expenditure|energy expenditure
5075626|NCT03526445|Lipid metabolism|lipid metabolism
5075627|NCT03526445|Glucose metabolism|glucose metabolism
5075628|NCT03526445|Appetite|appetite
5075629|NCT03526419|Liposomal bupivacaine|liposomal bupivacaine
5075630|NCT03526419|TAP block|tap block
5075631|NCT03526419|cesarean section|cesarean section
5075632|NCT03526406|Cognition|cognition
5075633|NCT03526406|Mood|mood
5075636|NCT03526406|Catechin|catechin
5075637|NCT03526406|Epicatechin|epicatechin
5369137|NCT01861158|Delinquency|delinquency
5075638|NCT03526406|Proanthocyanidin|proanthocyanidin
5075639|NCT03526380|Drug overdose|drug overdose
5075640|NCT03526380|Substance-Related Disorders|substance-related disorders
5075641|NCT03526380|Chemically-Induced Disorders|chemically-induced disorders
5075642|NCT03526380|Risk Reduction Behavior|risk reduction behavior
5075643|NCT03526380|Harm Reduction|harm reduction
5075644|NCT03526354|Schizophrenia|schizophrenia
5075645|NCT03526354|Schizoaffective Disorder|schizoaffective disorder
5074693|NCT03531905|T2D|t2d
5075649|NCT03526354|Cocaine Use Disorder|cocaine use disorder
5075650|NCT03526354|Heroin Use Disorder|heroin use disorder
5075651|NCT03526328|DCLK1|dclk1
5075652|NCT03526328|Serum Biomarker|serum biomarker
5075653|NCT03526328|Barrett's Esophagus|barrett's esophagus
5075654|NCT03526328|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5075655|NCT03526328|Tumor Stem Cell Marker|tumor stem cell marker
5075656|NCT03526315|CPP-ACP paste|cpp-acp paste
5075657|NCT03526315|Fluoride toothpaste|fluoride toothpaste
5075658|NCT03526315|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
5075659|NCT03526315|MS reduction|ms reduction
5075660|NCT03526315|Antibacterial|antibacterial
5075661|NCT03526315|Children|children
5075662|NCT03526276|Quantitative Laser Fluorescence (QLF)|quantitative laser fluorescence (qlf)
5075663|NCT03526276|CPP-ACP paste|cpp-acp paste
5075664|NCT03526276|Fluoride toothpaste|fluoride toothpaste
5075665|NCT03526276|Combined use of fluoride and CPP-ACP paste|combined use of fluoride and cpp-acp paste
5075666|NCT03526276|Primary teeth|primary teeth
5075667|NCT03526263|Gastric Mucosal Devitalization|gastric mucosal devitalization
5075668|NCT03526263|Obesity|obesity
5075669|NCT03526263|Endoscopic Bariatric Therapies|endoscopic bariatric therapies
5075670|NCT03526263|Bariatric surgery|bariatric surgery
5075671|NCT03526237|diabetes|diabetes
5075672|NCT03526237|prevention|prevention
5075673|NCT03526237|risk|risk
5075674|NCT03526237|obesity|obesity
5075675|NCT03526237|weight loss|weight loss
5075676|NCT03526237|community based|community based
5075677|NCT03526211|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
5075678|NCT03526211|Cycloergometer|cycloergometer
5075679|NCT03526211|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5075680|NCT03526211|FES Cycling|fes cycling
5075681|NCT03526198|Force plate|force plate
5075682|NCT03526198|Center of mass|center of mass
5075683|NCT03526159|Herlitz|herlitz
5075684|NCT03526159|Laminin 332|laminin 332
5075685|NCT03526159|Laminin beta 3|laminin beta 3
5075686|NCT03526159|JEB|jeb
5075687|NCT03526133|sleep apnea|sleep apnea
5075688|NCT03526133|polygraph|polygraph
5075689|NCT03526133|home sleep apnea test (HSAT)|home sleep apnea test (hsat)
4998764|NCT04002154|HPV|hpv
5075690|NCT03526133|apnea hypopnea index (AHI)|apnea hypopnea index (ahi)
5075691|NCT03526133|oxygen desaturation index (ODI)|oxygen desaturation index (odi)
5075692|NCT03526133|portable monitor|portable monitor
5075693|NCT03526133|sleep actimetry|sleep actimetry
5075694|NCT03526133|snoring|snoring
5075695|NCT03526120|Human subjects|human subjects
5075696|NCT03526120|Pistachio snack|pistachio snack
5075697|NCT03526120|Body mass index|body mass index
5075698|NCT03526120|Energy intake|energy intake
5075699|NCT03526120|Fat mass|fat mass
5075700|NCT03526107|flavanol|flavanol
5075701|NCT03526107|ADME|adme
5075702|NCT03526107|polyphenols|polyphenols
5075703|NCT03526107|cocoa|cocoa
5075704|NCT03526107|epicatechin|epicatechin
5075705|NCT03526107|methylxanthine|methylxanthine
5075706|NCT03526107|caffeine|caffeine
5075707|NCT03526094|flavanol|flavanol
5075708|NCT03526094|ADME|adme
5075709|NCT03526094|polyphenols|polyphenols
5075710|NCT03526094|Cocoa|cocoa
5075711|NCT03526094|Banana|banana
5075712|NCT03526094|epicatechin|epicatechin
5075713|NCT03526081|flavone|flavone
5075714|NCT03526081|ADME|adme
5075715|NCT03526081|apigenin|apigenin
5075716|NCT03526081|parsley|parsley
5075717|NCT03526081|chamomile|chamomile
5075718|NCT03526081|polyphenols|polyphenols
5075719|NCT03526016|Sleep Apnea|sleep apnea
5075720|NCT03526016|Acromegaly|acromegaly
5075721|NCT03526016|Transsphenoidal surgery|transsphenoidal surgery
5075722|NCT03526016|Respiratory polygraphy|respiratory polygraphy
5075723|NCT03525964|Individualized treatment|individualized treatment
5075724|NCT03525964|Functional outcome|functional outcome
5075725|NCT03525847|Contrast endosonograpy|contrast endosonograpy
5075726|NCT03525834|TSC|tsc
5075727|NCT03525834|tuberous sclerosis complex|tuberous sclerosis complex
5075728|NCT03525834|AML|aml
5075729|NCT03525834|afinitor|afinitor
5075730|NCT03525834|everolimus|everolimus
5075731|NCT03525834|RAD001|rad001
5075732|NCT03525834|mTOR|mtor
5075733|NCT03525834|kidney|kidney
5075734|NCT03525834|lymphangioleiomyomatosis|lymphangioleiomyomatosis
5075735|NCT03525834|renal angiomyolipoma|renal angiomyolipoma
5075743|NCT03525782|Non-small cell lung cancer|non-small cell lung cancer
5075744|NCT03525756|cystogram|cystogram
5075745|NCT03525756|Foley catheter|foley catheter
5075746|NCT03525743|Intubation|intubation
5075747|NCT03525730|HIV|hiv
5075748|NCT03525730|Latency reversing agents|latency reversing agents
5075749|NCT03525730|HDAC inhibitor|hdac inhibitor
5075750|NCT03525730|BAF inhibitor|baf inhibitor
5075751|NCT03525730|HIV reservoir|hiv reservoir
5075752|NCT03525730|HIV cure|hiv cure
5075753|NCT03525717|healthy volunteers|healthy volunteers
5075754|NCT03525717|metabolism|metabolism
5075755|NCT03525717|fat oxidation|fat oxidation
5075756|NCT03525717|obesity|obesity
5075757|NCT03525717|sleep|sleep
5075758|NCT03525678|Relapsed|relapsed
5075759|NCT03525678|Refractory multiple myeloma|refractory multiple myeloma
5075760|NCT03525678|Antibody-drug conjugate|antibody-drug conjugate
5075761|NCT03525678|Patient-Reported Outcome Version of the Common Term Criteria for Adverse Events|patient-reported outcome version of the common term criteria for adverse events
5075762|NCT03525678|Quality of Life Questionnaire 20-item Multiple Myeloma module|quality of life questionnaire 20-item multiple myeloma module
5075763|NCT03525678|Multiple Myeloma|multiple myeloma
5075764|NCT03525678|Quality of Life Questionnaire 30-item Core module|quality of life questionnaire 30-item core module
5075765|NCT03525665|Follicular lymphoma|follicular lymphoma
5075766|NCT03525665|FDG-PET|fdg-pet
5075767|NCT03525665|Relapse/progression|relapse/progression
5075768|NCT03525652|Prostate Cancer|prostate cancer
5075769|NCT03525652|Therapeutic vaccine|therapeutic vaccine
5075770|NCT03525652|PD-1 knockout|pd-1 knockout
5075771|NCT03525639|Cardiac Magnetic Resonance|cardiac magnetic resonance
5075772|NCT03525639|Acute Myocarditis|acute myocarditis
5075773|NCT03525639|Myocardial Inflammation|myocardial inflammation
5075774|NCT03525626|Tic Disorders|tic disorders
5075775|NCT03525626|Mindfulness|mindfulness
5075776|NCT03525626|Meditation|meditation
5075777|NCT03525626|Online|online
5075778|NCT03525626|Internet-based|internet-based
5075779|NCT03525626|Treatment|treatment
5075780|NCT03525587|Quality Improvement|quality improvement
5075781|NCT03525587|Quality of Life|quality of life
5075782|NCT03525587|Smartphone APP|smartphone app
5075783|NCT03525522|Lichen sclerosus|lichen sclerosus
5075784|NCT03525522|laser|laser
5075785|NCT03525522|Nd:YAG|nd:yag
5075786|NCT03525522|randomized controlled trial|randomized controlled trial
5075787|NCT03525509|Methadone|methadone
5075788|NCT03525509|Morphine|morphine
5075789|NCT03525509|Quantitative sensory testing|quantitative sensory testing
5075790|NCT03525509|Epidural|epidural
5075791|NCT03525496|Iodinated contrast agents|iodinated contrast agents
5075792|NCT03525496|Immediate hypersensitivity reactions|immediate hypersensitivity reactions
5075793|NCT03525496|Reintroduction tests|reintroduction tests
5075794|NCT03525483|ECMO|ecmo
5075795|NCT03525483|Acute renal failure|acute renal failure
5075796|NCT03525470|Hydration|hydration
5075797|NCT03525470|Brain functioning|brain functioning
5075798|NCT03525470|Heart-rate variability|heart-rate variability
5075799|NCT03525457|Glomerular filtration rate|glomerular filtration rate
5075800|NCT03525457|Periodontitis|periodontitis
5075801|NCT03525457|Chronic kidney disease|chronic kidney disease
5075802|NCT03525431|Exome|exome
5075803|NCT03525431|Sequencing|sequencing
5075804|NCT03525431|Clinical Utility|clinical utility
5075805|NCT03525431|Pediatric|pediatric
5075806|NCT03525431|Underrepresented|underrepresented
5075807|NCT03525431|Underserved|underserved
5075808|NCT03525418|Pediatrics|pediatrics
5075809|NCT03525379|Skeletal Muscle Blood Flow|skeletal muscle blood flow
5075810|NCT03525379|(calf muscle) targeted exercise|(calf muscle) targeted exercise
5075811|NCT03525340|Engagement to care, peer navigation, transgender|engagement to care, peer navigation, transgender
5075812|NCT03525327|Dance|dance
5075813|NCT03525301|Short Course Radiotherapy|short course radiotherapy
5075814|NCT03525301|Symptomatic brain metastases|symptomatic brain metastases
5075815|NCT03525262|Erectile dysfunction, Neurovascular, Prostate, Rectal spacer, Radiotherapy|erectile dysfunction, neurovascular, prostate, rectal spacer, radiotherapy
5075816|NCT03525223|23Na MRI|23na mri
5075817|NCT03525197|Muscle Physiology|muscle physiology
5075818|NCT03525197|Nutrition|nutrition
5075819|NCT03525145|Platelet Reactivity|platelet reactivity
5075820|NCT03525145|Thrombotic Events|thrombotic events
5075821|NCT03525119|Vaccine|vaccine
5075822|NCT03525054|Psychotic Disorders|psychotic disorders
5075823|NCT03525054|Diagnosis, Psychiatric|diagnosis, psychiatric
5075824|NCT03525054|Schizophrenia Prodromal|schizophrenia prodromal
5075825|NCT03525054|Ultra High Risk|ultra high risk
5075844|NCT03524937|Prevention|prevention
5075845|NCT03524937|Pharmacokinetics|pharmacokinetics
5075846|NCT03524937|Melatonin|melatonin
5075847|NCT03524924|atrial fibrillation|atrial fibrillation
5075848|NCT03524924|elderly|elderly
5075849|NCT03524924|edoxaban|edoxaban
5075850|NCT03524924|frailty|frailty
5075851|NCT03524924|SHARE-FI|share-fi
5075852|NCT03524924|Stroke|stroke
5075853|NCT03524924|Major bleeding|major bleeding
5075854|NCT03524911|Nutrition education|nutrition education
5075855|NCT03524911|Evaluation|evaluation
5075856|NCT03524911|Child diet|child diet
5075857|NCT03524911|EFNEP|efnep
5075858|NCT03524898|Nab-Paclitaxel|nab-paclitaxel
5075859|NCT03524898|Gemcitabine|gemcitabine
5075860|NCT03524898|Advanced soft tissue sarcoma|advanced soft tissue sarcoma
5075861|NCT03524898|Cancer|cancer
5075862|NCT03524898|Sarcoma|sarcoma
5075863|NCT03524898|Abraxane®|abraxane®
5075864|NCT03524859|Cystic Fibrosis|cystic fibrosis
5075865|NCT03524859|Sit-to-stand|sit-to-stand
5075866|NCT03524859|Lung Function|lung function
5075867|NCT03524859|Handgrip|handgrip
5075868|NCT03524859|Walking Speed|walking speed
5075869|NCT03524859|Power|power
5075870|NCT03524859|Velocity|velocity
5075874|NCT03524846|hemodialysis vascular access|hemodialysis vascular access
5075875|NCT03524846|restenosis|restenosis
5075876|NCT03524833|Lansoprazole, Amoxicillin, Metronidazole|lansoprazole, amoxicillin, metronidazole
5075877|NCT03524820|cetuximab, colon cancer, RAS|cetuximab, colon cancer, ras
5075878|NCT03524807|pelvic floor muscle electrophysiologic therapy|pelvic floor muscle electrophysiologic therapy
5075879|NCT03524807|enhanced recovery|enhanced recovery
5075880|NCT03524807|muscle soreness|muscle soreness
5075881|NCT03524807|postoperative retention of urine|postoperative retention of urine
5075882|NCT03524807|Intrauterine Adhesions|intrauterine adhesions
5075883|NCT03524807|enhanced recovery after gynecologic surgery|enhanced recovery after gynecologic surgery
5075884|NCT03524781|Anti-reflux surgery|anti-reflux surgery
5075885|NCT03524781|Proton-pump inhibitors|proton-pump inhibitors
5075886|NCT03524781|Upper endoscopy|upper endoscopy
5075887|NCT03524768|endothelial function, microvascular|endothelial function, microvascular
5075888|NCT03524768|laser speckle contrast imaging|laser speckle contrast imaging
5075889|NCT03524768|capillaroscopy, skin|capillaroscopy, skin
5075890|NCT03524742|Diet|diet
5075891|NCT03524742|Cholesterol|cholesterol
5075892|NCT03524729|Rocker bottom shoe|rocker bottom shoe
5075893|NCT03524729|Ankle-foot orthosis|ankle-foot orthosis
5075894|NCT03524729|Ankle osteoarthritis|ankle osteoarthritis
5075895|NCT03524716|physical activity|physical activity
5075896|NCT03524716|digital health|digital health
5075897|NCT03524716|text messages|text messages
5075898|NCT03524716|intervention|intervention
5075899|NCT03524716|exercise|exercise
5075900|NCT03524716|randomized|randomized
5075901|NCT03524716|Fitbit|fitbit
5075902|NCT03524703|dysphagia|dysphagia
5075903|NCT03524703|anterior cervical fusion|anterior cervical fusion
5075904|NCT03524703|chewing gum|chewing gum
5075905|NCT03524677|pancreatic cancer|pancreatic cancer
5075906|NCT03524677|liquid biopsy|liquid biopsy
5075907|NCT03524677|vascular invasion|vascular invasion
5075908|NCT03524677|early recurrence|early recurrence
5075909|NCT03524651|Iron Deficiency Anemia|iron deficiency anemia
5075910|NCT03524651|Fe-ASP|fe-asp
5075911|NCT03524651|Casein|casein
5075912|NCT03524651|Iron protein acetyl aspartate|iron protein acetyl aspartate
5075913|NCT03524651|Restoration of decreased hemoglobin|restoration of decreased hemoglobin
5075914|NCT03524651|Ferrous sulfate|ferrous sulfate
5075925|NCT03524599|Heavy drinking|heavy drinking
5075926|NCT03524599|Primary health care|primary health care
5075927|NCT03524599|Training|training
5075928|NCT03524599|Community|community
5076024|NCT03523962|Peri-operative Preparation Solutions|peri-operative preparation solutions
5075930|NCT03524482|culturally specific|culturally specific
5075931|NCT03524456|home blood pressure monitoring|home blood pressure monitoring
5075932|NCT03524456|sms|sms
5075933|NCT03524456|primary care|primary care
5075934|NCT03524443|Affective symptom|affective symptom
5075935|NCT03524443|Art Therapy|art therapy
5075936|NCT03524443|alexithymia|alexithymia
5075937|NCT03524443|emotional disturbance|emotional disturbance
5075938|NCT03524443|hyperphagia|hyperphagia
5075939|NCT03524443|psychotherapy|psychotherapy
5075940|NCT03524443|rehabilitation|rehabilitation
5075941|NCT03524443|factor of resistance|factor of resistance
5075942|NCT03524430|Early breast cancer|early breast cancer
5075943|NCT03524417|Rabies immunoglobulin|rabies immunoglobulin
5075944|NCT03524378|repetitive strain|repetitive strain
5075945|NCT03524378|ergonomics|ergonomics
5075946|NCT03524378|participatory ergonomics|participatory ergonomics
5075947|NCT03524378|chronic low back pain|chronic low back pain
5075948|NCT03524378|seafood workers|seafood workers
5075949|NCT03524352|recurrent pouchitis|recurrent pouchitis
5075950|NCT03524352|fecal microbiota transplant|fecal microbiota transplant
5075951|NCT03524326|cetuximab|cetuximab
5075952|NCT03524326|Lenvatinib|lenvatinib
5356802|NCT01917942|Humidification|humidification
5075958|NCT03524313|intensive care|intensive care
5075959|NCT03524300|Stomach Neoplasm|stomach neoplasm
5075960|NCT03524300|Robotic Surgery|robotic surgery
5075961|NCT03524300|Total Gastrectomy|total gastrectomy
5075962|NCT03524287|Stomach Neoplasms|stomach neoplasms
5075963|NCT03524287|Robotic Surgery|robotic surgery
5075964|NCT03524287|Spleen-Preserving|spleen-preserving
5075965|NCT03524287|No.10 Lymph Node Dissection|no.10 lymph node dissection
5075966|NCT03524274|PD-1 activated CIK|pd-1 activated cik
5075967|NCT03524274|MUC1|muc1
5075968|NCT03524274|bispecific antibody|bispecific antibody
5075969|NCT03524274|Colorectal Cancer|colorectal cancer
5075970|NCT03524261|activated CIK|activated cik
5075971|NCT03524261|MUC1|muc1
5075972|NCT03524261|bispecific antibody|bispecific antibody
5075973|NCT03524261|breast cancer|breast cancer
5075974|NCT03524235|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
5075975|NCT03524235|Multiple Myeloma|multiple myeloma
5075977|NCT03524235|Bendamustine|bendamustine
5075978|NCT03524235|Haploidentical Stem Cell Transplantation|haploidentical stem cell transplantation
5075979|NCT03524235|GVHD|gvhd
5075985|NCT03524235|Minimal Residual Disease|minimal residual disease
5075986|NCT03524235|Hodgkin Lymphoma|hodgkin lymphoma
5075987|NCT03524209|Spondylodiscitis|spondylodiscitis
5075988|NCT03524209|spinal infection|spinal infection
5075989|NCT03524209|back pain|back pain
5075990|NCT03524209|quality of life|quality of life
5075991|NCT03524209|fusion|fusion
5075992|NCT03524209|minimal invasive surgery|minimal invasive surgery
5075993|NCT03524209|brace treatment|brace treatment
5075994|NCT03524157|Humylub PF|humylub pf
5075995|NCT03524157|artificial tears|artificial tears
5075996|NCT03524157|Ophthalmic lubricant|ophthalmic lubricant
5075997|NCT03524157|Chondroitin sulfate|chondroitin sulfate
5075998|NCT03524157|Sodium hyaluronate|sodium hyaluronate
5076007|NCT03524040|Selective Photothermolysis|selective photothermolysis
5076008|NCT03524040|Reflectance Confocal Microscopy|reflectance confocal microscopy
5076009|NCT03524040|Optical Coherence Tomography|optical coherence tomography
5076010|NCT03524040|Pilosebaceous Unit|pilosebaceous unit
5076011|NCT03524040|Gold Microparticles|gold microparticles
5076012|NCT03524027|Vertebral Column Resection|vertebral column resection
5076013|NCT03524027|Congenital Spinal Deformity|congenital spinal deformity
5076014|NCT03524027|Congenital Thoracolumbar Kyphoscoliosis|congenital thoracolumbar kyphoscoliosis
5076015|NCT03523988|Pre-emptive analgesics|pre-emptive analgesics
5076016|NCT03523988|Acetaminophen|acetaminophen
5076017|NCT03523988|Ibuprofen|ibuprofen
5076018|NCT03523962|Surgical Site Infection|surgical site infection
5076019|NCT03523962|Open Fracture|open fracture
5076020|NCT03523962|Lower Extremity Fracture|lower extremity fracture
5076021|NCT03523962|Pelvis; Fracture|pelvis; fracture
5076022|NCT03523962|DuraPrep|duraprep
5076023|NCT03523962|ChloraPrep|chloraprep
5076035|NCT03523754|isosorbide mononitrate|isosorbide mononitrate
5076036|NCT03523754|misoprostol|misoprostol
5076037|NCT03523741|genetic polymorphism|genetic polymorphism
5076038|NCT03523741|pharmacodynamic variability|pharmacodynamic variability
5076039|NCT03523741|personalized pharmacotherapy|personalized pharmacotherapy
5076040|NCT03523741|adverse drug reaction|adverse drug reaction
5076041|NCT03523741|quality of life|quality of life
5076045|NCT03523624|factor XIII|factor xiii
5076046|NCT03523624|intramyocardial haemorrhage|intramyocardial haemorrhage
5076047|NCT03523624|microvascular injury|microvascular injury
5076048|NCT03523624|STEMI|stemi
5076054|NCT03523585|DS 8201a|ds 8201a
5076055|NCT03523585|DESTINY - Breast 02|destiny - breast 02
5076056|NCT03523572|Human epidermal growth factor receptor-2|human epidermal growth factor receptor-2
5076057|NCT03523572|HER2|her2
5076058|NCT03523572|Refractory|refractory
5076059|NCT03523572|Metastatic|metastatic
5076060|NCT03523572|Urothelial cancer|urothelial cancer
5076061|NCT03523572|Breast Cancer|breast cancer
5076062|NCT03523520|constipation|constipation
5076063|NCT03523520|opioid|opioid
5076064|NCT03523507|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5076065|NCT03523507|Military|military
5076066|NCT03523468|VATS|vats
5076067|NCT03523468|Lung Cancer|lung cancer
5076068|NCT03523455|Iron|iron
5076069|NCT03523455|Exercise Performance|exercise performance
5076070|NCT03523455|Fatigue|fatigue
5076071|NCT03523403|Obesity|obesity
5076072|NCT03523403|Diet|diet
5076073|NCT03523403|Apples|apples
5076074|NCT03523403|Polyphenols|polyphenols
5076075|NCT03523403|Soluble fibre|soluble fibre
5076076|NCT03523403|Blood lipids|blood lipids
5076077|NCT03523403|Lipid digestion|lipid digestion
5076078|NCT03523403|Inflammation|inflammation
5076079|NCT03523403|Cytokines|cytokines
5076080|NCT03523403|Microbiota|microbiota
5076081|NCT03523403|Dysbiosis|dysbiosis
5076082|NCT03523403|Type 2 diabetes risk|type 2 diabetes risk
5076083|NCT03523403|Cardiovascular disease risk|cardiovascular disease risk
5076084|NCT03523390|Metastatic Solid Tumors|metastatic solid tumors
5076085|NCT03523390|Avelumab|avelumab
5076086|NCT03523390|MSB0010718C|msb0010718c
5076087|NCT03523377|Fasting|fasting
5076088|NCT03523377|18-199|18-199
5076089|NCT03523351|Palliative Radiation|palliative radiation
5076090|NCT03523351|18-196|18-196
5076091|NCT03523325|Tendinopathy|tendinopathy
5076092|NCT03523325|Tendon|tendon
5076093|NCT03523325|Rehabilitation|rehabilitation
5076094|NCT03523325|Exercise treatment|exercise treatment
5076095|NCT03523312|Ablative Irradiation|ablative irradiation
5076096|NCT03523312|18-090|18-090
5076097|NCT03523299|invasive ductal carcinoma|invasive ductal carcinoma
5076098|NCT03523299|breast cancer|breast cancer
5076099|NCT03523299|cryoablation|cryoablation
5076100|NCT03523286|Catheter ablation|catheter ablation
5076101|NCT03523286|ECG imaging|ecg imaging
5076110|NCT03523234|neoadjuvant therapy|neoadjuvant therapy
5076111|NCT03523234|surgery|surgery
5076113|NCT03523182|Micronutrient supplementation|micronutrient supplementation
5076114|NCT03523182|Home fortification|home fortification
5076115|NCT03523182|Spirulina|spirulina
5076116|NCT03523182|Zambia|zambia
5076117|NCT03523169|Septic associated encephalopathy|septic associated encephalopathy
5076118|NCT03523169|Cerebral oxygenation|cerebral oxygenation
5076119|NCT03523169|Prognosis|prognosis
5895988|NCT03199898|Lung/Growth & Development|lung/growth & development
5076120|NCT03523169|Passive leg raising|passive leg raising
5076121|NCT03523156|Antibiotics|antibiotics
5076122|NCT03523156|Infectious diseases|infectious diseases
5076123|NCT03523156|Tropical medicine|tropical medicine
5076124|NCT03523156|Public health|public health
5076125|NCT03523143|early screening|early screening
5076126|NCT03523143|early intervention|early intervention
5076127|NCT03523143|gestational diabetes mellitus|gestational diabetes mellitus
5076128|NCT03523143|pregnancy outcomes|pregnancy outcomes
5076129|NCT03523143|randomized controlled trial|randomized controlled trial
5076130|NCT03523130|Macrophage-specific inflammation|macrophage-specific inflammation
5076131|NCT03523130|Arterial inflammation|arterial inflammation
5076132|NCT03523130|Neuroinflammation|neuroinflammation
5076133|NCT03523130|SPECT/CT|spect/ct
5076134|NCT03523130|Tilmanocept|tilmanocept
5076135|NCT03523091|OnabotulinumtoxinA|onabotulinumtoxina
5076136|NCT03523091|Bladder Injections|bladder injections
5076137|NCT03523039|Cardiac Arrest|cardiac arrest
5076138|NCT03523039|Cytokine Hemoadsorption|cytokine hemoadsorption
5076139|NCT03523026|Metabolic Syndrome|metabolic syndrome
5076140|NCT03523026|Coronary Artery Patients|coronary artery patients
5076141|NCT03523026|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5076142|NCT03523026|Respiratory Muscle Training|respiratory muscle training
5076143|NCT03523026|Peripheral Muscle Training|peripheral muscle training
5076144|NCT03523000|intractable chronic low back pain|intractable chronic low back pain
5076145|NCT03523000|lumbar post-laminectomy syndrome|lumbar post-laminectomy syndrome
5076146|NCT03523000|vertebral compression fracture|vertebral compression fracture
5076147|NCT03523000|intrathecal drug delivery system|intrathecal drug delivery system
5076148|NCT03522987|Neurologic Disorders|neurologic disorders
5076149|NCT03522987|Chronic Care|chronic care
5076150|NCT03522987|Management|management
5076151|NCT03522987|Treatment|treatment
5076152|NCT03522987|SSRI Medication|ssri medication
5076153|NCT03522987|SNRI Medication|snri medication
5076154|NCT03522987|Learning Healthcare System|learning healthcare system
5076155|NCT03522948|heavy drinking|heavy drinking
5076156|NCT03522948|sexual risk behavior|sexual risk behavior
5076157|NCT03522922|Acne scars|acne scars
5076158|NCT03522922|dermaroller|dermaroller
5076159|NCT03522922|vitamin C|vitamin c
5076160|NCT03522909|obstetric anesthesia|obstetric anesthesia
5076161|NCT03522909|telemedicine|telemedicine
5076162|NCT03522883|Martial Arts|martial arts
5076163|NCT03522870|Flash glucose monitoring system|flash glucose monitoring system
5076164|NCT03522870|FGMS|fgms
5076165|NCT03522844|mindfulness|mindfulness
5076166|NCT03522844|escitalopram|escitalopram
5076167|NCT03522844|anxiety|anxiety
5076168|NCT03522831|dyspnea|dyspnea
5076169|NCT03522831|exercise endurance|exercise endurance
5076170|NCT03522831|lung disease|lung disease
5076171|NCT03522805|copd|copd
5076172|NCT03522805|lung|lung
5076173|NCT03522805|non-invasive ventilation|non-invasive ventilation
5076174|NCT03522805|hypercapnia|hypercapnia
5076175|NCT03522805|hypoventilation|hypoventilation
5076176|NCT03522792|food intake|food intake
5076177|NCT03522792|appetite|appetite
5076178|NCT03522792|obesity treatment|obesity treatment
5067858|NCT03574987|Sugar|sugar
5076179|NCT03522792|neurotensin|neurotensin
5076180|NCT03522792|gastrointestinal|gastrointestinal
5076181|NCT03522792|peptide|peptide
5076182|NCT03522740|Chronic Kidney Disease|chronic kidney disease
5076183|NCT03522740|Chronic Kidney Failure|chronic kidney failure
5076184|NCT03522740|Palliative Care|palliative care
5076185|NCT03522740|Dialysis|dialysis
5076186|NCT03522740|End-of-life care|end-of-life care
5076187|NCT03522740|Decision making|decision making
5076188|NCT03522714|support surface, pressure ulcer, flap closure|support surface, pressure ulcer, flap closure
5076189|NCT03522701|Adolescents|adolescents
5076190|NCT03522701|Youth|youth
5076191|NCT03522701|Insomnia|insomnia
5076192|NCT03522688|dexmedetomidine|dexmedetomidine
5076193|NCT03522688|acute kidney injury|acute kidney injury
5076194|NCT03522688|liver transplantation|liver transplantation
5076195|NCT03522649|CRC|crc
5076196|NCT03522636|Prehospital transfusion|prehospital transfusion
5076197|NCT03522636|Trauma|trauma
5076198|NCT03522636|Trauma induced coagulopathy|trauma induced coagulopathy
5076199|NCT03522623|colitis|colitis
5076200|NCT03522623|costs|costs
5076201|NCT03522623|Crohn|crohn
5076202|NCT03522623|IBD|ibd
5076203|NCT03522610|Prevention|prevention
5076204|NCT03522610|Military Families|military families
5076205|NCT03522610|Parenting|parenting
5076206|NCT03522597|Obesity|obesity
5076207|NCT03522597|Gestational Diabetes|gestational diabetes
5076208|NCT03522597|Breast Milk|breast milk
5076220|NCT03522519|Upper Extremity|upper extremity
5076221|NCT03522519|Movement Sensors|movement sensors
5076222|NCT03522519|Prognosis|prognosis
5961324|NCT04287842|preconditioning|preconditioning
5076231|NCT03522467|Pain|pain
5076232|NCT03522467|Cancer|cancer
5076234|NCT03522454|TAVR|tavr
5076235|NCT03522428|vitamin b12|vitamin b12
5076236|NCT03522428|pregnancy|pregnancy
5076237|NCT03522428|anemia|anemia
5961325|NCT04287816|Vitamin E|vitamin e
5076238|NCT03522402|head position|head position
5076239|NCT03522402|obstructive airway|obstructive airway
5076240|NCT03522402|minimum alveolar concentration(MACendotracheal intubation)|minimum alveolar concentration(macendotracheal intubation)
5076241|NCT03522402|sevoflurane concentration|sevoflurane concentration
5076242|NCT03522389|Action Observation Training|action observation training
5076243|NCT03522389|Gait|gait
5076244|NCT03522363|oral health|oral health
5076245|NCT03522363|Streptococcus dentisani|streptococcus dentisani
5076246|NCT03522350|Infertility|infertility
5076247|NCT03522350|Embryo develpoment|embryo develpoment
5076249|NCT03522350|ICSI|icsi
5076250|NCT03522350|EmbryoScope|embryoscope
5076251|NCT03522337|preschool children|preschool children
5076252|NCT03522337|special needs|special needs
5076253|NCT03522337|tooth brushing|tooth brushing
5076254|NCT03522337|social story|social story
5076255|NCT03522337|visual pedagogy|visual pedagogy
5076256|NCT03522324|Cannabis|cannabis
5076257|NCT03522324|Pain|pain
5076258|NCT03522324|Cytokines|cytokines
5076259|NCT03522324|Inflammation|inflammation
5076260|NCT03522324|Cognition|cognition
5076263|NCT03522285|hip arthroplasty|hip arthroplasty
5076264|NCT03522285|chronic renal diseases|chronic renal diseases
5076265|NCT03522272|denture|denture
5076266|NCT03522272|removable partial denture|removable partial denture
5076267|NCT03522272|denture cleansers|denture cleansers
5076268|NCT03522272|ultrasonics|ultrasonics
5076273|NCT03522272|yeast|yeast
5076274|NCT03522259|Rivaroxaban|rivaroxaban
5076275|NCT03522259|Thromboembolic prophylaxis|thromboembolic prophylaxis
5076276|NCT03522259|Venous thromboembolism|venous thromboembolism
5076277|NCT03522246|PARP inhibitor|parp inhibitor
5076278|NCT03522246|PARPi|parpi
5076280|NCT03522246|ATHENA|athena
5076281|NCT03522246|homologous recombination|homologous recombination
5076282|NCT03522246|DNA repair|dna repair
5076283|NCT03522246|LOH|loh
5076284|NCT03522246|DNA defect|dna defect
5076285|NCT03522246|DNA anomaly|dna anomaly
5076286|NCT03522246|Rucaparib|rucaparib
5076287|NCT03522246|Nivolumab|nivolumab
5076288|NCT03522246|PD-1|pd-1
5076289|NCT03522246|Immuno-|immuno-
5076290|NCT03522246|oncology|oncology
5076291|NCT03522246|Tumor|tumor
5076292|NCT03522246|mutational|mutational
5076293|NCT03522246|burden|burden
5076294|NCT03522246|BRCA|brca
5076295|NCT03522246|First-line|first-line
5076296|NCT03522246|Primary Therapy|primary therapy
5076297|NCT03522246|Primary Treatment|primary treatment
5076298|NCT03522155|Conjoint Analysis|conjoint analysis
5076299|NCT03522155|Life Expectancy|life expectancy
5076300|NCT03522155|Patient-centered|patient-centered
5076301|NCT03522142|Advanced solid tumors|advanced solid tumors
5076302|NCT03522142|AXL|axl
5076303|NCT03522142|MER|mer
5076304|NCT03522142|AXL/MER|axl/mer
5076305|NCT03522129|Alzheimer's Disease|alzheimer's disease
5076306|NCT03522103|Cannabis|cannabis
5076307|NCT03522103|Marijuana|marijuana
5076308|NCT03522103|Cognition|cognition
5076309|NCT03522077|Angiogram|angiogram
5076310|NCT03522077|Hemostatic|hemostatic
5076311|NCT03522077|Activated clotting time|activated clotting time
5076312|NCT03522077|Quality of Life|quality of life
5076313|NCT03522064|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
5076314|NCT03522064|bipolar androgen therapy|bipolar androgen therapy
5076315|NCT03522064|homologous recombination deficiency|homologous recombination deficiency
5076316|NCT03522064|BRCA|brca
5075321|NCT03528044|Reward|reward
5076330|NCT03521999|digital story telling|digital story telling
5076331|NCT03521986|Mediastinal Neoplasms|mediastinal neoplasms
5076332|NCT03521986|Pain|pain
5076333|NCT03521986|Quality of life|quality of life
5076334|NCT03521973|Plasmodium falciparum|plasmodium falciparum
5076335|NCT03521973|PfSPZ Vaccine|pfspz vaccine
5076336|NCT03521960|Buspirone|buspirone
5076337|NCT03521947|MCP|mcp
5076338|NCT03521856|spinal cord injuries|spinal cord injuries
5076339|NCT03521856|SCI|sci
5076340|NCT03521843|femoropopliteal occlusive disease|femoropopliteal occlusive disease
5076341|NCT03521843|local drug delivery|local drug delivery
5076342|NCT03521843|endovascular treatment|endovascular treatment
5076343|NCT03521804|Chronic Total Occlusion|chronic total occlusion
5076344|NCT03521804|coronary|coronary
5076345|NCT03521804|SoundBite™ Crossing System|soundbite™ crossing system
5076346|NCT03521804|CTO|cto
5076347|NCT03521804|distal cap|distal cap
5076348|NCT03521804|true lumen|true lumen
5076349|NCT03521804|Active wire|active wire
5076350|NCT03521804|Device|device
5076351|NCT03521804|Procedure|procedure
5076352|NCT03521804|Stenosis|stenosis
5076353|NCT03521804|CAD|cad
5076354|NCT03521804|Coronary Artery Disease|coronary artery disease
5076355|NCT03521791|zebesten|zebesten
5076356|NCT03521791|ocular anti-inflammatory|ocular anti-inflammatory
5076357|NCT03521791|ocular analgesic|ocular analgesic
5076358|NCT03521791|pterygium|pterygium
5076359|NCT03521791|anti-inflammatory non-steroidal ophthalmic|anti-inflammatory non-steroidal ophthalmic
5076360|NCT03521765|quality of life|quality of life
5076361|NCT03521765|occupational therapy|occupational therapy
5076362|NCT03521752|BALANCE|balance
5076363|NCT03521752|INSTITUTIONALIZED ELDERLY PEOPLE|institutionalized elderly people
5076364|NCT03521752|THERAPEUTIC EXERCISE|therapeutic exercise
5076365|NCT03521752|FUNCTIONAL CAPACITY|functional capacity
5076366|NCT03521739|blood pressure|blood pressure
5076367|NCT03521739|pulse wave velocity|pulse wave velocity
5076368|NCT03521739|ankle brachial index|ankle brachial index
5076369|NCT03521739|cardiovascular events|cardiovascular events
5076370|NCT03521726|Rabeprazole|rabeprazole
5076371|NCT03521726|Amoxicillin|amoxicillin
5076372|NCT03521726|Helicobacter Pylori|helicobacter pylori
5076373|NCT03521700|Renal Artery Obstruction|renal artery obstruction
5076374|NCT03521700|Stents|stents
5076375|NCT03521700|Glomerular filtration rate|glomerular filtration rate
5076376|NCT03521687|Central centrifugal cicatricial alopecia|central centrifugal cicatricial alopecia
5076377|NCT03521687|open-label pilot study|open-label pilot study
5076378|NCT03521674|second trimester pregnancy termination|second trimester pregnancy termination
5076379|NCT03521674|double-balloon catheter|double-balloon catheter
5076380|NCT03521674|foley catheter|foley catheter
5076381|NCT03521661|Vertebral fracture|vertebral fracture
5076382|NCT03521661|Kyphotic deformity|kyphotic deformity
5076383|NCT03521661|Kyphoplasty|kyphoplasty
5076384|NCT03521661|Vertebroplasty|vertebroplasty
5076385|NCT03521648|Prostatic Artery Embolization|prostatic artery embolization
5076386|NCT03521648|Transurethral Prostate Resection|transurethral prostate resection
5076387|NCT03521648|Transurethral Electroresection of Prostate|transurethral electroresection of prostate
5076388|NCT03521648|Contact Laser Ablation of Prostate|contact laser ablation of prostate
5076389|NCT03521648|Laser Enucleation of Prostate|laser enucleation of prostate
5076390|NCT03521648|Open prostatectomy|open prostatectomy
5076391|NCT03521622|counseling|counseling
5076392|NCT03521622|behavioral therapy|behavioral therapy
5076393|NCT03521622|tobacco|tobacco
5076394|NCT03521622|alcohol drinking|alcohol drinking
5076395|NCT03521596|IgM monoclonal gammopathy|igm monoclonal gammopathy
5076396|NCT03521596|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
5076397|NCT03521596|Minimal residual disease|minimal residual disease
5076398|NCT03521596|Clonal evolution|clonal evolution
5075408|NCT03527420|Obesity|obesity
5356803|NCT01917942|Mucositis|mucositis
5076399|NCT03521583|von Willebrand disease|von willebrand disease
5076400|NCT03521583|von Willebrand factor|von willebrand factor
5076401|NCT03521583|Nationwide study|nationwide study
5076402|NCT03521583|Prospective study|prospective study
5076404|NCT03521531|Sarcoma|sarcoma
5076405|NCT03521531|Patient Reported Outcomes|patient reported outcomes
5076406|NCT03521505|Sedation|sedation
5076407|NCT03521505|dexmedetomidine|dexmedetomidine
5076408|NCT03521505|brain perfusion|brain perfusion
5076411|NCT03521479|Squaric Acid|squaric acid
5076412|NCT03521479|SADBE|sadbe
5076413|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester
5076414|NCT03521466|Smoking cessation counselling|smoking cessation counselling
5076415|NCT03521466|Medical Student education|medical student education
5076416|NCT03521466|India|india
5076417|NCT03521440|Therapeutic relaxation|therapeutic relaxation
5076418|NCT03521440|Elderly|elderly
5076419|NCT03521440|Community dwelling|community dwelling
5076420|NCT03521427|Intensive Therapy|intensive therapy
5076421|NCT03521427|Cerebral Palsy|cerebral palsy
5076422|NCT03521414|Bispectral index|bispectral index
5076423|NCT03521414|Glasgow Coma Scale|glasgow coma scale
5076427|NCT03521401|Inflammation|inflammation
5076428|NCT03521401|Resilience|resilience
5076429|NCT03521401|Health|health
5076430|NCT03521388|depression|depression
5076431|NCT03521388|adolescence|adolescence
5076432|NCT03521388|prevention|prevention
5076433|NCT03521388|early intervention|early intervention
5076434|NCT03521388|internet-based|internet-based
5076435|NCT03521375|lung|lung
5076436|NCT03521375|cancer|cancer
5076437|NCT03521375|lobectomy|lobectomy
5076438|NCT03521362|mHealth|mhealth
5076439|NCT03521362|Adolescent|adolescent
5076440|NCT03521349|Electroencephalography|electroencephalography
5076441|NCT03521349|Executive Function|executive function
5076442|NCT03521349|Egg|egg
5076443|NCT03521349|Diet|diet
5076444|NCT03521336|Spinal cord injury|spinal cord injury
5076445|NCT03521336|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5076446|NCT03521323|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5076447|NCT03521323|spinal cord injury|spinal cord injury
5076448|NCT03521310|IPISTOSS|ipistoss
5076449|NCT03521310|Skin to skin|skin to skin
5076451|NCT03521310|Neonatal|neonatal
5076452|NCT03521297|Probiotics|probiotics
5076453|NCT03521297|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
5076454|NCT03521284|perinatal period|perinatal period
5076455|NCT03521271|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5076456|NCT03521271|Upper limb|upper limb
5076457|NCT03521271|Hand functions|hand functions
5076458|NCT03521271|Performance|performance
5076459|NCT03521271|Grip Strength|grip strength
5076460|NCT03521245|breast cancer|breast cancer
5076461|NCT03521245|epidermal growth factor receptor|epidermal growth factor receptor
5076462|NCT03521245|HER2|her2
5076463|NCT03521245|EGFR|egfr
5076464|NCT03521245|biomarkers|biomarkers
5076465|NCT03521245|targeted therapy|targeted therapy
5076467|NCT03521245|RNAseq|rnaseq
5076468|NCT03521245|mRNA|mrna
5076469|NCT03521245|transcriptome analysis|transcriptome analysis
5076470|NCT03521245|signaling pathway|signaling pathway
5076471|NCT03521245|intracellular molecular pathway|intracellular molecular pathway
5076472|NCT03521245|Oncobox|oncobox
5076473|NCT03521245|trastuzumab|trastuzumab
5076474|NCT03521206|Advance directives|advance directives
5076475|NCT03521206|Effectiveness|effectiveness
5076476|NCT03521206|Process evaluation|process evaluation
5076477|NCT03521206|Care staff|care staff
5076478|NCT03521193|Migraine;|migraine;
5076479|NCT03521193|PFO|pfo
5076480|NCT03521193|platelet reactivity|platelet reactivity
5076481|NCT03521193|aura|aura
5076486|NCT03521154|Phase III|phase iii
5076487|NCT03521154|Osimertinib|osimertinib
5076488|NCT03521154|Non Small Cell Lung Cancer (Stage III)|non small cell lung cancer (stage iii)
5076489|NCT03521154|Unresectable NSCLC|unresectable nsclc
5076490|NCT03521154|EGFR|egfr
5076491|NCT03521154|chemoradiation therapy|chemoradiation therapy
5076492|NCT03521141|Tobacco Use Cessation|tobacco use cessation
5076493|NCT03521141|Precision Medicine|precision medicine
5076494|NCT03521089|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5076495|NCT03521089|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5076496|NCT03521076|Botulinum Toxin Injections|botulinum toxin injections
5076497|NCT03521076|Virtual Reality|virtual reality
5076498|NCT03521063|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5076499|NCT03521063|respiratory distress syndrome|respiratory distress syndrome
5076500|NCT03521063|budesonide|budesonide
5076501|NCT03521063|poractant alfa|poractant alfa
5076502|NCT03521037|rucaparib|rucaparib
5076503|NCT03521037|CO-338|co-338
5076504|NCT03521037|Clovis|clovis
5076505|NCT03521037|Clovis Oncology|clovis oncology
5076506|NCT03521037|PARP inhibitor|parp inhibitor
5076507|NCT03521037|hepatic impairment|hepatic impairment
5076508|NCT03521024|Zirconia implants|zirconia implants
5076509|NCT03521024|PEKK crowns|pekk crowns
5076510|NCT03521024|high performance polymer crowns|high performance polymer crowns
5076511|NCT03520985|refractory Multiple Myeloma|refractory multiple myeloma
5076512|NCT03520985|Phase II|phase ii
5076513|NCT03520985|Pomalidomide|pomalidomide
5076515|NCT03520959|Synovate Study|synovate study
5076518|NCT03520959|Sarcoma|sarcoma
5076519|NCT03520959|soft tissue sarcoma|soft tissue sarcoma
5076520|NCT03520959|immunotherapy|immunotherapy
5076521|NCT03520946|colorectal cancer|colorectal cancer
5076522|NCT03520946|ramucirumab|ramucirumab
5076523|NCT03520946|tas102|tas102
5076524|NCT03520933|Embryo|embryo
5076525|NCT03520933|Blastocyst|blastocyst
5076526|NCT03520933|Non-invasive|non-invasive
5076527|NCT03520933|PGT-A|pgt-a
5076528|NCT03520933|Chromosome|chromosome
5076539|NCT03520816|Fibronectin|fibronectin
5076540|NCT03520816|Prealbumin|prealbumin
5076541|NCT03520816|Physiotherapy|physiotherapy
5076542|NCT03520816|Major Burns|major burns
5076543|NCT03520816|biochemical parameters|biochemical parameters
5076544|NCT03520803|obesity|obesity
5076545|NCT03520803|bariatric surgery|bariatric surgery
5076546|NCT03520803|enhanced recovery after surgery|enhanced recovery after surgery
5076547|NCT03520803|sleeve gastrectomy|sleeve gastrectomy
5076548|NCT03520803|gastric bypass|gastric bypass
5076549|NCT03520790|Pancreatic Cancer|pancreatic cancer
5076553|NCT03520725|antioxidant capacity|antioxidant capacity
5076554|NCT03520712|Hemophilia A|hemophilia a
5076555|NCT03520712|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5076556|NCT03520712|Blood Coagulation Disorders|blood coagulation disorders
5076557|NCT03520712|Hematologic Diseases|hematologic diseases
5076558|NCT03520712|Coagulation Protein Disorders|coagulation protein disorders
5076559|NCT03520712|Hemorrhagic Disorders|hemorrhagic disorders
5076560|NCT03520712|Genetic Diseases, Inborn|genetic diseases, inborn
5076561|NCT03520712|Factor VIII|factor viii
5076562|NCT03520712|Coagulants|coagulants
5076563|NCT03520712|AAV5 antibodies|aav5 antibodies
5076564|NCT03520699|metabolic surgery|metabolic surgery
5076565|NCT03520699|metabolic disease|metabolic disease
5076566|NCT03520686|Pembrolizumab|pembrolizumab
5076568|NCT03520686|Non-Small Cell Lung Cancer|non-small cell lung cancer
5076569|NCT03520686|Immunotherapy|immunotherapy
5076570|NCT03520673|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5076571|NCT03520673|Primary Care|primary care
5076572|NCT03520673|Urology|urology
5076573|NCT03520660|Natural History|natural history
5076574|NCT03520660|Hepatitis C Virus|hepatitis c virus
5076575|NCT03520660|Hepatocellular Carcinoma|hepatocellular carcinoma
5076576|NCT03520660|Fibrosis|fibrosis
5076577|NCT03520660|Immune Response|immune response
5076578|NCT03520647|Haploidentical CD34+cells|haploidentical cd34+cells
5076579|NCT03520647|Non-Myeloablative|non-myeloablative
5076580|NCT03520634|Melanoma|melanoma
5076581|NCT03520634|PD-L1|pd-l1
5076582|NCT03520634|Brain metastases|brain metastases
5076583|NCT03520634|PET imaging|pet imaging
5076584|NCT03520621|sulfur amino acid|sulfur amino acid
5076594|NCT03520543|PET imaging|pet imaging
5076595|NCT03520543|Noradrenaline|noradrenaline
5076596|NCT03520543|Radiotracer|radiotracer
5076597|NCT03520530|second stage|second stage
5076598|NCT03520530|spontaneous vaginal delivery|spontaneous vaginal delivery
5076599|NCT03520517|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5076601|NCT03520517|Biohaven|biohaven
5076602|NCT03520517|Motor Neuron Disease, Amyotrophic Lateral Sclerosis|motor neuron disease, amyotrophic lateral sclerosis
5076603|NCT03520517|Lou Gehrig's Disease|lou gehrig's disease
5076614|NCT03520504|18-205|18-205
5076615|NCT03520491|Immunotherapy|immunotherapy
5076616|NCT03520491|Nivolumab|nivolumab
5076617|NCT03520491|Ipilimumab|ipilimumab
5076618|NCT03520491|18-042|18-042
5076619|NCT03520478|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
5076620|NCT03520478|SHR3680|shr3680
5076621|NCT03520478|Anti-androgen receptor|anti-androgen receptor
5076622|NCT03520439|Adenomyosis|adenomyosis
5076623|NCT03520439|mifepristone|mifepristone
5076624|NCT03520439|the selective progesterone receptor modulators|the selective progesterone receptor modulators
5076625|NCT03520439|treatment|treatment
5076626|NCT03520413|Complex Care|complex care
5076627|NCT03520413|Outcomes|outcomes
5076628|NCT03520413|Telemedicine|telemedicine
5077416|NCT03515538|mouth|mouth
5076631|NCT03520400|Cardiovascular Disease|cardiovascular disease
5076632|NCT03520400|Percutaneous Intervention|percutaneous intervention
5076633|NCT03520400|coronary artery disease|coronary artery disease
5076634|NCT03520400|exercise therapy|exercise therapy
5076635|NCT03520387|Randomized controlled trial|randomized controlled trial
5076636|NCT03520387|Chronic pain|chronic pain
5076637|NCT03520374|ultrasound|ultrasound
5076638|NCT03520374|gastric contents|gastric contents
5076639|NCT03520361|Colonoscopy|colonoscopy
5076640|NCT03520361|Bowel preparation|bowel preparation
5076641|NCT03520361|Oral sulfate solution|oral sulfate solution
5076642|NCT03520361|Polyethylene glycol|polyethylene glycol
5076643|NCT03520361|Ascorbic acid|ascorbic acid
5076644|NCT03520348|dry eye|dry eye
5076645|NCT03520348|eye lubricants|eye lubricants
5076646|NCT03520348|eye lubricant gel|eye lubricant gel
5076647|NCT03520348|PRO-167|pro-167
5076648|NCT03520335|stroke|stroke
5076649|NCT03520335|conjugated eye deviation|conjugated eye deviation
5076654|NCT03520309|Visual inspection|visual inspection
5076655|NCT03520309|Quality of Life|quality of life
5076656|NCT03520309|Restorations|restorations
5076657|NCT03520244|Microbiome|microbiome
5076658|NCT03520244|High intensity interval training|high intensity interval training
5076659|NCT03520244|Exercise|exercise
5076660|NCT03520244|Holistic education|holistic education
5076661|NCT03520244|Quality of life|quality of life
5076663|NCT03520205|stress response|stress response
5076664|NCT03520205|kidney donor|kidney donor
5076665|NCT03520205|Cellular Imunological Function|cellular imunological function
5076666|NCT03520205|quadratus lumborum block|quadratus lumborum block
5076667|NCT03520205|numerical rating scale|numerical rating scale
5076668|NCT03520205|morphine patient controlled analgesia|morphine patient controlled analgesia
5076669|NCT03520192|Paediatric|paediatric
5076670|NCT03520192|Critical care|critical care
5076671|NCT03520192|Transport|transport
5076672|NCT03520166|urgency|urgency
5076673|NCT03520166|frequency|frequency
5076674|NCT03520166|overactive bladder|overactive bladder
5076675|NCT03520166|LUTS|luts
5076676|NCT03520166|pelvic pain|pelvic pain
5076677|NCT03520166|electrostimulation|electrostimulation
5076678|NCT03520140|Familial hypercholesterolemia|familial hypercholesterolemia
5076679|NCT03520140|Coronary artery disease|coronary artery disease
5076680|NCT03520114|Retropubic sling|retropubic sling
5076681|NCT03520114|Single-incision sling|single-incision sling
5076682|NCT03520114|Vaginal repair|vaginal repair
5076683|NCT03520114|Management|management
5076684|NCT03520088|Rectal cancer|rectal cancer
5076685|NCT03520088|Sexual dysfunction|sexual dysfunction
5076686|NCT03520088|Urinary dysfunction|urinary dysfunction
5076687|NCT03520088|Rectal nerves damage|rectal nerves damage
5076688|NCT03520088|Total Mesorectal Excision|total mesorectal excision
5076689|NCT03520075|Neoplasms|neoplasms
5076690|NCT03520075|Solid Tumors|solid tumors
5076691|NCT03520075|Antineoplastic Agents|antineoplastic agents
5076692|NCT03520075|MAPK|mapk
5076693|NCT03520075|ERK|erk
5076694|NCT03520062|Amylase|amylase
5076696|NCT03520062|GLP-1|glp-1
5076697|NCT03520049|Thrombocytopenia|thrombocytopenia
5076698|NCT03520049|ITP|itp
5076699|NCT03520049|Platelets|platelets
5076700|NCT03520049|Bleeding|bleeding
5076701|NCT03520049|Immune|immune
5076702|NCT03520049|Oseltamivir|oseltamivir
5076703|NCT03520049|Glycoprotein|glycoprotein
5076704|NCT03520049|Sialylation|sialylation
5076705|NCT03520049|Antibody|antibody
5076706|NCT03520049|Autoantibody|autoantibody
5076707|NCT03519971|Locally Advanced, Unresectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-Small-Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer, nsclc, carcinoma, non-small-cell lung cancer
5076709|NCT03519906|Bariatric surgery|bariatric surgery
5076710|NCT03519906|Gastrointestinal tract|gastrointestinal tract
5961326|NCT04287816|Vitamin K|vitamin k
5076711|NCT03519906|Biological availability|biological availability
5076712|NCT03519906|Pharmacokinetics|pharmacokinetics
5076713|NCT03519906|Metoprolol|metoprolol
5076714|NCT03519893|Bariatric surgery|bariatric surgery
5076715|NCT03519893|Gastrointestinal tract|gastrointestinal tract
5076716|NCT03519893|Biological availability|biological availability
5076717|NCT03519893|Pharmacokinetics|pharmacokinetics
5076718|NCT03519893|Losartan|losartan
5076719|NCT03519880|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3D-printing|amyotrophic lateral sclerosis, non-invasive ventilation, mask, custom, 3d-printing
5076720|NCT03519841|Non-invasive glucose monitoring|non-invasive glucose monitoring
5076721|NCT03519841|Raman spectroscopy|raman spectroscopy
5076722|NCT03519815|dry eye|dry eye
5076723|NCT03519815|eye spray|eye spray
5076724|NCT03519802|Cognitive functions|cognitive functions
5076725|NCT03519802|MoCA test|moca test
5076726|NCT03519789|Change blindness|change blindness
5076727|NCT03519789|Eye tracking|eye tracking
5076728|NCT03519789|Implicit response|implicit response
5076729|NCT03519750|Melatonin|melatonin
5076730|NCT03519750|Safety|safety
5076731|NCT03519750|Pharmacokinetics|pharmacokinetics
5076732|NCT03519737|Stroke|stroke
5076733|NCT03519737|Acute Stroke|acute stroke
5076734|NCT03519685|Contraception|contraception
5076735|NCT03519685|Hormonal contraception|hormonal contraception
5076736|NCT03519685|Long-acting reversible contraception|long-acting reversible contraception
5076737|NCT03519685|Condoms|condoms
5076738|NCT03519685|Emergency contraception|emergency contraception
5076739|NCT03519685|Family planning services|family planning services
5076740|NCT03519646|Enzyme Replacement Therapy|enzyme replacement therapy
5076741|NCT03519646|Eliglustat (Cerdelga®)|eliglustat (cerdelga®)
5076742|NCT03519607|Infertility|infertility
5076743|NCT03519607|Distress|distress
5075741|NCT03525782|MUC+|muc+
5076754|NCT03519516|ophthalmic antibiotic|ophthalmic antibiotic
5076755|NCT03519516|antibiotic in drops|antibiotic in drops
5076756|NCT03519503|HIV|hiv
5076757|NCT03519503|Neuropsychological tests|neuropsychological tests
5076758|NCT03519503|PMTCT|pmtct
5076759|NCT03519503|PreP|prep
5076760|NCT03519490|Myopia|myopia
5076761|NCT03519490|Myopia Control|myopia control
5076762|NCT03519490|Bifocal Contact Lenses|bifocal contact lenses
5076763|NCT03519490|Multifocal Contact Lenses|multifocal contact lenses
5076764|NCT03519490|Hybrid Contact Lenses|hybrid contact lenses
5076765|NCT03519490|Randomized Controlled Clinical Trial|randomized controlled clinical trial
5076766|NCT03519490|Distance Center Multifocal Contact Lens|distance center multifocal contact lens
5076767|NCT03519490|Near Center Multifocal Contact Lens|near center multifocal contact lens
5076768|NCT03519477|clinical decision support|clinical decision support
5076769|NCT03519477|drug levels in blood|drug levels in blood
5076770|NCT03519477|therapeutic drug monitoring|therapeutic drug monitoring
5076771|NCT03519477|medication adherence|medication adherence
5076772|NCT03519477|medication therapy management|medication therapy management
5076773|NCT03519464|Gardasil 9|gardasil 9
5076774|NCT03519464|Seroconversion|seroconversion
5076775|NCT03519464|Humoral immune response|humoral immune response
5076776|NCT03519464|Cellular Immune Response|cellular immune response
5076777|NCT03519464|Mucosal Lesions|mucosal lesions
5076778|NCT03519425|Tuberculosis|tuberculosis
5076779|NCT03519425|HIV|hiv
5076780|NCT03519425|Randomised controlled trial|randomised controlled trial
5076781|NCT03519425|Africa|africa
5076782|NCT03519425|Public Health|public health
5076783|NCT03519425|Screening|screening
5076784|NCT03519412|DNA Mismatch Repair|dna mismatch repair
5076785|NCT03519412|Pembrolizumab|pembrolizumab
5076786|NCT03519399|Bile Acids, Fetal ECG, Stillbirth,|bile acids, fetal ecg, stillbirth,
5076787|NCT03519360|arrythmia|arrythmia
5076788|NCT03519360|hemodialysis|hemodialysis
5076789|NCT03519347|arrythmia|arrythmia
5076790|NCT03519347|hemodialysis|hemodialysis
5076791|NCT03519334|Employment|employment
5076792|NCT03519334|Return to work|return to work
5076793|NCT03519334|Career Mobility|career mobility
5076794|NCT03519334|Employment supported|employment supported
5076796|NCT03519334|Chronic disease|chronic disease
5076797|NCT03519321|Early Onset Scoliosis (EOS)|early onset scoliosis (eos)
5076798|NCT03519295|Epidermoid Cancers of the Anal Canal|epidermoid cancers of the anal canal
5076799|NCT03519269|total knee replacement|total knee replacement
5076800|NCT03519269|robotic surgery|robotic surgery
5076801|NCT03519191|teen dating violence|teen dating violence
5076802|NCT03519191|sexual assault|sexual assault
5076803|NCT03519191|reproductive coercion|reproductive coercion
5076804|NCT03519178|Hormone Receptor (HR) Positive Breast Cancer|hormone receptor (hr) positive breast cancer
5076805|NCT03519178|Estrogen receptor (ER) positive|estrogen receptor (er) positive
5076806|NCT03519178|Progesterone receptor (PR) positive|progesterone receptor (pr) positive
5076807|NCT03519178|Cyclin-dependent kinase (CDK)|cyclin-dependent kinase (cdk)
5076808|NCT03519178|Human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
5076809|NCT03519178|Advanced breast cancer|advanced breast cancer
5076810|NCT03519178|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
5961327|NCT04287816|Egg|egg
5961328|NCT04287816|Spinach|spinach
5076811|NCT03519178|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5076812|NCT03519178|Epithelial ovarian cancer (EOC)|epithelial ovarian cancer (eoc)
5076813|NCT03519178|Fallopian tube cancer|fallopian tube cancer
5076814|NCT03519178|Primary peritoneal cancer (PPC)|primary peritoneal cancer (ppc)
5076815|NCT03519178|CDK4/6 inhibitor|cdk4/6 inhibitor
5076816|NCT03519178|Endocrine Therapy (ET)|endocrine therapy (et)
5076817|NCT03519178|Measurable disease|measurable disease
5076818|NCT03519178|Luteinizing Hormone Releasing Hormone (LHRH) Agonist|luteinizing hormone releasing hormone (lhrh) agonist
5076819|NCT03519178|Goserelin|goserelin
5076820|NCT03519178|Leuprolide acetate|leuprolide acetate
5076821|NCT03519165|Ovarian cancer|ovarian cancer
5076822|NCT03519165|goal-directed fluid therapy|goal-directed fluid therapy
5076823|NCT03519165|SVV|svv
5076824|NCT03519139|Geriatric patients, nutritional counselling, homevisit|geriatric patients, nutritional counselling, homevisit
5076825|NCT03519126|Urinary Bladder, Overactive; Electric Stimulation|urinary bladder, overactive; electric stimulation
5076826|NCT03519113|HBV-related liver transplantation|hbv-related liver transplantation
5076827|NCT03519113|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
5076829|NCT03519035|hallucinations|hallucinations
5076830|NCT03519035|dissociation|dissociation
5076831|NCT03519035|post-traumatic stress disorder|post-traumatic stress disorder
5076832|NCT03519009|Employment|employment
5076833|NCT03518970|uncertainty|uncertainty
5076834|NCT03518970|caregivers|caregivers
5076835|NCT03518970|palliative care|palliative care
5076836|NCT03518970|nursing|nursing
5076837|NCT03518970|Hospice and Palliative Care Nursing|hospice and palliative care nursing
5076838|NCT03518918|Premature ovarian insufficiency|premature ovarian insufficiency
5076839|NCT03518918|Diagnosis standard|diagnosis standard
5076840|NCT03518918|Risk factors|risk factors
5076841|NCT03518892|Resting Metabolic Rate|resting metabolic rate
5076842|NCT03518879|informatics|informatics
5076843|NCT03518879|asthma|asthma
5076844|NCT03518827|asymmetry|asymmetry
5076845|NCT03518827|pain|pain
5076846|NCT03518827|sport|sport
5076847|NCT03518827|injury|injury
5076848|NCT03518827|risk factor|risk factor
5076849|NCT03518814|Melanoma stage IV|melanoma stage iv
5076850|NCT03518814|Remission|remission
5076851|NCT03518814|Quality of life|quality of life
5076852|NCT03518801|cannabidiol|cannabidiol
5076853|NCT03518801|CBD|cbd
5076854|NCT03518801|PTSD|ptsd
5076855|NCT03518801|Veterans|veterans
5076856|NCT03518749|Depression|depression
5076857|NCT03518749|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5076858|NCT03518723|Muscle dysfunction|muscle dysfunction
5076859|NCT03518710|child|child
5076860|NCT03518710|reading|reading
5076861|NCT03518710|vision|vision
5134354|NCT03153813|pain|pain
4960273|NCT04237246|liver|liver
5076862|NCT03518710|attention|attention
5076863|NCT03518710|therapeutical perspectives|therapeutical perspectives
5076864|NCT03518697|Exercise|exercise
5076865|NCT03518697|Physical fitness|physical fitness
5076866|NCT03518697|Physical activity|physical activity
5076867|NCT03518697|Accelerometer|accelerometer
5076868|NCT03518697|Sleep|sleep
5076869|NCT03518671|head and neck cancer|head and neck cancer
5076870|NCT03518671|body image disturbance|body image disturbance
5076871|NCT03518671|cognitive behavioral therapy|cognitive behavioral therapy
5076872|NCT03518671|survivorship|survivorship
5076873|NCT03518658|remote monitoring|remote monitoring
5076874|NCT03518658|transmission compliance|transmission compliance
5076875|NCT03518658|patient engagement|patient engagement
5076876|NCT03518645|Coronary Artery Disease|coronary artery disease
5076877|NCT03518645|OPN NC|opn nc
5076878|NCT03518645|Angina|angina
5076879|NCT03518645|Stable|stable
5076880|NCT03518645|Unstable|unstable
5076881|NCT03518632|Exercise|exercise
5076882|NCT03518632|Adapted physical activity|adapted physical activity
5076883|NCT03518632|preoperative|preoperative
5076884|NCT03518632|liver resection|liver resection
5076885|NCT03518632|hepatectomy|hepatectomy
5088864|NCT03442790|CXR|cxr
5076890|NCT03518606|High mutational load malignancies|high mutational load malignancies
5076891|NCT03518606|Immunotherapy|immunotherapy
5076892|NCT03518606|Early phase|early phase
5076893|NCT03518606|Combination study|combination study
5076894|NCT03518580|mobile technology|mobile technology
5076895|NCT03518580|real-time assessment|real-time assessment
5076896|NCT03518580|active life engagement|active life engagement
5076897|NCT03518554|JAB-3068|jab-3068
5076898|NCT03518554|SHP2|shp2
5076899|NCT03518554|advanced solid tumor|advanced solid tumor
5076900|NCT03518554|NSCLC|nsclc
5076901|NCT03518554|ESCC|escc
5076902|NCT03518554|HNSCC|hnscc
5076903|NCT03518554|PTPN11|ptpn11
5076904|NCT03518554|EGFR|egfr
5076905|NCT03518554|Colorectal cancer|colorectal cancer
5076906|NCT03518515|nutrition intervention|nutrition intervention
5076907|NCT03518515|potato consumption|potato consumption
5076908|NCT03518515|energy balance|energy balance
5076909|NCT03518437|coronary artery disease|coronary artery disease
5076910|NCT03518437|CT|ct
5076911|NCT03518437|MACE|mace
5076912|NCT03518424|Association football|association football
5076913|NCT03518424|Soccer|soccer
5076914|NCT03518424|Injury|injury
5076915|NCT03518424|Epidemiology|epidemiology
5076916|NCT03518398|Intense pulsed light|intense pulsed light
5076917|NCT03518398|Meibomian gland dysfunction|meibomian gland dysfunction
5076918|NCT03518398|Dry eye|dry eye
5076919|NCT03518398|cytokines|cytokines
5076920|NCT03518372|Hypoxia|hypoxia
5076921|NCT03518372|Myocardial Injury|myocardial injury
5076922|NCT03518372|Surgery--Complications|surgery--complications
5076923|NCT03518372|Tissue Oximetry|tissue oximetry
5077517|NCT03515096|rhTPO|rhtpo
5076941|NCT03518255|Oncological Nursing|oncological nursing
5076942|NCT03518255|Photography|photography
5076943|NCT03518229|cancer prevention|cancer prevention
5076945|NCT03518216|cognitive behavioral therapy|cognitive behavioral therapy
5076946|NCT03518216|mindfulness meditation|mindfulness meditation
5076947|NCT03518216|fMRI|fmri
5076948|NCT03518216|neuroimaging|neuroimaging
5076949|NCT03518203|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5076954|NCT03518125|Bacillaceae Infections|bacillaceae infections
5076955|NCT03518125|Gram-Positive Bacterial Infections|gram-positive bacterial infections
5076956|NCT03518125|Bacterial Infections|bacterial infections
5076957|NCT03518125|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
5076959|NCT03518125|AV7909|av7909
5076960|NCT03518125|CPG 7909|cpg 7909
5076961|NCT03518125|Adjuvant|adjuvant
5076962|NCT03518125|Vaccines|vaccines
5076963|NCT03518125|Post-exposure Prophylaxis|post-exposure prophylaxis
5076979|NCT03518034|hypogonadism|hypogonadism
5076980|NCT03518034|cardiovascular (CV) disease|cardiovascular (cv) disease
5076981|NCT03518034|AndroGel|androgel
5076982|NCT03518034|testosterone replacement therapy (TRT)|testosterone replacement therapy (trt)
5076983|NCT03518021|Naloxone|naloxone
5076984|NCT03518021|Administration, Intranasal|administration, intranasal
5076985|NCT03518021|Injections, Intramuscular|injections, intramuscular
5076986|NCT03518021|Narcotic Antagonists|narcotic antagonists
5076987|NCT03518008|soft contact lenses|soft contact lenses
5076988|NCT03518008|vision|vision
5076989|NCT03518008|eyesight|eyesight
5076990|NCT03517995|primary bladder tumor|primary bladder tumor
5076991|NCT03517995|non-muscle invasive bladder tumor|non-muscle invasive bladder tumor
5738865|NCT00361803|cancer|cancer
4960370|NCT04236700|Buccal cancer|buccal cancer
5076992|NCT03517995|muscle invasive bladder tumor|muscle invasive bladder tumor
5076993|NCT03517995|sulforaphane|sulforaphane
5076994|NCT03517995|chemoprevention|chemoprevention
5076995|NCT03517982|MyOra|myora
5076996|NCT03517982|Mycophenolate Mofetil|mycophenolate mofetil
5076997|NCT03517982|End stage renal disease|end stage renal disease
5076998|NCT03517982|De novo Renal transplant|de novo renal transplant
5076999|NCT03517982|Post authorization safety study|post authorization safety study
5077000|NCT03517982|Immunosuppressant|immunosuppressant
5077001|NCT03517982|Cohort study|cohort study
5077002|NCT03517956|Phase I|phase i
5077003|NCT03517956|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
5077004|NCT03517956|Urothelial cancer|urothelial cancer
5077005|NCT03517956|FGFR inhibitor|fgfr inhibitor
5077006|NCT03517943|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
5077007|NCT03517930|Upper respiratory allergy symptoms including congestion|upper respiratory allergy symptoms including congestion
5077008|NCT03517904|Femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy|femoropopliteal artery disease, drug-coated balloon, angioplasty, antiplatelet therapy
5077063|NCT03517527|Metabolic Control|metabolic control
5077064|NCT03517527|Walking Exercise|walking exercise
5077065|NCT03517527|Transtheoretical Model|transtheoretical model
5077066|NCT03517527|Nurse|nurse
5077067|NCT03517514|Heart Failure|heart failure
5077068|NCT03517514|Physical Therapy|physical therapy
5077069|NCT03517514|Hospital Readmission|hospital readmission
5077098|NCT03517462|mass drug administration|mass drug administration
5077099|NCT03517462|ophthalmology|ophthalmology
5077100|NCT03517449|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5077101|NCT03517449|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5077102|NCT03517449|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5077103|NCT03517449|vascular endothelial growth factor (VEGF) receptors|vascular endothelial growth factor (vegf) receptors
5077104|NCT03517449|lenvatinib|lenvatinib
5077105|NCT03517449|pembrolizumab|pembrolizumab
5077106|NCT03517449|doxorubicin|doxorubicin
5077107|NCT03517449|paclitaxel|paclitaxel
5077108|NCT03517449|phase 3 endometrial cancer|phase 3 endometrial cancer
5077109|NCT03517436|THV|thv
5077110|NCT03517436|Transcatheter Heart Valve|transcatheter heart valve
5077111|NCT03517436|CENTERA|centera
5077112|NCT03517436|self-expanding|self-expanding
5077113|NCT03517423|brivaracetam|brivaracetam
5077114|NCT03517423|post-marketing observational study|post-marketing observational study
5077121|NCT03517397|Socioeconomic Disadvantage|socioeconomic disadvantage
5077122|NCT03517397|Contingency Management|contingency management
5077123|NCT03517397|Financial Incentives|financial incentives
5077124|NCT03517397|Mobile Health|mobile health
5077125|NCT03517397|Biochemical Verification|biochemical verification
5961329|NCT04287803|prehospital|prehospital
5961330|NCT04287803|paramedic|paramedic
5077126|NCT03517371|Parkinson disease|parkinson disease
5077127|NCT03517371|Walking|walking
5077128|NCT03517371|Exercise|exercise
5077129|NCT03517371|Mobile Health|mobile health
5077130|NCT03517371|Physical Therapy|physical therapy
5077131|NCT03517371|Cognitive Behavioral|cognitive behavioral
5077132|NCT03517345|Bariatric surgery|bariatric surgery
5077133|NCT03517345|Prebiotics|prebiotics
5077134|NCT03517345|gut microbiota|gut microbiota
5077135|NCT03517345|GLP-1|glp-1
5077136|NCT03517345|PYY|pyy
5076049|NCT03523624|cardiac magnetic resonance|cardiac magnetic resonance
5077139|NCT03517280|Childhood Cancer|childhood cancer
5077140|NCT03517280|Nutrition Aspect of Cancer|nutrition aspect of cancer
5077141|NCT03517280|Child Malnutrition|child malnutrition
5077142|NCT03517280|Brazil|brazil
5077143|NCT03517280|Sao Paolo|sao paolo
5077144|NCT03517254|Glutamine,|glutamine,
5077145|NCT03517228|Robotic Uterine Manipulator|robotic uterine manipulator
5077147|NCT03517202|Urologic surgery|urologic surgery
5077148|NCT03517202|Urinary incontinence|urinary incontinence
5077149|NCT03517202|Tension Free Vaginal Tape|tension free vaginal tape
5077150|NCT03517202|Post-operative urinary retention|post-operative urinary retention
5077151|NCT03517202|Outpatient surgery|outpatient surgery
5077152|NCT03517163|Asperger's|asperger's
5077153|NCT03517163|autism|autism
5077154|NCT03517163|autism spectrum disorder|autism spectrum disorder
5077155|NCT03517163|ASD|asd
5077156|NCT03517137|advanced Hodgkin lymphoma|advanced hodgkin lymphoma
5077157|NCT03517137|brentuximab vedotin|brentuximab vedotin
5077158|NCT03517137|phase 2|phase 2
5077159|NCT03517124|Zirconium oxide|zirconium oxide
5077160|NCT03517124|surface treatment|surface treatment
5077161|NCT03517124|resin cement|resin cement
5077162|NCT03517098|Enhanced recovery after surgery|enhanced recovery after surgery
5077163|NCT03517098|General anesthesia|general anesthesia
5077164|NCT03517098|Total hip arthroplasty|total hip arthroplasty
5077165|NCT03517098|Total knee arthroplasty|total knee arthroplasty
5077166|NCT03517085|glycogen storage disorder Ia|glycogen storage disorder ia
5077167|NCT03517085|AAV|aav
4960481|NCT04236011|CD19|cd19
5077175|NCT03517046|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5077176|NCT03517046|Degenerative Arthritis|degenerative arthritis
5077177|NCT03517046|Cartilage Lesion|cartilage lesion
5077178|NCT03517046|Cartilage Defect|cartilage defect
5077179|NCT03517007|antibiotic de-escalation|antibiotic de-escalation
5077180|NCT03517007|sepsis|sepsis
5077181|NCT03517007|antimicrobial stewardship|antimicrobial stewardship
5077182|NCT03516994|Advance Care Planning|advance care planning
5077183|NCT03516994|Disparities|disparities
5077184|NCT03516994|Palliative Care|palliative care
5077185|NCT03516994|End of Life Care|end of life care
5077186|NCT03516994|African Americans|african americans
5077189|NCT03516968|Obesity|obesity
5077190|NCT03516968|Vitamin D deficiency,|vitamin d deficiency,
5077191|NCT03516968|supplementation,|supplementation,
5077192|NCT03516968|Child|child
5077193|NCT03516968|Adolescent|adolescent
5077194|NCT03516955|Superstat|superstat
5077195|NCT03516955|Rosuvastatin|rosuvastatin
5077196|NCT03516955|Statins|statins
5077197|NCT03516955|LDL-C|ldl-c
5077198|NCT03516955|Cholesterol|cholesterol
5077199|NCT03516955|Hypercholesterolemia|hypercholesterolemia
5077200|NCT03516955|Dyslipidemia|dyslipidemia
5077201|NCT03516955|Coronary Artery Disease|coronary artery disease
5077202|NCT03516955|Cardiovascular Disease|cardiovascular disease
5077203|NCT03516916|Rectal cancer, HRQoL, Stoma, Colostomy, Patient reported outcome measure (PROM)|rectal cancer, hrqol, stoma, colostomy, patient reported outcome measure (prom)
5077207|NCT03516890|Partial hepatectomy|partial hepatectomy
5077208|NCT03516890|Emergency|emergency
5077209|NCT03516890|Staged|staged
5077210|NCT03516890|Peritoneal dissemination|peritoneal dissemination
5077211|NCT03516890|Propensity score matching|propensity score matching
5077212|NCT03516877|Mindfulness-Bases Stress Reduction, Stress, Resilience, Well-being|mindfulness-bases stress reduction, stress, resilience, well-being
5077213|NCT03516864|tissue oxygenation|tissue oxygenation
5077214|NCT03516864|near-infrared|near-infrared
5077215|NCT03516864|diabetic foot ulcer (DFU)|diabetic foot ulcer (dfu)
5077216|NCT03516864|diabetes|diabetes
5077217|NCT03516864|vascularity|vascularity
5077218|NCT03516851|Moyamoya Disease|moyamoya disease
5077219|NCT03516851|multimodal neuronavigation|multimodal neuronavigation
5077220|NCT03516851|flow800|flow800
5077221|NCT03516851|direct revascularization|direct revascularization
5077222|NCT03516838|Dental caries|dental caries
5077223|NCT03516838|Class II|class ii
5077224|NCT03516838|Primary molar|primary molar
5077225|NCT03516838|Restorative material|restorative material
5077226|NCT03516838|Bioactive material|bioactive material
5077227|NCT03516838|Compomer|compomer
5077228|NCT03516838|Activa bioactive|activa bioactive
5077229|NCT03516838|Ryge criteria|ryge criteria
5077230|NCT03516825|Musical Neglect Training|musical neglect training
5077231|NCT03516825|Neurologic Music Therapy|neurologic music therapy
5077232|NCT03516825|unilateral visual neglect|unilateral visual neglect
5077233|NCT03516825|hemispatial neglect|hemispatial neglect
5077234|NCT03516825|stroke|stroke
5077235|NCT03516825|spatial perception and attention|spatial perception and attention
5077236|NCT03516825|music therapy|music therapy
5077237|NCT03516799|pain management of adolescent and young adults with cancer|pain management of adolescent and young adults with cancer
5077238|NCT03516773|Hypoparathyroidism, PTH(1-34), Parathyroid Hormone|hypoparathyroidism, pth(1-34), parathyroid hormone
5077239|NCT03516747|cytology|cytology
5077240|NCT03516747|parathyroidectomy|parathyroidectomy
5077245|NCT03516695|Liver Cancers|liver cancers
5077246|NCT03516695|HCC|hcc
5077247|NCT03516695|Dosimetry|dosimetry
5077248|NCT03516695|Simplicit90Y™|simplicit90y™
5077249|NCT03516695|TheraSphere®|therasphere®
5068839|NCT03569020|Diet|diet
5077250|NCT03516682|Logistic Barriers to Vaccination|logistic barriers to vaccination
5077251|NCT03516669|Lansoprazole, Amoxicillin, clarithromycin|lansoprazole, amoxicillin, clarithromycin
5077252|NCT03516630|Trazodone|trazodone
5077253|NCT03516630|QTc interval|qtc interval
5077254|NCT03516630|Moxifloxacin|moxifloxacin
5077255|NCT03516578|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5077256|NCT03516578|cardiac magnetic resonance|cardiac magnetic resonance
5077257|NCT03516578|prognosis|prognosis
5077258|NCT03516565|gingivitis|gingivitis
5077259|NCT03516565|saliva|saliva
5089152|NCT03440814|PWS|pws
5077271|NCT03516461|Fecal Microbiota Transplantation|fecal microbiota transplantation
5077272|NCT03516435|Intravaginal electrical stimulation|intravaginal electrical stimulation
5077273|NCT03516435|Parasacral transcutaneous electrical stimulation|parasacral transcutaneous electrical stimulation
5077274|NCT03516422|ultrasound debridement|ultrasound debridement
5077275|NCT03516422|diabetic foot ulcer|diabetic foot ulcer
5077276|NCT03516422|chronic wound|chronic wound
5077277|NCT03516422|biofilm|biofilm
5077278|NCT03516409|probiotics|probiotics
5077279|NCT03516409|prebiotics|prebiotics
5077280|NCT03516409|diarrhoea|diarrhoea
5077281|NCT03516396|Nepal|nepal
5077282|NCT03516396|child growth|child growth
5077283|NCT03516396|nutrition education|nutrition education
5077284|NCT03516396|community development|community development
5077285|NCT03516370|chronic periodontitis|chronic periodontitis
5077286|NCT03516370|Sacchraomyces boulardii|sacchraomyces boulardii
5077287|NCT03516370|probiotics|probiotics
5077288|NCT03516344|Breathing Exercises|breathing exercises
5077289|NCT03516344|Manipulation, Osteopathic|manipulation, osteopathic
5077290|NCT03516344|Quantitative Ultrasonography|quantitative ultrasonography
5077291|NCT03516344|Therapy, Soft Tissue|therapy, soft tissue
5077292|NCT03516344|Portal Vein|portal vein
5077293|NCT03516344|Venous flow|venous flow
5077294|NCT03516331|Cystic Fibrosis|cystic fibrosis
5077295|NCT03516318|HIV|hiv
5077296|NCT03516318|Youth|youth
5077297|NCT03516318|Social support|social support
5077298|NCT03516318|Social media|social media
5077299|NCT03516318|Retention|retention
5077300|NCT03516292|overactive bladder|overactive bladder
5077301|NCT03516292|biomarker|biomarker
5077302|NCT03516292|nerve growth factor|nerve growth factor
5077303|NCT03516292|vaginal prolapse|vaginal prolapse
5077304|NCT03516292|urinary incontinence|urinary incontinence
5077305|NCT03516266|Pelvic floor muscle strength|pelvic floor muscle strength
5077306|NCT03516266|Premenopausal nullipara|premenopausal nullipara
5077307|NCT03516266|Childbirth|childbirth
5077310|NCT03516214|EGFR p.T790M-positive|egfr p.t790m-positive
5077311|NCT03516214|osimertinib resistance|osimertinib resistance
5077312|NCT03516214|EGFR p.T790M-negative|egfr p.t790m-negative
5077313|NCT03516201|bariatric surgery|bariatric surgery
5077315|NCT03516201|Caries|caries
5077316|NCT03516201|erosive tooth wear|erosive tooth wear
5077317|NCT03516201|Gingivitis|gingivitis
5077318|NCT03516201|BMI|bmi
5077319|NCT03516201|oral health|oral health
5077320|NCT03516201|obesity|obesity
5077321|NCT03516188|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5077322|NCT03516188|Acid pocket|acid pocket
5077323|NCT03516188|Acid Reflux|acid reflux
5077324|NCT03516188|Alginate antacid|alginate antacid
5077325|NCT03516188|Obesity|obesity
5077326|NCT03516162|Behaviour|behaviour
5077327|NCT03516162|Brain Tumor|brain tumor
5077328|NCT03516162|Hydrocephalus|hydrocephalus
5077329|NCT03516162|Smartphone|smartphone
5077330|NCT03516162|Big Data|big data
5077331|NCT03516162|Neuropsychology|neuropsychology
5077332|NCT03516162|Neuroradiology|neuroradiology
5077333|NCT03516162|Neurosurgery|neurosurgery
5077334|NCT03516162|Outcome Assessment|outcome assessment
5077335|NCT03516162|Functional Impairment|functional impairment
5077336|NCT03516162|Cognitive Function|cognitive function
5077337|NCT03516162|Touchscreen|touchscreen
5077338|NCT03516162|Arteriovenous malformation|arteriovenous malformation
5077339|NCT03516162|AVM|avm
5077340|NCT03516149|elbow|elbow
5077341|NCT03516149|foam rolling|foam rolling
5077342|NCT03516149|proprioception|proprioception
5077343|NCT03516149|sensorimotor|sensorimotor
5077344|NCT03516149|acute|acute
5077345|NCT03516071|Hepatocellular Carcinoma|hepatocellular carcinoma
5077346|NCT03516071|HCC|hcc
5077347|NCT03516071|Brivanib|brivanib
5077348|NCT03516045|18F-AlF-NOTA-neurotensin|18f-alf-nota-neurotensin
5077349|NCT03516032|exercises therapy|exercises therapy
5961331|NCT04287803|ambulance|ambulance
5961332|NCT04287803|methoxyflurane|methoxyflurane
5076272|NCT03522272|Candida|candida
5077352|NCT03516032|inpatients|inpatients
5077353|NCT03516019|mHealth|mhealth
5077354|NCT03516019|digital BP monitoring|digital bp monitoring
5077361|NCT03515993|quality of life|quality of life
5077362|NCT03515967|concussion, mild traumatic brain injury|concussion, mild traumatic brain injury
5077363|NCT03515954|conjunctiva|conjunctiva
5077364|NCT03515954|squamous neoplasia|squamous neoplasia
5077365|NCT03515954|amniotic|amniotic
5077368|NCT03515928|Ultrasound, Hearing|ultrasound, hearing
5077369|NCT03515915|multiple myeloma|multiple myeloma
5077370|NCT03515915|HDAC inhibitor|hdac inhibitor
5077371|NCT03515915|Biomarker|biomarker
5077372|NCT03515902|Dentine Hypersensitivity|dentine hypersensitivity
5077373|NCT03515902|Toothpaste|toothpaste
5077374|NCT03515902|Tooth erosion|tooth erosion
5077379|NCT03515785|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5077380|NCT03515785|ponatinib|ponatinib
5077381|NCT03515785|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5077382|NCT03515772|dolutegravir|dolutegravir
5077383|NCT03515772|darunavir|darunavir
5077384|NCT03515772|amlodipine|amlodipine
5077385|NCT03515772|rosuvastatin|rosuvastatin
5077386|NCT03515772|atorvastatin|atorvastatin
5077387|NCT03515759|PREECLAMPSIA|preeclampsia
5077388|NCT03515759|DOPPLER|doppler
5077389|NCT03515759|IUGR|iugr
5077390|NCT03515759|UMBILICAL ARTERY|umbilical artery
5077391|NCT03515759|MIDDLE CEREBRAL ARTERY|middle cerebral artery
5077392|NCT03515746|exergaming|exergaming
5077393|NCT03515746|physiotherapy|physiotherapy
5077394|NCT03515746|upper extremities|upper extremities
5077395|NCT03515746|telerehabilitation|telerehabilitation
5077396|NCT03515694|Bridion|bridion
5077397|NCT03515694|Sugammadex|sugammadex
5077399|NCT03515681|Text messaging|text messaging
5077400|NCT03515642|Gut microbiota|gut microbiota
5077401|NCT03515642|Hepatic function|hepatic function
5077402|NCT03515642|Obesity|obesity
5077403|NCT03515642|Exercise|exercise
5077404|NCT03515629|Stage IIIB|stage iiib
5077405|NCT03515629|Stage IV|stage iv
5077406|NCT03515629|Non-squamous NSCLC|non-squamous nsclc
5077407|NCT03515629|Squamous NSCLC|squamous nsclc
5077408|NCT03515551|IMCnyeso|imcnyeso
5077409|NCT03515551|Immunotherapy|immunotherapy
5077410|NCT03515538|head and neck cancer|head and neck cancer
5077411|NCT03515538|squamous|squamous
5077412|NCT03515538|neck cancer|neck cancer
5077413|NCT03515538|oral cancer|oral cancer
5077414|NCT03515538|mucositis|mucositis
5077415|NCT03515538|sores|sores
5077425|NCT03515486|Depression|depression
5077426|NCT03515486|Anxiety|anxiety
5077427|NCT03515486|Mood|mood
5077428|NCT03515486|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5077429|NCT03515473|cochlear implant|cochlear implant
5077430|NCT03515473|CI532|ci532
5077431|NCT03515473|CI512|ci512
5077432|NCT03515473|CI522|ci522
5077433|NCT03515473|electrode array|electrode array
5077434|NCT03515473|perimodiolar|perimodiolar
5077435|NCT03515473|electrophysiology|electrophysiology
5077440|NCT03515447|transfusion saving strategy|transfusion saving strategy
5077441|NCT03515447|heart or lung transplantation|heart or lung transplantation
5077442|NCT03515447|assist device|assist device
5077443|NCT03515447|Extra Corporal Life Support (ECLS)|extra corporal life support (ecls)
5077444|NCT03515447|Left Ventricular Assist Device (LVAD )|left ventricular assist device (lvad )
5077445|NCT03515447|Total artificial Heart|total artificial heart
5077446|NCT03515408|fMRI|fmri
5077447|NCT03515408|rTMS|rtms
5077448|NCT03515408|functional connectivity|functional connectivity
5077449|NCT03515395|exergaming|exergaming
5077450|NCT03515395|hip fracture|hip fracture
5077451|NCT03515395|training|training
5077452|NCT03515395|acceptance|acceptance
5077453|NCT03515369|hepatocellular carcinoma|hepatocellular carcinoma
5077454|NCT03515369|tumor recurrence|tumor recurrence
5077455|NCT03515369|adjuvant therapy|adjuvant therapy
5077456|NCT03515369|traditional Chinese medicine|traditional chinese medicine
5077457|NCT03515343|Cancer prevention|cancer prevention
5077458|NCT03515343|Endoscopy|endoscopy
5077459|NCT03515343|Gastroenterology|gastroenterology
5077460|NCT03515330|mHealth|mhealth
5077461|NCT03515330|liver transplantation|liver transplantation
5077462|NCT03515330|medication adherence|medication adherence
5077463|NCT03515330|video directly observed therapy|video directly observed therapy
5077464|NCT03515317|Cognitive impairments|cognitive impairments
5077465|NCT03515317|Low Resolution tomography|low resolution tomography
5077466|NCT03515317|Neurofeedback|neurofeedback
5077467|NCT03515317|Traumatic brain injury|traumatic brain injury
5077468|NCT03515291|Heart|heart
5077469|NCT03515291|CABG|cabg
5077470|NCT03515291|Injection|injection
5077474|NCT03515291|Progenitor|progenitor
5077475|NCT03515291|Immunomodulatory|immunomodulatory
5077477|NCT03515291|Randomized|randomized
5077478|NCT03515278|Frozen shoulder|frozen shoulder
5077479|NCT03515278|adhesive capsulitis|adhesive capsulitis
5077480|NCT03515278|ultrasound-guided intervention|ultrasound-guided intervention
5077481|NCT03515278|suprascapular nerve block|suprascapular nerve block
5077482|NCT03515278|intra-articular injection|intra-articular injection
5939336|NCT01256047|immunonutrition|immunonutrition
5939337|NCT01256047|hepatectomy|hepatectomy
5077483|NCT03515265|Fiber reinforced composite|fiber reinforced composite
5077484|NCT03515265|Microhybrid composite|microhybrid composite
5077485|NCT03515226|workforce development|workforce development
5077486|NCT03515226|intelligent tutoring systems|intelligent tutoring systems
5077487|NCT03515187|Dug induced dry eye|dug induced dry eye
5077488|NCT03515187|meibomian gland dysfunction, MGD|meibomian gland dysfunction, mgd
5077489|NCT03515187|Sodium hyaluronate ophthalmic solution|sodium hyaluronate ophthalmic solution
5077490|NCT03515187|Sodium bromide hydrate eye drops|sodium bromide hydrate eye drops
5077491|NCT03515187|Meibomian gland massage|meibomian gland massage
5077492|NCT03515174|Adolescent and Young Adult Oncology|adolescent and young adult oncology
5077493|NCT03515174|Carcinoma|carcinoma
5077494|NCT03515174|Lymphoma|lymphoma
5077495|NCT03515174|Sarcoma|sarcoma
5077496|NCT03515174|Cancer|cancer
5077497|NCT03515161|closedloop|closedloop
5077498|NCT03515161|vasopressor|vasopressor
5077499|NCT03515148|Achilles Tendinopathy|achilles tendinopathy
5077500|NCT03515148|Rectus Abominis|rectus abominis
5077501|NCT03515148|Vibration|vibration
5077502|NCT03515148|Cryotherapy|cryotherapy
5077503|NCT03515148|Eccentric Exercise|eccentric exercise
5077504|NCT03515135|ADHD|adhd
5077505|NCT03515135|executive function|executive function
5077506|NCT03515135|preschool|preschool
5077507|NCT03515135|intervention|intervention
5077508|NCT03515122|Epidemiology|epidemiology
5077509|NCT03515122|Rehabilitation|rehabilitation
5077510|NCT03515122|Clinical protocols|clinical protocols
5077511|NCT03515122|Middle aged|middle aged
5077512|NCT03515109|stress incontinence|stress incontinence
5077513|NCT03515109|female|female
5077514|NCT03515109|altis|altis
5077515|NCT03515109|transobturator tape|transobturator tape
5077516|NCT03515109|minisling|minisling
5077521|NCT03515083|atrial fibrillation|atrial fibrillation
5077524|NCT03515031|High Flow Nasal Cannula|high flow nasal cannula
5077525|NCT03515031|Venturi mask|venturi mask
5077526|NCT03515018|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
5077527|NCT03515018|hydroxyurea|hydroxyurea
5077528|NCT03515018|Imatinib Mesylate|imatinib mesylate
5077529|NCT03515018|Pulse Therapy, Drug|pulse therapy, drug
5077530|NCT03515005|Hypertension|hypertension
5077531|NCT03515005|Community Health Workers|community health workers
5077532|NCT03515005|Community-Based Participatory Research|community-based participatory research
5077533|NCT03515005|Health Equity|health equity
5077534|NCT03514966|Position change|position change
5077535|NCT03514966|Gastric cleanliness|gastric cleanliness
5077536|NCT03514966|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
5077537|NCT03514914|LARC, contraception, family planning, India, male engagement|larc, contraception, family planning, india, male engagement
5077538|NCT03514888|High-risk bladder cancer|high-risk bladder cancer
5077539|NCT03514888|Urothelial cancer|urothelial cancer
5077540|NCT03514888|HIPEC|hipec
5077541|NCT03514888|Mitomycin|mitomycin
5077542|NCT03514836|Castrate-resistant|castrate-resistant
5077543|NCT03514810|Major depressive disorder|major depressive disorder
5077544|NCT03514810|sertraline|sertraline
5077545|NCT03514810|ketoprofen|ketoprofen
5077546|NCT03514797|Tooth bleaching|tooth bleaching
5077547|NCT03514797|Hydrogen peroxide|hydrogen peroxide
5077548|NCT03514797|Carbamide peroxide|carbamide peroxide
5077549|NCT03514797|Tooth Bleaching Agents|tooth bleaching agents
5077550|NCT03514784|Autism Spectrum Disorder, ASD, Gastrointestinal Symptoms, Constipation, Diarrhea|autism spectrum disorder, asd, gastrointestinal symptoms, constipation, diarrhea
5077551|NCT03514719|89Zr-avelumab PET|89zr-avelumab pet
5077552|NCT03514719|avelumab|avelumab
5077553|NCT03514706|Extravascular lung water|extravascular lung water
5077554|NCT03514706|one lung ventilation|one lung ventilation
5077555|NCT03514706|volume controlled ventilation|volume controlled ventilation
5077556|NCT03514706|pressure controlled ventilation|pressure controlled ventilation
5077557|NCT03514693|Persistent atrial fibrillation|persistent atrial fibrillation
5077558|NCT03514693|non-inferiority trial|non-inferiority trial
5077559|NCT03514680|Cancer Care|cancer care
5077560|NCT03514680|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5077561|NCT03514654|Breast Cancer|breast cancer
5077562|NCT03514654|Mastectomy|mastectomy
5077563|NCT03514654|Therapeutic Mammoplasty|therapeutic mammoplasty
5077564|NCT03514654|Multiple Ipsilateral Breast Cancers|multiple ipsilateral breast cancers
5077565|NCT03514628|Valsalva Manoeuvre|valsalva manoeuvre
5077567|NCT03514628|Valsalva Assist Device|valsalva assist device
5077568|NCT03514576|gastric bypass|gastric bypass
5077569|NCT03514576|hypoglycemia|hypoglycemia
5077570|NCT03514576|hyperinsulinemia|hyperinsulinemia
5077571|NCT03514563|Cleft Lip and Palate|cleft lip and palate
5077572|NCT03514563|Maxillofacial|maxillofacial
5077573|NCT03514563|Growth|growth
5077575|NCT03514498|anesthesia|anesthesia
5077576|NCT03514485|asthma disparities|asthma disparities
5077577|NCT03514485|community health worker|community health worker
5077578|NCT03514485|childhood asthma|childhood asthma
5961333|NCT04287803|Penthrox|penthrox
5961334|NCT04287803|Penthrane|penthrane
5961335|NCT04287790|Implementation|implementation
5077579|NCT03514472|Hb, Anemia,|hb, anemia,
5077580|NCT03514433|Patient Navigation|patient navigation
5077581|NCT03514433|Disparity|disparity
5077590|NCT03514407|bromodomain-containing protein (BRD) inhibitor|bromodomain-containing protein (brd) inhibitor
5077591|NCT03514407|lysine demethylase 1 (LSD1) inhibitor|lysine demethylase 1 (lsd1) inhibitor
5077592|NCT03514381|Soft Tissue Sarcoma|soft tissue sarcoma
5077593|NCT03514381|Ifosfamide|ifosfamide
5077594|NCT03514381|Aprepitant|aprepitant
5077595|NCT03514381|Doxorubicin|doxorubicin
5077596|NCT03514368|Immune checkpoint modulation|immune checkpoint modulation
5077597|NCT03514368|Tumor antigens|tumor antigens
5077598|NCT03514368|Adaptive immune responses|adaptive immune responses
5077599|NCT03514368|Tumor molecular signature|tumor molecular signature
5077600|NCT03514342|Heart rate variability|heart rate variability
5077601|NCT03514342|Scotopic pupil size|scotopic pupil size
5077602|NCT03514329|Non Small Cell Lung Cancer|non small cell lung cancer
5077603|NCT03514329|Metastatic Lung Cancer|metastatic lung cancer
5077604|NCT03514329|Lung Cancer|lung cancer
5077605|NCT03514329|Vapor Ablation|vapor ablation
5077606|NCT03514329|BTVA|btva
5077607|NCT03514316|gingival overgrowth|gingival overgrowth
5077608|NCT03514316|diode laser gingivectomy|diode laser gingivectomy
5077609|NCT03514316|scalpel gingivectomy|scalpel gingivectomy
5078001|NCT03512340|solid tumor|solid tumor
5077619|NCT03514264|Root canal obturation|root canal obturation
5077620|NCT03514251|Thyroid Cancer|thyroid cancer
5077621|NCT03514251|Hypoparathyroidism|hypoparathyroidism
5077622|NCT03514251|parathyroid marker|parathyroid marker
5077623|NCT03514238|Exercise|exercise
5077624|NCT03514238|Physical Activity|physical activity
5077625|NCT03514238|Cardio-metabolic Health|cardio-metabolic health
5077626|NCT03514238|Myokines|myokines
5077627|NCT03514238|Cardiorespiratory Fitness|cardiorespiratory fitness
5077628|NCT03514238|Obesity|obesity
5077629|NCT03514238|Type 2 Diabetes|type 2 diabetes
5077630|NCT03514225|Metacognitive Therapy|metacognitive therapy
5077631|NCT03514212|physical activity|physical activity
5077632|NCT03514212|intervention|intervention
5077633|NCT03514212|walking|walking
5077634|NCT03514186|Aphasia|aphasia
5077635|NCT03514186|Speech and Language Treatment|speech and language treatment
5077636|NCT03514186|ICAP|icap
5077637|NCT03514186|Intensive Comprehensive Aphasia Program|intensive comprehensive aphasia program
5077638|NCT03514147|Women|women
5077639|NCT03514147|Pelvic Floor Muscles|pelvic floor muscles
5077646|NCT03514069|ruxolitinib|ruxolitinib
5077647|NCT03514069|radiation|radiation
5077648|NCT03514069|temozolomide|temozolomide
5077652|NCT03514043|Ambulatory care|ambulatory care
5077653|NCT03514043|Emergency general surgery|emergency general surgery
5077654|NCT03514043|Patient satisfaction|patient satisfaction
5077655|NCT03514017|Lymphocytic|lymphocytic
5077656|NCT03514017|Leukemia|leukemia
5077657|NCT03514017|CLL|cll
5077658|NCT03514017|Blood disease|blood disease
5077659|NCT03514017|White blood cells|white blood cells
5077660|NCT03514017|Bone marrow disease|bone marrow disease
5077661|NCT03514017|Immunotherapy|immunotherapy
5077662|NCT03514004|Suicide prevention|suicide prevention
5077663|NCT03514004|Information and Communication Technologies|information and communication technologies
5077664|NCT03514004|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5077665|NCT03514004|Latin America|latin america
5077666|NCT03513991|human milk|human milk
5077667|NCT03513991|infant formula with low protein|infant formula with low protein
5077668|NCT03513991|alpha lactoalbumin|alpha lactoalbumin
5077669|NCT03513991|growth velocity|growth velocity
5077670|NCT03513991|gastrointestinal events|gastrointestinal events
5077671|NCT03513978|Soccer|soccer
5077672|NCT03513978|Prevention injury|prevention injury
5077673|NCT03513965|food allergy|food allergy
5077674|NCT03513965|oral immunotherapy|oral immunotherapy
5077675|NCT03513965|mindsets|mindsets
5077676|NCT03513965|patient experience|patient experience
5077677|NCT03513939|Type 1 Diabetes Mellitus, Diabetes, hypoglycemia|type 1 diabetes mellitus, diabetes, hypoglycemia
5077678|NCT03513926|miRNA|mirna
5077679|NCT03513926|Cardiovascular Risk|cardiovascular risk
5077680|NCT03513926|CPAP|cpap
5077681|NCT03513926|Obstructive Sleep Apnea|obstructive sleep apnea
5077682|NCT03513926|Hypertension|hypertension
5077687|NCT03513913|Assisted reproduction|assisted reproduction
5077688|NCT03513900|Non-invasive methods|non-invasive methods
5077689|NCT03513900|Cirrhosis|cirrhosis
5077690|NCT03513900|Potal hypertensive gastropathy|potal hypertensive gastropathy
5077691|NCT03513900|Diagnostic accuracy|diagnostic accuracy
5077692|NCT03513887|cirrhosis,varices,variceal bleeding, noninvasive tests,TE|cirrhosis,varices,variceal bleeding, noninvasive tests,te
5077693|NCT03513861|Low and Middle Income Countries|low and middle income countries
5077694|NCT03513861|Limited resource settings|limited resource settings
5077695|NCT03513861|Early warning signs|early warning signs
5077696|NCT03513822|KETAMINE|ketamine
5077697|NCT03513822|CHRONIC PAIN|chronic pain
5077698|NCT03513822|NEUROPATHIC PAIN|neuropathic pain
5077699|NCT03513822|KYNURENINE|kynurenine
5077700|NCT03513822|KYNURENINE PATHWAY|kynurenine pathway
5077701|NCT03513822|BEDSORES|bedsores
5077702|NCT03513822|ANTI-INFLAMMATORY|anti-inflammatory
5939338|NCT01256047|Th1|th1
5939339|NCT01256047|Th2|th2
5077703|NCT03513822|ULCER PRESSURE|ulcer pressure
5077704|NCT03513809|Acute Hypoxemic Respiratory Failure|acute hypoxemic respiratory failure
5077706|NCT03513809|Electrical impedance tomography|electrical impedance tomography
5077710|NCT03513783|Spinal Cord Injury|spinal cord injury
5077711|NCT03513783|tendon transfer|tendon transfer
5077712|NCT03513783|muscle synergy|muscle synergy
5077713|NCT03513783|muscle co-activation|muscle co-activation
5077714|NCT03513783|electromyography|electromyography
5077715|NCT03513744|human milk oligosaccharides|human milk oligosaccharides
5077716|NCT03513744|infant formula|infant formula
5077717|NCT03513718|Acute kidney injury, AKI|acute kidney injury, aki
5077718|NCT03513705|implementation|implementation
5077719|NCT03513705|randomized trial|randomized trial
5077720|NCT03513705|pancreatic cancer|pancreatic cancer
5077721|NCT03513705|nationwide|nationwide
5077722|NCT03513705|survival|survival
5077723|NCT03513705|quality of life|quality of life
5077724|NCT03513653|acute heart failure|acute heart failure
5077725|NCT03513653|global longitudinal strain|global longitudinal strain
5077726|NCT03513653|ejection fraction|ejection fraction
5077727|NCT03513653|echocardiography|echocardiography
5077728|NCT03513653|mortality|mortality
5077729|NCT03513627|periimplant soft tissue|periimplant soft tissue
5077730|NCT03513627|gingiva|gingiva
5077731|NCT03513627|human|human
5077732|NCT03513627|microcirculation|microcirculation
5077733|NCT03513614|Tailored Axillary Surgery|tailored axillary surgery
5077734|NCT03513614|TAXIS|taxis
5077735|NCT03513614|Breast Cancer|breast cancer
5077736|NCT03513614|node-positive breast cancer|node-positive breast cancer
5077737|NCT03513614|phase III trial|phase iii trial
5077738|NCT03513614|IBCSG 57-18|ibcsg 57-18
5077739|NCT03513614|ABCSG|abcsg
5077740|NCT03513601|Curative effect evaluation|curative effect evaluation
5077741|NCT03513601|Adverse reactions|adverse reactions
5077742|NCT03513601|Clinical characteristics|clinical characteristics
5077744|NCT03513601|PFS|pfs
5077745|NCT03513601|OS|os
5077746|NCT03513575|pH of saliva|ph of saliva
5077747|NCT03513575|Flavored Milk|flavored milk
5077748|NCT03513575|buffering agent|buffering agent
5077749|NCT03513575|oral hygiene|oral hygiene
5077750|NCT03513549|Agitation|agitation
5077751|NCT03513549|Schizophrenia|schizophrenia
5077752|NCT03513549|Bipolar I disorder|bipolar i disorder
5077753|NCT03513536|Aromatherapy|aromatherapy
5077754|NCT03513536|Essential Oils|essential oils
5077755|NCT03513510|evidence-based programs|evidence-based programs
5077756|NCT03513510|community-based participatory research|community-based participatory research
5077757|NCT03513510|program adoption|program adoption
5077758|NCT03513497|Teeth|teeth
5077759|NCT03513497|Periodontal disease|periodontal disease
5077760|NCT03513497|acute inflammatory response|acute inflammatory response
5077761|NCT03513497|stent-induced biofilm overgrowth|stent-induced biofilm overgrowth
5077762|NCT03513497|periodontal pathogens|periodontal pathogens
5077763|NCT03513471|Late Phase Asthmatic Response|late phase asthmatic response
5077764|NCT03513471|Allergen Challenge|allergen challenge
5077765|NCT03513458|Late Phase Asthmatic Response|late phase asthmatic response
5077766|NCT03513458|Allergen Challenge|allergen challenge
5077767|NCT03513432|Gut microbiota|gut microbiota
5077768|NCT03513432|Beer|beer
5077769|NCT03513432|Alcohol|alcohol
5077770|NCT03513432|Cardiovascular disease|cardiovascular disease
5077771|NCT03513406|muscle function|muscle function
5077772|NCT03513393|velpatasvir|velpatasvir
5077773|NCT03513393|cola|cola
5077774|NCT03513393|omeprazole|omeprazole
5077775|NCT03513393|proton pump inhibitors|proton pump inhibitors
5077776|NCT03513380|Exercise therapy|exercise therapy
5077777|NCT03513380|Physical fitness|physical fitness
5077778|NCT03513380|Gaming|gaming
5077779|NCT03513380|Adult|adult
5077780|NCT03513380|Healthy lifestyle|healthy lifestyle
5077781|NCT03513380|Fitness testing|fitness testing
5077782|NCT03513367|Duchenne Muscular Dystrophy,|duchenne muscular dystrophy,
5077783|NCT03513367|Pediatric Quality of Life Inventory|pediatric quality of life inventory
5077784|NCT03513367|disability paradox|disability paradox
5077785|NCT03513354|Aging|aging
5077786|NCT03513354|Physical activity|physical activity
5077787|NCT03513354|Motor activity|motor activity
5076695|NCT03520062|Lipase|lipase
5077788|NCT03513341|Physical activity|physical activity
5077789|NCT03513341|Sedentary behaviour|sedentary behaviour
5077790|NCT03513341|Undergraduate|undergraduate
5077791|NCT03513328|human leukocyte antigen (HLA)|human leukocyte antigen (hla)
5077792|NCT03513315|Heat-related illnesses|heat-related illnesses
5077793|NCT03513315|Heat Illnesses|heat illnesses
5077794|NCT03513315|Community based interventions|community based interventions
5077796|NCT03513315|Pakistan|pakistan
5077797|NCT03513315|emergency preparedness|emergency preparedness
5077798|NCT03513315|emergency medicine|emergency medicine
5077799|NCT03513315|heat stroke|heat stroke
5077800|NCT03513315|heat exhaustion|heat exhaustion
5077801|NCT03513315|urban health|urban health
5077802|NCT03513302|nitric oxide|nitric oxide
5077816|NCT03513172|Anti-VEGF Agents|anti-vegf agents
5961336|NCT04287790|Medications for alcohol use disorder|medications for alcohol use disorder
5077817|NCT03513172|alpha2-agonists|alpha2-agonists
5077819|NCT03513133|working memory|working memory
5077820|NCT03513133|cognitive rehabilitation|cognitive rehabilitation
5077821|NCT03513133|functional neuroimaging|functional neuroimaging
5077822|NCT03513120|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5077823|NCT03513120|Posterior Spinal Fusion|posterior spinal fusion
5077824|NCT03513120|Return to Sport|return to sport
5077825|NCT03513107|Osteoporosis|osteoporosis
5077826|NCT03513094|Kinetics|kinetics
5077827|NCT03513094|Transversus abdominis|transversus abdominis
5077828|NCT03513081|food neophobia|food neophobia
5077829|NCT03513081|preschool|preschool
5077830|NCT03513081|children|children
5077831|NCT03513068|COPD|copd
5077833|NCT03513068|Oxygen|oxygen
5077834|NCT03513068|QoL|qol
5077835|NCT03513055|glucose excursions|glucose excursions
5077836|NCT03513055|insulin technique|insulin technique
5077837|NCT03513055|insulin antibodies|insulin antibodies
5077838|NCT03513055|premixed insulin|premixed insulin
5077851|NCT03513029|atrial fibrillation|atrial fibrillation
5077852|NCT03513029|ablation|ablation
5077853|NCT03513029|low intensity collimated ultrasound|low intensity collimated ultrasound
5077854|NCT03513016|Osteoarthritis|osteoarthritis
5077855|NCT03513016|Painful Osteoarthritis|painful osteoarthritis
5077856|NCT03513016|Osteoarthritis, Knee|osteoarthritis, knee
5077857|NCT03513016|Senescence|senescence
5077858|NCT03512990|Brachial Plexus Block|brachial plexus block
5077859|NCT03512990|Superior Trunk|superior trunk
5077860|NCT03512990|Phrenic Nerve|phrenic nerve
5077861|NCT03512977|spinal anesthesia|spinal anesthesia
5077862|NCT03512977|sphenopalatine ganglion block|sphenopalatine ganglion block
5077863|NCT03512977|postspinal headache|postspinal headache
5077864|NCT03512951|Hearing aids|hearing aids
5077865|NCT03512951|Remote microphone systems|remote microphone systems
5077866|NCT03512951|Roger technology|roger technology
5077867|NCT03512951|Sound externalization|sound externalization
5077868|NCT03512951|Auditory distance estimation|auditory distance estimation
5077869|NCT03512938|Generalized aggressive periodontitis|generalized aggressive periodontitis
5077870|NCT03512938|Non-surgical periodontal therapy|non-surgical periodontal therapy
5077871|NCT03512938|Periodontopathogens|periodontopathogens
5077872|NCT03512938|Smoking|smoking
5077873|NCT03512938|Gingival crevicular fluid|gingival crevicular fluid
5077874|NCT03512925|Coercion|coercion
5077875|NCT03512925|Post-coercion review|post-coercion review
5077876|NCT03512925|Mental health|mental health
5077877|NCT03512925|Seclusion|seclusion
5077878|NCT03512925|Mechanical restraint|mechanical restraint
5077879|NCT03512899|implantable port|implantable port
5077880|NCT03512886|Multiple sclerosis|multiple sclerosis
5077881|NCT03512886|Multi-task training|multi-task training
5077882|NCT03512886|Balance|balance
5077883|NCT03512886|Mobility|mobility
5077884|NCT03512886|Cognition|cognition
5077885|NCT03512886|Upper extremity function|upper extremity function
5077886|NCT03512873|Scleredema Diabeticorum|scleredema diabeticorum
5077887|NCT03512873|Tranilast|tranilast
5077888|NCT03512860|Estetrol|estetrol
5077889|NCT03512860|Drospirenone|drospirenone
5077890|NCT03512860|Uridine diphosphate glucuronosyltransferase-2B7|uridine diphosphate glucuronosyltransferase-2b7
5077891|NCT03512860|Drug-drug interaction|drug-drug interaction
5077892|NCT03512860|Valproic acid|valproic acid
5077893|NCT03512847|liquid biopsy|liquid biopsy
5077894|NCT03512847|genomic profiling|genomic profiling
5077895|NCT03512847|ctDNA|ctdna
5077896|NCT03512834|angiosarcoma|angiosarcoma
5077897|NCT03512834|paclitaxel|paclitaxel
5077898|NCT03512834|avelumab|avelumab
5078002|NCT03512340|Phase 1|phase 1
5078003|NCT03512340|safety|safety
5077902|NCT03512756|Pancreatic|pancreatic
5077908|NCT03512756|SM-88|sm-88
5077909|NCT03512756|SM88|sm88
5077910|NCT03512756|3rd line|3rd line
5077911|NCT03512756|third line|third line
5077912|NCT03512756|CMBT|cmbt
5135482|NCT03146559|EMG|emg
5077913|NCT03512756|well tolerated|well tolerated
5077915|NCT03512756|Racemetyrosine|racemetyrosine
5077916|NCT03512756|Methoxsalen|methoxsalen
5077917|NCT03512756|Sirolimus|sirolimus
5077918|NCT03512756|Phenytoin|phenytoin
5077919|NCT03512743|bone mineral density|bone mineral density
5077920|NCT03512743|bone turnover markers|bone turnover markers
5077925|NCT03512704|health services research|health services research
5077926|NCT03512691|Risk perceptions and attitudes, time preference, information|risk perceptions and attitudes, time preference, information
5077927|NCT03512665|Pre-diabetes|pre-diabetes
5077928|NCT03512665|cardiovascular risk|cardiovascular risk
5077929|NCT03512665|lipids|lipids
5077930|NCT03512665|insulin resistance|insulin resistance
5077931|NCT03512665|obesity|obesity
5077932|NCT03512665|overweight|overweight
5077933|NCT03512639|Mastectomy, Breast Reconstruction, Homeopathic Treatment|mastectomy, breast reconstruction, homeopathic treatment
5077934|NCT03512626|OptiVis|optivis
5356806|NCT01917903|Parkinson's disease|parkinson's disease
5961337|NCT04287790|Pharmacotherapy|pharmacotherapy
5077935|NCT03512626|hybrid multifocal intraocular lens|hybrid multifocal intraocular lens
5961338|NCT04287777|Impetigo|impetigo
5077936|NCT03512626|multifocal intraocular lens|multifocal intraocular lens
5077937|NCT03512626|presbyopia|presbyopia
5077938|NCT03512600|lithiasis|lithiasis
5077939|NCT03512600|uric acid|uric acid
5077940|NCT03512600|crystallization|crystallization
5077941|NCT03512587|Personalized quantum sonotherapy|personalized quantum sonotherapy
5077942|NCT03512587|Regional anesthesia|regional anesthesia
5077943|NCT03512587|Peripheral nerve block|peripheral nerve block
5077944|NCT03512574|pregabalin, dexmedetomidine, postoperative pain|pregabalin, dexmedetomidine, postoperative pain
5077945|NCT03512522|chronic pain|chronic pain
5077946|NCT03512522|pain self-management|pain self-management
5077947|NCT03512522|remote delivery|remote delivery
5077948|NCT03512522|workbook|workbook
5077949|NCT03512522|online|online
5077950|NCT03512496|Energy Drink|energy drink
5077951|NCT03512496|Pediatric|pediatric
5077952|NCT03512496|Metabolism|metabolism
5077953|NCT03512496|Glucose|glucose
5077954|NCT03512496|Caffeine|caffeine
5077955|NCT03512496|Obesity|obesity
5077956|NCT03512496|Nutrition|nutrition
5077957|NCT03512496|Metabolomics|metabolomics
5077958|NCT03512496|Health Behavior|health behavior
5077959|NCT03512496|Glucose Intolerance|glucose intolerance
5077960|NCT03512483|Atrial Fibrillation|atrial fibrillation
5077961|NCT03512483|Rural|rural
5077962|NCT03512483|Virtual|virtual
5077963|NCT03512483|Older Adults|older adults
5077964|NCT03512470|surgical wound|surgical wound
5077965|NCT03512470|Prevena System|prevena system
5077966|NCT03512457|Melanoma|melanoma
5077967|NCT03512457|Skin self-examination|skin self-examination
5077968|NCT03512457|mammogram|mammogram
5077969|NCT03512444|negative pressure therapy|negative pressure therapy
5077970|NCT03512444|negative pressure|negative pressure
5077971|NCT03512444|Wound therapy|wound therapy
5077972|NCT03512444|NPWT|npwt
5077973|NCT03512444|Vacuum therapy|vacuum therapy
5077974|NCT03512444|VAC|vac
5077975|NCT03512431|analytical method validation|analytical method validation
5077976|NCT03512431|renal transplantation|renal transplantation
5077977|NCT03512431|limited sampling strategy|limited sampling strategy
5077983|NCT03512392|fluid therapy|fluid therapy
5077984|NCT03512392|furosemide|furosemide
5077985|NCT03512392|diuretics|diuretics
5077986|NCT03512392|Injections, Intravenous|injections, intravenous
5077987|NCT03512392|Infusions, Intravenous|infusions, intravenous
5077988|NCT03512392|Spironolactone|spironolactone
5077989|NCT03512392|Indapamide|indapamide
5077990|NCT03512379|robot-assisted surgery|robot-assisted surgery
5077991|NCT03512379|pedicle screw|pedicle screw
5077992|NCT03512379|spine|spine
5077993|NCT03512366|inguinal hernia|inguinal hernia
5077994|NCT03512366|lichtenstein's technique|lichtenstein's technique
5077995|NCT03512366|desarda's technique|desarda's technique
5077996|NCT03512366|local anaesthesia|local anaesthesia
5077997|NCT03512340|CD47|cd47
5077998|NCT03512340|SiRP α|sirp α
5077999|NCT03512340|tumor microenvironment|tumor microenvironment
5078000|NCT03512340|macrophage|macrophage
5078009|NCT03512262|abaloparatide|abaloparatide
5078010|NCT03512262|abaloparatide-SC|abaloparatide-sc
5078011|NCT03512262|osteoporosis|osteoporosis
5078012|NCT03512262|male osteoporosis|male osteoporosis
5078013|NCT03512262|TYMLOS™|tymlos™
5078014|NCT03512262|fracture|fracture
5078025|NCT03512197|combination treatment|combination treatment
5078026|NCT03512197|induction failure|induction failure
5078027|NCT03512197|event free survival|event free survival
5078029|NCT03512197|minimal residual disease|minimal residual disease
5078030|NCT03512119|Cystic fibrosis|cystic fibrosis
5078031|NCT03512119|Glucose tolerance abnormalities|glucose tolerance abnormalities
5078032|NCT03512119|CFTR corrector and potentiator|cftr corrector and potentiator
5078033|NCT03512106|Arterial Hypertension|arterial hypertension
5078034|NCT03512106|Acupuncture|acupuncture
5078035|NCT03512093|Preterm Infant|preterm infant
5078036|NCT03512080|Warfarin|warfarin
5078037|NCT03512080|Anticoagulation|anticoagulation
5078038|NCT03512080|Clinical Dosing Algorithm|clinical dosing algorithm
5078039|NCT03512080|Genetic Dosing Algorithm|genetic dosing algorithm
5078052|NCT03512054|Brain injury|brain injury
5078053|NCT03512054|Neurosurgery|neurosurgery
5078054|NCT03512041|ischemic conditioning, motor learning|ischemic conditioning, motor learning
5078055|NCT03512028|ischemic conditioning, motor learning, strength, cognition|ischemic conditioning, motor learning, strength, cognition
5078056|NCT03512015|Lung Cancer|lung cancer
5078057|NCT03512002|Neurotechnology|neurotechnology
5078058|NCT03512002|Autonomic Dysregulation|autonomic dysregulation
5078059|NCT03512002|Hyperarousal|hyperarousal
5078060|NCT03512002|Brain Electrical Activity|brain electrical activity
5078061|NCT03512002|HIRREM|hirrem
5078062|NCT03512002|Acoustic Stimulation|acoustic stimulation
5078063|NCT03512002|Perimenopausal|perimenopausal
5078064|NCT03512002|Postmenopausal|postmenopausal
5078065|NCT03512002|Hot Flashes|hot flashes
5078066|NCT03512002|Night Sweats|night sweats
5078067|NCT03512002|Vasomotor Symptoms|vasomotor symptoms
5078068|NCT03512002|Allostatis|allostatis
5078069|NCT03511937|Food and beverage purchases|food and beverage purchases
5078070|NCT03511937|Sugar-sweetened beverages|sugar-sweetened beverages
5078071|NCT03511937|Beverages|beverages
5078072|NCT03511924|resistance training|resistance training
5078073|NCT03511924|circulating miRNA|circulating mirna
5078074|NCT03511924|muscle strength|muscle strength
5078075|NCT03511911|Pelvic floor muscle strength|pelvic floor muscle strength
5078076|NCT03511911|modified Oxford Grading Scale|modified oxford grading scale
5078077|NCT03511911|Levator ani testing|levator ani testing
5078078|NCT03511911|vaginal contraction pressure|vaginal contraction pressure
5078079|NCT03511911|reliability|reliability
5078080|NCT03511885|Cardiovascular|cardiovascular
5078081|NCT03511885|Prevention|prevention
5078082|NCT03511885|EUROASPIRE|euroaspire
5078083|NCT03511872|Basic life support|basic life support
5078084|NCT03511872|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5078085|NCT03511872|medical undergraduate students|medical undergraduate students
5078086|NCT03511872|crisis|crisis
5078087|NCT03511872|randomized controlled trial.|randomized controlled trial.
5078088|NCT03511859|Breast cancer. Circulating tumor cells. CTCs. Cell free DNA. cfDNA|breast cancer. circulating tumor cells. ctcs. cell free dna. cfdna
5078089|NCT03511846|Brain Freeze|brain freeze
5078090|NCT03511846|Capsaicin|capsaicin
5078091|NCT03511833|Intra nasal ketamine|intra nasal ketamine
5078092|NCT03511833|IV morphine|iv morphine
5078093|NCT03511833|acute traumatic pain|acute traumatic pain
5078094|NCT03511820|Amphotericin B|amphotericin b
5078095|NCT03511820|liposome|liposome
5078096|NCT03511820|post marketing surveillance|post marketing surveillance
5078099|NCT03511768|18F-AlF-NOTA-octreotide|18f-alf-nota-octreotide
5078100|NCT03511729|Tau/P-Tau|tau/p-tau
5078101|NCT03511729|biomarker|biomarker
5078102|NCT03511729|neurocognitive|neurocognitive
5078108|NCT03511677|Insole|insole
5078109|NCT03511677|Morton Neuroma|morton neuroma
5078110|NCT03511677|Pain|pain
5078111|NCT03511677|Function|function
5078112|NCT03511664|mCRPC|mcrpc
5078113|NCT03511664|177Lu-PSMA-617|177lu-psma-617
5078114|NCT03511664|PSMA-617|psma-617
5078115|NCT03511664|PSMA-11|psma-11
5078116|NCT03511664|radioligand therapy|radioligand therapy
5078117|NCT03511560|Envarsus XR|envarsus xr
5078118|NCT03511560|Tacrolimus|tacrolimus
5078119|NCT03511560|Kidney Transplantation|kidney transplantation
5078120|NCT03511534|treatment, psychotherapy, pharmacotherapy|treatment, psychotherapy, pharmacotherapy
5078121|NCT03511521|steroid|steroid
5078122|NCT03511521|prednisone|prednisone
5738970|NCT00361504|Knee Pain|knee pain
5078123|NCT03511521|methylprednisolone|methylprednisolone
5078124|NCT03511521|hyperglycemia|hyperglycemia
5078125|NCT03511521|insulin|insulin
5078126|NCT03511521|hypoglycemia|hypoglycemia
5078127|NCT03511508|pregnancy|pregnancy
5078128|NCT03511508|maternity Care|maternity care
5078129|NCT03511508|complex intervention|complex intervention
5078130|NCT03511508|interdisiplinary team|interdisiplinary team
5078138|NCT03511443|hsRDT|hsrdt
5078139|NCT03511443|usRDT|usrdt
5078140|NCT03511443|Reactive Case Detection (RCD)|reactive case detection (rcd)
5078141|NCT03511443|High risk for malaria|high risk for malaria
5078142|NCT03511430|Acute Coronary Syndrome|acute coronary syndrome
5078143|NCT03511430|Heart Diseases|heart diseases
5078144|NCT03511430|Cardiovascular Diseases|cardiovascular diseases
5078145|NCT03511430|Vascular Diseases|vascular diseases
5078146|NCT03511404|Non specific chronic low back pain|non specific chronic low back pain
5078147|NCT03511404|surface electromyography (EMG)|surface electromyography (emg)
5078148|NCT03511404|neuromuscular function|neuromuscular function
5078149|NCT03511404|physiotherapy|physiotherapy
5078150|NCT03511404|Numeric Pain Rating Scale|numeric pain rating scale
5078151|NCT03511391|radiotherapy|radiotherapy
5078152|NCT03511391|checkpoint inhibitors|checkpoint inhibitors
5078153|NCT03511378|Breast Carcinoma|breast carcinoma
5078154|NCT03511378|Breast neoplasms|breast neoplasms
5078155|NCT03511378|Breast Tumors|breast tumors
5078156|NCT03511378|Cancer of Breast|cancer of breast
5078157|NCT03511378|Anti-Drug Antibodies (ADA)|anti-drug antibodies (ada)
5078158|NCT03511378|Immunogenicity|immunogenicity
5078165|NCT03511313|Primary Hypertension|primary hypertension
5078166|NCT03511313|Renal Denervation|renal denervation
5078168|NCT03511300|Apathy|apathy
5078169|NCT03511287|inspiratory muscle training|inspiratory muscle training
5078170|NCT03511287|advanced lung disease|advanced lung disease
5078171|NCT03511287|maximal inspiratory pressure|maximal inspiratory pressure
5078172|NCT03511287|inspiratory endurance|inspiratory endurance
5078173|NCT03511274|Cytomegalovirus Congenital|cytomegalovirus congenital
5078174|NCT03511274|CMV|cmv
5078175|NCT03511274|Cytomegalovirus infections|cytomegalovirus infections
5078176|NCT03511261|Oral submucous fibrosis|oral submucous fibrosis
5078177|NCT03511261|curcumin|curcumin
5078178|NCT03511261|potentially malignant disease|potentially malignant disease
5078179|NCT03511248|Heart Failure|heart failure
5078180|NCT03511248|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5078181|NCT03511248|Nitric Oxide|nitric oxide
5078182|NCT03511248|Inorganic Nitrate|inorganic nitrate
5078183|NCT03511209|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5078184|NCT03511209|Hypnotics and Sedatives|hypnotics and sedatives
5961339|NCT04287777|Mupirocin|mupirocin
5078185|NCT03511196|stage IV castration sensitive prostate cancer|stage iv castration sensitive prostate cancer
5078186|NCT03511196|advanced castration sensitive prostate cancer|advanced castration sensitive prostate cancer
5078187|NCT03511157|ischemic preconditioning|ischemic preconditioning
5078188|NCT03511131|HIV prevention|hiv prevention
5078189|NCT03511131|Adolescent risk-taking behaviors|adolescent risk-taking behaviors
5078190|NCT03511105|Lipopolysaccharide|lipopolysaccharide
5090055|NCT03435640|NKTR-262|nktr-262
5078195|NCT03511105|Segmental challenge|segmental challenge
5078196|NCT03511092|Leucine metabolites|leucine metabolites
5078197|NCT03511092|Resistance training|resistance training
5078198|NCT03511092|Hypertrophy|hypertrophy
5078199|NCT03511092|Strength|strength
5078200|NCT03511092|Supplement|supplement
5078201|NCT03511079|Music|music
5078202|NCT03511066|efficacy|efficacy
5078203|NCT03511066|safety|safety
5078204|NCT03511027|Medication Adherence|medication adherence
5078205|NCT03511027|Medication Dispensing|medication dispensing
5078206|NCT03511027|Homecare|homecare
5078207|NCT03511027|Elderly|elderly
5078208|NCT03510975|behavioural therapy|behavioural therapy
5078209|NCT03510975|mono symptomatic nocturnal enuresis|mono symptomatic nocturnal enuresis
5078210|NCT03510975|compliance|compliance
5078211|NCT03510975|response|response
5078212|NCT03510962|pH of saliva|ph of saliva
5078213|NCT03510962|Fruit juice|fruit juice
5078214|NCT03510962|buffering agent|buffering agent
5078215|NCT03510962|oral hygiene|oral hygiene
5078216|NCT03510936|Probiotics|probiotics
5078217|NCT03510936|Gut Microbiome|gut microbiome
5078218|NCT03510936|Infants|infants
5078219|NCT03510936|Jaundice|jaundice
5078228|NCT03510897|MAKE|make
5078230|NCT03510871|neoadjuvant therapy|neoadjuvant therapy
5078231|NCT03510819|Dental trauma|dental trauma
5078232|NCT03510819|Emergency management|emergency management
5078233|NCT03510819|Tooth avulsion|tooth avulsion
5078234|NCT03510819|Knowledge|knowledge
5078235|NCT03510819|Practice|practice
5078236|NCT03510819|Traumatic injuries|traumatic injuries
5078237|NCT03510819|Attitude|attitude
5078247|NCT03510741|Sodium Benzoate|sodium benzoate
5078248|NCT03510741|N-Acetylcysteine|n-acetylcysteine
5078249|NCT03510741|NMDA receptor|nmda receptor
5078250|NCT03510741|Psychopharmacology|psychopharmacology
5078251|NCT03510741|Anti-oxidant|anti-oxidant
5078252|NCT03510741|Inflammation|inflammation
5078253|NCT03510728|Protective Behavioral Strategies|protective behavioral strategies
5078254|NCT03510702|Epigenetic.|epigenetic.
5078255|NCT03510702|microRNA.|microrna.
5078256|NCT03510702|Periodontitis.|periodontitis.
5078257|NCT03510689|Cardio-oncology|cardio-oncology
5078258|NCT03510650|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5078259|NCT03510650|Hemophagocytic syndrome (HPS)|hemophagocytic syndrome (hps)
5078260|NCT03510650|critically ill|critically ill
5078261|NCT03510650|Intensive care unit (ICU)|intensive care unit (icu)
5078262|NCT03510637|Hepatitis C, Genotype 4, DAAs, Real life evaluation|hepatitis c, genotype 4, daas, real life evaluation
5078263|NCT03510585|mucociliary clearance|mucociliary clearance
5078264|NCT03510585|air pollution|air pollution
5078265|NCT03510585|nasal lavage|nasal lavage
5078266|NCT03510585|exhaled breath condensate|exhaled breath condensate
5078267|NCT03510585|inflammation|inflammation
5078268|NCT03510572|[18F]PI-2620, tauopathy, positron emission computed tomography|[18f]pi-2620, tauopathy, positron emission computed tomography
4961580|NCT04229888|lipiflow|lipiflow
5078269|NCT03510533|autoantibodies (autoAc) circulating|autoantibodies (autoac) circulating
5078270|NCT03510533|neuropeptides (Ghrelin, l'α-MSH)|neuropeptides (ghrelin, l'α-msh)
5078271|NCT03510533|potential digestive origin|potential digestive origin
5078272|NCT03510520|Hemodialysis|hemodialysis
5078273|NCT03510520|Haemodialysis|haemodialysis
5078274|NCT03510520|Hemodiafiltration|hemodiafiltration
5078275|NCT03510520|Haemodiafiltration|haemodiafiltration
5078276|NCT03510520|Dialysis membrane|dialysis membrane
5078277|NCT03510520|Endothelial Microvesicles|endothelial microvesicles
5078278|NCT03510520|Pulse Wave Velocity|pulse wave velocity
5078279|NCT03510507|Lyme arthritis|lyme arthritis
5078280|NCT03510507|Borrelia burgdorferi|borrelia burgdorferi
5078281|NCT03510507|vector tick|vector tick
5078282|NCT03510507|Arthritis|arthritis
5078283|NCT03510507|joints|joints
5078284|NCT03510481|VENOUS|venous
5078285|NCT03510481|Malaria|malaria
5078286|NCT03510481|Efficacy|efficacy
5078287|NCT03510481|Booster|booster
5090157|NCT03435068|wound healing|wound healing
5078323|NCT03510234|Self-confidence|self-confidence
5078324|NCT03510221|Hypertension|hypertension
5078325|NCT03510221|Oxidative stress|oxidative stress
5078326|NCT03510221|Antioxidant|antioxidant
5078327|NCT03510221|Autonomic imbalance|autonomic imbalance
5078328|NCT03510221|Insulin resistance|insulin resistance
5078329|NCT03510221|Cytokines|cytokines
5078330|NCT03510143|thyroid cancer|thyroid cancer
5078331|NCT03510143|Neoveil|neoveil
5078332|NCT03510143|seroma|seroma
5078333|NCT03510143|chyle leakage|chyle leakage
5078334|NCT03510117|Mindfulness|mindfulness
5078335|NCT03510117|Patient reported outcomes measures|patient reported outcomes measures
5078336|NCT03510117|PROMIS|promis
5078338|NCT03510078|Diabetes Mellitus|diabetes mellitus
5078339|NCT03510078|hyperglycemic control|hyperglycemic control
5078340|NCT03510078|hospitalization|hospitalization
5078341|NCT03510078|internal medicine|internal medicine
5078342|NCT03510065|hip arthroplasty|hip arthroplasty
5078343|NCT03510065|revision arthroplasty|revision arthroplasty
5078344|NCT03510065|survival|survival
5078345|NCT03510052|diet|diet
5078346|NCT03510052|Fecal Incontinence|fecal incontinence
5078347|NCT03510052|FI|fi
5078348|NCT03510052|ABL|abl
5078349|NCT03510039|Involuntary commitment hospitalization|involuntary commitment hospitalization
5078350|NCT03510039|close relative|close relative
5078351|NCT03510026|internal thoracic artery harvesting|internal thoracic artery harvesting
5078356|NCT03510013|wash-in|wash-in
5078357|NCT03510013|sevoflurane|sevoflurane
5078358|NCT03510000|T1DM|t1dm
5078359|NCT03510000|artificial pancreas|artificial pancreas
5078360|NCT03510000|insulin pump|insulin pump
5078361|NCT03510000|empagliflozin|empagliflozin
5078362|NCT03510000|SGLT2 inhibitor|sglt2 inhibitor
5078370|NCT03509870|diabetes|diabetes
5078371|NCT03509857|Pain|pain
5078372|NCT03509857|Acute pain|acute pain
5078373|NCT03509857|Analgesia|analgesia
5078374|NCT03509857|Propofol infusion|propofol infusion
5078375|NCT03509818|Klotho|klotho
5078376|NCT03509818|Exercise|exercise
5078377|NCT03509818|Physical Fitness|physical fitness
5078378|NCT03509805|sleep apnea syndrome|sleep apnea syndrome
5078379|NCT03509805|obesity|obesity
5078380|NCT03509805|pregnancy|pregnancy
5078381|NCT03509805|preeclampsia|preeclampsia
5078382|NCT03509766|allergic|allergic
5078383|NCT03509766|rhinitis|rhinitis
5078384|NCT03509766|allergy|allergy
5078385|NCT03509766|asthma|asthma
5078386|NCT03509766|food allergy|food allergy
5078387|NCT03509766|skin testing|skin testing
5078388|NCT03509766|skin prick test|skin prick test
5078389|NCT03509753|Prebiotic fiber|prebiotic fiber
5078390|NCT03509701|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
5078391|NCT03509701|Herpes zoster|herpes zoster
5078392|NCT03509701|Varicella-zoster virus infection|varicella-zoster virus infection
5078393|NCT03509688|entecavir|entecavir
5078394|NCT03509688|resveratrol|resveratrol
5078395|NCT03509688|thymosin|thymosin
5078396|NCT03509688|hepatitis B|hepatitis b
5078397|NCT03509675|Oral Ulceration|oral ulceration
5078398|NCT03509662|Vitamin C|vitamin c
5078408|NCT03509623|Fibrinogen|fibrinogen
5078409|NCT03509610|Nutrition|nutrition
5078410|NCT03509610|Carbohydrates|carbohydrates
5078411|NCT03509597|Cognitive remediation|cognitive remediation
5078412|NCT03509597|Aerobic exercise|aerobic exercise
5078413|NCT03509597|Physical exercise|physical exercise
5078414|NCT03509597|Negative symptoms|negative symptoms
5078415|NCT03509597|Functional outcome|functional outcome
5078416|NCT03509597|Cognition|cognition
5078417|NCT03509558|Spinal electrical stimulation|spinal electrical stimulation
5078418|NCT03509545|natriuresis|natriuresis
5078419|NCT03509519|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5078420|NCT03509519|physical activity|physical activity
5078421|NCT03509519|muscular strength|muscular strength
5078422|NCT03509493|Primary prevention|primary prevention
5078423|NCT03509493|Secondary prevention|secondary prevention
5078424|NCT03509493|Clinical practice|clinical practice
5078425|NCT03509467|skin cancer prevention|skin cancer prevention
5078426|NCT03509467|educational materials|educational materials
5078427|NCT03509467|skin cancer risk|skin cancer risk
5078428|NCT03509467|questionnaire|questionnaire
5078429|NCT03509467|MC1R genotype|mc1r genotype
5078430|NCT03509441|South Asian|south asian
5078431|NCT03509441|Insulin Resistance|insulin resistance
5078432|NCT03509441|Cardiac Fibrosis|cardiac fibrosis
5078433|NCT03509441|MRI|mri
5078434|NCT03509441|Diabetes|diabetes
5078435|NCT03509441|Cardiomyopathy|cardiomyopathy
5078436|NCT03509428|Exercise|exercise
5078437|NCT03509428|mortality|mortality
5078438|NCT03509428|morbidity|morbidity
5078439|NCT03509428|surgery|surgery
5078440|NCT03509428|colorectal|colorectal
5078441|NCT03509428|upper gastrointestinal|upper gastrointestinal
5078442|NCT03509428|hepatobiliary|hepatobiliary
5078443|NCT03509428|urology|urology
5078444|NCT03509428|lung|lung
5078445|NCT03509428|nutrition|nutrition
5078446|NCT03509428|psychology|psychology
5078447|NCT03509415|Confocal|confocal
5078448|NCT03509415|RCM|rcm
5078449|NCT03509415|Imaging|imaging
5078450|NCT03509415|Skin cancer|skin cancer
5078451|NCT03509402|short dental implants|short dental implants
5078452|NCT03509402|full-arch prosthesis|full-arch prosthesis
5078453|NCT03509350|Vitamin C|vitamin c
5078454|NCT03509350|Thiamine|thiamine
5078455|NCT03509350|Corticosteroid|corticosteroid
5078456|NCT03509337|Elastography, Nervous tissue, Muscle tonus|elastography, nervous tissue, muscle tonus
5078457|NCT03509311|Asthma|asthma
5078458|NCT03509311|Physical activity|physical activity
5078459|NCT03509311|Cardiorespiratory fitness|cardiorespiratory fitness
5078460|NCT03509311|Quality of life|quality of life
5078461|NCT03509298|activated CIK|activated cik
5078462|NCT03509298|MUC1|muc1
5078463|NCT03509298|bispecific antibody|bispecific antibody
5078464|NCT03509298|pancreatic cancer|pancreatic cancer
5078465|NCT03509233|periodontitis|periodontitis
5078466|NCT03509233|full mouth scaling|full mouth scaling
5078467|NCT03509233|air abrasion|air abrasion
5078468|NCT03509233|scaling|scaling
5078469|NCT03509220|Colonoscopy|colonoscopy
5078470|NCT03509220|PBK-1701TC|pbk-1701tc
5078473|NCT03509207|Histone deacetylases|histone deacetylases
5078475|NCT03509194|children|children
5078476|NCT03509194|liver transplantation|liver transplantation
5078477|NCT03509194|liver cirrhosis|liver cirrhosis
5078481|NCT03509155|Infant and Young Child Feeding|infant and young child feeding
5078482|NCT03509155|Program Evaluation|program evaluation
5078483|NCT03509155|Food Supplementation|food supplementation
5078484|NCT03509155|Biscuit|biscuit
5078485|NCT03509155|wasting children|wasting children
5078492|NCT03509103|Partograpgh|partograpgh
5078493|NCT03509090|regional anesthesia|regional anesthesia
5078494|NCT03509090|erector spinae plane block|erector spinae plane block
5078495|NCT03509090|postoperative pain|postoperative pain
5078496|NCT03509077|geriatric|geriatric
5078497|NCT03509077|addiction|addiction
5078498|NCT03509064|Primary sjogren syndrome|primary sjogren syndrome
5078499|NCT03509064|Small fiber neuropathy|small fiber neuropathy
5078500|NCT03509064|Quality of life|quality of life
5078502|NCT03509051|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5078503|NCT03509012|Durvalumab|durvalumab
5078504|NCT03509012|Chemotherapy|chemotherapy
5078505|NCT03509012|Radiotherapy|radiotherapy
5078506|NCT03509012|HNSCC|hnscc
5078507|NCT03509012|NSCLC|nsclc
5078508|NCT03509012|SCLC|sclc
5078509|NCT03509012|locally-advanced|locally-advanced
5078510|NCT03509012|limited stage|limited stage
5078511|NCT03509012|first line|first line
5078512|NCT03508934|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5078513|NCT03508934|hypoglycemia|hypoglycemia
5078514|NCT03508934|Continuous Glucose Monitoring|continuous glucose monitoring
5078515|NCT03508934|hospital|hospital
5078516|NCT03508934|inpatient|inpatient
5078517|NCT03508921|Onabotulinumtoxin|onabotulinumtoxin
5078518|NCT03508908|HIV testing|hiv testing
5078519|NCT03508908|ART|art
5078520|NCT03508908|partner notification|partner notification
5078521|NCT03508908|PrEP|prep
5078522|NCT03508895|Hemp protein|hemp protein
5078523|NCT03508895|Protein hydrolysate|protein hydrolysate
5078524|NCT03508895|Bioactive peptides|bioactive peptides
5078525|NCT03508895|Cannabis sativa|cannabis sativa
5078526|NCT03508882|Eyelid|eyelid
5078527|NCT03508882|Dystonia|dystonia
5078528|NCT03508882|Botulinum injection|botulinum injection
5078529|NCT03508882|Oculoplastics|oculoplastics
5078530|NCT03508830|Liposomal Bupivacaine|liposomal bupivacaine
5078531|NCT03508830|Intercostal Nerve Block|intercostal nerve block
5078532|NCT03508830|Minimally Invasive Thoracic Surgery|minimally invasive thoracic surgery
5078533|NCT03508817|Atropine, myopia, children|atropine, myopia, children
5078534|NCT03508804|surgical abortion|surgical abortion
5078535|NCT03508804|cervical anesthesia|cervical anesthesia
5078536|NCT03508804|pain control|pain control
5078537|NCT03508765|ASCT|asct
5078538|NCT03508765|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5078539|NCT03508765|18-154|18-154
5078540|NCT03508726|Sarcoma|sarcoma
5078541|NCT03508726|Soft tissue|soft tissue
5078542|NCT03508713|Rheumatoid Arthritis|rheumatoid arthritis
5078543|NCT03508713|prognosis|prognosis
5078544|NCT03508700|TNX-102 SL|tnx-102 sl
5078545|NCT03508700|Bedtime|bedtime
5078546|NCT03508700|Sublingual|sublingual
5078547|NCT03508700|Safety|safety
5078548|NCT03508700|PTSD|ptsd
5078549|NCT03508661|Scleroderma|scleroderma
5078550|NCT03508661|Systemic Sclerosis|systemic sclerosis
5078551|NCT03508661|Support group|support group
5078552|NCT03508661|Training|training
5078553|NCT03508661|Feasibility|feasibility
5078554|NCT03508635|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
5078555|NCT03508583|mpoc|mpoc
5078556|NCT03508583|Validity and Reliability|validity and reliability
5078557|NCT03508518|Accessibility of health services|accessibility of health services
5078558|NCT03508518|Access to psychiatric care|access to psychiatric care
5078559|NCT03508518|Consultation-liaison|consultation-liaison
5078560|NCT03508518|General practitioner and psychiatrist collaboration|general practitioner and psychiatrist collaboration
5078561|NCT03508518|Care pathway|care pathway
5078562|NCT03508505|Acute Heart Failure|acute heart failure
5078563|NCT03508505|Low Output Heart Failure|low output heart failure
5078564|NCT03508505|Cardiac Low Output|cardiac low output
5078565|NCT03508505|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5078566|NCT03508505|ECMO|ecmo
5078567|NCT03508505|Venoarterial Extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
5078568|NCT03508505|Cardiac Surgery|cardiac surgery
5078570|NCT03508453|monoclonal antibody|monoclonal antibody
5078571|NCT03508427|Bipolar Disorder|bipolar disorder
5078572|NCT03508427|Smartphone|smartphone
5078573|NCT03508427|Self-monitoring|self-monitoring
5078575|NCT03508414|Relapse-remitting Multiple Sclerosis|relapse-remitting multiple sclerosis
4964784|NCT04209426|complex|complex
5078576|NCT03508401|superior vena cava|superior vena cava
5078577|NCT03508388|Liver volume|liver volume
5078578|NCT03508388|Alcoholic cirrhosis|alcoholic cirrhosis
5077476|NCT03515291|MRI|mri
5078579|NCT03508388|Liver transplantation|liver transplantation
5078580|NCT03508336|disorders of consciousness|disorders of consciousness
5078582|NCT03508336|prognosis prediction|prognosis prediction
5078583|NCT03508336|minimally conscious state|minimally conscious state
5078585|NCT03508297|Confocal|confocal
5078587|NCT03508297|Imaging|imaging
5078588|NCT03508297|Skin cancer|skin cancer
5078589|NCT03508284|Multiple sclerosis|multiple sclerosis
5078590|NCT03508284|Dual-task|dual-task
5078591|NCT03508284|Balance|balance
5078592|NCT03508284|Mobility|mobility
5078593|NCT03508284|Cognition|cognition
5078594|NCT03508245|Tourette Syndrome|tourette syndrome
5078595|NCT03508245|Tourette's|tourette's
5078596|NCT03508245|Tics|tics
5078597|NCT03508245|Circadian|circadian
5078598|NCT03508245|Sleep|sleep
5078599|NCT03508219|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5078600|NCT03508219|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5078610|NCT03508180|nausea|nausea
5078611|NCT03508180|vomiting|vomiting
5078612|NCT03508141|Fibrinogen Concentrate|fibrinogen concentrate
5078613|NCT03508141|Cryoprecipitate|cryoprecipitate
5078614|NCT03508102|remifentanil|remifentanil
5078615|NCT03508102|bispectral index|bispectral index
5078616|NCT03508102|Caesarean delivery|caesarean delivery
5078617|NCT03508102|general anesthesia|general anesthesia
5078618|NCT03508076|Vibrating Capsule|vibrating capsule
5078619|NCT03508076|Efficacy and Safety|efficacy and safety
5078620|NCT03508076|Chronic Constipation|chronic constipation
5078621|NCT03508076|different vibrating modes|different vibrating modes
5078622|NCT03508011|Breast Cancer|breast cancer
5078623|NCT03508011|Ovarian Cancer|ovarian cancer
5078624|NCT03508011|Prostate Cancer|prostate cancer
5078625|NCT03508011|Advanced solid tumours|advanced solid tumours
5078626|NCT03507985|morphine|morphine
5078627|NCT03507985|attention disorders|attention disorders
5078628|NCT03507972|ankle|ankle
5078629|NCT03507972|diagnostic|diagnostic
5078630|NCT03507972|ankle's ultrasound|ankle's ultrasound
5078631|NCT03507972|traumatic lesion|traumatic lesion
5078632|NCT03507933|villo-nodular synovitis|villo-nodular synovitis
5078633|NCT03507933|Hip|hip
5078634|NCT03507933|Surgery|surgery
5078635|NCT03507907|neck pain|neck pain
5078636|NCT03507907|older adults|older adults
5078637|NCT03507907|mobilization|mobilization
5078638|NCT03507894|rehabilitation|rehabilitation
5078639|NCT03507894|exercise|exercise
5078640|NCT03507894|stroke|stroke
5078641|NCT03507894|adherence|adherence
5078642|NCT03507881|isthmic spondylolisthesis|isthmic spondylolisthesis
5078643|NCT03507816|Tuberculosis|tuberculosis
5078644|NCT03507816|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
5078645|NCT03507816|Observational retrospective study|observational retrospective study
5078646|NCT03507816|Clinical epidemiology|clinical epidemiology
5078647|NCT03507816|Treatment outcome|treatment outcome
5078648|NCT03507816|Migrant|migrant
5078649|NCT03507816|Precarity|precarity
5078650|NCT03507803|Gait training|gait training
5078651|NCT03507803|Walking|walking
5078652|NCT03507790|Alzheimer's Disease|alzheimer's disease
5078653|NCT03507764|Treadmills|treadmills
5078654|NCT03507764|Exercise|exercise
5078655|NCT03507764|Number of steps|number of steps
5078656|NCT03507764|Dispatchers|dispatchers
5078657|NCT03507725|mind-body intervention|mind-body intervention
5078658|NCT03507725|18-189|18-189
5078659|NCT03507712|Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric|asymmetric, inferior oblique, overaction, surgery, symmetric
5078660|NCT03507699|radiotherapy|radiotherapy
5078661|NCT03507699|radiosurgery|radiosurgery
5078662|NCT03507699|immunotherapy|immunotherapy
5078663|NCT03507699|PD-1|pd-1
5078664|NCT03507699|CTLA-4|ctla-4
5078665|NCT03507699|TLR9|tlr9
5078674|NCT03507660|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
5078675|NCT03507647|randomized controlled trial|randomized controlled trial
5078676|NCT03507647|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
5078677|NCT03507647|clinical effectiveness|clinical effectiveness
5078678|NCT03507647|cost-effectiveness|cost-effectiveness
5078679|NCT03507647|working mechanisms|working mechanisms
5078680|NCT03507634|Lidocaine|lidocaine
5078681|NCT03507634|Dexmedetomidine|dexmedetomidine
5078682|NCT03507634|Opioid Free|opioid free
5078683|NCT03507634|Bariatric surgery|bariatric surgery
5078684|NCT03507595|prostate specific membrane antigen(PMSA)|prostate specific membrane antigen(pmsa)
5078685|NCT03507595|prostate cancer|prostate cancer
5078686|NCT03507595|PET/CT|pet/ct
5078688|NCT03507543|Breast Cancer|breast cancer
5078689|NCT03507543|Ovarian Cancer|ovarian cancer
5078690|NCT03507543|Prostate Cancer|prostate cancer
5961340|NCT04287777|Mupirocin gel|mupirocin gel
5961341|NCT04287777|Mupirocin ointment|mupirocin ointment
5961342|NCT04287777|Impetigo in children|impetigo in children
5961343|NCT04287751|Obstructive Sleep Apnoea|obstructive sleep apnoea
5090554|NCT03432871|Mitochondria|mitochondria
5078697|NCT03507504|psychiatric aspects|psychiatric aspects
5078698|NCT03507491|Pediatric|pediatric
5078699|NCT03507491|Sarcoma|sarcoma
5078700|NCT03507491|Neuroblastoma|neuroblastoma
5078701|NCT03507491|Ewing sarcoma|ewing sarcoma
5078702|NCT03507491|Osteosarcoma|osteosarcoma
5078707|NCT03507491|Germ cell tumor|germ cell tumor
5078709|NCT03507465|metronomic|metronomic
5078717|NCT03507439|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5078718|NCT03507439|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
5078720|NCT03507426|Ketamine|ketamine
5078721|NCT03507426|Ocular enucleation|ocular enucleation
5078722|NCT03507426|Analgesia|analgesia
5078723|NCT03507413|abdominal aortic aneurysm|abdominal aortic aneurysm
5078724|NCT03507413|metformin|metformin
5078725|NCT03507413|non-diabetic|non-diabetic
5078727|NCT03507400|Introvision: mental and emotional self-regulation technique|introvision: mental and emotional self-regulation technique
5078728|NCT03507400|Mindfulness, perception technique|mindfulness, perception technique
5078729|NCT03507400|Migraine|migraine
5078730|NCT03507387|Intramuscular|intramuscular
5078731|NCT03507387|Phenylephrine|phenylephrine
5078732|NCT03507374|Stroke|stroke
5078733|NCT03507374|alirocumab|alirocumab
5078734|NCT03507374|Intracranial Atherosclerosis|intracranial atherosclerosis
5078735|NCT03507374|Intraplaque Hemorrhage|intraplaque hemorrhage
5078736|NCT03507374|atorvastatin|atorvastatin
5078737|NCT03507374|praluent|praluent
5078738|NCT03507348|Anti-HLA alloantibodies|anti-hla alloantibodies
5078739|NCT03507348|Desensitization therapy|desensitization therapy
5078740|NCT03507348|Tocilizumab|tocilizumab
5078741|NCT03507348|Rituximab|rituximab
5078742|NCT03507335|Arrhythmia Atrial|arrhythmia atrial
5078743|NCT03507335|heart rate monitoring|heart rate monitoring
5078744|NCT03507335|stroke|stroke
5078745|NCT03507335|atrial fibrillation|atrial fibrillation
5078746|NCT03507322|texturization|texturization
5078747|NCT03507322|pregnancy rate|pregnancy rate
5078748|NCT03507322|oocyte donation|oocyte donation
5078749|NCT03507322|2D ultrasound|2d ultrasound
5078750|NCT03507322|3D ultrasound|3d ultrasound
5078751|NCT03507322|assisted reproductive technology (ART)|assisted reproductive technology (art)
5078773|NCT03507231|incentives|incentives
5078774|NCT03507231|field study|field study
5078775|NCT03507231|vaccination|vaccination
5078776|NCT03507218|Obsessive Compulsive Disorder|obsessive compulsive disorder
5078777|NCT03507218|Anxiety Disorder|anxiety disorder
4962014|NCT04227262|mirror therapy|mirror therapy
5078778|NCT03507218|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
5078779|NCT03507218|Eating Disorders|eating disorders
5078780|NCT03507205|Everolimus|everolimus
5078781|NCT03507205|Sirolimus|sirolimus
5078782|NCT03507205|Zotarolimus|zotarolimus
5078783|NCT03507205|Biolimus|biolimus
5078784|NCT03507205|Drug-eluting stent|drug-eluting stent
5078785|NCT03507192|MCI, Alzheimer's disease, muscle relaxation|mci, alzheimer's disease, muscle relaxation
5078786|NCT03507166|RC48-ADC|rc48-adc
5078787|NCT03507166|HER2|her2
5078788|NCT03507153|"Nylon denture base and PEEK partial denture"|"nylon denture base and peek partial denture"
5078789|NCT03507140|cirrhosis|cirrhosis
5078798|NCT03507088|fluorine-18 fluoroestradiol PET-CT|fluorine-18 fluoroestradiol pet-ct
5078800|NCT03507062|crystalloids|crystalloids
5078801|NCT03507036|knee area|knee area
5078802|NCT03507036|suprapatellar skin|suprapatellar skin
5078803|NCT03507036|aging|aging
5078804|NCT03507036|laxity|laxity
5078805|NCT03507010|Radiotherapy|radiotherapy
5078806|NCT03507010|Pain|pain
5078807|NCT03506997|Immune checkpoint inhibitor|immune checkpoint inhibitor
5078808|NCT03506997|Pembrolizumab|pembrolizumab
5078809|NCT03506971|Young child's development|young child's development
5078810|NCT03506971|Home visits|home visits
5078811|NCT03506971|Early interactions|early interactions
5078812|NCT03506971|attachment|attachment
5078813|NCT03506971|parenthood|parenthood
5078814|NCT03506932|blood sugar|blood sugar
5078815|NCT03506932|insulin|insulin
5078816|NCT03506932|peas|peas
5078817|NCT03506932|bread|bread
5078818|NCT03506932|metabolites|metabolites
5078819|NCT03506906|Chronic hypoventilation syndrome|chronic hypoventilation syndrome
5078820|NCT03506906|Polysomnography|polysomnography
5078821|NCT03506906|Transcutaneous Capnometry|transcutaneous capnometry
5078822|NCT03506906|Noninvasive Ventilation|noninvasive ventilation
5078823|NCT03506906|home mechanical ventilation|home mechanical ventilation
5078824|NCT03506906|Ventilator´s set-up|ventilator´s set-up
5078825|NCT03506893|refractory ascite|refractory ascite
5078826|NCT03506893|pump system|pump system
5078827|NCT03506867|Health Equity|health equity
5078828|NCT03506867|Community Based Participatory Action Research|community based participatory action research
5078829|NCT03506867|Poverty Reduction|poverty reduction
5078830|NCT03506815|Upper Extremity Deep Vein Thrombosis|upper extremity deep vein thrombosis
5078831|NCT03506815|Thromboprophylaxis|thromboprophylaxis
5078832|NCT03506815|Cancer|cancer
5078833|NCT03506815|Randomized Trial|randomized trial
5077686|NCT03513913|fertilization|fertilization
5078834|NCT03506763|office hysteroscopy, pain measure|office hysteroscopy, pain measure
5078835|NCT03506750|Conbercept|conbercept
5078836|NCT03506750|PLGF|plgf
5078837|NCT03506724|Hypertension, Pregnancy-induced|hypertension, pregnancy-induced
5078838|NCT03506724|Pregnancy Induced Hypertension|pregnancy induced hypertension
5078839|NCT03506724|Gestational Hypertension|gestational hypertension
5078840|NCT03506724|Transient Hypertension, Pregnancy|transient hypertension, pregnancy
5078841|NCT03506724|Pharmacogenetics|pharmacogenetics
5078842|NCT03506711|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5078843|NCT03506711|MRI|mri
5078844|NCT03506711|Isometric handgrip exercise|isometric handgrip exercise
5078845|NCT03506711|Children|children
5078846|NCT03506711|Adolescents|adolescents
5078847|NCT03506698|Birth weight|birth weight
5078848|NCT03506685|dry needling|dry needling
5078849|NCT03506685|ACL reconstruction|acl reconstruction
5078850|NCT03506685|knee ROM|knee rom
5078851|NCT03506685|pain management|pain management
5078852|NCT03506685|opioid use|opioid use
5078853|NCT03506672|Behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
5078854|NCT03506672|Psychosocial interventions|psychosocial interventions
5078855|NCT03506672|Well-being|well-being
5078856|NCT03506672|Long-term care facilities|long-term care facilities
5078857|NCT03506672|Family and formal caregivers|family and formal caregivers
5078858|NCT03506672|Partnership|partnership
5078859|NCT03506620|femoroacetabular impingement|femoroacetabular impingement
5078860|NCT03506620|hip arthroscopy|hip arthroscopy
5078861|NCT03506620|QL nerve block|ql nerve block
5078862|NCT03506607|exercise|exercise
5078863|NCT03506607|cardiovascular|cardiovascular
5078864|NCT03506607|normobaric hypoxia|normobaric hypoxia
5078865|NCT03506568|Adherence|adherence
5078866|NCT03506568|Medication|medication
5078867|NCT03506568|Glaucoma|glaucoma
5078868|NCT03506568|Device|device
5078869|NCT03506555|Laparoscopy|laparoscopy
5078870|NCT03506555|Hasson technique|hasson technique
5078871|NCT03506555|Veress needle technique|veress needle technique
5078872|NCT03506555|complications|complications
5078873|NCT03506529|TEP|tep
5078874|NCT03506529|hypermetabolism|hypermetabolism
5078875|NCT03506516|alcohol, hangover|alcohol, hangover
5078876|NCT03506503|nanofat|nanofat
5078877|NCT03506503|hair loss|hair loss
5078878|NCT03506503|prp|prp
5078879|NCT03506477|skin of color|skin of color
5078880|NCT03506477|psoriasis|psoriasis
5078881|NCT03506477|Enstilar|enstilar
5078884|NCT03506464|physical therapy|physical therapy
5078885|NCT03506464|sonoelastography|sonoelastography
5078886|NCT03506451|Financial toxicity|financial toxicity
5078887|NCT03506438|critical illness|critical illness
5078888|NCT03506438|palliative care|palliative care
5078889|NCT03506438|mobile app|mobile app
5078890|NCT03506438|psychological distress|psychological distress
5078891|NCT03506438|depression|depression
5078892|NCT03506438|anxiety|anxiety
5078893|NCT03506438|informal caregiver|informal caregiver
5078894|NCT03506412|Heart Failure|heart failure
5078895|NCT03506412|HFpEF|hfpef
5078896|NCT03506412|Entresto™|entresto™
5078897|NCT03506412|Neprilysin|neprilysin
5078898|NCT03506412|Diastolic Heart Failure|diastolic heart failure
5078899|NCT03506386|Real World Evidence , Multiple Myeloma Profile, Brazil|real world evidence , multiple myeloma profile, brazil
5078900|NCT03506321|colonoscopy|colonoscopy
5078901|NCT03506321|Residual adenoma|residual adenoma
5078902|NCT03506321|Recurrent adenoma|recurrent adenoma
5078903|NCT03506282|Running biomechanics|running biomechanics
5078904|NCT03506282|Vertical loading rate|vertical loading rate
5078905|NCT03506282|Music exercise|music exercise
5078906|NCT03506282|Gait analysis|gait analysis
5078907|NCT03506256|urinary tract infection|urinary tract infection
5078908|NCT03506256|Norfloxacin|norfloxacin
5078909|NCT03506256|Fluroquinolone|fluroquinolone
5078910|NCT03506256|Safety|safety
5078911|NCT03506256|Pakistan|pakistan
5078912|NCT03506243|IVF, rhFSH|ivf, rhfsh
5078913|NCT03506230|Rewards|rewards
5078914|NCT03506230|Medication Adherence|medication adherence
5078915|NCT03506230|Health Behavior|health behavior
5078916|NCT03506230|Diabetes Mellitus|diabetes mellitus
5078917|NCT03506230|Copayments|copayments
5078918|NCT03506217|mitral valve prolaps,|mitral valve prolaps,
5078919|NCT03506217|chorda tendinea,|chorda tendinea,
5078920|NCT03506217|cardiac output|cardiac output
5078921|NCT03506204|Pelvic floor muscle strength|pelvic floor muscle strength
5078922|NCT03506204|Pelvic floor dysfunction|pelvic floor dysfunction
5078923|NCT03506204|Postpartum|postpartum
5078924|NCT03506204|primipara|primipara
5078925|NCT03506191|Stenotrophomonas maltophilia|stenotrophomonas maltophilia
5078926|NCT03506191|Pneumonia|pneumonia
5078927|NCT03506191|Intensive Care Unit|intensive care unit
5078928|NCT03506178|Upper airway|upper airway
5078929|NCT03506178|Obstructive sleep apnea|obstructive sleep apnea
5078930|NCT03506178|Polysomnography|polysomnography
5078931|NCT03506139|Radiotherapy|radiotherapy
5078932|NCT03506139|Magnetic Resonance Imaging|magnetic resonance imaging
5078933|NCT03506126|amino acid requirement|amino acid requirement
5078934|NCT03506126|elderly|elderly
5961344|NCT04287751|Overnight Oximetry|overnight oximetry
5961345|NCT04287738|Pragmatic Clinical Trial|pragmatic clinical trial
5078935|NCT03506126|leucine|leucine
5078936|NCT03506126|dietary requirement|dietary requirement
5078941|NCT03506113|Mechanical ventilation|mechanical ventilation
5078942|NCT03506113|Intensive care|intensive care
5078943|NCT03506113|Sepsis|sepsis
5078944|NCT03506100|Spirometry|spirometry
5078945|NCT03506100|swimming|swimming
5078946|NCT03506100|water walking|water walking
5078947|NCT03506087|Advance Care Planning|advance care planning
5078948|NCT03506087|Shared Decision Making|shared decision making
5078949|NCT03506074|Obesity|obesity
5078950|NCT03506074|Flavor|flavor
5078951|NCT03506035|Shared epitope|shared epitope
5078952|NCT03506035|HLA-DRB1|hla-drb1
5078953|NCT03506035|Citrullinated peptides|citrullinated peptides
5078954|NCT03506035|Autoantibodies|autoantibodies
5078955|NCT03506022|Sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (CGMS )|sleep apnea syndrome, polysomnography and glucose monitoring continu glycemia (cgms )
5078956|NCT03505983|Prosthetic Limb Design|prosthetic limb design
5078957|NCT03505983|Prosthesis Fitting|prosthesis fitting
5078958|NCT03505970|Physiological Phenomena|physiological phenomena
5078959|NCT03505957|IV Dislodgement|iv dislodgement
5078960|NCT03505931|Peripheral artery disease|peripheral artery disease
5078961|NCT03505931|femoropopliteal|femoropopliteal
5078962|NCT03505931|drug-eluting stent|drug-eluting stent
5078963|NCT03505931|restenosis|restenosis
5078964|NCT03505905|Pregnenolone|pregnenolone
5078965|NCT03505892|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
5078966|NCT03505892|Adalimumab|adalimumab
5078967|NCT03505892|Humira|humira
5078968|NCT03505879|Next Generation Sequencing|next generation sequencing
5078969|NCT03505866|HIV|hiv
5078970|NCT03505866|Anti-retroviral therapy|anti-retroviral therapy
5078971|NCT03505866|Intervention|intervention
5078972|NCT03505866|Mental Health|mental health
5078973|NCT03505853|RNAi therapeutic|rnai therapeutic
5078974|NCT03505853|Porphyria|porphyria
5078975|NCT03505853|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
5078976|NCT03505853|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
5078977|NCT03505827|TECNIS Symfony|tecnis symfony
5078978|NCT03505814|post extubation care|post extubation care
5078979|NCT03505814|neonatal surgical critical care|neonatal surgical critical care
5078980|NCT03505814|oxygen therapy|oxygen therapy
5078981|NCT03505814|high nasal flow cannula|high nasal flow cannula
5078982|NCT03505775|Hormone replacement|hormone replacement
5078983|NCT03505775|Mineralocorticoids|mineralocorticoids
5078984|NCT03505775|23Na-magnetic resonance imaging|23na-magnetic resonance imaging
5078985|NCT03505775|Tissue sodium content|tissue sodium content
5078986|NCT03505723|Noncardiac surgery|noncardiac surgery
5078987|NCT03505723|Myocardial injury|myocardial injury
5078988|NCT03505723|Perioperative myocardial infarction|perioperative myocardial infarction
5078989|NCT03505723|Tranexamic Acid|tranexamic acid
5078990|NCT03505723|Hypotension|hypotension
5078991|NCT03505723|Hypertension|hypertension
5078992|NCT03505710|HER2 over-expression|her2 over-expression
5078993|NCT03505710|HER2 mutation|her2 mutation
5078994|NCT03505710|Unresectable or metastatic|unresectable or metastatic
5078995|NCT03505710|Non-squamous|non-squamous
5078997|NCT03505697|rehabilitation|rehabilitation
5079007|NCT03505554|ALK|alk
5079008|NCT03505554|relapsed|relapsed
5079009|NCT03505554|lorlatinib|lorlatinib
5079010|NCT03505528|Nanoparticle albumin-bound paclitaxel (Abraxane)|nanoparticle albumin-bound paclitaxel (abraxane)
5079011|NCT03505528|Phenelzine Sulfate|phenelzine sulfate
5079012|NCT03505528|Cancer stem cells|cancer stem cells
5079013|NCT03505528|epigenetics|epigenetics
5079014|NCT03505528|LSD1|lsd1
5079015|NCT03505502|Cesarean Myomectomy|cesarean myomectomy
5079016|NCT03505502|Tranexamic Acid|tranexamic acid
5079017|NCT03505489|Mannitol|mannitol
5079018|NCT03505489|Methacholine|methacholine
5079019|NCT03505489|Deep inhalation|deep inhalation
5079020|NCT03505489|Tidal breathing|tidal breathing
5079021|NCT03505476|Ileus|ileus
5079022|NCT03505476|Abdominal surgery|abdominal surgery
5079023|NCT03505476|Bowel obstruction|bowel obstruction
5079024|NCT03505476|Postoperative Ileus|postoperative ileus
5079025|NCT03505463|Spinal cord injury|spinal cord injury
5079026|NCT03505463|Biomarkers|biomarkers
5079027|NCT03505463|Inflammation|inflammation
5079028|NCT03505463|Trauma|trauma
5079029|NCT03505450|decision support tools,|decision support tools,
5079030|NCT03505437|anxiety disorders|anxiety disorders
5079031|NCT03505437|spider phobia|spider phobia
5079032|NCT03505437|stress|stress
5079033|NCT03505437|exposure therapy|exposure therapy
5079034|NCT03505437|generalization|generalization
5079035|NCT03505424|Premature Infant|premature infant
5079036|NCT03505424|Premature Birth|premature birth
5079037|NCT03505424|Smartphone App|smartphone app
5079038|NCT03505424|NICU|nicu
5079039|NCT03505411|Melatonin|melatonin
5079040|NCT03505411|Glutathione|glutathione
5077903|NCT03512756|Pancreas|pancreas
5079051|NCT03505385|Service-learning methodology|service-learning methodology
5079052|NCT03505372|Atypical ductal hyperplasia|atypical ductal hyperplasia
5079053|NCT03505372|ADH|adh
5079054|NCT03505346|Positron Emission Tomography|positron emission tomography
5079055|NCT03505346|nuclear medicine|nuclear medicine
4987962|NCT04066556|Stroke|stroke
5079056|NCT03505346|prognosis|prognosis
5079057|NCT03505320|zolbetuximab|zolbetuximab
5079058|NCT03505320|oxaliplatin|oxaliplatin
5079059|NCT03505320|fluorouracil|fluorouracil
5079060|NCT03505320|claudiximab|claudiximab
5079061|NCT03505320|IMAB362|imab362
5079062|NCT03505320|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
5079063|NCT03505320|Gastric cancer|gastric cancer
5079064|NCT03505294|Multiple Sclerosis|multiple sclerosis
5079065|NCT03505294|task-oriented training|task-oriented training
5079066|NCT03505294|physical performance|physical performance
5079067|NCT03505294|cognition|cognition
5079068|NCT03505268|Glycosylated hemoglobin A1c (HbA1c), Telemedicine|glycosylated hemoglobin a1c (hba1c), telemedicine
5079069|NCT03505164|Doxorubicin|doxorubicin
5079070|NCT03505164|suPAR|supar
5079071|NCT03505164|Caridomyopathy|caridomyopathy
5079072|NCT03505164|Heart Failure|heart failure
5079073|NCT03505164|Breast Cancer|breast cancer
5079074|NCT03505138|COPD|copd
5079075|NCT03505138|hospitalization|hospitalization
5079076|NCT03505138|telemedicine platform|telemedicine platform
5079077|NCT03505112|Goal-directed therapy|goal-directed therapy
5079078|NCT03505112|stroke volume index|stroke volume index
5079079|NCT03505099|gene therapy|gene therapy
5079081|NCT03505047|second trimester medical abortion|second trimester medical abortion
5079082|NCT03505047|Immediate versus delayed insertion|immediate versus delayed insertion
5079083|NCT03505047|copper intrauterine device|copper intrauterine device
4962373|NCT04225247|Dentin hypersensitivity|dentin hypersensitivity
5079084|NCT03505034|Spinal cord injury，Umbilical Cord Mesenchymal Stem Cells|spinal cord injury，umbilical cord mesenchymal stem cells
5079091|NCT03504995|Prostate|prostate
5079092|NCT03504995|Irreversible Electroporation|irreversible electroporation
5079128|NCT03504813|Quality of life|quality of life
5079129|NCT03504813|Wearables|wearables
5079130|NCT03504813|Urinary incontinence|urinary incontinence
5079131|NCT03504813|Insomnia|insomnia
5079132|NCT03504813|Risk of falls|risk of falls
5079133|NCT03504800|OCT|oct
5079134|NCT03504800|Keratoconus|keratoconus
5079135|NCT03504787|cerebral palsy|cerebral palsy
5079136|NCT03504787|upper extremity|upper extremity
5079137|NCT03504787|selective motor control|selective motor control
5079138|NCT03504774|OIT|oit
5079139|NCT03504774|Oral Immunotherapy|oral immunotherapy
5079140|NCT03504774|Cashew Allergy|cashew allergy
5079141|NCT03504774|Shrimp Allergy|shrimp allergy
5079142|NCT03504748|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
5079143|NCT03504748|chronic pain|chronic pain
5079144|NCT03504748|parkinson|parkinson
5079145|NCT03504748|treatment|treatment
5079146|NCT03504748|non-motor symptom|non-motor symptom
5079151|NCT03504657|Vertebral Artery Stenosis|vertebral artery stenosis
5079152|NCT03504657|Drug-coated balloon angioplasty|drug-coated balloon angioplasty
5079153|NCT03504657|Stenting|stenting
5079154|NCT03504631|tamoxifen|tamoxifen
5079155|NCT03504631|breast cancer|breast cancer
5079156|NCT03504631|Z-endoxifen|z-endoxifen
5079157|NCT03504579|rt-fMRI|rt-fmri
5079158|NCT03504579|MRI|mri
5079159|NCT03504579|schizophrenia|schizophrenia
5079160|NCT03504579|auditory hallucinations|auditory hallucinations
5079161|NCT03504579|neurofeedback|neurofeedback
5079162|NCT03504540|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5079163|NCT03504540|Age Related Macular Degeneration|age related macular degeneration
5079164|NCT03504540|"Pseudo-drusen-like deposits"|"pseudo-drusen-like deposits"
5079165|NCT03504527|ICS|ics
5079166|NCT03504527|LABA|laba
5079167|NCT03504527|LAMA|lama
5079168|NCT03504527|therapy|therapy
5079169|NCT03504527|asthma|asthma
5079170|NCT03504527|COPD|copd
5079171|NCT03504527|ACO|aco
5079172|NCT03504514|non invasive ventilation|non invasive ventilation
5079173|NCT03504514|invasive ventilation|invasive ventilation
5079174|NCT03504514|neuromuscular disorder|neuromuscular disorder
5079175|NCT03504514|phonation|phonation
5079179|NCT03504462|Regional Anesthesia|regional anesthesia
5079180|NCT03504462|Regional Analgesia|regional analgesia
5079181|NCT03504462|Ultrasound|ultrasound
5079182|NCT03504462|Distal block|distal block
5079183|NCT03504462|Plantar nerve block|plantar nerve block
5079195|NCT03504371|oesophageal surgeries-epidural-erector block|oesophageal surgeries-epidural-erector block
5079196|NCT03504358|surgery|surgery
5079197|NCT03504358|scoring system|scoring system
5079198|NCT03504358|hepatocellular carcinoma|hepatocellular carcinoma
5079886|NCT03499912|IDH2|idh2
5079202|NCT03504319|exercise|exercise
5079203|NCT03504319|inflammation|inflammation
5079204|NCT03504319|metabolic inflexibility|metabolic inflexibility
5079205|NCT03504319|insulin resistance|insulin resistance
5079206|NCT03504319|neonatal adiposity|neonatal adiposity
5079207|NCT03504293|Endosonography|endosonography
5079208|NCT03504293|Endoscopic retrograde choledochography|endoscopic retrograde choledochography
5079210|NCT03504280|cholecalciferol|cholecalciferol
5079211|NCT03504280|mehadose|mehadose
5079212|NCT03504267|physical activity|physical activity
5079213|NCT03504267|exercise|exercise
5961346|NCT04287738|Family Caregivers|family caregivers
5961347|NCT04287738|Patient Care Management|patient care management
5079214|NCT03504267|patient-provider communication|patient-provider communication
5079215|NCT03504254|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5079216|NCT03504254|diffusion tensor imaging|diffusion tensor imaging
5079217|NCT03504254|functional magnetic resonance imaging|functional magnetic resonance imaging
5079218|NCT03504241|mesenchymal stromal cells (MSCs)|mesenchymal stromal cells (mscs)
5079219|NCT03504241|anti-rejection drugs|anti-rejection drugs
5079220|NCT03504241|operational tolerance|operational tolerance
5079221|NCT03504215|extremely preterm|extremely preterm
5079223|NCT03504215|term|term
5079224|NCT03504215|exercise capacity|exercise capacity
5079225|NCT03504215|pulmonary function|pulmonary function
5079226|NCT03504215|muscle oxygenation|muscle oxygenation
5079228|NCT03504163|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
5079229|NCT03504163|17-602|17-602
5079230|NCT03504137|mHealth|mhealth
5079231|NCT03504137|kidney transplantation|kidney transplantation
5079232|NCT03504137|medication adherence|medication adherence
5079233|NCT03504137|video directly observed therapy|video directly observed therapy
5079234|NCT03504098|One-carbon metabolism|one-carbon metabolism
5079235|NCT03504098|Folate|folate
5079236|NCT03504098|Choline|choline
5079237|NCT03504098|metabolomic marker|metabolomic marker
5079238|NCT03504098|Cancer risk|cancer risk
5079239|NCT03504085|Chronic Low Back Pain|chronic low back pain
5079240|NCT03504085|CLBP|clbp
5079241|NCT03504085|Chronic Neck Pain|chronic neck pain
5079242|NCT03504085|CNP|cnp
5079243|NCT03504085|Chronic Pain|chronic pain
5079244|NCT03504085|Military|military
5079245|NCT03504085|Active Duty|active duty
5079246|NCT03504085|Yoga|yoga
5079247|NCT03504085|Mindbody|mindbody
5079248|NCT03504072|Etanercept|etanercept
5079249|NCT03504072|Infection|infection
5079250|NCT03504072|Tofacitinib|tofacitinib
5079251|NCT03504072|Tuberculosis|tuberculosis
5079252|NCT03504072|Spondyloarthritis|spondyloarthritis
5079253|NCT03504059|Obesity|obesity
5079254|NCT03504059|Cardiovascular Health|cardiovascular health
5079255|NCT03504059|Diabetes|diabetes
5079256|NCT03504059|Adolescents|adolescents
5079257|NCT03504059|Physical Activity|physical activity
5079258|NCT03504059|Diet|diet
5079259|NCT03504059|School-Based|school-based
5079260|NCT03504046|artificial pancreas|artificial pancreas
5079261|NCT03504046|hyperglycemia|hyperglycemia
5079262|NCT03504046|hypoglycemia|hypoglycemia
5079263|NCT03504033|Xenon|xenon
5079264|NCT03504033|Liver resection|liver resection
5079265|NCT03504033|post-operative liver failure|post-operative liver failure
5079266|NCT03504033|anesthetics, inhalation|anesthetics, inhalation
5079267|NCT03504033|Desflurane|desflurane
5079268|NCT03504033|Randomized controlled trail|randomized controlled trail
5079269|NCT03504033|RCT|rct
5079270|NCT03504007|Deep Vein Thrombosis|deep vein thrombosis
5079271|NCT03504007|Pulmonary Embolism|pulmonary embolism
5079272|NCT03504007|Apixaban|apixaban
5079273|NCT03504007|Rivaroxaban|rivaroxaban
5079274|NCT03504007|Dabigatran|dabigatran
5079275|NCT03504007|Edoxaban|edoxaban
5079276|NCT03503981|Process-outcome study|process-outcome study
5079277|NCT03503981|Mechanisms of change|mechanisms of change
5079278|NCT03503916|Accidental fall|accidental fall
5079279|NCT03503916|Postural Balance|postural balance
5079282|NCT03503890|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme
5079283|NCT03503864|Neuroblastoma|neuroblastoma
5079284|NCT03503864|Arsenic Trioxide|arsenic trioxide
5079287|NCT03503851|transcatheter mitral valve repair|transcatheter mitral valve repair
5079289|NCT03503812|Randomized clinical trial|randomized clinical trial
5079290|NCT03503812|Public Health Intervention|public health intervention
5079291|NCT03503812|Behavioral Intervention|behavioral intervention
5079292|NCT03503812|Exposure-Reduction Approaches|exposure-reduction approaches
5079293|NCT03503812|Desert dust storm events|desert dust storm events
5079294|NCT03503812|Climate change|climate change
5079299|NCT03503799|EndoPredict®|endopredict®
5079300|NCT03503799|endocrine therapy|endocrine therapy
5079301|NCT03503786|PD-L1 Expression|pd-l1 expression
5079302|NCT03503786|advanced endometrial cancer|advanced endometrial cancer
5079303|NCT03503786|recurrent endometrial cancer|recurrent endometrial cancer
5079304|NCT03503786|Patient reported outcomes|patient reported outcomes
5079305|NCT03503773|Renal Denervation|renal denervation
5079306|NCT03503773|Neurolysis|neurolysis
5079307|NCT03503760|Extremely low magnetic field (ELF)|extremely low magnetic field (elf)
5079308|NCT03503760|Fibromyalgia impact questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
5079309|NCT03503760|Pittsburgh Sleep Quality Index (PSQI)|pittsburgh sleep quality index (psqi)
5091172|NCT03428659|Gait|gait
5079310|NCT03503760|Short Form-12 of Physical and Mental Health Summary (SF-12)|short form-12 of physical and mental health summary (sf-12)
5079311|NCT03503760|"LIMFA Therapy® machine from Eywa Srl system"|"limfa therapy® machine from eywa srl system"
5079313|NCT03503747|Infants|infants
5079314|NCT03503747|INGR1D|ingr1d
5079315|NCT03503721|BipolEP|bipolep
5079316|NCT03503721|TURP|turp
5079317|NCT03503695|auricular acupuncture|auricular acupuncture
5079318|NCT03503695|battlefield acupuncture|battlefield acupuncture
5079319|NCT03503695|insomnia|insomnia
5079320|NCT03503695|chronic pain|chronic pain
5079321|NCT03503695|randomized|randomized
5079322|NCT03503682|Short Course Radiotherapy|short course radiotherapy
5079323|NCT03503682|Complicated Bone Metastases|complicated bone metastases
5079324|NCT03503669|Memory impairment|memory impairment
5079325|NCT03503669|Meditation|meditation
5079326|NCT03503669|Yoga|yoga
5079327|NCT03503669|Memory Training|memory training
5079328|NCT03503669|Mild Cognitive Impairment|mild cognitive impairment
5079329|NCT03503669|MCI|mci
5079330|NCT03503669|Geriatric|geriatric
5079331|NCT03503669|fMRI|fmri
5079332|NCT03503669|Alzheimer's disease|alzheimer's disease
5079333|NCT03503669|Cardiovascular risk|cardiovascular risk
5079334|NCT03503643|prostate cancer|prostate cancer
5079335|NCT03503643|cryoablation|cryoablation
5079336|NCT03503630|Locally advanced rectal cancer|locally advanced rectal cancer
5079337|NCT03503630|Immunotherapy|immunotherapy
5079338|NCT03503630|Short course radiation|short course radiation
5079339|NCT03503630|Folfox|folfox
5079340|NCT03503630|Response rate|response rate
5079341|NCT03503604|mAb|mab
5079342|NCT03503604|VEGF|vegf
5079343|NCT03503604|antibody|antibody
5079344|NCT03503604|phase1|phase1
5079345|NCT03503591|tympanostomy|tympanostomy
5079346|NCT03503591|myringotomy|myringotomy
5079347|NCT03503591|otitis media|otitis media
5079348|NCT03503591|ear tubes|ear tubes
5079349|NCT03503591|ear infection|ear infection
5079350|NCT03503565|one-lung ventilation|one-lung ventilation
5079351|NCT03503565|thoracic surgery|thoracic surgery
5079352|NCT03503565|atelectasis|atelectasis
5079353|NCT03503565|postoperative pulmonary complication|postoperative pulmonary complication
5079354|NCT03503500|Breastfeeding|breastfeeding
5079355|NCT03503500|Laid-back position|laid-back position
5079356|NCT03503500|Breast problems|breast problems
5079357|NCT03503500|Exclusive breastfeeding|exclusive breastfeeding
5079358|NCT03503461|Calcineurin inhibitors|calcineurin inhibitors
5079359|NCT03503461|hypertension|hypertension
5079360|NCT03503461|kidney transplant|kidney transplant
5079361|NCT03503461|acidosis|acidosis
5079362|NCT03503461|Gordon syndrome|gordon syndrome
5079366|NCT03503435|Art Therapy|art therapy
5079367|NCT03503435|Total Laryngectomy|total laryngectomy
5079368|NCT03503396|drunk driving|drunk driving
5079369|NCT03503396|alcohol impaired driving|alcohol impaired driving
5079370|NCT03503396|drinking and driving|drinking and driving
5079371|NCT03503396|ambulatory assessment|ambulatory assessment
5079372|NCT03503383|Hypertension with pregnancy|hypertension with pregnancy
5079373|NCT03503383|anxiety|anxiety
5079374|NCT03503383|depression|depression
5079375|NCT03503383|preeclampsia|preeclampsia
5079376|NCT03503383|mental health|mental health
5079377|NCT03503370|topical chlorhexidine|topical chlorhexidine
5079378|NCT03503370|prevention|prevention
5079379|NCT03503370|clinical trial|clinical trial
5079380|NCT03503357|Consciousness|consciousness
5079381|NCT03503357|Electroencephalography|electroencephalography
5079382|NCT03503357|Anesthesia|anesthesia
5079383|NCT03503305|Adipose-derived stem cells|adipose-derived stem cells
5079384|NCT03503305|osteoarthritis|osteoarthritis
5079385|NCT03503292|Pharmacogenetics|pharmacogenetics
5079386|NCT03503292|CYP2D6|cyp2d6
5079436|NCT03502915|nitrous oxide|nitrous oxide
5079437|NCT03502915|analgesia|analgesia
5079438|NCT03502915|pregnancy|pregnancy
5079439|NCT03502889|Total Knee Arthroplasty|total knee arthroplasty
5079440|NCT03502889|SPANK Block|spank block
5079441|NCT03502889|Adductor Canal Block|adductor canal block
5079442|NCT03502889|Regional Anesthesia|regional anesthesia
5079443|NCT03502837|ERP;DOC;auditory|erp;doc;auditory
5079453|NCT03502811|MitraClip|mitraclip
5079454|NCT03502811|MitraClip NTR|mitraclip ntr
5079455|NCT03502811|MitraClip XTR|mitraclip xtr
5079456|NCT03502811|Mitral Regurgitation|mitral regurgitation
5079457|NCT03502759|SUDEP|sudep
5079458|NCT03502759|Epilepsy|epilepsy
5079459|NCT03502681|Cisplatin-Ineligible|cisplatin-ineligible
5079460|NCT03502681|Avelumab|avelumab
5079461|NCT03502681|PD-L1 Monoclonal Antibody|pd-l1 monoclonal antibody
5079462|NCT03502681|Eribulin Mesylate|eribulin mesylate
5079463|NCT03502668|low risk myelodysplastic syndromes, MDS, ASTX727|low risk myelodysplastic syndromes, mds, astx727
5079464|NCT03502655|Pain|pain
5079465|NCT03502655|Peripheral intravenous catheter|peripheral intravenous catheter
5079466|NCT03502655|Peripheral catheterization|peripheral catheterization
5079467|NCT03502655|Communication|communication
5079468|NCT03502655|Emergency Department|emergency department
5079469|NCT03502642|Ropivacaine|ropivacaine
5079470|NCT03502642|wound infusion|wound infusion
5079471|NCT03502642|analgesia|analgesia
5078293|NCT03510455|FGF-23|fgf-23
5079476|NCT03502564|Eating disorders|eating disorders
5079477|NCT03502564|Cognitive behavior therapy|cognitive behavior therapy
5079478|NCT03502564|Cognitive processing therapy|cognitive processing therapy
5079479|NCT03502564|Randomized controlled trial|randomized controlled trial
5079480|NCT03502551|ketamine|ketamine
5961348|NCT04287712|Early-Stage Lung Cancer|early-stage lung cancer
5079481|NCT03502551|suicide|suicide
5079482|NCT03502473|fat flanks|fat flanks
5079483|NCT03502460|Lung ultrasonography|lung ultrasonography
5079484|NCT03502460|fluid administration|fluid administration
5079485|NCT03502460|limitation|limitation
5079486|NCT03502460|stroke volume variation|stroke volume variation
5079487|NCT03502460|esophageal Doppler|esophageal doppler
5079488|NCT03502421|Ketamine|ketamine
5079489|NCT03502343|Pancreatic cancer|pancreatic cancer
5079490|NCT03502343|Metastatic|metastatic
5079491|NCT03502343|Modified|modified
5079492|NCT03502343|Gemcitabine|gemcitabine
5079493|NCT03502343|nab-Paclitaxel|nab-paclitaxel
5079499|NCT03502304|Metabolic syndrome|metabolic syndrome
5079500|NCT03502304|Obesity|obesity
5079501|NCT03502291|Human challenge models|human challenge models
5079502|NCT03502291|Immunity|immunity
5079503|NCT03502291|Streptococcus pneumoniae|streptococcus pneumoniae
5079504|NCT03502291|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
5079505|NCT03502278|refugee|refugee
5079506|NCT03502252|early childhood development|early childhood development
5079507|NCT03502252|social and emotional development|social and emotional development
5079508|NCT03502252|secure parenting relationships|secure parenting relationships
5079509|NCT03502213|Prostate Cancer|prostate cancer
5079510|NCT03502213|Localized Prostate Cancer|localized prostate cancer
5079511|NCT03502213|Low Risk Prostate Cancer|low risk prostate cancer
5079512|NCT03502213|Active Surveillance|active surveillance
5079513|NCT03502213|Active Monitoring|active monitoring
5079514|NCT03502213|OncotypeDX GPS|oncotypedx gps
5079515|NCT03502213|Genomic Prostate Score|genomic prostate score
5079516|NCT03502213|Genomic Test|genomic test
5079517|NCT03502213|Molecular Test|molecular test
5079518|NCT03502122|stroke|stroke
5079519|NCT03502122|rehabilitation|rehabilitation
5079520|NCT03502109|Medication review|medication review
5079521|NCT03502109|Pharmacist|pharmacist
5738971|NCT00361504|Backache|backache
5079522|NCT03502109|Medication therapy management|medication therapy management
5079523|NCT03502109|Cardiovascular diseases|cardiovascular diseases
5079524|NCT03502109|Economics|economics
5079525|NCT03502109|Elderly|elderly
5079536|NCT03502018|Bupivacaine|bupivacaine
5079537|NCT03502018|Intracapsular Fracture of the Femur|intracapsular fracture of the femur
5079538|NCT03502018|Femoral Neck Fracture|femoral neck fracture
5079539|NCT03502018|Hip Hemiarthroplasty|hip hemiarthroplasty
5079540|NCT03501992|Papillomavirus vaccines|papillomavirus vaccines
5079541|NCT03501992|Vaccination|vaccination
5079542|NCT03501992|Patient acceptance of health care|patient acceptance of health care
5079543|NCT03501992|Child|child
5079544|NCT03501992|Parents|parents
5079545|NCT03501992|Primary health care|primary health care
5079546|NCT03501992|Health personnel|health personnel
5079547|NCT03501992|Primary prevention|primary prevention
5079548|NCT03501992|Neoplasms|neoplasms
5079549|NCT03501979|HER2+|her2+
5079550|NCT03501979|metastatic breast cancer|metastatic breast cancer
5079551|NCT03501979|leptomeningeal disease|leptomeningeal disease
5079552|NCT03501979|tucatinib|tucatinib
5079553|NCT03501979|trastuzumab|trastuzumab
5079554|NCT03501979|capecitabine|capecitabine
5079555|NCT03501966|headache|headache
5079556|NCT03501966|idiopathic intracranial hypertension (IIH)|idiopathic intracranial hypertension (iih)
5079557|NCT03501966|shunt|shunt
5079558|NCT03501966|fenestration|fenestration
5079559|NCT03501966|acetazolamide|acetazolamide
5079561|NCT03501966|diamox|diamox
5079562|NCT03501953|Cognitive Change|cognitive change
5079563|NCT03501953|Physical Activity|physical activity
5079564|NCT03501953|Environmental Exposure|environmental exposure
5079565|NCT03501953|Health Behavior|health behavior
5079566|NCT03501927|Ultrasound|ultrasound
5079567|NCT03501927|FOCUS|focus
5079568|NCT03501927|Surgery|surgery
5079569|NCT03501927|Anesthesia|anesthesia
5079570|NCT03501914|Care givers|care givers
5079571|NCT03501914|Adults|adults
5079572|NCT03501914|Intellectual Disability|intellectual disability
5079573|NCT03501914|Mindfulness|mindfulness
5079574|NCT03501901|ESBL-producing enterobacteria|esbl-producing enterobacteria
5079575|NCT03501901|hospital- and community-acquired urinary tract infections|hospital- and community-acquired urinary tract infections
5079576|NCT03501888|Acceptance and Commitment Therapy|acceptance and commitment therapy
5079577|NCT03501888|ACT|act
5079578|NCT03501888|Cognitive Behavior Therapy|cognitive behavior therapy
5079579|NCT03501888|CBT|cbt
5079580|NCT03501888|Schizophrenia|schizophrenia
5079581|NCT03501888|Psychoses|psychoses
5079582|NCT03501862|Mindfulness|mindfulness
5079583|NCT03501862|Cognitive therapy|cognitive therapy
5079584|NCT03501849|Cancer prevention|cancer prevention
5079585|NCT03501849|Cancer detection|cancer detection
5079586|NCT03501849|Colonoscopy|colonoscopy
5079587|NCT03501849|Polypectomy|polypectomy
5079588|NCT03501849|Cold Snare|cold snare
5079589|NCT03501849|Optivista|optivista
5079590|NCT03501771|Acupuncture|acupuncture
5079591|NCT03501771|Back pain|back pain
5079592|NCT03501771|Low Back Pain|low back pain
5079593|NCT03501771|Lumbago|lumbago
5079594|NCT03501771|pulse diagnosis|pulse diagnosis
5079595|NCT03501771|radial pressure pulse|radial pressure pulse
5079596|NCT03501758|ulcerative colitis|ulcerative colitis
5079597|NCT03501758|ultrasound|ultrasound
5961349|NCT04287712|Plasma Metabolomics|plasma metabolomics
5079598|NCT03501758|remission|remission
5079599|NCT03501758|relapse|relapse
5079601|NCT03501719|inflammation|inflammation
5079602|NCT03501719|antiretroviral therapy|antiretroviral therapy
5079603|NCT03501719|cohort studies|cohort studies
5079604|NCT03501719|mortality|mortality
5079605|NCT03501719|non-AIDS events|non-aids events
5079606|NCT03501706|intertemporal tradeoffs|intertemporal tradeoffs
5079607|NCT03501706|delayed gratification|delayed gratification
5079608|NCT03501706|executive functioning|executive functioning
5079609|NCT03501706|delay discounting|delay discounting
5079610|NCT03501706|working memory|working memory
5079611|NCT03501680|hyperlipidaemic pancreatitis|hyperlipidaemic pancreatitis
5079612|NCT03501680|Plasmapheresis|plasmapheresis
5079613|NCT03501680|insulin|insulin
5079614|NCT03501654|Lenses, Intraocular|lenses, intraocular
5079615|NCT03501641|cognitive load|cognitive load
5079616|NCT03501641|competence|competence
5079617|NCT03501641|heart rate variation|heart rate variation
5079618|NCT03501641|learning|learning
5079619|NCT03501641|otolaryngology|otolaryngology
5079620|NCT03501641|video|video
5079621|NCT03501641|virtual reality|virtual reality
5738972|NCT00361504|Tapentadol|tapentadol
5079622|NCT03501615|Early Access|early access
5079623|NCT03501615|Leukemia|leukemia
5079624|NCT03501615|Hairy cell|hairy cell
5079625|NCT03501615|Moxetumomab Pasudotox|moxetumomab pasudotox
5079626|NCT03501615|PNA|pna
5079627|NCT03501615|Purine analog|purine analog
5079628|NCT03501615|BRAF Inhibitor|braf inhibitor
5079629|NCT03501615|Rituximab|rituximab
5079630|NCT03501615|Pseudomonas-immunotoxin naïve|pseudomonas-immunotoxin naïve
5079631|NCT03501602|aintree, LMA protector; I-gel LMA, Fiberoptic Bronchoscope|aintree, lma protector; i-gel lma, fiberoptic bronchoscope
5079632|NCT03501563|hypotensive anesthesia|hypotensive anesthesia
5079633|NCT03501563|thiol / disulfide|thiol / disulfide
5079634|NCT03501563|oxidative stress markers|oxidative stress markers
5079635|NCT03501563|septoplasty|septoplasty
5079636|NCT03501550|HCV|hcv
5079637|NCT03501550|GT1|gt1
5079638|NCT03501511|Diabetes MellitusType1;Fasting;Health Education;Hypoglycemia|diabetes mellitustype1;fasting;health education;hypoglycemia
5079639|NCT03501498|Intestinal Transit, Bile Salts, Gut Bacteria, Volatile Organic Compounds|intestinal transit, bile salts, gut bacteria, volatile organic compounds
5079640|NCT03501472|pictorial warning labels|pictorial warning labels
5079641|NCT03501472|risk knowledge|risk knowledge
5079642|NCT03501472|emotion|emotion
5079643|NCT03501472|memory|memory
5079644|NCT03501472|risk perceptions|risk perceptions
5079645|NCT03501472|quit intentions|quit intentions
5079646|NCT03501472|numeracy|numeracy
5079647|NCT03501446|PEEP optimization|peep optimization
5079648|NCT03501446|Lung volumes|lung volumes
5079649|NCT03501433|postpandial|postpandial
5079650|NCT03501433|lipemia|lipemia
5079651|NCT03501433|microvascular|microvascular
5079652|NCT03501420|Belimumab|belimumab
5079653|NCT03501420|Disease Specific Programme|disease specific programme
5079654|NCT03501420|rheumatologist|rheumatologist
5079655|NCT03501420|Benlysta|benlysta
5079656|NCT03501420|Primary Sjögren's Syndrome|primary sjögren's syndrome
5079657|NCT03501420|Adelphi pSS DSP|adelphi pss dsp
5079658|NCT03501394|Magnetic Resonance Imaging|magnetic resonance imaging
5079659|NCT03501394|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5079660|NCT03501368|cutaneous|cutaneous
5079661|NCT03501368|refractory|refractory
5079662|NCT03501368|melanoma|melanoma
5079663|NCT03501368|ceritinib|ceritinib
5079664|NCT03501355|pacemaker|pacemaker
5079665|NCT03501355|inspiratory muscle training|inspiratory muscle training
5079666|NCT03501355|exercise capacity|exercise capacity
5079667|NCT03501355|Quality of Life|quality of life
5079668|NCT03501355|Respiratory Muscle Strength|respiratory muscle strength
5079669|NCT03501342|Multiple Sclerosis|multiple sclerosis
5079670|NCT03501342|virtual reality|virtual reality
5079671|NCT03501342|balance|balance
5079672|NCT03501342|mobility|mobility
5079673|NCT03501342|fatigue|fatigue
5079674|NCT03501316|Root Surface Debridement|root surface debridement
5079675|NCT03501316|Hand Instrumentation|hand instrumentation
5079676|NCT03501316|Ultrasonic Instrumentation|ultrasonic instrumentation
5079677|NCT03501316|Systemic|systemic
5079678|NCT03501316|Immune|immune
5079679|NCT03501316|CRP|crp
5079680|NCT03501290|Frailty|frailty
5079681|NCT03501290|Malnutrition|malnutrition
5079682|NCT03501290|Older adults|older adults
5079684|NCT03501290|Compliance|compliance
5079685|NCT03501277|Drug therapy|drug therapy
5079686|NCT03501199|immediate implant placement|immediate implant placement
5079687|NCT03501186|Backward walking, stroke, gait training|backward walking, stroke, gait training
5079688|NCT03501160|Regressive behaviors|regressive behaviors
5079689|NCT03501160|Childish behaviors|childish behaviors
5079690|NCT03501160|Socially Inappropriate Behaviors|socially inappropriate behaviors
5079691|NCT03501160|Qualitative study|qualitative study
5079692|NCT03501160|Schizophrenic spectrum disorder|schizophrenic spectrum disorder
5961350|NCT04287712|Lipids|lipids
5080286|NCT03497273|Japan|japan
5079697|NCT03501134|Katherine Peters|katherine peters
5079698|NCT03501134|Optune|optune
4965661|NCT04204304|D014807|d014807
5079699|NCT03501134|NovoTTF|novottf
5079700|NCT03501134|ACTION|action
5079701|NCT03501134|Quality of life|quality of life
5079702|NCT03501134|Tumor treating fields|tumor treating fields
5079703|NCT03501121|intra-operative radiation therapy|intra-operative radiation therapy
5079704|NCT03501108|Polypharmacy|polypharmacy
5079705|NCT03501108|Multi-morbidity|multi-morbidity
5079706|NCT03501108|Deprescribing|deprescribing
5079707|NCT03501108|Older people|older people
5079708|NCT03501108|Elderly|elderly
5079709|NCT03501082|Gut microbiome|gut microbiome
5079710|NCT03501069|Drug Therapy|drug therapy
5079711|NCT03501056|PD-1 activated CIK|pd-1 activated cik
5079712|NCT03501056|MUC1|muc1
5079713|NCT03501056|Bispecific antibody|bispecific antibody
5079714|NCT03501056|lung cancer|lung cancer
5079715|NCT03500991|CNS, CAR T cell, HER2-positive, brain tumor|cns, car t cell, her2-positive, brain tumor
5079716|NCT03500991|pediatric, young adults|pediatric, young adults
5079726|NCT03500900|gastric accommodation|gastric accommodation
5079727|NCT03500900|food intake|food intake
5079728|NCT03500900|gastrointestinal hormones|gastrointestinal hormones
5079729|NCT03500861|headache characteristics, health-related quality of life.|headache characteristics, health-related quality of life.
5079730|NCT03500848|Liver transplantation|liver transplantation
5079731|NCT03500848|Sirolimus|sirolimus
5079732|NCT03500848|Tacrolimus|tacrolimus
5079733|NCT03500848|HCC recurrence free survival|hcc recurrence free survival
5079734|NCT03500822|dynamic hyperinflation|dynamic hyperinflation
5079735|NCT03500822|diastolic dysfunction|diastolic dysfunction
5079736|NCT03500822|COPD|copd
5079737|NCT03500822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5079738|NCT03500822|Metronome-paced Tachypnea|metronome-paced tachypnea
5079739|NCT03500822|Expiratory-stenosis Breathing|expiratory-stenosis breathing
5079740|NCT03500783|Cardioprotection|cardioprotection
5079741|NCT03500783|Ischemia-reperfusion injury|ischemia-reperfusion injury
5079742|NCT03500783|Nitric oxide|nitric oxide
5079743|NCT03500783|Cardiopulmonary bypass|cardiopulmonary bypass
5079744|NCT03500783|Coronary artery bypass grafting|coronary artery bypass grafting
5079745|NCT03500770|Post Treatment Lyme Disease Syndrome|post treatment lyme disease syndrome
5079746|NCT03500757|HoloLens|hololens
5079747|NCT03500757|3D holographic guidance|3d holographic guidance
5079748|NCT03500731|Lung Transplantation|lung transplantation
5079749|NCT03500731|Stem Cell Transplantation|stem cell transplantation
5079750|NCT03500731|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5079751|NCT03500731|Emphysema or COPD|emphysema or copd
5079752|NCT03500731|Bone marrow transplantation|bone marrow transplantation
5079753|NCT03500731|Cadaveric donor|cadaveric donor
5079754|NCT03500731|Unrelated donor|unrelated donor
5079755|NCT03500731|HLA-Mismatch|hla-mismatch
5079757|NCT03500731|HSCT|hsct
5079758|NCT03500731|IPF|ipf
5079759|NCT03500731|Pulmonary fibrosis|pulmonary fibrosis
5079763|NCT03500692|Mitral Valve Regurgitation|mitral valve regurgitation
5079764|NCT03500692|MitraClip|mitraclip
5079765|NCT03500692|MitraClip NT|mitraclip nt
5079766|NCT03500692|Japan MitraClip NT Postmarketing Surveillance|japan mitraclip nt postmarketing surveillance
5079767|NCT03500666|Thyroid carcinoma|thyroid carcinoma
5079768|NCT03500666|Robot surgery|robot surgery
5127738|NCT03195712|BMI|bmi
5079769|NCT03500666|Endoscopic surgery|endoscopic surgery
5079770|NCT03500640|Intervention|intervention
5079771|NCT03500640|Prevention|prevention
5079772|NCT03500640|Weight Management|weight management
5079773|NCT03500640|Physical Activity|physical activity
5079774|NCT03500640|Physical Function|physical function
5079775|NCT03500627|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
5079776|NCT03500627|Childhood Cerebral Adrenoleukodystrophy (ccALD)|childhood cerebral adrenoleukodystrophy (ccald)
5079777|NCT03500627|OP-101|op-101
5079778|NCT03500627|Dendrimer|dendrimer
5079779|NCT03500627|N-Acetyl-Cysteine (NAC)|n-acetyl-cysteine (nac)
5079780|NCT03500614|particulate matter|particulate matter
5079781|NCT03500614|phthalates|phthalates
5079782|NCT03500614|cytokines|cytokines
5079783|NCT03500614|chemokines|chemokines
5079784|NCT03500614|epigenetics|epigenetics
5079785|NCT03500614|DNA methylation|dna methylation
5079786|NCT03500614|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5079787|NCT03500614|immune function|immune function
5079801|NCT03500432|local anesthesia|local anesthesia
5078574|NCT03508427|Objective data|objective data
5079809|NCT03500276|health-related quality of life|health-related quality of life
5079811|NCT03500276|inflammatory markers|inflammatory markers
5079812|NCT03500276|rheumatoid arthritis|rheumatoid arthritis
5079813|NCT03500250|Complex intervention|complex intervention
5079814|NCT03500250|Depression|depression
5079815|NCT03500250|Nursing|nursing
5079816|NCT03500250|Stroke|stroke
5079817|NCT03500250|Feasibility|feasibility
5079826|NCT03500224|Drug therapy|drug therapy
5091654|NCT03425890|Upper Limb|upper limb
5079827|NCT03500211|Cesarean section|cesarean section
5079828|NCT03500211|Postoperative pain|postoperative pain
5961351|NCT04287712|Machine Learning|machine learning
5961352|NCT04287686|SARS-CoV-2|sars-cov-2
4963134|NCT04220749|Randomized|randomized
5961353|NCT04287686|Renin-angiotensin-system (RAS)|renin-angiotensin-system (ras)
5961354|NCT04287673|Trunk control|trunk control
4988808|NCT04061499|hip|hip
5079829|NCT03500185|Physiotherapy|physiotherapy
5079830|NCT03500185|Pelvic floor|pelvic floor
5079831|NCT03500185|Urinary Incontinence|urinary incontinence
5079832|NCT03500172|HIV|hiv
5079833|NCT03500172|Female Sex Workers|female sex workers
5079834|NCT03500172|Viral Suppression|viral suppression
5079835|NCT03500172|South Africa|south africa
5079836|NCT03500172|Decentralized care|decentralized care
5079837|NCT03500172|Antiretroviral therapy|antiretroviral therapy
5079838|NCT03500172|Differentiated care|differentiated care
5079839|NCT03500133|Pediatric Hodgkin Lymphoma, therapy, reduced radiotherapy|pediatric hodgkin lymphoma, therapy, reduced radiotherapy
5079840|NCT03500120|Saline suppression testing, Seated, Recumbent|saline suppression testing, seated, recumbent
5079841|NCT03500107|Blue Light Emitting Diode|blue light emitting diode
5079842|NCT03500107|Women|women
5079843|NCT03500094|Lysosomal storage disease|lysosomal storage disease
5079844|NCT03500094|migalastat|migalastat
5079845|NCT03500094|AT1001|at1001
5079846|NCT03500068|Pancreatic cancer|pancreatic cancer
5079847|NCT03500068|Organoids|organoids
5079848|NCT03500042|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5079849|NCT03500042|inspiratory muscle training|inspiratory muscle training
5079850|NCT03500042|expiratory muscle training|expiratory muscle training
5079851|NCT03500042|Neural Respiratory Drive|neural respiratory drive
5079852|NCT03500029|Depression|depression
5079853|NCT03500029|Transcranial magnetic stimulation(TMS)|transcranial magnetic stimulation(tms)
5079854|NCT03500029|Resting-state functional MRI(fMRI)|resting-state functional mri(fmri)
5079855|NCT03500016|Insulin resistance|insulin resistance
5079856|NCT03500016|Obesity|obesity
5079857|NCT03500016|Type 2 diabetes|type 2 diabetes
5079858|NCT03500016|Exercise training|exercise training
5079859|NCT03500003|dairy products|dairy products
5079860|NCT03500003|milk|milk
5079861|NCT03500003|yogurt|yogurt
5079862|NCT03500003|metabolomics|metabolomics
5079863|NCT03500003|elderly|elderly
5079864|NCT03499990|Adrenal crisis|adrenal crisis
5079865|NCT03499990|Risk factors|risk factors
5079866|NCT03499977|Physical Activity|physical activity
5079867|NCT03499977|Executive function|executive function
5079868|NCT03499977|Anti-saccade|anti-saccade
5079869|NCT03499964|pivotal trial|pivotal trial
5079870|NCT03499964|randomized|randomized
5079871|NCT03499964|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5079872|NCT03499964|urethral stricture|urethral stricture
5079873|NCT03499964|obstruction|obstruction
5079874|NCT03499951|Quality of life|quality of life
5079875|NCT03499951|Participation|participation
5079876|NCT03499951|Training|training
5079881|NCT03499925|mental health|mental health
5079882|NCT03499925|intervention|intervention
5079883|NCT03499925|pregnancy-related complications|pregnancy-related complications
5079884|NCT03499912|Acute myeloid leukemia|acute myeloid leukemia
5079885|NCT03499912|IDH1|idh1
5079889|NCT03499899|advanced triple-negative breast cancer|advanced triple-negative breast cancer
5079890|NCT03499899|triple-negative breast cancer|triple-negative breast cancer
5079893|NCT03499899|spartalizumab|spartalizumab
5079894|NCT03499899|PDR001|pdr001
5079895|NCT03499899|carboplatin|carboplatin
5079896|NCT03499834|Immune Cell Therapy|immune cell therapy
5079897|NCT03499834|IKC|ikc
5079898|NCT03499795|High-grade squamous intraepithelial lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
5079899|NCT03499795|Human papillomavirus (HPV)|human papillomavirus (hpv)
5079900|NCT03499795|HPV-16|hpv-16
5079901|NCT03499795|HPV-18|hpv-18
5079902|NCT03499795|Anal intraepithelial neoplasia 2 (AIN2)|anal intraepithelial neoplasia 2 (ain2)
5079903|NCT03499795|Anal intraepithelial neoplasia 3 (AIN3)|anal intraepithelial neoplasia 3 (ain3)
5079904|NCT03499795|Peri-anal intraepithelial neoplasia 2 (PAIN2)|peri-anal intraepithelial neoplasia 2 (pain2)
5079912|NCT03499717|Fall Risk|fall risk
5079913|NCT03499717|Patient Falls|patient falls
5079914|NCT03499717|Fall Prevention|fall prevention
5079915|NCT03499717|Patient Safety|patient safety
5079916|NCT03499704|Drug therapy|drug therapy
5079917|NCT03499665|Bruxism|bruxism
5079918|NCT03499665|Pain|pain
5079919|NCT03499665|Exercises|exercises
5079920|NCT03499665|Myofascial|myofascial
5079921|NCT03499665|Releasing|releasing
5079922|NCT03499613|Movement analysis|movement analysis
5079923|NCT03499613|Spinal kinematics|spinal kinematics
5079924|NCT03499613|Muscle activity|muscle activity
5079925|NCT03499613|Pain-related fear|pain-related fear
5079926|NCT03499613|Rehabilitation|rehabilitation
5079927|NCT03499613|Spine|spine
5079928|NCT03499600|Cultural assessment|cultural assessment
5079929|NCT03499600|Engagement|engagement
5079930|NCT03499600|Diverse Populations|diverse populations
5079931|NCT03499548|Intensive|intensive
5079955|NCT03499405|development and health disparities and navigation|development and health disparities and navigation
5079956|NCT03499392|psychological factors|psychological factors
5079957|NCT03499379|Intrauterine device (IUD)|intrauterine device (iud)
5079958|NCT03499379|Depression|depression
5079959|NCT03499379|Stress hormones|stress hormones
5079960|NCT03499379|Mood changes|mood changes
5079961|NCT03499366|enterovirus D68|enterovirus d68
5079962|NCT03499366|AFP|afp
5961355|NCT04287673|Postural Control|postural control
5079963|NCT03499366|AFM|afm
5079964|NCT03499366|EV-D68|ev-d68
5079965|NCT03499366|acute flaccid myelitis|acute flaccid myelitis
5079966|NCT03499366|acute flaccid paresis|acute flaccid paresis
5079968|NCT03499340|pictorial warning labels|pictorial warning labels
5079969|NCT03499340|risk knowledge|risk knowledge
5079970|NCT03499340|emotion|emotion
5079971|NCT03499340|memory|memory
5079972|NCT03499340|risk perceptions|risk perceptions
5079973|NCT03499340|quit intentions|quit intentions
5079974|NCT03499327|vitamin D|vitamin d
5079975|NCT03499327|ergosterol|ergosterol
5079976|NCT03499327|7-dehydro-cholesterol|7-dehydro-cholesterol
5079977|NCT03499327|wheat germ oil|wheat germ oil
5079978|NCT03499314|Anodal transcranial stimulation (tDCS)|anodal transcranial stimulation (tdcs)
5079979|NCT03499301|Chronic pain|chronic pain
5079980|NCT03499301|Emergency|emergency
5079981|NCT03499301|Satisfaction|satisfaction
5079982|NCT03499288|Cerebral Palsy|cerebral palsy
5079983|NCT03499275|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5079984|NCT03499262|Social ABCs|social abcs
5079986|NCT03499262|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5079987|NCT03499262|Toddler|toddler
5079988|NCT03499262|Pivotal Response Treatment (PRT)|pivotal response treatment (prt)
5079989|NCT03499262|Group Intervention|group intervention
5079990|NCT03499262|Parent-Mediated|parent-mediated
5079991|NCT03499262|Caregiver-Mediated|caregiver-mediated
5079992|NCT03499262|Social Communication|social communication
5079993|NCT03499262|Positive Affect|positive affect
5079994|NCT03499262|Social Smiling|social smiling
5079995|NCT03499262|Social Orienting|social orienting
5079996|NCT03499262|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
5079997|NCT03499262|NDBI|ndbi
5079998|NCT03499262|Autism|autism
5079999|NCT03499262|Early Identification|early identification
5080000|NCT03499249|Biliary Atresia|biliary atresia
5080001|NCT03499249|N-Acetylcysteine|n-acetylcysteine
5080002|NCT03499249|Glutathione|glutathione
5080003|NCT03499249|Kasai portoenterostomy|kasai portoenterostomy
5080004|NCT03499249|Bile flow|bile flow
5080005|NCT03499249|Serum bile acids|serum bile acids
5080006|NCT03499249|Serum bilirubin|serum bilirubin
5080007|NCT03499210|Stroke|stroke
5080008|NCT03499210|Exoskeleton|exoskeleton
5080009|NCT03499210|Hemiparesis|hemiparesis
5080010|NCT03499210|Hemiplegia|hemiplegia
5080011|NCT03499145|conjunctivitis|conjunctivitis
5080020|NCT03499054|fatigue|fatigue
5080021|NCT03499054|quality of life|quality of life
5080022|NCT03499002|Simulation|simulation
5080023|NCT03499002|Medical Students|medical students
5080024|NCT03499002|In Situ Simulation|in situ simulation
5080025|NCT03498976|painful shoulder|painful shoulder
5080026|NCT03498937|Borderline Personality Disorder|borderline personality disorder
5080027|NCT03498937|Impulsive behavior|impulsive behavior
5080028|NCT03498937|Suicidal behavior|suicidal behavior
5080029|NCT03498937|Cognitive control|cognitive control
5080030|NCT03498937|tDCS|tdcs
5080035|NCT03498924|staging|staging
5080036|NCT03498924|diagnosis|diagnosis
5080037|NCT03498924|Endometrial Cancer|endometrial cancer
5080038|NCT03498898|Beta adrenergic receptor blockers|beta adrenergic receptor blockers
5080039|NCT03498898|Analgesia nociceptive index|analgesia nociceptive index
5080040|NCT03498898|Total hip replacement|total hip replacement
5080041|NCT03498898|Total knee replacement|total knee replacement
5080042|NCT03498885|Rectal Cancer|rectal cancer
5080043|NCT03498885|inferior mesenteric artery|inferior mesenteric artery
5080044|NCT03498885|Laparoscopic|laparoscopic
5080045|NCT03498872|AMPfoot|ampfoot
5080046|NCT03498872|Prosthetics|prosthetics
5080047|NCT03498872|gait|gait
5080048|NCT03498872|electro-encephalography|electro-encephalography
5080049|NCT03498872|dual-task walking|dual-task walking
5080050|NCT03498859|Rehabilitation|rehabilitation
5080051|NCT03498833|domains|domains
5080052|NCT03498833|item development|item development
5080053|NCT03498833|osteoarthritis|osteoarthritis
5080054|NCT03498833|scale formulation|scale formulation
5080055|NCT03498833|test retest reliability|test retest reliability
5080056|NCT03498820|Analgesia-Nociception Index (ANI)|analgesia-nociception index (ani)
5080057|NCT03498820|General anesthesia|general anesthesia
5080058|NCT03498820|Opioids|opioids
5080059|NCT03498820|Remifentanil|remifentanil
4963342|NCT04219059|MRI|mri
5080060|NCT03498820|Pain|pain
5080061|NCT03498820|Monitoring|monitoring
5080062|NCT03498807|ARDS|ards
5080063|NCT03498807|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5080064|NCT03498807|PEEP|peep
5080065|NCT03498807|pressure-volume loop|pressure-volume loop
5080066|NCT03498807|Positive End-Expiratory Pressure|positive end-expiratory pressure
5080067|NCT03498807|hysteresis|hysteresis
5080068|NCT03498781|Exercise|exercise
5080069|NCT03498755|fisheries|fisheries
5080070|NCT03498755|Ghana|ghana
5080071|NCT03498755|sub-Saharan Africa|sub-saharan africa
5080072|NCT03498755|value chain|value chain
5080073|NCT03498755|fish processing|fish processing
5080074|NCT03498755|fish smoking|fish smoking
5080075|NCT03498742|asthma|asthma
5080076|NCT03498742|SABA|saba
5080077|NCT03498729|Autoimmune Diseases|autoimmune diseases
5961356|NCT04287673|Cerebral Palsy|cerebral palsy
5080078|NCT03498690|online trial|online trial
5080079|NCT03498690|decision analysis|decision analysis
5080080|NCT03498677|online trial|online trial
5080081|NCT03498677|decision analysis|decision analysis
5080082|NCT03498664|EMR-C; EMR-S; LST|emr-c; emr-s; lst
5080083|NCT03498651|Anxiety|anxiety
5080084|NCT03498651|Cognitive bias|cognitive bias
5080085|NCT03498651|Telemedicine|telemedicine
5080089|NCT03498547|caudal block|caudal block
5080090|NCT03498547|saddle block|saddle block
5080091|NCT03498534|Treatment|treatment
5080092|NCT03498534|Latent infection|latent infection
5080093|NCT03498534|Tuberculosis|tuberculosis
5080094|NCT03498534|Interferon gamma|interferon gamma
5080095|NCT03498508|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5080096|NCT03498508|Knowledge|knowledge
5080097|NCT03498508|In-hospital cardiac arrest|in-hospital cardiac arrest
5080098|NCT03498508|Skills|skills
5080099|NCT03498469|reintegration, reunification, child development|reintegration, reunification, child development
5080101|NCT03498378|Avelumab|avelumab
5080102|NCT03498378|Palbociclib|palbociclib
5080103|NCT03498378|Cetuximab|cetuximab
5080104|NCT03498378|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5080105|NCT03498378|cancer|cancer
5080106|NCT03498378|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
5080108|NCT03498365|decision analysis|decision analysis
5080109|NCT03498365|decision support|decision support
5080110|NCT03498352|cardiopulmonary exercise testing, thoracic surgery|cardiopulmonary exercise testing, thoracic surgery
5080111|NCT03498326|pancreatic cancer|pancreatic cancer
5080112|NCT03498326|gemcitabine|gemcitabine
5080113|NCT03498326|celecoxib|celecoxib
5080114|NCT03498326|R0 resection|r0 resection
5080115|NCT03498313|steroid hormones|steroid hormones
5080116|NCT03498313|estradiol|estradiol
5080117|NCT03498313|estrogen|estrogen
5080118|NCT03498313|progesterone|progesterone
5080119|NCT03498313|depression|depression
5080120|NCT03498313|suicide|suicide
5080121|NCT03498287|carpal tunnel syndrome|carpal tunnel syndrome
5080122|NCT03498287|carpal tunnel|carpal tunnel
5080123|NCT03498287|CTS|cts
5080124|NCT03498287|musculoskeletal disorder|musculoskeletal disorder
5080125|NCT03498287|peripheral neuropathy|peripheral neuropathy
5080126|NCT03498287|repetitive stress injury|repetitive stress injury
5080127|NCT03498287|non-invasive device|non-invasive device
5080128|NCT03498287|non-significant risk|non-significant risk
5080129|NCT03498287|medical device|medical device
5080130|NCT03498287|wrist pain|wrist pain
5080131|NCT03498274|Fitting|fitting
5080132|NCT03498235|sevoflurane|sevoflurane
5080133|NCT03498235|propofol|propofol
5080134|NCT03498235|intracranial pressure|intracranial pressure
5080135|NCT03498235|optic nerve sheath diameter|optic nerve sheath diameter
5080136|NCT03498196|muscle invasive bladder cancer|muscle invasive bladder cancer
5080137|NCT03498196|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5080138|NCT03498196|radical cystectomy|radical cystectomy
5080139|NCT03498196|monoclonal antibodies|monoclonal antibodies
5080140|NCT03498196|Avelumab|avelumab
5080141|NCT03498196|Invasive Resectable disease|invasive resectable disease
5080143|NCT03498196|NMIBC|nmibc
5080144|NCT03498196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5080145|NCT03498170|Healthy Male Volunteers|healthy male volunteers
5080146|NCT03498157|Prehabilitation|prehabilitation
5080147|NCT03498157|Exercise|exercise
5080148|NCT03498157|Breast Cancer|breast cancer
5080149|NCT03498157|Physical Activity|physical activity
5080150|NCT03498157|Surgery|surgery
5080151|NCT03498144|acquired punctal stenosis|acquired punctal stenosis
5080152|NCT03498144|epiphora|epiphora
5080153|NCT03498144|lower punctum|lower punctum
5080154|NCT03498144|AS-OCT|as-oct
5080155|NCT03498131|Multiple Sclerosis|multiple sclerosis
5080156|NCT03498131|MS|ms
5080157|NCT03498131|Melatonin|melatonin
5080158|NCT03498131|Supplement|supplement
5080159|NCT03498118|Transversus Abdominis Plane Block|transversus abdominis plane block
5080160|NCT03498118|Cesarean Delivery|cesarean delivery
5080161|NCT03498105|Acute Chest Syndrome|acute chest syndrome
5080162|NCT03498066|Myocardial Infarction|myocardial infarction
5080163|NCT03498066|Beta-Blockers|beta-blockers
5080164|NCT03498066|Stable Coronary Artery Disease|stable coronary artery disease
5080165|NCT03497936|vaccine narratives|vaccine narratives
5080166|NCT03497936|HPV prevention|hpv prevention
5080167|NCT03497936|vaccine promotion|vaccine promotion
5080168|NCT03497923|rocuronium, magnesium sulphate, neostigmine, sugammadex|rocuronium, magnesium sulphate, neostigmine, sugammadex
5080169|NCT03497897|Acne, efficacy, safety|acne, efficacy, safety
5080170|NCT03497884|fMRI|fmri
5080171|NCT03497884|rTMS|rtms
5080172|NCT03497884|functional connectivity|functional connectivity
5080173|NCT03497871|Heart failure|heart failure
5080174|NCT03497871|Self-management|self-management
5080175|NCT03497871|Health-related quality of life|health-related quality of life
5080176|NCT03497871|mHealth|mhealth
5080177|NCT03497845|vaccine|vaccine
5080178|NCT03497845|adjuvant|adjuvant
5080179|NCT03497845|Influenza in Birds|influenza in birds
5080180|NCT03497845|MF59|mf59
5080181|NCT03497845|AS03|as03
5080182|NCT03497832|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
5080183|NCT03497819|CART|cart
5080189|NCT03497806|FMT|fmt
5080190|NCT03497806|CDI|cdi
5080191|NCT03497806|C. difficile|c. difficile
5080192|NCT03497806|C. diff|c. diff
5080193|NCT03497806|Recurrent Clostridium Difficile Infection|recurrent clostridium difficile infection
5080194|NCT03497806|Recurrent C. diff|recurrent c. diff
5080195|NCT03497806|Recurrent CDI|recurrent cdi
5080196|NCT03497806|Finch|finch
5080197|NCT03497806|Fecal transplant|fecal transplant
5080198|NCT03497806|Fecal microbiota transplant|fecal microbiota transplant
5080199|NCT03497806|rCDI|rcdi
5080200|NCT03497806|Finch Therapeutics|finch therapeutics
5080201|NCT03497780|Healthy Volunteers|healthy volunteers
5080202|NCT03497780|ACL (Anterior Cruciate Ligament) tear|acl (anterior cruciate ligament) tear
5080207|NCT03497754|ultrasound|ultrasound
5080208|NCT03497754|cardiac output|cardiac output
5080209|NCT03497754|Probefix|probefix
5080210|NCT03497754|passive leg raising test|passive leg raising test
5080211|NCT03497741|Intensive Care Unit|intensive care unit
5080212|NCT03497689|pulmonary hypertension|pulmonary hypertension
5080225|NCT03497663|family based intervention|family based intervention
5080226|NCT03497611|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5080227|NCT03497611|Pacemaker|pacemaker
5080228|NCT03497611|Aortic valve calcification|aortic valve calcification
5080231|NCT03497585|Rehabilitation|rehabilitation
5080232|NCT03497585|Pain Management|pain management
5080233|NCT03497572|Leptospirosis|leptospirosis
5080234|NCT03497546|Morbid obesity|morbid obesity
5080235|NCT03497546|Exercise|exercise
5080236|NCT03497546|Weight loss|weight loss
5080237|NCT03497546|Cardiometabolic risk|cardiometabolic risk
5080238|NCT03497546|Bariatric surgery|bariatric surgery
5080239|NCT03497533|CD19|cd19
5080240|NCT03497533|CAR-T|car-t
5080241|NCT03497533|TriCAR-T-CD19|tricar-t-cd19
5080242|NCT03497533|non-Hodgkin lymphoma|non-hodgkin lymphoma
5080243|NCT03497533|NHL|nhl
5080244|NCT03497520|surface EMG|surface emg
5080245|NCT03497520|cobb angle|cobb angle
5080246|NCT03497520|exercise|exercise
5080247|NCT03497520|Spinal Curvatures|spinal curvatures
5080248|NCT03497507|Shivering|shivering
5080249|NCT03497507|Cesarean delivery|cesarean delivery
5080250|NCT03497507|acupressure|acupressure
5080251|NCT03497507|P6 acupoint|p6 acupoint
5080252|NCT03497481|eye's anterior chamber fluid|eye's anterior chamber fluid
5080253|NCT03497481|cerebrospinal fluid|cerebrospinal fluid
5080254|NCT03497481|inflammatory pathology|inflammatory pathology
5080255|NCT03497468|task-oriented training|task-oriented training
5078996|NCT03505710|NSCLC|nsclc
5080273|NCT03497312|handicapped children|handicapped children
5080274|NCT03497312|full mouth rehabilitation|full mouth rehabilitation
5080275|NCT03497299|Schizophrenia|schizophrenia
5080276|NCT03497299|Smoking|smoking
5080277|NCT03497299|Lapse|lapse
5080278|NCT03497299|Varenicline|varenicline
4963570|NCT04217616|heat pain threshold|heat pain threshold
5080279|NCT03497299|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
5080280|NCT03497286|maternal health|maternal health
5080281|NCT03497286|maternal stress|maternal stress
5080282|NCT03497286|infant health|infant health
5080283|NCT03497273|JAK1 inhibitor|jak1 inhibitor
5080284|NCT03497273|GVHD|gvhd
5080285|NCT03497273|acute GVHD|acute gvhd
5080287|NCT03497273|corticosteroids|corticosteroids
5080288|NCT03497260|Type 1 Diabetes, Fructose, Exercise, Hypoglycaemia, Degludec|type 1 diabetes, fructose, exercise, hypoglycaemia, degludec
5080289|NCT03497221|Nursing Education|nursing education
5080290|NCT03497208|Surgery|surgery
5080291|NCT03497208|melanocytes|melanocytes
5080292|NCT03497208|dermarolling system|dermarolling system
5080293|NCT03497169|Bariatric surgery|bariatric surgery
5080294|NCT03497169|Gastrointestinal tract|gastrointestinal tract
5080295|NCT03497169|Biological availability|biological availability
5080296|NCT03497169|Pharmacokinetics|pharmacokinetics
5080297|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
5080298|NCT03497156|Bariatric surgery|bariatric surgery
5080299|NCT03497156|Gastrointestinal tract|gastrointestinal tract
5080300|NCT03497156|Biological availability|biological availability
5080301|NCT03497156|Pharmacokinetics|pharmacokinetics
5080307|NCT03497143|Lamotrigine|lamotrigine
5080308|NCT03497130|skin regimen|skin regimen
5080309|NCT03497130|moisturizer|moisturizer
5080310|NCT03497130|dry skin|dry skin
5080311|NCT03497130|dry|dry
5080312|NCT03497130|itchy skin|itchy skin
5080313|NCT03497130|skin care|skin care
5080314|NCT03497117|imaging|imaging
5080315|NCT03497117|hyperpolarized|hyperpolarized
5080316|NCT03497117|perfluorinated|perfluorinated
5080317|NCT03497117|MRI|mri
5080318|NCT03497117|lung|lung
5080319|NCT03497117|multiple breath washout|multiple breath washout
5080320|NCT03497117|lung clearance index|lung clearance index
5080321|NCT03497078|collimator|collimator
5080322|NCT03497078|bone scintigraphy|bone scintigraphy
5080323|NCT03497078|image quality|image quality
5080324|NCT03497078|scintigraphy|scintigraphy
5080325|NCT03497065|Dental devices|dental devices
5080326|NCT03497065|Home care|home care
5080327|NCT03497065|Awareness|awareness
5080328|NCT03497065|Peri-implant mucositis|peri-implant mucositis
5080329|NCT03497065|Peri-implantitis|peri-implantitis
5080330|NCT03497052|IVF culture media|ivf culture media
5080331|NCT03497052|Blastocyst|blastocyst
5080332|NCT03497052|Time-lapse microscopy|time-lapse microscopy
5080333|NCT03497013|transcranial Direct Current Stimulation|transcranial direct current stimulation
5080334|NCT03497013|Randomized Controlled Trial|randomized controlled trial
5080335|NCT03497013|Schizophrenia|schizophrenia
5080336|NCT03497013|Tardive Dyskinesia|tardive dyskinesia
5080337|NCT03497013|Abnormal Involuntary Movements Scale|abnormal involuntary movements scale
5080338|NCT03497013|Tardive Dyskinesia Rating Scale|tardive dyskinesia rating scale
5080339|NCT03497013|Cognition|cognition
5080340|NCT03497000|optical coherence tomography angiography|optical coherence tomography angiography
5080341|NCT03497000|central serous chorioretinopathy|central serous chorioretinopathy
5080343|NCT03496987|Pleural Effusion|pleural effusion
5080344|NCT03496987|Pleural Drainage|pleural drainage
5080345|NCT03496987|Thoracentesis|thoracentesis
5080346|NCT03496961|Yan Nian Jiu Zhuan Fa|yan nian jiu zhuan fa
5080347|NCT03496948|PAD|pad
5080348|NCT03496948|Peripheral Artery Disease|peripheral artery disease
5080349|NCT03496948|Peripheral Arterial Disease|peripheral arterial disease
5080350|NCT03496935|Renal replacement therapy|renal replacement therapy
5080351|NCT03496922|Unventilated Cigarettes|unventilated cigarettes
5080352|NCT03496922|Experimental Tobacco Marketplace|experimental tobacco marketplace
5080353|NCT03496922|Demand|demand
5080354|NCT03496922|Delay Discounting|delay discounting
5738973|NCT00361491|Depression|depression
5080355|NCT03496896|Randomized Controlled Trial|randomized controlled trial
5080356|NCT03496896|Patient readmission|patient readmission
5080357|NCT03496896|Patient transfer|patient transfer
5080358|NCT03496896|Health care utilization|health care utilization
5080359|NCT03496896|Prognosis|prognosis
5080360|NCT03496896|Multimorbidity|multimorbidity
5080361|NCT03496896|Internal medicine|internal medicine
5080362|NCT03496857|labor pain|labor pain
5080363|NCT03496831|Hospitalization|hospitalization
5080364|NCT03496831|Infection|infection
5080365|NCT03496805|Muscadine Grape Extract|muscadine grape extract
5080366|NCT03496805|Androgen Deprivation Therapy|androgen deprivation therapy
5080367|NCT03496792|venous distension reflex|venous distension reflex
5080368|NCT03496779|Brentuximab Vedotin|brentuximab vedotin
5080369|NCT03496779|T-cell lymphoma|t-cell lymphoma
5080370|NCT03496753|nipple fissure|nipple fissure
5080371|NCT03496740|Postoperative pain|postoperative pain
5080372|NCT03496740|Ultrasound|ultrasound
5080373|NCT03496740|Dorsal Penile Nerve Block|dorsal penile nerve block
5080374|NCT03496740|Pudendal Block|pudendal block
5080375|NCT03496740|Hypospadias|hypospadias
5080376|NCT03496727|pain, VATS|pain, vats
5080377|NCT03496714|Posttraumatic stress disorder|posttraumatic stress disorder
5080378|NCT03496714|Safety behaviors|safety behaviors
5080379|NCT03496714|Threat appraisal|threat appraisal
5080380|NCT03496714|Secondary prevention|secondary prevention
5080381|NCT03496714|Internet-based|internet-based
5080382|NCT03496714|PTSD|ptsd
5080383|NCT03496688|Sinus floor augmentation|sinus floor augmentation
5080386|NCT03496688|Biocompatible materials|biocompatible materials
5080387|NCT03496688|Bone transplantation|bone transplantation
5080388|NCT03496649|Primary Adductor tendinopathies|primary adductor tendinopathies
5080389|NCT03496649|Pubalgia|pubalgia
5080390|NCT03496649|Botulinum toxin type A|botulinum toxin type a
5080391|NCT03496636|Ovary|ovary
5080392|NCT03496636|Transplant|transplant
5080393|NCT03496623|Pulmonary Hypertension|pulmonary hypertension
5080394|NCT03496623|COPD|copd
5080395|NCT03496623|Inhaled Treprostinil|inhaled treprostinil
5080401|NCT03496571|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5080402|NCT03496571|Eosinophil|eosinophil
5080404|NCT03496571|EGE|ege
5080405|NCT03496571|Eosinophilic gastrointestinal disorders|eosinophilic gastrointestinal disorders
5080406|NCT03496571|EGID|egid
5080407|NCT03496558|lactogenesis, pregnant, TG, lipidic profile, breastfeeding.|lactogenesis, pregnant, tg, lipidic profile, breastfeeding.
5080408|NCT03496545|fever|fever
5080409|NCT03496545|central fever|central fever
5080410|NCT03496545|neurogenic fever|neurogenic fever
5080411|NCT03496545|hyperthermia|hyperthermia
5080412|NCT03496545|bromocriptine|bromocriptine
5080413|NCT03496545|subarachnoid hemorrhage|subarachnoid hemorrhage
5080414|NCT03496545|SAH|sah
5080415|NCT03496545|subdural hematoma|subdural hematoma
5080416|NCT03496545|SDH|sdh
5080417|NCT03496545|intracerebral hemorrhage|intracerebral hemorrhage
5080418|NCT03496545|ICH|ich
5080419|NCT03496545|traumatic brain injury|traumatic brain injury
5080420|NCT03496545|TBI|tbi
5080421|NCT03496545|ischemic stroke|ischemic stroke
5080422|NCT03496519|Durvalumab|durvalumab
5080423|NCT03496519|Trabectedin|trabectedin
5080424|NCT03496519|Maximum Tolerated Dose|maximum tolerated dose
5080425|NCT03496519|Lung Cancer|lung cancer
5080426|NCT03496519|Sarcoma|sarcoma
5080427|NCT03496506|selexipag|selexipag
5080428|NCT03496506|clopidogrel|clopidogrel
5080429|NCT03496493|perioperative|perioperative
5080430|NCT03496493|monitoring|monitoring
5080431|NCT03496493|plethysmography|plethysmography
5899334|NCT02373566|wound closure|wound closure
5080432|NCT03496493|pulse oximetery|pulse oximetery
5080433|NCT03496480|ptsd|ptsd
5080434|NCT03496480|stress|stress
5080435|NCT03496480|traumatization|traumatization
5080436|NCT03496467|Treatment of pain and inflammation after Cataract Surgery|treatment of pain and inflammation after cataract surgery
5080437|NCT03496454|malaria|malaria
5080438|NCT03496454|infection|infection
5080439|NCT03496454|controlled|controlled
5080440|NCT03496428|intra-oral scanner|intra-oral scanner
5080441|NCT03496428|customized impression coping|customized impression coping
5080442|NCT03496428|extra-oral scanner|extra-oral scanner
5080443|NCT03496428|accuracy|accuracy
5080444|NCT03496376|kinesio taping|kinesio taping
5080445|NCT03496376|COPD|copd
5080446|NCT03496376|functional capacity|functional capacity
5080447|NCT03496376|pulmonary functions|pulmonary functions
5080448|NCT03496376|pulmonary rehabilitation|pulmonary rehabilitation
5080450|NCT03496337|activities of daily living|activities of daily living
5080451|NCT03496337|assessment of motor and process skills|assessment of motor and process skills
5080452|NCT03496337|validation study|validation study
5080453|NCT03496337|responsiveness study|responsiveness study
5356807|NCT01917903|physical therapy|physical therapy
5356808|NCT01917903|falls|falls
5080454|NCT03496259|Postoperative pain, on-Q pump, epidural, children|postoperative pain, on-q pump, epidural, children
5080456|NCT03496181|fMRI|fmri
5080457|NCT03496181|MRI|mri
5080458|NCT03496181|18-121|18-121
5080459|NCT03496181|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5080460|NCT03496168|Symptomatic|symptomatic
5080461|NCT03496168|Obstructive|obstructive
5080462|NCT03496168|Left ventricular outflow tract gradient|left ventricular outflow tract gradient
5080463|NCT03496155|parent-teen communication|parent-teen communication
5080464|NCT03496155|teen strengths|teen strengths
5080465|NCT03496155|adolescence|adolescence
5080466|NCT03496142|Prostate biopsy approach|prostate biopsy approach
5080467|NCT03496142|Transrectal prostate biopsy|transrectal prostate biopsy
5080468|NCT03496142|Transperineal prostate biopsy|transperineal prostate biopsy
5080469|NCT03496142|Iatrogenic infection|iatrogenic infection
5080470|NCT03496142|Prevention|prevention
5080471|NCT03496090|Diverticulitis|diverticulitis
5080472|NCT03496090|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
5080473|NCT03496090|Free diet|free diet
5080474|NCT03496090|Dietary restriction|dietary restriction
5080475|NCT03496090|Acute Diverticulitis|acute diverticulitis
5080476|NCT03496077|Dual Use|dual use
5080477|NCT03496077|Little Cigars and Cigarillos|little cigars and cigarillos
5080478|NCT03496077|Cigarettes|cigarettes
5080479|NCT03496077|Flavored Tobacco Use|flavored tobacco use
5080480|NCT03496077|Addiction Potential|addiction potential
5080481|NCT03496064|Thrombectomy|thrombectomy
5080482|NCT03496064|Eligibility|eligibility
5080483|NCT03496064|Large vessel occlusion|large vessel occlusion
5080503|NCT03495960|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5080504|NCT03495960|elderly|elderly
5080505|NCT03495960|PCNSL|pcnsl
5080506|NCT03495947|High Flow Nasal Cannula (HFNC).|high flow nasal cannula (hfnc).
5080507|NCT03495947|Mechanical ventilation|mechanical ventilation
5080508|NCT03495947|Extubation failure|extubation failure
5080509|NCT03495921|ESFT|esft
5080510|NCT03495921|Immunotherapy|immunotherapy
5080511|NCT03495921|Phase 3|phase 3
5080512|NCT03495921|irinotecan|irinotecan
5080513|NCT03495921|temozolomide|temozolomide
5080515|NCT03495921|Second Line|second line
5080516|NCT03495921|Vigil|vigil
5080517|NCT03495921|vaccine|vaccine
5080518|NCT03495921|orphan drug|orphan drug
5080519|NCT03495921|soft bone|soft bone
5080520|NCT03495921|pediatric|pediatric
5080521|NCT03495921|FLI|fli
5080522|NCT03495921|EWS|ews
5080523|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5080524|NCT03495921|Antineoplastic Agents|antineoplastic agents
5080525|NCT03495908|VGo|vgo
5080526|NCT03495908|Insulin|insulin
5080527|NCT03495908|Type 2 Diabetes|type 2 diabetes
5080528|NCT03495895|Disadvantaged families|disadvantaged families
5080529|NCT03495895|Pregnancy|pregnancy
5080530|NCT03495895|Intervention|intervention
5080531|NCT03495895|Minding the Baby|minding the baby
5080532|NCT03495856|Mindfulness-based stress reduction|mindfulness-based stress reduction
5080533|NCT03495856|Mindfulness|mindfulness
5080534|NCT03495856|chronic pain|chronic pain
5080535|NCT03495856|Feasibility|feasibility
5080536|NCT03495856|Intervention|intervention
5080537|NCT03495804|CT enterography|ct enterography
5080538|NCT03495804|oral contrast agent|oral contrast agent
5080539|NCT03495791|RA|ra
5080540|NCT03495791|Rheumatoid Arthritis|rheumatoid arthritis
5080541|NCT03495791|Arthritis|arthritis
5080542|NCT03495765|Diabetic macular oedema|diabetic macular oedema
5080543|NCT03495765|Lucentis|lucentis
5080544|NCT03495752|muscle performance|muscle performance
5080545|NCT03495752|injury prevention|injury prevention
5080546|NCT03495752|step down|step down
5080547|NCT03495752|fatigue|fatigue
5080551|NCT03495687|Respiratory function|respiratory function
5961357|NCT04287673|Rehabilitation|rehabilitation
5080552|NCT03495687|Spinal mobility|spinal mobility
5080553|NCT03495687|Chest expansion|chest expansion
5080554|NCT03495661|lumbar spine stenosis|lumbar spine stenosis
5080555|NCT03495661|decompression|decompression
5080556|NCT03495661|laminectomy|laminectomy
5080557|NCT03495661|physiotherapy|physiotherapy
5080558|NCT03495661|physical therapy|physical therapy
5080559|NCT03495661|electroneurography|electroneurography
5080560|NCT03495661|ENG|eng
5080561|NCT03495661|electromyography|electromyography
5080562|NCT03495661|EMG|emg
5080563|NCT03495661|Neurogenic Claudication|neurogenic claudication
5080564|NCT03495661|Pseudoclaudication|pseudoclaudication
5080565|NCT03495648|farmers market|farmers market
5080566|NCT03495648|Appalachia|appalachia
5080567|NCT03495648|physical activity|physical activity
5080568|NCT03495648|fruit and vegetable voucher program|fruit and vegetable voucher program
5080569|NCT03495635|mentoring|mentoring
5080576|NCT03495583|Food allergy|food allergy
5080577|NCT03495583|Child Health|child health
5080578|NCT03495583|Oral tolerance induction|oral tolerance induction
5080579|NCT03495583|Food allergic sensitisation|food allergic sensitisation
5080580|NCT03495583|Obesity|obesity
5080581|NCT03495570|immunological|immunological
5080582|NCT03495557|Hernia|hernia
5080583|NCT03495557|Cholecystectomy|cholecystectomy
5080584|NCT03495557|Mesh fixation|mesh fixation
5080585|NCT03495531|virtual reality|virtual reality
5080586|NCT03495531|obstetrics|obstetrics
5080587|NCT03495531|labor procedures|labor procedures
5080588|NCT03495531|regional anesthesia|regional anesthesia
5080589|NCT03495518|Cancer|cancer
5080590|NCT03495518|Randomized Control Trial|randomized control trial
5080591|NCT03495518|Children|children
5080592|NCT03495518|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5080593|NCT03495518|Quality of Life|quality of life
5080594|NCT03495505|WiSE-CRT|wise-crt
5080595|NCT03495505|Endocardial Pacing Optimisation|endocardial pacing optimisation
5080596|NCT03495505|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5080597|NCT03495492|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5080598|NCT03495492|CLL|cll
5080599|NCT03495492|Dermal Chelation|dermal chelation
5080600|NCT03495492|Nutritional Therapy|nutritional therapy
5080601|NCT03495479|Prostate Cancer|prostate cancer
5080602|NCT03495479|PC|pc
5080603|NCT03495479|Active Surveillance|active surveillance
5080604|NCT03495479|Chemonaiive|chemonaiive
5080605|NCT03495479|OMN54|omn54
5080606|NCT03495479|Aneustat (TM)|aneustat (tm)
5080607|NCT03495479|PSA|psa
5080608|NCT03495479|BPH|bph
5080609|NCT03495440|Emotional Security|emotional security
5080610|NCT03495440|Intellectual Disability|intellectual disability
5080611|NCT03495440|Developmental Disability|developmental disability
5080612|NCT03495427|radioactive diagnostic imaging|radioactive diagnostic imaging
5080613|NCT03495375|Impulsivity|impulsivity
5080614|NCT03495375|Compulsivity|compulsivity
5080615|NCT03495375|Aggression|aggression
5080616|NCT03495375|Microbiome|microbiome
5080617|NCT03495375|Probiotic|probiotic
5080618|NCT03495375|Nutrition|nutrition
5080619|NCT03495375|Psychiatric disorders|psychiatric disorders
5080625|NCT03495336|Boiled coffee|boiled coffee
5080626|NCT03495336|Cardiovascular disease|cardiovascular disease
5080627|NCT03495336|Cholesterol|cholesterol
5080628|NCT03495336|Homocysteine|homocysteine
5080629|NCT03495336|Turkish coffee|turkish coffee
5080630|NCT03495336|Diterpenes|diterpenes
5080631|NCT03495336|Unfiltered coffee|unfiltered coffee
5080632|NCT03495323|Cancer Care|cancer care
5080633|NCT03495297|subcutaneous implantable cardioverter defibrillator|subcutaneous implantable cardioverter defibrillator
5080634|NCT03495297|Defibrillation testing|defibrillation testing
5080635|NCT03495271|Hemodialysis|hemodialysis
5080636|NCT03495271|Taste|taste
5080637|NCT03495271|Blood|blood
5080638|NCT03495271|Saliva|saliva
5080639|NCT03495245|pain|pain
5080640|NCT03495245|opioid|opioid
5080641|NCT03495245|fibromyalgia|fibromyalgia
5080642|NCT03495232|Total Knee Arthroplasty|total knee arthroplasty
5080643|NCT03495232|Persona knee system|persona knee system
5080644|NCT03495232|osteoarthrosis|osteoarthrosis
5080645|NCT03495232|Knee|knee
5080646|NCT03495193|exercise|exercise
5080647|NCT03495128|muscle protein breakdown|muscle protein breakdown
5080648|NCT03495128|inactivity|inactivity
5080649|NCT03495128|bed rest|bed rest
5080650|NCT03495115|Breast Cancer|breast cancer
5080651|NCT03495089|Screening; Sudomotor reflex; DEC; Primary Care|screening; sudomotor reflex; dec; primary care
5080652|NCT03495076|Tactile acuity|tactile acuity
5080653|NCT03495076|Tactile dysfunction|tactile dysfunction
5080654|NCT03495076|Sensory dissociation|sensory dissociation
5080655|NCT03495076|Two-point discrimination|two-point discrimination
5080656|NCT03495076|Perception|perception
5080657|NCT03495050|Bicuspid|bicuspid
5080658|NCT03495050|TAVI|tavi
5080659|NCT03495050|TAVR|tavr
5080660|NCT03495050|self-expanding|self-expanding
5080661|NCT03495050|Evolut|evolut
5080662|NCT03495037|Age-related cognitive changes|age-related cognitive changes
5080663|NCT03495024|Schizophrenia|schizophrenia
5080664|NCT03495024|Schizoaffective disorder|schizoaffective disorder
5080665|NCT03495024|Antipsychotics|antipsychotics
5080666|NCT03495024|Tobacco smoking|tobacco smoking
5080667|NCT03495024|Tardive dyskinesia|tardive dyskinesia
5080668|NCT03495024|Parkinsonism|parkinsonism
5080669|NCT03495011|Ductal Carcinoma in Situ|ductal carcinoma in situ
5080681|NCT03494920|Cerebral Infarction|cerebral infarction
5356809|NCT01917903|memory|memory
5080682|NCT03494920|Cerebrovascular Disorders|cerebrovascular disorders
5080683|NCT03494920|Brain Diseases|brain diseases
5080684|NCT03494920|Central Nervous System Diseases|central nervous system diseases
5080685|NCT03494920|Nervous System Diseases|nervous system diseases
5080686|NCT03494920|Vascular Diseases|vascular diseases
5080687|NCT03494920|Cardiovascular Diseases|cardiovascular diseases
5080688|NCT03494920|Pathologic Processes|pathologic processes
5080689|NCT03494920|Brain Infarction|brain infarction
5080693|NCT03494920|Fibrinolytic Agents|fibrinolytic agents
5080694|NCT03494920|Fibrin Modulating Agents|fibrin modulating agents
5080695|NCT03494920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5080696|NCT03494842|TENS|tens
5080697|NCT03494842|pain relief|pain relief
5080698|NCT03494842|STOP|stop
5080699|NCT03494842|surgical abortion|surgical abortion
5080700|NCT03494829|early onset scoliosis|early onset scoliosis
5080701|NCT03494829|motor competence|motor competence
5080702|NCT03494829|physical activity|physical activity
5080703|NCT03494829|pulmonary function|pulmonary function
5080704|NCT03494829|health related quality of life|health related quality of life
5080705|NCT03494816|Neoadjuvant|neoadjuvant
5080706|NCT03494816|Venous Tumour Thrombus|venous tumour thrombus
5080707|NCT03494816|Axitinib|axitinib
5080708|NCT03494816|Mayo Classification|mayo classification
5080709|NCT03494816|Nephrectomy|nephrectomy
5080710|NCT03494816|Thrombectomy|thrombectomy
5080711|NCT03494790|MMP|mmp
5080712|NCT03494790|Matrix metalloproteinase|matrix metalloproteinase
5080713|NCT03494790|Metabolomics|metabolomics
5080714|NCT03494790|FGF-21|fgf-21
5080715|NCT03494790|Quick SOFA|quick sofa
5080716|NCT03494790|Infection|infection
5080717|NCT03494790|Triage|triage
5080718|NCT03494777|ART adherence|art adherence
5080719|NCT03494764|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5080721|NCT03494751|Myocardial infarction|myocardial infarction
5080722|NCT03494751|Clinical trial|clinical trial
5080723|NCT03494738|Prenatal alcohol exposure|prenatal alcohol exposure
5080724|NCT03494725|Probiotic|probiotic
5080725|NCT03494725|Gut-brain axis|gut-brain axis
5080726|NCT03494725|Stress|stress
5080727|NCT03494725|Anxiety|anxiety
5080731|NCT03494686|conization|conization
5080732|NCT03494686|LLETZ|lletz
5080733|NCT03494686|randomized controlled trial|randomized controlled trial
5080734|NCT03494686|loop excision|loop excision
5080735|NCT03494686|general anaesthesia|general anaesthesia
5080736|NCT03494686|local anaesthesia|local anaesthesia
5080737|NCT03494673|White matter hyperintensity|white matter hyperintensity
5080738|NCT03494673|Cerebrovascular reactivity|cerebrovascular reactivity
5080739|NCT03494660|Subchondroplasty|subchondroplasty
5080740|NCT03494660|Bone Marrow Lesion|bone marrow lesion
5080741|NCT03494660|Arthroscopy|arthroscopy
5080742|NCT03494660|Bone Substitute Material|bone substitute material
5080743|NCT03494660|AccuFill|accufill
5080744|NCT03494660|Subchondral Bone Defect|subchondral bone defect
5080745|NCT03494608|cognitive function|cognitive function
5080746|NCT03494608|quality of life|quality of life
5080747|NCT03494608|anxiety|anxiety
5080748|NCT03494608|depression|depression
5080749|NCT03494608|neurological function|neurological function
5080750|NCT03494595|Pediatric Liver Transplantation, Thromboelastometry|pediatric liver transplantation, thromboelastometry
5080751|NCT03494543|Ampullary Adenoma|ampullary adenoma
5080752|NCT03494543|Endoscopic Papillectomy|endoscopic papillectomy
5080753|NCT03494543|Familial Adenomatous Polyposis|familial adenomatous polyposis
5080754|NCT03494504|reproxalap|reproxalap
5080755|NCT03494478|Cohort study|cohort study
5080756|NCT03494478|Emotion dysregulation|emotion dysregulation
5080757|NCT03494478|Questionnaires|questionnaires
5080758|NCT03494478|Actimetry|actimetry
5080759|NCT03494478|Neuropsychology|neuropsychology
5080760|NCT03494452|electromyography, strength, strength endurance|electromyography, strength, strength endurance
5080761|NCT03494400|Breast cancer|breast cancer
5079535|NCT03502018|Exparel|exparel
5080762|NCT03494400|Physical exercise|physical exercise
5080763|NCT03494400|Body mass|body mass
5080764|NCT03494387|Antioxidant|antioxidant
5080765|NCT03494387|Hyperoxia|hyperoxia
5080766|NCT03494387|Troponin|troponin
5080767|NCT03494387|MINS|mins
5080768|NCT03494387|Ascorbic acid|ascorbic acid
5080769|NCT03494387|N-acetylcysteine|n-acetylcysteine
5080770|NCT03494374|pes planus|pes planus
5080771|NCT03494374|UCBL|ucbl
5080772|NCT03494374|exercise|exercise
5080773|NCT03494361|deglutition disorders|deglutition disorders
5080774|NCT03494361|electromyography|electromyography
5080775|NCT03494348|Radiostereometry (RSA)|radiostereometry (rsa)
5080776|NCT03494348|Total Knee Arthroplasty|total knee arthroplasty
5080777|NCT03494309|Mandibular Subcondylar Fractures|mandibular subcondylar fractures
5080778|NCT03494309|Mouth Opening|mouth opening
5080779|NCT03494309|Open Reduction and Internal Fixation|open reduction and internal fixation
5080780|NCT03494309|Closed Reduction with External Fixation|closed reduction with external fixation
5080781|NCT03494283|CrossFit injuries|crossfit injuries
5080782|NCT03494257|phacoemulsification|phacoemulsification
5080783|NCT03494257|intraocular pressure|intraocular pressure
5080784|NCT03494257|cataract|cataract
5080785|NCT03494257|brinzolamide|brinzolamide
5080798|NCT03494218|minimally conscious state|minimally conscious state
5080799|NCT03494218|consciousness|consciousness
5080800|NCT03494218|pain assessment|pain assessment
5080801|NCT03494218|nociception test|nociception test
5080802|NCT03494205|Radiation Dermatitis|radiation dermatitis
5080803|NCT03494205|Urtica comp.|urtica comp.
5080804|NCT03494192|acromiohumeral distance|acromiohumeral distance
5080806|NCT03494192|functional level|functional level
5080807|NCT03494192|Subacromial Impingement Syndrome|subacromial impingement syndrome
5080808|NCT03494127|wheelchair seating|wheelchair seating
5080809|NCT03494127|tissue health|tissue health
5080810|NCT03494088|Autism|autism
5080811|NCT03494088|Abdominal Pain|abdominal pain
5080812|NCT03494075|Patients|patients
5080813|NCT03494075|Caregivers|caregivers
5080814|NCT03494036|synbiotic|synbiotic
5080815|NCT03494036|probiotic|probiotic
5080816|NCT03494036|lupus|lupus
5080817|NCT03494036|connective tissue disease|connective tissue disease
5080818|NCT03494010|Kidney Transplantation|kidney transplantation
5080819|NCT03493971|carotid endarterectomy|carotid endarterectomy
5080820|NCT03493971|carotid stenting|carotid stenting
5080821|NCT03493971|autonomic function|autonomic function
5080822|NCT03493971|computational fluid dynamic|computational fluid dynamic
5080823|NCT03493971|cognitive function|cognitive function
5092642|NCT03419676|Sealant|sealant
5080837|NCT03493919|Immunological assays|immunological assays
5080838|NCT03493919|Human blood donors|human blood donors
5080839|NCT03493919|Meningococcal vaccination|meningococcal vaccination
5080840|NCT03493919|Meningococcal disease|meningococcal disease
5080841|NCT03493867|Non-invasive blood pressure monitoring|non-invasive blood pressure monitoring
5080842|NCT03493867|Wearable device|wearable device
5080843|NCT03493867|Medical device verification study|medical device verification study
5080844|NCT03493802|ADPKD|adpkd
5080845|NCT03493802|Endothelial dysfunction|endothelial dysfunction
5080846|NCT03493802|Oxidative stress|oxidative stress
5080847|NCT03493802|NADPH oxidase 4 (NOX4)|nadph oxidase 4 (nox4)
5080848|NCT03493802|Mitochondria|mitochondria
5080849|NCT03493763|Recurrence Monitoring|recurrence monitoring
5080850|NCT03493763|5-Hydroxymethylcytosine|5-hydroxymethylcytosine
5080851|NCT03493763|Liquid biopsy|liquid biopsy
5080852|NCT03493763|Cell-free DNA|cell-free dna
5080853|NCT03493672|Phase I clinical trial|phase i clinical trial
5080854|NCT03493672|Phase II clinical trial|phase ii clinical trial
5080855|NCT03493672|Early trial discontinuation|early trial discontinuation
5080856|NCT03493672|Objective smartphone measurements|objective smartphone measurements
5080857|NCT03493672|Physical activity|physical activity
5080858|NCT03493672|Physical fitness|physical fitness
5080859|NCT03493659|Standing|standing
5080860|NCT03493659|Sitting|sitting
5080861|NCT03493659|Learning|learning
5080862|NCT03493659|Problem-Based Learning|problem-based learning
5080863|NCT03493659|Undergraduate|undergraduate
5080864|NCT03493646|Myelodysplastic Syndrome|myelodysplastic syndrome
5080866|NCT03493646|Acute Myeloid Leukemia|acute myeloid leukemia
5080868|NCT03493646|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5080869|NCT03493646|CMML|cmml
5080870|NCT03493607|AMO-01|amo-01
5080871|NCT03493607|Shank3|shank3
5080872|NCT03493607|Clinical Trial|clinical trial
5080873|NCT03493594|Early nutrition|early nutrition
5080874|NCT03493594|Breastfeeding|breastfeeding
5080875|NCT03493594|Infant growth|infant growth
5080876|NCT03493529|Endometrial microbiome|endometrial microbiome
5080877|NCT03493529|Obesity|obesity
5080878|NCT03493529|Bacterial pathogens|bacterial pathogens
5080879|NCT03493529|Dysbiosis|dysbiosis
5080880|NCT03493529|Endometrial receptivity|endometrial receptivity
5080881|NCT03493516|Positron Emission Tomography|positron emission tomography
5080882|NCT03493516|Sympathetic Innervation|sympathetic innervation
5080883|NCT03493516|Sudden Death|sudden death
5080884|NCT03493516|Ventricular Fibrillation|ventricular fibrillation
5080885|NCT03493516|LMI-1195|lmi-1195
5080905|NCT03493451|Refractory|refractory
5080906|NCT03493399|Gambling|gambling
5080907|NCT03493399|Craving|craving
5080908|NCT03493399|Urge|urge
5080909|NCT03493399|Desire|desire
5080910|NCT03493399|Interference|interference
5080911|NCT03493399|Elaborated Intrusion Theory|elaborated intrusion theory
5080912|NCT03493399|Treatment|treatment
5080913|NCT03493399|Intervention|intervention
5080914|NCT03493399|Clinical Sample|clinical sample
5080915|NCT03493399|Single case|single case
5080916|NCT03493386|Japan|japan
5080917|NCT03493386|Crossover|crossover
5080918|NCT03493386|Daprodustat|daprodustat
5080919|NCT03493386|Bioequivalence|bioequivalence
5080920|NCT03493386|Pharmacokinetics|pharmacokinetics
5080922|NCT03493243|Adolescent|adolescent
5080923|NCT03493243|Post Traumatic Stress Disorder|post traumatic stress disorder
4964211|NCT04213066|Grating acuity|grating acuity
5080924|NCT03493243|Terrorist Attack|terrorist attack
5080925|NCT03493204|Hepatic Encephalopathy|hepatic encephalopathy
5080926|NCT03493204|Ascites|ascites
5080927|NCT03493204|Liver Diseases|liver diseases
5080928|NCT03493204|Cirrhosis|cirrhosis
5080929|NCT03493126|postpartum, local estrogen|postpartum, local estrogen
5080930|NCT03493113|EEG|eeg
5080931|NCT03493100|oral nutritional supplementation|oral nutritional supplementation
5080932|NCT03493100|geriatrics|geriatrics
5080933|NCT03493100|bone fracture|bone fracture
5080934|NCT03493087|Dialysis, Vitamin-K, Malnutrition|dialysis, vitamin-k, malnutrition
5080935|NCT03493035|Middle Cerebral Artery|middle cerebral artery
5080936|NCT03493035|Cerebral Aneurysm|cerebral aneurysm
5080937|NCT03493035|Transcranial Color-Coded Sonography|transcranial color-coded sonography
5080938|NCT03493035|Three-Dimensional Computed Tomography Angiography|three-dimensional computed tomography angiography
5080945|NCT03492957|physical activity|physical activity
5080946|NCT03492957|exercise|exercise
5080947|NCT03492957|non-ambulatory|non-ambulatory
5080948|NCT03492957|feasibility|feasibility
5080949|NCT03492957|mixed methods|mixed methods
5080950|NCT03492931|Hb SS disease, Hb S Beta 0 Thalassemia|hb ss disease, hb s beta 0 thalassemia
5080951|NCT03492892|acupuncture|acupuncture
5080952|NCT03492892|hypertension|hypertension
5080953|NCT03492892|targeted metabolome|targeted metabolome
5080954|NCT03492892|pilot clinical trial|pilot clinical trial
5080955|NCT03492814|impacted third molar|impacted third molar
5080956|NCT03492814|suturing|suturing
5080957|NCT03492814|post-operative morbidity|post-operative morbidity
5080958|NCT03492788|cardiac resynchronization therapy|cardiac resynchronization therapy
5080959|NCT03492788|electrocardiographic imaging|electrocardiographic imaging
5080960|NCT03492775|indolent lymphoma|indolent lymphoma
5080961|NCT03492775|Obinutuzumab|obinutuzumab
5080963|NCT03492775|Bendamustine|bendamustine
5080964|NCT03492775|medically non-fit patients|medically non-fit patients
5080965|NCT03492684|nerve injury after total hip arthroplasty|nerve injury after total hip arthroplasty
5080966|NCT03492671|Pancreatic Cancer|pancreatic cancer
5080969|NCT03492632|psoriasis|psoriasis
5080970|NCT03492632|Anti mullerian hormone|anti mullerian hormone
5080971|NCT03492632|ovarian reserve|ovarian reserve
5080972|NCT03492632|antral follicle count|antral follicle count
5080973|NCT03492619|obesity|obesity
5080974|NCT03492619|food insecurity|food insecurity
5080975|NCT03492619|depressive symptoms|depressive symptoms
5080976|NCT03492619|empowerment|empowerment
5080977|NCT03492593|carotenoids|carotenoids
5080978|NCT03492593|vitamin E|vitamin e
5080979|NCT03492593|digestion|digestion
5080980|NCT03492593|stability|stability
5080981|NCT03492593|metabolism|metabolism
5080982|NCT03492567|Cystic fibrosis|cystic fibrosis
5080983|NCT03492567|CFTR|cftr
5080984|NCT03492567|CFTR modulators|cftr modulators
5080985|NCT03492567|Monocyte|monocyte
5080986|NCT03492567|Osteoclast|osteoclast
5080987|NCT03492567|Osteoporosis|osteoporosis
5080988|NCT03492541|mixed dry eye|mixed dry eye
5080989|NCT03492541|aqueous-deficient dry eye|aqueous-deficient dry eye
5080990|NCT03492541|lipid-deficient dry eye|lipid-deficient dry eye
5080992|NCT03492541|tear film|tear film
5080993|NCT03492541|eye drops|eye drops
5080994|NCT03492541|artificial tears|artificial tears
5080995|NCT03492541|lipid layer|lipid layer
5080996|NCT03492541|eye symptoms|eye symptoms
5080997|NCT03492541|meibomian gland dysfunction|meibomian gland dysfunction
5080998|NCT03492541|MGD|mgd
5080999|NCT03492541|SYSTANE|systane
5081000|NCT03492541|SYSTANE Complete|systane complete
5081001|NCT03492541|nanoemulsion|nanoemulsion
5081002|NCT03492515|immune thrombocytopenia|immune thrombocytopenia
5081003|NCT03492502|Fecal microbiota transplantation|fecal microbiota transplantation
5081004|NCT03492502|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5081005|NCT03492502|microbiome|microbiome
5081006|NCT03492476|Lymphedema of Upper Arm reduction|lymphedema of upper arm reduction
5081007|NCT03492476|Lymphedema Upper Arm device|lymphedema upper arm device
5081008|NCT03492463|Nicotine addiction|nicotine addiction
5081009|NCT03492463|Cigarette smoking|cigarette smoking
5081010|NCT03492463|Nicotine patches|nicotine patches
5081011|NCT03492463|E-cigarettes|e-cigarettes
5081012|NCT03492450|Treadmill training|treadmill training
5081013|NCT03492450|Instrumented assessment|instrumented assessment
5081014|NCT03492450|Disease progression|disease progression
5081015|NCT03492437|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5081016|NCT03492437|P-glycoprotein|p-glycoprotein
5081017|NCT03492437|Tepotinib|tepotinib
5081018|NCT03492437|Dabigatran Etexilate|dabigatran etexilate
5081019|NCT03492424|prostate cancer|prostate cancer
5081020|NCT03492424|cryotherapy|cryotherapy
5081021|NCT03492424|focal therapy|focal therapy
5081022|NCT03492411|Breastfeeding|breastfeeding
5081023|NCT03492411|Co-parenting|co-parenting
5081024|NCT03492411|eHealth|ehealth
5081025|NCT03492411|patient education|patient education
5081026|NCT03492411|fathers|fathers
5081027|NCT03492398|atopic dermatitis|atopic dermatitis
5961358|NCT04287673|Axial segments|axial segments
5961359|NCT04287660|BiRd|bird
5081028|NCT03492359|COPD, Structured Light Plethysmography, COPD severity|copd, structured light plethysmography, copd severity
5081029|NCT03492346|LGMD2E|lgmd2e
5081030|NCT03492346|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
5081031|NCT03492346|sarcoglycanopathy|sarcoglycanopathy
5081032|NCT03492346|β -sarcoglycan|β -sarcoglycan
5081033|NCT03492346|Natural History|natural history
5081034|NCT03492333|antigliadin, gluten free diet, transit|antigliadin, gluten free diet, transit
5081035|NCT03492320|HRQoL|hrqol
5081036|NCT03492320|Quality of Life|quality of life
5081037|NCT03492320|End Stage Osteoarthritis|end stage osteoarthritis
5081038|NCT03492320|Total Knee Arthroplasty|total knee arthroplasty
5081039|NCT03492320|WOMAC|womac
5081040|NCT03492320|SF 36|sf 36
5081041|NCT03492320|Total Knee Replacement|total knee replacement
5081042|NCT03492307|High Flow Nasal Cannula|high flow nasal cannula
5081043|NCT03492294|disorders of consciousness|disorders of consciousness
5081044|NCT03492294|music stimulation|music stimulation
5081045|NCT03492294|functional magnetic resonance imaging|functional magnetic resonance imaging
5081046|NCT03492281|Beta-3 adrenergic receptor (β3-AR) agonists|beta-3 adrenergic receptor (β3-ar) agonists
5081047|NCT03492281|Incontinence|incontinence
5081048|NCT03492281|OAB|oab
5081049|NCT03492281|Vibegron|vibegron
5081050|NCT03492281|Urge urinary incontinence|urge urinary incontinence
5081051|NCT03492281|Urinary bladder, overactive|urinary bladder, overactive
5081073|NCT03492151|Confocal laser endomicroscopy|confocal laser endomicroscopy
5081075|NCT03492138|Relapsed and Refractory|relapsed and refractory
5081076|NCT03492086|Rosmarinus officinalis L|rosmarinus officinalis l
5081077|NCT03492086|alkylglycerols|alkylglycerols
5081078|NCT03492086|immuno-nutrition|immuno-nutrition
5081079|NCT03492086|colon cancer|colon cancer
5081080|NCT03492073|Mindfulness|mindfulness
5081081|NCT03492073|Oncology|oncology
5081082|NCT03492073|Cancer|cancer
5081083|NCT03492073|Emotional distress|emotional distress
5081084|NCT03492073|Quality of life|quality of life
5081085|NCT03492060|Gene Variant|gene variant
5081086|NCT03492060|HNRNPA1|hnrnpa1
5081087|NCT03492060|HNRNPA2|hnrnpa2
5081088|NCT03492060|HNRNPB1|hnrnpb1
5081089|NCT03492060|HNRNPC1|hnrnpc1
5081103|NCT03492060|HNRNPP|hnrnpp
5081104|NCT03492060|HNRNPQ1|hnrnpq1
5081105|NCT03492060|HNRNPQ2|hnrnpq2
5081106|NCT03492060|HNRNPQ3|hnrnpq3
5081107|NCT03492060|HNRNPR|hnrnpr
5081108|NCT03492060|HNRNPU|hnrnpu
5081112|NCT03492021|rehabilitative nutrition|rehabilitative nutrition
5081113|NCT03492021|protein|protein
5081114|NCT03492021|beef|beef
5081115|NCT03492021|ACL reconstruction|acl reconstruction
5081116|NCT03492021|protein synthesis|protein synthesis
5081117|NCT03492021|proteolysis|proteolysis
5081118|NCT03492021|muscle mass|muscle mass
5081119|NCT03492021|muscle strength|muscle strength
5081120|NCT03492008|nasogastric tube|nasogastric tube
5081121|NCT03492008|general anesthesia|general anesthesia
5081122|NCT03492008|head position|head position
5081123|NCT03491982|Cardiac Rehabilitation|cardiac rehabilitation
5081124|NCT03491930|Weight Loss|weight loss
5081125|NCT03491930|Obesity|obesity
5081126|NCT03491930|Pre-Diabetes|pre-diabetes
5081127|NCT03491930|Metabolic Syndrome|metabolic syndrome
5081128|NCT03491891|Very Late Stent Thrombosis|very late stent thrombosis
5081129|NCT03491891|New generation DES|new generation des
5081130|NCT03491774|memory impairment, montessori intervention, neurocognitive disorder|memory impairment, montessori intervention, neurocognitive disorder
5081131|NCT03491761|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
5081132|NCT03491761|Viscosupplementation|viscosupplementation
5081133|NCT03491761|Knee Osteoarthritis|knee osteoarthritis
5081134|NCT03491761|Hyaluronic Acid (HA)|hyaluronic acid (ha)
5081185|NCT03491540|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
5081186|NCT03491540|Oral antibiotics|oral antibiotics
5081187|NCT03491540|Rectal cancer surgery|rectal cancer surgery
5081188|NCT03491540|Surgical site infection|surgical site infection
5081189|NCT03491501|Industrial work|industrial work
5081190|NCT03491501|physical effort|physical effort
5081191|NCT03491501|mental effort|mental effort
5081192|NCT03491501|questionnaires|questionnaires
5081193|NCT03491501|ergonomic evaluation|ergonomic evaluation
5081207|NCT03491397|Chronic Pain|chronic pain
5081208|NCT03491397|Embozene|embozene
5081209|NCT03491384|anxiety|anxiety
5081210|NCT03491384|inflammation|inflammation
5081211|NCT03491384|cannabis|cannabis
5081212|NCT03491384|marijuana|marijuana
5081213|NCT03491384|stress|stress
5081214|NCT03491371|apatinib|apatinib
5081215|NCT03491371|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
5081216|NCT03491371|osteosarcoma|osteosarcoma
5081217|NCT03491371|Ewing sarcoma|ewing sarcoma
5081218|NCT03491371|chondrosarcoma|chondrosarcoma
5081219|NCT03491371|soft-tissue sarcoma|soft-tissue sarcoma
5081220|NCT03491358|vibrating mesh nebulizer|vibrating mesh nebulizer
5081221|NCT03491358|allergen challenge|allergen challenge
5081222|NCT03491319|Anesthetics, Local|anesthetics, local
5081223|NCT03491319|Head-Down Tilt|head-down tilt
5961360|NCT04287660|CART|cart
5081224|NCT03491319|Anesthesia, Spinal|anesthesia, spinal
5081225|NCT03491319|hypotension|hypotension
5961361|NCT04287660|BCMA|bcma
5081226|NCT03491306|PEEK|peek
5081227|NCT03491306|Breflex|breflex
5081228|NCT03491293|internet|internet
5081229|NCT03491293|behavioral weight loss|behavioral weight loss
5081230|NCT03491293|obesity|obesity
5081231|NCT03491280|Rare Diseases|rare diseases
5081232|NCT03491280|Genetic Predisposition|genetic predisposition
5081233|NCT03491280|Omics Technology|omics technology
5081234|NCT03491280|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
5081235|NCT03491267|alopecia|alopecia
5081245|NCT03491176|Head and Neck Cancer|head and neck cancer
5081246|NCT03491176|Magnetic resonance imaging|magnetic resonance imaging
5081248|NCT03491176|Biomarker testing|biomarker testing
5081249|NCT03491176|Blood draws|blood draws
5081250|NCT03491176|Questionnaires|questionnaires
5081251|NCT03491176|Surveys|surveys
5081252|NCT03491163|syndecan-1|syndecan-1
5081253|NCT03491163|endothelial glycocalyx|endothelial glycocalyx
5081254|NCT03491163|On-pump heart surgery|on-pump heart surgery
5081255|NCT03491150|Dementia|dementia
5081256|NCT03491150|Neurodegenerative Diseases|neurodegenerative diseases
5081257|NCT03491150|Brain Diseases|brain diseases
5081258|NCT03491150|Central Nervous System Diseases|central nervous system diseases
5081259|NCT03491150|Nervous System Diseases|nervous system diseases
5081260|NCT03491150|Tauopathies|tauopathies
5081261|NCT03491150|Neurocognitive Disorders|neurocognitive disorders
5079932|NCT03499548|Cognitive Behavioral Therapy|cognitive behavioral therapy
5081274|NCT03491033|advanced-stage ovarian cancer|advanced-stage ovarian cancer
5081275|NCT03491033|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5081277|NCT03491033|genomic profiling|genomic profiling
5081278|NCT03491033|immunohistochemistry|immunohistochemistry
5081279|NCT03491020|Emission Patterns|emission patterns
5081280|NCT03491020|Respiratory|respiratory
5081281|NCT03491020|Aerosolization|aerosolization
5081282|NCT03491020|Airborne|airborne
5081283|NCT03491007|PTSD|ptsd
5081284|NCT03491007|DHEA|dhea
5081285|NCT03490981|primary care|primary care
5081286|NCT03490981|chronic pain|chronic pain
5081287|NCT03490981|musculoskeletal pain|musculoskeletal pain
5081288|NCT03490981|cognitive behavioral therapy|cognitive behavioral therapy
5081289|NCT03490981|integrated primary care|integrated primary care
5081593|NCT03489343|Anti-TIM-3|anti-tim-3
5081293|NCT03490916|High-altitude illness|high-altitude illness
5081294|NCT03490916|High-altitude pulmonary edema|high-altitude pulmonary edema
5081295|NCT03490916|Lung comets|lung comets
5081296|NCT03490916|Lung ultrasound|lung ultrasound
5081297|NCT03490916|Subclinical high-altitude pulmonary edema|subclinical high-altitude pulmonary edema
5081298|NCT03490903|virtual reality|virtual reality
5081299|NCT03490903|anxiety|anxiety
5081300|NCT03490903|vasospasm|vasospasm
5081301|NCT03490903|pain|pain
5081302|NCT03490903|coronary artery angiography|coronary artery angiography
5081303|NCT03490903|angiogram|angiogram
5081305|NCT03490890|microwave ablation|microwave ablation
5081306|NCT03490890|lung cancer|lung cancer
5081307|NCT03490890|ground glass nodules|ground glass nodules
5081308|NCT03490877|Atopic Dermatitis|atopic dermatitis
5072578|NCT03545555|kale|kale
5081309|NCT03490877|Pruritus|pruritus
5081310|NCT03490877|Sleep Disturbance|sleep disturbance
5081311|NCT03490786|GT-001|gt-001
5081312|NCT03490773|Cpeptide|cpeptide
5081313|NCT03490773|Immunology|immunology
5081314|NCT03490760|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
5081315|NCT03490747|Physical Activity|physical activity
5081316|NCT03490747|Pragmatic Evaluation|pragmatic evaluation
5081317|NCT03490747|Exercise Referral|exercise referral
5081318|NCT03490747|Mixed-methods|mixed-methods
5081319|NCT03490747|Behaviour Change|behaviour change
5081320|NCT03490747|Intervention|intervention
5081321|NCT03490734|nutrition|nutrition
5081322|NCT03490734|obesity|obesity
5081323|NCT03490734|weight gain|weight gain
5081324|NCT03490734|sugar|sugar
5081325|NCT03490734|sugar sweetened beverage|sugar sweetened beverage
5081326|NCT03490734|dopamine|dopamine
5081327|NCT03490734|neurobehavioral adaptation|neurobehavioral adaptation
5081328|NCT03490708|Mucinoses|mucinoses
5081329|NCT03490708|Tranilast|tranilast
5081330|NCT03490643|Plantar Pressure Distribution|plantar pressure distribution
5081331|NCT03490643|Posture|posture
5081332|NCT03490643|Posturescreen Mobile|posturescreen mobile
5081333|NCT03490643|RDC/TMD|rdc/tmd
5081334|NCT03490643|TMD|tmd
5081335|NCT03490630|patient reported outcome|patient reported outcome
5081336|NCT03490630|postoperative pain|postoperative pain
5081337|NCT03490630|pain related impairment|pain related impairment
5081338|NCT03490630|quality of life|quality of life
5081339|NCT03490630|prospective association study|prospective association study
5081340|NCT03490617|Intrauterine device|intrauterine device
5081341|NCT03490617|Misoprostol|misoprostol
5081342|NCT03490617|Nulliparous women|nulliparous women
5081343|NCT03490617|Contraception|contraception
5081344|NCT03490591|Cerebral Palsy|cerebral palsy
5081345|NCT03490591|Robotic rehabilitation|robotic rehabilitation
5081346|NCT03490591|Hand function|hand function
5081347|NCT03490591|Activities of Daily Living|activities of daily living
5081348|NCT03490578|Parkinson Disease|parkinson disease
5081349|NCT03490578|Gait|gait
5081350|NCT03490578|Balance|balance
5081351|NCT03490578|Rehabilitation|rehabilitation
5081361|NCT03490500|headache|headache
5081362|NCT03490500|intracranial hemorrhage|intracranial hemorrhage
5081363|NCT03490474|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
5081364|NCT03490474|diffuse noxious inhibitory control (DNIC)|diffuse noxious inhibitory control (dnic)
5081366|NCT03490474|hypoalgesia|hypoalgesia
5081367|NCT03490448|vitamin D|vitamin d
5081372|NCT03490435|Per os invasions|per os invasions
5081373|NCT03490435|Giardiasis|giardiasis
5081374|NCT03490435|Toxoplasmosis|toxoplasmosis
5081375|NCT03490435|Taeniasis|taeniasis
5081376|NCT03490435|Cryptosporidiosis|cryptosporidiosis
5081377|NCT03490435|Trichinosis|trichinosis
5081378|NCT03490435|Ascariasis|ascariasis
5081379|NCT03490435|Echinococcosis|echinococcosis
5081380|NCT03490422|pulpotomy|pulpotomy
5081381|NCT03490422|permanent teeth|permanent teeth
5081382|NCT03490422|deep caries management|deep caries management
5081383|NCT03490422|risk factors|risk factors
5081384|NCT03490422|clinical indicators for pulpotomy|clinical indicators for pulpotomy
5081385|NCT03490409|Arthroplasty|arthroplasty
5081386|NCT03490409|Replacement|replacement
5081387|NCT03490409|Knee|knee
5081388|NCT03490409|Compression|compression
5081389|NCT03490409|Edema|edema
5081390|NCT03490409|Pain|pain
5081391|NCT03490396|Oral Mucositis|oral mucositis
5081392|NCT03490396|Stomatitis|stomatitis
5081393|NCT03490396|Myeloablative|myeloablative
5081394|NCT03490383|ERCP|ercp
5081395|NCT03490383|CBD stone|cbd stone
5081396|NCT03490383|Microbial Colonization|microbial colonization
5081397|NCT03490344|bony plasmacytoma|bony plasmacytoma
5081398|NCT03490344|extramedullary plasmacytoma|extramedullary plasmacytoma
5081399|NCT03490344|Daratumumab|daratumumab
5081400|NCT03490344|lenalidomide|lenalidomide
5081401|NCT03490344|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5081402|NCT03490344|18-048|18-048
5081404|NCT03490331|Stem cells|stem cells
5081405|NCT03490331|Gene Therapy|gene therapy
5081406|NCT03490305|War injury|war injury
5081407|NCT03490305|Penetrating abdominal trauma|penetrating abdominal trauma
5081408|NCT03490305|Exploratory laparotomy|exploratory laparotomy
5081409|NCT03490305|Improvised explosive device|improvised explosive device
5081410|NCT03490305|Mosul|mosul
5081411|NCT03490266|Ventral Hernia|ventral hernia
5081412|NCT03490266|Hernia Repair|hernia repair
5081413|NCT03490227|neonates|neonates
5081414|NCT03490227|brown adipose tissue|brown adipose tissue
5081415|NCT03490227|body composition|body composition
5081416|NCT03490214|Optoacoustics|optoacoustics
5081417|NCT03490214|MSOT|msot
5081418|NCT03490214|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
5081419|NCT03490175|genetic association study|genetic association study
5081420|NCT03490175|postoperative nausea and vomiting|postoperative nausea and vomiting
5081421|NCT03490175|patient reported outcome|patient reported outcome
5081422|NCT03490175|antiemetics|antiemetics
5081423|NCT03490162|Anti-Malarial|anti-malarial
5081424|NCT03490162|DM1157|dm1157
5081425|NCT03490162|Pharmacokinetics|pharmacokinetics
5081426|NCT03490162|Safety|safety
5081427|NCT03490149|ECT|ect
5081428|NCT03490149|Electroconvulsive Therapy|electroconvulsive therapy
5081429|NCT03490149|Depression|depression
5081430|NCT03490149|Memory|memory
5081431|NCT03490149|Memory Impairment|memory impairment
5081432|NCT03490123|Azithromycin|azithromycin
5081433|NCT03490123|Endemic treponematoses|endemic treponematoses
5081434|NCT03490123|Mass drug administration|mass drug administration
5081435|NCT03490123|Eradication|eradication
5081436|NCT03490123|Papua New Guinea|papua new guinea
5081437|NCT03490110|cognitive rehabilitation|cognitive rehabilitation
5081438|NCT03490110|EEG|eeg
5081439|NCT03490110|TBI|tbi
5081440|NCT03490110|brain networks|brain networks
5081441|NCT03490110|attention|attention
5081442|NCT03490110|memory|memory
5081443|NCT03490110|executive function|executive function
5093250|NCT03416023|Implant|implant
5081462|NCT03490045|Basic Needs|basic needs
5081463|NCT03490006|regional anesthesia|regional anesthesia
5081464|NCT03490006|postoperative pain|postoperative pain
5081465|NCT03490006|mastectomy|mastectomy
5081466|NCT03490006|erector spinae plane block|erector spinae plane block
5081467|NCT03490006|paravertebral block|paravertebral block
5081468|NCT03489993|FGF23|fgf23
5081469|NCT03489993|Angiotensin-(1-7)|angiotensin-(1-7)
5081470|NCT03489993|Hypophosphatemia|hypophosphatemia
5081471|NCT03489980|STAI Questionnaire|stai questionnaire
5081472|NCT03489980|ECTM2-Qa|ectm2-qa
5081473|NCT03489967|Hypoglycemia, carbohydrates|hypoglycemia, carbohydrates
5081474|NCT03489954|Non-specific Chronic Neck Pain|non-specific chronic neck pain
5081475|NCT03489954|Balance Master|balance master
5081476|NCT03489954|Joint Position Error|joint position error
5081477|NCT03489954|Neck pain|neck pain
5081478|NCT03489928|Labour|labour
5081479|NCT03489928|Induction|induction
5961362|NCT04287660|MM|mm
5081480|NCT03489928|Misoprostol|misoprostol
5081481|NCT03489928|Dinoprostone|dinoprostone
5081482|NCT03489928|Oxytocin|oxytocin
5081483|NCT03489889|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
5081484|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid
5081502|NCT03489759|Acute Kidney Injury|acute kidney injury
5081503|NCT03489759|Oxidative Stress|oxidative stress
5081504|NCT03489759|Renal Replacement Therapy|renal replacement therapy
5081505|NCT03489759|Vitamine E-coated Polysulfone Membrane|vitamine e-coated polysulfone membrane
5081506|NCT03489746|Inhaled corticosteroids|inhaled corticosteroids
5081507|NCT03489746|Quality improvement|quality improvement
5081508|NCT03489746|Cluster randomized Trial|cluster randomized trial
5081509|NCT03489707|anal cancer|anal cancer
5081510|NCT03489707|human papillomavirus|human papillomavirus
5081511|NCT03489694|skin test endpoint|skin test endpoint
5081512|NCT03489681|acupuncture, sciatica, default mode network|acupuncture, sciatica, default mode network
5081513|NCT03489668|PCOS|pcos
5081514|NCT03489668|Androgen|androgen
5081515|NCT03489668|3D ultrasound|3d ultrasound
5081516|NCT03489655|Healthy Homes|healthy homes
5081517|NCT03489655|Asthma|asthma
5081518|NCT03489655|Community Health Worker|community health worker
5081519|NCT03489629|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5081520|NCT03489629|Early infection|early infection
5081521|NCT03489629|Treatment|treatment
5081522|NCT03489629|Forced Expiratory Volume in 1 Second (FEV1)|forced expiratory volume in 1 second (fev1)
5081523|NCT03489603|Troponin|troponin
5081524|NCT03489590|Lung|lung
5081525|NCT03489590|Imaging|imaging
5081526|NCT03489590|Hyperpolarized|hyperpolarized
5081527|NCT03489590|Perfluorinated|perfluorinated
5081528|NCT03489590|MRI|mri
5081529|NCT03489577|Inflammation|inflammation
5081530|NCT03489577|Multiple Organ Failure|multiple organ failure
5081531|NCT03489577|Sepsis|sepsis
5081532|NCT03489577|Wounds and Injuries|wounds and injuries
5081533|NCT03489577|Pathologic Processes|pathologic processes
5081534|NCT03489577|Shock|shock
5081535|NCT03489577|Infection|infection
5081536|NCT03489577|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5081537|NCT03489577|Neutrophils|neutrophils
5081538|NCT03489577|PMN|pmn
5081539|NCT03489577|Granulocytes|granulocytes
5356810|NCT01917903|attention|attention
5081540|NCT03489577|Innate immunity|innate immunity
5081541|NCT03489577|ICU|icu
5081542|NCT03489577|Intensive Care|intensive care
5081543|NCT03489577|polytrauma|polytrauma
5081544|NCT03489577|host-pathogen|host-pathogen
5081545|NCT03489564|Pregnancy|pregnancy
5081548|NCT03489538|bariatric surgery|bariatric surgery
5081549|NCT03489538|gastric bypass|gastric bypass
5081550|NCT03489538|homocysteine|homocysteine
5081551|NCT03489538|folate|folate
5081552|NCT03489538|vitamin b12|vitamin b12
5081556|NCT03489499|postoperative pain|postoperative pain
5081557|NCT03489499|analgesics|analgesics
5081558|NCT03489499|patient reported outcome|patient reported outcome
5081559|NCT03489499|pain related impairment|pain related impairment
5081560|NCT03489499|genetic association study|genetic association study
5081561|NCT03489486|Presepsin|presepsin
5081562|NCT03489486|sCD14-ST|scd14-st
5081563|NCT03489486|biomarker|biomarker
5081564|NCT03489486|perioperative risk|perioperative risk
5081565|NCT03489473|Hormonal therapy|hormonal therapy
5081566|NCT03489473|FES PET scan|fes pet scan
5081567|NCT03489473|Estrogen receptor|estrogen receptor
5081568|NCT03489460|sleep health|sleep health
5081569|NCT03489434|adolescents|adolescents
5081570|NCT03489434|primary care|primary care
5081571|NCT03489434|sexual assault|sexual assault
5081572|NCT03489434|substance use|substance use
5081573|NCT03489434|sexual risk behavior|sexual risk behavior
5081576|NCT03489382|self-harm|self-harm
5081577|NCT03489382|problem-solving therapy|problem-solving therapy
5081578|NCT03489382|emergency department|emergency department
5081579|NCT03489382|e-therapy|e-therapy
5081580|NCT03489382|suicide prevention|suicide prevention
5081581|NCT03489369|Locally advanced/unresectable|locally advanced/unresectable
5081582|NCT03489369|Metastatic solid tumor|metastatic solid tumor
5081583|NCT03489369|Lymphoma|lymphoma
5081589|NCT03489356|Addressing Behavior Change (ABC) Intervention Method|addressing behavior change (abc) intervention method
5081590|NCT03489343|Locally advanced/unresectable|locally advanced/unresectable
5081591|NCT03489343|Metastatic solid tumor|metastatic solid tumor
5081592|NCT03489343|Lymphoma|lymphoma
5081594|NCT03489343|TIM-3|tim-3
5081595|NCT03489343|TIM3|tim3
5081596|NCT03489330|Anti-Bacterial Agents/therapeutic use|anti-bacterial agents/therapeutic use
5081597|NCT03489330|Drug Utilization/statistics & numerical data|drug utilization/statistics & numerical data
5081598|NCT03489330|Hospitals/statistics & numerical data|hospitals/statistics & numerical data
5081599|NCT03489330|Data Analysis, Statistical|data analysis, statistical
5081600|NCT03489330|Interpretation, Statistical Data|interpretation, statistical data
5081601|NCT03489330|Antibiotic Stewardship|antibiotic stewardship
5081602|NCT03489330|Electronic Medical Record|electronic medical record
5081603|NCT03489317|gut microbiome|gut microbiome
5081604|NCT03489317|stool|stool
5081605|NCT03489304|Insomnia|insomnia
5081606|NCT03489304|Zaleplon|zaleplon
5081607|NCT03489291|Hemophilia,|hemophilia,
5081608|NCT03489291|Gene Therapy|gene therapy
5081609|NCT03489291|Bleeding|bleeding
5081610|NCT03489291|Factor IX|factor ix
5081612|NCT03489291|viral vector|viral vector
5081613|NCT03489291|Padua|padua
5081614|NCT03489226|capsaicin|capsaicin
5081615|NCT03489226|energy expenditure|energy expenditure
5081616|NCT03489226|satiety|satiety
5081617|NCT03489226|food intake|food intake
5081618|NCT03489174|Opioid Substitution Therapy|opioid substitution therapy
5081619|NCT03489174|Pregnancy Tests|pregnancy tests
5081620|NCT03489148|Stress|stress
5081621|NCT03489148|Relaxation|relaxation
5081622|NCT03489148|Health promotion|health promotion
5081623|NCT03489122|Depressive Disorder, Major|depressive disorder, major
5081624|NCT03489122|yoga|yoga
5081625|NCT03489122|breathing exercise|breathing exercise
5081626|NCT03489122|parasympathetic|parasympathetic
5081627|NCT03489122|anxiety|anxiety
5081628|NCT03489122|Post Traumatic Stress Disorder|post traumatic stress disorder
5081629|NCT03489122|polyvagal|polyvagal
5081630|NCT03489109|Fasting|fasting
5081631|NCT03489096|Cryoballoon Ablation|cryoballoon ablation
5081632|NCT03489096|Persistent atrial fibrillation|persistent atrial fibrillation
5081633|NCT03489096|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5081634|NCT03489083|Diabetes|diabetes
5081635|NCT03489083|Heat Shock Response|heat shock response
5081636|NCT03489083|Aging|aging
5081637|NCT03489083|Exercise|exercise
5081638|NCT03489070|Liver resection|liver resection
5081639|NCT03489070|Liver Hemorrhage|liver hemorrhage
5081640|NCT03489070|Traumastem|traumastem
5081641|NCT03489070|Surgicel|surgicel
5081642|NCT03489057|symptom|symptom
5081643|NCT03489057|family research|family research
5081644|NCT03489057|self-management|self-management
5081645|NCT03489057|caregiving|caregiving
5081646|NCT03489057|social support|social support
5081647|NCT03489057|mHealth|mhealth
5081648|NCT03489057|healthy behavior|healthy behavior
5081649|NCT03489057|self-efficacy|self-efficacy
5081650|NCT03489057|quality of life|quality of life
5081656|NCT03489044|Levetiracetam|levetiracetam
5081657|NCT03489005|BIA 5-1058|bia 5-1058
5081658|NCT03489005|Pulmonary arterial hypertension|pulmonary arterial hypertension
5081659|NCT03489005|Heart failure|heart failure
5081660|NCT03489005|Cardiovascular Disease|cardiovascular disease
5081661|NCT03488992|dietary supplement, cardiovascular health, oxidative stress|dietary supplement, cardiovascular health, oxidative stress
5081662|NCT03488979|Heart Failure|heart failure
5081663|NCT03488979|Medication Adherence|medication adherence
5081664|NCT03488966|Mindfulness|mindfulness
5081665|NCT03488966|Bariatric Surgery|bariatric surgery
5081666|NCT03488966|Obesity|obesity
5739307|NCT00360568|efficacy|efficacy
5081667|NCT03488966|Group psychotherapy|group psychotherapy
5081668|NCT03488953|Liver transplantation|liver transplantation
5081669|NCT03488953|Two-stage hepatectomy|two-stage hepatectomy
5081670|NCT03488953|Living donor liver transplantation|living donor liver transplantation
5081671|NCT03488940|Sepsis|sepsis
5081672|NCT03488940|intestinal dysfunction|intestinal dysfunction
5081673|NCT03488940|enteral feeding|enteral feeding
5081674|NCT03488927|Sexual Violence|sexual violence
5081675|NCT03488927|Interpersonal Violence|interpersonal violence
5081676|NCT03488927|Prevention|prevention
5081677|NCT03488927|Mixed-Methods|mixed-methods
5081678|NCT03488927|Randomized Controlled Trial|randomized controlled trial
5081679|NCT03488927|Outcome Evaluation|outcome evaluation
5081680|NCT03488927|College Students|college students
5081681|NCT03488927|Post-traumatic Stress Disorder|post-traumatic stress disorder
5081682|NCT03488927|Alcohol|alcohol
5081687|NCT03488927|Depression|depression
5081688|NCT03488927|Intervention|intervention
5081689|NCT03488823|Endothelial Function|endothelial function
5081690|NCT03488823|Flavonols|flavonols
5081691|NCT03488823|Intima Injury|intima injury
5081692|NCT03488810|Apalutamide Prostate Cancer Radiotherapy|apalutamide prostate cancer radiotherapy
5081693|NCT03488771|kidney transplantation|kidney transplantation
5081694|NCT03488771|rejection|rejection
5081697|NCT03488667|resectable adenocarcinoma of Gastroesophageal Junction|resectable adenocarcinoma of gastroesophageal junction
5081698|NCT03488667|resectable adenocarcinoma of Stomach|resectable adenocarcinoma of stomach
5081699|NCT03488641|Biomarker|biomarker
5081700|NCT03488641|Signal Transduction Pathway Deregulation|signal transduction pathway deregulation
5081701|NCT03488641|Outcome|outcome
5081702|NCT03488641|Drug sensitivity testing|drug sensitivity testing
5081703|NCT03488641|Targeted Therapy|targeted therapy
5081704|NCT03488641|Genomic landscape|genomic landscape
5081705|NCT03488628|respiratory failure|respiratory failure
5081706|NCT03488628|oxygen therapy|oxygen therapy
5081707|NCT03488628|Noninvasive ventilation|noninvasive ventilation
5081708|NCT03488563|Headache|headache
5081709|NCT03488498|Balneotherapy|balneotherapy
5081710|NCT03488498|Chronic low back pain|chronic low back pain
5081711|NCT03488498|Controlled|controlled
5081712|NCT03488498|Randomized trial|randomized trial
5081713|NCT03488498|weight bath traction|weight bath traction
5081714|NCT03488498|follow-up|follow-up
5369138|NCT01861158|Online intervention|online intervention
5961363|NCT04287595|anxiety|anxiety
5961364|NCT04287595|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5900331|NCT02046096|vena cava filters|vena cava filters
5081715|NCT03488485|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
5081716|NCT03488485|Direct antivirals, DAAs|direct antivirals, daas
5081717|NCT03488485|Chronic hepatitis C|chronic hepatitis c
5081718|NCT03488459|anxiety|anxiety
5081719|NCT03488459|preoperative education|preoperative education
5081720|NCT03488459|psychologist|psychologist
5081721|NCT03488459|thoracotomy|thoracotomy
5081722|NCT03488459|Ravitch procedure|ravitch procedure
5081723|NCT03488459|postoperative pain|postoperative pain
5081724|NCT03488446|Gastric Cancer|gastric cancer
5081725|NCT03488446|Radiomics|radiomics
5081726|NCT03488446|Computed Tomograpy|computed tomograpy
5081727|NCT03488446|Lymph Node Metastasis|lymph node metastasis
5081728|NCT03488446|Prediction|prediction
5081729|NCT03488433|Postoperative shoulder immobilization|postoperative shoulder immobilization
5081730|NCT03488433|Reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
5081731|NCT03488433|Neutral rotation shoulder brace|neutral rotation shoulder brace
5081732|NCT03488433|Antirotation sling|antirotation sling
5081733|NCT03488407|Primary angioplasty|primary angioplasty
5081734|NCT03488407|Radial access|radial access
5081735|NCT03488407|STEMI|stemi
5081736|NCT03488394|Mucopolysaccharidosis IH|mucopolysaccharidosis ih
5081737|NCT03488394|Gene Therapy|gene therapy
5081738|NCT03488394|Transplantation, Autologous|transplantation, autologous
5081739|NCT03488394|Lentiviral vector|lentiviral vector
5081740|NCT03488355|Catheter|catheter
5081741|NCT03488342|Rives technique|rives technique
5081742|NCT03488342|Lichtenstein repair|lichtenstein repair
5081746|NCT03488290|Young Children|young children
5081747|NCT03488290|Trauma Focused Cognitive Behavior Therapy|trauma focused cognitive behavior therapy
5081748|NCT03488290|Learning Through Play|learning through play
5081749|NCT03488160|lymphoma CAR-T|lymphoma car-t
5081750|NCT03488147|Esomeprazole Magnesium|esomeprazole magnesium
5081751|NCT03488147|Postoperative dysphagia|postoperative dysphagia
5081752|NCT03488147|Gastroesophageal reflux disease|gastroesophageal reflux disease
5081753|NCT03488147|Anterior cervical surgery|anterior cervical surgery
5081754|NCT03488147|Proton pump inhibitor|proton pump inhibitor
5081756|NCT03488134|Anaplastic thyroid cancer|anaplastic thyroid cancer
5081757|NCT03488134|Urine|urine
5081758|NCT03488134|Biological marker|biological marker
5081759|NCT03488134|Thyroglobuin|thyroglobuin
5081760|NCT03488134|Galectin-3|galectin-3
5081761|NCT03488095|Tobacco, smokeless, chewing, betel quid|tobacco, smokeless, chewing, betel quid
5081762|NCT03488082|saccadic adaptation|saccadic adaptation
5081763|NCT03488082|visual-spatial perception|visual-spatial perception
5081764|NCT03488082|fMRI|fmri
5081765|NCT03488069|critical care|critical care
5081766|NCT03488069|sedation|sedation
5081767|NCT03488069|practice|practice
5081768|NCT03488069|survey|survey
5081769|NCT03488056|Dental Caries, ICCMS, Risk Assessment|dental caries, iccms, risk assessment
5081770|NCT03488043|Lung lesions|lung lesions
5081771|NCT03488043|Pneumothorax|pneumothorax
5081772|NCT03488043|CT-guided transthoracic biopsy|ct-guided transthoracic biopsy
5081773|NCT03488043|Risk score|risk score
5081774|NCT03488030|Drug therapy|drug therapy
5081775|NCT03487991|autonomic balance|autonomic balance
5081776|NCT03487991|sleep|sleep
5081777|NCT03487991|endothelial function|endothelial function
5081778|NCT03487991|behavior|behavior
5081779|NCT03487991|stress|stress
5080397|NCT03496623|Tyvaso|tyvaso
5081781|NCT03487965|skin elasticity|skin elasticity
5081782|NCT03487965|glycation|glycation
5081783|NCT03487952|Lung nodule|lung nodule
5081784|NCT03487952|Computed tomography|computed tomography
5081785|NCT03487952|Artificial intelligence|artificial intelligence
5081786|NCT03487887|continuous glucose monitoring|continuous glucose monitoring
5081787|NCT03487887|glycemic variability|glycemic variability
5081788|NCT03487887|hypoglycemia|hypoglycemia
5081789|NCT03487874|8th cervical nerve root block|8th cervical nerve root block
5082187|NCT03484988|Metabolites|metabolites
5081790|NCT03487861|transglutaminase type 2|transglutaminase type 2
5081791|NCT03487861|kidney transplantation|kidney transplantation
5081792|NCT03487861|chronic allograft nephropathy|chronic allograft nephropathy
5081793|NCT03487861|biomarker|biomarker
5081794|NCT03487835|Athletic tape. Accidental Falls. Aging.|athletic tape. accidental falls. aging.
5081795|NCT03487809|Asthma|asthma
5081796|NCT03487809|Inhaled corticosteroid|inhaled corticosteroid
5081797|NCT03487809|pharmacogenomics|pharmacogenomics
5081798|NCT03487809|Therapeutic effect|therapeutic effect
5081799|NCT03487783|Tourette|tourette
5081800|NCT03487783|Aripiprazole Oral Solution|aripiprazole oral solution
5081801|NCT03487770|Autistic|autistic
5081802|NCT03487770|Aripiprazole Oral Solution|aripiprazole oral solution
5081803|NCT03487744|Tube Feeding|tube feeding
5081804|NCT03487744|Diarrhea|diarrhea
5081805|NCT03487744|Enteral Nutrition|enteral nutrition
5081806|NCT03487744|Critically Ill|critically ill
5081807|NCT03487744|Surgical|surgical
5081808|NCT03487744|Cardiovascular|cardiovascular
5081809|NCT03487731|stem cells|stem cells
5081810|NCT03487731|back pain|back pain
5961365|NCT04287595|inhalation aromatherapy|inhalation aromatherapy
5961366|NCT04287595|nausea|nausea
5081811|NCT03487718|Platelet-Rich Fibrin|platelet-rich fibrin
5081812|NCT03487718|high-density polytetrafluoroethylene membrane|high-density polytetrafluoroethylene membrane
5081813|NCT03487692|diabetes|diabetes
5081814|NCT03487692|group visit|group visit
5081815|NCT03487692|shared medical appointment|shared medical appointment
5081816|NCT03487692|text messaging|text messaging
5081817|NCT03487679|Microbiome|microbiome
5081818|NCT03487679|High Density Lipoprotein|high density lipoprotein
5081819|NCT03487679|Inflammation|inflammation
5081820|NCT03487666|Triple Negative Breast Cancer|triple negative breast cancer
5081821|NCT03487666|Nivolumab|nivolumab
5081822|NCT03487666|Capecitabine|capecitabine
5081823|NCT03487640|constipation, surgery|constipation, surgery
5081824|NCT03487627|adolescent|adolescent
5081825|NCT03487627|parental support|parental support
5081826|NCT03487627|parental coping|parental coping
5081827|NCT03487614|pediatric obesity|pediatric obesity
5081828|NCT03487614|preschool children|preschool children
5081829|NCT03487614|non-responsive feeding|non-responsive feeding
5081830|NCT03487614|body mass index|body mass index
5081831|NCT03487614|parenting|parenting
5081832|NCT03487601|docetaxel|docetaxel
5081833|NCT03487601|Stage I - IV|stage i - iv
5081834|NCT03487601|chemotherapy|chemotherapy
5081835|NCT03487575|Adolescent|adolescent
5081836|NCT03487575|Parental Support|parental support
5081837|NCT03487575|Parental Coping|parental coping
5081838|NCT03487523|Behavioural Economics|behavioural economics
5081839|NCT03487510|treatment standards|treatment standards
5081840|NCT03487510|diagnostical approaches|diagnostical approaches
5081841|NCT03487510|descriptive|descriptive
5081852|NCT03487393|cerebral blood flow|cerebral blood flow
5081853|NCT03487367|spinocerebellar ataxia|spinocerebellar ataxia
5081854|NCT03487367|ataxia|ataxia
5081855|NCT03487367|ataxias|ataxias
5081856|NCT03487367|SCA1|sca1
5081857|NCT03487367|SCA3|sca3
5081858|NCT03487367|spinocerebellar ataxia type 1|spinocerebellar ataxia type 1
5081859|NCT03487367|spinocerebellar ataxia type 3|spinocerebellar ataxia type 3
5081860|NCT03487367|READISCA|readisca
5081861|NCT03487328|treatment|treatment
5081862|NCT03487276|hidradenitis suppurativa|hidradenitis suppurativa
5081863|NCT03487276|monoclonal antibody|monoclonal antibody
5081864|NCT03487276|complement factor C5a|complement factor c5a
5081865|NCT03487276|IFX-1|ifx-1
5081866|NCT03487276|hidradenitis Suppurativa Clinical Response|hidradenitis suppurativa clinical response
5081867|NCT03487276|Inflammation|inflammation
5081868|NCT03487276|skin diseases|skin diseases
5081869|NCT03487263|motor neurone disease|motor neurone disease
5081870|NCT03487263|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5081871|NCT03487263|IC14 [anti-CD14 (cluster of differentiation 14) monoclonal antibody]|ic14 [anti-cd14 (cluster of differentiation 14) monoclonal antibody]
5081872|NCT03487263|monoclonal antibody|monoclonal antibody
5081873|NCT03487263|anti-CD14|anti-cd14
5081874|NCT03487237|Syncope|syncope
5081875|NCT03487237|Pulmonary embolism|pulmonary embolism
5081876|NCT03487237|emergency department|emergency department
5081877|NCT03487237|clinical decision rule|clinical decision rule
5081878|NCT03487224|Hoarding Disorder|hoarding disorder
5081882|NCT03487198|Major Depressive Disorder|major depressive disorder
5081883|NCT03487198|Brexpiprazole|brexpiprazole
5081889|NCT03487029|high intensity interval training|high intensity interval training
5081890|NCT03487029|cardiorespiratory fitness|cardiorespiratory fitness
5081892|NCT03487016|First line|first line
5081898|NCT03486990|tolerability|tolerability
5081899|NCT03486990|pharmacokinetics|pharmacokinetics
5081900|NCT03486990|celiac|celiac
5081901|NCT03486990|gliadin|gliadin
5081902|NCT03486990|gluten|gluten
5081903|NCT03486951|outpatient surgery|outpatient surgery
5081904|NCT03486951|ambulatory surgery|ambulatory surgery
5081905|NCT03486951|length of hospital stay|length of hospital stay
5081906|NCT03486925|oxytocin, eye-tracking, attention inhibition|oxytocin, eye-tracking, attention inhibition
5081911|NCT03486821|Radiation Therapy|radiation therapy
5081912|NCT03486821|ultra-short Radiation|ultra-short radiation
5081913|NCT03486821|SBRT|sbrt
5081914|NCT03486821|prostate|prostate
5081915|NCT03486821|quality of life|quality of life
5081916|NCT03486821|financial toxicity|financial toxicity
5081917|NCT03486808|transcranial direct current stimulation|transcranial direct current stimulation
5081918|NCT03486808|motor function|motor function
5081919|NCT03486795|transcranial direct current stimulation|transcranial direct current stimulation
5081920|NCT03486795|motor function|motor function
5081921|NCT03486782|transcranial direct current stimulation|transcranial direct current stimulation
5081922|NCT03486782|dual stimulation|dual stimulation
5081923|NCT03486769|transcranial direct current stimulation|transcranial direct current stimulation
5081924|NCT03486769|dual stimulation|dual stimulation
5081925|NCT03486756|Asthma|asthma
5081926|NCT03486756|Anxiety|anxiety
5081927|NCT03486756|Stress|stress
5081928|NCT03486743|LARC contraception cultural acceptance|larc contraception cultural acceptance
5081930|NCT03486678|PD-1 antibody|pd-1 antibody
5081931|NCT03486639|Urodynamics|urodynamics
5081932|NCT03486639|Bladder sensation|bladder sensation
5081933|NCT03486639|confounding factors|confounding factors
5081935|NCT03486587|diarrhea|diarrhea
5081936|NCT03486587|Bacillus Cereus|bacillus cereus
5081937|NCT03486587|NSCLC|nsclc
5081938|NCT03486561|Ranolazine|ranolazine
5093721|NCT03412903|Elderly|elderly
5081939|NCT03486561|Pakistan|pakistan
5081940|NCT03486561|Ischemic Heart Disease|ischemic heart disease
5081941|NCT03486548|popliteal sciatic nerve block|popliteal sciatic nerve block
5081942|NCT03486548|total knee artgroplasty|total knee artgroplasty
5081943|NCT03486548|adductor canal block|adductor canal block
5081944|NCT03486548|dexamethasone|dexamethasone
5081945|NCT03486535|Diabetes mellitus|diabetes mellitus
5081946|NCT03486535|Infraclavicular brachial plexus block|infraclavicular brachial plexus block
5081947|NCT03486535|Block duration|block duration
5081948|NCT03486535|Time-to-first pain|time-to-first pain
5081949|NCT03486535|Postoperative analgesia|postoperative analgesia
5081950|NCT03486522|termination of pregnancy|termination of pregnancy
5081951|NCT03486509|afatinib|afatinib
5081952|NCT03486496|Lung Adenocarcinoma|lung adenocarcinoma
5081953|NCT03486496|EGFR mutation|egfr mutation
5081954|NCT03486496|Gefitinib|gefitinib
5081955|NCT03486496|Berberine|berberine
5081956|NCT03486457|psoriatic arthritis|psoriatic arthritis
5081957|NCT03486457|tofacitinib|tofacitinib
5081958|NCT03486431|Stereotactic Ablative Body Radiotherapy (SABR)|stereotactic ablative body radiotherapy (sabr)
5081959|NCT03486366|epilepsy, TSC, biomarkers, mTOR pathway|epilepsy, tsc, biomarkers, mtor pathway
5081960|NCT03486353|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5081961|NCT03486314|Drug therapy|drug therapy
5081962|NCT03486301|TLR|tlr
5081963|NCT03486301|Immuno-oncology|immuno-oncology
5081964|NCT03486288|delirium|delirium
5081965|NCT03486288|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5081966|NCT03486288|spine surgery|spine surgery
5081967|NCT03486288|elderly|elderly
5081968|NCT03486288|neuroinflammation|neuroinflammation
5081969|NCT03486288|magnetic resonance imaging|magnetic resonance imaging
5081970|NCT03486288|resting state fmri|resting state fmri
5081971|NCT03486288|cerebral vasculature|cerebral vasculature
5081972|NCT03486288|quality of life|quality of life
5081973|NCT03486275|GENERAL PRACTICE|general practice
5081974|NCT03486275|SERIOUS GAME|serious game
5081975|NCT03486275|EVIDENCE BASED MEDICINE|evidence based medicine
5081976|NCT03486275|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
5081977|NCT03486275|PEDAGOGY|pedagogy
5081978|NCT03486262|Lung cancer; Idiopathic pulmonary fibrosis|lung cancer; idiopathic pulmonary fibrosis
5081979|NCT03486249|diaphragm dysfunction|diaphragm dysfunction
5081980|NCT03486249|ventilator weaning|ventilator weaning
5081981|NCT03486249|pulmonary edema|pulmonary edema
5081982|NCT03486171|difficult intubation|difficult intubation
5081983|NCT03486171|prehospital emergency|prehospital emergency
5081989|NCT03486158|Recurrence|recurrence
5081990|NCT03486158|Prognosis|prognosis
5081991|NCT03486158|Clinical Chemistry Tests|clinical chemistry tests
5081992|NCT03486145|beetroot juice|beetroot juice
5081993|NCT03486145|nitrates and nitrites|nitrates and nitrites
5081995|NCT03486093|Venous central catheter|venous central catheter
5081996|NCT03486093|Central line-associated bloodstream infections|central line-associated bloodstream infections
5081997|NCT03486093|Port protector|port protector
5081998|NCT03486093|Respiratory semi-Intensive Care Unit|respiratory semi-intensive care unit
5081999|NCT03486067|Multiple Myeloma|multiple myeloma
5082000|NCT03486067|BCMA X CD3 T Cell|bcma x cd3 t cell
5082001|NCT03486067|Antibody|antibody
5082002|NCT03486067|CC-93269|cc-93269
5082003|NCT03486067|Relapsed and Refractory|relapsed and refractory
5082004|NCT03486054|Anemia|anemia
5082005|NCT03486054|Transfusion|transfusion
5082006|NCT03486054|Pathogen inactivation|pathogen inactivation
5082007|NCT03486054|low-resource|low-resource
5082008|NCT03486054|Sub-saharan Africa|sub-saharan africa
5082009|NCT03486054|Côte d'Ivoire|côte d'ivoire
5082010|NCT03486054|Transfusion-transmitted infection|transfusion-transmitted infection
5082011|NCT03486054|Red Blood Cells|red blood cells
5082012|NCT03486054|Whole blood|whole blood
5082013|NCT03486054|Pathogen reduction|pathogen reduction
5082014|NCT03486028|Patient-Centered Outcomes Research Institute (PCORI)|patient-centered outcomes research institute (pcori)
5082015|NCT03486028|American Society of Addiction Medicine (ASAM)|american society of addiction medicine (asam)
5082016|NCT03486028|substance use|substance use
5082017|NCT03486028|addiction|addiction
5082018|NCT03486028|treatment|treatment
5082019|NCT03486028|RTI International|rti international
5082020|NCT03486028|UCLA|ucla
5082021|NCT03485989|hazelnuts|hazelnuts
5082022|NCT03485989|vitamin E|vitamin e
5082023|NCT03485989|aging|aging
5082024|NCT03485976|Ixekizumab|ixekizumab
5082025|NCT03485976|IL-17|il-17
5082026|NCT03485976|Pityriasis Rubra Pilaris (PRP)|pityriasis rubra pilaris (prp)
5082027|NCT03485950|Other infectious diseases|other infectious diseases
5082028|NCT03485950|Febrile neutropenic adults with cancer|febrile neutropenic adults with cancer
5082029|NCT03485950|Ceftolozane-Tazobactam|ceftolozane-tazobactam
5082030|NCT03485950|Cefepime|cefepime
5082031|NCT03485950|Meropenem|meropenem
5082032|NCT03485950|Piperacillin/Tazobactam|piperacillin/tazobactam
5082033|NCT03485937|anxiety|anxiety
5082034|NCT03485937|patient satisfaction|patient satisfaction
5082035|NCT03485937|video education|video education
5082036|NCT03485937|skin cancer|skin cancer
5082037|NCT03485937|linear closure on the face|linear closure on the face
5082038|NCT03485911|BCX7353|bcx7353
5082044|NCT03485846|hepatitis C|hepatitis c
5082045|NCT03485846|chronic|chronic
5082046|NCT03485846|1b genotype|1b genotype
5082047|NCT03485846|oral treatment|oral treatment
5082048|NCT03485833|end-expiratory occlusion test|end-expiratory occlusion test
5082049|NCT03485833|end-inspiratory occlusion test|end-inspiratory occlusion test
5082050|NCT03485833|transesophageal echocardiography|transesophageal echocardiography
5082051|NCT03485833|passive legs raising|passive legs raising
5082052|NCT03485833|fluid challenge|fluid challenge
5082053|NCT03485820|environmental modifications|environmental modifications
5082054|NCT03485820|activity performance|activity performance
5082059|NCT03485781|Intensive Care|intensive care
5082060|NCT03485781|Propofol|propofol
5082061|NCT03485768|cervical vertigo|cervical vertigo
5082062|NCT03485768|percutaneous disc decompression with coblation nucleoplasty|percutaneous disc decompression with coblation nucleoplasty
5082063|NCT03485768|manual therapy|manual therapy
5082064|NCT03485768|clinical efficacy|clinical efficacy
5082065|NCT03485768|randomized controlled trial|randomized controlled trial
5082066|NCT03485755|microflora|microflora
5082067|NCT03485755|microbiome|microbiome
5082068|NCT03485755|bacteria taxa|bacteria taxa
5082069|NCT03485716|metabolism|metabolism
5082070|NCT03485716|metabolome|metabolome
5082071|NCT03485716|physical activity|physical activity
5082072|NCT03485716|hypoxia|hypoxia
5082073|NCT03485690|COPD|copd
5082074|NCT03485690|Cohort study|cohort study
5082075|NCT03485690|Prospective|prospective
5082076|NCT03485651|adrexal mass|adrexal mass
5082077|NCT03485651|ovarian cancer|ovarian cancer
5082078|NCT03485651|fallopian tube cancer|fallopian tube cancer
5082079|NCT03485651|peritoneal cancer|peritoneal cancer
5082090|NCT03485521|High Fidelity Simulation Training|high fidelity simulation training
5082091|NCT03485521|physiotherapy|physiotherapy
5082092|NCT03485521|tracheobronchial aspiration.|tracheobronchial aspiration.
5082093|NCT03485482|Pharmacokinetic drug interaction|pharmacokinetic drug interaction
5082094|NCT03485482|ivabtadine|ivabtadine
5082095|NCT03485482|bisoprolol|bisoprolol
5082096|NCT03485469|Obesity|obesity
5082097|NCT03485469|bariatric surgery|bariatric surgery
5082098|NCT03485469|Hypnosis|hypnosis
5082099|NCT03485456|Dry powder inhalation|dry powder inhalation
5082100|NCT03485456|Tobramycin|tobramycin
5082101|NCT03485443|fluid infusion|fluid infusion
5082102|NCT03485443|vomiting|vomiting
5082103|NCT03485443|otorhinolaringology|otorhinolaringology
5082104|NCT03485417|stimulant|stimulant
5082105|NCT03485417|psychosis|psychosis
5082106|NCT03485417|schizophrenia|schizophrenia
5082107|NCT03485417|dependence|dependence
5082108|NCT03485417|pharmacotherapy|pharmacotherapy
5082109|NCT03485404|POCD|pocd
5082110|NCT03485404|vitamin B12|vitamin b12
5082111|NCT03485404|folic acid|folic acid
5082112|NCT03485378|Stereotactic|stereotactic
5082113|NCT03485378|Ablative|ablative
5082114|NCT03485378|Radiation|radiation
5082115|NCT03485365|Pain|pain
5082116|NCT03485365|Osteoarthritis of the knee|osteoarthritis of the knee
5082117|NCT03485365|Target engagement|target engagement
5082118|NCT03485365|GSK3858279|gsk3858279
5082119|NCT03485365|Pharmacokinetics|pharmacokinetics
5082120|NCT03485365|Sequential|sequential
5082121|NCT03485352|Bariatric Surgery|bariatric surgery
5082122|NCT03485352|Sleep|sleep
5082123|NCT03485352|Chronotype|chronotype
5082124|NCT03485326|Osimertinib|osimertinib
5082125|NCT03485326|Tagrisso|tagrisso
5082126|NCT03485326|NSCLC|nsclc
5082127|NCT03485326|Non-small cell lung cancer|non-small cell lung cancer
5082128|NCT03485326|Safety|safety
5082129|NCT03485313|Healthy|healthy
5082130|NCT03485313|Volunteer|volunteer
5082131|NCT03485313|Female|female
5082132|NCT03485313|Pregnancy|pregnancy
5082136|NCT03485274|Cannabis|cannabis
5082137|NCT03485274|depression|depression
5082138|NCT03485274|anxiety|anxiety
5082139|NCT03485274|medication|medication
5082140|NCT03485248|HIV/AIDS|hiv/aids
5082141|NCT03485248|Arterial stiffness|arterial stiffness
5082142|NCT03485248|Flow mediated-dilatation|flow mediated-dilatation
5082143|NCT03485248|Muscle oxygenation parameters|muscle oxygenation parameters
5082144|NCT03485248|Microcirculation|microcirculation
5082145|NCT03485248|Dietary Nitrate|dietary nitrate
5082158|NCT03485196|Microsatellite Instability|microsatellite instability
5082159|NCT03485196|Fluorouracil|fluorouracil
5082160|NCT03485196|Adjuvant chemotherapy|adjuvant chemotherapy
5082161|NCT03485196|Efficacy|efficacy
5082162|NCT03485196|Operation|operation
5082163|NCT03485183|delirium|delirium
5082164|NCT03485183|white noise|white noise
5082165|NCT03485183|pink noise|pink noise
5082166|NCT03485170|Hemophilia|hemophilia
5082167|NCT03485170|Hemophilic arthropathy|hemophilic arthropathy
5082168|NCT03485170|PET|pet
5082169|NCT03485144|Dengue Vaccine|dengue vaccine
5692265|NCT00528723|wheezing|wheezing
5082170|NCT03485118|Previously untreated DLBCL|previously untreated dlbcl
5082171|NCT03485105|Gastric cancer|gastric cancer
5082172|NCT03485105|biomarker|biomarker
5082173|NCT03485105|chemotherapy|chemotherapy
5082174|NCT03485105|precise medicine|precise medicine
5082175|NCT03485092|heart failure|heart failure
5082176|NCT03485092|diabetes mellitus|diabetes mellitus
5082177|NCT03485092|empagliflozin|empagliflozin
5082178|NCT03485092|Randomised, placebo controlled trial|randomised, placebo controlled trial
5082179|NCT03485040|Rehabilitation|rehabilitation
5082180|NCT03485040|Neurorehabilitation|neurorehabilitation
5082181|NCT03485040|Neurotechnology|neurotechnology
5082182|NCT03485040|Neurorecovery|neurorecovery
5082183|NCT03485040|Neurorestoration|neurorestoration
5082184|NCT03484988|Polyunsaturated fatty acids|polyunsaturated fatty acids
5082185|NCT03484988|Echium oil|echium oil
5082186|NCT03484988|Hyperlipidemias|hyperlipidemias
5082227|NCT03484767|methylmalonic acidemia|methylmalonic acidemia
5740129|NCT00357435|Mapping|mapping
5082229|NCT03484767|organic acidemia|organic acidemia
5082230|NCT03484767|mut deficiency|mut deficiency
5082231|NCT03484767|inborn errors of metabolism|inborn errors of metabolism
5082233|NCT03484767|mut-|mut-
5082234|NCT03484767|PA|pa
5082235|NCT03484767|PCCA|pcca
5082236|NCT03484767|PCCB|pccb
5082237|NCT03484767|propionic acidemia|propionic acidemia
5082238|NCT03484728|Conditional pain modulation|conditional pain modulation
5082239|NCT03484728|pain|pain
5082240|NCT03484728|placebo|placebo
5082241|NCT03484715|Physical Activity|physical activity
5082242|NCT03484715|Nursing Home|nursing home
5082243|NCT03484715|Feasibility|feasibility
5082244|NCT03484715|Older Adults|older adults
5082256|NCT03484689|Diabetes-related distress|diabetes-related distress
5082257|NCT03484689|Mindfulness|mindfulness
5082258|NCT03484637|motivation|motivation
5082259|NCT03484637|Treatment adherence|treatment adherence
5082260|NCT03484637|Waist circumference|waist circumference
5082261|NCT03484637|obesity|obesity
5082262|NCT03484637|overweight|overweight
5082263|NCT03484624|Muscle; Fatigue|muscle; fatigue
5082264|NCT03484624|Wearable hip assist robot|wearable hip assist robot
5082265|NCT03484624|Metabolic energy expenditure|metabolic energy expenditure
5082266|NCT03484585|Mass Balance, metabolism and excretion pattern|mass balance, metabolism and excretion pattern
5082267|NCT03484559|In-hospital Cardiac Arrest|in-hospital cardiac arrest
5082268|NCT03484546|ovarian reserve|ovarian reserve
5082269|NCT03484546|endometriosis|endometriosis
5082270|NCT03484546|endometrioma|endometrioma
5082271|NCT03484520|Cancer|cancer
5082272|NCT03484520|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5082273|NCT03484520|venetoclax|venetoclax
5082274|NCT03484520|dinaciclib|dinaciclib
5082275|NCT03484520|Relapsed/refractory AML|relapsed/refractory aml
5082276|NCT03484520|Pharmacokinetics|pharmacokinetics
5082277|NCT03484494|Geriatric|geriatric
5082278|NCT03484494|Low Field Magnetic Stimulation|low field magnetic stimulation
5082279|NCT03484494|Antidepressant|antidepressant
5082280|NCT03484494|fMRI|fmri
5082281|NCT03484494|MRS|mrs
5082282|NCT03484468|lasik|lasik
5082284|NCT03484468|femtosecond|femtosecond
5082285|NCT03484468|laser|laser
5082286|NCT03484468|moria|moria
5082287|NCT03484468|microkeratome|microkeratome
5082288|NCT03484429|Neurostimulation|neurostimulation
5082289|NCT03484429|Peripheral nerve stimulation|peripheral nerve stimulation
5082290|NCT03484390|mindfulness|mindfulness
5082291|NCT03484390|posttraumatic stress disorder|posttraumatic stress disorder
5082292|NCT03484351|Falls|falls
5082293|NCT03484325|Registry|registry
5082294|NCT03484325|Joint Registry|joint registry
5082295|NCT03484325|OA|oa
5082296|NCT03484325|Osteoarthritis|osteoarthritis
5082297|NCT03484325|Osteo arthritis|osteo arthritis
5082298|NCT03484325|knee|knee
5082299|NCT03484325|hip|hip
5082300|NCT03484325|tka|tka
5082301|NCT03484325|tha|tha
5082302|NCT03484273|Tilt Table|tilt table
5082303|NCT03484273|Compression|compression
5082304|NCT03484273|Dysautonomia|dysautonomia
5082305|NCT03484273|POTS|pots
5082306|NCT03484260|Risk factors predicting the initiation of testosterone use|risk factors predicting the initiation of testosterone use
5961367|NCT04287595|randomized controlled trial|randomized controlled trial
5961368|NCT04287582|duchenne muscular dystrophy|duchenne muscular dystrophy
5082307|NCT03484247|infraclavicular block|infraclavicular block
5082308|NCT03484247|axillary block|axillary block
5082309|NCT03484234|Drug eluting stent|drug eluting stent
5082310|NCT03484234|everolimus eluting stent|everolimus eluting stent
5082311|NCT03484234|sirolimus eluting stent|sirolimus eluting stent
5082312|NCT03484182|Upper extremity|upper extremity
5082313|NCT03484182|Stroke|stroke
5082314|NCT03484182|Web-based program|web-based program
5082315|NCT03484182|Home exercise training|home exercise training
5082316|NCT03484169|Muscle Stretching Exercises|muscle stretching exercises
5082317|NCT03484169|Pelvic Floor|pelvic floor
5082318|NCT03484169|motor control|motor control
5082319|NCT03484169|motor skill|motor skill
5082320|NCT03484169|motor activity|motor activity
5082321|NCT03484156|Elderly|elderly
5082328|NCT03484104|Hypothermic circulatory arrest|hypothermic circulatory arrest
5082329|NCT03484104|Aortic arch surgery|aortic arch surgery
5082331|NCT03484091|Hylan G-F 20|hylan g-f 20
5082332|NCT03484091|Hyaluronic acid|hyaluronic acid
5082333|NCT03484091|Knee osteoarthritis|knee osteoarthritis
5082334|NCT03484091|Pain level|pain level
5082335|NCT03484065|Congenital fibrinogen disorders|congenital fibrinogen disorders
5082336|NCT03484039|memory problems|memory problems
5082337|NCT03484039|stress|stress
5082338|NCT03484039|depression|depression
5082339|NCT03484039|adherence|adherence
5082340|NCT03484039|seizure documentation|seizure documentation
5082341|NCT03484026|Iron Deficiency|iron deficiency
5082342|NCT03484026|Anemia|anemia
5082343|NCT03484026|Medical Food|medical food
5082344|NCT03483987|Hepatitis c virus|hepatitis c virus
5082345|NCT03483987|Direct acting antiviral drugs|direct acting antiviral drugs
5082346|NCT03483987|Virological relapse|virological relapse
5082347|NCT03483974|Hyperspectrum, excreta, neoplasm,|hyperspectrum, excreta, neoplasm,
5082348|NCT03483909|gesture|gesture
5082349|NCT03483909|rTMS|rtms
5082350|NCT03483909|nonverbal communication|nonverbal communication
5082351|NCT03483909|schizophrenia|schizophrenia
5082352|NCT03483909|psychosis|psychosis
5082353|NCT03483870|Granisetron, serum serotonin, morphine|granisetron, serum serotonin, morphine
5082354|NCT03483857|Peer Navigation|peer navigation
5082355|NCT03483844|scoliosis|scoliosis
5082356|NCT03483844|low dose|low dose
5082357|NCT03483844|arthrodesis|arthrodesis
5082358|NCT03483844|dual-energy CT|dual-energy ct
5082359|NCT03483818|Community Pharmacy|community pharmacy
5082360|NCT03483818|Antiviral Therapy|antiviral therapy
5082361|NCT03483805|synbiotic|synbiotic
5082365|NCT03483805|quality of life|quality of life
5082366|NCT03483805|digestive comfort|digestive comfort
5082367|NCT03483792|PCOS|pcos
5082369|NCT03483792|Pregnancy|pregnancy
5082370|NCT03483792|Heritability|heritability
5082371|NCT03483792|LH|lh
5082372|NCT03483753|Vasopressin|vasopressin
5082373|NCT03483753|Norepinephrine|norepinephrine
5082374|NCT03483753|Post-operative|post-operative
5082375|NCT03483753|Critical Care|critical care
5082376|NCT03483740|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
5082377|NCT03483740|Cognitive remediation group therapy|cognitive remediation group therapy
5082378|NCT03483740|Mutual aid group therapy|mutual aid group therapy
5082379|NCT03483714|Manipulation|manipulation
5082380|NCT03483714|Spinal|spinal
5082381|NCT03483714|electromyography|electromyography
5082382|NCT03483714|kinetics|kinetics
5082383|NCT03483714|kinematic|kinematic
5082384|NCT03483701|Cognitive Remediation Therapy|cognitive remediation therapy
5082385|NCT03483688|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
5082386|NCT03483688|Refractory|refractory
5082387|NCT03483688|Relapsed|relapsed
5082388|NCT03483662|hypertension|hypertension
5082389|NCT03483662|blood pressure|blood pressure
5082390|NCT03483662|medication adherence|medication adherence
5082391|NCT03483662|lifestyle modification|lifestyle modification
5082392|NCT03483662|blood pressure control|blood pressure control
5082400|NCT03483623|Dolphin Fluid Immersion System|dolphin fluid immersion system
5082401|NCT03483623|Raven 90C litter|raven 90c litter
5082433|NCT03483285|intubation|intubation
5082434|NCT03483285|airtraq|airtraq
5082435|NCT03483285|open heart surgery|open heart surgery
5961369|NCT04287582|surface electromyography|surface electromyography
5082436|NCT03483285|hemodynamic parameters|hemodynamic parameters
5082437|NCT03483272|Terlipressin|terlipressin
5082438|NCT03483272|Pharmacological respons|pharmacological respons
5082439|NCT03483272|Magnetic Resonance Imaging|magnetic resonance imaging
5082440|NCT03483272|Hemodynamic assessments|hemodynamic assessments
5082441|NCT03483272|Echocardiography|echocardiography
5082442|NCT03483272|Hepatorenal syndrome - acute kidney injury|hepatorenal syndrome - acute kidney injury
5082443|NCT03483259|Pharmacokinetics|pharmacokinetics
5082444|NCT03483259|Relative bioavailability|relative bioavailability
5082445|NCT03483246|Ulcerative colitis|ulcerative colitis
5082446|NCT03483246|Inflammatory bowel disease|inflammatory bowel disease
5082447|NCT03483246|Fecal microbiota transplantation|fecal microbiota transplantation
5082448|NCT03483233|Gyrus Cinguli|gyrus cinguli
5082449|NCT03483233|Cognitive Control Process|cognitive control process
5082450|NCT03483233|Check process|check process
5082451|NCT03483233|Decision Making|decision making
5082452|NCT03483233|fMRI|fmri
5082453|NCT03483220|Addiction, MRI, Decision making|addiction, mri, decision making
5082454|NCT03483194|Therapeutic Virtual Reality|therapeutic virtual reality
5082455|NCT03483194|Pain related medical procedure management|pain related medical procedure management
5082456|NCT03483194|Anxiety management|anxiety management
5082457|NCT03483194|Osteo-medullary biopsy|osteo-medullary biopsy
5082461|NCT03483103|JCAR017|jcar017
5082462|NCT03483103|lisocabtagene maraleucel|lisocabtagene maraleucel
5082464|NCT03483103|chimeric antigen receptor|chimeric antigen receptor
5082465|NCT03483103|CAR|car
5082466|NCT03483103|CAR T cell|car t cell
5082467|NCT03483103|autologous T cell therapy|autologous t cell therapy
5082468|NCT03483103|immunotherapy|immunotherapy
5082469|NCT03483103|cell therapy|cell therapy
5082470|NCT03483103|liso-cel|liso-cel
5082471|NCT03483090|mild|mild
5082472|NCT03483090|moderate|moderate
5082473|NCT03483090|krill oil|krill oil
5082474|NCT03483090|pain|pain
5082475|NCT03483090|osteoarthritis|osteoarthritis
5082476|NCT03483090|supplement|supplement
5356811|NCT01917903|multitasking|multitasking
5082477|NCT03483051|aortic stenosis, aortic valve replacement|aortic stenosis, aortic valve replacement
5082484|NCT03483012|Breast Cancer|breast cancer
5082485|NCT03482986|Diet|diet
5082486|NCT03482986|Dietary Habits|dietary habits
5082487|NCT03482986|Weight changes|weight changes
5082493|NCT03482960|perfluorinated|perfluorinated
5082495|NCT03482960|lung|lung
5082496|NCT03482947|Dexmedetomidine|dexmedetomidine
5082497|NCT03482947|pediatrics; postoperative;|pediatrics; postoperative;
5082498|NCT03482947|Analgesia; caudal|analgesia; caudal
5082499|NCT03482908|Responsive parenting|responsive parenting
5082500|NCT03482895|Gastric Bypass|gastric bypass
5082501|NCT03482895|Intestinal Absorption|intestinal absorption
5082502|NCT03482895|Gastrointestinal Hormones|gastrointestinal hormones
5082503|NCT03482895|Enteroendocrine Cells|enteroendocrine cells
5082538|NCT03482661|CECR|cecr
5082539|NCT03482648|Pellino-1|pellino-1
5082540|NCT03482622|Raman spectroscopy|raman spectroscopy
5082541|NCT03482596|Sedentary Behaviour|sedentary behaviour
5082542|NCT03482596|Prevention|prevention
5082543|NCT03482583|Smoking, Cancer, Treatment|smoking, cancer, treatment
5082544|NCT03482570|Activity behaviors|activity behaviors
5082545|NCT03482570|Malignant pleural effusion|malignant pleural effusion
5082546|NCT03482557|Breast Cancer|breast cancer
5082547|NCT03482557|screening|screening
5082548|NCT03482557|breast MRI|breast mri
5082549|NCT03482557|contrast enhanced spectral mammography|contrast enhanced spectral mammography
5082550|NCT03482544|pregabalin|pregabalin
4965840|NCT04202705|ADC|adc
5082551|NCT03482544|ischemia reperfusion injury|ischemia reperfusion injury
5082552|NCT03482544|muscle|muscle
5740130|NCT00357435|Molecular|molecular
5082553|NCT03482531|limit nocturnal activity|limit nocturnal activity
5082554|NCT03482531|cervical ripening|cervical ripening
5082555|NCT03482492|Acetaminophen|acetaminophen
5082556|NCT03482492|Tramadol|tramadol
5082557|NCT03482492|Discogenic pain|discogenic pain
5082558|NCT03482492|Lumbar Discectomy|lumbar discectomy
5082559|NCT03482453|Drug Therapy|drug therapy
5082560|NCT03482440|preeclampsia|preeclampsia
5082561|NCT03482440|microvascular|microvascular
5082562|NCT03482440|inflammation|inflammation
5082563|NCT03482440|angiotensin II|angiotensin ii
5082564|NCT03482414|stroke|stroke
5082565|NCT03482414|upper limb rehabilitation|upper limb rehabilitation
5082566|NCT03482414|neuro-rehabilitation|neuro-rehabilitation
5082567|NCT03482401|Polyphenol|polyphenol
5082568|NCT03482401|Methylxanthine|methylxanthine
5082569|NCT03482401|Metabolism|metabolism
5082570|NCT03482401|Breast tissue|breast tissue
5082571|NCT03482401|Disposition|disposition
5082572|NCT03482401|UPLC-QTOF|uplc-qtof
5082573|NCT03482388|Hepatitis|hepatitis
5082574|NCT03482388|Hepatitis B|hepatitis b
5082575|NCT03482388|Hepatitis C|hepatitis c
5082576|NCT03482388|Men who have sex with men|men who have sex with men
5082577|NCT03482388|Crowdsourcing|crowdsourcing
5082578|NCT03482388|China|china
5082579|NCT03482388|Testing|testing
5082580|NCT03482375|Gall Stones|gall stones
5082581|NCT03482375|ERCP|ercp
5082582|NCT03482375|Cholangioscopy|cholangioscopy
5082583|NCT03482362|vinorelbine|vinorelbine
5082584|NCT03482336|labeling|labeling
5082585|NCT03482336|Front of pack|front of pack
5082586|NCT03482336|nutrition|nutrition
5082587|NCT03482336|nutrition facts panel|nutrition facts panel
5082588|NCT03482310|Brain computer interface|brain computer interface
5082589|NCT03482310|electric stimulation|electric stimulation
5082591|NCT03482258|Galactooligosaccharide|galactooligosaccharide
5082592|NCT03482258|Prebiotic|prebiotic
5082593|NCT03482258|Early life stress|early life stress
5082594|NCT03482258|Emotional eating|emotional eating
5082595|NCT03482258|Gut microbiota|gut microbiota
5082596|NCT03482258|Short-chain fatty acids|short-chain fatty acids
5082597|NCT03482258|Serotonin|serotonin
5082598|NCT03482258|Cortisol|cortisol
5082599|NCT03482245|pneumonia|pneumonia
5082600|NCT03482245|appendicitis|appendicitis
5082601|NCT03482245|diverticulitis|diverticulitis
5082602|NCT03482245|circadian rhythms|circadian rhythms
5082603|NCT03482245|blue light|blue light
5082605|NCT03482232|patient safety|patient safety
5082606|NCT03482232|quality assurance|quality assurance
5082629|NCT03481998|Breast cancer|breast cancer
5082630|NCT03481998|Postmenopausal women|postmenopausal women
5082631|NCT03481998|Hormone-receptor positive|hormone-receptor positive
5082632|NCT03481998|HER2 negative|her2 negative
5961370|NCT04287582|muscle activation|muscle activation
5082633|NCT03481998|Premenopausal women|premenopausal women
5082634|NCT03481985|Fontan-associated liver disease|fontan-associated liver disease
5082635|NCT03481959|TDAH|tdah
5082636|NCT03481959|Methylphenidate|methylphenidate
5082637|NCT03481959|Cannabis|cannabis
5082638|NCT03481920|pancreatic cancer, inmunotherapy|pancreatic cancer, inmunotherapy
5082639|NCT03481907|collagen powder|collagen powder
5961371|NCT04287582|stair climbing|stair climbing
4967912|NCT04190472|HSIL|hsil
5082640|NCT03481907|punch biopsy wound|punch biopsy wound
5082641|NCT03481894|Parenteral nutrition|parenteral nutrition
5082642|NCT03481894|Malnutrition|malnutrition
5082643|NCT03481894|Pediatrics|pediatrics
5082644|NCT03481894|nutritional needs|nutritional needs
5082646|NCT03481868|chronic myeloid leukemia|chronic myeloid leukemia
5082647|NCT03481868|epigenetic|epigenetic
5082648|NCT03481868|leukemic stem cell|leukemic stem cell
5082649|NCT03481842|Endometriosis|endometriosis
5082650|NCT03481842|VEGF(R)|vegf(r)
5082651|NCT03481829|American Indians|american indians
5082652|NCT03481829|Obesity|obesity
5082653|NCT03481829|Pregnancy|pregnancy
5082654|NCT03481829|Diabetes|diabetes
5082655|NCT03481829|Children|children
5082661|NCT03481803|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
4965894|NCT04202367|Bupivacaine|bupivacaine
5082662|NCT03481790|iron deficiency anemia of pregnancy - lactoferrin|iron deficiency anemia of pregnancy - lactoferrin
5082663|NCT03481777|Remote Ischemic Conditioning|remote ischemic conditioning
5082664|NCT03481777|Neuroprotection|neuroprotection
5082665|NCT03481764|febrile seizure|febrile seizure
5082666|NCT03481764|HRC-test|hrc-test
5082667|NCT03481764|genetic variation|genetic variation
5082668|NCT03481764|epilepsy|epilepsy
5082669|NCT03481751|Crohn Disease|crohn disease
5082670|NCT03481751|Ultrasound|ultrasound
5082671|NCT03481751|Monitoring|monitoring
5082672|NCT03481751|Disease activity|disease activity
5082673|NCT03481738|Glycolytic enzymopathy|glycolytic enzymopathy
5082674|NCT03481738|Congenital Non-spherocytic hemolytic anemia (CNSA)|congenital non-spherocytic hemolytic anemia (cnsa)
5082675|NCT03481699|Adolescence|adolescence
5082676|NCT03481699|Prevention|prevention
5082677|NCT03481699|Emotional disorders|emotional disorders
5082678|NCT03481699|Aggressive behavior|aggressive behavior
5082679|NCT03481686|Erythropoiesis|erythropoiesis
5082680|NCT03481686|stimulating|stimulating
5082681|NCT03481686|agents|agents
5082682|NCT03481686|therapeutic|therapeutic
5082683|NCT03481686|education|education
5082684|NCT03481686|program|program
5082685|NCT03481673|Childhood Asthma|childhood asthma
5082686|NCT03481673|Childhood Anxiety|childhood anxiety
5082687|NCT03481673|Childhood Depression|childhood depression
5082688|NCT03481673|Childhood Quality of Life|childhood quality of life
5082706|NCT03481582|Nitroglycerin Trans-dermal Patch|nitroglycerin trans-dermal patch
5082707|NCT03481543|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5082708|NCT03481543|Nebulization|nebulization
5082709|NCT03481543|Respiratory failure|respiratory failure
5082710|NCT03481543|Non-invasive ventilation(NIV)|non-invasive ventilation(niv)
5082711|NCT03481517|adult|adult
5082712|NCT03481517|appendectomy|appendectomy
5082713|NCT03481517|appendicitis|appendicitis
5082714|NCT03481517|local anesthesia|local anesthesia
5082715|NCT03481517|pain|pain
5082716|NCT03481491|Cerebellum|cerebellum
5082717|NCT03481491|Striatum|striatum
5082718|NCT03481491|Human|human
5082719|NCT03481491|fMRI|fmri
5423202|NCT01616667|Controlled Clinical Trial|controlled clinical trial
5082723|NCT03481478|proximal humeral neck fractures|proximal humeral neck fractures
5082724|NCT03481478|greater tuberosity|greater tuberosity
5082725|NCT03481478|shoulder dislocation|shoulder dislocation
5082726|NCT03481465|Biomarkers|biomarkers
5082727|NCT03481465|Hepatic dysfunction|hepatic dysfunction
5082728|NCT03481465|Metabolic dysfunction|metabolic dysfunction
5082729|NCT03481465|Endothelial dysfunction|endothelial dysfunction
5082730|NCT03481465|Antipsychotics|antipsychotics
5082731|NCT03481465|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5082732|NCT03481452|anxiety|anxiety
5082733|NCT03481452|regulation of states|regulation of states
5082735|NCT03481452|HAMA|hama
5082736|NCT03481439|Pharmacist|pharmacist
5082737|NCT03481439|Led medication review|led medication review
5082746|NCT03481361|Insulin-Dependent Diabetes Mellitus (IDDM)|insulin-dependent diabetes mellitus (iddm)
5082747|NCT03481322|sodium chloride|sodium chloride
5082748|NCT03481322|diet|diet
5082749|NCT03481322|cooking|cooking
5082750|NCT03481309|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5082751|NCT03481309|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5082752|NCT03481309|electroencephalography (EEG)|electroencephalography (eeg)
5082753|NCT03481296|Colorectal Cancer Screening|colorectal cancer screening
5082754|NCT03481296|Asian Americans|asian americans
5082755|NCT03481296|Patient Navigation|patient navigation
5082756|NCT03481296|Decision Counseling Program|decision counseling program
5082758|NCT03481218|Type 1 diabetes|type 1 diabetes
5082759|NCT03481218|Quality of life|quality of life
5961372|NCT04287569|digestive inflammation|digestive inflammation
5961373|NCT04287569|multispectral imaging|multispectral imaging
5961374|NCT04287569|multispectral gastroscopy|multispectral gastroscopy
5082760|NCT03481218|Personality traits|personality traits
5082761|NCT03481218|Young adults|young adults
5082762|NCT03481205|remote limb ischemic conditioning|remote limb ischemic conditioning
5082763|NCT03481205|large vessel occlusion|large vessel occlusion
5082764|NCT03481205|helicopter transport|helicopter transport
5369139|NCT01861158|Juvenile Justice|juvenile justice
5369140|NCT01861145|Intranasal steroids|intranasal steroids
5082765|NCT03481179|Repetitive transcranial magnetic stimulation, Physiotherapy, Stroke, Spasticity|repetitive transcranial magnetic stimulation, physiotherapy, stroke, spasticity
5740131|NCT00357435|Bietti|bietti
5082767|NCT03481166|randomized controlled trial|randomized controlled trial
5082768|NCT03481166|prenatal education|prenatal education
5082769|NCT03481166|anticipatory guidance|anticipatory guidance
5082773|NCT03481101|early response evaluation|early response evaluation
5082774|NCT03481101|immunotherapy|immunotherapy
5082775|NCT03481101|chemotherapy|chemotherapy
5082776|NCT03481101|liquid biopsy|liquid biopsy
5082777|NCT03481101|FDG-PET/CT|fdg-pet/ct
5082778|NCT03481075|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
4965988|NCT04201990|MPLC|mplc
5082779|NCT03481075|Imaging, Three-Dimensional|imaging, three-dimensional
5082780|NCT03481075|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
5082781|NCT03481075|Angiography, Digital Subtraction|angiography, digital subtraction
5082782|NCT03481075|Endovascular Procedures|endovascular procedures
5082783|NCT03481075|Radiography, Interventional|radiography, interventional
5082784|NCT03481036|Mukh Mantri Punjab Hepatitis C Relief Fund,MMPHCRF|mukh mantri punjab hepatitis c relief fund,mmphcrf
5082794|NCT03480958|erector spinae plane block|erector spinae plane block
5082795|NCT03480958|thoracic paravertebral block|thoracic paravertebral block
5082797|NCT03480958|postoperative pain|postoperative pain
5082798|NCT03480932|directly observed therapy|directly observed therapy
5082799|NCT03480932|sofosbuvir|sofosbuvir
5082800|NCT03480932|daclatasvir|daclatasvir
5082801|NCT03480932|pegylated interferon|pegylated interferon
5082802|NCT03480932|resource-limited setting|resource-limited setting
5082803|NCT03480893|laminectomy|laminectomy
5082804|NCT03480893|laminotomy|laminotomy
5082805|NCT03480893|lumbar canal stenosis|lumbar canal stenosis
5082806|NCT03480880|Bispectral Index|bispectral index
5082807|NCT03480815|Asthma|asthma
5082808|NCT03480815|Controlled Laminar Airflow Device|controlled laminar airflow device
5082809|NCT03480815|Omalizumab|omalizumab
5082810|NCT03480802|Conjugate pneumococcal vaccine, 15-valent, 22F, 33F|conjugate pneumococcal vaccine, 15-valent, 22f, 33f
5082811|NCT03480750|Copper chelator|copper chelator
5082812|NCT03480750|Epithelial ovarian cancer|epithelial ovarian cancer
5082813|NCT03480750|Tubal cancer|tubal cancer
5082814|NCT03480750|Peritoneal cancer|peritoneal cancer
5082815|NCT03480750|Trientine|trientine
5082816|NCT03480750|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5082817|NCT03480750|Carboplatin|carboplatin
5082818|NCT03480711|subscleral trabeculectomy|subscleral trabeculectomy
5082819|NCT03480711|extended subscleral tunnel|extended subscleral tunnel
5082825|NCT03480620|Telehealth|telehealth
5082826|NCT03480620|Telerehabilitation|telerehabilitation
5082827|NCT03480620|Chronic pain|chronic pain
5082828|NCT03480620|Post-discharge care|post-discharge care
5082836|NCT03480568|Alirocumab|alirocumab
5082838|NCT03480529|adverse event|adverse event
5082839|NCT03480529|arthritis|arthritis
5082840|NCT03480529|Systemic Lupus Erythematosus|systemic lupus erythematosus
5082841|NCT03480529|Capillary Leak Syndrome|capillary leak syndrome
5082842|NCT03480529|Hepatitis|hepatitis
5081353|NCT03490565|exercise training|exercise training
5082854|NCT03480412|In Vitro Fertilization|in vitro fertilization
5082855|NCT03480399|retroperitoneal sarcoma|retroperitoneal sarcoma
5082856|NCT03480399|quality of life|quality of life
5082857|NCT03480399|morbidity|morbidity
5082858|NCT03480399|surgery|surgery
5082859|NCT03480386|Pulmonary Rehabilitation|pulmonary rehabilitation
5082860|NCT03480373|Nicotine|nicotine
5082861|NCT03480373|Nicotine addiction|nicotine addiction
5082862|NCT03480373|Tobacco Use Disorder|tobacco use disorder
5082863|NCT03480373|Pregnancy|pregnancy
5082864|NCT03480373|Electronic cigarettes|electronic cigarettes
5082865|NCT03480373|Cigarettes|cigarettes
5082866|NCT03480373|Vaping|vaping
5082867|NCT03480373|Carcinoma|carcinoma
5082868|NCT03480373|Pregnant|pregnant
5082869|NCT03480373|Birth Outcomes|birth outcomes
5082870|NCT03480373|E-liquid|e-liquid
5082871|NCT03480360|haploidentical|haploidentical
5082872|NCT03480360|transplant|transplant
5082873|NCT03480360|peripheral blood|peripheral blood
5082874|NCT03480360|allogeneic|allogeneic
5082875|NCT03480321|Peripheral Artery Disease|peripheral artery disease
5082876|NCT03480321|Cilostazol|cilostazol
5082878|NCT03480321|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
5082879|NCT03480282|Life expectancy|life expectancy
5082880|NCT03480282|Older adults|older adults
5082887|NCT03480243|Padsevonil|padsevonil
5082888|NCT03480230|Non-small cell lung cancer|non-small cell lung cancer
5082889|NCT03480230|Platinum doublet chemotherapy|platinum doublet chemotherapy
5082890|NCT03480230|Neoadjuvant|neoadjuvant
5082891|NCT03480217|hypertension|hypertension
5082892|NCT03480217|screening|screening
5082893|NCT03480217|guidelines|guidelines
5082894|NCT03480217|implementation|implementation
5082895|NCT03480217|randomized|randomized
5082896|NCT03480204|Telemetry, Patch Monitor, Alarm Fatigue|telemetry, patch monitor, alarm fatigue
5082897|NCT03480165|Randomized controlled trial|randomized controlled trial
5082898|NCT03480165|Double blind|double blind
5082899|NCT03480165|Parallel group|parallel group
4968199|NCT04188704|ACL|acl
5082900|NCT03480152|Metastatic Cancer|metastatic cancer
5082901|NCT03480152|Immunotherapy|immunotherapy
5082902|NCT03480152|Tumor Regression|tumor regression
5082903|NCT03480152|Cancer Vaccine|cancer vaccine
5082904|NCT03480152|Gene Therapy|gene therapy
5082910|NCT03480100|rhinosinusitis|rhinosinusitis
5082911|NCT03480100|nasal irrigation|nasal irrigation
5082912|NCT03480100|nasal douche|nasal douche
5082913|NCT03480100|Ectoin|ectoin
5082914|NCT03480087|strain-rate echocardiography|strain-rate echocardiography
5082915|NCT03480087|chemotherapy|chemotherapy
5082916|NCT03480087|radiotherapy, mediastinal|radiotherapy, mediastinal
5082917|NCT03480087|Lymphoma|lymphoma
5082918|NCT03480087|Hodgkin|hodgkin
5082919|NCT03480022|prediabetes|prediabetes
5082920|NCT03480022|PCOS|pcos
5082921|NCT03480022|GLP-1 agonist|glp-1 agonist
5082922|NCT03480022|weight loss|weight loss
5082923|NCT03480009|medication abortion|medication abortion
5082924|NCT03480009|dextromethorphan|dextromethorphan
5082925|NCT03480009|pain control|pain control
5082926|NCT03479983|Indian gooseberry|indian gooseberry
5082927|NCT03479983|Total cholesterol|total cholesterol
5082928|NCT03479983|Triglycerides|triglycerides
5082929|NCT03479866|Gut microbiome|gut microbiome
5082930|NCT03479866|Personalised Nutrition|personalised nutrition
5082931|NCT03479866|Metabolic health|metabolic health
5082932|NCT03479853|Ocular Rosacea|ocular rosacea
5082933|NCT03479853|Keratoconjunctivitis|keratoconjunctivitis
5082934|NCT03479853|Meibomian Gland|meibomian gland
5082935|NCT03479853|Interferometry|interferometry
5082936|NCT03479853|Child|child
5082937|NCT03479840|SYNTAX score, PCI, elderly|syntax score, pci, elderly
5082940|NCT03479814|IMRT-SIB|imrt-sib
5082941|NCT03479814|adaptive radiotherapy|adaptive radiotherapy
5082942|NCT03479788|sleep apnea, coronary artery, diabetes|sleep apnea, coronary artery, diabetes
5082944|NCT03479697|Neurotechnology|neurotechnology
5082945|NCT03479697|Closed-Loop|closed-loop
5082946|NCT03479697|Allostasis|allostasis
5082947|NCT03479697|Stress|stress
5082948|NCT03479697|Autonomic Dysregulation|autonomic dysregulation
5082950|NCT03479697|Brain Electrical Activity|brain electrical activity
5082952|NCT03479697|Primary Hypertension|primary hypertension
5082953|NCT03479697|High Blood Pressure|high blood pressure
5082954|NCT03479684|warfarin|warfarin
5082955|NCT03479684|gene|gene
5082956|NCT03479658|HIIT|hiit
5082957|NCT03479658|nutritional education|nutritional education
5082958|NCT03479658|Dose-effect|dose-effect
5082959|NCT03479658|school|school
5082960|NCT03479658|children|children
5082961|NCT03479658|cardiovascular|cardiovascular
5082962|NCT03479658|adiposity|adiposity
5082963|NCT03479658|blood pressure|blood pressure
5082964|NCT03479658|fitness|fitness
5082965|NCT03479645|Colon cancer|colon cancer
5082966|NCT03479645|Bowel cancer|bowel cancer
5082967|NCT03479645|Cancer screening|cancer screening
5082968|NCT03479645|text message|text message
5082969|NCT03479645|Fecal immunochemistry test (FIT)|fecal immunochemistry test (fit)
5082970|NCT03479645|opt-out|opt-out
5082971|NCT03479645|behavioral intervention|behavioral intervention
5082972|NCT03479619|lancing device|lancing device
5082973|NCT03479619|lancet|lancet
5082974|NCT03479606|Traumatic Brain Injury|traumatic brain injury
5082975|NCT03479606|TBI|tbi
5082976|NCT03479606|Executive Dysfunction|executive dysfunction
5082977|NCT03479606|Emotional Regulation|emotional regulation
5082978|NCT03479606|Emotional Dysfunction|emotional dysfunction
5082979|NCT03479606|Problem Solving|problem solving
5082980|NCT03479606|Self-regulation|self-regulation
5082981|NCT03479606|Cognitive Rehabilitation|cognitive rehabilitation
5082982|NCT03479606|Metacognitive Strategies|metacognitive strategies
5082992|NCT03479593|Optical Coherence Tomography|optical coherence tomography
5082993|NCT03479580|Cardiomyopathy|cardiomyopathy
5082994|NCT03479580|Multimodal imaging|multimodal imaging
5082995|NCT03479580|Coronary artery disease|coronary artery disease
5082996|NCT03479580|Coronary microvascular disease|coronary microvascular disease
5082997|NCT03479580|Prognosis|prognosis
5082998|NCT03479580|Atherosclerosis|atherosclerosis
5082999|NCT03479580|Myocardial ischemia|myocardial ischemia
5083000|NCT03479554|antihypertensive treatment|antihypertensive treatment
5083001|NCT03479541|mild traumatic brain injury|mild traumatic brain injury
5083002|NCT03479541|vestibular impairment|vestibular impairment
5083003|NCT03479541|balance and gait|balance and gait
5083004|NCT03479541|dual-tasking|dual-tasking
5083005|NCT03479541|veterans|veterans
5083006|NCT03479541|quality of life|quality of life
5083007|NCT03479541|rehabilitation|rehabilitation
5083008|NCT03479528|Dyspepsia,alarm symptoms，Roman IV|dyspepsia,alarm symptoms，roman iv
5083009|NCT03479476|Congenital Abnormalities|congenital abnormalities
5083010|NCT03479476|Metformin|metformin
5083011|NCT03479476|Nervous System Diseases|nervous system diseases
5083012|NCT03479476|Chromosome Disorders|chromosome disorders
5083022|NCT03479424|hospitalization|hospitalization
5083023|NCT03479398|Fidelity|fidelity
5083024|NCT03479398|Cognitive Behavioral Therapy|cognitive behavioral therapy
5961375|NCT04287569|multispectral coloscopy|multispectral coloscopy
5083025|NCT03479398|Mobile Application|mobile application
5083026|NCT03479398|Routine Practice|routine practice
5083028|NCT03479372|wet AMD|wet amd
5083029|NCT03479372|exudative AMD|exudative amd
5083030|NCT03479372|macular degeneration|macular degeneration
5083031|NCT03479359|Prostate cancer; Benign Prostatic Hyperplasia; Digital Rectal Examination; Accuracy|prostate cancer; benign prostatic hyperplasia; digital rectal examination; accuracy
5083032|NCT03479346|Obesity|obesity
5083033|NCT03479346|Metabolic syndrome|metabolic syndrome
5083034|NCT03479346|Traditional Korean Medicine|traditional korean medicine
5083035|NCT03479346|Galgeun-tang|galgeun-tang
5083036|NCT03479255|Smartphone|smartphone
5083037|NCT03479255|Exercise|exercise
5083038|NCT03479255|Functional capacity|functional capacity
5083039|NCT03479229|vaginal laxity|vaginal laxity
5083040|NCT03479229|sexual function|sexual function
5083041|NCT03479229|vaginal childbirth|vaginal childbirth
5083042|NCT03479229|sexual dysfunction|sexual dysfunction
5083043|NCT03479229|diminished sexual function|diminished sexual function
5083044|NCT03479229|satisfaction|satisfaction
5083045|NCT03479229|arousal|arousal
5083046|NCT03479229|desire|desire
5083047|NCT03479229|lubrication|lubrication
5083048|NCT03479229|orgasm|orgasm
5083049|NCT03479216|Analgesia|analgesia
5083050|NCT03479216|Anesthesia|anesthesia
5083051|NCT03479216|Arthroscopy|arthroscopy
5083052|NCT03479216|Bupivacaine|bupivacaine
5083053|NCT03479216|Dexmedetomidine|dexmedetomidine
5083057|NCT03479203|Inflammation|inflammation
5083058|NCT03479151|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5083059|NCT03479151|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
5083060|NCT03479138|severe asthma|severe asthma
5083061|NCT03479138|induced sputum|induced sputum
5083062|NCT03479138|asthma phenotypes|asthma phenotypes
5083063|NCT03479138|neutrophilic inflammation|neutrophilic inflammation
5083064|NCT03479138|microbiome|microbiome
5083065|NCT03479112|Tourniquets, Layperson, hemorrhage control, first responder|tourniquets, layperson, hemorrhage control, first responder
5083066|NCT03479099|Lung cancer|lung cancer
5083071|NCT03479060|Migraine|migraine
5083073|NCT03479047|diaphragm ultrasound|diaphragm ultrasound
5083074|NCT03479047|spontaneous breathing trial|spontaneous breathing trial
5083075|NCT03479047|mechanical ventilation weaning|mechanical ventilation weaning
5083076|NCT03479047|rapid shallow breathing index|rapid shallow breathing index
5083077|NCT03479034|digital|digital
5083078|NCT03479034|prescription|prescription
5083079|NCT03479034|Application|application
5083080|NCT03478995|Phase1b|phase1b
5083115|NCT03478761|24-hydroxylase deficiency|24-hydroxylase deficiency
5083116|NCT03478748|Dental caries|dental caries
5083117|NCT03478748|Oral health literacy|oral health literacy
5083118|NCT03478709|vasoplegia|vasoplegia
5083119|NCT03478709|dynamic arterial elastance|dynamic arterial elastance
5083120|NCT03478709|microcirculation|microcirculation
5083121|NCT03478696|fluticasone furoate/umeclidinium/vilanterol|fluticasone furoate/umeclidinium/vilanterol
5083122|NCT03478696|HRQoL|hrqol
5083123|NCT03478696|COPD|copd
5083124|NCT03478696|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
5083125|NCT03478696|Tiotropium|tiotropium
5083126|NCT03478696|Budesonide/formoterol|budesonide/formoterol
5083127|NCT03478683|long-acting muscarinic receptor antagonists|long-acting muscarinic receptor antagonists
5083128|NCT03478683|tiotropium|tiotropium
5083129|NCT03478683|HRQoL|hrqol
5083130|NCT03478683|Budesonide/formoterol|budesonide/formoterol
5083131|NCT03478683|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5083132|NCT03478683|COPD|copd
5083133|NCT03478670|gene therapy|gene therapy
5083134|NCT03478670|retroviral vector|retroviral vector
5083135|NCT03478670|inherited immune disorder|inherited immune disorder
5083136|NCT03478670|ADA-SCID|ada-scid
5083137|NCT03478670|previously GSK2696273|previously gsk2696273
5083138|NCT03478670|Strimvelis|strimvelis
5083139|NCT03478657|Asthma|asthma
5083140|NCT03478657|Dry Powder Inhaler|dry powder inhaler
5083141|NCT03478657|Metered Dose Inhaler|metered dose inhaler
5083142|NCT03478657|Long Acting beta 2 Agonist|long acting beta 2 agonist
5083143|NCT03478657|ELLIPTA|ellipta
5083144|NCT03478631|nitrate|nitrate
5083145|NCT03478631|vegetables|vegetables
5083146|NCT03478605|olanzapine|olanzapine
5083147|NCT03478605|aprepitant|aprepitant
5083148|NCT03478605|CINV|cinv
5083149|NCT03478605|nausea|nausea
5083150|NCT03478605|vomiting|vomiting
5083151|NCT03478605|nausea and vomiting|nausea and vomiting
5083152|NCT03478605|antiemetics|antiemetics
4966361|NCT04199884|Anxiety|anxiety
5083153|NCT03478592|Slow-freezing|slow-freezing
5083154|NCT03478592|Vitrification|vitrification
5083155|NCT03478592|Automated system|automated system
5083156|NCT03478592|Embryos|embryos
5083157|NCT03478592|Implantation|implantation
5083158|NCT03478579|serious game|serious game
5083159|NCT03478579|simulation|simulation
5083160|NCT03478579|virtual emergency department|virtual emergency department
5083161|NCT03478579|nontechnical skills|nontechnical skills
5083162|NCT03478527|Probiotics|probiotics
5083163|NCT03478527|Psychiatric Symptoms|psychiatric symptoms
5083164|NCT03478527|Cognitive Function|cognitive function
5083165|NCT03478527|Hippocampus|hippocampus
5083166|NCT03478527|Oxytocin|oxytocin
5083167|NCT03478527|Immunological Parameters|immunological parameters
5083168|NCT03478514|mantle cell lymphoma|mantle cell lymphoma
5083169|NCT03478514|B-cell lymphoma|b-cell lymphoma
5083170|NCT03478514|palbociclib|palbociclib
5083171|NCT03478501|firearm|firearm
5083172|NCT03478501|lethal means|lethal means
5083173|NCT03478501|decision aid|decision aid
5083174|NCT03478475|Vitamin D|vitamin d
5083175|NCT03478475|HOMA-IR|homa-ir
5083176|NCT03478475|Glucose|glucose
5083177|NCT03478475|HbA1C|hba1c
5083178|NCT03478475|insulin resistance|insulin resistance
5083477|NCT03476525|Fluoxetine|fluoxetine
5083228|NCT03478176|Intraabdominal hypertension|intraabdominal hypertension
5083229|NCT03478176|Kidney transplantation|kidney transplantation
5083230|NCT03478163|Bakri|bakri
5083231|NCT03478163|Intrauterine balloon tamponade|intrauterine balloon tamponade
5083232|NCT03478163|Antibiotics|antibiotics
5083233|NCT03478137|Cognition|cognition
5083234|NCT03478137|Intervention|intervention
5083235|NCT03478098|Gut hormones|gut hormones
5083236|NCT03478098|Glucose excursions|glucose excursions
5083237|NCT03478033|Tuberculosis|tuberculosis
5083238|NCT03478033|AIDS|aids
5083239|NCT03478033|Rifampicin|rifampicin
5083240|NCT03478033|Rifabutin|rifabutin
5083241|NCT03478007|Exercise Compliance|exercise compliance
5083242|NCT03478007|Health Coaching|health coaching
5083243|NCT03477994|dexmedetomidine, clonidine, postoperative, CABG|dexmedetomidine, clonidine, postoperative, cabg
5083244|NCT03477955|spinopelvic alignment|spinopelvic alignment
5083245|NCT03477955|short lumbosacral instrumentation|short lumbosacral instrumentation
5083246|NCT03477955|PEEK|peek
5083247|NCT03477955|silicon spacer|silicon spacer
5083248|NCT03477929|In vitro fertilization|in vitro fertilization
5083249|NCT03477929|gnrh antagonist|gnrh antagonist
5083250|NCT03477929|pituitary suppression|pituitary suppression
5083251|NCT03477903|Drug therapy|drug therapy
5083252|NCT03477877|Intimate Partner Violence|intimate partner violence
5083253|NCT03477877|Gender-Based violence|gender-based violence
5083254|NCT03477877|Spouse Abuse|spouse abuse
5083256|NCT03477877|Heterosexual Couples|heterosexual couples
5083257|NCT03477877|Activists|activists
5083258|NCT03477877|Opinion Leaders|opinion leaders
5083259|NCT03477877|Social Change|social change
5083260|NCT03477877|Social-Ecological Model|social-ecological model
5083261|NCT03477877|Diffusion of Innovation|diffusion of innovation
5083262|NCT03477877|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5083263|NCT03477877|Community Randomized Controlled Trial|community randomized controlled trial
5083264|NCT03477851|sciatic nerve block|sciatic nerve block
5083265|NCT03477851|tramadol|tramadol
5083266|NCT03477851|foot fracture|foot fracture
5356812|NCT01917903|exercise|exercise
5083267|NCT03477838|continuous glucose monitoring|continuous glucose monitoring
5083268|NCT03477799|gambling disorder|gambling disorder
5083269|NCT03477799|cognition|cognition
5083270|NCT03477773|high-intensity interval training|high-intensity interval training
5083271|NCT03477773|video games|video games
5083272|NCT03477773|heart rate|heart rate
5083273|NCT03477773|boxing|boxing
5083274|NCT03477773|metabolic syndrome|metabolic syndrome
5083275|NCT03477747|Microcurrent|microcurrent
5083276|NCT03477747|Exercise training|exercise training
5083277|NCT03477747|Hypertrophy|hypertrophy
5083278|NCT03477747|Muscle damage|muscle damage
5083279|NCT03477747|Recovery|recovery
5083280|NCT03477747|Performance|performance
5083281|NCT03477721|Agrin Fragment C-terminus (CAF)|agrin fragment c-terminus (caf)
5083282|NCT03477669|Colic|colic
5083287|NCT03477656|Living donor kidney transplantation|living donor kidney transplantation
5083290|NCT03477604|Stent|stent
5083294|NCT03477552|Sickle Cell Crisis|sickle cell crisis
5083295|NCT03477552|intravenous catheter|intravenous catheter
5083296|NCT03477552|transillumination|transillumination
5083297|NCT03477526|pulmonary fibrosis|pulmonary fibrosis
5083298|NCT03477526|COPD|copd
5083299|NCT03477526|pulmonary rehabilitation|pulmonary rehabilitation
5083300|NCT03477526|mental status (anxiety and depression)|mental status (anxiety and depression)
5083301|NCT03477526|quality of life|quality of life
5083302|NCT03477526|physical activity|physical activity
5083303|NCT03477500|multiple sclerosis,|multiple sclerosis,
5083304|NCT03477500|HSCT|hsct
5083305|NCT03477500|alemtuzumab|alemtuzumab
5083306|NCT03477500|RCT|rct
5083307|NCT03477487|inflammation|inflammation
5083308|NCT03477487|Cytokines|cytokines
5083309|NCT03477487|Interleukin-10|interleukin-10
5083310|NCT03477487|Gene therapy|gene therapy
5083311|NCT03477474|Guardant Health|guardant health
5083312|NCT03477435|smoking|smoking
5083313|NCT03477435|tobacco dependence|tobacco dependence
5083314|NCT03477435|quitline|quitline
5083315|NCT03477435|smoking cessation|smoking cessation
5083316|NCT03477422|CSE-1034 Double Blind Study|cse-1034 double blind study
5083317|NCT03477422|Elores|elores
5083318|NCT03477422|Meropenem|meropenem
5083319|NCT03477422|PLEA-CT|plea-ct
5083320|NCT03477422|Bacterial Infections|bacterial infections
5083321|NCT03477422|ESBL|esbl
5083322|NCT03477422|MBL|mbl
5083323|NCT03477422|beta-lactamase|beta-lactamase
5961376|NCT04287543|melatonin|melatonin
5342881|NCT01981681|Healthy|healthy
5342883|NCT01981655|Sodium Lactate|sodium lactate
5342884|NCT01981655|Acute|acute
4955450|NCT04267458|DAA|daa
4976316|NCT04140240|nursing|nursing
4957162|NCT04256564|Y-Shape|y-shape
5342888|NCT01981629|Shock|shock
5342889|NCT01981629|USCOM|uscom
4958283|NCT04249492|IOL|iol
4958447|NCT04248517|EMA|ema
5342890|NCT01981629|Cardiac Ultrasound|cardiac ultrasound
5681302|NCT00573898|daptomycin|daptomycin
5342891|NCT01981629|Emergency Department|emergency department
4958824|NCT04245982|RXR|rxr
5903416|NCT00397280|Inflammatory Response|inflammatory response
5681398|NCT00573534|Adolescent|adolescent
4959103|NCT04244669|SCS|scs
5682893|NCT00567099|Psychiatry|psychiatry
5683378|NCT00565045|stroke|stroke
4959657|NCT04241354|PRP|prp
5903417|NCT00397280|Lipopolysaccharide|lipopolysaccharide
4960912|NCT04233944|Growth|growth
4982830|NCT04099433|HIV|hiv
5342892|NCT01981616|Drug therapy|drug therapy
5342893|NCT01981603|Navigators|navigators
5684498|NCT00560222|children|children
5903425|NCT00395278|Antibody|antibody
4963289|NCT04219592|SSc|ssc
5684499|NCT00560222|diarrhea|diarrhea
5903426|NCT00395278|Kaposi's Sarcoma|kaposi's sarcoma
5684598|NCT00559702|Tysabri ®|tysabri ®
4986071|NCT04078412|cohort|cohort
5903427|NCT00395278|HIV|hiv
4963917|NCT04214990|Aspirin|aspirin
5903428|NCT00395278|Kaposi Sarcoma|kaposi sarcoma
4964468|NCT04211493|EMS|ems
5342894|NCT01981603|Kidney Transplant|kidney transplant
5684704|NCT00559195|fatigue|fatigue
5083324|NCT03477422|Anti-Infective Agents, Urinary|anti-infective agents, urinary
5083325|NCT03477422|Anti-Infective Agents|anti-infective agents
5083326|NCT03477422|Urinary Tract Infections|urinary tract infections
5083327|NCT03477422|Pyelonephritis|pyelonephritis
5083328|NCT03477422|Infection|infection
5083329|NCT03477422|Sulbactam|sulbactam
5083330|NCT03477422|EDTA|edta
5083331|NCT03477422|Disodium EDTA|disodium edta
5083332|NCT03477422|Antibiotic Adjuvant Entity|antibiotic adjuvant entity
5083333|NCT03477422|Antibiotic Resistance Breaker|antibiotic resistance breaker
5083334|NCT03477409|plasticizers|plasticizers
5083335|NCT03477409|medical devices|medical devices
5083336|NCT03477409|neonates|neonates
5083337|NCT03477409|exposition|exposition
5083338|NCT03477383|diagnosis|diagnosis
5083339|NCT03477383|economics|economics
5083340|NCT03477383|cell-free DNA|cell-free dna
5083341|NCT03477383|digital droplet PCR|digital droplet pcr
5083342|NCT03477383|heart failure|heart failure
5083346|NCT03477331|Direct oral anticoagulant|direct oral anticoagulant
5083347|NCT03477331|P2Y12 inhibitors|p2y12 inhibitors
5083348|NCT03477331|Physiologically-based pharmacokinetic model (PBPK)|physiologically-based pharmacokinetic model (pbpk)
5083349|NCT03477331|Population-based pharmacokinetic model (POPPK)|population-based pharmacokinetic model (poppk)
5083350|NCT03477318|colonoscopy, polyp, endoscopist|colonoscopy, polyp, endoscopist
5083351|NCT03477305|older adults|older adults
4966641|NCT04198103|BPH|bph
5083352|NCT03477305|community gardening|community gardening
5083353|NCT03477305|cooperative extension|cooperative extension
5083354|NCT03477279|couple HIV testing and counseling|couple hiv testing and counseling
5083355|NCT03477279|disclosure|disclosure
5083356|NCT03477279|Malawi|malawi
5083368|NCT03477188|Stroke|stroke
5083369|NCT03477188|Vestibular|vestibular
5083370|NCT03477188|Somatosensory|somatosensory
5083371|NCT03477188|Rehabilitation|rehabilitation
5961377|NCT04287543|clock genes|clock genes
5961378|NCT04287543|BMAL1 gene|bmal1 gene
5961379|NCT04287543|PER1 gene|per1 gene
5961380|NCT04287517|Myofascial Neck Pain|myofascial neck pain
5961381|NCT04287517|Capacitive-resistive Therapy|capacitive-resistive therapy
5961382|NCT04287504|point-of-care test|point-of-care test
5961383|NCT04287504|validation|validation
5961384|NCT04287504|preterm birth|preterm birth
5961385|NCT04287504|bacterial vaginosis|bacterial vaginosis
5961386|NCT04287504|candidosis|candidosis
5961387|NCT04287478|Antimicrobial Resistance|antimicrobial resistance
5961388|NCT04287478|Bacteriophage|bacteriophage
5961389|NCT04287478|Urinary Tract Infections|urinary tract infections
5961390|NCT04287478|Phage|phage
5961391|NCT04287439|Fatigue, meditation, diabetic neuropathy, relaxation, quality of life.|fatigue, meditation, diabetic neuropathy, relaxation, quality of life.
5961392|NCT04287387|type 2 diabetes mellitus|type 2 diabetes mellitus
5961393|NCT04287387|gut microbiota|gut microbiota
5961394|NCT04287387|hypoglycemic drugs|hypoglycemic drugs
5961395|NCT04287348|AMD, poor responders, aflibercept, brolucizumab|amd, poor responders, aflibercept, brolucizumab
5961396|NCT04287335|Cancer|cancer
5961397|NCT04287335|Colorectal Cancer|colorectal cancer
5961398|NCT04287335|Colorectal Neoplasms|colorectal neoplasms
5961399|NCT04287335|Adenomatous Polyps|adenomatous polyps
5961400|NCT04287335|Adenoma|adenoma
5961401|NCT04287335|Advanced adenoma|advanced adenoma
5961402|NCT04287335|Gastrointestinal Diseases|gastrointestinal diseases
5961403|NCT04287335|Colonic Diseases|colonic diseases
5961404|NCT04287335|Neoplasms|neoplasms
5961405|NCT04287335|Digestive System Diseases|digestive system diseases
5961406|NCT04287335|Intestinal Neoplasms|intestinal neoplasms
5961407|NCT04287335|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5961408|NCT04287335|Digestive System Neoplasms|digestive system neoplasms
5961409|NCT04287335|Neoplasms by Site|neoplasms by site
5961410|NCT04287335|Intestinal Diseases|intestinal diseases
5961411|NCT04287335|Rectal Diseases|rectal diseases
5961412|NCT04287335|Glandular and Epithelial|glandular and epithelial
5083372|NCT03477188|Balance|balance
5005995|NCT03959241|Lymphoma|lymphoma
5083373|NCT03477175|lenvatinib|lenvatinib
5083374|NCT03477175|E7080|e7080
5083375|NCT03477149|liquid embolics|liquid embolics
5083376|NCT03477123|Incomplete spinal cord injury|incomplete spinal cord injury
5083377|NCT03477123|Walking|walking
5083378|NCT03477123|Rehabilitation|rehabilitation
5083379|NCT03477123|Robotic exoskeleton|robotic exoskeleton
5083380|NCT03477097|Frailty|frailty
5083381|NCT03477097|Social Determinants|social determinants
5083382|NCT03477097|Biological Risk Factors|biological risk factors
5083383|NCT03477097|Intervention|intervention
5083384|NCT03477097|Cost Effectiveness|cost effectiveness
5083385|NCT03477071|Transplant renal artery stenosis|transplant renal artery stenosis
5083386|NCT03477071|Endovascular repair|endovascular repair
5083387|NCT03477071|Post-operative outcome|post-operative outcome
5083388|NCT03477058|chronic pruritus|chronic pruritus
5083389|NCT03477058|acute pruritus|acute pruritus
5083390|NCT03477045|omega 3 polyunsaturated fatty acid|omega 3 polyunsaturated fatty acid
5083391|NCT03477045|camelina sativa|camelina sativa
5083392|NCT03477045|fatty acid composition|fatty acid composition
5083393|NCT03477045|immune modulation|immune modulation
5083394|NCT03477019|Contrast Agent BR|contrast agent br
5083395|NCT03477019|SonoVue|sonovue
5083396|NCT03477019|Ultrasonic Therapy|ultrasonic therapy
5083397|NCT03477019|Neoplasm Metastasis|neoplasm metastasis
5083398|NCT03477019|Liver|liver
5083399|NCT03477019|Microbubbles|microbubbles
5083400|NCT03476993|primary biliary cholangitis|primary biliary cholangitis
5083401|NCT03476993|IL-17 monoclonal antibody|il-17 monoclonal antibody
5083402|NCT03476980|Neurodevelopmental impairment, prematurity|neurodevelopmental impairment, prematurity
5083403|NCT03476980|Disability|disability
5083404|NCT03476980|Umbilical cord milking|umbilical cord milking
5083405|NCT03476980|Delayed cord clamping|delayed cord clamping
5083406|NCT03476967|optic disc topography|optic disc topography
5083407|NCT03476967|panretinal photocoagulation|panretinal photocoagulation
5083408|NCT03476967|confocal scanning laser ophthalmoscopy|confocal scanning laser ophthalmoscopy
5083409|NCT03476967|stereoscopic disc photographs|stereoscopic disc photographs
5083410|NCT03476967|diabetic retinopathy|diabetic retinopathy
5083411|NCT03476967|optic nerve head parameters|optic nerve head parameters
5083413|NCT03476902|Mobile|mobile
5083414|NCT03476902|Technology|technology
5083415|NCT03476902|CBT|cbt
5083416|NCT03476902|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5083417|NCT03476876|acellular matrix|acellular matrix
5083418|NCT03476837|secondhand smoke, African Americans, policies, tobacco use|secondhand smoke, african americans, policies, tobacco use
5083419|NCT03476785|LVH|lvh
4966740|NCT04197479|NASH resolution|nash resolution
5083420|NCT03476785|Ventricular Stiffness|ventricular stiffness
5083421|NCT03476785|Fitness|fitness
5083422|NCT03476785|HFpEF|hfpef
5083423|NCT03476733|Drug related problem|drug related problem
5083424|NCT03476733|inpatient|inpatient
5083425|NCT03476733|Medication Error|medication error
5083426|NCT03476733|Clinical Pharmacist|clinical pharmacist
5083427|NCT03476681|NEO-201|neo-201
5083428|NCT03476681|Monoclonal Antibody|monoclonal antibody
5083429|NCT03476681|Colorectal Cancer|colorectal cancer
5083430|NCT03476681|Pancreatic Cancer|pancreatic cancer
5083431|NCT03476681|Adenocarcinoma of Lung|adenocarcinoma of lung
5083432|NCT03476681|Squamous Cell Lung Cancer|squamous cell lung cancer
5083433|NCT03476681|Breast Cancer|breast cancer
5083434|NCT03476681|Mucinous Carcinoma of Ovary|mucinous carcinoma of ovary
5083435|NCT03476681|Signet Ring Cell Carcinoma of Ovary|signet ring cell carcinoma of ovary
5083436|NCT03476629|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5083437|NCT03476629|Rehabilitation|rehabilitation
5083438|NCT03476629|Distance Traveled|distance traveled
5083439|NCT03476629|Functional Capacity|functional capacity
5083440|NCT03476629|Autonomic Nervous System|autonomic nervous system
5083442|NCT03476616|Obesity|obesity
5083443|NCT03476616|Ambulatory Blood Pressure|ambulatory blood pressure
5083444|NCT03476616|Eplerenone|eplerenone
5083445|NCT03476616|Valsartan|valsartan
5083446|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
5083447|NCT03476616|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
5083448|NCT03476603|Bariatric surgery|bariatric surgery
5083449|NCT03476603|Gastrointestinal tract|gastrointestinal tract
5083450|NCT03476603|Biological availability|biological availability
5083451|NCT03476603|Pharmacokinetics|pharmacokinetics
5083452|NCT03476603|Irbesartan|irbesartan
5083453|NCT03476590|heart failure|heart failure
5083454|NCT03476590|ambulatory care|ambulatory care
5083455|NCT03476590|telemedicine|telemedicine
5083456|NCT03476590|impedance cardiography|impedance cardiography
5083457|NCT03476577|Bariatric surgery|bariatric surgery
5083458|NCT03476577|Gastrointestinal tract|gastrointestinal tract
5083459|NCT03476577|Biological availability|biological availability
5083460|NCT03476577|Pharmacokinetics|pharmacokinetics
5083461|NCT03476577|Ibuprofen|ibuprofen
5083462|NCT03476564|assisted reproductive techniques|assisted reproductive techniques
5083463|NCT03476551|Bariatric surgery|bariatric surgery
5083464|NCT03476551|Gastrointestinal tract|gastrointestinal tract
5083465|NCT03476551|Biological availability|biological availability
5961413|NCT04287335|Neoplasms by Histologic Type|neoplasms by histologic type
5083466|NCT03476551|Pharmacokinetics|pharmacokinetics
5083467|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide
5083468|NCT03476538|Bariatric surgery|bariatric surgery
5083469|NCT03476538|Gastrointestinal tract|gastrointestinal tract
5083470|NCT03476538|Biological availability|biological availability
5083471|NCT03476538|Pharmacokinetics|pharmacokinetics
5083472|NCT03476538|Gabapentin|gabapentin
5083473|NCT03476525|Bariatric surgery|bariatric surgery
5083474|NCT03476525|Gastrointestinal tract|gastrointestinal tract
5083475|NCT03476525|Biological availability|biological availability
5083476|NCT03476525|Pharmacokinetics|pharmacokinetics
5083478|NCT03476512|Treatment adherence|treatment adherence
5083479|NCT03476512|Ambulatory hypertensive patients|ambulatory hypertensive patients
5083480|NCT03476512|Blood pressure|blood pressure
5083481|NCT03476512|Non-pharmacological measures|non-pharmacological measures
5083483|NCT03476473|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5083484|NCT03476473|Spirometry|spirometry
5083485|NCT03476473|Lung disease|lung disease
5083486|NCT03476473|Smoke|smoke
5083487|NCT03476460|Acute kidney failure|acute kidney failure
5083488|NCT03476460|CT scan|ct scan
5083489|NCT03476460|Iodine contrast|iodine contrast
5083490|NCT03476460|Sodium chloride|sodium chloride
5083491|NCT03476434|sessile serrated polyp|sessile serrated polyp
5083492|NCT03476434|chromoendoscopy|chromoendoscopy
5083493|NCT03476434|indigo carmine|indigo carmine
5083494|NCT03476382|Osteoarthritis|osteoarthritis
5083495|NCT03476382|Knee|knee
5083496|NCT03476382|Bone Growth Stimulators|bone growth stimulators
5083497|NCT03476382|Rheumatic Diseases|rheumatic diseases
5083498|NCT03476382|Musculoskeletal Diseases|musculoskeletal diseases
5083499|NCT03476382|Joint Diseases|joint diseases
5083500|NCT03476382|Arthritis|arthritis
5083501|NCT03476343|NICU|nicu
5083502|NCT03476343|MRI|mri
5083503|NCT03476343|Neonatal|neonatal
5083504|NCT03476343|Cincinnati|cincinnati
5083505|NCT03476330|Hematopoietic cell transplantation|hematopoietic cell transplantation
5083506|NCT03476291|macular diseases|macular diseases
5083507|NCT03476291|screening|screening
5083508|NCT03476291|OCT|oct
5083509|NCT03476291|Deep learning|deep learning
5083510|NCT03476291|AI|ai
5083511|NCT03476278|Outcome Assessment (Health Care)|outcome assessment (health care)
5083512|NCT03476278|Patient Satisfaction|patient satisfaction
5083513|NCT03476278|Perioperative Period|perioperative period
5083514|NCT03476278|Regional Anesthesia|regional anesthesia
5083515|NCT03476278|Surveys and Questionnaires|surveys and questionnaires
5083516|NCT03476239|Relapsed|relapsed
5083517|NCT03476239|Refractory|refractory
5083518|NCT03476239|B-precursor|b-precursor
5083519|NCT03476239|Acute Lymphoblastic|acute lymphoblastic
5083520|NCT03476239|Leukemia ALL|leukemia all
5083521|NCT03476239|Blinatumomab|blinatumomab
5083522|NCT03476239|Chinese Adult Subjects|chinese adult subjects
5083523|NCT03476226|Quality of Life|quality of life
5083524|NCT03476226|Cognitive Dysfunction|cognitive dysfunction
5083525|NCT03476226|Breast Cancer|breast cancer
5083526|NCT03476213|Anesthesia Awareness|anesthesia awareness
5083527|NCT03476213|Dreaming in anesthesia|dreaming in anesthesia
5083528|NCT03476213|Total intravenous anesthesia|total intravenous anesthesia
5083529|NCT03476213|Target-controll infusion|target-controll infusion
5083530|NCT03476200|Cognitive Behavioral Therapy|cognitive behavioral therapy
5083531|NCT03476200|Hair Cortisol|hair cortisol
5083532|NCT03476200|Hypothalamic Pituitary Adrenal Axis|hypothalamic pituitary adrenal axis
5083533|NCT03476200|Stress|stress
5083534|NCT03476200|Psychopathology|psychopathology
5083535|NCT03476135|Meningococcal Meningitis|meningococcal meningitis
5083536|NCT03476135|MenACYW conjugate vaccine|menacyw conjugate vaccine
5083537|NCT03476135|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
5083538|NCT03476122|Colorectal cancer|colorectal cancer
5083539|NCT03476122|CRC|crc
5083540|NCT03476122|Circulating tumor cells|circulating tumor cells
5083546|NCT03476083|Mother to Child Transmission|mother to child transmission
5083548|NCT03476083|Congenital Defects or Malformation|congenital defects or malformation
5083549|NCT03476083|Hepatitis B Vaccine|hepatitis b vaccine
5083550|NCT03476083|Hepatitis B Immunoglobulin|hepatitis b immunoglobulin
5083551|NCT03476083|Pregnancy|pregnancy
5083552|NCT03476083|Antiviral Treatment|antiviral treatment
5083553|NCT03476070|Adolescents and Young Adults (AYA)|adolescents and young adults (aya)
5083554|NCT03476070|breast cancer|breast cancer
5083555|NCT03476070|lymphoma|lymphoma
5083556|NCT03476070|germ cell tumor|germ cell tumor
5083557|NCT03476070|cognitive impairment|cognitive impairment
5083558|NCT03476070|survivorship|survivorship
5083559|NCT03476070|Singapore|singapore
5083560|NCT03476057|NGS|ngs
5083561|NCT03476057|cfDNA|cfdna
5083562|NCT03476057|OS|os
5083563|NCT03476057|Tumor Burden|tumor burden
5083564|NCT03475966|Nutrition|nutrition
5083565|NCT03475966|Exercise|exercise
5083566|NCT03475966|Relaxation techniques|relaxation techniques
5083567|NCT03475966|Prehabilitation|prehabilitation
5083568|NCT03475953|Advanced solid tumor|advanced solid tumor
5083569|NCT03475953|Metastatic tumor|metastatic tumor
5083570|NCT03475953|Phase Ib/II trial|phase ib/ii trial
5356813|NCT01917890|curcumin|curcumin
5083571|NCT03475953|Colorectal cancer not MSI-H or MMR-deficient|colorectal cancer not msi-h or mmr-deficient
5083573|NCT03475953|Oesophageal or Gastric Carcinoma|oesophageal or gastric carcinoma
5083574|NCT03475953|Biliary Tract cancer|biliary tract cancer
5083575|NCT03475953|Hepatocellular Carcinoma|hepatocellular carcinoma
5083966|NCT03473847|SMILE|smile
5083576|NCT03475953|Soft-tissue sarcoma|soft-tissue sarcoma
5083577|NCT03475953|Thyroid cancer|thyroid cancer
5083578|NCT03475953|Neuroendocrine gastroenteropancreatic tumors|neuroendocrine gastroenteropancreatic tumors
5083579|NCT03475914|Psoriasis Guttate, Psoriasis vulgaris|psoriasis guttate, psoriasis vulgaris
5083580|NCT03475901|procedural anxiety|procedural anxiety
5083581|NCT03475901|virtual reality|virtual reality
5083582|NCT03475901|anxiolysis|anxiolysis
5083583|NCT03475901|laceration repair|laceration repair
5083584|NCT03475901|pediatric|pediatric
5083585|NCT03475888|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
5083586|NCT03475888|Ventricular Arrythmia|ventricular arrythmia
5083587|NCT03475888|Sustained VT|sustained vt
5083588|NCT03475888|Ventricular Fibrillation|ventricular fibrillation
5083589|NCT03475888|Implantable loop recorder|implantable loop recorder
5142019|NCT03103542|ITI|iti
5083590|NCT03475849|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
5083591|NCT03475849|Bile Acid Circulation|bile acid circulation
5083592|NCT03475849|Obesity|obesity
5083593|NCT03475849|Bariatric Surgery|bariatric surgery
5083594|NCT03475836|Mentha|mentha
5083595|NCT03475836|Mint|mint
5083596|NCT03475836|Essential oil|essential oil
5083597|NCT03475836|Cognition|cognition
5083598|NCT03475836|Mood|mood
5083599|NCT03475836|Humans|humans
5083600|NCT03475810|VIRTUAL REALITY|virtual reality
5083601|NCT03475810|ANXIETY|anxiety
5083602|NCT03475810|SPINAL ANESTHESIA|spinal anesthesia
5083603|NCT03475745|resting-state|resting-state
5083604|NCT03475745|DTI|dti
5083605|NCT03475745|aphasia|aphasia
5083606|NCT03475745|stroke|stroke
5083607|NCT03475732|XueBiJing injection|xuebijing injection
5083608|NCT03475732|Sepsis|sepsis
5083609|NCT03475732|Septic shock|septic shock
5083610|NCT03475732|Pharmacokinetics|pharmacokinetics
5083611|NCT03475706|overactive bladder|overactive bladder
5083612|NCT03475706|urinary conditions|urinary conditions
5083613|NCT03475706|urgency urinary incontinence|urgency urinary incontinence
5083614|NCT03475706|urgency|urgency
5083615|NCT03475706|micturitions|micturitions
5083616|NCT03475680|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
5083617|NCT03475680|Oral antibiotics|oral antibiotics
5083618|NCT03475680|Colon cancer surgery|colon cancer surgery
5083619|NCT03475680|Surgical site infection|surgical site infection
5083620|NCT03475667|Septic Shock|septic shock
5083621|NCT03475667|hemodynamic monitoring|hemodynamic monitoring
5083622|NCT03475667|blood pressure determination|blood pressure determination
5083623|NCT03475654|exercise|exercise
5083624|NCT03475654|therapy|therapy
5083625|NCT03475654|rehabilitation|rehabilitation
5083626|NCT03475654|home|home
5083627|NCT03475641|pain|pain
5083628|NCT03475641|femoral nerve blockade|femoral nerve blockade
5083629|NCT03475641|varicose vein|varicose vein
5083630|NCT03475589|apatinib； Adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer|apatinib； adverse drug reactions； gastric cancer; non-small cell lung cancer;breast cancer; ovarian cancer
5083632|NCT03475576|caregiving|caregiving
5083634|NCT03475576|support|support
5083635|NCT03475563|Drug-eluting stent|drug-eluting stent
5083636|NCT03475563|Dedicated bifurcation stent|dedicated bifurcation stent
5083637|NCT03475563|Cobalt-chromium|cobalt-chromium
5083638|NCT03475563|Sirolimus-eluting stent|sirolimus-eluting stent
5083639|NCT03475485|Ingestion event marker|ingestion event marker
5083640|NCT03475485|Ingestible sensor|ingestible sensor
5083641|NCT03475485|Medication adherence|medication adherence
5083642|NCT03475485|ID-Cap Medication Adherence Feedback System|id-cap medication adherence feedback system
5083643|NCT03475459|QTc prolongation effect|qtc prolongation effect
5083644|NCT03475446|Cognitive Training|cognitive training
5083645|NCT03475446|Memory Impairment|memory impairment
5083646|NCT03475446|Mild Cognitive Impairment|mild cognitive impairment
5083647|NCT03475446|Alzheimer's Disease|alzheimer's disease
5083648|NCT03475446|tES|tes
5083649|NCT03475446|tACS|tacs
5083650|NCT03475446|tDCS|tdcs
5083651|NCT03475433|Cancer|cancer
5083652|NCT03475433|Questionnaire|questionnaire
5083653|NCT03475433|Survey|survey
5083654|NCT03475433|Sleep Disturbance|sleep disturbance
5083655|NCT03475433|Sleep Quality|sleep quality
5083656|NCT03475433|E-health|e-health
5083657|NCT03475433|M-health|m-health
5083658|NCT03475433|Actigraphy|actigraphy
5083659|NCT03475433|Physical activity|physical activity
5083660|NCT03475433|Dyssomnias Medical Subject Headings [MeSH]|dyssomnias medical subject headings [mesh]
5083661|NCT03475433|Sleep Wake Disorders [MeSH]|sleep wake disorders [mesh]
5083662|NCT03475433|Parasomnias [MeSH]|parasomnias [mesh]
5083663|NCT03475433|Nervous System Diseases [MeSH]|nervous system diseases [mesh]
5083664|NCT03475433|Mental Disorders [MeSH]|mental disorders [mesh]
5083665|NCT03475433|Neurologic Manifestations [MeSH]|neurologic manifestations [mesh]
5083666|NCT03475433|Signs and Symptoms [MeSH]|signs and symptoms [mesh]
5083667|NCT03475433|Telemedicine [MeSH]|telemedicine [mesh]
5083668|NCT03475433|Actigraphy [MeSH]|actigraphy [mesh]
5083669|NCT03475433|Quality of Life [MeSH]|quality of life [mesh]
5083670|NCT03475433|Motor Activity [MeSH]|motor activity [mesh]
5083671|NCT03475433|Breast Neoplasms [MeSH]|breast neoplasms [mesh]
5084168|NCT03472664|Memory|memory
5083686|NCT03475355|action observation|action observation
5083687|NCT03475355|parkinson's disease|parkinson's disease
5083688|NCT03475355|physical therapy|physical therapy
5083690|NCT03475355|neural plasticity|neural plasticity
5083691|NCT03475355|telerehabilitation|telerehabilitation
5083698|NCT03475329|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy|pediatric obstructive sleep disordered breathing-partial tonsillectomy -unilateral complete tonsillectomy -adenoidectomy
5083699|NCT03475290|e-mental health|e-mental health
5083700|NCT03475290|stress|stress
5083701|NCT03475290|burnout|burnout
5083702|NCT03475290|self-efficacy|self-efficacy
5083703|NCT03475290|social support|social support
5083704|NCT03475264|Lung MRI, Bronchopulmonary Dysplasia, hyperpolarized xenon,|lung mri, bronchopulmonary dysplasia, hyperpolarized xenon,
5083705|NCT03475238|critical care|critical care
5083706|NCT03475225|Epilepsy|epilepsy
5083707|NCT03475225|Drug-resistance|drug-resistance
5083708|NCT03475225|Vitamin D deficiency|vitamin d deficiency
5083709|NCT03475225|Metabolism|metabolism
5083710|NCT03475225|Controlled study antiepileptic drugs|controlled study antiepileptic drugs
4967124|NCT04195152|Lingual nerve injury|lingual nerve injury
5083711|NCT03475212|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5083712|NCT03475212|Primary Immune Deficiency Disease|primary immune deficiency disease
5083713|NCT03475186|Memory|memory
5083714|NCT03475186|Brain Cancer|brain cancer
5083715|NCT03475186|Ramipril|ramipril
5083716|NCT03475173|Optic Neuropathy|optic neuropathy
5083717|NCT03475173|, Retinopathy|, retinopathy
5083718|NCT03475095|Low Back Pain|low back pain
5083719|NCT03475095|Tuina therapy|tuina therapy
5083720|NCT03475095|lumbar disc herniation|lumbar disc herniation
5083721|NCT03475095|central motion control|central motion control
5083722|NCT03475095|functional magnetic resonanceimaging|functional magnetic resonanceimaging
5083723|NCT03475095|effect mechanism|effect mechanism
5083724|NCT03475095|Chronic nonspecific low Back pain|chronic nonspecific low back pain
5083725|NCT03475069|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5083726|NCT03475069|Exercise|exercise
5083727|NCT03475069|Physical Performance|physical performance
5083728|NCT03475069|Physiological Cost Index|physiological cost index
5083732|NCT03475004|Pembrolizumab|pembrolizumab
5083733|NCT03475004|Binimetinib|binimetinib
5083734|NCT03475004|Bevacizumab|bevacizumab
5083735|NCT03475004|Combination Therapy|combination therapy
5083742|NCT03474952|remote ischemic preconditioning|remote ischemic preconditioning
5083743|NCT03474952|free flap reconstruction|free flap reconstruction
5083744|NCT03474952|tissue oxygen saturation|tissue oxygen saturation
5083745|NCT03474926|urothelial cancer|urothelial cancer
5083746|NCT03474926|nephroureterectomy|nephroureterectomy
5083747|NCT03474926|Upper urinary tract|upper urinary tract
5083748|NCT03474913|Prostate Cancer|prostate cancer
5083749|NCT03474913|Magnetic Resonance Imaging|magnetic resonance imaging
5083750|NCT03474913|case cross over|case cross over
5083751|NCT03474913|diagnostic|diagnostic
5083752|NCT03474913|clinical trial|clinical trial
5083786|NCT03474718|platelet-rich plasma therapy|platelet-rich plasma therapy
5083788|NCT03474705|Hyperalgesia|hyperalgesia
5083789|NCT03474705|Intervention|intervention
5083790|NCT03474705|Musculoskeletal disorders|musculoskeletal disorders
5083791|NCT03474705|Computer Work|computer work
5083792|NCT03474705|Strength Training|strength training
5083793|NCT03474666|Liver Transplantation|liver transplantation
5083794|NCT03474666|Surgical Wound Infection|surgical wound infection
5083795|NCT03474666|Hiperglycemia|hiperglycemia
5083811|NCT03474601|Pituitary Diseases|pituitary diseases
5083812|NCT03474601|Pituitary incidentaloma|pituitary incidentaloma
5083813|NCT03474601|Central Diabetes Insipidus|central diabetes insipidus
5083814|NCT03474601|Pituitary Neoplasms|pituitary neoplasms
5083815|NCT03474575|homecare, COPD, Exacerbation|homecare, copd, exacerbation
5083816|NCT03474549|Mechanical thrombectomy,|mechanical thrombectomy,
5083817|NCT03474549|Brain|brain
5083818|NCT03474549|Brain clot|brain clot
5083819|NCT03474549|Brain infarction|brain infarction
5083820|NCT03474549|Cerebral ischemia|cerebral ischemia
5083821|NCT03474549|Neurovascular intervention|neurovascular intervention
5083822|NCT03474549|Revascularization|revascularization
5083823|NCT03474549|Reperfusion|reperfusion
5083824|NCT03474549|Stent retriever|stent retriever
5083825|NCT03474549|Tigertriever|tigertriever
5083826|NCT03474549|Stroke|stroke
5083827|NCT03474549|Rapid Medical|rapid medical
5083828|NCT03474536|Lung transplantation|lung transplantation
5083829|NCT03474536|HLA antibodies|hla antibodies
5083830|NCT03474536|concentration|concentration
5083832|NCT03474536|surface plasmon resonance|surface plasmon resonance
5083833|NCT03474523|radio frequency diathermy|radio frequency diathermy
5083834|NCT03474523|cavitation|cavitation
5887395|NCT04259970|LCI|lci
5083835|NCT03474523|ultrasound|ultrasound
5083836|NCT03474523|edemato-fibrosclerotic panniculopathy|edemato-fibrosclerotic panniculopathy
5083837|NCT03474523|cellulitis|cellulitis
5142273|NCT03101618|allergy|allergy
5083838|NCT03474510|pain control|pain control
5083839|NCT03474510|EXPAREL|exparel
5083840|NCT03474510|shoulder surgery|shoulder surgery
5083841|NCT03474510|continuous interscalene nerve block|continuous interscalene nerve block
5083842|NCT03474484|Biomarkers|biomarkers
5083843|NCT03474484|Sensitivity and Specificity|sensitivity and specificity
5083844|NCT03474484|Clinical Deterioration|clinical deterioration
5083845|NCT03474380|Caregiver|caregiver
5083846|NCT03474380|Veterans|veterans
5083847|NCT03474380|Skills training|skills training
5083848|NCT03474380|Informal care|informal care
5083849|NCT03474380|Days at home|days at home
5083850|NCT03474367|Unplanned Peritoneal Dialysis|unplanned peritoneal dialysis
5083851|NCT03474367|Unplanned Hemodialysis|unplanned hemodialysis
5083852|NCT03474367|Cost-Benefit Analysis|cost-benefit analysis
5083853|NCT03474367|Dialysis|dialysis
5083854|NCT03474367|Peritoneal Dialysis|peritoneal dialysis
5083855|NCT03474367|Hemodialysis|hemodialysis
5083856|NCT03474354|chemoembolization|chemoembolization
5083857|NCT03474354|drug eluting beads|drug eluting beads
5083858|NCT03474341|Neoadjuvant chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
4967222|NCT04194372|Diabetic|diabetic
5083859|NCT03474341|Pathologic complete response (pCR)|pathologic complete response (pcr)
5083860|NCT03474341|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5083861|NCT03474341|PET-CT|pet-ct
5083862|NCT03474341|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
5083863|NCT03474341|endoscopy|endoscopy
5083864|NCT03474315|Cardiac implantable electronic device|cardiac implantable electronic device
5084169|NCT03472664|Diet|diet
5083873|NCT03474302|Cognition|cognition
5083874|NCT03474276|Children|children
5083875|NCT03474276|Africa|africa
5083876|NCT03474276|Metagenomic|metagenomic
5083888|NCT03474237|adrenal incidentaloma|adrenal incidentaloma
5083889|NCT03474237|adreocortical carcinoma|adreocortical carcinoma
5083890|NCT03474237|primary hyperaldosteronism|primary hyperaldosteronism
5083891|NCT03474224|stroke volume|stroke volume
5083892|NCT03474224|goal directed therapy|goal directed therapy
5083893|NCT03474224|major abdominal surgery|major abdominal surgery
5083899|NCT03474159|Bicuspid aortic valve|bicuspid aortic valve
5083900|NCT03474159|aortic aneurysm|aortic aneurysm
5083902|NCT03474159|Pulse wave velocity|pulse wave velocity
5083903|NCT03474146|Mouthrinse|mouthrinse
5083904|NCT03474146|Ocimum sanctum|ocimum sanctum
5083905|NCT03474146|Periodontal Diseases|periodontal diseases
5083906|NCT03474146|Tulsi|tulsi
5083907|NCT03474133|Hodgkin's lymphoma|hodgkin's lymphoma
5083908|NCT03474133|Hodgkin lymphoma|hodgkin lymphoma
5083930|NCT03474081|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5083932|NCT03474081|Vilanterol|vilanterol
5083933|NCT03474081|HANDIHALER|handihaler
5083934|NCT03474081|Tiotropium|tiotropium
5083935|NCT03474081|Fluticasone furoate|fluticasone furoate
5083936|NCT03474068|Emergency Medical Services, Stroke, Ambulances|emergency medical services, stroke, ambulances
5083937|NCT03474055|Liquid rotavirus vaccine|liquid rotavirus vaccine
5083938|NCT03474055|LBRV-PV|lbrv-pv
5083939|NCT03474055|Gastroenteritis|gastroenteritis
5083940|NCT03474055|Diarrhoea|diarrhoea
5083941|NCT03474029|latent tuberculosis|latent tuberculosis
5083942|NCT03474029|rifapentine|rifapentine
5083943|NCT03474003|Score prediction|score prediction
5083944|NCT03474003|Allograft survival|allograft survival
5083945|NCT03473990|Home-based|home-based
5083946|NCT03473990|Short-term|short-term
5083947|NCT03473990|Randomised Control Trial|randomised control trial
5083948|NCT03473951|Hyperuricemia|hyperuricemia
5083949|NCT03473951|Metabolic syndrome|metabolic syndrome
5083950|NCT03473951|Left ventricular hypertrophy|left ventricular hypertrophy
5083951|NCT03473938|Obesity|obesity
5083952|NCT03473938|Weight loss|weight loss
5083953|NCT03473938|Intragastric balloons|intragastric balloons
5083954|NCT03473938|Adjustable gastric balloon|adjustable gastric balloon
5083955|NCT03473938|Weight loss plateau|weight loss plateau
5083956|NCT03473938|Intolerance|intolerance
5083957|NCT03473860|prognosis|prognosis
5083958|NCT03473860|all-cause mortality|all-cause mortality
5083959|NCT03473860|myocardial infarction|myocardial infarction
5083960|NCT03473860|stroke|stroke
5083961|NCT03473847|VHF digital ultrasound|vhf digital ultrasound
5083962|NCT03473847|Optical coherence tomography|optical coherence tomography
5083963|NCT03473847|Corneal thickness|corneal thickness
5083964|NCT03473847|Epithelial thickness|epithelial thickness
5083965|NCT03473847|LASIK|lasik
5083972|NCT03473821|Return to Sport|return to sport
5083973|NCT03473821|Mental Training|mental training
5083974|NCT03473821|Dynamic Motor Imagery|dynamic motor imagery
5961414|NCT04287322|Maternal voice and tactile-kinesthetic stimulation|maternal voice and tactile-kinesthetic stimulation
5083975|NCT03473821|Anterior Cruciate Ligament|anterior cruciate ligament
5083976|NCT03473821|Knee Injury|knee injury
5083977|NCT03473808|Hand Function|hand function
5083978|NCT03473808|Occupational Therapy|occupational therapy
5095513|NCT03401320|letrozole|letrozole
5083981|NCT03473795|18-114|18-114
5891800|NCT03842189|Isoimmune|isoimmune
5891801|NCT03842189|Isoimmunized|isoimmunized
5891802|NCT03842189|Isoimmunization|isoimmunization
5891803|NCT03842189|Alloimmune|alloimmune
5891804|NCT03842189|Alloimmunized|alloimmunized
5891805|NCT03842189|Alloimmunization|alloimmunization
5891806|NCT03842189|Pregnant women|pregnant women
5891807|NCT03841526|Exercise|exercise
5891808|NCT03841526|Glucagon|glucagon
5891809|NCT03841526|Insulin|insulin
5892351|NCT03798418|fall|fall
5892355|NCT03797326|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5892356|NCT03797326|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5892357|NCT03797326|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5892358|NCT03797326|tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
5892359|NCT03797326|multiple TKI|multiple tki
5892360|NCT03797326|Vascular Endothelial Growth Factor Receptor (VEFG)|vascular endothelial growth factor receptor (vefg)
5892361|NCT03797326|Fibroblast Growth Factor (FGF)|fibroblast growth factor (fgf)
5892362|NCT03797326|Platelet-Derived Growth Factor (PDGF)|platelet-derived growth factor (pdgf)
5892885|NCT03640858|Theranova|theranova
5892894|NCT03640286|Overweight|overweight
5892895|NCT03640286|Metabolic syndrome|metabolic syndrome
5083982|NCT03473769|Hospital Admission|hospital admission
5083987|NCT03473717|pain|pain
5083988|NCT03473717|Intrauterine device (IUD)|intrauterine device (iud)
5083989|NCT03473717|Intrauterine system (IUS)|intrauterine system (ius)
5083990|NCT03473717|Patient-Reported Outcome|patient-reported outcome
5083991|NCT03473704|Type 1 diabetes|type 1 diabetes
5083992|NCT03473704|Depression|depression
5083993|NCT03473704|Telematic Program|telematic program
5083994|NCT03473704|Treatment|treatment
5083995|NCT03473704|Web-based|web-based
5083996|NCT03473665|ankylsoing spondylitis|ankylsoing spondylitis
5083997|NCT03473665|spondyloarthritis|spondyloarthritis
5084000|NCT03473613|Calcium infusion|calcium infusion
5084001|NCT03473613|Cabergoline|cabergoline
5084002|NCT03473548|Childhood OSA|childhood osa
5084003|NCT03473535|self-harm|self-harm
5084004|NCT03473535|problem-solving therapy|problem-solving therapy
5084005|NCT03473535|emergency department|emergency department
5084006|NCT03473535|e-therapy|e-therapy
5084007|NCT03473535|suicide prevention|suicide prevention
5084008|NCT03473522|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5084009|NCT03473522|therapeutic exercises|therapeutic exercises
5084010|NCT03473522|Parkinson|parkinson
5084011|NCT03473496|BCMA-CART|bcma-cart
5084012|NCT03473496|CD138-CART|cd138-cart
5084024|NCT03473457|CD123-CART|cd123-cart
5084025|NCT03473457|CD117-CART|cd117-cart
5084026|NCT03473457|CD133-CART|cd133-cart
5084027|NCT03473457|CD34-CART|cd34-cart
5084028|NCT03473457|Mucl-CART|mucl-cart
5084029|NCT03473444|uric acid|uric acid
5084030|NCT03473444|prevalence|prevalence
5084031|NCT03473444|pakistan|pakistan
5084032|NCT03473405|Total knee replacement|total knee replacement
5084033|NCT03473405|Operating room airborne CFU|operating room airborne cfu
5084034|NCT03473392|pre-treatment|pre-treatment
5084035|NCT03473392|antibiotherapy|antibiotherapy
5084036|NCT03473392|prosthetic joint infection|prosthetic joint infection
5084037|NCT03473392|treatment failure|treatment failure
5084038|NCT03473379|economic difficulty, financial toxicity|economic difficulty, financial toxicity
5084039|NCT03473353|Medical Scribe|medical scribe
5084040|NCT03473353|Outpatient|outpatient
5084041|NCT03473353|EHR|ehr
5084042|NCT03473340|CLAD|clad
5084043|NCT03473340|Chronic Rejection|chronic rejection
5084044|NCT03473340|Lung Transplant|lung transplant
5084045|NCT03473327|colorectal neoplasms|colorectal neoplasms
5084046|NCT03473327|Immunologic Factors|immunologic factors
5084047|NCT03473327|Postoperative Period|postoperative period
5084048|NCT03473314|Inhaled nitric oxide|inhaled nitric oxide
5084049|NCT03473314|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
5961415|NCT04287296|mental health|mental health
5961416|NCT04287296|mental wellbeing|mental wellbeing
5961417|NCT04287296|wellbeing|wellbeing
5961418|NCT04287296|edutainment|edutainment
5961419|NCT04287296|brekfast show|brekfast show
5961420|NCT04287296|feasibility study|feasibility study
5961421|NCT04287270|Multiple System Atrophy|multiple system atrophy
5961422|NCT04287270|Respiratory Muscle Strength|respiratory muscle strength
5961423|NCT04287270|Sniff Nasal Inspiratory Pressure|sniff nasal inspiratory pressure
5961424|NCT04287218|internet-based|internet-based
5961425|NCT04287218|digital health|digital health
5961426|NCT04287218|cognitive therapy|cognitive therapy
5961427|NCT04287218|randomized controlled trial|randomized controlled trial
5961428|NCT04287166|Diagnosis|diagnosis
5961429|NCT04287166|Videos|videos
5961430|NCT04287166|Smartphone app|smartphone app
5961431|NCT04287166|Movement|movement
5961432|NCT04287166|Movement disorders|movement disorders
5961433|NCT04287166|Infants|infants
5961434|NCT04287153|obesity|obesity
5961435|NCT04287153|cryotherapy|cryotherapy
5961436|NCT04287153|weight loss|weight loss
5961437|NCT04287153|saddlebags|saddlebags
5961438|NCT04287140|migraine|migraine
5961439|NCT04287140|pain|pain
5961440|NCT04287140|normal saline|normal saline
5961441|NCT04287140|diclofenac|diclofenac
5961442|NCT04287140|emergency department|emergency department
5961443|NCT04287140|adult|adult
5961444|NCT04287140|acute attack|acute attack
5961445|NCT04287101|Hip fractures|hip fractures
5961446|NCT04287101|Post-acute care|post-acute care
5897016|NCT02984995|Positive refractory or relapsed acute myeloid leukemia|positive refractory or relapsed acute myeloid leukemia
5897017|NCT02984995|Hematology malignancy|hematology malignancy
5897018|NCT02984995|Developmental Phase II|developmental phase ii
5897084|NCT02967302|knee arthritis, morphine, local injection, pain|knee arthritis, morphine, local injection, pain
5897095|NCT02962713|Atraumatic Restorative Treatment|atraumatic restorative treatment
5897096|NCT02962713|glass ionomer cement|glass ionomer cement
5897097|NCT02962713|primary teeth|primary teeth
5897098|NCT02962713|dental caries.|dental caries.
5084050|NCT03473314|Drug resistant bacteria|drug resistant bacteria
5084051|NCT03473314|Antimicrobial drug resistance|antimicrobial drug resistance
5084052|NCT03473301|CP|cp
5084053|NCT03473301|Cerebral Palsy|cerebral palsy
5084054|NCT03473301|Stem Cell|stem cell
5084055|NCT03473301|Cord Blood|cord blood
5084056|NCT03473301|MSCs|mscs
5084057|NCT03473275|Sympathetic nervous system|sympathetic nervous system
5084058|NCT03473275|Blood oxygen level dependent|blood oxygen level dependent
5084059|NCT03473275|Brainstem|brainstem
5673266|NCT00608621|Mobilisation|mobilisation
5084060|NCT03473275|Contrast enhanced ultrasound|contrast enhanced ultrasound
5084061|NCT03473275|Kidney function|kidney function
5084062|NCT03473275|Hypertension|hypertension
5084063|NCT03473275|Renal denervation|renal denervation
5084064|NCT03473262|Type 2 diabetes|type 2 diabetes
5084065|NCT03473262|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
5084066|NCT03473262|Empagliflozin|empagliflozin
5084077|NCT03473158|multifetal pregnancy|multifetal pregnancy
5084078|NCT03473119|Sphingosine-1-phosphate|sphingosine-1-phosphate
5084079|NCT03473106|Pneumatic Tourniquet|pneumatic tourniquet
5084080|NCT03473106|Postoperative Muscle Dysfunction|postoperative muscle dysfunction
5084082|NCT03473080|ASD|asd
5084083|NCT03473080|Obsessive Compulsive Disorder|obsessive compulsive disorder
5084084|NCT03473080|Autism Spectrum Disorder|autism spectrum disorder
5084085|NCT03473080|ICBT|icbt
5084086|NCT03473080|eHealth|ehealth
5084087|NCT03473080|Internet|internet
5084088|NCT03473080|CBT|cbt
5084089|NCT03473080|Pediatric|pediatric
5084090|NCT03473080|Adolescents|adolescents
5084091|NCT03473080|Children|children
5084092|NCT03473080|Internet-delivered|internet-delivered
5084093|NCT03473054|Stroke|stroke
5084098|NCT03473054|Mindfulness|mindfulness
5084099|NCT03473054|Family caregivers|family caregivers
5084100|NCT03473054|Web-based|web-based
5084101|NCT03473041|female stress incontinence|female stress incontinence
5084102|NCT03473041|Transobturator tension free vaginal tape TVTO|transobturator tension free vaginal tape tvto
5084103|NCT03473028|obesity|obesity
5084104|NCT03473028|embryo transfer|embryo transfer
5084105|NCT03473028|invitro fertilization|invitro fertilization
5084106|NCT03473002|Immunogenicity|immunogenicity
5084107|NCT03473002|Respiratory Syncytial Virus|respiratory syncytial virus
5084108|NCT03473002|Safety|safety
5084109|NCT03473002|Sendai Virus|sendai virus
5084110|NCT03473002|Vaccine|vaccine
5084111|NCT03472989|plantar fasciopathy|plantar fasciopathy
5084112|NCT03472989|plantar fasciitis|plantar fasciitis
5084113|NCT03472989|radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
5084114|NCT03472989|sham- radial extracorporeal shock wave therapy|sham- radial extracorporeal shock wave therapy
5082520|NCT03482726|cadence|cadence
5084130|NCT03472937|Cervical ripening|cervical ripening
5084131|NCT03472937|Induction of labor|induction of labor
5084133|NCT03472885|PNH|pnh
5084134|NCT03472885|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5084135|NCT03472885|ACH-0144471|ach-0144471
5084136|NCT03472885|eculizumab|eculizumab
5084137|NCT03472872|acetaminophen|acetaminophen
5084138|NCT03472872|ketorolac|ketorolac
5084139|NCT03472872|prochlorperazine|prochlorperazine
5084140|NCT03472872|diphenhydramine|diphenhydramine
5084141|NCT03472859|laser|laser
5084142|NCT03472859|lasers|lasers
5084143|NCT03472859|KTP|ktp
5084144|NCT03472859|semiconductor|semiconductor
5084145|NCT03472859|tgs|tgs
5084146|NCT03472859|rosacea|rosacea
5084147|NCT03472859|telangiectasia|telangiectasia
5084148|NCT03472833|V|v
5084149|NCT03472820|Diet|diet
5084150|NCT03472820|Lifestyle|lifestyle
5084151|NCT03472820|DNA methylation|dna methylation
5084152|NCT03472768|ECMO|ecmo
5084153|NCT03472755|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy|hip arthroplasty, surgeries, physical fitness, perception, energetic cost, autonomy
4967540|NCT04192721|depression|depression
5084157|NCT03472716|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5084158|NCT03472716|βig-h3|βig-h3
5084159|NCT03472716|Pronostic marker|pronostic marker
5084160|NCT03472703|fMRI|fmri
5961447|NCT04287101|Home-based care|home-based care
5961448|NCT04287101|Hospital-based care|hospital-based care
5961449|NCT04287101|Activities of daily living|activities of daily living
5961450|NCT04287101|Cost effectiveness analysis|cost effectiveness analysis
5961451|NCT04287088|bpMRI|bpmri
5961452|NCT04287088|shared decision making|shared decision making
5961453|NCT04287088|IMPROD|improd
5961454|NCT04287088|risk calculation|risk calculation
5961455|NCT04287075|Peripheral Nerve Injuries|peripheral nerve injuries
5961456|NCT04287075|Peripheral Nervous System Disease|peripheral nervous system disease
5961457|NCT04287075|Neuropathic Pain|neuropathic pain
5961458|NCT04287075|Neuroma|neuroma
5961459|NCT04287075|Chronic Pain|chronic pain
5897122|NCT02955225|Knee loads|knee loads
5897123|NCT02955225|Knee adduction moment|knee adduction moment
5897124|NCT02955225|Biomechanical intervention|biomechanical intervention
5897125|NCT02955225|Insole|insole
5897126|NCT02955225|Shoe|shoe
5006001|NCT03959202|older adults|older adults
5897190|NCT02945085|older adults|older adults
5897191|NCT02945085|family caregivers|family caregivers
5897192|NCT02945085|Medicare Advantage beneficiaries|medicare advantage beneficiaries
5356770|NCT01918033|Respiratory Tract Diseases|respiratory tract diseases
5084161|NCT03472703|Cognitive processes|cognitive processes
5084162|NCT03472703|Inhibition|inhibition
5084163|NCT03472703|Food reward|food reward
5084164|NCT03472703|Appetite|appetite
5084166|NCT03472677|Osteoarthritis|osteoarthritis
5084167|NCT03472677|Knee Pain|knee pain
5084172|NCT03472612|CPAP|cpap
5084173|NCT03472612|upper airway collapse|upper airway collapse
5084174|NCT03472612|neural respiratory drive|neural respiratory drive
5084175|NCT03472599|Neurogenic bladder dysfunction|neurogenic bladder dysfunction
5084176|NCT03472599|Genital Nerve Stimulation|genital nerve stimulation
5084177|NCT03472599|Electrical Stimulation|electrical stimulation
5084178|NCT03472599|Urinary Incontinence|urinary incontinence
5084179|NCT03472599|Spinal cord injury|spinal cord injury
5084180|NCT03472560|Cancer|cancer
5084181|NCT03472560|non-small cell lung cancer|non-small cell lung cancer
5084182|NCT03472560|non small cell lung cancer|non small cell lung cancer
5084183|NCT03472560|NSCLC|nsclc
5084184|NCT03472560|lung cancer|lung cancer
5084185|NCT03472560|urothelial cancer|urothelial cancer
5084186|NCT03472560|bladder cancer|bladder cancer
5084187|NCT03472560|Avelumab|avelumab
5084188|NCT03472560|Bavencio|bavencio
5084189|NCT03472560|Axitinib|axitinib
5084191|NCT03472508|Folic acid|folic acid
5084192|NCT03472508|Homocysteine|homocysteine
5084193|NCT03472508|MTHFR C677T|mthfr c677t
5084194|NCT03472508|RCT|rct
5084195|NCT03472508|Precision treatment|precision treatment
5084196|NCT03472495|Diltiazem|diltiazem
5084197|NCT03472495|Atrial Fibrillation|atrial fibrillation
5084198|NCT03472495|Atrial Flutter|atrial flutter
5084199|NCT03472495|Emergency Medicine|emergency medicine
5084200|NCT03472482|Alzheimer's disease|alzheimer's disease
5084201|NCT03472482|Dementia|dementia
5084202|NCT03472482|Lewy body disease|lewy body disease
5084204|NCT03472482|Retinal imaging|retinal imaging
5084205|NCT03472482|Optical Coherence Tomography|optical coherence tomography
5084206|NCT03472482|Hyperspectral imaging|hyperspectral imaging
5095708|NCT03400176|CLL|cll
5084210|NCT03472430|Pain relief|pain relief
5084211|NCT03472430|Conscious sedation|conscious sedation
5084212|NCT03472365|PD-1|pd-1
5084213|NCT03472365|SHR-1210|shr-1210
5084214|NCT03472365|Capecitabine|capecitabine
5084215|NCT03472365|Oxaliplatin|oxaliplatin
5084216|NCT03472365|Apatinib|apatinib
5084217|NCT03472339|Acute limb injury, Diclofenac, pain management|acute limb injury, diclofenac, pain management
5084218|NCT03472313|HV|hv
5084219|NCT03472300|Knee Osteoarthritis|knee osteoarthritis
5084220|NCT03472300|pain|pain
5084221|NCT03472300|Complementary Therapies|complementary therapies
5084222|NCT03472300|Survey|survey
5084223|NCT03472300|questionnaire|questionnaire
5084224|NCT03472287|EB|eb
5084225|NCT03472287|EBS|ebs
5084226|NCT03472287|DEB|deb
5084227|NCT03472287|JEB|jeb
5082615|NCT03482115|coma|coma
5084232|NCT03472248|Acceptance and Commitment Therapy|acceptance and commitment therapy
5084233|NCT03472248|Smartphone|smartphone
5084234|NCT03472209|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5084235|NCT03472209|Gynecological Laparoscopic Surgery|gynecological laparoscopic surgery
5084236|NCT03472209|End-tidal carbon dioxide|end-tidal carbon dioxide
5084237|NCT03472183|Enteric nervous system|enteric nervous system
5084238|NCT03472183|Alzheimer disease|alzheimer disease
5084239|NCT03472183|biomarker|biomarker
5084240|NCT03472183|colonic biopsies|colonic biopsies
5084241|NCT03472183|neurodegenerative disease|neurodegenerative disease
5084242|NCT03472170|bovine lactoferrin|bovine lactoferrin
5084243|NCT03472170|late sepsis|late sepsis
5084244|NCT03472157|Gastric bypass|gastric bypass
5084245|NCT03472157|Sleeve gastrectomy|sleeve gastrectomy
5084246|NCT03472157|Lifestyle therapy|lifestyle therapy
5084247|NCT03472157|NASH|nash
5084248|NCT03472157|Advanced fibrosis|advanced fibrosis
5961460|NCT04287075|Symptomatic Neuroma|symptomatic neuroma
5961461|NCT04286997|GRAIL|grail
5961462|NCT04286997|children|children
5961463|NCT04286997|rehabilitation|rehabilitation
5961464|NCT04286997|virtual reality|virtual reality
5961465|NCT04286997|hemiparesis|hemiparesis
5961466|NCT04286984|Gastric Cancer|gastric cancer
5961467|NCT04286984|Anemia|anemia
5961468|NCT04286984|Intravenous Iron|intravenous iron
5961469|NCT04286984|Patient Blood Management|patient blood management
5084249|NCT03472157|Cirrhosis|cirrhosis
5084250|NCT03472131|Spondylodiscitis|spondylodiscitis
5084251|NCT03472131|Titanium Cage|titanium cage
5084252|NCT03472131|Posterolateral Debridement|posterolateral debridement
5084253|NCT03472131|Immunosuppressed|immunosuppressed
5961470|NCT04286984|Surgery|surgery
5961471|NCT04286971|continuous peripheral block|continuous peripheral block
5961472|NCT04286971|sciatic block|sciatic block
5961473|NCT04286971|ischemic pain|ischemic pain
5903434|NCT00392756|Kallmann Syndrome|kallmann syndrome
5897241|NCT02933034|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
5897242|NCT02933034|MYOCARDIAL INFARCTION|myocardial infarction
5897243|NCT02933034|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
5897244|NCT02933034|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
5897245|NCT02933034|MANGANESE-ENHANCED MRI|manganese-enhanced mri
5897246|NCT02933034|INFARCT VOLUME/SIZE|infarct volume/size
5897247|NCT02933034|ALL CAUSE MORTALITY|all cause mortality
5897248|NCT02933034|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
5897256|NCT02931682|intellectual disability|intellectual disability
5897257|NCT02931682|X-linked|x-linked
5897258|NCT02931682|language|language
5897260|NCT02931682|observational|observational
5897261|NCT02931682|brain spectroscopy|brain spectroscopy
5897299|NCT02925949|Treatment|treatment
5897300|NCT02925949|Adherence|adherence
5897301|NCT02925949|Intervention|intervention
5897302|NCT02925949|Sexual and Gender Minority Couples|sexual and gender minority couples
5897308|NCT02925234|Molecular tumor profile|molecular tumor profile
5897309|NCT02925234|Multidisciplinary tumor board|multidisciplinary tumor board
5084254|NCT03472131|Less Invasive|less invasive
5084255|NCT03472131|Spine Infection|spine infection
5084256|NCT03472118|Anesthesia, general|anesthesia, general
5084257|NCT03472118|Adult|adult
5084258|NCT03472118|Humans|humans
5084259|NCT03472118|Apnea|apnea
5084260|NCT03472118|Oxygen|oxygen
5084261|NCT03472118|Carbon dioxide|carbon dioxide
5084262|NCT03472118|Acidosis, respiratory|acidosis, respiratory
5084263|NCT03472118|Administration, Intranals/methods|administration, intranals/methods
5084264|NCT03472118|Airway management/methods|airway management/methods
5084265|NCT03472118|Continuous positive airway pressure/methods|continuous positive airway pressure/methods
5084266|NCT03472118|Insufflation/methods|insufflation/methods
5084267|NCT03472118|Oxygen/administration&dosage|oxygen/administration&dosage
5084268|NCT03472118|Laryngoscopy|laryngoscopy
5084269|NCT03472118|Larynx/surgery|larynx/surgery
5084293|NCT03471988|AK1820|ak1820
5084294|NCT03471988|Cresemba|cresemba
5084295|NCT03471975|Video laryngoscopy|video laryngoscopy
5084296|NCT03471962|respiratory quotient (RQ)|respiratory quotient (rq)
5084297|NCT03471962|anaerobic metabolism|anaerobic metabolism
5084298|NCT03471962|major surgery|major surgery
5084299|NCT03471936|Congenital Heart Disease|congenital heart disease
5084300|NCT03471936|pressure-volume loops|pressure-volume loops
5084301|NCT03471936|diastolic function|diastolic function
5084302|NCT03471910|Chronic venous insufficiency|chronic venous insufficiency
5084303|NCT03471910|Diosmin|diosmin
5084304|NCT03471910|Hesperidin|hesperidin
5084305|NCT03471897|glycosaminoglycans|glycosaminoglycans
5084306|NCT03471897|biomarkers|biomarkers
5084307|NCT03471897|diagnostics|diagnostics
5084308|NCT03471897|prognostic|prognostic
5084309|NCT03471897|liquid biopsy|liquid biopsy
5084310|NCT03471884|Thoracoscopic surgery,Airway Management,Anesthesia|thoracoscopic surgery,airway management,anesthesia
5084317|NCT03471858|caesarean, uterus|caesarean, uterus
5084318|NCT03471845|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
5084319|NCT03471845|Myocardial Infarction (MI)|myocardial infarction (mi)
5084320|NCT03471845|Late Lumen Loss (LLL)|late lumen loss (lll)
5084321|NCT03471845|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
5084322|NCT03471845|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
5084323|NCT03471845|Target Vessel Failure (TVF)|target vessel failure (tvf)
5084324|NCT03471845|Target Lesion Failure (TLF)|target lesion failure (tlf)
5084325|NCT03471845|Stent Thrombosis (ST)|stent thrombosis (st)
5084326|NCT03471845|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5084327|NCT03471819|Atopic Dermatitis|atopic dermatitis
5084338|NCT03471767|Nicotine dependence|nicotine dependence
5084339|NCT03471767|Bupropion|bupropion
5084340|NCT03471767|DXM|dxm
5084341|NCT03471767|Nicotine addiction|nicotine addiction
5961474|NCT04286945|SENSORY EXOTROPIA|sensory exotropia
5961475|NCT04286945|LATERAL RECTUS ELONGATION|lateral rectus elongation
5961476|NCT04286945|AUTOGRAFT|autograft
5961477|NCT04286919|Exercise|exercise
5961478|NCT04286919|Adherence|adherence
5961479|NCT04286906|Asthma|asthma
5961480|NCT04286906|Breathlessness|breathlessness
5961481|NCT04286854|Echocardiography, Stress|echocardiography, stress
5961482|NCT04286854|Right ventricle|right ventricle
5961483|NCT04286854|Mexican population|mexican population
5961484|NCT04286841|neoadjuvant immunotherapy|neoadjuvant immunotherapy
5961485|NCT04286841|NSCLC|nsclc
5961486|NCT04286828|Multiple Sclerosis|multiple sclerosis
5961487|NCT04286828|Proprioception|proprioception
5961488|NCT04286828|Postural balance|postural balance
5961489|NCT04286828|Task performance and analysis|task performance and analysis
5961490|NCT04286815|Gene Therapy|gene therapy
5961491|NCT04286815|X Linked Severe Combined Immunodeficiency|x linked severe combined immunodeficiency
5961492|NCT04286815|Lentiviral Vector|lentiviral vector
5961493|NCT04286802|hypertension|hypertension
5961494|NCT04286802|uncontrolled|uncontrolled
5961495|NCT04286802|salt, excess|salt, excess
5961496|NCT04286802|salt meter|salt meter
5961497|NCT04286776|episodic memory|episodic memory
5961498|NCT04286763|bile duct injury|bile duct injury
5961499|NCT04286763|surgery|surgery
5961500|NCT04286763|laparoscopy|laparoscopy
5961501|NCT04286763|cholecystectomy|cholecystectomy
5961502|NCT04286763|Bile duct stricture|bile duct stricture
5961503|NCT04286737|Therapeutic Touch|therapeutic touch
5961504|NCT04286737|infantile colic|infantile colic
5897310|NCT02925234|Antitumor drugs|antitumor drugs
5897311|NCT02925234|Molecular Targeted Therapy|molecular targeted therapy
5897312|NCT02925234|Drug Repositioning|drug repositioning
5897313|NCT02925234|Off-Label Use|off-label use
5897314|NCT02925234|Sequence Analysis, DNA|sequence analysis, dna
5006002|NCT03959202|exercise intervention|exercise intervention
5897406|NCT02910973|Inflammation, Vagus Nerve Stimulation|inflammation, vagus nerve stimulation
5084342|NCT03471767|Cigarette smoking|cigarette smoking
5084343|NCT03471767|Dextromethorphan|dextromethorphan
5084344|NCT03471754|Depression, transcranial electronic stimulation, pilot, open label, safety, efficacy|depression, transcranial electronic stimulation, pilot, open label, safety, efficacy
5084345|NCT03471741|breast cancer|breast cancer
5084346|NCT03471741|radiotherapy|radiotherapy
5084347|NCT03471741|cutaneous toxicity|cutaneous toxicity
5084348|NCT03471741|subcutaneous toxicity|subcutaneous toxicity
5084349|NCT03471741|local control|local control
5084350|NCT03471741|IMRT|imrt
5084351|NCT03471728|Linaclotide|linaclotide
5084352|NCT03471728|Linzess|linzess
5084353|NCT03471728|Irritable Bowel Syndrome|irritable bowel syndrome
5084354|NCT03471728|Chronic Constipation|chronic constipation
5084355|NCT03471715|frequency fenesration dehiscence cbct population|frequency fenesration dehiscence cbct population
5084361|NCT03471650|PSMA|psma
5084362|NCT03471650|18F-DCFPyL PET/CT|18f-dcfpyl pet/ct
5084363|NCT03471637|Chronic Pain|chronic pain
5084364|NCT03471637|Compassion-Focused Therapy|compassion-focused therapy
5084365|NCT03471637|Self-Compassion|self-compassion
5084366|NCT03471637|Psychological Flexibility|psychological flexibility
5084376|NCT03471494|Surgery|surgery
5084377|NCT03471494|Quality|quality
5084378|NCT03471494|Outcomes|outcomes
5084384|NCT03471429|Anxiety|anxiety
5084385|NCT03471429|Dog|dog
5084386|NCT03471429|Canine|canine
5084387|NCT03471429|Therapy|therapy
5084388|NCT03471429|Depression|depression
5084389|NCT03471429|Pain|pain
5084390|NCT03471416|Guatemala|guatemala
5084391|NCT03471416|Guatemala City|guatemala city
5084392|NCT03471416|Malnutrition|malnutrition
5084393|NCT03471416|Leukemia|leukemia
5084394|NCT03471416|Childhood Cancer|childhood cancer
5084395|NCT03471403|Cold snare polypectomy|cold snare polypectomy
5084396|NCT03471390|Nursing Home|nursing home
5084397|NCT03471377|Planned Surgical Case|planned surgical case
5084398|NCT03471377|Predictive Modeling|predictive modeling
5084399|NCT03471377|18-115|18-115
5084400|NCT03471351|Hodgkin lymphoma|hodgkin lymphoma
5084401|NCT03471351|RP6530|rp6530
5084402|NCT03471351|Pembrolizumab|pembrolizumab
5084403|NCT03471351|Tenalisib|tenalisib
5084404|NCT03471338|multiple sclerosis|multiple sclerosis
5084405|NCT03471338|cognition|cognition
5084406|NCT03471338|neuropsychology|neuropsychology
5084407|NCT03471338|cognitive rehabilitation|cognitive rehabilitation
5084408|NCT03471325|plaque removal|plaque removal
5084409|NCT03471299|Ultrafiltration rate|ultrafiltration rate
5084410|NCT03471234|coronary disease|coronary disease
5084411|NCT03471234|drug eluting stent|drug eluting stent
5084412|NCT03471234|Inspiron|inspiron
5084413|NCT03471182|Cocaine Dependence|cocaine dependence
5084414|NCT03471182|Cocaine Addiction|cocaine addiction
5084415|NCT03471169|antithrombotic therapy|antithrombotic therapy
5084416|NCT03471117|blood pressure|blood pressure
5084417|NCT03471117|pioglitazone|pioglitazone
5084418|NCT03471117|hypertension|hypertension
5084419|NCT03471104|Diabetes-related distress|diabetes-related distress
5084420|NCT03471104|Living with diabetes|living with diabetes
5084421|NCT03471104|Patient-Reported Outcome Measures (PROMs)|patient-reported outcome measures (proms)
5084422|NCT03471078|CIT|cit
5084423|NCT03471078|Thrombocytopenia|thrombocytopenia
5084427|NCT03471013|schizophrenia|schizophrenia
5084428|NCT03471013|beliefs|beliefs
5084429|NCT03471013|caregiver|caregiver
5084430|NCT03471000|implant|implant
5084431|NCT03471000|dental implant|dental implant
5084432|NCT03470987|obesity|obesity
5084433|NCT03470987|periodontitis|periodontitis
5084434|NCT03470987|cytokines|cytokines
5084435|NCT03470961|Grafalon ATG SPK|grafalon atg spk
5084436|NCT03470948|surgical apgar score, postoperative complication|surgical apgar score, postoperative complication
5084437|NCT03470935|breast cancer|breast cancer
5084438|NCT03470935|young women|young women
5084441|NCT03470909|Remaining breast tissue|remaining breast tissue
5084442|NCT03470909|Skin-Sparing Mastectomy|skin-sparing mastectomy
5084443|NCT03470909|Nipple-Sparing Mastectomy|nipple-sparing mastectomy
5961505|NCT04286737|infant|infant
5961506|NCT04286737|nursing|nursing
5961507|NCT04286737|Symptom|symptom
5961508|NCT04286711|Apatinib Albumin-paclitaxel Camrelizumab Gastric cancer|apatinib albumin-paclitaxel camrelizumab gastric cancer
5961509|NCT04286698|Complex decongestive physiotherapy|complex decongestive physiotherapy
5961510|NCT04286698|Home program|home program
5961511|NCT04286698|Manual lymph drainage|manual lymph drainage
5961512|NCT04286698|Face mask|face mask
5084444|NCT03470909|Prophylactic|prophylactic
5084445|NCT03470896|preanesthesia teleconsultation|preanesthesia teleconsultation
5084446|NCT03470896|video-conference|video-conference
5084447|NCT03470896|ambulatory surgery|ambulatory surgery
5961513|NCT04286698|3D analysis|3d analysis
5961514|NCT04286685|Non cardiac surgery|non cardiac surgery
5961515|NCT04286646|Cataract|cataract
4969420|NCT04180592|MRI|mri
5693032|NCT00525928|depression|depression
5897417|NCT02903823|spinal cord injury|spinal cord injury
5897418|NCT02903823|cerebral palsy|cerebral palsy
5897419|NCT02903823|stroke|stroke
5897440|NCT02897167|Antipsychotic Agents|antipsychotic agents
5897441|NCT02897167|Immunology|immunology
5897442|NCT02897167|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
5897459|NCT02885766|CML|cml
5897460|NCT02885766|Myeloid leukaemia chronic|myeloid leukaemia chronic
5897461|NCT02885766|CML progression|cml progression
5897462|NCT02885766|Chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia
5897463|NCT02885766|PF-114|pf-114
5897464|NCT02885766|Cytogenetic response CCyR|cytogenetic response ccyr
5897465|NCT02885766|Major molecular response MMR|major molecular response mmr
5897466|NCT02885766|Complete molecular response CMR|complete molecular response cmr
5897467|NCT02885766|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5897468|NCT02885766|2-nd generation Bcr-Abl inhibitors resistant|2-nd generation bcr-abl inhibitors resistant
5006003|NCT03959202|cognition|cognition
5084448|NCT03470896|telemedicine|telemedicine
5084449|NCT03470883|endoscopic resection|endoscopic resection
5084450|NCT03470883|colorectal adenomas|colorectal adenomas
5084451|NCT03470883|Colorectal adenocarcinomas|colorectal adenocarcinomas
5084452|NCT03470870|Enhanced recovery after surgery|enhanced recovery after surgery
5084453|NCT03470870|gynecologic oncology surgery|gynecologic oncology surgery
5084454|NCT03470870|Nomogram control|nomogram control
5084455|NCT03470857|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
5084456|NCT03470857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5084457|NCT03470857|Cancer|cancer
5084458|NCT03470857|Superooxide Dismutase|superooxide dismutase
5084459|NCT03470857|Catalase|catalase
5084460|NCT03470857|Glutathione Peroxidase|glutathione peroxidase
5084461|NCT03470857|Malondialdehyde|malondialdehyde
5084462|NCT03470857|Conjugated Dienes|conjugated dienes
5084463|NCT03470857|Acid Phosphatase|acid phosphatase
5084464|NCT03470857|Cathepsin D|cathepsin d
5084465|NCT03470857|Alpha-1-Antitrypsin|alpha-1-antitrypsin
5084466|NCT03470857|Arylsulfatase|arylsulfatase
5084467|NCT03470857|8-iso-Prostaglandin F2alpha|8-iso-prostaglandin f2alpha
5084469|NCT03470857|Total Antioxidant Capacity|total antioxidant capacity
5084470|NCT03470857|Vitamin A|vitamin a
5084471|NCT03470857|Vitamin E|vitamin e
5084472|NCT03470844|Major burns|major burns
5084475|NCT03470844|Functional magnetic resonance imaging|functional magnetic resonance imaging
5084476|NCT03470844|Neuroinflammation|neuroinflammation
5084477|NCT03470844|Long term quality of life|long term quality of life
5084478|NCT03470818|Medical Education|medical education
5084479|NCT03470818|Flipped Classroom|flipped classroom
5084481|NCT03470818|Simulation|simulation
5084482|NCT03470818|Achievement Emotions|achievement emotions
5084483|NCT03470792|Microcirculation, extracorporeal membrane oxygenation|microcirculation, extracorporeal membrane oxygenation
5084484|NCT03470766|Neuromodulation|neuromodulation
5084485|NCT03470766|HF10|hf10
5084486|NCT03470766|HF-10|hf-10
5084487|NCT03470766|Nevro|nevro
5084488|NCT03470766|High-frequency|high-frequency
5084489|NCT03470766|10kHz|10khz
5084490|NCT03470766|Spinal Cord Stimulation|spinal cord stimulation
5084491|NCT03470766|CNLBP|cnlbp
5084492|NCT03470766|Chronic Neuropathic Low Back Pain|chronic neuropathic low back pain
5084493|NCT03470766|Double blind randomised sham-controlled|double blind randomised sham-controlled
5084494|NCT03470766|PANARC|panarc
5084496|NCT03470740|rheumatoid arthritis, self-management, self-efficacy|rheumatoid arthritis, self-management, self-efficacy
5084497|NCT03470714|Force Irradiation|force irradiation
5084498|NCT03470714|Kinesiotaping|kinesiotaping
5084499|NCT03470714|EMG|emg
5084500|NCT03470662|Hip fractures|hip fractures
5084501|NCT03470662|Delirium|delirium
5084502|NCT03470662|Aged|aged
5084503|NCT03470662|Care bundle|care bundle
5961516|NCT04286646|Pupillary changes|pupillary changes
5961517|NCT04286646|Age|age
5961518|NCT04286646|Anterior chamber depth|anterior chamber depth
5961519|NCT04286620|LASIK complications|lasik complications
5961520|NCT04286568|Health Disparities|health disparities
5961521|NCT04286568|Outreach|outreach
5961522|NCT04286568|Health Behavior|health behavior
5961523|NCT04286568|Under-served communities|under-served communities
5961524|NCT04286555|diet|diet
5961525|NCT04286555|DASH|dash
5961526|NCT04286555|sodium|sodium
5961527|NCT04286529|Pre-menopausal women|pre-menopausal women
5961528|NCT04286477|Peritoneal Dialysis|peritoneal dialysis
5961529|NCT04286477|Hemodiafiltration|hemodiafiltration
5961530|NCT04286477|Expanded Hemodialysis|expanded hemodialysis
5961531|NCT04286477|Monocytes subpopulations|monocytes subpopulations
5961532|NCT04286477|Regulatory T cells|regulatory t cells
5961533|NCT04286477|Natural Killer cells|natural killer cells
5961534|NCT04286477|Lymphocytes|lymphocytes
5961535|NCT04286464|infants|infants
5961536|NCT04286464|children|children
5961537|NCT04286464|healthy|healthy
5961538|NCT04286464|term born|term born
5961539|NCT04286464|preterm born|preterm born
5961540|NCT04286464|fetal growth restriction|fetal growth restriction
5961541|NCT04286464|intrauterine growth restriction or preeclampsia|intrauterine growth restriction or preeclampsia
5961542|NCT04286464|with gestational diabetes|with gestational diabetes
5961543|NCT04286464|with IVF or amnion dysfunction|with ivf or amnion dysfunction
5961544|NCT04286438|Bleeding|bleeding
5961545|NCT04286425|fertility|fertility
5897590|NCT02860741|Sub-Clinical Depression|sub-clinical depression
5084504|NCT03470623|hallux valgus|hallux valgus
5084505|NCT03470623|chevron osteotomy|chevron osteotomy
5084506|NCT03470623|bioabsorbable screw|bioabsorbable screw
5084507|NCT03470623|steel screw|steel screw
5084508|NCT03470610|Progesterone|progesterone
5084509|NCT03470610|HRT|hrt
5084510|NCT03470610|frozen embryo transfer|frozen embryo transfer
5084511|NCT03470584|Diet, vegetarian|diet, vegetarian
5084512|NCT03470584|Dementia|dementia
5084513|NCT03470584|Depression|depression
5084514|NCT03470584|Cardiovascular Diseases|cardiovascular diseases
5084515|NCT03470584|Stroke|stroke
5084516|NCT03470584|Gout|gout
5084517|NCT03470584|Cataract|cataract
5084518|NCT03470584|Gallstone|gallstone
5084519|NCT03470584|Urinary Tract Infections|urinary tract infections
5084520|NCT03470558|Diet|diet
5084521|NCT03470558|Dietary Habits|dietary habits
5084522|NCT03470558|Weight changes|weight changes
5084523|NCT03470545|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
5084524|NCT03470428|Fontan|fontan
5084525|NCT03470428|Single Ventricle|single ventricle
5084526|NCT03470402|Breast Cancer Prevention|breast cancer prevention
5084527|NCT03470402|Genetic Testing|genetic testing
5084528|NCT03470402|Genetic Counseling|genetic counseling
5084529|NCT03470402|Personalized Prevention|personalized prevention
5084530|NCT03470402|Precision Prevention|precision prevention
5084531|NCT03470402|Precision Medicine|precision medicine
5084532|NCT03470402|Risk Assessment|risk assessment
5084533|NCT03470402|Decision Making|decision making
5084534|NCT03470402|Decision Aid|decision aid
5084535|NCT03470389|Liver Cirrhosis|liver cirrhosis
5084536|NCT03470389|Hypertension, Portal|hypertension, portal
5084537|NCT03470389|Hepatic Venous Pressure Gradient (HVPG)|hepatic venous pressure gradient (hvpg)
5084540|NCT03470376|cholesterol|cholesterol
5084541|NCT03470376|nutraceutical|nutraceutical
5084543|NCT03470376|PCSK9|pcsk9
5084544|NCT03470376|hsCRP|hscrp
5084545|NCT03470376|stiffness|stiffness
5084546|NCT03470363|total knee arthroplasty|total knee arthroplasty
5084547|NCT03470363|tourniquet|tourniquet
5084548|NCT03470363|sevoflurane|sevoflurane
5084549|NCT03470363|spinal anesthesia|spinal anesthesia
5084550|NCT03470363|myeloperoxidase|myeloperoxidase
5084551|NCT03470363|elastase|elastase
5084552|NCT03470363|neutrophil|neutrophil
5084553|NCT03470350|TGF-beta activatied|tgf-beta activatied
5084554|NCT03470337|Thrombophlebitis|thrombophlebitis
5084555|NCT03470324|Parkinson's disease|parkinson's disease
5084556|NCT03470324|Dysphagia|dysphagia
5084557|NCT03470324|Parkinsonian Disorders|parkinsonian disorders
5084558|NCT03470324|Neurodegenerative Diseases|neurodegenerative diseases
5084559|NCT03470324|Movement Disorders|movement disorders
5084560|NCT03470324|Nervous System Diseases|nervous system diseases
5084561|NCT03470324|Basal Ganglia Diseases|basal ganglia diseases
5084562|NCT03470324|Brain Diseases|brain diseases
5084563|NCT03470324|Central Nervous System Diseases|central nervous system diseases
5084564|NCT03470324|Deep brain stimulation|deep brain stimulation
5084565|NCT03470324|substantia nigra pars reticulata|substantia nigra pars reticulata
5084566|NCT03470324|subthalamic nucleus|subthalamic nucleus
5084575|NCT03470285|Small solid renal tumors|small solid renal tumors
5084576|NCT03470246|Accelerometer|accelerometer
5084577|NCT03470246|Aortic valve replacement|aortic valve replacement
5084578|NCT03470246|Aortic valve stenosis|aortic valve stenosis
5084579|NCT03470246|Coronary artery bypass grafting|coronary artery bypass grafting
5084584|NCT03470246|Mitral valve repair|mitral valve repair
5084585|NCT03470246|Rehabilitation|rehabilitation
5084586|NCT03470194|Quality Care|quality care
5084587|NCT03470194|Access to health care|access to health care
5084588|NCT03470194|Interpretation services|interpretation services
5084590|NCT03470155|annuloplasty mitral valve|annuloplasty mitral valve
5084591|NCT03470155|reduced LV function|reduced lv function
5084592|NCT03470142|laparoscopy-assisted surgery|laparoscopy-assisted surgery
5084593|NCT03470142|NOSES|noses
5084594|NCT03470116|MacGrath MAC|macgrath mac
5084595|NCT03470116|curarization|curarization
5084596|NCT03470116|intubation|intubation
5084597|NCT03470116|MacIntosh|macintosh
5084598|NCT03470116|laryngoscope|laryngoscope
5084601|NCT03470090|Physical activity|physical activity
5084602|NCT03470090|Function|function
5084603|NCT03470090|Balance|balance
5084604|NCT03470090|Neuromuscular exercises|neuromuscular exercises
5084605|NCT03470090|Osteoarthritis|osteoarthritis
5084606|NCT03470038|NGF-induced pain|ngf-induced pain
5084607|NCT03470038|Ischemia-induced pain|ischemia-induced pain
5084608|NCT03470038|Hyperalgesia|hyperalgesia
5084609|NCT03470038|NGF pain model|ngf pain model
5084610|NCT03470025|Rehabilitation|rehabilitation
5084611|NCT03470025|Psychological Intervention|psychological intervention
5084612|NCT03470025|Quality of life|quality of life
5084613|NCT03469999|Botulinum toxin A|botulinum toxin a
5084614|NCT03469999|Walking efficiency|walking efficiency
5084615|NCT03469999|Spasticity|spasticity
5961546|NCT04286425|seminal plasma|seminal plasma
5084616|NCT03469999|Dysport|dysport
5084617|NCT03469999|Pediatric|pediatric
5084618|NCT03469960|IFCT|ifct
5897635|NCT02850016|Romidepsin|romidepsin
5897636|NCT02850016|3BNC117|3bnc117
5897637|NCT02850016|Broadly neutralizing antibody|broadly neutralizing antibody
5897670|NCT02836691|Autonomic nervous system|autonomic nervous system
5897671|NCT02836691|Uncontrolled severe asthma|uncontrolled severe asthma
5897672|NCT02836691|Paucigranulocitic asthma phenotype|paucigranulocitic asthma phenotype
5897673|NCT02836691|Stress|stress
5897679|NCT02836249|Hepatitis|hepatitis
5897680|NCT02836249|Tenofovir|tenofovir
5897681|NCT02836249|Viread|viread
4967709|NCT04191798|TKR|tkr
5897705|NCT02823769|clinical study|clinical study
5897706|NCT02823769|dental fillings|dental fillings
5897707|NCT02822989|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5897708|NCT02822989|Musculoskeletal Pain|musculoskeletal pain
5897709|NCT02822989|Inflammation|inflammation
5897722|NCT02819726|an inadequate response to anti -TNF therapy|an inadequate response to anti -tnf therapy
5084619|NCT03469960|DICIPLE|diciple
5084620|NCT03469960|NSCLC|nsclc
5084621|NCT03469947|Tranexamic Acid|tranexamic acid
5084623|NCT03469921|Malignant haemopathies|malignant haemopathies
5084624|NCT03469921|Acute Leukemia|acute leukemia
5084625|NCT03469921|Non-hodgkin Lymphoma|non-hodgkin lymphoma
5084626|NCT03469921|Hodgkin Lymphoma|hodgkin lymphoma
5084627|NCT03469921|Young adults|young adults
5084628|NCT03469921|Adolescent|adolescent
5084629|NCT03469895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5084630|NCT03469895|Autoimmune Cytopenias|autoimmune cytopenias
5084631|NCT03469895|BCR inhibitors|bcr inhibitors
5084632|NCT03469882|Protein, exercise, critical illness, outcome,|protein, exercise, critical illness, outcome,
5084633|NCT03469869|Obesity|obesity
5084634|NCT03469843|Congenital Heart Disease|congenital heart disease
5740132|NCT00357435|Fleck|fleck
5084635|NCT03469843|Cardiac denervation|cardiac denervation
5084636|NCT03469843|123I-metaiodobenzylguanidine|123i-metaiodobenzylguanidine
5084637|NCT03469843|Arterial switch operation|arterial switch operation
5084638|NCT03469830|insert|insert
5084639|NCT03469830|pressure therapy|pressure therapy
5084640|NCT03469830|silicone gel|silicone gel
5084641|NCT03469817|Bone apposition|bone apposition
5084642|NCT03469817|Stryker|stryker
5084643|NCT03469817|MRI|mri
5084644|NCT03469817|Trident II|trident ii
5084645|NCT03469817|Total Hip Replacement|total hip replacement
5084646|NCT03469791|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5084674|NCT03469609|bowel reanastomosis|bowel reanastomosis
5084675|NCT03469609|enteral feeding|enteral feeding
5084676|NCT03469609|caloric intake|caloric intake
5084677|NCT03469609|parenteral nutrition|parenteral nutrition
5084678|NCT03469609|complication rate|complication rate
5084679|NCT03469609|reduction of hospital expenses|reduction of hospital expenses
5084680|NCT03469609|length of hospital stay|length of hospital stay
5084682|NCT03469570|Non-Thoracic|non-thoracic
5084683|NCT03469570|Fluid Management|fluid management
5084684|NCT03469570|Perioperative Goal Directed Therapy|perioperative goal directed therapy
5084685|NCT03469531|Cervical Cancer|cervical cancer
5084686|NCT03469531|Radiation Therapy|radiation therapy
5084687|NCT03469531|Chemotherapy|chemotherapy
5084688|NCT03469531|Nimotuzumab|nimotuzumab
5084689|NCT03469531|Cisplatin|cisplatin
5084690|NCT03469518|beta-cryptoxanthin|beta-cryptoxanthin
5084691|NCT03469518|cholesterol|cholesterol
5084692|NCT03469518|Galactooligosaccharides|galactooligosaccharides
5084693|NCT03469518|Plant Sterols|plant sterols
5084694|NCT03469518|Cardiovascular risk|cardiovascular risk
5084695|NCT03469518|Bone Turnover markers|bone turnover markers
5084696|NCT03469518|Intestinal Inflammatory markers|intestinal inflammatory markers
5084697|NCT03469518|Microbiota|microbiota
5084698|NCT03469479|Neoadjuvant hepatic arterial infusion chemotherapy|neoadjuvant hepatic arterial infusion chemotherapy
5084699|NCT03469479|BCLC A/B|bclc a/b
5084700|NCT03469479|FOLFOX|folfox
5084701|NCT03469479|Resection|resection
5084702|NCT03469453|GAD|gad
5084703|NCT03469453|Adolescents|adolescents
5084704|NCT03469453|Internet-delivered Cognitive behavioral therapy|internet-delivered cognitive behavioral therapy
5084705|NCT03469453|ICBT|icbt
5084706|NCT03469453|CBT|cbt
5084707|NCT03469440|lactate|lactate
5084708|NCT03469440|central venous saturation|central venous saturation
5961547|NCT04286425|endometrium|endometrium
5961548|NCT04286373|axial spondyloarthritis|axial spondyloarthritis
5961549|NCT04286373|vagus nerve stimulation|vagus nerve stimulation
5961550|NCT04286360|RASopathie|rasopathie
5961551|NCT04286321|Vitamin E|vitamin e
5961552|NCT04286321|Vitamin K|vitamin k
5961553|NCT04286321|Egg|egg
5961554|NCT04286321|Spinach|spinach
5961555|NCT04286295|Tobacco|tobacco
5961556|NCT04286295|Relapse prevention|relapse prevention
5961557|NCT04286269|Music Based Intervention|music based intervention
5961558|NCT04286269|Preterm Infant Pain Profile|preterm infant pain profile
5961559|NCT04286256|Early Childhood Caries|early childhood caries
5961560|NCT04286256|Motivational Interviewing|motivational interviewing
5961561|NCT04286230|Adherence|adherence
5961562|NCT04286230|Oral antibiotics|oral antibiotics
5961563|NCT04286230|Electronic monitoring|electronic monitoring
5961564|NCT04286217|human pregnancy|human pregnancy
5961565|NCT04286217|hemodynamic changes in pregnancy|hemodynamic changes in pregnancy
5961566|NCT04286217|macular thickness|macular thickness
5961567|NCT04286217|microcirculation|microcirculation
5961568|NCT04286217|autoregulation|autoregulation
5961569|NCT04286217|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5694795|NCT00519454|Hormones|hormones
5897757|NCT02814123|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5897758|NCT02814123|Pramlintide|pramlintide
5897759|NCT02814123|Artificial Pancreas|artificial pancreas
5897760|NCT02814123|Closed-Loop System|closed-loop system
5897761|NCT02814123|Insulin|insulin
5897762|NCT02813252|long-term follow-up|long-term follow-up
5897763|NCT02813252|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
5897764|NCT02813252|JCAR015|jcar015
5897767|NCT02810418|Immunotoxin|immunotoxin
5897768|NCT02810418|Mesothelin|mesothelin
5897769|NCT02810418|Antibody-based Therapeutics|antibody-based therapeutics
5897770|NCT02810418|Advanced Cancer|advanced cancer
4967794|NCT04191109|Stroke|stroke
5897792|NCT02801487|Carbon Ion Therapy|carbon ion therapy
5897793|NCT02801487|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5897794|NCT02800356|Age-Related Macular Degeneration|age-related macular degeneration
5897795|NCT02800356|Geographic Atrophy|geographic atrophy
5897796|NCT02800356|Reticular pseudodrusen|reticular pseudodrusen
5897797|NCT02800356|Lasers|lasers
5897798|NCT02800356|PASCAL 577|pascal 577
5897812|NCT02795195|re-irradiation|re-irradiation
5897813|NCT02795195|carbon ion therapy|carbon ion therapy
5897814|NCT02791399|opioid safety|opioid safety
5897815|NCT02791399|opioid misuse|opioid misuse
5897816|NCT02791399|opioid abuse|opioid abuse
5897817|NCT02791399|patient-centered|patient-centered
5897818|NCT02791399|opioid|opioid
5897819|NCT02791399|opiate|opiate
5897820|NCT02791399|chronic pain|chronic pain
5897821|NCT02791399|primary care|primary care
5897822|NCT02791399|Veteran|veteran
5897823|NCT02791399|clinical care|clinical care
5084709|NCT03469440|Pediatric Cardiac Surgery|pediatric cardiac surgery
5084710|NCT03469388|EVAR, central pressure, arterial stiffness, AAA, elective surgery|evar, central pressure, arterial stiffness, aaa, elective surgery
5084711|NCT03469375|FOLFIRINOX|folfirinox
5084712|NCT03469375|Pancreatic cancer|pancreatic cancer
5084713|NCT03469375|Conversion surgery|conversion surgery
5084714|NCT03469375|Overall survival|overall survival
5084715|NCT03469349|Drug Therapy|drug therapy
5084716|NCT03469336|Psoriasis|psoriasis
5084717|NCT03469336|Topical|topical
5084718|NCT03469323|Nonintubated video-assisted thoracic surgery (VATS)|nonintubated video-assisted thoracic surgery (vats)
5084719|NCT03469310|endocrine surgery|endocrine surgery
5084720|NCT03469310|opioid addiction|opioid addiction
5084721|NCT03469310|pain management|pain management
5084722|NCT03469310|analgesia|analgesia
5084723|NCT03469271|Pneumonia|pneumonia
5084724|NCT03469258|Pancreatic Cancer|pancreatic cancer
5084725|NCT03469245|Endovascular|endovascular
5084726|NCT03469245|Fenestrated endovascular repair|fenestrated endovascular repair
5084727|NCT03469245|numerical simulation|numerical simulation
5084728|NCT03469219|granulysin|granulysin
5084729|NCT03469193|knee unicompartmental prosthesis|knee unicompartmental prosthesis
5084730|NCT03469193|KneeKG system|kneekg system
5084731|NCT03469193|robotic-assisted|robotic-assisted
5084732|NCT03469193|alignment|alignment
5084733|NCT03469193|implants positioning|implants positioning
5084734|NCT03469193|International Knee Society|international knee society
5084735|NCT03469193|Forgotten joint score|forgotten joint score
5084736|NCT03469180|Treadmill Training|treadmill training
5084737|NCT03469180|Whole Body Vibration Training|whole body vibration training
5084738|NCT03469167|Bleeding|bleeding
5084739|NCT03469154|Layperson|layperson
5084740|NCT03469154|Paediatric Basic life Support|paediatric basic life support
5961570|NCT04286204|Cardiac Arrest|cardiac arrest
5961571|NCT04286204|Basic Life Support|basic life support
5961572|NCT04286204|New Information and Communication Technologies|new information and communication technologies
5961573|NCT04286191|Corticospinal Tract|corticospinal tract
5961574|NCT04286191|Neuroplasticity|neuroplasticity
5961575|NCT04286165|PTSD|ptsd
5961576|NCT04286165|Post Traumatic Stress Disorder|post traumatic stress disorder
5961577|NCT04286165|Depression|depression
5961578|NCT04286165|Emotion Regulation|emotion regulation
5961579|NCT04286165|Skills Building|skills building
5961580|NCT04286165|Peer|peer
5961581|NCT04286165|Coaching|coaching
5961582|NCT04286165|Online|online
5961583|NCT04286139|Health promotion|health promotion
5961584|NCT04286139|Self-management|self-management
5961585|NCT04286126|transcranial magnetic stimulation|transcranial magnetic stimulation
5961586|NCT04286126|theta burst|theta burst
5961587|NCT04286100|Coronary artery disease|coronary artery disease
5961588|NCT04286100|Myocardial contrast echocardiography|myocardial contrast echocardiography
5961589|NCT04286100|Left ventricle opacification|left ventricle opacification
5961590|NCT04286074|Breathing exercises|breathing exercises
5961591|NCT04286074|Soccer|soccer
5961592|NCT04286074|Maximal respiratory pressures|maximal respiratory pressures
5961593|NCT04286074|Muscle Strength|muscle strength
5961594|NCT04286074|Muscle fatigue|muscle fatigue
5961595|NCT04286061|Rugby|rugby
5961596|NCT04286061|Pubalgia|pubalgia
5961597|NCT04286061|Strength|strength
5961598|NCT04286061|Range of motion|range of motion
5961599|NCT04286061|Instrument-assisted soft tissue mobilization.|instrument-assisted soft tissue mobilization.
5961600|NCT04286048|Baseball|baseball
5961601|NCT04286048|Pitchers|pitchers
5961602|NCT04286048|Weight implements|weight implements
5961603|NCT04286048|Speed of pitches|speed of pitches
5961604|NCT04286048|Range of motion|range of motion
5961605|NCT04286035|femoral nerve block, adductor canal block, total knee arthroplasty|femoral nerve block, adductor canal block, total knee arthroplasty
5961606|NCT04286022|Strength training|strength training
5961607|NCT04286022|Neuromuscular adaptation|neuromuscular adaptation
5961608|NCT04285996|Breast Cancer|breast cancer
5897829|NCT02789878|Neoadjuvant therapy|neoadjuvant therapy
5897830|NCT02789878|High-risk Prostate Cancer|high-risk prostate cancer
5897831|NCT02788656|heart failure|heart failure
5897832|NCT02788656|neprilysin|neprilysin
5897833|NCT02788656|implantable hemodynamic monitor|implantable hemodynamic monitor
5897834|NCT02788656|angiotensin-receptor blocker|angiotensin-receptor blocker
5897835|NCT02788656|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5897885|NCT02782663|Crohn's Disease|crohn's disease
5897886|NCT02782663|Efficacy|efficacy
5897887|NCT02782663|Safety|safety
5897888|NCT02782663|Tolerability|tolerability
5897889|NCT02782663|ABT-494|abt-494
5897890|NCT02781610|Cystic fibrosis|cystic fibrosis
5897891|NCT02781610|Pulmonary exacerbation|pulmonary exacerbation
5897892|NCT02781610|Antibiotic|antibiotic
5897893|NCT02781610|Treatment duration|treatment duration
5897894|NCT02781610|Lung infection|lung infection
5897895|NCT02781610|Cystic Fibrosis Foundation|cystic fibrosis foundation
5897896|NCT02781610|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
5897913|NCT02775435|PD1|pd1
5897914|NCT02775435|PD-1|pd-1
5897915|NCT02775435|PDL1|pdl1
5897916|NCT02775435|PD-L1|pd-l1
5897917|NCT02772055|Moxa smoke|moxa smoke
5897918|NCT02772055|Moxibustion|moxibustion
5897919|NCT02772055|Knee osteoarthritis|knee osteoarthritis
5084741|NCT03469154|education|education
5084742|NCT03469141|Wheelchair|wheelchair
5084743|NCT03469141|Pressure Relief|pressure relief
5084744|NCT03469141|Activity|activity
5084745|NCT03469141|Monitor|monitor
5084746|NCT03469128|PTSD|ptsd
5084747|NCT03469128|CPT|cpt
5084748|NCT03469128|SUD|sud
5084749|NCT03469102|Positron emission tomography|positron emission tomography
5084750|NCT03469102|Texture indices|texture indices
5084751|NCT03469102|Diagnostic performance|diagnostic performance
5084752|NCT03469089|schizophrenia|schizophrenia
5084753|NCT03469089|cognitive symptom|cognitive symptom
5084754|NCT03469089|healthy volunteer|healthy volunteer
5084755|NCT03469089|cognitive testing|cognitive testing
5084756|NCT03469076|Acne, Comedonal, Mild to Moderate Papulopustular Acne|acne, comedonal, mild to moderate papulopustular acne
5084757|NCT03469050|Recurrent acute diverticulitis|recurrent acute diverticulitis
5084758|NCT03469050|Prevention|prevention
5084759|NCT03469050|Diverticular complications|diverticular complications
5084760|NCT03469050|Rifaximin delayed release|rifaximin delayed release
5084761|NCT03469050|Diverticulitis|diverticulitis
5084762|NCT03469050|SIBO|sibo
5084763|NCT03469037|Dyspnea, High flow nasal cannula|dyspnea, high flow nasal cannula
5084764|NCT03469024|Low back pain|low back pain
5084765|NCT03469024|Electroanalgesia|electroanalgesia
5084766|NCT03469024|Exercise program|exercise program
5084767|NCT03469024|Randomized clinical trial|randomized clinical trial
5084768|NCT03468998|Bone allograft|bone allograft
5084769|NCT03468998|Particle size|particle size
5084770|NCT03468998|Ridge preservation|ridge preservation
5084771|NCT03468998|Ridge augmentation|ridge augmentation
5084772|NCT03468998|Socket grafting|socket grafting
5084773|NCT03468998|Histology|histology
5084774|NCT03468998|New bone|new bone
5084775|NCT03468972|IgA nephropathy|iga nephropathy
5084776|NCT03468972|immunosuppression|immunosuppression
5084777|NCT03468946|taste perception|taste perception
5084778|NCT03468946|caries risk|caries risk
5084779|NCT03468946|cariogram|cariogram
5084780|NCT03468946|children|children
5084781|NCT03468907|hepatitis B virus|hepatitis b virus
5084782|NCT03468907|exacerbation|exacerbation
5084783|NCT03468907|antiviral agents|antiviral agents
5084784|NCT03468907|pregnancy|pregnancy
5084786|NCT03468894|prolonged sitting|prolonged sitting
5084787|NCT03468894|sedentary behaviour|sedentary behaviour
5084788|NCT03468894|physical activity|physical activity
5961609|NCT04285996|Pancreatic Cancer|pancreatic cancer
5961610|NCT04285996|Head &Neck Cancer|head &neck cancer
5961611|NCT04285970|detection rate of propulsion cycles|detection rate of propulsion cycles
5961612|NCT04285957|participation|participation
5961613|NCT04285957|Frenchay Activity Index|frenchay activity index
5961614|NCT04285957|Walking Handicap Classification|walking handicap classification
5961615|NCT04285957|Stroke Rehabilitation|stroke rehabilitation
5961616|NCT04285905|Tuberculosis|tuberculosis
5961617|NCT04285879|physical therapy|physical therapy
5961618|NCT04285879|rehabilitation|rehabilitation
5961619|NCT04285866|Locally advanced small cell lung cancer|locally advanced small cell lung cancer
5961620|NCT04285866|SCLC|sclc
5961621|NCT04285866|lung cancer|lung cancer
5961622|NCT04285866|durvalumab after chemotherapy|durvalumab after chemotherapy
5961623|NCT04285866|real world data|real world data
5961624|NCT04285853|Opioids|opioids
5961625|NCT04285814|noninvasive prenatal testing|noninvasive prenatal testing
5961626|NCT04285814|microarray|microarray
5961627|NCT04285814|fetal cells|fetal cells
5961628|NCT04285814|prenatal diagnosis|prenatal diagnosis
5961629|NCT04285775|Dialysis|dialysis
5961630|NCT04285775|Catheter|catheter
5961631|NCT04285775|Access|access
5961632|NCT04285775|Bleeding|bleeding
5961633|NCT04285775|Haemorrhage|haemorrhage
5961634|NCT04285775|Mortality|mortality
5961635|NCT04285775|Monitoring|monitoring
5961636|NCT04285775|Detection|detection
5961637|NCT04285723|alpelisib|alpelisib
5961638|NCT04285723|PIK3CA|pik3ca
5961639|NCT04285723|BYL719|byl719
5961640|NCT04285723|PROS|pros
5961641|NCT04285723|Retrospective chart review study|retrospective chart review study
5961642|NCT04285723|EPIK-P1|epik-p1
5897935|NCT02769572|Knee osteoarthritis|knee osteoarthritis
5897936|NCT02769572|moxibustion|moxibustion
5897937|NCT02769572|diclofenac sodium gel|diclofenac sodium gel
5897956|NCT02764762|Drug Therapy|drug therapy
5897973|NCT02757664|achilles|achilles
5897974|NCT02757664|tendinopathy|tendinopathy
5897975|NCT02757664|Physical Therapy Modalities|physical therapy modalities
5897976|NCT02757664|High-Energy Shock Waves|high-energy shock waves
5897999|NCT02746081|BAY1436032|bay1436032
5898000|NCT02746081|Solid tumors|solid tumors
5898001|NCT02746081|IDH1|idh1
5898002|NCT02746081|Cancer|cancer
5898003|NCT02746081|Safety|safety
5898004|NCT02746081|Tolerability|tolerability
5898005|NCT02746081|Pharmacokinetics|pharmacokinetics
5898006|NCT02746081|Pharmacodynamics|pharmacodynamics
5898007|NCT02746081|Efficacy|efficacy
5898008|NCT02746081|Food-effect|food-effect
5084789|NCT03468894|office workplace|office workplace
5084790|NCT03468868|Multiple sclerosis|multiple sclerosis
5084791|NCT03468868|Exercise|exercise
5084792|NCT03468868|Physical activity|physical activity
5084793|NCT03468868|Telerehabilitation|telerehabilitation
5084794|NCT03468868|Comparative effectiveness study|comparative effectiveness study
5084795|NCT03468868|Social cognitive theory|social cognitive theory
5084796|NCT03468868|Health behavior change|health behavior change
5084797|NCT03468842|Streptococcus dentisani|streptococcus dentisani
5084799|NCT03468842|salivary pH|salivary ph
5084800|NCT03468842|S. mutans|s. mutans
5084801|NCT03468764|anesthesia|anesthesia
5084802|NCT03468764|hemodynamic management|hemodynamic management
5084803|NCT03468764|lung recruitment maneuver|lung recruitment maneuver
5084804|NCT03468764|hypovolemia|hypovolemia
5862706|NCT00001543|Pharmacokinetics|pharmacokinetics
5084805|NCT03468751|Metastatic; Refractory; Cancer; Solid; Tumor|metastatic; refractory; cancer; solid; tumor
5084806|NCT03468725|Transcranial magnetic stimulation|transcranial magnetic stimulation
5084808|NCT03468712|morbidity|morbidity
5084809|NCT03468712|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5084810|NCT03468712|laparoscopic gastrectomy|laparoscopic gastrectomy
5084811|NCT03468712|gastric cancer|gastric cancer
5084812|NCT03468699|Autologous bone marrow Transplantation|autologous bone marrow transplantation
5084813|NCT03468699|biliary atresia|biliary atresia
5084814|NCT03468699|Kasai's operation|kasai's operation
5084830|NCT03468621|surgical|surgical
5084831|NCT03468621|site|site
5084832|NCT03468621|infection|infection
5084833|NCT03468621|intrademal|intrademal
5084834|NCT03468621|transdermal|transdermal
5084835|NCT03468621|suture|suture
5084836|NCT03468608|procedural sedation|procedural sedation
5084837|NCT03468608|paediatric|paediatric
5084838|NCT03468608|parental satisfaction|parental satisfaction
5084839|NCT03468595|Listerine, CHX|listerine, chx
5084840|NCT03468569|Athletic Performance|athletic performance
5084841|NCT03468569|Functional Movement Screen|functional movement screen
5084842|NCT03468569|Handball Athletes|handball athletes
5084843|NCT03468569|Injury Prevention|injury prevention
5084844|NCT03468569|Injury History|injury history
5084845|NCT03468517|General Anaesthesia|general anaesthesia
5084846|NCT03468517|Preoperative Anxiety|preoperative anxiety
5084847|NCT03468517|BATHE method|bathe method
5084848|NCT03468465|Hyperactive Bladder Syndrome|hyperactive bladder syndrome
5084849|NCT03468439|nerve block|nerve block
5084850|NCT03468413|CP1050|cp1050
5084851|NCT03468413|Phase 1|phase 1
5084852|NCT03468413|Healthy subjects|healthy subjects
5084853|NCT03468400|sleep disorders|sleep disorders
5084854|NCT03468400|assessment|assessment
5084855|NCT03468400|diagnosis|diagnosis
5084856|NCT03468348|duloxetine|duloxetine
5084857|NCT03468348|mastectomy|mastectomy
5084858|NCT03468348|postoperative pain|postoperative pain
5084859|NCT03468335|Second-line therapy|second-line therapy
5084860|NCT03468335|Nal-IRI|nal-iri
5084861|NCT03468335|failure gemcitabine/nab-paclitaxel|failure gemcitabine/nab-paclitaxel
5084862|NCT03468335|predictive role of 1st-line therapy|predictive role of 1st-line therapy
5084863|NCT03468309|polypharmacy|polypharmacy
5084864|NCT03468309|drug interactions|drug interactions
5084865|NCT03468309|DNA testing|dna testing
5084866|NCT03468309|mental health diagnosis|mental health diagnosis
5961643|NCT04285710|Phototherapy|phototherapy
5961644|NCT04285710|Blue Light Phototherapy|blue light phototherapy
5961645|NCT04285710|Light Therapy|light therapy
5961646|NCT04285697|Care Bundles,|care bundles,
5961647|NCT04285697|Surgical Wound Infection,|surgical wound infection,
5961648|NCT04285697|craniyal surgery|craniyal surgery
5961649|NCT04285697|nursing care|nursing care
5961650|NCT04285684|ketamine, lactation, postpartum depression, breast feeding, infant exposure|ketamine, lactation, postpartum depression, breast feeding, infant exposure
5961651|NCT04285658|kidney|kidney
5961652|NCT04285658|kidney stone|kidney stone
5961653|NCT04285658|nephrolithiasis|nephrolithiasis
5961654|NCT04285658|Comparative Effectiveness|comparative effectiveness
5961655|NCT04285658|Patient Reported Outcomes|patient reported outcomes
5961656|NCT04285645|Rugby|rugby
5961657|NCT04285645|Injury|injury
5961658|NCT04285645|Knee|knee
5961659|NCT04285645|Stability|stability
5961660|NCT04285645|Strength Training|strength training
5961661|NCT04285632|Basketball|basketball
5084867|NCT03468309|drug side effects|drug side effects
5961662|NCT04285632|Plyometric Exercise|plyometric exercise
5961663|NCT04285632|Range of motion|range of motion
5961664|NCT04285632|Randomized clinical trial|randomized clinical trial
5961665|NCT04285632|Strength Training|strength training
5898040|NCT02732834|Clinician-Patient Communication|clinician-patient communication
5898041|NCT02732834|16-001|16-001
4968087|NCT04189445|Solid tumor|solid tumor
5898094|NCT02711137|Solid tumor|solid tumor
5898095|NCT02711137|lymphoma|lymphoma
5898096|NCT02711137|leukemia|leukemia
5898098|NCT02711137|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5898099|NCT02711137|multiple myeloma|multiple myeloma
5898100|NCT02711137|myeloproliferative neoplasm (MPN)|myeloproliferative neoplasm (mpn)
5898101|NCT02711137|MDS/MPN|mds/mpn
5898102|NCT02711137|myelofibrosis (MF)|myelofibrosis (mf)
5898103|NCT02711137|pancreatic cancer|pancreatic cancer
5898104|NCT02711137|colorectal cancer|colorectal cancer
5898105|NCT02711137|non-small cell lung cancer|non-small cell lung cancer
5898106|NCT02711137|prostate cancer|prostate cancer
5898107|NCT02711137|breast cancer|breast cancer
5898108|NCT02711137|ovarian cancer|ovarian cancer
5898109|NCT02711137|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5898110|NCT02711137|NUT midline carcinoma|nut midline carcinoma
5898111|NCT02711137|non-Hodgkin lymphoma|non-hodgkin lymphoma
5898112|NCT02711137|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5898113|NCT02711137|double-hit|double-hit
5898114|NCT02711137|triple-hit|triple-hit
5898115|NCT02711137|myc|myc
5898116|NCT02711137|bromodomain and extra-terminal (BET) inhibitor|bromodomain and extra-terminal (bet) inhibitor
5084868|NCT03468309|presciption treatment plans|presciption treatment plans
5084869|NCT03468309|mental health medication treatment plans|mental health medication treatment plans
5084870|NCT03468296|age-related macular degeneration|age-related macular degeneration
5084871|NCT03468283|Mobile healthcare|mobile healthcare
4968722|NCT04185012|Biomarkers|biomarkers
5084872|NCT03468283|Health Services Research|health services research
5084873|NCT03468283|Community Health Services|community health services
5084874|NCT03468283|Diabetes self-management education|diabetes self-management education
5084875|NCT03468231|Hepatocellular Carcinoma|hepatocellular carcinoma
5084876|NCT03468231|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5084877|NCT03468231|Sorafenib|sorafenib
5084878|NCT03468231|Oxaliplatin plus Fluorouracil/Leucovorin|oxaliplatin plus fluorouracil/leucovorin
5084879|NCT03468231|Oxaliplatin|oxaliplatin
5084880|NCT03468205|breathlessness|breathlessness
5084881|NCT03468205|dyspnea|dyspnea
5084882|NCT03468205|measurement|measurement
5084883|NCT03468179|Diet|diet
5084884|NCT03468179|N-acyl-phosphatidylethanolamine|n-acyl-phosphatidylethanolamine
5084885|NCT03468179|N-acyl-ethanolamine|n-acyl-ethanolamine
5084886|NCT03468179|NAPE|nape
5084887|NCT03468179|NAE|nae
5084888|NCT03468179|Oatmeal|oatmeal
5084889|NCT03468166|Motor function|motor function
5084890|NCT03468166|Gait pattern|gait pattern
5084891|NCT03468127|Soy protein|soy protein
5084892|NCT03468127|LDL-Cholesterol|ldl-cholesterol
5084893|NCT03468127|Total Cholesterol|total cholesterol
5084894|NCT03468127|Cardiovascular disease|cardiovascular disease
5084895|NCT03468101|COPD|copd
5084896|NCT03468101|Dairy farmers|dairy farmers
5084897|NCT03468101|Exposure Occupational|exposure occupational
5084899|NCT03468075|Sarcoma|sarcoma
5084900|NCT03468075|Soft tissue|soft tissue
5084901|NCT03468075|Ascorbate|ascorbate
5084914|NCT03467971|Pharmacokinetics|pharmacokinetics
5084924|NCT03467945|Gliclazide|gliclazide
5084925|NCT03467945|Bioequivalence|bioequivalence
5084926|NCT03467945|Drug-drug Interaction|drug-drug interaction
5084927|NCT03467945|Pharmacokinetics|pharmacokinetics
5084928|NCT03467919|osteoarthritis|osteoarthritis
5084929|NCT03467919|stem cell|stem cell
5084930|NCT03467919|knee pain|knee pain
5084931|NCT03467919|adipose derived stem cell|adipose derived stem cell
5084932|NCT03467919|injection|injection
5084933|NCT03467906|Diet|diet
5084934|NCT03467906|Dietary Habits|dietary habits
5084935|NCT03467906|Weight changes|weight changes
5961666|NCT04285619|Amateur runners|amateur runners
5961667|NCT04285619|Ankle dorsiflexion|ankle dorsiflexion
5961668|NCT04285619|Flossing|flossing
5961669|NCT04285619|Expectancy|expectancy
5961670|NCT04285619|Randomized clinical trial|randomized clinical trial
5961671|NCT04285606|Reverse shoulder arthroplasty|reverse shoulder arthroplasty
5961672|NCT04285606|Rehabilitation|rehabilitation
5961673|NCT04285606|Shoulder arthritis|shoulder arthritis
5961674|NCT04285606|Rotator cuff tear arthropathy|rotator cuff tear arthropathy
5961675|NCT04285593|Football|football
5961676|NCT04285593|Knee|knee
5961677|NCT04285593|Bulgarian squat|bulgarian squat
5961678|NCT04285593|Vertical jump|vertical jump
5961679|NCT04285593|Functional movement screen|functional movement screen
5961680|NCT04285593|Hamstring|hamstring
5961681|NCT04285554|Metabolic Syndrome|metabolic syndrome
5961682|NCT04285554|NAFLD|nafld
5961683|NCT04285554|Hypertension|hypertension
5961684|NCT04285554|High Blood Pressure|high blood pressure
5961685|NCT04285554|Glycemic Control|glycemic control
5961686|NCT04285554|Diabetes|diabetes
5961687|NCT04285554|Denervation|denervation
5961688|NCT04285554|Sympathetic Nervous System|sympathetic nervous system
5961689|NCT04285528|General anesthesia|general anesthesia
5961690|NCT04285528|Sedation|sedation
5961691|NCT04285528|Propofol|propofol
5961692|NCT04285528|Fentanyl|fentanyl
5961693|NCT04285528|Ketamine|ketamine
5961694|NCT04285528|Hypotension|hypotension
5961695|NCT04285502|surgical drain|surgical drain
5961696|NCT04285502|visual analog scale|visual analog scale
5961697|NCT04285502|hematocrit|hematocrit
5961698|NCT04285437|infant massage|infant massage
5961699|NCT04285398|RHO|rho
5898152|NCT02705846|BRCA2|brca2
5898153|NCT02705846|Lynch Syndrome|lynch syndrome
5898157|NCT02703571|Trametinib|trametinib
5898158|NCT02703571|Ribociclib|ribociclib
5898163|NCT02703571|KRAS-mutant colorectal cancer|kras-mutant colorectal cancer
5898164|NCT02703571|colorectal cancer|colorectal cancer
5898165|NCT02703571|advanced pancreatic cancer|advanced pancreatic cancer
5898166|NCT02703571|metastatic pancreatic cancer|metastatic pancreatic cancer
5898168|NCT02702401|PD-1|pd-1
5898169|NCT02702401|PDL1|pdl1
5898170|NCT02702401|PD-L1|pd-l1
5898192|NCT02693847|HCV|hcv
5898193|NCT02693847|HIV|hiv
5898194|NCT02693847|Liver cirrhosis|liver cirrhosis
5898195|NCT02693847|Hepatocellular carcinoma|hepatocellular carcinoma
5898196|NCT02693847|Liver transplant|liver transplant
5898197|NCT02693847|Liver stiffness|liver stiffness
5898198|NCT02693847|Transient elastography|transient elastography
5898215|NCT02688010|noise|noise
5898216|NCT02688010|sound|sound
5898217|NCT02688010|cycled light|cycled light
5898218|NCT02688010|preterm infants|preterm infants
5898219|NCT02688010|neonatal care|neonatal care
5898220|NCT02688010|growth|growth
5898221|NCT02688010|visual development|visual development
5084936|NCT03467880|Impulse Oscillometry|impulse oscillometry
5084937|NCT03467880|Chinese|chinese
5084938|NCT03467880|Healthy Subjects|healthy subjects
5084939|NCT03467880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5084941|NCT03467880|Interstitial Lung Disease|interstitial lung disease
5084942|NCT03467880|Upper Airway Obstruction|upper airway obstruction
5084943|NCT03467880|Reference Values|reference values
5084944|NCT03467867|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5084945|NCT03467867|Leukemia|leukemia
5084946|NCT03467867|Venetoclax|venetoclax
5084947|NCT03467867|Rituximab|rituximab
5084948|NCT03467867|Lymphoid|lymphoid
5084949|NCT03467867|Lymphoproliferative Disorders|lymphoproliferative disorders
5084950|NCT03467867|Antineoplastic Agents|antineoplastic agents
5084951|NCT03467867|Neoplasm|neoplasm
5084952|NCT03467854|ECMO|ecmo
5084953|NCT03467854|Antimicrobials|antimicrobials
5084954|NCT03467815|Wireless monitoring|wireless monitoring
5084955|NCT03467815|Continuous monitoring|continuous monitoring
5084956|NCT03467815|Vital parameters|vital parameters
5084957|NCT03467815|Clinical deterioration|clinical deterioration
5084958|NCT03467802|Gingival Recession|gingival recession
5084959|NCT03467802|Enamel Matrix Derivative|enamel matrix derivative
5084960|NCT03467802|Porcine Collagen Matrix|porcine collagen matrix
5084961|NCT03467789|Vitamin D|vitamin d
5084962|NCT03467789|Photodynamic Therapy|photodynamic therapy
5084963|NCT03467776|infants|infants
5084964|NCT03467776|asthma|asthma
5084965|NCT03467776|bronchial dilation test|bronchial dilation test
5084966|NCT03467776|plethysmography|plethysmography
5084976|NCT03467698|transcranial direct current stimulation|transcranial direct current stimulation
5084978|NCT03467568|Mood Salt|mood salt
5084979|NCT03467542|Fistula|fistula
5084980|NCT03467542|Intracranial|intracranial
5084981|NCT03467542|Dural|dural
5084982|NCT03467542|Arteriovenous|arteriovenous
5084983|NCT03467542|Liquid Embolic|liquid embolic
5084984|NCT03467529|Superficial esophageal cancer|superficial esophageal cancer
5084985|NCT03467529|Squamous cell cancer|squamous cell cancer
5084986|NCT03467529|Mini invasive imaging|mini invasive imaging
5084987|NCT03467529|Pre therapeutic assessment|pre therapeutic assessment
5084988|NCT03467529|Optical coherence tomography|optical coherence tomography
5084992|NCT03467464|Autism, EMDR; Children|autism, emdr; children
5084993|NCT03467438|heartburn|heartburn
5084994|NCT03467438|pyrosis|pyrosis
5084995|NCT03467438|regurgitation|regurgitation
5084996|NCT03467425|FF/VI/UMEC|ff/vi/umec
5084997|NCT03467425|TRELEGY ELLIPTA|trelegy ellipta
5084998|NCT03467425|COPD|copd
5084999|NCT03467425|Effectiveness|effectiveness
5961700|NCT04285398|PDE6A|pde6a
5961701|NCT04285398|PDE6B|pde6b
5961702|NCT04285398|Pathogenic Mutation|pathogenic mutation
5961703|NCT04285398|Prospective|prospective
5961704|NCT04285398|Natural History|natural history
5961705|NCT04285398|Retinal Disease|retinal disease
5961706|NCT04285398|Eye Disease|eye disease
5961707|NCT04285398|Blindness|blindness
5961708|NCT04285398|Inherited Eye Disease|inherited eye disease
5961709|NCT04285398|Vision Disorder|vision disorder
5961710|NCT04285398|Inherited Retinal Disorder|inherited retinal disorder
5961711|NCT04285398|Rod-Cone Dystrophy|rod-cone dystrophy
5961712|NCT04285385|aromatherapy|aromatherapy
5961713|NCT04285385|lavender|lavender
5961714|NCT04285385|anxiety|anxiety
5961715|NCT04285372|Coronary disease|coronary disease
5961716|NCT04285372|Bifurcation lesion|bifurcation lesion
5961717|NCT04285333|hip fracture|hip fracture
5961718|NCT04285333|nerve block|nerve block
5961719|NCT04285333|spinal anesthesia|spinal anesthesia
5961720|NCT04285333|analgesia|analgesia
5961721|NCT04285320|Antibiotic bladder instillation|antibiotic bladder instillation
5961722|NCT04285320|Intravesical antibiotic instillation|intravesical antibiotic instillation
5961723|NCT04285320|Oral suppressive therapy|oral suppressive therapy
5961724|NCT04285320|Recurrent UTI|recurrent uti
5961725|NCT04285307|Actigraphy|actigraphy
5961726|NCT04285307|Sleep Extension|sleep extension
5961727|NCT04285281|Gabapentin|gabapentin
5961728|NCT04285281|Pain management|pain management
5961729|NCT04285281|Physiotherapy|physiotherapy
5961730|NCT04285242|Cancer|cancer
5694990|NCT00518648|Prevention|prevention
5898278|NCT02668770|Advanced Cancers|advanced cancers
5898279|NCT02668770|Melanoma|melanoma
5898280|NCT02668770|Advanced solid malignancies|advanced solid malignancies
5898281|NCT02668770|Metastatic|metastatic
5898282|NCT02668770|MGN1703|mgn1703
5898283|NCT02668770|Ipilimumab|ipilimumab
5898284|NCT02668770|Yervoy|yervoy
5898285|NCT02668770|BMS-734016|bms-734016
5898286|NCT02668770|MDX010|mdx010
5898287|NCT02668770|Refractory|refractory
5898288|NCT02668770|Relapsed|relapsed
5898318|NCT02651883|Cervical cancer screening|cervical cancer screening
5898319|NCT02651883|HPV testing|hpv testing
5898320|NCT02651883|Self-collection|self-collection
4968381|NCT04187209|Stroke|stroke
5898351|NCT02643797|diabetes|diabetes
5898352|NCT02643797|medical assistant|medical assistant
5898353|NCT02643797|health coach|health coach
5085000|NCT03467347|Healthy Women|healthy women
5085001|NCT03467347|Contraception|contraception
5085002|NCT03467347|Vaginal Ring|vaginal ring
5085003|NCT03467347|dapivirine|dapivirine
5085004|NCT03467347|Levonorgestrel|levonorgestrel
5085005|NCT03467334|Infant colic|infant colic
5085006|NCT03467334|Bifidobacterium breve|bifidobacterium breve
5085007|NCT03467334|Lactobacillus fermentum|lactobacillus fermentum
5085008|NCT03467308|colorectal cancer|colorectal cancer
5085009|NCT03467308|TIGAR|tigar
5085010|NCT03467308|TRIM59|trim59
5085011|NCT03467295|Cavernous Malformations, treatment.|cavernous malformations, treatment.
5085012|NCT03467243|schizophrenia|schizophrenia
5085013|NCT03467243|Veterans|veterans
5085014|NCT03467243|depression|depression
5085015|NCT03467243|peer specialist|peer specialist
5085016|NCT03467243|social skills training|social skills training
5085017|NCT03467217|Losartan|losartan
5085018|NCT03467217|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5085019|NCT03467165|MRgFUS|mrgfus
5085020|NCT03467165|Pain|pain
5085022|NCT03467165|Trapeziometacarpal joint|trapeziometacarpal joint
5085023|NCT03467165|Osteoarthritis|osteoarthritis
5085029|NCT03467139|Adhesive Capsulitis|adhesive capsulitis
5085030|NCT03467139|Breathing exercises|breathing exercises
5085031|NCT03467139|Pain|pain
5085032|NCT03467139|Sleep quality|sleep quality
5085033|NCT03467139|Quality of life|quality of life
5085034|NCT03467113|Dravet Syndrome|dravet syndrome
5085035|NCT03467113|LGS|lgs
5085036|NCT03467087|Stem cell transplantation|stem cell transplantation
5085037|NCT03467087|Chemotherapy|chemotherapy
5085038|NCT03467087|Rehabilitation|rehabilitation
5085039|NCT03467087|Electrical muscle stimulation|electrical muscle stimulation
5085040|NCT03467022|alcohol withdrawal|alcohol withdrawal
5085041|NCT03467022|scurvy|scurvy
5085042|NCT03467022|vitamin C|vitamin c
5085043|NCT03467022|tiredness|tiredness
5085044|NCT03467009|cyber-victimization|cyber-victimization
5085045|NCT03467009|text message|text message
5085046|NCT03467009|mhealth|mhealth
5085047|NCT03466996|Transition to adult care|transition to adult care
5085048|NCT03466996|Telemedicine|telemedicine
5085049|NCT03466996|Myelomeningocele|myelomeningocele
5085050|NCT03466957|image guided brachytherapy|image guided brachytherapy
5085051|NCT03466957|3D print|3d print
5143640|NCT03093987|Shock|shock
5085052|NCT03466957|gynecological cancer|gynecological cancer
5085053|NCT03466944|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5085054|NCT03466944|Leukaemia|leukaemia
5085055|NCT03466944|Whole-Body DiffusionWeighted-Magnetic Resonance Imaging (WB DW-MRI)|whole-body diffusionweighted-magnetic resonance imaging (wb dw-mri)
5085056|NCT03466944|Paediatrics|paediatrics
5085057|NCT03466918|TAVI|tavi
5085058|NCT03466918|TAVR|tavr
5085059|NCT03466918|CHINA|china
5085060|NCT03466918|SAPIEN 3|sapien 3
5085061|NCT03466918|High Risk|high risk
5085062|NCT03466918|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5085063|NCT03466918|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5085064|NCT03466892|Repetitive Negative Thinking|repetitive negative thinking
5085065|NCT03466892|Rumination|rumination
5085066|NCT03466892|Fibromyalgia|fibromyalgia
5085069|NCT03466840|Ridge Augmentation|ridge augmentation
5085070|NCT03466840|Titanium mesh|titanium mesh
5085071|NCT03466840|Flap advancement|flap advancement
5961731|NCT04285242|Non-haematological|non-haematological
5961732|NCT04285229|Ankylosing spondylitis|ankylosing spondylitis
5961733|NCT04285216|Dry needling|dry needling
5961734|NCT04285216|Myofacial tigger points|myofacial tigger points
5961735|NCT04285216|Upper Trapezius|upper trapezius
5961736|NCT04285216|Strain counter strain|strain counter strain
5961737|NCT04285190|COVID-19|covid-19
5961738|NCT04285164|falls|falls
5961739|NCT04285164|Frail Elders|frail elders
5961740|NCT04285164|balance|balance
5961741|NCT04285138|Phantom|phantom
5961742|NCT04285138|Amputation|amputation
5961743|NCT04285138|Prosthesis|prosthesis
5961744|NCT04285112|Pediatric pain|pediatric pain
5961745|NCT04285112|pain|pain
5961746|NCT04285099|Parkinson Disease, Freezing of Gait, Deep Brain Stimulation|parkinson disease, freezing of gait, deep brain stimulation
5961747|NCT04285086|Essential Thrombocythemia|essential thrombocythemia
5961748|NCT04285086|Ropeginterferon|ropeginterferon
5961749|NCT04285086|P1101|p1101
5961750|NCT04285086|PharmaEssentia|pharmaessentia
5961751|NCT04285073|hemodialysis|hemodialysis
5961752|NCT04285073|vascular access|vascular access
5961753|NCT04285073|arteriovenous graft|arteriovenous graft
5898354|NCT02643797|glycemic control|glycemic control
5898355|NCT02643797|pragmatic trial|pragmatic trial
5898450|NCT02625441|Breast cancer|breast cancer
5898451|NCT02625441|docetaxel|docetaxel
5898452|NCT02625441|pertuzumab|pertuzumab
5898453|NCT02625441|trastuzumab|trastuzumab
5898454|NCT02625441|HER2|her2
5085072|NCT03466801|prednisone alone|prednisone alone
5085073|NCT03466801|methylprednisolone and cyclophosphamide|methylprednisolone and cyclophosphamide
5085074|NCT03466801|membranous nephropathy in stage I|membranous nephropathy in stage i
5085075|NCT03466775|Kidney transplantation|kidney transplantation
5085076|NCT03466775|Allograft rejection|allograft rejection
5085077|NCT03466775|Allograft survival|allograft survival
5085078|NCT03466775|Anti-angiotensin II type 1 receptor antibody|anti-angiotensin ii type 1 receptor antibody
5085079|NCT03466762|Quality of life|quality of life
5085080|NCT03466762|Resilience|resilience
5085081|NCT03466762|Cancer Survivors|cancer survivors
5085082|NCT03466762|Life Satisfaction|life satisfaction
5085083|NCT03466762|Post-Cancer Depression|post-cancer depression
5085084|NCT03466762|Coping|coping
5085085|NCT03466749|Coronary Disease|coronary disease
5085086|NCT03466749|Drug eluting balloon|drug eluting balloon
5085087|NCT03466749|De-novo lesions|de-novo lesions
5085088|NCT03466736|practice effects|practice effects
5085089|NCT03466736|amyloid imaging|amyloid imaging
5085090|NCT03466710|Colposcopy|colposcopy
5085091|NCT03466710|Uterine cervical neoplasm|uterine cervical neoplasm
5085092|NCT03466710|HPV|hpv
5085093|NCT03466710|Pap|pap
5085094|NCT03466684|Trauma|trauma
5085095|NCT03466684|Open abdomen|open abdomen
5085096|NCT03466684|Fluid resuscitation|fluid resuscitation
5085097|NCT03466684|Fascial closure|fascial closure
5085098|NCT03466684|Bioelectrical impedance analysis|bioelectrical impedance analysis
5085099|NCT03466645|SSI|ssi
5085100|NCT03466645|elective Craniotomy|elective craniotomy
5085101|NCT03466645|Vancomycin|vancomycin
5085102|NCT03466645|Cefazolin|cefazolin
5085103|NCT03466645|Antibiotic|antibiotic
5085104|NCT03466593|Prehabilitation|prehabilitation
5085105|NCT03466593|Recovery|recovery
5085106|NCT03466593|Complications|complications
5085107|NCT03466580|Caregivers|caregivers
5085108|NCT03466580|Support needs|support needs
5085109|NCT03466580|Intervention|intervention
5085110|NCT03466580|Randomised controlled trial|randomised controlled trial
5085111|NCT03466541|Alcohol consumption|alcohol consumption
5085112|NCT03466541|Sick leave|sick leave
5085113|NCT03466541|Workplace interventions|workplace interventions
5085114|NCT03466541|Presenteeism|presenteeism
5085115|NCT03466515|stem cells therapy|stem cells therapy
5085116|NCT03466502|vancomycin|vancomycin
5085117|NCT03466502|Clostridium difficile|clostridium difficile
5085118|NCT03466502|Clostridium difficile infection|clostridium difficile infection
5085125|NCT03466450|glioblastoma|glioblastoma
5085127|NCT03466450|temozolomide|temozolomide
5085128|NCT03466450|combined therapy|combined therapy
5085129|NCT03466424|Short-course radiotherapy|short-course radiotherapy
5085130|NCT03466424|dose escalation|dose escalation
5085131|NCT03466424|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5085132|NCT03466424|mFOLFOX6|mfolfox6
5085133|NCT03466424|rectal cancer|rectal cancer
5085134|NCT03466424|Phase I trial|phase i trial
5085135|NCT03466398|Remote Patient Monitoring|remote patient monitoring
5085136|NCT03466398|Adolescents|adolescents
5085139|NCT03466372|gait biofeedback|gait biofeedback
5085140|NCT03466372|gait rehabilitation|gait rehabilitation
5085141|NCT03466372|paretic propulsion|paretic propulsion
5085142|NCT03466372|gait motor learning|gait motor learning
5085143|NCT03466359|appetite control|appetite control
5085144|NCT03466359|obesity|obesity
5085145|NCT03466359|Adolescents|adolescents
5085146|NCT03466359|Physical activity|physical activity
5085147|NCT03466333|preterm pre-eclampsia|preterm pre-eclampsia
5085148|NCT03466333|cardiovascular dysfunction|cardiovascular dysfunction
5085149|NCT03466307|Nocturnal pain|nocturnal pain
5085150|NCT03466307|shoulder pain|shoulder pain
5085151|NCT03466307|ultrasonography|ultrasonography
5085152|NCT03466307|resistive index|resistive index
5085153|NCT03466307|quality of life|quality of life
5085154|NCT03466307|anterior circumflex humeral artery|anterior circumflex humeral artery
5085155|NCT03466294|Azacitidine|azacitidine
5085156|NCT03466294|Venetoclax|venetoclax
5085158|NCT03466268|Safety|safety
5085159|NCT03466268|Tolerability|tolerability
5085160|NCT03466268|Pharmacokinetics|pharmacokinetics
5085161|NCT03466268|Anti-tumor activity|anti-tumor activity
5085162|NCT03466242|intranasal dexmedetomidine|intranasal dexmedetomidine
5085163|NCT03466229|sperm DNA strand breaks|sperm dna strand breaks
5085164|NCT03466229|antioxidants|antioxidants
4969191|NCT04182282|Improved Care|improved care
5961754|NCT04285073|paclitaxel-eluting graft|paclitaxel-eluting graft
5961755|NCT04285060|Stroke|stroke
5961756|NCT04285060|Exoskeleton|exoskeleton
5961757|NCT04285047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5961758|NCT04285047|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5961759|NCT04285047|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5961760|NCT04285047|Registry|registry
5961761|NCT04285047|Electronic Health Record|electronic health record
5085165|NCT03466216|somatostatin receptor|somatostatin receptor
4970424|NCT04175496|Snack|snack
5672667|NCT00611286|bare metal stent|bare metal stent
5898533|NCT02598661|Myelodysplastic Syndromes|myelodysplastic syndromes
5898534|NCT02598661|Imetelstat|imetelstat
5898535|NCT02598661|GRN163L|grn163l
5898541|NCT02597075|Colorectal Cancer|colorectal cancer
5898542|NCT02597075|Metastatic Colorectal Cancer|metastatic colorectal cancer
5898543|NCT02597075|Physical Activity|physical activity
5898544|NCT02597075|Quality of life|quality of life
5085166|NCT03466203|obesity|obesity
5085167|NCT03466203|hypertriglyceridemia|hypertriglyceridemia
5862707|NCT00001543|Half-Life|half-life
5862708|NCT00001543|Bioavailability|bioavailability
5085168|NCT03466190|Mandibular body fractures, PEEK plates, titanium plates.|mandibular body fractures, peek plates, titanium plates.
5085170|NCT03466177|Dementia|dementia
5085171|NCT03466177|Mild cognitive impairment|mild cognitive impairment
5085172|NCT03466177|Optical coherence tomography|optical coherence tomography
5085173|NCT03466177|Hyperspectral imaging|hyperspectral imaging
5085174|NCT03466177|Multimodal retinal imaging|multimodal retinal imaging
5085175|NCT03466151|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
5085176|NCT03466151|Myocardial Infarction (MI)|myocardial infarction (mi)
5085177|NCT03466151|Late Lumen Loss (LLL)|late lumen loss (lll)
5085178|NCT03466151|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
5085179|NCT03466151|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
5085180|NCT03466151|Target Vessel Failure (TVF)|target vessel failure (tvf)
5085181|NCT03466151|Target Lesion Failure (TLF)|target lesion failure (tlf)
5085182|NCT03466151|Stent Thrombosis (ST)|stent thrombosis (st)
5085183|NCT03466151|The Randomized Controlled Trial|the randomized controlled trial
5085184|NCT03466151|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5085185|NCT03466112|exercise|exercise
5085186|NCT03466073|Recombinant human plasma gelsolin (rhu-pGSN)|recombinant human plasma gelsolin (rhu-pgsn)
5085187|NCT03466073|Severe community-acquired pneumonia (sCAP)|severe community-acquired pneumonia (scap)
5085188|NCT03466073|Adjunctive therapy|adjunctive therapy
5085189|NCT03466034|TP53|tp53
5085190|NCT03466034|Hypoxia|hypoxia
5085191|NCT03466034|Endometriod and Mucinous Carcinomas|endometriod and mucinous carcinomas
5085192|NCT03466034|Serous and Clear Cell Carcinomas|serous and clear cell carcinomas
5085193|NCT03466034|Magnetic Resonance Imaging, MRI|magnetic resonance imaging, mri
5085194|NCT03466021|GLP-1 receptor agonist|glp-1 receptor agonist
5085195|NCT03466021|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5085196|NCT03466021|FDG/PET-CT|fdg/pet-ct
5085197|NCT03466021|inflammation|inflammation
5085198|NCT03466021|weightloss|weightloss
5085199|NCT03466021|quality of life|quality of life
5085200|NCT03466008|whole body cryotherapy|whole body cryotherapy
5085201|NCT03466008|fibromyalgia|fibromyalgia
5085202|NCT03466008|chronic pain|chronic pain
5085203|NCT03466008|quality of life|quality of life
5085204|NCT03466008|perceived health|perceived health
5085205|NCT03465982|rectal cancer|rectal cancer
5085206|NCT03465982|robotic rectal cancer resection|robotic rectal cancer resection
5085207|NCT03465982|minimally invasive surgery|minimally invasive surgery
5085208|NCT03465982|Colorectal Cancer|colorectal cancer
5085209|NCT03465982|chemoradiation treatment rectal cancer|chemoradiation treatment rectal cancer
5085210|NCT03465969|Kidney transplantation|kidney transplantation
5085211|NCT03465969|A Bioanalytical Method Cross-validation|a bioanalytical method cross-validation
5085212|NCT03465969|Advagraf|advagraf
5085213|NCT03465969|Liver transplantation|liver transplantation
5085214|NCT03465930|Lymphedema|lymphedema
5085215|NCT03465930|Lymphatic collecting vessels|lymphatic collecting vessels
5085216|NCT03465930|Supermicrosurgery|supermicrosurgery
5085217|NCT03465930|Lymphatic-venous anastomoses|lymphatic-venous anastomoses
5085218|NCT03465930|Immunohistochemistry|immunohistochemistry
5085219|NCT03465891|Advanced Stage Follicular Lymphoma|advanced stage follicular lymphoma
5085220|NCT03465891|Relapsed|relapsed
5085221|NCT03465891|Refractory|refractory
5085222|NCT03465891|Atezolizumab|atezolizumab
5085223|NCT03465891|Dose Local Radiotherapy (2 x 2Gy)|dose local radiotherapy (2 x 2gy)
5085224|NCT03465891|17-360|17-360
5085225|NCT03465800|overweight|overweight
5085226|NCT03465800|obesity|obesity
5085227|NCT03465800|physical activity|physical activity
5085228|NCT03465800|exercise|exercise
5085229|NCT03465787|Schizophrenia|schizophrenia
5085230|NCT03465787|Acutely Psychotic Patients with Schizophrenia|acutely psychotic patients with schizophrenia
5085231|NCT03465787|Latuda|latuda
5085232|NCT03465787|Lurasidone|lurasidone
5085233|NCT03465761|MRgFUS|mrgfus
5085234|NCT03465761|ExAblate|exablate
5961762|NCT04285047|Electronic Medical Record|electronic medical record
5961763|NCT04285047|Patient Reported Information and Outcomes|patient reported information and outcomes
5961764|NCT04285047|Treatment|treatment
5961765|NCT04285047|Therapy|therapy
5961766|NCT04285021|Febrile illness|febrile illness
5961767|NCT04285021|Biomarker|biomarker
5961768|NCT04285021|Clinical Severity Scale|clinical severity scale
5961769|NCT04285021|Disease severity|disease severity
5961770|NCT04285021|Resource-limited setting|resource-limited setting
5961771|NCT04285008|colonoscopy|colonoscopy
5961772|NCT04284982|Exercise therapy|exercise therapy
5961773|NCT04284982|Resistance training|resistance training
5961774|NCT04284969|Cytoreductive surgery|cytoreductive surgery
5898557|NCT02590952|safety, PK|safety, pk
5898562|NCT02583646|Obesity|obesity
5898563|NCT02583646|Puberty|puberty
5898564|NCT02583646|Ultrasound|ultrasound
5898565|NCT02583646|Pediatric|pediatric
4966846|NCT04196959|AKU|aku
5898591|NCT02580552|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5898592|NCT02580552|CTCL|ctcl
5898593|NCT02580552|Mycosis Fungoides|mycosis fungoides
5898594|NCT02580552|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5898595|NCT02580552|CLL|cll
5898596|NCT02580552|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5898597|NCT02580552|DLBCL|dlbcl
5898598|NCT02580552|Adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5898599|NCT02580552|ATLL|atll
5898604|NCT02577770|Acupuncture|acupuncture
5898605|NCT02577770|caffeine|caffeine
5898606|NCT02577770|pain|pain
5898630|NCT02569788|re-irradiation|re-irradiation
5898631|NCT02569788|carbon ion radiotherapy|carbon ion radiotherapy
5898633|NCT02568930|quality of life heart failure mechanical support transplant|quality of life heart failure mechanical support transplant
5898634|NCT02567357|change triggered temper outbursts|change triggered temper outbursts
5898635|NCT02567357|parent training|parent training
5898689|NCT02562482|Vaccine-Mediated Protection|vaccine-mediated protection
5898690|NCT02562482|Chikungunya Virus|chikungunya virus
5898691|NCT02562482|Vaccines, Virus-like Particles|vaccines, virus-like particles
5900464|NCT02010203|GP96|gp96
5900465|NCT02010203|Vaccine|vaccine
5900466|NCT02010203|Immunotherapy|immunotherapy
5900467|NCT02010203|Heat Biologics|heat biologics
5900469|NCT02010203|Bacillus Calmette-Guerin|bacillus calmette-guerin
5900470|NCT02010203|Bacillus Calmette-Guérin|bacillus calmette-guérin
4970664|NCT04173754|ROM|rom
5901563|NCT01498328|Tumor|tumor
5901564|NCT01498328|Bevacizumab|bevacizumab
5901565|NCT01498328|Relapsed|relapsed
5901566|NCT01498328|Returned|returned
5901567|NCT01498328|Recurrent|recurrent
5901568|NCT01498328|EGFR variant III|egfr variant iii
5901605|NCT01475162|acute Graft versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
5901606|NCT01475162|steroid refractory acute Graft versus Host Disease (aGVHD)|steroid refractory acute graft versus host disease (agvhd)
5901607|NCT01475162|chronic Graft versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
5085235|NCT03465761|Bilateral Essential Tremor|bilateral essential tremor
5085236|NCT03465735|Deep|deep
5085237|NCT03465735|Pulmonary|pulmonary
5085239|NCT03465735|Vascular|vascular
5085240|NCT03465735|Post|post
5085241|NCT03465735|Vein|vein
5085242|NCT03465735|Thrombosis|thrombosis
5085243|NCT03465735|Embolism|embolism
5085244|NCT03465735|Thromboembolism|thromboembolism
5085245|NCT03465735|Thrombotic|thrombotic
5085246|NCT03465735|Syndrome|syndrome
5085247|NCT03465722|Other Relapsed or Refractory Solid Tumors|other relapsed or refractory solid tumors
5085248|NCT03465722|BLU-285|blu-285
5961775|NCT04284969|Older|older
5961776|NCT04284969|Senior adult|senior adult
5961777|NCT04284969|Prehabilitation|prehabilitation
5961778|NCT04284956|leg wound complication|leg wound complication
5961779|NCT04284956|No-Touch saphenous vein harvesting technique|no-touch saphenous vein harvesting technique
5961780|NCT04284956|coronary artery bypass graft|coronary artery bypass graft
5961781|NCT04284943|Gastric Cancer|gastric cancer
5961782|NCT04284943|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5961783|NCT04284943|Subtotal Gastrectomy|subtotal gastrectomy
5961784|NCT04284930|local anesthetic continuous infusion pump|local anesthetic continuous infusion pump
5961785|NCT04284930|local injection of Exparel|local injection of exparel
5961786|NCT04284917|Carglumic Acid (Carbaglu®)|carglumic acid (carbaglu®)
5961787|NCT04284891|Respiratory Diseases, ex-prematurity|respiratory diseases, ex-prematurity
5961788|NCT04284891|Respiratory Failure|respiratory failure
5961789|NCT04284891|Pediatric Intensive Care|pediatric intensive care
5961790|NCT04284865|Self-management|self-management
5961791|NCT04284865|Long-term care|long-term care
5961792|NCT04284865|Telehealth|telehealth
5961793|NCT04284852|advanced|advanced
5961794|NCT04284852|ovarian|ovarian
5961795|NCT04284852|cancer|cancer
5961796|NCT04284852|neoadjuvant|neoadjuvant
5961797|NCT04284852|niraparib|niraparib
5961798|NCT04284839|Direct Oral Anticoagulant|direct oral anticoagulant
5961799|NCT04284839|Vitamin K Antagonist|vitamin k antagonist
5961800|NCT04284839|Bleeding|bleeding
5961801|NCT04284826|Esophageal Stricture|esophageal stricture
5961802|NCT04284826|mitomycin C|mitomycin c
5961803|NCT04284826|endoscopy|endoscopy
5961804|NCT04284813|Family|family
5961805|NCT04284813|Substance Use Disorder|substance use disorder
5961806|NCT04284813|Psychosis|psychosis
5961807|NCT04284800|Defibrillation Threshold Testing|defibrillation threshold testing
5961808|NCT04284748|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5961809|NCT04284748|atrophy|atrophy
5961810|NCT04284748|knee function|knee function
5961811|NCT04284735|Rheumatoid arthritis|rheumatoid arthritis
5961812|NCT04284735|Interstitial lung disease|interstitial lung disease
5961813|NCT04284735|Autotaxin|autotaxin
5961814|NCT04284735|Lysophosphatidic acid|lysophosphatidic acid
5961815|NCT04284683|RMR|rmr
5961816|NCT04284683|Macro nutrients|macro nutrients
5961817|NCT04284683|Exercise|exercise
5961818|NCT04284670|eccentric training|eccentric training
5961819|NCT04284670|childhood obesity|childhood obesity
5961820|NCT04284670|decline treadmill|decline treadmill
5961821|NCT04284657|Polycystic Kidney Disease|polycystic kidney disease
5961822|NCT04284657|ADPKD|adpkd
5961823|NCT04284657|PKD|pkd
5961824|NCT04284644|General anesthesia|general anesthesia
5961825|NCT04284644|Propofol|propofol
5961826|NCT04284644|Sevoflurane|sevoflurane
5961827|NCT04284644|Co-induction|co-induction
5961828|NCT04284644|Laryngeal mask airway|laryngeal mask airway
5085249|NCT03465722|BLU 285|blu 285
5085250|NCT03465722|BLUE-285|blue-285
5085251|NCT03465722|BLUE 285|blue 285
5085252|NCT03465722|Avapritinib|avapritinib
5085253|NCT03465722|GIST imatinib relapse|gist imatinib relapse
5085254|NCT03465722|GIST gleevec relapse|gist gleevec relapse
5085255|NCT03465722|GIST KIT|gist kit
5085256|NCT03465722|GIST relapse|gist relapse
5085257|NCT03465722|GIST refractory|gist refractory
5085258|NCT03465722|GIST imatinib intolerance|gist imatinib intolerance
5085259|NCT03465722|GIST TKI treatment|gist tki treatment
5083633|NCT03475576|needs|needs
5085269|NCT03465722|KIT-mutant GIST|kit-mutant gist
5085271|NCT03465722|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5085272|NCT03465722|gist cancer|gist cancer
5085273|NCT03465722|PDGFRA|pdgfra
5085274|NCT03465696|psoriasis|psoriasis
5085275|NCT03465696|biologics|biologics
5085276|NCT03465696|treatment decision-making|treatment decision-making
5085277|NCT03465670|chlorhexidine|chlorhexidine
5085278|NCT03465670|hyaluronic acid|hyaluronic acid
5085279|NCT03465670|tooth discoloration|tooth discoloration
5085280|NCT03465657|Child Health|child health
5085281|NCT03465657|Sodium intake|sodium intake
5085282|NCT03465657|Food Sources|food sources
5085283|NCT03465657|Blood Pressure|blood pressure
5085284|NCT03465657|BMI|bmi
5085285|NCT03465657|Urinary sodium excretion|urinary sodium excretion
5085286|NCT03465644|antithrombotic strategy|antithrombotic strategy
5085287|NCT03465644|dual antiplatelet therapy|dual antiplatelet therapy
5085288|NCT03465631|stroke rehabilitation|stroke rehabilitation
5085289|NCT03465618|89Zr-cRGDY Ultrasmall Silica Particle Tracers|89zr-crgdy ultrasmall silica particle tracers
5085290|NCT03465618|Pet Scan|pet scan
5085291|NCT03465618|17-599|17-599
5085292|NCT03465579|Diagnosis Prostate Cancer|diagnosis prostate cancer
5085293|NCT03465579|TNM staging|tnm staging
5085294|NCT03465579|68Ga-PSMA PET/CT guided prostate biopsy|68ga-psma pet/ct guided prostate biopsy
5085295|NCT03465579|mp-3TMRI guided prostate biopsy|mp-3tmri guided prostate biopsy
5085296|NCT03465579|pre-surgical staging|pre-surgical staging
5085297|NCT03465579|clinically-suspected prostate cancer|clinically-suspected prostate cancer
5085298|NCT03465566|Emotion|emotion
5085299|NCT03465566|Social cognition|social cognition
5085300|NCT03465566|Childhood epilepsy|childhood epilepsy
5085301|NCT03465553|palliative care|palliative care
5085302|NCT03465553|thoracic cancer|thoracic cancer
5085303|NCT03465553|radiotherapy|radiotherapy
5085311|NCT03465540|MM|mm
5085312|NCT03465540|DLBCL|dlbcl
5085313|NCT03465540|Myeloid Cell Leukemia 1 Inhibitor|myeloid cell leukemia 1 inhibitor
5085314|NCT03465540|MCL1 Inhibitor|mcl1 inhibitor
5085315|NCT03465540|MCL1|mcl1
5085316|NCT03465501|Anal Canal Cancer|anal canal cancer
5085317|NCT03465501|brachytherapy|brachytherapy
5085318|NCT03465488|parasitology|parasitology
5085319|NCT03465488|helminth infections|helminth infections
5085320|NCT03465488|diagnosis|diagnosis
5085321|NCT03465488|drug resistance|drug resistance
5085322|NCT03465488|albendazole|albendazole
5085323|NCT03465488|benzimidazole drugs|benzimidazole drugs
5085324|NCT03465488|Ascaris|ascaris
5085325|NCT03465488|Trichuris|trichuris
5085326|NCT03465488|hookworm|hookworm
5085327|NCT03465488|qPCR|qpcr
5085328|NCT03465488|microscopy|microscopy
5085329|NCT03465475|Low flow anesthesia|low flow anesthesia
5085330|NCT03465475|Desflurane|desflurane
5085331|NCT03465475|Cost analysis|cost analysis
5085332|NCT03465462|hypertension,|hypertension,
5085333|NCT03465462|zinc|zinc
5085334|NCT03465462|zinc supplementation|zinc supplementation
5085335|NCT03465462|antihypertensive monotherapy|antihypertensive monotherapy
5085336|NCT03465462|mineral status|mineral status
5085337|NCT03465384|Parent-Child relations|parent-child relations
5085338|NCT03465384|Parenting|parenting
5085339|NCT03465384|Non-inferiority trial|non-inferiority trial
5085340|NCT03465384|Externalizing behaviors|externalizing behaviors
5085341|NCT03465384|Randomized controlled trial|randomized controlled trial
5085342|NCT03465384|Cost-effectiveness|cost-effectiveness
5085343|NCT03465332|blood eosinophil count|blood eosinophil count
5085345|NCT03465332|diagnostic test|diagnostic test
5085346|NCT03465332|doctor's questionnaire|doctor's questionnaire
5085347|NCT03465332|Lung specialist|lung specialist
5085348|NCT03465319|oxygen concentration|oxygen concentration
5085349|NCT03465319|volatile anesthetics concentration|volatile anesthetics concentration
5085350|NCT03465319|prediction model|prediction model
5085351|NCT03465306|Obesity|obesity
5085352|NCT03465306|Cognitive Behavioral Therapy|cognitive behavioral therapy
5085353|NCT03465293|Symptomatic diverticulosis|symptomatic diverticulosis
5085354|NCT03465293|Microbiota|microbiota
5085365|NCT03465228|Photobiomodulation|photobiomodulation
5085366|NCT03465228|Deep Water Running|deep water running
5085367|NCT03465228|Training|training
5085368|NCT03465228|Running|running
5085369|NCT03465202|Capecitabine|capecitabine
5085370|NCT03465202|Pharmacokinetics|pharmacokinetics
5085371|NCT03465202|Ageing|ageing
5085372|NCT03465202|Frailty|frailty
5085373|NCT03465202|Breast cancer|breast cancer
5085374|NCT03465202|Colorectal cancer|colorectal cancer
5085375|NCT03465176|aromatherapy|aromatherapy
4955241|NCT04268810|interstitial cystitis|interstitial cystitis
4955242|NCT04268810|chondroitin sulphate|chondroitin sulphate
4955243|NCT04268810|DMSO|dmso
4955249|NCT04268693|bisphenol|bisphenol
4955250|NCT04268693|phthalate|phthalate
5085376|NCT03465176|fatigue|fatigue
5085377|NCT03465176|hypothyroidism|hypothyroidism
5085378|NCT03465176|essential oils|essential oils
5085379|NCT03465150|Acne|acne
5085380|NCT03465150|Cohort|cohort
5085381|NCT03465150|prospective|prospective
5085382|NCT03465150|risk factors|risk factors
5085383|NCT03465137|Exposure therapy|exposure therapy
5085384|NCT03465137|Behavioral therapy|behavioral therapy
5085385|NCT03465137|fMRI|fmri
5085386|NCT03465137|Extinction learning|extinction learning
5085387|NCT03465137|Social anxiety|social anxiety
5085388|NCT03465111|Scleritis|scleritis
5085389|NCT03465111|anterior|anterior
5085390|NCT03465111|adrenocorticotropic hormone|adrenocorticotropic hormone
5085391|NCT03465111|ACTH|acth
5085392|NCT03465111|Non-infectious|non-infectious
5085393|NCT03465098|Infective endocarditis|infective endocarditis
5085394|NCT03465098|PET/CT 18F-FDG|pet/ct 18f-fdg
5085395|NCT03465098|Low carbohydrate diet as Atkins diet|low carbohydrate diet as atkins diet
5085396|NCT03465085|ARDS|ards
5085397|NCT03465085|Streptokinase|streptokinase
5085398|NCT03465085|Heparin|heparin
5085399|NCT03465085|Nebulization|nebulization
5085400|NCT03465085|Inhaled Thrombolytics|inhaled thrombolytics
5085406|NCT03465059|hepatic impairment|hepatic impairment
5085407|NCT03465046|infantile hemiplegia|infantile hemiplegia
5085408|NCT03465046|upper extremity|upper extremity
5085409|NCT03465046|physical therapy|physical therapy
5085410|NCT03465033|Orthognathic surgery|orthognathic surgery
5085411|NCT03465033|Jaw rehabilitation|jaw rehabilitation
5085412|NCT03465033|Jaw Physiotherapy|jaw physiotherapy
5085413|NCT03465033|Pain|pain
5085414|NCT03465033|Mandibular range of motion|mandibular range of motion
5085415|NCT03465033|Sensorial disturbance|sensorial disturbance
5085416|NCT03465020|Idiopathic|idiopathic
5085417|NCT03465020|Thrombocytopenic|thrombocytopenic
5085418|NCT03465020|Purpura|purpura
5085419|NCT03465007|hemodialysis|hemodialysis
5085420|NCT03465007|cortisol|cortisol
5085421|NCT03465007|Hydrocortisone|hydrocortisone
5085422|NCT03464994|Hereditary ichthyosis|hereditary ichthyosis
5085423|NCT03464994|keratoconus|keratoconus
5085424|NCT03464968|second line|second line
5085425|NCT03464968|FOLFOX|folfox
5085426|NCT03464968|FOLFIRI|folfiri
5085427|NCT03464916|CAR2 Anti-CD38 A2 CAR-T Cells|car2 anti-cd38 a2 car-t cells
5085428|NCT03464903|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5085429|NCT03464903|progressive muscular atrophy|progressive muscular atrophy
5085430|NCT03464903|motor neuron disease|motor neuron disease
5085431|NCT03464903|ALS reversals|als reversals
5085432|NCT03464903|whole genome sequencing|whole genome sequencing
5085433|NCT03464851|carotid artery stenosis|carotid artery stenosis
5085434|NCT03464851|plaque|plaque
5085435|NCT03464851|carotid duplex|carotid duplex
5085436|NCT03464851|ultrasound|ultrasound
5085437|NCT03464851|fibromsucular dysplasia|fibromsucular dysplasia
5085438|NCT03464851|carotid atherosclerosis|carotid atherosclerosis
5085439|NCT03464812|Diabetes education|diabetes education
5085440|NCT03464812|Psychosocial management of diabetes|psychosocial management of diabetes
5085441|NCT03464747|Lactic Acid|lactic acid
5085442|NCT03464708|Critical illness|critical illness
5085444|NCT03464708|Nutrition|nutrition
5085445|NCT03464708|Muscle wasting|muscle wasting
5085446|NCT03464708|Recovery|recovery
5085447|NCT03464695|closed-loop|closed-loop
5085448|NCT03464695|oxygen treatment|oxygen treatment
5085451|NCT03464656|semen quality|semen quality
5085452|NCT03464656|sperm DNA fragmentation|sperm dna fragmentation
5085453|NCT03464656|oxidation reduction potential|oxidation reduction potential
5085454|NCT03464565|Large Vessel Occlusion|large vessel occlusion
5085455|NCT03464565|Acute Ischemic Stroke|acute ischemic stroke
5085456|NCT03464565|Mechanical Thrombectomy|mechanical thrombectomy
5085457|NCT03464565|Penumbra System|penumbra system
5085458|NCT03464565|3D Revascularization|3d revascularization
5085556|NCT03463967|obesity|obesity
5085557|NCT03463967|dyslipidemia|dyslipidemia
5085459|NCT03464552|colposcopy - colposcopic directed biopsy - celecoxib|colposcopy - colposcopic directed biopsy - celecoxib
5085460|NCT03464448|Teriflunomide|teriflunomide
5085461|NCT03464448|B cell|b cell
5085462|NCT03464448|T cell|t cell
5085463|NCT03464448|cytokines|cytokines
5085464|NCT03464435|Refractory Vernal Keratoconjunctivitis|refractory vernal keratoconjunctivitis
5085465|NCT03464435|0.1% tacrolimus|0.1% tacrolimus
5085466|NCT03464435|loteprednol etabonate 0.5%/tobramycin 0.3%|loteprednol etabonate 0.5%/tobramycin 0.3%
5085469|NCT03464409|Nerve Transfer Surgery|nerve transfer surgery
5085470|NCT03464409|Tendon Transfer Surgery|tendon transfer surgery
5085471|NCT03464409|Decision Support Intervention|decision support intervention
5085472|NCT03464396|Periodic breathing|periodic breathing
5961829|NCT04284592|on-pump cardiac surgery|on-pump cardiac surgery
5961830|NCT04284592|HIF-1α|hif-1α
5961831|NCT04284592|Remote ischemic postconditioning|remote ischemic postconditioning
5961832|NCT04284592|postoperative cardiac markers|postoperative cardiac markers
5961833|NCT04284592|cardiopulmonary bypass|cardiopulmonary bypass
5085473|NCT03464396|Apnea of prematurity|apnea of prematurity
5085474|NCT03464396|Chronic Lung disease|chronic lung disease
5085475|NCT03464396|Prematurity|prematurity
5085476|NCT03464396|Respiratory disease|respiratory disease
5085477|NCT03464396|Hypoxia|hypoxia
5085478|NCT03464396|Pulmonary Hypertension|pulmonary hypertension
5085479|NCT03464383|Neurologic Disorders|neurologic disorders
5085480|NCT03464383|Chronic Care|chronic care
5085481|NCT03464383|Management|management
5085482|NCT03464383|Treatment|treatment
5085483|NCT03464383|SSRI Medication|ssri medication
5085484|NCT03464383|SNRI Medication|snri medication
5085485|NCT03464383|Learning Healthcare System|learning healthcare system
5085486|NCT03464370|amygdala enlargement|amygdala enlargement
5085487|NCT03464370|temporal lobe epilepsy|temporal lobe epilepsy
5085488|NCT03464370|stress|stress
5085489|NCT03464370|attentional bias|attentional bias
5085490|NCT03464370|anxiety|anxiety
5085491|NCT03464370|depression|depression
5085492|NCT03464370|PTSD|ptsd
5085493|NCT03464357|functional MRI|functional mri
5085507|NCT03464305|Neoplasms|neoplasms
5085508|NCT03464305|Colonic Diseases|colonic diseases
5085509|NCT03464305|Aspirin|aspirin
5085510|NCT03464305|Recurrence|recurrence
5085511|NCT03464305|Digestive System Diseases|digestive system diseases
5085512|NCT03464305|Intestinal Diseases|intestinal diseases
5085513|NCT03464305|Disease Attributes|disease attributes
5085514|NCT03464305|Pathologic Processes|pathologic processes
5085515|NCT03464227|Phase 1|phase 1
5085516|NCT03464227|UCB0107|ucb0107
5085517|NCT03464214|Vibration|vibration
5085518|NCT03464214|Cervical stabilization exercises|cervical stabilization exercises
5085519|NCT03464214|Physiotherapy and rehabilitation|physiotherapy and rehabilitation
5085520|NCT03464214|Sensory organization test|sensory organization test
5085521|NCT03464214|Balance|balance
5085522|NCT03464188|early palliative care|early palliative care
5085523|NCT03464188|family caregiver|family caregiver
5085524|NCT03464188|rural|rural
5085525|NCT03464188|African-American|african-american
5085526|NCT03464188|telehealth|telehealth
5085527|NCT03464162|Social Network Meetings|social network meetings
5085528|NCT03464162|First Episode Psychosis|first episode psychosis
5085529|NCT03464162|OnTrackNY|ontrackny
5085538|NCT03464071|sepsis|sepsis
5085539|NCT03464071|biomarkers|biomarkers
5085540|NCT03464071|lung injury|lung injury
5085541|NCT03464058|Pharmacokinetics|pharmacokinetics
5085542|NCT03464058|Food Effect|food effect
5085543|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors
5085544|NCT03464058|Drug Interaction|drug interaction
5085545|NCT03464058|Oral Prototype Formulations|oral prototype formulations
5085546|NCT03464019|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5085547|NCT03464019|cardiac monitoring|cardiac monitoring
5085548|NCT03464019|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
5085549|NCT03464019|atrioventricular reciprocating tachycardia|atrioventricular reciprocating tachycardia
5085550|NCT03464019|calcium channel blocker|calcium channel blocker
5085551|NCT03464019|conversion rate|conversion rate
5085552|NCT03463980|Meditation|meditation
5085553|NCT03463980|African American|african american
5085554|NCT03463980|Randomized controlled trial|randomized controlled trial
5085555|NCT03463967|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5085562|NCT03463941|African American|african american
5085563|NCT03463941|Faith institutions|faith institutions
5085565|NCT03463941|Health disparities|health disparities
5085566|NCT03463915|Interstitial cystitis|interstitial cystitis
5085567|NCT03463915|Bladder pain syndrome|bladder pain syndrome
5085568|NCT03463915|IC/BPS|ic/bps
5085581|NCT03463798|transdiaphragmatic pressure|transdiaphragmatic pressure
5085582|NCT03463785|obstructive sleep apnea|obstructive sleep apnea
5085590|NCT03463733|Recurrent glioma|recurrent glioma
5085591|NCT03463733|Glioblastoma multiforme|glioblastoma multiforme
5085592|NCT03463733|Recurrent Glioblastoma multiforme|recurrent glioblastoma multiforme
5085594|NCT03463733|Temozolomide|temozolomide
5085595|NCT03463668|duodenal stenosis|duodenal stenosis
5085596|NCT03463668|pyloric stenosis|pyloric stenosis
5085597|NCT03463668|digestive neoplasias|digestive neoplasias
5085598|NCT03463668|non-digestive neoplasias|non-digestive neoplasias
5085599|NCT03463668|duodenal prosthesis|duodenal prosthesis
5085600|NCT03463655|palliative|palliative
5085601|NCT03463655|solid tumor|solid tumor
5085602|NCT03463655|ascites|ascites
5085603|NCT03463629|Multidisciplinary Team|multidisciplinary team
5085604|NCT03463629|Hispanic adults|hispanic adults
5085605|NCT03463616|Rectal Cancer|rectal cancer
5085606|NCT03463616|Liver Metastases|liver metastases
5085607|NCT03463616|CT abdomen|ct abdomen
5085608|NCT03463616|MRI Liver|mri liver
5085609|NCT03463603|ischemic heart disease|ischemic heart disease
5085610|NCT03463603|acute coronary syndrome|acute coronary syndrome
5085611|NCT03463603|racial bias|racial bias
5085612|NCT03463590|Habenula|habenula
5085613|NCT03463590|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5085614|NCT03463590|Deep brain stimulation|deep brain stimulation
5085615|NCT03463577|whooping cough, Boostrix, Tdap, safety, pregnancy, infants|whooping cough, boostrix, tdap, safety, pregnancy, infants
5085616|NCT03463564|type 1 diabetes|type 1 diabetes
5085617|NCT03463564|transition|transition
5085619|NCT03463564|MDI|mdi
5085620|NCT03463564|glycemic control|glycemic control
5085621|NCT03463564|glucose variability|glucose variability
5085622|NCT03463525|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5085623|NCT03463486|outpatient cardiac rehabilitation, exercise training,|outpatient cardiac rehabilitation, exercise training,
5085624|NCT03463447|Dynamometer|dynamometer
5085625|NCT03463447|Handgrip|handgrip
5085626|NCT03463447|children|children
5085627|NCT03463434|pressure ulcer treatment|pressure ulcer treatment
5085628|NCT03463434|wound healing|wound healing
5085629|NCT03463421|Adherence to oral anticoagulation|adherence to oral anticoagulation
5085630|NCT03463421|Persistence to oral anticoagulation|persistence to oral anticoagulation
5085631|NCT03463421|AF patients|af patients
5085632|NCT03463421|Previous ischemic stroke|previous ischemic stroke
5085633|NCT03463408|Sarcoma|sarcoma
5085634|NCT03463382|Pediatric Surgery|pediatric surgery
5085635|NCT03463382|Postoperative Pain|postoperative pain
5085636|NCT03463382|Erector spinae plane block|erector spinae plane block
5740474|NCT00356304|Dysthymia|dysthymia
5085637|NCT03463382|quadratus lumborum block|quadratus lumborum block
5085638|NCT03463317|Atrial Fibrillation|atrial fibrillation
5085639|NCT03463317|Anticoagulation|anticoagulation
5085640|NCT03463317|Left atrial appendage closure|left atrial appendage closure
5085641|NCT03463317|Stroke|stroke
5085647|NCT03463278|blastocyst|blastocyst
5085648|NCT03463278|Freeze-all|freeze-all
5085649|NCT03463278|IVF|ivf
5085650|NCT03463278|Cumulative results|cumulative results
5085651|NCT03463278|cumulative delivery rate|cumulative delivery rate
5085653|NCT03463226|Testosterone Deficiency|testosterone deficiency
5085654|NCT03463226|Sympathetic overactivity|sympathetic overactivity
5085655|NCT03463226|Exercise Intolerance|exercise intolerance
5085656|NCT03463213|health behavior|health behavior
5085657|NCT03463213|chronic disease prevention|chronic disease prevention
5085658|NCT03463213|healthy lifestyle|healthy lifestyle
5085659|NCT03463200|bandage|bandage
5085660|NCT03463200|low back pain|low back pain
5085661|NCT03463200|muscle fatigue|muscle fatigue
5085662|NCT03463200|electromyography|electromyography
5085663|NCT03463174|overdenture|overdenture
5085664|NCT03463174|edentulism|edentulism
5085665|NCT03463174|dental implant|dental implant
5076567|NCT03520686|N-803|n-803
5085666|NCT03463174|cost-effectiveness|cost-effectiveness
5085667|NCT03463174|economic analysis|economic analysis
5085668|NCT03463174|effectiveness|effectiveness
5085669|NCT03463122|stroke|stroke
5085670|NCT03463122|neglect|neglect
5085671|NCT03463122|virtual reality|virtual reality
5085672|NCT03463122|head mount display|head mount display
5085673|NCT03463122|rehabilitation|rehabilitation
5085674|NCT03463109|Chronic low back pain|chronic low back pain
5085675|NCT03463096|respiratory|respiratory
5085676|NCT03463096|physiology|physiology
5085677|NCT03463096|gravity|gravity
5085678|NCT03463070|misoprostol|misoprostol
5085679|NCT03463070|postpartum haemorrhage|postpartum haemorrhage
5085680|NCT03463031|GSP 301 nasal spray for the treatment of Seasonal Allergic Rhinitis|gsp 301 nasal spray for the treatment of seasonal allergic rhinitis
5085688|NCT03462940|Tauroursodeoxycholic acid (TUDCA)|tauroursodeoxycholic acid (tudca)
5085689|NCT03462940|Endothelial function in humans|endothelial function in humans
5085690|NCT03462940|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
5085691|NCT03462901|Fixation of midshaft clavicular fracture by intramedullary|fixation of midshaft clavicular fracture by intramedullary
5085693|NCT03462888|Adolescents and young adults|adolescents and young adults
5085694|NCT03462888|prognostic factors|prognostic factors
5085695|NCT03462888|molecular profiling|molecular profiling
5085696|NCT03462875|Crohn's Disease|crohn's disease
5085697|NCT03462875|Microbiota|microbiota
5085698|NCT03462875|Dietary Pattern|dietary pattern
5085699|NCT03462875|Environmental factors|environmental factors
5085700|NCT03462862|PEEK|peek
5085701|NCT03462862|Breflex|breflex
5085702|NCT03462849|ARDS|ards
5085703|NCT03462849|expiratory flow limitation|expiratory flow limitation
5085704|NCT03462849|trans-pulmonary pressure|trans-pulmonary pressure
5085705|NCT03462849|airway closure|airway closure
5085706|NCT03462823|ACL Reconstruction|acl reconstruction
5085707|NCT03462823|Osteoconductive Scaffold|osteoconductive scaffold
5085708|NCT03462823|Bone Tunnel Widening|bone tunnel widening
5085709|NCT03462810|cabotegravir, CAB|cabotegravir, cab
5085710|NCT03462810|GSK1265744|gsk1265744
5085711|NCT03462810|Individual Patient Compassionate Use|individual patient compassionate use
5085712|NCT03462810|HIV|hiv
5085713|NCT03462771|elderly|elderly
5085714|NCT03462771|sarcopenia|sarcopenia
5085715|NCT03462771|dietary supplementation|dietary supplementation
5085716|NCT03462771|omega-3 fatty acid|omega-3 fatty acid
5085717|NCT03462758|Mirena|mirena
5085718|NCT03462758|ParaGard|paragard
5085719|NCT03462758|Skyla|skyla
5085720|NCT03462758|Liletta|liletta
5085721|NCT03462758|Kyleena|kyleena
5085722|NCT03462758|Intrauterine Device|intrauterine device
5085723|NCT03462758|Intrauterine System|intrauterine system
5085724|NCT03462758|Postpartum|postpartum
5085725|NCT03462758|Expulsion|expulsion
5085726|NCT03462706|Polyp Resection|polyp resection
5085727|NCT03462706|Cold Snare|cold snare
5085728|NCT03462706|Hot Snare|hot snare
5085729|NCT03462706|Cold Endoscopic Mucosal Resection (EMR)|cold endoscopic mucosal resection (emr)
5085730|NCT03462706|Hot Endoscopic Mucosal Resection (EMR)|hot endoscopic mucosal resection (emr)
5085731|NCT03462706|Colonoscopy|colonoscopy
5085732|NCT03462654|Health promotion|health promotion
5085733|NCT03462654|Behaviour change|behaviour change
5085734|NCT03462654|Physical activity|physical activity
5085735|NCT03462654|Fall prevention|fall prevention
5085736|NCT03462641|Gait|gait
5085737|NCT03462641|Balance|balance
5085738|NCT03462641|Flumazenil|flumazenil
5085739|NCT03462641|PET Imaging|pet imaging
5085740|NCT03462641|MRI|mri
5085741|NCT03462641|Mobility|mobility
5085742|NCT03462641|Intravenous|intravenous
5085743|NCT03462628|substrate modification|substrate modification
5085744|NCT03462628|pulmonary vein isolation|pulmonary vein isolation
5085745|NCT03462628|ablation|ablation
5085746|NCT03462628|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5085747|NCT03462615|malaria|malaria
5085748|NCT03462615|pregnancy|pregnancy
5085749|NCT03462615|diagnosis|diagnosis
5085750|NCT03462615|rapid diagnostic test|rapid diagnostic test
5085751|NCT03462537|Aerobic Exercise|aerobic exercise
5085752|NCT03462537|Lipolytic Laser|lipolytic laser
5085753|NCT03462537|Lipid Profile|lipid profile
5085754|NCT03462537|C-reactive protein|c-reactive protein
5085755|NCT03462537|Lipolysis|lipolysis
5085756|NCT03462511|Hydroxyurea|hydroxyurea
5085859|NCT03461705|Resting Flow Reserve (RFR)|resting flow reserve (rfr)
4969975|NCT04177810|Anti-PD-L1|anti-pd-l1
5085760|NCT03462498|Acute Coronary Syndrome|acute coronary syndrome
5085761|NCT03462498|Acute Myocardial Infarction|acute myocardial infarction
5085762|NCT03462498|Coronary Artery Disease|coronary artery disease
5085763|NCT03462498|Percutaneous Coronary Intervention|percutaneous coronary intervention
5085764|NCT03462498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5085765|NCT03462459|Oral vancomycin|oral vancomycin
5085766|NCT03462459|vancomycin|vancomycin
5085767|NCT03462459|antibiotic|antibiotic
5085768|NCT03462446|Atrial fibrillation|atrial fibrillation
5085770|NCT03462446|Stroke|stroke
5085771|NCT03462433|Ruptured Intracranial Aneurysms|ruptured intracranial aneurysms
5085772|NCT03462433|Unruptured Intracranial Aneurysms|unruptured intracranial aneurysms
5085773|NCT03462433|Prospective cohort study|prospective cohort study
5085774|NCT03462433|China|china
5085775|NCT03462420|Adhesive capsulitis|adhesive capsulitis
5085776|NCT03462420|Frozen shoulder|frozen shoulder
5085777|NCT03462420|Diabetes|diabetes
5085778|NCT03462420|Physiotherapy|physiotherapy
5085788|NCT03462251|Breast Cancer|breast cancer
5085789|NCT03462251|HR positive|hr positive
5085790|NCT03462251|HER2 negative|her2 negative
5085791|NCT03462251|Mamma carcinoma|mamma carcinoma
5085792|NCT03462199|Kiwi|kiwi
5085793|NCT03462199|Constipation|constipation
5085794|NCT03462199|Bowel Movements|bowel movements
5085795|NCT03462199|Healthy|healthy
5085796|NCT03462199|Functional Constipation|functional constipation
5085797|NCT03462160|Urinary Tract Infection|urinary tract infection
5085798|NCT03462160|prophylaxis|prophylaxis
5085799|NCT03462160|probiotics|probiotics
5085800|NCT03462121|Alzheimer's Disease,|alzheimer's disease,
5085801|NCT03462121|Dementia|dementia
5085802|NCT03462082|Parkinson's disease|parkinson's disease
5085803|NCT03462082|axial motor dysfunction|axial motor dysfunction
5085804|NCT03462082|asymmetric neuromodulation|asymmetric neuromodulation
5085805|NCT03462082|subthalamic nucleus deep brain stimulation|subthalamic nucleus deep brain stimulation
5085806|NCT03462030|food allergy|food allergy
5085807|NCT03462030|oral immunotherapy|oral immunotherapy
5085808|NCT03462004|Healthy Volunteer|healthy volunteer
5085809|NCT03461965|3D printing|3d printing
5085810|NCT03461965|Patient education|patient education
5085811|NCT03461939|ePRIME|eprime
5085813|NCT03461939|PROM|prom
5085814|NCT03461939|Adverse event|adverse event
5085815|NCT03461939|QTool|qtool
5085816|NCT03461939|Early phase|early phase
5085817|NCT03461939|CTCAE|ctcae
5085818|NCT03461926|Sedentary Behaviour|sedentary behaviour
5085819|NCT03461926|Health Behaviour Change|health behaviour change
5085820|NCT03461926|Health Action Process Approach|health action process approach
5085821|NCT03461926|mHealth|mhealth
5085822|NCT03461926|Intervention|intervention
5085823|NCT03461926|Non-Sedentary Behaviours|non-sedentary behaviours
5085824|NCT03461926|Break Frequency|break frequency
5085825|NCT03461926|Break Duration|break duration
5085826|NCT03461926|Action Planning|action planning
5085827|NCT03461926|Coping Planning|coping planning
5085828|NCT03461926|Work Performance|work performance
5085829|NCT03461926|Health Outcomes|health outcomes
5085834|NCT03461887|exercise|exercise
5085835|NCT03461887|minimal equipment|minimal equipment
5085836|NCT03461887|home-based|home-based
5085837|NCT03461887|COPD|copd
5085838|NCT03461874|High-Frequency Migraine without aura|high-frequency migraine without aura
5085840|NCT03461861|Healthy|healthy
5085841|NCT03461861|Adult|adult
5085842|NCT03461861|Normal Memory|normal memory
5085843|NCT03461861|APOE 4|apoe 4
5085844|NCT03461861|Brain|brain
5740680|NCT00355576|Minocycline|minocycline
5085845|NCT03461861|Magnetic Resonance Imaging|magnetic resonance imaging
5085846|NCT03461861|MRI|mri
5085847|NCT03461861|Alzheimer's disease|alzheimer's disease
5085848|NCT03461861|Hippocampus|hippocampus
5085849|NCT03461861|Genetic testing|genetic testing
5085850|NCT03461861|Dementia|dementia
5085851|NCT03461861|AGB101|agb101
5085852|NCT03461809|diplopia; ocular motor nerve palsy; acupuncture|diplopia; ocular motor nerve palsy; acupuncture
5085853|NCT03461770|atelectasis|atelectasis
5085854|NCT03461770|children|children
5085855|NCT03461770|ultrasound|ultrasound
5085856|NCT03461731|Low-Level Light Therapy|low-level light therapy
5085857|NCT03461705|Coronary Artery Stenosis|coronary artery stenosis
5085858|NCT03461705|Stenosis|stenosis
5086154|NCT03459677|Anxiety|anxiety
5085868|NCT03461627|positive-controlled|positive-controlled
5085869|NCT03461627|parallel-group|parallel-group
5085870|NCT03461614|pulmonary function|pulmonary function
5085871|NCT03461614|respiratory muscle strength|respiratory muscle strength
5085872|NCT03461614|functional capacity|functional capacity
5085873|NCT03461614|core exercises|core exercises
5085874|NCT03461614|rehabilitation|rehabilitation
5085875|NCT03461562|Aerobic Exercise|aerobic exercise
5085876|NCT03461562|Whole Body Vibration Therapy|whole body vibration therapy
5085877|NCT03461549|pressure sensor|pressure sensor
5085878|NCT03461549|temperature sensor|temperature sensor
5085879|NCT03461549|wearables|wearables
5085880|NCT03461510|Cognition|cognition
5085882|NCT03461510|Functional MRI|functional mri
5085883|NCT03461510|Pediatric Obesity|pediatric obesity
5085884|NCT03461510|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5085885|NCT03461510|Adolescents|adolescents
5085886|NCT03461510|Continuous Glucose Monitoring|continuous glucose monitoring
5085887|NCT03461510|Insulin Clamp|insulin clamp
5085888|NCT03461497|Patient-Reported Outcome|patient-reported outcome
5085889|NCT03461497|Patient Outcome Assessment|patient outcome assessment
5085890|NCT03461497|Questionnaire|questionnaire
5085891|NCT03461497|Self-Report|self-report
5085892|NCT03461497|Abdominal Surgery|abdominal surgery
5085893|NCT03461497|Postoperative Period|postoperative period
5085894|NCT03461497|Recovery of Function|recovery of function
5085895|NCT03461497|Psychometrics|psychometrics
5085896|NCT03461497|Qualitative Research|qualitative research
5085897|NCT03461497|Patient-Centered|patient-centered
5085899|NCT03461458|Musculoskeletal Diseases|musculoskeletal diseases
5085900|NCT03461458|Lumbar|lumbar
5085901|NCT03461445|Elderly|elderly
5085902|NCT03461445|Neurotoxicity|neurotoxicity
5085903|NCT03461445|Calcineurin inhibitors|calcineurin inhibitors
5085904|NCT03461445|Tacrolimus|tacrolimus
5085905|NCT03461432|Cognitive Remediation Therapy CRT|cognitive remediation therapy crt
5085906|NCT03461419|Multiple Sclerosis|multiple sclerosis
5085907|NCT03461419|Demyelinating Disease|demyelinating disease
5085908|NCT03461419|Nervous System Degenerative Disease|nervous system degenerative disease
5085909|NCT03461419|Autoimmune Disease|autoimmune disease
5085910|NCT03461393|AMD|amd
5085911|NCT03461393|Mobile Device|mobile device
5085912|NCT03461393|Training|training
5085913|NCT03461380|Cimicifuga, Rhodiola, Menopause Symptoms|cimicifuga, rhodiola, menopause symptoms
5085914|NCT03461328|magnesium sulphate, chronic obstructive pulmonary diseases|magnesium sulphate, chronic obstructive pulmonary diseases
5085915|NCT03461315|home care|home care
5085916|NCT03461315|primary care|primary care
5085917|NCT03461315|preventive home visits|preventive home visits
5085918|NCT03461250|HCV infection|hcv infection
5085919|NCT03461250|hemodialysis|hemodialysis
5085920|NCT03461250|HCV genotype|hcv genotype
5085921|NCT03461250|Liver Fibrosis stage|liver fibrosis stage
5085922|NCT03461237|Second Hip Fracture|second hip fracture
5085923|NCT03461237|Quantitative Computed Tomography|quantitative computed tomography
5085924|NCT03461237|Bone structure|bone structure
5085925|NCT03461237|Muscle|muscle
5085926|NCT03461224|breast cancer|breast cancer
5085927|NCT03461224|radiotherapy|radiotherapy
5085928|NCT03461224|cutaneous toxicity|cutaneous toxicity
5085929|NCT03461224|subcutaneous toxicity|subcutaneous toxicity
5085930|NCT03461224|IMRT|imrt
5085931|NCT03461172|surgery|surgery
5085932|NCT03461172|breast cancer|breast cancer
5085933|NCT03461159|operant conditioning|operant conditioning
5085934|NCT03461159|H-reflex|h-reflex
5085935|NCT03461159|motor evoked potential|motor evoked potential
5085936|NCT03461159|transcranial magnetic stimulation|transcranial magnetic stimulation
5085937|NCT03461159|motor control|motor control
5085938|NCT03461042|Chronic insomnia|chronic insomnia
5085939|NCT03461042|Ramelteon|ramelteon
5085940|NCT03461042|Rozerem|rozerem
5085941|NCT03461042|dose reduction|dose reduction
5085942|NCT03461029|Sedation|sedation
5085943|NCT03461016|Smartphones|smartphones
5085944|NCT03461016|Exposure Therapy|exposure therapy
5085945|NCT03461016|Dental Anxiety|dental anxiety
5086155|NCT03459677|Depression|depression
5085967|NCT03460951|DTI parameters (Fractional Anisotropy, Apparent Diffusion Coefficient)|dti parameters (fractional anisotropy, apparent diffusion coefficient)
5085969|NCT03460925|pancreatic cancer|pancreatic cancer
5085970|NCT03460925|stereotactic body radiotherapy|stereotactic body radiotherapy
5085971|NCT03460925|resectability|resectability
5085972|NCT03460912|IONM|ionm
5085973|NCT03460912|thyroidectomy|thyroidectomy
5085974|NCT03460912|bipolar probe|bipolar probe
5085975|NCT03460912|monopolar probe|monopolar probe
5085976|NCT03460899|Hypoglycaemia|hypoglycaemia
5085977|NCT03460899|Platelet activity|platelet activity
5085978|NCT03460899|Type 2 diabetes mellitus|type 2 diabetes mellitus
5085979|NCT03460886|transcranial direct current stimulation|transcranial direct current stimulation
5085980|NCT03460834|Asthma|asthma
5085981|NCT03460834|Obesity|obesity
5085982|NCT03460834|Observational Study|observational study
5085983|NCT03460808|steroid-resistant|steroid-resistant
5085984|NCT03460808|refractory|refractory
5085985|NCT03460808|Atorvastatin|atorvastatin
5085986|NCT03460808|Acetylcysteine|acetylcysteine
5085987|NCT03460808|Danazol|danazol
5085988|NCT03460782|Ipilimumab|ipilimumab
5085989|NCT03460782|Glioblastoma|glioblastoma
5085990|NCT03460782|Glioma|glioma
5085991|NCT03460769|Pancreatic Cancer|pancreatic cancer
5085992|NCT03460769|Chronic Pancreatitis|chronic pancreatitis
5085993|NCT03460769|Diabetes Mellitus Type 3c|diabetes mellitus type 3c
5085994|NCT03460769|Data management|data management
5085995|NCT03460756|Postpartum Care|postpartum care
5085996|NCT03460756|Postpartum Depression|postpartum depression
5085997|NCT03460743|hemagglutinin influenza vaccine|hemagglutinin influenza vaccine
5085998|NCT03460743|recombinant influenza vaccine|recombinant influenza vaccine
5085999|NCT03460730|Invasive Pneumococcal Disease|invasive pneumococcal disease
5086000|NCT03460691|bariatric surgery|bariatric surgery
5086001|NCT03460691|central sensitization|central sensitization
5086002|NCT03460691|knee pain|knee pain
5086003|NCT03460691|function|function
5086006|NCT03460678|Generic Pemetrexed|generic pemetrexed
5086008|NCT03460678|Non-squamous|non-squamous
5086009|NCT03460678|Randomized Study|randomized study
5086010|NCT03460678|Maintenance Therapy|maintenance therapy
5086011|NCT03460678|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5086012|NCT03460678|Antifolate antineoplastic agents|antifolate antineoplastic agents
5086013|NCT03460639|Masseter muscle|masseter muscle
5086014|NCT03460639|initial fatigue|initial fatigue
5086027|NCT03460444|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
5086029|NCT03460444|3-Hydroxybutyric Acid|3-hydroxybutyric acid
5086030|NCT03460444|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5086032|NCT03460392|Human microbiota|human microbiota
5086033|NCT03460379|Bariatric surgery|bariatric surgery
5086034|NCT03460379|Gastrointestinal tract|gastrointestinal tract
5086035|NCT03460379|Biological availability|biological availability
5086036|NCT03460379|Pharmacokinetics|pharmacokinetics
5086037|NCT03460379|Citalopram|citalopram
5086038|NCT03460366|Bariatric surgery|bariatric surgery
5086039|NCT03460366|Gastrointestinal tract|gastrointestinal tract
5086040|NCT03460366|Biological availability|biological availability
5086041|NCT03460366|Pharmacokinetics|pharmacokinetics
5086042|NCT03460366|Enalapril|enalapril
5086043|NCT03460353|Bariatric surgery|bariatric surgery
5086044|NCT03460353|Gastrointestinal tract|gastrointestinal tract
5086045|NCT03460353|Biological availability|biological availability
5086046|NCT03460353|Pharmacokinetics|pharmacokinetics
5086047|NCT03460353|Dextroamphetamine|dextroamphetamine
5086048|NCT03460340|dTMS|dtms
5086049|NCT03460340|Fibromyalgia|fibromyalgia
5086050|NCT03460327|Bariatric surgery|bariatric surgery
5086051|NCT03460327|Gastrointestinal tract|gastrointestinal tract
5086052|NCT03460327|Biological availability|biological availability
5086053|NCT03460327|Pharmacokinetics|pharmacokinetics
5086054|NCT03460327|Candesartan|candesartan
5086058|NCT03460314|Pharmacokinetics|pharmacokinetics
5086059|NCT03460314|Buprenorphine|buprenorphine
5086060|NCT03460288|Gambling, Problematic Gambling, Pathological Gambling|gambling, problematic gambling, pathological gambling
5086061|NCT03460275|Osimertinib|osimertinib
5086062|NCT03460236|PRP|prp
5086063|NCT03460236|osteoarthritis|osteoarthritis
5086064|NCT03460236|MRI|mri
5086065|NCT03460236|gait|gait
5086066|NCT03460236|patient reported outcome|patient reported outcome
5086067|NCT03460210|Bariatric surgery|bariatric surgery
5086068|NCT03460210|Gastrointestinal tract|gastrointestinal tract
5086069|NCT03460210|Biological availability|biological availability
5086070|NCT03460210|Pharmacokinetics|pharmacokinetics
5086071|NCT03460210|Atomoxetine hydrochloride|atomoxetine hydrochloride
5086072|NCT03460197|Capillary technique|capillary technique
5086073|NCT03460197|Wet technique|wet technique
5086074|NCT03460197|Endoscopic Ultrasound-Guided Fine-Needle Aspiration|endoscopic ultrasound-guided fine-needle aspiration
5086075|NCT03460171|Human Metapneumovirus|human metapneumovirus
5086076|NCT03460171|Paramyxoviridae infections|paramyxoviridae infections
5086077|NCT03460171|Lower-respiratory tract infections|lower-respiratory tract infections
5086078|NCT03460171|Pneumonia|pneumonia
5086079|NCT03460158|facial filler|facial filler
5086080|NCT03460158|Retylane|retylane
5086081|NCT03460158|aesthetic improvement|aesthetic improvement
5086082|NCT03460158|volumizing fillers|volumizing fillers
5086083|NCT03460145|Lavender Oil,|lavender oil,
5086084|NCT03460145|Propofol|propofol
5086085|NCT03460132|orthodontic miniscrews|orthodontic miniscrews
5086086|NCT03460132|biological effect|biological effect
5086087|NCT03460132|cytotoxicity|cytotoxicity
5086088|NCT03460132|metal release|metal release
5086089|NCT03460119|High Flow Nasal Cannula|high flow nasal cannula
5086090|NCT03460119|Emergency department|emergency department
5086091|NCT03460119|Respiratory care|respiratory care
5086092|NCT03460106|Asthma Medical Adherence|asthma medical adherence
5086093|NCT03460093|nerve blockade|nerve blockade
5086094|NCT03460093|hypogastric plexus|hypogastric plexus
5086095|NCT03460093|cesarean section|cesarean section
5086096|NCT03460080|Hepatocellular carcinoma|hepatocellular carcinoma
5086097|NCT03460080|AFP-L3|afp-l3
5086098|NCT03460080|PIVKA-II|pivka-ii
5086099|NCT03460067|omission of radiation|omission of radiation
5086100|NCT03460067|trastuzumab|trastuzumab
5086101|NCT03460067|pertuzumab|pertuzumab
5086102|NCT03460067|biospecimen collection|biospecimen collection
5086107|NCT03460002|Measles vaccine|measles vaccine
5086108|NCT03460002|Oral polio vaccine|oral polio vaccine
5086110|NCT03460002|Child mortality|child mortality
5086111|NCT03460002|Child morbidity|child morbidity
5086112|NCT03460002|Non-specific effects|non-specific effects
5086113|NCT03459989|hadlock|hadlock
5086114|NCT03459989|thigh soft tissue|thigh soft tissue
5086115|NCT03459963|catheter|catheter
5086117|NCT03459963|urinary tract infection|urinary tract infection
5086118|NCT03459963|patient's satisfaction|patient's satisfaction
5086119|NCT03459937|obesity|obesity
5086120|NCT03459937|yoga|yoga
5086151|NCT03459677|School Refusal|school refusal
5086153|NCT03459677|School Absenteeism|school absenteeism
5086171|NCT03459599|Prophylaxis|prophylaxis
5086172|NCT03459599|Ragged membranes|ragged membranes
5086173|NCT03459586|Parkinson|parkinson
5086174|NCT03459560|antihypertensive agents|antihypertensive agents
5086175|NCT03459560|acetylsalicylic acid|acetylsalicylic acid
5086176|NCT03459560|atorvastatin|atorvastatin
5086177|NCT03459508|Antiphospholipid Syndrome - Bad obstetric history - Ocular|antiphospholipid syndrome - bad obstetric history - ocular
5086178|NCT03459495|migraine, therapeutic ultrasound, pain, disability|migraine, therapeutic ultrasound, pain, disability
5086180|NCT03459456|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5086181|NCT03459443|factor D|factor d
5086182|NCT03459443|fD|fd
5086183|NCT03459443|alternative pathway|alternative pathway
5086184|NCT03459443|complement mediated disease|complement mediated disease
5086185|NCT03459443|C3GN|c3gn
5086186|NCT03459443|DDD|ddd
5086187|NCT03459443|idiopathic MPGN|idiopathic mpgn
5086188|NCT03459443|MPGN Type I|mpgn type i
5086189|NCT03459443|MPGN Type II|mpgn type ii
5086190|NCT03459443|MPGN Type III|mpgn type iii
5086191|NCT03459443|Primary MPGN|primary mpgn
5086192|NCT03459443|MCGN|mcgn
5086193|NCT03459443|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
5086194|NCT03459430|trunk stability|trunk stability
5086195|NCT03459430|accelerometer|accelerometer
5086196|NCT03459430|smartphone|smartphone
5086197|NCT03459430|core training|core training
5086198|NCT03459430|isometric exercises|isometric exercises
5086199|NCT03459391|Healthy volunteers|healthy volunteers
5086200|NCT03459391|Phase I|phase i
5086201|NCT03459391|PHARMENTERPRISES|pharmenterprises
5086202|NCT03459352|Cancer|cancer
5086203|NCT03459352|Patient Reported Outcomes|patient reported outcomes
5086204|NCT03459352|Symptom management|symptom management
5086205|NCT03459339|Barrett's Esophagus|barrett's esophagus
5086206|NCT03459339|Natural History|natural history
5086207|NCT03459339|Capsule|capsule
5086208|NCT03459339|OCT|oct
5086209|NCT03459339|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
5086210|NCT03459326|male sexuality|male sexuality
5086211|NCT03459326|medical assisted to procreation|medical assisted to procreation
5084651|NCT03469778|stroke|stroke
5086212|NCT03459326|International Index of Erectile Function questionnaire|international index of erectile function questionnaire
5086213|NCT03459300|actimetry|actimetry
5086214|NCT03459287|INTERCEPT|intercept
5086215|NCT03459287|Red Blood Cells|red blood cells
5086216|NCT03459287|RBC|rbc
5086217|NCT03459287|Pathogen Inactivation|pathogen inactivation
5086218|NCT03459287|Cerus|cerus
5086219|NCT03459287|Pathogen Reduction|pathogen reduction
5086220|NCT03459287|Cardiovascular surgery|cardiovascular surgery
5086221|NCT03459261|osteomyelitis|osteomyelitis
5086222|NCT03459261|tibial fracture|tibial fracture
5086223|NCT03459261|cytokines|cytokines
5086224|NCT03459261|PCT|pct
5086225|NCT03459261|CRP|crp
5086226|NCT03459261|albumin|albumin
5086227|NCT03459235|rectal cancer|rectal cancer
5086228|NCT03459235|proctectomy|proctectomy
5086229|NCT03459235|digestive sequelae|digestive sequelae
5086230|NCT03459235|quality of life|quality of life
5086231|NCT03459235|Urinary and Sexual sequelae|urinary and sexual sequelae
5086232|NCT03459222|immunotherapy|immunotherapy
5086233|NCT03459222|Relatlimab|relatlimab
5086234|NCT03459196|Interventional|interventional
5086235|NCT03459196|Radiofrequency Ablation|radiofrequency ablation
5086236|NCT03459196|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5086237|NCT03459170|leukemia|leukemia
5086238|NCT03459170|myelodysplastic syndrome|myelodysplastic syndrome
5086239|NCT03459170|lymphoma|lymphoma
5086240|NCT03459170|minimal residual disease|minimal residual disease
5086241|NCT03459170|BPX-501|bpx-501
5086242|NCT03459170|AP1903|ap1903
5086243|NCT03459170|rimiducid|rimiducid
5086244|NCT03459157|HIV infection|hiv infection
5086245|NCT03459157|Men who have sex with men|men who have sex with men
5086246|NCT03459157|Pre-exposure prophylaxis|pre-exposure prophylaxis
5086247|NCT03459144|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5086248|NCT03459144|photodynamic therapy|photodynamic therapy
5086249|NCT03459144|ranibizumab|ranibizumab
5086250|NCT03459144|combination therapy|combination therapy
5086251|NCT03459144|cost-benefit|cost-benefit
5086252|NCT03459092|Botulinum toxin, strabismus surgery, binocular vision|botulinum toxin, strabismus surgery, binocular vision
5086253|NCT03459066|Spasticity|spasticity
5086254|NCT03459066|Stroke|stroke
5086255|NCT03459066|Predictors|predictors
5086256|NCT03459066|Functionality|functionality
5086262|NCT03459014|Robot-Assisted Gait Training|robot-assisted gait training
5086263|NCT03459014|Virtual Reality|virtual reality
5086264|NCT03459014|Optic Flow|optic flow
5086265|NCT03459014|Active Participation|active participation
5086266|NCT03458988|Blood pressure measuring|blood pressure measuring
5086267|NCT03458975|microbubbles|microbubbles
5086268|NCT03458975|sonoporation|sonoporation
5086269|NCT03458975|hepatic metastases of colorectal cancer|hepatic metastases of colorectal cancer
5086270|NCT03458962|Nicklaus Children's|nicklaus children's
5086271|NCT03458962|Pediatric|pediatric
5086272|NCT03458962|Genomic|genomic
5086273|NCT03458962|Precision Medicine|precision medicine
5086274|NCT03458962|Biorepository|biorepository
5086275|NCT03458962|Rady Children's|rady children's
5086276|NCT03458936|Depression|depression
5086277|NCT03458936|Adolescence|adolescence
5086278|NCT03458936|Resilience|resilience
5086279|NCT03458936|Risk Factor|risk factor
5086280|NCT03458936|Biomarker|biomarker
5086281|NCT03458923|Diclofenac|diclofenac
5086282|NCT03458923|Ranibizumab|ranibizumab
5086283|NCT03458923|Diabetic Macular Edema|diabetic macular edema
5086284|NCT03458910|heart rate variability, HRV|heart rate variability, hrv
5086285|NCT03458897|bone marrow cellularity|bone marrow cellularity
5086286|NCT03458897|bone marrow transplant|bone marrow transplant
5086287|NCT03458884|Stroke|stroke
5086288|NCT03458884|Fatigue|fatigue
5086289|NCT03458884|PROBE design|probe design
5086290|NCT03458884|Cardiorespiratory fitness|cardiorespiratory fitness
5086291|NCT03458884|Cardiorespiratory training|cardiorespiratory training
5086292|NCT03458871|electric stimulation|electric stimulation
5086293|NCT03458845|Cirrhosis|cirrhosis
5086294|NCT03458845|Sarcopenia|sarcopenia
5086295|NCT03458845|Malnutrition|malnutrition
5086296|NCT03458845|Inguinal hernia|inguinal hernia
5086297|NCT03458845|Umbilical hernia|umbilical hernia
5086298|NCT03458845|Undernutrition|undernutrition
5086299|NCT03458832|muscular dystrophy.|muscular dystrophy.
5086300|NCT03458832|FSHD|fshd
5086301|NCT03458806|Auscultation|auscultation
5086302|NCT03458806|Phonocardiogram|phonocardiogram
5086303|NCT03458806|Machine Learning|machine learning
5086304|NCT03458806|Heart Sounds|heart sounds
5086305|NCT03458793|randomised controlled study|randomised controlled study
5086306|NCT03458793|physical activity|physical activity
5086307|NCT03458793|loneliness|loneliness
5086308|NCT03458780|yellow fever vaccine|yellow fever vaccine
5086309|NCT03458780|immune response|immune response
5086310|NCT03458780|"droplet microfluidics single cell (inDrop) RNA-Seq"|"droplet microfluidics single cell (indrop) rna-seq"
5086311|NCT03458767|Cognitive function|cognitive function
5086312|NCT03458767|Physical activity|physical activity
5086313|NCT03458767|Self-management|self-management
5086314|NCT03458754|Peripheral Arterial Disease|peripheral arterial disease
5086315|NCT03458754|Exercise capacity|exercise capacity
5086316|NCT03458754|Physical activity|physical activity
5086342|NCT03458533|Metabolic syndrome|metabolic syndrome
5086344|NCT03458507|Neuromuscular diseases|neuromuscular diseases
5086345|NCT03458507|Non-invasive ventilation|non-invasive ventilation
5086346|NCT03458507|Nasal mask|nasal mask
5086347|NCT03458507|Oronasal mask|oronasal mask
5086348|NCT03458507|Alveolar hypoventilation|alveolar hypoventilation
5134733|NCT03151564|CT|ct
5086349|NCT03458507|leaks|leaks
5086350|NCT03458507|Sleep disorder breathing|sleep disorder breathing
5086351|NCT03458507|Side effects|side effects
5086352|NCT03458494|type 2 diabetes|type 2 diabetes
5086353|NCT03458494|glucose|glucose
5086354|NCT03458494|insulin|insulin
5086355|NCT03458494|CRP|crp
5086356|NCT03458494|Metabolomics|metabolomics
5086357|NCT03458494|gene-diet interaction|gene-diet interaction
5086358|NCT03458494|TCF7L2|tcf7l2
5086359|NCT03458481|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
5086360|NCT03458468|tranexamic acid|tranexamic acid
5086361|NCT03458468|anterior shoulder instability|anterior shoulder instability
5086362|NCT03458468|latarjet|latarjet
5086363|NCT03458468|hematoma|hematoma
5086364|NCT03458455|TREATMENT|treatment
5086365|NCT03458455|Vessel Architectural Imaging|vessel architectural imaging
4970572|NCT04174417|HIF 1a|hif 1a
5086366|NCT03458455|Brain Metastases|brain metastases
5086367|NCT03458442|education|education
5086368|NCT03458442|developing country|developing country
5086369|NCT03458442|developing countries|developing countries
5086370|NCT03458442|low-and middle-income country|low-and middle-income country
5086371|NCT03458442|low-and middle-income countries|low-and middle-income countries
5086372|NCT03458442|surgical training|surgical training
5086373|NCT03458442|blindness|blindness
5086374|NCT03458442|china|china
5086375|NCT03458442|simulation|simulation
5086376|NCT03458442|model|model
5086377|NCT03458429|Young Donor Plasma|young donor plasma
5086378|NCT03458429|Frailty|frailty
5086379|NCT03458429|Aging|aging
5086380|NCT03458429|Immune Function|immune function
5086381|NCT03458429|G-CSF|g-csf
5086382|NCT03458403|Digestive endoscopy|digestive endoscopy
5086383|NCT03458403|Tracking motion|tracking motion
5086384|NCT03458377|Colonoscopy|colonoscopy
5086385|NCT03458377|Quality|quality
5086386|NCT03458377|Telephone intervention|telephone intervention
5086387|NCT03458364|Weaning; Noninvasive ventilation; High flow nasal cannula|weaning; noninvasive ventilation; high flow nasal cannula
5086388|NCT03458351|platelet activation|platelet activation
5086389|NCT03458351|remote ischemic preconditioning|remote ischemic preconditioning
5086390|NCT03458338|chronic kidney disease|chronic kidney disease
5086391|NCT03458338|communicable disease|communicable disease
5086392|NCT03458338|sub-Saharan Africa|sub-saharan africa
5086393|NCT03458338|Tanzania|tanzania
5086394|NCT03458338|neglected disease|neglected disease
5086395|NCT03458338|prevalence|prevalence
5086396|NCT03458338|double burden|double burden
5086397|NCT03458299|American Indian|american indian
5086398|NCT03458286|Diabetic Foot Ulcers|diabetic foot ulcers
5086399|NCT03458286|Chronic|chronic
5086400|NCT03458286|Combined ultrasound and electric current stimulation|combined ultrasound and electric current stimulation
5086401|NCT03458286|Adjunctive therapy|adjunctive therapy
5086402|NCT03458273|Atrial Arrhythmia|atrial arrhythmia
5086403|NCT03458273|Ventricular Arrythmia|ventricular arrythmia
5086404|NCT03458273|ablation|ablation
5086405|NCT03458273|fluoroscopy|fluoroscopy
5086406|NCT03458260|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5086407|NCT03458260|relapsed or refractory|relapsed or refractory
5086408|NCT03458247|Prostate Cancer|prostate cancer
5086409|NCT03458247|Castration resistance|castration resistance
5086410|NCT03458247|Drug monitoring|drug monitoring
5086411|NCT03458247|Abiraterone acetate|abiraterone acetate
5084816|NCT03468673|AIDS|aids
5086427|NCT03458143|remifentanil|remifentanil
5086428|NCT03458078|Bupivacaine,|bupivacaine,
5086429|NCT03458078|Anesthetics|anesthetics
5086430|NCT03458078|Adjuvants|adjuvants
5086431|NCT03458078|Analgesics|analgesics
5086432|NCT03458078|Peripheral system|peripheral system
5086433|NCT03458078|Central Nervous|central nervous
5086434|NCT03458078|sensory system|sensory system
5086435|NCT03458078|Agents|agents
5086436|NCT03458078|Physiological effects of drugs|physiological effects of drugs
5086437|NCT03458078|opioid|opioid
5086438|NCT03458078|Pain|pain
5086439|NCT03458078|Postoperative|postoperative
5086440|NCT03458078|Signs and Symptoms|signs and symptoms
5086441|NCT03458052|Intensive and critical care|intensive and critical care
5086442|NCT03458052|Organ donation|organ donation
5086443|NCT03458052|Knowledge|knowledge
5086444|NCT03458039|mental health capacity building|mental health capacity building
5086445|NCT03458039|low and middle-income country|low and middle-income country
5086446|NCT03458039|train the trainer strategy|train the trainer strategy
5086447|NCT03458039|technology-based training|technology-based training
5086448|NCT03458026|activity|activity
5086449|NCT03458026|Connected object|connected object
5086450|NCT03458013|Mindfulness|mindfulness
5086451|NCT03458013|Complementary Medicine|complementary medicine
5086452|NCT03458013|Integrative Health|integrative health
5086453|NCT03458013|Hand Therapy|hand therapy
5086454|NCT03457987|protein load|protein load
5086472|NCT03457896|BRAF|braf
5086473|NCT03457896|PIK3CA wild-type|pik3ca wild-type
5086474|NCT03457896|Quadruple wild-type|quadruple wild-type
5086475|NCT03457896|HER2 status|her2 status
5086476|NCT03457883|Pelvic organ prolapse|pelvic organ prolapse
5086477|NCT03457883|Vaginal mesh|vaginal mesh
5086478|NCT03457883|biological graft|biological graft
5086479|NCT03457883|Recurrence|recurrence
5086486|NCT03457857|Microbiome|microbiome
5086487|NCT03457857|Microbiota|microbiota
5086488|NCT03457818|Prolia|prolia
5086489|NCT03457818|Denosumab|denosumab
5086490|NCT03457818|Diabetes|diabetes
5086491|NCT03457805|prostate cancer|prostate cancer
5086492|NCT03457805|prostate|prostate
5086493|NCT03457805|embolization|embolization
5086494|NCT03457805|minimally invasive|minimally invasive
5086495|NCT03457805|cytoreductive therapy|cytoreductive therapy
5086496|NCT03457753|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5086497|NCT03457740|muscular strength|muscular strength
5086498|NCT03457740|testosterone|testosterone
5086499|NCT03457740|sexual function|sexual function
5086500|NCT03457740|quality of life|quality of life
5086501|NCT03457727|Danirixin|danirixin
5086502|NCT03457727|Healthy|healthy
5086503|NCT03457727|Food effect|food effect
5086504|NCT03457727|Relative Bioavailability|relative bioavailability
5086505|NCT03457727|Hydrobromide Salt|hydrobromide salt
5086506|NCT03457714|spinal cord injuries|spinal cord injuries
5086507|NCT03457714|anxiety|anxiety
5086508|NCT03457714|depression|depression
5086509|NCT03457714|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5086510|NCT03457714|pilot study|pilot study
5086511|NCT03457701|recombinant human erythropoietin|recombinant human erythropoietin
5086512|NCT03457701|anemia|anemia
5086513|NCT03457701|daprodustat|daprodustat
5086514|NCT03457701|chronic kidney disease|chronic kidney disease
5086521|NCT03457610|chronic cough|chronic cough
5740681|NCT00355576|Combination|combination
5086522|NCT03457610|speech and language intervention|speech and language intervention
5086523|NCT03457610|difficult-to-treat cough|difficult-to-treat cough
5086524|NCT03457532|Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity|safety, tolerability, pharmacokinetics, anti-tumor activity
5086525|NCT03457519|ChARM|charm
5086526|NCT03457519|community health worker|community health worker
5086527|NCT03457506|Cancer|cancer
5086528|NCT03457506|Digital pet|digital pet
5086529|NCT03457506|Conventional pet|conventional pet
5086530|NCT03457480|Cancer Prevention|cancer prevention
5086531|NCT03457480|Focus Group|focus group
5086532|NCT03457480|Text messaging|text messaging
5086533|NCT03457480|Questionnaires|questionnaires
5086535|NCT03457467|oligometacosis|oligometacosis
5086536|NCT03457467|anti-angiogenic|anti-angiogenic
5086537|NCT03457467|apatinib|apatinib
5086538|NCT03457428|obstructive sleep apnea|obstructive sleep apnea
5086539|NCT03457428|home sleep testing|home sleep testing
5086540|NCT03457415|LDCT|ldct
5086541|NCT03457415|Sputum|sputum
5086542|NCT03457415|High-risk Smoker|high-risk smoker
5086543|NCT03457415|Porphyrin|porphyrin
5086544|NCT03457415|Early detection|early detection
5086547|NCT03457389|Prolactinoma|prolactinoma
5086548|NCT03457389|Cabergoline|cabergoline
5086549|NCT03457389|Recurrence|recurrence
5086565|NCT03457272|Quality Indicators, Health Care|quality indicators, health care
5086566|NCT03457272|Risk Assessment|risk assessment
5086567|NCT03457259|Midline catheter, peripheral venous catheter, central venous catheter, complication rate|midline catheter, peripheral venous catheter, central venous catheter, complication rate
5086568|NCT03457246|solar lentigos|solar lentigos
5086569|NCT03457246|physical Hyperpigmentation therapies|physical hyperpigmentation therapies
5086570|NCT03457246|cosmetic topical depigmenting product|cosmetic topical depigmenting product
5086571|NCT03457246|topical Hyperpigmentation therapies|topical hyperpigmentation therapies
5086573|NCT03457194|Vaccination|vaccination
5086574|NCT03457194|Pregnancy|pregnancy
5086575|NCT03457194|Influenza|influenza
5086576|NCT03457194|Pertussis|pertussis
5086577|NCT03457194|Maternal antibodies|maternal antibodies
5086578|NCT03457168|Sleep-time hypertension|sleep-time hypertension
5086579|NCT03457168|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5086580|NCT03457168|Hypertension chronotherapy|hypertension chronotherapy
5086581|NCT03457168|Asleep blood pressure|asleep blood pressure
5086582|NCT03457168|Cardiovascular risk|cardiovascular risk
5086583|NCT03457168|Type 2 diabetes|type 2 diabetes
5086584|NCT03457168|Chronic kidney disease|chronic kidney disease
5086585|NCT03457129|Epilepsy|epilepsy
5086586|NCT03457129|Epilepsy, partial onset|epilepsy, partial onset
5086587|NCT03457129|Epilepsy, generalized onset|epilepsy, generalized onset
5086588|NCT03457129|Fycompa|fycompa
5086589|NCT03457129|perampanel|perampanel
5086590|NCT03457090|neurologic complication, transcranial Doppler ultrasound|neurologic complication, transcranial doppler ultrasound
5086591|NCT03457077|brief intervention|brief intervention
5086592|NCT03457077|fMRI|fmri
5086593|NCT03457038|Mannose-Binding Lectin, PAMPs,|mannose-binding lectin, pamps,
5086594|NCT03457025|Oxygen Therapy|oxygen therapy
5086595|NCT03457025|Bells Palsy|bells palsy
5086596|NCT03456999|BKV, renal transplant, renal and kidney transplant|bkv, renal transplant, renal and kidney transplant
5086597|NCT03456960|Drug Therapy|drug therapy
5086598|NCT03456934|Protein requirements|protein requirements
5086599|NCT03456934|Adiposity|adiposity
5086600|NCT03456934|Body composition|body composition
5086601|NCT03456934|Cardiovascular health|cardiovascular health
5086602|NCT03456921|health games|health games
5086603|NCT03456921|community engagement|community engagement
5086604|NCT03456921|serious games|serious games
5086605|NCT03456882|AMYOTROPHIC LATERAL SCLEROSIS|amyotrophic lateral sclerosis
5086606|NCT03456882|RNS60|rns60
5086607|NCT03456882|Biomarkers|biomarkers
5086608|NCT03456882|clinical trial|clinical trial
5086609|NCT03456882|therapy|therapy
5086610|NCT03456869|patient specific implant|patient specific implant
5086611|NCT03456869|computer-aided surgery|computer-aided surgery
5086612|NCT03456869|clinical accuracy|clinical accuracy
5086613|NCT03456856|Cardiac|cardiac
5086614|NCT03456856|Congestive|congestive
5086615|NCT03456856|Decompensation|decompensation
5086616|NCT03456856|Heart Failure|heart failure
5086617|NCT03456856|Left-Sided|left-sided
5086618|NCT03456856|Myocardial|myocardial
5086619|NCT03456856|Corlanor|corlanor
5086620|NCT03456856|Ivabradine|ivabradine
5086621|NCT03456856|African American|african american
5086623|NCT03456856|Michigan|michigan
5086628|NCT03456791|Epididymal secretory protein E4|epididymal secretory protein e4
5423365|NCT01615926|respiratory rate|respiratory rate
5086631|NCT03456778|Platelet-rich plasma (PRP) injection|platelet-rich plasma (prp) injection
5086632|NCT03456778|Shear Wave Elastography|shear wave elastography
5086633|NCT03456752|Inflammatory Bowel Diseases|inflammatory bowel diseases
5086634|NCT03456752|Glucocorticosteroids|glucocorticosteroids
5086635|NCT03456752|Postoperative Outcome|postoperative outcome
5086636|NCT03456726|EZH2 gene mutation|ezh2 gene mutation
5086637|NCT03456726|Tazemetostat|tazemetostat
5086638|NCT03456726|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5086639|NCT03456726|Follicular lymphoma|follicular lymphoma
5086640|NCT03456687|Exenatide|exenatide
5086641|NCT03456661|Pectoral block|pectoral block
5086642|NCT03456661|Ultrasound|ultrasound
5086643|NCT03456661|Mastectomy|mastectomy
5086644|NCT03456661|Levobupivacaine|levobupivacaine
5086645|NCT03456661|Dexmedetomidine|dexmedetomidine
5086646|NCT03456635|antimicrobial|antimicrobial
5086647|NCT03456635|prophylaxys|prophylaxys
5086648|NCT03456635|CDSS|cdss
5086650|NCT03456596|CBPR|cbpr
5086659|NCT03456375|artificial endometrial preparation cycle|artificial endometrial preparation cycle
5086660|NCT03456375|endometrial receptivity|endometrial receptivity
5086661|NCT03456349|Alzheimer's disease|alzheimer's disease
5086662|NCT03456323|Critical Illness|critical illness
5086663|NCT03456323|Frailty|frailty
5086664|NCT03456323|Palliative Care|palliative care
5086665|NCT03456297|Web-based clinical pedagogy program|web-based clinical pedagogy program
5086666|NCT03456297|nurse preceptors|nurse preceptors
5086667|NCT03456297|teaching competency|teaching competency
5086668|NCT03456232|hemodialysis|hemodialysis
5086669|NCT03456232|hemodiafiltration|hemodiafiltration
5086670|NCT03456232|end-stage renal disease|end-stage renal disease
5086671|NCT03456219|Food intake|food intake
5086672|NCT03456219|Sleep|sleep
5086673|NCT03456219|Shift work|shift work
5086674|NCT03456219|Postprandial metabolic response|postprandial metabolic response
5086675|NCT03456206|Life Style|life style
5086676|NCT03456206|Diet|diet
5086677|NCT03456206|Food|food
5086679|NCT03456206|Disease risk|disease risk
5086680|NCT03456180|septic shock|septic shock
5086681|NCT03456180|microcirculation|microcirculation
5086682|NCT03456180|acute renal failure|acute renal failure
5086683|NCT03456180|renal replacement therapy|renal replacement therapy
5086684|NCT03456180|haemoadsorption|haemoadsorption
5086685|NCT03456167|telemedicine|telemedicine
5086686|NCT03456167|mobile applications|mobile applications
5086687|NCT03456167|ERAS|eras
5086688|NCT03456167|postoperative care|postoperative care
5086689|NCT03456167|patient satisfaction|patient satisfaction
5086690|NCT03456167|breast reconstruction|breast reconstruction
5086691|NCT03456167|gynecologic oncology|gynecologic oncology
5086692|NCT03456167|mastectomy|mastectomy
5086693|NCT03456128|Older Adult|older adult
5086694|NCT03456128|Rehospitalization|rehospitalization
5086695|NCT03456128|Physical function|physical function
5086696|NCT03456115|nasal obstruction|nasal obstruction
5086697|NCT03456115|nasal valve collapse|nasal valve collapse
5086698|NCT03456089|urodynamics|urodynamics
5086699|NCT03456089|neurogenic|neurogenic
5086700|NCT03456089|bladder|bladder
5086701|NCT03456076|NSCLC, alectinib, ALK positive,adjuvant treatment, platinum based chemotherapy, complete resection, Stage IB-IIIA.|nsclc, alectinib, alk positive,adjuvant treatment, platinum based chemotherapy, complete resection, stage ib-iiia.
5086702|NCT03456037|HBsAg|hbsag
5086703|NCT03456037|Anti-HCV,|anti-hcv,
5086704|NCT03456037|seropositivity|seropositivity
5086705|NCT03455998|morbid obesity|morbid obesity
5086706|NCT03455998|gastric bypass|gastric bypass
5086707|NCT03455998|pain|pain
5086708|NCT03455998|symptoms|symptoms
5086709|NCT03455959|Asthma|asthma
5086710|NCT03455959|Allergic|allergic
5086711|NCT03455959|Inflammation|inflammation
5086712|NCT03455959|Airway|airway
5086713|NCT03455946|Digital Health|digital health
5086714|NCT03455946|Amazon Alexa|amazon alexa
5086715|NCT03455907|Bevacizumab|bevacizumab
5086716|NCT03455894|Fall detection|fall detection
5086717|NCT03455894|Smart carpet|smart carpet
5086718|NCT03455894|Elderly people|elderly people
5086720|NCT03455881|EA|ea
5086721|NCT03455881|Tracheal Esophageal birth Defect (TED)|tracheal esophageal birth defect (ted)
5086722|NCT03455855|Atherectomy|atherectomy
5086723|NCT03455855|occlusive atherosclerotic lesions|occlusive atherosclerotic lesions
5086724|NCT03455829|Lung Cancer|lung cancer
5086725|NCT03455829|Non-small Cell Lung Cancer|non-small cell lung cancer
5423366|NCT01615926|orthopnea|orthopnea
5086726|NCT03455829|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5086727|NCT03455829|EGFR-Positive|egfr-positive
5086728|NCT03455829|EGFR Mutation- Positive|egfr mutation- positive
5086729|NCT03455829|T790M|t790m
5086730|NCT03455829|EGFR Mutant|egfr mutant
5086731|NCT03455816|mobile app|mobile app
5086732|NCT03455790|Wheelchair Basketball,|wheelchair basketball,
5086733|NCT03455790|Isokinetic|isokinetic
5086734|NCT03455790|Anaerobic Capacity|anaerobic capacity
5086735|NCT03455790|Shoulder Muscle Strength|shoulder muscle strength
5086736|NCT03455790|Aerobic Capacity,|aerobic capacity,
5086737|NCT03455790|Sportive Performance|sportive performance
5086738|NCT03455764|Melanoma|melanoma
5086739|NCT03455751|Pain Management|pain management
5086740|NCT03455751|Pharmacogenomics|pharmacogenomics
5086741|NCT03455738|Vasoplegia, norepinephrine, dynamic arterial elastance|vasoplegia, norepinephrine, dynamic arterial elastance
5085120|NCT03466489|total joint arthroplasty|total joint arthroplasty
5086742|NCT03455725|Cardiovascular Stem Cell Therapy|cardiovascular stem cell therapy
5086743|NCT03455725|Bone Marrow Mononuclear Stem Cells|bone marrow mononuclear stem cells
5086744|NCT03455725|Intramyocardial Injection|intramyocardial injection
5086745|NCT03455712|Pregnancy|pregnancy
5086746|NCT03455712|Gestational weight gain|gestational weight gain
5086747|NCT03455712|Weight gain|weight gain
5086748|NCT03455712|Patient education|patient education
5086749|NCT03455712|Patient knowledge|patient knowledge
5086750|NCT03455712|Institute of Medicine|institute of medicine
5086751|NCT03455699|GSV|gsv
5086752|NCT03455686|magnetic resonance imaging|magnetic resonance imaging
5086761|NCT03455634|quality of life|quality of life
5086762|NCT03455621|dental caries|dental caries
5086763|NCT03455621|fluoride|fluoride
5086764|NCT03455621|toothpaste|toothpaste
5086765|NCT03455621|dentifrice|dentifrice
5086766|NCT03455608|dysphagia|dysphagia
5086767|NCT03455608|swallowing disorder|swallowing disorder
5086768|NCT03455608|speech pathology|speech pathology
5086769|NCT03455608|swallowing therapy|swallowing therapy
5086770|NCT03455608|head and neck cancer|head and neck cancer
5086771|NCT03455608|radiotherapy|radiotherapy
5086772|NCT03455608|toxicity|toxicity
5086773|NCT03455608|supportive care|supportive care
5086774|NCT03455582|cognitive impairment|cognitive impairment
5086775|NCT03455582|ecological assessment|ecological assessment
5086776|NCT03455582|brain MRI|brain mri
5086777|NCT03455569|Behavioral sleep management|behavioral sleep management
5086778|NCT03455569|Alzheimer's disease|alzheimer's disease
5086779|NCT03455569|Informal caregiver|informal caregiver
5086780|NCT03455517|Chronic myeloid leukemia|chronic myeloid leukemia
5086781|NCT03455517|Umutated IGVH|umutated igvh
5086782|NCT03455517|Disrupted TP53|disrupted tp53
5086783|NCT03455504|Acute myeloid leukemia|acute myeloid leukemia
5086784|NCT03455504|Venetoclax|venetoclax
5086785|NCT03455413|electrical impedance tomography|electrical impedance tomography
5086786|NCT03455387|sFLt1|sflt1
5086787|NCT03455387|PlGF|plgf
5086788|NCT03455361|implant stability, dental implants, primary stability|implant stability, dental implants, primary stability
5086789|NCT03455309|Als3|als3
5086790|NCT03455309|SSTI|ssti
5086791|NCT03455309|vaccine|vaccine
5086792|NCT03455309|NDV-3A|ndv-3a
5086793|NCT03455309|incident nasal colonization|incident nasal colonization
5086803|NCT03455231|palliative care|palliative care
5086804|NCT03455231|complicated bone metastases|complicated bone metastases
5086805|NCT03455231|radiotherapy|radiotherapy
5086806|NCT03455231|pain|pain
5086807|NCT03455231|quality of life|quality of life
5086808|NCT03455218|Cardiopulmonary Bypass|cardiopulmonary bypass
5086809|NCT03455218|Infant|infant
5086810|NCT03455218|Nitric Oxide|nitric oxide
5086811|NCT03455218|Thrombocytopenia|thrombocytopenia
5086812|NCT03455218|Blood Platelets|blood platelets
5086813|NCT03455192|gingivitis|gingivitis
5086814|NCT03455192|gingival crevicular fluid|gingival crevicular fluid
5086815|NCT03455192|probiotics|probiotics
5086816|NCT03455192|smoking|smoking
5086817|NCT03455192|periodontal medicine|periodontal medicine
5086818|NCT03455179|Older|older
5086819|NCT03455179|Physical function|physical function
5086820|NCT03455179|Power training|power training
5086821|NCT03455179|Oxidative stress|oxidative stress
5086822|NCT03455179|Elastic band|elastic band
5086823|NCT03455179|OMNI-RES perceived exertion scale|omni-res perceived exertion scale
5086824|NCT03455179|Strength training|strength training
5086825|NCT03455153|Pulmonary Rehabilitation|pulmonary rehabilitation
5086826|NCT03455153|Neutrophils|neutrophils
5086827|NCT03455140|Arginine|arginine
5086828|NCT03455140|Arginase|arginase
5086829|NCT03455140|Children|children
5086830|NCT03455140|Young Adult|young adult
5086831|NCT03455127|Child Development|child development
5086832|NCT03455127|Home Visiting|home visiting
5086833|NCT03455127|Parenting Program|parenting program
5086834|NCT03455127|Social Protection|social protection
5086835|NCT03455127|Public Works|public works
5086836|NCT03455101|Cardiovascular risk status|cardiovascular risk status
5086837|NCT03455101|Optimal metabolic control|optimal metabolic control
5086838|NCT03455075|Healthy Men|healthy men
5086839|NCT03455075|Male Contraception|male contraception
5086840|NCT03455075|Androgen|androgen
5086841|NCT03455075|Dimethandrolone|dimethandrolone
5086842|NCT03455075|Levonorgestrel|levonorgestrel
5086847|NCT03455010|Ambulatory load|ambulatory load
5086848|NCT03455010|Biomarker|biomarker
5086849|NCT03455010|Articular cartilage|articular cartilage
5086850|NCT03454945|Mycosis fungoides|mycosis fungoides
5086851|NCT03454945|Doxycycline|doxycycline
5086852|NCT03454932|Rheumatoid Arthritis|rheumatoid arthritis
5086853|NCT03454932|Psoriatic Arthritis|psoriatic arthritis
5086854|NCT03454932|Spondylarthritis|spondylarthritis
5086855|NCT03454932|Rheumatic diseases|rheumatic diseases
5086878|NCT03454815|Apical Patency|apical patency
5086879|NCT03454815|Root Canal Treatment|root canal treatment
5086880|NCT03454789|brachial plexus block|brachial plexus block
5086881|NCT03454789|local anesthetic mixture solution|local anesthetic mixture solution
5086882|NCT03454789|axillary-supraclavicular approach|axillary-supraclavicular approach
5086883|NCT03454789|outcome quality|outcome quality
5086884|NCT03454789|lidocaine, bupivacaine|lidocaine, bupivacaine
5086891|NCT03454750|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5086892|NCT03454750|68Ga-PSMA PET/CT positive|68ga-psma pet/ct positive
5086893|NCT03454724|BioResorbable Vascular Scaffold System|bioresorbable vascular scaffold system
5086895|NCT03454711|Food addictions|food addictions
5086896|NCT03454711|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5086897|NCT03454711|Metabolomics|metabolomics
5086898|NCT03454633|Hyperthermic circulatory arrest; Surgery|hyperthermic circulatory arrest; surgery
5086899|NCT03454607|FREE|free
5086900|NCT03454607|Robotic|robotic
5086901|NCT03454594|hypertension|hypertension
5086902|NCT03454594|high blood viscosity|high blood viscosity
5086903|NCT03454594|hypercholesterolemia|hypercholesterolemia
5086904|NCT03454581|Temporomandibular Diseases|temporomandibular diseases
5086905|NCT03454581|Photobiomodulation|photobiomodulation
5086906|NCT03454581|Low level laser|low level laser
5086907|NCT03454581|Treatment|treatment
5086908|NCT03454581|Manual Therapy|manual therapy
5086910|NCT03454555|Pragmatic Clinical Trial|pragmatic clinical trial
5086911|NCT03454555|Comparative Effectiveness Research|comparative effectiveness research
5086912|NCT03454555|Analgesics, Opioid|analgesics, opioid
5086913|NCT03454555|Decision Making, Shared|decision making, shared
5086914|NCT03454555|Motivational Interviewing|motivational interviewing
5086915|NCT03454555|Cognitive Therapy|cognitive therapy
5086916|NCT03454555|Patient Reported Outcome Measures|patient reported outcome measures
5086917|NCT03454516|Hypertension|hypertension
5086918|NCT03454516|Telemonitoring|telemonitoring
5086919|NCT03454516|Digital Health|digital health
5086920|NCT03454503|Imatinib|imatinib
5086921|NCT03454503|Generic Imatinib|generic imatinib
5086922|NCT03454503|Leukemia|leukemia
5086923|NCT03454503|Chronic myeloid leukemia|chronic myeloid leukemia
5086924|NCT03454503|Philadelphia chromosome-positive|philadelphia chromosome-positive
5086925|NCT03454503|Chronic phase|chronic phase
5086926|NCT03454503|Observational study|observational study
5086927|NCT03454503|Switched patients|switched patients
5086928|NCT03454503|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5086929|NCT03454490|Gingival graft|gingival graft
5086930|NCT03454490|Pseudoaneurysm|pseudoaneurysm
5086931|NCT03454490|Postoperative complication|postoperative complication
5086932|NCT03454490|Gingival recession treatment|gingival recession treatment
5086933|NCT03454490|Palatine mass|palatine mass
5086934|NCT03454490|Palatine bleeding|palatine bleeding
5086935|NCT03454477|Endoscopy|endoscopy
5086936|NCT03454477|Robotics|robotics
5086937|NCT03454477|Thyroidectomy|thyroidectomy
5086938|NCT03454477|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
5086957|NCT03454425|Parkinson's Disease|parkinson's disease
5086958|NCT03454425|ExAblate|exablate
5086959|NCT03454425|MRgFUS|mrgfus
5086960|NCT03454425|Sub-Thalamotomy|sub-thalamotomy
5086964|NCT03454386|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5086965|NCT03454386|Stress|stress
5086966|NCT03454386|Resilience|resilience
5086967|NCT03454386|Stress Management and Resilience Training Program (SMART)|stress management and resilience training program (smart)
5086968|NCT03454373|HIV|hiv
5086969|NCT03454373|Food Insecurities|food insecurities
5740682|NCT00355576|Selection|selection
5086970|NCT03454373|Antiretroviral Therapy|antiretroviral therapy
5086971|NCT03454360|TAVI|tavi
5086972|NCT03454360|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5086973|NCT03454360|Transcatheter Aortic Valve|transcatheter aortic valve
5086974|NCT03454360|Transapical Access|transapical access
5086975|NCT03454321|Rotator cuff tendinopathy|rotator cuff tendinopathy
5086976|NCT03454321|ultrasound|ultrasound
5086977|NCT03454321|subacromial bursitis|subacromial bursitis
5086978|NCT03454321|steroid injection|steroid injection
5086979|NCT03454295|Cancer Caregivers|cancer caregivers
5086980|NCT03454295|Caregiver|caregiver
5086981|NCT03454295|Caregivers|caregivers
5086982|NCT03454295|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5086983|NCT03454295|18-075|18-075
5086984|NCT03454282|Breast|breast
5086985|NCT03454282|Cancer|cancer
5086986|NCT03454282|Malignant|malignant
5086987|NCT03454282|Melanoma|melanoma
5086988|NCT03454282|Fasting Mimicking Diet (FMD)|fasting mimicking diet (fmd)
5086989|NCT03454282|Tumor|tumor
5086990|NCT03454282|Immunity|immunity
5086991|NCT03454282|Metabolic Effects|metabolic effects
5086992|NCT03454282|Immunological Effects|immunological effects
5086993|NCT03454269|Parkinson disease|parkinson disease
5086994|NCT03454269|Visual Hallucinations|visual hallucinations
5087001|NCT03454256|Gait|gait
5087002|NCT03454243|Solid Tumors|solid tumors
5087003|NCT03454243|TYRO3|tyro3
5087004|NCT03454243|AXL|axl
5087005|NCT03454243|MER|mer
5087006|NCT03454243|Receptor tyrosine kinases (RTKs)|receptor tyrosine kinases (rtks)
5087007|NCT03454243|Checkpoint inhibitors|checkpoint inhibitors
5087008|NCT03454243|Melanoma|melanoma
5087009|NCT03454243|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5087010|NCT03454243|Squamous cell carcinoma|squamous cell carcinoma
5087011|NCT03454243|Hodgkin lymphoma|hodgkin lymphoma
5087012|NCT03454243|Urothelial carcinoma|urothelial carcinoma
5087013|NCT03454243|Microsatellite instability-high carcinomas|microsatellite instability-high carcinomas
5087014|NCT03454243|TAM Inhibitor|tam inhibitor
5087015|NCT03454230|Intensive care unit|intensive care unit
5087016|NCT03454230|ICU|icu
5087017|NCT03454230|adult critical care patients|adult critical care patients
5087018|NCT03454230|repositioning schedule|repositioning schedule
5087019|NCT03454230|patient handling|patient handling
5087020|NCT03454230|practical nursing|practical nursing
5087021|NCT03454230|nursing care|nursing care
5087022|NCT03454230|pressure ulcers|pressure ulcers
5087023|NCT03454230|decubitus ulcers|decubitus ulcers
5087024|NCT03454230|pressure injury|pressure injury
5087025|NCT03454178|AOBP|aobp
5087026|NCT03454178|ABPM|abpm
5087027|NCT03454139|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5087028|NCT03454139|subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
5087029|NCT03454139|pain|pain
5087030|NCT03454139|paracetamol|paracetamol
5087031|NCT03454139|tramadol|tramadol
5087032|NCT03454139|morphine|morphine
5087033|NCT03454139|nephrolithiasis|nephrolithiasis
5087034|NCT03454139|lidocaine|lidocaine
5087035|NCT03454139|bupivacaine|bupivacaine
5087036|NCT03454126|Chronic pain|chronic pain
5087037|NCT03454126|Neuropathic pain|neuropathic pain
5087038|NCT03454126|Neuralgia|neuralgia
5087039|NCT03454126|Healthy volunteers|healthy volunteers
5087040|NCT03454113|dialysis autogenous arterio-venous fistula|dialysis autogenous arterio-venous fistula
5087041|NCT03454087|enteral nutrition|enteral nutrition
5087042|NCT03454087|inflammation|inflammation
5087043|NCT03454087|incretin hormones|incretin hormones
5087044|NCT03454087|microbiome|microbiome
5087045|NCT03454074|healthy aging|healthy aging
5087046|NCT03454074|behavior change|behavior change
5087047|NCT03454074|older adults|older adults
5087048|NCT03454061|sport|sport
5087049|NCT03454061|physical activity|physical activity
5087050|NCT03454061|education|education
5087051|NCT03454061|fundamental motor skills|fundamental motor skills
5087052|NCT03454061|childhood|childhood
5087053|NCT03454061|exercise|exercise
5087054|NCT03454061|health|health
5087055|NCT03454061|training|training
5087056|NCT03454061|intervention|intervention
5087057|NCT03454061|gross motor development|gross motor development
5087058|NCT03454009|multi-modal intervention;|multi-modal intervention;
5087059|NCT03454009|office-based employees|office-based employees
5087060|NCT03454009|hand hygiene|hand hygiene
5087061|NCT03454009|hand sanitizer|hand sanitizer
5087062|NCT03454009|hand sanitizer surface wipes|hand sanitizer surface wipes
5087063|NCT03454009|self-reported infections|self-reported infections
5087064|NCT03454009|absenteeism|absenteeism
5087065|NCT03454009|presenteeism|presenteeism
5087066|NCT03453996|acute kidney injury|acute kidney injury
5087067|NCT03453996|heart disease|heart disease
5087068|NCT03453996|cardiac catheterization|cardiac catheterization
5740683|NCT00355576|ALS|als
5087069|NCT03453983|Neurodevelopment|neurodevelopment
5087070|NCT03453983|Pediatrics|pediatrics
5087071|NCT03453983|Motor Learning|motor learning
5087072|NCT03453983|Brain Imaging|brain imaging
5087073|NCT03453983|Neuroscience|neuroscience
5087074|NCT03453970|patient education|patient education
5087075|NCT03453970|self-care|self-care
5087076|NCT03453970|Controlled Trial|controlled trial
5087077|NCT03453957|Practice based research|practice based research
5087078|NCT03453944|Expiratory muscles|expiratory muscles
5087079|NCT03453944|Mechanically ventilated patients|mechanically ventilated patients
5087080|NCT03453944|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5087081|NCT03453944|Respiratory function|respiratory function
5087082|NCT03453944|Ventilator-acquired muscle atrophy|ventilator-acquired muscle atrophy
5087083|NCT03453931|Corticosteroids|corticosteroids
5087084|NCT03453931|Arrhythmia|arrhythmia
5087085|NCT03453931|Heart Rate Variability|heart rate variability
5087086|NCT03453931|Albuminuria|albuminuria
5087087|NCT03453918|Iron absorption|iron absorption
5087088|NCT03453918|Polyphenols|polyphenols
5087102|NCT03453866|Hip Arthroscopy|hip arthroscopy
5087103|NCT03453866|Warmed Fluids|warmed fluids
5087104|NCT03453853|Percutaneous mitral valve repair|percutaneous mitral valve repair
5087105|NCT03453853|Coronary sinus annuloplasty|coronary sinus annuloplasty
5087106|NCT03453853|Mitral loop cerclage|mitral loop cerclage
5087107|NCT03453853|atrial fibrillation|atrial fibrillation
4957227|NCT04256187|caregivers|caregivers
4957231|NCT04256148|Warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
4957235|NCT04256135|Mulligan mobilization|mulligan mobilization
5087108|NCT03453853|Mitral Regurgitation|mitral regurgitation
5087109|NCT03453840|malaria|malaria
5087110|NCT03453840|HIV|hiv
5087111|NCT03453840|Children|children
5087112|NCT03453840|Efavirenz|efavirenz
5087113|NCT03453840|artemether|artemether
5087114|NCT03453840|lumefantrine|lumefantrine
5087115|NCT03453827|Pseudoexfoliation Syndrome|pseudoexfoliation syndrome
5087116|NCT03453827|Cataract|cataract
5087117|NCT03453827|Aberration|aberration
5087118|NCT03453827|IOL decentration|iol decentration
5087119|NCT03453827|IOL tilt|iol tilt
5087120|NCT03453814|PICU|picu
5087121|NCT03453814|critical care|critical care
5087122|NCT03453814|music|music
5087123|NCT03453814|music therapy|music therapy
5087124|NCT03453814|agitation|agitation
5087125|NCT03453801|Inactivated, influenza vaccine quadrivalent|inactivated, influenza vaccine quadrivalent
5087126|NCT03453801|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
5087127|NCT03453801|Young children|young children
5087128|NCT03453801|Identical twins|identical twins
5087129|NCT03453788|follow up|follow up
5087130|NCT03453788|side effects|side effects
5087131|NCT03453788|smartphone app|smartphone app
5087132|NCT03453788|physical activity|physical activity
5087133|NCT03453788|empowerment|empowerment
5087134|NCT03453788|patient reported outcomes|patient reported outcomes
5087135|NCT03453749|Traumatic brain injury|traumatic brain injury
5087136|NCT03453749|Cerebral edema|cerebral edema
5087137|NCT03453749|Microdialysis|microdialysis
5087138|NCT03453749|Inflammatory cytokines|inflammatory cytokines
5087139|NCT03453736|Robotic surgery|robotic surgery
5087140|NCT03453736|theatre staff|theatre staff
5087141|NCT03453736|teamwork|teamwork
5087142|NCT03453736|patient safety|patient safety
5087143|NCT03453723|hypnoanalgesia|hypnoanalgesia
5087144|NCT03453723|lidocaine|lidocaine
5087145|NCT03453723|propofol|propofol
5087146|NCT03453723|children|children
5087147|NCT03453710|Bankart Repair|bankart repair
5087148|NCT03453710|Remplissage|remplissage
5087149|NCT03453710|Latarjet coracoid transfer|latarjet coracoid transfer
5087150|NCT03453697|Intermittent Hypoxemia|intermittent hypoxemia
5087151|NCT03453697|diffusion tensor imaging|diffusion tensor imaging
5087152|NCT03453697|oxidative stress|oxidative stress
5087153|NCT03453658|Endodontics|endodontics
5087156|NCT03453658|Mechanized instrumentation|mechanized instrumentation
5087157|NCT03453645|ablation|ablation
5087158|NCT03453645|sudden death|sudden death
5087159|NCT03453645|signal averaged ECG|signal averaged ecg
5087160|NCT03453645|T wave alternans|t wave alternans
5087161|NCT03453645|heart rate variability|heart rate variability
5087162|NCT03453632|Dermatology|dermatology
5087163|NCT03453632|Rare skin diseases|rare skin diseases
5087164|NCT03453632|epidermolysis bullosa simplex|epidermolysis bullosa simplex
5087165|NCT03453632|botulinic toxin|botulinic toxin
5087166|NCT03453632|blisters|blisters
5087167|NCT03453606|Pulmonary rehabilitation|pulmonary rehabilitation
5087168|NCT03453606|home-based|home-based
5087172|NCT03453567|TAVR|tavr
5087173|NCT03453567|SAVR|savr
5087174|NCT03453567|TAVI|tavi
4971407|NCT04169529|COPD|copd
5087175|NCT03453567|Conventional AVR|conventional avr
5087176|NCT03453567|Sutureless AVR|sutureless avr
5087177|NCT03453554|technology|technology
5087178|NCT03453554|activities of daily living|activities of daily living
5087180|NCT03453554|quality of life|quality of life
5087181|NCT03453554|memory impairment|memory impairment
5087182|NCT03453528|mCRPC or advanced/metastatic solid tumors|mcrpc or advanced/metastatic solid tumors
5087183|NCT03453528|Prostate-specific membrane antigen|prostate-specific membrane antigen
5087184|NCT03453502|quality improvement|quality improvement
5087185|NCT03453502|breast milk|breast milk
5087186|NCT03453476|Photodynamic therapy|photodynamic therapy
5087187|NCT03453476|Interleukin 1-beta|interleukin 1-beta
5087188|NCT03453476|Tumour necrosis factor - alpha|tumour necrosis factor - alpha
5087189|NCT03453476|Interleukin-6|interleukin-6
5087190|NCT03453476|Interleukin-8|interleukin-8
5087191|NCT03453476|Matrix metalloproteinase-8|matrix metalloproteinase-8
5087192|NCT03453463|sarcopenia|sarcopenia
5087193|NCT03453463|osteopenia|osteopenia
5087194|NCT03453463|older men|older men
5087195|NCT03453463|community dwelling|community dwelling
5087196|NCT03453463|physical functioning|physical functioning
5087197|NCT03453450|Primary Care|primary care
5087198|NCT03453411|Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO)|equimolar mixture of oxygen and nitrous oxide (emono)
5087199|NCT03453411|Substance-Related Disorders|substance-related disorders
5087200|NCT03453398|Chronotype|chronotype
5087201|NCT03453398|Shift work|shift work
5087202|NCT03453398|Health status|health status
5087203|NCT03453385|Smoking|smoking
5087204|NCT03453385|Nicotine|nicotine
5087205|NCT03453385|Tobacco|tobacco
5087206|NCT03453385|Electronic Cigarette|electronic cigarette
5961834|NCT04284579|child, general anesthesia, induction of anesthesia, sevoflurane, venous cannulation|child, general anesthesia, induction of anesthesia, sevoflurane, venous cannulation
5961835|NCT04284566|multicomponent treatment|multicomponent treatment
5961836|NCT04284566|chronic pain|chronic pain
5087207|NCT03453372|Osteoarthritis|osteoarthritis
5087208|NCT03453372|Knee|knee
5087209|NCT03453372|MRgFUS|mrgfus
5087210|NCT03453372|ExAblate|exablate
5087211|NCT03453372|Pain|pain
5087212|NCT03453372|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
5087213|NCT03453359|deep sedation|deep sedation
5087214|NCT03453359|spontaneous ventilation|spontaneous ventilation
5087215|NCT03453346|Hepatitis C virus|hepatitis c virus
5087216|NCT03453346|Sofosbuvir|sofosbuvir
5087217|NCT03453346|RNA polymerase inhibitor|rna polymerase inhibitor
5087218|NCT03453346|Ribavirin|ribavirin
5087219|NCT03453346|Genotype 2|genotype 2
5087220|NCT03453346|Sustained virologic response|sustained virologic response
5087221|NCT03453346|Confirmatory study|confirmatory study
5087222|NCT03453307|Tumor Organoids|tumor organoids
5087223|NCT03453307|Drug Sensitivity|drug sensitivity
5087224|NCT03453307|NSCLC|nsclc
5087225|NCT03453294|THRIVE|thrive
5087226|NCT03453281|Aflibercept|aflibercept
5087227|NCT03453281|Diabetic Macular Edema|diabetic macular edema
5087228|NCT03453281|Electroretinogram|electroretinogram
5087229|NCT03453281|Central Macular Thickness|central macular thickness
5087230|NCT03453281|ETDRS|etdrs
5087231|NCT03453268|Blood pressure|blood pressure
5087232|NCT03453268|Aged|aged
5087233|NCT03453268|Frailty|frailty
5087234|NCT03453268|Polypharmacy|polypharmacy
5087235|NCT03453255|AML, chidamide, decitabine|aml, chidamide, decitabine
5087236|NCT03453242|Osteoporosis|osteoporosis
5087237|NCT03453203|Chronic migraine|chronic migraine
5087238|NCT03453203|Osteopathic manipulative treatment|osteopathic manipulative treatment
5087239|NCT03453203|Cervicalgia|cervicalgia
5087240|NCT03453164|Radiotherapy|radiotherapy
5087241|NCT03453164|anti-PD-1 antibody|anti-pd-1 antibody
5087242|NCT03453138|laryngel mask airway|laryngel mask airway
5087243|NCT03453138|laparoscopic surgery|laparoscopic surgery
5087244|NCT03453125|cognitive rehabilitation|cognitive rehabilitation
5087245|NCT03453125|memory|memory
5087246|NCT03453112|Peek Expiratory Flow (PEF) Lung function tests|peek expiratory flow (pef) lung function tests
5087247|NCT03453099|propofol|propofol
5087248|NCT03453099|anaesthetic dose|anaesthetic dose
5087249|NCT03453099|sleep|sleep
5087250|NCT03453099|caffeine|caffeine
5087251|NCT03453099|anxiety|anxiety
5087252|NCT03453099|induction|induction
5087253|NCT03453073|Coronary heart disease|coronary heart disease
5087254|NCT03453073|stroke|stroke
5087261|NCT03453047|Neuron specific enolase|neuron specific enolase
5087262|NCT03453047|Liver transplantation|liver transplantation
5087264|NCT03453034|tumor|tumor
5087265|NCT03453034|toleration|toleration
5087266|NCT03453034|pharmacokinetics|pharmacokinetics
5087267|NCT03453021|asthma|asthma
5087268|NCT03453021|mepolizumab|mepolizumab
5087269|NCT03453021|corticosteroids|corticosteroids
5087270|NCT03453008|Cerebrovascular Accident|cerebrovascular accident
5087271|NCT03453008|Botulinum toxin A|botulinum toxin a
5087272|NCT03453008|Stroke|stroke
5087273|NCT03452982|SENTINEL LYMPH NODE|sentinel lymph node
5087274|NCT03452969|visual outcomes|visual outcomes
5087275|NCT03452969|mulitfocal intraocular lens|mulitfocal intraocular lens
5087276|NCT03452969|patient satisfaction|patient satisfaction
5740975|NCT00354562|docetaxel|docetaxel
5087277|NCT03452969|spectacle independence|spectacle independence
5087278|NCT03452969|contrast sensitivity|contrast sensitivity
5087279|NCT03452943|Tourette Syndrome|tourette syndrome
5087280|NCT03452943|adolescents|adolescents
5087281|NCT03452943|children|children
5087282|NCT03452904|In suit coronary lesions|in suit coronary lesions
5087283|NCT03452904|Drug-coated balloon|drug-coated balloon
5087291|NCT03452865|organ failure|organ failure
5087292|NCT03452865|SOFA|sofa
5087293|NCT03452865|mortality|mortality
5087294|NCT03452852|Split thickness skin graft|split thickness skin graft
5087295|NCT03452852|Lower leg|lower leg
5087296|NCT03452852|Compression therapy|compression therapy
5087297|NCT03452852|PICO|pico
5087298|NCT03452852|Coban 2 lite|coban 2 lite
5087299|NCT03452839|meropenem|meropenem
5087300|NCT03452839|antibiotic resistance|antibiotic resistance
5087301|NCT03452839|critical illness|critical illness
5087302|NCT03452839|β-lactams|β-lactams
5087303|NCT03452839|continuous antibacterial drug infusion|continuous antibacterial drug infusion
5087304|NCT03452839|mortality|mortality
5087305|NCT03452813|transitions of care|transitions of care
5087306|NCT03452813|stroke disparities|stroke disparities
5087307|NCT03452800|addiction|addiction
5087308|NCT03452800|mental health|mental health
5087309|NCT03452787|Body mass index|body mass index
5087310|NCT03452787|genetics|genetics
5087311|NCT03452787|diet|diet
5087312|NCT03452787|saturated fat|saturated fat
5087313|NCT03452774|artificial intelligence|artificial intelligence
5087314|NCT03452774|virtual tumor board|virtual tumor board
5087315|NCT03452774|clinical trial|clinical trial
5087316|NCT03452774|clinical trial matching|clinical trial matching
5087317|NCT03452774|electronic medical record|electronic medical record
5087318|NCT03452774|machine learning|machine learning
5087319|NCT03452774|cost of care|cost of care
5087320|NCT03452774|targeted therapy|targeted therapy
5087321|NCT03452774|immunotherapy|immunotherapy
5087322|NCT03452774|precision medicine|precision medicine
5087323|NCT03452774|precision oncology|precision oncology
5087324|NCT03452774|cancer|cancer
5087325|NCT03452774|value based care|value based care
5087326|NCT03452774|real world data|real world data
5087327|NCT03452774|data analytics|data analytics
5087328|NCT03452761|exogenous ketone salts|exogenous ketone salts
5087329|NCT03452761|ketosis|ketosis
5087330|NCT03452761|safety|safety
5087331|NCT03452761|comprehensive metabolic panel|comprehensive metabolic panel
5087332|NCT03452761|complete blood count|complete blood count
5087333|NCT03452761|lipid panel|lipid panel
5087334|NCT03452761|insulin|insulin
5087335|NCT03452735|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
5087336|NCT03452735|Fertility|fertility
5087337|NCT03452735|Procreation|procreation
5087338|NCT03452722|secondary brain injury|secondary brain injury
5087339|NCT03452722|neuroinflammation|neuroinflammation
5087340|NCT03452709|Cardiovascular Disease;|cardiovascular disease;
5087341|NCT03452709|primary prevention;|primary prevention;
5087342|NCT03452709|physical activity;|physical activity;
5087343|NCT03452709|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5087350|NCT03452644|US-CNB|us-cnb
5087351|NCT03452644|Soft Tissue Mass|soft tissue mass
5087352|NCT03452644|Soft Tissue Sarcoma|soft tissue sarcoma
5087353|NCT03452644|Soft Tissue Neoplasm|soft tissue neoplasm
5087354|NCT03452644|Soft Tissue Lesion|soft tissue lesion
5087355|NCT03452631|Psoas hematomas|psoas hematomas
5087356|NCT03452618|diagnostic criteria|diagnostic criteria
5087357|NCT03452579|Nivolumab|nivolumab
5087358|NCT03452579|Bevacizumab|bevacizumab
5087359|NCT03452566|actinic cheilitis|actinic cheilitis
5087360|NCT03452566|ingenol mebutate|ingenol mebutate
5087361|NCT03452566|treatment|treatment
5087362|NCT03452566|phase 1/2 clinical trial|phase 1/2 clinical trial
5087363|NCT03452553|Liver Cancer|liver cancer
5087364|NCT03452553|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5087365|NCT03452553|Trans Arterial Chemo Embolization (TACE)|trans arterial chemo embolization (tace)
5087366|NCT03452553|Drug Eluting Beads (DEB)|drug eluting beads (deb)
5087367|NCT03452553|Doxorubicin (DOX)|doxorubicin (dox)
5087368|NCT03452501|Infliximab|infliximab
5087369|NCT03452501|Remsima|remsima
5087370|NCT03452501|Biosimilar|biosimilar
5087371|NCT03452501|Inflammatory Bowel Diseases|inflammatory bowel diseases
5087372|NCT03452501|Crohn's Disease|crohn's disease
4971635|NCT04167982|Acne|acne
5087373|NCT03452501|Ulcerative Colitis|ulcerative colitis
5087374|NCT03452501|Fistulizing Crohn's Disease|fistulizing crohn's disease
5087375|NCT03452501|Observational|observational
5087376|NCT03452501|Follow up|follow up
5087377|NCT03452501|Safety|safety
5087378|NCT03452501|Effectiveness|effectiveness
5087379|NCT03452501|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
5087380|NCT03452501|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
5087381|NCT03452488|Sarcopenia|sarcopenia
5087382|NCT03452488|Sarcopenic Obesity|sarcopenic obesity
5087383|NCT03452488|6-minute walking distance|6-minute walking distance
5087384|NCT03452488|400 meters walking test|400 meters walking test
5087385|NCT03452488|Patient Reported Outcomes|patient reported outcomes
5087386|NCT03452488|BIO101|bio101
5087387|NCT03452488|SPPB|sppb
5087388|NCT03452488|ALM; ALM/BMI|alm; alm/bmi
5087389|NCT03452449|activity monitor|activity monitor
5087390|NCT03452449|questionnaire|questionnaire
5087391|NCT03452449|Oswestry Disability Index|oswestry disability index
5087392|NCT03452436|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
5087393|NCT03452436|Cognitive Dysfunction|cognitive dysfunction
5087394|NCT03452436|Cognition Disorders|cognition disorders
5087395|NCT03452436|Neurocognitive Disorder|neurocognitive disorder
5087396|NCT03452436|Testosterone|testosterone
5087397|NCT03452436|Endocrinology|endocrinology
5087398|NCT03452436|Testicular Cancer|testicular cancer
5087399|NCT03452436|Prostate Cancer|prostate cancer
5087400|NCT03452423|Osteoarthritis of knees|osteoarthritis of knees
5087401|NCT03452423|Arthroscopic cartilage regeneration facilitating procedure (ACRFP)|arthroscopic cartilage regeneration facilitating procedure (acrfp)
5087402|NCT03452423|Foot pressure|foot pressure
5087403|NCT03452423|Gait|gait
5087404|NCT03452410|Vestibular neuritis|vestibular neuritis
5087405|NCT03452410|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5087406|NCT03452410|Vertigo|vertigo
5087407|NCT03452410|Fluid attenuated inversion recuperation (FLAIR)|fluid attenuated inversion recuperation (flair)
5087408|NCT03452384|Acupuncture|acupuncture
5087409|NCT03452384|Traditional chinese medicine|traditional chinese medicine
5087410|NCT03452384|Major depressive disorder|major depressive disorder
5087411|NCT03452371|Patient Navigation|patient navigation
5087412|NCT03452371|Hospitalized smokers|hospitalized smokers
5087413|NCT03452319|Thoracoabdominal surgery|thoracoabdominal surgery
5087414|NCT03452319|Physical Therapy|physical therapy
5087415|NCT03452319|Inspiratory Muscle Training|inspiratory muscle training
5087416|NCT03452319|Physical Activity|physical activity
5087418|NCT03452306|Cmax|cmax
5087419|NCT03452306|Pharmacokinetics|pharmacokinetics
5087420|NCT03452306|metformin|metformin
5087421|NCT03452306|fed|fed
5087422|NCT03452306|fasting|fasting
5087423|NCT03452254|Stroke|stroke
5087424|NCT03452254|Upper Extremity Paresis|upper extremity paresis
5087425|NCT03452254|Neuro Rehabilitation|neuro rehabilitation
5087426|NCT03452254|tDCS|tdcs
5087427|NCT03452254|mCIMT|mcimt
5087428|NCT03452254|Occupational Therapy|occupational therapy
5087429|NCT03452241|Screening, Brief Intervention, and Referral to Treatment|screening, brief intervention, and referral to treatment
5087430|NCT03452241|Substance Use|substance use
5087431|NCT03452215|Pregnancy|pregnancy
5087432|NCT03452215|Mobile Phone Application|mobile phone application
5087433|NCT03452202|Stroke|stroke
5087434|NCT03452111|Healthy Men|healthy men
5087435|NCT03452111|Couple|couple
5087436|NCT03452111|Gel|gel
5087437|NCT03452111|Male Contraception|male contraception
5087438|NCT03452111|Nestorone|nestorone
5087439|NCT03452111|Testosterone|testosterone
5087440|NCT03452085|xerostomia|xerostomia
5087441|NCT03452085|diabetes type II|diabetes type ii
5087442|NCT03452085|salivary flow|salivary flow
5087443|NCT03452085|antioxidant capacity of saliva|antioxidant capacity of saliva
5087444|NCT03452085|aldiamed|aldiamed
5087445|NCT03452059|Paralysis|paralysis
5087446|NCT03452059|Lower Extremities|lower extremities
5087447|NCT03452059|Ai-Robotics|ai-robotics
5087448|NCT03452046|Ultrasound,inferior vena cava, positive pressure|ultrasound,inferior vena cava, positive pressure
5087449|NCT03452033|glaucoma|glaucoma
5087450|NCT03452007|Epidural Stimulation|epidural stimulation
5087451|NCT03452007|Bladder dysfunction|bladder dysfunction
5087452|NCT03452007|Spinal cord injury|spinal cord injury
5087559|NCT03451331|gemcitabine|gemcitabine
5087463|NCT03451955|intestinal permeability|intestinal permeability
5087464|NCT03451955|neuroinflammation|neuroinflammation
5087465|NCT03451955|autoimmunity|autoimmunity
5087466|NCT03451929|primary healthcare|primary healthcare
5087467|NCT03451929|cohort|cohort
5087468|NCT03451903|stroke|stroke
5087469|NCT03451903|thrombectomy|thrombectomy
5087470|NCT03451903|procedure time|procedure time
5087471|NCT03451903|revascularisation|revascularisation
5087472|NCT03451903|thrombolytic therapy|thrombolytic therapy
5087473|NCT03451890|Healthy participants|healthy participants
5087474|NCT03451890|E2730|e2730
5087475|NCT03451890|Pharmacokinetics|pharmacokinetics
5087476|NCT03451877|High myopia|high myopia
5087477|NCT03451877|TGFB1Gene Polymorphisms|tgfb1gene polymorphisms
5087478|NCT03451877|LAMA1 Gene Polymorphisms|lama1 gene polymorphisms
5087485|NCT03451812|prostate cancer|prostate cancer
5087486|NCT03451812|metabolomics|metabolomics
5087487|NCT03451812|molecular imaging|molecular imaging
5087488|NCT03451812|PET|pet
5087489|NCT03451812|MRI|mri
5087490|NCT03451812|11C-choline tracer|11c-choline tracer
5087491|NCT03451799|Glioblastoma|glioblastoma
5087492|NCT03451799|Ketogenic diet|ketogenic diet
5087493|NCT03451799|Keto diet|keto diet
5087494|NCT03451799|GBM|gbm
5087495|NCT03451773|TGF Ligand Trap|tgf ligand trap
5087496|NCT03451773|Extracellular Domain of Human TGF Receptor II|extracellular domain of human tgf receptor ii
5087497|NCT03451773|Avelumab|avelumab
5087498|NCT03451773|Human IgG1 mAb Directed Against Human PD-L1|human igg1 mab directed against human pd-l1
5087499|NCT03451773|Health-Related Quality of Life|health-related quality of life
5087500|NCT03451747|hypertension|hypertension
5087511|NCT03451565|Hypotension|hypotension
5087512|NCT03451565|Systemic blood pressure|systemic blood pressure
5087513|NCT03451552|Community Resources, Patient Navigator|community resources, patient navigator
5087514|NCT03451539|Anaesthetist|anaesthetist
5087516|NCT03451539|Intensif care unit|intensif care unit
5087517|NCT03451526|Chinese|chinese
5087518|NCT03451526|real-world evidences|real-world evidences
5087522|NCT03451513|Sexual minority men|sexual minority men
5087523|NCT03451513|Internalization of the appearance ideal|internalization of the appearance ideal
5087524|NCT03451513|Body dissatisfaction|body dissatisfaction
5087525|NCT03451500|GPR 143|gpr 143
5087526|NCT03451500|PEDF|pedf
5087527|NCT03451500|VEGF|vegf
5087528|NCT03451500|LDOPA|ldopa
5087529|NCT03451487|acetaminophen|acetaminophen
5087530|NCT03451487|acute liver failure|acute liver failure
5087531|NCT03451461|Asynchronies|asynchronies
5087532|NCT03451448|PET/MRI|pet/mri
5087533|NCT03451448|ultra-small-superparamagnetic particles|ultra-small-superparamagnetic particles
5087534|NCT03451422|AMG 592|amg 592
5087535|NCT03451422|Systemic lupus erythematosus|systemic lupus erythematosus
5087536|NCT03451422|Phase 1b/2a|phase 1b/2a
5087537|NCT03451396|Dry eye|dry eye
5087538|NCT03451396|Tear osmolarity|tear osmolarity
5087539|NCT03451396|Lifitegrast|lifitegrast
5087540|NCT03451383|breast cancer|breast cancer
5087541|NCT03451383|cognitive decline|cognitive decline
5087548|NCT03451357|stroke|stroke
5087549|NCT03451357|dependence degree|dependence degree
5087550|NCT03451357|social care|social care
5087551|NCT03451357|health care|health care
5087552|NCT03451357|disability|disability
5087553|NCT03451344|Mobile Health|mobile health
5087554|NCT03451344|Illicit drug use|illicit drug use
5087555|NCT03451344|Rehabilitation|rehabilitation
5087556|NCT03451344|Community|community
5087557|NCT03451344|China|china
4957788|NCT04252573|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
4957789|NCT04252573|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4957790|NCT04252547|kangaroo care|kangaroo care
4957791|NCT04252547|test weighing|test weighing
4957792|NCT04252547|Heart rate|heart rate
5087558|NCT03451331|cisplatin-ineligible|cisplatin-ineligible
5087568|NCT03451240|Resilience|resilience
5087569|NCT03451227|Sedation, Analgesia|sedation, analgesia
5087570|NCT03451201|Exercise|exercise
5087571|NCT03451201|High-Intensity Interval Training|high-intensity interval training
5087572|NCT03451201|Type 1 diabetes|type 1 diabetes
5087573|NCT03451201|Endothelial Dysfunction|endothelial dysfunction
5087574|NCT03451175|Overactive Detrusor|overactive detrusor
5087575|NCT03451175|Multiple Sclerosis|multiple sclerosis
5087576|NCT03451175|Reproductibility|reproductibility
5087577|NCT03451175|Cystometry|cystometry
5087578|NCT03451149|TIPS|tips
5087579|NCT03451136|Placenta previa|placenta previa
5087580|NCT03451136|Cervical length|cervical length
5087581|NCT03451136|Antepartum haemorrhage|antepartum haemorrhage
5087582|NCT03451110|Drug-Drug Interactions|drug-drug interactions
5087583|NCT03451110|Lemborexant|lemborexant
5087584|NCT03451110|Oral Contraceptive|oral contraceptive
5087585|NCT03451110|Famotidine|famotidine
5087586|NCT03451110|Fluconazole|fluconazole
5087587|NCT03451110|Pharmacokinetics|pharmacokinetics
5087588|NCT03451110|Proton pump inhibitors|proton pump inhibitors
5087589|NCT03451110|CYP3A inhibitors|cyp3a inhibitors
5087590|NCT03451084|AML, ASLAN, DHODH|aml, aslan, dhodh
5087591|NCT03451058|Traumatic brain injury, eye tracking, EEG, cognition|traumatic brain injury, eye tracking, eeg, cognition
5087592|NCT03451045|Pulmonary exacerbation, lenabasum, JBT-101|pulmonary exacerbation, lenabasum, jbt-101
5087593|NCT03451032|HIV exposition treatment|hiv exposition treatment
5087594|NCT03451032|sexual risk|sexual risk
5087595|NCT03451032|blood risk|blood risk
5087596|NCT03451019|chronic kidney disease - mineral bone disorder, phosphate-binders|chronic kidney disease - mineral bone disorder, phosphate-binders
5087597|NCT03450993|Mind-Body|mind-body
5087599|NCT03450928|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5087600|NCT03450928|Endoscopy|endoscopy
5087601|NCT03450928|POEM|poem
5087602|NCT03450928|Submucosal endoscopy|submucosal endoscopy
5087609|NCT03450902|Urinary incontinence, Chinese herb, Acupuncture|urinary incontinence, chinese herb, acupuncture
5356814|NCT01917890|radioprotective|radioprotective
5087610|NCT03450837|Coronary artery disease; HDL; anabolic steroids|coronary artery disease; hdl; anabolic steroids
5087611|NCT03450824|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5087614|NCT03450811|complication|complication
5087615|NCT03450811|uroflowmetry|uroflowmetry
5087616|NCT03450759|Heart failure.|heart failure.
5087617|NCT03450759|Mineralocorticoid receptor modulator.|mineralocorticoid receptor modulator.
5087618|NCT03450759|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
5087619|NCT03450733|Metal-on-Metal|metal-on-metal
5087620|NCT03450733|MOM|mom
5087621|NCT03450733|Total Hip Arthroplasty|total hip arthroplasty
5087622|NCT03450733|THA|tha
5087623|NCT03450707|cardiac arrest|cardiac arrest
5087624|NCT03450707|post-arrest|post-arrest
5087625|NCT03450681|Pain Management|pain management
5087626|NCT03450681|Knee Replacement Arthroplasty|knee replacement arthroplasty
5087627|NCT03450681|Postoperative Pain|postoperative pain
5087628|NCT03450681|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
5087630|NCT03450590|heart rate variability|heart rate variability
5087631|NCT03450590|intraarterial chemotherapy|intraarterial chemotherapy
5087632|NCT03450590|ophthalmic arterial chemotherapy|ophthalmic arterial chemotherapy
5087636|NCT03450512|Neutropenic enterocolitis|neutropenic enterocolitis
5087637|NCT03450512|Acute myeloid leukemia|acute myeloid leukemia
5087638|NCT03450512|Abdominal tomodensitometry|abdominal tomodensitometry
5087639|NCT03450486|dynamic balance|dynamic balance
5087652|NCT03450382|mental health|mental health
5087653|NCT03450382|behavior change|behavior change
5087654|NCT03450382|social support|social support
5087657|NCT03450304|Pulmonary Embolism|pulmonary embolism
5087658|NCT03450304|Hypertension Pulmonary Secondary|hypertension pulmonary secondary
5087661|NCT03450252|Mid-cavity|mid-cavity
5087662|NCT03450252|Pacing|pacing
5087663|NCT03450239|MRI|mri
5087664|NCT03450200|Diabetic Peripheral Neuropathy, Exercises|diabetic peripheral neuropathy, exercises
5087665|NCT03450148|aversive therapy|aversive therapy
5087666|NCT03450135|puberty|puberty
5087667|NCT03450135|EEG|eeg
5087668|NCT03450135|estradiol|estradiol
5087669|NCT03450135|mood|mood
5087670|NCT03450135|stress|stress
5087671|NCT03450044|Chemotherapy|chemotherapy
5087672|NCT03450044|Breast Cancer|breast cancer
5087673|NCT03450044|Dendritic cells|dendritic cells
5087674|NCT03450044|Immunotherapy|immunotherapy
5087675|NCT03450044|Doxorubicine|doxorubicine
5087676|NCT03450018|Gemcitabine|gemcitabine
5087677|NCT03450018|SLC-0111|slc-0111
5087678|NCT03450018|PDAC|pdac
5961837|NCT04284566|Fibromyalgia|fibromyalgia
5961838|NCT04284566|pain neuroscience education|pain neuroscience education
5961839|NCT04284566|therapeutic exercise|therapeutic exercise
5961840|NCT04284566|cognitive behavioural therapy|cognitive behavioural therapy
5961841|NCT04284566|mindfulness|mindfulness
5961842|NCT04284566|randomized controlled trial|randomized controlled trial
4957907|NCT04251793|Laser|laser
5087679|NCT03449979|tACS|tacs
5087680|NCT03449979|transcranial alternating current stimulation|transcranial alternating current stimulation
5087681|NCT03449979|stimulation|stimulation
5087682|NCT03449979|heart rate variability|heart rate variability
5087683|NCT03449979|electroencephalogram|electroencephalogram
5087685|NCT03449966|pCLE|pcle
5087686|NCT03449966|confocal|confocal
5087687|NCT03449966|Advanced gastric cancer|advanced gastric cancer
5087688|NCT03449966|chemotherapy|chemotherapy
5087689|NCT03449940|Penile fracture|penile fracture
5087690|NCT03449940|Delayed|delayed
5087691|NCT03449940|Localized|localized
5087692|NCT03449940|Repair|repair
5087693|NCT03449927|Nutrition Tool|nutrition tool
5087694|NCT03449927|Melphalan Autologous Transplant|melphalan autologous transplant
5087698|NCT03449823|Renal Artery Doppler|renal artery doppler
5087699|NCT03449810|Muscles Energy Technique, Low Back Pain|muscles energy technique, low back pain
5087700|NCT03449797|aldosterone|aldosterone
5087701|NCT03449797|cortisol|cortisol
5087702|NCT03449797|adrenal vein sampling|adrenal vein sampling
5087703|NCT03449797|primary aldosteronism|primary aldosteronism
5087704|NCT03449784|dyslipidemia|dyslipidemia
5087705|NCT03449784|lipid-lowering therapy|lipid-lowering therapy
5087706|NCT03449784|cardiovascular risk|cardiovascular risk
5087707|NCT03449784|diabetes|diabetes
5087708|NCT03449784|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
5087709|NCT03449771|HIV|hiv
5087710|NCT03449771|Pre-exposure prophylaxis|pre-exposure prophylaxis
5087711|NCT03449771|Recreational drugs|recreational drugs
5087712|NCT03449771|Chemsex|chemsex
5087713|NCT03449771|Mental disorders|mental disorders
5087714|NCT03449745|Acute Myeloid Leukemia|acute myeloid leukemia
5087715|NCT03449745|Immune Checkpoint Ligand|immune checkpoint ligand
5087716|NCT03449745|Flow Cytometry|flow cytometry
5087718|NCT03449680|hip arthroscopy|hip arthroscopy
5087719|NCT03449680|femoral articular branch block|femoral articular branch block
5740976|NCT00354562|Taxotere|taxotere
5087720|NCT03449615|Cutaneous melanoma|cutaneous melanoma
5087734|NCT03449563|thoracic paravertebral block|thoracic paravertebral block
5087735|NCT03449563|postoperative analgesia|postoperative analgesia
5087736|NCT03449563|pulmonary lobectomy|pulmonary lobectomy
5087737|NCT03449550|Child obstructive sleep apnea|child obstructive sleep apnea
5087738|NCT03449550|Home Respiratory Polygraphy|home respiratory polygraphy
5087739|NCT03449550|Diagnosis|diagnosis
5087740|NCT03449550|Validity|validity
5087741|NCT03449550|Polysomnography|polysomnography
5087742|NCT03449524|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5087743|NCT03449524|Pulmonary Hypertension|pulmonary hypertension
5087744|NCT03449524|PAH|pah
5087745|NCT03449524|Connective Tissue Disease-Associated|connective tissue disease-associated
5087746|NCT03449524|6 Minute Walk Test|6 minute walk test
5087751|NCT03449524|Hypertension|hypertension
5087752|NCT03449524|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
5087753|NCT03449524|Connective Tissue Diseases|connective tissue diseases
5087754|NCT03449524|Vascular Diseases|vascular diseases
5087755|NCT03449524|Cardiovascular Diseases|cardiovascular diseases
5087757|NCT03449524|Lung Diseases|lung diseases
5087763|NCT03449472|Bariatric surgery|bariatric surgery
5087764|NCT03449472|Gastrointestinal tract|gastrointestinal tract
5087765|NCT03449472|Biological availability|biological availability
5087766|NCT03449472|Pharmacokinetics|pharmacokinetics
5087767|NCT03449472|Quetiapine fumarate|quetiapine fumarate
5087768|NCT03449459|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5087769|NCT03449459|aerosol inhaled amikacin|aerosol inhaled amikacin
5087770|NCT03449459|oral probiotics|oral probiotics
5087771|NCT03449459|combined influenza and pneumococcal vaccine inoculation|combined influenza and pneumococcal vaccine inoculation
5087772|NCT03449459|bacterial decolonization in lower respiratory tract|bacterial decolonization in lower respiratory tract
5087773|NCT03449420|thromboelastography|thromboelastography
5087774|NCT03449407|Auditory hallucinations|auditory hallucinations
5087775|NCT03449407|Psychosis|psychosis
5087776|NCT03449407|Mood|mood
5087777|NCT03449407|Brain imaging|brain imaging
5087778|NCT03449407|Experience sampling method|experience sampling method
5087779|NCT03449394|Psychosis|psychosis
5087780|NCT03449394|Depression|depression
5087781|NCT03449394|Metacognition|metacognition
5087782|NCT03449394|Attribution|attribution
5087783|NCT03449394|Emotions|emotions
5087784|NCT03449355|sexuality|sexuality
5087785|NCT03449355|mode of delivery|mode of delivery
5087786|NCT03449355|quality of life|quality of life
5087787|NCT03449316|Nebulizers and Vaporizers|nebulizers and vaporizers
5087788|NCT03449303|breast cancer|breast cancer
5087789|NCT03449303|CIPN|cipn
5087790|NCT03449303|Pain|pain
5087792|NCT03449303|Essential Oils|essential oils
5087793|NCT03449251|Apelin|apelin
5087794|NCT03449251|Relaxin|relaxin
5087795|NCT03449212|SOD1|sod1
5087796|NCT03449212|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5087797|NCT03449212|ALS|als
5087798|NCT03449212|Kinetics|kinetics
5961843|NCT04284553|Benzodiazepine|benzodiazepine
5961844|NCT04284553|Sedative hypnotic|sedative hypnotic
4997672|NCT04008810|AKI|aki
4958006|NCT04251273|Digital Intervention|digital intervention
4958007|NCT04251260|preterm|preterm
4958008|NCT04251260|positioning|positioning
5087799|NCT03449212|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
5087800|NCT03449212|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
5087801|NCT03449186|periodontitis|periodontitis
5087802|NCT03449186|postpartum|postpartum
5087803|NCT03449121|Breathing|breathing
5087804|NCT03449121|Mind-body|mind-body
5087805|NCT03449082|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
5087824|NCT03448978|Multiple Myeloma|multiple myeloma
5087825|NCT03448978|BCMA|bcma
5087826|NCT03448978|B-cell maturation antigen|b-cell maturation antigen
5087827|NCT03448978|B cell maturation antigen|b cell maturation antigen
5087828|NCT03448939|papulopustular rosacea|papulopustular rosacea
5087829|NCT03448926|DCIS|dcis
5087830|NCT03448926|molecular testing|molecular testing
5087831|NCT03448926|risk of recurrence|risk of recurrence
5087832|NCT03448913|Anesthesia, Regional ;PECS block|anesthesia, regional ;pecs block
5087833|NCT03448900|Cessation|cessation
5087834|NCT03448900|College student|college student
5087835|NCT03448900|Motivational Interview|motivational interview
5087836|NCT03448900|Self-efficacy|self-efficacy
5087837|NCT03448900|Intention|intention
5087838|NCT03448900|Beliefs|beliefs
5087839|NCT03448900|Young adult|young adult
5087840|NCT03448887|End-stage renal disease|end-stage renal disease
5087841|NCT03448887|Medium cut-off dialyzer|medium cut-off dialyzer
5087842|NCT03448887|Hemodiafiltration|hemodiafiltration
5087843|NCT03448887|Cardiovascular|cardiovascular
5087844|NCT03448887|Pulse wave velocity|pulse wave velocity
5087845|NCT03448835|short term immunotherapy|short term immunotherapy
5087846|NCT03448835|surgical resection|surgical resection
5087847|NCT03448835|atezolizumab|atezolizumab
5087853|NCT03448809|Community Health Care|community health care
5087854|NCT03448809|Early Intervention|early intervention
5087855|NCT03448809|Feasibility Study|feasibility study
5087865|NCT03448757|LEEF|leef
5087866|NCT03448757|hemodynamic parameters|hemodynamic parameters
5087867|NCT03448757|heart beat|heart beat
5087868|NCT03448757|biofeedback effect|biofeedback effect
5087869|NCT03448744|thymosin alpha|thymosin alpha
5087870|NCT03448744|entecavir|entecavir
5087871|NCT03448705|influenza|influenza
5087873|NCT03448679|glycocalyx|glycocalyx
5087874|NCT03448679|serum albumin|serum albumin
5087875|NCT03448679|orthotopic liver transplantation|orthotopic liver transplantation
5087998|NCT03447834|intracoronary cooling|intracoronary cooling
5087876|NCT03448679|colloid osmotic pressure|colloid osmotic pressure
5087877|NCT03448679|endothelial dysfunction|endothelial dysfunction
5087879|NCT03448666|pembrolizumab|pembrolizumab
5087880|NCT03448666|advanced melanoma|advanced melanoma
5087881|NCT03448627|stem cell transplantation|stem cell transplantation
5087882|NCT03448627|Pulmonary Functions|pulmonary functions
5087883|NCT03448627|muscle strength|muscle strength
5087884|NCT03448627|exercise capacity|exercise capacity
5087885|NCT03448614|skull base reconstrction|skull base reconstrction
5087886|NCT03448601|Precision Medicine|precision medicine
5087892|NCT03448562|Atrial Fibrillation|atrial fibrillation
5087893|NCT03448562|Pulmonary Vein Isolation|pulmonary vein isolation
5087894|NCT03448562|Catheter Ablation|catheter ablation
5087895|NCT03448562|Substrate Modification|substrate modification
5087896|NCT03448549|Tegafur，gimeracil and oteracil potassium|tegafur，gimeracil and oteracil potassium
5087897|NCT03448549|Capecitabine|capecitabine
5087898|NCT03448549|compliance|compliance
5087899|NCT03448549|quality of life|quality of life
5087900|NCT03448549|adverse reaction|adverse reaction
5087901|NCT03448549|disease free survival|disease free survival
5087902|NCT03448549|overall survival|overall survival
5087903|NCT03448536|Primary dysmenorrhea of at least moderate severity|primary dysmenorrhea of at least moderate severity
5087904|NCT03448510|lower urinary tract symptoms|lower urinary tract symptoms
5087906|NCT03448510|benign prostatic obstruction|benign prostatic obstruction
5087907|NCT03448510|irreversible electroporation|irreversible electroporation
5087908|NCT03448510|urodynamics|urodynamics
5087909|NCT03448471|stem cell transplantation|stem cell transplantation
5087910|NCT03448471|Fatigue|fatigue
5087911|NCT03448471|muscle strength|muscle strength
5087912|NCT03448471|exercise capacity|exercise capacity
5087913|NCT03448471|Depression|depression
5087914|NCT03448471|Quality of Life|quality of life
5087915|NCT03448445|High-risk|high-risk
5087916|NCT03448445|Low-risk|low-risk
5087917|NCT03448445|Alzheimer's disease|alzheimer's disease
5087918|NCT03448445|Observational study|observational study
5087919|NCT03448432|Pregnancy Anemia|pregnancy anemia
5087925|NCT03448354|HIPEC|hipec
5741066|NCT00354263|Adjuvant|adjuvant
5087926|NCT03448354|Interval debulking surgery|interval debulking surgery
5087927|NCT03448341|radiotherapy|radiotherapy
5087928|NCT03448341|IMRT|imrt
5087929|NCT03448341|dysphagia|dysphagia
5087930|NCT03448341|Oropharynx|oropharynx
5961845|NCT04284553|Overprescribing|overprescribing
5961846|NCT04284553|Anticholinergic|anticholinergic
5961847|NCT04284540|Head and Neck Cancer|head and neck cancer
5961848|NCT04284540|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5087931|NCT03448341|Nasopharynx|nasopharynx
5087932|NCT03448341|FEES|fees
5087934|NCT03448328|muscular strength|muscular strength
5087935|NCT03448328|inflammation|inflammation
5087936|NCT03448328|protein|protein
5087937|NCT03448315|brain stimulation, tDCS, acute postoperative pain, chronic pain|brain stimulation, tdcs, acute postoperative pain, chronic pain
5087938|NCT03448289|Postpartum|postpartum
5087939|NCT03448289|Contraception|contraception
5087940|NCT03448276|Osteoporosis|osteoporosis
5087941|NCT03448276|Muscle Strength|muscle strength
5087942|NCT03448276|Postural Balance|postural balance
5087943|NCT03448276|Vibration|vibration
5087944|NCT03448276|Walking|walking
5087945|NCT03448263|pain|pain
5087946|NCT03448263|post endodontic pain|post endodontic pain
5087947|NCT03448263|root canal treatment|root canal treatment
5087948|NCT03448198|total knee arthroplasty|total knee arthroplasty
5087949|NCT03448198|patellar resurfacing|patellar resurfacing
5087950|NCT03448198|patellar tracking|patellar tracking
5087951|NCT03448198|patello-femoral joint kinematics|patello-femoral joint kinematics
5087952|NCT03448198|surgical navigation|surgical navigation
5087963|NCT03448107|dental caries|dental caries
5087964|NCT03448107|caries arrest|caries arrest
5087965|NCT03448107|caries prevention|caries prevention
5087966|NCT03448107|silver diamine fluoride|silver diamine fluoride
5087967|NCT03448107|sealants|sealants
5087968|NCT03448107|interim therapeutic restorations|interim therapeutic restorations
4972333|NCT04164407|Keratoconus|keratoconus
4972334|NCT04164407|Cornea transplant|cornea transplant
5087969|NCT03448055|MCI, AD, MRI, GSH, Immunocal, brain health, neuropsychological evaluation|mci, ad, mri, gsh, immunocal, brain health, neuropsychological evaluation
5087971|NCT03448029|Peripheral Artery Disease|peripheral artery disease
5087972|NCT03448029|Revascularisation|revascularisation
5087973|NCT03448029|Outcome|outcome
5087974|NCT03448029|Quality Management|quality management
5087975|NCT03448029|Registry|registry
5087976|NCT03448029|Endovascular Intervention|endovascular intervention
5087977|NCT03448029|Limb Amputation|limb amputation
5087978|NCT03447977|neck pain|neck pain
5087979|NCT03447977|manual therapy|manual therapy
5087980|NCT03447977|respiratory function|respiratory function
5087981|NCT03447964|sphingolipids|sphingolipids
5087982|NCT03447964|hepatic steatosis|hepatic steatosis
5087983|NCT03447964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5087984|NCT03447964|macrovascular complications|macrovascular complications
5087985|NCT03447964|insulin resistance|insulin resistance
5087986|NCT03447964|microvasclar complications|microvasclar complications
5087987|NCT03447964|NAFLD|nafld
5087988|NCT03447925|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents|callosities; keratosis; diabetes mellitus; plants, medicinal; herbal medicine; keratolytic agents
5087989|NCT03447912|Behavioral intervention|behavioral intervention
5087990|NCT03447912|Social intervention|social intervention
5087991|NCT03447912|Public health|public health
5088011|NCT03447717|hemiplegic gait|hemiplegic gait
5088012|NCT03447717|peroneal nerve stimulation|peroneal nerve stimulation
5088013|NCT03447717|gait analysis|gait analysis
5088014|NCT03447704|Ankylosing Spondylitis|ankylosing spondylitis
5088015|NCT03447704|interleukin 17|interleukin 17
5088016|NCT03447704|monoclonal antibody|monoclonal antibody
5088028|NCT03447587|Traditional Chinese medicine|traditional chinese medicine
5088029|NCT03447587|Oxidative stress|oxidative stress
5088030|NCT03447561|Dopamine|dopamine
5088031|NCT03447561|Food|food
5088032|NCT03447561|Reward|reward
5088033|NCT03447561|Anticipatory|anticipatory
5088034|NCT03447561|Consummatory|consummatory
5088035|NCT03447561|Positron Emission Tomography|positron emission tomography
5088036|NCT03447561|Magnetic Resonance|magnetic resonance
5088037|NCT03447561|Metabolic hormones|metabolic hormones
5088038|NCT03447548|Cognitive training|cognitive training
5088039|NCT03447548|Social function|social function
5088040|NCT03447548|Processing speed|processing speed
5088041|NCT03447535|Oppositional defiant disorder|oppositional defiant disorder
5088043|NCT03447535|Disruptive, impulse control and conduct disorders|disruptive, impulse control and conduct disorders
5088044|NCT03447535|Anxiety disorder|anxiety disorder
5088045|NCT03447535|Intrafamilial disruptive behaviours disorder|intrafamilial disruptive behaviours disorder
5088046|NCT03447509|Spinal cord injury|spinal cord injury
5088047|NCT03447509|neural control|neural control
5088048|NCT03447509|motor function|motor function
5088049|NCT03447509|hand movement|hand movement
5088050|NCT03447483|Solid tumor|solid tumor
5088051|NCT03447483|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5088052|NCT03447483|immune-related Adverse Event|immune-related adverse event
5088053|NCT03447444|dignity|dignity
5088054|NCT03447444|music therapy|music therapy
5088055|NCT03447444|physical activity|physical activity
5088056|NCT03447431|colorectal cancers|colorectal cancers
5088057|NCT03447431|Microsatellite Instability|microsatellite instability
5088058|NCT03447431|Tumor development|tumor development
5088059|NCT03447418|Lung Clearance Index|lung clearance index
5088060|NCT03447418|Breath Nitrogen Washout|breath nitrogen washout
5088061|NCT03447418|Healthy subjects|healthy subjects
5088062|NCT03447405|Music Therapy|music therapy
5088063|NCT03447405|NICU|nicu
5088064|NCT03447405|Infants|infants
5961849|NCT04284540|Radiotherapy|radiotherapy
5088065|NCT03447405|multisensory processing|multisensory processing
5088066|NCT03447392|Patient Education|patient education
5088067|NCT03447392|Chinese Medicine|chinese medicine
5088068|NCT03447353|driving|driving
5088069|NCT03447353|Xanax|xanax
5088070|NCT03447353|Norco|norco
5088071|NCT03447353|simulation|simulation
5088087|NCT03447301|Saudi Arabia, Extra Virgin Olive Oil, Blood Glucose|saudi arabia, extra virgin olive oil, blood glucose
5088088|NCT03447288|Dyssynchrony|dyssynchrony
5088089|NCT03447288|Breath-stacking|breath-stacking
5088090|NCT03447288|Asynchrony|asynchrony
5088091|NCT03447288|Reverse Triggering|reverse triggering
5088092|NCT03447288|Mechanical Ventilation|mechanical ventilation
5088093|NCT03447288|Sedation|sedation
5088094|NCT03447236|Older people|older people
5088095|NCT03447236|Cognitive training|cognitive training
5088096|NCT03447236|MCI|mci
5088097|NCT03447223|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5088098|NCT03447223|circulating metabolites|circulating metabolites
5088099|NCT03447223|metagenome|metagenome
5088100|NCT03447210|Persons who inject drugs (PWID)|persons who inject drugs (pwid)
5088101|NCT03447210|Phylogenetics|phylogenetics
5088102|NCT03447210|HIV testing|hiv testing
5088103|NCT03447210|HCV testing|hcv testing
5088104|NCT03447210|HIV care cascade|hiv care cascade
5088105|NCT03447210|Assisted partner services|assisted partner services
5088106|NCT03447171|Amblyopia|amblyopia
5088107|NCT03447171|Myopia|myopia
5088108|NCT03447171|Hyperopia|hyperopia
5088109|NCT03447171|Risk Factors|risk factors
5088110|NCT03447171|Amblyopia Risk Factors|amblyopia risk factors
5088111|NCT03447171|Smartphone Application (App)|smartphone application (app)
5088112|NCT03447171|Photoscreening|photoscreening
5088113|NCT03447171|Vision Screening|vision screening
5088114|NCT03447171|Mobile Vision Screening|mobile vision screening
5088115|NCT03447171|Vision Screening App|vision screening app
5088116|NCT03447171|Preschool children|preschool children
5088117|NCT03447171|Objective vision screening|objective vision screening
5088122|NCT03447132|Surgery|surgery
5088123|NCT03447093|oral microbiota|oral microbiota
5088124|NCT03447093|16S rRNA gene|16s rrna gene
5088125|NCT03447093|Graves' disease|graves' disease
5088126|NCT03447093|Methimazole|methimazole
5088127|NCT03447093|Propylthiouracil|propylthiouracil
5088128|NCT03447093|Hashimoto's thyroiditis|hashimoto's thyroiditis
5088129|NCT03447054|Alcohol|alcohol
5088130|NCT03447054|tDCS|tdcs
5088131|NCT03447054|inhibition|inhibition
5088132|NCT03447054|cognitive training|cognitive training
5088133|NCT03447054|implicit cognition|implicit cognition
5088134|NCT03447054|relapse|relapse
5088135|NCT03447054|craving|craving
5088136|NCT03447041|Keratopathy|keratopathy
5088137|NCT03447041|Visual Quality|visual quality
5088138|NCT03447041|Contrast Sensitivity Function|contrast sensitivity function
5088139|NCT03447028|Triglyseride-Glucose index|triglyseride-glucose index
5088140|NCT03447028|prostate cancer|prostate cancer
5088141|NCT03447028|radical prostatectomy|radical prostatectomy
5088142|NCT03447028|metabolic syndrome|metabolic syndrome
5088143|NCT03447015|ambulation|ambulation
5088144|NCT03447015|labour|labour
5088145|NCT03447015|Randomized Controlled Trial|randomized controlled trial
5088146|NCT03447015|Jordan|jordan
5088147|NCT03447002|premature|premature
5088149|NCT03446989|case management|case management
5088150|NCT03446989|rheumatoid arthritis|rheumatoid arthritis
5088151|NCT03446989|Effectiveness|effectiveness
5088348|NCT03445741|Pedometer|pedometer
5088162|NCT03446924|Muscle anabolism|muscle anabolism
5088163|NCT03446924|Ageing|ageing
5088164|NCT03446911|SABR|sabr
5088165|NCT03446911|Immunotherapy|immunotherapy
5088166|NCT03446859|Transcutaneous nerve electrical stimulation,|transcutaneous nerve electrical stimulation,
5088167|NCT03446859|Pain intensity|pain intensity
5088168|NCT03446859|Primary dysmenorrhea|primary dysmenorrhea
5088169|NCT03446859|Female|female
5088170|NCT03446859|Undergraduates|undergraduates
5088171|NCT03446833|Parkinson's Disease|parkinson's disease
5088172|NCT03446833|Deep Brain Stimulation|deep brain stimulation
5088173|NCT03446807|fatigue|fatigue
5088174|NCT03446807|Droxidopa|droxidopa
5088175|NCT03446794|Left Atrial Appendage Closure|left atrial appendage closure
5088176|NCT03446794|Watchman device|watchman device
5088177|NCT03446768|COPD|copd
5088179|NCT03446742|Rehabilitation Service|rehabilitation service
5088180|NCT03446742|Signals and symptons|signals and symptons
5088181|NCT03446742|Heart Rate|heart rate
5088182|NCT03446742|Blood pressure|blood pressure
5088183|NCT03446742|Respiratory Muscles|respiratory muscles
5088184|NCT03446742|autonomic modulation|autonomic modulation
5088185|NCT03446742|exercise|exercise
5088186|NCT03446742|risk measurement|risk measurement
5088187|NCT03446742|muscle strength|muscle strength
5088188|NCT03446742|inflammation|inflammation
5088189|NCT03446742|cytosines|cytosines
5088190|NCT03446703|social cognition|social cognition
5088191|NCT03446703|psychotherapy|psychotherapy
5088192|NCT03446703|rehabilitation|rehabilitation
5088193|NCT03446703|theory of mind|theory of mind
5088194|NCT03446690|Enamel decalcification|enamel decalcification
5088195|NCT03446677|HIV|hiv
5088196|NCT03446677|Balance|balance
5088197|NCT03446677|Vestibular|vestibular
5088198|NCT03446677|Somatosensory|somatosensory
5088199|NCT03446677|postural stability|postural stability
5088200|NCT03446677|center of pressure|center of pressure
5088202|NCT03446638|myelodysplastic syndromes|myelodysplastic syndromes
5088203|NCT03446638|MDS|mds
5088204|NCT03446638|computational biology|computational biology
5088205|NCT03446638|relapsed|relapsed
5088206|NCT03446638|refractory|refractory
5088207|NCT03446625|resveratrol|resveratrol
5088208|NCT03446625|OHSS|ohss
5088209|NCT03446625|PCOS|pcos
5088210|NCT03446612|darbepoetin alpha|darbepoetin alpha
5088211|NCT03446612|challenge agents|challenge agents
5088212|NCT03446612|daprodustat|daprodustat
5088213|NCT03446612|FBF-CKD|fbf-ckd
5088214|NCT03446599|cardiac surgery|cardiac surgery
5088215|NCT03446599|vasoplegia|vasoplegia
5088216|NCT03446599|cardiopulmonary bypass|cardiopulmonary bypass
5088217|NCT03446573|Switch study|switch study
5088218|NCT03446573|non-inferiority|non-inferiority
5088219|NCT03446573|HIV-1|hiv-1
5088220|NCT03446573|tenofovir alafenamide|tenofovir alafenamide
5088221|NCT03446573|dolutegravir plus lamivudine|dolutegravir plus lamivudine
5088222|NCT03446560|Compliance|compliance
5088223|NCT03446560|Telemedicine|telemedicine
5088224|NCT03446560|Patient related outcome measures|patient related outcome measures
5088225|NCT03446547|SBRT|sbrt
5088226|NCT03446547|Immunotherapy|immunotherapy
5088227|NCT03446534|pneumonia|pneumonia
5088228|NCT03446534|pre-school children|pre-school children
5088229|NCT03446534|antibiotics|antibiotics
5088230|NCT03446534|amoxicillin|amoxicillin
5088231|NCT03446508|High definition transcranial direct stimulation|high definition transcranial direct stimulation
5088232|NCT03446508|Mild Cognitive Impairment|mild cognitive impairment
5088233|NCT03446508|Memory|memory
5088248|NCT03446365|peer models|peer models
5088249|NCT03446365|educational intervention|educational intervention
5088250|NCT03446365|high school students|high school students
5088251|NCT03446352|Falls|falls
5088252|NCT03446352|Elderly|elderly
5088253|NCT03446352|Psychomotor exercise program|psychomotor exercise program
5088254|NCT03446352|Whole body vibration|whole body vibration
5088255|NCT03446326|pacemaker|pacemaker
5088256|NCT03446326|stroke volume|stroke volume
5088257|NCT03446326|cardiac output|cardiac output
5088258|NCT03446326|heart rate|heart rate
5088259|NCT03446300|High Myopia, fundus structure, early visual impairment|high myopia, fundus structure, early visual impairment
5088260|NCT03446248|vibroacoustic stimulation|vibroacoustic stimulation
5088261|NCT03446235|Obesity|obesity
5088262|NCT03446235|Physical Activity|physical activity
5088263|NCT03446235|Exercise|exercise
5088264|NCT03446235|Wearable device|wearable device
5088265|NCT03446196|Transplantation, Fluid Balance|transplantation, fluid balance
5088266|NCT03446170|Young adults|young adults
5088267|NCT03446170|Cigarette smoking|cigarette smoking
5088268|NCT03446170|Warning labels|warning labels
5088269|NCT03446157|colon cancer|colon cancer
5088270|NCT03446157|metastatic colon cancer|metastatic colon cancer
5088271|NCT03446157|palbociclib|palbociclib
5088272|NCT03446157|cetuximab|cetuximab
5088273|NCT03446144|Geographic Atrophy|geographic atrophy
5088274|NCT03446144|Age Related Macular Degeneration|age related macular degeneration
5088275|NCT03446144|IONIS-FB-Lrx|ionis-fb-lrx
5088276|NCT03446144|Complement Factor B|complement factor b
5088277|NCT03446131|transfemoral amputation|transfemoral amputation
5088278|NCT03446131|limb salvage|limb salvage
5088279|NCT03446131|bilateral amputation|bilateral amputation
5088280|NCT03446131|Department of Defense|department of defense
5088281|NCT03446131|orthosis|orthosis
5088282|NCT03446131|prosthesis|prosthesis
5088283|NCT03446131|rehabilitation|rehabilitation
5088284|NCT03446131|military treatment facilities|military treatment facilities
5088285|NCT03446131|military|military
5088286|NCT03446131|injured lower extremity|injured lower extremity
5088287|NCT03446131|prevent falls|prevent falls
5088288|NCT03446131|trauma lower extremity|trauma lower extremity
5088289|NCT03446131|service members|service members
5088290|NCT03446131|retired service members|retired service members
5088291|NCT03446131|active service members|active service members
5088292|NCT03446131|unilateral lower extremity trauma|unilateral lower extremity trauma
5088293|NCT03446131|limb amputation|limb amputation
5088294|NCT03446131|limb preservation|limb preservation
5088295|NCT03446131|preserved limb|preserved limb
5088296|NCT03446131|trips|trips
5088297|NCT03446131|slips|slips
5088298|NCT03446131|transtibial amputation|transtibial amputation
5088299|NCT03446118|EoE|eoe
5088300|NCT03446105|Cancer survivor|cancer survivor
5088301|NCT03446105|App-based intervention|app-based intervention
5088302|NCT03446105|Behavioral intervention|behavioral intervention
5088303|NCT03446092|Cancer|cancer
5088304|NCT03446092|Mindfulness|mindfulness
5088305|NCT03446092|Palliative care|palliative care
5088306|NCT03446079|Genetic|genetic
5088307|NCT03446079|Skin|skin
5088308|NCT03446079|Anti Aging|anti aging
5088309|NCT03446079|SNP|snp
5088310|NCT03446053|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5961850|NCT04284540|Over 70 years of age|over 70 years of age
5961851|NCT04284540|Elderly|elderly
5088311|NCT03446053|Methicillin-Sensitive Staphylococcus Aureus|methicillin-sensitive staphylococcus aureus
5088312|NCT03446053|N-Rephasin SAL200|n-rephasin sal200
5088313|NCT03445962|Autonomic nervous system|autonomic nervous system
5088314|NCT03445962|Heart rate variability|heart rate variability
5088318|NCT03445962|cephalometry|cephalometry
5088319|NCT03445962|body composition|body composition
5088320|NCT03445962|actigraphy|actigraphy
5088321|NCT03445962|motor capacity|motor capacity
5088322|NCT03445962|physical fitness|physical fitness
5088323|NCT03445962|aerobic capacity|aerobic capacity
5088324|NCT03445962|seismocardiography|seismocardiography
5088325|NCT03445949|atrial fibrillation, stroke, bleeding, left atrial appendage|atrial fibrillation, stroke, bleeding, left atrial appendage
5088326|NCT03445936|loop-ileostomy reversal|loop-ileostomy reversal
5088327|NCT03445936|hernia prevention|hernia prevention
5088328|NCT03445910|human chorionic gonadotropin|human chorionic gonadotropin
5088337|NCT03445845|change of biotherapy|change of biotherapy
5088338|NCT03445819|Patella Fracture, elderly|patella fracture, elderly
5088339|NCT03445806|IOP fluctuations|iop fluctuations
5088340|NCT03445806|iCare Home|icare home
5088341|NCT03445806|Trabeculectomy|trabeculectomy
5088342|NCT03445806|self-tonometry|self-tonometry
5088343|NCT03445793|DeltaF508deletion (F508del) mutation in 2 copies|deltaf508deletion (f508del) mutation in 2 copies
5088344|NCT03445767|Peri-operative care|peri-operative care
5741067|NCT00354263|Monotherapy|monotherapy
5088345|NCT03445767|Medication management|medication management
5088346|NCT03445741|Aerobic exercise|aerobic exercise
5088347|NCT03445741|Metabolic syndrome|metabolic syndrome
5088356|NCT03445637|Metastatic breast cancer, safety, ibrance|metastatic breast cancer, safety, ibrance
5088360|NCT03445598|psychotherapy|psychotherapy
5088361|NCT03445598|e-health|e-health
5088362|NCT03445598|CCBT|ccbt
5088363|NCT03445559|Prostate Cancer|prostate cancer
5088364|NCT03445559|Imaging|imaging
5088365|NCT03445559|Veterans Affairs|veterans affairs
5088366|NCT03445559|Guideline Adherence|guideline adherence
5088367|NCT03445559|Implementation|implementation
5088368|NCT03445533|Melanoma|melanoma
5088370|NCT03445533|PD-1|pd-1
5088371|NCT03445533|refractory|refractory
5088372|NCT03445533|metastatic|metastatic
5088373|NCT03445533|IMO-2125|imo-2125
5088374|NCT03445533|illuminate 301|illuminate 301
5088375|NCT03445533|TLR9 agonist|tlr9 agonist
5088376|NCT03445533|advanced melanoma|advanced melanoma
5088377|NCT03445533|CTLA4|ctla4
5088378|NCT03445533|CTLA-4|ctla-4
5088379|NCT03445533|immunotherapy|immunotherapy
5088380|NCT03445533|skin cancer|skin cancer
5088381|NCT03445533|ILLUMINATE-301|illuminate-301
5088382|NCT03445520|Transitions|transitions
5088383|NCT03445520|Passport|passport
5088384|NCT03445520|Building Better Bridges|building better bridges
5088385|NCT03445520|Snapshot|snapshot
5088386|NCT03445507|tobacco|tobacco
5088387|NCT03445507|cessation|cessation
5088388|NCT03445507|medical apps for smartphones|medical apps for smartphones
5088389|NCT03445468|Influenza vaccine|influenza vaccine
5088390|NCT03445468|Split influenza vaccine|split influenza vaccine
5088391|NCT03445468|Seasonal influenza vaccine|seasonal influenza vaccine
5088392|NCT03445442|Elderly|elderly
5088393|NCT03445442|Native tissue repair|native tissue repair
5088394|NCT03445442|Pelvic Organ Prolapse|pelvic organ prolapse
5088395|NCT03445442|Sacrocolpopexy|sacrocolpopexy
5088396|NCT03445442|Vaginal mesh repair|vaginal mesh repair
5088397|NCT03445403|Offset analgesia|offset analgesia
5088398|NCT03445403|Quantitive sensory testing|quantitive sensory testing
5088399|NCT03445364|Primary PCI|primary pci
5088400|NCT03445364|Coronary injection pressure|coronary injection pressure
5088401|NCT03445364|Reperfusion|reperfusion
5088402|NCT03445364|Resolution of ST elevation|resolution of st elevation
5088403|NCT03445364|Myocardial Blush Grade|myocardial blush grade
5088404|NCT03445351|Exercise Therapy;|exercise therapy;
5088405|NCT03445351|Sleep;|sleep;
5088406|NCT03445351|; Immune Markers;|; immune markers;
5088407|NCT03445351|HIV|hiv
5088408|NCT03445325|obesity|obesity
5088409|NCT03445325|physical activity|physical activity
5088410|NCT03445325|nutrition|nutrition
5088411|NCT03445325|adolescents|adolescents
5088412|NCT03445325|gamification|gamification
5088413|NCT03445325|sedentary activity|sedentary activity
5088414|NCT03445286|Gingivitis and geriatric patients|gingivitis and geriatric patients
5088415|NCT03445286|Silver Diamine Fluoride and gingivitis|silver diamine fluoride and gingivitis
5088416|NCT03445286|Sliver Diamine Fluoride|sliver diamine fluoride
5088417|NCT03445247|Diabetic Nephropathies|diabetic nephropathies
5088418|NCT03445247|Extracorporeal low intensity shockwave therapy|extracorporeal low intensity shockwave therapy
5088419|NCT03445247|Proteinuria|proteinuria
5088420|NCT03445234|exercise|exercise
5088421|NCT03445234|innate immune function|innate immune function
5088422|NCT03445234|metabolomics|metabolomics
5088423|NCT03445234|inflammation|inflammation
5088424|NCT03445221|Oral Immunonutrition|oral immunonutrition
5088433|NCT03445156|Headshot|headshot
5088434|NCT03445156|Gun|gun
5088435|NCT03445156|Operant conditioning theory|operant conditioning theory
5088436|NCT03445130|Preoperative Anxiety|preoperative anxiety
5086678|NCT03456206|CID|cid
5088437|NCT03445130|Breast Surgery|breast surgery
4970112|NCT04177121|Physician|physician
5088438|NCT03445130|Lavender Aromatherapy|lavender aromatherapy
5088439|NCT03445117|Influenza Vaccines|influenza vaccines
5088440|NCT03445117|Pneumococcal Vaccines|pneumococcal vaccines
5088441|NCT03445117|Primary Health Care|primary health care
5088442|NCT03445117|Health Communication|health communication
5088443|NCT03445117|Cross-Over Studies|cross-over studies
5088444|NCT03445117|Randomized Controlled Trial|randomized controlled trial
5088446|NCT03445104|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5088447|NCT03445104|AChEI|achei
5088448|NCT03445104|exercise|exercise
5088652|NCT03443908|sdb|sdb
5088449|NCT03445104|Physical performance|physical performance
5088450|NCT03445104|cognitive function|cognitive function
5088451|NCT03445104|rating of perceived exertion|rating of perceived exertion
5088452|NCT03445104|RPE|rpe
5741166|NCT00353886|Epilepsy|epilepsy
5088453|NCT03445091|compression socks|compression socks
5088454|NCT03445091|venous insufficiency|venous insufficiency
5088455|NCT03445091|compression stockings|compression stockings
5088456|NCT03445091|compression|compression
5088457|NCT03445091|compression therapy|compression therapy
5088458|NCT03445052|Adherence|adherence
5088459|NCT03445052|Behaviour change|behaviour change
5088460|NCT03445052|Intervention|intervention
5088461|NCT03445052|Photoprotection|photoprotection
5088462|NCT03445052|Ultraviolet radiation|ultraviolet radiation
5088463|NCT03445039|Dental implants, Trans-alveolar sinus floor elevation, Bone grafting|dental implants, trans-alveolar sinus floor elevation, bone grafting
5088464|NCT03445000|RET-rearrangement|ret-rearrangement
5088465|NCT03445000|advanced NSCLC|advanced nsclc
5088466|NCT03444987|Uterine fibroid|uterine fibroid
5088467|NCT03444987|FAP|fap
5088468|NCT03444987|Autophagy|autophagy
5088469|NCT03444974|drugs|drugs
5088470|NCT03444974|youth|youth
5088471|NCT03444974|adolescence|adolescence
5088472|NCT03444974|abuse|abuse
5088473|NCT03444974|dependence|dependence
5088474|NCT03444974|Tetrahydrocannabinol (THC)|tetrahydrocannabinol (thc)
5088475|NCT03444974|Methamphetamine (Crystal Meth)|methamphetamine (crystal meth)
5088476|NCT03444974|Marihuana|marihuana
5088477|NCT03444974|comorbidity|comorbidity
5088478|NCT03444974|treatment|treatment
5088479|NCT03444974|etiopathology|etiopathology
5088480|NCT03444974|sociodemographics|sociodemographics
5088481|NCT03444974|Saxony|saxony
5088482|NCT03444974|MATRIX|matrix
5088483|NCT03444974|Psychotherapy|psychotherapy
5088484|NCT03444961|Argus II Retinal Prosthesis System|argus ii retinal prosthesis system
5088485|NCT03444961|Rehabilitation|rehabilitation
5088486|NCT03444935|Phone|phone
5088487|NCT03444935|Brief Contact Intervention|brief contact intervention
5088488|NCT03444935|Caring Contact|caring contact
5088489|NCT03444935|Follow-up|follow-up
5088490|NCT03444935|Suicide|suicide
5088491|NCT03444935|Suicidal Ideation|suicidal ideation
5088492|NCT03444935|Suicidal Behaviour|suicidal behaviour
5088493|NCT03444935|Suicide Attempt|suicide attempt
5088494|NCT03444909|Monitoring|monitoring
5088495|NCT03444857|Continuous Positive Airway Pressure|continuous positive airway pressure
5088496|NCT03444857|Myocardial Salvage|myocardial salvage
5088497|NCT03444857|Obstructive Sleep Apnea|obstructive sleep apnea
5088498|NCT03444857|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5088499|NCT03444831|Functional Dyspepsia|functional dyspepsia
5088500|NCT03444818|E6007|e6007
5088501|NCT03444818|Pharmacokinetics|pharmacokinetics
5088502|NCT03444818|Radioactivity|radioactivity
5088503|NCT03444805|Autoimmune diseases|autoimmune diseases
5088504|NCT03444805|Systemic sclerosis|systemic sclerosis
5088505|NCT03444805|Autologous hematopoietic stem cell transplant (AHSCT)|autologous hematopoietic stem cell transplant (ahsct)
5088506|NCT03444805|Post-AHSCT management|post-ahsct management
5088507|NCT03444805|Immune reconstitution|immune reconstitution
5088508|NCT03444779|tibial plateau fracture|tibial plateau fracture
5088509|NCT03444779|minimally invasive surgery|minimally invasive surgery
5088510|NCT03444779|ballon reduction|ballon reduction
5088511|NCT03444727|vulvar biopsy|vulvar biopsy
5088512|NCT03444727|ice|ice
5088513|NCT03444727|anesthesia|anesthesia
5088514|NCT03444727|pain|pain
5088515|NCT03444727|vulva|vulva
5088516|NCT03444714|intratumoral|intratumoral
5088520|NCT03444688|Robotic Walker|robotic walker
5088533|NCT03444636|Postoperative Complications|postoperative complications
5088534|NCT03444636|Patient Satisfaction|patient satisfaction
5088535|NCT03444623|predictive factor|predictive factor
5088536|NCT03444623|prognostic factor|prognostic factor
5088537|NCT03444584|0382|0382
5088538|NCT03444584|T2DM|t2dm
5088539|NCT03444558|metabolic parameters|metabolic parameters
5088540|NCT03444558|cardio-metabolic parameters|cardio-metabolic parameters
5088541|NCT03444545|Cardiac output|cardiac output
5088542|NCT03444545|Carbon dioxide|carbon dioxide
5088543|NCT03444545|Intraoperative monitoring|intraoperative monitoring
5088544|NCT03444545|Pulmonary blood flow|pulmonary blood flow
5088545|NCT03444519|brain relaxation|brain relaxation
5088546|NCT03444519|mannitol|mannitol
5088547|NCT03444519|supratentorial tumours|supratentorial tumours
5088549|NCT03444454|Telerehabilitation|telerehabilitation
5088556|NCT03444441|FAOS|faos
5088557|NCT03444441|EFAS|efas
5088558|NCT03444441|LEFS|lefs
5088559|NCT03444441|FAAM|faam
5088560|NCT03444441|VAS-FA|vas-fa
5088561|NCT03444441|MOxFA|moxfa
5088562|NCT03444415|Obesity|obesity
5088563|NCT03444415|Children|children
5088564|NCT03444415|Pregnancy|pregnancy
5088565|NCT03444415|Motivational interview|motivational interview
5088566|NCT03444415|Family Care|family care
5088567|NCT03444415|Primary Care|primary care
5088568|NCT03444402|CKD-381|ckd-381
5088569|NCT03444402|Nexium|nexium
5088570|NCT03444376|keytruda|keytruda
5088571|NCT03444376|pembrolizumab|pembrolizumab
5088572|NCT03444376|GX-188E|gx-188e
5088573|NCT03444376|TDS-IM device|tds-im device
5088574|NCT03444363|laser|laser
5088575|NCT03444363|periodontal treatment|periodontal treatment
5088576|NCT03444363|systemic inflammation|systemic inflammation
5088577|NCT03444363|glycemic control|glycemic control
5088578|NCT03444350|Periodontal treatment|periodontal treatment
5088579|NCT03444350|Ozone|ozone
5088580|NCT03444350|oxidative stress|oxidative stress
5088581|NCT03444337|ablation|ablation
5088582|NCT03444337|atrial fibrillation|atrial fibrillation
5088583|NCT03444337|FIRM|firm
5088584|NCT03444324|Fibrinogen|fibrinogen
5088585|NCT03444311|microbiota|microbiota
5088586|NCT03444311|ulcerative colitis|ulcerative colitis
5088587|NCT03444311|fiber|fiber
5088588|NCT03444311|probiotic|probiotic
5088589|NCT03444285|Thermotherapy|thermotherapy
5088590|NCT03444285|warm-up|warm-up
5088591|NCT03444285|extensibility|extensibility
5088592|NCT03444285|pain|pain
5088593|NCT03444285|athletes|athletes
5088594|NCT03444259|Atrial fibrillation|atrial fibrillation
5088595|NCT03444259|Aortic stenosis|aortic stenosis
5088596|NCT03444259|Coronary artery disease|coronary artery disease
5088597|NCT03444259|Cardiac surgery|cardiac surgery
5088598|NCT03444259|Atrial appendage|atrial appendage
5088599|NCT03444207|obesity|obesity
5088600|NCT03444207|inflammation|inflammation
5088601|NCT03444207|C-reactive protein|c-reactive protein
5088602|NCT03444207|training|training
5088603|NCT03444207|tumor necrosis factor alfa|tumor necrosis factor alfa
5088604|NCT03444194|liver metastasis|liver metastasis
5088605|NCT03444194|chemotherapy|chemotherapy
5088606|NCT03444194|liver biopsy|liver biopsy
5088607|NCT03444194|colorectal caner|colorectal caner
5088608|NCT03444168|lumbar spine surgery|lumbar spine surgery
5088609|NCT03444168|lumbar failed back surgery syndrome|lumbar failed back surgery syndrome
5088610|NCT03444142|Diabetes|diabetes
5088611|NCT03444142|Hyperglycemia|hyperglycemia
5088612|NCT03444142|ABPM|abpm
5088613|NCT03444142|Variability of blood pressure|variability of blood pressure
5088614|NCT03444142|Exenatide LAR or Dulaglutide 0.75mg|exenatide lar or dulaglutide 0.75mg
5088615|NCT03444142|Glucagon-like peptide analogues type 1 (GLP1).|glucagon-like peptide analogues type 1 (glp1).
5088617|NCT03444064|Islet transplantation|islet transplantation
5088618|NCT03444064|Diabetes treatment|diabetes treatment
5088619|NCT03444064|PolyTregs|polytregs
5088620|NCT03444064|Immunotherapy|immunotherapy
5088621|NCT03444051|EUS-FNB|eus-fnb
5088622|NCT03444051|comparative study|comparative study
5088623|NCT03443999|Coronary Artery Disease|coronary artery disease
5088624|NCT03443999|Sirolimus-eluting Stent|sirolimus-eluting stent
5088625|NCT03443999|Biodegradable Polymers|biodegradable polymers
5088626|NCT03443986|Diabetes Mellitus|diabetes mellitus
5088627|NCT03443986|Blood Flow Velocity|blood flow velocity
5088628|NCT03443986|Skin Temperature|skin temperature
5088629|NCT03443986|Postural Balance|postural balance
5088630|NCT03443986|Combined Modality Therapy|combined modality therapy
5088631|NCT03443986|Vibration|vibration
5088632|NCT03443986|Resistance Training|resistance training
5088633|NCT03443934|Hemodynamic assessments|hemodynamic assessments
5088634|NCT03443934|Echocardiography|echocardiography
5088635|NCT03443934|MR-Elastography|mr-elastography
5088636|NCT03443934|Liver vein catheterization|liver vein catheterization
5088637|NCT03443934|Liver Cirrhosis|liver cirrhosis
5088638|NCT03443934|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
5088639|NCT03443934|Cirrhotic complications|cirrhotic complications
5088640|NCT03443934|Magnetic Resonance Imaging|magnetic resonance imaging
5088641|NCT03443921|Artery Divestment Technique|artery divestment technique
5088642|NCT03443921|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5088643|NCT03443921|Neoadjuvant Therapy|neoadjuvant therapy
5088644|NCT03443921|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
5088645|NCT03443908|lung cancer|lung cancer
5088646|NCT03443908|non small cell lung cancer|non small cell lung cancer
5088647|NCT03443908|nsclc|nsclc
5088648|NCT03443908|small cell lung cancer|small cell lung cancer
5088649|NCT03443908|sclc|sclc
5088650|NCT03443908|metastic lung mass|metastic lung mass
5088651|NCT03443908|sleep disordered breathing|sleep disordered breathing
5088664|NCT03443791|CMV|cmv
5088665|NCT03443791|Congenital Birth|congenital birth
5088666|NCT03443791|Infectious Diseases|infectious diseases
5088667|NCT03443778|tonsillectomy pain|tonsillectomy pain
5088668|NCT03443778|dexamethasone|dexamethasone
5088669|NCT03443778|bupivacaine|bupivacaine
5088670|NCT03443739|Intermittent Fasting|intermittent fasting
5088671|NCT03443739|Religious Fast|religious fast
5088672|NCT03443739|Bahá'í|bahá'í
5088673|NCT03443739|Hydration|hydration
5088674|NCT03443739|Calorimetry|calorimetry
5088675|NCT03443739|Microdialysis|microdialysis
5088676|NCT03443739|circadian clock|circadian clock
5088677|NCT03443739|circadian rhythm|circadian rhythm
5088678|NCT03443739|spirituality|spirituality
5088679|NCT03443739|self-efficacy|self-efficacy
5088680|NCT03443726|Lower third molar extraction|lower third molar extraction
5088681|NCT03443726|Infiltration anesthesia|infiltration anesthesia
5088682|NCT03443726|Articaine|articaine
5088695|NCT03443661|5-Fluorouracil|5-fluorouracil
5088696|NCT03443661|rectal cancer|rectal cancer
5088697|NCT03443661|irinotecan|irinotecan
5088698|NCT03443661|oxaliplatin|oxaliplatin
5088699|NCT03443661|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5088700|NCT03443622|SC-43|sc-43
5088701|NCT03443622|refractory solid tumor|refractory solid tumor
5088702|NCT03443622|Phase I|phase i
5088703|NCT03443609|occult prostate cancer recurrence|occult prostate cancer recurrence
5088704|NCT03443609|PSA|psa
5088705|NCT03443609|68Ga-HBED-CC-PSMA PET / CT|68ga-hbed-cc-psma pet / ct
5088706|NCT03443596|stroke|stroke
5088707|NCT03443596|blood pressure|blood pressure
5088708|NCT03443596|hemodynamic|hemodynamic
5088709|NCT03443570|immune thrombocytopenia|immune thrombocytopenia
5088710|NCT03443570|Thrombocytopenia|thrombocytopenia
5088711|NCT03443557|Oral nutrition supplement|oral nutrition supplement
5088712|NCT03443557|malnutrition|malnutrition
5088713|NCT03443557|mortality|mortality
5088714|NCT03443544|fournier's|fournier's
5088715|NCT03443544|gangrene|gangrene
5088716|NCT03443531|Bronchiectasis|bronchiectasis
5088717|NCT03443531|Traditional Chinese Medicine|traditional chinese medicine
5088718|NCT03443518|EVAR, analgesia|evar, analgesia
5088719|NCT03443505|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5088720|NCT03443505|Acute exacerbation|acute exacerbation
5088721|NCT03443505|Neural respiratory drive|neural respiratory drive
5088722|NCT03443505|Parasternal electromyography|parasternal electromyography
5088723|NCT03443505|Respiratory physiology|respiratory physiology
5088724|NCT03443505|Lung function|lung function
5088725|NCT03443479|Non invasive ventilation|non invasive ventilation
5088726|NCT03443479|BiPAP|bipap
5088727|NCT03443479|High-Flow Oxygen Therapy|high-flow oxygen therapy
5088728|NCT03443479|High-Flow Nasal Cannula|high-flow nasal cannula
5088729|NCT03443479|COPD|copd
5088730|NCT03443479|Hypercapnia|hypercapnia
5088731|NCT03443479|Hypercapnic Respiratory failure|hypercapnic respiratory failure
5088732|NCT03443479|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5088733|NCT03443466|Electric stimulation|electric stimulation
5088734|NCT03443466|Cesarean section|cesarean section
5088740|NCT03443427|Immunogenicity|immunogenicity
5088741|NCT03443414|COPD, bronchodilation, FEV1|copd, bronchodilation, fev1
5088742|NCT03443388|head injury from seizures|head injury from seizures
5088743|NCT03443388|seizures resulting in fall|seizures resulting in fall
5088744|NCT03443388|helmet for seizures|helmet for seizures
5088745|NCT03443388|novel helmet design|novel helmet design
5088746|NCT03443388|inflatable helmet|inflatable helmet
5088747|NCT03443388|Hovding Inc|hovding inc
5088748|NCT03443388|helmet|helmet
5088749|NCT03443388|device|device
5088750|NCT03443375|Older adults|older adults
5088751|NCT03443375|Physical function|physical function
5088752|NCT03443375|Muscle mass|muscle mass
5088753|NCT03443375|Short-term memory|short-term memory
5088754|NCT03443375|Executive function|executive function
5088755|NCT03443375|Blood Pressure|blood pressure
5088756|NCT03443375|Resistance training|resistance training
5088757|NCT03443375|Exercise training|exercise training
5088758|NCT03443375|Periodization|periodization
5088759|NCT03443362|Chronic Urticaria|chronic urticaria
5088760|NCT03443362|Endothelial cells|endothelial cells
5088761|NCT03443349|Delivering Women|delivering women
5088762|NCT03443323|Executive Function|executive function
5088763|NCT03443323|Behavioral Research|behavioral research
5088764|NCT03443323|Cost Analysis|cost analysis
5088765|NCT03443323|Students|students
5088767|NCT03443323|Randomized Controlled Trial|randomized controlled trial
5088768|NCT03443323|Behavior Therapy|behavior therapy
5088770|NCT03443310|TKA|tka
5088771|NCT03443310|THA|tha
5088772|NCT03443310|Hip Fracture|hip fracture
5088773|NCT03443310|High risk|high risk
5088774|NCT03443310|Ultrasound|ultrasound
5088775|NCT03443310|U/S|u/s
5088776|NCT03443284|Total Knee Arthroplasty|total knee arthroplasty
5088777|NCT03443284|Total Hip Arthroplasty|total hip arthroplasty
5088778|NCT03443284|Total Knee Replacement|total knee replacement
5088779|NCT03443284|Total Hip Replacement|total hip replacement
5088780|NCT03443284|Hospital Care Plan|hospital care plan
5088781|NCT03443284|mHealth|mhealth
5088782|NCT03443271|transversus abdominis plane block|transversus abdominis plane block
5088783|NCT03443271|abdominal hysterectomy|abdominal hysterectomy
5088784|NCT03443271|stress response|stress response
5088785|NCT03443219|Airway Management|airway management
5088786|NCT03443219|Extraglottic airway device|extraglottic airway device
5088787|NCT03443219|Laryngeal mask airway|laryngeal mask airway
5088788|NCT03443219|Spritztube|spritztube
5088789|NCT03443206|adolescent|adolescent
5088790|NCT03443206|mental health|mental health
5088791|NCT03443206|social media|social media
5088792|NCT03443193|aerobic exercise training|aerobic exercise training
5088793|NCT03443193|periodization|periodization
5088794|NCT03443193|cerebral oxygenation and perfusion|cerebral oxygenation and perfusion
5088795|NCT03443193|cognition|cognition
5088796|NCT03443180|Siblings|siblings
5088797|NCT03443167|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5088798|NCT03443167|Teaching Material|teaching material
5088799|NCT03443167|Primary education|primary education
5088800|NCT03443154|Cerclage|cerclage
5088801|NCT03443154|Preterm birth|preterm birth
5088802|NCT03443128|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5088803|NCT03443128|Recurrent|recurrent
5088804|NCT03443128|Childhood|childhood
5088805|NCT03443128|Adolescent|adolescent
5088806|NCT03443128|Treatment|treatment
5088807|NCT03443089|medroxyprogesterone acetate|medroxyprogesterone acetate
5088808|NCT03443089|estradiol cypionate|estradiol cypionate
5088809|NCT03443089|bioavailability|bioavailability
5088810|NCT03443089|monthly contraceptive|monthly contraceptive
5088811|NCT03443063|severe renal impairment|severe renal impairment
5088812|NCT03443063|lemborexant|lemborexant
5088813|NCT03443063|normal renal function|normal renal function
5088814|NCT03443063|healthy participants|healthy participants
5088815|NCT03443063|metabolites|metabolites
5088817|NCT03443063|pharmacokinetics|pharmacokinetics
5088818|NCT03443037|Coma|coma
5088819|NCT03443037|Disability|disability
5088820|NCT03443037|amantadine|amantadine
5088821|NCT03443024|Eczema|eczema
5088822|NCT03442985|Multiple osteochondromas|multiple osteochondromas
5088823|NCT03442985|Osteochondroma|osteochondroma
5088824|NCT03442985|Palovarotene|palovarotene
5088825|NCT03442985|Hereditary multiple exostoses|hereditary multiple exostoses
5088826|NCT03442985|HME|hme
5088827|NCT03442985|MO|mo
5088828|NCT03442985|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
5088829|NCT03442985|Retinoic acid receptor agonist|retinoic acid receptor agonist
5088830|NCT03442972|Intestinal lipoprotein|intestinal lipoprotein
5088834|NCT03442959|Small intestine neuroendocrine tumor|small intestine neuroendocrine tumor
5088835|NCT03442959|palliative surgery|palliative surgery
5088836|NCT03442946|nutrition guidelines|nutrition guidelines
5088837|NCT03442946|critical care|critical care
5088838|NCT03442946|cardiovascular|cardiovascular
5088839|NCT03442946|nutrition therapy|nutrition therapy
5088840|NCT03442933|Muscle Fatigue|muscle fatigue
5088841|NCT03442933|Cycling|cycling
5088842|NCT03442933|MTB|mtb
5088843|NCT03442933|Tensiomiography|tensiomiography
5088844|NCT03442920|obesity|obesity
5088845|NCT03442920|periodontal diseases|periodontal diseases
5088846|NCT03442920|gingival crevicular fluid|gingival crevicular fluid
5088847|NCT03442920|saliva|saliva
5088848|NCT03442920|serum|serum
5088849|NCT03442894|Shoulder pain|shoulder pain
5088850|NCT03442894|Subacromial|subacromial
5088851|NCT03442894|bursitis|bursitis
5088852|NCT03442894|rotator cuff|rotator cuff
5088853|NCT03442894|tendinopathy|tendinopathy
5088854|NCT03442894|dry needling|dry needling
5088855|NCT03442894|myofascial trigger point|myofascial trigger point
5088856|NCT03442855|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5088857|NCT03442829|sweet taste, food preferences, food intake|sweet taste, food preferences, food intake
5088858|NCT03442803|sedation|sedation
5088859|NCT03442803|Emergency Department|emergency department
5088860|NCT03442803|Target Controlled infusion|target controlled infusion
5088861|NCT03442803|propofol|propofol
5088862|NCT03442790|CVC confirmation|cvc confirmation
5088863|NCT03442790|Agitated Saline|agitated saline
5088865|NCT03442738|ADR|adr
5088866|NCT03442738|adenoma|adenoma
5088867|NCT03442738|polyp|polyp
5088868|NCT03442738|colon|colon
5088869|NCT03442738|screening|screening
5088870|NCT03442738|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
5088871|NCT03442738|cap|cap
5088872|NCT03442738|endoscopy|endoscopy
5088873|NCT03442738|colonoscopy|colonoscopy
5088874|NCT03442738|private practice|private practice
5088875|NCT03442712|obesity|obesity
5088876|NCT03442712|weight loss|weight loss
5088877|NCT03442712|ear acupressure|ear acupressure
5741515|NCT00352612|randomized|randomized
5088878|NCT03442712|smartphone application|smartphone application
5088879|NCT03442699|cognitive behavioral therapy|cognitive behavioral therapy
5088880|NCT03442699|suicidal ideology|suicidal ideology
5088881|NCT03442699|suicidal behavior|suicidal behavior
5088882|NCT03442673|Multiple Myeloma|multiple myeloma
5088883|NCT03442673|Vinorelbine|vinorelbine
5088884|NCT03442673|Gemcitabine|gemcitabine
5088885|NCT03442673|G-CSF|g-csf
5088886|NCT03442673|ASCT|asct
5088887|NCT03442634|bowel movements|bowel movements
5088888|NCT03442634|cesarean section|cesarean section
5088889|NCT03442634|oral hydration|oral hydration
5088890|NCT03442543|sentinel lymph node biopsy|sentinel lymph node biopsy
5088891|NCT03442530|pregnancy, smoking cessation, tobacco, preterm birth, ToPIC|pregnancy, smoking cessation, tobacco, preterm birth, topic
5088892|NCT03442517|group-based counseling|group-based counseling
5088893|NCT03442517|phone counseling|phone counseling
5088894|NCT03442517|conference calls|conference calls
5088895|NCT03442504|metastatic Breast cancer|metastatic breast cancer
5088897|NCT03442504|menopausal patients|menopausal patients
5088898|NCT03442504|recurrence after a 1st line of hormone therapy|recurrence after a 1st line of hormone therapy
5088899|NCT03442491|Postpartum Hemorrhage|postpartum hemorrhage
5088900|NCT03442491|Hayman's Haemostatic Suture|hayman's haemostatic suture
5088901|NCT03442465|18-014|18-014
5088902|NCT03442465|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5088903|NCT03442439|Family Nurture Intervention|family nurture intervention
5088904|NCT03442439|Martha G. Welch MD|martha g. welch md
5088905|NCT03442439|Randomized Controlled Trial|randomized controlled trial
5088906|NCT03442439|Preschool Intervention|preschool intervention
5088907|NCT03442439|Pre-school Intervention|pre-school intervention
5088908|NCT03442439|Multiple Family Group Intervention|multiple family group intervention
5088909|NCT03442439|Emotional Connection|emotional connection
5088910|NCT03442439|Co-regulation|co-regulation
5088911|NCT03442426|Primary Health Care|primary health care
5088912|NCT03442426|Frail Elderly|frail elderly
5088913|NCT03442426|Qualitative Methods|qualitative methods
5088914|NCT03442426|Quantitative Methods|quantitative methods
5088915|NCT03442426|Cost-Benefit Analysis|cost-benefit analysis
5088916|NCT03442426|Patient Participation|patient participation
5088917|NCT03442400|Coronary Artery Stenoses|coronary artery stenoses
5088918|NCT03442400|Aortic Stenosis|aortic stenosis
5088919|NCT03442374|Multifidus|multifidus
5088920|NCT03442374|Muscle|muscle
5088921|NCT03442374|Degeneration|degeneration
5088922|NCT03442374|Lumbar Spine|lumbar spine
5088923|NCT03442374|Disc|disc
5088924|NCT03442348|Omega 3|omega 3
5088925|NCT03442348|Fibre|fibre
5088926|NCT03442348|Gut microbiome|gut microbiome
5088927|NCT03442348|Metabolic profile|metabolic profile
5088930|NCT03442335|embryo implantation|embryo implantation
5088931|NCT03442335|endometrial receptivity|endometrial receptivity
5088932|NCT03442335|chromohysteroscopy|chromohysteroscopy
5088933|NCT03442335|transcriptomics|transcriptomics
5088934|NCT03442335|proteomics|proteomics
5088935|NCT03442335|metabolomics|metabolomics
5088936|NCT03442335|implantation window|implantation window
5088937|NCT03442335|luteal phase|luteal phase
5088938|NCT03442322|long term care residents|long term care residents
5088939|NCT03442322|nursing home care|nursing home care
5088940|NCT03442309|dental caries|dental caries
5088941|NCT03442309|caries arrest|caries arrest
5088942|NCT03442309|caries prevention|caries prevention
5088943|NCT03442309|quality of life|quality of life
5088944|NCT03442309|silver diamine fluoride|silver diamine fluoride
5088945|NCT03442309|sealants|sealants
5088946|NCT03442309|interim therapeutic restorations|interim therapeutic restorations
5088947|NCT03442309|student achievement|student achievement
5088948|NCT03442309|school attendance|school attendance
5088949|NCT03442283|Supplements, Cardiovascular Diseases, All-cause mortality, Meta-Analysis|supplements, cardiovascular diseases, all-cause mortality, meta-analysis
5088950|NCT03442270|Serrated Adenoma, Colonoscopy|serrated adenoma, colonoscopy
5088951|NCT03442257|Hypertension|hypertension
5088952|NCT03442257|Text Messaging|text messaging
5088953|NCT03442257|Primary Prevention|primary prevention
5088954|NCT03442257|Cardiovascular Risk Factor|cardiovascular risk factor
5088955|NCT03442257|Primary Health Care|primary health care
5088956|NCT03442257|Health Promotion|health promotion
5088957|NCT03442231|osteoarthritis|osteoarthritis
5088958|NCT03442231|traumatic arthritis|traumatic arthritis
5088959|NCT03442231|avascular necrosis|avascular necrosis
5088960|NCT03442218|Cesarean|cesarean
5088961|NCT03442218|Operative site infection|operative site infection
5088962|NCT03442218|Vaginal wash|vaginal wash
5088963|NCT03442218|Clorhexidine|clorhexidine
5088964|NCT03442218|Endometritis|endometritis
5088965|NCT03442205|Common Bile Duct Stone;|common bile duct stone;
5088966|NCT03442205|Laparoscopic Common Bile Duct Exploration;|laparoscopic common bile duct exploration;
5088967|NCT03442205|ERCP;|ercp;
5088969|NCT03442192|virtual|virtual
5088970|NCT03442192|adherence|adherence
5088971|NCT03442192|retention|retention
5088972|NCT03442179|Aging|aging
5088973|NCT03442179|Anesthesia|anesthesia
5088974|NCT03442179|EEG monitoring|eeg monitoring
5088975|NCT03442179|Burst suppression|burst suppression
5088976|NCT03442140|COPD|copd
5088977|NCT03442140|Shortness of breath|shortness of breath
5088978|NCT03442140|Harmonica|harmonica
5088979|NCT03442114|shared decision making|shared decision making
5088980|NCT03442114|parent-provider communication|parent-provider communication
5088981|NCT03442114|hydroxyurea|hydroxyurea
5088982|NCT03442114|sickle cell disease|sickle cell disease
5088987|NCT03442049|Multiple Sclerosis|multiple sclerosis
5088988|NCT03442049|Gait|gait
5088989|NCT03442049|Spinal Stabilization Exercises|spinal stabilization exercises
4957722|NCT04252924|sleep|sleep
4959155|NCT04244409|MRKH|mrkh
4959156|NCT04244409|Pregnancy|pregnancy
4959157|NCT04244409|Transplantation|transplantation
4959158|NCT04244409|Uterus|uterus
4959159|NCT04244396|Persistent Atrial Fibrillation|persistent atrial fibrillation
4959458|NCT04242472|Nutrition|nutrition
5088990|NCT03442049|Plantar Pressure Distribution|plantar pressure distribution
5088991|NCT03442049|Rehabilitation|rehabilitation
5088992|NCT03442036|Regional Anesthesia|regional anesthesia
5088993|NCT03442036|Sciatic Nerve Block|sciatic nerve block
5088994|NCT03442036|Continuous Nerve Block|continuous nerve block
5088995|NCT03442036|Perineural Catheter|perineural catheter
5088996|NCT03442023|Chlorhexidine|chlorhexidine
5088997|NCT03442023|Gram-negative|gram-negative
5088998|NCT03442023|Colonization|colonization
5088999|NCT03442010|Emergency department|emergency department
5089000|NCT03442010|Clinical Pharmacist|clinical pharmacist
5089001|NCT03442010|Adverse drug event|adverse drug event
5089002|NCT03441997|exercise|exercise
5089003|NCT03441997|low intensity exercise|low intensity exercise
5089004|NCT03441997|pain|pain
5089005|NCT03441997|fatigue|fatigue
5089006|NCT03441997|sleep problems|sleep problems
5089007|NCT03441984|Pediatric dispersible tablets|pediatric dispersible tablets
5089008|NCT03441984|Bioavailability|bioavailability
5089009|NCT03441958|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5089010|NCT03441958|Expanded cord blood|expanded cord blood
5089011|NCT03441945|Magnetic|magnetic
5089012|NCT03441945|Capsule Endoscopy|capsule endoscopy
5089013|NCT03441945|enhance|enhance
5089014|NCT03441945|gastric emptying|gastric emptying
5089015|NCT03441932|Dysphagia|dysphagia
5089016|NCT03441932|Pharyngeal residue scale|pharyngeal residue scale
5089017|NCT03441932|Stroke|stroke
5089018|NCT03441932|Pneumonia|pneumonia
5089019|NCT03441893|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy|ulcerative colitis, intestinal parasites, helminths, intestinal protozoan, nitazoxanide, mesalazine, combination therapy
5100302|NCT03370991|Blueberries|blueberries
5089023|NCT03441867|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5089025|NCT03441867|civilians|civilians
5089026|NCT03441854|Gas exchange|gas exchange
5089027|NCT03441854|Non invasive ventilation|non invasive ventilation
5089028|NCT03441854|Liver transplantation|liver transplantation
5089029|NCT03441841|local anesthetics|local anesthetics
5089030|NCT03441841|pharmacokinetics|pharmacokinetics
5089031|NCT03441841|nanotechnology|nanotechnology
4973521|NCT04157049|COPD|copd
5089032|NCT03441815|Healthy volunteers|healthy volunteers
5089033|NCT03441815|Phase I|phase i
5089034|NCT03441815|Histamine glutarimide|histamine glutarimide
5089035|NCT03441815|PHARMENTERPRISES|pharmenterprises
5089037|NCT03441776|Rehabilitation|rehabilitation
5089038|NCT03441776|Vestibular|vestibular
5089039|NCT03441776|Dizziness|dizziness
5089040|NCT03441763|Foot pressure, Obese, and normal Subjects|foot pressure, obese, and normal subjects
5089041|NCT03441737|Aerobic exercise|aerobic exercise
5089042|NCT03441737|Antisaccades|antisaccades
5089043|NCT03441737|Urge to Smoke|urge to smoke
5089044|NCT03441737|Adults|adults
5089045|NCT03441672|Prenatal Screening|prenatal screening
5089046|NCT03441672|Interactive educational technology|interactive educational technology
5089047|NCT03441633|atrial fibrillation|atrial fibrillation
5089048|NCT03441633|apixaban|apixaban
5089049|NCT03441633|stroke|stroke
5089050|NCT03441594|Food Insecurity|food insecurity
5089063|NCT03441490|Adolescents|adolescents
5089064|NCT03441464|Fluorescence|fluorescence
5089065|NCT03441464|Prostate|prostate
5089066|NCT03441464|Cancer detection|cancer detection
5089067|NCT03441451|Bariatric Surgery|bariatric surgery
5089068|NCT03441438|alcohol sensitivity|alcohol sensitivity
5089069|NCT03441438|red wine|red wine
5089070|NCT03441438|aerd|aerd
5089071|NCT03441425|CRM Skills|crm skills
5089072|NCT03441425|ACLS|acls
5089073|NCT03441425|Simulation|simulation
5089074|NCT03441425|Stress|stress
5089075|NCT03441399|Medication Adherence|medication adherence
5089076|NCT03441360|eribulin mesylate|eribulin mesylate
5089077|NCT03441360|pediatric|pediatric
5089078|NCT03441347|Physical therapy|physical therapy
5089079|NCT03441347|Occupational therapy|occupational therapy
5089080|NCT03441347|Rehabilitation|rehabilitation
5741516|NCT00352612|blinded|blinded
5148405|NCT03065491|Lipids|lipids
5089081|NCT03441347|Motor control|motor control
5089086|NCT03441269|Emergency Medicine|emergency medicine
5089087|NCT03441269|Acute Pain|acute pain
5089088|NCT03441269|Oral Ibuprofen|oral ibuprofen
5089089|NCT03441230|stomach|stomach
5089090|NCT03441230|motility|motility
5089091|NCT03441217|Duration of labor|duration of labor
5089092|NCT03441217|Hyoscine butylbromide|hyoscine butylbromide
5089093|NCT03441204|COPD|copd
5961852|NCT04284540|shorter course of radiation treatment|shorter course of radiation treatment
5961853|NCT04284527|physiotherapy|physiotherapy
5961854|NCT04284527|student|student
5961855|NCT04284527|assesment tool|assesment tool
5961856|NCT04284462|sweetness|sweetness
5961857|NCT04284462|liking|liking
5961858|NCT04284462|adaptation|adaptation
5961859|NCT04284462|intensity|intensity
5961860|NCT04284462|low calorie sweetener|low calorie sweetener
4959291|NCT04243590|child rehabilitation|child rehabilitation
4959292|NCT04243590|upper extremity|upper extremity
5961861|NCT04284462|full sugar|full sugar
4959293|NCT04243590|hand use at home questionnaire|hand use at home questionnaire
5961862|NCT04284462|carbonated soft drink|carbonated soft drink
5961863|NCT04284462|sensory|sensory
4959294|NCT04243551|Celiac|celiac
5089094|NCT03441204|Long-term oxygen therapy (LTOT)|long-term oxygen therapy (ltot)
5089095|NCT03441204|Registry|registry
5087284|NCT03452904|Drug-eluting stent|drug-eluting stent
5089096|NCT03441204|Registry-based randomized controlled trial (R-RCT)|registry-based randomized controlled trial (r-rct)
5089097|NCT03441204|Treatment duration|treatment duration
5089099|NCT03441165|ACL|acl
5089100|NCT03441165|MAT|mat
5089101|NCT03441165|REVISION|revision
5089102|NCT03441165|LAXITY|laxity
5089103|NCT03441152|Mild Cognitive Impairment|mild cognitive impairment
5089104|NCT03441152|Neuromodulation|neuromodulation
5089105|NCT03441139|Randomized controlled trial|randomized controlled trial
5089106|NCT03441139|Musculoskeletal metastasis|musculoskeletal metastasis
5089107|NCT03441139|Cancer pain|cancer pain
5089108|NCT03441139|Percutaneous cryotherapy|percutaneous cryotherapy
5089109|NCT03441139|Medical supportive care|medical supportive care
5089110|NCT03441126|Diagnostic Stewardship|diagnostic stewardship
5089111|NCT03441126|Pediatric|pediatric
5089112|NCT03441126|Blood Culture Test|blood culture test
5089120|NCT03441087|transvaginal ultrasonography|transvaginal ultrasonography
5089121|NCT03441087|hysteroscopy|hysteroscopy
5089122|NCT03441087|abnormal uterine bleeding|abnormal uterine bleeding
5089123|NCT03441048|Acute myeloid leukemia|acute myeloid leukemia
5089124|NCT03441048|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
5089125|NCT03441048|CLAG-M|clag-m
5089126|NCT03441048|Lintuzumab|lintuzumab
5089130|NCT03441009|PSH, Rehabilitation, Medication, ANS|psh, rehabilitation, medication, ans
5089131|NCT03440996|toothpaste|toothpaste
5089132|NCT03440983|optimize the imaging protocols|optimize the imaging protocols
5089133|NCT03440983|validate technical parameters in healthy volunteers|validate technical parameters in healthy volunteers
5089135|NCT03440957|advanced cancer|advanced cancer
5089136|NCT03440957|osteopathy|osteopathy
5089137|NCT03440957|pain|pain
5089138|NCT03440957|bedridden|bedridden
5089139|NCT03440944|vascular access|vascular access
5089140|NCT03440944|midline cather|midline cather
5089146|NCT03440892|methotrexate|methotrexate
5089147|NCT03440892|sulfasalazin|sulfasalazin
5089148|NCT03440892|abatacept|abatacept
5089149|NCT03440892|tocilizumab|tocilizumab
5089150|NCT03440892|tofacitinib/baricitinib|tofacitinib/baricitinib
5089555|NCT03438591|wide QRS|wide qrs
5089157|NCT03440762|Stroke prevention|stroke prevention
5089158|NCT03440749|rhythm|rhythm
5089159|NCT03440749|serial Reaction Time Task|serial reaction time task
5089160|NCT03440736|Psoriasis|psoriasis
5089161|NCT03440736|Metabolic syndrome|metabolic syndrome
5089162|NCT03440736|Diabetes|diabetes
5089163|NCT03440736|Obesity|obesity
5089164|NCT03440736|Life-style|life-style
5089165|NCT03440736|Life-style intervention|life-style intervention
5089166|NCT03440736|Secukinumab|secukinumab
5089167|NCT03440736|CAIN457A|cain457a
5089168|NCT03440736|CAIN457ADE08|cain457ade08
5089169|NCT03440736|AIN457A|ain457a
5089170|NCT03440736|Skin condition|skin condition
5089171|NCT03440736|skin disease|skin disease
5089172|NCT03440736|itching condition|itching condition
5089173|NCT03440736|psoriasis vulgaris|psoriasis vulgaris
5089174|NCT03440736|relapsing/remitting psoriasis|relapsing/remitting psoriasis
5089175|NCT03440736|immune-mediated systemic disease|immune-mediated systemic disease
5089176|NCT03440736|skin lesions|skin lesions
5089177|NCT03440736|red skin lesions|red skin lesions
5089178|NCT03440736|scaly patches|scaly patches
5089179|NCT03440736|papules|papules
5089180|NCT03440736|plaques|plaques
5089181|NCT03440736|itching|itching
5089182|NCT03440723|Cervical Dilation|cervical dilation
5089183|NCT03440723|Dilation|dilation
5089184|NCT03440723|Sterile vaginal examination|sterile vaginal examination
5089185|NCT03440697|Cardiovascular Disease|cardiovascular disease
5089186|NCT03440684|Core stability, hand, function, balance, strength|core stability, hand, function, balance, strength
5089187|NCT03440658|brachial plexus palsy|brachial plexus palsy
5089188|NCT03440658|isokinetics|isokinetics
5089189|NCT03440658|shoulder|shoulder
5089190|NCT03440658|strenght|strenght
5089191|NCT03440606|Randomized Wait-List Control Trial|randomized wait-list control trial
5089192|NCT03440606|Mindful-Compassion Art Therapy Supervision|mindful-compassion art therapy supervision
5089193|NCT03440606|End-of-Life Care|end-of-life care
5089194|NCT03440606|Self-Care|self-care
5089195|NCT03440593|sepsis|sepsis
5089196|NCT03440593|nutrition|nutrition
5089197|NCT03440593|indirect calorimetry|indirect calorimetry
5089198|NCT03440593|muscle thickness|muscle thickness
5089199|NCT03440580|physical activity|physical activity
5089200|NCT03440580|serious game|serious game
5089201|NCT03440580|school intervention|school intervention
5089202|NCT03440580|children|children
5961864|NCT04284462|taste|taste
5961865|NCT04284462|dietary compensation|dietary compensation
5961866|NCT04284462|beverage|beverage
5089203|NCT03440554|Prostate Cancer|prostate cancer
5089204|NCT03440554|Restriction spectrum imaging|restriction spectrum imaging
5089205|NCT03440554|Magnetic resonance imaging|magnetic resonance imaging
5089206|NCT03440554|MRI|mri
5089207|NCT03440554|RSI|rsi
5089208|NCT03440541|Amniotic membrane|amniotic membrane
5089209|NCT03440541|Psoriasis|psoriasis
5089210|NCT03440541|Treatment|treatment
5089211|NCT03440528|Skin ulcer, Human amniotic membrane, Treatment|skin ulcer, human amniotic membrane, treatment
5089212|NCT03440515|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5089213|NCT03440515|skin rash|skin rash
5089214|NCT03440515|imatinib|imatinib
5089225|NCT03440437|PK|pk
5089226|NCT03440437|PD|pd
5089227|NCT03440437|biomarker|biomarker
5089228|NCT03440424|mild hepatic impairment|mild hepatic impairment
5089229|NCT03440424|moderate hepatic impairment|moderate hepatic impairment
5089230|NCT03440424|lemborexant|lemborexant
5089231|NCT03440424|healthy participants|healthy participants
5089232|NCT03440424|metabolites|metabolites
5089233|NCT03440424|E2006|e2006
5089234|NCT03440424|pharmacokinetics|pharmacokinetics
5089235|NCT03440411|biochemical relapse|biochemical relapse
5089236|NCT03440398|Robotic Mastectomy|robotic mastectomy
5089237|NCT03440398|Nipple Sparing Mastectomy|nipple sparing mastectomy
5089238|NCT03440398|Conservative mastectomy|conservative mastectomy
5089239|NCT03440398|Breast reconstruction|breast reconstruction
5089264|NCT03440346|gut|gut
5089265|NCT03440346|microbiota|microbiota
5089266|NCT03440320|Caregiving Dyad|caregiving dyad
5089267|NCT03440320|Pain-related Disability|pain-related disability
4973775|NCT04155645|PD|pd
5089268|NCT03440294|windsurfer|windsurfer
5089269|NCT03440294|wetsuit|wetsuit
5089270|NCT03440294|spirometry|spirometry
5089271|NCT03440294|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5089272|NCT03440294|lung function|lung function
5089273|NCT03440294|pulmonary function|pulmonary function
5089274|NCT03440294|oxygen uptake|oxygen uptake
5089275|NCT03440268|cardiac surgery|cardiac surgery
5089276|NCT03440268|post operatory complications|post operatory complications
5089277|NCT03440268|Acute kidney injury|acute kidney injury
5089278|NCT03440268|N-acetylcystein|n-acetylcystein
5089279|NCT03440255|Transcutaneous Vagus nerve Stimulation|transcutaneous vagus nerve stimulation
5089280|NCT03440255|Generalized Anxiety Disorder|generalized anxiety disorder
5089281|NCT03440255|Chronic Pain|chronic pain
5089282|NCT03440255|Irritable Bowel Syndrome|irritable bowel syndrome
5089283|NCT03440255|Private Practice|private practice
5089284|NCT03440216|temocillin|temocillin
5089285|NCT03440216|ceftriaxone|ceftriaxone
5089286|NCT03440216|meropenem|meropenem
5089287|NCT03440216|pharmacokinetics|pharmacokinetics
5089288|NCT03440216|pharmacodynamics|pharmacodynamics
5089289|NCT03440216|Intensive Care|intensive care
5089290|NCT03440216|dosing|dosing
5089291|NCT03440216|total concentration|total concentration
5089292|NCT03440216|free concentration|free concentration
5089303|NCT03440164|liver fibrosis|liver fibrosis
5089304|NCT03440164|Hepatoprotective|hepatoprotective
5089305|NCT03440164|Sylimarin|sylimarin
5089306|NCT03440151|Tongue Squamous Cell Carcinoma,|tongue squamous cell carcinoma,
5089307|NCT03440151|Contralateral Submental Flap|contralateral submental flap
5089308|NCT03440151|Submental Flap|submental flap
5089309|NCT03440151|oncological safety|oncological safety
5089310|NCT03440125|Low Back Pain|low back pain
5089311|NCT03440125|Capsicum|capsicum
5089312|NCT03440125|Physical Therapy|physical therapy
5089313|NCT03440125|Pain|pain
5089314|NCT03440112|Gait|gait
5089315|NCT03440112|Balance|balance
5089316|NCT03440112|GABA|gaba
5089317|NCT03440112|Clarithromycin|clarithromycin
5089318|NCT03440112|PET Imaging|pet imaging
5089319|NCT03440112|MRI|mri
5089320|NCT03440112|Mobility|mobility
5089321|NCT03440099|Resistance Training|resistance training
5089322|NCT03440099|Sex Differences|sex differences
5089323|NCT03440086|Laparoscopic surgery|laparoscopic surgery
5089324|NCT03440086|Pain|pain
5089325|NCT03440086|Jackson-Pratt drain|jackson-pratt drain
5089326|NCT03440073|pregnancy|pregnancy
5089327|NCT03440073|pain|pain
5089328|NCT03440073|pelvis|pelvis
5089329|NCT03440073|spine|spine
5089330|NCT03440073|manual therapy|manual therapy
5089331|NCT03440060|procalcitonin|procalcitonin
5089332|NCT03440060|mechanical ventilation|mechanical ventilation
5089333|NCT03440060|COPD exacerbation|copd exacerbation
5089334|NCT03440047|endoscopic image|endoscopic image
5089335|NCT03440047|Fujifilm|fujifilm
5089336|NCT03440047|Blue light imaging|blue light imaging
5089337|NCT03440034|IBM|ibm
5089338|NCT03440034|inclusion body myositis|inclusion body myositis
5089339|NCT03440021|Noradrenalin Agents|noradrenalin agents
5089340|NCT03440021|Physiological Effects of Drugs|physiological effects of drugs
5089341|NCT03440021|Mood disorders|mood disorders
5089343|NCT03439982|Hepatic encephalopathy, fecal microbiota transplant|hepatic encephalopathy, fecal microbiota transplant
5089344|NCT03439969|Gingivitis|gingivitis
5089345|NCT03439969|SMS|sms
5089346|NCT03439969|Text messages|text messages
5089347|NCT03439969|Behavior change|behavior change
5089348|NCT03439969|HAPA|hapa
5089349|NCT03439969|Dental Hygiene|dental hygiene
5089350|NCT03439956|Obstetric outcomes|obstetric outcomes
5089351|NCT03439956|Transvaginal specimen extraction|transvaginal specimen extraction
5089352|NCT03439956|Gynecological laparoscopy|gynecological laparoscopy
5089353|NCT03439904|pharmaceutical care|pharmaceutical care
5089354|NCT03439904|adherence|adherence
5089355|NCT03439852|physical activity|physical activity
5089359|NCT03439813|transient ischemic attack|transient ischemic attack
5089360|NCT03439813|anxiety|anxiety
5089361|NCT03439813|psychotherapy|psychotherapy
5089362|NCT03439787|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5089363|NCT03439787|Anesthetics, Local|anesthetics, local
5089364|NCT03439787|Pain, Postoperative|pain, postoperative
5089365|NCT03439787|Nerve Block|nerve block
5089366|NCT03439787|Bupivacaine|bupivacaine
5089367|NCT03439787|Epinephrine|epinephrine
5089368|NCT03439735|Breast Cancer|breast cancer
5089369|NCT03439735|Metastatic Breast Cancer|metastatic breast cancer
5089370|NCT03439735|Aromatase Inhibitors|aromatase inhibitors
5089371|NCT03439735|Palbociclib|palbociclib
5089372|NCT03439735|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
5089373|NCT03439722|cluster headache|cluster headache
5089374|NCT03439722|sleep disturbances|sleep disturbances
5089375|NCT03439709|acromegaly|acromegaly
5089376|NCT03439709|pituitary adenoma|pituitary adenoma
5089377|NCT03439709|gamma knife radiosurgery|gamma knife radiosurgery
5089378|NCT03439709|adjuvant treatment|adjuvant treatment
5089392|NCT03439605|Haemolysis|haemolysis
5089393|NCT03439579|Telehealth|telehealth
5089394|NCT03439579|Remote weight loss|remote weight loss
5089395|NCT03439579|Self-monitoring|self-monitoring
5089396|NCT03439579|Diet|diet
5089397|NCT03439579|Physical activity|physical activity
5089398|NCT03439566|pain measures|pain measures
5089399|NCT03439566|prediction of pain|prediction of pain
5089400|NCT03439566|pain management|pain management
5089401|NCT03439540|Plantago major|plantago major
5089402|NCT03439540|obesity|obesity
5089403|NCT03439540|mineral content|mineral content
5089404|NCT03439540|adipose tissue|adipose tissue
5089405|NCT03439527|Muscle Precursor Cells|muscle precursor cells
5089406|NCT03439514|cardiomyopathy|cardiomyopathy
5089407|NCT03439514|Lamin Type A|lamin type a
5089408|NCT03439514|heart failure|heart failure
5089409|NCT03439514|ARRY-797|arry-797
5089410|NCT03439488|First in Human|first in human
5089411|NCT03439488|Healthy Volunteers|healthy volunteers
5089412|NCT03439488|Hepatitis B Virus|hepatitis b virus
5089413|NCT03439488|JNJ-64530440|jnj-64530440
5089414|NCT03439475|Refractory Celiac Disease Type II|refractory celiac disease type ii
5089415|NCT03439449|History taking, Risk stratification|history taking, risk stratification
5089416|NCT03439410|Internal medicine|internal medicine
5089417|NCT03439410|Chronic disease|chronic disease
5089418|NCT03439410|Healthcare expenditure|healthcare expenditure
5089419|NCT03439371|Acute Myeloid Leukemia|acute myeloid leukemia
5089420|NCT03439371|Micro-transplantation|micro-transplantation
5089421|NCT03439371|Elderly|elderly
5089422|NCT03439371|Graft-versus-leukemia|graft-versus-leukemia
5089423|NCT03439358|Epidural top-up|epidural top-up
5089424|NCT03439358|Shivering|shivering
5089425|NCT03439358|Magnesium|magnesium
5089426|NCT03439332|Highly infiltrative|highly infiltrative
5089427|NCT03439332|Deeply invasive|deeply invasive
5089428|NCT03439332|Strong vascular proliferation|strong vascular proliferation
5089429|NCT03439332|Robust angiogenesis|robust angiogenesis
5741517|NCT00352612|controlled|controlled
5089430|NCT03439332|Vascular heterogeneity|vascular heterogeneity
5089431|NCT03439332|Perfusion Biormarker|perfusion biormarker
5089432|NCT03439332|Non-Invasive Biomarker|non-invasive biomarker
5089433|NCT03439332|Predictor of overall survival|predictor of overall survival
5089434|NCT03439332|Predictor of progression-free survival|predictor of progression-free survival
5089435|NCT03439319|MyndMove|myndmove
5089436|NCT03439319|Electrical neuromodulation|electrical neuromodulation
5089437|NCT03439319|conventional therapy|conventional therapy
5089438|NCT03439293|Drug Therapy|drug therapy
5089439|NCT03439293|Ixazomib|ixazomib
5089440|NCT03439293|Daratumumab|daratumumab
5089441|NCT03439293|Dexamethasone|dexamethasone
5089442|NCT03439280|Drug therapy, TAK-079, pomalidomide and dexamethasone, CD38 monoclonal antibody|drug therapy, tak-079, pomalidomide and dexamethasone, cd38 monoclonal antibody
5089447|NCT03439215|ROS1 positive|ros1 positive
5089448|NCT03439215|NSCLC|nsclc
5089449|NCT03439202|Hypoxia|hypoxia
5089450|NCT03439202|Baro-reflex sensitivity|baro-reflex sensitivity
5089451|NCT03439202|Low-intensity exercise|low-intensity exercise
5089452|NCT03439202|Hear rate variability|hear rate variability
5089656|NCT03437902|Rutin|rutin
5089455|NCT03439150|Absolute flow measurement|absolute flow measurement
5089456|NCT03439150|Microvascular resistance|microvascular resistance
5089472|NCT03439046|CDK6|cdk6
5089473|NCT03439046|CDK4/6|cdk4/6
5089474|NCT03439046|Phase IIIb|phase iiib
5089477|NCT03439046|postmenopausal|postmenopausal
5089478|NCT03439046|biomarker|biomarker
5089479|NCT03439046|ctDNA|ctdna
5089480|NCT03439046|liquid biopsy|liquid biopsy
5089481|NCT03439046|PIK3CA|pik3ca
5089482|NCT03439046|alpelisib|alpelisib
5089483|NCT03439046|fulvestrant|fulvestrant
5089484|NCT03439046|BYL719|byl719
5089485|NCT03439033|prostate cancer|prostate cancer
5089486|NCT03439007|Dehydration|dehydration
5089487|NCT03438994|autism|autism
5089488|NCT03438994|movement|movement
5089489|NCT03438994|tablet|tablet
5089490|NCT03438994|gameplay|gameplay
5089491|NCT03438981|Pharmacokinetics|pharmacokinetics
5089492|NCT03438981|Ceftriaxone|ceftriaxone
5089493|NCT03438981|critical illness|critical illness
5089494|NCT03438981|capillary leak|capillary leak
5089495|NCT03438981|hypoalbuminemia|hypoalbuminemia
5089496|NCT03438942|iron|iron
5089497|NCT03438942|folate|folate
5089498|NCT03438942|childbearing age|childbearing age
5089499|NCT03438942|bioavailability|bioavailability
5089500|NCT03438916|Non-selective beta-blocker|non-selective beta-blocker
5089501|NCT03438916|Pharmacological respons|pharmacological respons
5089502|NCT03438916|Magnetic Resonance Imaging|magnetic resonance imaging
5089503|NCT03438916|Hemodynamic assessments|hemodynamic assessments
5089504|NCT03438916|Echocardiography|echocardiography
5089505|NCT03438916|MR-elastography|mr-elastography
5089506|NCT03438916|Propranolol|propranolol
5089507|NCT03438916|Liver vein catheterization|liver vein catheterization
5089508|NCT03438877|acute kidney injury|acute kidney injury
5089509|NCT03438877|peritoneal dialysis|peritoneal dialysis
5089510|NCT03438877|dosage|dosage
5089511|NCT03438864|Radius fracture, Interferential current, edema, pain|radius fracture, interferential current, edema, pain
5089512|NCT03438838|Achalasia, LHM, Anterior fundoplication|achalasia, lhm, anterior fundoplication
5089513|NCT03438773|Hispanic|hispanic
5089514|NCT03438773|First time kidney recipients|first time kidney recipients
5089515|NCT03438760|Language Disorders|language disorders
5089516|NCT03438760|Communication Disorders|communication disorders
5089517|NCT03438760|Neurobehavioral Manifestations|neurobehavioral manifestations
5089518|NCT03438760|Developmental Language Disorder|developmental language disorder
5089519|NCT03438760|Randomized Controlled Trial|randomized controlled trial
5089520|NCT03438734|Bariatric surgery|bariatric surgery
5089521|NCT03438734|Low flow anesthesia|low flow anesthesia
5089522|NCT03438734|Bispectral index|bispectral index
5089523|NCT03438734|Regional cerebral oximetry|regional cerebral oximetry
5089524|NCT03438708|Renal Cell Carcinoma|renal cell carcinoma
5089525|NCT03438708|Axitinib|axitinib
5089526|NCT03438708|Nephrectomy|nephrectomy
5089527|NCT03438708|Neoadjuvant|neoadjuvant
5089528|NCT03438708|Clear Cell Renal Carcinoma|clear cell renal carcinoma
5089529|NCT03438695|endoscopy, motorized spiral enteroscopy|endoscopy, motorized spiral enteroscopy
5089530|NCT03438669|visual acuity|visual acuity
5089531|NCT03438669|ETDRS|etdrs
5089532|NCT03438669|quality of life|quality of life
5089533|NCT03438656|Depression|depression
5089534|NCT03438656|Childhood adversity|childhood adversity
5089535|NCT03438656|Behavioral Activation|behavioral activation
5089536|NCT03438656|Reward Processing|reward processing
5089537|NCT03438656|fMRI|fmri
5089538|NCT03438643|Graft versus host disease|graft versus host disease
5089539|NCT03438643|Extracorporeal photopheresis|extracorporeal photopheresis
5089540|NCT03438643|Immunomodulatory|immunomodulatory
5089541|NCT03438630|socioeconomic factors|socioeconomic factors
5089542|NCT03438630|comorbidity|comorbidity
5089543|NCT03438630|replacement surgery|replacement surgery
5089544|NCT03438617|Diabetes|diabetes
5089545|NCT03438617|Self-Management|self-management
5089546|NCT03438617|Primary Care|primary care
5089547|NCT03438617|Community Health Center|community health center
5089548|NCT03438617|Peer Support|peer support
5089549|NCT03438617|Group Support|group support
5089567|NCT03438513|Problem solving therapy|problem solving therapy
5089568|NCT03438448|Ultrasensitive Troponin T|ultrasensitive troponin t
5089569|NCT03438448|MINS|mins
5089570|NCT03438448|Cost-effectiveness|cost-effectiveness
5089571|NCT03438448|Myocardial Ischemia|myocardial ischemia
5089572|NCT03438383|Bi-PAP|bi-pap
5089573|NCT03438383|BiPAP|bipap
5089574|NCT03438383|morbid obesity|morbid obesity
5089575|NCT03438383|anesthesia|anesthesia
5089581|NCT03438331|Depression|depression
5089582|NCT03438331|Adolescents|adolescents
5089583|NCT03438331|Youth|youth
5089584|NCT03438292|Berberine|berberine
5089585|NCT03438292|TPGS|tpgs
5089586|NCT03438292|Pharmacokinetics|pharmacokinetics
5089587|NCT03438292|Human intervention study|human intervention study
5089588|NCT03438292|Quillaja extract|quillaja extract
5089589|NCT03438253|Intraoperative penile engorgement|intraoperative penile engorgement
5089590|NCT03438253|Anaesthesia|anaesthesia
5089591|NCT03438253|Urogenital surgery|urogenital surgery
5089592|NCT03438227|Iron Deficiency Anemia of Pregnancy|iron deficiency anemia of pregnancy
5089593|NCT03438227|oral iron supplementation|oral iron supplementation
5089594|NCT03438227|parenteral iron supplementation|parenteral iron supplementation
5089595|NCT03438227|maternal anemia|maternal anemia
5089596|NCT03438214|Vancomycin infusion|vancomycin infusion
5089597|NCT03438214|critical ill patients|critical ill patients
5089598|NCT03438214|MRSA|mrsa
5089599|NCT03438201|Cancer, ICU, Surgery, Protein, Physical Activity|cancer, icu, surgery, protein, physical activity
5089600|NCT03438188|Nicotine Addiction|nicotine addiction
5961867|NCT04284462|perception|perception
4999458|NCT03998150|BPH|bph
5089601|NCT03438188|Quitting Smoking|quitting smoking
5089602|NCT03438175|Post-traumatic Stress Disorder|post-traumatic stress disorder
5089603|NCT03438175|Web-site|web-site
5089604|NCT03438175|Communication|communication
5089605|NCT03438175|Intensive Care Unit|intensive care unit
5089606|NCT03438175|Comprehension|comprehension
5089607|NCT03438149|microparticles|microparticles
5089608|NCT03438149|cardiovascular outcomes|cardiovascular outcomes
5089609|NCT03438110|Preterm birth|preterm birth
5089610|NCT03438110|Neonatal death|neonatal death
5089611|NCT03438110|Stillbirth|stillbirth
5089612|NCT03438110|Asia|asia
5089613|NCT03438110|Africa|africa
5089614|NCT03438097|Fluid therapy|fluid therapy
5089615|NCT03438097|Non-resuscitation fluids|non-resuscitation fluids
5089616|NCT03438097|Septic shock|septic shock
5089617|NCT03438084|Interesterified|interesterified
5089618|NCT03438084|Postprandial|postprandial
5089619|NCT03438084|Lipid|lipid
5089620|NCT03438058|Solid Organ Transplantation|solid organ transplantation
5089621|NCT03438058|Graft survival|graft survival
5089622|NCT03438058|Rejection|rejection
5089623|NCT03438058|Complement-activating anti-HLA DSA|complement-activating anti-hla dsa
5089624|NCT03438058|Meta-analysis|meta-analysis
5089625|NCT03438058|Prognosis|prognosis
5089626|NCT03438045|Chinese American|chinese american
5089627|NCT03438045|implementation science|implementation science
5089628|NCT03438045|feasibility|feasibility
5089629|NCT03438045|acceptability|acceptability
5089630|NCT03438045|oral health|oral health
5089631|NCT03438045|dental care|dental care
5089632|NCT03438045|health equity|health equity
5089633|NCT03438045|urban health|urban health
5089634|NCT03438019|Maximal Respiratory Pressures, Inspiratory Muscle Training, TIRE, COPD|maximal respiratory pressures, inspiratory muscle training, tire, copd
5089635|NCT03438006|Safety|safety
5089636|NCT03438006|Human Papillomavirus Vaccine|human papillomavirus vaccine
5089637|NCT03438006|Adverse Event Following Immunization|adverse event following immunization
5089638|NCT03437993|ADHD|adhd
5089639|NCT03437993|executive functioning|executive functioning
5089641|NCT03437941|Prostate Cancer|prostate cancer
5089642|NCT03437941|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5089643|NCT03437941|Glucocorticoid receptor|glucocorticoid receptor
5089644|NCT03437941|Antagonist|antagonist
5089645|NCT03437941|mCRPC|mcrpc
5089646|NCT03437941|enzalutamide|enzalutamide
5089647|NCT03437941|androgen receptor|androgen receptor
5089648|NCT03437928|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5089649|NCT03437928|MDD|mdd
5089650|NCT03437928|Neuromodulation|neuromodulation
5089651|NCT03437928|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5089652|NCT03437928|DBS|dbs
5089653|NCT03437928|Electrophysiology|electrophysiology
5089654|NCT03437928|Imaging|imaging
5089655|NCT03437902|Type 2 diabetes|type 2 diabetes
5089662|NCT03437876|HBV induced cirrhosis|hbv induced cirrhosis
5089663|NCT03437876|intestinal microbiota transplantation|intestinal microbiota transplantation
5089664|NCT03437876|microbiota|microbiota
5089665|NCT03437863|self-management|self-management
5089666|NCT03437863|health assets|health assets
5089667|NCT03437863|Strengths|strengths
5089669|NCT03437863|Feasibility|feasibility
5089670|NCT03437811|airway clearance system|airway clearance system
5089671|NCT03437811|cystic fibrosis|cystic fibrosis
5089672|NCT03437811|lung secretion clearance|lung secretion clearance
5089673|NCT03437798|Periodontal Disease|periodontal disease
5089674|NCT03437798|Diabetes|diabetes
5089675|NCT03437798|Osteoporosis|osteoporosis
5100893|NCT03367624|ICU|icu
5089678|NCT03437785|Acute Gastritis|acute gastritis
5089679|NCT03437785|Chronic Gastritis|chronic gastritis
5089680|NCT03437785|Cinnamic acid|cinnamic acid
5089681|NCT03437785|CKD-495|ckd-495
5089682|NCT03437759|macular hole (MH)|macular hole (mh)
5089683|NCT03437759|exosomes|exosomes
5089684|NCT03437759|mesenchymal stem cells|mesenchymal stem cells
5089685|NCT03437759|pars plana vitrectomy|pars plana vitrectomy
5089686|NCT03437733|Radiofrequency Ablation|radiofrequency ablation
5089687|NCT03437733|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5089688|NCT03437707|Postoperative pain|postoperative pain
5089689|NCT03437707|Intravenous ibuprofen|intravenous ibuprofen
5089690|NCT03437707|Intravenous paracetamol|intravenous paracetamol
5089691|NCT03437707|Lumbar disc surgery|lumbar disc surgery
5089692|NCT03437694|HIV|hiv
5089693|NCT03437694|AIDS|aids
5089694|NCT03437694|Diabetes Melliltus, Type 2|diabetes melliltus, type 2
5089695|NCT03437694|Hypertension|hypertension
5089696|NCT03437694|Pharmacist|pharmacist
5089697|NCT03437694|Medication optimization|medication optimization
5089698|NCT03437694|medication therapy management|medication therapy management
5089699|NCT03437681|Sleep|sleep
5089700|NCT03437681|Blood Sugar|blood sugar
5089703|NCT03437616|Rehabilitation|rehabilitation
5089704|NCT03437616|Coronary heart disease|coronary heart disease
5089705|NCT03437616|Cardiovascular diseases|cardiovascular diseases
5089706|NCT03437616|Risk factors|risk factors
5089707|NCT03437616|Life-style changes|life-style changes
5089708|NCT03437616|Efficacy|efficacy
5961868|NCT04284449|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5089709|NCT03437603|Eltrombopag|eltrombopag
5089710|NCT03437603|Allogenetic Hematopoietic Stem Cell Transplantation|allogenetic hematopoietic stem cell transplantation
5089711|NCT03437603|Poor Graft Function|poor graft function
5089712|NCT03437577|Kidney|kidney
5089713|NCT03437577|Transplant|transplant
5089714|NCT03437551|Diabetes Mellitus 1|diabetes mellitus 1
5089715|NCT03437551|long-term intensified insulin therapy|long-term intensified insulin therapy
5089716|NCT03437551|diabetic retinopathy|diabetic retinopathy
5089717|NCT03437551|diabetic macular edema|diabetic macular edema
5089718|NCT03437538|Dialysis|dialysis
5089719|NCT03437538|MCO|mco
5089720|NCT03437538|Middle molecules|middle molecules
5089721|NCT03437538|High Retention Onset|high retention onset
5089722|NCT03437538|Medium Cut-Off|medium cut-off
5089723|NCT03437525|Diabetes|diabetes
5089724|NCT03437525|Self-Management|self-management
5089725|NCT03437525|Primary Care|primary care
5089726|NCT03437525|Community Health Center|community health center
5089727|NCT03437525|Peer Support|peer support
5089728|NCT03437525|Group Support|group support
5089729|NCT03437525|Integrated Care|integrated care
5089730|NCT03437525|Insulin|insulin
5089731|NCT03437525|China|china
5089732|NCT03437525|Urban|urban
5089737|NCT03437460|Productivity|productivity
5089738|NCT03437460|Cognitive Function|cognitive function
5089739|NCT03437460|Decision Making|decision making
5089740|NCT03437460|Well-Being|well-being
5089741|NCT03437460|Health|health
5089742|NCT03437460|Labor|labor
5089743|NCT03437447|Bioavailability|bioavailability
5089744|NCT03437447|Bioequivalence|bioequivalence
5089745|NCT03437447|Praziquantel|praziquantel
5089746|NCT03437447|Cysticide|cysticide
5089747|NCT03437447|Pharmacokinetics|pharmacokinetics
5089748|NCT03437421|myocardial function|myocardial function
5089749|NCT03437421|vitamin D|vitamin d
5089750|NCT03437421|stress echocardiography|stress echocardiography
5089751|NCT03437421|diabetes|diabetes
5089752|NCT03437408|Ventricular Tachycardia|ventricular tachycardia
5089753|NCT03437408|Catheter Ablation|catheter ablation
5089754|NCT03437408|Late Potential|late potential
5089755|NCT03437408|Ablation Index|ablation index
5089765|NCT03437369|Ivabradine, heart rate, acute heart failure|ivabradine, heart rate, acute heart failure
5089766|NCT03437356|persistent atrial fibrillation|persistent atrial fibrillation
5089768|NCT03437356|antiarrhythmic drug therapy|antiarrhythmic drug therapy
5089769|NCT03437343|EOS|eos
5089770|NCT03437343|total hip arthroplasty|total hip arthroplasty
5089771|NCT03437343|performance of surgeons|performance of surgeons
5089772|NCT03437343|leg length discrepancy|leg length discrepancy
5089774|NCT03437317|Social Anxiety|social anxiety
5089775|NCT03437317|Threat processing|threat processing
5089776|NCT03437317|Magnetoencephalography (MEG)|magnetoencephalography (meg)
5089777|NCT03437304|Vaccine|vaccine
5089791|NCT03437174|SF-36|sf-36
5089792|NCT03437174|Quality of Life|quality of life
5089793|NCT03437161|Radiation|radiation
5089794|NCT03437161|Prone position|prone position
5089795|NCT03437161|Supine position|supine position
5089796|NCT03437161|DIBH|dibh
5089797|NCT03437161|Invasive Breast Carcinoma|invasive breast carcinoma
5089798|NCT03437161|Ductal Breast Carcinoma In Situ|ductal breast carcinoma in situ
5089799|NCT03437148|Pulmonary to systemic blood flow|pulmonary to systemic blood flow
5089800|NCT03437148|Non-invasive measurement|non-invasive measurement
5089801|NCT03437148|Inert gas rebreathing|inert gas rebreathing
5089802|NCT03437148|Bioimpedance cardiograph|bioimpedance cardiograph
5089803|NCT03437148|Atrial Septal Defect|atrial septal defect
5089804|NCT03437148|Congenital heart disease|congenital heart disease
5089805|NCT03437148|Cardiac Output|cardiac output
5089806|NCT03437135|diabetes|diabetes
5089807|NCT03437135|hearing problems|hearing problems
5089808|NCT03437135|otoscopy|otoscopy
5089809|NCT03437122|lung, nasal mucosa, respiratory mucosa|lung, nasal mucosa, respiratory mucosa
5089810|NCT03437083|Breast neoplasms|breast neoplasms
5089811|NCT03437083|Metastatic breast cancer|metastatic breast cancer
5089812|NCT03437083|E7389|e7389
5089813|NCT03437070|Advanced Leiomyosarcoma|advanced leiomyosarcoma
5089814|NCT03437070|Recurrent Leiomyosarcoma|recurrent leiomyosarcoma
5089815|NCT03437057|ECL|ecl
5089816|NCT03437057|Hematoma|hematoma
5089817|NCT03437057|Antiplatelet|antiplatelet
5089818|NCT03437044|diabetes mellitus|diabetes mellitus
5089819|NCT03437044|percutaneous coronary intervention|percutaneous coronary intervention
5089820|NCT03437044|ticagrelor|ticagrelor
5089821|NCT03437044|clopidogrel|clopidogrel
5089822|NCT03437044|coronary artery disease|coronary artery disease
5089823|NCT03437031|Labor Pain|labor pain
5089824|NCT03437031|Virtual Reality|virtual reality
5089825|NCT03437031|Alternative Medicine|alternative medicine
5089826|NCT03437018|moderate diabetic retinopathy|moderate diabetic retinopathy
5089827|NCT03437018|tele-expertise|tele-expertise
5089828|NCT03437005|Human microbiome|human microbiome
5089829|NCT03437005|Topical|topical
5089830|NCT03437005|Steroid|steroid
5089831|NCT03437005|Anti-fungal|anti-fungal
5089832|NCT03436992|Estrogen, Diabetes|estrogen, diabetes
5089833|NCT03436979|prolapse|prolapse
5089834|NCT03436979|sacrospinous fixation|sacrospinous fixation
5961869|NCT04284449|Cognitive Decline|cognitive decline
5089835|NCT03436979|minimally invasive|minimally invasive
5089836|NCT03436927|Multiple Sclerosis|multiple sclerosis
5089837|NCT03436927|rehabilitation|rehabilitation
5089838|NCT03436927|postural balance|postural balance
5089839|NCT03436927|exercise|exercise
5089840|NCT03436901|magnetic resonance imaging|magnetic resonance imaging
5741782|NCT00351988|Survey|survey
5089841|NCT03436901|diffusion weighted imaging|diffusion weighted imaging
5089842|NCT03436862|Nivolumab|nivolumab
5089843|NCT03436862|Autologous Stem Cell Transplant|autologous stem cell transplant
5089844|NCT03436862|Blood cancers|blood cancers
5089845|NCT03436849|ASP2693|asp2693
5089846|NCT03436849|Pharmacodynamics|pharmacodynamics
5089847|NCT03436849|Pharmacokinetics|pharmacokinetics
5089848|NCT03436849|ESN364|esn364
5089849|NCT03436849|Safety|safety
5089850|NCT03436810|Motor Imagery|motor imagery
5088018|NCT03447665|Infant sleep|infant sleep
5089851|NCT03436810|Task-Oriented Circuit Class Training|task-oriented circuit class training
5089852|NCT03436810|Health Education|health education
5089853|NCT03436771|long-term follow-up|long-term follow-up
5089854|NCT03436771|chimeric antigen receptor (CAR) T cells|chimeric antigen receptor (car) t cells
5089866|NCT03436732|Rapamycin|rapamycin
5089867|NCT03436732|Targeted Therapy|targeted therapy
5089868|NCT03436732|Mesothelin|mesothelin
5089869|NCT03436719|Surgical Site Infection|surgical site infection
5089870|NCT03436719|Rectal Cancer Surgery|rectal cancer surgery
5089878|NCT03436654|apalutamide|apalutamide
5089879|NCT03436654|abiraterone acetate|abiraterone acetate
5089880|NCT03436654|memorial sloan kettering cancer center|memorial sloan kettering cancer center
5089881|NCT03436654|17-646|17-646
5089882|NCT03436602|Personalized risk assessment|personalized risk assessment
5089883|NCT03436602|Risk stratification model|risk stratification model
5089884|NCT03436589|Supplemental Nutrition Assistance Program-Education|supplemental nutrition assistance program-education
5089885|NCT03436589|nutrition education intervention|nutrition education intervention
5089886|NCT03436576|Autologous serum|autologous serum
5089888|NCT03436576|Autologous serum 20%|autologous serum 20%
5089889|NCT03436576|Autologous serum 50%|autologous serum 50%
5089890|NCT03436576|Severe dry eye|severe dry eye
5089891|NCT03436563|colon cancer|colon cancer
5089892|NCT03436563|rectal cancer|rectal cancer
5089893|NCT03436563|colorectal cancer|colorectal cancer
5089894|NCT03436563|microsatellite instability|microsatellite instability
5089895|NCT03436563|circulating tumor DNA|circulating tumor dna
5089896|NCT03436563|metastasis|metastasis
5089898|NCT03436550|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5089899|NCT03436550|Magnetic Resonance Imaging|magnetic resonance imaging
5089900|NCT03436550|Acoustic Radiation Force Impulse|acoustic radiation force impulse
5089901|NCT03436550|Elastography|elastography
5089902|NCT03436550|Ultrasound|ultrasound
5089903|NCT03436550|Liver Cirrhosis|liver cirrhosis
5089904|NCT03436537|aesthetic|aesthetic
5089905|NCT03436537|development|development
5089906|NCT03436537|periodontal|periodontal
5089907|NCT03436537|reliability|reliability
5089908|NCT03436537|validity|validity
5089909|NCT03436524|Early stage CLL|early stage cll
5089910|NCT03436524|Binet A|binet a
5089911|NCT03436524|Prognosis|prognosis
5089912|NCT03436511|Health resource utilization|health resource utilization
5089913|NCT03436511|Eosinophilic COPD|eosinophilic copd
5089914|NCT03436511|Mepolizumab|mepolizumab
5089915|NCT03436472|aged|aged
5089916|NCT03436472|operative|operative
5089917|NCT03436472|delirium|delirium
5089918|NCT03436472|dexmedetomidine|dexmedetomidine
5089919|NCT03436472|long-term outcome|long-term outcome
5089920|NCT03436459|extracorporeal shock wave therapy (ESWT)|extracorporeal shock wave therapy (eswt)
5089921|NCT03436459|Low level laser therapy (LLLT)|low level laser therapy (lllt)
5089922|NCT03436459|Myofascial Pain Syndrome|myofascial pain syndrome
5089923|NCT03436446|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
5089924|NCT03436446|Social Incentives|social incentives
5089925|NCT03436433|anti-epileptic drugs|anti-epileptic drugs
5089926|NCT03436433|seizure prophylaxis|seizure prophylaxis
5089927|NCT03436433|levetiracetam|levetiracetam
5089928|NCT03436420|Pediatrics|pediatrics
5089929|NCT03436420|Lipids|lipids
5089930|NCT03436420|Liver Diseases|liver diseases
5089931|NCT03436420|Obesity|obesity
5089932|NCT03436394|Renal Impairment|renal impairment
5089933|NCT03436394|Evobrutinib|evobrutinib
5089934|NCT03436394|Pharmacokinetics|pharmacokinetics
5089935|NCT03436368|Continuous spinal anesthesia|continuous spinal anesthesia
5089936|NCT03436368|General anesthesia|general anesthesia
5089937|NCT03436368|Renal transplantation|renal transplantation
5089938|NCT03436368|Chronic renal failure|chronic renal failure
5089939|NCT03436355|Behavioral|behavioral
5089940|NCT03436355|Physical activity|physical activity
5089941|NCT03436355|Intervention|intervention
5089942|NCT03436355|School children|school children
5089943|NCT03436329|Lung cancer|lung cancer
5089944|NCT03436329|Surgical technique|surgical technique
5089945|NCT03436329|vessel ligation|vessel ligation
5089946|NCT03436329|Circulating tumor cell|circulating tumor cell
5089947|NCT03436316|Phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
5089948|NCT03436316|First-in-human (FiH) study|first-in-human (fih) study
5089949|NCT03436303|Menopause Syndrome|menopause syndrome
5089950|NCT03436303|low dose estrogen|low dose estrogen
5089952|NCT03436290|Palliative Care|palliative care
5089953|NCT03436277|Overweight|overweight
5089954|NCT03436277|Obesity|obesity
5089955|NCT03436277|L-Carnitine|l-carnitine
5089968|NCT03436186|Thyroidectomy|thyroidectomy
5089969|NCT03436186|voice|voice
5089970|NCT03436186|swallowing problems|swallowing problems
5089971|NCT03436186|dysphagia|dysphagia
5089972|NCT03436147|vaginal hysterectomy|vaginal hysterectomy
5089973|NCT03436147|laparoscopic hysteropexy|laparoscopic hysteropexy
5089976|NCT03436134|Double-Filtration PlasmaPheresis (DFPP)|double-filtration plasmapheresis (dfpp)
5089977|NCT03436134|Plasma Exchange (PE)|plasma exchange (pe)
5089979|NCT03436095|difficult ventilator weaning|difficult ventilator weaning
5089980|NCT03436069|Breast cancer|breast cancer
5089981|NCT03436069|biomarkers|biomarkers
5089982|NCT03436069|prognostic|prognostic
5089983|NCT03436069|ectopic gene expression|ectopic gene expression
5089984|NCT03436069|expression profile|expression profile
5089985|NCT03436069|tissue-specific genes|tissue-specific genes
5089986|NCT03436069|response to treatment|response to treatment
5089987|NCT03436056|Non-small-cell lunG cancer|non-small-cell lung cancer
5089988|NCT03436056|NSCLC|nsclc
5089989|NCT03436056|metastatic|metastatic
5089990|NCT03436056|pembrolizumab|pembrolizumab
5089991|NCT03436056|radiotherapy|radiotherapy
5089992|NCT03436043|Walled of necrosis|walled of necrosis
5089993|NCT03436017|adhd|adhd
5089994|NCT03436017|metabolomics|metabolomics
5089995|NCT03436017|child|child
5089996|NCT03436004|Colonoscopy|colonoscopy
5089997|NCT03436004|Adenoma|adenoma
5089998|NCT03436004|Adenoma detection rate|adenoma detection rate
5090003|NCT03435978|diet|diet
5090004|NCT03435978|metabolic syndrome|metabolic syndrome
5090005|NCT03435978|obese children|obese children
5090006|NCT03435952|Pembrolizumab|pembrolizumab
5090007|NCT03435952|Keytruda|keytruda
5090008|NCT03435952|MK-3475|mk-3475
5090009|NCT03435952|SCH-900475|sch-900475
5090010|NCT03435952|Clostridium Novyi-NT|clostridium novyi-nt
5090011|NCT03435952|C. novyi-NT|c. novyi-nt
5090012|NCT03435952|Doxycycline|doxycycline
5090013|NCT03435952|Vibramycin|vibramycin
5090014|NCT03435952|Periostat|periostat
5090015|NCT03435952|Doryx|doryx
5090016|NCT03435952|Solid tumor malignancies|solid tumor malignancies
5090017|NCT03435913|Mechanical ventilation|mechanical ventilation
5090018|NCT03435913|Driving Pressure|driving pressure
5090019|NCT03435913|Protective Lung VEntilation|protective lung ventilation
5090020|NCT03435887|Point of Care Testing|point of care testing
5090022|NCT03435887|Pediatric HIV-exposed infants|pediatric hiv-exposed infants
5090023|NCT03435887|at-birth testing|at-birth testing
5090024|NCT03435887|early infant diagnosis|early infant diagnosis
5090026|NCT03435848|Acute Myeloid Leukemia|acute myeloid leukemia
5090027|NCT03435848|Unfit for standard induction therapy|unfit for standard induction therapy
5090028|NCT03435848|Cytarabine|cytarabine
5090029|NCT03435822|asthma|asthma
5090030|NCT03435822|children|children
5090031|NCT03435822|action plan|action plan
5090032|NCT03435822|China|china
5090033|NCT03435822|CCAAP|ccaap
5090037|NCT03435770|EUS-guided RFA|eus-guided rfa
5090038|NCT03435770|Endoscopic ultrasound|endoscopic ultrasound
5090039|NCT03435770|radio frequency ablation|radio frequency ablation
5090041|NCT03435731|Continous Positive Airway Pressure (CPAP)|continous positive airway pressure (cpap)
5090042|NCT03435731|Mandibular Advancement Split (MAS)|mandibular advancement split (mas)
5090043|NCT03435731|Mandibular Advancement Oral Appliance|mandibular advancement oral appliance
5090044|NCT03435731|Dual Therapy|dual therapy
5090045|NCT03435718|oxfendazole|oxfendazole
5090046|NCT03435718|albendazole|albendazole
5090047|NCT03435718|Trichuris trichiura|trichuris trichiura
5090048|NCT03435679|infection|infection
5090049|NCT03435679|knee arthroplasty|knee arthroplasty
5090050|NCT03435679|surgical treatment|surgical treatment
5090051|NCT03435679|one-stage|one-stage
5090052|NCT03435679|two-stage|two-stage
5090053|NCT03435679|outcome|outcome
5090054|NCT03435640|Bempegaldesleukin (NKTR-214)|bempegaldesleukin (nktr-214)
5090061|NCT03435640|TLR7/8|tlr7/8
5090062|NCT03435640|CD122|cd122
5090063|NCT03435614|Opioid|opioid
5090064|NCT03435614|Withdrawal|withdrawal
5090065|NCT03435614|Critically ill adults|critically ill adults
5090066|NCT03435614|Cortisol|cortisol
5090067|NCT03435601|Rheumatoid Arthritis|rheumatoid arthritis
5090068|NCT03435601|RA|ra
5090069|NCT03435601|IFN-Signature|ifn-signature
5090070|NCT03435601|Anifrolumab|anifrolumab
5090071|NCT03435575|physical activity|physical activity
5090072|NCT03435575|serious game|serious game
5090073|NCT03435575|childhood obesity|childhood obesity
5090074|NCT03435536|circulating tumor DNA|circulating tumor dna
5090075|NCT03435536|kinetic|kinetic
5090076|NCT03435536|pancreatic cancer|pancreatic cancer
5090077|NCT03435536|pancreatoduodenectomy|pancreatoduodenectomy
5090078|NCT03435536|Next Generation Sequencing|next generation sequencing
5090079|NCT03435510|Live Donor Kidney Transplant|live donor kidney transplant
5090080|NCT03435510|Education|education
5090081|NCT03435510|Advocacy|advocacy
5090082|NCT03435510|Live Donor|live donor
5090083|NCT03435471|Prophylactic Swallowing Therapy|prophylactic swallowing therapy
5090084|NCT03435458|Induced labor|induced labor
5090085|NCT03435458|Maternal obesity|maternal obesity
5090090|NCT03435419|cutaneous leishmaniasis|cutaneous leishmaniasis
5090092|NCT03435419|LAMP|lamp
5090093|NCT03435419|PCR|pcr
5090094|NCT03435406|Hepatitis B, Chronic|hepatitis b, chronic
5090095|NCT03435406|Cirrhosis|cirrhosis
5090096|NCT03435406|Hepatopulmonary Syndrome|hepatopulmonary syndrome
5090097|NCT03435380|Cancer Survivors|cancer survivors
5090098|NCT03435380|Smartphone|smartphone
5090099|NCT03435380|Mobile Applications|mobile applications
5090100|NCT03435354|Physical activity|physical activity
5090101|NCT03435354|Quality of life|quality of life
5090112|NCT03435328|TENS|tens
5090113|NCT03435302|Mucosal Melanoma,Adjuvant Therapy,IFN-a2b,Temozolomide|mucosal melanoma,adjuvant therapy,ifn-a2b,temozolomide
5090114|NCT03435289|Advanced Pancreatic Cancer|advanced pancreatic cancer
5090115|NCT03435276|Heart failure.|heart failure.
5090116|NCT03435276|Oral selective mineralocorticoid receptor modulator.|oral selective mineralocorticoid receptor modulator.
5090117|NCT03435276|Heart failure with preserved ejection fraction (HFpEF).|heart failure with preserved ejection fraction (hfpef).
5090118|NCT03435263|premature rupture of membranes|premature rupture of membranes
5090125|NCT03435237|Optical Coherence Tomography|optical coherence tomography
5090126|NCT03435237|Bronchial Thermoplasty|bronchial thermoplasty
5090127|NCT03435185|Pain|pain
5090128|NCT03435185|Nerve Blocks|nerve blocks
5090129|NCT03435185|Headache|headache
5090130|NCT03435185|Local Anaesthetics|local anaesthetics
5090131|NCT03435185|Migraine|migraine
5138966|NCT03122223|HIV|hiv
5090132|NCT03435172|Thermal Burn|thermal burn
5090133|NCT03435172|Adipose Derived Regenerative Cells|adipose derived regenerative cells
5090134|NCT03435172|Skin Graft|skin graft
5090135|NCT03435159|Chiropractic, Manipulation, Vertebrobasilar Artery|chiropractic, manipulation, vertebrobasilar artery
5090136|NCT03435146|3HP|3hp
5090137|NCT03435146|LTBI|ltbi
5090138|NCT03435146|IMPAACT4TB|impaact4tb
5090139|NCT03435146|DDI|ddi
5090140|NCT03435146|Pharmacokinetics|pharmacokinetics
5090141|NCT03435146|Dolutegravir|dolutegravir
5090142|NCT03435133|Primary angioplasty|primary angioplasty
5090143|NCT03435133|Prasugrel|prasugrel
5090144|NCT03435133|Ticagrelor|ticagrelor
5090145|NCT03435133|STEMI|stemi
5090146|NCT03435133|cardiac magnetic resonance|cardiac magnetic resonance
5090147|NCT03435133|infarct size|infarct size
5090148|NCT03435133|infarct injury|infarct injury
5090149|NCT03435120|Breakthrough Cancer Pain|breakthrough cancer pain
5090150|NCT03435120|Quality of life|quality of life
5090151|NCT03435120|Medical Oncology|medical oncology
5090152|NCT03435081|eczema|eczema
5090153|NCT03435081|atopic eczema|atopic eczema
5090154|NCT03435068|rotary|rotary
5090155|NCT03435068|diode laser|diode laser
5090156|NCT03435068|gingivectomy|gingivectomy
5090160|NCT03435029|REHACOP|rehacop
5090161|NCT03435003|Bariatric Procedure|bariatric procedure
5090162|NCT03434990|spinal manipulative therapy|spinal manipulative therapy
5090163|NCT03434990|Myofascial release|myofascial release
5090164|NCT03434990|Low back pain|low back pain
5090165|NCT03434977|Drug Therapy|drug therapy
5090166|NCT03434938|Stroke|stroke
5090167|NCT03434938|Geriatric|geriatric
5090168|NCT03434938|Rehabilitation|rehabilitation
5090169|NCT03434938|Functional recovery|functional recovery
5090170|NCT03434938|Physical activity|physical activity
5090171|NCT03434938|Motivational interviewing|motivational interviewing
5090172|NCT03434938|Adherence|adherence
5090173|NCT03434938|Clinical trial|clinical trial
5090174|NCT03434925|colorectal neoplasia|colorectal neoplasia
5090175|NCT03434925|adenoma|adenoma
5090176|NCT03434925|colonoscopy|colonoscopy
5090177|NCT03434925|gene mutation|gene mutation
5090178|NCT03434925|follow-up|follow-up
5090179|NCT03434925|recurrence|recurrence
5090180|NCT03434925|multiparametric test|multiparametric test
5090181|NCT03434873|magnetic stimulation, multiple sclerosis|magnetic stimulation, multiple sclerosis
5090182|NCT03434821|Hyperoxemia|hyperoxemia
5090183|NCT03434821|ventilator-associated|ventilator-associated
5090184|NCT03434821|pneumonia|pneumonia
5090185|NCT03434821|critical illness|critical illness
5090189|NCT03434756|ultrasound imaging|ultrasound imaging
5090190|NCT03434756|propioception|propioception
5090191|NCT03434756|training|training
5090192|NCT03434743|oral feeding|oral feeding
5090193|NCT03434743|early intervention|early intervention
5090194|NCT03434743|premature infant|premature infant
5090195|NCT03434743|sucking|sucking
5090197|NCT03434730|17-616|17-616
5090198|NCT03434730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5090199|NCT03434678|General Anesthesia|general anesthesia
5090200|NCT03434678|Epidural|epidural
5090201|NCT03434678|Pancreaticoduodenectomy|pancreaticoduodenectomy
5090202|NCT03434678|18-056|18-056
5090203|NCT03434665|Angiography|angiography
5090211|NCT03434639|Wearable sensor|wearable sensor
5090212|NCT03434639|Leaky gut|leaky gut
5090213|NCT03434587|fifth metacarpal neck, fracture, syndactyly, inmobilization, RCT|fifth metacarpal neck, fracture, syndactyly, inmobilization, rct
5090214|NCT03434574|(Poly)phenols|(poly)phenols
5090215|NCT03434574|Aronia berry|aronia berry
5090216|NCT03434574|Blood pressure|blood pressure
5090217|NCT03434574|Vascular function|vascular function
5090218|NCT03434561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5090219|NCT03434509|Motor Control|motor control
5090220|NCT03434509|Attention|attention
5090221|NCT03434509|Cognitive Control|cognitive control
5090222|NCT03434496|PD; Gait training 3; treadmill.|pd; gait training 3; treadmill.
5090223|NCT03434483|Microbiota|microbiota
5090224|NCT03434483|Immunity|immunity
5090225|NCT03434483|Genetics|genetics
5090226|NCT03434483|Atherosclerosis|atherosclerosis
5090227|NCT03434470|Ultrasound|ultrasound
5090228|NCT03434470|Shear wave elastography|shear wave elastography
5090229|NCT03434470|SWE|swe
5090230|NCT03434470|Hepatitis C|hepatitis c
5090231|NCT03434470|HCV|hcv
5090232|NCT03434457|Fetal growth retardation|fetal growth retardation
5090233|NCT03434457|Early adversity|early adversity
5090234|NCT03434457|Depressive Symptoms|depressive symptoms
5090235|NCT03434444|propranolol|propranolol
5090236|NCT03434444|oxytocin|oxytocin
5090237|NCT03434444|uterine contraction|uterine contraction
5090238|NCT03434431|metabolic adaptation|metabolic adaptation
5090239|NCT03434431|weight regain|weight regain
5090240|NCT03434431|reverse dieting|reverse dieting
5090241|NCT03434418|EGFR Mutation|egfr mutation
5090242|NCT03434418|osimertinib|osimertinib
5090243|NCT03434418|exon 18 G719X|exon 18 g719x
5090244|NCT03434418|exon 20 S7681|exon 20 s7681
5090245|NCT03434418|exon 21 L861Q|exon 21 l861q
5090246|NCT03434405|schizophrenia|schizophrenia
5090247|NCT03434405|mindfulness|mindfulness
5090248|NCT03434405|social cognition|social cognition
5090249|NCT03434405|SocialMind|socialmind
5090250|NCT03434405|AGES-Mind|ages-mind
5090251|NCT03434392|Chronic Pain|chronic pain
5090252|NCT03434392|Chronic Pancreatitis|chronic pancreatitis
5090253|NCT03434392|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5090254|NCT03434392|Recurrent Acute Pancreatitis|recurrent acute pancreatitis
5090255|NCT03434392|Chronic Abdominal Pain|chronic abdominal pain
5090256|NCT03434392|Functional Dyspepsia|functional dyspepsia
5090257|NCT03434366|Autism Spectrum Disorder|autism spectrum disorder
5090258|NCT03434366|ketamine|ketamine
5090293|NCT03434314|Paraspinal collateral network|paraspinal collateral network
5090294|NCT03434314|Paraspinous collateral network|paraspinous collateral network
5090295|NCT03434314|Arteriogenesis|arteriogenesis
5090296|NCT03434314|Intercostal arteries|intercostal arteries
5090297|NCT03434301|Surgery|surgery
5090298|NCT03434301|Laparotomy|laparotomy
5090299|NCT03434301|Tack|tack
5090300|NCT03434301|Non-absorbable Tack|non-absorbable tack
5090301|NCT03434301|Absorbable Tack|absorbable tack
5090302|NCT03434301|Pain|pain
5090303|NCT03434288|Diabetes|diabetes
5090304|NCT03434288|Diabetic foot|diabetic foot
5090305|NCT03434288|Osteomyelitis|osteomyelitis
5090306|NCT03434275|Total Knee Arthroplasty|total knee arthroplasty
5090307|NCT03434275|Pain|pain
5090308|NCT03434275|Analgesia|analgesia
5090309|NCT03434275|N1539|n1539
5090310|NCT03434275|Phase 3b|phase 3b
5090311|NCT03434275|Knee Replacement|knee replacement
5090350|NCT03434249|Bifidobacterium|bifidobacterium
5090351|NCT03434236|omega-3|omega-3
5090352|NCT03434236|specialized proresolving mediators|specialized proresolving mediators
5090353|NCT03434210|schizophrenia|schizophrenia
5090354|NCT03434210|violence risk|violence risk
5744435|NCT00341471|Curricular|curricular
5090355|NCT03434210|long-acting antipsychotics|long-acting antipsychotics
5090356|NCT03434210|community-based|community-based
5090357|NCT03434197|Osteoarthritis Knee Pain|osteoarthritis knee pain
5090358|NCT03434184|Walking analysis|walking analysis
5090363|NCT03434132|Open Radical Cystectomy|open radical cystectomy
5090364|NCT03434132|Robotic Radical cystectomy|robotic radical cystectomy
5090365|NCT03434132|Intracorporeal urinary diversion|intracorporeal urinary diversion
5090366|NCT03434132|Prospective randdomized trial|prospective randdomized trial
5090367|NCT03434106|meibomian gland dysfunction|meibomian gland dysfunction
5090368|NCT03434106|Sjögren's syndrome|sjögren's syndrome
5090369|NCT03434106|dry eye disease|dry eye disease
5101570|NCT03363581|Fat|fat
5090370|NCT03434093|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
5088428|NCT03445182|paediatric dental patients|paediatric dental patients
5090388|NCT03434028|Fluid management|fluid management
5090389|NCT03434028|Sepsis-induced hypotension|sepsis-induced hypotension
5090390|NCT03434028|vasopressors|vasopressors
5090391|NCT03434015|Atrial fibrillation|atrial fibrillation
5090392|NCT03434015|Left atrial septal closure|left atrial septal closure
5090393|NCT03434002|Virtual Reality Simulation|virtual reality simulation
5090394|NCT03434002|Teaching and Assessment|teaching and assessment
5090395|NCT03434002|Anesthesia Crisis Management|anesthesia crisis management
4960510|NCT04235816|U5|u5
5090396|NCT03433989|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5090397|NCT03433989|Pregnancy loss|pregnancy loss
5090398|NCT03433976|Caesarean section|caesarean section
5090399|NCT03433976|spinal anesthesia|spinal anesthesia
5090400|NCT03433976|Prilocaïne|prilocaïne
5090401|NCT03433976|motor block|motor block
5090402|NCT03433963|air pollution|air pollution
5090403|NCT03433963|blood pressure|blood pressure
5090404|NCT03433963|cardiac ischemia|cardiac ischemia
5090405|NCT03433963|L-arginine|l-arginine
5090406|NCT03433963|nitric oxide|nitric oxide
5090407|NCT03433950|antiparkinson|antiparkinson
5090408|NCT03433911|Permanent contraception|permanent contraception
5090409|NCT03433911|Birth control|birth control
5090410|NCT03433885|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
5090411|NCT03433885|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5090412|NCT03433885|drusen|drusen
5090413|NCT03433885|Chroidal neovascularization (CNV)|chroidal neovascularization (cnv)
5090414|NCT03433885|lutein|lutein
5090415|NCT03433885|zeaxanthin|zeaxanthin
5090416|NCT03433872|Infant-toddler care|infant-toddler care
5090417|NCT03433872|Early child development|early child development
5090418|NCT03433872|Professional development|professional development
5090419|NCT03433846|Sepsis|sepsis
5090420|NCT03433846|Prematurity|prematurity
5090421|NCT03433807|idebenone, DMD, Duchenne|idebenone, dmd, duchenne
5090422|NCT03433781|ASCORBIC ACID|ascorbic acid
5090423|NCT03433755|Evolocumab|evolocumab
5090424|NCT03433755|Repatha|repatha
5090425|NCT03433755|Statin|statin
5090426|NCT03433755|Chinese|chinese
5090427|NCT03433755|China|china
5090428|NCT03433755|Hypercholesterolemia|hypercholesterolemia
5090429|NCT03433755|Mixed Dyslipidemia|mixed dyslipidemia
5090430|NCT03433755|High Cholesterol|high cholesterol
5090431|NCT03433755|Lowering cholesterol|lowering cholesterol
5090432|NCT03433742|metal ion levels, total hip replacement, Trident II cup.|metal ion levels, total hip replacement, trident ii cup.
5090433|NCT03433729|Outpatient Clinics, Hospital|outpatient clinics, hospital
5090434|NCT03433729|Humans|humans
5090435|NCT03433729|Outcome Assessment (Health Care)|outcome assessment (health care)
5090436|NCT03433729|Patient Outcome Assessment|patient outcome assessment
5090437|NCT03433729|Patient satisfaction|patient satisfaction
5090438|NCT03433729|Hospitalists|hospitalists
5090439|NCT03433729|Secondary care|secondary care
5090440|NCT03433716|Percutaneous Neuromodulation, radial nerve, pain|percutaneous neuromodulation, radial nerve, pain
5090441|NCT03433703|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5090442|NCT03433703|Lenvatinib|lenvatinib
5090443|NCT03433703|E7080|e7080
5090444|NCT03433690|Child Obesity|child obesity
5090445|NCT03433690|Adolescents|adolescents
5090446|NCT03433690|High Intensity Interval Training|high intensity interval training
5090447|NCT03433690|Moderate training|moderate training
5090448|NCT03433677|insulin pump|insulin pump
5090449|NCT03433664|CO2 laser|co2 laser
5090450|NCT03433664|Ablative fractional laser|ablative fractional laser
5090451|NCT03433651|depression|depression
5090452|NCT03433638|Juvenile dermatomyositis|juvenile dermatomyositis
5090453|NCT03433638|Inflammatory myopathy|inflammatory myopathy
5090454|NCT03433638|Clinical features|clinical features
5090455|NCT03433638|Treatment|treatment
4974995|NCT04148690|Surveillance|surveillance
5090456|NCT03433625|Cognitive-behavioural therapy|cognitive-behavioural therapy
5090457|NCT03433612|Anatomical Landmarks|anatomical landmarks
5090458|NCT03433599|Intermittent Hypoxia|intermittent hypoxia
5088526|NCT03444649|AML|aml
5090459|NCT03433599|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5090461|NCT03433560|neutropenia|neutropenia
5090462|NCT03433547|macular buckling|macular buckling
5090463|NCT03433547|full-thickness macular hole|full-thickness macular hole
5090464|NCT03433547|macular detachment|macular detachment
5090465|NCT03433547|internal limiting membrane peeling|internal limiting membrane peeling
5090466|NCT03433547|high myopia|high myopia
5090467|NCT03433534|nivolumab|nivolumab
5090468|NCT03433534|monoclonal antibody|monoclonal antibody
5090469|NCT03433534|Opdivo|opdivo
5090477|NCT03433482|Meningococcal disease|meningococcal disease
5090478|NCT03433482|Liquid formulation|liquid formulation
5090479|NCT03433482|Meningitis|meningitis
5090481|NCT03433456|low-income|low-income
5090482|NCT03433456|health disparities|health disparities
5090483|NCT03433456|home visitation|home visitation
5090484|NCT03433456|prevention|prevention
5090485|NCT03433456|childhood obesity|childhood obesity
5090486|NCT03433456|habit|habit
5090487|NCT03433443|Spinal Fusion|spinal fusion
5090488|NCT03433443|Case Managers|case managers
5090489|NCT03433443|Rehabilitation|rehabilitation
5090490|NCT03433352|gut microbiota|gut microbiota
5090491|NCT03433352|16S rRNA gene|16s rrna gene
5090492|NCT03433352|Graves' disease|graves' disease
5090493|NCT03433352|Methimazole|methimazole
5090494|NCT03433352|Propylthiouracil|propylthiouracil
5090495|NCT03433339|depression|depression
5090496|NCT03433339|transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
5090497|NCT03433339|non-invasive|non-invasive
5961870|NCT04284449|Alzheimer's Disease (AD)|alzheimer's disease (ad)
4959104|NCT04244669|HD|hd
5090498|NCT03433339|major depressive disorder|major depressive disorder
5090499|NCT03433248|Type 2 diabetes mellitus|type 2 diabetes mellitus
5090500|NCT03433248|Diabetic kidney disease|diabetic kidney disease
5090501|NCT03433248|Diabetic nephropathy|diabetic nephropathy
5090502|NCT03433248|Renoprotection|renoprotection
5090503|NCT03433248|SGLT2 inhibitor|sglt2 inhibitor
5090504|NCT03433248|Empagliflozin|empagliflozin
5090505|NCT03433248|DPP-4 inhibitor|dpp-4 inhibitor
5090506|NCT03433248|Linagliptin|linagliptin
5090507|NCT03433248|SU derivative|su derivative
5090508|NCT03433248|Gliclazide|gliclazide
5090509|NCT03433222|light emitting diode-red light|light emitting diode-red light
5090510|NCT03433222|high fluence|high fluence
5090511|NCT03433222|red light|red light
5090512|NCT03433222|RCT|rct
5090513|NCT03433209|Advanced bipolar energy devices|advanced bipolar energy devices
5090514|NCT03433209|ENSEAL|enseal
5090515|NCT03433209|LigaSure|ligasure
5090516|NCT03433209|Operative time|operative time
5090517|NCT03433209|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
5090518|NCT03433157|stainless stain crowns|stainless stain crowns
5090519|NCT03433157|Hall technique|hall technique
5090520|NCT03433157|children|children
5090521|NCT03433118|fatigue|fatigue
5090522|NCT03433118|health-related quality of life|health-related quality of life
5090523|NCT03433105|oxygen uptake|oxygen uptake
5090524|NCT03433105|prolonged mechanical ventilation|prolonged mechanical ventilation
5090525|NCT03433105|weaning|weaning
5090526|NCT03433092|Serum carotenoids|serum carotenoids
5090527|NCT03433092|Gastrointestinal tract cancer|gastrointestinal tract cancer
5090528|NCT03433092|Meta-analysis|meta-analysis
5090529|NCT03433079|Acute Kidney Injury|acute kidney injury
5090530|NCT03433079|Severe Trauma|severe trauma
5090531|NCT03433079|NGAL|ngal
5090532|NCT03433079|Tissue Hypoxia|tissue hypoxia
5090533|NCT03433079|Inflammatory Response|inflammatory response
5090534|NCT03433079|Rhabdomyolysis|rhabdomyolysis
5090535|NCT03433066|advanced platelet-rich fibrin|advanced platelet-rich fibrin
5090536|NCT03432988|Nursing Solution-Focused|nursing solution-focused
5090537|NCT03432988|hemodialysis|hemodialysis
5090538|NCT03432988|Psychosocial intervention|psychosocial intervention
5090539|NCT03432988|Adherence|adherence
5090540|NCT03432949|Radium-223|radium-223
5090541|NCT03432949|Dexamethasone|dexamethasone
5090542|NCT03432949|mCRPC|mcrpc
5090543|NCT03432910|Forced Breath Technique|forced breath technique
5090544|NCT03432910|auto-CPAP|auto-cpap
5090545|NCT03432910|CPAP|cpap
5090546|NCT03432910|Obstructive sleep apnea|obstructive sleep apnea
5090547|NCT03432910|central sleep apnea|central sleep apnea
5090548|NCT03432897|High risk|high risk
5090549|NCT03432897|Defects|defects
4975132|NCT04147624|Memory|memory
5090550|NCT03432897|prostate|prostate
5090551|NCT03432884|Phase 1|phase 1
5090552|NCT03432884|pharmacokinetics|pharmacokinetics
5090553|NCT03432884|safety|safety
5090555|NCT03432871|Mitochondrial disease|mitochondrial disease
5744731|NCT00340704|pediatric|pediatric
5150047|NCT03054363|ONT-380|ont-380
5090556|NCT03432871|Nicotinamide Riboside|nicotinamide riboside
5090558|NCT03432871|PEO|peo
5090559|NCT03432871|Single deletion|single deletion
5090560|NCT03432871|mtDNA deletion|mtdna deletion
5090561|NCT03432871|MELAS|melas
5090562|NCT03432871|m.3243A>G|m.3243a>g
5090563|NCT03432858|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
5101684|NCT03362580|Epiretinal Membrane|epiretinal membrane
5090565|NCT03432819|Latino, men who have sex with men|latino, men who have sex with men
5090566|NCT03432806|Tissue samples|tissue samples
5090567|NCT03432806|17-594|17-594
5090576|NCT03432767|pregnancy|pregnancy
5090577|NCT03432767|postpartum hemorrhage|postpartum hemorrhage
5090578|NCT03432767|vaginal delivery|vaginal delivery
5090579|NCT03432767|shock index|shock index
5090580|NCT03432767|hemoglobin|hemoglobin
5090581|NCT03432754|Older adults|older adults
5090582|NCT03432754|Mindfulness|mindfulness
5090583|NCT03432754|Mind wandering|mind wandering
5090584|NCT03432754|Health education|health education
5090585|NCT03432754|Working memory|working memory
5090586|NCT03432754|Cognitive functioning|cognitive functioning
5090587|NCT03432754|Emotion regulation|emotion regulation
5090588|NCT03432754|Emotional functioning|emotional functioning
5090589|NCT03432728|Antioxidant Capacity|antioxidant capacity
5090590|NCT03432715|School|school
5090591|NCT03432715|Policy|policy
5090592|NCT03432715|Nutrition|nutrition
5090593|NCT03432715|Physical Activity|physical activity
5090594|NCT03432715|Local Wellness Policy|local wellness policy
5090595|NCT03432663|Atrial Fibrillation|atrial fibrillation
5090596|NCT03432663|Intravenous Amiodarone|intravenous amiodarone
5961871|NCT04284449|Dementia|dementia
5090597|NCT03432663|Drug safety profile|drug safety profile
5090598|NCT03432663|Chemical cardioversion|chemical cardioversion
5090599|NCT03432637|Complications, Postoperative/Perioperative|complications, postoperative/perioperative
5090600|NCT03432637|video assisted thoracic surgery|video assisted thoracic surgery
5090601|NCT03432637|non-intubated anaesthesia|non-intubated anaesthesia
5090602|NCT03432611|mHealth|mhealth
5090603|NCT03432611|dysmenorrhea|dysmenorrhea
5090604|NCT03432611|acupressure|acupressure
4960742|NCT04234711|TAPVC|tapvc
5090605|NCT03432611|self-management|self-management
5090606|NCT03432611|self-care|self-care
5090607|NCT03432585|feasibility|feasibility
5090608|NCT03432585|attendance|attendance
5090609|NCT03432585|conference|conference
5090610|NCT03432559|endoscopy|endoscopy
5090611|NCT03432533|Post-Menopausal osteoporosis|post-menopausal osteoporosis
5090612|NCT03432494|Transcather|transcather
5090613|NCT03432494|Transcaval|transcaval
5090614|NCT03432494|Bioprosthesis|bioprosthesis
5090615|NCT03432494|Closure Device|closure device
5090616|NCT03432494|Aortic Stenosis|aortic stenosis
5090617|NCT03432481|Osteoarthritis, Knee|osteoarthritis, knee
5090618|NCT03432468|Hypertension|hypertension
5090619|NCT03432468|Left Ventricular Hypertrophy|left ventricular hypertrophy
5090620|NCT03432468|Women|women
5090621|NCT03432455|Incidence|incidence
5090625|NCT03432455|inflammatory myopathy|inflammatory myopathy
5090626|NCT03432429|Tumours|tumours
5090627|NCT03432429|Breast conserving surgery|breast conserving surgery
5090628|NCT03432429|Margin assessment technology|margin assessment technology
5090629|NCT03432429|Mass spectrometry|mass spectrometry
5090630|NCT03432416|Healthy Women|healthy women
5090631|NCT03432416|Female Contraception|female contraception
5090632|NCT03432416|Vaginal Ring|vaginal ring
5090633|NCT03432416|Contraceptive Vaginal Ring|contraceptive vaginal ring
5090634|NCT03432364|Beta thalassemia|beta thalassemia
5090635|NCT03432364|Beta-thalassemia|beta-thalassemia
5090636|NCT03432364|Thalassemia major|thalassemia major
5090637|NCT03432364|Cooley's anemia|cooley's anemia
5090638|NCT03432364|ZFN mediated genome editing|zfn mediated genome editing
5090639|NCT03432364|zinc finger nuclease|zinc finger nuclease
5090643|NCT03432299|Thyroid Diseases|thyroid diseases
5090644|NCT03432299|Radiofrequency Ablation|radiofrequency ablation
5090647|NCT03432260|Alcoholic Hepatitis|alcoholic hepatitis
5090648|NCT03432260|acute alcoholic liver disease|acute alcoholic liver disease
5090649|NCT03432260|progressive inflammatory liver injury|progressive inflammatory liver injury
5090650|NCT03432260|IV infusion|iv infusion
5090651|NCT03432247|music therapy|music therapy
5090652|NCT03432247|bone pain|bone pain
5090653|NCT03432247|pain management|pain management
5090654|NCT03432247|advanced cancer|advanced cancer
5090655|NCT03432234|COPD|copd
5090661|NCT03432182|body movement|body movement
5744857|NCT00340366|Pregnancy|pregnancy
5150162|NCT03053791|DBS|dbs
5090662|NCT03432182|neurodevelopmental outcome|neurodevelopmental outcome
5090663|NCT03432156|immunotherapy|immunotherapy
5090664|NCT03432156|NSCLC|nsclc
5090665|NCT03432143|Peer Review|peer review
5090666|NCT03432143|Community-Based Research|community-based research
5090667|NCT03432143|Community Perspectives|community perspectives
5090668|NCT03432130|hip-hop dance, injuries, body fat|hip-hop dance, injuries, body fat
5090674|NCT03432065|Autism Spectrum Disorders|autism spectrum disorders
5090676|NCT03432065|Pervasive Developmental Disorders|pervasive developmental disorders
5090677|NCT03432065|Buspar|buspar
5090678|NCT03432065|Buspirone|buspirone
5090679|NCT03432052|centralization|centralization
5090685|NCT03431987|Driving Simulation|driving simulation
5090686|NCT03431987|Cannabis|cannabis
5090687|NCT03431987|Intoxication|intoxication
5090688|NCT03431974|Anti-folate|anti-folate
5090689|NCT03431935|Health Care Transition|health care transition
5090690|NCT03431935|Adolescent|adolescent
5090691|NCT03431935|Young Adult|young adult
5090692|NCT03431909|Human Urinary Kallidinogenase|human urinary kallidinogenase
5090693|NCT03431909|Acute ischemic stroke|acute ischemic stroke
5090694|NCT03431909|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5090695|NCT03431909|CT perfusion|ct perfusion
5090696|NCT03431857|Shoulder arthroplasty|shoulder arthroplasty
5090697|NCT03431857|Medical device|medical device
5090698|NCT03431857|Shoulder prosthesis|shoulder prosthesis
5090699|NCT03431857|Performance|performance
5090700|NCT03431805|Randomized|randomized
5090701|NCT03431805|double blind placebo controlled trial|double blind placebo controlled trial
5090702|NCT03431805|prevention|prevention
5090703|NCT03431805|tranexamic acid|tranexamic acid
5090704|NCT03431805|postpartum hemorrhage|postpartum hemorrhage
5090705|NCT03431805|cesarean|cesarean
5090706|NCT03431792|CDH, FETO, fetal surgery, long tail FETO|cdh, feto, fetal surgery, long tail feto
5090707|NCT03431766|chlorhexidine gel|chlorhexidine gel
5090708|NCT03431766|dental implant|dental implant
5090709|NCT03431753|STHLM3-test|sthlm3-test
5090710|NCT03431753|prostate cancer|prostate cancer
5090711|NCT03431753|MR-imaging|mr-imaging
5090712|NCT03431753|MR-targeted biopsy|mr-targeted biopsy
5090713|NCT03431753|MRI|mri
5090714|NCT03431753|Novel biomarkers|novel biomarkers
5090715|NCT03431753|Genetic screening|genetic screening
5090716|NCT03431636|sports for people with disabilities|sports for people with disabilities
5090717|NCT03431636|immersion therapy|immersion therapy
5090718|NCT03431636|cryotherapy|cryotherapy
5090719|NCT03431636|physiotherapy|physiotherapy
5090727|NCT03431558|Bovine Lactoferrin, Neonatal infection, Low Birth Weight|bovine lactoferrin, neonatal infection, low birth weight
5090728|NCT03431532|anesthesia|anesthesia
5961872|NCT04284410|depression|depression
5961873|NCT04284397|Aging|aging
4960881|NCT04234048|CTCL|ctcl
5090729|NCT03431532|general anesthesia|general anesthesia
5090730|NCT03431532|neuraxial anesthesia|neuraxial anesthesia
5090731|NCT03431532|monocyte funtion|monocyte funtion
5090732|NCT03431532|CD 14, HLA-DR|cd 14, hla-dr
5090733|NCT03431532|Interleukines|interleukines
5090734|NCT03431519|Thoracolumbar fractures|thoracolumbar fractures
5090735|NCT03431519|PMMA|pmma
5090736|NCT03431519|KIVA|kiva
5090737|NCT03431519|PEEK|peek
5090738|NCT03431480|cord blood stem cell|cord blood stem cell
5090739|NCT03431480|Norwood heart surgery|norwood heart surgery
5090740|NCT03431480|congenital|congenital
5090741|NCT03431480|heart|heart
5090742|NCT03431467|ECMO|ecmo
5090743|NCT03431467|Heart Failure|heart failure
5090744|NCT03431467|RCT|rct
5090745|NCT03431467|Mechanical unloading|mechanical unloading
5090746|NCT03431415|Lung|lung
5090747|NCT03431415|Cancer|cancer
5090748|NCT03431415|Early-Stage|early-stage
5090749|NCT03431415|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
5090750|NCT03431415|VATS|vats
5090751|NCT03431415|SBRT|sbrt
5090752|NCT03431415|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5090753|NCT03431376|potato consumption|potato consumption
5090754|NCT03431376|hypertension|hypertension
5090755|NCT03431376|CHNS|chns
5090756|NCT03431311|MSI|msi
5090764|NCT03431233|satiety related hormones|satiety related hormones
5090765|NCT03431194|Acute Kidney Injury|acute kidney injury
5090767|NCT03431194|intensive care unit|intensive care unit
5090768|NCT03431168|STI Prevention|sti prevention
5090769|NCT03431168|Cameroon|cameroon
5090770|NCT03431168|sub-Saharan Africa|sub-saharan africa
5090771|NCT03431168|HIV pregnancy|hiv pregnancy
5090772|NCT03431168|Malaria in pregnancy|malaria in pregnancy
5090773|NCT03431155|children|children
5090774|NCT03431155|cancer|cancer
5090775|NCT03431155|care giver|care giver
5090776|NCT03431155|uncertainty|uncertainty
5090777|NCT03431155|nursing intervention|nursing intervention
5090778|NCT03431155|education|education
5101879|NCT03361319|Adenocarcinoma of lung|adenocarcinoma of lung
5090779|NCT03431129|Xenon MRI, Lung, Radiation Induced Lung Injury,|xenon mri, lung, radiation induced lung injury,
5090780|NCT03431103|overlap|overlap
5090781|NCT03431103|exercise|exercise
5090782|NCT03431103|inflammation|inflammation
5090783|NCT03431051|Healthy Beverage Initiative, Sugar Sweetened Beverages|healthy beverage initiative, sugar sweetened beverages
5090784|NCT03431012|Adherence, medication|adherence, medication
5090785|NCT03431012|Pandemic Influenza|pandemic influenza
5090786|NCT03430973|aggressive driving; road rage|aggressive driving; road rage
5090787|NCT03430960|mCare|mcare
5090788|NCT03430960|post surgery|post surgery
5090789|NCT03430960|mobile|mobile
5090790|NCT03430960|healthcare|healthcare
5090791|NCT03430960|application|application
5090792|NCT03430947|Stereotactic radiosurgery|stereotactic radiosurgery
5090793|NCT03430947|BRAF inhibitor|braf inhibitor
5090796|NCT03430947|Cobimetinib|cobimetinib
5090797|NCT03430934|Mohs tumor|mohs tumor
5090798|NCT03430908|endotracheal tube|endotracheal tube
5090799|NCT03430908|gastric tube|gastric tube
5090801|NCT03430908|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5090802|NCT03430895|Durvalumab (MEDI4736)|durvalumab (medi4736)
5090803|NCT03430895|Tremelimumab|tremelimumab
5090804|NCT03430895|immunotherapy|immunotherapy
5090805|NCT03430895|17-511|17-511
5090806|NCT03430869|late-life depression|late-life depression
5090807|NCT03430869|major depressive disorder|major depressive disorder
5090808|NCT03430869|Alzheimer's disease dementia|alzheimer's disease dementia
5090809|NCT03430869|neurodegeneration|neurodegeneration
5090810|NCT03430869|amyloid plague, tau protein|amyloid plague, tau protein
5090811|NCT03430856|Oral insulin|oral insulin
5090821|NCT03430791|recurrent glioblastoma|recurrent glioblastoma
5090822|NCT03430739|Deformational Plagiocephaly, Orthotics, Helmet|deformational plagiocephaly, orthotics, helmet
5090823|NCT03430726|Probiotics; paediatrics; gut microbiota|probiotics; paediatrics; gut microbiota
5090824|NCT03430713|tooth color|tooth color
5090825|NCT03430713|measurement|measurement
5090826|NCT03430713|accuracy|accuracy
5090827|NCT03430713|shade guide|shade guide
5090828|NCT03430713|spectrophotometer|spectrophotometer
5090829|NCT03430700|platinum-resistant|platinum-resistant
5090830|NCT03430648|Tau protein|tau protein
5090831|NCT03430648|PET imaging|pet imaging
5090832|NCT03430648|Alzheimer's disease|alzheimer's disease
5090833|NCT03430609|endometrioma|endometrioma
5090834|NCT03430609|laparoscopy|laparoscopy
5090835|NCT03430609|ovarian reserve|ovarian reserve
5090836|NCT03430609|anti-mullerian hormone|anti-mullerian hormone
5090837|NCT03430596|Extrapyramidal syndromes praminpexole pilot study|extrapyramidal syndromes praminpexole pilot study
5090838|NCT03430583|Fontan|fontan
5090839|NCT03430583|Ultrasound|ultrasound
5090840|NCT03430583|Magnetic Resonance Imaging Elastography|magnetic resonance imaging elastography
5090841|NCT03430570|Adolescent risk behavior|adolescent risk behavior
5961874|NCT04284397|Thermoregulation|thermoregulation
5090842|NCT03430570|digital|digital
5090843|NCT03430570|early adolescence|early adolescence
5090844|NCT03430570|emotion regulation|emotion regulation
4961052|NCT04233034|hcl|hcl
5090845|NCT03430570|prevention|prevention
5090846|NCT03430557|Endodontic surgery|endodontic surgery
5090847|NCT03430544|cariprazine|cariprazine
5090848|NCT03430544|fMRI|fmri
5090849|NCT03430544|D3 receptor|d3 receptor
5090850|NCT03430544|cocaine use disorder|cocaine use disorder
5090851|NCT03430544|urine|urine
5090852|NCT03430518|Durvalumab (MEDI4736) (Anti-PDL1)|durvalumab (medi4736) (anti-pdl1)
5090853|NCT03430518|Eribulin|eribulin
5090854|NCT03430518|Recurrent Ovarian cancer|recurrent ovarian cancer
5090855|NCT03430518|Her2-negative Metastatic Breast Cancer|her2-negative metastatic breast cancer
5090857|NCT03430518|Metastatic Breast Cancer|metastatic breast cancer
5090858|NCT03430505|Asthma, noninvasive ventilation|asthma, noninvasive ventilation
5090859|NCT03430492|Psychological Resilience|psychological resilience
5090861|NCT03430492|Molecular Fingerprint|molecular fingerprint
5090862|NCT03430492|Quality of Life (QoL)|quality of life (qol)
5090863|NCT03430492|Body and Mind|body and mind
5090864|NCT03430492|CD-RISC|cd-risc
5090865|NCT03430492|SF-36|sf-36
5090866|NCT03430453|Regional Anesthesia|regional anesthesia
5090867|NCT03430453|Ultrasound guidance|ultrasound guidance
5090868|NCT03430453|Nerve stimulation|nerve stimulation
5090869|NCT03430453|Orthopedic surgery|orthopedic surgery
5090870|NCT03430427|BNET|bnet
5090871|NCT03430427|Brain Networks|brain networks
5090872|NCT03430427|Mobility Function|mobility function
5090873|NCT03430427|SMCCS|smccs
5090874|NCT03430401|memory encoding|memory encoding
5090875|NCT03430401|functional performance|functional performance
5090876|NCT03430388|vaccine|vaccine
5090877|NCT03430388|Yellow Fever|yellow fever
5090878|NCT03430388|Rheumatic disease|rheumatic disease
5090879|NCT03430375|wheelchair cushion|wheelchair cushion
5090880|NCT03430375|pressure mapping|pressure mapping
5090881|NCT03430375|pressure wounds|pressure wounds
5090882|NCT03430349|IPV-primed|ipv-primed
5090883|NCT03430349|adults|adults
5090884|NCT03430349|vaccination|vaccination
5090885|NCT03430349|containment|containment
5090886|NCT03430349|shedding|shedding
5090887|NCT03430349|genetic stability|genetic stability
5090888|NCT03430349|safety|safety
5090892|NCT03430297|the First Line Therapy|the first line therapy
5090894|NCT03430297|Melanoma|melanoma
5090895|NCT03430284|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5090896|NCT03430284|Diabetic Vascular Complications|diabetic vascular complications
5090897|NCT03430284|Multifactorial Intervention|multifactorial intervention
5090898|NCT03430284|Digital and Network Management|digital and network management
5090899|NCT03430245|Circumference reduction|circumference reduction
5090900|NCT03430219|AccuFill|accufill
5090901|NCT03430219|Injectable Calcium Phosphate|injectable calcium phosphate
5090902|NCT03430219|Subchondroplasty|subchondroplasty
5090903|NCT03430206|high-flow|high-flow
5090904|NCT03430206|nasal cannula|nasal cannula
5090910|NCT03430206|pediatric|pediatric
5090911|NCT03430193|rehabilitation|rehabilitation
5090912|NCT03430193|multi-disciplinary rehabilitation|multi-disciplinary rehabilitation
5090913|NCT03430193|clinical pathway|clinical pathway
5090914|NCT03430193|Fragility|fragility
5090915|NCT03430167|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5090916|NCT03430167|post operative physical therapy|post operative physical therapy
5090917|NCT03430115|Obese|obese
5090918|NCT03430115|Exercise|exercise
5090919|NCT03430089|Influenza|influenza
5090920|NCT03430089|Flu|flu
5090921|NCT03430076|vascular prostheses|vascular prostheses
5090922|NCT03430076|heparin|heparin
5090923|NCT03430076|ischemia lesions|ischemia lesions
5090924|NCT03430076|vascular|vascular
5090925|NCT03430076|critical limb ischemia lesions|critical limb ischemia lesions
5090926|NCT03430063|Advanced non-squamous NSCLC|advanced non-squamous nsclc
5090927|NCT03430063|Advanced squamous NSCLC|advanced squamous nsclc
5090928|NCT03430050|Progesterone|progesterone
5090929|NCT03430050|Ovarian hormones|ovarian hormones
5090930|NCT03430050|Gender|gender
5090931|NCT03430050|Cannabis|cannabis
5090932|NCT03430050|Withdrawal|withdrawal
5090933|NCT03430050|Cognitive functioning|cognitive functioning
5090936|NCT03430024|Myosin VI|myosin vi
5090937|NCT03430024|Estrogen receptor|estrogen receptor
5090938|NCT03430011|JCARH125|jcarh125
5090939|NCT03430011|chimeric antigen receptor|chimeric antigen receptor
5090940|NCT03430011|multiple myeloma|multiple myeloma
5090941|NCT03430011|CAR T cells|car t cells
5090942|NCT03430011|B-cell maturation antigen|b-cell maturation antigen
5090943|NCT03430011|BCMA|bcma
5090944|NCT03430011|autologous T-cell therapy|autologous t-cell therapy
5090945|NCT03430011|immunotherapy|immunotherapy
5090946|NCT03429998|cardiovascular risk|cardiovascular risk
5090947|NCT03429998|evolocumab|evolocumab
5090948|NCT03429998|LDL-apheresis|ldl-apheresis
5090949|NCT03429985|Sexual and Reproductive Health|sexual and reproductive health
5090950|NCT03429985|Parent-based Intervention|parent-based intervention
5090951|NCT03429985|Sexual risk behavior|sexual risk behavior
5090952|NCT03429985|Adolescent males|adolescent males
5090953|NCT03429985|Father-son Intervention|father-son intervention
5090954|NCT03429972|Paclitaxel|paclitaxel
5961875|NCT04284397|Heat stress|heat stress
5090955|NCT03429972|Neuropathy|neuropathy
5090956|NCT03429920|Fermented Soy|fermented soy
5090957|NCT03429920|Cardiovascular Disease|cardiovascular disease
5090958|NCT03429920|Inflammation|inflammation
5090959|NCT03429920|DNA Methylation|dna methylation
5090960|NCT03429907|Malignant neoplasm of breast|malignant neoplasm of breast
5090961|NCT03429907|Mind-Body Exercises|mind-body exercises
5090962|NCT03429907|Questionnaires|questionnaires
5090964|NCT03429868|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5090965|NCT03429868|Nead neck cancer|nead neck cancer
5090966|NCT03429868|Prognosis|prognosis
5090967|NCT03429868|PET|pet
5090968|NCT03429868|MRI|mri
5090969|NCT03429855|Physiotherapy|physiotherapy
5090970|NCT03429855|Trunk control|trunk control
5090971|NCT03429855|Bobath concept|bobath concept
5090972|NCT03429855|Stroke rehabilitation|stroke rehabilitation
5090973|NCT03429829|Caries|caries
5090974|NCT03429829|Fluoride Varnish|fluoride varnish
5090975|NCT03429829|Dental Health|dental health
5090976|NCT03429803|low-grade glioma|low-grade glioma
5090977|NCT03429790|caesarean section|caesarean section
5090978|NCT03429790|cell salvage|cell salvage
5090979|NCT03429790|blood transfusion|blood transfusion
5090980|NCT03429777|Smartphone|smartphone
5090981|NCT03429777|Medical application|medical application
5090982|NCT03429777|Hearing-in-noise test|hearing-in-noise test
5090983|NCT03429777|Digits-in-noise test|digits-in-noise test
5090984|NCT03429777|Speech reception threshold|speech reception threshold
5090985|NCT03429777|Hearing Loss|hearing loss
5090986|NCT03429777|Hearing Disorders|hearing disorders
5090998|NCT03429738|pseudoephedrine hydrochloride|pseudoephedrine hydrochloride
5090999|NCT03429712|CT Scan|ct scan
5091000|NCT03429686|dementia|dementia
5091001|NCT03429686|reminiscence therapy|reminiscence therapy
5091002|NCT03429686|touch screen technology|touch screen technology
5091003|NCT03429686|digital reminiscence therapy|digital reminiscence therapy
5091004|NCT03429673|Chinese|chinese
5091005|NCT03429673|real-world evidences|real-world evidences
5091006|NCT03429673|NSCLC|nsclc
5091007|NCT03429673|surgeries|surgeries
5091008|NCT03429660|Disease epidemiology|disease epidemiology
5091009|NCT03429660|Risk assessment|risk assessment
5091010|NCT03429660|Drug utilisation study|drug utilisation study
5091011|NCT03429660|Effectiveness evaluation|effectiveness evaluation
5091012|NCT03429582|Human Papilloma Virus|human papilloma virus
5091013|NCT03429582|Thermoablation|thermoablation
5091014|NCT03429582|Thermocoagulation|thermocoagulation
5091020|NCT03429569|Confocal microscopy|confocal microscopy
5091021|NCT03429569|Postoperative morphological|postoperative morphological
5091022|NCT03429569|Iotonphoresis|iotonphoresis
5091023|NCT03429556|pain, neurotoxin|pain, neurotoxin
5091024|NCT03429517|HDL-C|hdl-c
5091025|NCT03429517|Triglycerides|triglycerides
5091026|NCT03429517|Non HDL-C and Acute coronary syndrome|non hdl-c and acute coronary syndrome
5091027|NCT03429504|Obesity|obesity
5091028|NCT03429504|Breast cancer|breast cancer
5091029|NCT03429504|Body mass index|body mass index
5091030|NCT03429478|Music|music
5091031|NCT03429478|Laparoscopic Surgery|laparoscopic surgery
5091032|NCT03429478|Sterile Inflammation|sterile inflammation
5091033|NCT03429465|Digital Health Intervention|digital health intervention
5091034|NCT03429465|Executive Function|executive function
5091035|NCT03429465|Depression|depression
5091036|NCT03429465|Anxiety|anxiety
5091037|NCT03429452|structural heart abnormality|structural heart abnormality
5091038|NCT03429452|spatial method|spatial method
5091039|NCT03429452|echocardiography|echocardiography
5091040|NCT03429452|electrocardiogram|electrocardiogram
5091041|NCT03429452|mediterranean diet|mediterranean diet
5091042|NCT03429452|exercise|exercise
5091043|NCT03429452|social status|social status
5091044|NCT03429452|rural|rural
5091045|NCT03429439|chronic hepatitis B|chronic hepatitis b
5091046|NCT03429439|intestinal microbiota transplantation|intestinal microbiota transplantation
5091047|NCT03429439|microbiota|microbiota
5091048|NCT03429439|antiviral therapy|antiviral therapy
5091049|NCT03429426|Rheumatoid Arthritis|rheumatoid arthritis
5091050|NCT03429426|High-resolution peripheral quantitative computed tomography|high-resolution peripheral quantitative computed tomography
5091051|NCT03429426|Radiography|radiography
5091052|NCT03429413|Health Information Technology (HIT)|health information technology (hit)
5091053|NCT03429387|Diagnosis|diagnosis
5091054|NCT03429348|Firefighter|firefighter
5091077|NCT03429257|Linear Growth Faltering|linear growth faltering
5091078|NCT03429257|Birth Outcomes|birth outcomes
5091079|NCT03429257|Uganda|uganda
5091086|NCT03429205|Sleeve gastrectomy|sleeve gastrectomy
5091087|NCT03429205|Roux-Y gastric bypass|roux-y gastric bypass
5091088|NCT03429205|Single anastomosis gastric bypass|single anastomosis gastric bypass
5091089|NCT03429205|Hypothermia|hypothermia
5091090|NCT03429205|External heating blanket|external heating blanket
5091091|NCT03429192|Chinese, real-world evidences, NSCLC, lymph skip metastases|chinese, real-world evidences, nsclc, lymph skip metastases
5091092|NCT03429179|butorphanol|butorphanol
5091093|NCT03429179|preoperative anxiety|preoperative anxiety
5091094|NCT03429179|sedation|sedation
5091095|NCT03429179|recommend dose|recommend dose
5091096|NCT03429153|endocarditis|endocarditis
5091097|NCT03429127|balanced fluids, neurosurgery, plasma osmolality|balanced fluids, neurosurgery, plasma osmolality
5091098|NCT03429101|Poziotinib|poziotinib
5091119|NCT03429023|Mucormycosis|mucormycosis
5091120|NCT03429010|Anesthesia|anesthesia
5091121|NCT03429010|Hip Fracture|hip fracture
5091122|NCT03428971|atrial fibrillation|atrial fibrillation
5091124|NCT03428971|hospitalization|hospitalization
5091125|NCT03428958|Relapsed metastatic adenocarcinoma of colon/rectum|relapsed metastatic adenocarcinoma of colon/rectum
5091126|NCT03428945|TrialNet|trialnet
5091127|NCT03428932|Insulin pump|insulin pump
5091128|NCT03428932|Closed loop|closed loop
5091129|NCT03428932|Brain development|brain development
5091130|NCT03428932|Pediatric|pediatric
5091131|NCT03428932|Type 1 Diabetes|type 1 diabetes
5091133|NCT03428932|Cognitive development|cognitive development
5091137|NCT03428906|intranasal oxytocin|intranasal oxytocin
5091138|NCT03428906|functional brain network|functional brain network
5091139|NCT03428906|multiple tasks|multiple tasks
5091140|NCT03428906|resting state|resting state
5091141|NCT03428893|Exercise, mhealth, physical therapy|exercise, mhealth, physical therapy
5091142|NCT03428880|quadratus lumborum block|quadratus lumborum block
5091143|NCT03428880|cesarean section|cesarean section
5091144|NCT03428880|spinal morphine|spinal morphine
5091145|NCT03428880|ultrasound guidance|ultrasound guidance
5091146|NCT03428841|audiometry|audiometry
5091147|NCT03428841|dural puncture|dural puncture
5091148|NCT03428841|epidural|epidural
5091149|NCT03428828|Neurofeedback|neurofeedback
5091150|NCT03428828|major depressive disorder|major depressive disorder
5091151|NCT03428828|treatment resistant|treatment resistant
5091152|NCT03428828|amygdala|amygdala
5091153|NCT03428789|breast reconstruction|breast reconstruction
5091154|NCT03428789|DIEP flap|diep flap
5091155|NCT03428789|Nerve coaptation|nerve coaptation
5091156|NCT03428789|Sensory recovery|sensory recovery
5091749|NCT03425162|ultrasound|ultrasound
5091157|NCT03428763|Arthritis, Rheumatoid|arthritis, rheumatoid
5091158|NCT03428763|Telerehabilitation|telerehabilitation
5091159|NCT03428763|controlled randomised trial|controlled randomised trial
5091160|NCT03428737|pressure support ventilation|pressure support ventilation
5091161|NCT03428737|pressure control ventilation|pressure control ventilation
5091162|NCT03428737|sleep, weaning|sleep, weaning
5091163|NCT03428737|chronic obstructive respiratory disease|chronic obstructive respiratory disease
5091164|NCT03428737|weaning duration period|weaning duration period
5091165|NCT03428711|Superficial Venous Thrombosis of Leg|superficial venous thrombosis of leg
5091166|NCT03428711|secondary prevention|secondary prevention
5091167|NCT03428711|prophylaxis|prophylaxis
5091168|NCT03428698|third molar extraction|third molar extraction
5091169|NCT03428698|hyaluronic acid|hyaluronic acid
5091170|NCT03428659|Motor function|motor function
5091171|NCT03428659|Recovery|recovery
5091173|NCT03428659|Magnetic resonance imaging|magnetic resonance imaging
5091174|NCT03428646|Eczema|eczema
5091175|NCT03428620|Functional Performance|functional performance
5091176|NCT03428620|Rehabilitation|rehabilitation
5091177|NCT03428620|Manipulation|manipulation
5091178|NCT03428581|Axillary|axillary
5091179|NCT03428581|Lymph node|lymph node
5091180|NCT03428581|Dissection|dissection
5091181|NCT03428581|Reverse Mapping|reverse mapping
5091182|NCT03428581|Lympho-venous Bypass|lympho-venous bypass
5091183|NCT03428568|Herbal Melanin|herbal melanin
5091184|NCT03428568|H.Pylori|h.pylori
5091185|NCT03428542|yoga|yoga
5091186|NCT03428542|stress|stress
5091187|NCT03428542|anxiety|anxiety
5091188|NCT03428542|depression|depression
5091189|NCT03428542|sleep quality|sleep quality
5091190|NCT03428542|physiological stress|physiological stress
5091191|NCT03428542|biomarkers|biomarkers
5091192|NCT03428503|paracetamol|paracetamol
5091193|NCT03428503|dexketoprofen|dexketoprofen
5091194|NCT03428503|emergency department|emergency department
5091195|NCT03428503|musculoskeletal pain|musculoskeletal pain
5091196|NCT03428490|Integrated Treatment|integrated treatment
5091197|NCT03428490|Alcohol Use Disorder|alcohol use disorder
5091198|NCT03428490|Social Anxiety Disorder|social anxiety disorder
5091199|NCT03428490|Comorbidity|comorbidity
5091200|NCT03428490|Cognitive Behavioral Therapy|cognitive behavioral therapy
5091201|NCT03428477|Liver metastases|liver metastases
5091202|NCT03428477|Colon Cancer|colon cancer
5091203|NCT03428451|TURP|turp
5091204|NCT03428451|hypertonic saline|hypertonic saline
5091205|NCT03428451|TURP syndrome|turp syndrome
5091206|NCT03428451|hyponatraemia|hyponatraemia
5091207|NCT03428412|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5091208|NCT03428412|Acute exacerbation|acute exacerbation
5091209|NCT03428412|Traditional Chinese medicine|traditional chinese medicine
5091210|NCT03428399|breast reconstruction|breast reconstruction
5091211|NCT03428399|mastectomy|mastectomy
5091212|NCT03428373|Multiple Myeloma|multiple myeloma
5091213|NCT03428360|Seizure|seizure
5091214|NCT03428347|Ebola|ebola
5091215|NCT03428347|Ebola Virus Disease|ebola virus disease
5091216|NCT03428347|Monoclonal antibody|monoclonal antibody
4959731|NCT04240886|APX001|apx001
4961320|NCT04231500|allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
4961321|NCT04231474|Urodynamics|urodynamics
5091217|NCT03428334|Sputum leukocyte density|sputum leukocyte density
5091218|NCT03428321|Microwave ablation|microwave ablation
5091219|NCT03428321|Percutaneous thermalablation|percutaneous thermalablation
5091220|NCT03428321|High risk location|high risk location
5091221|NCT03428321|Articifial pneumothorax|articifial pneumothorax
5091222|NCT03428321|Lipiodol marked|lipiodol marked
5091223|NCT03428321|Prognostic factor|prognostic factor
5091224|NCT03428295|artificial pancreas|artificial pancreas
5091225|NCT03428295|automated insulin delivery|automated insulin delivery
5091226|NCT03428295|hybrid closed loop|hybrid closed loop
5091227|NCT03428295|APDS|apds
5091228|NCT03428295|fully automated closed loop|fully automated closed loop
5091229|NCT03428269|simulation|simulation
5091230|NCT03428269|clinical reasoning|clinical reasoning
4975891|NCT04142645|Aged|aged
5091231|NCT03428269|patient deterioration|patient deterioration
5091232|NCT03428256|Obesity|obesity
5091233|NCT03428256|Bariatric Surgery|bariatric surgery
5091234|NCT03428217|Tumor Metabolism|tumor metabolism
5091235|NCT03428217|RCC|rcc
5091236|NCT03428217|Glutaminase Inhibitor|glutaminase inhibitor
5091237|NCT03428217|CB-839|cb-839
5091238|NCT03428217|CANTATA|cantata
5091239|NCT03428217|TKI|tki
5091240|NCT03428217|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5091241|NCT03428217|cabozantinib|cabozantinib
5091242|NCT03428217|Cabometyx|cabometyx
5091243|NCT03428217|Cometriq|cometriq
5091244|NCT03428217|glutaminase|glutaminase
5091245|NCT03428217|glutamine|glutamine
5091246|NCT03428217|renal cell|renal cell
5091247|NCT03428217|clear cell|clear cell
5091248|NCT03428217|kidney cancer|kidney cancer
5091249|NCT03428217|cMET|cmet
5091250|NCT03428217|MET|met
5091251|NCT03428217|HGFR|hgfr
5091252|NCT03428217|telaglenastat|telaglenastat
5091253|NCT03428191|dexmedetomidine|dexmedetomidine
5091254|NCT03428191|remifentanil|remifentanil
5091255|NCT03428191|prostate puncture and biopsy|prostate puncture and biopsy
5091256|NCT03428178|Acute LHON|acute lhon
5091257|NCT03428178|onset within three months|onset within three months
5091258|NCT03428178|onset between 3 to 6 months|onset between 3 to 6 months
5091268|NCT03428139|Alpha Lipoic acid|alpha lipoic acid
5091269|NCT03428126|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
5091270|NCT03428126|Colorectal Cancer|colorectal cancer
5091272|NCT03428126|Durvalumab|durvalumab
5091273|NCT03428126|MEDI4736|medi4736
5091274|NCT03428126|Trametinib|trametinib
5091275|NCT03428126|GSK1120212|gsk1120212
5091276|NCT03428100|eczema|eczema
5091277|NCT03428100|atopic eczema|atopic eczema
5091278|NCT03428074|Chinese, esophageal cancer, surgeries of Ivor-Lewis/Mckeown|chinese, esophageal cancer, surgeries of ivor-lewis/mckeown
5091279|NCT03428061|Prevention|prevention
5091280|NCT03428061|Disease Management|disease management
5091281|NCT03428061|Integrated care|integrated care
5091282|NCT03428061|Primary Health Care|primary health care
5091283|NCT03428035|Randomized controlled trial|randomized controlled trial
5091284|NCT03428035|package insert|package insert
5091285|NCT03428035|nocebo|nocebo
5091286|NCT03428022|Apatinib|apatinib
5091287|NCT03428022|EGFR-TKI resistance|egfr-tki resistance
5091288|NCT03428022|slowly progress|slowly progress
5091289|NCT03428009|Dystonia|dystonia
5091290|NCT03428009|Control|control
5091291|NCT03428009|Magnetic Resonance Imagine|magnetic resonance imagine
5091292|NCT03428009|Genotype|genotype
5091293|NCT03428009|Phenotype|phenotype
5091294|NCT03427996|rotational atherectomy|rotational atherectomy
5091295|NCT03427957|Hysteroscopy|hysteroscopy
5091296|NCT03427957|Endometrial biopsy|endometrial biopsy
5091297|NCT03427957|Menopause|menopause
5091298|NCT03427944|Calcium Dobesilate|calcium dobesilate
5091299|NCT03427944|Non Dialysis Patients With CKD(3-5)|non dialysis patients with ckd(3-5)
5091300|NCT03427944|Glomerular filtration rate|glomerular filtration rate
5091301|NCT03427944|serum creatinine|serum creatinine
5091302|NCT03427931|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5091303|NCT03427931|Islet Transplantation|islet transplantation
5423367|NCT01615913|onychomycosis|onychomycosis
5091304|NCT03427931|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5091305|NCT03427892|mood|mood
5091306|NCT03427892|bipolar|bipolar
5091307|NCT03427892|depression|depression
5091308|NCT03427866|Myelofibrosis|myelofibrosis
5091309|NCT03427840|Superior Hypogastric Plexus Block|superior hypogastric plexus block
5091310|NCT03427840|Hysterectomy|hysterectomy
5091311|NCT03427840|Minimally invasive surgery|minimally invasive surgery
5091312|NCT03427840|Laparoscopy|laparoscopy
5091313|NCT03427840|Pain|pain
5091314|NCT03427840|Gynecologic Disease|gynecologic disease
5091315|NCT03427827|PD-1 antibody|pd-1 antibody
5091316|NCT03427827|Adjuvant treatment|adjuvant treatment
5091317|NCT03427827|Immune checkpoint inhibitors|immune checkpoint inhibitors
5091319|NCT03427814|PARP inhibitor|parp inhibitor
5961876|NCT04284371|Liver Steatosis|liver steatosis
5961877|NCT04284371|Overweight Adolescents|overweight adolescents
5961878|NCT04284358|Neuromuscular Training|neuromuscular training
5961879|NCT04284332|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4961440|NCT04230733|Pelvic height|pelvic height
4961441|NCT04230733|Leg Length Discrepancy|leg length discrepancy
4961442|NCT04230733|Sacral angle|sacral angle
4961446|NCT04230694|diabetes|diabetes
4961447|NCT04230668|Cognitive Processing Therapy|cognitive processing therapy
4961448|NCT04230668|Suicide Risk Management|suicide risk management
5091320|NCT03427814|Phase 3|phase 3
5091321|NCT03427814|maintenance therapy|maintenance therapy
5091322|NCT03427814|gastric cancer|gastric cancer
5091323|NCT03427814|oral treatment|oral treatment
5091324|NCT03427814|PARALLEL303|parallel303
5091325|NCT03427814|PARALLEL 303|parallel 303
5091326|NCT03427814|PARALLEL|parallel
5091327|NCT03427814|BGB290303|bgb290303
5091328|NCT03427814|BGB-290-303|bgb-290-303
5091329|NCT03427801|erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5091330|NCT03427775|multimodal analgesia|multimodal analgesia
5091331|NCT03427775|quality of recovery|quality of recovery
5091332|NCT03427775|quality of pain management|quality of pain management
5091333|NCT03427762|balance|balance
5091334|NCT03427762|postural controll|postural controll
5091335|NCT03427762|motor controll|motor controll
5091336|NCT03427762|posturgraphy|posturgraphy
5091337|NCT03427762|quality of life|quality of life
5091338|NCT03427749|Myocardial Blood Flow|myocardial blood flow
5091339|NCT03427749|SPECT|spect
5091340|NCT03427723|Peripheral intravenous cannulation|peripheral intravenous cannulation
5091341|NCT03427723|children|children
5091342|NCT03427723|near-infrared light|near-infrared light
5091343|NCT03427684|Gastric cancer|gastric cancer
5091344|NCT03427684|Chemo-radiotherapy|chemo-radiotherapy
5091345|NCT03427684|Phase I study|phase i study
5089380|NCT03439696|VATS|vats
5091347|NCT03427658|sweet taste|sweet taste
5091348|NCT03427658|food preferences|food preferences
5091349|NCT03427658|food intake|food intake
5091350|NCT03427645|surrogate decision maker|surrogate decision maker
5091351|NCT03427632|PVP|pvp
5091352|NCT03427632|bone tumor|bone tumor
5091353|NCT03427606|sacral colpopexy|sacral colpopexy
5091354|NCT03427606|laparoscopy|laparoscopy
5091355|NCT03427606|mesh fixation|mesh fixation
5091362|NCT03427580|Metacognitive abilities|metacognitive abilities
5091363|NCT03427580|Session by session assessment|session by session assessment
5091364|NCT03427580|Outcome|outcome
5091365|NCT03427567|Chinese|chinese
5091366|NCT03427567|real-world evidences|real-world evidences
5091367|NCT03427567|NSCLC|nsclc
5091368|NCT03427567|sublobar dissection|sublobar dissection
5091369|NCT03427541|Chinese|chinese
5091370|NCT03427541|non-small cell lung cancer|non-small cell lung cancer
5091371|NCT03427541|oligometastases|oligometastases
5091372|NCT03427515|Psychobiotics|psychobiotics
5091373|NCT03427515|Probiotics|probiotics
5091374|NCT03427515|Examination|examination
5091375|NCT03427515|Stress|stress
5091376|NCT03427502|general anesthesia|general anesthesia
5091377|NCT03427502|nasal surgery|nasal surgery
5091378|NCT03427502|anterior ehtmoidal nerve block|anterior ehtmoidal nerve block
5091379|NCT03427502|bupivacaine|bupivacaine
5091380|NCT03427502|postoperative confusion|postoperative confusion
5091381|NCT03427489|Biomarkers|biomarkers
5091382|NCT03427489|Genetic Markers|genetic markers
5091383|NCT03427489|Controls|controls
5091384|NCT03427476|renal cell carcinoma|renal cell carcinoma
5091385|NCT03427476|RCC|rcc
5091386|NCT03427476|prostate specific membrane antigen|prostate specific membrane antigen
5091387|NCT03427476|PSMA|psma
5091388|NCT03427476|metastatic renal cancer|metastatic renal cancer
5091389|NCT03427476|positron emission tomography|positron emission tomography
5091390|NCT03427476|PET|pet
5091391|NCT03427450|circulating tumor cells|circulating tumor cells
5091392|NCT03427450|liquid biopsy|liquid biopsy
5091393|NCT03427450|microfluidics|microfluidics
5091394|NCT03427437|sacral canal|sacral canal
5091395|NCT03427437|sacral hiatus|sacral hiatus
5091396|NCT03427437|ultrasound|ultrasound
5091397|NCT03427424|Opioid use Disorder|opioid use disorder
5091398|NCT03427424|Alcohol use Disorder|alcohol use disorder
5091399|NCT03427424|Physician Health Program|physician health program
5091400|NCT03427424|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5091401|NCT03427424|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5091402|NCT03427411|TGFR1 pathway signaling and overexpression|tgfr1 pathway signaling and overexpression
5091403|NCT03427411|PD-1 inhibitors|pd-1 inhibitors
5091404|NCT03427411|Manageable Safety Profile|manageable safety profile
5091405|NCT03427411|Bifunctional Fusion Protein|bifunctional fusion protein
5091406|NCT03427411|Refractory/Recurrent HPV Associated Malignancies|refractory/recurrent hpv associated malignancies
5091407|NCT03427385|Neuromuscular blockade|neuromuscular blockade
5091408|NCT03427359|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5961880|NCT04284332|NPC|npc
5961881|NCT04284332|non-keratinizing|non-keratinizing
5961882|NCT04284332|immunotherapy|immunotherapy
5961883|NCT04284332|bifunctional|bifunctional
5961884|NCT04284332|fusion protein|fusion protein
5961885|NCT04284319|Heart Transplantation|heart transplantation
5423368|NCT01615913|terbinafine|terbinafine
5091409|NCT03427359|induction chemotherapy|induction chemotherapy
5091410|NCT03427359|cisplatin|cisplatin
5961886|NCT04284319|Normothermic Regional Perfusion|normothermic regional perfusion
5961887|NCT04284319|NRP|nrp
5091411|NCT03427359|capecitabine|capecitabine
5091412|NCT03427359|chemoradiotherapy|chemoradiotherapy
5091413|NCT03427346|Barrett Esophagus|barrett esophagus
5091415|NCT03427346|EMR|emr
5091416|NCT03427346|Esophagus Neoplasm|esophagus neoplasm
5091417|NCT03427346|endoscopic resection technique|endoscopic resection technique
5091418|NCT03427346|ablation of esophageal mucosa|ablation of esophageal mucosa
5091420|NCT03427333|Pacemaker Lead Extraction|pacemaker lead extraction
5091421|NCT03427333|epicardial access|epicardial access
5091422|NCT03427333|pericardial access|pericardial access
5091423|NCT03427320|[131]I-IAZA Imaging study|[131]i-iaza imaging study
5091424|NCT03427307|Lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
5091425|NCT03427307|inflammation|inflammation
5091426|NCT03427307|ASCVD|ascvd
5091427|NCT03427255|superficial dyspareunia; CBT|superficial dyspareunia; cbt
5091428|NCT03427242|biliary tract carcinoma|biliary tract carcinoma
5091429|NCT03427242|apatinib|apatinib
5091430|NCT03427229|fecal microbiota transplantation|fecal microbiota transplantation
5091431|NCT03427229|Clostridium difficile infection|clostridium difficile infection
5091432|NCT03427229|pseudomembranous colitis|pseudomembranous colitis
5091433|NCT03427190|Suicide|suicide
5091434|NCT03427190|Suicide attempted|suicide attempted
5091435|NCT03427190|Secondary Prevention|secondary prevention
5091436|NCT03427190|Relapse prevention|relapse prevention
5091437|NCT03427190|Case Management|case management
5091438|NCT03427190|Intervention Study|intervention study
5091439|NCT03427164|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5091440|NCT03427164|TIPS|tips
5091441|NCT03427164|cirrhosis|cirrhosis
5091442|NCT03427164|hepatitis|hepatitis
5091443|NCT03427164|portal vein thrombosis|portal vein thrombosis
5091444|NCT03427164|Budd-Chiari Disease|budd-chiari disease
5091445|NCT03427164|Elastography|elastography
5091446|NCT03427086|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5091453|NCT03427008|mHealth|mhealth
5091454|NCT03427008|kidney transplantation|kidney transplantation
5092139|NCT03422939|FBDG|fbdg
5091476|NCT03426852|Gait|gait
5091477|NCT03426852|Lumbar Disc Degeneration|lumbar disc degeneration
5091478|NCT03426839|hemostatic techniques|hemostatic techniques
5091479|NCT03426839|perioperative hemorrhage|perioperative hemorrhage
5091480|NCT03426839|platelet function test|platelet function test
5091481|NCT03426839|point of care technology|point of care technology
5091482|NCT03426839|thromboelastometry|thromboelastometry
5091483|NCT03426839|vascular surgical procedures|vascular surgical procedures
5091484|NCT03426826|FMT|fmt
5091485|NCT03426826|Gut Microbiome|gut microbiome
5091486|NCT03426826|Fecal Microbiata Transplantation|fecal microbiata transplantation
5091487|NCT03426826|Autism Spectrum Disorder|autism spectrum disorder
5091488|NCT03426826|16s rRNA|16s rrna
5091489|NCT03426826|Gastro-Intestinal Disorder|gastro-intestinal disorder
5091490|NCT03426813|mobilization|mobilization
5091491|NCT03426813|physiotherapy|physiotherapy
5091492|NCT03426813|community-acquired pneumonia|community-acquired pneumonia
5091493|NCT03426800|Acupuncture|acupuncture
5091494|NCT03426800|Training|training
5091495|NCT03426800|Children|children
5091496|NCT03426800|Effect|effect
5091497|NCT03426787|Patient Centered|patient centered
5091498|NCT03426787|Pre-Post Design|pre-post design
5091499|NCT03426787|Decision Support|decision support
5091500|NCT03426787|Health Literacy|health literacy
5091501|NCT03426748|Brachytherapy|brachytherapy
5091502|NCT03426748|Quality of life|quality of life
5091503|NCT03426748|High dose rate vs. low dose rate|high dose rate vs. low dose rate
5091504|NCT03426748|Intermediate risk group|intermediate risk group
5091505|NCT03426735|Iodine|iodine
5091506|NCT03426735|Iodized|iodized
5091507|NCT03426735|Computerized Tomography|computerized tomography
5091508|NCT03426735|Extravasation|extravasation
5091509|NCT03426735|contrast media|contrast media
5091510|NCT03426709|Depression|depression
5091511|NCT03426709|Multimorbidity|multimorbidity
5091512|NCT03426709|Computer-delivered psychotherapy|computer-delivered psychotherapy
5091513|NCT03426709|Randomized-controlled trial|randomized-controlled trial
5091514|NCT03426709|Cost-effectiveness|cost-effectiveness
5091515|NCT03426696|psychological status|psychological status
5091516|NCT03426696|Related Factors|related factors
5091517|NCT03426696|Thyroid Related Eye Disease|thyroid related eye disease
5091518|NCT03426683|Inflammatory Bowel Disease(IBD)|inflammatory bowel disease(ibd)
5091519|NCT03426683|Ulcerative colitis(UC)|ulcerative colitis(uc)
5091520|NCT03426683|Crohn's disease(CD)|crohn's disease(cd)
5091521|NCT03426683|intestinal microbiota transplantation|intestinal microbiota transplantation
5091522|NCT03426683|microbiota|microbiota
5091526|NCT03426644|Childhood sleep promotion|childhood sleep promotion
5091527|NCT03426644|Sleep promotion|sleep promotion
5091528|NCT03426644|Sleep|sleep
5091529|NCT03426592|HIV|hiv
5091530|NCT03426592|Inflammation|inflammation
5091531|NCT03426592|Vitamin D|vitamin d
5091532|NCT03426592|Immunomodulation|immunomodulation
5091533|NCT03426592|Virus latency|virus latency
5091534|NCT03426566|diabetic foot|diabetic foot
5091535|NCT03426566|pedobarography|pedobarography
5091536|NCT03426566|diabetic neuropathy|diabetic neuropathy
5091537|NCT03426566|plantar pressure|plantar pressure
5091538|NCT03426553|Patogen inactivation|patogen inactivation
5091539|NCT03426553|Pathogen reduction|pathogen reduction
5091540|NCT03426553|clinical use|clinical use
5091541|NCT03426553|riboflavin+UV|riboflavin+uv
5091542|NCT03426553|RBC transfusion|rbc transfusion
5091543|NCT03426553|whole blood|whole blood
5091544|NCT03426514|Colorectal cancer|colorectal cancer
5091545|NCT03426514|Laparoscopic surgery|laparoscopic surgery
5091546|NCT03426514|Three-port|three-port
5091547|NCT03426501|heart rate variability|heart rate variability
5091548|NCT03426501|prognosis|prognosis
5091549|NCT03426475|nursing home residents|nursing home residents
5091550|NCT03426475|interprofessional collaboration|interprofessional collaboration
5091551|NCT03426475|reduction of hospitalisation|reduction of hospitalisation
5091552|NCT03426462|Pharmacodynamic|pharmacodynamic
5091553|NCT03426462|Permutation Entropy|permutation entropy
5091554|NCT03426462|EEG|eeg
5091555|NCT03426423|Gender|gender
5091556|NCT03426423|Metabolism|metabolism
5091557|NCT03426423|Microbiota|microbiota
5091558|NCT03426397|Complete response|complete response
5091559|NCT03426397|Organ preservation|organ preservation
5091560|NCT03426397|Wait-and-See|wait-and-see
5091561|NCT03426397|Watch-and-Wait|watch-and-wait
5091562|NCT03426397|Watchful Waiting|watchful waiting
5091563|NCT03426384|SLE|sle
5091564|NCT03426384|FLARE|flare
5091565|NCT03426384|Lupus|lupus
5091568|NCT03426384|Smartphone App|smartphone app
5091569|NCT03426358|Veno Occlusive Disease|veno occlusive disease
5091570|NCT03426358|Sinusoidal Obstruction Syndrome|sinusoidal obstruction syndrome
5091571|NCT03426358|HSCT|hsct
5091572|NCT03426358|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5091573|NCT03426358|Stem Cell Transplant Complications|stem cell transplant complications
5091574|NCT03426358|Liver Stiffness Measurement|liver stiffness measurement
5091575|NCT03426358|Sinusoidal Obstructive Syndrome|sinusoidal obstructive syndrome
5091576|NCT03426358|Transient Elastography|transient elastography
5091577|NCT03426332|Adrenal Insufficiency|adrenal insufficiency
5091578|NCT03426332|Adrenal crisis|adrenal crisis
5091579|NCT03426332|Adrenal emergency|adrenal emergency
5091580|NCT03426332|Glucocorticoid injection|glucocorticoid injection
5091581|NCT03426319|Primary adrenal insufficiency|primary adrenal insufficiency
5091582|NCT03426319|Cardiovascular status|cardiovascular status
5091583|NCT03426319|Metabolic profile|metabolic profile
5091584|NCT03426306|4-Dimensional Computed Tomography|4-dimensional computed tomography
5091585|NCT03426293|heparin;ACT;non-cardiac vascular;peri-procedural|heparin;act;non-cardiac vascular;peri-procedural
5091586|NCT03426254|Subcutaneously Talazoparib|subcutaneously talazoparib
5091587|NCT03426241|chronic periodontitis|chronic periodontitis
5091588|NCT03426241|smoking|smoking
5091589|NCT03426241|mmp-2|mmp-2
5091590|NCT03426241|mmp-9|mmp-9
5091591|NCT03426228|IVF, Glucose Homeostasis, Metabolic Parameters|ivf, glucose homeostasis, metabolic parameters
5091592|NCT03426202|modafinil|modafinil
5091593|NCT03426202|emotion|emotion
5091594|NCT03426202|cognitive processing|cognitive processing
5091595|NCT03426189|HIV|hiv
5091596|NCT03426189|Latent reservoir|latent reservoir
5091597|NCT03426189|Leukapheresis|leukapheresis
5091598|NCT03426189|Inguinal lymph node biopsy|inguinal lymph node biopsy
5091599|NCT03426189|Immune checkpoint|immune checkpoint
5091600|NCT03426189|PD1|pd1
5091601|NCT03426189|CTLA4|ctla4
5091602|NCT03426176|oxytocin|oxytocin
5091603|NCT03426176|acute tryptophan depletion|acute tryptophan depletion
5091604|NCT03426176|emotion|emotion
5091605|NCT03426163|virtual reality|virtual reality
5091606|NCT03426163|knee|knee
5091607|NCT03426137|Oxycodone|oxycodone
5091608|NCT03426137|Placebo|placebo
5091609|NCT03426137|Expectancy Induced Analgesia|expectancy induced analgesia
5091610|NCT03426137|NSAID|nsaid
5091611|NCT03426124|venous thromboembolism|venous thromboembolism
5091612|NCT03426111|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5091613|NCT03426111|NASH|nash
5091614|NCT03426111|Obesity|obesity
5091615|NCT03426111|Endoscopic gastric tubulization|endoscopic gastric tubulization
5091616|NCT03426111|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5091617|NCT03426072|quality improvement|quality improvement
5091618|NCT03426059|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
5091619|NCT03426059|PMS|pms
5091620|NCT03426059|Genotype|genotype
5091621|NCT03426059|Phenotype|phenotype
5091622|NCT03426059|Mapping|mapping
5091623|NCT03426059|22q13 Deletion Syndrome|22q13 deletion syndrome
5091624|NCT03426059|SHANK3|shank3
5091625|NCT03426059|Autism Spectrum Disorder|autism spectrum disorder
5091626|NCT03426059|ASD|asd
5091627|NCT03426059|Intellectual Disability|intellectual disability
5091628|NCT03426059|ID|id
5091629|NCT03426046|Biodentine|biodentine
5091640|NCT03426007|blastocyst|blastocyst
5091641|NCT03426007|in vivo|in vivo
5091642|NCT03426007|superovulation|superovulation
5091643|NCT03425981|WB-EMS|wb-ems
5091644|NCT03425981|Running economy|running economy
5091645|NCT03425981|VO2max|vo2max
5091646|NCT03425968|Injury rate|injury rate
4961768|NCT04228653|CDNF|cdnf
5356815|NCT01917890|radiosensitizer|radiosensitizer
5082232|NCT03484767|mut0|mut0
5091647|NCT03425942|Cognitive Behavioral Therapy|cognitive behavioral therapy
5091648|NCT03425942|Applied Relaxation Techniques|applied relaxation techniques
5091649|NCT03425942|Internet treatment|internet treatment
5091650|NCT03425929|amygdala, fear, intrusion, oxytocin, trauma disclosure|amygdala, fear, intrusion, oxytocin, trauma disclosure
5091651|NCT03425916|Hypopressive exercises|hypopressive exercises
5091652|NCT03425916|Ultrasonography|ultrasonography
5091658|NCT03425864|connective tissue graft|connective tissue graft
5091660|NCT03425851|Infants|infants
5091661|NCT03425851|Well baby visits|well baby visits
5091662|NCT03425851|Low-income families|low-income families
5091663|NCT03425851|Caregiver stress|caregiver stress
5091664|NCT03425838|CDK 4/6 inhibitor|cdk 4/6 inhibitor
5091665|NCT03425825|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5091666|NCT03425812|Axial Spondyloarthritis|axial spondyloarthritis
5091667|NCT03425812|Anti-Inflammatory Drugs|anti-inflammatory drugs
5091668|NCT03425812|Flare|flare
5091686|NCT03425708|Uric Acid|uric acid
5091687|NCT03425708|Febuxostat|febuxostat
5091688|NCT03425708|Chronic Renal Disease|chronic renal disease
5091689|NCT03425695|Free gingival graft, Low level laser therapy, Shrinkage|free gingival graft, low level laser therapy, shrinkage
5091690|NCT03425682|Anterior Cervical Discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5091703|NCT03425513|Risk factor|risk factor
5091704|NCT03425513|Ethnicity|ethnicity
5091705|NCT03425513|Linkage of care|linkage of care
5091706|NCT03425487|Mindfulness|mindfulness
5091707|NCT03425487|Compassion|compassion
5091708|NCT03425487|Mental Health Services|mental health services
5091709|NCT03425422|Vagus nerve stimulation|vagus nerve stimulation
5091710|NCT03425383|Cardiovascular disease, FMD, c-IMT|cardiovascular disease, fmd, c-imt
5091711|NCT03425370|Surgical wounds|surgical wounds
5091712|NCT03425370|Tissue adhesive|tissue adhesive
5091713|NCT03425370|Sutures|sutures
5091714|NCT03425370|Wound healing|wound healing
5091715|NCT03425331|Non-Small Cell Lung Cancer|non-small cell lung cancer
5091716|NCT03425305|Serum uric acid|serum uric acid
5091717|NCT03425305|Cardiovascular disease|cardiovascular disease
5091718|NCT03425305|Atherosclerosis|atherosclerosis
5091719|NCT03425292|immunotherapy|immunotherapy
5091720|NCT03425292|nivolumab|nivolumab
5091721|NCT03425292|ipilimumab|ipilimumab
5091722|NCT03425292|bevcizumab|bevcizumab
5091723|NCT03425292|temozolomide|temozolomide
5091724|NCT03425266|shared decision-making|shared decision-making
5091725|NCT03425266|decision support tool|decision support tool
5091726|NCT03425266|patient-provider communication|patient-provider communication
5091727|NCT03425266|managing chronic pain|managing chronic pain
5091728|NCT03425266|patient preferences|patient preferences
5091729|NCT03425266|values clarification|values clarification
5091730|NCT03425253|Lower Face Contouring|lower face contouring
5091731|NCT03425240|Erectile Dysfunction|erectile dysfunction
5091732|NCT03425240|Prostate Cancer|prostate cancer
5091733|NCT03425240|Neuromodulation|neuromodulation
5091734|NCT03425227|Frailty|frailty
5091735|NCT03425227|Elderly People|elderly people
5091736|NCT03425227|Exergame|exergame
5091737|NCT03425227|Physical Activity|physical activity
5091738|NCT03425227|Kinect|kinect
5091739|NCT03425227|Biofeeback|biofeeback
5091740|NCT03425214|functional MRI|functional mri
5091745|NCT03425175|Surgical safety|surgical safety
5091746|NCT03425175|Audio recording|audio recording
5091747|NCT03425162|quadratus lumborum block|quadratus lumborum block
5091750|NCT03425162|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5091751|NCT03425149|vaccine|vaccine
5091752|NCT03425149|prevention|prevention
5091753|NCT03425136|Prevention of Mother-to-Child HIV Transmission|prevention of mother-to-child hiv transmission
5091755|NCT03425136|PMTCT|pmtct
5091756|NCT03425123|Regenerative endodontic procedure (REP)|regenerative endodontic procedure (rep)
5091757|NCT03425123|Mineral Trioxide Aggregate (MTA) apexification|mineral trioxide aggregate (mta) apexification
5091758|NCT03425123|Calcium Hydroxide -Ca(OH)2|calcium hydroxide -ca(oh)2
5091759|NCT03425123|Permanent non-vital tooth|permanent non-vital tooth
5091760|NCT03425123|Children 7-18 years of age|children 7-18 years of age
5091761|NCT03425071|Tacrolimus|tacrolimus
5091762|NCT03425071|T Lymphocytes|t lymphocytes
5091763|NCT03425071|B lymphocytes|b lymphocytes
5091764|NCT03425071|Monitoring, Immunologic|monitoring, immunologic
5091765|NCT03425058|Molecular Evaluation|molecular evaluation
5091766|NCT03425058|Locally Advanced Gastric Cancer|locally advanced gastric cancer
5091767|NCT03425058|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5091768|NCT03425058|ctDNA|ctdna
5091770|NCT03425058|dMMR/MSI|dmmr/msi
5091771|NCT03425045|chronic tinnitus|chronic tinnitus
5091772|NCT03425045|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5091773|NCT03425045|hypacusion|hypacusion
5091774|NCT03425045|depression|depression
5091775|NCT03425045|treatment|treatment
5091776|NCT03425045|placebo|placebo
5961888|NCT04284319|Donation After Circulatory Death|donation after circulatory death
5091777|NCT03425045|medication therapy|medication therapy
5091778|NCT03425019|Knee Osteoarthritis|knee osteoarthritis
5091779|NCT03425019|Chronic Pain|chronic pain
5091787|NCT03424993|Dietary Sodium|dietary sodium
5091788|NCT03424993|Dietary Counseling|dietary counseling
5091789|NCT03424980|Non-small cell lung cancer, Chinese, brain metastases|non-small cell lung cancer, chinese, brain metastases
5091790|NCT03424967|attention-bias modification|attention-bias modification
5091791|NCT03424967|statistical learning|statistical learning
5091792|NCT03424967|social anxiety disorder|social anxiety disorder
5091793|NCT03424967|treatment outcome|treatment outcome
5091794|NCT03424941|Aortic Stenosis (AS)|aortic stenosis (as)
5091795|NCT03424941|Multi Vessel Coronary Artery Disease (MVD)|multi vessel coronary artery disease (mvd)
5091796|NCT03424941|TransCatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
5091797|NCT03424941|Coronary Artery By-pass Grafting (CABG)|coronary artery by-pass grafting (cabg)
5091798|NCT03424941|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5091799|NCT03424941|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5091800|NCT03424941|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
5091801|NCT03424928|Pomalidomide|pomalidomide
5091802|NCT03424928|Multiple myeloma|multiple myeloma
5091803|NCT03424928|Bioequivalence|bioequivalence
5091804|NCT03424889|Bronchoscopy|bronchoscopy
5091805|NCT03424889|Lignocaine|lignocaine
5091806|NCT03424889|Anaesthesia|anaesthesia
5091807|NCT03424876|Sunitinib Imatinib|sunitinib imatinib
5091808|NCT03424798|mechanical ventilation|mechanical ventilation
5091809|NCT03424798|lung function|lung function
5091810|NCT03424798|cardiopulmonary monitoring|cardiopulmonary monitoring
5091811|NCT03424785|Aortic intramural hematoma|aortic intramural hematoma
5091812|NCT03424785|Chinese patients|chinese patients
5091813|NCT03424785|Clinical outcomes|clinical outcomes
5091814|NCT03424733|demyelination|demyelination
5091815|NCT03424733|relapse rate|relapse rate
5091816|NCT03424733|Pegylated interferon beta-1a|pegylated interferon beta-1a
5091817|NCT03424733|side effects|side effects
5091818|NCT03424733|flu-like symptoms|flu-like symptoms
5091819|NCT03424733|injection site reactions|injection site reactions
5091820|NCT03424733|prednisone|prednisone
5091821|NCT03424694|Brachytherapy|brachytherapy
5091822|NCT03424694|Monotherapy|monotherapy
5091823|NCT03424694|HDR Brachytherapy|hdr brachytherapy
5091824|NCT03424694|Toxicity|toxicity
5091825|NCT03424694|Quality of Life|quality of life
5091826|NCT03424694|Progression Free Survival|progression free survival
5091827|NCT03424668|nutrition|nutrition
5091828|NCT03424668|physical activity|physical activity
5091829|NCT03424668|lifestyle|lifestyle
5091830|NCT03424668|smoking|smoking
5091831|NCT03424655|post -endodontic pain|post -endodontic pain
5091832|NCT03424655|endodontic pain|endodontic pain
5091833|NCT03424655|pain|pain
5091834|NCT03424642|prenatal depression|prenatal depression
5091835|NCT03424642|prenatal anxiety|prenatal anxiety
5091836|NCT03424642|prenatal mental disorders|prenatal mental disorders
5091837|NCT03424642|interactive ultrasound examination|interactive ultrasound examination
5091838|NCT03424642|maternal-fetal relations|maternal-fetal relations
5091839|NCT03424629|psoriasis|psoriasis
5091840|NCT03424629|UC-MSCs|uc-mscs
5091841|NCT03424616|Opiate dependence|opiate dependence
5091842|NCT03424616|Deep brain stimulation|deep brain stimulation
5092140|NCT03422939|dietitians|dietitians
5091884|NCT03424460|Myotonic dystrophy 1|myotonic dystrophy 1
5091885|NCT03424460|Venous thromboembolism|venous thromboembolism
5091886|NCT03424460|Pulmonary embolism|pulmonary embolism
5091887|NCT03424460|Deep vein thrombosis|deep vein thrombosis
5091888|NCT03424460|Hypercoagulability|hypercoagulability
5091889|NCT03424460|Thrombophilia|thrombophilia
5091890|NCT03424460|RNA alternative splicing|rna alternative splicing
5091891|NCT03424434|Occupational blood exposure|occupational blood exposure
5091892|NCT03424434|underreporting|underreporting
5091893|NCT03424434|medical|medical
5091894|NCT03424434|hospital|hospital
5091895|NCT03424421|Shoulder Joint|shoulder joint
5091896|NCT03424421|Orthopedics|orthopedics
5091897|NCT03424421|Arthroscopy|arthroscopy
5091898|NCT03424395|personalized dietary and wellness program|personalized dietary and wellness program
5356816|NCT01917877|Becacizumab|becacizumab
5091899|NCT03424395|oral protein glucose lipid tolerance test|oral protein glucose lipid tolerance test
5091901|NCT03424395|behavior|behavior
5091902|NCT03424395|health|health
5091903|NCT03424395|body composition|body composition
5091904|NCT03424395|single nucleotide polymorphisms|single nucleotide polymorphisms
5091905|NCT03424395|genotype|genotype
5091909|NCT03424356|Rocuronium bromur|rocuronium bromur
5091910|NCT03424356|propofol|propofol
5091911|NCT03424343|survivors|survivors
5091912|NCT03424343|parents|parents
5091913|NCT03424343|sibling|sibling
5091914|NCT03424343|family environment|family environment
5091915|NCT03424343|psychosocial functioning|psychosocial functioning
5091916|NCT03424343|longitudinal|longitudinal
5091917|NCT03424343|cancer|cancer
5091918|NCT03424343|identity|identity
5091919|NCT03424343|adolescence|adolescence
5091920|NCT03424343|emerging adulthood|emerging adulthood
5091921|NCT03424278|Low back pain|low back pain
5091922|NCT03424278|Exercise|exercise
5091923|NCT03424252|Cystic Fibrosis|cystic fibrosis
5091925|NCT03424174|TKA, cytokine, coating|tka, cytokine, coating
5091926|NCT03424122|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5091927|NCT03424122|follicular lymphoma (FL)|follicular lymphoma (fl)
5091928|NCT03424122|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
5091929|NCT03424122|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5091930|NCT03424122|phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase delta (pi3kδ) inhibitor
5091931|NCT03424109|Emergency Department|emergency department
5091932|NCT03424109|Palliative Care|palliative care
5091933|NCT03424070|laryngoscopy|laryngoscopy
5091934|NCT03424070|pediatric|pediatric
5091935|NCT03424070|airway|airway
5091936|NCT03424070|gel roll|gel roll
5091937|NCT03424070|larynx|larynx
5091938|NCT03424070|glottis|glottis
5091949|NCT03424018|Bone Diseases, Developmental|bone diseases, developmental
5091951|NCT03424018|Genetic Diseases, Inborn|genetic diseases, inborn
5091952|NCT03424018|Musculoskeletal Diseases|musculoskeletal diseases
5091953|NCT03424018|Natriuretic Agents|natriuretic agents
5091954|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
5091955|NCT03424018|Osteochondrodysplasias|osteochondrodysplasias
5091956|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs
5091957|NCT03424018|Skeletal Dysplasias|skeletal dysplasias
5091959|NCT03423953|osteoarthritis|osteoarthritis
5091960|NCT03423953|avascular necrosis|avascular necrosis
5091961|NCT03423953|rheumatoid arthritis|rheumatoid arthritis
5091962|NCT03423940|Functional communication training|functional communication training
5091963|NCT03423940|Reinforcement Schedule Thinning|reinforcement schedule thinning
5091964|NCT03423940|Resurgence|resurgence
5091965|NCT03423940|Treatment Dosage|treatment dosage
5091966|NCT03423940|Treatment Relapse|treatment relapse
5091970|NCT03423901|Complications|complications
5091971|NCT03423888|Dyspnea|dyspnea
5091972|NCT03423888|palliative care|palliative care
5091973|NCT03423888|high-flow nasal oxygen|high-flow nasal oxygen
5091974|NCT03423888|pilot study|pilot study
5091975|NCT03423875|Delirium, Delirium Recognition|delirium, delirium recognition
5091976|NCT03423823|Neovascularization|neovascularization
5091977|NCT03423797|silver nitrate|silver nitrate
5091978|NCT03423797|sodium fluoride|sodium fluoride
5091979|NCT03423797|dental caries|dental caries
5091980|NCT03423797|equivalence trial|equivalence trial
5091981|NCT03423784|teething in infants and children|teething in infants and children
5091985|NCT03423745|intubation|intubation
5091986|NCT03423745|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5091987|NCT03423745|number of endotracheal intubation experience|number of endotracheal intubation experience
5091988|NCT03423693|Small airway obstruction|small airway obstruction
5091989|NCT03423693|Asthma|asthma
5091990|NCT03423693|COPD|copd
5091991|NCT03423693|ACOS|acos
5091992|NCT03423667|N-acetylcysteine|n-acetylcysteine
5091993|NCT03423667|Craving|craving
5091994|NCT03423641|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5091995|NCT03423641|Antiviral Agents / Adverse Effects|antiviral agents / adverse effects
5091996|NCT03423641|Antiviral Agents / Toxicity|antiviral agents / toxicity
5091997|NCT03423641|Simeprevir|simeprevir
5091998|NCT03423641|Sofosbuvir|sofosbuvir
5091999|NCT03423641|Ledipasvir|ledipasvir
5092000|NCT03423641|Ombitasvir|ombitasvir
5092001|NCT03423641|Paritaprevir|paritaprevir
5092002|NCT03423641|Ritonavir|ritonavir
5092003|NCT03423641|Dasabuvir|dasabuvir
5092004|NCT03423641|Daclatasvir|daclatasvir
5092005|NCT03423641|Elbasvir|elbasvir
5092006|NCT03423641|Grazoprevir|grazoprevir
5092007|NCT03423641|Velpatasvir|velpatasvir
5092008|NCT03423641|Ribavirin|ribavirin
5092009|NCT03423628|glioblastoma|glioblastoma
5092010|NCT03423628|brain metastases|brain metastases
5092011|NCT03423628|Ataxia-telangiectasia mutated kinase (ATM) inhibition|ataxia-telangiectasia mutated kinase (atm) inhibition
5092012|NCT03423628|radiation therapy|radiation therapy
5092013|NCT03423615|School Health Services|school health services
5092014|NCT03423615|Health Education|health education
5092015|NCT03423615|Primary Schools|primary schools
5092016|NCT03423615|Republic of India|republic of india
5092019|NCT03423602|Arteriotomy closure|arteriotomy closure
5092020|NCT03423602|Vascular closure device|vascular closure device
5092021|NCT03423589|Siblings|siblings
5092022|NCT03423576|health services|health services
5092023|NCT03423576|FEV1|fev1
5092025|NCT03423576|quality of life|quality of life
5092026|NCT03423576|mental stress|mental stress
5092027|NCT03423524|Intraocular lens|intraocular lens
5092028|NCT03423524|Monofocal|monofocal
5092029|NCT03423524|Hydrophobic|hydrophobic
5092244|NCT03422406|Cause|cause
5092041|NCT03423498|abductor hallucis muscle|abductor hallucis muscle
5092042|NCT03423498|surface electromyography|surface electromyography
5092043|NCT03423485|Colorectal Surgery|colorectal surgery
5092044|NCT03423472|Nutrition|nutrition
5092045|NCT03423472|Women|women
5092046|NCT03423472|Young children|young children
5092047|NCT03423472|Ethiopia|ethiopia
5092048|NCT03423472|Vitamin A|vitamin a
5092049|NCT03423472|Orange flesh sweet potato|orange flesh sweet potato
5092050|NCT03423433|Chronic|chronic
5092051|NCT03423433|Stroke|stroke
5092052|NCT03423433|Blood Pressure|blood pressure
5092053|NCT03423433|Oxygen Perfusion|oxygen perfusion
5092054|NCT03423433|Stroop|stroop
5092055|NCT03423433|Cognitive Performance|cognitive performance
5092056|NCT03423433|Cognition|cognition
5092057|NCT03423394|Motivational enhancement therapy|motivational enhancement therapy
5092058|NCT03423368|Libramed|libramed
5092059|NCT03423368|Policaptil Gel Retard|policaptil gel retard
5092060|NCT03423368|Overweight|overweight
5092061|NCT03423368|Obesity|obesity
5092062|NCT03423368|Medical Device|medical device
5092063|NCT03423368|glycemic profile|glycemic profile
5092064|NCT03423368|lipid profile|lipid profile
5092065|NCT03423342|nicotinamide riboside|nicotinamide riboside
5092066|NCT03423342|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
5092067|NCT03423303|Prostate cancer|prostate cancer
5092068|NCT03423303|Screening|screening
5092069|NCT03423303|Randomised trial|randomised trial
5092070|NCT03423303|Kallikrein|kallikrein
5092071|NCT03423303|Magnetic resonance imaging|magnetic resonance imaging
5092072|NCT03423303|Prostate-specific antigen|prostate-specific antigen
5092073|NCT03423264|HPV-related oropharyngeal cancer|hpv-related oropharyngeal cancer
5092074|NCT03423264|oropharyngeal cancer|oropharyngeal cancer
5092075|NCT03423264|HPV-related squamous cell carcinoma|hpv-related squamous cell carcinoma
5092076|NCT03423264|prophylactic gabapentin|prophylactic gabapentin
5092077|NCT03423264|Optima II study|optima ii study
5092078|NCT03423238|Cardiac|cardiac
5092079|NCT03423238|Rehab|rehab
5092080|NCT03423238|Diet|diet
5092081|NCT03423238|Exercise|exercise
5092082|NCT03423238|Obese|obese
5092083|NCT03423225|ADVAGRAF®|advagraf®
5092084|NCT03423225|Liver Transplantation|liver transplantation
5092085|NCT03423225|tacrolimus|tacrolimus
5092086|NCT03423199|breast Cancer|breast cancer
5092087|NCT03423199|palbociclib (PD-0332991)|palbociclib (pd-0332991)
5092089|NCT03423199|goserelin|goserelin
5092090|NCT03423199|any menopausal status|any menopausal status
5092091|NCT03423199|hormone receptor positive|hormone receptor positive
5092092|NCT03423199|HER2 negative|her2 negative
5092093|NCT03423199|locally advanced|locally advanced
5092094|NCT03423199|metastatic|metastatic
5092095|NCT03423173|Vaccine|vaccine
5092096|NCT03423147|Cesarean section|cesarean section
5092097|NCT03423147|Labor|labor
5092098|NCT03423147|Surgical Site Infections|surgical site infections
5092099|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate
5092100|NCT03423108|Exercise|exercise
5092101|NCT03423108|Aging|aging
5092102|NCT03423108|Elderly|elderly
5092103|NCT03423108|Physical Activity|physical activity
5092104|NCT03423108|Cardiovascular Disease|cardiovascular disease
5092105|NCT03423069|Irritable bowel syndrome|irritable bowel syndrome
5092106|NCT03423069|FODMAPs|fodmaps
5092107|NCT03423069|Dietary advice|dietary advice
5092108|NCT03423069|Gastrointestinal symptoms|gastrointestinal symptoms
5092109|NCT03423069|Intestinal permeability|intestinal permeability
4976767|NCT04137575|Cancer Survivorship|cancer survivorship
5092110|NCT03423069|Gastrointestinal peptides|gastrointestinal peptides
5092111|NCT03423069|Microbiome|microbiome
5092112|NCT03423069|Lipidomic profile|lipidomic profile
5092113|NCT03423056|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5092114|NCT03423056|Exercise|exercise
5092115|NCT03423056|Preoperative Period|preoperative period
5092116|NCT03423056|Preoperative Care|preoperative care
5092117|NCT03423017|Pierre Robin sequence|pierre robin sequence
5092118|NCT03423017|Brainstem|brainstem
5092119|NCT03423017|pathogenesis|pathogenesis
5092120|NCT03423017|swallowing|swallowing
5092121|NCT03423017|apnea|apnea
5092122|NCT03423004|psoriasis|psoriasis
5092123|NCT03423004|IL-22|il-22
5092124|NCT03423004|miR-21|mir-21
5092125|NCT03422991|Heart Failure|heart failure
5092126|NCT03422991|Heart Diseases|heart diseases
5092127|NCT03422991|Cardiovascular Diseases|cardiovascular diseases
5092129|NCT03422991|Cohort|cohort
5092130|NCT03422978|Dexmedetomidine|dexmedetomidine
5092131|NCT03422965|Retina|retina
5092132|NCT03422965|OCT|oct
5092133|NCT03422965|Optical Coherence Tomography|optical coherence tomography
5092134|NCT03422965|Optical Coherence Tomography Angiography|optical coherence tomography angiography
5092135|NCT03422965|Systemic|systemic
5092136|NCT03422965|Blood|blood
5092137|NCT03422965|Diabetes Mellitus|diabetes mellitus
5092138|NCT03422965|Diabetic Retinopathy|diabetic retinopathy
5092156|NCT03422848|water|water
5092157|NCT03422848|vasopressin|vasopressin
5092158|NCT03422848|copeptin|copeptin
5092159|NCT03422848|glucose|glucose
5092160|NCT03422848|OGTT|ogtt
5092161|NCT03422848|insulin|insulin
5092162|NCT03422848|glucagon|glucagon
5092163|NCT03422835|transanal surgery|transanal surgery
5092164|NCT03422835|robotic surgery|robotic surgery
5092165|NCT03422835|total mesorectal excision|total mesorectal excision
5092171|NCT03422809|Plasma volume, micronutrient, estrogen, progesterone|plasma volume, micronutrient, estrogen, progesterone
5092172|NCT03422783|Monitoring|monitoring
5092173|NCT03422783|Biomarker|biomarker
5092174|NCT03422783|Thoracoscopy|thoracoscopy
5092181|NCT03422718|stroke|stroke
5092182|NCT03422718|hypertension|hypertension
5961889|NCT04284319|DCD|dcd
5092183|NCT03422692|Resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.|resorbable membrane, amnion-chorion membrane, collagen membrane, ridge preservation.
5092184|NCT03422679|advanced solid tumours|advanced solid tumours
5092185|NCT03422679|haematological malignancies|haematological malignancies
5092186|NCT03422679|phase I/II|phase i/ii
5092187|NCT03422679|NOTCH pathway|notch pathway
5092188|NCT03422679|pan-NOTCH inhibitor|pan-notch inhibitor
5092189|NCT03422666|Intestinal lipoprotein|intestinal lipoprotein
5092190|NCT03422666|Gut Peptide|gut peptide
5092191|NCT03422666|Chylomicrons|chylomicrons
5092192|NCT03422653|CR845|cr845
5092193|NCT03422653|Pruritus|pruritus
5092194|NCT03422653|Chronic Itch|chronic itch
5092195|NCT03422653|Itch|itch
5092196|NCT03422653|Itching|itching
5092197|NCT03422653|difelikefalin|difelikefalin
5092198|NCT03422653|Hemodialysis|hemodialysis
5092199|NCT03422653|Uremic Pruritus|uremic pruritus
5092200|NCT03422653|Dialysis|dialysis
5092202|NCT03422653|CKD-associated pruritus|ckd-associated pruritus
5092203|NCT03422653|CKD-aP|ckd-ap
5092204|NCT03422653|ESRD (end stage renal disease)|esrd (end stage renal disease)
5092205|NCT03422653|KALM|kalm
5092206|NCT03422653|Chronic Kidney Disease|chronic kidney disease
5092207|NCT03422653|Kidney failure, chronic|kidney failure, chronic
5092208|NCT03422653|Kidney dysfunction|kidney dysfunction
5092209|NCT03422653|Generalized pruritus|generalized pruritus
5092210|NCT03422640|Frontal Fibrosing Alopecia|frontal fibrosing alopecia
5092211|NCT03422640|Apremilast|apremilast
5092212|NCT03422549|diaphragm|diaphragm
5092213|NCT03422549|non-invasive ventilation|non-invasive ventilation
5092214|NCT03422549|high-frequency oscillation|high-frequency oscillation
5092215|NCT03422549|CPAP|cpap
5092216|NCT03422536|Head and Neck Cancer|head and neck cancer
5092217|NCT03422536|Oropharyngeal Cancer|oropharyngeal cancer
5092221|NCT03422536|HNSCC|hnscc
5092222|NCT03422536|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5092223|NCT03422536|AVEO|aveo
5092224|NCT03422523|Refractory|refractory
5092225|NCT03422523|Relapsed|relapsed
5092226|NCT03422523|Hematological cancer|hematological cancer
5092227|NCT03422510|FSGS|fsgs
5092228|NCT03422510|Kidney Disease|kidney disease
5092229|NCT03422510|Proteinuria|proteinuria
5744858|NCT00340366|Folate|folate
5092230|NCT03422510|Nephrotic Syndrome|nephrotic syndrome
5092232|NCT03422510|Nitro fatty acids|nitro fatty acids
5092233|NCT03422510|OA-NO2|oa-no2
5092234|NCT03422510|10-nitro oleic acid|10-nitro oleic acid
5092235|NCT03422510|Nitro oleic acid|nitro oleic acid
5092236|NCT03422484|Internal medecine unit|internal medecine unit
5092237|NCT03422484|Medication Error|medication error
5092238|NCT03422484|Clinical Pharmacist|clinical pharmacist
5092239|NCT03422484|Medication reconciliation|medication reconciliation
5092240|NCT03422445|Apatinib|apatinib
5092241|NCT03422445|Temozolomide|temozolomide
5092242|NCT03422445|Advanced Melanoma|advanced melanoma
5092243|NCT03422406|Iodine excess|iodine excess
5092249|NCT03422393|venetoclax|venetoclax
5092250|NCT03422393|ibrutinib|ibrutinib
5092251|NCT03422393|high-dose ibrutinib|high-dose ibrutinib
5092252|NCT03422393|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5092253|NCT03422393|progressive disease|progressive disease
5092254|NCT03422393|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5092255|NCT03422393|cancer|cancer
5092256|NCT03422380|energy expenditure|energy expenditure
5092257|NCT03422380|adaptive thermogenesis|adaptive thermogenesis
5092258|NCT03422380|metabolic adaptation|metabolic adaptation
5092259|NCT03422380|weight loss maintenance|weight loss maintenance
5092260|NCT03422367|autism|autism
5092261|NCT03422367|epilepsy|epilepsy
5092263|NCT03422367|TSC|tsc
5092264|NCT03422367|UCLA|ucla
5092265|NCT03422367|Los Angeles|los angeles
5092266|NCT03422367|JASPER|jasper
5092267|NCT03422367|intervention|intervention
5092268|NCT03422367|Boston|boston
5092269|NCT03422367|BCH|bch
5092270|NCT03422367|MGH|mgh
5092271|NCT03422328|macitentan|macitentan
5092272|NCT03422328|long-term safety|long-term safety
5092273|NCT03422328|open-label|open-label
5092274|NCT03422328|single-arm|single-arm
5092275|NCT03422315|Propofol|propofol
5092276|NCT03422315|Population pharmacokinetics|population pharmacokinetics
5092277|NCT03422315|Individualized administration|individualized administration
5092278|NCT03422289|myo-inositol|myo-inositol
5092279|NCT03422289|alpha-lactalbumin|alpha-lactalbumin
5092280|NCT03422289|anovulation|anovulation
5092281|NCT03422289|infertility|infertility
5092282|NCT03422276|Transition|transition
5092283|NCT03422276|Rehabilitation Discharge|rehabilitation discharge
5092284|NCT03422263|Type 2 diabetes mellitus, SGLT-2-Inhibitors, Empagliflozin, Canagliflozin, Dapagliflozin, 6-minute walk test.|type 2 diabetes mellitus, sglt-2-inhibitors, empagliflozin, canagliflozin, dapagliflozin, 6-minute walk test.
5092290|NCT03422120|Immune Suppression|immune suppression
5092291|NCT03422120|Natural Killer Cell Mediated Immunity|natural killer cell mediated immunity
5092292|NCT03422120|Natural Killer Cell Cytokine Production|natural killer cell cytokine production
5092293|NCT03422120|Perioperative/Postoperative Complications|perioperative/postoperative complications
5961890|NCT04284306|PDL-1|pdl-1
5092294|NCT03422107|Peripheral Nerve Injuries|peripheral nerve injuries
5092295|NCT03422107|Thoracic Surgery|thoracic surgery
5092296|NCT03422107|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
5092297|NCT03422081|endothelial dysfunction|endothelial dysfunction
5092298|NCT03422081|doppler ultrasound examination|doppler ultrasound examination
5092299|NCT03422081|nitric oxide|nitric oxide
5092300|NCT03422055|safety 99mTc-Fucoïdane scintigraphy|safety 99mtc-fucoïdane scintigraphy
5092301|NCT03422029|ORR|orr
5092302|NCT03422029|Safety|safety
5092303|NCT03422029|PFS|pfs
5092304|NCT03422016|electroretinogram|electroretinogram
5092305|NCT03422003|Breast Cancer|breast cancer
5092306|NCT03422003|Radiation|radiation
5092307|NCT03422003|Hypofractionation|hypofractionation
5092308|NCT03422003|Randomization|randomization
5092309|NCT03421951|spine|spine
5092310|NCT03421951|lower limb|lower limb
5092311|NCT03421938|total knee arthroplasty|total knee arthroplasty
5092312|NCT03421938|walking exercises|walking exercises
5092313|NCT03421938|uphill-downhill walking exercises|uphill-downhill walking exercises
5092314|NCT03421938|functional level|functional level
5092315|NCT03421912|Prevention strategy|prevention strategy
5092316|NCT03421912|Cutaneous toxicity|cutaneous toxicity
5092317|NCT03421912|Quality of life|quality of life
5092318|NCT03421912|Patient satisfaction|patient satisfaction
5092319|NCT03421912|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
5092320|NCT03421912|Epidermal Repair Score (SCOREPI)|epidermal repair score (scorepi)
5092321|NCT03421912|Topical treatment|topical treatment
5092325|NCT03421899|PINK1|pink1
5092326|NCT03421860|Spinal anesthesia|spinal anesthesia
5092327|NCT03421860|cardiac output|cardiac output
5092328|NCT03421860|vasopressor|vasopressor
5092329|NCT03421847|depression|depression
5092330|NCT03421847|vestibular disorder|vestibular disorder
5092331|NCT03421847|rotatory test|rotatory test
5092332|NCT03421847|electronystagmography|electronystagmography
5092333|NCT03421834|Ventricular Tachycardia|ventricular tachycardia
5092334|NCT03421834|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5092335|NCT03421834|Primary prevention|primary prevention
5092336|NCT03421834|Heart Failure|heart failure
5092337|NCT03421821|quadratus lumborum block|quadratus lumborum block
5092338|NCT03421821|anterior thoracolumbar fascia|anterior thoracolumbar fascia
5092339|NCT03421821|subfascial injection|subfascial injection
5092446|NCT03421015|genomic|genomic
5092340|NCT03421821|extrafascial injection|extrafascial injection
5092342|NCT03421808|transcranial magnetic stimulation|transcranial magnetic stimulation
5092343|NCT03421808|brain stimulation|brain stimulation
5092344|NCT03421795|pain assessment/management|pain assessment/management
5092345|NCT03421795|developmental disabilities|developmental disabilities
5092346|NCT03421795|children|children
5092347|NCT03421795|education|education
5092348|NCT03421795|respite workers|respite workers
5092349|NCT03421730|mild asthma|mild asthma
5092350|NCT03421730|budesonide|budesonide
5092351|NCT03421730|nebulizer|nebulizer
5092352|NCT03421730|pediatric|pediatric
5092353|NCT03421730|pharmacokinetics|pharmacokinetics
5092354|NCT03421665|titanium wedge|titanium wedge
5092355|NCT03421665|Evans|evans
5092356|NCT03421665|Cotton|cotton
5092357|NCT03421613|PHN, acute, herpes zoster|phn, acute, herpes zoster
5092358|NCT03421600|image enhanced endoscopy|image enhanced endoscopy
5092359|NCT03421600|colonoscopy|colonoscopy
5092360|NCT03421600|colonic polyp|colonic polyp
5092361|NCT03421600|colonic adenoma|colonic adenoma
5092362|NCT03421535|Glenohumeral internal rotational deficit|glenohumeral internal rotational deficit
5092363|NCT03421535|GIRD|gird
5092364|NCT03421535|Sleeper stretch|sleeper stretch
5092365|NCT03421535|SI joint stretch|si joint stretch
5092374|NCT03421483|Colon|colon
5092375|NCT03421483|Receptor|receptor
5092376|NCT03421483|Enzyme|enzyme
5092377|NCT03421457|Pelvic Organ Prolapse|pelvic organ prolapse
5092378|NCT03421457|Translabial ultrasound|translabial ultrasound
5092386|NCT03421457|fertility-sparing|fertility-sparing
5092387|NCT03421457|sacropexy|sacropexy
5092388|NCT03421457|cervicopexy|cervicopexy
5092389|NCT03421457|sacrocervicopexy|sacrocervicopexy
5092390|NCT03421457|sacrohysteropexy|sacrohysteropexy
5092391|NCT03421457|mesh prolapse surgery|mesh prolapse surgery
5092392|NCT03421444|Children|children
5092393|NCT03421444|Obesity|obesity
5092394|NCT03421444|Metabolic Disease|metabolic disease
5092395|NCT03421431|NASH|nash
5092396|NCT03421431|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5092397|NCT03421392|constitutive thrombocytopenia|constitutive thrombocytopenia
5092398|NCT03421392|central thrombocytopenia|central thrombocytopenia
5092399|NCT03421392|platelets|platelets
5092400|NCT03421392|sialylation|sialylation
5092401|NCT03421392|flow cytometry|flow cytometry
5092402|NCT03421366|posaconazole|posaconazole
5092403|NCT03421353|AZD9150|azd9150
5092404|NCT03421353|Durvalumab|durvalumab
5092405|NCT03421353|Advanced solid tumours|advanced solid tumours
5092413|NCT03421301|gut microbiota|gut microbiota
5092414|NCT03421301|functional foods|functional foods
5092415|NCT03421301|branched chain amino acids|branched chain amino acids
5092416|NCT03421301|TMAO|tmao
4962479|NCT04224285|mHealth|mhealth
4962480|NCT04224272|HER2|her2
4962481|NCT04224272|HR|hr
4962482|NCT04224272|Bispecific antibody|bispecific antibody
4962509|NCT04224142|GMP|gmp
5092417|NCT03421301|type 2 diabetes|type 2 diabetes
5092418|NCT03421275|fentanyl|fentanyl
5092419|NCT03421275|esketamine|esketamine
5092420|NCT03421275|ketamine|ketamine
5092421|NCT03421275|analgesia|analgesia
5092422|NCT03421275|acute pain|acute pain
5092424|NCT03421184|autoimmune disease|autoimmune disease
5092425|NCT03421184|endocrine disruptors|endocrine disruptors
5092426|NCT03421184|isoflavones|isoflavones
5092427|NCT03421184|lignans|lignans
5092428|NCT03421184|diet exposure|diet exposure
5092429|NCT03421184|risk factor|risk factor
5092430|NCT03421158|neonates|neonates
5092431|NCT03421158|Non-pharmacological|non-pharmacological
5092432|NCT03421119|type 2 diabetes|type 2 diabetes
5092433|NCT03421119|liraglutide|liraglutide
5092434|NCT03421119|efficacy|efficacy
5092435|NCT03421119|safety|safety
5092436|NCT03421106|Food insecurity|food insecurity
5092437|NCT03421106|Food pantries|food pantries
5092438|NCT03421093|Lung cancer|lung cancer
5092439|NCT03421093|Chinese|chinese
5092440|NCT03421093|surgeries|surgeries
5092441|NCT03421093|adjuvant therapies|adjuvant therapies
5092442|NCT03421015|localized prostate cancer|localized prostate cancer
5092443|NCT03421015|prostatectomy|prostatectomy
5092444|NCT03421015|biomarkers|biomarkers
5092445|NCT03421015|metastatic recurrence|metastatic recurrence
5092447|NCT03421002|candida meningitis|candida meningitis
5092448|NCT03421002|Mycamine|mycamine
5092449|NCT03421002|candidiasis, systemic|candidiasis, systemic
5092450|NCT03421002|micafungin|micafungin
5092451|NCT03420989|carob|carob
5092452|NCT03420989|seaweed|seaweed
5092453|NCT03420989|snack food|snack food
5092454|NCT03420989|obese subjects|obese subjects
5092455|NCT03420976|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5092456|NCT03420976|SIBO|sibo
5092457|NCT03420937|deep neuromuscular block|deep neuromuscular block
5092458|NCT03420937|laparoscopic surgery|laparoscopic surgery
5092459|NCT03420937|robotic surgery|robotic surgery
5092460|NCT03420937|lung protective ventilation|lung protective ventilation
5092461|NCT03420937|respiratory functions|respiratory functions
5092462|NCT03420937|post-operative recovery|post-operative recovery
5092463|NCT03420924|intraoperative hypothermia|intraoperative hypothermia
5092464|NCT03420924|thermal suit|thermal suit
5092465|NCT03420924|forced-air warming|forced-air warming
5092466|NCT03420911|pain|pain
5092467|NCT03420911|anxiety|anxiety
5092468|NCT03420911|emergency department|emergency department
5092469|NCT03420911|pain management|pain management
5092470|NCT03420885|Ba Duan Jin|ba duan jin
5092471|NCT03420885|Pulmonary Nodules|pulmonary nodules
5092472|NCT03420885|Clinical Intervention|clinical intervention
5092473|NCT03420872|Nutrition|nutrition
5092474|NCT03420872|Nutrients|nutrients
5092475|NCT03420872|Mixtures|mixtures
5092476|NCT03420872|Neurodevelopment|neurodevelopment
5092477|NCT03420872|Prenatal|prenatal
5092478|NCT03420872|Children|children
5092479|NCT03420820|intravitreal injection|intravitreal injection
5092480|NCT03420820|povidone-iodine|povidone-iodine
5092481|NCT03420820|ocular surface flora|ocular surface flora
5092482|NCT03420820|endophthalmitis|endophthalmitis
5092484|NCT03420781|diabetic gastroparesis|diabetic gastroparesis
5092486|NCT03420742|Drug therapy, brigatinib, lung cancer, ALK, ROS1|drug therapy, brigatinib, lung cancer, alk, ros1
5092487|NCT03420716|functional foods|functional foods
5092488|NCT03420716|dairy foods|dairy foods
5092489|NCT03420716|calcium absorption|calcium absorption
5092490|NCT03420716|prebiotics and probiotics|prebiotics and probiotics
5092491|NCT03420716|young women|young women
5092492|NCT03420716|bone health|bone health
5092493|NCT03420703|erector spinae plane block|erector spinae plane block
5092494|NCT03420703|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5092495|NCT03420703|postoperative pain|postoperative pain
5092496|NCT03420664|cast|cast
5092497|NCT03420664|orthosis|orthosis
5092498|NCT03420664|immobilisation|immobilisation
5092499|NCT03420664|venous stasis|venous stasis
5092500|NCT03420664|circulation|circulation
5092501|NCT03420638|Adults|adults
5092502|NCT03420638|Pain|pain
5092503|NCT03420625|Intermittent Pneumatic Compression Devices|intermittent pneumatic compression devices
5092504|NCT03420625|Electric Stimulation Therapy|electric stimulation therapy
5961891|NCT04284306|LC3B|lc3b
5961892|NCT04284293|RP|rp
5961893|NCT04284293|Retinopathy|retinopathy
5961894|NCT04284293|Pigmentary Retinopathy|pigmentary retinopathy
5961895|NCT04284293|Retinal Degeneration|retinal degeneration
5092505|NCT03420625|Blood Flow Velocity|blood flow velocity
5092506|NCT03420625|Hemodynamics|hemodynamics
5092507|NCT03420599|Gut microbiota|gut microbiota
5092508|NCT03420599|Splenectomy|splenectomy
5092509|NCT03420599|Infection|infection
5092510|NCT03420599|Immune|immune
5092511|NCT03420599|Cytokines|cytokines
5092512|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation
5092513|NCT03420586|Anesthesia Recovery Period|anesthesia recovery period
5092514|NCT03420586|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5092515|NCT03420586|Pain, Postoperative|pain, postoperative
5092516|NCT03420508|Ensartinib|ensartinib
5092517|NCT03420508|ALK Inhibitor|alk inhibitor
5092518|NCT03420508|ALK Alterations|alk alterations
5092519|NCT03420508|Aberrant ALK Expression|aberrant alk expression
5092520|NCT03420508|17-471|17-471
5092522|NCT03420495|Intolerance of Uncertainty|intolerance of uncertainty
5092523|NCT03420482|Microbiome|microbiome
5092524|NCT03420482|Fecal Microbiota Transplant|fecal microbiota transplant
5092525|NCT03420443|radiotherapy, probiotics|radiotherapy, probiotics
5092531|NCT03420391|time-window|time-window
5092532|NCT03420378|Central Sensitisation|central sensitisation
5092533|NCT03420378|Cutaneous Silent Period|cutaneous silent period
5092534|NCT03420378|Vitamin D Deficiency|vitamin d deficiency
5092535|NCT03420339|stimulant medication|stimulant medication
5092536|NCT03420339|behavioral function|behavioral function
5092537|NCT03420339|preferences|preferences
5092538|NCT03420339|delay discounting|delay discounting
5092539|NCT03420326|Atrial Fibrillation|atrial fibrillation
5092540|NCT03420326|Frailty status|frailty status
5092541|NCT03420326|Body composition|body composition
5092542|NCT03420326|Sarcopenia|sarcopenia
5092543|NCT03420313|buprenorphine|buprenorphine
5092544|NCT03420313|waitlist|waitlist
5092545|NCT03420313|interim treatment|interim treatment
5092546|NCT03420313|opioid use disorder|opioid use disorder
5092551|NCT03420274|Prenatal genetic testing|prenatal genetic testing
5092552|NCT03420274|Noninvasive prenatal testing (NIPT)|noninvasive prenatal testing (nipt)
5092553|NCT03420274|Cell free fetal DNA (cfDNA)|cell free fetal dna (cfdna)
5092554|NCT03420274|Informed consent|informed consent
5092555|NCT03420261|Goal-directed therapy|goal-directed therapy
5092556|NCT03420261|Fluid loading|fluid loading
5092557|NCT03420261|Abdominal surgery|abdominal surgery
5092558|NCT03420261|Postoperative morbidity|postoperative morbidity
5092559|NCT03420261|Postoperative mortality|postoperative mortality
5092560|NCT03420261|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
4977202|NCT04134988|Older adults|older adults
5092561|NCT03420261|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
5092562|NCT03420261|General Anesthesia|general anesthesia
5092563|NCT03420261|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
5092564|NCT03420235|quality of life|quality of life
5092565|NCT03420235|eHealth|ehealth
5092566|NCT03420235|patient-reported outcomes|patient-reported outcomes
5092567|NCT03420235|home spirometry|home spirometry
5092568|NCT03420235|cost-effectiveness|cost-effectiveness
5092569|NCT03420235|home monitoring|home monitoring
5092570|NCT03420222|Intermittent Explosive Disorder|intermittent explosive disorder
5092571|NCT03420222|AVP-786|avp-786
5092576|NCT03420196|low back pain|low back pain
5092577|NCT03420196|physical therapy|physical therapy
5092578|NCT03420196|randomized clinical trial|randomized clinical trial
5092579|NCT03420196|exercise program|exercise program
5092580|NCT03420170|Spinal Cord Injuries|spinal cord injuries
5092581|NCT03420170|Physical Fitness|physical fitness
5092582|NCT03420170|Exercise Self-Efficacy|exercise self-efficacy
5092583|NCT03420170|Physical Activity|physical activity
5092584|NCT03420157|Cervical cancer screening|cervical cancer screening
5092585|NCT03420157|vaginal self-sampling|vaginal self-sampling
5092586|NCT03420157|Focus group|focus group
5092587|NCT03420157|communication|communication
5092588|NCT03420144|Growth hormone|growth hormone
5092589|NCT03420144|cirrhosis|cirrhosis
5092590|NCT03420131|instantaneous Flow Ratio|instantaneous flow ratio
5092597|NCT03420053|Plasmodium falciparum|plasmodium falciparum
5092598|NCT03420053|Sporozoites|sporozoites
5092599|NCT03420040|Glargine Insulin|glargine insulin
5092600|NCT03420040|QS-M Needle Free Injector|qs-m needle free injector
5092601|NCT03420027|predictive score|predictive score
5092602|NCT03420027|difficult intubation|difficult intubation
5092603|NCT03420001|VBAC, levator ani avulsion, quality of life|vbac, levator ani avulsion, quality of life
5092605|NCT03419949|pain|pain
5092606|NCT03419936|Stomach Neoplasms|stomach neoplasms
5092607|NCT03419936|Helicobacter pylori|helicobacter pylori
5092608|NCT03419936|Subtotal gastrectomy|subtotal gastrectomy
5092609|NCT03419897|Advanced liver cancer|advanced liver cancer
5092610|NCT03419897|RATIONALE-208|rationale-208
5092611|NCT03419871|economically stressed communities|economically stressed communities
5092612|NCT03419858|Pain|pain
5092613|NCT03419858|Slow-Breathing|slow-breathing
5092614|NCT03419858|Mindfulness|mindfulness
5092615|NCT03419858|Opioids|opioids
5092616|NCT03419858|Placebo|placebo
5092617|NCT03419832|ARIC|aric
5092618|NCT03419819|Phenylketonuria|phenylketonuria
5092620|NCT03419819|Sphere|sphere
5092621|NCT03419819|Child|child
5092622|NCT03419819|Adult|adult
5092623|NCT03419819|Phenylalanine|phenylalanine
5092625|NCT03419819|Glycomacropeptide|glycomacropeptide
5092626|NCT03419767|carotid stenosis|carotid stenosis
5092628|NCT03419767|insulin resistance|insulin resistance
5092629|NCT03419767|inflammation|inflammation
5092630|NCT03419767|carotid revascularization|carotid revascularization
5092631|NCT03419767|antioxidants|antioxidants
5092632|NCT03419741|Cancer, Nicotine Addiction, Smoking Cessation|cancer, nicotine addiction, smoking cessation
5092633|NCT03419728|Teen pregnancy prevention|teen pregnancy prevention
5092634|NCT03419728|Long-acting reversible contraception (LARCs)|long-acting reversible contraception (larcs)
5092635|NCT03419728|Healthy Families Healthy Futures|healthy families healthy futures
5092636|NCT03419728|Home visiting|home visiting
5092637|NCT03419715|migraine|migraine
5092638|NCT03419715|headache|headache
5092639|NCT03419715|bimatoprost|bimatoprost
5092640|NCT03419676|Pancreatoduodenectomy|pancreatoduodenectomy
5092641|NCT03419676|Postoperative pancreatic fistula|postoperative pancreatic fistula
5092643|NCT03419676|Hemopatch|hemopatch
5092645|NCT03419663|whole grain|whole grain
5092646|NCT03419663|refined grain|refined grain
5092647|NCT03419663|gastric cancer|gastric cancer
5092648|NCT03419663|meta analysis|meta analysis
5092649|NCT03419650|PsA|psa
5092650|NCT03419624|Dapagliflozin|dapagliflozin
5092651|NCT03419624|Exenatide|exenatide
5092652|NCT03419624|high-dose insulin therapy|high-dose insulin therapy
5092653|NCT03419624|SGLT-2 inhibitor|sglt-2 inhibitor
5092654|NCT03419624|GLP-1 receptor agonist|glp-1 receptor agonist
5092655|NCT03419611|Communication Intervention|communication intervention
5092656|NCT03419598|virtual clinical trial|virtual clinical trial
5092657|NCT03419598|high tibial osteotomy|high tibial osteotomy
5092658|NCT03419598|3D|3d
5092659|NCT03419598|computer simulation|computer simulation
5092660|NCT03419598|finite element analysis|finite element analysis
5092661|NCT03419598|medial unicompartmental knee osteoarthritis|medial unicompartmental knee osteoarthritis
5092662|NCT03419559|LN-145|ln-145
5092663|NCT03419559|Cell Therapy|cell therapy
5092664|NCT03419559|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
5092665|NCT03419559|Cellular Immuno-therapy|cellular immuno-therapy
5092666|NCT03419559|TIL|til
5092667|NCT03419559|IL-2|il-2
5092668|NCT03419559|Durvalumab|durvalumab
5092669|NCT03419520|Schoolchildren|schoolchildren
5092670|NCT03419520|Overweight|overweight
5092671|NCT03419520|Obesity|obesity
5092672|NCT03419520|Polymorphisms|polymorphisms
5092673|NCT03419520|Genetics|genetics
5092674|NCT03419520|Nutritional counseling|nutritional counseling
5092675|NCT03419520|Healthy strategies|healthy strategies
5092676|NCT03419507|endotracheal tube introducer|endotracheal tube introducer
5092677|NCT03419507|manikin|manikin
5092678|NCT03419507|chest compression|chest compression
5092679|NCT03419455|Obesity|obesity
5092680|NCT03419455|Lifelong Obesity|lifelong obesity
5092681|NCT03419455|Metabolic abnormalties|metabolic abnormalties
5092682|NCT03419455|Low-grade chronic inflammation|low-grade chronic inflammation
5092683|NCT03419455|Hyperinsulinemia|hyperinsulinemia
5092684|NCT03419455|IGF signalling|igf signalling
5092685|NCT03419455|Sex hormones|sex hormones
5092686|NCT03419455|Inflammatory response|inflammatory response
5092687|NCT03419455|Adipokines|adipokines
5092689|NCT03419442|Prostate cancer|prostate cancer
5092690|NCT03419442|Bone metastases|bone metastases
5092691|NCT03419442|Xofigo|xofigo
5092692|NCT03419429|Guided tissue membranes|guided tissue membranes
5092693|NCT03419429|EDTA|edta
5092694|NCT03419429|Simvastatin|simvastatin
5092695|NCT03419403|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5092696|NCT03419403|cancer|cancer
5092697|NCT03419403|chemoradiation therapy|chemoradiation therapy
5092698|NCT03419403|epidermal growth factor receptor-amplified glioblastoma|epidermal growth factor receptor-amplified glioblastoma
5092699|NCT03419403|radiation|radiation
5092700|NCT03419403|temozolomide|temozolomide
5092701|NCT03419390|Hydra01|hydra01
5092702|NCT03419377|Treatment|treatment
5092703|NCT03419377|Quality of Life|quality of life
5092704|NCT03419377|Sexology|sexology
5092705|NCT03419377|Women|women
5092706|NCT03419338|Maxillary Sinus|maxillary sinus
5092707|NCT03419338|Sinus lifting|sinus lifting
5092708|NCT03419338|Bone graft|bone graft
5092709|NCT03419325|percutaneous coronary interventions (PCI)|percutaneous coronary interventions (pci)
5092710|NCT03419325|secondary stroke prevention|secondary stroke prevention
5092711|NCT03419325|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
5092712|NCT03419312|Spinal Cord Stimulation|spinal cord stimulation
5092713|NCT03419312|Burst Spinal Cord Stimulation|burst spinal cord stimulation
5092714|NCT03419312|SCS|scs
5092715|NCT03419260|seizures|seizures
5092716|NCT03419260|status epilepticus|status epilepticus
5092717|NCT03419260|EEG monitoring|eeg monitoring
5092718|NCT03419221|Staphylococcus aureus|staphylococcus aureus
5092719|NCT03419221|bloodstream infection|bloodstream infection
5092720|NCT03419221|deep foci of infection|deep foci of infection
5092721|NCT03419221|18 FDG PET/CT|18 fdg pet/ct
5092722|NCT03419221|antibiotics|antibiotics
5092723|NCT03419208|Systemic Sclerosis|systemic sclerosis
5092724|NCT03419208|Scleroderma|scleroderma
5092725|NCT03419208|Hand Function|hand function
5092726|NCT03419208|Intervention|intervention
5092727|NCT03419208|Exercise|exercise
5092728|NCT03419208|Telerehabilitation|telerehabilitation
5092729|NCT03419208|eHealth|ehealth
5092730|NCT03419208|Physical Therapy|physical therapy
5092731|NCT03419195|Type 2 Diabetes|type 2 diabetes
5092732|NCT03419195|Overweight|overweight
5092733|NCT03419195|Exercise Training|exercise training
5961896|NCT04284280|Premature Human Milk|premature human milk
5092734|NCT03419195|Exercise Impairment|exercise impairment
5092735|NCT03419195|Healthy Control|healthy control
5092736|NCT03419195|Veteran|veteran
5092737|NCT03419195|Blood Flow|blood flow
5092738|NCT03419182|Geriatric|geriatric
5092739|NCT03419182|Acetabular|acetabular
5092740|NCT03419182|Arthroplasty|arthroplasty
5092741|NCT03419169|Patient|patient
5092742|NCT03419169|Rehabilitation|rehabilitation
5092743|NCT03419169|Ligament reconstruction|ligament reconstruction
5092744|NCT03419169|Surgery|surgery
5092745|NCT03419156|text message|text message
5092746|NCT03419156|telemedicine|telemedicine
5092747|NCT03419104|bariatric surgery|bariatric surgery
5092748|NCT03419104|extubation|extubation
5092749|NCT03419091|ureteroscopy|ureteroscopy
5092750|NCT03419091|lithovue|lithovue
5092751|NCT03419091|nephrolithiasis|nephrolithiasis
5092752|NCT03419091|single use ureteroscope|single use ureteroscope
5092753|NCT03419078|enteral nutrition|enteral nutrition
5092754|NCT03419078|parenteral nutrition|parenteral nutrition
5092755|NCT03419078|artificial nutrition support|artificial nutrition support
5092756|NCT03419078|non-relapse mortality|non-relapse mortality
5092757|NCT03419078|survival|survival
5092758|NCT03419039|Mild Cognitive Impairment|mild cognitive impairment
5092759|NCT03419000|GTCS|gtcs
5092760|NCT03419000|Epilepsies, Partial|epilepsies, partial
5092761|NCT03419000|Drug Resistant Epilepsy|drug resistant epilepsy
5092762|NCT03419000|Circulating MicroRNA|circulating microrna
5092763|NCT03419000|Diagnostic|diagnostic
5092764|NCT03418987|3D imaging|3d imaging
5092765|NCT03418987|vertebral vector|vertebral vector
5092766|NCT03418987|Scoliosis|scoliosis
5092767|NCT03418974|Dyslipidemia|dyslipidemia
5092768|NCT03418974|Cardiovascular Diseases|cardiovascular diseases
5092769|NCT03418974|Hypertension|hypertension
5092770|NCT03418974|LDL-C|ldl-c
5092771|NCT03418935|obstructive jaundice, non-malignant|obstructive jaundice, non-malignant
5092772|NCT03418935|mechanical jaundice, non-malignant|mechanical jaundice, non-malignant
5092773|NCT03418935|Methionine|methionine
5092774|NCT03418935|Succinic acid|succinic acid
5092775|NCT03418883|Stroke|stroke
5092776|NCT03418883|rehabilitation|rehabilitation
5092777|NCT03418883|mirror therapy|mirror therapy
5092778|NCT03418883|upper limb|upper limb
5092779|NCT03418870|Intensive Care Units, Neonatal|intensive care units, neonatal
5092780|NCT03418870|Parents|parents
5092781|NCT03418870|Mobile application|mobile application
5092782|NCT03418857|probiotics|probiotics
5092783|NCT03418857|Human|human
5092784|NCT03418857|obesity|obesity
5092785|NCT03418857|non-pharmacologic therapy|non-pharmacologic therapy
5092786|NCT03418857|gut health|gut health
5092787|NCT03418857|microbiome|microbiome
5092788|NCT03418857|inflammation|inflammation
5092789|NCT03418831|negtive symptoms|negtive symptoms
5092796|NCT03418805|Controlled-Release|controlled-release
5092797|NCT03418805|pain control|pain control
5092798|NCT03418805|Healthy Volunteers|healthy volunteers
5092799|NCT03418805|Food Effect|food effect
5092800|NCT03418779|IgA nephropathy|iga nephropathy
5092801|NCT03418779|immunosuppressive therapy|immunosuppressive therapy
5092802|NCT03418779|Yi-Qi-Qing-Jie herbal compound|yi-qi-qing-jie herbal compound
5092803|NCT03418779|high-risk IgAN|high-risk igan
5092804|NCT03418779|traditional chinese medicine|traditional chinese medicine
5092805|NCT03418766|Right-to-left Shunt|right-to-left shunt
5092806|NCT03418766|Brain White Matter Lesions|brain white matter lesions
5092807|NCT03418766|Migraine|migraine
5092808|NCT03418753|noninvasive diagnosis|noninvasive diagnosis
5092809|NCT03418740|Friedreich|friedreich
5092810|NCT03418740|Ataxia|ataxia
5092811|NCT03418740|FRDA|frda
5092813|NCT03418740|Friedrich Ataxia (FRDA)|friedrich ataxia (frda)
5092814|NCT03418701|Women's health|women's health
5092815|NCT03418662|Colonoscopy|colonoscopy
5092816|NCT03418649|low back pain|low back pain
5092817|NCT03418649|radicular pain|radicular pain
5092818|NCT03418649|degenerative disc disease|degenerative disc disease
5092819|NCT03418636|People who inject drugs|people who inject drugs
5092820|NCT03418636|Hepatitis C prevention|hepatitis c prevention
5092821|NCT03418636|Young adults|young adults
5092822|NCT03418636|Behavioral interventions|behavioral interventions
5092823|NCT03418623|Glutamate|glutamate
5092824|NCT03418623|Alcohol use|alcohol use
5092825|NCT03418623|GABA|gaba
5092826|NCT03418623|GET73|get73
5092827|NCT03418623|Non-treatment seeking|non-treatment seeking
5092828|NCT03418610|Rosacea|rosacea
5092829|NCT03418597|Virtual reality|virtual reality
5092830|NCT03418597|Radio-guided biopsy|radio-guided biopsy
5092831|NCT03418597|Pain|pain
5092832|NCT03418597|Anxiety|anxiety
5092833|NCT03418597|Patient's satisfaction|patient's satisfaction
5092834|NCT03418584|argon plasma coagulation|argon plasma coagulation
5092835|NCT03418584|submucosal injection|submucosal injection
5092836|NCT03418584|Barrett Esophagus|barrett esophagus
5092837|NCT03418558|HER2 AMPLIFICATION|her2 amplification
5092838|NCT03418532|DARPin®protein|darpin®protein
5092839|NCT03418532|MP0250|mp0250
5092840|NCT03418532|VEGF|vegf
5092841|NCT03418532|HGF|hgf
5092842|NCT03418532|NSCLC|nsclc
5092843|NCT03418532|EGFR mutated|egfr mutated
5092844|NCT03418532|Osimertinib|osimertinib
5092845|NCT03418506|Smokeless tobacco|smokeless tobacco
5092846|NCT03418506|adolescent|adolescent
5092847|NCT03418506|oral cancer|oral cancer
5092848|NCT03418506|betal quid|betal quid
5092849|NCT03418506|areca nut|areca nut
5092850|NCT03418467|Tachycardiomyopathy|tachycardiomyopathy
5092851|NCT03418467|atrial fibrillation|atrial fibrillation
5092852|NCT03418467|EMID (enrichment of mitochondria at the intercalated discs)|emid (enrichment of mitochondria at the intercalated discs)
5092853|NCT03418467|Biopsy|biopsy
5092854|NCT03418467|empathy|empathy
5092855|NCT03418441|Nationwide prospective observational cohort study|nationwide prospective observational cohort study
5092856|NCT03418441|Epidemiology|epidemiology
5092857|NCT03418441|Central Nervous System Infections|central nervous system infections
5092858|NCT03418441|Meningitis|meningitis
5092859|NCT03418441|Encephalitis|encephalitis
5092860|NCT03418441|Brain abscess|brain abscess
5092861|NCT03418441|Lyme disease|lyme disease
5092862|NCT03418441|Neuroborreliosis|neuroborreliosis
5092863|NCT03418441|Neurosyphilis|neurosyphilis
5092864|NCT03418441|Tertiary syphilis|tertiary syphilis
5092865|NCT03418363|Oral contraceptives|oral contraceptives
5092866|NCT03418363|Venous thromboembolism|venous thromboembolism
5092867|NCT03418363|androgenic combined oral contraception|androgenic combined oral contraception
5092868|NCT03418337|cough, dexlansoprazole, GERD, globus, non-cardiac chest pain|cough, dexlansoprazole, gerd, globus, non-cardiac chest pain
5092869|NCT03418324|Prostate Cancer|prostate cancer
5092870|NCT03418324|Metastatic Prostate Cancer|metastatic prostate cancer
5092871|NCT03418324|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5092872|NCT03418324|Metastatic Castration Resistant|metastatic castration resistant
5092873|NCT03418311|Twin pregnancy|twin pregnancy
5092874|NCT03418311|Cervical Pessary|cervical pessary
5092875|NCT03418311|short cervix|short cervix
5092876|NCT03418311|Prevention|prevention
5092878|NCT03418272|OR|or
5092879|NCT03418272|Pneumonia|pneumonia
5092880|NCT03418272|PICU|picu
5092881|NCT03418272|Pediatric|pediatric
5092882|NCT03418272|PCR|pcr
5092884|NCT03418246|plaque|plaque
5092885|NCT03418246|pocket depth|pocket depth
5092886|NCT03418220|Age related Macular Degeneration|age related macular degeneration
5092887|NCT03418220|Atrophy|atrophy
5092899|NCT03418181|Preserve Residual Kidney Function|preserve residual kidney function
5092900|NCT03418129|Military Veterans|military veterans
5092901|NCT03418051|Ankle Instability|ankle instability
5092902|NCT03418051|Manual Therapy|manual therapy
5092903|NCT03418051|Massage|massage
5092904|NCT03418051|Ankle Joint Mobilization|ankle joint mobilization
5092905|NCT03418051|Biomechanics|biomechanics
5092906|NCT03418051|Neuromuscular|neuromuscular
5092907|NCT03418012|Cervical Pessary|cervical pessary
5092908|NCT03418012|Short Cervix|short cervix
5092909|NCT03418012|Recurrent Preterm Birth|recurrent preterm birth
5092910|NCT03418012|history of cervical surgery|history of cervical surgery
5092911|NCT03418012|history of conisation|history of conisation
5092912|NCT03417999|Intranasal|intranasal
5092913|NCT03417999|Pharmacokinetic|pharmacokinetic
5092914|NCT03417999|Pediatric|pediatric
5092915|NCT03417986|Thiethylperazine|thiethylperazine
5092916|NCT03417986|Alzheimer Disease|alzheimer disease
5092917|NCT03417973|dorsal root ganglion|dorsal root ganglion
5092918|NCT03417960|post partum depression|post partum depression
5092919|NCT03417960|theta burst|theta burst
5092920|NCT03417960|transcranial magnetic stimulation|transcranial magnetic stimulation
5092921|NCT03417947|Bolus supplementation|bolus supplementation
5092922|NCT03417947|Pilot randomised controlled trial|pilot randomised controlled trial
5092923|NCT03417947|Vitamin D|vitamin d
5092924|NCT03417908|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
5092925|NCT03417908|Pulmonary Rehabilitation|pulmonary rehabilitation
5092926|NCT03417908|muscle activation|muscle activation
5092927|NCT03417908|COPD|copd
5092928|NCT03417882|PD-L1+|pd-l1+
5092932|NCT03417843|pancreatic premalignant and early malignant cystic lesion|pancreatic premalignant and early malignant cystic lesion
5092933|NCT03417830|miridesap|miridesap
5092934|NCT03417830|GSK2315698|gsk2315698
5092935|NCT03417830|89Zirconium labelled|89zirconium labelled
5092936|NCT03417830|Positron Emission Tomography|positron emission tomography
5092937|NCT03417830|Transthyretin cardiomyopathy|transthyretin cardiomyopathy
5092938|NCT03417830|GSK2398852|gsk2398852
5092939|NCT03417830|dezamizumab|dezamizumab
5092940|NCT03417791|recovery|recovery
5092941|NCT03417791|serum creatinine|serum creatinine
5092942|NCT03417765|gastrointestinal mucositis|gastrointestinal mucositis
5092943|NCT03417765|myeloablative chemotherapy|myeloablative chemotherapy
5094010|NCT03411148|prosthetic|prosthetic
5092963|NCT03417609|Sarcopenia|sarcopenia
5092964|NCT03417609|Tongue strength|tongue strength
5092965|NCT03417544|HER2-positive metastatic Breast Cancer|her2-positive metastatic breast cancer
5092966|NCT03417544|Central Nervous System Metastases|central nervous system metastases
5092967|NCT03417531|Protein supplementation|protein supplementation
5092968|NCT03417531|Home exercise program|home exercise program
4963243|NCT04219761|PCI|pci
5092969|NCT03417531|Falls prevention|falls prevention
5092971|NCT03417531|Autonomy|autonomy
4977662|NCT04132102|LSQC|lsqc
5092972|NCT03417518|Oxidative stress|oxidative stress
5092973|NCT03417518|Bariatric surgery|bariatric surgery
5092974|NCT03417505|Contact lens discomfort|contact lens discomfort
5092975|NCT03417505|Scleral lens|scleral lens
5092976|NCT03417505|Tangible Hydra-PEG|tangible hydra-peg
5092977|NCT03417492|TBI|tbi
5092978|NCT03417492|CVR|cvr
5092979|NCT03417492|Hypercapnia|hypercapnia
5092980|NCT03417492|fNIRS|fnirs
5092981|NCT03417492|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5092982|NCT03417492|American football|american football
5092983|NCT03417466|Diabetes Type I Type II|diabetes type i type ii
5092984|NCT03417453|normal patients|normal patients
5092985|NCT03417453|eye drops dispensers|eye drops dispensers
5092986|NCT03417453|aids|aids
5092987|NCT03417453|glacuoma|glacuoma
5092988|NCT03417453|cataract|cataract
5092989|NCT03417440|smartphone app, physical activity, older adults|smartphone app, physical activity, older adults
5092990|NCT03417427|acute myeloid leukemia|acute myeloid leukemia
5092991|NCT03417427|Intermediate-risk|intermediate-risk
5092992|NCT03417427|demethylation drug|demethylation drug
5093005|NCT03417349|Observational study|observational study
5093006|NCT03417310|closed reduction|closed reduction
5093007|NCT03417310|locked intramedullary nailing|locked intramedullary nailing
5093009|NCT03417258|isoflavones|isoflavones
5093010|NCT03417258|adenomatous polyps|adenomatous polyps
5093011|NCT03417258|microbiome|microbiome
5093028|NCT03417232|gingival recession|gingival recession
5093029|NCT03417232|coronally advanced flap|coronally advanced flap
5093030|NCT03417232|complete root coverage|complete root coverage
5093031|NCT03417232|flap elevation|flap elevation
5093032|NCT03417232|flap thickness|flap thickness
5093033|NCT03417219|Caregivers|caregivers
5093034|NCT03417219|Family|family
5093035|NCT03417219|Veterans|veterans
5093036|NCT03417219|Alzheimer Disease|alzheimer disease
5093037|NCT03417219|Memory|memory
5093038|NCT03417206|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
5093039|NCT03417206|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
5093040|NCT03417206|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
5093057|NCT03417167|synovial biopsy|synovial biopsy
5093058|NCT03417167|US guided synovial biopsy|us guided synovial biopsy
5093059|NCT03417154|AML|aml
5093060|NCT03417154|MDS|mds
5093061|NCT03417141|Valchor|valchor
5093062|NCT03417115|Breast Cancer|breast cancer
5093063|NCT03417115|Epidemiology|epidemiology
5093064|NCT03417115|Registry|registry
5093065|NCT03417115|Health Services Research|health services research
5093066|NCT03417115|Germany|germany
5093067|NCT03417115|Palliative Treatment|palliative treatment
5093086|NCT03417063|Intracranial artery|intracranial artery
5093087|NCT03417063|Atherosclerosis|atherosclerosis
5093088|NCT03417063|Intracranial artery stenosis|intracranial artery stenosis
5093089|NCT03417063|High-Resolution Magnetic Resonance|high-resolution magnetic resonance
5093090|NCT03417050|coronary artery bypass grafting|coronary artery bypass grafting
5093091|NCT03417050|percutaneous coronary intervention|percutaneous coronary intervention
5093092|NCT03417050|drug eluting stent|drug eluting stent
5093093|NCT03417050|survival status|survival status
5093094|NCT03417050|long-term follow-up|long-term follow-up
5103946|NCT03347643|response inhibition|response inhibition
5093095|NCT03417050|complex coronary artery disease|complex coronary artery disease
5093096|NCT03416998|Photherapy|photherapy
5093097|NCT03416998|Photobiomodulation|photobiomodulation
5093098|NCT03416998|Creatine Kinase|creatine kinase
5093099|NCT03416998|Soccer|soccer
5093100|NCT03416998|Muscle Recovery|muscle recovery
5093101|NCT03416946|Total knee replacement|total knee replacement
5093102|NCT03416933|ctDNA|ctdna
5093103|NCT03416933|MAPK inhibition|mapk inhibition
5093104|NCT03416933|BRAF(V600) mutated|braf(v600) mutated
5093105|NCT03416907|Informed consent|informed consent
5093106|NCT03416881|HIV infection|hiv infection
5093107|NCT03416881|antiretroviral|antiretroviral
5093108|NCT03416881|aging population|aging population
5093109|NCT03416881|drug interactions|drug interactions
5093110|NCT03416881|cross-sectional study|cross-sectional study
5093111|NCT03416881|SNIIRAM|sniiram
5093112|NCT03416868|Ambulatory|ambulatory
5093113|NCT03416868|Biofeedback|biofeedback
5093114|NCT03416868|Voice|voice
5093115|NCT03416842|outpatient|outpatient
5093116|NCT03416842|wearable sensors|wearable sensors
5093117|NCT03416842|home exercise|home exercise
5093118|NCT03416829|Ambulatory|ambulatory
5093119|NCT03416829|Biofeedback|biofeedback
5093120|NCT03416829|Voice|voice
5093121|NCT03416816|DSP-0337|dsp-0337
5093122|NCT03416790|Central Nervous System|central nervous system
5093123|NCT03416790|HIV Persistence|hiv persistence
5093124|NCT03416790|HIV Reservoirs|hiv reservoirs
5093125|NCT03416777|vegetarian|vegetarian
5961897|NCT04284280|Pasteurized Premature Human Milk|pasteurized premature human milk
5093126|NCT03416777|meat|meat
5093127|NCT03416777|fish|fish
5093128|NCT03416764|PTSD, neurofeedback (NF)|ptsd, neurofeedback (nf)
5093129|NCT03416712|Social Determinants of Health|social determinants of health
5093130|NCT03416699|Transnal Total Mesorectal Excision|transnal total mesorectal excision
5093131|NCT03416699|Rectal Cancer|rectal cancer
5093132|NCT03416686|differentiated thyroid cancer|differentiated thyroid cancer
5093133|NCT03416686|Radiofrequency|radiofrequency
5093134|NCT03416660|Fractional laser|fractional laser
5093135|NCT03416660|Postburn scar|postburn scar
5093136|NCT03416660|Density|density
5093137|NCT03416647|Superior Mesenteric Artery Syndrome|superior mesenteric artery syndrome
5093138|NCT03416647|Chronic duodenal obstruction|chronic duodenal obstruction
5093153|NCT03416595|Lactobacillus paracasei N1115|lactobacillus paracasei n1115
5093154|NCT03416595|young children|young children
5093155|NCT03416543|Rheumatoid arthritis|rheumatoid arthritis
5093156|NCT03416543|Dendritics cells|dendritics cells
5093157|NCT03416517|Ewing Sarcoma|ewing sarcoma
5093158|NCT03416517|Anlotinib|anlotinib
5093159|NCT03416517|Irinotecan|irinotecan
5093160|NCT03416517|Refractory|refractory
5093161|NCT03416517|Metastatic|metastatic
5093163|NCT03416491|Chronic hepatitis C|chronic hepatitis c
5093164|NCT03416491|Hepatitis C virus|hepatitis c virus
5093165|NCT03416491|KW-136|kw-136
5093166|NCT03416491|sofosbuvir|sofosbuvir
5093167|NCT03416491|nonstructural protein 5A|nonstructural protein 5a
5093168|NCT03416491|nonstructural protein 5B|nonstructural protein 5b
5093169|NCT03416491|panogentypic regimen|panogentypic regimen
5093170|NCT03416478|Colorectal Cancer|colorectal cancer
5093171|NCT03416478|ctDNA|ctdna
5093172|NCT03416478|Surveillance|surveillance
5093173|NCT03416465|hospitalization|hospitalization
5093174|NCT03416465|cancer|cancer
5093175|NCT03416465|general practitioner|general practitioner
5093176|NCT03416452|Gait|gait
5093177|NCT03416452|Parkinson's Disease|parkinson's disease
5093178|NCT03416426|patent foramen ovale|patent foramen ovale
5093179|NCT03416426|PFO closure|pfo closure
5093180|NCT03416426|residual shunt|residual shunt
5093181|NCT03416426|bubble contrast transesophageal echocardiography|bubble contrast transesophageal echocardiography
5093182|NCT03416400|Vitrification|vitrification
5093183|NCT03416400|In vitro maturation|in vitro maturation
5093184|NCT03416400|Cytoskeleton|cytoskeleton
5093185|NCT03416400|chromosomes|chromosomes
5093186|NCT03416400|High resolution imaging|high resolution imaging
5093187|NCT03416387|complex liver surgery|complex liver surgery
5093188|NCT03416387|3D printing|3d printing
5093189|NCT03416361|Left ventricular dysfunction|left ventricular dysfunction
5093190|NCT03416361|Vitamin D|vitamin d
5093191|NCT03416348|amputation|amputation
5093192|NCT03416348|amputations|amputations
5093193|NCT03416348|sweating|sweating
5093194|NCT03416348|residual limb|residual limb
5093195|NCT03416348|service members|service members
5093196|NCT03416348|civilians|civilians
5093197|NCT03416335|DSP-0509|dsp-0509
5093198|NCT03416335|Toll-Like Receptor 7 (TLR-7)|toll-like receptor 7 (tlr-7)
5093199|NCT03416335|BLRM (Bayesian Logistic Regression Model)|blrm (bayesian logistic regression model)
5093200|NCT03416322|Adenoma|adenoma
5093201|NCT03416322|Adenoma detection rate|adenoma detection rate
5093202|NCT03416322|Colorectal cancer|colorectal cancer
5093203|NCT03416309|pharmacokinetics|pharmacokinetics
5093204|NCT03416309|pharmacogenetics|pharmacogenetics
5093205|NCT03416309|Time To Positivity|time to positivity
5093206|NCT03416270|SGLT2 inhibtion|sglt2 inhibtion
5093207|NCT03416270|Ertugliflozin|ertugliflozin
5093208|NCT03416270|Type 2 Diabetes|type 2 diabetes
5093209|NCT03416270|Heart Failure|heart failure
5093210|NCT03416231|apatinib|apatinib
5093211|NCT03416231|Docetaxel|docetaxel
5093223|NCT03416127|Glycemic control|glycemic control
5093224|NCT03416127|Propolis|propolis
5093225|NCT03416127|Metformin|metformin
5093226|NCT03416114|rare headaches|rare headaches
5093227|NCT03416114|epidemiology|epidemiology
5093228|NCT03416101|esophageal cancer|esophageal cancer
5745044|NCT00339703|Asthma|asthma
5093229|NCT03416101|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5093230|NCT03416101|esophageal surgery|esophageal surgery
5093231|NCT03416088|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography|wine,coffee,reading,retinal microcirculation,optical coherence tomography angiography
5093232|NCT03416062|Jaundice, obstructive|jaundice, obstructive
5093233|NCT03416062|Methionine|methionine
5093234|NCT03416062|Succinic acid|succinic acid
5093235|NCT03416049|ulcers|ulcers
5093236|NCT03416049|leg ulcers|leg ulcers
5093237|NCT03416049|venous stasis|venous stasis
5093238|NCT03416049|ulcer treatment|ulcer treatment
5094109|NCT03410745|cytokines|cytokines
5093243|NCT03416049|pulsed electromagnetic therapy|pulsed electromagnetic therapy
5093244|NCT03416049|pulsed electromagnetic treatment|pulsed electromagnetic treatment
5093245|NCT03416049|pulsed magnetic|pulsed magnetic
5093246|NCT03416049|pulsed magnetic therapy|pulsed magnetic therapy
5093247|NCT03416049|pulsed magnetic treatment|pulsed magnetic treatment
5093248|NCT03416049|varicose Ulcer|varicose ulcer
5093249|NCT03416049|ulcer pain|ulcer pain
5093251|NCT03416023|continence control|continence control
5093252|NCT03416023|titanium|titanium
5093253|NCT03416010|emotional distress pregnancy disparities minority depression|emotional distress pregnancy disparities minority depression
5093254|NCT03415984|Parkinson Disease|parkinson disease
5093255|NCT03415984|Age Related Macular Degeneration|age related macular degeneration
5093256|NCT03415984|L-DOPA|l-dopa
5093257|NCT03415958|prospective|prospective
5093258|NCT03415958|adolescent|adolescent
5093259|NCT03415958|displaced|displaced
5093260|NCT03415958|clavicle|clavicle
5093261|NCT03415958|fracture|fracture
5093262|NCT03415958|mid-shaft|mid-shaft
5093263|NCT03415906|angiotensin receptor blocker|angiotensin receptor blocker
5093264|NCT03415906|neprilysin inhibition|neprilysin inhibition
5093265|NCT03415906|sympathetic activity|sympathetic activity
5093266|NCT03415906|baroreflex|baroreflex
5093267|NCT03415906|microneurography|microneurography
5093268|NCT03415906|functional MRI|functional mri
5093269|NCT03415893|high-resolution manometry|high-resolution manometry
5093270|NCT03415893|esophageal atresia|esophageal atresia
5093271|NCT03415893|teenagers|teenagers
5093272|NCT03415880|Diabetes mellitus|diabetes mellitus
5093273|NCT03415880|Type2 Diabetes|type2 diabetes
5093274|NCT03415880|Sedentary Lifestyle|sedentary lifestyle
5093275|NCT03415880|Physical Activity|physical activity
5093276|NCT03415880|Pulse wave velocity|pulse wave velocity
5093277|NCT03415880|arterial stiffness|arterial stiffness
5093278|NCT03415880|aortic stiffness|aortic stiffness
5093279|NCT03415880|artery disease|artery disease
5093280|NCT03415880|light intensity physical activity|light intensity physical activity
5093281|NCT03415867|Graft-versus-host disease|graft-versus-host disease
5093282|NCT03415867|Bone marrow transplantation|bone marrow transplantation
5093283|NCT03415867|Hedgehog inhibitor|hedgehog inhibitor
5093285|NCT03415841|Cardiac Rehabilitation|cardiac rehabilitation
5093286|NCT03415841|Wearable Devices|wearable devices
5093287|NCT03415841|Smartphone-based Program|smartphone-based program
5093288|NCT03415815|Chinese, real-world evidences, T1-T3 esophageal cancer|chinese, real-world evidences, t1-t3 esophageal cancer
5093289|NCT03415802|Nab-Paclitaxel|nab-paclitaxel
5093291|NCT03415802|Advanced Pancreatic Cancer|advanced pancreatic cancer
5093292|NCT03415789|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
5093293|NCT03415789|Cardiac thrombosis|cardiac thrombosis
5093294|NCT03415789|Silent brain infarct|silent brain infarct
5093295|NCT03415789|Fluid dynamics|fluid dynamics
5093296|NCT03415789|Intracardiac blood flow|intracardiac blood flow
5093297|NCT03415789|Echocardiography|echocardiography
5093298|NCT03415776|Hemodialysis|hemodialysis
5093299|NCT03415776|Sessions frequency|sessions frequency
5093300|NCT03415776|Mortality|mortality
5093301|NCT03415776|Morbidity|morbidity
5093302|NCT03415763|Rectal Neoplasms|rectal neoplasms
5093303|NCT03415763|Adjuvant Chemotherapy|adjuvant chemotherapy
5104151|NCT03346317|Estrogen|estrogen
5093307|NCT03415672|Interleukin-2|interleukin-2
5093308|NCT03415672|Hepatitis B Vaccines|hepatitis b vaccines
5093309|NCT03415672|Non-responders|non-responders
5093310|NCT03415672|Liver Diseases|liver diseases
5093311|NCT03415672|Digestive system|digestive system
5093312|NCT03415672|Vaccines|vaccines
5093319|NCT03415646|erector spinae plane block|erector spinae plane block
5093320|NCT03415646|breast surgery|breast surgery
5093321|NCT03415646|postoperative pain|postoperative pain
5093322|NCT03415633|Home Respiratory Polygraphy|home respiratory polygraphy
5093323|NCT03415633|Standard Polysomnography|standard polysomnography
5093324|NCT03415633|Validity|validity
5093325|NCT03415633|Cost-effectiveness|cost-effectiveness
5093326|NCT03415568|Postprandial lipid metabolism|postprandial lipid metabolism
5093327|NCT03415568|Medium-chain triglycerides|medium-chain triglycerides
5093328|NCT03415568|Diacylglycerols|diacylglycerols
5093329|NCT03415568|Serum triglycerides|serum triglycerides
5093330|NCT03415568|Chylomicron triglycerides|chylomicron triglycerides
5093331|NCT03415555|Erector Spinae Plane blockade|erector spinae plane blockade
5093332|NCT03415555|patient control anlagesia|patient control anlagesia
5094110|NCT03410745|collagen|collagen
5093340|NCT03415529|Outcome Research|outcome research
5093341|NCT03415529|Respiratory infection|respiratory infection
5093342|NCT03415529|Sepsis|sepsis
4977987|NCT04129463|SST|sst
5093343|NCT03415529|Organ failure|organ failure
5093344|NCT03415529|Hypercapnia|hypercapnia
5093345|NCT03415503|anthocyanins|anthocyanins
5093346|NCT03415503|dyslipidemias|dyslipidemias
5093347|NCT03415503|dose response|dose response
5093348|NCT03415490|general anesthesia|general anesthesia
5093349|NCT03415490|self-adherent wrap|self-adherent wrap
5093350|NCT03415490|pressure|pressure
5093351|NCT03415477|aneurysmal bone cyst, denosumab, surgical treatment, complication|aneurysmal bone cyst, denosumab, surgical treatment, complication
5093352|NCT03415451|cancer patients, Nutritional status|cancer patients, nutritional status
5093353|NCT03415438|thoracolumbar fascia|thoracolumbar fascia
5093354|NCT03415438|subacromial impingement syndrome|subacromial impingement syndrome
5093355|NCT03415412|non-caries cervical lesion|non-caries cervical lesion
5093356|NCT03415412|universal adhesives|universal adhesives
5093357|NCT03415399|relapsed/refractory CD19+ Lymphomas, B-Cell|relapsed/refractory cd19+ lymphomas, b-cell
5093358|NCT03415360|cryoablation|cryoablation
5093359|NCT03415347|Pilonidal abscess|pilonidal abscess
5093360|NCT03415347|Pilonidal disease|pilonidal disease
5093361|NCT03415347|Pilonidal sinus|pilonidal sinus
4963509|NCT04217941|Randomized control trial|randomized control trial
4963510|NCT04217941|Health education|health education
4963511|NCT04217915|analgesia|analgesia
5093362|NCT03415334|Hepatitis C|hepatitis c
5093363|NCT03415334|social marketing|social marketing
5093364|NCT03415334|Communication for behavior development|communication for behavior development
5093366|NCT03415308|Implicit Bias|implicit bias
5093367|NCT03415308|Healthcare Equity|healthcare equity
5093368|NCT03415295|Trimethylamine-N-oxide; Gestational diabetes mellitus|trimethylamine-n-oxide; gestational diabetes mellitus
5093369|NCT03415269|acute|acute
5093370|NCT03415191|ketamine, post-thoracotomy pain, analgesia|ketamine, post-thoracotomy pain, analgesia
5093371|NCT03415152|Omacor|omacor
5093372|NCT03415152|Omega-3-acid ethyl esters|omega-3-acid ethyl esters
5093373|NCT03415152|patient adherence|patient adherence
5093374|NCT03415152|patient reported outcomes|patient reported outcomes
5093376|NCT03415126|NRAS mutant|nras mutant
5093377|NCT03415126|BRAF mutant|braf mutant
5093378|NCT03415126|HRAS mutant|hras mutant
5093379|NCT03415126|ERK 1/2 inhibitor|erk 1/2 inhibitor
5093380|NCT03415113|Medication reconciliation at discharge, potentially inappropriate medications, elderly.|medication reconciliation at discharge, potentially inappropriate medications, elderly.
5093383|NCT03415035|Venetoclax|venetoclax
5093384|NCT03415035|Venclyxto|venclyxto
5093385|NCT03415035|Cancer|cancer
5093386|NCT03415035|Chronic Lynmphocytic Leukemia (CLL)|chronic lynmphocytic leukemia (cll)
5093390|NCT03415009|IL28B gene|il28b gene
5093391|NCT03414996|Interval training|interval training
5093392|NCT03414996|Autonomic nervous system|autonomic nervous system
5093393|NCT03414996|Post-acute coronary syndrome|post-acute coronary syndrome
5093394|NCT03414957|Malay women, PCOS, Metabolic Syndrome, Rotterdam criteria|malay women, pcos, metabolic syndrome, rotterdam criteria
5093395|NCT03414944|Non-small cell lung cancer|non-small cell lung cancer
5093396|NCT03414944|Brain metastases|brain metastases
5093397|NCT03414944|SIB|sib
5093398|NCT03414944|hippocampus avoidance|hippocampus avoidance
5093399|NCT03414944|inner ear avoidance|inner ear avoidance
5093400|NCT03414918|Macrolides, KCNJ5 potassium channel, aldosteronism|macrolides, kcnj5 potassium channel, aldosteronism
5093401|NCT03414892|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5093402|NCT03414892|Glucokinase Activator|glucokinase activator
5093403|NCT03414866|Thoracic Aorta|thoracic aorta
5093404|NCT03414866|Dissection|dissection
5093405|NCT03414866|Aneurysm|aneurysm
5093406|NCT03414866|Frozen Elephant Trunk|frozen elephant trunk
5423203|NCT01616667|Operative Surgical Procedures|operative surgical procedures
5093409|NCT03414840|coronary computed tomography angiography|coronary computed tomography angiography
5093411|NCT03414840|coronary atherosclerosis|coronary atherosclerosis
5093412|NCT03414814|NSCLC|nsclc
5093413|NCT03414814|Osimertinib|osimertinib
5093414|NCT03414814|EGFR exon 20 insertion mutation|egfr exon 20 insertion mutation
5093415|NCT03414801|Environmental Exposure Unit|environmental exposure unit
5093416|NCT03414801|Cat Allergen|cat allergen
5093417|NCT03414801|Rhinitis|rhinitis
5093418|NCT03414801|Subject Validation|subject validation
5093419|NCT03414788|Positron Emission Tomography (PET), Ulcerative Colitis, Safety, PKPlasma|positron emission tomography (pet), ulcerative colitis, safety, pkplasma
5093420|NCT03414775|microbiome|microbiome
5095207|NCT03403764|Intention|intention
5093423|NCT03414775|critical illness|critical illness
5093424|NCT03414762|cesarean section|cesarean section
5093425|NCT03414762|negative-pressure wound therapy|negative-pressure wound therapy
5093426|NCT03414762|surgical wound dehiscence|surgical wound dehiscence
5093427|NCT03414762|hospital readmission|hospital readmission
5093428|NCT03414762|surgical site infection|surgical site infection
5093429|NCT03414749|Chiropractic|chiropractic
5093430|NCT03414749|postural sway|postural sway
5093431|NCT03414749|manipulation|manipulation
5093432|NCT03414710|uptake of voluntary medical male circumcision|uptake of voluntary medical male circumcision
4978128|NCT04128670|eccentric exercise|eccentric exercise
5093433|NCT03414697|umbilical cord-derived mesenchymal stem cells|umbilical cord-derived mesenchymal stem cells
5093434|NCT03414697|cerebral palsy|cerebral palsy
5093435|NCT03414684|Breast Cancer|breast cancer
5093436|NCT03414671|apnea|apnea
5093437|NCT03414658|Breast Cancer|breast cancer
5093438|NCT03414632|Heart Failure|heart failure
5093439|NCT03414632|Diastolic Heart Failure|diastolic heart failure
5093440|NCT03414632|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5093441|NCT03414632|Transthyretin Cardiac Amyloidosis|transthyretin cardiac amyloidosis
5093442|NCT03414632|Amyloidosis|amyloidosis
5093444|NCT03414619|GAD|gad
5093445|NCT03414619|MDD|mdd
5093446|NCT03414619|Rumination|rumination
5093447|NCT03414619|Obsession|obsession
5093448|NCT03414619|Worry|worry
5093449|NCT03414593|preemptive analgic effect|preemptive analgic effect
5093450|NCT03414593|popliteal sciatic nerve block|popliteal sciatic nerve block
5093451|NCT03414593|Bilateral Hallux Valgus|bilateral hallux valgus
5093452|NCT03414567|Follicular fluid|follicular fluid
5093453|NCT03414567|nicotine|nicotine
5093454|NCT03414567|cotinine|cotinine
5093455|NCT03414567|Benzo(a)pyrene|benzo(a)pyrene
5961898|NCT04284280|Human Milk Donor Fortifier|human milk donor fortifier
5961899|NCT04284280|Neurodevelopmental followup|neurodevelopmental followup
5961900|NCT04284267|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4963615|NCT04217187|Upper Extremity|upper extremity
5093456|NCT03414502|Methotrexate|methotrexate
5093457|NCT03414489|Clinical Trial, Phase II|clinical trial, phase ii
5093458|NCT03414489|Multicenter Trials|multicenter trials
5093459|NCT03414489|Clinical Study|clinical study
5093460|NCT03414489|Clinical Trials, Non-Randomized|clinical trials, non-randomized
5093461|NCT03414489|Oral capsule|oral capsule
5093462|NCT03414489|Single arm|single arm
5093463|NCT03414489|Anti-cancer|anti-cancer
5093464|NCT03414489|Anti-inflammatory|anti-inflammatory
5093465|NCT03414489|ABC294640|abc294640
5093466|NCT03414489|Expanded Access Program|expanded access program
5093467|NCT03414489|Compassionate Use|compassionate use
5093468|NCT03414489|Special Access Program|special access program
5093469|NCT03414489|Yeliva ®|yeliva ®
5093470|NCT03414489|opaganib|opaganib
5093471|NCT03414463|Brain Injury|brain injury
5093472|NCT03414450|Mnk kinase inhibitor, Mnk kinase|mnk kinase inhibitor, mnk kinase
5093473|NCT03414424|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5093474|NCT03414424|transcranial magnetic stimulation|transcranial magnetic stimulation
5093475|NCT03414411|HIV|hiv
5093476|NCT03414411|Alcohol Use|alcohol use
5093477|NCT03414411|Substance Use|substance use
5093478|NCT03414411|Bone Disease|bone disease
5093479|NCT03414411|Falls|falls
5093480|NCT03414411|Fractures|fractures
5093481|NCT03414372|MSM|msm
5093482|NCT03414372|HIV|hiv
5093484|NCT03414372|eHealth|ehealth
5093485|NCT03414372|virtual reality|virtual reality
5093486|NCT03414346|Cryotherapy|cryotherapy
5093487|NCT03414346|Skin temperature|skin temperature
5093488|NCT03414346|Physical therapy modalities|physical therapy modalities
5093489|NCT03414346|Physical therapy|physical therapy
5093490|NCT03414346|Thermography|thermography
5093491|NCT03414346|Pain measurement|pain measurement
5093492|NCT03414333|obesity|obesity
5093493|NCT03414333|cognitive dysfunction|cognitive dysfunction
5093494|NCT03414320|type 1 diabetes|type 1 diabetes
5093495|NCT03414320|insulin pump|insulin pump
5093496|NCT03414320|bolus calculator|bolus calculator
5093497|NCT03414320|continuous glucose monitoring|continuous glucose monitoring
5093498|NCT03414320|carbohydrate to insulin ratio|carbohydrate to insulin ratio
5104341|NCT03345043|VAL-339851|val-339851
5093499|NCT03414320|insulin sensitivity factor|insulin sensitivity factor
5093500|NCT03414281|quadratus lumborum block, thoracic paravertebral block, nephrectomy|quadratus lumborum block, thoracic paravertebral block, nephrectomy
5093503|NCT03414255|Chronic Achilles Tendonitis|chronic achilles tendonitis
5093504|NCT03414229|Epacadostat|epacadostat
5093505|NCT03414229|Pembrolizumab|pembrolizumab
5093506|NCT03414229|17-508|17-508
5093507|NCT03414203|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5093508|NCT03414203|Migraine Disorders|migraine disorders
5093509|NCT03414203|Cognitive Symptoms|cognitive symptoms
5093510|NCT03414190|Acute Coronary Syndrome|acute coronary syndrome
5093511|NCT03414190|Text Messaging|text messaging
5093512|NCT03414190|Risk Factors|risk factors
5093513|NCT03414177|Telemedicine|telemedicine
5093514|NCT03414177|Clinical follow up visits|clinical follow up visits
5093515|NCT03414138|Pain|pain
5093516|NCT03414138|Mindfulness|mindfulness
5093517|NCT03414138|Meditation|meditation
5093518|NCT03414138|fMRI|fmri
5093523|NCT03414125|Colorectal Neoplasms|colorectal neoplasms
4978249|NCT04127812|eating|eating
5093524|NCT03414125|Mass Screening|mass screening
5093525|NCT03414125|Health Services Research|health services research
5093526|NCT03414125|Comparative Effectiveness Research|comparative effectiveness research
5093527|NCT03414099|Pain|pain
5093528|NCT03414099|Kratom|kratom
5093529|NCT03414099|Ketum|ketum
5093530|NCT03414099|mitragynine|mitragynine
5093531|NCT03414086|PM|pm
5093532|NCT03414086|DM|dm
5093533|NCT03414073|dental floss|dental floss
5093534|NCT03414073|gingival embrasure|gingival embrasure
5745045|NCT00339703|CRP|crp
5093535|NCT03414073|oral hygiene|oral hygiene
5093536|NCT03414073|interdental brush|interdental brush
5093537|NCT03414060|obstetric fistula|obstetric fistula
5093538|NCT03414060|vesicovaginal fistula|vesicovaginal fistula
5093539|NCT03414060|menstrual cup|menstrual cup
5093540|NCT03414060|pad test|pad test
5093541|NCT03414060|non-surgical management|non-surgical management
5093542|NCT03414060|feasibility|feasibility
5093543|NCT03414060|acceptability|acceptability
5093544|NCT03414060|innovation|innovation
5093545|NCT03414060|coping|coping
5093546|NCT03414060|incontinence|incontinence
5093547|NCT03414047|DNA damage repair|dna damage repair
5093548|NCT03414047|replication stress|replication stress
5093549|NCT03414034|PLK1|plk1
5093550|NCT03414034|PLK Inhibitor|plk inhibitor
5093551|NCT03414034|Onvansertib|onvansertib
5093552|NCT03414021|Nuclear Medicine|nuclear medicine
5961901|NCT04284267|Emotion Regulation|emotion regulation
5093553|NCT03414021|SPECT-CT Scan|spect-ct scan
5093554|NCT03414021|gamma-camera with semiconductor|gamma-camera with semiconductor
5093556|NCT03413956|Chinese|chinese
5093557|NCT03413956|T1 non-small cell lung cancer|t1 non-small cell lung cancer
5093558|NCT03413956|Lymph metastases|lymph metastases
5093562|NCT03413917|genomic markers|genomic markers
5961902|NCT04284254|MPS IH|mps ih
5003607|NCT03973827|Stromal|stromal
5093563|NCT03413904|taTME|tatme
5093564|NCT03413891|Anticoagulants|anticoagulants
5093565|NCT03413891|Tranexamic Acid|tranexamic acid
5093566|NCT03413878|snow|snow
5093567|NCT03413878|avalanche|avalanche
5093568|NCT03413878|hypercapnia|hypercapnia
5093569|NCT03413878|work of breathing|work of breathing
5093570|NCT03413839|Scoliosis|scoliosis
5093571|NCT03413839|PSSE|psse
5093572|NCT03413826|weight loss|weight loss
5093573|NCT03413826|exercise|exercise
5093574|NCT03413826|reinforcement|reinforcement
5093575|NCT03413826|compensation|compensation
5093576|NCT03413813|Magmaris|magmaris
5093577|NCT03413800|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5093578|NCT03413800|lenalidomide|lenalidomide
5093579|NCT03413800|DLI|dli
5093580|NCT03413722|Kidney transplant|kidney transplant
5093581|NCT03413722|Cognitive function|cognitive function
5093582|NCT03413709|Parenting Time, Father Involvement|parenting time, father involvement
5093583|NCT03413696|HIV|hiv
5093584|NCT03413696|Health literacy|health literacy
5093585|NCT03413696|Hepatitis C|hepatitis c
5093595|NCT03413631|prenatal intervention|prenatal intervention
5093596|NCT03413631|ultrasound|ultrasound
5093597|NCT03413631|perinatal outcome|perinatal outcome
5093598|NCT03413631|fetal exposure|fetal exposure
5093599|NCT03413631|parenting|parenting
5093600|NCT03413631|parenthood|parenthood
5093601|NCT03413631|prenatal treatment|prenatal treatment
5093602|NCT03413618|deep vein thrombosis|deep vein thrombosis
5093603|NCT03413618|postthrombotic syndrome|postthrombotic syndrome
5093604|NCT03413618|anticoagulation|anticoagulation
5093605|NCT03413618|treatment|treatment
5093606|NCT03413618|prevention|prevention
5093607|NCT03413579|Cervix|cervix
5093608|NCT03413579|Oncology,|oncology,
5093609|NCT03413579|hR3,|hr3,
5093610|NCT03413579|Nimotuzumab,|nimotuzumab,
5093611|NCT03413579|Chemotherapy,|chemotherapy,
5093616|NCT03413579|Vinorelbine|vinorelbine
5093617|NCT03413579|Paclitaxel|paclitaxel
5093618|NCT03413579|Carboplatine|carboplatine
5093619|NCT03413579|Randomisation|randomisation
5093620|NCT03413579|Placebo|placebo
5093621|NCT03413579|cancer|cancer
5093622|NCT03413579|cimahope|cimahope
5093623|NCT03413566|Trends|trends
5093624|NCT03413566|Prevalence|prevalence
5093625|NCT03413566|Registries/statistics & numerical data|registries/statistics & numerical data
5093626|NCT03413566|Epidemiology|epidemiology
5093627|NCT03413553|immediate implant|immediate implant
5093628|NCT03413553|connective tissue graft|connective tissue graft
5093629|NCT03413553|platelet rich fibrin|platelet rich fibrin
5093630|NCT03413540|jumping|jumping
5093631|NCT03413540|bone health|bone health
5093632|NCT03413527|rTMS|rtms
5093633|NCT03413514|shared decision making|shared decision making
5093634|NCT03413514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5093635|NCT03413514|cycle|cycle
5093636|NCT03413514|MRI|mri
5093637|NCT03413514|clinical response|clinical response
5093638|NCT03413488|Shoulder impingement syndrome|shoulder impingement syndrome
5093639|NCT03413488|Kinesio tape|kinesio tape
5093640|NCT03413488|Round shoulder posture|round shoulder posture
5093641|NCT03413475|Edentulism|edentulism
5093642|NCT03413475|complete removable prosthesis|complete removable prosthesis
5093643|NCT03413475|quality of life|quality of life
5093644|NCT03413436|adjuvant chemotherapy|adjuvant chemotherapy
5093645|NCT03413436|multicenter retrospective study|multicenter retrospective study
5093646|NCT03413423|smoking|smoking
5093647|NCT03413423|depression|depression
5093648|NCT03413423|Behavioral Activation|behavioral activation
5093649|NCT03413423|Mood management|mood management
5093650|NCT03413423|Secondary Prevention|secondary prevention
5093651|NCT03413384|Parkinson's Disease|parkinson's disease
5093652|NCT03413384|Parkinson's Disease Dementia|parkinson's disease dementia
5093653|NCT03413371|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5093654|NCT03413371|General Anaesthesia (GA),|general anaesthesia (ga),
5093655|NCT03413371|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
5093656|NCT03413371|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5093657|NCT03413371|Peribulbar Block (PBB)|peribulbar block (pbb)
5093658|NCT03413371|bupivacaine|bupivacaine
5093659|NCT03413371|ropivacaine|ropivacaine
5093660|NCT03413371|lidocaine|lidocaine
5093661|NCT03413332|Chinese American Women|chinese american women
5093662|NCT03413332|Provider-patient Communication|provider-patient communication
5093663|NCT03413332|Survivorship Care|survivorship care
5093664|NCT03413306|aplastic anemia|aplastic anemia
5093665|NCT03413306|immunosupressive therapy|immunosupressive therapy
5093666|NCT03413306|ATG|atg
5093667|NCT03413306|eltrombopag|eltrombopag
5093668|NCT03413280|preemptive analgic effect|preemptive analgic effect
5093669|NCT03413280|Rectus Sheath Block|rectus sheath block
5093670|NCT03413280|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5093671|NCT03413267|micronutrient|micronutrient
5093672|NCT03413267|bioavailability|bioavailability
5093673|NCT03413267|bioaccessibility|bioaccessibility
5961903|NCT04284254|Hurler syndrome|hurler syndrome
5093674|NCT03413267|food structure|food structure
5093675|NCT03413267|food texture|food texture
5093676|NCT03413254|pT4 colon cancer|pt4 colon cancer
5093677|NCT03413254|Peritoneal metastases|peritoneal metastases
5093678|NCT03413254|Early detection|early detection
5091631|NCT03426046|MTA|mta
5093684|NCT03413202|large-artery atherosclerosis acute ischemic stroke|large-artery atherosclerosis acute ischemic stroke
5093685|NCT03413202|dynamic Cerebral Autoregulation(dCA)|dynamic cerebral autoregulation(dca)
5093686|NCT03413189|Exercise|exercise
5093687|NCT03413189|Dosage|dosage
5093688|NCT03413189|Function|function
5093689|NCT03413176|VEGFR|vegfr
5093690|NCT03413176|VEGF|vegf
5093691|NCT03413176|antiangiogenics|antiangiogenics
5093692|NCT03413176|angiogenesis|angiogenesis
5093693|NCT03413163|Ultrasound Guided Erector Spinae Plane Block|ultrasound guided erector spinae plane block
5093694|NCT03413163|postoperative pain|postoperative pain
5093695|NCT03413163|retropubic radical prostatectomy|retropubic radical prostatectomy
5093696|NCT03413137|Prostate cancer|prostate cancer
5093697|NCT03413137|transperineal mp-MRI-fusion/TRUS biopsies|transperineal mp-mri-fusion/trus biopsies
5093698|NCT03413137|mp-MRI fusion/TRUS transrectal biopsy|mp-mri fusion/trus transrectal biopsy
5093700|NCT03413111|double guidewire technique|double guidewire technique
5093701|NCT03413085|Myopia control|myopia control
5093702|NCT03413046|Regulatory T cell|regulatory t cell
5093703|NCT03413046|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5093704|NCT03413046|Minimal residual disease|minimal residual disease
5093708|NCT03413033|voice therapy|voice therapy
5093709|NCT03413020|Helicobacter pylori|helicobacter pylori
5093710|NCT03413020|Rescue therapy|rescue therapy
5093711|NCT03413020|Tailored therapy|tailored therapy
5093712|NCT03413020|Antimicrobial susceptibility testing|antimicrobial susceptibility testing
5093713|NCT03412942|Comfort|comfort
5093714|NCT03412942|Confidence|confidence
5093715|NCT03412942|Usage outcomes|usage outcomes
5093716|NCT03412916|Chronic Pain|chronic pain
5093717|NCT03412916|Physical Activity|physical activity
5093718|NCT03412916|Mind-body|mind-body
5095311|NCT03403036|Psoriasis|psoriasis
5093725|NCT03412903|Medication reconciliation|medication reconciliation
5093726|NCT03412903|Adherence|adherence
5093727|NCT03412903|Medication therapy management|medication therapy management
5093728|NCT03412903|Pharmaceutical consultation|pharmaceutical consultation
5093729|NCT03412903|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5093730|NCT03412903|Drug interactions|drug interactions
5093731|NCT03412903|Pharmaceutical Council|pharmaceutical council
5093732|NCT03412903|Drug regime acceptance|drug regime acceptance
5093733|NCT03412903|Patient Care Team|patient care team
5093734|NCT03412903|Hospital Pharmacy Service|hospital pharmacy service
5093735|NCT03412903|Polypharmacy|polypharmacy
5093736|NCT03412903|Hospitalization|hospitalization
5093737|NCT03412903|Pharmaceutical Services|pharmaceutical services
5093738|NCT03412877|Gene Therapy|gene therapy
5093739|NCT03412877|Immunotherapy|immunotherapy
5093740|NCT03412877|Cell Therapy|cell therapy
5093741|NCT03412877|Adoptive Cell Therapy|adoptive cell therapy
5093742|NCT03412864|chondrocyte cells|chondrocyte cells
4978467|NCT04126564|Burnout|burnout
5093743|NCT03412864|osteoarthritis|osteoarthritis
5093744|NCT03412864|gene therapy|gene therapy
5093748|NCT03412838|Bone block allograft|bone block allograft
5093749|NCT03412838|Bone density|bone density
5093750|NCT03412838|Graft resorption|graft resorption
5093751|NCT03412838|PRP|prp
5093752|NCT03412838|RCT|rct
5093753|NCT03412812|Brain Metastases|brain metastases
5093754|NCT03412812|Stereotactic Radiosurgery|stereotactic radiosurgery
5093755|NCT03412773|Advanced liver cancer|advanced liver cancer
5093756|NCT03412773|RATIONALE-301|rationale-301
5093757|NCT03412760|hydrops fetalis|hydrops fetalis
5093758|NCT03412760|birth defect|birth defect
5093759|NCT03412760|fetal anomaly|fetal anomaly
5093760|NCT03412760|whole exome sequencing|whole exome sequencing
5093761|NCT03412747|Bimekizumab|bimekizumab
5093762|NCT03412747|PSO|pso
5093763|NCT03412747|Psoriasis|psoriasis
5093764|NCT03412721|laser analgesia|laser analgesia
5093765|NCT03412721|pediatric dentistry|pediatric dentistry
5093766|NCT03412695|Disease-related malnutrition|disease-related malnutrition
5093767|NCT03412695|eHealth|ehealth
5093768|NCT03412695|Decision support system|decision support system
5093769|NCT03412695|Clinical nutrition|clinical nutrition
5093770|NCT03412682|Ulcerative colitis|ulcerative colitis
5093771|NCT03412682|FE999315|fe999315
5093772|NCT03412682|Mesalazine|mesalazine
5093773|NCT03412682|Colitis|colitis
5093774|NCT03412682|Colitis, Ulcerative|colitis, ulcerative
5093775|NCT03412669|Addiction affected family members|addiction affected family members
5093776|NCT03412669|Counselling|counselling
5093777|NCT03412669|Psychosocial intervention|psychosocial intervention
5093778|NCT03412669|Low and Middle Income Countries|low and middle income countries
5093779|NCT03412669|India|india
5093780|NCT03412669|Pilot Randomised Controlled Trial|pilot randomised controlled trial
5093786|NCT03412617|Healthy Eating|healthy eating
5093787|NCT03412617|Blood glucose|blood glucose
5093788|NCT03412617|Bifidobacterium|bifidobacterium
5093789|NCT03412617|Obese women|obese women
5093790|NCT03412604|Alzheimer Disease|alzheimer disease
5093791|NCT03412539|resistant pain|resistant pain
5093792|NCT03412513|Overactive Bladder|overactive bladder
5093793|NCT03412513|Parkinson Disease|parkinson disease
5093794|NCT03412500|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5093795|NCT03412500|Vancomycin|vancomycin
5093796|NCT03412474|suprazygomatic block, dexmedetomidine|suprazygomatic block, dexmedetomidine
5093797|NCT03412461|Transition-aged youth|transition-aged youth
5093798|NCT03412461|Mental Health|mental health
5093799|NCT03412461|Accessibility|accessibility
5093800|NCT03412448|chronic pain|chronic pain
5093801|NCT03412448|cardiac surgery|cardiac surgery
5093802|NCT03412448|opioids|opioids
5093803|NCT03412435|Acute myocardial infarction|acute myocardial infarction
5093804|NCT03412435|Myocardial infarction|myocardial infarction
5093805|NCT03412422|Passive Leg Raise|passive leg raise
5093806|NCT03412422|Fluid Challenge|fluid challenge
5093807|NCT03412422|Common carotid artery|common carotid artery
5093808|NCT03412409|RIC regimen|ric regimen
5093809|NCT03412409|comorbidity|comorbidity
5093810|NCT03412409|elderly|elderly
5093811|NCT03412409|haploidentical|haploidentical
5093812|NCT03412409|transplant-related mortality|transplant-related mortality
5093818|NCT03412305|Dental implants, antibiotic prophylaxis|dental implants, antibiotic prophylaxis
5093819|NCT03412279|Chronic Low Back Pain|chronic low back pain
5093820|NCT03412279|Oswestry Disability Index|oswestry disability index
5093821|NCT03412279|Numeric Pain Rating Scale|numeric pain rating scale
5093822|NCT03412279|Roland Morris Disability Questionnaire|roland morris disability questionnaire
5093823|NCT03412279|SF-12 Health Survey|sf-12 health survey
5093824|NCT03412279|Fear-Avoidance Beliefs Questionnaire|fear-avoidance beliefs questionnaire
5093825|NCT03412279|Pain Catastrophizing Scale|pain catastrophizing scale
5093826|NCT03412279|Global Rating of Change Scale|global rating of change scale
5093827|NCT03412279|Back Beliefs Questionnaire|back beliefs questionnaire
5093828|NCT03412266|RIC regimen; MDS; haplo-HSCT; survival|ric regimen; mds; haplo-hsct; survival
5093829|NCT03412253|metabolic surgery, BMI 25-30 kg/m2, SAGB, T2DM remission.|metabolic surgery, bmi 25-30 kg/m2, sagb, t2dm remission.
5093830|NCT03412227|Anxiety|anxiety
5093831|NCT03412227|Depression|depression
5093832|NCT03412227|Children|children
5093833|NCT03412227|Adolescents|adolescents
5093835|NCT03412201|Disease management|disease management
5093836|NCT03412201|Medication therapy management|medication therapy management
5093837|NCT03412201|Biomarkers|biomarkers
5093838|NCT03412188|Chronic ITP|chronic itp
5093839|NCT03412188|persistent ITP|persistent itp
5093840|NCT03412188|Eltrombopag|eltrombopag
5093841|NCT03412188|GPVI receptor|gpvi receptor
5093842|NCT03412162|Discrimination|discrimination
5093843|NCT03412162|Cortisol|cortisol
5093844|NCT03412162|Sleep|sleep
5093845|NCT03412162|Identity|identity
5093846|NCT03412149|Malabsorption, Mini Gastric Bypass, Roux en Y Gastric Bypass|malabsorption, mini gastric bypass, roux en y gastric bypass
5093847|NCT03412136|Testosterone|testosterone
5093848|NCT03412136|Food Intake|food intake
5093849|NCT03412136|Appetite|appetite
5093850|NCT03412110|chiropractic|chiropractic
5093852|NCT03412110|Active surveillance reporting system|active surveillance reporting system
5093853|NCT03412097|chiropractic|chiropractic
5093854|NCT03412097|SMT|smt
5093855|NCT03412097|active surveillance reporting system|active surveillance reporting system
5093856|NCT03412084|Sedentary Lifestyle|sedentary lifestyle
5093857|NCT03412084|physical function|physical function
5093858|NCT03412058|PD-1|pd-1
5093859|NCT03412058|PD-L1|pd-l1
5093860|NCT03412019|Music|music
5093861|NCT03412019|Patient Satisfaction|patient satisfaction
5093862|NCT03412006|type II diabetes|type ii diabetes
5093863|NCT03412006|diabetic kidney disease|diabetic kidney disease
5093864|NCT03411980|Pharmacokinetics|pharmacokinetics
5093865|NCT03411954|hippocampus avoidance|hippocampus avoidance
5093866|NCT03411954|cognitive changes|cognitive changes
5093867|NCT03411954|intensity modulated radiotherapy|intensity modulated radiotherapy
5093868|NCT03411941|nAMD: neovascular Age-related Macular Degeneration|namd: neovascular age-related macular degeneration
5093869|NCT03411915|NET|net
5093870|NCT03411915|GIST|gist
5093871|NCT03411915|DUET-1|duet-1
5093872|NCT03411902|Bone Health|bone health
5093873|NCT03411876|IPF|ipf
5093874|NCT03411876|Oxymizer|oxymizer
5093875|NCT03411876|oxygen conserving device|oxygen conserving device
5093876|NCT03411876|pulmonary disease|pulmonary disease
5093877|NCT03411863|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5093878|NCT03411863|transcranial magnetic stimulation|transcranial magnetic stimulation
5093879|NCT03411837|Atopic Dermatitis, dupilumab|atopic dermatitis, dupilumab
5093880|NCT03411824|diagnosis|diagnosis
5093881|NCT03411824|Point-of-Care-Ultrasound|point-of-care-ultrasound
5093882|NCT03411824|lung ultrasound|lung ultrasound
5093883|NCT03411811|tendinopathy|tendinopathy
5093884|NCT03411811|wrist|wrist
5093885|NCT03411811|chronic pain|chronic pain
5093886|NCT03411811|sprain|sprain
5093891|NCT03411759|CYP2D6|cyp2d6
5093892|NCT03411759|Chronic pain|chronic pain
5093893|NCT03411759|Cytochrome P450|cytochrome p450
5093894|NCT03411759|Opioids|opioids
5093895|NCT03411733|acne vlugaris|acne vlugaris
5093896|NCT03411733|prevalence|prevalence
5093897|NCT03411733|Helicobacter Pylori|helicobacter pylori
5093898|NCT03411707|Colorectal cancer screening|colorectal cancer screening
5093899|NCT03411707|Stool DNA test|stool dna test
5093900|NCT03411707|Blood mRNA test|blood mrna test
5093901|NCT03411694|Survey|survey
5093902|NCT03411694|Anesthesia|anesthesia
5093903|NCT03411694|Anesthesiologist|anesthesiologist
5093904|NCT03411694|Patient perspective|patient perspective
5093905|NCT03411668|undergraduate nursing students|undergraduate nursing students
5093906|NCT03411668|evidence based practice beliefs|evidence based practice beliefs
5093907|NCT03411668|evidence based practice knowledge|evidence based practice knowledge
5093908|NCT03411668|evidence based practice implementation|evidence based practice implementation
5093909|NCT03411668|Evidence based practice Education programme|evidence based practice education programme
5093910|NCT03411642|Stroke, echocardiography|stroke, echocardiography
5093911|NCT03411629|Necrotizing Pancreatitis|necrotizing pancreatitis
5093912|NCT03411629|Critically ill|critically ill
5093913|NCT03411629|Mortality|mortality
5093914|NCT03411616|Eating behavior|eating behavior
5093915|NCT03411616|Excessive weight|excessive weight
5093916|NCT03411616|Food craving|food craving
5093917|NCT03411616|Liver transplantation|liver transplantation
5093918|NCT03411616|Obesity|obesity
5093919|NCT03411616|Weight gain|weight gain
5093920|NCT03411603|nutrient profiling|nutrient profiling
5093921|NCT03411564|dating violence|dating violence
5093922|NCT03411564|health promotion|health promotion
5093923|NCT03411564|educational intervention|educational intervention
5093924|NCT03411564|health assets|health assets
5093925|NCT03411564|participation action research|participation action research
5093926|NCT03411551|Intravenous anesthesia|intravenous anesthesia
5093927|NCT03411551|Nerve Block|nerve block
5093928|NCT03411551|Regional anesthesia|regional anesthesia
5093929|NCT03411538|antibiotic-resistant infections|antibiotic-resistant infections
5093930|NCT03411538|risk factors|risk factors
5093931|NCT03411538|prospective surveillance|prospective surveillance
5093932|NCT03411512|congenital heart defects|congenital heart defects
5093933|NCT03411512|near-infrared spectroscopy|near-infrared spectroscopy
5093934|NCT03411512|newborn|newborn
5093935|NCT03411512|tissue oxygenation|tissue oxygenation
5093936|NCT03411499|Adult|adult
5093937|NCT03411499|Endocarditis/surgery|endocarditis/surgery
5093938|NCT03411499|Embolism/prevention & control|embolism/prevention & control
5093939|NCT03411499|Cardiovascular Diseases|cardiovascular diseases
5093940|NCT03411499|Costs and Cost Analysis|costs and cost analysis
5093941|NCT03411499|Quality of life|quality of life
5093942|NCT03411447|vasoactive drug|vasoactive drug
5093943|NCT03411447|mechanical ventilation|mechanical ventilation
4978702|NCT04125238|Functional MRI|functional mri
5093944|NCT03411447|early enteral nutrition|early enteral nutrition
5093945|NCT03411447|intensive care unit|intensive care unit
5093946|NCT03411447|early parenteral nutrition|early parenteral nutrition
5093947|NCT03411447|critical care medicine|critical care medicine
5093948|NCT03411447|nosocomial infection|nosocomial infection
5093949|NCT03411447|mortality|mortality
5093950|NCT03411447|shock|shock
5093951|NCT03411434|oculomotor performances|oculomotor performances
5093952|NCT03411434|neurocognition|neurocognition
5093953|NCT03411434|methylphenidate|methylphenidate
5093954|NCT03411408|Hypofractionated radiotherapy|hypofractionated radiotherapy
5093955|NCT03411408|image - guided helical tomotherapy|image - guided helical tomotherapy
5093956|NCT03411408|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5093957|NCT03411408|malignant glioma|malignant glioma
5093958|NCT03411408|high grade glioma|high grade glioma
5093959|NCT03411408|recurrent glioma|recurrent glioma
5093960|NCT03411395|Diabetes|diabetes
5093961|NCT03411395|Prediabetes|prediabetes
5093962|NCT03411395|Blood sugar regulation|blood sugar regulation
5093963|NCT03411369|Creatine, ribose, ischemic heart disease.|creatine, ribose, ischemic heart disease.
5093964|NCT03411343|Postoperative Shoulder Analgesia|postoperative shoulder analgesia
5093965|NCT03411343|Hemidiaphragmatic Paralysis|hemidiaphragmatic paralysis
5093966|NCT03411343|Alternative blocks|alternative blocks
5093967|NCT03411317|Aortic stenosis|aortic stenosis
5093968|NCT03411317|progression|progression
5093969|NCT03411317|Left ventricular remodeling|left ventricular remodeling
5093970|NCT03411304|Aortic valvular replacement|aortic valvular replacement
5093971|NCT03411304|Aortic stenosis|aortic stenosis
5093972|NCT03411304|Left ventricular remodeling|left ventricular remodeling
5093973|NCT03411304|biomarkers|biomarkers
5093974|NCT03411291|Alzheimer's, magnetic resonance imaging|alzheimer's, magnetic resonance imaging
5093975|NCT03411278|recovery|recovery
5093977|NCT03411278|soccer|soccer
5093978|NCT03411278|sports|sports
5093979|NCT03411278|training|training
5093980|NCT03411278|electrotherapy|electrotherapy
5093981|NCT03411278|physical therapy|physical therapy
5093982|NCT03411239|Airway pressure|airway pressure
5093983|NCT03411239|Oesophageal pressure|oesophageal pressure
5093984|NCT03411239|transpulmonary pressure|transpulmonary pressure
5093985|NCT03411239|laparoscopic surgery|laparoscopic surgery
5093986|NCT03411226|Inguinal Hernia|inguinal hernia
5093987|NCT03411226|TREPP|trepp
5093988|NCT03411226|Recurrence|recurrence
5093989|NCT03411200|Older|older
5093990|NCT03411200|Advanced Cancer|advanced cancer
5093991|NCT03411200|Exercise|exercise
5093992|NCT03411200|Resistance training|resistance training
5093993|NCT03411200|Counseling|counseling
5093994|NCT03411200|Mobilization|mobilization
5093995|NCT03411187|Endoscopy|endoscopy
5093996|NCT03411187|Thyroidectomy|thyroidectomy
5093997|NCT03411187|Thyroid Cancer|thyroid cancer
5093998|NCT03411174|breast cancer|breast cancer
5094008|NCT03411148|cognitive behavioral therapy|cognitive behavioral therapy
5094009|NCT03411148|physical therapy|physical therapy
5094012|NCT03411148|gait|gait
5094013|NCT03411122|Enzyme Inhibitors|enzyme inhibitors
5094014|NCT03411122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers
5094015|NCT03411109|intrathecal analgesia|intrathecal analgesia
5094016|NCT03411109|colorectal|colorectal
5094017|NCT03411109|enhanced recovery|enhanced recovery
5094018|NCT03411083|Rehabilitation|rehabilitation
5094019|NCT03411083|Recovery of function|recovery of function
5094020|NCT03411083|Outcome Assessment (Health Care)|outcome assessment (health care)
5094021|NCT03411083|Patient Reported outcome Measures|patient reported outcome measures
5094022|NCT03411083|Treatment Outcome|treatment outcome
5094023|NCT03411083|Pain, Postoperative|pain, postoperative
5094024|NCT03411083|Pain Management|pain management
5094025|NCT03411083|Orthopedic Surgery|orthopedic surgery
5094026|NCT03411057|Mindfulness|mindfulness
5094027|NCT03411057|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5094028|NCT03411057|Rheumatoid Arthritis|rheumatoid arthritis
5094029|NCT03411057|Anxiety|anxiety
5094030|NCT03411057|Depression|depression
5094031|NCT03411057|Psoriatic Arthritis|psoriatic arthritis
5094032|NCT03411057|scleroderma|scleroderma
5094033|NCT03411044|Total Hip Arthroplasty|total hip arthroplasty
5094034|NCT03411044|Fitmore|fitmore
5094035|NCT03411044|Minimal Invasive Surgery|minimal invasive surgery
5094036|NCT03411044|Short Stem|short stem
5094037|NCT03411031|lenalidomide maintenance|lenalidomide maintenance
5094038|NCT03411031|hematopoietic cell transplantation|hematopoietic cell transplantation
5094039|NCT03411031|serologic relapse|serologic relapse
5094040|NCT03411018|lung protective strategies|lung protective strategies
4978815|NCT04124549|Dialysis Efficacy|dialysis efficacy
5094041|NCT03411018|Less invasive respiratory support|less invasive respiratory support
5094042|NCT03411018|preterm infant|preterm infant
5094043|NCT03411005|Lysine, Adult, Protein Quality|lysine, adult, protein quality
5094044|NCT03410992|Bimekizumab|bimekizumab
5094046|NCT03410992|Psoriasis|psoriasis
5094047|NCT03410940|Total Hip Arthroplasty|total hip arthroplasty
5094048|NCT03410940|CLS Brevius|cls brevius
5094049|NCT03410940|Kinectiv|kinectiv
5094050|NCT03410940|Medical Device|medical device
5094051|NCT03410940|Performance|performance
5094052|NCT03410940|Safety|safety
5094053|NCT03410940|Hip Prosthesis|hip prosthesis
5094054|NCT03410927|Phase I|phase i
5094055|NCT03410927|solid tumors|solid tumors
5094056|NCT03410927|pharmacokinetics|pharmacokinetics
5094057|NCT03410927|pharmacodynamics|pharmacodynamics
5094059|NCT03410927|TAS0728|tas0728
5094060|NCT03410927|HER2|her2
5094061|NCT03410927|HER3 mutation|her3 mutation
5094062|NCT03410927|amplification or overexpression|amplification or overexpression
5094063|NCT03410927|Urothelial cancer with HER2 or HER3 mutation|urothelial cancer with her2 or her3 mutation
5094064|NCT03410927|Biliary tract cancer with HER2 or HER3 mutation|biliary tract cancer with her2 or her3 mutation
5094065|NCT03410927|MBC with HER2 amplification or overexpression or HER3 mutation|mbc with her2 amplification or overexpression or her3 mutation
5094066|NCT03410927|NSCLC with HER2 or HER3 mutation|nsclc with her2 or her3 mutation
5094067|NCT03410927|CRC with HER2 or HER3 mutation|crc with her2 or her3 mutation
5094068|NCT03410927|amplification|amplification
5094069|NCT03410914|Hemopatch|hemopatch
5094070|NCT03410888|sciatic nerve block|sciatic nerve block
5094071|NCT03410888|infragluteal approach|infragluteal approach
5094072|NCT03410888|popliteal approach|popliteal approach
5094073|NCT03410875|Leukemia|leukemia
5094074|NCT03410875|Hairy Cell Leukemia|hairy cell leukemia
5094075|NCT03410875|BRAF|braf
5094076|NCT03410875|vemurafenib|vemurafenib
5094077|NCT03410875|obinutuzumab|obinutuzumab
5094078|NCT03410875|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5094079|NCT03410875|17-513|17-513
5094080|NCT03410862|Elderberry|elderberry
5094081|NCT03410862|Influenza|influenza
5094082|NCT03410836|lidocaine|lidocaine
5094083|NCT03410836|colorectal cancer|colorectal cancer
5094084|NCT03410836|laparoscopy surgery|laparoscopy surgery
5094085|NCT03410836|anesthesia|anesthesia
5094130|NCT03410641|dietary intervention|dietary intervention
5094131|NCT03410641|weight loss|weight loss
5094132|NCT03410602|Nonsurgical periodontal therapy|nonsurgical periodontal therapy
5094133|NCT03410602|Orthodontic bands|orthodontic bands
5094134|NCT03410576|Matrix metalloproteinase|matrix metalloproteinase
5094135|NCT03410576|Carotid artery stenting|carotid artery stenting
5094136|NCT03410576|Carotid endarterectomy|carotid endarterectomy
5094137|NCT03410563|Pain|pain
5094138|NCT03410563|Auditory inputs|auditory inputs
5094139|NCT03410524|Bowel wall visualization|bowel wall visualization
5094140|NCT03410524|Intraluminal bubbles|intraluminal bubbles
5094141|NCT03410524|Intraluminal foam|intraluminal foam
5094142|NCT03410524|Simethicone|simethicone
5094144|NCT03410485|Bispectral index|bispectral index
5094145|NCT03410485|Intraoperative monitoring|intraoperative monitoring
5094146|NCT03410420|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5094148|NCT03410420|Ascending Aorta|ascending aorta
5094149|NCT03410420|Hypoxyprobe|hypoxyprobe
5094150|NCT03410420|Pimonidazole|pimonidazole
5094151|NCT03410407|Acute Myeloid Leukemia|acute myeloid leukemia
5094152|NCT03410407|Central Nervous System|central nervous system
5094153|NCT03410407|Relapse|relapse
5094154|NCT03410407|Prognostic factors|prognostic factors
5094155|NCT03410394|adrenal|adrenal
5094156|NCT03410394|thyroid|thyroid
5094157|NCT03410394|parathyroid|parathyroid
5094158|NCT03410394|endocrine pancreas|endocrine pancreas
5094159|NCT03410394|endocrine digestive tube|endocrine digestive tube
5094160|NCT03410381|Psychiatry|psychiatry
5094161|NCT03410381|Suicide|suicide
5094162|NCT03410381|Prediction|prediction
5094163|NCT03410381|Smartphone application|smartphone application
5094164|NCT03410381|Ecological Momentary Assessment|ecological momentary assessment
5094165|NCT03410368|maintenance therapy|maintenance therapy
5094166|NCT03410368|immunotherapy|immunotherapy
5094167|NCT03410368|adoptive cell transfer|adoptive cell transfer
5094168|NCT03410368|natural killer cell|natural killer cell
5094169|NCT03410316|Obesity|obesity
5094170|NCT03410316|Common diseases|common diseases
5094179|NCT03410160|predisposing factors|predisposing factors
5094180|NCT03410134|Permanent teeth|permanent teeth
5094181|NCT03410134|Vital pulp therapy|vital pulp therapy
5094183|NCT03410017|Functional Listening Index|functional listening index
5094184|NCT03409991|Psychiatric Rehabilitation|psychiatric rehabilitation
5094185|NCT03409991|Career Counseling|career counseling
5094192|NCT03409939|nutrition|nutrition
5094193|NCT03409939|phenylalanine|phenylalanine
5094194|NCT03409939|tyrosine|tyrosine
5094195|NCT03409939|stable isotope|stable isotope
5094196|NCT03409926|Heart Disease|heart disease
5094197|NCT03409926|Cardiovascular Disease|cardiovascular disease
5094199|NCT03409926|Fiber|fiber
5094200|NCT03409926|Microbiome|microbiome
5094201|NCT03409913|positron emissions tomography|positron emissions tomography
5094202|NCT03409913|diagnostic accuracy|diagnostic accuracy
5094203|NCT03409913|case-control|case-control
5094204|NCT03409900|Lumbar Plexus Block|lumbar plexus block
5094205|NCT03409900|Quadratus Lumborum Block|quadratus lumborum block
5094206|NCT03409900|Direct Anterior Approach|direct anterior approach
5094207|NCT03409900|Post-Operative|post-operative
5094208|NCT03409900|Pain Management|pain management
5094209|NCT03409887|root canal treatment, intraorifice barrier.|root canal treatment, intraorifice barrier.
5094210|NCT03409809|Implementation Support|implementation support
5094211|NCT03409809|Eating Disorder|eating disorder
5094219|NCT03409731|Bio-resolvable Scaffold (BRS)|bio-resolvable scaffold (brs)
5094220|NCT03409731|Real world|real world
5094221|NCT03409718|Total Shoulder Arthroplasty|total shoulder arthroplasty
5094222|NCT03409718|Medical Device|medical device
5094223|NCT03409718|Performance|performance
5094224|NCT03409718|Safety|safety
5094225|NCT03409718|Shoulder Prosthesis|shoulder prosthesis
5094226|NCT03409666|Total Hip Arthroplasty|total hip arthroplasty
5094227|NCT03409666|Medical Device|medical device
5094228|NCT03409666|Performance|performance
5094229|NCT03409666|Safety|safety
5094230|NCT03409666|Hip prosthesis|hip prosthesis
5094231|NCT03409666|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
5094232|NCT03409653|fatigue|fatigue
5094233|NCT03409653|pain|pain
5094234|NCT03409653|chronic pain|chronic pain
5094235|NCT03409653|Data registry|data registry
5094236|NCT03409653|ME/CFS|me/cfs
5094237|NCT03409653|CFS|cfs
5094238|NCT03409653|FM|fm
5094239|NCT03409653|Post-exertional malaise|post-exertional malaise
5094240|NCT03409653|Lyme|lyme
5094241|NCT03409627|retrograde coronary sinus infusion|retrograde coronary sinus infusion
5094242|NCT03409627|DNA|dna
5094243|NCT03409627|non-viral|non-viral
5094244|NCT03409627|triple effector plasmid|triple effector plasmid
5094245|NCT03409627|gene therapy|gene therapy
5094246|NCT03409627|regenerative medicine|regenerative medicine
5094254|NCT03409588|Chronic Thromboembolic Disease|chronic thromboembolic disease
5094255|NCT03409588|CTED|cted
5094256|NCT03409588|Treatment Post PEA surgery|treatment post pea surgery
5094257|NCT03409575|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5094258|NCT03409575|geriatric population|geriatric population
5094259|NCT03409575|physical function|physical function
5094260|NCT03409575|quadriceps|quadriceps
5094261|NCT03409575|fatigue|fatigue
5094262|NCT03409562|low back pain|low back pain
5094263|NCT03409562|pain neurophysiology education|pain neurophysiology education
5094264|NCT03409562|motor control|motor control
5094267|NCT03409510|vitamin D|vitamin d
5094268|NCT03409510|25(OH)D|25(oh)d
5094269|NCT03409510|skin pigmentation|skin pigmentation
5094270|NCT03409510|UVB|uvb
5094271|NCT03409510|pigment genes|pigment genes
5094272|NCT03409471|Urine|urine
5094273|NCT03409471|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
4964460|NCT04211506|Genetic|genetic
5094275|NCT03409471|HPV Testing|hpv testing
5094276|NCT03409471|Cervical Cancer Screening|cervical cancer screening
5094277|NCT03409471|ASCUS|ascus
5094278|NCT03409471|LSIL|lsil
5094279|NCT03409458|Advanced Solid Tumors|advanced solid tumors
5094280|NCT03409458|NSCLC|nsclc
5094281|NCT03409458|mUC|muc
5094282|NCT03409458|mBC|mbc
5094283|NCT03409458|CRPC|crpc
5094284|NCT03409458|SCCHN|scchn
5094291|NCT03409406|parent training|parent training
5094292|NCT03409406|communication intervention|communication intervention
5094293|NCT03409393|Human|human
5094294|NCT03409393|Denmark|denmark
5094295|NCT03409393|Adult|adult
5094296|NCT03409393|Adolescent|adolescent
5094297|NCT03409393|Young Adult|young adult
5094298|NCT03409393|Male|male
5094299|NCT03409393|Female|female
5094300|NCT03409393|Physical Activity|physical activity
5094301|NCT03409393|Maximum Oxygen Consumption|maximum oxygen consumption
5094302|NCT03409393|Resistance Training|resistance training
5094303|NCT03409393|High-Intensity Functional Training|high-intensity functional training
5094304|NCT03409393|Aerobic Exercise|aerobic exercise
5094305|NCT03409393|Motivation|motivation
5094306|NCT03409393|Feasibility|feasibility
5094307|NCT03409393|Relevance|relevance
5094308|NCT03409393|Health Behavior|health behavior
5094309|NCT03409380|growth hormone|growth hormone
5094310|NCT03409367|Prevention|prevention
5094311|NCT03409367|Emollient|emollient
5094312|NCT03409367|Pragmatic clinical trial|pragmatic clinical trial
5094313|NCT03409315|Centralized Therapeutic Drug Monitoring|centralized therapeutic drug monitoring
5094314|NCT03409315|Fluoroquinolones|fluoroquinolones
5094315|NCT03409302|ACT|act
5094325|NCT03409263|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5094326|NCT03409250|CNV due to Age Related Macular Degeneration|cnv due to age related macular degeneration
5094328|NCT03409185|Cataract surgery|cataract surgery
5094329|NCT03409185|Intraocular lens|intraocular lens
5094330|NCT03409185|Glistenings|glistenings
5094331|NCT03409172|High intensity interval training|high intensity interval training
5094332|NCT03409172|Inflammation|inflammation
5094333|NCT03409172|Obesity|obesity
5094334|NCT03409172|adipokines|adipokines
5094338|NCT03409120|Dystonia|dystonia
5094339|NCT03409120|Parkinson's Disease|parkinson's disease
5094346|NCT03409081|Expanded Access|expanded access
5094347|NCT03409081|FMS-like Tyrosine Kinase 3|fms-like tyrosine kinase 3
5094348|NCT03409081|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5094349|NCT03409081|gilteritinib|gilteritinib
5094350|NCT03409081|ASP2215|asp2215
5094351|NCT03409068|Carotid thromboendarterectomy|carotid thromboendarterectomy
5094352|NCT03409068|Carotidodynia|carotidodynia
5094353|NCT03409042|Caloric compensation|caloric compensation
5094354|NCT03409029|bladder|bladder
5094355|NCT03409029|radiotherapy|radiotherapy
5094356|NCT03409029|magnetic resonance imaging|magnetic resonance imaging
5094357|NCT03409016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
5094358|NCT03409016|Biomarkers|biomarkers
5094359|NCT03409016|Immune Related Adverse Event|immune related adverse event
5094361|NCT03408977|meal ingestion|meal ingestion
5094362|NCT03408977|meal tolerance|meal tolerance
5094363|NCT03408977|postprandial responses|postprandial responses
5094364|NCT03408977|hedonic sensations|hedonic sensations
5094365|NCT03408977|homeostatic sensations|homeostatic sensations
5094367|NCT03408899|Microbicides|microbicides
5094368|NCT03408886|fecal transplant|fecal transplant
5094369|NCT03408886|fecal microbiota transplant|fecal microbiota transplant
5094370|NCT03408886|microbiota transplant|microbiota transplant
5094371|NCT03408886|vancomycin|vancomycin
5094372|NCT03408886|moviprep|moviprep
5094373|NCT03408873|Antipsychotic Drugs|antipsychotic drugs
5094374|NCT03408873|Antipsychotics|antipsychotics
5094375|NCT03408873|Injectables|injectables
5094376|NCT03408873|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
5094377|NCT03408873|Bipolar Disorder|bipolar disorder
5094378|NCT03408873|Medication Adherence|medication adherence
5094380|NCT03408847|Ulcerative colitis|ulcerative colitis
5094381|NCT03408847|UC|uc
5094382|NCT03408847|Extra virgin olive oil|extra virgin olive oil
5094383|NCT03408847|Polyphenols|polyphenols
5094384|NCT03408834|NGAL|ngal
5094385|NCT03408834|PVI|pvi
5094386|NCT03408808|wrist|wrist
5094387|NCT03408808|ganglion|ganglion
5094388|NCT03408808|platelet rich plasma|platelet rich plasma
5094389|NCT03408808|aspiration|aspiration
5094390|NCT03408782|Surgical Site Infection|surgical site infection
5094391|NCT03408782|Surgical drains|surgical drains
5094392|NCT03408769|Cancer|cancer
5094393|NCT03408769|Sexuality|sexuality
5094394|NCT03408769|Quality of life|quality of life
5094395|NCT03408769|Intimacy|intimacy
5094396|NCT03408769|BISF-WBrief Index of Sexual Functioning for Women questionnaire|bisf-wbrief index of sexual functioning for women questionnaire
5094397|NCT03408769|Quality of life questionnaire (EORTC QLQ-BR23):|quality of life questionnaire (eortc qlq-br23):
5961904|NCT04284241|Pediatric urolithiasis|pediatric urolithiasis
5105230|NCT03339310|CCM Therapy|ccm therapy
5094421|NCT03408613|Glucose Metabolism|glucose metabolism
5094422|NCT03408600|Abdominal sepsis|abdominal sepsis
5094423|NCT03408600|Secondary peritonitis|secondary peritonitis
5094424|NCT03408600|Complicated intra-abdominal infections|complicated intra-abdominal infections
5094426|NCT03408587|CAVATAK|cavatak
5094427|NCT03408587|Coxsackievirus|coxsackievirus
5094428|NCT03408587|ocular|ocular
5094430|NCT03408587|ipilimumab|ipilimumab
5094431|NCT03408587|yervoy|yervoy
5094432|NCT03408587|oncolytic|oncolytic
5094433|NCT03408587|virus|virus
5094434|NCT03408587|checkpoint|checkpoint
5094435|NCT03408587|CTLA-4|ctla-4
5094436|NCT03408574|nicotinic system|nicotinic system
5094437|NCT03408574|cognitive aging|cognitive aging
5094438|NCT03408574|working memory|working memory
5094439|NCT03408574|fMRI|fmri
5094440|NCT03408548|Bifidobacterium animalis subsp. lactis|bifidobacterium animalis subsp. lactis
5094441|NCT03408548|Probiotic|probiotic
5094442|NCT03408548|Periodontitis treatment|periodontitis treatment
5094443|NCT03408548|Periodontitis|periodontitis
5094444|NCT03408535|eHealth|ehealth
5094445|NCT03408535|Online Rehabilitation|online rehabilitation
5094446|NCT03408535|Hearing Problems|hearing problems
5094447|NCT03408535|Adult|adult
5094448|NCT03408535|Hearing Aids|hearing aids
5094449|NCT03408496|Myofascial release|myofascial release
5094450|NCT03408496|Pain|pain
5094451|NCT03408496|Manual therapy|manual therapy
5094452|NCT03408496|Muscle stretching|muscle stretching
5094453|NCT03408496|Quality of life|quality of life
5094454|NCT03408483|Quadratus Lumborum Block|quadratus lumborum block
5094455|NCT03408470|Absolute Bioavailability|absolute bioavailability
5094456|NCT03408470|ADME|adme
5094457|NCT03408470|Healthy Normal Males|healthy normal males
5094458|NCT03408457|Surgical wound infection|surgical wound infection
5094459|NCT03408457|antibiotic concentration|antibiotic concentration
5094460|NCT03408457|blood level|blood level
5094461|NCT03408418|Platelet-rich fibrin|platelet-rich fibrin
5094462|NCT03408418|Tooth Extraction|tooth extraction
5094463|NCT03408418|Alveolar Bone Grafting|alveolar bone grafting
5094472|NCT03408366|Laparotomy|laparotomy
5094473|NCT03408366|Surgical Incisions|surgical incisions
5094474|NCT03408366|Wound Perfusion|wound perfusion
5094475|NCT03408366|17-650|17-650
5094476|NCT03408340|Anesthesiology|anesthesiology
5094477|NCT03408340|Pediatric surgery|pediatric surgery
5094478|NCT03408340|Anesthesia, Regional|anesthesia, regional
5094479|NCT03408340|Anesthesia, Cardiac Procedures|anesthesia, cardiac procedures
5094480|NCT03408340|Nerve Block|nerve block
5094481|NCT03408327|Schizophrenia|schizophrenia
5094482|NCT03408327|Physical Activity|physical activity
5094483|NCT03408327|Health Promotion|health promotion
5094484|NCT03408327|Wearable Technology|wearable technology
5094485|NCT03408327|Fitness Wristband|fitness wristband
5094486|NCT03408327|mobile health, mHealth|mobile health, mhealth
5094487|NCT03408314|Advanced Cancer|advanced cancer
5094488|NCT03408275|Dietary patterns|dietary patterns
5094489|NCT03408275|Pregnancy|pregnancy
5094490|NCT03408275|Woman|woman
5094491|NCT03408275|Diet|diet
5094492|NCT03408275|Lead|lead
5094493|NCT03408275|ALSPAC|alspac
5094494|NCT03408249|Crohn's disease, ulcerative colitis, fecal calprotectin|crohn's disease, ulcerative colitis, fecal calprotectin
5094495|NCT03408197|inadvertent, intraoperative hypothermia, prewarming|inadvertent, intraoperative hypothermia, prewarming
5094496|NCT03408197|core temperature monitoring|core temperature monitoring
5745046|NCT00339703|Diabetes|diabetes
5094497|NCT03408171|liver biopsy|liver biopsy
5094498|NCT03408171|endoscopic ultrasound guided liver biopsy|endoscopic ultrasound guided liver biopsy
5094499|NCT03408171|FNA|fna
5094500|NCT03408171|FNB|fnb
5094501|NCT03408158|HPA|hpa
5094511|NCT03408119|men|men
5094512|NCT03408093|Interferon beta-1b (INFb-1b)|interferon beta-1b (infb-1b)
5094513|NCT03408093|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5094516|NCT03408093|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
5094517|NCT03408054|Uterine contraction|uterine contraction
5094518|NCT03408054|Oxytocin|oxytocin
5094519|NCT03408054|Nitroglycerin|nitroglycerin
5094525|NCT03408015|dry eye disease|dry eye disease
5094526|NCT03408015|neutrophil|neutrophil
5094527|NCT03408015|T cell|t cell
5094528|NCT03408015|lifitegrast|lifitegrast
5094529|NCT03408015|contact lens discomfort|contact lens discomfort
5094530|NCT03408015|ocular surface homeostasis|ocular surface homeostasis
5094531|NCT03408002|preoperative anxiety|preoperative anxiety
5094532|NCT03408002|self-efficacy|self-efficacy
5094533|NCT03408002|psychophysiology|psychophysiology
5094534|NCT03408002|psychotherapy|psychotherapy
5094535|NCT03408002|pancreatic surgery|pancreatic surgery
5094536|NCT03407950|Deficit Schizophrenia|deficit schizophrenia
5094537|NCT03407950|long stay inpatients|long stay inpatients
5094538|NCT03407950|cognitive remediation|cognitive remediation
5094539|NCT03407950|negative symptoms|negative symptoms
5094540|NCT03407937|Hypnosis|hypnosis
5094541|NCT03407937|Meditation|meditation
5094542|NCT03407937|Conditioned pain modulation|conditioned pain modulation
5094543|NCT03407937|Placebo|placebo
5094544|NCT03407937|Endocannabinoids|endocannabinoids
5094545|NCT03407937|Opioid peptides|opioid peptides
5094546|NCT03407937|Norepinephrine|norepinephrine
5094547|NCT03407937|Pain|pain
5094548|NCT03407937|Analgesia|analgesia
5094549|NCT03407937|Genes|genes
5094550|NCT03407937|Heart rate variability|heart rate variability
5094551|NCT03407911|Peri-implant pocket microbiota|peri-implant pocket microbiota
5094552|NCT03407911|Periodontal pocket microbiota|periodontal pocket microbiota
5094553|NCT03407859|CD19-CART|cd19-cart
5094554|NCT03407859|CD20-CART|cd20-cart
5094555|NCT03407859|CD10-CART|cd10-cart
5094556|NCT03407859|CD22-CART|cd22-cart
5094557|NCT03407859|Relapsed/Refractory B-ALL|relapsed/refractory b-all
5094558|NCT03407859|MRD|mrd
5094559|NCT03407807|Fetal Splenic cyst|fetal splenic cyst
5094560|NCT03407807|Differential Diagnosis|differential diagnosis
5094561|NCT03407807|Evolution and complication|evolution and complication
5094562|NCT03407768|Premenopausal breast cancer|premenopausal breast cancer
5094563|NCT03407768|Individualized interventions|individualized interventions
5094564|NCT03407768|Exercise|exercise
5094565|NCT03407768|Combination hormone therapy|combination hormone therapy
5094566|NCT03407768|Massage therapy|massage therapy
5094567|NCT03407768|Yoga|yoga
5094568|NCT03407768|Acupuncture|acupuncture
5094569|NCT03407768|Treatment tolerance|treatment tolerance
5094570|NCT03407768|Treatment adherence|treatment adherence
5094571|NCT03407768|Adverse effects|adverse effects
5094572|NCT03407768|Quality of life|quality of life
5094573|NCT03407755|Intraocular gas|intraocular gas
5094574|NCT03407755|Positioning|positioning
5094575|NCT03407755|DMEK|dmek
5094576|NCT03407755|Endothelial keratoplasty|endothelial keratoplasty
5094577|NCT03407729|Hypoxia, Brain|hypoxia, brain
5094578|NCT03407729|Neural networks|neural networks
5094579|NCT03407729|Magnetic Resonance Imaging|magnetic resonance imaging
5094580|NCT03407729|EEG|eeg
5094581|NCT03407703|genotype 1|genotype 1
5094582|NCT03407703|genotype 4|genotype 4
5094583|NCT03407638|Opioid Use Disorder|opioid use disorder
5094584|NCT03407638|Primary Care|primary care
5094585|NCT03407638|Buprenorphine|buprenorphine
5094586|NCT03407638|Naltrexone|naltrexone
5094587|NCT03407625|Pregnancy|pregnancy
5094588|NCT03407625|Labor Induction|labor induction
5094589|NCT03407625|Cervical Ripening|cervical ripening
5094590|NCT03407612|continuous passive motion device|continuous passive motion device
5094591|NCT03407612|HOS-ADL|hos-adl
5094592|NCT03407612|hip arthroscopy|hip arthroscopy
5094593|NCT03407586|point-of-care testing|point-of-care testing
5094594|NCT03407586|sexually transmitted infections|sexually transmitted infections
5094595|NCT03407586|expedited partner therapy|expedited partner therapy
5094596|NCT03407586|genital inflammation|genital inflammation
5094602|NCT03407547|somatosensory|somatosensory
5094603|NCT03407547|impairment|impairment
5094604|NCT03407547|electroencephalography|electroencephalography
5094605|NCT03407547|acute phase|acute phase
5094606|NCT03407534|Exocrine|exocrine
5094607|NCT03407534|Pancreatic Insufficiency|pancreatic insufficiency
5094608|NCT03407534|Diarrhea|diarrhea
5094609|NCT03407534|Bloating|bloating
5094610|NCT03407534|Loose Stool|loose stool
5094611|NCT03407521|second trimester abortion|second trimester abortion
5094618|NCT03407443|mental health promotion campaign|mental health promotion campaign
5094619|NCT03407443|veterans|veterans
5094620|NCT03407430|Pregabalin|pregabalin
5094621|NCT03407430|Bone pain|bone pain
5094622|NCT03407430|Pegfilgrastim|pegfilgrastim
5094623|NCT03407430|Supportive care|supportive care
5094624|NCT03407430|prevention|prevention
5094625|NCT03407391|Picky eater|picky eater
5094626|NCT03407391|Fussy eater|fussy eater
5094627|NCT03407391|Faddy eater|faddy eater
5094629|NCT03407352|Exercise|exercise
5094630|NCT03407352|Video Games|video games
5094631|NCT03407352|Physical Activity|physical activity
5094632|NCT03407352|Children|children
5094633|NCT03407352|Appetite|appetite
5094634|NCT03407326|severe acute malnutrition, SAM|severe acute malnutrition, sam
5094635|NCT03407313|Submental fullness|submental fullness
5094636|NCT03407313|Submental fat|submental fat
5094637|NCT03407313|Loose skin|loose skin
5094638|NCT03407300|Non-small Cell Lung Cancer (NSCLC), XH1|non-small cell lung cancer (nsclc), xh1
5094639|NCT03407222|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5094640|NCT03407222|Physical Activity|physical activity
5094641|NCT03407222|Personal health record|personal health record
5094642|NCT03407222|Intervention|intervention
5094643|NCT03407209|Epidural analgesia|epidural analgesia
5094770|NCT03406650|radical cystectomy|radical cystectomy
5094644|NCT03407209|Patient Controlled Epidural Analgesia (PCEA)|patient controlled epidural analgesia (pcea)
5094645|NCT03407209|Patient Epidural Intermittent Bolus (PEIB)|patient epidural intermittent bolus (peib)
5094646|NCT03407209|Local anesthetics|local anesthetics
5094647|NCT03407196|Diabetes|diabetes
5094648|NCT03407196|Dapagliflozin|dapagliflozin
5094655|NCT03407170|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
5094657|NCT03407170|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
5094658|NCT03407170|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
5094659|NCT03407170|PDL1|pdl1
5094660|NCT03407170|PDL2|pdl2
5094661|NCT03407157|Probiotics|probiotics
5094662|NCT03407157|Pregnancy|pregnancy
5094663|NCT03407157|GBS|gbs
5094664|NCT03407157|Group B Streptococcus|group b streptococcus
5094669|NCT03407131|Intertrochanteric fracture, Medical complications|intertrochanteric fracture, medical complications
5094675|NCT03407066|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5094676|NCT03407066|MEG|meg
5094677|NCT03407066|Color Vision|color vision
5094678|NCT03407066|Neuroimaging|neuroimaging
5094684|NCT03407040|Blood|blood
5094685|NCT03407040|Tissue|tissue
5094686|NCT03407040|Immunotherapy|immunotherapy
5094687|NCT03407040|Tumor|tumor
5094688|NCT03407040|Somatic|somatic
5094689|NCT03407027|Quadratus lumborum syndrome; ultrasound- guided infiltration|quadratus lumborum syndrome; ultrasound- guided infiltration
5094690|NCT03406988|Systemic Sclerosis|systemic sclerosis
4979384|NCT04121247|pain|pain
5094691|NCT03406988|Digital Ulcer|digital ulcer
5094692|NCT03406988|Autologous fat grafting|autologous fat grafting
5094693|NCT03406988|Adipose tissue stem cells|adipose tissue stem cells
5094694|NCT03406962|inherited metabolic disorders|inherited metabolic disorders
5094695|NCT03406962|cerebral adrenoleukodystrophy|cerebral adrenoleukodystrophy
5094696|NCT03406962|Hurler syndrome|hurler syndrome
5094697|NCT03406962|globoid cell leukodystrophy|globoid cell leukodystrophy
5094698|NCT03406962|Krabbe disease|krabbe disease
5094699|NCT03406962|metachromatic leukodystrophy|metachromatic leukodystrophy
5094700|NCT03406962|hematopoietic stem cells|hematopoietic stem cells
5094701|NCT03406962|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5094702|NCT03406962|umbilical cord blood|umbilical cord blood
5094703|NCT03406962|umbilical cord blood transplant|umbilical cord blood transplant
5094704|NCT03406962|MGTA-456|mgta-456
5094717|NCT03406910|Vegetarian cohort|vegetarian cohort
5094718|NCT03406910|Adventist|adventist
5094721|NCT03406871|Regorafenib|regorafenib
5094722|NCT03406871|Nivolumab|nivolumab
5094723|NCT03406871|Phase I clinical trial|phase i clinical trial
5094724|NCT03406832|Prevention|prevention
5094725|NCT03406832|Slow flow|slow flow
5094726|NCT03406832|No reflow|no reflow
5094727|NCT03406832|Nitroprusside|nitroprusside
5094728|NCT03406832|Tirofiban|tirofiban
5094729|NCT03406819|Prevention|prevention
5094730|NCT03406819|Slow flow|slow flow
5094731|NCT03406819|No reflow|no reflow
5094732|NCT03406819|Nitroprusside|nitroprusside
5094733|NCT03406819|Tirofiban|tirofiban
5094734|NCT03406793|Zinc|zinc
5094735|NCT03406793|Multiple micronutrient powders|multiple micronutrient powders
5094736|NCT03406793|Diarrhea|diarrhea
5094737|NCT03406793|Stunting|stunting
5094745|NCT03406728|Parkinson's Disease|parkinson's disease
5094746|NCT03406728|Virtual Reality|virtual reality
5094747|NCT03406728|Training|training
5094748|NCT03406728|Balance|balance
5094749|NCT03406728|Falls|falls
5094750|NCT03406728|PDSAFEX|pdsafex
5094751|NCT03406715|SCLC|sclc
5094752|NCT03406715|Lung Cancer|lung cancer
5094753|NCT03406715|Lung Disease|lung disease
5094754|NCT03406715|Relapsed SCLC|relapsed sclc
5094755|NCT03406702|Epilepsy, Idiopathic Generalized Epilepsy, Absence Seizures|epilepsy, idiopathic generalized epilepsy, absence seizures
5094756|NCT03406689|Pain|pain
5094757|NCT03406689|Intravitreal Injection|intravitreal injection
5094758|NCT03406689|Anti-VEGF|anti-vegf
5094759|NCT03406689|Nepafenac eye drops|nepafenac eye drops
5094760|NCT03406689|Short Form McGill Pain Questionnaire|short form mcgill pain questionnaire
5094761|NCT03406676|Methylene blue; Peripheral vascular resistance|methylene blue; peripheral vascular resistance
5094762|NCT03406663|Insulin|insulin
5094763|NCT03406650|muscle invasive urothelial cancer|muscle invasive urothelial cancer
5094764|NCT03406650|cancer|cancer
5094768|NCT03406650|adjuvant|adjuvant
5094769|NCT03406650|neoadjuvant|neoadjuvant
5094771|NCT03406650|bladder|bladder
5094772|NCT03406624|Modic changes|modic changes
5094773|NCT03406624|biomarkers|biomarkers
5094774|NCT03406624|low back pain|low back pain
5094775|NCT03406598|Shock|shock
5094776|NCT03406598|Microcirculation|microcirculation
5094777|NCT03406598|Nurses|nurses
5094778|NCT03406572|Acute on chronic respiratory failure|acute on chronic respiratory failure
5094779|NCT03406572|High-Flow heated and humidified nasal oxygen therapy|high-flow heated and humidified nasal oxygen therapy
5094780|NCT03406520|peritoneal dialysis|peritoneal dialysis
5094781|NCT03406520|chlorhexidine|chlorhexidine
5094782|NCT03406520|exit site infection|exit site infection
5094783|NCT03406520|tunnel tract infection|tunnel tract infection
5094784|NCT03406494|sepsis|sepsis
5094785|NCT03406494|critical illness|critical illness
5094786|NCT03406494|intensive care unit|intensive care unit
5094787|NCT03406494|mechanical ventilation|mechanical ventilation
5094788|NCT03406494|rehabilitation|rehabilitation
5094789|NCT03406494|mortality|mortality
5094790|NCT03406494|physical function|physical function
5094791|NCT03406494|health-related quality of life|health-related quality of life
5094792|NCT03406468|non small cell lung cancer|non small cell lung cancer
5094793|NCT03406468|immune therapy|immune therapy
5094794|NCT03406468|radiotherapy|radiotherapy
5094795|NCT03406455|wearable|wearable
5094796|NCT03406455|mhealth|mhealth
5094797|NCT03406429|rTMS|rtms
5094799|NCT03406390|contrast sensitivity|contrast sensitivity
5094800|NCT03406390|Pterygium|pterygium
5094801|NCT03406325|mast cell|mast cell
4964973|NCT04208516|quadratus lumborum block|quadratus lumborum block
4964974|NCT04208516|thoracic surgery|thoracic surgery
4964975|NCT04208516|abdominal surgery|abdominal surgery
4964978|NCT04208503|ultrasound|ultrasound
5094802|NCT03406325|allergy|allergy
5094803|NCT03406325|genomic|genomic
5094804|NCT03406325|biomarkers|biomarkers
5094805|NCT03406312|Roux en Y Gastric Bypass Surgery, Hypoglycemia, Postprandial|roux en y gastric bypass surgery, hypoglycemia, postprandial
5094806|NCT03406299|SLOG|slog
5094808|NCT03406208|Psychiatry|psychiatry
5094809|NCT03406208|Psychology|psychology
5094810|NCT03406208|Psychosocial|psychosocial
5094811|NCT03406208|Behavioral|behavioral
5094812|NCT03406195|transcranial magnetic stimulation|transcranial magnetic stimulation
5094818|NCT03406182|women|women
5094819|NCT03406182|body mass index|body mass index
5094820|NCT03406182|growth|growth
5094821|NCT03406169|penile rehabilitation|penile rehabilitation
5094822|NCT03406156|Cancer|cancer
5094823|NCT03406156|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5094824|NCT03406156|17p Deletion|17p deletion
5094825|NCT03406156|debulking|debulking
5094826|NCT03406156|obinutuzumab|obinutuzumab
5094827|NCT03406156|bendamustine|bendamustine
5094828|NCT03406156|tumor lysis syndrome|tumor lysis syndrome
5094829|NCT03406156|venetoclax|venetoclax
5094830|NCT03406156|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5094831|NCT03406104|Heredity Optic Atrophy|heredity optic atrophy
5094832|NCT03406104|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5094833|NCT03406104|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5094834|NCT03406104|LHON|lhon
5094835|NCT03406104|Eye Diseases|eye diseases
5094836|NCT03406104|Hereditary Eye Diseases|hereditary eye diseases
5094837|NCT03406104|Inborn Genetic Disease|inborn genetic disease
5094838|NCT03406104|Gene Therapy|gene therapy
5094839|NCT03406104|Intravitreal Injections|intravitreal injections
5094840|NCT03406104|Mitochondrial Disease|mitochondrial disease
5094841|NCT03406104|AAV2 Vectors|aav2 vectors
5094842|NCT03406104|Nervous System Diseases|nervous system diseases
5094843|NCT03406104|Neurodegenerative Disease|neurodegenerative disease
5094844|NCT03406104|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
5094845|NCT03406078|Asthma|asthma
5094846|NCT03406065|Sodium bicarbonate|sodium bicarbonate
5094847|NCT03406065|NaHCO3|nahco3
5094848|NCT03406065|Combat Sports|combat sports
5094849|NCT03406065|Physical capacity|physical capacity
5094850|NCT03406065|Dummy test|dummy test
5094851|NCT03406039|Alcohol Use Disorder|alcohol use disorder
5094852|NCT03406039|Emotional Disorder|emotional disorder
5094853|NCT03406039|Cognitive Behavioural Therapy|cognitive behavioural therapy
5094854|NCT03406039|Motivational Interviewing|motivational interviewing
5094855|NCT03406039|Online Intervention|online intervention
5094856|NCT03406039|Randomized Controlled Trial|randomized controlled trial
5094857|NCT03406026|Stroke|stroke
5094858|NCT03406026|Balance rehabilitation|balance rehabilitation
5094859|NCT03406026|Physiotherapy|physiotherapy
5094860|NCT03405974|Osteonecrosis|osteonecrosis
5094861|NCT03405974|Aspirin|aspirin
5094862|NCT03405961|PAR scoring|par scoring
5094863|NCT03405961|Digital study models|digital study models
5094864|NCT03405909|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5094865|NCT03405909|non-invasive diagnosis|non-invasive diagnosis
5094866|NCT03405909|focal liver lesion|focal liver lesion
5094867|NCT03405909|liver cirrhosis|liver cirrhosis
5094868|NCT03405909|standardised diagnostic algorithm|standardised diagnostic algorithm
5094869|NCT03405909|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
5094870|NCT03405909|ESCULAP|esculap
5094871|NCT03405909|CEUS LI-RADS|ceus li-rads
5094872|NCT03405909|imaging|imaging
5094873|NCT03405909|hepatocellular carcinoma|hepatocellular carcinoma
5094874|NCT03405909|MRI|mri
5094875|NCT03405909|diagnostic accuracy|diagnostic accuracy
5094876|NCT03405909|interobserver agreement|interobserver agreement
5094877|NCT03405909|Erlanger Synopsis of CEUS for Liver lesion Assessment in Patients at risk|erlanger synopsis of ceus for liver lesion assessment in patients at risk
5094878|NCT03405909|CEUS Liver Imaging Reporting and Data System|ceus liver imaging reporting and data system
5094882|NCT03405857|mild cognitive impairment|mild cognitive impairment
5094887|NCT03405831|Heart transplantation|heart transplantation
5094888|NCT03405831|Exercise capacity|exercise capacity
5094889|NCT03405831|Heart rate|heart rate
5094890|NCT03405831|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
5094891|NCT03405818|Fungal infection of the nail|fungal infection of the nail
5094892|NCT03405792|Tumor Treating Electric Fields (TTFields)|tumor treating electric fields (ttfields)
5094899|NCT03405688|Sickle cell|sickle cell
5094900|NCT03405688|Heterozygous|heterozygous
5094901|NCT03405688|Blood donor|blood donor
5094902|NCT03405675|Dementia|dementia
5094903|NCT03405675|Mild cognitive impairment|mild cognitive impairment
5094904|NCT03405675|Cognitive abilities and changes|cognitive abilities and changes
5961905|NCT04284241|Uyghur|uyghur
5961906|NCT04284241|Parents'Health-Education Handbook|parents'health-education handbook
5961907|NCT04284228|AML|aml
5961908|NCT04284228|MDS|mds
5961909|NCT04284228|HCT|hct
5961910|NCT04284189|Childhood Cancer Survivor|childhood cancer survivor
5094905|NCT03405675|Functional change and disabilities|functional change and disabilities
5094906|NCT03405675|Depression|depression
5094907|NCT03405675|Health and social services utilization|health and social services utilization
5094908|NCT03405675|Quality of life|quality of life
5094909|NCT03405675|Adverse drug effects|adverse drug effects
5094910|NCT03405675|Social network and support|social network and support
5094911|NCT03405675|Self-rated health|self-rated health
5094914|NCT03405675|Health risk behaviors|health risk behaviors
5094915|NCT03405675|Nutrition|nutrition
5094916|NCT03405675|Apo-E lipoprotein|apo-e lipoprotein
5094917|NCT03405675|Phytochemicals|phytochemicals
5094919|NCT03405675|Folate|folate
5094920|NCT03405675|Homocysteine|homocysteine
5094921|NCT03405675|Lifestyle|lifestyle
5094922|NCT03405675|Physical activity|physical activity
5094923|NCT03405675|Leisure activity|leisure activity
5094924|NCT03405675|Successful ageing|successful ageing
5094925|NCT03405675|Mortality|mortality
5094926|NCT03405649|postpartum|postpartum
5094927|NCT03405649|exercise|exercise
5094928|NCT03405649|intervention|intervention
5094929|NCT03405610|Psychiatry|psychiatry
5094930|NCT03405610|Psychology|psychology
5094931|NCT03405610|Psychosocial|psychosocial
5094932|NCT03405610|Mind-Body|mind-body
5094933|NCT03405584|Helicobacter pylori|helicobacter pylori
5094934|NCT03405584|Therapy|therapy
5094935|NCT03405506|Fractional Flow Reserve|fractional flow reserve
5094936|NCT03405506|Quantitative Coronary Angiography|quantitative coronary angiography
5094937|NCT03405506|Coronary artery disease|coronary artery disease
5094938|NCT03405506|Quantitative Flow Ratio|quantitative flow ratio
5094939|NCT03405506|Tandem lesion|tandem lesion
5094940|NCT03405506|Virtual stenting|virtual stenting
5094941|NCT03405493|Circadian Rhythm|circadian rhythm
5094942|NCT03405493|Light Therapy|light therapy
5094943|NCT03405493|Wake Therapy|wake therapy
5094944|NCT03405493|Sleep Phase Advance|sleep phase advance
5094945|NCT03405493|Major Depression|major depression
5094946|NCT03405480|Pulmonary embolism|pulmonary embolism
5094947|NCT03405480|Dyspnea|dyspnea
5094948|NCT03405480|Post Pulmonary Embolism Syndrome|post pulmonary embolism syndrome
5094950|NCT03405480|Rehabilitation|rehabilitation
5094951|NCT03405480|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
5094952|NCT03405428|Ultrasonography|ultrasonography
5094953|NCT03405428|Radial Artery Diameter|radial artery diameter
5094954|NCT03405428|Allen Test|allen test
5094955|NCT03405428|Arterial Cannulation|arterial cannulation
5094956|NCT03405428|Doppler Ultrasonography|doppler ultrasonography
5094957|NCT03405428|Ulnar Artery|ulnar artery
5094958|NCT03405402|Sickle cell disease|sickle cell disease
5094959|NCT03405402|Allo-immunization|allo-immunization
5094960|NCT03405402|Blood transfusion|blood transfusion
5094961|NCT03405389|mandibulo-maxillary fixation|mandibulo-maxillary fixation
5094962|NCT03405389|malocclusion|malocclusion
5094963|NCT03405324|brain stimulation, tDCS, nausea and vomiting|brain stimulation, tdcs, nausea and vomiting
5094964|NCT03405311|Labor analgesia|labor analgesia
5094965|NCT03405311|Ultrasound|ultrasound
5094966|NCT03405311|Obesity, Morbid|obesity, morbid
5094967|NCT03405311|Pregnancy|pregnancy
5094968|NCT03405311|Labor Epidural Analgesia|labor epidural analgesia
5094969|NCT03405285|Improved Bladder Management|improved bladder management
5094970|NCT03405285|Neurogenic Lower Urinary Tract Dysfunction|neurogenic lower urinary tract dysfunction
5094971|NCT03405285|Bladder function following Spinal Cord Injury|bladder function following spinal cord injury
5094972|NCT03405285|Urinary Retention|urinary retention
5094973|NCT03405272|Full human anti-EGFR monoclonal antibody (SCT200)|full human anti-egfr monoclonal antibody (sct200)
5094974|NCT03405272|metastatic colorectal cancer （mCRC）|metastatic colorectal cancer （mcrc）
5094975|NCT03405246|Childhood obesity|childhood obesity
5094976|NCT03405246|Weight gain in children|weight gain in children
5094982|NCT03405220|self-affirmation|self-affirmation
5094983|NCT03405220|mobile application|mobile application
5094984|NCT03405220|cessation|cessation
5094985|NCT03405194|HIV/AIDS|hiv/aids
5094986|NCT03405194|Same-Day ART|same-day art
5094987|NCT03405194|Genvoya|genvoya
5094988|NCT03405194|Efavirenz|efavirenz
5094989|NCT03405129|Smoking Cessation|smoking cessation
5094990|NCT03405129|Smartphone App|smartphone app
5094991|NCT03405129|Dynamic Treatment|dynamic treatment
5094992|NCT03405103|self-management|self-management
5094993|NCT03405103|m-Health|m-health
5094994|NCT03405077|interpersonal psychotherapy|interpersonal psychotherapy
5094995|NCT03405077|treatment|treatment
5094996|NCT03405077|training|training
5094997|NCT03405077|dissemination and implementation|dissemination and implementation
5094998|NCT03405077|eating disorders|eating disorders
5094999|NCT03405051|hypokalemia|hypokalemia
5095000|NCT03405051|cardiac failure|cardiac failure
5095001|NCT03404960|Platinum|platinum
5095002|NCT03404960|chemotherapy|chemotherapy
5095003|NCT03404960|Niraparib|niraparib
5095004|NCT03404960|Ipilimumab|ipilimumab
5095005|NCT03404960|Nivolumab|nivolumab
5095006|NCT03404960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5095007|NCT03404960|PARP inhibitor|parp inhibitor
5423204|NCT01616667|Treatment Outcome|treatment outcome
5095008|NCT03404960|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5095010|NCT03404960|PDAC|pdac
5095011|NCT03404947|Exercise|exercise
5095012|NCT03404947|Metabolism|metabolism
5095013|NCT03404947|Nutrition|nutrition
5095014|NCT03404934|Adaptive anastomosis|adaptive anastomosis
5095015|NCT03404934|C-REX|c-rex
5095016|NCT03404934|Colorectal cancer|colorectal cancer
5095017|NCT03404921|Endoscopic submucosal dissection|endoscopic submucosal dissection
5095018|NCT03404921|Endoscopic submucosal tunnelling dissection|endoscopic submucosal tunnelling dissection
5095019|NCT03404921|procedure time|procedure time
5095020|NCT03404908|transversus abdominis plane block|transversus abdominis plane block
5095021|NCT03404908|quadratus lumborum block|quadratus lumborum block
5095022|NCT03404908|neuropathic pain|neuropathic pain
5095024|NCT03404895|Vein|vein
5095025|NCT03404895|Stent|stent
5095026|NCT03404869|CDGIb MANNOSEPHOSPHATE ISOMERASE DEFICIENCY MPI DEFICIENCY PROTEIN-LOSING ENTEROPATHY-HEPATIC FIBROSIS SYNDROME SAGUENAY-LAC SAINT-JEAN SYNDROME SLSJ SYNDROME|cdgib mannosephosphate isomerase deficiency mpi deficiency protein-losing enteropathy-hepatic fibrosis syndrome saguenay-lac saint-jean syndrome slsj syndrome
5095027|NCT03404856|CDG It; CDGIt PHOSPHOGLUCOMUTASE 1 DEFICIENCY PGM1 DEFICIENCY GLYCOGEN STORAGE DISEASE XIV; GSD14 GSD XIV|cdg it; cdgit phosphoglucomutase 1 deficiency pgm1 deficiency glycogen storage disease xiv; gsd14 gsd xiv
5095028|NCT03404791|Bladder Cancer|bladder cancer
5095029|NCT03404791|Urothelial Carcinoma|urothelial carcinoma
5095030|NCT03404791|Cystectomy|cystectomy
5095031|NCT03404791|Radical Cystectomy|radical cystectomy
5095032|NCT03404778|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
5095033|NCT03404778|Medical Device|medical device
5095034|NCT03404778|Performance|performance
5095035|NCT03404778|Safety|safety
5095036|NCT03404778|Shoulder Prosthesis|shoulder prosthesis
5095037|NCT03404778|Glenoid Erosion|glenoid erosion
5095038|NCT03404765|Tai Chi|tai chi
5095039|NCT03404765|Cognition|cognition
5095040|NCT03404765|Instrumental activities of daily living|instrumental activities of daily living
5095041|NCT03404765|Health-related Quality of Life|health-related quality of life
5095042|NCT03404752|breast cancer|breast cancer
5095043|NCT03404752|chemotherapy|chemotherapy
5095044|NCT03404752|Neutropenia|neutropenia
5095045|NCT03404752|Peg-filgrastim|peg-filgrastim
5095046|NCT03404752|biosimilar|biosimilar
5095047|NCT03404739|Antibiotic prophylaxis|antibiotic prophylaxis
5095048|NCT03404739|Infectious complications|infectious complications
5095049|NCT03404739|Peroral endoscopic myotomy|peroral endoscopic myotomy
5095050|NCT03404726|Acute myeloid leukemia|acute myeloid leukemia
5095051|NCT03404726|Myelodysplastic Syndromes|myelodysplastic syndromes
5095052|NCT03404726|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5095053|NCT03404726|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
5095054|NCT03404713|adolescence|adolescence
5095055|NCT03404713|adolescent|adolescent
5095056|NCT03404713|binge eating|binge eating
5095057|NCT03404713|loss-of-control eating|loss-of-control eating
5095058|NCT03404713|behavioral weight loss|behavioral weight loss
5095059|NCT03404713|weight management|weight management
5095060|NCT03404713|acceptance commitment therapy|acceptance commitment therapy
5095061|NCT03404713|overweight|overweight
5095062|NCT03404713|obesity|obesity
5095063|NCT03404700|Eggs, saturated fat, insulin resistance,|eggs, saturated fat, insulin resistance,
5095064|NCT03404674|ETEC|etec
5095065|NCT03404674|Escherichia coli|escherichia coli
5095066|NCT03404674|enteric|enteric
5095068|NCT03404648|prostate cancer|prostate cancer
5095069|NCT03404648|C11-choline|c11-choline
5095070|NCT03404648|PET/MR|pet/mr
5095071|NCT03404648|mpMRI|mpmri
5095072|NCT03404596|cigarettes|cigarettes
5095073|NCT03404596|quit smoking|quit smoking
5095074|NCT03404596|nicotine|nicotine
5095075|NCT03404596|mindfulness|mindfulness
5095076|NCT03404596|mHealth|mhealth
5095077|NCT03404596|mobile health|mobile health
5095078|NCT03404583|Person-centred care|person-centred care
5095079|NCT03404570|Sweaty Hands|sweaty hands
5095080|NCT03404557|Crohn's Disease|crohn's disease
5095081|NCT03404557|Ulcerative colitis|ulcerative colitis
5095082|NCT03404557|Macrophages|macrophages
5095083|NCT03404557|Adherent-Invasive Escherichia coli|adherent-invasive escherichia coli
5095084|NCT03404557|Proteomic analysis|proteomic analysis
5095085|NCT03404518|Thyroidectomy|thyroidectomy
5095086|NCT03404518|Parotidectomy|parotidectomy
5095087|NCT03404518|Tympanoplasty|tympanoplasty
5095088|NCT03404518|Mastoidectomy|mastoidectomy
5095089|NCT03404518|Septoplasty|septoplasty
5095090|NCT03404518|Sinus Surgery|sinus surgery
5095091|NCT03404518|Postoperative pain|postoperative pain
5095092|NCT03404518|Outpatient surgery|outpatient surgery
5095093|NCT03404505|infant|infant
5095094|NCT03404505|play|play
5095095|NCT03404505|parents|parents
5095096|NCT03404479|Knee Osteoarthritis|knee osteoarthritis
5095097|NCT03404479|Diacerein|diacerein
5095098|NCT03404453|Airway prediction|airway prediction
5095099|NCT03404453|Difficult airway|difficult airway
5095100|NCT03404440|helicobacter pylori|helicobacter pylori
5095101|NCT03404440|L. Reuteri|l. reuteri
5095102|NCT03404440|Proton Pump Inhibitor|proton pump inhibitor
5095103|NCT03404375|scheduled cesarean section|scheduled cesarean section
5095104|NCT03404375|term pregnancy|term pregnancy
5095105|NCT03404375|estimated blood loss|estimated blood loss
5095106|NCT03404375|postpartum hemorrhage|postpartum hemorrhage
5095107|NCT03404362|Bone Metastases|bone metastases
5095109|NCT03404336|chronic|chronic
5095110|NCT03404336|well-being therapy|well-being therapy
5095111|NCT03404336|psychotherapy|psychotherapy
5095112|NCT03404336|therapy|therapy
5095113|NCT03404323|central retinal thickness|central retinal thickness
5095114|NCT03404323|epiretinal membrane|epiretinal membrane
5095115|NCT03404323|cataract surgery|cataract surgery
5095116|NCT03404323|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
5095118|NCT03404310|ASCUS|ascus
5095119|NCT03404310|LSIL|lsil
5095120|NCT03404310|Cervical Cancer|cervical cancer
5095121|NCT03404297|compression therapy|compression therapy
5095122|NCT03404297|Kenya|kenya
5095123|NCT03404297|Kaposi Sarcoma|kaposi sarcoma
5095124|NCT03404297|Locally sourced|locally sourced
5095125|NCT03404297|wrapping|wrapping
5095126|NCT03404297|chronic leg ulcers|chronic leg ulcers
5095127|NCT03404284|Immunization|immunization
5095128|NCT03404245|Physical Activity|physical activity
5095129|NCT03404245|Exercise|exercise
5095130|NCT03404245|Rheumatoid|rheumatoid
5095131|NCT03404245|Arthritis|arthritis
5095132|NCT03404245|Self-management|self-management
5095133|NCT03404245|Symptoms|symptoms
5095134|NCT03404206|Postsurgical pain|postsurgical pain
5095135|NCT03404193|Other diseases of blood and blood-forming organs|other diseases of blood and blood-forming organs
5095136|NCT03404193|Acute Myeloid Leukemia|acute myeloid leukemia
5095137|NCT03404193|AML|aml
5095138|NCT03404193|Myelodysplastic Syndrome|myelodysplastic syndrome
5095139|NCT03404193|MDS|mds
5095140|NCT03404193|Decitabine|decitabine
5095141|NCT03404193|Dacogen|dacogen
5095142|NCT03404193|Ventoclax|ventoclax
5095143|NCT03404193|ABT-199|abt-199
5095144|NCT03404193|GDC-0199|gdc-0199
5095145|NCT03404167|ETX0914|etx0914
5095146|NCT03404167|Plasma Pharmacokinetic|plasma pharmacokinetic
5095147|NCT03404167|Safety|safety
5095148|NCT03404167|Tolerability|tolerability
5095149|NCT03404167|Zoliflodacin|zoliflodacin
5095150|NCT03404141|Stress|stress
5095151|NCT03404141|pregnancy|pregnancy
5095152|NCT03404141|psychological therapy|psychological therapy
5095153|NCT03404141|cortisol|cortisol
5095154|NCT03404115|reproxalap|reproxalap
5095155|NCT03404089|device drug monitoring|device drug monitoring
5095156|NCT03404089|β-lactam antibiotic|β-lactam antibiotic
5095157|NCT03404089|health care-associated infection|health care-associated infection
5095158|NCT03404089|MON4STRAT|mon4strat
5095159|NCT03404076|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
5095160|NCT03404076|Dual Energy CT|dual energy ct
5095161|NCT03404076|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
5095162|NCT03404024|gene therapy|gene therapy
5095163|NCT03403998|Pain|pain
5095164|NCT03403998|Temporomandibular Disorders|temporomandibular disorders
5095165|NCT03403998|Therapeutic exercises|therapeutic exercises
5095166|NCT03403998|Musculoskeletal disorders|musculoskeletal disorders
5095167|NCT03403998|Randomized controlled trial|randomized controlled trial
5095168|NCT03403998|Imaging|imaging
5095169|NCT03403998|Brain plasticity|brain plasticity
5095170|NCT03403998|Clinical outcomes|clinical outcomes
5095171|NCT03403998|Chronic pain|chronic pain
5095172|NCT03403998|Neck|neck
5095183|NCT03403946|carvical collar|carvical collar
5095184|NCT03403946|endotracheal intubation|endotracheal intubation
5095185|NCT03403920|validity|validity
5095186|NCT03403920|low back pain|low back pain
5095187|NCT03403920|functional|functional
5095188|NCT03403920|pain|pain
5095189|NCT03403920|questionnaire|questionnaire
5095190|NCT03403907|epilepsy|epilepsy
5095191|NCT03403907|microbiota|microbiota
5095192|NCT03403907|probiotics|probiotics
5095193|NCT03403881|Exercise|exercise
5095194|NCT03403881|Physical activity|physical activity
5095195|NCT03403881|Behavioral change|behavioral change
5095196|NCT03403881|Depression|depression
5095197|NCT03403881|Major Depressive Disorder|major depressive disorder
5095198|NCT03403881|Health promotion|health promotion
5095199|NCT03403803|Glioblastoma|glioblastoma
5095200|NCT03403803|Brain Tumor|brain tumor
5095201|NCT03403790|Bipresso|bipresso
5095202|NCT03403790|Drug use-results survey|drug use-results survey
5095203|NCT03403790|Quetiapine|quetiapine
5095204|NCT03403777|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
5095205|NCT03403777|Avelumab|avelumab
5095206|NCT03403777|Anti PD-L1|anti pd-l1
5095208|NCT03403764|Distant Healing|distant healing
5095209|NCT03403764|Wellness|wellness
5095210|NCT03403764|Distant Intentionality|distant intentionality
5095211|NCT03403764|Distant Healing Intention|distant healing intention
5095212|NCT03403751|Abdominal sepsis|abdominal sepsis
5095214|NCT03403751|NSTI|nsti
5095215|NCT03403725|Solid Tumors|solid tumors
5095216|NCT03403725|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5095218|NCT03403725|MEN1309|men1309
5095219|NCT03403725|CD205|cd205
5095220|NCT03403725|Relapsed|relapsed
5095221|NCT03403725|Refractory|refractory
5095222|NCT03403725|R-R NHL|r-r nhl
5095223|NCT03403725|ADC|adc
5095224|NCT03403725|Antibody-Drug Coniugate|antibody-drug coniugate
5095225|NCT03403725|Metastatic Tumors|metastatic tumors
5095226|NCT03403699|inducible pluripotent stem cells|inducible pluripotent stem cells
5095227|NCT03403686|Liver X receptor|liver x receptor
5095228|NCT03403686|Circulating angiogenic cells|circulating angiogenic cells
5095229|NCT03403660|Attire|attire
5095230|NCT03403660|White coat|white coat
5095231|NCT03403660|Patient physician communication|patient physician communication
5095232|NCT03403569|CD4 cell recovery|cd4 cell recovery
5095233|NCT03403569|immune activation|immune activation
5095234|NCT03403569|anti-inflammation|anti-inflammation
5095235|NCT03403556|High ASCVD risk patients with type 2 diabetes|high ascvd risk patients with type 2 diabetes
5095236|NCT03403530|IgM|igm
5095237|NCT03403530|Immunoglobulin|immunoglobulin
5095238|NCT03403530|Neonatal sepsis|neonatal sepsis
5095239|NCT03403530|very low birth weight preterm|very low birth weight preterm
5095240|NCT03403517|steroids|steroids
5095241|NCT03403517|glucocorticoids|glucocorticoids
5095242|NCT03403517|liver surgery|liver surgery
5095243|NCT03403517|hepatectomy|hepatectomy
5095244|NCT03403478|Hemodynamics|hemodynamics
5095245|NCT03403478|Aquatic exercise|aquatic exercise
5095246|NCT03403478|Elderly|elderly
5095247|NCT03403374|Evolocumab|evolocumab
5095248|NCT03403374|Hypercholesterolemia|hypercholesterolemia
5095249|NCT03403322|intervention|intervention
5095250|NCT03403322|children|children
5095251|NCT03403309|Multiple system atrophy|multiple system atrophy
5095252|NCT03403309|Uric acid|uric acid
5095253|NCT03403309|Inosine 5'-monophosphate|inosine 5'-monophosphate
5095254|NCT03403309|Inosine monophosphate|inosine monophosphate
5095255|NCT03403309|Inosinic acid|inosinic acid
5095256|NCT03403270|Mobile App|mobile app
5095257|NCT03403270|Sedentary Behaviour|sedentary behaviour
5095258|NCT03403270|Workplace Wellness|workplace wellness
5095259|NCT03403270|Sitting Time|sitting time
5095260|NCT03403257|Caregiving|caregiving
5095261|NCT03403257|Hispanic|hispanic
5095262|NCT03403257|Mexican American|mexican american
5095263|NCT03403257|Epidemiology|epidemiology
5095264|NCT03403257|Community|community
5095265|NCT03403231|Veterans|veterans
5095266|NCT03403231|Type 2 diabetes mellitus|type 2 diabetes mellitus
5095267|NCT03403231|Prediabetes|prediabetes
5095268|NCT03403231|Secure Messaging|secure messaging
5095269|NCT03403231|Health Promotion|health promotion
5095270|NCT03403231|Prevention and Control|prevention and control
5095275|NCT03403192|Double Lumen Tube|double lumen tube
5095276|NCT03403192|Thoracic Surgery|thoracic surgery
5095277|NCT03403179|Cognition|cognition
5095278|NCT03403179|Cognitive Remediation|cognitive remediation
5095279|NCT03403179|Mood Disorder|mood disorder
5095280|NCT03403179|Functional Impairment|functional impairment
5095281|NCT03403179|Psychosocial intervention|psychosocial intervention
5095282|NCT03403153|Parent-Child Relationship|parent-child relationship
5095283|NCT03403153|military family|military family
5095284|NCT03403153|veterans health|veterans health
5095285|NCT03403153|stress disorders|stress disorders
5095286|NCT03403114|Vaccine hesitancy|vaccine hesitancy
5095287|NCT03403114|Hospital specialists (HS)|hospital specialists (hs)
5095288|NCT03403114|Vaccination survey|vaccination survey
5095289|NCT03403088|Non-carious cervical lesions|non-carious cervical lesions
5095290|NCT03403088|dentin hypersensitivity|dentin hypersensitivity
5095291|NCT03403075|blood cancer|blood cancer
5095292|NCT03403075|exercise|exercise
5095293|NCT03403075|therapeutic education|therapeutic education
5095294|NCT03403075|fatigue|fatigue
5095295|NCT03403075|feasibility|feasibility
5095296|NCT03403062|Sepsis|sepsis
5095297|NCT03403062|red cell distribution width (RDW)|red cell distribution width (rdw)
5095298|NCT03403062|Late onset sepsis (LOS)|late onset sepsis (los)
5095299|NCT03403062|Early onset sepsis (EOS)|early onset sepsis (eos)
5095300|NCT03403049|pancreatic cancer|pancreatic cancer
5095301|NCT03403049|pancreas|pancreas
5095302|NCT03403049|cancer|cancer
5095303|NCT03403049|locally advanced|locally advanced
5095304|NCT03403049|unresectable|unresectable
5095305|NCT03403049|radiation|radiation
5095306|NCT03403049|radiation therapy|radiation therapy
5095307|NCT03403049|radiotherapy|radiotherapy
5095315|NCT03403023|tear film|tear film
5095316|NCT03403023|Cyclosporine|cyclosporine
5095317|NCT03403023|dry eye syndrome|dry eye syndrome
5095318|NCT03403023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5095319|NCT03402984|Gastric motility|gastric motility
5095320|NCT03402984|Gastric emptying|gastric emptying
5095321|NCT03402971|right heart|right heart
5095322|NCT03402971|pregnancy|pregnancy
5095323|NCT03402971|echocardiography|echocardiography
5095324|NCT03402971|reference values|reference values
5095325|NCT03402945|negative pressure wound management system|negative pressure wound management system
5095326|NCT03402945|open-heart surgery|open-heart surgery
5095327|NCT03402945|antibiotic prophylaxis|antibiotic prophylaxis
5095328|NCT03402945|surgical site infection|surgical site infection
5095329|NCT03402854|pediatric|pediatric
5095330|NCT03402854|children|children
5095331|NCT03402854|non-invasive brain stimulation|non-invasive brain stimulation
5095332|NCT03402854|transcranial direct current stimulation|transcranial direct current stimulation
5095333|NCT03402854|bimanual training|bimanual training
5095334|NCT03402854|hand training|hand training
5095335|NCT03402841|Ovarian cancer|ovarian cancer
5095336|NCT03402841|non-gBRCA|non-gbrca
5095337|NCT03402841|Platinum|platinum
5095338|NCT03402841|Chemotherapy|chemotherapy
5095339|NCT03402828|Topicals|topicals
5095340|NCT03402828|Long-term|long-term
5095342|NCT03402815|Maraviroc|maraviroc
5095343|NCT03402815|Atherosclerosis|atherosclerosis
5095344|NCT03402802|eye drop|eye drop
5095345|NCT03402789|Docosahexaenoic acid|docosahexaenoic acid
5095346|NCT03402789|Long chain fatty acid|long chain fatty acid
5095347|NCT03402776|haemopoietic stem cell transplantation|haemopoietic stem cell transplantation
5095348|NCT03402776|vaccine|vaccine
5095349|NCT03402776|diphteria|diphteria
5095350|NCT03402776|tetanus|tetanus
5095351|NCT03402776|haemophilus influenza|haemophilus influenza
5095352|NCT03402776|poliomyelitis|poliomyelitis
5095353|NCT03402776|hepatitis B|hepatitis b
5095354|NCT03402763|Advance care planning|advance care planning
5095355|NCT03402763|Older adults|older adults
5095356|NCT03402763|Emergency department|emergency department
5095357|NCT03402750|Adherence, Medication, Prescription|adherence, medication, prescription
5095358|NCT03402737|Stereotactic body radiotherapy|stereotactic body radiotherapy
5095359|NCT03402737|Immunomodulating systemic therapy|immunomodulating systemic therapy
5095360|NCT03402711|ACS|acs
5095361|NCT03402711|PCI|pci
5095362|NCT03402711|Bleeding risk|bleeding risk
5095363|NCT03402698|cholecalciferol|cholecalciferol
5095364|NCT03402698|BMI|bmi
5095365|NCT03402698|winter|winter
5095366|NCT03402607|Unresectable|unresectable
5095367|NCT03402594|High flow oxygen therapy|high flow oxygen therapy
5095368|NCT03402594|Oxygen desaturation index|oxygen desaturation index
5095369|NCT03402594|Acute ischemic stroke|acute ischemic stroke
5095370|NCT03402568|alcohol|alcohol
5095371|NCT03402568|targeted metabolomics|targeted metabolomics
5095372|NCT03402568|lipid metabolites|lipid metabolites
5095373|NCT03402568|amino acids|amino acids
5095378|NCT03402516|18.5Fr resector|18.5fr resector
5095379|NCT03402490|Motivational interviewing|motivational interviewing
5095380|NCT03402490|physical activity|physical activity
5095381|NCT03402490|feasibility|feasibility
5095382|NCT03402490|HFpEF|hfpef
5095383|NCT03402477|locally advanced, neo-adjuvant treatment, Watch & Wait|locally advanced, neo-adjuvant treatment, watch & wait
5095384|NCT03402425|FET|fet
5095385|NCT03402425|PET/MRI|pet/mri
5095386|NCT03402425|child|child
5095387|NCT03402360|Virtual Reality|virtual reality
5095388|NCT03402360|Rehabilitation|rehabilitation
5095389|NCT03402360|Acquired Brain Injury|acquired brain injury
5095390|NCT03402347|Ex vivo|ex vivo
5095391|NCT03402347|Gastric bypass|gastric bypass
5095392|NCT03402321|alveogyl, gelatin sponge, free gingival graft, palate, pain|alveogyl, gelatin sponge, free gingival graft, palate, pain
5095393|NCT03402282|hemorrhoidal disease|hemorrhoidal disease
5095394|NCT03402282|embolization|embolization
5095395|NCT03402256|Mobile Technology|mobile technology
5095396|NCT03402256|Alcohol|alcohol
5095397|NCT03402256|Alcoholic Liver Disease|alcoholic liver disease
5095398|NCT03402256|Ethyl Glucuronide|ethyl glucuronide
5095399|NCT03402217|Contraception|contraception
5095400|NCT03402217|Post Partum Contraception|post partum contraception
5095401|NCT03402204|Simvastatin|simvastatin
5095402|NCT03402204|Plaque stability|plaque stability
5095403|NCT03402204|Acute ischemic stroke|acute ischemic stroke
5095404|NCT03402178|E2082|e2082
5095405|NCT03402178|male|male
5095408|NCT03402152|Biomarker|biomarker
5095409|NCT03402100|myopia|myopia
5095410|NCT03402100|schoolchildren|schoolchildren
5095411|NCT03402100|atropine|atropine
5095412|NCT03402100|allergy|allergy
5095426|NCT03402022|trail running|trail running
5095427|NCT03402022|doping|doping
5095428|NCT03402009|meditation|meditation
5095429|NCT03402009|Mindfulness|mindfulness
5095430|NCT03402009|stress|stress
5095431|NCT03402009|anxiety|anxiety
5095432|NCT03401983|exercise|exercise
5095433|NCT03401983|pelvic floor|pelvic floor
5095434|NCT03401983|stress urinary incontinence|stress urinary incontinence
5095435|NCT03401970|Body composition|body composition
5095436|NCT03401970|Internal body fat|internal body fat
5095437|NCT03401970|Dietary pattern|dietary pattern
5095438|NCT03401970|Dietary carbohydrate|dietary carbohydrate
5095439|NCT03401957|colorectal cancer|colorectal cancer
5095440|NCT03401957|cetuximab resistance|cetuximab resistance
5095441|NCT03401957|liquid biopsy|liquid biopsy
5095442|NCT03401957|RAS mutation|ras mutation
5095443|NCT03401905|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
5095444|NCT03401905|Myofascial trigger point|myofascial trigger point
5095445|NCT03401866|brain tumor|brain tumor
5095446|NCT03401840|Head and neck cancers|head and neck cancers
5095447|NCT03401840|Radiation oncology|radiation oncology
5095448|NCT03401840|Stereotactic radiotherapy|stereotactic radiotherapy
5095449|NCT03401827|pancreatic cancer|pancreatic cancer
5095450|NCT03401827|second line chemotherapy|second line chemotherapy
5095451|NCT03401827|nab-paclitaxel|nab-paclitaxel
5095452|NCT03401775|aging, computerized cognitive training|aging, computerized cognitive training
5095453|NCT03401762|rehabilitation|rehabilitation
5095454|NCT03401736|Sedatives and Hypnotics,Mechanical Ventilation|sedatives and hypnotics,mechanical ventilation
5095455|NCT03401723|Validation study|validation study
5095456|NCT03401723|Simulation|simulation
5095457|NCT03401723|Endoscopy|endoscopy
5095458|NCT03401710|Anemia, Acute Kidney injury, ESA, Erythropoietin|anemia, acute kidney injury, esa, erythropoietin
5095459|NCT03401684|firefighters|firefighters
5095460|NCT03401684|mental resiliency|mental resiliency
5095461|NCT03401684|peer support|peer support
5095462|NCT03401671|Lanadelumab|lanadelumab
5095466|NCT03401606|sedation|sedation
5095467|NCT03401606|dexmedetomidine|dexmedetomidine
5095468|NCT03401606|remifentanil|remifentanil
5095469|NCT03401606|cataract surgery|cataract surgery
5095470|NCT03401606|surgeon satisfaction|surgeon satisfaction
5095471|NCT03401606|patient satisfaction|patient satisfaction
5095472|NCT03401593|ablation|ablation
5095473|NCT03401593|atrial fibrillation|atrial fibrillation
5095474|NCT03401593|stroke|stroke
5095475|NCT03401567|blood flow restriction|blood flow restriction
5095476|NCT03401567|proprioception|proprioception
5095477|NCT03401567|functional performance|functional performance
5095478|NCT03401567|muscle strength|muscle strength
5095479|NCT03401541|Calcifediol (25(OH)D)|calcifediol (25(oh)d)
5095480|NCT03401541|Calciferol (Vitamin D)|calciferol (vitamin d)
5095481|NCT03401463|endotracheal tube cuff pressure|endotracheal tube cuff pressure
5095482|NCT03401463|Ventilator-Induced Lung Injury|ventilator-induced lung injury
5095483|NCT03401463|traning|traning
5095484|NCT03401437|adverse effects|adverse effects
5095485|NCT03401437|Salpingectomy|salpingectomy
5095486|NCT03401437|Essure® device ablation|essure® device ablation
5095487|NCT03401437|Cornual resection|cornual resection
5095488|NCT03401424|congenital cyst of common bile duct|congenital cyst of common bile duct
5095489|NCT03401424|Biliary enteric anastomosis|biliary enteric anastomosis
5095491|NCT03401411|ICU Triage Practices|icu triage practices
5095492|NCT03401411|Cancer Patients|cancer patients
5095493|NCT03401411|Oncology ICU|oncology icu
5095502|NCT03401385|Non-small cell lung cancer|non-small cell lung cancer
5095503|NCT03401385|NSCLC|nsclc
5095504|NCT03401385|Other solid tumors|other solid tumors
5095505|NCT03401372|Primary light chain amyloidosis|primary light chain amyloidosis
5095506|NCT03401372|Doxycycline|doxycycline
5095507|NCT03401372|Bortezomib|bortezomib
5095508|NCT03401372|Prognosis|prognosis
5095509|NCT03401372|Progression-free survival|progression-free survival
5095510|NCT03401372|Overall survival|overall survival
5095525|NCT03401255|transvaginal ultrasound|transvaginal ultrasound
5095527|NCT03401242|Carbapenemase|carbapenemase
5095528|NCT03401242|Enterobacteriaceae|enterobacteriaceae
5095529|NCT03401242|extended spectrum beta-lactamases|extended spectrum beta-lactamases
5095530|NCT03401242|nursing homes|nursing homes
5095531|NCT03401242|prevalence|prevalence
5095532|NCT03401229|Polyps|polyps
5095533|NCT03401229|Nasal polyps|nasal polyps
5095534|NCT03401229|Nasal polyposis|nasal polyposis
5095535|NCT03401229|Nose diseases|nose diseases
5095536|NCT03401229|Respiratory tract diseases|respiratory tract diseases
4980247|NCT04116281|Upper limb function|upper limb function
5095537|NCT03401229|Otorhinolaryngologic diseases|otorhinolaryngologic diseases
5095538|NCT03401229|Benralizumab|benralizumab
5095539|NCT03401229|Mometasone furoate|mometasone furoate
5106332|NCT03333200|Cognitive|cognitive
5095547|NCT03401203|DEB|deb
5095548|NCT03401203|PCI|pci
5095549|NCT03401151|Heart failure|heart failure
5095550|NCT03401151|Skeletal muscle|skeletal muscle
5095551|NCT03401151|Exercise capacity|exercise capacity
5095552|NCT03401151|Lung function|lung function
5095553|NCT03401151|Gene expression|gene expression
5095554|NCT03401138|Peripheral perfusion|peripheral perfusion
5095555|NCT03401138|Blood Volume|blood volume
5095556|NCT03401138|Tissue Prefusion|tissue prefusion
5095557|NCT03401138|Near-infrared spectroscopy|near-infrared spectroscopy
5095558|NCT03401138|Hemodynamic monitoring|hemodynamic monitoring
5095559|NCT03401138|Hemodynamic optimization|hemodynamic optimization
5095560|NCT03401138|Preoperative resuscitation|preoperative resuscitation
5095561|NCT03401125|Sickle cell disease|sickle cell disease
5095562|NCT03401125|Allo-immunization|allo-immunization
5095567|NCT03401073|small Fiber Neuropathy|small fiber neuropathy
5095568|NCT03401073|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
5095569|NCT03401073|IVIg|ivig
5095570|NCT03401073|Gamunex-C|gamunex-c
5095571|NCT03401060|Systemic mastocytosis|systemic mastocytosis
5095572|NCT03401060|Osteoporosis|osteoporosis
5095573|NCT03401060|Bone mineral density (BMD)|bone mineral density (bmd)
5095574|NCT03401060|Denosumab|denosumab
5095575|NCT03401060|RANKL|rankl
5095576|NCT03401047|Polycystic ovary syndrome|polycystic ovary syndrome
5095577|NCT03401021|intention to quit smoking|intention to quit smoking
5095578|NCT03401021|male smoker|male smoker
5095579|NCT03401021|smoking cessation|smoking cessation
5095580|NCT03401021|expectant fathers|expectant fathers
5095581|NCT03401008|Acromegaly|acromegaly
5095582|NCT03401008|Oral manifestations|oral manifestations
5095583|NCT03400969|Palliative|palliative
5095584|NCT03400969|Moisturisers|moisturisers
5095585|NCT03400969|Dry mouth|dry mouth
5095586|NCT03400969|Xerostomia|xerostomia
5095591|NCT03400930|Severe Acute Malnutrition|severe acute malnutrition
5095592|NCT03400865|cabergoline|cabergoline
5095593|NCT03400865|prolactinomas|prolactinomas
5095594|NCT03400865|resistant|resistant
5095595|NCT03400865|hydroxychloroquine|hydroxychloroquine
5095596|NCT03400865|chloroquine|chloroquine
5095597|NCT03400852|Muscular Dystrophy|muscular dystrophy
5095598|NCT03400852|DMD|dmd
5095599|NCT03400852|Duchenne|duchenne
5095600|NCT03400839|Interstitial Lung disease|interstitial lung disease
5095601|NCT03400839|prognosis|prognosis
5095602|NCT03400839|clinical endpoints|clinical endpoints
5095603|NCT03400839|association|association
5095604|NCT03400826|simvastatin|simvastatin
5095605|NCT03400826|fibroids|fibroids
5095606|NCT03400826|medical management|medical management
5095607|NCT03400826|uterine fibroids|uterine fibroids
5095608|NCT03400826|leiomyoma|leiomyoma
5095609|NCT03400813|Eye-Movement Desensitization|eye-movement desensitization
5095610|NCT03400813|Reprocessing|reprocessing
5095611|NCT03400800|Inclisiran sodium|inclisiran sodium
5095612|NCT03400800|ASCVD|ascvd
5095613|NCT03400800|LDL-C|ldl-c
5095614|NCT03400787|nasal airway obstruction|nasal airway obstruction
5095615|NCT03400787|sham-control|sham-control
5095616|NCT03400787|Polylactide absorbable implant|polylactide absorbable implant
5095617|NCT03400748|Electrosurgery|electrosurgery
5095618|NCT03400748|RF ablation|rf ablation
5095619|NCT03400748|Minimally invasive|minimally invasive
5095620|NCT03400748|Lung cancer|lung cancer
5095621|NCT03400748|Lung metastasis|lung metastasis
5095622|NCT03400748|Lung tumor|lung tumor
5095623|NCT03400748|Primary|primary
5095629|NCT03400722|Infertility, Female|infertility, female
5095630|NCT03400722|In Vitro Fertilisation|in vitro fertilisation
5095631|NCT03400709|Cisplatin|cisplatin
5095632|NCT03400709|Ototoxicity|ototoxicity
5095633|NCT03400709|N-acetylcisteine|n-acetylcisteine
5095634|NCT03400696|nutrition, diet, genetics, physical activity, weight loss|nutrition, diet, genetics, physical activity, weight loss
5095635|NCT03400670|NCPAP|ncpap
5095636|NCT03400670|Respiratory Distress Syndrome|respiratory distress syndrome
5095637|NCT03400644|open-door laminoplasty, laminoplasty, cervical collars|open-door laminoplasty, laminoplasty, cervical collars
5095638|NCT03400631|Cytokine|cytokine
5095639|NCT03400618|Carbohydrates|carbohydrates
5095640|NCT03400618|Diet|diet
5095641|NCT03400618|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5095642|NCT03400592|gastric adenocarcinoma|gastric adenocarcinoma
5095653|NCT03400488|5-lipoxygenase activating protein (FLAP) inhibitor,|5-lipoxygenase activating protein (flap) inhibitor,
5095654|NCT03400488|Leukotrienes.|leukotrienes.
5095655|NCT03400475|topical|topical
5095656|NCT03400475|subgingival|subgingival
5095657|NCT03400475|simvastatin|simvastatin
4980354|NCT04115774|Brittle Bone Disease|brittle bone disease
5095658|NCT03400462|Dry needling, occlusal splint, NSAID, nimesulide|dry needling, occlusal splint, nsaid, nimesulide
5095659|NCT03400423|Caffeine|caffeine
5095660|NCT03400423|Caffeine Withdrawal|caffeine withdrawal
5095661|NCT03400423|Acute Aerobic Exercise|acute aerobic exercise
5095662|NCT03400423|Cognition|cognition
5095663|NCT03400423|Working Memory|working memory
5095664|NCT03400410|Contraception|contraception
5095665|NCT03400410|Education|education
5095666|NCT03400410|Male adolescents|male adolescents
5095667|NCT03400410|Emergency Department|emergency department
5095668|NCT03400410|Unintended pregnancy|unintended pregnancy
5095669|NCT03400397|Anxiety|anxiety
5095670|NCT03400397|Child|child
5095671|NCT03400397|Cognitive behaviour therapy|cognitive behaviour therapy
5095673|NCT03400397|effectiveness|effectiveness
5095674|NCT03400397|treatment|treatment
5095675|NCT03400397|Cool Kids|cool kids
5095676|NCT03400384|Deprescribing|deprescribing
5095677|NCT03400371|JME|jme
5095678|NCT03400371|Epilepsy|epilepsy
5095679|NCT03400371|Juvenile Myoclonic Epilepsy|juvenile myoclonic epilepsy
5095680|NCT03400371|Genomewide Association Study|genomewide association study
5095681|NCT03400371|Genetics|genetics
5095682|NCT03400358|uterocervical angle|uterocervical angle
5095683|NCT03400358|multiparous|multiparous
5095684|NCT03400345|Hand Transplant|hand transplant
5095685|NCT03400345|composite tissue allograft (CTA)|composite tissue allograft (cta)
5095686|NCT03400345|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
5095687|NCT03400345|Amputation|amputation
5095688|NCT03400345|Upper Limb|upper limb
5095689|NCT03400345|Immunosuppression|immunosuppression
5095690|NCT03400319|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5095691|NCT03400319|Obstructive Sleep Apnea|obstructive sleep apnea
5095692|NCT03400306|Cancer - Ovarian cancer|cancer - ovarian cancer
5095693|NCT03400306|Bioavailability|bioavailability
5095694|NCT03400306|Pharmacokinetics|pharmacokinetics
5095695|NCT03400306|Bioequivalence|bioequivalence
5095696|NCT03400293|Human Immunodeficiency virus|human immunodeficiency virus
5095697|NCT03400293|Health Related Quality of Life|health related quality of life
5095698|NCT03400293|Functional Assessment of HIV Infection|functional assessment of hiv infection
5095699|NCT03400293|Mobile app|mobile app
5095700|NCT03400280|Postoperative pancreatic fistula|postoperative pancreatic fistula
5095701|NCT03400280|Pancreatic resection|pancreatic resection
5095702|NCT03400228|Probiotics|probiotics
5095703|NCT03400228|Chronic kidney disease|chronic kidney disease
5095704|NCT03400228|Cardiovascular risk|cardiovascular risk
5095705|NCT03400176|Ibrutinib|ibrutinib
5095706|NCT03400176|VAY736|vay736
5095800|NCT03399383|Adherence|adherence
5095710|NCT03400176|BTK mutation|btk mutation
5095714|NCT03400085|living donor kidney transplant|living donor kidney transplant
5095715|NCT03400085|follow-up|follow-up
5095716|NCT03400085|health utilization|health utilization
5095717|NCT03400059|Prophylaxis, Headache, Preventative Treatment|prophylaxis, headache, preventative treatment
5095719|NCT03400007|dynamic floor magnetic resonance imaging|dynamic floor magnetic resonance imaging
5095720|NCT03400007|colpocystodefecagraphy|colpocystodefecagraphy
5095721|NCT03400007|prolapse surgery|prolapse surgery
5095722|NCT03399968|shockwave|shockwave
5095723|NCT03399968|ESWT|eswt
5095724|NCT03399929|Rehabilitation|rehabilitation
5095725|NCT03399929|Long term outcome|long term outcome
5095726|NCT03399838|Procedural Sedation and Analgesia|procedural sedation and analgesia
5095727|NCT03399838|Pediatric Emergency Department|pediatric emergency department
5095728|NCT03399838|intranasal|intranasal
5095729|NCT03399838|dexmedetomidine|dexmedetomidine
5095737|NCT03399760|cone-beam computed tomography|cone-beam computed tomography
5095738|NCT03399734|Perampanel|perampanel
5095739|NCT03399734|Bioequivalence|bioequivalence
5095740|NCT03399734|fine granules|fine granules
5095742|NCT03399734|Japanese|japanese
5095743|NCT03399708|apremilast|apremilast
5095744|NCT03399708|PDE4 inhibition|pde4 inhibition
5095745|NCT03399708|cardiometabolic|cardiometabolic
5095746|NCT03399708|immune profile|immune profile
5095747|NCT03399695|preoxygenation|preoxygenation
5095748|NCT03399695|high flow oxygen|high flow oxygen
5095749|NCT03399682|cystography|cystography
5095750|NCT03399682|pediatry|pediatry
5095751|NCT03399682|urinary infection|urinary infection
5095752|NCT03399630|Osteo Arthritis Knee|osteo arthritis knee
5095753|NCT03399630|Autologous Adipose Tissue|autologous adipose tissue
5095754|NCT03399617|Stunting|stunting
5095755|NCT03399617|Obesity|obesity
5095756|NCT03399617|Lipid-based Nutrient Supplements (LNS)|lipid-based nutrient supplements (lns)
5095757|NCT03399617|Latin America|latin america
5095758|NCT03399617|Child nutrition|child nutrition
5095759|NCT03399617|Feeding practices|feeding practices
5095760|NCT03399604|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5095761|NCT03399604|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5095762|NCT03399604|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
5095763|NCT03399604|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
5095764|NCT03399604|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
5095765|NCT03399604|Connective tissue disease|connective tissue disease
5095766|NCT03399591|Gait Disorders|gait disorders
5095767|NCT03399591|Spatio-temporal parameters of walking|spatio-temporal parameters of walking
5095768|NCT03399591|Alzheimer's disease|alzheimer's disease
5095769|NCT03399591|Lewy body disease|lewy body disease
5095770|NCT03399552|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5095771|NCT03399552|Avelumab Immunotherapy|avelumab immunotherapy
5095772|NCT03399552|17-358|17-358
5095773|NCT03399513|Ibrutinib|ibrutinib
5095774|NCT03399500|Case Management|case management
5095775|NCT03399500|Homelessness|homelessness
5095776|NCT03399500|Smartphone|smartphone
5095777|NCT03399500|Health Related Quality of Life|health related quality of life
5095778|NCT03399500|Mental Health|mental health
5095779|NCT03399500|Substance Use Disorders|substance use disorders
5095780|NCT03399487|NSCLC|nsclc
5095781|NCT03399487|ROS1 rearrangement|ros1 rearrangement
5095782|NCT03399487|Ceritinib|ceritinib
5095783|NCT03399487|LDK378|ldk378
5095784|NCT03399474|Regional Anesthesia, Dexmedetomidine and lidocaine|regional anesthesia, dexmedetomidine and lidocaine
5095785|NCT03399461|United States|united states
5095786|NCT03399461|United Kingdom|united kingdom
5095787|NCT03399461|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5095788|NCT03399461|Caregiver|caregiver
5095789|NCT03399461|Interview|interview
5095790|NCT03399461|immune deficiency|immune deficiency
5095791|NCT03399461|France|france
5095792|NCT03399435|Regional anesthesia|regional anesthesia
5095793|NCT03399435|Brachial plexus blockade|brachial plexus blockade
5095794|NCT03399435|Sensory and motor function testing|sensory and motor function testing
5095795|NCT03399422|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
5095796|NCT03399422|canine retraction|canine retraction
5095797|NCT03399422|pain and discomfort|pain and discomfort
5095798|NCT03399383|Adrenal Insufficiency|adrenal insufficiency
5095799|NCT03399383|Adrenal crisis|adrenal crisis
5095805|NCT03399331|honey, olive oil, oral mucositis, pain|honey, olive oil, oral mucositis, pain
5095806|NCT03399318|HRP2|hrp2
5095809|NCT03399279|nanohydroxyapatite|nanohydroxyapatite
5095810|NCT03399279|Perforated membrane|perforated membrane
5095811|NCT03399279|occlusive membrane|occlusive membrane
5095812|NCT03399279|Aggressive periodontitis|aggressive periodontitis
5095813|NCT03399266|Induction of labor|induction of labor
5095814|NCT03399266|Previous cesarean delivery|previous cesarean delivery
5095815|NCT03399266|Trial of labor after cesarean|trial of labor after cesarean
5095816|NCT03399266|Prelabor rupture of membranes|prelabor rupture of membranes
5095817|NCT03399266|balloon induction|balloon induction
5095818|NCT03399253|Distal Gastric Cancer, Gastrectomy, Metastasectomy|distal gastric cancer, gastrectomy, metastasectomy
5095820|NCT03399188|Inflammatory Bowel Diseases, Fecal microbiota transplantation, microbiome|inflammatory bowel diseases, fecal microbiota transplantation, microbiome
5095821|NCT03399175|Vogt-Koyanagi-Harada disease|vogt-koyanagi-harada disease
5095822|NCT03399175|Immunosuppressive therapy|immunosuppressive therapy
5095823|NCT03399175|Indocyanine green angiography|indocyanine green angiography
5095824|NCT03399175|Enhanced depth imaging optical coherence tomography|enhanced depth imaging optical coherence tomography
5095827|NCT03399149|Hematologic Malignancy|hematologic malignancy
5095828|NCT03399149|Intensive Care Unit|intensive care unit
5095829|NCT03399136|Exercise training|exercise training
5095830|NCT03399136|Intervention|intervention
5093706|NCT03413033|resonance tubes|resonance tubes
5095837|NCT03399084|Ferric carboxymaltose|ferric carboxymaltose
5095838|NCT03399084|Anemia|anemia
5095839|NCT03399071|Gastric cancer|gastric cancer
5095840|NCT03399071|Oesophageal cancer|oesophageal cancer
5095841|NCT03399071|Gastro-oesophageal cancer|gastro-oesophageal cancer
5095842|NCT03399071|Perioperative|perioperative
5095843|NCT03399071|Immunotherapy|immunotherapy
5095844|NCT03399071|Anti PDL1|anti pdl1
5095845|NCT03399071|Avelumab|avelumab
5095846|NCT03399071|FLOT|flot
5095847|NCT03399032|caspofungin|caspofungin
5095848|NCT03399032|pharmacokinetics|pharmacokinetics
5095849|NCT03399019|Bispectral index monitor|bispectral index monitor
5095850|NCT03398980|Childhood and Adolescent|childhood and adolescent
5095851|NCT03398980|Survivors|survivors
5095852|NCT03398980|Radiotherapy|radiotherapy
5095853|NCT03398980|Late Sequelae|late sequelae
5095854|NCT03398941|Pancreatic fistula|pancreatic fistula
5095855|NCT03398915|robotic|robotic
5095856|NCT03398915|robot-guided|robot-guided
5095857|NCT03398915|navigated|navigated
5095858|NCT03398915|computer-assisted|computer-assisted
5095859|NCT03398915|pedicle screw|pedicle screw
5095860|NCT03398915|instrumentation|instrumentation
5095861|NCT03398915|thoracolumbar|thoracolumbar
5095862|NCT03398902|sleep|sleep
5095863|NCT03398902|sleep extension|sleep extension
5095864|NCT03398902|sleep patterns|sleep patterns
5095865|NCT03398902|type 2 diabetes|type 2 diabetes
5095866|NCT03398902|glucose regulation|glucose regulation
5095867|NCT03398902|behavioral intervention|behavioral intervention
5095868|NCT03398902|adults|adults
5095869|NCT03398889|intestinal microbiome|intestinal microbiome
5095870|NCT03398889|atherosclerosis|atherosclerosis
5095871|NCT03398889|nutrients|nutrients
5095872|NCT03398889|renal function|renal function
5095873|NCT03398850|spontaneous coronary artery dissection|spontaneous coronary artery dissection
5095874|NCT03398850|acute coronary syndrome|acute coronary syndrome
5095875|NCT03398850|coronary angiography|coronary angiography
5095876|NCT03398850|coronary tomography|coronary tomography
5095877|NCT03398837|Scleroderma|scleroderma
5095878|NCT03398837|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
5095879|NCT03398837|anabasum|anabasum
5095880|NCT03398837|JBT-101|jbt-101
5095881|NCT03398837|lenabasum|lenabasum
5095882|NCT03398824|Fanconi Anemia|fanconi anemia
5095883|NCT03398824|Metformin|metformin
5095884|NCT03398798|archwire dimension|archwire dimension
5095885|NCT03398798|ligation method|ligation method
5095886|NCT03398798|bracket type|bracket type
5095887|NCT03398785|Primary Aldosteronism|primary aldosteronism
5095888|NCT03398785|Hypertension|hypertension
5095889|NCT03398785|Ablation|ablation
5095890|NCT03398785|Adrenal Gland|adrenal gland
5095891|NCT03398759|Butorphanol|butorphanol
5095892|NCT03398759|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5095893|NCT03398759|Emergence agitation|emergence agitation
5095894|NCT03398746|soft tissue infection|soft tissue infection
5095895|NCT03398746|MRSA|mrsa
5095915|NCT03398642|Health promotion|health promotion
5095916|NCT03398642|Life Style|life style
5095917|NCT03398642|Quality of life|quality of life
5095918|NCT03398642|Aging|aging
5095919|NCT03398642|Aged|aged
5095920|NCT03398642|Community participation|community participation
5095921|NCT03398616|Retinal Bloodflow Pressure|retinal bloodflow pressure
5095922|NCT03398603|"AMH measurement ElecSys"|"amh measurement elecsys"
5095923|NCT03398590|Type 2 Diabetes|type 2 diabetes
5095924|NCT03398590|Obesity|obesity
5095925|NCT03398577|Coronary disease|coronary disease
5095926|NCT03398577|diabetes|diabetes
5095927|NCT03398577|SGLT2I|sglt2i
5095928|NCT03398577|Inflammation Mediators|inflammation mediators
5961911|NCT04284189|Transition of follow-up care|transition of follow-up care
5095929|NCT03398564|Erecror Spinae Plan Block|erecror spinae plan block
5095930|NCT03398564|postoperative pain|postoperative pain
5095931|NCT03398564|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5095932|NCT03398551|pregnancy|pregnancy
5095933|NCT03398551|machine learning|machine learning
5095934|NCT03398551|fetal Doppler echocardiography|fetal doppler echocardiography
5095936|NCT03398538|Ulcer|ulcer
5095937|NCT03398525|central venous catheter|central venous catheter
5095938|NCT03398525|intensive care|intensive care
5095939|NCT03398525|music therapy|music therapy
5095940|NCT03398499|pain|pain
5095941|NCT03398499|orthognathic surgery|orthognathic surgery
5106723|NCT03330756|Mini gastric bypass|mini gastric bypass
5095942|NCT03398499|temporomandibular disorders (TMD)|temporomandibular disorders (tmd)
5095943|NCT03398499|Electromagnetic Therapy|electromagnetic therapy
5095945|NCT03398486|Kinesiotaping, Manual therapy|kinesiotaping, manual therapy
5095946|NCT03398486|Physiotherapy|physiotherapy
5095947|NCT03398473|Epoetin Hospira|epoetin hospira
5095948|NCT03398473|Pharmacokinetics|pharmacokinetics
5095949|NCT03398434|MAA868|maa868
5095950|NCT03398434|apixaban|apixaban
5095951|NCT03398434|atrial fibrillation|atrial fibrillation
5095952|NCT03398434|anticoagulant|anticoagulant
5095953|NCT03398434|Factor XI|factor xi
5095954|NCT03398434|D-dimer|d-dimer
5095955|NCT03398434|systemic thromboembolic events|systemic thromboembolic events
5095956|NCT03398421|Nemiralisib|nemiralisib
5095957|NCT03398421|Pharmacokinetics|pharmacokinetics
5095958|NCT03398421|Itraconazole|itraconazole
5095959|NCT03398421|Drug-drug Interaction|drug-drug interaction
5095960|NCT03398421|Cross-over|cross-over
5095961|NCT03398382|Magnesium citrate|magnesium citrate
5095962|NCT03398382|Trismus after surgical removal of the lower third molars|trismus after surgical removal of the lower third molars
5095963|NCT03398382|Local anesthesia|local anesthesia
5342956|NCT01981382|quantitative sensory testing|quantitative sensory testing
5095964|NCT03398382|Analgesia after surgical removal of the lower third molars|analgesia after surgical removal of the lower third molars
5095965|NCT03398382|Swelling after surgical removal of the lower third molars|swelling after surgical removal of the lower third molars
5095966|NCT03398382|Surgical removal of the lower third molars|surgical removal of the lower third molars
5095967|NCT03398382|Oral surgical procedures|oral surgical procedures
5095968|NCT03398382|Placebo effect|placebo effect
5095969|NCT03398356|prediabetes|prediabetes
5095970|NCT03398356|impaired fasting glucose|impaired fasting glucose
5095971|NCT03398356|impaired glucose tolerance|impaired glucose tolerance
5095972|NCT03398356|metformin|metformin
5095973|NCT03398356|nitric oxide|nitric oxide
5095975|NCT03398317|DFI|dfi
5095976|NCT03398317|sperm selection|sperm selection
5095977|NCT03398317|PICSI|picsi
5095978|NCT03398317|MACS|macs
5095979|NCT03398239|respiratory failure, hypercapnia, BPAP, AVAPS|respiratory failure, hypercapnia, bpap, avaps
5095980|NCT03398174|Rural dwellers|rural dwellers
5095981|NCT03398174|Patient Education|patient education
5095982|NCT03398174|Exercise|exercise
5095983|NCT03398148|ABBV-066|abbv-066
5095984|NCT03398148|BI 655066|bi 655066
5095985|NCT03398135|ABBV-066|abbv-066
5095986|NCT03398135|BI 655066|bi 655066
5095987|NCT03398122|Apatinib|apatinib
5095988|NCT03398122|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5095989|NCT03398070|Functional Neurological Disorder|functional neurological disorder
5095990|NCT03398070|Functional Movement Disorder|functional movement disorder
5095991|NCT03398070|Psychogenic Nonepileptic Seizures|psychogenic nonepileptic seizures
5096079|NCT03397459|lordosis|lordosis
5095992|NCT03398070|Functional Limb Weakness|functional limb weakness
5095993|NCT03398057|Breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.|breast cancer screening; health education; breast self-examination; clinical breast examination; mammography.
5095994|NCT03398018|dry eye|dry eye
5095995|NCT03398018|corticotropin|corticotropin
5095996|NCT03398005|Omega-3 Fatty acids|omega-3 fatty acids
5095997|NCT03398005|Triglycerides|triglycerides
5095998|NCT03397979|atopic dermatitis|atopic dermatitis
5095999|NCT03397979|bathing|bathing
5096000|NCT03397979|baths|baths
5096001|NCT03397966|obesity|obesity
5096002|NCT03397966|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
5096003|NCT03397966|metabolism|metabolism
5096004|NCT03397966|Energy Metabolism|energy metabolism
5096005|NCT03397953|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5096006|NCT03397953|Childhood|childhood
5096007|NCT03397953|Adolescent|adolescent
5096008|NCT03397953|Recurrent|recurrent
5096009|NCT03397953|Treatment|treatment
5096010|NCT03397927|ballet shoe|ballet shoe
5096011|NCT03397927|orthosis|orthosis
5096012|NCT03397927|pain|pain
5096013|NCT03397901|chronic radiation proctitis|chronic radiation proctitis
5096014|NCT03397901|rectal bleeding|rectal bleeding
5096015|NCT03397901|transverse colostomy|transverse colostomy
5096016|NCT03397901|refractory|refractory
5096017|NCT03397901|moderate to severe anemia|moderate to severe anemia
5096018|NCT03397849|Primary prevention|primary prevention
5096019|NCT03397849|Lifestyle intervention|lifestyle intervention
5006245|NCT03957395|SCS|scs
5096020|NCT03397849|Digital health|digital health
5096021|NCT03397849|Cardiovascular disease prevention|cardiovascular disease prevention
5096022|NCT03397836|Older adults|older adults
5096023|NCT03397836|Optimal aging|optimal aging
5096024|NCT03397836|Primary health care|primary health care
5096025|NCT03397836|Randomized control trial|randomized control trial
5096026|NCT03397836|Integrated care|integrated care
5096027|NCT03397836|Health care volunteers|health care volunteers
5096028|NCT03397836|interdisciplinary health care teams|interdisciplinary health care teams
5096029|NCT03397836|Implementation|implementation
5096030|NCT03397836|Health services research|health services research
5096031|NCT03397836|Patient centered care|patient centered care
5106822|NCT03330080|Sleepiness|sleepiness
5096042|NCT03397745|bispectral index|bispectral index
5096043|NCT03397745|lateral decubitus position|lateral decubitus position
5096044|NCT03397745|one lung ventilation|one lung ventilation
5096045|NCT03397732|Matrix metalloproteinase|matrix metalloproteinase
5862709|NCT00001543|Cushing's Syndrome|cushing's syndrome
5096053|NCT03397706|EBV+ post-transplant lymphoproliferative malignancy|ebv+ post-transplant lymphoproliferative malignancy
5096054|NCT03397706|EBV-associated lymphoproliferative disorders associated with acquired immunodeficiency including HIV-positive|ebv-associated lymphoproliferative disorders associated with acquired immunodeficiency including hiv-positive
5096055|NCT03397706|Relapsed, refractory, EBV+ lymphoid malignancy|relapsed, refractory, ebv+ lymphoid malignancy
5096056|NCT03397693|PCOS|pcos
5096057|NCT03397693|Unexplained infertiltiy|unexplained infertiltiy
5096058|NCT03397693|3D Power Doppler|3d power doppler
5096059|NCT03397693|Endometrial thickness|endometrial thickness
5096060|NCT03397693|Subendometrial blood perfusion|subendometrial blood perfusion
5096061|NCT03397680|Helicobacter Pylori infection|helicobacter pylori infection
5096062|NCT03397680|Non-ulcer Dyspepsia|non-ulcer dyspepsia
5096063|NCT03397680|Rabeprazole-Levofloxacin|rabeprazole-levofloxacin
5096064|NCT03397602|atrial fibrillation|atrial fibrillation
5096065|NCT03397602|exercise|exercise
5096066|NCT03397576|Prisoner|prisoner
5096067|NCT03397563|Continuous Positive Airway Pressure|continuous positive airway pressure
5096068|NCT03397563|Sleep Apnea, Obstructive|sleep apnea, obstructive
5096069|NCT03397563|Polysomnography|polysomnography
5096070|NCT03397550|taste threshold|taste threshold
5096071|NCT03397550|salt restriction|salt restriction
5096072|NCT03397537|Breast Neoplasms Endocrine-responsive Neoadjuvant Duration Letrozole|breast neoplasms endocrine-responsive neoadjuvant duration letrozole
5096073|NCT03397498|computerized cognitive training|computerized cognitive training
5096074|NCT03397472|Insomnia|insomnia
5096075|NCT03397472|Treatment|treatment
5096076|NCT03397472|magnetic field modulation|magnetic field modulation
5096077|NCT03397459|cervicobrachial neuralgia|cervicobrachial neuralgia
5096078|NCT03397459|sagittal balance|sagittal balance
5096080|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
5096081|NCT03397446|Lisdexamfetamine|lisdexamfetamine
5096082|NCT03397446|Vyvanse|vyvanse
5096083|NCT03397446|Eating Disorders|eating disorders
5096084|NCT03397446|Mental Disorders|mental disorders
5096085|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants
5096086|NCT03397446|Dextroamphetamine|dextroamphetamine
5096088|NCT03397446|Binge Eating|binge eating
5096089|NCT03397446|Purging|purging
5096090|NCT03397446|Bulimia Nervosa|bulimia nervosa
5096091|NCT03397433|Antibiotic Stewardship|antibiotic stewardship
5096092|NCT03397433|Information Technology|information technology
5096093|NCT03397433|Healthcare Outcomes|healthcare outcomes
5096094|NCT03397433|Antibiotic Resistance|antibiotic resistance
5096095|NCT03397433|Bacterial Infection|bacterial infection
5096096|NCT03397394|PARP inhibitor|parp inhibitor
5096097|NCT03397394|PARPi|parpi
5096099|NCT03397394|ATLAS|atlas
5096100|NCT03397394|homologous recombination|homologous recombination
5096101|NCT03397394|DNA repair|dna repair
5096102|NCT03397394|LOH|loh
5096103|NCT03397394|DNA defect|dna defect
5096104|NCT03397394|DNA anomaly|dna anomaly
5096105|NCT03397394|Rucaparib|rucaparib
5096106|NCT03397394|MIBC|mibc
5096107|NCT03397355|Pulmonary Nodule; Lung Cancer; Biopsy; Biomarker.|pulmonary nodule; lung cancer; biopsy; biomarker.
5096108|NCT03397329|Healthy Volunteers|healthy volunteers
5096109|NCT03397316|immediate implant|immediate implant
5106924|NCT03329573|GSKT|gskt
5096123|NCT03397160|Transformative Impact Award|transformative impact award
5096124|NCT03397160|Early stage|early stage
5096125|NCT03397160|Active surveillance|active surveillance
5096126|NCT03397160|Decision aid|decision aid
5096127|NCT03397160|Coaching session|coaching session
5096128|NCT03397160|Personalized|personalized
5096129|NCT03397160|University of California, San Francisco (UCSF)|university of california, san francisco (ucsf)
5096130|NCT03397160|Validation|validation
5096131|NCT03397121|HeFH|hefh
5096132|NCT03397121|LDL-C|ldl-c
5096133|NCT03397121|Inclisiran|inclisiran
5096134|NCT03397108|Inflammatory Bowel Disease|inflammatory bowel disease
5096135|NCT03397108|Crohn disease|crohn disease
5096136|NCT03397108|Colitis|colitis
5096137|NCT03397108|TNF|tnf
5096138|NCT03397108|Breast milk|breast milk
5961912|NCT04284150|Supraventricular tachycardia|supraventricular tachycardia
5096139|NCT03397108|monoclonal antibody|monoclonal antibody
5096140|NCT03397095|stem cells, ischemic heart disease.|stem cells, ischemic heart disease.
5096141|NCT03397082|Endouterine manual aspiration|endouterine manual aspiration
5096171|NCT03396861|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5096172|NCT03396861|subconjunctival injection|subconjunctival injection
5096173|NCT03396848|Rehabilitation|rehabilitation
5096174|NCT03396848|Online Clinic|online clinic
5096175|NCT03396822|multiple sclerosis|multiple sclerosis
5096176|NCT03396822|7T MRI|7t mri
5096177|NCT03396822|Meningeal inflammation|meningeal inflammation
5096178|NCT03396809|punctal plugs|punctal plugs
5096179|NCT03396809|dry eye|dry eye
5096180|NCT03396809|ocular surface disease index|ocular surface disease index
5096181|NCT03396796|Vagus nerve|vagus nerve
5096235|NCT03396575|Total tumor mRNA-pulsed autologous Dendritic Cells (DCs) (TTRNA-DCs)|total tumor mrna-pulsed autologous dendritic cells (dcs) (ttrna-dcs)
5096236|NCT03396575|Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)|tumor-specific ex vivo expanded autologous lymphocyte transfer (ttrna-xalt)
5096238|NCT03396575|Temozolomide (TMZ)|temozolomide (tmz)
5096239|NCT03396575|Cyclophosphamide (CTX)|cyclophosphamide (ctx)
5096240|NCT03396575|Fludarabine (Flu)|fludarabine (flu)
5096241|NCT03396575|Immunotherapy|immunotherapy
5096242|NCT03396575|Pediatric|pediatric
5096243|NCT03396575|Young Adult|young adult
5096244|NCT03396575|Brain Tumor|brain tumor
5096246|NCT03396575|Vaccine Therapy|vaccine therapy
5096247|NCT03396562|body composition|body composition
5096248|NCT03396562|klinefelter syndrome|klinefelter syndrome
5096249|NCT03396562|XXY|xxy
5096250|NCT03396562|Trisomy X|trisomy x
5096251|NCT03396562|XXX|xxx
5096257|NCT03396562|sex chromosome aneuploidy|sex chromosome aneuploidy
5096258|NCT03396562|sex chromosome trisomy|sex chromosome trisomy
5096259|NCT03396562|testosterone|testosterone
5096260|NCT03396562|XYYY|xyyy
5096261|NCT03396562|XXXX|xxxx
5096262|NCT03396562|XXXXX|xxxxx
5096263|NCT03396562|XXXYY|xxxyy
5096264|NCT03396562|XXYYY|xxyyy
5096265|NCT03396562|XYYYY|xyyyy
5096266|NCT03396562|developmental delay|developmental delay
5096267|NCT03396562|speech development|speech development
5096268|NCT03396549|tDCS|tdcs
5096269|NCT03396549|food craving|food craving
5096270|NCT03396549|tDCS sham procedure|tdcs sham procedure
5096271|NCT03396549|montage|montage
5094099|NCT03410797|MTD|mtd
5096281|NCT03396458|Disease prevalence|disease prevalence
5096283|NCT03396458|Migrant|migrant
5096284|NCT03396458|Turkish|turkish
5096285|NCT03396458|Belgium|belgium
5096286|NCT03396432|laryngoscope|laryngoscope
5096287|NCT03396432|intubation|intubation
5096288|NCT03396432|first attempt success|first attempt success
5096289|NCT03396432|oxygen saturation|oxygen saturation
5096290|NCT03396432|airway management|airway management
5096291|NCT03396432|Videolaryngoscopy|videolaryngoscopy
5096292|NCT03396432|Direct laryngoscopy|direct laryngoscopy
5096293|NCT03396406|trigeminal neuralgia, radiofrequency|trigeminal neuralgia, radiofrequency
5096294|NCT03396393|Dihydroartemisinin;Systemic Lupus Erythematosus|dihydroartemisinin;systemic lupus erythematosus
5096295|NCT03396367|Relationships|relationships
5096296|NCT03396367|YMSM|ymsm
5096297|NCT03396367|HIV/AIDS|hiv/aids
5096298|NCT03396367|PrEP|prep
5096299|NCT03396367|Drug Use|drug use
5096300|NCT03396341|BRCA1/2 Mutations|brca1/2 mutations
5096301|NCT03396341|17-489|17-489
5096302|NCT03396315|premenopausal women|premenopausal women
5096303|NCT03396302|Exercise|exercise
5096304|NCT03396302|Nutrition|nutrition
5096305|NCT03396302|Internet|internet
5096306|NCT03396302|Obesity|obesity
5096307|NCT03396302|Hypertension|hypertension
5096308|NCT03396289|Cerebral Palsy|cerebral palsy
5096309|NCT03396289|Balance|balance
5096310|NCT03396289|Inspiratory Muscle Training|inspiratory muscle training
5096311|NCT03396289|6-Minute Walk Test|6-minute walk test
5096312|NCT03396289|Pulmonary Function Test|pulmonary function test
5096313|NCT03396289|Postural Stability|postural stability
5096314|NCT03396263|Personalised nutrition|personalised nutrition
5096315|NCT03396263|Mobile web application|mobile web application
5096316|NCT03396224|Total hip arthroplasty|total hip arthroplasty
5096317|NCT03396224|Hip implant|hip implant
5096318|NCT03396211|Metastatic|metastatic
5096319|NCT03396211|Unresectable|unresectable
5096320|NCT03396198|Gastrointestinal Microbiome|gastrointestinal microbiome
5096321|NCT03396198|Infants|infants
5096322|NCT03396172|COPD|copd
5096323|NCT03396172|Homecare|homecare
5096324|NCT03396172|Oxygen|oxygen
5096325|NCT03396172|Telemedicine|telemedicine
5096326|NCT03396172|Automated oxygen adjustment|automated oxygen adjustment
5096327|NCT03396172|Rehabilitation program|rehabilitation program
5096328|NCT03396159|liver transplantation|liver transplantation
5096329|NCT03396159|mini fluid challenge|mini fluid challenge
5096330|NCT03396146|Pancreatic polypeptide|pancreatic polypeptide
5096331|NCT03396146|Type 1 diabetes|type 1 diabetes
5096332|NCT03396146|Chronic pancreatitis|chronic pancreatitis
5096337|NCT03396094|high flow oxygenation, rapid sequence intubation|high flow oxygenation, rapid sequence intubation
5096338|NCT03396081|Heart Failure|heart failure
5096339|NCT03396081|Care pathway|care pathway
5096340|NCT03396081|Transition program|transition program
5096341|NCT03396081|Efficiency|efficiency
5096342|NCT03396055|decompression surgery|decompression surgery
5096343|NCT03396055|functional outcome|functional outcome
5096344|NCT03396055|biomechanic|biomechanic
5096345|NCT03396055|rehabilitation|rehabilitation
5096346|NCT03396042|CEP290|cep290
5096347|NCT03396042|LCA10|lca10
5096348|NCT03396042|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
5096349|NCT03396042|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
5096350|NCT03396042|Congenital Retinal Blindness|congenital retinal blindness
5096351|NCT03396042|p.Cys998X|p.cys998x
5096352|NCT03396042|c.2991+1655A>G|c.2991+1655a>g
5096353|NCT03396042|Eye Diseases Signs and Symptoms|eye diseases signs and symptoms
5096354|NCT03396042|Genetic Diseases, Inborn|genetic diseases, inborn
5096355|NCT03396042|Congenital Abnormalities|congenital abnormalities
5096356|NCT03396042|Eye Abnormalities|eye abnormalities
5096357|NCT03396029|Lifestyle intervention|lifestyle intervention
5096358|NCT03396029|Diet|diet
5096359|NCT03396029|Smoking cessation|smoking cessation
5096360|NCT03396029|Physical activity|physical activity
5096361|NCT03396029|Alcohol|alcohol
5096362|NCT03396029|Body mass index|body mass index
5096363|NCT03396029|colorectal cancer screening|colorectal cancer screening
5096364|NCT03396029|sigmoidoscopy|sigmoidoscopy
5096365|NCT03395990|femoral nerve block|femoral nerve block
5096366|NCT03395990|adductor canal block|adductor canal block
5096367|NCT03395990|analgesia|analgesia
5094177|NCT03410212|success|success
5096375|NCT03395951|Fluid Balance|fluid balance
5096376|NCT03395951|De-escalation fluid therapy|de-escalation fluid therapy
5096377|NCT03395951|De-resuscitation|de-resuscitation
5096378|NCT03395951|Guyton|guyton
5096379|NCT03395951|Guytonian Approach|guytonian approach
5096380|NCT03395951|Furosemide|furosemide
5096381|NCT03395951|Cardiac Output|cardiac output
5096382|NCT03395951|Cardiac Index|cardiac index
5096383|NCT03395938|SCREENING|screening
5096404|NCT03395821|gynecology|gynecology
5096405|NCT03395821|laparoscopy|laparoscopy
5096406|NCT03395821|resident education|resident education
5096407|NCT03395821|simulation|simulation
5096408|NCT03395821|surgical curriculum|surgical curriculum
5096409|NCT03395795|Infantile Spinal Muscular Atrophy|infantile spinal muscular atrophy
5096410|NCT03395795|Respiratory Decompensations|respiratory decompensations
5096411|NCT03395756|Depot Medroxyprogesterone acetate|depot medroxyprogesterone acetate
4981052|NCT04111133|Carvedilol|carvedilol
5096412|NCT03395756|Injectable birth control|injectable birth control
5096413|NCT03395717|Stroke|stroke
5096414|NCT03395717|Robot|robot
5096415|NCT03395717|Hemiparesis|hemiparesis
5096416|NCT03395717|Gait Training|gait training
5096417|NCT03395717|Rehabilitation|rehabilitation
5096418|NCT03395717|Exoskeleton|exoskeleton
5096419|NCT03395717|Functional Recovery|functional recovery
5096420|NCT03395691|axillary vein|axillary vein
5096421|NCT03395691|central venous catheterization|central venous catheterization
5096422|NCT03395691|ultrasound|ultrasound
5096423|NCT03395691|cardiac surgery|cardiac surgery
5096424|NCT03395691|complication|complication
5096425|NCT03395678|Microneedling|microneedling
5096426|NCT03395678|Nonablative fractional lasers|nonablative fractional lasers
5096427|NCT03395678|Fitzpatrick skin types III-V|fitzpatrick skin types iii-v
5096428|NCT03395678|Arophic acne scarring|arophic acne scarring
5096429|NCT03395652|pregnancy, physical activity, fetal growth|pregnancy, physical activity, fetal growth
5096430|NCT03395639|Children|children
5096431|NCT03395639|Pediatrics|pediatrics
5096432|NCT03395639|Cardiac disease with potential for thromboembolic complications|cardiac disease with potential for thromboembolic complications
5096433|NCT03395639|Prophylactic treatment|prophylactic treatment
5096434|NCT03395639|Anticoagulant drugs|anticoagulant drugs
5096435|NCT03395587|glioblastoma,|glioblastoma,
5096436|NCT03395587|immunotherapy|immunotherapy
5096437|NCT03395587|dendritic cells|dendritic cells
5096438|NCT03395587|vaccination|vaccination
5096439|NCT03395535|Primary Open Angle Glaucoma|primary open angle glaucoma
5096440|NCT03395535|Glaucoma|glaucoma
5096441|NCT03395535|Ocular Hypertension|ocular hypertension
5096442|NCT03395535|POAG|poag
5096444|NCT03395535|Laser|laser
5096445|NCT03395509|Mass screening|mass screening
5096446|NCT03395509|cardiovascular disease|cardiovascular disease
5096447|NCT03395509|diabetes|diabetes
5096448|NCT03395496|pulpotomy|pulpotomy
5096449|NCT03395496|pediatric dentistry|pediatric dentistry
5096450|NCT03395496|primary molars|primary molars
5096451|NCT03395483|peripheral perfusion|peripheral perfusion
5096452|NCT03395483|Haemodynamic Instability|haemodynamic instability
5096453|NCT03395483|mesenteric bloodflow|mesenteric bloodflow
5096454|NCT03395431|Autologuous serum|autologuous serum
5096455|NCT03395431|dry eyes disease|dry eyes disease
5096456|NCT03395431|fingerprick blood|fingerprick blood
5096457|NCT03395418|COPD|copd
5096458|NCT03395418|Asthma|asthma
5096459|NCT03395418|Inhaled Therapeutics|inhaled therapeutics
5096468|NCT03395379|Radiofrequency|radiofrequency
5096469|NCT03395379|Thermal Protection|thermal protection
5096470|NCT03395379|Percutaneous thermal ablation|percutaneous thermal ablation
5096471|NCT03395379|Kidney neoplasms|kidney neoplasms
5096472|NCT03395366|Hemodialysis|hemodialysis
5096473|NCT03395366|End Stage Renal Disease|end stage renal disease
5096475|NCT03395340|Epidermal|epidermal
5096476|NCT03395340|JAK Inhibitors|jak inhibitors
5096477|NCT03395340|Skin|skin
5096478|NCT03395340|JAK-STAT|jak-stat
5096479|NCT03395314|Borderline Personality Disorder|borderline personality disorder
5096480|NCT03395314|Ketamine|ketamine
5096481|NCT03395314|Suicide|suicide
5096482|NCT03395314|Social Cognition|social cognition
5096483|NCT03395301|hysteroscopy|hysteroscopy
5096489|NCT03395249|tolerability|tolerability
5096490|NCT03395249|pharmacokinetics|pharmacokinetics
5096492|NCT03395223|Acquired Methaemoglobinemia|acquired methaemoglobinemia
5096493|NCT03395223|Methylene Blue|methylene blue
5096495|NCT03395119|Ozone exposure|ozone exposure
5096496|NCT03395119|Healthy Adults|healthy adults
5096497|NCT03395106|vaccine|vaccine
5096498|NCT03395106|public health|public health
5096499|NCT03395093|bronchoscopy|bronchoscopy
5096500|NCT03395093|conscious sedation|conscious sedation
5096501|NCT03395093|fentanyl|fentanyl
5096516|NCT03395054|cervical stabilization exercises|cervical stabilization exercises
5096517|NCT03395041|vulnerable plaque, CT imaging, oral bacteria, inflammation|vulnerable plaque, ct imaging, oral bacteria, inflammation
5096521|NCT03395015|Reconstructive surgical procedures|reconstructive surgical procedures
5096523|NCT03395015|Treatment outcome|treatment outcome
5096524|NCT03395015|Outcome Assessment (Health Care)|outcome assessment (health care)
5096525|NCT03395015|Photogrammetry|photogrammetry
5096526|NCT03395015|Physical Appearance, Body|physical appearance, body
5096527|NCT03395002|Tiotropium|tiotropium
5096528|NCT03395002|Salmeterol|salmeterol
5096529|NCT03395002|Fluticasone|fluticasone
5096530|NCT03395002|COPD|copd
5096531|NCT03395002|Bronchodilator effect|bronchodilator effect
5096532|NCT03395002|Discair|discair
5096533|NCT03395002|Diskus|diskus
5096534|NCT03395002|Spirometry|spirometry
5096535|NCT03394963|Food-Based Dietary guideline|food-based dietary guideline
5096536|NCT03394963|Healthy Eating Index|healthy eating index
5096537|NCT03394963|Healthy Diet|healthy diet
5096538|NCT03394963|Protocol|protocol
5096539|NCT03394963|Ethiopia|ethiopia
5096540|NCT03394950|thrombolysis|thrombolysis
5096541|NCT03394950|Butyphthalide|butyphthalide
5096542|NCT03394924|PBC|pbc
5096543|NCT03394924|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
5096544|NCT03394898|Chronic Pain|chronic pain
5096545|NCT03394898|Body Mass Index|body mass index
5096546|NCT03394898|Eating Habits|eating habits
5096547|NCT03394872|Pleural effusion|pleural effusion
5096548|NCT03394872|Mechanical Ventilation|mechanical ventilation
5096549|NCT03394872|Ultrasonography|ultrasonography
5096550|NCT03394872|Drainage|drainage
5096551|NCT03394833|preoperative|preoperative
5096552|NCT03394833|fluid therapy|fluid therapy
5096553|NCT03394833|hemodynamics|hemodynamics
5096554|NCT03394833|anesthesia induction|anesthesia induction
5096555|NCT03394833|rapid sequence induction|rapid sequence induction
5096556|NCT03394833|TCI|tci
5096557|NCT03394820|Dexamethasone|dexamethasone
5096558|NCT03394820|Supraclavicular block|supraclavicular block
5096559|NCT03394794|anorectal physiology|anorectal physiology
5096560|NCT03394794|therapies|therapies
5096561|NCT03394794|quality fo life|quality fo life
5096562|NCT03394755|thrombocytopenia|thrombocytopenia
5096563|NCT03394755|bleeding|bleeding
5096564|NCT03394742|Peer Group|peer group
5096565|NCT03394742|Quality of Life|quality of life
5096566|NCT03394729|Propole|propole
5096567|NCT03394729|Xylitol|xylitol
5096568|NCT03394729|Saliva|saliva
5096569|NCT03394716|MRI|mri
5096570|NCT03394716|Radiotherapy|radiotherapy
5096572|NCT03394703|screening|screening
5096573|NCT03394703|Low-dose Computed Tomography|low-dose computed tomography
5096574|NCT03394703|Smokers|smokers
5096575|NCT03394664|Body composition|body composition
5096576|NCT03394664|Feeding study|feeding study
5096577|NCT03394664|Ketogenic diet|ketogenic diet
5096578|NCT03394664|Weight loss|weight loss
5096579|NCT03394664|Energy Expenditure|energy expenditure
5096580|NCT03394651|male|male
5096581|NCT03394651|lower urinary tract symptoms|lower urinary tract symptoms
5096582|NCT03394651|comorbidities|comorbidities
5096583|NCT03394651|chronic kidney diseases|chronic kidney diseases
5096584|NCT03394651|urodynamics|urodynamics
5096585|NCT03394651|medical therapy|medical therapy
5096586|NCT03394651|surgical treatment|surgical treatment
5096587|NCT03394638|eHealth|ehealth
5096588|NCT03394638|Bariatric surgery|bariatric surgery
5096589|NCT03394638|Obesity|obesity
5096590|NCT03394638|Telemedicine|telemedicine
5096591|NCT03394625|Socket Shield|socket shield
5096592|NCT03394625|immediate implant|immediate implant
5096593|NCT03394625|ridge preservation|ridge preservation
5096594|NCT03394612|Scar|scar
5096607|NCT03394586|Clinical Response|clinical response
5096608|NCT03394586|Clinical Remission|clinical remission
5096609|NCT03394586|Ulcerative Colitis|ulcerative colitis
5096610|NCT03394573|Diabetic macular edema|diabetic macular edema
5096611|NCT03394560|Spinal Cord Injury|spinal cord injury
5096612|NCT03394560|transcranial magnetic stimulation|transcranial magnetic stimulation
5096613|NCT03394560|body weight-support treadmill training|body weight-support treadmill training
5096615|NCT03394534|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5096616|NCT03394534|Frailty|frailty
5096617|NCT03394534|electronic Frailty Index|electronic frailty index
5096618|NCT03394534|eFI|efi
5096619|NCT03394534|Care and Support plan|care and support plan
5096620|NCT03394534|Primary Care|primary care
5096621|NCT03394521|glaucoma suspect|glaucoma suspect
5096622|NCT03394521|ocular hypertension|ocular hypertension
5096623|NCT03394521|progression|progression
5096624|NCT03394495|Fatigue|fatigue
5096625|NCT03394495|Frailty|frailty
5096626|NCT03394495|Cluster-RCT|cluster-rct
5096627|NCT03394495|Exercise|exercise
5096628|NCT03394495|Behavioral change|behavioral change
5096629|NCT03394469|Obesity|obesity
5096630|NCT03394469|Sarcopenia|sarcopenia
5096631|NCT03394430|sevoflurane|sevoflurane
5096632|NCT03394430|epileptiform EEG|epileptiform eeg
5096633|NCT03394430|midazolam|midazolam
5096634|NCT03394430|dexmedetomidine|dexmedetomidine
5096635|NCT03394404|ECG-I Mapping Pulmonary Vein Isolation|ecg-i mapping pulmonary vein isolation
5096636|NCT03394391|Adherence|adherence
5096637|NCT03394391|Adolescents|adolescents
5096638|NCT03394391|Antiretroviral therapy|antiretroviral therapy
5096639|NCT03394391|HIV|hiv
5096640|NCT03394391|Nigeria|nigeria
5096641|NCT03394391|Randomized controlled trial|randomized controlled trial
5096642|NCT03394391|Short message services|short message services
5096643|NCT03394365|Epstein-Barr Virus (EBV)-associated Lymphoproliferative Disease (LPD)|epstein-barr virus (ebv)-associated lymphoproliferative disease (lpd)
5096644|NCT03394365|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5096645|NCT03394365|Cytotoxic T lymphocyte (CTL)|cytotoxic t lymphocyte (ctl)
5096646|NCT03394365|Cancer After Transplant|cancer after transplant
5096647|NCT03394365|Kidney transplant|kidney transplant
5096648|NCT03394365|Renal transplant|renal transplant
5096649|NCT03394365|Liver transplant|liver transplant
5096650|NCT03394365|Heart transplant|heart transplant
5096651|NCT03394365|Lung transplant|lung transplant
5096652|NCT03394365|Intestinal transplant|intestinal transplant
5096653|NCT03394365|Pancreas transplant|pancreas transplant
5096654|NCT03394365|Post-transplant Lymphoma|post-transplant lymphoma
5096655|NCT03394365|Solid Organ Transplant (SOT)|solid organ transplant (sot)
5096656|NCT03394365|Bone Marrow Transplant Complications|bone marrow transplant complications
5096657|NCT03394365|Epstein-Barr Virus-specific Cytotoxic T Lymphocytes (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocytes (ebv-ctl)
5096658|NCT03394365|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
5096659|NCT03394365|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5096660|NCT03394365|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
5096661|NCT03394365|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
5096662|NCT03394352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5096663|NCT03394352|Insulin pump|insulin pump
5096664|NCT03394352|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5096665|NCT03394352|Exercise|exercise
5096666|NCT03394352|Activity on Board|activity on board
5096667|NCT03394352|Decision Support System|decision support system
5096668|NCT03394339|Systematic review and meta-anaylsis|systematic review and meta-anaylsis
5096669|NCT03394339|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5096670|NCT03394339|Dietary guidelines|dietary guidelines
5096671|NCT03394339|Fruit|fruit
5096672|NCT03394339|Vegetables|vegetables
5096673|NCT03394313|Registry|registry
5096674|NCT03394274|transfusion|transfusion
5096675|NCT03394274|liberal|liberal
5096676|NCT03394274|restrictive|restrictive
5096677|NCT03394261|Opioid Use Disorder (OUD)|opioid use disorder (oud)
5096678|NCT03394261|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
5096679|NCT03394261|Patient Decision Aid|patient decision aid
5096680|NCT03394248|Subconcussive head injury|subconcussive head injury
5096681|NCT03394235|hair transplant|hair transplant
5096687|NCT03394183|functional capacity|functional capacity
5094504|NCT03408145|Injection|injection
5096697|NCT03394079|PCI|pci
5096698|NCT03394066|Repetitive TMS (rTMS)|repetitive tms (rtms)
5096699|NCT03394066|Simultaneous TMS and MRI|simultaneous tms and mri
5096700|NCT03394053|SCID|scid
5096701|NCT03394053|Natural Killer (NK) cell defieciency|natural killer (nk) cell defieciency
5096702|NCT03394053|Combined Immunodeficiency|combined immunodeficiency
5096703|NCT03394053|T-Cell Lymphocytopenia|t-cell lymphocytopenia
5096704|NCT03394053|Of Immune Pathways|of immune pathways
5096705|NCT03394040|Diarrhea|diarrhea
5096706|NCT03394040|Point-of-Need|point-of-need
5096707|NCT03394040|Pathogen Identification|pathogen identification
5096712|NCT03393988|Transversus abdominis plane block,|transversus abdominis plane block,
5096713|NCT03393988|Dexmedetomidine|dexmedetomidine
5096714|NCT03393988|Fentanyl|fentanyl
5096715|NCT03393988|Live liver donor|live liver donor
5096716|NCT03393988|Liver transplantation|liver transplantation
5096717|NCT03393962|Ovarian cancer|ovarian cancer
5096718|NCT03393962|Cytotoxic lymphocyte|cytotoxic lymphocyte
4967064|NCT04195438|Hepatic Regeneration|hepatic regeneration
4967065|NCT04195438|Arterial Blood Gas|arterial blood gas
4967066|NCT04195438|CO Production|co production
5096719|NCT03393962|Cancer specific antigen|cancer specific antigen
5096720|NCT03393949|Methylprednisolone|methylprednisolone
5096721|NCT03393949|Postoperative cognitive function|postoperative cognitive function
5096722|NCT03393949|Immunological function|immunological function
5096723|NCT03393936|CCT301-38|cct301-38
5096724|NCT03393936|CCT301-59|cct301-59
5096725|NCT03393936|stage IV metastatic renal cell carcinoma|stage iv metastatic renal cell carcinoma
5096726|NCT03393936|AXL|axl
5096727|NCT03393936|ROR2|ror2
5096728|NCT03393897|fluid responsiveness|fluid responsiveness
5096729|NCT03393897|cardiac surgery|cardiac surgery
5096730|NCT03393832|Oral care|oral care
5096731|NCT03393832|Oropharyngeal mother's milk|oropharyngeal mother's milk
5096732|NCT03393819|antimicrobial skin solution|antimicrobial skin solution
5096733|NCT03393819|skin preparation|skin preparation
5096734|NCT03393806|Asthma Control Questionnaire|asthma control questionnaire
5096735|NCT03393806|Allergic fungal airway disease|allergic fungal airway disease
5096736|NCT03393806|Asthma Quality of Life Questionnaire|asthma quality of life questionnaire
5096737|NCT03393806|Holter monitoring|holter monitoring
5096738|NCT03393806|Asthma|asthma
5096739|NCT03393793|Heart transplantation|heart transplantation
5096740|NCT03393767|CNV|cnv
5096741|NCT03393767|AMD|amd
5096742|NCT03393767|ranibizumab|ranibizumab
5096743|NCT03393754|Hepatitis B Vaccines|hepatitis b vaccines
5096744|NCT03393741|Metastatic breast cancer|metastatic breast cancer
5096745|NCT03393728|hyperthyroidism|hyperthyroidism
5096746|NCT03393728|heart rate variability|heart rate variability
5096747|NCT03393728|propanolol|propanolol
5096748|NCT03393728|Africa|africa
5096749|NCT03393715|Diabetes|diabetes
5096750|NCT03393715|Hypertension|hypertension
5096751|NCT03393715|Perindopril|perindopril
5096752|NCT03393715|chronobiology|chronobiology
5096753|NCT03393715|Africa|africa
5096754|NCT03393702|Postoperative pain|postoperative pain
5096755|NCT03393702|Anxiety|anxiety
5096756|NCT03393702|Postoperative Complications|postoperative complications
5096757|NCT03393702|Patient Satisfaction|patient satisfaction
5096758|NCT03393689|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
5096759|NCT03393689|Angiogenesis PET/MR|angiogenesis pet/mr
5096760|NCT03393689|Acoustic Neuroma|acoustic neuroma
5096764|NCT03393663|chronic kidney disease|chronic kidney disease
5096765|NCT03393663|cardiovascular disease|cardiovascular disease
5096766|NCT03393663|mortality|mortality
5096767|NCT03393663|end stage renal disease|end stage renal disease
5096768|NCT03393650|exercise|exercise
5096769|NCT03393650|protein|protein
5096770|NCT03393650|muscle function|muscle function
5096771|NCT03393650|aging|aging
5096772|NCT03393637|prenatal anxiety|prenatal anxiety
5096773|NCT03393637|pregnancy|pregnancy
5096774|NCT03393637|depression|depression
5096775|NCT03393637|military|military
5096776|NCT03393637|intervention|intervention
5096777|NCT03393624|Dark circles|dark circles
5096778|NCT03393624|Periorbital hyperchromia|periorbital hyperchromia
5096779|NCT03393624|Sleep Quality|sleep quality
5096780|NCT03393624|Facial aesthetics|facial aesthetics
5096781|NCT03393585|Respiratory Rates|respiratory rates
5096782|NCT03393546|pain|pain
5096783|NCT03393546|acupressure|acupressure
5096784|NCT03393546|alzheimer|alzheimer
5096785|NCT03393533|Third molar;|third molar;
5096786|NCT03393533|Oral surgery;|oral surgery;
5096787|NCT03393533|Pain;|pain;
5096788|NCT03393533|Edema;|edema;
5096789|NCT03393533|Trismus.|trismus.
5096790|NCT03393520|Agitation|agitation
5096791|NCT03393520|Dementia of the Alzheimer's type|dementia of the alzheimer's type
5096792|NCT03393520|Alzheimer's disease|alzheimer's disease
5096803|NCT03393442|Magnetic Resonance Imaging|magnetic resonance imaging
5096805|NCT03393442|Gd-deposits|gd-deposits
5096806|NCT03393442|brain imaging|brain imaging
5096807|NCT03393442|breast cancer screening|breast cancer screening
5096808|NCT03393416|MASCT-I|masct-i
5096809|NCT03393403|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
5096810|NCT03393377|arterial stiffness|arterial stiffness
5096811|NCT03393377|endothelial dysfunction|endothelial dysfunction
5096812|NCT03393377|fluvastatin|fluvastatin
5096813|NCT03393377|valsartan|valsartan
5096814|NCT03393377|inflammatory markers|inflammatory markers
5096815|NCT03393377|oxidative stress|oxidative stress
5096816|NCT03393377|SIRT1|sirt1
5096817|NCT03393351|Shared Decision-Making|shared decision-making
5096818|NCT03393351|Decision Making|decision making
5096819|NCT03393351|Patient Participation|patient participation
5096820|NCT03393351|Patient Centeredness|patient centeredness
5096821|NCT03393351|Health Services Research|health services research
5096822|NCT03393351|Implementation Research|implementation research
5096823|NCT03393351|Oncology|oncology
5096824|NCT03393351|Stepped Wedge Design|stepped wedge design
5096825|NCT03393351|Mixed Methods|mixed methods
5961913|NCT04284150|Dexmedetomidine|dexmedetomidine
5961914|NCT04284150|Midazolam|midazolam
5961915|NCT04284150|Heart rate variability|heart rate variability
5961916|NCT04284137|Physical Activity|physical activity
5096826|NCT03393338|Diabetes|diabetes
5096827|NCT03393338|African American|african american
5096828|NCT03393338|Emergency Department visits|emergency department visits
5096829|NCT03393312|Transcranial direct current stimulation|transcranial direct current stimulation
5096830|NCT03393312|Biological Psychiatry|biological psychiatry
5096831|NCT03393312|Depression|depression
5096832|NCT03393312|Decision-making|decision-making
5096833|NCT03393299|elderly people|elderly people
5096834|NCT03393299|geriatric short-stay|geriatric short-stay
5096835|NCT03393299|STOPP/START criteria|stopp/start criteria
5096836|NCT03393273|Stem Cell autologous graft|stem cell autologous graft
5096837|NCT03393273|Elotuzumab|elotuzumab
5096838|NCT03393273|Multiple myeloma|multiple myeloma
5096839|NCT03393273|Elderly|elderly
5096840|NCT03393260|cancer|cancer
5745049|NCT00339690|Allergy|allergy
5096841|NCT03393260|emergency departments (ED)|emergency departments (ed)
5096842|NCT03393247|infliximab|infliximab
5096843|NCT03393247|azathioprine|azathioprine
5096844|NCT03393234|Ultra-low rectal cancer|ultra-low rectal cancer
5096845|NCT03393234|Intersphincteric resection|intersphincteric resection
5096846|NCT03393234|IORT|iort
5096847|NCT03393208|Diabetes Mellitus|diabetes mellitus
5096848|NCT03393208|Glucophage Immediate Release (GIR)|glucophage immediate release (gir)
5096849|NCT03393208|Bioequivalence Study|bioequivalence study
5096850|NCT03393195|Weight loss|weight loss
5096851|NCT03393195|Diet|diet
5096852|NCT03393195|Time-restricted feeding|time-restricted feeding
4981555|NCT04108117|Recurrence|recurrence
5096853|NCT03393143|Primary Health Care; Analgesics, Opioid; Medicaid|primary health care; analgesics, opioid; medicaid
5096854|NCT03393130|Burns|burns
5096855|NCT03393130|Young Adult|young adult
5096856|NCT03393130|Cognitive Impairment|cognitive impairment
5096857|NCT03393130|Apolipoprotein E, Deficiency or Defect of|apolipoprotein e, deficiency or defect of
5096858|NCT03393130|Intensive Care Neurological Disorder|intensive care neurological disorder
5096859|NCT03393130|Quality of Life|quality of life
5096860|NCT03393130|Inflammation, Brain|inflammation, brain
5096861|NCT03393117|Reconstruction|reconstruction
5096862|NCT03393117|Bupivacaine|bupivacaine
5096863|NCT03393117|Liposomal Bupivacaine|liposomal bupivacaine
5096864|NCT03393104|Chronic Low Back Pain|chronic low back pain
5096865|NCT03393104|Motor Control Exercise|motor control exercise
5096866|NCT03393104|Patient Education|patient education
5096867|NCT03393065|lung ultrasounds|lung ultrasounds
5096868|NCT03393065|fluid managements|fluid managements
5096869|NCT03393065|critical care patients|critical care patients
5096870|NCT03393052|L-RECORD|l-record
5096871|NCT03393052|Radial|radial
5096872|NCT03393052|Femoral|femoral
5096873|NCT03393052|CABG|cabg
5096874|NCT03393052|coronary artery bypass graft|coronary artery bypass graft
5096875|NCT03393039|fMRI|fmri
5096876|NCT03393039|Reward|reward
5096877|NCT03393039|Food Choices|food choices
5087289|NCT03452865|sepsis|sepsis
5096884|NCT03393013|nephritis|nephritis
5096893|NCT03392974|Gene Therapy|gene therapy
5096894|NCT03392974|Clotting Disorders|clotting disorders
5096895|NCT03392974|Blood Disorder|blood disorder
5096896|NCT03392974|Blood Coagulation Disorders|blood coagulation disorders
5096897|NCT03392974|Inherited Blood Coagulation Disorders|inherited blood coagulation disorders
5096898|NCT03392974|Hematologic Diseases|hematologic diseases
5096899|NCT03392974|Coagulation Protein Disorders|coagulation protein disorders
5096905|NCT03392961|Oral insulin|oral insulin
5096907|NCT03392961|Insulin concentration|insulin concentration
5096908|NCT03392961|Prandial insulin|prandial insulin
5096909|NCT03392961|Post Prandial Glucose (PPG)|post prandial glucose (ppg)
5096910|NCT03392948|atrial fibrillation|atrial fibrillation
5096911|NCT03392948|prosthetic valves|prosthetic valves
5096912|NCT03392948|pulmonary embolism|pulmonary embolism
5096913|NCT03392948|venous thrombosis|venous thrombosis
5096914|NCT03392948|percutaneous coronary interventions|percutaneous coronary interventions
5096915|NCT03392948|chronic anticoagulant treatment|chronic anticoagulant treatment
5096916|NCT03392909|Nonsense Mutations|nonsense mutations
5096917|NCT03392883|Latin America|latin america
5096918|NCT03392883|Depression|depression
5096919|NCT03392883|mHealth|mhealth
5096920|NCT03392883|Problematic Alcohol Use|problematic alcohol use
5096921|NCT03392870|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5096922|NCT03392870|Transition program|transition program
5096923|NCT03392857|Critical care|critical care
5096924|NCT03392831|Central Venous Catheters|central venous catheters
5096925|NCT03392831|Vascular Access Devices|vascular access devices
5096926|NCT03392831|Nursing|nursing
5096927|NCT03392831|Cost Effectiveness|cost effectiveness
5096928|NCT03392831|PICC|picc
5096929|NCT03392766|fibreoptic intubation|fibreoptic intubation
5096930|NCT03392766|double lumen tube|double lumen tube
5096931|NCT03392766|difficult intubation|difficult intubation
5096932|NCT03392714|Bendamustine|bendamustine
5096934|NCT03392714|Pharmacokinetics|pharmacokinetics
5096935|NCT03392714|PCNSL|pcnsl
5096936|NCT03392714|Salvage therapy|salvage therapy
5096937|NCT03392688|onset , hamstring muscles, patellofemoral pain|onset , hamstring muscles, patellofemoral pain
5096938|NCT03392675|Breast and Nipple Pain|breast and nipple pain
5961917|NCT04284137|Qi Gong|qi gong
5096939|NCT03392675|Quantitative Sensory Testing|quantitative sensory testing
5096940|NCT03392675|Genotyping|genotyping
5096941|NCT03392675|Breastfeeding|breastfeeding
5096942|NCT03392649|Postoperative Atrial Fibrillation|postoperative atrial fibrillation
5096943|NCT03392649|Tragus Stimulation|tragus stimulation
5096944|NCT03392623|Epigenetics, Malar melasma,|epigenetics, malar melasma,
5342957|NCT01981369|Dexmedetomidine sedation|dexmedetomidine sedation
5342958|NCT01981369|Regional Anesthesia|regional anesthesia
5096945|NCT03392610|Intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection|intratracheal intubation, bronchoscopy, bronchoalveolar lavage, endoscopy, pulmonary medicine, critical care, anesthesia department, disinfection
5096946|NCT03392584|Locally advanced rectal cancer|locally advanced rectal cancer
5096947|NCT03392584|Deep infection|deep infection
5096948|NCT03392584|Microdialysis|microdialysis
5096949|NCT03392584|Surgical site infection|surgical site infection
5096950|NCT03392571|Resectable pancreatic cancer, NGC-triple regimen|resectable pancreatic cancer, ngc-triple regimen
5096952|NCT03392545|radiotherapy|radiotherapy
5096953|NCT03392545|immunetherapy|immunetherapy
5096954|NCT03392532|Astigmatism|astigmatism
5096955|NCT03392532|Axis orientation|axis orientation
5096956|NCT03392519|Brain connectivity|brain connectivity
4981670|NCT04107545|weight cycling|weight cycling
5096957|NCT03392519|Magnetic resonance imaging|magnetic resonance imaging
5096958|NCT03392519|Brain plasticity|brain plasticity
5096959|NCT03392519|Recovery|recovery
5096960|NCT03392506|CP-EBUS|cp-ebus
5096961|NCT03392506|EBUS-TBNA|ebus-tbna
5096962|NCT03392506|Real time elasticity|real time elasticity
5096963|NCT03392506|Staging of lung cancer|staging of lung cancer
5096964|NCT03392493|Stroke|stroke
5096965|NCT03392493|Robotic rehabilitation|robotic rehabilitation
5096966|NCT03392493|Hand function|hand function
5096967|NCT03392493|Activities of Daily Living|activities of daily living
5096968|NCT03392454|Partial Trapeziectomy|partial trapeziectomy
5096969|NCT03392454|Tendon Interposition|tendon interposition
5096970|NCT03392454|Trapeziectomy|trapeziectomy
5097063|NCT03391934|Cetuximab|cetuximab
5096977|NCT03392415|CTO|cto
5096978|NCT03392415|PCI|pci
5096979|NCT03392415|percutaneus coronary intervention|percutaneus coronary intervention
5096980|NCT03392402|Thyroid nodule|thyroid nodule
5096981|NCT03392402|Indeterminate thyroid nodule|indeterminate thyroid nodule
5096982|NCT03392402|Molecular biopsy|molecular biopsy
5096983|NCT03392402|Gene expression classifier|gene expression classifier
5096984|NCT03392389|mRNA-1653|mrna-1653
5096985|NCT03392389|human metapneumovirus|human metapneumovirus
5096986|NCT03392389|human parainfluenza vaccine|human parainfluenza vaccine
5096987|NCT03392376|ICU Delirium|icu delirium
5096990|NCT03392324|geographic atrophy|geographic atrophy
5096995|NCT03392324|dry macular degeneration|dry macular degeneration
5096996|NCT03392324|AMD|amd
5096997|NCT03392298|Thalassemia|thalassemia
5096998|NCT03392298|Pregnancy|pregnancy
5096999|NCT03392298|Globin expression|globin expression
5097000|NCT03392298|Colla corii asini|colla corii asini
5097001|NCT03392272|Ptosis|ptosis
5097002|NCT03392272|Müller's Muscle-Conjunctival Resection (MMCR)|müller's muscle-conjunctival resection (mmcr)
5097003|NCT03392272|Fibrin Glue|fibrin glue
5097004|NCT03392246|Non-Small Cell Lung Cancer|non-small cell lung cancer
5097005|NCT03392233|spinal metastases|spinal metastases
5097006|NCT03392233|Stereotactic body radiation therapy(SBRT)|stereotactic body radiation therapy(sbrt)
5097007|NCT03392233|breast cancer|breast cancer
5097008|NCT03392233|prostate cancer|prostate cancer
5097009|NCT03392233|non small cell lung cancer|non small cell lung cancer
5097010|NCT03392220|clinically negative neck|clinically negative neck
5097011|NCT03392220|regional control rate|regional control rate
5097012|NCT03392194|Behavioral interventions|behavioral interventions
5097013|NCT03392194|Sleep hygiene|sleep hygiene
5097014|NCT03392194|Yoga|yoga
5097015|NCT03392194|Community research|community research
5097016|NCT03392194|Short sleep duration|short sleep duration
5097017|NCT03392194|Low-income population|low-income population
5097018|NCT03392168|Psoriasis|psoriasis
5097019|NCT03392168|Plaque Psoriasis|plaque psoriasis
5097020|NCT03392142|Epstein-Barr Virus (EBV)-associated Lymphoproliferative Disease (LPD)|epstein-barr virus (ebv)-associated lymphoproliferative disease (lpd)
5097021|NCT03392142|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
5097022|NCT03392142|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5097023|NCT03392142|Allogeneic Hematopoietic Cell Transplant|allogeneic hematopoietic cell transplant
5097024|NCT03392142|Bone Marrow Transplant Complications|bone marrow transplant complications
5097025|NCT03392142|Cancer After Transplant|cancer after transplant
5097026|NCT03392142|Cytotoxic T lymphocyte (CTL)|cytotoxic t lymphocyte (ctl)
5097027|NCT03392142|Epstein-Barr Virus-specific Cytotoxic T Lymphocytes (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocytes (ebv-ctl)
5097028|NCT03392142|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
5097029|NCT03392142|Post-transplant Lymphoma|post-transplant lymphoma
5097030|NCT03392142|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5097031|NCT03392129|Asthma|asthma
5097032|NCT03392129|Child|child
5097033|NCT03392129|respiratory exercises|respiratory exercises
5097034|NCT03392129|Hydrotherapy|hydrotherapy
5097035|NCT03392129|Physical Therapy Specialty|physical therapy specialty
5097037|NCT03392129|Quality of life|quality of life
5097038|NCT03392129|Anxiety|anxiety
5097039|NCT03392129|Spirometry|spirometry
5097040|NCT03392129|Clinical trial|clinical trial
5097041|NCT03392103|Raltitrexed|raltitrexed
5097042|NCT03392103|IMRT|imrt
5097047|NCT03392012|anesthesia, patient safety, respiratory complications|anesthesia, patient safety, respiratory complications
5097048|NCT03391999|Mental Health, Physical Health|mental health, physical health
5097052|NCT03391960|CLABSI|clabsi
5097053|NCT03391960|Septicemia|septicemia
5097054|NCT03391960|Bloodstream infection|bloodstream infection
4981776|NCT04107064|ASD|asd
5097055|NCT03391960|Central line associated bloodstream infection|central line associated bloodstream infection
5097056|NCT03391960|Catheter related bloodstream infection|catheter related bloodstream infection
5097057|NCT03391960|Intravascular device|intravascular device
5097058|NCT03391960|Catheter port|catheter port
5097059|NCT03391947|gingival recession|gingival recession
5097060|NCT03391947|semilunar coronally flap|semilunar coronally flap
5097061|NCT03391947|coronally advanced flap|coronally advanced flap
5097062|NCT03391934|RAS Wild-type|ras wild-type
5097079|NCT03391843|Local Advanced Rectal Cancer|local advanced rectal cancer
5097081|NCT03391843|FOLFOXIRI|folfoxiri
5097082|NCT03391843|Cetuximab|cetuximab
5097083|NCT03391843|EGFR wild type|egfr wild type
5097088|NCT03391791|Cell Therapy|cell therapy
5097089|NCT03391791|T Cell Therapy|t cell therapy
5097090|NCT03391791|SPEAR T Cell|spear t cell
5097091|NCT03391791|Immuno-oncology|immuno-oncology
5097092|NCT03391791|Metastatic|metastatic
5097093|NCT03391791|T Cell Receptor|t cell receptor
5097094|NCT03391791|Long Term Follow Up|long term follow up
5097095|NCT03391791|Genetically Engineered|genetically engineered
5097108|NCT03391765|tauopathy|tauopathy
5097109|NCT03391765|Steele-Richardson-Olszewski Syndrome|steele-richardson-olszewski syndrome
5097111|NCT03391752|malnutrition, screening, assessment, treatment|malnutrition, screening, assessment, treatment
5097112|NCT03391713|awareness|awareness
5097113|NCT03391713|poster|poster
5097114|NCT03391713|stroke|stroke
5097115|NCT03391700|muscle relaxant|muscle relaxant
5097116|NCT03391687|Gastric Cancer|gastric cancer
5097117|NCT03391687|Pancreatic Fistula|pancreatic fistula
5097118|NCT03391687|Gastrectomy|gastrectomy
5097122|NCT03391635|randomized controlled trial|randomized controlled trial
5097123|NCT03391622|thrombin generation|thrombin generation
5097124|NCT03391622|calibrated automated thrombogram|calibrated automated thrombogram
5097125|NCT03391622|ischemic heart disease|ischemic heart disease
5097126|NCT03391622|Percutaneous Coronary Intervention|percutaneous coronary intervention
5097127|NCT03391596|Family caregivers|family caregivers
5097128|NCT03391596|Depressive symptoms|depressive symptoms
5097129|NCT03391596|Psychological wellbeing|psychological wellbeing
5097130|NCT03391596|Internet-based intervention|internet-based intervention
5097131|NCT03391596|Acceptance and Commitment Therapy|acceptance and commitment therapy
5097134|NCT03391570|Laparoscopic surgery|laparoscopic surgery
5097135|NCT03391570|COX-2 inhibitor|cox-2 inhibitor
5097136|NCT03391570|Celecoxib|celecoxib
5097137|NCT03391570|Prostanoid|prostanoid
5097138|NCT03391557|Elastography|elastography
5097139|NCT03391557|Lymph node|lymph node
5097140|NCT03391557|Diagnosis|diagnosis
5097141|NCT03391531|surgery: laparoscopic cholecystectomy|surgery: laparoscopic cholecystectomy
5097142|NCT03391531|analgesia: postoperative|analgesia: postoperative
5097143|NCT03391531|locoregional analgesia: transversus abdominis plane block|locoregional analgesia: transversus abdominis plane block
5097144|NCT03391531|opioid: side effects|opioid: side effects
5097145|NCT03391505|Cognition|cognition
5097146|NCT03391505|Physical activity|physical activity
5097147|NCT03391505|Memory|memory
5097148|NCT03391505|Health|health
5097149|NCT03391492|ICU|icu
5097150|NCT03391427|Lidocaine|lidocaine
5097151|NCT03391427|Ketamine|ketamine
5097152|NCT03391427|postoperative analgesia|postoperative analgesia
5097153|NCT03391414|thick mucus|thick mucus
5097154|NCT03391414|obstructive lung disease|obstructive lung disease
5097155|NCT03391362|Small Cell Lung Cancer|small cell lung cancer
5097156|NCT03391362|Brain Metastases|brain metastases
5097157|NCT03391362|Brain metastasis|brain metastasis
5097158|NCT03391362|Lung cancer|lung cancer
5097159|NCT03391362|Stereotactic radiation|stereotactic radiation
5097160|NCT03391362|Stereotactic radiosurgery|stereotactic radiosurgery
5097162|NCT03391362|Stereotactic|stereotactic
5097163|NCT03391362|Radiation|radiation
5097164|NCT03391362|Quality of life|quality of life
5097165|NCT03391362|Neurocognitive|neurocognitive
5097166|NCT03391362|Neurocognition|neurocognition
5097167|NCT03391349|proteomes, chronic periodontitis|proteomes, chronic periodontitis
5097168|NCT03391336|Carpal tunnel syndrome|carpal tunnel syndrome
5097169|NCT03391336|Median nerve injury|median nerve injury
5097170|NCT03391336|Steroids|steroids
5097171|NCT03391336|Ultrasound|ultrasound
5097172|NCT03391336|Injections|injections
5097173|NCT03391297|PTSD; prolonged exposure; posttraumatic growth|ptsd; prolonged exposure; posttraumatic growth
5097174|NCT03391258|Maxilary atrophy|maxilary atrophy
5097175|NCT03391258|Leucocyte-platelet-rich-fibrin|leucocyte-platelet-rich-fibrin
5097176|NCT03391258|bone resorption|bone resorption
5097177|NCT03391258|autologous growth factors|autologous growth factors
5097178|NCT03391258|guided-bone-regeneration|guided-bone-regeneration
5097179|NCT03391258|lip support|lip support
5097180|NCT03391206|Breast cancer related lymphedemas|breast cancer related lymphedemas
5097181|NCT03391206|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5097182|NCT03391206|Axillary Lymph Node Dissection|axillary lymph node dissection
5097183|NCT03391206|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
4981874|NCT04106219|kinase|kinase
5097184|NCT03391206|Dietary Fat|dietary fat
5097185|NCT03391193|Influenza|influenza
5097186|NCT03391193|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5097187|NCT03391193|Multi-dose Presentation|multi-dose presentation
5097188|NCT03391141|obstructive sleep apnea|obstructive sleep apnea
5097189|NCT03391141|sleep endoscopy|sleep endoscopy
5097190|NCT03391141|drug induced sleep endoscopy|drug induced sleep endoscopy
5097191|NCT03391141|diagnostic validation|diagnostic validation
5097192|NCT03391115|Psychosocial|psychosocial
5097193|NCT03391115|Underserved|underserved
5097194|NCT03391115|Palliative|palliative
5097195|NCT03391115|Electronic Health Record|electronic health record
5097196|NCT03391115|Narrative|narrative
5097197|NCT03391102|Epidemiology|epidemiology
5097198|NCT03391102|Community-based study|community-based study
5097199|NCT03391050|Melanoma|melanoma
5097200|NCT03391050|Malignant melanoma|malignant melanoma
5097201|NCT03391050|Skin cancer|skin cancer
5097202|NCT03391050|Resistant cancer|resistant cancer
5097203|NCT03391050|Unresectable cancer|unresectable cancer
5097204|NCT03391050|Metastatic cancer|metastatic cancer
5097205|NCT03391050|BRAF mutant|braf mutant
5097206|NCT03390998|Pregnancy-related SCAD|pregnancy-related scad
5097207|NCT03390998|Myocardial Infarction|myocardial infarction
5097208|NCT03390972|Dexmedetomidine|dexmedetomidine
5107916|NCT03323528|Dorithricin|dorithricin
5097212|NCT03390959|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5097213|NCT03390959|Postural Balance|postural balance
5097214|NCT03390959|Gait|gait
5097215|NCT03390959|Posture|posture
5097216|NCT03390946|four-drugs, interval-compression|four-drugs, interval-compression
5097217|NCT03390920|regenerative medicine|regenerative medicine
5097218|NCT03390920|arthritis|arthritis
5097219|NCT03390920|amniotic|amniotic
5097220|NCT03390920|stem cell|stem cell
5146657|NCT03075735|ATM|atm
5097221|NCT03390920|growth factor|growth factor
5097226|NCT03390907|Laterally spreading tumor|laterally spreading tumor
5097227|NCT03390894|Long-term Follow-Up|long-term follow-up
5097228|NCT03390894|Invasive Breast Cancer Early Stages|invasive breast cancer early stages
5097229|NCT03390894|Previous Neoadjuvant treatment|previous neoadjuvant treatment
5097230|NCT03390894|Previous Adjuvant treatment|previous adjuvant treatment
5097231|NCT03390881|breath acetone|breath acetone
5097232|NCT03390881|energy balance|energy balance
5097233|NCT03390868|Interaction|interaction
5097234|NCT03390868|challenging behaviour|challenging behaviour
5097235|NCT03390868|training|training
5097236|NCT03390855|IL-6|il-6
5097237|NCT03390855|Glucosinolate|glucosinolate
5097238|NCT03390855|Brassica oleracea|brassica oleracea
5097239|NCT03390855|Sulphoraphane|sulphoraphane
5097240|NCT03390855|Biomarkers|biomarkers
5097241|NCT03390855|Bioavailability|bioavailability
5097242|NCT03390855|Inflammation|inflammation
5097243|NCT03390842|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
5097244|NCT03390816|malnutrition|malnutrition
5097245|NCT03390816|cancer|cancer
5097246|NCT03390816|elderly|elderly
5097247|NCT03390764|Incisional hernia|incisional hernia
5097248|NCT03390764|4:1-technique|4:1-technique
5097249|NCT03390764|RTL-suture|rtl-suture
5097250|NCT03390751|atropinic drugs|atropinic drugs
5097251|NCT03390751|confusion|confusion
5097252|NCT03390751|elderly patients|elderly patients
5097253|NCT03390725|Prevention, obesity, parenting, diet, physical activity|prevention, obesity, parenting, diet, physical activity
5097254|NCT03390712|Paliperidone palmitate|paliperidone palmitate
5097255|NCT03390712|Risperidone long-acting injection|risperidone long-acting injection
5097256|NCT03390712|mirror-image|mirror-image
5097257|NCT03390673|randomized|randomized
5097258|NCT03390673|double-blind|double-blind
5097260|NCT03390647|Healthy adult male participants|healthy adult male participants
5097261|NCT03390647|Phase 1|phase 1
5097262|NCT03390647|Pharmacokinetics|pharmacokinetics
5097263|NCT03390621|parent feeding styles|parent feeding styles
5097264|NCT03390621|dietary quality|dietary quality
5097265|NCT03390621|dinner meal|dinner meal
5097266|NCT03390621|preschool|preschool
5097267|NCT03390621|low-income|low-income
5097268|NCT03390595|Urothelial carcinoma|urothelial carcinoma
5097269|NCT03390582|Gut Microbiota|gut microbiota
5097270|NCT03390582|Hashimoto Thyroiditis|hashimoto thyroiditis
5097271|NCT03390582|Graves' Disease|graves' disease
5097272|NCT03390582|Methimazole|methimazole
5097273|NCT03390582|Levothyroxine sodium|levothyroxine sodium
5097274|NCT03390582|16S rRNA gene|16s rrna gene
5097275|NCT03390582|Metabonomics|metabonomics
5097276|NCT03390569|GBM|gbm
4967623|NCT04192240|mobility|mobility
4967628|NCT04192201|Multiple Pulmonary Nodules|multiple pulmonary nodules
4967629|NCT04192201|Lung Neoplasms|lung neoplasms
4967630|NCT04192162|osteoarthritis|osteoarthritis
4967631|NCT04192162|balneotherapy|balneotherapy
4967632|NCT04192162|mud therapy|mud therapy
4967633|NCT04192162|sulfuric water|sulfuric water
5097277|NCT03390569|Glioblastoma|glioblastoma
5097278|NCT03390569|Brain Cancer|brain cancer
5097279|NCT03390569|High-Grade Glioma|high-grade glioma
5097280|NCT03390569|Glioma|glioma
5097281|NCT03390530|Thyroxine|thyroxine
5097282|NCT03390530|Intraventricular hemorrhage|intraventricular hemorrhage
5097283|NCT03390530|MRI with DTI,|mri with dti,
5097284|NCT03390530|Neurodevelopmental outcome|neurodevelopmental outcome
5097285|NCT03390517|fluorescence angiography|fluorescence angiography
5097286|NCT03390517|indocyanine green|indocyanine green
5097287|NCT03390517|anastomotic leakage|anastomotic leakage
5097288|NCT03390478|Frailty|frailty
5097289|NCT03390478|Aged|aged
5097290|NCT03390478|Cognitive Stimulation|cognitive stimulation
5097291|NCT03390478|Technology|technology
5097292|NCT03390452|mHealth|mhealth
5097293|NCT03390452|Oral Health|oral health
5097294|NCT03390452|Primary School Children|primary school children
5097295|NCT03390452|Mobile Phone Messaging|mobile phone messaging
5097296|NCT03390439|Striae alba|striae alba
5097297|NCT03390439|Microneedling|microneedling
5097298|NCT03390439|Fractional nonablative laser|fractional nonablative laser
5097299|NCT03390439|dermaroller|dermaroller
5097300|NCT03390439|Nd-yap 1340nm laser|nd-yap 1340nm laser
5097301|NCT03390439|Percutaneous Collagen Induction Therapy|percutaneous collagen induction therapy
5097302|NCT03390426|Perifemoral|perifemoral
5097303|NCT03390426|Tourniquet|tourniquet
5097304|NCT03390426|Mepivacaine|mepivacaine
5097305|NCT03390426|Tourniquet Hypertension|tourniquet hypertension
5097306|NCT03390413|Cryoablation|cryoablation
5097307|NCT03390413|Robot-assisted surgical resection|robot-assisted surgical resection
5097308|NCT03390400|Laser Cataract Surgery|laser cataract surgery
5097309|NCT03390387|Acute lymphoblastic leukemia, children, adolescents, treatment|acute lymphoblastic leukemia, children, adolescents, treatment
5097310|NCT03390374|Nystatin|nystatin
5097311|NCT03390374|Fungal colonization|fungal colonization
5097312|NCT03390374|Systemic fungal infections|systemic fungal infections
5097313|NCT03390361|Laser Cataract Surgery|laser cataract surgery
5097314|NCT03390361|Prostaglandin|prostaglandin
5097315|NCT03390270|intensive care units|intensive care units
5097316|NCT03390270|critical care|critical care
5097317|NCT03390270|risk assessment|risk assessment
5095312|NCT03403036|brodalumab|brodalumab
5097318|NCT03390270|electronic health records|electronic health records
5097320|NCT03390231|Stem Cell Educator|stem cell educator
5097321|NCT03390231|Immune modulation|immune modulation
5097322|NCT03390231|Diabetes|diabetes
5097323|NCT03390231|Autoimmune|autoimmune
5097324|NCT03390231|Insulin resistance|insulin resistance
5097325|NCT03390231|Pancreatic islets|pancreatic islets
5097326|NCT03390192|Noninvasive brain stimulation|noninvasive brain stimulation
5097327|NCT03390192|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5097328|NCT03390192|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5097329|NCT03390179|diabetes|diabetes
5097330|NCT03390179|anesthesia|anesthesia
5097331|NCT03390179|surgery|surgery
5097332|NCT03390179|glucose|glucose
5097333|NCT03390166|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
5097334|NCT03390166|Tri Fluvac vaccine|tri fluvac vaccine
5097335|NCT03390140|Spinal Cord Injuries|spinal cord injuries
5097336|NCT03390140|Group Intervention|group intervention
5097337|NCT03390140|Self Efficacy|self efficacy
5097338|NCT03390127|elderly|elderly
5097339|NCT03390127|lithotomy position|lithotomy position
5097340|NCT03390127|PEEP|peep
5097341|NCT03390127|laryngeal mask airway|laryngeal mask airway
5097343|NCT03390114|Insomnia|insomnia
5097344|NCT03390114|Cognitive Behavioral Therapy|cognitive behavioral therapy
5097345|NCT03390088|Heart failure|heart failure
5097346|NCT03390075|shelf nutrition label, NuVal|shelf nutrition label, nuval
5097347|NCT03390049|SmartXide 2 V 2 LR|smartxide 2 v 2 lr
5097348|NCT03390049|MonaLisa Touch|monalisa touch
5097349|NCT03390049|DEKA|deka
5097350|NCT03390049|Fractional CO2 Laser|fractional co2 laser
5097351|NCT03390049|Sham Laser|sham laser
5097352|NCT03390049|Vulvodynia|vulvodynia
5097353|NCT03390049|PVD|pvd
5097354|NCT03390049|Provoked vestibulodynia|provoked vestibulodynia
5097355|NCT03390023|Prenatal Care|prenatal care
5097356|NCT03390023|Barriers|barriers
5097357|NCT03390023|Clinical Trials|clinical trials
5097358|NCT03389997|respiratory tract infections|respiratory tract infections
5097359|NCT03389997|virus shedding|virus shedding
5961918|NCT04284137|Physical Function|physical function
5961919|NCT04284137|Cognitive Function|cognitive function
5961920|NCT04284137|Mind-body Exercise|mind-body exercise
5961921|NCT04284137|Hispanic|hispanic
5961922|NCT04284137|Aging Population|aging population
5961923|NCT04284072|Seizure detection|seizure detection
5961924|NCT04284072|Wearable|wearable
5097360|NCT03389997|cancer|cancer
5097361|NCT03389997|Immunocompromised Host|immunocompromised host
5961925|NCT04284072|Epilepsy|epilepsy
5961926|NCT04284072|Seizure|seizure
4967746|NCT04191538|Electrical Stimulation|electrical stimulation
4967747|NCT04191525|Diabetes Mellitus|diabetes mellitus
4967748|NCT04191525|Microbiote|microbiote
4967749|NCT04191525|Cardiovascular Risk|cardiovascular risk
5097362|NCT03389958|intrauterine device|intrauterine device
5745235|NCT00339196|AML|aml
5097363|NCT03389958|postpartum contraception|postpartum contraception
5097364|NCT03389958|repeat pregnancy|repeat pregnancy
5097365|NCT03389958|adolescent pregnancy|adolescent pregnancy
5097366|NCT03389945|Labor analgesia|labor analgesia
5097367|NCT03389945|Dural puncture epidural|dural puncture epidural
5097368|NCT03389945|Postdural puncture headache|postdural puncture headache
5097369|NCT03389945|Neuraxial analgesia|neuraxial analgesia
5097370|NCT03389893|randomized double-masked (blind) placebo-controlled trial|randomized double-masked (blind) placebo-controlled trial
5097371|NCT03389893|Thelper2 (Th2) effect|thelper2 (th2) effect
5097372|NCT03389893|cutaneous microbial community|cutaneous microbial community
5097373|NCT03389893|skin barrier|skin barrier
5097374|NCT03389867|Male sexual health|male sexual health
5097375|NCT03389867|Erectile function|erectile function
5097376|NCT03389841|home care services|home care services
5097377|NCT03389841|comorbidity|comorbidity
5097378|NCT03389841|heart failure|heart failure
5097379|NCT03389841|caregivers|caregivers
5097380|NCT03389841|health education|health education
5097381|NCT03389841|patient admission|patient admission
5097382|NCT03389828|Focus Group|focus group
5097383|NCT03389828|Health Disparities|health disparities
5097384|NCT03389828|Occupational Health|occupational health
5097385|NCT03389828|Behaviors|behaviors
5097386|NCT03389789|pain|pain
5097387|NCT03389789|infant|infant
5097388|NCT03389789|near-infrared spectroscopy|near-infrared spectroscopy
5097389|NCT03389789|non pharmacological analgesia|non pharmacological analgesia
5097390|NCT03389763|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5097391|NCT03389763|Pupillary Dilatation Reflex (PRD)|pupillary dilatation reflex (prd)
5097392|NCT03389763|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
5097393|NCT03389763|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
5097394|NCT03389763|Spectral Entropy (SE)|spectral entropy (se)
5097395|NCT03389763|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5097396|NCT03389763|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
5097397|NCT03389711|Rheumatoid Arthritis Mexico|rheumatoid arthritis mexico
5097398|NCT03389711|Early Rheumatoid Arthritis Cohort Mexico|early rheumatoid arthritis cohort mexico
5097399|NCT03389685|Platelet Rich Plasma|platelet rich plasma
5108171|NCT03322046|CVD|cvd
5097400|NCT03389672|patient safety|patient safety
5097401|NCT03389672|residency training|residency training
5097402|NCT03389659|mCRC|mcrc
5097403|NCT03389659|oxaliplatin plus fluoropyrimidine|oxaliplatin plus fluoropyrimidine
5097404|NCT03389620|CT-fluoroscopy|ct-fluoroscopy
5097405|NCT03389620|Corticosteroid injection|corticosteroid injection
5097406|NCT03389607|SCUBE-1|scube-1
5097407|NCT03389594|Surgical guide|surgical guide
5097408|NCT03389594|Computer guided implantology|computer guided implantology
5097409|NCT03389594|CBCT voxel size|cbct voxel size
5097410|NCT03389555|Sepsis|sepsis
5095213|NCT03403751|AKI|aki
5097415|NCT03389503|Learning curve|learning curve
5097416|NCT03389451|68Ga-PSMA-11|68ga-psma-11
5097417|NCT03389451|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
5097418|NCT03389451|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
5097419|NCT03389438|Immunotherapy|immunotherapy
5097420|NCT03389399|Brigatinib|brigatinib
5097421|NCT03389399|Early Onset Pulmonary Events|early onset pulmonary events
5097422|NCT03389386|Congestive Heart Failure|congestive heart failure
5097423|NCT03389386|Catestatin|catestatin
5097424|NCT03389386|Chromogranin A|chromogranin a
5097425|NCT03389386|Echocardiography|echocardiography
5097426|NCT03389386|Biomarkers|biomarkers
5097427|NCT03389386|Ventricular Dysfunction, Left|ventricular dysfunction, left
5097428|NCT03389386|Comorbidity|comorbidity
5097429|NCT03389373|Dental Caries|dental caries
5097430|NCT03389321|pharmacokinetics|pharmacokinetics
5097431|NCT03389321|macitentan|macitentan
5097432|NCT03389321|riociguat|riociguat
5097433|NCT03389308|Epidermolysis Bullosa (EB)|epidermolysis bullosa (eb)
5097434|NCT03389308|Epidermolysis Bullosa Simplex (EBS)|epidermolysis bullosa simplex (ebs)
5097435|NCT03389295|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5097436|NCT03389295|Reduced Target Delineation and Radiation Doses|reduced target delineation and radiation doses
5097437|NCT03389295|Sequential chemoradiotherapy|sequential chemoradiotherapy
5097438|NCT03389282|Tear, Metabolite|tear, metabolite
5097439|NCT03389256|apatinib|apatinib
5097440|NCT03389256|T790 negative|t790 negative
5097441|NCT03389256|NSCLC|nsclc
5097442|NCT03389243|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5097443|NCT03389243|General Anaesthesia (GA),|general anaesthesia (ga),
5097444|NCT03389243|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
5097445|NCT03389243|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5961927|NCT04284072|Sensor Dot|sensor dot
5961928|NCT04284059|Vitamin A|vitamin a
5961929|NCT04284059|Vitamin D|vitamin d
5961930|NCT04284059|Methylphenidate|methylphenidate
5961931|NCT04284059|ADHD|adhd
5961932|NCT04283942|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5097446|NCT03389243|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
5097447|NCT03389243|paracetamol|paracetamol
5097448|NCT03389243|metamizole|metamizole
5097449|NCT03389217|Multiple Sclerosis|multiple sclerosis
5097450|NCT03389217|Pain|pain
5097451|NCT03389217|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5097452|NCT03389217|tDCS|tdcs
5097453|NCT03389204|Breast surgery|breast surgery
5097454|NCT03389204|Physiotherapy|physiotherapy
5097455|NCT03389204|Breast Cancer|breast cancer
5097456|NCT03389204|Shoulder pain|shoulder pain
5097457|NCT03389204|Shoulder motion|shoulder motion
5097458|NCT03389178|prenatal stress|prenatal stress
5097459|NCT03389178|fetal autonomic nervous system|fetal autonomic nervous system
5097460|NCT03389178|multidimensional FHR variability assessment|multidimensional fhr variability assessment
5097461|NCT03389165|Wearable hip assist robot|wearable hip assist robot
5097462|NCT03389165|Elderly adult|elderly adult
5097463|NCT03389165|Metabolic energy expenditure|metabolic energy expenditure
5097464|NCT03389165|Stair ascent|stair ascent
5097465|NCT03389139|Cesarean|cesarean
5097466|NCT03389139|newborn|newborn
5097467|NCT03389139|cerebral and renal oxygenation|cerebral and renal oxygenation
5097468|NCT03389139|anesthesia|anesthesia
5097469|NCT03389100|diabetes|diabetes
5097470|NCT03389100|hyperglycemia|hyperglycemia
5097471|NCT03389100|tau|tau
5097472|NCT03389061|Epclusa|epclusa
5097473|NCT03389061|Pharmacokinetics|pharmacokinetics
5097474|NCT03389061|Crushing|crushing
5097475|NCT03389035|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5097476|NCT03389035|CAR-T|car-t
5097477|NCT03389035|CARCIK|carcik
5097478|NCT03389035|Transposon|transposon
5097479|NCT03388983|Prehabilitation|prehabilitation
5097480|NCT03388983|Physical activity|physical activity
5097481|NCT03388983|Lumbar decompression surgery|lumbar decompression surgery
5097482|NCT03388983|Randomized controlled trial|randomized controlled trial
5097483|NCT03388970|vitamin K1|vitamin k1
5097484|NCT03388970|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5097485|NCT03388970|effectiveness|effectiveness
5097486|NCT03388970|outcome|outcome
5097487|NCT03388931|Radiotherapy Dose Escalation|radiotherapy dose escalation
5097488|NCT03388918|Quality of life|quality of life
5097489|NCT03388918|Telerehabilitation|telerehabilitation
5097490|NCT03388918|Cardiac patients|cardiac patients
5097491|NCT03388918|Heart failure|heart failure
5097492|NCT03388905|LifeVest wearable|lifevest wearable
5097493|NCT03388905|cardioverter defibrillator|cardioverter defibrillator
5097494|NCT03388905|LVEF|lvef
5097495|NCT03388892|Angioplasty|angioplasty
5097496|NCT03388892|Drug Eluting Balloon|drug eluting balloon
5097497|NCT03388892|Arteriovenous Graft|arteriovenous graft
5097498|NCT03388866|inhaled aeroallergens|inhaled aeroallergens
5097499|NCT03388866|eczema|eczema
5097500|NCT03388866|pruritus|pruritus
5097501|NCT03388866|life quality|life quality
5097502|NCT03388866|immunotheraphy|immunotheraphy
5097503|NCT03388866|atopic dermatitis|atopic dermatitis
5097506|NCT03388853|Doxofylline|doxofylline
5097507|NCT03388853|Effervescent Tablet|effervescent tablet
5097508|NCT03388853|COPD|copd
5097509|NCT03388840|platelet rich plasma|platelet rich plasma
5097510|NCT03388840|adipose derived stem cells|adipose derived stem cells
5097511|NCT03388840|follicular unit extraction|follicular unit extraction
5097512|NCT03388840|hair transplantation|hair transplantation
5097513|NCT03388814|PPBCS|ppbcs
5097514|NCT03388814|Acute|acute
5097515|NCT03388814|Postoperative|postoperative
5097516|NCT03388814|Mastectomy|mastectomy
5097517|NCT03388814|Breast Reconstruction|breast reconstruction
5097518|NCT03388775|deep vein thrombosis|deep vein thrombosis
5097519|NCT03388775|assessment|assessment
5097520|NCT03388775|risk factors|risk factors
5097521|NCT03388762|Hyperglycemia|hyperglycemia
5097522|NCT03388762|Prediabetes|prediabetes
5097523|NCT03388762|Botanical|botanical
5097524|NCT03388762|Phytochemicals|phytochemicals
5097525|NCT03388762|Dietary Supplements|dietary supplements
5097526|NCT03388762|Berberine|berberine
5097527|NCT03388762|Fenugreek|fenugreek
5097528|NCT03388762|American Ginseng|american ginseng
5097529|NCT03388762|Gymnema|gymnema
5097530|NCT03388762|Banaba|banaba
5097531|NCT03388762|Kudzu|kudzu
5097532|NCT03388762|Cinnamon|cinnamon
5097533|NCT03388762|Glycated hemoglobin|glycated hemoglobin
5097534|NCT03388762|Trigonella|trigonella
5097535|NCT03388762|Blood Glucose|blood glucose
5097536|NCT03388762|Panax|panax
5097537|NCT03388762|Plant Extracts|plant extracts
5097538|NCT03388762|Public Health|public health
5097539|NCT03388762|Chronic Disease|chronic disease
5097540|NCT03388736|preoperative|preoperative
5097541|NCT03388736|anxiety|anxiety
5097542|NCT03388736|orthognathic surgery|orthognathic surgery
5097543|NCT03388736|lavender oil|lavender oil
4982337|NCT04102722|breast|breast
5097544|NCT03388723|Epigenetics|epigenetics
5097545|NCT03388723|Cardiometabolic risk factors|cardiometabolic risk factors
5097546|NCT03388710|airway, children, endotracheal tube, cuff|airway, children, endotracheal tube, cuff
5097547|NCT03388658|Atrial Fibrillation; Cryoballoon; Ablation;|atrial fibrillation; cryoballoon; ablation;
5097548|NCT03388645|RSV Shedding|rsv shedding
5097549|NCT03388645|Immune Responses|immune responses
5097550|NCT03388645|Neutralizing Antibody Titer|neutralizing antibody titer
5097750|NCT03387345|whole grain|whole grain
5097563|NCT03388606|Major Depressive Disorder|major depressive disorder
5097564|NCT03388606|Mood Disorder|mood disorder
5097565|NCT03388606|Biomarkers|biomarkers
5097566|NCT03388606|Mechanism|mechanism
5097567|NCT03388593|chronic heart failure|chronic heart failure
5097568|NCT03388593|neuregulin|neuregulin
5097569|NCT03388593|mortality|mortality
5097570|NCT03388567|Dispensation|dispensation
5097571|NCT03388567|Health Education|health education
5097572|NCT03388567|Pharmacovigilance|pharmacovigilance
5097573|NCT03388567|Pharmacists|pharmacists
5097574|NCT03388528|Dysmotility|dysmotility
5097575|NCT03388528|Microbiome|microbiome
5097576|NCT03388528|Transit Time|transit time
5097577|NCT03388528|Gastrointestinal|gastrointestinal
5097578|NCT03388502|Total knee arthroplasty|total knee arthroplasty
5097579|NCT03388502|Total hip arthroplasty|total hip arthroplasty
5097580|NCT03388476|pulmonary hypertension|pulmonary hypertension
5097581|NCT03388476|endtidal co2|endtidal co2
5097582|NCT03388476|endtidal carbon dioxide|endtidal carbon dioxide
5097583|NCT03388476|pulmonary arterial hypertension|pulmonary arterial hypertension
5097584|NCT03388437|Non-invasive Neurally Adjusted Ventilatory Assist NI-NAVA|non-invasive neurally adjusted ventilatory assist ni-nava
5097585|NCT03388437|Nasal Intermittent Positive Pressure Ventilation NIPPV|nasal intermittent positive pressure ventilation nippv
5097586|NCT03388437|post extubation|post extubation
5097587|NCT03388424|bacterial DNA, RNA16S gene|bacterial dna, rna16s gene
5097588|NCT03388411|Microbiome|microbiome
5097589|NCT03388411|Gut|gut
5097590|NCT03388398|Mother-to-child transmission of HIV (MTCT)|mother-to-child transmission of hiv (mtct)
5097591|NCT03388398|Prevention of mother-to-child HIV transmission (PMTCT)|prevention of mother-to-child hiv transmission (pmtct)
5097592|NCT03388398|Antiretroviral therapy (ART)|antiretroviral therapy (art)
5097593|NCT03388398|Antenatal care (ANC)|antenatal care (anc)
5097594|NCT03388398|Pediatric infections|pediatric infections
5097595|NCT03388398|Pregnancy|pregnancy
5097596|NCT03388385|CKD, anemia, iron, endothelial dysfunction, oxidative stress|ckd, anemia, iron, endothelial dysfunction, oxidative stress
5097597|NCT03388372|glioma|glioma
5097598|NCT03388372|phase 2|phase 2
5097599|NCT03388372|nimotozumab|nimotozumab
5097600|NCT03388372|temozolomide|temozolomide
5097601|NCT03388372|radiotherapy|radiotherapy
5097608|NCT03388346|68Ga-PSMA-11|68ga-psma-11
5097609|NCT03388346|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
5097610|NCT03388346|68Ga PSMA-HBED-CC|68ga psma-hbed-cc
5097611|NCT03388294|communication|communication
5097616|NCT03388281|Gender differences|gender differences
5097617|NCT03388281|Survival|survival
5097618|NCT03388281|Retrospective|retrospective
5097619|NCT03388268|Clostridium difficile|clostridium difficile
5097627|NCT03388229|UAE|uae
5097628|NCT03388203|25(OH)D|25(oh)d
5097629|NCT03388203|PTH|pth
5097630|NCT03388203|mass spectrometry|mass spectrometry
5097631|NCT03388203|data mining|data mining
5097640|NCT03388177|Depression|depression
5097641|NCT03388177|Young adult women|young adult women
5097642|NCT03388177|Yoga|yoga
5097643|NCT03388112|Probiotics,Gut Microbiome,Antibiotics,Infants|probiotics,gut microbiome,antibiotics,infants
5097644|NCT03388099|gonadotrophin receptor polymorphism|gonadotrophin receptor polymorphism
5097645|NCT03388099|antimüllerian hormone|antimüllerian hormone
5097646|NCT03388099|ovarian response|ovarian response
5097647|NCT03388099|ovarian stimulation|ovarian stimulation
5097648|NCT03388060|Oral Dissolution Therapy|oral dissolution therapy
5097654|NCT03388021|limb ischemia|limb ischemia
5097655|NCT03388021|completion angiography|completion angiography
5097656|NCT03388021|thromboembolectomy|thromboembolectomy
5097657|NCT03388008|donor-specific HLA antibodies|donor-specific hla antibodies
5097658|NCT03388008|lung transplantation|lung transplantation
5097659|NCT03387995|treatment outcome|treatment outcome
5097660|NCT03387956|Postoperative Nuasea|postoperative nuasea
5097661|NCT03387930|Low back pain|low back pain
5097662|NCT03387930|lumbar multifidus|lumbar multifidus
5097663|NCT03387930|Proprioception|proprioception
5097664|NCT03387930|Elastography|elastography
5097665|NCT03387930|Magnetic resonance imaging|magnetic resonance imaging
5097666|NCT03387917|Advanced Solid Tumors|advanced solid tumors
5097667|NCT03387917|doxorubicin|doxorubicin
5097668|NCT03387917|TLD-1|tld-1
5097669|NCT03387917|phase I|phase i
5097670|NCT03387917|Talidox|talidox
5097671|NCT03387917|Liposomal|liposomal
5097672|NCT03387904|Anlotinib|anlotinib
5097673|NCT03387865|banking, biological sampling, tumor tissue, tumor response|banking, biological sampling, tumor tissue, tumor response
5097674|NCT03387826|ticagrelor|ticagrelor
5097675|NCT03387826|prasugrel|prasugrel
5097676|NCT03387813|Heart Failure|heart failure
5097677|NCT03387813|Hemodynamic Monitoring|hemodynamic monitoring
5097678|NCT03387813|CardioMEMS|cardiomems
5745338|NCT00338780|Lamivudine|lamivudine
5097679|NCT03387813|Pulmonary Artery Pressure|pulmonary artery pressure
5097680|NCT03387800|randomized controlled trial|randomized controlled trial
5097681|NCT03387800|smoking cessation|smoking cessation
5097682|NCT03387800|social support|social support
5097683|NCT03387800|positive effect|positive effect
5097684|NCT03387800|online social networking|online social networking
5097685|NCT03387800|theory-based|theory-based
5097686|NCT03387787|GlucoTab, Tresiba, Type 2 Diabetes|glucotab, tresiba, type 2 diabetes
5097687|NCT03387774|Ulinastatin|ulinastatin
5097688|NCT03387774|Radiation-induced acute oral mucositis|radiation-induced acute oral mucositis
5097689|NCT03387774|Localregionally Advanced Nasopharyngeal Carcinoma|localregionally advanced nasopharyngeal carcinoma
5097690|NCT03387774|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5097691|NCT03387761|Urothelial cancer|urothelial cancer
5097692|NCT03387761|Bladder cancer|bladder cancer
5097693|NCT03387761|Cancer|cancer
5097694|NCT03387761|Resectable|resectable
5097695|NCT03387761|Operable|operable
5097696|NCT03387761|immunotherapy|immunotherapy
5097697|NCT03387761|Ipilimumab|ipilimumab
5097698|NCT03387761|Nivolumab|nivolumab
5097699|NCT03387761|Neo-Adjuvant|neo-adjuvant
5097700|NCT03387735|Hypertension, Hyperlipidemia, Diabetes, Arthritis, Obesity|hypertension, hyperlipidemia, diabetes, arthritis, obesity
5097701|NCT03387709|Nondiabetic|nondiabetic
5097702|NCT03387709|Overweight|overweight
5097703|NCT03387709|Obesity|obesity
5097704|NCT03387709|Men|men
5097705|NCT03387709|Women|women
5097706|NCT03387709|San Diego|san diego
5097707|NCT03387709|Weight Loss|weight loss
5097708|NCT03387696|Mucormycosis|mucormycosis
5097709|NCT03387696|Intensive Care Medicine|intensive care medicine
5097710|NCT03387631|Efficacy safety uncomplicated malaria AL|efficacy safety uncomplicated malaria al
5097711|NCT03387592|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5097712|NCT03387592|second line therapy|second line therapy
5097713|NCT03387592|PET imaging|pet imaging
5097714|NCT03387592|FOLFIRI|folfiri
5097715|NCT03387592|CAPTEM|captem
5097716|NCT03387553|Immunotherapy|immunotherapy
5097717|NCT03387553|Dendritic Cell Vaccine|dendritic cell vaccine
5097718|NCT03387553|DC1|dc1
5097719|NCT03387540|Anti-PD-1|anti-pd-1
5097720|NCT03387540|Anti-PD-L1|anti-pd-l1
5097721|NCT03387540|Anti CTLA-4|anti ctla-4
5097722|NCT03387540|Immune checkpoint inhibitors|immune checkpoint inhibitors
5097723|NCT03387527|Decision Aid|decision aid
5097724|NCT03387514|Clear Cell|clear cell
5097725|NCT03387514|Kidney Cancer|kidney cancer
5097726|NCT03387514|RCC|rcc
5097744|NCT03387358|small bore feeding tube|small bore feeding tube
5097745|NCT03387358|adverse events|adverse events
5097746|NCT03387358|enteral nutrition|enteral nutrition
5097747|NCT03387345|glucose|glucose
5097748|NCT03387345|dietary fiber|dietary fiber
5097749|NCT03387345|glycemia|glycemia
5097751|NCT03387332|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
5097752|NCT03387319|Social stress|social stress
5097753|NCT03387319|Inflammation|inflammation
5097754|NCT03387306|serum bilirubin|serum bilirubin
5097755|NCT03387306|normal-tension glaucoma|normal-tension glaucoma
5097756|NCT03387306|oxidative stress|oxidative stress
5097757|NCT03387293|Pediatric Obesity|pediatric obesity
5097758|NCT03387293|Insulin Resistance|insulin resistance
5097759|NCT03387293|Diet|diet
5097760|NCT03387280|acute myocardial infarction|acute myocardial infarction
5097761|NCT03387280|electrocardiogram|electrocardiogram
5097762|NCT03387280|coronary angiography|coronary angiography
5097763|NCT03387254|virtual reality|virtual reality
5097764|NCT03387254|brain stimulation|brain stimulation
5097765|NCT03387241|moderate|moderate
5097766|NCT03387241|severe|severe
5097767|NCT03387241|persistent|persistent
5097768|NCT03387241|reversible|reversible
5097769|NCT03387241|Seretide|seretide
5097770|NCT03387241|Flutiform|flutiform
5097771|NCT03387228|back pain|back pain
5097772|NCT03387228|low back pain|low back pain
5097773|NCT03387228|Explain Pain|explain pain
5097774|NCT03387228|Pain education|pain education
5097775|NCT03387202|Pelvic Organ Prolapse|pelvic organ prolapse
5097776|NCT03387202|Translabial ultrasound|translabial ultrasound
5097777|NCT03387202|Transperineal ultrasound|transperineal ultrasound
5097778|NCT03387202|Lateral Mesh Suspension|lateral mesh suspension
5097779|NCT03387202|Descensus uteri|descensus uteri
5097780|NCT03387202|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
5097781|NCT03387163|Heart failure|heart failure
5097782|NCT03387163|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
5745542|NCT00338026|Colorectal|colorectal
5097783|NCT03387163|Chronic Systolic Heart failure|chronic systolic heart failure
5097784|NCT03387163|Sacubitril /Valsartan|sacubitril /valsartan
5097785|NCT03387163|Patient reported outcomes (PRO)|patient reported outcomes (pro)
5097786|NCT03387163|Kansas City Cardiomyopathy Questionnaire (KCCQ)|kansas city cardiomyopathy questionnaire (kccq)
5097787|NCT03387163|Patient Centered Outcomes Research Network (PCORNeT)|patient centered outcomes research network (pcornet)
5097788|NCT03387163|Common Data Model (CDM)|common data model (cdm)
5097789|NCT03387072|Mental stress|mental stress
5097790|NCT03387072|Sudden cardiac death|sudden cardiac death
5097791|NCT03387072|arrhythmias|arrhythmias
5097792|NCT03387072|long QT syndrome|long qt syndrome
5097793|NCT03387059|Infertility|infertility
5097794|NCT03387059|Forielle|forielle
5097795|NCT03387059|Assisted Reproductive Technique (ART)|assisted reproductive technique (art)
4966019|NCT04201743|Knee|knee
5097796|NCT03387059|Controlled Ovarian Stimulation (COS)|controlled ovarian stimulation (cos)
5097797|NCT03387046|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5097798|NCT03387046|D-Aspartate|d-aspartate
5097799|NCT03387046|interferon beta-1a|interferon beta-1a
5097800|NCT03387007|adolescent|adolescent
5097801|NCT03387007|mental health|mental health
5097802|NCT03387007|hope|hope
5097803|NCT03387007|psycho-social support|psycho-social support
5097804|NCT03387007|school teachers|school teachers
5097805|NCT03387007|earthquake|earthquake
5097806|NCT03386981|Energy metabolism|energy metabolism
5097807|NCT03386981|Homeostasis|homeostasis
5097808|NCT03386981|Bone turnover markers|bone turnover markers
5097809|NCT03386968|virtual reality|virtual reality
5097810|NCT03386968|hemiplegia|hemiplegia
5097811|NCT03386968|diplegia|diplegia
5097812|NCT03386968|video gaming|video gaming
5097813|NCT03386968|active video games|active video games
5097814|NCT03386968|Playstation X-Box 360|playstation x-box 360
5097815|NCT03386968|Rutgers V-Step|rutgers v-step
5097816|NCT03386968|Microsoft Kinect|microsoft kinect
5095643|NCT03400592|EGFR|egfr
5097821|NCT03386929|NSCLC|nsclc
5097822|NCT03386929|tri-therapy|tri-therapy
5097831|NCT03386890|Non-invasive Assessment|non-invasive assessment
5097832|NCT03386890|Transient Elastography|transient elastography
5097833|NCT03386890|Controlled Attenuation Parameter|controlled attenuation parameter
5097834|NCT03386864|Heart Failure, Diabetes Mellitus, Mitochondrial Respiration|heart failure, diabetes mellitus, mitochondrial respiration
5097835|NCT03386825|Metastatic Colorectal Cancer|metastatic colorectal cancer
5356817|NCT01917877|pulmonary fibrosis|pulmonary fibrosis
5097836|NCT03386812|androgen deprivation therapy|androgen deprivation therapy
5097838|NCT03386812|bone loss|bone loss
5097839|NCT03386799|Power assistance device|power assistance device
5097840|NCT03386799|Wheelchair|wheelchair
5097937|NCT03386110|Drug Use|drug use
5097848|NCT03386773|patient reported outcome measures|patient reported outcome measures
5097849|NCT03386773|health information technology|health information technology
5097851|NCT03386773|consumer health informatics|consumer health informatics
5097852|NCT03386760|tattoo|tattoo
5097853|NCT03386747|child development|child development
5097854|NCT03386747|neonatal mortality|neonatal mortality
5097855|NCT03386708|Healing Poor After Uterus Injury, Mesenchymal Stem Cell|healing poor after uterus injury, mesenchymal stem cell
5097856|NCT03386695|Cervical Cancer and HPV infection|cervical cancer and hpv infection
5097857|NCT03386669|18F-THK5351 PET|18f-thk5351 pet
5097858|NCT03386669|Tauopathies|tauopathies
5097859|NCT03386656|Osteoarthritis|osteoarthritis
5097860|NCT03386656|Tranexamic acid|tranexamic acid
5097861|NCT03386643|Oral lichen planus|oral lichen planus
5097862|NCT03386643|Probiotics|probiotics
5097863|NCT03386643|Immunomodulation.|immunomodulation.
5097864|NCT03386604|Whey Protein|whey protein
5097865|NCT03386539|heart transplantation|heart transplantation
5097866|NCT03386539|children|children
5097867|NCT03386539|everolimus|everolimus
5097868|NCT03386539|tacrolimus|tacrolimus
5097869|NCT03386539|mycophenolate mofetil|mycophenolate mofetil
5097870|NCT03386539|randomized clinical trial|randomized clinical trial
5097871|NCT03386526|IAP inhibitor|iap inhibitor
5097872|NCT03386513|Antibody Drug Conjugate|antibody drug conjugate
5097873|NCT03386513|Other Hematologic Malignancies|other hematologic malignancies
5097874|NCT03386513|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5097875|NCT03386513|CD123|cd123
5097876|NCT03386513|MDS|mds
5097877|NCT03386513|Relapsed, Refractory|relapsed, refractory
5097878|NCT03386513|Acute Lymphocytic Leukaemia|acute lymphocytic leukaemia
5097879|NCT03386513|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
5097880|NCT03386513|Acute Myeloid Leukemia|acute myeloid leukemia
5097881|NCT03386474|double-masked, extension study|double-masked, extension study
5097882|NCT03386474|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5097883|NCT03386474|intravitreal injection|intravitreal injection
5097884|NCT03386474|brolucizumab|brolucizumab
5097885|NCT03386474|aflibercept|aflibercept
5097892|NCT03386435|remote ischemic preconditioning|remote ischemic preconditioning
5097893|NCT03386435|liver donors|liver donors
5097894|NCT03386422|Mindfulness|mindfulness
5097895|NCT03386422|Self-Compassion|self-compassion
5097896|NCT03386422|Chronic Pain|chronic pain
5097897|NCT03386422|Psychological Intervention|psychological intervention
5097898|NCT03386422|Cognitive-Behavioural therapy|cognitive-behavioural therapy
5097899|NCT03386422|acceptance|acceptance
5097900|NCT03386422|catastrophising|catastrophising
5097901|NCT03386422|Self-Care|self-care
5097902|NCT03386422|Quality of life|quality of life
5097903|NCT03386409|Injury prevention|injury prevention
5097904|NCT03386383|adolescent and young adult|adolescent and young adult
5097905|NCT03386383|cancer survivor|cancer survivor
5097906|NCT03386370|Acute ischemia|acute ischemia
5097907|NCT03386370|Lower Limb|lower limb
5097908|NCT03386318|concentration|concentration
5097909|NCT03386292|prevalence|prevalence
5097910|NCT03386292|urinary incontinence|urinary incontinence
5097911|NCT03386292|anal incontinence|anal incontinence
5961933|NCT04283942|Type 2 Diabetes|type 2 diabetes
5097912|NCT03386292|risk factors|risk factors
5097913|NCT03386292|women|women
5108601|NCT03319173|Delta G|delta g
5097924|NCT03386149|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
5097925|NCT03386149|Low Back Pain|low back pain
5097926|NCT03386149|Radiculopathy|radiculopathy
5097927|NCT03386149|Bosinji|bosinji
5097928|NCT03386149|Herbal Medicine|herbal medicine
5097929|NCT03386136|bowel ischemia|bowel ischemia
5097930|NCT03386136|bowel perforation|bowel perforation
5097931|NCT03386123|Tinnitus|tinnitus
5097932|NCT03386123|Insomnia|insomnia
5097933|NCT03386123|Cognitive Behaviour Therapy|cognitive behaviour therapy
5097934|NCT03386110|Couples|couples
5097935|NCT03386110|MSM|msm
5097942|NCT03386019|lymphatic massage|lymphatic massage
5097943|NCT03386019|static stretching|static stretching
5097944|NCT03386019|cold water immersion|cold water immersion
5097951|NCT03385993|Delirium Prevention|delirium prevention
5097952|NCT03385993|Virtual Reality|virtual reality
5097953|NCT03385993|VR|vr
5097954|NCT03385967|upper extremity bone fracture|upper extremity bone fracture
5097955|NCT03385954|nursing|nursing
5097956|NCT03385954|distance|distance
5097957|NCT03385954|education|education
5097958|NCT03385954|RSI/WRMD|rsi/wrmd
5097959|NCT03385928|ICH|ich
5097960|NCT03385928|Stroke|stroke
5097961|NCT03385928|Cerebrovascular Disorders|cerebrovascular disorders
5097962|NCT03385928|Brain Diseases|brain diseases
5097963|NCT03385928|Central Nervous System Diseases|central nervous system diseases
5097964|NCT03385928|Nervous System Diseases|nervous system diseases
5097965|NCT03385928|Vascular Diseases|vascular diseases
5097966|NCT03385928|Cardiovascular Diseases|cardiovascular diseases
5097967|NCT03385928|Tranexamic Acid|tranexamic acid
5097968|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents
5097969|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents
5097970|NCT03385928|Pharmacologic Actions|pharmacologic actions
5097971|NCT03385928|Cardiovascular Agents|cardiovascular agents
5097972|NCT03385928|Therapeutic Uses|therapeutic uses
5097973|NCT03385928|Hematologic Agents|hematologic agents
5097974|NCT03385928|Hemostatics|hemostatics
5097975|NCT03385928|Contrast Media|contrast media
5097976|NCT03385928|Angiography|angiography
5097977|NCT03385928|Cerebral Angiography|cerebral angiography
5097978|NCT03385928|Tomography, X-Ray Computed|tomography, x-ray computed
5097979|NCT03385915|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5097980|NCT03385915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5097981|NCT03385915|TAVI|tavi
5097982|NCT03385915|TAVR|tavr
5097983|NCT03385915|Aortic valve replacement|aortic valve replacement
5097984|NCT03385915|Surgical aortic valve replacement|surgical aortic valve replacement
5097985|NCT03385915|Sutureless|sutureless
5097986|NCT03385902|advanced chronic kidney disease|advanced chronic kidney disease
5097987|NCT03385902|timing of dialysis initiation|timing of dialysis initiation
5097988|NCT03385902|hemodialysis|hemodialysis
5097989|NCT03385902|fuzzy mathematics|fuzzy mathematics
5097990|NCT03385902|glomerular filtration rate|glomerular filtration rate
5097991|NCT03385889|Cervicogenic Headache|cervicogenic headache
5097992|NCT03385889|Manual Therapy|manual therapy
5097993|NCT03385889|Joint Position Sense|joint position sense
5097994|NCT03385889|Balance|balance
5097995|NCT03385876|Rady Children's|rady children's
5097996|NCT03385876|Pediatric|pediatric
5097997|NCT03385876|Genomic|genomic
5097998|NCT03385876|Precision Medicine|precision medicine
5097999|NCT03385876|Biorepository|biorepository
5098000|NCT03385824|traumatic brain injury|traumatic brain injury
5098001|NCT03385824|advocacy|advocacy
5098002|NCT03385811|Professional quality of life, Medical Professionals, Job Involvement, Intention to Stay,|professional quality of life, medical professionals, job involvement, intention to stay,
5098005|NCT03385785|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5098006|NCT03385785|Pressure Recording Analytical Method|pressure recording analytical method
5098007|NCT03385785|Ventriculo-arterial coupling|ventriculo-arterial coupling
5098008|NCT03385785|Monitoring|monitoring
5098009|NCT03385785|Hemodynamic|hemodynamic
5098010|NCT03385772|sphenopalatine block|sphenopalatine block
5098011|NCT03385759|unicompartmental knee|unicompartmental knee
5098012|NCT03385759|total knee arthroplasty|total knee arthroplasty
5098013|NCT03385759|osteoarthritis|osteoarthritis
5098014|NCT03385733|pulmonary hypertension|pulmonary hypertension
5098024|NCT03385681|children|children
5098025|NCT03385681|nurses|nurses
5098026|NCT03385668|Pulmonary fibrosis|pulmonary fibrosis
5098027|NCT03385668|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
5098028|NCT03385668|Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis|anti-neutrophil cytoplasmic antibody (anca)-associated vasculitis
5098029|NCT03385668|Pirfenidone|pirfenidone
5098030|NCT03385668|Microscopic Polyangiitis|microscopic polyangiitis
5098226|NCT03384459|recurrence|recurrence
5098044|NCT03385499|Neonatal biological diagnosis of congenital toxoplasmosis|neonatal biological diagnosis of congenital toxoplasmosis
5098045|NCT03385499|neonatal diagnosis|neonatal diagnosis
5098046|NCT03385499|ELISPOT|elispot
5098047|NCT03385499|IgG|igg
5098048|NCT03385486|Melanoma|melanoma
5098049|NCT03385486|Resistant|resistant
4968512|NCT04186468|ICU|icu
5098050|NCT03385486|Refractory|refractory
5098051|NCT03385460|Overactive bladder|overactive bladder
5098052|NCT03385460|Botulinum Toxin|botulinum toxin
5098053|NCT03385460|low energy shock waves|low energy shock waves
5098054|NCT03385460|Intravesical|intravesical
5098055|NCT03385434|Colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy|colonoscopy; adenoma detection rate; endorings-2; endorings; device-assisted colonoscopy
5098056|NCT03385369|MEDI0382|medi0382
5098058|NCT03385369|Tolerability|tolerability
5098059|NCT03385369|Pharmacokinetics|pharmacokinetics
5098060|NCT03385369|Immunogenicity|immunogenicity
5098066|NCT03385304|Surgical Site Infection|surgical site infection
5098067|NCT03385304|Open Fracture|open fracture
5098068|NCT03385304|Povidone-iodine|povidone-iodine
5098069|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate
5098070|NCT03385304|Peri-operative Preparation Solutions|peri-operative preparation solutions
5098071|NCT03385291|EEG;DOC;auditory|eeg;doc;auditory
5098072|NCT03385278|TMS;DOC|tms;doc
5098090|NCT03385226|Relapsed|relapsed
5098091|NCT03385226|Refractory|refractory
5098092|NCT03385213|Microbiota|microbiota
5098093|NCT03385213|colorectal cancer|colorectal cancer
5098094|NCT03385213|relapse|relapse
5098095|NCT03385213|surveillance|surveillance
5098096|NCT03385200|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles|breast cancer, neoadjuvant chemotherapy, ultrasound, microbubbles
5098097|NCT03385161|ethanol ablation of the prostate|ethanol ablation of the prostate
5356818|NCT01917877|irradiation|irradiation
5098098|NCT03385161|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5098100|NCT03385161|Ethanol|ethanol
5098101|NCT03385161|Transrectal|transrectal
5098103|NCT03385161|onaBoNT-A|onabont-a
5098104|NCT03385161|Botox|botox
5098105|NCT03385161|Lower urinary tract symptoms|lower urinary tract symptoms
5098106|NCT03385161|Botulinum toxin|botulinum toxin
5098107|NCT03385161|OnabotulinumtoxinA|onabotulinumtoxina
5098108|NCT03385161|Quality of life|quality of life
5098109|NCT03385161|IPSS|ipss
5098110|NCT03385161|Randomised controlled study|randomised controlled study
5098111|NCT03385135|allopurinol|allopurinol
5098112|NCT03385135|coronary artery disease|coronary artery disease
5098113|NCT03385135|diabetes|diabetes
5098114|NCT03385135|endothelial function|endothelial function
5098115|NCT03385122|Cardiovascular disease|cardiovascular disease
5098116|NCT03385109|Robotic|robotic
5098117|NCT03385109|Laparoscopic|laparoscopic
5098118|NCT03385044|Endotracheal tube|endotracheal tube
5098119|NCT03385044|Intracuff pressure|intracuff pressure
5098120|NCT03385044|Minimal occlusive volume technique|minimal occlusive volume technique
5098121|NCT03385044|Spirometer|spirometer
5098122|NCT03385044|Endotracheal sealing|endotracheal sealing
5098123|NCT03385031|Dose-guided radiation therapy|dose-guided radiation therapy
5098124|NCT03385031|CBCT|cbct
5098125|NCT03385005|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
5098126|NCT03385005|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5098130|NCT03384992|Fear of Cancer Recurrence|fear of cancer recurrence
5098131|NCT03384992|ehealth interventions|ehealth interventions
5098132|NCT03384992|PROMIS|promis
5098133|NCT03384992|FoR|for
5098134|NCT03384940|Oncology|oncology
5098135|NCT03384940|HER2|her2
5098136|NCT03384940|Colorectal cancer|colorectal cancer
5098137|NCT03384940|Antibody drug conjugate|antibody drug conjugate
5098138|NCT03384940|ADC|adc
5098141|NCT03384914|HER-2 directed treatment|her-2 directed treatment
5098142|NCT03384888|Fibromyalgia, Neurostimulation, TDCS|fibromyalgia, neurostimulation, tdcs
5098143|NCT03384875|CytoSorb device|cytosorb device
5098144|NCT03384875|Plasma free hemoglobin|plasma free hemoglobin
5098145|NCT03384875|inflammation|inflammation
5098146|NCT03384875|extracorporeal cardiopulmonary bypass|extracorporeal cardiopulmonary bypass
5098147|NCT03384875|cardiopulmonary bypass|cardiopulmonary bypass
5098148|NCT03384875|Acute Kidney Injury|acute kidney injury
5098149|NCT03384862|Arsenic exposure|arsenic exposure
5098150|NCT03384849|Fiber-optic sensor system|fiber-optic sensor system
5098151|NCT03384849|Magnetic resonance imaging|magnetic resonance imaging
5098152|NCT03384849|Medical monitoring|medical monitoring
5098153|NCT03384849|Physiological parameters|physiological parameters
5098157|NCT03384823|First-in-Human|first-in-human
5098158|NCT03384823|Single Ascending Dose|single ascending dose
5098159|NCT03384823|Multiple Ascending Dose|multiple ascending dose
5098161|NCT03384810|cardiac arrest|cardiac arrest
5098162|NCT03384810|inhospital|inhospital
5098163|NCT03384797|blood|blood
5098164|NCT03384797|biomarker|biomarker
5098165|NCT03384797|Parkinson's disease|parkinson's disease
5098166|NCT03384784|HIV|hiv
5098167|NCT03384784|Neurocognition|neurocognition
5098168|NCT03384784|Inflammation|inflammation
5098169|NCT03384784|Galantamine|galantamine
5098170|NCT03384784|Nicotine|nicotine
5098171|NCT03384784|Tobacco Use|tobacco use
5098172|NCT03384771|mindfulness, MBSR, teaching|mindfulness, mbsr, teaching
5098173|NCT03384758|Compression therapy|compression therapy
5098174|NCT03384758|Microcirculation|microcirculation
5961934|NCT04283864|Crohn Disease|crohn disease
5098175|NCT03384758|Diabetes mellitus|diabetes mellitus
5098176|NCT03384758|Peripheral Arterial Disease|peripheral arterial disease
5098177|NCT03384732|community-dwelling elderly|community-dwelling elderly
5098178|NCT03384732|ICF|icf
5098179|NCT03384732|core set development|core set development
5098180|NCT03384732|geriatric|geriatric
5098181|NCT03384732|functioning|functioning
5098182|NCT03384732|health|health
5098183|NCT03384732|ageing|ageing
5098184|NCT03384719|Growth factor|growth factor
5098185|NCT03384719|Protein|protein
5098196|NCT03384693|hematopoeitic stem cell transplant|hematopoeitic stem cell transplant
5098197|NCT03384693|prophylactic defibrotide|prophylactic defibrotide
5098198|NCT03384667|Maekmoondong-tang|maekmoondong-tang
5098199|NCT03384667|Mai-men-dong-tang|mai-men-dong-tang
5098200|NCT03384667|Bakumondo-to|bakumondo-to
5098201|NCT03384628|Contact lens|contact lens
5098202|NCT03384628|The Young Theory|the young theory
5098203|NCT03384602|subjective cognitive decline|subjective cognitive decline
5098204|NCT03384602|falls prevention|falls prevention
5098205|NCT03384602|cognitive function|cognitive function
5098206|NCT03384602|dalcroze eurhythmics|dalcroze eurhythmics
5098207|NCT03384602|home exercise program|home exercise program
5098208|NCT03384602|seniors|seniors
5098209|NCT03384576|Music|music
5098210|NCT03384576|Emergency|emergency
5098211|NCT03384576|caregivers|caregivers
5098212|NCT03384563|pediatric|pediatric
5098213|NCT03384563|anesthesia|anesthesia
5098214|NCT03384563|dexmedetomidine|dexmedetomidine
5098215|NCT03384537|intra-oral microorganisms.|intra-oral microorganisms.
5098216|NCT03384537|cariogenic microorganisms|cariogenic microorganisms
5098217|NCT03384511|RGD PET-CT|rgd pet-ct
5098218|NCT03384511|Apatinib|apatinib
5098219|NCT03384498|Genetic epidemiology|genetic epidemiology
5098220|NCT03384498|Antimalarial drug resistance|antimalarial drug resistance
5098221|NCT03384472|Malaria Genetic Surveillance|malaria genetic surveillance
5098222|NCT03384472|Cambodia|cambodia
5098223|NCT03384459|vitiligo|vitiligo
5098224|NCT03384459|308-nm excimer laser|308-nm excimer laser
5098225|NCT03384459|maintenance therapy|maintenance therapy
5098227|NCT03384420|Autologous stem cell transplantation|autologous stem cell transplantation
5098228|NCT03384355|varicose veins|varicose veins
5098229|NCT03384355|chronic venous disease|chronic venous disease
5098230|NCT03384355|ecchymosis|ecchymosis
5098231|NCT03384355|symptoms|symptoms
5098232|NCT03384316|Combination Vaccine|combination vaccine
5098233|NCT03384316|Adenoviral|adenoviral
5098234|NCT03384316|ETBX-011|etbx-011
5098235|NCT03384316|ETBX-061|etbx-061
5098236|NCT03384316|ETBX-051|etbx-051
5098237|NCT03384303|Incretines|incretines
5098238|NCT03384303|Bile acids|bile acids
5098242|NCT03384303|Bariatric surgery|bariatric surgery
5098243|NCT03384303|Gastric bypass|gastric bypass
5098244|NCT03384290|Asthma|asthma
5098245|NCT03384290|Anticalin|anticalin
5098246|NCT03384290|PRS-060|prs-060
5098247|NCT03384290|Healthy Volunteers|healthy volunteers
5098248|NCT03384290|Pieris|pieris
5098249|NCT03384290|IL-4 receptor alpha|il-4 receptor alpha
5098250|NCT03384290|IL-13|il-13
5098251|NCT03384290|IL-4|il-4
5098252|NCT03384277|Acquired hemophilia A|acquired hemophilia a
5098253|NCT03384277|Cyclophosphamide|cyclophosphamide
5098254|NCT03384277|Rituximab|rituximab
5098255|NCT03384277|Steroid|steroid
5098256|NCT03384251|Adolescent pregnancy|adolescent pregnancy
5098257|NCT03384251|Teenage pregnancy|teenage pregnancy
5098258|NCT03384251|Prevention|prevention
5098259|NCT03384251|Ghana|ghana
5098260|NCT03384225|cladribine|cladribine
5098261|NCT03384225|fludarabine|fludarabine
5098262|NCT03384225|relapse|relapse
5098263|NCT03384212|cladribine|cladribine
5098264|NCT03384212|fludarabine|fludarabine
5098265|NCT03384212|relapse|relapse
5098266|NCT03384199|Localized Prostate|localized prostate
5098267|NCT03384199|VMAT|vmat
5098268|NCT03384199|Dose escalation|dose escalation
5098269|NCT03384199|Fiducial marker|fiducial marker
5098270|NCT03384199|Focal Lesion|focal lesion
5098271|NCT03384199|Random error during dose escalation radiotherapy|random error during dose escalation radiotherapy
5098272|NCT03384199|fiducial marker image guided technique|fiducial marker image guided technique
5098273|NCT03384173|Near Infrared Spectroscopy|near infrared spectroscopy
5098274|NCT03384173|Creatinine|creatinine
5098275|NCT03384173|Urine Output|urine output
5098276|NCT03384160|Pain|pain
5098277|NCT03384160|Third molar|third molar
5096087|NCT03397446|LDX|ldx
5098290|NCT03384069|Cognitive Impairment|cognitive impairment
5098291|NCT03384069|Cognitive- behavioral therapy|cognitive- behavioral therapy
5098292|NCT03384069|African Americans|african americans
5098293|NCT03384030|Malodor|malodor
5098294|NCT03384030|Stress|stress
5098295|NCT03384030|STMST|stmst
5098296|NCT03384004|Root Canal Treatment|root canal treatment
5098297|NCT03383991|Humeral Fracture, Proximal|humeral fracture, proximal
5098298|NCT03383991|Arthroplasty, Replacement, Shoulder|arthroplasty, replacement, shoulder
5098299|NCT03383991|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5098300|NCT03383991|Shoulder Hemiarthroplasty|shoulder hemiarthroplasty
5098301|NCT03383939|bronchiectasis|bronchiectasis
5098302|NCT03383939|alpha1-antitrypsin|alpha1-antitrypsin
5098303|NCT03383939|neutrophilic elastase|neutrophilic elastase
5098305|NCT03383926|Hemorrhoids|hemorrhoids
5098306|NCT03383926|Rectal|rectal
5098307|NCT03383926|Prolapse|prolapse
5098308|NCT03383926|Anal|anal
5098309|NCT03383913|Heart Rate Variability Biofeedback|heart rate variability biofeedback
5098310|NCT03383913|Sickle Cell Disease|sickle cell disease
5098311|NCT03383835|Omega 3 supplement|omega 3 supplement
5098312|NCT03383835|pre-menopausal|pre-menopausal
5098313|NCT03383835|pregnancy|pregnancy
5098314|NCT03383809|Self-reported healthy adults|self-reported healthy adults
5098315|NCT03383796|Cholangiocarcinoma perihilar|cholangiocarcinoma perihilar
5098316|NCT03383796|three dimension laparoscopic|three dimension laparoscopic
5098318|NCT03383731|Operation mode|operation mode
5098319|NCT03383731|Air tamponade|air tamponade
5098320|NCT03383731|High myopia|high myopia
5098321|NCT03383731|Macular hole retinal detachment|macular hole retinal detachment
5098322|NCT03383718|Coronary Artery Disease|coronary artery disease
5098323|NCT03383718|Fractional Flow Reserve|fractional flow reserve
5098324|NCT03383718|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
5098325|NCT03383718|Stable Coronary Artery Disease|stable coronary artery disease
5098326|NCT03383718|Bystander Coronary Artery Disease|bystander coronary artery disease
5098327|NCT03383718|Non-Culprit Lesions|non-culprit lesions
5098332|NCT03383692|Oncology|oncology
5098333|NCT03383692|HER2|her2
5098334|NCT03383692|Antibody drug conjugate|antibody drug conjugate
5098336|NCT03383666|Unruptured|unruptured
5098337|NCT03383666|intracranial aneurysms|intracranial aneurysms
5098338|NCT03383666|Endovascular|endovascular
5098339|NCT03383653|Td Vaccine|td vaccine
5098340|NCT03383653|Safety|safety
5098341|NCT03383653|Pregnant|pregnant
5108995|NCT03316573|Lymphoma|lymphoma
5098343|NCT03383627|Chronic Kidney Disease|chronic kidney disease
5098344|NCT03383601|COPD|copd
5098345|NCT03383601|Exacerbation of respiratory symptoms|exacerbation of respiratory symptoms
5098346|NCT03383601|Functional exercise capacity|functional exercise capacity
5098347|NCT03383601|Heated Tobacco Products|heated tobacco products
5098348|NCT03383601|Respiratory symptoms|respiratory symptoms
5098349|NCT03383549|Telerehabilitation [E02.831.891]|telerehabilitation [e02.831.891]
5098350|NCT03383549|Cognitive Aging [G07.345.124.260]|cognitive aging [g07.345.124.260]
5098351|NCT03383549|Exercise Therapy [E02.760.169.063.500.387]|exercise therapy [e02.760.169.063.500.387]
5098352|NCT03383536|fMRI|fmri
5098353|NCT03383536|stress|stress
5098354|NCT03383536|peptide|peptide
5098355|NCT03383536|social|social
5098356|NCT03383536|neuroimaging|neuroimaging
5098357|NCT03383484|polycystic ovary syndrome|polycystic ovary syndrome
5098358|NCT03383484|hyperandrogenism|hyperandrogenism
5098359|NCT03383484|nonpharmacological|nonpharmacological
5098360|NCT03383484|yoga|yoga
5098361|NCT03383484|osteopathic manipulative medicine|osteopathic manipulative medicine
5098362|NCT03383471|chondrocyte cells|chondrocyte cells
5098363|NCT03383471|osteoarthritis|osteoarthritis
5098364|NCT03383471|gene therapy|gene therapy
5098365|NCT03383419|Heart Failure, Heart Transplant|heart failure, heart transplant
5098371|NCT03383367|mass screening|mass screening
5098372|NCT03383367|colonoscopy surveillance|colonoscopy surveillance
5098377|NCT03383341|inflammation|inflammation
5098378|NCT03383341|dietary intervention|dietary intervention
5098379|NCT03383328|Cataract|cataract
5098380|NCT03383328|Cataract Surgery|cataract surgery
5098381|NCT03383302|Non-small cell lung cancer|non-small cell lung cancer
5098382|NCT03383302|NSCLC|nsclc
5098383|NCT03383263|Humira®|humira®
5098384|NCT03383263|polyarticular juvenile arthritis|polyarticular juvenile arthritis
5098385|NCT03383263|Adalimumab|adalimumab
5098386|NCT03383250|meal ingestion|meal ingestion
5098387|NCT03383250|postprandial sensations|postprandial sensations
5098388|NCT03383250|circulating metabolites|circulating metabolites
5098389|NCT03383224|smoking cessation treatment|smoking cessation treatment
5098390|NCT03383211|RNAseq|rnaseq
5098391|NCT03383211|Next Generation Sequencing|next generation sequencing
5098392|NCT03383211|Transcriptome|transcriptome
5098393|NCT03383211|Peripheral blood transcripts|peripheral blood transcripts
5098394|NCT03383211|Tempus Blood RNA Tubes|tempus blood rna tubes
5098395|NCT03383185|contraception|contraception
5098396|NCT03383185|Body mass index|body mass index
5098397|NCT03383185|Metabolic Syndrome|metabolic syndrome
5098398|NCT03383185|obesity|obesity
5098399|NCT03383172|Prevention|prevention
5098400|NCT03383172|Promotion|promotion
5098401|NCT03383172|Mental Health|mental health
5098402|NCT03383159|Microbiota|microbiota
5098403|NCT03383159|Metachronous Adenoma|metachronous adenoma
5098404|NCT03383159|Colorectal Cancer|colorectal cancer
5098405|NCT03383159|Colonoscopy|colonoscopy
5098406|NCT03383146|diabetic gastroparesis|diabetic gastroparesis
5098407|NCT03383146|vomiting|vomiting
5098408|NCT03383133|sulfotransferase|sulfotransferase
5098409|NCT03383133|metabolism|metabolism
5098410|NCT03383133|acetaminophen|acetaminophen
5098411|NCT03383133|dehydroepiandrosterone|dehydroepiandrosterone
5098412|NCT03383133|mefenamic acid|mefenamic acid
5098413|NCT03383133|allostery|allostery
5098414|NCT03383120|Peri-implantitis|peri-implantitis
5098415|NCT03383120|Diode laser|diode laser
5098416|NCT03383120|Surgical debridement|surgical debridement
5098417|NCT03383094|cancer|cancer
5098418|NCT03383094|Head and Neck|head and neck
5159207|NCT02997046|MRI|mri
5098419|NCT03383094|Pembrolizumab|pembrolizumab
5098420|NCT03383094|Cisplatin|cisplatin
5098421|NCT03383094|Radiotherapy|radiotherapy
5098422|NCT03383094|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5098423|NCT03383094|p16+|p16+
5098424|NCT03383094|immunotherapy|immunotherapy
5098425|NCT03383094|pd-1|pd-1
5098426|NCT03383094|chemotherapy|chemotherapy
5098427|NCT03383094|T1|t1
5098428|NCT03383094|T2|t2
5098429|NCT03383094|T3|t3
5098430|NCT03383094|N2|n2
5098431|NCT03383094|M0|m0
5098432|NCT03383094|T4|t4
5098433|NCT03383094|N3|n3
5098434|NCT03383094|N1|n1
5098435|NCT03383081|osteoarthritis, mesenchymal stem cell|osteoarthritis, mesenchymal stem cell
5098436|NCT03383068|PCOS|pcos
5098437|NCT03383068|imparied glucose tolerance|imparied glucose tolerance
5098438|NCT03383029|Nutrition|nutrition
5098439|NCT03383029|Behavioral|behavioral
5098440|NCT03383016|Prostate cancer risk|prostate cancer risk
5098441|NCT03383016|Environmental risk factors|environmental risk factors
5098442|NCT03383016|Biomarkers|biomarkers
4983224|NCT04096924|ASD|asd
5098443|NCT03383016|Inflammation and prostate cancer|inflammation and prostate cancer
5098444|NCT03383003|Helicobacter pylori eradication|helicobacter pylori eradication
5098445|NCT03383003|High dose proton pump inhibitor|high dose proton pump inhibitor
5098447|NCT03383003|Concomitant therapy|concomitant therapy
5098448|NCT03382990|Atrial fibrillation|atrial fibrillation
5098449|NCT03382990|Acute myocardial infarction|acute myocardial infarction
5098450|NCT03382990|Drug-eluting stent|drug-eluting stent
5098452|NCT03382977|Glioblastoma|glioblastoma
5098453|NCT03382977|eVLP|evlp
5098454|NCT03382977|VBI-1901|vbi-1901
5098455|NCT03382977|vaccine|vaccine
5098456|NCT03382977|immunotherapy|immunotherapy
5098457|NCT03382977|CMV|cmv
5098458|NCT03382977|CNS|cns
5098459|NCT03382977|Brain|brain
5098460|NCT03382977|Cancer|cancer
5098461|NCT03382964|VLA1553|vla1553
5098462|NCT03382964|Chikungunya|chikungunya
5098463|NCT03382964|CHIKV|chikv
5098464|NCT03382964|Live-attenuated Chikungunya virus vaccine|live-attenuated chikungunya virus vaccine
5098465|NCT03382938|dexmedetomidine|dexmedetomidine
5098466|NCT03382938|ropivacaine|ropivacaine
5098467|NCT03382938|wound infiltration|wound infiltration
5098468|NCT03382938|ceasarean section|ceasarean section
5098469|NCT03382925|cervical epidural steroid injection|cervical epidural steroid injection
5098470|NCT03382925|local anesthetic|local anesthetic
5098471|NCT03382925|upper extremity weakness|upper extremity weakness
5098472|NCT03382886|Advanced and/or metastatic|advanced and/or metastatic
5098473|NCT03382873|Hyperglycemia|hyperglycemia
5098474|NCT03382873|Obese|obese
5098475|NCT03382873|Overweight|overweight
5098476|NCT03382860|Intracranial Hypertension|intracranial hypertension
5098477|NCT03382860|Intracranial pressure monitoring|intracranial pressure monitoring
5098478|NCT03382860|Non-invasive point-of-care device|non-invasive point-of-care device
5098479|NCT03382860|Normal pressure hydrocephalus|normal pressure hydrocephalus
5098480|NCT03382821|cervical epidural steroid injection|cervical epidural steroid injection
5098481|NCT03382821|transforaminal approach|transforaminal approach
5098482|NCT03382821|epidural catheter targeted|epidural catheter targeted
5098483|NCT03382821|interlaminar approach|interlaminar approach
5098484|NCT03382821|cervical radicular pain|cervical radicular pain
5098485|NCT03382795|Epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
5098486|NCT03382795|Cytotoxic chemotherapy|cytotoxic chemotherapy
5098487|NCT03382795|Epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
5098488|NCT03382782|Obesity|obesity
5098489|NCT03382782|Mental Disorder|mental disorder
5098490|NCT03382782|Peer Navigator|peer navigator
5098491|NCT03382782|Physical Health|physical health
5098492|NCT03382782|Overweight|overweight
5098493|NCT03382782|Serious Mental Illness|serious mental illness
5098494|NCT03382743|office hysteroscopy|office hysteroscopy
5098495|NCT03382743|Lidocaine spray|lidocaine spray
5098496|NCT03382704|Peri-ocular|peri-ocular
5098497|NCT03382678|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
5098498|NCT03382665|Revision total hip arthroplasty|revision total hip arthroplasty
5098499|NCT03382665|Medical Device|medical device
5098500|NCT03382665|Post Market Surveillance Study|post market surveillance study
5098501|NCT03382665|Primary total hip arthroplasty|primary total hip arthroplasty
5098502|NCT03382652|Total hip arthroplasty|total hip arthroplasty
5098503|NCT03382652|Medical Device|medical device
5098504|NCT03382652|Post Market Surveillance Study|post market surveillance study
5098505|NCT03382652|Performance|performance
5098506|NCT03382652|Safety|safety
5098507|NCT03382639|Drug therapy|drug therapy
5098508|NCT03382626|Traumatic Brain Injury|traumatic brain injury
5098509|NCT03382626|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5098510|NCT03382626|Computer-assisted training|computer-assisted training
5098511|NCT03382626|Cognitive training|cognitive training
5098512|NCT03382626|Cognitive function|cognitive function
5098513|NCT03382626|Executive function|executive function
5098514|NCT03382626|Working memory|working memory
5098515|NCT03382626|Attention|attention
5098516|NCT03382548|Ventilator Associated Pneumonia|ventilator associated pneumonia
5098517|NCT03382548|Pneumonia|pneumonia
5098518|NCT03382535|Voice disorder|voice disorder
5098519|NCT03382535|Teacher's voice|teacher's voice
5098520|NCT03382535|Voice SPL (Voice sound pressure level)|voice spl (voice sound pressure level)
5098521|NCT03382535|Voice F0 (Voice fundamental frequency)|voice f0 (voice fundamental frequency)
5098522|NCT03382535|Voice therapy|voice therapy
5098523|NCT03382535|Voice accumulator|voice accumulator
5098524|NCT03382535|Activity noise|activity noise
5098525|NCT03382535|Classroom|classroom
5098526|NCT03382522|bone scintigraphy|bone scintigraphy
5098527|NCT03382522|quantification|quantification
5098528|NCT03382522|prostate cancer|prostate cancer
5098529|NCT03382522|prognosis|prognosis
5098530|NCT03382457|Functional|functional
5098532|NCT03382457|FTR|ftr
5098533|NCT03382457|Transcatheter|transcatheter
5098534|NCT03382457|Reconstruction|reconstruction
5098535|NCT03382444|cognitive impairment|cognitive impairment
5098536|NCT03382444|hemodialysis|hemodialysis
5098537|NCT03382444|dementia|dementia
5098538|NCT03382444|end stage renal disease|end stage renal disease
5098539|NCT03382405|cytomegalovirus vaccine|cytomegalovirus vaccine
5098540|NCT03382405|mRNA-1647|mrna-1647
5098541|NCT03382405|mRNA-1443|mrna-1443
5098542|NCT03382405|Moderna|moderna
5098543|NCT03382392|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
5098544|NCT03382392|Resting energy expenditure|resting energy expenditure
5098545|NCT03382392|Predictive equation|predictive equation
5098546|NCT03382379|methamphetamine|methamphetamine
5098547|NCT03382379|transcranial Direct Current Stimulation|transcranial direct current stimulation
5098548|NCT03382379|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5098549|NCT03382379|amphetamine|amphetamine
5098550|NCT03382379|drug craving|drug craving
5098551|NCT03382366|Sarcopenia|sarcopenia
5098552|NCT03382366|Risk of fall|risk of fall
5098553|NCT03382366|Osteoporosis|osteoporosis
5098554|NCT03382366|Muscle|muscle
5098555|NCT03382366|DXA|dxa
5098556|NCT03382366|MR|mr
5098557|NCT03382366|Muscle metabolism|muscle metabolism
5098558|NCT03382353|primary prevention|primary prevention
5098559|NCT03382353|Subjective Cognitive Decline|subjective cognitive decline
5098560|NCT03382353|Neuroimaging|neuroimaging
5098561|NCT03382353|Alzheimer's disease|alzheimer's disease
5098562|NCT03382353|nonpharmacological interventions|nonpharmacological interventions
5098563|NCT03382353|multidomain lifestyle interventions|multidomain lifestyle interventions
5098564|NCT03382327|Surgical planning|surgical planning
5098565|NCT03382327|CT-scan|ct-scan
5098566|NCT03382327|MRI|mri
5098567|NCT03382327|3D model|3d model
5862710|NCT00001541|Vasculitis|vasculitis
5098568|NCT03382327|Hepatocarcinoma eligible for surgical resection|hepatocarcinoma eligible for surgical resection
5098569|NCT03382301|Ischemia reperfusion injuries|ischemia reperfusion injuries
5098570|NCT03382301|Renal artery stenosis|renal artery stenosis
5098571|NCT03382301|Renal functional imaging|renal functional imaging
5098572|NCT03382262|Osteoarthritis|osteoarthritis
5098573|NCT03382262|Shoulder|shoulder
5098574|NCT03382262|Hip|hip
5098575|NCT03382262|Pain|pain
5098576|NCT03382262|Intra-articular|intra-articular
5098577|NCT03382262|Injection|injection
5098578|NCT03382262|Corticosteroid|corticosteroid
5098579|NCT03382210|Enhanced Recovery Program|enhanced recovery program
5098580|NCT03382197|aerosol therapy|aerosol therapy
5098581|NCT03382197|positive pressure|positive pressure
5098582|NCT03382197|electrical impedance tomography|electrical impedance tomography
5098583|NCT03382197|pulmonary scintigraphy|pulmonary scintigraphy
5098584|NCT03382158|pleuropulmonary blastoma|pleuropulmonary blastoma
5098585|NCT03382158|PPB|ppb
5098586|NCT03382158|DICER1|dicer1
5098587|NCT03382158|Sertoli-Leydig cell tumor|sertoli-leydig cell tumor
5098588|NCT03382158|cystic nephroma|cystic nephroma
5098589|NCT03382119|liver stiffness Fontan|liver stiffness fontan
5098590|NCT03382093|Anxiety Sensitivity|anxiety sensitivity
5098591|NCT03382093|Tobacco|tobacco
5098592|NCT03382093|Smoking|smoking
5098593|NCT03382093|Anxiety|anxiety
5098594|NCT03382093|Feedback|feedback
5098595|NCT03382093|Stress|stress
5098596|NCT03382080|randomized controlled trial|randomized controlled trial
5098597|NCT03382080|drop out|drop out
5098598|NCT03382080|upper secondary school|upper secondary school
5098599|NCT03382080|psychosocial learning environments|psychosocial learning environments
5098600|NCT03382028|developmental abnormalities|developmental abnormalities
5098601|NCT03382028|psychomotor development|psychomotor development
5098602|NCT03381989|TAVR|tavr
5098603|NCT03381989|Native Aortic Valve Failure|native aortic valve failure
5098604|NCT03381989|TAVR Associated Coronary Artery Obstruction|tavr associated coronary artery obstruction
5098605|NCT03381989|Electrosurgery|electrosurgery
5098606|NCT03381963|tamoxifen|tamoxifen
5098607|NCT03381963|aromatase inhibitors|aromatase inhibitors
5098608|NCT03381963|breast cancer|breast cancer
4969009|NCT04183322|PCV|pcv
5098609|NCT03381963|venous thromboembolism|venous thromboembolism
5098610|NCT03381950|chronic kidney disease|chronic kidney disease
5098611|NCT03381950|prospective cohort study|prospective cohort study
5098612|NCT03381950|risk profile|risk profile
5098613|NCT03381950|patient-reported-outcomes|patient-reported-outcomes
5098614|NCT03381937|mechanical ventilation|mechanical ventilation
5098615|NCT03381937|noninvasive ventilation|noninvasive ventilation
5098616|NCT03381937|neuromuscular disorder|neuromuscular disorder
5098617|NCT03381937|phonation|phonation
5098618|NCT03381937|mouthpiece ventilation|mouthpiece ventilation
5098619|NCT03381924|Migraine disorders|migraine disorders
5098620|NCT03381924|Educational models|educational models
5098621|NCT03381924|Neuroscience|neuroscience
5098622|NCT03381898|Telehealth|telehealth
5099117|NCT03378570|Targeting|targeting
5098623|NCT03381898|Physical therapy exercise|physical therapy exercise
5098624|NCT03381898|Speech therapy Lee Silverman voice treatment|speech therapy lee silverman voice treatment
5098625|NCT03381898|Pharmacy medication management|pharmacy medication management
5098626|NCT03381872|Intravascular Imaging|intravascular imaging
5098627|NCT03381872|Intravascular Ultrasound|intravascular ultrasound
5098628|NCT03381872|Optical Coherence Tomography|optical coherence tomography
5098629|NCT03381872|Complex Lesion|complex lesion
5098630|NCT03381872|Percutaneous Coronary Intervention|percutaneous coronary intervention
5098631|NCT03381859|Hepatitis C Virus|hepatitis c virus
5098632|NCT03381859|Genotype 4|genotype 4
5098633|NCT03381859|End Stage Renal Disease|end stage renal disease
5098634|NCT03381820|music therapy|music therapy
5098635|NCT03381820|hypertension|hypertension
5098638|NCT03381794|Keratoplasty Registry, PKP, DSAEK, DMEK, DALK|keratoplasty registry, pkp, dsaek, dmek, dalk
5098639|NCT03381781|p53 mutation|p53 mutation
5098640|NCT03381781|acute myeloid leukemia|acute myeloid leukemia
5098642|NCT03381781|Arsenic trioxide|arsenic trioxide
5098643|NCT03381781|cytarabine|cytarabine
5098644|NCT03381768|PD-L1|pd-l1
5098645|NCT03381768|PD-L2|pd-l2
5098646|NCT03381768|peptide vaccine|peptide vaccine
5098647|NCT03381729|Gene Transfer|gene transfer
5098648|NCT03381729|Gene Therapy|gene therapy
5098649|NCT03381729|Adeno-associated virus|adeno-associated virus
5098650|NCT03381729|Survival Motor Neuron|survival motor neuron
5098651|NCT03381729|SMN|smn
5098652|NCT03381729|AAV9|aav9
5098653|NCT03381716|aortic dissection|aortic dissection
5098654|NCT03381716|sex|sex
5098655|NCT03381716|treatment|treatment
5098656|NCT03381703|Accelerated Mass Spectrometry|accelerated mass spectrometry
5098657|NCT03381703|Microtracer|microtracer
5098658|NCT03381703|Microdose|microdose
5098659|NCT03381703|hAME|hame
5098660|NCT03381703|Absolute bioavailability|absolute bioavailability
5098661|NCT03381677|pedicle lengthening osteotomy|pedicle lengthening osteotomy
5098662|NCT03381677|spinal stenosis|spinal stenosis
5098663|NCT03381677|decompression|decompression
5098664|NCT03381664|bioavailability|bioavailability
5098665|NCT03381664|pharmacokinetics|pharmacokinetics
5098666|NCT03381664|safety|safety
5098671|NCT03381651|Radiation dose|radiation dose
5098672|NCT03381638|Concussion|concussion
5098673|NCT03381638|TBI|tbi
5098674|NCT03381638|Sports|sports
5098675|NCT03381638|Medical Device|medical device
5098676|NCT03381638|Fast|fast
5098677|NCT03381612|Female circumcision, Young Women, Dysmenorrhea,Dysuria|female circumcision, young women, dysmenorrhea,dysuria
5098678|NCT03381586|ALT-803|alt-803
5098679|NCT03381586|PK|pk
5098680|NCT03381560|LASSYC; COPD symptoms.|lassyc; copd symptoms.
5098681|NCT03381534|vertebral artery origin|vertebral artery origin
5098682|NCT03381534|angioplasty|angioplasty
5098683|NCT03381534|distal embolic protection|distal embolic protection
5098684|NCT03381521|nerve hydrodissection|nerve hydrodissection
5098685|NCT03381508|CPAP|cpap
5098686|NCT03381508|masks|masks
5098687|NCT03381508|unintentional leak|unintentional leak
5098688|NCT03381508|leakage|leakage
5098689|NCT03381495|Epidural Labor Analgesia|epidural labor analgesia
5098690|NCT03381495|length of labor stage|length of labor stage
5098691|NCT03381495|fetal outcomes|fetal outcomes
5098692|NCT03381495|maternal outcomes|maternal outcomes
5098693|NCT03381495|postpartum depression|postpartum depression
5098694|NCT03381495|exercise|exercise
5098695|NCT03381482|Alzheimer disease|alzheimer disease
5098696|NCT03381482|Extracellular vesicles|extracellular vesicles
5098697|NCT03381482|Biomarker|biomarker
5098698|NCT03381482|Tau|tau
5098699|NCT03381482|CSF|csf
5098700|NCT03381482|Plasma|plasma
5098701|NCT03381404|Mass Balance Study with MT-8554|mass balance study with mt-8554
5098702|NCT03381378|Vitamin D|vitamin d
5098703|NCT03381378|s-25-hydroxyvitamin D|s-25-hydroxyvitamin d
5098704|NCT03381378|hand grip strength|hand grip strength
5098705|NCT03381378|myopathy|myopathy
5098706|NCT03381378|muscle|muscle
5098707|NCT03381352|Radiotherapy|radiotherapy
5098708|NCT03381352|Anal cancer|anal cancer
5098709|NCT03381352|IMRT|imrt
5098710|NCT03381339|power toothbrush, oscillating rotating|power toothbrush, oscillating rotating
5961935|NCT04283864|microbiome|microbiome
5159568|NCT02994381|14C|14c
5098711|NCT03381326|circulating tumor cells|circulating tumor cells
5098712|NCT03381326|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5098713|NCT03381326|cabazitaxel|cabazitaxel
5098714|NCT03381326|biomarker|biomarker
5098715|NCT03381326|free DNA|free dna
5098716|NCT03381326|stem cells|stem cells
5098717|NCT03381326|EMT related antigens|emt related antigens
5098718|NCT03381274|EGFR mutated, CD73, A2AR, oleclumab, MEDI9447, AZD4635, osimertinib, NSCLC, immunotherapy|egfr mutated, cd73, a2ar, oleclumab, medi9447, azd4635, osimertinib, nsclc, immunotherapy
5098719|NCT03381261|chronic migraine|chronic migraine
4983544|NCT04095013|sensory block|sensory block
5098720|NCT03381261|trigeminal neuralgia|trigeminal neuralgia
5098721|NCT03381261|migraine surgery|migraine surgery
5099319|NCT03377387|17-585|17-585
5098725|NCT03381248|radiofrequency ablation|radiofrequency ablation
5098727|NCT03381248|genicular|genicular
5098728|NCT03381248|cross-over|cross-over
5098729|NCT03381248|viscosupplemention|viscosupplemention
5098730|NCT03381235|Exercise|exercise
5098731|NCT03381235|Quality of life|quality of life
5098732|NCT03381235|Progression of disease|progression of disease
5098733|NCT03381235|Retinitis|retinitis
5098734|NCT03381209|Sugammadex|sugammadex
5098735|NCT03381209|morbidly obese patients|morbidly obese patients
5098736|NCT03381209|bariatric surgery|bariatric surgery
5098737|NCT03381209|neuromuscular blockade|neuromuscular blockade
5098738|NCT03381170|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5098739|NCT03381157|general movements, fidgety movements, motor optimality score|general movements, fidgety movements, motor optimality score
5098740|NCT03381105|Diagnostics, over-diagnosis|diagnostics, over-diagnosis
5098741|NCT03381092|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5098742|NCT03381092|sentinel lymph node biopsy|sentinel lymph node biopsy
5098743|NCT03381092|axillary lymph node dissection|axillary lymph node dissection
5098744|NCT03381092|Predictive model|predictive model
5098746|NCT03381066|EGFR|egfr
5098747|NCT03381066|adjuvant|adjuvant
5098748|NCT03381066|gefitinib|gefitinib
5098749|NCT03381066|intercalating|intercalating
5098750|NCT03381053|GIST|gist
5098751|NCT03381053|Grading and Staging|grading and staging
5098752|NCT03381027|Infant Sleep|infant sleep
5098753|NCT03381027|Baby Massage|baby massage
5098754|NCT03381027|Neurodevelopmental Disorders|neurodevelopmental disorders
5098755|NCT03381001|cryopreservation|cryopreservation
5098756|NCT03381001|human embryos|human embryos
5098757|NCT03381001|vitrification|vitrification
5098758|NCT03381001|embryo culture|embryo culture
5098759|NCT03381001|embryo transfer|embryo transfer
5098760|NCT03381001|pregnancy rate|pregnancy rate
5098761|NCT03380975|MAAP|maap
5098762|NCT03380975|Asthma|asthma
5098763|NCT03380975|Allergic rhinits|allergic rhinits
5098764|NCT03380962|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
5098765|NCT03380962|Kidney Transplantation|kidney transplantation
5098770|NCT03380949|Sufentanil|sufentanil
5098771|NCT03380949|Sevoflurane|sevoflurane
5098772|NCT03380936|subclinical|subclinical
5098773|NCT03380936|graft rejection|graft rejection
5098774|NCT03380936|AMR (antibody-mediated rejection)|amr (antibody-mediated rejection)
5098775|NCT03380936|AMBR (acute antibody-mediated rejection)|ambr (acute antibody-mediated rejection)
5098776|NCT03380936|DSA (donor specific antibodies)|dsa (donor specific antibodies)
5098777|NCT03380923|epigenetics|epigenetics
5098778|NCT03380923|exercise dose-response|exercise dose-response
5098779|NCT03380923|inter-individual response heterogeneity|inter-individual response heterogeneity
5098780|NCT03380923|exercise training adaptations|exercise training adaptations
5098781|NCT03380897|induction of labor|induction of labor
5098782|NCT03380897|double balloon catheter|double balloon catheter
5098783|NCT03380897|mechanical ripening|mechanical ripening
5098784|NCT03380884|Distal Radius Fracture, Osteoporosis, Vibration Therapy|distal radius fracture, osteoporosis, vibration therapy
5098785|NCT03380871|Personal Vaccine|personal vaccine
5098786|NCT03380871|Neoantigen|neoantigen
5098787|NCT03380871|Immunotherapy|immunotherapy
5098788|NCT03380871|Poly-ICLC|poly-iclc
5098789|NCT03380871|Peptide|peptide
5098790|NCT03380871|Checkpoint Inhibitor|checkpoint inhibitor
5098791|NCT03380806|stereotactic body radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5098792|NCT03380806|conventional radiotherapy (CRT)|conventional radiotherapy (crt)
5098793|NCT03380806|High risk prostate cancer|high risk prostate cancer
5098794|NCT03380806|quality of life (QoL)|quality of life (qol)
5098795|NCT03380806|The Expanded Prostate cancer Index Composite (EPIC-26)|the expanded prostate cancer index composite (epic-26)
5098796|NCT03380806|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5098797|NCT03380767|trauma-induced coagulopathy|trauma-induced coagulopathy
5098803|NCT03380715|Sinusitis|sinusitis
5098804|NCT03380715|Endoscopy|endoscopy
5098805|NCT03380715|Rhinitis|rhinitis
5098806|NCT03380702|colour|colour
5098807|NCT03380702|dental aesthetics|dental aesthetics
5098808|NCT03380702|perceptions|perceptions
5098809|NCT03380702|quality of life|quality of life
5098810|NCT03380702|tooth whitening|tooth whitening
5098811|NCT03380663|blood flow restricted resistance exercise|blood flow restricted resistance exercise
5098812|NCT03380663|remote ischemic conditioning|remote ischemic conditioning
5098813|NCT03380663|miRNA|mirna
5098814|NCT03380650|femoropopliteal occlusive disease|femoropopliteal occlusive disease
5098815|NCT03380650|directional atherectomy|directional atherectomy
5098816|NCT03380650|local drug delivery|local drug delivery
5098817|NCT03380650|endovascular treatment|endovascular treatment
5098818|NCT03380598|Mobile Health, Self-Monitoring, Behavioural Treatment|mobile health, self-monitoring, behavioural treatment
5098819|NCT03380572|Robotic Surgery|robotic surgery
5098820|NCT03380559|Epicondylitis|epicondylitis
5098821|NCT03380559|Botulinum toxin|botulinum toxin
5098822|NCT03380559|Corticoid|corticoid
5098823|NCT03380546|Diabetes|diabetes
5098824|NCT03380546|Pregnancy|pregnancy
5098825|NCT03380546|Gestational|gestational
5098826|NCT03380546|Acarbose|acarbose
5098827|NCT03380507|Septic Shock|septic shock
5098828|NCT03380507|Vitamin C|vitamin c
5098829|NCT03380507|Thiamine|thiamine
5098830|NCT03380507|Hydrocortisone|hydrocortisone
5098831|NCT03380507|Critically Ill|critically ill
5098832|NCT03380494|Overhead perturbation training; instability, glenohumeral joint|overhead perturbation training; instability, glenohumeral joint
5098833|NCT03380468|Lung adenocarcinoma|lung adenocarcinoma
5098834|NCT03380468|adjuvant chemotherapy|adjuvant chemotherapy
5098835|NCT03380442|fMRI|fmri
5098836|NCT03380442|psilocybin|psilocybin
5098837|NCT03380442|ketamine|ketamine
5098838|NCT03380442|biomarker|biomarker
5098839|NCT03380442|rapid-acting antidepressants|rapid-acting antidepressants
5098840|NCT03380429|Connected Inhaler System|connected inhaler system
5098841|NCT03380429|Metered Dose Inhaler|metered dose inhaler
5098842|NCT03380429|ELLIPTA|ellipta
5098843|NCT03380429|RELVAR/BREO|relvar/breo
5098844|NCT03380429|Dry Powder Inhaler|dry powder inhaler
5098845|NCT03380429|Salbutamol|salbutamol
5098846|NCT03380429|Asthma|asthma
5098847|NCT03380403|diabetic foot|diabetic foot
5098848|NCT03380403|Osteomyelitis|osteomyelitis
5098849|NCT03380403|PACT|pact
5098850|NCT03380403|PDT|pdt
5098851|NCT03380403|Singlet oxygen|singlet oxygen
5098852|NCT03380403|antimicrobial|antimicrobial
5098853|NCT03380403|diabetes|diabetes
5098854|NCT03380403|Wagner scale|wagner scale
5098855|NCT03380377|kidney transplant|kidney transplant
5098856|NCT03380377|Chronic antibody mediated rejection|chronic antibody mediated rejection
5098857|NCT03380377|donor specific antibody|donor specific antibody
5098858|NCT03380338|Gut microbiota|gut microbiota
5098859|NCT03380325|Capillary recruitment|capillary recruitment
5098860|NCT03380286|Firehawk|firehawk
5098861|NCT03380286|Coronary Artery Disease|coronary artery disease
5096691|NCT03394118|T790 mutation|t790 mutation
5098863|NCT03380247|Emergency, trauma pain, analgesia, Methoxyfurane|emergency, trauma pain, analgesia, methoxyfurane
5098864|NCT03380234|Smoking|smoking
5098865|NCT03380234|Secondhand smoke|secondhand smoke
5098866|NCT03380234|Thirdhand smoke|thirdhand smoke
5098867|NCT03380234|Children|children
5098868|NCT03380234|Cluster randomised controlled trial|cluster randomised controlled trial
5098869|NCT03380182|acupuncture|acupuncture
5098870|NCT03380182|acupressure|acupressure
5098871|NCT03380143|Children|children
5098872|NCT03380143|Cancer Prevention|cancer prevention
5098873|NCT03380143|Population Health|population health
5098874|NCT03380143|Rural|rural
5098875|NCT03380143|Community|community
5098876|NCT03380143|School|school
5098877|NCT03380143|After School|after school
5098878|NCT03380143|Youth Sport|youth sport
5098879|NCT03380143|Intervention|intervention
5098880|NCT03380143|Multilevel|multilevel
5098881|NCT03380143|Systems|systems
5098882|NCT03380130|Hepatocellular Carcinoma|hepatocellular carcinoma
5098883|NCT03380130|Liver cancer|liver cancer
5098884|NCT03380130|Hepatoma|hepatoma
5098885|NCT03380117|Suicidal Ideation|suicidal ideation
5098886|NCT03380117|Suicide Attempt|suicide attempt
5098887|NCT03380117|Risk Screening|risk screening
5098888|NCT03380117|Online Intervention|online intervention
5098889|NCT03380117|Online Counseling|online counseling
5098890|NCT03380117|College Students|college students
5098891|NCT03380117|Motivational Interviewing|motivational interviewing
5098892|NCT03380117|Linkage to Care|linkage to care
5098893|NCT03380104|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
5098894|NCT03380091|PCOS|pcos
5098895|NCT03380091|Depression|depression
5098896|NCT03380091|Vitamin D|vitamin d
5098897|NCT03380091|Insulin Resistance|insulin resistance
5098898|NCT03380091|Anxiety|anxiety
5098899|NCT03380091|Quality of life|quality of life
5098900|NCT03380091|Mood disorders|mood disorders
5098901|NCT03380078|Implementation Mechanism|implementation mechanism
5098902|NCT03380078|Autism Spectrum Disorder|autism spectrum disorder
5098903|NCT03380078|Children's Mental Health Services|children's mental health services
5098904|NCT03380078|School Services|school services
5098905|NCT03380065|coronary angiogram|coronary angiogram
5098906|NCT03380065|radial artery|radial artery
5098907|NCT03380052|OLGA|olga
5098908|NCT03380052|OLGIM|olgim
5098909|NCT03380052|Helicobacter pylori|helicobacter pylori
5098910|NCT03380052|Gastric cancer|gastric cancer
5098911|NCT03380052|pepsinogen|pepsinogen
5098913|NCT03380026|topical mechlorethamine|topical mechlorethamine
5098914|NCT03380026|Valchlor|valchlor
5098915|NCT03380026|contact dermatitis|contact dermatitis
5098916|NCT03380026|triamcinolone|triamcinolone
5098917|NCT03380026|MF|mf
5098918|NCT03380026|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5098928|NCT03379870|cochlear implant|cochlear implant
5098929|NCT03379870|electric acoustic stimulation|electric acoustic stimulation
5098931|NCT03379870|hearing loss|hearing loss
5098932|NCT03379870|pediatric|pediatric
5098933|NCT03379831|systemic right ventricle|systemic right ventricle
5098934|NCT03379831|quality of life|quality of life
5098935|NCT03379831|VO2|vo2
5098936|NCT03379831|oxygen uptake|oxygen uptake
5098937|NCT03379831|exercise test|exercise test
5098938|NCT03379831|congenital heart disease|congenital heart disease
5098939|NCT03379818|Shape bias|shape bias
5098940|NCT03379818|Late Talkers|late talkers
5098941|NCT03379792|Obesity|obesity
5098942|NCT03379779|Microbiota|microbiota
5098943|NCT03379779|Respiratory Failure|respiratory failure
5098944|NCT03379779|Pneumonia|pneumonia
5098945|NCT03379779|Lower Respiratory Tract Infection|lower respiratory tract infection
5098946|NCT03379740|Nicotine-containing product|nicotine-containing product
5098947|NCT03379740|Alternative to cigarettes|alternative to cigarettes
5098963|NCT03379662|Irritability|irritability
5098964|NCT03379662|laser|laser
5098965|NCT03379662|light therapy|light therapy
5098966|NCT03379649|Recurrent implantation failure|recurrent implantation failure
5098967|NCT03379636|Athletic tape|athletic tape
5098968|NCT03379636|Electromyography|electromyography
5098969|NCT03379636|Rehabilitation|rehabilitation
5098970|NCT03379636|Shoulder|shoulder
5098971|NCT03379597|Schizophrenia|schizophrenia
5098972|NCT03379597|probiotics|probiotics
5098973|NCT03379597|cognitive impairment|cognitive impairment
5098974|NCT03379597|Metabolic syndrome|metabolic syndrome
5098975|NCT03379597|clinical trail|clinical trail
5098976|NCT03379597|Efficacy|efficacy
5098977|NCT03379597|Safety|safety
5098978|NCT03379584|Multiple myeloma|multiple myeloma
5098979|NCT03379584|Antibody-drug conjugate|antibody-drug conjugate
5098980|NCT03379571|Chronic kidney disease|chronic kidney disease
5098981|NCT03379571|Competing-risk analysis|competing-risk analysis
5098982|NCT03379571|Epidemiological study|epidemiological study
5098983|NCT03379571|Incidence|incidence
5098984|NCT03379571|Outcomes|outcomes
5098985|NCT03379571|Risk factors|risk factors
5098986|NCT03379493|relapsed/refractory CD19+ Lymphomas Non-Hodgkin's B-Cell|relapsed/refractory cd19+ lymphomas non-hodgkin's b-cell
5098987|NCT03379480|Schizophrenia|schizophrenia
5098993|NCT03379428|Metastatic Breast Cancer|metastatic breast cancer
5098994|NCT03379428|HER2-amplified Metastatic Breast Cancer|her2-amplified metastatic breast cancer
5098995|NCT03379428|HER2-positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
5098997|NCT03379415|Footwear|footwear
5098998|NCT03379415|Osteoarthritis|osteoarthritis
5098999|NCT03379402|causes of community-acquired sepsis|causes of community-acquired sepsis
5099000|NCT03379402|diagnostic tests|diagnostic tests
5099001|NCT03379363|cushing syndrome, hypercortisolism|cushing syndrome, hypercortisolism
5099002|NCT03379350|lung cancer|lung cancer
5099003|NCT03379350|surgery|surgery
5099004|NCT03379350|chest tube clamping|chest tube clamping
5099005|NCT03379350|duration of chest tube drainage|duration of chest tube drainage
5099006|NCT03379350|postoperative stay|postoperative stay
5099007|NCT03379337|Imaging|imaging
5099008|NCT03379324|Rotator Cuff|rotator cuff
5099009|NCT03379324|Human Amniotic Fluid|human amniotic fluid
5099010|NCT03379324|Amniotic Fluid Allograft|amniotic fluid allograft
5099011|NCT03379324|FlōGraft®|flōgraft®
5099012|NCT03379324|Amniotic Fluid Biologic|amniotic fluid biologic
5099013|NCT03379324|Fatty Atrophy|fatty atrophy
5099014|NCT03379324|Fat Degeneration|fat degeneration
5099015|NCT03379311|AKC|akc
5099016|NCT03379311|PAC|pac
5099017|NCT03379311|VKC|vkc
5099018|NCT03379285|Gastro Intestinal Bleeding;|gastro intestinal bleeding;
5099019|NCT03379285|Transfusion,|transfusion,
5099020|NCT03379285|Outcomes|outcomes
5099021|NCT03379272|Electroencephalography|electroencephalography
5099022|NCT03379272|Epilepsy|epilepsy
5099023|NCT03379272|EEG|eeg
5099024|NCT03379233|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5099025|NCT03379233|Adherence|adherence
5099026|NCT03379233|Dose Tracking|dose tracking
5099027|NCT03379233|Concept2|concept2
5099028|NCT03379233|Digital Adherence System|digital adherence system
5099029|NCT03379233|Ultibro Breezhaler|ultibro breezhaler
5099030|NCT03379207|Community-acquired Pneumonia|community-acquired pneumonia
5099031|NCT03379207|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5099032|NCT03379207|Innate Immunity|innate immunity
5099033|NCT03379207|Non Conventional T Lymphocytes|non conventional t lymphocytes
4983906|NCT04092777|Ethnic|ethnic
5099034|NCT03379194|antibiotic prescriptions|antibiotic prescriptions
5099036|NCT03379194|feedback|feedback
5099037|NCT03379194|primary care|primary care
5099038|NCT03379181|Brown adipose tissue (BAT)|brown adipose tissue (bat)
5099039|NCT03379181|Hyperthyroidism|hyperthyroidism
5099040|NCT03379168|knee osteoarthritis|knee osteoarthritis
5099041|NCT03379168|mesenchymal stem cell|mesenchymal stem cell
5099042|NCT03379168|adipose tissue|adipose tissue
5099043|NCT03379168|injection|injection
5099044|NCT03379168|nonoperative treatment|nonoperative treatment
5961936|NCT04283864|Personal diet|personal diet
4969531|NCT04179981|Respiration Disorders|respiration disorders
4969532|NCT04179981|Respiratory Tract Diseases|respiratory tract diseases
4969533|NCT04179981|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
4969534|NCT04179981|positive airway pressure|positive airway pressure
4969535|NCT04179981|cognitive function|cognitive function
4969536|NCT04179981|quality of life|quality of life
4969537|NCT04179981|sleepiness|sleepiness
4969545|NCT04179942|OSA|osa
5099045|NCT03379142|Faith-Based; Community-engaged; Text messaging; Tobacco|faith-based; community-engaged; text messaging; tobacco
5099046|NCT03379103|Blood Loss, Surgical|blood loss, surgical
5099047|NCT03379103|Blood Transfusion|blood transfusion
5099048|NCT03379103|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5099049|NCT03379077|Mothers|mothers
5099050|NCT03379077|young children|young children
5099051|NCT03379077|Implementation|implementation
5099052|NCT03379077|Learning through play Plus|learning through play plus
5099053|NCT03379077|Cognitive Behavior Therapy|cognitive behavior therapy
5099054|NCT03379064|Irritable Bowel Syndrome, Low Income Country|irritable bowel syndrome, low income country
5099055|NCT03379038|Cerebral Palsy|cerebral palsy
5099056|NCT03379038|Spasticity|spasticity
5099057|NCT03379038|Constipation|constipation
5099058|NCT03379038|Gross Motor Functional Classification Scale|gross motor functional classification scale
5099059|NCT03379038|Defecation Frequency|defecation frequency
5099060|NCT03379038|Constipation Severity|constipation severity
5099061|NCT03379025|electronic cigarettes; e-cigarettes|electronic cigarettes; e-cigarettes
5099062|NCT03378973|motor evoked potentials|motor evoked potentials
5099063|NCT03378947|EBV, DLBCL|ebv, dlbcl
5099064|NCT03378934|Coronary Artery Disease|coronary artery disease
5099065|NCT03378934|Percutaneous Coronary Intervention|percutaneous coronary intervention
5099066|NCT03378934|Antiplatelet|antiplatelet
5099067|NCT03378934|Berberine|berberine
5099068|NCT03378921|FMT|fmt
5099069|NCT03378908|medical therapy nutrition|medical therapy nutrition
5099070|NCT03378908|meal|meal
5099071|NCT03378908|carbohydrates|carbohydrates
5099072|NCT03378908|intervention|intervention
5099073|NCT03378908|food intake|food intake
5099074|NCT03378882|Angiostrongylosis|angiostrongylosis
5099075|NCT03378882|Hypereosinophilia|hypereosinophilia
5099076|NCT03378882|Eosinophilic meningitis|eosinophilic meningitis
5099077|NCT03378882|Meningoencephalitis|meningoencephalitis
5099078|NCT03378882|Achatina fulica|achatina fulica
5099082|NCT03378830|Pain|pain
5099083|NCT03378830|Sleep Disordered Breathing|sleep disordered breathing
5099084|NCT03378817|Extended criteria donor|extended criteria donor
5099085|NCT03378817|Donation after brain death|donation after brain death
5099086|NCT03378817|HOPE|hope
5099087|NCT03378817|Kidney transplantation|kidney transplantation
5099088|NCT03378804|PCEA|pcea
5099089|NCT03378804|PIEB|pieb
5099090|NCT03378804|epidural analgesia|epidural analgesia
5099091|NCT03378752|Computer tomography|computer tomography
5099092|NCT03378752|Liver tumor thermoablation|liver tumor thermoablation
5099093|NCT03378739|cardiogenic|cardiogenic
5099094|NCT03378739|shock|shock
5099095|NCT03378713|Poor Ovarian Response|poor ovarian response
5099096|NCT03378700|CKD|ckd
5099097|NCT03378700|Hope Intervention|hope intervention
5099098|NCT03378700|decision making|decision making
5099099|NCT03378687|Status Epilepticus|status epilepticus
5099100|NCT03378687|Children|children
5099101|NCT03378687|Multi-center|multi-center
5099102|NCT03378687|etiology|etiology
5099103|NCT03378687|treatment|treatment
5099104|NCT03378687|outcome|outcome
5099105|NCT03378687|risk factor|risk factor
5099106|NCT03378661|Chronic, Indeterminate|chronic, indeterminate
5099107|NCT03378635|Glucagon|glucagon
5099108|NCT03378596|Post-Exercise Hypotension|post-exercise hypotension
5099109|NCT03378596|Exercise|exercise
5099110|NCT03378596|Arginine|arginine
5099111|NCT03378596|Citrulline|citrulline
5099112|NCT03378570|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5099113|NCT03378570|rTMS|rtms
5099114|NCT03378570|TMS|tms
5099115|NCT03378570|F3|f3
5099116|NCT03378570|5.5cm rule|5.5cm rule
5099130|NCT03378388|Drug therapy|drug therapy
5099131|NCT03378323|upper extremity surgery|upper extremity surgery
5099132|NCT03378297|Ovarian cancer|ovarian cancer
5099133|NCT03378297|Phase 0|phase 0
5099134|NCT03378297|Window-of-opportunity|window-of-opportunity
5099135|NCT03378297|Suregry|suregry
5099136|NCT03378297|Repurposing|repurposing
5099137|NCT03378297|Metformin|metformin
5099138|NCT03378297|Acetylsalicylic acid|acetylsalicylic acid
5099139|NCT03378297|Olaparib|olaparib
5099140|NCT03378297|Letrozol|letrozol
5099141|NCT03378271|Continuous Glucose Monitoring|continuous glucose monitoring
5099142|NCT03378271|Flash glucose Monitoring|flash glucose monitoring
5961937|NCT04283864|personalized nutrition|personalized nutrition
5961938|NCT04283864|Nutribiome|nutribiome
5961939|NCT04283851|fluid responsiveness|fluid responsiveness
5961940|NCT04283851|fluid administration|fluid administration
5961941|NCT04283851|volume expansion|volume expansion
5961942|NCT04283851|end-expiratory occlusion test|end-expiratory occlusion test
5961943|NCT04283851|end-inspiratory occlusion test|end-inspiratory occlusion test
5961944|NCT04283851|diastolic parameters of cardiac ventricles|diastolic parameters of cardiac ventricles
5961945|NCT04283851|echocardiography|echocardiography
5961946|NCT04283851|heart-lung interactions|heart-lung interactions
5099143|NCT03378271|Renal Impairment|renal impairment
5099144|NCT03378271|Type 1 Diabetes|type 1 diabetes
5099145|NCT03378271|Type 2 Diabetes|type 2 diabetes
5099146|NCT03378258|meningococcal|meningococcal
5099147|NCT03378258|neisseria meningitidis|neisseria meningitidis
5099148|NCT03378258|sepsis|sepsis
5099149|NCT03378258|meningitis|meningitis
5099150|NCT03378258|procalcitonin|procalcitonin
5099151|NCT03378258|PCT|pct
5099152|NCT03378258|LAMP|lamp
5099153|NCT03378258|loop-mediated-isothermal AMPlification|loop-mediated-isothermal amplification
5099154|NCT03378232|DHA|dha
5099155|NCT03378232|EPA|epa
5099156|NCT03378232|fatty acids|fatty acids
5099157|NCT03378232|blood pressure|blood pressure
5099158|NCT03378232|resting metabolic rate|resting metabolic rate
5099159|NCT03378232|blood lipids|blood lipids
5099160|NCT03378232|muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
5099161|NCT03378206|genu valgum or varum|genu valgum or varum
5099162|NCT03378206|eight-plate|eight-plate
5099163|NCT03378206|epiphysis arrest|epiphysis arrest
5099164|NCT03378206|hemiepiphysiodesis|hemiepiphysiodesis
5099187|NCT03378128|Ovarian Cancer|ovarian cancer
5099188|NCT03378102|T Cell Therapy|t cell therapy
5099189|NCT03378102|Opportunistic Infection|opportunistic infection
5099190|NCT03378089|Music Therapy|music therapy
5099191|NCT03378076|Osteoarthritis|osteoarthritis
5099192|NCT03378076|Knee|knee
5099193|NCT03378076|Corticosteroid|corticosteroid
5099194|NCT03378076|Bilateral|bilateral
5099195|NCT03378076|Pain|pain
5099196|NCT03378076|Intra-articular|intra-articular
5099197|NCT03378076|Injection|injection
5099198|NCT03378037|Brain Injuries, Traumatic|brain injuries, traumatic
5099199|NCT03378037|Alzheimer's disease|alzheimer's disease
5099200|NCT03378037|Magnetic resonance imaging|magnetic resonance imaging
5099201|NCT03378037|white matter integrity|white matter integrity
5099202|NCT03378037|beta-Amyloid|beta-amyloid
5099203|NCT03378024|Oscillometric device|oscillometric device
5099204|NCT03378024|repetitive Active Pedal Plantarflexion (APP) exercise test|repetitive active pedal plantarflexion (app) exercise test
5099205|NCT03378024|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
5099206|NCT03377959|dance|dance
5099207|NCT03377959|ballet|ballet
5099208|NCT03377959|Exercise Movement Techniques|exercise movement techniques
5099209|NCT03377959|turnout|turnout
5099210|NCT03377946|pre-diabetes,diabetes,probiotics|pre-diabetes,diabetes,probiotics
5099216|NCT03377907|IVRA|ivra
5099217|NCT03377907|hematoma block|hematoma block
5099218|NCT03377842|apatinib|apatinib
5099318|NCT03377387|HER2-Positive|her2-positive
5099237|NCT03377790|Skin Diseases; Infectious|skin diseases; infectious
5099238|NCT03377790|Skin Diseases; Viral|skin diseases; viral
5099239|NCT03377790|DNA Poxvirus|dna poxvirus
5099240|NCT03377777|Anemia|anemia
5099241|NCT03377777|Iron-deficiency|iron-deficiency
5099242|NCT03377777|Iron-deficiency anemia|iron-deficiency anemia
5099243|NCT03377777|Infants|infants
5099244|NCT03377777|Metabolomics|metabolomics
5099245|NCT03377777|Microbiome|microbiome
5099246|NCT03377764|Spinal Anesthetic,|spinal anesthetic,
5099247|NCT03377764|Ultrasound guided Neuroaxial block,|ultrasound guided neuroaxial block,
5099248|NCT03377764|Anesthesia Trainees|anesthesia trainees
5099249|NCT03377751|Catheter ablation|catheter ablation
5099250|NCT03377751|Atrial fibrillation|atrial fibrillation
5099251|NCT03377751|Low voltage area|low voltage area
5099252|NCT03377738|Spirometry|spirometry
5099253|NCT03377738|Primary care|primary care
5099254|NCT03377738|Smoking Cessations|smoking cessations
5099255|NCT03377725|Myelodysplastic Syndromes|myelodysplastic syndromes
5099256|NCT03377725|Decitabine|decitabine
5099257|NCT03377725|Arsenic Trioxide|arsenic trioxide
5099258|NCT03377725|P53 Mutations|p53 mutations
5099259|NCT03377686|paediatrics|paediatrics
5099260|NCT03377686|breath analysis|breath analysis
5099261|NCT03377686|volatile organic compounds|volatile organic compounds
5099262|NCT03377686|respiratory diseases|respiratory diseases
5099263|NCT03377660|Esophagectomy|esophagectomy
5099264|NCT03377660|Unintentional weight loss|unintentional weight loss
5099265|NCT03377660|Gut hormones|gut hormones
5099266|NCT03377634|Older Adults|older adults
5099267|NCT03377634|Physical Activity|physical activity
5099268|NCT03377634|MORPH|morph
5099269|NCT03377634|Telecoaching|telecoaching
5099270|NCT03377634|mHealth|mhealth
5099271|NCT03377634|Weight Loss|weight loss
5099272|NCT03377634|Sedentary Behavior|sedentary behavior
5099273|NCT03377634|Pain|pain
5099274|NCT03377634|Design|design
5099276|NCT03377634|Randomized Controlled Trial|randomized controlled trial
5099277|NCT03377621|whole body vibration|whole body vibration
5099278|NCT03377621|sleep|sleep
5099279|NCT03377621|apnea|apnea
5099280|NCT03377608|tenofovir|tenofovir
5099281|NCT03377608|microbiome|microbiome
5099282|NCT03377608|inflammation|inflammation
5099283|NCT03377582|cardiovascular diseases|cardiovascular diseases
5099284|NCT03377582|cardiac rehabilitation|cardiac rehabilitation
5099285|NCT03377582|sympathetic nervous system|sympathetic nervous system
5099286|NCT03377582|heart rate|heart rate
5099287|NCT03377582|blood pressure|blood pressure
5099288|NCT03377582|clinical trial|clinical trial
5109885|NCT03311087|adults|adults
5099289|NCT03377582|virtual reality exposure therapy|virtual reality exposure therapy
5099290|NCT03377582|barriers to cardiac rehabilitation|barriers to cardiac rehabilitation
5099291|NCT03377582|motivation|motivation
5099292|NCT03377582|adherence patient|adherence patient
5099293|NCT03377582|engagement|engagement
5099294|NCT03377582|perceived exertion|perceived exertion
5099295|NCT03377582|oxygen saturation|oxygen saturation
5099296|NCT03377569|Deep Brain Stimulation|deep brain stimulation
5099297|NCT03377569|Polysomnography|polysomnography
5099298|NCT03377569|Actigraphy|actigraphy
5099299|NCT03377530|Bacillus Cereus|bacillus cereus
5099300|NCT03377530|Premature neonates|premature neonates
5099312|NCT03377439|Platelet function|platelet function
5099313|NCT03377439|Bleeding risk|bleeding risk
5099314|NCT03377439|Immune Thrombocytopenia|immune thrombocytopenia
5099315|NCT03377426|Urinary tract infection, LYS228, beta-lactam antibiotics, creatinine clearance, Enterobactericeae|urinary tract infection, lys228, beta-lactam antibiotics, creatinine clearance, enterobactericeae
5099316|NCT03377387|Capecitabine|capecitabine
5099317|NCT03377387|Neratinib|neratinib
5099320|NCT03377335|Dapagliflozin|dapagliflozin
5099321|NCT03377335|Type 2 diabetes mellitus|type 2 diabetes mellitus
5099322|NCT03377335|Carotid intima-media thickness|carotid intima-media thickness
5099323|NCT03377335|Endothelial dysfunction|endothelial dysfunction
5099324|NCT03377335|Atherogenic lipoproteins|atherogenic lipoproteins
5099325|NCT03377335|Inflammatory markers|inflammatory markers
5099326|NCT03377335|microRNAs|micrornas
5099327|NCT03377309|Safety|safety
5099328|NCT03377309|Tolerability|tolerability
5099329|NCT03377309|Perampanel|perampanel
5099330|NCT03377270|Oropharyngeal Head and Neck Cancer|oropharyngeal head and neck cancer
5099331|NCT03377270|dysphagia|dysphagia
5099332|NCT03377270|Respiratory Swallow Training|respiratory swallow training
5099333|NCT03377257|Cluster headache|cluster headache
5099334|NCT03377257|zolmitriptan|zolmitriptan
5099335|NCT03377257|Sublingual administration|sublingual administration
5099337|NCT03377192|Impedance pneumography|impedance pneumography
5099338|NCT03377192|Respiratory function|respiratory function
5099339|NCT03377192|Asthma management|asthma management
5099340|NCT03377179|Clinical Trial, Phase II|clinical trial, phase ii
5099341|NCT03377179|Multicenter Trials|multicenter trials
5099342|NCT03377179|Clinical Study|clinical study
5099343|NCT03377179|Clinical Trials, Non-Randomized|clinical trials, non-randomized
5099344|NCT03377179|Oral capsule|oral capsule
5099346|NCT03377179|Anti-cancer|anti-cancer
5099347|NCT03377179|Anti-inflammatory|anti-inflammatory
5099348|NCT03377179|ABC294640|abc294640
5099349|NCT03377179|Yeliva ®|yeliva ®
5099350|NCT03377179|opaganib|opaganib
5099351|NCT03377179|Hydroxychloroquine Sulfate|hydroxychloroquine sulfate
5099352|NCT03377179|HCQ|hcq
5099353|NCT03377179|Autophagy|autophagy
5099354|NCT03377127|diabetes|diabetes
5099355|NCT03377127|pharmacy clinic|pharmacy clinic
5099356|NCT03377127|education|education
5099357|NCT03377127|diabetes complications|diabetes complications
5099358|NCT03377127|hemoglobin A1c|hemoglobin a1c
5099359|NCT03377127|health-care cost|health-care cost
5099360|NCT03377127|'no show' rate|'no show' rate
5099361|NCT03377127|compliance|compliance
5099362|NCT03377127|diabetes core measures|diabetes core measures
5099363|NCT03377114|Nasotracheal intubation|nasotracheal intubation
5099364|NCT03377049|acetazolamide challenge|acetazolamide challenge
5099365|NCT03377049|cerebral vasospasm|cerebral vasospasm
5099366|NCT03377049|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5099367|NCT03377036|Breast Cancer|breast cancer
5099368|NCT03377036|Population-based Screening|population-based screening
5099369|NCT03377036|Digital Breast Tomosynthesis plus synthesized Mammography|digital breast tomosynthesis plus synthesized mammography
5099370|NCT03377036|Reconstructed Mammography|reconstructed mammography
5099371|NCT03377036|Full-Field Digital Mammography (FFDM)|full-field digital mammography (ffdm)
5099372|NCT03377036|Multicentric Randomized Controlled Trial|multicentric randomized controlled trial
5099373|NCT03377036|Diagnostic Performance|diagnostic performance
5099374|NCT03377036|Recall Rate|recall rate
5099375|NCT03377036|Interval Cancer|interval cancer
5099376|NCT03377023|Nivolumab|nivolumab
5099377|NCT03377023|Ipilimumab|ipilimumab
5099378|NCT03377023|Nintedanib|nintedanib
5099379|NCT03377023|Immunotherapy|immunotherapy
5099380|NCT03377023|Advanced stage non-small cell lung cancer|advanced stage non-small cell lung cancer
5099381|NCT03377023|Locally advanced non-small cell lung cancer|locally advanced non-small cell lung cancer
5099382|NCT03376997|Bioavailability|bioavailability
5099383|NCT03376997|Perampanel|perampanel
5099384|NCT03376984|Root Canal Therapy|root canal therapy
5099385|NCT03376971|Lesion|lesion
5099386|NCT03376971|Lung|lung
5099387|NCT03376971|Cancer|cancer
5099388|NCT03376971|Diagnosis|diagnosis
5099389|NCT03376971|Optical Biopsy|optical biopsy
5099391|NCT03376958|R R DLBCL|r r dlbcl
5099392|NCT03376958|ORR|orr
5099393|NCT03376958|PFS|pfs
5099394|NCT03376958|OS|os
5099395|NCT03376945|n-3|n-3
5099396|NCT03376945|Parenteral nutrition|parenteral nutrition
5099398|NCT03376945|Propensity score match|propensity score match
5099399|NCT03376932|Vilanterol|vilanterol
5099400|NCT03376932|Fluticasone furoate|fluticasone furoate
5099401|NCT03376932|Connected Inhaler System|connected inhaler system
5099402|NCT03376932|Dry powder inhaler|dry powder inhaler
5099403|NCT03376932|Umeclidinium|umeclidinium
5099404|NCT03376932|Asthma|asthma
5099405|NCT03376919|wearable robotics|wearable robotics
5099406|NCT03376919|Unilateral Lower Limb Amputation|unilateral lower limb amputation
5099407|NCT03376919|gait efficiency|gait efficiency
5099408|NCT03376906|Obesity|obesity
5099409|NCT03376906|aerobic exercise|aerobic exercise
5099410|NCT03376906|interval exercise|interval exercise
5099411|NCT03376867|conditioned pain modulation (CPM)|conditioned pain modulation (cpm)
5099412|NCT03376867|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
5099413|NCT03376867|pressure pain threshold (PPT)|pressure pain threshold (ppt)
5099414|NCT03376867|reference values|reference values
5099415|NCT03376867|clinical decision rule|clinical decision rule
5099416|NCT03376854|ARDS, temperature management, neuromuscular blockade|ards, temperature management, neuromuscular blockade
5099417|NCT03376841|Liver insufficiency|liver insufficiency
5099418|NCT03376841|Hepatic Impairment|hepatic impairment
5099419|NCT03376841|Cenicriviroc|cenicriviroc
5099420|NCT03376841|Pharmacokinetics|pharmacokinetics
5099421|NCT03376828|laryngoscopy|laryngoscopy
5099422|NCT03376828|videolaryngoscopy|videolaryngoscopy
5099423|NCT03376828|hypertension|hypertension
5099424|NCT03376815|Tumor ,landscape ,pathological diagnosis|tumor ,landscape ,pathological diagnosis
5099425|NCT03376776|idiopathic macular hole|idiopathic macular hole
5099426|NCT03376763|aripiprazole|aripiprazole
5099427|NCT03376763|Long-Acting Injection|long-acting injection
5099428|NCT03376750|telerehabilitation|telerehabilitation
5097211|NCT03390959|Proprioception|proprioception
5099429|NCT03376750|occupational therapy|occupational therapy
5099431|NCT03376750|participation|participation
5099432|NCT03376750|quality of life|quality of life
5099433|NCT03376750|intervention|intervention
5099434|NCT03376750|older adults|older adults
5099435|NCT03376659|PD-L1|pd-l1
5099436|NCT03376633|Randomized Controlled Trial|randomized controlled trial
5099437|NCT03376633|RCT|rct
5099438|NCT03376633|Chicago Public Schools|chicago public schools
5099439|NCT03376633|high school|high school
5099440|NCT03376633|trauma-informed counseling|trauma-informed counseling
5099441|NCT03376633|group-based counseling|group-based counseling
5099442|NCT03376633|counseling|counseling
5099443|NCT03376633|mentoring|mentoring
5099444|NCT03376633|Cognitive Behavioral Therapy|cognitive behavioral therapy
5099445|NCT03376633|CBT|cbt
5099446|NCT03376633|adolescents|adolescents
5099447|NCT03376633|females|females
5099448|NCT03376633|trauma|trauma
5099449|NCT03376633|stress|stress
5099450|NCT03376633|PTSD|ptsd
5099451|NCT03376633|anxiety|anxiety
5099452|NCT03376633|depression|depression
5099453|NCT03376633|graduation|graduation
5099454|NCT03376620|Prevention of hypertrophic scar|prevention of hypertrophic scar
5099455|NCT03376607|Primary Health Care|primary health care
5099456|NCT03376607|Health Behavior|health behavior
5099457|NCT03376607|Quality of Life|quality of life
5099458|NCT03376607|Health Literacy|health literacy
5099459|NCT03376607|Global Health|global health
5099460|NCT03376607|Medication Adherence|medication adherence
5099461|NCT03376594|Benjakul Extract|benjakul extract
5099462|NCT03376594|Allergic Rhinitis|allergic rhinitis
5099463|NCT03376594|Herbal Medicine|herbal medicine
5099464|NCT03376568|polysomnographic|polysomnographic
5099465|NCT03376568|multiple sleep latency test|multiple sleep latency test
5099466|NCT03376568|fMRI|fmri
5099467|NCT03376555|Sodium|sodium
5099468|NCT03376555|Hypertension|hypertension
5099469|NCT03376555|Blood Pressure|blood pressure
5099470|NCT03376555|Cardiovascular Disease|cardiovascular disease
5099471|NCT03376555|Nitric Oxide|nitric oxide
5099472|NCT03376555|Skin|skin
5099473|NCT03376555|Dairy|dairy
5099474|NCT03376555|Cheese|cheese
5099475|NCT03376555|Oxidative Stress|oxidative stress
5099476|NCT03376555|Diet|diet
5099477|NCT03376555|Flow Mediated Vasodilation|flow mediated vasodilation
5099478|NCT03376555|Nitroglycerin|nitroglycerin
5099479|NCT03376555|Superoxide|superoxide
5099480|NCT03376555|Microcirculation|microcirculation
5099481|NCT03376529|safety|safety
5099482|NCT03376529|tolerability|tolerability
5099483|NCT03376529|pharmacokinetics|pharmacokinetics
5099484|NCT03376529|drug-drug interaction|drug-drug interaction
5099485|NCT03376529|SPR741|spr741
5099486|NCT03376529|antibiotic|antibiotic
5099487|NCT03376477|Lenalidomide|lenalidomide
5099488|NCT03376477|M-spike negative|m-spike negative
5099489|NCT03376477|GVax|gvax
5099490|NCT03376477|GM-CSF secreting myeloma vaccine|gm-csf secreting myeloma vaccine
5099491|NCT03376477|MRD positive|mrd positive
5099492|NCT03376464|Xeomin Cosmetic;|xeomin cosmetic;
5099493|NCT03376464|Masseteric Hypertrophy|masseteric hypertrophy
5099494|NCT03376425|Chest ultrasound,Lung tumor|chest ultrasound,lung tumor
5099495|NCT03376399|Sleeve Gastrectomy|sleeve gastrectomy
5099496|NCT03376399|Gastric Emptying|gastric emptying
5099499|NCT03376386|Adaptive|adaptive
5099500|NCT03376386|Image-guided|image-guided
5099501|NCT03376386|Radiotherapy|radiotherapy
5099502|NCT03376386|Head and Neck cancer|head and neck cancer
5099503|NCT03376360|prostate cancer|prostate cancer
5099504|NCT03376360|Fcholine|fcholine
5099505|NCT03376360|positron emission tomography|positron emission tomography
5099507|NCT03376347|intraoperative|intraoperative
5099508|NCT03376347|hypotension|hypotension
5099509|NCT03376347|Hypotension Probability Index|hypotension probability index
5099511|NCT03376334|Mental motor imagery|mental motor imagery
5099513|NCT03376308|rocuronium|rocuronium
5099514|NCT03376308|propofol|propofol
5099515|NCT03376308|pain|pain
5099516|NCT03376308|withdrawal|withdrawal
5099517|NCT03376308|venous diameter|venous diameter
5099518|NCT03376282|HBO|hbo
5099519|NCT03376282|kidney functions|kidney functions
5099520|NCT03376282|markers|markers
5099521|NCT03376269|more than 1 year|more than 1 year
5099522|NCT03376256|thoracic epidural|thoracic epidural
5099523|NCT03376256|pressure measurement|pressure measurement
5099524|NCT03376256|device|device
5099525|NCT03376243|Atopic eczema, prevention|atopic eczema, prevention
5099526|NCT03376230|Environmental risk factors|environmental risk factors
5099527|NCT03376230|Xenobiotic detoxification|xenobiotic detoxification
5099528|NCT03376217|malaria|malaria
5099529|NCT03376217|malaria in pregnancy|malaria in pregnancy
5099530|NCT03376217|intermittent preventive treatment in pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
5099531|NCT03376217|community health workers|community health workers
5099532|NCT03376217|Sulfadoxine-pyrimethamine (SP)|sulfadoxine-pyrimethamine (sp)
5099533|NCT03376204|Bronchiectasis|bronchiectasis
5099534|NCT03376204|Pain mechanisms|pain mechanisms
5099535|NCT03376204|Pressure pain threshold|pressure pain threshold
5099536|NCT03376204|Referred pain|referred pain
5099537|NCT03376191|Apatinib|apatinib
5099538|NCT03376191|lung cancer|lung cancer
5099539|NCT03376191|angiogenesis inhibitors|angiogenesis inhibitors
5099540|NCT03376191|efficacy|efficacy
5099541|NCT03376191|safety|safety
5099542|NCT03376178|multiorifice or endhole femoral nerve catheter|multiorifice or endhole femoral nerve catheter
5099543|NCT03376165|prognosis|prognosis
5099544|NCT03376165|translational research|translational research
5099545|NCT03376139|Alcohol|alcohol
5099546|NCT03376139|Alcoholic|alcoholic
5099547|NCT03376139|Alcoholism|alcoholism
5099548|NCT03376139|Alcohol abuse|alcohol abuse
5099549|NCT03376139|Alcohol Use Disorder|alcohol use disorder
5099550|NCT03376139|Alcohol use|alcohol use
5099551|NCT03376139|Alcohol dependence|alcohol dependence
5099552|NCT03376139|Alcohol dependent|alcohol dependent
5099553|NCT03376139|PTSD|ptsd
5099554|NCT03376139|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5099555|NCT03376139|Veteran|veteran
5099556|NCT03376126|isolated limb perfusion|isolated limb perfusion
5099557|NCT03376113|self-harm|self-harm
5099558|NCT03376113|psychological intervention|psychological intervention
5099559|NCT03376087|Epilepsy|epilepsy
5099560|NCT03376087|heart block|heart block
5099561|NCT03376087|sudden cardiac death|sudden cardiac death
5099562|NCT03376087|loop recorder|loop recorder
5099563|NCT03376074|liver transplantation|liver transplantation
5099564|NCT03376074|hypothermic machine liver perfusion|hypothermic machine liver perfusion
5099565|NCT03376074|extended criteria liver grafts|extended criteria liver grafts
5099566|NCT03376061|Tranexamic Acid|tranexamic acid
5099567|NCT03376061|Cardiac surgery|cardiac surgery
5099568|NCT03376022|Attitudes|attitudes
5099569|NCT03376022|Knowledge|knowledge
5099570|NCT03376022|Oral Health|oral health
5099571|NCT03376022|Nursing personnel|nursing personnel
5099572|NCT03376009|Biomarker|biomarker
5099573|NCT03375983|Advanced cancer|advanced cancer
5099574|NCT03375983|Plasmodium immunotherapy|plasmodium immunotherapy
5099575|NCT03375983|Plasmodiun vivax|plasmodiun vivax
5099576|NCT03375944|Cardiac tele-rehabilitation, Myocardial revascularization|cardiac tele-rehabilitation, myocardial revascularization
5099577|NCT03375931|Quality of Recovery 40 Questionaries|quality of recovery 40 questionaries
5099578|NCT03375918|Healthcare disparities|healthcare disparities
5099579|NCT03375918|Racial Bias|racial bias
5099580|NCT03375905|ethnic Japanese|ethnic japanese
5099581|NCT03375892|radiation|radiation
5099582|NCT03375892|Deep Inspiration Breath Hold|deep inspiration breath hold
5099583|NCT03375892|stage I|stage i
5099584|NCT03375892|stage II|stage ii
5099585|NCT03375892|stage IIa|stage iia
5099586|NCT03375879|Ptosis|ptosis
5099587|NCT03375879|Blepharoptosis|blepharoptosis
5099588|NCT03375879|bandage contact lens|bandage contact lens
5099589|NCT03375879|fasanella servat procedure|fasanella servat procedure
5099590|NCT03375853|Obesity|obesity
5099591|NCT03375853|Dissonance|dissonance
5099592|NCT03375853|Response Training|response training
5099593|NCT03375853|Eating Disorder|eating disorder
5099594|NCT03375853|Computer-based Training|computer-based training
5099595|NCT03375840|pictorial warning labels|pictorial warning labels
5099596|NCT03375840|risk knowledge|risk knowledge
5099597|NCT03375840|emotion|emotion
5099598|NCT03375840|memory|memory
5099599|NCT03375840|risk perceptions|risk perceptions
5099600|NCT03375840|quit intentions|quit intentions
5099601|NCT03375827|Breast Cancer|breast cancer
5099602|NCT03375814|Crocin, osteoarthritis, Inflammation, IL-17,T-helper,T-reg|crocin, osteoarthritis, inflammation, il-17,t-helper,t-reg
5099603|NCT03375788|tesamorelin|tesamorelin
5099604|NCT03375788|obesity|obesity
5099605|NCT03375788|fatty liver|fatty liver
5099606|NCT03375749|sitting|sitting
5099607|NCT03375736|whole body vibration|whole body vibration
5099608|NCT03375736|cerebral palsy|cerebral palsy
5099609|NCT03375736|functional abilities|functional abilities
5099610|NCT03375736|children|children
5099611|NCT03375736|adults|adults
5099612|NCT03375723|Pain measurement|pain measurement
5099613|NCT03375723|Pain|pain
5099614|NCT03375710|Heart Failure|heart failure
5099615|NCT03375710|Heart Diseases|heart diseases
5099616|NCT03375710|Cardiovascular Disease|cardiovascular disease
5099617|NCT03375684|Cystic Fibrosis|cystic fibrosis
5099618|NCT03375684|Inspiratory Muscle Training|inspiratory muscle training
5099619|NCT03375684|Chest Physiotherapy|chest physiotherapy
5099621|NCT03375684|Postural Stability|postural stability
5099622|NCT03375684|Pulmonary Function Test|pulmonary function test
5099623|NCT03375684|6-Minute Walk Test|6-minute walk test
5099624|NCT03375671|ketamine|ketamine
5099625|NCT03375671|aggressive behaviour|aggressive behaviour
5099626|NCT03375671|midazolam|midazolam
5099627|NCT03375671|haloperidol|haloperidol
5099628|NCT03375671|emergency department|emergency department
5099629|NCT03375658|Information Science: Algorithms|information science: algorithms
5099630|NCT03375658|Information Science: Informatics: Nursing Informatics|information science: informatics: nursing informatics
5099631|NCT03375658|Information Science: Data Display: Computer graphics|information science: data display: computer graphics
5099632|NCT03375658|Diagnosis: Diagnostic Techiques and Procedures: Monitoring, Physiologic|diagnosis: diagnostic techiques and procedures: monitoring, physiologic
5862711|NCT00001541|Inflammation|inflammation
5099633|NCT03375658|Health care facilities, Manpower and services: Health services: Emergency Medical Services: Triage|health care facilities, manpower and services: health services: emergency medical services: triage
5099634|NCT03375619|CAR-20/19 T-Cell Therapy|car-20/19 t-cell therapy
5099635|NCT03375593|pain management|pain management
5099637|NCT03375554|esophageal steothoscope, tracheal intubation|esophageal steothoscope, tracheal intubation
5099638|NCT03375528|Matrix metalloproteinase|matrix metalloproteinase
5099639|NCT03375528|neointimal hyperplasia|neointimal hyperplasia
5099640|NCT03375515|hydromorphone titration|hydromorphone titration
5099641|NCT03375489|Lung Cancer palliative care|lung cancer palliative care
5099642|NCT03375476|postoperative myocardial infraction|postoperative myocardial infraction
5099643|NCT03375476|myocardial injury|myocardial injury
5099644|NCT03375476|general anesthesia|general anesthesia
5099645|NCT03375476|vascular surgery|vascular surgery
5099646|NCT03375476|surgical stress|surgical stress
5099647|NCT03375476|surgical plethysmographic index|surgical plethysmographic index
5099648|NCT03375450|Epidemiology, Chronic Obstructive Disease, Comparative Effectiveness, Exacerbation|epidemiology, chronic obstructive disease, comparative effectiveness, exacerbation
5099649|NCT03375437|Clinical Trial|clinical trial
5099650|NCT03375437|Multicenter Trial|multicenter trial
5099651|NCT03375437|NTRK1|ntrk1
5099652|NCT03375437|NTRK2|ntrk2
5099653|NCT03375437|NTRK3|ntrk3
5099654|NCT03375437|ROS1|ros1
5099656|NCT03375437|RNAseq|rnaseq
5099657|NCT03375437|entrectinib|entrectinib
5099658|NCT03375437|STARTRK-2|startrk-2
5099659|NCT03375424|Vedolizumab, Crohns disease, Ulcerative colitis, safety|vedolizumab, crohns disease, ulcerative colitis, safety
5099660|NCT03375398|SUGARDOWN™|sugardown™
5099661|NCT03375398|Galactomannan|galactomannan
5099662|NCT03375398|Postprandial blood glucose|postprandial blood glucose
5099663|NCT03375398|Insulin|insulin
5099664|NCT03375346|Whole body vibration exercise|whole body vibration exercise
5099665|NCT03375333|ultrasound|ultrasound
5099666|NCT03375333|diagnostics|diagnostics
5099667|NCT03375333|general practice|general practice
5099668|NCT03375333|family medicine|family medicine
5099670|NCT03375255|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5099671|NCT03375255|Exon Skipping|exon skipping
5099672|NCT03375255|DMD|dmd
5099673|NCT03375255|Exon 51|exon 51
5099674|NCT03375255|Ambulatory|ambulatory
5099675|NCT03375255|Pediatric|pediatric
5099676|NCT03375255|Nonambulatory|nonambulatory
5099677|NCT03375255|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
5099678|NCT03375255|Duchenne|duchenne
5099679|NCT03375229|Myofascial Pain|myofascial pain
5099680|NCT03375229|Pain Pressure Threshold|pain pressure threshold
5099681|NCT03375229|Low-Level Laser Therapy|low-level laser therapy
5099682|NCT03375229|Dry Needling|dry needling
5099683|NCT03375177|multiple sclerosis|multiple sclerosis
5099684|NCT03375177|Argentina|argentina
5099685|NCT03375177|epidemiology|epidemiology
5099686|NCT03375177|registry|registry
5099687|NCT03375164|Duchenne|duchenne
5099688|NCT03375164|gene therapy|gene therapy
5099696|NCT03375099|Firearms|firearms
5099697|NCT03375099|Guns|guns
5099698|NCT03375099|Suicide|suicide
5099699|NCT03375099|Means Safety|means safety
5099700|NCT03375099|Means Restriction|means restriction
5099701|NCT03375099|Lethal Means Counseling|lethal means counseling
5099702|NCT03375047|Cystic Fibrosis|cystic fibrosis
5099703|NCT03375047|CF|cf
5099704|NCT03375034|Chronic pain|chronic pain
5099705|NCT03375034|Benzodiazepine|benzodiazepine
5099706|NCT03375034|Central sensitization|central sensitization
5099707|NCT03375034|Selective compound|selective compound
5099708|NCT03375034|GABAA receptors|gabaa receptors
5099709|NCT03375034|Antihyperalgesia|antihyperalgesia
5099710|NCT03375034|RCT|rct
5099711|NCT03375021|ADHD, ampakine, Phase II clinical trial|adhd, ampakine, phase ii clinical trial
5099712|NCT03375008|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
5099908|NCT03373591|bariatric surgery|bariatric surgery
5099722|NCT03374904|Parental Reflective Function|parental reflective function
5099723|NCT03374904|Child Psychopathology|child psychopathology
5099724|NCT03374891|Shared Decision Making;|shared decision making;
5099725|NCT03374891|Defibrillator|defibrillator
5099726|NCT03374878|exercise|exercise
5099727|NCT03374878|oral contraceptive|oral contraceptive
5099728|NCT03374878|strength training|strength training
5099729|NCT03374813|Bone graft substitutes|bone graft substitutes
5099730|NCT03374813|Synthetic graft|synthetic graft
5099731|NCT03374813|Xenograft|xenograft
5099732|NCT03374813|Ridge preservation|ridge preservation
5099733|NCT03374813|Alveolar defect|alveolar defect
5099734|NCT03374761|child abuse|child abuse
5099735|NCT03374761|parenting|parenting
5099736|NCT03374761|low and middle income countries|low and middle income countries
5099737|NCT03374761|child discipline|child discipline
5099738|NCT03374761|Indonesia|indonesia
5099739|NCT03374696|Chlamydia infections|chlamydia infections
5099740|NCT03374696|condoms|condoms
5099741|NCT03374696|theater,|theater,
5099742|NCT03374696|sex education|sex education
5099743|NCT03374683|Risky play|risky play
5099744|NCT03374683|Physical activity|physical activity
5099745|NCT03374683|Injury prevention|injury prevention
5099750|NCT03374670|aflibercept|aflibercept
5099752|NCT03374670|avacincaptad pegol|avacincaptad pegol
4984693|NCT04087629|GVHD|gvhd
5099753|NCT03374670|complement factor C5 inhibitor|complement factor c5 inhibitor
5099754|NCT03374657|Clinical trials, dark adaptation, gene therapy, RLBP1 mutation, retinitis pigmentosa.|clinical trials, dark adaptation, gene therapy, rlbp1 mutation, retinitis pigmentosa.
5099755|NCT03374644|Correlation|correlation
5099756|NCT03374644|ETCO2|etco2
5099757|NCT03374644|PaCO2|paco2
5099758|NCT03374644|nasal cannula|nasal cannula
5099759|NCT03374644|Sentri Nasal Cannula|sentri nasal cannula
5099760|NCT03374592|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5099761|NCT03374592|Volumetric intensity-modulated arc therapy|volumetric intensity-modulated arc therapy
5099762|NCT03374592|Radiotherapy|radiotherapy
5099763|NCT03374592|Pain|pain
5099764|NCT03374592|Metastasis|metastasis
5099765|NCT03374592|Quality of Life|quality of life
5099766|NCT03374592|Acute Toxicity|acute toxicity
5099771|NCT03374527|T-cells|t-cells
5099772|NCT03374527|circulation|circulation
5099773|NCT03374527|synovial fluid|synovial fluid
5099774|NCT03374527|psoriasis|psoriasis
5099775|NCT03374527|psoriatic arthritis|psoriatic arthritis
5099776|NCT03374514|corticosteroids|corticosteroids
5099777|NCT03374514|Electric impedance|electric impedance
5099778|NCT03374501|Sugardown™|sugardown™
5099779|NCT03374501|Galactomannan|galactomannan
5745543|NCT00338026|Lung|lung
5099780|NCT03374501|Postprandial blood glucose|postprandial blood glucose
5099781|NCT03374501|Insulin|insulin
5099782|NCT03374488|Urothelial carcinoma|urothelial carcinoma
5099783|NCT03374488|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
5099784|NCT03374488|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
5099789|NCT03374397|Laparoscopic unilateral ovarian cystectomy|laparoscopic unilateral ovarian cystectomy
5099790|NCT03374397|SurgiGuard|surgiguard
5099791|NCT03374397|Hemostasis|hemostasis
5099792|NCT03374397|Ovarian function preservation|ovarian function preservation
5099793|NCT03374397|Bipolar electrocauterization|bipolar electrocauterization
5099794|NCT03374371|Staphylococcus epidermidis Infection|staphylococcus epidermidis infection
5423205|NCT01616667|Pain Measurement|pain measurement
5099805|NCT03374306|Myopia|myopia
5099806|NCT03374306|Myopia control|myopia control
5099807|NCT03374306|Atropine|atropine
5099808|NCT03374306|Electroretinogram|electroretinogram
5099812|NCT03374293|Anti-PD-1 Antibody|anti-pd-1 antibody
5099813|NCT03374280|non small cell lung cancer|non small cell lung cancer
5099815|NCT03374280|EGFR negative|egfr negative
5099816|NCT03374280|Pemetrexed|pemetrexed
5099823|NCT03374202|ARV Therapy|arv therapy
5099824|NCT03374202|Broadly Neutralizing|broadly neutralizing
5099825|NCT03374202|Gene Transfer|gene transfer
5099826|NCT03374202|Monoclonal Antibody|monoclonal antibody
5099827|NCT03374202|AAV8|aav8
5099828|NCT03374176|periodontitis|periodontitis
5099829|NCT03374176|diabetes mellitus|diabetes mellitus
5099830|NCT03374176|systemic antimicrobials|systemic antimicrobials
5099831|NCT03374163|infertility , implantion failure, intracytoplasmic sperm injection|infertility , implantion failure, intracytoplasmic sperm injection
5099832|NCT03374150|Low-Calorie Diet|low-calorie diet
5099833|NCT03374150|Diet, High-Protein|diet, high-protein
5099835|NCT03374150|weight cycling|weight cycling
5099836|NCT03374150|body composition|body composition
5099837|NCT03374150|high-sensitivity C-Reactive protein|high-sensitivity c-reactive protein
5099838|NCT03374150|malondialdehyde|malondialdehyde
5099839|NCT03374150|glutathione|glutathione
5099840|NCT03374124|Chronic rhinosinusitis|chronic rhinosinusitis
5099841|NCT03374124|Eosinophil|eosinophil
5099842|NCT03374124|Surgery|surgery
5099843|NCT03374124|Diagnosis|diagnosis
5099844|NCT03374111|Thalassemia;|thalassemia;
5099845|NCT03374111|the Syndrome of Blood Deficiency|the syndrome of blood deficiency
5099846|NCT03374111|Anemia|anemia
5099847|NCT03374111|Colla Corii Asini|colla corii asini
5099848|NCT03374098|Medicaid|medicaid
5099849|NCT03374098|Mississippi|mississippi
5099850|NCT03374085|Multiple Myeloma|multiple myeloma
5099851|NCT03374085|Safety|safety
5099852|NCT03374085|Efficacy|efficacy
5099853|NCT03374085|CC-92480|cc-92480
5099854|NCT03374085|Relapsed|relapsed
5099855|NCT03374085|Refractory|refractory
5099856|NCT03374033|Preterm infants, growth, nutrition, physical activity|preterm infants, growth, nutrition, physical activity
5099858|NCT03373955|T Cell repertoire|t cell repertoire
5099859|NCT03373955|lung cancer|lung cancer
5099860|NCT03373955|tumor mutation burden|tumor mutation burden
5099861|NCT03373955|Circulating tumour DNA|circulating tumour dna
5099862|NCT03373942|glaucoma|glaucoma
5099863|NCT03373942|EDI OCT|edi oct
5099864|NCT03373942|pseudoexfoliation|pseudoexfoliation
5099865|NCT03373942|choroidal thickness|choroidal thickness
5099866|NCT03373916|Peer Mentorship|peer mentorship
5099867|NCT03373916|Psychiatric Hospitalization|psychiatric hospitalization
5099868|NCT03373916|Suicide Risk|suicide risk
5099869|NCT03373864|Unilateral spinal anesthesia|unilateral spinal anesthesia
5099870|NCT03373864|general anesthesia|general anesthesia
5099871|NCT03373864|hemodynamic stability|hemodynamic stability
5099872|NCT03373864|MINS|mins
5099873|NCT03373864|hip fracture|hip fracture
5099874|NCT03373864|elderly|elderly
5099876|NCT03373825|overdose prevention|overdose prevention
5099877|NCT03373825|opioid overdose|opioid overdose
5099878|NCT03373825|risk behavior|risk behavior
5099879|NCT03373825|harm reduction|harm reduction
5099880|NCT03373799|rotator cuff|rotator cuff
5099881|NCT03373799|physiotherapy|physiotherapy
5099882|NCT03373799|video-based rehabilitation|video-based rehabilitation
5099883|NCT03373799|exercise|exercise
5099884|NCT03373786|Kidney disease|kidney disease
5099885|NCT03373786|Nephritis|nephritis
5099886|NCT03373786|Hereditary kidney disease|hereditary kidney disease
5099887|NCT03373786|Hereditary nephritis|hereditary nephritis
5099888|NCT03373773|pelvic reconstructive surgery|pelvic reconstructive surgery
5099889|NCT03373773|foley catheter|foley catheter
5099890|NCT03373773|Foley removal|foley removal
5099891|NCT03373773|Urogynecology|urogynecology
5099892|NCT03373773|Urinary Retention|urinary retention
5099893|NCT03373773|Gynecologic surgery|gynecologic surgery
5110486|NCT03307096|renal calculus|renal calculus
5099897|NCT03373669|oral cholera vaccine|oral cholera vaccine
5099898|NCT03373669|OCV|ocv
5099899|NCT03373669|dose interval|dose interval
5099900|NCT03373656|Vaccination|vaccination
5099901|NCT03373656|Childhood|childhood
5099902|NCT03373656|Hematologic Malignancy|hematologic malignancy
5099903|NCT03373656|Solid Tumor|solid tumor
5099904|NCT03373656|Immune Deficiency|immune deficiency
5099905|NCT03373604|18F-MK-6240|18f-mk-6240
5099906|NCT03373604|Cognitive Impairment|cognitive impairment
5099907|NCT03373604|Alzheimer's|alzheimer's
5099918|NCT03373526|Aerobic Exercise|aerobic exercise
5099919|NCT03373526|Breathing Exercises|breathing exercises
5099920|NCT03373526|Inspiratory Capacity|inspiratory capacity
5099921|NCT03373526|Muscle Strength|muscle strength
5099922|NCT03373526|Exercise Tolerance|exercise tolerance
5099923|NCT03373526|Autonomic Nervous System|autonomic nervous system
5099924|NCT03373513|Return-to-work, Visual analogue pain score, Cosmesis|return-to-work, visual analogue pain score, cosmesis
5099926|NCT03373409|Dry Powder Inhaler|dry powder inhaler
5099927|NCT03373396|Chlordecone|chlordecone
5099928|NCT03373396|fibrosis|fibrosis
5099929|NCT03373396|cirrhosis|cirrhosis
5099930|NCT03373396|chronic hepatitis B, C|chronic hepatitis b, c
5099932|NCT03373396|viral hepatitis|viral hepatitis
5099933|NCT03373396|transaminases|transaminases
5099934|NCT03373396|fibroscan|fibroscan
5099935|NCT03373383|Epilepsy|epilepsy
5099936|NCT03373383|Padsevonil|padsevonil
5099937|NCT03373357|sleep apnea|sleep apnea
5099938|NCT03373357|arterial hypertension|arterial hypertension
5099939|NCT03373357|cardiovascular risk|cardiovascular risk
5099947|NCT03373292|Stenting|stenting
5099948|NCT03373292|Jugular vein stenosis|jugular vein stenosis
5099949|NCT03373292|Intracranial hypertension|intracranial hypertension
5099950|NCT03373292|Headache|headache
5099951|NCT03373292|Tinnitus|tinnitus
5099952|NCT03373292|Papilledema|papilledema
5099953|NCT03373292|Visual impairment|visual impairment
5099954|NCT03373279|Heart Transplant|heart transplant
5099955|NCT03373240|Drug use Disorders|drug use disorders
4970477|NCT04175015|SMARTY|smarty
5099956|NCT03373240|Cognitive Remediation|cognitive remediation
5099957|NCT03373227|Heart Transplant|heart transplant
5099958|NCT03373214|Human Hookworm|human hookworm
5099959|NCT03373214|Necator americanus|necator americanus
5099960|NCT03373214|Hookworm|hookworm
5099961|NCT03373214|Hookworm Disease|hookworm disease
5099962|NCT03373214|Iron-deficiency anemia|iron-deficiency anemia
5099963|NCT03373214|Soil-transmitted helminth infection|soil-transmitted helminth infection
5099964|NCT03373214|Neglected Tropical Disease|neglected tropical disease
5099965|NCT03373214|Na-GST-1|na-gst-1
5099967|NCT03373175|Monitoring NIV, inspiratory muscular unloading, EMG|monitoring niv, inspiratory muscular unloading, emg
5099968|NCT03373149|IVF|ivf
5099969|NCT03373149|Growth hormone|growth hormone
5099970|NCT03373149|Poor responders|poor responders
5099971|NCT03373123|Esophageal Varices|esophageal varices
5099972|NCT03373123|Variceal Hemorrhage|variceal hemorrhage
5099973|NCT03373123|Endoscopy|endoscopy
5099974|NCT03373123|Radiomics|radiomics
5099975|NCT03373123|Hepatitis B Virus|hepatitis b virus
5099976|NCT03373110|Online Therapy|online therapy
5099977|NCT03373110|Fitbit|fitbit
5099978|NCT03373110|Depression|depression
5099979|NCT03373110|Cardiovascular Disease|cardiovascular disease
5099980|NCT03373097|Neuroblastoma|neuroblastoma
5099981|NCT03373097|GD2 CAR T cell|gd2 car t cell
5099983|NCT03373084|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5099984|NCT03373084|Ultrasound|ultrasound
5099985|NCT03373084|Sport|sport
5099986|NCT03373084|Hamstring muscle|hamstring muscle
5099987|NCT03373084|Injury|injury
5099988|NCT03373071|CD19-CAR T cell|cd19-car t cell
5099989|NCT03373071|CD19-malignancy|cd19-malignancy
5099990|NCT03373071|CAR T cell|car t cell
5099991|NCT03373071|CD19-ALL|cd19-all
5100006|NCT03373019|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5100007|NCT03372980|Biomarkers|biomarkers
5100008|NCT03372967|preventable disease|preventable disease
5100009|NCT03372967|vaccine|vaccine
5100010|NCT03372967|public health|public health
5100011|NCT03372967|vaccine history|vaccine history
5100012|NCT03372967|point-of-care|point-of-care
5100013|NCT03372941|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
5100016|NCT03372941|Dalbavancin|dalbavancin
5100017|NCT03372941|Emergency department|emergency department
5100018|NCT03372902|Breast imaging|breast imaging
5100019|NCT03372902|17-598|17-598
5100020|NCT03372889|Anterior Cruciate Ligament|anterior cruciate ligament
5100021|NCT03372889|On-Q Catheter|on-q catheter
5100022|NCT03372889|nerve block|nerve block
5100023|NCT03372889|ACL reconstruction|acl reconstruction
5100024|NCT03372889|patient education materials|patient education materials
5100025|NCT03372837|Diffuse large B-cell lymphoma, rituximab, SyB L-0501, combination therapy|diffuse large b-cell lymphoma, rituximab, syb l-0501, combination therapy
5100026|NCT03372824|mass screening|mass screening
5100027|NCT03372798|catheter ablation|catheter ablation
5100028|NCT03372798|intraprocedural left atrial wall thickness imaging|intraprocedural left atrial wall thickness imaging
5100029|NCT03372785|coronary artery disease|coronary artery disease
5100030|NCT03372785|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
5100031|NCT03372785|Myocardial Stunning|myocardial stunning
5100032|NCT03372785|Percutaneous Coronary Intervention|percutaneous coronary intervention
5100033|NCT03372785|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
5100034|NCT03372772|Fatigue, Levocarnitine,|fatigue, levocarnitine,
5100035|NCT03372746|Biopsy|biopsy
5100036|NCT03372733|Omega-7|omega-7
5100037|NCT03372733|Palmitoleic Acid|palmitoleic acid
5100038|NCT03372733|Monounsaturated Fatty Acids|monounsaturated fatty acids
5100039|NCT03372733|Lipoproteins|lipoproteins
5100040|NCT03372733|Satiety|satiety
5100041|NCT03372707|Cuff leak test|cuff leak test
5100042|NCT03372707|Post-extubation airway obstruction|post-extubation airway obstruction
5100043|NCT03372707|Laryngeal edema|laryngeal edema
5100044|NCT03372681|Distal Gastrectomy|distal gastrectomy
5100045|NCT03372681|Postoperative Reflux Rate|postoperative reflux rate
5100046|NCT03372681|Gastric Cance|gastric cance
5100047|NCT03372681|Laparoscopic Surgery|laparoscopic surgery
5100048|NCT03372668|lower limb amputation|lower limb amputation
5100049|NCT03372668|PLP|plp
5100050|NCT03372616|aortic blood pressure|aortic blood pressure
5100051|NCT03372616|diastolic dysfuntion|diastolic dysfuntion
5100052|NCT03372616|echocardiography|echocardiography
5100053|NCT03372616|left ventricular ejection fraction|left ventricular ejection fraction
5100054|NCT03372603|GSK2798745, efficacy, safety, chronic cough, crossover study|gsk2798745, efficacy, safety, chronic cough, crossover study
5100055|NCT03372590|general movement assessment|general movement assessment
5100056|NCT03372538|placenta accreta|placenta accreta
5100057|NCT03372499|Hepatic Encephalopathy|hepatic encephalopathy
5100058|NCT03372499|Diet Management|diet management
5100059|NCT03372499|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5100060|NCT03372460|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5100061|NCT03372460|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5100062|NCT03372460|Virtual Reality|virtual reality
5961947|NCT04283838|coronavirus disease 2019|coronavirus disease 2019
5100063|NCT03372460|Prefrontal Cortex|prefrontal cortex
5100064|NCT03372460|Veterans|veterans
5100065|NCT03372460|Quality of Life|quality of life
5100066|NCT03372395|probiotics implementation|probiotics implementation
5100067|NCT03372395|HPV infection|hpv infection
5100068|NCT03372395|vaginosis|vaginosis
5100069|NCT03372395|yeast vaginitis|yeast vaginitis
5100070|NCT03372382|postpartum|postpartum
5100071|NCT03372369|contraceptive knowledge|contraceptive knowledge
5100072|NCT03372369|contraceptive use|contraceptive use
5100073|NCT03372369|educational intervention|educational intervention
5100074|NCT03372369|poster|poster
5097823|NCT03386929|avelumab|avelumab
5100085|NCT03372317|Cognition|cognition
5100086|NCT03372304|Peripheral regional anesthesia|peripheral regional anesthesia
5100087|NCT03372291|Acute Myeloid Leukemia|acute myeloid leukemia
5100088|NCT03372278|Total hip arthroplasty|total hip arthroplasty
5100089|NCT03372278|Medical Device|medical device
5100090|NCT03372278|Safety|safety
5100091|NCT03372278|Prothesis|prothesis
5100092|NCT03372265|Peripheral regional anesthesia|peripheral regional anesthesia
5100093|NCT03372239|Indoximod|indoximod
5100094|NCT03372226|Gambling|gambling
5100095|NCT03372226|Problematic Gambling|problematic gambling
5100096|NCT03372226|Pathological Gambling|pathological gambling
5100097|NCT03372187|diet|diet
5100098|NCT03372187|MS|ms
5100099|NCT03372187|Telehealth|telehealth
5100100|NCT03372174|cardiac surgery|cardiac surgery
5100101|NCT03372174|mechanical ventilation|mechanical ventilation
5100108|NCT03372135|Trendelenburg Position|trendelenburg position
5100109|NCT03372096|embolization|embolization
5100110|NCT03372096|prostate|prostate
5100111|NCT03372083|Iron Chelation Therapy|iron chelation therapy
5100112|NCT03372083|Deferasirox|deferasirox
5100131|NCT03372031|multisensory integration|multisensory integration
5100132|NCT03372031|bimanual coupling|bimanual coupling
5100133|NCT03372031|auditory feedback|auditory feedback
5100134|NCT03372031|dexterity|dexterity
5100135|NCT03372031|piano therapy|piano therapy
5100136|NCT03371992|immunotherapy|immunotherapy
5100137|NCT03371992|anti-PD1|anti-pd1
5100138|NCT03371992|anti-PDL1|anti-pdl1
5100139|NCT03371992|biomarker|biomarker
5100140|NCT03371992|drug mechanism|drug mechanism
5100141|NCT03371966|Beetroot Juice|beetroot juice
5100142|NCT03371966|Older Adults|older adults
5100144|NCT03371966|Nitrite|nitrite
5100145|NCT03371966|Nitric Oxide|nitric oxide
5100146|NCT03371953|vecuronium|vecuronium
5100147|NCT03371953|atracurium|atracurium
5100148|NCT03371953|combination|combination
5100149|NCT03371927|Premature Infants|premature infants
5100150|NCT03371927|SINC feeding protocol|sinc feeding protocol
5100151|NCT03371914|costing|costing
5100152|NCT03371914|behavioral intervention|behavioral intervention
5100153|NCT03371914|management|management
5100154|NCT03371901|Menisci, Tibial|menisci, tibial
5100155|NCT03371901|Cartilage, Articular|cartilage, articular
5100156|NCT03371901|Blood Flow Restriction Training|blood flow restriction training
5100157|NCT03371901|Resistance training|resistance training
5100158|NCT03371901|Physical Therapy Modalities|physical therapy modalities
5100159|NCT03371901|Feasibility Studies|feasibility studies
5100160|NCT03371862|Liraglutide|liraglutide
5100161|NCT03371862|Victoza|victoza
5100163|NCT03371823|Hypertension|hypertension
5100164|NCT03371823|Endothelin-1 receptor|endothelin-1 receptor
5100165|NCT03371810|attention-deficit / hyperactivity disorder|attention-deficit / hyperactivity disorder
5100166|NCT03371810|depression|depression
5100167|NCT03371810|obesity|obesity
5100168|NCT03371810|prevention|prevention
5100169|NCT03371810|bright light therapy|bright light therapy
5100170|NCT03371810|exercise|exercise
5100171|NCT03371810|mobile healthy system|mobile healthy system
5100172|NCT03371797|ALERT, MSSBP, MSDBP|alert, mssbp, msdbp
5100177|NCT03371732|Psychological intervention Alcohol|psychological intervention alcohol
5100178|NCT03371732|Tobacco consumption|tobacco consumption
5100179|NCT03371732|Substance use|substance use
5100180|NCT03371732|Health risk behavior|health risk behavior
5100181|NCT03371732|Oncology setting|oncology setting
5100182|NCT03371732|Women|women
5100183|NCT03371732|Supportive care|supportive care
5100184|NCT03371706|aphasia|aphasia
5100185|NCT03371706|primary progressive aphasia|primary progressive aphasia
5100186|NCT03371706|dementia|dementia
5100187|NCT03371706|communication|communication
5100188|NCT03371706|frontotemporal dementia|frontotemporal dementia
5100189|NCT03371706|Alzheimer's disease|alzheimer's disease
5100190|NCT03371693|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5100191|NCT03371693|epithelial ovarian cancer|epithelial ovarian cancer
5100192|NCT03371667|Hematopoietic Stem Cell|hematopoietic stem cell
5100193|NCT03371667|Methotrexate|methotrexate
5100194|NCT03371667|Corticosteroids therapy|corticosteroids therapy
5100195|NCT03371667|Acute GVHD|acute gvhd
5100196|NCT03371667|Allogenic stem cell transplantation|allogenic stem cell transplantation
5100197|NCT03371641|Fetal Alcohol Syndrome|fetal alcohol syndrome
5100198|NCT03371641|Pregnancy|pregnancy
5100219|NCT03371368|Gastric Bypass|gastric bypass
5100220|NCT03371368|Sleeve Gastrectomy|sleeve gastrectomy
5961948|NCT04283838|Humanistic Care|humanistic care
5100221|NCT03371355|Type 2 Diabetes|type 2 diabetes
5100222|NCT03371355|Hepatic Steatosis|hepatic steatosis
5100223|NCT03371355|Triglycerides|triglycerides
5100224|NCT03371355|AKCEA-ANGPTL3-Lrx|akcea-angptl3-lrx
5100225|NCT03371355|IONIS-ANGPTL3-Lrx|ionis-angptl3-lrx
5100226|NCT03371355|Fatty Liver|fatty liver
5100227|NCT03371355|Fatty Liver Without Mention of Alcohol|fatty liver without mention of alcohol
5100228|NCT03371355|Liver Fat|liver fat
5100229|NCT03371355|Liver Diseases|liver diseases
5100230|NCT03371355|Diabetes Mellitus Type 2 in Nonobese|diabetes mellitus type 2 in nonobese
5100231|NCT03371355|Diabetes Mellitus|diabetes mellitus
5100232|NCT03371355|Triglycerides High|triglycerides high
5100233|NCT03371355|High Triglycerides|high triglycerides
5100234|NCT03371355|Metabolic Disease|metabolic disease
4985124|NCT04084587|Rehabilitation|rehabilitation
5100235|NCT03371355|Endocrine System Diseases|endocrine system diseases
5100236|NCT03371355|Digestive System Disease|digestive system disease
5100237|NCT03371355|Glucose Metabolism Disorders|glucose metabolism disorders
5100238|NCT03371329|mesenchymal stem cell|mesenchymal stem cell
5100239|NCT03371329|stroke|stroke
5100240|NCT03371329|intracerebral hemorrhage|intracerebral hemorrhage
5100241|NCT03371329|cell therapy|cell therapy
5100242|NCT03371264|Liver transplantation|liver transplantation
5100243|NCT03371264|Allocation process|allocation process
5100244|NCT03371264|Extended-criteria donors|extended-criteria donors
5100245|NCT03371264|Survival|survival
5100246|NCT03371251|Adults|adults
5100247|NCT03371251|BOS161721|bos161721
5100248|NCT03371251|standard of care|standard of care
5100249|NCT03371251|moderately to severely active Systemic Lupus Erythematosus|moderately to severely active systemic lupus erythematosus
5100250|NCT03371212|Dual Mobility|dual mobility
5100251|NCT03371212|Serum metal levels|serum metal levels
5100252|NCT03371186|Implementation Research|implementation research
5100253|NCT03371186|Maternal Mortality and Morbidity|maternal mortality and morbidity
5100254|NCT03371186|Neonatal Mortality and Morbidity|neonatal mortality and morbidity
5100255|NCT03371186|Infant Mortality and Morbidity|infant mortality and morbidity
5100256|NCT03371186|Child Mortality and Morbidity|child mortality and morbidity
5100257|NCT03371186|Community Health Workers|community health workers
5100258|NCT03371186|Health Systems Strengthening|health systems strengthening
5100259|NCT03371173|Pulmonary Hypertension|pulmonary hypertension
5100260|NCT03371173|Iron Deficiency|iron deficiency
5100261|NCT03371108|Diabetes|diabetes
5100262|NCT03371108|Diabetes Type 2|diabetes type 2
5100263|NCT03371108|Type 2|type 2
5100264|NCT03371108|Basal|basal
5100265|NCT03371108|Insulin|insulin
5100266|NCT03371108|Glargine|glargine
5100267|NCT03371108|T2DM|t2dm
5100268|NCT03371108|Diabetes Mellitus|diabetes mellitus
5100269|NCT03371095|Behcet's Disease|behcet's disease
5100270|NCT03371095|Vasculitis|vasculitis
5100271|NCT03371095|Biotherapy|biotherapy
5100272|NCT03371095|immunosuppressant|immunosuppressant
5100273|NCT03371095|Infliximab|infliximab
5100274|NCT03371082|Diabetes|diabetes
5100275|NCT03371082|Diabetes Type 1|diabetes type 1
5100276|NCT03371082|Type 1|type 1
5100277|NCT03371082|Basal|basal
5100278|NCT03371082|Insulin|insulin
5100279|NCT03371082|Glargine|glargine
5100280|NCT03371082|T1DM|t1dm
5100281|NCT03371082|Diabetes Mellitus|diabetes mellitus
5100282|NCT03371082|Insulin Dependent Diabetes|insulin dependent diabetes
5100283|NCT03371069|methylphenidate|methylphenidate
5100284|NCT03371069|drug utilisation study|drug utilisation study
5100285|NCT03371069|pediatrics|pediatrics
5100286|NCT03371056|Neonatal infections|neonatal infections
5100287|NCT03371056|maternal-fetal infection|maternal-fetal infection
5100288|NCT03371056|group B streptococcus|group b streptococcus
5100289|NCT03371056|vaginal sample|vaginal sample
5100290|NCT03371056|antibiotic prophylaxis|antibiotic prophylaxis
5100291|NCT03371056|bacterial resistance|bacterial resistance
5100292|NCT03371043|analgesics|analgesics
5100294|NCT03371043|outpatient drug use|outpatient drug use
5100295|NCT03371043|pediatrics|pediatrics
5100299|NCT03371004|DM-CHOC-PEN|dm-choc-pen
5100300|NCT03371004|Radiation|radiation
5100301|NCT03371004|Cancer|cancer
5100304|NCT03370991|Cardiovascular Disease|cardiovascular disease
5098019|NCT03385681|pediatric pain|pediatric pain
5100308|NCT03370991|Endothelium|endothelium
5100309|NCT03370991|Vasodilation|vasodilation
5100310|NCT03370991|Blood Pressure|blood pressure
5100311|NCT03370991|Menopause|menopause
5100312|NCT03370991|Women's Health|women's health
5100313|NCT03370991|Functional Food|functional food
5100314|NCT03370991|Bioactive Compounds|bioactive compounds
5100315|NCT03370991|Dietary Supplements|dietary supplements
5100316|NCT03370991|Aging|aging
5100317|NCT03370965|optic neuritis|optic neuritis
5100318|NCT03370965|neuromyelitis optica|neuromyelitis optica
5100319|NCT03370965|multiple sclerosis|multiple sclerosis
5100320|NCT03370965|emergent treatment of optic neuritis|emergent treatment of optic neuritis
5100321|NCT03370965|optic neuritis disease modifying therapy|optic neuritis disease modifying therapy
5100322|NCT03370965|optic neuritis treatment trial|optic neuritis treatment trial
5100323|NCT03370965|plasma exchange|plasma exchange
5100324|NCT03370939|ischemic stroke|ischemic stroke
5100325|NCT03370939|endovascular treatment|endovascular treatment
5100326|NCT03370939|workflow|workflow
5100327|NCT03370913|Gene Therapy|gene therapy
5100328|NCT03370913|Clotting Disorders|clotting disorders
5100329|NCT03370913|Blood Disorder|blood disorder
5100330|NCT03370913|Blood Coagulation Disorders|blood coagulation disorders
5100331|NCT03370913|Inherited Blood Coagulation disorders|inherited blood coagulation disorders
5100332|NCT03370913|Hematologic Diseases|hematologic diseases
5100333|NCT03370913|Coagulation Protein Disorders|coagulation protein disorders
5100334|NCT03370913|Hemorrhagic Disorders|hemorrhagic disorders
5100335|NCT03370913|Genetic Diseases|genetic diseases
5100336|NCT03370913|Inborn|inborn
5100337|NCT03370913|Factor VIII|factor viii
5100338|NCT03370913|Coagulants|coagulants
4985244|NCT04084106|metagenomics|metagenomics
5100339|NCT03370900|Education (Medical); Retention;|education (medical); retention;
5100340|NCT03370848|Niacin|niacin
5100341|NCT03370848|Psyllium|psyllium
5100342|NCT03370848|Dietary fiber|dietary fiber
5100343|NCT03370835|Beta-Blocker|beta-blocker
5100344|NCT03370835|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5100345|NCT03370835|COPD|copd
5100346|NCT03370835|Cardioselective|cardioselective
5100347|NCT03370822|Fetal monitoring|fetal monitoring
5100348|NCT03370822|Acceptability|acceptability
5100349|NCT03370822|Fetal Heart Rate|fetal heart rate
5100350|NCT03370809|Frailty|frailty
5100351|NCT03370809|Oncogeriatric|oncogeriatric
5100352|NCT03370809|PET 18F-FDG|pet 18f-fdg
5100353|NCT03370809|SPM (Statistical Parametric Mapping)|spm (statistical parametric mapping)
5100354|NCT03370809|Neurology|neurology
5100355|NCT03370796|dementia|dementia
5100356|NCT03370796|cognitive impairment|cognitive impairment
5100357|NCT03370796|cognition|cognition
5100358|NCT03370796|quality of life|quality of life
5100359|NCT03370796|depressive symptoms|depressive symptoms
5100360|NCT03370796|Reminiscence Therapy|reminiscence therapy
5100361|NCT03370744|subjective cognitive decline|subjective cognitive decline
5100362|NCT03370744|brain network|brain network
5100363|NCT03370744|multi-modality|multi-modality
5100364|NCT03370744|magnetic resonance imaging|magnetic resonance imaging
5100365|NCT03370731|pediatric|pediatric
5100366|NCT03370731|obstructive sleep apnea|obstructive sleep apnea
5100367|NCT03370731|polysomnography|polysomnography
5100368|NCT03370731|quality of life|quality of life
5100369|NCT03370731|adenotonsillectomy|adenotonsillectomy
5100370|NCT03370692|Outcome|outcome
5100371|NCT03370692|Survival|survival
5100372|NCT03370692|Prognostication|prognostication
5100373|NCT03370679|Premature|premature
5100374|NCT03370679|Ventricular|ventricular
5100375|NCT03370679|Complexes|complexes
5100376|NCT03370679|Beats|beats
5100377|NCT03370679|Prognosis|prognosis
5100378|NCT03370653|MPS VI|mps vi
5100379|NCT03370653|Lysosomal disease|lysosomal disease
5100380|NCT03370653|Glycoaminoglycans (GAG)|glycoaminoglycans (gag)
5100381|NCT03370653|Odiparcil|odiparcil
5100382|NCT03370627|Autoimmune Diseases|autoimmune diseases
5100383|NCT03370627|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
5100384|NCT03370627|Type I Interferons|type i interferons
5100385|NCT03370627|Antibodies|antibodies
5100386|NCT03370627|Anti-CD303|anti-cd303
5100388|NCT03370614|MRI|mri
5100389|NCT03370614|Irritable Bowel Syndrome|irritable bowel syndrome
5100390|NCT03370614|Irritable Bowel|irritable bowel
5100391|NCT03370614|Positron emission tomography|positron emission tomography
5100392|NCT03370614|Magnetic resonance imaging|magnetic resonance imaging
5100393|NCT03370614|FDG|fdg
5100394|NCT03370614|Fluorodeoxyglucose|fluorodeoxyglucose
5100395|NCT03370601|crohn's disease|crohn's disease
5100396|NCT03370601|ulcerative colitis|ulcerative colitis
5100397|NCT03370601|infliximab|infliximab
5100398|NCT03370601|loss of response|loss of response
5100402|NCT03370549|Mental health|mental health
5100411|NCT03370471|language|language
5100412|NCT03370471|cognition|cognition
5100413|NCT03370432|Vitamin D|vitamin d
5100414|NCT03370432|GC|gc
5100415|NCT03370432|CYP2R1|cyp2r1
5100416|NCT03370432|Gene-environment interaction|gene-environment interaction
5100419|NCT03370432|colorectal cancer|colorectal cancer
5100420|NCT03370419|Metabolic syndrome|metabolic syndrome
5100421|NCT03370419|Habits|habits
5100422|NCT03370419|African American|african american
5745545|NCT00338026|Ovarian|ovarian
5100423|NCT03370419|Emergency Medicine|emergency medicine
5100424|NCT03370406|Squamous Cell|squamous cell
5100425|NCT03370406|Carcinoma|carcinoma
5100426|NCT03370406|Lower Extremities|lower extremities
5100427|NCT03370406|5-Fluorouracil|5-fluorouracil
5100428|NCT03370406|Imiquimod|imiquimod
5100429|NCT03370393|Reward-drive|reward-drive
5100430|NCT03370393|Cogntiive-control|cogntiive-control
5100431|NCT03370315|Parkinsonian Disorders|parkinsonian disorders
5100432|NCT03370315|Dance Therapy|dance therapy
5100433|NCT03370315|Rehabilitation|rehabilitation
5100434|NCT03370315|Kinematics|kinematics
5100435|NCT03370315|Locomotion|locomotion
5100436|NCT03370315|Quality of Life|quality of life
5100437|NCT03370302|Drug therapy|drug therapy
5100438|NCT03370263|Benlysta, systemic lupus erythematosus, safety, efficacy|benlysta, systemic lupus erythematosus, safety, efficacy
5100439|NCT03370250|immediate breast reconstruction|immediate breast reconstruction
4970999|NCT04171778|CKD|ckd
5100440|NCT03370250|free greater omentum|free greater omentum
5100441|NCT03370250|breast-conserving surgery|breast-conserving surgery
5100442|NCT03370250|luminal breast cancer|luminal breast cancer
5100443|NCT03370237|Diabetic foot ulcer|diabetic foot ulcer
5100444|NCT03370237|type 2 diabetes|type 2 diabetes
5100445|NCT03370237|foot ulcer risk|foot ulcer risk
5100446|NCT03370224|Memory|memory
5100447|NCT03370224|Learning|learning
5100448|NCT03370224|Cognition|cognition
5100449|NCT03370224|Treatment|treatment
5100450|NCT03370211|resistance training|resistance training
4985364|NCT04083313|Endoloop|endoloop
5100451|NCT03370211|inflammatory markers|inflammatory markers
5100452|NCT03370211|functional capacity|functional capacity
5100453|NCT03370185|Leukemia|leukemia
5100454|NCT03370185|Lymphoma|lymphoma
5100455|NCT03370185|Refractory|refractory
5100456|NCT03370185|Relapse|relapse
5100457|NCT03370133|Bimekizumab|bimekizumab
5100458|NCT03370133|PSO|pso
5100459|NCT03370133|Psoriasis|psoriasis
5100462|NCT03370081|Capnometry|capnometry
5100463|NCT03370081|Capnography|capnography
5100464|NCT03370081|ETCO2|etco2
5100465|NCT03370081|Recovery room|recovery room
5100466|NCT03370081|Post-anesthesia care unit|post-anesthesia care unit
5100467|NCT03370068|ICSI|icsi
5100468|NCT03370068|IVF|ivf
5100469|NCT03370068|Infertility|infertility
5100470|NCT03370068|non-male factor|non-male factor
5100471|NCT03370068|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5100472|NCT03370068|In vitro fertilization|in vitro fertilization
5100473|NCT03370055|Exposed tendon or bone|exposed tendon or bone
5100474|NCT03370055|LeucoPatch|leucopatch
5100475|NCT03370055|Plastic Surgery|plastic surgery
5100476|NCT03370055|Granulation tissue|granulation tissue
5100477|NCT03370055|Wound|wound
5100478|NCT03370042|aesthetics|aesthetics
5100479|NCT03370042|root coverage|root coverage
5100480|NCT03370042|semilunar coronally positioned flap|semilunar coronally positioned flap
5100481|NCT03370042|free gingival graft|free gingival graft
5100482|NCT03370042|width of keratinised tissue|width of keratinised tissue
5100483|NCT03370029|Exercise capacity|exercise capacity
5100484|NCT03370029|Respiratory muscle strength|respiratory muscle strength
5100485|NCT03370029|Physical inactivity|physical inactivity
5100486|NCT03370029|Quality of life|quality of life
5100489|NCT03369977|BioGlue Surgical Adhesive|bioglue surgical adhesive
5100490|NCT03369977|Type A Aortic Dissection|type a aortic dissection
5100491|NCT03369951|ACUMIN|acumin
5100492|NCT03369951|Infusion|infusion
5100493|NCT03369951|Injection|injection
5100494|NCT03369951|Minocycline|minocycline
5100495|NCT03369951|Pharmacokinetic|pharmacokinetic
5100496|NCT03369951|PK|pk
5100497|NCT03369938|left ventricular assist device|left ventricular assist device
5100498|NCT03369938|exercise training|exercise training
5100499|NCT03369912|Safety, efficacy|safety, efficacy
5100500|NCT03369912|pregnant women|pregnant women
5100501|NCT03369912|CSJ148|csj148
5100502|NCT03369912|HCMV infection|hcmv infection
5100503|NCT03369912|congenital HCMV|congenital hcmv
5100505|NCT03369886|Angiography|angiography
5100886|NCT03367650|genetic|genetic
5100506|NCT03369886|Artificial neural network|artificial neural network
5100507|NCT03369873|cardiac catheterization|cardiac catheterization
5100508|NCT03369873|anxiety|anxiety
5100509|NCT03369873|stress|stress
5100510|NCT03369873|nursing orientation|nursing orientation
5100511|NCT03369847|inhaled corticosteroids|inhaled corticosteroids
5100512|NCT03369847|budesonide|budesonide
5100513|NCT03369847|beclomethasone|beclomethasone
5100514|NCT03369834|phototherapy|phototherapy
5100515|NCT03369834|diabetes mellitus|diabetes mellitus
5100516|NCT03369834|exercise|exercise
5100517|NCT03369821|type 1 diabetes|type 1 diabetes
5100518|NCT03369821|monogenic diabetes|monogenic diabetes
5100519|NCT03369821|autoimmune diabetes|autoimmune diabetes
5100520|NCT03369821|early-onset autoimmune diabetes|early-onset autoimmune diabetes
5100521|NCT03369821|beta cell (β-cell) destruction|beta cell (β-cell) destruction
5100522|NCT03369821|type 1 diabetes genetic risk|type 1 diabetes genetic risk
5100523|NCT03369821|extremely early-onset Type 1 diabetes|extremely early-onset type 1 diabetes
5100525|NCT03369808|H7N9|h7n9
5100526|NCT03369795|methotrexate|methotrexate
5100527|NCT03369795|add-on|add-on
5100528|NCT03369795|schizophrenia|schizophrenia
5100529|NCT03369795|schizoaffective|schizoaffective
5100530|NCT03369782|Muscle Tension|muscle tension
5100531|NCT03369782|Skeletal Muscle Relaxants|skeletal muscle relaxants
5100532|NCT03369782|Arthroplasties, Hip Replacement|arthroplasties, hip replacement
5100533|NCT03369782|Rocuronium|rocuronium
5100534|NCT03369782|sugammadex|sugammadex
5100535|NCT03369730|Screening|screening
5100536|NCT03369730|Duration of Untreated Psychosis (DUP)|duration of untreated psychosis (dup)
5100537|NCT03369730|Coordinated Specialty Care (CSC)|coordinated specialty care (csc)
5100538|NCT03369730|First Episode Psychosis (FEP)|first episode psychosis (fep)
5100539|NCT03369730|At Risk Mental State (ARMS)|at risk mental state (arms)
5100540|NCT03369730|Clinical High Risk for Psychosis (CHR)|clinical high risk for psychosis (chr)
5100541|NCT03369717|endoscopic sinus surgery|endoscopic sinus surgery
5100542|NCT03369717|antibiotics|antibiotics
5961949|NCT04283838|mental health|mental health
5100543|NCT03369704|cryptomeria, omalizumab, seasonal allergic rhinitis|cryptomeria, omalizumab, seasonal allergic rhinitis
5100544|NCT03369678|Cultural Safety|cultural safety
5100545|NCT03369678|Discrimination|discrimination
5100546|NCT03369678|Emergency Departments|emergency departments
5100547|NCT03369678|Health Equity|health equity
5100548|NCT03369678|Indigenous Populations|indigenous populations
5100549|NCT03369678|Marginalized Populations|marginalized populations
5100550|NCT03369678|Patient Experiences of Care|patient experiences of care
5100551|NCT03369678|Trauma- and Violence-Informed Care|trauma- and violence-informed care
4985486|NCT04082598|tooth infection|tooth infection
5100552|NCT03369678|Staff Engagement|staff engagement
5100553|NCT03369678|Harm Reduction|harm reduction
5100554|NCT03369665|Multiple sclerosis|multiple sclerosis
5100555|NCT03369665|Mavenclad®|mavenclad®
5100556|NCT03369665|Cladribine|cladribine
5100557|NCT03369665|Health-related Quality of Life|health-related quality of life
5100558|NCT03369639|late life|late life
5100560|NCT03369639|depression|depression
5100561|NCT03369639|anxiety|anxiety
5100562|NCT03369639|dronabinol|dronabinol
5100563|NCT03369600|elastography|elastography
5100564|NCT03369587|Handwriting, Micrographia|handwriting, micrographia
5100565|NCT03369548|Bile acids|bile acids
5100566|NCT03369548|Lipid metabolism|lipid metabolism
5100567|NCT03369548|Cholesterol|cholesterol
5100568|NCT03369548|Probiotics|probiotics
5100569|NCT03369548|Polyphenols|polyphenols
5100570|NCT03369548|Prebiotics|prebiotics
5100571|NCT03369548|Gut bacteria|gut bacteria
5100572|NCT03369548|Gut microbiota|gut microbiota
5100573|NCT03369535|hypertension|hypertension
5100574|NCT03369522|seizure detection|seizure detection
5100575|NCT03369509|Drug hypersensitivity, drug allergy, cross reaction|drug hypersensitivity, drug allergy, cross reaction
5100576|NCT03369496|Social Capital|social capital
5100577|NCT03369496|Social Support|social support
5100578|NCT03369496|Neighborhood|neighborhood
5100579|NCT03369496|Population Health|population health
5100580|NCT03369496|Healthy Aging|healthy aging
5100581|NCT03369496|Adult|adult
5100582|NCT03369496|Canada|canada
5100583|NCT03369431|Autism|autism
5100584|NCT03369431|Gastrointestinal|gastrointestinal
5100585|NCT03369431|behaviour|behaviour
5100586|NCT03369431|constipation|constipation
5100587|NCT03369431|diarrhoea|diarrhoea
5100588|NCT03369431|probiotic|probiotic
5100589|NCT03369431|sociability|sociability
5100590|NCT03369405|periodontitis|periodontitis
5100591|NCT03369405|hypothyroidism|hypothyroidism
5100592|NCT03369379|Fibromyalgia|fibromyalgia
5100593|NCT03369379|D Vitamin|d vitamin
5100594|NCT03369366|Maxillofacial Defects|maxillofacial defects
5100595|NCT03369366|Benign, large tumors requiring surgical resection|benign, large tumors requiring surgical resection
5100596|NCT03369353|Bone Marrow Transplantation|bone marrow transplantation
5100597|NCT03369353|Graft Vs Host Disease|graft vs host disease
5100598|NCT03369353|Inflammatory Bowel Diseases|inflammatory bowel diseases
5100599|NCT03369353|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
5100600|NCT03369353|Cellular Therapy|cellular therapy
5100601|NCT03369340|Nicotine|nicotine
5100602|NCT03369340|Nicotine-containing product|nicotine-containing product
5100603|NCT03369275|Mesenchymal Stem Cells|mesenchymal stem cells
5100725|NCT03368586|Adolescents|adolescents
5100604|NCT03369275|Mesenchymal Stromal Cells|mesenchymal stromal cells
5100605|NCT03369275|Randomized Controlled Trial|randomized controlled trial
5100610|NCT03369262|preterm birth|preterm birth
5100611|NCT03369262|premature birth|premature birth
5100612|NCT03369262|tocolysis|tocolysis
5100613|NCT03369262|prostaglandin F2α antagonist|prostaglandin f2α antagonist
5100614|NCT03369262|PGF2α|pgf2α
5100615|NCT03369262|tocolytic|tocolytic
5100616|NCT03369236|factor D|factor d
5100618|NCT03369236|alternative pathway|alternative pathway
5098342|NCT03383653|Pregnant Women|pregnant women
5100620|NCT03369236|Membranoproliferative Glomerulonephritis|membranoproliferative glomerulonephritis
5100621|NCT03369236|Primary MPGN|primary mpgn
5100623|NCT03369236|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
5100624|NCT03369236|idiopathic MPGN|idiopathic mpgn
5100625|NCT03369236|DDD|ddd
5100626|NCT03369236|C3GN|c3gn
5100627|NCT03369223|Antibodies|antibodies
5100628|NCT03369223|Antineoplastic Agents|antineoplastic agents
5100629|NCT03369223|Immunologic Factors|immunologic factors
5100630|NCT03369223|Nivolumab|nivolumab
5100631|NCT03369223|Antibodies, Monoclonal|antibodies, monoclonal
5100632|NCT03369223|Physiological Effects of Drugs|physiological effects of drugs
5100633|NCT03369197|procedural sedation|procedural sedation
5100634|NCT03369197|monitored anesthesia care|monitored anesthesia care
5100635|NCT03369197|endoscopy|endoscopy
5100636|NCT03369184|Coronary flow|coronary flow
5100637|NCT03369184|Coronary vascular resistance|coronary vascular resistance
5100638|NCT03369184|Supplemental oxygen|supplemental oxygen
5100639|NCT03369145|Hepatokines|hepatokines
5100640|NCT03369145|High Fat Diet|high fat diet
5100641|NCT03369145|Glycaemic Control|glycaemic control
4985611|NCT04081519|rTMS|rtms
5100642|NCT03369145|Fibroblast Growth Factor 21|fibroblast growth factor 21
5100643|NCT03369145|Leukocyte Cell-derived Chemotaxin 2|leukocyte cell-derived chemotaxin 2
5100644|NCT03369145|Fetuin-A|fetuin-a
5100645|NCT03369145|Appetite|appetite
5100646|NCT03369145|Ghrelin|ghrelin
5100647|NCT03369145|Peptide YY|peptide yy
5100648|NCT03369119|Acute asthma|acute asthma
5100649|NCT03369119|Montelukast|montelukast
5100650|NCT03369119|Hospitalized children|hospitalized children
5100651|NCT03369119|Preschool children|preschool children
5100652|NCT03369093|RCT|rct
5100653|NCT03369093|severe pneumonia|severe pneumonia
5100654|NCT03369093|amoxicillin|amoxicillin
5100655|NCT03369093|under five|under five
5100656|NCT03369080|Body Mass Index|body mass index
5100657|NCT03369067|Artificial Pancreas (AP)|artificial pancreas (ap)
5100658|NCT03369067|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5100659|NCT03369067|Closed Loop Control (CLC)|closed loop control (clc)
5100660|NCT03369067|Insulin Pump|insulin pump
5100661|NCT03369041|chemoembolization|chemoembolization
5100662|NCT03369015|Reward Learning|reward learning
5100663|NCT03369015|Decision Making|decision making
5100664|NCT03369002|Hepatic Impairment|hepatic impairment
5100665|NCT03368950|Anxiety|anxiety
5100666|NCT03368950|Depression|depression
5100667|NCT03368950|Stress|stress
5100668|NCT03368937|Artificial Pancreas (AP)|artificial pancreas (ap)
5100669|NCT03368937|Closed Loop Control (CLC)|closed loop control (clc)
5100670|NCT03368937|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5100671|NCT03368937|Insulin Pump|insulin pump
5100672|NCT03368924|sickle cell anemia red blood cell oxidation|sickle cell anemia red blood cell oxidation
5100673|NCT03368924|vaso-occlusive crises|vaso-occlusive crises
5100674|NCT03368924|anti bande 3 antibodies|anti bande 3 antibodies
5100675|NCT03368924|red blood cell oxidation|red blood cell oxidation
5100676|NCT03368911|Hoarseness|hoarseness
5100677|NCT03368911|Sore Throat|sore throat
5100678|NCT03368911|Thyroidectomy|thyroidectomy
5100679|NCT03368885|MIYCN -Maternal Infant Young Child Nutrition|miycn -maternal infant young child nutrition
5100680|NCT03368885|CGPP - Core Group Polio Project|cgpp - core group polio project
5100681|NCT03368885|A&T- Alive and Thrive|a&t- alive and thrive
5100682|NCT03368885|PCI- Project Concern International|pci- project concern international
5100683|NCT03368885|UP- Uttar Pradesh|up- uttar pradesh
5100684|NCT03368885|VHSNC -Village Health, Sanitation and Nutrition Committee|vhsnc -village health, sanitation and nutrition committee
5100685|NCT03368885|CMC- Community Mobilization Coordinator|cmc- community mobilization coordinator
5100686|NCT03368872|Sarcopenia, muscle function, muscle endurance, fatigue|sarcopenia, muscle function, muscle endurance, fatigue
5100687|NCT03368859|cancer|cancer
5100688|NCT03368859|colorectal cancer|colorectal cancer
5100689|NCT03368859|ABT-165|abt-165
5100690|NCT03368859|FOLFIRI|folfiri
5100691|NCT03368859|Bevacizumab|bevacizumab
5100692|NCT03368859|bowel cancer|bowel cancer
5091123|NCT03428971|p-wave|p-wave
5100693|NCT03368859|metastatic colorectal cancer|metastatic colorectal cancer
5100694|NCT03368859|metastatic colorectal|metastatic colorectal
5100695|NCT03368820|lung neoplasms|lung neoplasms
5100696|NCT03368820|cardiovascular co-morbidity|cardiovascular co-morbidity
5100697|NCT03368781|Atrial Fibrillation|atrial fibrillation
5100707|NCT03368716|Behavioral Intervention|behavioral intervention
5100709|NCT03368703|Transcranial direct-current stimulation|transcranial direct-current stimulation
5100710|NCT03368703|Transcranial magnetic stimulation|transcranial magnetic stimulation
5100711|NCT03368703|Motor-evoked potentials|motor-evoked potentials
5100712|NCT03368703|Inhibition|inhibition
5100713|NCT03368703|Muscle weakness|muscle weakness
5100714|NCT03368690|pine barkextract, antioxidant, ADHD, catecholamine|pine barkextract, antioxidant, adhd, catecholamine
5100720|NCT03368625|Stereotactic Radiosurgery|stereotactic radiosurgery
5100721|NCT03368625|Radiation|radiation
5100722|NCT03368625|Surgery|surgery
5100723|NCT03368586|Flash Glucose Monitoring|flash glucose monitoring
5100729|NCT03368573|Medication|medication
5100730|NCT03368573|Feasibility|feasibility
5100731|NCT03368560|Treatment-resistant Late Life Depression|treatment-resistant late life depression
5100732|NCT03368560|Sudarshan Kriya Yoga|sudarshan kriya yoga
5100733|NCT03368560|Glutathione|glutathione
5100734|NCT03368508|Simulation|simulation
5100735|NCT03368508|Physiotherapy training|physiotherapy training
5100736|NCT03368508|360-degree video|360-degree video
5100737|NCT03368495|yellow fever vaccine|yellow fever vaccine
5100738|NCT03368495|MMR vaccine|mmr vaccine
5100739|NCT03368495|immunogenicity|immunogenicity
5100740|NCT03368482|cognition disorders|cognition disorders
5100741|NCT03368482|frail elderly|frail elderly
5100742|NCT03368482|human physical conditioning|human physical conditioning
5100743|NCT03368482|institutionalization|institutionalization
5100744|NCT03368482|physical activity|physical activity
5100745|NCT03368469|Transcranial|transcranial
5100746|NCT03368469|Stimulation|stimulation
5100747|NCT03368456|mhealth|mhealth
5100748|NCT03368456|preventive intervention|preventive intervention
5100749|NCT03368456|primary health care|primary health care
5100754|NCT03368430|Melatonin; Chronic periodontitis; Host modulation therapy|melatonin; chronic periodontitis; host modulation therapy
5100755|NCT03368417|Hypertension|hypertension
5100756|NCT03368417|Wireless Home Blood Pressure Monitoring|wireless home blood pressure monitoring
5100757|NCT03368417|Medication Adherence|medication adherence
5100758|NCT03368417|Medication Titration|medication titration
4968955|NCT04183608|IBD|ibd
5100759|NCT03368417|Financial Incentives|financial incentives
5100760|NCT03368417|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5100761|NCT03368378|prostate cancer|prostate cancer
5100762|NCT03368378|radical prostatectomy|radical prostatectomy
5100763|NCT03368378|deep venous complex ligation|deep venous complex ligation
5100764|NCT03368365|Monitoring|monitoring
5100765|NCT03368365|Home|home
5100766|NCT03368365|Lung|lung
5100767|NCT03368365|Transplant|transplant
5100768|NCT03368365|Hospitalization|hospitalization
5100769|NCT03368365|Respiratory function at rest|respiratory function at rest
5100770|NCT03368365|Monitoring modem|monitoring modem
5100771|NCT03368352|Melatonin|melatonin
5100772|NCT03368352|Altitude|altitude
5100773|NCT03368352|Sleep|sleep
5100774|NCT03368352|Ventilation|ventilation
5100775|NCT03368352|Cognition|cognition
5100776|NCT03368313|Nonelastic compression theraphy|nonelastic compression theraphy
5100777|NCT03368313|Compression theraphy|compression theraphy
5100778|NCT03368313|Compression stockings|compression stockings
5100779|NCT03368300|progressive supranuclear palsy|progressive supranuclear palsy
5100780|NCT03368300|Caribbean atypical Parkinsonism|caribbean atypical parkinsonism
5100781|NCT03368300|Annona Muricata|annona muricata
5100782|NCT03368287|Total Knee Arthroplasty|total knee arthroplasty
5100783|NCT03368287|steps|steps
5100784|NCT03368287|rehabilitation|rehabilitation
5100785|NCT03368287|activity tracker|activity tracker
5100786|NCT03368261|Pulmonary arterial hypertension|pulmonary arterial hypertension
5100787|NCT03368261|SCD|scd
5100788|NCT03368261|Epidemiology|epidemiology
5100789|NCT03368248|Palliative care|palliative care
5100790|NCT03368248|Collegial meetings|collegial meetings
5100791|NCT03368248|Neonatal resuscitation services|neonatal resuscitation services
5100792|NCT03368248|Survey|survey
5100794|NCT03368235|rheumatoid arthritis, swollen joints, tender joints, autoimmunity|rheumatoid arthritis, swollen joints, tender joints, autoimmunity
5100795|NCT03368209|Non-invasive glucose monitoring|non-invasive glucose monitoring
5100796|NCT03368196|Stomach cancer|stomach cancer
5100797|NCT03368196|Cancer where the esophagus meets the stomach|cancer where the esophagus meets the stomach
5100798|NCT03368196|Human epidermal growth factor 2|human epidermal growth factor 2
5100799|NCT03368196|HER2|her2
5100800|NCT03368196|Breast Cancer|breast cancer
5100801|NCT03368196|Adenocarcinoma, Gastroesophageal Junction (GEJ)|adenocarcinoma, gastroesophageal junction (gej)
5100802|NCT03368196|Gastric Cancer|gastric cancer
5100803|NCT03368196|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5100804|NCT03368196|Oncology|oncology
5100805|NCT03368170|Levodopa induced dyskinesia|levodopa induced dyskinesia
5100806|NCT03368118|ABX464|abx464
5100807|NCT03368118|Ulcerative Colitis|ulcerative colitis
5100808|NCT03368105|Clostridium difficile Infection|clostridium difficile infection
5100809|NCT03368105|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
5100810|NCT03368105|organ transplantation|organ transplantation
5100814|NCT03368092|damage-associated molecular patterns|damage-associated molecular patterns
5100815|NCT03368092|neutrophil extracellular traps|neutrophil extracellular traps
5100816|NCT03368092|dornase alfa|dornase alfa
5100817|NCT03368079|Dysphagia|dysphagia
5100818|NCT03368079|Oropharyngeal dysphagia|oropharyngeal dysphagia
5100819|NCT03368079|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
5100820|NCT03368053|gp120|gp120
5100821|NCT03368053|HIV infections|hiv infections
5100822|NCT03368053|RV144|rv144
5100825|NCT03368040|body core temperature|body core temperature
5100828|NCT03368014|Mind|mind
5100829|NCT03368014|Enjoyment|enjoyment
5100830|NCT03368001|Autism|autism
5100831|NCT03367988|Opioid Dependence|opioid dependence
5100832|NCT03367988|Analagesia|analagesia
5100833|NCT03367988|Opioid-free Anesthesia|opioid-free anesthesia
5100834|NCT03367962|PET-CT scan|pet-ct scan
5100835|NCT03367962|[18F]F-AraG|[18f]f-arag
4985793|NCT04080193|Overweight|overweight
5100836|NCT03367949|Surgical guide|surgical guide
5100837|NCT03367949|impression inversion|impression inversion
5100838|NCT03367949|stereolithographic surgical guides|stereolithographic surgical guides
5100839|NCT03367936|mobile technology|mobile technology
5100840|NCT03367936|feedback message|feedback message
5100841|NCT03367936|self-monitoring|self-monitoring
5100842|NCT03367910|Urinary tract infection|urinary tract infection
5100843|NCT03367910|Multidrug resistant organism|multidrug resistant organism
5100844|NCT03367910|Fecal microbiota transplantation|fecal microbiota transplantation
5100845|NCT03367897|Helicobacter pylori|helicobacter pylori
5100846|NCT03367897|peptic ulcer|peptic ulcer
5100847|NCT03367897|erosions|erosions
5100848|NCT03367897|bleeding|bleeding
5100849|NCT03367897|Nsaids|nsaids
5100850|NCT03367897|Noac|noac
5100851|NCT03367884|Hypopharyngeal cancer|hypopharyngeal cancer
5100852|NCT03367884|Neck dissection|neck dissection
5100853|NCT03367884|Induction chemotherapy|induction chemotherapy
5100854|NCT03367884|Cervical lymph node metastasis|cervical lymph node metastasis
5100855|NCT03367884|definitive radiotherapy|definitive radiotherapy
5100856|NCT03367871|Recurrent Cervical Cancer|recurrent cervical cancer
5100857|NCT03367871|Persistent Cervical Cancer|persistent cervical cancer
5961950|NCT04283838|post-traumatic stress disorder|post-traumatic stress disorder
5100858|NCT03367871|Metastatic Cervical Cancer|metastatic cervical cancer
5100859|NCT03367845|Parent sensitivity|parent sensitivity
5100860|NCT03367845|Fathers|fathers
5100861|NCT03367845|Attachment|attachment
5100862|NCT03367845|Marital communication|marital communication
5100863|NCT03367780|Head-neck tumours|head-neck tumours
5100864|NCT03367780|Radiotherapy|radiotherapy
5100865|NCT03367780|Salivary gland toxicity|salivary gland toxicity
5100866|NCT03367780|PSMA PET/CT|psma pet/ct
5100867|NCT03367767|Blood Sample|blood sample
5100868|NCT03367767|Medical History|medical history
5100869|NCT03367767|Optical Imaging|optical imaging
5100870|NCT03367754|Immunotherapy|immunotherapy
5100871|NCT03367754|Immunologic Non-Responder|immunologic non-responder
5100872|NCT03367754|Immunologic Response|immunologic response
5100873|NCT03367754|Randomized|randomized
5100874|NCT03367754|PD-1|pd-1
5100875|NCT03367728|Bariatric Surgery|bariatric surgery
5100876|NCT03367728|Bariatrics|bariatrics
5100877|NCT03367728|Ropivacaine|ropivacaine
5100878|NCT03367728|Randomized Controlled Trial|randomized controlled trial
5100879|NCT03367728|Enhanced Recovery After Bariatric Surgery|enhanced recovery after bariatric surgery
5100880|NCT03367728|TAP Block|tap block
5100881|NCT03367728|Rectus Sheath Block|rectus sheath block
5100882|NCT03367676|trastuzumab|trastuzumab
5100883|NCT03367676|adjuvant therapy|adjuvant therapy
5100884|NCT03367650|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5100885|NCT03367650|epidemiology|epidemiology
5100890|NCT03367624|Staphylococcus Aureus|staphylococcus aureus
5100891|NCT03367624|Pneumonia|pneumonia
5100892|NCT03367624|PV leukocidin|pv leukocidin
5100894|NCT03367611|Immunochemical faecal occult blood test|immunochemical faecal occult blood test
5100895|NCT03367611|iFOBT|ifobt
5100896|NCT03367611|Cancer patient pathway|cancer patient pathway
5100897|NCT03367611|Colonoscopy|colonoscopy
5100898|NCT03367611|Colorectal cancer|colorectal cancer
5100899|NCT03367585|Supplementary Feeding|supplementary feeding
5100900|NCT03367585|vitamin D|vitamin d
5100901|NCT03367585|Muscle Strength|muscle strength
5100902|NCT03367585|postural balance|postural balance
5100903|NCT03367585|exercise|exercise
5100904|NCT03367585|aged|aged
5100905|NCT03367559|Rotavirus|rotavirus
5100906|NCT03367559|ROTAVAC|rotavac
5100907|NCT03367559|Vaccine|vaccine
5100908|NCT03367559|Vietnam|vietnam
5100910|NCT03367546|cALD|cald
5100911|NCT03367481|Gingival fissures|gingival fissures
5111520|NCT03300427|HF|hf
5100912|NCT03367481|Gingival recession|gingival recession
5100913|NCT03367481|Risk factors|risk factors
5100914|NCT03367481|Traumatic toothbrusing|traumatic toothbrusing
5100915|NCT03367468|Plantar fascitis|plantar fascitis
5100917|NCT03367468|Exercise|exercise
5100918|NCT03367468|Physiotherapy|physiotherapy
5100919|NCT03367468|Quality of life|quality of life
5100920|NCT03367455|Potassium|potassium
5100921|NCT03367455|Genetic Variants|genetic variants
5100922|NCT03367442|Thoracic trauma|thoracic trauma
5100923|NCT03367442|mechanical ventilation|mechanical ventilation
5100924|NCT03367442|Acute respiratory distress syndrome|acute respiratory distress syndrome
5100925|NCT03367442|Esophageal pressure|esophageal pressure
5100926|NCT03367442|Pleural pressure|pleural pressure
5100928|NCT03367429|spasticity|spasticity
5026363|NCT03833752|UTI|uti
5100929|NCT03367403|TRAILBLAZER-ALZ|trailblazer-alz
5100930|NCT03367364|Venous Thromboembolism, Deep Venous Thrombosis, Clots|venous thromboembolism, deep venous thrombosis, clots
5745546|NCT00338026|Pancreatic|pancreatic
5100931|NCT03367325|non-valvular atrial fibrillation|non-valvular atrial fibrillation
5100932|NCT03367325|time in therapeutic range|time in therapeutic range
5100933|NCT03367325|primary care|primary care
5100934|NCT03367299|Acute Lymphoid Leukemia|acute lymphoid leukemia
5100935|NCT03367299|Philadelphia Chromosome-Negative B-Cell Precursor|philadelphia chromosome-negative b-cell precursor
5100936|NCT03367299|Adults|adults
5100937|NCT03367299|Minimal residual disease|minimal residual disease
5100938|NCT03367299|Blinatumomab|blinatumomab
5100939|NCT03367260|patient preferences|patient preferences
5100940|NCT03367247|Ovarian Cancer|ovarian cancer
5100941|NCT03367247|Bowel blockage|bowel blockage
5100942|NCT03367247|Ascites|ascites
5100943|NCT03367247|Supportive care|supportive care
5100944|NCT03367247|Nursing|nursing
5100945|NCT03367247|Mobile health|mobile health
5100946|NCT03367247|m-Health|m-health
5100947|NCT03367247|Tele-health|tele-health
5100948|NCT03367247|Palliative Care|palliative care
5100949|NCT03367247|Symptom management|symptom management
5100950|NCT03367234|Federally Qualified Health Center|federally qualified health center
5100951|NCT03367234|Contingency Management|contingency management
5100952|NCT03367234|Cognitive Behavioral Therapy|cognitive behavioral therapy
5100953|NCT03367234|Cognitive Behavioral / Relapse Prevention|cognitive behavioral / relapse prevention
5100954|NCT03367234|Medication Assisted Treatment|medication assisted treatment
5100955|NCT03367234|Behavioral Health Consultant|behavioral health consultant
5100956|NCT03367234|Integrated Care|integrated care
5100957|NCT03367208|metabolomic|metabolomic
5100958|NCT03367195|GERD|gerd
5100959|NCT03367195|DLBS2411|dlbs2411
5100960|NCT03367195|omeprazole|omeprazole
5100961|NCT03367169|Pilon fractures|pilon fractures
5100962|NCT03367169|Osteosynthesis|osteosynthesis
5100963|NCT03367169|Mini invasive plate osteosynthesis|mini invasive plate osteosynthesis
5100964|NCT03367169|Locked plate|locked plate
5100965|NCT03367169|Open reduction|open reduction
5100966|NCT03367130|Antiretroviral therapy, clinic attendance, Nepal|antiretroviral therapy, clinic attendance, nepal
5100967|NCT03367091|Wearable Exoskeleton|wearable exoskeleton
5100968|NCT03367091|Stroke|stroke
5100969|NCT03367091|Energy Consumption|energy consumption
5100970|NCT03367091|Cardiorespiratory Load|cardiorespiratory load
5100976|NCT03367052|ProDisc-C vivo|prodisc-c vivo
5100977|NCT03367052|Hybrid|hybrid
5100978|NCT03367052|Cervical degenerative disc disease|cervical degenerative disc disease
5100979|NCT03367039|ProDisc-C vivo|prodisc-c vivo
5100980|NCT03367039|ACDF|acdf
5100981|NCT03367039|Cervical degenerative disc disease|cervical degenerative disc disease
5100982|NCT03367026|ivabradine|ivabradine
5100983|NCT03367026|sepsis|sepsis
5100984|NCT03367026|heart rate|heart rate
5100985|NCT03366935|labor analgesia|labor analgesia
5100987|NCT03366935|standard Epidural (EPL)|standard epidural (epl)
5100988|NCT03366935|continuous epidural infusion (CEI)|continuous epidural infusion (cei)
5100989|NCT03366935|programmed intermittent epidural bolus (PIEB)|programmed intermittent epidural bolus (pieb)
5100991|NCT03366909|cannabis use|cannabis use
5100992|NCT03366883|preoperative chemotherapy|preoperative chemotherapy
5100993|NCT03366883|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5100994|NCT03366883|clinical trial|clinical trial
5100995|NCT03366883|phase III|phase iii
5100996|NCT03366883|Esophageal squamous cancer|esophageal squamous cancer
5100997|NCT03366870|CBT-I|cbt-i
5100998|NCT03366870|Insomnia|insomnia
5100999|NCT03366844|invasive adenocarcinoma of the breast|invasive adenocarcinoma of the breast
5101000|NCT03366844|ER-positive and HER2-negative breast cancer|er-positive and her2-negative breast cancer
5101001|NCT03366844|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5101002|NCT03366844|immunotherapy|immunotherapy
5101003|NCT03366844|checkpoint inhibitor|checkpoint inhibitor
5101004|NCT03366844|HR-positive|hr-positive
5101005|NCT03366805|opioid|opioid
5101006|NCT03366805|analgesic|analgesic
5101007|NCT03366805|ambulatory|ambulatory
5101008|NCT03366805|orthopedic|orthopedic
5101009|NCT03366805|surgery|surgery
5101010|NCT03366805|patient education|patient education
5101011|NCT03366805|video|video
5101012|NCT03366805|medication diary|medication diary
5101020|NCT03366740|green banana|green banana
5101022|NCT03366740|milk suji|milk suji
5101023|NCT03366740|comminuted chicken|comminuted chicken
5101024|NCT03366727|drug eluting balloon|drug eluting balloon
5101026|NCT03366701|physical activity|physical activity
5101027|NCT03366701|sedentary behavior|sedentary behavior
5101028|NCT03366701|implicit attitudes|implicit attitudes
5101029|NCT03366701|self regulation|self regulation
5101030|NCT03366701|intention|intention
4985990|NCT04078815|Beneficence|beneficence
5101031|NCT03366701|chronic diseases|chronic diseases
5101032|NCT03366662|Electromyography|electromyography
5101033|NCT03366649|Bypass Surgery|bypass surgery
5101034|NCT03366649|Cardiology|cardiology
5101035|NCT03366649|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5101036|NCT03366649|Mitral Valve Repair|mitral valve repair
5101037|NCT03366649|Mitral Valve Surgery|mitral valve surgery
5101038|NCT03366649|Coronary Revascularization|coronary revascularization
5101039|NCT03366636|Pregnancy|pregnancy
5101040|NCT03366636|Adolescents|adolescents
5101041|NCT03366636|STIs/STDs|stis/stds
5101042|NCT03366636|Self-sufficiency|self-sufficiency
5101043|NCT03366623|Pain assessment|pain assessment
5101044|NCT03366623|Self report|self report
5101045|NCT03366623|Hospital clown intervention|hospital clown intervention
5101046|NCT03366597|sevoflurane|sevoflurane
5101047|NCT03366597|S100β protein|s100β protein
5101048|NCT03366597|regional cerebral oxygen saturation|regional cerebral oxygen saturation
5101049|NCT03366597|infant|infant
5101050|NCT03366571|Liver Cirrhosis|liver cirrhosis
5101051|NCT03366558|motion detectors|motion detectors
5101052|NCT03366558|early stage Parkinson's disease|early stage parkinson's disease
5101053|NCT03366558|advanced Parkinson's disease|advanced parkinson's disease
5101054|NCT03366558|UPDRS|updrs
5101055|NCT03366558|observational study with non-diseased controls|observational study with non-diseased controls
5101056|NCT03366545|cardiac resynchronization therapy|cardiac resynchronization therapy
5101057|NCT03366545|CRT|crt
5101058|NCT03366545|clinical routine|clinical routine
5101059|NCT03366532|diet|diet
5101060|NCT03366532|food frequency questionnaire|food frequency questionnaire
5101061|NCT03366532|nutrient|nutrient
5101062|NCT03366519|Embolism, Pulmonary|embolism, pulmonary
5101063|NCT03366519|echocardiography|echocardiography
5101064|NCT03366519|emergency|emergency
5101065|NCT03366519|prognosis|prognosis
5101066|NCT03366467|dental treatment|dental treatment
5101067|NCT03366467|sensory adapted environment|sensory adapted environment
5101068|NCT03366428|HER2|her2
5101069|NCT03366428|Breast cancer|breast cancer
5101070|NCT03366428|Oncology|oncology
5101071|NCT03366428|Antibody drug conjugate|antibody drug conjugate
5101072|NCT03366428|ADC|adc
4971725|NCT04167540|Glial cell line-derived neurotrophic factor|glial cell line-derived neurotrophic factor
4971726|NCT04167540|GDNF|gdnf
4971728|NCT04167540|Gene therapy|gene therapy
4971746|NCT04167436|Prehabilitation|prehabilitation
4971750|NCT04167436|Exercise|exercise
5101073|NCT03366415|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5101074|NCT03366415|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5101075|NCT03366415|sequential chemoradiotherapy|sequential chemoradiotherapy
5101076|NCT03366376|hippocampus|hippocampus
5101077|NCT03366376|radiotherapy|radiotherapy
5101078|NCT03366363|Knee osteoarthritis|knee osteoarthritis
5101079|NCT03366363|acupuncture|acupuncture
5101080|NCT03366363|electroacupuncture|electroacupuncture
5101095|NCT03366285|Bonding|bonding
5101096|NCT03366285|Gene expression|gene expression
5101097|NCT03366285|Stress response|stress response
5101098|NCT03366285|Neurodevelopment|neurodevelopment
5101099|NCT03366246|topical anesthetic|topical anesthetic
5101100|NCT03366246|nanocapsules|nanocapsules
5101101|NCT03366246|nanotechnology|nanotechnology
5101102|NCT03366246|lidocaine|lidocaine
5101103|NCT03366246|prilocaine|prilocaine
5101104|NCT03366246|fractional CO2 laser resurfacing|fractional co2 laser resurfacing
5101108|NCT03366155|Unresectable Liver Tumor|unresectable liver tumor
5101109|NCT03366155|Response Rates|response rates
5101110|NCT03366155|Progression-Free Survival|progression-free survival
5101111|NCT03366155|Patient Survival|patient survival
5101112|NCT03366142|Autosomal Recessive Disorder|autosomal recessive disorder
5101113|NCT03366142|Immune|immune
5101114|NCT03366142|Gingival|gingival
5101115|NCT03366142|Oral Ulcer|oral ulcer
5101116|NCT03366142|Cytokine Expression|cytokine expression
5101121|NCT03366116|Pharmacodynamics|pharmacodynamics
5111697|NCT03299361|Injection|injection
5101126|NCT03366064|Non-small cell lung cancer|non-small cell lung cancer
5101127|NCT03366064|Natural killer cells|natural killer cells
5101128|NCT03366064|HLA-haploidentical family donor|hla-haploidentical family donor
5101129|NCT03366051|Endometrial Cancer|endometrial cancer
5101130|NCT03366051|Sentinel Lymph Node|sentinel lymph node
5101131|NCT03366051|Lymphadenectomy|lymphadenectomy
5101132|NCT03366038|pancreaticoduodenectomy|pancreaticoduodenectomy
5101133|NCT03366038|pancreaticojejunostomy|pancreaticojejunostomy
5101134|NCT03366038|pancreatic fistula|pancreatic fistula
5101135|NCT03366012|Cytosponge|cytosponge
5101137|NCT03365986|hereditary|hereditary
5101138|NCT03365986|colorectal cancer|colorectal cancer
4986102|NCT04078269|vaccine|vaccine
5101139|NCT03365986|screening|screening
5101140|NCT03365973|Pathological Fracture|pathological fracture
5101141|NCT03365973|Indeterminate Instability|indeterminate instability
5101142|NCT03365973|Spinal Metastases|spinal metastases
5101143|NCT03365973|Breast Cancer|breast cancer
5101144|NCT03365960|Watermelon|watermelon
5101145|NCT03365960|Watermelon phytochemicals bioavailability|watermelon phytochemicals bioavailability
5101146|NCT03365960|Flow Mediated Vasodilation|flow mediated vasodilation
5101147|NCT03365960|Pharmacokinetics|pharmacokinetics
5101148|NCT03365934|Microflora|microflora
5101149|NCT03365934|Microbiome|microbiome
5101150|NCT03365934|skin physiology|skin physiology
5101151|NCT03365934|Fitzpatrick Skin Types I-III|fitzpatrick skin types i-iii
5101152|NCT03365934|Tape-stripped wounds|tape-stripped wounds
5101153|NCT03365908|ACL|acl
5101154|NCT03365895|diffusion|diffusion
5101155|NCT03365895|tensor|tensor
5101156|NCT03365895|imaging|imaging
5101157|NCT03365895|chemotherapy|chemotherapy
5101158|NCT03365895|peripheral neuropathy|peripheral neuropathy
5101159|NCT03365895|breast cancer|breast cancer
5101160|NCT03365895|MRI|mri
5101165|NCT03365817|cognitive function|cognitive function
5101166|NCT03365817|opioid dependence|opioid dependence
5101167|NCT03365817|opioid withdrawal|opioid withdrawal
5101168|NCT03365817|quality of life|quality of life
5101169|NCT03365817|side effect|side effect
5101170|NCT03365804|Ultrasound|ultrasound
5101171|NCT03365804|Scoliosis|scoliosis
5101172|NCT03365804|Orthoses|orthoses
5101173|NCT03365804|3D Printing|3d printing
5101193|NCT03365739|Mango pulp phytochemicals bioavailability|mango pulp phytochemicals bioavailability
5101194|NCT03365739|Pharmacokinetics|pharmacokinetics
5101196|NCT03365713|Spirometry|spirometry
5101197|NCT03365713|COPD Diagnosis|copd diagnosis
5101198|NCT03365713|PEF|pef
5101199|NCT03365713|Case Finding|case finding
5101200|NCT03365713|LMIC|lmic
5101201|NCT03365700|Persistent atrial fibrillation|persistent atrial fibrillation
5101202|NCT03365700|Catheter ablation|catheter ablation
5101203|NCT03365687|Children|children
5101204|NCT03365687|Vitamin D|vitamin d
5101205|NCT03365687|Respiratory viral infection|respiratory viral infection
5101206|NCT03365687|Randomized controlled trial|randomized controlled trial
5101207|NCT03365687|Asthma exacerbations|asthma exacerbations
5101208|NCT03365674|Myofascial Pain Syndromes, Gastrocnemius, Trigger points, Injections, Vibration|myofascial pain syndromes, gastrocnemius, trigger points, injections, vibration
5961951|NCT04283838|Healthcare Workers|healthcare workers
5961952|NCT04283825|coronavirus disease 2019|coronavirus disease 2019
5961953|NCT04283825|physical rehabilitation|physical rehabilitation
5961954|NCT04283825|psychological rehabilitation|psychological rehabilitation
5961955|NCT04283812|deep brain stimulation|deep brain stimulation
5961956|NCT04283812|sterotactic surgery|sterotactic surgery
5101209|NCT03365661|AML|aml
5101210|NCT03365661|MDS|mds
5101211|NCT03365596|Brain connectivity|brain connectivity
5101212|NCT03365596|Magnetic resonance imaging|magnetic resonance imaging
5101213|NCT03365596|Recovery prediction|recovery prediction
5101214|NCT03365583|Vitamin B12|vitamin b12
5101215|NCT03365583|Microbiome|microbiome
5101216|NCT03365583|infant|infant
5101217|NCT03365570|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study|hemoglobin, iron, oral lesions, oral manifestations,cross-sectional study
5101218|NCT03365531|fasting|fasting
5101219|NCT03365518|Psychological Treatment|psychological treatment
5101220|NCT03365518|Intimacy|intimacy
5101221|NCT03365518|Cognitive Behavioural Therapy|cognitive behavioural therapy
5101222|NCT03365518|Cognitive Behavioral Therapy|cognitive behavioral therapy
5101223|NCT03365518|Mindfulness|mindfulness
5101224|NCT03365518|Group Therapy|group therapy
5101225|NCT03365518|Couples Therapy|couples therapy
5101226|NCT03365479|pulmonary hypertension|pulmonary hypertension
5101227|NCT03365479|iloprost|iloprost
5101228|NCT03365479|inhaled|inhaled
5101229|NCT03365479|breelib|breelib
5101230|NCT03365479|nebulizer|nebulizer
5101231|NCT03365479|pulmonary arterial hypertension|pulmonary arterial hypertension
5101232|NCT03365466|recurrent implantation failure|recurrent implantation failure
5101233|NCT03365466|aspirin|aspirin
5101234|NCT03365466|low molecular weight heparin|low molecular weight heparin
5101236|NCT03365440|cardiac arrhythmia|cardiac arrhythmia
5101237|NCT03365440|heart rhythm|heart rhythm
5101238|NCT03365440|esophageal ECG|esophageal ecg
5101239|NCT03365440|non-invasive mapping|non-invasive mapping
4986215|NCT04077593|Respiratory Rate|respiratory rate
5101240|NCT03365440|supraventricular tachycardia|supraventricular tachycardia
5101241|NCT03365440|atrial fibrillation|atrial fibrillation
5101242|NCT03365440|atrial flutter|atrial flutter
5101243|NCT03365440|extrasystole|extrasystole
5101244|NCT03365427|rehabilitation|rehabilitation
5101245|NCT03365427|application on smart phones|application on smart phones
5101246|NCT03365414|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
5101247|NCT03365414|POTS|pots
5101248|NCT03365414|Syncope|syncope
5101249|NCT03365414|Vasovagal|vasovagal
5101250|NCT03365414|Hypotension|hypotension
5101251|NCT03365414|Tachycardia|tachycardia
5101252|NCT03365401|surgery|surgery
5101253|NCT03365401|decompression|decompression
5101254|NCT03365375|Chest Pain|chest pain
5101255|NCT03365375|Anxiety|anxiety
5101256|NCT03365375|Mindfulness|mindfulness
5101257|NCT03365375|Emergency Service, Hospital|emergency service, hospital
5101258|NCT03365362|directly observed therapy|directly observed therapy
5101259|NCT03365362|varenicline|varenicline
5101260|NCT03365362|long-term pharmacotherapy|long-term pharmacotherapy
5101261|NCT03365323|Periprosthetic Joint Infection|periprosthetic joint infection
5101262|NCT03365284|total knee arthroplasty|total knee arthroplasty
5101263|NCT03365284|rehabilitation|rehabilitation
5101264|NCT03365284|Smart Kneebrace|smart kneebrace
5101265|NCT03365219|Surgical Site Infection|surgical site infection
5101266|NCT03365219|Cesarean delivery infection|cesarean delivery infection
5101267|NCT03365167|LANAP|lanap
5101268|NCT03365167|Periodontitis|periodontitis
5101269|NCT03365154|Peripheral Artery Disease|peripheral artery disease
5101270|NCT03365154|Atherectomy|atherectomy
5101271|NCT03365154|Orbital Atherectomy|orbital atherectomy
5101272|NCT03365141|vitiligo|vitiligo
5101273|NCT03365141|intralesional injection|intralesional injection
5101274|NCT03365141|corticosteroid|corticosteroid
5101275|NCT03365141|triamcinolone|triamcinolone
5101276|NCT03365115|spinal anesthesia|spinal anesthesia
5101277|NCT03365115|morphine|morphine
5101278|NCT03365115|fentanyl|fentanyl
5101280|NCT03365115|knee|knee
5101281|NCT03365089|Hemodialysis fistula|hemodialysis fistula
5101282|NCT03365089|Failure to mature|failure to mature
5101283|NCT03365089|Collateral vein|collateral vein
5101284|NCT03365063|Knowledge Translation|knowledge translation
5101285|NCT03365063|Chronic Kidney Disease|chronic kidney disease
5101286|NCT03365063|Matched Cluster Randomized Trial|matched cluster randomized trial
5101287|NCT03365024|CBT-I|cbt-i
5101288|NCT03365024|Insomnia|insomnia
5101289|NCT03365011|Nitrous Oxide|nitrous oxide
5101290|NCT03364972|cataract|cataract
5101291|NCT03364972|cataract extraction|cataract extraction
5101292|NCT03364972|interocular lens implant|interocular lens implant
5101293|NCT03364972|glistenings|glistenings
5101294|NCT03364972|phacoemulsification|phacoemulsification
5101295|NCT03364972|hydrophobic acrylic|hydrophobic acrylic
5101296|NCT03364972|light scatter|light scatter
5101297|NCT03364972|patient related outcome measures|patient related outcome measures
5101298|NCT03364933|Child|child
5101299|NCT03364933|Critical Illness|critical illness
5101300|NCT03364933|Length of Stay|length of stay
5101301|NCT03364933|Satisfaction|satisfaction
5101302|NCT03364920|Maresin-1|maresin-1
5101303|NCT03364920|SAP|sap
5101304|NCT03364920|IPN|ipn
5101305|NCT03364920|MODS|mods
5101306|NCT03364920|Mortality|mortality
5101307|NCT03364907|HIPEC|hipec
5101308|NCT03364907|oxaliplatin|oxaliplatin
5101309|NCT03364907|flushing|flushing
5101310|NCT03364907|peritoneal carcinomatosis|peritoneal carcinomatosis
5961957|NCT04283812|neurological disorders|neurological disorders
5101311|NCT03364894|Parkinson's Disease|parkinson's disease
5101312|NCT03364894|Biomarkers|biomarkers
5101313|NCT03364894|Wearable sensors|wearable sensors
5101314|NCT03364894|Imaging|imaging
5101315|NCT03364894|Disease progression|disease progression
5101316|NCT03364868|Type 1 diabetes|type 1 diabetes
5101317|NCT03364868|T1D|t1d
5101318|NCT03364868|diabetes mellitus|diabetes mellitus
5101319|NCT03364868|oral insulin|oral insulin
5101320|NCT03364868|oral tolerance|oral tolerance
5101321|NCT03364868|autoantigen|autoantigen
5101322|NCT03364868|self tolerance|self tolerance
5101323|NCT03364868|prevention|prevention
5101324|NCT03364868|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
5101325|NCT03364868|juvenile diabetes|juvenile diabetes
5101326|NCT03364868|autoimmune diabetes|autoimmune diabetes
5101327|NCT03364855|Balance|balance
5101328|NCT03364855|Patellofemoral pain syndrome|patellofemoral pain syndrome
5101329|NCT03364855|Star excursion balance test|star excursion balance test
5101330|NCT03364855|Kinesthetic Ability Trainer 2000|kinesthetic ability trainer 2000
5101331|NCT03364816|cervical spondylosis|cervical spondylosis
5101332|NCT03364816|artificial disc replacement|artificial disc replacement
5101333|NCT03364816|complications|complications
4986322|NCT04076995|dehydration|dehydration
5101334|NCT03364816|photographic indicators|photographic indicators
5101335|NCT03364816|functional efficacy|functional efficacy
5101336|NCT03364803|Cushing Syndrome|cushing syndrome
5101337|NCT03364803|Cushing's Disease|cushing's disease
5101338|NCT03364803|Cushing Disease|cushing disease
5101346|NCT03364777|lumbar surgery, emotional state|lumbar surgery, emotional state
5101347|NCT03364764|sirolimus|sirolimus
5101348|NCT03364764|refractory pure red cell aplasia|refractory pure red cell aplasia
5101349|NCT03364764|prospective study|prospective study
5101350|NCT03364751|Oral Health|oral health
5101352|NCT03364751|Cigarette|cigarette
5101353|NCT03364751|Reduced risk product|reduced risk product
5101354|NCT03364751|Tobacco heating system|tobacco heating system
5101355|NCT03364751|THS|ths
5101356|NCT03364751|Modified risk tobacco product|modified risk tobacco product
5101357|NCT03364751|Clinical attachment level|clinical attachment level
5101358|NCT03364699|strenuous exercise|strenuous exercise
5101359|NCT03364699|dietary supplementation|dietary supplementation
5101360|NCT03364699|immune system|immune system
5101361|NCT03364699|leucocyte function|leucocyte function
5101362|NCT03364699|inflammation|inflammation
5101363|NCT03364686|BioRBCs|biorbcs
5101364|NCT03364686|Biotin labeled red blood cells|biotin labeled red blood cells
5101365|NCT03364673|Ovarian Cancer|ovarian cancer
5101366|NCT03364673|Physical Activity|physical activity
5101367|NCT03364673|Mobile Health|mobile health
5101368|NCT03364673|Fitness Tracker|fitness tracker
5101369|NCT03364673|Survivorship|survivorship
5101370|NCT03364673|Quality of Life|quality of life
5101371|NCT03364660|Epidural Stimulation|epidural stimulation
5101372|NCT03364660|Spinal Cord Injury|spinal cord injury
5101373|NCT03364660|Task-Specific|task-specific
5101374|NCT03364634|decompressive craniectomy|decompressive craniectomy
5101375|NCT03364634|intracranial pressure|intracranial pressure
5101377|NCT03364634|telemetry|telemetry
5101378|NCT03364634|telemetric|telemetric
5101379|NCT03364621|Liver resection|liver resection
5101383|NCT03364621|Genomic analysis|genomic analysis
5101384|NCT03364621|Sequencing|sequencing
5101385|NCT03364595|radial head fracture|radial head fracture
5101386|NCT03364595|replacement|replacement
5101387|NCT03364595|plate|plate
5101396|NCT03364517|SPIA|spia
5101397|NCT03364517|Imminent delivery|imminent delivery
5101399|NCT03364504|renal cells|renal cells
5101400|NCT03364504|urine|urine
5101401|NCT03364504|calcification|calcification
5101402|NCT03364504|omics|omics
5101403|NCT03364504|drug screening|drug screening
5101407|NCT03364478|Surgical approach|surgical approach
5101408|NCT03364478|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
5101409|NCT03364452|Dietary Assessment Methodology|dietary assessment methodology
5101410|NCT03364452|beverages|beverages
5101411|NCT03364452|non-nutritive sweeteners|non-nutritive sweeteners
5101412|NCT03364439|DLBCL|dlbcl
5101413|NCT03364387|Acute Coronary Syndrome|acute coronary syndrome
5101414|NCT03364387|MINOCA|minoca
5101415|NCT03364387|Myocardial Infarction|myocardial infarction
5101416|NCT03364387|Atrial Fibrillation|atrial fibrillation
5101417|NCT03364374|Stroke rehabilitation|stroke rehabilitation
5101418|NCT03364374|Upper extremity|upper extremity
5101419|NCT03364374|Posture|posture
5101420|NCT03364309|plaque psoriasis|plaque psoriasis
5101421|NCT03364309|ixekizumab|ixekizumab
5101422|NCT03364309|skin condition|skin condition
5101423|NCT03364309|skin disease|skin disease
5101424|NCT03364309|itching|itching
5101425|NCT03364309|psoriasis vulgaris|psoriasis vulgaris
5101426|NCT03364309|immune-mediated systemic disease|immune-mediated systemic disease
5101427|NCT03364309|skin lesions|skin lesions
5101428|NCT03364309|scaly patches|scaly patches
5101429|NCT03364309|papules|papules
5101430|NCT03364296|Acute stroke, Biomarkers|acute stroke, biomarkers
5101431|NCT03364283|Posterior fossa|posterior fossa
5101432|NCT03364283|Pineal region|pineal region
5101433|NCT03364270|atherosclerosis|atherosclerosis
5101434|NCT03364257|metagenomic|metagenomic
5101435|NCT03364257|infection|infection
5101436|NCT03364257|diagnosis|diagnosis
5101437|NCT03364244|Revatio|revatio
5101438|NCT03364244|Pulmonary arterial hypertension|pulmonary arterial hypertension
5101439|NCT03364244|Pediatric patients|pediatric patients
5101440|NCT03364205|SFA interview technique|sfa interview technique
5101441|NCT03364205|adolescence|adolescence
5101442|NCT03364205|obesity|obesity
5101443|NCT03364205|nutrition|nutrition
5101444|NCT03364205|exercise|exercise
5101445|NCT03364192|Whole Health Coaching|whole health coaching
5101446|NCT03364192|Integrative Health Coaching|integrative health coaching
5101447|NCT03364192|Peer Support Specialist|peer support specialist
5101448|NCT03364192|Personalized Health Plan|personalized health plan
5101449|NCT03364179|dementia|dementia
5101450|NCT03364179|young onset dementia|young onset dementia
5101451|NCT03364179|quality of death|quality of death
5101452|NCT03364179|late onset dementia|late onset dementia
5101453|NCT03364179|palliative care|palliative care
5101454|NCT03364166|buccal squamous cell carcinoma|buccal squamous cell carcinoma
5101455|NCT03364153|Zimura|zimura
5101456|NCT03364153|ARC1905|arc1905
5101457|NCT03364153|complement factor C5 inhibitor|complement factor c5 inhibitor
5101458|NCT03364153|avacincaptad pegol|avacincaptad pegol
5101459|NCT03364153|STGD1|stgd1
5101460|NCT03364140|Peripartum Cardiomyopathy|peripartum cardiomyopathy
5101461|NCT03364140|Heart Failure|heart failure
5101462|NCT03364127|Vulvar Pain, Dyspareunia|vulvar pain, dyspareunia
5101463|NCT03364088|Total knee arthroplasty|total knee arthroplasty
5101464|NCT03364088|Anesthesia|anesthesia
5101465|NCT03364088|Surgical tourniquet|surgical tourniquet
5101466|NCT03364088|Pain|pain
5101467|NCT03364088|Postoperative nausea and vomiting|postoperative nausea and vomiting
5101468|NCT03364088|Quality of life|quality of life
5101469|NCT03364088|Length of stay|length of stay
5101470|NCT03364088|Knee function|knee function
5101471|NCT03364088|Bioelectrical impedance|bioelectrical impedance
5101472|NCT03364088|Knee endoprosthesis|knee endoprosthesis
5101473|NCT03364062|Blood Pressure|blood pressure
5101474|NCT03364062|shoulder replacement|shoulder replacement
5101475|NCT03364062|proximal humeral fracture|proximal humeral fracture
5101479|NCT03364010|Motor control|motor control
5101480|NCT03364010|Proprioception|proprioception
5101482|NCT03363997|pharmacokinetic|pharmacokinetic
5101483|NCT03363997|pharmacodynamic|pharmacodynamic
5101484|NCT03363997|hormone replacement therapy|hormone replacement therapy
5101485|NCT03363997|vaginal ring administration|vaginal ring administration
5101486|NCT03363971|soft tissue, pain|soft tissue, pain
5099166|NCT03378193|FDG PET/CT|fdg pet/ct
5101487|NCT03363958|myocardial protection|myocardial protection
5101488|NCT03363958|remote ischemic preconditioning|remote ischemic preconditioning
5101489|NCT03363958|remote ischemic postconditioning|remote ischemic postconditioning
5101491|NCT03363945|kidney transplant|kidney transplant
5101492|NCT03363945|cellular therapy|cellular therapy
5101493|NCT03363945|anti-rejection therapy|anti-rejection therapy
5101494|NCT03363945|living donor|living donor
5101495|NCT03363945|HLA-matched|hla-matched
5101496|NCT03363945|hematopoietic stem cells (HSC)|hematopoietic stem cells (hsc)
5101497|NCT03363945|CD34+|cd34+
5101498|NCT03363945|CD3+|cd3+
5101499|NCT03363945|T cells|t cells
5101500|NCT03363932|Ventricular septal defect|ventricular septal defect
5101501|NCT03363932|Congenital heart disease|congenital heart disease
5101502|NCT03363932|Outcome|outcome
5101503|NCT03363919|adolescent|adolescent
5101504|NCT03363919|biomarkers|biomarkers
5101505|NCT03363893|Neoplasms|neoplasms
5101506|NCT03363880|Severe trauma|severe trauma
5101507|NCT03363880|Multiple trauma|multiple trauma
5101508|NCT03363880|Regional Trauma management system|regional trauma management system
5101509|NCT03363880|Trauma management team|trauma management team
5101510|NCT03363867|High grade serous|high grade serous
5101511|NCT03363867|Platinum resistant|platinum resistant
5101512|NCT03363867|Recurrent ovarian cancer|recurrent ovarian cancer
5101513|NCT03363841|Candida auris|candida auris
5101514|NCT03363815|Healthy Volunteer|healthy volunteer
5101515|NCT03363815|CC-90001|cc-90001
5101516|NCT03363815|Pharmacokinetics|pharmacokinetics
5101517|NCT03363815|Omeprazole|omeprazole
5101518|NCT03363815|Midazolam|midazolam
5101519|NCT03363815|Warfarin|warfarin
5101520|NCT03363815|Rosuvastatin|rosuvastatin
5101521|NCT03363815|Metformin|metformin
5101522|NCT03363815|Digoxin|digoxin
5101523|NCT03363815|Nintedanib|nintedanib
5101524|NCT03363763|rash|rash
5101525|NCT03363763|fibroma|fibroma
5101526|NCT03363763|skin|skin
5101527|NCT03363763|facial|facial
5101528|NCT03363763|face|face
5101529|NCT03363763|bumps|bumps
5101530|NCT03363763|redness|redness
5101531|NCT03363763|erythema|erythema
5101532|NCT03363763|lesions|lesions
5101533|NCT03363763|papules|papules
5101534|NCT03363763|blood vessel|blood vessel
5101535|NCT03363763|cheeks|cheeks
5101536|NCT03363750|Depression|depression
5101537|NCT03363750|Adolescent|adolescent
5101538|NCT03363750|mind-body-skills|mind-body-skills
5101539|NCT03363750|group therapy|group therapy
5101540|NCT03363750|primary care|primary care
5101541|NCT03363724|Parkinson Disease|parkinson disease
5101542|NCT03363724|Deep Brain Stimulation|deep brain stimulation
5101543|NCT03363724|Microelectrodes recording|microelectrodes recording
5101545|NCT03363724|Alpha Omega Engineering Ltd.|alpha omega engineering ltd.
5101546|NCT03363698|Chronic Cough|chronic cough
5101547|NCT03363698|Upper-Airway Cough Syndrome|upper-airway cough syndrome
5101548|NCT03363698|GERD|gerd
5101549|NCT03363698|Allergic Rhinitis|allergic rhinitis
5101550|NCT03363698|Methacholine Challenge Test|methacholine challenge test
5101551|NCT03363698|Cough Challenge|cough challenge
5101552|NCT03363698|Capsaicin|capsaicin
5101553|NCT03363685|Survival Prediction|survival prediction
5101554|NCT03363685|Spinal Metastases|spinal metastases
5101555|NCT03363685|Non Small Cell Lung Cancer Metastatic|non small cell lung cancer metastatic
5101556|NCT03363672|Chronic Postoperative Pain|chronic postoperative pain
5101557|NCT03363672|Daily Life|daily life
5101558|NCT03363672|Risk Factor|risk factor
5101559|NCT03363659|Glioblastoma|glioblastoma
5101560|NCT03363659|Glioblastoma Multiforme|glioblastoma multiforme
5101561|NCT03363659|Anaplastic Glioma|anaplastic glioma
5101562|NCT03363659|Unmethylated|unmethylated
5101563|NCT03363633|Venous Ulceration|venous ulceration
5101564|NCT03363633|Refluxing Perforator Veins|refluxing perforator veins
5101565|NCT03363620|maxillary expansion|maxillary expansion
5101566|NCT03363620|self ligating|self ligating
5101567|NCT03363620|arch form|arch form
5101568|NCT03363594|Diabetes, T2D|diabetes, t2d
5101569|NCT03363581|Food preferences|food preferences
5101571|NCT03363581|Weight loss|weight loss
5101572|NCT03363529|Dynamic lighting, ipRGC|dynamic lighting, iprgc
5101573|NCT03363503|COPD|copd
5101574|NCT03363503|Salmeterol/Fluticasone|salmeterol/fluticasone
5101575|NCT03363503|Discair|discair
5101576|NCT03363503|Diskus|diskus
5101577|NCT03363503|Spirometry|spirometry
5101578|NCT03363490|Self-Management|self-management
5101579|NCT03363490|Neuromuscular Exercise Therapy|neuromuscular exercise therapy
5101580|NCT03363490|Knee osteoarthritis|knee osteoarthritis
5101581|NCT03363477|antithrombotic|antithrombotic
5101582|NCT03363477|heparin|heparin
5101583|NCT03363477|anticoagulant|anticoagulant
5101584|NCT03363477|low molecular weight heparin|low molecular weight heparin
5101585|NCT03363477|pharmacodynamic equivalence|pharmacodynamic equivalence
5101586|NCT03363425|Dexmedetomidine|dexmedetomidine
5101587|NCT03363425|Lidocaine|lidocaine
5101588|NCT03363425|Postoperative Pain|postoperative pain
5101589|NCT03363425|Analgesic Consumption|analgesic consumption
5101590|NCT03363425|Recovery|recovery
5101591|NCT03363425|Abdominal Gynaecological Surgery|abdominal gynaecological surgery
5101592|NCT03363399|Diagnostic accuracy study|diagnostic accuracy study
5101593|NCT03363399|Flow cytometry analysis|flow cytometry analysis
5101595|NCT03363399|Peripheral blood sample|peripheral blood sample
5101596|NCT03363386|aerobic exercise|aerobic exercise
5101597|NCT03363386|dynamic balance|dynamic balance
5101598|NCT03363386|functional capacity|functional capacity
5101599|NCT03363386|HbA1c|hba1c
5101600|NCT03363386|proprioceptive exercise training|proprioceptive exercise training
5101601|NCT03363373|Antibody, Neuroblastoma, Pediatric, Adult|antibody, neuroblastoma, pediatric, adult
5101602|NCT03363334|ITP|itp
5101603|NCT03363334|Immune Thrombocytopenia|immune thrombocytopenia
5101604|NCT03363321|hemophilia|hemophilia
5101605|NCT03363295|endophthalmitis|endophthalmitis
5101606|NCT03363282|Crosslinking|crosslinking
5101607|NCT03363256|Digital therapeutics|digital therapeutics
5101608|NCT03363256|Adaptation|adaptation
5101609|NCT03363230|mindfulness|mindfulness
5101610|NCT03363230|emotion regulation|emotion regulation
5101611|NCT03363230|impulsivity|impulsivity
5101612|NCT03363217|Glioma|glioma
5101613|NCT03363217|Optic Pathway Glioma|optic pathway glioma
5101614|NCT03363217|Low grade glioma|low grade glioma
5101615|NCT03363217|MAPK/ERK|mapk/erk
5101616|NCT03363217|Plexiform Neurofibroma|plexiform neurofibroma
5101617|NCT03363217|Neurofibromatosis Type 1|neurofibromatosis type 1
5101618|NCT03363217|Central Nervous System|central nervous system
5101619|NCT03363217|CNS|cns
5101620|NCT03363217|Brain Tumor|brain tumor
5101621|NCT03363217|LGG|lgg
5101622|NCT03363217|NF1|nf1
5101623|NCT03363217|KIAA1549-BRAF|kiaa1549-braf
5101624|NCT03363217|Mitogen-activated Protein Kinase (MEK) inhibitor|mitogen-activated protein kinase (mek) inhibitor
5101625|NCT03363217|Trametinib|trametinib
5101626|NCT03363191|fluticasone furoate/vilanterol, efficacy, asthma, Chronic obstructive pulmonary disease|fluticasone furoate/vilanterol, efficacy, asthma, chronic obstructive pulmonary disease
5101627|NCT03363165|PAD|pad
5101628|NCT03363087|Atrial Scar|atrial scar
5101629|NCT03363087|Atrial Fibrillation Ablation|atrial fibrillation ablation
5101630|NCT03363087|Mapping|mapping
5101631|NCT03363087|Persistent Atrial Fibrillation|persistent atrial fibrillation
5101632|NCT03363087|Catheter Ablation|catheter ablation
5101633|NCT03363074|Low-Level Laser Therapy, Orthotic Insoles|low-level laser therapy, orthotic insoles
5101634|NCT03363048|Food restrictions/incentives|food restrictions/incentives
5101635|NCT03363048|Food Stamp program|food stamp program
5101636|NCT03363048|Policy change|policy change
5101637|NCT03363048|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
5101638|NCT03363009|prehabilitation|prehabilitation
5101639|NCT03363009|connected devices|connected devices
5101640|NCT03362996|extra virgin olive oil|extra virgin olive oil
5101641|NCT03362996|mild cognitive impairment|mild cognitive impairment
5101642|NCT03362996|randomized double blind clinical trial|randomized double blind clinical trial
5101643|NCT03362970|Bloody Diarrhea|bloody diarrhea
5101645|NCT03362970|Hematochezia|hematochezia
5101646|NCT03362970|BioFire FilmArray|biofire filmarray
5101647|NCT03362970|Child|child
5101648|NCT03362957|embolization|embolization
5101649|NCT03362957|vascular|vascular
5101650|NCT03362905|Lidocaine|lidocaine
5101651|NCT03362905|Dosage forms|dosage forms
5101652|NCT03362905|Pain scores|pain scores
5101653|NCT03362879|Advanced Parkinson's Disease|advanced parkinson's disease
5101654|NCT03362879|Levodopa-Carbidopa Intestinal Gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
5101655|NCT03362827|Low back pain|low back pain
5101656|NCT03362827|Long-term potentiation|long-term potentiation
5101657|NCT03362827|Hyperalgesia|hyperalgesia
5101658|NCT03362827|Allodynia|allodynia
5101659|NCT03362814|HCV|hcv
5101660|NCT03362814|Ravidasvir|ravidasvir
5101661|NCT03362814|SVR12|svr12
5101662|NCT03362801|physical activity|physical activity
5101663|NCT03362801|elderly|elderly
5101664|NCT03362788|Antithrombotics Antiplatelets Stents Angioplasty|antithrombotics antiplatelets stents angioplasty
5101665|NCT03362762|Type 2 diabetes|type 2 diabetes
5101666|NCT03362762|insulin|insulin
5101667|NCT03362762|Hb1Ac|hb1ac
5101668|NCT03362762|glycemia|glycemia
5101669|NCT03362762|Guadeloupe|guadeloupe
5101670|NCT03362671|OSA|osa
5101671|NCT03362671|Mandibular Advancement Splint|mandibular advancement splint
5101672|NCT03362671|Oral Appliance|oral appliance
5101673|NCT03362671|Treatment|treatment
5101674|NCT03362671|Orthodontic Implants|orthodontic implants
5101675|NCT03362658|Magnetic Resonance Imaging|magnetic resonance imaging
5101676|NCT03362658|MRI|mri
5101677|NCT03362658|Biomarker|biomarker
5101678|NCT03362619|Cervical cancer|cervical cancer
5101679|NCT03362619|Cytotoxic lymphocyte|cytotoxic lymphocyte
5101680|NCT03362619|CC-CTL|cc-ctl
5101681|NCT03362606|Ovarian cancer|ovarian cancer
5101682|NCT03362606|Cytotoxic lymphocyte|cytotoxic lymphocyte
5101683|NCT03362606|OC-CTL|oc-ctl
5101691|NCT03362554|Insulin|insulin
5101692|NCT03362554|Glucose|glucose
5101693|NCT03362554|Rab3|rab3
5101698|NCT03362502|gene therapy, mini-dystrophin, AAV|gene therapy, mini-dystrophin, aav
5101699|NCT03362489|In Vitro Fertilization|in vitro fertilization
5101702|NCT03362476|Human Immunodeficiency Virus|human immunodeficiency virus
5101704|NCT03362476|Computer Intervention|computer intervention
5101705|NCT03362476|Alcoholism|alcoholism
5101706|NCT03362476|Women|women
5101707|NCT03362476|Russia|russia
5101708|NCT03362450|Midgut volvulus|midgut volvulus
5101709|NCT03362450|Fetal volvulus|fetal volvulus
5101710|NCT03362450|Whirlpool sign|whirlpool sign
5101711|NCT03362450|Pregnant women|pregnant women
5101712|NCT03362450|Position of mesenteric vessels|position of mesenteric vessels
5101713|NCT03362450|Post natal surgery|post natal surgery
5101714|NCT03362450|Foetopathology if performed|foetopathology if performed
5101715|NCT03362450|Hydro-meconium level in the dilated loops|hydro-meconium level in the dilated loops
5101716|NCT03362411|Healthy participants|healthy participants
5101717|NCT03362411|Healthy subjects|healthy subjects
5101718|NCT03362385|Obstructive sleep apnea|obstructive sleep apnea
5101719|NCT03362385|Acute coronary syndrome|acute coronary syndrome
5101720|NCT03362385|Continuous positive airway pressure|continuous positive airway pressure
5101721|NCT03362385|Outcome|outcome
5101722|NCT03362359|prostatectomy|prostatectomy
5101723|NCT03362359|68Ga-PSMA-11|68ga-psma-11
5101724|NCT03362359|EPLND|eplnd
5101725|NCT03362346|Wavelet transform|wavelet transform
5101726|NCT03362346|Deep learning|deep learning
5101727|NCT03362307|Low-Level Light Therapy, Osseointegration|low-level light therapy, osseointegration
5101728|NCT03362281|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5101729|NCT03362281|Proton Pump Inhibitor|proton pump inhibitor
5101730|NCT03362255|Optic Nerve Sheath Diameter Injection Speed|optic nerve sheath diameter injection speed
5101731|NCT03362216|soft tissue, pain|soft tissue, pain
5101732|NCT03362203|Conditioned pain modulation, neck pain|conditioned pain modulation, neck pain
5101733|NCT03362190|Zimura|zimura
5101734|NCT03362190|ARC1905|arc1905
5101735|NCT03362190|Lucentis|lucentis
5101736|NCT03362190|ranibizumab|ranibizumab
5101737|NCT03362190|Wet AMD|wet amd
5101738|NCT03362190|avacincaptad pegol|avacincaptad pegol
5101739|NCT03362190|complement factor C5 inhibitor|complement factor c5 inhibitor
5101743|NCT03362164|Fabry|fabry
5101744|NCT03362164|Fibrosis|fibrosis
5101745|NCT03362164|Dialysis|dialysis
5101746|NCT03362164|Stroke|stroke
5101747|NCT03362164|Chronic kidney disease|chronic kidney disease
5101748|NCT03362151|type 1 diabetes|type 1 diabetes
5101749|NCT03362151|pasta|pasta
5101750|NCT03362151|rice|rice
5101751|NCT03362151|protein|protein
5101752|NCT03362151|carbohydrate|carbohydrate
5101753|NCT03362138|melanoma|melanoma
5101754|NCT03362138|dysplastic nevus|dysplastic nevus
5101755|NCT03362138|artificial intelligence|artificial intelligence
5101756|NCT03362138|early diagnosis|early diagnosis
5112291|NCT03295227|Thymic cancer|thymic cancer
5101762|NCT03362073|Refractory cancer pain|refractory cancer pain
5101763|NCT03362073|Terminally ill cancer patients|terminally ill cancer patients
5101765|NCT03362060|Triple Negative Breast Cancer|triple negative breast cancer
5101766|NCT03362060|Vaccine|vaccine
5101767|NCT03362060|Immunotherapy|immunotherapy
5101768|NCT03362060|PD-1 Inhibitor|pd-1 inhibitor
5101769|NCT03362060|Metastatic Breast Cancer|metastatic breast cancer
5101770|NCT03362021|transvaginal oocyte retrieval|transvaginal oocyte retrieval
5101771|NCT03362021|sedation|sedation
5101772|NCT03362021|dexmedetomidine|dexmedetomidine
5101773|NCT03362021|fentanyl|fentanyl
5101774|NCT03362021|remifentanil|remifentanil
5101775|NCT03362021|midazolam|midazolam
5101777|NCT03361969|quality of life|quality of life
5101778|NCT03361969|hot flushes|hot flushes
5101779|NCT03361969|prostate cancer|prostate cancer
5101780|NCT03361969|testosterone|testosterone
5101875|NCT03361345|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
5101876|NCT03361345|Acne|acne
5101781|NCT03361930|spastic unilateral cerebral palsy, ankle-foot orthosis, AFO, muscle activity, muscular activity, electromyography, EMG,|spastic unilateral cerebral palsy, ankle-foot orthosis, afo, muscle activity, muscular activity, electromyography, emg,
5101782|NCT03361917|Colonoscopy screening|colonoscopy screening
5101783|NCT03361917|Colonscopy procedure|colonscopy procedure
5101784|NCT03361878|Metformin|metformin
5101785|NCT03361878|Intolerance|intolerance
5101786|NCT03361878|Pharmacokinetics|pharmacokinetics
5101787|NCT03361865|Urothelial cancer, programmed cell death 1 (PD-1) inhibitor|urothelial cancer, programmed cell death 1 (pd-1) inhibitor
5101788|NCT03361865|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
5101789|NCT03361852|Follicular Lymphoma|follicular lymphoma
5101790|NCT03361826|Magnetic seizure therapy (MST)|magnetic seizure therapy (mst)
5101791|NCT03361826|Treatment resistance|treatment resistance
5101792|NCT03361826|Open-label trial|open-label trial
5101793|NCT03361826|Borderline Personality Disorder|borderline personality disorder
5101794|NCT03361826|Suicidal Ideation|suicidal ideation
5101795|NCT03361826|Treatment-resistant depression|treatment-resistant depression
5101796|NCT03361826|Dialectical behavior therapy (DBT)|dialectical behavior therapy (dbt)
5101797|NCT03361826|MST + DBT|mst + dbt
5101798|NCT03361826|Neuroimaging-based biomarkers|neuroimaging-based biomarkers
5101799|NCT03361800|Breast Cancer|breast cancer
5101800|NCT03361800|ER Negative Breast Cancer|er negative breast cancer
5101801|NCT03361800|Triple Negative Breast Cancer|triple negative breast cancer
5101802|NCT03361800|PR Negative Breast Cancer|pr negative breast cancer
5101803|NCT03361800|ER Positive PR Positive Breast Cancer|er positive pr positive breast cancer
5101804|NCT03361787|adolescents|adolescents
5101805|NCT03361787|parents|parents
5101806|NCT03361787|coaching|coaching
5101807|NCT03361761|Chronic disease|chronic disease
5101808|NCT03361761|precariousness and vulnerability|precariousness and vulnerability
5101809|NCT03361761|Health education|health education
5101810|NCT03361748|Multiple Myeloma|multiple myeloma
5101811|NCT03361748|Efficacy and Safety|efficacy and safety
5101812|NCT03361748|BB2121|bb2121
5101813|NCT03361748|CAR T Cell|car t cell
5101814|NCT03361748|BCMA|bcma
5101815|NCT03361748|Relapsed and Refractory|relapsed and refractory
5101816|NCT03361735|PSA Level Greater than or Equal to 0.2|psa level greater than or equal to 0.2
5101817|NCT03361735|Stage IV Prostate Adenocarcinoma AJCC v7|stage iv prostate adenocarcinoma ajcc v7
5101818|NCT03361683|High-Flow nasal oxygen|high-flow nasal oxygen
5101819|NCT03361618|Uric acid|uric acid
5101820|NCT03361618|Adenosine deaminase|adenosine deaminase
5101821|NCT03361618|Zinc Sulfate|zinc sulfate
5101822|NCT03361618|5'-nucleotidase|5'-nucleotidase
5101823|NCT03361618|Asthenospermia.|asthenospermia.
5101824|NCT03361618|Xanthine oxidase|xanthine oxidase
5101825|NCT03361592|symmetry index, functional performance tests, SMT|symmetry index, functional performance tests, smt
5101826|NCT03361579|Placebo|placebo
5101827|NCT03361566|physical activity|physical activity
5101828|NCT03361566|energy balance|energy balance
5101829|NCT03361566|caloric restriction|caloric restriction
5101830|NCT03361566|overfeeding|overfeeding
5101831|NCT03361566|appetite regulation|appetite regulation
5101832|NCT03361540|Pharmacokinetics|pharmacokinetics
5101833|NCT03361540|Safety|safety
5101834|NCT03361540|ASP8302|asp8302
5101835|NCT03361514|antidepressants, discontinuation, primary care, MBCT|antidepressants, discontinuation, primary care, mbct
5101836|NCT03361501|Omega-3 Fatty acids|omega-3 fatty acids
5101837|NCT03361501|Triglycerides|triglycerides
5101838|NCT03361475|Sharing|sharing
5101839|NCT03361475|Mind|mind
5101840|NCT03361475|Enjoyment|enjoyment
5101841|NCT03361462|Sharing|sharing
5101842|NCT03361462|Mind|mind
5101843|NCT03361462|Enjoyment|enjoyment
5101844|NCT03361410|Mild Decline in Cognition|mild decline in cognition
5101845|NCT03361410|Mild Cognitive Decline|mild cognitive decline
5101846|NCT03361410|Mild Cognitive Impairment|mild cognitive impairment
5101847|NCT03361410|Dementia|dementia
5101848|NCT03361410|Positron Emission Tomography (PET)|positron emission tomography (pet)
5101849|NCT03361410|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
5101850|NCT03361410|Cerebral Metabolism|cerebral metabolism
5101851|NCT03361410|Dietary Supplement|dietary supplement
5101852|NCT03361410|MCI|mci
5101853|NCT03361410|MDC|mdc
5101854|NCT03361410|Grape|grape
5101855|NCT03361410|Memory|memory
5101856|NCT03361410|Randomized|randomized
5101857|NCT03361410|Non-Drug|non-drug
5101858|NCT03361410|Supplement|supplement
5101859|NCT03361410|Non-Pharmacologic|non-pharmacologic
5101860|NCT03361410|Natural|natural
5101861|NCT03361410|Red Wine|red wine
5101862|NCT03361410|Free|free
5101863|NCT03361410|UCLA|ucla
5101864|NCT03361410|Brain Scan|brain scan
5101865|NCT03361410|Alzheimer's Disease|alzheimer's disease
5101866|NCT03361410|Brain Diseases|brain diseases
5101867|NCT03361410|Central Nervous System Diseases|central nervous system diseases
5101868|NCT03361410|Cognition|cognition
5101869|NCT03361410|Cognitive|cognitive
5101870|NCT03361410|Neurocognitive|neurocognitive
5101871|NCT03361410|Neurodegenerative|neurodegenerative
5101872|NCT03361384|men who have sex with men|men who have sex with men
5101873|NCT03361371|Nose suctioning|nose suctioning
5101874|NCT03361371|Pediatric|pediatric
5101877|NCT03361319|NSCLC|nsclc
5101890|NCT03361228|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5101891|NCT03361228|melanoma|melanoma
5101892|NCT03361228|urothelial carcinoma|urothelial carcinoma
5745547|NCT00338026|Prostate|prostate
5356819|NCT01917877|chemotherapy|chemotherapy
5356820|NCT01917864|Autism|autism
5092341|NCT03421808|TMS|tms
5101893|NCT03361228|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5101894|NCT03361228|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5101895|NCT03361228|colorectal cancer (CRC)|colorectal cancer (crc)
5101896|NCT03361228|arginase 1 inhibitor|arginase 1 inhibitor
5101897|NCT03361228|indoleamine 2,3-dioxygenase 1 inhibitor|indoleamine 2,3-dioxygenase 1 inhibitor
5101898|NCT03361228|programmed death-1 receptor (PD-1) inhibitor|programmed death-1 receptor (pd-1) inhibitor
5101899|NCT03361215|Disease progression|disease progression
5101900|NCT03361215|Disease course|disease course
5101901|NCT03361215|Immunological characterization|immunological characterization
5101902|NCT03361189|Congenital heart disease|congenital heart disease
5101903|NCT03361189|Pacemaker|pacemaker
5101904|NCT03361189|Sinus node dysfunction|sinus node dysfunction
5101911|NCT03361163|Controlled human infection model|controlled human infection model
5101912|NCT03361163|Challenge study|challenge study
5101913|NCT03361150|prehabilitation|prehabilitation
5101914|NCT03361111|severe asthma|severe asthma
5101916|NCT03361111|periostin|periostin
5101917|NCT03361111|induced sputum,|induced sputum,
5101918|NCT03361111|exhaled breath condensate|exhaled breath condensate
5101919|NCT03361098|SGLT2 inhibition; dapagliflozin|sglt2 inhibition; dapagliflozin
5101920|NCT03361098|GLP-1 receptor agonist; exenatide|glp-1 receptor agonist; exenatide
5101921|NCT03361098|Central satiety and reward circuits|central satiety and reward circuits
5101922|NCT03361098|bodyweight|bodyweight
5101924|NCT03361085|non-ventilator-associated hospital acquired pneumonia|non-ventilator-associated hospital acquired pneumonia
5101925|NCT03361085|Hospital-acquired Pneumonia|hospital-acquired pneumonia
5101926|NCT03361085|Healthcare Associated Infection|healthcare associated infection
5101927|NCT03361085|Adherence|adherence
5101928|NCT03361085|infection prevention|infection prevention
5101929|NCT03361085|implementation|implementation
5101930|NCT03361072|oral immunotherapy|oral immunotherapy
5101931|NCT03361072|milk|milk
5101932|NCT03361072|peanut|peanut
5101933|NCT03361072|egg|egg
5101934|NCT03361072|adult|adult
5101935|NCT03361059|risk factors|risk factors
5101936|NCT03361059|elderly patients|elderly patients
5101937|NCT03361059|risk of falling|risk of falling
5101938|NCT03361046|TAVI|tavi
5101939|NCT03361046|valve-in-valve|valve-in-valve
5101940|NCT03361046|aortic stenosis|aortic stenosis
5101941|NCT03361033|Survivorship|survivorship
5101942|NCT03361033|Social Functioning|social functioning
5101943|NCT03361033|Social Outcomes|social outcomes
5101944|NCT03361007|TAVI|tavi
5101945|NCT03361007|common carotid artery|common carotid artery
5101946|NCT03360955|Extubation|extubation
5101947|NCT03360955|Cardiac Surgery|cardiac surgery
5101949|NCT03360916|high cholesterol|high cholesterol
5101950|NCT03360916|exercise|exercise
5101951|NCT03360916|statins|statins
5101952|NCT03360890|thyroid cancer|thyroid cancer
5101953|NCT03360890|salivary gland cancer|salivary gland cancer
5101956|NCT03360864|Therapeutic education|therapeutic education
5101957|NCT03360812|Medical Students|medical students
5101958|NCT03360812|Education|education
5101959|NCT03360812|Prognosis|prognosis
5101960|NCT03360812|Online training resource|online training resource
5101961|NCT03360786|sport concussion|sport concussion
5101962|NCT03360786|cervical spine|cervical spine
5101963|NCT03360786|youth|youth
5101964|NCT03360760|osteosarcoma|osteosarcoma
5101965|NCT03360760|pelvis|pelvis
5101966|NCT03360760|sacrum|sacrum
5961958|NCT04283812|stereotactic instruments|stereotactic instruments
5101967|NCT03360747|Familial Lipoprotein Lipase Deficiency|familial lipoprotein lipase deficiency
5101968|NCT03360747|Hyperlipoproteinemias|hyperlipoproteinemias
5101969|NCT03360747|Familial Hyperlipoproteinemia Type 1|familial hyperlipoproteinemia type 1
5101970|NCT03360747|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
5101971|NCT03360747|Hyperchylomicronemia, Familial|hyperchylomicronemia, familial
5101972|NCT03360747|Lipoprotein Lipase Deficiency, Familial|lipoprotein lipase deficiency, familial
5101973|NCT03360747|Hyperlipidemias|hyperlipidemias
5101974|NCT03360747|Dyslipidemias|dyslipidemias
5101975|NCT03360747|Lipid Metabolism Disorders|lipid metabolism disorders
5101976|NCT03360747|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5101977|NCT03360747|Metabolic Diseases|metabolic diseases
5101978|NCT03360747|Metabolism, Inborn Errors|metabolism, inborn errors
5101979|NCT03360747|Genetic Diseases, Inborn|genetic diseases, inborn
5101980|NCT03360721|mCRPC|mcrpc
5101981|NCT03360721|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5101982|NCT03360721|nonsteroidal antiandrogen|nonsteroidal antiandrogen
5101983|NCT03360721|androgen signaling|androgen signaling
5101984|NCT03360695|Cancer Care|cancer care
5101985|NCT03360695|Major Depression and Cancer|major depression and cancer
5101986|NCT03360695|Schizophrenia and Cancer|schizophrenia and cancer
5101987|NCT03360695|Bipolar Disorder and Cancer|bipolar disorder and cancer
5101988|NCT03360695|Lung Cancer|lung cancer
5101989|NCT03360695|Breast Cancer|breast cancer
5101990|NCT03360695|Head and Neck Cancer|head and neck cancer
5101991|NCT03360695|Gastrointestinal Cancer|gastrointestinal cancer
5101992|NCT03360695|Schizophrenia|schizophrenia
5101993|NCT03360695|Bipolar Disorder|bipolar disorder
5102004|NCT03360617|Piggyback|piggyback
5102005|NCT03360617|Antibiotics|antibiotics
5102006|NCT03360617|Beta Lactam|beta lactam
5102007|NCT03360617|Infection|infection
5102008|NCT03360604|glycaemic index|glycaemic index
5102009|NCT03360604|glycaemia|glycaemia
5102010|NCT03360604|diabetes mellitus|diabetes mellitus
5102011|NCT03360604|type 2 diabetes|type 2 diabetes
5102012|NCT03360565|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
5102013|NCT03360526|PICSI|picsi
5102014|NCT03360526|ORP|orp
5102015|NCT03360526|TESA|tesa
5102016|NCT03360526|seminal oxidation reduction potential|seminal oxidation reduction potential
5102017|NCT03360513|Orthodontics|orthodontics
5102018|NCT03360513|Dental arch|dental arch
5102019|NCT03360513|Orthodontic appliance design.|orthodontic appliance design.
5102020|NCT03360500|Osteoarthritis, Knee|osteoarthritis, knee
5102021|NCT03360500|Cryotherapy|cryotherapy
5102022|NCT03360500|Exercise|exercise
5102023|NCT03360500|Physiotherapy|physiotherapy
5102024|NCT03360500|Knee|knee
5102025|NCT03360448|Gene Transfer|gene transfer
5102026|NCT03360422|MSM, young adult|msm, young adult
5102027|NCT03360409|Cervical Disc Degeneration|cervical disc degeneration
5102028|NCT03360409|cervical anterior discectomy|cervical anterior discectomy
5102029|NCT03360409|Spinal alignment|spinal alignment
5102030|NCT03360396|severe heterogeneous emphysema|severe heterogeneous emphysema
5102031|NCT03360396|severe homogeneous emphysema|severe homogeneous emphysema
5102032|NCT03360383|Spinal Fractures/surgery|spinal fractures/surgery
5102033|NCT03360383|Vertebroplasty|vertebroplasty
5102034|NCT03360383|Quality-Adjusted Life Years|quality-adjusted life years
5102035|NCT03360370|Neurodevelopmental disorders,|neurodevelopmental disorders,
5102036|NCT03360370|Congenital heart disease|congenital heart disease
5102037|NCT03360370|Children|children
5102038|NCT03360344|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape|carpal tunnel syndrome, forearm wrist hand pain, kinesio tape
5102039|NCT03360318|pediatric|pediatric
5102040|NCT03360318|elbow fractures|elbow fractures
5102041|NCT03360318|management|management
5102042|NCT03360305|emergency department|emergency department
5102043|NCT03360305|prevention|prevention
5102044|NCT03360305|transitions of care|transitions of care
5102058|NCT03360214|Tissue expander|tissue expander
5102059|NCT03360214|PEMF|pemf
5102060|NCT03360214|PIB|pib
5102061|NCT03360201|Africa|africa
5102062|NCT03360201|Kenya|kenya
5102063|NCT03360201|Family relations|family relations
5102064|NCT03360201|Child mental health|child mental health
5102065|NCT03360201|Adolescent mental health|adolescent mental health
5102066|NCT03360201|Family therapy|family therapy
5102070|NCT03360201|Domestic Violence|domestic violence
5102071|NCT03360201|Parenting|parenting
5102072|NCT03360201|Parent-Child Relations|parent-child relations
5102073|NCT03360201|child abuse|child abuse
5102074|NCT03360201|low- and middle-income country|low- and middle-income country
5102075|NCT03360149|Hemophilia pregnant|hemophilia pregnant
5102076|NCT03360149|Hemophilia delivery|hemophilia delivery
5102077|NCT03360149|Hemophilia children|hemophilia children
5102078|NCT03360136|Exhaustion Disorder|exhaustion disorder
5102079|NCT03360136|Burnout|burnout
5102080|NCT03360136|Clinical Burnout|clinical burnout
5102081|NCT03360097|In vitro Fertilization|in vitro fertilization
5745548|NCT00338013|sleep|sleep
5102082|NCT03360097|Slow Developing Blastocyst|slow developing blastocyst
5102083|NCT03360097|Fresh Embryo Transfer|fresh embryo transfer
5102084|NCT03360097|Frozen Embryo Transfer|frozen embryo transfer
4972979|NCT04160871|dbt|dbt
5102085|NCT03360097|Live Birth Rate|live birth rate
5102086|NCT03360084|CT|ct
5102087|NCT03360084|Interventional radiology|interventional radiology
5102088|NCT03360084|Lung biopsy|lung biopsy
5102089|NCT03360084|Transthoracic biopsy|transthoracic biopsy
5102090|NCT03360084|Systemic air embolism|systemic air embolism
5102091|NCT03360058|motivational techniques|motivational techniques
5102092|NCT03360058|primary care|primary care
5102093|NCT03360032|Incremental shuttle walk test|incremental shuttle walk test
5099796|NCT03374371|intravascular device|intravascular device
5102096|NCT03360006|Castrate-Resistant Prostate Cancer (CRPC)|castrate-resistant prostate cancer (crpc)
5102097|NCT03360006|Metastatic Castrate-Resistant Prostate Cancer (CRPC)|metastatic castrate-resistant prostate cancer (crpc)
5102099|NCT03360006|Relapsing acute myeloid leukemia|relapsing acute myeloid leukemia
5102100|NCT03360006|Remitting acute myeloid leukemia|remitting acute myeloid leukemia
5102101|NCT03360006|Dose-limiting toxicity|dose-limiting toxicity
5102102|NCT03360006|Recommended phase two dose|recommended phase two dose
5102103|NCT03360006|Pharmacokinetics|pharmacokinetics
5102107|NCT03359941|Integrative Treatments|integrative treatments
5102108|NCT03359941|Korean Traditional medicine|korean traditional medicine
5102109|NCT03359915|COPD|copd
5102110|NCT03359915|Self-Management|self-management
5102111|NCT03359915|Action Plan|action plan
5102112|NCT03359915|SGRQ|sgrq
5102113|NCT03359915|LMIC|lmic
5102114|NCT03359915|COPD Diagnosis|copd diagnosis
5102115|NCT03359902|Mild Cognitive Impairment|mild cognitive impairment
5102116|NCT03359902|Vagal Nerve Stimulation|vagal nerve stimulation
5102117|NCT03359902|tVNS|tvns
5102118|NCT03359902|Alzheimer's disease|alzheimer's disease
5102119|NCT03359876|Real-world study|real-world study
5102120|NCT03359876|Atrial fibrillation|atrial fibrillation
5102121|NCT03359876|Renal dysfunction|renal dysfunction
5102122|NCT03359876|Rivaroxaban|rivaroxaban
5102123|NCT03359876|Warfarin|warfarin
5102124|NCT03359824|exercise, brown adipose tissue|exercise, brown adipose tissue
5102125|NCT03359811|Local Anesthetic Solution|local anesthetic solution
5102126|NCT03359811|Bupivacaine HCl|bupivacaine hcl
5102127|NCT03359811|Liposomal Bupivacaine|liposomal bupivacaine
5102128|NCT03359811|Peritoneal Cancer|peritoneal cancer
5102129|NCT03359785|Drug therapy|drug therapy
5102130|NCT03359772|Neuropathic Pain|neuropathic pain
5102131|NCT03359772|Balance|balance
5102132|NCT03359772|Kinesthetic Ability Trainer|kinesthetic ability trainer
5102139|NCT03359694|breast cancer, neoadjuvant chemotherapy,susceptible gene|breast cancer, neoadjuvant chemotherapy,susceptible gene
5102140|NCT03359655|misoprostol|misoprostol
5102141|NCT03359655|hyoscine butyl bromide|hyoscine butyl bromide
5102142|NCT03359655|cervical dilatation|cervical dilatation
5102143|NCT03359655|cervical ripening|cervical ripening
5102144|NCT03359655|hysteroscopy|hysteroscopy
5102145|NCT03359655|pain|pain
5102146|NCT03359642|Microbiota|microbiota
5102147|NCT03359642|inflammatory bowel disease|inflammatory bowel disease
5102148|NCT03359642|inflammation|inflammation
5102149|NCT03359642|anti-TNF alpha|anti-tnf alpha
5102150|NCT03359629|Spectrophon|spectrophon
5102151|NCT03359629|Glucose|glucose
5102152|NCT03359629|Biosensor|biosensor
5102153|NCT03359629|Non-invasive testing|non-invasive testing
5102154|NCT03359616|rectal cancer|rectal cancer
5102155|NCT03359616|laparoscopic surgery|laparoscopic surgery
5102156|NCT03359616|total mesorectal excision|total mesorectal excision
5102157|NCT03359616|transanal surgery|transanal surgery
5102158|NCT03359603|Electro-acupuncture|electro-acupuncture
5102159|NCT03359603|Knee osteoarthritis|knee osteoarthritis
5102160|NCT03359603|Treatment frequency|treatment frequency
5102161|NCT03359577|Chronic plaque psoriasis|chronic plaque psoriasis
5102179|NCT03359473|post-menopausal|post-menopausal
5102180|NCT03359473|selective androgen receptor modulator|selective androgen receptor modulator
5102181|NCT03359447|infant|infant
5102182|NCT03359447|primary prevention|primary prevention
5102191|NCT03359408|Health care|health care
5102192|NCT03359408|Dementia care|dementia care
5102193|NCT03359408|Collaborative care|collaborative care
5102194|NCT03359408|Discharge management|discharge management
5102195|NCT03359408|Hospital|hospital
5102196|NCT03359408|Primary care|primary care
5102198|NCT03359356|alopecia|alopecia
5102199|NCT03359356|alopecia areata|alopecia areata
5102200|NCT03359356|alopecia universalis|alopecia universalis
5102201|NCT03359356|alopecia totalis|alopecia totalis
5102202|NCT03359356|dupixent|dupixent
5102203|NCT03359356|dupilumab|dupilumab
5163722|NCT02969577|ADT|adt
5102204|NCT03359330|Peripheral nervous system diseases|peripheral nervous system diseases
5102205|NCT03359330|Wounds and injuries|wounds and injuries
5102206|NCT03359330|Nerve regeneration|nerve regeneration
5102207|NCT03359330|Biocompatible materials|biocompatible materials
5102208|NCT03359330|Surgical procedures|surgical procedures
5102209|NCT03359317|Osteoporosis|osteoporosis
5102210|NCT03359317|Bone Diseases|bone diseases
5102211|NCT03359304|bone tumor|bone tumor
5102212|NCT03359291|macitentan|macitentan
5102213|NCT03359291|rosuvastatin|rosuvastatin
5102214|NCT03359291|pharmacokinetics|pharmacokinetics
5961959|NCT04283786|bisphosphonates|bisphosphonates
5102215|NCT03359278|distal radius fracture, sigmoid notch|distal radius fracture, sigmoid notch
5102216|NCT03359252|coil embolization|coil embolization
5102217|NCT03359252|headache|headache
5102219|NCT03359239|PGV001|pgv001
5102220|NCT03359239|atezolizumab|atezolizumab
5102221|NCT03359239|urothelial cancer|urothelial cancer
5102223|NCT03359187|Radiation- induced mucositis|radiation- induced mucositis
5102225|NCT03359187|Radiation therapy side effect|radiation therapy side effect
5102226|NCT03359161|ambulatory|ambulatory
5102227|NCT03359161|Subcutaneous|subcutaneous
5102228|NCT03359161|furosemide|furosemide
5102229|NCT03359148|Nosocomial infection|nosocomial infection
5102230|NCT03359148|Ventilator system|ventilator system
5102231|NCT03359148|Closed suction system|closed suction system
5102232|NCT03359148|Open suction system|open suction system
5102233|NCT03359148|Bacterial contamination|bacterial contamination
5102234|NCT03359135|Compression garment|compression garment
5102235|NCT03359096|Sleep apnea|sleep apnea
5102236|NCT03359096|Tongue stimulation|tongue stimulation
5102237|NCT03359096|Cardiovascular function|cardiovascular function
5102238|NCT03359083|foot-ankle characteristic|foot-ankle characteristic
5102239|NCT03359083|lumbopelvic control|lumbopelvic control
5102240|NCT03359083|balance|balance
5102241|NCT03359083|physical performance|physical performance
5102242|NCT03359070|Tinea cruris|tinea cruris
5102243|NCT03359070|dapaconazole|dapaconazole
5102244|NCT03359070|topical antifungal|topical antifungal
5102245|NCT03359070|dermatophytoses|dermatophytoses
5102246|NCT03359057|Folic acid|folic acid
5102247|NCT03359057|Supplementation|supplementation
5102248|NCT03359057|Ethinyl estradiol|ethinyl estradiol
5102249|NCT03359057|Levonorgestrel|levonorgestrel
5102250|NCT03359057|Oral contraceptive|oral contraceptive
5102255|NCT03359018|advanced|advanced
5102256|NCT03359018|apatinib|apatinib
5102257|NCT03359018|PD-1|pd-1
5102258|NCT03359005|Ewing Sarcoma|ewing sarcoma
5102259|NCT03359005|Irinotecan|irinotecan
5102260|NCT03359005|Temozolomide|temozolomide
5102261|NCT03358992|CESOFB|cesofb
5102262|NCT03358992|clinical evaluation|clinical evaluation
5102263|NCT03358992|RECIST|recist
5102264|NCT03358992|histological response|histological response
5102271|NCT03358979|CD147|cd147
5102272|NCT03358966|chronic kidney disease|chronic kidney disease
5102273|NCT03358966|energy expenditure|energy expenditure
5102274|NCT03358966|metabolic rate|metabolic rate
5102275|NCT03358953|electronic cigarettes|electronic cigarettes
5102276|NCT03358953|cardiovascular|cardiovascular
5102277|NCT03358953|nicotine replacement patches|nicotine replacement patches
5102278|NCT03358940|Non-medical abortion|non-medical abortion
5102279|NCT03358940|Misoprostol|misoprostol
5102280|NCT03358940|miscarriage complications|miscarriage complications
5102281|NCT03358940|Guadeloupe|guadeloupe
5102282|NCT03358927|HIV/AIDS|hiv/aids
5102283|NCT03358927|Fast-track care|fast-track care
5102284|NCT03358927|Behavioral economics|behavioral economics
5102285|NCT03358927|Differentiated care|differentiated care
5102286|NCT03358914|psoriasis, adolescents, quality of life, PRO (patient-reported outcome), validation|psoriasis, adolescents, quality of life, pro (patient-reported outcome), validation
5102287|NCT03358862|myopia|myopia
5102288|NCT03358862|progressive myopia|progressive myopia
5102289|NCT03358862|contact lenses|contact lenses
5102290|NCT03358862|extended depth of focus|extended depth of focus
5102291|NCT03358862|retrospective clinical series|retrospective clinical series
5102292|NCT03358862|axial length|axial length
5102293|NCT03358862|refractive error|refractive error
5102294|NCT03358836|Hemophilia B|hemophilia b
5102296|NCT03358836|Factor IX|factor ix
5102297|NCT03358836|Factor 9|factor 9
5102298|NCT03358823|AS database ; Brain Image;Neural-EEG Data|as database ; brain image;neural-eeg data
5102299|NCT03358797|Community-based Intervention|community-based intervention
5102300|NCT03358797|Lifestyle intervention|lifestyle intervention
5102301|NCT03358797|Diabetes prevention|diabetes prevention
5102302|NCT03358797|Leadership|leadership
5102303|NCT03358797|Resilience|resilience
5102304|NCT03358797|Women's health|women's health
5102305|NCT03358784|Humeral Fractures, Proximal|humeral fractures, proximal
5102306|NCT03358784|Arthroplasty, Shoulder Replacement|arthroplasty, shoulder replacement
5102307|NCT03358784|Bone Plates|bone plates
5102308|NCT03358771|COPD|copd
5102309|NCT03358771|AECOPD|aecopd
5102310|NCT03358771|Discharge care bundle|discharge care bundle
5102311|NCT03358771|Patient Care Bundles|patient care bundles
5102312|NCT03358758|Trauma|trauma
5102313|NCT03358758|War-Related Injuries|war-related injuries
5102314|NCT03358758|Firearm|firearm
5102315|NCT03358758|Explosion|explosion
5102316|NCT03358758|Bomb|bomb
5102317|NCT03358758|Ordnance|ordnance
5102318|NCT03358758|IED|ied
5102319|NCT03358758|Epidemiology|epidemiology
5102320|NCT03358758|Public Health|public health
5102321|NCT03358745|Type 2 diabetes risk|type 2 diabetes risk
5102322|NCT03358745|Cardiovascular disease risk|cardiovascular disease risk
5102323|NCT03358732|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, IVF|embryo transfer, mock embryo transfer, endometrial receptivity, endometrial scratching, ivf
5961960|NCT04283786|systematic review|systematic review
5102324|NCT03358667|peri-implant soft tissue augmentation|peri-implant soft tissue augmentation
5102325|NCT03358654|Umbilical Cord Bleeding|umbilical cord bleeding
5102326|NCT03358654|Knee Osteoarthritis|knee osteoarthritis
5102349|NCT03358472|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
5102350|NCT03358472|indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor|indoleamine 2,3-dioxygenase 1 (ido1) inhibitor
5102351|NCT03358459|phenotype; genotype|phenotype; genotype
5102352|NCT03358446|central catheterization|central catheterization
5102362|NCT03358355|unacylated ghrelin|unacylated ghrelin
5102363|NCT03358355|Peripheral Artery Disease|peripheral artery disease
5102364|NCT03358329|corticosteroid|corticosteroid
5102365|NCT03358329|implant|implant
5102366|NCT03358316|Rotator Cuff Tear|rotator cuff tear
5102367|NCT03358316|Magnetic Resonance Imaging|magnetic resonance imaging
5102368|NCT03358316|humeral migration|humeral migration
5102369|NCT03358303|telemonitoring|telemonitoring
5102370|NCT03358303|smartphone application|smartphone application
5102371|NCT03358290|JTE-051|jte-051
5102372|NCT03358290|Psoriasis|psoriasis
5102373|NCT03358264|Vascular dysfunction, L-citrulline, arginase|vascular dysfunction, l-citrulline, arginase
5102374|NCT03358225|Hybrid surgery,ACDF,C-ADR,bi-level cervical spondylosis|hybrid surgery,acdf,c-adr,bi-level cervical spondylosis
5102375|NCT03358212|giant cell tumor of bone|giant cell tumor of bone
5102376|NCT03358212|Denosumab|denosumab
5102377|NCT03358212|post-operative|post-operative
5102378|NCT03358199|LOD|lod
5102379|NCT03358199|PCOS|pcos
5102380|NCT03358199|AMH|amh
5102381|NCT03358199|OHSS|ohss
5102382|NCT03358186|Periprosthetic Fractures|periprosthetic fractures
5102383|NCT03358186|Arthroplasty|arthroplasty
5102384|NCT03358186|Surgical procedures|surgical procedures
5102385|NCT03358173|Humeral Fractures|humeral fractures
5102386|NCT03358173|plate|plate
5102387|NCT03358173|Conservative Treatment|conservative treatment
5102388|NCT03358134|Peripheral Spondylarthropathies|peripheral spondylarthropathies
5102389|NCT03358134|Psoriatic arthritis|psoriatic arthritis
5102390|NCT03358134|Reactive arthritis|reactive arthritis
5102391|NCT03358056|Mindfulness|mindfulness
5102392|NCT03358056|Emotion|emotion
5102393|NCT03358056|Mindfulenss-based cognitive therapy|mindfulenss-based cognitive therapy
5102394|NCT03358043|respiratory failure|respiratory failure
5102395|NCT03358043|mechanical ventilation|mechanical ventilation
5102396|NCT03358043|prevalence|prevalence
5102397|NCT03358017|Triple negative breast cancer|triple negative breast cancer
5102398|NCT03358017|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5102399|NCT03358017|p53|p53
5102400|NCT03358017|Zoledronate|zoledronate
5102401|NCT03358017|Atorvastatin|atorvastatin
5102402|NCT03358017|Mevalonate pathway inhibitors|mevalonate pathway inhibitors
5102403|NCT03358017|Hippo pathway|hippo pathway
5102404|NCT03358004|TNBC|tnbc
5102405|NCT03358004|metronomic chemotherapy|metronomic chemotherapy
5102406|NCT03358004|vinorelbine|vinorelbine
5102407|NCT03358004|capecitabine|capecitabine
5102408|NCT03357991|E6/E7 mRNA|e6/e7 mrna
5102409|NCT03357991|anal cancer screening|anal cancer screening
5102410|NCT03357991|men who have sex with men|men who have sex with men
5102411|NCT03357991|cost-effectiveness analysis|cost-effectiveness analysis
5102412|NCT03357991|High resolution anoscopy|high resolution anoscopy
5102413|NCT03357978|immunodeficiency|immunodeficiency
5102414|NCT03357978|liver disease|liver disease
5102415|NCT03357978|cancer risk|cancer risk
5102416|NCT03357965|maternal infant bonding|maternal infant bonding
5102417|NCT03357965|depression|depression
5102418|NCT03357965|anxiety|anxiety
5102419|NCT03357939|HLX03|hlx03
5102420|NCT03357939|adalimumab|adalimumab
5102431|NCT03357835|software|software
5102432|NCT03357835|emergency|emergency
5102433|NCT03357822|Chronic hepatitis B|chronic hepatitis b
5102434|NCT03357822|Nucleoside analog|nucleoside analog
5102435|NCT03357822|Pegylated Interferon|pegylated interferon
5102436|NCT03357822|Sequential combination therapy|sequential combination therapy
5102437|NCT03357822|HBsAg loss|hbsag loss
5102438|NCT03357796|Depressive Disorder, Major|depressive disorder, major
5102439|NCT03357796|Depressive Disorder|depressive disorder
5102440|NCT03357796|Mood Disorders|mood disorders
5102441|NCT03357796|Mental Disorders|mental disorders
5102442|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate
5112982|NCT03290638|Ridge Preservation|ridge preservation
5102445|NCT03357796|Membrane Transport Modulators|membrane transport modulators
5102446|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5102447|NCT03357796|Neurotransmitter Agents|neurotransmitter agents
5102448|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs
5102449|NCT03357796|Antidepressive Agents|antidepressive agents
5102450|NCT03357796|Psychotropic Drugs|psychotropic drugs
5102451|NCT03357783|Frequency|frequency
5102452|NCT03357783|Macroscopic|macroscopic
5102453|NCT03357783|Deciduosis|deciduosis
5102454|NCT03357783|Ovarian|ovarian
5102455|NCT03357783|Neoplasm|neoplasm
5102456|NCT03357783|Pregnancy|pregnancy
5103544|NCT03349840|Ramadan|ramadan
5102457|NCT03357770|mesenchymal stem cells|mesenchymal stem cells
5102458|NCT03357770|Knee Osteoarthritis|knee osteoarthritis
5102459|NCT03357770|Umbilical Cord|umbilical cord
5102460|NCT03357744|distress|distress
5102461|NCT03357744|assessment methods|assessment methods
5102462|NCT03357718|premedication|premedication
5102463|NCT03357705|alveolar ridge preservation|alveolar ridge preservation
5102464|NCT03357692|all on four; piezoelectric; implant; trans-sinusal|all on four; piezoelectric; implant; trans-sinusal
5102465|NCT03357679|Bed up head elevated position|bed up head elevated position
5102466|NCT03357679|Glidescope assisted tracheal intubation|glidescope assisted tracheal intubation
5102467|NCT03357679|Laryngeal exposure|laryngeal exposure
5102468|NCT03357679|Time to intubation|time to intubation
5102469|NCT03357653|proteinuria|proteinuria
5102470|NCT03357653|progression|progression
5102471|NCT03357653|early immunoglobulin A (IgA) nephropathy|early immunoglobulin a (iga) nephropathy
5102472|NCT03357627|Drug therapy|drug therapy
5102473|NCT03357601|High Intensity Interval|high intensity interval
5102474|NCT03357601|Moderate Endurance Exercise|moderate endurance exercise
5102475|NCT03357601|Fat Loss|fat loss
5102476|NCT03357601|Endurance Capacity|endurance capacity
5102477|NCT03357575|Knee Osteoarthritis|knee osteoarthritis
5102478|NCT03357575|adipose|adipose
5102479|NCT03357575|mesenchymal stem cells|mesenchymal stem cells
5102480|NCT03357562|Cystic fibrosis|cystic fibrosis
5102481|NCT03357562|CT|ct
5102482|NCT03357562|MRI|mri
5102483|NCT03357562|radiation dose|radiation dose
5102484|NCT03357562|contrast agent|contrast agent
5102485|NCT03357549|Breast Feeding|breast feeding
5102486|NCT03357549|Motivational Interviewing|motivational interviewing
5102487|NCT03357549|Self Efficacy|self efficacy
5102488|NCT03357497|colorectal surgery, early mobilization, postoperative care|colorectal surgery, early mobilization, postoperative care
5102489|NCT03357484|impacted tooth|impacted tooth
5102490|NCT03357484|pain|pain
5102491|NCT03357484|platelet-rich fibrin|platelet-rich fibrin
5102492|NCT03357484|third molar|third molar
5102493|NCT03357484|tooth extraction|tooth extraction
5102494|NCT03357484|wound healing|wound healing
5102495|NCT03357471|Certolizumab Pegol|certolizumab pegol
5102496|NCT03357471|E-Device|e-device
5102497|NCT03357458|Family Integrated Care|family integrated care
5102498|NCT03357458|Parenting education|parenting education
5102499|NCT03357458|Nursing|nursing
5102500|NCT03357458|Cost effectiveness|cost effectiveness
5102501|NCT03357458|Patient engagement|patient engagement
5102502|NCT03357458|Randomized controlled trial|randomized controlled trial
5102503|NCT03357458|Neonatal intensive care unit|neonatal intensive care unit
5102504|NCT03357445|Total hip Arthroplasty|total hip arthroplasty
5102505|NCT03357445|Hip implant|hip implant
5102506|NCT03357432|collagen|collagen
5102507|NCT03357432|gelatin|gelatin
5102508|NCT03357432|PINP|pinp
5102510|NCT03357406|piezoelectric|piezoelectric
5102511|NCT03357406|drills|drills
5102512|NCT03357406|immediate loading|immediate loading
5102513|NCT03357341|electronic health record|electronic health record
5102514|NCT03357341|Pilot|pilot
5102515|NCT03357341|COPD|copd
5102516|NCT03357341|Sensor|sensor
5102517|NCT03357341|Asthma|asthma
5102518|NCT03357328|Phototherapy|phototherapy
5102519|NCT03357328|Nursing home|nursing home
5102520|NCT03357328|Light therapy|light therapy
5102521|NCT03357250|biomarkers|biomarkers
5102522|NCT03357185|Femoral bifurcation|femoral bifurcation
5102523|NCT03357185|Peripheral arterial disease|peripheral arterial disease
5102524|NCT03357185|Vascular surgery|vascular surgery
5102525|NCT03357185|Eversion|eversion
5102526|NCT03357185|Open surgery|open surgery
5102527|NCT03357172|Immune recovery|immune recovery
5102528|NCT03357172|Immunomodulatory cells|immunomodulatory cells
5102529|NCT03357172|GVHD|gvhd
5102530|NCT03357172|GVL|gvl
5102531|NCT03357159|anti thymocyte globulin|anti thymocyte globulin
5102532|NCT03357159|cyclophospamide|cyclophospamide
5102533|NCT03357159|graft-versus-host disease|graft-versus-host disease
5102534|NCT03357159|stem cell transplantation|stem cell transplantation
5102535|NCT03357120|Breast Cancer|breast cancer
5113084|NCT03290066|Kinesio Taping|kinesio taping
5102537|NCT03357120|Circulating tumor DNA|circulating tumor dna
5102538|NCT03357094|Pulmonary ventilation|pulmonary ventilation
5102539|NCT03357094|Pulmonary perfusion|pulmonary perfusion
5102540|NCT03357094|Single Photon Emission Computed Tomography|single photon emission computed tomography
5102541|NCT03357055|tourniquet, pain, ketamine|tourniquet, pain, ketamine
5102542|NCT03357029|Chronic pancreatitis|chronic pancreatitis
5102543|NCT03357029|Vagal nerve stimulation|vagal nerve stimulation
5102544|NCT03357029|Visceral Pain|visceral pain
5102545|NCT03357016|interval training|interval training
5102546|NCT03357016|abdominal fat mass|abdominal fat mass
5102547|NCT03357016|postmenopausal women|postmenopausal women
5102548|NCT03357016|lipids oxidation|lipids oxidation
5102549|NCT03356964|endometrial receptivity progesterone elevation|endometrial receptivity progesterone elevation
5102550|NCT03356925|Xpert®MTB/RIF|xpert®mtb/rif
5102551|NCT03356925|Xpert®MTB/RIF Ultra|xpert®mtb/rif ultra
5102552|NCT03356886|Chronic Low Back Pain|chronic low back pain
5102553|NCT03356886|Pain Neuroscience Education|pain neuroscience education
5102554|NCT03356886|Spinal Manipulative Techniques|spinal manipulative techniques
5102555|NCT03356886|Psychosocial Factors|psychosocial factors
4970811|NCT04172831|FM|fm
5102556|NCT03356860|breast cancer|breast cancer
5102557|NCT03356860|immunotherapy|immunotherapy
5102558|NCT03356860|anti-PD-L1|anti-pd-l1
5102559|NCT03356834|Chronic hepatitis B|chronic hepatitis b
5102560|NCT03356834|Efficacy, safety, and tolerability|efficacy, safety, and tolerability
5102561|NCT03356834|Tenofovir alafenamide|tenofovir alafenamide
5102562|NCT03356808|Lung cancer|lung cancer
5102564|NCT03356808|mesothelin|mesothelin
5102565|NCT03356808|Muc1|muc1
5102566|NCT03356808|GD2|gd2
5102567|NCT03356808|MAGE-A4|mage-a4
5102568|NCT03356795|Cervical cancer|cervical cancer
5102569|NCT03356795|CAR-T|car-t
5102570|NCT03356795|GD2|gd2
5102571|NCT03356795|PSMA|psma
5102572|NCT03356795|Muc1|muc1
5102573|NCT03356795|Mesothelin|mesothelin
5102574|NCT03356795|HPV|hpv
5102575|NCT03356795|solid tumor|solid tumor
5102576|NCT03356782|CART|cart
5102577|NCT03356782|PD-1|pd-1
5102578|NCT03356782|PDL-1|pdl-1
5102579|NCT03356782|CTLA-4|ctla-4
5102580|NCT03356782|sarcoma|sarcoma
5102581|NCT03356782|solid tumor|solid tumor
5102582|NCT03356769|refractory seizure|refractory seizure
5102583|NCT03356769|cognitive impairment|cognitive impairment
5102584|NCT03356769|electroencephalography improvement|electroencephalography improvement
5102585|NCT03356769|seizure reduction|seizure reduction
5102586|NCT03356769|seizure free|seizure free
5102587|NCT03356769|aspirin|aspirin
5102588|NCT03356743|lobectomy|lobectomy
5102589|NCT03356730|Implants|implants
5102590|NCT03356730|Vitamin D|vitamin d
5102591|NCT03356730|Osseointegration|osseointegration
5102592|NCT03356730|Histomorphometric|histomorphometric
5102593|NCT03356717|simulation, high-fidelity, observer tool; learning outcomes|simulation, high-fidelity, observer tool; learning outcomes
5102594|NCT03356704|adults|adults
5102595|NCT03356691|Spiritist pass|spiritist pass
5102596|NCT03356691|adult|adult
5102597|NCT03356691|laying of hands|laying of hands
5102598|NCT03356665|diagnosis|diagnosis
5102599|NCT03356665|sensitivity|sensitivity
5102600|NCT03356665|specificity|specificity
5102601|NCT03356665|rapid diagnostic test|rapid diagnostic test
5102602|NCT03356665|molecular biology|molecular biology
5102603|NCT03356665|LAMP|lamp
5102604|NCT03356665|RT-PCR|rt-pcr
5102605|NCT03356665|serology|serology
5102606|NCT03356665|ELISA|elisa
5102607|NCT03356665|immune trypanolysis|immune trypanolysis
5102608|NCT03356665|clinical symptom|clinical symptom
5102609|NCT03356652|Cardiac resynchronizaton therapy|cardiac resynchronizaton therapy
5102610|NCT03356652|Electrical activation mapping|electrical activation mapping
5102611|NCT03356652|Noninvasive|noninvasive
5100293|NCT03371043|opioids|opioids
5102616|NCT03356639|Phase 1|phase 1
5102617|NCT03356626|fever, inflammation|fever, inflammation
5102618|NCT03356600|Brain Metastases|brain metastases
5102620|NCT03356587|Nanostring|nanostring
5102621|NCT03356587|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
5102622|NCT03356587|abemaciclib|abemaciclib
5102623|NCT03356535|targeted metabolomics|targeted metabolomics
5102624|NCT03356535|multivariate statistics|multivariate statistics
5102625|NCT03356535|metabolic signatures|metabolic signatures
5102626|NCT03356535|partial least squares|partial least squares
5102627|NCT03356535|healthy lifestyle index|healthy lifestyle index
5102628|NCT03356535|EPIC|epic
5102629|NCT03356483|Psilocybin|psilocybin
5102630|NCT03356470|melanoma|melanoma
5102631|NCT03356470|antimelanoma T cells|antimelanoma t cells
5102632|NCT03356444|abiraterone|abiraterone
5102633|NCT03356444|docetaxel|docetaxel
5102634|NCT03356444|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5102635|NCT03356431|Exercise therapy|exercise therapy
5102636|NCT03356431|Physical Therapy|physical therapy
5102639|NCT03356418|Torque|torque
5102640|NCT03356418|Aging|aging
5102641|NCT03356392|acute stroke, thrombectomy, endovascular treatment|acute stroke, thrombectomy, endovascular treatment
5102642|NCT03356379|Diagnosis|diagnosis
5102643|NCT03356379|Peripheral artery disease|peripheral artery disease
5102644|NCT03356379|sports|sports
5102645|NCT03356314|superior mesenteric artery|superior mesenteric artery
5102646|NCT03356314|superior mesenteric vein|superior mesenteric vein
5102647|NCT03356314|intestinal malrotation|intestinal malrotation
5102648|NCT03356314|volvulus|volvulus
5102649|NCT03356314|pregnant women|pregnant women
5102650|NCT03356314|mesenteric vessels position|mesenteric vessels position
5102651|NCT03356314|postnatal diagnosis|postnatal diagnosis
5102652|NCT03356314|prophylactic surgery|prophylactic surgery
5102653|NCT03356301|Aortic compliance|aortic compliance
5102654|NCT03356301|Aortic distensibility|aortic distensibility
5102655|NCT03356301|CMR|cmr
5102656|NCT03356301|Triathletes|triathletes
5102657|NCT03356301|Ventriculo-atrial coupling|ventriculo-atrial coupling
5961961|NCT04283786|qualitative interviews|qualitative interviews
5102658|NCT03356288|Capnography, Diagnosis. Breathlessness, Exacerbations, Device|capnography, diagnosis. breathlessness, exacerbations, device
5102659|NCT03356262|Cohort study|cohort study
5102660|NCT03356249|Sepsis|sepsis
5102661|NCT03356249|Septic shock|septic shock
5102662|NCT03356249|Next-Generation Sequencing|next-generation sequencing
5102663|NCT03356249|Bacteremia|bacteremia
4970853|NCT04172558|ICI|ici
5102664|NCT03356223|Clinical Trial|clinical trial
5102665|NCT03356223|Phase II|phase ii
5102666|NCT03356223|Monotherapy|monotherapy
5102667|NCT03356223|Abemaciclib|abemaciclib
5102668|NCT03356223|Homozygous deletion of CDKN2A|homozygous deletion of cdkn2a
5102669|NCT03356223|Amplification of CCND1|amplification of ccnd1
5102670|NCT03356223|Amplification of CDK6|amplification of cdk6
5102671|NCT03356223|Multicenter Trial|multicenter trial
5102672|NCT03356158|Metastatic Colorectal Cancer,|metastatic colorectal cancer,
5102673|NCT03356158|Recombinant Anti-EGFR Monoclonal Antibody|recombinant anti-egfr monoclonal antibody
5102674|NCT03356145|paracervical block|paracervical block
5102675|NCT03356145|abortion|abortion
5102676|NCT03356145|dilation and evacuation|dilation and evacuation
5102677|NCT03356145|cervical preparation|cervical preparation
5102678|NCT03356132|breast implant|breast implant
5102679|NCT03356132|complication|complication
5102680|NCT03356132|satisfaction|satisfaction
5102681|NCT03356132|quality of life|quality of life
5102682|NCT03356132|augmentation|augmentation
5102683|NCT03356132|textured|textured
5102684|NCT03356132|polyurethane|polyurethane
5102685|NCT03356119|Contraceptive Implant|contraceptive implant
5102686|NCT03356106|Obstructive sleep apnea|obstructive sleep apnea
5102687|NCT03356106|Pre-Eclampsia|pre-eclampsia
5102688|NCT03356093|head and neck cancer, symptom cluster, change, radiotherapy|head and neck cancer, symptom cluster, change, radiotherapy
5102689|NCT03356080|decitabine|decitabine
5102690|NCT03356080|retinoid acid|retinoid acid
5102691|NCT03356080|cytarabine C|cytarabine c
5102692|NCT03356080|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5102693|NCT03356080|acute myeloid leukemia|acute myeloid leukemia
5102694|NCT03356080|Myelodysplastic Syndrome|myelodysplastic syndrome
5102695|NCT03356028|Trauma|trauma
5102696|NCT03356028|Psychiatric Disorder|psychiatric disorder
5102697|NCT03356028|mass trauma|mass trauma
5102698|NCT03356015|Polyp detection rate|polyp detection rate
5102699|NCT03356015|Adenoma detection rate|adenoma detection rate
5102700|NCT03356015|Boston Bowel Preparation Scale|boston bowel preparation scale
5102701|NCT03355989|Conditional Cash Transfer|conditional cash transfer
5102702|NCT03355989|Immunization coverage|immunization coverage
5102703|NCT03355989|Immunization reminder|immunization reminder
5102704|NCT03355976|recurrent|recurrent
5102705|NCT03355976|advanced|advanced
5102706|NCT03355976|metastatitic|metastatitic
5102707|NCT03355937|unexplained infertility|unexplained infertility
5102708|NCT03355937|recurrent implantation failure|recurrent implantation failure
5102709|NCT03355885|early onset pneumonia|early onset pneumonia
5102710|NCT03355885|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5102711|NCT03355885|prognosis|prognosis
5102712|NCT03355885|antibiotic|antibiotic
5102713|NCT03355859|Non Hodgkin Lymphoma|non hodgkin lymphoma
5102714|NCT03355859|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
5102715|NCT03355859|JWCAR029|jwcar029
5102716|NCT03355846|Anal Fissure|anal fissure
5102717|NCT03355846|local therapy|local therapy
5102719|NCT03355846|defecation|defecation
5102720|NCT03355846|bleeding|bleeding
5102721|NCT03355820|Immune response|immune response
5102722|NCT03355820|Cervarix|cervarix
5102723|NCT03355820|Persistence|persistence
5102724|NCT03355820|Chinese|chinese
5102725|NCT03355820|Human papillomavirus|human papillomavirus
5102726|NCT03355807|sleeve gastrectomy|sleeve gastrectomy
5102727|NCT03355807|magnesium sulfate|magnesium sulfate
5102728|NCT03355807|postoperative pain|postoperative pain
5102729|NCT03355807|bariatric surgery|bariatric surgery
5102730|NCT03355794|DIPG|dipg
5102731|NCT03355794|High Grade Glioma|high grade glioma
5102762|NCT03355664|Artemisinins|artemisinins
5102763|NCT03355664|Dihydroartemisinin|dihydroartemisinin
5102764|NCT03355664|Mefloquine|mefloquine
5102765|NCT03355664|Artemisinin|artemisinin
5102766|NCT03355664|Antimalarials|antimalarials
5102767|NCT03355664|Antiparasitic Agents|antiparasitic agents
5102768|NCT03355664|Anti-Infective Agents|anti-infective agents
5102770|NCT03355664|TACT|tact
5102771|NCT03355664|Triple ACT(s)|triple act(s)
5102772|NCT03355664|Resistance|resistance
5102773|NCT03355664|Antimalarial resistance|antimalarial resistance
5102774|NCT03355664|Cardiotoxicity|cardiotoxicity
5102775|NCT03355664|Safety|safety
5102776|NCT03355664|Tolerability|tolerability
5102777|NCT03355664|Efficacy|efficacy
5102778|NCT03355651|Anterior Cruciate Ligament Tears|anterior cruciate ligament tears
5102779|NCT03355651|Dietary Supplementations|dietary supplementations
5102780|NCT03355651|Plasma Rich Proteins|plasma rich proteins
5102781|NCT03355651|Collagen|collagen
5102782|NCT03355651|Chondroitin Sulfate|chondroitin sulfate
5961962|NCT04283786|osteoporosis|osteoporosis
5102783|NCT03355651|Hyaluronic Acid|hyaluronic acid
5102784|NCT03355625|Flow Cytometry|flow cytometry
5102785|NCT03355625|eCPR|ecpr
5102786|NCT03355625|Extracorporeal Life Support|extracorporeal life support
5102787|NCT03355586|Lung diseases|lung diseases
5102788|NCT03355586|Cancer|cancer
5102789|NCT03355586|Interventional pulmonology|interventional pulmonology
5102790|NCT03355586|Peripheral nodule|peripheral nodule
5102791|NCT03355573|Bimekizumab|bimekizumab
5102792|NCT03355573|Ankylosing Spondylitis|ankylosing spondylitis
5102794|NCT03355534|dexmedetomidine|dexmedetomidine
5102795|NCT03355534|general anesthesia|general anesthesia
5102796|NCT03355534|cerebral aneurysm|cerebral aneurysm
5102797|NCT03355521|functionality|functionality
5102798|NCT03355521|gait|gait
5102799|NCT03355521|kinematics|kinematics
5102800|NCT03355521|electromyographic activity|electromyographic activity
5102801|NCT03355521|depressive symptoms|depressive symptoms
5102802|NCT03355521|quality of life|quality of life
5102805|NCT03355456|Persistent atrial fibrillation|persistent atrial fibrillation
5102807|NCT03355456|Pulmonary vein isolation procedure|pulmonary vein isolation procedure
5102808|NCT03355456|Low voltage directed ablation|low voltage directed ablation
5102810|NCT03355443|Lower Gastrointestinal Tract|lower gastrointestinal tract
5102811|NCT03355443|Re-examination|re-examination
5102812|NCT03355443|Retroflexion|retroflexion
5102813|NCT03355391|SCREENING|screening
5102814|NCT03355391|RISK FACTOR|risk factor
5102815|NCT03355365|Mesenchymal Stem Cells|mesenchymal stem cells
5102816|NCT03355365|Neural Progenitors|neural progenitors
5102817|NCT03355365|Autologous|autologous
5102818|NCT03355365|Bone Marrow|bone marrow
5102819|NCT03355365|Multiple Sclerosis|multiple sclerosis
5102820|NCT03355352|Zalviso|zalviso
5102821|NCT03355352|sufentanyl|sufentanyl
5102822|NCT03355352|PCA|pca
5102823|NCT03355352|Dipidolor|dipidolor
5102824|NCT03355339|Balance|balance
5102825|NCT03355339|Dual-task|dual-task
5102826|NCT03355339|King-Devick Test|king-devick test
5102827|NCT03355339|Saccades|saccades
5102828|NCT03355339|Binasal Occlusion|binasal occlusion
5102829|NCT03355313|saliva|saliva
5102830|NCT03355313|Low-level light therapy|low-level light therapy
5102831|NCT03355313|salivary glands|salivary glands
5102832|NCT03355274|Transcutaneous Oximetry|transcutaneous oximetry
5102833|NCT03355248|postpartum|postpartum
5102834|NCT03355248|postoperative cesarean pain management|postoperative cesarean pain management
5102835|NCT03355248|opioid requirements|opioid requirements
5102836|NCT03355222|complementary feeding|complementary feeding
5102837|NCT03355222|calcium|calcium
5102838|NCT03355209|LGS|lgs
5102839|NCT03355196|Osteoarthritic patients|osteoarthritic patients
5102840|NCT03355196|Cartilage|cartilage
5102841|NCT03355196|Safety|safety
5102842|NCT03355183|isokinetics|isokinetics
5102843|NCT03355183|knee|knee
5102844|NCT03355157|Palbociclib|palbociclib
5102845|NCT03355157|Endocrine Therapy|endocrine therapy
5102849|NCT03355157|Daily Monitoring Treatment Impact|daily monitoring treatment impact
5102850|NCT03355157|Health care utilization (call tracking, geofencing)|health care utilization (call tracking, geofencing)
5102851|NCT03355105|Neuromuscular disease|neuromuscular disease
5102852|NCT03355066|Wnt pathway|wnt pathway
5102853|NCT03355066|Wnt inhibition|wnt inhibition
5102854|NCT03355066|SM08502|sm08502
5102859|NCT03355027|Alirocumab|alirocumab
5102860|NCT03355027|Flow Mediated Dilatation|flow mediated dilatation
5102861|NCT03355027|Arterial Stiffness|arterial stiffness
5102862|NCT03355027|Carotid Intima Media Thickness|carotid intima media thickness
5102863|NCT03355027|Inflammation|inflammation
5102864|NCT03355027|Endothelial function|endothelial function
5102865|NCT03355027|FDG PET-CT|fdg pet-ct
5102866|NCT03355027|PET-MR|pet-mr
5102867|NCT03355027|Ezetimibe|ezetimibe
5102868|NCT03354962|Melanoma|melanoma
5102869|NCT03354962|Immune checkpoint|immune checkpoint
5102870|NCT03354962|Nivolumab|nivolumab
5102871|NCT03354962|Ipilimumab|ipilimumab
5102872|NCT03354962|Abscopal effect|abscopal effect
5102873|NCT03354962|Stereotactic radiotherapy|stereotactic radiotherapy
5102874|NCT03354962|PD-1|pd-1
5102875|NCT03354962|CTLA-4|ctla-4
5102877|NCT03354949|Hemiplegia|hemiplegia
5102878|NCT03354949|Stroke|stroke
5102879|NCT03354949|Postural control|postural control
5102880|NCT03354949|Pain|pain
5102881|NCT03354910|Live Donor Kidney Transplantation|live donor kidney transplantation
5102882|NCT03354910|LDKT|ldkt
5102883|NCT03354910|Disparity|disparity
5102884|NCT03354910|African American|african american
5102885|NCT03354910|Education|education
5102886|NCT03354910|Patient Support|patient support
5102887|NCT03354897|stratified medicine, UMOD, torasemide|stratified medicine, umod, torasemide
5102888|NCT03354858|follicle flushing|follicle flushing
5102889|NCT03354858|direct follicle aspiration|direct follicle aspiration
5102890|NCT03354858|fertilization rate|fertilization rate
5102891|NCT03354858|maturation|maturation
5102892|NCT03354754|Intra-abdominal infection|intra-abdominal infection
5102893|NCT03354754|LYS228|lys228
5102894|NCT03354754|beta-lactam antibiotics|beta-lactam antibiotics
5102895|NCT03354754|creatinine clearance|creatinine clearance
5102896|NCT03354754|enterobacteriaceae|enterobacteriaceae
5102897|NCT03354676|adipokines, metabolic syndrome, obese children|adipokines, metabolic syndrome, obese children
5102898|NCT03354663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5102899|NCT03354663|PAF|paf
5102900|NCT03354663|ablation|ablation
5102901|NCT03354585|Mindfulness|mindfulness
5102902|NCT03354585|fMRI|fmri
5102903|NCT03354585|Pain|pain
5102904|NCT03354585|Low Back|low back
5102905|NCT03354585|Radicular|radicular
5102906|NCT03354559|coagulopathy|coagulopathy
5102907|NCT03354559|trauma|trauma
5102908|NCT03354559|bleeding|bleeding
5102909|NCT03354559|fibrinogen|fibrinogen
5102910|NCT03354559|transfusion|transfusion
5102911|NCT03354507|topiramate|topiramate
5102912|NCT03354507|epilepsy|epilepsy
5102913|NCT03354507|sodium bicarbonate|sodium bicarbonate
5102914|NCT03354507|urine alkalinization|urine alkalinization
5102915|NCT03354494|Oocyte donors|oocyte donors
5102916|NCT03354494|Ovarian stimulation|ovarian stimulation
5102917|NCT03354494|Desogestrel|desogestrel
5102918|NCT03354494|Corifolitropina alfa|corifolitropina alfa
5102919|NCT03354494|Gonadotropins|gonadotropins
5102920|NCT03354481|Dyscalculia|dyscalculia
5102921|NCT03354468|Prevention and Control|prevention and control
5102922|NCT03354468|Patient Safety|patient safety
5102923|NCT03354468|Aged|aged
5102924|NCT03354468|Risk Management|risk management
5102925|NCT03354442|Class III treatment|class iii treatment
5102926|NCT03354442|Modified Fixed Mandibular Retractor Appliance|modified fixed mandibular retractor appliance
5102927|NCT03354442|RCT|rct
5102928|NCT03354429|Acute ischaemic stroke; Transient Ischaemic Attack (TIA); Stroke|acute ischaemic stroke; transient ischaemic attack (tia); stroke
5102929|NCT03354416|Imaging-Based Prognostic Markers|imaging-based prognostic markers
5102930|NCT03354416|Multiparametric MRI (mpMRI)|multiparametric mri (mpmri)
5102931|NCT03354416|Translation of Imaging into Treatment Decisions|translation of imaging into treatment decisions
5102932|NCT03354416|Decision-Support System|decision-support system
5102933|NCT03354416|Artificial Intelligence Research|artificial intelligence research
5102934|NCT03354403|XLRS|xlrs
5102935|NCT03354403|RS1|rs1
5102936|NCT03354403|Carrier|carrier
5102941|NCT03354351|Stepped-care model|stepped-care model
5102942|NCT03354351|Men's health|men's health
5102943|NCT03354351|Prevention|prevention
5102944|NCT03354351|Early treatment|early treatment
5102945|NCT03354351|Psychotherapy|psychotherapy
5102946|NCT03354338|Periodontal disease|periodontal disease
5102947|NCT03354338|Bacteremia|bacteremia
5102948|NCT03354338|Amoxicilline|amoxicilline
5102949|NCT03354338|Inflamatory markers|inflamatory markers
5102950|NCT03354325|Office Visits|office visits
5102951|NCT03354312|scaling and root planing|scaling and root planing
5102952|NCT03354312|topical anesthesia|topical anesthesia
5102953|NCT03354299|malnutrition|malnutrition
5102954|NCT03354299|liver cirrhosis|liver cirrhosis
5102955|NCT03354299|coconut milk|coconut milk
5102956|NCT03354286|670G|670g
5102957|NCT03354286|Hybrid closed-loop system|hybrid closed-loop system
5102958|NCT03354286|pediatric|pediatric
5102959|NCT03354234|Gz accelerations|gz accelerations
5102960|NCT03354234|Head up tilt (HUT) test|head up tilt (hut) test
5102961|NCT03354234|Lower body negative pressure (LBNP) method|lower body negative pressure (lbnp) method
5102962|NCT03354234|Physiological parameters|physiological parameters
5102963|NCT03354234|Variable gravitational stimuli|variable gravitational stimuli
5102964|NCT03354221|EoE|eoe
5102965|NCT03354208|biomarkers|biomarkers
5102966|NCT03354182|Mandibular type II furcations|mandibular type ii furcations
5102967|NCT03354182|Periodontal treatment|periodontal treatment
5102968|NCT03354182|Demineralized bovine bone mineral|demineralized bovine bone mineral
5102969|NCT03354182|Collagen membrane|collagen membrane
5102970|NCT03354169|Metabolism|metabolism
5102971|NCT03354169|Eating|eating
5102972|NCT03354169|Circadian Rhythms|circadian rhythms
5102973|NCT03354143|Dementia|dementia
5102974|NCT03354143|Alzheimer's Disease|alzheimer's disease
5102975|NCT03354143|Blood Pressure|blood pressure
5102976|NCT03354143|Cognitive Function|cognitive function
5102977|NCT03354143|Magnetic Resonance Imaging|magnetic resonance imaging
5102978|NCT03354078|Cesarean section|cesarean section
5102979|NCT03354078|Wound infection|wound infection
5102980|NCT03354078|Gapping|gapping
5102981|NCT03354065|pancreatitis|pancreatitis
5102982|NCT03354065|mild|mild
5102983|NCT03354065|biliary|biliary
5102984|NCT03354065|referring|referring
5102985|NCT03354052|Pain|pain
5102986|NCT03354052|rTMS|rtms
5102987|NCT03354052|Rehabilitation|rehabilitation
5102988|NCT03354039|DMD|dmd
5102989|NCT03354026|Blood-breaking Decotion|blood-breaking decotion
5102990|NCT03354013|AOA|aoa
5102991|NCT03354013|embryo developmental problems|embryo developmental problems
5102992|NCT03354013|genetic screening|genetic screening
5102993|NCT03354013|calcium pattern analysis|calcium pattern analysis
5102994|NCT03354000|Patient Portal|patient portal
5102995|NCT03354000|Healthcare disparities|healthcare disparities
5102996|NCT03354000|Safety net healthcare system|safety net healthcare system
5102997|NCT03353987|Post-op cognitive dysfunction|post-op cognitive dysfunction
5102998|NCT03353987|Cognitive training|cognitive training
5102999|NCT03353987|Logbook|logbook
5103000|NCT03353987|Elderly|elderly
5103001|NCT03353974|Multiple Sclerosis|multiple sclerosis
5103002|NCT03353974|Video game therapy|video game therapy
5103003|NCT03353974|Balance|balance
5103004|NCT03353974|Cognitive functions|cognitive functions
5103005|NCT03353961|NSSI|nssi
5103006|NCT03353948|Polycystic Ovary Syndrome|polycystic ovary syndrome
5103008|NCT03353948|Infertility|infertility
5103010|NCT03353935|surgery|surgery
5103011|NCT03353935|pelvic function|pelvic function
5103012|NCT03353922|cognitive function|cognitive function
5103013|NCT03353909|Intrauterine adhesion|intrauterine adhesion
5103014|NCT03353909|Delayed miscarriage|delayed miscarriage
5103019|NCT03353779|Percutaneous coronary intervention|percutaneous coronary intervention
5103021|NCT03353779|platelet function|platelet function
5103022|NCT03353779|prognosis|prognosis
5103023|NCT03353766|Early Orthodontic treatment|early orthodontic treatment
5103024|NCT03353766|Orthodontic treatment outcome|orthodontic treatment outcome
5103025|NCT03353766|Crossbite treatment|crossbite treatment
5103026|NCT03353727|Orthoptic rehabilitation|orthoptic rehabilitation
5103027|NCT03353727|low vision|low vision
5103028|NCT03353727|eye tracker|eye tracker
5103029|NCT03353727|tactile device|tactile device
5103030|NCT03353688|Parkinson's|parkinson's
5103031|NCT03353688|Parkinson Disease|parkinson disease
5103032|NCT03353675|Nivolumab|nivolumab
5103033|NCT03353675|Therapeutic Vaccine|therapeutic vaccine
5103034|NCT03353662|bio fortification|bio fortification
5103035|NCT03353623|Immersive Virtual Environments|immersive virtual environments
5103036|NCT03353623|Wearable Haptic Devices|wearable haptic devices
5103037|NCT03353623|Neuromotor Impairments|neuromotor impairments
5103038|NCT03353623|Rehabilitation|rehabilitation
5103039|NCT03353623|Serious Game|serious game
5103040|NCT03353623|Randomized Controlled Trial|randomized controlled trial
5103041|NCT03353610|Tachycardia|tachycardia
5103042|NCT03353610|PSVT episodes|psvt episodes
5103043|NCT03353584|Virtual reality|virtual reality
5103044|NCT03353584|Pain|pain
5103045|NCT03353584|Nonpharmacological|nonpharmacological
5103046|NCT03353493|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5103047|NCT03353493|Neural, psychological and molecular mechanisms|neural, psychological and molecular mechanisms
5103048|NCT03353480|Azithromycin tablet, Bioequivalence, Phase I, Chinese, Healthy Subjects|azithromycin tablet, bioequivalence, phase i, chinese, healthy subjects
5103049|NCT03353454|Cholestasis|cholestasis
5103050|NCT03353454|Maralixibat|maralixibat
5103051|NCT03353454|Mutation|mutation
5103252|NCT03352154|cochlear implant|cochlear implant
5103056|NCT03353441|Learning and recognition|learning and recognition
5103057|NCT03353441|CogTrack|cogtrack
5103062|NCT03353415|Post-bariatric Hypoglycemia;|post-bariatric hypoglycemia;
5103064|NCT03353402|Fecal Microbiota Transplantation|fecal microbiota transplantation
5103065|NCT03353402|Immunotherapy|immunotherapy
5103066|NCT03353389|Acute Kidney Injury|acute kidney injury
5103067|NCT03353389|Hospital-acquired Acute Kidney Injury|hospital-acquired acute kidney injury
5103068|NCT03353389|Community-acquired Acute Kidney Injury|community-acquired acute kidney injury
5103069|NCT03353389|Acute Renal Failure|acute renal failure
5103070|NCT03353363|cesarean delivery|cesarean delivery
5103071|NCT03353363|liposomal bupivacaine|liposomal bupivacaine
5103072|NCT03353363|Exparel|exparel
5103073|NCT03353363|bupivacaine|bupivacaine
5103074|NCT03353363|wound infiltration|wound infiltration
5103075|NCT03353337|neurocognition|neurocognition
5103076|NCT03353337|prognosis|prognosis
5103077|NCT03353337|aerobic exercise|aerobic exercise
5103078|NCT03353311|ERAS|eras
5103079|NCT03353311|Fast-track|fast-track
5103080|NCT03353311|colorectal surgery|colorectal surgery
5103081|NCT03353311|immuno-nutrition|immuno-nutrition
5103082|NCT03353298|Uric acid|uric acid
5103083|NCT03353298|Left ventricular mass|left ventricular mass
5103084|NCT03353298|Nephrectomy|nephrectomy
5103085|NCT03353298|Allopurinol|allopurinol
5103086|NCT03353298|Magnetic resonance imaging|magnetic resonance imaging
5103087|NCT03353233|iPACK|ipack
5103088|NCT03353233|Interspace between the Popliteal Artery and Capsule of the Knee|interspace between the popliteal artery and capsule of the knee
5103089|NCT03353233|Posterior Capsule block|posterior capsule block
5103090|NCT03353233|Nerve Block|nerve block
5103096|NCT03353207|REM Sleep Without Atonia|rem sleep without atonia
5103097|NCT03353207|Dopamine transmission|dopamine transmission
5103098|NCT03353207|Neurodegeneration|neurodegeneration
5103099|NCT03353194|Cerebral Palsy|cerebral palsy
5103101|NCT03353194|Registry|registry
5103102|NCT03353181|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5103103|NCT03353181|endoscopic drainage|endoscopic drainage
5103104|NCT03353181|endoscopic nasobiliary drainage|endoscopic nasobiliary drainage
5103105|NCT03353181|stent|stent
5103106|NCT03353168|fear|fear
5103107|NCT03353168|anxiety|anxiety
5103108|NCT03353168|childbirth|childbirth
5103109|NCT03353168|pregnancy|pregnancy
5103110|NCT03353129|Quality Improvement|quality improvement
5103111|NCT03353129|Patient Safety|patient safety
5103112|NCT03353129|Outcome Improvements|outcome improvements
5103113|NCT03353077|Skin SCC|skin scc
5103114|NCT03353077|Skin Carcinoma, Squamous|skin carcinoma, squamous
5103115|NCT03353038|assistive technology|assistive technology
5103116|NCT03353038|3 Dimensional Printing|3 dimensional printing
5103117|NCT03353038|Self-Management|self-management
5103118|NCT03353025|non-invasive prolactinoma|non-invasive prolactinoma
5103119|NCT03353012|Immediate postpartum implant|immediate postpartum implant
5103120|NCT03353012|postpartum implant|postpartum implant
5103121|NCT03353012|implant contraception|implant contraception
5103122|NCT03353012|Etonogestrel|etonogestrel
5103123|NCT03353012|Levonorgestrel|levonorgestrel
5103124|NCT03352999|Refractory out-hospital cardiac arrest|refractory out-hospital cardiac arrest
5103125|NCT03352999|Extracorporeal Life Support|extracorporeal life support
5103126|NCT03352986|Sickle cell disease|sickle cell disease
5103127|NCT03352986|anemia|anemia
5103128|NCT03352986|Africa|africa
5103129|NCT03352934|avelumab|avelumab
5103130|NCT03352934|anti-PD-L1|anti-pd-l1
5103131|NCT03352934|neuroendocrine tumor|neuroendocrine tumor
5103132|NCT03352934|NET G3|net g3
5103133|NCT03352934|neuroendocrine carcinoma|neuroendocrine carcinoma
5103134|NCT03352934|NEC G3|nec g3
5103135|NCT03352921|clinical pilates|clinical pilates
5103136|NCT03352921|exercise|exercise
5103137|NCT03352921|Sagital Cervical Disorientation|sagital cervical disorientation
5103138|NCT03352921|Disorientation|disorientation
5103139|NCT03352921|Forward Head Posture|forward head posture
5103140|NCT03352908|Dysphagia|dysphagia
5103141|NCT03352908|Aspiration|aspiration
5103142|NCT03352908|YSP|ysp
5103143|NCT03352908|FEES|fees
4988317|NCT04064632|PI|pi
5103144|NCT03352908|Swallow Problems|swallow problems
5103145|NCT03352895|Resveratrol|resveratrol
5103146|NCT03352895|chronic kidney disease|chronic kidney disease
5103147|NCT03352869|Polycystic Ovary Syndrome|polycystic ovary syndrome
5103148|NCT03352869|Overweight and Obesity|overweight and obesity
5103149|NCT03352869|Impaired Glucose Regulation|impaired glucose regulation
5103150|NCT03352869|Exenatide|exenatide
5103151|NCT03352869|Metformin|metformin
5103152|NCT03352856|Cereal allergy; barley starch, DBPC|cereal allergy; barley starch, dbpc
5103153|NCT03352830|household air pollution|household air pollution
5103154|NCT03352830|health promotion|health promotion
5103155|NCT03352830|clean cookstove adoption|clean cookstove adoption
5103156|NCT03352830|clean cookstove sustained use|clean cookstove sustained use
5103157|NCT03352765|Rituximab|rituximab
5103158|NCT03352765|Bendamustine|bendamustine
5103159|NCT03352765|Melphalan|melphalan
5103160|NCT03352765|Autologous Stem Cell Transplantation (ASCT)|autologous stem cell transplantation (asct)
5103162|NCT03352752|virtual reality|virtual reality
5103163|NCT03352752|fractional laser|fractional laser
5103164|NCT03352752|scars|scars
5103165|NCT03352752|acute pain|acute pain
5103166|NCT03352752|anxiety score|anxiety score
5103167|NCT03352726|EPIT|epit
5103168|NCT03352726|Epicutaneous|epicutaneous
5103169|NCT03352726|Immunotherapy|immunotherapy
5103170|NCT03352726|Viaskin|viaskin
5103171|NCT03352713|self-regulation|self-regulation
5103172|NCT03352713|binge eating|binge eating
5103173|NCT03352713|smoking|smoking
5103174|NCT03352713|ecological momentary assessment|ecological momentary assessment
5103175|NCT03352713|mobile sensing|mobile sensing
5103176|NCT03352713|mHealth|mhealth
5103177|NCT03352687|Shoulder surgery|shoulder surgery
5103178|NCT03352687|Local regional anesthesia|local regional anesthesia
5103179|NCT03352674|insulin glargine|insulin glargine
5103180|NCT03352674|diabetes mellitus|diabetes mellitus
5103181|NCT03352674|immunogenicity|immunogenicity
5103182|NCT03352635|Ethnic Differences|ethnic differences
5103183|NCT03352622|PHARMACOGENOMICS|pharmacogenomics
5103184|NCT03352622|POLYMORPHISM|polymorphism
5103186|NCT03352609|rTMS|rtms
5103187|NCT03352609|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5103188|NCT03352609|Smoking|smoking
5103189|NCT03352609|Nicotine|nicotine
5103190|NCT03352570|anastomotic leakage|anastomotic leakage
5103191|NCT03352570|fistula|fistula
5103192|NCT03352557|Mild cognitive impairment|mild cognitive impairment
5103193|NCT03352557|Alzheimer's disease|alzheimer's disease
5103194|NCT03352531|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5103195|NCT03352531|immunotherapy|immunotherapy
5103196|NCT03352531|immuno-oncology|immuno-oncology
5103197|NCT03352531|advanced solid tumors|advanced solid tumors
5103198|NCT03352466|Anthrax|anthrax
5103199|NCT03352440|Cerebral Palsy|cerebral palsy
5103200|NCT03352440|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5103201|NCT03352440|Learning|learning
5103202|NCT03352440|Motor Activity|motor activity
5103203|NCT03352440|Motor Skills|motor skills
5103204|NCT03352414|HIPEC|hipec
5103205|NCT03352414|peritoneal carcinomatosis|peritoneal carcinomatosis
5103206|NCT03352401|Pulmonary aspiration, full stomach, gastric content inhalation, Mendelson syndrom|pulmonary aspiration, full stomach, gastric content inhalation, mendelson syndrom
5103207|NCT03352388|Older people|older people
5103208|NCT03352388|Nutrition|nutrition
5103209|NCT03352388|Snack|snack
5103210|NCT03352388|Dairy|dairy
5103211|NCT03352388|Protein|protein
5103212|NCT03352388|Berries|berries
5103213|NCT03352349|Terlipressinum|terlipressinum
5103214|NCT03352349|Portal Vein Pressure|portal vein pressure
5103215|NCT03352349|Liver Tumor Resection|liver tumor resection
5103217|NCT03352336|Oxygenation|oxygenation
5103218|NCT03352336|Venous admixture|venous admixture
5103219|NCT03352336|Computed Tomography|computed tomography
5103220|NCT03352336|Oxygenation test|oxygenation test
5103221|NCT03352310|umbilical cord blood|umbilical cord blood
4971414|NCT04169464|HCV|hcv
5103222|NCT03352297|Post burn scar face|post burn scar face
5103223|NCT03352297|Unfiltered nanofat|unfiltered nanofat
5103224|NCT03352297|Adipose tissue growth factors|adipose tissue growth factors
5103225|NCT03352297|Adipose stem cells|adipose stem cells
5103226|NCT03352297|POSAS|posas
5103227|NCT03352297|Image J|image j
5103228|NCT03352297|Face|face
5103229|NCT03352284|Zirconia implant|zirconia implant
5103230|NCT03352284|One-piece|one-piece
5103231|NCT03352284|Monoblock|monoblock
5103232|NCT03352284|Single tooth|single tooth
5103233|NCT03352271|Incremental hemodialysis|incremental hemodialysis
5103234|NCT03352271|Precision medicine|precision medicine
5103235|NCT03352271|Individualized care|individualized care
4988420|NCT04064099|contact sports|contact sports
5103236|NCT03352258|Alzheimer's Disease|alzheimer's disease
5103237|NCT03352258|Amyloid|amyloid
5103238|NCT03352258|Radiotherapy|radiotherapy
5103239|NCT03352219|Human immunodeficiency virus|human immunodeficiency virus
5103240|NCT03352219|Sexually transmitted disease|sexually transmitted disease
5103241|NCT03352219|African Americans|african americans
5103242|NCT03352219|Young adults|young adults
5103243|NCT03352219|Behavioral intervention|behavioral intervention
5103244|NCT03352219|Entertainment-Education|entertainment-education
5103245|NCT03352219|Serial drama|serial drama
5103246|NCT03352219|Sexual behavior|sexual behavior
5103247|NCT03352219|HIV testing|hiv testing
5103248|NCT03352219|Homophobia|homophobia
5103249|NCT03352219|Social cognitive theory|social cognitive theory
5103250|NCT03352206|Mass drug administration|mass drug administration
5103251|NCT03352206|Effectiveness|effectiveness
5103256|NCT03352102|Mechanical Ventilation|mechanical ventilation
5103257|NCT03352102|Ventilator Weaning|ventilator weaning
5103258|NCT03352089|Magnetic resonance imaging|magnetic resonance imaging
5103259|NCT03352089|Positron emission tomography|positron emission tomography
5103260|NCT03352076|Danazol|danazol
5103261|NCT03352024|neuro degenerative diseases|neuro degenerative diseases
5100916|NCT03367468|Pain|pain
5103272|NCT03351998|skeletal muscle mitochondrial function|skeletal muscle mitochondrial function
5103273|NCT03351959|ypT0|ypt0
5103274|NCT03351946|Atelectasis|atelectasis
5103275|NCT03351946|Oxygenation|oxygenation
5103276|NCT03351946|Positive end-expiratory pressure|positive end-expiratory pressure
5103277|NCT03351946|Mechanical ventilation|mechanical ventilation
5103278|NCT03351946|General anesthesia|general anesthesia
5103279|NCT03351946|Computed tomography|computed tomography
5103280|NCT03351868|Fanconi anemia|fanconi anemia
5103281|NCT03351868|Lentiviral vector|lentiviral vector
5103282|NCT03351868|FANCA|fanca
5103283|NCT03351868|Gene|gene
5103284|NCT03351855|Human papilloma virus|human papilloma virus
5103285|NCT03351855|Cytotoxic lymphocyte|cytotoxic lymphocyte
5103286|NCT03351855|HPV-CTL|hpv-ctl
5103287|NCT03351842|Adjuvant chemotherapy|adjuvant chemotherapy
5103288|NCT03351842|Micropapillary Component|micropapillary component
5103289|NCT03351842|Early stage lung cancer|early stage lung cancer
5103290|NCT03351829|Beta Thalassemia|beta thalassemia
5103291|NCT03351829|Lentiviral vector|lentiviral vector
5103292|NCT03351829|Gene|gene
5103297|NCT03351764|Non-Invasive Brain Stimulation|non-invasive brain stimulation
5103298|NCT03351764|fMRI|fmri
5103299|NCT03351764|TMS-Evoked Potential|tms-evoked potential
5103300|NCT03351764|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5103302|NCT03351751|PF-06372865|pf-06372865
5103303|NCT03351751|Safety|safety
5103304|NCT03351751|Tolerability|tolerability
5103305|NCT03351751|Pharmacokinetics|pharmacokinetics
5103306|NCT03351751|Multiple dose|multiple dose
5103307|NCT03351751|Healthy subjects|healthy subjects
5103308|NCT03351738|Coronary heart disease|coronary heart disease
5103309|NCT03351738|Pharmacokinetic|pharmacokinetic
5103310|NCT03351738|Pharmacodynamics|pharmacodynamics
5103311|NCT03351725|peripheral venous catheter|peripheral venous catheter
5103312|NCT03351725|catheter colonization|catheter colonization
5103313|NCT03351712|Wearables|wearables
5103314|NCT03351712|Activity Trackers|activity trackers
5103315|NCT03351712|ACT|act
5103316|NCT03351712|Health promotion|health promotion
5103317|NCT03351712|Obesity|obesity
5748072|NCT00327210|Awareness|awareness
5103318|NCT03351712|Chronic Health Condition|chronic health condition
5103319|NCT03351712|Psychological well-being|psychological well-being
5103320|NCT03351712|Quality of life|quality of life
5103321|NCT03351712|Behavior modification|behavior modification
5103325|NCT03351647|Ustekinumab|ustekinumab
5103326|NCT03351647|Vedolizumab|vedolizumab
5103327|NCT03351647|anti-TNF|anti-tnf
5103328|NCT03351647|CRP|crp
5103329|NCT03351647|calprotectin|calprotectin
5103330|NCT03351647|cohort|cohort
5103331|NCT03351595|Growth pattern|growth pattern
5103332|NCT03351595|Environmental and prenatal exposure|environmental and prenatal exposure
5103333|NCT03351582|family therapy|family therapy
5103334|NCT03351582|psychological health|psychological health
5103335|NCT03351569|Unverricht-Lundborg disease|unverricht-lundborg disease
5103336|NCT03351569|progressive myoclonus epilepsy|progressive myoclonus epilepsy
5961963|NCT04283773|OGCTs, P16 , IHC|ogcts, p16 , ihc
5103337|NCT03351569|pharmacoresistant epilepsy|pharmacoresistant epilepsy
5961964|NCT04283760|acute stroke|acute stroke
5103338|NCT03351543|vaccine response|vaccine response
5103339|NCT03351543|immune system activity|immune system activity
5103340|NCT03351504|household air pollution|household air pollution
5103341|NCT03351504|fine particulate matter|fine particulate matter
5103342|NCT03351504|kerosene|kerosene
5103343|NCT03351491|Health mobile applications|health mobile applications
5103344|NCT03351491|Apps|apps
5103345|NCT03351491|mhealth|mhealth
5103346|NCT03351491|ehealth|ehealth
5103347|NCT03351491|France|france
5103348|NCT03351491|msanté|msanté
5103349|NCT03351491|applications mobiles|applications mobiles
5103350|NCT03351439|Hip Arthroscopy|hip arthroscopy
5103351|NCT03351426|obesity|obesity
5103352|NCT03351426|overweight|overweight
5103353|NCT03351426|neuromodulation|neuromodulation
5103543|NCT03349840|degludec|degludec
5103356|NCT03351413|Older Adults|older adults
5103357|NCT03351400|cardiac stem cells|cardiac stem cells
5103358|NCT03351400|c-kit|c-kit
5103359|NCT03351387|amputation|amputation
5103360|NCT03351387|necrosis|necrosis
5101017|NCT03366753|blood viscosity|blood viscosity
5103365|NCT03351348|Bupivacaine|bupivacaine
5103366|NCT03351348|Mastectomy|mastectomy
5103367|NCT03351348|Sentinel lymph node biopsy SLNB|sentinel lymph node biopsy slnb
5103368|NCT03351348|17-576|17-576
5103369|NCT03351322|Alopecia|alopecia
5103370|NCT03351322|Hair Loss|hair loss
5103371|NCT03351322|Female Pattern Baldness|female pattern baldness
5103373|NCT03351270|XLMTM|xlmtm
5103374|NCT03351270|Myotubular myopathy|myotubular myopathy
5103375|NCT03351205|Asherman syndrome|asherman syndrome
5103376|NCT03351205|hysteroscopy|hysteroscopy
5103377|NCT03351205|uterine stent|uterine stent
5103378|NCT03351205|Estrogen|estrogen
5103379|NCT03351205|Amnion|amnion
5103380|NCT03351205|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
5103381|NCT03351179|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5103382|NCT03351179|Acute MyocAcute Myocardial Infarction|acute myocacute myocardial infarction
5103383|NCT03351179|Predictive factors|predictive factors
5103384|NCT03351140|Multiple Myeloma|multiple myeloma
5103385|NCT03351140|Patient‐Reported Outcome Measurement Information System (PROMIS)|patient‐reported outcome measurement information system (promis)
5103386|NCT03351140|Non‐Small Cell Lung Cancer (NSCLC)|non‐small cell lung cancer (nsclc)
5103387|NCT03351140|Breast cancer|breast cancer
5103388|NCT03351140|Diffuse Large B‐Cell (DLBCL)|diffuse large b‐cell (dlbcl)
5103389|NCT03351140|Follicular Lymphoma|follicular lymphoma
5103390|NCT03351140|Prostate Cancer|prostate cancer
5103391|NCT03351140|Qualitative interview|qualitative interview
5103392|NCT03351114|Morphea, Localized Scleroderma|morphea, localized scleroderma
5103393|NCT03351062|premenopausal|premenopausal
5103394|NCT03351062|early breast cancer|early breast cancer
5103395|NCT03351062|estrogen receptor positive|estrogen receptor positive
5103396|NCT03351049|Acute care, support surface|acute care, support surface
5103397|NCT03351036|Hypothermia|hypothermia
5103398|NCT03351010|Mindfulness, Cancer, Pain Management|mindfulness, cancer, pain management
5103400|NCT03350971|virtual reality|virtual reality
5103401|NCT03350971|physical therapy|physical therapy
5103402|NCT03350971|myocardial revascualrization|myocardial revascualrization
5103403|NCT03350932|sensory imagination; foods|sensory imagination; foods
5103404|NCT03350906|Exercise|exercise
5103405|NCT03350906|muscle function|muscle function
5103406|NCT03350880|Passive|passive
5103407|NCT03350880|Stretching|stretching
5103408|NCT03350880|Water|water
5103409|NCT03350880|Proprioceptive Neuromuscular Facilitation (PNF)|proprioceptive neuromuscular facilitation (pnf)
5103410|NCT03350867|Posture|posture
5103411|NCT03350867|Orthosis|orthosis
5103412|NCT03350867|Foot|foot
5103413|NCT03350867|Biomechanical Phenomena|biomechanical phenomena
5103414|NCT03350854|early stage breast cancer;|early stage breast cancer;
5103415|NCT03350854|treatment decision making|treatment decision making
5103416|NCT03350854|newly diagnosed breast cancer|newly diagnosed breast cancer
5103417|NCT03350828|CF|cf
5103418|NCT03350828|Cystic Fibrosis|cystic fibrosis
5103419|NCT03350828|Sweat|sweat
5103420|NCT03350828|Sweat chloride|sweat chloride
5103421|NCT03350828|CFTR Modulator|cftr modulator
5103423|NCT03350789|acupuncture|acupuncture
5103424|NCT03350789|sciatica|sciatica
5103425|NCT03350789|MRI, functional|mri, functional
5103426|NCT03350776|Neoplasm|neoplasm
5103427|NCT03350776|Chronic disease|chronic disease
5103428|NCT03350776|Complex cases|complex cases
5103429|NCT03350776|Care coordination|care coordination
5103430|NCT03350776|Oncologic nursing|oncologic nursing
5103431|NCT03350776|Theoretical model|theoretical model
5103432|NCT03350763|Pancreatic Cancer|pancreatic cancer
5103433|NCT03350763|Biliary decompression|biliary decompression
5103434|NCT03350737|No-option patients|no-option patients
5103435|NCT03350711|Microbiota composition|microbiota composition
5103436|NCT03350711|Microbiota Enrichment Program|microbiota enrichment program
5103437|NCT03350711|Fecal microbiota transplant (FMT)|fecal microbiota transplant (fmt)
5103438|NCT03350698|Human papilloma virus|human papilloma virus
5103439|NCT03350672|HIV prevention|hiv prevention
5103440|NCT03350672|PrEP|prep
5103441|NCT03350672|Descovy|descovy
5103442|NCT03350659|orthostatic hypotension|orthostatic hypotension
5103443|NCT03350659|midodrine|midodrine
5103444|NCT03350659|atomoxetine|atomoxetine
5103445|NCT03350659|treatment|treatment
5103446|NCT03350646|embryo transfer|embryo transfer
5103447|NCT03350646|volume|volume
5103448|NCT03350646|culture medium|culture medium
5103449|NCT03350646|loading the catheter|loading the catheter
5103450|NCT03350646|clinical pregnancy rate|clinical pregnancy rate
5103451|NCT03350620|child, myopia, nearsightedness|child, myopia, nearsightedness
5103452|NCT03350607|Epiretinal membrane, sweeper, forceps, microperimetry|epiretinal membrane, sweeper, forceps, microperimetry
5103453|NCT03350594|Anorexia Nervosa|anorexia nervosa
5101125|NCT03366116|Epigenetics|epigenetics
5103454|NCT03350594|Multiple Family Therapy|multiple family therapy
5103455|NCT03350594|Systemic Family Therapy|systemic family therapy
5103457|NCT03350594|Randomised controled trial|randomised controled trial
5103458|NCT03350581|Catheter ablation|catheter ablation
5103459|NCT03350581|Fast anatomical mapping (FAM)|fast anatomical mapping (fam)
5103460|NCT03350581|Computed tomography (CT)|computed tomography (ct)
5103461|NCT03350581|Magnetic resonance image (MRI)|magnetic resonance image (mri)
5103462|NCT03350581|Contact force|contact force
5103463|NCT03350581|Atrial fibrillation|atrial fibrillation
5103464|NCT03350568|Antioxidants|antioxidants
5103465|NCT03350568|Oxidative Stress|oxidative stress
5103466|NCT03350568|Atherosclerosis|atherosclerosis
5103467|NCT03350568|Epidemiology|epidemiology
5103468|NCT03350542|Drug-Eluting Stents|drug-eluting stents
5103469|NCT03350529|prostate cancer|prostate cancer
5103470|NCT03350529|benign prostatic hyperplasia|benign prostatic hyperplasia
5103471|NCT03350529|benign prostatic obstruction|benign prostatic obstruction
5103472|NCT03350529|high intensity focused ultrasound|high intensity focused ultrasound
5103473|NCT03350529|real-time temperature feedback control|real-time temperature feedback control
5103474|NCT03350529|magnetic resonance imaging|magnetic resonance imaging
5103475|NCT03350503|phacoemulsification|phacoemulsification
5103476|NCT03350503|intraocular lens|intraocular lens
5103477|NCT03350503|vision|vision
5103478|NCT03350503|toric|toric
5103479|NCT03350490|Cancer ablation|cancer ablation
5103480|NCT03350490|Life information rehabilitation therapy|life information rehabilitation therapy
5103481|NCT03350477|Cancer ablation|cancer ablation
5103482|NCT03350477|Life information rehabilitation therapy|life information rehabilitation therapy
5103483|NCT03350451|Hyperoxaluria, Primary|hyperoxaluria, primary
5103484|NCT03350451|Hyperoxaluria|hyperoxaluria
5103485|NCT03350451|Kidney Diseases|kidney diseases
5103486|NCT03350451|Urologic Diseases|urologic diseases
5103487|NCT03350451|Metabolism, Inborn Errors|metabolism, inborn errors
5103488|NCT03350451|Genetic Diseases, Inborn|genetic diseases, inborn
5103489|NCT03350451|Metabolic Diseases|metabolic diseases
5103490|NCT03350438|participation|participation
5103491|NCT03350438|quality of life|quality of life
5103492|NCT03350438|occupational therapy|occupational therapy
5103493|NCT03350425|hemodialysis|hemodialysis
5103494|NCT03350425|pneumococcal vaccination|pneumococcal vaccination
5103496|NCT03350334|Duloxetine|duloxetine
5103497|NCT03350334|laparoscopic hysterectomy|laparoscopic hysterectomy
5103498|NCT03350334|postoperative pain|postoperative pain
5103499|NCT03350334|postoperative recovery|postoperative recovery
5103500|NCT03350295|Relative bioavailability|relative bioavailability
5103501|NCT03350295|In vitro dissolution|in vitro dissolution
5103502|NCT03350269|Living kidney donation|living kidney donation
5103503|NCT03350269|Kidney transplant|kidney transplant
5103504|NCT03350269|Lost Wage Reimbursement|lost wage reimbursement
5103505|NCT03350243|Neonatal Intensive Care Unit|neonatal intensive care unit
5103506|NCT03350243|Mindfulness|mindfulness
5103507|NCT03350243|Care coordination|care coordination
5103508|NCT03350243|Anticipatory guidance|anticipatory guidance
5103509|NCT03350243|Parental support|parental support
5103510|NCT03350243|Neonatal follow-up|neonatal follow-up
5103511|NCT03350152|Chemotherapy, Low-intensity therapy, elderly, prognosis,|chemotherapy, low-intensity therapy, elderly, prognosis,
5103512|NCT03350126|MSI or MMR|msi or mmr
5103513|NCT03350113|prognosis|prognosis
5103514|NCT03350113|diagnosis|diagnosis
5103515|NCT03350087|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5103517|NCT03350087|optimal treatment protocol|optimal treatment protocol
5103518|NCT03350087|VR-based cycling training (VCT)|vr-based cycling training (vct)
5103519|NCT03350087|randomized controlled trial|randomized controlled trial
5103520|NCT03350087|motor control|motor control
5103521|NCT03350087|clinical predictors|clinical predictors
5103522|NCT03350074|Hepatitis B virus|hepatitis b virus
5103523|NCT03350074|PreS/S variability|pres/s variability
5103524|NCT03350074|Anti-HBV treatment|anti-hbv treatment
5103525|NCT03350048|Tuberculosis|tuberculosis
5103526|NCT03350048|Point-of-care test|point-of-care test
5103527|NCT03350048|Diagnostics|diagnostics
5103528|NCT03350048|Biomarkers|biomarkers
5103529|NCT03349957|TACE|tace
5103530|NCT03349944|exercise|exercise
5103531|NCT03349931|Aspergillosis,|aspergillosis,
5103532|NCT03349931|qPCR|qpcr
5103533|NCT03349931|allogenic haemopoietic stem-cell transplantation|allogenic haemopoietic stem-cell transplantation
5103534|NCT03349931|leukemia|leukemia
5103535|NCT03349905|Freeze all|freeze all
5103536|NCT03349905|IVF|ivf
5103537|NCT03349905|deferred embryo transfer|deferred embryo transfer
5103538|NCT03349905|endometriosis|endometriosis
5103539|NCT03349853|Palliative care; Acetaminophen; Subcutaneous route; Pain treatment|palliative care; acetaminophen; subcutaneous route; pain treatment
5103540|NCT03349840|type 2 diabetes|type 2 diabetes
5103541|NCT03349840|insulin|insulin
5103542|NCT03349840|glargine u100|glargine u100
5103551|NCT03349788|Left colic artery|left colic artery
5103552|NCT03349788|Laparoscopic Surgery|laparoscopic surgery
5103553|NCT03349788|Anterior resection of rectum|anterior resection of rectum
5103554|NCT03349788|Rectum cancer|rectum cancer
5103561|NCT03349762|Huaier Granule|huaier granule
5103562|NCT03349762|multisite|multisite
5103571|NCT03349736|Pelvic floor muscle|pelvic floor muscle
5103572|NCT03349697|Liver Health|liver health
5103573|NCT03349697|Hangover|hangover
5103574|NCT03349697|Herbal supplement|herbal supplement
5103575|NCT03349697|Liver function|liver function
5103576|NCT03349658|total hip arthroplasty|total hip arthroplasty
5103577|NCT03349658|cerebral oxygen saturation|cerebral oxygen saturation
5103578|NCT03349658|general anesthesia|general anesthesia
5103579|NCT03349658|spinal anesthesia|spinal anesthesia
5103580|NCT03349632|Contact lenses|contact lenses
5103581|NCT03349632|Myopia|myopia
5103582|NCT03349632|Near-sighted|near-sighted
5103583|NCT03349632|Daily disposable|daily disposable
5103584|NCT03349593|Heart failure, diastolic dysfunction, venous return|heart failure, diastolic dysfunction, venous return
5103585|NCT03349593|Left ventricular filling pressures|left ventricular filling pressures
5103586|NCT03349580|rehabilitation|rehabilitation
5103587|NCT03349580|randomized controlled trial|randomized controlled trial
5103588|NCT03349580|strength training|strength training
5103589|NCT03349580|early initiation|early initiation
5103590|NCT03349580|intra-abdominal pressure|intra-abdominal pressure
5103591|NCT03349554|Parkinson's disease|parkinson's disease
5103592|NCT03349554|anxiety|anxiety
5103593|NCT03349554|meditation|meditation
5103594|NCT03349554|in-patients|in-patients
5103595|NCT03349528|bipolar disorder|bipolar disorder
5103596|NCT03349528|bipolar depression|bipolar depression
5103597|NCT03349528|depressive episode|depressive episode
5103598|NCT03349528|probiotic supplement|probiotic supplement
5103599|NCT03349528|probiotics|probiotics
5103600|NCT03349528|relapse prevention|relapse prevention
5103601|NCT03349528|rehospitalization|rehospitalization
5103602|NCT03349502|Allogeneic natural killer cell, MG4101|allogeneic natural killer cell, mg4101
5103603|NCT03349489|Type 1 diabetes|type 1 diabetes
5103604|NCT03349489|Exercise|exercise
5103605|NCT03349489|Hypoglycemia|hypoglycemia
5103606|NCT03349489|Insulin pump|insulin pump
5103607|NCT03349476|Atrial Fibrillation|atrial fibrillation
5103608|NCT03349476|AFIB|afib
5103609|NCT03349476|Ablation|ablation
5103610|NCT03349476|Paroxysmal|paroxysmal
5103611|NCT03349476|Persistent|persistent
5103612|NCT03349450|Lymphoma|lymphoma
5103613|NCT03349450|DLBCL|dlbcl
5103614|NCT03349450|Lymphoma, B-Cell|lymphoma, b-cell
5103615|NCT03349450|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5103616|NCT03349450|Neoplasms by Histologic Type|neoplasms by histologic type
5103617|NCT03349450|Neoplasms|neoplasms
5103618|NCT03349450|Lymphoproliferative Disorders|lymphoproliferative disorders
5103619|NCT03349450|Lymphatic Diseases|lymphatic diseases
5103620|NCT03349450|Immunoproliferative Disorders|immunoproliferative disorders
5103621|NCT03349450|Immune System Diseases|immune system diseases
5103622|NCT03349450|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5103623|NCT03349450|Cyclophosphamide|cyclophosphamide
5103624|NCT03349450|Pembrolizumab|pembrolizumab
5103625|NCT03349450|Immunosuppressive Agents|immunosuppressive agents
5103632|NCT03349450|Antineoplastic Agents|antineoplastic agents
5103633|NCT03349450|Myeloablative Agonists|myeloablative agonists
5103635|NCT03349450|Ontario|ontario
5103636|NCT03349450|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5103637|NCT03349450|refractory|refractory
5103638|NCT03349450|relapsed|relapsed
5103639|NCT03349450|checkpoint inhibitor|checkpoint inhibitor
5103640|NCT03349450|vaccine|vaccine
5103641|NCT03349450|DPX-Survivac|dpx-survivac
5103642|NCT03349450|Survivin|survivin
5103643|NCT03349450|Immunotherapy|immunotherapy
5103644|NCT03349450|Transformed Lymphoma|transformed lymphoma
5103645|NCT03349450|Double Hit|double hit
5103646|NCT03349450|Large Cell Lymphoma|large cell lymphoma
5103647|NCT03349450|Keytruda|keytruda
5103648|NCT03349424|Somatostatin|somatostatin
5103649|NCT03349424|Pancreatic Fistula|pancreatic fistula
5103650|NCT03349424|Intermediate Risk|intermediate risk
5103651|NCT03349424|Pancreaticoduodenectomy|pancreaticoduodenectomy
5103652|NCT03349398|Uncut Roux-en-Y|uncut roux-en-y
5103653|NCT03349398|Roux-en-Y|roux-en-y
5103654|NCT03349385|Secondary revascularization|secondary revascularization
5103655|NCT03349385|Repeat revascularization|repeat revascularization
5103656|NCT03349385|Coronary revascularization|coronary revascularization
5103657|NCT03349385|Coronary artery bypass graft|coronary artery bypass graft
5103658|NCT03349333|FOT12-CN-301|fot12-cn-301
4974734|NCT04150042|BCNU|bcnu
5101339|NCT03364803|17-592|17-592
5103659|NCT03349333|PTCL (peripheral T-cell lymphoma)|ptcl (peripheral t-cell lymphoma)
5103660|NCT03349333|pralatrexate|pralatrexate
5103661|NCT03349333|vitamin B12|vitamin b12
5103662|NCT03349333|folic acid|folic acid
5103663|NCT03349320|Alzheimer|alzheimer
5103664|NCT03349320|APOE|apoe
5103665|NCT03349320|CYP2D6|cyp2d6
5103666|NCT03349320|Donepezil|donepezil
5103667|NCT03349320|Genetics|genetics
5103668|NCT03349307|lobectomy|lobectomy
5103669|NCT03349294|Thyroid|thyroid
5103670|NCT03349294|Thyroidectomy|thyroidectomy
5103671|NCT03349294|Iodine|iodine
5103672|NCT03349294|Biokinetic|biokinetic
5103673|NCT03349294|Ablation|ablation
5103674|NCT03349255|alpha-fetoprotein|alpha-fetoprotein
5103675|NCT03349255|AFP|afp
5103676|NCT03349255|HCC|hcc
5103677|NCT03349255|CAR T cell therapy|car t cell therapy
5103678|NCT03349229|care practices|care practices
5103679|NCT03349229|geriatry|geriatry
5103680|NCT03349229|oncology|oncology
5103681|NCT03349151|Postoperative maternal feeding, cesarean section|postoperative maternal feeding, cesarean section
5103682|NCT03349138|rehabilitation|rehabilitation
5103683|NCT03349138|functional electrical stimulation|functional electrical stimulation
5103684|NCT03349138|electrode array|electrode array
5103685|NCT03349138|upper limb|upper limb
5103686|NCT03349138|chronic|chronic
5103687|NCT03349138|motor relearning|motor relearning
5103688|NCT03349125|Cervical Brace|cervical brace
5103689|NCT03349125|Elderly|elderly
5103690|NCT03349125|Dysphagia|dysphagia
5103691|NCT03349125|VFSS|vfss
5103692|NCT03349125|Videoflouroscopy|videoflouroscopy
5103693|NCT03349125|Swallow Problems|swallow problems
5103694|NCT03349112|Manometry|manometry
5103695|NCT03349112|Lidocaine|lidocaine
5103696|NCT03349112|Pharyngeal|pharyngeal
5103697|NCT03349112|High Resolution Pharyngeal Manometry (HRPM)|high resolution pharyngeal manometry (hrpm)
5103698|NCT03349112|Pressure|pressure
5103699|NCT03349086|Botox Injection|botox injection
5103700|NCT03349086|Spasmodic|spasmodic
5103701|NCT03349086|Dysphonia|dysphonia
5103702|NCT03349086|Voice Therapy|voice therapy
5103703|NCT03349086|Speech Therapy|speech therapy
5103704|NCT03349086|Voice Rest|voice rest
5103705|NCT03349060|atopic dermatitis|atopic dermatitis
5103706|NCT03349060|atopic eczema|atopic eczema
5103707|NCT03349060|eczema|eczema
5103708|NCT03349060|JAK|jak
5103709|NCT03349060|janus kinase|janus kinase
5103710|NCT03349047|Food Allergy|food allergy
5103711|NCT03349047|Anxiety|anxiety
5103712|NCT03349047|Casual Exposure|casual exposure
5103713|NCT03349047|Peanut Hypersensitivity|peanut hypersensitivity
5103714|NCT03349047|Tree nut Hypersensitivity|tree nut hypersensitivity
5103715|NCT03349047|Adolescents|adolescents
5103716|NCT03349034|Local anesthetics|local anesthetics
5103717|NCT03349034|Randomized Control Trial|randomized control trial
5103718|NCT03349034|Free tissue transfer|free tissue transfer
5103719|NCT03349034|Head and neck|head and neck
5103738|NCT03348904|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
5103739|NCT03348904|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
5103740|NCT03348891|Melanoma|melanoma
5103742|NCT03348891|Immune checkpoints|immune checkpoints
5103743|NCT03348891|Tumor-infiltrating lymphocytes|tumor-infiltrating lymphocytes
5103744|NCT03348891|Cytokines|cytokines
5103745|NCT03348891|Circulating leukocytes|circulating leukocytes
5103746|NCT03348878|drug compliance|drug compliance
5103747|NCT03348878|hypertension|hypertension
5103748|NCT03348878|anti-hypertensive agents|anti-hypertensive agents
5103749|NCT03348865|Cognitive Behavioural Therapy|cognitive behavioural therapy
5103750|NCT03348839|telemedicine|telemedicine
5103751|NCT03348839|telemonitoring|telemonitoring
5103752|NCT03348839|educational therapy|educational therapy
5103753|NCT03348813|Black|black
5103754|NCT03348813|Adolescents|adolescents
5103755|NCT03348813|Community-based research|community-based research
5103756|NCT03348813|Randomized controlled trial|randomized controlled trial
5103757|NCT03348813|Intervention|intervention
5103758|NCT03348813|Behavioral science|behavioral science
5103759|NCT03348800|Child|child
5103761|NCT03348800|Anesthesia|anesthesia
5103762|NCT03348800|Tooth extraction|tooth extraction
4988933|NCT04060485|Myelodysplastic Syndromes|myelodysplastic syndromes
5103763|NCT03348787|Behavioral and Cognitive Therapies|behavioral and cognitive therapies
5103764|NCT03348774|Disease Course|disease course
5103765|NCT03348761|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5103766|NCT03348761|resting-state Functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
5103767|NCT03348761|treatment response trajectories|treatment response trajectories
5103768|NCT03348722|Active surveillance|active surveillance
5103769|NCT03348722|Low risk prostate cancer|low risk prostate cancer
5103770|NCT03348722|Prostatic neoplasm/therapy (MESH)|prostatic neoplasm/therapy (mesh)
5103771|NCT03348722|Prostatic neoplasm/surgery (MESH)|prostatic neoplasm/surgery (mesh)
5103772|NCT03348722|Prostatic neoplasm/radiotherapy (MESH)|prostatic neoplasm/radiotherapy (mesh)
5103773|NCT03348722|Prostatectomy (MESH)|prostatectomy (mesh)
5961965|NCT04283760|motor imagery|motor imagery
5961966|NCT04283760|visual imagery|visual imagery
5103774|NCT03348722|Quality of life (MESH)|quality of life (mesh)
5103775|NCT03348722|Costs and Cost Analysis (MESH)|costs and cost analysis (mesh)
5103776|NCT03348683|Induction|induction
5103777|NCT03348683|Labor|labor
5103779|NCT03348670|SCLC|sclc
5103780|NCT03348670|SNP|snp
5103781|NCT03348670|Oncology|oncology
5103782|NCT03348670|Drug|drug
5103783|NCT03348670|Etoposide|etoposide
5103784|NCT03348670|Methotrexate|methotrexate
5103785|NCT03348670|Lung|lung
5103786|NCT03348670|Cancer|cancer
5103787|NCT03348670|Topotecan|topotecan
5103788|NCT03348670|Everolimus|everolimus
5103789|NCT03348618|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5103790|NCT03348618|Anxiety|anxiety
5103791|NCT03348618|PANS|pans
5103792|NCT03348618|PANDAS|pandas
5103793|NCT03348618|Children|children
5103794|NCT03348605|Amputation|amputation
5103795|NCT03348605|Phantom Pain|phantom pain
5103796|NCT03348605|Gait analysis|gait analysis
5103797|NCT03348592|Microbiome, p-inulin|microbiome, p-inulin
5103798|NCT03348579|Intensive care unit|intensive care unit
5103799|NCT03348579|Pneumonia|pneumonia
5114385|NCT03281733|malnutrition|malnutrition
5103800|NCT03348579|Ventilator associated|ventilator associated
5103801|NCT03348579|Hospital acquired pneumonia|hospital acquired pneumonia
5103802|NCT03348579|Guidelines|guidelines
5103803|NCT03348553|Omega-fatty-acids|omega-fatty-acids
5103804|NCT03348553|Absorption|absorption
5103805|NCT03348553|Bioavailability|bioavailability
5103806|NCT03348553|Fruit & Vegetable concentrate|fruit & vegetable concentrate
5103807|NCT03348553|Lipid Metabolism|lipid metabolism
5103808|NCT03348475|Guided self-help|guided self-help
5103809|NCT03348475|Group-based intervention|group-based intervention
5103810|NCT03348475|Binge Focused Therapy|binge focused therapy
5103811|NCT03348475|Brain Over Binge|brain over binge
5103812|NCT03348475|Non-expert guided|non-expert guided
5103813|NCT03348475|Minimally intensive|minimally intensive
5103814|NCT03348462|psoriasis|psoriasis
5103815|NCT03348462|anthralin|anthralin
5103816|NCT03348462|ethosome|ethosome
5103817|NCT03348462|liposome|liposome
5103818|NCT03348449|HIV|hiv
5103819|NCT03348449|Dual therapy|dual therapy
5103820|NCT03348449|Comorbidities|comorbidities
5103821|NCT03348449|Nucleoside analogues sparing-regimens|nucleoside analogues sparing-regimens
5103822|NCT03348436|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5103823|NCT03348436|Left Atrial Function|left atrial function
5103824|NCT03348423|Peri-procedural pain|peri-procedural pain
5103826|NCT03348423|Anxiety|anxiety
5103827|NCT03348423|Analgesia|analgesia
5103828|NCT03348423|Anxiolysis|anxiolysis
5103829|NCT03348371|Incretin effect|incretin effect
5103830|NCT03348371|Ethanol|ethanol
5103831|NCT03348345|eating disorders|eating disorders
5103832|NCT03348345|prevention|prevention
5103833|NCT03348345|yoga|yoga
5103834|NCT03348345|mindfulness|mindfulness
5103835|NCT03348345|embodiment|embodiment
5103836|NCT03348345|self-regulation|self-regulation
5103837|NCT03348345|functional action|functional action
5103838|NCT03348345|interoceptive awareness|interoceptive awareness
5103839|NCT03348332|exercise|exercise
5103840|NCT03348332|intrapartum|intrapartum
5103841|NCT03348332|aerobic exercise|aerobic exercise
5103842|NCT03348332|resistance exercise|resistance exercise
5103843|NCT03348332|wellbeing|wellbeing
5103844|NCT03348293|biodegradable scaffold|biodegradable scaffold
5103845|NCT03348293|immediate breast reconstruction|immediate breast reconstruction
5103846|NCT03348293|3D printing|3d printing
5103847|NCT03348241|Gum Arabic|gum arabic
5103848|NCT03348241|Cancer patients|cancer patients
5103849|NCT03348241|Chemotherapy|chemotherapy
5103850|NCT03348241|Oral mucositis|oral mucositis
5103851|NCT03348228|Hydroxycitrate Supplements|hydroxycitrate supplements
5103852|NCT03348215|Gait rehabilitation|gait rehabilitation
5103853|NCT03348163|Transgender women|transgender women
5103854|NCT03348163|Bictegravir|bictegravir
5103855|NCT03348150|HIPEC|hipec
5103856|NCT03348150|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5103857|NCT03348150|gastrectomy|gastrectomy
5103858|NCT03348150|cytoreductive surgery|cytoreductive surgery
5103859|NCT03348150|oxaliplatin|oxaliplatin
5103860|NCT03348150|docetaxel|docetaxel
5103861|NCT03348124|Intellectual disability|intellectual disability
5103862|NCT03348124|Parenthood|parenthood
5103863|NCT03348124|Reproduction|reproduction
5103864|NCT03348124|Intervention|intervention
5103865|NCT03348124|Adolescents|adolescents
5103866|NCT03348111|Mucositis|mucositis
5103867|NCT03348111|Peri-Implantitis|peri-implantitis
5103868|NCT03348111|Air-Flow Master Piezon®|air-flow master piezon®
5103869|NCT03348098|Triple negative breast cancer|triple negative breast cancer
5103870|NCT03348046|Infliximab|infliximab
5103871|NCT03348046|Remsima|remsima
5103872|NCT03348046|Biosimilar|biosimilar
5103873|NCT03348046|Autoimmune Disease|autoimmune disease
5103874|NCT03348046|Rheumatoid Arthritis|rheumatoid arthritis
5103875|NCT03348046|Cohort Study|cohort study
5103876|NCT03348046|Disease modifying anti-rheumatic drugs|disease modifying anti-rheumatic drugs
5961967|NCT04283760|kinesthetic imagery|kinesthetic imagery
5103877|NCT03348046|Tumor necrosis factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
5103878|NCT03347994|Acute Myeloid Leukemia|acute myeloid leukemia
5103880|NCT03347994|Refractory AML|refractory aml
5103881|NCT03347994|Relapsed AML|relapsed aml
5103882|NCT03347994|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5103883|NCT03347994|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5103884|NCT03347981|Intraocular Lens|intraocular lens
5103885|NCT03347981|trifocal|trifocal
5103886|NCT03347981|hydrophobic|hydrophobic
5103887|NCT03347981|hydrophilic|hydrophilic
5103888|NCT03347968|type 2 Diabetes Mellitus, MEDI0382|type 2 diabetes mellitus, medi0382
5103889|NCT03347955|placebo effect|placebo effect
5103890|NCT03347942|Overweight|overweight
5103892|NCT03347942|Satiety|satiety
5103893|NCT03347942|Cardiovascular risk|cardiovascular risk
5103894|NCT03347903|esophagus|esophagus
5103895|NCT03347903|motility|motility
5103896|NCT03347890|GLP-1|glp-1
5103897|NCT03347890|fMRI|fmri
5103898|NCT03347877|autologous osteo-periosteal cylinder graft|autologous osteo-periosteal cylinder graft
5103899|NCT03347877|autologous osteochondral graft|autologous osteochondral graft
5103900|NCT03347877|randomized controlled trial|randomized controlled trial
5423206|NCT01616667|Quality of Life|quality of life
5103901|NCT03347877|Hepple V osteochondral lesions of the talus|hepple v osteochondral lesions of the talus
5103902|NCT03347851|mechanical heart valve|mechanical heart valve
5103903|NCT03347851|On-X|on-x
5103904|NCT03347838|PD-1|pd-1
5103905|NCT03347838|Precancerous Conditions|precancerous conditions
5103906|NCT03347838|Nivolumab|nivolumab
5103907|NCT03347838|Lung Cancer Immunoprevention|lung cancer immunoprevention
5103908|NCT03347812|Aortic Arch|aortic arch
5103909|NCT03347812|Endovascular Treatment|endovascular treatment
5103910|NCT03347812|Traditional Open Surgery|traditional open surgery
5103911|NCT03347812|Chimney Technique|chimney technique
5103912|NCT03347812|Fenestration Technique|fenestration technique
5103913|NCT03347812|Branched Stent-grafts Technique|branched stent-grafts technique
5103914|NCT03347799|very premature infants|very premature infants
5103915|NCT03347799|screening|screening
5103916|NCT03347799|retinopathy|retinopathy
5103917|NCT03347773|Oral nutritional supplement|oral nutritional supplement
5103918|NCT03347773|Sarcopenic obesity|sarcopenic obesity
5103919|NCT03347773|Body composition|body composition
5103920|NCT03347760|68-Ga-DOTATOC PET|68-ga-dotatoc pet
5103921|NCT03347760|Myocarditis|myocarditis
5103922|NCT03347734|eye exercises|eye exercises
5103923|NCT03347734|convergence exercise|convergence exercise
5103924|NCT03347734|hyperopia|hyperopia
5103925|NCT03347734|oculomotor exercise|oculomotor exercise
5103926|NCT03347734|school-age children|school-age children
5103927|NCT03347708|Lumbar disc degeneration|lumbar disc degeneration
5103928|NCT03347708|Low back pain|low back pain
5103929|NCT03347708|Intervertebral disc degeneration|intervertebral disc degeneration
5103930|NCT03347695|modified Cox-Maze|modified cox-maze
5103931|NCT03347695|atrial fibrillation|atrial fibrillation
5103932|NCT03347695|surgery|surgery
5103933|NCT03347682|Amputation, prosthesis,psychometrics, questionnaires|amputation, prosthesis,psychometrics, questionnaires
5103934|NCT03347669|Fibromyalgia|fibromyalgia
5103935|NCT03347669|Small fiber neuropathy|small fiber neuropathy
5103936|NCT03347669|Sudoscan®|sudoscan®
5103937|NCT03347656|Mobilization Therapy|mobilization therapy
5103938|NCT03347656|Clitical Illness|clitical illness
5103939|NCT03347656|Stroke|stroke
5103940|NCT03347656|Intensive Care|intensive care
5103941|NCT03347656|Functional Mobility|functional mobility
5103942|NCT03347656|Quality of Life|quality of life
5103943|NCT03347643|Internet game addiction|internet game addiction
5103944|NCT03347643|Internet gaming disorder|internet gaming disorder
5104447|NCT03344471|PTSD|ptsd
5103948|NCT03347643|cue reactivity|cue reactivity
5103950|NCT03347630|oesophagus cancer|oesophagus cancer
5103951|NCT03347630|Staging|staging
5103952|NCT03347591|Fibrinogen|fibrinogen
5103953|NCT03347591|Factor II|factor ii
5103954|NCT03347591|Factor V|factor v
5103955|NCT03347591|Factor V & VIII|factor v & viii
5103956|NCT03347591|Factor VII|factor vii
5103957|NCT03347591|Factor X|factor x
5103958|NCT03347591|Factor XI|factor xi
5103959|NCT03347591|Factor XIII|factor xiii
5103960|NCT03347591|α2-antiplasmin|α2-antiplasmin
5103961|NCT03347591|Plasminogen activator inhibitor 1|plasminogen activator inhibitor 1
5103962|NCT03347591|Epidemiology|epidemiology
5103963|NCT03347591|Genetics|genetics
5103964|NCT03347591|Phenotype|phenotype
5103965|NCT03347565|adolescents, healthy controls|adolescents, healthy controls
5103966|NCT03347552|treatment engagement|treatment engagement
5103967|NCT03347526|Vigabatrin|vigabatrin
5103968|NCT03347526|Cosyntropin|cosyntropin
5103969|NCT03347513|H-pylori|h-pylori
5103970|NCT03347513|iron deficiency anemia|iron deficiency anemia
5103971|NCT03347513|Pregnancy|pregnancy
5103972|NCT03347513|iron therapy|iron therapy
5103973|NCT03347487|Bilateral Habenula|bilateral habenula
5103974|NCT03347487|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
5103975|NCT03347474|Bilateral Nucleus Accumbens|bilateral nucleus accumbens
5103976|NCT03347474|Methamphetamine Addiction|methamphetamine addiction
5103977|NCT03347461|Tympanostomy tube placement|tympanostomy tube placement
5103978|NCT03347461|Otiprio|otiprio
5103979|NCT03347461|Ciprodex drops|ciprodex drops
5101644|NCT03362970|STEC|stec
5103987|NCT03347435|acute coronary syndromes|acute coronary syndromes
5103988|NCT03347409|ERAS, Fast-track surgery, gynecology|eras, fast-track surgery, gynecology
5103989|NCT03347370|subcutaneous interferon beta therapy multiple sclerosis (MS)|subcutaneous interferon beta therapy multiple sclerosis (ms)
5103990|NCT03347370|injection site reactions (ISR)|injection site reactions (isr)
5103991|NCT03347370|flu-like symptoms (FLS)|flu-like symptoms (fls)
5103992|NCT03347370|non-interventional study (NIS)|non-interventional study (nis)
5103993|NCT03347370|SC Peginterferon beta-1a|sc peginterferon beta-1a
5103994|NCT03347370|SC interferon beta-1a|sc interferon beta-1a
5103995|NCT03347370|SC interferon beta-1b|sc interferon beta-1b
5103996|NCT03347370|Plegridy®|plegridy®
5103997|NCT03347370|Betaferon®|betaferon®
5103998|NCT03347370|Extavia®|extavia®
5103999|NCT03347370|Rebif®|rebif®
5104006|NCT03347292|Liver cell carcinoma|liver cell carcinoma
5104008|NCT03347279|Asthma, Uncontrolled Asthma, Severe Uncontrolled Asthma|asthma, uncontrolled asthma, severe uncontrolled asthma
5104012|NCT03347214|dbGaP|dbgap
5104013|NCT03347201|Cardiopulmonary bypass, Heparin, Protamine|cardiopulmonary bypass, heparin, protamine
5104014|NCT03347188|posttraumatic headache (PTH)|posttraumatic headache (pth)
5104015|NCT03347175|Respiration, Artificial|respiration, artificial
5104016|NCT03347175|Advanced Cardiac Life Support|advanced cardiac life support
5104017|NCT03347175|Heart Massage|heart massage
5104018|NCT03347175|Emergency Service, Hospital|emergency service, hospital
5104019|NCT03347162|Cancer|cancer
5104020|NCT03347162|Muscle mass|muscle mass
5104021|NCT03347162|Muscle strength|muscle strength
5104022|NCT03347162|Complications|complications
5104023|NCT03347162|Patient reported outcomes|patient reported outcomes
5104025|NCT03347162|Physical function|physical function
5104026|NCT03347149|Alarms|alarms
5104027|NCT03347149|Alarm Fatigue|alarm fatigue
5104028|NCT03347149|Alarm Nuisance|alarm nuisance
5104029|NCT03347149|Alarm Reduction|alarm reduction
5104030|NCT03347149|Patient Monitoring|patient monitoring
5104031|NCT03347149|Intensive Care|intensive care
5104032|NCT03347123|Epacadostat|epacadostat
5104033|NCT03347123|nivolumab|nivolumab
5104034|NCT03347123|ipilimumab|ipilimumab
5104035|NCT03347123|lirilumab|lirilumab
5104036|NCT03347123|solid tumor|solid tumor
5104037|NCT03347123|melanoma|melanoma
5104038|NCT03347123|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5104039|NCT03347123|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5104040|NCT03347123|IDO inhibitor|ido inhibitor
5104044|NCT03347097|glioma|glioma
5104045|NCT03347097|TIL|til
5104046|NCT03347097|PD1-TIL|pd1-til
5104047|NCT03347097|immunotherapy|immunotherapy
5104048|NCT03347084|DBS|dbs
5104049|NCT03347084|brain imaging|brain imaging
5104050|NCT03347084|Memory|memory
5104051|NCT03347084|fMRI|fmri
5104052|NCT03347071|prevention|prevention
5104053|NCT03347071|collegiate athletes|collegiate athletes
5104054|NCT03347071|yoga|yoga
5104055|NCT03347058|immunotherapy|immunotherapy
5104056|NCT03347045|cystectomy|cystectomy
5104057|NCT03347045|nutrition|nutrition
5104058|NCT03347045|physiotherapy|physiotherapy
5104059|NCT03347045|prehabilitation|prehabilitation
5104060|NCT03347045|enhanced recovery after surgery|enhanced recovery after surgery
5104061|NCT03347019|bankart repair|bankart repair
5104062|NCT03347019|accelerated rehabilitation|accelerated rehabilitation
5104063|NCT03347019|shoulder|shoulder
5104064|NCT03346993|Bupivacaine|bupivacaine
5104065|NCT03346993|Brachial Plexus Block|brachial plexus block
5104066|NCT03346993|Ultrasound|ultrasound
5104067|NCT03346980|Spigelman|spigelman
5104068|NCT03346967|AD mesenchymal stem cells;sexual hormone deficiency|ad mesenchymal stem cells;sexual hormone deficiency
5104069|NCT03346954|: Cushing's disease, [11C]-Methionine PET/MRI, Sensitivity|: cushing's disease, [11c]-methionine pet/mri, sensitivity
5104070|NCT03346915|HPV vaccinaton|hpv vaccinaton
5104071|NCT03346915|Cervical cancer screening|cervical cancer screening
5104072|NCT03346915|Web-based mobile health education|web-based mobile health education
5104073|NCT03346915|brief negotiated interview (BNI|brief negotiated interview (bni
5104074|NCT03346889|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5104075|NCT03346889|head impulse testing|head impulse testing
5104076|NCT03346889|quality of life|quality of life
5104077|NCT03346876|Pectus excavatum, heart rate variability|pectus excavatum, heart rate variability
5104078|NCT03346863|Electrical Cardioversion|electrical cardioversion
5104079|NCT03346824|Levosimendan|levosimendan
5104080|NCT03346824|Veno-arterial ECMO|veno-arterial ecmo
5104081|NCT03346824|Weaning|weaning
5104082|NCT03346798|External eating|external eating
5104083|NCT03346798|Technology|technology
5104084|NCT03346798|Photography|photography
5104085|NCT03346798|Social media|social media
5104086|NCT03346785|External eating|external eating
5104087|NCT03346785|Technology|technology
5104088|NCT03346785|Photography|photography
5104089|NCT03346785|Social media|social media
5104090|NCT03346759|tampon|tampon
5104091|NCT03346759|menstruation|menstruation
5104092|NCT03346759|menstrual period|menstrual period
5104093|NCT03346746|cognition|cognition
5104094|NCT03346746|glycaemic|glycaemic
5104101|NCT03346642|Relapsed/Refractory|relapsed/refractory
5104102|NCT03346642|primary mediastinal large B-cell lymphoma|primary mediastinal large b-cell lymphoma
5104103|NCT03346642|PD-1 antibody|pd-1 antibody
5104105|NCT03346642|GVD chemotherapy|gvd chemotherapy
5104106|NCT03346564|Head and neck cancer|head and neck cancer
5104107|NCT03346564|Ritual training|ritual training
5104108|NCT03346564|disfigurement|disfigurement
5104109|NCT03346564|body image|body image
5104110|NCT03346551|Postnatal depression|postnatal depression
5104111|NCT03346551|Attachment|attachment
5104112|NCT03346551|Self-defining memories|self-defining memories
5104113|NCT03346525|echocardiography|echocardiography
5104114|NCT03346525|penicillin prophylaxis|penicillin prophylaxis
5104115|NCT03346525|intramuscular benzathine penicillin G|intramuscular benzathine penicillin g
5104116|NCT03346525|benzathine penicillin G|benzathine penicillin g
5104117|NCT03346525|low-resource setting|low-resource setting
5104119|NCT03346486|Diet|diet
5104120|NCT03346486|Metabolites|metabolites
5104121|NCT03346486|Cognitive function|cognitive function
5104122|NCT03346486|Physiology|physiology
5104123|NCT03346486|LDL|ldl
5104124|NCT03346486|Diet Habit|diet habit
5104125|NCT03346486|Diet Modification|diet modification
5104126|NCT03346434|Eczema|eczema
5104127|NCT03346408|Analgesics|analgesics
5104128|NCT03346395|Adjustment disorders|adjustment disorders
5104129|NCT03346395|Anxiety disorders|anxiety disorders
5104130|NCT03346395|Depression|depression
5104131|NCT03346395|Mental disorders|mental disorders
5104132|NCT03346395|Interventional study|interventional study
5104133|NCT03346395|Primary health care|primary health care
5104134|NCT03346395|Problem solving|problem solving
5104135|NCT03346395|Randomized controlled trial|randomized controlled trial
5104136|NCT03346395|Return to work|return to work
5104137|NCT03346395|Sick leave|sick leave
5104138|NCT03346382|Epilepsy|epilepsy
5104139|NCT03346382|Emergency medical services|emergency medical services
5104140|NCT03346369|Nephrolithiasis|nephrolithiasis
5104141|NCT03346369|Urolithiasis|urolithiasis
5104142|NCT03346369|Secondary Hyperoxaluria|secondary hyperoxaluria
5104143|NCT03346369|Hyperoxaluria|hyperoxaluria
5104153|NCT03346317|Hysteroscopic Adhesiolysis|hysteroscopic adhesiolysis
5104154|NCT03346304|Autofluorescence Broncoscopy (AFB)|autofluorescence broncoscopy (afb)
5104155|NCT03346304|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5104156|NCT03346304|High Grade Lesions (HGLs)|high grade lesions (hgls)
5104157|NCT03346304|lung cancer|lung cancer
5104158|NCT03346304|photosensitiser|photosensitiser
5104160|NCT03346278|Cardiac Rehabilitation|cardiac rehabilitation
5104161|NCT03346278|Text Messaging|text messaging
5104162|NCT03346265|progressive modular rebalancing|progressive modular rebalancing
5104163|NCT03346265|PMR|pmr
5104164|NCT03346265|visual sensory cues|visual sensory cues
5104165|NCT03346265|SC|sc
5104166|NCT03346265|Parkinson Disease|parkinson disease
5104167|NCT03346265|Movement Disorders|movement disorders
5104168|NCT03346265|Parkinson rehabilitation|parkinson rehabilitation
5104169|NCT03346265|neurocognitive method|neurocognitive method
5104170|NCT03346265|motor performance|motor performance
5104171|NCT03346265|improving gait|improving gait
5104172|NCT03346265|physiotherapy|physiotherapy
5104173|NCT03346265|3D motion analysis system|3d motion analysis system
5104174|NCT03346265|improvements|improvements
5104175|NCT03346226|Delirium Dexmedetomidine elderly|delirium dexmedetomidine elderly
5104176|NCT03346213|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5104177|NCT03346213|Intravenous iron|intravenous iron
5104178|NCT03346213|Total haemoglobin mass|total haemoglobin mass
5104179|NCT03346148|Food Allergy, Restaurant staff|food allergy, restaurant staff
5104180|NCT03346109|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5104181|NCT03346109|medial group retropharyngeal node|medial group retropharyngeal node
5104182|NCT03346096|TEAM (Thiotepa, Etoposide, Cytosar, Melphalan )|team (thiotepa, etoposide, cytosar, melphalan )
5104183|NCT03346096|autologous stem-cell transplantation (ASCT)|autologous stem-cell transplantation (asct)
5104184|NCT03346096|malignant lymphoma|malignant lymphoma
5104185|NCT03346057|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia|arrhythmia, bradycardia, neuromuscular blocking agents, surgery, tachycardia
5104186|NCT03346031|music therapy, pain, oxidative stress parameters|music therapy, pain, oxidative stress parameters
5104188|NCT03345979|Alkermes|alkermes
5104189|NCT03345979|schizophrenia|schizophrenia
5104190|NCT03345979|aripiprazole lauroxil|aripiprazole lauroxil
5104191|NCT03345979|ARISTADA|aristada
5104192|NCT03345979|ARISTADA INITIO|aristada initio
5104193|NCT03345940|Multiple Sclerosis|multiple sclerosis
5104194|NCT03345927|S-adenosylhomocysteine|s-adenosylhomocysteine
5104195|NCT03345927|Endothelial function|endothelial function
5104199|NCT03345875|cervical cancer|cervical cancer
5104200|NCT03345875|self-collection|self-collection
5104201|NCT03345862|Social isolation, Loneliness, Health Related Quality of Life|social isolation, loneliness, health related quality of life
5104211|NCT03345823|Upadacitinib|upadacitinib
5104212|NCT03345823|ABT-494|abt-494
5104213|NCT03345823|Extension Study|extension study
5104214|NCT03345823|Efficacy|efficacy
5104215|NCT03345823|Safety|safety
5104216|NCT03345823|Crohn's Disease|crohn's disease
5104217|NCT03345823|Maintenance Study|maintenance study
5104218|NCT03345810|NSCLC|nsclc
5104219|NCT03345810|Non small cell lung cancer|non small cell lung cancer
5104220|NCT03345797|Paediatric|paediatric
5104221|NCT03345758|respiratory failure, circulatory failure|respiratory failure, circulatory failure
5104222|NCT03345745|Fetuin-A|fetuin-a
5104223|NCT03345745|S100A12|s100a12
5104224|NCT03345745|C-Reactive Protein|c-reactive protein
5104225|NCT03345745|Chronic Periodontitis|chronic periodontitis
5104226|NCT03345706|Hypothermia,ECPR|hypothermia,ecpr
5104227|NCT03345693|Rehabilitation|rehabilitation
5104228|NCT03345693|MoTrack Therapy|motrack therapy
5104229|NCT03345693|Telemedicine|telemedicine
5104230|NCT03345693|Computer Vision|computer vision
5104231|NCT03345693|Compliance|compliance
5104232|NCT03345680|Dental visits|dental visits
5104233|NCT03345680|School-based program|school-based program
5104234|NCT03345680|Dental screening|dental screening
5104235|NCT03345680|Dental Caries|dental caries
5104236|NCT03345641|premature birth|premature birth
5104237|NCT03345641|mother's post-traumatic reaction|mother's post-traumatic reaction
5104238|NCT03345641|mother-infant interactions|mother-infant interactions
5104246|NCT03345615|oral anticoagulation|oral anticoagulation
5104247|NCT03345615|hospitalization|hospitalization
5104248|NCT03345589|Ursodeoxycholic Acid|ursodeoxycholic acid
5104249|NCT03345576|Electric Stimulation|electric stimulation
5104250|NCT03345576|Spinal Cord Injuries|spinal cord injuries
5104251|NCT03345576|Muscle Denervation|muscle denervation
5104252|NCT03345576|carbohydrate metabolism|carbohydrate metabolism
5104253|NCT03345576|Lipids metabolism|lipids metabolism
5094713|NCT03406910|meat|meat
5104254|NCT03345576|Basal Metabolic Rate|basal metabolic rate
5104255|NCT03345576|Muscle Proteins|muscle proteins
5104256|NCT03345576|Mitochondria, Muscle|mitochondria, muscle
5104257|NCT03345576|RNA|rna
5104258|NCT03345576|Rehabilitation|rehabilitation
5104259|NCT03345563|Prostate Cancer|prostate cancer
5104260|NCT03345563|Fatigue|fatigue
5104261|NCT03345563|Elderly|elderly
5104262|NCT03345563|Supportive Care|supportive care
5104263|NCT03345563|Light Exercise|light exercise
5104264|NCT03345563|Quality of Life|quality of life
5104265|NCT03345537|Inflammatory|inflammatory
5104266|NCT03345537|Optic neuritis|optic neuritis
5104267|NCT03345537|autoantibodies anti MOG|autoantibodies anti mog
5104268|NCT03345524|Obstructive Sleep Apnea|obstructive sleep apnea
5104269|NCT03345524|OSA|osa
5104270|NCT03345524|Peer-Buddies|peer-buddies
5104271|NCT03345524|CPAP|cpap
5104272|NCT03345524|CPAP Adherence|cpap adherence
5104273|NCT03345511|ultrasound guided caudal block|ultrasound guided caudal block
5104274|NCT03345511|anal surgery|anal surgery
5104275|NCT03345485|Phase 1 clinical trial|phase 1 clinical trial
5104276|NCT03345485|Solid Tumor|solid tumor
5104277|NCT03345485|Small Cell Lung Cancer|small cell lung cancer
5104278|NCT03345485|Breast Cancer|breast cancer
5104279|NCT03345485|Ovarian Cancer|ovarian cancer
5104280|NCT03345485|Soft Tissue Sarcoma|soft tissue sarcoma
5104281|NCT03345485|Relapsed/Refractory|relapsed/refractory
5104282|NCT03345485|Triple Negative|triple negative
5104283|NCT03345485|GIST|gist
5104284|NCT03345485|Epithelial cancer|epithelial cancer
5104285|NCT03345485|Peritoneal cancer|peritoneal cancer
5104286|NCT03345485|Fallopian tube cancer|fallopian tube cancer
5104287|NCT03345485|Metastatic|metastatic
5104288|NCT03345485|Advanced|advanced
5104289|NCT03345485|Endometrial|endometrial
5104290|NCT03345485|Phase 2 clinical trial|phase 2 clinical trial
5104292|NCT03345407|Nemiralisib|nemiralisib
5104293|NCT03345407|Dose-Finding|dose-finding
5104294|NCT03345407|GSK2269557|gsk2269557
5104295|NCT03345407|Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease|acute moderate or severe exacerbation of chronic obstructive pulmonary disease
5104296|NCT03345394|crack cocaine|crack cocaine
5104297|NCT03345394|contingency management|contingency management
5104298|NCT03345394|ambulatory treatment|ambulatory treatment
5104299|NCT03345394|Brazil|brazil
5104300|NCT03345368|transcranial magnetic stimulation|transcranial magnetic stimulation
5104301|NCT03345368|obesity|obesity
5104302|NCT03345368|diet|diet
5104303|NCT03345303|Bortezomib|bortezomib
5104304|NCT03345290|Aging|aging
5104305|NCT03345290|Central pressure|central pressure
5104306|NCT03345290|FDG PET|fdg pet
5104307|NCT03345290|Quantita|quantita
5104308|NCT03345277|Termperature|termperature
5104309|NCT03345277|Fever|fever
5104310|NCT03345277|Vital Signs|vital signs
5104327|NCT03345147|dietary assessment|dietary assessment
5104328|NCT03345095|Marizomib|marizomib
5104329|NCT03345095|Temozolomide|temozolomide
5104330|NCT03345095|Glioblastoma|glioblastoma
5104331|NCT03345095|Phase III|phase iii
5104332|NCT03345069|Premature|premature
5104333|NCT03345069|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5104334|NCT03345069|Neurodevelopmental impairment|neurodevelopmental impairment
5104335|NCT03345069|Cerebral Palsy|cerebral palsy
5104336|NCT03345069|Cognitive Impairment|cognitive impairment
5166389|NCT02952534|ATM|atm
5104337|NCT03345069|Diffusion MRI|diffusion mri
5104338|NCT03345069|Functional MRI|functional mri
5104339|NCT03345069|Infant|infant
5104448|NCT03344471|prematurity|prematurity
5104344|NCT03345043|Moderna|moderna
5104345|NCT03345030|comet assay|comet assay
5104346|NCT03345030|DNA damage|dna damage
5104347|NCT03345030|granulosa|granulosa
5104348|NCT03345030|IVF outcome|ivf outcome
5104349|NCT03345004|Diamyd|diamyd
5104350|NCT03345004|Diabetes|diabetes
5104351|NCT03345004|Juvenile Diabetes|juvenile diabetes
5104352|NCT03345004|Diabetes Type 1|diabetes type 1
5104353|NCT03345004|Type 1 Diabetes|type 1 diabetes
5104354|NCT03345004|Autoimmune Diabetes|autoimmune diabetes
5104355|NCT03345004|Insulin Dependent Diabetes|insulin dependent diabetes
5104356|NCT03345004|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5104357|NCT03345004|rhGAD65|rhgad65
5104358|NCT03345004|GAD65|gad65
5104359|NCT03345004|GAD-Alum|gad-alum
5104360|NCT03345004|Diabetes Mellitus|diabetes mellitus
5104361|NCT03345004|Diabetes Mellitus Type 1|diabetes mellitus type 1
5104362|NCT03345004|Glucose Metabolism Disorders|glucose metabolism disorders
5104363|NCT03345004|Metabolic Diseases|metabolic diseases
5104364|NCT03345004|Vitamin D|vitamin d
5104365|NCT03345004|Vitamins|vitamins
5104366|NCT03345004|Micronutrients|micronutrients
5104367|NCT03345004|Cholecalciferol|cholecalciferol
5104368|NCT03345004|Ergocalciferols|ergocalciferols
5104369|NCT03344991|Hypothermia|hypothermia
5104370|NCT03344991|Newborn|newborn
5104371|NCT03344978|Neonate|neonate
5104372|NCT03344978|Premature|premature
5104373|NCT03344978|Hypothermia|hypothermia
5104374|NCT03344978|Cardboard|cardboard
5104375|NCT03344978|Cot|cot
5104376|NCT03344965|Metastatic Breast Cancer|metastatic breast cancer
5104377|NCT03344965|Invasive Breast Cancer|invasive breast cancer
5104378|NCT03344965|Somatic Mutation Breast Cancer (BRCA1)|somatic mutation breast cancer (brca1)
5104379|NCT03344965|Somatic Mutation Breast Cancer (BRCA2)|somatic mutation breast cancer (brca2)
5104380|NCT03344926|Acceptance and Commitment therapy|acceptance and commitment therapy
5104381|NCT03344926|ACT|act
5104382|NCT03344926|CBT|cbt
5104383|NCT03344926|Smart phone|smart phone
5104384|NCT03344926|Internet|internet
5104385|NCT03344926|Intervention|intervention
5104386|NCT03344900|mHealth|mhealth
5104387|NCT03344900|Medication adherence|medication adherence
5104388|NCT03344900|Barriers to adherence|barriers to adherence
5104389|NCT03344887|anemia|anemia
5104390|NCT03344887|donor sex|donor sex
5104391|NCT03344887|prospective blinded pragmatic randomized|prospective blinded pragmatic randomized
5104392|NCT03344874|heart sounds|heart sounds
5104393|NCT03344874|Stethee|stethee
5104394|NCT03344874|electronic stethoscope|electronic stethoscope
5104395|NCT03344861|lung cancer|lung cancer
5104396|NCT03344861|lung carcinoma|lung carcinoma
5104397|NCT03344861|lung metastases|lung metastases
5104398|NCT03344835|Prostate Cancer|prostate cancer
5104399|NCT03344835|Disease Outcome|disease outcome
5104400|NCT03344822|68Ga-PSMA PET|68ga-psma pet
5104401|NCT03344809|lymphoma|lymphoma
5104402|NCT03344809|unclassifiable|unclassifiable
5104415|NCT03344757|stress management|stress management
5104416|NCT03344744|Subarachnoid Haemorrhage|subarachnoid haemorrhage
5104417|NCT03344679|Pectoral nerve block|pectoral nerve block
5104419|NCT03344679|Magnesium sulphate|magnesium sulphate
5104425|NCT03344614|third-line treatment|third-line treatment
5104427|NCT03344614|raltitrexed|raltitrexed
5104428|NCT03344549|eHealth|ehealth
5104429|NCT03344549|Nutrition Therapy|nutrition therapy
5104430|NCT03344549|Telehealth|telehealth
5104431|NCT03344549|Diabetic Kidney Disease|diabetic kidney disease
5104432|NCT03344549|Chronic Kidney Disease|chronic kidney disease
5104433|NCT03344536|Debio 1347|debio 1347
5104434|NCT03344536|Fulvestrant|fulvestrant
5104435|NCT03344536|17-379|17-379
5104436|NCT03344510|lidocaine|lidocaine
5104437|NCT03344510|vibration|vibration
5104438|NCT03344510|anesthesia|anesthesia
5104439|NCT03344510|injection|injection
5104440|NCT03344510|pain|pain
5104441|NCT03344510|discomfort|discomfort
5104442|NCT03344510|dermatology|dermatology
5104443|NCT03344510|dermatologic surgery|dermatologic surgery
5104444|NCT03344510|local|local
5104445|NCT03344510|device|device
5104446|NCT03344471|preterm delivery|preterm delivery
5104449|NCT03344471|birth|birth
5104450|NCT03344471|personality|personality
5104451|NCT03344458|Human Growth Hormone|human growth hormone
5104452|NCT03344458|hGH|hgh
5104453|NCT03344458|GHD|ghd
5104454|NCT03344458|rhGH|rhgh
5104455|NCT03344458|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
5104456|NCT03344458|Long Acting Growth Hormone|long acting growth hormone
5104457|NCT03344458|Somatropin|somatropin
5104458|NCT03344458|Prodrug|prodrug
5104459|NCT03344458|Growth Failure|growth failure
5104460|NCT03344458|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5104461|NCT03344458|Sustained Release Growth Hormone|sustained release growth hormone
5104462|NCT03344458|Growth Hormone Deficiency|growth hormone deficiency
5104463|NCT03344458|TransCon GH|transcon gh
5104464|NCT03344419|cocaine|cocaine
5104465|NCT03344419|mindfulness based relapse prevention|mindfulness based relapse prevention
5104466|NCT03344419|motivational enhancement therapy|motivational enhancement therapy
5104467|NCT03344406|Asthma|asthma
5104468|NCT03344406|Telephone interview|telephone interview
5104469|NCT03344406|Cross-sectional|cross-sectional
5104470|NCT03344406|Qualitative research|qualitative research
5104471|NCT03344406|E-RS: COPD|e-rs: copd
5104472|NCT03344380|Gene polymorphism|gene polymorphism
5104473|NCT03344380|acute kidney injury|acute kidney injury
5104474|NCT03344380|liver transplantation|liver transplantation
5104475|NCT03344367|Non Hodgkin Lymphoma|non hodgkin lymphoma
5356821|NCT01917864|Autism Spectrum Disorders|autism spectrum disorders
5104476|NCT03344367|CD19-targeted chimeric antigen receptor|cd19-targeted chimeric antigen receptor
5104477|NCT03344367|JWCAR029|jwcar029
5104479|NCT03344328|Chemotherapy|chemotherapy
5104480|NCT03344328|Bortezomib|bortezomib
5104481|NCT03344328|Multiple myeloma|multiple myeloma
5104482|NCT03344315|Gingival recession|gingival recession
5104483|NCT03344315|Collagen matrix|collagen matrix
5104484|NCT03344315|Connective tissue graft|connective tissue graft
5104485|NCT03344315|Coronally advanced flap|coronally advanced flap
5104486|NCT03344315|Root coverage|root coverage
5104487|NCT03344315|keratinized tissue|keratinized tissue
5104488|NCT03344315|Periodontal disease|periodontal disease
5104489|NCT03344289|Linked-color-imaging|linked-color-imaging
5104490|NCT03344289|Advanced Imaging Techniques|advanced imaging techniques
5104491|NCT03344276|carotid stenosis|carotid stenosis
5104492|NCT03344276|neurocognition|neurocognition
5104493|NCT03344276|carotid stenting|carotid stenting
5104494|NCT03344276|circle of willis|circle of willis
4989734|NCT04055454|Phase 1|phase 1
5104495|NCT03344250|Adoptive Cell Therapy|adoptive cell therapy
5104496|NCT03344250|Armed Activated T-cells|armed activated t-cells
5104497|NCT03344250|Bispecific Antibodies|bispecific antibodies
5104498|NCT03344250|Immunotherapy|immunotherapy
5104499|NCT03344198|Cardiovascular Disease|cardiovascular disease
5104500|NCT03344198|Mediterranean Diet|mediterranean diet
5104501|NCT03344198|Exercise Training|exercise training
5104502|NCT03344198|Blood Pressure|blood pressure
5104503|NCT03344185|glycaemic index|glycaemic index
5104504|NCT03344185|mood|mood
5104505|NCT03344185|glucose|glucose
5104506|NCT03344185|diet|diet
5104507|NCT03344159|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5104508|NCT03344159|Brain natriuretic peptide (BNP)|brain natriuretic peptide (bnp)
5104509|NCT03344159|Sympathetic Nervous System|sympathetic nervous system
5104512|NCT03344133|Obesity|obesity
5104513|NCT03344133|Exercise|exercise
5104514|NCT03344133|CVD risk factors|cvd risk factors
5104515|NCT03344133|Appetite Regulation|appetite regulation
5104516|NCT03344133|Gut Microbiota|gut microbiota
5104517|NCT03344120|Symptoms and Signs|symptoms and signs
5104518|NCT03344120|Pain|pain
5104519|NCT03344120|Ureteral Calculi|ureteral calculi
5104520|NCT03344120|Ureteroscopy|ureteroscopy
5104521|NCT03344120|Ureteral Stents|ureteral stents
5104522|NCT03344107|Symptoms and Signs|symptoms and signs
5104525|NCT03344107|Ureteral Stent|ureteral stent
5104526|NCT03344107|Ureteroscopy|ureteroscopy
5104527|NCT03344081|attention|attention
5104528|NCT03344081|interoception|interoception
5104529|NCT03344081|meditation|meditation
5104530|NCT03344081|mind wandering|mind wandering
5104531|NCT03344068|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5104532|NCT03344068|nutritional support|nutritional support
5104533|NCT03344068|early and whole course|early and whole course
5104534|NCT03344068|efficacy and safety|efficacy and safety
5104535|NCT03344055|Adenoma Detection Rate|adenoma detection rate
5104536|NCT03344055|Endocuff|endocuff
5104537|NCT03344055|Colonoscopy|colonoscopy
5104538|NCT03344029|Influenza|influenza
5104540|NCT03343964|aEEG, cEEG|aeeg, ceeg
5104541|NCT03343951|Physical Therapists|physical therapists
5104542|NCT03343951|Diagnosis|diagnosis
5104543|NCT03343951|Clinical Competence|clinical competence
5104544|NCT03343951|Interprofessional Relations|interprofessional relations
5104545|NCT03343951|Cost Analysis|cost analysis
5104546|NCT03343938|Group embryo culture|group embryo culture
5104550|NCT03343925|Reinfection|reinfection
5104551|NCT03343912|Estriol|estriol
5104552|NCT03343912|Trimegestone|trimegestone
5104553|NCT03343912|Vaginal Ring|vaginal ring
5104554|NCT03343886|Health Status|health status
5104555|NCT03343886|Well-being|well-being
5104556|NCT03343886|Mental Health|mental health
5104557|NCT03343886|Risk Factors|risk factors
5104558|NCT03343886|Aging|aging
5104559|NCT03343873|anesthetics; fMRI; EEG; functional connectivity|anesthetics; fmri; eeg; functional connectivity
5104560|NCT03343834|Allogenic cell stem transplant (HSCT)|allogenic cell stem transplant (hsct)
5104561|NCT03343834|EBV-induced lymphoproliferation|ebv-induced lymphoproliferation
5104562|NCT03343834|Epigenetic|epigenetic
5104563|NCT03343808|Cooled radiofrequency|cooled radiofrequency
5104564|NCT03343808|chronic knee pain|chronic knee pain
5104565|NCT03343808|knee arthroplasty|knee arthroplasty
5104566|NCT03343808|genicular nerve|genicular nerve
5104567|NCT03343782|Diabetes|diabetes
4975802|NCT04143230|cancer|cancer
5104568|NCT03343782|BM mesenchymal stem cell|bm mesenchymal stem cell
5104569|NCT03343717|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5104570|NCT03343717|Mechanical ventilation|mechanical ventilation
5104571|NCT03343717|Physical therapy|physical therapy
5104572|NCT03343665|Nivolumab|nivolumab
5104573|NCT03343652|Hodgkin's Lymphoma|hodgkin's lymphoma
5104574|NCT03343652|Nivolumab|nivolumab
5104575|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride
5104576|NCT03343626|Drug therapy|drug therapy
5104580|NCT03343574|Parkinson's Disease|parkinson's disease
5104581|NCT03343574|Neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
5104582|NCT03343574|Orthostatic intolerance|orthostatic intolerance
5104583|NCT03343574|Exercise|exercise
5104584|NCT03343574|Abdominal binder|abdominal binder
5104585|NCT03343574|Autonomic dysfunction|autonomic dysfunction
5104586|NCT03343574|Dizziness|dizziness
5104587|NCT03343574|Physical Therapy|physical therapy
5104588|NCT03343574|Blood pressure|blood pressure
5104589|NCT03343574|Heart rate|heart rate
5104590|NCT03343574|Autonomic function testing|autonomic function testing
5104591|NCT03343574|Neurology|neurology
5104592|NCT03343574|Falls risk|falls risk
5104593|NCT03343574|Autonomic Nervous System|autonomic nervous system
5104594|NCT03343574|Autonomic reflex screening|autonomic reflex screening
5104595|NCT03343574|Cerebral blood flow|cerebral blood flow
4989842|NCT04054973|MRS|mrs
5104596|NCT03343574|Cerebral perfusion|cerebral perfusion
5104597|NCT03343574|Activities of Daily Living|activities of daily living
5104598|NCT03343535|portable ex-vivo lung perfusion|portable ex-vivo lung perfusion
5104599|NCT03343535|breathing lung transplant|breathing lung transplant
5104600|NCT03343535|portable OCS Lung System|portable ocs lung system
5104601|NCT03343522|Vascular function|vascular function
5104602|NCT03343522|Physical training|physical training
5104603|NCT03343522|Laser Speckle Contrast Imaging|laser speckle contrast imaging
5104604|NCT03343509|Hemorrhoidectomy|hemorrhoidectomy
5104605|NCT03343509|Metronidazole|metronidazole
5104606|NCT03343509|Postoperative analgesia|postoperative analgesia
5104607|NCT03343496|Awake fiberoptic intubation|awake fiberoptic intubation
5104617|NCT03343470|Immunological profile|immunological profile
5104618|NCT03343470|Cushing Disease|cushing disease
5104619|NCT03343457|Anxiety|anxiety
5104620|NCT03343457|Chronic Pain|chronic pain
5104621|NCT03343431|Hepatitis B|hepatitis b
5104622|NCT03343431|Hepatitis B eAg|hepatitis b eag
5104623|NCT03343431|Pregnancy|pregnancy
5104624|NCT03343418|Bleeding|bleeding
5104625|NCT03343418|Valve Cardiac Surgery|valve cardiac surgery
5104626|NCT03343418|Desmopressin|desmopressin
5104627|NCT03343405|Mind/Body|mind/body
5104628|NCT03343392|Hydrogen Peroxide|hydrogen peroxide
5104629|NCT03343392|Analgesics|analgesics
5104630|NCT03343392|Tooth Bleaching|tooth bleaching
5104631|NCT03343379|Abdominal muscles|abdominal muscles
5104632|NCT03343379|Back muscles|back muscles
5104633|NCT03343379|Core stability|core stability
5104634|NCT03343379|Field test|field test
5104635|NCT03343379|Muscle strength dynamometer|muscle strength dynamometer
5104636|NCT03343379|Lower extremity injury|lower extremity injury
5104637|NCT03343379|Risk assessment|risk assessment
5104638|NCT03343379|Prospective studies|prospective studies
5104639|NCT03343366|fasting plasma glucose|fasting plasma glucose
5104640|NCT03343366|fasting plasma insulin|fasting plasma insulin
5104641|NCT03343366|HOMA-IR insulin resistance|homa-ir insulin resistance
5104642|NCT03343366|clinical attachment loss|clinical attachment loss
5104643|NCT03343353|burn injury, phototherapy, wound healing|burn injury, phototherapy, wound healing
5104646|NCT03343288|Antimicrobial|antimicrobial
5104647|NCT03343288|Medical Device|medical device
5104648|NCT03343275|Stent, incrustation, pH Control|stent, incrustation, ph control
5104649|NCT03343236|Head and neck cancer|head and neck cancer
5104650|NCT03343236|Observational study|observational study
5748374|NCT00326066|Cataract|cataract
5104651|NCT03343236|Three tertiary hospitals|three tertiary hospitals
5104652|NCT03343236|Long-term follow-up|long-term follow-up
5104653|NCT03343236|Survival|survival
5104654|NCT03343236|Immune response|immune response
5104655|NCT03343236|Metabolomics|metabolomics
5104656|NCT03343197|Glioma|glioma
5104657|NCT03343197|IDH1|idh1
5104658|NCT03343197|AG-120|ag-120
5104659|NCT03343197|AG-881|ag-881
5104660|NCT03343184|dentin bonding agents|dentin bonding agents
5104661|NCT03343184|tooth sensitivity|tooth sensitivity
5104662|NCT03343184|composite resin restoration|composite resin restoration
5104663|NCT03343171|total hip arthroplasty|total hip arthroplasty
5104664|NCT03343145|Neutropenia|neutropenia
5104665|NCT03343106|Acceptance and Commitment Therapy|acceptance and commitment therapy
5104666|NCT03343106|Exposure and Response Prevention|exposure and response prevention
5104667|NCT03343106|Psychotherapy|psychotherapy
5104668|NCT03343106|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5104669|NCT03343106|Treatment Acceptability|treatment acceptability
5104670|NCT03343106|Treatment Adherence|treatment adherence
5104671|NCT03343093|Erectile Dysfunction|erectile dysfunction
5104672|NCT03343080|Cardiac Surgery|cardiac surgery
5961968|NCT04283747|Rituximab|rituximab
5961969|NCT04283747|Varicella Zoster|varicella zoster
5104673|NCT03343067|Endometriosis associated pain|endometriosis associated pain
5104674|NCT03343067|Elagolix|elagolix
5104675|NCT03343067|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
5104676|NCT03343067|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5104677|NCT03343054|Phase 1|phase 1
5104678|NCT03343054|talazoparib|talazoparib
5104679|NCT03343054|PF-06944076|pf-06944076
5104680|NCT03343054|MDV3800|mdv3800
5104681|NCT03343054|BMN673|bmn673
5104682|NCT03343054|PARP inhibitor|parp inhibitor
5104683|NCT03343054|Japanese|japanese
5104684|NCT03343054|solid tumors|solid tumors
5104685|NCT03343054|breast cancer|breast cancer
5104686|NCT03343054|C3441030|c3441030
5104687|NCT03343028|veterans|veterans
5104688|NCT03343028|post traumatic stress disorder|post traumatic stress disorder
5104689|NCT03343028|depression|depression
5104690|NCT03343015|TMD, centric relation, complete dentures|tmd, centric relation, complete dentures
5104691|NCT03342989|delirium|delirium
5104692|NCT03342989|speed of processing|speed of processing
5104693|NCT03342989|cognitive decline|cognitive decline
5104694|NCT03342976|Frailty|frailty
5104695|NCT03342976|Physical impairment|physical impairment
5104696|NCT03342976|Cognitive decline|cognitive decline
5104701|NCT03342924|cognitive control|cognitive control
5104702|NCT03342924|physical fitness|physical fitness
5104703|NCT03342924|minority|minority
5104708|NCT03342872|Substance Use Disorders|substance use disorders
5104709|NCT03342859|Uterine fibroids|uterine fibroids
5104710|NCT03342859|Bleeding reduction|bleeding reduction
5104711|NCT03342859|Vilaprisan|vilaprisan
5104712|NCT03342859|Mode of action|mode of action
5104713|NCT03342859|Hysterectomy|hysterectomy
5104714|NCT03342859|Myomectomy|myomectomy
5104715|NCT03342859|Pharmacodynamic|pharmacodynamic
5104716|NCT03342807|Hypertriglyceridemia-induced acute pancreatitis|hypertriglyceridemia-induced acute pancreatitis
5104717|NCT03342807|insulin|insulin
5104718|NCT03342807|triglyceride|triglyceride
5104719|NCT03342807|treatment|treatment
5104720|NCT03342781|bronchiolitis|bronchiolitis
5104721|NCT03342781|diffuser mask|diffuser mask
5104722|NCT03342781|high-flow nasal oxygen|high-flow nasal oxygen
5104723|NCT03342781|pediatric intensive-care unit|pediatric intensive-care unit
5104724|NCT03342716|Pancreatitis|pancreatitis
5104725|NCT03342716|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
5104726|NCT03342690|Selara|selara
5104727|NCT03342690|Chronic Heart Failure|chronic heart failure
5104728|NCT03342677|Cirrhosis|cirrhosis
5104730|NCT03342677|Primovist|primovist
5104731|NCT03342664|ICH|ich
5104732|NCT03342651|Vitamin D|vitamin d
5104733|NCT03342651|general anesthesia|general anesthesia
5104734|NCT03342651|respiratory complications|respiratory complications
5104735|NCT03342638|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5104736|NCT03342638|Stem Cells|stem cells
5104737|NCT03342638|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5104738|NCT03342625|High intensity focused ultrasound|high intensity focused ultrasound
5104739|NCT03342599|Alpha Lipoic Acid|alpha lipoic acid
5104740|NCT03342586|resting state functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
5104741|NCT03342586|rsfMRI|rsfmri
5104742|NCT03342586|17-403|17-403
5104749|NCT03342521|myocardial infarction|myocardial infarction
5104750|NCT03342521|optical coherence tomography|optical coherence tomography
5104751|NCT03342521|intracoronary thrombus|intracoronary thrombus
5104752|NCT03342521|VerifyNow|verifynow
5104753|NCT03342508|Maternal outcomes|maternal outcomes
5104754|NCT03342508|Neonatal Outcomes|neonatal outcomes
5104755|NCT03342495|transition, young adults, transfer|transition, young adults, transfer
5104756|NCT03342482|MSG|msg
5104757|NCT03342482|Gulf War Syndrome|gulf war syndrome
5104758|NCT03342482|Diet|diet
5104759|NCT03342482|Glutamate|glutamate
5104760|NCT03342469|ADHD|adhd
5104761|NCT03342469|Food Additives|food additives
5104762|NCT03342469|Artificial Food Coloring|artificial food coloring
5104763|NCT03342469|Diet|diet
5104764|NCT03342456|Helicobacter pylori eradication|helicobacter pylori eradication
5104765|NCT03342456|Duodenal Ulcer|duodenal ulcer
5104766|NCT03342456|Ilaprazole/Doxycycline-based Bismuth-containing quadruple therapy|ilaprazole/doxycycline-based bismuth-containing quadruple therapy
5104767|NCT03342443|memantine|memantine
5104768|NCT03342443|radiotherapy-related cognitive impairment|radiotherapy-related cognitive impairment
5104769|NCT03342417|breast cancer|breast cancer
5104770|NCT03342417|ovarian cancer|ovarian cancer
5104771|NCT03342417|gastric cancer|gastric cancer
5104772|NCT03342404|(β)-Thalassemia|(β)-thalassemia
5104773|NCT03342404|Beta-Thalassemia|beta-thalassemia
5104774|NCT03342404|Phase 2|phase 2
5104775|NCT03342404|Luspatercept|luspatercept
5104776|NCT03342404|ACE-536|ace-536
5104777|NCT03342404|Safety|safety
5104778|NCT03342404|Efficacy|efficacy
5104779|NCT03342404|Placebo|placebo
5104780|NCT03342404|Red Blood Cell Transfusions|red blood cell transfusions
5104781|NCT03342404|Erythrocyte transfusion|erythrocyte transfusion
5104782|NCT03342404|Hb increase|hb increase
5104783|NCT03342404|NTDT|ntdt
5104784|NCT03342378|HPV|hpv
5104785|NCT03342378|HPV-positive|hpv-positive
5104786|NCT03342378|Oropharynx Cancer|oropharynx cancer
5104787|NCT03342352|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5104788|NCT03342352|programmed cell death protein 1 (PD-1) antibody|programmed cell death protein 1 (pd-1) antibody
5104789|NCT03342352|indoleamine 2,3-dioxygenase (IDO) inhibitor|indoleamine 2,3-dioxygenase (ido) inhibitor
5104790|NCT03342339|influence of emotions|influence of emotions
5104791|NCT03342339|positif emotional induction|positif emotional induction
5104792|NCT03342339|decision making|decision making
5104793|NCT03342339|Iowa Gambling Task|iowa gambling task
5104794|NCT03342326|Lexical priming|lexical priming
5104795|NCT03342326|Healthy Aging|healthy aging
5104796|NCT03342300|soft tissue sarcoma|soft tissue sarcoma
5104797|NCT03342300|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5104798|NCT03342300|pirarubicin|pirarubicin
5104799|NCT03342300|toxicity for heart|toxicity for heart
5104800|NCT03342300|cumulative dose|cumulative dose
5104805|NCT03342235|Excimer Laser Surgery|excimer laser surgery
5104806|NCT03342235|Photorefractive Keratectomy|photorefractive keratectomy
5104809|NCT03342235|Refractive Surgical Procedures|refractive surgical procedures
5104810|NCT03342235|PRK|prk
5104811|NCT03342222|PEEK Interference Screw; Fixation; Anterior Cruciate Ligament Reconstruction|peek interference screw; fixation; anterior cruciate ligament reconstruction
5104812|NCT03342209|carbon monoxide toxicity|carbon monoxide toxicity
5104813|NCT03342209|high flow nasal cannula|high flow nasal cannula
5104814|NCT03342209|emergency department|emergency department
5104815|NCT03342196|Thiotepa|thiotepa
5104816|NCT03342196|Fludarabine|fludarabine
5104817|NCT03342196|Melphalan|melphalan
5104818|NCT03342183|Dialysis|dialysis
5104819|NCT03342183|Hemodialysis|hemodialysis
5104820|NCT03342183|Remote Ischemic Preconditioning|remote ischemic preconditioning
5104821|NCT03342144|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5104822|NCT03342144|Cancer|cancer
5104823|NCT03342144|Leukemia|leukemia
5104824|NCT03342144|venetoclax|venetoclax
5104825|NCT03342131|Wnt signaling|wnt signaling
5104826|NCT03342105|Rhinitis, Allergic|rhinitis, allergic
5104827|NCT03342105|Moxibustion|moxibustion
5104828|NCT03342040|TAP block|tap block
5104829|NCT03342040|laparoscopic IPOM|laparoscopic ipom
5104830|NCT03342040|post operative pain|post operative pain
5104834|NCT03341936|Squamous Cell Carcinoma|squamous cell carcinoma
5104835|NCT03341923|contact lenses|contact lenses
5104836|NCT03341923|lens centration|lens centration
5104837|NCT03341923|multifocal|multifocal
5104838|NCT03341897|embolization|embolization
5104839|NCT03341897|coiling|coiling
5104840|NCT03341897|varicocele|varicocele
5104841|NCT03341871|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
5104842|NCT03341871|Genotype|genotype
5104843|NCT03341871|glecaprevir|glecaprevir
5104844|NCT03341871|pibrentasvir|pibrentasvir
5104845|NCT03341871|sustained virologic response|sustained virologic response
5104846|NCT03341871|chronic hepatitis C virus genotype 1|chronic hepatitis c virus genotype 1
5104847|NCT03341871|chronic hepatitis C virus genotype 2|chronic hepatitis c virus genotype 2
5104848|NCT03341871|chronic hepatitis C virus genotype 3|chronic hepatitis c virus genotype 3
5104849|NCT03341871|chronic hepatitis C virus genotype 4|chronic hepatitis c virus genotype 4
5104850|NCT03341871|chronic hepatitis C virus genotype 5|chronic hepatitis c virus genotype 5
5104851|NCT03341871|chronic hepatitis C virus genotype 6|chronic hepatitis c virus genotype 6
5104852|NCT03341806|GBM|gbm
5104853|NCT03341806|LITT|litt
5104854|NCT03341806|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5104855|NCT03341806|Bavencio|bavencio
5104856|NCT03341806|immunotherapy|immunotherapy
5104857|NCT03341767|HIV|hiv
5104858|NCT03341767|Cryptosporidium|cryptosporidium
5104859|NCT03341767|Clofazimine|clofazimine
5104860|NCT03341754|Malaria Infection|malaria infection
5104861|NCT03341741|chronic pulmonary infection|chronic pulmonary infection
5104862|NCT03341702|jail|jail
5104863|NCT03341702|violence|violence
5104864|NCT03341702|predictive factors|predictive factors
5104865|NCT03341702|prevention|prevention
5104866|NCT03341689|Psilocybin|psilocybin
5104867|NCT03341663|Stable Angina Pectoris|stable angina pectoris
5104868|NCT03341663|Acupoint sensitization|acupoint sensitization
5104869|NCT03341663|Correlation analysis|correlation analysis
5104870|NCT03341663|Diagnostic value|diagnostic value
5104871|NCT03341650|Mediterranean Diet|mediterranean diet
5104872|NCT03341650|BMI|bmi
5104873|NCT03341650|weight loss|weight loss
5104874|NCT03341650|pasta|pasta
5104875|NCT03341650|obesity|obesity
5104876|NCT03341637|Drug Therapy|drug therapy
5104877|NCT03341624|persistent fetal vasculature|persistent fetal vasculature
5104878|NCT03341624|congenital cataract|congenital cataract
5104879|NCT03341533|Analgesia|analgesia
5104880|NCT03341533|Laparoscopy|laparoscopy
5104881|NCT03341533|Pain|pain
5104882|NCT03341507|laryngoscopy|laryngoscopy
5104883|NCT03341507|retromolar|retromolar
5104884|NCT03341481|galactagogues, lactogenesis, preterm labor|galactagogues, lactogenesis, preterm labor
5356822|NCT01917864|Prosody|prosody
5104885|NCT03341468|Urethral catheter discomfort|urethral catheter discomfort
5104886|NCT03341468|Urethral catheter pain|urethral catheter pain
5961970|NCT04283747|Hypogammaglobulinemia|hypogammaglobulinemia
5104887|NCT03341468|Urethral catheter immobilization device|urethral catheter immobilization device
5104888|NCT03341468|Prolonged urethral catheterization|prolonged urethral catheterization
5104889|NCT03341468|Foley catheter|foley catheter
5104890|NCT03341468|Urinary catheter|urinary catheter
5104891|NCT03341468|Indwelling urethral catheter support|indwelling urethral catheter support
5104892|NCT03341455|Sri Lanka|sri lanka
5104893|NCT03341455|preschool|preschool
5104894|NCT03341455|randomized control trial|randomized control trial
5104896|NCT03341429|GLP-1|glp-1
5104897|NCT03341429|liraglutide|liraglutide
5104898|NCT03341429|diabetes|diabetes
5104899|NCT03341429|bariatric surgery|bariatric surgery
5104900|NCT03341416|cerebellar ataxia|cerebellar ataxia
5104901|NCT03341416|stroke|stroke
5104902|NCT03341416|Spinocerebellar ataxia|spinocerebellar ataxia
5104903|NCT03341416|deep brain stimulation|deep brain stimulation
5104906|NCT03341403|synbiotic|synbiotic
5104907|NCT03341403|immunomodulation|immunomodulation
5104908|NCT03341403|sputum|sputum
5104909|NCT03341390|Healthy participants|healthy participants
5104910|NCT03341390|Healthy subjects|healthy subjects
5104911|NCT03341390|Strokes|strokes
5104912|NCT03341377|utility parameter|utility parameter
5104913|NCT03341377|patient-reported outcome|patient-reported outcome
5104914|NCT03341377|perioperative symptom management|perioperative symptom management
5104915|NCT03341377|lung cancer|lung cancer
5104916|NCT03341351|Fourth-degree laceration|fourth-degree laceration
5104917|NCT03341351|Beef tongue model|beef tongue model
5104918|NCT03341325|animal-assisted therapy|animal-assisted therapy
5104919|NCT03341273|Antibiotic Reduction|antibiotic reduction
5104920|NCT03341273|Antibiotic Therapy|antibiotic therapy
5104921|NCT03341273|Azyithromycin|azyithromycin
5104922|NCT03341273|Lower Respiratory Tract Infection|lower respiratory tract infection
5104923|NCT03341273|Procalcitonin|procalcitonin
5104924|NCT03341260|Pulpitis, irreversible Pulpitis,|pulpitis, irreversible pulpitis,
5104925|NCT03341260|Diclofenac Potassium|diclofenac potassium
5104926|NCT03341260|Premedication, Preoperative Analgesic|premedication, preoperative analgesic
5104927|NCT03341260|Postoperative pain|postoperative pain
5104928|NCT03341247|Obesity|obesity
5104929|NCT03341247|Portion Size Effect|portion size effect
5104930|NCT03341247|fMRI|fmri
5104931|NCT03341247|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5104932|NCT03341247|Inhibition|inhibition
5104933|NCT03341247|Decision Making|decision making
5104934|NCT03341247|Satiety Responsiveness|satiety responsiveness
5104935|NCT03341247|Anthropometrics|anthropometrics
5104946|NCT03341195|mHealth|mhealth
5104947|NCT03341182|epidural steroid injection|epidural steroid injection
5104948|NCT03341182|radiation exposure|radiation exposure
5104949|NCT03341182|mirror|mirror
5104950|NCT03341156|Heart transplantation|heart transplantation
5104954|NCT03341130|OSA|osa
5104955|NCT03341130|Mandibular Advancement Splint|mandibular advancement splint
5104956|NCT03341130|Oral Appliance|oral appliance
5104957|NCT03341130|Treatment|treatment
5104958|NCT03341130|Repositioning Splint|repositioning splint
5104959|NCT03341117|acetylsalicylic acid|acetylsalicylic acid
5104960|NCT03341117|antioxidant enzyme system|antioxidant enzyme system
5104961|NCT03341117|stress oxidative|stress oxidative
5104962|NCT03341117|type 2 diabetes mellitus.|type 2 diabetes mellitus.
5104963|NCT03341091|Tai-chi|tai-chi
5104964|NCT03341091|Dementia|dementia
5104965|NCT03341091|Dyad approach|dyad approach
5104966|NCT03341091|Fall prevention|fall prevention
5104967|NCT03341091|Mobility|mobility
5104968|NCT03341078|Ibudilast|ibudilast
5104969|NCT03341078|Methamphetamine|methamphetamine
5104970|NCT03341078|Neuroinflammation|neuroinflammation
5104971|NCT03341013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5104972|NCT03341013|GLP-1 receptor agonists|glp-1 receptor agonists
5104973|NCT03340987|vestibular incision subperiosteal tunnel access|vestibular incision subperiosteal tunnel access
5104974|NCT03340987|coronally advanced flap|coronally advanced flap
5104975|NCT03340987|subepithelial connective tissue graft|subepithelial connective tissue graft
5104976|NCT03340987|multiple gingival recessions|multiple gingival recessions
5104977|NCT03340974|Super Oxide Dismutase|super oxide dismutase
5104978|NCT03340948|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5104979|NCT03340948|Depressive symptoms|depressive symptoms
5104980|NCT03340948|Coronary Artery Disease|coronary artery disease
5104982|NCT03340935|fasting mimicking diet|fasting mimicking diet
5104983|NCT03340935|malignant neoplasm|malignant neoplasm
5104984|NCT03340935|metabolism|metabolism
5104985|NCT03340935|metabolic effects|metabolic effects
5104986|NCT03340935|adjuvant treatment|adjuvant treatment
5104987|NCT03340935|metastatic setting|metastatic setting
5104992|NCT03340896|Larynx, hypopharynx|larynx, hypopharynx
5104993|NCT03340857|Post-cancer retraining|post-cancer retraining
5104994|NCT03340857|Physical activity|physical activity
5104995|NCT03340857|Intelligent electric bicycle|intelligent electric bicycle
5104996|NCT03340818|Low back pain, bone marrow concentrate, disc degeneration|low back pain, bone marrow concentrate, disc degeneration
5104998|NCT03340805|Septic shock|septic shock
5104999|NCT03340805|Pediatric|pediatric
5105000|NCT03340805|Fluid resuscitation|fluid resuscitation
5105001|NCT03340805|Saline|saline
5105002|NCT03340805|Lactated Ringer's|lactated ringer's
5105003|NCT03340805|Crystalloid|crystalloid
5105004|NCT03340805|Mortality|mortality
5105005|NCT03340805|Pragmatic trial|pragmatic trial
5105006|NCT03340805|Feasibility|feasibility
5105007|NCT03340792|Exoskeleton Device|exoskeleton device
5105008|NCT03340792|Rehabilitation|rehabilitation
5105009|NCT03340792|Body composition|body composition
5105010|NCT03340792|Quality of Life|quality of life
5105011|NCT03340779|Norepinephrine|norepinephrine
5105012|NCT03340779|Dobutamine|dobutamine
5105013|NCT03340779|Shock|shock
5105014|NCT03340766|DLBCL Relapsed post-autologous or allogeneic hematopoietic stem cell transplantation (HSCT)|dlbcl relapsed post-autologous or allogeneic hematopoietic stem cell transplantation (hsct)
5105101|NCT03340259|Congenital malformations of the gastrointestinal tract|congenital malformations of the gastrointestinal tract
5105104|NCT03340259|Necrotizing enterocolitis|necrotizing enterocolitis
5105106|NCT03340259|Spontaneous intestinal perforation|spontaneous intestinal perforation
5105107|NCT03340246|Varicose veins, phlebectomy|varicose veins, phlebectomy
5105108|NCT03340233|diastolic dysfunction|diastolic dysfunction
5105109|NCT03340233|mechanism|mechanism
5105110|NCT03340233|MRI magnetic resonance imaging|mri magnetic resonance imaging
5105111|NCT03340233|ejection fraction|ejection fraction
5105112|NCT03340220|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5105113|NCT03340207|intubation|intubation
5105114|NCT03340207|anesthesiology|anesthesiology
5105115|NCT03340194|Systemic sclerosis|systemic sclerosis
5105116|NCT03340194|Calcinosis cutis|calcinosis cutis
5105117|NCT03340181|RIPC, myocardial protective effect|ripc, myocardial protective effect
5105118|NCT03340168|Bisphenol S, toxicokinetics|bisphenol s, toxicokinetics
5105126|NCT03340103|Lutein/Zeaxanthin|lutein/zeaxanthin
5105127|NCT03340103|Antioxidant|antioxidant
5105128|NCT03340103|Oxidative stress|oxidative stress
5105129|NCT03340103|Carotenoid|carotenoid
5105130|NCT03340103|Preterm newborn|preterm newborn
5105131|NCT03340064|Epilepsy|epilepsy
5105132|NCT03340064|Partial Seizures|partial seizures
5105133|NCT03340064|Levetiracetam|levetiracetam
5105141|NCT03339986|Feasibility|feasibility
5105142|NCT03339986|Acceptability|acceptability
5105143|NCT03339986|Snacking|snacking
5105144|NCT03339986|Preschool children|preschool children
5105153|NCT03339947|Multidrug-resistant Enterobacteriaceae acquisition|multidrug-resistant enterobacteriaceae acquisition
5105154|NCT03339947|travellers' diarrhoea|travellers' diarrhoea
5105155|NCT03339947|international travel|international travel
5105156|NCT03339895|COLORECTAL SURGERY|colorectal surgery
5105157|NCT03339895|PVI GUIDED FLUID MANAGEMENT|pvi guided fluid management
5105158|NCT03339895|GOAL DIRECTED THERAPY|goal directed therapy
5105159|NCT03339882|remifemin|remifemin
5105160|NCT03339882|preventive effect|preventive effect
5105165|NCT03339830|Spinal Muscular Atrophy|spinal muscular atrophy
5105166|NCT03339830|Neuromuscular disease|neuromuscular disease
5105167|NCT03339830|Spinraza|spinraza
5105168|NCT03339804|Chemotherapy|chemotherapy
5105169|NCT03339804|Muscle sympathetic nervous activity|muscle sympathetic nervous activity
5105170|NCT03339804|Blood flow|blood flow
5105171|NCT03339804|Endothelial microparticles|endothelial microparticles
5105172|NCT03339765|Self-advocacy|self-advocacy
5105173|NCT03339765|Advanced cancer|advanced cancer
5105174|NCT03339765|Serious games|serious games
5105175|NCT03339765|Self-management|self-management
5105176|NCT03339739|Musculoskeletal Pain|musculoskeletal pain
5105177|NCT03339739|Orofacial Pain|orofacial pain
5105178|NCT03339739|Physical Therapy Modalities|physical therapy modalities
5105179|NCT03339739|Oral Contraceptives|oral contraceptives
5105180|NCT03339739|Mandibular Diseases|mandibular diseases
5105181|NCT03339739|Muscular Diseases|muscular diseases
5105182|NCT03339739|Risk factors|risk factors
5105183|NCT03339739|Contraceptive Usage|contraceptive usage
5105184|NCT03339739|Pain, Chronic|pain, chronic
5105185|NCT03339739|Craniomandibular Disorders|craniomandibular disorders
5105186|NCT03339661|CMV infection|cmv infection
5105187|NCT03339661|kidney transplant|kidney transplant
5105188|NCT03339661|γδ T cells monitoring|γδ t cells monitoring
5105189|NCT03339648|School Resource Officer|school resource officer
5105190|NCT03339648|Trauma Informed Care|trauma informed care
5105191|NCT03339648|Cultural Competency|cultural competency
5105192|NCT03339648|Restorative Problem Solving|restorative problem solving
5105193|NCT03339648|Social Emotional Learning|social emotional learning
5105194|NCT03339648|Professional Development|professional development
5105195|NCT03339648|School Violence|school violence
5105196|NCT03339622|uncontrollable cancer pain|uncontrollable cancer pain
5105197|NCT03339622|incurable malignancy,|incurable malignancy,
5105198|NCT03339596|electroconvulsive therapy|electroconvulsive therapy
5105199|NCT03339596|depression|depression
5105200|NCT03339596|cognition|cognition
5105201|NCT03339596|cognitive side-effects|cognitive side-effects
5105202|NCT03339596|erythropoietin|erythropoietin
5105203|NCT03339596|functional magnetic resonance imaging|functional magnetic resonance imaging
5105204|NCT03339583|chronic insomnia|chronic insomnia
5105205|NCT03339583|brief behavioral treatment|brief behavioral treatment
5105206|NCT03339583|behavioral treatment|behavioral treatment
5105207|NCT03339583|insomnia severity index|insomnia severity index
5105208|NCT03339583|predictors|predictors
5105209|NCT03339583|treatment response|treatment response
5105211|NCT03339531|prostate neoplasms|prostate neoplasms
5105212|NCT03339531|radiotherapy|radiotherapy
5105213|NCT03339531|simulation|simulation
5105214|NCT03339492|rotator cuff|rotator cuff
5105215|NCT03339492|PEMF|pemf
5105216|NCT03339492|Pulsed Electromagnetic Field|pulsed electromagnetic field
5105217|NCT03339492|Rotator Cuff Repair|rotator cuff repair
5105218|NCT03339492|adjunctive therapy|adjunctive therapy
5105219|NCT03339479|dielectric property|dielectric property
5105220|NCT03339479|lung nodules|lung nodules
5105226|NCT03339362|low back pain|low back pain
5105227|NCT03339362|lumbar facet joint pain|lumbar facet joint pain
5105228|NCT03339362|feasibility|feasibility
5105229|NCT03339362|lumbar facet joint injection|lumbar facet joint injection
5105236|NCT03339258|PTSD|ptsd
5105237|NCT03339258|Doxazosin|doxazosin
5105238|NCT03339258|Nightmares|nightmares
5105239|NCT03339258|Sleep Disturbance|sleep disturbance
5105240|NCT03339245|obesity|obesity
5105241|NCT03339245|fructose|fructose
5105242|NCT03339245|glucose|glucose
5105243|NCT03339245|fecal microbiota|fecal microbiota
5105244|NCT03339245|intestinal permiability|intestinal permiability
5105245|NCT03339245|fecal metabolites|fecal metabolites
5105246|NCT03339193|atrial fibrillation|atrial fibrillation
5105247|NCT03339193|stroke|stroke
5105248|NCT03339193|atrial appendage|atrial appendage
5105249|NCT03339180|cardiac troponin|cardiac troponin
5105250|NCT03339167|Lysine, Adult, Protein Quality|lysine, adult, protein quality
5105251|NCT03339154|Healthy|healthy
5105253|NCT03339154|Adults|adults
5105254|NCT03339154|Methionine|methionine
5105255|NCT03339141|Intubation conditions|intubation conditions
5105256|NCT03339141|Anaesthetic techniques|anaesthetic techniques
5105257|NCT03339141|Laryngoscopy|laryngoscopy
5105258|NCT03339128|Irritable Bowel Syndrome with Diarrhea|irritable bowel syndrome with diarrhea
5105259|NCT03339128|IBSD|ibsd
5105260|NCT03339128|IBS-D|ibs-d
5105261|NCT03339128|Irritable Bowel Syndrome|irritable bowel syndrome
5105262|NCT03339128|Pediatric|pediatric
5105263|NCT03339115|Mitral Insufficiency|mitral insufficiency
5105264|NCT03339115|Heart Failure|heart failure
5105265|NCT03339115|Mitral Valve|mitral valve
5105266|NCT03339115|Heart Diseases|heart diseases
5105267|NCT03339115|Valvular Heart Disease|valvular heart disease
5105268|NCT03339102|Non-infectious intermediate, posterior and panuveitis|non-infectious intermediate, posterior and panuveitis
5105269|NCT03339102|Post-Marketing Surveillance|post-marketing surveillance
5105270|NCT03339102|Humira®|humira®
5105271|NCT03339089|rheumatoid arthritis|rheumatoid arthritis
5105272|NCT03339089|plaque psoriasis|plaque psoriasis
5105273|NCT03339089|ankylosing spondylitis|ankylosing spondylitis
5105274|NCT03339089|Immune-Mediated Inflammatory Diseases|immune-mediated inflammatory diseases
5105275|NCT03339089|Chinese Patients|chinese patients
5105276|NCT03339063|Nontuberculous Mycobacteria|nontuberculous mycobacteria
5105277|NCT03339063|Non-tuberculous mycobacteria|non-tuberculous mycobacteria
5105278|NCT03339063|NTM-PD|ntm-pd
5105279|NCT03339063|NTM-LD|ntm-ld
5105281|NCT03339063|M. avium|m. avium
5105282|NCT03339063|M. intracellulare|m. intracellulare
5105283|NCT03339063|M. abscessus|m. abscessus
5105284|NCT03339063|Atypical mycobacteria|atypical mycobacteria
5105285|NCT03339063|NTM|ntm
5105286|NCT03339050|church-based health promotion|church-based health promotion
5105287|NCT03339050|African Americans|african americans
5105288|NCT03339037|HBOT|hbot
5105289|NCT03339037|TBI|tbi
5105290|NCT03339037|pediatrics|pediatrics
5105291|NCT03339037|PCS|pcs
5105292|NCT03339037|PPCS|ppcs
5105293|NCT03339037|concussion|concussion
5105294|NCT03339037|traumatic brain injury|traumatic brain injury
5105295|NCT03339037|hyperbaric oxygen|hyperbaric oxygen
5105300|NCT03338998|stroke|stroke
5105301|NCT03338998|intracerebral hemorrhage|intracerebral hemorrhage
5105302|NCT03338998|ICH|ich
5105303|NCT03338998|BAF312|baf312
5105304|NCT03338998|siponimod|siponimod
5105305|NCT03338998|sphingosine-1-phosphate receptor|sphingosine-1-phosphate receptor
5105306|NCT03338946|Remote monitoring|remote monitoring
5105307|NCT03338920|acute migraine|acute migraine
5105308|NCT03338920|aura|aura
5105309|NCT03338920|sumatriptan nasal powder|sumatriptan nasal powder
5105310|NCT03338920|AVP-825|avp-825
5105311|NCT03338920|adolescents|adolescents
5105312|NCT03338907|cerebral hypoxia|cerebral hypoxia
5105313|NCT03338907|CO2|co2
5105314|NCT03338907|cerebral perfusion|cerebral perfusion
5105315|NCT03338907|hypoxia|hypoxia
5105316|NCT03338881|Drug therapy|drug therapy
5105317|NCT03338868|physical activity|physical activity
5105318|NCT03338868|pain|pain
5105319|NCT03338868|uric acid|uric acid
5105320|NCT03338855|T2DM, insulin resistance, skeletal muscle, mitochondria, dapagliflozin|t2dm, insulin resistance, skeletal muscle, mitochondria, dapagliflozin
5105321|NCT03338816|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
5105322|NCT03338816|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
5105323|NCT03338816|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
5105324|NCT03338816|Variegate Porphyria (VP)|variegate porphyria (vp)
5105325|NCT03338816|ALA dehydratase deficient porphyria (ADP) (ALAD)|ala dehydratase deficient porphyria (adp) (alad)
5105326|NCT03338816|RNAi therapeutic|rnai therapeutic
5105327|NCT03338816|Porphyria|porphyria
5105350|NCT03338686|Patient-centered outcomes|patient-centered outcomes
5105351|NCT03338647|Stereotactic body radiation therapy|stereotactic body radiation therapy
5105352|NCT03338647|transarterial chemoembolization|transarterial chemoembolization
5105353|NCT03338647|SBRT|sbrt
5105354|NCT03338647|TACE|tace
5105355|NCT03338634|Portion Size Effect|portion size effect
5105356|NCT03338634|Childhood Obesity|childhood obesity
5105357|NCT03338634|fMRI|fmri
5105358|NCT03338621|tuberculosis|tuberculosis
5105359|NCT03338621|drug-resistant tuberculosis|drug-resistant tuberculosis
5105360|NCT03338621|TB|tb
5105361|NCT03338621|DR-TB|dr-tb
5105362|NCT03338621|pretomanid|pretomanid
5105363|NCT03338621|PA-824|pa-824
5105364|NCT03338621|bedaquiline|bedaquiline
5105365|NCT03338621|TMC207|tmc207
5105366|NCT03338621|moxifloxacin|moxifloxacin
5105367|NCT03338621|pyrazinamide|pyrazinamide
5105368|NCT03338621|HRZE|hrze
5105369|NCT03338621|TB Alliance|tb alliance
5105370|NCT03338621|NC-008|nc-008
5105371|NCT03338621|drug-sensitive tuberculosis|drug-sensitive tuberculosis
5105372|NCT03338621|DS-TB|ds-tb
5105373|NCT03338608|Cosmesis|cosmesis
5105374|NCT03338608|Wound Healing|wound healing
5105375|NCT03338608|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
5105376|NCT03338608|ACDF|acdf
5105377|NCT03338608|Platysma|platysma
5105378|NCT03338595|arterial stiffness|arterial stiffness
5105379|NCT03338595|flow-mediated dilation|flow-mediated dilation
5105380|NCT03338595|endothelial function|endothelial function
5105381|NCT03338595|Orkambi|orkambi
5105382|NCT03338595|exercise capacity|exercise capacity
5105383|NCT03338582|Pacemaker|pacemaker
5105384|NCT03338582|Conduction disturbance|conduction disturbance
5105385|NCT03338582|TAVI|tavi
5105386|NCT03338556|Rhinovirus|rhinovirus
5105387|NCT03338556|Healthy volunteer|healthy volunteer
5105388|NCT03338556|Outpatient|outpatient
5105389|NCT03338556|Cold virus|cold virus
5105390|NCT03338556|HRV-16|hrv-16
5105391|NCT03338543|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
5105392|NCT03338543|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5105393|NCT03338543|pain|pain
5105394|NCT03338543|liver cancer|liver cancer
5105395|NCT03338543|hepatocellular carcinoma|hepatocellular carcinoma
5105400|NCT03338465|Greater Trochanteric Pain Syndrome,|greater trochanteric pain syndrome,
5105401|NCT03338465|Gluteal|gluteal
5105402|NCT03338465|Tendinopathy|tendinopathy
5105403|NCT03338465|ESWT|eswt
5105404|NCT03338465|shockwave|shockwave
5105405|NCT03338452|ketogenic diet|ketogenic diet
5105406|NCT03338452|body composition|body composition
5105407|NCT03338452|metabolism|metabolism
5105408|NCT03338452|body dissatisfaction|body dissatisfaction
5105409|NCT03338452|cognition|cognition
5105410|NCT03338413|Rehabilitation|rehabilitation
5105411|NCT03338400|Quality of Recovery, Dexamethasone, Same day surgery|quality of recovery, dexamethasone, same day surgery
5105412|NCT03338387|neuropeptides|neuropeptides
5105413|NCT03338387|microdialysis|microdialysis
5105414|NCT03338374|Cardiac chronotropy|cardiac chronotropy
5105415|NCT03338374|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5105416|NCT03338374|Rate responsive pacemaker|rate responsive pacemaker
5105417|NCT03338374|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5105418|NCT03338361|approach avoidance training|approach avoidance training
5105419|NCT03338361|attentional bias training|attentional bias training
5105420|NCT03338361|alcohol depencence|alcohol depencence
5105421|NCT03338361|relapse|relapse
5105422|NCT03338348|Vosaroxin|vosaroxin
5105423|NCT03338322|postoperative pain|postoperative pain
5105424|NCT03338322|reciproc|reciproc
5105425|NCT03338322|twisted file adaptive|twisted file adaptive
5105426|NCT03338309|Fractional flow reserve|fractional flow reserve
5105427|NCT03338309|Instantaneous wave-free ratio|instantaneous wave-free ratio
5105428|NCT03338309|Ischemic heart disease|ischemic heart disease
5105438|NCT03338257|Pre-school children|pre-school children
5105439|NCT03338257|fruit and vegetable acceptance|fruit and vegetable acceptance
5105440|NCT03338257|service-learning|service-learning
5105441|NCT03338257|pre-school nutrition education|pre-school nutrition education
5105442|NCT03338257|childhood obesity|childhood obesity
5105443|NCT03338244|Childhood mortality|childhood mortality
5105444|NCT03338244|Mass treatment|mass treatment
5105445|NCT03338244|Azithromycin|azithromycin
5105446|NCT03338244|Infection|infection
5105447|NCT03338231|Immunity duration|immunity duration
5105448|NCT03338218|Hydroxyethylstarch (HES)|hydroxyethylstarch (hes)
5105449|NCT03338205|ketamine|ketamine
5105450|NCT03338205|pediatric status asthmaticus|pediatric status asthmaticus
5105451|NCT03338192|Low back pain|low back pain
5105452|NCT03338192|Chronic pain|chronic pain
5105453|NCT03338192|Health disparities in chronic low back pain|health disparities in chronic low back pain
5105467|NCT03338010|Insulin glargine|insulin glargine
5105468|NCT03337997|Irreversible Electroporation|irreversible electroporation
5105469|NCT03337997|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5105470|NCT03337984|Diverticulitis|diverticulitis
5105471|NCT03337984|Damage Control Surgery|damage control surgery
5105472|NCT03337971|Post-menopausal|post-menopausal
5105473|NCT03337971|Osteoporosis|osteoporosis
5105474|NCT03337971|Bone Turnover Markers|bone turnover markers
5105475|NCT03337971|Dairy Products|dairy products
5105476|NCT03337958|Education|education
5105477|NCT03337958|Dry Powder Inhalers|dry powder inhalers
5105478|NCT03337958|Metered Dose Inhalers|metered dose inhalers
5105479|NCT03337958|Pulmonary Disease|pulmonary disease
5105480|NCT03337958|Chronic Obstructive|chronic obstructive
5105481|NCT03337945|CYP450 phenotyping in patients with liver cirrhosis|cyp450 phenotyping in patients with liver cirrhosis
5105482|NCT03337906|HIV|hiv
5105483|NCT03337867|Recurrent stroke|recurrent stroke
5105484|NCT03337867|Stroke|stroke
5105485|NCT03337867|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5105486|NCT03337867|Theta-Burst-Stimulation|theta-burst-stimulation
5105487|NCT03337854|prognostic|prognostic
5105488|NCT03337854|phenotype|phenotype
5105489|NCT03337854|Computed tomography|computed tomography
5105490|NCT03337854|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5105491|NCT03337841|Hepatocellular carcinoma|hepatocellular carcinoma
5105492|NCT03337841|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
5105493|NCT03337841|Adjuvant chemotherapy|adjuvant chemotherapy
5105494|NCT03337841|Immune checkpoint inhibitor|immune checkpoint inhibitor
5105495|NCT03337841|Pembrolizumab|pembrolizumab
5105496|NCT03337828|Alcohol-free beer|alcohol-free beer
5105497|NCT03337828|Carbohydrates|carbohydrates
5105498|NCT03337828|Overweight|overweight
5105499|NCT03337828|Obesity|obesity
5105500|NCT03337828|Diabetes mellitus type 2|diabetes mellitus type 2
5105501|NCT03337828|Microbiota|microbiota
5105502|NCT03337828|Glucose metabolism|glucose metabolism
5105503|NCT03337776|WhatsApp messenger|whatsapp messenger
5105504|NCT03337776|crc screening|crc screening
5103015|NCT03353909|hyaluronan gel|hyaluronan gel
5105514|NCT03337711|NSCLC;ctDNA;IIA-IIIA|nsclc;ctdna;iia-iiia
5105515|NCT03337659|Family-integrated care|family-integrated care
5105516|NCT03337659|neonatal intensive care unit|neonatal intensive care unit
5105517|NCT03337659|premature|premature
5105518|NCT03337659|infant development|infant development
5105519|NCT03337646|vyvanse|vyvanse
5105520|NCT03337646|executive function|executive function
5105521|NCT03337646|safety|safety
5105522|NCT03337633|cognitive load|cognitive load
5105523|NCT03337633|galvanic skin response|galvanic skin response
5105524|NCT03337633|meal size|meal size
5105525|NCT03337633|kilocalories|kilocalories
5105526|NCT03337633|menu design|menu design
5105528|NCT03337607|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5105529|NCT03337607|ESWT|eswt
5105530|NCT03337607|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
5105531|NCT03337607|rESWT|reswt
5105532|NCT03337607|Chronic non-specific low back pain|chronic non-specific low back pain
5105533|NCT03337607|Non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
5105534|NCT03337594|Gadolinium|gadolinium
5105535|NCT03337594|MultiHance|multihance
5105536|NCT03337594|Dotarem|dotarem
5105537|NCT03337594|Contrast agents|contrast agents
5105538|NCT03337594|Magnetic Resonance Imaging|magnetic resonance imaging
5105539|NCT03337594|Gadolinium retention|gadolinium retention
5105540|NCT03337594|Pediatric|pediatric
5105541|NCT03337594|Bone|bone
5105542|NCT03337581|Dexmedetomidine|dexmedetomidine
5105543|NCT03337581|pediatrics|pediatrics
5105544|NCT03337581|Pharmacodynamics|pharmacodynamics
5105545|NCT03337581|Pharmacokinetics|pharmacokinetics
5105546|NCT03337568|AML CR|aml cr
5105547|NCT03337568|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5105553|NCT03337542|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5105554|NCT03337542|OIT (oral immunotherapy)|oit (oral immunotherapy)
5105555|NCT03337542|Peanut Allergy|peanut allergy
5105556|NCT03337542|Peanut-Allergic Children|peanut-allergic children
5105557|NCT03337542|Desensitization|desensitization
5105558|NCT03337542|Food Allergy|food allergy
5105559|NCT03337464|exercise|exercise
5105560|NCT03337464|EEG|eeg
5105561|NCT03337464|EMG|emg
5105562|NCT03337464|Motor function|motor function
5105563|NCT03337464|Mood|mood
5105564|NCT03337464|Cognition|cognition
5105565|NCT03337425|Psychotherapy, group|psychotherapy, group
5105566|NCT03337425|Adults|adults
5105567|NCT03337412|Therapeutic Education|therapeutic education
5105568|NCT03337412|physical activity|physical activity
4990853|NCT04049240|Obesity|obesity
5105569|NCT03337412|overweight|overweight
5105570|NCT03337412|obesity|obesity
5105571|NCT03337399|Lung Cancer|lung cancer
5105572|NCT03337373|Critical care|critical care
5105573|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents
5105574|NCT03337373|Pharmacodynamics|pharmacodynamics
5105575|NCT03337373|Pharmacokinetics|pharmacokinetics
5105576|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs
5105577|NCT03337360|fertility|fertility
5105578|NCT03337360|male subfertility|male subfertility
5105579|NCT03337360|foodsupplement|foodsupplement
5105580|NCT03337360|oxidative stress|oxidative stress
5105581|NCT03337347|Prognostic significance|prognostic significance
5105582|NCT03337321|pregnancy|pregnancy
5105583|NCT03337321|emotions|emotions
5105584|NCT03337321|patient experience|patient experience
5105585|NCT03337321|maternal care|maternal care
5105586|NCT03337308|hyperlipidemia|hyperlipidemia
5105587|NCT03337308|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5105588|NCT03337308|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5105589|NCT03337308|high cholesterol|high cholesterol
5105590|NCT03337308|ASCVD|ascvd
5105591|NCT03337308|HeFH|hefh
5105593|NCT03337295|Meibomian Gland Dysfunction|meibomian gland dysfunction
5105594|NCT03337295|Lipid Layer Thickness|lipid layer thickness
5105595|NCT03337282|anesthesia|anesthesia
5105596|NCT03337282|noncardiac surgery|noncardiac surgery
5105597|NCT03337282|major surgery|major surgery
5105598|NCT03337282|POCD|pocd
5105599|NCT03337243|Stem Cell Injection|stem cell injection
5105600|NCT03337243|Cytokine|cytokine
5105601|NCT03337243|Wharton's Jelly|wharton's jelly
5105602|NCT03337243|Stem Cells|stem cells
5105603|NCT03337230|Cancer|cancer
5105604|NCT03337230|Weight-Loss|weight-loss
5105605|NCT03337230|Social Media|social media
5105606|NCT03337217|colonoscopy|colonoscopy
5105607|NCT03337191|ultrasound guided caudal injection|ultrasound guided caudal injection
5105608|NCT03337191|sacral hiatus|sacral hiatus
5105609|NCT03337191|sacral canal|sacral canal
5105610|NCT03337165|Rheumatoid arthritis|rheumatoid arthritis
5105611|NCT03337165|Auto-immune disorders|auto-immune disorders
5105612|NCT03337165|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
5105613|NCT03337139|Weight Loss|weight loss
5105614|NCT03337139|Obesity|obesity
5105615|NCT03337139|Overweight|overweight
5105616|NCT03337139|Behavioral Weight Loss|behavioral weight loss
5105617|NCT03337100|Opioids|opioids
5105618|NCT03337100|Naloxone|naloxone
5105619|NCT03337100|Co-dispensing|co-dispensing
5105620|NCT03337100|Cluster randomized trial|cluster randomized trial
5105621|NCT03337100|Opioid antagonist|opioid antagonist
5105622|NCT03337035|Probiotics, Oxytocin|probiotics, oxytocin
5105624|NCT03337022|CC-90006|cc-90006
5105625|NCT03337022|Mild to moderate plaque-type psoriasis|mild to moderate plaque-type psoriasis
5105626|NCT03337022|Safety|safety
5105627|NCT03337022|Pharmacokinetics|pharmacokinetics
5105628|NCT03337022|Pharmacodynamics|pharmacodynamics
5105629|NCT03337009|Opioid antagonist|opioid antagonist
5105633|NCT03336996|Motor nerve injury|motor nerve injury
5105634|NCT03336996|umbilical cord interstitial stem cell|umbilical cord interstitial stem cell
5105635|NCT03336996|bold-DTI|bold-dti
5105636|NCT03336996|reconstruction of motor circuits|reconstruction of motor circuits
5105637|NCT03336983|prostate cancer|prostate cancer
5105638|NCT03336983|bone metastasis|bone metastasis
5105639|NCT03336983|enzalutamide|enzalutamide
5105640|NCT03336983|zoledronic acid|zoledronic acid
5105641|NCT03336970|single visit root canal treatment, chlorhexidine|single visit root canal treatment, chlorhexidine
5105642|NCT03336957|chromogranin A, stress, gingivitis, pregnancy|chromogranin a, stress, gingivitis, pregnancy
5105643|NCT03336931|children|children
5105644|NCT03336931|precision medicine|precision medicine
5105645|NCT03336931|personalised medicine|personalised medicine
5105646|NCT03336931|high-risk cancer|high-risk cancer
5105647|NCT03336931|refractory|refractory
5105648|NCT03336931|recurrent|recurrent
5105649|NCT03336931|sequencing|sequencing
5105650|NCT03336931|patient derived xenograft|patient derived xenograft
5105651|NCT03336931|molecular profiling|molecular profiling
5105652|NCT03336931|paediatric|paediatric
5105653|NCT03336918|Bipolar Disorder|bipolar disorder
5105654|NCT03336918|Bipolar I and II Depression|bipolar i and ii depression
5105655|NCT03336918|Lithium|lithium
5105656|NCT03336918|Depression|depression
5105657|NCT03336905|Adolescent and young adult|adolescent and young adult
5105658|NCT03336892|Care Coordination|care coordination
5105659|NCT03336879|Gambling Disorder|gambling disorder
5105660|NCT03336879|Mental Disorder|mental disorder
5105661|NCT03336879|Behavioral Addiction|behavioral addiction
5105662|NCT03336827|Emotion Regulation|emotion regulation
5105663|NCT03336827|Post-Treatment Breast Cancer Care|post-treatment breast cancer care
5105664|NCT03336827|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5105665|NCT03336827|CBT|cbt
5105666|NCT03336827|Hypnosis|hypnosis
5105667|NCT03336814|Terlipressin|terlipressin
5105668|NCT03336814|norepinephrine|norepinephrine
5105669|NCT03336801|sevoflurane|sevoflurane
5105670|NCT03336801|propofol|propofol
5105671|NCT03336775|acupuncure|acupuncure
5105672|NCT03336775|dysphagia|dysphagia
5105673|NCT03336775|radiation|radiation
5105674|NCT03336749|Stroke, upper limb, sensory training, rehabilitation|stroke, upper limb, sensory training, rehabilitation
5105675|NCT03336736|Physical Activity|physical activity
5105676|NCT03336736|Diet|diet
5105677|NCT03336736|Exercise|exercise
5105678|NCT03336736|Sarcoidosis|sarcoidosis
5105679|NCT03336736|Pulmonary sarcoidosis|pulmonary sarcoidosis
5105680|NCT03336736|Lung Function|lung function
5105681|NCT03336736|Fitness|fitness
5105682|NCT03336736|Strength|strength
5167843|NCT02943213|USL|usl
5105683|NCT03336736|Endurance|endurance
5105684|NCT03336710|Self-control|self-control
5105685|NCT03336710|Ecological Momentary Assessment|ecological momentary assessment
5105686|NCT03336710|Attentional bias|attentional bias
5105687|NCT03336710|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
5105688|NCT03336710|Affect|affect
5105689|NCT03336710|Emotion Regulation|emotion regulation
5105690|NCT03336710|Well-being|well-being
5105691|NCT03336710|Decentering|decentering
5105692|NCT03336710|Affective disorders|affective disorders
5105693|NCT03336684|Patient education|patient education
5105694|NCT03336684|Rheumatoid arthritis|rheumatoid arthritis
5105695|NCT03336684|Knowledge|knowledge
5105696|NCT03336684|Attitudes|attitudes
5105697|NCT03336684|Practice|practice
5105698|NCT03336671|Pediatric|pediatric
5105699|NCT03336671|Chronic Sinusitis|chronic sinusitis
5105703|NCT03336632|PBSCT|pbsct
5105704|NCT03336632|myeloablative conditioning|myeloablative conditioning
5105705|NCT03336632|HDACi|hdaci
5105706|NCT03336632|chidamide|chidamide
5105707|NCT03336619|Influenza|influenza
5105708|NCT03336606|immunotherapy|immunotherapy
5105709|NCT03336606|OX40|ox40
5105710|NCT03336606|antibodies|antibodies
5105711|NCT03336606|HNSCC|hnscc
5105712|NCT03336606|melanoma|melanoma
5105713|NCT03336606|phase 1|phase 1
5105714|NCT03336606|squamous cell|squamous cell
5105715|NCT03336567|telephonic interview|telephonic interview
5105716|NCT03336567|TCR Therapy|tcr therapy
5105717|NCT03336567|cross-sectional|cross-sectional
5105718|NCT03336567|CGT|cgt
5105719|NCT03336567|qualitative|qualitative
5105720|NCT03336554|osteosarcoma|osteosarcoma
5105721|NCT03336554|epigenetic biomarker|epigenetic biomarker
5105722|NCT03336554|hMe-Seal technique|hme-seal technique
5105723|NCT03336541|Prenatal depression|prenatal depression
5105724|NCT03336541|Ketamine|ketamine
5105725|NCT03336541|Cesarean delivery|cesarean delivery
5105728|NCT03336515|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
5105729|NCT03336515|Postural Device|postural device
5105730|NCT03336515|Treatment|treatment
5105731|NCT03336476|Direct laryngoscopy|direct laryngoscopy
5105732|NCT03336476|Videolaryngoscopy|videolaryngoscopy
5105733|NCT03336476|Diabetes Mellitus|diabetes mellitus
5105734|NCT03336476|Intubation|intubation
5105735|NCT03336476|Anesthesia|anesthesia
5105736|NCT03336463|Thrombophilia screening|thrombophilia screening
5105737|NCT03336463|Genetic risk score|genetic risk score
5105738|NCT03336437|Menopause|menopause
5105739|NCT03336437|Vaginal dryness|vaginal dryness
5105740|NCT03336437|Vaginal atrophy|vaginal atrophy
5105741|NCT03336437|Postmenopause|postmenopause
5105742|NCT03336437|Estrogen|estrogen
5105743|NCT03336437|Urinary microbiome|urinary microbiome
5105744|NCT03336437|Estradiol vaginal ring|estradiol vaginal ring
5105745|NCT03336437|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
5105746|NCT03336437|Vaginal microbiome|vaginal microbiome
5105747|NCT03336424|MS|ms
5105748|NCT03336424|Multiple sclerosis|multiple sclerosis
5105749|NCT03336424|urinary Bladder, Neurogenic|urinary bladder, neurogenic
5105750|NCT03336424|Urodynamics|urodynamics
5105751|NCT03336424|Randomized controlled trial|randomized controlled trial
5105752|NCT03336385|Older adults|older adults
5105763|NCT03336333|BTK inhibitor|btk inhibitor
5105764|NCT03336333|bendamustine|bendamustine
5105765|NCT03336333|rituximab|rituximab
5105766|NCT03336333|venetoclax|venetoclax
5105767|NCT03336333|BGB-3111|bgb-3111
5105768|NCT03336333|Phase 3|phase 3
5105769|NCT03336307|Parkinson disease|parkinson disease
5105770|NCT03336307|movement Disorders|movement disorders
5105771|NCT03336307|gait disturbance|gait disturbance
5105772|NCT03336307|Parkinson|parkinson
5105773|NCT03336307|Parkinson gait|parkinson gait
5105774|NCT03336307|3D motion analysis systems|3d motion analysis systems
5105775|NCT03336307|motion analysis|motion analysis
5105776|NCT03336307|Parkinson rehabilitation|parkinson rehabilitation
5105777|NCT03336307|rehabilitation gait improvement|rehabilitation gait improvement
5105778|NCT03336307|gait improvement|gait improvement
5105779|NCT03336307|SMART Capture|smart capture
5105780|NCT03336307|MATLAB software|matlab software
5105781|NCT03336294|Sarcopenia|sarcopenia
5105782|NCT03336294|Muscle strength|muscle strength
5105783|NCT03336294|SRM P31|srm p31
5105784|NCT03336294|Phosphocreatine|phosphocreatine
5105785|NCT03336268|Opioid Use Disorder|opioid use disorder
5105786|NCT03336268|Peer Recovery Coach|peer recovery coach
5105787|NCT03336229|cancer|cancer
5105788|NCT03336229|colorectal|colorectal
5105789|NCT03336229|exercise|exercise
5105790|NCT03336229|physical fitness|physical fitness
5105791|NCT03336203|eGFR, gout, CKD, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat|egfr, gout, ckd, uric acid, uric acid lowering therapy, hyperuricemia, allopurinol, febuxostat
5105792|NCT03336190|military|military
5105793|NCT03336190|caregiver|caregiver
5105795|NCT03336177|cancer|cancer
5105796|NCT03336177|aged|aged
5105797|NCT03336177|delay|delay
5105798|NCT03336177|help-seeking behavior|help-seeking behavior
5105799|NCT03336177|qualitative research|qualitative research
5105800|NCT03336177|semiopragmatic analysis|semiopragmatic analysis
5105801|NCT03336177|psychodynamic analysis|psychodynamic analysis
5105802|NCT03336112|Non-cardiac chest pain|non-cardiac chest pain
5105803|NCT03336112|Psychological distress|psychological distress
5105804|NCT03336112|I-CBT|i-cbt
5105805|NCT03336047|Exercise|exercise
5105806|NCT03336047|Actigraphy|actigraphy
5105807|NCT03336047|Prevention and Control|prevention and control
5105808|NCT03336047|Cardiorespiratory Fitness|cardiorespiratory fitness
5105814|NCT03335995|mechanical invasive ventilation|mechanical invasive ventilation
5105815|NCT03335995|course of the care|course of the care
5105816|NCT03335995|prognosis|prognosis
5105817|NCT03335995|stroke|stroke
5105818|NCT03335982|transendoscopic enteral tubing|transendoscopic enteral tubing
5105819|NCT03335982|mid-gut|mid-gut
5105820|NCT03335982|endoscopy|endoscopy
5105821|NCT03335982|nasal-jejunal tube|nasal-jejunal tube
5105822|NCT03335982|fecal microbiota transplantation|fecal microbiota transplantation
5105823|NCT03335982|enteral nutrition|enteral nutrition
5105824|NCT03335956|Glucocorticoid receptor; antagonist|glucocorticoid receptor; antagonist
5105825|NCT03335943|CDA-2, MDS|cda-2, mds
5105826|NCT03335930|exercise|exercise
5105827|NCT03335930|blood glucose response|blood glucose response
5105828|NCT03335930|metabolic control|metabolic control
5105829|NCT03335930|type 2 diabetes.|type 2 diabetes.
5105830|NCT03335904|Angiotensin receptor blockade|angiotensin receptor blockade
5105831|NCT03335904|control of breathing|control of breathing
5105834|NCT03335891|balance|balance
5105835|NCT03335891|core stabilization exercises|core stabilization exercises
5105837|NCT03335826|Elderly|elderly
5105838|NCT03335826|Cancer surgery|cancer surgery
5105839|NCT03335826|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
5105840|NCT03335826|Long-term survival|long-term survival
5105841|NCT03335826|Quality of life|quality of life
5105842|NCT03335813|brachytherapy|brachytherapy
5105843|NCT03335813|multichannel balloon applicator|multichannel balloon applicator
5105844|NCT03335787|Athletic Tape|athletic tape
5105845|NCT03335787|Proprioception|proprioception
5105846|NCT03335787|Hemiplegia|hemiplegia
5105847|NCT03335787|Gait|gait
5105848|NCT03335761|Urinary|urinary
5105849|NCT03335761|Incontinence|incontinence
5105850|NCT03335748|ADHD|adhd
5105851|NCT03335748|Combined type|combined type
5116283|NCT03269136|BCMA|bcma
5105861|NCT03335722|electrical current stimulation|electrical current stimulation
5105862|NCT03335722|metronome-timed speech|metronome-timed speech
5105863|NCT03335709|Occupational therapy|occupational therapy
5105864|NCT03335696|Epidemiology|epidemiology
5105865|NCT03335696|Magnetic resonance imaging|magnetic resonance imaging
5105866|NCT03335696|Diffusion tensor imaging|diffusion tensor imaging
5105867|NCT03335696|White matter|white matter
5105868|NCT03335696|Functional MRI|functional mri
5105869|NCT03335696|Connectome|connectome
5105870|NCT03335696|Resting state brain networks|resting state brain networks
5105871|NCT03335696|Neuropsychology|neuropsychology
5105872|NCT03335670|68Ga-pentixafor|68ga-pentixafor
5105873|NCT03335670|(68Ga)pentixafor|(68ga)pentixafor
5105874|NCT03335670|Gallium Radioisotopes|gallium radioisotopes
5105875|NCT03335670|CXCR4|cxcr4
5105876|NCT03335644|determinants of dietary patterns and nutritional status|determinants of dietary patterns and nutritional status
5105877|NCT03335618|Activity|activity
5105878|NCT03335618|Mood|mood
5105879|NCT03335605|primary immunodeficiency|primary immunodeficiency
5105880|NCT03335527|Aged|aged
5105881|NCT03335527|Postoperative period|postoperative period
5105882|NCT03335527|Intensive Care Unit|intensive care unit
5105883|NCT03335527|Mechanical ventilation|mechanical ventilation
5105884|NCT03335527|Sleep quality|sleep quality
5105885|NCT03335527|Dexmedetomidine|dexmedetomidine
5105886|NCT03335514|GALNT4|galnt4
5749073|NCT00323739|bevacizumab|bevacizumab
5105887|NCT03335501|Closed-loop control|closed-loop control
5105888|NCT03335501|Artificial pancreas|artificial pancreas
5105889|NCT03335501|Postprandial glucose control|postprandial glucose control
5105890|NCT03335501|Insulin|insulin
5105893|NCT03335475|congenital heart disease|congenital heart disease
5105894|NCT03335475|physical activity|physical activity
5105895|NCT03335436|buprenorphine maintenance|buprenorphine maintenance
5105896|NCT03335397|education|education
5105897|NCT03335397|health science|health science
5105898|NCT03335397|app|app
5105899|NCT03335397|m-learning|m-learning
5105900|NCT03335358|couples|couples
5105901|NCT03335358|positive psychology|positive psychology
5105902|NCT03335358|behavioral intervention|behavioral intervention
5105903|NCT03335358|stroke|stroke
5105904|NCT03335358|depression|depression
5105905|NCT03335358|wellbeing|wellbeing
5105906|NCT03335358|caregiver|caregiver
5105907|NCT03335345|Airway Extubation/adverse effects/ Methods|airway extubation/adverse effects/ methods
5105908|NCT03335345|Nutrition|nutrition
5105909|NCT03335345|Ventilator Weaning/methods|ventilator weaning/methods
5105910|NCT03335345|Intensive care Unit|intensive care unit
5105911|NCT03335345|Enteral Nutrition|enteral nutrition
5105912|NCT03335332|High intensity exercise|high intensity exercise
5105913|NCT03335332|Cardiorespiratory fitness|cardiorespiratory fitness
5105914|NCT03335332|Stroke volume reserve|stroke volume reserve
5105915|NCT03335332|Arrhythmia burden|arrhythmia burden
5105916|NCT03335319|Cardiovascular Disease|cardiovascular disease
5105917|NCT03335319|Coronary Artery Disease|coronary artery disease
5105918|NCT03335319|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5105919|NCT03335319|Oxygen Uptake Kinetics|oxygen uptake kinetics
5105920|NCT03335319|Skeletal Muscle Oxygenation|skeletal muscle oxygenation
5105921|NCT03335319|Exercise Training|exercise training
5105922|NCT03335319|Periodized Exercise|periodized exercise
5105923|NCT03335306|Body constitution|body constitution
5105924|NCT03335306|Chinese Medicine|chinese medicine
5105925|NCT03335306|Validation|validation
5105926|NCT03335293|pregnancy|pregnancy
5105927|NCT03335293|repeat cesarean section|repeat cesarean section
5105928|NCT03335293|spinal anesthesia|spinal anesthesia
5105929|NCT03335293|bupivacaine|bupivacaine
5105930|NCT03335293|epinephrine|epinephrine
5105931|NCT03335293|intrathecal|intrathecal
5105932|NCT03335293|analgesia|analgesia
5105933|NCT03335254|Hypogonadism|hypogonadism
5105934|NCT03335254|Testosterone|testosterone
5105935|NCT03335254|Testosterone undecanoate|testosterone undecanoate
5105936|NCT03335241|Ovarian Cancer|ovarian cancer
5105937|NCT03335241|Fludarabine|fludarabine
5105938|NCT03335241|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5105939|NCT03335241|Chemotherapy|chemotherapy
5105940|NCT03335228|platelet rich plasma, frontal fibrosing alopecia|platelet rich plasma, frontal fibrosing alopecia
5105941|NCT03335202|respiratory and intestinal microbiome|respiratory and intestinal microbiome
5116388|NCT03268590|Hyperoxia|hyperoxia
5105953|NCT03335124|Sepsis|sepsis
5105954|NCT03335124|Vitamin C|vitamin c
5105955|NCT03335124|Hydrocortisone|hydrocortisone
5105956|NCT03335124|Thiamine|thiamine
5105957|NCT03335124|Critical Illness|critical illness
5105958|NCT03335124|Fluid Responsiveness|fluid responsiveness
5105960|NCT03335111|Remote Ischemic Postconditioning|remote ischemic postconditioning
5105961|NCT03335111|Peripheral Immunity|peripheral immunity
5105962|NCT03335098|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5105963|NCT03335098|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5105965|NCT03335098|Thalidomide|thalidomide
5105966|NCT03335072|Azithromycin|azithromycin
5105967|NCT03335072|Mass Drug Administration|mass drug administration
5105968|NCT03335072|Antibiotic Resistance|antibiotic resistance
5105970|NCT03335059|Bacillus Calmette-Guérin|bacillus calmette-guérin
5105971|NCT03335059|CIS|cis
5105972|NCT03335059|BCG-unresponsive|bcg-unresponsive
5105973|NCT03335059|Synergo|synergo
5105974|NCT03335059|chemohyperthermia|chemohyperthermia
5105975|NCT03335059|thermochemotherapy|thermochemotherapy
5105976|NCT03335059|RF|rf
5105977|NCT03335059|radio frequency|radio frequency
5105978|NCT03335059|RITE|rite
5105979|NCT03335046|Home Visit|home visit
5105980|NCT03335046|School Absenteeism|school absenteeism
5105981|NCT03335033|Carotid Plaque|carotid plaque
5105982|NCT03335033|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
5105983|NCT03335033|Shear Wave Elastography|shear wave elastography
5105984|NCT03335033|Endarterectomy|endarterectomy
5105985|NCT03335033|Stenosis|stenosis
5105986|NCT03335020|Ultrasound|ultrasound
5105987|NCT03335020|3D ultrasonography|3d ultrasonography
5105988|NCT03335020|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5105989|NCT03335020|Shear wave elastography|shear wave elastography
5105990|NCT03335007|Aceclofenac|aceclofenac
5105991|NCT03335007|pain|pain
5105992|NCT03335007|irreversible pulpitis|irreversible pulpitis
5105993|NCT03334994|Immediate dental implant, Connective tissue graft, Esthetic zone.|immediate dental implant, connective tissue graft, esthetic zone.
5105994|NCT03334981|meconium concentration|meconium concentration
5105995|NCT03334981|buprenorphine|buprenorphine
5105996|NCT03334981|methadone|methadone
5105997|NCT03334981|pregnant|pregnant
5105998|NCT03334981|liquid chromatography-tandem mass spectrometry|liquid chromatography-tandem mass spectrometry
5105999|NCT03334981|opioid-dependant woman|opioid-dependant woman
5106000|NCT03334968|Stroke|stroke
5106001|NCT03334968|prolidase|prolidase
5106002|NCT03334968|prognosis|prognosis
5106003|NCT03334968|biomarker|biomarker
5106004|NCT03334955|Polycystic Ovary Syndrome|polycystic ovary syndrome
5106005|NCT03334955|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
5106006|NCT03334955|subendometrial blood flow|subendometrial blood flow
5106007|NCT03334942|youth|youth
5106008|NCT03334942|parents|parents
5106009|NCT03334942|posttraumatic stress|posttraumatic stress
5106010|NCT03334942|violence|violence
5106011|NCT03334942|violent injuries|violent injuries
5106012|NCT03334929|virtual reality|virtual reality
5106013|NCT03334929|trigger point injections|trigger point injections
5106014|NCT03334903|Total Knee Arthroplasty|total knee arthroplasty
5106015|NCT03334903|Neurontin|neurontin
5106016|NCT03334903|Gabapentin|gabapentin
5106017|NCT03334903|Opioid Tapering|opioid tapering
5106018|NCT03334890|colorectal cancer|colorectal cancer
5106019|NCT03334890|septin 9|septin 9
5106020|NCT03334890|SEPT9|sept9
5106021|NCT03334890|methylation|methylation
5106022|NCT03334890|CEA|cea
5106023|NCT03334864|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5106026|NCT03334825|HIV|hiv
5106027|NCT03334825|housing|housing
5106028|NCT03334825|homelessness|homelessness
5106029|NCT03334812|cartilage lesion, ACI|cartilage lesion, aci
5106030|NCT03334799|sacroiliac belt|sacroiliac belt
5106031|NCT03334799|kinematics|kinematics
5106033|NCT03334799|pelvic girdle pain|pelvic girdle pain
5116483|NCT03267979|analgesic treatment|analgesic treatment
5106053|NCT03334669|Head Start|head start
5106054|NCT03334669|Family Interventions|family interventions
5106055|NCT03334669|Community Based Participatory Research (CBPR)|community based participatory research (cbpr)
5106056|NCT03334669|Empowerment Theory|empowerment theory
5106057|NCT03334669|Family Ecological Theory|family ecological theory
5106058|NCT03334669|Step Wedge Design|step wedge design
5106059|NCT03334669|Low Income|low income
5106060|NCT03334656|Split thickness skin graft donor site|split thickness skin graft donor site
5106061|NCT03334656|wound healing|wound healing
5106062|NCT03334656|Fetal skin bioconstruct|fetal skin bioconstruct
5106063|NCT03334656|Fibroblasts|fibroblasts
5106064|NCT03334656|Keratinocytes|keratinocytes
5106065|NCT03334643|Type 2 Diabetes|type 2 diabetes
5106066|NCT03334643|Dietary fiber|dietary fiber
5106067|NCT03334643|Glycemic response|glycemic response
5106091|NCT03334604|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5106092|NCT03334604|probiotics|probiotics
5106093|NCT03334513|Bevacizumab|bevacizumab
5106094|NCT03334513|Biometry|biometry
5106095|NCT03334513|Ranibizumab|ranibizumab
5106096|NCT03334513|Refractive error|refractive error
5106097|NCT03334513|Retinopathy of prematurity|retinopathy of prematurity
5106098|NCT03334487|Cancer|cancer
5106099|NCT03334487|Small Cell Lung Cancer|small cell lung cancer
5106100|NCT03334487|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
5106111|NCT03334396|eczema|eczema
5106112|NCT03334396|atopic eczema|atopic eczema
5106113|NCT03334383|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5106114|NCT03334383|Retractor sponge|retractor sponge
5106115|NCT03334383|Trendelenburg position|trendelenburg position
5106116|NCT03334383|Postoperative complications|postoperative complications
5106117|NCT03334370|Diabetes mellitus|diabetes mellitus
5106118|NCT03334357|Physical fitness|physical fitness
5106119|NCT03334357|Klotho|klotho
5106120|NCT03334357|Training|training
5106121|NCT03334357|HIIT|hiit
5106122|NCT03334357|WB-EMS|wb-ems
5106123|NCT03334305|Immunotherapy|immunotherapy
5106124|NCT03334305|Pediatric|pediatric
5106125|NCT03334305|Vaccine Therapy|vaccine therapy
5106126|NCT03334305|Young adult|young adult
5106127|NCT03334305|Immune system|immune system
5106128|NCT03334305|Dendritic Cell|dendritic cell
5106129|NCT03334292|Wilson Disease|wilson disease
5106130|NCT03334266|sugar|sugar
5106131|NCT03334266|sweetened|sweetened
5106132|NCT03334266|beverages|beverages
5106133|NCT03334266|responsive|responsive
5106134|NCT03334253|Myopia|myopia
5106135|NCT03334253|atropine|atropine
5106136|NCT03334240|HPV|hpv
5106137|NCT03334240|Digoxin|digoxin
5106138|NCT03334240|Furosemide|furosemide
5106139|NCT03334240|Vulvar HSIL|vulvar hsil
5106142|NCT03334227|qSOFA|qsofa
5106143|NCT03334214|Hepatic Steatosis|hepatic steatosis
5106144|NCT03334214|IONIS-DGAT2Rx|ionis-dgat2rx
5106145|NCT03334214|Type 2 Diabetes|type 2 diabetes
5106146|NCT03334162|Children|children
5106147|NCT03334162|Adolescents|adolescents
5106148|NCT03334162|Cancer|cancer
5106149|NCT03334162|brain Tumor|brain tumor
5106150|NCT03334162|exercise|exercise
5106151|NCT03334162|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
5106152|NCT03334162|CIPN|cipn
4991391|NCT04046432|probiotics|probiotics
5106153|NCT03334162|Sensorimotor Training|sensorimotor training
5106154|NCT03334123|exercise|exercise
5106155|NCT03334123|aerobic exercise|aerobic exercise
5106156|NCT03334123|functional training|functional training
5106157|NCT03334123|strength training|strength training
5106158|NCT03334123|resistance training|resistance training
5106159|NCT03334123|kidney failure|kidney failure
5106160|NCT03334123|rehabilitation|rehabilitation
5106161|NCT03334123|physical activity|physical activity
5106162|NCT03334123|hemodialysis|hemodialysis
5106163|NCT03334123|dialysis patients|dialysis patients
5106164|NCT03334123|chronic renal failure|chronic renal failure
5106165|NCT03334123|chronic kidney disease|chronic kidney disease
5106166|NCT03334123|end-stage renal disease|end-stage renal disease
5106167|NCT03334123|intradialytic exercise|intradialytic exercise
5106168|NCT03334097|Pregnancy|pregnancy
5106169|NCT03334097|fear|fear
5106170|NCT03334097|Parturition|parturition
5106171|NCT03334097|Prenatal Education|prenatal education
5106172|NCT03334045|Neurobiology|neurobiology
5106173|NCT03334045|Occupational Stress|occupational stress
5106174|NCT03334045|Dopamine|dopamine
5106175|NCT03334032|Body composition|body composition
5106176|NCT03334032|Total body protein|total body protein
5106177|NCT03334032|nutritional recovery|nutritional recovery
5106178|NCT03334032|Exercise status|exercise status
5106179|NCT03334032|In-vivo neutron activation analysis|in-vivo neutron activation analysis
5106180|NCT03334032|Protein depletion|protein depletion
5106181|NCT03334006|Pentaglobin®|pentaglobin®
5106182|NCT03334006|Personalised Medicine|personalised medicine
5106183|NCT03333993|Pilates exercise|pilates exercise
5106185|NCT03333993|Quality of Life|quality of life
5106186|NCT03333967|apatinib|apatinib
5106187|NCT03333954|atrophic macular degeneration|atrophic macular degeneration
5106188|NCT03333954|geographic atrophy|geographic atrophy
5106189|NCT03333954|macular degeneration|macular degeneration
5106190|NCT03333954|dry macular degeneration|dry macular degeneration
5106191|NCT03333954|AMD|amd
5106192|NCT03333954|retina implant|retina implant
5106193|NCT03333954|retinal prosthesis|retinal prosthesis
5106194|NCT03333954|visual prosthesis|visual prosthesis
5106195|NCT03333902|quadratus lumborum block|quadratus lumborum block
5106196|NCT03333902|anesthesia|anesthesia
5106197|NCT03333902|pain, postoperative|pain, postoperative
5106198|NCT03333837|Improvisation|improvisation
5106199|NCT03333837|Memory loss|memory loss
5106215|NCT03333785|Oncology|oncology
5106216|NCT03333785|Continuity of care|continuity of care
5106217|NCT03333785|Integration of care|integration of care
5106218|NCT03333785|Communication|communication
5106219|NCT03333759|laser|laser
5106220|NCT03333759|Er:YAG laser|er:yag laser
5106221|NCT03333759|acne|acne
5106222|NCT03333759|acne vulgaris|acne vulgaris
5106223|NCT03333759|optical coherence tomography|optical coherence tomography
5106224|NCT03333720|Phenylketonuria|phenylketonuria
5106225|NCT03333720|Inherited Metabolic Disorders|inherited metabolic disorders
5106226|NCT03333694|Cutaneous Squamous Cell Carcinoma (cSCC) in situ, mTOR kinase inhibitors, PI3K inhibitor.|cutaneous squamous cell carcinoma (cscc) in situ, mtor kinase inhibitors, pi3k inhibitor.
5106227|NCT03333681|Rheumatoid arthritis|rheumatoid arthritis
5106228|NCT03333681|Stem Cells|stem cells
5106229|NCT03333681|Cellular immunity|cellular immunity
5106230|NCT03333681|Humoral immunity|humoral immunity
5106231|NCT03333681|chemokines|chemokines
5106232|NCT03333681|homing of immune cells|homing of immune cells
5106233|NCT03333668|Lisdexamfetamine|lisdexamfetamine
5106237|NCT03333655|Metastatic Cancer|metastatic cancer
5106238|NCT03333642|diabetes|diabetes
5106252|NCT03333564|menopausal|menopausal
5106255|NCT03333538|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
5106256|NCT03333538|Ebola Virus Disease|ebola virus disease
5106257|NCT03333538|Ebola Virus Vaccines|ebola virus vaccines
5106258|NCT03333538|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
5106259|NCT03333538|GP protein, Ebola virus|gp protein, ebola virus
5106260|NCT03333538|Filoviridae Infections|filoviridae infections
5106261|NCT03333538|RNA Virus Infections|rna virus infections
5106262|NCT03333525|Fat-protein counting|fat-protein counting
5106263|NCT03333525|Type 1 diabetes|type 1 diabetes
5106264|NCT03333525|Postprandial glucose level|postprandial glucose level
5106265|NCT03333512|Nap|nap
5106266|NCT03333512|Recovery Sleep|recovery sleep
5106267|NCT03333512|Cognitive Functions|cognitive functions
5106268|NCT03333512|Glucose Metabolism|glucose metabolism
5106269|NCT03333512|Neurobehavioral Functions|neurobehavioral functions
5106270|NCT03333512|Mood|mood
5106271|NCT03333512|Subjective Sleepiness|subjective sleepiness
5106272|NCT03333460|cocaine|cocaine
5106273|NCT03333460|addiction|addiction
5106274|NCT03333460|transcranial magnetic stimulation|transcranial magnetic stimulation
5106275|NCT03333460|neuromodulation|neuromodulation
5106276|NCT03333460|neuroimaging|neuroimaging
5106277|NCT03333460|brain stimulation|brain stimulation
5106278|NCT03333395|Mechanical ventilation|mechanical ventilation
5106279|NCT03333395|Acute Exacerbation of chronic obstructive airway disease (AECOPD)|acute exacerbation of chronic obstructive airway disease (aecopd)
5106280|NCT03333395|Nebulized heparin|nebulized heparin
5106281|NCT03333395|C-Reactive Protein (CRP|c-reactive protein (crp
5106282|NCT03333369|resting-state functional MRI|resting-state functional mri
5106283|NCT03333369|Dopamine|dopamine
5106284|NCT03333369|functional connectivity|functional connectivity
5106285|NCT03333343|EGFR-mutant NSCLC|egfr-mutant nsclc
5106286|NCT03333343|EGF816|egf816
5106287|NCT03333343|LXH254|lxh254
5106288|NCT03333343|INC280|inc280
5106289|NCT03333343|ribociclib|ribociclib
5106290|NCT03333343|trametinib|trametinib
5106291|NCT03333343|gefitinib|gefitinib
5106292|NCT03333343|EGFR T790M|egfr t790m
5106293|NCT03333343|BRAF mutation|braf mutation
5106294|NCT03333343|BRAF fusion|braf fusion
5106295|NCT03333343|BRAF rearrangement|braf rearrangement
5106296|NCT03333343|MET amplification|met amplification
5106297|NCT03333330|Carotid atherosclerosis|carotid atherosclerosis
5106298|NCT03333330|Carotid plaque|carotid plaque
5106299|NCT03333330|Brain magnetic resonance imaging|brain magnetic resonance imaging
5106300|NCT03333330|Contrast enhanced ultrasound|contrast enhanced ultrasound
5106301|NCT03333330|Carotid CT angiography|carotid ct angiography
5106302|NCT03333330|Silent brain ischemia|silent brain ischemia
5106303|NCT03333330|Vascular cognitive impairment|vascular cognitive impairment
5106304|NCT03333304|Procalcitonin|procalcitonin
5106305|NCT03333278|Critical Care|critical care
5106306|NCT03333278|Shock, Septic|shock, septic
5106307|NCT03333278|Ascorbic Acid|ascorbic acid
5106308|NCT03333278|Adult|adult
5106309|NCT03333252|Caregiver|caregiver
5106310|NCT03333252|Psycho-social intervention|psycho-social intervention
5106311|NCT03333252|Cognitive training|cognitive training
5106312|NCT03333252|Quality of life|quality of life
5106313|NCT03333252|Early on-set Alzheimer's Disease|early on-set alzheimer's disease
5106314|NCT03333239|childhood and adolescence|childhood and adolescence
5106315|NCT03333226|Breast Neoplasms|breast neoplasms
5106316|NCT03333226|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5106317|NCT03333226|Lymph Node Excision|lymph node excision
5106318|NCT03333226|Technetium Tc 99m|technetium tc 99m
5106319|NCT03333226|Indocyanine Green|indocyanine green
5106320|NCT03333226|Lymphatic System|lymphatic system
5106321|NCT03333226|Secondary Prevention|secondary prevention
5106322|NCT03333200|Pediatric|pediatric
5106323|NCT03333200|Rare|rare
5106324|NCT03333200|Neurodegenerative|neurodegenerative
5106325|NCT03333200|Genetic|genetic
5106326|NCT03333200|Neurodevelopment|neurodevelopment
5106327|NCT03333200|Brain|brain
5106328|NCT03333200|MRI|mri
5106329|NCT03333200|Biorepository|biorepository
5106335|NCT03333200|Adaptive behavior|adaptive behavior
5106336|NCT03333187|Myelofibrosis, Myeloproliferative Disease|myelofibrosis, myeloproliferative disease
5106337|NCT03333174|apnea of prematurity|apnea of prematurity
5106339|NCT03333174|hypoxemic episode|hypoxemic episode
5106340|NCT03333174|oxygen delivery|oxygen delivery
5106341|NCT03333161|apnea of prematurity|apnea of prematurity
5106342|NCT03333161|bradycardia|bradycardia
5106343|NCT03333161|hypoxemic episode|hypoxemic episode
5106344|NCT03333161|permissive hypercapnia|permissive hypercapnia
5106345|NCT03333148|Colorectal Surgery|colorectal surgery
5106346|NCT03333148|Immunonutrition|immunonutrition
5106347|NCT03333148|Complications|complications
5106348|NCT03333148|Microbiome|microbiome
5106349|NCT03333148|Preoperative nutrition|preoperative nutrition
5106350|NCT03333135|Ultramarathons|ultramarathons
5106351|NCT03333135|Electromagnetic field therapy|electromagnetic field therapy
5106352|NCT03333135|Endurance|endurance
5106353|NCT03333135|Exercise|exercise
5106354|NCT03333135|Environmental conditions|environmental conditions
5106356|NCT03333096|Glaucoma|glaucoma
5106357|NCT03333096|Mild Cognitive Impairment|mild cognitive impairment
5106358|NCT03333096|Ocusweep|ocusweep
5106359|NCT03333096|Reaction Time|reaction time
5106360|NCT03333096|Neuropsychology|neuropsychology
5106361|NCT03333096|Dementia|dementia
5106362|NCT03333096|Alzheimer's Disease|alzheimer's disease
5106363|NCT03333096|Brain Diseases|brain diseases
5106364|NCT03333083|Lamivudine|lamivudine
5106365|NCT03333083|Raltegravir|raltegravir
5106366|NCT03333031|cancer|cancer
5106367|NCT03333031|imaging agent|imaging agent
5106368|NCT03333031|HSP90|hsp90
5106369|NCT03333018|COPD|copd
5106370|NCT03332979|pre-death grief|pre-death grief
5106371|NCT03332979|palliative care|palliative care
5106372|NCT03332979|dementia|dementia
5106373|NCT03332979|caregiver|caregiver
5106374|NCT03332979|preparation for end of life|preparation for end of life
5106375|NCT03332966|adolescent|adolescent
5106376|NCT03332966|outpatients|outpatients
5106377|NCT03332966|questionnaire|questionnaire
5106378|NCT03332966|psychotic-like symptoms|psychotic-like symptoms
5106379|NCT03332966|psychosis risk|psychosis risk
5106380|NCT03332940|Tc99m-tilmanocept|tc99m-tilmanocept
5106381|NCT03332940|Tilmanocept|tilmanocept
5106382|NCT03332940|NASH|nash
5106383|NCT03332940|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5106384|NCT03332914|Osteoarthritis|osteoarthritis
5106385|NCT03332914|microcurrent|microcurrent
5106386|NCT03332914|knee|knee
5106387|NCT03332914|electrotherapy|electrotherapy
5106388|NCT03332875|OurRelationship|ourrelationship
5106389|NCT03332875|Couple therapy|couple therapy
5106390|NCT03332875|Internet|internet
5106391|NCT03332875|Marriage Counseling|marriage counseling
5106392|NCT03332862|Catheter Ablation|catheter ablation
5106393|NCT03332862|Atrial Fibrillation|atrial fibrillation
5106394|NCT03332862|Contact Force|contact force
5106395|NCT03332862|Continuous Ablation|continuous ablation
5106396|NCT03332823|Mental health|mental health
5106397|NCT03332823|Mental well-being|mental well-being
5106398|NCT03332823|Community-based engagement|community-based engagement
5106399|NCT03332823|Positive psychology|positive psychology
5106400|NCT03332823|Public health approach|public health approach
5106401|NCT03332810|Mental health|mental health
5106402|NCT03332810|Mental well-being|mental well-being
5106403|NCT03332810|Community-based engagement|community-based engagement
5106404|NCT03332810|Positive psychology|positive psychology
5106405|NCT03332810|Public health approach|public health approach
5106406|NCT03332758|retinal detachment|retinal detachment
5106407|NCT03332758|inflammasome|inflammasome
5106408|NCT03332758|macular hole|macular hole
5106409|NCT03332745|Troponin|troponin
5106410|NCT03332732|Healthy Volunteers|healthy volunteers
5106411|NCT03332732|Pharmacokinetics|pharmacokinetics
5106412|NCT03332654|Urinary Incontinence, Stress|urinary incontinence, stress
5106413|NCT03332654|Multiple Sclerosis|multiple sclerosis
5106414|NCT03332654|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5106415|NCT03332628|Peer Reviewed Research|peer reviewed research
5106416|NCT03332615|Palliative Care|palliative care
5106417|NCT03332602|Iron deficiency|iron deficiency
5106418|NCT03332602|Iron fortification|iron fortification
5106419|NCT03332602|Iron encapsulation|iron encapsulation
5106420|NCT03332589|Melanoma|melanoma
5106421|NCT03332589|CNS metastases|cns metastases
5106422|NCT03332589|BRAF mutation|braf mutation
5106423|NCT03332589|MEK mutation|mek mutation
5106424|NCT03332589|E6201|e6201
5106425|NCT03332576|vaccine|vaccine
5356824|NCT01917851|Accurate|accurate
5106426|NCT03332576|immunotherapy|immunotherapy
5106427|NCT03332576|combination therapy|combination therapy
5106428|NCT03332563|Adolescent|adolescent
5106429|NCT03332563|Cognitive Behavioral Therapy|cognitive behavioral therapy
5106430|NCT03332563|Chronic Pain|chronic pain
5106431|NCT03332563|smartphone application|smartphone application
5106439|NCT03332537|Genetics|genetics
5106440|NCT03332537|Online education|online education
5106441|NCT03332524|1st degree burn|1st degree burn
5106443|NCT03332498|rectum|rectum
5106444|NCT03332498|advanced|advanced
5106445|NCT03332498|refractory|refractory
5106446|NCT03332472|type 1 diabetes|type 1 diabetes
5106447|NCT03332446|cold water immersion, strength training, training effect|cold water immersion, strength training, training effect
5106448|NCT03332433|Hypoxia|hypoxia
5106449|NCT03332433|Gastroscope|gastroscope
5106450|NCT03332433|High-flow nasal cannula|high-flow nasal cannula
5106451|NCT03332420|Huaiqihuang granule|huaiqihuang granule
5106452|NCT03332420|primary nephrotic syndrome|primary nephrotic syndrome
5106453|NCT03332420|multisite|multisite
5106454|NCT03332420|prospective|prospective
5106455|NCT03332420|open-label|open-label
5106456|NCT03332407|Postoperative delirium|postoperative delirium
5106457|NCT03332407|Sleep quality|sleep quality
5106458|NCT03332407|Pediatric anesthesia|pediatric anesthesia
5106459|NCT03332407|Strabismus surgery|strabismus surgery
5106460|NCT03332394|Care Model|care model
5106461|NCT03332394|COPD|copd
5106462|NCT03332394|Exacerbations|exacerbations
5106463|NCT03332394|Health Confidence Score|health confidence score
5106464|NCT03332368|Triple-negative breast cancer|triple-negative breast cancer
5106465|NCT03332368|Traditional Chinese Medicine|traditional chinese medicine
5106466|NCT03332355|glioblastoma multiforme|glioblastoma multiforme
5106467|NCT03332355|anaplastic astrocytoma|anaplastic astrocytoma
5106468|NCT03332355|high grade glioma|high grade glioma
5106469|NCT03332355|temozolomide|temozolomide
5106470|NCT03332355|PROCASPASE ACTIVATING COMPOUND-1 (PAC-1)|procaspase activating compound-1 (pac-1)
5106471|NCT03332355|advanced malignancy|advanced malignancy
5106472|NCT03332355|maximal tolerated dose (MTD)|maximal tolerated dose (mtd)
5106473|NCT03332342|dry eye disease|dry eye disease
5106474|NCT03332342|tears|tears
5106475|NCT03332342|inflammation|inflammation
5106476|NCT03332342|ocular surface|ocular surface
5106477|NCT03332329|HBsAg|hbsag
5106478|NCT03332329|PegIFN|pegifn
5106479|NCT03332329|ETV|etv
5106480|NCT03332329|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
5106481|NCT03332329|HBV|hbv
5106482|NCT03332329|GMCSF|gmcsf
5106483|NCT03332303|Vaginal Dryness|vaginal dryness
5106484|NCT03332303|Vaginal and/or Vulvar Irritation/Itching|vaginal and/or vulvar irritation/itching
5106485|NCT03332303|Dysuria|dysuria
5106486|NCT03332303|Vaginal Pain and Bleeding|vaginal pain and bleeding
5106487|NCT03332277|Active Bodysuits|active bodysuits
5106488|NCT03332264|PAOD|paod
5106489|NCT03332264|drug coated balloon|drug coated balloon
5106490|NCT03332264|drug coated stent|drug coated stent
5106491|NCT03332264|percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5106492|NCT03332251|Posture Correction Girdle|posture correction girdle
5106499|NCT03332199|symptom cluster|symptom cluster
5106500|NCT03332199|oncology|oncology
5106501|NCT03332199|psychoeducation|psychoeducation
5106502|NCT03332199|symptom management|symptom management
5106503|NCT03332199|fatigue|fatigue
5106504|NCT03332199|pain|pain
5106505|NCT03332199|sleep disturbance|sleep disturbance
5106506|NCT03332160|Lymphedema|lymphedema
5106507|NCT03332160|Cancer|cancer
5106508|NCT03332160|Head Cancer|head cancer
5106509|NCT03332160|Neck Cancer|neck cancer
5106510|NCT03332160|Head and Neck Cancer|head and neck cancer
5106511|NCT03332108|mobile health (mHealth)|mobile health (mhealth)
5106512|NCT03332108|electronic health (eHealth)|electronic health (ehealth)
5106513|NCT03332108|breastfeeding|breastfeeding
5106514|NCT03332108|infant nutrition|infant nutrition
5106515|NCT03332108|text messaging intervention|text messaging intervention
5106526|NCT03332043|Allostatic|allostatic
5106527|NCT03332043|Heart rate variability|heart rate variability
5106528|NCT03332043|Baroreflex sensitivity|baroreflex sensitivity
5106529|NCT03332043|Blood pressure management|blood pressure management
5106530|NCT03332043|Autocalibration|autocalibration
5106531|NCT03332043|Neural oscillations|neural oscillations
5106532|NCT03332043|Relaxation|relaxation
5106533|NCT03332043|Electroencephalic|electroencephalic
5106543|NCT03331965|Interventional Radiology|interventional radiology
5106545|NCT03331965|Gastrojejenostomy|gastrojejenostomy
5106546|NCT03331952|Streptococcal Pneumonia|streptococcal pneumonia
5106547|NCT03331952|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5106548|NCT03331887|endodontically treate teeth|endodontically treate teeth
5106549|NCT03331887|Emax crowns|emax crowns
5106550|NCT03331887|Fiber reinforced composite post|fiber reinforced composite post
5106551|NCT03331887|Endocrowns|endocrowns
5106552|NCT03331874|confocal|confocal
5106553|NCT03331874|basal|basal
5106554|NCT03331874|carcinoma|carcinoma
5106567|NCT03331796|transcranial magnetic stimulation|transcranial magnetic stimulation
5106568|NCT03331796|noninvasive brain stimulation|noninvasive brain stimulation
5106570|NCT03331770|Benzalkonium Chloride|benzalkonium chloride
5106571|NCT03331770|Latanoprost|latanoprost
5106572|NCT03331770|BAK-free|bak-free
5106573|NCT03331770|Glaucoma|glaucoma
5106574|NCT03331770|Ocular hypertension|ocular hypertension
5106575|NCT03331770|conjunctival hyperemia|conjunctival hyperemia
5106577|NCT03331770|OSDI|osdi
5106578|NCT03331770|Schirmer I|schirmer i
5106579|NCT03331770|Corneal staining|corneal staining
5106580|NCT03331770|Tear meniscus height|tear meniscus height
5106581|NCT03331744|Infantile hemangioma|infantile hemangioma
5106582|NCT03331744|Infantile hepatic hemangioma|infantile hepatic hemangioma
5106583|NCT03331744|Ulcerated infantile hemangioma|ulcerated infantile hemangioma
5106584|NCT03331744|Clinical characteristics|clinical characteristics
5106585|NCT03331744|Demographic characteristics|demographic characteristics
5106586|NCT03331718|pancreatoduodenectomy|pancreatoduodenectomy
5106587|NCT03331718|pancreaticojejunostomy|pancreaticojejunostomy
5106588|NCT03331718|polyglycolic acid|polyglycolic acid
5106589|NCT03331718|Neoveil|neoveil
5106590|NCT03331718|pancreatic fistula|pancreatic fistula
5106591|NCT03331718|pancreas|pancreas
5106592|NCT03331666|Hyperlipidemia, Hypercholesterolemia, atherothrombosis|hyperlipidemia, hypercholesterolemia, atherothrombosis
5106593|NCT03331653|Cervical Pain|cervical pain
5106594|NCT03331653|Motor Control|motor control
5106595|NCT03331653|Sternocleidomastoid|sternocleidomastoid
5106596|NCT03331653|Dry Needling|dry needling
5106597|NCT03331601|Brain metastasis|brain metastasis
5106598|NCT03331601|HER2|her2
5106599|NCT03331588|Lung cancer|lung cancer
5106600|NCT03331588|Pain|pain
5106601|NCT03331588|Quality of life|quality of life
5106610|NCT03331510|Shoulder, Instability, Latarjet, Dislocation, Strength|shoulder, instability, latarjet, dislocation, strength
5106611|NCT03331484|percutaneous coronary intervention|percutaneous coronary intervention
5106612|NCT03331484|bleeding|bleeding
5106613|NCT03331484|atrial fibrillation|atrial fibrillation
5106614|NCT03331484|Ticagrelor|ticagrelor
5106615|NCT03331484|Rivaroxaban|rivaroxaban
5106616|NCT03331458|physical activity|physical activity
5106617|NCT03331445|inhaled nitric oxide|inhaled nitric oxide
5106618|NCT03331445|non tuberculous mycobacteria|non tuberculous mycobacteria
5106619|NCT03331445|drug resistant pneumonia|drug resistant pneumonia
5106620|NCT03331406|Metastatic gastrointestinal cancer|metastatic gastrointestinal cancer
5106621|NCT03331406|Physical Activity|physical activity
5106627|NCT03331367|Cryotherapy|cryotherapy
5106628|NCT03331367|Radiation|radiation
5106629|NCT03331367|Prostatectomy|prostatectomy
5106630|NCT03331367|Immune Response|immune response
5106636|NCT03331250|Epithelioid hemangioendothelioma (EHE)|epithelioid hemangioendothelioma (ehe)
5106637|NCT03331250|Angiosarcoma|angiosarcoma
5106638|NCT03331211|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
5106640|NCT03331198|chimeric antigen receptor|chimeric antigen receptor
5106641|NCT03331198|CLL|cll
5106642|NCT03331198|SLL|sll
5106643|NCT03331198|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5106644|NCT03331198|small lymphocytic lymphoma|small lymphocytic lymphoma
5106645|NCT03331198|CAR|car
5106652|NCT03331185|Leukocytic Platelet Rich Fibrin|leukocytic platelet rich fibrin
5106653|NCT03331185|Volumetric Changes|volumetric changes
5106654|NCT03331185|Dense Polytetrafluoroethylene Membrane|dense polytetrafluoroethylene membrane
5106655|NCT03331172|HIFU|hifu
5106656|NCT03331172|thyroid nodule|thyroid nodule
5106657|NCT03331172|Benign|benign
5106658|NCT03331172|Reapplication|reapplication
5106666|NCT03331133|Twin|twin
5106667|NCT03331133|Early Development|early development
5106668|NCT03331133|Cohort|cohort
5106669|NCT03331120|Neck pain|neck pain
5106670|NCT03331120|Ambulatory|ambulatory
5106671|NCT03331120|Orthotic|orthotic
5106672|NCT03331081|Overactive Bladder Syndrome|overactive bladder syndrome
5106673|NCT03331055|percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
5106674|NCT03331055|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5106675|NCT03331055|pain|pain
5106676|NCT03331055|pancreatic cancer|pancreatic cancer
5106677|NCT03331042|Insomnia|insomnia
5106678|NCT03331042|Transient Insomnia|transient insomnia
5106679|NCT03331042|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
5356826|NCT01917851|noninvasive measurement|noninvasive measurement
5106680|NCT03331029|3 D Ultrasound, left atrium, Mitral inflow velocity, systolic and diastolic ventricular function|3 d ultrasound, left atrium, mitral inflow velocity, systolic and diastolic ventricular function
5106681|NCT03331016|Foster caregiver|foster caregiver
5106682|NCT03331016|Kinship caregiver|kinship caregiver
5106683|NCT03331016|Foster youth|foster youth
5106684|NCT03331016|Unintended pregnancy|unintended pregnancy
5106685|NCT03331016|Curriculum|curriculum
5106686|NCT03331016|Intervention|intervention
5106687|NCT03331016|sexually transmitted infections|sexually transmitted infections
5106688|NCT03331016|Behaviorism|behaviorism
5106689|NCT03331016|Monitoring|monitoring
5106690|NCT03331016|Communication|communication
5106691|NCT03331016|Adolescent development|adolescent development
5106692|NCT03331016|sexually transmitted diseases|sexually transmitted diseases
5106693|NCT03330951|HbA1c|hba1c
5106694|NCT03330951|Glycated albumin|glycated albumin
5106695|NCT03330938|Hemodialysis|hemodialysis
5106696|NCT03330938|Resilience|resilience
5106697|NCT03330938|Cognitive Behavioral Therapy|cognitive behavioral therapy
5106698|NCT03330873|Asherman syndrome|asherman syndrome
5106699|NCT03330873|disposable balloon uterine stent|disposable balloon uterine stent
5106700|NCT03330873|hysteroscopy|hysteroscopy
5106701|NCT03330873|Foley catheter|foley catheter
5106706|NCT03330834|CAR-T|car-t
5106707|NCT03330834|advanced lung cancer|advanced lung cancer
5106708|NCT03330834|single-arm|single-arm
5106709|NCT03330834|phase I clinical study|phase i clinical study
5106710|NCT03330795|end-stage lung disease|end-stage lung disease
5106711|NCT03330795|Bilateral Orthotopic Lung Transplant (BOLT) candidate|bilateral orthotopic lung transplant (bolt) candidate
5106712|NCT03330795|CD3/CD19 negative allogeneic hematopoietic stem cells (HSCT)|cd3/cd19 negative allogeneic hematopoietic stem cells (hsct)
5106713|NCT03330795|CD3+/CD19+ depleted Bone Marrow Transplant (BMT)|cd3+/cd19+ depleted bone marrow transplant (bmt)
5106714|NCT03330795|Cadaveric (Deceased) Donor|cadaveric (deceased) donor
5106715|NCT03330795|Unrelated (Deceased) Donor|unrelated (deceased) donor
5106716|NCT03330782|pain|pain
5106717|NCT03330782|propofol|propofol
5106718|NCT03330782|remifentanil|remifentanil
5106719|NCT03330769|Psoriatic Arthritis|psoriatic arthritis
5106720|NCT03330769|Ultrasonography|ultrasonography
5106721|NCT03330769|Minimal disease activity|minimal disease activity
5106722|NCT03330756|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5106725|NCT03330756|Morbid Obesity|morbid obesity
5106726|NCT03330691|CD19|cd19
5106727|NCT03330691|CD22|cd22
5106728|NCT03330691|CAR T-cell|car t-cell
5106729|NCT03330678|Probiotic|probiotic
5106730|NCT03330678|Gut microbiome|gut microbiome
5106731|NCT03330678|VSL#3|vsl#3
5106732|NCT03330652|Quality of life|quality of life
5106733|NCT03330652|Cognitive function|cognitive function
5106734|NCT03330652|Mental state|mental state
5106735|NCT03330652|Functional capacity|functional capacity
5106736|NCT03330652|EQ5D|eq5d
5106737|NCT03330652|HADS|hads
5106738|NCT03330652|Barthel Index|barthel index
5106740|NCT03330626|Fluid management|fluid management
5106741|NCT03330626|conventional method|conventional method
5106742|NCT03330626|InBody S10|inbody s10
5106743|NCT03330626|CRRT|crrt
5106744|NCT03330574|Glaucoma|glaucoma
5106745|NCT03330561|HER2-positive breast cancer|her2-positive breast cancer
5106746|NCT03330561|HER2 -positive gastric cancer|her2 -positive gastric cancer
5106747|NCT03330561|HER2-positive bladder cancer|her2-positive bladder cancer
5106748|NCT03330561|Pieris|pieris
5106749|NCT03330561|PRS-343|prs-343
5106750|NCT03330561|Anticalin|anticalin
5106751|NCT03330561|Bi-specific|bi-specific
5106752|NCT03330561|4-1BB|4-1bb
5106753|NCT03330561|CD137|cd137
5106760|NCT03330509|Palliative care|palliative care
5106761|NCT03330509|Consultation model|consultation model
5106762|NCT03330496|infant-newborn|infant-newborn
5106763|NCT03330496|infant-premature|infant-premature
5106764|NCT03330496|pain|pain
5106765|NCT03330496|acute pain|acute pain
5106766|NCT03330496|repetitive pain|repetitive pain
5106767|NCT03330483|pain|pain
5106768|NCT03330483|discomfort|discomfort
5106769|NCT03330483|hydrophylic catheter|hydrophylic catheter
5106770|NCT03330483|urodynamic study|urodynamic study
5106771|NCT03330444|Endometrial microbiota|endometrial microbiota
5106772|NCT03330444|Bacterial pathogens|bacterial pathogens
5106773|NCT03330444|Assisted reproductive techniques|assisted reproductive techniques
5106774|NCT03330444|Dysbiosis|dysbiosis
5106775|NCT03330444|Endometrial receptivity|endometrial receptivity
5106776|NCT03330444|Endometrial diagnosis|endometrial diagnosis
5106778|NCT03330379|Endotracheal tube|endotracheal tube
5106779|NCT03330379|ventilator's associated pneumonia|ventilator's associated pneumonia
5106780|NCT03330379|intensive care unit|intensive care unit
5106781|NCT03330379|orotracheal intubation|orotracheal intubation
5106782|NCT03330340|vertebral compression fracture|vertebral compression fracture
5106783|NCT03330340|osteoporosis|osteoporosis
5106784|NCT03330340|glucocorticoids|glucocorticoids
5106785|NCT03330340|vertebroplasty|vertebroplasty
5106786|NCT03330262|Postural Instability|postural instability
5106787|NCT03330262|Balance Disorder|balance disorder
5106788|NCT03330262|Balance Prosthesis|balance prosthesis
5097036|NCT03392129|Sleep|sleep
5106789|NCT03330262|Dizziness|dizziness
5106790|NCT03330236|Electroencephalography|electroencephalography
5106791|NCT03330236|Spectral edge frequency|spectral edge frequency
5106792|NCT03330236|Patient state index|patient state index
5106793|NCT03330236|Anesthesia|anesthesia
5106794|NCT03330236|Laparoscopic surgery|laparoscopic surgery
5106795|NCT03330236|Postoperative delirium|postoperative delirium
5106796|NCT03330236|Emergence delirium|emergence delirium
5106797|NCT03330210|LAAC|laac
5106798|NCT03330210|3D printing|3d printing
5106799|NCT03330210|Procedure success|procedure success
5106800|NCT03330210|Procedure-related complications|procedure-related complications
5106801|NCT03330197|DIPG|dipg
5106802|NCT03330197|Glioblastoma|glioblastoma
5106803|NCT03330197|Anaplastic Astrocytoma|anaplastic astrocytoma
5106804|NCT03330197|High Grade Glioma (HGG) Not Otherwise Specified (NOS)|high grade glioma (hgg) not otherwise specified (nos)
5106805|NCT03330197|Supratentorial Tumor NOS|supratentorial tumor nos
5106806|NCT03330184|Bifidobacterium|bifidobacterium
5106807|NCT03330184|People With Abnormal Glucose Level|people with abnormal glucose level
5106811|NCT03330145|Complicated Grief|complicated grief
5106812|NCT03330145|Risk Factors|risk factors
5106813|NCT03330145|Cancer|cancer
5106814|NCT03330145|Children|children
5106815|NCT03330119|Pregnancy|pregnancy
5106816|NCT03330119|cesarean section|cesarean section
5106817|NCT03330119|enhanced recovery|enhanced recovery
5106818|NCT03330119|narcotic use|narcotic use
5106819|NCT03330106|Drug therapy|drug therapy
5106820|NCT03330093|Children|children
5106821|NCT03330080|Ecological momentary assessment|ecological momentary assessment
5106823|NCT03330080|Fatigue|fatigue
5106824|NCT03330080|Endocrinopathy|endocrinopathy
5106825|NCT03330080|Family functioning|family functioning
5106827|NCT03330041|Cutaneous Sutures|cutaneous sutures
5106828|NCT03330041|Scar Cosmesis|scar cosmesis
5106829|NCT03330041|Linear Wound Closure|linear wound closure
5106830|NCT03330041|Wound Cosmesis|wound cosmesis
5106831|NCT03330028|Diseases of oesophagus stomach and duodenum|diseases of oesophagus stomach and duodenum
5106832|NCT03330028|Gastric cancer|gastric cancer
5106833|NCT03330028|Gastroesophageal cancer|gastroesophageal cancer
5342959|NCT01981369|Infraclavicular block|infraclavicular block
5106834|NCT03330028|Adenocarcinoma of the stomach or gastroesophageal junction|adenocarcinoma of the stomach or gastroesophageal junction
5106835|NCT03330028|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5106836|NCT03330028|HIPEC|hipec
5106837|NCT03330028|Paclitaxel|paclitaxel
5106838|NCT03330028|Taxol|taxol
5106839|NCT03330028|Dexamethasone|dexamethasone
5106840|NCT03330028|Decadron|decadron
5106841|NCT03330028|Diphenhydramine|diphenhydramine
5106842|NCT03330028|Benadryl|benadryl
5106843|NCT03330028|Cisplatin|cisplatin
5106844|NCT03330028|Platinol-AQ|platinol-aq
5106845|NCT03330028|Platinol|platinol
5106846|NCT03330028|CDDP|cddp
5106847|NCT03330028|Mitomycin-C|mitomycin-c
5106848|NCT03330028|Mitomycin|mitomycin
5106849|NCT03330028|Famotidine|famotidine
5106850|NCT03330028|Pepcid|pepcid
5106851|NCT03330015|postmenopausal bleeding|postmenopausal bleeding
5106852|NCT03330015|endometrial cancer|endometrial cancer
5106855|NCT03330002|Arterial Closure Device|arterial closure device
5106856|NCT03330002|Large Bore Closure Device|large bore closure device
5106857|NCT03329950|CDX-1140|cdx-1140
5106858|NCT03329950|Solid Tumors|solid tumors
5106866|NCT03329950|CD-40|cd-40
5106867|NCT03329950|Flt3l|flt3l
5106868|NCT03329950|CDX-301|cdx-301
5106869|NCT03329950|Lung Cancer|lung cancer
5106870|NCT03329950|Bile duct cancer|bile duct cancer
5106871|NCT03329950|TNBC|tnbc
5106872|NCT03329950|RCC|rcc
5106873|NCT03329950|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5106874|NCT03329950|Follicular Lymphoma|follicular lymphoma
5106875|NCT03329950|Dendritic cell|dendritic cell
5106876|NCT03329950|Keynote A-23|keynote a-23
5106877|NCT03329950|pembrolizumab|pembrolizumab
5106878|NCT03329950|Keytruda|keytruda
5106879|NCT03329898|Asherman syndrome|asherman syndrome
5106880|NCT03329898|uterine stent|uterine stent
5106881|NCT03329898|hysteroscopy|hysteroscopy
5106882|NCT03329872|Neuro-Orthopedics|neuro-orthopedics
5106883|NCT03329872|Register|register
5106884|NCT03329833|Parkinson's Disease|parkinson's disease
5106885|NCT03329833|Parkinson's|parkinson's
5106886|NCT03329833|Motivational Interviewing|motivational interviewing
5106887|NCT03329833|Exercise|exercise
5106888|NCT03329833|Motivation|motivation
5106889|NCT03329820|Chronic hepatitis B infection|chronic hepatitis b infection
5106890|NCT03329820|Health-related quality of life|health-related quality of life
5106891|NCT03329820|Cost-effectiveness|cost-effectiveness
5106892|NCT03329820|Treatment|treatment
5106893|NCT03329820|Chinese|chinese
5106894|NCT03329781|Endotoxaemia, Curcumin.|endotoxaemia, curcumin.
5106895|NCT03329755|Advanced melanoma|advanced melanoma
5106896|NCT03329755|Immune checkpoint|immune checkpoint
5106897|NCT03329755|E-follow-up|e-follow-up
5106898|NCT03329716|brace-weaning, cost-effectiveness|brace-weaning, cost-effectiveness
5106900|NCT03329703|UPLIFT|uplift
5106901|NCT03329703|Depression|depression
5106902|NCT03329703|Mindfulness|mindfulness
5106903|NCT03329703|CBT|cbt
5106904|NCT03329703|Managing Epilepsy Well (MEW) Network|managing epilepsy well (mew) network
5106905|NCT03329703|Psychogenic Seizures|psychogenic seizures
5106906|NCT03329703|Non-Epileptic Seizures|non-epileptic seizures
5106907|NCT03329690|Adenocarcinoma Metastatic|adenocarcinoma metastatic
5106908|NCT03329690|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
5106909|NCT03329690|Adenocarcinoma of the Gastroesophageal Junction|adenocarcinoma of the gastroesophageal junction
5106910|NCT03329690|HER2 Overexpression|her2 overexpression
5106911|NCT03329690|Adenocarcinoma, Locally Advanced|adenocarcinoma, locally advanced
5106912|NCT03329690|DESTINY - Gastric 01|destiny - gastric 01
5106913|NCT03329625|Triple P|triple p
5106914|NCT03329625|RCT|rct
5106915|NCT03329625|parent management training|parent management training
5106916|NCT03329625|Child welfare|child welfare
5106917|NCT03329625|child behavior problems|child behavior problems
5106918|NCT03329586|maximum oxygen consumption|maximum oxygen consumption
5106919|NCT03329586|organ transplantation|organ transplantation
5106920|NCT03329586|physical fitness|physical fitness
5106921|NCT03329586|rehabilitation|rehabilitation
5106922|NCT03329573|Cross-over|cross-over
5106923|NCT03329573|Chinese|chinese
5106941|NCT03329495|superior mesenteric vein|superior mesenteric vein
5106942|NCT03329482|Ultrasound|ultrasound
5106943|NCT03329482|kneading-massage|kneading-massage
5106944|NCT03329482|low back pain|low back pain
5106945|NCT03329482|pain intensity|pain intensity
5106946|NCT03329482|disability|disability
5106947|NCT03329469|Computed Tomography Fractional Flow Reserve (CT-FFR),|computed tomography fractional flow reserve (ct-ffr),
5106948|NCT03329469|Computed Coronary Tomography Angiography (CCTA)|computed coronary tomography angiography (ccta)
4992254|NCT04041401|intervention|intervention
5106949|NCT03329469|Invasive Fractional Flow Reserve (iFFR)|invasive fractional flow reserve (iffr)
5106950|NCT03329469|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5106951|NCT03329469|Emergency Department (ED)|emergency department (ed)
5106952|NCT03329469|Emergency Room (ER)|emergency room (er)
5106953|NCT03329443|spironolactone|spironolactone
5106954|NCT03329404|Thalassemia|thalassemia
5106955|NCT03329404|pathogen reduction therapy|pathogen reduction therapy
5106956|NCT03329391|Psychosocial model,nursing intervention|psychosocial model,nursing intervention
5106957|NCT03329378|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5106958|NCT03329378|locally advanced breast cancer|locally advanced breast cancer
5106959|NCT03329378|Her2neu|her2neu
5106960|NCT03329365|Flow cytometry|flow cytometry
5106961|NCT03329365|Lactate dehydrogenase (LDH) release|lactate dehydrogenase (ldh) release
5106962|NCT03329365|Anemia|anemia
5106963|NCT03329365|Cytopenia|cytopenia
5106964|NCT03329339|diet|diet
5106965|NCT03329326|standardized test|standardized test
5106971|NCT03329313|intermittent hemodialysis/diafiltration|intermittent hemodialysis/diafiltration
5106973|NCT03329300|Executive Function|executive function
5104313|NCT03345264|Cancer|cancer
5106975|NCT03329287|Simplified Cognitive Behavioral Therapy (SCBT)|simplified cognitive behavioral therapy (scbt)
5106976|NCT03329287|Generalized Anxiety Disorder|generalized anxiety disorder
5106978|NCT03329287|Operating manual|operating manual
5106979|NCT03329287|Efficacy|efficacy
5106980|NCT03329274|registry|registry
5106981|NCT03329209|Drug therapy|drug therapy
5106982|NCT03329183|Irinotecan|irinotecan
5106983|NCT03329183|UGT1A1|ugt1a1
5106984|NCT03329183|Advanced Colorectal Cancer|advanced colorectal cancer
5106985|NCT03329170|Oral health|oral health
5106986|NCT03329170|Dental caries|dental caries
5106987|NCT03329170|Heart Defects|heart defects
5106988|NCT03329170|Congenital|congenital
5106989|NCT03329144|Young mother|young mother
5106990|NCT03329144|Depression|depression
5106991|NCT03329144|Anxiety|anxiety
5106992|NCT03329144|Resilience|resilience
5106993|NCT03329144|Emotion regulation|emotion regulation
5106994|NCT03329144|Parenting|parenting
5106995|NCT03329144|CBT|cbt
5106996|NCT03329118|SHR3824,simvastatin, drug-drug interaction|shr3824,simvastatin, drug-drug interaction
5106997|NCT03329105|Gingival Health|gingival health
5106998|NCT03329105|Biofilm Formation|biofilm formation
5107005|NCT03329079|rural|rural
5107006|NCT03329079|men|men
5107007|NCT03329079|community-based participatory research|community-based participatory research
5107008|NCT03329079|weight loss|weight loss
5107009|NCT03329079|mobile applications|mobile applications
5107010|NCT03329079|text messaging|text messaging
5107011|NCT03329066|Asthma|asthma
5107012|NCT03329066|Sleep|sleep
5107013|NCT03329066|Adolescents|adolescents
5107014|NCT03329066|Urban|urban
5107015|NCT03329066|Intervention|intervention
5107016|NCT03329066|High school|high school
5107017|NCT03329053|exercise prescription|exercise prescription
5107018|NCT03329053|digital exercise prescription tool|digital exercise prescription tool
5107019|NCT03329040|Hyperbilirubinemia|hyperbilirubinemia
5107020|NCT03329040|Primiparity|primiparity
5107039|NCT03328897|China|china
5107040|NCT03328871|Striae Gravidarum|striae gravidarum
5107041|NCT03328871|Fractional Laser|fractional laser
5107042|NCT03328871|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
5107043|NCT03328871|Nanofat Graft|nanofat graft
5107044|NCT03328871|Combination Therapy|combination therapy
5107045|NCT03328858|Ketogenic Diet, brain tumors|ketogenic diet, brain tumors
5107046|NCT03328845|Oxidation|oxidation
5107047|NCT03328845|Insulin analogues|insulin analogues
5107048|NCT03328845|Type 1 diabetes mellitus|type 1 diabetes mellitus
5107049|NCT03328832|Thrombin-gelatin matrix|thrombin-gelatin matrix
5107050|NCT03328832|Floseal|floseal
5107051|NCT03328832|Tranexamic Acid|tranexamic acid
5107052|NCT03328832|Total Knee Arthroplasty|total knee arthroplasty
5107053|NCT03328819|Acupuncture|acupuncture
5107054|NCT03328819|Chronic pain|chronic pain
5107055|NCT03328819|Major depressive disorder|major depressive disorder
5107056|NCT03328819|Biomarkers|biomarkers
5107057|NCT03328819|Gene|gene
5107058|NCT03328819|Comorbidity|comorbidity
5107059|NCT03328806|low back pain|low back pain
5107060|NCT03328806|outcome measures|outcome measures
5107061|NCT03328806|cross culture adaptation|cross culture adaptation
5107062|NCT03328806|Core Outcome Measure Index|core outcome measure index
5107063|NCT03328793|music|music
5107064|NCT03328793|gait|gait
5107065|NCT03328793|emotions|emotions
5107066|NCT03328793|communication|communication
5107067|NCT03328780|preoperative|preoperative
5107068|NCT03328780|orthopedic surgery|orthopedic surgery
5107069|NCT03328754|Pitchfork|pitchfork
5107070|NCT03328754|Class II malocclusion|class ii malocclusion
5107071|NCT03328754|PowerScope|powerscope
4992393|NCT04040803|frequency|frequency
5107072|NCT03328741|Clinical Trials, Randomized|clinical trials, randomized
5107073|NCT03328741|Telemedicine|telemedicine
5107074|NCT03328702|Dysphagia|dysphagia
5107075|NCT03328702|Oropharyngeal dysphagia|oropharyngeal dysphagia
5107076|NCT03328702|Total Laryngectomy|total laryngectomy
5107077|NCT03328702|Video Fluoroscopic Swallowing Exam (VFSE)|video fluoroscopic swallowing exam (vfse)
5107082|NCT03328663|Cancer Care|cancer care
5107083|NCT03328637|Smartphone Addiction|smartphone addiction
5107084|NCT03328637|CBT|cbt
5107085|NCT03328637|Evidence based intervention|evidence based intervention
5107086|NCT03328585|CBT-I|cbt-i
5107087|NCT03328585|Telemedicine|telemedicine
5107091|NCT03328468|Stroke|stroke
5107092|NCT03328429|bartholin|bartholin
5107112|NCT03328351|physiotherapy|physiotherapy
5107113|NCT03328338|Mitochondria|mitochondria
5107114|NCT03328338|Oxidative phosphorylation (mitochondrial respiration)|oxidative phosphorylation (mitochondrial respiration)
5107115|NCT03328338|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
5107117|NCT03328325|B Cell Response|b cell response
5107118|NCT03328325|Children|children
5107119|NCT03328325|Evaluation|evaluation
5107120|NCT03328325|Healthy Adults|healthy adults
5107125|NCT03328221|Rehabilitation|rehabilitation
5107126|NCT03328208|Nonpharmacologic analgesia|nonpharmacologic analgesia
5107127|NCT03328208|Medical app|medical app
5107128|NCT03328208|Relaxation|relaxation
5107130|NCT03328130|Adeno-associated virus|adeno-associated virus
5107132|NCT03328130|Retinitis Pigmentosa|retinitis pigmentosa
5107133|NCT03328130|PDE6B|pde6b
5107134|NCT03328130|Gene Therapy|gene therapy
5107135|NCT03328130|Gene Transfer|gene transfer
5107136|NCT03328130|Retinal Dystrophy|retinal dystrophy
5107137|NCT03328130|Eye Diseases|eye diseases
5107138|NCT03328130|Vision Disorders|vision disorders
5107139|NCT03328130|Eye Diseases, Hereditary|eye diseases, hereditary
5107140|NCT03328130|Retinal Diseases|retinal diseases
5107141|NCT03328130|Retinal Degeneration|retinal degeneration
5107142|NCT03328104|T- cell acute lymphoblastic leukemia|t- cell acute lymphoblastic leukemia
5107143|NCT03328104|T-ALL|t-all
5107144|NCT03328104|T-cell lymphoblastic lymphoma|t-cell lymphoblastic lymphoma
5107145|NCT03328104|T-LLy|t-lly
5107146|NCT03328104|Everolimus|everolimus
5107147|NCT03328104|Maximum tolerated dose|maximum tolerated dose
5107148|NCT03328091|Prostate Cancer|prostate cancer
5107149|NCT03328091|Genetics|genetics
5107150|NCT03328078|DLBCL|dlbcl
5107151|NCT03328078|MCL|mcl
5107152|NCT03328078|WM|wm
5107153|NCT03328078|LPL|lpl
5107154|NCT03328078|MYD88|myd88
5107155|NCT03328078|IRAK4|irak4
5107156|NCT03328078|NHL|nhl
5107157|NCT03328078|AML|aml
5107158|NCT03327987|vaccine immunogenicity|vaccine immunogenicity
5107159|NCT03327987|vaccine safety|vaccine safety
5107160|NCT03327974|Aged between 18 and 65|aged between 18 and 65
5107161|NCT03327974|Major depressive disorder|major depressive disorder
5107162|NCT03327974|Suicide|suicide
5107163|NCT03327974|Ecological momentary assessment|ecological momentary assessment
5107164|NCT03327974|Smartphone application|smartphone application
5107165|NCT03327948|Sacral neuromodulation (SNM)|sacral neuromodulation (snm)
5107166|NCT03327948|SNM|snm
5107167|NCT03327922|Subdermal|subdermal
5107168|NCT03327922|Suture|suture
5107169|NCT03327922|Wound Closure|wound closure
5107170|NCT03327922|Wound Cosmesis|wound cosmesis
5107171|NCT03327909|Intradialytic Hypotension, Hypertension, Ambulatory Blood Pressure|intradialytic hypotension, hypertension, ambulatory blood pressure
5107172|NCT03327896|Quality Measures, Social Determinants of Health|quality measures, social determinants of health
5107173|NCT03327883|Diagnostic Imaging|diagnostic imaging
5117595|NCT03260478|Anemia|anemia
5107174|NCT03327883|Review of Patients Records|review of patients records
5107177|NCT03327870|Sjogren's Syndrome|sjogren's syndrome
5107178|NCT03327870|Sicca|sicca
5107179|NCT03327844|Regenerative Endodontic Therapy|regenerative endodontic therapy
5750631|NCT00317590|Management|management
5107180|NCT03327844|Infected immature permanent teeth|infected immature permanent teeth
5107181|NCT03327831|aminolevulinic acid|aminolevulinic acid
5107183|NCT03327831|photodynamic therapy|photodynamic therapy
5107184|NCT03327831|Photochemotherapy|photochemotherapy
5107185|NCT03327805|Choline|choline
5107186|NCT03327805|Trimethylamine N-Oxide|trimethylamine n-oxide
5107187|NCT03327805|Vascular health|vascular health
5107188|NCT03327766|vitamin D and recurrent pregnancy loss|vitamin d and recurrent pregnancy loss
5107189|NCT03327753|exercise|exercise
5107190|NCT03327753|mobility|mobility
5107191|NCT03327753|physiotherapy|physiotherapy
5107192|NCT03327753|validation|validation
5107193|NCT03327740|Hypersensitivity reactions (HSR)|hypersensitivity reactions (hsr)
5107194|NCT03327740|HIV|hiv
5107195|NCT03327740|Dolutegravir|dolutegravir
5107196|NCT03327727|IA|ia
5107203|NCT03327701|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5107204|NCT03327701|Benralizumab|benralizumab
5107205|NCT03327701|Antiinterleukin 5 receptor α monoclonal antibody|antiinterleukin 5 receptor α monoclonal antibody
4992530|NCT04040010|bone metabolism|bone metabolism
5107206|NCT03327688|Focus assesment with sonography for trauma|focus assesment with sonography for trauma
5107207|NCT03327688|POCUS|pocus
5107208|NCT03327688|LOS|los
5107209|NCT03327688|Point-of-care ultrasound|point-of-care ultrasound
5107210|NCT03327688|length of stay|length of stay
5107211|NCT03327688|cost-minimization|cost-minimization
5107212|NCT03327688|primary health care|primary health care
5107213|NCT03327688|Ultrasound|ultrasound
5107214|NCT03327688|Emergency department|emergency department
5107215|NCT03327675|prostate-specific membrane antigen|prostate-specific membrane antigen
5107216|NCT03327675|Lymph Node Dissection|lymph node dissection
5107217|NCT03327675|Prostatectomy|prostatectomy
5107218|NCT03327675|Positron-Emission Tomography|positron-emission tomography
5107219|NCT03327662|Cabazitaxel|cabazitaxel
5107220|NCT03327662|Docetaxel|docetaxel
5107221|NCT03327662|Circulating Tumour Cells|circulating tumour cells
5107222|NCT03327649|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5107223|NCT03327649|inflammation|inflammation
5107224|NCT03327636|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
5107225|NCT03327636|High intensity focused ultrasound|high intensity focused ultrasound
5107226|NCT03327636|Active surveillance|active surveillance
5107227|NCT03327623|sleep apnea|sleep apnea
5107228|NCT03327623|arrhythmia|arrhythmia
5107229|NCT03327610|Respiratory Therapy|respiratory therapy
5107230|NCT03327610|Positive Pressure Respiration|positive pressure respiration
5107231|NCT03327610|Physical Therapy Modalities|physical therapy modalities
5107232|NCT03327597|MGUS|mgus
5107233|NCT03327597|Screening|screening
5107234|NCT03327597|Population-based|population-based
5107235|NCT03327571|Drug therapy|drug therapy
5107236|NCT03327545|Trigger points|trigger points
5107237|NCT03327545|Trigegeminal nerve|trigegeminal nerve
5107238|NCT03327545|Pain|pain
5107239|NCT03327532|Acute Heart Failure|acute heart failure
5107240|NCT03327532|Congestion|congestion
5107241|NCT03327532|Ultrasound|ultrasound
5107242|NCT03327519|Asthma|asthma
5107243|NCT03327519|Insomnia|insomnia
5107244|NCT03327506|Premedication/ Hypnosis/ Anxiety/Surgery|premedication/ hypnosis/ anxiety/surgery
5107245|NCT03327493|Cardiogenic shock|cardiogenic shock
5107246|NCT03327493|Extra-Corporeal-Life-Support (ECLS)|extra-corporeal-life-support (ecls)
5107247|NCT03327493|inflammation|inflammation
5107248|NCT03327493|adrenergic system|adrenergic system
5107249|NCT03327480|osteoarthritis thumb|osteoarthritis thumb
5107250|NCT03327480|orthosis|orthosis
5107251|NCT03327480|functioning|functioning
5107252|NCT03327454|Ankylosing spondylitis|ankylosing spondylitis
5107253|NCT03327454|Axial spondyloarthritis|axial spondyloarthritis
5107254|NCT03327454|Benepali pen|benepali pen
5107255|NCT03327454|Etanercept|etanercept
5107256|NCT03327454|Patient questionnaire|patient questionnaire
5107257|NCT03327454|Pre-filled pen|pre-filled pen
5107258|NCT03327454|Biological DMARDs|biological dmards
5107259|NCT03327454|Antirheumatic drug|antirheumatic drug
5107260|NCT03327428|Anemia, Sickle Cell|anemia, sickle cell
5107261|NCT03327428|Sickle Cell disease|sickle cell disease
5107262|NCT03327415|Children|children
5107263|NCT03327415|Food practice|food practice
5107264|NCT03327415|Food consumption|food consumption
5107265|NCT03327415|Nutrient intake|nutrient intake
5107266|NCT03327402|SHP465|shp465
5107267|NCT03327402|ADHD|adhd
5107268|NCT03327402|Hyperactivity|hyperactivity
5107269|NCT03327376|central venous catheters|central venous catheters
5107270|NCT03327376|venous thrombosis|venous thrombosis
5107271|NCT03327376|ultrasound|ultrasound
5107272|NCT03327376|critical care|critical care
5107273|NCT03327363|ICT based clinical trial,|ict based clinical trial,
5107275|NCT03327363|electronic -institutional review board (eIRB),|electronic -institutional review board (eirb),
5107276|NCT03327363|Centralized monitoring|centralized monitoring
5107277|NCT03327363|contract research organization (CRO)|contract research organization (cro)
5107278|NCT03327311|No condition|no condition
5107279|NCT03327298|Pedicle screw. Free hand. Lumbar fixation|pedicle screw. free hand. lumbar fixation
5107280|NCT03327285|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5107281|NCT03327285|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5107282|NCT03327285|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
5107283|NCT03327181|short chain fatty acid metabolism|short chain fatty acid metabolism
5107284|NCT03327168|Adipose Tissue, Brown|adipose tissue, brown
5107285|NCT03327155|HIV prevention|hiv prevention
5107286|NCT03327155|PrEP|prep
5107287|NCT03327142|Adrenal Gland|adrenal gland
5107288|NCT03327142|Endoscopic Ultrasound Guided FNA|endoscopic ultrasound guided fna
5107289|NCT03327116|atopic dermatitis|atopic dermatitis
5107290|NCT03327116|pruritus|pruritus
5107291|NCT03327116|methotrexate|methotrexate
5107292|NCT03327116|inflamation|inflamation
5107293|NCT03327116|IL-31|il-31
5107294|NCT03327103|decision making|decision making
5107295|NCT03327103|advanced prostate cancer|advanced prostate cancer
5107296|NCT03327103|decision aid|decision aid
5107297|NCT03327103|minorities|minorities
5107298|NCT03327103|mHealth|mhealth
5107299|NCT03327103|community patient navigator|community patient navigator
5107300|NCT03327090|Olympic Weightlifting|olympic weightlifting
5107301|NCT03327090|Taping|taping
5107302|NCT03327090|Muscles Facilitation|muscles facilitation
5107303|NCT03327090|Jumps|jumps
5107304|NCT03326999|adductor canal regional block|adductor canal regional block
5107305|NCT03326999|obturator nerve regional block|obturator nerve regional block
5107306|NCT03326999|total knee arthroplasty|total knee arthroplasty
5107307|NCT03326999|knee replacement surgery|knee replacement surgery
5107308|NCT03326999|Knee rheumatoid arthritis|knee rheumatoid arthritis
5107309|NCT03326973|Quality of Life (QoL)|quality of life (qol)
5107310|NCT03326973|17-518|17-518
5107311|NCT03326960|general anesthesia|general anesthesia
5107312|NCT03326960|postoperative delirium|postoperative delirium
5107313|NCT03326960|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5107314|NCT03326960|retinal nerve fiber layer|retinal nerve fiber layer
5107315|NCT03326960|biomarker|biomarker
5107316|NCT03326947|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
5107317|NCT03326921|HA-1|ha-1
5107319|NCT03326921|Immunotherapy|immunotherapy
5107320|NCT03326921|Leukemia|leukemia
5107321|NCT03326843|low platelet count|low platelet count
5107323|NCT03326830|Respiratory Insufficiency|respiratory insufficiency
5107324|NCT03326830|Oxygen Inhalation Therapy|oxygen inhalation therapy
5107325|NCT03326817|Degenerative Arthritis, Rheumatic Diseases|degenerative arthritis, rheumatic diseases
5107326|NCT03326804|Hip Resurfacing Arthroplasty|hip resurfacing arthroplasty
5107327|NCT03326804|Ceramic|ceramic
5107329|NCT03326791|Acetylsalicylic acid|acetylsalicylic acid
5107330|NCT03326791|Aspirin|aspirin
5107331|NCT03326791|Trombyl|trombyl
5107332|NCT03326791|Secondary prevention|secondary prevention
5107333|NCT03326778|Aortic Valve Stenosis|aortic valve stenosis
5107334|NCT03326778|Rapid deployment Valve|rapid deployment valve
5107335|NCT03326778|CABG|cabg
5107336|NCT03326778|Edwards Intuity Elite|edwards intuity elite
5107337|NCT03326765|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
5107338|NCT03326765|Children|children
5107339|NCT03326765|Adults|adults
5107340|NCT03326752|Cancer|cancer
5107341|NCT03326752|Lung Cancer|lung cancer
5107342|NCT03326752|NSCLC|nsclc
5107343|NCT03326752|Anti-PD-1 inhibitor|anti-pd-1 inhibitor
5107344|NCT03326752|Immuno-oncology|immuno-oncology
5107345|NCT03326752|Toll-Like Receptor (TLR) agonist|toll-like receptor (tlr) agonist
5107346|NCT03326713|Genetic Testing|genetic testing
5107347|NCT03326713|Prevention|prevention
5107348|NCT03326687|Language|language
5107349|NCT03326687|Anomia|anomia
5107350|NCT03326687|Therapy|therapy
5107351|NCT03326674|Tesetaxel|tesetaxel
5107352|NCT03326674|Capecitabine|capecitabine
5107353|NCT03326674|HER2 negative|her2 negative
5107354|NCT03326674|Hormone Receptor positive|hormone receptor positive
5107355|NCT03326674|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5107356|NCT03326674|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
5107357|NCT03326674|Taxanes|taxanes
5107358|NCT03326674|Metastatic breast cancer|metastatic breast cancer
5107359|NCT03326674|Breast cancer|breast cancer
5107360|NCT03326674|Central nervous system (CNS) metastases|central nervous system (cns) metastases
5107361|NCT03326661|Tonsillectomy|tonsillectomy
5107362|NCT03326661|Aspiration|aspiration
5107363|NCT03326661|Quinsy|quinsy
5107364|NCT03326648|Sarcopenia|sarcopenia
5107365|NCT03326648|Frailty|frailty
5107366|NCT03326648|Strength training|strength training
5107367|NCT03326648|Autophagy|autophagy
5107368|NCT03326635|Resuscitation|resuscitation
5107369|NCT03326635|Frailty|frailty
5107370|NCT03326635|ICU|icu
5107371|NCT03326635|Ageing|ageing
5107372|NCT03326635|Rehabilitation|rehabilitation
5107382|NCT03326583|End Stage Renal Disease|end stage renal disease
5107383|NCT03326583|ESRD|esrd
4978600|NCT04125784|HIV|hiv
5107384|NCT03326583|Hyperkalemia|hyperkalemia
5107385|NCT03326570|Lung cancer|lung cancer
5107386|NCT03326570|Data collection post bronchoscopy|data collection post bronchoscopy
5107387|NCT03326557|Induction of Labour|induction of labour
5107388|NCT03326557|Previous Caesarean delivery|previous caesarean delivery
5107389|NCT03326557|Foley|foley
5107390|NCT03326557|Membrane sweeping|membrane sweeping
5107391|NCT03326557|Vaginal delivery|vaginal delivery
5107392|NCT03326505|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5107393|NCT03326505|Multiple Sclerosis|multiple sclerosis
5107394|NCT03326505|Neuroimmunology|neuroimmunology
5107395|NCT03326505|Autoimmune disease|autoimmune disease
5107396|NCT03326505|Physical therapy|physical therapy
5107397|NCT03326492|Snake bites|snake bites
5107398|NCT03326492|Antivenom serum|antivenom serum
5107399|NCT03326492|Snake venoms|snake venoms
5107400|NCT03326479|Molecular Profiling|molecular profiling
5107401|NCT03326479|Biomarker Analysis|biomarker analysis
5107402|NCT03326479|Outcomes Database|outcomes database
5107403|NCT03326466|Subacromial Impingement Syndrome|subacromial impingement syndrome
4992776|NCT04038814|VAP|vap
5107404|NCT03326466|Central Nervous System Sensitization|central nervous system sensitization
5107405|NCT03326466|Muscle Function|muscle function
5107406|NCT03326466|EMG|emg
5107407|NCT03326466|Force Steadiness|force steadiness
5107408|NCT03326466|CUFF Algometry|cuff algometry
5107409|NCT03326466|Manual Algometry|manual algometry
5107410|NCT03326466|Pain|pain
5107411|NCT03326466|Maximal Voluntary Isometric Contraction|maximal voluntary isometric contraction
5107412|NCT03326453|mini dental implant|mini dental implant
5107413|NCT03326453|overdenture|overdenture
5107414|NCT03326453|Patient satisfaction|patient satisfaction
5107421|NCT03326401|glycemic load|glycemic load
5107422|NCT03326401|glycemic index|glycemic index
5107423|NCT03326401|nutrient intake|nutrient intake
5107424|NCT03326375|TACE|tace
5107425|NCT03326375|SBRT|sbrt
5107426|NCT03326362|chronic low back pain|chronic low back pain
5107427|NCT03326362|strength training|strength training
5107428|NCT03326362|biomechanics|biomechanics
5107429|NCT03326362|inflammatory biomarkers|inflammatory biomarkers
5107430|NCT03326349|computerized cognitive rehabilitation|computerized cognitive rehabilitation
5107431|NCT03326336|Eye Diseases|eye diseases
5107432|NCT03326336|Hereditary Eye Diseases|hereditary eye diseases
5107433|NCT03326336|Retinal degeneration|retinal degeneration
5107434|NCT03326336|Inherited retinal diseases|inherited retinal diseases
5107435|NCT03326336|Rod & cone dystrophies|rod & cone dystrophies
5107436|NCT03326336|Retinitis Pigmentosa|retinitis pigmentosa
5107437|NCT03326336|Gene Therapy|gene therapy
5107438|NCT03326336|Optogenetic|optogenetic
5107439|NCT03326336|Intravitreal Injections|intravitreal injections
5107440|NCT03326336|AAV Vectors|aav vectors
5107441|NCT03326336|Medical device|medical device
5107442|NCT03326336|Visual Interface|visual interface
5107443|NCT03326323|acute normovolemic hemodilution|acute normovolemic hemodilution
5107444|NCT03326310|Chronic Myeloid Leukemia|chronic myeloid leukemia
5107445|NCT03326310|Myelofibrosis|myelofibrosis
5107446|NCT03326310|selumetinib|selumetinib
5107447|NCT03326310|azacitidine|azacitidine
5107448|NCT03326297|Infant Colic|infant colic
5107449|NCT03326297|Osteopathy|osteopathy
5107450|NCT03326297|Stress|stress
5107451|NCT03326297|Physiotherapy|physiotherapy
5107452|NCT03326284|Hypocaloric diet|hypocaloric diet
5107453|NCT03326284|Dietary protein|dietary protein
5107454|NCT03326245|Pharmacological MRI|pharmacological mri
5107455|NCT03326245|C-11 Raclopride|c-11 raclopride
5107456|NCT03326245|PET Imaging|pet imaging
5107457|NCT03326245|Neuropsychological Testing|neuropsychological testing
5107458|NCT03326219|MOCA|moca
5107459|NCT03326219|VSM|vsm
5107460|NCT03326219|Clarivein|clarivein
5107461|NCT03326219|Histological|histological
5107462|NCT03326206|Navajo|navajo
5107463|NCT03326206|Community Health Workers|community health workers
5107464|NCT03326206|Community Health Representatives|community health representatives
5107465|NCT03326206|Tribal health systems|tribal health systems
5107466|NCT03326206|American Indian|american indian
5107467|NCT03326206|Rural|rural
5107468|NCT03326206|Health disparities|health disparities
5107469|NCT03326193|Stage IIIb - IV|stage iiib - iv
5107470|NCT03326193|gBRCAmut|gbrcamut
5107472|NCT03326193|PARP inhibitor|parp inhibitor
5107473|NCT03326193|Ovarian|ovarian
5107474|NCT03326193|Primary Peritoneal|primary peritoneal
5107475|NCT03326193|Fallopian Tube|fallopian tube
5107476|NCT03326193|VEGF inhibitor|vegf inhibitor
5107477|NCT03326193|Bevacizumab|bevacizumab
5107478|NCT03326193|Niraparib|niraparib
5107479|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors
5107480|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents
5750923|NCT00316459|Healthy|healthy
5107481|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors
5107482|NCT03326154|cholecystectomy|cholecystectomy
5107483|NCT03326154|quality of life|quality of life
5107484|NCT03326128|Bupropion XL|bupropion xl
5961971|NCT04283734|Diffuse coronary artery disease|diffuse coronary artery disease
5107485|NCT03326128|Anhedonia|anhedonia
5107486|NCT03326128|Heavy Smokers|heavy smokers
5107487|NCT03326128|Smoking cessation|smoking cessation
5107488|NCT03326115|patient activation|patient activation
5107489|NCT03326115|peer visitation|peer visitation
5107490|NCT03326115|amputee|amputee
5107491|NCT03326102|Breast Cancer|breast cancer
5107492|NCT03326102|DHP107|dhp107
5107493|NCT03326102|Paclitaxel|paclitaxel
5107494|NCT03326102|Liporaxel|liporaxel
5107495|NCT03326089|pulmonary rehabilitation|pulmonary rehabilitation
5107496|NCT03326050|Rhinoscleroma|rhinoscleroma
5107497|NCT03326050|Gemifloxacin|gemifloxacin
5107498|NCT03326050|Ciprofloxacin|ciprofloxacin
5107499|NCT03326037|Nephrotic Syndrome|nephrotic syndrome
5107500|NCT03326037|NPHS2 gene mutation|nphs2 gene mutation
5107501|NCT03326037|disease association|disease association
5107502|NCT03326011|Exoskeleton Device|exoskeleton device
5107503|NCT03326011|Gait rehabilitation|gait rehabilitation
5107504|NCT03326011|Chronic storke|chronic storke
5107505|NCT03325998|Exoskeleton Device|exoskeleton device
5107506|NCT03325998|Elderly|elderly
5107507|NCT03325998|Gait rehabilitation|gait rehabilitation
5107508|NCT03325959|hyperbaric oxygen|hyperbaric oxygen
5107509|NCT03325959|HBOT|hbot
5107510|NCT03325959|fibromyalgia|fibromyalgia
5107511|NCT03325959|pain|pain
5107512|NCT03325933|insulin sensitivity|insulin sensitivity
5107513|NCT03325933|muscle|muscle
5107514|NCT03325933|strength|strength
5107515|NCT03325933|resistance training|resistance training
5107516|NCT03325933|strength training|strength training
5107520|NCT03325920|sleep bruxism|sleep bruxism
5107521|NCT03325920|diagnosis|diagnosis
5107522|NCT03325920|validation study|validation study
5107523|NCT03325920|assessment|assessment
5107524|NCT03325907|Biopsy, Needle|biopsy, needle
5107525|NCT03325907|Printing, Three-Dimensional|printing, three-dimensional
5107526|NCT03325907|Image-Guided Biopsy|image-guided biopsy
5107527|NCT03325894|ADHD|adhd
5107528|NCT03325894|SHP465|shp465
5107529|NCT03325894|Hyperactivity|hyperactivity
5107530|NCT03325881|ADHD|adhd
5107531|NCT03325881|Hyperactivity|hyperactivity
5107532|NCT03325881|SHP465|shp465
5107533|NCT03325868|heavy periods, painful periods, adenomyosis|heavy periods, painful periods, adenomyosis
5107535|NCT03325855|CDI|cdi
5107536|NCT03325855|Fecal Matter Transplant|fecal matter transplant
5107537|NCT03325842|Cross-cultural comparison|cross-cultural comparison
5107538|NCT03325842|Disability evaluation|disability evaluation
5107539|NCT03325842|Self-assessment|self-assessment
5107540|NCT03325842|Child|child
5107541|NCT03325842|Adolescent|adolescent
5107542|NCT03325829|Registry|registry
5107543|NCT03325829|Diverticular Disease|diverticular disease
5107544|NCT03325829|Diverticulitis|diverticulitis
5107545|NCT03325829|Uncomplicated Diverticular Disease|uncomplicated diverticular disease
5107549|NCT03325803|actinic keratosis|actinic keratosis
5107550|NCT03325803|ablative fractional laser|ablative fractional laser
5107551|NCT03325803|photodynamic therapy|photodynamic therapy
5107553|NCT03325803|protoporphyrin IX|protoporphyrin ix
5107554|NCT03325790|Meniere's disease|meniere's disease
5107555|NCT03325790|Hearing Loss|hearing loss
5107556|NCT03325790|Vertigo|vertigo
5107557|NCT03325790|Tinnitus|tinnitus
5107558|NCT03325790|Ebselen|ebselen
5107559|NCT03325790|Pharmacokinetics|pharmacokinetics
5107560|NCT03325790|Safety|safety
5107561|NCT03325790|Efficacy|efficacy
5107562|NCT03325790|Speech|speech
5107563|NCT03325777|Cigarettes|cigarettes
5107564|NCT03325777|Tobacco Use|tobacco use
5107565|NCT03325764|Obesity|obesity
5107566|NCT03325764|bariatric surgery|bariatric surgery
5107567|NCT03325764|sleeve gastrectomy|sleeve gastrectomy
5107568|NCT03325764|physical activity|physical activity
5107569|NCT03325764|movement analysis|movement analysis
5107570|NCT03325725|severe aspiration|severe aspiration
5107571|NCT03325699|Mild dementia|mild dementia
5107572|NCT03325699|Cognitive impairment|cognitive impairment
5107573|NCT03325699|Informal caregiver|informal caregiver
5107574|NCT03325699|Aging|aging
5107575|NCT03325699|Quality of life|quality of life
5107576|NCT03325699|Health application|health application
5107577|NCT03325699|Information and communication technology (ICT)|information and communication technology (ict)
5107578|NCT03325686|vitamin D|vitamin d
5107579|NCT03325686|atletes|atletes
5107580|NCT03325686|physical performance|physical performance
5107581|NCT03325660|Whole body vibration, Pelvic floor muscle|whole body vibration, pelvic floor muscle
5107582|NCT03325647|body composition|body composition
5107583|NCT03325647|klinefelter syndrome|klinefelter syndrome
5107584|NCT03325647|XXY|xxy
5107585|NCT03325647|sex chromosome variation|sex chromosome variation
5107586|NCT03325647|sex chromosome aneuploidy|sex chromosome aneuploidy
5107587|NCT03325647|testosterone|testosterone
5107588|NCT03325621|Hepcidin|hepcidin
5107589|NCT03325621|Hemoglobin|hemoglobin
5107590|NCT03325621|Iron|iron
5107591|NCT03325621|Anemia of chronic disease|anemia of chronic disease
5107592|NCT03325582|Perianal Fistula Crohn's disease, MRI|perianal fistula crohn's disease, mri
5107593|NCT03325556|Dementia|dementia
5107594|NCT03325556|Dementia-related psychosis|dementia-related psychosis
5107595|NCT03325556|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
5107596|NCT03325556|Dementia with Lewy bodies|dementia with lewy bodies
5107597|NCT03325556|Alzheimer's disease|alzheimer's disease
5107598|NCT03325556|Behavioral variant frontotemporal dementia|behavioral variant frontotemporal dementia
5107599|NCT03325556|Progressive supranuclear palsy|progressive supranuclear palsy
5107600|NCT03325556|Corticobasal degeneration|corticobasal degeneration
5107601|NCT03325556|Vascular dementia|vascular dementia
5107602|NCT03325556|Hallucinations|hallucinations
5107603|NCT03325556|Delusions|delusions
5107604|NCT03325556|Psychosis|psychosis
5107605|NCT03325543|Urinary Incontinence, Stress|urinary incontinence, stress
5107606|NCT03325543|Pelvic Floor|pelvic floor
5107607|NCT03325543|Exercise|exercise
5107608|NCT03325530|Adolescent|adolescent
5107609|NCT03325530|Nutrition|nutrition
5107610|NCT03325530|Physical Activity|physical activity
5107611|NCT03325504|Non-union|non-union
5107612|NCT03325504|Advanced therapies|advanced therapies
5107613|NCT03325504|Mesenchymal stem cells|mesenchymal stem cells
5107614|NCT03325504|Long bone|long bone
5107615|NCT03325465|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5107616|NCT03325465|head and neck cancer|head and neck cancer
5107617|NCT03325465|neoadjuvant pembrolizumab|neoadjuvant pembrolizumab
5107618|NCT03325465|epacadostat|epacadostat
5107619|NCT03325439|Electroencephalographic neonatal seizures|electroencephalographic neonatal seizures
5107620|NCT03325439|Brivaracetam|brivaracetam
5107621|NCT03325439|Epilepsy|epilepsy
5107623|NCT03325439|Newborns|newborns
5107624|NCT03325439|Pharmacokinetic|pharmacokinetic
5107625|NCT03325413|Perioperative geriatric care|perioperative geriatric care
5107626|NCT03325413|Geriatric assessment|geriatric assessment
5107627|NCT03325413|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5107629|NCT03325413|Frailty|frailty
5107630|NCT03325413|Depression|depression
5107631|NCT03325413|Physical fitness|physical fitness
5107632|NCT03325413|Geriatric anesthesia|geriatric anesthesia
5107633|NCT03325413|IADL|iadl
5107634|NCT03325413|Postoperative functional status|postoperative functional status
5107635|NCT03325413|Quality of life|quality of life
5107636|NCT03325400|Fluoride toothpaste|fluoride toothpaste
5107637|NCT03325400|Cytogenetic damage|cytogenetic damage
5107638|NCT03325400|Exfoliated buccal cells|exfoliated buccal cells
5107639|NCT03325400|Micronucleus assay|micronucleus assay
5107640|NCT03325348|Severe Pre eclampsia|severe pre eclampsia
5107641|NCT03325348|Nifidepine|nifidepine
5107642|NCT03325348|Labetalol|labetalol
5107643|NCT03325335|midazolam premedication|midazolam premedication
5107644|NCT03325322|Frailty|frailty
5107645|NCT03325322|Inflammation|inflammation
5107646|NCT03325322|Mesenchymal stem cell|mesenchymal stem cell
5107647|NCT03325322|Mesenchymal stromal cell|mesenchymal stromal cell
5107648|NCT03325309|Lumbar spinal stenosis|lumbar spinal stenosis
5107649|NCT03325309|Cycling|cycling
5104936|NCT03341247|DXA|dxa
5107650|NCT03325309|Lumbar-flexion-based training|lumbar-flexion-based training
5107652|NCT03325283|embolic protection|embolic protection
5107653|NCT03325283|cognition|cognition
5107654|NCT03325270|prebiotics|prebiotics
5107655|NCT03325270|Galacto-oligosaccharides|galacto-oligosaccharides
5107656|NCT03325270|Iron-deficiency|iron-deficiency
5107657|NCT03325257|Unresectable melanoma|unresectable melanoma
5107658|NCT03325257|metastatic melanoma|metastatic melanoma
5107659|NCT03325257|Immunotherapy|immunotherapy
5107660|NCT03325257|Nivolumab|nivolumab
5107661|NCT03325257|Temporary Auhorization for Use (ATU)|temporary auhorization for use (atu)
5107662|NCT03325205|Transcranial direct current stimulation|transcranial direct current stimulation
5107663|NCT03325205|Neuromodulation|neuromodulation
5107664|NCT03325205|Individualizing brain stimulation|individualizing brain stimulation
5107665|NCT03325205|Neuropsychology|neuropsychology
5107666|NCT03325192|Indwelling Pleural Catheter|indwelling pleural catheter
5107667|NCT03325192|Pleurodesis|pleurodesis
5107668|NCT03325192|Iodopovidone|iodopovidone
5107669|NCT03325192|Pleural Effusion, Malignant|pleural effusion, malignant
5107670|NCT03325179|Simple Obesity|simple obesity
5107671|NCT03325179|Thread-embedding Therapy|thread-embedding therapy
5107672|NCT03325179|Acupuncture|acupuncture
5107673|NCT03325153|Obstructive Sleep Apnea|obstructive sleep apnea
5107681|NCT03325088|airway smooth muscle cells|airway smooth muscle cells
5107682|NCT03325088|Rac1 protein|rac1 protein
5107683|NCT03325075|VAL-181388|val-181388
5107684|NCT03325075|Chikungunya vaccine|chikungunya vaccine
5107685|NCT03325049|Family Relations|family relations
5107686|NCT03325049|Family Health|family health
5107687|NCT03325049|Intervention study|intervention study
5107688|NCT03325049|Social support|social support
5107689|NCT03325049|Intensive care unit|intensive care unit
5107690|NCT03325023|PCOS, microbiota, probiotic,obesity|pcos, microbiota, probiotic,obesity
5107691|NCT03324984|Spinal anesthesia|spinal anesthesia
5107693|NCT03324984|Chloroprocaine|chloroprocaine
5107694|NCT03324958|Endometrial cancer|endometrial cancer
5107695|NCT03324958|Brachytherapy|brachytherapy
5107696|NCT03324958|Virtual reality|virtual reality
5107697|NCT03324958|Pain|pain
5107698|NCT03324958|Anxiety|anxiety
5107699|NCT03324932|bone health|bone health
5961972|NCT04283734|Instantaneous Wave Free Ratio|instantaneous wave free ratio
4979331|NCT04121494|Mucosal|mucosal
5107700|NCT03324932|hormone-sensitive breast cancer|hormone-sensitive breast cancer
5107701|NCT03324932|postmenopausal|postmenopausal
5107702|NCT03324932|aromatase inhibitor|aromatase inhibitor
5107703|NCT03324932|bone mineral density|bone mineral density
5107704|NCT03324919|Psoriasis|psoriasis
5107705|NCT03324919|Urticaria|urticaria
5107706|NCT03324919|Lupus erythematodes|lupus erythematodes
5107707|NCT03324919|qualtiy of life|qualtiy of life
5107708|NCT03324906|Prader-Willi Syndrome|prader-willi syndrome
5107709|NCT03324906|Obesity|obesity
5107710|NCT03324906|Depressive disorder|depressive disorder
5107711|NCT03324906|Obsessive-compulsive disorder|obsessive-compulsive disorder
5107712|NCT03324906|noninvasive brain stimulation|noninvasive brain stimulation
5107718|NCT03324854|Mesh|mesh
5107719|NCT03324854|Polypropylene mesh|polypropylene mesh
5107720|NCT03324854|Prolene mesh|prolene mesh
5107721|NCT03324854|ventral hernia|ventral hernia
5107722|NCT03324854|hernia|hernia
5107723|NCT03324841|Molecular Profiling|molecular profiling
5107724|NCT03324841|Biomarker Analysis|biomarker analysis
5107725|NCT03324841|Next Generation Sequencing|next generation sequencing
5107726|NCT03324828|anxiety|anxiety
5107727|NCT03324828|surgery|surgery
5107728|NCT03324828|clown|clown
5107729|NCT03324815|Morphine|morphine
5107730|NCT03324815|Methadone|methadone
5107731|NCT03324815|Pain|pain
5107732|NCT03324789|Single implant|single implant
5107733|NCT03324789|Anterior edentulism|anterior edentulism
5107734|NCT03324789|partial denture|partial denture
5107735|NCT03324776|inhaled insulin|inhaled insulin
5107736|NCT03324750|corticotherapy|corticotherapy
5107737|NCT03324750|qualitative study|qualitative study
5107738|NCT03324750|therapeutic education|therapeutic education
5107739|NCT03324750|lifestyle change|lifestyle change
5107740|NCT03324750|diet|diet
5107741|NCT03324737|Prevention|prevention
5107742|NCT03324737|Smartphone application|smartphone application
5107743|NCT03324737|Randomized control trial|randomized control trial
5107744|NCT03324711|Cognitive disorders|cognitive disorders
5107745|NCT03324711|Alzheimer's disease|alzheimer's disease
5107746|NCT03324711|Mini Mental State Examination|mini mental state examination
5107747|NCT03324711|Geriatry|geriatry
5107748|NCT03324685|Oral Contraceptive, Healthy Volunteers, Ethinyl Estradiol,|oral contraceptive, healthy volunteers, ethinyl estradiol,
5107749|NCT03324685|Levonorgestrel|levonorgestrel
5107750|NCT03324672|lumbar pain; pregnancy;|lumbar pain; pregnancy;
5107751|NCT03324659|Mindfulness|mindfulness
5107752|NCT03324659|Exercise|exercise
5107753|NCT03324659|Meditation|meditation
5107754|NCT03324659|Back pain|back pain
5107755|NCT03324646|Research|research
5107756|NCT03324646|Brain|brain
5107757|NCT03324646|Inflammation|inflammation
5107758|NCT03324633|HIV|hiv
5107759|NCT03324633|HCV|hcv
5107760|NCT03324633|cohort|cohort
5107761|NCT03324633|natural history|natural history
5107762|NCT03324633|cure|cure
5107768|NCT03324620|Allogeneic|allogeneic
5107769|NCT03324620|Quality of Life|quality of life
5107770|NCT03324620|Rehabilitation|rehabilitation
5107771|NCT03324620|Physical Activity|physical activity
5118167|NCT03257241|DAC|dac
5107777|NCT03324516|Temporal hollowing|temporal hollowing
5107784|NCT03324490|Mid-thoracic spinal anesthesia|mid-thoracic spinal anesthesia
5107785|NCT03324490|Mid-thoracic epidural anesthesia|mid-thoracic epidural anesthesia
5107786|NCT03324490|Nephrectomy|nephrectomy
5107787|NCT03324490|Lung disease|lung disease
5107788|NCT03324438|pediatrics|pediatrics
5107789|NCT03324425|breast cancer|breast cancer
5107790|NCT03324425|metastatic breast cancer|metastatic breast cancer
5107791|NCT03324399|ALS|als
5107792|NCT03324399|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5107793|NCT03324386|Hypertension|hypertension
5107794|NCT03324386|Tecnology|tecnology
5107795|NCT03324386|Nursing|nursing
5107796|NCT03324386|Education|education
5107797|NCT03324347|Animal-Assisted Intervention|animal-assisted intervention
5107798|NCT03324347|Dog-Assisted Intervention|dog-assisted intervention
5107799|NCT03324347|Dental Care|dental care
5107800|NCT03324347|Questionnaire|questionnaire
5107801|NCT03324347|Pilot Project|pilot project
5107802|NCT03324347|Dental Clinic|dental clinic
5107803|NCT03324321|Cerebral Haemodynamics|cerebral haemodynamics
5107804|NCT03324321|Carbon Dioxide|carbon dioxide
5107805|NCT03324321|Cerebral Autoregulation|cerebral autoregulation
5107806|NCT03324308|Coronary Artery Disease|coronary artery disease
5107807|NCT03324308|Ischemia|ischemia
5107808|NCT03324308|Computed Tomography|computed tomography
5107809|NCT03324308|Myocardial perfusion|myocardial perfusion
5107810|NCT03324308|Dynamic Imaging|dynamic imaging
5107811|NCT03324282|Anti PD1|anti pd1
5107812|NCT03324282|Bladder carcinoma|bladder carcinoma
5107813|NCT03324282|Chemotherapy|chemotherapy
5107814|NCT03324282|Immunological monitoring|immunological monitoring
5961973|NCT04283734|Long coronary lesion|long coronary lesion
5107815|NCT03324256|Energy drink consumption|energy drink consumption
5107816|NCT03324230|Monoclonal antibody|monoclonal antibody
5107817|NCT03324230|Mepolizumab|mepolizumab
5107818|NCT03324230|Eosinophil|eosinophil
5107819|NCT03324217|motor imagery|motor imagery
5107820|NCT03324217|action observation|action observation
5107821|NCT03324191|Tea extract|tea extract
5107822|NCT03324191|Triglycerides|triglycerides
5107823|NCT03324191|Energy metabolism|energy metabolism
5107824|NCT03324178|Neurofeedback|neurofeedback
5107825|NCT03324178|Attention|attention
5107826|NCT03324165|Computed Tomography|computed tomography
5107827|NCT03324165|Algorithm|algorithm
5107828|NCT03324165|Alvarado Score|alvarado score
5107829|NCT03324152|High-intensity interval training|high-intensity interval training
5107830|NCT03324152|Exercise|exercise
5107831|NCT03324152|Muscle function|muscle function
5107832|NCT03324152|Inflammation|inflammation
5107833|NCT03324126|Preterm infants|preterm infants
5107834|NCT03324126|very low birth weight|very low birth weight
5107835|NCT03324126|breast milk|breast milk
5107836|NCT03324126|individualized fortification|individualized fortification
5107837|NCT03324126|targeted protein fortification|targeted protein fortification
5107838|NCT03324126|adjustable protein fortification|adjustable protein fortification
5107839|NCT03324126|growth|growth
5107840|NCT03324087|HRQoL|hrqol
5107841|NCT03324087|Immune Thrombocytopenia|immune thrombocytopenia
5107842|NCT03324048|Preoperative anxiety|preoperative anxiety
5107843|NCT03324048|Relaxation|relaxation
5107844|NCT03324048|Autonomous nervous system|autonomous nervous system
5107845|NCT03324048|Surgery|surgery
5107846|NCT03324048|Visual Analogue Scale (VAS)|visual analogue scale (vas)
5107847|NCT03324048|State-Trait Anxiety Inventory (STAI-Y)|state-trait anxiety inventory (stai-y)
5107848|NCT03324022|Fibroblast growth factors|fibroblast growth factors
5107849|NCT03324022|Fibroblast growth factors receptors|fibroblast growth factors receptors
5107850|NCT03324022|Thyroid orbitopathy|thyroid orbitopathy
5107851|NCT03323944|metastatic adenocarcinoma, pancreas|metastatic adenocarcinoma, pancreas
5107852|NCT03323931|autism spectrum disorder|autism spectrum disorder
5107853|NCT03323931|robot-enhanced intervention|robot-enhanced intervention
5107854|NCT03323931|imitation|imitation
5107855|NCT03323931|joint attention|joint attention
5107856|NCT03323931|turn-taking|turn-taking
5107857|NCT03323892|preimplantation development|preimplantation development
5107858|NCT03323892|DNA fragmentation|dna fragmentation
5107859|NCT03323892|abstinence duration|abstinence duration
5107860|NCT03323879|brachytherapy|brachytherapy
5107862|NCT03323879|HDR|hdr
5107863|NCT03323879|monotherapy|monotherapy
5107864|NCT03323879|focal|focal
5107865|NCT03323801|Infertility|infertility
5107866|NCT03323762|Pre-Eclampsia; Mild|pre-eclampsia; mild
5105223|NCT03339427|vitamin D|vitamin d
5107867|NCT03323762|Pre-Eclampsia; Moderate|pre-eclampsia; moderate
5107868|NCT03323762|Gestational Hypertension|gestational hypertension
5107869|NCT03323762|Remote ischemic conditioning|remote ischemic conditioning
5107870|NCT03323749|Myopathy|myopathy
5107871|NCT03323749|PMD|pmd
5107872|NCT03323749|Primary Mitochondrial Disease|primary mitochondrial disease
5107873|NCT03323749|MTP-131|mtp-131
5107874|NCT03323749|elamipretide|elamipretide
5107875|NCT03323710|Metastatic|metastatic
5107876|NCT03323710|Renal Cell Carcinoma|renal cell carcinoma
5107877|NCT03323710|Kidney Cancer|kidney cancer
5107878|NCT03323710|Sunitinib|sunitinib
5107879|NCT03323710|Sutent|sutent
5107880|NCT03323710|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5107881|NCT03323710|Angiogenesis Inhibitor|angiogenesis inhibitor
5107882|NCT03323710|Propranolol|propranolol
5107883|NCT03323710|Beta-blocker|beta-blocker
5107884|NCT03323710|First-line|first-line
5107885|NCT03323697|Depression|depression
5107886|NCT03323697|Anxiety|anxiety
5107887|NCT03323697|Herbal Medicine|herbal medicine
5107888|NCT03323697|Chinese Medicine|chinese medicine
5107889|NCT03323697|Hamilton Scale|hamilton scale
5107890|NCT03323697|SSRI|ssri
5107891|NCT03323671|primary dysmenorrhea|primary dysmenorrhea
5107892|NCT03323671|preemptive analgesia|preemptive analgesia
5107893|NCT03323645|prostate cancer|prostate cancer
5107894|NCT03323645|erectile dysfunction|erectile dysfunction
5107895|NCT03323645|penile prosthesis|penile prosthesis
5107896|NCT03323632|Stroke|stroke
5107897|NCT03323632|Cerebrovascular accident|cerebrovascular accident
5107898|NCT03323632|Upper extremity|upper extremity
5107899|NCT03323632|Cerebral Infarction|cerebral infarction
5107900|NCT03323632|Brain Infarction|brain infarction
5107901|NCT03323632|Brain Ischemia|brain ischemia
5107902|NCT03323632|Cerebrovascular Disorders|cerebrovascular disorders
5107903|NCT03323632|Cardiovascular Diseases|cardiovascular diseases
5107904|NCT03323632|Nervous System Diseases|nervous system diseases
5107905|NCT03323632|Central Nervous System Diseases|central nervous system diseases
5107906|NCT03323619|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5107907|NCT03323619|Anesthesia technique|anesthesia technique
5107909|NCT03323567|TMD, collagen, intramuscular injection, trigger point|tmd, collagen, intramuscular injection, trigger point
5107910|NCT03323554|radical prostatectomy , Device,|radical prostatectomy , device,
5107911|NCT03323541|biosimilars|biosimilars
5107912|NCT03323541|filgrastim|filgrastim
5107913|NCT03323541|Stem cell transplantation|stem cell transplantation
5107914|NCT03323541|lymphoma|lymphoma
5107919|NCT03323528|Benzocaine|benzocaine
5107920|NCT03323528|placebo-controlled|placebo-controlled
5107921|NCT03323528|Pharyngitis|pharyngitis
5107922|NCT03323528|sore throat|sore throat
5107923|NCT03323528|throat pain|throat pain
5107924|NCT03323528|difficulty swallowing|difficulty swallowing
5107925|NCT03323528|complete responder|complete responder
5107927|NCT03323528|Non-streptococcal Infections|non-streptococcal infections
5107928|NCT03323502|Nursing Homes|nursing homes
5107929|NCT03323502|Skilled Nursing Facilities|skilled nursing facilities
5107930|NCT03323502|Advance Care Planning|advance care planning
5107931|NCT03323502|Advance Directives|advance directives
5107932|NCT03323502|Alzheimer Disease|alzheimer disease
5107933|NCT03323502|Dementia|dementia
5107934|NCT03323502|Do Not Resuscitate Orders|do not resuscitate orders
5107935|NCT03323502|Physician Orders for Life-Sustaining Treatment|physician orders for life-sustaining treatment
5107936|NCT03323502|Artificial Nutrition|artificial nutrition
5107937|NCT03323502|Hospitalization|hospitalization
5107938|NCT03323502|Intubation|intubation
5107939|NCT03323502|Pragmatic Clinical Trials|pragmatic clinical trials
5107940|NCT03323502|Randomized Controlled Trials|randomized controlled trials
5107941|NCT03323502|Patient Preferences|patient preferences
5107942|NCT03323502|Resuscitation Orders|resuscitation orders
5107943|NCT03323489|celiac|celiac
5107944|NCT03323489|radiosurgery|radiosurgery
5107945|NCT03323489|sbrt|sbrt
5107946|NCT03323489|radiotherapy|radiotherapy
5107947|NCT03323489|pain|pain
5107948|NCT03323463|squamous cell carcinoma of the neck of unknown primary|squamous cell carcinoma of the neck of unknown primary
5107949|NCT03323463|HPV-Associated Oropharyngeal Squamous Cell Carcinoma|hpv-associated oropharyngeal squamous cell carcinoma
5107950|NCT03323463|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5107951|NCT03323463|17-409|17-409
5107952|NCT03323463|Hypoxia negative|hypoxia negative
5107953|NCT03323463|N1-2c oropharyngeal squamous cell carcinoma|n1-2c oropharyngeal squamous cell carcinoma
5107954|NCT03323450|High grade gliomas (WHO grade III or IV)|high grade gliomas (who grade iii or iv)
5107955|NCT03323450|Low grade gliomas (WHO Grade II)|low grade gliomas (who grade ii)
5107956|NCT03323424|Metastatic cancer|metastatic cancer
5107957|NCT03323424|Abscopal effect|abscopal effect
5107958|NCT03323424|Ionizing radiation|ionizing radiation
5107959|NCT03323424|Antibody-Dependant Cell Cytotoxicity (ADCC)|antibody-dependant cell cytotoxicity (adcc)
5107960|NCT03323424|Immuno-Radiation effect|immuno-radiation effect
5107961|NCT03323424|Stereotactic Body Radio-Therapy (SBRT)|stereotactic body radio-therapy (sbrt)
5107962|NCT03323424|Targeted therapies|targeted therapies
5107963|NCT03323398|mRNA-2416|mrna-2416
5107964|NCT03323398|OX40 ligand|ox40 ligand
5107965|NCT03323398|OX40L|ox40l
5107989|NCT03323268|Intensive care|intensive care
5107990|NCT03323268|Cardiogenic shock|cardiogenic shock
5107991|NCT03323268|Peripheral veno-arterial extracorporeal membrane oxygenation|peripheral veno-arterial extracorporeal membrane oxygenation
5107992|NCT03323268|Left ventricular overload|left ventricular overload
5107993|NCT03323268|Native cardiac output|native cardiac output
5107994|NCT03323268|Pulmonary artery blood flow|pulmonary artery blood flow
5107995|NCT03323268|End-tidal carbon dioxide|end-tidal carbon dioxide
5107996|NCT03323268|Swan Ganz catheter|swan ganz catheter
5107997|NCT03323268|Blood gaz|blood gaz
5107998|NCT03323242|Vessel Sealing Devices|vessel sealing devices
5107999|NCT03323242|Liver Transplantation|liver transplantation
5108000|NCT03323229|Ultrasonography|ultrasonography
5108001|NCT03323229|Ambulances|ambulances
5108002|NCT03323229|Satellite Communications|satellite communications
5108003|NCT03323229|Telemedicine|telemedicine
5108004|NCT03323151|Relapsed Mantle-Cell Lymphoma|relapsed mantle-cell lymphoma
5108005|NCT03323151|Refractory Mantle-Cell Lymphoma|refractory mantle-cell lymphoma
5108006|NCT03323151|Ixazomib|ixazomib
5108007|NCT03323151|Ibrutinib|ibrutinib
5108008|NCT03323151|Proteasome Inhibitor|proteasome inhibitor
5108009|NCT03323151|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
5108012|NCT03323138|filtration surgery|filtration surgery
5108013|NCT03323138|phacoemulsification|phacoemulsification
5108020|NCT03323073|unipolar|unipolar
5108021|NCT03323073|bipolar|bipolar
5108022|NCT03323073|depression|depression
5108023|NCT03323073|resting state fMRI|resting state fmri
5108024|NCT03323073|neural network|neural network
5108025|NCT03323073|connectivity|connectivity
5108026|NCT03323047|tonsillectomy|tonsillectomy
5108027|NCT03323047|acetaminophen|acetaminophen
5108028|NCT03323047|dexamethasone|dexamethasone
5108029|NCT03323008|Prisoners|prisoners
5108030|NCT03323008|End-of-life Care|end-of-life care
5108031|NCT03323008|Geriatric Care|geriatric care
5108032|NCT03323008|Palliative Care|palliative care
5108033|NCT03323008|Hospice Care|hospice care
5108034|NCT03323008|Prison|prison
5108035|NCT03323008|Corrections|corrections
5108036|NCT03323008|Inmates|inmates
5108037|NCT03322995|Neoadjuvant Therapy|neoadjuvant therapy
5108038|NCT03322982|diet, low-fat|diet, low-fat
5108039|NCT03322956|Low back/lumbar spine|low back/lumbar spine
5108040|NCT03322956|Multimodal Physical therapy|multimodal physical therapy
5108041|NCT03322956|Quality of life|quality of life
5108042|NCT03322956|Range of Motion|range of motion
5108043|NCT03322956|Pain|pain
5108044|NCT03322943|Ursodeoxycholic Acid|ursodeoxycholic acid
4979294|NCT04121689|Protein|protein
5108045|NCT03322943|Response|response
5108046|NCT03322930|microperimetry|microperimetry
5108047|NCT03322930|rod visual fields|rod visual fields
5108048|NCT03322917|dry eye|dry eye
5108050|NCT03322917|autologous|autologous
5108051|NCT03322917|after LASIK|after lasik
5108052|NCT03322917|ocular surface|ocular surface
5108053|NCT03322904|iris collarette; autonomous nervous system|iris collarette; autonomous nervous system
5108054|NCT03322891|Urology|urology
5108055|NCT03322878|postoperative pain , pediatrics , magnesium sulfate|postoperative pain , pediatrics , magnesium sulfate
5108059|NCT03322839|Guideline-adherence|guideline-adherence
5108060|NCT03322839|Implementation|implementation
5108061|NCT03322839|Implementation-strategies|implementation-strategies
5108062|NCT03322839|Randomized-controlled-trial|randomized-controlled-trial
5108063|NCT03322839|Organisational risk-factors|organisational risk-factors
5108064|NCT03322839|Schools|schools
5108065|NCT03322839|Social risk-factors|social risk-factors
5108066|NCT03322813|Glioblastoma|glioblastoma
5108067|NCT03322813|Blood Brain Barrier|blood brain barrier
5108068|NCT03322813|BBB|bbb
5108069|NCT03322813|ExAblate|exablate
5108070|NCT03322813|Blood Brain Barrier Disruption|blood brain barrier disruption
5108071|NCT03322813|Infiltrating glioma|infiltrating glioma
5108072|NCT03322774|Stepped Care|stepped care
5108073|NCT03322761|Multiple sclerosis|multiple sclerosis
5108074|NCT03322761|Exercise|exercise
5108075|NCT03322761|Disease-modifying treatment|disease-modifying treatment
5105454|NCT03338179|Metamemory|metamemory
5108081|NCT03322670|community-acquired pneumonia|community-acquired pneumonia
5108083|NCT03322670|streptococcus pneumoniae|streptococcus pneumoniae
5108084|NCT03322657|Sugammadex|sugammadex
5108085|NCT03322657|Neostigmine|neostigmine
5108086|NCT03322657|Reversal of neuromuscular block|reversal of neuromuscular block
5108087|NCT03322644|Pancreatitis|pancreatitis
5108088|NCT03322644|Pain|pain
5108089|NCT03322644|Internet Intervention|internet intervention
5108090|NCT03322644|Behavioral Intervention|behavioral intervention
5108216|NCT03321721|children|children
5108091|NCT03322566|Non-small cell lung cancer|non-small cell lung cancer
5108092|NCT03322566|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
5108093|NCT03322566|indoleamine 2|indoleamine 2
5108094|NCT03322566|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
5108095|NCT03322566|chemotherapy|chemotherapy
5108096|NCT03322540|non-small cell lung cancer|non-small cell lung cancer
5750924|NCT00316459|Cardiac|cardiac
5108097|NCT03322540|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
5108098|NCT03322540|indoleamine 2|indoleamine 2
5108099|NCT03322540|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
5108100|NCT03322514|gut hormones|gut hormones
5108101|NCT03322514|obesity|obesity
5108102|NCT03322514|appetite|appetite
5108103|NCT03322514|propionate|propionate
5108104|NCT03322514|fermentation|fermentation
5108105|NCT03322449|APOA2|apoa2
5108106|NCT03322449|Inflammation|inflammation
5108107|NCT03322449|gene|gene
5108108|NCT03322449|diet|diet
5108109|NCT03322410|Fluid overload|fluid overload
5108110|NCT03322410|Hydratation statud|hydratation statud
5108111|NCT03322410|Peritoneal hypepermeability|peritoneal hypepermeability
5108112|NCT03322410|Peritoneal dialysis|peritoneal dialysis
5108113|NCT03322410|Impedancemetry|impedancemetry
5108114|NCT03322397|adolescence|adolescence
5108115|NCT03322397|immune function|immune function
5108116|NCT03322397|gene expression|gene expression
5108117|NCT03322397|psychological well-being|psychological well-being
5108118|NCT03322397|social connection|social connection
5108119|NCT03322397|kindness|kindness
5108120|NCT03322345|lymph flow|lymph flow
5108121|NCT03322345|Fontan|fontan
5108122|NCT03322332|adiponectin|adiponectin
5108123|NCT03322332|omentin-1|omentin-1
5108124|NCT03322332|resistin|resistin
5108125|NCT03322332|RBP4|rbp4
5108126|NCT03322332|epicardial fat|epicardial fat
5108127|NCT03322332|Coronary artery disease|coronary artery disease
5108128|NCT03322319|Cardiac amyloidosis|cardiac amyloidosis
5108129|NCT03322319|Caribbean|caribbean
5108130|NCT03322319|Diagnosis|diagnosis
5108131|NCT03322319|Transthyretin|transthyretin
5108132|NCT03322306|genetic screening|genetic screening
5108133|NCT03322306|neuro-degenerative disease|neuro-degenerative disease
5108134|NCT03322293|Actinic Keratoses|actinic keratoses
5108135|NCT03322293|photodynamic therapy|photodynamic therapy
5108136|NCT03322293|aminolevulinic acid|aminolevulinic acid
5108137|NCT03322293|precancerous skin lesion|precancerous skin lesion
5108138|NCT03322280|Hepatocellular carcinoma|hepatocellular carcinoma
4993521|NCT04034329|Long-term efficacy|long-term efficacy
5108139|NCT03322280|Portal vein tumor thrombus|portal vein tumor thrombus
5108140|NCT03322280|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5108141|NCT03322280|iodine-125 seed|iodine-125 seed
5108142|NCT03322267|Adjuvant pembrolizumab|adjuvant pembrolizumab
5108143|NCT03322267|Chemoradiotherapy|chemoradiotherapy
5961974|NCT04283708|Submental liposuction|submental liposuction
5108144|NCT03322228|Hospice|hospice
5108145|NCT03322228|Palliative Care|palliative care
5108146|NCT03322228|Integrative Medicine|integrative medicine
5108147|NCT03322228|Music Therapy|music therapy
5108148|NCT03322228|Inpatient|inpatient
5108149|NCT03322228|Caregiver|caregiver
5108150|NCT03322215|palbociclib|palbociclib
5108151|NCT03322215|fulvestrant|fulvestrant
5108152|NCT03322215|capecitabine|capecitabine
5108153|NCT03322202|Spinal Cord Injury|spinal cord injury
5108154|NCT03322202|Motivational Interviewing|motivational interviewing
5108155|NCT03322150|Atropine|atropine
5108156|NCT03322150|glycopyrrolate|glycopyrrolate
5108157|NCT03322150|bradycardia|bradycardia
5108158|NCT03322150|dexmedetomidine|dexmedetomidine
5108159|NCT03322150|spinal anesthesia|spinal anesthesia
5108160|NCT03322098|Atropine|atropine
5108161|NCT03322098|glycopyrrolate|glycopyrrolate
5108162|NCT03322098|bradycardia|bradycardia
5108163|NCT03322098|dexmedetomidine|dexmedetomidine
5108164|NCT03322098|spinal anesthesia|spinal anesthesia
5108165|NCT03322085|atrial fibrillation|atrial fibrillation
5108166|NCT03322085|atrial electrical remodeling|atrial electrical remodeling
5108167|NCT03322046|Therapeutic Lifestyle Change|therapeutic lifestyle change
5108168|NCT03322046|Cardiovascular Disease|cardiovascular disease
5108169|NCT03322046|First Responders|first responders
5108172|NCT03321981|Bispecific Antibody IgG1, HER2 HER3|bispecific antibody igg1, her2 her3
5108173|NCT03321981|MCLA-128|mcla-128
5108174|NCT03321981|Antibodies, bispecific|antibodies, bispecific
5108175|NCT03321981|Immunologic Factors|immunologic factors
5108176|NCT03321981|Cytokines|cytokines
5108177|NCT03321981|combination Trastuzumab with and without Vinorelbine|combination trastuzumab with and without vinorelbine
5108178|NCT03321968|Influenza|influenza
5108182|NCT03321968|Immunologic|immunologic
5108183|NCT03321968|Orthomyxoviridae Infections|orthomyxoviridae infections
5108184|NCT03321968|Infection|infection
5108185|NCT03321968|Virus Diseases|virus diseases
5108186|NCT03321942|Adipose Tissue-derived Mesenchymal Stem Cells|adipose tissue-derived mesenchymal stem cells
5108187|NCT03321942|Chronic Kidney Diseases|chronic kidney diseases
5108188|NCT03321916|MacTel|mactel
5108189|NCT03321903|Oxygen|oxygen
5108190|NCT03321903|Oximetry|oximetry
5108191|NCT03321903|Electron Spin Resonance Spectroscopy|electron spin resonance spectroscopy
5108192|NCT03321903|Carbon|carbon
5108193|NCT03321903|Charcoal|charcoal
5108194|NCT03321903|Radiotherapy|radiotherapy
5108195|NCT03321903|India Ink|india ink
5108196|NCT03321903|EPR|epr
5108197|NCT03321903|ESR|esr
5108198|NCT03321903|Immunotherapy|immunotherapy
5108199|NCT03321890|relapsed or refractory|relapsed or refractory
5108200|NCT03321890|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5108201|NCT03321890|Combination therapy|combination therapy
5108202|NCT03321864|Transperineal biopsy|transperineal biopsy
5108203|NCT03321864|Prostate cancer|prostate cancer
5108204|NCT03321864|Transrectal ultrasound|transrectal ultrasound
5108205|NCT03321864|Fusion biopsy techniques|fusion biopsy techniques
5108206|NCT03321812|decalcification bone scaffold|decalcification bone scaffold
5108207|NCT03321812|microfracture|microfracture
5108208|NCT03321812|randomized controlled trial|randomized controlled trial
5108209|NCT03321812|cartilage lesions of the knee|cartilage lesions of the knee
5108210|NCT03321773|Helicobacter pylori|helicobacter pylori
5108211|NCT03321773|Eradication rate|eradication rate
5108212|NCT03321734|Caffeine|caffeine
5108213|NCT03321734|Prematurity|prematurity
5108214|NCT03321721|hand|hand
5108215|NCT03321721|feet lacerations|feet lacerations
5108217|NCT03321721|conservative management|conservative management
5108218|NCT03321682|Cardiopulmonary Capacity|cardiopulmonary capacity
5108219|NCT03321682|Quality of Life|quality of life
5108220|NCT03321682|Functional Capacity|functional capacity
5108221|NCT03321682|Functional Training|functional training
5108222|NCT03321630|Pebrolizumab|pebrolizumab
5108223|NCT03321630|Lenvatinib|lenvatinib
5108224|NCT03321604|Hemodialysis|hemodialysis
5108225|NCT03321604|Kidney|kidney
5108226|NCT03321604|Dialysis|dialysis
5108227|NCT03321604|Kindred|kindred
5108228|NCT03321604|Fabry|fabry
5108229|NCT03321604|Massachusetts General Hospital|massachusetts general hospital
5108230|NCT03321578|nosocomial|nosocomial
5108231|NCT03321578|hospital acquired|hospital acquired
5108232|NCT03321578|clostridium difficile|clostridium difficile
5108233|NCT03321565|obesity|obesity
5108234|NCT03321552|Desert foot|desert foot
5108235|NCT03321552|No-option patients|no-option patients
5108236|NCT03321552|Venous arterialization|venous arterialization
5108237|NCT03321539|Nasopharyngeal carcinoma;adjuvant chemotherapy|nasopharyngeal carcinoma;adjuvant chemotherapy
5108238|NCT03321513|Diabetic Macular Edema|diabetic macular edema
5108239|NCT03321513|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5108240|NCT03321487|Blood-Brain Barrier disruption|blood-brain barrier disruption
5108241|NCT03321487|Blood-Brain Barrier opening|blood-brain barrier opening
5108242|NCT03321487|magnetic resonance-guided focused ultrasound|magnetic resonance-guided focused ultrasound
5108243|NCT03321409|Somatic symptom|somatic symptom
5108244|NCT03321409|SSS-CN|sss-cn
5108245|NCT03321409|PHQ-15|phq-15
5108246|NCT03321409|Suspected CAD|suspected cad
5108247|NCT03321409|Coronary angiography|coronary angiography
5108248|NCT03321396|Sodium Alginate|sodium alginate
5108249|NCT03321396|Calcium Lactate|calcium lactate
5108250|NCT03321396|Gel|gel
5108251|NCT03321383|dyspepsia|dyspepsia
5108252|NCT03321383|health related quality of life|health related quality of life
5108253|NCT03321331|Mobile Health|mobile health
5108254|NCT03321331|mobile apps|mobile apps
5108255|NCT03321331|weight control|weight control
5108256|NCT03321331|weight management|weight management
5108257|NCT03321331|self-directed intervention|self-directed intervention
5108258|NCT03321331|behavioral intervention|behavioral intervention
5108259|NCT03321266|Fistula plug|fistula plug
5108260|NCT03321253|Posterior Capsule Opacification|posterior capsule opacification
5108261|NCT03321253|Macular Pigment Optical Density|macular pigment optical density
5108262|NCT03321253|Anterior Chamber Parameters|anterior chamber parameters
5108263|NCT03321253|Nd: YAG Laser Posterior Capsulotomy|nd: yag laser posterior capsulotomy
5108264|NCT03321253|Posterior Capsulotomy|posterior capsulotomy
5108265|NCT03321253|Cystoid Macular Edema|cystoid macular edema
5108266|NCT03321253|Choroidal Thickness|choroidal thickness
5108267|NCT03321240|focal cortical dysplasia|focal cortical dysplasia
5108268|NCT03321240|Pronostic|pronostic
5108269|NCT03321240|Epilepsy surgery|epilepsy surgery
5108280|NCT03321188|Heated intraperitoneal chemotherapy|heated intraperitoneal chemotherapy
5108282|NCT03321188|cisplatin|cisplatin
5108283|NCT03321188|paclitaxel|paclitaxel
5108284|NCT03321188|carboplatin|carboplatin
5108285|NCT03321188|adjuvant IV chemotherapy|adjuvant iv chemotherapy
5108286|NCT03321175|Wound|wound
5108287|NCT03321175|infection|infection
5108288|NCT03321175|cesarean section|cesarean section
5108289|NCT03321162|surgical guide , double scan , triple scan protocol|surgical guide , double scan , triple scan protocol
5108290|NCT03321149|Web-based intervention|web-based intervention
5108291|NCT03321149|Sedentary behavior|sedentary behavior
5108292|NCT03321149|Lifestyle intervention|lifestyle intervention
5108293|NCT03321149|Feasibility|feasibility
5108294|NCT03321123|B cell Acute Lymphoblastic Leukemia|b cell acute lymphoblastic leukemia
5108295|NCT03321123|relapsed or refractory|relapsed or refractory
5108296|NCT03321123|CD-19 Positive|cd-19 positive
5108297|NCT03321097|stroke rehabilitation|stroke rehabilitation
5108298|NCT03321097|spasticity|spasticity
5108299|NCT03321097|Botulinum toxin type A injection|botulinum toxin type a injection
5108300|NCT03321097|robot-assisted therapy|robot-assisted therapy
5108301|NCT03321097|massed therapy|massed therapy
5108302|NCT03321097|distributed therapy|distributed therapy
5108303|NCT03321084|Osteoarthrosis|osteoarthrosis
5108304|NCT03321084|Exercise Movement Techniques|exercise movement techniques
5108305|NCT03321084|Pilates|pilates
5108306|NCT03321084|Elderly|elderly
5108307|NCT03321084|Physiotherapy|physiotherapy
5108308|NCT03321058|Drug Substitution|drug substitution
5108309|NCT03321058|Multicompartment Compliance Aid|multicompartment compliance aid
5108310|NCT03321045|89Zr-Trastuzumab, HER2 Imaging|89zr-trastuzumab, her2 imaging
5108311|NCT03321032|Coronary Artery Disease|coronary artery disease
5108312|NCT03321032|Diabetes Mellitus|diabetes mellitus
5108313|NCT03321032|Drug-eluting stents|drug-eluting stents
5108314|NCT03321032|Restenosis|restenosis
5108315|NCT03320993|post-prandial glucose control|post-prandial glucose control
5108316|NCT03320993|alcohol|alcohol
5108317|NCT03320980|ALPPS|alpps
5108318|NCT03320980|RALPPS|ralpps
5108319|NCT03320980|Portal Vein Embolization|portal vein embolization
5108320|NCT03320980|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
5108321|NCT03320980|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5108322|NCT03320954|Language|language
5108323|NCT03320954|Anomia|anomia
5108324|NCT03320941|Obesity disease|obesity disease
5108325|NCT03320941|Over weight|over weight
5108326|NCT03320941|T2DM|t2dm
5108327|NCT03320941|interventional study|interventional study
5108328|NCT03320941|Weight loss|weight loss
5108329|NCT03320902|Family members|family members
5108330|NCT03320902|sudden death|sudden death
5108331|NCT03320902|sudden death counseling|sudden death counseling
5108332|NCT03320902|depression|depression
5108333|NCT03320837|metabolomics|metabolomics
5108334|NCT03320837|microbiome|microbiome
5108335|NCT03320837|infant formula|infant formula
5108336|NCT03320837|synbiotics|synbiotics
5108337|NCT03320837|urine samples|urine samples
5108338|NCT03320837|NMR analysis|nmr analysis
5108339|NCT03320811|Celiac disease|celiac disease
5108340|NCT03320811|serological tests|serological tests
5108341|NCT03320811|anti-deamidated gliadin peptide antibodies|anti-deamidated gliadin peptide antibodies
5108342|NCT03320798|Bullous pemphigoid|bullous pemphigoid
4993761|NCT04033029|CRRT|crrt
5108343|NCT03320798|neurologic disorders|neurologic disorders
5108344|NCT03320785|preterm infants|preterm infants
5108345|NCT03320785|sepsis|sepsis
5108346|NCT03320785|chorioamnionitis|chorioamnionitis
5108347|NCT03320785|circulating markers|circulating markers
5108348|NCT03320746|Physical activity|physical activity
5108349|NCT03320746|Sedentary time|sedentary time
5108350|NCT03320746|Intervention|intervention
5108351|NCT03320746|Retiree|retiree
5108352|NCT03320733|dual energy CT|dual energy ct
5108353|NCT03320694|Gestational Diabetes Mellitus, Metformin, Insulin|gestational diabetes mellitus, metformin, insulin
5108354|NCT03320681|Neurostimulator|neurostimulator
5108355|NCT03320668|Falls Prevention|falls prevention
5108356|NCT03320668|Otago Program|otago program
5108357|NCT03320668|Community-Dwelling|community-dwelling
5108358|NCT03320655|Chronic Heart Failure|chronic heart failure
5108359|NCT03320655|Fragility|fragility
5105758|NCT03336346|DTG|dtg
5108367|NCT03320642|Hodgkin's lymphoma|hodgkin's lymphoma
5108368|NCT03320642|mantle cell lymphoma|mantle cell lymphoma
5108369|NCT03320642|Janus kinase inhibitor|janus kinase inhibitor
5108370|NCT03320642|graft-versus-host disease|graft-versus-host disease
5108376|NCT03320564|fluorodeoxyglucose F-18|fluorodeoxyglucose f-18
5108377|NCT03320551|Education|education
5108378|NCT03320538|Hou Gu Mi Xi|hou gu mi xi
5108379|NCT03320538|peptic ulcer disease|peptic ulcer disease
5108380|NCT03320538|traditional Chinese medicine|traditional chinese medicine
5108381|NCT03320538|randomized controlled trial|randomized controlled trial
5108382|NCT03320538|dietary therapy|dietary therapy
5108383|NCT03320525|YKL-40|ykl-40
5108384|NCT03320525|Pharmacokinetic|pharmacokinetic
5108385|NCT03320525|Solid tumors|solid tumors
5108386|NCT03320525|T-ChOS|t-chos
5108387|NCT03320525|Benecta|benecta
5108388|NCT03320525|chitinase 3 like-1 protein (CHI3L1)|chitinase 3 like-1 protein (chi3l1)
5108389|NCT03320512|PrEP|prep
5108390|NCT03320512|gamification|gamification
5108391|NCT03320512|mHealth|mhealth
5108392|NCT03320512|HIV prevention|hiv prevention
5108393|NCT03320512|truvada|truvada
5108394|NCT03320512|eHealth|ehealth
5108396|NCT03320512|adherence|adherence
5108397|NCT03320512|ymsm|ymsm
5108398|NCT03320512|transgender women|transgender women
5108399|NCT03320486|Mycoses|mycoses
5108400|NCT03320486|Dermatomycoses|dermatomycoses
5108401|NCT03320486|Antifugal Agents|antifugal agents
5108402|NCT03320486|Dapaconazole|dapaconazole
5108403|NCT03320460|oral lichen planus; photobiomodulation; inflammation|oral lichen planus; photobiomodulation; inflammation
5108404|NCT03320447|ablative fractional laser|ablative fractional laser
5108405|NCT03320447|photodynamic therapy|photodynamic therapy
5108406|NCT03320447|protoporphyrin IX|protoporphyrin ix
5108407|NCT03320447|methy-aminolevulinate|methy-aminolevulinate
5108410|NCT03320421|breast conserving surgery|breast conserving surgery
5108411|NCT03320421|simultaneous boost radiation|simultaneous boost radiation
5108413|NCT03320408|pathogenesis|pathogenesis
5108414|NCT03320408|Aortic Aneurysm|aortic aneurysm
5108415|NCT03320304|Difficult to Treat Depression|difficult to treat depression
5108417|NCT03320304|VNS Therapy|vns therapy
5108418|NCT03320304|Vagus Nerve Stimulation|vagus nerve stimulation
5108419|NCT03320304|VNS|vns
5108420|NCT03320291|Rhizarthrosis|rhizarthrosis
5108421|NCT03320291|Regjoint|regjoint
5108422|NCT03320291|Trapeziectomy|trapeziectomy
5108423|NCT03320278|endotracheal intubation|endotracheal intubation
5108424|NCT03320278|airway management|airway management
5108425|NCT03320265|Phosphorylcholine human monoclonal antibody|phosphorylcholine human monoclonal antibody
5108426|NCT03320265|Lipoprotein a|lipoprotein a
5108427|NCT03320252|CHEVAR|chevar
5108428|NCT03320252|Chimney|chimney
5108429|NCT03320252|Juxtarenal|juxtarenal
5108430|NCT03320252|Short Infrarenal /neck|short infrarenal /neck
5108431|NCT03320252|Endurant|endurant
5108432|NCT03320239|HIV|hiv
5108433|NCT03320239|risk assessment|risk assessment
5108434|NCT03320239|HIV testing|hiv testing
5108435|NCT03320239|unprotected anal intercourse|unprotected anal intercourse
5108436|NCT03320239|Social medica|social medica
5108437|NCT03320213|CA125|ca125
5108438|NCT03320213|Yolk sac morphology|yolk sac morphology
5108439|NCT03320213|Threatened miscarriage|threatened miscarriage
5108440|NCT03320174|tafenoquine|tafenoquine
5108441|NCT03320174|australia|australia
5108442|NCT03320161|Supportive care|supportive care
5108443|NCT03320161|Cancer|cancer
5108444|NCT03320161|Health-related quality of life|health-related quality of life
5108445|NCT03320161|Consensus|consensus
5108446|NCT03320161|Participative approach|participative approach
5108447|NCT03320161|Patient involvement|patient involvement
5108448|NCT03320161|DELPHI method|delphi method
5108449|NCT03320135|enamel matrix derivative|enamel matrix derivative
5108450|NCT03320135|proximal furcation|proximal furcation
5108451|NCT03320135|randomized clinical trial|randomized clinical trial
5108453|NCT03320083|sleep, infants, behavioural insomnia, breastfeeding|sleep, infants, behavioural insomnia, breastfeeding
5108456|NCT03320044|Circulating Tumor DNA|circulating tumor dna
5108457|NCT03320044|Lung cancer Surgery|lung cancer surgery
5108458|NCT03320044|early diagnosis|early diagnosis
5108459|NCT03320044|immuno-sequencing|immuno-sequencing
5108460|NCT03320031|Linagliptin|linagliptin
5108461|NCT03320031|premixedinsulin therapy|premixedinsulin therapy
5108462|NCT03320031|peritoneal dialysis|peritoneal dialysis
5108471|NCT03319992|Rehabilitation Research [H01.770.644.145.472]|rehabilitation research [h01.770.644.145.472]
5108472|NCT03319992|Physical and Rehabilitation Medicine [H02.403.680]|physical and rehabilitation medicine [h02.403.680]
5108474|NCT03319992|Patient Outcome Assessment [N05.715.360.575.575.399]|patient outcome assessment [n05.715.360.575.575.399]
5108476|NCT03319953|Drug therapy|drug therapy
5108477|NCT03319940|Half Life Extended (HLE) Bispecific T cell engager (BiTE®)|half life extended (hle) bispecific t cell engager (bite®)
5108478|NCT03319940|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
5961975|NCT04283708|Advancement genioplasty|advancement genioplasty
5108479|NCT03319927|integrated pest management|integrated pest management
5108480|NCT03319927|environmental health|environmental health
5108481|NCT03319927|child care|child care
5108482|NCT03319927|preschool children|preschool children
5108483|NCT03319927|pesticides|pesticides
5108484|NCT03319914|calciphylaxis, calcific uremic arteriolopathy,|calciphylaxis, calcific uremic arteriolopathy,
5108485|NCT03319914|calcium metabolism disorders|calcium metabolism disorders
5108486|NCT03319914|metabolic diseases|metabolic diseases
5108487|NCT03319914|sodium thiosulfate|sodium thiosulfate
5108488|NCT03319901|Leukemia|leukemia
5108489|NCT03319888|CPAP, Chronic kidney disease, sleep apnea|cpap, chronic kidney disease, sleep apnea
5108490|NCT03319875|Epiduroscopy|epiduroscopy
5108491|NCT03319875|Discectomy|discectomy
5108492|NCT03319875|Holmium Yag laser|holmium yag laser
5108493|NCT03319875|Lumbar disc herniation|lumbar disc herniation
5108494|NCT03319875|Minimally invasive treatment|minimally invasive treatment
5108495|NCT03319849|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
5108496|NCT03319849|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
5108497|NCT03319810|MCI, Alzheimer Disease, AD|mci, alzheimer disease, ad
5108498|NCT03319797|Autologous chondrocyte transplantation ACT|autologous chondrocyte transplantation act
5108499|NCT03319771|exercise|exercise
5108500|NCT03319771|neuroimaging|neuroimaging
5108502|NCT03319771|multiple sclerosis|multiple sclerosis
5108503|NCT03319758|bone augmentation|bone augmentation
5108504|NCT03319758|esthetics|esthetics
5108505|NCT03319758|immediate implant|immediate implant
5108506|NCT03319758|buccal bone defects|buccal bone defects
5108507|NCT03319654|Unexplained Infertility|unexplained infertility
5108508|NCT03319654|Idiopathic Infertility|idiopathic infertility
5108509|NCT03319654|DNA damage|dna damage
5108510|NCT03319654|DNA fragmentation|dna fragmentation
5108511|NCT03319654|Insemination|insemination
5108512|NCT03319641|68Ga-PSMA|68ga-psma
5108513|NCT03319641|Positron-Emission Tomography|positron-emission tomography
5108514|NCT03319641|Immunohistochemistry|immunohistochemistry
5108515|NCT03319615|Appetite|appetite
5108516|NCT03319615|Energy Intake|energy intake
5108517|NCT03319615|Body Composition|body composition
5108518|NCT03319615|Energy Expenditure|energy expenditure
5108519|NCT03319602|oxygen mask|oxygen mask
5108520|NCT03319602|high-flow oxygen therapy|high-flow oxygen therapy
5108521|NCT03319602|acute respiratory failure|acute respiratory failure
5108522|NCT03319576|Gastrostomy|gastrostomy
5108524|NCT03319576|G-tube|g-tube
5108525|NCT03319550|milk protein, endotoxemia, muscle protein synthesis, whey, casein|milk protein, endotoxemia, muscle protein synthesis, whey, casein
5108526|NCT03319537|Pevonedistat|pevonedistat
5108527|NCT03319537|Pemetrexed|pemetrexed
5108528|NCT03319537|Cisplatin|cisplatin
5108529|NCT03319537|17-361|17-361
5108530|NCT03319511|thoracic spinal|thoracic spinal
5108531|NCT03319511|awake mastectomy|awake mastectomy
5108532|NCT03319511|paravertebral block|paravertebral block
5108533|NCT03319511|analgesia|analgesia
5108534|NCT03319511|ultrasound|ultrasound
5108535|NCT03319511|breast cancer|breast cancer
5108536|NCT03319485|ExAblate|exablate
5108537|NCT03319485|MRgFUS|mrgfus
5108538|NCT03319485|Pallidotomy|pallidotomy
5108539|NCT03319472|malignant|malignant
5108540|NCT03319472|cancer|cancer
5108541|NCT03319472|simple bedside test|simple bedside test
5108542|NCT03319472|rapid|rapid
5108543|NCT03319472|score|score
5108544|NCT03319472|widely available|widely available
5108545|NCT03319472|feasible|feasible
5108546|NCT03319459|Solid Tumor|solid tumor
5108547|NCT03319459|HER2|her2
5108568|NCT03319433|caesarean section|caesarean section
5108569|NCT03319394|Firefighters|firefighters
5108570|NCT03319394|Exercise Training|exercise training
5108571|NCT03319394|Resistance Training|resistance training
5108572|NCT03319394|Exercise Test|exercise test
5108573|NCT03319394|High-Intensity Interval Training|high-intensity interval training
5108574|NCT03319381|Algorithm|algorithm
5108575|NCT03319381|In-hospital mortality|in-hospital mortality
5108576|NCT03319381|Multiple trauma|multiple trauma
5108577|NCT03319381|Standard of care|standard of care
5108578|NCT03319355|multicomponent therapy|multicomponent therapy
5108579|NCT03319264|Spondylarthropathy|spondylarthropathy
5108580|NCT03319264|Sarcopenia|sarcopenia
5108581|NCT03319264|lean mass|lean mass
5108582|NCT03319264|fat mass|fat mass
5108583|NCT03319238|Chronic pain|chronic pain
5108584|NCT03319238|Neuropathic pain|neuropathic pain
5108585|NCT03319238|Ketamine|ketamine
5108586|NCT03319238|Concomitant treatment|concomitant treatment
5171358|NCT02921373|MRI|mri
5108587|NCT03319238|Adverse effect|adverse effect
5108588|NCT03319173|Mild Cognitive Impairment|mild cognitive impairment
5108589|NCT03319173|AMPK activation|ampk activation
5108590|NCT03319173|DNA global hypo-methylation|dna global hypo-methylation
5108591|NCT03319173|Metabolic Syndrome|metabolic syndrome
5108592|NCT03319173|Ketogenic diet|ketogenic diet
5108593|NCT03319173|SAM/SAH Index|sam/sah index
5108594|NCT03319173|S-adenosylmethionine (SAM)|s-adenosylmethionine (sam)
5108595|NCT03319173|S-adenosylhomocysteine (SAH)|s-adenosylhomocysteine (sah)
5961976|NCT04283708|Double chin patients|double chin patients
5108596|NCT03319173|Region-Specific hyper-methylation|region-specific hyper-methylation
5108597|NCT03319173|mTOR kinase pathway|mtor kinase pathway
5108598|NCT03319173|AMP/ATP ratio|amp/atp ratio
5108599|NCT03319173|Low Reduction Potential|low reduction potential
5109778|NCT03311503|lentiviral|lentiviral
5108611|NCT03319147|muscle|muscle
5108612|NCT03319147|protein|protein
5108613|NCT03319121|Non cardiac chest pain|non cardiac chest pain
5108614|NCT03319121|Empirical therapy|empirical therapy
5108615|NCT03319121|Guided therapy|guided therapy
5108616|NCT03319095|pelvic floor, muscle, electrical stimulation, physiotherapy|pelvic floor, muscle, electrical stimulation, physiotherapy
5108617|NCT03319043|Cough Variant Asthma|cough variant asthma
5108618|NCT03319043|impedance|impedance
5108619|NCT03319043|inflammation|inflammation
5108620|NCT03319043|Chanqin granules|chanqin granules
5108621|NCT03319030|exercise|exercise
5108622|NCT03319030|Aerobic Exercise|aerobic exercise
5108623|NCT03319017|Hypoxia|hypoxia
5108624|NCT03319017|Hyperinflammatory|hyperinflammatory
5108626|NCT03319017|Apoptosis|apoptosis
5108627|NCT03319017|Oxygenation|oxygenation
5108628|NCT03319017|Polymorphonuclear Cells|polymorphonuclear cells
5108629|NCT03319017|Tumor necrosis factor(TNF)-α|tumor necrosis factor(tnf)-α
5108630|NCT03319017|Cytokine|cytokine
5108631|NCT03318991|thulium laser|thulium laser
5108632|NCT03318991|GreenLight laser|greenlight laser
5108633|NCT03318991|laser therapy|laser therapy
5108634|NCT03318991|resection of the prostate|resection of the prostate
5108635|NCT03318991|prostate hyperplasia|prostate hyperplasia
5108636|NCT03318978|Benzo[a]pyrene|benzo[a]pyrene
5106034|NCT03334799|sacroiliac instability|sacroiliac instability
5108639|NCT03318965|Mortality|mortality
5108640|NCT03318965|Anthropometry|anthropometry
5108641|NCT03318965|Nutrition Assessment|nutrition assessment
5108642|NCT03318965|Caliper|caliper
5108650|NCT03318926|tea, cup-year, renal stone disease|tea, cup-year, renal stone disease
5108651|NCT03318913|Vascular function|vascular function
5108652|NCT03318913|Type 2 diabetes mellitus|type 2 diabetes mellitus
5108653|NCT03318913|Fish protein hydrolysates|fish protein hydrolysates
5108654|NCT03318887|Cirrhosis|cirrhosis
5108655|NCT03318887|Direct acting antiviral agents|direct acting antiviral agents
5108656|NCT03318887|Hepatitis C|hepatitis c
5108657|NCT03318887|Pharmacological monitoring|pharmacological monitoring
5108658|NCT03318874|Dry Eye Disease|dry eye disease
5108659|NCT03318874|Meibomian Gland Dysfunction|meibomian gland dysfunction
5108660|NCT03318874|Blephasteam|blephasteam
5108661|NCT03318874|THERA°PEARL Eye Mask|thera°pearl eye mask
5108662|NCT03318848|students, nursing|students, nursing
5108663|NCT03318848|simulation training|simulation training
5108664|NCT03318848|Instructional Films and Videos|instructional films and videos
5108665|NCT03318848|Aptitude|aptitude
5108666|NCT03318835|Thalidomide|thalidomide
5108667|NCT03318835|R-CHOP|r-chop
5108668|NCT03318835|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5108669|NCT03318822|brain injury|brain injury
5108670|NCT03318809|Cardiovascular Diseases|cardiovascular diseases
5108671|NCT03318809|Renal Impairment|renal impairment
5108672|NCT03318809|Heart Diseases|heart diseases
5108673|NCT03318796|Bifurcation lesions|bifurcation lesions
5108674|NCT03318783|Eicosanoids|eicosanoids
5108677|NCT03318770|adult|adult
5108678|NCT03318770|dasatinib|dasatinib
5108679|NCT03318770|blinatumomab|blinatumomab
5108680|NCT03318770|LAL2116|lal2116
5108685|NCT03318744|Silent Brain Infarction|silent brain infarction
5108686|NCT03318744|Antithrombotics|antithrombotics
5108687|NCT03318744|Antiplatelet|antiplatelet
5108688|NCT03318744|Aspirin|aspirin
5108689|NCT03318744|Asymptomatic|asymptomatic
5108690|NCT03318731|fenugreek extract|fenugreek extract
5108691|NCT03318731|non-resistance trained|non-resistance trained
5108692|NCT03318666|Adolescent|adolescent
5108693|NCT03318666|Adolescent Medicine|adolescent medicine
5108694|NCT03318666|Mental Health Services|mental health services
5108695|NCT03318666|eHealth|ehealth
5108697|NCT03318666|Primary Health Care|primary health care
5108699|NCT03318666|Social support|social support
5108700|NCT03318653|Blood pressure|blood pressure
5108701|NCT03318653|Dialysis|dialysis
5108702|NCT03318640|schizophrenia|schizophrenia
5108703|NCT03318640|mindfulness|mindfulness
5108704|NCT03318640|parasympathetic system|parasympathetic system
5108705|NCT03318614|Gut Microbiota|gut microbiota
5108706|NCT03318614|Probiotics|probiotics
5108707|NCT03318614|Abdominal Pain|abdominal pain
5108708|NCT03318614|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5108709|NCT03318614|Mental|mental
5108710|NCT03318601|cirrhotic|cirrhotic
5108711|NCT03318601|ascite|ascite
5108712|NCT03318601|copeptin|copeptin
5108713|NCT03318588|Retinal detachment|retinal detachment
5108714|NCT03318588|Photoreceptor apoptosis|photoreceptor apoptosis
5108715|NCT03318588|Cytokine|cytokine
5108716|NCT03318575|remote ischemic conditioning (RIC)|remote ischemic conditioning (ric)
5108717|NCT03318575|percutaneous coronary intervention|percutaneous coronary intervention
5108719|NCT03318575|cardiac troponin I|cardiac troponin i
5108720|NCT03318575|cardiac catheterization|cardiac catheterization
5020031|NCT03871959|MSI|msi
5108721|NCT03318575|myocardial injury|myocardial injury
5108722|NCT03318575|myocardial necrosis|myocardial necrosis
5108723|NCT03318575|autoRIC|autoric
5108724|NCT03318575|Ischemia-Reperfusion Injury (IRI)|ischemia-reperfusion injury (iri)
5108725|NCT03318575|Automated Remote Ischemic Conditioning|automated remote ischemic conditioning
5108726|NCT03318549|virtual reality|virtual reality
5108727|NCT03318549|glaucoma|glaucoma
5108728|NCT03318549|age related macular degeneration|age related macular degeneration
5108729|NCT03318549|quality of life|quality of life
5108730|NCT03318549|visual field|visual field
5108731|NCT03318549|optical coherence tomography|optical coherence tomography
5108732|NCT03318536|Serotonin Antagonists|serotonin antagonists
5108733|NCT03318536|Sympathomimetics|sympathomimetics
5108736|NCT03318497|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5108737|NCT03318497|18F-FLT|18f-flt
5108738|NCT03318497|FLT|flt
5108739|NCT03318497|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
5108740|NCT03318497|Borderline resectable pancreatic adenocarcinoma|borderline resectable pancreatic adenocarcinoma
5108741|NCT03318497|resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
5108742|NCT03318471|MgSo4, Mayfield clamp, pressor effect|mgso4, mayfield clamp, pressor effect
5108743|NCT03318445|DNA repair mutation|dna repair mutation
5108744|NCT03318432|Stroke|stroke
5108745|NCT03318432|Acute Stroke|acute stroke
5108746|NCT03318432|Ischemic Stroke|ischemic stroke
5108747|NCT03318432|Hemorrhagic Stroke|hemorrhagic stroke
5108759|NCT03318341|stroke rehabilitation|stroke rehabilitation
5108760|NCT03318341|upper extremity|upper extremity
5108762|NCT03318341|patient safety|patient safety
5108763|NCT03318315|AS03-adjuvanted Inactivated Influenza Vaccine|as03-adjuvanted inactivated influenza vaccine
5108764|NCT03318315|Co-Administered|co-administered
5108765|NCT03318315|Healthy Adults|healthy adults
5108766|NCT03318315|Immunogenicity|immunogenicity
5108767|NCT03318315|Inactivated Seasonal Influenza Vaccine|inactivated seasonal influenza vaccine
5108768|NCT03318315|Phase II|phase ii
5108769|NCT03318315|Safety|safety
5108770|NCT03318263|Estrogen-receptor-positive breast cancer|estrogen-receptor-positive breast cancer
5108771|NCT03318263|aromatase inhibitor,|aromatase inhibitor,
5108772|NCT03318263|ESR1,|esr1,
5108773|NCT03318263|PIK3CA|pik3ca
5108774|NCT03318263|AKT|akt
5108775|NCT03318263|endocrine resistance|endocrine resistance
5108776|NCT03318263|circulating tumor DNA|circulating tumor dna
5108777|NCT03318250|DRG Stimulation|drg stimulation
5108778|NCT03318211|preeclampsia|preeclampsia
5108779|NCT03318211|Magnisium sulfate|magnisium sulfate
5108780|NCT03318198|Graduate Medical Education|graduate medical education
5108781|NCT03318198|Attending Supervision of Residents|attending supervision of residents
5108782|NCT03318198|Patient Safety|patient safety
5108783|NCT03318185|gasless single-port laparoscopic surgery;rectal carcinoma|gasless single-port laparoscopic surgery;rectal carcinoma
5108784|NCT03318172|Spinal Cord Stimulation|spinal cord stimulation
5108785|NCT03318172|High Density Stimulation|high density stimulation
5108786|NCT03318146|Plugged Tear Duct|plugged tear duct
5108787|NCT03318133|general anesthesia|general anesthesia
5108788|NCT03318133|sacral plexus block|sacral plexus block
5108789|NCT03318133|lumbar plexus block|lumbar plexus block
5108790|NCT03318133|hip fracture|hip fracture
5108791|NCT03318133|elderly|elderly
5108796|NCT03318081|Amphetamine-type stimulants|amphetamine-type stimulants
5108797|NCT03318081|prefrontal-striatal circuits|prefrontal-striatal circuits
5108798|NCT03318081|cognitive rehabilitation therapy|cognitive rehabilitation therapy
5108800|NCT03318068|Pediatric cancer|pediatric cancer
5108801|NCT03318068|Yoga|yoga
5108802|NCT03318068|Psychological distress|psychological distress
5108803|NCT03318068|Outpatient chemotherapy|outpatient chemotherapy
5108804|NCT03318029|Vitamin D|vitamin d
5108805|NCT03318029|Supplementation|supplementation
5108806|NCT03318029|Sunlight|sunlight
5108807|NCT03318016|Arsenic Trioxide|arsenic trioxide
5108808|NCT03318016|Cyclophosphamide|cyclophosphamide
5108813|NCT03317977|Asthma management, adolescents|asthma management, adolescents
5108814|NCT03317925|Pediatric Renal Transplant|pediatric renal transplant
5108815|NCT03317925|Renal Allograft|renal allograft
5108816|NCT03317925|Angiotensin II|angiotensin ii
5108817|NCT03317925|Angiotensin-(1-7)|angiotensin-(1-7)
5108818|NCT03317925|ACE|ace
5108819|NCT03317925|ACE2|ace2
5108820|NCT03317860|perceptual disorders|perceptual disorders
5108821|NCT03317860|cerebrovascular disorders|cerebrovascular disorders
5108822|NCT03317860|neurobehavioral manifestations|neurobehavioral manifestations
5108823|NCT03317860|neurologic manifestations|neurologic manifestations
5108824|NCT03317860|neglect|neglect
5108825|NCT03317860|non-invasive brain stimulation|non-invasive brain stimulation
5108826|NCT03317860|rehabilitation|rehabilitation
5108827|NCT03317860|tDCS|tdcs
5108828|NCT03317860|paresis|paresis
5108829|NCT03317795|Menorrhagia|menorrhagia
5108830|NCT03317795|FIbroids|fibroids
5108831|NCT03317795|Menstrual Bleeding|menstrual bleeding
5108832|NCT03317795|Heavy Bleeding|heavy bleeding
5108833|NCT03317795|Menses|menses
5108834|NCT03317795|Uterine Fibroids|uterine fibroids
5961977|NCT04283682|Skin Contact|skin contact
4980101|NCT04117243|high risk pregnancy|high risk pregnancy
5108835|NCT03317730|Xtampza ER|xtampza er
5108836|NCT03317730|LAHNC|lahnc
5108837|NCT03317730|Head and neck cancer|head and neck cancer
5108838|NCT03317730|Pain management|pain management
5108839|NCT03317691|myocardial infarction|myocardial infarction
5108840|NCT03317691|artificial Intelligence|artificial intelligence
5108841|NCT03317691|12 lead electrocardiogram|12 lead electrocardiogram
5108842|NCT03317665|biologic|biologic
5108847|NCT03317613|Capsaicin|capsaicin
5108848|NCT03317613|Cancer patient|cancer patient
5108851|NCT03317535|Anesthesia Methods|anesthesia methods
5108852|NCT03317535|Acute Ischemic Stroke|acute ischemic stroke
5108853|NCT03317535|Endovascular Treatment|endovascular treatment
5108854|NCT03317522|Pregnancy|pregnancy
5108855|NCT03317522|teratogenesis|teratogenesis
5108856|NCT03317496|Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC), carboplatin, pemetrexed, gemcitabine, cisplatin|avelumab, immunotherapy, pd-l1 inhibitor, non-small cell lung cancer (nsclc), urothelial cancer (uc), carboplatin, pemetrexed, gemcitabine, cisplatin
5108857|NCT03317444|blood bicarbonate, kidney disease|blood bicarbonate, kidney disease
5108858|NCT03317431|dopamine,mechanical ventilation,lung injury|dopamine,mechanical ventilation,lung injury
5108859|NCT03317366|ARQ 092|arq 092
5108860|NCT03317366|ArQule|arqule
5108861|NCT03317366|AKT|akt
5108862|NCT03317366|PIK3CA|pik3ca
5108863|NCT03317366|Overgrowth|overgrowth
5108864|NCT03317366|Congenital malformations|congenital malformations
5108865|NCT03317353|Vestibular Rehabilitation|vestibular rehabilitation
5108866|NCT03317353|Falls in elderly|falls in elderly
5108867|NCT03317353|Computerized Dynamic Posturography|computerized dynamic posturography
5108868|NCT03317353|Optokinetic stimuli|optokinetic stimuli
5108869|NCT03317327|HNSCC|hnscc
5108870|NCT03317327|Nivolumab|nivolumab
5108871|NCT03317327|immunotherapy|immunotherapy
5108872|NCT03317301|Pruritus cutaneus|pruritus cutaneus
5108873|NCT03317288|spinal cord injury|spinal cord injury
5108874|NCT03317288|pressure ulcer|pressure ulcer
5108875|NCT03317288|laser Doppler flowmetry|laser doppler flowmetry
5108876|NCT03317262|quality of life, citalopram, quetiapine, pregabalin|quality of life, citalopram, quetiapine, pregabalin
5108877|NCT03317249|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
5108878|NCT03317249|Pregnancy Related|pregnancy related
5108879|NCT03317249|IST|ist
5108880|NCT03317236|Bioequivalence|bioequivalence
5108881|NCT03317236|Quetiapine|quetiapine
5108882|NCT03317197|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5108888|NCT03317184|Pfannenstiel incision|pfannenstiel incision
5108889|NCT03317184|Periumbilical incision|periumbilical incision
5108890|NCT03317171|dietary supplementation|dietary supplementation
5108892|NCT03317171|omega 3|omega 3
5108896|NCT03317145|venous thromboembolism|venous thromboembolism
5108897|NCT03317145|deep vein thrombosis|deep vein thrombosis
5108898|NCT03317145|pulmonary embolism|pulmonary embolism
5108899|NCT03317145|neuromuscular electrostimulation|neuromuscular electrostimulation
5108900|NCT03317145|foot compression|foot compression
5108901|NCT03317145|hip replacement|hip replacement
5108902|NCT03317132|Vocational, First-episode psychosis|vocational, first-episode psychosis
5108903|NCT03317080|lung cancer|lung cancer
5108904|NCT03317080|circulating tumor DNA|circulating tumor dna
5751434|NCT00314600|Midshaft|midshaft
5108905|NCT03317080|molecular classification|molecular classification
5108906|NCT03317080|dynamic monitoring|dynamic monitoring
5108907|NCT03317080|next generation sequencing|next generation sequencing
5108908|NCT03317080|diagnosis|diagnosis
5108909|NCT03317080|postoperative relapse|postoperative relapse
5108910|NCT03317067|Dexmdetomidine|dexmdetomidine
5108911|NCT03317067|Haloperidol|haloperidol
5108912|NCT03317067|Delirium|delirium
5108913|NCT03317067|Productive Delirium|productive delirium
5108914|NCT03317067|Agitation|agitation
5108915|NCT03317067|Intubation|intubation
5108916|NCT03317067|Ventilatory free days|ventilatory free days
5108917|NCT03317067|Sedation|sedation
5108918|NCT03317067|ICU patients|icu patients
5108919|NCT03317067|Mechanical Ventilation|mechanical ventilation
5108920|NCT03317054|Gambing|gambing
5108921|NCT03317054|occupational health services|occupational health services
5108922|NCT03317054|psychosocial risks|psychosocial risks
5108923|NCT03317041|Capacitive-resistive electric transfer therapy|capacitive-resistive electric transfer therapy
5108924|NCT03317041|Radiofrequency therapy|radiofrequency therapy
5108925|NCT03317041|Recovery intervention|recovery intervention
5108926|NCT03317041|Fatigue|fatigue
5108927|NCT03317041|Running|running
5108928|NCT03316976|Drug therapy|drug therapy
5108929|NCT03316963|Neostigmine|neostigmine
5108930|NCT03316963|Nerve stimulant medication|nerve stimulant medication
5108931|NCT03316963|Treatments for snoring|treatments for snoring
5108932|NCT03316950|postmenopause|postmenopause
5108933|NCT03316950|rejuvenation|rejuvenation
5108934|NCT03316950|radiofrequency|radiofrequency
5108935|NCT03316950|diva|diva
5108937|NCT03316846|Chronic Pain|chronic pain
5108938|NCT03316846|Depression|depression
5108939|NCT03316846|Anxiety|anxiety
5108940|NCT03316846|Stress|stress
5108941|NCT03316846|iCBT|icbt
5961978|NCT04283682|bresatfeeding|bresatfeeding
4977185|NCT04135105|Chinese|chinese
5108942|NCT03316846|Cognitive behavioral therapy|cognitive behavioral therapy
5108943|NCT03316846|Internet delivered|internet delivered
5108944|NCT03316846|Tailored treatment|tailored treatment
5108945|NCT03316807|Hepatitis B, Vaccine|hepatitis b, vaccine
5108946|NCT03316807|Randomized Controlled Trial|randomized controlled trial
5108948|NCT03316807|Immunogenicity|immunogenicity
5108949|NCT03316794|Triple Negative Breast Cancer|triple negative breast cancer
5108950|NCT03316794|Cancer|cancer
5108951|NCT03316794|Breast Cancer|breast cancer
5108952|NCT03316794|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5108953|NCT03316794|Pharmacokinetics|pharmacokinetics
5108954|NCT03316768|grip|grip
5108955|NCT03316768|pinch|pinch
5108956|NCT03316768|forces|forces
5108957|NCT03316768|pressure|pressure
5108958|NCT03316768|Tekscan|tekscan
5108959|NCT03316768|sensor|sensor
5108960|NCT03316768|ADL|adl
5108961|NCT03316768|activities of daily living|activities of daily living
5108962|NCT03316768|work requirements|work requirements
5108963|NCT03316768|hand biomechanics|hand biomechanics
5108964|NCT03316768|forceful precision grip|forceful precision grip
5108965|NCT03316768|power grip|power grip
5108966|NCT03316768|hominid|hominid
5108967|NCT03316768|hominin|hominin
5108968|NCT03316768|prehistoric|prehistoric
5108969|NCT03316742|Obese|obese
5108970|NCT03316742|Overweight|overweight
5108971|NCT03316742|Weight loss|weight loss
5108972|NCT03316742|West Africa|west africa
5108973|NCT03316729|Sub-massive acute pulmonary embolism|sub-massive acute pulmonary embolism
5108974|NCT03316716|caesarean section|caesarean section
5108975|NCT03316716|neonatal hypothermia|neonatal hypothermia
5108976|NCT03316716|maternal hypothermia|maternal hypothermia
5108977|NCT03316716|active warming|active warming
5108978|NCT03316716|skin-to-skin contact|skin-to-skin contact
5108979|NCT03316703|Spine, Spinal injuries, Fractures, Bone|spine, spinal injuries, fractures, bone
5108980|NCT03316677|anastomotic leak|anastomotic leak
5108981|NCT03316677|colorectal|colorectal
5108982|NCT03316677|anastomosis testing|anastomosis testing
5108983|NCT03316677|Intraoperative testing|intraoperative testing
5108984|NCT03316664|cognitive behavioural therapy|cognitive behavioural therapy
5108985|NCT03316664|psychotic disorder|psychotic disorder
5108986|NCT03316664|schizophrenia|schizophrenia
5108988|NCT03316664|psychological intervention|psychological intervention
5108989|NCT03316651|pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
5108990|NCT03316651|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
5108991|NCT03316651|whole lung lavage|whole lung lavage
5108992|NCT03316612|Advanced Glycation End Products, Metabolites, Gut Microbiota|advanced glycation end products, metabolites, gut microbiota
5108993|NCT03316599|Pancreatic Cancer|pancreatic cancer
5108994|NCT03316586|Breast Cancer|breast cancer
5108996|NCT03316573|Histiocyte sarcoma|histiocyte sarcoma
5108997|NCT03316573|Follicular Dendritic Cell Saroma|follicular dendritic cell saroma
5108998|NCT03316573|Interdigitating dendritic cell sarcoma|interdigitating dendritic cell sarcoma
5108999|NCT03316560|XLRP|xlrp
5109000|NCT03316560|retinal degeneration|retinal degeneration
5109001|NCT03316560|RPGR|rpgr
5109002|NCT03316560|adeno-associated virus|adeno-associated virus
5109003|NCT03316560|gene therapy|gene therapy
5109004|NCT03316560|AAV|aav
5109005|NCT03316547|preterm|preterm
5109006|NCT03316521|complement inhibition|complement inhibition
5109007|NCT03316521|C3 complement inhibitor|c3 complement inhibitor
5109008|NCT03316521|AMY-101|amy-101
5109009|NCT03316521|Compstatin Cp40|compstatin cp40
5109010|NCT03316521|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5109011|NCT03316521|C3 glomerulopathy (C3G)|c3 glomerulopathy (c3g)
5109012|NCT03316521|Periodontal disease|periodontal disease
5109013|NCT03316521|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5109014|NCT03316521|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
5109015|NCT03316508|copeptin|copeptin
5109016|NCT03316508|pediatric cardiac surgery|pediatric cardiac surgery
5109017|NCT03316508|heart lung machine|heart lung machine
5109018|NCT03316469|Anti-mullerian hormone|anti-mullerian hormone
5109019|NCT03316456|AL|al
5109020|NCT03316443|Glidescope,Macintosh, Laryngscope, intubation,Hypertension.|glidescope,macintosh, laryngscope, intubation,hypertension.
5109021|NCT03316404|Multiple Sclerosis|multiple sclerosis
5109022|NCT03316404|MS|ms
5109023|NCT03316378|Human|human
5109024|NCT03316378|Pain|pain
5109025|NCT03316378|Biomechanics|biomechanics
5109026|NCT03316378|Anesthetics|anesthetics
5109027|NCT03316313|Public Health|public health
5109028|NCT03316313|Patient Education as Topic|patient education as topic
5109029|NCT03316313|Hepatitis C|hepatitis c
5109030|NCT03316300|Ciliary Neurotrophic Factor (CNTF)|ciliary neurotrophic factor (cntf)
5109031|NCT03316300|Macular Telangiectasia (MacTel)|macular telangiectasia (mactel)
5109032|NCT03316261|infants|infants
5109033|NCT03316261|type 1 diabetes|type 1 diabetes
5109034|NCT03316261|Freder1k|freder1k
5109035|NCT03316248|Transtibial amputation|transtibial amputation
5109036|NCT03316248|visual feedback|visual feedback
5109037|NCT03316248|rehabilitation|rehabilitation
5961979|NCT04283682|premature|premature
5109038|NCT03316196|trauma|trauma
5109039|NCT03316196|PTSD|ptsd
5109040|NCT03316196|cognition|cognition
5109041|NCT03316183|cerebral oximetry|cerebral oximetry
5109042|NCT03316183|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5109043|NCT03316183|metabolomic profiling|metabolomic profiling
5109056|NCT03316131|Dapagliflozin|dapagliflozin
5109057|NCT03316131|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
5109058|NCT03316131|Xanthine Oxidase Inhibitor|xanthine oxidase inhibitor
5109059|NCT03316131|Sodium-glucose cotransporter 2 (SGLT2) Inhibitor|sodium-glucose cotransporter 2 (sglt2) inhibitor
5109060|NCT03316118|anesthesiology|anesthesiology
5109061|NCT03316118|pain|pain
5109062|NCT03316118|arthroplasty|arthroplasty
5109063|NCT03316079|intensive care|intensive care
5109064|NCT03316079|invasive mechanical ventilation|invasive mechanical ventilation
5109065|NCT03316079|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
5109066|NCT03316079|airway mucus clearance|airway mucus clearance
5109067|NCT03316079|chest physiotherapy|chest physiotherapy
5109068|NCT03316079|peak expiratory flow|peak expiratory flow
5109069|NCT03316079|pulmonary mechanics|pulmonary mechanics
5109072|NCT03316040|HIV/AIDS|hiv/aids
5109073|NCT03316040|Join-in-Circuit|join-in-circuit
5109074|NCT03316014|Pediatry; Adverse drug reactions; Pharmacovigilance|pediatry; adverse drug reactions; pharmacovigilance
5109075|NCT03315988|type 2 diabetes|type 2 diabetes
5109076|NCT03315988|vegan diet|vegan diet
5109077|NCT03315988|TMAO|tmao
5109078|NCT03315988|cardiovascular disease|cardiovascular disease
5109089|NCT03315910|Cancer Screening|cancer screening
5109090|NCT03315910|17-500|17-500
5109091|NCT03315897|bipolar disorder|bipolar disorder
5109092|NCT03315897|cognition|cognition
5109093|NCT03315897|cognitive dysfunction|cognitive dysfunction
5109094|NCT03315897|erythropoietin|erythropoietin
5109095|NCT03315897|pro-cognitive efficacy|pro-cognitive efficacy
5109096|NCT03315897|prefrontal cortex|prefrontal cortex
5109097|NCT03315897|functional magnetic resonance imaging|functional magnetic resonance imaging
5109098|NCT03315897|biomarker|biomarker
5109099|NCT03315884|TASC C, D|tasc c, d
5109100|NCT03315884|CFA|cfa
5109101|NCT03315884|Supera|supera
5109102|NCT03315884|iliac arteries|iliac arteries
5109103|NCT03315884|common femoral artery|common femoral artery
5109104|NCT03315884|plasty of the common femoral artery|plasty of the common femoral artery
5109105|NCT03315884|stenting Supera|stenting supera
5109106|NCT03315871|Vaccine|vaccine
5109107|NCT03315871|PSA|psa
5109108|NCT03315871|Immunotherapy|immunotherapy
5109109|NCT03315871|Immune Response|immune response
5109110|NCT03315871|Checkpoint Inhibitor|checkpoint inhibitor
5109111|NCT03315858|NFAT|nfat
5109112|NCT03315858|gene expression|gene expression
5109113|NCT03315858|tacrolimus|tacrolimus
5109114|NCT03315845|BMI|bmi
5109115|NCT03315845|obstetric anaesthesia|obstetric anaesthesia
5109116|NCT03315845|neuraxial anaesthesia|neuraxial anaesthesia
5109117|NCT03315845|neuraxial ultrasound|neuraxial ultrasound
5109118|NCT03315845|difficult neuraxial anaesthesia|difficult neuraxial anaesthesia
5109119|NCT03315832|Aortic Valve Stenosis|aortic valve stenosis
5109120|NCT03315832|Valsartan|valsartan
5109121|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
5109122|NCT03315832|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5109123|NCT03315832|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5109124|NCT03315832|double-blind phase II study|double-blind phase ii study
5109125|NCT03315832|left ventricular mass|left ventricular mass
5109126|NCT03315819|glenohumeral dislocation|glenohumeral dislocation
5109127|NCT03315819|Arthroscopic|arthroscopic
5109128|NCT03315819|capsular lesions|capsular lesions
5109129|NCT03315806|Dietary nitrate|dietary nitrate
5109130|NCT03315806|Nitrate|nitrate
5109131|NCT03315806|Flow-mediated dilation|flow-mediated dilation
5109132|NCT03315806|Tissue oxygen saturation|tissue oxygen saturation
5109133|NCT03315767|HVPG|hvpg
5109134|NCT03315767|portal hypertension|portal hypertension
5109135|NCT03315767|ARFI|arfi
5109136|NCT03315767|portal vein flow|portal vein flow
5109137|NCT03315767|advanced liver chronic disease (ACLD)|advanced liver chronic disease (acld)
5109138|NCT03315741|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5109139|NCT03315728|Quality improvement|quality improvement
5109147|NCT03315650|Non-valvular AF|non-valvular af
5109148|NCT03315650|ACS|acs
5109149|NCT03315650|PCI|pci
5109150|NCT03315650|NOAC|noac
5109151|NCT03315650|Rivaroxaban|rivaroxaban
5109152|NCT03315624|Hemodialysis|hemodialysis
5109153|NCT03315624|Hemodiafiltration|hemodiafiltration
5109154|NCT03315624|Renal replacement therapy|renal replacement therapy
5109155|NCT03315598|Neuralgia, Acupuncture Treatment|neuralgia, acupuncture treatment
5109156|NCT03315585|focal therapy|focal therapy
5109158|NCT03315585|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
5109159|NCT03315585|prostate cancer|prostate cancer
5109160|NCT03315572|caregiver|caregiver
5109161|NCT03315572|ELLIPTA|ellipta
5109162|NCT03315572|Asthma|asthma
5109163|NCT03315572|Dry Powder Inhaler|dry powder inhaler
5109164|NCT03315572|pediatric|pediatric
5109165|NCT03315559|GSK2269557|gsk2269557
5119534|NCT03248531|HS|hs
5109166|NCT03315559|Pharmacokinetics|pharmacokinetics
5109167|NCT03315559|Radiolabel|radiolabel
5109168|NCT03315559|Healthy|healthy
5109169|NCT03315559|Excretion|excretion
5109170|NCT03315559|Bioavailability|bioavailability
5109171|NCT03315546|deep inspiration breath-hold|deep inspiration breath-hold
5109172|NCT03315546|radiotherapy|radiotherapy
5109173|NCT03315546|late effects|late effects
5109174|NCT03315546|pediatric cancer|pediatric cancer
5109175|NCT03315520|Hodgkin Lymphoma|hodgkin lymphoma
5109176|NCT03315520|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5109177|NCT03315520|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
5109178|NCT03315520|conditioning regimen|conditioning regimen
5109179|NCT03315494|rheumatoid arthritis|rheumatoid arthritis
5109180|NCT03315494|healthy volunteers|healthy volunteers
5109181|NCT03315494|moderate to severe|moderate to severe
5109182|NCT03315468|melanoma|melanoma
5109183|NCT03315468|database|database
5109185|NCT03315442|Fluid|fluid
5109186|NCT03315442|Balance|balance
5109187|NCT03315416|Speech Disorder|speech disorder
5109188|NCT03315416|Breast Feeding|breast feeding
5109189|NCT03315416|Infant Feeding|infant feeding
5109190|NCT03315416|Bottle Feeding|bottle feeding
5109191|NCT03315416|Speech Development|speech development
4994573|NCT04027816|PLA2G6|pla2g6
5109192|NCT03315416|Speech Sound Development|speech sound development
5109193|NCT03315416|Speech Sound Disorder|speech sound disorder
5109194|NCT03315416|Non-nutritive Sucking|non-nutritive sucking
5109195|NCT03315403|quantitative polymerase chain reaction|quantitative polymerase chain reaction
5109196|NCT03315403|qPCR|qpcr
5109197|NCT03315403|autolysin|autolysin
5109198|NCT03315403|lytA|lyta
5109199|NCT03315403|Pneumococcal pneumonia|pneumococcal pneumonia
5109200|NCT03315403|Diagnostics|diagnostics
5751435|NCT00314600|Child|child
5172102|NCT02916992|BHD|bhd
5109201|NCT03315403|Community-acquired Pneumonia|community-acquired pneumonia
5109202|NCT03315403|Antibiotic resistance|antibiotic resistance
5109203|NCT03315390|post-traumatic stress, primary health care, stress disorder|post-traumatic stress, primary health care, stress disorder
5109204|NCT03315364|Recurrent breast cancer|recurrent breast cancer
5109205|NCT03315364|Metastatic breast cancer|metastatic breast cancer
5109206|NCT03315364|MBC|mbc
5109207|NCT03315364|Firstline chemotherapy|firstline chemotherapy
5109208|NCT03315364|Paclitaxel|paclitaxel
5109209|NCT03315364|Liporaxel|liporaxel
5109210|NCT03315364|Taxol|taxol
5109211|NCT03315351|PET-scan|pet-scan
5109212|NCT03315351|Brachytherapy|brachytherapy
5109213|NCT03315351|Cervical Cancer|cervical cancer
5109214|NCT03315325|Aging|aging
5109215|NCT03315286|ultraviolet light|ultraviolet light
5109216|NCT03315286|dosimetry|dosimetry
5109217|NCT03315286|actinic keratosis|actinic keratosis
5109218|NCT03315286|skin cancer|skin cancer
5109219|NCT03315286|sun counseling|sun counseling
5109220|NCT03315286|wearable device|wearable device
5109221|NCT03315273|Traumatic brain injury, motor imagery ability, validation|traumatic brain injury, motor imagery ability, validation
5109222|NCT03315260|Castration resistant prostate cancer|castration resistant prostate cancer
5109223|NCT03315260|Patient reported outcome|patient reported outcome
5109224|NCT03315247|Obesity|obesity
5109225|NCT03315247|Bariatric Surgery|bariatric surgery
5109226|NCT03315247|Bariatrics|bariatrics
5109227|NCT03315247|Cognitive Therapy|cognitive therapy
5109228|NCT03315247|Binge Eating|binge eating
5109229|NCT03315234|SYNTAX score|syntax score
5109230|NCT03315234|Coronary Atherosclerosis|coronary atherosclerosis
5109236|NCT03315208|transdiagnostic treatment|transdiagnostic treatment
5109237|NCT03315208|cognitive-behavioral therapy|cognitive-behavioral therapy
5109238|NCT03315208|Unified Protocol|unified protocol
5109239|NCT03315208|young adults|young adults
5109240|NCT03315208|substance use disorder|substance use disorder
5109241|NCT03315208|emotional disorder|emotional disorder
5109242|NCT03315208|depression|depression
5109243|NCT03315208|anxiety|anxiety
5109244|NCT03315208|emotion dysregulation|emotion dysregulation
5109245|NCT03315208|self-injurious thoughts and behaviors|self-injurious thoughts and behaviors
5109246|NCT03315182|MPS IIIB|mps iiib
5109247|NCT03315182|Sanfilippo Syndrome B|sanfilippo syndrome b
5109248|NCT03315169|Incision and Drainage|incision and drainage
5109249|NCT03315169|Packing|packing
5109250|NCT03315156|Acute otitis media|acute otitis media
5109251|NCT03315156|AOM|aom
5109252|NCT03315156|Electrogustometer|electrogustometer
5109253|NCT03315156|EGM|egm
5109254|NCT03315156|Taste threshold|taste threshold
5109255|NCT03315104|influenza A|influenza a
5109256|NCT03315104|hospitalized|hospitalized
5109257|NCT03315104|H1N1|h1n1
5109258|NCT03315104|H3N2|h3n2
5109259|NCT03315104|human flu|human flu
5109260|NCT03315104|respiratory tract infection|respiratory tract infection
5109261|NCT03315104|serious illness|serious illness
5109262|NCT03315104|flu|flu
5109263|NCT03315091|Pharmacokinetics, WEE1 inhibitor, food effect, safety assessments|pharmacokinetics, wee1 inhibitor, food effect, safety assessments
5109269|NCT03315052|Diabetes|diabetes
5109270|NCT03315052|Hypertension|hypertension
5109271|NCT03315026|Siltuximab|siltuximab
5109272|NCT03315026|Autologous Stem Cell Transplantation (AST)|autologous stem cell transplantation (ast)
5109273|NCT03315026|17-365|17-365
5109274|NCT03315013|Antiretroviral therapy initiation|antiretroviral therapy initiation
5109275|NCT03315013|Sub-Sahara Africa|sub-sahara africa
5109276|NCT03315013|ART|art
5109277|NCT03315000|methacholine|methacholine
5109278|NCT03315000|airway hyperresponsiveness|airway hyperresponsiveness
5109279|NCT03314987|air pollution|air pollution
5109280|NCT03314987|oxidative stress|oxidative stress
5109281|NCT03314987|intervention|intervention
5109282|NCT03314974|AML|aml
5109283|NCT03314974|ALL|all
5109284|NCT03314974|MDS|mds
5109285|NCT03314974|NHL|nhl
5109286|NCT03314974|CLL|cll
5109287|NCT03314974|CML|cml
5109288|NCT03314974|SLL|sll
5109289|NCT03314961|rectal cancer|rectal cancer
5109290|NCT03314935|INCB001158|incb001158
5109291|NCT03314935|arginase inhibitor|arginase inhibitor
5109292|NCT03314935|oxaliplatin|oxaliplatin
5109293|NCT03314935|leucovorin|leucovorin
5109294|NCT03314935|5 fluorouracil|5 fluorouracil
5109295|NCT03314935|gemcitabine|gemcitabine
5109296|NCT03314935|cisplatin|cisplatin
5109297|NCT03314935|paclitaxel|paclitaxel
5109298|NCT03314935|solid tumors|solid tumors
5109299|NCT03314935|colorectal cancer|colorectal cancer
5751436|NCT00314600|Cast|cast
5109300|NCT03314935|biliary tract cancer|biliary tract cancer
5109301|NCT03314935|gastroesophageal cancer|gastroesophageal cancer
5109302|NCT03314935|endometrial cancer|endometrial cancer
5109303|NCT03314935|ovarian cancer|ovarian cancer
5109304|NCT03314922|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5109305|NCT03314922|follicular lymphoma (FL)|follicular lymphoma (fl)
5109306|NCT03314922|marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
5109307|NCT03314922|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5109308|NCT03314922|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5109309|NCT03314909|Renal Dialysis|renal dialysis
5109310|NCT03314909|Hemoperfusion|hemoperfusion
5109311|NCT03314909|Paraquat|paraquat
5109312|NCT03314896|Colonic Neoplasms|colonic neoplasms
5109313|NCT03314896|Laparoscopic Surgery|laparoscopic surgery
5109314|NCT03314896|T4|t4
5109315|NCT03314883|Ultrasound|ultrasound
5109316|NCT03314883|Diaphragm|diaphragm
5109317|NCT03314883|Non Invasive Ventilation|non invasive ventilation
5109318|NCT03314857|TAVI|tavi
5109319|NCT03314857|TAVR|tavr
5109320|NCT03314857|CHINA|china
5109321|NCT03314857|SAPIEN XT|sapien xt
5109322|NCT03314857|High Risk|high risk
5109323|NCT03314857|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5109324|NCT03314857|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5109325|NCT03314831|sepsis|sepsis
5109326|NCT03314831|septic shock|septic shock
5109327|NCT03314831|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5109328|NCT03314831|tetradecanoic acid|tetradecanoic acid
5109329|NCT03314831|myristic acid|myristic acid
5109330|NCT03314818|carotid atherosclerosis|carotid atherosclerosis
5106754|NCT03330561|HER2|her2
5109333|NCT03314805|astragalus polysaccharides|astragalus polysaccharides
5109334|NCT03314805|breast cancer|breast cancer
5109335|NCT03314805|adjuvant chemotherapy|adjuvant chemotherapy
5109336|NCT03314792|pain|pain
5109337|NCT03314792|postoperative pain|postoperative pain
5109338|NCT03314792|postoperative pain management|postoperative pain management
5109339|NCT03314792|opioid|opioid
5109340|NCT03314792|analgesia|analgesia
5109341|NCT03314792|oxycodone|oxycodone
5109342|NCT03314792|tapentadol|tapentadol
5109343|NCT03314792|hysterectomy|hysterectomy
5109344|NCT03314792|respiratory depression|respiratory depression
5109345|NCT03314727|Osmolar Concentration|osmolar concentration
5109346|NCT03314727|Oxidative Stress|oxidative stress
5109347|NCT03314727|Salt|salt
5109348|NCT03314727|Inflammation|inflammation
5109349|NCT03314727|Endothelial Function|endothelial function
5109350|NCT03314727|Hypertension|hypertension
5109351|NCT03314701|Resting Energy Expenditure|resting energy expenditure
5109352|NCT03314701|Multiple Fracture Ribs|multiple fracture ribs
5109353|NCT03314701|Ventilation|ventilation
5109354|NCT03314675|CRT-D, LV Latency|crt-d, lv latency
5109355|NCT03314649|Peritoneal Lavage, Gene Mutation, Peritoneal Metastasis,Gastric Cancer|peritoneal lavage, gene mutation, peritoneal metastasis,gastric cancer
5109356|NCT03314584|TBI|tbi
5109357|NCT03314584|traumatic brain injury|traumatic brain injury
5423207|NCT01616667|Questionnaires/standards|questionnaires/standards
5109360|NCT03314571|Epidural analgesia|epidural analgesia
5109362|NCT03314571|Satisfaction|satisfaction
5109363|NCT03314571|Care assessment|care assessment
5109364|NCT03314571|Psychometry|psychometry
5109365|NCT03314558|COPD|copd
5109366|NCT03314558|pulmonary rehabilitation|pulmonary rehabilitation
5109367|NCT03314558|insomnia|insomnia
5109368|NCT03314558|sleep quality|sleep quality
5109369|NCT03314558|physical activity|physical activity
5109370|NCT03314545|endocrown|endocrown
5109371|NCT03314545|laminate veneer with coronal post|laminate veneer with coronal post
5109372|NCT03314545|post and core|post and core
5109373|NCT03314545|crown|crown
5109374|NCT03314532|Surgical Resection|surgical resection
5109375|NCT03314532|TILA-TACE|tila-tace
5109376|NCT03314532|Hepatocellular carcinoma|hepatocellular carcinoma
5109377|NCT03314519|Lung ultrasonography|lung ultrasonography
5109380|NCT03314519|double lumen tube|double lumen tube
5109382|NCT03314519|one lung ventilation|one lung ventilation
5109383|NCT03314519|thoracic surgery|thoracic surgery
5109384|NCT03314519|thoracic anaesthesia|thoracic anaesthesia
5109385|NCT03314519|lung ultrasound|lung ultrasound
5109387|NCT03314493|Vascular calcification|vascular calcification
5109388|NCT03314493|Coronary calcification|coronary calcification
5109389|NCT03314493|Peritoneal Dialysis|peritoneal dialysis
5109390|NCT03314493|Spironolactone|spironolactone
5109391|NCT03314480|Multidetector Computed Tomography|multidetector computed tomography
5109392|NCT03314480|Cone Beam Computed Tomography|cone beam computed tomography
5109393|NCT03314480|Maxillofacial fractures|maxillofacial fractures
5109394|NCT03314480|zygomaticomaxillary fractures|zygomaticomaxillary fractures
5109395|NCT03314467|diabetic retinopathy|diabetic retinopathy
5109396|NCT03314467|diabetes|diabetes
5109397|NCT03314467|arterial hypertension|arterial hypertension
5109398|NCT03314467|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5109400|NCT03314441|sleep quality|sleep quality
5109401|NCT03314441|sleep quantity|sleep quantity
5109402|NCT03314441|sleep efficiency|sleep efficiency
5109403|NCT03314441|insomnia|insomnia
5109404|NCT03314415|overweight|overweight
5109405|NCT03314415|obesity|obesity
5109406|NCT03314415|weight loss|weight loss
5109407|NCT03314415|robot|robot
5109408|NCT03314402|JAK2 inhibitor|jak2 inhibitor
5109409|NCT03314402|Tolerance|tolerance
5109410|NCT03314402|Pharmacokinetics|pharmacokinetics
5109411|NCT03314402|Dose-escalated|dose-escalated
5109412|NCT03314389|Cochet bonnet esthesiometer|cochet bonnet esthesiometer
5109413|NCT03314376|prehabilitation|prehabilitation
5109414|NCT03314376|surgery|surgery
5109415|NCT03314376|exercise program|exercise program
5109416|NCT03314376|transplant|transplant
5109417|NCT03314376|postoperative|postoperative
5109418|NCT03314363|Calorimetry, Indirect|calorimetry, indirect
5109419|NCT03314363|respiratory dialysis|respiratory dialysis
5109420|NCT03314350|Geriatrics|geriatrics
5109421|NCT03314350|Frailty|frailty
5109422|NCT03314337|Distal Pancreatectomy|distal pancreatectomy
5109423|NCT03314337|Pancreatic stent|pancreatic stent
5109424|NCT03314337|Post-operative pancreatic fistula|post-operative pancreatic fistula
5109425|NCT03314311|Rehabilitation|rehabilitation
5109426|NCT03314311|Exercise|exercise
5109427|NCT03314311|Nutrition Therapy|nutrition therapy
5109428|NCT03314311|Patient Education as Topic|patient education as topic
5109429|NCT03314285|Cervicalgia|cervicalgia
5109433|NCT03314207|XLRP|xlrp
5109434|NCT03314207|retinal degeneration|retinal degeneration
5109435|NCT03314207|RPGR|rpgr
5109436|NCT03314207|ORF15|orf15
5109440|NCT03314181|Relapsed Multiple Myeloma|relapsed multiple myeloma
5109441|NCT03314181|Refractory Multiple Myeloma|refractory multiple myeloma
5109443|NCT03314181|Cancer|cancer
5109444|NCT03314168|Breast Cancer|breast cancer
5109445|NCT03314168|Combined training|combined training
5109446|NCT03314168|Fatigue|fatigue
5109447|NCT03314155|Depressive disorder|depressive disorder
5109448|NCT03314155|Treatment Resistant Depression|treatment resistant depression
5109449|NCT03314155|[18 F ] DPA- 714|[18 f ] dpa- 714
5109450|NCT03314155|PET|pet
5109451|NCT03314155|MRI|mri
5109452|NCT03314155|Inflammation|inflammation
5109453|NCT03314142|blood glucose|blood glucose
5109454|NCT03314142|bran particle size|bran particle size
5109455|NCT03314142|glucemic index|glucemic index
5109456|NCT03314116|hearing loss During basic training, otoacoustic emission|hearing loss during basic training, otoacoustic emission
5109457|NCT03314090|Cleft lip|cleft lip
5109459|NCT03314090|Silicone sheet|silicone sheet
5109460|NCT03314090|Silicone gel|silicone gel
5109462|NCT03314064|Russian Federation|russian federation
5109463|NCT03314064|dolutegravir|dolutegravir
5109464|NCT03314064|long-term safety|long-term safety
5109465|NCT03314064|Human Immunodeficiency Virus|human immunodeficiency virus
5109466|NCT03314051|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5109467|NCT03314051|plasma EBV DNA|plasma ebv dna
5109468|NCT03314038|Chronic Atrophic Gastritis|chronic atrophic gastritis
5109469|NCT03314038|Malignant Transformation|malignant transformation
5109470|NCT03314038|Syndrome|syndrome
5109471|NCT03314038|Traditional Chinese Medicine|traditional chinese medicine
5109472|NCT03314038|Cross-sectional Study|cross-sectional study
5109475|NCT03313986|penile curvature|penile curvature
5109476|NCT03313986|Peyronie's disease|peyronie's disease
5109477|NCT03313986|Nesbit|nesbit
5109478|NCT03313960|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5109479|NCT03313960|Afrezza|afrezza
5109480|NCT03313934|Hyaluronic Acid Filler|hyaluronic acid filler
5109481|NCT03313934|Platelet Rich Fibrin (PRF)|platelet rich fibrin (prf)
5109482|NCT03313934|Tear Trough Filler|tear trough filler
5109483|NCT03313921|myopia|myopia
5109484|NCT03313921|astigmatism|astigmatism
5109485|NCT03313921|online assessment|online assessment
4980757|NCT04112979|pain|pain
5109486|NCT03313921|refractive error|refractive error
5109487|NCT03313895|cognitive impairment, Alzheimer's disease, exercise, cognitive training, imaging|cognitive impairment, alzheimer's disease, exercise, cognitive training, imaging
5109488|NCT03313882|RNA Stability|rna stability
5109489|NCT03313882|HuR protein|hur protein
5109490|NCT03313882|SCN5A|scn5a
5109491|NCT03313869|Metabolism|metabolism
5109492|NCT03313869|Lipid oxidation|lipid oxidation
5109493|NCT03313869|micronutrient cocktail supplementation|micronutrient cocktail supplementation
5109494|NCT03313869|physical inactivity|physical inactivity
5109495|NCT03313869|glucose intolerance|glucose intolerance
5109496|NCT03313869|oxidative stress|oxidative stress
5109497|NCT03313843|Optical Coherence Tomography|optical coherence tomography
5109498|NCT03313830|Whey|whey
5109499|NCT03313830|Muscle Protein Synthesis|muscle protein synthesis
5109500|NCT03313778|mRNA-4157|mrna-4157
5109501|NCT03313778|Personalized cancer vaccine|personalized cancer vaccine
5109502|NCT03313778|PCV|pcv
5109503|NCT03313778|pembrolizumab|pembrolizumab
5109504|NCT03313752|diabetes, heart, dapagliflozin,|diabetes, heart, dapagliflozin,
5109505|NCT03313726|PSMA-PET|psma-pet
5109506|NCT03313700|Stomach Neoplasm|stomach neoplasm
5109507|NCT03313700|Robotic Surgery|robotic surgery
5109508|NCT03313700|Distal Gastrectomy|distal gastrectomy
5109509|NCT03313648|Recurrent HCC|recurrent hcc
5109510|NCT03313648|Laparoscopic Hepatectomy|laparoscopic hepatectomy
5109511|NCT03313648|RFA|rfa
5109512|NCT03313648|RCT|rct
5109513|NCT03313635|Prealbumin|prealbumin
5109514|NCT03313622|OCD|ocd
5109515|NCT03313622|Obsessive Compulsive Disorder|obsessive compulsive disorder
5109516|NCT03313557|Continued access, safety assessments|continued access, safety assessments
5109517|NCT03313531|Thrombin generation|thrombin generation
5109518|NCT03313531|variability|variability
5109519|NCT03313531|level of agreement|level of agreement
5109520|NCT03313531|hemophilia|hemophilia
5109521|NCT03313518|tDCS, Alzheimer Disease|tdcs, alzheimer disease
5109522|NCT03313479|Nausea, vomiting|nausea, vomiting
5109523|NCT03313440|Fibre|fibre
5109524|NCT03313440|diet|diet
5109525|NCT03313440|fecal bulk|fecal bulk
5109526|NCT03313414|HCV|hcv
5109527|NCT03313414|Needlestick|needlestick
5109528|NCT03313375|hemodynamics|hemodynamics
5109529|NCT03313375|exercise|exercise
5106966|NCT03329326|prosthesis|prosthesis
5109547|NCT03313271|lymphoma|lymphoma
5109549|NCT03313271|China|china
5109550|NCT03313271|patient registry|patient registry
5109551|NCT03313193|nausea|nausea
5109552|NCT03313193|vomiting|vomiting
5109553|NCT03313193|pain|pain
5109554|NCT03313193|fatigue|fatigue
5109555|NCT03313193|depression|depression
5109556|NCT03313193|anxiety|anxiety
5109557|NCT03313193|PTSD-parent|ptsd-parent
5109558|NCT03313193|caregiver self efficacy-parent|caregiver self efficacy-parent
5109559|NCT03313154|Quality of Life|quality of life
5109576|NCT03313076|chronic pain due to trauma|chronic pain due to trauma
5109577|NCT03313063|magnetic resonance imaging|magnetic resonance imaging
5109579|NCT03313063|preeclampsia|preeclampsia
5109580|NCT03313011|apraxia of speech|apraxia of speech
5109581|NCT03312972|Cancer|cancer
5109582|NCT03312972|HDR Brachytherapy|hdr brachytherapy
5109583|NCT03312972|Prostate Cancer|prostate cancer
5109584|NCT03312920|tDCS, accelerated learning, memory|tdcs, accelerated learning, memory
5109585|NCT03312907|immunosuppressants|immunosuppressants
5109586|NCT03312907|Systemic Lupus Erythematosus Disease Activity Index|systemic lupus erythematosus disease activity index
5109587|NCT03312907|Belimumab|belimumab
5109588|NCT03312907|Lupus Low Disease Activity State|lupus low disease activity state
5109589|NCT03312907|Systemic Lupus Erythematosus|systemic lupus erythematosus
5109590|NCT03312894|Drug therapy|drug therapy
5109591|NCT03312881|pain|pain
5109592|NCT03312881|neuropathic|neuropathic
5109593|NCT03312881|children|children
5109594|NCT03312881|QST|qst
5109595|NCT03312868|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5109596|NCT03312855|coronary artery disease|coronary artery disease
5109597|NCT03312855|platelet inhibition|platelet inhibition
5109598|NCT03312790|augmented reality|augmented reality
5109599|NCT03312790|fatigue|fatigue
5109600|NCT03312790|muscle|muscle
5109601|NCT03312790|heart rate|heart rate
5109602|NCT03312790|mental function|mental function
4994979|NCT04025190|depression|depression
5109603|NCT03312777|analgesia, Cytochrome P450 2D6|analgesia, cytochrome p450 2d6
5109604|NCT03312764|Prediabetes|prediabetes
5109605|NCT03312764|Obesity|obesity
5109606|NCT03312764|Intensive behavioral counseling|intensive behavioral counseling
5109607|NCT03312764|Type 2 Diabetes|type 2 diabetes
5109608|NCT03312751|Interferon-gamma|interferon-gamma
5109609|NCT03312751|NI-0501|ni-0501
5109610|NCT03312751|primary HLH|primary hlh
5961980|NCT04283682|oral feeding|oral feeding
5109611|NCT03312751|emapalumab|emapalumab
5109612|NCT03312738|everolimus|everolimus
5109613|NCT03312738|exemestane|exemestane
5109614|NCT03312738|advanced Breast Cancer|advanced breast cancer
5109615|NCT03312738|non-steroidal aromatase inhibitors|non-steroidal aromatase inhibitors
5109616|NCT03312738|breast carcinoma|breast carcinoma
5109617|NCT03312738|breast cancer|breast cancer
5109618|NCT03312738|breast lump|breast lump
5109619|NCT03312738|HER2 negative|her2 negative
5109620|NCT03312738|breast cancer progression|breast cancer progression
5109622|NCT03312712|PET|pet
5109623|NCT03312712|CT|ct
5109624|NCT03312712|Sarcoidosis|sarcoidosis
5107094|NCT03328429|abscess|abscess
5109625|NCT03312699|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
5109626|NCT03312699|Inactivated Hepatitis A vaccine|inactivated hepatitis a vaccine
5109627|NCT03312699|Inactivated, trivalent high-dose influenza vaccine|inactivated, trivalent high-dose influenza vaccine
5109628|NCT03312699|Typhoid Vi Polysaccharide Vaccine|typhoid vi polysaccharide vaccine
5109629|NCT03312699|Typhoid Vaccine Live Oral Ty21a|typhoid vaccine live oral ty21a
5109630|NCT03312699|Influenza Vaccine, Adjuvanted|influenza vaccine, adjuvanted
5109632|NCT03312660|Prebiotics|prebiotics
5109633|NCT03312660|kefir|kefir
5109634|NCT03312647|Adverse Drug Reaction|adverse drug reaction
5109635|NCT03312647|Latent Tuberculosis Infection|latent tuberculosis infection
5109636|NCT03312647|Tuberculosis|tuberculosis
5109637|NCT03312634|Interventional study|interventional study
5109638|NCT03312634|Clinical trial phase 3|clinical trial phase 3
5109639|NCT03312634|Efficacy and safety|efficacy and safety
5109640|NCT03312634|Heterotopic ossification|heterotopic ossification
5109641|NCT03312634|Flare-up|flare-up
5109645|NCT03312634|Clementia|clementia
5109646|NCT03312634|Myositis Ossificans Progressiva|myositis ossificans progressiva
5109647|NCT03312634|Munchmeyer's Disease|munchmeyer's disease
5109649|NCT03312634|FOP variants|fop variants
5109650|NCT03312621|Adolescent Health|adolescent health
5109651|NCT03312608|cerebral reorganization, TMS|cerebral reorganization, tms
5109652|NCT03312556|hypertension|hypertension
5109653|NCT03312556|supine hypertension|supine hypertension
5109654|NCT03312556|autonomic failure|autonomic failure
5109655|NCT03312556|pure autonomic failure|pure autonomic failure
5109656|NCT03312556|multiple system atrophy|multiple system atrophy
5109657|NCT03312556|cpap|cpap
5109658|NCT03312543|Photoaging of Skin, Skin Wrinkling, Solar Aging of Skin, light therapy|photoaging of skin, skin wrinkling, solar aging of skin, light therapy
5109659|NCT03312517|insomnia|insomnia
5109660|NCT03312517|belsomra|belsomra
5109661|NCT03312517|suvorexant|suvorexant
5109662|NCT03312504|sport injury|sport injury
5109663|NCT03312504|injury prevention|injury prevention
5109664|NCT03312504|fitness|fitness
5109665|NCT03312504|neuromuscular training|neuromuscular training
5109666|NCT03312504|implementation|implementation
5109667|NCT03312465|Total Shoulder Arthroplasty|total shoulder arthroplasty
5109668|NCT03312465|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
5109669|NCT03312452|Pediatric|pediatric
5109670|NCT03312452|Perioperative|perioperative
5109676|NCT03312439|Dementia|dementia
5109677|NCT03312439|Fractures|fractures
5109678|NCT03312426|Cancer|cancer
5109679|NCT03312426|Tumor|tumor
5109680|NCT03312426|Healthy Participants|healthy participants
5109681|NCT03312426|Healthy Subjects|healthy subjects
5109682|NCT03312426|Neoplasm|neoplasm
5109683|NCT03312413|dexmedetomidine|dexmedetomidine
5109684|NCT03312413|coughing during anesthetic emergence|coughing during anesthetic emergence
5109685|NCT03312413|thyroid surgery|thyroid surgery
5109691|NCT03312335|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5109692|NCT03312335|SLE|sle
5109693|NCT03312335|Interleukin-2|interleukin-2
5109694|NCT03312335|IL-2|il-2
5109695|NCT03312335|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5109696|NCT03312335|Treg|treg
5109697|NCT03312296|Stent Thrombosis|stent thrombosis
5109698|NCT03312270|aphasia|aphasia
5109699|NCT03312270|comprehension|comprehension
5109700|NCT03312270|text-to-speech|text-to-speech
5109701|NCT03312270|social validity|social validity
5109702|NCT03312231|A/H7N9|a/h7n9
5109703|NCT03312231|Immunogenicity|immunogenicity
5109704|NCT03312231|Influenza|influenza
5109705|NCT03312231|Safety|safety
5109706|NCT03312231|Sanofi Pasteur|sanofi pasteur
5109707|NCT03312231|Vaccine|vaccine
5109708|NCT03312192|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5109709|NCT03312192|Stand-Alone Cage|stand-alone cage
5109710|NCT03312192|Anterior Plating|anterior plating
5109711|NCT03312166|ear lobe|ear lobe
5109712|NCT03312166|compression|compression
5109713|NCT03312166|medical device|medical device
5109714|NCT03312166|recurrence|recurrence
5109715|NCT03312101|exercise program|exercise program
5109716|NCT03312062|elbow|elbow
5109717|NCT03312062|foam rolling|foam rolling
5109718|NCT03312062|proprioception|proprioception
5109719|NCT03312062|motor performance|motor performance
5109720|NCT03312062|strength|strength
5109721|NCT03312049|Aflatoxin B1|aflatoxin b1
5109722|NCT03312049|Aflatoxin M1|aflatoxin m1
5109723|NCT03312049|Aflatoxin|aflatoxin
5109724|NCT03312049|Mycotoxin|mycotoxin
5109725|NCT03312049|Stunting|stunting
5109726|NCT03312049|Linear growth|linear growth
5109727|NCT03312049|Pregnancy|pregnancy
5109728|NCT03312049|Birth outcomes|birth outcomes
5109729|NCT03312049|Nepal|nepal
5109730|NCT03312036|CPFA|cpfa
5109731|NCT03312036|Liver failure|liver failure
5109732|NCT03312036|Resin|resin
5109733|NCT03312036|detoxification|detoxification
5109735|NCT03312023|HBsAg|hbsag
5109736|NCT03312023|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
5109737|NCT03312023|Hepatitis B treatment|hepatitis b treatment
5109738|NCT03311997|RCT|rct
5109739|NCT03311997|Hamstring|hamstring
5109740|NCT03311997|Suture|suture
5109741|NCT03311945|Raltegravir|raltegravir
5109742|NCT03311945|Lamivudine|lamivudine
5109743|NCT03311776|Pancreatic cancer|pancreatic cancer
5109744|NCT03311776|Biomarkers|biomarkers
5109745|NCT03311776|Biobank|biobank
5109746|NCT03311776|Diagnostic biomarkers|diagnostic biomarkers
5109747|NCT03311776|Predictive biomarkers|predictive biomarkers
5109748|NCT03311776|Prognostic biomarkers|prognostic biomarkers
5109749|NCT03311763|implementation|implementation
5109750|NCT03311711|Alzheimer's Disease|alzheimer's disease
5109751|NCT03311711|Aging|aging
5109753|NCT03311659|Diphtheria|diphtheria
5109754|NCT03311659|Pertussis|pertussis
5109755|NCT03311659|Tetanus|tetanus
5109756|NCT03311659|Immunogenicity|immunogenicity
5109761|NCT03311607|Post-kala-azar Dermal Leishmaniasis|post-kala-azar dermal leishmaniasis
5109762|NCT03311607|Visceral Leishmaniasis|visceral leishmaniasis
5109763|NCT03311607|AmBisome|ambisome
5109764|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b
5109765|NCT03311607|Bangladesh|bangladesh
5109766|NCT03311607|Kala azar|kala azar
5109767|NCT03311594|Alcohol|alcohol
5109768|NCT03311594|Pain|pain
5109769|NCT03311568|Ultrasonography|ultrasonography
5109770|NCT03311568|Microvessels|microvessels
5109771|NCT03311568|Physiopathology|physiopathology
5109772|NCT03311568|Diagnostic Imaging|diagnostic imaging
5109773|NCT03311568|Critical Care|critical care
5109774|NCT03311555|Recurrent PSA-only prostate cancer following prostatectomy|recurrent psa-only prostate cancer following prostatectomy
5109775|NCT03311542|GBM|gbm
5109776|NCT03311542|Glioma|glioma
5109777|NCT03311516|insulin therapy|insulin therapy
5109779|NCT03311503|Gene therapy|gene therapy
5109780|NCT03311503|busulfan|busulfan
5109781|NCT03311490|Ankle Sprain|ankle sprain
5109782|NCT03311490|Prophylaxis|prophylaxis
5109783|NCT03311490|Indoor Sports|indoor sports
5109784|NCT03311490|Ligamentous sprain|ligamentous sprain
5109785|NCT03311490|Prevention|prevention
5109786|NCT03311477|ABBV-399|abbv-399
5109787|NCT03311477|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5109788|NCT03311477|Maximally administered dose (MAD)|maximally administered dose (mad)
5109789|NCT03311477|Dose escalation|dose escalation
5109790|NCT03311477|Pharmacokinetics|pharmacokinetics
5109791|NCT03311477|Advanced solid tumors|advanced solid tumors
5109792|NCT03311477|Cancer|cancer
5109793|NCT03311477|Solid tumors|solid tumors
5109794|NCT03311464|Pyoderma Gangrenosum|pyoderma gangrenosum
5109795|NCT03311464|Ulcer|ulcer
5109796|NCT03311464|Efficacy|efficacy
5109797|NCT03311464|Safety|safety
5109798|NCT03311464|Adalimumab|adalimumab
5109799|NCT03311464|Humira®|humira®
5109800|NCT03311464|Japan|japan
5109801|NCT03311425|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5109802|NCT03311425|prevertebral swelling|prevertebral swelling
5109803|NCT03311425|swallowing|swallowing
5109804|NCT03311425|methylprednisolone|methylprednisolone
5109805|NCT03311425|intraoperative steroid|intraoperative steroid
5109806|NCT03311412|Locally advanced/unresectable|locally advanced/unresectable
5109807|NCT03311412|Metastatic solid tumor|metastatic solid tumor
5109808|NCT03311412|Lymphoma|lymphoma
5109809|NCT03311412|Anti-PD-1|anti-pd-1
5109810|NCT03311412|PD-1|pd-1
5109811|NCT03311412|PD1|pd1
5109812|NCT03311412|Anti-LAG-3|anti-lag-3
5109813|NCT03311412|LAG-3|lag-3
5109814|NCT03311412|LAG3|lag3
5109815|NCT03311412|Anti-TIM-3|anti-tim-3
5109816|NCT03311412|TIM-3|tim-3
5109817|NCT03311412|TIM3|tim3
5109818|NCT03311399|Surgical Site Infection|surgical site infection
5109819|NCT03311399|mHealth|mhealth
5109820|NCT03311399|Cesarean Section|cesarean section
5109821|NCT03311373|COPD|copd
5109822|NCT03311360|vertebral artery origin stenosis|vertebral artery origin stenosis
5109823|NCT03311360|drug-coated balloon|drug-coated balloon
5109824|NCT03311360|stenting|stenting
5109825|NCT03311360|medical treatment|medical treatment
5109826|NCT03311347|pulmonary ultrasound|pulmonary ultrasound
5109827|NCT03311347|hypergravity|hypergravity
5109828|NCT03311347|human physiology|human physiology
5109829|NCT03311347|oxygen|oxygen
5109830|NCT03311347|lung ventilation|lung ventilation
5109831|NCT03311347|lung perfusion|lung perfusion
5109832|NCT03311347|computed tomography|computed tomography
5109833|NCT03311347|electrical impedance tomography|electrical impedance tomography
5109834|NCT03311347|altitude chamber|altitude chamber
5109835|NCT03311334|DSP-7888|dsp-7888
5109836|NCT03311334|nivolumab|nivolumab
5109837|NCT03311334|pembrolizumab|pembrolizumab
5109838|NCT03311334|immune checkpoint inhibitor|immune checkpoint inhibitor
5109839|NCT03311334|cancer vaccine|cancer vaccine
5109840|NCT03311334|WT1|wt1
5109841|NCT03311334|ICI|ici
5109842|NCT03311334|Wilms Tumor 1|wilms tumor 1
5109843|NCT03311321|Arterial Stiffness|arterial stiffness
5109844|NCT03311321|Endothelial Function|endothelial function
5109845|NCT03311321|Vitamin K|vitamin k
5109846|NCT03311308|Melanoma|melanoma
5109847|NCT03311308|Unresectable|unresectable
5109848|NCT03311308|Stage III|stage iii
5109849|NCT03311308|Stage IV|stage iv
5107318|NCT03326921|TCR|tcr
5109860|NCT03311204|tear film|tear film
5109861|NCT03311204|debridement|debridement
5109880|NCT03311139|Atrial Fibrillation|atrial fibrillation
5109881|NCT03311139|Acute Coronary Syndrome|acute coronary syndrome
5109882|NCT03311139|Anticoagulation|anticoagulation
5110485|NCT03307096|microperc|microperc
5109898|NCT03311061|College and Career Readiness|college and career readiness
5109899|NCT03311061|School Based Intervention|school based intervention
5109900|NCT03311061|Age 13-19|age 13-19
5109901|NCT03311061|Behavior Modification|behavior modification
5109902|NCT03311048|Cleaning workers|cleaning workers
5109903|NCT03311048|Work-related asthma|work-related asthma
5109904|NCT03311048|Work-related rhinitis|work-related rhinitis
5109905|NCT03311048|Respiratory symptoms|respiratory symptoms
5109906|NCT03311048|Nasal swab|nasal swab
5109907|NCT03310996|working memory|working memory
5109908|NCT03310983|Fat mass|fat mass
5109909|NCT03310983|Gestational weight gain|gestational weight gain
5109910|NCT03310983|Fetal adipose tissue|fetal adipose tissue
5109911|NCT03310970|Peer Reviewed Research|peer reviewed research
5109924|NCT03310905|Research|research
5109925|NCT03310905|Transplant|transplant
5109926|NCT03310905|Abdominal Wall|abdominal wall
5109927|NCT03310905|Hernia|hernia
5109928|NCT03310892|Colorectal cancer screening|colorectal cancer screening
5109929|NCT03310879|Cancer|cancer
5109930|NCT03310853|probiotics|probiotics
5109931|NCT03310853|infections|infections
5109932|NCT03310853|bacterial vaginosis|bacterial vaginosis
5109933|NCT03310827|Nutrition|nutrition
5109934|NCT03310827|Nutrigenomics|nutrigenomics
5109935|NCT03310801|left atrial appendage occlusion|left atrial appendage occlusion
5109936|NCT03310801|antithrombotic therapy|antithrombotic therapy
5109937|NCT03310801|atrial fibrillation|atrial fibrillation
5109938|NCT03310801|percutaneous coronary intervention|percutaneous coronary intervention
5109939|NCT03310801|drug eluting stent|drug eluting stent
5109940|NCT03310788|IOP fluctuations|iop fluctuations
5109941|NCT03310788|iCare Home|icare home
5109942|NCT03310788|SLT|slt
5109944|NCT03310775|Social skill training|social skill training
5109945|NCT03310775|PEERS|peers
5109946|NCT03310762|immunization coverage|immunization coverage
5109947|NCT03310762|silicon bracelet|silicon bracelet
5109948|NCT03310762|immunization reminders|immunization reminders
5109949|NCT03310749|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5109950|NCT03310749|DPP-IV inhibitor|dpp-iv inhibitor
5109951|NCT03310749|Drug-Drug Interactions|drug-drug interactions
5109952|NCT03310749|Ethnicity|ethnicity
5109953|NCT03310736|iron deficiency|iron deficiency
5109954|NCT03310736|anemia|anemia
5109955|NCT03310736|hepcidin|hepcidin
5109956|NCT03310697|Afebrile seizure|afebrile seizure
5109957|NCT03310697|Toxicological screening|toxicological screening
5109958|NCT03310697|Chromatography|chromatography
5109959|NCT03310697|Mass spectrometry|mass spectrometry
5109960|NCT03310697|Children|children
5109961|NCT03310684|Renin-Angiotensin system|renin-angiotensin system
5109962|NCT03310684|Hypertension|hypertension
5109963|NCT03310684|Obesity|obesity
5109964|NCT03310684|Angiotensin-(1-7)|angiotensin-(1-7)
5109965|NCT03310684|Angiotensin II|angiotensin ii
5109966|NCT03310684|FGF23|fgf23
5109967|NCT03310684|Klotho|klotho
5120329|NCT03242980|HIV|hiv
5109981|NCT03310606|Therapeutic drug monitoring|therapeutic drug monitoring
5109983|NCT03310593|bipolar depression|bipolar depression
5109984|NCT03310593|cannabidiol|cannabidiol
5109985|NCT03310593|endocannabinoids|endocannabinoids
5109986|NCT03310541|AZD5363|azd5363
5109987|NCT03310541|AKT Mutations|akt mutations
5109988|NCT03310541|17-322|17-322
5109989|NCT03310528|Aspiration risk|aspiration risk
5109990|NCT03310528|GI Endoscopy|gi endoscopy
5109991|NCT03310528|Fasting guidelines|fasting guidelines
5109992|NCT03310528|Delayed gastric emptying|delayed gastric emptying
5109993|NCT03310515|PrEP|prep
5109994|NCT03310515|MSM|msm
5109995|NCT03310515|seroincidence|seroincidence
5109996|NCT03310515|HIV-1|hiv-1
5109997|NCT03310515|TGW|tgw
5109998|NCT03310515|STIs|stis
5109999|NCT03310502|positron emission tomography|positron emission tomography
5110000|NCT03310502|skeletal muscle|skeletal muscle
5110002|NCT03310502|adipose tissue|adipose tissue
5110003|NCT03310502|brain|brain
5110004|NCT03310502|genetics|genetics
5110005|NCT03310463|infection|infection
5110006|NCT03310463|gram-negative bacterium|gram-negative bacterium
5110007|NCT03310463|renal impairment|renal impairment
5110008|NCT03310450|troponin-I|troponin-i
5110009|NCT03310450|hs-CRP|hs-crp
5110010|NCT03310450|Malondialdehyde|malondialdehyde
5110011|NCT03310450|predictors|predictors
5110012|NCT03310385|Acute Bronchitis, Herbal Medicine|acute bronchitis, herbal medicine
5110013|NCT03310333|PROM|prom
5110014|NCT03310333|Dinoprostone|dinoprostone
5110015|NCT03310333|cervical ripening device|cervical ripening device
4981286|NCT04109573|AIN|ain
5110016|NCT03310333|oxytocin|oxytocin
5110017|NCT03310320|Plaque psoriasis|plaque psoriasis
5110018|NCT03310320|PASI|pasi
5110019|NCT03310320|BSA|bsa
5110020|NCT03310320|sPGA|spga
5110021|NCT03310320|P-VAS|p-vas
5110022|NCT03310320|IL17A-|il17a-
5110023|NCT03310320|CCL20|ccl20
5110024|NCT03310320|PK|pk
5110025|NCT03310307|Homocysteine|homocysteine
5110026|NCT03310307|Overweight|overweight
5110027|NCT03310307|vitamin D3|vitamin d3
5751437|NCT00314587|fracture|fracture
5110028|NCT03310307|Reproductive women|reproductive women
5110029|NCT03310307|RCT|rct
5110030|NCT03310294|Lactobacillus|lactobacillus
5110031|NCT03310294|Herpes Labial|herpes labial
5110032|NCT03310294|Immune repsonse|immune repsonse
5110033|NCT03310281|Depression|depression
5110034|NCT03310229|cardiovascular complications|cardiovascular complications
5110035|NCT03310216|artificial intelligent|artificial intelligent
5110036|NCT03310216|visual inspection|visual inspection
5110037|NCT03310190|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5110038|NCT03310190|Deletion of the short arm of chromosome 17 (Del[17p])|deletion of the short arm of chromosome 17 (del[17p])
5110039|NCT03310190|Relapse Chronic Lymphocytic Leukemia|relapse chronic lymphocytic leukemia
5110040|NCT03310190|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5110041|NCT03310190|Chronic Lymphocytic Leukemia with deletion of the short arm of chromosome 17|chronic lymphocytic leukemia with deletion of the short arm of chromosome 17
5110042|NCT03310190|Cancer|cancer
5110043|NCT03310177|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5110044|NCT03310177|Metabolomics|metabolomics
5110045|NCT03310138|treatment|treatment
5110046|NCT03310138|brain stimulation|brain stimulation
5110047|NCT03310125|Atrial Fibrillation|atrial fibrillation
5110048|NCT03310125|Inflammation|inflammation
5110049|NCT03310125|Thoracic Surgery|thoracic surgery
5110050|NCT03310125|Randomized|randomized
5110051|NCT03310125|Colchicine|colchicine
5110052|NCT03310099|Obesity|obesity
5110053|NCT03310099|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5110054|NCT03310099|HFpEF|hfpef
5110055|NCT03310099|unsaturated fatty acids|unsaturated fatty acids
5110056|NCT03310099|cardiorespiratory fitness|cardiorespiratory fitness
5110057|NCT03310099|dietary intervention|dietary intervention
5110059|NCT03310086|CBCT|cbct
5110060|NCT03310086|Crowding|crowding
5110061|NCT03309995|Cough|cough
5110062|NCT03309995|Laryngitis|laryngitis
5110063|NCT03309995|Pharyngitis|pharyngitis
5110064|NCT03309995|Rhinitis|rhinitis
5110065|NCT03309995|Zinc Acetate|zinc acetate
5110066|NCT03309995|Zinc Lozenge|zinc lozenge
5110067|NCT03309956|Ambulatory Electrocardiography|ambulatory electrocardiography
5110068|NCT03309956|Holter Monitor|holter monitor
5110069|NCT03309956|Zio Patch Monitor|zio patch monitor
5110070|NCT03309956|Pediatrics|pediatrics
5110071|NCT03309930|comprehension|comprehension
5110072|NCT03309930|Strategies|strategies
5110073|NCT03309930|repeated exposure|repeated exposure
5110074|NCT03309865|semi-vegetarian diet|semi-vegetarian diet
5110075|NCT03309865|vedolizumab|vedolizumab
5110076|NCT03309865|ulcerative colitis|ulcerative colitis
5110077|NCT03309839|HLA-DR expression|hla-dr expression
5110078|NCT03309839|cardiopulmonary bypass|cardiopulmonary bypass
5110079|NCT03309839|neonate|neonate
5110080|NCT03309826|gestational hypertension|gestational hypertension
5110081|NCT03309826|pre-eclampsia|pre-eclampsia
5110082|NCT03309826|eclampsia|eclampsia
5111096|NCT03303339|Onvansertib|onvansertib
5110083|NCT03309826|obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
5110084|NCT03309826|positive airway pressure|positive airway pressure
5110085|NCT03309826|polysomnography|polysomnography
5110086|NCT03309826|blood pressure|blood pressure
5110087|NCT03309826|arterial stiffness|arterial stiffness
5110088|NCT03309813|ExAblate|exablate
5110089|NCT03309813|TcMRgFUS|tcmrgfus
5110090|NCT03309813|Thalamotomy|thalamotomy
5110091|NCT03309800|Acute Bronchitis|acute bronchitis
5110092|NCT03309774|Children|children
5110093|NCT03309774|Complex Regional Pain Syndrome|complex regional pain syndrome
5110094|NCT03309774|Relaxation|relaxation
5110095|NCT03309774|Bergès relaxation|bergès relaxation
5110097|NCT03309748|photodynamic therapy|photodynamic therapy
5110098|NCT03309748|black-stain|black-stain
5110099|NCT03309748|Pigmented bacteria|pigmented bacteria
5110100|NCT03309748|Tannerella forsythia|tannerella forsythia
5110101|NCT03309735|threatened miscarriage|threatened miscarriage
5110102|NCT03309735|miscarriage|miscarriage
5110103|NCT03309735|micronized progesterone|micronized progesterone
5110104|NCT03309735|dydrogesterone|dydrogesterone
5110105|NCT03309670|psychiatric outcome|psychiatric outcome
5110106|NCT03309670|psychosocial outcome|psychosocial outcome
5110107|NCT03309670|young|young
5110108|NCT03309644|Unplanned admissions|unplanned admissions
5110109|NCT03309644|Visits to the ED|visits to the ed
5110110|NCT03309644|Readmissions|readmissions
5110111|NCT03309644|Death|death
5110112|NCT03309631|Gene classifier|gene classifier
5961981|NCT04283643|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5110113|NCT03309618|myocardial infarction|myocardial infarction
5110114|NCT03309618|arterial stiffness|arterial stiffness
5110115|NCT03309618|pulse wave velocity|pulse wave velocity
5110116|NCT03309618|flow mediated dilatation|flow mediated dilatation
5110117|NCT03309618|fluvastatin|fluvastatin
5110118|NCT03309618|valsartan|valsartan
5110119|NCT03309605|Translational read through|translational read through
5110120|NCT03309579|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
5110121|NCT03309579|Red Blood Cell Transfusion (RBC)|red blood cell transfusion (rbc)
5110122|NCT03309579|Vasospasm|vasospasm
5110123|NCT03309579|Intracranial Hemorrhages|intracranial hemorrhages
5110124|NCT03309579|Cardiovascular Diseases|cardiovascular diseases
5110125|NCT03309540|Low back/lumbar spine|low back/lumbar spine
5110126|NCT03309540|Multimodal Physical therapy|multimodal physical therapy
5110127|NCT03309540|Quality of life|quality of life
5110128|NCT03309540|Range of Motion|range of motion
5110130|NCT03309527|insomia|insomia
5110131|NCT03309527|Depression|depression
5110132|NCT03309527|Self Harm|self harm
5110133|NCT03309527|Suicide|suicide
5110134|NCT03309527|guided self-help|guided self-help
5110135|NCT03309527|psychological treatment|psychological treatment
5110136|NCT03309527|eCBTI|ecbti
5110137|NCT03309527|internet|internet
5110138|NCT03309527|Psychotherapy|psychotherapy
5110139|NCT03309501|Knee osteoarthritis|knee osteoarthritis
5110140|NCT03309501|Randomised Double-blind Controlled trial|randomised double-blind controlled trial
5110141|NCT03309501|Tong-Luo-Qu-Tong Plaster|tong-luo-qu-tong plaster
5110142|NCT03309488|Food allergy|food allergy
5110143|NCT03309488|Milk allergy|milk allergy
5110144|NCT03309488|Egg allergy|egg allergy
5110145|NCT03309488|Nut allergy|nut allergy
5110146|NCT03309488|Basophil activation test|basophil activation test
5110147|NCT03309488|Diagnosis|diagnosis
5110148|NCT03309488|Specific IgE|specific ige
5110149|NCT03309488|Skin prick test|skin prick test
5110150|NCT03309475|first episode psychosis|first episode psychosis
5110151|NCT03309475|early psychosis|early psychosis
5110152|NCT03309475|schizophrenia|schizophrenia
5110153|NCT03309475|mindfulness|mindfulness
5110154|NCT03309475|social cognition|social cognition
5110155|NCT03309475|social functioning|social functioning
5110156|NCT03309475|AGES-Mind|ages-mind
5110157|NCT03309475|SocialMind|socialmind
5110158|NCT03309462|Next generation sequencing|next generation sequencing
5110159|NCT03309462|Re-biopsy|re-biopsy
5110160|NCT03309462|Acquired resistance|acquired resistance
5110161|NCT03309462|Tissue sample|tissue sample
5110162|NCT03309462|Peripheral blood|peripheral blood
5110163|NCT03309423|Blood gas analysis|blood gas analysis
5110164|NCT03309423|Critical care|critical care
5110165|NCT03309423|venus to arterial conversion|venus to arterial conversion
5110166|NCT03309410|Blood Gas Analysis|blood gas analysis
5110173|NCT03309358|Pulmonary inflammation|pulmonary inflammation
5110174|NCT03309358|Respiratory tract disease|respiratory tract disease
5110175|NCT03309358|Pulmonary disease|pulmonary disease
5110176|NCT03309358|Biofilms|biofilms
5110177|NCT03309267|pain, thoracotomy|pain, thoracotomy
5110178|NCT03309228|elderly people|elderly people
5110179|NCT03309228|polymedication,|polymedication,
5110180|NCT03309228|ethics|ethics
5110181|NCT03309228|qualitative research|qualitative research
5111588|NCT03300024|Bovine|bovine
5110182|NCT03309150|Ataxia telangiectasia mutated and Rad3-related protein inhibitor (ATRi)|ataxia telangiectasia mutated and rad3-related protein inhibitor (atri)
5110185|NCT03309137|Blood stream infections|blood stream infections
5110186|NCT03309137|Prospective|prospective
5110187|NCT03309137|Preventative|preventative
5110188|NCT03309137|Randomized|randomized
5110189|NCT03309124|White potatoes|white potatoes
5110190|NCT03309124|Older adults|older adults
5110191|NCT03309124|Satiety|satiety
5110192|NCT03309124|Glycaemia|glycaemia
5110193|NCT03309111|GBR 1342 CD38/CD3 Bispecific Antibody|gbr 1342 cd38/cd3 bispecific antibody
5110194|NCT03309111|GBR 1342 in Previously Treated Multiple Myeloma|gbr 1342 in previously treated multiple myeloma
5110195|NCT03309072|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5110196|NCT03309072|accelerated learning|accelerated learning
5110197|NCT03309072|memory|memory
5110198|NCT03309059|Nursing care|nursing care
5110199|NCT03309059|diaper rash|diaper rash
5110200|NCT03309059|fecal incontinence|fecal incontinence
5110201|NCT03309059|urinary incontinence|urinary incontinence
5110202|NCT03309046|Parents|parents
5110203|NCT03309046|Caregivers|caregivers
5110204|NCT03309046|Veterans|veterans
5110205|NCT03309033|Vaccine Efficacy|vaccine efficacy
5110215|NCT03308994|Therapeutical delays|therapeutical delays
5110216|NCT03308994|Socio-Economic Status|socio-economic status
5110217|NCT03308981|therapeutic online game|therapeutic online game
5110218|NCT03308981|resilience|resilience
5110219|NCT03308981|prevention|prevention
5110220|NCT03308981|emotional disorders|emotional disorders
5110221|NCT03308981|child|child
5110222|NCT03308981|adolescent|adolescent
5110223|NCT03308942|Niraparib|niraparib
5110224|NCT03308942|Zejula|zejula
5110225|NCT03308942|PARP Inhibitor|parp inhibitor
5110226|NCT03308942|PD-1 Inhibitor|pd-1 inhibitor
5110227|NCT03308916|elastography|elastography
5110228|NCT03308916|screening|screening
5110229|NCT03308916|non-invasive markers|non-invasive markers
5110230|NCT03308916|microbiome|microbiome
5110231|NCT03308916|gut-liver-axis|gut-liver-axis
5110232|NCT03308916|cost-benefit|cost-benefit
5110233|NCT03308916|fibroscan|fibroscan
5110234|NCT03308916|aixplorer|aixplorer
5110235|NCT03308916|ultrasound elastography|ultrasound elastography
5110236|NCT03308916|liver fibrosis|liver fibrosis
5110237|NCT03308916|alcoholic liver disease|alcoholic liver disease
5110238|NCT03308916|advanced fibrosis|advanced fibrosis
5110239|NCT03308916|enhanced liver fibrosis test|enhanced liver fibrosis test
5110240|NCT03308916|direct liver fibrosis markers|direct liver fibrosis markers
5110241|NCT03308916|ELF|elf
5110242|NCT03308916|cytokeratin-18|cytokeratin-18
5110243|NCT03308916|neoepitopes|neoepitopes
5110244|NCT03308916|collagen|collagen
5110245|NCT03308916|NAFLD|nafld
5110246|NCT03308916|ALD|ald
5110247|NCT03308916|metabolomics|metabolomics
5110248|NCT03308916|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5110249|NCT03308825|Influenza|influenza
5110250|NCT03308825|Flu|flu
5110251|NCT03308812|Cardiovascular health|cardiovascular health
5110252|NCT03308812|Health coach|health coach
5110253|NCT03308812|Cardiovascular risk factors|cardiovascular risk factors
5110254|NCT03308812|Ethnic disparities|ethnic disparities
5110255|NCT03308812|Behavioral intervention|behavioral intervention
5110256|NCT03308812|E-health lifestyle intervention|e-health lifestyle intervention
5110257|NCT03308812|Health360x|health360x
5110258|NCT03308812|eHealthyStrides|ehealthystrides
5110259|NCT03308773|Prediabetes|prediabetes
5110260|NCT03308773|insulin resistance|insulin resistance
5110264|NCT03308747|Muscle protein synthesis|muscle protein synthesis
5110265|NCT03308747|Proteasome activation|proteasome activation
5110266|NCT03308747|Anabolic signaling|anabolic signaling
5110267|NCT03308747|Aging|aging
5110268|NCT03308747|Sarcopenia|sarcopenia
5110269|NCT03308734|High-intensity interval training|high-intensity interval training
5110270|NCT03308734|REHIT|rehit
5110271|NCT03308734|Prostate cancer|prostate cancer
5110272|NCT03308734|cardiorespiratory fitness|cardiorespiratory fitness
5110273|NCT03308656|uterocervical angle, labor induction|uterocervical angle, labor induction
5110274|NCT03308643|myomectomy|myomectomy
5110275|NCT03308643|oxytocin|oxytocin
5110276|NCT03308643|blood loss|blood loss
5110277|NCT03308617|sonication|sonication
5110280|NCT03308565|AIS grade A or B|ais grade a or b
5110281|NCT03308513|Prolonged acute mechanical ventilation|prolonged acute mechanical ventilation
5110284|NCT03308500|Cardiorespiratory fitness|cardiorespiratory fitness
5110285|NCT03308500|Body composition|body composition
5110286|NCT03308487|Vitamin D|vitamin d
5110287|NCT03308487|pregnancy|pregnancy
5110288|NCT03308461|difficult defecation|difficult defecation
5110289|NCT03308461|fecal microbiota transplantation|fecal microbiota transplantation
5110290|NCT03308461|stool pattern|stool pattern
5110291|NCT03308448|Traumatic optic neuropathy|traumatic optic neuropathy
5110292|NCT03308448|Erythropoietin|erythropoietin
5110293|NCT03308448|EPO|epo
5110294|NCT03308448|Eprex|eprex
5110295|NCT03308422|screens|screens
5110296|NCT03308422|preschool children|preschool children
5110297|NCT03308422|parenting education|parenting education
5110298|NCT03308422|social perceptions|social perceptions
5110299|NCT03308396|Durvalumab|durvalumab
5110300|NCT03308396|Guadecitabine|guadecitabine
5110301|NCT03308357|drug monitoring|drug monitoring
5110302|NCT03308331|HIV|hiv
5110303|NCT03308331|nicotine|nicotine
5110304|NCT03308331|brain|brain
5110305|NCT03308331|smoking|smoking
5110306|NCT03308318|Deep temporal fascia|deep temporal fascia
5107674|NCT03325153|Bronchoscopy|bronchoscopy
5110310|NCT03308318|Temporal anatomy|temporal anatomy
5110311|NCT03308305|Coma|coma
5110312|NCT03308305|Cardiac arrest|cardiac arrest
5110313|NCT03308305|Prognosis|prognosis
5110314|NCT03308305|MRI|mri
5110315|NCT03308279|dry needling|dry needling
5110316|NCT03308279|median nerve|median nerve
5110317|NCT03308279|Pronator Teres|pronator teres
5110318|NCT03308253|Vascular Surgery|vascular surgery
5110319|NCT03308253|Surgical Site Infection|surgical site infection
5110320|NCT03308253|Prophylactic Antibiotics|prophylactic antibiotics
5110321|NCT03308253|Implantable Beads|implantable beads
5110322|NCT03308240|Magic|magic
5110323|NCT03308240|Anxiety|anxiety
5110324|NCT03308240|Pediatric|pediatric
5110325|NCT03308227|Linezolid; PK/PD; Septic shock|linezolid; pk/pd; septic shock
5110326|NCT03308214|septic shock; imipenem; VD ;pharmacokinetics|septic shock; imipenem; vd ;pharmacokinetics
5110327|NCT03308188|Opioid therapy|opioid therapy
5110328|NCT03308188|web-based intervention|web-based intervention
5110329|NCT03308188|self-management|self-management
5110330|NCT03308162|Integrated Behavioral Health Care|integrated behavioral health care
5110331|NCT03308136|epidural steroid injection|epidural steroid injection
5110332|NCT03308136|procedural pain|procedural pain
5110333|NCT03308136|local Anesthetic Injection|local anesthetic injection
5110335|NCT03308097|Uptake|uptake
5110336|NCT03308097|MSM|msm
5110337|NCT03308097|Black|black
5110338|NCT03308084|transforaminal lumbar interbody fusion, methylprednisolone|transforaminal lumbar interbody fusion, methylprednisolone
5110339|NCT03308071|Hypnosis|hypnosis
5110340|NCT03308071|Hypnotherapy|hypnotherapy
5110341|NCT03308071|Perioperative Pain Management|perioperative pain management
5110342|NCT03308071|Narcotic reduction|narcotic reduction
5110343|NCT03308071|Perioperative Outcomes|perioperative outcomes
5110344|NCT03308071|Total knee replacement|total knee replacement
5110345|NCT03308071|Total knee arthroplasty|total knee arthroplasty
5110346|NCT03308058|Breastfeeding Rural Hispanic Pregnant|breastfeeding rural hispanic pregnant
5110347|NCT03308045|plasmid|plasmid
5110348|NCT03308045|electrotransfer|electrotransfer
5110349|NCT03308045|ciliary muscle|ciliary muscle
5110350|NCT03308045|uveitis|uveitis
5110351|NCT03307993|Lu AE58054|lu ae58054
5110352|NCT03307980|gene therapy|gene therapy
5110353|NCT03307928|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5110354|NCT03307928|Aged|aged
5110355|NCT03307928|Hypertension|hypertension
5110356|NCT03307928|Oxygen Consumption|oxygen consumption
5110357|NCT03307928|Exercise|exercise
5110358|NCT03307902|Vaccination|vaccination
5110359|NCT03307889|perioperative monitoring|perioperative monitoring
5110360|NCT03307876|biologic,|biologic,
5110363|NCT03307876|back pain|back pain
5110364|NCT03307876|APIC|apic
5110365|NCT03307876|FAC|fac
5110366|NCT03307876|FACT|fact
5110367|NCT03307863|etonogestrel implant|etonogestrel implant
5110368|NCT03307863|anti-epileptic drugs|anti-epileptic drugs
5110369|NCT03307863|pharmacokinetics|pharmacokinetics
5110370|NCT03307850|type 1 diabetes|type 1 diabetes
5110371|NCT03307850|hypoglycemia|hypoglycemia
5110372|NCT03307850|exercise|exercise
5110373|NCT03307850|stress|stress
5110374|NCT03307850|artificial pancreas|artificial pancreas
5110375|NCT03307850|cortisol|cortisol
5110376|NCT03307837|nilateral Transpositional First Metatarsal Osteotomy|nilateral transpositional first metatarsal osteotomy
5110377|NCT03307824|Laparoscopic Surgery|laparoscopic surgery
5110378|NCT03307824|synthetic glue IFABONDTM|synthetic glue ifabondtm
5110379|NCT03307824|time of surgery|time of surgery
5110380|NCT03307811|liver|liver
5110381|NCT03307811|biopsy|biopsy
5110382|NCT03307811|hepatic|hepatic
5110383|NCT03307811|EUS|eus
5110384|NCT03307811|fine needle biopsy|fine needle biopsy
5110391|NCT03307720|Controlled ovarian stimulation (COS)|controlled ovarian stimulation (cos)
5110392|NCT03307720|Poor responder|poor responder
5110393|NCT03307707|FGF23|fgf23
5110394|NCT03307707|klotho|klotho
5110395|NCT03307707|Mineral Bone Disorder|mineral bone disorder
5110396|NCT03307694|Cancer|cancer
5110397|NCT03307694|Thyroid nodule|thyroid nodule
5110398|NCT03307694|Imaging|imaging
5110399|NCT03307694|Radiology|radiology
5110400|NCT03307681|White potatoes|white potatoes
5110401|NCT03307681|Children|children
5110402|NCT03307681|Satiety|satiety
5110403|NCT03307681|Glycaemia|glycaemia
5110404|NCT03307655|nitric oxide|nitric oxide
5110405|NCT03307655|follicular fluid|follicular fluid
5110406|NCT03307655|sperm|sperm
5110407|NCT03307655|capacitation|capacitation
5110408|NCT03307655|fertilization|fertilization
5110409|NCT03307655|phosphorylation|phosphorylation
5110410|NCT03307655|nitrosylation|nitrosylation
5110411|NCT03307642|Influenza vaccination rates|influenza vaccination rates
4995783|NCT04020146|VDR|vdr
5110412|NCT03307642|Respiratory Tract Diseases|respiratory tract diseases
5110413|NCT03307603|Yttrium-90 radioembolization|yttrium-90 radioembolization
5110414|NCT03307603|Nivolumab|nivolumab
5110415|NCT03307551|propofol, automated, manual|propofol, automated, manual
5110416|NCT03307538|Perihilar cholangiocarcinoma|perihilar cholangiocarcinoma
5110417|NCT03307538|Klatskin tumor|klatskin tumor
5110418|NCT03307538|Stereotactic body radiation therapy|stereotactic body radiation therapy
5110419|NCT03307512|inhaled insulin|inhaled insulin
5110420|NCT03307512|asthma|asthma
5110421|NCT03307512|COPD|copd
5110422|NCT03307486|Gestational diabetes|gestational diabetes
5110423|NCT03307486|Type 2 DM after GDM|type 2 dm after gdm
5110424|NCT03307473|Physical activity|physical activity
5110425|NCT03307473|Bicycling|bicycling
5110426|NCT03307473|Transportation|transportation
5110427|NCT03307473|Public health|public health
5110428|NCT03307447|optical coherence tomography|optical coherence tomography
5110429|NCT03307434|Program|program
5110430|NCT03307434|Prevention|prevention
5110431|NCT03307434|Injury|injury
5110432|NCT03307434|Athletics|athletics
5110433|NCT03307421|simulation|simulation
5110434|NCT03307421|debriefing|debriefing
5110435|NCT03307421|team score|team score
5110436|NCT03307421|multidisciplinarity|multidisciplinarity
5110437|NCT03307421|DEBRIEF sim II|debrief sim ii
5110438|NCT03307395|Chronic Subdural Hematoma|chronic subdural hematoma
5110439|NCT03307395|Embolization|embolization
5110440|NCT03307395|Middle meningeal artery|middle meningeal artery
5110441|NCT03307382|Biliary stricture, cholangioscopy|biliary stricture, cholangioscopy
5110442|NCT03307369|Severe malaria|severe malaria
5110443|NCT03307369|plasmodium vivax|plasmodium vivax
5110444|NCT03307356|Uterine Transplant|uterine transplant
5961982|NCT04283643|Focused Ultrasound|focused ultrasound
5110446|NCT03307343|sedentary behavior|sedentary behavior
5110447|NCT03307343|light intensity physical activity|light intensity physical activity
5110448|NCT03307343|behavioral intervention|behavioral intervention
5110449|NCT03307343|office workers|office workers
5110450|NCT03307343|blood pressure|blood pressure
5110451|NCT03307343|pulse wave velocity|pulse wave velocity
5110452|NCT03307343|randomized clinical trial|randomized clinical trial
5110455|NCT03307317|Near Infrared Spectroscopy|near infrared spectroscopy
5110456|NCT03307317|EEG|eeg
5110457|NCT03307317|Functional Brain Activity|functional brain activity
5110458|NCT03307317|Neurodevelopment|neurodevelopment
5110464|NCT03307265|Weighted Jacket|weighted jacket
5110465|NCT03307265|Balance disorder|balance disorder
5110466|NCT03307265|Equilibrium disorder|equilibrium disorder
5110467|NCT03307226|Suubi|suubi
5110468|NCT03307226|Adolescent Girls|adolescent girls
5110469|NCT03307226|Poverty|poverty
5110470|NCT03307226|Economic Empowement Interventions|economic empowement interventions
5110471|NCT03307226|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
5110472|NCT03307226|HIV/AIDS-impacted girls|hiv/aids-impacted girls
5110473|NCT03307226|Uganda|uganda
5110474|NCT03307226|Cost-effectiveness|cost-effectiveness
5110495|NCT03307018|Bronchoscopy|bronchoscopy
5110496|NCT03307018|Respiratory Complications|respiratory complications
5110497|NCT03307018|Anatomical Lung Resection|anatomical lung resection
5110498|NCT03306992|Exercise|exercise
5110499|NCT03306966|Ascending colon|ascending colon
5110500|NCT03306940|botulinum toxin A|botulinum toxin a
5110501|NCT03306927|blood sugar|blood sugar
5110502|NCT03306927|insulin|insulin
5110503|NCT03306927|appetite|appetite
5110504|NCT03306927|peas|peas
5110505|NCT03306875|multiple sclerosis|multiple sclerosis
5110506|NCT03306875|cognitive training|cognitive training
5110507|NCT03306875|telerehabilitation|telerehabilitation
5110508|NCT03306875|personality|personality
5110509|NCT03306875|Conscientiousness|conscientiousness
5110510|NCT03306875|predict|predict
5110511|NCT03306862|blood sugar|blood sugar
5110512|NCT03306862|insulin|insulin
5110513|NCT03306862|peas|peas
5110514|NCT03306836|Hybrid operation|hybrid operation
5110515|NCT03306836|Cerebral Aneurysm|cerebral aneurysm
5110516|NCT03306836|Arteriovenous Malformations|arteriovenous malformations
5110517|NCT03306836|Anticoagulation|anticoagulation
5110518|NCT03306823|Cerebral Aneurysm|cerebral aneurysm
5110519|NCT03306823|Arteriovenous Malformations|arteriovenous malformations
5110520|NCT03306823|Hybrid operation|hybrid operation
5110521|NCT03306823|Anticoagulation|anticoagulation
5110522|NCT03306810|Perioperative complications|perioperative complications
5110523|NCT03306810|Dysglycemia management team|dysglycemia management team
5110524|NCT03306810|Nurse Practitioner|nurse practitioner
5110525|NCT03306810|Hospital|hospital
5110526|NCT03306797|Music therapy|music therapy
5110527|NCT03306797|Sonification technique|sonification technique
5110528|NCT03306797|Rehabilitation|rehabilitation
5110529|NCT03306784|RAPID3|rapid3
5110530|NCT03306784|pain catastrophizing|pain catastrophizing
5110531|NCT03306771|Morbid Obesity|morbid obesity
5110532|NCT03306771|Carotid Stenosis|carotid stenosis
5110533|NCT03306771|Metabolic Syndrome|metabolic syndrome
5110534|NCT03306745|Polycystic Ovary Syndrome|polycystic ovary syndrome
5110535|NCT03306745|Anti-Mullerian Hormone|anti-mullerian hormone
5110536|NCT03306745|Androgens|androgens
5110537|NCT03306745|Micronutrient Supplementation|micronutrient supplementation
5110538|NCT03306732|Thiamine|thiamine
5110544|NCT03306706|blood sugar|blood sugar
5110545|NCT03306706|insulin|insulin
5110546|NCT03306706|appetite|appetite
5110547|NCT03306706|peas|peas
5110548|NCT03306693|Emotional Intelligence|emotional intelligence
5110549|NCT03306693|Quality of Life|quality of life
5110550|NCT03306628|Skin Scarring|skin scarring
5110551|NCT03306628|keloids|keloids
5110552|NCT03306628|hypertrophic scars|hypertrophic scars
5110553|NCT03306628|CO2 laser therapy|co2 laser therapy
5110559|NCT03306602|Composite Resins|composite resins
5110560|NCT03306602|Dental Restorations|dental restorations
5110561|NCT03306589|Inflammation|inflammation
5110562|NCT03306589|GM-CSF|gm-csf
5110564|NCT03306589|Skin blisters|skin blisters
5110565|NCT03306589|Healthy subjects|healthy subjects
5110566|NCT03306589|cantharidin|cantharidin
5110569|NCT03306563|Mild traumatic brain injury|mild traumatic brain injury
5110570|NCT03306563|Concussion|concussion
5110571|NCT03306563|Diagnostics|diagnostics
5110572|NCT03306563|Rapid test|rapid test
5110573|NCT03306563|Traumatic Brain Injury|traumatic brain injury
5110574|NCT03306563|mTBI|mtbi
5110575|NCT03306550|drug-drug interaction|drug-drug interaction
5110576|NCT03306550|Asprin|asprin
5110577|NCT03306550|salvianolate injection|salvianolate injection
5110584|NCT03306524|Circuit flow|circuit flow
5110585|NCT03306524|Slope time|slope time
5110586|NCT03306524|neonatal intensive care|neonatal intensive care
5110587|NCT03306498|plasma free amino acids|plasma free amino acids
5110588|NCT03306459|PCOS|pcos
5110589|NCT03306459|Quality of life|quality of life
5110590|NCT03306459|Sexuality|sexuality
5110591|NCT03306459|Psychological traits|psychological traits
5110592|NCT03306433|dental caries|dental caries
5110593|NCT03306433|white spot lesion|white spot lesion
5110594|NCT03306433|prevention|prevention
5110595|NCT03306433|smooth surface sealant|smooth surface sealant
5110596|NCT03306420|MS201408-0005A|ms201408-0005a
5110597|NCT03306420|MS201408-0005B|ms201408-0005b
5110598|NCT03306420|MS201408-0005C|ms201408-0005c
5110599|NCT03306420|First-in-Human|first-in-human
5110600|NCT03306420|Advanced solid tumors|advanced solid tumors
5110601|NCT03306394|metastatic|metastatic
5110602|NCT03306394|colorectal|colorectal
5110604|NCT03306394|trifluridine/tipiracil|trifluridine/tipiracil
5110605|NCT03306394|early access|early access
5110607|NCT03306381|Epigenetics|epigenetics
5110608|NCT03306381|Dietary intervention|dietary intervention
5110609|NCT03306381|Gut Microbiota|gut microbiota
5110610|NCT03306381|Inflammation|inflammation
5110611|NCT03306381|Genetics|genetics
5110613|NCT03306368|XR-NTX|xr-ntx
5110614|NCT03306368|assertive outreach|assertive outreach
5110615|NCT03306368|youth|youth
5110616|NCT03306355|Intraocular Lens|intraocular lens
5110617|NCT03306355|trifocal|trifocal
5110618|NCT03306355|hydrophobic|hydrophobic
5110619|NCT03306355|hydrophilic|hydrophilic
5110620|NCT03306342|Intraocular Lens|intraocular lens
5110621|NCT03306342|trifocal|trifocal
5110622|NCT03306342|hydrophobic|hydrophobic
5110623|NCT03306342|hydrophilic|hydrophilic
5110624|NCT03306303|melatonin|melatonin
5110625|NCT03306303|STEMI|stemi
5110626|NCT03306303|No-reflow|no-reflow
5110627|NCT03306290|Obese|obese
5110628|NCT03306290|Bariatric surgery|bariatric surgery
5110629|NCT03306290|Antibiotic prophylaxis|antibiotic prophylaxis
5110630|NCT03306290|Cefoxitin|cefoxitin
5110631|NCT03306264|MDS|mds
5110632|NCT03306264|CMML|cmml
5110633|NCT03306264|decitabine|decitabine
5110634|NCT03306264|Myelodysplastic Syndromes|myelodysplastic syndromes
5110635|NCT03306264|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5110636|NCT03306264|Acute Myeloid Leukemia|acute myeloid leukemia
5110637|NCT03306264|AML|aml
5110638|NCT03306251|HIV|hiv
5110639|NCT03306251|Pregnancy|pregnancy
5110640|NCT03306251|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
5110641|NCT03306238|laparoscopy/ key-hole|laparoscopy/ key-hole
5110642|NCT03306238|renal surgery|renal surgery
5110643|NCT03306238|open/hasson|open/hasson
5110644|NCT03306238|closed/veress|closed/veress
5110645|NCT03306212|cerebral palsy|cerebral palsy
5110646|NCT03306212|casting|casting
5110647|NCT03306212|Botulinum toxin A|botulinum toxin a
5110648|NCT03306186|diagnosis|diagnosis
5110649|NCT03306186|prognosis|prognosis
5110650|NCT03306160|central blood pressure|central blood pressure
5110651|NCT03306160|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5110652|NCT03306160|blood pressure variability|blood pressure variability
5110653|NCT03306147|Pain|pain
5110654|NCT03306147|Opioid|opioid
5110655|NCT03306147|Drug monitoring|drug monitoring
5110657|NCT03306121|Nasopharyngeal carcinoma;Induction chemotherapy|nasopharyngeal carcinoma;induction chemotherapy
5110658|NCT03306069|Aerobic exercise|aerobic exercise
5110659|NCT03306069|Interval training|interval training
5110660|NCT03306069|VO2max|vo2max
5110661|NCT03306069|Health Promotion|health promotion
5110662|NCT03306069|Inflammation|inflammation
5110663|NCT03306069|Body Composition|body composition
5110664|NCT03306056|Exercise|exercise
5110665|NCT03306056|Strength Training|strength training
5110666|NCT03306056|Health Promotion|health promotion
5110667|NCT03306056|Inflammation|inflammation
5110668|NCT03306056|Body Composition|body composition
5110669|NCT03306043|hypereosinophilic syndrome|hypereosinophilic syndrome
5110670|NCT03306043|hypereosinophilic syndrome flare|hypereosinophilic syndrome flare
5110671|NCT03306043|open-label extension study|open-label extension study
5110672|NCT03306043|Mepolizumab|mepolizumab
5110673|NCT03306043|SB240563|sb240563
5110674|NCT03306043|Long-term safety|long-term safety
5110675|NCT03306030|PEG|peg
5110676|NCT03306030|Bowel preparation|bowel preparation
5110677|NCT03306030|Colonoscopy|colonoscopy
5110678|NCT03306030|split-does|split-does
5121009|NCT03238807|hCG|hcg
5110681|NCT03306017|lipo-oxygenase products|lipo-oxygenase products
5110685|NCT03305978|Ultra low dose chest CT|ultra low dose chest ct
5110686|NCT03305978|lung cancer screening|lung cancer screening
5110687|NCT03305939|Gestational Diabetes,Lifestyle,Type 2 DM|gestational diabetes,lifestyle,type 2 dm
5110688|NCT03305913|mCRC|mcrc
5110689|NCT03305900|formate|formate
5110690|NCT03305900|one-carbon metabolism|one-carbon metabolism
5110691|NCT03305887|TKA|tka
5110692|NCT03305887|Barbed suture|barbed suture
5110693|NCT03305887|Surgical time|surgical time
5110694|NCT03305874|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
5110696|NCT03305874|computer-based risk tool|computer-based risk tool
5110697|NCT03305861|Thulium Laser Enucleation of the Prostate (ThuLEP)|thulium laser enucleation of the prostate (thulep)
5110698|NCT03305861|Greenlight Laser Enucleation of the Prostate (Green LEP)|greenlight laser enucleation of the prostate (green lep)
5110699|NCT03305835|Primary Hyperoxaluria (PH)|primary hyperoxaluria (ph)
5110700|NCT03305835|Hyperoxaluria|hyperoxaluria
5110701|NCT03305835|PH|ph
5110702|NCT03305835|PH 1|ph 1
5110703|NCT03305835|PH 2|ph 2
5110704|NCT03305835|PH 3|ph 3
5110705|NCT03305835|Dent Disease|dent disease
5110706|NCT03305835|Dent 1|dent 1
5110707|NCT03305835|Dent 2|dent 2
5110708|NCT03305835|Cystinuria|cystinuria
5110709|NCT03305835|APRT Deficiency|aprt deficiency
5110710|NCT03305835|24-Hydroxylase Deficiency|24-hydroxylase deficiency
5110711|NCT03305835|CYP24A1|cyp24a1
5110712|NCT03305809|Parkinson Disease Dementia|parkinson disease dementia
5110713|NCT03305809|Parkinson Disease|parkinson disease
5110714|NCT03305809|Dopamine|dopamine
5110715|NCT03305809|Cognition|cognition
5110716|NCT03305809|Lewy Body Dementia|lewy body dementia
5110717|NCT03305809|Dementia with Lewy Bodies|dementia with lewy bodies
5110718|NCT03305770|soft contact lenses|soft contact lenses
5110719|NCT03305770|vision|vision
5110720|NCT03305770|eyesight|eyesight
5110721|NCT03305744|Athlete|athlete
5110722|NCT03305744|Middle-aged|middle-aged
5110723|NCT03305744|Endurance training|endurance training
5110724|NCT03305744|Cardiac Function|cardiac function
5110725|NCT03305744|Atrial Fibrillation|atrial fibrillation
5110728|NCT03305692|cardiac resynchronization therapy|cardiac resynchronization therapy
5110729|NCT03305692|pacing|pacing
5110730|NCT03305692|echocardiography|echocardiography
5110731|NCT03305692|optimization|optimization
5110732|NCT03305692|heart failure|heart failure
5110733|NCT03305653|Pediatrics|pediatrics
5110734|NCT03305588|essential tremor (ET)|essential tremor (et)
5110735|NCT03305588|stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
5110736|NCT03305588|radiosurgery (RS)|radiosurgery (rs)
5110737|NCT03305588|deep brain stimulation (DBS)|deep brain stimulation (dbs)
5110738|NCT03305588|Parkinson's Disease (PD)|parkinson's disease (pd)
5110739|NCT03305588|tremor-dominant Parkinson's disease (TDPD)|tremor-dominant parkinson's disease (tdpd)
5110740|NCT03305575|Cervical Cerclage|cervical cerclage
5110741|NCT03305575|Bupivacaine|bupivacaine
5110742|NCT03305575|Chloroprocaine|chloroprocaine
5110743|NCT03305575|spinal anesthesia|spinal anesthesia
5110744|NCT03305562|Hypertension|hypertension
5110745|NCT03305549|Dialysis-requiring Acute Kidney Injury|dialysis-requiring acute kidney injury
5110746|NCT03305549|Renal Recovery|renal recovery
5110747|NCT03305536|AVD|avd
5110748|NCT03305523|circumcision; Thermocautery; Complication|circumcision; thermocautery; complication
5110749|NCT03305497|Opioid Overdose; Naloxone|opioid overdose; naloxone
5110750|NCT03305484|contact lenses|contact lenses
5110751|NCT03305484|red eye|red eye
5110752|NCT03305484|corneal infiltrate|corneal infiltrate
5110753|NCT03305471|Chronic hemodialysis|chronic hemodialysis
5110754|NCT03305471|Investigational drug|investigational drug
5110755|NCT03305445|Immunotransplant|immunotransplant
5110756|NCT03305445|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
5751438|NCT00314587|forearm|forearm
5108082|NCT03322670|family practice|family practice
5110759|NCT03305445|Ipilimumab|ipilimumab
5110760|NCT03305419|Crossover|crossover
5110761|NCT03305419|Sequential|sequential
5110762|NCT03305419|GSK2982772|gsk2982772
5110763|NCT03305419|Safety|safety
5110764|NCT03305419|Pharmacokinetics|pharmacokinetics
5110765|NCT03305419|Healthy subjects|healthy subjects
5110766|NCT03305393|Heart Failure|heart failure
5110768|NCT03305393|Cardiac Recynchronization Therapy|cardiac recynchronization therapy
5110769|NCT03305393|left bundle branch block|left bundle branch block
5110770|NCT03305393|atrio-ventricular conduction|atrio-ventricular conduction
5110771|NCT03305380|anti-PD1|anti-pd1
5110772|NCT03305380|anti-PD-L1|anti-pd-l1
5110773|NCT03305354|mobile health|mobile health
5110774|NCT03305354|physical activity|physical activity
5110775|NCT03305341|SCLC|sclc
5110776|NCT03305341|SNP|snp
5110777|NCT03305341|Oncology|oncology
5110778|NCT03305341|Drug|drug
5110779|NCT03305341|Etoposide|etoposide
5110813|NCT03305042|vitamin A biomarkers|vitamin a biomarkers
5110814|NCT03305042|serum retinol|serum retinol
5110815|NCT03305029|Age related macular degeneration|age related macular degeneration
5110816|NCT03305029|embryonic stem cells|embryonic stem cells
5110817|NCT03305029|somatic cell nuclear transfer|somatic cell nuclear transfer
5110831|NCT03304964|FP-025, MMP-12 inhibitor|fp-025, mmp-12 inhibitor
5110832|NCT03304912|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5110833|NCT03304912|Injection Drug Use|injection drug use
5110834|NCT03304873|rectal MRSA|rectal mrsa
5110835|NCT03304873|mupirocin-resistant nasal MRSA|mupirocin-resistant nasal mrsa
5110836|NCT03304834|HIFU|hifu
5110837|NCT03304834|High intensity focused ultrasound|high intensity focused ultrasound
5110838|NCT03304821|Atherosclerotic peripheral artery disease|atherosclerotic peripheral artery disease
5110839|NCT03304821|Granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
5110840|NCT03304821|Atherosclerosis|atherosclerosis
5110841|NCT03304821|Cardiology|cardiology
5110842|NCT03304821|Vascular disease|vascular disease
5110843|NCT03304808|premature ejaculation|premature ejaculation
5110844|NCT03304808|cognitive-behavior|cognitive-behavior
4982123|NCT04104217|19-270|19-270
5110845|NCT03304808|treatment|treatment
5110846|NCT03304808|device|device
5110847|NCT03304795|Vitamin D|vitamin d
5110848|NCT03304795|Asia|asia
5110849|NCT03304795|Trend|trend
5110850|NCT03304795|KNHANES|knhanes
5110851|NCT03304795|Temporal change|temporal change
5110852|NCT03304782|Preterm Birth|preterm birth
5110853|NCT03304782|Fitbit|fitbit
5110854|NCT03304782|Preterm Delivery|preterm delivery
5110855|NCT03304769|Virtual Reality Distraction|virtual reality distraction
5110856|NCT03304769|Pediatric IV placement|pediatric iv placement
5110857|NCT03304756|locally advanced breast cancer|locally advanced breast cancer
5110858|NCT03304756|triple negative|triple negative
5110859|NCT03304756|cisplatin|cisplatin
5110860|NCT03304743|dental panoramic radiographs|dental panoramic radiographs
5110861|NCT03304743|osteoporosis|osteoporosis
5110862|NCT03304743|feasibility study|feasibility study
5110863|NCT03304730|Zygapophyseal Joint|zygapophyseal joint
5110864|NCT03304730|Low Back Pain|low back pain
5110865|NCT03304730|Spine Osteoarthritis|spine osteoarthritis
5110866|NCT03304717|Leukodystrophy|leukodystrophy
5110867|NCT03304717|Antiretroviral Drugs|antiretroviral drugs
5110878|NCT03304678|mTORC1 Inhibition|mtorc1 inhibition
5110879|NCT03304678|VEGF-D|vegf-d
5110880|NCT03304678|MicroRNA|microrna
5110881|NCT03304665|Healthy Volunteers|healthy volunteers
5110882|NCT03304665|Mental Health|mental health
5110883|NCT03304665|Common Data Elements|common data elements
5110885|NCT03304600|tDCS|tdcs
5110886|NCT03304561|knee|knee
5110887|NCT03304561|rehabilitation|rehabilitation
5110888|NCT03304561|ACL|acl
5110889|NCT03304561|Contralateral training|contralateral training
5110890|NCT03304548|Telephone interviews|telephone interviews
5110891|NCT03304548|Subcutaneous|subcutaneous
5110892|NCT03304548|Low-interventional|low-interventional
5110893|NCT03304548|Qualitative research|qualitative research
5110894|NCT03304548|PAH|pah
5110895|NCT03304535|Glaucoma|glaucoma
5110904|NCT03304496|Percutaneous Coronary Intervention|percutaneous coronary intervention
5110906|NCT03304457|Olanzapine|olanzapine
5110907|NCT03304457|Brain derived neurotrophic factor|brain derived neurotrophic factor
5110908|NCT03304457|Nerve growth factor|nerve growth factor
5110909|NCT03304457|Neurotrophin 3|neurotrophin 3
5110910|NCT03304431|QT dispersion|qt dispersion
5110911|NCT03304431|topical lidocaine|topical lidocaine
5110912|NCT03304431|P-wave values|p-wave values
5110922|NCT03304353|Plantar heel pain|plantar heel pain
5110923|NCT03304353|Resistance training|resistance training
5110924|NCT03304340|acute stroke,TENS ,posture stability, function|acute stroke,tens ,posture stability, function
5110925|NCT03304327|Yoga|yoga
5110926|NCT03304327|Mindfulness|mindfulness
5110927|NCT03304314|PTC|ptc
5110928|NCT03304314|EYES|eyes
5110929|NCT03304314|Pseudotumor cerebri|pseudotumor cerebri
5110930|NCT03304314|increased Intracranial pressure|increased intracranial pressure
5110932|NCT03304301|sunlight exposure|sunlight exposure
5110933|NCT03304301|institutionalized elderly|institutionalized elderly
5110934|NCT03304301|depression|depression
5110935|NCT03304301|quality of life|quality of life
5110936|NCT03304301|cognition function|cognition function
5110937|NCT03304288|all-trans retinoid acid|all-trans retinoid acid
5110938|NCT03304288|rituximab|rituximab
5110939|NCT03304288|steroid-resistant|steroid-resistant
5110940|NCT03304288|refractory|refractory
5110941|NCT03304288|low-dose|low-dose
5110942|NCT03304275|Pertussis|pertussis
5110943|NCT03304275|Vaccination|vaccination
5110944|NCT03304275|Emergency Department|emergency department
5110945|NCT03304262|Metaplasticity|metaplasticity
5110946|NCT03304262|Motor excitability|motor excitability
5110947|NCT03304262|rTMS|rtms
5110948|NCT03304262|tDCS|tdcs
5110949|NCT03304236|Cervical Myelopathy|cervical myelopathy
5110950|NCT03304236|sEMG|semg
5110951|NCT03304236|Motion capture analysis|motion capture analysis
5110952|NCT03304210|PIPAC|pipac
5110953|NCT03304210|Peritoneal carcinomatosis|peritoneal carcinomatosis
5110954|NCT03304210|Ovarian cancer|ovarian cancer
5110955|NCT03304210|Pharmacokinetics|pharmacokinetics
5110956|NCT03304210|Pharmacodynamics|pharmacodynamics
5110957|NCT03304210|Safety and efficacy|safety and efficacy
5110958|NCT03304210|Abraxane|abraxane
5110959|NCT03304210|Breast cancer|breast cancer
5110960|NCT03304210|Pancreas cancer|pancreas cancer
5110961|NCT03304210|Stomach cancer|stomach cancer
5110962|NCT03304158|Diabetes|diabetes
5110963|NCT03304158|Non-communicable disease|non-communicable disease
5110964|NCT03304158|Primary health care|primary health care
5961983|NCT04283643|Noninvasive Neuromodulation|noninvasive neuromodulation
5110965|NCT03304158|Nepal|nepal
5110967|NCT03304132|Oral Microbiome|oral microbiome
5110968|NCT03304132|reflux disorders|reflux disorders
5110969|NCT03304132|esophageal microbiome|esophageal microbiome
5110970|NCT03304132|Alcohol Use|alcohol use
5110971|NCT03304132|Tobacco Use|tobacco use
5110972|NCT03304119|Torsion of tibial tuberosity|torsion of tibial tuberosity
5110973|NCT03304119|Recurrent patellar dislocation|recurrent patellar dislocation
5110974|NCT03304119|MRI Measurements|mri measurements
5110975|NCT03304119|Patellar instability|patellar instability
5110976|NCT03304119|Patellar dislocation|patellar dislocation
5110977|NCT03304119|Tibial tubercle position|tibial tubercle position
5110978|NCT03304119|Tibial tubercle torsion|tibial tubercle torsion
5110980|NCT03304093|VIH|vih
5110981|NCT03304093|Nivolumab|nivolumab
5110982|NCT03304093|NSCLC|nsclc
5110983|NCT03304080|Breast Neoplasms|breast neoplasms
5110984|NCT03304080|Breast Diseases|breast diseases
5110985|NCT03304080|Palbociclib|palbociclib
5110986|NCT03304080|Trastuzumab|trastuzumab
5110987|NCT03304080|Pertuzumab|pertuzumab
5110988|NCT03304080|Hormone Antagonists|hormone antagonists
5110989|NCT03304080|Anastrozole|anastrozole
5110990|NCT03304080|Arimidex|arimidex
5110991|NCT03304080|Ibrance|ibrance
5110992|NCT03304080|Perjeta|perjeta
5110993|NCT03304054|MuSK antibody positive|musk antibody positive
5110994|NCT03304041|low-FODMAP|low-fodmap
5110995|NCT03304041|Irritable Bowel Syndrome|irritable bowel syndrome
5110996|NCT03304041|stool fermentation|stool fermentation
5110997|NCT03304041|Breath test|breath test
5110998|NCT03304028|Connected Devices|connected devices
5110999|NCT03304028|Pulmonary Exacerbations|pulmonary exacerbations
5111000|NCT03304028|Cumulative Sum (CUSUM) Chart|cumulative sum (cusum) chart
5111002|NCT03304015|Violence against Women|violence against women
5111003|NCT03304015|Female Garment Workers|female garment workers
5111004|NCT03304015|Bangladesh|bangladesh
5111005|NCT03303976|pneumococcal vaccine|pneumococcal vaccine
5111006|NCT03303976|bioconjugate|bioconjugate
5111007|NCT03303963|culture-free|culture-free
5111008|NCT03303963|tuberculosis|tuberculosis
5111009|NCT03303963|multidrug resistant|multidrug resistant
5111010|NCT03303963|diagnosis|diagnosis
5111011|NCT03303963|follow-up|follow-up
5111012|NCT03303963|africa|africa
5111013|NCT03303963|molecular tools|molecular tools
5111014|NCT03303937|virulence factor genes;|virulence factor genes;
5111015|NCT03303937|phenotyping|phenotyping
5111016|NCT03303937|genotyping|genotyping
5111017|NCT03303937|antimicrobial susceptibility|antimicrobial susceptibility
5111018|NCT03303924|Pharmacokinetic|pharmacokinetic
5111019|NCT03303924|Bronchoalveolar Lavage|bronchoalveolar lavage
5111020|NCT03303924|Epithelial Lining Fluid|epithelial lining fluid
5111021|NCT03303924|Alveolar Macrophage|alveolar macrophage
5111022|NCT03303924|Gram-negative bacterium|gram-negative bacterium
5111023|NCT03303924|Acinetobacter baumannii|acinetobacter baumannii
5111024|NCT03303872|atrial high rate episode|atrial high rate episode
5111025|NCT03303872|pacemaker|pacemaker
5111026|NCT03303872|atrial fibrillation|atrial fibrillation
5111027|NCT03303872|stroke|stroke
5111028|NCT03303859|Bacterial vaginosis, preterm delivery, Martinique, stress|bacterial vaginosis, preterm delivery, martinique, stress
5111029|NCT03303833|Lifestyle|lifestyle
5111030|NCT03303833|Nutrition|nutrition
5111031|NCT03303807|Extracorporeal CO2 removal (ECCO2-R)|extracorporeal co2 removal (ecco2-r)
5111032|NCT03303807|ARDS|ards
5111040|NCT03303703|cardiac rehabilitation|cardiac rehabilitation
5111041|NCT03303677|endoscopic sinus surgery|endoscopic sinus surgery
5111042|NCT03303677|topical nasal therapy|topical nasal therapy
5111043|NCT03303664|opioid|opioid
5111044|NCT03303664|inpatient|inpatient
5111045|NCT03303664|pain|pain
5111046|NCT03303664|multimodal|multimodal
5111047|NCT03303651|Analgesia, Monitoring, Opioid, Sufentanil, Sevoflurane|analgesia, monitoring, opioid, sufentanil, sevoflurane
5111048|NCT03303638|Multi-sensory environment|multi-sensory environment
5111049|NCT03303638|Snoezelen|snoezelen
5111050|NCT03303638|Bathing|bathing
5111051|NCT03303638|Showering|showering
5111052|NCT03303638|Tub Bathing|tub bathing
5111053|NCT03303599|Chronic Hepatitis C|chronic hepatitis c
5111054|NCT03303599|Sustained Virological Response|sustained virological response
5111055|NCT03303599|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5111056|NCT03303599|Chronic Hepatitis C genotype 2|chronic hepatitis c genotype 2
5111057|NCT03303599|Chronic Hepatitis C genotype 3|chronic hepatitis c genotype 3
5111058|NCT03303599|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5111059|NCT03303599|Chronic Hepatitis C genotype 5|chronic hepatitis c genotype 5
5111060|NCT03303599|Chronic Hepatitis C genotype 6|chronic hepatitis c genotype 6
5111061|NCT03303599|Hepatitis C|hepatitis c
5111062|NCT03303586|Asthma|asthma
5111063|NCT03303586|Fluid Shift|fluid shift
5111064|NCT03303586|Compression stockings|compression stockings
5111065|NCT03303586|intrathoracic airway narrowing|intrathoracic airway narrowing
5111066|NCT03303573|Erythropoeitin|erythropoeitin
5111068|NCT03303547|Tissue|tissue
5111069|NCT03303547|Imaging|imaging
5111070|NCT03303547|Pathology|pathology
5111071|NCT03303547|Rectal|rectal
5111072|NCT03303547|Cancer|cancer
5111073|NCT03303534|inflammation|inflammation
5111074|NCT03303534|hydrogen sulfide|hydrogen sulfide
5111075|NCT03303534|caloric restriction|caloric restriction
5111076|NCT03303534|vascular surgery|vascular surgery
5111077|NCT03303495|FOLFIRI|folfiri
5111078|NCT03303495|CPT-11|cpt-11
5111079|NCT03303495|Bevacizumab|bevacizumab
5111080|NCT03303495|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
5111081|NCT03303456|early psychosis|early psychosis
5111082|NCT03303456|clinical high risk|clinical high risk
5111083|NCT03303456|mobile health|mobile health
5111084|NCT03303430|cerebral microembolisation|cerebral microembolisation
5111085|NCT03303430|plaque characteristics|plaque characteristics
5111086|NCT03303417|Kiwifruit|kiwifruit
5111087|NCT03303378|melatonin|melatonin
5111088|NCT03303378|Reperfusion Injury|reperfusion injury
5111089|NCT03303378|myocardial infarction|myocardial infarction
5111090|NCT03303365|Brain Metastases|brain metastases
5111091|NCT03303365|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
5111092|NCT03303365|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
5111093|NCT03303365|CYBER-Knife|cyber-knife
5111094|NCT03303339|PLK1|plk1
5111095|NCT03303339|PLK Inhibitor|plk inhibitor
5111099|NCT03303313|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5111101|NCT03303313|Thrombocytopenia|thrombocytopenia
5111103|NCT03303313|Thrombotic Microangiopathy|thrombotic microangiopathy
5111104|NCT03303313|aHUS|ahus
5111105|NCT03303313|TMA|tma
5111106|NCT03303287|health education|health education
5111107|NCT03303235|methylergonovine|methylergonovine
5111108|NCT03303209|opioid|opioid
5111109|NCT03303209|opioids|opioids
5111110|NCT03303209|taper|taper
5111111|NCT03303209|chronic pain|chronic pain
5111112|NCT03303196|Post-Pancreatectomy Diabetes|post-pancreatectomy diabetes
5111113|NCT03303196|Insulin Therapy|insulin therapy
4996445|NCT04016246|surfactant|surfactant
5111114|NCT03303144|Pharmacokinetics|pharmacokinetics
5111115|NCT03303144|Equivalence|equivalence
5111116|NCT03303118|Hypoxia|hypoxia
5111117|NCT03303118|Brain|brain
5111118|NCT03303118|Cerebral vaso-reactivity|cerebral vaso-reactivity
5111119|NCT03303118|EEG|eeg
5111120|NCT03303118|Concentration performance|concentration performance
5111121|NCT03303118|Cerebral oxygenation|cerebral oxygenation
5111122|NCT03303118|Cerebral blood-flow|cerebral blood-flow
5111123|NCT03303118|Heart rate variability|heart rate variability
5111124|NCT03303066|Myelodysplastic Syndromes|myelodysplastic syndromes
5111125|NCT03303066|Anemia|anemia
5111128|NCT03303053|Hyperthyroidism,Graves disease,Cholestyramine,Prednisolone|hyperthyroidism,graves disease,cholestyramine,prednisolone
5111129|NCT03303040|Mechanical ventilation|mechanical ventilation
5111130|NCT03303040|Diaphragm weakness|diaphragm weakness
5111131|NCT03303040|Difficulty weaning from mechanical ventilation|difficulty weaning from mechanical ventilation
5111133|NCT03303027|Cosmesis|cosmesis
5111134|NCT03303027|Surgical Wound|surgical wound
5111135|NCT03303027|Fast Absorbing Gut|fast absorbing gut
5111136|NCT03303027|Linear Cutaneous Wound|linear cutaneous wound
5111137|NCT03303014|Suture|suture
5111138|NCT03303014|Absorbable|absorbable
5111139|NCT03303014|Non-absorbable|non-absorbable
5111140|NCT03303014|Split wound|split wound
5111141|NCT03303014|Cutaneous Wound|cutaneous wound
5111145|NCT03302988|Wound Edge Eversion|wound edge eversion
5111146|NCT03302988|Dermal Sutures|dermal sutures
5111147|NCT03302975|Running|running
5111148|NCT03302975|Biomechanics|biomechanics
5111149|NCT03302975|Kinetics|kinetics
5111150|NCT03302962|asthma|asthma
5111151|NCT03302962|pediatric|pediatric
5111152|NCT03302962|american indian|american indian
5111153|NCT03302962|children|children
5111154|NCT03302949|Nutritional Supplement|nutritional supplement
5111155|NCT03302949|Health-related Quality of Life|health-related quality of life
5111156|NCT03302949|Dietary Intake|dietary intake
5111157|NCT03302936|Midurethral sling|midurethral sling
5111158|NCT03302936|Pyridium|pyridium
5111159|NCT03302923|Nursing home residents|nursing home residents
5111160|NCT03302923|Brisk walking|brisk walking
5111161|NCT03302910|Acute Heart Failure, Chronic Heart Failure, Heart Failure, Heart conditions, nitroglycerin|acute heart failure, chronic heart failure, heart failure, heart conditions, nitroglycerin
5111162|NCT03302897|Leprosy, vaccine, adjuvant, GLA, GLA-SE|leprosy, vaccine, adjuvant, gla, gla-se
5111163|NCT03302871|cerebral palsy|cerebral palsy
5111164|NCT03302871|botulinum toxin A|botulinum toxin a
5111165|NCT03302871|constraint induced movement therapy|constraint induced movement therapy
5111166|NCT03302871|transcranial direct current stimulation|transcranial direct current stimulation
5111167|NCT03302832|Total Knee Arthroplasty|total knee arthroplasty
5111168|NCT03302832|Total Knee Replacement|total knee replacement
5111169|NCT03302806|disability|disability
5111170|NCT03302806|EDSS|edss
5111171|NCT03302767|Oncology|oncology
5111172|NCT03302767|Work Keeping|work keeping
5111173|NCT03302767|Social difficulties|social difficulties
5111174|NCT03302767|Cognitive Disorders|cognitive disorders
5111175|NCT03302741|stroke|stroke
5111176|NCT03302728|CD 30 positive, relapsed, refractory|cd 30 positive, relapsed, refractory
5111177|NCT03302702|exercise|exercise
5111178|NCT03302702|duration|duration
5111179|NCT03302689|TAP-block|tap-block
5111180|NCT03302689|VAS of pain|vas of pain
5111181|NCT03302689|Cesarean section|cesarean section
5111182|NCT03302689|Postoperative analgesia|postoperative analgesia
5111183|NCT03302676|Saliva substitute|saliva substitute
5111184|NCT03302663|Fetal bone heart abnormality|fetal bone heart abnormality
5111185|NCT03302624|acute kidney injury|acute kidney injury
5111186|NCT03302624|quality of life|quality of life
5111187|NCT03302624|Renal replacement therapy|renal replacement therapy
5111188|NCT03302624|Intensive care unit|intensive care unit
5961984|NCT04283630|Nitrate|nitrate
5111189|NCT03302611|major depressive disorder|major depressive disorder
5111190|NCT03302611|military|military
5111191|NCT03302611|surf therapy|surf therapy
5111192|NCT03302611|hike therapy|hike therapy
5111193|NCT03302611|randomized controlled trial|randomized controlled trial
5111194|NCT03302598|enterocutaneous fistula - C-reactive protein- surgical repair|enterocutaneous fistula - c-reactive protein- surgical repair
5111195|NCT03302585|Optic Neuritis|optic neuritis
5111196|NCT03302585|Vitamin D|vitamin d
5111197|NCT03302572|primary care|primary care
5111198|NCT03302572|advance directives|advance directives
5111199|NCT03302572|randomized controlled trial|randomized controlled trial
5111200|NCT03302533|distal humerus fracture|distal humerus fracture
5111201|NCT03302533|total elbow arthroplasty|total elbow arthroplasty
5111202|NCT03302533|elbow prosthesis|elbow prosthesis
5111203|NCT03302533|delayed arthroplasty|delayed arthroplasty
5111204|NCT03302533|revision surgery|revision surgery
5111205|NCT03302494|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5111206|NCT03302494|Left Atrial Appendage|left atrial appendage
5111208|NCT03302481|liver|liver
5111209|NCT03302481|mitochondria|mitochondria
5111210|NCT03302481|steatosis|steatosis
5111211|NCT03302455|insomia|insomia
5111212|NCT03302455|eCBTI|ecbti
5111213|NCT03302455|internet|internet
5111214|NCT03302455|psychotherapy|psychotherapy
5111215|NCT03302455|guided self-help|guided self-help
5111216|NCT03302455|psychological treatment|psychological treatment
5111217|NCT03302429|Alveolar cleft -Platelet rich fibrin- calcium phosphate|alveolar cleft -platelet rich fibrin- calcium phosphate
5111218|NCT03302377|Feasibility|feasibility
5111219|NCT03302338|Feeding intolerance|feeding intolerance
5111223|NCT03302312|Posttraumatic Stress Disorder|posttraumatic stress disorder
5111224|NCT03302312|Generalized Anxiety Disorder|generalized anxiety disorder
5111225|NCT03302312|Depression|depression
5111226|NCT03302312|Distress|distress
5111227|NCT03302312|Alcohol Use|alcohol use
5111228|NCT03302312|Pain|pain
5111229|NCT03302299|Adherence|adherence
5111230|NCT03302299|Hepatotoxicity|hepatotoxicity
5111231|NCT03302299|Phosphatidtylethanol|phosphatidtylethanol
5111232|NCT03302286|Heart-Lung Machine|heart-lung machine
5111233|NCT03302286|Cardiopulmonary Bypass|cardiopulmonary bypass
5111236|NCT03302260|maternal health|maternal health
5111237|NCT03302260|pregnancy|pregnancy
5111238|NCT03302260|pre-eclampsia|pre-eclampsia
5111239|NCT03302234|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5111240|NCT03302234|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5111241|NCT03302234|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
5111242|NCT03302234|PD1|pd1
5111243|NCT03302234|PD-1|pd-1
5111244|NCT03302234|PDL1|pdl1
5111245|NCT03302234|PD-L1|pd-l1
5111246|NCT03302234|CTLA4|ctla4
5111247|NCT03302208|General Anesthesia|general anesthesia
5111248|NCT03302195|Heparin|heparin
5111249|NCT03302195|Allogeneic blood product transfusions|allogeneic blood product transfusions
5111250|NCT03302195|Bleeding|bleeding
5111251|NCT03302195|Cardiac surgery|cardiac surgery
5111252|NCT03302195|Obesity|obesity
5111253|NCT03302169|Prostate Cancer|prostate cancer
5111254|NCT03302169|Urinary incontinence|urinary incontinence
5111255|NCT03302169|Radical prostatectomy|radical prostatectomy
5111256|NCT03302169|Rhabdosphincter|rhabdosphincter
5111257|NCT03302169|Robotic Surgery|robotic surgery
5111258|NCT03302156|Uterine cancer|uterine cancer
5111259|NCT03302156|Ovarian cancer|ovarian cancer
5111260|NCT03302156|Hysterectomy|hysterectomy
5111261|NCT03302156|Salpingo-oophorectomy|salpingo-oophorectomy
5111262|NCT03302143|Dental Implant|dental implant
5111263|NCT03302143|Guided Bone Regeneration|guided bone regeneration
5111264|NCT03302143|Contour Augmentation|contour augmentation
5111265|NCT03302117|Wood smoke|wood smoke
5111266|NCT03302117|Bronchoscopy|bronchoscopy
5111267|NCT03302065|inhalation|inhalation
5111268|NCT03302065|anticholinergic|anticholinergic
5111269|NCT03302026|nicotine treatment|nicotine treatment
5111270|NCT03302026|real time fMRI|real time fmri
5111271|NCT03302013|Arthroplasty|arthroplasty
5111272|NCT03302013|Knee|knee
5111273|NCT03302013|Bicruciate retaining|bicruciate retaining
5111274|NCT03302013|Vanguard XP|vanguard xp
5111275|NCT03302013|Vanguard CR|vanguard cr
5111276|NCT03302013|Surgery|surgery
5111277|NCT03302013|Zimmer Biomet|zimmer biomet
5111278|NCT03302013|Joint Replacement|joint replacement
5111279|NCT03302013|Osteoarthritis|osteoarthritis
5111280|NCT03302000|prematurity|prematurity
5111281|NCT03302000|sensory stimulation|sensory stimulation
5111282|NCT03302000|rehabilitation|rehabilitation
5111283|NCT03302000|infant|infant
5111284|NCT03301961|Circulating Tumor DNA|circulating tumor dna
5111285|NCT03301961|Early diagnosis|early diagnosis
5111286|NCT03301961|Surveillance|surveillance
5111287|NCT03301961|Methylation|methylation
5111288|NCT03301961|Somatic mutation|somatic mutation
5111289|NCT03301935|Risk assessment|risk assessment
5111290|NCT03301922|Occupational Health Services|occupational health services
5111291|NCT03301922|Metacognitive therapy|metacognitive therapy
5111589|NCT03300011|ultrasonic|ultrasonic
5111296|NCT03301896|PDR001|pdr001
5111297|NCT03301896|intratumoral injection|intratumoral injection
5111298|NCT03301896|abscopal|abscopal
5111299|NCT03301896|checkpoint inhibitor|checkpoint inhibitor
5111300|NCT03301896|programmed cell death|programmed cell death
5111301|NCT03301896|PD-1|pd-1
5111302|NCT03301896|TLR-7|tlr-7
5111303|NCT03301896|toll-like receptor|toll-like receptor
5111304|NCT03301896|melanoma|melanoma
5111305|NCT03301896|head and neck|head and neck
5111306|NCT03301831|Parents|parents
5111307|NCT03301831|Technology-Dependent Child|technology-dependent child
5111308|NCT03301831|Resourcefulness|resourcefulness
5111309|NCT03301792|Group prenatal care|group prenatal care
5111310|NCT03301792|Diabetes|diabetes
5111311|NCT03301779|Red Blood Cells|red blood cells
5111312|NCT03301766|lidocaine|lidocaine
5111313|NCT03301740|Ultrafiltration profiling|ultrafiltration profiling
5111314|NCT03301740|Hemodialysis|hemodialysis
5111315|NCT03301740|Dialysis|dialysis
5111316|NCT03301740|Cardiovascular outcomes|cardiovascular outcomes
5111317|NCT03301740|Patient-reported outcomes|patient-reported outcomes
5111318|NCT03301740|Crossover study design|crossover study design
5111319|NCT03301740|End Stage Renal Disease|end stage renal disease
5111320|NCT03301740|Ultrafiltration|ultrafiltration
5111321|NCT03301740|Echocardiogram|echocardiogram
5111322|NCT03301740|Blood pressure|blood pressure
5111324|NCT03301740|Symptoms|symptoms
5111325|NCT03301714|motivational interviewing|motivational interviewing
5111327|NCT03301714|oral health|oral health
5111328|NCT03301688|PD-1 antibody|pd-1 antibody
5111329|NCT03301688|phase 1 trial|phase 1 trial
5111330|NCT03301675|Orange juice|orange juice
5111331|NCT03301675|Healthy diet|healthy diet
5111332|NCT03301675|Metabolic syndrome|metabolic syndrome
5111333|NCT03301675|Cardiometabolic risk factors|cardiometabolic risk factors
5111334|NCT03301675|Body composition|body composition
5111335|NCT03301662|atrial fibrillation|atrial fibrillation
5111336|NCT03301662|cryptogenic stroke|cryptogenic stroke
5111337|NCT03301662|ECG screening|ecg screening
5108564|NCT03319459|Non small cell lung cancer|non small cell lung cancer
5111340|NCT03301662|stroke|stroke
5111341|NCT03301662|thumb-ECG|thumb-ecg
5111342|NCT03301636|Melanoma, Metastaic Melanoma|melanoma, metastaic melanoma
5111343|NCT03301623|Clinical Decision Support|clinical decision support
5111344|NCT03301623|Patient Education Materials|patient education materials
5111345|NCT03301623|Opioid Use|opioid use
5111346|NCT03301623|Chronic Noncancer Pain|chronic noncancer pain
5111347|NCT03301610|Pain Education|pain education
5111348|NCT03301610|Information Delivery|information delivery
5111349|NCT03301610|Mobile Application|mobile application
5111350|NCT03301597|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
5111351|NCT03301597|Bacterial Infections|bacterial infections
5111352|NCT03301597|Fungal Infections|fungal infections
5111353|NCT03301584|Hip fracture|hip fracture
5111354|NCT03301584|ADL|adl
5111355|NCT03301584|patient participation|patient participation
5111356|NCT03301584|functional balance|functional balance
5111357|NCT03301584|physical performance|physical performance
5111358|NCT03301571|Coronary artery bypass graft|coronary artery bypass graft
5111359|NCT03301571|Echocardiography|echocardiography
5111360|NCT03301545|Bariatric surgery|bariatric surgery
5111361|NCT03301545|Obesity|obesity
5111362|NCT03301545|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5111363|NCT03301545|Indigenous Population|indigenous population
5111364|NCT03301545|Randomized Control Trial|randomized control trial
5111365|NCT03301545|Glycoslyated Hemoglobin A1C|glycoslyated hemoglobin a1c
5111366|NCT03301545|Anthropometric measurements|anthropometric measurements
5111367|NCT03301545|Medication Use|medication use
5111368|NCT03301532|G1D, glucose, transporter|g1d, glucose, transporter
5111369|NCT03301506|PBC|pbc
5111370|NCT03301506|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
5111371|NCT03301467|C3 Glomerulonephritis|c3 glomerulonephritis
5111372|NCT03301467|C3 glomerulopathy|c3 glomerulopathy
5111373|NCT03301467|C3G|c3g
5111374|NCT03301467|DDD|ddd
5111375|NCT03301467|dense deposit disease|dense deposit disease
5111376|NCT03301467|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
5111377|NCT03301467|MPGN|mpgn
5111378|NCT03301467|C3GN|c3gn
5111379|NCT03301467|idiopathic MPGN|idiopathic mpgn
5111380|NCT03301441|migraine|migraine
5111381|NCT03301441|migraine with aura|migraine with aura
5111382|NCT03301441|migraine without aura|migraine without aura
5111383|NCT03301441|ischemic stroke|ischemic stroke
5111384|NCT03301441|Mismatch|mismatch
5111388|NCT03301337|Amino acid uptake|amino acid uptake
5111389|NCT03301337|Aging|aging
5111390|NCT03301337|Meat protein|meat protein
5111391|NCT03301324|intubation|intubation
5111392|NCT03301272|Parkinson, Botox, Tremor|parkinson, botox, tremor
5111393|NCT03301259|Necrotic pulp|necrotic pulp
5111394|NCT03301259|wave-one|wave-one
5111395|NCT03301259|one-shape|one-shape
5111396|NCT03301259|periapical lesion|periapical lesion
5111397|NCT03301194|Hypertension|hypertension
5111398|NCT03301194|Effectiveness|effectiveness
5111399|NCT03301194|Cost Effectiveness|cost effectiveness
5111400|NCT03301194|Cost|cost
5111401|NCT03301194|Multi-disciplinary|multi-disciplinary
5111402|NCT03301194|Risk Stratification|risk stratification
5111403|NCT03301168|ALL|all
5111404|NCT03301168|AML|aml
5111405|NCT03301168|hematologic neoplasms|hematologic neoplasms
5111406|NCT03301168|hematologic malignancies|hematologic malignancies
5111407|NCT03301168|primary immune deficiences|primary immune deficiences
5111408|NCT03301168|allogeneic stem cell transplant|allogeneic stem cell transplant
5111409|NCT03301142|urinary stress incontinence|urinary stress incontinence
5111410|NCT03301142|urinary incontinence,stress|urinary incontinence,stress
5111411|NCT03301142|laser|laser
5111412|NCT03301142|physiotherapy|physiotherapy
5111413|NCT03301142|kinesiotherapy|kinesiotherapy
5111414|NCT03301116|Exercise|exercise
5111415|NCT03301116|Frail Elderly|frail elderly
5111416|NCT03301116|Homebound Persons|homebound persons
5111417|NCT03301116|Activities of Daily Living|activities of daily living
5111418|NCT03301116|Mobility Limitation|mobility limitation
5111419|NCT03301116|Home Care Services|home care services
5111420|NCT03301116|Long-Term Care|long-term care
5111421|NCT03301116|Dual MEDICAID MEDICARE Eligibility|dual medicaid medicare eligibility
5111422|NCT03301103|Nutrition|nutrition
5111423|NCT03301103|Gastroenteritis|gastroenteritis
5111424|NCT03301103|Traveler's diarrhea|traveler's diarrhea
5111425|NCT03301103|E. coli|e. coli
5111426|NCT03301090|Adults|adults
5111427|NCT03301090|Evaluate|evaluate
5111428|NCT03301090|Healthy|healthy
5111429|NCT03301090|Immunogenicity|immunogenicity
5111430|NCT03301090|MERS-CoV|mers-cov
5111431|NCT03301090|Pharmacokinetics|pharmacokinetics
5111432|NCT03301090|Phase I|phase i
5111433|NCT03301090|Placebo|placebo
5111434|NCT03301090|REGN MERS|regn mers
5111435|NCT03301090|Safety|safety
5111436|NCT03301090|Tolerability|tolerability
5111437|NCT03301077|children and adolescents|children and adolescents
5111438|NCT03301077|mental health|mental health
5111439|NCT03301077|epidemiology|epidemiology
5111440|NCT03301077|psychiatric disorders|psychiatric disorders
5111441|NCT03301064|alcohol, intervention, Latino, community|alcohol, intervention, latino, community
5111442|NCT03301051|Influenza|influenza
5111443|NCT03301051|Human|human
5111444|NCT03301051|RNA Virus Infections|rna virus infections
5111445|NCT03301051|Efficacy|efficacy
5111446|NCT03301051|Immunologic|immunologic
5111447|NCT03301051|Immunogenic Factors|immunogenic factors
5111448|NCT03301051|Physiological Effects of Drug|physiological effects of drug
5111449|NCT03301051|Virus Diseases|virus diseases
5111450|NCT03301051|Orthomyxoviridae Infections|orthomyxoviridae infections
5111451|NCT03301051|Infection|infection
5111452|NCT03301038|hypercalcemia|hypercalcemia
5111453|NCT03301038|nephrocalcinosis|nephrocalcinosis
5111454|NCT03301038|CYP24A1|cyp24a1
5111455|NCT03301038|hypercalciuria|hypercalciuria
5111456|NCT03301025|Pregabalin, hypotensive anesthesia, blood loss, analgesia|pregabalin, hypotensive anesthesia, blood loss, analgesia
5111457|NCT03301012|Adolescent|adolescent
5111458|NCT03301012|Relapse Prevention|relapse prevention
5111459|NCT03301012|Smartphone|smartphone
5111460|NCT03301012|Recovery Support|recovery support
5111461|NCT03300999|ginger tea|ginger tea
5111462|NCT03300973|urodynamic study|urodynamic study
5111463|NCT03300973|stress urinary incontinence|stress urinary incontinence
5111464|NCT03300882|Study co-enrollment (CTOT-20 and CTOT-22)|study co-enrollment (ctot-20 and ctot-22)
5111465|NCT03300882|cytomegalovirus (CMV)|cytomegalovirus (cmv)
5111466|NCT03300882|CMV seropositive positive recipient|cmv seropositive positive recipient
5111467|NCT03300882|CMV infection|cmv infection
5111468|NCT03300882|CMV-specific immunity|cmv-specific immunity
5111469|NCT03300882|immunologic monitoring|immunologic monitoring
5111470|NCT03300869|Spinal Muscular Atrophy|spinal muscular atrophy
5111471|NCT03300869|Natural History|natural history
5111472|NCT03300856|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5111473|NCT03300856|Electrophysiology|electrophysiology
5111474|NCT03300843|Cell Therapy|cell therapy
5111475|NCT03300843|Immunotherapy|immunotherapy
5111476|NCT03300843|Vaccines|vaccines
5111477|NCT03300830|Immunodeficiency|immunodeficiency
5111478|NCT03300830|Viral-Associated Cancer|viral-associated cancer
5111479|NCT03300830|Kaposi Sarcoma Herpes Virus|kaposi sarcoma herpes virus
5111480|NCT03300830|Idiopathic Castleman Disease|idiopathic castleman disease
5111481|NCT03300830|Endogenous Retroviruses|endogenous retroviruses
5111483|NCT03300791|heart failure|heart failure
5111484|NCT03300791|readmission|readmission
5111485|NCT03300791|predictive models|predictive models
5111486|NCT03300778|neurocognition|neurocognition
5111487|NCT03300778|high-risk|high-risk
5111488|NCT03300778|prognosis|prognosis
5111489|NCT03300765|Thyroid Cancer|thyroid cancer
5111490|NCT03300765|Apatinib|apatinib
5111895|NCT03297931|Appetite|appetite
5111494|NCT03300713|Pediatrician training|pediatrician training
5111497|NCT03300583|Interstitial lung disease|interstitial lung disease
5111498|NCT03300583|Self-Management|self-management
5111499|NCT03300583|Service provision|service provision
5111500|NCT03300531|Pure Platelet-rich Plasma|pure platelet-rich plasma
5111501|NCT03300531|Randomized Controlled Trial|randomized controlled trial
5111502|NCT03300518|GnRH antagonist|gnrh antagonist
5111503|NCT03300518|Estrogen pretreatment|estrogen pretreatment
5111504|NCT03300518|Poor response patient|poor response patient
5111505|NCT03300492|Natural Killer cells|natural killer cells
5111506|NCT03300492|NK cells|nk cells
5111507|NCT03300492|Immunotherapy|immunotherapy
5111508|NCT03300492|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5111509|NCT03300479|nontraumatic intracerebral hemorrhage|nontraumatic intracerebral hemorrhage
5111510|NCT03300479|Cleviprex®|cleviprex®
5111511|NCT03300479|Ebrantil®|ebrantil®
5111512|NCT03300479|Systolic blood pressure|systolic blood pressure
5111513|NCT03300466|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
5111514|NCT03300427|Heart failure with reduced left ventricular ejection fraction|heart failure with reduced left ventricular ejection fraction
5111516|NCT03300427|Cardiac dysfunction|cardiac dysfunction
5111517|NCT03300427|Heart muscle dysfunction|heart muscle dysfunction
5111518|NCT03300427|Left ventricular (LV) dilation|left ventricular (lv) dilation
5111519|NCT03300427|Left ventricular hypertrophy|left ventricular hypertrophy
5111521|NCT03300427|AHF|ahf
5111522|NCT03300427|CHF|chf
5111523|NCT03300427|CCF|ccf
5111529|NCT03300388|Exercise|exercise
5111530|NCT03300388|Omega-3 fatty acids|omega-3 fatty acids
5111531|NCT03300388|Adipose tissue|adipose tissue
5111532|NCT03300349|Breast cancer|breast cancer
5111533|NCT03300349|Breast cancer-related lymphedema|breast cancer-related lymphedema
5111534|NCT03300349|Shoulder injury|shoulder injury
5111535|NCT03300349|Prevention|prevention
5111536|NCT03300349|Educational activity|educational activity
5111537|NCT03300349|Physiotherapy|physiotherapy
5111539|NCT03300336|Inpatients|inpatients
5111540|NCT03300336|Veterans|veterans
5111541|NCT03300336|Early Ambulation|early ambulation
5111542|NCT03300336|Quality of Life|quality of life
5111543|NCT03300323|peri-operative|peri-operative
5111544|NCT03300323|fluid|fluid
5111545|NCT03300323|microcirculation|microcirculation
5111550|NCT03300297|Temporomandibular Disorders|temporomandibular disorders
5111554|NCT03300219|telerehabilitation|telerehabilitation
5111555|NCT03300219|occupational therapy|occupational therapy
5111557|NCT03300219|participation|participation
5111558|NCT03300219|quality of life|quality of life
5111559|NCT03300219|intervention|intervention
5111560|NCT03300219|older adults|older adults
5111561|NCT03300206|Breast Biopsy|breast biopsy
5111562|NCT03300206|Breast Biopsy Imaging|breast biopsy imaging
5111563|NCT03300206|Stereotactic Biopsy|stereotactic biopsy
5111564|NCT03300193|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
5111565|NCT03300193|Tremor|tremor
5111566|NCT03300193|Essential Tremor|essential tremor
5111567|NCT03300193|Parkinson's Disease|parkinson's disease
5111568|NCT03300154|Cardiovascular risk|cardiovascular risk
5111569|NCT03300154|Behavioral economics|behavioral economics
5111570|NCT03300154|Text messages|text messages
5111571|NCT03300154|Financial incentives|financial incentives
5111572|NCT03300141|Upper Extremity|upper extremity
5111573|NCT03300141|Rehabilitation|rehabilitation
5111574|NCT03300141|Arm|arm
5111575|NCT03300141|Robotics|robotics
5111576|NCT03300141|Stroke Rehabilitation|stroke rehabilitation
5111577|NCT03300141|Virtual Reality Thearpy|virtual reality thearpy
5111578|NCT03300128|autism|autism
5111579|NCT03300128|parenting|parenting
5111580|NCT03300128|Incredible Years|incredible years
5111581|NCT03300102|personalised medicine|personalised medicine
5111582|NCT03300050|live attenuated influenza vaccine|live attenuated influenza vaccine
5111583|NCT03300050|inactivated influenza vaccine|inactivated influenza vaccine
5111584|NCT03300024|Hemodialysis|hemodialysis
5111585|NCT03300024|Arteriovenous|arteriovenous
5111586|NCT03300024|Graft|graft
5111587|NCT03300024|polytetrafluoroethylene|polytetrafluoroethylene
5111590|NCT03300011|chronic total occlusion|chronic total occlusion
5111591|NCT03300011|heart function|heart function
5111592|NCT03299985|Gastroesophageal reflux Disease|gastroesophageal reflux disease
5111593|NCT03299985|Myofascial release|myofascial release
5111594|NCT03299985|Diaphragm|diaphragm
5111595|NCT03299972|Sarcopenia|sarcopenia
5111596|NCT03299972|Resistance exercise|resistance exercise
5111597|NCT03299972|Protein|protein
5111598|NCT03299946|Nivolumab|nivolumab
5111599|NCT03299946|Cabozantinib|cabozantinib
5111600|NCT03299946|Neoadjuvant|neoadjuvant
5111601|NCT03299946|Immunotherapy|immunotherapy
5111602|NCT03299946|Liver Cancer|liver cancer
5111603|NCT03299946|Borderline Resectable|borderline resectable
5111604|NCT03299946|Advance Resectable|advance resectable
5111605|NCT03299946|Neoplasms|neoplasms
5111606|NCT03299946|Hepatocellular Carcinoma|hepatocellular carcinoma
5111607|NCT03299946|HCC|hcc
5111608|NCT03299946|Resection|resection
5111609|NCT03299894|Sepsis|sepsis
5111610|NCT03299894|Shock, septic|shock, septic
5111611|NCT03299894|Emergency service, hospital|emergency service, hospital
5111612|NCT03299894|Anti-infective agents|anti-infective agents
5111613|NCT03299894|Outcome assessment|outcome assessment
5111614|NCT03299868|Peripherally inserted central catheter|peripherally inserted central catheter
5111615|NCT03299868|Terminally ill cancer patients|terminally ill cancer patients
5111616|NCT03299868|Palliative care|palliative care
5111617|NCT03299855|oncogeriatric|oncogeriatric
5111618|NCT03299855|MMS|mms
5111619|NCT03299855|MoCA|moca
5111620|NCT03299842|seizure|seizure
5111621|NCT03299842|tonic clonic|tonic clonic
5111622|NCT03299842|epilepsy|epilepsy
5111623|NCT03299842|myoclonic|myoclonic
5111624|NCT03299842|encephalopathy|encephalopathy
5111625|NCT03299829|trientine|trientine
5111626|NCT03299829|Wilson's disease|wilson's disease
5111627|NCT03299816|Chronic Kidney Disease|chronic kidney disease
5111628|NCT03299816|Hypertension|hypertension
5111629|NCT03299816|Albuminuria|albuminuria
5111630|NCT03299816|African Americans|african americans
5111631|NCT03299790|Type 2 diabetes|type 2 diabetes
5111632|NCT03299790|Diabetic cardiomyopathy|diabetic cardiomyopathy
5111633|NCT03299790|Cardiac function|cardiac function
5111634|NCT03299790|Exercise echocardiography|exercise echocardiography
5111635|NCT03299790|Exercise training|exercise training
5111636|NCT03299751|neonatal sepsis|neonatal sepsis
5111637|NCT03299751|biomarker combination|biomarker combination
5111638|NCT03299751|diagnostic|diagnostic
5111639|NCT03299751|antibiotic use|antibiotic use
5111640|NCT03299751|newborn|newborn
5111641|NCT03299751|preterm neonates|preterm neonates
5111642|NCT03299751|NICU|nicu
5111643|NCT03299686|Asthma, allergic, eosinophilic, non-T2 high|asthma, allergic, eosinophilic, non-t2 high
5111644|NCT03299647|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5111645|NCT03299647|behavioral deficits|behavioral deficits
5111646|NCT03299647|cognitive function|cognitive function
5111647|NCT03299647|polyunsaturated fatty acids|polyunsaturated fatty acids
5111648|NCT03299647|visual memory|visual memory
5111649|NCT03299582|paclitaxel|paclitaxel
5111650|NCT03299582|neuropathy|neuropathy
5111651|NCT03299582|hypothermia|hypothermia
5111652|NCT03299582|cryocompression|cryocompression
5111653|NCT03299556|Wearable Health Technology|wearable health technology
5111655|NCT03299556|Apple Watch|apple watch
5111656|NCT03299556|Pain Medication|pain medication
5111657|NCT03299543|beta-hydroxybutyrate|beta-hydroxybutyrate
5111658|NCT03299543|breath acetone|breath acetone
5111659|NCT03299530|Corneal Astigmatism|corneal astigmatism
5111660|NCT03299530|Scheimpflug|scheimpflug
5111661|NCT03299530|pupil size|pupil size
5111662|NCT03299530|Toric|toric
5111663|NCT03299517|lidocaine|lidocaine
5111664|NCT03299517|amiodarone|amiodarone
5111665|NCT03299491|Maternity Waiting Area|maternity waiting area
5111666|NCT03299491|Ethiopia|ethiopia
5111667|NCT03299491|Community Leader|community leader
5111668|NCT03299491|Religious Leader|religious leader
5111669|NCT03299491|Skilled birth attendance|skilled birth attendance
5111670|NCT03299491|Postnatal care|postnatal care
5111671|NCT03299491|Information, Education, Communication|information, education, communication
5111672|NCT03299491|Safe Motherhood|safe motherhood
5111673|NCT03299491|Health Extension Worker|health extension worker
5111674|NCT03299491|Antenatal Care|antenatal care
5111675|NCT03299465|bone marrow transplantation|bone marrow transplantation
5111676|NCT03299465|yoga|yoga
5111677|NCT03299452|ex vivo high-throughput drug screening assay|ex vivo high-throughput drug screening assay
5111678|NCT03299426|Typhoid|typhoid
5111679|NCT03299426|Typhoid in Malawi|typhoid in malawi
5111680|NCT03299426|Typhoid Vaccine|typhoid vaccine
5111681|NCT03299413|Inflammatory Bowel Disease|inflammatory bowel disease
5111682|NCT03299413|Mesenchymal stem cells|mesenchymal stem cells
5111683|NCT03299413|Ulcerative colitis|ulcerative colitis
5111684|NCT03299413|Neutrophils|neutrophils
5111685|NCT03299400|IOP|iop
5111686|NCT03299387|urinary tract|urinary tract
5111687|NCT03299387|infection|infection
5111688|NCT03299387|recurrent|recurrent
5111689|NCT03299387|women|women
5111690|NCT03299374|Pilates|pilates
5111691|NCT03299374|Balance|balance
5111692|NCT03299374|Falls|falls
5111702|NCT03299322|Bronchial Asthma，TCM，microorganism|bronchial asthma，tcm，microorganism
5111710|NCT03299296|Thromboprophylaxis|thromboprophylaxis
5111711|NCT03299296|orthopedic|orthopedic
5111712|NCT03299296|rivaroxaban|rivaroxaban
5111713|NCT03299296|enoxaparin|enoxaparin
5111714|NCT03299270|Surgery|surgery
5111715|NCT03299270|Solid malignancy|solid malignancy
5111716|NCT03299270|Elderly|elderly
5111717|NCT03299270|Functional recovery|functional recovery
5111718|NCT03299257|OSA|osa
5111719|NCT03299257|CPAP|cpap
5111720|NCT03299257|sleepiness|sleepiness
5111721|NCT03299257|donepezil|donepezil
5111722|NCT03299231|COPD|copd
5111723|NCT03299231|acute exacerbation|acute exacerbation
5111724|NCT03299231|OPEP|opep
5111725|NCT03299218|Specialized Nutritious Food (SNF)|specialized nutritious food (snf)
5111726|NCT03299218|Social and Behaviour change communication (SBCC)|social and behaviour change communication (sbcc)
5111727|NCT03299218|Cash-based transfers|cash-based transfers
5111728|NCT03299140|Bipolar disorder|bipolar disorder
5111729|NCT03299140|Children|children
5111730|NCT03299140|Family Focused Therapy|family focused therapy
5111732|NCT03299114|Neuropathic Pain|neuropathic pain
5111733|NCT03299114|Whirlpool|whirlpool
5111734|NCT03299114|Osteoarthritis|osteoarthritis
4983060|NCT04098068|POLE|pole
5111735|NCT03299114|Sleep|sleep
5111736|NCT03299101|Frailty|frailty
5111737|NCT03299101|Prehabilitation|prehabilitation
5111738|NCT03299101|Exercise therapy|exercise therapy
5111739|NCT03299101|Surgery|surgery
5111740|NCT03299101|Nutrition support|nutrition support
5111741|NCT03299075|External eating|external eating
5111742|NCT03299075|Technology|technology
5111743|NCT03299075|Photography|photography
5111744|NCT03299075|Social media|social media
5111745|NCT03299049|Long acting Cabotegravir|long acting cabotegravir
5111746|NCT03299049|Safety|safety
5111747|NCT03299049|HIV-1|hiv-1
5111748|NCT03299049|Efficacy|efficacy
5111749|NCT03299049|Tolerability|tolerability
5111750|NCT03299049|ATLAS-2M|atlas-2m
5111751|NCT03299049|Long acting Rilpivirine|long acting rilpivirine
5111752|NCT03299036|Hepatoma|hepatoma
5111753|NCT03299036|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
5111754|NCT03299036|Microsphere|microsphere
5111755|NCT03299036|Doxorubicin|doxorubicin
5111756|NCT03299023|Obstructive Sleep Apnea|obstructive sleep apnea
5111757|NCT03299023|Orthodontics|orthodontics
5111758|NCT03299023|Tooth Movement|tooth movement
5111759|NCT03299023|Medibyte|medibyte
5111760|NCT03299023|Apnea|apnea
5111761|NCT03299023|Hypopnea|hypopnea
5111762|NCT03299023|Sleep|sleep
5111763|NCT03299023|Disturbed Breathing|disturbed breathing
5111764|NCT03299010|Diabetes Mellitus|diabetes mellitus
5111765|NCT03299010|Risk|risk
5111766|NCT03299010|Complications|complications
5111782|NCT03298932|Aortic valve replacement|aortic valve replacement
5111783|NCT03298932|2D strain of right ventricle|2d strain of right ventricle
5111784|NCT03298893|cervical cancer|cervical cancer
5111786|NCT03298893|cisplatin|cisplatin
5111787|NCT03298893|radiotherapy|radiotherapy
5111788|NCT03298880|Valsalva manoeuvre|valsalva manoeuvre
5111789|NCT03298880|Vagal tone|vagal tone
5111790|NCT03298880|Modified Valsalva|modified valsalva
5111791|NCT03298880|Valsalva Assist Device|valsalva assist device
5111792|NCT03298867|Proptosis|proptosis
5111793|NCT03298867|Human monoclonal antibody|human monoclonal antibody
5111794|NCT03298867|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
5111795|NCT03298867|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
5111796|NCT03298867|Hyperthyroidism|hyperthyroidism
5111896|NCT03297931|Food intake|food intake
5111800|NCT03298802|hydrochlorothiazide|hydrochlorothiazide
5111801|NCT03298789|static stretching|static stretching
5111802|NCT03298789|muscle power|muscle power
5111803|NCT03298789|countermovement jump|countermovement jump
5111804|NCT03298789|dynamometry|dynamometry
5111805|NCT03298789|warm up|warm up
5111806|NCT03298789|force plate|force plate
5111807|NCT03298750|Mechanical Laboratory Ovarian Stimulation Poor responders|mechanical laboratory ovarian stimulation poor responders
5111808|NCT03298711|Central Nervous System Sensitization|central nervous system sensitization
5111809|NCT03298711|Neuropeptides|neuropeptides
5111810|NCT03298698|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5111811|NCT03298698|Minimal change disease|minimal change disease
5111812|NCT03298698|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5111813|NCT03298698|Rituximab|rituximab
5111814|NCT03298698|Randomized clinical trial|randomized clinical trial
5111815|NCT03298685|transition|transition
5111816|NCT03298685|care program|care program
5111817|NCT03298685|needs|needs
5111818|NCT03298672|Alzheimer's Disease|alzheimer's disease
5111819|NCT03298672|Dementia|dementia
5111820|NCT03298672|Brain Diseases|brain diseases
5111821|NCT03298672|Central Nervous System Diseases|central nervous system diseases
5111822|NCT03298672|Cognition|cognition
5111823|NCT03298672|Neurodegenerative Diseases|neurodegenerative diseases
5111824|NCT03298672|Neurocognitive Disorders|neurocognitive disorders
5111825|NCT03298672|Mental Disorders|mental disorders
5111826|NCT03298633|Male infertility|male infertility
5111827|NCT03298633|In vitro fertilization|in vitro fertilization
5111828|NCT03298633|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5111829|NCT03298620|nursing home|nursing home
5111830|NCT03298620|gerodontology|gerodontology
5111831|NCT03298620|oral hygiene|oral hygiene
5111832|NCT03298568|food intolerance|food intolerance
5111833|NCT03298568|histamine intolerance|histamine intolerance
5111834|NCT03298568|diamine oxidase|diamine oxidase
5111835|NCT03298568|DAO|dao
5111836|NCT03298568|DAOsin|daosin
5111837|NCT03298529|Glycemic index|glycemic index
5111838|NCT03298529|Insulinemic index|insulinemic index
5111839|NCT03298529|Traditional egg pasta|traditional egg pasta
5111840|NCT03298503|Parkinson's disease|parkinson's disease
5111841|NCT03298503|posture balance|posture balance
5111842|NCT03298503|attention|attention
5111843|NCT03298490|validity|validity
5111844|NCT03298490|reliability|reliability
5111845|NCT03298490|low back pain|low back pain
5111847|NCT03298399|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
5111848|NCT03298399|Haploidentical|haploidentical
5111849|NCT03298399|Mesenchymal stromal cells|mesenchymal stromal cells
5111851|NCT03298386|Multimorbidity|multimorbidity
5961985|NCT04283630|Vitamin C|vitamin c
5111852|NCT03298386|Polypharmacy|polypharmacy
5111853|NCT03298373|Healthy Men|healthy men
5111854|NCT03298373|Male Contraception|male contraception
5111855|NCT03298373|Androgen|androgen
5111856|NCT03298360|HIV cell reservoir|hiv cell reservoir
5111857|NCT03298295|Diabetes Mellitus|diabetes mellitus
5111858|NCT03298295|Insulin Pump Therapy|insulin pump therapy
5111859|NCT03298295|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5111864|NCT03298217|Inspiratory flow|inspiratory flow
5111865|NCT03298217|High flow nasal cannula, spirometry|high flow nasal cannula, spirometry
5111866|NCT03298217|spirometry|spirometry
5111867|NCT03298217|physiologic study|physiologic study
5111868|NCT03298217|Bronchiolitis patients sverity score mWCAS/ 3-5.|bronchiolitis patients sverity score mwcas/ 3-5.
5111870|NCT03298178|TAVI|tavi
5111871|NCT03298178|SAVR|savr
5111872|NCT03298152|lithium disilicate endocrowns|lithium disilicate endocrowns
5111873|NCT03298152|cerasmart endocrowns|cerasmart endocrowns
5111874|NCT03298126|Radial artery occlusion|radial artery occlusion
5111875|NCT03298126|TR band|tr band
5111876|NCT03298126|Transradial catheterization|transradial catheterization
5111877|NCT03298087|oligometastatic|oligometastatic
5111878|NCT03298087|SBRT|sbrt
5111879|NCT03298087|abiraterone|abiraterone
5111880|NCT03298087|apalutamide|apalutamide
5111881|NCT03298074|platinum-resistant|platinum-resistant
5111882|NCT03298074|recurrent|recurrent
5111883|NCT03298061|Eosinophilic Granulomatosis|eosinophilic granulomatosis
5111884|NCT03298061|MEA115921|mea115921
5111885|NCT03298061|Polyangiitis|polyangiitis
5111886|NCT03298061|Long-term access program|long-term access program
5111887|NCT03298061|mepolizumab|mepolizumab
5111888|NCT03298022|Ulcerative Colitis|ulcerative colitis
5111889|NCT03297983|M7583|m7583
5111890|NCT03297983|Healthy Subjects|healthy subjects
5111891|NCT03297983|Cross-over|cross-over
5111892|NCT03297931|Pulse|pulse
5111893|NCT03297931|Snack|snack
5111894|NCT03297931|Post-prandial glycemia|post-prandial glycemia
5111897|NCT03297931|Young adults|young adults
5111898|NCT03297931|Satiety|satiety
5111899|NCT03297905|Chronic Pain|chronic pain
5111900|NCT03297905|Military|military
5111901|NCT03297853|Descriptive|descriptive
5111902|NCT03297853|Support|support
5111903|NCT03297853|Retrospective|retrospective
5111904|NCT03297853|survey|survey
5111905|NCT03297827|diagnosis|diagnosis
5111906|NCT03297827|inflammatory biomarkers|inflammatory biomarkers
5111907|NCT03297827|cytokines|cytokines
5111908|NCT03297827|interleukin|interleukin
5111909|NCT03297827|interferons|interferons
5111910|NCT03297814|Peripheral arterial disease|peripheral arterial disease
5111911|NCT03297814|Platelet lysate|platelet lysate
5111912|NCT03297788|SCLC|sclc
5111913|NCT03297788|Brain Metastases|brain metastases
5111914|NCT03297788|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
5111915|NCT03297788|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
5111916|NCT03297775|Rheumatoid Arthritis|rheumatoid arthritis
5111917|NCT03297775|RA|ra
5111918|NCT03297775|Interstitial Lung Disease|interstitial lung disease
5111919|NCT03297775|ILD|ild
5111920|NCT03297775|lung disease|lung disease
5111921|NCT03297775|connective tissue disease|connective tissue disease
5111922|NCT03297775|CTD|ctd
5111923|NCT03297775|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5111924|NCT03297775|IPF|ipf
5111925|NCT03297775|airways disease|airways disease
5111926|NCT03297593|renal cell carcinoma|renal cell carcinoma
5111927|NCT03297593|Nivolumab|nivolumab
5111928|NCT03297593|Ipilimumab|ipilimumab
5111929|NCT03297593|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5111930|NCT03297593|immunotherapy|immunotherapy
5111931|NCT03297593|Opdivo|opdivo
5111932|NCT03297593|Yervoy|yervoy
5111933|NCT03297567|Elderly|elderly
5111934|NCT03297567|Hospitalization|hospitalization
5111935|NCT03297567|Immobilization|immobilization
5111936|NCT03297567|Exercise|exercise
5111937|NCT03297567|Accelerometry|accelerometry
5111938|NCT03297515|Omega-3|omega-3
5111939|NCT03297515|dry AMD|dry amd
5111940|NCT03297515|Stargardt|stargardt
5111941|NCT03297515|visual acuity|visual acuity
5111942|NCT03297424|PLX2853|plx2853
5111943|NCT03297424|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5111944|NCT03297424|Uveal Melanoma|uveal melanoma
5111945|NCT03297424|Ovarian Clear Cell Carcinoma|ovarian clear cell carcinoma
5111946|NCT03297424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5111947|NCT03297424|Advanced Malignancies|advanced malignancies
5111948|NCT03297424|Solid Tumor|solid tumor
5111949|NCT03297424|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
5751439|NCT00314587|midshaft|midshaft
5111950|NCT03297424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
5111951|NCT03297424|ARID1A|arid1a
5111952|NCT03297411|electroconvulsive therapy|electroconvulsive therapy
5111953|NCT03297411|computer modelling|computer modelling
5111954|NCT03297385|Prostate Cancer|prostate cancer
5111955|NCT03297385|Androgen Receptor Genomics|androgen receptor genomics
5111956|NCT03297385|Enzalutamide|enzalutamide
5111957|NCT03297385|Prostatectomy|prostatectomy
5111958|NCT03297385|Neoadjuvant androgen ablation|neoadjuvant androgen ablation
5111959|NCT03297372|Intraocular lens|intraocular lens
5111961|NCT03297372|cataract|cataract
5111962|NCT03297372|PhysIOL|physiol
5111963|NCT03297359|Dalteparin|dalteparin
5111964|NCT03297359|Fragmin|fragmin
5111965|NCT03297346|radiotherapy|radiotherapy
5111966|NCT03297346|cardiovascular changes|cardiovascular changes
5111967|NCT03297346|cardiac imaging|cardiac imaging
5111968|NCT03297346|circulating biomarkers|circulating biomarkers
5111969|NCT03297346|dosimetry|dosimetry
5111970|NCT03297333|Obesity|obesity
5111975|NCT03297320|Advance Care Planning, End of life, CPR|advance care planning, end of life, cpr
5111976|NCT03297294|Painful diabetic neuropathy|painful diabetic neuropathy
5111978|NCT03297294|Angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
5111979|NCT03297281|Photovaporization|photovaporization
5111980|NCT03297281|Laser|laser
5111981|NCT03297281|Benign prostatic hyperplasia|benign prostatic hyperplasia
5111982|NCT03297281|Oral anticoagulation|oral anticoagulation
5111983|NCT03297281|Complication|complication
5111984|NCT03297268|Dementia Caregiver Empowerment|dementia caregiver empowerment
5111985|NCT03297268|Caregiver Burden|caregiver burden
5111986|NCT03297268|Agitation in Dementia|agitation in dementia
5111987|NCT03297268|Environmental Sensors|environmental sensors
5111988|NCT03297268|Wearable Technology|wearable technology
5111989|NCT03297255|Primary Liver Cancer; Cohort Study|primary liver cancer; cohort study
5111990|NCT03297242|Helicobacter Pylori eradication|helicobacter pylori eradication
5111991|NCT03297229|Peer mentoring|peer mentoring
5111992|NCT03297229|Self-monitoring|self-monitoring
5111993|NCT03297229|Behavioral economics|behavioral economics
5111994|NCT03297229|Hypertension|hypertension
5111995|NCT03297216|PreTerm Birth|preterm birth
5111996|NCT03297216|HIV-1-infection|hiv-1-infection
5111997|NCT03297216|Antiretroviral Treatment|antiretroviral treatment
5112003|NCT03297151|Protein Synthesis|protein synthesis
5112004|NCT03297125|Optune Therapy|optune therapy
5112006|NCT03297125|NovoCure-TTF-200A|novocure-ttf-200a
5112007|NCT03297099|robot-assisted laparosocpic|robot-assisted laparosocpic
5112008|NCT03297099|hepatectomy|hepatectomy
5112009|NCT03297086|multifocal intraocular lens, angle kappa, presbyopia|multifocal intraocular lens, angle kappa, presbyopia
5112010|NCT03297060|Alcohol Screening|alcohol screening
5112011|NCT03297047|cast, fracture, immobilization, displacement, child|cast, fracture, immobilization, displacement, child
5112012|NCT03297034|Late effects|late effects
5112013|NCT03297034|Childhood cancer survivors|childhood cancer survivors
5112014|NCT03297034|Swiss Childhood Cancer Registry|swiss childhood cancer registry
5112015|NCT03297034|Europe|europe
5112016|NCT03297021|ambulatory surgery|ambulatory surgery
5112017|NCT03297021|post-operative nausea and vomiting|post-operative nausea and vomiting
5112018|NCT03297021|general anesthesia|general anesthesia
5112019|NCT03297008|healthy|healthy
5112020|NCT03297008|saliva|saliva
5112021|NCT03297008|stool|stool
5112022|NCT03297008|biomarkers|biomarkers
5112023|NCT03297008|Respiratory Syncytial Virus|respiratory syncytial virus
5112024|NCT03297008|Rotavirus|rotavirus
5112025|NCT03297008|Immunoglobulin|immunoglobulin
5112026|NCT03297008|Antibody|antibody
5112027|NCT03296995|glucose|glucose
5112028|NCT03296995|systemic lupus erythematosus|systemic lupus erythematosus
5112029|NCT03296982|Whole blood clotting time|whole blood clotting time
5112030|NCT03296956|Postpartum|postpartum
5112031|NCT03296956|Dietary Supplement|dietary supplement
5112032|NCT03296956|Mood Symptoms|mood symptoms
5112033|NCT03296930|Direct Acting Antiviral Agents (DAAs)|direct acting antiviral agents (daas)
5112034|NCT03296904|Lower limb amputation|lower limb amputation
5112035|NCT03296904|Wearable robotics|wearable robotics
5112036|NCT03296891|Ultrasonography|ultrasonography
5112037|NCT03296891|Point-of-care ultrasound|point-of-care ultrasound
5112038|NCT03296891|Resuscitation|resuscitation
5112039|NCT03296891|Critical Care|critical care
5112040|NCT03296878|low income|low income
5112041|NCT03296865|taping|taping
5112042|NCT03296865|functionality|functionality
5112043|NCT03296865|rehabilitation|rehabilitation
5112044|NCT03296865|muscle activity|muscle activity
5112045|NCT03296865|electromyography|electromyography
5112046|NCT03296813|loop diuretic|loop diuretic
5112047|NCT03296787|Drug therapy|drug therapy
5112048|NCT03296748|asymptomatic cystocele.|asymptomatic cystocele.
5112049|NCT03296748|stress urinary incontinence|stress urinary incontinence
5112055|NCT03296670|CSFP|csfp
5112056|NCT03296670|Alprostadil|alprostadil
5112057|NCT03296670|targeted perfusion microcatheter|targeted perfusion microcatheter
5112058|NCT03296631|microbiome|microbiome
5112059|NCT03296631|gut|gut
5112060|NCT03296631|infant gut|infant gut
5112061|NCT03296631|phages|phages
5112062|NCT03296631|phages-bacteria interactions|phages-bacteria interactions
5112066|NCT03296618|transplant|transplant
5112067|NCT03296618|paralysis|paralysis
5112068|NCT03296605|Obesity|obesity
5112069|NCT03296592|myelopathy|myelopathy
5112070|NCT03296592|diffusion MRI|diffusion mri
5112071|NCT03296592|spinal cord injury|spinal cord injury
5112072|NCT03296592|spinal cord compression|spinal cord compression
5112073|NCT03296592|spondylosis|spondylosis
5112074|NCT03296592|cervical|cervical
5112075|NCT03296540|STEMI|stemi
5112076|NCT03296501|ALS|als
5112079|NCT03296501|intraspinal transplantation|intraspinal transplantation
5112081|NCT03296488|post-laparotomy wound pain|post-laparotomy wound pain
5112082|NCT03296488|NALDEBAIN (150 mg Nalbuphine Sebacate)|naldebain (150 mg nalbuphine sebacate)
5112083|NCT03296488|PCA (patient-control-ed alagesia)|pca (patient-control-ed alagesia)
5112084|NCT03296449|Hypoxia|hypoxia
5112085|NCT03296449|High-Frequency Jet Ventilation|high-frequency jet ventilation
5112086|NCT03296449|Continuous Positive Airway Pressure|continuous positive airway pressure
5112088|NCT03296410|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
5112089|NCT03296410|immunogenicity|immunogenicity
5112090|NCT03296410|safety|safety
5112091|NCT03296397|Genital warts|genital warts
5112092|NCT03296397|HPV vaccine|hpv vaccine
5112093|NCT03296397|Relapse|relapse
5112094|NCT03296384|schizophrenia|schizophrenia
5112095|NCT03296384|environmental factors|environmental factors
5112290|NCT03295227|Thymoma|thymoma
5112096|NCT03296358|Acute urticaria|acute urticaria
5112097|NCT03296358|Emergency department|emergency department
5112098|NCT03296358|Acute allergic syndrome|acute allergic syndrome
5112099|NCT03296358|Corticosteroid|corticosteroid
5112100|NCT03296358|H1-Antihistamines|h1-antihistamines
5112101|NCT03296358|Chronic urticaria|chronic urticaria
5112102|NCT03296345|Ketamine|ketamine
5112103|NCT03296345|Sickle Cell Disease|sickle cell disease
5112104|NCT03296345|Vaso-Occlusive Crisis|vaso-occlusive crisis
5112105|NCT03296332|Evaluation|evaluation
5112106|NCT03296332|Population-based Intervention|population-based intervention
5112107|NCT03296332|Salt intake|salt intake
5112108|NCT03296332|Hypertension|hypertension
5112109|NCT03296306|urothelial carcinoma|urothelial carcinoma
5112110|NCT03296306|cisplatin|cisplatin
5112111|NCT03296306|first-line chemotherapy|first-line chemotherapy
5112112|NCT03296293|Positive end-expiratory pressure(PEEP)|positive end-expiratory pressure(peep)
5112113|NCT03296293|intracranial pressure(ICP)|intracranial pressure(icp)
5112114|NCT03296293|central venous pressure(CVP)|central venous pressure(cvp)
5112115|NCT03296293|intracranial central venous pressure difference(IVPD)|intracranial central venous pressure difference(ivpd)
5112116|NCT03296280|ultrasound|ultrasound
5112117|NCT03296280|ultrasonography|ultrasonography
5112118|NCT03296280|point of care|point of care
5112119|NCT03296280|Doppler ultrasound|doppler ultrasound
5112120|NCT03296280|ultrasound imaging|ultrasound imaging
5112121|NCT03296280|diagnostic ultrasound|diagnostic ultrasound
5112122|NCT03296267|bile acid|bile acid
5112123|NCT03296267|bacterial uptake|bacterial uptake
5112124|NCT03296254|mindfulness|mindfulness
5112125|NCT03296254|meditation|meditation
5112126|NCT03296254|stress|stress
5112127|NCT03296254|burn-out|burn-out
5112128|NCT03296254|personality|personality
5112129|NCT03296254|randomized controlled trial|randomized controlled trial
5112130|NCT03296241|stress urinary incontinence|stress urinary incontinence
5112131|NCT03296241|sexual dysfunction|sexual dysfunction
5112132|NCT03296241|laser|laser
5112133|NCT03296241|Er:YAG|er:yag
5112134|NCT03296241|vaginal laser|vaginal laser
5112135|NCT03296241|vaginal tightening|vaginal tightening
5112136|NCT03296241|non-ablative|non-ablative
5112137|NCT03296241|minimally-invasive|minimally-invasive
5112138|NCT03296228|AIS|ais
5112139|NCT03296202|HIV|hiv
5112140|NCT03296202|cohort studies|cohort studies
5112141|NCT03296202|antiretroviral treatment|antiretroviral treatment
5112142|NCT03296189|ureteroscopy|ureteroscopy
5112143|NCT03296189|ureteric stent|ureteric stent
5112144|NCT03296189|intraluminal|intraluminal
5112145|NCT03296189|local anaesthetic/anesthetic|local anaesthetic/anesthetic
5112146|NCT03296189|steroid/glucocorticoid|steroid/glucocorticoid
5112147|NCT03296150|therapeutic educational program|therapeutic educational program
5112148|NCT03296150|adherence|adherence
5112149|NCT03296150|quality of life|quality of life
5112150|NCT03296150|elderly|elderly
5112151|NCT03296150|cancer|cancer
5112152|NCT03296137|immune therapy|immune therapy
5112154|NCT03296137|Adoptive cell therapy|adoptive cell therapy
5112155|NCT03296124|Prostate Cancer|prostate cancer
5112156|NCT03296124|Proton Radiation|proton radiation
5112157|NCT03296098|Contraception|contraception
5112158|NCT03296098|Healthy Female|healthy female
5112159|NCT03296098|Progestin|progestin
5112160|NCT03296098|ulipristal acetate|ulipristal acetate
5112173|NCT03295903|Cannabidiol supplementation|cannabidiol supplementation
5112174|NCT03295890|myofascial trigger point, tinnitus, dry needling|myofascial trigger point, tinnitus, dry needling
5112175|NCT03295864|Arnold-Chiari Malformation, Type 1|arnold-chiari malformation, type 1
5112176|NCT03295864|Multifrequency tympanometry|multifrequency tympanometry
4997603|NCT04009226|GNE Myopathy|gne myopathy
5112177|NCT03295864|Inner ear pressure|inner ear pressure
5112178|NCT03295851|Anemia|anemia
5112179|NCT03295851|Pre-operative|pre-operative
5112180|NCT03295851|Intravenous Iron|intravenous iron
5112181|NCT03295851|Ferric carboxymaltose|ferric carboxymaltose
5112182|NCT03295851|abdominal surgery|abdominal surgery
5109359|NCT03314584|headache|headache
5112183|NCT03295838|Borderline personality disorder|borderline personality disorder
5112184|NCT03295838|Psychotherapy|psychotherapy
5112185|NCT03295838|Treatment outcome|treatment outcome
5112186|NCT03295838|Pragmatic clinical trials as topic|pragmatic clinical trials as topic
5112187|NCT03295838|Mentalization-based treatment|mentalization-based treatment
5112189|NCT03295825|Heparin binding protein|heparin binding protein
5112190|NCT03295825|Mortality|mortality
5112191|NCT03295786|Parkinson|parkinson
5112192|NCT03295786|CDNF|cdnf
5112193|NCT03295786|Drug Delivery System|drug delivery system
5112194|NCT03295786|Intracerebral|intracerebral
5112781|NCT03292250|Nanostring|nanostring
5112195|NCT03295773|Ischemic Stroke|ischemic stroke
5112196|NCT03295773|3D-rotational angiography|3d-rotational angiography
5112197|NCT03295773|Morphology|morphology
5112198|NCT03295773|Atherosclerosis|atherosclerosis
5112199|NCT03295721|bunion|bunion
5112200|NCT03295721|bunionectomy|bunionectomy
5112201|NCT03295721|bunion surgery|bunion surgery
5112202|NCT03295721|postoperative pain|postoperative pain
5112203|NCT03295708|Major depressive disorder,Fish Oil|major depressive disorder,fish oil
5112204|NCT03295695|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
5112205|NCT03295695|Tumor blood perfusion|tumor blood perfusion
5112206|NCT03295630|Accelerometry|accelerometry
5112207|NCT03295630|Validity|validity
5112208|NCT03295617|spinal thoracic herniation|spinal thoracic herniation
5112209|NCT03295617|surgery|surgery
5112210|NCT03295617|endoscopic approach|endoscopic approach
5112211|NCT03295617|thoracic spine|thoracic spine
5112212|NCT03295617|minimal invasive access|minimal invasive access
5112213|NCT03295604|Gingival recession|gingival recession
5112214|NCT03295604|Subepithelial connective tissue grafts|subepithelial connective tissue grafts
5112215|NCT03295604|CAD/CAM|cad/cam
5112216|NCT03295591|Metastatic colorectal cancer|metastatic colorectal cancer
5112217|NCT03295591|Liver resection|liver resection
5112218|NCT03295591|Circulating tumor cells|circulating tumor cells
5112219|NCT03295578|employees|employees
5112220|NCT03295578|continuous glucose monitoring|continuous glucose monitoring
5112221|NCT03295578|personalized feedback|personalized feedback
5112222|NCT03295578|cognition|cognition
5112223|NCT03295578|wellbeing|wellbeing
5112224|NCT03295565|Sequencing|sequencing
5112225|NCT03295565|cabazitaxel|cabazitaxel
5112226|NCT03295565|abiraterone|abiraterone
5112227|NCT03295565|enzalutamide|enzalutamide
5112228|NCT03295565|clinical benefit rate|clinical benefit rate
5112229|NCT03295565|docetaxel|docetaxel
5112230|NCT03295565|second line treatment|second line treatment
5112231|NCT03295552|decitabine|decitabine
5112232|NCT03295552|triple negative breast cancer|triple negative breast cancer
5112233|NCT03295552|carboplatin|carboplatin
5112234|NCT03295552|metastatic|metastatic
5112235|NCT03295526|Cervical Cancer, Lymph nodes debulking surgery|cervical cancer, lymph nodes debulking surgery
5112236|NCT03295513|mutilated, root canal treated teeth, and coronal fracture|mutilated, root canal treated teeth, and coronal fracture
5112237|NCT03295500|CyberKnife|cyberknife
5112238|NCT03295500|hepatocellular|hepatocellular
5112239|NCT03295500|dose fraction|dose fraction
5112240|NCT03295500|ICG R15|icg r15
5112241|NCT03295487|post menopausal stress incontinence|post menopausal stress incontinence
5112242|NCT03295487|local estrogen|local estrogen
5112243|NCT03295448|fatty acids|fatty acids
5112244|NCT03295448|biomarker|biomarker
5112245|NCT03295448|carbohydrate|carbohydrate
5112246|NCT03295448|lipogenesis|lipogenesis
5112247|NCT03295435|Diet|diet
5112248|NCT03295435|Oral Health|oral health
5112249|NCT03295435|Nutrition|nutrition
5112250|NCT03295435|Dentition|dentition
5112251|NCT03295422|Persistent Atrial Fibrillation|persistent atrial fibrillation
5112252|NCT03295422|Radiofrequency ablation|radiofrequency ablation
5122463|NCT03229850|Insulin|insulin
5112253|NCT03295422|Catheter ablation|catheter ablation
5112254|NCT03295383|cyclophosphamide|cyclophosphamide
5112256|NCT03295370|Pain mechanisms|pain mechanisms
5112257|NCT03295370|Cortical activation|cortical activation
5112258|NCT03295370|fNIRS|fnirs
5112259|NCT03295370|Accessory spinal nerve|accessory spinal nerve
5112260|NCT03295370|Autonomic response|autonomic response
5112261|NCT03295370|Muscular perfusion|muscular perfusion
5112262|NCT03295318|Neisseria meningitidis|neisseria meningitidis
5112263|NCT03295318|conjugate meningococcal vaccine|conjugate meningococcal vaccine
5112264|NCT03295318|meningococcal serogroup X|meningococcal serogroup x
5112265|NCT03295305|Biomarker|biomarker
5112266|NCT03295305|Bipolar Disorder|bipolar disorder
5112267|NCT03295305|Cognition|cognition
5112268|NCT03295305|Cognitive Impairment|cognitive impairment
5112269|NCT03295305|cognitive remediation|cognitive remediation
5112270|NCT03295305|functional magnetic resonance imaging|functional magnetic resonance imaging
5112271|NCT03295305|pro-cognitive effect|pro-cognitive effect
5112272|NCT03295292|Phototherapeutic Keratectomy (PTK)|phototherapeutic keratectomy (ptk)
5112273|NCT03295292|photorefractive Keratectomy (PRK)|photorefractive keratectomy (prk)
5112274|NCT03295292|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
5112275|NCT03295292|Stem Cell Therapy|stem cell therapy
5112276|NCT03295279|World Trade Center|world trade center
5109461|NCT03314064|Phase 4|phase 4
5112293|NCT03295227|Keytruda|keytruda
5112295|NCT03295227|SCH-900475|sch-900475
5961986|NCT04283630|Endothelial function|endothelial function
4983766|NCT04093570|MDS|mds
5112296|NCT03295214|Acetaminophen|acetaminophen
5112297|NCT03295214|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5112298|NCT03295201|Cystic Fibrosis|cystic fibrosis
5112299|NCT03295201|Postural exercise|postural exercise
5112300|NCT03295201|Pulmonary rehabilitation|pulmonary rehabilitation
5112301|NCT03295175|Congenital Abnormalities|congenital abnormalities
5112302|NCT03295175|Hypospadias|hypospadias
5112303|NCT03295175|Congenital megaprepuce|congenital megaprepuce
5112304|NCT03295175|Histology|histology
5112305|NCT03295110|Alzheimer's disease and Related Disorders (ADRD)|alzheimer's disease and related disorders (adrd)
5112306|NCT03295110|natural caregiver|natural caregiver
5112307|NCT03295110|non-medical connected device|non-medical connected device
5112308|NCT03295110|caregiver's burden|caregiver's burden
5112309|NCT03295110|anxiety|anxiety
5112310|NCT03295110|costs|costs
5112311|NCT03295110|quality of life|quality of life
5112312|NCT03295110|depressive symptoms|depressive symptoms
5112313|NCT03295110|independence|independence
5112315|NCT03295071|Heredity Optic Atrophy|heredity optic atrophy
5112316|NCT03295071|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5112317|NCT03295071|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5112318|NCT03295071|Eye Diseases|eye diseases
5112319|NCT03295071|Hereditary Eye Diseases|hereditary eye diseases
5112320|NCT03295071|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
5112321|NCT03295071|Inborn Genetic Disease|inborn genetic disease
5112322|NCT03295071|Gene Therapy|gene therapy
5112323|NCT03295071|Intravitreal Injections|intravitreal injections
5112324|NCT03295071|Mitochondrial Disease|mitochondrial disease
5112325|NCT03295071|AAV2 Vectors|aav2 vectors
5112326|NCT03295071|Nervous System Diseases|nervous system diseases
5112327|NCT03295071|Neurodegenerative Disease|neurodegenerative disease
5112328|NCT03295071|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
5112329|NCT03295006|TheraSphere, hepatocellular carcinoma, dosimetry|therasphere, hepatocellular carcinoma, dosimetry
5112330|NCT03294980|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5112331|NCT03294980|Observational study|observational study
5112332|NCT03294967|High Myopia|high myopia
5112333|NCT03294967|Caffeine|caffeine
5112334|NCT03294967|Choroidal Thickness|choroidal thickness
5112335|NCT03294967|Choroidal Volume|choroidal volume
5112336|NCT03294967|Optical Coherence Tomography|optical coherence tomography
5112337|NCT03294967|Optical Coherence Tomography Angiography|optical coherence tomography angiography
5112338|NCT03294954|Neuroblastoma|neuroblastoma
5112339|NCT03294954|Natural Killer T-Cells|natural killer t-cells
5175855|NCT02892149|CKD|ckd
5112340|NCT03294954|Chimerical Antigen Receptor|chimerical antigen receptor
5112341|NCT03294915|prediabetes|prediabetes
5112342|NCT03294915|resistant starch|resistant starch
5112343|NCT03294915|insulin sensitivity|insulin sensitivity
5112344|NCT03294889|Prostate cancer|prostate cancer
5112347|NCT03294876|Glucocorticoid|glucocorticoid
5112348|NCT03294876|HPA axis|hpa axis
5112349|NCT03294863|Scar|scar
5112350|NCT03294863|Cosmesis|cosmesis
5112351|NCT03294863|Embrace Device|embrace device
5112352|NCT03294863|Split Wound|split wound
5112353|NCT03294863|Wound Closure|wound closure
5112354|NCT03294863|Cutaneous Wound|cutaneous wound
5112355|NCT03294824|NK cells|nk cells
5112356|NCT03294824|Cytomegalovirus|cytomegalovirus
5112357|NCT03294824|adenovirus|adenovirus
5109564|NCT03313089|spinkles|spinkles
5112362|NCT03294772|handwashing|handwashing
5112363|NCT03294772|day care|day care
5112365|NCT03294759|stem cell|stem cell
5112366|NCT03294759|acl|acl
5112367|NCT03294746|Drug induced interstitial lung disease (DIILD)|drug induced interstitial lung disease (diild)
5112368|NCT03294694|Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer|metastatic hormone-receptor-positive (hr+) breast cancer
5112369|NCT03294694|HER2-Negative Breast Cancer|her2-negative breast cancer
5112370|NCT03294694|Metastatic Epithelial Ovarian Cancer|metastatic epithelial ovarian cancer
4997826|NCT04007822|self-efficacy|self-efficacy
5112371|NCT03294668|social skills group training|social skills group training
5112372|NCT03294668|Adolescents|adolescents
5112373|NCT03294668|Active control group|active control group
5112374|NCT03294668|Australian|australian
5112375|NCT03294642|exercise|exercise
5112376|NCT03294642|FODMAP|fodmap
5112377|NCT03294642|gastrointestinal|gastrointestinal
5112378|NCT03294642|endurance|endurance
5112379|NCT03294642|cycling|cycling
5112380|NCT03294629|cPAP|cpap
5112381|NCT03294629|SenseAwake|senseawake
5112382|NCT03294616|transcutaneous electroacupuncture|transcutaneous electroacupuncture
5112383|NCT03294603|Healthy Volunteer|healthy volunteer
5112384|NCT03294603|CC-220|cc-220
5112385|NCT03294603|Male|male
5112391|NCT03294590|Bottle/sippy cup use|bottle/sippy cup use
5112392|NCT03294590|Sugar sweetened beverage consumption|sugar sweetened beverage consumption
5112393|NCT03294590|Fluoride varnish|fluoride varnish
5112394|NCT03294590|Healthy eating|healthy eating
5112395|NCT03294590|Parent oral health behaviors|parent oral health behaviors
5112396|NCT03294590|Parent oral health attitudes|parent oral health attitudes
5112397|NCT03294590|Fluoride|fluoride
5961987|NCT04283630|Nitric Oxide|nitric oxide
5112398|NCT03294577|Plinabulin|plinabulin
5112399|NCT03294577|Pegfilgrastim|pegfilgrastim
5112400|NCT03294577|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
5112401|NCT03294577|bone pain|bone pain
5112402|NCT03294564|Inflammation|inflammation
5112403|NCT03294564|Threat sensitivity|threat sensitivity
5112404|NCT03294564|Reward sensitivity|reward sensitivity
5112405|NCT03294551|HPV Vaccine|hpv vaccine
5112406|NCT03294551|immunization registry|immunization registry
5112407|NCT03294551|Reminder recall (R/R)|reminder recall (r/r)
5112408|NCT03294486|Glioblastoma|glioblastoma
5112409|NCT03294486|Oncolytic viruses|oncolytic viruses
5112410|NCT03294473|reminder recall (R/R), influenza vaccines|reminder recall (r/r), influenza vaccines
5112415|NCT03294447|Fear of falling|fear of falling
5112416|NCT03294408|fractal analysis|fractal analysis
5112417|NCT03294408|trabecular bone texture|trabecular bone texture
5112418|NCT03294408|knee osteoarthritis|knee osteoarthritis
5112419|NCT03294408|subchondral bone|subchondral bone
5112420|NCT03294408|Medical Resonnance Imaging|medical resonnance imaging
5112421|NCT03294395|Antimicrobial resistance|antimicrobial resistance
5112422|NCT03294395|Antibiotics|antibiotics
5112423|NCT03294395|Fosfomycin|fosfomycin
5112424|NCT03294395|Ertapenem|ertapenem
5112425|NCT03294395|Gentamicin|gentamicin
5112426|NCT03294395|Neisseria Gonorrhoeae|neisseria gonorrhoeae
5112427|NCT03294382|epicanthoplasty|epicanthoplasty
5112428|NCT03294382|Botulinum Toxins|botulinum toxins
5112429|NCT03294382|scar|scar
5112430|NCT03294382|intercanthal distance|intercanthal distance
5112431|NCT03294382|blepharoplasty|blepharoplasty
5112432|NCT03294369|Hypertension|hypertension
5112433|NCT03294369|Diabetes|diabetes
5112434|NCT03294369|Dyslipidemia|dyslipidemia
5112435|NCT03294369|Smoking|smoking
5112436|NCT03294369|Cardiovascular|cardiovascular
5112437|NCT03294369|Toledo|toledo
5112438|NCT03294317|His bundle pacing|his bundle pacing
5112439|NCT03294317|Pacemaker|pacemaker
5112440|NCT03294304|MIBC|mibc
5112442|NCT03294304|Immunotherapy|immunotherapy
5112443|NCT03294304|Bladder Cancer|bladder cancer
5112444|NCT03294304|Neoadjuvant|neoadjuvant
5112445|NCT03294304|Nivolumab|nivolumab
5112446|NCT03294304|Cisplatin|cisplatin
5112447|NCT03294304|Gemcitabine|gemcitabine
5112448|NCT03294265|Diabetes|diabetes
5112449|NCT03294265|Peer support|peer support
5112450|NCT03294265|WhatsApp|whatsapp
5112451|NCT03294252|PIPAC|pipac
5112452|NCT03294252|oxaliplatin|oxaliplatin
5112457|NCT03294187|Randomized Controlled Trial|randomized controlled trial
5112458|NCT03294161|Meglumine antimoniate|meglumine antimoniate
5112459|NCT03294161|L.Braziliensis|l.braziliensis
5112460|NCT03294161|Immunotherapy|immunotherapy
5112461|NCT03294161|Immucillin|immucillin
5112462|NCT03294148|Placebo|placebo
5112463|NCT03294148|Back|back
5112464|NCT03294148|Pain|pain
5112465|NCT03294148|Chronic|chronic
5112466|NCT03294148|Mind-Body|mind-body
5112467|NCT03294135|Encepur|encepur
5112468|NCT03294135|Adults|adults
5109642|NCT03312634|Palovarotene|palovarotene
5112470|NCT03294135|Tick-borne Encephalitis vaccine|tick-borne encephalitis vaccine
5112471|NCT03294135|Booster|booster
5112472|NCT03294122|Radiotherapy|radiotherapy
5112473|NCT03294122|Adverse effects|adverse effects
5112474|NCT03294122|Prostate cancer|prostate cancer
4997960|NCT04007185|surgery|surgery
5112475|NCT03294122|Head and neck cancer|head and neck cancer
5112476|NCT03294122|Patient risk stratification|patient risk stratification
5112477|NCT03294122|Mathematical models|mathematical models
5112478|NCT03294122|Microbiome|microbiome
5112479|NCT03294122|Inflammatory cytokines|inflammatory cytokines
5112480|NCT03294122|Magnetic Resonance Imaging|magnetic resonance imaging
5112481|NCT03294109|TQL block, TAP block, donor nephrectomy, pain, patient satisfaction|tql block, tap block, donor nephrectomy, pain, patient satisfaction
5112482|NCT03294083|Cancer|cancer
5112483|NCT03294083|Renal cell carcinoma|renal cell carcinoma
5112484|NCT03294083|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
5112485|NCT03294070|hemodynamic parameters|hemodynamic parameters
5112486|NCT03294070|arterial stiffness|arterial stiffness
5112487|NCT03294057|Self-Management IT Program|self-management it program
5112488|NCT03294044|Self-Management IT Program|self-management it program
5112489|NCT03294031|Parkinson Disease|parkinson disease
5112490|NCT03294031|Neurodegenerative Disorder|neurodegenerative disorder
5112491|NCT03294031|Physical Activity|physical activity
5112492|NCT03294031|Pilates Method|pilates method
5112493|NCT03294031|Stabilometer|stabilometer
5112496|NCT03293953|Liver Fibrosis|liver fibrosis
5112497|NCT03293953|Liver Iron Overload|liver iron overload
5112498|NCT03293940|Breast Pain|breast pain
5112499|NCT03293940|Nerve Pain|nerve pain
5112500|NCT03293940|Mastectomy|mastectomy
5112501|NCT03293940|Lumpectomy|lumpectomy
5112502|NCT03293940|Breast Reconstruction|breast reconstruction
5112503|NCT03293927|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy|children, mechanically ventilated, fentanyl, dexmedetomidine, delirium, polypharmacy
5112504|NCT03293888|Spectral Diagnosis Probe|spectral diagnosis probe
5112505|NCT03293888|Chaos Wand|chaos wand
5112506|NCT03293888|Spectral Analysis|spectral analysis
5112507|NCT03293888|Optical Spectroscopy|optical spectroscopy
5112508|NCT03293862|laparotomy|laparotomy
5112509|NCT03293862|emergency surgery|emergency surgery
5112510|NCT03293862|abdominal wound dehiscence|abdominal wound dehiscence
5112511|NCT03293862|prophylactic mesh|prophylactic mesh
5112512|NCT03293836|Varicose ulcer|varicose ulcer
5112513|NCT03293836|Venous ulcer|venous ulcer
5112514|NCT03293836|Radiofrequency ablation|radiofrequency ablation
5112515|NCT03293836|Perforating veins insufficiency|perforating veins insufficiency
5112516|NCT03293836|Varicose veins treatment|varicose veins treatment
5112517|NCT03293797|Mindfulness-based Therapy|mindfulness-based therapy
5112518|NCT03293797|Wellbeing|wellbeing
5112519|NCT03293797|Treatment|treatment
5112520|NCT03293784|Melanoma|melanoma
5112521|NCT03293784|Immune checkpoint|immune checkpoint
5112522|NCT03293784|Nivolumab|nivolumab
5112523|NCT03293784|Ipilimumab|ipilimumab
5112524|NCT03293784|Infliximab|infliximab
5112525|NCT03293784|Certolizumab|certolizumab
5112526|NCT03293784|PD-1|pd-1
5112527|NCT03293784|TNFa|tnfa
5112528|NCT03293784|CTLA-4|ctla-4
5112529|NCT03293771|Transgender women|transgender women
5112530|NCT03293771|Male-to-female|male-to-female
5112531|NCT03293771|Gender confirmation surgery|gender confirmation surgery
5112532|NCT03293771|Voiding disorder|voiding disorder
5112533|NCT03293771|Vaginal dysfunction|vaginal dysfunction
5112534|NCT03293693|beta-glucan|beta-glucan
5112535|NCT03293693|Blood glucose|blood glucose
5112536|NCT03293693|Gut microbiota|gut microbiota
5112537|NCT03293693|Satiety|satiety
5112538|NCT03293693|Dietary intervention|dietary intervention
5112539|NCT03293667|Rheumatoid Arthritis|rheumatoid arthritis
5112540|NCT03293667|Regulatory T Cells|regulatory t cells
5112541|NCT03293641|Children, Sickle Cell Disease, Zinc|children, sickle cell disease, zinc
5112542|NCT03293628|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5112543|NCT03293628|haemostasis|haemostasis
5112544|NCT03293628|vaginal pack|vaginal pack
5112545|NCT03293628|Loop electrical excision procedure|loop electrical excision procedure
5112546|NCT03293628|randomized clinical trials|randomized clinical trials
5112553|NCT03293589|end-stage renal disease|end-stage renal disease
5112554|NCT03293589|critical limb ischemia|critical limb ischemia
5112555|NCT03293589|surgical revascularisation|surgical revascularisation
5112556|NCT03293589|endovascular therapy|endovascular therapy
5112557|NCT03293576|Behavioural Medicine|behavioural medicine
5112558|NCT03293576|Health Psychology|health psychology
5112559|NCT03293576|Psychosocial Intervention|psychosocial intervention
5112560|NCT03293576|People Who Inject Drugs|people who inject drugs
5112561|NCT03293563|Kidney cancer|kidney cancer
5112562|NCT03293563|Surgical approaches|surgical approaches
5112563|NCT03293563|Medical treatment|medical treatment
5112564|NCT03293563|Multicentric and multidisciplinary network|multicentric and multidisciplinary network
5112565|NCT03293537|Dementia|dementia
5112566|NCT03293537|Aphathy|aphathy
5112567|NCT03293537|Emotion|emotion
5112568|NCT03293537|Images|images
5112569|NCT03293537|Skin conductance|skin conductance
5112588|NCT03293524|Anesthetics|anesthetics
5112589|NCT03293524|Central Nervous System Depressants|central nervous system depressants
5112590|NCT03293524|Physiological Effects of Drugs|physiological effects of drugs
5112591|NCT03293511|Oxytocin|oxytocin
5112592|NCT03293511|Eye tracking|eye tracking
5112593|NCT03293511|Autistic trait|autistic trait
5112596|NCT03293394|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5112597|NCT03293394|Motor Neuron Disease|motor neuron disease
5112598|NCT03293394|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5112599|NCT03293368|Oral|oral
5112600|NCT03293368|Lichen planus|lichen planus
5112602|NCT03293355|People Living with HIV Who Use Drugs (PLHWUD)|people living with hiv who use drugs (plhwud)
5112603|NCT03293355|Community Health Workers (CHW)|community health workers (chw)
5112604|NCT03293355|Multilevel Service Integration|multilevel service integration
5112605|NCT03293355|HIV/AIDS|hiv/aids
5112606|NCT03293355|Vietnam|vietnam
5112607|NCT03293329|rotator cuff injury|rotator cuff injury
5112608|NCT03293329|diaphragm|diaphragm
5112609|NCT03293329|physical therapy|physical therapy
5112610|NCT03293329|manual therapy|manual therapy
5112611|NCT03293316|Transcranial electrical stimulation; random noise;|transcranial electrical stimulation; random noise;
5112612|NCT03293316|cognitive interventions; electroencephalography;|cognitive interventions; electroencephalography;
5112613|NCT03293316|inter-individual variability; stochastic resonance;|inter-individual variability; stochastic resonance;
5112614|NCT03293303|Prevention|prevention
5112615|NCT03293303|Physical activity|physical activity
5112616|NCT03293303|Sedentary behaviour|sedentary behaviour
5112617|NCT03293303|Daily activities|daily activities
5112618|NCT03293303|Homecare|homecare
5112619|NCT03293303|Nursing|nursing
5112620|NCT03293303|Primary care|primary care
5112621|NCT03293303|Older adults|older adults
5112622|NCT03293303|Function Focused Care|function focused care
5112623|NCT03293303|Reablement|reablement
5112624|NCT03293303|Restorative Care|restorative care
5112625|NCT03293290|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
5112626|NCT03293290|criminal justice|criminal justice
5112627|NCT03293290|women|women
5112628|NCT03293290|risk networks|risk networks
5112629|NCT03293264|metabolic syndrome|metabolic syndrome
5112630|NCT03293264|exercise training|exercise training
5112631|NCT03293264|employees|employees
5112632|NCT03293264|workplace|workplace
5112633|NCT03293264|operational health service|operational health service
5112634|NCT03293238|knee|knee
5112635|NCT03293238|osteoarthritis|osteoarthritis
5112636|NCT03293238|ultrasound|ultrasound
5112637|NCT03293238|sonography|sonography
5112638|NCT03293238|injection|injection
5112639|NCT03293225|cu|cu
5112640|NCT03293212|Postoperative pain|postoperative pain
5112641|NCT03293212|Failed back surgery syndrome|failed back surgery syndrome
5112642|NCT03293212|Korean medicine|korean medicine
5112643|NCT03293173|DLBCL|dlbcl
5112644|NCT03293173|Chemoimmunotherapy|chemoimmunotherapy
5112645|NCT03293173|High risk|high risk
5112646|NCT03293173|CNS prophylaxis|cns prophylaxis
5112647|NCT03293173|Biomarker-driven|biomarker-driven
5112648|NCT03293147|Blood pressure|blood pressure
5112649|NCT03293147|Antihypertensive treatment|antihypertensive treatment
5112650|NCT03293147|Adherence|adherence
5112660|NCT03293095|motion capture|motion capture
5112661|NCT03293095|functional task|functional task
5112662|NCT03293095|biomarker|biomarker
5112663|NCT03293069|Conservative Iron Chelation|conservative iron chelation
5112664|NCT03293069|Disease-modifying Strategy|disease-modifying strategy
5112665|NCT03293056|aerobic exercises|aerobic exercises
5112666|NCT03293056|training|training
5112667|NCT03293056|aquatic|aquatic
5112668|NCT03293030|atopic dermatitis|atopic dermatitis
5112669|NCT03293030|eczema|eczema
5112670|NCT03293030|dupilumab|dupilumab
5112671|NCT03293030|atopic eczema|atopic eczema
5112672|NCT03293004|collagen|collagen
5112673|NCT03293004|tendon|tendon
5112674|NCT03293004|procollagen type I N-terminal|procollagen type i n-terminal
5112675|NCT03293004|athletes|athletes
5112676|NCT03293004|vitamin C|vitamin c
5112677|NCT03293004|hydrolyzed collagen|hydrolyzed collagen
5112678|NCT03292991|Hepatocellular Carcinoma|hepatocellular carcinoma
5112679|NCT03292991|SIR Spheres|sir spheres
5112680|NCT03292991|SIRT|sirt
5112681|NCT03292939|progestrone|progestrone
5112697|NCT03292796|Cataract|cataract
5112698|NCT03292796|Phacoemulsification,|phacoemulsification,
5112699|NCT03292796|Cystoid Macular Oedema,|cystoid macular oedema,
4998153|NCT04005729|P2Y12|p2y12
5112700|NCT03292796|Prostaglandin Analogues|prostaglandin analogues
5112701|NCT03292783|VEGF|vegf
5112702|NCT03292783|DLL4|dll4
5112703|NCT03292783|Solid Tumors|solid tumors
5112704|NCT03292783|bispecific antibody|bispecific antibody
5112705|NCT03292783|anti-angiogenic|anti-angiogenic
5112706|NCT03292770|Embryo Transfer|embryo transfer
5112707|NCT03292770|Flushing catheter|flushing catheter
5112708|NCT03292770|Pregnancy rate|pregnancy rate
5112709|NCT03292770|Frozen Embryo Tranfer|frozen embryo tranfer
5112710|NCT03292757|Fluorescence|fluorescence
5112711|NCT03292744|immunosenescence|immunosenescence
5112712|NCT03292718|PERT|pert
5112713|NCT03292718|mobile application|mobile application
5112714|NCT03292705|cognitive training|cognitive training
5112715|NCT03292705|person-centered approach|person-centered approach
5112716|NCT03292614|Multifocal Intraocular Lens|multifocal intraocular lens
5112717|NCT03292614|Postoperative Measurements of refraction|postoperative measurements of refraction
5112718|NCT03292601|Spinal Orthosis|spinal orthosis
5112719|NCT03292601|Spinal Brace|spinal brace
5112720|NCT03292588|urban setting|urban setting
5112721|NCT03292588|children and adolescents|children and adolescents
5112722|NCT03292588|double-masked, placebo-controlled randomized trial|double-masked, placebo-controlled randomized trial
5112723|NCT03292588|asthma exacerbations (attacks)|asthma exacerbations (attacks)
5112724|NCT03292588|mepolizumab adjunctive therapy|mepolizumab adjunctive therapy
5112725|NCT03292588|asthma exacerbations prevention|asthma exacerbations prevention
5112726|NCT03292588|difficult-to-control exacerbation-prone asthma|difficult-to-control exacerbation-prone asthma
5112727|NCT03292549|Urology|urology
5112728|NCT03292549|Robotic surgery|robotic surgery
5112729|NCT03292549|Haemostasis|haemostasis
5112730|NCT03292549|Partial Nephrectomy|partial nephrectomy
5112731|NCT03292523|Hyperventilation syndrome|hyperventilation syndrome
5112732|NCT03292523|Work productivity|work productivity
5112733|NCT03292523|Absenteeism|absenteeism
5112734|NCT03292523|Presenteeism|presenteeism
5112744|NCT03292471|Aphasia|aphasia
5112745|NCT03292471|Rehabilitation|rehabilitation
5112746|NCT03292471|Stroke|stroke
5112751|NCT03292432|Adherence, Medication|adherence, medication
5112752|NCT03292406|T-Cell|t-cell
5112753|NCT03292406|Lymphoma|lymphoma
5112754|NCT03292406|Cutaneous|cutaneous
5112755|NCT03292406|CTCL|ctcl
5112756|NCT03292393|Hypertension|hypertension
5112757|NCT03292393|Medication|medication
5112758|NCT03292393|Adherence|adherence
5112759|NCT03292380|Caffeine|caffeine
5112760|NCT03292380|Dietary intake|dietary intake
5112761|NCT03292380|Validation|validation
5112762|NCT03292380|Dietary methods|dietary methods
5112763|NCT03292354|Coronary Computed Tomography Angiography|coronary computed tomography angiography
5112764|NCT03292354|Image Quality|image quality
5112765|NCT03292354|Contrast Media Reduction|contrast media reduction
5112766|NCT03292354|Personalised Injection Protocols|personalised injection protocols
5112767|NCT03292328|breast cancer|breast cancer
5112768|NCT03292328|neuropathy|neuropathy
5112769|NCT03292328|peripheral neuropathy|peripheral neuropathy
5112770|NCT03292328|yoga|yoga
5112771|NCT03292328|17-449|17-449
5112772|NCT03292315|Glucagon-Like Peptide-1|glucagon-like peptide-1
5112773|NCT03292302|Translational read through|translational read through
5112774|NCT03292289|proctectomy|proctectomy
5112775|NCT03292289|coloanal continuity reconstruction|coloanal continuity reconstruction
5112776|NCT03292263|Multiple Myeloma|multiple myeloma
5112777|NCT03292263|Nivolumab|nivolumab
5112778|NCT03292263|Melphalan|melphalan
5112779|NCT03292263|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5112780|NCT03292250|NGS|ngs
5112786|NCT03292237|Nutrition|nutrition
5112787|NCT03292237|Critical illness|critical illness
5112788|NCT03292237|Parenteral nutrition|parenteral nutrition
5112789|NCT03292237|Intensive care unit|intensive care unit
5112790|NCT03292237|Ward|ward
5112791|NCT03292237|Randomised Controlled Trial|randomised controlled trial
5112792|NCT03292237|Intensive Nutrition|intensive nutrition
5112793|NCT03292211|Early mobilization|early mobilization
5112794|NCT03292211|Acute stroke|acute stroke
5112795|NCT03292211|Early intervention|early intervention
5112796|NCT03292211|Early mobilization therapy|early mobilization therapy
5112800|NCT03292159|stroke|stroke
5112801|NCT03292159|vagus nerve stimulation|vagus nerve stimulation
5112802|NCT03292159|upper extremity paresis|upper extremity paresis
5112803|NCT03292133|Lung Cancer|lung cancer
5112805|NCT03292094|Healthy|healthy
5112806|NCT03292094|African|african
5112807|NCT03292094|Longitudinal|longitudinal
5112808|NCT03292094|Hypertension|hypertension
5112809|NCT03292094|Salt intake|salt intake
5112810|NCT03292094|Obesity|obesity
5112811|NCT03292094|Organ damage|organ damage
5112812|NCT03292081|Intracoronary Imaging|intracoronary imaging
5112813|NCT03292081|Optical Frequency Domain Imaging|optical frequency domain imaging
5112814|NCT03292081|Intravascular Ultrasound|intravascular ultrasound
5112815|NCT03292081|Percutaneous Coronary Intervention|percutaneous coronary intervention
5112816|NCT03292081|Drug Eluting Stent|drug eluting stent
5112817|NCT03292055|food frequency questionnaire; psychometric properties|food frequency questionnaire; psychometric properties
5112818|NCT03292042|metabolic syndrome|metabolic syndrome
5112819|NCT03292042|lifestyle intervention|lifestyle intervention
5112820|NCT03292042|health promotion|health promotion
5112821|NCT03292042|mental health nurse|mental health nurse
5112822|NCT03292042|serious mental illness|serious mental illness
5112823|NCT03292029|Renal replacement therapy|renal replacement therapy
5112824|NCT03292029|Haemodialsysis|haemodialsysis
5112825|NCT03292029|Calcification Inhibition Test|calcification inhibition test
5112826|NCT03292016|Off Episodes|off episodes
5112827|NCT03292016|Parkinson Disease|parkinson disease
5112828|NCT03292003|rheumatoid arthritis|rheumatoid arthritis
5112829|NCT03292003|post-traumatic arthritis|post-traumatic arthritis
5112830|NCT03292003|osteoarthritis|osteoarthritis
5112831|NCT03292003|degenerative arthritis|degenerative arthritis
5112832|NCT03292003|failed osteotomy|failed osteotomy
5112833|NCT03291977|surgery - glioblastoma - fluorescein|surgery - glioblastoma - fluorescein
5112834|NCT03291847|maternal opioid use|maternal opioid use
5112835|NCT03291847|neonatal abstinence syndrome|neonatal abstinence syndrome
5112836|NCT03291847|buprenorphine-naloxone|buprenorphine-naloxone
5112837|NCT03291834|type 1 diabetes mellitus|type 1 diabetes mellitus
5112838|NCT03291834|sports|sports
5112839|NCT03291834|child|child
5112840|NCT03291834|adolescent|adolescent
5112841|NCT03291821|DuoStim|duostim
5112842|NCT03291821|MitoScore|mitoscore
5112843|NCT03291821|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
5112844|NCT03291821|MII oocyte|mii oocyte
5112848|NCT03291743|Crohn's|crohn's
5112849|NCT03291743|Capsule endoscopy|capsule endoscopy
5112850|NCT03291743|IBD|ibd
5112851|NCT03291730|Anxiety|anxiety
5112852|NCT03291717|Mental Illness|mental illness
5112853|NCT03291717|Community Participation|community participation
5112854|NCT03291717|Stigma|stigma
5112855|NCT03291717|Photovoice|photovoice
5112856|NCT03291704|Dry Eye|dry eye
5112857|NCT03291704|Thermal Therapy|thermal therapy
5112858|NCT03291704|Meibomian Gland Dysfunction|meibomian gland dysfunction
5112859|NCT03291691|Protective Nerve Stimulation|protective nerve stimulation
5112860|NCT03291691|Regional Anesthesia|regional anesthesia
5112861|NCT03291691|Sciatic nerve block|sciatic nerve block
5112862|NCT03291691|femoral nerve block|femoral nerve block
5112863|NCT03291691|brachial plexus block|brachial plexus block
5112864|NCT03291665|Plantar Fasciitis|plantar fasciitis
5112865|NCT03291665|Plantar heel pain|plantar heel pain
5112866|NCT03291652|Ischemic Stroke|ischemic stroke
5112867|NCT03291652|atherosclerosis|atherosclerosis
5112868|NCT03291652|Plaque morphology|plaque morphology
5112869|NCT03291652|DSA/3DRA|dsa/3dra
5112870|NCT03291613|Sickle Cell Disease|sickle cell disease
5112871|NCT03291613|Adolescence|adolescence
5112872|NCT03291613|Pain Assessment|pain assessment
5112873|NCT03291613|Tablet Application|tablet application
5112874|NCT03291613|Pain|pain
5112875|NCT03291613|mHealth|mhealth
5112876|NCT03291587|lung cancer|lung cancer
5112877|NCT03291587|cancer screening|cancer screening
5112878|NCT03291587|tobacco use|tobacco use
5112879|NCT03291548|Quinoa|quinoa
5112880|NCT03291548|Functional food|functional food
5112892|NCT03291483|Physical fitness|physical fitness
5112900|NCT03291418|Healthy Volunteers, ATB-346, Naproxen sodium, GI safety|healthy volunteers, atb-346, naproxen sodium, gi safety
5112901|NCT03291392|Genetics|genetics
5112902|NCT03291392|Stroke|stroke
5112903|NCT03291392|Biobank|biobank
5112904|NCT03291392|Atherosclerosis|atherosclerosis
5112905|NCT03291379|mCRC, HCC, radiopaque beads, vandetanib|mcrc, hcc, radiopaque beads, vandetanib
5112906|NCT03291301|Insomnia|insomnia
5112907|NCT03291301|Cognitive Behavioral Therapy|cognitive behavioral therapy
5112908|NCT03291301|CBT-I|cbt-i
5112909|NCT03291301|Acupressure|acupressure
5112910|NCT03291301|Traditional Chinese Medicine|traditional chinese medicine
5112911|NCT03291288|Tenosynovial Giant Cell Tumors (TGCT)|tenosynovial giant cell tumors (tgct)
5112912|NCT03291288|Kit-mutant melanoma|kit-mutant melanoma
5112913|NCT03291288|Kit-mutant gastrointestinal stromal tumor (GIST)|kit-mutant gastrointestinal stromal tumor (gist)
5112914|NCT03291288|Cocktail drug-drug interaction (DDI)|cocktail drug-drug interaction (ddi)
5112915|NCT03291210|hyperoxemia|hyperoxemia
5112916|NCT03291210|myocardial injury|myocardial injury
5112917|NCT03291210|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5112918|NCT03291197|Suprascapular nerve block|suprascapular nerve block
5112919|NCT03291197|Median nerve block|median nerve block
5112920|NCT03291197|CRPS|crps
5112921|NCT03291197|Shoulder hand syndrome|shoulder hand syndrome
5112922|NCT03291184|neuromuscular blockade|neuromuscular blockade
5112923|NCT03291184|neuromuscular monitoring|neuromuscular monitoring
5112924|NCT03291171|physical activity|physical activity
5112925|NCT03291171|sedentary behaviour|sedentary behaviour
5112926|NCT03291171|type 2 diabetes|type 2 diabetes
5112927|NCT03291171|eHealth|ehealth
5112928|NCT03291171|mHealth|mhealth
5112929|NCT03291171|self-regulation|self-regulation
5112930|NCT03291171|behaviour change techniques|behaviour change techniques
5112931|NCT03291158|Bacterial Infections|bacterial infections
5112932|NCT03291145|Long QT Syndrome|long qt syndrome
5112933|NCT03291132|Smoke-free|smoke-free
5112934|NCT03291132|Teens|teens
5112935|NCT03291119|Cervico-medullary, Extubation Failure, Risk Predictors|cervico-medullary, extubation failure, risk predictors
5112936|NCT03291093|PET/MRI|pet/mri
5112937|NCT03291093|Amyloid|amyloid
5112938|NCT03291093|Flutemetamol|flutemetamol
5112939|NCT03291054|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5112940|NCT03291054|GIST|gist
5112941|NCT03291054|Pembrolizumab|pembrolizumab
5112942|NCT03291054|Epacadostat|epacadostat
5112943|NCT03291054|Columbia|columbia
5112944|NCT03291015|arthroscopy|arthroscopy
5112945|NCT03291015|radiographic(plain X ray)|radiographic(plain x ray)
5112946|NCT03290963|depression|depression
5112947|NCT03290963|bipolar I disorder|bipolar i disorder
5112948|NCT03290963|bipolar II disorder|bipolar ii disorder
5112954|NCT03290924|institutional delivery|institutional delivery
5112955|NCT03290911|low responders|low responders
5112956|NCT03290898|Asthma|asthma
5112957|NCT03290898|Exercise|exercise
5112958|NCT03290898|Asthma treatment|asthma treatment
5112959|NCT03290898|Inhaled corticosteroid|inhaled corticosteroid
5112960|NCT03290898|Rehabilitation|rehabilitation
5112961|NCT03290859|Procedural Sedation|procedural sedation
5112962|NCT03290833|Robotics|robotics
5112963|NCT03290833|Stroke|stroke
5112964|NCT03290833|Hand|hand
5112965|NCT03290833|neurorehabilitation|neurorehabilitation
5112966|NCT03290820|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5112967|NCT03290820|N2-3 disease|n2-3 disease
5112968|NCT03290820|distant metastasis|distant metastasis
5112969|NCT03290820|aspirin|aspirin
5112970|NCT03290820|survival|survival
5112971|NCT03290781|Ulcerative colitis|ulcerative colitis
5112972|NCT03290755|Hepatitis C|hepatitis c
5112973|NCT03290755|sexual network|sexual network
5112974|NCT03290755|sexual transmitted|sexual transmitted
5112975|NCT03290755|men who have sex with men|men who have sex with men
5112976|NCT03290755|HIV positive|hiv positive
5112977|NCT03290755|sexual behaviour|sexual behaviour
5112978|NCT03290729|wedge implants; atrophic bone|wedge implants; atrophic bone
5112997|NCT03290534|CivaTech Oncology|civatech oncology
5112998|NCT03290534|lung cancer|lung cancer
5112999|NCT03290534|lung|lung
5113000|NCT03290521|pain|pain
5113001|NCT03290521|laparoscopy|laparoscopy
5113002|NCT03290521|washing|washing
5113003|NCT03290521|intraperitoneal irrigation|intraperitoneal irrigation
5113004|NCT03290508|Prolaris|prolaris
5113005|NCT03290508|Prostate Cancer|prostate cancer
5113006|NCT03290508|Cell Cycle Progression Test|cell cycle progression test
5113007|NCT03290495|ketamine|ketamine
5113011|NCT03290495|recovery|recovery
5113012|NCT03290495|anesthesia|anesthesia
5113014|NCT03290469|Intensive Care Unit|intensive care unit
5113015|NCT03290456|Vasculitis|vasculitis
5113016|NCT03290456|GPA|gpa
5113017|NCT03290456|Granulomatosis with Polyangitis|granulomatosis with polyangitis
5113018|NCT03290456|MPA|mpa
5113019|NCT03290456|Microscopic Polyangitis|microscopic polyangitis
5113020|NCT03290456|Systemic anti-neutrophil cytoplasmic antibodies (ANCA)|systemic anti-neutrophil cytoplasmic antibodies (anca)
5113021|NCT03290456|Prednisone|prednisone
5113022|NCT03290456|glucocorticoids|glucocorticoids
5113023|NCT03290456|Remission Maintenance|remission maintenance
5113024|NCT03290456|Rituximab|rituximab
5113025|NCT03290456|Cyclophosphamide|cyclophosphamide
5113026|NCT03290443|Hepatic|hepatic
5113027|NCT03290443|Pharmacokinetics|pharmacokinetics
5113028|NCT03290443|Phase 1|phase 1
5113029|NCT03290443|Enasidenib|enasidenib
5113030|NCT03290443|CC-90007|cc-90007
5113031|NCT03290430|Nicotine Dependence|nicotine dependence
5113032|NCT03290430|applied behavioral research|applied behavioral research
5113037|NCT03290404|Axillary Block|axillary block
5113038|NCT03290404|LidocaÏne 1% adrenaliné|lidocaïne 1% adrenaliné
5113039|NCT03290391|Russia|russia
5113040|NCT03290391|Substance use|substance use
5113041|NCT03290391|Peer case managers|peer case managers
5113042|NCT03290391|ART|art
4998487|NCT04003961|Lung Cancer|lung cancer
5113044|NCT03290365|Platelet rich plasma|platelet rich plasma
5113045|NCT03290365|Osteoarthritis of knee|osteoarthritis of knee
5113046|NCT03290365|Hyaluronic acid|hyaluronic acid
5113047|NCT03290339|one-day surgery|one-day surgery
5113048|NCT03290339|hysterectomy|hysterectomy
5113049|NCT03290339|ambulatory|ambulatory
5113050|NCT03290326|Alzheimer|alzheimer
5113051|NCT03290326|Memory Problems|memory problems
5113052|NCT03290313|Depression|depression
5113053|NCT03290313|erectile dysfunction|erectile dysfunction
5113054|NCT03290313|shu gan yi yang|shu gan yi yang
5113055|NCT03290300|Nasal valve|nasal valve
5113056|NCT03290300|Nasal airway obstruction|nasal airway obstruction
5113057|NCT03290300|Quality of Life|quality of life
5113059|NCT03290274|Deep brain stimulation|deep brain stimulation
5113060|NCT03290274|Alzheimer´s Disease|alzheimer´s disease
5113061|NCT03290274|Fornix|fornix
5113062|NCT03290274|Basal nucleus of Meynert|basal nucleus of meynert
5113063|NCT03290222|Respiratory symptoms|respiratory symptoms
5113064|NCT03290222|Children|children
5113065|NCT03290209|Stomach Neoplasm|stomach neoplasm
5113066|NCT03290209|Elderly Patients|elderly patients
5113067|NCT03290209|Laparoscopic D1 Lymphadenectomy|laparoscopic d1 lymphadenectomy
5113068|NCT03290196|Shoulder|shoulder
5113069|NCT03290196|Rotator cuff|rotator cuff
5113070|NCT03290183|Confocal laser endomicroscopy|confocal laser endomicroscopy
5113071|NCT03290157|Colonoscopy|colonoscopy
5113072|NCT03290157|preparation|preparation
5113073|NCT03290157|new media|new media
5113074|NCT03290157|SPA|spa
5113075|NCT03290157|APP|app
5113076|NCT03290144|Cystic fibrosis - Pregnancy - Diabetes|cystic fibrosis - pregnancy - diabetes
5113077|NCT03290105|oropharyngeal colonization|oropharyngeal colonization
5113094|NCT03289936|preterm|preterm
5113095|NCT03289936|ventilation|ventilation
5113096|NCT03289936|nasal intermittent positive pressure ventilation|nasal intermittent positive pressure ventilation
5113097|NCT03289936|synchronization|synchronization
5113098|NCT03289936|cardio-respiratory events|cardio-respiratory events
5113099|NCT03289936|newborn|newborn
5113103|NCT03289832|Sulforaphane|sulforaphane
5113104|NCT03289832|Curcumin|curcumin
5113105|NCT03289832|Crucera-SGS|crucera-sgs
5113106|NCT03289832|Meriva-SF|meriva-sf
5113108|NCT03289832|erythema|erythema
5113109|NCT03289832|UV|uv
5113110|NCT03289832|Sunburn|sunburn
5113111|NCT03289832|Inflammation|inflammation
5113112|NCT03289832|Redness|redness
5113113|NCT03289832|ultra-violet|ultra-violet
5113114|NCT03289832|sunlight|sunlight
5113115|NCT03289819|TNBC|tnbc
5113116|NCT03289819|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5113117|NCT03289819|triple negative breast cancer|triple negative breast cancer
5113118|NCT03289793|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5113119|NCT03289793|ADHD|adhd
5113120|NCT03289793|Children|children
5113121|NCT03289793|Inattention|inattention
5113122|NCT03289793|Hyperactivity|hyperactivity
5113123|NCT03289793|Neurofeedback|neurofeedback
5113124|NCT03289793|Neuropsychology|neuropsychology
5113125|NCT03289754|knee implant|knee implant
5113126|NCT03289754|osteoarthritis|osteoarthritis
5113127|NCT03289754|patient-specific|patient-specific
5113128|NCT03289754|knee osteoarthritis|knee osteoarthritis
5113129|NCT03289741|Octreotide|octreotide
5113130|NCT03289741|Lanreotide|lanreotide
5113131|NCT03289741|17-422|17-422
5113132|NCT03289728|elderly patients|elderly patients
5113133|NCT03289728|myocardial infarction|myocardial infarction
5113134|NCT03289728|myocardial revascularization strategy|myocardial revascularization strategy
5113136|NCT03289728|coronary artery disease|coronary artery disease
5113137|NCT03289663|synergistic combination|synergistic combination
5113138|NCT03289663|insecticide resistance|insecticide resistance
5113140|NCT03289650|immunosuppression|immunosuppression
5113141|NCT03289624|Care Planning|care planning
5113142|NCT03289624|Care Values and Preferences|care values and preferences
5113143|NCT03289611|Preeclampsia|preeclampsia
5113145|NCT03289611|biomarkers|biomarkers
5113146|NCT03289611|prediction|prediction
5113147|NCT03289611|safety|safety
5113148|NCT03289611|cost|cost
5113149|NCT03289585|Hidradenitis Suppurativa|hidradenitis suppurativa
5113150|NCT03289585|Registry|registry
5113151|NCT03289546|mindfulness|mindfulness
5113152|NCT03289546|exercise|exercise
5113153|NCT03289546|cognitive function|cognitive function
5113154|NCT03289533|Cancer|cancer
5113155|NCT03289533|Hepatocellular carcinoma|hepatocellular carcinoma
5113156|NCT03289533|Liver disease|liver disease
5113157|NCT03289533|Avelumab|avelumab
5113158|NCT03289533|Axitinib|axitinib
5113159|NCT03289520|Access Blood Flow Monitoring|access blood flow monitoring
5113160|NCT03289520|Clinical Trial Vascular Access|clinical trial vascular access
5113161|NCT03289520|Fistula Failure|fistula failure
5113162|NCT03289520|Hemodialysis|hemodialysis
5113163|NCT03289520|Vascular Access|vascular access
5113164|NCT03289507|Longvida Curcumin|longvida curcumin
5113165|NCT03289507|Pharmacokinetics|pharmacokinetics
5113166|NCT03289494|Slowly Digestible Starch|slowly digestible starch
5113168|NCT03289494|Type 2 diabetes|type 2 diabetes
5113169|NCT03289494|T2D|t2d
5113170|NCT03289494|Glycemic response|glycemic response
5113171|NCT03289494|Continuous Glucose Monitoring System|continuous glucose monitoring system
5113172|NCT03289494|CGMS|cgms
5113173|NCT03289481|Heart failure|heart failure
5113174|NCT03289481|HFpEF|hfpef
5113175|NCT03289481|Nitrate supplement|nitrate supplement
5113176|NCT03289455|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
5113177|NCT03289455|CD19 Positive|cd19 positive
5113178|NCT03289455|CD22 Positive|cd22 positive
5113179|NCT03289455|Relapsed Acute Lymphoblastic Leukaemia|relapsed acute lymphoblastic leukaemia
5113180|NCT03289455|Refractory Acute Lymphoblastic Leukaemia|refractory acute lymphoblastic leukaemia
5113181|NCT03289455|AUTO3|auto3
5113184|NCT03289429|POAF|poaf
5113185|NCT03289429|Cardiac|cardiac
5113186|NCT03289429|Valve|valve
5113187|NCT03289416|knee|knee
5113188|NCT03289416|osteoarthritis|osteoarthritis
5113189|NCT03289416|platelet rich plasma (PRP)|platelet rich plasma (prp)
5113190|NCT03289416|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
5113191|NCT03289364|Breast Cancer|breast cancer
5113192|NCT03289364|Alopecia|alopecia
5113193|NCT03289364|Hair Loss|hair loss
5113194|NCT03289364|Scalp Cooling|scalp cooling
5113195|NCT03289364|Penguin Cold Caps|penguin cold caps
5113196|NCT03289338|Zoledronic acid|zoledronic acid
5113197|NCT03289338|Methylprednisolone|methylprednisolone
5113198|NCT03289338|Active Charcot's disease|active charcot's disease
5113199|NCT03289325|Cardiac surgery|cardiac surgery
5113200|NCT03289325|Dexmedetomidine|dexmedetomidine
5113201|NCT03289325|Long-term outcome|long-term outcome
5113202|NCT03289325|Mortality|mortality
5113203|NCT03289325|Quality of life|quality of life
5113204|NCT03289312|sepsis, lymphocyte|sepsis, lymphocyte
5113205|NCT03289299|myeloma|myeloma
5113206|NCT03289299|MRD|mrd
5113207|NCT03289299|smoldering|smoldering
5113208|NCT03289286|Breast Cancer|breast cancer
5113209|NCT03289286|Ambulatory surgery|ambulatory surgery
5113213|NCT03289273|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5113214|NCT03289273|real-world practice conditions|real-world practice conditions
5113215|NCT03289273|safety and effectiveness|safety and effectiveness
5113216|NCT03289273|management and treatment of liver cancer|management and treatment of liver cancer
5113217|NCT03289260|Condylomata acuminata, Fulguration, Imiquimod|condylomata acuminata, fulguration, imiquimod
5113221|NCT03289143|Alzheimer Disease|alzheimer disease
5113222|NCT03289143|Brain Diseases|brain diseases
5113224|NCT03289143|Neurodegenerative Diseases|neurodegenerative diseases
5113225|NCT03289143|Neurocognitive Disorders|neurocognitive disorders
5113226|NCT03289117|Urinary catheterization|urinary catheterization
5113227|NCT03289117|Gel installation|gel installation
5113228|NCT03289117|Novel medical device|novel medical device
5113229|NCT03289117|Indwelling urinary catheter|indwelling urinary catheter
5113230|NCT03289117|Long-term urinary catheter|long-term urinary catheter
5113231|NCT03289117|Male patients|male patients
5113232|NCT03289091|aerobic training|aerobic training
5113233|NCT03289091|aquatic exercise|aquatic exercise
5113234|NCT03289091|aging|aging
5113235|NCT03289065|Genetic|genetic
5113236|NCT03289065|Fabry Disease|fabry disease
5113237|NCT03289065|Glycolipid|glycolipid
5113238|NCT03289065|lysosomal|lysosomal
5113239|NCT03289052|Hyaluronic acid, midface|hyaluronic acid, midface
5113240|NCT03289039|Breast Cancer|breast cancer
5110361|NCT03307876|Alpha 2 Macroglobulin|alpha 2 macroglobulin
5113253|NCT03288935|refugee|refugee
5113254|NCT03288935|trauma-informed case management (TICM)|trauma-informed case management (ticm)
5113255|NCT03288935|trauma-informed cultural orientation (TICO)|trauma-informed cultural orientation (tico)
5113256|NCT03288935|PTSD|ptsd
5113257|NCT03288935|depression|depression
5113258|NCT03288935|refugee resettlement|refugee resettlement
5113259|NCT03288922|Online Hemodiafiltration|online hemodiafiltration
5113260|NCT03288922|Super high-flux dialyzer|super high-flux dialyzer
5113261|NCT03288922|Protein-bound uremic toxin|protein-bound uremic toxin
5113262|NCT03288922|P-cresol|p-cresol
5113263|NCT03288896|Adolescence|adolescence
5113264|NCT03288896|Alcohol Drinking|alcohol drinking
5113265|NCT03288896|Binge Drinking|binge drinking
5113266|NCT03288896|I-Change model|i-change model
5113267|NCT03288896|Web-based interventions|web-based interventions
5113268|NCT03288896|Computer-tailoring|computer-tailoring
5113269|NCT03288857|Naspira|naspira
5113270|NCT03288857|Suctioning|suctioning
5113271|NCT03288857|Nasal suction device|nasal suction device
5113272|NCT03288857|Children|children
5113273|NCT03288844|LSCD, Holoclar, follow-up|lscd, holoclar, follow-up
5113274|NCT03288831|Randomized, double-blinded, placebo-controlled trial|randomized, double-blinded, placebo-controlled trial
5113275|NCT03288831|Oral food challenge|oral food challenge
5113276|NCT03288753|Cochlear implant|cochlear implant
5113277|NCT03288714|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5113279|NCT03288714|sTMS|stms
5113281|NCT03288701|cardial decompensation|cardial decompensation
5113282|NCT03288701|smart scale|smart scale
5113283|NCT03288701|bioimpedance analysis|bioimpedance analysis
5113284|NCT03288701|whole body water|whole body water
5113285|NCT03288675|Major depressive disorder|major depressive disorder
5113286|NCT03288675|Treatment resistant depression|treatment resistant depression
5113287|NCT03288675|Accelerated intermittent thetaburst stimulation|accelerated intermittent thetaburst stimulation
5113288|NCT03288675|Cognitive control training|cognitive control training
5113289|NCT03288675|Neuroimaging|neuroimaging
5113290|NCT03288662|Computed tomography|computed tomography
5113291|NCT03288662|thymic epithelial tumors|thymic epithelial tumors
5113292|NCT03288610|Copeptin|copeptin
5113293|NCT03288610|Vasopressin|vasopressin
5113294|NCT03288610|Microcirculation|microcirculation
5113295|NCT03288610|Inflammation|inflammation
5113296|NCT03288610|Vasodilation|vasodilation
5113297|NCT03288610|Cardiopulmonary bypass|cardiopulmonary bypass
5113298|NCT03288597|positive rate|positive rate
5113299|NCT03288597|SUVmax|suvmax
5113300|NCT03288597|relationship|relationship
5113301|NCT03288584|Arterial stiffness|arterial stiffness
5113302|NCT03288584|Endothelial function|endothelial function
5113303|NCT03288584|Endothelial glycocalyx|endothelial glycocalyx
5113327|NCT03288545|Gemcitabine|gemcitabine
5113328|NCT03288545|Muscle invasive urothelial cancer|muscle invasive urothelial cancer
5113329|NCT03288545|Muscle invasive bladder cancer|muscle invasive bladder cancer
5113330|NCT03288545|Checkpoint Inhibitors|checkpoint inhibitors
5113331|NCT03288545|Pembrolizumab|pembrolizumab
5113332|NCT03288532|Renal Cell Carcinoma|renal cell carcinoma
5113333|NCT03288532|Immunotherapy|immunotherapy
5113334|NCT03288532|Multi-Arm Multi-Stage|multi-arm multi-stage
5113335|NCT03288519|Cerebral aneurysm|cerebral aneurysm
5113336|NCT03288519|Endovascular therapy|endovascular therapy
5113337|NCT03288519|Classic laryngeal mask airway|classic laryngeal mask airway
5113338|NCT03288519|Hemodynamic changes|hemodynamic changes
5113339|NCT03288493|CAR-T cells|car-t cells
5113340|NCT03288454|Ciraparantag|ciraparantag
5113341|NCT03288454|PER977|per977
5113342|NCT03288454|Apixaban|apixaban
5113343|NCT03288454|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
5113344|NCT03288441|Hematologic Neoplasms|hematologic neoplasms
5113355|NCT03288376|obstructive sleep apnea|obstructive sleep apnea
5113356|NCT03288376|polysomnography|polysomnography
5113358|NCT03288363|cognition|cognition
5113359|NCT03288350|Phase II Trial|phase ii trial
5113360|NCT03288350|Esophago-Gastric Adenocarcinoma|esophago-gastric adenocarcinoma
5113361|NCT03288350|Avelumab|avelumab
5113362|NCT03288337|Hidradenitis Suppurativa|hidradenitis suppurativa
5113363|NCT03288337|Quality of Life|quality of life
5113364|NCT03288298|TSCC|tscc
5113365|NCT03288298|OSCC|oscc
5113366|NCT03288298|luteolin|luteolin
5113367|NCT03288298|nanoluteolin|nanoluteolin
5113368|NCT03288298|nanotechnology|nanotechnology
5113369|NCT03288298|oral cancer|oral cancer
5113370|NCT03288298|apoptosis|apoptosis
5113373|NCT03288298|ELISA reader|elisa reader
5113374|NCT03288285|hemodiafiltration|hemodiafiltration
5113375|NCT03288285|pre-dilution|pre-dilution
5113376|NCT03288285|post-dilution|post-dilution
5113377|NCT03288285|uremic toxins|uremic toxins
5113378|NCT03288259|Transnasal endoscopy - Obesity - endoscopy without sedation|transnasal endoscopy - obesity - endoscopy without sedation
5113420|NCT03287934|selective laser sintering, stereolithography stents|selective laser sintering, stereolithography stents
5113421|NCT03287921|pulmonary care|pulmonary care
5123570|NCT03223103|GBM|gbm
5113422|NCT03287921|COPD|copd
5113423|NCT03287921|small airway disease|small airway disease
5113424|NCT03287921|hyperinflation|hyperinflation
5113425|NCT03287908|Amgen|amgen
5113426|NCT03287908|Phase 1|phase 1
5113427|NCT03287908|Phase 2|phase 2
5113428|NCT03287908|Phase 1/2|phase 1/2
5113429|NCT03287908|Clinical Trial|clinical trial
5113430|NCT03287908|Oncology/Hematology|oncology/hematology
5113431|NCT03287908|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5113432|NCT03287908|Immunotherapy|immunotherapy
5113433|NCT03287895|Cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
5113435|NCT03287895|Decision-making|decision-making
5113436|NCT03287895|Advance Care Planning|advance care planning
5113437|NCT03287895|End of life|end of life
5113438|NCT03287895|Code Status|code status
5113439|NCT03287895|Goals of Care|goals of care
5113440|NCT03287895|Communication|communication
5113441|NCT03287882|preconception supplementation|preconception supplementation
5113442|NCT03287882|multiple micronutrients|multiple micronutrients
5113443|NCT03287882|low birth weight|low birth weight
5113445|NCT03287869|Mania|mania
5113446|NCT03287869|Brexpiprazole|brexpiprazole
5113447|NCT03287856|Valve-in-valve|valve-in-valve
5113448|NCT03287856|TAVI|tavi
5113449|NCT03287843|Locally advanced rectal cancer|locally advanced rectal cancer
5113450|NCT03287843|Neoadjuvant chemoradiation|neoadjuvant chemoradiation
5113451|NCT03287830|text message|text message
5751440|NCT00314587|child|child
5113452|NCT03287830|Short message service (SMS)|short message service (sms)
5113453|NCT03287830|mHealth|mhealth
5113460|NCT03287804|Multiple Myeloma|multiple myeloma
5113461|NCT03287804|Relapsed Multiple Myeloma|relapsed multiple myeloma
5113462|NCT03287804|Refractory Multiple Myeloma|refractory multiple myeloma
5113463|NCT03287804|AUTO2|auto2
5113479|NCT03287739|Upper Extremity|upper extremity
5113480|NCT03287739|Cohort Studies|cohort studies
5113481|NCT03287739|Prognosis|prognosis
5113484|NCT03287726|Gastrointestinal microbiome|gastrointestinal microbiome
5113486|NCT03287726|Body weight maintenance|body weight maintenance
5113487|NCT03287726|Body composition|body composition
5113488|NCT03287661|chronic pain|chronic pain
5113489|NCT03287661|online treatment|online treatment
5113490|NCT03287661|acceptance-based therapy|acceptance-based therapy
5113491|NCT03287648|optical coherence tomography|optical coherence tomography
5113492|NCT03287648|blue fundus autofluorescence|blue fundus autofluorescence
5113493|NCT03287596|Spondylarthropathy|spondylarthropathy
5113494|NCT03287596|Tendinopathy|tendinopathy
5113496|NCT03287596|Healthy Volunteer|healthy volunteer
5113497|NCT03287570|Osteoarthritis, Knee|osteoarthritis, knee
5113498|NCT03287570|Moxibustion|moxibustion
5113499|NCT03287544|Aphasia|aphasia
5113500|NCT03287544|Rehabilitation|rehabilitation
5113501|NCT03287544|Communication|communication
5113502|NCT03287544|Linguistics|linguistics
5113503|NCT03287531|conventional therapy|conventional therapy
5113504|NCT03287518|Endothelial function|endothelial function
5113505|NCT03287518|Blood pressure|blood pressure
5113506|NCT03287518|Lipid metabolism|lipid metabolism
5113507|NCT03287518|EndoPAT score RHI|endopat score rhi
5113508|NCT03287479|vitrification|vitrification
5113509|NCT03287479|semi-automated|semi-automated
5113510|NCT03287479|manual|manual
5113511|NCT03287466|oxygen|oxygen
5110578|NCT03306550|PK-PD model|pk-pd model
5113515|NCT03287440|Lung Diseases|lung diseases
5113516|NCT03287440|Self-management|self-management
5113517|NCT03287440|Chronic Disease|chronic disease
5113518|NCT03287440|Socio-economic status|socio-economic status
5113519|NCT03287427|Advanced|advanced
5113520|NCT03287427|Metastatic|metastatic
5113521|NCT03287401|EEG|eeg
5113522|NCT03287401|PACU Delirium|pacu delirium
5113523|NCT03287388|Laparoscopic surgery|laparoscopic surgery
5113524|NCT03287388|Abdominal working space|abdominal working space
5113525|NCT03287388|Moderate neuromuscular blockade|moderate neuromuscular blockade
5113526|NCT03287388|Deep neuromuscular blockade|deep neuromuscular blockade
5113527|NCT03287388|MRI measurement|mri measurement
5113528|NCT03287362|major depressive disorder|major depressive disorder
5113529|NCT03287362|cognitive behavioral therapy|cognitive behavioral therapy
5113530|NCT03287362|supportive therapy|supportive therapy
5113531|NCT03287362|schema therapy|schema therapy
5113532|NCT03287362|biomarkers|biomarkers
5113533|NCT03287362|neuropsychology|neuropsychology
5113534|NCT03287362|circadian rhythm|circadian rhythm
5113537|NCT03287323|palliative care|palliative care
5113538|NCT03287323|surgical intensive care|surgical intensive care
5113539|NCT03287323|family satisfaction|family satisfaction
5113540|NCT03287323|ICU decision-making|icu decision-making
5113541|NCT03287323|end-of-life care|end-of-life care
5113542|NCT03287310|eosinophils|eosinophils
5113543|NCT03287310|pharmacokinetics|pharmacokinetics
5113544|NCT03287310|First time in Human|first time in human
5113545|NCT03287310|GSK3511294|gsk3511294
5113546|NCT03287310|pharmacodynamics|pharmacodynamics
5113547|NCT03287310|asthma|asthma
5113548|NCT03287271|ovarian cancer|ovarian cancer
5113549|NCT03287271|cancer|cancer
5113552|NCT03287271|paclitaxel|paclitaxel
5113553|NCT03287271|VS-6063|vs-6063
5113554|NCT03287271|primary peritoneal carcinoma|primary peritoneal carcinoma
5113555|NCT03287271|fallopian tube|fallopian tube
5113556|NCT03287271|defactinib|defactinib
5113557|NCT03287258|perineal massage|perineal massage
5113558|NCT03287258|health education|health education
5113559|NCT03287258|perineal tear|perineal tear
5113560|NCT03287258|episiotomy|episiotomy
5113561|NCT03287258|pelvic floor muscle exercise|pelvic floor muscle exercise
5113562|NCT03287245|polycythemia vera|polycythemia vera
5113563|NCT03287245|PV|pv
5113564|NCT03287245|P vera|p vera
5113565|NCT03287245|myeloproliferative diseases|myeloproliferative diseases
5113566|NCT03287245|hematologic diseases|hematologic diseases
5113567|NCT03287245|myeloproliferative neoplasm|myeloproliferative neoplasm
5113569|NCT03287232|Prasterone|prasterone
5113570|NCT03287232|DHEA|dhea
5113571|NCT03287232|Menopause|menopause
5113572|NCT03287232|Sexual Disorder|sexual disorder
5113573|NCT03287180|Adolescent Community Reinforcement Approach|adolescent community reinforcement approach
5113574|NCT03287180|A-CRA|a-cra
5113575|NCT03287180|Opioid-Related Disorders|opioid-related disorders
5113576|NCT03287180|Behavior|behavior
5113577|NCT03287180|Psychosocial treatment|psychosocial treatment
5177238|NCT02883153|PET/CT|pet/ct
5113578|NCT03287180|Pharmacotherapy|pharmacotherapy
5113579|NCT03287180|Randomized controlled|randomized controlled
5113580|NCT03287180|Adolescent|adolescent
4998974|NCT04001023|hypoxia|hypoxia
5113581|NCT03287180|Young adult|young adult
5113582|NCT03287154|Alcohol Abstinence|alcohol abstinence
5113583|NCT03287154|Alcohol Addiction|alcohol addiction
5114180|NCT03283046|Yervoy|yervoy
5113584|NCT03287154|Alcohol Consumption|alcohol consumption
5113585|NCT03287154|Alcohol Dependence|alcohol dependence
5113586|NCT03287141|noninvasive ventilation|noninvasive ventilation
5113587|NCT03287141|continuous positive airway pressure|continuous positive airway pressure
5113588|NCT03287141|intermittent positive-pressure breathing|intermittent positive-pressure breathing
5113589|NCT03287141|exercise test|exercise test
5113590|NCT03287141|physical endurance|physical endurance
5113591|NCT03287141|physical fitness|physical fitness
5113592|NCT03287089|Nitrofurantoin|nitrofurantoin
5113593|NCT03287089|Prolapse|prolapse
5113594|NCT03287089|Pelvic Organ Prolapse|pelvic organ prolapse
5113595|NCT03287089|Anti-incontinence procedure|anti-incontinence procedure
5113596|NCT03287089|Urinary retention|urinary retention
5113597|NCT03287089|Urinary Tract Infection|urinary tract infection
5113598|NCT03287089|Short-term catheterization|short-term catheterization
5113599|NCT03287076|stroke|stroke
5113600|NCT03287076|glucose|glucose
5113601|NCT03287076|exenatide|exenatide
5113602|NCT03287037|Unipolar depression|unipolar depression
5113603|NCT03287037|bipolar depression|bipolar depression
5113604|NCT03287037|Transcranial direct current stimulation|transcranial direct current stimulation
5113605|NCT03287011|dental plaque|dental plaque
5113606|NCT03287011|tooth pastes|tooth pastes
5113607|NCT03287011|oral hygiene|oral hygiene
5113608|NCT03286998|placenta previa|placenta previa
5113609|NCT03286998|color doppler|color doppler
5113610|NCT03286998|placenta accreta|placenta accreta
5113625|NCT03286842|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
5113627|NCT03286842|Somatic BRCA1/2 mutations|somatic brca1/2 mutations
5113628|NCT03286842|BRCA1|brca1
5113629|NCT03286842|BRCA2|brca2
5113630|NCT03286816|type 1 diabetes mellitus|type 1 diabetes mellitus
5113631|NCT03286816|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
5113632|NCT03286816|lactate|lactate
5113633|NCT03286816|MR spectroscopy|mr spectroscopy
5113634|NCT03286790|elderly|elderly
5113635|NCT03286777|6-prenylnaringenin|6-prenylnaringenin
5113636|NCT03286777|Bioavailability|bioavailability
5113637|NCT03286777|Pharmacokinetics|pharmacokinetics
5113638|NCT03286777|PBMC|pbmc
5113639|NCT03286712|Flow mediated dilatation|flow mediated dilatation
5113640|NCT03286712|Brachial artery|brachial artery
5113641|NCT03286712|Anemia|anemia
5113642|NCT03286712|Chronic kidney disease|chronic kidney disease
5113643|NCT03286712|Renogen|renogen
5113644|NCT03286712|Erythropoietin Alpha|erythropoietin alpha
5113645|NCT03286686|optic ataxia|optic ataxia
5113646|NCT03286686|posterior parietal cortex functions|posterior parietal cortex functions
5113652|NCT03286673|calcium and phosphorus metabolism|calcium and phosphorus metabolism
5113654|NCT03286660|COPD|copd
5113655|NCT03286660|Rehabilitation|rehabilitation
5113656|NCT03286647|grief, periodontal disease|grief, periodontal disease
5113657|NCT03286621|eye tracking|eye tracking
5113658|NCT03286621|visual preference|visual preference
5113659|NCT03286595|early psychosis|early psychosis
5113660|NCT03286595|clinical high risk|clinical high risk
5113661|NCT03286595|mobile health|mobile health
5113662|NCT03286556|Acute Exacerbation of Idiopathic Pulmonary Fibrosis|acute exacerbation of idiopathic pulmonary fibrosis
5113663|NCT03286543|electrical stimulation|electrical stimulation
5113664|NCT03286543|neurostimulation|neurostimulation
5113666|NCT03286543|pain following total knee replacement|pain following total knee replacement
5113667|NCT03286543|total knee arthroplasty|total knee arthroplasty
5113668|NCT03286530|Acute Myeloid Leukemia|acute myeloid leukemia
5113669|NCT03286530|Acute Myeloid Leukemia in Remission|acute myeloid leukemia in remission
5751441|NCT00314587|treatment|treatment
5113670|NCT03286530|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
5113671|NCT03286517|Puberty, Sexuality|puberty, sexuality
5113672|NCT03286491|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system|acute coronary syndrome, risk classification, 30 day adverse event, clinical decision support system
5113673|NCT03286478|body image|body image
5113674|NCT03286478|school|school
5113675|NCT03286478|adolescence|adolescence
5113676|NCT03286478|intervention|intervention
5113677|NCT03286478|task-shifting|task-shifting
5114181|NCT03283046|BMS-734016|bms-734016
5113684|NCT03286452|Chronic wounds|chronic wounds
5113685|NCT03286452|Acute wounds|acute wounds
5113686|NCT03286426|vision screening|vision screening
5113687|NCT03286426|portable fundus camera|portable fundus camera
5113688|NCT03286426|acne medication|acne medication
5113689|NCT03286400|CTAG|ctag
5113690|NCT03286400|TEVAR|tevar
5113691|NCT03286387|Memory|memory
5113692|NCT03286387|naturalistic|naturalistic
5113693|NCT03286387|context|context
5113694|NCT03286387|fMRI|fmri
5113695|NCT03286387|Attention|attention
5113696|NCT03286374|Obesity|obesity
5113697|NCT03286374|Occupational rehabilitation|occupational rehabilitation
5113698|NCT03286374|Sick leave|sick leave
5113699|NCT03286374|Life style treatment|life style treatment
5113700|NCT03286335|Brain Tumor|brain tumor
5113701|NCT03286283|Rhytides|rhytides
5113702|NCT03286283|Wrinkle Reduction|wrinkle reduction
5113703|NCT03286283|J-Plasma|j-plasma
5113704|NCT03286283|Dermal Resurfacing|dermal resurfacing
5113706|NCT03286270|validation tool|validation tool
5113707|NCT03286270|Impaired fractures|impaired fractures
5113708|NCT03286257|Vascular function|vascular function
5113709|NCT03286257|Vascular structure|vascular structure
5113710|NCT03286257|Thermoregulation|thermoregulation
5113711|NCT03286257|Hot flushes|hot flushes
5113712|NCT03286257|Cerebral blood flow|cerebral blood flow
5113713|NCT03286257|Exercise training|exercise training
5113717|NCT03286153|Hemophilia A|hemophilia a
5113718|NCT03286153|FVIII|fviii
5113719|NCT03286153|Ideal body weight|ideal body weight
5113720|NCT03286153|Actual body weight|actual body weight
5113721|NCT03286140|endovenous ablation|endovenous ablation
5113722|NCT03286075|DLPFC, tDCS, emotional processing|dlpfc, tdcs, emotional processing
5113723|NCT03286036|Biomarkers, early detection|biomarkers, early detection
5113724|NCT03286023|brain metastases|brain metastases
5113725|NCT03286023|stereotactic radiation|stereotactic radiation
5113726|NCT03286023|cyberknife|cyberknife
5113727|NCT03285997|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
5113853|NCT03285178|Olinciguat|olinciguat
5113728|NCT03285945|Positron-Emission Tomography|positron-emission tomography
5113729|NCT03285932|Brain Metastase|brain metastase
5113730|NCT03285932|Radiation of resection cavity|radiation of resection cavity
5113731|NCT03285932|WBRT (whole brain radiotherapy)|wbrt (whole brain radiotherapy)
5113732|NCT03285932|SRS (stereotactic radiosurgery)|srs (stereotactic radiosurgery)
5113733|NCT03285919|perturbed walking|perturbed walking
5113734|NCT03285919|stepping response|stepping response
5113736|NCT03285854|Dialysis|dialysis
5113737|NCT03285854|calcium|calcium
5113738|NCT03285854|mineral and bone disorder (MBD)|mineral and bone disorder (mbd)
5113739|NCT03285854|calcification|calcification
5113740|NCT03285854|DEXA|dexa
5113741|NCT03285854|peripheral quantitative CT scan (pqCT)|peripheral quantitative ct scan (pqct)
5113742|NCT03285841|cervical cancer|cervical cancer
5113743|NCT03285841|vulvar cancer|vulvar cancer
5113762|NCT03285724|posterior prolapse|posterior prolapse
5113763|NCT03285685|Analgesia|analgesia
5113764|NCT03285685|Facial pain|facial pain
5113765|NCT03285685|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5113766|NCT03285685|Temporomandibular disorders|temporomandibular disorders
5113767|NCT03285672|Hot Flashes, vasomotor symptoms, postmenopausal|hot flashes, vasomotor symptoms, postmenopausal
5113768|NCT03285659|depression|depression
5113769|NCT03285659|Primary Health Care|primary health care
5113770|NCT03285659|Health Plan Implementation|health plan implementation
5113771|NCT03285659|Collaborative care|collaborative care
5113772|NCT03285659|Patient-Centered Care|patient-centered care
5113773|NCT03285646|Knee|knee
5113774|NCT03285646|Hip|hip
5113775|NCT03285555|barbed suture|barbed suture
5113776|NCT03285555|knoteless suture|knoteless suture
5113777|NCT03285555|closure|closure
5113778|NCT03285555|wound|wound
5113779|NCT03285555|time|time
5113780|NCT03285555|total hip arthroplasty|total hip arthroplasty
5113781|NCT03285542|adhesive|adhesive
5113782|NCT03285542|total knee arthroplasty|total knee arthroplasty
5113783|NCT03285542|wound|wound
5113784|NCT03285542|closure|closure
5113785|NCT03285542|time|time
5113786|NCT03285542|barbed suture|barbed suture
5113787|NCT03285542|knoteless suture|knoteless suture
5113788|NCT03285529|barbed suture|barbed suture
5113789|NCT03285529|knoteless suture|knoteless suture
5113790|NCT03285529|total knee arthroplasty|total knee arthroplasty
5113791|NCT03285529|wound|wound
5113792|NCT03285529|closure|closure
5113793|NCT03285529|time|time
5113794|NCT03285516|transdiagnostic treatment|transdiagnostic treatment
5113795|NCT03285516|emotional disorders|emotional disorders
5113796|NCT03285516|veterans|veterans
5113797|NCT03285516|rural|rural
5113798|NCT03285490|Actinic Keratosis|actinic keratosis
5113799|NCT03285490|Keratosis|keratosis
5113800|NCT03285490|Keratosis, Actinic|keratosis, actinic
5113801|NCT03285490|Precancerous Conditions|precancerous conditions
5113802|NCT03285490|Neoplasms|neoplasms
5113803|NCT03285490|Sun Damaged Skin|sun damaged skin
5113805|NCT03285477|Actinic Keratosis|actinic keratosis
5113806|NCT03285477|Keratosis|keratosis
5113807|NCT03285477|Keratosis, Actinic|keratosis, actinic
5113808|NCT03285477|Skin Diseases|skin diseases
5113809|NCT03285477|Actinic Keratoses|actinic keratoses
5113810|NCT03285477|Precancerous Conditions|precancerous conditions
5113811|NCT03285477|Neoplasms|neoplasms
5113812|NCT03285464|knee|knee
5113813|NCT03285464|hip|hip
5113814|NCT03285464|exercise|exercise
5113815|NCT03285464|proximal control|proximal control
5113816|NCT03285464|PFPS|pfps
5113817|NCT03285451|Submental ultrasound, Obstructive sleep apnea|submental ultrasound, obstructive sleep apnea
5113818|NCT03285438|Venous Thromboembolism|venous thromboembolism
5113819|NCT03285438|Anticoagulant|anticoagulant
5113820|NCT03285438|Direct oral anticoagulant|direct oral anticoagulant
5113821|NCT03285438|risk of recurrent venous thromboembolism|risk of recurrent venous thromboembolism
5113822|NCT03285438|anticoagulant-related bleeding|anticoagulant-related bleeding
5113823|NCT03285425|Batten's disease|batten's disease
5113824|NCT03285425|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
5113825|NCT03285412|Breast Cancer|breast cancer
5113826|NCT03285399|Nepal|nepal
5113827|NCT03285399|Breastfeeding|breastfeeding
5113828|NCT03285399|Micronutrients|micronutrients
5113829|NCT03285399|Women|women
5113830|NCT03285399|Infants|infants
5113831|NCT03285360|Bifluoride, sylc, hypersensitivity,|bifluoride, sylc, hypersensitivity,
5113832|NCT03285347|parkinson|parkinson
5113844|NCT03285204|optical coherence tomography|optical coherence tomography
5113845|NCT03285204|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5113847|NCT03285191|Concept elicitation|concept elicitation
5113848|NCT03285191|Real-time data capture|real-time data capture
5113849|NCT03285191|Rheumatoid arthritis|rheumatoid arthritis
5113850|NCT03285191|GSK3196165|gsk3196165
5113851|NCT03285178|Sickle Cell Disease|sickle cell disease
5113852|NCT03285178|SCD|scd
5113854|NCT03285178|IW-1701|iw-1701
5113855|NCT03285152|Ketogenic Diet|ketogenic diet
5113856|NCT03285152|17-396|17-396
5113857|NCT03285139|Postpartum depression|postpartum depression
5113858|NCT03285139|CBT|cbt
5113859|NCT03285139|Lay Peer|lay peer
5113860|NCT03285074|Diagnostic discordance of obesity|diagnostic discordance of obesity
5113861|NCT03285074|all-cause mortality|all-cause mortality
5113862|NCT03285048|cognitive impairment|cognitive impairment
5113863|NCT03285035|Cryotherapy|cryotherapy
5113864|NCT03285035|Palliation|palliation
5113865|NCT03285035|Dysphagia|dysphagia
5113866|NCT03285022|Incomplete caries removel|incomplete caries removel
5113867|NCT03285022|Partial caries removel|partial caries removel
5113868|NCT03284970|Interferon beta-1a|interferon beta-1a
5113869|NCT03284970|Dimethyl fumarate|dimethyl fumarate
5113870|NCT03284970|Rebif|rebif
5113871|NCT03284970|Tecfidera|tecfidera
5113872|NCT03284970|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5113873|NCT03284892|postextubation dysphagia|postextubation dysphagia
5113874|NCT03284892|endotracheal intubation|endotracheal intubation
5752147|NCT00311792|training|training
5113875|NCT03284892|randomized controlled trial|randomized controlled trial
5113876|NCT03284892|dysphagia intervention|dysphagia intervention
5113877|NCT03284892|dysphagia screening|dysphagia screening
5113879|NCT03284879|Psoriasis arthropathica|psoriasis arthropathica
5113880|NCT03284879|Serious infections|serious infections
5113881|NCT03284879|Gastrointestinal Disorders|gastrointestinal disorders
5113882|NCT03284879|Serious Hypersensitivity|serious hypersensitivity
5113883|NCT03284879|Weight Decrease|weight decrease
5113884|NCT03284879|Vasculitis|vasculitis
5113885|NCT03284879|Malignancies|malignancies
5113886|NCT03284879|Depression and Suicidal Ideation|depression and suicidal ideation
5113891|NCT03284827|edoxaban|edoxaban
5113892|NCT03284827|dual antiplatelet therapy|dual antiplatelet therapy
5113893|NCT03284827|cerebral embolization|cerebral embolization
5113894|NCT03284827|leaflet thrombosis|leaflet thrombosis
5113895|NCT03284814|coenzyme q10|coenzyme q10
5113896|NCT03284814|single dose bioavailability|single dose bioavailability
5113897|NCT03284814|multiple dose bioavailability|multiple dose bioavailability
5113898|NCT03284788|acceptance-based therapy|acceptance-based therapy
5113899|NCT03284788|adolescents|adolescents
5113900|NCT03284788|weight|weight
5113901|NCT03284788|weight loss|weight loss
5113902|NCT03284788|obesity|obesity
5113903|NCT03284788|overweight|overweight
5113904|NCT03284749|Copper Oxide|copper oxide
5113905|NCT03284749|Antibiotic Resistance|antibiotic resistance
5113906|NCT03284723|HER2|her2
5113907|NCT03284723|PF-06804103|pf-06804103
5113908|NCT03284723|ADC|adc
5113909|NCT03284723|breast cancer|breast cancer
5113910|NCT03284723|gastric cancer|gastric cancer
5113911|NCT03284723|esophagogastric cancer|esophagogastric cancer
5113912|NCT03284723|non-small cell lung cancer|non-small cell lung cancer
5113913|NCT03284723|neoplasms|neoplasms
5113914|NCT03284723|solid tumors|solid tumors
5113915|NCT03284723|human epidermal growth receptor 2|human epidermal growth receptor 2
5113916|NCT03284723|NSCLC|nsclc
5113917|NCT03284710|HIV|hiv
5113918|NCT03284671|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5113919|NCT03284671|Supplementary motor area|supplementary motor area
5113920|NCT03284671|Orbitofrontal cortex|orbitofrontal cortex
5113921|NCT03284658|Tyrosinemia Type 1|tyrosinemia type 1
5113923|NCT03284632|Tobacco|tobacco
5113924|NCT03284632|E-Cigarettes|e-cigarettes
5113925|NCT03284632|Toxicants|toxicants
5113926|NCT03284632|Formaldehyde DNA Adducts|formaldehyde dna adducts
5113927|NCT03284632|Oxidative Damage|oxidative damage
5113928|NCT03284567|Breast cancer|breast cancer
5113929|NCT03284567|Football|football
5113930|NCT03284567|Late effects|late effects
4999303|NCT03999151|Diet|diet
5113931|NCT03284567|Physical exercise|physical exercise
5113932|NCT03284567|Soccer training|soccer training
5113933|NCT03284567|Rehabilitation|rehabilitation
5113934|NCT03284567|Bone mineralization|bone mineralization
5113935|NCT03284567|Body composition|body composition
5113936|NCT03284567|Fitness|fitness
5113937|NCT03284567|Aerobic capacity|aerobic capacity
5113938|NCT03284554|Satiety|satiety
5113939|NCT03284554|Nutrients|nutrients
5113940|NCT03284554|Appetite|appetite
5113941|NCT03284554|Encapsulation|encapsulation
5113942|NCT03284554|Lipid|lipid
5113946|NCT03284476|Nosocomial Peritonitis|nosocomial peritonitis
5113947|NCT03284476|Community-acquired Peritonitis|community-acquired peritonitis
5113948|NCT03284476|Post-operative Peritonitis|post-operative peritonitis
5113949|NCT03284463|acute ischemic stroke|acute ischemic stroke
5113950|NCT03284463|glibenclamide|glibenclamide
5113951|NCT03284463|rt-PA|rt-pa
5113952|NCT03284463|blood-brain barrier|blood-brain barrier
5113953|NCT03284463|brain edema|brain edema
5113954|NCT03284450|Dance|dance
5113955|NCT03284450|Sprint|sprint
5113956|NCT03284450|Females|females
5113957|NCT03284450|Recovery|recovery
5113958|NCT03284424|PD1|pd1
5113959|NCT03284424|PD-1|pd-1
5113960|NCT03284424|PDL1|pdl1
5113961|NCT03284424|PD-L1|pd-l1
5113962|NCT03284398|parenteral nutrition|parenteral nutrition
5113963|NCT03284398|ICU|icu
5113964|NCT03284398|3-chamber bags|3-chamber bags
5113965|NCT03284398|ICD-9-CM|icd-9-cm
5113966|NCT03284398|BSI|bsi
5113967|NCT03284398|Medical records system|medical records system
5113968|NCT03284398|computerized|computerized
5113969|NCT03284359|Critical Illness|critical illness
5113970|NCT03284359|Mechanical Ventilation|mechanical ventilation
5113971|NCT03284359|Economics, Behavioral|economics, behavioral
5113972|NCT03284359|Surrogate decision maker|surrogate decision maker
5113973|NCT03284307|Sedation|sedation
5113974|NCT03284307|Propofol|propofol
5113975|NCT03284307|Dexmedetomidine|dexmedetomidine
5113976|NCT03284307|Ketamine|ketamine
5113977|NCT03284307|Sevoflurane|sevoflurane
5113978|NCT03284307|Electroencephalogram|electroencephalogram
5113980|NCT03284255|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
5114182|NCT03283046|MDX010|mdx010
5113982|NCT03284255|Cardiac Catheterization|cardiac catheterization
5113983|NCT03284255|Tomography, Optical Coherence|tomography, optical coherence
5113985|NCT03284242|Transplant|transplant
5113986|NCT03284229|ELCA|elca
5113987|NCT03284229|Coronary Artery Disease|coronary artery disease
5113988|NCT03284229|India|india
5113989|NCT03284151|prostate cancer|prostate cancer
5113990|NCT03284151|good prognosis|good prognosis
5113991|NCT03284151|focused treatment|focused treatment
5113992|NCT03284151|Cyberknife|cyberknife
5113993|NCT03284138|Schizophrenia|schizophrenia
5113994|NCT03284138|rTMS|rtms
5113995|NCT03284138|first rank symptoms|first rank symptoms
5113996|NCT03284112|Dementia, Schools, Nutrition, Health|dementia, schools, nutrition, health
5113997|NCT03284086|Oxygen consumption|oxygen consumption
5113998|NCT03284086|Physical endurance|physical endurance
5113999|NCT03284073|uterus|uterus
5114000|NCT03284073|transplantation|transplantation
5114001|NCT03284073|infertility|infertility
5114002|NCT03284060|Cognitive remediation, 22q11.2 deletion syndrome|cognitive remediation, 22q11.2 deletion syndrome
5114003|NCT03284008|Breast Neoplasm|breast neoplasm
5114004|NCT03284008|Physiotherapy|physiotherapy
5114005|NCT03284008|Rehabilitation|rehabilitation
5114006|NCT03283982|Ventral Hernia|ventral hernia
5114007|NCT03283982|Robotic|robotic
5114008|NCT03283982|Laparoscopic|laparoscopic
5114009|NCT03283982|Pain scores|pain scores
5114010|NCT03283930|anxiety, cbt, abmt|anxiety, cbt, abmt
5114011|NCT03283904|Children|children
5114012|NCT03283904|Schools|schools
5114013|NCT03283891|Educational intervention|educational intervention
5114014|NCT03283891|Watson's theory of human caring|watson's theory of human caring
5114015|NCT03283891|Quality of working life of haemodialysis nurses|quality of working life of haemodialysis nurses
5114016|NCT03283891|Quality of life of haemodialysis patients|quality of life of haemodialysis patients
5114017|NCT03283839|Temporo-mandibular dysfunction|temporo-mandibular dysfunction
5114018|NCT03283839|Balance control|balance control
5114019|NCT03283839|Orientation function|orientation function
5114020|NCT03283826|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5114021|NCT03283826|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5114022|NCT03283826|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5114039|NCT03283800|Copper Oxide|copper oxide
5114040|NCT03283800|Compression Therapy|compression therapy
5114041|NCT03283800|Chronic Venous Disease|chronic venous disease
5114042|NCT03283800|Randomised Controlled Trial|randomised controlled trial
5114043|NCT03283800|Lipodermatosclerosis|lipodermatosclerosis
5114044|NCT03283787|Pressure Ulcer|pressure ulcer
5114046|NCT03283787|ACell MicroMatrix®|acell micromatrix®
5114047|NCT03283787|ACell Cytal™|acell cytal™
5114048|NCT03283787|Extracellular Matrix|extracellular matrix
5114049|NCT03283787|Urinary Bladder Matrix|urinary bladder matrix
5114050|NCT03283787|Wound|wound
5114051|NCT03283761|FOLFOX|folfox
5114052|NCT03283761|Nab-Paclitaxel|nab-paclitaxel
5114053|NCT03283735|Deprescribing|deprescribing
5114054|NCT03283735|Polypharmacy|polypharmacy
5114055|NCT03283735|Elderly|elderly
5114056|NCT03283735|Enablement|enablement
5114057|NCT03283735|Quality of Life|quality of life
5114058|NCT03283683|rest-activity rhythm|rest-activity rhythm
5114066|NCT03283644|Matched Healthy Controls|matched healthy controls
5114067|NCT03283631|Malignant Glioma|malignant glioma
5114068|NCT03283631|INTERCEPT|intercept
5114069|NCT03283631|Pro00083828|pro00083828
5114070|NCT03283631|Adult|adult
5114071|NCT03283631|Chimeric Antigen Receptor|chimeric antigen receptor
5114072|NCT03283631|CAR T cell|car t cell
5114073|NCT03283631|EGFRvIII|egfrviii
5114074|NCT03283618|Weight loss|weight loss
5114075|NCT03283618|Video conferencing|video conferencing
5114076|NCT03283618|Health coaching|health coaching
5114077|NCT03283618|Telemedicine|telemedicine
5114078|NCT03283618|mHealth|mhealth
5114079|NCT03283618|Obesity|obesity
5114080|NCT03283566|Pancreatectomy|pancreatectomy
5752148|NCT00311792|teaching|teaching
5114081|NCT03283566|Autologous Islet Transplantation|autologous islet transplantation
5114082|NCT03283566|Pancreatitis|pancreatitis
5114083|NCT03283566|Diabetes|diabetes
5114084|NCT03283566|Hydroxychloroquine|hydroxychloroquine
5114085|NCT03283553|breast cancer|breast cancer
5114086|NCT03283540|Low Anterior Resection|low anterior resection
5114088|NCT03283501|PCI|pci
5114089|NCT03283488|anorexia|anorexia
5114090|NCT03283488|cachexia|cachexia
5114091|NCT03283488|mirtazapine|mirtazapine
5114092|NCT03283488|megestrol|megestrol
5114093|NCT03283488|palliative care|palliative care
5114094|NCT03283436|Laparoscopy|laparoscopy
5114095|NCT03283436|Superior hypogastric plexus block|superior hypogastric plexus block
5114096|NCT03283410|propofol|propofol
5114097|NCT03283410|dose-response|dose-response
5114098|NCT03283410|elderly|elderly
5114099|NCT03283410|young adults|young adults
5114100|NCT03283384|Breast cancer|breast cancer
5114101|NCT03283384|Ribociclib|ribociclib
5114102|NCT03283384|Letrozole|letrozole
5114103|NCT03283384|Chemotherapy|chemotherapy
5114104|NCT03283384|CDK4|cdk4
5114105|NCT03283384|CDK6|cdk6
5114106|NCT03283384|Ki67|ki67
5114107|NCT03283384|NEOLBC|neolbc
5114108|NCT03283371|Drug Resistant Focal Epilepsy, Natalizumab, Seizure|drug resistant focal epilepsy, natalizumab, seizure
5114109|NCT03283358|Prevention and control|prevention and control
5114110|NCT03283345|breast cancer|breast cancer
5114111|NCT03283345|menstrual cycle|menstrual cycle
5114112|NCT03283345|breast surgery|breast surgery
5114124|NCT03283319|Virus Diseases|virus diseases
5114125|NCT03283319|Respiratory Tract Infections|respiratory tract infections
5114126|NCT03283319|Respiratory Tract Diseases|respiratory tract diseases
5114127|NCT03283319|MF59|mf59
5114128|NCT03283319|AS03|as03
5114129|NCT03283319|Adjuvants|adjuvants
5114130|NCT03283319|Immunologic|immunologic
5114131|NCT03283293|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5114132|NCT03283293|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
5114133|NCT03283293|Target Volume Delineation|target volume delineation
5114134|NCT03283293|Locoregional Failure Pattern|locoregional failure pattern
5114135|NCT03283293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5114136|NCT03283280|Short fiber reinforced resin composite|short fiber reinforced resin composite
5114137|NCT03283280|Nanohybrid resin composite|nanohybrid resin composite
5114138|NCT03283280|Indirect resin composite restoration|indirect resin composite restoration
5114139|NCT03283267|Healthy Chinese Subjects, Pharmacodynamic Study|healthy chinese subjects, pharmacodynamic study
5114140|NCT03283254|Postpartum Depression Treatment|postpartum depression treatment
5114141|NCT03283202|Diffuse B-Cell Lymphoma|diffuse b-cell lymphoma
5114142|NCT03283202|R-CHOP-21|r-chop-21
5114143|NCT03283202|International Prognostic Index (IPI)|international prognostic index (ipi)
5114144|NCT03283189|Use of cosmetics|use of cosmetics
5114145|NCT03283189|Pregnant women|pregnant women
5114146|NCT03283189|Risk perception|risk perception
5114147|NCT03283189|Preventive attitude|preventive attitude
5114148|NCT03283189|Qualitative study|qualitative study
5114149|NCT03283150|Deep Brain Stimulation(DBS)|deep brain stimulation(dbs)
5114150|NCT03283150|Sedation|sedation
5114151|NCT03283150|DBS Implantation|dbs implantation
5114152|NCT03283150|Microelectrode recording(MER)|microelectrode recording(mer)
5114153|NCT03283137|CLL|cll
5114154|NCT03283137|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
5114155|NCT03283137|pembrolizumab|pembrolizumab
5114156|NCT03283137|TGR-1202|tgr-1202
5114157|NCT03283098|Secondary hyperparathyroidism|secondary hyperparathyroidism
5114158|NCT03283098|Chronic kidney disease CKD|chronic kidney disease ckd
5114159|NCT03283098|Intact parathyroid hormone iPTH|intact parathyroid hormone ipth
5114160|NCT03283098|Hemodialysis|hemodialysis
5114161|NCT03283085|Immunosuppressants|immunosuppressants
5114162|NCT03283085|Mesalamine|mesalamine
5114163|NCT03283085|Ulcerative Colitis|ulcerative colitis
5114164|NCT03283085|Crohn's disease|crohn's disease
5114165|NCT03283085|Gastroenteritis|gastroenteritis
5114166|NCT03283072|thermal threshold|thermal threshold
5114167|NCT03283072|pressure pain threshold|pressure pain threshold
5114168|NCT03283072|temporal summation|temporal summation
5114169|NCT03283046|Multiple myeloma|multiple myeloma
5114171|NCT03283046|Nivolumab|nivolumab
5114172|NCT03283046|BMS-936558|bms-936558
5114173|NCT03283046|Opdivo|opdivo
5114174|NCT03283046|Lenalidomide|lenalidomide
5114175|NCT03283046|CC-5013|cc-5013
5114176|NCT03283046|Revlimid|revlimid
5114177|NCT03283046|Dexamethasone|dexamethasone
5114178|NCT03283046|Decadron|decadron
5114179|NCT03283046|Ipilimumab|ipilimumab
5114183|NCT03283033|Children|children
5114184|NCT03283033|Plate Waste|plate waste
5114185|NCT03283033|Fruit and vegetable intake|fruit and vegetable intake
5114186|NCT03283033|School lunch|school lunch
5114187|NCT03283033|social marketing|social marketing
5114188|NCT03283020|Remifentanil|remifentanil
5114189|NCT03283020|Methylnaltrexone|methylnaltrexone
5114190|NCT03283020|Pharyngeal dysfunction|pharyngeal dysfunction
5114191|NCT03283020|Anesthetic sedation|anesthetic sedation
5114192|NCT03283007|Nintedanib, lung transplantation, bronchiolitis obliterans syndrome|nintedanib, lung transplantation, bronchiolitis obliterans syndrome
5114193|NCT03282968|exergaming|exergaming
5114194|NCT03282968|physiotherapy|physiotherapy
5114195|NCT03282968|balance|balance
5114196|NCT03282942|hypertension|hypertension
5114197|NCT03282942|Aerobic training|aerobic training
5114198|NCT03282942|Strength training|strength training
5114199|NCT03282916|Valacyclovir|valacyclovir
5124341|NCT03218163|Medi-551|medi-551
5114200|NCT03282916|Anti-viral treatment|anti-viral treatment
5114202|NCT03282890|Substance Abuse|substance abuse
5114203|NCT03282890|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5114204|NCT03282890|HIV Risk Behavior|hiv risk behavior
5114205|NCT03282890|Methadone Maintenance|methadone maintenance
5114206|NCT03282864|asthma|asthma
5114207|NCT03282864|air pollution|air pollution
5114208|NCT03282864|air filtration|air filtration
5114209|NCT03282864|indoor air quality|indoor air quality
5114210|NCT03282864|respiratory health|respiratory health
5114211|NCT03282851|MSB11456|msb11456
5114212|NCT03282851|Actemra®|actemra®
5114213|NCT03282851|RoActemra®|roactemra®
5114214|NCT03282799|etonogestrel|etonogestrel
5114215|NCT03282799|efavirenz|efavirenz
5114216|NCT03282799|antiretroviral therapy|antiretroviral therapy
5114217|NCT03282799|HIV|hiv
5114218|NCT03282786|Inflammatory Bowel Disease|inflammatory bowel disease
5114219|NCT03282786|Crohn's Disease|crohn's disease
5114220|NCT03282786|Ulcerative Colitis|ulcerative colitis
5114221|NCT03282786|Carbon Dioxide (CO2)|carbon dioxide (co2)
5114222|NCT03282786|Colonoscopy|colonoscopy
5114223|NCT03282773|acute myocardial infarction|acute myocardial infarction
5114224|NCT03282773|percutaneous coronary intervention|percutaneous coronary intervention
5114225|NCT03282773|deferred stent implantation|deferred stent implantation
5114226|NCT03282760|Cell Transplantation|cell transplantation
5114227|NCT03282760|Neural Stem Cells|neural stem cells
5114228|NCT03282708|intestinal microbiome|intestinal microbiome
5114229|NCT03282708|captive great apes|captive great apes
5114230|NCT03282708|human beings|human beings
5114231|NCT03282695|Disc Herniation|disc herniation
5114232|NCT03282695|Lumbar Herniated Disc|lumbar herniated disc
5114233|NCT03282695|Ozone Therapy|ozone therapy
5114234|NCT03282682|hypogonadism|hypogonadism
5114235|NCT03282682|aging male|aging male
5114236|NCT03282682|strength training|strength training
5114237|NCT03282682|physical activity|physical activity
5114238|NCT03282682|testosterone|testosterone
5114239|NCT03282669|Pregnancy|pregnancy
5114240|NCT03282669|Transcutaneous Carbon Dioxide Monitoring|transcutaneous carbon dioxide monitoring
5114241|NCT03282669|Pulse Oximetry|pulse oximetry
5114242|NCT03282669|Cesarean Section|cesarean section
5114243|NCT03282669|Postoperative pain control|postoperative pain control
5114244|NCT03282669|High BMI|high bmi
5114245|NCT03282669|Hypercarbia|hypercarbia
5114246|NCT03282669|Hypoxemia|hypoxemia
5114247|NCT03282656|Gene therapy|gene therapy
5114248|NCT03282656|lentivirus vector|lentivirus vector
5114249|NCT03282656|BCL11A|bcl11a
5114250|NCT03282656|Fetal Hemoglobin|fetal hemoglobin
5114251|NCT03282630|Acupuncture|acupuncture
5114252|NCT03282630|Sphenopalatine ganglion|sphenopalatine ganglion
5114253|NCT03282630|Allergic rhinitis|allergic rhinitis
5114254|NCT03282630|Randomized Trial|randomized trial
5114255|NCT03282604|Intubation|intubation
5114256|NCT03282604|Intratracheal|intratracheal
5114257|NCT03282604|Nasopharynx|nasopharynx
5114258|NCT03282578|sternum|sternum
5114259|NCT03282578|bone healing|bone healing
5114260|NCT03282578|recovery|recovery
5114262|NCT03282565|Quadriceps|quadriceps
5114263|NCT03282565|Muscle|muscle
5114264|NCT03282565|Resistance Training|resistance training
5114265|NCT03282539|Lumen apposing metal stents|lumen apposing metal stents
5114266|NCT03282539|Double pigtail stents|double pigtail stents
5114267|NCT03282539|Endoscopic ultrasonography|endoscopic ultrasonography
5114268|NCT03282513|AG-120|ag-120
5114269|NCT03282513|Healthy Volunteer|healthy volunteer
4999699|NCT03996785|Stress|stress
5114270|NCT03282513|Clinical Pharmacology|clinical pharmacology
5111323|NCT03301740|Hypotension|hypotension
5114271|NCT03282513|Hepatic Impairment|hepatic impairment
5114272|NCT03282487|cortisol|cortisol
5114273|NCT03282487|adrenal insufficiency|adrenal insufficiency
5114274|NCT03282487|hypopituitarism|hypopituitarism
5114275|NCT03282487|hydrocortisone|hydrocortisone
5114276|NCT03282474|Hepatitis E|hepatitis e
5114277|NCT03282422|Cerebral palsy|cerebral palsy
5114278|NCT03282422|Hemiplegia|hemiplegia
5114279|NCT03282422|Upper-limb splint|upper-limb splint
5114280|NCT03282422|Home-based|home-based
5114281|NCT03282422|Social Participation|social participation
5114282|NCT03282409|Prediction|prediction
5114283|NCT03282409|Chronic Renal Disease|chronic renal disease
5114295|NCT03282331|Lung aeration|lung aeration
5114296|NCT03282331|Alveolar recruitment|alveolar recruitment
5114300|NCT03282279|oocyte retrieval|oocyte retrieval
5114301|NCT03282279|surgical complications|surgical complications
5114302|NCT03282240|Influenza|influenza
5114303|NCT03282227|migraine|migraine
5114304|NCT03282227|migraine headache|migraine headache
5114305|NCT03282227|acute migraine|acute migraine
5114306|NCT03282227|acute migraine headache|acute migraine headache
5114307|NCT03282214|Energy conservation|energy conservation
5114308|NCT03282214|Self management|self management
5114309|NCT03282175|BDNF|bdnf
5114310|NCT03282175|interleukin-15|interleukin-15
5114311|NCT03282175|interleukin-8|interleukin-8
5114312|NCT03282175|resistin|resistin
5114313|NCT03282175|SPPB|sppb
5114314|NCT03282162|Oxytocin|oxytocin
5114315|NCT03282162|affective touch|affective touch
5114316|NCT03282162|trait autism|trait autism
5114317|NCT03282149|inflammation|inflammation
5114328|NCT03282071|Public health approach|public health approach
5114329|NCT03282058|Silastic Stenting|silastic stenting
5114330|NCT03282058|Trans-nasal Endoscopic Surgery|trans-nasal endoscopic surgery
5114331|NCT03282058|Post-operative Intra-nasal Re-mucosalization|post-operative intra-nasal re-mucosalization
5114332|NCT03282045|acute sore throat|acute sore throat
5114334|NCT03282019|myAIRVO2|myairvo2
5114335|NCT03282019|high-flow nasal cannula therapy|high-flow nasal cannula therapy
5114336|NCT03282019|home oxygen therapy|home oxygen therapy
5114338|NCT03282019|COPD|copd
5114339|NCT03282006|Pivmecillinam|pivmecillinam
5114340|NCT03281993|apnea test, brain death, pupillometry|apnea test, brain death, pupillometry
5114341|NCT03281980|Bangladesh|bangladesh
5114342|NCT03281980|Child development|child development
5114343|NCT03281980|Poor mothers|poor mothers
5114344|NCT03281980|Psycho social stimulation|psycho social stimulation
5114345|NCT03281980|Unconditional cash transfer|unconditional cash transfer
5114346|NCT03281954|anti-PD-L1 antibody|anti-pd-l1 antibody
5114347|NCT03281954|TNBC|tnbc
5114348|NCT03281915|infertility|infertility
5114349|NCT03281915|pain|pain
5114350|NCT03281915|pregnancy|pregnancy
5114351|NCT03281889|Brain Tumor|brain tumor
5114352|NCT03281876|Immunogenicity|immunogenicity
5114353|NCT03281876|Vaccination|vaccination
5114354|NCT03281876|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5114355|NCT03281876|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
5114356|NCT03281876|Acute exacerbation of COPD|acute exacerbation of copd
5114357|NCT03281876|Moraxella catarrhalis|moraxella catarrhalis
5114358|NCT03281876|Efficacy|efficacy
5114359|NCT03281876|Safety|safety
5114360|NCT03281837|osteoarthritis|osteoarthritis
5114361|NCT03281837|knee osteoarthritis|knee osteoarthritis
5114362|NCT03281837|patellofemoral osteoarthritis|patellofemoral osteoarthritis
5114363|NCT03281837|tibiofemoral osteoarthritis|tibiofemoral osteoarthritis
5114364|NCT03281837|hyaluronan|hyaluronan
5114365|NCT03281837|hyaluronic acid|hyaluronic acid
5114366|NCT03281837|intra-articular|intra-articular
5114367|NCT03281837|arthritis|arthritis
5114368|NCT03281837|joint disease|joint disease
5114369|NCT03281837|active|active
5114370|NCT03281837|viscosupplements|viscosupplements
5114371|NCT03281837|Hymovis|hymovis
5114375|NCT03281772|hypertension|hypertension
5114376|NCT03281772|clinical decision support software|clinical decision support software
5114377|NCT03281772|renin|renin
5114378|NCT03281772|aldosterone|aldosterone
5114379|NCT03281759|Brain Injuries, Traumatic;|brain injuries, traumatic;
5114380|NCT03281759|Diffuse Axonal Injury|diffuse axonal injury
5114381|NCT03281759|Low-Level Light Therapy|low-level light therapy
5114382|NCT03281759|Neurologic Manifestations|neurologic manifestations
5114383|NCT03281759|Quality of Life|quality of life
5114384|NCT03281759|Rehabilitation|rehabilitation
5114404|NCT03281681|ovarian carcinoma|ovarian carcinoma
5114405|NCT03281668|Knee osteoarthritis|knee osteoarthritis
5114406|NCT03281655|Visnadine|visnadine
5114407|NCT03281655|Prenylflavonoids|prenylflavonoids
5114408|NCT03281655|Bovine colostrum|bovine colostrum
5114409|NCT03281655|Sexual wellbeing|sexual wellbeing
4999803|NCT03996421|Low iron stores|low iron stores
5114410|NCT03281629|Transcranial magnetic stimulation|transcranial magnetic stimulation
5114411|NCT03281629|schizophrenia|schizophrenia
5114412|NCT03281629|MRI|mri
5114413|NCT03281629|smoking|smoking
5114414|NCT03281603|Patient satisfaction|patient satisfaction
5114415|NCT03281603|Retention|retention
5114416|NCT03281590|identification|identification
5114417|NCT03281590|diagnosis|diagnosis
5114418|NCT03281590|management|management
5114426|NCT03281577|Drug Therapy|drug therapy
5114444|NCT03281525|cardiotransplant|cardiotransplant
5114445|NCT03281512|Saturated fatty acids|saturated fatty acids
5114447|NCT03281473|ARDS|ards
5114448|NCT03281473|Esophageal pressure|esophageal pressure
5114449|NCT03281473|Mechanical ventilation|mechanical ventilation
5114450|NCT03281460|Hysterectomy, Vaginal|hysterectomy, vaginal
5114451|NCT03281460|Uterine Myomatosis|uterine myomatosis
5114452|NCT03281460|Morcellation|morcellation
5114458|NCT03281447|Needs assessment|needs assessment
5114459|NCT03281447|Quality of Life|quality of life
5114460|NCT03281447|Colorectal Neoplasms|colorectal neoplasms
5114461|NCT03281447|Case Management|case management
5114462|NCT03281434|Skeletal muscle|skeletal muscle
5114463|NCT03281434|Protein synthesis|protein synthesis
5114464|NCT03281434|Protein ingestion|protein ingestion
5114465|NCT03281434|Resistance exercise|resistance exercise
5114467|NCT03281356|Early childhood development|early childhood development
5114471|NCT03281317|vasoplegicsyndrome|vasoplegicsyndrome
5114472|NCT03281317|cardiac surgery|cardiac surgery
5114473|NCT03281317|predictive risk score|predictive risk score
5114474|NCT03281304|ulcerative colitis|ulcerative colitis
5114475|NCT03281304|inflammatory bowel disease|inflammatory bowel disease
5114476|NCT03281291|malaria vaccine|malaria vaccine
5114477|NCT03281291|infants|infants
5114478|NCT03281291|Malaria|malaria
5114479|NCT03281291|RTS,S/AS01|rts,s/as01
5114480|NCT03281291|falciparum|falciparum
5114481|NCT03281291|genomics|genomics
5114482|NCT03281291|efficacy|efficacy
5114483|NCT03281278|Thrombelastography,acute on chronic liver failure, platelet|thrombelastography,acute on chronic liver failure, platelet
5114484|NCT03281265|pre-acute-on-chronic liver failure|pre-acute-on-chronic liver failure
5114485|NCT03281265|hepatitis B|hepatitis b
5114486|NCT03281252|liver failure|liver failure
5114487|NCT03281239|welder, airport agent, Welding fumes|welder, airport agent, welding fumes
5114488|NCT03281226|Pulmonary tuberculosis|pulmonary tuberculosis
5114489|NCT03281226|HIV/AIDS|hiv/aids
5114490|NCT03281226|Glutathione|glutathione
5114491|NCT03281226|N-acetylcysteine|n-acetylcysteine
5114492|NCT03281226|Oxidative stress|oxidative stress
5114493|NCT03281187|Hormonal reposition, Testosterone nasal, Nasotestt|hormonal reposition, testosterone nasal, nasotestt
5114494|NCT03281174|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
5114495|NCT03281174|5-year Immune Persistence|5-year immune persistence
5114496|NCT03281161|skin cancer|skin cancer
5114497|NCT03281161|prevention|prevention
5114498|NCT03281161|worksite|worksite
5114499|NCT03281161|policy|policy
5114500|NCT03281161|cost and effectiveness|cost and effectiveness
5114501|NCT03281161|implementation|implementation
5114502|NCT03281148|immediate implants, accuracy,extraction sockets|immediate implants, accuracy,extraction sockets
5114503|NCT03281135|Cervical cancer screening|cervical cancer screening
5114504|NCT03281135|Adherance|adherance
5114505|NCT03281135|HPV typing|hpv typing
5114506|NCT03281135|HDSS|hdss
5114507|NCT03281135|Ethiopia|ethiopia
5114508|NCT03281109|menstrual cycle|menstrual cycle
5114509|NCT03281109|gingivitis|gingivitis
5114510|NCT03281109|interleukin 1|interleukin 1
5114511|NCT03281109|tumor necrosis factor alpha|tumor necrosis factor alpha
5114512|NCT03281083|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5114513|NCT03281083|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5114514|NCT03281083|Thyroid hormone|thyroid hormone
5114515|NCT03281083|Levothyroxine|levothyroxine
5114516|NCT03281070|Anastomotic leakage|anastomotic leakage
5114517|NCT03281070|Anterior resection|anterior resection
5114518|NCT03281070|Risk factors|risk factors
5114519|NCT03281070|Incidence|incidence
5114520|NCT03281070|Rectal Cancer|rectal cancer
5114521|NCT03281031|MRI|mri
5114522|NCT03281031|Acute abdominal pain|acute abdominal pain
5114523|NCT03281031|Pelvic pain|pelvic pain
5114524|NCT03281031|Diagnostic performance|diagnostic performance
5114525|NCT03281031|Young women|young women
5114526|NCT03281018|hypnosis|hypnosis
5114527|NCT03281018|preoperative anxiety|preoperative anxiety
5114528|NCT03281018|hysterectomy|hysterectomy
5114529|NCT03281018|hospitalisation|hospitalisation
5114530|NCT03281005|Retinitis pigmentosa|retinitis pigmentosa
5114531|NCT03281005|Visual function evaluation|visual function evaluation
5114532|NCT03280940|Inflammation|inflammation
5114533|NCT03280940|Immune activation|immune activation
5114534|NCT03280940|Integrase Inhibitors|integrase inhibitors
5114535|NCT03280940|Naive patients|naive patients
5114536|NCT03280927|Onychomycosis|onychomycosis
5114537|NCT03280914|obstructive sleep apnea|obstructive sleep apnea
5114538|NCT03280914|real world|real world
5114539|NCT03280914|community|community
5114540|NCT03280901|renal replacement therapy|renal replacement therapy
5114541|NCT03280901|haemodialysis|haemodialysis
5114542|NCT03280901|haemodiafiltration|haemodiafiltration
5114543|NCT03280862|Heart Failure|heart failure
5114544|NCT03280862|Branch Block|branch block
5114545|NCT03280862|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5114546|NCT03280849|chitosan|chitosan
5114547|NCT03280849|endoscopic|endoscopic
5114548|NCT03280849|sellar tumor|sellar tumor
5114550|NCT03280849|transphenoidal|transphenoidal
5114551|NCT03280823|complement system|complement system
5114552|NCT03280810|Schizophrenia|schizophrenia
5114554|NCT03280810|Cognitive|cognitive
5114555|NCT03280810|task|task
5114556|NCT03280758|Resistance training|resistance training
5114557|NCT03280758|Diabetes Mellitus|diabetes mellitus
5114558|NCT03280758|blood-glucose control|blood-glucose control
5114559|NCT03280758|Muscle|muscle
5114560|NCT03280758|Function|function
5114561|NCT03280732|Lung Ultrasound|lung ultrasound
5114562|NCT03280732|Chest X-Ray|chest x-ray
5114563|NCT03280732|Pneumonia|pneumonia
5114564|NCT03280732|Pneumothorax|pneumothorax
5114565|NCT03280732|Pleural effusion|pleural effusion
5114566|NCT03280719|Prone position|prone position
5114567|NCT03280719|Supine position|supine position
5114568|NCT03280719|Hypofractionation|hypofractionation
5114569|NCT03280719|Accelerated radiotherapy|accelerated radiotherapy
5114570|NCT03280719|Regional nodal irradiation|regional nodal irradiation
5114571|NCT03280706|Gastric Emptying|gastric emptying
5114572|NCT03280706|labor|labor
5114573|NCT03280706|maltodextrin|maltodextrin
5114574|NCT03280706|orange juice|orange juice
5114575|NCT03280706|coffee|coffee
5114576|NCT03280706|ultrasound|ultrasound
5114577|NCT03280693|Body mass index,|body mass index,
5114578|NCT03280693|Bone density|bone density
5114579|NCT03280693|Balance|balance
5114580|NCT03280693|Postmenopause|postmenopause
5114581|NCT03280680|Violence against young women and girls|violence against young women and girls
5114582|NCT03280680|Sexual and reproductive health and rights|sexual and reproductive health and rights
5114583|NCT03280680|Consent|consent
5114584|NCT03280680|Health services|health services
5114585|NCT03280680|Legal services|legal services
5114586|NCT03280680|Awareness raising|awareness raising
5114587|NCT03280680|Community mobilization|community mobilization
5114588|NCT03280654|Obesity|obesity
5114589|NCT03280654|Overactive Bladder|overactive bladder
5114590|NCT03280654|Urinary incontinence|urinary incontinence
5114591|NCT03280654|Visceral Adiposity Index|visceral adiposity index
5114592|NCT03280654|Waist Circumference|waist circumference
5114593|NCT03280615|Albuminuria|albuminuria
5114594|NCT03280615|Carotid Intima-Media Thickness|carotid intima-media thickness
5114595|NCT03280615|Pulse Wave Velocity|pulse wave velocity
5114596|NCT03280615|Inflammation|inflammation
5114597|NCT03280589|Heart Rate Variability|heart rate variability
5114599|NCT03280589|Respiration|respiration
5114600|NCT03280576|Postoperative|postoperative
5114601|NCT03280576|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
5114602|NCT03280524|Reflexology,diabetes, quality of life|reflexology,diabetes, quality of life
5114603|NCT03280485|TBI|tbi
5114604|NCT03280485|management|management
5114605|NCT03280485|S100B|s100b
5114606|NCT03280485|biomarkers|biomarkers
5114607|NCT03280485|mild head injury|mild head injury
5114608|NCT03280485|intracranial complication|intracranial complication
5114609|NCT03280472|Interpretation Bias|interpretation bias
5114610|NCT03280472|Interpretation Modification Program|interpretation modification program
5114611|NCT03280433|Epicardial adipose tissue|epicardial adipose tissue
5114612|NCT03280433|Coronary artery disease|coronary artery disease
5114613|NCT03280433|Atrial fibrillation|atrial fibrillation
5114614|NCT03280433|Severe aortic stenosis|severe aortic stenosis
5114615|NCT03280433|Proteome|proteome
5114616|NCT03280433|Mass spectrometry|mass spectrometry
5114617|NCT03280433|Computed tomography|computed tomography
5114618|NCT03280420|Acute urinary retention|acute urinary retention
5114619|NCT03280420|BPH|bph
5114620|NCT03280420|TWOC|twoc
5114621|NCT03280420|Tamsulosin|tamsulosin
5114622|NCT03280407|Neoadjuvant chemotherapy,|neoadjuvant chemotherapy,
5114623|NCT03280407|locally advanced rectal cancer,|locally advanced rectal cancer,
5114624|NCT03280407|chemotherapy|chemotherapy
5114625|NCT03280407|CAPOX (oxaliplatin/capecitabine)|capox (oxaliplatin/capecitabine)
5114626|NCT03280407|FOLFOX (oxaliplatin/leucovorin/5FU)|folfox (oxaliplatin/leucovorin/5fu)
5114627|NCT03280394|Liquid biopsy|liquid biopsy
5114628|NCT03280394|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5114629|NCT03280394|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5114630|NCT03280394|Follicular Lymphoma|follicular lymphoma
5114631|NCT03280394|Mantle Cell Lymphoma|mantle cell lymphoma
5114632|NCT03280394|Mutations|mutations
5114633|NCT03280381|Nifty Cup|nifty cup
5114634|NCT03280381|breastfeeding difficulties|breastfeeding difficulties
5114635|NCT03280381|preterm infant|preterm infant
5114636|NCT03280381|cup feeding|cup feeding
5114637|NCT03280355|COPD|copd
5114638|NCT03280355|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5114639|NCT03280355|Randomised controlled trial (RCT)|randomised controlled trial (rct)
5114640|NCT03280355|Rehabilitation|rehabilitation
5114641|NCT03280355|Singing Training|singing training
5114642|NCT03280342|Migraine|migraine
5114643|NCT03280342|Headache|headache
5114644|NCT03280316|Spinal Vascular Disorder|spinal vascular disorder
5114645|NCT03280316|Overactive Bladder|overactive bladder
5114651|NCT03280251|cognitive training|cognitive training
5114652|NCT03280251|symptomatic treatment|symptomatic treatment
5114653|NCT03280251|Methylphenidate|methylphenidate
5114654|NCT03280251|elderly|elderly
5114655|NCT03280225|Suicide|suicide
5114656|NCT03280225|Prevention|prevention
5114657|NCT03280225|Implementation|implementation
5114658|NCT03280225|Facilitation|facilitation
5114659|NCT03280212|Chronic subdural hematoma|chronic subdural hematoma
5114660|NCT03280212|Tranexamic acid|tranexamic acid
5114661|NCT03280212|TXA|txa
5114662|NCT03280186|Spinal Vascular Malformations|spinal vascular malformations
5114663|NCT03280186|Bladder|bladder
5114664|NCT03280186|Surgical intervention|surgical intervention
5114665|NCT03280186|Urodynamics|urodynamics
5114666|NCT03280147|Neonate|neonate
5114667|NCT03280147|Sepsis|sepsis
5114668|NCT03280147|Antibiotics|antibiotics
5114669|NCT03280147|Duration|duration
5114670|NCT03280134|non-sentinel lymph node|non-sentinel lymph node
5114671|NCT03280134|breast cancer|breast cancer
5114672|NCT03280134|prediction|prediction
5114673|NCT03280134|CK19|ck19
5114674|NCT03280134|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5114675|NCT03280121|transoral incisionless|transoral incisionless
5114676|NCT03280108|Intraocular lens|intraocular lens
5114677|NCT03280108|IOL|iol
5114678|NCT03280056|MSC|msc
5114679|NCT03280056|Autologous|autologous
5114680|NCT03280056|Neurotrophic factors|neurotrophic factors
5114681|NCT03280043|Breast reduction|breast reduction
5114682|NCT03280043|Reduction mammoplasty|reduction mammoplasty
5114683|NCT03280043|Hematoma|hematoma
5114684|NCT03280043|Hemorrhage|hemorrhage
5114685|NCT03280043|Ketorolac|ketorolac
5114686|NCT03280043|Toradol|toradol
5114687|NCT03280030|midostaurin|midostaurin
5114688|NCT03280030|PKC412|pkc412
5114689|NCT03280030|cytarabine|cytarabine
5114690|NCT03280030|daunorubicin|daunorubicin
5114697|NCT03280017|thoracic surgery|thoracic surgery
5114698|NCT03280017|thoracic paravertebral block|thoracic paravertebral block
5114699|NCT03280017|ketamine|ketamine
5114700|NCT03279991|biobank|biobank
5114701|NCT03279991|chronic disease|chronic disease
5114702|NCT03279991|omics|omics
5114703|NCT03279991|big data|big data
5114704|NCT03279991|4 P medicine|4 p medicine
5114705|NCT03279965|Lung MRI cystic fibrosis primary ciliary dyskinesia|lung mri cystic fibrosis primary ciliary dyskinesia
5114706|NCT03279913|Depression, neurofeedback, TMS|depression, neurofeedback, tms
5114707|NCT03279874|decision-making|decision-making
5114708|NCT03279874|repair behavior|repair behavior
5114709|NCT03279874|interviews|interviews
5114710|NCT03279796|Adipose-drived mesenchymal stem cells|adipose-drived mesenchymal stem cells
5114711|NCT03279796|Rotator cuff injury|rotator cuff injury
5114712|NCT03279796|Lateral Epicondylitis|lateral epicondylitis
5114713|NCT03279796|Randomized controlled trials|randomized controlled trials
5114714|NCT03279770|lnRNA|lnrna
5114715|NCT03279770|CV disease|cv disease
5114716|NCT03279757|Fractional laser|fractional laser
5114717|NCT03279757|Topical anesthesia|topical anesthesia
5114718|NCT03279757|Drug delivery|drug delivery
5114719|NCT03279757|CO2 laser|co2 laser
5114720|NCT03279744|Oral Verrucous Hyperplasia|oral verrucous hyperplasia
5114721|NCT03279744|Oral Erythroleukoplakia|oral erythroleukoplakia
5114722|NCT03279731|eating disorder, pharmacotherapy|eating disorder, pharmacotherapy
5114723|NCT03279705|water exchange|water exchange
5114724|NCT03279705|water jet channel colonoscopy|water jet channel colonoscopy
5114725|NCT03279705|colonoscopy|colonoscopy
5114726|NCT03279705|cecal insertion time|cecal insertion time
5114727|NCT03279705|adenoma detection rate|adenoma detection rate
5114728|NCT03279692|Meningioma|meningioma
5114729|NCT03279679|costoclavicular|costoclavicular
5114730|NCT03279679|paracoracoid|paracoracoid
5114731|NCT03279679|brachial plexus|brachial plexus
5114732|NCT03279640|Motor Network|motor network
5114733|NCT03279640|Resting-state fMRI|resting-state fmri
5114734|NCT03279640|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5114735|NCT03279640|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5114736|NCT03279627|inpatient|inpatient
5114737|NCT03279627|hypoglycemia|hypoglycemia
5752149|NCT00311792|curriculum|curriculum
5114738|NCT03279627|hyperglycemia|hyperglycemia
5114739|NCT03279627|hospital readmission|hospital readmission
5114740|NCT03279627|discharge planning|discharge planning
5114742|NCT03279614|OS|os
5114743|NCT03279614|PFS|pfs
5114744|NCT03279614|safety|safety
5114745|NCT03279601|chemotherapy|chemotherapy
5114746|NCT03279601|OS|os
5114747|NCT03279601|ORR|orr
5114748|NCT03279601|PFS|pfs
5114749|NCT03279601|safety|safety
5114762|NCT03279484|safety , electrical performance|safety , electrical performance
5114764|NCT03279471|anxiety|anxiety
5114765|NCT03279471|cognitive behavior therapy|cognitive behavior therapy
5114766|NCT03279471|functional neuroimaging|functional neuroimaging
5114768|NCT03279432|VDR, MEGALIN, haplotypes, obesity, metabolic syndrome|vdr, megalin, haplotypes, obesity, metabolic syndrome
5114769|NCT03279406|Atrial fibrillation|atrial fibrillation
5114770|NCT03279406|Stroke|stroke
5114771|NCT03279406|Thrombus|thrombus
5114772|NCT03279406|Left atrial appendage|left atrial appendage
5114773|NCT03279406|Bleeding|bleeding
5114774|NCT03279393|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5114775|NCT03279393|PTSD|ptsd
5114776|NCT03279393|trauma|trauma
5114777|NCT03279393|stress|stress
5114778|NCT03279393|atherosclerosis|atherosclerosis
5114779|NCT03279393|macrophage|macrophage
5114780|NCT03279393|plaque burden|plaque burden
5114781|NCT03279393|vascular inflammation|vascular inflammation
5114782|NCT03279393|atherosclerotic inflammation|atherosclerotic inflammation
5114783|NCT03279393|PET/MRI|pet/mri
5114784|NCT03279393|18F-FDG-PET|18f-fdg-pet
5114785|NCT03279380|genetic polymorphism|genetic polymorphism
5114786|NCT03279380|sport performance|sport performance
5114787|NCT03279380|myokines|myokines
5114788|NCT03279354|Health-related quality of life|health-related quality of life
5114789|NCT03279354|Physical activity|physical activity
5114796|NCT03279315|Chinese women|chinese women
5114797|NCT03279315|Euthyroid|euthyroid
5114798|NCT03279289|FOLFIRI|folfiri
5114799|NCT03279289|aflibercept|aflibercept
5114800|NCT03279289|5-FU|5-fu
5114801|NCT03279289|oxaliplatin|oxaliplatin
5114802|NCT03279289|elderly|elderly
5114803|NCT03279289|metastatic colorectal cancer|metastatic colorectal cancer
5114804|NCT03279276|Hip arthroplasty|hip arthroplasty
5114805|NCT03279237|GastroEsophageal Cancer|gastroesophageal cancer
5114806|NCT03279224|Bipolar, Depression, FMT, Microbiome|bipolar, depression, fmt, microbiome
5114807|NCT03279211|digestibility|digestibility
5114808|NCT03279211|whey protein|whey protein
5114809|NCT03279211|zein|zein
5114810|NCT03279211|bioavailability|bioavailability
5114811|NCT03279198|breast cancer screening|breast cancer screening
5114812|NCT03279198|colorectal cancer screening|colorectal cancer screening
5114813|NCT03279198|cervical cancer screening|cervical cancer screening
5114814|NCT03279198|cancer screening beliefs|cancer screening beliefs
5114815|NCT03279198|cost-effectiveness|cost-effectiveness
5114816|NCT03279198|demographics|demographics
5114817|NCT03279198|tailored intervention|tailored intervention
5114818|NCT03279185|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
5114819|NCT03279172|videolaryngoscope|videolaryngoscope
5114820|NCT03279172|intraocular pressure|intraocular pressure
5114821|NCT03279172|Direct laryngoscope|direct laryngoscope
5114822|NCT03279120|HIV|hiv
5114823|NCT03279120|LNG|lng
5114824|NCT03279120|TFV|tfv
5114825|NCT03279120|IVR|ivr
5114826|NCT03279120|Contraception|contraception
5114827|NCT03279120|Prevention|prevention
5114828|NCT03279094|Sickle Cell Disease|sickle cell disease
5114829|NCT03279094|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5114830|NCT03279094|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5114831|NCT03279094|Post-transplant Cytoxan|post-transplant cytoxan
5114832|NCT03279081|Crohn's disease|crohn's disease
5114833|NCT03279081|complex perianal fistula(s)|complex perianal fistula(s)
5114834|NCT03279068|electronic fetal monitoring|electronic fetal monitoring
5114835|NCT03279055|Insomnia|insomnia
5114836|NCT03279042|En masse retraction|en masse retraction
5114837|NCT03279042|Corticotomy|corticotomy
5114838|NCT03279042|Acceleration of tooth movement|acceleration of tooth movement
5114839|NCT03279042|Piezocision|piezocision
5114840|NCT03279042|Flapless corticotomy|flapless corticotomy
5114841|NCT03279042|Class II division 1 malocclusion|class ii division 1 malocclusion
5114842|NCT03279042|Protrusion of upper incisors|protrusion of upper incisors
5114843|NCT03279042|Sliding mechanics|sliding mechanics
5114844|NCT03279042|mini-implant based anchorage|mini-implant based anchorage
5114845|NCT03279042|temporary anchorage devices|temporary anchorage devices
5114846|NCT03278990|PrEP|prep
5114847|NCT03278990|Prevention|prevention
5114848|NCT03278990|Value Affirmation|value affirmation
5114849|NCT03278990|Future Selves|future selves
5114850|NCT03278990|Behavioral Intervention|behavioral intervention
5114851|NCT03278977|Apparent Life-Threatening Event|apparent life-threatening event
5114852|NCT03278977|ALTE|alte
5114853|NCT03278977|Sudden Infant Death|sudden infant death
5114855|NCT03278964|Orbital decompression|orbital decompression
5114856|NCT03278964|Graves Orbitopathy|graves orbitopathy
5114857|NCT03278964|Exophthalmos|exophthalmos
5114858|NCT03278964|Diplopia|diplopia
5114859|NCT03278964|Restrictive Strabismus|restrictive strabismus
5114860|NCT03278951|Weight loss|weight loss
5114861|NCT03278951|video conferencing|video conferencing
5114862|NCT03278951|mHealth|mhealth
5114863|NCT03278951|Telemedicine|telemedicine
5114864|NCT03278951|glycemic control|glycemic control
5114865|NCT03278938|depression|depression
5114866|NCT03278938|citalopram|citalopram
5114867|NCT03278938|bupropion|bupropion
5114868|NCT03278938|combination therapy|combination therapy
5111850|NCT03298386|Elderly|elderly
5114875|NCT03278899|X-ALD|x-ald
5114876|NCT03278899|ALD|ald
5114877|NCT03278886|Alcohol Use|alcohol use
5114878|NCT03278886|Pain|pain
5114879|NCT03278886|HIV|hiv
5114880|NCT03278886|Low-dose naltrexone|low-dose naltrexone
5114881|NCT03278886|Nalmefene|nalmefene
5114882|NCT03278873|Achromatopsia|achromatopsia
5114883|NCT03278873|CNGB3|cngb3
5114884|NCT03278873|CNGA3|cnga3
5114885|NCT03278860|Oxytocin|oxytocin
5114886|NCT03278860|social touch|social touch
5114887|NCT03278847|NNRD|nnrd
5114888|NCT03278847|matching|matching
5114889|NCT03278847|propensity score|propensity score
5114890|NCT03278821|Informed choice|informed choice
5114891|NCT03278821|Alcohol use disorder|alcohol use disorder
5114892|NCT03278821|Addiction treatment|addiction treatment
5114893|NCT03278795|Weaning, ventilatory support, assisted ventilation modes|weaning, ventilatory support, assisted ventilation modes
5114894|NCT03278756|Depression|depression
5114895|NCT03278756|Remission|remission
5114896|NCT03278756|Relapse prevention|relapse prevention
5114897|NCT03278756|Cognitive control training|cognitive control training
5114898|NCT03278756|Internet intervention|internet intervention
5114899|NCT03278743|tea|tea
5114900|NCT03278743|cognition|cognition
5114901|NCT03278743|very old|very old
5114902|NCT03278743|Newcastle 85+|newcastle 85+
5114903|NCT03278743|epidemiology|epidemiology
5114904|NCT03278730|sepsis|sepsis
5114905|NCT03278730|para-Tyrosine|para-tyrosine
5114906|NCT03278730|ortho-Tyrosine|ortho-tyrosine
5114907|NCT03278730|meta-Tyrosine|meta-tyrosine
5114908|NCT03278704|Concurrent training|concurrent training
5114909|NCT03278704|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5114910|NCT03278704|Resistance exercise|resistance exercise
5114911|NCT03278704|High-Intensity Interval Training (HIIT)|high-intensity interval training (hiit)
5114912|NCT03278704|Muscle hypertrophy|muscle hypertrophy
5114913|NCT03278704|Interference effect|interference effect
5114914|NCT03278678|Nutritional screening MNA-SF malnutrition Case Management|nutritional screening mna-sf malnutrition case management
5114915|NCT03278665|Cutaneous melanoma|cutaneous melanoma
5114916|NCT03278639|gait disorders|gait disorders
5114917|NCT03278639|balance disorders|balance disorders
5114918|NCT03278639|music|music
5114919|NCT03278639|tango|tango
5114920|NCT03278639|rhythmic auditory stimulation|rhythmic auditory stimulation
5114921|NCT03278639|health-related quality of life|health-related quality of life
5114922|NCT03278626|Locally Advanced Esophageal Squamous Cell Carcinoma|locally advanced esophageal squamous cell carcinoma
5114923|NCT03278561|asthma|asthma
5114924|NCT03278561|age of onset|age of onset
5114925|NCT03278561|inflammation|inflammation
5114926|NCT03278561|comorbidity|comorbidity
5114927|NCT03278561|microbiome|microbiome
5114928|NCT03278548|HES|hes
5114929|NCT03278548|Hydroxyethylstarch|hydroxyethylstarch
5114930|NCT03278522|ramosetron|ramosetron
5114931|NCT03278496|addiction|addiction
5114932|NCT03278496|substance abuse treatment|substance abuse treatment
5114933|NCT03278496|aftercare|aftercare
5114934|NCT03278496|outpatient counseling|outpatient counseling
5114935|NCT03278496|opiates|opiates
5114936|NCT03278496|cocaine|cocaine
5114937|NCT03278483|Latent tuberculosis, ,|latent tuberculosis, ,
5114938|NCT03278483|isoniazid, rifampin,|isoniazid, rifampin,
5114940|NCT03278483|adverse,|adverse,
5114941|NCT03278483|diabetes mellitus|diabetes mellitus
5114942|NCT03278457|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5114943|NCT03278457|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5114944|NCT03278457|positron emission tomography|positron emission tomography
5114945|NCT03278392|pregnancy|pregnancy
5114946|NCT03278392|metabolism|metabolism
5114947|NCT03278392|stress|stress
5114948|NCT03278392|emotional state|emotional state
5114949|NCT03278392|diet|diet
5114950|NCT03278392|glycemic response|glycemic response
5114951|NCT03278353|Expectation|expectation
5114952|NCT03278353|Conservative Intervention|conservative intervention
5114953|NCT03278340|Skin Cancer|skin cancer
5114954|NCT03278340|Prevention|prevention
5114955|NCT03278340|Policy|policy
5114956|NCT03278340|Worksite|worksite
5114957|NCT03278340|Scale-up|scale-up
5114958|NCT03278340|Cost and Effectiveness|cost and effectiveness
5114959|NCT03278275|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
5114960|NCT03278275|uPAR PET/CT|upar pet/ct
5114961|NCT03278275|positron emission tomography|positron emission tomography
5114963|NCT03278249|brain tumor|brain tumor
5114964|NCT03278223|Multipurpose Contact Lens Care System|multipurpose contact lens care system
5114965|NCT03278210|EEG-fMRI|eeg-fmri
5114966|NCT03278210|brain imaging|brain imaging
5114967|NCT03278210|presurgical evaluation|presurgical evaluation
5114968|NCT03278210|epilepsy surgery|epilepsy surgery
5114969|NCT03278158|safety|safety
5114970|NCT03278158|tolerability|tolerability
5114971|NCT03278132|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
5114972|NCT03278132|Safety|safety
5114973|NCT03278132|Immunogenicity|immunogenicity
4986272|NCT04077255|EGFR|egfr
5114974|NCT03278132|Infant|infant
5114975|NCT03278093|Physiotherapy|physiotherapy
5114980|NCT03278067|Adverse Event of Interest|adverse event of interest
5114981|NCT03278067|Seasonal influenza vaccines|seasonal influenza vaccines
5114982|NCT03278067|Pilot study|pilot study
5114983|NCT03278067|Prospective passive enhanced safety surveillance|prospective passive enhanced safety surveillance
5114984|NCT03278054|apical periodontitis|apical periodontitis
5114985|NCT03278054|hybrid|hybrid
5114986|NCT03278054|ProTaper|protaper
5114987|NCT03278054|rotary|rotary
5114988|NCT03278015|S-1|s-1
5114989|NCT03278015|nab-paclitaxel|nab-paclitaxel
5114990|NCT03277976|atrial fibrillation;|atrial fibrillation;
5114991|NCT03277976|catheter ablation;|catheter ablation;
5114992|NCT03277976|pulmonary vein isolation|pulmonary vein isolation
5114993|NCT03277976|ablation index|ablation index
5114994|NCT03277963|Obesity|obesity
5114995|NCT03277963|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5114996|NCT03277950|virtual reality|virtual reality
5114997|NCT03277950|feedback|feedback
5114998|NCT03277937|gastric varices|gastric varices
5114999|NCT03277937|endoscopic ultrasound|endoscopic ultrasound
5115000|NCT03277937|coils|coils
5115001|NCT03277937|cyanoacrylate|cyanoacrylate
5115002|NCT03277898|Breast Neoplasms|breast neoplasms
5115003|NCT03277898|"Exercis* OR Aerobic Exercise"|"exercis* or aerobic exercise"
5115004|NCT03277898|Cognitive Function*|cognitive function*
5115005|NCT03277898|"Antineoplastic therapy OR Antineoplastic agent"|"antineoplastic therapy or antineoplastic agent"
5115006|NCT03277898|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5115007|NCT03277885|Work related chronic pain|work related chronic pain
5115008|NCT03277885|Preventive care|preventive care
5115009|NCT03277859|Yoga|yoga
5115010|NCT03277859|Veterans|veterans
5115011|NCT03277859|Traumatic Brain Injury|traumatic brain injury
5115012|NCT03277859|Post-concussive Headaches|post-concussive headaches
5115013|NCT03277859|Post-concussive Symptoms|post-concussive symptoms
5115014|NCT03277768|Premature infant|premature infant
5115015|NCT03277768|Tissue Oxygenation|tissue oxygenation
5115016|NCT03277768|Patent Ductus Arteriosus|patent ductus arteriosus
5115017|NCT03277716|Huge hepatocellular carcinoma|huge hepatocellular carcinoma
5115018|NCT03277716|Microwave ablation|microwave ablation
5115019|NCT03277716|TACE|tace
5115020|NCT03277716|Safety|safety
5115021|NCT03277716|Non-resectable|non-resectable
5115022|NCT03277716|Treatment|treatment
5115023|NCT03277703|Influenza vaccine|influenza vaccine
5115024|NCT03277703|Booster dose|booster dose
5115025|NCT03277703|immunocompromised|immunocompromised
5115026|NCT03277703|Biologic therapy|biologic therapy
5115027|NCT03277703|Rheumatologic disease|rheumatologic disease
5115028|NCT03277703|inflammatory bowel disease|inflammatory bowel disease
5115029|NCT03277690|Cushing Syndrome, Adrenocortical Hyperfunction|cushing syndrome, adrenocortical hyperfunction
5115030|NCT03277664|pediatric|pediatric
5115031|NCT03277664|asthma adherence|asthma adherence
5115032|NCT03277664|electronic device|electronic device
5115033|NCT03277651|noninvasive|noninvasive
5115034|NCT03277651|Hemodynamics|hemodynamics
5115035|NCT03277638|recurrent glioblastoma|recurrent glioblastoma
5115036|NCT03277638|brain cancer|brain cancer
5115037|NCT03277625|pancreaticoduodenectomy|pancreaticoduodenectomy
5115038|NCT03277573|Salsalate|salsalate
5115039|NCT03277560|Major Trauma Centre|major trauma centre
5115041|NCT03277560|Outcome Measures|outcome measures
5115042|NCT03277534|electrical stimulation|electrical stimulation
5115043|NCT03277508|Brain-computer integration|brain-computer integration
5115044|NCT03277482|Recurrent gynecological cancer|recurrent gynecological cancer
5115045|NCT03277482|Metastatic Cervical Cancer|metastatic cervical cancer
5115046|NCT03277482|Metastatic Ovarian Cancer|metastatic ovarian cancer
5115047|NCT03277482|Metastatic Vaginal Cancer|metastatic vaginal cancer
5115048|NCT03277482|Metastatic Vulvar Cancer|metastatic vulvar cancer
5115049|NCT03277482|Metastatic Endometrial Cancer|metastatic endometrial cancer
5342960|NCT01981356|Psychotic Disorders|psychotic disorders
5115050|NCT03277482|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
5000452|NCT03992430|Pediatric|pediatric
5115051|NCT03277482|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
5115052|NCT03277482|Recurrent Vaginal Cancer|recurrent vaginal cancer
5115053|NCT03277482|Recurrent Vulvar Cancer|recurrent vulvar cancer
5115054|NCT03277482|Recurrent Endometrial Cancer|recurrent endometrial cancer
5115055|NCT03277469|Gynecologic Cancer|gynecologic cancer
5115056|NCT03277443|Skeletal open bite|skeletal open bite
5115057|NCT03277430|uterus transplantation, absolute uterine factor infertility|uterus transplantation, absolute uterine factor infertility
5115058|NCT03277404|EDTA|edta
5115059|NCT03277404|Postoperative pain|postoperative pain
5115060|NCT03277404|Pulp necrosis|pulp necrosis
5115061|NCT03277404|Smear layer|smear layer
5115062|NCT03277352|cervical cancer|cervical cancer
5115063|NCT03277352|endometrial cancer|endometrial cancer
5115064|NCT03277352|gastric cancer (including stomach and gastroesophageal junction (GEJ))|gastric cancer (including stomach and gastroesophageal junction (gej))
5115070|NCT03277352|microsatellite instability-high (MSI-H)|microsatellite instability-high (msi-h)
5961988|NCT04283617|continuous glucose monitoring|continuous glucose monitoring
5961989|NCT04283604|Concerta|concerta
5115072|NCT03277352|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5115073|NCT03277352|ovarian cancer|ovarian cancer
5115074|NCT03277352|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5115075|NCT03277352|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5115076|NCT03277352|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5115077|NCT03277352|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
5115078|NCT03277352|urothelial carcinoma|urothelial carcinoma
5115177|NCT03276715|malignant pleural effusion|malignant pleural effusion
5115079|NCT03277352|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
5115080|NCT03277339|Generalized anxious disorders|generalized anxious disorders
5115082|NCT03277339|paroxetine|paroxetine
5115083|NCT03277274|Drug Therapy|drug therapy
5115084|NCT03277235|fatigue|fatigue
5115085|NCT03277235|colon cancer|colon cancer
5115086|NCT03277235|quality of life|quality of life
5115087|NCT03277222|Neurocognitive impairment|neurocognitive impairment
5115088|NCT03277222|HIV-1|hiv-1
5115089|NCT03277222|Intranasal insulin|intranasal insulin
5115090|NCT03277222|Neurocognitive Disorder|neurocognitive disorder
5115091|NCT03277222|Cognition|cognition
5115092|NCT03277222|Memory|memory
5115094|NCT03277170|acute asthma exacerbation|acute asthma exacerbation
5115095|NCT03277170|pediatric asthma|pediatric asthma
5115096|NCT03277170|leukotriene receptor antagonist|leukotriene receptor antagonist
5115097|NCT03277170|montelukast|montelukast
5115098|NCT03277144|linear stapler|linear stapler
5115099|NCT03277092|Child, blood drawing procedure, near Infrared light|child, blood drawing procedure, near infrared light
5115100|NCT03277079|coronary artery disease|coronary artery disease
5115101|NCT03277079|LDL cholesterol|ldl cholesterol
5115102|NCT03277079|therapeutic target|therapeutic target
5115103|NCT03277053|colorectal|colorectal
5115104|NCT03277053|laparoscopic|laparoscopic
5115105|NCT03277053|application|application
5115107|NCT03277053|adherence|adherence
5115108|NCT03277053|mobile|mobile
5115109|NCT03277027|cerebral palsy|cerebral palsy
5115110|NCT03277027|Health-Related Quality Of Life|health-related quality of life
5115111|NCT03277027|Physical Activity|physical activity
5115112|NCT03277014|Nutritional monitoring|nutritional monitoring
5115113|NCT03277014|insulin-like growth factor-1|insulin-like growth factor-1
5115114|NCT03277001|AECOPD|aecopd
5115115|NCT03277001|VTE prevention|vte prevention
5115116|NCT03277001|Rivaroxaban|rivaroxaban
5115117|NCT03277001|LMWHs|lmwhs
5115118|NCT03276988|Thyroid cancer|thyroid cancer
5115119|NCT03276988|Thyroidectomy|thyroidectomy
5115120|NCT03276988|rhTSH|rhtsh
5115121|NCT03276988|GX-30|gx-30
5115122|NCT03276975|CT fluoroscopy|ct fluoroscopy
5115123|NCT03276975|epidural patching|epidural patching
5115124|NCT03276975|spontaneous intracranial hypotension|spontaneous intracranial hypotension
5115125|NCT03276962|falciparum, efficacy|falciparum, efficacy
5115127|NCT03276962|malaria vaccine|malaria vaccine
5115128|NCT03276962|safety|safety
5115129|NCT03276962|Malaria|malaria
5115130|NCT03276962|immunogenicity|immunogenicity
5115131|NCT03276962|infants|infants
5115132|NCT03276949|Blood glucose|blood glucose
5115133|NCT03276949|non-invasive|non-invasive
5115134|NCT03276949|Raman spectroscopy|raman spectroscopy
5115135|NCT03276910|antidoping|antidoping
5115136|NCT03276871|Balloon dissection|balloon dissection
5115137|NCT03276871|Telescopic dissection|telescopic dissection
5115138|NCT03276871|Inguinal hernia|inguinal hernia
5115139|NCT03276871|TEP|tep
5115140|NCT03276845|Ultrasound|ultrasound
5115141|NCT03276845|Elastography|elastography
5115142|NCT03276845|Doppler Ultrasound|doppler ultrasound
5752353|NCT00310908|Treatment|treatment
5115143|NCT03276845|Contrast enhanced Ultrasound|contrast enhanced ultrasound
5115144|NCT03276845|Three-dimensional Ultrasound|three-dimensional ultrasound
5115145|NCT03276819|Oral potentially malignant lesions (OPML)|oral potentially malignant lesions (opml)
5115146|NCT03276819|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5115147|NCT03276819|Biomarkers|biomarkers
5115148|NCT03276819|Smoking cessation program|smoking cessation program
5115149|NCT03276819|Loss of heterozigoty (LOH)|loss of heterozigoty (loh)
5115150|NCT03276819|Medico-economics|medico-economics
5115151|NCT03276819|Sociology|sociology
5115152|NCT03276819|Psychology|psychology
5112168|NCT03295994|surgery|surgery
5115154|NCT03276806|nurse led intervention|nurse led intervention
5115155|NCT03276806|safety net hospital|safety net hospital
5115156|NCT03276806|lung cancer screening with CTLD|lung cancer screening with ctld
5115157|NCT03276767|online intervention|online intervention
5115158|NCT03276767|e-Health|e-health
5115159|NCT03276767|reminder|reminder
5115160|NCT03276767|SMS-textmessage|sms-textmessage
5115161|NCT03276767|e-mail|e-mail
5115162|NCT03276767|mobile phone|mobile phone
5115163|NCT03276767|cell phone|cell phone
5115164|NCT03276754|Pneumococcal infections|pneumococcal infections
5115165|NCT03276754|COPD exacerbations|copd exacerbations
5115166|NCT03276741|labor|labor
5115167|NCT03276741|anesthesia|anesthesia
5115168|NCT03276741|oral intake|oral intake
5115169|NCT03276741|maternal satisfaction|maternal satisfaction
5115170|NCT03276741|newborn complications|newborn complications
5115171|NCT03276728|Heart Failure|heart failure
5115172|NCT03276728|Cardiovascular Diseases|cardiovascular diseases
5115173|NCT03276728|Heart Diseases|heart diseases
5115174|NCT03276728|Ejection fraction|ejection fraction
5115175|NCT03276728|Heart Failure with reduced ejection fraction|heart failure with reduced ejection fraction
5115176|NCT03276728|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
5115178|NCT03276715|lung cancer|lung cancer
5115180|NCT03276637|Exome Sequencing|exome sequencing
5115181|NCT03276637|Military|military
5115182|NCT03276637|Air Force|air force
5115183|NCT03276611|Assessment|assessment
5115184|NCT03276611|pulmonary|pulmonary
5115185|NCT03276611|artery|artery
5115186|NCT03276611|right|right
5115187|NCT03276611|sided|sided
5115188|NCT03276611|hemodynamics|hemodynamics
5115189|NCT03276611|patients|patients
5115190|NCT03276611|sleep|sleep
5115191|NCT03276611|apnea|apnea
5115192|NCT03276611|syndrome|syndrome
5115193|NCT03276611|contionous|contionous
5115194|NCT03276611|positive|positive
5115196|NCT03276611|way|way
5115197|NCT03276611|pressure|pressure
5115198|NCT03276611|treatment|treatment
5115199|NCT03276585|home sleep monitor|home sleep monitor
5115200|NCT03276585|Sleep Apnea Syndromes|sleep apnea syndromes
5115201|NCT03276585|questionnaire|questionnaire
5115202|NCT03276559|critically ill|critically ill
5115203|NCT03276559|ICU|icu
5115204|NCT03276559|uncommunicative|uncommunicative
5115205|NCT03276559|caregivers|caregivers
5115206|NCT03276559|surrogate|surrogate
5115207|NCT03276559|decision-making|decision-making
5115209|NCT03276520|ethyl glucuronide, biomarker, diagnostic randomized trial|ethyl glucuronide, biomarker, diagnostic randomized trial
5115210|NCT03276481|melphalan|melphalan
5115211|NCT03276481|stem cell transplantation|stem cell transplantation
5115212|NCT03276481|17-404|17-404
5115213|NCT03276481|hematopoietic cell transplantation|hematopoietic cell transplantation
5115214|NCT03276481|HCT|hct
5115215|NCT03276468|venetoclax; obinutuzumab; atezolizumab; lymphoma|venetoclax; obinutuzumab; atezolizumab; lymphoma
5115216|NCT03276455|Beta thalassemia|beta thalassemia
5115217|NCT03276455|Gene therapy|gene therapy
5115218|NCT03276455|Beta-globin|beta-globin
5115219|NCT03276455|Hematopoietic stem cells|hematopoietic stem cells
5115220|NCT03276455|Lentiviral vector|lentiviral vector
5115221|NCT03276429|NSCLC|nsclc
5115222|NCT03276429|SCLC|sclc
5115223|NCT03276429|MOLECULAR BIOMARKERS|molecular biomarkers
5115224|NCT03276390|health disparities|health disparities
5115225|NCT03276390|living donation|living donation
5115226|NCT03276312|Lipogems|lipogems
5115227|NCT03276312|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
5115228|NCT03276312|Lipofilling|lipofilling
5115229|NCT03276312|Diabetic foot|diabetic foot
5115230|NCT03276208|Pregnancy|pregnancy
5115231|NCT03276208|Tobacco|tobacco
5115232|NCT03276208|Massage Therapy|massage therapy
5115233|NCT03276208|Mindfulness|mindfulness
5115234|NCT03276195|Neurodevelopmental Disorder|neurodevelopmental disorder
5115235|NCT03276195|Genomics|genomics
5115236|NCT03276195|Genetics|genetics
5115237|NCT03276169|atrial fibrillation|atrial fibrillation
5115238|NCT03276169|left atrial appendage closure|left atrial appendage closure
5115239|NCT03276169|left atrial function|left atrial function
5115240|NCT03276130|Blood coagulation disorder|blood coagulation disorder
5115241|NCT03276130|Haematologic diseases|haematologic diseases
5115242|NCT03276130|Coagulation protein disorder|coagulation protein disorder
5115243|NCT03276130|Hemorrhagic disorder|hemorrhagic disorder
5115244|NCT03276130|Genetic diseases, inborn|genetic diseases, inborn
5115245|NCT03276130|Pain|pain
5115246|NCT03276130|Anxiety|anxiety
5115247|NCT03276130|Pain medication|pain medication
5115248|NCT03276130|Anxiety medication|anxiety medication
5115249|NCT03276117|pregnancy.obstructed labour|pregnancy.obstructed labour
5115250|NCT03276104|IOL dislocation|iol dislocation
5115251|NCT03276104|Cataract|cataract
5115252|NCT03276104|Cataract surgery|cataract surgery
5115256|NCT03276104|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
5115257|NCT03276091|colonoscopy|colonoscopy
5115258|NCT03276091|immunochemical fecal test|immunochemical fecal test
5115259|NCT03276091|screening|screening
5115260|NCT03276078|COPD|copd
5115264|NCT03276013|Oncology|oncology
5115265|NCT03276013|Endometrial Cancer|endometrial cancer
5115266|NCT03276013|Pembrolizumab|pembrolizumab
5115267|NCT03276013|Doxorubicin|doxorubicin
5115268|NCT03276013|Metastatic Endometrial Cancer|metastatic endometrial cancer
5115269|NCT03276000|Misoprostol ,office hysteroscopy|misoprostol ,office hysteroscopy
5115270|NCT03275987|cancer screening|cancer screening
5115271|NCT03275935|ACOS|acos
5115272|NCT03275935|Asthma|asthma
5115273|NCT03275935|COPD|copd
5115274|NCT03275935|inhalation technique|inhalation technique
5115275|NCT03275922|Migraine|migraine
5115276|NCT03275922|Headache|headache
5115277|NCT03275922|Pain|pain
5115278|NCT03275922|Efficacy|efficacy
5115279|NCT03275922|Pediatric|pediatric
4986622|NCT04075383|esthetics|esthetics
5115280|NCT03275909|Chronic schizophrenia|chronic schizophrenia
5115281|NCT03275909|Emotional Management Therapy|emotional management therapy
5115282|NCT03275909|Integrated Psychological Therapy|integrated psychological therapy
5115283|NCT03275844|Physical activity|physical activity
5115284|NCT03275844|Physical capacity|physical capacity
5115285|NCT03275844|Children|children
5115286|NCT03275818|sarcoma|sarcoma
5115287|NCT03275818|Desmoid tumor|desmoid tumor
5115288|NCT03275818|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
5115289|NCT03275818|Ewing sarcoma|ewing sarcoma
5115290|NCT03275818|relapsed|relapsed
5115291|NCT03275818|refractory|refractory
5115292|NCT03275805|Residual dysplasia|residual dysplasia
5115293|NCT03275805|Pavlik Harness|pavlik harness
5115294|NCT03275792|Shiga-Toxigenic Escherichia coli|shiga-toxigenic escherichia coli
5115295|NCT03275792|Child|child
5115296|NCT03275753|Visual function|visual function
5115297|NCT03275753|Critical flicker fusion|critical flicker fusion
5115298|NCT03275753|Dark adaptation|dark adaptation
5115299|NCT03275753|Reading test|reading test
5115300|NCT03275727|Breast Cancer|breast cancer
5115301|NCT03275727|Survivors|survivors
5115302|NCT03275727|Internet intervention|internet intervention
5115303|NCT03275727|Psychosocial intervention|psychosocial intervention
5115304|NCT03275727|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5115305|NCT03275727|Randomized controlled trial|randomized controlled trial
5115306|NCT03275688|lung cancer|lung cancer
5115307|NCT03275688|volatile organic compound|volatile organic compound
5115308|NCT03275688|screening|screening
5115309|NCT03275688|VOC|voc
5115310|NCT03275688|clinical trial|clinical trial
5115311|NCT03275675|Cancer|cancer
5115312|NCT03275675|Oral chemotherapy|oral chemotherapy
5115313|NCT03275675|Community Pharmacy|community pharmacy
5115314|NCT03275675|Satisfaction|satisfaction
5115315|NCT03275636|Haploidentical|haploidentical
5115316|NCT03275636|mismatched unrelated donor|mismatched unrelated donor
5115317|NCT03275636|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5115318|NCT03275636|donor comparison|donor comparison
5115319|NCT03275584|positron emission tomography|positron emission tomography
5115320|NCT03275584|NH3|nh3
5115321|NCT03275571|Cognition|cognition
5115322|NCT03275571|Intervention|intervention
5115323|NCT03275571|Therapy|therapy
5115324|NCT03275558|Nasal Spray|nasal spray
5115325|NCT03275558|Gliosarcoma|gliosarcoma
5115326|NCT03275558|Glioblastoma|glioblastoma
5115328|NCT03275519|distal hypospadias repair|distal hypospadias repair
5115329|NCT03275519|urinary tract infection|urinary tract infection
5115330|NCT03275519|prophylactic antibiotic use|prophylactic antibiotic use
5115331|NCT03275506|neoadjuvant|neoadjuvant
5115332|NCT03275506|debulking surgery|debulking surgery
5115333|NCT03275493|CD19+ ,CAR-T, CRS|cd19+ ,car-t, crs
5115334|NCT03275454|Autoimmune Diseases|autoimmune diseases
5115335|NCT03275454|Hematologic Diseases|hematologic diseases
5115336|NCT03275454|Immune System Diseases|immune system diseases
5115337|NCT03275454|Blood Platelet Disorders|blood platelet disorders
5115338|NCT03275441|electroretinogram|electroretinogram
5115339|NCT03275441|ERG|erg
5115340|NCT03275441|dark-adaptation|dark-adaptation
5115341|NCT03275441|ophthalmology|ophthalmology
5115342|NCT03275441|electrophysiology|electrophysiology
5115343|NCT03275441|ISCEV|iscev
5115344|NCT03275441|electroretinography|electroretinography
5115345|NCT03275441|scotopic|scotopic
5115347|NCT03275428|Non-intubated thoracic surgery|non-intubated thoracic surgery
5115348|NCT03275415|BPD|bpd
5115349|NCT03275415|surfactant|surfactant
5115350|NCT03275415|budesonide|budesonide
5115351|NCT03275415|respiratory distress syndrome|respiratory distress syndrome
5115354|NCT03275402|CNS Metastases|cns metastases
5115355|NCT03275402|Leptomeningeal Metastases|leptomeningeal metastases
5115356|NCT03275402|Pediatric|pediatric
5115357|NCT03275389|Safety|safety
5115358|NCT03275389|Healthy adults|healthy adults
5115359|NCT03275389|Immunogenicity|immunogenicity
5115360|NCT03275389|Supra-seasonal universal influenza vaccines - inactivated (SUIVs)|supra-seasonal universal influenza vaccines - inactivated (suivs)
5115365|NCT03275337|Social Phobia|social phobia
5115366|NCT03275337|Anxiety|anxiety
5115367|NCT03275337|Cerebellum|cerebellum
5115368|NCT03275337|tDCS|tdcs
5115369|NCT03275337|Neuromodulation|neuromodulation
5115370|NCT03275337|Fear Extinction|fear extinction
5115371|NCT03275311|metastatic breast cancer|metastatic breast cancer
5115372|NCT03275311|observational study|observational study
5115373|NCT03275311|survival|survival
5115374|NCT03275311|real world data|real world data
5115375|NCT03275311|real life setting|real life setting
5961990|NCT04283604|Physical Activity|physical activity
5115376|NCT03275298|ovarian cancer|ovarian cancer
5115377|NCT03275298|observational study|observational study
5115378|NCT03275298|survival|survival
5115379|NCT03275298|real world data|real world data
5115380|NCT03275298|real life setting|real life setting
5115381|NCT03275259|Shock wave|shock wave
5115582|NCT03273725|Vitamin D|vitamin d
5115382|NCT03275259|Gynoid lipodystrophy|gynoid lipodystrophy
5115383|NCT03275259|Cellulits|cellulits
5115384|NCT03275246|Primary total knee replacement|primary total knee replacement
5115385|NCT03275207|Chronic pain|chronic pain
5115386|NCT03275207|CPSP|cpsp
5115387|NCT03275207|Dexmedetomidine|dexmedetomidine
5115388|NCT03275207|Surgery|surgery
5115389|NCT03275155|Autonomic Dysfunction|autonomic dysfunction
5115390|NCT03275155|Inflammation|inflammation
5115391|NCT03275155|Cognitive impairment|cognitive impairment
5115392|NCT03275155|Interoception|interoception
5115393|NCT03275155|Gait impairment|gait impairment
5115394|NCT03275129|ultrasound assessment|ultrasound assessment
5115395|NCT03275116|Bronchodilation|bronchodilation
5115396|NCT03275116|Hyperinflation|hyperinflation
5115397|NCT03275116|Physical activity|physical activity
5115398|NCT03275116|Sleep quality|sleep quality
5115399|NCT03275090|lipid emulsions; preterm; sepsis|lipid emulsions; preterm; sepsis
5115400|NCT03275077|End stage renal disease|end stage renal disease
5115401|NCT03275077|ESRD|esrd
5115402|NCT03275077|Thromboelastography|thromboelastography
5115403|NCT03275077|Fibrinogen|fibrinogen
5115404|NCT03275064|Articular cartilage, partial thickness cartilage lesion, knee, cartilage|articular cartilage, partial thickness cartilage lesion, knee, cartilage
5115405|NCT03275064|regeneration|regeneration
5115406|NCT03275051|Beta Thalassaemia|beta thalassaemia
5115407|NCT03275051|previously GSK2696277|previously gsk2696277
5115408|NCT03275051|Lentiviral vector|lentiviral vector
5115409|NCT03275051|TIGET-BTHAL|tiget-bthal
5115410|NCT03275051|Gene therapy|gene therapy
5115411|NCT03275038|Neuroimage|neuroimage
5115412|NCT03275038|Training|training
5115413|NCT03275038|Aging|aging
5115414|NCT03275038|Brain|brain
5115415|NCT03275038|Cardiovascular risks|cardiovascular risks
5115416|NCT03274960|asymptomati bacteriuria, Griess nitrite test, preterm birth|asymptomati bacteriuria, griess nitrite test, preterm birth
5115417|NCT03274947|Oropharyngeal Dysphagia|oropharyngeal dysphagia
5115418|NCT03274947|Stroke|stroke
5115419|NCT03274934|Adolescents|adolescents
5115420|NCT03274934|Web- and mobile-based intervention|web- and mobile-based intervention
5115421|NCT03274934|Acceptance and Commitment therapy|acceptance and commitment therapy
5115422|NCT03274934|Psychological well-being|psychological well-being
5115423|NCT03274934|Career preparation|career preparation
5115424|NCT03274934|Lifecontrol|lifecontrol
5115425|NCT03274934|Successful educational transitions|successful educational transitions
5115426|NCT03274934|Learning difficulties|learning difficulties
5115427|NCT03274934|Psychological flexibility and mindfulness skills|psychological flexibility and mindfulness skills
5115428|NCT03274921|cardiovascular complications|cardiovascular complications
5115429|NCT03274921|biomarkers|biomarkers
5115430|NCT03274882|metastatic|metastatic
5115431|NCT03274882|colorectal|colorectal
5115432|NCT03274882|cancer|cancer
5115433|NCT03274882|Lonsurf|lonsurf
5115434|NCT03274882|S95005|s95005
5115435|NCT03274882|Russia|russia
5115436|NCT03274869|Scrub typhus|scrub typhus
5115437|NCT03274869|Cardiovascular Complication|cardiovascular complication
5115438|NCT03274830|primary osteoarthritis|primary osteoarthritis
5115439|NCT03274830|secondary osteoarthritis|secondary osteoarthritis
5115440|NCT03274830|femoral head fracture|femoral head fracture
5115441|NCT03274830|necrosis|necrosis
5115442|NCT03274817|Alzheimer's Disease|alzheimer's disease
5115443|NCT03274817|Depression|depression
5115444|NCT03274817|Escitalopram|escitalopram
5115445|NCT03274817|Venlafaxine|venlafaxine
5115446|NCT03274791|COPD|copd
5115447|NCT03274791|smoking|smoking
5115448|NCT03274791|induced sputum|induced sputum
5115449|NCT03274791|clinical features|clinical features
5115450|NCT03274765|ovarian stimulation|ovarian stimulation
5115451|NCT03274765|blood test|blood test
5115452|NCT03274765|Medically Assisted Procreation|medically assisted procreation
5115453|NCT03274752|Paroxetine|paroxetine
5115455|NCT03274674|I-PRF|i-prf
5115460|NCT03274661|solid tumor, Pembrolizumab,|solid tumor, pembrolizumab,
5115461|NCT03274609|Lung diseases|lung diseases
5115462|NCT03274609|cancer|cancer
5115463|NCT03274609|Interventional pulmonology|interventional pulmonology
5115464|NCT03274609|peripheral nodule|peripheral nodule
5115465|NCT03274596|Oxidative Damage|oxidative damage
5115466|NCT03274596|Vitamin E|vitamin e
5115467|NCT03274596|Total Antioxidant Capacity|total antioxidant capacity
5115468|NCT03274596|Retinopathy of Prematurity|retinopathy of prematurity
5115469|NCT03274583|atrial fibrillation|atrial fibrillation
5115470|NCT03274583|smartphone|smartphone
5115471|NCT03274583|detection|detection
5115472|NCT03274557|Achilles, tendinose, tendinopathy, pain|achilles, tendinose, tendinopathy, pain
5115473|NCT03274544|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5115474|NCT03274544|Chinese Medicine|chinese medicine
5115475|NCT03274544|Herbal Medicine|herbal medicine
5115476|NCT03274518|Hemodialysis|hemodialysis
5115477|NCT03274518|Hemodiafiltration|hemodiafiltration
5115478|NCT03274518|fluid status|fluid status
5115479|NCT03274518|hemodynamics|hemodynamics
5115480|NCT03274479|adenosine receptors|adenosine receptors
5115481|NCT03274479|checkpoint inhibitors|checkpoint inhibitors
5115482|NCT03274479|immune system activator|immune system activator
5115483|NCT03274440|OCD|ocd
5115484|NCT03274440|Marijuana|marijuana
5115485|NCT03274440|THC|thc
4986832|NCT04073940|dance|dance
5115486|NCT03274440|Cannabis|cannabis
5115488|NCT03274440|Cannabinoid|cannabinoid
5115489|NCT03274414|squamous cell carcinoma|squamous cell carcinoma
5115490|NCT03274414|esthesioneuroblastoma|esthesioneuroblastoma
5115491|NCT03274414|adenoid cystic carcinoma|adenoid cystic carcinoma
5115492|NCT03274414|adenocarcinoma|adenocarcinoma
5115493|NCT03274414|cisplatin|cisplatin
5115494|NCT03274414|17-442|17-442
5115495|NCT03274401|Atrial fibrillation|atrial fibrillation
5115496|NCT03274401|Pulmonary embolism|pulmonary embolism
5115497|NCT03274401|Screening|screening
5115498|NCT03274375|Anti-NMDAR encephalitis|anti-nmdar encephalitis
5115499|NCT03274375|IA adsorption|ia adsorption
5115500|NCT03274375|Paediatric|paediatric
5115501|NCT03274336|patient satisfaction|patient satisfaction
5115502|NCT03274336|preanesthesia|preanesthesia
5115503|NCT03274336|movie|movie
5115504|NCT03274336|brochure|brochure
5115505|NCT03274336|face-to-face interview|face-to-face interview
5115506|NCT03274310|Influenza|influenza
5115507|NCT03274310|Text message|text message
5115508|NCT03274310|Influenza-like Illness|influenza-like illness
5115509|NCT03274310|Acute Respiratory Infection|acute respiratory infection
5115510|NCT03274284|chemoradiation for|chemoradiation for
5115511|NCT03274284|T1G3 BC|t1g3 bc
5115512|NCT03274271|physical activity|physical activity
5115513|NCT03274271|sedentary behaviour|sedentary behaviour
5115514|NCT03274271|eHealth|ehealth
5115515|NCT03274271|mHealth|mhealth
5115516|NCT03274271|self-regulation|self-regulation
5115517|NCT03274271|behaviour change techniques|behaviour change techniques
5115518|NCT03274271|action planning|action planning
5115519|NCT03274271|coping planning|coping planning
5115520|NCT03274271|self-monitoring|self-monitoring
5115521|NCT03274271|prevention|prevention
5115522|NCT03274245|Public Health|public health
5115523|NCT03274206|Cervical Intraepithelian Neoplasia Grade 2/3|cervical intraepithelian neoplasia grade 2/3
5115524|NCT03274206|CIN 2/3|cin 2/3
5115526|NCT03274180|Travel consultation|travel consultation
5115527|NCT03274102|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
5115528|NCT03274102|Concomitant vaccination|concomitant vaccination
5115529|NCT03274102|Safety|safety
5115530|NCT03274102|Immunogenicity|immunogenicity
5115531|NCT03274102|Infant|infant
5115532|NCT03274076|diffuse|diffuse
5115533|NCT03274076|scleroderma|scleroderma
5115534|NCT03274076|systemic sclerosis|systemic sclerosis
5115535|NCT03274050|robot|robot
5115536|NCT03274050|surgery|surgery
5115537|NCT03274050|pediatry|pediatry
5115538|NCT03273998|coagulation|coagulation
5115539|NCT03273998|bleeding|bleeding
5115540|NCT03273972|Healthy Volunteers|healthy volunteers
5115541|NCT03273972|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
5115542|NCT03273972|PCSK9|pcsk9
5115543|NCT03273972|Alirocumab|alirocumab
5115544|NCT03273972|Forearm Blood Flow|forearm blood flow
5115545|NCT03273972|Arterial Stiffness|arterial stiffness
5115546|NCT03273972|Carotid Intima Media Thickness|carotid intima media thickness
5115547|NCT03273972|Inflammation|inflammation
5115548|NCT03273972|Endothelial function|endothelial function
5115549|NCT03273959|Physiotherapy|physiotherapy
5115557|NCT03273946|Post-marketing|post-marketing
5115558|NCT03273946|Fluticasone propionate|fluticasone propionate
5115560|NCT03273920|laparoscopy-assisted gastrectomy|laparoscopy-assisted gastrectomy
5112549|NCT03293602|MRI|mri
5115561|NCT03273920|robot-assisted gastrectomy|robot-assisted gastrectomy
5115562|NCT03273920|advanced gastric cancer|advanced gastric cancer
5115563|NCT03273920|D2 Lymphadenectomy|d2 lymphadenectomy
5115564|NCT03273907|CyPass Micro-Stent|cypass micro-stent
5115565|NCT03273894|Hypothermia, temperature management|hypothermia, temperature management
5115566|NCT03273881|Gestational diabetes mellitus|gestational diabetes mellitus
5115567|NCT03273881|Pre-gestational diabetes mellitus|pre-gestational diabetes mellitus
5115568|NCT03273881|Treatment|treatment
5115569|NCT03273881|Neonatal hypoglycemia|neonatal hypoglycemia
5115570|NCT03273803|Heart sounds, smartphone, application|heart sounds, smartphone, application
5115571|NCT03273777|Cesarean section|cesarean section
5115572|NCT03273777|Skin incision|skin incision
5115573|NCT03273777|Skewness|skewness
5115574|NCT03273777|Line drawing|line drawing
5115575|NCT03273764|Preterm, RDS, Surfactant, CPAP|preterm, rds, surfactant, cpap
5115576|NCT03273751|Remote Ischemic Preconditioning|remote ischemic preconditioning
5115577|NCT03273751|Partial nephrectomy|partial nephrectomy
5115578|NCT03273751|Acute kidney injury|acute kidney injury
5115579|NCT03273738|type 2 diabetes|type 2 diabetes
5115580|NCT03273738|postmenopausal|postmenopausal
5115581|NCT03273725|Oral Health|oral health
5115583|NCT03273686|Esophageal Cancer|esophageal cancer
5115584|NCT03273686|Nasogastric Tube|nasogastric tube
5115585|NCT03273673|Secondary ACL Injury Prevention|secondary acl injury prevention
5115586|NCT03273673|Visual Biofeedback|visual biofeedback
5115587|NCT03273673|Tactile Biofeedback|tactile biofeedback
5115588|NCT03273634|Palpitations|palpitations
5115589|NCT03273608|Hepatocellular Carcinoma|hepatocellular carcinoma
5115590|NCT03273608|Advanced HCC|advanced hcc
5961991|NCT04283604|Motor test|motor test
4986937|NCT04073069|Ropivacaine|ropivacaine
5115591|NCT03273608|Unresectable|unresectable
5115592|NCT03273608|deTACE|detace
5115593|NCT03273608|HepaSphere|hepasphere
5115594|NCT03273517|Glycemia|glycemia
5115595|NCT03273517|Preoperative fasting|preoperative fasting
5115596|NCT03273517|Pediatric patients|pediatric patients
5115597|NCT03273517|Anesthesia|anesthesia
5115598|NCT03273517|Knowledge of the resident|knowledge of the resident
5115599|NCT03273491|self-weighing|self-weighing
5115600|NCT03273491|weight gain|weight gain
5115601|NCT03273491|Ecological Momentary Assessment|ecological momentary assessment
5115602|NCT03273491|mood|mood
5115603|NCT03273491|emerging adulthood|emerging adulthood
5115604|NCT03273491|obesity|obesity
5115605|NCT03273491|eating disorders|eating disorders
5115606|NCT03273478|Bifurcation aneurysm|bifurcation aneurysm
5115607|NCT03273478|Unruptured bifurcation aneurysm|unruptured bifurcation aneurysm
5115608|NCT03273478|Ruptured bifurcation aneurysm|ruptured bifurcation aneurysm
5115609|NCT03273478|Stent-assisted coiling|stent-assisted coiling
5115610|NCT03273478|pCONUS2 Bifurcation Aneurysm Implant|pconus2 bifurcation aneurysm implant
5115611|NCT03273465|IBD|ibd
5115612|NCT03273465|Colitis|colitis
5115613|NCT03273465|fecal|fecal
5115614|NCT03273465|FMT|fmt
5115615|NCT03273465|microbiota|microbiota
5115616|NCT03273465|transplantation|transplantation
5115617|NCT03273439|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5115618|NCT03273439|Negative symptoms|negative symptoms
5115619|NCT03273439|randomized controlled trial|randomized controlled trial
5115620|NCT03273439|Schizophrenia|schizophrenia
5115621|NCT03273439|cognition|cognition
5115622|NCT03273413|Pravastatin|pravastatin
5115623|NCT03273413|Statin|statin
5115624|NCT03273400|Lumbar, Hamstring, Mobilisation|lumbar, hamstring, mobilisation
5115625|NCT03273322|Left atrial appendage closure|left atrial appendage closure
5115626|NCT03273322|Rivaroxaban|rivaroxaban
5115627|NCT03273322|Dual antiplatelet therapy|dual antiplatelet therapy
5115628|NCT03273322|Anticoagulation|anticoagulation
5115629|NCT03273322|Stroke prevention|stroke prevention
5115630|NCT03273296|microbiota|microbiota
5115631|NCT03273296|metabolize|metabolize
5115632|NCT03273257|Pulmonary endarterectomy|pulmonary endarterectomy
5115634|NCT03273257|Medical therapy|medical therapy
5115635|NCT03273218|coronary angiography|coronary angiography
5115636|NCT03273218|diagnosctic transradial catheter|diagnosctic transradial catheter
5115637|NCT03273218|transradial catheter|transradial catheter
5115638|NCT03273205|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5752354|NCT00310895|Refractory|refractory
5115639|NCT03273192|healthy subjects|healthy subjects
5115644|NCT03273179|cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
5115645|NCT03273179|CSF pressure|csf pressure
5115646|NCT03273179|modified Rankin Scale|modified rankin scale
5115647|NCT03273179|papilledema|papilledema
5115648|NCT03273179|NIHSS|nihss
5115649|NCT03273127|Asthma, placebo, abediterol, DPI, corticosteroids|asthma, placebo, abediterol, dpi, corticosteroids
5115650|NCT03273114|back pain|back pain
5115651|NCT03273114|physiotherapy|physiotherapy
5115652|NCT03273114|exercise therapy|exercise therapy
5115653|NCT03273114|cognitive functional therapy|cognitive functional therapy
5115654|NCT03273114|low back pain|low back pain
5115655|NCT03273114|backache|backache
5115656|NCT03273114|lower back pain|lower back pain
5115657|NCT03273114|lumbago|lumbago
5115658|NCT03273114|multidimensional|multidimensional
5115659|NCT03273114|biopsychosocial|biopsychosocial
5115660|NCT03273088|healthy subjects|healthy subjects
5115661|NCT03273088|Pharmacokinetics|pharmacokinetics
5115662|NCT03273088|etanercept|etanercept
5115663|NCT03273088|single dose|single dose
5115664|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5115665|NCT03273075|P2Y12r inhibitor|p2y12r inhibitor
5115666|NCT03273075|Cardiac Arrest|cardiac arrest
5115667|NCT03273075|STEMI|stemi
5115668|NCT03273075|HTPR|htpr
5115669|NCT03273062|Brain Injury|brain injury
5115670|NCT03273062|Traumatic Brain Injury|traumatic brain injury
5115671|NCT03273062|Acquired Brain Injury|acquired brain injury
5115672|NCT03273062|Cognition|cognition
5115673|NCT03273062|Neuropsychiatric Symptopms|neuropsychiatric symptopms
5115674|NCT03273062|COMT|comt
5115675|NCT03272997|Positron emission thomography|positron emission thomography
5115676|NCT03272997|Computed tomography|computed tomography
5115677|NCT03272997|Sensitivity|sensitivity
5115678|NCT03272997|Specificity|specificity
5115679|NCT03272971|lung cancer|lung cancer
5115680|NCT03272971|radiofrequency ablation|radiofrequency ablation
5115681|NCT03272971|bronchoscopy|bronchoscopy
5115682|NCT03272971|NSCLC|nsclc
5115684|NCT03272958|Bullous pemphigoid|bullous pemphigoid
5115685|NCT03272919|Breast Cancer, Peripheral neuropathy, Taxol, carboplatin|breast cancer, peripheral neuropathy, taxol, carboplatin
5115686|NCT03272906|aphasia|aphasia
5115687|NCT03272906|stroke|stroke
5115688|NCT03272906|tDCS|tdcs
5961992|NCT04283604|Exercise|exercise
5115689|NCT03272906|language|language
5115690|NCT03272906|stimulation|stimulation
5115691|NCT03272906|brain|brain
5961993|NCT04283604|Ritalin|ritalin
5115692|NCT03272906|speech therapy|speech therapy
5115694|NCT03272880|Art Therapy|art therapy
5115695|NCT03272880|Music Therapy|music therapy
5115696|NCT03272815|pneumothorax|pneumothorax
5115697|NCT03272815|chest tube removal|chest tube removal
5115698|NCT03272815|percussion|percussion
5115699|NCT03272802|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5115700|NCT03272802|Edaravone|edaravone
5115701|NCT03272776|LMA Protector|lma protector
5115702|NCT03272776|Second Generation Laryngeal Masks|second generation laryngeal masks
5115703|NCT03272776|Airway|airway
5115704|NCT03272776|Dual Gastric Acces|dual gastric acces
5115705|NCT03272776|Teleflex|teleflex
5115706|NCT03272776|Supraglottic Devices|supraglottic devices
5115707|NCT03272776|Ambulatory Surgery|ambulatory surgery
5115708|NCT03272737|KAATSU|kaatsu
5115709|NCT03272737|Cardiovascular system|cardiovascular system
5115710|NCT03272737|Elderly|elderly
5115711|NCT03272711|Vortioxetine|vortioxetine
5115712|NCT03272711|Elderly|elderly
5115713|NCT03272711|Online cognitive training|online cognitive training
5115714|NCT03272698|ketamine|ketamine
5115715|NCT03272698|treatment-resistant depression|treatment-resistant depression
5115716|NCT03272698|electroconvulsive therapy|electroconvulsive therapy
5115717|NCT03272685|Reduced nicotine cigarettes|reduced nicotine cigarettes
5115718|NCT03272685|Alternative nicotine products|alternative nicotine products
5115719|NCT03272685|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5115720|NCT03272659|Fluorescence Sigmoidoscopy|fluorescence sigmoidoscopy
5115721|NCT03272659|PDD|pdd
5115722|NCT03272659|Photodynamic Diagnosis|photodynamic diagnosis
5115723|NCT03272646|Gastric Cancer|gastric cancer
5115724|NCT03272607|Adverse Drug Event|adverse drug event
5115725|NCT03272607|Choosing Wisely Canada|choosing wisely canada
5115726|NCT03272607|Deprescribing|deprescribing
5115727|NCT03272607|Elderly|elderly
5115728|NCT03272607|Frailty|frailty
5115729|NCT03272607|High value healthcare|high value healthcare
5115730|NCT03272607|Medication rationalization|medication rationalization
5115731|NCT03272607|Medication stewardship|medication stewardship
5115732|NCT03272607|Polypharmacy|polypharmacy
5115733|NCT03272594|Neonatal pain|neonatal pain
5115734|NCT03272594|Pediatric pain|pediatric pain
5115735|NCT03272594|Pain assessment|pain assessment
5115736|NCT03272594|Breastfeeding|breastfeeding
5115738|NCT03272594|Randomized controlled trial|randomized controlled trial
5115739|NCT03272594|Behavioural pain response|behavioural pain response
5752355|NCT00310895|Relapsed|relapsed
5115740|NCT03272594|Neurophysiological pain response|neurophysiological pain response
5115741|NCT03272581|Functional|functional
5115742|NCT03272581|Training|training
5115743|NCT03272581|Performance|performance
5115744|NCT03272568|Extended Life Plasma Derived Factor Products|extended life plasma derived factor products
5115745|NCT03272568|Female hemophilia A and B carriers|female hemophilia a and b carriers
5115746|NCT03272568|Menorrhagia|menorrhagia
5115747|NCT03272542|gastric bypass|gastric bypass
5115748|NCT03272542|calcium absorption|calcium absorption
5115749|NCT03272542|postmenopausal women|postmenopausal women
5115750|NCT03272516|Mild to moderate Depression|mild to moderate depression
5115751|NCT03272516|Mild to moderate Anxiety|mild to moderate anxiety
5115752|NCT03272516|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
5115753|NCT03272516|Primary care|primary care
5115754|NCT03272516|PHQ-9|phq-9
5115755|NCT03272516|GAD-7|gad-7
5115756|NCT03272516|Antidepressants|antidepressants
5115757|NCT03272516|Anxiolytica|anxiolytica
5115758|NCT03272516|Subjective wellbeing|subjective wellbeing
5115759|NCT03272503|Pimozide|pimozide
5115760|NCT03272490|locking plate|locking plate
5115761|NCT03272490|anatomical preshaped|anatomical preshaped
5115769|NCT03272438|steps|steps
5115770|NCT03272438|goals|goals
5115771|NCT03272386|pelvic floor muscles|pelvic floor muscles
5115772|NCT03272386|instruction|instruction
5115773|NCT03272386|assessment|assessment
5115774|NCT03272386|acceptability|acceptability
5115775|NCT03272386|understanding|understanding
5115776|NCT03272334|Metastatic Breast Cancer|metastatic breast cancer
5115777|NCT03272334|Adoptive Cell Therapy|adoptive cell therapy
5115778|NCT03272334|Armed Activated T-cells|armed activated t-cells
5115779|NCT03272334|Bispecific Antibodies|bispecific antibodies
5115780|NCT03272334|Immunotherapy|immunotherapy
5115781|NCT03272321|biomedical intervention|biomedical intervention
5115788|NCT03272282|WHO PARTOGRAPG.OBSTRUCTED LABOUR. managment of labour|who partograpg.obstructed labour. managment of labour
5115789|NCT03272269|Diabetes Mellitus type 1|diabetes mellitus type 1
5115790|NCT03272269|Autoimmune disease|autoimmune disease
5115791|NCT03272269|Immunotherapy|immunotherapy
5115792|NCT03272269|Diabetes treatment|diabetes treatment
5115793|NCT03272269|Residual beta cell function|residual beta cell function
5115794|NCT03272269|Adult patients|adult patients
5115795|NCT03272243|thoracolumbar fracture|thoracolumbar fracture
5115796|NCT03272243|short segment fixation|short segment fixation
5115797|NCT03272243|long segment fixation|long segment fixation
5115798|NCT03272243|index level|index level
5115799|NCT03272230|Apathy|apathy
5115800|NCT03272230|Goal-directed behavior|goal-directed behavior
5115801|NCT03272230|Assessment|assessment
5115802|NCT03272230|Diagnosis|diagnosis
5115803|NCT03272230|Sensor|sensor
5115804|NCT03272230|Ecological condition|ecological condition
5115805|NCT03272230|Neurological disease|neurological disease
5115806|NCT03272217|Atezolizumab|atezolizumab
5115807|NCT03272217|MPDL3280A|mpdl3280a
5115808|NCT03272217|Bevacizumab|bevacizumab
5115809|NCT03272217|Avastin|avastin
5115810|NCT03272217|Cisplatin-Ineligible|cisplatin-ineligible
5115811|NCT03272217|Anti-PD-L1 Antibodies|anti-pd-l1 antibodies
5115812|NCT03272204|pubic hair; grooming; urinary tract symptoms; vaginitis|pubic hair; grooming; urinary tract symptoms; vaginitis
5115813|NCT03272191|MI|mi
5115814|NCT03272191|Infarction|infarction
5115815|NCT03272191|Infarct|infarct
5115816|NCT03272191|Subacute MI|subacute mi
5115817|NCT03272191|stem cell|stem cell
5115824|NCT03272126|vitamin D|vitamin d
5115825|NCT03272100|lateral approach|lateral approach
5115826|NCT03272100|bone augmentation|bone augmentation
5115827|NCT03272100|sinus lift|sinus lift
5115828|NCT03272100|flap|flap
5115829|NCT03272087|Thoracoscopy|thoracoscopy
5115830|NCT03272048|Firearms|firearms
5115831|NCT03272035|General practice|general practice
5115832|NCT03272035|death|death
5115833|NCT03272035|bereavement|bereavement
5115834|NCT03272022|cobalamin, folate|cobalamin, folate
5115835|NCT03271996|Pilonidal sinus|pilonidal sinus
5115836|NCT03271996|Bascom|bascom
5115837|NCT03271996|Cleft lift|cleft lift
5115838|NCT03271996|Fistulectomy|fistulectomy
5115839|NCT03271996|Karydakis|karydakis
5115840|NCT03271918|Pituitary Adenoma|pituitary adenoma
5115841|NCT03271918|Dopaminergic Agonist|dopaminergic agonist
5115842|NCT03271918|Nonfunctioning Pituitary Adenoma|nonfunctioning pituitary adenoma
5115843|NCT03271918|Cabergoline|cabergoline
5115844|NCT03271892|papillary thyroid cancer|papillary thyroid cancer
5115845|NCT03271892|thyroidectomy|thyroidectomy
5115846|NCT03271892|active surveillance|active surveillance
5115847|NCT03271879|Diabetes|diabetes
5115848|NCT03271879|Heart|heart
5115849|NCT03271879|Arrhythmia|arrhythmia
5115850|NCT03271866|Schizophrenia|schizophrenia
5115860|NCT03271775|Instability|instability
5115861|NCT03271762|MITRACLIP|mitraclip
5115862|NCT03271762|primary Mitral Regurgitation|primary mitral regurgitation
5115863|NCT03271762|high surgical risks|high surgical risks
5115864|NCT03271749|Fast Track surgical recovery|fast track surgical recovery
5115865|NCT03271749|Surgical recovery|surgical recovery
5115866|NCT03271749|Thoracic surgery|thoracic surgery
5115867|NCT03271736|Parkinson's disease|parkinson's disease
5115868|NCT03271736|Auditory cues|auditory cues
5115869|NCT03271736|step in place|step in place
5115870|NCT03271736|transcranial magnetic stimulation|transcranial magnetic stimulation
5115871|NCT03271736|cortical excitability|cortical excitability
5115872|NCT03271723|cohort studies|cohort studies
5115873|NCT03271723|infant development|infant development
5115874|NCT03271723|pregnancy|pregnancy
5115875|NCT03271723|Brazil|brazil
5115883|NCT03271671|neurally adjusted ventilator assist|neurally adjusted ventilator assist
5115884|NCT03271671|Pressure support ventilation|pressure support ventilation
5115885|NCT03271671|non invasive ventilation|non invasive ventilation
5115887|NCT03271658|patient decision aid|patient decision aid
5115888|NCT03271658|end-of-life care|end-of-life care
5115889|NCT03271658|shared decision making|shared decision making
5115890|NCT03271658|informed decision|informed decision
5115891|NCT03271658|decision-making|decision-making
5115892|NCT03271658|clinical decision-making|clinical decision-making
5115893|NCT03271658|web-based decision aid|web-based decision aid
5115894|NCT03271658|palliative|palliative
5115895|NCT03271658|critical care|critical care
5115896|NCT03271658|nursing|nursing
5115897|NCT03271645|Depression|depression
5115898|NCT03271645|Anxiety|anxiety
5115899|NCT03271645|Stress|stress
5115900|NCT03271645|Internet-delivered interventions|internet-delivered interventions
5115901|NCT03271632|multiple myeloma|multiple myeloma
5115902|NCT03271632|chimeric antigen receptor|chimeric antigen receptor
5115903|NCT03271632|BCMA|bcma
5115904|NCT03271632|CD38|cd38
5115905|NCT03271632|CD56|cd56
5115906|NCT03271632|CD138|cd138
5115907|NCT03271619|Safety Issues|safety issues
5115912|NCT03271528|Lacosamide|lacosamide
5115913|NCT03271528|Alcohol craving|alcohol craving
5115914|NCT03271528|Alcohol Urge Questionnaire|alcohol urge questionnaire
5115915|NCT03271528|Obsessive-Compulsive Drinking Scale|obsessive-compulsive drinking scale
5115916|NCT03271515|leukemia|leukemia
5115917|NCT03271515|lymphoma|lymphoma
5115918|NCT03271515|CAR-T|car-t
5115919|NCT03271515|bispecific|bispecific
5115920|NCT03271515|CD20|cd20
5115921|NCT03271515|CD19|cd19
5115922|NCT03271489|Elagolix Sodium|elagolix sodium
5115923|NCT03271489|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
5115924|NCT03271489|Heavy Uterine Bleeding|heavy uterine bleeding
5115925|NCT03271489|Leiomyomata|leiomyomata
5115926|NCT03271489|Menorrhagia|menorrhagia
5115927|NCT03271489|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
5115928|NCT03271489|Elagolix + E2/NETA|elagolix + e2/neta
5115929|NCT03271489|Elagolix|elagolix
5115930|NCT03271489|Safety|safety
5115931|NCT03271489|Efficacy|efficacy
5115932|NCT03271489|ABT-620|abt-620
5115933|NCT03271476|Breast Cancer|breast cancer
5115934|NCT03271476|EMDR|emdr
5115935|NCT03271463|stroke|stroke
5115936|NCT03271463|selective voluntary motor control|selective voluntary motor control
5115937|NCT03271450|dabigatran|dabigatran
5115938|NCT03271450|warfarin|warfarin
5115939|NCT03271450|apixaban|apixaban
5115940|NCT03271450|edoxaban|edoxaban
5115941|NCT03271450|extended treatment|extended treatment
5115942|NCT03271450|oral anticoagulant|oral anticoagulant
5115943|NCT03271450|rivaroxaban|rivaroxaban
5115950|NCT03271307|testing|testing
5115951|NCT03271307|cost-effectiveness|cost-effectiveness
5115952|NCT03271294|pelvic organ prolapse|pelvic organ prolapse
5115953|NCT03271294|Exair|exair
5115954|NCT03271294|Transvaginal mesh|transvaginal mesh
5115955|NCT03271281|68Ga-NODAGA-E[c(RGDyK)]2|68ga-nodaga-e[c(rgdyk)]2
5115956|NCT03271281|Angiogenesis PET/CT|angiogenesis pet/ct
5115957|NCT03271281|Neuroendocrine tumors|neuroendocrine tumors
5115958|NCT03271268|Vascular filling|vascular filling
5115959|NCT03271268|Fluid overload|fluid overload
5115960|NCT03271268|Biomarkers|biomarkers
5115961|NCT03271268|Lung edema|lung edema
5115962|NCT03271255|apatinib|apatinib
5115963|NCT03271255|bevacizumab|bevacizumab
5115965|NCT03271255|colorectal cancer|colorectal cancer
5115966|NCT03271229|Platelet rich plasma|platelet rich plasma
5115967|NCT03271229|bone marrow|bone marrow
5115968|NCT03271229|stem cell|stem cell
5115969|NCT03271203|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
5115970|NCT03271203|Real-time data capture|real-time data capture
5115971|NCT03271203|Cognitive debriefing|cognitive debriefing
5115972|NCT03271203|Hand Osteoarthritis|hand osteoarthritis
5115973|NCT03271203|Concept elicitation|concept elicitation
5115974|NCT03271190|aging|aging
5115975|NCT03271190|memory complaint|memory complaint
5115976|NCT03271177|transradial percutaneous coronary intervention|transradial percutaneous coronary intervention
5115977|NCT03271138|Celiac Disease|celiac disease
5115978|NCT03271138|Gluten-Free Diet|gluten-free diet
5115979|NCT03271138|Bifidobacterium infantis NLS super strain|bifidobacterium infantis nls super strain
5115980|NCT03271138|gastrointestinal symptoms|gastrointestinal symptoms
5115981|NCT03271138|quality of life|quality of life
5115995|NCT03271073|gastroesophageal junction cancer|gastroesophageal junction cancer
5115996|NCT03271073|Apatinib|apatinib
5115998|NCT03271047|cancer|cancer
5115999|NCT03271034|Lipedema|lipedema
5116000|NCT03271034|Metabolism|metabolism
5116001|NCT03271034|Body Composition|body composition
5116002|NCT03271034|Fat Distribution|fat distribution
5116003|NCT03271034|Immunology|immunology
5116012|NCT03270982|Non Inflammatory Degenerative Joint Disease|non inflammatory degenerative joint disease
5116013|NCT03270982|Rheumatoid Arthritis|rheumatoid arthritis
5116014|NCT03270982|Revision where other devices have failed|revision where other devices have failed
5116015|NCT03270982|Correction of functional deformity|correction of functional deformity
5116016|NCT03270982|Oncology Applications|oncology applications
5116017|NCT03270982|Treatment of acute or Chronic fractures|treatment of acute or chronic fractures
5116018|NCT03270930|Operative duration|operative duration
5116019|NCT03270930|Pediatric surgery|pediatric surgery
5116020|NCT03270930|Emergency laparotomy|emergency laparotomy
5116021|NCT03270930|Mortality rate|mortality rate
5116022|NCT03270930|Survival|survival
5116023|NCT03270930|Kaplan-Meier analysis|kaplan-meier analysis
5116024|NCT03270930|ROC curve analysis|roc curve analysis
5116025|NCT03270930|Senior resident|senior resident
5116030|NCT03270891|Pharmacogenomics|pharmacogenomics
5116031|NCT03270891|Primary care physicians|primary care physicians
5116032|NCT03270878|Glasdegib|glasdegib
5116033|NCT03270878|PF-04449913|pf-04449913
5116034|NCT03270878|Pharmacokinetics|pharmacokinetics
5116035|NCT03270878|Bioavailability|bioavailability
5116036|NCT03270813|Child|child
5116037|NCT03270813|Adolescent|adolescent
5116038|NCT03270787|Acute Mountain sickness|acute mountain sickness
5116039|NCT03270787|Compound Danshen Dripping Pills|compound danshen dripping pills
5116040|NCT03270748|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5116041|NCT03270748|acute graft-versus-host disease|acute graft-versus-host disease
5116042|NCT03270748|Unrelated donors|unrelated donors
5116043|NCT03270748|Post-transplant cyclophosphamide|post-transplant cyclophosphamide
5116044|NCT03270748|Myeloid Malignancies|myeloid malignancies
5116045|NCT03270748|unrelated hematopoietic cell transplantation|unrelated hematopoietic cell transplantation
5116046|NCT03270748|GITMO|gitmo
5116047|NCT03270709|Vitamin D3|vitamin d3
5116048|NCT03270709|Pulmonary disease|pulmonary disease
5116049|NCT03270709|Immunosuppression|immunosuppression
5116050|NCT03270709|HIV|hiv
5116051|NCT03270709|Smoking|smoking
5116052|NCT03270683|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5116053|NCT03270683|transcranial Doppler sonography|transcranial doppler sonography
5116054|NCT03270683|cerebrovascular circulation|cerebrovascular circulation
5116055|NCT03270683|prognosis|prognosis
5116056|NCT03270657|Deep Brain Stimulation|deep brain stimulation
5116057|NCT03270592|Service dogs|service dogs
5116058|NCT03270592|Alert dogs|alert dogs
5116059|NCT03270592|Costs|costs
5116060|NCT03270592|Quality of Life|quality of life
5116061|NCT03270592|Cost-effectiveness|cost-effectiveness
5116062|NCT03270566|Water hardness|water hardness
5116063|NCT03270566|Atopic eczema prevention|atopic eczema prevention
5116064|NCT03270566|Skin barrier function|skin barrier function
5116065|NCT03270566|Skin microbiome|skin microbiome
5752456|NCT00310440|Bone graft|bone graft
5116066|NCT03270527|Dietary fat modification|dietary fat modification
5116067|NCT03270527|Lipids|lipids
5116068|NCT03270527|LDL cholesterol|ldl cholesterol
5116069|NCT03270527|Dietary fatty acids|dietary fatty acids
5116070|NCT03270527|Saturated fat|saturated fat
5116071|NCT03270514|cardiac surgery|cardiac surgery
5116072|NCT03270514|sternotomy|sternotomy
5116073|NCT03270514|post-operative pain|post-operative pain
5116074|NCT03270514|sternal wound infiltration|sternal wound infiltration
5116075|NCT03270488|Thumb|thumb
5116076|NCT03270488|Osteoarthritis|osteoarthritis
5116077|NCT03270488|Physical Therapy|physical therapy
5116078|NCT03270488|Pain|pain
5116079|NCT03270449|fibromyalgia|fibromyalgia
5116080|NCT03270449|community-based|community-based
5116084|NCT03270397|Self Esteem|self esteem
5116085|NCT03270397|Body Image|body image
5116086|NCT03270397|Eating disorders|eating disorders
5116087|NCT03270384|early feasibility|early feasibility
5116088|NCT03270384|non-randomized|non-randomized
5116089|NCT03270345|Decubitus|decubitus
5116090|NCT03270345|Pressure|pressure
5116092|NCT03270345|Injuries|injuries
5116093|NCT03270345|Sores|sores
5116094|NCT03270345|Intensive care|intensive care
5116095|NCT03270319|Measurement of cardiac output|measurement of cardiac output
5116096|NCT03270280|Chronic Periodontitis|chronic periodontitis
5116097|NCT03270280|Phytomedicines|phytomedicines
5116098|NCT03270280|Nigella sativa|nigella sativa
5116103|NCT03270241|Paid|paid
5116104|NCT03270241|Phototherapy|phototherapy
5116105|NCT03270241|NB-UVB|nb-uvb
5116106|NCT03270241|Light treatment|light treatment
5116107|NCT03270241|Skin|skin
5116108|NCT03270241|Biopsies|biopsies
5116109|NCT03270241|Money|money
5116110|NCT03270241|Short-term|short-term
5116111|NCT03270228|Incidence of cancer|incidence of cancer
5116112|NCT03270228|Survival|survival
5116113|NCT03270215|Computed Tomography|computed tomography
5116114|NCT03270215|Specificity|specificity
5116115|NCT03270215|Sensitivity|sensitivity
5116116|NCT03270202|Exercise|exercise
5116117|NCT03270202|Cardiorespiratory fitness|cardiorespiratory fitness
5116118|NCT03270202|Risk factors|risk factors
5116119|NCT03270202|Monitoring, physiologic|monitoring, physiologic
5116120|NCT03270202|Monitoring, ambulatory|monitoring, ambulatory
5116121|NCT03270202|Prognosis|prognosis
5116122|NCT03270202|Norway|norway
5116123|NCT03270163|Intensive care unit acquired muscle weakness|intensive care unit acquired muscle weakness
5116124|NCT03270163|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
5116125|NCT03270137|Alzheimer Disease|alzheimer disease
5116126|NCT03270137|rTMS|rtms
5116127|NCT03270137|Cognition|cognition
5116128|NCT03270137|Behavioral Symptoms|behavioral symptoms
5116129|NCT03270137|Functionality|functionality
5116130|NCT03270124|Aortic Valve Stenosis|aortic valve stenosis
5116131|NCT03270124|Fitbit|fitbit
5116132|NCT03270124|iPAD|ipad
5116133|NCT03270124|Physical Exercises|physical exercises
5116134|NCT03270124|Quality of Life|quality of life
5116135|NCT03270111|breast cancer survivor|breast cancer survivor
5116136|NCT03270111|weight loss program|weight loss program
5116137|NCT03270098|Schizophrenia|schizophrenia
5116138|NCT03270098|Aerobic Exercise|aerobic exercise
5116139|NCT03270098|Cognition|cognition
5116140|NCT03270098|Daily Functioning|daily functioning
5116141|NCT03270098|Biomarkers|biomarkers
5116142|NCT03270098|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
5116143|NCT03270046|Bowel preparation|bowel preparation
5116144|NCT03270046|CRC screening|crc screening
5116145|NCT03270033|Shoulder Joint|shoulder joint
5116146|NCT03270033|Arthroscopy|arthroscopy
5116147|NCT03270033|Ambulatory surgical procedures|ambulatory surgical procedures
5116148|NCT03270033|Pain, Postoperative|pain, postoperative
5116149|NCT03270033|Brachial Plexus Block|brachial plexus block
5116150|NCT03270033|Corticosteroid|corticosteroid
5116151|NCT03270033|Dexamethasone|dexamethasone
5116152|NCT03270033|Dexmedetomidine|dexmedetomidine
5116153|NCT03270033|Bupivacaine|bupivacaine
5116154|NCT03270033|Alpha 2 agonist|alpha 2 agonist
5116155|NCT03270033|Postoperative analgesia|postoperative analgesia
5116156|NCT03270020|treatment|treatment
5116157|NCT03270020|denosumab|denosumab
5116158|NCT03270020|Positron Emission Tomography (PET) CT scan|positron emission tomography (pet) ct scan
5116163|NCT03269981|Adjuvant radiotherapy|adjuvant radiotherapy
5116164|NCT03269981|Lymphatic irradiation|lymphatic irradiation
5116165|NCT03269981|Taxane|taxane
5116166|NCT03269981|Anthracycline|anthracycline
5116175|NCT03269799|vitamin C|vitamin c
5116176|NCT03269773|Atopic Dermatitis|atopic dermatitis
5116177|NCT03269773|Stem cell|stem cell
5116178|NCT03269773|Cell therapy|cell therapy
5961994|NCT04283591|stroke|stroke
4984040|NCT04091932|AIDS|aids
5116179|NCT03269773|skin disease|skin disease
5116180|NCT03269773|Umbilical cord Blood|umbilical cord blood
5116181|NCT03269773|UCB-MSC|ucb-msc
5116182|NCT03269773|hUCB-MSC|hucb-msc
5116183|NCT03269773|AD|ad
5116184|NCT03269773|furestem|furestem
5116185|NCT03269773|dermatitis|dermatitis
5116186|NCT03269773|eczema|eczema
5116187|NCT03269747|glucocorticoids|glucocorticoids
5116188|NCT03269747|brown adipose tissue|brown adipose tissue
5116189|NCT03269747|cold induced thermogenesis|cold induced thermogenesis
5116190|NCT03269734|Vascular Diseases|vascular diseases
5116191|NCT03269734|Cerebrovascular Diseases|cerebrovascular diseases
5116192|NCT03269734|Cardiovascular Diseases|cardiovascular diseases
5116193|NCT03269734|Aortic aneurysm|aortic aneurysm
5116194|NCT03269734|Arteriovenous malformations|arteriovenous malformations
5116195|NCT03269734|Catheterization|catheterization
5116196|NCT03269721|Cognition|cognition
5116197|NCT03269721|Pulmonary|pulmonary
5116198|NCT03269721|COPD|copd
5116199|NCT03269721|Lung|lung
5116200|NCT03269656|Vitamin D|vitamin d
5116201|NCT03269656|Cancer|cancer
5116202|NCT03269656|Survival|survival
5116203|NCT03269643|Vital Sign|vital sign
5116204|NCT03269643|Vigilance System|vigilance system
5116205|NCT03269643|Heart Rate|heart rate
5116206|NCT03269617|dysbiosis|dysbiosis
5116207|NCT03269617|gut microbiota|gut microbiota
5116208|NCT03269617|bacteriophage|bacteriophage
5116209|NCT03269617|irritable bowel syndrome|irritable bowel syndrome
5116210|NCT03269617|gastrointestinal distress|gastrointestinal distress
5116211|NCT03269617|prebiotic|prebiotic
5116233|NCT03269461|stent, DES, INSPIRON, OCT, tissue repair|stent, des, inspiron, oct, tissue repair
5116234|NCT03269448|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5116235|NCT03269448|carbon dioxide|carbon dioxide
5116236|NCT03269448|peripheral venous blood|peripheral venous blood
5116237|NCT03269448|central venous blood|central venous blood
5116238|NCT03269448|venous blood gas|venous blood gas
5116239|NCT03269448|blood gas analysis|blood gas analysis
5116240|NCT03269422|17-407|17-407
5116241|NCT03269422|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
5116242|NCT03269422|DIL|dil
5116243|NCT03269422|Dominant Intra-Prostatic Lesion|dominant intra-prostatic lesion
5116244|NCT03269396|severe laryngotracheal dysfunction|severe laryngotracheal dysfunction
5116245|NCT03269383|stellate ganglion block|stellate ganglion block
5116246|NCT03269383|cardiac surgery|cardiac surgery
5116247|NCT03269383|atrial fibrillation|atrial fibrillation
5116248|NCT03269370|CBT|cbt
5116249|NCT03269370|Self-Help|self-help
5116250|NCT03269370|Family|family
5116251|NCT03269357|LARC|larc
5116252|NCT03269357|contraception|contraception
5116253|NCT03269357|counselling|counselling
5116254|NCT03269357|unplanned pregnancy|unplanned pregnancy
5116255|NCT03269331|nursing practice|nursing practice
5126319|NCT03204786|Autism|autism
5116260|NCT03269266|Positive Rapid Diagnostic Test|positive rapid diagnostic test
5116262|NCT03269253|longitudinal|longitudinal
5116263|NCT03269227|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5116264|NCT03269227|Radiotherapy|radiotherapy
5116265|NCT03269227|Tomotherapy|tomotherapy
5116266|NCT03269227|Hypofractionation|hypofractionation
5116267|NCT03269214|osteonecrosis|osteonecrosis
5116268|NCT03269214|mandible|mandible
5116269|NCT03269201|parkinsonism|parkinsonism
5116270|NCT03269201|ataxia|ataxia
5116271|NCT03269201|tremor|tremor
5116272|NCT03269201|dystonia|dystonia
5753921|NCT00305149|PET|pet
5116273|NCT03269175|Clinically Isolated Syndrome suggestive of Multiple Sclerosis or Multiple Sclerosis|clinically isolated syndrome suggestive of multiple sclerosis or multiple sclerosis
5116274|NCT03269149|Alzheimer's disease|alzheimer's disease
5116275|NCT03269149|African-American Women|african-american women
5116276|NCT03269149|Caregivers|caregivers
5116277|NCT03269149|Tango|tango
5116278|NCT03269149|Dance-based intervention|dance-based intervention
5116279|NCT03269136|Multiple Myeloma|multiple myeloma
5116280|NCT03269136|relapse/ refractory multiple myeloma|relapse/ refractory multiple myeloma
5116281|NCT03269136|bispecific antibody|bispecific antibody
5116285|NCT03269136|Phase 1|phase 1
5116286|NCT03269136|PF-06863135|pf-06863135
5116287|NCT03269123|Sensory trick|sensory trick
5116288|NCT03269123|Geste Antagoniste|geste antagoniste
5116289|NCT03269110|neurological|neurological
5116290|NCT03269110|autism|autism
5116291|NCT03269110|ASD|asd
5116292|NCT03269110|behaviour|behaviour
5116293|NCT03269110|folic acid|folic acid
5116294|NCT03269110|pre-eclampsia|pre-eclampsia
5116295|NCT03269110|asthma|asthma
5116296|NCT03269110|executive function|executive function
5116297|NCT03269071|Multiple Sclerosis|multiple sclerosis
5116298|NCT03269071|Cell Therapy|cell therapy
5116299|NCT03269071|Human Neural Stem Cells|human neural stem cells
5116300|NCT03269032|Mediterranean diet|mediterranean diet
5116301|NCT03269032|gut microbiome|gut microbiome
5116302|NCT03269032|gastrointestinal|gastrointestinal
5116303|NCT03269019|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5116305|NCT03269019|thrombin-antithrombin|thrombin-antithrombin
5961995|NCT04283591|acupuncture|acupuncture
5116306|NCT03269019|d-dimer|d-dimer
5116307|NCT03269019|Thrombelastograghy|thrombelastograghy
5116308|NCT03269006|Visceral leishmaniasis|visceral leishmaniasis
5116309|NCT03269006|Vector control|vector control
5116310|NCT03269006|Sand fly,|sand fly,
5116311|NCT03269006|Bangladesh|bangladesh
5116312|NCT03268993|prevention|prevention
5116313|NCT03268993|dietary supplement|dietary supplement
5116314|NCT03268993|broccoli|broccoli
5116315|NCT03268993|avmacol|avmacol
5116316|NCT03268967|intensive care|intensive care
5116317|NCT03268967|crisis resource management|crisis resource management
5116318|NCT03268967|simulation training|simulation training
5116319|NCT03268967|before and after study|before and after study
5116320|NCT03268954|Drug therapy|drug therapy
5116321|NCT03268941|Drug therapy|drug therapy
5116322|NCT03268928|Shared Book Reading|shared book reading
5116323|NCT03268928|Language Development|language development
5116324|NCT03268928|Syntax|syntax
5116325|NCT03268928|Vocabulary|vocabulary
5116326|NCT03268928|Phonological Awareness|phonological awareness
5116327|NCT03268928|Young Children|young children
5116328|NCT03268928|Randomised Control Trial|randomised control trial
5116329|NCT03268928|Language Intervention|language intervention
5116330|NCT03268915|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5116331|NCT03268915|3 minutes sit-to-stand test|3 minutes sit-to-stand test
5116332|NCT03268915|Interindividual reproductibility|interindividual reproductibility
5116333|NCT03268889|Chidamide, CHOP regimen|chidamide, chop regimen
5116337|NCT03268863|pain tolerance|pain tolerance
5116338|NCT03268863|perioperative pain|perioperative pain
5116339|NCT03268863|virtual reality therapy|virtual reality therapy
5116340|NCT03268850|LDKT|ldkt
5116341|NCT03268850|Live donor transplantation|live donor transplantation
5116342|NCT03268850|Kidney transplantation|kidney transplantation
5116343|NCT03268798|stroke|stroke
5116344|NCT03268798|strength training|strength training
5116345|NCT03268798|rehabilitation|rehabilitation
5116346|NCT03268785|Parathyroid glands|parathyroid glands
5116347|NCT03268785|Needle puncture|needle puncture
5116348|NCT03268785|Diff-quik staining|diff-quik staining
5116349|NCT03268785|PTH test assay|pth test assay
5116350|NCT03268785|Thyroid cancer|thyroid cancer
5116351|NCT03268759|substance abuse|substance abuse
5116352|NCT03268746|Korea|korea
5116353|NCT03268746|Trifocal|trifocal
5116354|NCT03268746|PanOptix|panoptix
5116355|NCT03268746|Bilateral implantation|bilateral implantation
5116359|NCT03268746|ACRYSOF|acrysof
5116360|NCT03268746|Model TFNT00|model tfnt00
5116361|NCT03268733|Folic acid|folic acid
5116362|NCT03268733|PCOS|pcos
5116363|NCT03268733|Insulin resistance|insulin resistance
5116364|NCT03268733|Infertility|infertility
5116365|NCT03268720|gluten sensitivity|gluten sensitivity
5116366|NCT03268720|gluten-free diet|gluten-free diet
5116367|NCT03268720|FODMAP diet|fodmap diet
5116368|NCT03268720|microbiome|microbiome
5116369|NCT03268707|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5116370|NCT03268707|Pulmonary Vein Isolation|pulmonary vein isolation
5116371|NCT03268707|Telemetry Monitoring|telemetry monitoring
5116372|NCT03268707|Cryoballoon ablation|cryoballoon ablation
5116373|NCT03268655|gingerol|gingerol
5116374|NCT03268655|microbiome|microbiome
5116375|NCT03268655|gut|gut
5116376|NCT03268655|ginger|ginger
5116377|NCT03268642|Fulminant Myocarditis|fulminant myocarditis
5116378|NCT03268642|Retrospective cohort study|retrospective cohort study
5116379|NCT03268629|Insomnia|insomnia
5116380|NCT03268629|Mindfulness-based Intervention|mindfulness-based intervention
5116381|NCT03268629|Mindfulness Meditation|mindfulness meditation
5116382|NCT03268629|Tai Chi|tai chi
5116383|NCT03268629|Inflammation|inflammation
5116384|NCT03268629|NF-κB|nf-κb
5117183|NCT03263312|Fontan|fontan
5116392|NCT03268512|growth factors|growth factors
5116393|NCT03268512|platelet concentrates|platelet concentrates
5116394|NCT03268486|Fetal monitoring|fetal monitoring
5116395|NCT03268486|cardiotocography|cardiotocography
5116396|NCT03268473|OSAS|osas
5116397|NCT03268473|Obstructive Sleep Apnea|obstructive sleep apnea
5116398|NCT03268473|Periodontitis|periodontitis
5116399|NCT03268434|Depression|depression
5116400|NCT03268434|Metacognition|metacognition
5116402|NCT03268434|D-MCT|d-mct
5116403|NCT03268434|cognitive bias|cognitive bias
5116411|NCT03268408|community intervention|community intervention
5116412|NCT03268408|newsletter|newsletter
5116413|NCT03268382|Ovarian Cancer|ovarian cancer
5116414|NCT03268382|Ovarian Carcinoma|ovarian carcinoma
5116415|NCT03268382|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
5116417|NCT03268382|Resistant Cancer|resistant cancer
5116418|NCT03268304|Upper Limb Motor Function Deficit|upper limb motor function deficit
5116419|NCT03268304|Neurorehabilitation|neurorehabilitation
5116421|NCT03268304|Action Research Arm Test|action research arm test
5116422|NCT03268291|Adherence to therapy|adherence to therapy
5116423|NCT03268291|Myocardial Infarction|myocardial infarction
5116424|NCT03268291|Coronary Artery Disease|coronary artery disease
5116425|NCT03268291|Communicational program|communicational program
5116426|NCT03268278|analgesia|analgesia
5116427|NCT03268278|endodontic|endodontic
5116428|NCT03268278|postoperative|postoperative
5116429|NCT03268187|Cognitive Fatigue|cognitive fatigue
5116430|NCT03268187|Multiple Sclerosis|multiple sclerosis
5116431|NCT03268187|Biofeedback|biofeedback
5116432|NCT03268187|Self-Alert Training|self-alert training
5116433|NCT03268187|Vigilance|vigilance
5116434|NCT03268187|Autonomic potentials|autonomic potentials
5116435|NCT03268161|anti-MAG neuropathy|anti-mag neuropathy
5116436|NCT03268161|Waldenström disease|waldenström disease
5116437|NCT03268161|Mutational analysis|mutational analysis
5116441|NCT03268135|miRNA|mirna
5116442|NCT03268135|lncRNAs|lncrnas
5116443|NCT03268135|transcriptome|transcriptome
5116444|NCT03268135|heart failure|heart failure
5116445|NCT03268135|aortic stenosis|aortic stenosis
5116446|NCT03268135|biomarkers|biomarkers
5116447|NCT03268122|Patient Isolation|patient isolation
5116448|NCT03268122|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5116449|NCT03268122|Vancomycin-Resistant Enterococci|vancomycin-resistant enterococci
5116450|NCT03268083|Foot-and-Mouth Disease|foot-and-mouth disease
5116451|NCT03268083|Vaccines|vaccines
5116452|NCT03268083|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5116453|NCT03268083|EV71 vaccine|ev71 vaccine
5116454|NCT03268070|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5116455|NCT03268070|Neurophysiology|neurophysiology
5116456|NCT03268070|Neuroscience|neuroscience
5116457|NCT03268070|Stroke Rehabilitation|stroke rehabilitation
5116458|NCT03268057|Non-Small-Cell Lung|non-small-cell lung
5116459|NCT03268057|Carcinoma|carcinoma
5116460|NCT03268057|Advanced|advanced
5116461|NCT03268057|VX15/2503|vx15/2503
5116462|NCT03268057|Semaphorin 4D|semaphorin 4d
5116463|NCT03268057|SEMA4D|sema4d
5116464|NCT03268057|safety tolerability|safety tolerability
5116465|NCT03268057|pharmacokinetics|pharmacokinetics
5116466|NCT03268057|monoclonal antibody|monoclonal antibody
5116467|NCT03268057|IO Failure|io failure
5116468|NCT03268057|Immunotherapy Failure|immunotherapy failure
5116469|NCT03268057|Decline Chemo|decline chemo
5116470|NCT03268031|artificial intelligence|artificial intelligence
5116471|NCT03268031|glaucoma|glaucoma
5116472|NCT03268018|calcium|calcium
5116473|NCT03268018|peripheral arterial disease|peripheral arterial disease
5116474|NCT03267992|COPD|copd
5116475|NCT03267992|Coils|coils
5116476|NCT03267992|App|app
5116477|NCT03267979|pain assessment|pain assessment
5116478|NCT03267979|pupillary diameter|pupillary diameter
5116479|NCT03267979|variation coefficient of pupillary diameter|variation coefficient of pupillary diameter
5116480|NCT03267979|pain self assessment|pain self assessment
5116481|NCT03267979|video-pupillometer|video-pupillometer
5116482|NCT03267979|electrocardiogram|electrocardiogram
5116489|NCT03267940|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
5116490|NCT03267940|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5116491|NCT03267940|Gallbladder Adenocarcinoma|gallbladder adenocarcinoma
5116492|NCT03267940|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
5116493|NCT03267940|PEGylated Recombinant Human Hyaluronidase with atezolizumab|pegylated recombinant human hyaluronidase with atezolizumab
5116494|NCT03267927|OSA|osa
5116495|NCT03267927|Polysomnography|polysomnography
5116496|NCT03267927|Rapid palatal expansion|rapid palatal expansion
5116497|NCT03267927|Mandibular advancement|mandibular advancement
5116498|NCT03267927|Sleep position|sleep position
5116499|NCT03267862|biomarker|biomarker
5116500|NCT03267849|biomarker|biomarker
5116501|NCT03267823|Bleeding|bleeding
5116502|NCT03267823|heart surgery|heart surgery
5116503|NCT03267823|coagulation|coagulation
5116504|NCT03267823|coagulopathy|coagulopathy
5116506|NCT03267810|Neuropathic Pain|neuropathic pain
5116507|NCT03267810|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5116508|NCT03267797|Recurrent Implantation Failure|recurrent implantation failure
5116509|NCT03267797|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
5116510|NCT03267797|Human chorionic gonadotropin|human chorionic gonadotropin
5116520|NCT03267745|protein|protein
5116521|NCT03267745|skeletal muscle|skeletal muscle
5116522|NCT03267745|immobilization|immobilization
5116523|NCT03267706|Primary care|primary care
5116524|NCT03267706|Palliative care|palliative care
5116525|NCT03267641|Intra-tumour heterogeneity|intra-tumour heterogeneity
5116526|NCT03267641|Cancer immunotherapy|cancer immunotherapy
5116527|NCT03267641|Tumour microenvironment|tumour microenvironment
5116528|NCT03267641|Driver mutations|driver mutations
5116535|NCT03267615|Portal Hypertension|portal hypertension
5116536|NCT03267589|immunotherapy|immunotherapy
5116537|NCT03267589|ovarian cancer|ovarian cancer
5116538|NCT03267589|durvalumab|durvalumab
5116539|NCT03267589|tremelilumab|tremelilumab
5116540|NCT03267589|MEDI 9447|medi 9447
5116541|NCT03267589|MEDI 0562|medi 0562
5116542|NCT03267563|prevention|prevention
5116543|NCT03267563|implementation|implementation
5116544|NCT03267563|sustainment|sustainment
5116545|NCT03267563|perinatal|perinatal
5116546|NCT03267563|pregnancy|pregnancy
5116547|NCT03267563|postpartum|postpartum
5116548|NCT03267537|Insomnia|insomnia
5116549|NCT03267537|Sleep|sleep
5116550|NCT03267537|Telemedicine|telemedicine
5116551|NCT03267368|Comprehensive Care Program|comprehensive care program
5116552|NCT03267368|Stereotactic Radiotherapy|stereotactic radiotherapy
5116553|NCT03267316|First-in-Human|first-in-human
5116554|NCT03267316|Phase 1|phase 1
5116555|NCT03267316|Phase 2|phase 2
5116556|NCT03267316|Antibody, Monoclonal|antibody, monoclonal
5116557|NCT03267316|IL1RAP|il1rap
5116558|NCT03267316|Safety|safety
5116559|NCT03267316|Tolerability|tolerability
5116560|NCT03267316|Cancer|cancer
5116561|NCT03267316|Solid tumor|solid tumor
5116562|NCT03267316|Malignant|malignant
5116563|NCT03267316|Dose escalation|dose escalation
5116564|NCT03267316|Dose expansion|dose expansion
5116565|NCT03267316|CAN04|can04
5116566|NCT03267316|Immunoglobulin|immunoglobulin
5116567|NCT03267316|Clinical Trial|clinical trial
5116568|NCT03267316|Infusion|infusion
5116569|NCT03267316|Antineoplastic|antineoplastic
5116570|NCT03267316|Anticancer|anticancer
5116571|NCT03267303|Narcolepsy|narcolepsy
5116572|NCT03267277|Calcinosis|calcinosis
5116573|NCT03267277|Dermatomyositis|dermatomyositis
5116574|NCT03267277|Juvenile Dermatomyositis|juvenile dermatomyositis
5116575|NCT03267277|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5116576|NCT03267277|Sodium Thiosulfate|sodium thiosulfate
5116577|NCT03267251|Vaccine Decision Making|vaccine decision making
5116578|NCT03267251|Public Health|public health
5116579|NCT03267251|Health Communication|health communication
5116580|NCT03267251|Digital Interventions|digital interventions
5116581|NCT03267225|drug interaction|drug interaction
5116582|NCT03267225|genetic polymorphism|genetic polymorphism
5116583|NCT03267212|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
5116584|NCT03267212|Ventilatory support|ventilatory support
5116585|NCT03267173|Pancreatic Cancer|pancreatic cancer
5116586|NCT03267173|CAR-T|car-t
5116587|NCT03267173|Mesothelin|mesothelin
5116589|NCT03267173|HER2|her2
5116590|NCT03267147|Anti-CCP|anti-ccp
5116591|NCT03267147|rheumatoid arthritis|rheumatoid arthritis
5116592|NCT03267121|head and neck cancer|head and neck cancer
5116593|NCT03267121|Apatinib|apatinib
5116594|NCT03267121|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
5116595|NCT03267121|induction chemotherapy|induction chemotherapy
5116596|NCT03267108|Pulmonary Fibrosis|pulmonary fibrosis
5116598|NCT03267108|Pulmonary Hypertension|pulmonary hypertension
5116599|NCT03267108|Inhaled Nitric Oxide|inhaled nitric oxide
5116600|NCT03267108|iNO|ino
5116601|NCT03267108|Long Term Oxygen Therapy|long term oxygen therapy
5116602|NCT03267108|Oxygen|oxygen
5116603|NCT03267056|drug-coated balloon|drug-coated balloon
5116604|NCT03267043|preterm birth|preterm birth
5116605|NCT03267043|NICU|nicu
5116606|NCT03267043|neonatal|neonatal
5116607|NCT03267043|skin to skin|skin to skin
5116608|NCT03267043|kangaroo care|kangaroo care
5116609|NCT03267043|separation stress|separation stress
5116610|NCT03267043|family nurture|family nurture
5116611|NCT03267043|maternal confidence|maternal confidence
5116612|NCT03267043|maternal competence|maternal competence
5116613|NCT03267043|calming cycle|calming cycle
5116614|NCT03267043|infant neurodevelopment|infant neurodevelopment
5116615|NCT03267043|infant psychological development|infant psychological development
5116616|NCT03267043|mother-infant co-regulation|mother-infant co-regulation
5116617|NCT03267043|postpartum depression|postpartum depression
5116618|NCT03267030|Hypersensitivity to PEG-asparaginase|hypersensitivity to peg-asparaginase
5116619|NCT03266965|Fatigue|fatigue
5116622|NCT03266952|race|race
5116623|NCT03266952|diet|diet
5116624|NCT03266952|diabetes|diabetes
5116625|NCT03266952|ethnicity|ethnicity
5116626|NCT03266952|myocardial infarction|myocardial infarction
5116627|NCT03266874|total hip arthroplasty|total hip arthroplasty
5116628|NCT03266848|Magnetic Resonance Imaging|magnetic resonance imaging
5116644|NCT03266744|Bone scan|bone scan
5116645|NCT03266718|cancer survivor|cancer survivor
5116646|NCT03266718|breast cancer|breast cancer
5116647|NCT03266718|prostate cancer|prostate cancer
5116648|NCT03266718|couples|couples
5116649|NCT03266692|BCMA|bcma
5116650|NCT03266692|SEA-BCMA|sea-bcma
5116651|NCT03266692|B Cell Maturation Antigen|b cell maturation antigen
5116652|NCT03266692|ACTR|actr
5116653|NCT03266692|ACTR087|actr087
5116654|NCT03266692|T cell|t cell
5116655|NCT03266692|T cell product|t cell product
5116656|NCT03266692|relapsed|relapsed
5116657|NCT03266692|refractory|refractory
5116658|NCT03266692|multiple myeloma|multiple myeloma
5116659|NCT03266692|adoptive T cells|adoptive t cells
5116660|NCT03266692|autologous|autologous
5116661|NCT03266692|gene therapy|gene therapy
5116662|NCT03266692|cell therapy|cell therapy
5116663|NCT03266679|bipolar disorder|bipolar disorder
5116664|NCT03266679|metacognition|metacognition
5116665|NCT03266679|reflective functioning|reflective functioning
5116666|NCT03266679|metacognition-based intervention|metacognition-based intervention
5116667|NCT03266679|sense of self|sense of self
5116668|NCT03266679|insight|insight
5116669|NCT03266666|grocery|grocery
5116670|NCT03266666|lifestyle|lifestyle
5116671|NCT03266666|lifestyle change|lifestyle change
5116672|NCT03266666|behavior|behavior
5116673|NCT03266666|nutrition|nutrition
5116674|NCT03266640|Cytomegalovirus|cytomegalovirus
5116676|NCT03266640|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
5116677|NCT03266627|adenovirus|adenovirus
5116678|NCT03266627|primary immune deficiency disorder|primary immune deficiency disorder
5116679|NCT03266627|cytotoxic t-lymphocytes|cytotoxic t-lymphocytes
5116680|NCT03266614|Mental Illness|mental illness
5116681|NCT03266614|Loneliness|loneliness
5116682|NCT03266614|Hope|hope
5116683|NCT03266614|Community|community
5116684|NCT03266614|Social Media|social media
5116787|NCT03265938|Head and Neck cancer|head and neck cancer
5116685|NCT03266601|Aged 1-7 years old, within 72 hours of onset patients with herpangina|aged 1-7 years old, within 72 hours of onset patients with herpangina
5116688|NCT03266575|Frailty|frailty
5116689|NCT03266575|Sarcopenia|sarcopenia
5116690|NCT03266575|Pulmonary Rehabilitation|pulmonary rehabilitation
5116691|NCT03266562|Positron Emission Mammography|positron emission mammography
5116692|NCT03266549|botulinum toxin|botulinum toxin
5116695|NCT03266523|CT|ct
5116696|NCT03266523|MRI|mri
5116697|NCT03266523|Anxiety-state|anxiety-state
5116698|NCT03266523|Anxiety State-Trait|anxiety state-trait
5116699|NCT03266510|Inspiratory muscle strength training|inspiratory muscle strength training
5116700|NCT03266497|diet quality|diet quality
5116701|NCT03266497|health disparities|health disparities
5116702|NCT03266497|immigrants|immigrants
5116703|NCT03266497|foreign-born|foreign-born
5116704|NCT03266497|Blacks/African Americans|blacks/african americans
5116705|NCT03266497|place of birth/nativity|place of birth/nativity
5116706|NCT03266497|length of residency|length of residency
5116707|NCT03266497|NHANES|nhanes
5116708|NCT03266497|acculturation|acculturation
5116709|NCT03266484|Microbiome|microbiome
5116710|NCT03266484|Fatigue|fatigue
5116711|NCT03266484|Probiotics|probiotics
5116712|NCT03266471|Cytokines|cytokines
5116713|NCT03266471|Pharmacogenetics|pharmacogenetics
5116714|NCT03266445|relapse|relapse
5116715|NCT03266445|buprenorphine/naloxone|buprenorphine/naloxone
5116716|NCT03266445|opioids|opioids
5116717|NCT03266445|narcotics|narcotics
5116718|NCT03266445|post-surgical pain|post-surgical pain
5116719|NCT03266393|Envarsus XR|envarsus xr
5116720|NCT03266393|Kidney transplantation|kidney transplantation
5116733|NCT03266237|Influenza|influenza
5116734|NCT03266237|Influenza Virus Vaccines|influenza virus vaccines
5116735|NCT03266237|Vaxigrip|vaxigrip
5116736|NCT03266237|Respiratory Tract Infections|respiratory tract infections
5116737|NCT03266237|Orthomyxoviridae Infections|orthomyxoviridae infections
5116738|NCT03266237|Frailty|frailty
5116739|NCT03266237|Aging|aging
5116740|NCT03266237|Safety|safety
5116741|NCT03266237|Immunogenicity|immunogenicity
5116742|NCT03266224|congenital muscular torticollis|congenital muscular torticollis
5116743|NCT03266224|wryneck|wryneck
5116744|NCT03266224|sternocleidomastoid|sternocleidomastoid
5116745|NCT03266224|ultrasonography|ultrasonography
5116746|NCT03266224|digital analysis|digital analysis
5116748|NCT03266172|immediate release tablet|immediate release tablet
5116749|NCT03266172|GSK2982772|gsk2982772
5116750|NCT03266172|Modified release|modified release
5116751|NCT03266172|minitablet|minitablet
5116752|NCT03266159|Dose escalation|dose escalation
5116753|NCT03266159|Small cell lung cancer|small cell lung cancer
5116754|NCT03266159|Trametinib|trametinib
5116755|NCT03266159|GSK525762|gsk525762
5116756|NCT03266159|Ras-mutations|ras-mutations
5116757|NCT03266159|BET inhibitor|bet inhibitor
5116758|NCT03266146|Drug-induced Liver Injury|drug-induced liver injury
5116759|NCT03266146|Recurrence|recurrence
5116760|NCT03266146|Methylprednisolone|methylprednisolone
5116761|NCT03266146|Short-term|short-term
5116762|NCT03266133|Gestational Diabetes Mellitus|gestational diabetes mellitus
5116763|NCT03266133|Sleep education|sleep education
5116764|NCT03266120|Gardening|gardening
5116765|NCT03266120|Therapeutic Arts|therapeutic arts
5116766|NCT03266120|Therapeutic Horticulture|therapeutic horticulture
5116767|NCT03266120|Anxiety|anxiety
5116768|NCT03266120|Depression|depression
5116769|NCT03266120|Mood States|mood states
5116770|NCT03266120|Quality of Life|quality of life
5116771|NCT03266120|Social Interactions|social interactions
5116772|NCT03266120|Stress|stress
5116773|NCT03266120|Wellness|wellness
5116776|NCT03266003|Tuberculosis|tuberculosis
5116777|NCT03266003|Directly observed therapy|directly observed therapy
5116778|NCT03266003|Adherence|adherence
5116779|NCT03266003|Video assisted directly observed therapy|video assisted directly observed therapy
5116780|NCT03266003|Electronic directly observed therapy|electronic directly observed therapy
5116781|NCT03266003|Mobile health|mobile health
5116782|NCT03265964|Suicidal Ideation|suicidal ideation
5116783|NCT03265964|Veteran|veteran
5116784|NCT03265964|Uridine|uridine
5116785|NCT03265964|Neuroimaging|neuroimaging
5116786|NCT03265951|sleep apnea, PTSD|sleep apnea, ptsd
5116797|NCT03265847|risk for future violence|risk for future violence
5116798|NCT03265847|risk for intimate partner homicide|risk for intimate partner homicide
5116800|NCT03265821|Periodontal treatment|periodontal treatment
4984650|NCT04087967|AML|aml
5116801|NCT03265821|Periodontal disease|periodontal disease
5116802|NCT03265821|Healing|healing
5116803|NCT03265808|stem cells|stem cells
5116804|NCT03265782|efficacy|efficacy
5116805|NCT03265782|safety|safety
5116806|NCT03265782|paracetamol|paracetamol
5116807|NCT03265782|ibuprofen|ibuprofen
5116808|NCT03265782|PDA|pda
5116832|NCT03265587|Inner harmony|inner harmony
5116834|NCT03265522|Mediterranean diet|mediterranean diet
5116835|NCT03265522|Lifestyle|lifestyle
5116836|NCT03265483|Personalized prevention trial|personalized prevention trial
5116837|NCT03265483|Magnesium|magnesium
5116838|NCT03265483|Vitamin D metabolism and synthesis|vitamin d metabolism and synthesis
5116839|NCT03265483|Magnesium-vitamin D interaction|magnesium-vitamin d interaction
5116840|NCT03265444|MSA|msa
5116841|NCT03265405|pulmonary sarcoidosis|pulmonary sarcoidosis
5116842|NCT03265405|corticosteroids|corticosteroids
5116843|NCT03265405|glucocorticoids|glucocorticoids
5116844|NCT03265405|relapse|relapse
5116845|NCT03265405|interstitial lung disease|interstitial lung disease
5116846|NCT03265405|diffuse parenchymal lung disease|diffuse parenchymal lung disease
5113834|NCT03285347|attention|attention
5116848|NCT03265405|mediastinal lymphadenopathy|mediastinal lymphadenopathy
5116849|NCT03265366|Ultrashort echo time magnetic resonance imaging|ultrashort echo time magnetic resonance imaging
5116850|NCT03265353|Potassium|potassium
5116851|NCT03265353|Sodium|sodium
5116852|NCT03265353|Vascular function|vascular function
5116853|NCT03265340|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5116859|NCT03265275|Fast track|fast track
5116860|NCT03265223|Ropivacaine|ropivacaine
5116861|NCT03265223|local anesthesia|local anesthesia
5116862|NCT03265223|intraincisional infiltration|intraincisional infiltration
5116863|NCT03265223|intraperitoneal instillation|intraperitoneal instillation
5116864|NCT03265223|post-laparoscopic cholecystectomy pain|post-laparoscopic cholecystectomy pain
5116865|NCT03265223|shoulder pain|shoulder pain
5116866|NCT03265223|rescue analgesia|rescue analgesia
5116867|NCT03265223|triple blinding|triple blinding
5116870|NCT03265197|Tinnitus|tinnitus
5116871|NCT03265197|Intra-tympanic|intra-tympanic
5116872|NCT03265197|Lidocaine|lidocaine
5116873|NCT03265197|Dexamethasone|dexamethasone
5116874|NCT03265132|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
5116875|NCT03265132|IL-1 receptor antagonist|il-1 receptor antagonist
5116876|NCT03265132|Kineret|kineret
5116877|NCT03265132|anakinra|anakinra
5116878|NCT03265132|Adult-Onset Still's Disease|adult-onset still's disease
5116879|NCT03265132|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5116880|NCT03265093|Pain Measurement|pain measurement
5116881|NCT03265093|Platelet Activation|platelet activation
5116882|NCT03265093|Quality of Life|quality of life
5116883|NCT03265028|primary care|primary care
5116884|NCT03265028|antibiotics|antibiotics
5116888|NCT03265028|ambulatory care|ambulatory care
5116889|NCT03265028|anti-bacterial agents|anti-bacterial agents
5116890|NCT03265002|fibre|fibre
5116891|NCT03265002|inulin|inulin
5116892|NCT03265002|psyllium|psyllium
5116893|NCT03265002|small bowel MRI|small bowel mri
5116894|NCT03264989|Sickle cell disease|sickle cell disease
5116895|NCT03264989|sickle cell anemia|sickle cell anemia
5116896|NCT03264989|vaso-occlusive crisis|vaso-occlusive crisis
5116897|NCT03264989|P-selectin|p-selectin
5116898|NCT03264989|SEG101|seg101
5126924|NCT03201003|ARTEMIS|artemis
5116903|NCT03264989|Hemoglobin SC Disease|hemoglobin sc disease
5116904|NCT03264989|Sickle Cell Disorders|sickle cell disorders
5116905|NCT03264989|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
5116906|NCT03264976|diabetic retinopathy|diabetic retinopathy
5116908|NCT03264976|serum exosomes|serum exosomes
5116909|NCT03264976|prognostic biomarker|prognostic biomarker
5116910|NCT03264963|Upper airway exercises|upper airway exercises
5116911|NCT03264963|Smart phone application|smart phone application
5116912|NCT03264937|TTR|ttr
5116913|NCT03264937|INR|inr
5116914|NCT03264937|Warfarin|warfarin
5116915|NCT03264937|social software|social software
5116919|NCT03264911|pharyngitis|pharyngitis
5116920|NCT03264911|amoxicillin|amoxicillin
5116921|NCT03264872|Motivational Interviewing|motivational interviewing
5116922|NCT03264859|NGAL|ngal
5116923|NCT03264859|STEMI|stemi
5116924|NCT03264859|no-reflow|no-reflow
5116925|NCT03264859|PCI (Percutaneous Coronary Intervention)|pci (percutaneous coronary intervention)
5116926|NCT03264820|digital obstructive arterial disease, DOAD|digital obstructive arterial disease, doad
5116927|NCT03264807|Lymph Node 14v|lymph node 14v
5116928|NCT03264807|D2 lymphadenectomy|d2 lymphadenectomy
5116929|NCT03264781|Cyclofem®|cyclofem®
5116930|NCT03264781|Implant|implant
5116931|NCT03264781|Jadelle|jadelle
5116932|NCT03264781|Implanon|implanon
5116933|NCT03264781|irregular uterine bleeding|irregular uterine bleeding
5116934|NCT03264781|randomized controlled trial|randomized controlled trial
5961996|NCT04283591|depression|depression
5116935|NCT03264768|valves|valves
5116936|NCT03264768|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5116937|NCT03264768|endoscopic long volume reduction|endoscopic long volume reduction
5116938|NCT03264742|ghreline, stroke|ghreline, stroke
5116939|NCT03264729|plantar heel pain|plantar heel pain
5116940|NCT03264716|TACE (transarterial chemoembolization)|tace (transarterial chemoembolization)
5116941|NCT03264716|colorectal liver metastasis|colorectal liver metastasis
5116942|NCT03264703|Joint pain|joint pain
5116943|NCT03264703|Joint stiffness|joint stiffness
5116944|NCT03264703|Joint redness|joint redness
5116945|NCT03264703|Loss of joint function|loss of joint function
5116946|NCT03264703|Swollen joints|swollen joints
5116947|NCT03264690|Crohn's disease|crohn's disease
5116948|NCT03264690|Ulcerative colitis|ulcerative colitis
5116949|NCT03264677|8-week HUT|8-week hut
5116950|NCT03264677|Hydro Boost|hydro boost
5116951|NCT03264677|Skin healthy signs|skin healthy signs
5116952|NCT03264677|Environmental aggressors|environmental aggressors
5116953|NCT03264677|Cosmetic|cosmetic
5116954|NCT03264664|E7386|e7386
5116955|NCT03264664|dose escalation|dose escalation
5116956|NCT03264664|advanced or recurrent neoplasms|advanced or recurrent neoplasms
5116957|NCT03264651|Selective androgen receptor modulator|selective androgen receptor modulator
5116958|NCT03264651|Aromatase inhibitor|aromatase inhibitor
5116959|NCT03264638|PCOS|pcos
5116978|NCT03264508|hot water immersion|hot water immersion
5116979|NCT03264443|physical activity|physical activity
5116980|NCT03264443|exercise|exercise
5116981|NCT03264443|aging|aging
5116982|NCT03264443|older|older
5116983|NCT03264430|Perianal fistula|perianal fistula
5116984|NCT03264430|Hemorrhoids|hemorrhoids
5116985|NCT03264404|Pancreas|pancreas
5116986|NCT03264404|pembrolizumab|pembrolizumab
5116987|NCT03264404|azacitidine|azacitidine
5116988|NCT03264404|metastatic pancreatic cancer|metastatic pancreatic cancer
5116989|NCT03264404|first-line|first-line
5116990|NCT03264391|OCT-A|oct-a
5116991|NCT03264391|Retinal vasculitis|retinal vasculitis
5116992|NCT03264391|Behcet's disease|behcet's disease
5116993|NCT03264365|Health-related quality of life|health-related quality of life
5116994|NCT03264365|Anxiety|anxiety
5116995|NCT03264365|Depression|depression
5116996|NCT03264365|Post-traumatic stress disorder|post-traumatic stress disorder
5116997|NCT03264365|Recovery programme|recovery programme
5116998|NCT03264365|Rehabilitation|rehabilitation
5117006|NCT03264339|Exercise|exercise
5117007|NCT03264339|Communication|communication
5117008|NCT03264313|tobacco|tobacco
5117009|NCT03264313|Smoking Cessation|smoking cessation
5117011|NCT03264313|Neuromodulation|neuromodulation
5117012|NCT03264313|transcranial magnetic stimulation|transcranial magnetic stimulation
5117013|NCT03264300|brain tumor, MRI|brain tumor, mri
5117014|NCT03264287|acne vulgaris|acne vulgaris
5117015|NCT03264287|acupuncture|acupuncture
5117016|NCT03264287|cupping|cupping
5117017|NCT03264287|ear point tapping|ear point tapping
5117018|NCT03264287|randomized controlled trial|randomized controlled trial
5117019|NCT03264274|Colorectal|colorectal
5117020|NCT03264274|Metastatic|metastatic
5117021|NCT03264274|Chemorefractory|chemorefractory
5117022|NCT03264274|Ultrasound|ultrasound
5117023|NCT03264274|Aflibercept|aflibercept
5117024|NCT03264261|stroke, locomotion|stroke, locomotion
5117025|NCT03264248|obesity|obesity
5117026|NCT03264248|overweight|overweight
5117027|NCT03264248|wheelchair|wheelchair
5117028|NCT03264235|Powered-Knee Exoskeleton|powered-knee exoskeleton
5117029|NCT03264235|Stair Training|stair training
5117030|NCT03264235|Keeogo|keeogo
5117031|NCT03264196|condylar hear|condylar hear
5117032|NCT03264196|fracture|fracture
5117033|NCT03264196|randomised controlled trial|randomised controlled trial
5117034|NCT03264144|Social norms|social norms
5117035|NCT03264144|Adolescent|adolescent
5117036|NCT03264144|Smoking|smoking
5117037|NCT03264144|Randomised controlled trial|randomised controlled trial
5117038|NCT03264131|Brentuximab Vedotin|brentuximab vedotin
5117039|NCT03264131|Adcetris|adcetris
5117040|NCT03264131|Lymphoma|lymphoma
5117041|NCT03264131|Leukemia|leukemia
5117042|NCT03264131|CD30|cd30
5117043|NCT03264118|Periodontal Guided Tissue Regeneration|periodontal guided tissue regeneration
5117044|NCT03264118|Photochemotherapy|photochemotherapy
5117045|NCT03264079|RTA 402|rta 402
5117046|NCT03264079|Bardoxolone methyl|bardoxolone methyl
5117047|NCT03264079|Itraconazole|itraconazole
5117048|NCT03264079|Sporanox|sporanox
5117049|NCT03264079|CYP3A4|cyp3a4
5117050|NCT03264053|socket shield technique|socket shield technique
5117051|NCT03264053|crestal bone loss|crestal bone loss
5117052|NCT03264053|immediate implanation|immediate implanation
5117053|NCT03264040|Mannosidosis|mannosidosis
5117054|NCT03264040|Biomarker|biomarker
5117055|NCT03263988|pulse contour analysis|pulse contour analysis
5117056|NCT03263988|capton|capton
5117069|NCT03263923|grandmother caregivers|grandmother caregivers
5117070|NCT03263923|grandfamily|grandfamily
5117071|NCT03263923|grandfamilies|grandfamilies
5117072|NCT03263923|custodial grandparent|custodial grandparent
5117073|NCT03263923|custodial grandmother|custodial grandmother
5117074|NCT03263923|multigenerational family|multigenerational family
5117075|NCT03263923|Grandmothers raising or living with grandchildren|grandmothers raising or living with grandchildren
5117076|NCT03263897|abortive effect|abortive effect
5117077|NCT03263897|mobile interface|mobile interface
5117078|NCT03263884|nerve growth factor|nerve growth factor
5117079|NCT03263884|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5117080|NCT03263884|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5117081|NCT03263871|nutrition|nutrition
5117082|NCT03263832|Antibiogramme|antibiogramme
5117083|NCT03263832|Antibiofilmogramme|antibiofilmogramme
5117084|NCT03263819|Postural Orthostatic Tachycardia Syndrome, gastrointestinal hormones|postural orthostatic tachycardia syndrome, gastrointestinal hormones
5117085|NCT03263806|angina|angina
5117086|NCT03263806|coronary artery disease|coronary artery disease
5117087|NCT03263806|coronary artery catheterization|coronary artery catheterization
5117088|NCT03263806|coronary CT angiography|coronary ct angiography
5117105|NCT03263741|Efficiency|efficiency
5117106|NCT03263741|safety|safety
5117107|NCT03263728|Stress Cardiac Magnetic Resonance|stress cardiac magnetic resonance
5127122|NCT03199781|cellulits of leg|cellulits of leg
5117120|NCT03263650|aggressive-variant prostate carcinomas|aggressive-variant prostate carcinomas
5117122|NCT03263650|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma
5117123|NCT03263637|Relapsed or refractory haematological malignancies|relapsed or refractory haematological malignancies
5117124|NCT03263637|AZD4573|azd4573
5117125|NCT03263637|CDK9i|cdk9i
5117126|NCT03263637|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5117127|NCT03263637|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5002447|NCT03980496|intragastric pH|intragastric ph
5117128|NCT03263637|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5117129|NCT03263637|High risk Myelodysplastic syndrome (MDS)|high risk myelodysplastic syndrome (mds)
5117130|NCT03263637|Chronic Myelomonocytic Leukemia (CML)|chronic myelomonocytic leukemia (cml)
5117131|NCT03263637|Richter's syndrome|richter's syndrome
5356827|NCT01917838|Mental Health Services|mental health services
5117133|NCT03263637|T-cell Non-Hodgkin Lymphoma (T-cell NHL)|t-cell non-hodgkin lymphoma (t-cell nhl)
5117134|NCT03263637|Small lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5117135|NCT03263637|Multiple Myeloma (MM)|multiple myeloma (mm)
5117136|NCT03263624|psoriasis|psoriasis
5117137|NCT03263624|laser|laser
5117138|NCT03263624|nail|nail
5117145|NCT03263585|Osteoporosis|osteoporosis
5117146|NCT03263585|Vertebral Fracture|vertebral fracture
5117147|NCT03263585|Back Pain|back pain
5117148|NCT03263585|Spinal orthosis|spinal orthosis
5117149|NCT03263585|Elderly women|elderly women
5117150|NCT03263559|Reduced Intensity Conditioning|reduced intensity conditioning
5117151|NCT03263559|Haploidentical|haploidentical
5117152|NCT03263559|Bone Marrow|bone marrow
5117153|NCT03263559|Transplant|transplant
5117154|NCT03263559|Sickle Cell Disease|sickle cell disease
5117155|NCT03263533|schizophrenia|schizophrenia
5117156|NCT03263533|clozapine|clozapine
5117157|NCT03263533|vorinostat|vorinostat
5117158|NCT03263533|HDAC|hdac
5117159|NCT03263533|histone deacetylase inhibitor|histone deacetylase inhibitor
5117160|NCT03263507|IONIS PKK-LRx|ionis pkk-lrx
5117161|NCT03263455|neglect,|neglect,
5117162|NCT03263455|stroke,|stroke,
5117163|NCT03263455|rehabilitation,|rehabilitation,
5117164|NCT03263455|range of motion|range of motion
5117165|NCT03263416|Metastatic solid tumor|metastatic solid tumor
5117166|NCT03263416|Oral Targeted Therapy|oral targeted therapy
5117167|NCT03263416|Treatment adherence|treatment adherence
5117168|NCT03263403|Meningococcal Vaccine|meningococcal vaccine
5117169|NCT03263403|Ingovax ACWY|ingovax acwy
5117170|NCT03263403|adults|adults
5117171|NCT03263403|Bangladeshi|bangladeshi
5117172|NCT03263403|immunogenicity|immunogenicity
5117173|NCT03263390|Obesity|obesity
5114114|NCT03283332|Ethnicity|ethnicity
5117174|NCT03263390|Bariatric Surgery|bariatric surgery
5117175|NCT03263390|Anti Obesity Medications|anti obesity medications
5117176|NCT03263390|Weight Regulation|weight regulation
5117177|NCT03263390|Pluripotent Stem Cells|pluripotent stem cells
5117178|NCT03263377|School feeding|school feeding
5117179|NCT03263377|Fortified Biscuits|fortified biscuits
5117180|NCT03263377|Bangladesh|bangladesh
5117181|NCT03263312|myocardial fibrosis|myocardial fibrosis
5117182|NCT03263312|exercise training|exercise training
5117192|NCT03263260|stent, DES, Inspiron|stent, des, inspiron
5117193|NCT03263195|HIV|hiv
5117194|NCT03263195|Zika Virus|zika virus
5117195|NCT03263195|Pregnancy|pregnancy
5117196|NCT03263195|MTCT|mtct
5117197|NCT03263182|childbirth|childbirth
5117198|NCT03263182|delivery|delivery
5117199|NCT03263169|e-health, community networks, pragmatic RCT|e-health, community networks, pragmatic rct
5117200|NCT03263156|sleep|sleep
5117201|NCT03263156|ADHD|adhd
5117202|NCT03263156|behavioural intervention|behavioural intervention
5117203|NCT03263156|insomnia|insomnia
5117204|NCT03263130|COPD, Emphysema, Asthma COPD Overlap|copd, emphysema, asthma copd overlap
5117205|NCT03263117|Acute stroke|acute stroke
5117206|NCT03263117|Cerebral Stroke|cerebral stroke
5117207|NCT03263091|Myelodysplastic Syndromes|myelodysplastic syndromes
5117208|NCT03263091|Anemia|anemia
5117209|NCT03263091|Hemoglobin (Hb)|hemoglobin (hb)
5117210|NCT03263091|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
5117211|NCT03263091|Low Risk MDS|low risk mds
5117212|NCT03263078|inhalation,intravenous anesthesia|inhalation,intravenous anesthesia
5117213|NCT03263065|Nopal|nopal
5117217|NCT03263052|immunosuppression|immunosuppression
5117218|NCT03263052|tacrolimus XR|tacrolimus xr
5117219|NCT03263052|elderly|elderly
5117220|NCT03263052|quality of life|quality of life
5117221|NCT03263052|neurological adverse events|neurological adverse events
5117222|NCT03263039|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
5117223|NCT03263039|Pembrolizumab|pembrolizumab
5117224|NCT03263039|Keytruda|keytruda
5117225|NCT03263039|MK-3475|mk-3475
5117226|NCT03263039|Urothelial Carcinoma|urothelial carcinoma
5117227|NCT03263026|Lymphoma|lymphoma
5117228|NCT03263026|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5117229|NCT03263026|enzastaurin|enzastaurin
5117230|NCT03263013|Functional (BOLD) MRI|functional (bold) mri
5117231|NCT03263000|Belpharospasm|belpharospasm
5117232|NCT03263000|Blink Reflex|blink reflex
5117233|NCT03263000|Eyeblink|eyeblink
5117234|NCT03262974|Imatinib|imatinib
5117235|NCT03262974|Pharmacogenetics|pharmacogenetics
5117236|NCT03262974|CML|cml
5117237|NCT03262974|Plasma level|plasma level
5117238|NCT03262961|Mild pre-eclampsia Sildenafil Citrate|mild pre-eclampsia sildenafil citrate
5117239|NCT03262922|systemic scleroderma|systemic scleroderma
5117240|NCT03262922|environmental and professional toxics|environmental and professional toxics
5117241|NCT03262909|cartilage damage|cartilage damage
5117242|NCT03262909|cartilage defect|cartilage defect
5117243|NCT03262909|chondral lesion|chondral lesion
5117244|NCT03262909|osteochondral lesion|osteochondral lesion
5117245|NCT03262909|femur|femur
5117246|NCT03262909|condyle|condyle
5117247|NCT03262896|Brain Death|brain death
5117248|NCT03262896|Spinal Reflex|spinal reflex
5117249|NCT03262896|Electromyography|electromyography
5117250|NCT03262883|Prolonged akut mechanical ventilation|prolonged akut mechanical ventilation
5117251|NCT03262883|Tracheotomy|tracheotomy
5117252|NCT03262857|magnesium sulfate|magnesium sulfate
5117253|NCT03262857|pulpitis|pulpitis
5117254|NCT03262857|anesthesia|anesthesia
5117256|NCT03262805|Joint Pain|joint pain
5117257|NCT03262805|Dietary supplement|dietary supplement
5117258|NCT03262805|WOMAC|womac
5117259|NCT03262805|Lequesne index|lequesne index
5117260|NCT03262805|hs-CRP|hs-crp
5117263|NCT03262714|Dance, walking, cardiovascular risk, functional capacity.|dance, walking, cardiovascular risk, functional capacity.
5117270|NCT03262675|Heart Failure|heart failure
5117271|NCT03262675|Acute Heart Failure|acute heart failure
5117272|NCT03262675|Chronic Heat Failure|chronic heat failure
5117273|NCT03262675|Cardiovascular diseases|cardiovascular diseases
5117274|NCT03262675|Heart diseases|heart diseases
5117275|NCT03262675|Registry|registry
5117276|NCT03262675|Tunisia|tunisia
5117277|NCT03262597|fluid balance|fluid balance
5117278|NCT03262597|dehydration|dehydration
5117279|NCT03262597|rehydration|rehydration
5117280|NCT03262597|electrolytes|electrolytes
5117281|NCT03262597|urine|urine
5117282|NCT03262571|Heart failure|heart failure
5117283|NCT03262571|Lung ultrasound|lung ultrasound
5117284|NCT03262571|B-lines|b-lines
5117285|NCT03262558|staphylococcus aureus|staphylococcus aureus
5117286|NCT03262558|nosocomial infection|nosocomial infection
5117287|NCT03262532|Interactive web-base simulation|interactive web-base simulation
5117288|NCT03262493|intubation, gastrointestinal|intubation, gastrointestinal
5117289|NCT03262493|nursing|nursing
5117290|NCT03262493|clinical trial|clinical trial
5117291|NCT03262493|enteral nutrition|enteral nutrition
5117292|NCT03262441|HIV|hiv
5117293|NCT03262441|Antiretroviral treatment|antiretroviral treatment
5117294|NCT03262441|Mycophenolate mofetil|mycophenolate mofetil
5117295|NCT03262441|Cure|cure
5117303|NCT03262402|Histatin-5|histatin-5
5117304|NCT03262402|Lactoferrin|lactoferrin
5117305|NCT03262389|positron emission tomography (PET)|positron emission tomography (pet)
5117306|NCT03262389|computerized tomography (CT)|computerized tomography (ct)
5117307|NCT03262389|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5117308|NCT03262389|Fludeoxyglucose (F-18 FDG)|fludeoxyglucose (f-18 fdg)
5117309|NCT03262389|C-11 acetate|c-11 acetate
5117311|NCT03262376|Anxiety|anxiety
5117312|NCT03262376|Cortisol|cortisol
5117313|NCT03262376|Vitamins|vitamins
5117314|NCT03262376|Botanicals|botanicals
5117315|NCT03262376|Minerals|minerals
5117316|NCT03262363|nutrigenomics|nutrigenomics
5117317|NCT03262363|Diet-gene interaction,|diet-gene interaction,
5117318|NCT03262363|Curcumin,|curcumin,
5117319|NCT03262363|Antioxidants,|antioxidants,
5117320|NCT03262363|Human NFE2L2 protein,|human nfe2l2 protein,
5117324|NCT03262324|Foot and Ankle|foot and ankle
5117325|NCT03262324|Disorders|disorders
5117326|NCT03262324|Outcome Measure|outcome measure
5117327|NCT03262298|CD22|cd22
5117328|NCT03262298|CAR-T|car-t
5117329|NCT03262298|Leukemia|leukemia
5117330|NCT03262298|Lymphoma|lymphoma
5117331|NCT03262220|Haematological malignancy|haematological malignancy
5117332|NCT03262220|Total Marrow Irradiation|total marrow irradiation
5117333|NCT03262220|Volumetric Arc Therapy|volumetric arc therapy
5117334|NCT03262181|Exercise|exercise
5117335|NCT03262181|Physical Activity|physical activity
5117336|NCT03262181|Biomechanics|biomechanics
5117337|NCT03262168|Exercise|exercise
5117338|NCT03262168|Physical Activity|physical activity
5117339|NCT03262142|COPD|copd
5117340|NCT03262142|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5117341|NCT03262116|bionic pancreas|bionic pancreas
5117342|NCT03262116|insulin|insulin
5117343|NCT03262116|continuous glucose monitor|continuous glucose monitor
5117344|NCT03262116|type 1 diabetes|type 1 diabetes
5117345|NCT03262116|insulin pharmacokinetics|insulin pharmacokinetics
5117346|NCT03262103|Prostate Cancer|prostate cancer
5117347|NCT03262103|Gleason 8-10|gleason 8-10
5117348|NCT03262103|Immunotherapy|immunotherapy
5117349|NCT03262103|Neoadjuvant|neoadjuvant
5117350|NCT03262090|Emergence Delirium|emergence delirium
5117351|NCT03262090|desoflurane|desoflurane
5117352|NCT03262090|general anesthesia|general anesthesia
5117353|NCT03262077|photodynamic therapy|photodynamic therapy
5117354|NCT03262077|periodontal disease|periodontal disease
5117355|NCT03262077|dosimetry|dosimetry
5117356|NCT03262077|methylene blue|methylene blue
5117357|NCT03262051|cytochrome|cytochrome
5117358|NCT03262051|chronic inflammation|chronic inflammation
5117359|NCT03262051|genotyping|genotyping
5117360|NCT03262051|phenotyping|phenotyping
5117361|NCT03262051|acute inflammation|acute inflammation
5117362|NCT03262051|rheumatoid arthritis|rheumatoid arthritis
5117363|NCT03262038|intrathecal morphine|intrathecal morphine
5117364|NCT03262025|Primary cecal pathology|primary cecal pathology
5117365|NCT03262025|Emergency laparotomy|emergency laparotomy
5117366|NCT03262025|Ruptured liver abscess|ruptured liver abscess
5117367|NCT03262025|Right hemicolectomy|right hemicolectomy
5117368|NCT03262025|Conservative colonic resection|conservative colonic resection
5117369|NCT03262025|Fulminant amoebic colitis|fulminant amoebic colitis
5117370|NCT03262025|Ileocecal resection|ileocecal resection
5117371|NCT03262025|Ileoascending anastomosis|ileoascending anastomosis
5117372|NCT03262025|Ileotransverse anastomosis|ileotransverse anastomosis
5117373|NCT03262025|Cecal diverticulitis|cecal diverticulitis
5117374|NCT03262025|Amoebic typhilitis|amoebic typhilitis
5117375|NCT03262025|Idiopathic typhilitis|idiopathic typhilitis
5117376|NCT03261999|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
5117377|NCT03261986|Trident|trident
5117378|NCT03261986|RSA|rsa
5117379|NCT03261986|THA|tha
5117380|NCT03261947|Drug therapy|drug therapy
5117381|NCT03261934|Chronic Atrophic Gastritis|chronic atrophic gastritis
5117382|NCT03261934|Malignant Transformation|malignant transformation
5117383|NCT03261934|Risk Assessment|risk assessment
5117384|NCT03261934|Syndrome Evolution|syndrome evolution
5117385|NCT03261934|Traditional Chinese Medicine|traditional chinese medicine
5117386|NCT03261934|Registry Study|registry study
5117391|NCT03261843|platelet rich plasma , posterior lumbar interbody fusion|platelet rich plasma , posterior lumbar interbody fusion
5117392|NCT03261830|Antibiotic|antibiotic
5117393|NCT03261830|Pediatric|pediatric
5117400|NCT03261817|hippocampus|hippocampus
5117401|NCT03261817|N acetyl aspartate|n acetyl aspartate
5117402|NCT03261817|white matter|white matter
5117403|NCT03261817|physical activity|physical activity
5117404|NCT03261791|hepatocellular carcinoma|hepatocellular carcinoma
5117405|NCT03261791|apatinib|apatinib
5117406|NCT03261791|portal vein invasion|portal vein invasion
5117407|NCT03261791|adjuvant therapy|adjuvant therapy
5117408|NCT03261791|resection|resection
5117409|NCT03261739|NAFLD, CB1 receptor blockade, anti-CB1 monoclonal antibody|nafld, cb1 receptor blockade, anti-cb1 monoclonal antibody
5117410|NCT03261726|unilateral deafness|unilateral deafness
5117411|NCT03261726|acoustic neuroma|acoustic neuroma
5117412|NCT03261726|cochlear implant|cochlear implant
5117413|NCT03261713|rehabilitation|rehabilitation
5117414|NCT03261713|telerehabilitation|telerehabilitation
5117415|NCT03261713|feasibility studies|feasibility studies
5117416|NCT03261713|virtual reality|virtual reality
5117419|NCT03261687|pregnancy|pregnancy
5117420|NCT03261687|pelvic girdle pain|pelvic girdle pain
5117421|NCT03261687|hydrotherapy|hydrotherapy
5117422|NCT03261687|quality of life|quality of life
5117439|NCT03261596|necator americanus|necator americanus
5117440|NCT03261596|ancylostoma duodenale|ancylostoma duodenale
5117441|NCT03261570|Postural Orthostatic Tachycardia Syndrome (POTS)|postural orthostatic tachycardia syndrome (pots)
5117442|NCT03261570|POTS|pots
5117443|NCT03261570|Orthostatic Intolerance|orthostatic intolerance
5117444|NCT03261570|Digoxin|digoxin
5117445|NCT03261570|Pyridostigmine|pyridostigmine
5117446|NCT03261570|Mestinon|mestinon
5117447|NCT03261531|Overweight|overweight
5117448|NCT03261531|Class I Obesity|class i obesity
5117449|NCT03261518|ileus|ileus
5117450|NCT03261518|Contrast-induced Nephropathy|contrast-induced nephropathy
5117451|NCT03261518|vena cava inferior|vena cava inferior
5117452|NCT03261505|fMRI|fmri
5117453|NCT03261505|acupuncture|acupuncture
5117454|NCT03261505|osteoarthritis|osteoarthritis
5117455|NCT03261479|pneumonia|pneumonia
5117456|NCT03261479|thermal imaging|thermal imaging
5117457|NCT03261479|respiratory distress|respiratory distress
5117458|NCT03261479|x-ray|x-ray
5117459|NCT03261479|thermal|thermal
5117460|NCT03261466|obesity|obesity
5117461|NCT03261466|paediatric|paediatric
5117462|NCT03261466|probiotic|probiotic
5117463|NCT03261401|Healthy Subjects|healthy subjects
5117464|NCT03261401|M5717|m5717
5117465|NCT03261401|Malaria|malaria
5117466|NCT03261401|Plasmodium falciparum|plasmodium falciparum
5117467|NCT03261349|Follicular lymphoma|follicular lymphoma
5117468|NCT03261349|MALT lymphoma|malt lymphoma
5117469|NCT03261349|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5117470|NCT03261349|Hepatitis C virus|hepatitis c virus
5117471|NCT03261323|Breast Reconstruction|breast reconstruction
5117729|NCT03259633|inoperable, progressive/symptomatic plexiform neurofibromas (PN) without any alternative therapeutic options|inoperable, progressive/symptomatic plexiform neurofibromas (pn) without any alternative therapeutic options
5117730|NCT03259633|mutation in the NF1 gene|mutation in the nf1 gene
5117731|NCT03259633|Selumetinib|selumetinib
5117732|NCT03259633|Early Access|early access
5117733|NCT03259633|Intermediate Access Protocol|intermediate access protocol
5117734|NCT03259607|Bioequivalence|bioequivalence
5117735|NCT03259594|Renal functional reserve|renal functional reserve
5117736|NCT03259594|Simple renal cysts|simple renal cysts
5117737|NCT03259594|Laparoscopic deroofing|laparoscopic deroofing
5117738|NCT03259581|transarterial chemoembolization|transarterial chemoembolization
5117740|NCT03259555|Brexpiprazole|brexpiprazole
5117741|NCT03259555|Bipolar|bipolar
5117742|NCT03259555|Manic episode|manic episode
5117743|NCT03259529|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5117744|NCT03259529|Nivolumab|nivolumab
5117745|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride
5117746|NCT03259529|Gemcitabine|gemcitabine
5117748|NCT03259516|myelodysplastic syndrome|myelodysplastic syndrome
5117749|NCT03259516|nivolumab|nivolumab
5117750|NCT03259516|5-azacitidine|5-azacitidine
5117751|NCT03259516|cytarabine|cytarabine
5117752|NCT03259516|melphalan|melphalan
5117753|NCT03259516|all-trans retinoic acid|all-trans retinoic acid
5117754|NCT03259516|lymphodepletion|lymphodepletion
5117755|NCT03259477|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
5117756|NCT03259477|precise segmental renal arterial clamping|precise segmental renal arterial clamping
5117757|NCT03259477|renal cell carcinoma|renal cell carcinoma
5117758|NCT03259477|renal functional reserve|renal functional reserve
5117759|NCT03259438|Qigong|qigong
5117760|NCT03259438|Comprehensive Health Improvement Program (CHIP)|comprehensive health improvement program (chip)
5117761|NCT03259438|Pre-Train Injury Prevention Program|pre-train injury prevention program
5117762|NCT03259438|Cancer Related Fatigue|cancer related fatigue
5117763|NCT03259438|Cancer Survivorship|cancer survivorship
5117764|NCT03259438|Inflammation|inflammation
5117765|NCT03259438|Flowmetry|flowmetry
5117766|NCT03259438|Corticomuscular coherence|corticomuscular coherence
5117767|NCT03259438|Heart Rate Variability|heart rate variability
5117774|NCT03259373|OAC|oac
5117775|NCT03259373|Atrial fibrillation|atrial fibrillation
5117776|NCT03259373|Oral anticoagulant|oral anticoagulant
5117777|NCT03259373|Education|education
5117778|NCT03259360|Tobacco|tobacco
5117779|NCT03259360|Gender Identity Minority|gender identity minority
5117780|NCT03259360|Sexual Identity Minority|sexual identity minority
5117781|NCT03259360|Cessation|cessation
5117782|NCT03259360|Intervention|intervention
5117783|NCT03259360|Young Adults|young adults
5117784|NCT03259360|Social Media|social media
5117785|NCT03259360|Internet|internet
5117786|NCT03259360|Cigarette|cigarette
5117787|NCT03259321|Fish|fish
5117788|NCT03259321|Polyunsaturated fatty acids|polyunsaturated fatty acids
5117789|NCT03259321|CHNS|chns
5117790|NCT03259295|skin tag|skin tag
5117791|NCT03259243|Bupivacaine, Port site infiltration ,Postoperative pain ,Gynecologic laparoscopy|bupivacaine, port site infiltration ,postoperative pain ,gynecologic laparoscopy
5117792|NCT03259230|Hemophagocytic Lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5117793|NCT03259230|Malignancy-Associated Hemophagocytic Lymphohistiocytosis|malignancy-associated hemophagocytic lymphohistiocytosis
5117794|NCT03259230|M-HLH|m-hlh
5117795|NCT03259230|Patients with known diagnosis of malignancy without HLH|patients with known diagnosis of malignancy without hlh
5117796|NCT03259230|Interferon Gamma|interferon gamma
5117797|NCT03259230|IFNγ|ifnγ
5117798|NCT03259230|Biomarkers|biomarkers
5117799|NCT03259230|Inflammatory Markers|inflammatory markers
5117800|NCT03259230|Blood draws|blood draws
5117801|NCT03259230|Data collection|data collection
5117802|NCT03259204|Achilles tendon|achilles tendon
5117803|NCT03259204|Microdialysis|microdialysis
5117804|NCT03259204|Immobilization|immobilization
5117805|NCT03259204|Wound healing|wound healing
5117806|NCT03259204|Intermittent Pneumatic Compression|intermittent pneumatic compression
5117807|NCT03259204|Ultrasonography|ultrasonography
5117808|NCT03259191|Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy|anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy
5117809|NCT03259178|Binocular vision test|binocular vision test
5117810|NCT03259165|Heart Failure|heart failure
5117811|NCT03259165|Acute Heart Failure|acute heart failure
5117812|NCT03259165|Pulmonary Edema|pulmonary edema
5117813|NCT03259165|Lung Ultrasound|lung ultrasound
5117814|NCT03259165|Extra vascular lung water|extra vascular lung water
5117815|NCT03259165|B-lines|b-lines
5117816|NCT03259165|Diuretics|diuretics
5117817|NCT03259165|Nitrates|nitrates
5117818|NCT03259152|Giant cell tumor of bone|giant cell tumor of bone
5117819|NCT03259152|Denousmab|denousmab
5117820|NCT03259152|Pathologic|pathologic
5117821|NCT03259152|Clinical|clinical
5117822|NCT03259152|Mechansim|mechansim
5117823|NCT03259139|adolescent|adolescent
5117824|NCT03259139|gun|gun
5117825|NCT03259139|violence|violence
5117826|NCT03259139|media|media
5117827|NCT03259126|Transradial|transradial
5117828|NCT03259126|Coronary|coronary
5117829|NCT03259126|X-ray|x-ray
5117830|NCT03259126|Radiation|radiation
5117831|NCT03259126|Curtain|curtain
5117832|NCT03259113|insertable cardiac monitor|insertable cardiac monitor
5117833|NCT03259113|atrial fibrillation|atrial fibrillation
5117834|NCT03259113|non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
5423208|NCT01616667|Activities of Daily Living|activities of daily living
4989248|NCT04058496|WNT|wnt
5117840|NCT03259009|biomarker|biomarker
5117841|NCT03259009|RAS mutations|ras mutations
5117842|NCT03258996|Gingival recession|gingival recession
5117843|NCT03258996|Class III gingival recession|class iii gingival recession
5117844|NCT03258996|Multiples gingival recessions|multiples gingival recessions
5117845|NCT03258996|Periodontitis|periodontitis
5117846|NCT03258996|Mucogingival surgery|mucogingival surgery
5117847|NCT03258996|Modified vestibular incision subperiosteal tunnel access|modified vestibular incision subperiosteal tunnel access
5117848|NCT03258996|Coronally advanced flap|coronally advanced flap
5117849|NCT03258996|Connective tissue graft|connective tissue graft
5117850|NCT03258996|Post-surgical pain|post-surgical pain
5117851|NCT03258983|Alpha-linolenic acid|alpha-linolenic acid
5117852|NCT03258983|Dietary intake|dietary intake
5117853|NCT03258983|Adipose tissue|adipose tissue
5117854|NCT03258983|Nutritional epidemiology|nutritional epidemiology
5117855|NCT03258970|vitamin supplement|vitamin supplement
5117856|NCT03258970|Vitamin C|vitamin c
5117857|NCT03258970|Vitamin E|vitamin e
5117858|NCT03258905|transition-age youth|transition-age youth
5117859|NCT03258905|mobile app|mobile app
5117860|NCT03258905|grounding|grounding
5117862|NCT03258879|Combined spinal epidural analgesia, dural puncture epidural|combined spinal epidural analgesia, dural puncture epidural
5117863|NCT03258866|thrombocytopenia|thrombocytopenia
5117864|NCT03258866|Immune Thrombocytopenia|immune thrombocytopenia
5117876|NCT03258827|sarcopenia|sarcopenia
5117877|NCT03258827|strengthening exercise|strengthening exercise
5117878|NCT03258814|axial spondyloarthritis|axial spondyloarthritis
5117879|NCT03258814|active supervised training|active supervised training
5117880|NCT03258814|physical training|physical training
5117881|NCT03258814|adalimumab|adalimumab
5117882|NCT03258814|spinal mobility|spinal mobility
5117883|NCT03258814|physiotherapy|physiotherapy
5117884|NCT03258814|physical function|physical function
5117885|NCT03258814|health-related quality of life|health-related quality of life
5117887|NCT03258814|disease activity|disease activity
5117888|NCT03258814|psychosocial risk factors|psychosocial risk factors
5117889|NCT03258814|workability|workability
5117890|NCT03258814|Bath Ankylosing Spondylitis Metrology Index (BASMI)|bath ankylosing spondylitis metrology index (basmi)
5117891|NCT03258775|RMR|rmr
5117892|NCT03258775|hydration|hydration
5117893|NCT03258775|substrate oxidation|substrate oxidation
5117894|NCT03258762|Japanese|japanese
5117895|NCT03258762|Caucasian|caucasian
5117896|NCT03258762|pharmacokinetics|pharmacokinetics
5117897|NCT03258762|pyrimethamine|pyrimethamine
5117898|NCT03258762|toxoplasmosis|toxoplasmosis
5117899|NCT03258749|COPD|copd
5117900|NCT03258749|GOLD|gold
5117901|NCT03258749|formoterol|formoterol
5117902|NCT03258749|tiotropium|tiotropium
5117903|NCT03258736|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric|pediatric, inguinal hernia, caudal, ilioinguinal/ilioihypogastric
5117904|NCT03258710|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5117905|NCT03258710|safety|safety
5117906|NCT03258710|chronic hepatitis B|chronic hepatitis b
5117907|NCT03258710|virological effect|virological effect
5117908|NCT03258697|Local analgesia, Pharmacokinetics, Total joint replacement|local analgesia, pharmacokinetics, total joint replacement
5117909|NCT03258684|corticosteroid|corticosteroid
5117910|NCT03258684|hydrocortisone|hydrocortisone
5117911|NCT03258684|septic shock|septic shock
5117912|NCT03258684|thiamine|thiamine
5117913|NCT03258684|vitamin C|vitamin c
5117914|NCT03258658|Urethral Stricture|urethral stricture
5117915|NCT03258632|Alcohol Use Disorder|alcohol use disorder
5117921|NCT03258593|Carcinoma-in-situ|carcinoma-in-situ
5117922|NCT03258593|High-grade Ta or T1 disease|high-grade ta or t1 disease
5117923|NCT03258593|Papillary Tumors|papillary tumors
5117930|NCT03258541|TraceIT®|traceit®
5117931|NCT03258541|Hydrogel spacer|hydrogel spacer
5117932|NCT03258541|Rectal cancer|rectal cancer
5117937|NCT03258437|sperm motility, Clinical Trial , DA-9401|sperm motility, clinical trial , da-9401
5117938|NCT03258385|Vitamin B12, Fortified milk, Immunity, Child development|vitamin b12, fortified milk, immunity, child development
5117939|NCT03258359|MDS|mds
5117940|NCT03258346|Pomegranate Juice|pomegranate juice
5117941|NCT03258346|Functional Tasks of Living|functional tasks of living
5117942|NCT03258333|aortic stenosis, aortic valve replacement, pericardium|aortic stenosis, aortic valve replacement, pericardium
5117943|NCT03258320|Cabazitaxel|cabazitaxel
5117944|NCT03258320|Docetaxel|docetaxel
5117945|NCT03258320|Mitoxantrone|mitoxantrone
5117946|NCT03258320|Satraplatin|satraplatin
5117947|NCT03258320|Surgery|surgery
5117948|NCT03258320|Prostate Cancer|prostate cancer
5117949|NCT03258320|Localized|localized
5117950|NCT03258320|High Risk|high risk
5117951|NCT03258294|melatonin|melatonin
5117952|NCT03258294|sleep disturbances|sleep disturbances
5117953|NCT03258229|Angelica gigas N. extract|angelica gigas n. extract
5117954|NCT03258229|Glucose|glucose
5117955|NCT03258229|Clinical Trial|clinical trial
5117956|NCT03258216|Upper gastrointestinal disorders|upper gastrointestinal disorders
5117957|NCT03258216|Automatic tongue diagnosis system|automatic tongue diagnosis system
5117958|NCT03258216|Panendoscopy|panendoscopy
5961998|NCT04283565|detection|detection
5117959|NCT03258190|Urolithiasis|urolithiasis
5117961|NCT03258190|Citrate|citrate
5117962|NCT03258190|Antioxidants|antioxidants
5117963|NCT03258190|Lime Powder Regimen|lime powder regimen
5117964|NCT03258177|Virtual Visits|virtual visits
5117965|NCT03258177|Telehealth|telehealth
5117966|NCT03258138|Pragmatic|pragmatic
5117967|NCT03258138|Pilot study|pilot study
5117968|NCT03258138|Mixed methods|mixed methods
5117969|NCT03258138|Randomized controlled trial|randomized controlled trial
5117970|NCT03258138|Implementation research|implementation research
5117971|NCT03258138|Person-centered care|person-centered care
5117972|NCT03258138|Multidisciplinary|multidisciplinary
5117973|NCT03258138|Ecological approach|ecological approach
5117974|NCT03258073|maternal|maternal
5117976|NCT03258073|resuscitation|resuscitation
5117977|NCT03258073|emergencies|emergencies
5117978|NCT03258073|medical simulation|medical simulation
5117979|NCT03258060|Heart Failure|heart failure
5117980|NCT03258060|Pacing|pacing
5117981|NCT03258060|Resynchronization|resynchronization
5117982|NCT03258060|Electrophysiology|electrophysiology
5117983|NCT03258060|Imaging|imaging
5117984|NCT03258060|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5117986|NCT03258021|Glioblastoma|glioblastoma
5117988|NCT03258021|Tumor-treating fields|tumor-treating fields
5117989|NCT03258021|TTFields|ttfields
5117990|NCT03258008|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5117991|NCT03258008|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
5117992|NCT03258008|Oropharyngeal Cancer|oropharyngeal cancer
5117993|NCT03258008|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5117994|NCT03258008|OPSCC|opscc
5117995|NCT03258008|Human Papillomavirus - positive (HPV+)|human papillomavirus - positive (hpv+)
5117996|NCT03258008|Utomilumab|utomilumab
5117997|NCT03258008|PF-05082566|pf-05082566
5117998|NCT03258008|Anti-CD137|anti-cd137
5117999|NCT03258008|ISA101b|isa101b
5118000|NCT03257995|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod|asthma, asthma attack, difficulty breathing, bronchial diseases, lung, lung diseases, inhaled drugs, bronchodilator, inhaled corticosteriod
5118001|NCT03257982|Brain-computer interface|brain-computer interface
5118002|NCT03257982|Functional electrical stimulation|functional electrical stimulation
5118003|NCT03257969|Oral chemotherapy|oral chemotherapy
5118004|NCT03257969|Health related program|health related program
5118005|NCT03257969|Secured drug intake|secured drug intake
5118006|NCT03257969|Pharmacist intervention|pharmacist intervention
5118007|NCT03257969|Cancer outpatient|cancer outpatient
5118008|NCT03257956|Vital Sign|vital sign
5118009|NCT03257956|Vigilance System|vigilance system
5118010|NCT03257956|Heart Rate|heart rate
5118011|NCT03257956|Respiratory Rate|respiratory rate
5118012|NCT03257917|Financial Burden|financial burden
5118013|NCT03257917|Out of Pocket expenses|out of pocket expenses
5118014|NCT03257917|Time spent on Healthcare|time spent on healthcare
5118015|NCT03257917|Metastatic Breast Cancer|metastatic breast cancer
5118016|NCT03257904|intracranial pressure|intracranial pressure
5118017|NCT03257891|Adrenocortical Carcinoma|adrenocortical carcinoma
5118018|NCT03257891|Cabazitaxel|cabazitaxel
5118019|NCT03257865|Brexpiprazole|brexpiprazole
5118020|NCT03257865|Bipolar|bipolar
5118021|NCT03257865|Manic episode|manic episode
5118022|NCT03257852|Methotrexate|methotrexate
5118023|NCT03257852|Arthritis, Rheumatoid|arthritis, rheumatoid
5118024|NCT03257852|ASP5094|asp5094
5118025|NCT03257839|SoftVue|softvue
5118026|NCT03257839|Dense Breast Tissue|dense breast tissue
5118027|NCT03257839|Breast Screening|breast screening
5118028|NCT03257839|Abnormal Breast|abnormal breast
5118029|NCT03257839|Normal Breast|normal breast
5118030|NCT03257839|Breast Imaging|breast imaging
5118031|NCT03257839|Breast Biopsy|breast biopsy
5118032|NCT03257839|Mammography|mammography
5118033|NCT03257839|Tomosynthesis|tomosynthesis
5118034|NCT03257839|Automated Breast Ultrasound|automated breast ultrasound
5118035|NCT03257839|Breast Cancer|breast cancer
5118036|NCT03257839|Breast Carcinoma|breast carcinoma
5118037|NCT03257839|Breast Tumors|breast tumors
5118038|NCT03257839|Mammary Carcinoma|mammary carcinoma
5118039|NCT03257839|Malignant Breast Tumor|malignant breast tumor
5118040|NCT03257839|Mammary Neoplasm|mammary neoplasm
5118041|NCT03257839|Mammary Cancer|mammary cancer
5118042|NCT03257839|ABUS|abus
5118043|NCT03257839|AWBUS|awbus
5118047|NCT03257839|Mammogram|mammogram
5118048|NCT03257839|3D Mammogram|3d mammogram
5118049|NCT03257839|3D ABUS|3d abus
5118050|NCT03257839|3D Breast Ultrasound|3d breast ultrasound
5118052|NCT03257839|FFDM|ffdm
5118053|NCT03257839|Digital Mammography|digital mammography
5118054|NCT03257839|Breast Ultrasound|breast ultrasound
5118055|NCT03257839|Dense Breasts|dense breasts
5118056|NCT03257839|Breast Density|breast density
5118057|NCT03257839|Dense Parenchyma|dense parenchyma
5118058|NCT03257839|Asymptomatic|asymptomatic
5118059|NCT03257839|Delphinus|delphinus
5118060|NCT03257839|Delphinus Medical Technologies|delphinus medical technologies
5961999|NCT04283565|cost-utility analysis|cost-utility analysis
4989441|NCT04057456|CBD|cbd
5118061|NCT03257839|Screening Breast Ultrasound|screening breast ultrasound
5118062|NCT03257826|congenital pseudarthrosis of the tibia|congenital pseudarthrosis of the tibia
5118063|NCT03257826|age of surgery|age of surgery
5118064|NCT03257826|Percutaneous Kirschner wire|percutaneous kirschner wire
5118065|NCT03257813|timolol|timolol
5118066|NCT03257813|dorzolamide|dorzolamide
5118067|NCT03257813|brimonidine|brimonidine
5118068|NCT03257813|Glaucoma|glaucoma
5118069|NCT03257813|Ocular hypertension|ocular hypertension
5118070|NCT03257800|ketamine|ketamine
5118071|NCT03257800|Propofol|propofol
5118072|NCT03257800|laryngeal masks|laryngeal masks
5118073|NCT03257800|anesthesia|anesthesia
5118074|NCT03257800|child|child
5118075|NCT03257722|Non Small Cell Lung Cancer|non small cell lung cancer
5118076|NCT03257722|Metastasis|metastasis
5118077|NCT03257722|Recurrence|recurrence
5118078|NCT03257722|Immunotherapy|immunotherapy
5118079|NCT03257670|Dyspareunia|dyspareunia
5118080|NCT03257670|Laser|laser
5118081|NCT03257670|CO2|co2
5118082|NCT03257670|Breast Cancer|breast cancer
5118083|NCT03257670|Vaginal Atrophy|vaginal atrophy
5118084|NCT03257670|Lidocaine|lidocaine
5118085|NCT03257644|Atopic dermatitis|atopic dermatitis
5118086|NCT03257644|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5118087|NCT03257644|pediatric|pediatric
5118088|NCT03257644|inflammation|inflammation
5118089|NCT03257631|Pediatric|pediatric
5118090|NCT03257631|Brain Tumor|brain tumor
5118091|NCT03257631|Central Nervous System Neoplasms|central nervous system neoplasms
5118092|NCT03257631|Glioma|glioma
5118093|NCT03257631|High-grade glioma|high-grade glioma
5118094|NCT03257631|HGG|hgg
5118095|NCT03257631|Ependymoma|ependymoma
5118096|NCT03257631|Medulloblastoma|medulloblastoma
5118097|NCT03257631|DIPG|dipg
5118098|NCT03257631|Diffuse intrinsic pontine gliomaProgressive|diffuse intrinsic pontine gliomaprogressive
5118099|NCT03257631|RecurrentPomalidomide|recurrentpomalidomide
5118100|NCT03257631|PomalystImnovid|pomalystimnovid
5118101|NCT03257631|CC-4047|cc-4047
5118102|NCT03257631|Children|children
5118103|NCT03257605|Pharmacogenomics|pharmacogenomics
5118104|NCT03257605|Medication Therapy Management|medication therapy management
5118105|NCT03257579|Myocardial Infarction|myocardial infarction
5118106|NCT03257579|Adherence|adherence
5118107|NCT03257579|Medication|medication
5118108|NCT03257540|bunion|bunion
5118109|NCT03257540|early weight-bearing|early weight-bearing
5118110|NCT03257540|Lapidus|lapidus
5118111|NCT03257540|arthrodesis|arthrodesis
5118112|NCT03257540|intramedullary nail|intramedullary nail
5118113|NCT03257540|Hallux Valgus|hallux valgus
5118114|NCT03257527|Well-being|well-being
5118115|NCT03257527|Comparative Clinical Trial|comparative clinical trial
5118116|NCT03257527|Positive Psychology Intervention|positive psychology intervention
5118117|NCT03257527|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
5118118|NCT03257527|Group Therapy|group therapy
5118119|NCT03257527|Happiness|happiness
5118120|NCT03257527|Bibliotherapy|bibliotherapy
5118121|NCT03257475|cervical cance|cervical cance
5118122|NCT03257475|vaginal radiation injury|vaginal radiation injury
5118123|NCT03257475|PIBS|pibs
5118125|NCT03257475|VRL|vrl
5118126|NCT03257462|17-hydroxyprogesterone|17-hydroxyprogesterone
5118127|NCT03257449|Body Weight|body weight
5118128|NCT03257449|Weight loss|weight loss
5118129|NCT03257449|BMI|bmi
5118130|NCT03257449|Waist Circumference|waist circumference
5118131|NCT03257449|Body Fat Percentage|body fat percentage
5118132|NCT03257449|Viscofiber|viscofiber
5118133|NCT03257449|Viscous Fibres|viscous fibres
5118134|NCT03257449|supplement|supplement
5118135|NCT03257436|Pacing|pacing
5118136|NCT03257423|Uncomplicated acute appendicitis|uncomplicated acute appendicitis
5118137|NCT03257423|Complicated acute appendicitis|complicated acute appendicitis
5118138|NCT03257423|Antibiotic therapy|antibiotic therapy
5118139|NCT03257423|Microbiological etiology|microbiological etiology
5118140|NCT03257358|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5118141|NCT03257358|RMS|rms
5118142|NCT03257358|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
5118143|NCT03257358|Multiple Sclerosis|multiple sclerosis
5118144|NCT03257358|MS|ms
5118145|NCT03257358|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5118146|NCT03257358|Fingolimod|fingolimod
5118147|NCT03257358|FLUENT|fluent
5118148|NCT03257358|Immune Phenotype|immune phenotype
5118149|NCT03257345|Real world outcomes|real world outcomes
5118150|NCT03257332|Rectum cancer|rectum cancer
5118151|NCT03257332|Low Anterior Rectal Syndrome|low anterior rectal syndrome
5118152|NCT03257332|Anorectal muscle function|anorectal muscle function
5118153|NCT03257306|Urinary tract stone|urinary tract stone
5118154|NCT03257306|ureter double-J stent|ureter double-j stent
5962000|NCT04283565|cost-effectiveness analysis|cost-effectiveness analysis
5118156|NCT03257254|AASV|aasv
5118157|NCT03257254|Vein|vein
5118158|NCT03257254|Venous|venous
5118159|NCT03257254|Ulcer|ulcer
5118160|NCT03257254|Varicose Vein|varicose vein
5118161|NCT03257254|VLU|vlu
5118162|NCT03257254|venous insufficiency|venous insufficiency
5118163|NCT03257254|venous disease|venous disease
5118164|NCT03257254|chronic VLU|chronic vlu
5118165|NCT03257241|aml|aml
5119231|NCT03250325|NY-ESO-1|ny-eso-1
5118175|NCT03257202|Surgical Site Infection|surgical site infection
5118177|NCT03257137|sleep|sleep
5118178|NCT03257137|macronutrients|macronutrients
5118179|NCT03257137|dietary patterns|dietary patterns
5118180|NCT03257137|sleep quality|sleep quality
5118181|NCT03257137|diet quality|diet quality
5118182|NCT03257137|polysomnography|polysomnography
5118183|NCT03257137|appetite|appetite
5118184|NCT03257137|mood|mood
5118185|NCT03257137|hunger|hunger
5118186|NCT03257111|rehabilitation outcomes|rehabilitation outcomes
5118187|NCT03257111|activity level|activity level
5118197|NCT03257072|hookworm|hookworm
5118198|NCT03257072|controlled human infection model|controlled human infection model
5118199|NCT03257020|OCT|oct
5118200|NCT03257020|RNFL|rnfl
5118201|NCT03257020|BMO-MRW|bmo-mrw
5118202|NCT03257020|Glaucoma|glaucoma
5118203|NCT03256981|SBRT|sbrt
5118204|NCT03256981|Oligoprogressive disease|oligoprogressive disease
5118205|NCT03256981|NSCLC|nsclc
5118206|NCT03256981|TKI|tki
5118207|NCT03256955|Validation study for a neuromuscular monitoring device|validation study for a neuromuscular monitoring device
5118208|NCT03256929|Personalized Diet|personalized diet
5118209|NCT03256929|Microbiota|microbiota
5118210|NCT03256929|Depression|depression
5118211|NCT03256929|Elderly|elderly
5118212|NCT03256929|Gut flora|gut flora
5118213|NCT03256916|Cervical cancer|cervical cancer
5118214|NCT03256903|Methoxyflurane|methoxyflurane
5118215|NCT03256903|emergency|emergency
5118216|NCT03256903|trauma pain|trauma pain
5118217|NCT03256903|inhaled analgesia|inhaled analgesia
5118218|NCT03256890|mindfulness|mindfulness
5118219|NCT03256890|blood pressure|blood pressure
5118220|NCT03256890|hypertension|hypertension
5118221|NCT03256890|prehypertension|prehypertension
5118222|NCT03256890|self regulation|self regulation
5118223|NCT03256890|Science of Behavior Change|science of behavior change
5118224|NCT03256890|attention control|attention control
5118225|NCT03256890|self awareness|self awareness
5118226|NCT03256890|emotion regulation|emotion regulation
5118227|NCT03256838|Citric Acid|citric acid
5118228|NCT03256838|Ferric Compounds|ferric compounds
5118229|NCT03256838|Renal Insufficiency|renal insufficiency
5118230|NCT03256838|Anticoagulants|anticoagulants
5118231|NCT03256838|Calcium Chelating Agents|calcium chelating agents
5118232|NCT03256838|Chelating Agents|chelating agents
5118233|NCT03256838|Sequestering Agents|sequestering agents
5118234|NCT03256838|Hemodialysis|hemodialysis
5118235|NCT03256838|Dialysis|dialysis
5118236|NCT03256838|Renal Failure|renal failure
5118237|NCT03256838|Kidney Failure|kidney failure
5118238|NCT03256838|Urologic Diseases|urologic diseases
5118239|NCT03256838|Metabolic Disease|metabolic disease
5118240|NCT03256838|Kidney Diseases|kidney diseases
5118241|NCT03256838|Renal Insufficiency, Chronic|renal insufficiency, chronic
5118242|NCT03256825|Diagnostic accuracy|diagnostic accuracy
5118243|NCT03256825|Anti-bacterial agents|anti-bacterial agents
5118244|NCT03256825|Decision support systems, clinical|decision support systems, clinical
5118245|NCT03256812|Arrhythmias, Atrial Fibrillation|arrhythmias, atrial fibrillation
5118246|NCT03256786|cesarean delivery with spinal anesthesia|cesarean delivery with spinal anesthesia
5118247|NCT03256786|Hypothermia and shivering|hypothermia and shivering
5118248|NCT03256786|Active warming|active warming
5118249|NCT03256760|Insomnia, depression|insomnia, depression
5118250|NCT03256747|Diabetes Mellitus|diabetes mellitus
5118251|NCT03256747|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5118252|NCT03256747|Glucose Metabolism Disorders|glucose metabolism disorders
5118253|NCT03256747|Metabolic Diseases|metabolic diseases
5118254|NCT03256747|Endocrine System Diseases|endocrine system diseases
5118255|NCT03256721|apatinib docetaxel pemetrexed|apatinib docetaxel pemetrexed
5118256|NCT03256708|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5118257|NCT03256708|probiotic|probiotic
5118258|NCT03256708|prebiotic|prebiotic
5118259|NCT03256708|placebo|placebo
5118260|NCT03256708|synbiotic|synbiotic
5118261|NCT03256682|Resilience|resilience
5118262|NCT03256682|Mobile video counseling|mobile video counseling
5118263|NCT03256682|Emotiona labor|emotiona labor
5118264|NCT03256643|traumatic brain injury|traumatic brain injury
5118265|NCT03256643|brain contusion|brain contusion
5118287|NCT03256409|methacrylates|methacrylates
5118288|NCT03256409|microbiology|microbiology
5118289|NCT03256409|implant dentistry/implantology|implant dentistry/implantology
5118290|NCT03256409|removable prosthodontics|removable prosthodontics
5118291|NCT03256409|clinical studies/trials|clinical studies/trials
5118292|NCT03256396|Intraoperative mechanical ventilation|intraoperative mechanical ventilation
5118293|NCT03256396|Positive-end expiratory pressure|positive-end expiratory pressure
5118294|NCT03256396|Esophageal pressure|esophageal pressure
5118295|NCT03256396|Transpulmonary pressure|transpulmonary pressure
5118296|NCT03256396|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5118297|NCT03256370|Allergic manifestation, Human milk oligosaccharides, Breast Milk|allergic manifestation, human milk oligosaccharides, breast milk
5118298|NCT03256357|unilateral cerebral palsy|unilateral cerebral palsy
5118299|NCT03256357|upper limb rehabilitation|upper limb rehabilitation
5118300|NCT03256344|Liver Metastases|liver metastases
5118301|NCT03256305|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5118302|NCT03256279|Orthodontic Wires|orthodontic wires
5118303|NCT03256279|Alloys/therapeutic use|alloys/therapeutic use
5118304|NCT03256279|Orthodontics, corrective|orthodontics, corrective
5118305|NCT03256253|alcohol use disorder|alcohol use disorder
5118306|NCT03256253|alcohol abuse|alcohol abuse
5118307|NCT03256253|treatment|treatment
5118308|NCT03256253|lyrica|lyrica
5118309|NCT03256240|Crohn's recurrence|crohn's recurrence
5118314|NCT03256201|Cancer|cancer
5118315|NCT03256201|prehabilitation|prehabilitation
5118316|NCT03256201|sarcopenia|sarcopenia
5118317|NCT03256188|classroom|classroom
5118318|NCT03256188|prolonged sitting|prolonged sitting
5118319|NCT03256188|sedentary time|sedentary time
5118320|NCT03256188|time-on-task|time-on-task
5118321|NCT03256188|children|children
5118322|NCT03256175|Myocardial Protection|myocardial protection
5118323|NCT03256175|Oxygen|oxygen
5118324|NCT03256175|Exercise Test|exercise test
5118325|NCT03256162|ketamine|ketamine
5118326|NCT03256162|glutamate|glutamate
5118327|NCT03256136|Lung Cancer|lung cancer
5118328|NCT03256123|Vitamin A Deficiency|vitamin a deficiency
5118332|NCT03256123|Red palm oil|red palm oil
5118333|NCT03256110|Advance Care Planning|advance care planning
5118334|NCT03256110|Palliative Care|palliative care
5118335|NCT03256110|Indians, North American|indians, north american
5118336|NCT03256110|Alaska Natives|alaska natives
5118337|NCT03256110|Health Communication|health communication
5118338|NCT03256110|Primary Health Care|primary health care
5118339|NCT03256097|Sound processing strategy|sound processing strategy
5118340|NCT03256019|intubation|intubation
5118341|NCT03256019|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5118342|NCT03256006|sport exercise|sport exercise
5118343|NCT03256006|ultra endurance|ultra endurance
5118344|NCT03255954|Interpersonal Counseling|interpersonal counseling
5118345|NCT03255941|LHV (Lady Health Visitor)|lhv (lady health visitor)
5118346|NCT03255941|LHW (Lady Health Worker|lhw (lady health worker
5118347|NCT03255941|DMPA (Depot medroxyprogesterone acetate or Depo Provera)|dmpa (depot medroxyprogesterone acetate or depo provera)
5423209|NCT01616667|Biomechanics|biomechanics
5118348|NCT03255941|DMPA IM (Depo Provera intramuscular injection)|dmpa im (depo provera intramuscular injection)
5118349|NCT03255941|SP (Sayana Press subcutaneous injection)|sp (sayana press subcutaneous injection)
5118350|NCT03255941|Contraception|contraception
5118351|NCT03255941|CBA2I (Community-based access to injectables)|cba2i (community-based access to injectables)
5118352|NCT03255941|Sayana (Sayana Press)|sayana (sayana press)
5118353|NCT03255941|JHPIEGO (Johns Hopkins Program for International Education in Gynaecology and Obstetrics)|jhpiego (johns hopkins program for international education in gynaecology and obstetrics)
5118355|NCT03255928|Platelet activation|platelet activation
5118356|NCT03255928|Ventricular Assist Device|ventricular assist device
5118357|NCT03255928|Thrombosis|thrombosis
5118358|NCT03255928|Bleeding|bleeding
5118359|NCT03255928|Antithrombotic Pharmacological Therapy|antithrombotic pharmacological therapy
5118360|NCT03255928|Mechanical Circulatory Support|mechanical circulatory support
5118361|NCT03255915|HIV Prevention|hiv prevention
5118362|NCT03255915|Intravaginal Ring|intravaginal ring
5118363|NCT03255915|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5118364|NCT03255915|Emtricitabine|emtricitabine
5118365|NCT03255902|Diabetes|diabetes
5118366|NCT03255889|Safety|safety
5118367|NCT03255889|Tolerability|tolerability
5118368|NCT03255889|Pharmacokinetics|pharmacokinetics
5118369|NCT03255889|Absorption|absorption
5118370|NCT03255876|Polyphenols|polyphenols
5118371|NCT03255876|Hyperglycemia|hyperglycemia
5118372|NCT03255876|Postprandial|postprandial
5118373|NCT03255876|Starch|starch
5118374|NCT03255876|Alpha-amylase|alpha-amylase
5118375|NCT03255863|Psychological Theory|psychological theory
5118376|NCT03255850|adolescents|adolescents
5118377|NCT03255850|quality of life|quality of life
5118378|NCT03255850|psychological well-being|psychological well-being
5118379|NCT03255837|Transcranial Stimulation|transcranial stimulation
5118380|NCT03255837|Memory|memory
5118381|NCT03255824|Oral Surgery|oral surgery
5118382|NCT03255824|Third Molars|third molars
5118383|NCT03255824|Intravenous Sedation|intravenous sedation
5118384|NCT03255824|Dexmedetomidine|dexmedetomidine
5118385|NCT03255811|Advanced gastric cancer apatinib Maintenance therapy|advanced gastric cancer apatinib maintenance therapy
5118386|NCT03255772|Magnetocardiography|magnetocardiography
5118387|NCT03255772|Chest pain|chest pain
5118388|NCT03255733|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
5118389|NCT03255733|Tennis Elbow|tennis elbow
5118390|NCT03255733|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
5118391|NCT03255733|Guided Therapy Systems (GTS)|guided therapy systems (gts)
5118392|NCT03255733|Ardent Sound, Inc.|ardent sound, inc.
5118393|NCT03255733|Actisound|actisound
5118394|NCT03255707|Amblyopia|amblyopia
5118395|NCT03255707|Interactive Binocular Treatment|interactive binocular treatment
5118396|NCT03255707|Dissociative Treatment|dissociative treatment
5118397|NCT03255707|Occlusion|occlusion
5118398|NCT03255707|Patching|patching
5118399|NCT03255681|Cosmetics|cosmetics
5118400|NCT03255681|Filler|filler
5118401|NCT03255668|Mercaptopurine, acute lymphoblastic leukemia, hematotoxicity|mercaptopurine, acute lymphoblastic leukemia, hematotoxicity
5118402|NCT03255655|Chronic Plantar Fasciitis|chronic plantar fasciitis
5118403|NCT03255655|Plantar Fascia Pain|plantar fascia pain
5118404|NCT03255655|Intense Therapeutic Ultrasound (ITU)|intense therapeutic ultrasound (itu)
5118405|NCT03255655|Guided Therapy Systems (GTS)|guided therapy systems (gts)
5118406|NCT03255655|Ardent Sound, Inc.|ardent sound, inc.
5118407|NCT03255655|Actisound|actisound
5118408|NCT03255642|Clonazepam|clonazepam
5118409|NCT03255642|Melatonin|melatonin
5118410|NCT03255642|Treatment|treatment
5118411|NCT03255642|REM Sleep Behavior Disorder|rem sleep behavior disorder
5118412|NCT03255603|Resistant Starch|resistant starch
5118413|NCT03255603|Dietary Fiber|dietary fiber
5118414|NCT03255603|Gastrointestinal Microbiome|gastrointestinal microbiome
5118415|NCT03255603|Gastrointestinal Tolerance|gastrointestinal tolerance
5118416|NCT03255590|motor recovery|motor recovery
5118419|NCT03255590|ischemic Stroke|ischemic stroke
5118420|NCT03255577|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5118421|NCT03255577|17-384|17-384
5118422|NCT03255538|patellar tendon|patellar tendon
5754661|NCT00302627|fractures|fractures
5183004|NCT02846311|test|test
5118423|NCT03255499|cognitive training|cognitive training
5118424|NCT03255499|physical exercise|physical exercise
5118425|NCT03255499|brain dynamics|brain dynamics
5118426|NCT03255499|cognitive abilities|cognitive abilities
5118427|NCT03255499|physiological markers|physiological markers
5118428|NCT03255460|Multiple Sclerosis|multiple sclerosis
5118429|NCT03255460|Fatigue|fatigue
5118430|NCT03255460|Physical Activity|physical activity
5118431|NCT03255460|Exercise|exercise
5118432|NCT03255447|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5118433|NCT03255447|Primary Membranous Nephropathy|primary membranous nephropathy
5118434|NCT03255447|Immunoadsorption|immunoadsorption
5118435|NCT03255447|Apharesis|apharesis
5118436|NCT03255421|urodynamic|urodynamic
5118437|NCT03255421|backwards cystometry|backwards cystometry
5118445|NCT03255382|ABBV-0066|abbv-0066
5118446|NCT03255382|BI 655066|bi 655066
5118447|NCT03255382|risankizumab|risankizumab
5118448|NCT03255369|Zika virus|zika virus
5118449|NCT03255369|Microcephaly|microcephaly
5118451|NCT03255369|pregnancy|pregnancy
5118653|NCT03254355|multimodal physiotherapy|multimodal physiotherapy
5118452|NCT03255356|Postoperative pulmonary complications|postoperative pulmonary complications
5118453|NCT03255356|Protective mechanical ventilation|protective mechanical ventilation
5118454|NCT03255356|Alveolar lung recruitment manoeuvres|alveolar lung recruitment manoeuvres
5118455|NCT03255356|Cardiac Surgery Procedures|cardiac surgery procedures
5118456|NCT03255317|Substance use, youth, mobile health, data collection adherence, user engagement|substance use, youth, mobile health, data collection adherence, user engagement
5118457|NCT03255278|Tuberculosis|tuberculosis
5118458|NCT03255278|Recombinant vaccine|recombinant vaccine
5118459|NCT03255278|Mycobacterium tuberculosis|mycobacterium tuberculosis
5118460|NCT03255265|organ transplantation|organ transplantation
5118461|NCT03255265|cfDNA|cfdna
5118462|NCT03255265|microchimerism|microchimerism
5118463|NCT03255265|acute rejection|acute rejection
5118464|NCT03255239|ventral hernia|ventral hernia
5118465|NCT03255239|Open mesh repair|open mesh repair
5118466|NCT03255239|Polyester mesh|polyester mesh
5118467|NCT03255239|Preperitoneal|preperitoneal
5118468|NCT03255239|Retromuscular|retromuscular
5118469|NCT03255187|Biomarker|biomarker
5003740|NCT03972930|SBRT|sbrt
5118470|NCT03255187|Fish oil|fish oil
5118471|NCT03255187|Oxidative stress|oxidative stress
5118472|NCT03255187|Air pollution|air pollution
5118473|NCT03255187|Cardiopulmonary system|cardiopulmonary system
5118474|NCT03255174|Bleeding, hemostasis, re-bleeding, hemostatic|bleeding, hemostasis, re-bleeding, hemostatic
5118475|NCT03255148|resting state|resting state
5118476|NCT03255148|EEG|eeg
5118477|NCT03255148|skin conductance|skin conductance
5118478|NCT03255148|heart rate|heart rate
5118479|NCT03255148|oxytocin|oxytocin
5118480|NCT03255109|Lung|lung
5118481|NCT03255109|acute|acute
5118482|NCT03255109|respiratory|respiratory
5118483|NCT03255109|distress|distress
5118484|NCT03255109|weaning|weaning
5118485|NCT03255109|mechanical ventilation|mechanical ventilation
5118486|NCT03255109|respiratory infection|respiratory infection
5118487|NCT03255083|Oncology|oncology
5118488|NCT03255083|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5118489|NCT03255083|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
5118490|NCT03255083|Metastatic|metastatic
5118491|NCT03255083|Non-resectable|non-resectable
5356828|NCT01917825|radicular pain|radicular pain
5118492|NCT03255083|Epidermal growth factor receptor|epidermal growth factor receptor
5118493|NCT03255083|EGFR|egfr
5118494|NCT03255070|HER2|her2
5118495|NCT03255070|Breast Cancer|breast cancer
5118496|NCT03255070|ADC|adc
5118497|NCT03255070|antibody drug conjugate|antibody drug conjugate
5118498|NCT03255070|elevated HER2 expression|elevated her2 expression
5030460|NCT03808935|cbd|cbd
5118499|NCT03255070|breast neoplasm|breast neoplasm
5118500|NCT03255070|stomach neoplasm|stomach neoplasm
5118501|NCT03255070|gastrointestinal neoplasm|gastrointestinal neoplasm
5118502|NCT03255070|digestive system|digestive system
5118503|NCT03255070|breast diseases|breast diseases
5118504|NCT03255070|digestive system neoplasm|digestive system neoplasm
5118505|NCT03255070|digestive system diseases|digestive system diseases
5118506|NCT03255070|stomach diseases|stomach diseases
5118507|NCT03255044|statin|statin
5118508|NCT03255044|hydrophilic|hydrophilic
5118509|NCT03255044|lipophilic|lipophilic
5118510|NCT03255031|Ketogenic Diet|ketogenic diet
5118511|NCT03255031|Detoxification|detoxification
5118512|NCT03255031|Functional MRI|functional mri
5118513|NCT03255031|MRI/MRS|mri/mrs
5118514|NCT03255031|Alcoholism|alcoholism
5118515|NCT03255018|Monoclonal Antibody|monoclonal antibody
5118516|NCT03255018|PD-1 Receptor|pd-1 receptor
5118517|NCT03255005|obesity|obesity
5118518|NCT03255005|endoscopy|endoscopy
5118519|NCT03255005|endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
5118520|NCT03254953|digital health|digital health
5118521|NCT03254953|eHealth|ehealth
5118522|NCT03254953|technology|technology
5118523|NCT03254953|smartphone|smartphone
5118524|NCT03254953|obesity|obesity
5118525|NCT03254953|overweight|overweight
5118526|NCT03254953|weight loss|weight loss
5118527|NCT03254953|behavioral intervention|behavioral intervention
5118528|NCT03254953|self-monitoring|self-monitoring
5118529|NCT03254953|tracking|tracking
5118530|NCT03254953|engagement|engagement
5118531|NCT03254953|adherence|adherence
5118532|NCT03254953|weight change|weight change
5118533|NCT03254953|e-mail|e-mail
5118534|NCT03254953|mobile application|mobile application
5118535|NCT03254953|goal setting|goal setting
5118536|NCT03254953|action plan|action plan
5118537|NCT03254953|feedback|feedback
5118538|NCT03254953|electronic health|electronic health
5118539|NCT03254940|text message|text message
5118540|NCT03254940|digital health|digital health
5118541|NCT03254940|weight loss|weight loss
5118542|NCT03254940|personalized|personalized
5118543|NCT03254927|Erbitux|erbitux
5118544|NCT03254927|Cetuximab|cetuximab
5118545|NCT03254927|Oral Cancer|oral cancer
5118546|NCT03254927|Oropharyngeal cancer|oropharyngeal cancer
5118547|NCT03254927|Laryngeal cancer|laryngeal cancer
5118548|NCT03254927|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5118549|NCT03254914|Home Blood Pressure|home blood pressure
5118550|NCT03254914|Fimasartan|fimasartan
5118551|NCT03254875|Breast cancer, Psychosocial intervention|breast cancer, psychosocial intervention
5118654|NCT03254329|human milk|human milk
5118552|NCT03254862|Functional electrical stimulation|functional electrical stimulation
5118553|NCT03254836|Actigraphy|actigraphy
5118554|NCT03254836|Major Depression Inventory (MDI)|major depression inventory (mdi)
5118555|NCT03254836|Insomnia Severity Index (ISI)|insomnia severity index (isi)
5118556|NCT03254797|Rehabilitation|rehabilitation
5118557|NCT03254797|Neurological condition|neurological condition
5118558|NCT03254797|Walking ability|walking ability
5118559|NCT03254797|Feedback|feedback
5118560|NCT03254797|External information|external information
5118561|NCT03254771|Knee ostheoartritis|knee ostheoartritis
5118562|NCT03254771|Arthroplasty|arthroplasty
5118563|NCT03254771|Clinical trial|clinical trial
5118564|NCT03254771|Decision aids|decision aids
5118565|NCT03254745|Rheumatoid Arthritis|rheumatoid arthritis
5118566|NCT03254745|Pakistan|pakistan
5118567|NCT03254745|Pharmacist|pharmacist
5118568|NCT03254745|Intervention|intervention
5118569|NCT03254745|Treatment outcome|treatment outcome
5118570|NCT03254719|Low Back Pain|low back pain
5118571|NCT03254719|Chiropractic|chiropractic
5118572|NCT03254719|Veterans|veterans
5118573|NCT03254719|PTSD|ptsd
5118574|NCT03254719|Depression|depression
5118575|NCT03254719|Anxiety|anxiety
5118576|NCT03254706|Dentin adhesive; Non-carious cervical lesions; Longevity.|dentin adhesive; non-carious cervical lesions; longevity.
5118577|NCT03254693|Non-carious cervical lesions; Universal system; Longevity.|non-carious cervical lesions; universal system; longevity.
5118578|NCT03254680|Turmeric Oil|turmeric oil
5118579|NCT03254680|antiseizure medications|antiseizure medications
5118580|NCT03254680|ar-turmerone|ar-turmerone
5118581|NCT03254615|Plain water|plain water
5118582|NCT03254615|Educative strategies|educative strategies
5118583|NCT03254615|Effectiveness|effectiveness
5118584|NCT03254589|Methotrexate|methotrexate
5118585|NCT03254589|Rheumatoid arthritis|rheumatoid arthritis
5118586|NCT03254589|Blood pressure|blood pressure
5118587|NCT03254589|Arterial stiffness|arterial stiffness
5118588|NCT03254589|Cardiovascular risk|cardiovascular risk
5118589|NCT03254576|Overweight|overweight
5118590|NCT03254576|Obesity|obesity
5118591|NCT03254576|Body Mass Index|body mass index
5118592|NCT03254576|Weight|weight
5962001|NCT04283565|blood pressure index measurement|blood pressure index measurement
5118593|NCT03254576|Brain imaging|brain imaging
5118594|NCT03254576|Child|child
5118595|NCT03254576|Learning|learning
5118596|NCT03254550|PrEP|prep
5118597|NCT03254524|Epidemiology Research|epidemiology research
5118598|NCT03254511|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5118599|NCT03254511|pathologic response|pathologic response
5118600|NCT03254511|low molecular weight heparin|low molecular weight heparin
5118601|NCT03254498|colonic adenoma|colonic adenoma
5118602|NCT03254498|serrated polyps|serrated polyps
5118603|NCT03254498|caecal intubation time|caecal intubation time
5118604|NCT03254498|withdrawal time|withdrawal time
5118605|NCT03254498|polyp miss rate|polyp miss rate
5118606|NCT03254485|Heart Failure|heart failure
5118607|NCT03254485|Cardiovascular|cardiovascular
5118610|NCT03254472|Biological markers|biological markers
5118611|NCT03254472|Professional practice|professional practice
5118612|NCT03254472|Big data analysis|big data analysis
5118613|NCT03254472|Measured concentrations|measured concentrations
5118614|NCT03254472|Cardiac markers|cardiac markers
5118615|NCT03254472|Troponin|troponin
5118616|NCT03254472|NTproBNP|ntprobnp
5118617|NCT03254472|Creatinin|creatinin
5118619|NCT03254472|Hemogram|hemogram
5118620|NCT03254472|Lipid profile|lipid profile
5118628|NCT03254407|bioequivalent|bioequivalent
5118629|NCT03254407|IV/PO switch|iv/po switch
5118630|NCT03254407|appropriateness|appropriateness
5118631|NCT03254407|clinical pharmacy|clinical pharmacy
5118632|NCT03254394|Oxaliplatin|oxaliplatin
5118633|NCT03254394|Cold hypersensitivity|cold hypersensitivity
5118634|NCT03254394|Neuropathy|neuropathy
5118635|NCT03254394|Colorectal cancer|colorectal cancer
5118636|NCT03254394|CIPN|cipn
5118637|NCT03254394|Neuropathic Pain|neuropathic pain
5118638|NCT03254381|cognitive assessment|cognitive assessment
5118639|NCT03254381|cognitive function|cognitive function
5118640|NCT03254381|community dwelling older people|community dwelling older people
5118641|NCT03254381|pre-diabetes|pre-diabetes
5118642|NCT03254381|randomized control trial|randomized control trial
5118643|NCT03254381|exercise|exercise
5118644|NCT03254381|pilot study|pilot study
5118645|NCT03254381|feasibility study|feasibility study
5118646|NCT03254368|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
5118647|NCT03254368|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5118648|NCT03254368|Blood Glucose|blood glucose
5118649|NCT03254368|Overweight|overweight
5118650|NCT03254368|Obesity|obesity
5118651|NCT03254355|avulsion injury|avulsion injury
5118652|NCT03254355|urinary incontinence|urinary incontinence
5118658|NCT03254329|milk composition|milk composition
5118659|NCT03254329|reference values|reference values
5118660|NCT03254303|Sevoflurane, Catheterization, Anesthetics Inhalation, child|sevoflurane, catheterization, anesthetics inhalation, child
5118661|NCT03254277|Broadly Neutralizing Antibody|broadly neutralizing antibody
5118662|NCT03254277|3BNC117-LS|3bnc117-ls
5118663|NCT03254277|First in Human|first in human
5118664|NCT03254277|Dose Escalation|dose escalation
5118665|NCT03254225|Hypertension|hypertension
5118666|NCT03254225|Elderly|elderly
5118667|NCT03254225|Resistance training|resistance training
5118668|NCT03254225|Heart rate variability|heart rate variability
5118672|NCT03254199|Charcot-Marie-Tooth|charcot-marie-tooth
5003948|NCT03971448|Cast|cast
5118674|NCT03254199|Muscle Cramps|muscle cramps
5118675|NCT03254199|Muscle Cramping|muscle cramping
5118676|NCT03254199|FLX-787|flx-787
5118677|NCT03254199|Hereditary Sensory and Motor Neuropathy|hereditary sensory and motor neuropathy
5118678|NCT03254199|Neurogenetic disorder|neurogenetic disorder
5118679|NCT03254199|Nervous System Malformations|nervous system malformations
5118680|NCT03254199|Nervous System Diseases|nervous system diseases
5118681|NCT03254199|Neurodegenerative Diseases|neurodegenerative diseases
5118682|NCT03254199|Neuromuscular Diseases|neuromuscular diseases
5118683|NCT03254186|Propranolol|propranolol
5118684|NCT03254186|Safety|safety
5118685|NCT03254186|Efficacy|efficacy
5118686|NCT03254186|Tardive Dyskinesia treatment|tardive dyskinesia treatment
5118687|NCT03254173|Mirtazapine|mirtazapine
5118688|NCT03254173|Anorexia - Cachexia|anorexia - cachexia
5118689|NCT03254173|Advanced Cancer|advanced cancer
5118690|NCT03254173|Appetite|appetite
5118691|NCT03254160|Stroke|stroke
5118692|NCT03254160|Rehabilitation|rehabilitation
5118693|NCT03254160|Ischemic|ischemic
5118694|NCT03254121|Sustained virological response|sustained virological response
5118695|NCT03254121|Whole genome sequencing|whole genome sequencing
5118696|NCT03254095|Skin temperature|skin temperature
5118697|NCT03254095|Plantar pressure|plantar pressure
5118698|NCT03254095|Diabetic foot|diabetic foot
5118699|NCT03254095|Tissue hardness|tissue hardness
5118700|NCT03254095|Neuropathy|neuropathy
5118701|NCT03254095|Peripheral artery disease|peripheral artery disease
5118703|NCT03254056|fascial closure device|fascial closure device
5118704|NCT03254056|laparoscopic surgery|laparoscopic surgery
5118705|NCT03254056|postoperative pain|postoperative pain
5118706|NCT03254030|Adenoma|adenoma
5118707|NCT03254030|Sessile serrated adenoma|sessile serrated adenoma
5118708|NCT03254017|Bilateral Habeluna|bilateral habeluna
5118709|NCT03254017|Remote Deep Brain Stimulation|remote deep brain stimulation
5118710|NCT03254017|Treatment Resistant Major Depressive Disorder|treatment resistant major depressive disorder
5118711|NCT03253900|wobble board|wobble board
5118712|NCT03253900|slides|slides
5118713|NCT03253900|rowing stroke|rowing stroke
5118714|NCT03253900|rowing biomechanics|rowing biomechanics
5118715|NCT03253900|power output|power output
5118716|NCT03253887|Central Venous Catheters|central venous catheters
5118717|NCT03253887|Child|child
5118718|NCT03253887|ethanol therapy|ethanol therapy
5118719|NCT03253887|CLABSI|clabsi
5118720|NCT03253874|Pre-operative Testing|pre-operative testing
5118721|NCT03253874|Cataract Surgery|cataract surgery
5755144|NCT00301054|Malaria|malaria
5118725|NCT03253861|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
5118726|NCT03253861|Acute pancreatitis|acute pancreatitis
5118727|NCT03253861|Sepsis/complications|sepsis/complications
5118728|NCT03253861|Infection|infection
5118729|NCT03253861|Organ Dysfunction Scores|organ dysfunction scores
5118730|NCT03253861|Drainage|drainage
5118731|NCT03253861|Catheters|catheters
5118732|NCT03253861|Antibiotics|antibiotics
5118733|NCT03253861|Multiresistant organism|multiresistant organism
5118734|NCT03253861|Pancreatitis/complications|pancreatitis/complications
5118735|NCT03253861|Pancreatitis/diagnosis|pancreatitis/diagnosis
5118736|NCT03253861|Pancreatitis/surgery|pancreatitis/surgery
5118737|NCT03253861|Pancreatitis/therapy|pancreatitis/therapy
5118738|NCT03253861|Pancreatitis, Acute Necrotizing/complications|pancreatitis, acute necrotizing/complications
5118739|NCT03253861|Pancreatitis, Acute Necrotizing/surgery|pancreatitis, acute necrotizing/surgery
5118740|NCT03253861|Pancreatitis, Acute Necrotizing/therapy|pancreatitis, acute necrotizing/therapy
5118741|NCT03253822|Colorectal Neoplasms|colorectal neoplasms
5118742|NCT03253822|Decision Support Techniques|decision support techniques
5118743|NCT03253822|Early Detection of Cancer|early detection of cancer
5118744|NCT03253822|Educational Status|educational status
5118745|NCT03253822|Decision Making|decision making
5118746|NCT03253822|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
5118747|NCT03253770|Cognitive Aid|cognitive aid
5118748|NCT03253757|PrEP|prep
5118751|NCT03253744|Dose Escalation|dose escalation
5118752|NCT03253744|Radiotherapy|radiotherapy
5118753|NCT03253744|Re-irradiation|re-irradiation
5118754|NCT03253744|Quality of Life|quality of life
5118755|NCT03253731|Brain Plasticity|brain plasticity
5118756|NCT03253731|Healthy Volunteers|healthy volunteers
5118758|NCT03253705|Assay Development|assay development
5118759|NCT03253705|Gene Expression|gene expression
5118760|NCT03253705|Metabolomics|metabolomics
5118761|NCT03253705|Induced Pluripotent Stem Cell (iPS)|induced pluripotent stem cell (ips)
5118762|NCT03253705|PBMCs/DNA/RNA|pbmcs/dna/rna
5118763|NCT03253692|Cardiac Computed Tomography|cardiac computed tomography
5118764|NCT03253692|Radiation|radiation
5118765|NCT03253692|Iterative Reconstruction|iterative reconstruction
5118766|NCT03253653|waterpipe|waterpipe
5118767|NCT03253653|hookah|hookah
5118768|NCT03253653|NNAL|nnal
5118769|NCT03253653|SPMA|spma
5118770|NCT03253653|1-HOP|1-hop
5118771|NCT03253653|Furan-BDA-NAL|furan-bda-nal
5118772|NCT03253653|Carbon monoxide|carbon monoxide
5118773|NCT03253653|Pulmonary Function|pulmonary function
5118774|NCT03253640|Costs and Cost Analysis|costs and cost analysis
5118775|NCT03253640|Quality of Life|quality of life
5118776|NCT03253640|Length of Stay|length of stay
5118777|NCT03253640|Cohort study|cohort study
5118778|NCT03253601|Rehabilitation|rehabilitation
5118779|NCT03253601|Disability|disability
5118780|NCT03253601|Mobile Health Technology|mobile health technology
5118781|NCT03253575|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5118782|NCT03253575|Breast Cancer|breast cancer
5118783|NCT03253575|Non-Small Cell Lung Cancer|non-small cell lung cancer
5118784|NCT03253575|Epithelial Ovarian Cancer|epithelial ovarian cancer
5118785|NCT03253575|Colorectal Cancer|colorectal cancer
5118786|NCT03253575|Local Recurrent Cancer|local recurrent cancer
5118787|NCT03253575|Late Stage Cancer|late stage cancer
5118788|NCT03253575|Clinical Utility|clinical utility
5118789|NCT03253575|Outcomes Study|outcomes study
5118790|NCT03253562|diabetes|diabetes
5118791|NCT03253562|Metformin|metformin
5118792|NCT03253562|vildagliptin|vildagliptin
5118793|NCT03253562|hypertension|hypertension
5118794|NCT03253562|cardiovascular risk|cardiovascular risk
5118795|NCT03253549|remote automated monitoring|remote automated monitoring
5118796|NCT03253549|hospital to home virtual care|hospital to home virtual care
5118797|NCT03253549|cardiac surgery|cardiac surgery
5118798|NCT03253549|major vascular surgery|major vascular surgery
5118799|NCT03253549|self-management|self-management
5118800|NCT03253536|Hepatocellular Cancer|hepatocellular cancer
5118801|NCT03253536|Quality of Life|quality of life
5118802|NCT03253536|stereotactic body radiation therapy|stereotactic body radiation therapy
5118803|NCT03253536|observational|observational
5118804|NCT03253497|chlorhexidine, benzidamine, laryngeal mask|chlorhexidine, benzidamine, laryngeal mask
5118805|NCT03253484|scar NAFL laser|scar nafl laser
5118806|NCT03253458|Optical coherence tomography|optical coherence tomography
5118807|NCT03253458|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5118808|NCT03253458|Histology|histology
5118809|NCT03253445|smoking cessation|smoking cessation
5118810|NCT03253445|acceptance and commitment therapy|acceptance and commitment therapy
5118811|NCT03253445|ACT|act
5118812|NCT03253445|schizophrenic patients|schizophrenic patients
5118813|NCT03253445|hostel setting|hostel setting
5118814|NCT03253445|randomised controlled trial|randomised controlled trial
5118815|NCT03253419|Falls|falls
5118816|NCT03253419|Hip Replacement|hip replacement
5118817|NCT03253419|Home Safety|home safety
5118818|NCT03253367|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
5118819|NCT03253341|exercise program|exercise program
5118820|NCT03253341|lifestyle changes|lifestyle changes
5118821|NCT03253341|fitness program|fitness program
5118822|NCT03253341|lifestyle intervention|lifestyle intervention
5118823|NCT03253302|transanal surgery|transanal surgery
5118824|NCT03253302|total mesorectal excision|total mesorectal excision
5118825|NCT03253302|rectal cancer|rectal cancer
5118826|NCT03253289|Hepatocellular carcinoma, HCC, Liver cancer|hepatocellular carcinoma, hcc, liver cancer
5118827|NCT03253276|Bile Acid Transporter|bile acid transporter
5118828|NCT03253237|Glycemic variability|glycemic variability
5118829|NCT03253237|Hypoglycemia|hypoglycemia
5118830|NCT03253211|Co-management model of care|co-management model of care
5118831|NCT03253211|Primary Care|primary care
5118832|NCT03253211|Specialty Care|specialty care
5118833|NCT03253211|Decision support tools|decision support tools
5423210|NCT01616667|Gait*|gait*
5118836|NCT03253185|Cancer|cancer
5118837|NCT03253185|Advanced cancer|advanced cancer
5118838|NCT03253185|Esophagogastric junction (EGJ) cancers|esophagogastric junction (egj) cancers
5118839|NCT03253185|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5118840|NCT03253185|Maximum Tolerated Dose|maximum tolerated dose
5118841|NCT03253185|Pharmacokinetics|pharmacokinetics
5118842|NCT03253146|Vimentin|vimentin
5118843|NCT03253146|sepsis|sepsis
5118844|NCT03253146|immune cells|immune cells
5118845|NCT03253146|apoptosis|apoptosis
5118853|NCT03253055|Injury|injury
5118854|NCT03253042|Exercise|exercise
5118855|NCT03253042|Vibration|vibration
5118856|NCT03253042|Torque|torque
5118857|NCT03253042|Aging|aging
5118858|NCT03253029|oncology, cancer cachexia, cachexia anorexia,|oncology, cancer cachexia, cachexia anorexia,
5118859|NCT03252977|fentanyl|fentanyl
5118860|NCT03252977|Pain Threshold|pain threshold
5118861|NCT03252977|predicted|predicted
5118862|NCT03252938|solid tumor|solid tumor
5118863|NCT03252938|peritoneal carcinomatosis|peritoneal carcinomatosis
5118865|NCT03252886|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5118866|NCT03252886|neck injury|neck injury
5118867|NCT03252873|adherence|adherence
5118868|NCT03252873|pulmonary rehabilitation|pulmonary rehabilitation
5118870|NCT03252847|XLRP RPGR|xlrp rpgr
5118871|NCT03252808|Unresectable pancreatic cancer|unresectable pancreatic cancer
5118872|NCT03252808|Metastatic pancreatic cancer|metastatic pancreatic cancer
5118873|NCT03252808|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5118874|NCT03252808|TBI-1401(HF10)|tbi-1401(hf10)
5118875|NCT03252808|HF10|hf10
5118876|NCT03252808|Oncolytic virus|oncolytic virus
5118877|NCT03252808|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
5118878|NCT03252808|Gemcitabine|gemcitabine
5118879|NCT03252808|Nab-paclitaxel|nab-paclitaxel
5118880|NCT03252808|Albumin-bound paclitaxel|albumin-bound paclitaxel
5118881|NCT03252808|Abraxane|abraxane
5118882|NCT03252808|Tegafur-gimeracil-oteracil potassium|tegafur-gimeracil-oteracil potassium
5118883|NCT03252808|TS-1|ts-1
5118884|NCT03252808|canerpaturev|canerpaturev
5118885|NCT03252795|Infertility, female|infertility, female
5118886|NCT03252795|Mayer Rokitansky Kuster Hauser Syndrome|mayer rokitansky kuster hauser syndrome
5118887|NCT03252795|Transplantation; Deceased donor|transplantation; deceased donor
5118888|NCT03252782|Soft Tissue|soft tissue
5118889|NCT03252782|Functional Appliance|functional appliance
5118890|NCT03252782|Maxillary Molar Distalization|maxillary molar distalization
5118891|NCT03252756|Cannabidiol|cannabidiol
5118892|NCT03252756|Alcohol Use Disorder|alcohol use disorder
5118893|NCT03252730|Dry scalp|dry scalp
5118894|NCT03252730|Itchy scalp|itchy scalp
5118895|NCT03252704|postprandial glucose insulin|postprandial glucose insulin
5118896|NCT03252678|Advanced Care Planning|advanced care planning
5118897|NCT03252665|STEMI|stemi
5118898|NCT03252665|myocardial perfusion|myocardial perfusion
5118899|NCT03252665|TMPFC|tmpfc
5118900|NCT03252665|Nicorandil|nicorandil
5118901|NCT03252665|Alprostadil|alprostadil
5118902|NCT03252652|Cranial vessels|cranial vessels
5118903|NCT03252652|Normal parameters|normal parameters
5118904|NCT03252652|Carotid Duplex|carotid duplex
5118905|NCT03252652|Egyptian|egyptian
5118906|NCT03252639|Renal Artery Stenosis|renal artery stenosis
5118907|NCT03252639|Renal Blood Perfusion|renal blood perfusion
5118908|NCT03252613|septic cardiomyopathy|septic cardiomyopathy
5118909|NCT03252613|cytokine|cytokine
5118910|NCT03252613|iPSC|ipsc
5118911|NCT03252613|Inducible pluripotent stem cell|inducible pluripotent stem cell
5118912|NCT03252561|TAP block|tap block
5118913|NCT03252561|Acute Appendicitis|acute appendicitis
5118914|NCT03252561|Post-operative analgesia|post-operative analgesia
5118915|NCT03252535|Huntington disease|huntington disease
5118916|NCT03252535|Stem cell therapy|stem cell therapy
5118917|NCT03252535|Dental pulp stem cell|dental pulp stem cell
5118927|NCT03252509|percutaneous radiologic gastrostomy|percutaneous radiologic gastrostomy
5118928|NCT03252509|Head and Neck Neoplasms|head and neck neoplasms
5118929|NCT03252470|2D laparoscopic surgery|2d laparoscopic surgery
5118930|NCT03252470|3D laparascopic surgery|3d laparascopic surgery
5118938|NCT03252418|ascorbic acid|ascorbic acid
5118939|NCT03252418|diode laser|diode laser
5118940|NCT03252418|gingival hyperpigmentation|gingival hyperpigmentation
5118941|NCT03252392|hearing and communication abnormalities|hearing and communication abnormalities
5118942|NCT03252366|MAXILLARY SINUS ELEVATION ,Simultaneous implant placement|maxillary sinus elevation ,simultaneous implant placement
5128917|NCT03188614|acute kidney injury|acute kidney injury
5118951|NCT03252236|Arterial compliance|arterial compliance
5118952|NCT03252236|Arterial stiffness|arterial stiffness
5118953|NCT03252236|Autonomic nervous system|autonomic nervous system
5118954|NCT03252236|Heart rate variability|heart rate variability
5118955|NCT03252223|polycystic ovary syndrome|polycystic ovary syndrome
5118956|NCT03252223|anovulation|anovulation
5118957|NCT03252223|hyperandrogenism|hyperandrogenism
5118958|NCT03252210|Preoperative localization|preoperative localization
5118959|NCT03252210|Stereoscopic Localization|stereoscopic localization
5118960|NCT03252210|Wedge Resection|wedge resection
5118961|NCT03252210|Ground Glass Opacity|ground glass opacity
5118962|NCT03252197|Ultrasound guided central venous cannulation|ultrasound guided central venous cannulation
5118963|NCT03252197|new device|new device
5118964|NCT03252197|first attempt success|first attempt success
5118965|NCT03252184|Phototherapy|phototherapy
5118966|NCT03252184|Laser Therapy|laser therapy
5118967|NCT03252184|Endothelium-Dependent|endothelium-dependent
5118968|NCT03252184|Vascular Endothelium|vascular endothelium
5118969|NCT03252184|Low Intensity Light Therapy|low intensity light therapy
5118970|NCT03252184|Relaxing Factors|relaxing factors
5118971|NCT03252171|CAR-T cell immunotherapy|car-t cell immunotherapy
5118974|NCT03252080|type 2 diabetes|type 2 diabetes
5118975|NCT03252080|holistic management|holistic management
5118976|NCT03252067|Azithromycin eyedrops, pharmacokinetics, tears|azithromycin eyedrops, pharmacokinetics, tears
5118978|NCT03252028|Hepatocyte growth factor, Nosocomial infections, VAP, Meningitis, In vitro, point of care, rapid test|hepatocyte growth factor, nosocomial infections, vap, meningitis, in vitro, point of care, rapid test
5118979|NCT03252002|Chronic kidney disease|chronic kidney disease
5118980|NCT03251989|Brain Tumor|brain tumor
5118981|NCT03251989|Central Nervous System Tumors|central nervous system tumors
5118982|NCT03251989|Choroid Plexus Tumors|choroid plexus tumors
5118983|NCT03251989|Gliomas|gliomas
5118984|NCT03251989|Atypical Teratoid Rhabdoid Tumor|atypical teratoid rhabdoid tumor
5118985|NCT03251976|ovarian cancer|ovarian cancer
5118986|NCT03251976|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5118987|NCT03251976|end of life care|end of life care
5118988|NCT03251976|endometrial cancer|endometrial cancer
5118989|NCT03251976|cervical cancer|cervical cancer
5118990|NCT03251950|Vegetable and fruit intake|vegetable and fruit intake
5118991|NCT03251937|Chronic Pain|chronic pain
5118992|NCT03251937|Back Pain|back pain
5118993|NCT03251937|Leg Pain|leg pain
5118994|NCT03251937|Pain|pain
5118995|NCT03251937|Stimulation|stimulation
5118996|NCT03251937|Spinal Cord Stimulator|spinal cord stimulator
5118997|NCT03251937|Implantable Pulse Generator|implantable pulse generator
5118998|NCT03251872|pulmonary arterial hypertension|pulmonary arterial hypertension
5118999|NCT03251872|PAH|pah
5119000|NCT03251872|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
5119001|NCT03251872|PARP-1 inhibition|parp-1 inhibition
5119002|NCT03251872|DNA damage|dna damage
5119003|NCT03251872|Early-phase clinical trial pilot study|early-phase clinical trial pilot study
5119004|NCT03251872|Olaparib|olaparib
5119005|NCT03251872|Safety and efficacy|safety and efficacy
5119006|NCT03251859|platelet reactivity|platelet reactivity
5119007|NCT03251859|ticagrelor|ticagrelor
5119008|NCT03251859|myocardial infarction|myocardial infarction
5119009|NCT03251859|pharmacodynamics|pharmacodynamics
5119010|NCT03251859|antiplatelet therapy|antiplatelet therapy
5119011|NCT03251846|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5119012|NCT03251846|self-monitoring blood glucose|self-monitoring blood glucose
5119013|NCT03251846|diabetes mobile application|diabetes mobile application
5119014|NCT03251846|diabetes management device|diabetes management device
5119015|NCT03251820|electrical status epilepticus during slow wave sleep|electrical status epilepticus during slow wave sleep
5119016|NCT03251820|seizure|seizure
5119022|NCT03251781|Minimal Clinically Important Difference|minimal clinically important difference
5119024|NCT03251781|Rehabilitation|rehabilitation
5119025|NCT03251781|Disability Evaluation|disability evaluation
5119026|NCT03251768|Chemotherapy|chemotherapy
5119027|NCT03251768|Neutropenia|neutropenia
5119028|NCT03251768|breast cancer|breast cancer
5119029|NCT03251755|type 2 diabetes mellitus|type 2 diabetes mellitus
5119030|NCT03251755|insomnia|insomnia
5119032|NCT03251742|Fontan operation|fontan operation
5119033|NCT03251742|Negative pressure ventilation|negative pressure ventilation
5119035|NCT03251729|cerclage, preterm birth, short cervix|cerclage, preterm birth, short cervix
5119036|NCT03251716|Metabolic syndrome|metabolic syndrome
5119040|NCT03251716|Berberine|berberine
5119041|NCT03251638|NHS( newborn hearing screening )|nhs( newborn hearing screening )
5119042|NCT03251599|peak temperature|peak temperature
5119043|NCT03251599|rewarming rate|rewarming rate
5119044|NCT03251599|surgical outcomes|surgical outcomes
5119045|NCT03251560|Fuke Qianjin capsule|fuke qianjin capsule
5119046|NCT03251560|chronic pelvic pain|chronic pelvic pain
5119047|NCT03251547|rFVIIa|rfviia
5119048|NCT03251547|Massive Hemorrhage|massive hemorrhage
5119049|NCT03251547|non-hemophilia|non-hemophilia
5119050|NCT03251534|Eos imaging stereography|eos imaging stereography
5119051|NCT03251534|Centromedullary nailing|centromedullary nailing
5119052|NCT03251534|Quantification of malunions|quantification of malunions
5119053|NCT03251521|pain|pain
5119054|NCT03251521|spasticity|spasticity
5119055|NCT03251521|stroke|stroke
5119056|NCT03251521|injection|injection
5119057|NCT03251521|botulinum toxin A|botulinum toxin a
5119058|NCT03251508|Peanut|peanut
5119059|NCT03251495|Vaccination|vaccination
5119060|NCT03251495|Contagious Diseases|contagious diseases
5119061|NCT03251495|Tropical Medicine|tropical medicine
5119062|NCT03251495|Infectious Diseases|infectious diseases
5119063|NCT03251469|tranexamic acid|tranexamic acid
5119064|NCT03251469|blood tranfusion|blood tranfusion
5119065|NCT03251469|hip fractures|hip fractures
5119066|NCT03251469|elderly|elderly
5119067|NCT03251469|blood loss|blood loss
5119068|NCT03251456|myopia|myopia
5119069|NCT03251456|Tertiary Care|tertiary care
5119070|NCT03251456|Pre-school Children|pre-school children
5119071|NCT03251417|Irinotecan|irinotecan
5119072|NCT03251417|Apatinib|apatinib
5119073|NCT03251391|revascularization|revascularization
5119074|NCT03251391|blocked arteries|blocked arteries
5119075|NCT03251391|leg arteries|leg arteries
5119076|NCT03251391|leg pain|leg pain
5119079|NCT03251365|Pancreatic cancer|pancreatic cancer
5119080|NCT03251365|Gemcitabine|gemcitabine
5119081|NCT03251365|Pancreatic carcinomatosis|pancreatic carcinomatosis
5119082|NCT03251365|Intrabdominal hyperthermic chemotherapy|intrabdominal hyperthermic chemotherapy
5119083|NCT03251352|TKI, CML, discontinuation|tki, cml, discontinuation
5119084|NCT03251339|Healthy Participants|healthy participants
5119085|NCT03251339|MSB11455|msb11455
5119086|NCT03251274|bath machine|bath machine
5119087|NCT03251274|sleep quality|sleep quality
5119088|NCT03251274|nursing home|nursing home
5119089|NCT03251274|heart rate variability|heart rate variability
5119090|NCT03251248|MSB11455|msb11455
5119091|NCT03251248|Healthy subjects|healthy subjects
5119092|NCT03251235|cognitive behaviour therapy|cognitive behaviour therapy
5119093|NCT03251222|conscious sedation, vitroretinal procedures|conscious sedation, vitroretinal procedures
5119094|NCT03251157|Asthma|asthma
5119095|NCT03251157|Adults|adults
5119096|NCT03251157|Europe|europe
5119097|NCT03251157|Lung function|lung function
5119098|NCT03251157|Allergy|allergy
5119099|NCT03251157|Atopy|atopy
5119100|NCT03251157|IgE|ige
5119101|NCT03251157|Sensitisation|sensitisation
5119102|NCT03251157|Diet|diet
5119103|NCT03251157|Dietary patterns|dietary patterns
5119104|NCT03251157|Dietary antioxidants|dietary antioxidants
5119105|NCT03251157|Flavonoids|flavonoids
5119106|NCT03251157|Fruits and vegetables|fruits and vegetables
5119107|NCT03251157|Food frequency questionnaire (FFQ)|food frequency questionnaire (ffq)
5119108|NCT03251157|Fatty acids|fatty acids
5119109|NCT03251144|HIV/AIDS|hiv/aids
5119230|NCT03250325|Immunotherapy|immunotherapy
5119110|NCT03251144|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
5119111|NCT03251144|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
5119112|NCT03251144|mitochondria|mitochondria
5119113|NCT03251144|toxicity|toxicity
5119115|NCT03251118|Ulcerative colitis|ulcerative colitis
5119116|NCT03251118|Indeterminate colitis|indeterminate colitis
5119117|NCT03251118|Digestive System Diseases|digestive system diseases
5119118|NCT03251066|Nose Saline Solution Irrigation Nasal Spray|nose saline solution irrigation nasal spray
5119119|NCT03251066|Sodium propionate Locke-Ringer Solution|sodium propionate locke-ringer solution
5119120|NCT03251040|Esophagogastric anastomosis|esophagogastric anastomosis
5119121|NCT03251040|Fibrin sealant|fibrin sealant
5119122|NCT03251040|Sealing|sealing
5119123|NCT03251014|Thrombosis|thrombosis
5119124|NCT03251014|Yellowstripe scad|yellowstripe scad
5119125|NCT03251014|Salmon|salmon
5119126|NCT03251014|Healthy overweight subjects|healthy overweight subjects
5119127|NCT03251014|Randomized crossover trial|randomized crossover trial
5119128|NCT03251001|gingiva|gingiva
5119129|NCT03251001|keratinized mucosa|keratinized mucosa
5119130|NCT03251001|gingival graft|gingival graft
5119143|NCT03250897|Broncho-alveolar lavage fluids|broncho-alveolar lavage fluids
5119144|NCT03250897|Non-infectious lung diseases|non-infectious lung diseases
5119145|NCT03250858|Personalised nutrition|personalised nutrition
5119146|NCT03250858|Mobile web application|mobile web application
5119147|NCT03250845|Multigam|multigam
5119148|NCT03250845|Immunoglobulin|immunoglobulin
5119149|NCT03250845|Secondary immunodeficiency|secondary immunodeficiency
5119150|NCT03250832|advanced solid tumors|advanced solid tumors
5119151|NCT03250832|endometrioid ovarian cancer|endometrioid ovarian cancer
5119152|NCT03250832|fallopian tube cancer|fallopian tube cancer
5119153|NCT03250832|primary peritoneal cancer|primary peritoneal cancer
5119154|NCT03250832|breast cancer|breast cancer
5119155|NCT03250832|bladder cancer|bladder cancer
5119156|NCT03250832|urothelial carcinoma|urothelial carcinoma
5119157|NCT03250832|TNBC|tnbc
5119158|NCT03250832|triple-negative breast cancer|triple-negative breast cancer
5119159|NCT03250832|LAG-3|lag-3
5119160|NCT03250832|colorectal cancer|colorectal cancer
5119161|NCT03250832|lung cancer|lung cancer
5119162|NCT03250806|aortic stenosis, auscultation, target echocardiography|aortic stenosis, auscultation, target echocardiography
5119163|NCT03250793|Hernia, DIaphragmatic, Congenital|hernia, diaphragmatic, congenital
5119164|NCT03250793|Respiration, Artificial|respiration, artificial
5119165|NCT03250793|physiologic pilot study|physiologic pilot study
5119166|NCT03250793|NAVA|nava
5119167|NCT03250793|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5119168|NCT03250793|esophageal transducer|esophageal transducer
5119169|NCT03250793|Work of Breathing|work of breathing
5119170|NCT03250754|Acupuncture|acupuncture
5119171|NCT03250754|Migraine|migraine
5119172|NCT03250754|Tension-type headache|tension-type headache
5119173|NCT03250741|Rotigotine|rotigotine
5119174|NCT03250741|Dopamine|dopamine
5119176|NCT03250728|Stroke-like|stroke-like
5119177|NCT03250728|Endothelial progenitor cells (EPCs)|endothelial progenitor cells (epcs)
5119178|NCT03250728|Protein C|protein c
5119179|NCT03250728|Congenital Disorders og Glycosylation|congenital disorders og glycosylation
5119180|NCT03250702|Tanzania|tanzania
5119181|NCT03250702|Observational|observational
5119182|NCT03250702|Sub-Saharan Africa|sub-saharan africa
5119183|NCT03250702|Treatment|treatment
5119184|NCT03250689|Danirixin|danirixin
5119185|NCT03250689|CXCR2|cxcr2
5119186|NCT03250689|NETs|nets
5119187|NCT03250689|GSK1325756|gsk1325756
5119188|NCT03250689|COPD|copd
5119189|NCT03250689|HBr|hbr
5119190|NCT03250676|HER2|her2
5119191|NCT03250676|estrogen receptor|estrogen receptor
5119192|NCT03250676|H3B-6545|h3b-6545
5119193|NCT03250676|breast cancer|breast cancer
5119194|NCT03250676|Endocrine Therapy|endocrine therapy
5119196|NCT03250650|Overactive Bladder|overactive bladder
5119197|NCT03250650|Electric Stimulation|electric stimulation
5119198|NCT03250650|Physical Therapy Modalities|physical therapy modalities
5119199|NCT03250637|Gene-environment interaction|gene-environment interaction
5119200|NCT03250637|Candidate gene|candidate gene
5119201|NCT03250637|Western style diet|western style diet
5119202|NCT03250637|Toll-like receptors|toll-like receptors
5119203|NCT03250637|Prospective study|prospective study
5119204|NCT03250637|Nested case-cohort|nested case-cohort
5119205|NCT03250611|Occipital condyle|occipital condyle
5119206|NCT03250611|Occipital condyle screw|occipital condyle screw
5119207|NCT03250598|Healthy|healthy
5119208|NCT03250598|Japanese|japanese
5119209|NCT03250585|acute chest syndrome|acute chest syndrome
5119210|NCT03250585|secretory phospholipases A2|secretory phospholipases a2
5119211|NCT03250585|exhaled breath condensate|exhaled breath condensate
5119212|NCT03250585|sickle cell disease|sickle cell disease
5119218|NCT03250507|Liposomal bupivicaine|liposomal bupivicaine
5119219|NCT03250494|Duloxetine, Dexamethasone, Postoperative pain, side effects.|duloxetine, dexamethasone, postoperative pain, side effects.
5119220|NCT03250481|Sedation, Responsiveness Index, Electromyogram|sedation, responsiveness index, electromyogram
5119221|NCT03250390|Lung cancer|lung cancer
5119222|NCT03250390|diagnosis|diagnosis
5119223|NCT03250390|volatile organic compounds|volatile organic compounds
5119224|NCT03250377|Brivaracetam|brivaracetam
5119225|NCT03250377|Epilepsy|epilepsy
5119236|NCT03250312|immune cells|immune cells
5119237|NCT03250273|Immunotherapy|immunotherapy
5119238|NCT03250273|Nivolumab|nivolumab
5119239|NCT03250273|Entinostat|entinostat
5119240|NCT03250273|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5119241|NCT03250273|Cholangiocarcinoma|cholangiocarcinoma
5119242|NCT03250273|Unresectable|unresectable
5119243|NCT03250273|Metastatic|metastatic
5119244|NCT03250273|PD-1|pd-1
5119245|NCT03250273|Antibody|antibody
5119246|NCT03250260|3-dimensional imaging|3-dimensional imaging
5119247|NCT03250260|Breast Conserving Treatment|breast conserving treatment
5119248|NCT03250260|Simulation|simulation
5119249|NCT03250247|deep vein thrombosis|deep vein thrombosis
5119250|NCT03250247|superficial venous reflux|superficial venous reflux
5119251|NCT03250247|blood clot|blood clot
5119252|NCT03250247|post thrombotic syndrome|post thrombotic syndrome
5119253|NCT03250247|iliac vein obstruction|iliac vein obstruction
5119254|NCT03250234|microRNA, carbohydrate oxidation|microrna, carbohydrate oxidation
5119255|NCT03250208|Microbiome|microbiome
5119256|NCT03250208|Lactobacillus|lactobacillus
5119257|NCT03250208|Probiotic|probiotic
5119258|NCT03250208|Fem-Dophilus|fem-dophilus
5119259|NCT03250156|Mindfulness|mindfulness
5119260|NCT03250156|Attention|attention
5119261|NCT03250156|Working Memory|working memory
5119262|NCT03250156|Psychological Well-Being|psychological well-being
5119263|NCT03250156|Proctored Practice|proctored practice
5119264|NCT03250117|Parkinson Disease|parkinson disease
5119266|NCT03250117|ropinirole|ropinirole
5119267|NCT03250117|implant|implant
5119268|NCT03250117|ProNeura|proneura
5119269|NCT03250117|movement disorders|movement disorders
5119270|NCT03250117|dopamine agonist|dopamine agonist
5119271|NCT03250117|extended-release|extended-release
5119272|NCT03250117|Parkinsonian disorders|parkinsonian disorders
5119273|NCT03250117|brain diseases|brain diseases
5119274|NCT03250117|central nervous system diseases|central nervous system diseases
5119275|NCT03250117|Neurodegenerative Diseases|neurodegenerative diseases
5119276|NCT03250117|Antiparkinson agents|antiparkinson agents
5119277|NCT03250117|Anti-dyskinesia agents|anti-dyskinesia agents
5119278|NCT03250117|dopamine agents|dopamine agents
5119279|NCT03250117|neurotransmitter agents|neurotransmitter agents
5119280|NCT03250117|REQUIP|requip
5119281|NCT03250117|subdermal|subdermal
5119282|NCT03250104|antimicrobial stewardship|antimicrobial stewardship
5119283|NCT03250104|infection control|infection control
5119284|NCT03250104|nosocomial infection|nosocomial infection
5119285|NCT03250104|clostridium difficile|clostridium difficile
5119286|NCT03250104|MRGN bacteria|mrgn bacteria
5119287|NCT03250104|health-care associated pathogens|health-care associated pathogens
5119288|NCT03250104|VRE|vre
5119289|NCT03250091|gastric precancerous lesions|gastric precancerous lesions
5119290|NCT03250091|gastric cancer|gastric cancer
5119291|NCT03250091|gastric intestinal Metaplasia|gastric intestinal metaplasia
5119292|NCT03250091|gastric atrophy|gastric atrophy
5119293|NCT03250091|gastric dysplasia|gastric dysplasia
5119294|NCT03250078|Pancreas|pancreas
5119295|NCT03250078|Cancer|cancer
5119296|NCT03250078|MRI|mri
5119297|NCT03250078|BRCA|brca
5119298|NCT03250078|Early Detection|early detection
5119299|NCT03250078|Genetics|genetics
5119300|NCT03250052|Fimasartan|fimasartan
5119301|NCT03250039|Absorption, Metabolism, Excretion, Absolute Bioavailability|absorption, metabolism, excretion, absolute bioavailability
5119302|NCT03250026|primary care|primary care
5119303|NCT03250026|convergence dialogue|convergence dialogue
5119304|NCT03250026|sick leave|sick leave
5119305|NCT03250026|care manager|care manager
5119306|NCT03249974|Enlite glucose monitoring|enlite glucose monitoring
5119308|NCT03249974|usability|usability
5119309|NCT03249974|skin reactions|skin reactions
5119310|NCT03249974|type 1 diabetes mellitus|type 1 diabetes mellitus
5119311|NCT03249961|motor|motor
5119312|NCT03249961|transcranial direct current stimulation|transcranial direct current stimulation
5119313|NCT03249961|transcranial magnetic stimulation|transcranial magnetic stimulation
5119314|NCT03249935|Azithromycin|azithromycin
5119315|NCT03249935|Chlamydia|chlamydia
5119316|NCT03249935|Correctional|correctional
5119323|NCT03249896|Gestational Diabetes|gestational diabetes
5119325|NCT03249896|Lifestyle coaching program|lifestyle coaching program
5119326|NCT03249896|Smartphone app|smartphone app
5119327|NCT03249896|Gestational weight gain|gestational weight gain
5119328|NCT03249883|prosthetic feet|prosthetic feet
5119329|NCT03249883|double blind study|double blind study
5119330|NCT03249883|limited ambulators|limited ambulators
5119331|NCT03249883|SACH foot|sach foot
5119334|NCT03249857|Cognition|cognition
5119335|NCT03249857|Emotion|emotion
5119336|NCT03249857|Embodiment|embodiment
5119337|NCT03249857|Sensorimotor|sensorimotor
5119338|NCT03249857|Simulation|simulation
5119339|NCT03249844|arterial ischemic stroke|arterial ischemic stroke
5119340|NCT03249844|children|children
5119341|NCT03249844|steroids|steroids
5119342|NCT03249844|aspirin|aspirin
5119343|NCT03249844|Methylprednisolone|methylprednisolone
5119344|NCT03249844|Prednisolone|prednisolone
5119345|NCT03249831|Sickle Cell Disease|sickle cell disease
5119346|NCT03249831|Sickle Cell Disorders|sickle cell disorders
5119347|NCT03249831|Hemoglobinopathies|hemoglobinopathies
5119348|NCT03249831|Thalassemia|thalassemia
5119349|NCT03249831|Anemia, Sickle Cell|anemia, sickle cell
5119350|NCT03249831|Haploidentical Transplant|haploidentical transplant
5119351|NCT03249831|Nonmyeloablative Conditioning|nonmyeloablative conditioning
5119352|NCT03249831|CD4+ T cell|cd4+ t cell
5119353|NCT03249831|CD4+ T cell-depleted Hematopoietic Cell Transplant|cd4+ t cell-depleted hematopoietic cell transplant
5119354|NCT03249831|Mixed Chimerism|mixed chimerism
5119355|NCT03249805|LMIC|lmic
5119356|NCT03249805|Medical device efficacy|medical device efficacy
5119357|NCT03249740|Age-related macular degeneration|age-related macular degeneration
5119358|NCT03249740|Choroidal neovascularization|choroidal neovascularization
5119359|NCT03249727|natural killer cells|natural killer cells
5119360|NCT03249727|natural killer cell activity|natural killer cell activity
5119362|NCT03249701|Acupoint Stimulation|acupoint stimulation
5119363|NCT03249701|postoperative recovery|postoperative recovery
5119364|NCT03249701|Postoperative Complications|postoperative complications
5119365|NCT03249701|Peri-operation|peri-operation
5119366|NCT03249688|Lifestyle intervention|lifestyle intervention
5119367|NCT03249688|Medical food|medical food
5119368|NCT03249688|Randomized controlled trial|randomized controlled trial
4990927|NCT04048772|Education|education
5119369|NCT03249688|Prodromal Alzheimer's disease|prodromal alzheimer's disease
5119370|NCT03249688|Prevention|prevention
5119371|NCT03249688|Intervention|intervention
5119372|NCT03249688|Multidomain|multidomain
5119373|NCT03249688|Multimodal|multimodal
5119374|NCT03249675|mild Traumatic Brain Injury|mild traumatic brain injury
5119375|NCT03249675|Concussion|concussion
5119376|NCT03249662|periarticular infiltration|periarticular infiltration
5119377|NCT03249662|postoperative pain management|postoperative pain management
5119378|NCT03249662|plasma level of bupivacaine|plasma level of bupivacaine
5119379|NCT03249649|defibulation|defibulation
5119380|NCT03249649|healthcare needs assessment|healthcare needs assessment
5119381|NCT03249649|CBPR|cbpr
5119382|NCT03249623|Weaning|weaning
5119383|NCT03249623|Intensive Care|intensive care
5119384|NCT03249623|Individualised Care|individualised care
5119385|NCT03249623|Open-Loop Decision Support System|open-loop decision support system
5119386|NCT03249623|Respiratory Failure|respiratory failure
5119387|NCT03249623|Mechanical Ventilation|mechanical ventilation
5119388|NCT03249623|Spontaneous breathing Tests|spontaneous breathing tests
5119389|NCT03249623|Extubation|extubation
5119390|NCT03249597|Sepsis|sepsis
5119391|NCT03249597|Emergency Medical Services|emergency medical services
5119392|NCT03249597|Prehospital|prehospital
5119393|NCT03249597|Emergency Care|emergency care
5119394|NCT03249597|Emergency Medicine|emergency medicine
5119395|NCT03249571|exercise|exercise
5119396|NCT03249571|flavonoids|flavonoids
5119397|NCT03249571|gut permeability|gut permeability
5119398|NCT03249571|gut-derived phenolics|gut-derived phenolics
5119399|NCT03249558|Pain|pain
5119400|NCT03249558|Pain Management|pain management
5119401|NCT03249519|Radiation therapy|radiation therapy
5119402|NCT03249519|Chemoradiation|chemoradiation
5119403|NCT03249519|Brachytherapy|brachytherapy
5119404|NCT03249519|Hyperthermia|hyperthermia
5119405|NCT03249519|Cervical cancer|cervical cancer
5119406|NCT03249519|Multimodality treatment of advanced cervical cancer|multimodality treatment of advanced cervical cancer
5119407|NCT03249493|Decentralised Area|decentralised area
5119408|NCT03249467|HAQ-II|haq-ii
5119409|NCT03249467|Rheumatoid arthritis|rheumatoid arthritis
5119410|NCT03249454|Incomplete SCI|incomplete sci
5119411|NCT03249415|Platelet-Rich Plasma|platelet-rich plasma
5119412|NCT03249415|Cell therapy|cell therapy
5119413|NCT03249415|Regenerative factors|regenerative factors
5119416|NCT03249363|Pulse Irrigation Povidone Iodine Spine Surgery|pulse irrigation povidone iodine spine surgery
5119417|NCT03249350|Substance Use Disorders|substance use disorders
5119419|NCT03249350|Treatment|treatment
5119420|NCT03249350|Mediation|mediation
5119421|NCT03249324|Pregnancy|pregnancy
5119422|NCT03249324|Overweight|overweight
5119423|NCT03249324|Obesity|obesity
5119424|NCT03249324|Prevention|prevention
5119425|NCT03249324|Positive-gain counseling|positive-gain counseling
5119426|NCT03249311|Levomilnacipran|levomilnacipran
5119427|NCT03249311|Antidepressant|antidepressant
5119428|NCT03249311|Ottawa|ottawa
5119429|NCT03249311|Selective Norepinephrine Reuptake Inhibitor|selective norepinephrine reuptake inhibitor
5119430|NCT03249311|Healthy males|healthy males
5119431|NCT03249311|Tyramine response|tyramine response
5119432|NCT03249311|Serotonin|serotonin
5119433|NCT03249311|Norepinephrine|norepinephrine
5119434|NCT03249285|hypertension|hypertension
5119435|NCT03249285|pharmacogenomics|pharmacogenomics
5119436|NCT03249285|anti-hypertensive therapy|anti-hypertensive therapy
5119437|NCT03249246|Sepsis|sepsis
5119438|NCT03249246|ICU|icu
5119439|NCT03249246|Point prevalence|point prevalence
5119440|NCT03249207|Aneurysmal|aneurysmal
5119441|NCT03249181|MTCT|mtct
5119442|NCT03249181|Antiretroviral|antiretroviral
5119443|NCT03249181|Pregnancy|pregnancy
5119444|NCT03249181|Africa|africa
5119445|NCT03249155|Freezing of Gait, Action Observation|freezing of gait, action observation
5119446|NCT03249142|Ovarian Cancer|ovarian cancer
5119447|NCT03249142|Anti-PD-L1|anti-pd-l1
5119448|NCT03249142|Anti-CLA-4|anti-cla-4
5119449|NCT03249142|Neo-adjuvant|neo-adjuvant
5119450|NCT03249129|Trauma|trauma
5119451|NCT03249129|spinal cord|spinal cord
5119452|NCT03249129|autoimmunity|autoimmunity
5119453|NCT03249129|antibody|antibody
5119454|NCT03249116|human-animal interaction|human-animal interaction
5119455|NCT03249116|animal-assisted intervention|animal-assisted intervention
5119456|NCT03249103|Fibromyalgia|fibromyalgia
5119457|NCT03249077|Prevention|prevention
5119458|NCT03249077|Medicare|medicare
5119459|NCT03249064|TREGS|tregs
5119460|NCT03249064|CD91|cd91
5119461|NCT03249064|LRP1|lrp1
5119462|NCT03249025|lidocaine|lidocaine
5119463|NCT03249025|ketamine|ketamine
5119464|NCT03249025|infusion|infusion
5119465|NCT03248999|multidrug resistance|multidrug resistance
5119466|NCT03248999|nursing home|nursing home
5119467|NCT03248999|ESBL|esbl
5119468|NCT03248999|CRE|cre
5119469|NCT03248947|opioid use disorder|opioid use disorder
5119470|NCT03248947|Medication-assisted treatment|medication-assisted treatment
5962002|NCT04283565|motivational interviewing|motivational interviewing
5962003|NCT04283539|checkpoint inhibitor|checkpoint inhibitor
4991048|NCT04048161|Tacrolimus|tacrolimus
5119471|NCT03248947|Buprenorphine treatment|buprenorphine treatment
5119472|NCT03248947|Collaborative care model|collaborative care model
5119473|NCT03248908|pupillary reflex|pupillary reflex
5119474|NCT03248908|nociception|nociception
5119475|NCT03248908|heart rate|heart rate
5119476|NCT03248908|intraoperative monitoring|intraoperative monitoring
5119477|NCT03248895|Inhaler assessment|inhaler assessment
5119478|NCT03248895|Direct observation of therapy|direct observation of therapy
5119479|NCT03248882|PF-05221304|pf-05221304
5119480|NCT03248882|NAFLD|nafld
5119481|NCT03248882|NASH|nash
5119482|NCT03248882|features of metabolic syndrome|features of metabolic syndrome
5119483|NCT03248882|Dose-Ranging Study|dose-ranging study
5119484|NCT03248869|asthma|asthma
5119485|NCT03248869|mobile application|mobile application
5119486|NCT03248869|mobile app|mobile app
5119487|NCT03248869|mobile health applications|mobile health applications
5119488|NCT03248869|asthma mobile health application|asthma mobile health application
5119489|NCT03248843|KN035|kn035
5119490|NCT03248843|Solid tumors|solid tumors
5119491|NCT03248843|Phase 1|phase 1
5119492|NCT03248804|Obesity|obesity
5119493|NCT03248804|Weight Loss|weight loss
5119494|NCT03248804|body composition|body composition
5119495|NCT03248804|dietary protein|dietary protein
5119496|NCT03248778|disclosure|disclosure
5119497|NCT03248752|Behavioural|behavioural
5119498|NCT03248739|Catheter|catheter
5119499|NCT03248739|Ventricular|ventricular
5119500|NCT03248739|External Ventricular Drain Catheter|external ventricular drain catheter
5119501|NCT03248739|EVD Catheter|evd catheter
5119502|NCT03248739|Occlusion|occlusion
5119503|NCT03248739|Ventriculostomy|ventriculostomy
5004858|NCT03966209|Immunotherapy|immunotherapy
5119504|NCT03248739|Clear Bactiseal catheter|clear bactiseal catheter
5119505|NCT03248739|Orange Bactiseal catheter|orange bactiseal catheter
5119506|NCT03248739|Ventriculostomy Occlusion|ventriculostomy occlusion
5119507|NCT03248739|Neurosurgery|neurosurgery
5119508|NCT03248726|Polyethylene Glycol|polyethylene glycol
5119509|NCT03248726|Bisacodyl|bisacodyl
5119510|NCT03248726|Colonoscopy|colonoscopy
5119511|NCT03248726|Bowel preparation|bowel preparation
5119512|NCT03248726|Ottawa bowel preparation scale|ottawa bowel preparation scale
5119513|NCT03248635|Survey|survey
5119514|NCT03248635|Pre-Test|pre-test
5119516|NCT03248622|Hepatitis B Surface Antigen|hepatitis b surface antigen
5119517|NCT03248622|Decompensation|decompensation
5356829|NCT01917812|physical activity|physical activity
5119518|NCT03248596|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
5119519|NCT03248596|Primary hemostasis|primary hemostasis
5119520|NCT03248583|Proof-of-principle|proof-of-principle
5119521|NCT03248583|Feasibility|feasibility
5119522|NCT03248557|resuscitation|resuscitation
5119523|NCT03248557|wavelet analysis|wavelet analysis
5119524|NCT03248557|spectral analysis|spectral analysis
5119525|NCT03248557|post-cardiac arrest syndrome|post-cardiac arrest syndrome
5119526|NCT03248544|vitamin D|vitamin d
5119527|NCT03248544|Brain Neoplasms|brain neoplasms
5119528|NCT03248544|perioperative complications|perioperative complications
5119529|NCT03248544|clinical outcomes|clinical outcomes
5119541|NCT03248518|Systemic Lupus Erythematosus|systemic lupus erythematosus
5119542|NCT03248518|Axial Spondyloarthritis|axial spondyloarthritis
5119549|NCT03248479|Hu5F9-G4|hu5f9-g4
5119550|NCT03248479|CD47|cd47
5119551|NCT03248479|azacitidine|azacitidine
5119552|NCT03248466|platelet rich gel|platelet rich gel
5119553|NCT03248466|BMMSCs|bmmscs
5119554|NCT03248466|diabetic foot ulcer|diabetic foot ulcer
5119555|NCT03248453|Simulated colonoscopy|simulated colonoscopy
5119556|NCT03248453|Self-regulated learning|self-regulated learning
5119557|NCT03248427|Breast Cancer|breast cancer
5119558|NCT03248427|Neoadjuvant|neoadjuvant
5119559|NCT03248427|Luminal B tumors|luminal b tumors
5119560|NCT03248427|Ribociclib|ribociclib
5119561|NCT03248375|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5119562|NCT03248375|Radioembolization|radioembolization
5119563|NCT03248375|Radiation Segmentectomy|radiation segmentectomy
5119564|NCT03248349|Critically ill children|critically ill children
5119565|NCT03248349|Pharmacokinetics|pharmacokinetics
5119566|NCT03248349|Anti-Bacterial agents|anti-bacterial agents
5119567|NCT03248310|Quality of Life (QoL)|quality of life (qol)
5119568|NCT03248310|17-377|17-377
5119569|NCT03248271|Diabetes|diabetes
5119570|NCT03248271|Sarcopenia|sarcopenia
5119571|NCT03248271|Hypotension|hypotension
5119572|NCT03248271|Tilt Table Test|tilt table test
5119573|NCT03248258|Metastatic Breast Cancer|metastatic breast cancer
5119574|NCT03248258|Treatment Decision Making|treatment decision making
5119575|NCT03248258|Shared Decision Making|shared decision making
5119576|NCT03248245|interprofessional team collaboration|interprofessional team collaboration
5119577|NCT03248245|primary school|primary school
5119578|NCT03248245|learning environment|learning environment
5119579|NCT03248245|teacher's self-efficacy|teacher's self-efficacy
5962004|NCT04283539|immuno-oncology|immuno-oncology
5119580|NCT03248245|teachers working ours|teachers working ours
5119581|NCT03248245|pupils learning outcome|pupils learning outcome
5119582|NCT03248245|cluster-randomized|cluster-randomized
5119583|NCT03248232|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5119584|NCT03248193|paclitaxel|paclitaxel
5119585|NCT03248193|neuropathy|neuropathy
5119586|NCT03248193|hypothermia|hypothermia
5119587|NCT03248193|cryocompression|cryocompression
5119588|NCT03248193|alopecia|alopecia
5119589|NCT03248180|antipsychotic|antipsychotic
5119590|NCT03248180|guided dose reduction|guided dose reduction
5119591|NCT03248180|maintenance treatment|maintenance treatment
5119592|NCT03248180|remitted psychosis|remitted psychosis
5119593|NCT03248180|relapse|relapse
5119594|NCT03248167|Cannabidiol|cannabidiol
5119595|NCT03248154|Biofilm|biofilm
5119596|NCT03248154|Procellera|procellera
5119597|NCT03248141|Hemophilia A Factor VIII|hemophilia a factor viii
5119598|NCT03248141|Hemophilia B Factor IX|hemophilia b factor ix
5119599|NCT03248141|Cross-sectional|cross-sectional
5119600|NCT03248141|Epidemiological|epidemiological
5119601|NCT03248141|Clinical practice|clinical practice
5119602|NCT03248141|United States|united states
5119610|NCT03248115|polyphenols|polyphenols
5119611|NCT03248115|green tea catechins|green tea catechins
5119612|NCT03248115|coffee caffeoylquinic acids|coffee caffeoylquinic acids
5119613|NCT03248115|metabolism|metabolism
5119614|NCT03248115|inter-individual variability|inter-individual variability
5119615|NCT03248115|colonic microbiota|colonic microbiota
5119616|NCT03248102|paediatric|paediatric
5119617|NCT03248063|Staphylococcus aureus|staphylococcus aureus
5119618|NCT03248063|bacteremia|bacteremia
5119619|NCT03248063|cloxacillin|cloxacillin
5119620|NCT03248063|cefazolin|cefazolin
5119621|NCT03248024|Chronic Disease|chronic disease
5119622|NCT03248024|Ulcerative Colitis|ulcerative colitis
5119623|NCT03248011|hamstring|hamstring
5119624|NCT03248011|ultrasound|ultrasound
5119625|NCT03248011|intervention|intervention
5119626|NCT03247998|Stroke|stroke
5119627|NCT03247998|endovascular repair|endovascular repair
5119628|NCT03247998|general anesthesia|general anesthesia
5119629|NCT03247998|conscious sedation|conscious sedation
5119630|NCT03247985|Mesh|mesh
5119631|NCT03247985|Repair|repair
5119632|NCT03247985|Peritoneal|peritoneal
5119633|NCT03247959|oral health education, distraction, videogame|oral health education, distraction, videogame
5119640|NCT03247920|Antibiotic switch therapy|antibiotic switch therapy
5119641|NCT03247920|Amoxicillin/clavulanic acid|amoxicillin/clavulanic acid
5119643|NCT03247842|post mastectomy pain|post mastectomy pain
5119644|NCT03247829|CardioMEMS|cardiomems
5119645|NCT03247829|Left Ventricular Assist Device|left ventricular assist device
5119646|NCT03247829|Hemodynamic Management|hemodynamic management
5119647|NCT03247803|Air-Q® SP|air-q® sp
5119648|NCT03247803|Williams Airway Intubator (WA)|williams airway intubator (wa)
5119649|NCT03247803|Flexible Bronchoscopic intubation (FBI)|flexible bronchoscopic intubation (fbi)
5119650|NCT03247803|Fiberoptic Intubation (FOI)|fiberoptic intubation (foi)
5119651|NCT03247803|Fiberoptic Intubating Airway(FIA)|fiberoptic intubating airway(fia)
5119652|NCT03247803|Laryngeal Mask Airway|laryngeal mask airway
5119653|NCT03247777|golf|golf
5119654|NCT03247777|strength training|strength training
5119655|NCT03247777|physical performance tests|physical performance tests
5119656|NCT03247777|body composition|body composition
5119657|NCT03247738|ticagrelor|ticagrelor
5119658|NCT03247738|cangrelor|cangrelor
5119659|NCT03247712|HNSCC|hnscc
5119660|NCT03247712|radiation|radiation
5119661|NCT03247712|surgery|surgery
5119662|NCT03247712|phase 1|phase 1
5119663|NCT03247712|immunotherapy|immunotherapy
5119664|NCT03247712|nivolumab|nivolumab
5119665|NCT03247712|antibodies|antibodies
5119666|NCT03247673|safety|safety
5119667|NCT03247673|Pharmacokinetics|pharmacokinetics
5119668|NCT03247673|Immunogenicity|immunogenicity
5119669|NCT03247647|Alcohol Intervention|alcohol intervention
5119670|NCT03247647|College Students|college students
5119671|NCT03247634|getting ahead|getting ahead
5119672|NCT03247634|vulnerable population|vulnerable population
5119673|NCT03247634|safety net practice network|safety net practice network
5119674|NCT03247621|external eating, technology|external eating, technology
5119675|NCT03247608|Ambio Health|ambio health
5119676|NCT03247595|Colonoscopy preparation|colonoscopy preparation
5119677|NCT03247595|Magnesium Citrate Capsules|magnesium citrate capsules
5119678|NCT03247582|Real World Evidence|real world evidence
5119679|NCT03247582|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5119680|NCT03247582|Observational Safety|observational safety
5119681|NCT03247569|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5119682|NCT03247569|Real World Evidence|real world evidence
5119683|NCT03247569|Observational Safety|observational safety
5119684|NCT03247491|Mindfulness|mindfulness
5119685|NCT03247491|Compassion|compassion
5119686|NCT03247491|Depression during Pregnancy and Postpartum|depression during pregnancy and postpartum
5119687|NCT03247491|Prevention|prevention
5119688|NCT03247491|Stress|stress
5119689|NCT03247478|Computed tomography (CT) reconstruction|computed tomography (ct) reconstruction
5119690|NCT03247478|axillary lymph node status|axillary lymph node status
5119691|NCT03247452|Low fiber diet|low fiber diet
5119692|NCT03247452|Colonoscopy|colonoscopy
5119693|NCT03247452|Bowel Cleansing|bowel cleansing
5119695|NCT03247439|Osteoarthritis|osteoarthritis
5119696|NCT03247439|Cartilage Replacement|cartilage replacement
5119697|NCT03247439|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
5119698|NCT03247439|Damaged Articular Surface|damaged articular surface
5119699|NCT03247439|LRTI|lrti
5119700|NCT03247439|Ligament Reconstruction Tendon Interposition|ligament reconstruction tendon interposition
5119701|NCT03247387|Wearable device|wearable device
5119702|NCT03247387|Patient monitor|patient monitor
5119703|NCT03247374|rehabilitation|rehabilitation
5119704|NCT03247374|treatment|treatment
5119705|NCT03247374|biofeedback|biofeedback
5119706|NCT03247374|bio-feedback|bio-feedback
5119707|NCT03247374|dysphagia|dysphagia
5119708|NCT03247374|swallowing disorders|swallowing disorders
5119709|NCT03247374|post-stroke|post-stroke
5119710|NCT03247374|deglutition disorders|deglutition disorders
5119711|NCT03247361|Heart Failure; Rehabilitation|heart failure; rehabilitation
5119712|NCT03247322|Medication Safety|medication safety
5119713|NCT03247322|Mobile Health Technology|mobile health technology
5119714|NCT03247309|T-cell therapy|t-cell therapy
5119715|NCT03247309|immunotherapy|immunotherapy
5119716|NCT03247309|adoptive cellular therapy|adoptive cellular therapy
5119717|NCT03247309|T-Cell Receptor|t-cell receptor
5119718|NCT03247309|IMA201|ima201
5119719|NCT03247309|Cytotherapy|cytotherapy
5119720|NCT03247309|Cell Therapy|cell therapy
5119721|NCT03247309|Gene Therapy|gene therapy
5119722|NCT03247296|Daclatasvir|daclatasvir
5119723|NCT03247296|HCC|hcc
5119724|NCT03247296|HCV|hcv
5119726|NCT03247244|Cannabis|cannabis
5119727|NCT03247244|Tics|tics
5119728|NCT03247244|Tourette Syndrome|tourette syndrome
5119729|NCT03247231|Subepithelial tumors|subepithelial tumors
5119733|NCT03247205|cognitive impairment|cognitive impairment
5119735|NCT03247192|resistance training|resistance training
5119736|NCT03247192|protein supplementation|protein supplementation
5119737|NCT03247192|aging|aging
5119738|NCT03247192|Randomized Controlled Trial|randomized controlled trial
5119739|NCT03247127|hippocampal avoidance whole brain radiotherapy (HA-WBRT)|hippocampal avoidance whole brain radiotherapy (ha-wbrt)
5119740|NCT03247127|brain metastases|brain metastases
5119741|NCT03247127|memory preservation|memory preservation
5119744|NCT03247075|Cognitive Behavior Therapy|cognitive behavior therapy
5119745|NCT03247075|Internet-delivered treatments|internet-delivered treatments
5119746|NCT03247075|Children and adolescents|children and adolescents
5119747|NCT03247075|Randomized controlled trial|randomized controlled trial
5119748|NCT03247062|agitation, sleep deprivation, bundle|agitation, sleep deprivation, bundle
5119749|NCT03246997|Food Insecure|food insecure
5119750|NCT03246958|Thyroid Cancer|thyroid cancer
5119751|NCT03246932|peer expert or specialist|peer expert or specialist
5119752|NCT03246932|psycho-education|psycho-education
5119753|NCT03246932|schizophrenia|schizophrenia
5119754|NCT03246932|outpatients|outpatients
5119755|NCT03246893|Sepsis|sepsis
5119756|NCT03246893|Septic shock|septic shock
5119757|NCT03246893|Severe sepsis|severe sepsis
5119758|NCT03246893|Extubation|extubation
5119759|NCT03246893|Reintubation|reintubation
5119760|NCT03246893|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5119761|NCT03246893|High flow oxygen nasal cannula|high flow oxygen nasal cannula
5119765|NCT03246854|DBPR112|dbpr112
5119766|NCT03246854|EGFR mutated NSCLC|egfr mutated nsclc
5119767|NCT03246854|squamous cell cancer of head and neck|squamous cell cancer of head and neck
5119768|NCT03246854|maximum tolerated dose|maximum tolerated dose
5119769|NCT03246854|recommended Phase 2 dose|recommended phase 2 dose
5119770|NCT03246841|Oncogeneticists|oncogeneticists
5119771|NCT03246841|Mutations|mutations
5119772|NCT03246841|Breast Cancer|breast cancer
5119773|NCT03246841|Ovarian cancer|ovarian cancer
5119774|NCT03246828|gliclazide|gliclazide
5119775|NCT03246828|glucagon|glucagon
5119776|NCT03246828|diabetes|diabetes
5119777|NCT03246802|recurrent prostate cancer|recurrent prostate cancer
5119778|NCT03246802|mpMRI|mpmri
5119779|NCT03246802|salvage HDR brachytherapy|salvage hdr brachytherapy
5119780|NCT03246763|childhood obesity|childhood obesity
5119781|NCT03246750|Brentuximab Vedotin|brentuximab vedotin
5119782|NCT03246724|Ocular surgery|ocular surgery
5119783|NCT03246724|Intravenous sedation|intravenous sedation
5119784|NCT03246724|Oral sedation|oral sedation
5119785|NCT03246698|Stretching|stretching
5119786|NCT03246698|Subacromial Impingement Syndrome|subacromial impingement syndrome
5119787|NCT03246698|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
5119788|NCT03246672|obesity, morbid|obesity, morbid
5119789|NCT03246659|medullary thyroid carcinoma|medullary thyroid carcinoma
5119790|NCT03246659|MTC|mtc
5119791|NCT03246659|new gastrin analog|new gastrin analog
5119792|NCT03246659|111In-CP04|111in-cp04
5119793|NCT03246659|CP04 indium|cp04 indium
5119794|NCT03246659|personalised diagnostics|personalised diagnostics
5119795|NCT03246659|personalised therapy|personalised therapy
5119796|NCT03246659|theranostics|theranostics
5119797|NCT03246659|advanced MTC|advanced mtc
5119798|NCT03246659|CCK-2/gastrin receptor|cck-2/gastrin receptor
4987512|NCT04069416|HCC|hcc
5119799|NCT03246646|Substance Abuse|substance abuse
5119800|NCT03246646|Alcohol Abuse|alcohol abuse
5119801|NCT03246620|emergency|emergency
5119802|NCT03246620|emergency medicine|emergency medicine
5119803|NCT03246620|sedation|sedation
5119804|NCT03246620|acute agitation|acute agitation
5119805|NCT03246594|atrial fibrillation|atrial fibrillation
5119806|NCT03246594|esophageal probe|esophageal probe
5119807|NCT03246594|thermolesion|thermolesion
5119808|NCT03246581|inhalation|inhalation
5119809|NCT03246581|anticholinergic|anticholinergic
5119810|NCT03246568|Ablation|ablation
5119811|NCT03246568|Renal Denervation|renal denervation
5119812|NCT03246568|Cryoballoon|cryoballoon
5119813|NCT03246477|maxillomandibular advancement osteotomy|maxillomandibular advancement osteotomy
5119814|NCT03246477|long-term results|long-term results
5119815|NCT03246477|quality of life|quality of life
5119816|NCT03246477|polysomnographic measurements|polysomnographic measurements
5119817|NCT03246477|skeletal stability|skeletal stability
5119818|NCT03246464|Contact lenses|contact lenses
5119819|NCT03246464|Children|children
5119820|NCT03246464|Myopia|myopia
5119821|NCT03246451|GLP-1|glp-1
5119822|NCT03246451|glucagon-like peptide-1|glucagon-like peptide-1
5119823|NCT03246451|Metformin|metformin
5119824|NCT03246451|Exendin(9-39)|exendin(9-39)
5119825|NCT03246399|SM04690|sm04690
5119826|NCT03246399|Wnt pathway|wnt pathway
5119827|NCT03246399|Samumed|samumed
5119828|NCT03246373|cognitive impairment|cognitive impairment
5119829|NCT03246334|Cohort study|cohort study
5119830|NCT03246334|Critical Care|critical care
5119831|NCT03246334|Follow-up study|follow-up study
5119832|NCT03246334|Intensive care units|intensive care units
5119833|NCT03246334|Long-term outcome|long-term outcome
5119834|NCT03246334|Outcome assessment|outcome assessment
5119835|NCT03246334|Quality of life|quality of life
5755844|NCT00298428|clopidogrel|clopidogrel
5119836|NCT03246321|Colorectal Neoplasms|colorectal neoplasms
5119837|NCT03246321|Peritoneal Neoplasms|peritoneal neoplasms
5119838|NCT03246321|Intraperitoneal Injections|intraperitoneal injections
5119839|NCT03246321|Laparoscopy|laparoscopy
5119857|NCT03246321|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
5119858|NCT03246321|Pressurised Intraperitoneal Aerosol Chemotherapy|pressurised intraperitoneal aerosol chemotherapy
5119859|NCT03246321|Peritoneum|peritoneum
5119860|NCT03246321|Cecal Neoplasms|cecal neoplasms
5119861|NCT03246321|Oxaliplatin|oxaliplatin
5119862|NCT03246295|Proteomics|proteomics
5119863|NCT03246295|Metabolomics|metabolomics
5119864|NCT03246256|acute|acute
5119865|NCT03246256|informed consent|informed consent
5119866|NCT03246256|thrombolysis|thrombolysis
5119867|NCT03246243|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5119868|NCT03246243|Bottle Feeding|bottle feeding
5119869|NCT03246230|newborn vaccine responses|newborn vaccine responses
5119870|NCT03246178|Haploidentical|haploidentical
5119871|NCT03246178|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5119872|NCT03246178|Severe aplastic anemia|severe aplastic anemia
5119873|NCT03246152|Anti-VEGF safety|anti-vegf safety
5119874|NCT03246152|Ischemic Maculopathy|ischemic maculopathy
5119875|NCT03246152|Diabetic Macular Edema|diabetic macular edema
5119876|NCT03246152|OCTA|octa
5119877|NCT03246139|stroke|stroke
5119878|NCT03246139|neurorehabilitation|neurorehabilitation
5119879|NCT03246139|mirror neuron system|mirror neuron system
5119880|NCT03246139|action observation|action observation
5119881|NCT03246139|motor imagery|motor imagery
5119883|NCT03246113|GBM WHO Grade IV|gbm who grade iv
5119884|NCT03246100|centralized reminder/recall|centralized reminder/recall
5119885|NCT03246100|influenza vaccine reminders|influenza vaccine reminders
5119886|NCT03246100|childhood influenza vaccines|childhood influenza vaccines
5119887|NCT03246087|acupuncture|acupuncture
5119888|NCT03246087|plantar fasiosis|plantar fasiosis
5119889|NCT03246074|Phase I|phase i
5119890|NCT03246074|Ovarian Cancer|ovarian cancer
5119891|NCT03246074|Fostamatinib and Paclitaxel|fostamatinib and paclitaxel
5119892|NCT03246035|Acute Decompensated Heart Failure|acute decompensated heart failure
5119893|NCT03246035|Heart Failure|heart failure
5119894|NCT03246035|Frailty|frailty
5119895|NCT03246035|Geriatrics|geriatrics
5119896|NCT03246035|Self-care|self-care
5119897|NCT03246035|Emergency Medicine|emergency medicine
5119898|NCT03246035|Cardiology|cardiology
5119899|NCT03246035|Patient Oriented Research|patient oriented research
5119900|NCT03246022|blood pressure fluctuation|blood pressure fluctuation
5119901|NCT03246022|hypertension|hypertension
5119902|NCT03246022|continuous positive airway pressure|continuous positive airway pressure
5119903|NCT03246022|intermittent hypixa|intermittent hypixa
5119904|NCT03246022|oxygen desaturation|oxygen desaturation
5119905|NCT03246009|Neutropenia|neutropenia
5119906|NCT03246009|Chemotherapy|chemotherapy
5119907|NCT03246009|rHSA/GCSF|rhsa/gcsf
5119908|NCT03245996|sick sinus syndrome|sick sinus syndrome
5119909|NCT03245996|heart rate|heart rate
5119910|NCT03245996|aortic blood pressure|aortic blood pressure
5962005|NCT04283539|cutaneous adverse events|cutaneous adverse events
5119911|NCT03245996|artificial pacemaker|artificial pacemaker
5119912|NCT03245996|beta-blockers|beta-blockers
5119913|NCT03245996|ivabradine|ivabradine
5119919|NCT03245892|17-182|17-182
5119920|NCT03245866|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5119921|NCT03245866|Intracranial Aneurysm|intracranial aneurysm
5120314|NCT03243058|Diabetes|diabetes
5119922|NCT03245866|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
5119931|NCT03245814|human-animal interaction|human-animal interaction
5119932|NCT03245801|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5119934|NCT03245801|Registry|registry
5119935|NCT03245801|Clinical outcomes|clinical outcomes
5119936|NCT03245801|Adverse events|adverse events
5119937|NCT03245801|CAPRI|capri
5119938|NCT03245788|Lay Navigator|lay navigator
5119939|NCT03245788|Quality of Care|quality of care
5119940|NCT03245788|High-Need Cancer Treatment Regimen|high-need cancer treatment regimen
5119941|NCT03245775|health disparities|health disparities
5119942|NCT03245775|community-based participatory research|community-based participatory research
5119943|NCT03245749|omega-3 status|omega-3 status
5119944|NCT03245749|blood lipids|blood lipids
5119945|NCT03245749|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5356831|NCT01917812|mHealth|mhealth
5119946|NCT03245749|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5119947|NCT03245723|premature adults|premature adults
5119948|NCT03245723|premature|premature
5119949|NCT03245723|premature lung function|premature lung function
5119950|NCT03245723|premature cardiac function|premature cardiac function
5119951|NCT03245723|MRI|mri
5119952|NCT03245723|PET|pet
5119953|NCT03245697|breast milk|breast milk
5119954|NCT03245697|composition|composition
5119955|NCT03245697|Galicia|galicia
5119956|NCT03245697|diet|diet
5119957|NCT03245697|lactation|lactation
5119958|NCT03245684|ARDS|ards
5119959|NCT03245684|Ventilator-induced Lung Injury|ventilator-induced lung injury
5119960|NCT03245684|cytokines|cytokines
5119961|NCT03245684|mechanical ventilation|mechanical ventilation
5119962|NCT03245645|FODMAP|fodmap
5119963|NCT03245645|IBS|ibs
5119964|NCT03245645|Diet|diet
5119965|NCT03245645|Re-introduction|re-introduction
5119966|NCT03245645|Fructose|fructose
5119967|NCT03245619|3-hydroxykynurenine|3-hydroxykynurenine
5119968|NCT03245619|Acute pancreatitis|acute pancreatitis
5119969|NCT03245619|Dose-escalation|dose-escalation
5119970|NCT03245619|Healthy subjects|healthy subjects
5119971|NCT03245619|GSK3335065|gsk3335065
5119972|NCT03245606|NAFLD|nafld
5119973|NCT03245606|steatosis|steatosis
5119974|NCT03245606|fibrosis|fibrosis
5119975|NCT03245606|transient elastography|transient elastography
5119976|NCT03245554|Gastrointestinal Cancer|gastrointestinal cancer
5119977|NCT03245554|Propranolol|propranolol
5119978|NCT03245541|SBRT/SABR; Durvalumab; Locally advanced; Borderline resectable|sbrt/sabr; durvalumab; locally advanced; borderline resectable
5119979|NCT03245502|tissue oxygenation|tissue oxygenation
5119980|NCT03245450|eribulin mesilate|eribulin mesilate
5119981|NCT03245450|irinotecan|irinotecan
5119982|NCT03245450|combination therapy|combination therapy
5119983|NCT03245450|children|children
5119984|NCT03245437|Social Cognition|social cognition
5119985|NCT03245437|Oxytocin|oxytocin
5119986|NCT03245372|cardiac output|cardiac output
5119987|NCT03245372|perioperative care|perioperative care
5119988|NCT03245372|postoperative complications|postoperative complications
5119989|NCT03245359|Total Knee Arthroplasty|total knee arthroplasty
5119990|NCT03245359|Intra-articular Analgesia|intra-articular analgesia
5119991|NCT03245359|Bupivacaine Hydrochloride|bupivacaine hydrochloride
5119992|NCT03245294|cervical epidural space|cervical epidural space
5119993|NCT03245294|abrupt pressure decrease|abrupt pressure decrease
5119994|NCT03245281|Heart Failure|heart failure
5119995|NCT03245268|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
5119996|NCT03245268|BPA|bpa
5119997|NCT03245255|pressure measurements|pressure measurements
5119998|NCT03245255|blood pressure|blood pressure
5119999|NCT03245255|contrast echocardiography|contrast echocardiography
5120000|NCT03245255|ventricular pressures|ventricular pressures
5120001|NCT03245255|catheterization|catheterization
5120002|NCT03245242|enhanced recovery after surgery|enhanced recovery after surgery
5120003|NCT03245242|urologic reconstruction|urologic reconstruction
5120004|NCT03245242|pediatric urology|pediatric urology
5120005|NCT03245242|bladder augmentation|bladder augmentation
5120006|NCT03245242|Mitrofanoff|mitrofanoff
5120007|NCT03245242|Malone antegrade continence enema channel|malone antegrade continence enema channel
5120008|NCT03245242|appendicovesicostomy|appendicovesicostomy
5120009|NCT03245242|ileovesicostomy|ileovesicostomy
5120010|NCT03245242|appendicocecostomy|appendicocecostomy
5120011|NCT03245216|Parkinson's Disease|parkinson's disease
5120012|NCT03245216|motor learning|motor learning
5120013|NCT03245216|aerobic exercise|aerobic exercise
5120014|NCT03245216|cardiovascular exercise|cardiovascular exercise
5120036|NCT03245060|solution focused brief therapy|solution focused brief therapy
5120037|NCT03245034|Medical Residents|medical residents
5120039|NCT03245034|Stress/Burnout in Medical Residents|stress/burnout in medical residents
5120040|NCT03244982|fluorescein|fluorescein
5120041|NCT03244982|angiography|angiography
5962006|NCT04283526|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5120042|NCT03244969|Hematoma fracture, angiogenesis, bone formation|hematoma fracture, angiogenesis, bone formation
5005457|NCT03962439|Aging|aging
5120043|NCT03244917|Nursing home|nursing home
5120044|NCT03244917|Palliative Care|palliative care
5120045|NCT03244917|Dementia|dementia
5120046|NCT03244917|Infection|infection
5120047|NCT03244917|Antimicrobials|antimicrobials
5120048|NCT03244904|NGS,SCLC, ctDNA|ngs,sclc, ctdna
5120049|NCT03244878|Cognitive Behavior Therapy|cognitive behavior therapy
5120050|NCT03244852|OCD|ocd
5120051|NCT03244852|deep brain stimulation|deep brain stimulation
5120052|NCT03244852|treatment-resistant OCD|treatment-resistant ocd
5120053|NCT03244826|Cancer|cancer
5120054|NCT03244800|0382, T2DM|0382, t2dm
5120055|NCT03244761|high flow tracheal oxygen|high flow tracheal oxygen
5120056|NCT03244761|modified interface|modified interface
5120057|NCT03244735|Ketogenic Diet|ketogenic diet
5356832|NCT01917812|smartphone|smartphone
5120058|NCT03244709|Giant cell arteritis,|giant cell arteritis,
5120059|NCT03244709|Tocilizumab|tocilizumab
5120060|NCT03244709|Aortitis|aortitis
5120061|NCT03244709|Remission|remission
5120062|NCT03244696|Multiple Sclerosis|multiple sclerosis
5120063|NCT03244696|Sclerosis|sclerosis
5120064|NCT03244696|Demyelinating Autoimmune Diseases, Central Nervous System|demyelinating autoimmune diseases, central nervous system
5120065|NCT03244696|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5120066|NCT03244696|Nervous System Diseases|nervous system diseases
5120067|NCT03244696|Demyelinating Diseases|demyelinating diseases
5120068|NCT03244696|Immune System Diseases|immune system diseases
5120069|NCT03244696|Physical Activity|physical activity
5120070|NCT03244696|Walking|walking
5120071|NCT03244696|Hydration|hydration
5120072|NCT03244696|Lifestyle Intervention|lifestyle intervention
5120073|NCT03244696|Health Behavior Tracking|health behavior tracking
5120074|NCT03244696|Inflammatory Biomarkers|inflammatory biomarkers
5120075|NCT03244696|Neurodegenerative Disease|neurodegenerative disease
5120076|NCT03244670|Myopia|myopia
5120087|NCT03244592|Minocycline|minocycline
5120088|NCT03244566|positron emission tomography|positron emission tomography
5120089|NCT03244566|cervical lymphatic metastasis|cervical lymphatic metastasis
5120094|NCT03244527|BCAA|bcaa
5120095|NCT03244527|stroke|stroke
5120096|NCT03244527|mobility|mobility
5120099|NCT03244501|tSMS|tsms
5120226|NCT03243682|Shock wave lithotripsy|shock wave lithotripsy
5120100|NCT03244501|Transcranial Static Magnetic Field Stimulation|transcranial static magnetic field stimulation
5120101|NCT03244501|healthy control|healthy control
5120102|NCT03244475|mild Traumatic Brain Injury|mild traumatic brain injury
5120103|NCT03244475|transcranial electrical stimulation|transcranial electrical stimulation
5120104|NCT03244475|neurofeedback|neurofeedback
5120105|NCT03244475|magnetoencephalography|magnetoencephalography
5120106|NCT03244475|post-traumatic stress disorder|post-traumatic stress disorder
5120107|NCT03244449|biomarker|biomarker
5120108|NCT03244449|insulin resistance|insulin resistance
5120110|NCT03244449|clamp|clamp
5120111|NCT03244423|Pediatric|pediatric
5120112|NCT03244423|Cyanotic heart disease|cyanotic heart disease
5120113|NCT03244423|Tranexamic acid|tranexamic acid
5120114|NCT03244423|Postoperative blood loss|postoperative blood loss
5121398|NCT03236363|Adiposity|adiposity
5120115|NCT03244358|Triple Negative Breast Cancer|triple negative breast cancer
5120116|NCT03244358|Epalrestat|epalrestat
5120117|NCT03244306|leukemia|leukemia
5120118|NCT03244306|CD 22|cd 22
5120119|NCT03244306|CAR T cell|car t cell
5120120|NCT03244306|pediatric|pediatric
5120121|NCT03244306|young adult|young adult
5120122|NCT03244306|chimeric antigen receptor|chimeric antigen receptor
5120123|NCT03244267|Orthopedics|orthopedics
5120124|NCT03244254|Celiac Disease|celiac disease
5120125|NCT03244254|Children|children
5120126|NCT03244254|I-FABP|i-fabp
5120127|NCT03244241|Type 2 diabetes, inpatient diabetes management, basal-bolus insulin|type 2 diabetes, inpatient diabetes management, basal-bolus insulin
5120128|NCT03244228|First in human|first in human
5120129|NCT03244228|Multiple ascending dose|multiple ascending dose
5120130|NCT03244228|Single ascending dose|single ascending dose
5120131|NCT03244215|Recurrence of stroke|recurrence of stroke
5120132|NCT03244215|Corneal Confocal Microscopy|corneal confocal microscopy
5120149|NCT03244150|Obesity|obesity
5120150|NCT03244150|Overweight|overweight
5120151|NCT03244150|Lifestyle|lifestyle
5120152|NCT03244150|Diet|diet
5120153|NCT03244124|dentin bonding agents|dentin bonding agents
5120154|NCT03244124|tooth sensitivity|tooth sensitivity
5120155|NCT03244124|composite resin restoration|composite resin restoration
5120156|NCT03244059|COPD|copd
5120157|NCT03244059|belimumab|belimumab
5120158|NCT03244059|biologic agent|biologic agent
5120159|NCT03244059|GRP78|grp78
5120160|NCT03244046|Low Back pain|low back pain
5120161|NCT03244046|Pain|pain
5120162|NCT03244046|Posttraumatic Stress Disorder|posttraumatic stress disorder
5120163|NCT03244046|PTSD|ptsd
5120164|NCT03244046|Somatic Experiencing|somatic experiencing
5120166|NCT03244033|context|context
5120167|NCT03244033|contextual error|contextual error
5120168|NCT03244033|contextual care|contextual care
5120169|NCT03244033|electronic medical record|electronic medical record
4991806|NCT04043962|sleep|sleep
5120170|NCT03244033|clinical decision support|clinical decision support
5120171|NCT03244007|macular hole|macular hole
5120172|NCT03244007|lamellar macular hole|lamellar macular hole
5120173|NCT03243994|Cor pulmonale|cor pulmonale
5120174|NCT03243994|COPD|copd
5120175|NCT03243994|Malabsorption|malabsorption
5120176|NCT03243994|D-xylose|d-xylose
5120177|NCT03243994|Zinc|zinc
5120178|NCT03243955|acupuncture|acupuncture
5120179|NCT03243955|TENS|tens
5120180|NCT03243955|TEAS|teas
5120181|NCT03243955|constipation|constipation
5120182|NCT03243955|transcutaneous|transcutaneous
5120183|NCT03243942|pressure measurements|pressure measurements
5120184|NCT03243942|blood pressure|blood pressure
5120185|NCT03243942|contrast echocardiography|contrast echocardiography
5120186|NCT03243942|ventricular pressures|ventricular pressures
5120187|NCT03243942|catheterization|catheterization
5120188|NCT03243916|interventional therapy|interventional therapy
5120189|NCT03243916|TACE|tace
5120190|NCT03243916|Cyberknife|cyberknife
5120191|NCT03243903|T2DM|t2dm
5120192|NCT03243903|QS-M needle free injector|qs-m needle free injector
5120193|NCT03243903|insulin pen|insulin pen
5120194|NCT03243903|effective|effective
5120195|NCT03243903|safety|safety
5120196|NCT03243877|Screening|screening
5120197|NCT03243877|Mammography|mammography
5120198|NCT03243851|Glioblastoma|glioblastoma
5120199|NCT03243838|Triple-Negative Breast Cancer|triple-negative breast cancer
5120200|NCT03243838|apatinib|apatinib
5120203|NCT03243838|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5120204|NCT03243825|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5120205|NCT03243825|brachytherapy|brachytherapy
5120206|NCT03243825|radiotherapy|radiotherapy
5120207|NCT03243812|Sickle Cell Disease|sickle cell disease
5120208|NCT03243812|Muscle function|muscle function
5120209|NCT03243812|Hemorheological disorders|hemorheological disorders
5120210|NCT03243760|CCI15106|cci15106
5120211|NCT03243760|pharmacokinetics|pharmacokinetics
5120212|NCT03243760|BAL|bal
5120213|NCT03243760|COPD|copd
5120214|NCT03243734|spray cryotherapy|spray cryotherapy
5120215|NCT03243734|quality of life|quality of life
5120216|NCT03243734|symptom reduction|symptom reduction
5121878|NCT03233802|Treatment|treatment
5120218|NCT03243734|liquid nitrogen|liquid nitrogen
5120219|NCT03243734|ablation|ablation
5120220|NCT03243721|multiple sclerosis|multiple sclerosis
5120221|NCT03243721|thalamus|thalamus
5120222|NCT03243721|high field MRI|high field mri
5120223|NCT03243721|cognition|cognition
5120224|NCT03243708|Venous Thromboembolism Risk Calculator|venous thromboembolism risk calculator
5120225|NCT03243695|immediate implants, implant failure, angled abutments|immediate implants, implant failure, angled abutments
5120227|NCT03243682|Bidirectional|bidirectional
5120228|NCT03243682|Stones|stones
5120229|NCT03243669|Colonoscopy|colonoscopy
5120230|NCT03243669|High-definition endoscopy|high-definition endoscopy
5120231|NCT03243669|Virtual chromoendoscopy|virtual chromoendoscopy
5120232|NCT03243669|Adenoma detection rate (ADR)|adenoma detection rate (adr)
5120233|NCT03243604|Cardiotoxicity|cardiotoxicity
5120234|NCT03243604|abiraterone acetate|abiraterone acetate
5120235|NCT03243604|androgen antagonist|androgen antagonist
5120236|NCT03243565|adenoid hypertrophy|adenoid hypertrophy
5120240|NCT03243565|adenotonsillectomy|adenotonsillectomy
5120241|NCT03243565|OM-85|om-85
5120242|NCT03243539|lung protective ventilation|lung protective ventilation
5120243|NCT03243500|atracurium|atracurium
5120244|NCT03243500|high myopes|high myopes
5120245|NCT03243500|percaruncular|percaruncular
5120246|NCT03243500|phacoemulsification|phacoemulsification
5120247|NCT03243500|medial canthal|medial canthal
5120248|NCT03243500|ophthalmic regional anesthesia|ophthalmic regional anesthesia
5120249|NCT03243461|Glioblastoma|glioblastoma
5120250|NCT03243461|high grade glioma|high grade glioma
5120251|NCT03243461|brain tumor|brain tumor
5120252|NCT03243461|Anaplastic astrocytoma|anaplastic astrocytoma
5120253|NCT03243461|DIPG|dipg
5120254|NCT03243461|Gliomatosis cerebri|gliomatosis cerebri
5120255|NCT03243461|Diffuse midline glioma|diffuse midline glioma
5120256|NCT03243409|reversed shoulder arthroplasties|reversed shoulder arthroplasties
5120257|NCT03243409|clinical complications|clinical complications
5120258|NCT03243409|complex proximal humeral fractures|complex proximal humeral fractures
5120259|NCT03243396|Mental health|mental health
5120260|NCT03243396|Cognitive behavioral therapy|cognitive behavioral therapy
5120261|NCT03243396|Task-shifting|task-shifting
5120262|NCT03243396|Global health|global health
5120263|NCT03243396|Teacher|teacher
5120264|NCT03243396|Community health volunteer|community health volunteer
5120265|NCT03243396|Children|children
5120266|NCT03243396|Orphans|orphans
5120267|NCT03243396|Abandoned children|abandoned children
5120268|NCT03243396|TF-CBT|tf-cbt
5120269|NCT03243396|Mental health policy|mental health policy
5120270|NCT03243396|Ministry of Education|ministry of education
5120271|NCT03243396|Ministry of Health|ministry of health
5120272|NCT03243396|Delivery|delivery
5120273|NCT03243396|Implementation science|implementation science
5962007|NCT04283526|PET-MF|pet-mf
5962008|NCT04283526|MF|mf
5120274|NCT03243396|Qualitative comparative analysis|qualitative comparative analysis
5120275|NCT03243396|Implementation practices and policies|implementation practices and policies
5120277|NCT03243396|Adoption|adoption
5120278|NCT03243396|Fidelity|fidelity
5120279|NCT03243396|Kenya|kenya
5120280|NCT03243396|Bungoma|bungoma
5120281|NCT03243396|Kanduyi|kanduyi
5120282|NCT03243396|East Africa|east africa
5120283|NCT03243396|Posttraumatic stress|posttraumatic stress
5120284|NCT03243396|Childhood traumatic grief|childhood traumatic grief
5120285|NCT03243396|Grief|grief
5120286|NCT03243396|Trauma|trauma
5120287|NCT03243383|readmission|readmission
5120288|NCT03243370|Validate the Clock'nTest|validate the clock'ntest
5120289|NCT03243357|Endodontics, molars, instrumentation, obturation, anatomy|endodontics, molars, instrumentation, obturation, anatomy
5120291|NCT03243292|Bronchial Thermoplasty|bronchial thermoplasty
5120292|NCT03243292|Alair|alair
5120293|NCT03243292|Registry|registry
5120294|NCT03243227|carpal tunnel syndrome|carpal tunnel syndrome
5120295|NCT03243227|neurodynamics|neurodynamics
5120296|NCT03243227|median nerve gliding exercise|median nerve gliding exercise
5120297|NCT03243214|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5120298|NCT03243188|Palliative Care|palliative care
5120299|NCT03243175|intracerebral hemorrhage|intracerebral hemorrhage
5120300|NCT03243175|atrial fibrillation|atrial fibrillation
5120301|NCT03243175|microhemorrhage|microhemorrhage
5120302|NCT03243175|oral anticoagulation|oral anticoagulation
5120303|NCT03243175|left atrial appendage closure|left atrial appendage closure
5120304|NCT03243084|tACS|tacs
5120305|NCT03243084|transcranial alternating current stimulation|transcranial alternating current stimulation
5120306|NCT03243084|low back pain|low back pain
5120307|NCT03243084|chronic pain|chronic pain
5120308|NCT03243084|alpha oscillations|alpha oscillations
5120309|NCT03243084|heart rate variability|heart rate variability
5120310|NCT03243071|Medical Care|medical care
5120311|NCT03243071|Racial Discrimination|racial discrimination
5120312|NCT03243071|Poor Health Literacy|poor health literacy
5120313|NCT03243071|Medical Care Disparities|medical care disparities
5120322|NCT03243045|Microcirculation|microcirculation
5120323|NCT03243045|Sympathetic nervous system|sympathetic nervous system
5120324|NCT03243019|cervico-facial|cervico-facial
5120325|NCT03243019|rapamycin|rapamycin
5120326|NCT03243006|acute pain|acute pain
5120327|NCT03243006|emergency department|emergency department
5120328|NCT03243006|opioid consumption|opioid consumption
5120330|NCT03242980|Adherence|adherence
5120331|NCT03242980|Viral re-suppression|viral re-suppression
5120332|NCT03242980|Step-wedgged randomized trial|step-wedgged randomized trial
5120333|NCT03242967|Anemia|anemia
5120334|NCT03242967|hemoglobin|hemoglobin
5120335|NCT03242967|darbepoetin alfa|darbepoetin alfa
5120336|NCT03242967|TIW|tiw
5120337|NCT03242967|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5120338|NCT03242967|HIF-PHI|hif-phi
5120339|NCT03242967|AKB-6548|akb-6548
5120340|NCT03242967|vadadustat|vadadustat
5120341|NCT03242967|renal|renal
5120345|NCT03242967|CKD|ckd
5120346|NCT03242967|DD-CKD|dd-ckd
5120347|NCT03242967|kidney|kidney
5120348|NCT03242967|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5120349|NCT03242967|ESA|esa
5120350|NCT03242928|Cocaine Use Disorder; cocaine dependence|cocaine use disorder; cocaine dependence
5120351|NCT03242902|light therapy|light therapy
5120352|NCT03242902|cancer related fatigue|cancer related fatigue
5120353|NCT03242902|sleep quality|sleep quality
5120354|NCT03242902|biological rhythms|biological rhythms
5120361|NCT03242811|Medical age assessment|medical age assessment
5120362|NCT03242798|liver cirrhosis|liver cirrhosis
5120363|NCT03242798|malnutrition|malnutrition
5120364|NCT03242798|nutritional status|nutritional status
5120365|NCT03242798|nutritional assessment|nutritional assessment
5120366|NCT03242785|Self-monitoring|self-monitoring
5120367|NCT03242785|Education|education
5120368|NCT03242785|Self-titration|self-titration
5120369|NCT03242785|antihypertensives|antihypertensives
5120370|NCT03242746|LEEP|leep
5120371|NCT03242746|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
5120372|NCT03242746|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5120373|NCT03242746|pregnancy outcome|pregnancy outcome
5120374|NCT03242733|Gastroparesis|gastroparesis
5120375|NCT03242694|persistent atrial fibrillation|persistent atrial fibrillation
5120376|NCT03242694|pulmonary vein isolation|pulmonary vein isolation
5120377|NCT03242694|catheter ablation|catheter ablation
5120378|NCT03242694|left atrial function|left atrial function
5120379|NCT03242694|left atrial pressure|left atrial pressure
5120380|NCT03242694|voltage map|voltage map
5120381|NCT03242694|strain|strain
5120382|NCT03242694|scar|scar
5120383|NCT03242694|success|success
5120384|NCT03242694|biomarker|biomarker
5120385|NCT03242668|paravertebral block,PVC,PCA|paravertebral block,pvc,pca
5120386|NCT03242642|Heart disease|heart disease
5120387|NCT03242642|valve disease|valve disease
5120388|NCT03242642|heart valve disease|heart valve disease
5120389|NCT03242642|mitral regurgitation|mitral regurgitation
5005828|NCT03960320|SDQ|sdq
5120390|NCT03242642|cardiovascular disease|cardiovascular disease
5120391|NCT03242642|mitral insufficiency|mitral insufficiency
5120392|NCT03242629|pediatric ophthalmic examination|pediatric ophthalmic examination
5120393|NCT03242629|chloral hydrate|chloral hydrate
5120394|NCT03242629|Effects Comparison|effects comparison
5120395|NCT03242603|Relapsed, Refractory, Neuroblastoma|relapsed, refractory, neuroblastoma
5120396|NCT03242603|Anti-GD2|anti-gd2
5120397|NCT03242603|Natural Killer (NK) Cells|natural killer (nk) cells
5120398|NCT03242603|Immunotherapy|immunotherapy
5120399|NCT03242538|Exercise|exercise
5120401|NCT03242512|osteoporosis|osteoporosis
5120402|NCT03242512|bone resorption|bone resorption
5120403|NCT03242512|post-menopausal women|post-menopausal women
5120404|NCT03242512|TK006|tk006
5120405|NCT03242434|Mannitol|mannitol
5120406|NCT03242434|Intestinal permeability|intestinal permeability
5120407|NCT03242434|Thermal injury|thermal injury
5120408|NCT03242434|HESTIA|hestia
5120409|NCT03242434|Sucralose|sucralose
5120410|NCT03242434|Lactulose|lactulose
5120413|NCT03242395|Neuroinflammation|neuroinflammation
5120414|NCT03242395|fMRI|fmri
5120415|NCT03242395|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
5120418|NCT03242382|advanced|advanced
5120419|NCT03242382|sarcoma|sarcoma
5120420|NCT03242382|cdk4|cdk4
5120421|NCT03242369|colorectal neoplasia|colorectal neoplasia
5120422|NCT03242369|colonoscopy|colonoscopy
5120423|NCT03242369|quality of bowel cleansing|quality of bowel cleansing
5120424|NCT03242369|bowel preparation|bowel preparation
5120425|NCT03242330|Implant survival|implant survival
5120426|NCT03242330|Patient satisfaction|patient satisfaction
5120427|NCT03242278|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5120428|NCT03242278|Prevention|prevention
5120429|NCT03242278|Stroke|stroke
5120430|NCT03242239|HER2 Positive Breast Cancer|her2 positive breast cancer
5120431|NCT03242239|Trastuzumab|trastuzumab
5120432|NCT03242239|Biosimilar|biosimilar
5120433|NCT03242226|+3.00ADD|+3.00add
5120434|NCT03242226|single vision spectacle|single vision spectacle
5120435|NCT03242200|survivors of childhood cancer|survivors of childhood cancer
5120436|NCT03242200|young adult female|young adult female
5120437|NCT03242200|mobile app|mobile app
5120438|NCT03242200|questionnaire|questionnaire
5120439|NCT03242200|health tracking|health tracking
5120440|NCT03242187|Minimally invasive surgery|minimally invasive surgery
5120441|NCT03242187|trans-anal total mesorectal excision|trans-anal total mesorectal excision
5120442|NCT03242187|Laparoscopic total mesoretal excision|laparoscopic total mesoretal excision
5120443|NCT03242070|Patient Portals|patient portals
5120444|NCT03242070|Chronic Disease|chronic disease
5120445|NCT03242070|Older Adults|older adults
5120449|NCT03241992|Inflammatory Bowel Disease|inflammatory bowel disease
5120451|NCT03241992|Electronic Health Record|electronic health record
5673410|NCT00608348|hypoglycemia|hypoglycemia
5120470|NCT03241888|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
5120471|NCT03241875|pregabalin|pregabalin
5120472|NCT03241875|gabapentin|gabapentin
5120473|NCT03241875|post operative pain|post operative pain
5120474|NCT03241875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5120475|NCT03241810|Breast Cancer, HER2 Negative, Hormone receptor positive, heregulin|breast cancer, her2 negative, hormone receptor positive, heregulin
5120477|NCT03241797|EUS-FNA|eus-fna
5120478|NCT03241784|ALS|als
5120479|NCT03241784|T-Regulatory Cells|t-regulatory cells
5120480|NCT03241745|Nivolumab|nivolumab
5120481|NCT03241745|17-180|17-180
5120482|NCT03241732|Traumatic Brain Injury|traumatic brain injury
5120483|NCT03241732|TBI|tbi
5120484|NCT03241732|Brain Trauma|brain trauma
5120485|NCT03241732|N-acetyl cysteine|n-acetyl cysteine
5120486|NCT03241732|Concussion|concussion
5120487|NCT03241732|NAC|nac
5120488|NCT03241732|Integrative Medicine|integrative medicine
5120489|NCT03241732|EEG|eeg
5120490|NCT03241732|electroencephalogram|electroencephalogram
5120491|NCT03241732|Functional magnetic resonance imaging or functional MRI|functional magnetic resonance imaging or functional mri
5120492|NCT03241732|fMRI|fmri
5120493|NCT03241732|PET|pet
5120494|NCT03241732|Positron emission tomography|positron emission tomography
5120495|NCT03241732|MRI|mri
5120496|NCT03241732|magnetic resonance imaging|magnetic resonance imaging
5120497|NCT03241706|hypoglycemia|hypoglycemia
5120498|NCT03241706|type 1 diabetes|type 1 diabetes
5120499|NCT03241706|liver glucose metabolism|liver glucose metabolism
5120500|NCT03241628|Skin blisters|skin blisters
5120501|NCT03241628|Finger webbing|finger webbing
5120502|NCT03241628|Finger contracture|finger contracture
5120503|NCT03241628|Hand contracture|hand contracture
5120504|NCT03241589|Teledermatology|teledermatology
5120505|NCT03241589|Telehealth|telehealth
5120506|NCT03241589|Dermatology|dermatology
5120507|NCT03241589|Telemedicine|telemedicine
5120508|NCT03241589|Mobile Application|mobile application
5962009|NCT04283526|myeloproliferative neoplasms|myeloproliferative neoplasms
5120509|NCT03241550|invasive fungal disease|invasive fungal disease
5120510|NCT03241550|Cresemba®|cresemba®
5120511|NCT03241550|Hematological malignancy|hematological malignancy
5120512|NCT03241550|isavuconazonium sulfate|isavuconazonium sulfate
5120513|NCT03241550|ASP9766|asp9766
5120514|NCT03241550|isavuconazole|isavuconazole
5120515|NCT03241550|pediatric population|pediatric population
5120516|NCT03241524|Pelvic Floor muscles|pelvic floor muscles
5120517|NCT03241524|Physical Therapy|physical therapy
5120518|NCT03241524|Sexual function evaluation|sexual function evaluation
5120519|NCT03241511|Periodontitis, End Stage Renal Disease, Periodontal treatment|periodontitis, end stage renal disease, periodontal treatment
5120520|NCT03241498|Medicines optimisation|medicines optimisation
5120521|NCT03241498|Healthcare resource utilisation|healthcare resource utilisation
5120522|NCT03241498|HRQOL|hrqol
5120523|NCT03241498|Pharmacist-led|pharmacist-led
5120524|NCT03241498|GP based|gp based
5120525|NCT03241459|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5120527|NCT03241459|Peripheral Artery Disease|peripheral artery disease
5120528|NCT03241459|PAD|pad
5120529|NCT03241459|Paclitaxel|paclitaxel
5120530|NCT03241433|Exercise|exercise
5120531|NCT03241394|Monocyte subsets|monocyte subsets
5120532|NCT03241394|Obesity|obesity
5120533|NCT03241394|Metabolic Syndrome|metabolic syndrome
5120534|NCT03241381|observational sample|observational sample
5117423|NCT03261687|physical therapy|physical therapy
5120547|NCT03241303|acarbose|acarbose
5120549|NCT03241290|Medical Imaging Device|medical imaging device
5120561|NCT03241212|young adult|young adult
5120562|NCT03241212|knowledge|knowledge
5120563|NCT03241212|self-care|self-care
5120564|NCT03241186|Ipilimumab|ipilimumab
5120565|NCT03241186|Nivolumab|nivolumab
5120566|NCT03241186|OPDIVO|opdivo
5120567|NCT03241186|IgG4 kappa immunoglobulin|igg4 kappa immunoglobulin
5120568|NCT03241173|advanced or metastatic cervical cancer|advanced or metastatic cervical cancer
5185644|NCT02829827|IS|is
5120569|NCT03241173|endometrial cancer|endometrial cancer
5120570|NCT03241173|esophageal cancer|esophageal cancer
5120571|NCT03241173|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5120572|NCT03241173|melanoma|melanoma
5120573|NCT03241173|Merkel cell carcinoma|merkel cell carcinoma
5120574|NCT03241173|mesothelioma|mesothelioma
5120575|NCT03241173|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer
5120576|NCT03241173|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5120577|NCT03241173|ovarian cancer|ovarian cancer
5120578|NCT03241173|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5120579|NCT03241173|small cell lung cancer (SLCL)|small cell lung cancer (slcl)
5120580|NCT03241173|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5120581|NCT03241173|triple-negative breast cancer|triple-negative breast cancer
5120582|NCT03241173|TNBC|tnbc
5120583|NCT03241173|urothelial carcinoma|urothelial carcinoma
5120584|NCT03241173|OX40 ligand (OX40)|ox40 ligand (ox40)
5120585|NCT03241173|SCCHN|scchn
5120586|NCT03241173|MSI-H CRC|msi-h crc
5120587|NCT03241173|gastric cancer (including stomach and gastroesophageal junction [GEJ])|gastric cancer (including stomach and gastroesophageal junction [gej])
5120588|NCT03241134|Dry needling|dry needling
5120589|NCT03241134|Sham needling|sham needling
5120590|NCT03241134|Office workers|office workers
5120591|NCT03241134|Myofascial pain|myofascial pain
5120592|NCT03241134|Surface electromyography|surface electromyography
5120593|NCT03241121|Time Restricted Feeding|time restricted feeding
5120594|NCT03241121|Eating patterns|eating patterns
5120595|NCT03241095|Osteopathic Manipulation Treatment|osteopathic manipulation treatment
5120596|NCT03241095|Golf|golf
5120597|NCT03241069|bio-impedance|bio-impedance
5120598|NCT03241069|BIOPAC system|biopac system
5120599|NCT03241069|dyspnea|dyspnea
5120600|NCT03241069|acute heart failure|acute heart failure
5120601|NCT03241043|Pharmacokinetic study|pharmacokinetic study
5120602|NCT03241043|Comparing Envarsus versus Advagraf|comparing envarsus versus advagraf
5120603|NCT03241017|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5120604|NCT03241017|Double-hit Lymphomas|double-hit lymphomas
5120605|NCT03241017|Grey Zone Lymphomas|grey zone lymphomas
5120606|NCT03241017|Double or Triple Expressor Lymphomas|double or triple expressor lymphomas
5120607|NCT03241017|Unclassifiable Aggressive Lymphoma types|unclassifiable aggressive lymphoma types
5120608|NCT03241017|Aggressive Lymphomas|aggressive lymphomas
5120609|NCT03240991|bradykinin-mediated angiodema|bradykinin-mediated angiodema
5120617|NCT03240926|COPD, Severe Early-Onset|copd, severe early-onset
5120618|NCT03240887|Teen pregnancy prevention|teen pregnancy prevention
5120619|NCT03240874|Gestational Diabetes|gestational diabetes
5120620|NCT03240874|Diabetes Type 2 in Pregnancy|diabetes type 2 in pregnancy
5120622|NCT03240861|stem cells|stem cells
5120623|NCT03240861|gene therapy|gene therapy
5120624|NCT03240861|NYESO|nyeso
5120625|NCT03240861|Sarcoma|sarcoma
5120626|NCT03240848|congenital cataract|congenital cataract
5120627|NCT03240848|artificial intelligent clinic|artificial intelligent clinic
5120628|NCT03240835|pre-Albumin|pre-albumin
5120629|NCT03240835|Retinol Conjugated Protein|retinol conjugated protein
5120630|NCT03240835|Transferrin|transferrin
5120631|NCT03240835|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
5120632|NCT03240835|nutrition|nutrition
5120633|NCT03240822|Penile Trauma|penile trauma
5130610|NCT03178084|HIV|hiv
5120638|NCT03240822|Penile Transplantation|penile transplantation
5120640|NCT03240822|Penile Injury|penile injury
5120641|NCT03240796|congenital cataract|congenital cataract
5120642|NCT03240796|intra-capsular IOL implantation|intra-capsular iol implantation
5120643|NCT03240796|ciliary sulcus fixation|ciliary sulcus fixation
5120644|NCT03240783|CT-Fluoroscopic Selective Transforaminal Epidural Steroid|ct-fluoroscopic selective transforaminal epidural steroid
5120645|NCT03240783|Oral Dexamethasone|oral dexamethasone
5120646|NCT03240783|Acute Lumbar Radiculopathy|acute lumbar radiculopathy
5120647|NCT03240783|Sciatic Neuropathy|sciatic neuropathy
5120648|NCT03240783|Betamethasone injectable|betamethasone injectable
5120649|NCT03240783|Dexamethasone injectable|dexamethasone injectable
5120650|NCT03240783|Acute Lumbar radicular pain|acute lumbar radicular pain
5120651|NCT03240783|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5120652|NCT03240783|Comparative Effectiveness Controlled Trial|comparative effectiveness controlled trial
5120653|NCT03240770|HFV|hfv
5120654|NCT03240770|HFA|hfa
5120655|NCT03240770|High Frequency Vibration|high frequency vibration
5120656|NCT03240757|meal absorption|meal absorption
5120657|NCT03240757|exercise|exercise
5120658|NCT03240757|energy balance|energy balance
5120659|NCT03240757|lipolysis|lipolysis
5120660|NCT03240744|immunogenicity|immunogenicity
5120661|NCT03240744|safety|safety
5120662|NCT03240744|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
5755845|NCT00298428|shear|shear
5120663|NCT03240731|sickle cell disease|sickle cell disease
5120664|NCT03240731|haploidentical|haploidentical
5120665|NCT03240731|graft|graft
5120666|NCT03240731|marrow|marrow
5120667|NCT03240705|Stress|stress
5120668|NCT03240705|Medical education|medical education
5120673|NCT03240679|Barrett's esophagus|barrett's esophagus
5120674|NCT03240679|Endoscopic Mucosal Resection|endoscopic mucosal resection
5120675|NCT03240640|Inspiratory muscle training|inspiratory muscle training
5120676|NCT03240640|COPD|copd
5120677|NCT03240640|Dyspnea|dyspnea
5120678|NCT03240640|Balance|balance
5120679|NCT03240562|serratus anterior plane block|serratus anterior plane block
5120680|NCT03240562|ultrasound-guided|ultrasound-guided
5120681|NCT03240562|regional anesthesia|regional anesthesia
5120682|NCT03240562|thoracic surgery|thoracic surgery
5120683|NCT03240562|postoperative pain|postoperative pain
5120684|NCT03240549|advanced pulmonary adenocarcinoma|advanced pulmonary adenocarcinoma
5120685|NCT03240549|Bevacizumab|bevacizumab
5120686|NCT03240549|First line chemotherapy|first line chemotherapy
5120687|NCT03240549|Stable disease|stable disease
5120690|NCT03240510|Breast cancer|breast cancer
5120691|NCT03240510|Male|male
5120692|NCT03240471|Distal radius fracture|distal radius fracture
5120693|NCT03240471|Conservative treatment|conservative treatment
5120694|NCT03240471|Patient rated outcome (PRO)|patient rated outcome (pro)
5120695|NCT03240419|Obesity|obesity
5120696|NCT03240419|Inflammation|inflammation
5120697|NCT03240419|Pregnancy|pregnancy
5120698|NCT03240419|Programming|programming
5120699|NCT03240393|Non Small Cell Lung Cancer|non small cell lung cancer
5120700|NCT03240393|NSCLC|nsclc
5120701|NCT03240393|INC280|inc280
5120702|NCT03240393|EGFR wild-type (wt)|egfr wild-type (wt)
5120703|NCT03240393|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5120704|NCT03240393|advanced/metastatic disease|advanced/metastatic disease
5120705|NCT03240393|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5120708|NCT03240393|lung adenocarcinoma|lung adenocarcinoma
5120709|NCT03240393|Non small cell lung carcinoma|non small cell lung carcinoma
5120710|NCT03240393|Non-small cell lung cancer|non-small cell lung cancer
5120711|NCT03240393|MET exon 14 deletion|met exon 14 deletion
5120712|NCT03240393|MET exon 14 skipping|met exon 14 skipping
5120713|NCT03240393|MET exon 14 mutation|met exon 14 mutation
5120715|NCT03240393|MET amplification|met amplification
5120716|NCT03240393|MET inhibitor|met inhibitor
5120717|NCT03240393|MET dysregulation|met dysregulation
5120718|NCT03240393|MET activation|met activation
5120719|NCT03240393|MET signaling|met signaling
5120720|NCT03240393|MET pathway|met pathway
5120721|NCT03240393|MET|met
5120722|NCT03240393|cMET|cmet
5120726|NCT03240263|Difficult to wean patients|difficult to wean patients
5120727|NCT03240263|ICU aquired muscle weakness|icu aquired muscle weakness
5120728|NCT03240263|Cerebral perfusion|cerebral perfusion
5120729|NCT03240263|Respiratroy muscles|respiratroy muscles
5120730|NCT03240263|IMT|imt
5120731|NCT03240263|Cerebral oxygenation|cerebral oxygenation
5120732|NCT03240263|Weaning outcomes|weaning outcomes
5120733|NCT03240250|VATS|vats
5120734|NCT03240250|Pulmonary lobectomy|pulmonary lobectomy
5120735|NCT03240250|Uniportal|uniportal
5120736|NCT03240250|Postoperative pain|postoperative pain
5117644|NCT03260166|nicotinamide|nicotinamide
5120737|NCT03240250|Thoracic surgery|thoracic surgery
5120739|NCT03240224|Cancer ablation|cancer ablation
5120740|NCT03240224|Life information rehabilitation therapy|life information rehabilitation therapy
5120741|NCT03240211|Pembrolizumab|pembrolizumab
5120742|NCT03240211|Decitabine|decitabine
5120743|NCT03240211|Pralatrexate|pralatrexate
5120744|NCT03240211|T-cell lymphoma|t-cell lymphoma
5120745|NCT03240198|occupational|occupational
5120747|NCT03240198|biomarkers|biomarkers
5120748|NCT03240185|hemorrhoid|hemorrhoid
5120749|NCT03240185|pain|pain
5120750|NCT03240185|deep breathing|deep breathing
5120751|NCT03240185|multimodal pain control|multimodal pain control
5120752|NCT03240133|HAE|hae
5120753|NCT03240133|hereditary angioedema|hereditary angioedema
5120754|NCT03240133|kallikrein inhibitor|kallikrein inhibitor
5120755|NCT03240133|plasma kallikrein|plasma kallikrein
5120756|NCT03240107|levator resection|levator resection
5120757|NCT03240107|levator tucking|levator tucking
5120758|NCT03240107|Fair levator function|fair levator function
5120759|NCT03240107|Eyelid contour|eyelid contour
5120760|NCT03240094|Ehealth|ehealth
5120761|NCT03240094|Older adults|older adults
5120762|NCT03240094|Undernutrition|undernutrition
5120763|NCT03240081|Post-menopause dyspareunia|post-menopause dyspareunia
5120764|NCT03240081|Vulvar vestibular pain|vulvar vestibular pain
5120765|NCT03240081|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
5120766|NCT03240081|Sexual pain|sexual pain
5120767|NCT03240068|Renin-Angiotensin System|renin-angiotensin system
5120768|NCT03240068|Inflammation|inflammation
5120769|NCT03240068|Cardiovascular|cardiovascular
5120770|NCT03240068|Atherosclerosis|atherosclerosis
5120771|NCT03240055|spinal anesthesia|spinal anesthesia
5120772|NCT03240055|etomidate|etomidate
5120773|NCT03240055|median effective dose|median effective dose
5120774|NCT03240055|BIS50|bis50
5185925|NCT02828007|EIT|eit
5120775|NCT03240042|anterior cervical spine surgery|anterior cervical spine surgery
5120776|NCT03240042|endotracheal cuff pressure|endotracheal cuff pressure
5120777|NCT03240042|endotracheal tracheal intubation|endotracheal tracheal intubation
5120778|NCT03240042|dysphonia|dysphonia
5120779|NCT03240029|children|children
5120780|NCT03240029|life quality|life quality
5120781|NCT03240029|school reintegration|school reintegration
5120782|NCT03240003|Social Anxiety|social anxiety
5120783|NCT03240003|Social Anxiety Disorder|social anxiety disorder
5120784|NCT03240003|SAD|sad
5120785|NCT03239990|Children's mental health|children's mental health
5120786|NCT03239990|Conduct disorders|conduct disorders
5120787|NCT03239990|Conduct problems|conduct problems
5120788|NCT03239990|Externalizing problems|externalizing problems
5120789|NCT03239990|Parental Intervention|parental intervention
5120790|NCT03239990|Groups based intervention|groups based intervention
5120791|NCT03239990|Finland|finland
5120792|NCT03239990|Social learning theory|social learning theory
5120793|NCT03239990|Cognitive-behavioral theory|cognitive-behavioral theory
5120794|NCT03239977|social intelligence|social intelligence
5120795|NCT03239977|quality of life|quality of life
5120796|NCT03239977|social competence|social competence
5120797|NCT03239964|recurrent keloid|recurrent keloid
5120798|NCT03239964|surgical excision|surgical excision
5120799|NCT03239964|steroids injection|steroids injection
5120800|NCT03239938|chronic whiplash associated disorders|chronic whiplash associated disorders
5120801|NCT03239938|central sensitization|central sensitization
5120802|NCT03239938|electroencephalography|electroencephalography
5120803|NCT03239938|physiotherapy|physiotherapy
5122164|NCT03231696|nerve block|nerve block
5120806|NCT03239938|quality of life|quality of life
5120807|NCT03239938|stress management|stress management
5120808|NCT03239938|randomized controlled trial|randomized controlled trial
5120809|NCT03239938|modern neuroscience approach|modern neuroscience approach
5110334|NCT03308097|PrEP|prep
5120810|NCT03239938|pain neuroscience education|pain neuroscience education
5120811|NCT03239938|neck school|neck school
5120812|NCT03239938|exercise therapy|exercise therapy
5120813|NCT03239938|pain cognitions|pain cognitions
5120814|NCT03239925|Cell phones, Electromagnetic Radiation|cell phones, electromagnetic radiation
5120815|NCT03239912|Low-level laser|low-level laser
5120816|NCT03239912|functional treatment|functional treatment
5120817|NCT03239912|twin-block|twin-block
5120818|NCT03239912|RCT|rct
5120819|NCT03239899|HIV|hiv
5120820|NCT03239899|Brain|brain
5120821|NCT03239899|Immunotherapy|immunotherapy
5120822|NCT03239860|Multiple Sclerosis|multiple sclerosis
5120823|NCT03239860|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
5120824|NCT03239860|GNbAC1|gnbac1
5120825|NCT03239860|MRI|mri
5120826|NCT03239860|Monoclonal antibody|monoclonal antibody
5120827|NCT03239860|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
5120828|NCT03239860|MS|ms
5120829|NCT03239860|RRMS|rrms
5120830|NCT03239860|HERV-W|herv-w
5120831|NCT03239808|once-weekly haemodialysis|once-weekly haemodialysis
5120832|NCT03239808|incremental haemodialysis|incremental haemodialysis
5120833|NCT03239808|randomized clinical trial|randomized clinical trial
5120834|NCT03239795|Posters|posters
5120835|NCT03239795|Pamphlets|pamphlets
5120845|NCT03239743|induction of anesthesia|induction of anesthesia
5120848|NCT03239730|pH|ph
5120849|NCT03239730|blood gas analysis|blood gas analysis
5120850|NCT03239730|emergency department|emergency department
5120851|NCT03239730|Intensive care unit|intensive care unit
5120852|NCT03239704|Inflammatory Bowel Disease|inflammatory bowel disease
5120853|NCT03239704|Ulcerative Colitis|ulcerative colitis
5120854|NCT03239704|Crohn Disease|crohn disease
5120855|NCT03239704|Quality Improvement|quality improvement
5120856|NCT03239704|Telemedicine|telemedicine
5120857|NCT03239678|Preoxygenation|preoxygenation
5120858|NCT03239678|Oxygen Concentration|oxygen concentration
5120859|NCT03239665|Vaccine|vaccine
5120860|NCT03239665|Educational intervention|educational intervention
5120861|NCT03239665|Senior Center Model of Care|senior center model of care
5120862|NCT03239665|Older adults|older adults
5120863|NCT03239652|Microsphere|microsphere
5120864|NCT03239652|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
5120866|NCT03239600|Anti-IL-7 Receptor-alpha Monoclonal Antibody|anti-il-7 receptor-alpha monoclonal antibody
5120867|NCT03239600|Safety|safety
5120868|NCT03239600|GSK2618960|gsk2618960
5120869|NCT03239600|Primary Sjögren's Syndrome|primary sjögren's syndrome
5673411|NCT00608348|sympathetic nerve activity|sympathetic nerve activity
5120870|NCT03239587|Symptoms and signs involving cognition perception emotion & behaviour|symptoms and signs involving cognition perception emotion & behaviour
5120871|NCT03239587|Abdominal cancer patients|abdominal cancer patients
5120872|NCT03239587|Musical preop intervention|musical preop intervention
5120873|NCT03239587|Surveys|surveys
5120874|NCT03239587|Questionnaires|questionnaires
5120875|NCT03239587|Blood draws|blood draws
5120876|NCT03239548|Opinion,|opinion,
5120877|NCT03239548|Doctors,|doctors,
5120878|NCT03239548|Nurses,|nurses,
5120879|NCT03239548|Key informants,|key informants,
5120880|NCT03239548|Independent Nurse Midwifery Practitioner|independent nurse midwifery practitioner
5120881|NCT03239522|GSK1278863|gsk1278863
5120882|NCT03239522|pharmacokinetics|pharmacokinetics
5120883|NCT03239522|mass balance|mass balance
5120884|NCT03239522|daprodustat|daprodustat
5120885|NCT03239509|long-term survival|long-term survival
5120886|NCT03239509|bioprosthesis|bioprosthesis
5120887|NCT03239509|complications|complications
5120888|NCT03239509|anticoagulation|anticoagulation
5120889|NCT03239509|mechanichal prosthesis|mechanichal prosthesis
5120890|NCT03239470|autologous polyclonal regulatory T cell therapy|autologous polyclonal regulatory t cell therapy
5120891|NCT03239470|PolyTregs|polytregs
5120892|NCT03239470|open-label|open-label
5120893|NCT03239470|Phase 1 (safety)|phase 1 (safety)
5120894|NCT03239444|ICE|ice
5120895|NCT03239444|Ablation|ablation
5120896|NCT03239444|Trans-septal|trans-septal
5120897|NCT03239444|Septum|septum
5120898|NCT03239444|Echocardiography|echocardiography
5120899|NCT03239431|asthma|asthma
5120900|NCT03239431|lung function|lung function
5120901|NCT03239431|forced oscillometry technique|forced oscillometry technique
5120917|NCT03239327|Misoprostol|misoprostol
5120918|NCT03239327|neonatal|neonatal
5120919|NCT03239327|respiratory distress|respiratory distress
5120920|NCT03239327|cesarean section|cesarean section
5120921|NCT03239288|Fiber|fiber
5120922|NCT03239288|Postprandial glucose|postprandial glucose
5120923|NCT03239288|Insulin|insulin
5120924|NCT03239288|Resistant Starch Type 4|resistant starch type 4
5120925|NCT03239275|en masse retraction|en masse retraction
5120926|NCT03239275|biocreative therapy|biocreative therapy
5120927|NCT03239275|class II|class ii
5120928|NCT03239275|skeletal anchorage|skeletal anchorage
5120929|NCT03239262|Atrial Fibrillation|atrial fibrillation
5120930|NCT03239262|Left Atrial Cryoablation|left atrial cryoablation
5120931|NCT03239262|Ganglionated Plexi|ganglionated plexi
5120932|NCT03239262|Open-Heart Surgery|open-heart surgery
5120933|NCT03239249|school dropout prevention|school dropout prevention
5120934|NCT03239249|intervention study|intervention study
5120935|NCT03239249|cluster-randomized|cluster-randomized
5120936|NCT03239210|Brain Function|brain function
5120937|NCT03239210|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5120938|NCT03239210|Sensory processing|sensory processing
5120939|NCT03239210|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5120940|NCT03239210|OCD|ocd
5120941|NCT03239184|Cancer ablation|cancer ablation
5120942|NCT03239184|Life information rehabilitation therapy|life information rehabilitation therapy
5120943|NCT03239171|Cancer ablation|cancer ablation
5445338|NCT01522287|Cognitive Therapy|cognitive therapy
5120944|NCT03239171|Life information rehabilitation therapy|life information rehabilitation therapy
5120945|NCT03239158|Cancer ablation|cancer ablation
5120946|NCT03239158|Life information rehabilitation therapy|life information rehabilitation therapy
5120947|NCT03239145|Advanced Solid Tumor|advanced solid tumor
5120948|NCT03239145|Melanoma|melanoma
5120949|NCT03239145|Ovarian Cancer|ovarian cancer
5120950|NCT03239145|Renal Cancer|renal cancer
5120951|NCT03239145|Colorectal Cancer|colorectal cancer
5120952|NCT03239119|rE-4|re-4
5120953|NCT03239119|Exenatide|exenatide
5120954|NCT03239119|Metformin|metformin
5120955|NCT03239119|Sulfonylurea|sulfonylurea
5120956|NCT03239106|itch|itch
5120957|NCT03239106|pruritus|pruritus
5120958|NCT03239106|CIP|cip
5962010|NCT04283526|thrombocythemia myelofibrosis|thrombocythemia myelofibrosis
5033263|NCT03791060|NLD|nld
5120959|NCT03239080|Rheumatoid Arthritis|rheumatoid arthritis
5120960|NCT03239080|HR-pQCT|hr-pqct
5120961|NCT03239080|erosion|erosion
5120962|NCT03239080|denosumab|denosumab
5120963|NCT03239067|Ticagrelor|ticagrelor
5120964|NCT03239067|Clopidogrel|clopidogrel
5120965|NCT03239067|Acute Coronary Syndrome|acute coronary syndrome
5120966|NCT03239067|Percutaneous Coronary Intervention|percutaneous coronary intervention
5120967|NCT03239028|diet quality|diet quality
5120968|NCT03239028|pregnancy|pregnancy
5120969|NCT03239028|adolescence|adolescence
5120970|NCT03239028|longitudinal study|longitudinal study
5120971|NCT03239028|food frequency questionnaire|food frequency questionnaire
5120972|NCT03238989|Interstitial lung disease|interstitial lung disease
5120973|NCT03238976|breast core biopsy|breast core biopsy
5120974|NCT03238976|core needle biopsies|core needle biopsies
5120975|NCT03238924|posttraumatic stress disorder|posttraumatic stress disorder
5120976|NCT03238924|oxytocin|oxytocin
5120977|NCT03238924|Prolonged Exposure|prolonged exposure
5120992|NCT03238898|muscle cramps|muscle cramps
5120993|NCT03238898|diabetic neuropathy|diabetic neuropathy
5120994|NCT03238898|botulinum toxin|botulinum toxin
5120995|NCT03238872|Anxiety|anxiety
5120996|NCT03238872|Depression|depression
5120998|NCT03238872|Outcome monitoring|outcome monitoring
5120999|NCT03238872|Dissemination|dissemination
5121000|NCT03238872|Routine services|routine services
5121001|NCT03238833|In vitro fertilization|in vitro fertilization
5121002|NCT03238833|Poor ovarian responder|poor ovarian responder
5121003|NCT03238833|Luteal ovarian stimulation|luteal ovarian stimulation
5121010|NCT03238807|Intrauterine hCG|intrauterine hcg
5121011|NCT03238807|IVF|ivf
5121012|NCT03238807|ICSI|icsi
5121013|NCT03238794|Body Mass Index|body mass index
5121014|NCT03238794|gastric|gastric
5121015|NCT03238794|bypass|bypass
5121016|NCT03238794|bariatric surgery|bariatric surgery
5121017|NCT03238794|bile acid|bile acid
5121018|NCT03238794|weight loss|weight loss
5121019|NCT03238794|diet|diet
5121020|NCT03238794|low calorie|low calorie
5121021|NCT03238781|Migraine|migraine
5121022|NCT03238781|Headache|headache
5121023|NCT03238781|Prevention|prevention
5121024|NCT03238781|Prophylaxis|prophylaxis
5121025|NCT03238768|Nutrition|nutrition
5121026|NCT03238768|Body Composition|body composition
5121027|NCT03238768|Preterm|preterm
5121028|NCT03238768|Neonate|neonate
5121029|NCT03238755|HIV|hiv
5121030|NCT03238755|Diastolic Dysfunction|diastolic dysfunction
5121031|NCT03238755|Myocardial fibrosis|myocardial fibrosis
5121032|NCT03238755|Statin|statin
5121033|NCT03238742|Xuebijing Injection, morality, sepsis|xuebijing injection, morality, sepsis
5121034|NCT03238690|LVAD|lvad
5121035|NCT03238690|Cardiac Recovery|cardiac recovery
5121036|NCT03238677|speech sound disorder|speech sound disorder
5121037|NCT03238651|Drug therapy|drug therapy
5121038|NCT03238638|Epacadostat|epacadostat
5121039|NCT03238638|Pembrolizumab|pembrolizumab
5121040|NCT03238638|PD-1|pd-1
5121041|NCT03238638|PD-L1|pd-l1
5121042|NCT03238612|influenza|influenza
5121043|NCT03238612|FFA|ffa
5121045|NCT03238612|mortality|mortality
5121046|NCT03238612|hospitalisation|hospitalisation
5121055|NCT03238573|Colorectal Sessile Serrated Adenomas/Polyps optical enhancement endoscopy|colorectal sessile serrated adenomas/polyps optical enhancement endoscopy
5121056|NCT03238508|Deferred stenting|deferred stenting
5121057|NCT03238508|Microvascular dysfunction|microvascular dysfunction
5121058|NCT03238495|Operable breast cancer|operable breast cancer
5121059|NCT03238495|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5121060|NCT03238469|Microwave Ablation|microwave ablation
5121061|NCT03238469|Hair Follicle|hair follicle
5121062|NCT03238469|Sweat gland|sweat gland
5121063|NCT03238456|Pacific Islander|pacific islander
5121064|NCT03238456|Native Hawaiian|native hawaiian
5121065|NCT03238456|NHPI|nhpi
5121066|NCT03238456|Tobacco Health|tobacco health
5121067|NCT03238456|Tobacco Use|tobacco use
5121068|NCT03238456|Tobacco Smoking|tobacco smoking
5121069|NCT03238456|Tobacco Use Cessation|tobacco use cessation
5121070|NCT03238456|Smoking Cessation|smoking cessation
5121071|NCT03238456|Smoking|smoking
5121072|NCT03238456|Cigarette Use|cigarette use
5121073|NCT03238456|Young Adult|young adult
5121074|NCT03238443|DSA|dsa
5121077|NCT03238417|primary health care|primary health care
5121078|NCT03238417|mental health|mental health
5121079|NCT03238417|Veterans|veterans
5121080|NCT03238417|quality improvement|quality improvement
5121081|NCT03238404|gastric cancer|gastric cancer
5121082|NCT03238404|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5121083|NCT03238404|enhanced recovery after surgery|enhanced recovery after surgery
5962011|NCT04283526|polycythemia vera|polycythemia vera
5121084|NCT03238404|gastrectomy|gastrectomy
5121085|NCT03238391|Contrast-induced nephropathy|contrast-induced nephropathy
5121086|NCT03238391|Ischemic preconditioning|ischemic preconditioning
5121087|NCT03238378|head and neck cancer|head and neck cancer
5423211|NCT01616667|Hip Joint/physiology*|hip joint/physiology*
5121088|NCT03238378|Locally recurrent head and neck cancer|locally recurrent head and neck cancer
5121089|NCT03238378|Brachytherapy|brachytherapy
4988743|NCT04061980|Phase 2|phase 2
5121090|NCT03238378|Hyperthermia|hyperthermia
5121091|NCT03238339|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5121092|NCT03238339|Respiratory Insufficiency|respiratory insufficiency
5121093|NCT03238339|Oxygen Inhalation Therapy|oxygen inhalation therapy
5121094|NCT03238339|Noninvasive Ventilation|noninvasive ventilation
5121095|NCT03238326|Brexpiprazole|brexpiprazole
5121096|NCT03238326|Schizophrenia|schizophrenia
5121097|NCT03238300|adolescent|adolescent
5121098|NCT03238287|Emergency|emergency
5121099|NCT03238287|Mechanical chest compression|mechanical chest compression
5121100|NCT03238287|Cerebral oximetry|cerebral oximetry
5121101|NCT03238222|Walking|walking
5121102|NCT03238222|Six-Minute Walk Distance|six-minute walk distance
5121103|NCT03238222|Illness Perceptions|illness perceptions
5121104|NCT03238222|Theory of Planned Behaviour|theory of planned behaviour
5121105|NCT03238209|neural respiratory drive|neural respiratory drive
5121106|NCT03238209|transesophageal diaphragmatic EMG|transesophageal diaphragmatic emg
5121107|NCT03238209|surface diaphragmatic EMG|surface diaphragmatic emg
5121108|NCT03238209|surface sternocleidomastoid EMG|surface sternocleidomastoid emg
5121109|NCT03238209|surface parasternal intercostal muscle EMG|surface parasternal intercostal muscle emg
5121110|NCT03238196|FGFR inhibitor|fgfr inhibitor
5121111|NCT03238196|ER+ metastatic breast cancer|er+ metastatic breast cancer
5121112|NCT03238196|CDK4/6 inhibitor|cdk4/6 inhibitor
5121113|NCT03238196|Endocrine therapy|endocrine therapy
5121114|NCT03238183|knee osteoarthritis|knee osteoarthritis
5121115|NCT03238183|hyaluronic acid|hyaluronic acid
5121116|NCT03238183|dextrose|dextrose
5121117|NCT03238183|therapeutic effects|therapeutic effects
5121118|NCT03238118|irritability|irritability
5121119|NCT03238118|severe mood dysregulation|severe mood dysregulation
5121120|NCT03238118|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
5121121|NCT03238105|Dark circles|dark circles
5121122|NCT03238105|Periorbital hyperchromia|periorbital hyperchromia
5121123|NCT03238105|Facial aesthetics|facial aesthetics
5121124|NCT03238092|in vitro fertilization|in vitro fertilization
5121125|NCT03238092|estradiol|estradiol
5121126|NCT03238092|gnrh antagonist|gnrh antagonist
5121127|NCT03238092|testosterone|testosterone
5121128|NCT03238053|laser treatment, randomized trial, menopause, vaginal symptoms, overactive bladder|laser treatment, randomized trial, menopause, vaginal symptoms, overactive bladder
5121129|NCT03238040|Critical illness|critical illness
5121130|NCT03238040|PICU|picu
5121131|NCT03238040|biomarkers|biomarkers
5121132|NCT03238027|SNDX-6352|sndx-6352
5121133|NCT03238027|CSF-1R inhibitor|csf-1r inhibitor
5121134|NCT03238027|Colony Stimulating factor 1 receptor inhibitor|colony stimulating factor 1 receptor inhibitor
5121135|NCT03238027|Solid Tumor|solid tumor
5121136|NCT03238027|Recurrent locally advanced tumor|recurrent locally advanced tumor
5121137|NCT03238027|unresectable solid tumor|unresectable solid tumor
5121138|NCT03238027|Metastatic tumor|metastatic tumor
5121139|NCT03238027|durvalumab|durvalumab
5121140|NCT03238001|Cognitive assessment|cognitive assessment
5121141|NCT03238001|Cognition|cognition
5121142|NCT03238001|Clock Test|clock test
5121143|NCT03237975|type 2 diabetes|type 2 diabetes
5121144|NCT03237975|sense of coherence|sense of coherence
5121145|NCT03237975|self-care|self-care
5121146|NCT03237975|strengths-based intervention|strengths-based intervention
5121147|NCT03237962|High flow nasal cannula|high flow nasal cannula
5121148|NCT03237962|Pulmonary rehab|pulmonary rehab
5121149|NCT03237962|Pulmonary rehabilitation|pulmonary rehabilitation
5121150|NCT03237962|Nasal cannula|nasal cannula
5121151|NCT03237962|Exercise endurance|exercise endurance
5121152|NCT03237962|Oxygen Therapy|oxygen therapy
5121153|NCT03237962|COPD|copd
5121154|NCT03237962|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5121155|NCT03237949|Tobacco Use Disorder|tobacco use disorder
5121156|NCT03237949|Hospitalized patients|hospitalized patients
5121157|NCT03237949|Text message|text message
5121158|NCT03237949|Motivational Interview|motivational interview
5121159|NCT03237949|Substance-Related Disorders|substance-related disorders
5118044|NCT03257839|Breast Tomography|breast tomography
5121160|NCT03237949|Behaviors and Mental Disorders|behaviors and mental disorders
5121161|NCT03237923|fluid|fluid
5121162|NCT03237910|amplitude spectrum area|amplitude spectrum area
5121163|NCT03237910|defibrillation|defibrillation
5121164|NCT03237910|waveform analysis|waveform analysis
5121165|NCT03237910|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5121166|NCT03237910|cardiac arrest|cardiac arrest
5121167|NCT03237897|ERAS|eras
5121168|NCT03237897|Enhanced recovery after surgery|enhanced recovery after surgery
5121169|NCT03237884|Palliative Care|palliative care
5121170|NCT03237884|Oncology|oncology
5121171|NCT03237884|advanced incurable cancer (any type)|advanced incurable cancer (any type)
5121172|NCT03237884|integration|integration
5121173|NCT03237884|development|development
5121174|NCT03237884|palliative care interventions|palliative care interventions
5121175|NCT03237884|process indicators|process indicators
5121176|NCT03237884|Romania|romania
5121177|NCT03237858|heart failure|heart failure
5962012|NCT04283526|essential thrombocythemia|essential thrombocythemia
4992906|NCT04038047|CF|cf
5121178|NCT03237858|diagnostics|diagnostics
5121179|NCT03237858|heart sounds|heart sounds
5121193|NCT03237702|prostate cancer|prostate cancer
5121194|NCT03237702|prostate biopsy|prostate biopsy
5121195|NCT03237702|biomarkers|biomarkers
5121196|NCT03237702|metabolomics|metabolomics
5121197|NCT03237702|overtreatment|overtreatment
5121198|NCT03237702|cancer screening|cancer screening
5121199|NCT03237702|urine|urine
5121200|NCT03237702|lycopene|lycopene
5121201|NCT03237676|cognitive rehabilitation|cognitive rehabilitation
5121202|NCT03237676|diffusion tensor imaging|diffusion tensor imaging
5121215|NCT03237585|impact assessment|impact assessment
5121216|NCT03237585|rural response system|rural response system
5121217|NCT03237585|cluster randomised controlled trial|cluster randomised controlled trial
5121219|NCT03237572|pembrolizumab|pembrolizumab
5121220|NCT03237572|focused ultrasound|focused ultrasound
5121221|NCT03237572|immunotherapy|immunotherapy
5121222|NCT03237559|Eugenics|eugenics
5121223|NCT03237559|Eligible Couples|eligible couples
5121224|NCT03237559|Knowledge|knowledge
5121225|NCT03237559|Attitude|attitude
5121226|NCT03237559|Practice|practice
5121227|NCT03237546|Robotic Cardiac Surgery|robotic cardiac surgery
5121228|NCT03237494|Peripheral Nervous System Diseases|peripheral nervous system diseases
5121229|NCT03237494|Transthyretin Amyloidosis|transthyretin amyloidosis
5121230|NCT03237494|Transthyretin-related familial amyloid polyneuropathy|transthyretin-related familial amyloid polyneuropathy
5121231|NCT03237494|Transthyretin-related familial amyloid cardiomyopathy|transthyretin-related familial amyloid cardiomyopathy
5121232|NCT03237481|inguinal hernia|inguinal hernia
5121233|NCT03237481|hernia|hernia
5121234|NCT03237481|hernia surgery|hernia surgery
5121235|NCT03237481|postoperative pain|postoperative pain
5121236|NCT03237481|herniorrhaphy|herniorrhaphy
5121237|NCT03237468|concussion|concussion
5121238|NCT03237468|football|football
5121239|NCT03237468|student|student
5121240|NCT03237468|athlete|athlete
5121241|NCT03237468|sports|sports
5121242|NCT03237429|bioimpedance spectroscopy|bioimpedance spectroscopy
5121243|NCT03237429|arterial stiffness|arterial stiffness
5121244|NCT03237416|Drug-drug interaction|drug-drug interaction
5121245|NCT03237403|Sepsis|sepsis
5121246|NCT03237403|Adults|adults
5121247|NCT03237403|Pre hospital settings|pre hospital settings
5121248|NCT03237403|Triage|triage
5121249|NCT03237403|Hospital orientation|hospital orientation
5121250|NCT03237403|Outcome|outcome
5121251|NCT03237364|deployed in Iraq and/or Afghanistan|deployed in iraq and/or afghanistan
5121252|NCT03237351|goal-directed fluid therapy|goal-directed fluid therapy
5121253|NCT03237351|thoracic surgery, video-assisted|thoracic surgery, video-assisted
5121254|NCT03237351|acute lung injury|acute lung injury
5121255|NCT03237325|OM|om
5121256|NCT03237325|Head and Neck Cancer|head and neck cancer
5121257|NCT03237325|SGX942|sgx942
5121258|NCT03237325|Dusquetide|dusquetide
5121259|NCT03237325|Squamous Cell Carcinoma|squamous cell carcinoma
5121260|NCT03237299|Pharyngitis|pharyngitis
5121261|NCT03237299|case-control study|case-control study
5110767|NCT03305393|CRT|crt
5121262|NCT03237299|loco-regional complications of pharyngitis|loco-regional complications of pharyngitis
5121263|NCT03237286|depression|depression
5121264|NCT03237286|ketamine|ketamine
5121265|NCT03237286|neurocognitive|neurocognitive
5121266|NCT03237286|fMRI|fmri
5121267|NCT03237286|cognitive training|cognitive training
5121268|NCT03237247|extrahepatic cholestasis, CBC|extrahepatic cholestasis, cbc
5121269|NCT03237208|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5121270|NCT03237208|emergency medicine|emergency medicine
5121272|NCT03237156|Drug therapy|drug therapy
5121273|NCT03237130|esophagus cancer; radiomics; computed tomograpy|esophagus cancer; radiomics; computed tomograpy
5121274|NCT03237104|Adolescent|adolescent
5121275|NCT03237104|Athlete|athlete
5121276|NCT03237091|non-invasive brain stimulation|non-invasive brain stimulation
5121277|NCT03237078|probiotics|probiotics
5121278|NCT03237078|major depressive disorder|major depressive disorder
5121279|NCT03237078|gut-brain axis|gut-brain axis
5121280|NCT03237078|inflammation|inflammation
5121295|NCT03237039|Roussouly type|roussouly type
5121296|NCT03237039|spine alignment|spine alignment
5121311|NCT03236961|uncomplicated acute appendicitis|uncomplicated acute appendicitis
5121312|NCT03236961|complicated acute appendicitis|complicated acute appendicitis
5121313|NCT03236961|antibiotic therapy|antibiotic therapy
5121314|NCT03236922|obstetric fistula, anti-incontinence techniques|obstetric fistula, anti-incontinence techniques
5121315|NCT03236896|Menopause|menopause
5121316|NCT03236896|Hot Flash|hot flash
5121317|NCT03236896|MENQOL|menqol
5121318|NCT03236896|Mobile exercise device|mobile exercise device
5121319|NCT03236870|psoriasis|psoriasis
5121320|NCT03236870|effectiveness|effectiveness
5121321|NCT03236870|safety|safety
5121322|NCT03236870|adalimumab|adalimumab
5121323|NCT03236857|Cancer|cancer
5962013|NCT04283526|primary myelofibrosis|primary myelofibrosis
5121324|NCT03236857|Venetoclax|venetoclax
5121325|NCT03236857|pediatric|pediatric
5673412|NCT00608335|Antifungal|antifungal
5121326|NCT03236857|relapsed or refractory|relapsed or refractory
5121327|NCT03236831|Ventricular Assist Device|ventricular assist device
5121328|NCT03236818|pulmonary arterial hypertension|pulmonary arterial hypertension
5121329|NCT03236818|right ventricle|right ventricle
5121330|NCT03236818|MRI|mri
5121331|NCT03236818|medical combination therapy|medical combination therapy
5121332|NCT03236805|Morphine|morphine
5121333|NCT03236805|Ketamine|ketamine
5121334|NCT03236805|Acute pain|acute pain
5121335|NCT03236805|prehospital|prehospital
5121336|NCT03236792|Newly Diagnosed|newly diagnosed
5121337|NCT03236792|AL Amyloidosis|al amyloidosis
5121338|NCT03236792|Amyloid|amyloid
5121339|NCT03236792|Light chain Amyloidosis|light chain amyloidosis
5121340|NCT03236753|Thread-Embedding Acupuncture|thread-embedding acupuncture
5121341|NCT03236753|Herniated Intervertebral Disc of Lumbar Spine|herniated intervertebral disc of lumbar spine
5121342|NCT03236753|Low Back Pain|low back pain
5121343|NCT03236753|Radiculopathy|radiculopathy
5121344|NCT03236727|Dexmedetomidine, spinal fusion, SSEP|dexmedetomidine, spinal fusion, ssep
5121345|NCT03236701|hyperphosphatemia|hyperphosphatemia
5121346|NCT03236701|hemodialysis|hemodialysis
5121347|NCT03236701|dietary treatment|dietary treatment
5121348|NCT03236701|egg white|egg white
5121349|NCT03236701|protein energy wasting|protein energy wasting
5121350|NCT03236662|BMD|bmd
5121351|NCT03236662|Becker muscular dystrophy|becker muscular dystrophy
5121352|NCT03236662|epicatechin|epicatechin
5121353|NCT03236662|clinical trial|clinical trial
5121354|NCT03236662|neuromuscular disease|neuromuscular disease
5121355|NCT03236623|Surgical Patient|surgical patient
5121356|NCT03236623|Menthol|menthol
5121357|NCT03236623|Clinical Study|clinical study
5121358|NCT03236571|Marfan syndrome|marfan syndrome
5121359|NCT03236571|Personal Training Program|personal training program
5121360|NCT03236571|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
5121361|NCT03236571|Muscular rehabilitation|muscular rehabilitation
5121362|NCT03236558|Type 1 diabetes|type 1 diabetes
5121363|NCT03236558|Juvenile diabetes|juvenile diabetes
5121364|NCT03236558|Immune-tolerance|immune-tolerance
5121365|NCT03236558|Regulatory T lymphocyte|regulatory t lymphocyte
5121366|NCT03236558|Treg|treg
5121367|NCT03236558|TCR|tcr
5121368|NCT03236558|Repertoire|repertoire
5121369|NCT03236532|HIV/AIDS; Resistance training, supplementation|hiv/aids; resistance training, supplementation
5121370|NCT03236506|Illicit drug|illicit drug
5121371|NCT03236506|Injecting drug|injecting drug
5121372|NCT03236467|Fibromyalgia and PTSD|fibromyalgia and ptsd
5121373|NCT03236454|brain stimulation|brain stimulation
5121374|NCT03236454|cognitive training|cognitive training
5121376|NCT03236454|treatment|treatment
5121377|NCT03236441|remote ischemic conditioning|remote ischemic conditioning
5121378|NCT03236441|contrast-induced nephropathy|contrast-induced nephropathy
5121379|NCT03236441|cardiac catheterization|cardiac catheterization
5121380|NCT03236441|coronary artery disease|coronary artery disease
5121381|NCT03236428|Smoldering Multiple Myeloma|smoldering multiple myeloma
5121382|NCT03236428|Monoclonal Gammopathy|monoclonal gammopathy
5121383|NCT03236402|Knowledge|knowledge
5121385|NCT03236402|Adoption|adoption
5121386|NCT03236402|Adults|adults
5121387|NCT03236402|Cross-Sectional|cross-sectional
5121388|NCT03236376|upper limb|upper limb
5121389|NCT03236376|somatosensory impairments|somatosensory impairments
5121390|NCT03236376|motor impairments|motor impairments
5121391|NCT03236376|brain imaging|brain imaging
5121392|NCT03236363|Physical activity|physical activity
5121393|NCT03236363|Obesity|obesity
5121394|NCT03236363|Children|children
5121395|NCT03236363|Cognitive function|cognitive function
5121396|NCT03236363|Academic achievement|academic achievement
5121399|NCT03236363|Cardiovascular fitness|cardiovascular fitness
5121400|NCT03236363|Aerobic capacity|aerobic capacity
5121401|NCT03236350|Chronic Kidney Disease|chronic kidney disease
5121402|NCT03236350|Hypertension|hypertension
5121403|NCT03236350|Cardiovascular Disease|cardiovascular disease
5121404|NCT03236350|Central Aortic Systolic Pressure|central aortic systolic pressure
5121405|NCT03236350|Proteinuria|proteinuria
5121406|NCT03236350|Remote Ischemic Conditioning|remote ischemic conditioning
5121407|NCT03236350|Left Ventricular Hypertrophy|left ventricular hypertrophy
5121408|NCT03236337|Physical activity|physical activity
5121409|NCT03236337|Obesity|obesity
5121410|NCT03236337|Children|children
5121411|NCT03236337|Cognitive function|cognitive function
5121412|NCT03236337|Academic achievement|academic achievement
5121413|NCT03236337|Cardiorespiratory fitness|cardiorespiratory fitness
5121414|NCT03236337|Adiposity|adiposity
5121415|NCT03236337|Cardiovascular fitness|cardiovascular fitness
5121416|NCT03236337|Atherosclerosis|atherosclerosis
5121417|NCT03236337|Aerobic capacity|aerobic capacity
5121418|NCT03236298|Epidural|epidural
5121419|NCT03236298|Labor analgesia|labor analgesia
5121420|NCT03236298|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5121421|NCT03236285|Obesity|obesity
5121422|NCT03236285|Microcirculation|microcirculation
5121423|NCT03236285|Endothelial function|endothelial function
5186685|NCT02823366|PBC|pbc
5121424|NCT03236285|Laser speckle imaging|laser speckle imaging
4993145|NCT04036422|stroke|stroke
5121425|NCT03236285|Capillary density|capillary density
5121426|NCT03236272|Biomarkers|biomarkers
5121427|NCT03236272|High-Throughput Screening Assays|high-throughput screening assays
5121428|NCT03236272|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5121429|NCT03236220|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5121430|NCT03236220|poor graft function|poor graft function
5121431|NCT03236220|prolonged isolated thrombocytopenia|prolonged isolated thrombocytopenia
5121432|NCT03236220|bone marrow endothelial cells|bone marrow endothelial cells
5121433|NCT03236220|N-acetyl-L-cysteine|n-acetyl-l-cysteine
5121434|NCT03236220|Acute leukemia|acute leukemia
5121435|NCT03236181|Energy Expenditure|energy expenditure
5121436|NCT03236181|Appetite|appetite
5121437|NCT03236181|Satiety|satiety
5121438|NCT03236155|Opioids|opioids
5121439|NCT03236142|bariatric|bariatric
5121440|NCT03236142|duodenal switch|duodenal switch
5121442|NCT03236142|weight loss surgery|weight loss surgery
5121443|NCT03236142|SIPS|sips
5121444|NCT03236142|Single Anastomosis|single anastomosis
5121445|NCT03236129|DLI|dli
5121446|NCT03236129|Regulatory T cells depletion|regulatory t cells depletion
5121447|NCT03236129|Hematological malignancies|hematological malignancies
5121448|NCT03236129|Relapse|relapse
5121449|NCT03236103|Ventricular assist device|ventricular assist device
5121450|NCT03236090|Cirrhosis|cirrhosis
5121451|NCT03236090|Probiotics|probiotics
5121452|NCT03236090|Systemic inflammation|systemic inflammation
5121453|NCT03236090|neuroinflammation|neuroinflammation
5121454|NCT03236090|Cognitive function|cognitive function
5121455|NCT03236090|Bacterial translocation|bacterial translocation
5121456|NCT03236077|obesity, women, exercise, physical activity,|obesity, women, exercise, physical activity,
5121457|NCT03236051|gastric cancer|gastric cancer
5121458|NCT03236051|gastrectomy|gastrectomy
5121459|NCT03236051|multimodal analgesia|multimodal analgesia
5121460|NCT03236051|parecoxib|parecoxib
5121461|NCT03236038|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5121462|NCT03236038|liver cirrhosis|liver cirrhosis
5121463|NCT03236038|decompensated cirrhosis|decompensated cirrhosis
5121465|NCT03236038|prevalence|prevalence
5121466|NCT03236025|smoking cessation|smoking cessation
5121467|NCT03236025|video|video
5121468|NCT03236025|male smoker|male smoker
5121469|NCT03236012|amputation, amputations, sweating, residual limb,|amputation, amputations, sweating, residual limb,
5121470|NCT03235986|RDS|rds
5121471|NCT03235973|refractory acute leukemia|refractory acute leukemia
5118354|NCT03255941|Sayana|sayana
5121477|NCT03235947|Urinary tract infection|urinary tract infection
5121478|NCT03235947|Asymptomatic bacteriuria|asymptomatic bacteriuria
5121480|NCT03235921|hemorrhagic shock|hemorrhagic shock
5121481|NCT03235921|perfusion index|perfusion index
5121482|NCT03235921|lactate|lactate
5121483|NCT03235921|nitroglycerin|nitroglycerin
5121484|NCT03235908|Copeptin|copeptin
5121485|NCT03235908|Outcome prediction|outcome prediction
5121486|NCT03235882|Lung surfactant|lung surfactant
5121487|NCT03235882|Mid-infrared spectroscopy|mid-infrared spectroscopy
5121488|NCT03235882|Prematurity|prematurity
5121489|NCT03235882|Respiratory distress syndrome|respiratory distress syndrome
5121491|NCT03235843|Chronotropic Incompetence|chronotropic incompetence
5121492|NCT03235843|Rate Adaptive Pacing|rate adaptive pacing
5121493|NCT03235843|Minute Ventilation Sensor|minute ventilation sensor
5121495|NCT03235843|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5121497|NCT03235843|Exercise Intolerance|exercise intolerance
5121498|NCT03235830|Healthcare utilization|healthcare utilization
5121500|NCT03235817|Proseal™ LMA|proseal™ lma
5121501|NCT03235817|infants|infants
5121502|NCT03235817|ventilation|ventilation
5121503|NCT03235817|general anesthesia|general anesthesia
5121504|NCT03235817|outpatient surgery|outpatient surgery
5121505|NCT03235804|High-protein diet|high-protein diet
5121506|NCT03235804|Inflammation|inflammation
5121507|NCT03235804|Gut microbiota|gut microbiota
5121508|NCT03235804|Energy metabolism|energy metabolism
5121509|NCT03235804|Body composition|body composition
5121510|NCT03235778|Tolerance; Pharmacokinetic characteristics|tolerance; pharmacokinetic characteristics
5121511|NCT03235765|NSCLC|nsclc
5121512|NCT03235765|Cancer panel|cancer panel
5121513|NCT03235765|NGS|ngs
5121514|NCT03235765|Actionable mutation|actionable mutation
5121515|NCT03235765|Immune checkpoint inhibitor|immune checkpoint inhibitor
5121516|NCT03235752|Randomized|randomized
5121517|NCT03235752|Double-blind|double-blind
5121518|NCT03235752|Placebo-controlled|placebo-controlled
5121519|NCT03235752|Safety|safety
5121520|NCT03235752|Efficacy|efficacy
5962014|NCT04283526|Myelofibrosis (PMF)|myelofibrosis (pmf)
5121521|NCT03235752|Active Ulcerative Colitis|active ulcerative colitis
5121522|NCT03235726|bystander|bystander
5121523|NCT03235726|inhalation powder|inhalation powder
5121524|NCT03235726|monodose device|monodose device
5121525|NCT03235726|COPD|copd
5121526|NCT03235726|pharmacokinetics|pharmacokinetics
5121527|NCT03235726|safety|safety
5121528|NCT03235726|Healthy|healthy
5121529|NCT03235726|CCI15106|cci15106
5121530|NCT03235726|tolerability|tolerability
5121531|NCT03235713|Ecological momentary assessments|ecological momentary assessments
5121532|NCT03235700|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5121533|NCT03235700|intermediate coronary stenosis|intermediate coronary stenosis
5121534|NCT03235700|adenosine|adenosine
5121535|NCT03235700|hyperemia|hyperemia
5121538|NCT03235635|microbiome|microbiome
5121539|NCT03235635|preterm|preterm
5121540|NCT03235635|newborn|newborn
5121541|NCT03235635|gut microbiome|gut microbiome
5121542|NCT03235635|allergic predisposition|allergic predisposition
5121543|NCT03235596|executive functions|executive functions
5121544|NCT03235596|tDCS|tdcs
5121545|NCT03235583|Energy expenditure|energy expenditure
5121546|NCT03235583|physical activity|physical activity
5121547|NCT03235583|accelerometer|accelerometer
5121548|NCT03235583|magnetometer|magnetometer
5121549|NCT03235583|monitoring|monitoring
5121550|NCT03235583|free-living conditions|free-living conditions
5121551|NCT03235583|doubly labelled water|doubly labelled water
5121552|NCT03235570|Solid tumor|solid tumor
5121553|NCT03235570|malignancy|malignancy
5121554|NCT03235570|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5121555|NCT03235570|fibroblast growth factor (FGF)/FGFR alteration|fibroblast growth factor (fgf)/fgfr alteration
5121556|NCT03235557|prostate|prostate
5121557|NCT03235557|cancer|cancer
5121558|NCT03235557|radiation|radiation
5121559|NCT03235557|stereotactic|stereotactic
5121560|NCT03235557|CyberKnife|cyberknife
5121561|NCT03235557|elderly|elderly
5121562|NCT03235544|Mantle cell lymphoma|mantle cell lymphoma
5121563|NCT03235544|non-Hodgkin lymphoma|non-hodgkin lymphoma
5121564|NCT03235544|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
5121565|NCT03235544|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5121566|NCT03235531|alcohol withdrawal syndrome|alcohol withdrawal syndrome
5121567|NCT03235531|trauma|trauma
5121568|NCT03235531|alcohol use disorder|alcohol use disorder
5121569|NCT03235531|alcohol|alcohol
5121570|NCT03235531|lorazepam|lorazepam
5121571|NCT03235531|benzodiazepine|benzodiazepine
5121572|NCT03235531|valproate|valproate
5121573|NCT03235518|HIV Prevention|hiv prevention
5121574|NCT03235518|Female sex workers|female sex workers
5121575|NCT03235505|Smoking Cessation|smoking cessation
5121576|NCT03235505|Electronic cigarette|electronic cigarette
5121577|NCT03235505|Adults|adults
5121578|NCT03235492|diabetes|diabetes
5121579|NCT03235492|salivary glycated albumin|salivary glycated albumin
5121580|NCT03235492|HbA1c|hba1c
5121581|NCT03235453|Parkinson|parkinson
5121582|NCT03235453|Quality of Life|quality of life
5121583|NCT03235453|Sleep Disorder|sleep disorder
5121584|NCT03235453|Gait Disorders|gait disorders
5121585|NCT03235453|Mobility|mobility
5121586|NCT03235427|Coronary|coronary
5121587|NCT03235427|Coronary Disease|coronary disease
5121588|NCT03235427|Coronary Arteriosclerosis|coronary arteriosclerosis
5121589|NCT03235427|Heart Disease|heart disease
5121590|NCT03235427|Cardiotoxicity|cardiotoxicity
5121591|NCT03235427|Breast Cancer|breast cancer
5121592|NCT03235427|Carcinoma|carcinoma
5121615|NCT03235401|patient-reported outcome measure|patient-reported outcome measure
5121616|NCT03235401|New York Heart Association (NYHA) functional class|new york heart association (nyha) functional class
5121622|NCT03235375|Kidney Failure, Kidney Insufficiency, Renal Failure, Renal Insufficiency, MEDI0382|kidney failure, kidney insufficiency, renal failure, renal insufficiency, medi0382
5121623|NCT03235349|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
5121624|NCT03235349|Genotype 1 to 6|genotype 1 to 6
5121625|NCT03235349|Cirrhosis|cirrhosis
5121626|NCT03235349|Compensated Cirrhosis|compensated cirrhosis
5121627|NCT03235349|Human Immunodeficiency Virus|human immunodeficiency virus
5121628|NCT03235349|co-infection|co-infection
5121629|NCT03235349|Treatment-naïve|treatment-naïve
5121630|NCT03235349|treatment-experienced|treatment-experienced
5121631|NCT03235349|interferon|interferon
5121632|NCT03235349|Asian|asian
5121633|NCT03235323|Vein Graft Failure|vein graft failure
5121634|NCT03235323|Coronary Artery Bypass|coronary artery bypass
5121635|NCT03235323|External Counterpulsation|external counterpulsation
5121637|NCT03235310|Pregnancy|pregnancy
5121638|NCT03235310|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
5121639|NCT03235297|Altitude|altitude
5121640|NCT03235297|Diffusing capacity for carbon monoxide|diffusing capacity for carbon monoxide
5121641|NCT03235297|COPD|copd
5121642|NCT03235297|Pulmonary function testing|pulmonary function testing
5121643|NCT03235284|Parkinson's Disease ande Video Games|parkinson's disease ande video games
5121644|NCT03235258|HIV Infection|hiv infection
5121645|NCT03235258|Adolescent|adolescent
5121649|NCT03235206|Police Officers|police officers
5121650|NCT03235154|HCV|hcv
5121651|NCT03235154|suboxone|suboxone
5121652|NCT03235154|epclusa|epclusa
5121653|NCT03235154|psychiatrist|psychiatrist
5121654|NCT03235141|Azithromycin eye drops|azithromycin eye drops
5121655|NCT03235141|Local Pharmacokinetics|local pharmacokinetics
5121656|NCT03235063|Dilated cardiomyopathy|dilated cardiomyopathy
5121658|NCT03235063|heart failure|heart failure
5121659|NCT03235063|pregnancy|pregnancy
5121660|NCT03234959|Early Intervention|early intervention
5121661|NCT03234959|Cerebral Palsy|cerebral palsy
5121662|NCT03234959|CareToy Intervention|caretoy intervention
5121663|NCT03234959|Infant Massage|infant massage
5121664|NCT03234959|Information Communication Technology|information communication technology
5121665|NCT03234946|Diabetes|diabetes
5121666|NCT03234946|Family|family
5121667|NCT03234946|Impaired fasting-glucose|impaired fasting-glucose
5121668|NCT03234946|Carbohydrate intolerance|carbohydrate intolerance
5121669|NCT03234933|Cancer|cancer
5121670|NCT03234920|cirrhosis|cirrhosis
5121671|NCT03234920|liver transplantation|liver transplantation
5121672|NCT03234920|HMB|hmb
5121673|NCT03234907|Drug therapy|drug therapy
5121674|NCT03234881|Binge Eating|binge eating
5121675|NCT03234881|Cognitive Behavioral Therapy|cognitive behavioral therapy
5121676|NCT03234881|Weight Management|weight management
5121677|NCT03234881|Veterans|veterans
5121678|NCT03234842|Esophagus|esophagus
5121679|NCT03234842|Proton|proton
5121680|NCT03234842|Radiation|radiation
5445339|NCT01522261|Mechanical Bowel Prep|mechanical bowel prep
5121681|NCT03234829|arch lengths, space analysis, arch prediction|arch lengths, space analysis, arch prediction
5131593|NCT03171220|SHR1210|shr1210
5121682|NCT03234790|Diesel Exhaust|diesel exhaust
5121683|NCT03234790|Air Pollution|air pollution
5121684|NCT03234790|Airway Responsiveness|airway responsiveness
5121685|NCT03234790|Proteomics|proteomics
5121686|NCT03234790|Urine PAH Metabolites|urine pah metabolites
5121687|NCT03234764|IgE|ige
5121688|NCT03234764|Allergy|allergy
5121689|NCT03234764|Tolerance|tolerance
5121690|NCT03234764|Immunotherapy|immunotherapy
5121691|NCT03234764|Desensitization|desensitization
5121692|NCT03234751|human B-type natriuretic peptide|human b-type natriuretic peptide
5121693|NCT03234725|Blue light imaging|blue light imaging
5121694|NCT03234725|Linked color imaging|linked color imaging
5121695|NCT03234725|Optical histology|optical histology
5121696|NCT03234725|Adenoma detection rate|adenoma detection rate
5121697|NCT03234725|Variable stiffness|variable stiffness
5121698|NCT03234725|Deep learning|deep learning
5121699|NCT03234712|Advanced Solid Tumors|advanced solid tumors
5121700|NCT03234712|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5121701|NCT03234712|Squamous cell carcinoma of the head and neck (HNSCC)|squamous cell carcinoma of the head and neck (hnscc)
5121702|NCT03234712|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5121703|NCT03234712|Glioblastoma (GBM)|glioblastoma (gbm)
5121705|NCT03234712|overexpression of Epidermal Growth Factor Receptor (EGFR)|overexpression of epidermal growth factor receptor (egfr)
5121706|NCT03234686|Dementia|dementia
5121707|NCT03234686|Alzheimer's Disease|alzheimer's disease
5121708|NCT03234621|protective ventilation strategy|protective ventilation strategy
5121709|NCT03234608|Healthcare services|healthcare services
5121710|NCT03234608|Adults|adults
5121711|NCT03234595|Cerebraca wafer|cerebraca wafer
5121712|NCT03234595|Recurrent high grade glioma|recurrent high grade glioma
5121713|NCT03234595|anaplastic astrocytoma|anaplastic astrocytoma
5121714|NCT03234595|glioblastoma multiforme|glioblastoma multiforme
5121715|NCT03234569|sonohysterosalpingography|sonohysterosalpingography
5121716|NCT03234569|hysterosalpingography|hysterosalpingography
5121717|NCT03234543|Abdominal Surgery|abdominal surgery
5121718|NCT03234543|Pre-conditioning|pre-conditioning
5121719|NCT03234543|Remote Ischemic Conditioning|remote ischemic conditioning
5121720|NCT03234543|Post-Operative Complications|post-operative complications
5121721|NCT03234543|Acute Phase Response|acute phase response
5121722|NCT03234530|albuminuria|albuminuria
5121723|NCT03234530|sleep apnea|sleep apnea
5121724|NCT03234530|particulate matter|particulate matter
5121725|NCT03234530|renal injury|renal injury
5121726|NCT03234491|Diabetes|diabetes
5121727|NCT03234491|Insulin|insulin
5121728|NCT03234478|deep brain stimulation|deep brain stimulation
5121729|NCT03234478|cognition|cognition
5121730|NCT03234478|young onset Parkinson disease|young onset parkinson disease
5121731|NCT03234452|Lactoflorene plus|lactoflorene plus
5121732|NCT03234452|Bifidobacterium animalis subsp. lactis, BB-12®|bifidobacterium animalis subsp. lactis, bb-12®
5121733|NCT03234452|Lactobacillus acidophilus, LA-5®|lactobacillus acidophilus, la-5®
5121734|NCT03234452|Lactobacillus paracasei subsp. paracasei, L. CASEI 431®|lactobacillus paracasei subsp. paracasei, l. casei 431®
5121735|NCT03234452|Inflammation|inflammation
5121736|NCT03234452|gut permeability|gut permeability
5121737|NCT03234452|disbiosis|disbiosis
5121738|NCT03234452|probiotic|probiotic
5121740|NCT03234452|IL10|il10
5121741|NCT03234439|digital behavioral health|digital behavioral health
5121742|NCT03234413|Botulinum Toxin-A|botulinum toxin-a
5121743|NCT03234374|Pharmacokinetics|pharmacokinetics
5121744|NCT03234374|Bioavailability|bioavailability
5121745|NCT03234374|Safety|safety
5121746|NCT03234374|Bupivacaine|bupivacaine
5121747|NCT03234374|Collagen|collagen
5121748|NCT03234374|Implant|implant
5121749|NCT03234374|Marcaine|marcaine
5121750|NCT03234374|Hernioplasty|hernioplasty
5121751|NCT03234361|Hypertension|hypertension
5121752|NCT03234361|High phosphorus diet|high phosphorus diet
5121753|NCT03234361|FGF 23|fgf 23
5121754|NCT03234361|24 hour ambulatory blood pressure|24 hour ambulatory blood pressure
5121755|NCT03234361|Muscle sympathetic nerve|muscle sympathetic nerve
5121756|NCT03234348|biodegradable stent|biodegradable stent
5121757|NCT03234348|STEMI|stemi
5121758|NCT03234348|Magnesium bioresorbable|magnesium bioresorbable
5121759|NCT03234348|Vasomotion|vasomotion
5121760|NCT03234335|Multiple Myeloma|multiple myeloma
5121761|NCT03234335|Renal Failure|renal failure
5121762|NCT03234335|Autologous Hematopoietic Stem Cell Transplantation (ASCT)|autologous hematopoietic stem cell transplantation (asct)
5121763|NCT03234335|Melphalan|melphalan
5121764|NCT03234322|prevention|prevention
5121765|NCT03234322|risk score|risk score
5121766|NCT03234322|behaviour|behaviour
5121767|NCT03234322|physical activity|physical activity
5121768|NCT03234296|uncomplicated acute appendicitis|uncomplicated acute appendicitis
5121769|NCT03234296|complicated acute appendicitis|complicated acute appendicitis
5121770|NCT03234296|antibiotic therapy|antibiotic therapy
5121771|NCT03234296|spontaneous resolution|spontaneous resolution
5121772|NCT03234283|Intubation|intubation
5121773|NCT03234270|Heat stress, pilots|heat stress, pilots
5445341|NCT01522248|cytokines|cytokines
5121774|NCT03234257|Carotid stenosis|carotid stenosis
5121775|NCT03234257|stiffness|stiffness
5121776|NCT03234257|ultrafast ultrasound imaging|ultrafast ultrasound imaging
5121778|NCT03234218|vitamin D, liver transplantation|vitamin d, liver transplantation
5121779|NCT03234192|extensor carpi radialis brevis|extensor carpi radialis brevis
5121780|NCT03234192|Therapeutic Ultrasound|therapeutic ultrasound
5121781|NCT03234192|Astym Treatment Technique|astym treatment technique
5121782|NCT03234192|Graston Treatment Technique|graston treatment technique
5121783|NCT03234179|Non small cell lung cancer|non small cell lung cancer
5121784|NCT03234179|Genetic study|genetic study
5121877|NCT03233802|Alcohol Use Disorder|alcohol use disorder
5121785|NCT03234166|Acute necrotizing pancreatitis Acute pancreatitis Pancreas disease Sepsis Infection Drainage Catheters Antibiotics Multiresistant organism|acute necrotizing pancreatitis acute pancreatitis pancreas disease sepsis infection drainage catheters antibiotics multiresistant organism
5121786|NCT03234153|Muscle-invasive Bladder Cancer|muscle-invasive bladder cancer
5121787|NCT03234153|Ineligible for Cisplatin-based Chemotherapy|ineligible for cisplatin-based chemotherapy
5121789|NCT03234153|Tremelimumab|tremelimumab
5121790|NCT03234114|new generation drug eluting stent (DES)|new generation drug eluting stent (des)
5121791|NCT03234114|antithrombotic therapy|antithrombotic therapy
5121792|NCT03234114|randomized clinical trial (RCT)|randomized clinical trial (rct)
5121793|NCT03234101|Systematic review and meta-analysis|systematic review and meta-analysis
5121794|NCT03234101|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5121795|NCT03234101|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5121796|NCT03234101|Clinical practice guidelines|clinical practice guidelines
5121797|NCT03234101|Prospective cohort studies|prospective cohort studies
5121798|NCT03234101|Low-risk lifestyle behaviours|low-risk lifestyle behaviours
5121799|NCT03234101|Healthy Diet|healthy diet
5121800|NCT03234101|Exercise|exercise
5121801|NCT03234101|Physical activity|physical activity
5121802|NCT03234101|Body weight|body weight
5121803|NCT03234101|Sleep|sleep
5121804|NCT03234101|alcohol|alcohol
5121805|NCT03234101|Smoking|smoking
5121806|NCT03234101|Cardiovascular disease|cardiovascular disease
5121807|NCT03234101|Coronary heart disease|coronary heart disease
5121808|NCT03234101|Stroke|stroke
5121809|NCT03234101|Diabetes|diabetes
5121810|NCT03234101|Cancer|cancer
5121811|NCT03234101|Cardiovascular disease mortality|cardiovascular disease mortality
5673413|NCT00608335|Micafungin|micafungin
5121812|NCT03234101|Coronary heart disease mortality|coronary heart disease mortality
5121813|NCT03234101|Stroke mortality|stroke mortality
5121814|NCT03234101|All-cause mortality|all-cause mortality
5121815|NCT03234088|Congestive Heart Failure|congestive heart failure
5121816|NCT03234088|Heart Failure|heart failure
5121817|NCT03234088|Home telemonitoring|home telemonitoring
5121818|NCT03234088|Telehealth|telehealth
5121819|NCT03234088|HF Disease Management|hf disease management
5121820|NCT03234088|Heart failure remote self management|heart failure remote self management
5121821|NCT03234049|pediatric|pediatric
5121822|NCT03234049|checklist|checklist
5121823|NCT03234049|cognitive aid|cognitive aid
5121824|NCT03234036|GSK2838232|gsk2838232
5121825|NCT03234036|safety|safety
5121826|NCT03234036|food effect|food effect
5121827|NCT03234036|capsule|capsule
5121828|NCT03234036|healthy|healthy
5121830|NCT03234036|tablet|tablet
5121831|NCT03233984|bisphenol-A|bisphenol-a
5121832|NCT03233984|prevention|prevention
5121833|NCT03233984|endocrine disruptors|endocrine disruptors
5121834|NCT03233932|CKD-841|ckd-841
5121835|NCT03233932|Leuplin|leuplin
5121836|NCT03233932|Postmenopausal|postmenopausal
5121837|NCT03233919|Remote Ischemic Conditioning|remote ischemic conditioning
5121838|NCT03233893|based dentin substitute|based dentin substitute
5121839|NCT03233893|dentin bridge|dentin bridge
5121840|NCT03233893|tertiary dentin|tertiary dentin
5121841|NCT03233893|indirect pulp treatment|indirect pulp treatment
5121842|NCT03233880|chlamydia|chlamydia
5121843|NCT03233880|prevention|prevention
4993592|NCT04034004|Mindfulness|mindfulness
5121844|NCT03233841|Natural History Study|natural history study
5121845|NCT03233841|Observational Study|observational study
5121846|NCT03233841|Prospective Study|prospective study
5121847|NCT03233841|Retrospective Study|retrospective study
5121848|NCT03233841|Farber Disease|farber disease
5121849|NCT03233841|Farber's Disease|farber's disease
5121850|NCT03233841|ASAH1|asah1
5121851|NCT03233841|Subcutaneous Nodules|subcutaneous nodules
5121852|NCT03233841|Lysosomal Storage Disease|lysosomal storage disease
5121853|NCT03233841|Lysosomal Storage Disease, Nervous System|lysosomal storage disease, nervous system
5121854|NCT03233841|Metabolic Diseases|metabolic diseases
5121855|NCT03233841|Lipid Metabolism Disorders|lipid metabolism disorders
5121856|NCT03233841|Lipidoses|lipidoses
5121857|NCT03233841|Sphingolipidoses|sphingolipidoses
5121858|NCT03233841|Genetic Disease, Inborn|genetic disease, inborn
5121859|NCT03233841|Musculoskeletal Diseases|musculoskeletal diseases
5121860|NCT03233841|Connective Tissue Diseases|connective tissue diseases
5445342|NCT01522248|chemokines|chemokines
5121861|NCT03233841|Central Nervous System Diseases|central nervous system diseases
5121862|NCT03233841|Brain Diseases, Metabolic, Inborn|brain diseases, metabolic, inborn
5121863|NCT03233841|Brain Diseases, Metabolic|brain diseases, metabolic
5121864|NCT03233841|Brain Diseases, Inborn|brain diseases, inborn
5121865|NCT03233841|Brain Diseases|brain diseases
5121867|NCT03233841|Inborn Errors of Metabolism|inborn errors of metabolism
5121868|NCT03233841|Inherited Metabolic Disease|inherited metabolic disease
5121869|NCT03233828|Intralesional Injection|intralesional injection
5121871|NCT03233828|Immune Response|immune response
5121872|NCT03233828|Interleukin-2 (Aldesleukin)|interleukin-2 (aldesleukin)
5121873|NCT03233828|Tumor Infiltration|tumor infiltration
5121874|NCT03233828|Metastasis Prevention|metastasis prevention
5121875|NCT03233815|Inhaled anesthesia|inhaled anesthesia
5121876|NCT03233815|Total intravenous anesthesia|total intravenous anesthesia
5121884|NCT03233776|Febrile neutropenia|febrile neutropenia
5121885|NCT03233737|local anesthesia|local anesthesia
5121886|NCT03233737|pain tolerance|pain tolerance
5121887|NCT03233737|experimental pain|experimental pain
5121893|NCT03233685|Tennis|tennis
5121894|NCT03233685|Reaction Time|reaction time
5118864|NCT03252886|intubation|intubation
5121897|NCT03233672|hypofractionation|hypofractionation
5121899|NCT03233672|phase I-II|phase i-ii
5121900|NCT03233672|prostate neoplasms|prostate neoplasms
5121901|NCT03233672|radiotherapy|radiotherapy
5121902|NCT03233659|Allogeneic Stem Cell Transplantation, APCs, GVHD|allogeneic stem cell transplantation, apcs, gvhd
5121903|NCT03233646|OCT angiography|oct angiography
5121904|NCT03233646|Optical Coherence Tomography|optical coherence tomography
5121905|NCT03233646|Vessel Density|vessel density
5121906|NCT03233646|Superficial Capillary Plexus|superficial capillary plexus
5121907|NCT03233646|retinal microvasculature|retinal microvasculature
5121908|NCT03233646|OCTA|octa
5121909|NCT03233633|pain management|pain management
5121910|NCT03233633|terminally ill|terminally ill
5121911|NCT03233620|knee arthroplasty|knee arthroplasty
5121912|NCT03233620|working-age|working-age
5121913|NCT03233620|patient related outcome measures|patient related outcome measures
5121914|NCT03233607|Postpartum|postpartum
5121915|NCT03233607|Hemoglobin|hemoglobin
5121916|NCT03233594|Chronic Pain Syndrome|chronic pain syndrome
5121917|NCT03233594|Chronic Pain|chronic pain
5121918|NCT03233594|Chiropractic|chiropractic
5121920|NCT03233594|MRI|mri
5121921|NCT03233594|Positron emission tomography|positron emission tomography
5121922|NCT03233594|Magnetic resonance imaging|magnetic resonance imaging
5121923|NCT03233542|Cognitive biases|cognitive biases
5121924|NCT03233542|Associations|associations
5121925|NCT03233542|Interpretations|interpretations
5121926|NCT03233542|Physiological and biological markers|physiological and biological markers
5121927|NCT03233529|atopic dermatitis|atopic dermatitis
5121928|NCT03233529|atopic eczema|atopic eczema
5121929|NCT03233529|eczema|eczema
5121930|NCT03233529|topical treatment|topical treatment
5121931|NCT03233529|skin diseases|skin diseases
5121932|NCT03233529|phosphodiesterase-4 inhibitor|phosphodiesterase-4 inhibitor
5121933|NCT03233529|PDE-4 inhibitor|pde-4 inhibitor
5121934|NCT03233529|crisaborole|crisaborole
5121935|NCT03233516|Community-acquired pneumonia|community-acquired pneumonia
5121936|NCT03233516|Pediatrics|pediatrics
5121937|NCT03233516|Etiology|etiology
5121938|NCT03233516|Point-of-care test|point-of-care test
5121940|NCT03233516|CRP|crp
5121941|NCT03233516|Procalcitonin|procalcitonin
5121942|NCT03233516|Infectious diseases|infectious diseases
5121943|NCT03233516|Respiratory viruses|respiratory viruses
5121944|NCT03233516|Pediatric asthma|pediatric asthma
5121945|NCT03233490|CPR training|cpr training
5121946|NCT03233490|students|students
5121947|NCT03233490|willingness|willingness
5121948|NCT03233477|Posner Schlossman Syndrome|posner schlossman syndrome
5121949|NCT03233477|cytokine expression|cytokine expression
5121950|NCT03233477|cytomegalovirus|cytomegalovirus
5121951|NCT03233438|Critical Pathways|critical pathways
5121952|NCT03233438|Health Facilities|health facilities
5121953|NCT03233438|Clinical Protocols|clinical protocols
5962015|NCT04283526|Post-Polycythemia Vera Myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
5121954|NCT03233438|Patient Satisfaction|patient satisfaction
5121955|NCT03233438|Absenteeism|absenteeism
5121956|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents
5121957|NCT03233438|Quality of Life|quality of life
5121958|NCT03233438|Economics, Medical|economics, medical
5121959|NCT03233438|Health Resources|health resources
5121960|NCT03233438|Health resource utilization|health resource utilization
5121961|NCT03233438|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
5121962|NCT03233425|Child|child
5121963|NCT03233425|adolescent|adolescent
5121964|NCT03233425|co-morbidity|co-morbidity
5121965|NCT03233425|psychology|psychology
5121966|NCT03233425|motivation|motivation
5121967|NCT03233425|physical activity|physical activity
5121968|NCT03233425|eating disorders|eating disorders
5121969|NCT03233425|quality of life|quality of life
5121970|NCT03233425|therapy|therapy
5121971|NCT03233425|predictors|predictors
5121972|NCT03233412|high grade cervical intraepithelial neoplasia|high grade cervical intraepithelial neoplasia
5121973|NCT03233412|Immunomodulatory treatment|immunomodulatory treatment
5121974|NCT03233399|Electroencephalography|electroencephalography
5121980|NCT03233373|Computer-Assisted Image Processing|computer-assisted image processing
5121981|NCT03233373|Thermal Analysis, Differential|thermal analysis, differential
5121982|NCT03233321|Dry cold application|dry cold application
5121984|NCT03233321|Bruise|bruise
5121985|NCT03233321|Subcutaneous injection|subcutaneous injection
5121986|NCT03233308|Aqueous Humor Dynamics|aqueous humor dynamics
5121987|NCT03233308|Trabecular Outflow|trabecular outflow
5121988|NCT03233308|Netarsudil|netarsudil
5121989|NCT03233243|Rosuvastatin|rosuvastatin
5121990|NCT03233243|Sodium fluoride|sodium fluoride
5121991|NCT03233243|Positron-emission tomography|positron-emission tomography
5121992|NCT03233230|Rheumatoid Arthritis|rheumatoid arthritis
5121993|NCT03233230|American College of Rheumatology|american college of rheumatology
5121994|NCT03233230|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
5121995|NCT03233230|Bruton's tyrosine kinase|bruton's tyrosine kinase
5121996|NCT03233217|Influenza|influenza
5122005|NCT03233152|recurrence|recurrence
5122006|NCT03233139|Japanese patients|japanese patients
5122007|NCT03233113|Exposure therapy|exposure therapy
5122008|NCT03233113|Cognitive-behavioral therapy|cognitive-behavioral therapy
5122009|NCT03233113|Anxiety disorders|anxiety disorders
5122010|NCT03233100|FMT|fmt
5122011|NCT03233100|gut microbiota|gut microbiota
5122012|NCT03233100|gut-brain disorder|gut-brain disorder
5122013|NCT03233100|constipation|constipation
5122014|NCT03233100|depression|depression
5122015|NCT03233100|anxiety|anxiety
5122016|NCT03233074|Myelodysplastic Syndromes|myelodysplastic syndromes
5122017|NCT03233074|Acute Myeloid Leukemia|acute myeloid leukemia
5122018|NCT03233074|Bone Marrow|bone marrow
5122019|NCT03233074|Mesenchymal stromal cell|mesenchymal stromal cell
5122020|NCT03233074|Healthy donor|healthy donor
5122021|NCT03233061|Obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women|obesity; cardiorespiratory fitness; oxygen uptake; household activities; physical activity; sedentary; intensity; obese women
5122022|NCT03233035|Ketamine-Intranasal-Acute pain-Emergency departement|ketamine-intranasal-acute pain-emergency departement
5122023|NCT03232996|Balance|balance
5122024|NCT03232996|Gait|gait
5122025|NCT03232957|Intrathecal morphine, total knee arthroplasty|intrathecal morphine, total knee arthroplasty
5122026|NCT03232931|auditory|auditory
5122027|NCT03232931|tactile|tactile
5122028|NCT03232931|mother's voice|mother's voice
5122029|NCT03232931|multisensory|multisensory
5122030|NCT03232892|NSCLC|nsclc
5122031|NCT03232892|NF-1 mutant|nf-1 mutant
5122032|NCT03232879|Motor Imagery|motor imagery
5122033|NCT03232879|Action Observation|action observation
5122034|NCT03232879|Heart Rate|heart rate
5122035|NCT03232879|Respiration Rate|respiration rate
5122036|NCT03232879|Electrodermal Activity|electrodermal activity
5122037|NCT03232866|Exercise Movement Techniques|exercise movement techniques
5122038|NCT03232866|Exercise|exercise
5122039|NCT03232866|Monitoring, Physiologic|monitoring, physiologic
5122040|NCT03232866|Heart Rate|heart rate
5122041|NCT03232866|Autonomic Nervous System|autonomic nervous system
5122042|NCT03232866|Heart rate variability|heart rate variability
5122043|NCT03232853|medical error in anesthesia|medical error in anesthesia
5122044|NCT03232853|drug error in anesthesia|drug error in anesthesia
5122045|NCT03232840|wrong site surgery in regional anesthesia|wrong site surgery in regional anesthesia
5122046|NCT03232801|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5122047|NCT03232801|female sexual dysfunction|female sexual dysfunction
5122048|NCT03232801|low libido|low libido
5122049|NCT03232801|female sexual interest-arousal disorder|female sexual interest-arousal disorder
5122050|NCT03232801|low desire|low desire
5122051|NCT03232801|sexual dysfunction|sexual dysfunction
5122052|NCT03232788|Periodontal disease|periodontal disease
5122053|NCT03232788|Recession|recession
5122054|NCT03232788|Black space|black space
5122055|NCT03232775|visual pedagogy|visual pedagogy
5122056|NCT03232723|Magnetoencephalography|magnetoencephalography
5122057|NCT03232723|Whole-cortex MEG System (with optional EEG)|whole-cortex meg system (with optional eeg)
5131983|NCT03168685|clinical trials|clinical trials
5122058|NCT03232580|Suspicion or confirmed diagnosis of Spondyloarthritis|suspicion or confirmed diagnosis of spondyloarthritis
5122059|NCT03232580|Ankylosing Spondylarthritis|ankylosing spondylarthritis
5122060|NCT03232580|Ankylosing Spondylitis|ankylosing spondylitis
5122061|NCT03232580|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
5122062|NCT03232580|Rheumatoid Spondylitis|rheumatoid spondylitis
5122063|NCT03232580|Spondylarthritis Ankylopoietica|spondylarthritis ankylopoietica
5122064|NCT03232580|Spondylitis Ankylopoietica|spondylitis ankylopoietica
5122065|NCT03232580|Spondyloarthritis Ankylopoietica|spondyloarthritis ankylopoietica
5122066|NCT03232580|Autoimmune systemic rheumatic disease|autoimmune systemic rheumatic disease
5122067|NCT03232580|Inflammatory bowel disease|inflammatory bowel disease
5122068|NCT03232580|Psoriatic arthritis|psoriatic arthritis
5122069|NCT03232580|Undifferentiated spondyloarthropathy.|undifferentiated spondyloarthropathy.
5122070|NCT03232554|Iron-Deficiency Anemia|iron-deficiency anemia
5122071|NCT03232554|Buxue Yimu Pills|buxue yimu pills
5122072|NCT03232554|Ferrous Sulfate|ferrous sulfate
5122073|NCT03232554|clinical observations|clinical observations
5122074|NCT03232554|adult women|adult women
5122075|NCT03232554|Metabonomics|metabonomics
5356833|NCT01917812|activity tracker|activity tracker
5122076|NCT03232515|Bioimpedance Vector Analysis (BIVA)|bioimpedance vector analysis (biva)
5118944|NCT03252301|pain|pain
5122077|NCT03232515|Chronic Renal Failure|chronic renal failure
5122079|NCT03232515|Dry weight|dry weight
5122080|NCT03232515|Blood Pressure|blood pressure
5122081|NCT03232437|HbA1c|hba1c
5122082|NCT03232411|prostate disease|prostate disease
5122083|NCT03232411|prostatic neoplasm|prostatic neoplasm
5122085|NCT03232411|prostate cancer in black males|prostate cancer in black males
5122086|NCT03232411|biospecimen|biospecimen
5122087|NCT03232411|smoking and the aggressiveness of prostate cancer|smoking and the aggressiveness of prostate cancer
5122088|NCT03232372|Bone loss, dental implant desing|bone loss, dental implant desing
5122089|NCT03232346|buprenorphine|buprenorphine
5122090|NCT03232346|naltrexone|naltrexone
5122091|NCT03232346|Vivitrol|vivitrol
5122092|NCT03232346|opioid dependence|opioid dependence
5122093|NCT03232294|fetal macrosomia|fetal macrosomia
5122094|NCT03232294|fetal abdominal wall thickness|fetal abdominal wall thickness
5122095|NCT03232294|subcutaneous adipose tissue|subcutaneous adipose tissue
5122096|NCT03232268|Microtransplantation|microtransplantation
5122097|NCT03232268|Myeloid Hemopathy|myeloid hemopathy
5122098|NCT03232203|Human leukocyte antigen|human leukocyte antigen
5122099|NCT03232203|Key Risk Message|key risk message
5122100|NCT03232203|ADA-SCID|ada-scid
5122101|NCT03232203|Health care providers|health care providers
5122102|NCT03232190|prematurity|prematurity
5122103|NCT03232190|psychomotor development|psychomotor development
5122104|NCT03232190|parent empowerment|parent empowerment
5122105|NCT03232190|e-health|e-health
5122106|NCT03232190|parental support|parental support
5122107|NCT03232190|post discharge follow-up|post discharge follow-up
5122108|NCT03232164|Prostate Cancer|prostate cancer
5122109|NCT03232164|Prostate neoplasm|prostate neoplasm
5122110|NCT03232151|Stroke|stroke
5122111|NCT03232138|Sulforaphane|sulforaphane
5122112|NCT03232138|Chemoprevention|chemoprevention
5122113|NCT03232138|Former Smokers|former smokers
5122114|NCT03232112|Alcohol|alcohol
5122115|NCT03232112|Addiction|addiction
5122116|NCT03232112|Glucagon Like Peptide-1|glucagon like peptide-1
5122117|NCT03232112|GLP-1|glp-1
5122118|NCT03232099|trimethylamine-N-oxide|trimethylamine-n-oxide
5122119|NCT03232099|TMAO|tmao
5122120|NCT03232099|Gut Microbiota|gut microbiota
5122121|NCT03232099|Gut Flora|gut flora
5122122|NCT03232099|Atherosclerosis|atherosclerosis
5122123|NCT03232099|Wine|wine
5122124|NCT03232099|Red Wine|red wine
5122125|NCT03232086|Controlled Human Exposure Study|controlled human exposure study
5122126|NCT03232086|Cardiovascular|cardiovascular
5122127|NCT03232047|Computerized, Executive function, memory, cognitive training|computerized, executive function, memory, cognitive training
5122128|NCT03232047|Mild Cognitive Impairment|mild cognitive impairment
5122129|NCT03232034|Calcium citrate, dairy product, whey protein, appetite, metabolism|calcium citrate, dairy product, whey protein, appetite, metabolism
5122130|NCT03232021|urinary bladder|urinary bladder
5122131|NCT03232021|urinary catheters|urinary catheters
5122132|NCT03232021|pregabalin|pregabalin
5122133|NCT03232008|Blood glucose|blood glucose
5122134|NCT03232008|Appetite|appetite
5122135|NCT03231995|Severe influenza|severe influenza
5122136|NCT03231995|biomarkers|biomarkers
5122137|NCT03231995|respiratory microbiome|respiratory microbiome
5122138|NCT03231995|prognosis|prognosis
5122139|NCT03231943|FTIH|ftih
5122140|NCT03231943|Healthy|healthy
5122141|NCT03231943|Tolerability|tolerability
5122142|NCT03231943|Dose-escalation|dose-escalation
5122143|NCT03231943|HIV-1|hiv-1
5122144|NCT03231943|Safety|safety
5122145|NCT03231943|PK|pk
5122146|NCT03231943|GSK3640254|gsk3640254
5122147|NCT03231943|Maturation inhibitor|maturation inhibitor
5122148|NCT03231930|Diagnosis|diagnosis
5122149|NCT03231930|Point of Care Diagnostics|point of care diagnostics
5122150|NCT03231930|Hepatitis|hepatitis
5122151|NCT03231826|Home monitoring|home monitoring
5122152|NCT03231826|ECG|ecg
5122153|NCT03231826|Myocardial Infarction|myocardial infarction
5122154|NCT03231826|Arrythmia|arrythmia
5122160|NCT03231774|Echocardiography|echocardiography
5122161|NCT03231774|Right heart catheterization|right heart catheterization
5122162|NCT03231722|mFOLFOXIRI + Panitumumab|mfolfoxiri + panitumumab
5122163|NCT03231722|RAS and BRAF wt|ras and braf wt
5122165|NCT03231696|peripheral nerve stimulation|peripheral nerve stimulation
5122166|NCT03231657|preeclampsia|preeclampsia
5122167|NCT03231657|intrauterine growth restriction|intrauterine growth restriction
5122168|NCT03231657|angiogenic factors|angiogenic factors
5122169|NCT03231644|Fibrous Dysplasia|fibrous dysplasia
5122170|NCT03231644|McCune-Albright Syndrome|mccune-albright syndrome
5122171|NCT03231644|Mazabrauds|mazabrauds
5122172|NCT03231644|FD/MAS|fd/mas
5122173|NCT03231631|Exercise|exercise
5122174|NCT03231631|Education|education
5122175|NCT03231631|Stents|stents
5122176|NCT03231631|Angioplasty|angioplasty
5122177|NCT03231631|Cardiac Rehabilitation|cardiac rehabilitation
5122178|NCT03231631|Cholesterol, HDL|cholesterol, hdl
5122179|NCT03231631|Metabolic Equivalent|metabolic equivalent
5122180|NCT03231618|dietary intake|dietary intake
5122181|NCT03231618|cross-over intervention|cross-over intervention
5122182|NCT03231618|energy expenditure|energy expenditure
5122199|NCT03231423|Pain|pain
5122200|NCT03231423|Laparoscopy|laparoscopy
5122201|NCT03231423|Bypass|bypass
5122202|NCT03231410|arteriovenous fistula|arteriovenous fistula
5122203|NCT03231410|maturation|maturation
5187656|NCT02817425|S-1|s-1
5122204|NCT03231410|monocyte adhesion|monocyte adhesion
5122205|NCT03231410|vascular access|vascular access
5122206|NCT03231397|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
5122207|NCT03231371|Orthotopic Heart Transplant|orthotopic heart transplant
5122208|NCT03231345|Peripheral IV|peripheral iv
5122209|NCT03231345|Internal jugular vein|internal jugular vein
5122210|NCT03231345|IJ|ij
5122211|NCT03231345|Peripheral IJ|peripheral ij
5122212|NCT03231345|Ultrasound-guided IJ|ultrasound-guided ij
5122213|NCT03231332|Helicobacter pylori|helicobacter pylori
5122214|NCT03231332|Eradication|eradication
5122215|NCT03231332|Microbiome|microbiome
5122216|NCT03231332|ESBL|esbl
5122217|NCT03231332|GIT|git
5122218|NCT03231306|Neurofibroma, Plexiform|neurofibroma, plexiform
5122219|NCT03231306|Genes, Neurofibromatosis|genes, neurofibromatosis
5122220|NCT03231306|Peripheral nerve tumors|peripheral nerve tumors
5122221|NCT03231306|Neurofibromatosis 1|neurofibromatosis 1
5122222|NCT03231306|Neurofibromas|neurofibromas
5122223|NCT03231280|knee|knee
5122224|NCT03231267|Multiresistant enterobacteriaceae|multiresistant enterobacteriaceae
5122225|NCT03231267|digestive colonization|digestive colonization
5122226|NCT03231267|bacteriophages|bacteriophages
5122227|NCT03231267|Admission in intensive care unit >72h|admission in intensive care unit >72h
5122228|NCT03231267|Presence of at least 2 consecutive stools|presence of at least 2 consecutive stools
5122229|NCT03231241|Headaches|headaches
5122230|NCT03231241|Tension-Type Headache|tension-type headache
5122231|NCT03231241|New Daily Persistent Headache (NDPH)|new daily persistent headache (ndph)
5122232|NCT03231241|Migraine|migraine
5122233|NCT03231202|Non-operative management|non-operative management
5122234|NCT03231202|Splenic Injury|splenic injury
5122235|NCT03231202|Blunt|blunt
5122236|NCT03231202|Splenic artery embolization|splenic artery embolization
5122237|NCT03231202|Trauma|trauma
5122238|NCT03231189|Coronary artery disease|coronary artery disease
5122239|NCT03231189|cardiac MRI|cardiac mri
5122240|NCT03231189|heart failure|heart failure
5122241|NCT03231176|Biliary Tract Neoplasms|biliary tract neoplasms
5122242|NCT03231176|Bile Duct Neoplasms|bile duct neoplasms
5122243|NCT03231176|Gallbladder Neoplasms|gallbladder neoplasms
5122244|NCT03231085|Craniosynostosis|craniosynostosis
5122245|NCT03231085|hemoglobin|hemoglobin
5122246|NCT03231085|iron peros|iron peros
5122258|NCT03231020|interstage|interstage
5122259|NCT03231020|home monitoring|home monitoring
5122260|NCT03231020|mHealth|mhealth
5122261|NCT03230994|adenomyosis|adenomyosis
5122262|NCT03230994|diagnosis|diagnosis
5122263|NCT03230994|treatment|treatment
5122264|NCT03230994|epidemiology|epidemiology
5122266|NCT03230981|biomechanics|biomechanics
5122267|NCT03230981|cornea|cornea
5122268|NCT03230981|optical coherence tomography|optical coherence tomography
5122269|NCT03230981|vibrography|vibrography
5122270|NCT03230981|brillouin microscopy|brillouin microscopy
5122271|NCT03230968|Practical Approach to Lung Health|practical approach to lung health
5122272|NCT03230968|Respiratory diseases|respiratory diseases
5122273|NCT03230968|Mexico|mexico
5122274|NCT03230955|Randomized clinical trial|randomized clinical trial
5122275|NCT03230955|Hotlines|hotlines
5122276|NCT03230942|patient education|patient education
5122277|NCT03230942|arthritis|arthritis
5122278|NCT03230942|knee|knee
5122279|NCT03230942|arthroplasty|arthroplasty
5122280|NCT03230942|gait|gait
5122285|NCT03230890|PTSD|ptsd
5122286|NCT03230890|military|military
5122287|NCT03230890|neurotechnology|neurotechnology
5122288|NCT03230890|HIRREM|hirrem
5122289|NCT03230890|allostasis|allostasis
5122290|NCT03230890|heart rate variability|heart rate variability
5122291|NCT03230890|baroreflex sensitivity|baroreflex sensitivity
5122292|NCT03230890|closed loop|closed loop
5122293|NCT03230890|acoustic stimulation|acoustic stimulation
5122294|NCT03230890|neural oscillations|neural oscillations
5122295|NCT03230890|autonomic|autonomic
5122296|NCT03230890|hyperarousal|hyperarousal
5122297|NCT03230864|Treatment-resistant schizophrenia|treatment-resistant schizophrenia
5122298|NCT03230864|Lu AF35700|lu af35700
5122299|NCT03230851|Light Transmittance Aggregometry|light transmittance aggregometry
5122300|NCT03230851|Indobufen|indobufen
5122301|NCT03230851|Aspirin|aspirin
5122302|NCT03230851|Plasma Thromboxane|plasma thromboxane
5122303|NCT03230851|Urine 11-dehydro thromboxane|urine 11-dehydro thromboxane
5122304|NCT03230825|incomplete abortion|incomplete abortion
5122305|NCT03230825|retained products of conception|retained products of conception
5122306|NCT03230825|combined oral contraceptives|combined oral contraceptives
5122307|NCT03230825|ultrasound|ultrasound
5122308|NCT03230812|Insulin sensitivity|insulin sensitivity
5122309|NCT03230812|Metabolic flexibility|metabolic flexibility
5122310|NCT03230799|congenital cataract|congenital cataract
5122311|NCT03230799|minimal invasive surgery|minimal invasive surgery
5122312|NCT03230799|secondary intraocular lens implantation|secondary intraocular lens implantation
5122313|NCT03230786|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5122314|NCT03230786|KBP-042|kbp-042
5122315|NCT03230760|acupuncture|acupuncture
5122316|NCT03230760|breast engorgement|breast engorgement
5122317|NCT03230760|lactation|lactation
5122318|NCT03230734|prostate cancer|prostate cancer
5122319|NCT03230734|castration-resistant prostate cancer|castration-resistant prostate cancer
5122320|NCT03230734|metastatic prostate cancer|metastatic prostate cancer
5122321|NCT03230734|bone only metastatic prostate cancer|bone only metastatic prostate cancer
5122322|NCT03230734|radium-223|radium-223
5122323|NCT03230734|Docetaxel|docetaxel
5122324|NCT03230721|laser|laser
5122325|NCT03230721|HoLEP|holep
5122326|NCT03230721|ThuLEP|thulep
5122327|NCT03230721|Thulium|thulium
5122328|NCT03230721|Thulium-fiber|thulium-fiber
5122330|NCT03230721|EEP|eep
5122331|NCT03230721|monopolar enucleation|monopolar enucleation
5122332|NCT03230708|Microparticles|microparticles
5122333|NCT03230708|Erythrocytes|erythrocytes
5122334|NCT03230708|Methotrexate|methotrexate
5122335|NCT03230695|stroke|stroke
5122343|NCT03230669|addiction|addiction
5122344|NCT03230669|etherapy|etherapy
5122345|NCT03230591|Fabry's disease|fabry's disease
5122346|NCT03230591|Agalsidase Alfa|agalsidase alfa
5122347|NCT03230591|Cardiomyopathy|cardiomyopathy
5122348|NCT03230591|Enzyme replacement therapy|enzyme replacement therapy
5122349|NCT03230591|Diastolic stress echocardiography|diastolic stress echocardiography
5122350|NCT03230591|LV vortex flow|lv vortex flow
5122351|NCT03230591|Cardiac MRI|cardiac mri
5122352|NCT03230578|Pharmacists|pharmacists
5122353|NCT03230578|Prescriptions|prescriptions
5122354|NCT03230513|vertigo|vertigo
5122355|NCT03230513|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5122356|NCT03230513|particle repositioning manoeuvre|particle repositioning manoeuvre
5122357|NCT03230500|computer guided|computer guided
5122358|NCT03230500|immediate implant|immediate implant
5122359|NCT03230500|patient satisfaction|patient satisfaction
5122360|NCT03230461|CPR|cpr
5122361|NCT03230461|Basic life support|basic life support
5122362|NCT03230448|Acute alcoholism|acute alcoholism
5122363|NCT03230435|anorexia nervosa, health-related quality of life|anorexia nervosa, health-related quality of life
5122461|NCT03229863|First foods|first foods
5122364|NCT03230422|infant, laryngoscopes, pediatrics|infant, laryngoscopes, pediatrics
5122365|NCT03230409|Tuberculosis, Latent Tuberculosis Infection, Adherence, Nursing, Pediatrics, Public Health.|tuberculosis, latent tuberculosis infection, adherence, nursing, pediatrics, public health.
5122366|NCT03230396|vitamins|vitamins
5122367|NCT03230396|dietary supplements|dietary supplements
5122368|NCT03230396|chewing gum|chewing gum
5122369|NCT03230396|pharmacokinetics|pharmacokinetics
5122370|NCT03230396|healthy human subjects|healthy human subjects
5122371|NCT03230370|intensity|intensity
5122372|NCT03230370|rehabilitation|rehabilitation
5122373|NCT03230318|iCCA|icca
5122374|NCT03230318|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5122375|NCT03230318|FGFR2 gene fusion or FGFR2 gene mutation or amplification|fgfr2 gene fusion or fgfr2 gene mutation or amplification
5122376|NCT03230318|biliary cancer|biliary cancer
5122377|NCT03230318|bile duct cancer|bile duct cancer
5122378|NCT03230318|FGFR2 gene rearrangement|fgfr2 gene rearrangement
5122380|NCT03230318|targeted therapy|targeted therapy
5122381|NCT03230318|combined hepatocellular and cholangiocarcinoma|combined hepatocellular and cholangiocarcinoma
5122382|NCT03230318|cHCC-CCA|chcc-cca
5122383|NCT03230318|derazantinib|derazantinib
5122384|NCT03230305|Elderly|elderly
5122385|NCT03230305|Cancer|cancer
5122386|NCT03230305|Ethnographic interview|ethnographic interview
5122387|NCT03230305|Social representation|social representation
5122388|NCT03230305|Clinical trials|clinical trials
5122389|NCT03230305|Reasons of non-participation|reasons of non-participation
5122390|NCT03230305|Qualitative method|qualitative method
5122391|NCT03230292|Psoriasis|psoriasis
5356834|NCT01917812|pedometer|pedometer
5122392|NCT03230292|Chronic Plaque Psoriasis|chronic plaque psoriasis
5122393|NCT03230292|Bimekizumab|bimekizumab
5122394|NCT03230279|Sacroiliac pain|sacroiliac pain
5122395|NCT03230279|Low back pain|low back pain
5122396|NCT03230188|asthma|asthma
5122397|NCT03230188|neurocircuitry|neurocircuitry
5122398|NCT03230188|severe asthma|severe asthma
5122399|NCT03230188|mild to moderate asthma|mild to moderate asthma
5122400|NCT03230188|neurocircuitry patterns|neurocircuitry patterns
5122401|NCT03230149|Fabry|fabry
5122402|NCT03230149|Stroke|stroke
5122403|NCT03230149|Cerebrovascular Accident|cerebrovascular accident
5122404|NCT03230149|small fiber neuropathy|small fiber neuropathy
5122405|NCT03230136|Myocardial injury|myocardial injury
5122406|NCT03230136|Ischemia reperfusion|ischemia reperfusion
5122407|NCT03230136|cardiac surgery|cardiac surgery
5122408|NCT03230136|cardioprotection|cardioprotection
5122409|NCT03230123|Diabetes Mellitus|diabetes mellitus
5122410|NCT03230123|green banana|green banana
5122411|NCT03230123|resistant starch|resistant starch
5122412|NCT03230123|glucose|glucose
5122413|NCT03230123|prebiotics|prebiotics
5122414|NCT03230123|insulin|insulin
5122415|NCT03230123|incretins|incretins
5122416|NCT03230110|Sleep disordered breathing|sleep disordered breathing
5122417|NCT03230110|Obstructive sleep apnea|obstructive sleep apnea
5122418|NCT03230110|Hypertension|hypertension
5122419|NCT03230110|Pregnancy|pregnancy
5122420|NCT03230084|Infertility|infertility
5122421|NCT03230084|Ovulation|ovulation
5122422|NCT03230084|Pregnanediol 3-glucuronide|pregnanediol 3-glucuronide
5122428|NCT03230084|Natural family planning|natural family planning
5122429|NCT03230084|Fertility awareness methods|fertility awareness methods
5122431|NCT03230071|Randomized controlled trial|randomized controlled trial
5122432|NCT03230071|Vascular Dementia|vascular dementia
5122433|NCT03230045|acupoint stimulation|acupoint stimulation
5122434|NCT03230045|elderly patients|elderly patients
5122435|NCT03230045|postoperative pulmonary complications|postoperative pulmonary complications
5122436|NCT03230019|wedge resection|wedge resection
5122437|NCT03230019|tubeless|tubeless
5122438|NCT03229980|myocardial protection|myocardial protection
5122439|NCT03229980|potassium cardioplegia|potassium cardioplegia
5122440|NCT03229980|tropinin|tropinin
5122441|NCT03229980|Custodiol|custodiol
5122442|NCT03229967|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5122443|NCT03229967|Microbiome|microbiome
5122444|NCT03229967|Microbiota|microbiota
5122445|NCT03229967|Premature infant|premature infant
5122446|NCT03229967|Observational cohort study|observational cohort study
5122447|NCT03229928|Behavior|behavior
5122448|NCT03229928|Outcome Measures|outcome measures
5122449|NCT03229928|Intellectual/Developmental Disabilities|intellectual/developmental disabilities
5122450|NCT03229902|stroke|stroke
5122451|NCT03229889|Access Sheath|access sheath
5122452|NCT03229889|PCNL|pcnl
5122453|NCT03229889|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
5122454|NCT03229889|Ureteroscopy|ureteroscopy
5122455|NCT03229889|Alpha Blocker|alpha blocker
5122456|NCT03229889|Flomax|flomax
5122457|NCT03229889|PDE-5 Inhibitor|pde-5 inhibitor
5122458|NCT03229889|Cialis|cialis
5122459|NCT03229889|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
5122460|NCT03229863|Breastfeeding|breastfeeding
5122468|NCT03229837|Patient-reported outcomes|patient-reported outcomes
5122469|NCT03229837|Pediatric cancer survivors|pediatric cancer survivors
5122470|NCT03229837|PROMIS pediatric measures|promis pediatric measures
5122472|NCT03229824|Bacterial colonization|bacterial colonization
5122473|NCT03229824|Surgical site infection|surgical site infection
5122474|NCT03229733|Stroke|stroke
5122475|NCT03229733|Kinect|kinect
5122476|NCT03229733|Rehabilitation|rehabilitation
5122477|NCT03229733|Upper limbs|upper limbs
5122478|NCT03229720|Audio Visual Distraction|audio visual distraction
5122479|NCT03229681|Baduanjin; CHF; 6MWT; CPET|baduanjin; chf; 6mwt; cpet
5122480|NCT03229668|urinary bladder|urinary bladder
5122481|NCT03229668|urinary catheters|urinary catheters
5122482|NCT03229668|pregabalin|pregabalin
5122483|NCT03229642|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5122484|NCT03229642|opioid use disorder|opioid use disorder
5122485|NCT03229642|craving|craving
5122486|NCT03229642|functional magnetic resonance imaging|functional magnetic resonance imaging
5122487|NCT03229642|neuropsychological tests|neuropsychological tests
5122488|NCT03229629|Behavior change communication|behavior change communication
5122489|NCT03229629|Ethiopia|ethiopia
5122490|NCT03229629|Food voucher|food voucher
5122491|NCT03229629|complementary feeding practice|complementary feeding practice
5122492|NCT03229629|affordability|affordability
5122493|NCT03229629|accessibility|accessibility
5122494|NCT03229629|gender|gender
5122495|NCT03229603|HPV infection and Cervical cancer|hpv infection and cervical cancer
5122496|NCT03229564|Burns|burns
5122497|NCT03229564|Scar|scar
5122498|NCT03229564|Skin|skin
5122499|NCT03229564|Wound healing|wound healing
5122500|NCT03229564|Tissue Engineering|tissue engineering
5122501|NCT03229564|Dermis|dermis
5122502|NCT03229564|Epidermis|epidermis
5122503|NCT03229564|Thermal Injuries|thermal injuries
5122504|NCT03229551|chronic rhinosinusitis|chronic rhinosinusitis
5122505|NCT03229551|chronically draining sinus|chronically draining sinus
5122506|NCT03229551|condemned sinus|condemned sinus
5122507|NCT03229551|post-endoscopic sinus surgery|post-endoscopic sinus surgery
5122508|NCT03229512|Hand Foot Skin Reaction|hand foot skin reaction
5122509|NCT03229512|Sildenafil|sildenafil
5122510|NCT03229499|Randomized Controlled Trial|randomized controlled trial
5122511|NCT03229499|clinical trial|clinical trial
5122512|NCT03229499|anastrozole|anastrozole
5122513|NCT03229499|pulmonary hypertension|pulmonary hypertension
5122514|NCT03229499|pulmonary arterial hypertension|pulmonary arterial hypertension
5122515|NCT03229499|PAH|pah
5122516|NCT03229486|emergence delirium|emergence delirium
5122517|NCT03229486|tonsillectomy|tonsillectomy
5122522|NCT03229434|affective responses|affective responses
5122523|NCT03229434|stress-related parameters|stress-related parameters
5122524|NCT03229434|green exercise|green exercise
5122525|NCT03229421|Zika Virus|zika virus
5122526|NCT03229408|Inflammation|inflammation
5122542|NCT03229317|Lung function|lung function
5122543|NCT03229317|Children|children
5122544|NCT03229317|Vitamin D|vitamin d
5122545|NCT03229317|COPD|copd
5122546|NCT03229291|SM04755|sm04755
5122547|NCT03229291|topical|topical
5122548|NCT03229291|Samumed|samumed
5122549|NCT03229291|Wnt inhibitor|wnt inhibitor
5122550|NCT03229226|Simulation|simulation
5122551|NCT03229226|Task Trainer|task trainer
5122556|NCT03229148|Anesthesia or Conscious sedation for Thrombectomy for Stroke|anesthesia or conscious sedation for thrombectomy for stroke
5122557|NCT03229148|Thrombectomy|thrombectomy
5122558|NCT03229148|Anesthesia|anesthesia
5122559|NCT03229148|Conscious sedation|conscious sedation
5122560|NCT03229148|Stroke|stroke
5122561|NCT03229122|ovarian cancer, gBRCAm|ovarian cancer, gbrcam
5122562|NCT03229109|dehydration|dehydration
5122563|NCT03229109|spectrophon|spectrophon
5122564|NCT03229109|device|device
5122565|NCT03229109|perspiration|perspiration
5122566|NCT03229096|gastric cancer|gastric cancer
5122567|NCT03229096|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5122568|NCT03229096|apatinib|apatinib
5122569|NCT03229070|Thoracic Surgery|thoracic surgery
5122570|NCT03229070|Postoperative Period|postoperative period
5122571|NCT03229070|Rehabilitation|rehabilitation
5122572|NCT03229070|Early mobilization|early mobilization
5122573|NCT03229070|Cycle-ergometer|cycle-ergometer
5122574|NCT03229044|adipokine, tetranectin, lipid metabolism, body mass index|adipokine, tetranectin, lipid metabolism, body mass index
5122575|NCT03229031|spinal cord, spinal cord injury|spinal cord, spinal cord injury
5122576|NCT03229005|soft tissue; implant; abutment;|soft tissue; implant; abutment;
5122577|NCT03228966|Pediatric|pediatric
5122578|NCT03228953|Pharmacogenomic testing|pharmacogenomic testing
5122579|NCT03228953|Depression|depression
5122580|NCT03228940|Cardiovascular Disease, Renal Disease|cardiovascular disease, renal disease
5122581|NCT03228901|Oxytocin|oxytocin
5122582|NCT03228901|Affiliation|affiliation
5122583|NCT03228888|Rhythm|rhythm
5122584|NCT03228888|Ecological sounds|ecological sounds
5122585|NCT03228888|Auditory stimuli|auditory stimuli
5122586|NCT03228888|rhythmic auditory stimulation|rhythmic auditory stimulation
5122587|NCT03228888|Parkinson's Disease|parkinson's disease
5122588|NCT03228888|Gait|gait
5122589|NCT03228888|Gait analysis|gait analysis
5122590|NCT03228888|Spatio-temporal parameters|spatio-temporal parameters
5122591|NCT03228875|pregnancy outcomes, birth outcomes, pediatric diseases|pregnancy outcomes, birth outcomes, pediatric diseases
5122592|NCT03228849|Bony mallet injury|bony mallet injury
5122593|NCT03228849|Anchor suture|anchor suture
5122594|NCT03228849|Conservative treatment|conservative treatment
5122595|NCT03228849|DIP joint|dip joint
5122596|NCT03228823|Premature Ventricular contractions|premature ventricular contractions
5122597|NCT03228823|Cardiomyopathy|cardiomyopathy
5122598|NCT03228797|pain|pain
5122599|NCT03228771|PRGF|prgf
5122600|NCT03228771|Statins|statins
5122601|NCT03228771|socket augmentation|socket augmentation
5122602|NCT03228758|POEM|poem
5122603|NCT03228745|mindfulness based stress reduction|mindfulness based stress reduction
5122604|NCT03228745|total knee arthroplasty|total knee arthroplasty
5122605|NCT03228745|pre-operative|pre-operative
5122606|NCT03228719|Total Knee Replacement|total knee replacement
5122607|NCT03228719|Physical Therapy|physical therapy
5122608|NCT03228706|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5122609|NCT03228706|Medication Adherence|medication adherence
5122610|NCT03228706|Malay patients|malay patients
5122611|NCT03228706|Structured Group-Based Intervention|structured group-based intervention
5122612|NCT03228706|Randomised controlled trial|randomised controlled trial
5122613|NCT03228693|Keloid|keloid
5122648|NCT03228576|Transplant|transplant
5122649|NCT03228550|omega-3 fatty acid|omega-3 fatty acid
5122650|NCT03228550|B vitamins|b vitamins
5122651|NCT03228550|vitamin E|vitamin e
5122652|NCT03228550|Phosphatidylserine|phosphatidylserine
5122653|NCT03228550|Gingko biloba|gingko biloba
4994371|NCT04029116|SCY-078|scy-078
5122654|NCT03228550|Gait|gait
5122655|NCT03228550|Aerobic Exercise|aerobic exercise
5122656|NCT03228550|Memory|memory
5112153|NCT03296137|TILs|tils
5122657|NCT03228550|Cognitive function|cognitive function
5122658|NCT03228485|Smartphone|smartphone
5122661|NCT03228485|mhealth|mhealth
5122662|NCT03228459|Kidney Diseases|kidney diseases
5122663|NCT03228459|Subclinical Disease and/or Syndrome|subclinical disease and/or syndrome
5122664|NCT03228459|Atherosclerosis|atherosclerosis
5122665|NCT03228459|Biomarkers|biomarkers
5122666|NCT03228459|Prevention|prevention
5122667|NCT03228459|Lung capacity|lung capacity
5122668|NCT03228459|Early diagnosis|early diagnosis
5122669|NCT03228459|Advanced glycation-end products|advanced glycation-end products
5122670|NCT03228459|Atrial fibrillation|atrial fibrillation
5122671|NCT03228459|Diabetes|diabetes
5122672|NCT03228459|Arterial ultrasound|arterial ultrasound
5122673|NCT03228446|training intervention|training intervention
5122674|NCT03228446|filter training|filter training
5122675|NCT03228446|distractor inhibition|distractor inhibition
5122676|NCT03228433|Drug Therapy|drug therapy
5122677|NCT03228394|Postpartum Care|postpartum care
5122678|NCT03228394|Postpartum Depression|postpartum depression
5122679|NCT03228381|Functional Mitral Regurgitation|functional mitral regurgitation
5122680|NCT03228381|Heart Failure|heart failure
5122681|NCT03228355|Levcromakalim|levcromakalim
5122682|NCT03228342|Rheumatoid Arthritis|rheumatoid arthritis
5122683|NCT03228342|Ultrasound|ultrasound
5122684|NCT03228342|Impact|impact
5122685|NCT03228329|cardiometry|cardiometry
5122686|NCT03228329|stroke volume|stroke volume
5122687|NCT03228329|liver transplantation|liver transplantation
5122688|NCT03228290|Cirrhosis|cirrhosis
5122689|NCT03228290|Liver|liver
5122690|NCT03228290|Liver Transplant|liver transplant
5122691|NCT03228290|Frailty|frailty
5122692|NCT03228290|end stage|end stage
5122693|NCT03228277|Extracellular vesicles|extracellular vesicles
5122694|NCT03228277|Bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
5122695|NCT03228277|Liquid biopsy|liquid biopsy
5122696|NCT03228277|T790M|t790m
5122697|NCT03228277|NSCLC|nsclc
5122698|NCT03228277|Exosomes|exosomes
5122699|NCT03228277|EGFR mutation testing|egfr mutation testing
5122700|NCT03228199|Randomised Control Trial|randomised control trial
5122701|NCT03228199|Productivity|productivity
5122702|NCT03228199|Agricultural workers|agricultural workers
5122703|NCT03228199|India|india
5122704|NCT03228199|Vision correction|vision correction
5122705|NCT03228173|Cognition|cognition
5122706|NCT03228173|Executive functioning|executive functioning
5122707|NCT03228173|Depression|depression
5122708|NCT03228173|Affect|affect
5122709|NCT03228173|adult females|adult females
5122710|NCT03228160|Sympathetically Maintained Pain|sympathetically maintained pain
5122711|NCT03228160|Linear-Polarized Near-Infrared Irradiation|linear-polarized near-infrared irradiation
5122712|NCT03228160|Stellate Ganglion|stellate ganglion
5122713|NCT03228160|Heart Rate Variability|heart rate variability
5122714|NCT03228160|Autonomic Dysfunction Outcome|autonomic dysfunction outcome
5122716|NCT03228108|Culture-guided|culture-guided
5122717|NCT03228108|Targeted prophylaxis|targeted prophylaxis
5122718|NCT03228108|Prostate biopsy|prostate biopsy
5122719|NCT03228108|Antibiotic prophylaxis|antibiotic prophylaxis
5122720|NCT03228095|Volatile Organic Compounds|volatile organic compounds
5122721|NCT03228095|Tuberculosis|tuberculosis
5122722|NCT03228095|Nano-sensors|nano-sensors
5122723|NCT03228095|Electronic nose|electronic nose
5122724|NCT03228095|Digestive cancers|digestive cancers
5122725|NCT03228082|Patient empowerment|patient empowerment
5122726|NCT03228082|Women's Health|women's health
5122727|NCT03228082|Home Blood Pressure Monitoring|home blood pressure monitoring
5122728|NCT03228069|rabies vaccination|rabies vaccination
5122729|NCT03228056|postoperative pain|postoperative pain
5122744|NCT03228030|congestive heart failure|congestive heart failure
5122745|NCT03228017|cardiovascular disease|cardiovascular disease
5122746|NCT03228017|CVD|cvd
5122747|NCT03227991|Suicide|suicide
5122748|NCT03227978|pleurodesis|pleurodesis
5122749|NCT03227978|PCL|pcl
5122750|NCT03227965|cancer|cancer
5122751|NCT03227926|RAS|ras
5122752|NCT03227926|Panitumumab|panitumumab
5122753|NCT03227926|EGFR|egfr
5122754|NCT03227926|Clonal evolution|clonal evolution
5122755|NCT03227835|contrast-induced nephropathy|contrast-induced nephropathy
5122756|NCT03227835|contrast-induced acute kidney injury|contrast-induced acute kidney injury
5122757|NCT03227835|prophylaxis|prophylaxis
5122758|NCT03227835|intravenous hydration|intravenous hydration
5123054|NCT03226119|HTLV|htlv
5122762|NCT03227809|Marijuana|marijuana
5122763|NCT03227809|Illicit drugs|illicit drugs
5122764|NCT03227809|Prescription drug misuse|prescription drug misuse
5962016|NCT04283526|Post-Essential Thrombocythemia Myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
5122778|NCT03227744|Prostate Cancer, Anxiety|prostate cancer, anxiety
5122779|NCT03227731|Preexposure prophylaxis|preexposure prophylaxis
5122780|NCT03227731|safety|safety
5122781|NCT03227731|HIV prevention|hiv prevention
5122782|NCT03227731|pregnant women|pregnant women
5122783|NCT03227731|lactating women|lactating women
5122785|NCT03227705|Preterm birth|preterm birth
5122786|NCT03227705|Short cervix|short cervix
5122787|NCT03227705|Pessary|pessary
5122788|NCT03227705|Progesterone|progesterone
5122789|NCT03227679|Personalized Medicine|personalized medicine
5122790|NCT03227679|Nicotine Metabolite Ratio (NMR)|nicotine metabolite ratio (nmr)
5122791|NCT03227679|Varenicline|varenicline
5122792|NCT03227679|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
5122793|NCT03227679|Smoking Cessation|smoking cessation
5122794|NCT03227679|Pharmacotherapy|pharmacotherapy
5122795|NCT03227666|Postural sway|postural sway
5122796|NCT03227666|Progressive balance exercise|progressive balance exercise
5122797|NCT03227666|RCT|rct
5122798|NCT03227666|Functional balance|functional balance
5122799|NCT03227653|Efavirenz|efavirenz
5122800|NCT03227653|Child Behavior|child behavior
5122801|NCT03227653|Cognition|cognition
5122802|NCT03227653|Medication Adherence|medication adherence
5122803|NCT03227653|Drug-Related Side Effects|drug-related side effects
5122804|NCT03227614|abortion|abortion
5122805|NCT03227614|social support|social support
5122806|NCT03227614|Anxiety|anxiety
5122807|NCT03227614|Pain|pain
5122808|NCT03227588|Fractional Flow Reserve|fractional flow reserve
5122809|NCT03227588|Percutaneous Coronary Intervention|percutaneous coronary intervention
5122810|NCT03227562|risperidone|risperidone
5122811|NCT03227562|anxiety|anxiety
5122812|NCT03227562|cognition|cognition
5122813|NCT03227562|stress|stress
5122814|NCT03227536|Neonatal asphyxia|neonatal asphyxia
5122815|NCT03227536|neonatal acidosis|neonatal acidosis
5122816|NCT03227536|fetal ECG|fetal ecg
5122817|NCT03227536|umbilical cord acid-base status|umbilical cord acid-base status
5122818|NCT03227523|low back pain|low back pain
5122819|NCT03227523|respiratory disorders|respiratory disorders
5122820|NCT03227523|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5122821|NCT03227523|postural balance|postural balance
5122822|NCT03227523|functional laterality|functional laterality
5122823|NCT03227523|diaphragm|diaphragm
5122830|NCT03227458|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5122831|NCT03227458|postmenopause|postmenopause
5122832|NCT03227458|exercise|exercise
5122833|NCT03227458|sex hormones|sex hormones
5122834|NCT03227445|DISKUS|diskus
5122835|NCT03227445|HandiHaler|handihaler
5122836|NCT03227445|COPD|copd
5122837|NCT03227445|Placebo|placebo
5122838|NCT03227445|Cross-over|cross-over
5122839|NCT03227445|Dry powder inhaler|dry powder inhaler
5122840|NCT03227445|ELLIPTA|ellipta
5122841|NCT03227432|Multiple Myeloma|multiple myeloma
5122842|NCT03227406|sleep|sleep
5122843|NCT03227406|memory|memory
5122844|NCT03227406|REM sleep|rem sleep
5122845|NCT03227406|slow wave sleep|slow wave sleep
5122846|NCT03227406|cognition|cognition
5122847|NCT03227406|sleep spindles|sleep spindles
5122848|NCT03227393|Heart Failure, Systolic|heart failure, systolic
5122849|NCT03227393|Defibrillators, Implantable|defibrillators, implantable
5122850|NCT03227393|Pacemaker, Artificial|pacemaker, artificial
5122851|NCT03227367|biomaterials|biomaterials
5122852|NCT03227367|apoptosis|apoptosis
5122853|NCT03227367|bone regeneration|bone regeneration
5122854|NCT03227354|Medical Device|medical device
5122855|NCT03227341|asthma control|asthma control
5122856|NCT03227341|pulmonary rehabilitation|pulmonary rehabilitation
5445343|NCT01522248|symptoms|symptoms
5122857|NCT03227328|HR-positive Breast Cancer|hr-positive breast cancer
5122858|NCT03227328|metastatic breast cancer|metastatic breast cancer
5122859|NCT03227328|First line treatment|first line treatment
5123363|NCT03224390|Kenya|kenya
5122864|NCT03227328|HR-negative Breast Cancer|hr-negative breast cancer
5122865|NCT03227328|CDK4/6 inhibitor|cdk4/6 inhibitor
5122869|NCT03227263|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5122870|NCT03227263|VEGF therapy|vegf therapy
5122871|NCT03227263|Bevacizumab|bevacizumab
5122872|NCT03227250|freezing of gait|freezing of gait
5122873|NCT03227250|Parkinson disease|parkinson disease
5122874|NCT03227250|GPi|gpi
5122875|NCT03227237|Impact, Interpersonal Relationship, Juvenile delinquency|impact, interpersonal relationship, juvenile delinquency
5122876|NCT03227211|COPD exacerbated|copd exacerbated
5122878|NCT03227211|Prospective cohort study|prospective cohort study
5122879|NCT03227211|Nested case control study|nested case control study
5122880|NCT03227211|Clinical prediction rules|clinical prediction rules
5122881|NCT03227159|Acute Myocardial Infarction|acute myocardial infarction
5122882|NCT03227159|Troponin|troponin
5122883|NCT03227159|Emergency department|emergency department
5122884|NCT03227146|Burns|burns
5122885|NCT03227146|Scar|scar
5122886|NCT03227146|Skin|skin
5122887|NCT03227146|Wound healing|wound healing
5122888|NCT03227146|Tissue Engineering|tissue engineering
5122889|NCT03227146|Dermis|dermis
5122890|NCT03227146|Epidermis|epidermis
5122891|NCT03227146|Thermal Injuries|thermal injuries
5122892|NCT03227120|Exercise Therapy|exercise therapy
5122893|NCT03227094|Diabetes|diabetes
5122894|NCT03227094|Screening test|screening test
5122895|NCT03227094|Continuous glucose monitoring|continuous glucose monitoring
5122896|NCT03227094|Oral glucose tolerance test|oral glucose tolerance test
5122897|NCT03227068|pediatric oncology|pediatric oncology
5122898|NCT03227068|parent|parent
5122899|NCT03227055|Arterial stiffness, children, chronic kidney disease, hypertension, microRNA|arterial stiffness, children, chronic kidney disease, hypertension, microrna
5122900|NCT03227042|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
5122901|NCT03227042|MPS IIIB|mps iiib
5122902|NCT03227042|MPS 3 B|mps 3 b
5122903|NCT03226990|pressure area|pressure area
5122904|NCT03226990|polyether elastomeric impression|polyether elastomeric impression
5122905|NCT03226990|wax spacer|wax spacer
5122906|NCT03226964|endobronchial ultrasound|endobronchial ultrasound
5122907|NCT03226964|high flow nasal oxygen|high flow nasal oxygen
5122908|NCT03226938|dietary patterns|dietary patterns
5122909|NCT03226938|dietary adherence|dietary adherence
5122910|NCT03226938|popular diets|popular diets
5122911|NCT03226938|Paleo|paleo
5122912|NCT03226938|vegan|vegan
5122913|NCT03226938|behavior change|behavior change
5122914|NCT03226938|adherence|adherence
5122915|NCT03226938|compliance|compliance
5122916|NCT03226938|vegetarian|vegetarian
5122917|NCT03226938|low carb|low carb
5122918|NCT03226938|low-carb|low-carb
5122919|NCT03226938|whole food plant-based|whole food plant-based
5122920|NCT03226938|social ecological model|social ecological model
5122921|NCT03226925|thoracic tumors|thoracic tumors
5122922|NCT03226925|motion management|motion management
5122928|NCT03226873|women|women
5122929|NCT03226847|Atrial Fibrillation, Athletes, Pulmonary Vein Isolation|atrial fibrillation, athletes, pulmonary vein isolation
5122930|NCT03226821|HIV Lipodystrophy|hiv lipodystrophy
5122931|NCT03226821|Tesamorelin|tesamorelin
5122932|NCT03226821|Body Composition|body composition
5122933|NCT03226821|Visceral Adiposity|visceral adiposity
5122934|NCT03226795|Cystic fibrosis|cystic fibrosis
5122935|NCT03226795|Therapeutic adherence|therapeutic adherence
5122936|NCT03226795|Co-constructed intervention|co-constructed intervention
5122937|NCT03226795|Patient involvement|patient involvement
5122938|NCT03226743|stepped and collaborative care|stepped and collaborative care
5122939|NCT03226743|cluster-randomized controlled trial|cluster-randomized controlled trial
5122940|NCT03226743|health services research|health services research
5122941|NCT03226743|evidence-based medicine|evidence-based medicine
5122942|NCT03226743|complex intervention|complex intervention
5122943|NCT03226743|guideline implementation|guideline implementation
5122944|NCT03226743|collaborative network|collaborative network
5122945|NCT03226730|Female Adolescent|female adolescent
5122946|NCT03226730|Married|married
5122947|NCT03226730|West Africa|west africa
5122948|NCT03226730|Family Planning|family planning
5122949|NCT03226730|Contraceptive Use|contraceptive use
5122950|NCT03226730|Birth Spacing|birth spacing
5122956|NCT03226691|Plerixafor|plerixafor
5122957|NCT03226691|Leukapheresis|leukapheresis
5122958|NCT03226691|Mobilization|mobilization
5122959|NCT03226691|Stem Cells|stem cells
5122960|NCT03226691|Sickle Cell Disease|sickle cell disease
5122961|NCT03226665|obstruction|obstruction
5122962|NCT03226665|small bowel|small bowel
5122963|NCT03226665|ultrasound|ultrasound
5122964|NCT03226639|Atrial Fibrillation|atrial fibrillation
5122965|NCT03226639|First Ablation|first ablation
5122966|NCT03226626|Tumescent|tumescent
5122967|NCT03226626|Lidocaine|lidocaine
5122968|NCT03226626|Epinephrine|epinephrine
5122969|NCT03226626|Cefazolin|cefazolin
5122970|NCT03226626|Metronidazole|metronidazole
5122971|NCT03226626|Surgical Site Infection|surgical site infection
5122972|NCT03226626|Thrombosis|thrombosis
5122973|NCT03226626|Sepsis|sepsis
5122974|NCT03226626|Prevention|prevention
5122975|NCT03226626|Prophylaxis|prophylaxis
5122976|NCT03226613|Human Papillomavirus|human papillomavirus
5122977|NCT03226613|Oropharyngeal Cancer|oropharyngeal cancer
5122978|NCT03226613|Base of Tongue Cancer|base of tongue cancer
5122979|NCT03226613|Tonsil Cancer|tonsil cancer
5122980|NCT03226600|Gingival Recession|gingival recession
5122981|NCT03226600|Connective Tissue Graft|connective tissue graft
5122982|NCT03226600|OrACELL|oracell
5122983|NCT03226600|Decellularized Dermis|decellularized dermis
5122984|NCT03226600|Periodontics|periodontics
5122985|NCT03226587|blue light|blue light
5122986|NCT03226587|blood pressure|blood pressure
5122987|NCT03226587|vascular function|vascular function
5122988|NCT03226587|endothelial function|endothelial function
5122989|NCT03226587|health volunteers|health volunteers
5122990|NCT03226574|Resiniferatoxin|resiniferatoxin
5122992|NCT03226574|Cancer pain|cancer pain
5122993|NCT03226548|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
5122994|NCT03226548|Tax Credit|tax credit
5122995|NCT03226548|Paycheck Plus|paycheck plus
5122996|NCT03226535|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
5122997|NCT03226535|Ultrasound-CT Fusion|ultrasound-ct fusion
5122998|NCT03226535|Image Fusion|image fusion
5122999|NCT03226535|Clear Guide SCENERGY|clear guide scenergy
5123000|NCT03226535|Needle path|needle path
5123001|NCT03226535|Needle Guidance|needle guidance
5123003|NCT03226535|Ultrasound|ultrasound
5123004|NCT03226509|cascade of care|cascade of care
5123005|NCT03226483|Brain Metastases|brain metastases
5123006|NCT03226483|Intraoperative Radiotherapy|intraoperative radiotherapy
5123007|NCT03226483|Neurosurgery|neurosurgery
5123008|NCT03226470|Transcription Activator-like Effector Nucleases|transcription activator-like effector nucleases
5123009|NCT03226470|Human papillomavirus|human papillomavirus
5123010|NCT03226470|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5123011|NCT03226457|Heart Failure|heart failure
5123012|NCT03226457|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5123013|NCT03226457|Sodium-Glucose co-Transporter 2 (SGLT2) inhibitors|sodium-glucose co-transporter 2 (sglt2) inhibitors
5123014|NCT03226457|Natriuresis|natriuresis
5123015|NCT03226457|Diuresis|diuresis
5123016|NCT03226444|Dry Eye|dry eye
5123017|NCT03226444|Primary Sjogren's Syndrome|primary sjogren's syndrome
5123018|NCT03226444|Sjogren's Syndrome|sjogren's syndrome
5123019|NCT03226405|Cancer|cancer
5123021|NCT03226366|door-to-antibiotic time|door-to-antibiotic time
5123022|NCT03226366|emergency department care|emergency department care
5123046|NCT03226210|Rapid-acting insulin analogues|rapid-acting insulin analogues
5123047|NCT03226210|Continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
5123048|NCT03226210|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5123049|NCT03226184|Er:YAG laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery|er:yag laser, laser, biofilm removal, biofilm, disinfection, septic revision surgery
5123050|NCT03226158|Next generation pathogen sequencing (NGPS)|next generation pathogen sequencing (ngps)
5123051|NCT03226158|Pediatric|pediatric
5123052|NCT03226158|Cancer|cancer
5123053|NCT03226158|Bloodstream infection (BSI)|bloodstream infection (bsi)
5123055|NCT03226119|Confirmatory|confirmatory
5123056|NCT03226119|Supplemental|supplemental
5123057|NCT03226119|Blot|blot
5123058|NCT03226119|HTLV-I|htlv-i
5123059|NCT03226119|HTLV-II|htlv-ii
5123060|NCT03226106|Rehabilitation|rehabilitation
5123061|NCT03226106|Total Knee Arthroplasty|total knee arthroplasty
5123062|NCT03226106|Telemedicine|telemedicine
5123063|NCT03226106|Physical Activity|physical activity
5123064|NCT03226054|Proton Pump Inhibitor|proton pump inhibitor
5123065|NCT03226041|transcutaneous carbon dioxide|transcutaneous carbon dioxide
5123066|NCT03226041|retroperitoneoscopic|retroperitoneoscopic
5123067|NCT03226041|urologic surgery|urologic surgery
5123068|NCT03226041|anesthesia|anesthesia
5123069|NCT03226015|Limbal Stem-cell Deficiency|limbal stem-cell deficiency
5123070|NCT03226015|Oral mucosa transplantation|oral mucosa transplantation
5123071|NCT03226015|Amniotic membrane|amniotic membrane
5123072|NCT03226015|Mesenchymal stem cells|mesenchymal stem cells
5123073|NCT03226002|Airtraq NT|airtraq nt
5123074|NCT03226002|nasotracheal intubation|nasotracheal intubation
5123075|NCT03226002|right|right
5123076|NCT03226002|left|left
5123077|NCT03225976|Phototherapy|phototherapy
5123078|NCT03225976|Athletic Performance|athletic performance
5123079|NCT03225976|Muscle Strength|muscle strength
5123080|NCT03225976|Fatigue|fatigue
5123081|NCT03225963|Glioblastoma|glioblastoma
5123082|NCT03225963|Bevacizumab|bevacizumab
5123083|NCT03225950|Periodontal disease|periodontal disease
5123084|NCT03225950|Periodontitis|periodontitis
5123085|NCT03225950|Aggressive periodontitis|aggressive periodontitis
5123086|NCT03225950|Dysbiosis|dysbiosis
5123087|NCT03225950|Inflammation|inflammation
5123088|NCT03225950|Regulation|regulation
5123089|NCT03225950|Cytokines|cytokines
5123090|NCT03225950|Bacteria|bacteria
5123091|NCT03225950|Porphyromonas gingivalis|porphyromonas gingivalis
5123092|NCT03225950|Saliva|saliva
5123093|NCT03225950|Anti-CCP|anti-ccp
5123094|NCT03225950|Peptidyl arginine deiminases|peptidyl arginine deiminases
5123095|NCT03225950|Single nucleotide polymorphisms|single nucleotide polymorphisms
5123096|NCT03225898|blood flow restriction|blood flow restriction
5123103|NCT03225885|random allocation|random allocation
5123104|NCT03225872|Osteosarcoma|osteosarcoma
5123105|NCT03225872|Bone cancer|bone cancer
5123106|NCT03225872|Family-based study|family-based study
5123107|NCT03225859|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5123108|NCT03225859|Self-Management|self-management
5123118|NCT03225807|Tidal Volumes|tidal volumes
5123119|NCT03225807|inflammation|inflammation
5123120|NCT03225807|cytokines|cytokines
5123121|NCT03225807|Pulmonary Infiltrate|pulmonary infiltrate
5123122|NCT03225807|Pulmonary Infiltrates|pulmonary infiltrates
5123123|NCT03225807|Low Tidal Volumes|low tidal volumes
5123124|NCT03225807|Protective Ventilation|protective ventilation
5123125|NCT03225794|Retrovirus|retrovirus
5123126|NCT03225794|Viral emergence|viral emergence
5123127|NCT03225755|Growth Hormone Deficiency|growth hormone deficiency
5123128|NCT03225755|Adipose Tissue|adipose tissue
5123129|NCT03225755|Inflammation|inflammation
5123130|NCT03225716|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5123131|NCT03225703|Exercise|exercise
5123132|NCT03225703|Osteoporosis|osteoporosis
5123133|NCT03225703|Osteoarthritis|osteoarthritis
5123136|NCT03225703|High Impact|high impact
5123137|NCT03225703|Cartilage|cartilage
5123138|NCT03225703|Bone|bone
5123139|NCT03225651|Stem cell|stem cell
5123140|NCT03225651|Autism|autism
5123141|NCT03225651|Psychological|psychological
4994788|NCT04026360|Tobacco|tobacco
5123142|NCT03225651|Rehabilitation|rehabilitation
5123143|NCT03225625|spinal cord injury|spinal cord injury
5123144|NCT03225625|spinal cord compression|spinal cord compression
5123145|NCT03225625|spinal cord ischemia|spinal cord ischemia
5123146|NCT03225625|spinal cord diseases|spinal cord diseases
5123147|NCT03225625|spinal paralysis|spinal paralysis
5123148|NCT03225625|paraplegia|paraplegia
5123149|NCT03225625|paraparesis|paraparesis
5123150|NCT03225625|SCI|sci
5123151|NCT03225586|Non-communicable Diseases, Risk Factors|non-communicable diseases, risk factors
5123152|NCT03225573|second mesiobuccal canal CBCT prevalence population|second mesiobuccal canal cbct prevalence population
5123153|NCT03225560|Smart Phone Application|smart phone application
5123154|NCT03225560|Bowel Preparation|bowel preparation
5123155|NCT03225560|Colorectal Cancer Screening|colorectal cancer screening
5123364|NCT03224390|Unmet Need|unmet need
5123165|NCT03225521|Physical Activity|physical activity
5123166|NCT03225521|Mobile Health|mobile health
5123167|NCT03225521|Self Monitoring|self monitoring
5123168|NCT03225521|Wearable Sensors|wearable sensors
5123169|NCT03225521|Tailored Health Communication|tailored health communication
5123170|NCT03225521|Implementation Intentions|implementation intentions
5123171|NCT03225521|Mobile Apps|mobile apps
5123172|NCT03225521|Anti-Sedentary Behavior|anti-sedentary behavior
5123173|NCT03225521|Opportunistic Physical Activity|opportunistic physical activity
5123174|NCT03225521|Health Belief Model|health belief model
5123175|NCT03225482|Mild Cognitive Impairment|mild cognitive impairment
5123176|NCT03225482|Cognitive rehabilitation|cognitive rehabilitation
5123177|NCT03225482|Cognitive training|cognitive training
5123178|NCT03225482|Cognitive remediation|cognitive remediation
5123179|NCT03225469|Bowel Preparation|bowel preparation
5123180|NCT03225469|Colonoscopy|colonoscopy
5123181|NCT03225469|Quality|quality
5123182|NCT03225469|Family Support|family support
5123183|NCT03225469|Education|education
5123184|NCT03225456|appetite regulation|appetite regulation
5123185|NCT03225456|obesity|obesity
5123186|NCT03225456|oxytocin|oxytocin
5123187|NCT03225443|Locally advanced cervical cancer|locally advanced cervical cancer
5123188|NCT03225443|Particle radiotherapy|particle radiotherapy
5123189|NCT03225443|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5123190|NCT03225417|Ixazomib|ixazomib
5123191|NCT03225404|Tendinopathy|tendinopathy
5008782|NCT03941561|S-1|s-1
5123192|NCT03225404|Electrolysis|electrolysis
5123193|NCT03225404|Exercise|exercise
5123194|NCT03225404|Dry needing|dry needing
5123198|NCT03225378|Fluid responsiveness|fluid responsiveness
5123199|NCT03225378|Passive leg raising|passive leg raising
5123200|NCT03225378|Pulse pressure variation|pulse pressure variation
5123201|NCT03225365|Melanoma|melanoma
5123206|NCT03225326|local anesthesia|local anesthesia
5123207|NCT03225326|AMSA|amsa
5123208|NCT03225300|Glioblastoma|glioblastoma
5123209|NCT03225300|Chemoradiation|chemoradiation
5123210|NCT03225300|Simultaneous integrated boost|simultaneous integrated boost
5123211|NCT03225274|Breathing exercises|breathing exercises
5123212|NCT03225274|Respiratory status|respiratory status
5123213|NCT03225274|Nebulization therapy|nebulization therapy
5123214|NCT03225274|lower respiratory tract disorders|lower respiratory tract disorders
5123215|NCT03225235|Prostate cancer, SBRT, Ultrafractionation, CyberKnife|prostate cancer, sbrt, ultrafractionation, cyberknife
5123216|NCT03225222|Prostate cancer|prostate cancer
5123217|NCT03225222|multivariate risk assessment|multivariate risk assessment
5123218|NCT03225222|MRI|mri
5123219|NCT03225222|biopsy|biopsy
5123220|NCT03225222|screening|screening
5123221|NCT03225222|multicenter|multicenter
5123222|NCT03225209|Roux-en-y gastric bypass|roux-en-y gastric bypass
5123223|NCT03225209|GLP-1|glp-1
5123224|NCT03225209|Liraglutide|liraglutide
5123225|NCT03225209|OPTIFAST|optifast
5123228|NCT03225183|TOPMed|topmed
5123229|NCT03225183|Blood Pressure|blood pressure
5123230|NCT03225183|Long Noncoding RNA|long noncoding rna
5123231|NCT03225183|Gene Expression|gene expression
5123232|NCT03225183|MicroRNA|microrna
5123238|NCT03225157|Audiogram|audiogram
5123239|NCT03225157|Statins|statins
5123240|NCT03225157|Drug Response|drug response
5123241|NCT03225157|Cancer Treatment|cancer treatment
5123242|NCT03225157|Head and Neck Cancer|head and neck cancer
5123243|NCT03225144|Motor Neuron Disease|motor neuron disease
5123244|NCT03225144|Frontotemporal Dementia|frontotemporal dementia
5123245|NCT03225144|Corticobasal Syndrome|corticobasal syndrome
5123246|NCT03225131|Age Related Macular Degeneration|age related macular degeneration
5123247|NCT03225131|Dark Adaptation|dark adaptation
5123248|NCT03225118|Rebound|rebound
5123249|NCT03225118|Reinitiation|reinitiation
5123250|NCT03225118|ART|art
5123251|NCT03225118|Reservoirs|reservoirs
5123252|NCT03225118|Immune Exhaustion|immune exhaustion
5123257|NCT03225092|Chronic Knee Pain|chronic knee pain
5123258|NCT03225092|Status-Post Total Knee Arthroplasty|status-post total knee arthroplasty
5123259|NCT03225092|Platelet Rich Plasma|platelet rich plasma
5123260|NCT03225079|Pentaglobin® use|pentaglobin® use
5123261|NCT03225079|severe bacterial infection|severe bacterial infection
5962017|NCT04283526|primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
5962018|NCT04283526|osteomyelofibrosis|osteomyelofibrosis
5123262|NCT03225053|Percutaneous microelectrolysis|percutaneous microelectrolysis
5123263|NCT03225053|Physiotherapy|physiotherapy
5123264|NCT03225040|Acromegaly|acromegaly
5123265|NCT03225040|Pegvisomant|pegvisomant
5123266|NCT03225040|Osteoporosis|osteoporosis
5123267|NCT03225027|Emotional prosody, schizophrenia|emotional prosody, schizophrenia
5123268|NCT03225001|Sapien XT|sapien xt
5123269|NCT03225001|Partner II|partner ii
5123270|NCT03225001|cardiovascular disease|cardiovascular disease
5123271|NCT03225001|heart disease|heart disease
5123272|NCT03225001|aortic disease|aortic disease
5123273|NCT03225001|SAVR|savr
5123274|NCT03225001|TAVR|tavr
5123275|NCT03225001|failing surgical valve|failing surgical valve
5123276|NCT03225001|failing valve|failing valve
5123277|NCT03225001|failing bioprosthetic valve|failing bioprosthetic valve
5123278|NCT03224988|Alzheimer's Disease|alzheimer's disease
5123279|NCT03224988|AD|ad
5123280|NCT03224988|MCI-AD|mci-ad
5123281|NCT03224988|MCI|mci
5123282|NCT03224988|Memory|memory
5123283|NCT03224988|TMS|tms
5123284|NCT03224988|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5123285|NCT03224988|Neuropsychological evaluation|neuropsychological evaluation
5123286|NCT03224988|MRI|mri
5123287|NCT03224988|DTI|dti
5123288|NCT03224988|EEG|eeg
5123289|NCT03224975|Pain|pain
5123290|NCT03224975|Brain responses|brain responses
5123291|NCT03224975|Neuroimaging|neuroimaging
5123292|NCT03224975|fMRI|fmri
5123293|NCT03224975|Burn|burn
5123294|NCT03224975|Memory|memory
5123295|NCT03224962|pit and fissure caries|pit and fissure caries
5123296|NCT03224936|DISE|dise
5123297|NCT03224936|OSAS|osas
5123298|NCT03224936|PSI|psi
5123299|NCT03224910|FNA, smears, imprints, ROSE|fna, smears, imprints, rose
5123300|NCT03224897|Reappraisal|reappraisal
5011522|NCT03924219|cmv|cmv
5123301|NCT03224897|Emotion Regulation|emotion regulation
5123302|NCT03224897|tDCS|tdcs
5123303|NCT03224897|Reinterpretation|reinterpretation
5123304|NCT03224858|Patient-Centered Care|patient-centered care
5123305|NCT03224858|Comorbidity|comorbidity
5123306|NCT03224754|Atypia, thyroid, malignancy|atypia, thyroid, malignancy
5123307|NCT03224741|Behavioral Economics|behavioral economics
5123308|NCT03224702|M6495|m6495
5123309|NCT03224702|anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody|anti-a disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody
5123310|NCT03224702|Osteoarthritis|osteoarthritis
5123311|NCT03224676|Quality of sleep|quality of sleep
5123318|NCT03224663|Knowledge|knowledge
5123319|NCT03224663|Practices|practices
5123320|NCT03224663|Nursing students|nursing students
5123321|NCT03224585|anakinra|anakinra
5123322|NCT03224585|Kineret|kineret
5123323|NCT03224585|pericarditis|pericarditis
5123324|NCT03224572|vitamin C|vitamin c
5123325|NCT03224572|quality of life|quality of life
5123326|NCT03224572|terminal cancer|terminal cancer
5123327|NCT03224533|nut consumption|nut consumption
5123328|NCT03224533|NHANES|nhanes
5123329|NCT03224533|epidemiology|epidemiology
5123330|NCT03224533|plasma glucose|plasma glucose
5123331|NCT03224533|hemoglobin A1c|hemoglobin a1c
5123332|NCT03224507|multiple myeloma|multiple myeloma
5123333|NCT03224507|induction therapy|induction therapy
5123334|NCT03224507|autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
5123335|NCT03224507|KRdD|krdd
5123346|NCT03224468|dependence|dependence
5123347|NCT03224468|neurocognition|neurocognition
5123348|NCT03224468|MRI|mri
5123349|NCT03224455|sleep|sleep
5123350|NCT03224455|sleep in children|sleep in children
5123351|NCT03224455|children and sleep|children and sleep
5123352|NCT03224455|environment|environment
5123353|NCT03224455|environment and sleep|environment and sleep
5123354|NCT03224455|environment and children|environment and children
5123355|NCT03224416|Alcohol|alcohol
5123356|NCT03224416|Delay Discounting|delay discounting
5123357|NCT03224416|Risky Sexual Behavior|risky sexual behavior
5123358|NCT03224416|Decision Making|decision making
5123359|NCT03224416|MSM|msm
5123360|NCT03224390|Contraception|contraception
5123361|NCT03224390|Family Planning|family planning
5123362|NCT03224390|Digital Health|digital health
5123365|NCT03224364|Solo surgery|solo surgery
5123366|NCT03224364|Camera holder|camera holder
5123367|NCT03224364|Laparoscopic Appendectomy|laparoscopic appendectomy
5123368|NCT03224325|Drug therapy|drug therapy
5123369|NCT03224312|Primary aldosteronism|primary aldosteronism
5123370|NCT03224312|cardiovascular events|cardiovascular events
5123371|NCT03224312|cerebrovascular events|cerebrovascular events
5123372|NCT03224286|Pressure sensitive mat|pressure sensitive mat
5123373|NCT03224273|proximal box design preparation|proximal box design preparation
5123374|NCT03224247|vertical splitting|vertical splitting
5123375|NCT03224247|Cesarean Section Complications|cesarean section complications
5123376|NCT03224247|uterine vessels|uterine vessels
5123377|NCT03224247|injury|injury
5123378|NCT03224234|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
5123379|NCT03224234|Insulclock|insulclock
5123380|NCT03224234|Electronic device|electronic device
5123381|NCT03224234|Alarm system|alarm system
5962019|NCT04283526|myeloproliferative neoplasm|myeloproliferative neoplasm
5123382|NCT03224221|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5123383|NCT03224221|apatinib|apatinib
5123384|NCT03224208|melanoma|melanoma
5123385|NCT03224208|advanced|advanced
5123386|NCT03224208|vemurafenib|vemurafenib
5123387|NCT03224208|cobimetinib|cobimetinib
5123388|NCT03224195|rehabilitation|rehabilitation
5123389|NCT03224195|patient perspective|patient perspective
5123390|NCT03224195|semi-structured interview|semi-structured interview
5123391|NCT03224143|dementia|dementia
5123392|NCT03224143|doll therapy|doll therapy
5123393|NCT03224143|attachment|attachment
5123394|NCT03224130|transitions of care|transitions of care
5123395|NCT03224130|reutilization|reutilization
5123396|NCT03224130|nurse phone call|nurse phone call
5123397|NCT03224104|elderly|elderly
5123398|NCT03224104|TG02|tg02
5123399|NCT03224104|newly diagnosed|newly diagnosed
5123400|NCT03224104|first relapse|first relapse
5123406|NCT03224052|Anti-Bacterial Agents|anti-bacterial agents
5123407|NCT03224052|Falciparum|falciparum
5123408|NCT03224052|Vivax|vivax
5123409|NCT03224000|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5123410|NCT03224000|Oropharyngeal Cancer|oropharyngeal cancer
5123411|NCT03224000|Human papilloma virus positive|human papilloma virus positive
5123412|NCT03224000|HPV+|hpv+
5123413|NCT03224000|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5123415|NCT03224000|Squamous cell carcinoma of the base of tongue|squamous cell carcinoma of the base of tongue
5123416|NCT03224000|Squamous cell carcinoma of the soft palate|squamous cell carcinoma of the soft palate
5123417|NCT03224000|Squamous cell carcinoma of the oropharyngeal walls|squamous cell carcinoma of the oropharyngeal walls
5123418|NCT03224000|Magnetic Resonance Imaging Guided Radiotherapy|magnetic resonance imaging guided radiotherapy
5123419|NCT03224000|Standard of Care Radiotherapy Planning|standard of care radiotherapy planning
5123421|NCT03224000|Intensity modulated radiotherapy|intensity modulated radiotherapy
5123422|NCT03224000|IMRT|imrt
5123423|NCT03224000|Modified Barium Swallow|modified barium swallow
5123424|NCT03224000|MBS|mbs
5123425|NCT03224000|Swallowing questionnaire|swallowing questionnaire
5123426|NCT03224000|The M.D. Anderson Dysphagia Inventory (MDADI)|the m.d. anderson dysphagia inventory (mdadi)
5123427|NCT03224000|Symptom questionnaire|symptom questionnaire
5123428|NCT03224000|The M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN)|the m.d. anderson symptom inventory for head and neck cancer (mdasi-hn)
5123429|NCT03224000|Video-Strobe Procedure|video-strobe procedure
5123430|NCT03223987|16S rRNA|16s rrna
5120144|NCT03244176|DLBCL|dlbcl
5123431|NCT03223987|Microbiome|microbiome
5123432|NCT03223987|Strath Herbal Yeast Preparation|strath herbal yeast preparation
5123433|NCT03223974|Angioplasty|angioplasty
5123434|NCT03223974|drug-coated balloon|drug-coated balloon
5123435|NCT03223974|bifurcation|bifurcation
5123436|NCT03223961|myelodysplastic syndrome|myelodysplastic syndrome
5123437|NCT03223961|erythropoetin|erythropoetin
5123438|NCT03223922|whole brain radiation therapy|whole brain radiation therapy
5123439|NCT03223922|genu of corpus callosum|genu of corpus callosum
5123440|NCT03223922|cognitive function|cognitive function
5123441|NCT03223909|dry eye|dry eye
5123442|NCT03223909|Chondroitin sulfate|chondroitin sulfate
5123443|NCT03223909|Ocular lubricants|ocular lubricants
5123444|NCT03223896|antagonist|antagonist
5123445|NCT03223896|nasal|nasal
5123446|NCT03223857|visual outcomes|visual outcomes
5123447|NCT03223857|multifocal intraocular lens|multifocal intraocular lens
5123448|NCT03223857|patient satisfaction|patient satisfaction
5123449|NCT03223857|spectacle independence|spectacle independence
5123450|NCT03223844|Dopamine|dopamine
5123451|NCT03223844|Amphetamine|amphetamine
5123452|NCT03223844|Positron Emission Tomography|positron emission tomography
5123453|NCT03223844|Magnetic Resonance Imaging|magnetic resonance imaging
5123454|NCT03223844|Schizophrenia|schizophrenia
5123455|NCT03223844|Psychosis|psychosis
5123456|NCT03223844|[18F]FDOPA|[18f]fdopa
5123457|NCT03223844|[11C]-(+)-PHNO|[11c]-(+)-phno
5356835|NCT01917812|text messaging|text messaging
5123459|NCT03223831|Partially covered pyloro-duodenal stents|partially covered pyloro-duodenal stents
5123460|NCT03223831|uncovered pyloro-duodenal stents|uncovered pyloro-duodenal stents
5123461|NCT03223818|Liver|liver
5123462|NCT03223818|Digestive system|digestive system
5123463|NCT03223779|Colorectal Cancer|colorectal cancer
5123464|NCT03223766|Proton therapy|proton therapy
5123465|NCT03223766|Long-term effects|long-term effects
5123466|NCT03223727|Radium-223|radium-223
5123467|NCT03223714|Conbercept ophthalmic injection|conbercept ophthalmic injection
5123468|NCT03223714|ME|me
5123469|NCT03223714|CRVO|crvo
5123470|NCT03223662|Neoadjuvant Chemoradiotherapy (nCRT)|neoadjuvant chemoradiotherapy (ncrt)
5123471|NCT03223662|Esophagectomy|esophagectomy
5123472|NCT03223662|Tissue or serologic biomarkers|tissue or serologic biomarkers
5123473|NCT03223649|Metabolism|metabolism
5123474|NCT03223649|Children|children
5123475|NCT03223649|Walking Bouts|walking bouts
5123476|NCT03223649|Glucose|glucose
5123477|NCT03223649|Insulin|insulin
5123478|NCT03223636|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5962020|NCT04283526|chronic idiopathic myelofibrosis (cIMF)|chronic idiopathic myelofibrosis (cimf)
4995133|NCT04024410|prone position|prone position
5123479|NCT03223636|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5123480|NCT03223636|Electroencephalogram (EEG)|electroencephalogram (eeg)
5123481|NCT03223636|Magnetoencephalogram|magnetoencephalogram
5009148|NCT03939091|Ultrasonography|ultrasonography
5123482|NCT03223636|Transcranial Electrical Stimulation (TES)|transcranial electrical stimulation (tes)
5123483|NCT03223623|Complex Regional Pain Syndrome|complex regional pain syndrome
5123484|NCT03223623|CRPS|crps
5123485|NCT03223623|Dystonia|dystonia
5123486|NCT03223610|Monoclonal Antibody|monoclonal antibody
5123487|NCT03223610|Dose-Finding|dose-finding
5123488|NCT03223597|Radium-223|radium-223
5123489|NCT03223597|quality of life|quality of life
5123490|NCT03223597|Pain|pain
5123491|NCT03223571|stroke|stroke
5123492|NCT03223571|Upper arm|upper arm
5123493|NCT03223571|Cerebral plasticity|cerebral plasticity
5123494|NCT03223571|Functional connectivity|functional connectivity
5123495|NCT03223571|Rehabilitation|rehabilitation
5123496|NCT03223558|cardiac rehabilitation|cardiac rehabilitation
5123497|NCT03223545|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5123498|NCT03223545|Meditation|meditation
5123499|NCT03223519|DOMS|doms
5123500|NCT03223519|Exercise|exercise
5123501|NCT03223519|Ibuprofen|ibuprofen
5123502|NCT03223519|Magnesium|magnesium
5123503|NCT03223519|Vitamin C|vitamin c
5123504|NCT03223519|Muscle pain|muscle pain
5123505|NCT03223467|Obesity|obesity
5123506|NCT03223467|Obstructive sleep apnea|obstructive sleep apnea
5123507|NCT03223467|Bariatric surgery candidate|bariatric surgery candidate
5123508|NCT03223467|Metabolic syndrome|metabolic syndrome
5123509|NCT03223441|Pulse wave velocity|pulse wave velocity
5123510|NCT03223441|anesthesia|anesthesia
5123511|NCT03223415|Clostridium difficile infection|clostridium difficile infection
5123512|NCT03223415|Infection Control|infection control
5123513|NCT03223415|Prevention|prevention
5123514|NCT03223415|Asymptomatic carriage|asymptomatic carriage
5123515|NCT03223415|Colonization|colonization
5123516|NCT03223415|Pilot Study|pilot study
5123517|NCT03223415|Contact Precaution|contact precaution
5123518|NCT03223415|Detection|detection
5123519|NCT03223363|Birth weight Prediction|birth weight prediction
5123520|NCT03223363|Two-dimensional Ultrasonography|two-dimensional ultrasonography
5123521|NCT03223363|Three-dimensional Ultrasonography|three-dimensional ultrasonography
5123522|NCT03223337|GSK1278863|gsk1278863
5123523|NCT03223337|Daprodustat|daprodustat
5123524|NCT03223337|Healthy control|healthy control
5123525|NCT03223337|Single dose|single dose
5123526|NCT03223337|Hepatic Impairment|hepatic impairment
5123527|NCT03223324|Threatened Premature Labor|threatened premature labor
5123528|NCT03223324|Abdominal Fetal ECG|abdominal fetal ecg
5123529|NCT03223298|Myofascial Pain|myofascial pain
5123530|NCT03223298|Myofascial Pain Disorder|myofascial pain disorder
5123531|NCT03223298|Maxillofacial Pain|maxillofacial pain
5123532|NCT03223298|Masseter Muscle|masseter muscle
5123533|NCT03223298|Temporalis Muscle|temporalis muscle
5123534|NCT03223298|Botulinum Toxin|botulinum toxin
5123535|NCT03223285|Cervical spine;|cervical spine;
5123537|NCT03223285|Manual Therapy|manual therapy
5123539|NCT03223285|Range of Motion|range of motion
5123543|NCT03223259|Dance Injuries|dance injuries
5123544|NCT03223259|Injury Prevention Workshops|injury prevention workshops
5123545|NCT03223259|Motor Skill Theory|motor skill theory
5123546|NCT03223259|Gross Motor Skills|gross motor skills
5123547|NCT03223220|Stroke, Neuroprotection, Ketamine|stroke, neuroprotection, ketamine
5123548|NCT03223194|Crigler-Najjar|crigler-najjar
5123549|NCT03223194|CN|cn
5123550|NCT03223194|AAV8 Delivered Gene Transfer|aav8 delivered gene transfer
5123551|NCT03223194|Adeno Associated Virus|adeno associated virus
5123552|NCT03223181|Comiss|comiss
5123553|NCT03223155|Small cell lung cancer|small cell lung cancer
5123554|NCT03223155|ipilimumab|ipilimumab
5123578|NCT03223051|Motor assessment|motor assessment
5123579|NCT03223051|Space exploration|space exploration
5123581|NCT03223038|Nutrition|nutrition
5123582|NCT03223025|IGHD|ighd
5123583|NCT03223025|somatropin|somatropin
5356836|NCT01917812|SMS|sms
5123591|NCT03222999|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5123592|NCT03222986|sepsis, nanoparticle tracking analysis|sepsis, nanoparticle tracking analysis
5123593|NCT03222973|Remyelination|remyelination
5123594|NCT03222973|Re-myelination|re-myelination
5123595|NCT03222973|DMT|dmt
5123596|NCT03222973|LINGO-1|lingo-1
5123597|NCT03222973|Anti-LINGO-1|anti-lingo-1
5123598|NCT03222973|Opicinumab|opicinumab
5123599|NCT03222921|high tibial osteotomy|high tibial osteotomy
5123600|NCT03222908|Behavior|behavior
5123601|NCT03222908|Perioperative/Postoperative Complications|perioperative/postoperative complications
5123602|NCT03222908|contract agreement|contract agreement
5123603|NCT03222908|implementation intentions|implementation intentions
5123604|NCT03222908|precommitment|precommitment
5123605|NCT03222908|smoking cessation|smoking cessation
5123606|NCT03222895|Esophageal Neoplasms|esophageal neoplasms
5123607|NCT03222895|Lymph node metastases|lymph node metastases
5123608|NCT03222895|Esophagectomy|esophagectomy
5123609|NCT03222843|ITP|itp
5123610|NCT03222804|Infants|infants
5962021|NCT04283526|Angnogenic myeloid metaplasia|angnogenic myeloid metaplasia
5123611|NCT03222804|Probiotic|probiotic
5123612|NCT03222804|B. Infantis|b. infantis
5123613|NCT03222791|Diabetes|diabetes
5123614|NCT03222778|fluid responsiveness|fluid responsiveness
5123615|NCT03222778|tissue doppler|tissue doppler
5123616|NCT03222778|off-pump coronary bypass surgery|off-pump coronary bypass surgery
5123617|NCT03222765|prediabetes lifestyle drugs microvascular complications|prediabetes lifestyle drugs microvascular complications
5123618|NCT03222752|Alpha-Stim|alpha-stim
5123619|NCT03222752|Cranial Electrotherapy Stimulation|cranial electrotherapy stimulation
5123621|NCT03222726|exercise, diabetic kidney disease, complications|exercise, diabetic kidney disease, complications
5123622|NCT03222687|tacrolimus, Henoch-Schönlein purpura nephritis, children|tacrolimus, henoch-schönlein purpura nephritis, children
5123623|NCT03222674|AML|aml
5123624|NCT03222674|CAR T|car t
5123625|NCT03222674|Muc1,CLL1, CD33, CD38, CD56, and/or CD123|muc1,cll1, cd33, cd38, cd56, and/or cd123
5123630|NCT03222635|Barrett's esophagus|barrett's esophagus
5123631|NCT03222635|Submucosal esophageal adenocarcinoma|submucosal esophageal adenocarcinoma
5123632|NCT03222635|Endoscopic treatment|endoscopic treatment
5123633|NCT03222635|Endoscopic follow-up|endoscopic follow-up
5123634|NCT03222622|EGFR inhibitor, topical agent, psoriasis, phase 2|egfr inhibitor, topical agent, psoriasis, phase 2
5123646|NCT03222596|Quality of Life|quality of life
5123647|NCT03222596|Fatigue|fatigue
5123648|NCT03222596|Physical Disability|physical disability
5123649|NCT03222596|Disabilities Psychological|disabilities psychological
5123653|NCT03222583|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
5123654|NCT03222583|Genotype 1 to 6|genotype 1 to 6
5123655|NCT03222583|Asian|asian
5123656|NCT03222583|non-cirrhotic|non-cirrhotic
5123657|NCT03222583|Human Immunodeficiency Virus|human immunodeficiency virus
5123658|NCT03222583|co-infection|co-infection
5123659|NCT03222583|Treatment-naïve|treatment-naïve
5123660|NCT03222583|Treatment-experienced|treatment-experienced
5123661|NCT03222583|interferon|interferon
5123662|NCT03222544|methylene blue|methylene blue
5123663|NCT03222544|Photodynamics Therapy|photodynamics therapy
5123664|NCT03222518|acute pain, trauma, paracetamol, NSAID|acute pain, trauma, paracetamol, nsaid
5123665|NCT03222505|Stroke|stroke
5123666|NCT03222505|Gait Stride Management Assist|gait stride management assist
5123667|NCT03222505|Stroke, post 1 year or longer|stroke, post 1 year or longer
5123668|NCT03222492|Diffuse Cutaneous Systemic Sclerosis (dcSSc)|diffuse cutaneous systemic sclerosis (dcssc)
5123669|NCT03222492|Phase 1/2 clinical trial|phase 1/2 clinical trial
5123670|NCT03222492|dose escalation randomized trial|dose escalation randomized trial
5123671|NCT03222492|Brentuximab vedotin|brentuximab vedotin
5123672|NCT03222466|Patient educational materials; prostate cancer; co-creation|patient educational materials; prostate cancer; co-creation
5123673|NCT03222453|thalassemia|thalassemia
5123676|NCT03222388|electronic validation|electronic validation
5123677|NCT03222375|Yaroshuk's MEGA-DISCOVERY · DIAGNOSTICS · TREATMENT|yaroshuk's mega-discovery · diagnostics · treatment
5123678|NCT03222375|Yaroshuk's Scientific Medical School|yaroshuk's scientific medical school
5123679|NCT03222375|Center of Synergetics|center of synergetics
5123680|NCT03222375|Controlling spatiotemporal chaos/Dr. Synergetic|controlling spatiotemporal chaos/dr. synergetic
5123681|NCT03222375|Autowave processes in Medicine|autowave processes in medicine
5123682|NCT03222375|Autowave Reverberator|autowave reverberator
5123683|NCT03222375|Bifurcation of Dynamic systems on a plane|bifurcation of dynamic systems on a plane
5123684|NCT03222375|Spiral Autowaves|spiral autowaves
5123685|NCT03222375|Drift of Spiral Autowaves|drift of spiral autowaves
5123686|NCT03222375|Excitable medium and Cellular Automata|excitable medium and cellular automata
5123687|NCT03222375|Stochastic Resonance and Coherence Resonance|stochastic resonance and coherence resonance
5123688|NCT03222375|Autowaves/SQUED|autowaves/squed
5123689|NCT03222375|Theory of Semiconducting QUantum Excitonic Device|theory of semiconducting quantum excitonic device
5123690|NCT03222362|retinal detachment|retinal detachment
5123692|NCT03222362|age related macular degeneration|age related macular degeneration
5123695|NCT03222323|volunteers|volunteers
5123696|NCT03222284|diabetes|diabetes
5123697|NCT03222284|type 2 diabetes|type 2 diabetes
5123698|NCT03222284|type ii diabetes|type ii diabetes
5123699|NCT03222284|insulin|insulin
5123700|NCT03222284|mobile applications|mobile applications
5123701|NCT03222284|Diabetes Mellitus|diabetes mellitus
5123702|NCT03222284|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5123704|NCT03222284|health application|health application
5123705|NCT03222271|NIV weaning strategy|niv weaning strategy
5123706|NCT03222258|Palliative Care|palliative care
5123707|NCT03222258|Quality of Life|quality of life
5123708|NCT03222258|Prospective Cohort Study|prospective cohort study
5123709|NCT03222258|Treatment decision|treatment decision
5123710|NCT03222258|Utilization of health care|utilization of health care
5123711|NCT03222232|intestinal failure|intestinal failure
5123712|NCT03222232|catheter-related bloodstream infections|catheter-related bloodstream infections
5123713|NCT03222232|catheter salvage|catheter salvage
5123714|NCT03222232|recurrent infections|recurrent infections
5123715|NCT03222232|home parenteral support|home parenteral support
5123716|NCT03222219|dental implant insertional torque stability|dental implant insertional torque stability
5123717|NCT03222206|Hepatokine|hepatokine
5123718|NCT03222206|Adipokine|adipokine
5123719|NCT03222206|Saccharometabolism|saccharometabolism
5123720|NCT03222206|Lipid metabolism|lipid metabolism
5123721|NCT03222193|Medical device|medical device
5123722|NCT03222193|Retraining|retraining
5123723|NCT03222193|Snoring|snoring
5123724|NCT03222193|TRP|trp
5123725|NCT03222193|Tongue|tongue
5123726|NCT03222167|Elbasvir|elbasvir
5123727|NCT03222167|Grazoprevir|grazoprevir
5123728|NCT03222167|SVR12|svr12
5123729|NCT03222167|hepatitis C|hepatitis c
5123730|NCT03222167|metabolic syndrome|metabolic syndrome
5123731|NCT03222154|High Energy Shock Waves|high energy shock waves
5123732|NCT03222154|physiotherapy|physiotherapy
5123733|NCT03222141|Sapien 3|sapien 3
5123734|NCT03222141|Transfemoral|transfemoral
5123735|NCT03222141|Transapical|transapical
5123736|NCT03222141|Transaortic|transaortic
5123737|NCT03222141|TAVI|tavi
5123738|NCT03222141|Aortic Stenosis|aortic stenosis
5123739|NCT03222141|THV|thv
5123740|NCT03222141|Aortic Valve|aortic valve
5123741|NCT03222141|Transcatheter Heart Valve|transcatheter heart valve
5123742|NCT03222141|TAVR|tavr
5123743|NCT03222128|SAPIEN 3|sapien 3
5123744|NCT03222128|Transfemoral|transfemoral
5123745|NCT03222128|Transapical|transapical
5123748|NCT03222128|TAVI|tavi
5123749|NCT03222128|Aortic Stenosis|aortic stenosis
5123750|NCT03222128|THV|thv
5123751|NCT03222128|Aortic Valve|aortic valve
5123752|NCT03222128|Transcatheter Heart Valve|transcatheter heart valve
5123753|NCT03222128|TAVR|tavr
5123754|NCT03222063|Play interventions, anxiety|play interventions, anxiety
5123755|NCT03222024|ischaemic stroke|ischaemic stroke
5123756|NCT03222024|severe|severe
5123757|NCT03222024|malignant|malignant
5123758|NCT03222024|courses|courses
5123759|NCT03222024|risk factors|risk factors
5123760|NCT03222024|clinical course|clinical course
5123761|NCT03222024|management|management
5123762|NCT03222024|prognosis|prognosis
5123763|NCT03222011|Crohn Disease|crohn disease
5123764|NCT03222011|Inflammatory Bowel Disease|inflammatory bowel disease
5123765|NCT03222011|Intestinal stricture|intestinal stricture
5123766|NCT03221998|morbidly obese|morbidly obese
5123767|NCT03221998|,elective sleeve|,elective sleeve
5123768|NCT03221998|gastrectomy|gastrectomy
5123769|NCT03221998|paracetamol|paracetamol
5123770|NCT03221998|IV Perfelgan|iv perfelgan
5123771|NCT03221985|experience sampling method|experience sampling method
5123772|NCT03221972|25 hydroxyvitamin D|25 hydroxyvitamin d
5123773|NCT03221972|6-17 years old|6-17 years old
5123774|NCT03221972|vitamin D deficiency|vitamin d deficiency
5123784|NCT03221829|elderly patients|elderly patients
5123785|NCT03221829|transurethral resection of bladder tumour|transurethral resection of bladder tumour
5123786|NCT03221816|Menopause|menopause
5123787|NCT03221816|homocysteine|homocysteine
5123788|NCT03221816|lipid profile|lipid profile
5123789|NCT03221790|Irritable bowel syndrome|irritable bowel syndrome
5123790|NCT03221790|Low FODMAP diet|low fodmap diet
5123791|NCT03221790|Mucosal Inflammation|mucosal inflammation
5123792|NCT03221751|randomized controlled trial|randomized controlled trial
5123793|NCT03221738|BDD|bdd
5123794|NCT03221725|sacrospinous ligament fixation|sacrospinous ligament fixation
5123795|NCT03221725|stress urinary incontinence|stress urinary incontinence
5123796|NCT03221712|cardiopulmonary exercise test|cardiopulmonary exercise test
5123797|NCT03221712|chronic total occlusion|chronic total occlusion
5123798|NCT03221712|cardiac rehabilitation|cardiac rehabilitation
5123799|NCT03221673|Exercise|exercise
5123800|NCT03221673|Children|children
5123801|NCT03221673|Arkansas|arkansas
5123802|NCT03221673|Physical activity|physical activity
5123803|NCT03221673|Sedentary|sedentary
5123804|NCT03221660|filling material, polymerization|filling material, polymerization
5009425|NCT03937583|Pulmonary Embolism|pulmonary embolism
5123805|NCT03221647|Celiac Disease; P31-43; Loxorubine; TLR7.|celiac disease; p31-43; loxorubine; tlr7.
5123806|NCT03221634|Programmed cell death 1 receptor (PD1)|programmed cell death 1 receptor (pd1)
5123807|NCT03221634|PD-1|pd-1
5123808|NCT03221634|Programmed cell death ligand 1 receptor (PDL1)|programmed cell death ligand 1 receptor (pdl1)
5123809|NCT03221634|PD-L1|pd-l1
5123810|NCT03221621|Acne inversa|acne inversa
5123811|NCT03221621|Adalimumab|adalimumab
5123812|NCT03221621|Cost-effectiveness|cost-effectiveness
5123813|NCT03221608|Colorectal Cancer|colorectal cancer
5123814|NCT03221608|HIPEC|hipec
5123815|NCT03221608|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5123816|NCT03221608|Lobaplatin|lobaplatin
5123817|NCT03221556|Comparative effectiveness research|comparative effectiveness research
5123818|NCT03221556|Patient-centered medical home|patient-centered medical home
5123819|NCT03221556|Shared decision-making|shared decision-making
5123820|NCT03221530|suicidal ideation|suicidal ideation
5123821|NCT03221530|mental health|mental health
5123822|NCT03221530|adolescent|adolescent
5123823|NCT03221530|Latino|latino
5123824|NCT03221530|immigrant|immigrant
5123825|NCT03221504|urinary tract infections|urinary tract infections
5123826|NCT03221504|pyelonephritis|pyelonephritis
5123827|NCT03221504|cefuroxime|cefuroxime
5123828|NCT03221504|children|children
5123829|NCT03221491|Analgesia|analgesia
5123830|NCT03221491|Colorectal Surgery|colorectal surgery
5123831|NCT03221491|Background Infusion|background infusion
5123832|NCT03221439|back pain|back pain
5123833|NCT03221439|physiotherapy|physiotherapy
5123834|NCT03221439|exercise therapy|exercise therapy
5123835|NCT03221439|cognitive functional therapy|cognitive functional therapy
5123836|NCT03221439|low back pain|low back pain
5123837|NCT03221439|backache|backache
5123838|NCT03221439|lower back pain|lower back pain
5123839|NCT03221439|lumbago|lumbago
5123840|NCT03221439|multidimensional|multidimensional
5123841|NCT03221439|biopsychosocial|biopsychosocial
5123943|NCT03220594|anti-mullerian hormone|anti-mullerian hormone
5123845|NCT03221413|Neuroimaging|neuroimaging
5123846|NCT03221413|EEG|eeg
5123847|NCT03221387|Therapy|therapy
5123848|NCT03221387|Noninvasive Ventilation|noninvasive ventilation
5123849|NCT03221335|EUS-guided RFA|eus-guided rfa
5123850|NCT03221335|liver|liver
5123851|NCT03221335|stomach|stomach
5123852|NCT03221335|adrenal|adrenal
5123853|NCT03221335|kidney tumour|kidney tumour
5123854|NCT03221283|Music therapy|music therapy
5123855|NCT03221283|Depression|depression
5123856|NCT03221283|Emotion|emotion
5123857|NCT03221283|Motivation|motivation
5123858|NCT03221270|tACS|tacs
5123859|NCT03221270|Sham|sham
5123860|NCT03221270|Auditory Hallucinations|auditory hallucinations
5123861|NCT03221270|Schizophrenia|schizophrenia
5123862|NCT03221270|Schizo Affective Disorder|schizo affective disorder
5123863|NCT03221270|EEG|eeg
5123864|NCT03221244|Distractibility|distractibility
5123866|NCT03221244|Attention|attention
5123867|NCT03221244|Child|child
5123868|NCT03221244|Pediatric|pediatric
5123869|NCT03221205|sleep apnea, obstructive|sleep apnea, obstructive
5123870|NCT03221205|obesity|obesity
5123871|NCT03221205|DM2|dm2
5123872|NCT03221205|TEI index|tei index
5123873|NCT03221205|CPAP|cpap
5123874|NCT03221192|Real-time data capture|real-time data capture
5123875|NCT03221192|Concept elicitation|concept elicitation
5123876|NCT03221192|Nasal polyps|nasal polyps
5123877|NCT03221192|Cognitive debriefing|cognitive debriefing
5123878|NCT03221192|Patient-reported outcomes|patient-reported outcomes
5123879|NCT03221192|HRQoL|hrqol
5123880|NCT03221166|Children|children
5123881|NCT03221166|Crohn disease|crohn disease
5123882|NCT03221166|Thalidomide|thalidomide
5123883|NCT03221166|Mucosal healing|mucosal healing
5123884|NCT03221153|Patient Safety|patient safety
5123885|NCT03221153|Quality|quality
5123886|NCT03221153|Simulation|simulation
5123887|NCT03221153|Undergraduate|undergraduate
5123888|NCT03221153|Medical Student|medical student
5123889|NCT03221114|Hispanics/Latinos|hispanics/latinos
5123890|NCT03221114|Underserved Population|underserved population
5123891|NCT03221075|Invasive Aspergillosis|invasive aspergillosis
5123892|NCT03221075|Azole resistance|azole resistance
5123893|NCT03221075|Aspergillus fumigatus|aspergillus fumigatus
5123894|NCT03221075|Efficacy of antifungal therapy|efficacy of antifungal therapy
5123895|NCT03221075|Patient registry|patient registry
5123896|NCT03221049|diagnosis performance|diagnosis performance
5123897|NCT03221049|hepatocellular carcinoma|hepatocellular carcinoma
5123898|NCT03221049|liver fibrosis|liver fibrosis
5123899|NCT03221049|progression|progression
5123900|NCT03221036|Drug therapy|drug therapy
5123901|NCT03221023|Vancomycin|vancomycin
5356837|NCT01917799|Aspirin|aspirin
5123902|NCT03221023|Implantable Neural Stimulator|implantable neural stimulator
5123903|NCT03221023|Deep Brain Stimulation|deep brain stimulation
5123904|NCT03221023|Surgical Site Infection|surgical site infection
5123905|NCT03221010|Smoking|smoking
5009536|NCT03937050|pregnancy|pregnancy
5123906|NCT03221010|Smoking cessation|smoking cessation
5123907|NCT03221010|Motivational Interviewing|motivational interviewing
5123908|NCT03221010|Primary health care|primary health care
5123909|NCT03221010|Randomized clinical trial|randomized clinical trial
5123910|NCT03220997|Sequela|sequela
5123911|NCT03220997|Ketosis|ketosis
5123912|NCT03220971|Lipoprotein and Apolipoproteins metabolism|lipoprotein and apolipoproteins metabolism
5123913|NCT03220932|Epithelial Ovarian Cancer - Platinum-resistant - Cytoreductive surgery - HIPEC - Quality of Life|epithelial ovarian cancer - platinum-resistant - cytoreductive surgery - hipec - quality of life
5123914|NCT03220919|Insulin|insulin
5123915|NCT03220919|Type 2 diabetes|type 2 diabetes
5123916|NCT03220880|Dexmedetomidine|dexmedetomidine
5123917|NCT03220880|Sedation|sedation
5123918|NCT03220880|Pediatric|pediatric
5123919|NCT03220841|Crohn Disease|crohn disease
5123920|NCT03220841|Inflammatory Bowel Disease|inflammatory bowel disease
5123921|NCT03220841|Intestinal stricture|intestinal stricture
5123922|NCT03220698|endotracheal intubation|endotracheal intubation
5123923|NCT03220698|confirmation|confirmation
5123924|NCT03220698|ultrasonography|ultrasonography
5123925|NCT03220685|Microbiota|microbiota
5123926|NCT03220672|Pelvic floor muscles|pelvic floor muscles
5123927|NCT03220672|pelvic floor muscle training|pelvic floor muscle training
5123928|NCT03220672|motor control|motor control
5123929|NCT03220672|Educational intervention|educational intervention
5123930|NCT03220672|menopause|menopause
5123931|NCT03220646|Abemaciclib (LY2835219)|abemaciclib (ly2835219)
5123932|NCT03220646|meningioma|meningioma
5036509|NCT03770910|GIP|gip
5123933|NCT03220646|Astrocytoma|astrocytoma
5123934|NCT03220646|ependymoma|ependymoma
5123935|NCT03220646|Oligodendroglioma|oligodendroglioma
5123936|NCT03220646|CNS lymphoma|cns lymphoma
5123937|NCT03220646|17-261|17-261
5123938|NCT03220620|fluid therapy|fluid therapy
5123939|NCT03220620|perioperative|perioperative
5123940|NCT03220620|hemodilution|hemodilution
5123941|NCT03220607|uterocervical angle, second trimester abortion|uterocervical angle, second trimester abortion
5123942|NCT03220594|hypogastric artery|hypogastric artery
5123961|NCT03220477|mocetinostat|mocetinostat
5123962|NCT03220477|17-241|17-241
5123971|NCT03220412|adolescent|adolescent
5123972|NCT03220412|gun|gun
5123973|NCT03220412|violence|violence
5123981|NCT03220373|Drop-out|drop-out
5123982|NCT03220373|Follow-up|follow-up
5123989|NCT03220308|Self-control|self-control
5123990|NCT03220308|Well-being|well-being
5123991|NCT03220269|Utstein|utstein
5123992|NCT03220269|Resuscitation|resuscitation
5123993|NCT03220269|Epidemiology|epidemiology
5123994|NCT03220269|Emergency medicine|emergency medicine
5123995|NCT03220269|Resuscitation Registry|resuscitation registry
5123996|NCT03220230|Next generation sequencing|next generation sequencing
5123997|NCT03220230|Lung cancer|lung cancer
5123998|NCT03220230|target therapies|target therapies
5123999|NCT03220204|Heart Failure|heart failure
5124000|NCT03220204|Positive Psychology|positive psychology
5124001|NCT03220204|Adherence to Health Behaviors|adherence to health behaviors
5124002|NCT03220178|breast cancer|breast cancer
5124003|NCT03220178|HER2 negative|her2 negative
5124004|NCT03220178|hormone receptor positive|hormone receptor positive
5124005|NCT03220178|advanced|advanced
5124006|NCT03220178|metastatic|metastatic
5124007|NCT03220113|Migraine|migraine
5124008|NCT03220113|Craniofacial Neuralgia|craniofacial neuralgia
5124009|NCT03220100|Lung Cancer|lung cancer
5124010|NCT03219983|interscalene block|interscalene block
5124011|NCT03219983|liposomal bupivacaine|liposomal bupivacaine
5124019|NCT03219931|infant colics|infant colics
5124020|NCT03219931|probiotic|probiotic
5124021|NCT03219931|gut microbiome|gut microbiome
5124022|NCT03219931|bifidobacterium breve|bifidobacterium breve
5124023|NCT03219931|crying time|crying time
5124024|NCT03219918|Colorectal adenoma|colorectal adenoma
5124025|NCT03219918|Colonoscopy|colonoscopy
5124026|NCT03219918|Caps|caps
5124027|NCT03219918|Adenoma detection rate|adenoma detection rate
5124028|NCT03219892|freezing of gait|freezing of gait
5124029|NCT03219892|rTMS|rtms
5124030|NCT03219892|fMRI|fmri
5124031|NCT03219879|Relapse prevention|relapse prevention
5124032|NCT03219879|Persistent depressive disorder|persistent depressive disorder
5124033|NCT03219879|Recurrent depressive disorder|recurrent depressive disorder
5124034|NCT03219879|Telephone-based intervention|telephone-based intervention
5124035|NCT03219879|Cognitive behavioral therapy|cognitive behavioral therapy
5124036|NCT03219866|Nebulizer|nebulizer
5124037|NCT03219866|Inhaler|inhaler
5124038|NCT03219840|Cetylpyridium Chloride (CPC)|cetylpyridium chloride (cpc)
5124039|NCT03219840|Chewing Gum|chewing gum
5124040|NCT03219814|body-image|body-image
5124041|NCT03219814|attention|attention
5124042|NCT03219814|cognitive dissonance|cognitive dissonance
5009663|NCT03936127|Transperineal|transperineal
5124043|NCT03219814|eating disorder prevention|eating disorder prevention
5124044|NCT03219788|emergence|emergence
5124045|NCT03219788|remifentanil|remifentanil
5124046|NCT03219788|recovery|recovery
5124047|NCT03219788|desflurene|desflurene
5124063|NCT03219606|Modified Rodnan skin score|modified rodnan skin score
5124064|NCT03219528|Irritable Bowel Syndrome|irritable bowel syndrome
5124065|NCT03219528|Diarrhea|diarrhea
5124066|NCT03219528|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5124067|NCT03219528|Gut Microbiota|gut microbiota
5124068|NCT03219489|Electronic Medical Record|electronic medical record
5124069|NCT03219489|Progesterone|progesterone
5124070|NCT03219476|aromatase inhibitor|aromatase inhibitor
5124071|NCT03219476|breast cancer|breast cancer
5124072|NCT03219476|estrogen receptor|estrogen receptor
5124073|NCT03219476|progesterone receptor|progesterone receptor
5124074|NCT03219476|endocrine-targeted therapy|endocrine-targeted therapy
5124075|NCT03219476|Anti-estrogen therapy|anti-estrogen therapy
5124077|NCT03219476|HER2-negative|her2-negative
5124078|NCT03219476|Neoadjuvant Treatment|neoadjuvant treatment
5124079|NCT03219450|Leukemia|leukemia
5124080|NCT03219450|Lymphocytic Leukemia|lymphocytic leukemia
5124081|NCT03219437|ABBV-066|abbv-066
5124082|NCT03219437|BI 655066|bi 655066
5124083|NCT03219424|Return to work status|return to work status
5124084|NCT03219424|Functional outcome|functional outcome
5124085|NCT03219424|Quality of life|quality of life
5124086|NCT03219398|Living donor laparoscopic nephrectomy|living donor laparoscopic nephrectomy
5124087|NCT03219398|Pneumoperitoneum|pneumoperitoneum
5124088|NCT03219398|Renal resistive index|renal resistive index
5124089|NCT03219398|Syndecan-1|syndecan-1
5124090|NCT03219398|soluble VEGF-R2|soluble vegf-r2
5962022|NCT04283526|myelofibrosis with myeloid metaplasia (MMM)|myelofibrosis with myeloid metaplasia (mmm)
5124091|NCT03219398|Occludin|occludin
5124092|NCT03219398|KIM-1|kim-1
5124093|NCT03219398|Interleukin-6|interleukin-6
5124094|NCT03219385|uterine leiomyoma|uterine leiomyoma
5124095|NCT03219385|uterine fibroid|uterine fibroid
5124100|NCT03219385|high-intensity focused ultrasound|high-intensity focused ultrasound
5124101|NCT03219385|ultrasound imaging|ultrasound imaging
5124103|NCT03219359|Inflammatory Bowel Diseases|inflammatory bowel diseases
5124104|NCT03219359|Gastroenteritis|gastroenteritis
5124105|NCT03219359|Crohn's disease|crohn's disease
5124107|NCT03219359|Vedolizumab|vedolizumab
5124108|NCT03219346|stroke , swallowing function ,oral health quality of life|stroke , swallowing function ,oral health quality of life
5124120|NCT03219320|Type 2 Diabetes|type 2 diabetes
5124121|NCT03219320|Neuropathic Pain|neuropathic pain
5124122|NCT03219320|Peripheral Nervous System|peripheral nervous system
5124123|NCT03219307|cartilage repair|cartilage repair
5124124|NCT03219307|cartilage regeneration|cartilage regeneration
5124125|NCT03219307|cartilage reconstruction|cartilage reconstruction
5124126|NCT03219307|cartilage restoration|cartilage restoration
5124127|NCT03219307|autologous chondrocyte implantation|autologous chondrocyte implantation
5124128|NCT03219307|matrix associated chondrocyte implantation|matrix associated chondrocyte implantation
5124129|NCT03219294|neuromuscular blockade|neuromuscular blockade
5124130|NCT03219294|sugammadex|sugammadex
5124131|NCT03219255|Post-marketing|post-marketing
5124132|NCT03219255|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5124133|NCT03219255|Drug use investigation|drug use investigation
5124134|NCT03219255|RELVAR 100 ELLIPTA|relvar 100 ellipta
5124135|NCT03219242|Advanced ovarian cancer|advanced ovarian cancer
5124136|NCT03219229|Fat-free mass|fat-free mass
5124137|NCT03219229|Tanner stage 1|tanner stage 1
5124139|NCT03219216|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
5124140|NCT03219216|Genotype 1 - 6|genotype 1 - 6
5124141|NCT03219216|Metavir System Fibrosis Score|metavir system fibrosis score
5124142|NCT03219216|Glecaprevir|glecaprevir
5124143|NCT03219216|Pibrentasvir|pibrentasvir
5124144|NCT03219216|Treatment naïve|treatment naïve
5124145|NCT03219216|Cirrhosis|cirrhosis
5124146|NCT03219216|Compensated cirrhosis|compensated cirrhosis
5124147|NCT03219203|HBV vaccination|hbv vaccination
5124148|NCT03219203|immunity|immunity
5124149|NCT03219138|muscle function tests|muscle function tests
5124150|NCT03219125|marrow adipose tissue|marrow adipose tissue
5124151|NCT03219125|bone marrow adiposity|bone marrow adiposity
5124152|NCT03219112|balance|balance
5124153|NCT03219112|rehabilitation|rehabilitation
5124154|NCT03219112|exergaming|exergaming
5124155|NCT03219112|virtual reality|virtual reality
5124156|NCT03219086|combined spinal epidural anesthesia|combined spinal epidural anesthesia
5124157|NCT03219086|caesarian section|caesarian section
5124158|NCT03219086|prilocaine|prilocaine
5124159|NCT03219086|bupivacaine|bupivacaine
5124160|NCT03219073|multiple sclerosis|multiple sclerosis
5124161|NCT03219073|neuropathic pain|neuropathic pain
5124162|NCT03219073|[18F] FDG-PET CT|[18f] fdg-pet ct
5124163|NCT03219073|tDCS|tdcs
5025005|NCT03841799|Microbiota|microbiota
5124164|NCT03219073|transcranial direct current stimulation|transcranial direct current stimulation
5124165|NCT03219060|Cognitive dissonance|cognitive dissonance
5124166|NCT03219060|Motivational interviewing|motivational interviewing
5124167|NCT03219060|Health Professional role|health professional role
5124168|NCT03219060|Nurses|nurses
5124169|NCT03219060|Health Promotion|health promotion
5124170|NCT03219060|Lifestyle|lifestyle
5124171|NCT03219060|Smoking cessation|smoking cessation
5124172|NCT03219034|oral appliance|oral appliance
5124173|NCT03219034|sleep quality|sleep quality
5124174|NCT03219034|sleep apnea|sleep apnea
5124175|NCT03219021|Cleft lip and Palate|cleft lip and palate
5124176|NCT03219021|unilateral cleft lip and palate|unilateral cleft lip and palate
5124177|NCT03219021|surgically repaired cleft lip and palate|surgically repaired cleft lip and palate
5124178|NCT03219021|arch dimensions|arch dimensions
5124179|NCT03219021|arch discrepancies|arch discrepancies
5124180|NCT03219021|dental arch dimensions|dental arch dimensions
5124181|NCT03219021|arch parameter|arch parameter
5124182|NCT03219021|arch circumference|arch circumference
5124183|NCT03219021|intercanine width|intercanine width
5124184|NCT03219021|first deciduous molar width|first deciduous molar width
5124185|NCT03219021|second deciduous molar width|second deciduous molar width
5124186|NCT03219021|permanent first molar width|permanent first molar width
5124187|NCT03219008|depressive disorder|depressive disorder
5124188|NCT03219008|multi-dimensional diagnosis technique|multi-dimensional diagnosis technique
5124189|NCT03219008|individualized therapy|individualized therapy
5124190|NCT03219008|management technique|management technique
5124191|NCT03219008|e-MBC|e-mbc
5124192|NCT03219008|MBC|mbc
5124193|NCT03218995|DMD|dmd
5124194|NCT03218995|Duchenne|duchenne
5124195|NCT03218995|Eteplirsen|eteplirsen
5124196|NCT03218995|dystrophy|dystrophy
5124198|NCT03218995|exon 51|exon 51
5124199|NCT03218982|Caregiver|caregiver
5124200|NCT03218982|Vietnamese|vietnamese
5124201|NCT03218982|Alzheimer's Disease|alzheimer's disease
5124202|NCT03218956|Protein requirement|protein requirement
5124203|NCT03218943|BiPAP|bipap
5124204|NCT03218943|APRV|aprv
4995862|NCT04019704|MDD|mdd
5124205|NCT03218943|Physiological dead space|physiological dead space
5124206|NCT03218943|volumetric capnography|volumetric capnography
5124207|NCT03218943|ARDS|ards
5124208|NCT03218943|impaired oxygenation|impaired oxygenation
5124209|NCT03218943|ICU|icu
5124210|NCT03218943|Mechanical ventilation|mechanical ventilation
5124211|NCT03218930|General Practice|general practice
5124212|NCT03218930|Social Marketing|social marketing
5124213|NCT03218930|Behavior Change|behavior change
5124214|NCT03218930|Antibiotic Prescribing|antibiotic prescribing
5124215|NCT03218917|P aeruginosa|p aeruginosa
5124216|NCT03218917|bronchiectasis|bronchiectasis
5124217|NCT03218917|active neutrophil elastase|active neutrophil elastase
5124218|NCT03218904|Glucose Breath Test|glucose breath test
5124219|NCT03218891|Refractory Angina|refractory angina
5124220|NCT03218891|Rehabilitation|rehabilitation
5124221|NCT03218839|PrePex|prepex
5124222|NCT03218839|HIV Seropositivity|hiv seropositivity
5124223|NCT03218800|subcutaneous|subcutaneous
5124224|NCT03218800|ertapenem|ertapenem
5124225|NCT03218800|urinary tract infection|urinary tract infection
5124226|NCT03218800|advanced cancer|advanced cancer
5124227|NCT03218800|palliative care|palliative care
5124228|NCT03218787|Coronary Artery Lesions|coronary artery lesions
5124229|NCT03218787|XIENCE|xience
5124230|NCT03218787|Dual Antiplatelet Therapy (DAPT)|dual antiplatelet therapy (dapt)
5124231|NCT03218787|Reduced DAPT|reduced dapt
5124232|NCT03218787|Risk of bleeding|risk of bleeding
5124233|NCT03218787|Drug-eluting stents|drug-eluting stents
5124234|NCT03218761|norepinephrine|norepinephrine
5124235|NCT03218761|norepinephrine transporter|norepinephrine transporter
5124236|NCT03218748|Mental illness|mental illness
5124237|NCT03218748|Disclosure|disclosure
5124239|NCT03218748|soldiers|soldiers
5124240|NCT03218748|secrecy|secrecy
5124241|NCT03218735|large for gestational age fetal growth|large for gestational age fetal growth
5124242|NCT03218722|Acute traumatic coagulopathy|acute traumatic coagulopathy
5124243|NCT03218722|Hemostasis|hemostasis
5124244|NCT03218722|Severe hemorrhage|severe hemorrhage
5124276|NCT03218540|stroke volume variation|stroke volume variation
5124277|NCT03218540|central venous pressure|central venous pressure
5124278|NCT03218540|serum lactate|serum lactate
5124279|NCT03218540|serum creatinine|serum creatinine
5124280|NCT03218514|Obesity|obesity
5124281|NCT03218514|Venous thromboembolism|venous thromboembolism
5124282|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5124283|NCT03218514|Body Composition|body composition
5124284|NCT03218514|Glomerular filtration rate|glomerular filtration rate
5124285|NCT03218514|Bariatric Surgery|bariatric surgery
5124286|NCT03218501|Uremic Pruritus|uremic pruritus
5124287|NCT03218462|sensory adapted environment|sensory adapted environment
5124288|NCT03218462|pediatric dentistry|pediatric dentistry
5124289|NCT03218462|oral health|oral health
5124290|NCT03218462|Developmental Disability|developmental disability
5124291|NCT03218462|Intellectual Disability|intellectual disability
5124292|NCT03218462|dental anxiety|dental anxiety
5124293|NCT03218462|autism spectrum|autism spectrum
5124294|NCT03218423|screening|screening
5124295|NCT03218423|plasma|plasma
5124296|NCT03218423|DNA methylation|dna methylation
5124297|NCT03218410|surgical embolectomy|surgical embolectomy
5124298|NCT03218410|catheter-directed therapy|catheter-directed therapy
5124299|NCT03218397|Gram-negative Bacteremia|gram-negative bacteremia
5124301|NCT03218397|Critically ill|critically ill
5124302|NCT03218397|Intensive Care Unit|intensive care unit
5124303|NCT03218397|Rapid identification|rapid identification
5124304|NCT03218397|Rapid susceptibility|rapid susceptibility
5124305|NCT03218397|Accelerate PhenoTest™ BC Kit|accelerate phenotest™ bc kit
5124306|NCT03218397|Accelerate Pheno™ System (AXDX)|accelerate pheno™ system (axdx)
5124307|NCT03218397|Antimicrobial stewardship|antimicrobial stewardship
5124308|NCT03218397|Antimicrobial use|antimicrobial use
5124309|NCT03218384|Injectafer|injectafer
5124310|NCT03218384|ferric carboxymaltose|ferric carboxymaltose
5124311|NCT03218384|Supplemental Iron|supplemental iron
5124312|NCT03218371|scleral indentation|scleral indentation
5124313|NCT03218371|chandelier light|chandelier light
5124314|NCT03218371|air vitrectomy|air vitrectomy
5124315|NCT03218371|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5124316|NCT03218345|EUS-guided RFA|eus-guided rfa
5124317|NCT03218345|pancreatic ca|pancreatic ca
5124318|NCT03218345|interventional EUS|interventional eus
5124319|NCT03218306|SPI|spi
5124320|NCT03218306|Remifentanil|remifentanil
5124321|NCT03218306|Target controlled infusion|target controlled infusion
5124322|NCT03218280|trauma|trauma
5124323|NCT03218280|antioxidant|antioxidant
5124324|NCT03218280|oxidative stress|oxidative stress
5124325|NCT03218280|Vitamin C|vitamin c
5124326|NCT03218280|Ascorbic Acid|ascorbic acid
5134176|NCT03155113|HCV|hcv
5124336|NCT03218202|Intestinal stricture|intestinal stricture
5124337|NCT03218189|Essential medicines lists|essential medicines lists
5124338|NCT03218163|bone marrow|bone marrow
5124339|NCT03218163|bone marrow transplant|bone marrow transplant
5124340|NCT03218163|allogeneic|allogeneic
5962023|NCT04283513|Hemmorrhagic Fever|hemmorrhagic fever
4995979|NCT04019054|Phobia|phobia
5124353|NCT03218085|prevention|prevention
5124354|NCT03218085|microbiome|microbiome
5124355|NCT03218085|cervicovaginal|cervicovaginal
5124356|NCT03218085|biopsy|biopsy
5124357|NCT03218085|swab|swab
5124358|NCT03218085|cytokines|cytokines
5124359|NCT03218085|inflammation|inflammation
5124360|NCT03218085|pharmacology|pharmacology
5124361|NCT03218059|Cesarean Scar Pregnancy|cesarean scar pregnancy
5124362|NCT03218033|systemic lupus|systemic lupus
5124363|NCT03218033|self-management|self-management
5124364|NCT03218033|social media|social media
5124365|NCT03217942|Muscle soreness|muscle soreness
5124366|NCT03217942|NGF-induced pain|ngf-induced pain
5124367|NCT03217942|Pain model|pain model
5124368|NCT03217942|Long-lasting sensitization|long-lasting sensitization
5124369|NCT03217929|vagus nerve|vagus nerve
5124370|NCT03217929|obesity|obesity
5124371|NCT03217929|craving|craving
5124372|NCT03217929|food|food
5124373|NCT03217916|podocyte glycoprotein|podocyte glycoprotein
5124374|NCT03217916|kidney injury|kidney injury
5124375|NCT03217916|preeclampsia|preeclampsia
5124376|NCT03217903|Myelodysplastic syndromes|myelodysplastic syndromes
5124377|NCT03217877|noninvasive stress testing|noninvasive stress testing
5124378|NCT03217877|high risk|high risk
5124379|NCT03217877|unstable angina|unstable angina
5124380|NCT03217877|PCI|pci
5124381|NCT03217864|Cancer|cancer
5124382|NCT03217864|palliative care|palliative care
5124383|NCT03217864|hospitalization at home|hospitalization at home
5124384|NCT03217864|home health care provider|home health care provider
5124385|NCT03217851|Plasmodium falciparum|plasmodium falciparum
5124386|NCT03217851|Prevalence Survey|prevalence survey
5124387|NCT03217851|Antimalarial Drug|antimalarial drug
5124398|NCT03217786|Macrovascular Disease|macrovascular disease
5124399|NCT03217786|Microvascular Coronary Artery Disease|microvascular coronary artery disease
5124400|NCT03217786|Cardiac Transplant Rejection|cardiac transplant rejection
5124401|NCT03217786|Transplant; Failure, Heart|transplant; failure, heart
5124402|NCT03217786|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
5124403|NCT03217786|Optical Coherence Tomography|optical coherence tomography
5010003|NCT03934060|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5124404|NCT03217786|Index of Microcirculatory Resistance|index of microcirculatory resistance
5124405|NCT03217786|Fractional Flow Reserve|fractional flow reserve
5124406|NCT03217786|Coronary Flow Reserve|coronary flow reserve
5124407|NCT03217786|Positron Emission Tomography|positron emission tomography
5124408|NCT03217786|Endomyocardial Biopsies|endomyocardial biopsies
5124409|NCT03217760|Induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.|induced stress, dental anxiety, endodontic treatment, salivary cortisol, cardiovascular parameters, pain, discomfort.
5124410|NCT03217695|Heart rate variability|heart rate variability
5124411|NCT03217695|Self-efficacy|self-efficacy
5124412|NCT03217695|Pediatrics|pediatrics
5124413|NCT03217695|Mindfulness-based yoga|mindfulness-based yoga
5124414|NCT03217695|Symptoms|symptoms
5124415|NCT03217682|Hospice|hospice
5124416|NCT03217682|Palliative Care|palliative care
5124417|NCT03217682|Integrative Medicine|integrative medicine
5124418|NCT03217682|Massage Therapy|massage therapy
5124419|NCT03217682|Music Therapy|music therapy
5124420|NCT03217682|Caregivers|caregivers
5124423|NCT03217617|SCID-X1|scid-x1
5124424|NCT03217617|lentiviral vector|lentiviral vector
5124425|NCT03217604|PF-06852231|pf-06852231
5124426|NCT03217604|Safety|safety
5124427|NCT03217604|Tolerability|tolerability
5124428|NCT03217604|Pharmacokinetics|pharmacokinetics
5124429|NCT03217604|First-in-human|first-in-human
5124430|NCT03217604|Healthy subjects|healthy subjects
5124431|NCT03217578|Spinal Muscular Atrophy|spinal muscular atrophy
5124432|NCT03217578|Newborn Screening|newborn screening
5124433|NCT03217526|Burn injury|burn injury
5124434|NCT03217526|Gait|gait
5124435|NCT03217526|Physical Function|physical function
5124436|NCT03217513|osteoporosis|osteoporosis
5124444|NCT03217383|mandibular protrusion|mandibular protrusion
5124445|NCT03217370|patient blood management|patient blood management
5124446|NCT03217370|restrictive transfusion|restrictive transfusion
5124447|NCT03217357|tDCS, non invasive brain stimulation|tdcs, non invasive brain stimulation
5124448|NCT03217318|ureteral stent|ureteral stent
5124449|NCT03217305|EIT. NAVA. Endexpiratory Lung Impedance.|eit. nava. endexpiratory lung impedance.
5124450|NCT03217279|stroke-participation|stroke-participation
5124451|NCT03217279|restriction-needs-cohort-patients-caregivers|restriction-needs-cohort-patients-caregivers
5124452|NCT03217201|Breast Cancer|breast cancer
5124454|NCT03217201|Circadian Rhythm|circadian rhythm
5124455|NCT03217201|Light Therapy|light therapy
5124456|NCT03217201|Chemotherapy side effects|chemotherapy side effects
5124457|NCT03217188|Proton Re-Irradiation|proton re-irradiation
5124459|NCT03217175|bionic pancreas|bionic pancreas
5124460|NCT03217175|type 1 diabetes|type 1 diabetes
5124461|NCT03217123|OCD, DBS, fMRI, Y-BOCS, tractography|ocd, dbs, fmri, y-bocs, tractography
5124462|NCT03217110|Cerebellum|cerebellum
5124463|NCT03217097|Neuroendocrine tumors|neuroendocrine tumors
5124464|NCT03217097|Methylation MGMT status|methylation mgmt status
5124465|NCT03217097|Alkylating agents|alkylating agents
5962024|NCT04283513|Ribavirin|ribavirin
5124466|NCT03217097|Oxaliplatin|oxaliplatin
5124467|NCT03217084|White spot lesion ,fluoride varnish|white spot lesion ,fluoride varnish
5124468|NCT03217071|non small cell lung cancer, resectable|non small cell lung cancer, resectable
5124469|NCT03217058|digital health|digital health
5124470|NCT03217058|implementation|implementation
5124471|NCT03217058|primary care|primary care
5124472|NCT03217032|Hemophilia A|hemophilia a
5124473|NCT03217032|factor VIII|factor viii
5124474|NCT03217032|Gene therapy|gene therapy
5124475|NCT03217032|lentiviral vector|lentiviral vector
5124476|NCT03217019|Radial Artery|radial artery
5124477|NCT03217019|Vascular Catheters|vascular catheters
5124478|NCT03217006|coronary artery bypass surgery|coronary artery bypass surgery
5124479|NCT03217006|multiple arterial graft|multiple arterial graft
5124480|NCT03217006|radial artery graft|radial artery graft
5124481|NCT03216993|feeding protocol|feeding protocol
5124482|NCT03216980|cardiovascular disease|cardiovascular disease
5124483|NCT03216980|vascular function|vascular function
5124484|NCT03216980|PTSD|ptsd
5124485|NCT03216980|GAD|gad
5124486|NCT03216941|Psychomotor agitation; Tranquilizing agents|psychomotor agitation; tranquilizing agents
5124487|NCT03216928|Reverse Signaling|reverse signaling
5124488|NCT03216928|Anti-TNF|anti-tnf
5124489|NCT03216915|Heart Rhythm|heart rhythm
5124490|NCT03216915|Fingolimod|fingolimod
5124491|NCT03216915|autonomic nervous system|autonomic nervous system
5124492|NCT03216915|Effects of Medicinal Substance|effects of medicinal substance
5124493|NCT03216902|Glaucoma|glaucoma
5124494|NCT03216889|Multiple Sclerosis|multiple sclerosis
5124495|NCT03216837|Perinatal stroke|perinatal stroke
5124496|NCT03216837|hemiplegia|hemiplegia
5124497|NCT03216837|hemiplegic cerebral palsy|hemiplegic cerebral palsy
5124498|NCT03216772|Gynecologic Surgery|gynecologic surgery
5124499|NCT03216772|larscopy|larscopy
5124500|NCT03216772|morcellation|morcellation
5862712|NCT00001541|Bronchoscopy|bronchoscopy
5124511|NCT03216720|Miniaturized extracorporeal circulation|miniaturized extracorporeal circulation
5124512|NCT03216720|Thrombin generation|thrombin generation
5124513|NCT03216655|congenital cataract|congenital cataract
5124514|NCT03216655|anxiety|anxiety
5124515|NCT03216655|guardian|guardian
5124516|NCT03216642|Dacryocystitis|dacryocystitis
5124517|NCT03216642|Bacteriology|bacteriology
5124518|NCT03216642|Microbial Sensitivity Tests|microbial sensitivity tests
5124519|NCT03216629|Pain|pain
5124520|NCT03216629|Empathy|empathy
5124521|NCT03216629|Dressing change|dressing change
5124522|NCT03216616|fatigue|fatigue
5124523|NCT03216616|Inflammatory Rheumatism|inflammatory rheumatism
5124524|NCT03216616|Coping|coping
5124525|NCT03216616|self-efficacy|self-efficacy
5124526|NCT03216603|Health literacy|health literacy
5124527|NCT03216590|Shoulder Arthroscopy|shoulder arthroscopy
5134375|NCT03153709|Women on efavirenz|women on efavirenz
5124531|NCT03216577|health-related quality of life|health-related quality of life
5124532|NCT03216551|selective mediastinal lymphadenectomy|selective mediastinal lymphadenectomy
5124533|NCT03216551|minimally invasive surgery|minimally invasive surgery
5124534|NCT03216460|T1D, Omnipod|t1d, omnipod
5124535|NCT03216447|adherence|adherence
5124536|NCT03216447|conversion|conversion
5124537|NCT03216447|advagraf|advagraf
5124538|NCT03216447|prograf|prograf
5124543|NCT03216421|Intraoperative Radiation (IORT)|intraoperative radiation (iort)
5124545|NCT03216421|Breast Conserving Surgery|breast conserving surgery
5124546|NCT03216382|High worry|high worry
5124547|NCT03216382|Anxiety|anxiety
5124548|NCT03216382|Attention Training Technique|attention training technique
5124549|NCT03216382|Attention Control|attention control
5124550|NCT03216382|Attention|attention
5124551|NCT03216382|Mindfulness|mindfulness
5124552|NCT03216382|Attention Bias|attention bias
5124553|NCT03216382|Worry|worry
5124554|NCT03216382|Pathological Worry|pathological worry
5124555|NCT03216382|Anxiety Disorder|anxiety disorder
5124556|NCT03216369|Arterial Spin Labeling|arterial spin labeling
5124557|NCT03216369|MRI|mri
5124558|NCT03216369|Perfusion|perfusion
5124559|NCT03216369|Carotid artery stenting|carotid artery stenting
5124560|NCT03216369|Carotid endarterectomy|carotid endarterectomy
5124561|NCT03216330|Quantitative sensory test (QST)|quantitative sensory test (qst)
5124562|NCT03216330|Deep dyspareunia|deep dyspareunia
5124563|NCT03216330|Electronic Thimble Algometer|electronic thimble algometer
5124564|NCT03216317|Hypertension|hypertension
5124565|NCT03216317|Hypotension|hypotension
5124566|NCT03216317|Cardiovascular system|cardiovascular system
5124567|NCT03216278|healthy,|healthy,
5124568|NCT03216278|fasted,|fasted,
5124569|NCT03216278|fed|fed
5124570|NCT03216226|Glucagon|glucagon
5124571|NCT03216148|FET PET|fet pet
5124572|NCT03216135|Microbiome|microbiome
5124573|NCT03216109|Supportive Care|supportive care
5124574|NCT03216109|Quality of Life|quality of life
5124575|NCT03216083|colpocleisis|colpocleisis
5124576|NCT03216083|vaginectomy|vaginectomy
5124577|NCT03216083|tranexamic acid|tranexamic acid
5124578|NCT03216070|Dasatinib|dasatinib
5124579|NCT03216057|hypertriglyceridemia|hypertriglyceridemia
5124580|NCT03216057|pediatric obesity|pediatric obesity
5124581|NCT03216057|omega 3|omega 3
5124582|NCT03216044|childbirth|childbirth
5124583|NCT03216044|caesarean delivery|caesarean delivery
5124584|NCT03216044|vaginal delivery|vaginal delivery
5124585|NCT03216044|chronic pain|chronic pain
5124586|NCT03216044|painful sexual intercourse|painful sexual intercourse
5124587|NCT03216031|Falls prevention|falls prevention
5124588|NCT03216031|Gardening|gardening
5124589|NCT03216018|resilience|resilience
5124590|NCT03216018|prevention program|prevention program
5124591|NCT03216018|body-image|body-image
5124592|NCT03216018|self-esteem|self-esteem
5124593|NCT03215992|Diffuse Optical Tomography|diffuse optical tomography
5124594|NCT03215966|bioequivalence|bioequivalence
5124595|NCT03215953|offloading|offloading
5124596|NCT03215953|plantar pressure|plantar pressure
5124597|NCT03215953|Diabetic Foot Ulcer|diabetic foot ulcer
5124598|NCT03215953|cast shoe|cast shoe
5124599|NCT03215953|forefoot offloading shoe|forefoot offloading shoe
5124601|NCT03215914|Closed loop insulin delivery system|closed loop insulin delivery system
5124602|NCT03215914|Insulin Pump|insulin pump
5124603|NCT03215914|Glycemic control|glycemic control
5124604|NCT03215914|Glucose Counterregulation|glucose counterregulation
5124605|NCT03215901|Population-based survey|population-based survey
5124606|NCT03215901|HIV treatment|hiv treatment
5124607|NCT03215901|HIV testing|hiv testing
5124608|NCT03215901|Survival expectations|survival expectations
5124609|NCT03215901|Condom use|condom use
5124610|NCT03215901|Life plans|life plans
5124611|NCT03215901|South African young adults|south african young adults
5124612|NCT03215862|Post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
5124613|NCT03215862|Normal Saline|normal saline
5124614|NCT03215862|Lactated Ringer's|lactated ringer's
5124615|NCT03215823|Intubation|intubation
5124616|NCT03215823|videolaryngoscope|videolaryngoscope
5124622|NCT03215797|svv|svv
5124623|NCT03215797|norepinephrine|norepinephrine
5124624|NCT03215797|phenylephrine|phenylephrine
5124625|NCT03215797|elderly|elderly
5124626|NCT03215784|obesity|obesity
5124627|NCT03215784|placenta|placenta
5124628|NCT03215784|inflammation|inflammation
5124629|NCT03215784|fish oil|fish oil
5124630|NCT03215784|probiotics|probiotics
5124631|NCT03215758|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
5124632|NCT03215745|Delirium|delirium
5124633|NCT03215745|Critical Care|critical care
5124634|NCT03215745|Prevention & control|prevention & control
5124635|NCT03215745|Clinical Trial|clinical trial
5124636|NCT03215732|prevalence|prevalence
5124637|NCT03215732|vaccine coverage|vaccine coverage
5124638|NCT03215732|risk factors|risk factors
5124640|NCT03215732|mortality|mortality
5124641|NCT03215732|quality of life|quality of life
5124642|NCT03215732|economic vulnerability|economic vulnerability
5125231|NCT03212092|omega-3|omega-3
5124648|NCT03215719|Radiation Therapy|radiation therapy
5124649|NCT03215680|Urinary iodine concentration|urinary iodine concentration
5124650|NCT03215654|mental health|mental health
5124651|NCT03215654|promotion|promotion
5124652|NCT03215654|prevention|prevention
5124653|NCT03215654|adolescence|adolescence
5124654|NCT03215654|school programs|school programs
5124655|NCT03215654|intervention|intervention
5124656|NCT03215641|obesity|obesity
5124657|NCT03215641|pediatrics|pediatrics
5124658|NCT03215641|weight management program|weight management program
5124659|NCT03215641|Fitbit|fitbit
5124660|NCT03215641|personal activity tracker|personal activity tracker
5124661|NCT03215628|CEUS|ceus
5124662|NCT03215628|TCEUS|tceus
5124663|NCT03215628|contrast enhanced ultrasound|contrast enhanced ultrasound
5124664|NCT03215628|perfusion|perfusion
5124665|NCT03215628|cerebral perfusion|cerebral perfusion
5124666|NCT03215628|sulphur hexafluoride|sulphur hexafluoride
5124667|NCT03215628|SonoVue|sonovue
5124668|NCT03215602|knee|knee
5124669|NCT03215602|osteoarthritis|osteoarthritis
5124670|NCT03215602|exercise|exercise
5124671|NCT03215602|quadriceps|quadriceps
5124672|NCT03215602|strength|strength
5124673|NCT03215602|activities of daily living|activities of daily living
5124674|NCT03215602|treatment outcome|treatment outcome
5124676|NCT03215563|atherosclerosis, imaging|atherosclerosis, imaging
5124677|NCT03215550|atherosclerosis, imaging|atherosclerosis, imaging
5124678|NCT03215537|physical activity|physical activity
5124679|NCT03215537|cardiopulmonary function|cardiopulmonary function
5124680|NCT03215537|quality of life|quality of life
5124681|NCT03215537|Perioperative management|perioperative management
5124682|NCT03215537|comprehensive intervention|comprehensive intervention
5124683|NCT03215537|health behavior model|health behavior model
5124684|NCT03215511|Solid Tumor|solid tumor
5124685|NCT03215511|Metastatic cancer|metastatic cancer
5124686|NCT03215511|Advanced cancer|advanced cancer
5124687|NCT03215511|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5124688|NCT03215511|NTRK1|ntrk1
5124689|NCT03215511|NTRK2|ntrk2
5124690|NCT03215511|NTRK3|ntrk3
5124691|NCT03215511|Fusion Positive|fusion positive
5124692|NCT03215511|Children|children
5124693|NCT03215485|adolescent|adolescent
5124694|NCT03215485|sports|sports
5124695|NCT03215485|nutrition|nutrition
5124696|NCT03215485|physical activity|physical activity
5124697|NCT03215485|body mass index|body mass index
5124698|NCT03215485|virtual world|virtual world
5124699|NCT03215459|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5124700|NCT03215394|Social ABCs|social abcs
5124701|NCT03215394|autism|autism
5124702|NCT03215394|autism spectrum disorder|autism spectrum disorder
5124703|NCT03215394|Early Intervention|early intervention
5124704|NCT03215394|Toddler|toddler
5124705|NCT03215394|Early Identification|early identification
5124706|NCT03215394|Pivotal Response Treatment|pivotal response treatment
5124707|NCT03215394|ASD|asd
5124708|NCT03215394|PRT|prt
5124709|NCT03215394|Control Group|control group
5124710|NCT03215394|treatment Group|treatment group
5124711|NCT03215394|At Risk|at risk
5124712|NCT03215394|Social Communication|social communication
5124713|NCT03215394|Positive Affect|positive affect
5124714|NCT03215394|Smiling|smiling
5124715|NCT03215394|Social Orienting|social orienting
5124716|NCT03215394|Attentional Control|attentional control
5124717|NCT03215394|Attentional Disengagement|attentional disengagement
5010306|NCT03932396|non-custodial sentences|non-custodial sentences
5124718|NCT03215394|Naturalistic Developmental Behaviour Intervention|naturalistic developmental behaviour intervention
5124719|NCT03215394|NDBI|ndbi
5124720|NCT03215381|Healthy Volunteer Male Subjects|healthy volunteer male subjects
5124721|NCT03215355|Adaptive radiotherapy|adaptive radiotherapy
5124722|NCT03215355|Contrast media|contrast media
5124723|NCT03215355|Cone-beam computed tomography|cone-beam computed tomography
5124724|NCT03215355|Stereotactic body radiation therapy|stereotactic body radiation therapy
5124725|NCT03215342|Child|child
5124726|NCT03215342|Rehabilitation|rehabilitation
5124727|NCT03215342|Psychotherapy, groups|psychotherapy, groups
5124731|NCT03215277|Ankylosing Spondylitis|ankylosing spondylitis
5124732|NCT03215277|Bimekizumab|bimekizumab
5124733|NCT03215277|AS|as
5124734|NCT03215277|Certolizumab Pegol|certolizumab pegol
5124735|NCT03215277|Cimzia|cimzia
5124736|NCT03215251|Thirst, Dry Mouth, Intervention Bundle|thirst, dry mouth, intervention bundle
5124737|NCT03215225|Endodontology|endodontology
5124738|NCT03215225|Endodontics|endodontics
5124739|NCT03215212|ear plug|ear plug
5124740|NCT03215212|eye mask|eye mask
5124741|NCT03215212|ocean sound|ocean sound
5124742|NCT03215212|sleep quality|sleep quality
5126615|NCT03203304|SBRT|sbrt
5124744|NCT03215186|congenital cataract|congenital cataract
5124745|NCT03215186|risk factor|risk factor
5124746|NCT03215186|mathematic model|mathematic model
5124755|NCT03215095|Radioiodine (RAI)|radioiodine (rai)
5124756|NCT03215095|Durvalumab (Medi4736)|durvalumab (medi4736)
5124757|NCT03215095|RAI-avid|rai-avid
5124758|NCT03215095|17-218|17-218
5124759|NCT03215069|gestational diabetes, SGLT-2 inhibitor, empagliflozin|gestational diabetes, sglt-2 inhibitor, empagliflozin
5124760|NCT03215043|Eriocitrin|eriocitrin
5124761|NCT03215043|Intermediate hyperglycemia|intermediate hyperglycemia
5124762|NCT03215043|Citrus bioflavonoids|citrus bioflavonoids
5124763|NCT03215030|Drug Therapy|drug therapy
5124764|NCT03215004|Volunteer|volunteer
5124765|NCT03215004|HIV|hiv
5124766|NCT03215004|Leukapheresis|leukapheresis
5124767|NCT03214978|thyroid|thyroid
5124768|NCT03214965|Kidney transplantation|kidney transplantation
5124769|NCT03214965|Facebook|facebook
5124770|NCT03214965|Education|education
5124771|NCT03214965|Adolescent|adolescent
5124772|NCT03214965|Social Networking|social networking
5124773|NCT03214939|dendritic cell, IL-12, IL-18, cytotoxicity|dendritic cell, il-12, il-18, cytotoxicity
5124774|NCT03214926|Parkinson's disease|parkinson's disease
5124775|NCT03214926|Dance|dance
5124776|NCT03214926|Google Glass|google glass
5124777|NCT03214926|Mobility|mobility
5124778|NCT03214926|Balance|balance
5124779|NCT03214913|resuscitation|resuscitation
5124780|NCT03214913|fluid therapy|fluid therapy
5124781|NCT03214887|Hyaluronan|hyaluronan
5124782|NCT03214887|Bone marrow mononuclear cells|bone marrow mononuclear cells
5124783|NCT03214848|Long-acting reversible contraceptive|long-acting reversible contraceptive
5124784|NCT03214848|Post Abortion|post abortion
5124785|NCT03214848|Iintrauterine device|iintrauterine device
5124786|NCT03214848|Contraceptive implant|contraceptive implant
5124787|NCT03214848|LARC|larc
5124788|NCT03214848|IUD|iud
5124789|NCT03214835|Larynx|larynx
5124790|NCT03214835|reflux|reflux
5124791|NCT03214835|LPR|lpr
5124792|NCT03214835|tumor|tumor
5124793|NCT03214835|lesion|lesion
5124794|NCT03214822|Microbiome|microbiome
5124795|NCT03214809|ultrasound|ultrasound
5124796|NCT03214809|MET team|met team
5124797|NCT03214809|Concordance|concordance
5124798|NCT03214783|artificial intelligence|artificial intelligence
5124799|NCT03214783|facial recognition|facial recognition
5124800|NCT03214783|facial characteristic|facial characteristic
5124802|NCT03214705|CT perfusion|ct perfusion
5124803|NCT03214705|Subarachnoid hemorrhage|subarachnoid hemorrhage
5124804|NCT03214705|Vasospasm|vasospasm
5124805|NCT03214705|Delayed cerebral ischemia|delayed cerebral ischemia
5124806|NCT03214692|Gum Arabic|gum arabic
5124807|NCT03214692|Renal failure|renal failure
5124808|NCT03214692|Hemodialysis|hemodialysis
5124809|NCT03214692|Antioxidant and anti-inflammatory|antioxidant and anti-inflammatory
5124810|NCT03214679|Hepatitis C|hepatitis c
5124812|NCT03214679|People who inject drugs|people who inject drugs
5124813|NCT03214666|MDS|mds
5124814|NCT03214666|AML|aml
5124815|NCT03214640|neuraxial analgesia|neuraxial analgesia
5124816|NCT03214640|spinal block|spinal block
5124817|NCT03214640|epidural block|epidural block
5124818|NCT03214588|Drug Therapy|drug therapy
5124819|NCT03214575|Central Venous Vascular Access|central venous vascular access
5124820|NCT03214575|Intensive Care Unit|intensive care unit
5124821|NCT03214575|Needle Navigation Technology|needle navigation technology
5124822|NCT03214536|spine surgery|spine surgery
5124823|NCT03214536|regional anaesthesia|regional anaesthesia
5124824|NCT03214536|opioid consumption|opioid consumption
5124825|NCT03214536|acute postoperative pain|acute postoperative pain
5124826|NCT03214523|sleep|sleep
5124827|NCT03214523|actigraphy|actigraphy
5124828|NCT03214497|laryngeal mask|laryngeal mask
5124831|NCT03214471|bariatric surgery|bariatric surgery
5124832|NCT03214471|healthy lifestyle|healthy lifestyle
5124834|NCT03214458|Noninvasive Ventilation|noninvasive ventilation
5124835|NCT03214432|Mild traumatic brain injury|mild traumatic brain injury
5124836|NCT03214432|Concussion|concussion
5124837|NCT03214432|Labour market affiliation|labour market affiliation
5124838|NCT03214432|Return to work|return to work
5124840|NCT03214432|Long-term sickness absence|long-term sickness absence
5124841|NCT03214432|Disability pension|disability pension
5124842|NCT03214419|Breast cancer|breast cancer
5124843|NCT03214419|3D Optical scanning|3d optical scanning
5124848|NCT03214354|red blood cell engraftment|red blood cell engraftment
5124849|NCT03214354|nonmyeloablative|nonmyeloablative
5124850|NCT03214354|pure red cell aplasia|pure red cell aplasia
5124851|NCT03214341|mediastinal masses|mediastinal masses
5124852|NCT03214341|MRI diffusion|mri diffusion
5124853|NCT03214315|Prostatectomy|prostatectomy
5124854|NCT03214302|antiviral treatment|antiviral treatment
5124855|NCT03214302|hepatitis B virus|hepatitis b virus
5124856|NCT03214302|pregnant woman|pregnant woman
5124857|NCT03214302|Postpartum hepatitis|postpartum hepatitis
5124858|NCT03214289|Fecal Microbiota Transplantation|fecal microbiota transplantation
5124859|NCT03214289|Intestinal Acute Graft Versus Host Disease|intestinal acute graft versus host disease
5124860|NCT03214289|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5124861|NCT03214276|polyphenols|polyphenols
5124862|NCT03214276|cycling|cycling
5124863|NCT03214276|endurance|endurance
5124864|NCT03214276|aerobic|aerobic
5124865|NCT03214276|pain|pain
5124866|NCT03214263|Inflammatory rheumatic diseases|inflammatory rheumatic diseases
5124867|NCT03214263|Biomarkers|biomarkers
5124868|NCT03214263|Tailored treatment|tailored treatment
5124869|NCT03214263|Personalised medicine|personalised medicine
5124870|NCT03214263|DANBIO|danbio
5124871|NCT03214263|Danish Rheumatologic Biobank|danish rheumatologic biobank
5124872|NCT03214263|clinical data|clinical data
5124873|NCT03214250|Nivolumab|nivolumab
5124874|NCT03214250|APX005M|apx005m
5124875|NCT03214250|previously untreated metastatic pancreatic adenocarcinoma|previously untreated metastatic pancreatic adenocarcinoma
5124876|NCT03214250|Gemcitabine|gemcitabine
5124877|NCT03214250|nab-Paclitaxel|nab-paclitaxel
5124878|NCT03214224|Telemedicine|telemedicine
5124879|NCT03214224|Pulmonary Function Testing|pulmonary function testing
5124880|NCT03214224|Telehealth|telehealth
5124881|NCT03214185|unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
5124882|NCT03214185|infertility, female|infertility, female
5124883|NCT03214185|preimplantation genetic screening|preimplantation genetic screening
5124884|NCT03214185|in vitro fertilization|in vitro fertilization
5124885|NCT03214185|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5124887|NCT03214146|Motor Neuron Disease|motor neuron disease
5124888|NCT03214146|Neuromuscular Disease|neuromuscular disease
5124889|NCT03214146|Neurodegenerative Disease|neurodegenerative disease
5124890|NCT03214146|Central Nervous System Disease|central nervous system disease
5124891|NCT03214146|HLA-haplo matched allogenic bone marrow derived stem cells|hla-haplo matched allogenic bone marrow derived stem cells
5124892|NCT03214120|thromboelastography, modified ultrafiltration|thromboelastography, modified ultrafiltration
5124893|NCT03214107|Exercise|exercise
5124894|NCT03214107|Hypoglycemia|hypoglycemia
5124895|NCT03214107|Carbohydrates|carbohydrates
5124896|NCT03214029|troponin|troponin
5124897|NCT03214029|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
5124898|NCT03214029|acute myocardial infarction|acute myocardial infarction
5124899|NCT03214016|Pilates Training|pilates training
5124900|NCT03214016|Aerobic Exercises|aerobic exercises
5124901|NCT03214016|Hypertension|hypertension
5124902|NCT03214016|Clinical trial|clinical trial
5124903|NCT03214003|small cell lung cancer limited stage|small cell lung cancer limited stage
5124904|NCT03214003|twice-daily radiotherapy|twice-daily radiotherapy
5124905|NCT03214003|simultaneous integrated boosting technique|simultaneous integrated boosting technique
5124906|NCT03213990|Sepsis|sepsis
5124907|NCT03213990|Beta-lactam antibiotics|beta-lactam antibiotics
5962025|NCT04283487|FODMAP|fodmap
5124908|NCT03213977|DLBCL, R-DA-EPOCH, R-CEOP90, auto-HSCT|dlbcl, r-da-epoch, r-ceop90, auto-hsct
5124909|NCT03213964|Recurrent|recurrent
5124910|NCT03213964|Platinum Resistant|platinum resistant
5124911|NCT03213964|Platinum Sensitive|platinum sensitive
5124912|NCT03213951|Surgical resection|surgical resection
5124913|NCT03213951|Margins of resection|margins of resection
5124914|NCT03213951|Beta radiopharmaceutical|beta radiopharmaceutical
5124915|NCT03213951|Beta probe device|beta probe device
5124916|NCT03213951|Ex-vivo|ex-vivo
5124917|NCT03213938|Chronic prostatitis|chronic prostatitis
5124918|NCT03213938|chronic pelvic pain syndrome|chronic pelvic pain syndrome
5124919|NCT03213938|acupuncture|acupuncture
5124920|NCT03213938|randomized controlled trial|randomized controlled trial
5124921|NCT03213912|effective concentration|effective concentration
5124922|NCT03213899|Subjective Global Assessment|subjective global assessment
5124923|NCT03213899|Nutritional Status|nutritional status
5124951|NCT03213769|topical Q10 gel|topical q10 gel
5124952|NCT03213769|topical antioxidant|topical antioxidant
5124953|NCT03213769|oral recurrent aphthous ulcer|oral recurrent aphthous ulcer
5124954|NCT03213769|oral aphthous stomatitis|oral aphthous stomatitis
5124955|NCT03213756|doppler ultrasound|doppler ultrasound
5124956|NCT03213756|physical exercise|physical exercise
5124957|NCT03213756|arteriovenous fistula maturation|arteriovenous fistula maturation
5124958|NCT03213717|Obesity|obesity
5124959|NCT03213717|Loading|loading
5124960|NCT03213717|Edema|edema
5124961|NCT03213717|Urine|urine
5124962|NCT03213613|Teen health|teen health
5124963|NCT03213613|Teen development|teen development
5124964|NCT03213613|Adolescent development|adolescent development
5124965|NCT03213613|Memory|memory
5124966|NCT03213613|Attention|attention
5124967|NCT03213613|Reward processing|reward processing
5124968|NCT03213574|Goal directed fluid therapy|goal directed fluid therapy
5124969|NCT03213548|alar base reduction|alar base reduction
5124970|NCT03213548|alar facial groove|alar facial groove
5124971|NCT03213548|alectomy|alectomy
5124972|NCT03213548|Flare|flare
5124973|NCT03213548|Nose|nose
5124974|NCT03213535|PROM|prom
5124975|NCT03213496|clinical trial, non cardiac surgery, walking.|clinical trial, non cardiac surgery, walking.
5124976|NCT03213483|gingival recession|gingival recession
5124977|NCT03213483|connective tissue graft|connective tissue graft
5124978|NCT03213483|deepithelialized free gingival graft|deepithelialized free gingival graft
5124979|NCT03213483|free gingival graft|free gingival graft
5124980|NCT03213457|Elagolix|elagolix
5124981|NCT03213457|Endometriosis associated pain|endometriosis associated pain
5124982|NCT03213457|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5124983|NCT03213457|Non-menstrual pelvic pain (NMPP)|non-menstrual pelvic pain (nmpp)
5124984|NCT03213444|Colon cancer|colon cancer
5124985|NCT03213444|adjuvant chemotherapy|adjuvant chemotherapy
5124986|NCT03213444|sympathetic nerve activity|sympathetic nerve activity
5124987|NCT03213444|peripheral vascular function|peripheral vascular function
5124988|NCT03213431|Cancer survivors|cancer survivors
5124989|NCT03213431|Instrument development|instrument development
5124990|NCT03213431|Neurocognitive functioning|neurocognitive functioning
5124991|NCT03213431|Patient-reported outcomes|patient-reported outcomes
5124992|NCT03213431|Qualitative interview|qualitative interview
5125001|NCT03213405|human Respiratory Syncytial Virus|human respiratory syncytial virus
5125002|NCT03213405|Phase I|phase i
5125003|NCT03213405|Recombinant BCG vaccine|recombinant bcg vaccine
5125004|NCT03213379|actimeter|actimeter
5125005|NCT03213379|apomorphin pump|apomorphin pump
5125006|NCT03213366|PrEP|prep
5125007|NCT03213366|HIV prevention|hiv prevention
5125008|NCT03213366|Public Health Social Media Campaign|public health social media campaign
5125009|NCT03213366|Peer Intervention|peer intervention
5125010|NCT03213327|mental health|mental health
5125011|NCT03213327|assessment|assessment
5125012|NCT03213327|health promotion|health promotion
5125013|NCT03213327|case management|case management
5125014|NCT03213327|health insurance|health insurance
5125015|NCT03213314|LiverMultiScan|livermultiscan
5125016|NCT03213314|multiparameter MRI|multiparameter mri
5125017|NCT03213314|functional liver remnant|functional liver remnant
5125018|NCT03213314|liver resection|liver resection
5125019|NCT03213314|hepatic resection|hepatic resection
5125020|NCT03213314|portal vein embolisation|portal vein embolisation
5125021|NCT03213314|preoperative liver function|preoperative liver function
5125022|NCT03213314|postoperative liver failure|postoperative liver failure
5125023|NCT03213301|Progressive Malignant Pleural Mesothelioma|progressive malignant pleural mesothelioma
5125024|NCT03213301|Lurbinectedin|lurbinectedin
5125025|NCT03213301|Mesothelioma|mesothelioma
5125026|NCT03213301|Phase II Trial|phase ii trial
5125027|NCT03213275|Extremely premature infants|extremely premature infants
5125028|NCT03213275|gut-immune-brain axis|gut-immune-brain axis
5125029|NCT03213275|neonatal brain injury|neonatal brain injury
5125030|NCT03213275|gut microbiome|gut microbiome
5126616|NCT03203291|stroke|stroke
5125031|NCT03213275|neurodevelopmental outcome|neurodevelopmental outcome
5125032|NCT03213275|neonatal immunity|neonatal immunity
5125033|NCT03213223|retention|retention
5125034|NCT03213223|attrition|attrition
5125035|NCT03213223|PMTCT|pmtct
5125036|NCT03213223|elimination of mother to child transmission of HIV|elimination of mother to child transmission of hiv
5125037|NCT03213184|Birth cohort|birth cohort
5125039|NCT03213184|allergies|allergies
5125040|NCT03213171|organ donation|organ donation
5125041|NCT03213171|family physician|family physician
5125042|NCT03213171|primary care|primary care
5125043|NCT03213171|clinical trial|clinical trial
5125044|NCT03213171|registry trial|registry trial
5125045|NCT03213171|cluster trial|cluster trial
5125046|NCT03213171|stepped-wedge|stepped-wedge
5125051|NCT03213119|Caloric Vestibular Stimulation Reward|caloric vestibular stimulation reward
5125052|NCT03213119|Brain Stimulation|brain stimulation
5125053|NCT03213119|Reward|reward
5125054|NCT03213119|Vestibular System|vestibular system
5125055|NCT03213119|Cingulate Cortex|cingulate cortex
5125056|NCT03213119|Cancellation Tasks|cancellation tasks
5125058|NCT03213106|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5125059|NCT03213106|Cerebellar Ataxia|cerebellar ataxia
5125060|NCT03213093|Diabetes|diabetes
5125061|NCT03213093|Diabetic Foot Ulcer|diabetic foot ulcer
5125062|NCT03213093|Plantar pressure|plantar pressure
5125063|NCT03213080|Targeted Lung Denervation|targeted lung denervation
5125064|NCT03213080|TLD|tld
5125065|NCT03213054|esophageal cancer|esophageal cancer
5125066|NCT03213054|OBP-301|obp-301
5125067|NCT03213054|radiation|radiation
5125068|NCT03213054|Telomelysin|telomelysin
5125069|NCT03213054|radiotherapy|radiotherapy
5125070|NCT03213054|oncolytic|oncolytic
5125071|NCT03213054|virotherapy|virotherapy
5125072|NCT03213054|loco regional|loco regional
5125073|NCT03213015|confiability|confiability
5125074|NCT03213015|ankle|ankle
5125075|NCT03213015|patellofemoral pain syndrome|patellofemoral pain syndrome
5125076|NCT03212989|HIV|hiv
5125077|NCT03212989|HXTC|hxtc
5125078|NCT03212989|Antiretroviral Therapy|antiretroviral therapy
5125079|NCT03212989|HIV-Infected|hiv-infected
5125080|NCT03212989|Vorinostat|vorinostat
5125081|NCT03212989|AIDS|aids
5125082|NCT03212976|Non-Invasive|non-invasive
5125083|NCT03212976|Magnetic Resonance Imaging|magnetic resonance imaging
5125084|NCT03212976|Ventricular catheters|ventricular catheters
5125085|NCT03212924|cochlear implant|cochlear implant
5125086|NCT03212924|Listening effort|listening effort
5125087|NCT03212924|pupillometry|pupillometry
5125088|NCT03212911|HBV vaccination, HIV, isolated anti-HBc|hbv vaccination, hiv, isolated anti-hbc
5125089|NCT03212898|pharmacist interventions, warfarin, elderly rural patients|pharmacist interventions, warfarin, elderly rural patients
5125090|NCT03212885|Deep Brain Stimulation|deep brain stimulation
5125091|NCT03212872|Ammonia|ammonia
5125092|NCT03212872|bleeding risk factors|bleeding risk factors
5125093|NCT03212872|endoscopic risk signs for bleeding|endoscopic risk signs for bleeding
5125094|NCT03212872|esophageal varices|esophageal varices
5125095|NCT03212859|older adults|older adults
5125096|NCT03212859|physiotherapy|physiotherapy
5125097|NCT03212859|physical activity|physical activity
5125098|NCT03212846|hippotherapy|hippotherapy
5125099|NCT03212846|cerebral palsy|cerebral palsy
5125100|NCT03212846|spasticity|spasticity
5125101|NCT03212807|Checkpoint inhibition|checkpoint inhibition
5125102|NCT03212807|PDL1|pdl1
5125103|NCT03212807|EBV DLBCL|ebv dlbcl
5125104|NCT03212807|PCNSL|pcnsl
5125105|NCT03212716|Infectiology|infectiology
5125106|NCT03212716|Biology of infectious agents|biology of infectious agents
5125108|NCT03212716|Intensive care|intensive care
5125109|NCT03212703|Mindfulness training|mindfulness training
5125110|NCT03212703|Parents and families|parents and families
5125111|NCT03212703|Pediatric OCD|pediatric ocd
5125112|NCT03212690|mechanical ventilation|mechanical ventilation
5125113|NCT03212690|echocardiography|echocardiography
5125114|NCT03212690|right ventricular function|right ventricular function
5125115|NCT03212690|Ang (1-7)|ang (1-7)
5125116|NCT03212690|Ang II|ang ii
5125117|NCT03212690|Renin-angiotensin system|renin-angiotensin system
5125118|NCT03212625|Urea Cream|urea cream
5125119|NCT03212625|Sorafenib|sorafenib
5125120|NCT03212612|Galectin-3 ,endometrosis|galectin-3 ,endometrosis
5125121|NCT03212599|APP-processing|app-processing
5125122|NCT03212599|Disulfiram|disulfiram
5125123|NCT03212599|ADAM10|adam10
5125124|NCT03212599|Alzheimer's disease|alzheimer's disease
5125125|NCT03212599|blood|blood
5125126|NCT03212560|Exercise capacity|exercise capacity
5125128|NCT03212560|Quality of life|quality of life
5125129|NCT03212560|Pulmonary functions|pulmonary functions
5125130|NCT03212560|Muscle strength|muscle strength
5125131|NCT03212560|Respiratory muscle strength|respiratory muscle strength
5125232|NCT03212092|n-3 fatty acids|n-3 fatty acids
5125132|NCT03212560|Respiratory muscle endurance|respiratory muscle endurance
5125133|NCT03212560|Dyspnea|dyspnea
5125134|NCT03212560|Anxiety|anxiety
5125135|NCT03212560|Fatigue|fatigue
5125136|NCT03212547|ADBB|adbb
5125137|NCT03212547|social withdrawal behavior|social withdrawal behavior
5125138|NCT03212547|preterm|preterm
5125139|NCT03212547|posttraumatic stress|posttraumatic stress
5125140|NCT03212547|postpartum depression|postpartum depression
5125141|NCT03212547|early detection|early detection
5125142|NCT03212547|interactional guidance|interactional guidance
5125143|NCT03212547|synchronization within parent infant interaction|synchronization within parent infant interaction
5125144|NCT03212534|Dascena|dascena
5125145|NCT03212534|patient mortality|patient mortality
5125146|NCT03212534|machine learning|machine learning
5125147|NCT03212534|algorithm|algorithm
5125148|NCT03212534|diagnostic|diagnostic
5125149|NCT03212521|chronic hepatitis C virus (HCV)|chronic hepatitis c virus (hcv)
5125150|NCT03212521|Hepatitis|hepatitis
5125151|NCT03212521|HCV genotype|hcv genotype
5125152|NCT03212521|aspartate aminotransferase|aspartate aminotransferase
5125153|NCT03212521|platelet|platelet
5125154|NCT03212521|Aspartate aminotransferase to Platelet Ratio Index (APRI)|aspartate aminotransferase to platelet ratio index (apri)
5125155|NCT03212521|glecaprevir|glecaprevir
5125156|NCT03212521|pibrentasvir|pibrentasvir
5125157|NCT03212521|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
5125158|NCT03212508|Continuous positive airway pressure, preterm|continuous positive airway pressure, preterm
5125159|NCT03212495|knee arthroscopy|knee arthroscopy
5125160|NCT03212495|dexmedetomidine|dexmedetomidine
5125161|NCT03212495|neostigmine|neostigmine
5125162|NCT03212482|brain-injured patients, patient-ventilator asychrony|brain-injured patients, patient-ventilator asychrony
5125163|NCT03212456|general anesthesia|general anesthesia
5125164|NCT03212456|cancer recurrence|cancer recurrence
5125165|NCT03212456|opioids analgesics|opioids analgesics
5125166|NCT03212456|neoplasm|neoplasm
5125167|NCT03212430|L-kynurenine|l-kynurenine
5125168|NCT03212430|Cerebral hemodynamic|cerebral hemodynamic
5125169|NCT03212430|Headache|headache
5125170|NCT03212430|Mohammad Al-Mahdi Al-Karagholi|mohammad al-mahdi al-karagholi
5125171|NCT03212404|Cancer|cancer
5125172|NCT03212404|PD-L1|pd-l1
5125173|NCT03212404|PDL1|pdl1
5125174|NCT03212404|PD-1|pd-1
5125175|NCT03212404|PD1|pd1
5125176|NCT03212404|Solid tumors|solid tumors
5125177|NCT03212404|Anti PD-L1|anti pd-l1
5125178|NCT03212404|MSI-High|msi-high
5125179|NCT03212404|Endometrial|endometrial
5125180|NCT03212404|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
5125181|NCT03212404|CK-301|ck-301
5125182|NCT03212352|miscarriage|miscarriage
5125183|NCT03212352|mifepristone|mifepristone
5125184|NCT03212352|misoprostol|misoprostol
5125185|NCT03212352|medical treatment|medical treatment
5125186|NCT03212352|patient satisfaction|patient satisfaction
5125187|NCT03212352|abortifacient agents|abortifacient agents
5125188|NCT03212339|parent-child interactions|parent-child interactions
5125189|NCT03212339|mental health care|mental health care
5125190|NCT03212339|child health services|child health services
5125191|NCT03212339|parenting confidence|parenting confidence
5125192|NCT03212339|adverse childhood events|adverse childhood events
5125193|NCT03212339|dyadic care model|dyadic care model
5125194|NCT03212313|Adults|adults
5125195|NCT03212313|Liver Disease|liver disease
5125196|NCT03212300|aerobic exercise training|aerobic exercise training
5125197|NCT03212300|delirium|delirium
5125198|NCT03212261|Lymphoma|lymphoma
5125199|NCT03212222|screening|screening
5125200|NCT03212222|cell phone application|cell phone application
5125201|NCT03212209|Sleep Apnea|sleep apnea
5125202|NCT03212209|CPAP|cpap
5125203|NCT03212196|Pancreaticoduodenectomy|pancreaticoduodenectomy
5125204|NCT03212196|Pancreaticogastrostomy|pancreaticogastrostomy
5125205|NCT03212196|Pancreaticojejunostomy|pancreaticojejunostomy
5125206|NCT03212196|Stent|stent
5125207|NCT03212196|Transanastomotic drain|transanastomotic drain
5125208|NCT03212183|web-based intervention|web-based intervention
5125209|NCT03212183|self-management|self-management
5125210|NCT03212183|nursing|nursing
5125211|NCT03212183|epilepsy|epilepsy
5125212|NCT03212183|seizures|seizures
5125213|NCT03212170|Invasive Breast Cancer|invasive breast cancer
5125214|NCT03212170|Metastatic Breast Cancer|metastatic breast cancer
5125215|NCT03212170|PR Positive Breast Cancer|pr positive breast cancer
5125216|NCT03212144|nuts|nuts
5125217|NCT03212144|exercise|exercise
5125218|NCT03212144|vagal activity|vagal activity
5125219|NCT03212144|peanuts|peanuts
5125220|NCT03212144|heart rate variability|heart rate variability
5125221|NCT03212118|Sick Leave|sick leave
5125222|NCT03212118|Return to work|return to work
5125223|NCT03212118|Motivational interviewing|motivational interviewing
5125226|NCT03212092|Aggression|aggression
5125227|NCT03212092|aggressive behavior|aggressive behavior
5125228|NCT03212092|nutritional supplements|nutritional supplements
5125229|NCT03212092|dietary supplements|dietary supplements
5125230|NCT03212092|vitamin, mineral|vitamin, mineral
5125233|NCT03212092|intellectual disability|intellectual disability
5125234|NCT03212079|Cancer Survivors|cancer survivors
5125235|NCT03212079|Physical Activities|physical activities
5125236|NCT03212079|Baltimore|baltimore
5125237|NCT03212079|State of Maryland|state of maryland
5125238|NCT03212053|Essential thrombocythemia|essential thrombocythemia
5125239|NCT03212053|Multiplate|multiplate
5125241|NCT03212053|haemorrhage|haemorrhage
5125242|NCT03212053|thrombosis|thrombosis
5125243|NCT03212053|Vasodilatator Stimulated Phosphoprotein (VASP)|vasodilatator stimulated phosphoprotein (vasp)
5125244|NCT03212027|apparent diffusion coefficient|apparent diffusion coefficient
5125245|NCT03212027|aquaporins|aquaporins
5125246|NCT03212014|Parkinson Disease|parkinson disease
5125247|NCT03212014|intelligent|intelligent
5125248|NCT03212014|Rehabilitaion|rehabilitaion
5125249|NCT03211988|abdominal|abdominal
5125250|NCT03211988|neuroendocrine tumor|neuroendocrine tumor
5125251|NCT03211988|columbia|columbia
5125252|NCT03211988|relapsed|relapsed
5125253|NCT03211988|refractory|refractory
5125254|NCT03211949|axillary nerve block|axillary nerve block
5125255|NCT03211923|muscle relaxation|muscle relaxation
5125256|NCT03211923|transcranial magnetic stimulation|transcranial magnetic stimulation
5125257|NCT03211923|myopathy|myopathy
5125258|NCT03211910|Sacral and trochenteric pressure ulcers|sacral and trochenteric pressure ulcers
5125259|NCT03211884|Problem solving therapy|problem solving therapy
5125260|NCT03211884|Military family caregivers|military family caregivers
5125261|NCT03211884|Cognitive impariment|cognitive impariment
5125262|NCT03211884|Traumatic brain injury|traumatic brain injury
5125263|NCT03211871|pain management, dexmedetomidine|pain management, dexmedetomidine
5125265|NCT03211845|Older adults|older adults
5125266|NCT03211845|Undernutrition|undernutrition
5125267|NCT03211845|Feasibility study|feasibility study
5125268|NCT03211832|Dissemination research|dissemination research
5125269|NCT03211832|Public health workforce|public health workforce
5125270|NCT03211832|Diabetes prevention|diabetes prevention
5125271|NCT03211832|Diabetes control|diabetes control
5125272|NCT03211832|Chronic disease prevention|chronic disease prevention
5125273|NCT03211832|Evidence-based public health|evidence-based public health
5125274|NCT03211832|Public health accreditation|public health accreditation
5125275|NCT03211819|immediate|immediate
5125276|NCT03211819|esthetics|esthetics
5125277|NCT03211793|systemic sclerosis|systemic sclerosis
5125278|NCT03211793|scleroderma|scleroderma
5125279|NCT03211793|digital ulcer|digital ulcer
5125280|NCT03211793|vasculopathy|vasculopathy
5125281|NCT03211793|mesenchymal stromal cell|mesenchymal stromal cell
5125282|NCT03211793|mesenchymal stem cell|mesenchymal stem cell
5125283|NCT03211754|Walnuts|walnuts
5125284|NCT03211754|almonds|almonds
5125285|NCT03211754|adiponectin|adiponectin
5125286|NCT03211754|lipocalin-2|lipocalin-2
5125287|NCT03211754|obesity|obesity
5125288|NCT03211741|Bevacizumab|bevacizumab
5125289|NCT03211702|geriatric assessments|geriatric assessments
5125290|NCT03211702|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5125291|NCT03211702|activity of daily living|activity of daily living
5125292|NCT03211702|instrumental activity of daily living|instrumental activity of daily living
5125293|NCT03211702|Charlson's comorbidity index|charlson's comorbidity index
5125294|NCT03211689|Exercise|exercise
5125295|NCT03211689|Stress|stress
5125296|NCT03211689|Fatigue|fatigue
5125297|NCT03211689|Quality of Life|quality of life
5125298|NCT03211676|dialyzer|dialyzer
5125299|NCT03211676|beta2-microglobilin|beta2-microglobilin
5125300|NCT03211676|myoglobin|myoglobin
5125301|NCT03211637|nursing care|nursing care
5125302|NCT03211637|skin lesions|skin lesions
5125303|NCT03211637|wound healing|wound healing
5125304|NCT03211637|varicose ulcers|varicose ulcers
5125305|NCT03211611|BRCA1/2 Mutation|brca1/2 mutation
5125306|NCT03211611|Breast cancer|breast cancer
5125307|NCT03211611|General practitionner|general practitionner
5125308|NCT03211572|breast|breast
5125309|NCT03211559|ankylosing spondylitis|ankylosing spondylitis
5125310|NCT03211559|clinical pilates exercise|clinical pilates exercise
5125311|NCT03211559|aerobic exercise|aerobic exercise
5125312|NCT03211559|functional exercise capacity|functional exercise capacity
5125313|NCT03211559|pulmonary function|pulmonary function
5125314|NCT03211546|Pediatric femur fracture|pediatric femur fracture
5125315|NCT03211546|Spica casting|spica casting
5125316|NCT03211546|Traction|traction
5125317|NCT03211546|Intramedullary nailing|intramedullary nailing
5125318|NCT03211546|Children|children
5125319|NCT03211546|Internal fixation|internal fixation
5125320|NCT03211546|External fixation|external fixation
5125321|NCT03211533|infants at risk of cerebral palsy|infants at risk of cerebral palsy
5125329|NCT03211494|Driving pressure|driving pressure
5125330|NCT03211494|Closed-loop ventilation|closed-loop ventilation
5125331|NCT03211494|Esophageal catheter|esophageal catheter
5125332|NCT03211455|bariatric surgery|bariatric surgery
5125333|NCT03211455|rehabilitation|rehabilitation
5125334|NCT03211455|lidocaine|lidocaine
5125335|NCT03211442|Breast cancer|breast cancer
5125336|NCT03211442|Radiotherapy|radiotherapy
5125337|NCT03211442|Cardiac complications|cardiac complications
5125338|NCT03211442|Acute coronary events|acute coronary events
5125339|NCT03211442|NTCP model|ntcp model
5125340|NCT03211325|Transient Receptor Potential Channels|transient receptor potential channels
5125341|NCT03211325|Raynaud's Phenomenon Isolated Primary|raynaud's phenomenon isolated primary
5125342|NCT03211325|Raynaud's Phenomenon (Secondary)|raynaud's phenomenon (secondary)
5125343|NCT03211312|Cardiovascular diseases|cardiovascular diseases
5125344|NCT03211312|Prediction model|prediction model
5125345|NCT03211312|Dental extraction|dental extraction
5125346|NCT03211312|Elderly patients|elderly patients
5125347|NCT03211286|Hip fracture|hip fracture
5125348|NCT03211286|Tranexamic acid|tranexamic acid
5125349|NCT03211286|Perioperative blood loss|perioperative blood loss
5125350|NCT03211286|Blood Transfusion|blood transfusion
5125351|NCT03211260|Parkinson Disease|parkinson disease
5125352|NCT03211260|Freezing of gait|freezing of gait
5125353|NCT03211260|Equistasi|equistasi
5125354|NCT03211247|EPIT|epit
5125355|NCT03211247|Epicutaneous|epicutaneous
5125356|NCT03211247|Immunotherapy|immunotherapy
5125357|NCT03211247|Viaskin|viaskin
5125359|NCT03211221|TMS|tms
5125360|NCT03211182|lifestyle intervention|lifestyle intervention
5125361|NCT03211182|prediabetes|prediabetes
5125362|NCT03211156|Amoxicillin|amoxicillin
5125363|NCT03211156|Gardnerella vaginalis|gardnerella vaginalis
5125364|NCT03211156|Vaginal Colonization|vaginal colonization
5125365|NCT03211143|GERD|gerd
5125366|NCT03211143|CKD-381|ckd-381
5125367|NCT03211143|Nexium|nexium
5125368|NCT03211143|Bioequivalence|bioequivalence
5125369|NCT03211130|medication adherence|medication adherence
5125370|NCT03211130|self-management|self-management
5125371|NCT03211130|antithrombotic|antithrombotic
5125372|NCT03211104|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
5125373|NCT03211104|curcumin|curcumin
5125374|NCT03211078|Early lung cancer|early lung cancer
5125375|NCT03211078|Photodynamic therapy|photodynamic therapy
5125376|NCT03211078|ENB|enb
5125377|NCT03211065|Rituximab|rituximab
5125378|NCT03211065|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5125379|NCT03211065|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
5125380|NCT03211039|Rady Children's|rady children's
5125381|NCT03211039|Pediatric|pediatric
5125382|NCT03211039|Genomic|genomic
5125383|NCT03211039|Precision Medicine|precision medicine
5125384|NCT03211039|Neonate|neonate
5125385|NCT03211026|Urinary tract infection|urinary tract infection
5125386|NCT03211026|Multidrug resistant bacteria|multidrug resistant bacteria
5125387|NCT03211026|Candiduria|candiduria
5125388|NCT03211026|Epidemiology|epidemiology
5125389|NCT03211026|Graft rejection|graft rejection
5125390|NCT03211026|Solid organ transplantation|solid organ transplantation
5125391|NCT03211013|oxytocin|oxytocin
5125392|NCT03211013|PTSD|ptsd
5125393|NCT03211013|attention bias|attention bias
5125394|NCT03211013|startle|startle
5125395|NCT03211000|aortic aneurysm|aortic aneurysm
5125396|NCT03211000|autophagy|autophagy
5125397|NCT03211000|oxidative stress|oxidative stress
5125398|NCT03211000|Hippo pathway|hippo pathway
5125399|NCT03210987|ward round|ward round
5125400|NCT03210987|patient case presentation|patient case presentation
5125401|NCT03210987|communication|communication
5125402|NCT03210987|patient-centered care|patient-centered care
5125403|NCT03210935|Adnexal cutaneous carcinoma|adnexal cutaneous carcinoma
5125404|NCT03210935|Merkel cell carcinoma|merkel cell carcinoma
5125405|NCT03210935|Advanced basal cell carcinoma requiring systemic treatment|advanced basal cell carcinoma requiring systemic treatment
5125406|NCT03210922|cervical collar, nasoendotracheal intubation, glidescope|cervical collar, nasoendotracheal intubation, glidescope
5125407|NCT03210870|Maternal health|maternal health
5125408|NCT03210870|maternal nutrition|maternal nutrition
5125409|NCT03210870|fetal health related to maternal nutrition|fetal health related to maternal nutrition
5125410|NCT03210857|apnea|apnea
5125411|NCT03210857|neck extension|neck extension
5125412|NCT03210857|syncope|syncope
5125413|NCT03210857|diving blackout|diving blackout
5125414|NCT03210857|right internal carotid arteria|right internal carotid arteria
5125415|NCT03210857|pulsatility index|pulsatility index
5125416|NCT03210857|healthy trained apnoea divers|healthy trained apnoea divers
5125417|NCT03210857|doppler ultrasonography|doppler ultrasonography
5125418|NCT03210844|total hip arthroplasty|total hip arthroplasty
5125419|NCT03210844|direct anterior|direct anterior
5125420|NCT03210844|posterior approach|posterior approach
5125421|NCT03210831|NEC, tissue oxygenation, gut inflammation|nec, tissue oxygenation, gut inflammation
5125422|NCT03210779|oral wound healing|oral wound healing
5125423|NCT03210779|probiotics|probiotics
5125424|NCT03210766|Cannabinoids, nabilone, FBSS, THC/CBD, refractory pain|cannabinoids, nabilone, fbss, thc/cbd, refractory pain
5125425|NCT03210753|Multiple Myeloma|multiple myeloma
5125426|NCT03210753|Peripheral neuropathy|peripheral neuropathy
5125618|NCT03209323|propofol|propofol
5125429|NCT03210753|Risk factors|risk factors
5125431|NCT03210701|pharmacist|pharmacist
5125433|NCT03210701|Implementation science|implementation science
5125434|NCT03210688|Prednisolone|prednisolone
5125435|NCT03210688|alfacalcidol|alfacalcidol
5125436|NCT03210688|Minimal change nephropathy|minimal change nephropathy
5125437|NCT03210649|Dyslipidemia|dyslipidemia
5125438|NCT03210597|water-base exercise|water-base exercise
5125439|NCT03210584|Knee joint|knee joint
5125440|NCT03210584|Cartilage degeneration|cartilage degeneration
5125441|NCT03210584|Ultrasound imaging|ultrasound imaging
5125442|NCT03210584|Full-Field Optical Coherence Tomography|full-field optical coherence tomography
5125443|NCT03210584|9,4 Tesla MRI|9,4 tesla mri
4997165|NCT04011969|NGS|ngs
5125444|NCT03210584|Multimodal evaluation|multimodal evaluation
5125445|NCT03210558|female athletes, testosterone, physical performance, body composition|female athletes, testosterone, physical performance, body composition
5125446|NCT03210545|Biomarker|biomarker
5125447|NCT03210545|Glucocorticoids|glucocorticoids
5125448|NCT03210545|Metabolism|metabolism
5125449|NCT03210506|chronic hepatitis B|chronic hepatitis b
5125450|NCT03210506|hepatitis B virus|hepatitis b virus
5125451|NCT03210506|Cytokines|cytokines
5125452|NCT03210506|Pegylated Interferon α-2a|pegylated interferon α-2a
5125453|NCT03210506|Nucleoside Analogues|nucleoside analogues
5125454|NCT03210493|chronic hepatitis B|chronic hepatitis b
5125455|NCT03210493|hepatitis B virus|hepatitis b virus
5125456|NCT03210493|Treg Cells|treg cells
5125457|NCT03210493|Pegylated Interferon α-2a|pegylated interferon α-2a
5125458|NCT03210493|Nucleoside Analogues|nucleoside analogues
5125459|NCT03210480|Lithium Sulphate|lithium sulphate
5125460|NCT03210480|Prolonged release formulation|prolonged release formulation
5125461|NCT03210480|Lithium carbonate|lithium carbonate
5125462|NCT03210480|Immediate release formulation|immediate release formulation
5125463|NCT03210480|Bipolar Disorder|bipolar disorder
5125465|NCT03210467|chronic hepatitis B|chronic hepatitis b
5125466|NCT03210467|hepatitis B virus|hepatitis b virus
5125467|NCT03210467|Pegylated Interferon α-2a|pegylated interferon α-2a
5125468|NCT03210467|entecavir|entecavir
5125469|NCT03210467|Plasmacytoid Dendritic Cells|plasmacytoid dendritic cells
5125470|NCT03210415|Preterm Labor|preterm labor
5125472|NCT03210415|Pregnant Women|pregnant women
5125473|NCT03210415|≥35 Years Old|≥35 years old
5125474|NCT03210389|Recurrent Nasopharyngeal Carcinoma|recurrent nasopharyngeal carcinoma
5125475|NCT03210389|lobaptin|lobaptin
5125476|NCT03210376|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
5125477|NCT03210376|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5755952|NCT00297882|Cameroon|cameroon
5125478|NCT03210376|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5125479|NCT03210376|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
5125480|NCT03210376|Neuromuscular blockade|neuromuscular blockade
5125481|NCT03210376|NMB|nmb
5125482|NCT03210376|Sugammadex|sugammadex
5125483|NCT03210376|Neostigmine|neostigmine
5125484|NCT03210376|Pain Assessment|pain assessment
5125485|NCT03210376|Survey|survey
5125486|NCT03210324|mifepristone antiprogestins|mifepristone antiprogestins
5125487|NCT03210298|Pressurized IntraPeritoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
5125488|NCT03210298|PIPAC|pipac
5125489|NCT03210298|Pressurized IntraThoracic Aerosol Chemotherapy|pressurized intrathoracic aerosol chemotherapy
5125490|NCT03210298|PITAC|pitac
5125491|NCT03210298|Cisplatin|cisplatin
5125492|NCT03210298|Oxaliplatin|oxaliplatin
5125493|NCT03210298|Gemcitabine|gemcitabine
5125494|NCT03210298|Paclitaxel|paclitaxel
5125495|NCT03210298|nab-Paclitaxel|nab-paclitaxel
5125496|NCT03210298|Doxorubicine|doxorubicine
5125497|NCT03210298|Mitomycin|mitomycin
5125498|NCT03210285|Whole exome sequencing|whole exome sequencing
5125499|NCT03210285|Neurofibromatosis Type 2|neurofibromatosis type 2
5125500|NCT03210285|Acoustic Neuroma|acoustic neuroma
5125501|NCT03210285|Vestibular schwannoma|vestibular schwannoma
5125502|NCT03210194|Inservice Training|inservice training
5125503|NCT03210194|Neonatal Resuscitation|neonatal resuscitation
5125504|NCT03210194|Randomized Cluster Trial|randomized cluster trial
5125505|NCT03210155|Cranial Electrotherapy Stimulation (CES)|cranial electrotherapy stimulation (ces)
5125506|NCT03210155|Efficacy|efficacy
5125513|NCT03210142|Sleep Apnea, Neural Stimulation|sleep apnea, neural stimulation
5125515|NCT03210129|Behavior|behavior
5125516|NCT03210129|Exercise|exercise
5125517|NCT03210129|Motivational interview|motivational interview
5125518|NCT03210129|Cancer|cancer
5125519|NCT03210129|economic evaluation|economic evaluation
5125523|NCT03210090|Cytomegalovirus infection|cytomegalovirus infection
5125524|NCT03210090|CMV-Specific Immune response|cmv-specific immune response
5125525|NCT03210090|Immune reconstitution|immune reconstitution
5125526|NCT03210090|Humoral/Cellular mismatch|humoral/cellular mismatch
5125528|NCT03210077|general anesthesia|general anesthesia
5125529|NCT03210077|Entropy|entropy
5125530|NCT03210077|Hypnosis|hypnosis
5125531|NCT03210064|Apatinib|apatinib
5125532|NCT03210051|Acute ischemic stroke|acute ischemic stroke
5125533|NCT03210051|Endovascular treatment|endovascular treatment
5125534|NCT03210051|Remote ischemic conditioning|remote ischemic conditioning
5125535|NCT03210051|Reperfusion therapy|reperfusion therapy
5125536|NCT03210051|Neuroprotection|neuroprotection
5125537|NCT03210038|Cystoscopy|cystoscopy
5125538|NCT03209986|Liver Cirrhosis|liver cirrhosis
5125539|NCT03209986|Mesenchymal Sem Cells|mesenchymal sem cells
5125541|NCT03209947|Ultrasound|ultrasound
5125542|NCT03209934|Bone and Joint Infection|bone and joint infection
5125543|NCT03209934|Daptomycin|daptomycin
5125544|NCT03209934|Eosinophilic pneumonia|eosinophilic pneumonia
5962026|NCT04283487|Irritable bowel syndrome|irritable bowel syndrome
5125545|NCT03209921|Bone and Joint Infection|bone and joint infection
5125546|NCT03209921|Daptomycin|daptomycin
5125547|NCT03209908|antiviral treatment|antiviral treatment
5125548|NCT03209908|hepatitis B virus|hepatitis b virus
5125549|NCT03209908|mother-to-child transmission|mother-to-child transmission
5125550|NCT03209908|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5125551|NCT03209882|Transcranial infrared laser stimulation (TILS)|transcranial infrared laser stimulation (tils)
5125552|NCT03209882|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5125553|NCT03209830|mental fatigue|mental fatigue
5125554|NCT03209830|drug therapy|drug therapy
5125555|NCT03209830|subarachnoid hemorrhage|subarachnoid hemorrhage
5125557|NCT03209804|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
5125558|NCT03209752|3D analysis|3d analysis
5125559|NCT03209752|Brace|brace
5125560|NCT03209752|EOS imagind system|eos imagind system
5125561|NCT03209752|Anatomical transfer|anatomical transfer
5125562|NCT03209713|Mexican|mexican
5125563|NCT03209713|Mexican-American|mexican-american
5125564|NCT03209713|17-336|17-336
5125565|NCT03209674|Cardiac surgery|cardiac surgery
5125566|NCT03209674|Thoracic surgery|thoracic surgery
5125567|NCT03209661|vascular function|vascular function
5125568|NCT03209622|Smoking Cessation|smoking cessation
5125569|NCT03209622|Acute Coronary Syndrome|acute coronary syndrome
5125570|NCT03209622|Cardiology|cardiology
5125571|NCT03209609|Coronary artery bypass|coronary artery bypass
5125572|NCT03209596|Athletes|athletes
5125573|NCT03209596|Food intake|food intake
5125574|NCT03209596|Supplementation|supplementation
5125575|NCT03209596|Biochemical biomarkers|biochemical biomarkers
5125576|NCT03209596|Soccer Players|soccer players
5755953|NCT00297856|Boostrix|boostrix
5125577|NCT03209570|urinary incontinence, nursing home|urinary incontinence, nursing home
5125578|NCT03209557|Mobile Technology|mobile technology
5125579|NCT03209557|Sociobehavioral|sociobehavioral
5125580|NCT03209544|Suicidal ideation|suicidal ideation
5125581|NCT03209544|Suicide|suicide
5125582|NCT03209544|Cognitive behavioral therapy|cognitive behavioral therapy
5125583|NCT03209544|Online intervention|online intervention
5125584|NCT03209531|Quadriceps activation deficits|quadriceps activation deficits
5125586|NCT03209531|Surgery|surgery
5125587|NCT03209531|Quadrcieps weakness|quadrcieps weakness
5125588|NCT03209531|Operant conditioning|operant conditioning
5125589|NCT03209531|Cortical excitability|cortical excitability
5125590|NCT03209505|Lid Wiper Epitheliopahty|lid wiper epitheliopahty
5125591|NCT03209505|Coefficient of Friction|coefficient of friction
5125592|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate
5125593|NCT03209466|Diabetic foot ulcer syndrome|diabetic foot ulcer syndrome
5125594|NCT03209466|Wound healing|wound healing
5125595|NCT03209453|family work shop|family work shop
5125596|NCT03209427|morphine, pruritus, serotonin|morphine, pruritus, serotonin
5125597|NCT03209414|Frailty syndrome|frailty syndrome
5125598|NCT03209414|Coronary heart disease|coronary heart disease
5125599|NCT03209414|Coronary revascularization|coronary revascularization
5125600|NCT03209414|Major adverse cardiovascular events|major adverse cardiovascular events
5122157|NCT03231813|emollients|emollients
5125614|NCT03209336|Intersphincteric resection|intersphincteric resection
5125616|NCT03209323|Epileptiform patterns|epileptiform patterns
5125617|NCT03209323|sevoflurane|sevoflurane
5125619|NCT03209323|bispectral index|bispectral index
5125620|NCT03209323|state entropy|state entropy
5125621|NCT03209323|response entropy|response entropy
5125622|NCT03209323|A-line Auto Regressive Index|a-line auto regressive index
5125623|NCT03209323|middle latency auditory evoked potentials|middle latency auditory evoked potentials
5125624|NCT03209284|maxillary atrophy|maxillary atrophy
5125625|NCT03209284|transcrestal sinus floor elevation|transcrestal sinus floor elevation
5125626|NCT03209271|Fluid therapy|fluid therapy
5125627|NCT03209258|Stroke|stroke
5125628|NCT03209258|Intracerebral Hemorrhage|intracerebral hemorrhage
5125629|NCT03209258|Care Bundle|care bundle
5125630|NCT03209258|Clinical Trial|clinical trial
5125631|NCT03209258|Stepped-wedge Cluster|stepped-wedge cluster
5125632|NCT03209258|Management|management
5125633|NCT03209258|Blood Pressure|blood pressure
5125634|NCT03209219|effectiveness, safety|effectiveness, safety
5135456|NCT03146793|Renal Dialysis|renal dialysis
5125637|NCT03209206|Radical Nephroureterectomy|radical nephroureterectomy
5125638|NCT03209193|off-pump coronary artery bypass|off-pump coronary artery bypass
5125639|NCT03209193|sevoflurane|sevoflurane
5125640|NCT03209193|desflurane|desflurane
5125641|NCT03209193|tissue oxygen saturation|tissue oxygen saturation
5125642|NCT03209180|HFrEF|hfref
5125643|NCT03209180|Carvedilol|carvedilol
5125644|NCT03209180|Slow Release|slow release
5125645|NCT03209180|NT-proBNP|nt-probnp
5125646|NCT03209167|Breast reconstruction; abdominoplasty; patient satisfaction|breast reconstruction; abdominoplasty; patient satisfaction
5125647|NCT03209154|Adherence|adherence
5125648|NCT03209154|Therapeutic Drug Monitoring|therapeutic drug monitoring
5125649|NCT03209154|Patient perspective|patient perspective
5125650|NCT03209141|hypertension|hypertension
5125651|NCT03209141|Diastolic Dysfunction|diastolic dysfunction
5125652|NCT03209141|impedance cardiography|impedance cardiography
5125653|NCT03209141|echocardiography|echocardiography
5125654|NCT03209076|rectal neoplasms|rectal neoplasms
5125655|NCT03209076|sexual dysfunctions|sexual dysfunctions
5125656|NCT03209076|Urinary incontinence|urinary incontinence
5125657|NCT03209076|Quality of life|quality of life
5125658|NCT03209076|robotic surgical procedures|robotic surgical procedures
5125659|NCT03209076|laparoscopy|laparoscopy
5125660|NCT03209037|chronic hepatitis B|chronic hepatitis b
5125661|NCT03209037|hepatitis B virus|hepatitis b virus
5125662|NCT03209037|CD8+T Cells|cd8+t cells
5125663|NCT03209037|Pegylated Interferon α-2a|pegylated interferon α-2a
5125664|NCT03209037|Nucleoside Analogues|nucleoside analogues
5125665|NCT03209024|hypertension|hypertension
5125666|NCT03209024|home blood pressure monitoring|home blood pressure monitoring
5125667|NCT03209024|self blood pressure monitoring|self blood pressure monitoring
5125668|NCT03209024|telemedicine|telemedicine
5125669|NCT03209024|health apps|health apps
5125670|NCT03209024|informatics|informatics
5125671|NCT03209024|data collection|data collection
5125672|NCT03209024|personal health records|personal health records
5125673|NCT03209024|smartphone|smartphone
5125674|NCT03209024|self care|self care
5125675|NCT03209024|blood pressure monitors|blood pressure monitors
5125676|NCT03209011|chronic hepatitis B|chronic hepatitis b
5125677|NCT03209011|hepatitis B virus|hepatitis b virus
5125678|NCT03209011|CD4+T Cells|cd4+t cells
5125679|NCT03209011|Pegylated Interferon α-2a|pegylated interferon α-2a
5125680|NCT03209011|Nucleoside Analogues|nucleoside analogues
5125681|NCT03208998|hepatitis B virus|hepatitis b virus
5125682|NCT03208998|Chronic Hepatitis B Infection|chronic hepatitis b infection
5125683|NCT03208998|Pegylated Interferon α-2a|pegylated interferon α-2a
5125684|NCT03208998|Nucleoside Analogues|nucleoside analogues
5125685|NCT03208998|Natural Killer Cells|natural killer cells
5125686|NCT03208985|Emergency contraception|emergency contraception
5125688|NCT03208972|ovarian stimulation|ovarian stimulation
5125697|NCT03208907|Vivax malaria|vivax malaria
5125698|NCT03208907|Radical cure|radical cure
5125699|NCT03208907|Elimination|elimination
5011368|NCT03925168|pain|pain
5125700|NCT03208881|Osteoarthritis, Obesity, Liraglutide, Ultrasound|osteoarthritis, obesity, liraglutide, ultrasound
5125701|NCT03208855|Cognitive Behavioral Therapy|cognitive behavioral therapy
5125702|NCT03208816|pain|pain
5125703|NCT03208816|constipation|constipation
5125704|NCT03208803|Myelofibrosis|myelofibrosis
5125705|NCT03208803|Erythropoiesis-stimulating Agents|erythropoiesis-stimulating agents
5125706|NCT03208803|Janus Kinase 2 inhibitors|janus kinase 2 inhibitors
5125707|NCT03208803|Ruxolitinib|ruxolitinib
5125708|NCT03208725|Malnutrition|malnutrition
5125709|NCT03208725|Hospitalization|hospitalization
5125710|NCT03208725|Acute Illness|acute illness
5125711|NCT03208725|Pediatric|pediatric
5125712|NCT03208725|Post-discharge mortality|post-discharge mortality
5125713|NCT03208725|Mortality|mortality
5125714|NCT03208725|Cohort|cohort
5125724|NCT03208686|Black/African American|black/african american
5125725|NCT03208686|Self-management|self-management
5125726|NCT03208660|seizure|seizure
5125727|NCT03208660|Fycompa|fycompa
5125728|NCT03208647|case-control study|case-control study
5125729|NCT03208647|Multiple risk factors|multiple risk factors
5125730|NCT03208634|robotics|robotics
5125731|NCT03208634|motor performance|motor performance
5125732|NCT03208634|stroke patient|stroke patient
5125733|NCT03208634|upper limb|upper limb
5125734|NCT03208634|rehabilitation|rehabilitation
5125735|NCT03208608|RBANS-H|rbans-h
5125736|NCT03208608|Older adults|older adults
5125737|NCT03208608|Normal hearing|normal hearing
5125738|NCT03208608|Cognition|cognition
5135558|NCT03145987|Vitis vinifera|vitis vinifera
5125739|NCT03208608|Age-related hearing loss|age-related hearing loss
5125740|NCT03208569|anticholinergic|anticholinergic
5125741|NCT03208569|alzheimer|alzheimer
5125742|NCT03208569|cognition|cognition
5125743|NCT03208569|MMSE|mmse
5125744|NCT03208569|anticholinergic cognitive burden scale|anticholinergic cognitive burden scale
5125745|NCT03208543|thermotherapy|thermotherapy
5125746|NCT03208543|Pakistan|pakistan
5125747|NCT03208504|Thoracic Aortic Disease|thoracic aortic disease
5125748|NCT03208504|Thoracic Aneurysm|thoracic aneurysm
5125749|NCT03208465|Empagliflozin|empagliflozin
5125750|NCT03208465|Sitagliptin|sitagliptin
5125751|NCT03208465|Myocardial perfusion reserve|myocardial perfusion reserve
5125752|NCT03208426|Efficacy, Self|efficacy, self
5125753|NCT03208413|thalidomide|thalidomide
5125754|NCT03208413|radiation-induced brain injury|radiation-induced brain injury
5125758|NCT03208374|Histologically confirmed cancer|histologically confirmed cancer
5125759|NCT03208374|IMPACT testing|impact testing
5125760|NCT03208374|17-327|17-327
5125761|NCT03208335|rh-endostatin|rh-endostatin
5125762|NCT03208335|radiotherapy|radiotherapy
5125763|NCT03208296|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5125764|NCT03208296|Basal Cell Carcinoma|basal cell carcinoma
5125765|NCT03208257|esmolol|esmolol
5125766|NCT03208257|adrenergic storm|adrenergic storm
5125767|NCT03208257|septic shock|septic shock
5125768|NCT03208244|Heart Disease|heart disease
5125769|NCT03208244|Heart Transplant|heart transplant
5125770|NCT03208244|HCV|hcv
5125771|NCT03208244|Hepatitis C|hepatitis c
5125772|NCT03208218|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
5125773|NCT03208218|Healthy volunteers|healthy volunteers
5125774|NCT03208218|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
5125775|NCT03208218|Healthy male volunteers|healthy male volunteers
5125776|NCT03208192|colorectal liver metastases|colorectal liver metastases
5125777|NCT03208192|hepatocellular carcinoma|hepatocellular carcinoma
5125778|NCT03208192|intrahepatic cholangiocellular carcinoma|intrahepatic cholangiocellular carcinoma
5125779|NCT03208192|tumor of liver|tumor of liver
5125780|NCT03208192|focal nodular hyperplasia liver|focal nodular hyperplasia liver
5125781|NCT03208192|hemangioma liver|hemangioma liver
5125782|NCT03208140|intubation to supraglottic devices|intubation to supraglottic devices
5125783|NCT03208140|intubation device|intubation device
5125784|NCT03208140|laryngeal vision|laryngeal vision
5125785|NCT03208140|success intubation|success intubation
5125786|NCT03208140|videolaryngoscope|videolaryngoscope
5125787|NCT03208140|direct intubation|direct intubation
5125788|NCT03208127|HCV|hcv
5125789|NCT03208127|Epclusa|epclusa
5125796|NCT03208062|Waste material|waste material
5125797|NCT03208062|Orthopaedic|orthopaedic
5125798|NCT03208049|Insomnia|insomnia
5125799|NCT03208049|CBT|cbt
5125800|NCT03208049|Gulf War Veterans|gulf war veterans
5125801|NCT03208049|Sleep|sleep
5011495|NCT03924414|Bone|bone
5125802|NCT03208036|schizophrenia|schizophrenia
5125803|NCT03208036|tdcs|tdcs
5125804|NCT03208036|working memory|working memory
5125805|NCT03208036|cognitive remediation|cognitive remediation
5125806|NCT03208036|cognition|cognition
5125811|NCT03207997|Scleroderma|scleroderma
5125812|NCT03207997|Pulmonary fibrosis|pulmonary fibrosis
5125813|NCT03207997|MRI|mri
5125814|NCT03207997|quantification|quantification
5125815|NCT03207984|Gingival Recession|gingival recession
5125816|NCT03207984|Collagen Matrix|collagen matrix
5125817|NCT03207984|Periodontics|periodontics
5125821|NCT03207919|maternal-fetal attachment|maternal-fetal attachment
5125822|NCT03207919|maternal health|maternal health
5125823|NCT03207919|maternal stress|maternal stress
5125824|NCT03207919|Lullaby Project|lullaby project
5125825|NCT03207880|pregnancy test|pregnancy test
5125826|NCT03207867|Immunotherapy, A2aR, PDR001, NIR178, NSCLC, solid tumors|immunotherapy, a2ar, pdr001, nir178, nsclc, solid tumors
5125827|NCT03207841|SCI|sci
5125828|NCT03207841|High Protein|high protein
5125829|NCT03207841|Low Carbohydrate|low carbohydrate
5125830|NCT03207841|Metabolic Health|metabolic health
5125831|NCT03207841|Microbiome|microbiome
5125832|NCT03207828|Behavioral activation|behavioral activation
5125833|NCT03207763|Safety|safety
5125834|NCT03207763|Reactogenicity|reactogenicity
5125835|NCT03207763|Acceptability|acceptability
5125836|NCT03207763|Microneedle patch|microneedle patch
5125837|NCT03207750|Immunogenicity|immunogenicity
5125838|NCT03207750|lyophilized formulation|lyophilized formulation
5125839|NCT03207750|United States|united states
5125840|NCT03207750|Reactogenicity|reactogenicity
5125841|NCT03207750|Safety|safety
5125842|NCT03207750|Porcine circovirus -free|porcine circovirus -free
5125843|NCT03207750|Human rotavirus vaccine|human rotavirus vaccine
5125844|NCT03207750|liquid formulation|liquid formulation
5125845|NCT03207750|Healthy infants|healthy infants
5125846|NCT03207737|Spinal Cord Injuries|spinal cord injuries
5125847|NCT03207737|SCI|sci
5125848|NCT03207737|Telehealth|telehealth
5125855|NCT03207724|new diagnosis|new diagnosis
5125856|NCT03207724|adenocarcinoma|adenocarcinoma
5125857|NCT03207685|Epilepsy|epilepsy
5125858|NCT03207685|Epilepsy Monitoring Unit|epilepsy monitoring unit
5125859|NCT03207685|EMU|emu
5125860|NCT03207685|Seizure|seizure
5125861|NCT03207685|Seizure Detection|seizure detection
5125866|NCT03207659|RIRS|rirs
5125867|NCT03207659|Renal stones|renal stones
5125868|NCT03207659|Efficacy|efficacy
5125869|NCT03207659|Safety|safety
5125870|NCT03207646|Cardiac Rehabiliation|cardiac rehabiliation
5125871|NCT03207646|Percutaneous Coronary Intervention|percutaneous coronary intervention
5125872|NCT03207646|Cardiovascular Risk Factor|cardiovascular risk factor
5125873|NCT03207646|Digital Health Solution|digital health solution
5125874|NCT03207646|Medication Adherence|medication adherence
5125875|NCT03207633|OCD, rTMS, right orbitofrontal cortex|ocd, rtms, right orbitofrontal cortex
5125876|NCT03207607|Adults|adults
5125877|NCT03207607|Snacks|snacks
5125878|NCT03207607|Appetite|appetite
5125879|NCT03207607|Blood glucose|blood glucose
5125880|NCT03207607|Insulin|insulin
5125881|NCT03207555|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
5125882|NCT03207555|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5125883|NCT03207555|CLL|cll
5125884|NCT03207555|Small Lymphocytic Leukemia|small lymphocytic leukemia
5125885|NCT03207555|SLL|sll
5125886|NCT03207555|Ibrutinib|ibrutinib
5125887|NCT03207555|PCI-32765|pci-32765
5125888|NCT03207555|Imbruvica|imbruvica
5342961|NCT01981356|Acceptance and Commitment Therapy|acceptance and commitment therapy
5125889|NCT03207542|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
5125890|NCT03207542|B-Cell Precursor Acute Lymphoblastic Leukemia|b-cell precursor acute lymphoblastic leukemia
5125891|NCT03207542|T-Cell Precursor Acute Lymphoblastic Leukemia|t-cell precursor acute lymphoblastic leukemia
5125892|NCT03207542|ALL|all
5125893|NCT03207542|Daratumumab|daratumumab
5125894|NCT03207516|sourdough; leavening process; fermentation; brewer's yeast|sourdough; leavening process; fermentation; brewer's yeast
5125895|NCT03207490|Hand|hand
5125896|NCT03207490|Rehabilitation|rehabilitation
5125897|NCT03207490|sEMG|semg
5125901|NCT03207451|Anti-Platelet Therapy|anti-platelet therapy
5125902|NCT03207425|Hepatic Impairment|hepatic impairment
5125918|NCT03207334|acute myeloid leukemia|acute myeloid leukemia
5125919|NCT03207334|genomic signatures|genomic signatures
5125920|NCT03207334|midostaurin|midostaurin
5125921|NCT03207334|relapsed|relapsed
5125922|NCT03207334|refractory|refractory
5125924|NCT03207308|Vitamin A Status|vitamin a status
5125925|NCT03207308|Retinol Isotope dilution|retinol isotope dilution
5125926|NCT03207308|Total body vitamin A stores|total body vitamin a stores
5125927|NCT03207308|Children|children
5125928|NCT03207308|Senegal|senegal
5125929|NCT03207295|Nesiritide|nesiritide
5125930|NCT03207295|Total Cavo-Pulmonary Connection|total cavo-pulmonary connection
5125931|NCT03207295|Congenital Heart Disease|congenital heart disease
5125932|NCT03207243|Severe asthma|severe asthma
5125933|NCT03207243|Safety|safety
5125934|NCT03207243|GSK3772847|gsk3772847
5125935|NCT03207243|Efficacy|efficacy
5125936|NCT03207217|Safety Planning|safety planning
5125937|NCT03207217|Access to Lethal Means|access to lethal means
5125938|NCT03207217|Zero Suicide|zero suicide
5125939|NCT03207204|Dental bleaching|dental bleaching
5125940|NCT03207204|Color|color
5125941|NCT03207204|Sensitivity|sensitivity
5125942|NCT03207204|violet LED|violet led
5125943|NCT03207204|Quality of life|quality of life
5125944|NCT03207165|Cardiogenic shock|cardiogenic shock
5125945|NCT03207165|Inotropes|inotropes
5125946|NCT03207165|Low cardiac output syndrome|low cardiac output syndrome
5125947|NCT03207139|cancer prostate|cancer prostate
5125948|NCT03207139|Ga-68 PSMA Ligand|ga-68 psma ligand
5125949|NCT03207139|staging|staging
5125950|NCT03207139|biochemical failure|biochemical failure
5125951|NCT03207126|Ultrasound|ultrasound
5125952|NCT03207126|Biopsy|biopsy
5125953|NCT03207126|Endometrial cancer|endometrial cancer
5125954|NCT03207113|prostate-specific antigen|prostate-specific antigen
5125955|NCT03207113|prostate cancer survivorship|prostate cancer survivorship
5125956|NCT03207113|mobile health|mobile health
5125957|NCT03207113|realist evaluation|realist evaluation
5125958|NCT03207113|case study|case study
5125959|NCT03207100|Intracerebral hemorrhage|intracerebral hemorrhage
5125960|NCT03207100|Early antihypertensive treatment|early antihypertensive treatment
5125961|NCT03207100|Analgesia-first|analgesia-first
5125962|NCT03207100|Sedation|sedation
5125963|NCT03207074|iKnife|iknife
5125964|NCT03207074|Mass Spectrometry|mass spectrometry
5125965|NCT03207074|Point-of-care|point-of-care
5125966|NCT03207074|Diagnosis|diagnosis
5125967|NCT03207074|Endometrial Cancer|endometrial cancer
5125968|NCT03207061|endometrial cancer|endometrial cancer
5125969|NCT03207061|staging|staging
5125970|NCT03207061|3 Dimensional|3 dimensional
5125971|NCT03207061|Ultrasound|ultrasound
5125972|NCT03207061|Myometrial invasion|myometrial invasion
5125973|NCT03206996|autism|autism
5125974|NCT03206996|sensory over-responsiveness|sensory over-responsiveness
5125975|NCT03206996|auditory hyper-sensitivity|auditory hyper-sensitivity
5125976|NCT03206996|auditory processing|auditory processing
5125977|NCT03206996|exposure therapy|exposure therapy
5125978|NCT03206996|exposure and response prevention|exposure and response prevention
5125979|NCT03206996|cognitive behavior therapy|cognitive behavior therapy
5125980|NCT03206996|occupational therapy|occupational therapy
5125981|NCT03206983|Small pupil|small pupil
5125982|NCT03206944|standardized tomato extract|standardized tomato extract
5125983|NCT03206944|anti-aggregation|anti-aggregation
5125984|NCT03206944|high cardiovascular risk|high cardiovascular risk
5125985|NCT03206944|diet supplement|diet supplement
5125986|NCT03206931|Metastatic cancer|metastatic cancer
5125987|NCT03206931|Advanced cancer|advanced cancer
5122527|NCT03229408|Hyperandrogenism|hyperandrogenism
5126000|NCT03206892|laparoscopy|laparoscopy
5126001|NCT03206892|minimally invasive surgery|minimally invasive surgery
5126002|NCT03206892|ovarian drilling|ovarian drilling
5126003|NCT03206892|PCOS|pcos
5126004|NCT03206892|Diagnostic laparoscopy|diagnostic laparoscopy
5126005|NCT03206879|ESBL|esbl
5126006|NCT03206879|Enterobacteriaceae|enterobacteriaceae
5126007|NCT03206879|multidrug-resistance|multidrug-resistance
5126008|NCT03206840|mindfulness meditation|mindfulness meditation
5126009|NCT03206840|hypnosis|hypnosis
5126010|NCT03206840|meta-awareness|meta-awareness
5126011|NCT03206840|absorption|absorption
5126012|NCT03206840|consciousness|consciousness
5126013|NCT03206840|self|self
5126014|NCT03206827|colorectal cancer|colorectal cancer
5126015|NCT03206827|type 2 diabetes|type 2 diabetes
5126016|NCT03206827|diet|diet
5126017|NCT03206827|plant protein|plant protein
5126514|NCT03203538|night work|night work
5126023|NCT03206801|Urine biomarker|urine biomarker
5126024|NCT03206801|CXCL10 chemokine|cxcl10 chemokine
5126025|NCT03206801|Post-transplant monitoring|post-transplant monitoring
5126026|NCT03206801|Protocol biopsy|protocol biopsy
5126030|NCT03206723|corneal abrasion|corneal abrasion
5126031|NCT03206723|contact lens|contact lens
5126032|NCT03206723|eye trauma|eye trauma
5126033|NCT03206710|vitamin C|vitamin c
5126034|NCT03206710|ascorbic acid|ascorbic acid
5126035|NCT03206710|wheeze|wheeze
5126036|NCT03206710|nicotine|nicotine
5011707|NCT03923218|LL-37|ll-37
5126037|NCT03206710|smoke exposure|smoke exposure
5126038|NCT03206710|long term follow up|long term follow up
5126039|NCT03206710|pulmonary function testing|pulmonary function testing
5126040|NCT03206710|forced expiratory flows|forced expiratory flows
5126041|NCT03206697|mitochondrial copy, number and energy|mitochondrial copy, number and energy
5126042|NCT03206658|acute kidney injury|acute kidney injury
5126043|NCT03206658|prevention|prevention
5126044|NCT03206658|severity|severity
5126045|NCT03206658|biomarker|biomarker
5126046|NCT03206619|smoking|smoking
5126047|NCT03206619|habit|habit
5126048|NCT03206619|preference|preference
5126049|NCT03206619|behavior|behavior
5126050|NCT03206619|tailoring|tailoring
5126051|NCT03206619|cessation|cessation
5126052|NCT03206619|engagement|engagement
5126053|NCT03206619|digital|digital
5126054|NCT03206619|mobile app|mobile app
5126055|NCT03206619|recommender system|recommender system
5126056|NCT03206606|COPD|copd
5126057|NCT03206606|Spirometry|spirometry
5126058|NCT03206606|Mobile application|mobile application
5126059|NCT03206580|aging|aging
5126066|NCT03206476|Food Habits|food habits
5126067|NCT03206476|Adolescents|adolescents
5126068|NCT03206476|Educative Intervention|educative intervention
5126069|NCT03206476|Nutrition Assessment|nutrition assessment
5126070|NCT03206476|Behavior Modifications|behavior modifications
5126071|NCT03206437|mindfulness|mindfulness
5126072|NCT03206437|meditation|meditation
5126073|NCT03206359|Unfolded Protein Response|unfolded protein response
5126074|NCT03206359|GADD34|gadd34
5126075|NCT03206359|Type I IFN|type i ifn
5126076|NCT03206359|IFN response genes|ifn response genes
5126077|NCT03206359|Type II IFN|type ii ifn
5126078|NCT03206359|anti-DNA autoantibodies|anti-dna autoantibodies
5126079|NCT03206333|Breast cancer|breast cancer
5126080|NCT03206333|Cardiovascular diseases|cardiovascular diseases
5126081|NCT03206333|Coronary artery calcium|coronary artery calcium
5126082|NCT03206333|Prediction|prediction
5126083|NCT03206333|Risk stratification|risk stratification
5126084|NCT03206333|Deep learning technique|deep learning technique
5126085|NCT03206333|Software development|software development
5126086|NCT03206333|Computed tomography scan|computed tomography scan
5126087|NCT03206307|Return to work|return to work
5126088|NCT03206307|medical rehabilitation|medical rehabilitation
5126089|NCT03206281|clinical weight estimation|clinical weight estimation
5126090|NCT03206268|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
5126091|NCT03206268|uveitis|uveitis
5126092|NCT03206268|SD-OCT|sd-oct
5126093|NCT03206268|GDx VCC|gdx vcc
5122636|NCT03228641|skin rejuvenation|skin rejuvenation
5126110|NCT03206190|longitudinal progression|longitudinal progression
5126111|NCT03206164|Health Services Research|health services research
5126112|NCT03206138|Investigator trial|investigator trial
5126113|NCT03206138|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5126114|NCT03206125|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5126115|NCT03206125|Case-Control Study|case-control study
5126116|NCT03206125|Risk Factors|risk factors
5126117|NCT03206125|Epidemiology|epidemiology
5126118|NCT03206112|Focal Dystonia|focal dystonia
5126125|NCT03206099|Genomics|genomics
5126126|NCT03206086|DNA Repair|dna repair
5126127|NCT03206086|Inflammation|inflammation
5126128|NCT03206086|Hematopoiesis|hematopoiesis
5126129|NCT03206086|Pancytopenia|pancytopenia
5126130|NCT03206073|Oncolytic Vaccinia Virus|oncolytic vaccinia virus
5126131|NCT03206073|Tumor Cell Death|tumor cell death
5126132|NCT03206073|Viral Therapy|viral therapy
5126133|NCT03206073|Anti-Tumor Immunity|anti-tumor immunity
5126140|NCT03206034|Cognition|cognition
5126141|NCT03205995|TMA|tma
5126142|NCT03205995|aHUS|ahus
5126143|NCT03205982|Wisepill|wisepill
5126144|NCT03205982|ART|art
5126145|NCT03205982|PLWH|plwh
5126146|NCT03205969|Breast Cancer|breast cancer
5126147|NCT03205969|chemotherapy side effect|chemotherapy side effect
5126148|NCT03205969|mobile game|mobile game
5126149|NCT03205956|Parkinson's disease|parkinson's disease
5126150|NCT03205956|PD|pd
5126151|NCT03205956|levodopa|levodopa
5126152|NCT03205943|ICON|icon
5126153|NCT03205904|cystic fibrosis related diabetes|cystic fibrosis related diabetes
5126154|NCT03205891|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
5126155|NCT03205891|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5126156|NCT03205891|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5126157|NCT03205891|CD30+ peripheral T-cell lymphoma|cd30+ peripheral t-cell lymphoma
5006858|NCT03953560|Dyspnea|dyspnea
5126158|NCT03205891|Brentuximab Vedotin|brentuximab vedotin
5126159|NCT03205891|SGN-35|sgn-35
5126160|NCT03205891|Adcetris|adcetris
5126162|NCT03205891|TAK-228|tak-228
5126163|NCT03205891|MLN0128|mln0128
5126164|NCT03205891|Glucose Monitor|glucose monitor
5126165|NCT03205891|Glucometer|glucometer
5126166|NCT03205826|Emphysema|emphysema
5126167|NCT03205826|Bronchoscopic intervention|bronchoscopic intervention
5126168|NCT03205826|CHARTIS measurement|chartis measurement
5126177|NCT03205761|Methylation|methylation
5126178|NCT03205709|memory|memory
5126179|NCT03205709|computerized training|computerized training
5126180|NCT03205709|cognition|cognition
5126181|NCT03205709|MRI|mri
5126182|NCT03205709|mci|mci
5126183|NCT03205709|memory problems|memory problems
5126184|NCT03205709|memory complaints|memory complaints
5126192|NCT03205540|Continuous epidural analgesia|continuous epidural analgesia
5126193|NCT03205540|Bilateral single-shot adductor canal blocks|bilateral single-shot adductor canal blocks
5126194|NCT03205527|Fall risk|fall risk
5126195|NCT03205527|Stroke survivors|stroke survivors
5126196|NCT03205527|Perturbation training|perturbation training
5126197|NCT03205501|BE|be
5126198|NCT03205501|EAC|eac
5126199|NCT03205501|HGD|hgd
5126200|NCT03205501|Esophagus|esophagus
5126201|NCT03205488|Northwestern|northwestern
5126202|NCT03205488|Nilotinib|nilotinib
5126203|NCT03205488|USA|usa
5126204|NCT03205488|NILO-PD|nilo-pd
5126205|NCT03205488|Parkinson Disease|parkinson disease
5126206|NCT03205475|Training|training
5126207|NCT03205475|Intervention|intervention
5126208|NCT03205475|Social Communication|social communication
5126209|NCT03205475|Play|play
5126210|NCT03205462|Pseudomanas Aeruginosa|pseudomanas aeruginosa
5126215|NCT03205462|chronic infection|chronic infection
5126216|NCT03205410|remote ischemic preconditioning|remote ischemic preconditioning
5126217|NCT03205410|cardiac surgery-associated acute kidney injury|cardiac surgery-associated acute kidney injury
5126218|NCT03205410|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5126515|NCT03203538|shift work|shift work
5126219|NCT03205384|Urgent abdominal surgery|urgent abdominal surgery
5126220|NCT03205371|Meningitis|meningitis
5126221|NCT03205371|Meningococcal Meningitis|meningococcal meningitis
5126222|NCT03205371|Meningococcal Infections|meningococcal infections
5126223|NCT03205371|MenACYW Conjugate vaccine|menacyw conjugate vaccine
5126224|NCT03205358|Meningitis|meningitis
5126225|NCT03205358|Meningococcal Meningitis|meningococcal meningitis
5126226|NCT03205358|MenACYW conjugate vaccine|menacyw conjugate vaccine
5126227|NCT03205358|NIMENRIX®|nimenrix®
5126228|NCT03205345|Cirrhosis|cirrhosis
5126229|NCT03205345|NASH Cirrhosis|nash cirrhosis
5126230|NCT03205345|Decompensated NASH cirrhosis|decompensated nash cirrhosis
5126231|NCT03205345|Cirrhosis, Liver|cirrhosis, liver
5126232|NCT03205345|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5126233|NCT03205332|Worry|worry
5126234|NCT03205332|Anxiety|anxiety
5126235|NCT03205319|Oesophagoduodenoscopy|oesophagoduodenoscopy
5126236|NCT03205319|E-learning|e-learning
5126237|NCT03205319|Appropriate use of healthcare|appropriate use of healthcare
5126238|NCT03205319|Deimplementation|deimplementation
5126239|NCT03205306|Myasthenia Gravis|myasthenia gravis
5126240|NCT03205306|Psyche|psyche
5126241|NCT03205306|Depression|depression
5126242|NCT03205306|Anxiety Disorder|anxiety disorder
5126243|NCT03205306|Posttraumatic Stress Disorder|posttraumatic stress disorder
5126244|NCT03205306|Disease Processing|disease processing
5126245|NCT03205293|School-Based Intervention|school-based intervention
5126246|NCT03205293|Ecological Model|ecological model
5126247|NCT03205293|Participatory Approach|participatory approach
5126248|NCT03205293|Palestinian Female Schoolchildren|palestinian female schoolchildren
5126249|NCT03205280|Multiple Sclerosis, Relapsing-Remitting, Computer-Assisted Diagnosis, MRI, Diagnosis, Treatment Efficacy|multiple sclerosis, relapsing-remitting, computer-assisted diagnosis, mri, diagnosis, treatment efficacy
5126250|NCT03205254|Mediterranean diet|mediterranean diet
5126251|NCT03205254|HDL|hdl
5126252|NCT03205254|Fast food|fast food
5126253|NCT03205254|Gut microbiota|gut microbiota
5126254|NCT03205254|Inflammation|inflammation
5126255|NCT03205241|Exercise|exercise
5126256|NCT03205241|Fish Oil|fish oil
5126257|NCT03205241|Cycling|cycling
5126258|NCT03205241|Inflammation|inflammation
5126259|NCT03205241|Oxidative stress|oxidative stress
5126260|NCT03205215|Hyperbaric oxygen|hyperbaric oxygen
5126261|NCT03205215|Pressurized oxygen|pressurized oxygen
5136065|NCT03142490|Stress|stress
5126263|NCT03205215|Post concussive syndrome|post concussive syndrome
5126264|NCT03205215|Oxygen therapy|oxygen therapy
5126265|NCT03205189|postoperative pain|postoperative pain
5126266|NCT03205189|ambulatory surgery|ambulatory surgery
5126267|NCT03205189|general anesthesia|general anesthesia
5126268|NCT03205189|anesthesia consultation|anesthesia consultation
5126269|NCT03205189|post-op prescription|post-op prescription
5126270|NCT03205176|AZD5153|azd5153
5126271|NCT03205176|Olaparib|olaparib
5126272|NCT03205176|Malignant solid tumors|malignant solid tumors
5126273|NCT03205176|Lymphoma|lymphoma
5126274|NCT03205176|Ovarian Cancer|ovarian cancer
5126275|NCT03205176|BRD4|brd4
5126276|NCT03205150|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5126277|NCT03205150|NASH|nash
5126278|NCT03205150|Obese|obese
5126279|NCT03205150|Type 2 diabetes mellitus|type 2 diabetes mellitus
5126280|NCT03205150|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5126281|NCT03205098|biological markers|biological markers
5126282|NCT03205098|mesenteric ischemia|mesenteric ischemia
5126283|NCT03205098|ultratrail|ultratrail
5126284|NCT03205072|ERCP|ercp
5126285|NCT03205072|Per-Oral Cholangioscopy|per-oral cholangioscopy
5126286|NCT03205072|Liver Transplantation|liver transplantation
5126287|NCT03205072|Spy Glass|spy glass
5126288|NCT03205033|Melatonin|melatonin
5126289|NCT03205033|Breast cancer|breast cancer
5126290|NCT03205033|Chemotherapy|chemotherapy
5126291|NCT03205033|Sleep-wake rhytms|sleep-wake rhytms
5126292|NCT03205033|Circadian rhythms|circadian rhythms
5126293|NCT03205007|Health Promotion|health promotion
5126294|NCT03205007|Nutrition|nutrition
5126295|NCT03205007|Older Adults|older adults
5126296|NCT03204994|Colorectal surgery|colorectal surgery
5126301|NCT03204968|Lung lobectomy|lung lobectomy
5126302|NCT03204955|Osmolar therapy|osmolar therapy
5126303|NCT03204955|Acetate|acetate
5126304|NCT03204942|Bone metastasis,Thoracic secondary, Cancer Pain,|bone metastasis,thoracic secondary, cancer pain,
5126305|NCT03204903|Dry eye|dry eye
5126306|NCT03204903|Laser acupuncture|laser acupuncture
5756057|NCT00297440|Girls|girls
5126307|NCT03204903|Traditional Chinese medicine|traditional chinese medicine
5126308|NCT03204877|Melatonin|melatonin
5126309|NCT03204877|Insulin sensitivity|insulin sensitivity
5126310|NCT03204877|Insulin secretion|insulin secretion
5126311|NCT03204877|Incretin response|incretin response
5126312|NCT03204838|IDH1, IDH2, MUTATION, AML|idh1, idh2, mutation, aml
5126313|NCT03204825|Patient education|patient education
5126314|NCT03204825|Pain management|pain management
5126516|NCT03203538|light|light
5126323|NCT03204747|overactive bladder|overactive bladder
5126325|NCT03204734|Capecitabine|capecitabine
5126326|NCT03204734|breast cancer|breast cancer
5126327|NCT03204708|postoperative analgsia|postoperative analgsia
5126328|NCT03204708|peripheral block catheter|peripheral block catheter
5126329|NCT03204708|modified radical mastectomy|modified radical mastectomy
5126330|NCT03204695|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5356839|NCT01917799|pregnancy|pregnancy
5126331|NCT03204695|Atrial Fibrillation|atrial fibrillation
5126332|NCT03204695|Stroke|stroke
5126333|NCT03204695|Left Atrial Appendage (LAA)|left atrial appendage (laa)
5126334|NCT03204695|LAA Closure|laa closure
5126335|NCT03204695|LAA Occlusion|laa occlusion
5126336|NCT03204695|WaveCrest|wavecrest
5126337|NCT03204682|Endometriosis|endometriosis
5126338|NCT03204682|Magnetic transcranial stimulation|magnetic transcranial stimulation
5126339|NCT03204682|Chronic pain|chronic pain
5126340|NCT03204682|Analgesic|analgesic
5126341|NCT03204669|Copper|copper
5126342|NCT03204669|Selenium|selenium
5126343|NCT03204669|Zinc|zinc
5126344|NCT03204669|Continuous renal replacement therapy|continuous renal replacement therapy
5126345|NCT03204656|difficult orotracheal intubation|difficult orotracheal intubation
5126346|NCT03204656|selective lung intubation|selective lung intubation
5126347|NCT03204656|unexpected difficult selective lung intubation|unexpected difficult selective lung intubation
5126348|NCT03204630|infant nutrition|infant nutrition
5126349|NCT03204630|probiotic|probiotic
5126350|NCT03204617|HIV infection|hiv infection
5126351|NCT03204617|First in Human|first in human
5126352|NCT03204617|Therapeutic Vaccines|therapeutic vaccines
5126354|NCT03204617|HIV reservoir|hiv reservoir
5126355|NCT03204604|Memory|memory
5126356|NCT03204604|Dietary Treatment|dietary treatment
5126357|NCT03204565|gingival recession, clinical trial(s).|gingival recession, clinical trial(s).
5126358|NCT03204539|inhibitor|inhibitor
5126359|NCT03204539|Factor VIII inhibitor|factor viii inhibitor
5126360|NCT03204513|Prosthesis|prosthesis
5126361|NCT03204513|Powered Prosthesis|powered prosthesis
5126362|NCT03204500|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5126363|NCT03204500|Dual therapy|dual therapy
5126364|NCT03204500|Randomized controlled trial|randomized controlled trial
5126365|NCT03204500|ALSFRS-R|alsfrs-r
5126366|NCT03204487|tear film thickness|tear film thickness
5126367|NCT03204487|ocular surface disease|ocular surface disease
5126369|NCT03204474|Lacosamide|lacosamide
5126370|NCT03204474|Bioequivalence|bioequivalence
5126371|NCT03204474|Intravenous solution|intravenous solution
5126372|NCT03204474|Tablet|tablet
5126373|NCT03204422|urinary sodium excretion|urinary sodium excretion
5126374|NCT03204422|24-hout urine|24-hout urine
5126375|NCT03204422|salt intakes|salt intakes
5126376|NCT03204422|hypertension|hypertension
5126377|NCT03204409|CHIKV|chikv
5126378|NCT03204409|DENGUE|dengue
5126379|NCT03204409|Chikungunya|chikungunya
5126380|NCT03204409|DENV|denv
5126381|NCT03204357|Cardiac surgery|cardiac surgery
5126382|NCT03204344|Gastrointestinal surgery|gastrointestinal surgery
5126383|NCT03204344|Preoperative oral carbohydrate|preoperative oral carbohydrate
5126384|NCT03204344|Diabetic patients|diabetic patients
5962027|NCT04283487|brain-gut axis|brain-gut axis
5126385|NCT03204344|Postoperative recovery|postoperative recovery
5126392|NCT03204305|Marijuana|marijuana
5126393|NCT03204305|cannabis|cannabis
5126394|NCT03204305|cannabinoid receptor|cannabinoid receptor
5126395|NCT03204292|Inferior vena cava|inferior vena cava
5126396|NCT03204292|Fluid responsiveness|fluid responsiveness
5126397|NCT03204292|Central venous pressure|central venous pressure
5126398|NCT03204266|urinary tract|urinary tract
5126399|NCT03204266|Bladder cancer|bladder cancer
5126400|NCT03204266|Radical cystectomy|radical cystectomy
5126401|NCT03204266|Omega-3 Fatty Acids|omega-3 fatty acids
5126406|NCT03204227|Japanese Encephalitis|japanese encephalitis
5126407|NCT03204227|JECEVAX|jecevax
5126434|NCT03204019|Thalidomide|thalidomide
5126435|NCT03204019|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
5126437|NCT03203967|Adults|adults
5126438|NCT03203967|Unilateral TKA|unilateral tka
5126439|NCT03203967|Single femoral nerve block|single femoral nerve block
5126440|NCT03203967|Low-dose epidural morphine|low-dose epidural morphine
5126441|NCT03203967|Effect of postoperative analgesia|effect of postoperative analgesia
5126442|NCT03203967|Quality of life|quality of life
5126443|NCT03203941|Autologous Cord Blood Stem Cells|autologous cord blood stem cells
5126444|NCT03203928|ADHD|adhd
5126445|NCT03203928|Occupational Therapy|occupational therapy
5126446|NCT03203915|cholesterol|cholesterol
5126447|NCT03203915|triglyceride|triglyceride
5126448|NCT03203915|grape seed extract|grape seed extract
5126449|NCT03203915|chardonnay pomace powder|chardonnay pomace powder
5126450|NCT03203915|polyphenol|polyphenol
5126451|NCT03203915|gut microbiome|gut microbiome
5126452|NCT03203902|Therapeutic touch|therapeutic touch
5126453|NCT03203902|Post-traumatic Stress Disorder|post-traumatic stress disorder
5126454|NCT03203902|Homeless|homeless
5126455|NCT03203889|American Indians|american indians
5126456|NCT03203889|Native Americans|native americans
5126457|NCT03203889|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
5126458|NCT03203889|Nar-Anonymous Facilitation|nar-anonymous facilitation
5126459|NCT03203889|Treatment Entry|treatment entry
5126460|NCT03203889|Cultural adaptations|cultural adaptations
5126461|NCT03203889|Spirituality|spirituality
5126466|NCT03203837|Radioembolization|radioembolization
5126468|NCT03203837|TheraSphere|therasphere
5126469|NCT03203837|HCC|hcc
5126470|NCT03203837|Biomarker|biomarker
5126471|NCT03203837|Prognostic factor|prognostic factor
5126472|NCT03203837|Angiogenesis|angiogenesis
5126473|NCT03203837|Inflammatory|inflammatory
5126474|NCT03203837|Liver|liver
5126475|NCT03203811|Healthy Subjects|healthy subjects
5126476|NCT03203746|Lycopene|lycopene
5126477|NCT03203746|Chronic periodontitis|chronic periodontitis
5126478|NCT03203746|Protein carbonyl|protein carbonyl
5126479|NCT03203733|Oral Mucositis , cooling, cryotherapy|oral mucositis , cooling, cryotherapy
5126480|NCT03203720|adherence|adherence
5126481|NCT03203720|adolescent|adolescent
5126482|NCT03203720|Motivational Intervention|motivational intervention
5126483|NCT03203707|IPSRT|ipsrt
5126485|NCT03203707|bipolar disorder|bipolar disorder
5126486|NCT03203668|Hyperparathyroidism|hyperparathyroidism
5126487|NCT03203668|Imaging|imaging
5126488|NCT03203668|Scintigraphy|scintigraphy
5126489|NCT03203668|18F-choline|18f-choline
5126490|NCT03203668|18F-fluorocholine|18f-fluorocholine
5126491|NCT03203668|PET|pet
5126492|NCT03203668|PET/CT|pet/ct
5126499|NCT03203642|Polycystic Kidney|polycystic kidney
5126500|NCT03203642|Tesevatinib|tesevatinib
5126501|NCT03203642|Polycystic Kidney Disease|polycystic kidney disease
5126502|NCT03203642|PKD|pkd
5126503|NCT03203603|asthma|asthma
5126504|NCT03203603|pulmonary function testing|pulmonary function testing
5126505|NCT03203603|wheeze|wheeze
5126506|NCT03203603|vitamin C|vitamin c
5126507|NCT03203603|antioxidants|antioxidants
5126508|NCT03203603|forced expiratory flows|forced expiratory flows
5126509|NCT03203551|Dentures|dentures
5126510|NCT03203551|Biofilms|biofilms
5126511|NCT03203551|Disinfection|disinfection
5126512|NCT03203551|Candidiasis|candidiasis
5126513|NCT03203551|Candida|candida
5126517|NCT03203538|bright light|bright light
5126518|NCT03203538|sleep|sleep
5126519|NCT03203538|cognitive performance|cognitive performance
5126520|NCT03203538|circadian rhythm|circadian rhythm
5126521|NCT03203525|Liver Cancer|liver cancer
5126522|NCT03203525|Hepatic metastases|hepatic metastases
5126523|NCT03203525|Advanced liver cancer|advanced liver cancer
5126524|NCT03203525|Eloxatin|eloxatin
5126525|NCT03203525|Oxaliplatin|oxaliplatin
5126526|NCT03203525|Leucovorin|leucovorin
5126527|NCT03203525|Citrovorum|citrovorum
5126528|NCT03203525|Wellcovorin|wellcovorin
5126529|NCT03203525|5-fluorouracil|5-fluorouracil
5126530|NCT03203525|Fluorouracil|fluorouracil
5126531|NCT03203525|5-FU|5-fu
5126532|NCT03203525|Adrucil|adrucil
5126533|NCT03203525|Efudex|efudex
5126534|NCT03203525|Bevacizumab|bevacizumab
5126535|NCT03203525|Avastin|avastin
5126536|NCT03203525|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5126537|NCT03203525|rhuMab-VEGF|rhumab-vegf
5126538|NCT03203525|Liposomal Doxorubicin|liposomal doxorubicin
5126540|NCT03203525|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
5126541|NCT03203525|Temsirolimus|temsirolimus
5126542|NCT03203525|CCI-779|cci-779
5126543|NCT03203525|Torisel|torisel
5126544|NCT03203525|NovoTTF-100L System|novottf-100l system
5126545|NCT03203512|Fish oil; N-3 polyunsaturated fatty acids|fish oil; n-3 polyunsaturated fatty acids
5126546|NCT03203499|Substance abuse disorder|substance abuse disorder
5126547|NCT03203486|NAFLD|nafld
5126548|NCT03203486|no fibrosis|no fibrosis
5126549|NCT03203486|Mediterranean diet|mediterranean diet
5126550|NCT03203486|STAT3|stat3
5126551|NCT03203486|GCKR|gckr
5126552|NCT03203486|visfatin|visfatin
5126553|NCT03203486|oxidized LDL|oxidized ldl
5126554|NCT03203486|fasting glucose|fasting glucose
5126555|NCT03203486|inflammation|inflammation
5126556|NCT03203473|Renal Cancer|renal cancer
5126557|NCT03203460|Prostate Cancer|prostate cancer
5126558|NCT03203460|Active Surveillance|active surveillance
5126559|NCT03203460|Exercise|exercise
5126560|NCT03203460|High-Intensity Interval Training|high-intensity interval training
5126561|NCT03203460|Randomized Controlled Trial|randomized controlled trial
5126563|NCT03203447|ME|me
5126564|NCT03203447|Microneedle|microneedle
5126565|NCT03203447|Microinjection|microinjection
5126566|NCT03203447|Triamcinolone|triamcinolone
5126567|NCT03203447|Choroid|choroid
5126568|NCT03203447|Choroid injection|choroid injection
5126569|NCT03203447|Suprachoroidal|suprachoroidal
5126570|NCT03203447|Anti-VEGF|anti-vegf
5126571|NCT03203447|Subretinal Fluid|subretinal fluid
5126572|NCT03203447|Cystoid Macular Edema|cystoid macular edema
5126573|NCT03203447|Optical Coherence Tomography|optical coherence tomography
5126574|NCT03203447|OCT|oct
5126575|NCT03203447|Central Subfield Thickness|central subfield thickness
5126576|NCT03203447|Lucentis|lucentis
5126577|NCT03203447|Avastin|avastin
5126578|NCT03203447|Ranibizumab|ranibizumab
5126579|NCT03203447|Bevacizumab|bevacizumab
5126580|NCT03203434|Pancreatic cancer|pancreatic cancer
5126581|NCT03203434|Esophageal cancer|esophageal cancer
5126582|NCT03203434|volatile organic compounds|volatile organic compounds
5126583|NCT03203434|Field asymmetric ion mobility spectrometry|field asymmetric ion mobility spectrometry
5126584|NCT03203395|Depression|depression
5126585|NCT03203395|Anxiety|anxiety
5126586|NCT03203395|Panic Attacks|panic attacks
5126587|NCT03203395|Collaborative Care|collaborative care
5126588|NCT03203395|Heart disease and depression|heart disease and depression
5126589|NCT03203395|Heart disease and anxiety|heart disease and anxiety
5126590|NCT03203395|Heart disease and panic attacks|heart disease and panic attacks
5126591|NCT03203369|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
5126596|NCT03203369|Chimeric Antigen Receptor T-cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
5126598|NCT03203369|Cluster of differentiation 4 (CD4)|cluster of differentiation 4 (cd4)
5126602|NCT03203356|adrenal function|adrenal function
5126603|NCT03203343|Inguinal Hernia, Indirect|inguinal hernia, indirect
5126604|NCT03203343|Children, Only|children, only
5126605|NCT03203343|Inflammatory Response|inflammatory response
5126606|NCT03203343|Surgery|surgery
5012275|NCT03919396|Myopia|myopia
5126607|NCT03203343|Interleukin-6|interleukin-6
5126608|NCT03203343|Tumor necrosis factor alpha|tumor necrosis factor alpha
5126609|NCT03203343|C reactive protein|c reactive protein
5126610|NCT03203343|Leukocytes|leukocytes
5126611|NCT03203304|hepatocellular carcinoma|hepatocellular carcinoma
5126612|NCT03203304|nivolumab|nivolumab
5126613|NCT03203304|ipilimumab|ipilimumab
5126614|NCT03203304|stereotactic body radiotherapy|stereotactic body radiotherapy
5126617|NCT03203291|robotic training|robotic training
5126618|NCT03203291|gait|gait
5126619|NCT03203278|South Asian|south asian
5126620|NCT03203265|HIV home testing|hiv home testing
5126621|NCT03203239|red light|red light
5126622|NCT03203239|vasodilation|vasodilation
5126623|NCT03203239|nitric oxide|nitric oxide
5126624|NCT03203226|Intellectual Disability|intellectual disability
5126625|NCT03203226|Feldenkrais Method|feldenkrais method
5126626|NCT03203226|Short Physical Performance Battery|short physical performance battery
5126627|NCT03203226|Stabilometry|stabilometry
5126628|NCT03203226|Supported employment|supported employment
5126629|NCT03203213|Poisoning|poisoning
5126630|NCT03203213|Psychoactive substances|psychoactive substances
5126631|NCT03203174|microneedle|microneedle
5126632|NCT03203174|botulinum toxin|botulinum toxin
5126633|NCT03203174|botox|botox
5126634|NCT03203174|palmar hyperhidrosis|palmar hyperhidrosis
5126635|NCT03203174|sweating|sweating
5126636|NCT03203174|hyperhidrosis|hyperhidrosis
5126637|NCT03203148|Cardiopulmonary Bypass|cardiopulmonary bypass
5126638|NCT03203148|Blood Coagulation Testing|blood coagulation testing
5126639|NCT03203148|Point-of-Care Testing|point-of-care testing
5126640|NCT03203109|lateropulsion|lateropulsion
5126641|NCT03203109|pusher syndrome|pusher syndrome
5126642|NCT03203109|posture|posture
5126643|NCT03203109|balance|balance
5126644|NCT03203109|PASS|pass
5126645|NCT03203109|verticality perception|verticality perception
5126646|NCT03203109|gait|gait
5126647|NCT03203096|magnesium, stress, metabolomics, heart rate variability|magnesium, stress, metabolomics, heart rate variability
5126648|NCT03203083|Reproducibility of Results|reproducibility of results
5126649|NCT03203083|Clinical Assessment|clinical assessment
5126650|NCT03203044|Dietary Intervention|dietary intervention
5126651|NCT03203031|pain|pain
5126652|NCT03203031|neonate|neonate
5126653|NCT03203031|regional anesthesia|regional anesthesia
5126654|NCT03203031|postoperative|postoperative
5126655|NCT03203018|Cardiovascular Diseases (CVD)|cardiovascular diseases (cvd)
5126656|NCT03203018|Community-based intervention|community-based intervention
5126657|NCT03203018|Socio-economic status (SES)|socio-economic status (ses)
5126658|NCT03203018|Health literacy (HL)|health literacy (hl)
5126659|NCT03202979|Trazodone|trazodone
5126660|NCT03202979|Placebo|placebo
5126661|NCT03202979|Gabapentin|gabapentin
5126662|NCT03202979|Neuropathic pain|neuropathic pain
5126663|NCT03202940|Lung Cancer|lung cancer
5126664|NCT03202901|knee-pain, curcuma, inflammation|knee-pain, curcuma, inflammation
5126665|NCT03202862|fulvestrant|fulvestrant
5126666|NCT03202862|ESR1|esr1
5126667|NCT03202849|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5126668|NCT03202849|vitamin a|vitamin a
5126669|NCT03202849|vitamin d|vitamin d
5126670|NCT03202810|optical imaging technology, loss of heterozygosity, prevention, miRNA, cost-effectiveness|optical imaging technology, loss of heterozygosity, prevention, mirna, cost-effectiveness
5126671|NCT03202758|Durvalumab|durvalumab
5126672|NCT03202758|Tremelimumab|tremelimumab
5126673|NCT03202758|FOLFOX|folfox
5126674|NCT03202758|metastatic colorectal cancer|metastatic colorectal cancer
5126675|NCT03202732|Self-management|self-management
5126676|NCT03202732|Patient Activeted measure|patient activeted measure
5126677|NCT03202732|Patient-reported outcome|patient-reported outcome
5126678|NCT03202732|Type 1 diabetes Mellitus|type 1 diabetes mellitus
5126679|NCT03202732|Non-inferiority study|non-inferiority study
5126683|NCT03202693|Tuberculosis, PA-824|tuberculosis, pa-824
5126684|NCT03202667|SGLT2-inhibitor|sglt2-inhibitor
5126685|NCT03202667|Treatment|treatment
5126687|NCT03202641|PEEP titration|peep titration
5126688|NCT03202641|Open Lung Strategy|open lung strategy
5126689|NCT03202641|Right heart function|right heart function
5126690|NCT03202641|Lung recruitment maneuver|lung recruitment maneuver
5126691|NCT03202641|Esophageal Pressure|esophageal pressure
5126692|NCT03202641|Respiratory system compliance|respiratory system compliance
5126693|NCT03202615|lactoferrin|lactoferrin
5126694|NCT03202615|iron deficiency anemia in pregnancy|iron deficiency anemia in pregnancy
5126695|NCT03202602|Obstructive sleep apnea|obstructive sleep apnea
5123202|NCT03225365|Nivolumab|nivolumab
5126702|NCT03202589|Geriatric|geriatric
5126703|NCT03202576|nasogastric tube|nasogastric tube
5126704|NCT03202576|microbridle|microbridle
5126705|NCT03202550|Oral Sedation|oral sedation
5126706|NCT03202550|Lorazepam|lorazepam
5126707|NCT03202550|Oxycodone|oxycodone
5126708|NCT03202524|Paracentesis|paracentesis
5126710|NCT03202524|Plasma|plasma
5126711|NCT03202498|Cirrhosis, Liver|cirrhosis, liver
5126712|NCT03202498|Fibrosis, Liver|fibrosis, liver
5126713|NCT03202498|Hepatic Cirrhosis|hepatic cirrhosis
5126714|NCT03202498|Liver Fibrosis|liver fibrosis
5126716|NCT03202485|high myopia|high myopia
5126717|NCT03202485|phakic intraocular lens|phakic intraocular lens
5126718|NCT03202485|astigmatic keratotomy|astigmatic keratotomy
5126719|NCT03202485|toric|toric
5126720|NCT03202459|Anesthesia|anesthesia
5126721|NCT03202459|Complications|complications
5126722|NCT03202459|Nausea|nausea
5126723|NCT03202459|Vomiting|vomiting
5126724|NCT03202433|Virtual Reality|virtual reality
5126725|NCT03202433|Stress Reduction|stress reduction
5126726|NCT03202433|Needle Aspiration|needle aspiration
5126727|NCT03202433|Blood Donors|blood donors
5126728|NCT03202433|Intervention|intervention
5126729|NCT03202394|intubation|intubation
5126730|NCT03202394|aerosol|aerosol
5126731|NCT03202394|sepsis|sepsis
5126732|NCT03202394|edema|edema
5126733|NCT03202381|Androgen deprivation therapy|androgen deprivation therapy
5126734|NCT03202381|GnRH antagonist|gnrh antagonist
5126735|NCT03202355|Alignment phase|alignment phase
5126736|NCT03202355|Photobiomodulation|photobiomodulation
5126737|NCT03202355|Orthodontic treatment|orthodontic treatment
5126738|NCT03202355|Malocclusion|malocclusion
5126739|NCT03202355|OrthoPulse™|orthopulse™
5126740|NCT03202303|Autism|autism
5126741|NCT03202303|Irritability|irritability
5126742|NCT03202303|Cannabinoids|cannabinoids
5126743|NCT03202277|physical activity, sleep, sedentary behavior, dietary intake, smartphone|physical activity, sleep, sedentary behavior, dietary intake, smartphone
5126744|NCT03202264|Polypharmacy|polypharmacy
5126745|NCT03202264|Mobility|mobility
5126746|NCT03202264|Multimorbidity|multimorbidity
5126747|NCT03202264|Drug Discontinuation|drug discontinuation
5126748|NCT03202264|Patient Preference|patient preference
5126749|NCT03202264|eHealth|ehealth
5126750|NCT03202251|overactive bladder|overactive bladder
5126751|NCT03202251|underactive bladder|underactive bladder
5126752|NCT03202251|urinary incontinence|urinary incontinence
5126753|NCT03202199|Adenocarcinoma, pancreas, PET/MRI|adenocarcinoma, pancreas, pet/mri
5126754|NCT03202173|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5126755|NCT03202173|Optical biopsy|optical biopsy
5126756|NCT03202160|Goiter|goiter
5126757|NCT03202147|Ischemic stroke, post-stroke cognitive impairment, PSCI|ischemic stroke, post-stroke cognitive impairment, psci
5126758|NCT03202108|Ketogenic|ketogenic
5126759|NCT03202108|Diet|diet
5126760|NCT03202108|Epilepsy|epilepsy
5126761|NCT03202108|Glut-1 DS|glut-1 ds
5126762|NCT03202108|Krio|krio
5126763|NCT03202095|Depression|depression
5126764|NCT03202095|Type 2 Diabetes|type 2 diabetes
5126765|NCT03202095|Creatine|creatine
5126766|NCT03202095|Diabetes|diabetes
5126767|NCT03202069|Protein|protein
5126768|NCT03202069|Weight Loss|weight loss
5126769|NCT03202056|hip osteoarthritis|hip osteoarthritis
5126770|NCT03202056|physiotherapy|physiotherapy
5126771|NCT03202056|manual therapy|manual therapy
5126772|NCT03202030|immediate dentoalveolar restoration|immediate dentoalveolar restoration
5126773|NCT03202030|bio-oss|bio-oss
5126774|NCT03202030|immediate dental implant|immediate dental implant
5126775|NCT03202030|bovine bone|bovine bone
5126776|NCT03202004|PGA|pga
5126777|NCT03202004|efficacy|efficacy
5126778|NCT03202004|PASI|pasi
5126779|NCT03202004|GSK2894512|gsk2894512
5126780|NCT03202004|NRS|nrs
5126781|NCT03202004|Topical|topical
5126782|NCT03202004|psoriasis|psoriasis
5126783|NCT03201991|ALS|als
5126784|NCT03201978|Healthy adults|healthy adults
5126785|NCT03201978|GSK2894512|gsk2894512
5126786|NCT03201978|Topical|topical
5126787|NCT03201978|Psoriasis|psoriasis
5126788|NCT03201978|Pharmacokinetics|pharmacokinetics
5126789|NCT03201952|Glucose|glucose
5126790|NCT03201952|Ileostomy|ileostomy
5126791|NCT03201939|HIV/AIDS|hiv/aids
5126792|NCT03201939|sub-Saharan Africa|sub-saharan africa
5126793|NCT03201939|Kidney disease|kidney disease
5126794|NCT03201939|Albuminuria|albuminuria
5126795|NCT03201939|Genetic risk|genetic risk
5126799|NCT03201848|randomized|randomized
5126800|NCT03201848|double-blind|double-blind
5126801|NCT03201848|placebo-controlled,|placebo-controlled,
5126802|NCT03201822|flavanol|flavanol
5126803|NCT03201822|ADME|adme
5126804|NCT03201822|cocoa flavanols|cocoa flavanols
5126805|NCT03201822|polyphenols|polyphenols
5126806|NCT03201796|Bacterial prostatitis|bacterial prostatitis
5126807|NCT03201796|CBP|cbp
5126808|NCT03201796|Levofloxacin|levofloxacin
5126809|NCT03201796|Prulifloxacin|prulifloxacin
5126810|NCT03201783|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5126811|NCT03201783|time interval|time interval
5126812|NCT03201770|Uncomplicated Malaria|uncomplicated malaria
5126813|NCT03201770|Pyramax|pyramax
5126814|NCT03201770|Pyronaridine artesunate|pyronaridine artesunate
5126815|NCT03201757|Alkermes|alkermes
5126816|NCT03201757|ALKS 3831|alks 3831
5126817|NCT03201757|Olanzapine|olanzapine
5126818|NCT03201757|Samidorphan|samidorphan
5126819|NCT03201757|Schizophrenia|schizophrenia
5126820|NCT03201757|Schizophreniform|schizophreniform
5126821|NCT03201757|Bipolar I|bipolar i
5126822|NCT03201718|Hepatitis C|hepatitis c
5126823|NCT03201718|Paritaprevir|paritaprevir
5126824|NCT03201718|Ritonavir|ritonavir
5126825|NCT03201718|Ombitasvir|ombitasvir
5126826|NCT03201718|Dasabuvir|dasabuvir
5126827|NCT03201705|Failed Back Surgery Syndrome|failed back surgery syndrome
5126828|NCT03201705|Spinal Cord Stimulation|spinal cord stimulation
5126829|NCT03201705|Pain Management|pain management
5126830|NCT03201705|Implantable Neurostimulator|implantable neurostimulator
5126831|NCT03201679|SIRS, systemic inflammatory response syndrome|sirs, systemic inflammatory response syndrome
5126832|NCT03201679|Hip Fracture Surgery|hip fracture surgery
5126833|NCT03201679|Sepsis|sepsis
5126834|NCT03201679|Mortality|mortality
5757031|NCT00294645|Diagnostic|diagnostic
5193195|NCT02785302|HIV|hiv
5126835|NCT03201666|prenatal diagnosis|prenatal diagnosis
5126836|NCT03201666|non-invasive prenatal tests|non-invasive prenatal tests
5126837|NCT03201666|chromosome microarray analysis|chromosome microarray analysis
5126838|NCT03201653|Distal Pancreatectomy|distal pancreatectomy
5126839|NCT03201653|Pancreatic Fistula|pancreatic fistula
5126840|NCT03201653|Oxidized Regenerated Cellulose|oxidized regenerated cellulose
5126841|NCT03201653|Pancreatectomy|pancreatectomy
5126842|NCT03201614|platelet-rich plasma, hyaluronic acid, knee osteroarthritis|platelet-rich plasma, hyaluronic acid, knee osteroarthritis
5126843|NCT03201601|Polycystic ovarian syndrome|polycystic ovarian syndrome
5126844|NCT03201601|D-chiro-inositol|d-chiro-inositol
5126845|NCT03201601|Fertility|fertility
5126846|NCT03201588|Retinopathy of Prematurity|retinopathy of prematurity
5126847|NCT03201575|Intensive care|intensive care
5126848|NCT03201575|septic shock|septic shock
5126849|NCT03201575|multiple organ failure|multiple organ failure
5126850|NCT03201575|Ischemia-reperfusion|ischemia-reperfusion
5126851|NCT03201575|ischemic conditioning|ischemic conditioning
5126852|NCT03201575|remote conditioning|remote conditioning
5126853|NCT03201575|SOFA score|sofa score
5126854|NCT03201536|ZipLine3 device vs. conventional sutures|zipline3 device vs. conventional sutures
5126855|NCT03201523|Community-based Intervention|community-based intervention
5126856|NCT03201523|Socio-ecological Model|socio-ecological model
5126857|NCT03201523|Participatory Approach|participatory approach
5126858|NCT03201523|Ultra-Orthodox Jewish women|ultra-orthodox jewish women
5126859|NCT03201432|Vertebral Artery Stenosis|vertebral artery stenosis
5126860|NCT03201432|Ischemic Stroke|ischemic stroke
5126861|NCT03201432|Stent|stent
5126862|NCT03201406|Renal biopsy, Chronic kidney disease,Diabetic nephropathy,Lupus Nephritis|renal biopsy, chronic kidney disease,diabetic nephropathy,lupus nephritis
5126863|NCT03201393|Back pain|back pain
5126864|NCT03201393|Neuropathic Pain|neuropathic pain
5126865|NCT03201393|Radiculopathy|radiculopathy
5126866|NCT03201393|Allodynia|allodynia
5126867|NCT03201367|Portal vein|portal vein
5126868|NCT03201367|thrombosis|thrombosis
5126870|NCT03201367|rivaroxaban|rivaroxaban
5126871|NCT03201354|Glaucoma|glaucoma
5126872|NCT03201354|Ocular hypertension|ocular hypertension
5126873|NCT03201354|Filtration surgery|filtration surgery
5126874|NCT03201354|Trabeculectomy with Ex-PRESS|trabeculectomy with ex-press
5126875|NCT03201354|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
5126876|NCT03201354|Phacoemulsification|phacoemulsification
5126877|NCT03201354|Combined surgery|combined surgery
5126878|NCT03201341|Stroke|stroke
5126884|NCT03201315|Fentanyl, opioids|fentanyl, opioids
5126885|NCT03201302|bone|bone
5126886|NCT03201302|childhood|childhood
5126887|NCT03201302|pre-adolescence|pre-adolescence
5126888|NCT03201302|bone turnover markers|bone turnover markers
5126889|NCT03201302|sclerostin|sclerostin
5126890|NCT03201302|sports|sports
5126891|NCT03201302|physical activity|physical activity
5126892|NCT03201302|nutrition|nutrition
5126893|NCT03201276|glucosamine sulfate|glucosamine sulfate
5126894|NCT03201276|individual differences|individual differences
5126895|NCT03201276|gene polymorphism|gene polymorphism
5126896|NCT03201250|carfilzomib|carfilzomib
5126897|NCT03201250|cabozantinib|cabozantinib
5126898|NCT03201250|proteasome inhibitor|proteasome inhibitor
5126899|NCT03201250|resistance|resistance
5126900|NCT03201237|Cerebral palsy|cerebral palsy
5126902|NCT03201211|Immunogenicity|immunogenicity
5126903|NCT03201198|physical activity|physical activity
5126904|NCT03201198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5126905|NCT03201185|Cardiovascular events|cardiovascular events
5126906|NCT03201185|Ventricular remodeling|ventricular remodeling
5126907|NCT03201159|ASH|ash
5126908|NCT03201081|elderly|elderly
5126909|NCT03201081|motivation|motivation
5126910|NCT03201081|adherence|adherence
5126911|NCT03201081|resistance-training|resistance-training
5126912|NCT03201081|health|health
5126913|NCT03201029|center for ethnic skin|center for ethnic skin
5126914|NCT03201029|skin of color clinic|skin of color clinic
5126915|NCT03201029|ethnic skin center|ethnic skin center
5126916|NCT03201016|cirrhosis|cirrhosis
5126917|NCT03201003|AR101|ar101
5126918|NCT03201003|Characterized Peanut Allergen|characterized peanut allergen
5127224|NCT03199183|registry|registry
5126939|NCT03200886|triamcinolone|triamcinolone
5126940|NCT03200886|osteoarthritis of the thumb|osteoarthritis of the thumb
5126941|NCT03200873|transcranial magnetic stimulation|transcranial magnetic stimulation
5126942|NCT03200873|theta burst stimulation|theta burst stimulation
5126943|NCT03200873|impulsivity|impulsivity
5126947|NCT03200847|Pembrolizumab|pembrolizumab
5126948|NCT03200847|All-Trans Retinoic Acid|all-trans retinoic acid
5126953|NCT03200808|Nonneoplastic Epithelial Disorders|nonneoplastic epithelial disorders
5126954|NCT03200808|methylene blue|methylene blue
5126955|NCT03200808|treatment|treatment
5126956|NCT03200795|Diabetes|diabetes
5126957|NCT03200795|Musculoskelatal pain|musculoskelatal pain
5126958|NCT03200795|Rebound exercises|rebound exercises
5126959|NCT03200795|Depression|depression
5126960|NCT03200795|Glucose|glucose
5126961|NCT03200795|Quality of life|quality of life
5126962|NCT03200782|postprandial hypoglycemia|postprandial hypoglycemia
5126963|NCT03200782|bariatric surgery|bariatric surgery
5126964|NCT03200782|late dumping syndrome|late dumping syndrome
5126965|NCT03200782|anakinra|anakinra
5126966|NCT03200782|empagliflozin|empagliflozin
5126967|NCT03200782|SGLT2 inhibitor|sglt2 inhibitor
5126968|NCT03200782|IL-1Beta|il-1beta
5126969|NCT03200782|IL1|il1
5126970|NCT03200769|CPAP|cpap
5126971|NCT03200769|Sleep Apnea Syndrome|sleep apnea syndrome
5126972|NCT03200769|Pharmacoresistant Epilepsy|pharmacoresistant epilepsy
5126973|NCT03200769|Apnea Hypopnea-Index|apnea hypopnea-index
5126974|NCT03200756|sedentary behavior|sedentary behavior
5126975|NCT03200743|Hypertension|hypertension
5126976|NCT03200743|Pregnancy|pregnancy
5126977|NCT03200743|Catestatin|catestatin
5126978|NCT03200730|Family Dignity Intervention|family dignity intervention
5126979|NCT03200730|Multicentre Randomized Control Trial|multicentre randomized control trial
5126980|NCT03200730|Palliative Care|palliative care
5126981|NCT03200730|End-of-Life Care|end-of-life care
5126992|NCT03200691|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5126993|NCT03200691|PD-1|pd-1
5126994|NCT03200691|Neoadjuvant treatment|neoadjuvant treatment
5126995|NCT03200678|knee muscle|knee muscle
5126996|NCT03200678|strength|strength
5126997|NCT03200678|fatigue|fatigue
5126998|NCT03200678|MRI|mri
5126999|NCT03200678|ACL|acl
5127000|NCT03200652|Lysine|lysine
5127001|NCT03200652|Adult|adult
5127002|NCT03200652|Protein Quality|protein quality
5127003|NCT03200639|Breast Cancer Female|breast cancer female
5127004|NCT03200639|Gynecologic Cancer|gynecologic cancer
5127005|NCT03200639|Menopause|menopause
5127006|NCT03200639|Physical Activity|physical activity
5127010|NCT03200600|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5127011|NCT03200600|Surgery|surgery
5127012|NCT03200600|Dexamethasone|dexamethasone
5127013|NCT03200600|Flubiprofen Axetil|flubiprofen axetil
5127014|NCT03200600|Delirium|delirium
5127015|NCT03200587|Metastatic|metastatic
5127018|NCT03200509|nonspecific low back pain|nonspecific low back pain
5127019|NCT03200509|chronic pain|chronic pain
5127047|NCT03200210|Continuous Ambulatory Peritoneal Dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
5127049|NCT03200210|Cardiovascular events|cardiovascular events
5127050|NCT03200210|Treatment|treatment
5127051|NCT03200197|Chewing gum|chewing gum
5127052|NCT03200197|Artificial saliva|artificial saliva
5127054|NCT03200197|Mastication|mastication
5127055|NCT03200197|Salivary glands|salivary glands
5127056|NCT03200197|Xerostomia|xerostomia
5127057|NCT03200184|Hepatitis C|hepatitis c
5127058|NCT03200184|sofosbuvir|sofosbuvir
5127059|NCT03200184|daclatasvir|daclatasvir
5127060|NCT03200171|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5127061|NCT03200171|Hepatitis C|hepatitis c
5127062|NCT03200158|Stress related mucosal disease (SRMD)|stress related mucosal disease (srmd)
5127063|NCT03200158|APACHEII score|apacheii score
5127064|NCT03200158|C-reactive protein|c-reactive protein
5127065|NCT03200158|Malondialdehyde (MDA)|malondialdehyde (mda)
5127066|NCT03200158|transforming growth factor (TGF)|transforming growth factor (tgf)
5127069|NCT03200093|C diff|c diff
5127070|NCT03200093|Oral Vancomycin|oral vancomycin
5127071|NCT03200093|Prophylaxis|prophylaxis
5127072|NCT03200054|therapy|therapy
5127073|NCT03200054|postnatal|postnatal
5342962|NCT01981356|Inpatient psychiatry|inpatient psychiatry
5127074|NCT03200002|Lupus Nephritis, cyclophosphamide, Mycophenolate mofetil|lupus nephritis, cyclophosphamide, mycophenolate mofetil
5127075|NCT03199989|colon cancer|colon cancer
5127076|NCT03199989|adjuvant chemotherapy|adjuvant chemotherapy
5127077|NCT03199989|high risk|high risk
5127079|NCT03199976|shortness of breath|shortness of breath
5127080|NCT03199963|Mammographic|mammographic
5127081|NCT03199963|Breast|breast
5127082|NCT03199963|Density|density
5127083|NCT03199963|BIRADS C or D|birads c or d
5127084|NCT03199950|Delirium|delirium
5127085|NCT03199950|Haloperidol|haloperidol
5127086|NCT03199950|Prophylactic|prophylactic
5127087|NCT03199950|High-risk|high-risk
5127088|NCT03199937|Autism Spectrum Disorder|autism spectrum disorder
5127089|NCT03199937|Executive Functioning|executive functioning
5127090|NCT03199937|Intervention|intervention
5127091|NCT03199937|Flexible|flexible
5127092|NCT03199937|Unstuck|unstuck
5127093|NCT03199937|Transition|transition
5127094|NCT03199937|Behavior|behavior
5127095|NCT03199937|High school|high school
5127096|NCT03199937|Problem Solving|problem solving
5127097|NCT03199937|Self-Control|self-control
5127101|NCT03199924|Diclofenac|diclofenac
5127102|NCT03199924|Lidocain|lidocain
5127103|NCT03199924|Magnesium sulfate|magnesium sulfate
5127108|NCT03199859|gastric cancer|gastric cancer
5127109|NCT03199859|postoperative|postoperative
5127110|NCT03199859|subsyndromal delirium|subsyndromal delirium
5127111|NCT03199859|quality of life|quality of life
5127112|NCT03199833|rehabilitation|rehabilitation
5127113|NCT03199833|orthosis|orthosis
5127114|NCT03199833|functional electrical stimulation|functional electrical stimulation
5127115|NCT03199833|electrode array|electrode array
5127116|NCT03199833|upper limb|upper limb
5127117|NCT03199833|sub-acute|sub-acute
5127118|NCT03199833|motor relearning|motor relearning
5127121|NCT03199807|TOMO radiotherapy|tomo radiotherapy
5128916|NCT03188614|crystalloid|crystalloid
5127129|NCT03199755|therapeutic|therapeutic
5127130|NCT03199755|ACT|act
5127131|NCT03199755|gametocyte|gametocyte
5127132|NCT03199729|Overground training|overground training
5127133|NCT03199729|Dynamic Stability|dynamic stability
5127134|NCT03199729|Fall risk|fall risk
5127135|NCT03199703|PVI Ablation|pvi ablation
5127136|NCT03199703|Cryoballoon|cryoballoon
5127137|NCT03199677|apatinib,refractory thyroid cancer|apatinib,refractory thyroid cancer
5127138|NCT03199638|Continuous Glucose Monitoring|continuous glucose monitoring
5127139|NCT03199638|Children|children
5127140|NCT03199638|Exercise|exercise
5127141|NCT03199638|Glycated hemoglobin|glycated hemoglobin
5127142|NCT03199638|Adolescents|adolescents
5127143|NCT03199638|Insulin sensitivity|insulin sensitivity
5127144|NCT03199638|Glutamine|glutamine
5127145|NCT03199625|cognitive-behavior therapy|cognitive-behavior therapy
5127146|NCT03199625|magnetic resonance imaging|magnetic resonance imaging
5127147|NCT03199625|Panic Disorder|panic disorder
5127148|NCT03199612|Thrombosis during Continuous Flow Pump Support|thrombosis during continuous flow pump support
5127149|NCT03199599|PET/CT|pet/ct
5127150|NCT03199599|image processing|image processing
5127151|NCT03199599|outcome|outcome
5127152|NCT03199586|Advanced or metastatic treatment-refractory solid tumor malignancies|advanced or metastatic treatment-refractory solid tumor malignancies
5127153|NCT03199573|sunscreen|sunscreen
5127161|NCT03199521|apixaban|apixaban
5127162|NCT03199521|endogenous fibrinolysis|endogenous fibrinolysis
5127163|NCT03199521|warfarin|warfarin
5127164|NCT03199521|aspirin|aspirin
5127165|NCT03199521|thrombotic status|thrombotic status
5127166|NCT03199508|Nocturnal Enuresis|nocturnal enuresis
5127167|NCT03199508|Voiding Diary|voiding diary
5127168|NCT03199495|traditional Chinese medicine|traditional chinese medicine
5127169|NCT03199495|electroacupuncture|electroacupuncture
5127170|NCT03199495|abdominal pain|abdominal pain
5127171|NCT03199469|AAV8-Delivered Gene Therapy|aav8-delivered gene therapy
5127172|NCT03199469|XLMTM|xlmtm
5127173|NCT03199469|Adeno Associated Virus|adeno associated virus
5127174|NCT03199443|Sacral neuromodulation|sacral neuromodulation
5127175|NCT03199443|Electromyography|electromyography
5127176|NCT03199443|Pelvic floor|pelvic floor
5127177|NCT03199430|catecholamines|catecholamines
5127178|NCT03199430|Exercise|exercise
5127179|NCT03199430|lipid metabolism|lipid metabolism
5127180|NCT03199339|tuberculosis|tuberculosis
5127181|NCT03199339|TBA7371|tba7371
5127182|NCT03199339|TBA-7371|tba-7371
5127183|NCT03199339|TB Alliance|tb alliance
5127184|NCT03199339|TB|tb
5127185|NCT03199339|Pulmonary Tuberculosis|pulmonary tuberculosis
5127186|NCT03199313|tuberculosis|tuberculosis
5127187|NCT03199313|TB|tb
5127188|NCT03199313|Sutezolid|sutezolid
5127189|NCT03199313|pulmonary tuberculosis|pulmonary tuberculosis
5127190|NCT03199300|bleomycin|bleomycin
5127191|NCT03199300|cisplatin|cisplatin
5127192|NCT03199300|trastuzumab|trastuzumab
5127193|NCT03199300|anthracyclines|anthracyclines
5127194|NCT03199300|toxicity|toxicity
5127195|NCT03199287|metagenomics|metagenomics
5127196|NCT03199287|next-generation sequencing|next-generation sequencing
5127197|NCT03199287|bioinformatics|bioinformatics
5127198|NCT03199287|antibiotic susceptibility|antibiotic susceptibility
5127199|NCT03199248|Digital Mucous Cyst|digital mucous cyst
5127200|NCT03199248|capsulotomy|capsulotomy
5127201|NCT03199235|iron intake|iron intake
5127202|NCT03199235|iron bioavailability|iron bioavailability
5127203|NCT03199222|amputation|amputation
5127204|NCT03199222|transtibial|transtibial
5127205|NCT03199222|socket|socket
5127206|NCT03199222|pressure|pressure
5127207|NCT03199209|physical activity|physical activity
5127208|NCT03199209|healthy eating|healthy eating
5127209|NCT03199209|behavioral intervention|behavioral intervention
5127210|NCT03199209|community health worker|community health worker
5127211|NCT03199209|Hispanic/Latino|hispanic/latino
5127212|NCT03199196|Cancer Prevention|cancer prevention
5127213|NCT03199196|African-American woman|african-american woman
5127214|NCT03199196|Hispanic woman|hispanic woman
5127215|NCT03199196|Sedentary|sedentary
5127216|NCT03199196|Activity Tracker|activity tracker
5127217|NCT03199196|Smartphone Application|smartphone application
5127218|NCT03199196|Questionnaires|questionnaires
5127220|NCT03199196|Focus Group|focus group
5127221|NCT03199196|Electronic Newsletters|electronic newsletters
5127222|NCT03199196|Telephone Counseling|telephone counseling
5127223|NCT03199183|Takayasu Arteritis|takayasu arteritis
5127229|NCT03199170|Intrathecal morphine|intrathecal morphine
5127230|NCT03199144|Pancreatic Neoplasms|pancreatic neoplasms
5127231|NCT03199144|Borderline resectable|borderline resectable
5127232|NCT03199144|Neoadjuvant treatment|neoadjuvant treatment
5127234|NCT03199144|Stereotactic radiation|stereotactic radiation
5127235|NCT03199118|root coverage|root coverage
5127236|NCT03199092|Reading|reading
5127237|NCT03199092|Developmental Dyslexia|developmental dyslexia
5127238|NCT03199092|Music|music
5127239|NCT03199092|Rhythm|rhythm
5127240|NCT03199092|Intervention|intervention
5127241|NCT03199066|survival|survival
5127242|NCT03199066|therapy|therapy
5127243|NCT03199066|epidemiology|epidemiology
5127245|NCT03199027|Adherence|adherence
5127246|NCT03199001|Fabry Disease|fabry disease
5127247|NCT03199001|T1 Mapping|t1 mapping
5127248|NCT03199001|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5127249|NCT03198975|magnetic resonance image features|magnetic resonance image features
5127250|NCT03198975|pathological differentiation|pathological differentiation
5127251|NCT03198975|machine learning-based model|machine learning-based model
5127252|NCT03198962|ATS, Thai MSM TG, Use of amphetamine-type stimulants, HIV, adherence|ats, thai msm tg, use of amphetamine-type stimulants, hiv, adherence
5127253|NCT03198923|Non-small Cell Lung Cancer|non-small cell lung cancer
5127254|NCT03198897|familial hypercholesterolaemia|familial hypercholesterolaemia
5127255|NCT03198897|Biomarker|biomarker
5127256|NCT03198871|Post-operative pain|post-operative pain
5127257|NCT03198871|Major abdominal surgery|major abdominal surgery
5127258|NCT03198871|Colorectal surgery|colorectal surgery
5127259|NCT03198871|Gastric surgery|gastric surgery
5356840|NCT01917799|miscarriage|miscarriage
5127260|NCT03198858|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5127261|NCT03198845|knee osteoarthritis|knee osteoarthritis
5127262|NCT03198845|video game|video game
5127263|NCT03198845|therapeutic effects|therapeutic effects
5127264|NCT03198832|Periodontal Disease|periodontal disease
5127265|NCT03198832|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5127266|NCT03198832|Z-scan|z-scan
5127267|NCT03198832|Atherosclerosis|atherosclerosis
5127268|NCT03198819|Topical rifampicin, neural tube defects, infection, newborn|topical rifampicin, neural tube defects, infection, newborn
5127269|NCT03198806|Autonomic Nervous System|autonomic nervous system
5127270|NCT03198806|Fluid Therapy|fluid therapy
5127271|NCT03198806|Heart Rate|heart rate
5127272|NCT03198806|Exercise|exercise
5127273|NCT03198767|obesity|obesity
5127274|NCT03198767|overweight|overweight
5127275|NCT03198767|body mass index|body mass index
5127276|NCT03198767|BMI|bmi
5127277|NCT03198767|diarrhea|diarrhea
5127278|NCT03198754|Autologous Stem Cell Transplant|autologous stem cell transplant
5127279|NCT03198754|Multiple Myeloma|multiple myeloma
5127280|NCT03198754|oncology|oncology
5127281|NCT03198754|circadian rhythms|circadian rhythms
5127282|NCT03198754|light therapy|light therapy
5127283|NCT03198754|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5127284|NCT03198715|Fibrinolysis enhancer|fibrinolysis enhancer
5127285|NCT03198715|TAFIa inhibitor|tafia inhibitor
5127286|NCT03198715|Developmental Phase I|developmental phase i
5127291|NCT03198689|systemic sclerosis|systemic sclerosis
5127292|NCT03198689|scleroderma|scleroderma
5127293|NCT03198689|brentuximab vedotin|brentuximab vedotin
5127294|NCT03198689|CD30-directed antibody-drug conjugate|cd30-directed antibody-drug conjugate
5127295|NCT03198689|antirheumatic agents|antirheumatic agents
5127296|NCT03198689|antineoplastic agents|antineoplastic agents
5127297|NCT03198689|connective tissue diseases|connective tissue diseases
5127298|NCT03198689|skin diseases|skin diseases
5127299|NCT03198689|immunologic factors|immunologic factors
5127300|NCT03198637|efficient|efficient
5127301|NCT03198637|neuromuscular|neuromuscular
5127302|NCT03198637|blockade|blockade
5127303|NCT03198572|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5127304|NCT03198559|HIV latency|hiv latency
5127305|NCT03198559|Disulfiram|disulfiram
5127306|NCT03198559|Vorinostat|vorinostat
5127307|NCT03198559|Latency Reversing Agents|latency reversing agents
5127308|NCT03198559|Histone Deacetylase Inhibitors (HDACi)|histone deacetylase inhibitors (hdaci)
5127309|NCT03198546|Hepatocellular carcinoma|hepatocellular carcinoma
5127310|NCT03198546|immunotherapy|immunotherapy
5127311|NCT03198546|CAR-T cell therapy|car-t cell therapy
5127312|NCT03198546|GPC3 or TGFβ targeting|gpc3 or tgfβ targeting
5127313|NCT03198546|Phase I clinical study|phase i clinical study
5127314|NCT03198546|squamous cell lung cancer|squamous cell lung cancer
5127315|NCT03198546|interventional radiology|interventional radiology
5127316|NCT03198546|IL7-CCL19-secreting|il7-ccl19-secreting
5127317|NCT03198533|Knee|knee
5127318|NCT03198533|Arthrosis|arthrosis
5127319|NCT03198533|Implant|implant
5127322|NCT03198481|preparedness|preparedness
5127323|NCT03198481|Video Counseling|video counseling
5127330|NCT03198429|dyadic mother-child intervention|dyadic mother-child intervention
5127332|NCT03198429|parenting|parenting
5127333|NCT03198429|young children|young children
5127334|NCT03198377|Pain Threshold|pain threshold
5127335|NCT03198377|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5127336|NCT03198377|Habituation|habituation
5127337|NCT03198325|HIV-1|hiv-1
5127338|NCT03198299|therapeutic effects|therapeutic effects
5127339|NCT03198299|insoles|insoles
5127340|NCT03198299|children|children
5127341|NCT03198273|clinical pilates|clinical pilates
5127342|NCT03198273|exercise|exercise
5127343|NCT03198273|lumbar disc herniation|lumbar disc herniation
5127344|NCT03198273|chronic low back pain|chronic low back pain
5127345|NCT03198234|Pediatric|pediatric
5127346|NCT03198234|GvHD|gvhd
5127347|NCT03198234|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5127348|NCT03198234|Stem Cells|stem cells
5127349|NCT03198234|Transplant|transplant
5127350|NCT03198234|BMT - bone marrow transplant|bmt - bone marrow transplant
5127351|NCT03198221|Golytely, Clenpiq, bowel prep|golytely, clenpiq, bowel prep
5127352|NCT03198156|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5127353|NCT03198156|Without Cataplexy|without cataplexy
5127354|NCT03198143|Decision-making|decision-making
5127355|NCT03198143|Ghrelin|ghrelin
5127356|NCT03198143|Healthy Volunteers|healthy volunteers
5127357|NCT03198143|Obese|obese
5127358|NCT03198104|Multiparametric MR Imaging|multiparametric mr imaging
5127359|NCT03198104|Paediatric|paediatric
5127360|NCT03198091|stable angina pectoris|stable angina pectoris
5127361|NCT03198091|Dun Ye Guan Xin Ning|dun ye guan xin ning
5127362|NCT03198078|Brexpiprazole|brexpiprazole
5127363|NCT03198078|Schizophrenia|schizophrenia
5127364|NCT03198078|Adolescent|adolescent
5127365|NCT03198065|Laparoscopic appendectomy|laparoscopic appendectomy
5127366|NCT03198065|Single-incision laparoscopic appendectomy|single-incision laparoscopic appendectomy
5127367|NCT03198065|Single-incision laparoscopic surgery setting|single-incision laparoscopic surgery setting
5127368|NCT03198065|Simple appendicitis|simple appendicitis
5127369|NCT03198065|Complicated appendicitis|complicated appendicitis
5127370|NCT03198052|Lung Cancer|lung cancer
5962028|NCT04283487|fMRI|fmri
5127371|NCT03198052|CAR-T Cell Therapy|car-t cell therapy
5127372|NCT03198052|PSCA|psca
5127373|NCT03198052|MUC1|muc1
5127374|NCT03198052|HER2|her2
5127375|NCT03198052|Mesothelin|mesothelin
5127376|NCT03198052|Lewis-Y, PD-L1|lewis-y, pd-l1
5127377|NCT03198039|Meditation|meditation
5127378|NCT03198039|Cognitive Dysfunction|cognitive dysfunction
5127379|NCT03198039|Postoperative Period|postoperative period
5127380|NCT03198039|Cardiac Surgery|cardiac surgery
5127381|NCT03198000|Eye Redness|eye redness
5127382|NCT03198000|Eye Comfort|eye comfort
5127383|NCT03198000|Red Eyes|red eyes
5127384|NCT03197987|adenoma detection rate|adenoma detection rate
5127385|NCT03197987|cap-assisted colonoscopy|cap-assisted colonoscopy
5127386|NCT03197987|endocuff|endocuff
5127387|NCT03197974|stage|stage
5127388|NCT03197974|online|online
5127389|NCT03197974|self-help|self-help
5127390|NCT03197974|coaching support|coaching support
5127391|NCT03197974|quality of life|quality of life
5127392|NCT03197974|mindfulness|mindfulness
5127393|NCT03197974|psychoeducation|psychoeducation
5127394|NCT03197974|persuasive systems design|persuasive systems design
5127395|NCT03197974|psychosocial|psychosocial
5127398|NCT03197909|COPD (Chronic Obstructive Pulmonary Patients)|copd (chronic obstructive pulmonary patients)
5127399|NCT03197909|Atrophy|atrophy
5127400|NCT03197909|cell cultur|cell cultur
5127401|NCT03197909|systemic inflammation|systemic inflammation
5127402|NCT03197909|Catabolism|catabolism
5127403|NCT03197857|Bariatric surgery|bariatric surgery
5127404|NCT03197857|Morbid obesity|morbid obesity
5127405|NCT03197857|Physical condition|physical condition
5127412|NCT03197818|Anticholinergics|anticholinergics
5127413|NCT03197818|Triple Combination|triple combination
5127414|NCT03197805|Equivocal Her 2|equivocal her 2
5127415|NCT03197805|Genomic test|genomic test
5127416|NCT03197792|Transesophageal ultrasound|transesophageal ultrasound
5127418|NCT03197792|Portal vein pulsatility|portal vein pulsatility
5127419|NCT03197792|Splenic vein pulsatility|splenic vein pulsatility
5127422|NCT03197792|Right ventricular dysfunction|right ventricular dysfunction
5127423|NCT03197792|Pulmonary hypertension|pulmonary hypertension
5127424|NCT03197792|Venous hypertension|venous hypertension
5127426|NCT03197766|Dwarfism|dwarfism
5127427|NCT03197766|Bone Diseases|bone diseases
5127428|NCT03197766|Bone Diseases, Developmental|bone diseases, developmental
5127429|NCT03197766|ACH|ach
5127430|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
5127431|NCT03197766|Musculoskeletal Diseases|musculoskeletal diseases
5127432|NCT03197766|Natriuretic Agents|natriuretic agents
5127433|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs
5127434|NCT03197766|Skeletal Dysplasias|skeletal dysplasias
5127435|NCT03197766|Genetic Diseases, Inborn|genetic diseases, inborn
5127436|NCT03197766|Osteochondrodysplasias|osteochondrodysplasias
5127437|NCT03197753|laryngeal mask airway|laryngeal mask airway
5127438|NCT03197753|nasotracheal intubation|nasotracheal intubation
5127439|NCT03197753|dental treatment|dental treatment
5127440|NCT03197727|Tooth wear, risk factors, saliva, diet, oral hygiene|tooth wear, risk factors, saliva, diet, oral hygiene
5127441|NCT03197714|Myeloid Leukemia|myeloid leukemia
5127442|NCT03197701|Lung function|lung function
5127443|NCT03197701|Inspiratory flow rates|inspiratory flow rates
5127444|NCT03197675|Chronic pain|chronic pain
5127445|NCT03197675|Acupuncture|acupuncture
5127446|NCT03197662|Prader-Willi Syndrome|prader-willi syndrome
5127447|NCT03197662|Hyperphagia|hyperphagia
5127448|NCT03197636|Vitamin D|vitamin d
5127449|NCT03197636|Soluble PD-1|soluble pd-1
5127451|NCT03197610|gingival recession|gingival recession
5127452|NCT03197610|sub epithelial connective tissue graft|sub epithelial connective tissue graft
5127453|NCT03197610|enamel matrix derivatives|enamel matrix derivatives
5127454|NCT03197610|root coverage aesthetic score|root coverage aesthetic score
5127455|NCT03197597|B. pertussis|b. pertussis
5127456|NCT03197597|Acellular vaccination|acellular vaccination
5127457|NCT03197597|Strain variation|strain variation
5127458|NCT03197532|fertility|fertility
5127459|NCT03197532|hormones|hormones
5127461|NCT03197532|chemotherapy|chemotherapy
5127462|NCT03197532|oncofertility|oncofertility
5127463|NCT03197532|alkylating agent|alkylating agent
5127464|NCT03197532|fertility after cancer|fertility after cancer
5127465|NCT03197532|late effects|late effects
5127466|NCT03197532|survivorship|survivorship
5127467|NCT03197532|healthy volunteers|healthy volunteers
5127468|NCT03197532|perimenopause|perimenopause
5127469|NCT03197532|middle age|middle age
5127470|NCT03197519|mHealth|mhealth
5127471|NCT03197519|Eating Disorders|eating disorders
5127472|NCT03197519|Randomised Controlled Trial|randomised controlled trial
5127473|NCT03197519|Cognitive Behavioural Therapy|cognitive behavioural therapy
5127474|NCT03197519|cost effectiveness|cost effectiveness
5127475|NCT03197480|Anti-Vascular Endothelial Growth Factor|anti-vascular endothelial growth factor
5127476|NCT03197480|Aflibercept|aflibercept
5127477|NCT03197480|Intravitreal injection|intravitreal injection
5127478|NCT03197480|Diabetic Macular Edema|diabetic macular edema
5127479|NCT03197441|Platelet-rich plasma|platelet-rich plasma
5127480|NCT03197441|Osteoarthritis Knee|osteoarthritis knee
5127481|NCT03197428|Platelet-Rich Plasma|platelet-rich plasma
5127482|NCT03197428|Ankle Injuries|ankle injuries
5127483|NCT03197428|Lateral Ligament, Ankle|lateral ligament, ankle
5127484|NCT03197415|Platelet-rich plasma|platelet-rich plasma
5127485|NCT03197415|Intervertebral Disc Degeneration|intervertebral disc degeneration
5127486|NCT03197415|Low Back Pain|low back pain
5127487|NCT03197402|Leucine|leucine
5127488|NCT03197402|Protein|protein
5127489|NCT03197402|Supplementation|supplementation
5127490|NCT03197389|Biomarker|biomarker
5127491|NCT03197363|Civilization diseases|civilization diseases
5127492|NCT03197363|Cardiovascular Risk Factor|cardiovascular risk factor
5127493|NCT03197363|Population study|population study
5127494|NCT03197363|Intestinal microbiome|intestinal microbiome
5127495|NCT03197363|Oral microbiome|oral microbiome
5013126|NCT03914716|Arthropathy|arthropathy
5127496|NCT03197350|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5127497|NCT03197350|Imaging|imaging
5127502|NCT03197337|Utero-Sacral ligaments laxity|utero-sacral ligaments laxity
5127504|NCT03197311|Medication adherence|medication adherence
5127505|NCT03197298|Acute Coronary Syndrome|acute coronary syndrome
5127506|NCT03197298|Percutaneous Coronary Intervention|percutaneous coronary intervention
5127507|NCT03197298|Drug-Eluting Stents|drug-eluting stents
5127508|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5127509|NCT03197298|Ticagrelor|ticagrelor
5127510|NCT03197298|clopidogrel|clopidogrel
5127511|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
5127512|NCT03197285|neck pain|neck pain
5127513|NCT03197285|eye|eye
5127524|NCT03197246|ICECG|icecg
5127530|NCT03197168|stigma|stigma
5127537|NCT03197103|Autologous fat grafting|autologous fat grafting
5127538|NCT03197103|Breast|breast
5127539|NCT03197103|Deformity|deformity
5127540|NCT03197103|Asymmetry|asymmetry
5127541|NCT03197103|Tuberous breast|tuberous breast
5127542|NCT03197103|Acetylcysteine|acetylcysteine
5127543|NCT03197090|Screening|screening
5127544|NCT03197090|Zenicor|zenicor
5127545|NCT03197051|Endothelial glycocalyx|endothelial glycocalyx
5127546|NCT03197051|Acute kidney injury|acute kidney injury
5127547|NCT03197051|Valvular heart disease|valvular heart disease
5127548|NCT03197038|Cognitive function|cognitive function
5127549|NCT03197038|Kidney Disease|kidney disease
5127550|NCT03197038|Exercise|exercise
5127551|NCT03197038|Older adults|older adults
5127552|NCT03197025|HPV-16|hpv-16
5127553|NCT03197025|Premalignancy|premalignancy
5127554|NCT03197025|T Cell Therapy|t cell therapy
5127555|NCT03197012|neuroendocrine tumor (NET)|neuroendocrine tumor (net)
5127556|NCT03197012|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
5127557|NCT03197012|somatostatin receptor (SSTR)|somatostatin receptor (sstr)
5127558|NCT03196999|PTSD|ptsd
5127559|NCT03196999|Attention bias modification|attention bias modification
5127560|NCT03196999|Remote app-based study|remote app-based study
5127561|NCT03196999|Digital Health|digital health
5127562|NCT03196960|Mobilization Therapy|mobilization therapy
5127563|NCT03196960|Critical Illness|critical illness
5127564|NCT03196960|Muscle Strength|muscle strength
5127565|NCT03196960|Functional Mobility|functional mobility
5127566|NCT03196960|Outcome|outcome
5127567|NCT03196960|Intensive Care Unit|intensive care unit
5127568|NCT03196960|Quality of Life|quality of life
5127569|NCT03196947|multiple myeloma|multiple myeloma
5127570|NCT03196947|APO010|apo010
5127571|NCT03196947|Drug Response Predictor|drug response predictor
5127572|NCT03196947|DRP|drp
5127573|NCT03196921|amphotericin B|amphotericin b
5127574|NCT03196921|cryptococcal|cryptococcal
5127575|NCT03196908|ECG|ecg
5127576|NCT03196908|Blood Pressure|blood pressure
5127577|NCT03196908|Energy Drinks|energy drinks
5127581|NCT03196882|pregnancy|pregnancy
5127582|NCT03196882|iron|iron
5127583|NCT03196882|hemoglobin|hemoglobin
5127584|NCT03196882|supplementation|supplementation
5127585|NCT03196882|neurodevelopment|neurodevelopment
5127586|NCT03196882|newborn|newborn
5127587|NCT03196882|anemia|anemia
5127588|NCT03196882|clinical trial|clinical trial
5127589|NCT03196869|NPC peripheral blood dendritic cell chronic-chemotherap|npc peripheral blood dendritic cell chronic-chemotherap
5127590|NCT03196856|Greek Yogurt|greek yogurt
5127591|NCT03196856|Muscle Size|muscle size
5127592|NCT03196856|Bone Health|bone health
5127593|NCT03196856|Body Composition|body composition
5127594|NCT03196856|Exercise|exercise
5127595|NCT03196843|raltitrexed|raltitrexed
5127596|NCT03196843|radiotherapy|radiotherapy
5127597|NCT03196843|older patient|older patient
5127598|NCT03196843|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5127599|NCT03196830|Relapse/refractory non-Hodgkin lymphoma|relapse/refractory non-hodgkin lymphoma
5127600|NCT03196830|CAR - T CD19/CD20/CD22/CD30|car - t cd19/cd20/cd22/cd30
5127601|NCT03196817|Random Allocation|random allocation
5127602|NCT03196817|Injections|injections
5127603|NCT03196817|Orthotic Devices|orthotic devices
5127604|NCT03196765|X-ALD|x-ald
5127605|NCT03196752|cricothyroid membrane|cricothyroid membrane
5127606|NCT03196726|cognitive-behavioral therapy|cognitive-behavioral therapy
5127607|NCT03196713|Allegiance|allegiance
5127608|NCT03196713|Knowledge|knowledge
5127609|NCT03196713|Supervision|supervision
5127610|NCT03196713|Early intervention|early intervention
5127611|NCT03196713|Autism|autism
5127612|NCT03196700|palliative care|palliative care
5127613|NCT03196700|head and neck cancer|head and neck cancer
5127614|NCT03196700|radiotherapy|radiotherapy
5127615|NCT03196700|pain|pain
5127616|NCT03196700|quality of life|quality of life
5127629|NCT03196609|Intestinal microbiota, microbial genes, oncology|intestinal microbiota, microbial genes, oncology
5127632|NCT03196583|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5127633|NCT03196583|video-polysomnography|video-polysomnography
5127634|NCT03196583|mandibular advancement device|mandibular advancement device
5127635|NCT03196583|oral device|oral device
5127636|NCT03196583|cephalometry|cephalometry
5127637|NCT03196518|PET Imaging|pet imaging
5127638|NCT03196518|18F-TFB|18f-tfb
5127639|NCT03196518|17-315|17-315
5127640|NCT03196505|Anesthetics, Local|anesthetics, local
5127646|NCT03196505|Laparoscopic Bariatric Surgery|laparoscopic bariatric surgery
5127647|NCT03196466|antiepileptics|antiepileptics
5127648|NCT03196466|pharmacokinetics|pharmacokinetics
5127649|NCT03196466|children|children
5127650|NCT03196453|overweight|overweight
5127651|NCT03196453|probiotic|probiotic
5127652|NCT03196453|weight management|weight management
5127653|NCT03196440|elderly|elderly
5127654|NCT03196440|taste|taste
5127655|NCT03196440|thresholds|thresholds
5127656|NCT03196427|Drug Therapy|drug therapy
5127657|NCT03196401|Durvalumb|durvalumb
5127658|NCT03196401|Radiation Therapy|radiation therapy
5127659|NCT03196401|Clonal Bone Marrow Plasmacytosis|clonal bone marrow plasmacytosis
5127660|NCT03196401|MEDI4736|medi4736
5127661|NCT03196401|17-269|17-269
5127662|NCT03196388|ENZALUTAMIDE|enzalutamide
5127663|NCT03196388|External Beam Hypofractionated Radiotherapy Intermediate Risk Prostate Cancer|external beam hypofractionated radiotherapy intermediate risk prostate cancer
5127664|NCT03196375|Motor Neuron Disease|motor neuron disease
5127665|NCT03196375|Neurodegenerative Diseases|neurodegenerative diseases
5127666|NCT03196375|Nervous System Diseases|nervous system diseases
5127667|NCT03196375|Neuromuscular Diseases|neuromuscular diseases
5127668|NCT03196375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5127669|NCT03196375|Primary Lateral Sclerosis|primary lateral sclerosis
5127670|NCT03196375|Progressive Muscular Atrophy|progressive muscular atrophy
5127671|NCT03196375|Muscle cramps|muscle cramps
5127672|NCT03196375|Muscle cramping|muscle cramping
5127673|NCT03196375|ALS|als
5127674|NCT03196375|MND|mnd
5127675|NCT03196375|PMA|pma
5127676|NCT03196375|PLS|pls
5127677|NCT03196375|FLX-787|flx-787
5127678|NCT03196362|short-term intensive insulin therapy|short-term intensive insulin therapy
5127679|NCT03196362|pioglitazone|pioglitazone
5127680|NCT03196362|metformin|metformin
5127681|NCT03196362|remission|remission
5127682|NCT03196362|sequential therapy|sequential therapy
5127688|NCT03196167|sugammadex|sugammadex
5127689|NCT03196167|extubation|extubation
5127690|NCT03196167|CABG, AVR, CABG/AVR combination|cabg, avr, cabg/avr combination
5127691|NCT03196154|Homeostasis Model Assessment|homeostasis model assessment
5127692|NCT03196154|Insulin Resistance|insulin resistance
5127693|NCT03196154|Beta Cell Function|beta cell function
5127694|NCT03196154|Liquid Chromatography Tandem Mass Spectrometry|liquid chromatography tandem mass spectrometry
5127695|NCT03196115|Hyaline Fibromatosis Syndrome|hyaline fibromatosis syndrome
5127696|NCT03196115|Biomarker|biomarker
5127697|NCT03196102|tobacco prevention; tobacco intervention; military; brief intervention|tobacco prevention; tobacco intervention; military; brief intervention
5127698|NCT03196063|Exercise Therapy|exercise therapy
5127699|NCT03196063|Heavy Slow Resistance Program|heavy slow resistance program
5127700|NCT03196063|Rehabilitation|rehabilitation
5127707|NCT03195972|Adherence, Patient, oncology, oral therapy|adherence, patient, oncology, oral therapy
5127708|NCT03195959|Pulmonary arterial hypertension|pulmonary arterial hypertension
5127807|NCT03195270|Chronic Pain|chronic pain
5127710|NCT03195959|Hypoxia|hypoxia
5127711|NCT03195959|Hyperoxia|hyperoxia
5127712|NCT03195933|Depression|depression
5127713|NCT03195933|Childhood Adversity|childhood adversity
5127714|NCT03195933|Childhood Abuse|childhood abuse
5127715|NCT03195933|Cortisol|cortisol
5127716|NCT03195933|Emotional Memory|emotional memory
5127717|NCT03195933|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5127718|NCT03195907|Stroke|stroke
5127719|NCT03195907|Mortality|mortality
5127720|NCT03195907|Intensive care unit|intensive care unit
5127721|NCT03195907|Pulmonary rehabilitation|pulmonary rehabilitation
5127722|NCT03195894|Alcohol abuse, Alcoholometer, Medical Device, App|alcohol abuse, alcoholometer, medical device, app
5127723|NCT03195868|chemotherapy|chemotherapy
5127724|NCT03195868|chemo-induced|chemo-induced
5127725|NCT03195868|CIPN|cipn
5127726|NCT03195829|Mild Cognitive Impairment|mild cognitive impairment
5127727|NCT03195829|Computerized Cognitive Stimulation|computerized cognitive stimulation
5127728|NCT03195829|Cognition|cognition
5127729|NCT03195829|Psychosocial factors|psychosocial factors
5127730|NCT03195816|Mild Cognitive Impairment|mild cognitive impairment
5757032|NCT00294645|Bradycardia|bradycardia
5127731|NCT03195816|white matter hyperintensities|white matter hyperintensities
5127732|NCT03195816|computerized cognitive training|computerized cognitive training
5127733|NCT03195816|brain plasticity|brain plasticity
5127734|NCT03195751|telemonitoring|telemonitoring
5127735|NCT03195738|pediatrics|pediatrics
5127736|NCT03195738|case series|case series
5127737|NCT03195738|feasibility|feasibility
5127739|NCT03195712|Obesity|obesity
5127741|NCT03195673|Carotid artery stenting|carotid artery stenting
5127758|NCT03195543|Blood coagulation disorders|blood coagulation disorders
5127760|NCT03195543|Thrombin|thrombin
5127761|NCT03195543|Treatment|treatment
5127762|NCT03195517|Osteopenia|osteopenia
5127763|NCT03195517|Physical activity|physical activity
5127764|NCT03195517|Bone turnover markers|bone turnover markers
5127765|NCT03195517|Osteoprogenitor cells|osteoprogenitor cells
5127766|NCT03195517|Quality of life|quality of life
5127767|NCT03195452|HIV|hiv
5127768|NCT03195452|Antiretrovirals|antiretrovirals
5127769|NCT03195452|Raltegravir|raltegravir
5127770|NCT03195413|Hand blast injury|hand blast injury
5127771|NCT03195413|Nerve block|nerve block
5127772|NCT03195413|Hand injury|hand injury
5127773|NCT03195413|Forearm nerve block|forearm nerve block
5127774|NCT03195413|Ultrasound guided nerve block|ultrasound guided nerve block
5127775|NCT03195413|Ultrasound nerve block|ultrasound nerve block
5127776|NCT03195413|Emergency department|emergency department
5127777|NCT03195413|Emergency physician|emergency physician
5127778|NCT03195413|Emergency room|emergency room
5127779|NCT03195387|malaria, P. falciparum, chemoprotection, Phase Ib|malaria, p. falciparum, chemoprotection, phase ib
5127780|NCT03195374|Analgesic opioids|analgesic opioids
5127781|NCT03195374|Misuse|misuse
5127782|NCT03195374|Use disorder|use disorder
5127783|NCT03195374|Pain|pain
5127784|NCT03195335|Cerebral Palsy|cerebral palsy
5127785|NCT03195335|Participation|participation
5127786|NCT03195335|LIFE Habits (life-H)|life habits (life-h)
5127787|NCT03195335|Validity|validity
5127788|NCT03195335|Reliability|reliability
5127789|NCT03195322|Immediate Breast Reconstruction|immediate breast reconstruction
5127790|NCT03195322|Pain Control|pain control
5127791|NCT03195322|Post Mastectomy Pain Control|post mastectomy pain control
5127792|NCT03195322|Acellular Dermal Matrix|acellular dermal matrix
5127793|NCT03195309|Cesarean Delivery|cesarean delivery
5127794|NCT03195309|Ropivacaine|ropivacaine
5127795|NCT03195309|Fentanyl|fentanyl
5127796|NCT03195309|Patient-controlled Epidural Analgesia|patient-controlled epidural analgesia
5127797|NCT03195283|meal service|meal service
5127798|NCT03195283|protein intake|protein intake
5127799|NCT03195283|satisfaction|satisfaction
5127800|NCT03195283|hospitalized patients|hospitalized patients
5127801|NCT03195270|Positron emission tomography|positron emission tomography
5127802|NCT03195270|Magnetic Resonance Imaging|magnetic resonance imaging
5127803|NCT03195270|PET/MRI|pet/mri
5127804|NCT03195270|Fluorodeoxyglucose|fluorodeoxyglucose
5127805|NCT03195270|FDG|fdg
5127806|NCT03195270|Pain|pain
5127808|NCT03195270|Neuropathic Pain|neuropathic pain
5127809|NCT03195270|Inflammatory Pain|inflammatory pain
5127810|NCT03195270|Nociceptive Pain|nociceptive pain
5127811|NCT03195244|aquatic therapy, hydrotherapy|aquatic therapy, hydrotherapy
5127812|NCT03195231|Parkinson`s disease|parkinson`s disease
5127813|NCT03195231|Depression|depression
5127814|NCT03195231|Wuling Powder|wuling powder
5127815|NCT03195218|Cancer prevention|cancer prevention
5127816|NCT03195218|Diagnosis|diagnosis
5127817|NCT03195218|Microendoscope|microendoscope
5127818|NCT03195218|High Resolution Microendoscope|high resolution microendoscope
5356841|NCT01917760|Gamma-aminobutyric acid|gamma-aminobutyric acid
5127819|NCT03195179|pelvic fracture urethral injury|pelvic fracture urethral injury
5127820|NCT03195179|urethra|urethra
5127821|NCT03195179|disruption|disruption
5127822|NCT03195179|trauma|trauma
5127823|NCT03195166|elderly spinal anesthesia|elderly spinal anesthesia
5127824|NCT03195140|Diabetes Mellitus|diabetes mellitus
5127825|NCT03195140|Diabetes|diabetes
5127826|NCT03195140|Sensor Augmented Pump|sensor augmented pump
5127827|NCT03195140|Hypoglycemia|hypoglycemia
5127828|NCT03195127|Physical Therapy Modalities|physical therapy modalities
5127829|NCT03195127|Rehabilitation|rehabilitation
5127830|NCT03195127|Exercise Therapy|exercise therapy
5127831|NCT03195127|Critical Illness|critical illness
5127832|NCT03195127|Respiration, Artificial|respiration, artificial
5127833|NCT03195127|Chronic Disease|chronic disease
5127834|NCT03195114|post TAVR quantification|post tavr quantification
5127841|NCT03195062|Obesity|obesity
5127849|NCT03195023|Renal insufficiency, Chronic|renal insufficiency, chronic
5127850|NCT03194997|Breast Cancer|breast cancer
5127851|NCT03194997|Quality of life|quality of life
5127852|NCT03194997|Lymphedema|lymphedema
5127853|NCT03194997|Fatigue|fatigue
5127854|NCT03194997|Depressive symptoms|depressive symptoms
5127855|NCT03194997|Body image|body image
5127856|NCT03194997|Self Esteem|self esteem
5127857|NCT03194997|Optimism|optimism
5127858|NCT03194997|Sexual function|sexual function
5127859|NCT03194997|Stress|stress
5127860|NCT03194997|Sleep quality|sleep quality
5127861|NCT03194997|Pain|pain
5127862|NCT03194997|Muscular strength|muscular strength
5127863|NCT03194997|Postural|postural
5127864|NCT03194997|Balance|balance
5127865|NCT03194997|Range of motion|range of motion
5127866|NCT03194997|Cardiorespiratory fitness|cardiorespiratory fitness
5127867|NCT03194984|dental whitening|dental whitening
5127868|NCT03194984|Dental office whitening|dental office whitening
5127869|NCT03194971|glioblastoma|glioblastoma
5127870|NCT03194971|brain tumor autopsy|brain tumor autopsy
5127871|NCT03194971|autopsy|autopsy
5127872|NCT03194971|Optune therapy|optune therapy
5127873|NCT03194971|tumor treatment fields|tumor treatment fields
5127874|NCT03194971|TTFields|ttfields
5127875|NCT03194971|Recurrent glioblastoma|recurrent glioblastoma
5127876|NCT03194971|grade IV|grade iv
5127877|NCT03194971|brain tumor|brain tumor
5127878|NCT03194971|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5127879|NCT03194945|Type 2 diabetes mellitus|type 2 diabetes mellitus
5127880|NCT03194945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5127881|NCT03194945|Metformin|metformin
5127882|NCT03194945|Linagliptin|linagliptin
5127883|NCT03194919|online intervention|online intervention
5127884|NCT03194919|e-Health|e-health
5127885|NCT03194919|negotiating quit date|negotiating quit date
5127886|NCT03194906|Pediatric oncology|pediatric oncology
5127887|NCT03194906|Brain tumor|brain tumor
5127888|NCT03194906|Low grade glioma|low grade glioma
5127889|NCT03194906|Cognitive late effects|cognitive late effects
5127890|NCT03194906|Radiation therapy|radiation therapy
5127891|NCT03194906|Neuroprotection|neuroprotection
5127892|NCT03194906|Memantine|memantine
5127893|NCT03194893|Non−small cell lung cancer (NSCLC)|non−small cell lung cancer (nsclc)
5127894|NCT03194893|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
5127895|NCT03194893|Rearranged during transfection (RET)|rearranged during transfection (ret)
5127896|NCT03194893|Alectinib|alectinib
5127897|NCT03194893|Crizotinib|crizotinib
5127898|NCT03194854|e-Health|e-health
5127899|NCT03194854|self-efficacy theory|self-efficacy theory
5127900|NCT03194854|mixture modeling|mixture modeling
5127901|NCT03194854|mobile health|mobile health
5127902|NCT03194854|complier average causal effect estimation|complier average causal effect estimation
5127903|NCT03194828|Adherence|adherence
5127904|NCT03194828|Mobile health|mobile health
5127905|NCT03194828|Real-time data|real-time data
5127906|NCT03194815|Psychosis|psychosis
5127907|NCT03194815|Immunotherapy|immunotherapy
5127909|NCT03194789|FGBMM|fgbmm
5127910|NCT03194789|LPSE|lpse
5127911|NCT03194789|UDI - 6|udi - 6
5127912|NCT03194789|UIQ - 7|uiq - 7
5127914|NCT03194776|peripheral artery|peripheral artery
5127915|NCT03194776|peripheral vascular disease|peripheral vascular disease
5127916|NCT03194776|leg pain|leg pain
5127917|NCT03194776|claudication|claudication
5127918|NCT03194776|leg pain with exercise|leg pain with exercise
5127919|NCT03194776|exercise test|exercise test
5127920|NCT03194776|walk test|walk test
5127921|NCT03194776|arterial disease|arterial disease
5127922|NCT03194737|Benign prostatic hyperplasia|benign prostatic hyperplasia
5127924|NCT03194737|Urinary retention|urinary retention
5127925|NCT03194737|prostate|prostate
5127926|NCT03194737|hypertrophy|hypertrophy
5127927|NCT03194711|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
5127928|NCT03194711|Optical Coherence Tomography|optical coherence tomography
5127929|NCT03194711|Stents, Drug-Eluting|stents, drug-eluting
5127930|NCT03194698|Intense Pulsed Light|intense pulsed light
5127931|NCT03194685|Acute Myeloid Leukemia|acute myeloid leukemia
5127946|NCT03194620|ECG|ecg
5127947|NCT03194620|Theaflavins|theaflavins
5127948|NCT03194620|Thearubigins|thearubigins
5127949|NCT03194594|Ketamine, dexamethasone, mood|ketamine, dexamethasone, mood
5127950|NCT03194568|Scoliosis|scoliosis
5127954|NCT03194555|Cytokines|cytokines
5127955|NCT03194555|Cox-2|cox-2
5127956|NCT03194555|Headache|headache
5127957|NCT03194555|Migraine|migraine
5127958|NCT03194555|Migraine Prevention|migraine prevention
5127968|NCT03194529|Crohn's Disease|crohn's disease
5127969|NCT03194529|PCDAI|pcdai
5127970|NCT03194529|16s rRNA|16s rrna
5127971|NCT03194529|Fecal Microbiota Transplantation|fecal microbiota transplantation
5127972|NCT03194529|Gut Microbiome|gut microbiome
5127973|NCT03194529|FMT|fmt
5127974|NCT03194516|prostate cancer|prostate cancer
5127975|NCT03194516|ketogenic diet|ketogenic diet
5127976|NCT03194516|overweight, obese|overweight, obese
5127977|NCT03194503|Intubation|intubation
5127978|NCT03194503|Video Laryngoscope|video laryngoscope
5127979|NCT03194503|Coaching/training|coaching/training
5127980|NCT03194477|HIV young Black men who have sex with men substance use|hiv young black men who have sex with men substance use
5127981|NCT03194464|hemiparesis|hemiparesis
5127982|NCT03194451|bone tissue engineering, dental stem cell differentiation|bone tissue engineering, dental stem cell differentiation
5127983|NCT03194438|Pulmonary Hypertension|pulmonary hypertension
5127984|NCT03194438|Symptom Management|symptom management
5127985|NCT03194438|Behavioral Intervention|behavioral intervention
5127986|NCT03194438|Integrative Therapy|integrative therapy
5127987|NCT03194438|Quality of Life|quality of life
5127988|NCT03194425|Sacral neuromodulation|sacral neuromodulation
5127989|NCT03194425|Electromyography|electromyography
5127990|NCT03194425|Pelvic floor|pelvic floor
5127991|NCT03194412|Frail Elderly|frail elderly
5127992|NCT03194412|Geriatric Assessment|geriatric assessment
5127993|NCT03194412|Humans|humans
5127994|NCT03194412|Aged|aged
5127995|NCT03194386|Post-Traumatic Syndrome|post-traumatic syndrome
5127996|NCT03194386|Eye-Movement Desensitization and Reprocessing|eye-movement desensitization and reprocessing
5127997|NCT03194334|vegetarianism|vegetarianism
5127998|NCT03194334|creatine|creatine
5127999|NCT03194334|carnosine|carnosine
5128000|NCT03194334|carnitine|carnitine
5128001|NCT03194308|HIV risk reduction|hiv risk reduction
5128002|NCT03194308|Safer Conception|safer conception
5128003|NCT03194308|Pre-exposure prophylaxis|pre-exposure prophylaxis
5128004|NCT03194308|South Africa|south africa
5128005|NCT03194308|Women|women
5128006|NCT03194308|Reproductive Health|reproductive health
5128007|NCT03194295|Drug-free community support|drug-free community support
5128008|NCT03194295|Methadone maintenance|methadone maintenance
5128009|NCT03194295|Social networks|social networks
5128010|NCT03194282|stroke|stroke
5128011|NCT03194282|balance|balance
5128012|NCT03194282|insole|insole
5128013|NCT03194256|Smoking|smoking
5128014|NCT03194256|Cigarettes|cigarettes
5128015|NCT03194256|E-Cigarettes|e-cigarettes
5128016|NCT03194243|acute dyspnea|acute dyspnea
5128017|NCT03194243|acute heart failure|acute heart failure
5128018|NCT03194243|emergency|emergency
5128019|NCT03194230|Cervical dilators|cervical dilators
5128020|NCT03194230|induction of labor|induction of labor
5128021|NCT03194230|cervical ripening|cervical ripening
5128022|NCT03194230|medical termination of pregnancy|medical termination of pregnancy
5128023|NCT03194230|second-trimester of pregnancy.|second-trimester of pregnancy.
5128024|NCT03194191|Insomnia|insomnia
5128025|NCT03194191|Pregnancy|pregnancy
5128026|NCT03194191|Acupuncture|acupuncture
5128027|NCT03194191|Insomnia severity index|insomnia severity index
5128028|NCT03194191|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
5128029|NCT03194191|Anxiety|anxiety
5128030|NCT03194191|Depression|depression
5128031|NCT03194165|antiretroviral|antiretroviral
5128032|NCT03194165|children|children
5128033|NCT03194165|pharmacokinetics|pharmacokinetics
5128034|NCT03194139|Healthy Adult|healthy adult
5128035|NCT03194139|Superoxide Dismutase|superoxide dismutase
5128036|NCT03194139|First in Human|first in human
5128037|NCT03194139|Free Radical Dismutase|free radical dismutase
5128038|NCT03194087|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5128039|NCT03194087|Low parathyroid hormone|low parathyroid hormone
5128040|NCT03194087|Hemodialysis|hemodialysis
5128041|NCT03194074|Laser Laryngeal Surgery|laser laryngeal surgery
5128042|NCT03194074|Desflurane|desflurane
5128043|NCT03194074|Propofol|propofol
5128044|NCT03194061|chemotherapy|chemotherapy
5128045|NCT03194061|complication|complication
5128046|NCT03194048|drooling|drooling
5128047|NCT03194048|tongue thrust|tongue thrust
5128048|NCT03194035|inflammation|inflammation
5128049|NCT03194035|exercise|exercise
5128050|NCT03194035|ultra endurance|ultra endurance
5128051|NCT03194009|diabetes|diabetes
5128052|NCT03194009|prevention|prevention
5128053|NCT03194009|metformin|metformin
5128054|NCT03194009|Mexico City|mexico city
5128055|NCT03193983|occlusive dressing|occlusive dressing
5128056|NCT03193970|Bladder Cancer|bladder cancer
5128058|NCT03193970|Post‐surgical outcomes|post‐surgical outcomes
5128059|NCT03193970|Radical cystectomy|radical cystectomy
5128060|NCT03193970|MD Anderson Symptom inventory|md anderson symptom inventory
5128061|NCT03193970|MDASI|mdasi
5128062|NCT03193892|registry|registry
5128063|NCT03193892|China|china
5128064|NCT03193892|lymphangioleiomyomatosis|lymphangioleiomyomatosis
5128065|NCT03193879|Pulmonary function|pulmonary function
5128066|NCT03193879|Particulate matter|particulate matter
5128067|NCT03193879|COPD|copd
5128068|NCT03193879|Asthma|asthma
5128069|NCT03193866|Immunomodulating treatment|immunomodulating treatment
5128070|NCT03193866|Cohort study|cohort study
5128071|NCT03193866|Dimethyl fumarate|dimethyl fumarate
5128072|NCT03193866|Fingolimod|fingolimod
5128073|NCT03193866|Interferon-beta|interferon-beta
5128074|NCT03193866|Natalizumab|natalizumab
5128075|NCT03193866|Rituximab|rituximab
5128076|NCT03193866|Glatiramer acetate|glatiramer acetate
5128077|NCT03193840|old acetabular fracture; posterior wall osteotomy|old acetabular fracture; posterior wall osteotomy
5128078|NCT03193827|vip score|vip score
5128079|NCT03193827|peripheral venous cannulation|peripheral venous cannulation
5128080|NCT03193827|particles|particles
5128081|NCT03193801|SAPIEN 3|sapien 3
5128082|NCT03193801|PARTNER 3|partner 3
5128083|NCT03193801|cardiovascular disease|cardiovascular disease
5128084|NCT03193801|TMVR|tmvr
5128085|NCT03193801|failing valve|failing valve
5128086|NCT03193801|failing bioprosthetic valve|failing bioprosthetic valve
5128087|NCT03193775|HBV vaccine|hbv vaccine
5128088|NCT03193775|persistent|persistent
5128090|NCT03193775|IP-10|ip-10
5128091|NCT03193762|pain|pain
5128092|NCT03193762|pain management|pain management
5128093|NCT03193762|anxiety|anxiety
5128094|NCT03193749|Chagas disease, cardiomyopathy, amiodarone, clinical trial|chagas disease, cardiomyopathy, amiodarone, clinical trial
5128095|NCT03193723|Hernia|hernia
5128096|NCT03193723|Local anesthesia|local anesthesia
5128097|NCT03193723|ultrasound|ultrasound
5128098|NCT03193710|Intravenous anesthesia|intravenous anesthesia
5128099|NCT03193710|Inhalational anesthesia|inhalational anesthesia
5128100|NCT03193710|Colorectal cancer resection|colorectal cancer resection
5128101|NCT03193710|Lymphocytes|lymphocytes
5128102|NCT03193710|Metastasis|metastasis
5128103|NCT03193710|Survival|survival
5128104|NCT03193710|Molecular mechanism|molecular mechanism
5128106|NCT03193671|CA125|ca125
5128107|NCT03193671|RMI|rmi
5128108|NCT03193671|ROMA|roma
5128109|NCT03193658|spine surgery|spine surgery
5128110|NCT03193658|Thoracolumbar Interfascial Plane block|thoracolumbar interfascial plane block
5128111|NCT03193658|regional anesthesia|regional anesthesia
5128112|NCT03193658|postoperative analgesia|postoperative analgesia
5128115|NCT03193632|resting energy expenditure|resting energy expenditure
5128116|NCT03193632|oxygen consumption|oxygen consumption
5128117|NCT03193632|Indirect calorimetry|indirect calorimetry
5128118|NCT03193632|carbon dioxide excretion|carbon dioxide excretion
5128119|NCT03193632|respiratory quotient|respiratory quotient
5128120|NCT03193580|Anodal Stimulation Transcranial Direct Current Stimulation|anodal stimulation transcranial direct current stimulation
5128121|NCT03193580|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
5128123|NCT03193580|Non-invasive brain stimulation|non-invasive brain stimulation
5128124|NCT03193580|Pediatrics|pediatrics
5128125|NCT03193489|Balance|balance
5128126|NCT03193489|Posturograpy|posturograpy
5128127|NCT03193489|quality of life|quality of life
5128128|NCT03193463|Topotecan|topotecan
5128129|NCT03193463|Convection-Enhanced Delivery|convection-enhanced delivery
5128130|NCT03193450|helicobactor pylori|helicobactor pylori
5128134|NCT03193398|Major Depressive Disorder|major depressive disorder
5128135|NCT03193398|Anhedonia|anhedonia
5128136|NCT03193398|antidepressant|antidepressant
5128137|NCT03193398|Nociceptin|nociceptin
5128138|NCT03193398|NOPR|nopr
5128139|NCT03193333|glaucoma|glaucoma
5128142|NCT03193333|Krytantek Ofteno®.|krytantek ofteno®.
5128143|NCT03193333|timolol|timolol
5128144|NCT03193333|brimonidine|brimonidine
5128145|NCT03193333|dorzolamide|dorzolamide
5128146|NCT03193320|plethysmographic variability index|plethysmographic variability index
5128148|NCT03193281|Dasatinib|dasatinib
5128149|NCT03193281|Imatinib|imatinib
5128150|NCT03193268|sensorimotor training|sensorimotor training
5128151|NCT03193268|quality of life|quality of life
5128152|NCT03193268|posture|posture
5128153|NCT03193242|Asthma|asthma
5128154|NCT03193242|Asthma Action Plan|asthma action plan
5128155|NCT03193216|Barrett's|barrett's
5128156|NCT03193216|GERD|gerd
5128157|NCT03193216|reflux|reflux
5128158|NCT03193216|alginate solution|alginate solution
5128159|NCT03193216|proton pump inhibitor|proton pump inhibitor
5128160|NCT03193177|fasting-like diet|fasting-like diet
5128161|NCT03193177|chronic diseases|chronic diseases
5128162|NCT03193177|autoimmune diseases|autoimmune diseases
5128163|NCT03193177|metabolic disorder|metabolic disorder
5128164|NCT03193164|Electric Stimulation Therapy; Endothelial Progenitor Cells.|electric stimulation therapy; endothelial progenitor cells.
5124639|NCT03215732|morbidity|morbidity
5128174|NCT03193112|Depression|depression
5128175|NCT03193112|Intraocular pressure|intraocular pressure
5128176|NCT03193086|Multiple Sclerosis|multiple sclerosis
5128177|NCT03193086|Blood-Brain-Barrier|blood-brain-barrier
5128178|NCT03193086|Treatment response|treatment response
5128179|NCT03193086|Metabolism|metabolism
5128180|NCT03193086|Alemtuzumab|alemtuzumab
5128181|NCT03193086|Perfusion|perfusion
5128182|NCT03193086|Oxygen consumption|oxygen consumption
5128183|NCT03193047|Cholesterol|cholesterol
5128184|NCT03193047|PCSK9|pcsk9
5128185|NCT03193047|Repatha|repatha
5128186|NCT03193047|evolocumab|evolocumab
5128187|NCT03193047|LDL-C|ldl-c
5128188|NCT03193034|Arthroplasty|arthroplasty
5128189|NCT03193034|replacement|replacement
5128190|NCT03193034|Knee|knee
5128191|NCT03193034|function|function
5128192|NCT03193034|radiographic|radiographic
5128193|NCT03193034|survivorship|survivorship
5128194|NCT03193021|vessel closure|vessel closure
5128195|NCT03193021|venous access site|venous access site
5128196|NCT03193021|femoral venotomy|femoral venotomy
5128197|NCT03193021|medium bore|medium bore
5128198|NCT03193021|multiple access sites|multiple access sites
5128199|NCT03193008|Breast Cancer|breast cancer
5128200|NCT03193008|Axillary ultrasound|axillary ultrasound
5128201|NCT03193008|Sentinel lymph node biopsy|sentinel lymph node biopsy
5128202|NCT03193008|Axillary management|axillary management
5128203|NCT03192995|HIV|hiv
5128204|NCT03192995|sexual behavior|sexual behavior
5128205|NCT03192956|Hyperbaric|hyperbaric
5128206|NCT03192956|Decompression sickness|decompression sickness
4999910|NCT03995485|KW-136|kw-136
5128207|NCT03192956|Decompression injury|decompression injury
5128208|NCT03192956|Inflammation|inflammation
5128209|NCT03192956|Central nervous injury|central nervous injury
5128210|NCT03192956|Hybervaric oxygen therapy|hybervaric oxygen therapy
5128211|NCT03192930|Hyperbaric|hyperbaric
5128212|NCT03192930|Saturation|saturation
5128213|NCT03192930|Decompression injury|decompression injury
5128214|NCT03192930|Decompression sickness|decompression sickness
5128215|NCT03192930|Inflammation|inflammation
5128216|NCT03192930|Central nervous system injury|central nervous system injury
5128217|NCT03192930|Diving medicine|diving medicine
5128218|NCT03192917|Shock wave therapy|shock wave therapy
5128219|NCT03192917|erectile dysfunction|erectile dysfunction
5128220|NCT03192904|Lung cancer|lung cancer
5128221|NCT03192904|Segmentectomy|segmentectomy
5128222|NCT03192904|Postoperative Complication|postoperative complication
5128223|NCT03192904|Stapling Device|stapling device
5128224|NCT03192904|Energy Device|energy device
5128225|NCT03192878|infliximab|infliximab
5128226|NCT03192878|biosimilars|biosimilars
5128227|NCT03192878|treatment|treatment
5128228|NCT03192852|Tooth bleaching color|tooth bleaching color
5128229|NCT03192852|dental esthetic|dental esthetic
5128230|NCT03192852|Clinical Trial|clinical trial
5128231|NCT03192852|Violet LED light|violet led light
5128232|NCT03192852|Violet LED|violet led
5128233|NCT03192852|color|color
5128234|NCT03192852|sensibility|sensibility
5128235|NCT03192852|dental aesthetic|dental aesthetic
5128236|NCT03192826|Nd-YAG capsulotomy|nd-yag capsulotomy
5128237|NCT03192826|ocular hypertension|ocular hypertension
5128238|NCT03192826|brimonidine|brimonidine
5128239|NCT03192826|brinzolamide|brinzolamide
5128247|NCT03192709|Sildenafil IVF ICI failure|sildenafil ivf ici failure
5128248|NCT03192631|financial incentive|financial incentive
5128249|NCT03192579|neoatherosclerosis|neoatherosclerosis
5128250|NCT03192566|Acetaminophen|acetaminophen
5128251|NCT03192566|Anesthesia|anesthesia
5128252|NCT03192566|Adolescent|adolescent
5128253|NCT03192566|Obesity|obesity
5128254|NCT03192553|donning|donning
5128255|NCT03192553|doffing|doffing
5128256|NCT03192553|self-contamination|self-contamination
5128257|NCT03192553|healthcare workers|healthcare workers
5128258|NCT03192540|Exercise|exercise
5128259|NCT03192527|KN015|kn015
5128260|NCT03192527|Long-acting FSH|long-acting fsh
5128261|NCT03192514|Polypharmacy|polypharmacy
5128262|NCT03192514|Benzodiazepine use|benzodiazepine use
5128263|NCT03192501|lung cancer|lung cancer
5128264|NCT03192501|iCAGES|icages
5128265|NCT03192501|gene mutation|gene mutation
5128266|NCT03192501|precision medicine|precision medicine
5128268|NCT03192462|Pancreatic Cancer|pancreatic cancer
5128269|NCT03192462|Immune-based therapies|immune-based therapies
5128270|NCT03192462|CytotoxicT Lymphocytes|cytotoxict lymphocytes
5128271|NCT03192423|Stress|stress
5128272|NCT03192423|Performance of procedures|performance of procedures
5128273|NCT03192423|Lumbar Puncture|lumbar puncture
5128274|NCT03192410|myocardial infarction|myocardial infarction
5128275|NCT03192410|cardiovascular diseases|cardiovascular diseases
5128276|NCT03192410|mortality|mortality
5128277|NCT03192410|post-myocardial infarction patients|post-myocardial infarction patients
5128278|NCT03192410|risk prediction|risk prediction
5128279|NCT03192410|kidney function|kidney function
5128280|NCT03192410|mental well-being|mental well-being
5128281|NCT03192410|cardiovascular drug treatment|cardiovascular drug treatment
5128282|NCT03192384|Hospital falls|hospital falls
5128283|NCT03192371|Zagreb regimen|zagreb regimen
5128284|NCT03192371|Encephalitis|encephalitis
5128285|NCT03192371|Antibody persistence|antibody persistence
5128286|NCT03192371|Essen regimen|essen regimen
5128287|NCT03192371|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
5128288|NCT03192371|Rabies|rabies
5128289|NCT03192358|Thickened Liquids|thickened liquids
5128290|NCT03192358|Dysphagia Management|dysphagia management
5128291|NCT03192358|Videofluoroscopy|videofluoroscopy
5128292|NCT03192358|Swallowing Physiology|swallowing physiology
5128293|NCT03192332|Intravenous thrombolysis|intravenous thrombolysis
5128294|NCT03192332|Endovascular treatment|endovascular treatment
5128295|NCT03192332|Mechanical thrombectomy|mechanical thrombectomy
5128296|NCT03192332|Bridging thrombolysis|bridging thrombolysis
5128297|NCT03192332|Acute ischemic stroke|acute ischemic stroke
5128298|NCT03192319|Herpes zoster vaccine|herpes zoster vaccine
5128299|NCT03192319|Cell-mediated immunity|cell-mediated immunity
5128300|NCT03192319|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5128301|NCT03192306|Herpes Labialis|herpes labialis
5128302|NCT03192306|Cold Sore|cold sore
5128303|NCT03192267|newly diagnosed rheumatoid arthritis|newly diagnosed rheumatoid arthritis
5128304|NCT03192267|lung disease|lung disease
5128305|NCT03192241|reading|reading
5128306|NCT03192228|Diabetes Mellitus, Type 2 +|diabetes mellitus, type 2 +
5128307|NCT03192228|Patient Education|patient education
5128308|NCT03192215|Atrial Cardiopathy|atrial cardiopathy
5128309|NCT03192215|Cryptogenic stroke|cryptogenic stroke
5128310|NCT03192215|Ischemic stroke|ischemic stroke
5128311|NCT03192215|Apixaban|apixaban
5962029|NCT04283487|abdominal MR|abdominal mr
5128312|NCT03192215|Aspirin|aspirin
5128313|NCT03192202|Lymphoma|lymphoma
5128513|NCT03191253|nutrition|nutrition
5128330|NCT03192111|Moderate Renal Impairment|moderate renal impairment
5128331|NCT03192111|Severe Renal Impairment|severe renal impairment
5128332|NCT03192111|Entinostat|entinostat
5128333|NCT03192111|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5128334|NCT03192111|HDAC|hdac
5128335|NCT03192059|Immunotherapy|immunotherapy
5128336|NCT03192059|Radiotherapy|radiotherapy
5128337|NCT03192059|Immune-modulatory cocktail|immune-modulatory cocktail
5128338|NCT03192020|Hand dysfunction|hand dysfunction
5128340|NCT03192020|Xiaflex|xiaflex
5128341|NCT03192020|Aponeurectomy|aponeurectomy
5128342|NCT03192020|Aponeurotomy|aponeurotomy
5128343|NCT03192020|Dupuytren disease|dupuytren disease
5128344|NCT03192020|Joint contracture|joint contracture
5128345|NCT03192020|Surgery|surgery
5128346|NCT03191968|Behavior change|behavior change
5128347|NCT03191968|Prostate cancer|prostate cancer
5128348|NCT03191968|Behavioral counseling|behavioral counseling
5128349|NCT03191968|Physical Activity|physical activity
5128350|NCT03191968|Randomized controlled trial|randomized controlled trial
5128351|NCT03191942|Myopia control|myopia control
5128352|NCT03191942|Orthokeratology|orthokeratology
5128353|NCT03191942|Children|children
5128354|NCT03191942|Treatment zone|treatment zone
5128355|NCT03191929|Depression|depression
5128356|NCT03191929|Post-traumatic Stress Disorder|post-traumatic stress disorder
5128357|NCT03191929|Health Information Technology (HIT)|health information technology (hit)
5128358|NCT03191929|Primary Care Provider|primary care provider
5128359|NCT03191929|Mental Health Screening|mental health screening
5128360|NCT03191916|Parkinson's Disease|parkinson's disease
5128361|NCT03191916|Mild Cognitive Impairment|mild cognitive impairment
5128362|NCT03191916|tDCS|tdcs
5128363|NCT03191916|Cognitive function|cognitive function
5128364|NCT03191890|in vivo culture|in vivo culture
5128365|NCT03191877|coffee consumption|coffee consumption
5128366|NCT03191877|Cesarean section|cesarean section
5128367|NCT03191877|intestinal motility|intestinal motility
5128380|NCT03191825|online intervention|online intervention
5128381|NCT03191825|mHealth m-Health|mhealth m-health
5128382|NCT03191825|eHealth e-Health|ehealth e-health
5128383|NCT03191825|smoking cessation|smoking cessation
5128384|NCT03191825|lapse management|lapse management
5128385|NCT03191825|relapse prevention|relapse prevention
5128390|NCT03191760|Posttraumatic Stress Disorder|posttraumatic stress disorder
5128391|NCT03191760|Social Support|social support
5128392|NCT03191760|Primary Care|primary care
5128393|NCT03191747|Masculine Norms|masculine norms
5128394|NCT03191747|Skin Care|skin care
5128396|NCT03191734|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5128397|NCT03191734|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5128398|NCT03191734|AQUABEAM|aquabeam
5128399|NCT03191734|Aquablation|aquablation
5128400|NCT03191721|Peri-implantitis|peri-implantitis
5128401|NCT03191721|Triclosan|triclosan
5128402|NCT03191721|Toothpastes|toothpastes
5128403|NCT03191721|Therapeutics|therapeutics
5128404|NCT03191721|Periodontal Diseases|periodontal diseases
5128405|NCT03191721|Periodontitis|periodontitis
5128406|NCT03191721|Dentifrices|dentifrices
5128407|NCT03191708|Fractional Flow Reserve|fractional flow reserve
5128408|NCT03191708|Quantitative Coronary Angiography|quantitative coronary angiography
5128409|NCT03191708|Coronary artery disease|coronary artery disease
5128410|NCT03191708|Angina pectoris|angina pectoris
5128411|NCT03191708|Quantitative Flow Ratio|quantitative flow ratio
5128412|NCT03191695|Participation|participation
5128413|NCT03191695|Activity|activity
5128414|NCT03191695|Cerebral Palsy|cerebral palsy
5128415|NCT03191695|LIFE Habits (life-H)|life habits (life-h)
5128416|NCT03191695|Gross Motor Function|gross motor function
5128417|NCT03191695|Health-related Quality of Life|health-related quality of life
5128419|NCT03191630|Kidney transplant|kidney transplant
5128420|NCT03191630|SystemCHANGE|systemchange
5128421|NCT03191630|physical activity|physical activity
5128422|NCT03191630|smart phone|smart phone
5128423|NCT03191630|Fitbit|fitbit
5128424|NCT03191630|activity monitor|activity monitor
5128425|NCT03191630|step count|step count
5128426|NCT03191630|post-surgery|post-surgery
5128427|NCT03191630|quality of life|quality of life
5128428|NCT03191630|cardiovascular|cardiovascular
5128429|NCT03191604|Endoscopy|endoscopy
5128430|NCT03191604|Narrow band imaging|narrow band imaging
5128431|NCT03191604|Dysplasia|dysplasia
5128432|NCT03191591|Overweight|overweight
5128433|NCT03191591|Obesity|obesity
5128434|NCT03191591|Maternal-child|maternal-child
5128435|NCT03191591|Social Determinants of Health|social determinants of health
5128436|NCT03191578|NMIBC|nmibc
5128437|NCT03191578|Immunotherapy|immunotherapy
5128438|NCT03191578|RUTI|ruti
5128439|NCT03191578|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5128440|NCT03191565|mhealth|mhealth
5128441|NCT03191565|self-monitoring|self-monitoring
5128442|NCT03191565|Outcome monitoring|outcome monitoring
5128443|NCT03191552|Cerebral palsy|cerebral palsy
5128444|NCT03191552|lycra garments|lycra garments
5000149|NCT03994081|MDD|mdd
5128445|NCT03191552|orthosis|orthosis
5128446|NCT03191552|suit therapy|suit therapy
5128447|NCT03191552|trunk control|trunk control
5128448|NCT03191513|Interesterified|interesterified
5128449|NCT03191513|Postprandial|postprandial
5128450|NCT03191513|Lipid|lipid
5128451|NCT03191474|PrEP|prep
5128452|NCT03191474|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5128453|NCT03191474|Truvada|truvada
5128454|NCT03191474|Client-centered case management|client-centered case management
5128455|NCT03191474|Transgender|transgender
5128456|NCT03191474|Gender non-conforming|gender non-conforming
5128457|NCT03191461|Anthracycline-based chemotherapy|anthracycline-based chemotherapy
5128458|NCT03191461|Anth-bC|anth-bc
5128459|NCT03191461|Chemotherapy|chemotherapy
5128460|NCT03191461|Myocardial Perfusion|myocardial perfusion
5128461|NCT03191435|Diabetes mellitus, type 2|diabetes mellitus, type 2
5128462|NCT03191435|Inspiratory muscle training|inspiratory muscle training
5128463|NCT03191435|Glycemic control|glycemic control
5128464|NCT03191435|Glucose|glucose
5128465|NCT03191435|Exercise|exercise
5128466|NCT03191435|Diaphragm exercise|diaphragm exercise
5128467|NCT03191435|Inspiratory loading|inspiratory loading
5128468|NCT03191422|Rehabilitation|rehabilitation
5128469|NCT03191422|Occupational Performance|occupational performance
5128470|NCT03191409|cognitive impairment|cognitive impairment
5128471|NCT03191409|ESRD|esrd
5128472|NCT03191409|functional MRI|functional mri
5128481|NCT03191344|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
5128482|NCT03191344|total thyroidectomy|total thyroidectomy
5128483|NCT03191344|thyroid cancer|thyroid cancer
5128484|NCT03191344|hypoparathyroidism|hypoparathyroidism
5128485|NCT03191344|prediction|prediction
5128486|NCT03191331|dietary intervention|dietary intervention
5128487|NCT03191331|gestational weight gain|gestational weight gain
5128488|NCT03191331|gestational diabetes|gestational diabetes
5128489|NCT03191331|overweight|overweight
5128490|NCT03191331|obesity|obesity
5128491|NCT03191318|ERAS|eras
5128492|NCT03191318|Enhanced recovery after sugery in bariatric surgery|enhanced recovery after sugery in bariatric surgery
5128493|NCT03191318|sleeve gastrectomy|sleeve gastrectomy
5128494|NCT03191292|probabilistic antibiotherapy|probabilistic antibiotherapy
5128495|NCT03191292|prosthetic joint infection|prosthetic joint infection
5128496|NCT03191292|treatment failure|treatment failure
5128497|NCT03191279|Wounds and injury|wounds and injury
5128498|NCT03191279|Trauma|trauma
5128499|NCT03191279|First aid|first aid
5128500|NCT03191279|Bystander|bystander
5128501|NCT03191279|Laypersons|laypersons
5128502|NCT03191266|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5128507|NCT03191253|food insecurity|food insecurity
5128508|NCT03191253|community-based|community-based
5128509|NCT03191253|food assistance|food assistance
5128510|NCT03191253|food support|food support
5128511|NCT03191253|intervention|intervention
5128512|NCT03191253|medically tailored|medically tailored
5128518|NCT03191175|HIV|hiv
5128519|NCT03191175|Inflammasome|inflammasome
5128520|NCT03191162|Benznidazole|benznidazole
5128521|NCT03191162|PCR|pcr
5014162|NCT03908424|chronic headache|chronic headache
5128522|NCT03191123|Hepatocellular Carcinoma|hepatocellular carcinoma
5128523|NCT03191123|Hepatic Resection|hepatic resection
5128524|NCT03191123|TACE|tace
5128525|NCT03191123|Solitary Huge Tumor|solitary huge tumor
5128526|NCT03191123|Overall Survival|overall survival
5128527|NCT03191110|COLON|colon
5128528|NCT03191110|colorectal cancer|colorectal cancer
5128529|NCT03191110|nutrition|nutrition
5128530|NCT03191110|lifestyle|lifestyle
5128531|NCT03191110|survival|survival
5128532|NCT03191110|recurrence|recurrence
5128533|NCT03191110|quality of life|quality of life
5128534|NCT03191084|marijuana|marijuana
5128535|NCT03191084|THC|thc
5128536|NCT03191084|cannabis|cannabis
5128537|NCT03191084|driving|driving
5128538|NCT03191084|impairment|impairment
5128539|NCT03191084|intoxication|intoxication
5128540|NCT03191071|pneumonia|pneumonia
5128541|NCT03191071|procalcitonin|procalcitonin
5128542|NCT03191071|lung ultrasound|lung ultrasound
5128543|NCT03191071|point of care testing|point of care testing
5128544|NCT03191071|antibiotic prescription|antibiotic prescription
5128545|NCT03191071|respiratory pathogens|respiratory pathogens
5128546|NCT03191071|host biomarkers|host biomarkers
5128547|NCT03191058|Depression|depression
5128548|NCT03191058|Unipolar Depression|unipolar depression
5128549|NCT03191058|Treatment Resistant Depression|treatment resistant depression
5128550|NCT03191058|Magnetic Seizure Therapy|magnetic seizure therapy
5128551|NCT03191058|Suicidal Ideation|suicidal ideation
5128552|NCT03191058|Electroconvulsive Therapy|electroconvulsive therapy
5128553|NCT03191045|MRI|mri
5962030|NCT04283461|Dose-escalation|dose-escalation
5128554|NCT03191045|motility|motility
5128555|NCT03191045|perfused manometry|perfused manometry
5128556|NCT03191045|stomach|stomach
5128557|NCT03191045|bowel|bowel
5128558|NCT03191045|water|water
5128559|NCT03191032|Peripheral nerves/lesions; hands; rehabilitation; fMRI|peripheral nerves/lesions; hands; rehabilitation; fmri
5128560|NCT03191019|Cell phones|cell phones
5128561|NCT03191019|Women|women
5128562|NCT03191006|effect|effect
5128563|NCT03191006|insoles|insoles
5128564|NCT03191006|children|children
5128565|NCT03190967|Ado-trastuzumab Emtansine|ado-trastuzumab emtansine
5128566|NCT03190967|Systemic Control of Disease|systemic control of disease
5128567|NCT03190967|Maximum Tolerated Dose|maximum tolerated dose
5138285|NCT03126864|AML|aml
5128595|NCT03190863|Physical therapy|physical therapy
5128596|NCT03190863|Cervical spinal cord injury|cervical spinal cord injury
5128597|NCT03190863|Tetraplegia|tetraplegia
5128598|NCT03190863|AIS A|ais a
5128599|NCT03190863|AIS B|ais b
5128600|NCT03190850|Sleep Apnea|sleep apnea
5128601|NCT03190850|Elderly|elderly
5128602|NCT03190850|Inspiratory training|inspiratory training
5128603|NCT03190837|gaucher|gaucher
5128604|NCT03190837|gaucher disease|gaucher disease
5128605|NCT03190824|melanoma|melanoma
5128606|NCT03190824|immunotherapy|immunotherapy
5128607|NCT03190824|immune oncology|immune oncology
5128608|NCT03190824|loco regional therapy|loco regional therapy
5128609|NCT03190824|adenovirus|adenovirus
5128610|NCT03190824|oncolytic virus|oncolytic virus
5128611|NCT03190824|unresectable|unresectable
5128612|NCT03190824|telomerase|telomerase
5128613|NCT03190811|advanced solid tumor|advanced solid tumor
5128614|NCT03190811|DC-CIK|dc-cik
5128615|NCT03190811|anti-PD-1 antibody|anti-pd-1 antibody
5128616|NCT03190811|immunotherapy|immunotherapy
5128617|NCT03190785|benzoic acid|benzoic acid
5128618|NCT03190785|endocrine disrupting chemicals|endocrine disrupting chemicals
5128619|NCT03190785|leptin|leptin
5128620|NCT03190785|metabolic rate|metabolic rate
5128621|NCT03190733|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5128622|NCT03190733|ATG|atg
5128623|NCT03190733|chronic GVHD|chronic gvhd
5128624|NCT03190733|leukemia relapse|leukemia relapse
5128625|NCT03190694|chronic kidney disease|chronic kidney disease
5128626|NCT03190694|non diabetic|non diabetic
5128627|NCT03190668|tissue microdialysis|tissue microdialysis
5128628|NCT03190668|spinal fusion|spinal fusion
5128629|NCT03190668|surgical site infection|surgical site infection
5128630|NCT03190642|Orthognathic Surgery|orthognathic surgery
5128631|NCT03190642|Swelling|swelling
5128632|NCT03190629|body composition|body composition
5128633|NCT03190629|bioimpedance|bioimpedance
5128634|NCT03190629|hemodialysis|hemodialysis
5125048|NCT03213132|sleep|sleep
5128635|NCT03190629|hemodiafiltration|hemodiafiltration
5128636|NCT03190629|nutritional status|nutritional status
5128637|NCT03190629|protein energy wasting|protein energy wasting
5128638|NCT03190590|transcranial magnetic stimulation|transcranial magnetic stimulation
5128639|NCT03190577|Transthyretin mutation|transthyretin mutation
5128640|NCT03190551|infraclavicular brachial plexus block|infraclavicular brachial plexus block
5128641|NCT03190551|retroclavicular approach|retroclavicular approach
5128642|NCT03190551|costoclavicular approach|costoclavicular approach
5128643|NCT03190551|upper limb surgery|upper limb surgery
5128644|NCT03190551|needle shaft visibility|needle shaft visibility
5128645|NCT03190512|Periodontal disease|periodontal disease
5128646|NCT03190512|depression|depression
5128647|NCT03190512|body image|body image
5128648|NCT03190512|self-esteem|self-esteem
5128649|NCT03190499|Cancer|cancer
5128650|NCT03190499|Leukemia|leukemia
5128656|NCT03190395|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5128657|NCT03190395|Circumferential Pulmonary Vein Isolation(CPVI)|circumferential pulmonary vein isolation(cpvi)
5128658|NCT03190395|Leftatrium Roofline Ablation(LARA)|leftatrium roofline ablation(lara)
5128659|NCT03190395|Longterm success rate|longterm success rate
5128660|NCT03190317|electronic medical record|electronic medical record
5128661|NCT03190317|personal health record|personal health record
5128663|NCT03190317|self-management|self-management
5128664|NCT03190278|Acute Myeloid Leukemia|acute myeloid leukemia
5128665|NCT03190278|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
5128666|NCT03190278|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
5128667|NCT03190278|Allogeneic|allogeneic
5128668|NCT03190278|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
5128669|NCT03190265|cy|cy
5128670|NCT03190265|Cyclophosphamide|cyclophosphamide
5128671|NCT03190265|Pancreatic Vaccine|pancreatic vaccine
5128672|NCT03190265|GVAX|gvax
5128673|NCT03190265|Nivolumab|nivolumab
5128674|NCT03190265|Vaccine|vaccine
5128675|NCT03190265|Ipilimumab|ipilimumab
5128676|NCT03190265|CRS-207|crs-207
5128677|NCT03190265|Immunotherapy|immunotherapy
5128678|NCT03190265|PD-1|pd-1
5128679|NCT03190265|Adenocarcinoma|adenocarcinoma
5128680|NCT03190265|Carcinoma|carcinoma
5128681|NCT03190265|Neoplasms|neoplasms
5128682|NCT03190252|Diving medicine|diving medicine
5128683|NCT03190252|Inflammation|inflammation
5128684|NCT03190252|Central nervous system injury|central nervous system injury
5128685|NCT03190252|Trimix|trimix
5128686|NCT03190252|Decompression sickness|decompression sickness
5128687|NCT03190252|Venous gas emboli|venous gas emboli
5128688|NCT03190226|L-PRF|l-prf
5128689|NCT03190226|keratinised tissues|keratinised tissues
5128690|NCT03190226|implant|implant
5041530|NCT03739684|BCR|bcr
5128691|NCT03190226|free gingival graft|free gingival graft
5128692|NCT03190213|high grade|high grade
5128693|NCT03190161|Schizophrenia|schizophrenia
5128694|NCT03190148|GLP-1|glp-1
5128695|NCT03190148|Ectopic Lipids|ectopic lipids
5128696|NCT03190135|Overweight|overweight
5128697|NCT03190135|Obesity|obesity
5128698|NCT03190135|School|school
5128699|NCT03190135|Physical Activity|physical activity
5128700|NCT03190109|bone age measurement|bone age measurement
5128701|NCT03190109|skeletal age measurement|skeletal age measurement
5128702|NCT03190109|ultrasound|ultrasound
5128703|NCT03190109|x-Ray|x-ray
5128704|NCT03190083|mastectomy|mastectomy
5128705|NCT03190083|lumpectomy|lumpectomy
5128706|NCT03190083|3-Dimensional Mammogram|3-dimensional mammogram
5128707|NCT03190083|digital breast tomosynthesis|digital breast tomosynthesis
5128708|NCT03190070|Renal reserve, physiological study, diagnostic testing|renal reserve, physiological study, diagnostic testing
5128709|NCT03190057|BioFreedom|biofreedom
5128710|NCT03190057|Drug Eluting Stent|drug eluting stent
5128711|NCT03190057|Coronary Artery Disease|coronary artery disease
5128712|NCT03190031|training|training
5128713|NCT03190031|exercise|exercise
5128714|NCT03190031|quality of life|quality of life
5128715|NCT03190005|PRU|pru
5128716|NCT03190005|P2Y12 receptor|p2y12 receptor
5128717|NCT03189979|community based participatory research|community based participatory research
5128718|NCT03189979|Childhood obesity|childhood obesity
5128719|NCT03189966|transversalis fascia plane block|transversalis fascia plane block
5128720|NCT03189966|quadratus lumborum block|quadratus lumborum block
5128721|NCT03189966|ultrasound-guided|ultrasound-guided
5128722|NCT03189966|Developmental Dysplasia of the Hip|developmental dysplasia of the hip
5128723|NCT03189966|postoperative analgesia|postoperative analgesia
5128724|NCT03189914|pancreatic cancer|pancreatic cancer
5128725|NCT03189914|Abraxane|abraxane
5128726|NCT03189914|first line|first line
5128727|NCT03189875|Systemic Lupus Erythematosus Disease|systemic lupus erythematosus disease
5128728|NCT03189849|Farming environment|farming environment
5128729|NCT03189836|CD20+|cd20+
5128730|NCT03189836|B cell|b cell
5128731|NCT03189836|ACTR|actr
5128732|NCT03189836|ACTR707|actr707
5128733|NCT03189836|relapsed|relapsed
5128734|NCT03189836|refractory|refractory
5128735|NCT03189836|T cell|t cell
5128736|NCT03189836|T cell product|t cell product
5128737|NCT03189836|adoptive T cells|adoptive t cells
5128738|NCT03189836|gene therapy|gene therapy
5445344|NCT01522235|Autoimmune autonomic neuropathy|autoimmune autonomic neuropathy
5128739|NCT03189810|Sham Repetitive Transcranial Magnetic Stimulation (rTMS)|sham repetitive transcranial magnetic stimulation (rtms)
5128741|NCT03189810|Cannabis Use Disorder|cannabis use disorder
5128742|NCT03189810|Cognitive Function|cognitive function
5128743|NCT03189758|chronic kidney disease|chronic kidney disease
5128744|NCT03189758|hemodialysis|hemodialysis
5128745|NCT03189758|sodium restriction|sodium restriction
5128747|NCT03189732|lipolysis|lipolysis
5128748|NCT03189732|adipose tissue|adipose tissue
5128749|NCT03189732|exercise|exercise
5128750|NCT03189719|Programmed Cell Death-1 (PD1, PD-1),|programmed cell death-1 (pd1, pd-1),
5128751|NCT03189719|Programmed Cell Death Receptor Ligand 1 (PDL1, PD-L1)|programmed cell death receptor ligand 1 (pdl1, pd-l1)
5128752|NCT03189719|Programmed Cell Death Receptor Ligand 2 (PDL2, PD-L2)|programmed cell death receptor ligand 2 (pdl2, pd-l2)
5128753|NCT03189706|Hu3F8|hu3f8
5128754|NCT03189706|Irinotecan|irinotecan
5128755|NCT03189706|Temozolomide|temozolomide
5128756|NCT03189706|Sargramostim|sargramostim
5128757|NCT03189706|Chemoimmunotherapy|chemoimmunotherapy
5128758|NCT03189706|17-251|17-251
5128759|NCT03189680|sensorimotor training|sensorimotor training
5128760|NCT03189680|exergaming|exergaming
5128761|NCT03189680|posture|posture
5128762|NCT03189680|quality of life|quality of life
5128763|NCT03189641|Drug eluting stents|drug eluting stents
5128764|NCT03189641|Coronary artery disease|coronary artery disease
5128765|NCT03189641|Coronary artery stenosis|coronary artery stenosis
5128766|NCT03189641|Myocardial ischemia|myocardial ischemia
5128767|NCT03189641|Angioplasty|angioplasty
5128768|NCT03189628|stromal vascular fraction|stromal vascular fraction
5128769|NCT03189628|skin regeneration|skin regeneration
5128770|NCT03189628|skin texture|skin texture
5128771|NCT03189628|anti-aging|anti-aging
5128772|NCT03189602|Takayasu Arteritis|takayasu arteritis
5128773|NCT03189602|Pulmonary artery hypertension|pulmonary artery hypertension
5128774|NCT03189589|Pharmacokinetics|pharmacokinetics
5128775|NCT03189589|Healthy|healthy
5128776|NCT03189589|ELLIPTA|ellipta
5128777|NCT03189589|Safety|safety
5128778|NCT03189589|GSK2269557|gsk2269557
5128779|NCT03189589|Inhalation|inhalation
5128780|NCT03189589|Tolerability|tolerability
5128781|NCT03189537|Profilaxis|profilaxis
5128782|NCT03189537|Ingavirin|ingavirin
5128783|NCT03189511|Brown Adipose Tissue|brown adipose tissue
5128784|NCT03189511|Brown Fat|brown fat
5128785|NCT03189511|Fluvastatin|fluvastatin
5128786|NCT03189511|Prospective Clinical Trial|prospective clinical trial
5128787|NCT03189446|Endometrial Cancer|endometrial cancer
5962031|NCT04283461|Immunogenicity|immunogenicity
5128788|NCT03189446|Gynecologic Cancer|gynecologic cancer
5128789|NCT03189420|glioma|glioma
5128790|NCT03189420|glioblastoma|glioblastoma
5128791|NCT03189420|low grade tumor|low grade tumor
5128792|NCT03189407|Moringa Oleifera tea|moringa oleifera tea
5128793|NCT03189407|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5128794|NCT03189407|Metformin Steady state concentrations|metformin steady state concentrations
5128795|NCT03189407|Herb-drug interaction|herb-drug interaction
5128796|NCT03189394|HIV|hiv
5128797|NCT03189394|gay couples|gay couples
5128798|NCT03189394|relationships|relationships
5128799|NCT03189394|dyads|dyads
5128800|NCT03189381|Whole Brain Radiation|whole brain radiation
5128801|NCT03189381|Simultaneous Integrated Boost|simultaneous integrated boost
5128802|NCT03189368|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5128803|NCT03189368|Multi-site Pacing|multi-site pacing
5128804|NCT03189368|Ventriculoarterial Coupling|ventriculoarterial coupling
5128805|NCT03189368|Energy Efficiency|energy efficiency
5128806|NCT03189342|Balance|balance
5128807|NCT03189342|Dual-task interference|dual-task interference
5128808|NCT03189342|Falls|falls
5128809|NCT03189342|Gait|gait
5128810|NCT03189342|Older Adults|older adults
5128811|NCT03189329|NIR spectroscopy, cognitive function, eye, nerve block|nir spectroscopy, cognitive function, eye, nerve block
5128812|NCT03189316|Peritoneal fluid|peritoneal fluid
5128813|NCT03189316|B cells|b cells
5128814|NCT03189316|Regulatory B cells|regulatory b cells
5128816|NCT03189264|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
5128817|NCT03189264|Postoperative Complications|postoperative complications
5128818|NCT03189264|Renal Stone|renal stone
5128819|NCT03189264|Surgical Success|surgical success
5128820|NCT03189264|Surgical Complications|surgical complications
5128821|NCT03189264|Pneumatic Dilation|pneumatic dilation
5128822|NCT03189212|Telemedicine|telemedicine
5128823|NCT03189186|Kidney Cancer|kidney cancer
5128824|NCT03189186|Immunotherapy|immunotherapy
5128825|NCT03189186|Renal Cell Carcinoma|renal cell carcinoma
5128826|NCT03189186|Cryoablation|cryoablation
5128827|NCT03189186|Metastatic Renal Cancer|metastatic renal cancer
5128828|NCT03189173|Obstructive Sleep Apnea|obstructive sleep apnea
5128829|NCT03189173|Ventilatory Control Instability|ventilatory control instability
5128830|NCT03189173|Complex Sleep Apnea|complex sleep apnea
5128831|NCT03189121|Metabolism|metabolism
5128832|NCT03189121|Macronutrients|macronutrients
5128833|NCT03189121|Obesity|obesity
5128834|NCT03189121|Energy Expenditure|energy expenditure
5128835|NCT03189121|Glucose|glucose
5014546|NCT03905954|work|work
5128836|NCT03189108|Malignant Effusion Composition|malignant effusion composition
5128837|NCT03189108|Paracentesis|paracentesis
5128838|NCT03189108|Thoracentesis|thoracentesis
5128839|NCT03189095|exercise|exercise
5128840|NCT03189095|physical activity|physical activity
5128842|NCT03189095|spinal cord injury|spinal cord injury
5128843|NCT03189095|online|online
5128844|NCT03189056|chronic Chagas disease|chronic chagas disease
5128845|NCT03189056|bladder|bladder
5128846|NCT03189056|lower urinary tract|lower urinary tract
5128847|NCT03189056|urodynamic|urodynamic
5128848|NCT03189030|metastatic|metastatic
5128849|NCT03189030|microsatellite stable (MSS)|microsatellite stable (mss)
5128850|NCT03189004|mHealth, health services, technology, smartphones, Bangladesh|mhealth, health services, technology, smartphones, bangladesh
5128851|NCT03188991|pancreatic cystic neoplasm|pancreatic cystic neoplasm
5128852|NCT03188991|pancreatic cyst|pancreatic cyst
5128853|NCT03188991|pancreatic mucinous cyst|pancreatic mucinous cyst
5128854|NCT03188991|pancreatic neoplasms|pancreatic neoplasms
5128855|NCT03188991|digestive system neoplasms|digestive system neoplasms
5128856|NCT03188991|pancreatic diseases|pancreatic diseases
5128857|NCT03188991|mucinous cystic neoplasm|mucinous cystic neoplasm
5128858|NCT03188965|First in human|first in human
5128859|NCT03188965|Solid tumors|solid tumors
5128860|NCT03188965|Lymphomas|lymphomas
5128861|NCT03188965|Dose escalation|dose escalation
5128862|NCT03188965|Dose expansion|dose expansion
5128863|NCT03188913|Burns|burns
5128864|NCT03188913|Coagulation|coagulation
5128865|NCT03188913|Factor XIII|factor xiii
5128866|NCT03188913|Glycocalix|glycocalix
5128867|NCT03188913|Cicatrization|cicatrization
5128868|NCT03188900|Preeclampsia|preeclampsia
5128869|NCT03188900|apheresis|apheresis
5128870|NCT03188900|sflt-1|sflt-1
5128871|NCT03188887|NIgA|niga
5128872|NCT03188887|Kidney biopsy|kidney biopsy
5128874|NCT03188887|Corticotherapy|corticotherapy
5128875|NCT03188861|mental health conditions in ACSC patients|mental health conditions in acsc patients
5128876|NCT03188861|multimorbidity|multimorbidity
5128877|NCT03188861|health care utilization|health care utilization
5128878|NCT03188809|Postoperative Pain|postoperative pain
5128879|NCT03188809|Functional Outcomes|functional outcomes
5128880|NCT03188809|Total Knee Arthroplasty|total knee arthroplasty
5128881|NCT03188809|Adductor Canal Block|adductor canal block
5128882|NCT03188809|Femoral Nerve Block|femoral nerve block
5128883|NCT03188796|vitamin D|vitamin d
5128884|NCT03188796|critical care|critical care
5128885|NCT03188770|Middle-income countries|middle-income countries
5128886|NCT03188744|Cervical cancer|cervical cancer
5128887|NCT03188744|Pelvic floor muscles|pelvic floor muscles
5128888|NCT03188744|Physiotherapy|physiotherapy
5962032|NCT04283461|nCov2019|ncov2019
5128889|NCT03188744|Quality of life|quality of life
5128892|NCT03188731|Chikungunya|chikungunya
5128893|NCT03188731|Pregnant Women|pregnant women
5128894|NCT03188731|Pregnant Woman|pregnant woman
5128895|NCT03188731|ZIKV|zikv
5128896|NCT03188718|Polysomnogram|polysomnogram
5128897|NCT03188718|Sleep Disordered Breathing|sleep disordered breathing
5128898|NCT03188705|pharmacogenetics|pharmacogenetics
5128899|NCT03188705|carboxylesterase|carboxylesterase
5128900|NCT03188705|Personalized Medicine|personalized medicine
5128901|NCT03188692|Haemophilus influenza type b|haemophilus influenza type b
5128902|NCT03188692|Adsorbed Diphtheria-Purified Pertussis-Tetanus-Inactivate|adsorbed diphtheria-purified pertussis-tetanus-inactivate
5128903|NCT03188692|poliovirus combined vaccine|poliovirus combined vaccine
5128904|NCT03188692|Hib|hib
5128905|NCT03188692|DPT-IPV|dpt-ipv
5128906|NCT03188692|Intramuscular|intramuscular
5128907|NCT03188679|CMV|cmv
5128908|NCT03188679|neurological impairment|neurological impairment
5128909|NCT03188679|outcome prediction|outcome prediction
5128910|NCT03188679|amniotic fluid biomarkers|amniotic fluid biomarkers
5128911|NCT03188640|Bariatric surgery|bariatric surgery
5128912|NCT03188640|Sex hormones|sex hormones
5128913|NCT03188640|Women|women
5128914|NCT03188640|Quality of life|quality of life
5128915|NCT03188614|shock|shock
5128919|NCT03188601|Immune System Diseases|immune system diseases
5128920|NCT03188601|Protease Inhibitors|protease inhibitors
5128921|NCT03188601|Alpha 1-Antitrypsin|alpha 1-antitrypsin
5128922|NCT03188601|Enzyme Inhibitors|enzyme inhibitors
5128923|NCT03188601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5128924|NCT03188601|Trypsin Inhibitors|trypsin inhibitors
5128925|NCT03188601|Serine Proteinase Inhibitors|serine proteinase inhibitors
5128926|NCT03188484|Atrial Fibrillation|atrial fibrillation
5128927|NCT03188484|Electrocardiography|electrocardiography
5128928|NCT03188484|Biological Markers|biological markers
5128929|NCT03188484|Risk Assessment|risk assessment
5128930|NCT03188458|Infants|infants
5128931|NCT03188458|Cord blood sample|cord blood sample
5128932|NCT03188458|Acellular pertussis|acellular pertussis
5128933|NCT03188458|Boostrix|boostrix
5128934|NCT03188458|Colombia|colombia
5128935|NCT03188458|Pregnant women|pregnant women
5128938|NCT03188406|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
5128939|NCT03188406|Epidemiology|epidemiology
5128940|NCT03188406|Risk Stratification|risk stratification
5128941|NCT03188406|Helicobacter Pylori|helicobacter pylori
5128943|NCT03188380|abdominal ultrasound|abdominal ultrasound
5128944|NCT03188380|abdominal radiograph|abdominal radiograph
5128946|NCT03188367|dose-finding|dose-finding
5128947|NCT03188367|extraintestinal symptoms|extraintestinal symptoms
5128948|NCT03188367|gluten|gluten
5128949|NCT03188367|intestinal symptoms|intestinal symptoms
5128950|NCT03188367|placebo|placebo
5128953|NCT03188341|vascular surgery|vascular surgery
5128954|NCT03188341|repolarization disturbances|repolarization disturbances
5128955|NCT03188341|cardiac complications|cardiac complications
5128956|NCT03188341|high risk patient|high risk patient
5128957|NCT03188341|high risk procedure|high risk procedure
5128958|NCT03188302|Stool consistency|stool consistency
5128959|NCT03188302|Texture Analyser|texture analyser
5128960|NCT03188302|Bristol Stool Form Scale|bristol stool form scale
5128962|NCT03188289|clorhexidine|clorhexidine
5128963|NCT03188289|suture|suture
5128964|NCT03188289|bacteria|bacteria
5128965|NCT03188289|wisdom|wisdom
5128966|NCT03188276|Chronic Hepatitis C|chronic hepatitis c
5128967|NCT03188276|direct-acting antiviral agents|direct-acting antiviral agents
5128968|NCT03188276|Myeloid-Derived Suppressor Cells|myeloid-derived suppressor cells
5128969|NCT03188276|NK cells|nk cells
5128970|NCT03188263|diabetes|diabetes
5128971|NCT03188263|sleep|sleep
5128972|NCT03188263|circadian rhythm|circadian rhythm
5128973|NCT03188263|light treatment|light treatment
5128974|NCT03188224|Transition|transition
5128975|NCT03188224|Improved patient outcomes|improved patient outcomes
5128976|NCT03188224|RCT|rct
5128977|NCT03188224|Child health|child health
5128978|NCT03188224|Empower youth|empower youth
5128979|NCT03188185|Alkermes|alkermes
5128980|NCT03188185|Major Depressive Disorder|major depressive disorder
5128981|NCT03188185|Treatment Refractory MDD|treatment refractory mdd
5128982|NCT03188185|ALKS 5461|alks 5461
5128983|NCT03188133|Schizophrenia|schizophrenia
5128984|NCT03188133|Visual Hallucination|visual hallucination
5128985|NCT03188133|False Perception|false perception
5128986|NCT03188133|emotional priming|emotional priming
5128987|NCT03188107|Risky Infant|risky infant
5128988|NCT03188107|Cerebral Palsy|cerebral palsy
5128989|NCT03188107|Down Syndrome|down syndrome
5128990|NCT03188107|Spina Bifida|spina bifida
5128991|NCT03188107|Infant Motor Profile|infant motor profile
5128992|NCT03188068|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
5128993|NCT03188068|Kasabach Merritt Phenomenon|kasabach merritt phenomenon
5128994|NCT03188068|Sirolimus|sirolimus
5128995|NCT03188068|Prednisolone|prednisolone
5128996|NCT03188055|patient decision making|patient decision making
5041839|NCT03737734|SCC|scc
5128997|NCT03188055|surgical decision making|surgical decision making
5128998|NCT03188055|shared decision making|shared decision making
5128999|NCT03188055|decision support techniques|decision support techniques
5129000|NCT03188042|Transorbital Alternating Current Stimulation|transorbital alternating current stimulation
5129001|NCT03188042|Glaucoma|glaucoma
5129002|NCT03188029|ethomidate adrenocortical insufficiency|ethomidate adrenocortical insufficiency
5129003|NCT03188016|"music therapy"|"music therapy"
5129004|NCT03188016|"Intensive Interaction"|"intensive interaction"
5129005|NCT03188016|"non-verbal communication"|"non-verbal communication"
5129006|NCT03188016|"musical improvisation"|"musical improvisation"
5129007|NCT03188016|"feasibility study"|"feasibility study"
5129008|NCT03188016|"randomised controlled trial"|"randomised controlled trial"
5129009|NCT03188003|Exercise Movement Techniques|exercise movement techniques
5129010|NCT03188003|Low Back Pain|low back pain
5129011|NCT03188003|Exercise|exercise
5129012|NCT03187990|PSMA PET/MRI|psma pet/mri
5129020|NCT03187964|Xpert Ultra|xpert ultra
5129021|NCT03187964|Antiretroviral treatment (ART)|antiretroviral treatment (art)
5129022|NCT03187951|Other disorders of glucose regulation and pancreatic internal secretion|other disorders of glucose regulation and pancreatic internal secretion
5129023|NCT03187951|Pancreatic cancer|pancreatic cancer
5129024|NCT03187951|Questionnaires|questionnaires
5129025|NCT03187951|Surveys|surveys
5129026|NCT03187951|Nutritional Questionnaire|nutritional questionnaire
5129027|NCT03187951|Nutritional Counseling|nutritional counseling
5129028|NCT03187951|Booklet|booklet
5129029|NCT03187951|Pamphlet|pamphlet
5129030|NCT03187951|Educational materials|educational materials
5129031|NCT03187951|Aerobic Exercise|aerobic exercise
5129032|NCT03187951|Strength Training Exercises|strength training exercises
5129033|NCT03187951|Physical Assessments|physical assessments
5129034|NCT03187951|Walk Test|walk test
5129035|NCT03187938|Alkaline Phosphatase|alkaline phosphatase
5129036|NCT03187938|Pregnancy|pregnancy
5129037|NCT03187938|Suboptimal fetal growth|suboptimal fetal growth
5129038|NCT03187938|Placental insufficiency|placental insufficiency
5129039|NCT03187938|Low birth weight|low birth weight
5129040|NCT03187938|IUGR|iugr
5129041|NCT03187899|cervical plexus block|cervical plexus block
5129043|NCT03187899|interscalene brachial plexus block|interscalene brachial plexus block
5129044|NCT03187886|Cerebral amyloid angiopathy|cerebral amyloid angiopathy
5129045|NCT03187886|CAA-RI|caa-ri
5129046|NCT03187886|MRI|mri
5129047|NCT03187886|Intracerebral hemorrhage|intracerebral hemorrhage
5129048|NCT03187873|community participation|community participation
5129049|NCT03187873|Maternal and child health|maternal and child health
5125464|NCT03210480|Tremor|tremor
5129052|NCT03187860|mucus|mucus
5129053|NCT03187860|Air Liquid Interface|air liquid interface
5129054|NCT03187847|Physical Activity|physical activity
5129055|NCT03187847|Fatigue|fatigue
5129056|NCT03187847|Rehabilitation|rehabilitation
5129057|NCT03187834|infection|infection
5129058|NCT03187834|azithromycin|azithromycin
5129059|NCT03187834|amoxicillin|amoxicillin
5129060|NCT03187834|co-trimoxazole|co-trimoxazole
5129061|NCT03187834|trachoma|trachoma
5129062|NCT03187834|mass treatment|mass treatment
5129063|NCT03187808|Neck pain, Thoracic manipulation, special massage|neck pain, thoracic manipulation, special massage
5129064|NCT03187795|Spinal Cord Injuries|spinal cord injuries
5129065|NCT03187795|Randomized Controlled Trial|randomized controlled trial
5129066|NCT03187795|Neurogenic Bladder|neurogenic bladder
5129067|NCT03187795|Rehabilitation|rehabilitation
5129068|NCT03187769|Alkermes|alkermes
5129069|NCT03187769|ALKS 3831|alks 3831
5129070|NCT03187769|Olanzapine|olanzapine
5129071|NCT03187769|Samidorphan|samidorphan
5129072|NCT03187769|Schizophrenia|schizophrenia
5129073|NCT03187769|Schizophreniform|schizophreniform
5129074|NCT03187769|Bipolar I|bipolar i
5129075|NCT03187756|Hematopoietic Malignancies|hematopoietic malignancies
5129076|NCT03187756|Nonmyeloablative Peripheral Blood Stem Cell Transplant|nonmyeloablative peripheral blood stem cell transplant
5129077|NCT03187756|Posttransplantation|posttransplantation
5129078|NCT03187743|Lupus erythematosus|lupus erythematosus
5129079|NCT03187743|Systemic|systemic
5129080|NCT03187743|Corticosteroid|corticosteroid
5129081|NCT03187743|Prednisone|prednisone
5129082|NCT03187743|Pharmacokinetics|pharmacokinetics
5129083|NCT03187730|Smoking Cassation|smoking cassation
5129084|NCT03187730|Immigrants|immigrants
5129085|NCT03187730|Economic Disparity|economic disparity
5129086|NCT03187717|Postoperative pain|postoperative pain
5129087|NCT03187717|Recovery period|recovery period
5129088|NCT03187717|Total intravenous anesthesia|total intravenous anesthesia
5129089|NCT03187717|Inhalation anesthesia|inhalation anesthesia
5129090|NCT03187704|air filtration, HEPA, In-home,|air filtration, hepa, in-home,
5129091|NCT03187678|switch|switch
5129092|NCT03187678|intravenous|intravenous
5129093|NCT03187678|selexipag|selexipag
5129094|NCT03187665|Pediatric|pediatric
5129095|NCT03187665|Pulse Oximeter|pulse oximeter
5129096|NCT03187665|Wireless|wireless
5129097|NCT03187665|Motion|motion
5129098|NCT03187665|False Alarm|false alarm
5962033|NCT04283461|novel coronavirus|novel coronavirus
5129106|NCT03187626|Base-of-thumb osteoarthritis|base-of-thumb osteoarthritis
5129107|NCT03187626|Botulinum toxin A|botulinum toxin a
5129108|NCT03187626|Intra-articular therapy|intra-articular therapy
5129109|NCT03187626|Randomized trial|randomized trial
5129110|NCT03187613|Retinal shift|retinal shift
5129111|NCT03187613|Aniseikonia|aniseikonia
5129112|NCT03187613|Metamorphopsia|metamorphopsia
5129113|NCT03187613|Autofluorescence|autofluorescence
5129114|NCT03187587|Hyperthermia, Induced|hyperthermia, induced
5129115|NCT03187587|Laser Coagulation|laser coagulation
5129116|NCT03187587|Laser Therapy|laser therapy
5129117|NCT03187574|vaginal prolapse, mesh kit, anatomic assessment, quality of life|vaginal prolapse, mesh kit, anatomic assessment, quality of life
5129118|NCT03187561|Sleep|sleep
5129119|NCT03187561|Parenting|parenting
5129120|NCT03187561|Marital relationship|marital relationship
5129121|NCT03187561|Parent-child relations|parent-child relations
5129123|NCT03187548|CPP-ACP|cpp-acp
5129124|NCT03187535|Transcutaneous Electrical Acupoint Stimulation|transcutaneous electrical acupoint stimulation
5129126|NCT03187522|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5129127|NCT03187509|Torsemide, loop diuretics, weight-based|torsemide, loop diuretics, weight-based
5129128|NCT03187496|drug-drug interaction|drug-drug interaction
5129129|NCT03187444|Cardiovascular risk|cardiovascular risk
5129130|NCT03187444|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
5129131|NCT03187444|Rheumatoid arthritis|rheumatoid arthritis
5129132|NCT03187444|Spondyloarthritis|spondyloarthritis
5129133|NCT03187444|Inflammation|inflammation
5129134|NCT03187431|Stem cell|stem cell
5129135|NCT03187431|Therapy|therapy
5129136|NCT03187431|IPF|ipf
5129137|NCT03187418|Cyclophotocoagulation|cyclophotocoagulation
5129138|NCT03187418|Micropulse TSCPC|micropulse tscpc
5129139|NCT03187418|Laser ablation|laser ablation
5129140|NCT03187418|Laser therapy|laser therapy
5129141|NCT03187405|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5129142|NCT03187405|Intracranial Aneurysm|intracranial aneurysm
5129143|NCT03187405|Cerebral Ischemia|cerebral ischemia
5129144|NCT03187405|Ventriculostomy|ventriculostomy
5129145|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator
5129146|NCT03187353|Cognitive complaints|cognitive complaints
5129147|NCT03187353|RRSO|rrso
5129148|NCT03187353|Oophorectomy|oophorectomy
5129149|NCT03187353|Memory|memory
5129150|NCT03187353|Cognition|cognition
5129151|NCT03187353|Early menopause|early menopause
5129152|NCT03187327|prophylactic salpingectomy|prophylactic salpingectomy
5129153|NCT03187327|vaginal hysterectomy|vaginal hysterectomy
5138839|NCT03123055|TCC|tcc
5129154|NCT03187327|p53 expression|p53 expression
5129158|NCT03187314|Anti-PD-1 Antibody|anti-pd-1 antibody
5129159|NCT03187301|Parkinson's Disease|parkinson's disease
5129160|NCT03187301|Off episodes|off episodes
5129161|NCT03187275|Cancer Related Fatigue (CRF)|cancer related fatigue (crf)
5129162|NCT03187275|Prostate Cancer|prostate cancer
5129163|NCT03187275|Swedish Massage Therapy (SMT)|swedish massage therapy (smt)
5129164|NCT03187275|Cancer|cancer
5129165|NCT03187275|Quality of Life (QOL)|quality of life (qol)
5129166|NCT03187262|Waldenström Macroglobulinemia|waldenström macroglobulinemia
5129167|NCT03187223|Multiple Myeloma|multiple myeloma
5129168|NCT03187223|Bendamustine|bendamustine
5129169|NCT03187223|Melphalan|melphalan
5129170|NCT03187223|ASCT|asct
5129171|NCT03187210|CD30+ Lymphoma|cd30+ lymphoma
5129172|NCT03187210|ASCT|asct
5129173|NCT03187210|Brentuximab Vedotin|brentuximab vedotin
5129174|NCT03187171|Anterior Cervical Spine Fusion|anterior cervical spine fusion
5129175|NCT03187132|virtual reality|virtual reality
5129176|NCT03187132|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5129177|NCT03187132|analgesia|analgesia
5129178|NCT03187119|Pediatric|pediatric
5129179|NCT03187119|Education|education
5129180|NCT03187119|Technology-supported intervention|technology-supported intervention
5129181|NCT03187119|Asthma Action Plan|asthma action plan
5129182|NCT03187119|Health literacy|health literacy
5129183|NCT03187093|MDD|mdd
5129184|NCT03187093|Vortioxetine|vortioxetine
5129185|NCT03187093|Cognitive dysfunction|cognitive dysfunction
5129186|NCT03187093|IGF-1|igf-1
5129187|NCT03187093|BDNF|bdnf
5129188|NCT03187093|Functioning|functioning
5129189|NCT03187067|pneumonia|pneumonia
5129190|NCT03187067|diagnostic|diagnostic
5129191|NCT03187067|ultrasound|ultrasound
5129192|NCT03187067|Pakistan|pakistan
5129193|NCT03187067|Mozambique|mozambique
5129194|NCT03187041|blood draw tourniquets|blood draw tourniquets
5129195|NCT03187041|skin surface pressure|skin surface pressure
5129196|NCT03187041|blood draw band|blood draw band
5129197|NCT03187041|elastic tourniquet|elastic tourniquet
5129198|NCT03187041|phlebotomy|phlebotomy
5129199|NCT03187041|tourniquet pressure|tourniquet pressure
5129200|NCT03187028|Cancer of Pancreas|cancer of pancreas
5129201|NCT03187028|Neoplasms, Pancreatic|neoplasms, pancreatic
5129202|NCT03187028|Pancreas Cancer|pancreas cancer
5129203|NCT03187028|Pancreas Neoplasms|pancreas neoplasms
5129204|NCT03187028|Cancer of the Pancreas|cancer of the pancreas
5129205|NCT03187028|Pancreatic Cancer|pancreatic cancer
5129206|NCT03187015|Healthy Volunteers|healthy volunteers
5129207|NCT03187015|Entinostat|entinostat
5129208|NCT03187015|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5129228|NCT03186846|hemodynamic monitoring|hemodynamic monitoring
5129229|NCT03186846|LIDCO|lidco
5129230|NCT03186846|INVOS|invos
5129231|NCT03186846|BIS|bis
5129232|NCT03186846|brain injury biomarkers|brain injury biomarkers
5129233|NCT03186820|Endometriosis|endometriosis
5129234|NCT03186820|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5129235|NCT03186820|Susceptibility-weighted imaging (SWI)|susceptibility-weighted imaging (swi)
5129236|NCT03186807|normogram|normogram
5129237|NCT03186807|brain lumination|brain lumination
5129238|NCT03186807|fetal cortex|fetal cortex
5129239|NCT03186807|ultrasound|ultrasound
5129240|NCT03186794|Rehabilitation|rehabilitation
5129241|NCT03186794|Fatigue|fatigue
5129242|NCT03186781|Flu Virus|flu virus
5129243|NCT03186781|Flu Shot|flu shot
5129244|NCT03186781|H2N2|h2n2
5129245|NCT03186781|Protein|protein
5129246|NCT03186781|Immune Response|immune response
5129247|NCT03186742|Eplerenone|eplerenone
5014994|NCT03903029|Low-dose|low-dose
5129248|NCT03186742|Concentric hypertrophy|concentric hypertrophy
5129249|NCT03186729|Intracerebral hemorrhage|intracerebral hemorrhage
5129250|NCT03186716|Colostrum|colostrum
5129251|NCT03186716|Enteral Nutrition|enteral nutrition
5129252|NCT03186716|Intestinal Permeability|intestinal permeability
5129253|NCT03186716|Intensive Care Unit|intensive care unit
5129260|NCT03186690|vital pulp therapy|vital pulp therapy
5129261|NCT03186690|Biodentine|biodentine
5129262|NCT03186690|Mineral Trioxide Aggregate|mineral trioxide aggregate
5129268|NCT03186651|Vaginal|vaginal
5129269|NCT03186651|Medical Device|medical device
5129270|NCT03186651|Female Stress Urinary Incontinence|female stress urinary incontinence
5129271|NCT03186625|acute coronary syndrome|acute coronary syndrome
5129272|NCT03186625|gut microbiota|gut microbiota
5129273|NCT03186625|Trimethylamine N-oxide|trimethylamine n-oxide
5129274|NCT03186625|percutaneous coronary intervention|percutaneous coronary intervention
5129275|NCT03186612|Video games; Virtual reality; Occupational therapy, Manual dexterity; Multiple sclerosis.|video games; virtual reality; occupational therapy, manual dexterity; multiple sclerosis.
5129276|NCT03186599|Medication Event Monitoring System|medication event monitoring system
5129277|NCT03186599|adherence|adherence
5129278|NCT03186586|Heavy Menstrual Bleeding|heavy menstrual bleeding
5129279|NCT03186586|Levonorgestrel relesing intrauterine system|levonorgestrel relesing intrauterine system
5129280|NCT03186560|Leg ulcers and use of geko device|leg ulcers and use of geko device
5129281|NCT03186508|obesity prevention|obesity prevention
5129282|NCT03186508|sleep|sleep
5129283|NCT03186508|behavioral intervention|behavioral intervention
5129284|NCT03186456|acute cerebral infarction|acute cerebral infarction
5129285|NCT03186456|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5129286|NCT03186443|herpetic neuralgia|herpetic neuralgia
5129287|NCT03186443|post-herpetic neuralgia|post-herpetic neuralgia
5129288|NCT03186443|pregabalin|pregabalin
5129289|NCT03186430|Vaccine|vaccine
5129290|NCT03186430|Vaccination|vaccination
5129291|NCT03186430|Behavioral Research|behavioral research
5129292|NCT03186430|Adolescent|adolescent
5129293|NCT03186430|Health Promotion|health promotion
5129294|NCT03186430|Public Health|public health
5129295|NCT03186417|Arthritis, Rheumatoid, Stem Cells, Mesenchymal, Autoimmune|arthritis, rheumatoid, stem cells, mesenchymal, autoimmune
5129296|NCT03186352|photodynamic therapy|photodynamic therapy
5129297|NCT03186352|photoactivated disinfection|photoactivated disinfection
5129298|NCT03186352|primary root caries lesion|primary root caries lesion
5129299|NCT03186352|cavity disinfection|cavity disinfection
5129300|NCT03186352|lasers|lasers
5129301|NCT03186352|root caries|root caries
5129303|NCT03186339|TAVI|tavi
5129304|NCT03186339|surgical aortic valve replacement|surgical aortic valve replacement
5129305|NCT03186339|Aortic stenosis|aortic stenosis
5129404|NCT03185728|Child Abuse|child abuse
5129312|NCT03186248|Achalasia cardia|achalasia cardia
5129313|NCT03186248|myotomy|myotomy
5129314|NCT03186248|Per oral endoscopic myotomy|per oral endoscopic myotomy
5757707|NCT00292370|Quetiapine|quetiapine
5129315|NCT03186248|laparoscopic fundoplication|laparoscopic fundoplication
5129321|NCT03186196|Folate|folate
5129322|NCT03186196|Polymorphism|polymorphism
5129323|NCT03186196|Overweight and Obesity|overweight and obesity
5129324|NCT03186196|Inflammatory markers|inflammatory markers
5129325|NCT03186183|HIV prevention|hiv prevention
5129326|NCT03186183|Sexual health|sexual health
5129327|NCT03186183|Motivational interviewing|motivational interviewing
5129328|NCT03186183|Information-Motivation-Behavioural skills model|information-motivation-behavioural skills model
5129329|NCT03186183|Health promotion|health promotion
5129330|NCT03186157|trephined syndrome|trephined syndrome
5129331|NCT03186157|sinking skin flap syndrome|sinking skin flap syndrome
5129332|NCT03186157|craniectomy|craniectomy
5129333|NCT03186157|decompressive craniectomy|decompressive craniectomy
5129334|NCT03186157|neurosurgical complications|neurosurgical complications
5129335|NCT03186118|pediatric|pediatric
5129336|NCT03186118|young adult|young adult
5129337|NCT03186118|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5129338|NCT03186118|CD 19|cd 19
5001076|NCT03988712|Anaemia|anaemia
5129339|NCT03186118|leukemia|leukemia
5129340|NCT03186118|chimeric antigen receptor|chimeric antigen receptor
5129341|NCT03186118|T cell|t cell
5129342|NCT03186105|Appendicitis Acute|appendicitis acute
5129343|NCT03186105|AMBULATORY|ambulatory
5129344|NCT03186092|Respiratory muscle strength|respiratory muscle strength
5129345|NCT03186092|Pulmonary hypertension|pulmonary hypertension
5129346|NCT03186092|Respiratory muscle training|respiratory muscle training
5129347|NCT03186027|chronic fatigue|chronic fatigue
5129348|NCT03186027|Sleep problems|sleep problems
5129349|NCT03186027|Autonomic dysfunction|autonomic dysfunction
5129350|NCT03186027|Health-Related Quality of Life|health-related quality of life
5129351|NCT03186027|Coenzyme Q10|coenzyme q10
5129352|NCT03186027|NADH|nadh
5129353|NCT03186014|Malignant dysphagia|malignant dysphagia
5129354|NCT03186014|Stent|stent
5129355|NCT03186014|Esophageal neoplasms|esophageal neoplasms
5129356|NCT03186014|Brachytherapy|brachytherapy
5129357|NCT03186001|frontalis|frontalis
5129358|NCT03186001|frontal line|frontal line
5129359|NCT03186001|glabellar line|glabellar line
5129360|NCT03186001|botulinum toxin|botulinum toxin
5129361|NCT03186001|abobotulinum|abobotulinum
5129362|NCT03185988|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5129363|NCT03185988|Biliary tract cancer|biliary tract cancer
5129364|NCT03185988|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5129365|NCT03185988|Targeted therapy|targeted therapy
5129366|NCT03185988|colorectal cancer|colorectal cancer
5129367|NCT03185975|HIV|hiv
5129368|NCT03185975|transgender|transgender
5129369|NCT03185975|trans|trans
5129370|NCT03185975|youth|youth
5129371|NCT03185975|home testing|home testing
5129372|NCT03185936|optic disc pit|optic disc pit
5129373|NCT03185936|retinal detachment|retinal detachment
5129374|NCT03185936|maculopathy|maculopathy
5129375|NCT03185923|Community-Acquired Infections|community-acquired infections
5129376|NCT03185923|Humans|humans
5356842|NCT01917760|Pharmacokinetics|pharmacokinetics
5129377|NCT03185923|Medicine, Chinese Traditional|medicine, chinese traditional
5129378|NCT03185871|Invasive breast carcinoma|invasive breast carcinoma
5129379|NCT03185871|breast carcinoma stage T1cN0 to N3N0|breast carcinoma stage t1cn0 to n3n0
5129380|NCT03185858|secondary prevention|secondary prevention
5129381|NCT03185858|primary healthcare|primary healthcare
5129382|NCT03185858|village doctors|village doctors
5129383|NCT03185858|rural China|rural china
5129384|NCT03185858|medication adherence|medication adherence
5129385|NCT03185858|physical activity|physical activity
5129386|NCT03185832|Hear failure|hear failure
5129394|NCT03185806|percutaneous catheter drainage|percutaneous catheter drainage
5129395|NCT03185793|SHR4640, Phase II, monotherapy, dose-finding|shr4640, phase ii, monotherapy, dose-finding
5129396|NCT03185780|complementary/integrative medicine|complementary/integrative medicine
5129397|NCT03185780|glioblastoma|glioblastoma
5129398|NCT03185780|quality of life|quality of life
5129399|NCT03185780|adherence|adherence
5129400|NCT03185754|lung cancer|lung cancer
5129401|NCT03185754|surgery|surgery
5129402|NCT03185754|lobectomy|lobectomy
5129403|NCT03185754|sublobar resection|sublobar resection
5129405|NCT03185728|Mandated Reporting|mandated reporting
5129406|NCT03185728|Online Learning|online learning
5129407|NCT03185728|Child Protection|child protection
5129408|NCT03185728|GAMIFICATION|gamification
5129409|NCT03185728|Early Childhood Education|early childhood education
5129410|NCT03185715|oocyte donation|oocyte donation
5129411|NCT03185715|recipient counselling|recipient counselling
5129412|NCT03185715|single embryo transfer (SET)|single embryo transfer (set)
5129413|NCT03185715|double embryo transfer (DET)|double embryo transfer (det)
5129414|NCT03185715|decision-making|decision-making
5129415|NCT03185689|Glycemic control|glycemic control
5129416|NCT03185689|Diabetes self-management education|diabetes self-management education
5129417|NCT03185650|Healthy Volunteers|healthy volunteers
5129418|NCT03185637|Outcomes|outcomes
5129419|NCT03185637|Mortality|mortality
5129420|NCT03185637|Complications|complications
5129421|NCT03185637|Neonatal surgery|neonatal surgery
5129422|NCT03185637|Paediatric surgery|paediatric surgery
5129423|NCT03185637|Childrens surgery|childrens surgery
5129424|NCT03185637|Sub-Saharan Africa|sub-saharan africa
5129425|NCT03185637|Research Collaboration|research collaboration
5129426|NCT03185637|Gastroschisis|gastroschisis
5129427|NCT03185637|Anorectal malformation|anorectal malformation
5129428|NCT03185637|Appendicitis|appendicitis
5129429|NCT03185637|Intussuception|intussuception
5129430|NCT03185637|Inguinal hernia|inguinal hernia
5129431|NCT03185585|Nutritional screenings|nutritional screenings
5129434|NCT03185520|Stroke|stroke
5129435|NCT03185520|Ischemic Stroke|ischemic stroke
5129436|NCT03185520|Cryptogenic Stroke|cryptogenic stroke
5129437|NCT03185520|Embolic stroke of undetermined source|embolic stroke of undetermined source
5129438|NCT03185520|ESUS|esus
5962034|NCT04283461|Safety|safety
5129439|NCT03185520|Cerebrovascular Disease|cerebrovascular disease
5129440|NCT03185481|Parkinson's Disease|parkinson's disease
5129441|NCT03185481|Motor Fluctuations|motor fluctuations
5962035|NCT04283461|Vaccine|vaccine
5129442|NCT03185481|D1 partial agonist|d1 partial agonist
5129443|NCT03185468|CAR T|car t
5129444|NCT03185468|Bladder|bladder
5129445|NCT03185455|Hypertension|hypertension
5129446|NCT03185455|Pregnancy|pregnancy
5129447|NCT03185455|Text|text
5129448|NCT03185442|fMRI|fmri
5129450|NCT03185416|Quality of Life|quality of life
5129451|NCT03185416|Caregiver|caregiver
5129452|NCT03185416|Quality Improvement|quality improvement
5129453|NCT03185403|hemodynamic effect|hemodynamic effect
5129454|NCT03185403|para vertebral block|para vertebral block
5129455|NCT03185390|periampullary lesions|periampullary lesions
5129456|NCT03185351|midazolam|midazolam
5129457|NCT03185351|brachial plexus block|brachial plexus block
5129458|NCT03185338|physical activity, promotion, school|physical activity, promotion, school
5129459|NCT03185299|Polyp detection rate|polyp detection rate
5129460|NCT03185299|Adenoma detection rate|adenoma detection rate
5129461|NCT03185299|Boston Bowel Preparation Scale|boston bowel preparation scale
5129462|NCT03185286|3D printing, metal implant, bone defect|3d printing, metal implant, bone defect
5129463|NCT03185260|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
5129464|NCT03185260|Cardiac Arrest|cardiac arrest
5129465|NCT03185260|Training|training
5129466|NCT03185247|Transdiagnostic|transdiagnostic
5129467|NCT03185247|POTS (Postural Orthostatic Tachycardia Syndrome)|pots (postural orthostatic tachycardia syndrome)
5129468|NCT03185247|Therapy|therapy
5129470|NCT03185221|Stents Coronary Artery Disease|stents coronary artery disease
5129471|NCT03185208|Lithium|lithium
5129472|NCT03185208|Mild Cognitive Impairment|mild cognitive impairment
5129474|NCT03185208|Dementia|dementia
5129475|NCT03185208|Alzheimer|alzheimer
5129476|NCT03185208|Alzheimer's Disease|alzheimer's disease
5129477|NCT03185208|Cognition|cognition
5129478|NCT03185208|Memory|memory
5129479|NCT03185208|Thinking|thinking
5129480|NCT03185208|Prevention|prevention
5129481|NCT03185208|amyloid|amyloid
5129482|NCT03185208|imaging|imaging
5129483|NCT03185208|MRI|mri
5129484|NCT03185208|PET|pet
5129485|NCT03185208|tau|tau
5129486|NCT03185208|plaques|plaques
5129487|NCT03185208|tangles|tangles
5129488|NCT03185182|Diagnosis|diagnosis
5129489|NCT03185182|Imaging|imaging
5129490|NCT03185169|breast cancer survivor|breast cancer survivor
5129495|NCT03185169|urinary tract infections|urinary tract infections
5129496|NCT03185169|urinary frequency|urinary frequency
5129497|NCT03185169|urinary urgency|urinary urgency
5129498|NCT03185169|genital burning|genital burning
5129499|NCT03185169|genital itching|genital itching
5129500|NCT03185169|genital dryness|genital dryness
5129501|NCT03185156|nausea and vomiting|nausea and vomiting
5129502|NCT03185156|hemabate|hemabate
5129503|NCT03185156|propofol|propofol
5129504|NCT03185130|Headache|headache
5129505|NCT03185130|Benign Headache|benign headache
5129506|NCT03185117|opioid consumption|opioid consumption
5129507|NCT03185117|postdischarge|postdischarge
5130103|NCT03181750|Latino|latino
5129508|NCT03185117|major orthopedic surgery|major orthopedic surgery
5129509|NCT03185104|removable partial denture|removable partial denture
5129510|NCT03185104|silver diamine fluoride|silver diamine fluoride
5129511|NCT03185078|physical therapy|physical therapy
5129512|NCT03185078|ESWT|eswt
5129513|NCT03185026|Psychiatry|psychiatry
5129514|NCT03185026|Suicide|suicide
5129515|NCT03185026|Psychoeducation|psychoeducation
5129516|NCT03185026|Randomized controlled trial|randomized controlled trial
5129517|NCT03185026|current suicidal behavior disorder|current suicidal behavior disorder
5129518|NCT03185026|DSM-5|dsm-5
5129519|NCT03185013|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5129520|NCT03185013|Human papillomavirus (HPV)|human papillomavirus (hpv)
5129521|NCT03185013|High grade squamous intraepithelial lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
5129522|NCT03185013|CIN 2|cin 2
5129523|NCT03185013|CIN 3|cin 3
5129524|NCT03185013|papillomavirus|papillomavirus
5129525|NCT03184987|fluticasone furoate|fluticasone furoate
5129526|NCT03184987|fixed dose combination|fixed dose combination
5129527|NCT03184987|Japanese subjects|japanese subjects
5129528|NCT03184987|vilanterol|vilanterol
5129529|NCT03184987|asthma|asthma
5129530|NCT03184987|umeclidinium bromide|umeclidinium bromide
5129531|NCT03184987|closed triple therapy|closed triple therapy
5129532|NCT03184935|Myelodysplastic Syndromes|myelodysplastic syndromes
5129533|NCT03184935|mesenchymal stem cells|mesenchymal stem cells
5129534|NCT03184922|femoral suspensory loops|femoral suspensory loops
5129535|NCT03184857|maxillary sinus|maxillary sinus
5129536|NCT03184857|augmentation|augmentation
5129537|NCT03184857|bovine bone|bovine bone
5129538|NCT03184857|Nano hydroxy appatite|nano hydroxy appatite
5129539|NCT03184844|Thalidomide TI|thalidomide ti
5129540|NCT03184831|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone|sinus lift, injectable platelet rich fibrin, sticky bone, bovine bone
5129542|NCT03184779|Ski|ski
5129543|NCT03184779|Snowboard|snowboard
5129544|NCT03184779|Snow Sport|snow sport
5129545|NCT03184779|Injury|injury
5129546|NCT03184779|Injury Prevention|injury prevention
5129547|NCT03184779|Safety|safety
5129548|NCT03184779|Safety Video|safety video
5129549|NCT03184779|Video Intervention|video intervention
5129550|NCT03184779|Youth|youth
5129551|NCT03184779|Children|children
5129552|NCT03184779|Adolescent|adolescent
5129553|NCT03184779|Education|education
5129554|NCT03184779|Knowledge|knowledge
5129555|NCT03184753|Autologous|autologous
5129556|NCT03184753|IgT|igt
5129557|NCT03184753|Ovarian Cancer|ovarian cancer
5129558|NCT03184753|CART|cart
5129559|NCT03184701|Telehealth|telehealth
5129560|NCT03184701|Quality of Life|quality of life
5129561|NCT03184688|platelet rich plasma|platelet rich plasma
5129562|NCT03184688|Perineural injection therapy|perineural injection therapy
5129563|NCT03184688|hydrodissection|hydrodissection
5129564|NCT03184662|High-intensity physical activity|high-intensity physical activity
5129565|NCT03184662|Diabetes|diabetes
5129566|NCT03184662|Renal function decline|renal function decline
5129567|NCT03184636|ACLF|aclf
5129568|NCT03184636|SOFA|sofa
5129569|NCT03184636|Zagazig university|zagazig university
5129570|NCT03184610|Keratoconus|keratoconus
5129571|NCT03184610|Optical Coherence Tomography|optical coherence tomography
5129572|NCT03184610|Corneal Epithelium Thickness Maps|corneal epithelium thickness maps
5129573|NCT03184597|HLA screening|hla screening
5129574|NCT03184597|SJS/TEN|sjs/ten
5129575|NCT03184597|MPE|mpe
5129576|NCT03184597|AEDs|aeds
5129577|NCT03184571|bemcentinib|bemcentinib
5129578|NCT03184571|NSCLC|nsclc
5129579|NCT03184571|pembrolizumab|pembrolizumab
5129580|NCT03184571|Keytruda|keytruda
5129581|NCT03184571|BGB324|bgb324
5129582|NCT03184558|bemcentinib|bemcentinib
5129583|NCT03184558|TNBC|tnbc
5129584|NCT03184558|pembrolizumab|pembrolizumab
5129585|NCT03184558|Keytruda|keytruda
5129586|NCT03184558|BGB324|bgb324
5129587|NCT03184545|anterior knee pain|anterior knee pain
5129588|NCT03184480|Drug Use Investigation|drug use investigation
5129589|NCT03184480|GW685698|gw685698
5129601|NCT03184389|Mobile Health|mobile health
5129602|NCT03184389|Heart Rate Variability Monitoring|heart rate variability monitoring
5129603|NCT03184389|Mindfulness-Based Exercises|mindfulness-based exercises
5129608|NCT03184389|Sensor-Triggered Stress Intervention|sensor-triggered stress intervention
5129609|NCT03184389|Smartphone Apps|smartphone apps
5129610|NCT03184389|Smoking Cessation|smoking cessation
5129611|NCT03184389|Wearable Sensors|wearable sensors
5129612|NCT03184389|Eating Behavior|eating behavior
5129613|NCT03184389|Stress-Related Eating|stress-related eating
5129614|NCT03184376|Gut microbiota|gut microbiota
5129615|NCT03184376|Prebiotic|prebiotic
5129616|NCT03184376|Liver biopsy|liver biopsy
5129617|NCT03184376|Oligofructose|oligofructose
5129618|NCT03184350|cervical cancer|cervical cancer
5129619|NCT03184350|endometrial cancer|endometrial cancer
5129620|NCT03184350|proton therapy|proton therapy
5129621|NCT03184337|Weight loss|weight loss
5129623|NCT03184337|Sleep|sleep
5129624|NCT03184337|Intervention|intervention
5129625|NCT03184337|Diet|diet
5129626|NCT03184337|Physical activity|physical activity
5129627|NCT03184337|Fitbit|fitbit
5129628|NCT03184311|Therapy response prediction|therapy response prediction
5129629|NCT03184311|Exercise tolerance|exercise tolerance
5129630|NCT03184311|High-intensity interval training|high-intensity interval training
5129631|NCT03184298|Military Personnel|military personnel
5129632|NCT03184298|Sexual Assault|sexual assault
5129633|NCT03184298|Military Sexual Trauma|military sexual trauma
5129634|NCT03184298|Alcohol and Substance Abuse|alcohol and substance abuse
5129635|NCT03184285|limitation in conventional monitoring|limitation in conventional monitoring
5129636|NCT03184272|limitation in conventional monitoring|limitation in conventional monitoring
5129637|NCT03184259|Stroke|stroke
5129638|NCT03184259|Exoskeleton Robot|exoskeleton robot
5129639|NCT03184259|Rehabilitation|rehabilitation
5129640|NCT03184259|Ankle Foot Orthosis|ankle foot orthosis
5129641|NCT03184259|Knee Brace|knee brace
5129642|NCT03184259|Foot Drop|foot drop
5129643|NCT03184246|Videolaryngoscopy (GlideScope)|videolaryngoscopy (glidescope)
5129644|NCT03184246|Direct laryngoscopy|direct laryngoscopy
5129645|NCT03184220|Neck Pain|neck pain
5129646|NCT03184220|Physical Therapy Modalities|physical therapy modalities
5129647|NCT03184220|Fascia|fascia
5129648|NCT03184220|Manual Therapy|manual therapy
5129649|NCT03184220|Massage|massage
5129650|NCT03184194|daratumumab|daratumumab
5129651|NCT03184194|nivolumab|nivolumab
5129652|NCT03184194|cyclophosphamide|cyclophosphamide
5129653|NCT03184181|tendinopathy|tendinopathy
5129654|NCT03184181|electrolysis|electrolysis
5129655|NCT03184181|exercise|exercise
5129656|NCT03184181|dry needling|dry needling
5129657|NCT03184168|healthy volunteers, lorlatinib, PF-06463922, ADME, NSCLC, radiolabel, metabolism|healthy volunteers, lorlatinib, pf-06463922, adme, nsclc, radiolabel, metabolism
5129658|NCT03184155|Nicardipine|nicardipine
5129659|NCT03184155|Percutaneous Coronary Intervention|percutaneous coronary intervention
5129660|NCT03184155|Coronary Artery Disease|coronary artery disease
5129661|NCT03184142|Intimidation|intimidation
5129662|NCT03184142|Simulation|simulation
5129663|NCT03184142|Medical education|medical education
5962036|NCT04283370|low back pain|low back pain
5042610|NCT03732872|EMT|emt
5129664|NCT03184142|Surgical education|surgical education
5129665|NCT03184077|Postpartum dyspareunia|postpartum dyspareunia
5129666|NCT03184077|Obestric laceration|obestric laceration
5129667|NCT03184064|Blackcurrant|blackcurrant
5129668|NCT03184064|Citrus|citrus
5129669|NCT03184064|Polyphenols|polyphenols
5129670|NCT03184064|Glucose|glucose
5129671|NCT03184064|Postprandial|postprandial
5129672|NCT03184064|Metabolism|metabolism
5129673|NCT03184051|Knee|knee
5129674|NCT03184051|Osteoarthritis|osteoarthritis
5139340|NCT03119805|composite scores|composite scores
5129675|NCT03184051|Ultrasonography evaluation/ultrasound|ultrasonography evaluation/ultrasound
5129676|NCT03184051|Articular cartilage|articular cartilage
5129677|NCT03184051|UltraSound Speed Of Sound (US-SOS)|ultrasound speed of sound (us-sos)
5129678|NCT03184051|UltraSound Time of Flight (US-TOF)|ultrasound time of flight (us-tof)
5129680|NCT03184012|full coverage|full coverage
5129681|NCT03184012|strip crown|strip crown
5129682|NCT03184012|Zirconia crown|zirconia crown
5129683|NCT03184012|primary anterior teeth|primary anterior teeth
5129684|NCT03184012|crown|crown
5129685|NCT03183960|Self-management|self-management
5129686|NCT03183960|Quality of Life|quality of life
5129687|NCT03183960|Self-efficacy|self-efficacy
5129688|NCT03183960|Support|support
5129689|NCT03183960|Stroke|stroke
5129690|NCT03183960|Older adults|older adults
5129692|NCT03183947|neurofeedback|neurofeedback
5129693|NCT03183947|emotion regulation|emotion regulation
5129694|NCT03183947|schizophrenia|schizophrenia
5129695|NCT03183947|cognitive reappraisal|cognitive reappraisal
5129696|NCT03183947|depression|depression
5129697|NCT03183934|Epidermolysis Bullosa|epidermolysis bullosa
5129705|NCT03183869|microbiota|microbiota
5129706|NCT03183869|gut|gut
5129707|NCT03183843|Atrial Fibrillation|atrial fibrillation
5130504|NCT03179007|CTLA-4|ctla-4
5129713|NCT03183843|Cox-Maze Procedure|cox-maze procedure
5129714|NCT03183830|Cardiovascular Disease|cardiovascular disease
5129715|NCT03183830|Inorganic nitrate|inorganic nitrate
5129716|NCT03183830|Nitric Oxide|nitric oxide
5129717|NCT03183830|Inflammation|inflammation
5129719|NCT03183778|Chronic kidney disease, stages 3B-4|chronic kidney disease, stages 3b-4
5129720|NCT03183752|thyroid|thyroid
5129721|NCT03183752|insulin|insulin
5129722|NCT03183752|thyroid nodule|thyroid nodule
5129723|NCT03183752|insulin resistance|insulin resistance
5129724|NCT03183752|thyroid volume|thyroid volume
5129725|NCT03183752|metformin|metformin
5129726|NCT03183739|ASP8062|asp8062
5129727|NCT03183739|Pharmacokinetics|pharmacokinetics
5129728|NCT03183739|Safety|safety
5129729|NCT03183700|Screening HPV|screening hpv
5129730|NCT03183700|Self sampling|self sampling
5129731|NCT03183700|DNA Methylation|dna methylation
5129732|NCT03183687|neurosurgery|neurosurgery
5129733|NCT03183687|resident wellness|resident wellness
5129734|NCT03183687|health|health
5129735|NCT03183687|mental health|mental health
5129736|NCT03183687|physical activity|physical activity
5129737|NCT03183687|physician health|physician health
5129738|NCT03183622|Deep Second-Degree Burn Wound|deep second-degree burn wound
5129739|NCT03183596|Deep Serratus Block|deep serratus block
5129740|NCT03183596|Reconstructive Breast Surgery|reconstructive breast surgery
5129741|NCT03183596|Superficial Serratus block|superficial serratus block
5129742|NCT03183583|Tissue Adhesive|tissue adhesive
5129743|NCT03183492|Israel|israel
5129744|NCT03183492|Universal Mass Vaccination|universal mass vaccination
5129745|NCT03183492|Havrix®|havrix®
5129746|NCT03183492|Hepatitis A|hepatitis a
5129747|NCT03183492|Healthy adults|healthy adults
5129748|NCT03183492|Long term persistence|long term persistence
5129749|NCT03183492|Toddlers|toddlers
5129754|NCT03183453|Confabulations|confabulations
5129755|NCT03183453|Neuropsychological rehabilitation|neuropsychological rehabilitation
5129756|NCT03183453|Memory|memory
5129757|NCT03183440|Atopic dermatitis|atopic dermatitis
5129758|NCT03183440|Prevention|prevention
5129759|NCT03183440|Prebiotics|prebiotics
5129760|NCT03183440|Pregnancy|pregnancy
5129761|NCT03183414|cardiac surgery|cardiac surgery
5129762|NCT03183414|transoesophageal echocardiography|transoesophageal echocardiography
5129763|NCT03183401|childhood cancer survivor|childhood cancer survivor
5129764|NCT03183388|psychotherapy|psychotherapy
5129765|NCT03183362|Barbed sutures,Cesarean Section, adhesions|barbed sutures,cesarean section, adhesions
5129766|NCT03183323|hfpef|hfpef
5129767|NCT03183323|hfref|hfref
5129768|NCT03183323|cardiorenal syndrome|cardiorenal syndrome
5129769|NCT03183323|exercise|exercise
5129770|NCT03183323|telerehabilitation|telerehabilitation
5129771|NCT03183323|rehabilitation|rehabilitation
5129772|NCT03183284|dexamethazone|dexamethazone
5129773|NCT03183284|prednislone|prednislone
5129774|NCT03183284|severe ITP|severe itp
5129775|NCT03183232|Immunotherapy, γδ T Cell, Lung Cancer|immunotherapy, γδ t cell, lung cancer
5129776|NCT03183219|Immunotherapy, γδ T Cell, Liver Cancer|immunotherapy, γδ t cell, liver cancer
5129777|NCT03183206|Immunotherapy, γδ T Cell, Breast Cancer|immunotherapy, γδ t cell, breast cancer
5962037|NCT04283370|electroanalgesia|electroanalgesia
5129778|NCT03183193|NAFLD|nafld
5129779|NCT03183193|NASH|nash
5129780|NCT03183193|Obesity|obesity
5129781|NCT03183193|AASLD|aasld
5129782|NCT03183193|AHA|aha
5129783|NCT03183193|Energy-restricted diet|energy-restricted diet
5129784|NCT03183193|Lifestyle intervention|lifestyle intervention
5129785|NCT03183193|Mediterranean diet|mediterranean diet
5129786|NCT03183193|Weight loss|weight loss
5129787|NCT03183193|Liver damage|liver damage
5129788|NCT03183193|Inflammation|inflammation
5129789|NCT03183193|Oxidative stress|oxidative stress
5129790|NCT03183193|Microbiota composition|microbiota composition
5129791|NCT03183193|Eating behaviour|eating behaviour
5129792|NCT03183193|Satiety|satiety
5129793|NCT03183193|Physical activity|physical activity
5129794|NCT03183193|Sedentary behaviours|sedentary behaviours
5129795|NCT03183193|Sleep quality|sleep quality
5129796|NCT03183193|Sleep duration|sleep duration
5129797|NCT03183193|Psychological factors|psychological factors
5129798|NCT03183193|Nutrigenomics|nutrigenomics
5129799|NCT03183193|Nutrigenetics|nutrigenetics
5126176|NCT03205761|BRCA|brca
5129802|NCT03183193|Metabolomics|metabolomics
5129803|NCT03183193|miRNAs|mirnas
5129804|NCT03183193|Lipidomics|lipidomics
5129805|NCT03183115|Early esophageal squamous cell neoplasm|early esophageal squamous cell neoplasm
5129806|NCT03183115|Radiofrequency ablation|radiofrequency ablation
5130505|NCT03179007|PD-1|pd-1
5129807|NCT03183115|Endoscopic submucosal dissection|endoscopic submucosal dissection
5129808|NCT03183115|Esophageal cancer|esophageal cancer
5129809|NCT03183115|Recurrence|recurrence
5129810|NCT03183115|Field cancerization|field cancerization
5129811|NCT03183076|epilepsy|epilepsy
5129812|NCT03183076|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5129813|NCT03183076|Drug Resistance|drug resistance
5129814|NCT03183037|Acupuncture|acupuncture
5129815|NCT03183037|17-298|17-298
5129816|NCT03183011|cardiac resynchronization therapy|cardiac resynchronization therapy
5129817|NCT03183011|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5129818|NCT03183011|heart failure|heart failure
5129819|NCT03183011|magnetic resonance imaging|magnetic resonance imaging
5129820|NCT03182972|intervention study|intervention study
5129821|NCT03182972|medication reconciliation|medication reconciliation
5129822|NCT03182972|pharmacists|pharmacists
5129823|NCT03182972|Nigeria|nigeria
5129824|NCT03182972|Diabetes|diabetes
5129825|NCT03182972|Hypertension|hypertension
5129826|NCT03182959|Nrf2 pathway|nrf2 pathway
5129827|NCT03182959|Oral mucosa|oral mucosa
5129828|NCT03182959|HNSCC|hnscc
5129829|NCT03182959|Head and Neck Cancer|head and neck cancer
5129830|NCT03182959|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5129831|NCT03182959|Avmacol|avmacol
5129832|NCT03182959|Tobacco-related Head and Neck Cancer|tobacco-related head and neck cancer
5129833|NCT03182959|broccoli sprout powder|broccoli sprout powder
5129834|NCT03182959|broccoli seed extract powder|broccoli seed extract powder
5129835|NCT03182933|10 meter walk test|10 meter walk test
5129836|NCT03182933|Opioid consumption|opioid consumption
5129837|NCT03182894|chemo-refractory|chemo-refractory
5129838|NCT03182894|pembrolizumab|pembrolizumab
5129839|NCT03182894|epacadostat|epacadostat
5129840|NCT03182894|azacitidine|azacitidine
5129841|NCT03182894|recommended phase 2 dose (RP2D)|recommended phase 2 dose (rp2d)
5129842|NCT03182894|microsatellite-stable (MSS) Metastatic Colorectal Cancer|microsatellite-stable (mss) metastatic colorectal cancer
5129843|NCT03182881|Myofascial-reléase|myofascial-reléase
5129844|NCT03182881|Fibromyalgia|fibromyalgia
5129845|NCT03182881|Lymphatic drainage|lymphatic drainage
5129846|NCT03182881|Breast cancer|breast cancer
5129847|NCT03182855|Acute Coronary Syndrome|acute coronary syndrome
5129848|NCT03182855|STEMI|stemi
5129849|NCT03182855|Platelet reactivity|platelet reactivity
5129850|NCT03182855|Anti-thrombotic therapy|anti-thrombotic therapy
5129851|NCT03182829|direct oral anticoagulants|direct oral anticoagulants
5129852|NCT03182829|apixaban|apixaban
5129853|NCT03182829|dabigatran|dabigatran
5129854|NCT03182829|edoxaban|edoxaban
5129855|NCT03182829|rivaroxaban|rivaroxaban
5129856|NCT03182829|urine|urine
5129857|NCT03182829|LC-MS/MS|lc-ms/ms
5129858|NCT03182829|evaluation study|evaluation study
5129859|NCT03182829|point of care test|point of care test
5129860|NCT03182829|blood coagulation|blood coagulation
5129861|NCT03182829|coagulation test|coagulation test
5129862|NCT03182829|anticoagulant|anticoagulant
5129863|NCT03182829|thrombosis|thrombosis
5129864|NCT03182829|pulmonary embolism|pulmonary embolism
5129865|NCT03182829|atrial fibrillation|atrial fibrillation
5129866|NCT03182829|anticoagulation|anticoagulation
5129867|NCT03182829|mass spectrometry|mass spectrometry
5129868|NCT03182829|POC test|poc test
5129869|NCT03182816|epidermal growth factor receptor|epidermal growth factor receptor
5129870|NCT03182816|CTLA-4|ctla-4
5129871|NCT03182816|PD-1|pd-1
5129872|NCT03182816|chimeric antigen receptor T cells|chimeric antigen receptor t cells
5129873|NCT03182816|solid tumor|solid tumor
5129874|NCT03182803|mesothelin|mesothelin
5129875|NCT03182803|CTLA-4|ctla-4
5129876|NCT03182803|PD-1|pd-1
5129877|NCT03182803|chimeric antigen receptor T cells|chimeric antigen receptor t cells
5129878|NCT03182803|solid tumor|solid tumor
5129879|NCT03182790|Smoking Cessation|smoking cessation
5129880|NCT03182790|Quit to Win|quit to win
5129881|NCT03182790|Brief intervention|brief intervention
5129882|NCT03182790|Semi-personalized Instant messaging|semi-personalized instant messaging
5129886|NCT03182790|Regular messages|regular messages
5129887|NCT03182777|arrhythmias, cardiac|arrhythmias, cardiac
5129888|NCT03182777|channelopathies|channelopathies
5129889|NCT03182777|death, sudden|death, sudden
5129890|NCT03182777|genetic testing|genetic testing
5129891|NCT03182777|electrocardiography, ambulatory|electrocardiography, ambulatory
5129892|NCT03182777|anesthesia, local|anesthesia, local
5129893|NCT03182777|dentistry|dentistry
5129894|NCT03182738|HIV/AIDS Health Management App|hiv/aids health management app
5129895|NCT03182738|HIV/AIDS symptoms|hiv/aids symptoms
5129896|NCT03182725|POTS|pots
5129897|NCT03182725|tachycardia|tachycardia
5129898|NCT03182725|ivabradine|ivabradine
5129899|NCT03182699|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5129900|NCT03182699|Hemodialysis|hemodialysis
5129901|NCT03182699|Left Ventricular Hypertrophy|left ventricular hypertrophy
5129903|NCT03182699|Etelcalcetide|etelcalcetide
5129904|NCT03182699|Alfacalcidol|alfacalcidol
5129905|NCT03182686|osteoarthritis|osteoarthritis
5129906|NCT03182686|osteoarthritis of the knee|osteoarthritis of the knee
5129909|NCT03182686|Kellgren Lawrence (KL)|kellgren lawrence (kl)
5129910|NCT03182673|advanced solid tumor|advanced solid tumor
5129911|NCT03182673|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
5129912|NCT03182673|Programmed Death 1(PD-1)|programmed death 1(pd-1)
5129913|NCT03182673|Safety|safety
5129914|NCT03182673|Pharmacokinetics|pharmacokinetics
5129915|NCT03182673|PARP inhibitor|parp inhibitor
5129916|NCT03182621|Physical Fitness|physical fitness
5129917|NCT03182621|Body Composition|body composition
5129918|NCT03182621|Executive Cognitive Function|executive cognitive function
5129919|NCT03182582|Laser Debridement|laser debridement
5129920|NCT03182582|Debridement|debridement
5129921|NCT03182556|Dance Therapy|dance therapy
5129922|NCT03182556|Exercise|exercise
5129923|NCT03182556|Myofeedback|myofeedback
5129924|NCT03182556|Fibromyalgia|fibromyalgia
5129925|NCT03182543|Exercise|exercise
5129926|NCT03182543|Oxidative stress|oxidative stress
5129927|NCT03182543|Antioxidant|antioxidant
5129928|NCT03182491|Platelet activating factor|platelet activating factor
5129929|NCT03182491|Basophil activation test|basophil activation test
5129930|NCT03182491|Anaphylatoxins|anaphylatoxins
5129931|NCT03182478|skin picking|skin picking
5129933|NCT03182478|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5129934|NCT03182478|CBT|cbt
5129935|NCT03182478|Group treatment|group treatment
5129936|NCT03182478|Rothbaum protocol|rothbaum protocol
5129937|NCT03182452|Alarms|alarms
5129938|NCT03182452|Alarm Fatigue|alarm fatigue
5129939|NCT03182452|Alarm Nuisance|alarm nuisance
5129940|NCT03182452|Alarm Reduction|alarm reduction
5129941|NCT03182452|Patient Monitoring|patient monitoring
5129942|NCT03182452|Intensive Care|intensive care
5129943|NCT03182439|WEARABLE HEART RATE MONITORS, ACCURACY|wearable heart rate monitors, accuracy
5129944|NCT03182413|modafinil|modafinil
5129945|NCT03182413|connexin|connexin
5129946|NCT03182413|sleep deprivation|sleep deprivation
5129947|NCT03182413|cognitive performance|cognitive performance
5129948|NCT03182387|Bronchoalveolar lavage|bronchoalveolar lavage
5129949|NCT03182387|amylase assay|amylase assay
5129950|NCT03182387|aspiration pneumonia|aspiration pneumonia
5129951|NCT03182374|Autologous Protein Solution (APS)|autologous protein solution (aps)
5129952|NCT03182374|Intra-articular Injection|intra-articular injection
5129953|NCT03182374|Osteoarthritis|osteoarthritis
5129954|NCT03182361|Auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, Holgers|auricular, nasal, orbital, extraoral prostheses, extraoral implants, peri-implant reactions, holgers
5129955|NCT03182348|Microvessels|microvessels
5129956|NCT03182348|Cardiovascular disease|cardiovascular disease
5129957|NCT03182348|OCT|oct
5129958|NCT03182322|Type 1 diabetes|type 1 diabetes
5129959|NCT03182322|T1D|t1d
5129960|NCT03182322|diabetes mellitus|diabetes mellitus
5129961|NCT03182322|intranasal insulin|intranasal insulin
5129962|NCT03182322|mucosal tolerance|mucosal tolerance
5129963|NCT03182322|autoantigen|autoantigen
5129964|NCT03182322|self tolerance|self tolerance
5129965|NCT03182322|prevention|prevention
5129966|NCT03182322|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
5129967|NCT03182322|juvenile diabetes|juvenile diabetes
5129968|NCT03182296|beta cell mass|beta cell mass
5129969|NCT03182296|exendin|exendin
5129970|NCT03182296|GLP-1 PET|glp-1 pet
5129971|NCT03182283|Person-centered care|person-centered care
5129972|NCT03182283|Psychosis care|psychosis care
5129973|NCT03182283|Integrated care|integrated care
5129974|NCT03182257|TRK|trk
5129975|NCT03182257|TRKA|trka
5129976|NCT03182257|TRKB|trkb
5129977|NCT03182257|TRKC|trkc
5129978|NCT03182257|NTRK1|ntrk1
5129979|NCT03182257|NTRK2|ntrk2
5129980|NCT03182257|NTRK3|ntrk3
5139646|NCT03117972|LDH|ldh
5129981|NCT03182257|NTRK fusion positive|ntrk fusion positive
5129982|NCT03182257|NTRK1 fusion|ntrk1 fusion
5129983|NCT03182257|NTRK2 fusion|ntrk2 fusion
5129984|NCT03182257|NTRK3 fusion|ntrk3 fusion
5129985|NCT03182257|NTRK1 gene rearrangement|ntrk1 gene rearrangement
5129986|NCT03182257|NTRK2 gene rearrangement|ntrk2 gene rearrangement
5129987|NCT03182257|NTRK3 gene fusion|ntrk3 gene fusion
5129988|NCT03182257|ETV6-NTRK3|etv6-ntrk3
5129989|NCT03182257|fusion|fusion
5129990|NCT03182257|tumors|tumors
5129991|NCT03182257|solid tumors|solid tumors
5129992|NCT03182257|CNS tumors|cns tumors
5129993|NCT03182257|central nervous system tumors|central nervous system tumors
5129994|NCT03182257|TRK fusion|trk fusion
5129995|NCT03182257|ETV6|etv6
5129996|NCT03182257|ETV6 fusion|etv6 fusion
5129997|NCT03182257|solid CNS tumor|solid cns tumor
5129998|NCT03182257|advanced CNS tumor|advanced cns tumor
5129999|NCT03182257|primary CNS tumor|primary cns tumor
5130000|NCT03182244|gilteritinib|gilteritinib
5130001|NCT03182244|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5130004|NCT03182231|GLP1|glp1
5130005|NCT03182231|beta cell mass|beta cell mass
5130006|NCT03182218|Periprocedural|periprocedural
5130016|NCT03182218|Perioperative medicine|perioperative medicine
5130017|NCT03182205|Breathing Exercises|breathing exercises
5130018|NCT03182205|Autonomic Nervous System|autonomic nervous system
5130019|NCT03182205|Hemodynamics|hemodynamics
5130020|NCT03182192|Betal cells|betal cells
5130021|NCT03182192|Roux- and Y gastic bypass|roux- and y gastic bypass
5130022|NCT03182192|exendin|exendin
5130023|NCT03182192|GLP1|glp1
5130024|NCT03182166|golimumab|golimumab
5130025|NCT03182166|clinical response|clinical response
5130026|NCT03182166|mayo score|mayo score
5130027|NCT03182166|rectosigmoidoscopy|rectosigmoidoscopy
5130028|NCT03182166|ulcerative colitis|ulcerative colitis
5130034|NCT03182075|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5130035|NCT03182075|OCD|ocd
5130036|NCT03182075|Obsessive Personality Disorder|obsessive personality disorder
5196977|NCT02763046|NSAID|nsaid
5130037|NCT03182075|Compulsive Behavior|compulsive behavior
5130038|NCT03182075|Personality Disorders|personality disorders
5130039|NCT03182075|Mental Disorders|mental disorders
5130040|NCT03182075|Anxiety Disorders|anxiety disorders
5130041|NCT03182075|Impulsive Behavior|impulsive behavior
5130042|NCT03182075|Cognition|cognition
5130043|NCT03182075|Emotion|emotion
5130044|NCT03182075|Emotional Regulation|emotional regulation
5130045|NCT03182062|one lung ventilation|one lung ventilation
5130046|NCT03182062|postoperative pulmonary complication|postoperative pulmonary complication
5130047|NCT03182062|perioperative lung protective ventilation|perioperative lung protective ventilation
5130048|NCT03182049|GPA|gpa
5130049|NCT03182049|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5130050|NCT03182049|Wegener's granulomatosis|wegener's granulomatosis
5130051|NCT03182049|Subglottic Stenosis|subglottic stenosis
5130052|NCT03182049|Bronchial Stenosis|bronchial stenosis
5130053|NCT03182023|outcome,ECMO,Respiratory Failure,Circulatory Failure|outcome,ecmo,respiratory failure,circulatory failure
5130054|NCT03182010|Cesarean section scar, Barbed suture, Conventional suture|cesarean section scar, barbed suture, conventional suture
5130055|NCT03181997|Aortic Valve Stenosis|aortic valve stenosis
5130056|NCT03181997|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5130057|NCT03181997|Cancer|cancer
5130058|NCT03181997|Malignancy|malignancy
5130059|NCT03181971|water|water
5130060|NCT03181971|sugar-sweetened beverages|sugar-sweetened beverages
5130061|NCT03181971|schools|schools
5130062|NCT03181958|nasal high frequency oscillation ventilation(NHFOV)|nasal high frequency oscillation ventilation(nhfov)
5130063|NCT03181958|nasal continuous positive airway pressure(NCPAP)|nasal continuous positive airway pressure(ncpap)
5130064|NCT03181958|nasal intermittent positive pressure ventilation（NIPPV）|nasal intermittent positive pressure ventilation（nippv）
5130065|NCT03181958|neonatal respiratory distress syndrome(NRDS)|neonatal respiratory distress syndrome(nrds)
5130066|NCT03181958|preterm infants|preterm infants
5130067|NCT03181906|medication discrepancy|medication discrepancy
5130068|NCT03181906|primary care|primary care
5130069|NCT03181906|transition of care|transition of care
5130070|NCT03181880|ASTUTE|astute
5130071|NCT03181880|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5130072|NCT03181880|Randomised|randomised
5130073|NCT03181880|Pragmatic|pragmatic
5130074|NCT03181880|Standard of Care|standard of care
5445345|NCT01522235|Orthostatic hypotension|orthostatic hypotension
5130075|NCT03181880|Aclidinium bromide/formoterol fumarate fixed-dose combination|aclidinium bromide/formoterol fumarate fixed-dose combination
5130076|NCT03181880|Duaklir|duaklir
5130077|NCT03181880|Genuair|genuair
5130078|NCT03181867|PET/ CT|pet/ ct
5130079|NCT03181867|Endorectal MRI|endorectal mri
5130080|NCT03181867|Imaging|imaging
5130081|NCT03181867|PSMA|psma
5130082|NCT03181867|Prostate Cancer Relapse|prostate cancer relapse
5130083|NCT03181854|Integrated Early Palliative Care|integrated early palliative care
5130084|NCT03181828|CPSI deficiency|cpsi deficiency
5130085|NCT03181828|OTC Deficiency|otc deficiency
5130086|NCT03181828|AS Deficiency|as deficiency
5130087|NCT03181828|AL Deficiency|al deficiency
5130088|NCT03181815|CLADRIBINE|cladribine
5369141|NCT01861132|Pregnancy, cesarean delivery, blood pressure, cardiac output|pregnancy, cesarean delivery, blood pressure, cardiac output
5130105|NCT03181737|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study|diabetes mellitus typ 2, adherence, psychological online-intervention, randomized controlled study
5130106|NCT03181711|Dental caries|dental caries
5130107|NCT03181711|Tooth, deciduous|tooth, deciduous
5130108|NCT03181711|Children|children
5130109|NCT03181711|Radiography/bitewing|radiography/bitewing
5130110|NCT03181711|diagnostic imaging|diagnostic imaging
5130111|NCT03181685|Progesterone supplementation|progesterone supplementation
5130112|NCT03181685|IVF|ivf
5130113|NCT03181685|Preference expressed by the patient|preference expressed by the patient
5130114|NCT03181672|Stellate ganglion block Tourniquet reaction|stellate ganglion block tourniquet reaction
5130115|NCT03181659|Musculoskeletal Manipulations|musculoskeletal manipulations
5130116|NCT03181659|Exercise|exercise
5130117|NCT03181659|Patient Education|patient education
5130118|NCT03181659|Low back pain|low back pain
5130119|NCT03181633|PNH|pnh
5130120|NCT03181633|Paroxysmal|paroxysmal
5130130|NCT03181555|Obese|obese
5130131|NCT03181555|Omic|omic
5130132|NCT03181490|Pulmonary Nodule|pulmonary nodule
5130133|NCT03181490|Solitary|solitary
5130134|NCT03181477|Phase II|phase ii
5130135|NCT03181477|Radiotherapy with SIB-IMRT|radiotherapy with sib-imrt
5130136|NCT03181477|Tomozolomide|tomozolomide
5130137|NCT03181438|Renal Transplantation|renal transplantation
5130138|NCT03181438|Acute pain|acute pain
5130139|NCT03181438|Regional Anesthesia|regional anesthesia
5130140|NCT03181438|TAP Block|tap block
5130141|NCT03181425|Knee cartilage|knee cartilage
5130142|NCT03181425|Early Osteoarthritis|early osteoarthritis
5130143|NCT03181425|MRI tractography|mri tractography
5130144|NCT03181425|Diffusion Tensor Imaging|diffusion tensor imaging
5130145|NCT03181386|Dabigatran|dabigatran
5130146|NCT03181386|Rivaroxaban|rivaroxaban
5130147|NCT03181386|Apixaban|apixaban
5130148|NCT03181386|Warfarin|warfarin
5130149|NCT03181386|Tooth Extraction|tooth extraction
5130150|NCT03181373|Craniocerebral injury|craniocerebral injury
5130151|NCT03181373|Mild and severe brain traumatic injury|mild and severe brain traumatic injury
5130152|NCT03181373|Neuropsychological abilities|neuropsychological abilities
5130153|NCT03181373|Clinical assessment|clinical assessment
5130154|NCT03181373|Anatomical and functional imaging|anatomical and functional imaging
5130155|NCT03181360|ischemic stroke|ischemic stroke
5130156|NCT03181360|wake-up|wake-up
5130157|NCT03181360|thrombolysis|thrombolysis
5130158|NCT03181360|tenecteplase|tenecteplase
5130159|NCT03181360|computed tomography|computed tomography
5130160|NCT03181347|Bariatrics|bariatrics
5130161|NCT03181347|Microbiology|microbiology
5130162|NCT03181334|colorectal|colorectal
5130163|NCT03181334|cancer|cancer
5130164|NCT03181334|neoplasm|neoplasm
5130165|NCT03181334|CRC screening|crc screening
5130166|NCT03181334|FIT|fit
5130167|NCT03181334|Fecal Immunochemical Test|fecal immunochemical test
5130168|NCT03181321|nutrition|nutrition
5130169|NCT03181321|fitness|fitness
5130170|NCT03181321|cardiovascular disease|cardiovascular disease
5130171|NCT03181321|firefighters|firefighters
5130172|NCT03181321|obesity|obesity
5130173|NCT03181321|injury|injury
5130174|NCT03181295|Family Medicine|family medicine
5130175|NCT03181295|Primary Care|primary care
5130176|NCT03181295|Exercise prescriptions|exercise prescriptions
5130177|NCT03181295|Technology|technology
5130178|NCT03181282|Deep brain stimulation|deep brain stimulation
5130179|NCT03181282|Balance|balance
5130180|NCT03181282|Gait|gait
5130181|NCT03181282|Physical Therapy|physical therapy
5130182|NCT03181282|Parkinson disease|parkinson disease
5130189|NCT03181178|Complementary food supplement|complementary food supplement
5130190|NCT03181178|Protein quality and linear growth|protein quality and linear growth
5423212|NCT01616667|Hip Joint/surgery*|hip joint/surgery*
5139836|NCT03116776|dry eye|dry eye
5130191|NCT03181178|Intervention targeting complementary foods and growth|intervention targeting complementary foods and growth
5130193|NCT03181165|Low calorie|low calorie
5130194|NCT03181165|Energy restricted|energy restricted
5130195|NCT03181139|Enhanced Recovery after Surgery (ERAS)|enhanced recovery after surgery (eras)
5130196|NCT03181139|Fast-track surgery|fast-track surgery
5130197|NCT03181139|Pec Blocks|pec blocks
5130198|NCT03181139|Mastectomy|mastectomy
5445346|NCT01522235|Dysautonomia|dysautonomia
5015982|NCT03897348|lacosamide|lacosamide
5130199|NCT03181126|Relapsed of Refractory Acute Lymphoblastic Leukemia|relapsed of refractory acute lymphoblastic leukemia
5130200|NCT03181126|Cancer|cancer
5130201|NCT03181126|Venetoclax|venetoclax
5130202|NCT03181126|Navitoclax|navitoclax
5130203|NCT03181113|peginterferon alpha|peginterferon alpha
5130215|NCT03181009|Omalizumab|omalizumab
5130216|NCT03181009|OIT|oit
5130217|NCT03181009|Xolair|xolair
5130218|NCT03180996|FEVAR|fevar
5130219|NCT03180996|Fenestrated|fenestrated
5130220|NCT03180996|Endovascular|endovascular
5130221|NCT03180996|AAA|aaa
5130222|NCT03180996|Custom device|custom device
5130223|NCT03180957|Dupuytren|dupuytren
5130224|NCT03180957|adalimumab|adalimumab
5130225|NCT03180957|anti TNF|anti tnf
5130226|NCT03180957|phase II clinical trial|phase ii clinical trial
5130227|NCT03180957|randomized controlled trial|randomized controlled trial
5962038|NCT04283370|exercise program|exercise program
5130228|NCT03180957|double-blind method|double-blind method
5130229|NCT03180957|Dupuytren's|dupuytren's
5130230|NCT03180957|Dupuytren's contracture|dupuytren's contracture
5130231|NCT03180944|Lugol's solution|lugol's solution
5130232|NCT03180944|esophageal squamous cell cancer|esophageal squamous cell cancer
5130237|NCT03180840|Enzyme-Replacement Therapy|enzyme-replacement therapy
5130238|NCT03180840|pegunigalsidase alfa|pegunigalsidase alfa
5130239|NCT03180840|Fabry Disease|fabry disease
5130240|NCT03180801|broad|broad
5130241|NCT03180801|universal|universal
5130242|NCT03180801|vaccine|vaccine
5130243|NCT03180801|influenza|influenza
5130244|NCT03180801|peptide|peptide
5130245|NCT03180801|T cell|t cell
5130246|NCT03180801|H1N1|h1n1
5130247|NCT03180801|human challenge|human challenge
5130248|NCT03180788|ESD|esd
5130249|NCT03180788|Traction assisted ESD|traction assisted esd
5130250|NCT03180788|Polypectomy|polypectomy
5130251|NCT03180788|Clip and thread ESD|clip and thread esd
5130252|NCT03180775|Amino acids|amino acids
5130253|NCT03180775|Macrophage atherogenicity|macrophage atherogenicity
5130254|NCT03180775|Triglycerides|triglycerides
5130255|NCT03180775|Cholesterol|cholesterol
5130256|NCT03180775|Lipoproteins|lipoproteins
5130257|NCT03180697|Amide Proton Transfer|amide proton transfer
5130258|NCT03180697|bevacizumab|bevacizumab
5130259|NCT03180697|recurrent malignant gliomas|recurrent malignant gliomas
5130260|NCT03180697|efficacy|efficacy
5130261|NCT03180684|HPV-16|hpv-16
5130262|NCT03180684|HPV-18|hpv-18
5130263|NCT03180671|anterior deprogrammer|anterior deprogrammer
5130264|NCT03180671|muscle pain|muscle pain
5130265|NCT03180671|centric relation|centric relation
5130266|NCT03180606|Elderly|elderly
5130267|NCT03180606|Frail|frail
5130268|NCT03180606|Primary care|primary care
5130269|NCT03180580|Childhood, Overweight, Obesity|childhood, overweight, obesity
5130276|NCT03180463|Osteonecrosis of Femoral Head|osteonecrosis of femoral head
5130277|NCT03180463|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5130278|NCT03180450|Heart Failure|heart failure
5130279|NCT03180450|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5130280|NCT03180437|Immunotherapy|immunotherapy
5130281|NCT03180437|γδ T Cell|γδ t cell
5130282|NCT03180437|Pancreatic Cancer|pancreatic cancer
5130283|NCT03180424|carnitine|carnitine
5130284|NCT03180424|elderly|elderly
5130285|NCT03180424|functional status|functional status
5130286|NCT03180411|Colorectal Cancer|colorectal cancer
5130287|NCT03180411|CRC|crc
5130288|NCT03180411|Colorectal cancer surveillance|colorectal cancer surveillance
5130289|NCT03180411|Decision support tool|decision support tool
5130290|NCT03180411|Interviews|interviews
5130291|NCT03180411|Questionnaire|questionnaire
5130292|NCT03180411|Survey|survey
5130293|NCT03180385|NAVA|nava
5130294|NCT03180385|BiPAP|bipap
5130295|NCT03180385|Pediatrics|pediatrics
5130296|NCT03180385|Cardiac Surgery|cardiac surgery
5130297|NCT03180359|solid transplant|solid transplant
5130298|NCT03180359|grafted children|grafted children
5130299|NCT03180359|vaccine recommendation|vaccine recommendation
5130300|NCT03180359|immunization efficacy|immunization efficacy
5130301|NCT03180359|solid grafted children|solid grafted children
5130302|NCT03180359|solid transplant candidate children|solid transplant candidate children
5130303|NCT03180333|Chronic Hepatitis B|chronic hepatitis b
5130304|NCT03180320|chronic heart failure|chronic heart failure
5130305|NCT03180320|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
5130307|NCT03180203|INTELLiVENT-ASV|intellivent-asv
5130308|NCT03180203|Fully closed-loop ventilation|fully closed-loop ventilation
5130309|NCT03180203|Wean|wean
5130310|NCT03180177|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5130311|NCT03180177|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5130312|NCT03180177|Interval Debulking Surgery|interval debulking surgery
5130313|NCT03180177|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
5130314|NCT03180177|Postoperative Chemotherapy|postoperative chemotherapy
5130315|NCT03180151|corticotomy|corticotomy
5130316|NCT03180151|enmass retraction|enmass retraction
5130317|NCT03180151|mini implant|mini implant
5016110|NCT03896412|Digital PCR|digital pcr
5130318|NCT03180138|mobile phone|mobile phone
5130319|NCT03180138|Children's Health|children's health
5130320|NCT03180125|hydrodissection|hydrodissection
5130321|NCT03180125|sodium hyaluorinate|sodium hyaluorinate
5130322|NCT03180099|Lumbar Disk Hernia|lumbar disk hernia
5130323|NCT03180099|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
5130324|NCT03180099|Lumbar Disk Surgery|lumbar disk surgery
5130325|NCT03180086|Breast cancer risk|breast cancer risk
5130326|NCT03180086|Primary Care|primary care
5130327|NCT03180086|Women|women
5130328|NCT03180060|Likelihood Ratio|likelihood ratio
5130329|NCT03180060|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5130330|NCT03180060|CMR|cmr
5130331|NCT03180060|Myocardial Perfusion|myocardial perfusion
5130332|NCT03180060|Predictive Values|predictive values
5130333|NCT03180060|Computed Tomography Perfusion|computed tomography perfusion
5130334|NCT03180060|CTP|ctp
5130336|NCT03180060|PET|pet
5130337|NCT03180060|Diagnostic Accuracy|diagnostic accuracy
5002086|NCT03982875|ostomy|ostomy
5130338|NCT03180060|Quantitative Coronary Angiography|quantitative coronary angiography
5130339|NCT03180060|Area Under the Curve|area under the curve
5130340|NCT03180060|ROC Curve|roc curve
5130341|NCT03180034|Human Papillomavirus|human papillomavirus
5130342|NCT03180034|Cervical Cancer|cervical cancer
5130343|NCT03180034|Costa Rica|costa rica
5130344|NCT03180034|Fewer Doses|fewer doses
5130345|NCT03180034|HPV-Associated Cancers|hpv-associated cancers
5130346|NCT03179995|Octreotide, Major Liver Resection|octreotide, major liver resection
5130347|NCT03179943|bladder cancer|bladder cancer
5130348|NCT03179943|Ureteral Cancer|ureteral cancer
5130349|NCT03179943|Urothelial cancer|urothelial cancer
5197384|NCT02760758|NNI|nni
5130350|NCT03179943|Urethral cancer|urethral cancer
5130351|NCT03179930|Entinostat|entinostat
5130352|NCT03179930|Pembrolizumab|pembrolizumab
5130353|NCT03179930|17-073|17-073
5130354|NCT03179917|Pembrolizumab|pembrolizumab
5130355|NCT03179917|Radiation Therapy|radiation therapy
5130356|NCT03179917|17-054|17-054
5130357|NCT03179891|Interictal Period A|interictal period a
5130358|NCT03179891|Icta/peri-ictal Period B|icta/peri-ictal period b
5130359|NCT03179839|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5130360|NCT03179813|hydrocortisone|hydrocortisone
5130361|NCT03179813|third molar|third molar
5130362|NCT03179813|oral surgery|oral surgery
5130363|NCT03179813|postoperative pain|postoperative pain
5130364|NCT03179813|edema|edema
5130365|NCT03179800|Hypertension|hypertension
5130366|NCT03179800|Resistant Hypertension|resistant hypertension
5130367|NCT03179800|Baroreceptor|baroreceptor
5130368|NCT03179800|BAT|bat
5130369|NCT03179722|Aging|aging
5130370|NCT03179722|Drug-related problems|drug-related problems
5130371|NCT03179722|Medication review|medication review
5130372|NCT03179722|Community pharmacist|community pharmacist
5130373|NCT03179722|Medication use|medication use
5130374|NCT03179709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5130375|NCT03179709|Neuromuscular Blockade|neuromuscular blockade
5130376|NCT03179709|Interviews|interviews
5130377|NCT03179709|Implementation Science|implementation science
5130378|NCT03179696|Schizophrenia|schizophrenia
5130379|NCT03179696|CBSST|cbsst
5130380|NCT03179696|mobile CBT|mobile cbt
5130381|NCT03179696|negative symptoms|negative symptoms
5130382|NCT03179683|aluminum step-wedge|aluminum step-wedge
5130383|NCT03179683|demineralized bone matrix|demineralized bone matrix
5130384|NCT03179683|dental implant|dental implant
5130385|NCT03179683|digital densitometry|digital densitometry
5130386|NCT03179683|low level laser therapy|low level laser therapy
5130387|NCT03179683|maxillary sinus augmentation.|maxillary sinus augmentation.
5130388|NCT03179657|Prospective Cohort study|prospective cohort study
5130389|NCT03179657|Nutrition|nutrition
5130390|NCT03179657|Diet|diet
5130391|NCT03179657|Guangzhou|guangzhou
5130392|NCT03179657|Chinese|chinese
5130393|NCT03179631|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5130394|NCT03179631|Dystrophinopathy|dystrophinopathy
5130395|NCT03179631|Nonsense Mutation|nonsense mutation
5130396|NCT03179631|Premature Stop Codon|premature stop codon
5130397|NCT03179631|Becker Muscular Dystrophy|becker muscular dystrophy
5130398|NCT03179631|DMD/BMD|dmd/bmd
5130399|NCT03179631|PTC124|ptc124
5130400|NCT03179631|Ataluren|ataluren
5130401|NCT03179618|Unstable Angina|unstable angina
5130402|NCT03179618|Xuefu Zhuyu Decoction|xuefu zhuyu decoction
5130403|NCT03179592|Computed Tomography|computed tomography
5130404|NCT03179579|Gastric Cancer|gastric cancer
5130705|NCT03177512|PrEP|prep
5130405|NCT03179579|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5423369|NCT01615913|ketoconazole|ketoconazole
5130416|NCT03179514|Gualou Xiebai Banxia Decoction|gualou xiebai banxia decoction
5130417|NCT03179514|Danshen Decoction|danshen decoction
5130418|NCT03179475|Spinal Cord Injury|spinal cord injury
5130419|NCT03179475|Traumatic Spinal Cord Injury|traumatic spinal cord injury
5130421|NCT03179475|Opioids|opioids
5130422|NCT03179475|Naloxone|naloxone
5130423|NCT03179475|Opioid Induced Constipation|opioid induced constipation
5130424|NCT03179475|Oxycodone-Naloxone|oxycodone-naloxone
5130425|NCT03179436|Programmed Death-1 (PD-1, PD1),|programmed death-1 (pd-1, pd1),
5130426|NCT03179436|Programmed Death-Ligand 1 (PD-L1, PDL1)|programmed death-ligand 1 (pd-l1, pdl1)
5130427|NCT03179423|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5130428|NCT03179423|T1D|t1d
5130429|NCT03179423|Monoclonal antibody|monoclonal antibody
5130430|NCT03179423|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
5130431|NCT03179423|Human Endogenous Retrovirus Type W (HERV-W)|human endogenous retrovirus type w (herv-w)
5130432|NCT03179423|GNbAC1|gnbac1
5130433|NCT03179410|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
5130434|NCT03179410|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
5130435|NCT03179345|Volunteer|volunteer
5130436|NCT03179345|Pharmacodynamics|pharmacodynamics
5130437|NCT03179345|Pharmacokinetics|pharmacokinetics
5130444|NCT03179306|Cervix|cervix
5130445|NCT03179306|HPV|hpv
5130446|NCT03179306|Imaging|imaging
5962039|NCT04283370|e-health|e-health
5130451|NCT03179267|vital signs|vital signs
5130452|NCT03179267|monitoring|monitoring
5130453|NCT03179267|early warning score|early warning score
5130454|NCT03179202|Electrical Stimulation|electrical stimulation
5130455|NCT03179202|Neurostimulation|neurostimulation
5130456|NCT03179202|Neuromodulation|neuromodulation
5130457|NCT03179202|Back Pain|back pain
5130458|NCT03179202|Low Back Pain|low back pain
5130459|NCT03179163|Hypertension|hypertension
5130460|NCT03179163|Blood Pressure|blood pressure
5130461|NCT03179163|Cardiovascular Disease|cardiovascular disease
5130462|NCT03179163|ACE Inhibitor|ace inhibitor
5130463|NCT03179163|Diuretic|diuretic
5130464|NCT03179163|Nitric Oxide|nitric oxide
5130465|NCT03179163|Hydrogen Sulfide|hydrogen sulfide
5130466|NCT03179163|Captopril|captopril
5130467|NCT03179163|Enalapril|enalapril
5130468|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide
5130469|NCT03179163|Microcirculation|microcirculation
5130471|NCT03179150|computer-aided diagnosis|computer-aided diagnosis
5130472|NCT03179150|Web|web
5130473|NCT03179150|Cloud computing|cloud computing
5130474|NCT03179150|lung cancer|lung cancer
5130475|NCT03179124|cerebral palsy|cerebral palsy
5130476|NCT03179124|trunk control|trunk control
5130477|NCT03179124|upper extremity|upper extremity
5130478|NCT03179098|Elbow|elbow
5130479|NCT03179098|Stretching|stretching
5130480|NCT03179098|Joint amplitude|joint amplitude
5130481|NCT03179098|Electromyography|electromyography
5130482|NCT03179098|Surface heat|surface heat
5130483|NCT03179098|Orthosis|orthosis
5130484|NCT03179098|Posttraumatic|posttraumatic
5130485|NCT03179085|Diabetes|diabetes
5130486|NCT03179085|American Indians|american indians
5130487|NCT03179085|Disparity|disparity
5130488|NCT03179085|microalbuminuria|microalbuminuria
5130489|NCT03179085|Telemedicine|telemedicine
5130490|NCT03179085|Community health representative (CHR)|community health representative (chr)
5130491|NCT03179085|Patient Activation Measure (PAM)|patient activation measure (pam)
5130492|NCT03179085|Home base kidney care|home base kidney care
5130493|NCT03179059|Reproductive Health|reproductive health
5130494|NCT03179059|Family Planning|family planning
5130495|NCT03179059|Randomization Trial|randomization trial
5130496|NCT03179059|Uganda|uganda
5130497|NCT03179033|LVAD|lvad
5140137|NCT03114566|17-211|17-211
5130503|NCT03179007|MUC1|muc1
5130507|NCT03179007|solid tumor|solid tumor
5130508|NCT03178994|Post - adolescence acne|post - adolescence acne
5130509|NCT03178994|Topical 2% ketoconazole cream|topical 2% ketoconazole cream
5130510|NCT03178877|IBS, Rome IV criteria, anxiety|ibs, rome iv criteria, anxiety
5130511|NCT03178864|cerebral venous thrombosis|cerebral venous thrombosis
5130512|NCT03178864|anticoagulation|anticoagulation
5130518|NCT03178786|Art Therapy|art therapy
5130519|NCT03178773|mobile health|mobile health
5130520|NCT03178773|social support|social support
5130521|NCT03178773|health disparity|health disparity
5130522|NCT03178773|Latino|latino
5130523|NCT03178760|Optic nerve sheath diameter|optic nerve sheath diameter
5130524|NCT03178760|average optic nerve sheath diameter for healthy children|average optic nerve sheath diameter for healthy children
5130525|NCT03178747|Methylene blue|methylene blue
5130526|NCT03178747|Giemsa|giemsa
5130527|NCT03178747|Tzanck smear|tzanck smear
5130528|NCT03178695|Infertility|infertility
5130529|NCT03178695|Pregnancy|pregnancy
5130530|NCT03178695|Menopause|menopause
5130531|NCT03178695|Perimenopause|perimenopause
5016365|NCT03894670|Gastric emptying|gastric emptying
5130532|NCT03178695|Premature Ovarian Failure|premature ovarian failure
5130533|NCT03178669|Colitis, Ulcerative|colitis, ulcerative
5130534|NCT03178669|Gastrointestinal Diseases|gastrointestinal diseases
5130535|NCT03178669|Inflammatory Bowel Disease|inflammatory bowel disease
5130536|NCT03178669|Immunomodulator Therapy|immunomodulator therapy
5130537|NCT03178669|Glucocorticoids|glucocorticoids
5130538|NCT03178669|Anti-Inflammatory Agents|anti-inflammatory agents
5130539|NCT03178669|Therapeutic uses|therapeutic uses
5130540|NCT03178669|Kappaproct|kappaproct
5130541|NCT03178669|IDX0150|idx0150
5130542|NCT03178669|DIMS0150|dims0150
5130543|NCT03178656|sorafenib, operation|sorafenib, operation
5130544|NCT03178578|Fluid therapy|fluid therapy
5130545|NCT03178565|Respiratory Failure|respiratory failure
5130546|NCT03178565|Mechanical Ventilation|mechanical ventilation
5130547|NCT03178565|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
5130548|NCT03178565|Airway mucus clearance|airway mucus clearance
5130549|NCT03178539|tonsillectomy|tonsillectomy
5130550|NCT03178539|post operative analgesia|post operative analgesia
5130551|NCT03178539|diklofanic|diklofanic
5130552|NCT03178539|ketorolac|ketorolac
5130553|NCT03178500|clomiphene citrate|clomiphene citrate
5130554|NCT03178500|stair- step|stair- step
5130555|NCT03178500|poly cystic ovary|poly cystic ovary
5130556|NCT03178487|Upadacitinib|upadacitinib
5130584|NCT03178331|Children|children
5130585|NCT03178331|Student|student
5130586|NCT03178331|Questionnaires|questionnaires
5130587|NCT03178331|Screening|screening
5130588|NCT03178331|Health check|health check
5130589|NCT03178331|School health services|school health services
5130591|NCT03178201|Relapsed follicular lymphoma|relapsed follicular lymphoma
5130592|NCT03178201|Refractory follicular lymphoma|refractory follicular lymphoma
5130593|NCT03178188|lupus erythematosus, Discoid|lupus erythematosus, discoid
5130594|NCT03178188|Pulsed-dye Laser|pulsed-dye laser
5130595|NCT03178175|Scalp acupuncture|scalp acupuncture
5130596|NCT03178175|Parkinson's disease|parkinson's disease
5130597|NCT03178175|Balance|balance
5130598|NCT03178162|limitation in conventional monitoring|limitation in conventional monitoring
5130599|NCT03178149|Age-related Macular Degeneration|age-related macular degeneration
5130600|NCT03178149|ASP7317|asp7317
5130601|NCT03178136|HR-HPV opportunistic screening|hr-hpv opportunistic screening
5130602|NCT03178136|virus load|virus load
5130603|NCT03178136|multi-site|multi-site
5130615|NCT03178071|NSCLC|nsclc
5130616|NCT03178032|Diffuse intrinsic pontine gliomas|diffuse intrinsic pontine gliomas
5130617|NCT03178032|Oncolytic adenovirus|oncolytic adenovirus
5130618|NCT03177980|Term infants|term infants
5130619|NCT03177980|Analgesia|analgesia
5130620|NCT03177980|fentanyl|fentanyl
5130621|NCT03177980|clonidine|clonidine
5130622|NCT03177980|pharmacokinetics|pharmacokinetics
5130623|NCT03177980|sedation|sedation
5130624|NCT03177980|pharmacodynamics|pharmacodynamics
5130625|NCT03177980|neurophysiology|neurophysiology
5130626|NCT03177980|pharmacogenetics|pharmacogenetics
5130627|NCT03177980|asphyxia|asphyxia
5130628|NCT03177980|hypothermia|hypothermia
5130629|NCT03177967|Insomnia|insomnia
5130630|NCT03177967|Cognitive behavioral treatment for insomnia (CBT-I)|cognitive behavioral treatment for insomnia (cbt-i)
5130631|NCT03177941|Melanoma|melanoma
5130632|NCT03177941|Skin Self-Examination|skin self-examination
5130633|NCT03177941|First-degree Relative|first-degree relative
5130634|NCT03177941|Mobile Application|mobile application
5130635|NCT03177876|tenting Hydroxyapetite nano particles implant immediate|tenting hydroxyapetite nano particles implant immediate
5130636|NCT03177863|neoplasm|neoplasm
5130637|NCT03177863|uterine cervix|uterine cervix
5130638|NCT03177850|sleep related breathing disturbances|sleep related breathing disturbances
5130639|NCT03177850|respiratory polygraphy|respiratory polygraphy
5130640|NCT03177850|airway disease|airway disease
5130641|NCT03177850|emphysema|emphysema
5130645|NCT03177837|exercise performance|exercise performance
5130646|NCT03177837|maximal spiroergometry|maximal spiroergometry
5130647|NCT03177837|airway disease|airway disease
5130648|NCT03177837|emphysema|emphysema
5130649|NCT03177837|prevention|prevention
5130650|NCT03177837|acetazolamide|acetazolamide
5130651|NCT03177837|altitude|altitude
5130652|NCT03177811|postural control|postural control
5130653|NCT03177811|balance performance|balance performance
5130654|NCT03177811|airway disease|airway disease
5130655|NCT03177811|altitude|altitude
5130656|NCT03177811|prevention|prevention
5130657|NCT03177811|acetazolamide|acetazolamide
5130663|NCT03177733|breast surgery|breast surgery
5130664|NCT03177733|acute pain|acute pain
5130665|NCT03177733|regional anesthesia|regional anesthesia
5130666|NCT03177694|cough|cough
5130667|NCT03177694|exacerbation|exacerbation
5130668|NCT03177694|connected device|connected device
5130669|NCT03177681|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5016476|NCT03893695|HCC|hcc
5130670|NCT03177681|Gastrointestinal symptoms|gastrointestinal symptoms
5130671|NCT03177681|Probiotics|probiotics
5130672|NCT03177681|Yogurt|yogurt
5130673|NCT03177681|Stool sample|stool sample
5130674|NCT03177681|Questionnaires|questionnaires
5130675|NCT03177681|Surveys|surveys
5130676|NCT03177681|Holter monitor|holter monitor
5130677|NCT03177629|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5130678|NCT03177629|Helicobacter pylori|helicobacter pylori
5130687|NCT03177603|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5130688|NCT03177603|Dose-escalation|dose-escalation
5130689|NCT03177603|Safety|safety
5130690|NCT03177603|Tolerability|tolerability
5130691|NCT03177603|GSK2586881|gsk2586881
5130692|NCT03177590|autism|autism
5130693|NCT03177590|Pervasive Developmental Disorder|pervasive developmental disorder
5130694|NCT03177564|driving pressure|driving pressure
5130695|NCT03177564|one-lung ventilation|one-lung ventilation
5130696|NCT03177551|Prostatic Neoplasms|prostatic neoplasms
5130697|NCT03177551|Nomograms|nomograms
5130698|NCT03177551|Drug Resistance, Neoplasm|drug resistance, neoplasm
5130699|NCT03177538|suboptimal response|suboptimal response
5130700|NCT03177538|Corifollitropin alfa|corifollitropin alfa
5130702|NCT03177538|Ovarian stimulation|ovarian stimulation
5130703|NCT03177525|parent training|parent training
5130704|NCT03177525|social skills|social skills
5130706|NCT03177512|HIV Testing|hiv testing
5130707|NCT03177512|STI Testing|sti testing
5130708|NCT03177512|Mobile app|mobile app
5130709|NCT03177512|Technology|technology
5130710|NCT03177512|Young men who have sex with men|young men who have sex with men
5130711|NCT03177499|Portal pressure gradient|portal pressure gradient
5130712|NCT03177499|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5130713|NCT03177499|Virtual imaging-based portal pressure gradient|virtual imaging-based portal pressure gradient
5130714|NCT03177486|Syntax score|syntax score
5130716|NCT03177486|Coronary angiography|coronary angiography
5130717|NCT03177473|degenerative disc disease|degenerative disc disease
5130718|NCT03177473|CervicalStim devic|cervicalstim devic
5130719|NCT03177473|cervical|cervical
5130720|NCT03177473|cervical fusion|cervical fusion
5130721|NCT03177447|Cardiac Failure|cardiac failure
5130722|NCT03177447|Congestive Heart Failure|congestive heart failure
5130723|NCT03177447|Heart Decompensation|heart decompensation
5130730|NCT03177408|Hypertension|hypertension
5130731|NCT03177408|HMGB1|hmgb1
5130732|NCT03177382|Total Neoadjuvant Treatment|total neoadjuvant treatment
5130733|NCT03177382|Rectal Cancer|rectal cancer
5130734|NCT03177382|High Risk Factors|high risk factors
5130735|NCT03177382|Chemoradiotherapy|chemoradiotherapy
5130736|NCT03177369|Bone and joint infection|bone and joint infection
5130737|NCT03177369|Staphylococcus aureus|staphylococcus aureus
5130738|NCT03177369|Teicoplanin|teicoplanin
5130739|NCT03177369|Subcutaneous administration|subcutaneous administration
5130740|NCT03177356|Platelet rich fibrin,xenograft|platelet rich fibrin,xenograft
5130741|NCT03177343|Pristinamycin|pristinamycin
5130742|NCT03177343|Staphylococcus aureus|staphylococcus aureus
5130743|NCT03177343|Bone and joint infection|bone and joint infection
5130744|NCT03177304|Interpersonal Psychotherapy|interpersonal psychotherapy
5130745|NCT03177304|Internet|internet
5130746|NCT03177304|Training|training
5130747|NCT03177304|Depression|depression
5130748|NCT03177304|Dissemination|dissemination
5130749|NCT03177291|NSCLC|nsclc
5130750|NCT03177291|SCLC|sclc
5130751|NCT03177265|nicotine dependence|nicotine dependence
5130752|NCT03177265|tobacco cessation|tobacco cessation
5130753|NCT03177174|locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
5130754|NCT03177174|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5130755|NCT03177174|Toxic reaction|toxic reaction
5130756|NCT03177161|PROM|prom
5127098|NCT03199937|Coping|coping
5130757|NCT03177161|Patient Reported Outcome Measure|patient reported outcome measure
5130759|NCT03177161|PROMIS-10|promis-10
5130760|NCT03177161|PROMIS Global Health|promis global health
5130761|NCT03177161|RiksStroke|riksstroke
5130762|NCT03177161|ICHOM|ichom
5130763|NCT03177161|International Consortium for Health Outcomes Measurement|international consortium for health outcomes measurement
5130764|NCT03177161|Wales|wales
5130765|NCT03177161|Administration|administration
5130766|NCT03177161|Method|method
5130767|NCT03177161|Delivery|delivery
5130768|NCT03177122|Polycystic Ovary Syndrome|polycystic ovary syndrome
5130769|NCT03177122|Myo-Inositol|myo-inositol
5130770|NCT03177122|Assisted Reproductive Technology|assisted reproductive technology
5130771|NCT03177122|oocyte performance|oocyte performance
5130772|NCT03177122|pregnancy|pregnancy
5130773|NCT03177109|Dentine Hypersensitivity|dentine hypersensitivity
5130774|NCT03177109|Fluoride varnish|fluoride varnish
5130775|NCT03177109|Desensitizing agents|desensitizing agents
5130776|NCT03177096|Type 1 diabetes children,School,Childcare facilities,Sensor|type 1 diabetes children,school,childcare facilities,sensor
5130777|NCT03177070|Ureteric injury|ureteric injury
5130778|NCT03177070|Colorectal Surgery|colorectal surgery
5130779|NCT03177044|Inflammatory bowel disease, pelvic floor exercise|inflammatory bowel disease, pelvic floor exercise
5130780|NCT03176992|ablation|ablation
5130781|NCT03176992|surgicel|surgicel
5130782|NCT03176953|PTSD|ptsd
5130783|NCT03176953|alcohol use disorder|alcohol use disorder
5130784|NCT03176953|Veterans|veterans
5130785|NCT03176940|Escalating Dosage|escalating dosage
5130786|NCT03176927|magnetogastrogram|magnetogastrogram
5130787|NCT03176927|gastroparesis|gastroparesis
5130788|NCT03176927|electrogastrogram|electrogastrogram
5130789|NCT03176927|gastric slow wave|gastric slow wave
5130790|NCT03176914|Community mobilisation|community mobilisation
5130791|NCT03176901|urinary urge incontinence|urinary urge incontinence
5130792|NCT03176901|urinary incontinence|urinary incontinence
5130793|NCT03176901|older adult women|older adult women
5130794|NCT03176901|older adults|older adults
5130795|NCT03176901|mindfulness-based stress reduction|mindfulness-based stress reduction
5130796|NCT03176901|health enhancement program|health enhancement program
5130797|NCT03176901|feasibility|feasibility
5130798|NCT03176901|randomized controlled trial|randomized controlled trial
5130799|NCT03176901|complementary|complementary
5130800|NCT03176901|integrative|integrative
5130801|NCT03176901|therapies|therapies
5130802|NCT03176888|Exercise|exercise
5130803|NCT03176888|Aerobic capacity|aerobic capacity
5130804|NCT03176888|Rehabilitation|rehabilitation
5130805|NCT03176810|percutaneous coronary intervention|percutaneous coronary intervention
5130806|NCT03176810|optical coherence tomography|optical coherence tomography
5130807|NCT03176797|Liver Fibrosis, multiparametric magnetic resonance imaging|liver fibrosis, multiparametric magnetic resonance imaging
5130808|NCT03176784|Varenicline|varenicline
5130809|NCT03176784|Nicotine Patch|nicotine patch
5130810|NCT03176784|Quit Smoking|quit smoking
5130811|NCT03176784|Tobacco|tobacco
5130812|NCT03176784|Cigarettes|cigarettes
5369142|NCT01861106|Allogeneic Donors|allogeneic donors
5130817|NCT03176680|Anesthesia,Esophagectomy,Esophageal cancer,Treatment outcome|anesthesia,esophagectomy,esophageal cancer,treatment outcome
5130818|NCT03176667|regional, erector spinae block, lobectomy, video-assisted|regional, erector spinae block, lobectomy, video-assisted
5130820|NCT03176641|Meniscus|meniscus
5130821|NCT03176641|Knee Injuries|knee injuries
5130822|NCT03176628|Pharmacokinetics|pharmacokinetics
5130823|NCT03176628|Pharmacodynamics|pharmacodynamics
5130824|NCT03176615|Gastric Bypass|gastric bypass
5130825|NCT03176602|Subjective Global Assessment|subjective global assessment
5130826|NCT03176602|Nutrition Risk in Critically ill Score|nutrition risk in critically ill score
5130827|NCT03176602|Critical Illness|critical illness
5130828|NCT03176589|positive expiratory pressure|positive expiratory pressure
5130829|NCT03176589|oxygen saturation|oxygen saturation
5130830|NCT03176589|abdominal surgery|abdominal surgery
5130831|NCT03176589|carbon dioxide|carbon dioxide
5130832|NCT03176576|cancer among adolescents|cancer among adolescents
5130833|NCT03176576|cancer among young adults|cancer among young adults
5130834|NCT03176576|adolescents and young adults (AYA)|adolescents and young adults (aya)
5130835|NCT03176576|quality of life|quality of life
5130836|NCT03176576|reduce stress|reduce stress
5130837|NCT03176576|patient navigation|patient navigation
5130838|NCT03176576|questionnaire|questionnaire
5130839|NCT03176576|supportive care|supportive care
5130840|NCT03176576|distress levels|distress levels
5130841|NCT03176576|support resources|support resources
5130842|NCT03176576|satisfaction survey|satisfaction survey
5130843|NCT03176576|teen cancer|teen cancer
5130844|NCT03176563|herbal treatment|herbal treatment
5130845|NCT03176563|antibiotics|antibiotics
5130846|NCT03176563|uncomplicated urinary tract infection|uncomplicated urinary tract infection
5130847|NCT03176511|older adults|older adults
5130848|NCT03176511|dual task|dual task
5130849|NCT03176511|A Matter of Balance|a matter of balance
5130850|NCT03176498|cerebral Infarction|cerebral infarction
5130851|NCT03176498|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5130852|NCT03176485|metastatic|metastatic
5130861|NCT03176485|Renal Cell Carcinoma|renal cell carcinoma
5130862|NCT03176472|Diabetic Neuropathic Pain|diabetic neuropathic pain
5130863|NCT03176472|Neuropathic Pain|neuropathic pain
5130865|NCT03176472|ricolinostat|ricolinostat
5130866|NCT03176459|bupvacaine|bupvacaine
5130867|NCT03176459|exparel|exparel
5130868|NCT03176459|analgesic|analgesic
5130869|NCT03176459|TAP Block|tap block
5130870|NCT03176407|sensor capsule|sensor capsule
5130871|NCT03176394|Foley, UTI, Biofilm, DNA|foley, uti, biofilm, dna
5130872|NCT03176381|Prostatic Neoplasms|prostatic neoplasms
5130873|NCT03176381|Abiraterone Acetate|abiraterone acetate
5130874|NCT03176381|FK506 binding protein 5|fk506 binding protein 5
5130875|NCT03176381|Neurotensin|neurotensin
5130876|NCT03176381|yes-associated protein 1|yes-associated protein 1
5130877|NCT03176381|AKR1C3 protein|akr1c3 protein
5130878|NCT03176381|Proliferating Cell Nuclear Antigen|proliferating cell nuclear antigen
5130879|NCT03176368|dry mouth|dry mouth
5130880|NCT03176368|coconut oil|coconut oil
5130881|NCT03176368|radiation|radiation
5130882|NCT03176342|Drug patch tests|drug patch tests
5130883|NCT03176329|Full closed-loop ventilation control|full closed-loop ventilation control
5130884|NCT03176329|Critical care|critical care
5130885|NCT03176316|ileus|ileus
5130886|NCT03176316|fusion of spine|fusion of spine
5130887|NCT03176277|Leukemia|leukemia
5130888|NCT03176277|Leukemia, Myeloid|leukemia, myeloid
5130889|NCT03176277|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5130891|NCT03176277|MERTK|mertk
5130892|NCT03176277|TYRO3|tyro3
5130893|NCT03176277|AXL|axl
5130894|NCT03176277|AML|aml
5130895|NCT03176277|de novo AML|de novo aml
5130896|NCT03176277|Relapsed/ Refractory AML|relapsed/ refractory aml
5130897|NCT03176277|TAM|tam
5130898|NCT03176277|MDS|mds
5130899|NCT03176277|Myelodysplastic Syndrome|myelodysplastic syndrome
5130900|NCT03176277|Relapsed/ Refractory MDS|relapsed/ refractory mds
5130901|NCT03176264|PDR001|pdr001
5130902|NCT03176264|immunotherapy|immunotherapy
5130903|NCT03176264|bevacizumab|bevacizumab
5130904|NCT03176264|mFOLFOX6|mfolfox6
5130905|NCT03176264|CRC|crc
5130906|NCT03176264|MMS|mms
5130907|NCT03176264|CMS4|cms4
5140545|NCT03112304|children|children
5130915|NCT03176238|endocrine therapy|endocrine therapy
5130916|NCT03176212|Gut permeability|gut permeability
5130918|NCT03176212|Endotoxin|endotoxin
5130919|NCT03176199|control-released oxycodone|control-released oxycodone
5130920|NCT03176199|immediate-released oxycodone|immediate-released oxycodone
5130921|NCT03176199|cancer pain|cancer pain
5130922|NCT03176199|opioid-naive|opioid-naive
5130923|NCT03176186|ischemic-reperfusion injury|ischemic-reperfusion injury
5130924|NCT03176186|out of hospital cardiac arrest|out of hospital cardiac arrest
5130925|NCT03176160|LITT|litt
5130926|NCT03176160|Fecci|fecci
5130927|NCT03176160|Pro00079623|pro00079623
5130928|NCT03176160|Glioblastoma|glioblastoma
5130929|NCT03176160|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5130930|NCT03176160|Palliative|palliative
5130931|NCT03176147|Anemia|anemia
5130932|NCT03176147|Pregnancy|pregnancy
5130933|NCT03176147|Hepcidine|hepcidine
5130934|NCT03176147|Iron|iron
5130935|NCT03176121|Oxycodone|oxycodone
5130936|NCT03176121|Cancer Pain|cancer pain
5130937|NCT03176121|Long-term use|long-term use
5130938|NCT03176082|colorectal cancer screening|colorectal cancer screening
5130939|NCT03176082|colorectal cancer|colorectal cancer
5130940|NCT03176069|Vaginismus|vaginismus
5130941|NCT03176069|Muscle Tone|muscle tone
5130942|NCT03176069|Sexual dysfunctions|sexual dysfunctions
5130943|NCT03176056|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5130944|NCT03176056|Low carbohydrate diet|low carbohydrate diet
5130945|NCT03176017|Transurethral Incision Of The Prostate|transurethral incision of the prostate
5130946|NCT03176017|Prostate|prostate
5130947|NCT03176017|Holmium Laser|holmium laser
5130948|NCT03176017|Ejaculatory Sparing|ejaculatory sparing
5130949|NCT03175965|Heart arrest, hypothermia, SEP, prognosis|heart arrest, hypothermia, sep, prognosis
5130950|NCT03175939|adjuvant chemotherapy|adjuvant chemotherapy
5130951|NCT03175939|NPC|npc
5130952|NCT03175926|Asthma|asthma
5130953|NCT03175926|inhaler device|inhaler device
5130954|NCT03175926|handling|handling
5130955|NCT03175900|Migraine|migraine
5130956|NCT03175900|Naoan dripping pills|naoan dripping pills
5130957|NCT03175900|Traditional Chinese Medicine|traditional chinese medicine
5130958|NCT03175900|fMRI|fmri
5130959|NCT03175900|Randomized Controlled trial|randomized controlled trial
5130960|NCT03175887|depression|depression
5130961|NCT03175887|trd|trd
5130962|NCT03175887|treatment-resistant depression|treatment-resistant depression
5130964|NCT03175874|Osteoporosis|osteoporosis
5130965|NCT03175874|Alzheimer Disease|alzheimer disease
5130966|NCT03175848|Cervical Cancer|cervical cancer
5130967|NCT03175848|Radiotherapy|radiotherapy
5130968|NCT03175848|Chemotherapy|chemotherapy
5130969|NCT03175848|stage IVB cervical cancer|stage ivb cervical cancer
5130970|NCT03175835|Dyslipidemia|dyslipidemia
5130971|NCT03175835|CKD-519|ckd-519
5130972|NCT03175835|Rosuvastatin|rosuvastatin
5130973|NCT03175835|Drug-Drug Interaction|drug-drug interaction
5130974|NCT03175809|Chronic pelvic pain|chronic pelvic pain
5130975|NCT03175809|Pain|pain
5130976|NCT03175809|Dry needling|dry needling
5130977|NCT03175809|Biofeedback|biofeedback
5130978|NCT03175809|Pelvic pain|pelvic pain
5130979|NCT03175731|Gastroesophageal varices|gastroesophageal varices
5130980|NCT03175731|Hemorrhage|hemorrhage
5130981|NCT03175718|Sarcoma|sarcoma
5130982|NCT03175718|Wound|wound
5130983|NCT03175718|Therapy|therapy
5130984|NCT03175627|Dental caries|dental caries
5130985|NCT03175627|Proximal surfaces|proximal surfaces
5130986|NCT03175627|Posterior teeth|posterior teeth
5130987|NCT03175627|Carious lesions|carious lesions
5130988|NCT03175627|Tooth diseases|tooth diseases
5130989|NCT03175627|Dental restorations|dental restorations
5130990|NCT03175627|Composite resin|composite resin
5130991|NCT03175614|Physical activity|physical activity
5130992|NCT03175614|Food Habits|food habits
5130993|NCT03175614|Information and communiation Technology|information and communiation technology
5130994|NCT03175614|Health education|health education
5130995|NCT03175601|Sleep disturbances|sleep disturbances
5130996|NCT03175601|Biomarkers|biomarkers
5130997|NCT03175601|Prefrailty|prefrailty
5130998|NCT03175601|Insulin resistance|insulin resistance
5130999|NCT03175601|Olfactory impairment|olfactory impairment
5131000|NCT03175601|Multiplex array|multiplex array
5131002|NCT03175536|high-deductible health plan|high-deductible health plan
5131003|NCT03175536|medication adherence|medication adherence
5131004|NCT03175536|out-of-pocket costs|out-of-pocket costs
5131005|NCT03175536|preventive drug list|preventive drug list
5131006|NCT03175536|value-based insurance design|value-based insurance design
5131007|NCT03175523|BioResorbable Scaffold|bioresorbable scaffold
5131008|NCT03175523|Quantitative Coronary Angiography|quantitative coronary angiography
5131009|NCT03175523|Intravascular Imaging|intravascular imaging
5131010|NCT03175510|validity, reliability, low back pain|validity, reliability, low back pain
5131011|NCT03175497|Gastric Cancer, VEGFR inhibitor|gastric cancer, vegfr inhibitor
5131012|NCT03175484|High Fidelity Simulation|high fidelity simulation
5131013|NCT03175484|Cognitive Load|cognitive load
5131014|NCT03175484|Simulation Training/methods*|simulation training/methods*
5131015|NCT03175484|Task Performance and Analysis*|task performance and analysis*
5131016|NCT03175484|Students, Medical|students, medical
5131017|NCT03175484|Prospective Studies|prospective studies
5131018|NCT03175458|tenting|tenting
5131019|NCT03175458|grafting|grafting
5131020|NCT03175458|implant placement|implant placement
5131021|NCT03175419|laparoscopic liver resection|laparoscopic liver resection
5131022|NCT03175341|breast cancer|breast cancer
5131023|NCT03175341|ascorbic acid|ascorbic acid
5131024|NCT03175341|vitamin C|vitamin c
5131025|NCT03175341|vitamin supplementation|vitamin supplementation
5131026|NCT03175341|quality of life|quality of life
5131027|NCT03175315|psychoeducation|psychoeducation
5131028|NCT03175315|treatment and education programme|treatment and education programme
5131029|NCT03175315|self-management|self-management
5131030|NCT03175315|diabetes education|diabetes education
5131031|NCT03175315|flash glucose monitoring|flash glucose monitoring
5131032|NCT03175302|cognitive processes|cognitive processes
5131033|NCT03175302|perioperative cognition|perioperative cognition
5131034|NCT03175302|neurocognitive impairment|neurocognitive impairment
5131036|NCT03175276|Cognitive decline|cognitive decline
5131037|NCT03175276|IQCODE|iqcode
5131038|NCT03175263|onabotulinumtoxinA, chronic migraine, myofascial pain|onabotulinumtoxina, chronic migraine, myofascial pain
5131039|NCT03175224|Advanced Solid Tumor|advanced solid tumor
5131040|NCT03175224|Relapsed Solid Tumor|relapsed solid tumor
5131041|NCT03175224|Recurrent Solid Tumor|recurrent solid tumor
5131042|NCT03175159|Risk Reduction|risk reduction
5131043|NCT03175159|Crystal Methamphetamine|crystal methamphetamine
5131044|NCT03175159|Cocaine|cocaine
5131045|NCT03175159|Stimulant Abuse|stimulant abuse
5131046|NCT03175159|HIV|hiv
5131047|NCT03175159|Behavioral Activation|behavioral activation
5131048|NCT03175133|rehabilitation|rehabilitation
5131049|NCT03175133|physical therapy|physical therapy
5131050|NCT03175107|exergaming|exergaming
5131051|NCT03175107|physiotherapy|physiotherapy
5131052|NCT03175107|upper extremities|upper extremities
5131053|NCT03175107|telerehabilitation|telerehabilitation
5131054|NCT03175094|women|women
5131055|NCT03175094|HIV prevention|hiv prevention
5131056|NCT03175094|criminal justice|criminal justice
5131062|NCT03175068|Electroencephalography|electroencephalography
5131063|NCT03175068|Cognitive Behavioral Therapy|cognitive behavioral therapy
5131064|NCT03175068|Supportive Therapy|supportive therapy
5131065|NCT03175029|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5131066|NCT03174990|aspirin|aspirin
5131067|NCT03174990|clopidogrel|clopidogrel
5131068|NCT03174990|peripheral arterial disease|peripheral arterial disease
5131069|NCT03174990|genetics|genetics
5131070|NCT03174964|Recurrent Implantation Failure|recurrent implantation failure
5131071|NCT03174964|IVIg|ivig
5131072|NCT03174964|Pregnancy Rate|pregnancy rate
5131073|NCT03174951|Recurrent Pregnancy Loss|recurrent pregnancy loss
5131074|NCT03174951|IVIg|ivig
5131075|NCT03174951|Pregnancy Rate|pregnancy rate
5131076|NCT03174938|Early diagnosis, biomarker, PET, MRI, β-amyloid, tau, CSF, cognitive test|early diagnosis, biomarker, pet, mri, β-amyloid, tau, csf, cognitive test
5131077|NCT03174912|EORTC|eortc
5131078|NCT03174912|CUETO|cueto
5131079|NCT03174912|bladder neoplasm|bladder neoplasm
5131080|NCT03174912|disease progression|disease progression
5131081|NCT03174912|recurrence|recurrence
5131082|NCT03174886|tau|tau
5131083|NCT03174886|neurofibrillary|neurofibrillary
5131084|NCT03174886|degeneration|degeneration
5131085|NCT03174886|primary progressive aphasia|primary progressive aphasia
5131086|NCT03174886|agrammatic|agrammatic
5131087|NCT03174886|tauopathy|tauopathy
5131088|NCT03174886|immunotherapy|immunotherapy
5131089|NCT03174886|immunization|immunization
5131090|NCT03174860|Pulpitis, irreversible Pulpitis, Hot tooth|pulpitis, irreversible pulpitis, hot tooth
5356843|NCT01917760|Pharmacodynamics|pharmacodynamics
5356844|NCT01917760|Insulin|insulin
5131091|NCT03174860|Cataflam, Diclofenac Potassium, Preoperative, Premedication, Analgesic|cataflam, diclofenac potassium, preoperative, premedication, analgesic
5423370|NCT01615913|transdermal topical therapy|transdermal topical therapy
5131092|NCT03174860|Local anesthesia, Articaine, Buccal infiltration|local anesthesia, articaine, buccal infiltration
5131093|NCT03174847|Primary aldosteronism|primary aldosteronism
5131094|NCT03174847|Blood pressure|blood pressure
5131095|NCT03174847|Adrenalectomy|adrenalectomy
5131292|NCT03173365|Mirvaso|mirvaso
5131096|NCT03174847|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
5131097|NCT03174847|Cardiovascular|cardiovascular
5131098|NCT03174847|Endothelial|endothelial
5131099|NCT03174847|Renal|renal
5131100|NCT03174834|Bladder Stimulation Technique|bladder stimulation technique
5131101|NCT03174834|Clean Catch Urine|clean catch urine
5131102|NCT03174834|UTI in infants less than 6 months|uti in infants less than 6 months
5131103|NCT03174821|Diabetic nephropathy|diabetic nephropathy
5131104|NCT03174821|Insulin pump intensive therapy|insulin pump intensive therapy
5131105|NCT03174808|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5131106|NCT03174756|Hypochlorous Acid|hypochlorous acid
5131107|NCT03174756|Chlorhexidine|chlorhexidine
5131108|NCT03174756|Antiplaque agents|antiplaque agents
5131109|NCT03174756|Substantivity|substantivity
5131110|NCT03174730|smoking|smoking
5131111|NCT03174730|smartphone|smartphone
5131112|NCT03174730|technology|technology
5131113|NCT03174730|addiction|addiction
5131114|NCT03174678|Dexmedetomidine|dexmedetomidine
5131115|NCT03174678|child|child
5131116|NCT03174678|premedication|premedication
5131117|NCT03174678|emergence delirium|emergence delirium
5131118|NCT03174678|dental treatment|dental treatment
5131119|NCT03174626|caregiver|caregiver
5131120|NCT03174626|stress management|stress management
5131121|NCT03174600|Stroke|stroke
5131122|NCT03174600|Lower urinary tract dysfunction|lower urinary tract dysfunction
5131123|NCT03174600|Functional status|functional status
5131124|NCT03174600|Mini mental test|mini mental test
5131125|NCT03174587|Systemic lupus erythematosus|systemic lupus erythematosus
5131126|NCT03174587|HLA-haplo-matching|hla-haplo-matching
5131127|NCT03174587|allogenic bone marrow derived mesenchymal stem cell|allogenic bone marrow derived mesenchymal stem cell
5131128|NCT03174587|Phase 1 clinical trial|phase 1 clinical trial
5131129|NCT03174535|Ischemic Stroke|ischemic stroke
5131130|NCT03174535|Secondary Prevention|secondary prevention
5131131|NCT03174535|Endpoint Events|endpoint events
5131132|NCT03174535|Risk Assessment|risk assessment
5131133|NCT03174535|Traditional Chinese Medicine|traditional chinese medicine
5131134|NCT03174535|Registry Study|registry study
5131135|NCT03174522|Autologous|autologous
5131136|NCT03174522|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
5131137|NCT03174522|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
5127531|NCT03197168|psychosocial intervention|psychosocial intervention
5131143|NCT03174509|airway extubation|airway extubation
5131144|NCT03174509|positive-pressure respiration|positive-pressure respiration
5131145|NCT03174509|suction|suction
5131146|NCT03174509|ventilator weaning|ventilator weaning
5131147|NCT03174457|Oesophageal Candidiasis|oesophageal candidiasis
5131148|NCT03174457|Paediatric|paediatric
5131149|NCT03174457|Invasive Candidiasis|invasive candidiasis
5131150|NCT03174457|Prophylaxis of Candida Infections|prophylaxis of candida infections
5131151|NCT03174457|Candidemia|candidemia
5131152|NCT03174457|Aspergillosis|aspergillosis
5131153|NCT03174457|Micafungin|micafungin
5131154|NCT03174444|Chinese American|chinese american
5131155|NCT03174444|Asian American|asian american
5131156|NCT03174444|Colorectal cancer screening|colorectal cancer screening
5131157|NCT03174444|Print materials|print materials
5131158|NCT03174418|Optical coherence tomography|optical coherence tomography
5131159|NCT03174418|Percutaneous coronary interventions|percutaneous coronary interventions
5131160|NCT03174418|Coronary atherosclerosis in bifurcations|coronary atherosclerosis in bifurcations
5131161|NCT03174392|Exercise|exercise
5131162|NCT03174392|Multimodal|multimodal
5131163|NCT03174392|Balance|balance
5131164|NCT03174392|Resistance|resistance
5131165|NCT03174392|Mobility|mobility
5131166|NCT03174314|Visual Impairment|visual impairment
5131167|NCT03174275|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5131168|NCT03174275|durvalumab|durvalumab
5131169|NCT03174275|neoadjuvant induction|neoadjuvant induction
5131170|NCT03174275|post-operative treatment|post-operative treatment
5131171|NCT03174262|Ergonomics|ergonomics
5131172|NCT03174262|Computer Workstation|computer workstation
5131173|NCT03174262|Habit|habit
5131174|NCT03174262|Self-efficacy|self-efficacy
5131175|NCT03174262|Knowledge|knowledge
5131176|NCT03174249|Behavioural therapy|behavioural therapy
5131177|NCT03174249|Exposure in vivo|exposure in vivo
5131178|NCT03174249|Cortical reorganisation|cortical reorganisation
5131179|NCT03174249|Mirror therapy|mirror therapy
5131180|NCT03174210|COPD|copd
5131181|NCT03174210|supplemental oxygen|supplemental oxygen
5131182|NCT03174210|oxygen concentrator|oxygen concentrator
5131183|NCT03174171|Everolimus, mTor inhibitor|everolimus, mtor inhibitor
5131184|NCT03174158|text messaging|text messaging
5131187|NCT03174080|PET Scan Tomography|pet scan tomography
5131188|NCT03174067|buprenorphine|buprenorphine
5131189|NCT03174067|emergency department|emergency department
5131190|NCT03174054|Men aged 40 and over|men aged 40 and over
5131202|NCT03174002|Critical care|critical care
5131203|NCT03173989|osteoarthritis|osteoarthritis
5131204|NCT03173989|hand deformities|hand deformities
5131205|NCT03173989|hand strength|hand strength
5131206|NCT03173989|assistive technology|assistive technology
5131207|NCT03173989|exercise|exercise
5131208|NCT03173989|health education|health education
5131219|NCT03173937|Haploidentical|haploidentical
5131220|NCT03173937|Nonmyeloablative|nonmyeloablative
5131221|NCT03173924|Small Molecule|small molecule
5131222|NCT03173924|Radiolabeled|radiolabeled
5131224|NCT03173924|Diagnostic|diagnostic
5131225|NCT03173924|PMSA|pmsa
5131226|NCT03173911|Balance|balance
5131227|NCT03173911|Postural control|postural control
5131228|NCT03173911|Elastic Bandages|elastic bandages
5131229|NCT03173911|Force plate|force plate
5131230|NCT03173898|PDL Injection; Infiltration; Anesthesia; Extraction|pdl injection; infiltration; anesthesia; extraction
5131231|NCT03173872|Reiki|reiki
5131232|NCT03173872|Chronic Pain|chronic pain
5131233|NCT03173872|Military|military
5131234|NCT03173859|prostate cancer, abiraterone, apalutamide|prostate cancer, abiraterone, apalutamide
5131235|NCT03173846|neurofeedback|neurofeedback
5131236|NCT03173846|episodic memory|episodic memory
5131237|NCT03173846|real-time functional MRI|real-time functional mri
5131238|NCT03173833|cancer patients, quality of life|cancer patients, quality of life
5131239|NCT03173820|tacrolimus|tacrolimus
5131240|NCT03173820|transplantation|transplantation
5131241|NCT03173820|CYP3A5|cyp3a5
5131242|NCT03173820|genotype|genotype
5131243|NCT03173768|intravenous antibiotics|intravenous antibiotics
5131244|NCT03173768|appropriateness|appropriateness
5131245|NCT03173768|outpatient antimicrobial therapy|outpatient antimicrobial therapy
5131246|NCT03173716|DEFINITY contrast|definity contrast
5131247|NCT03173677|Mononuclear cells|mononuclear cells
5131248|NCT03173677|Whey proteins|whey proteins
5131249|NCT03173677|Metabolically-Activated Macrophage|metabolically-activated macrophage
5131250|NCT03173677|Macrophage Polarization|macrophage polarization
5131251|NCT03173677|Macronutrients|macronutrients
5127641|NCT03196505|Liposomal Bupivacaine|liposomal bupivacaine
5131257|NCT03173586|Sugar sweetened beverage, biomarker|sugar sweetened beverage, biomarker
5131258|NCT03173573|Cystic Fibrosis|cystic fibrosis
5131259|NCT03173560|Renal Cell Carcinoma|renal cell carcinoma
5131260|NCT03173560|lenvatinib|lenvatinib
5131261|NCT03173560|everolimus|everolimus
5131262|NCT03173560|E7080|e7080
5198475|NCT02753842|HIV|hiv
5131263|NCT03173560|VEGF-targeted treatment|vegf-targeted treatment
5131264|NCT03173508|right ventricular function|right ventricular function
5131265|NCT03173508|echocardiography|echocardiography
5131266|NCT03173508|obstructive airway disease|obstructive airway disease
5131267|NCT03173508|emphysema|emphysema
5131268|NCT03173508|acetazolamide|acetazolamide
5131269|NCT03173508|altitude|altitude
5131270|NCT03173495|fat metabolism|fat metabolism
5131271|NCT03173495|fructose|fructose
5131272|NCT03173495|exercise|exercise
5131273|NCT03173456|acute pain|acute pain
5131274|NCT03173456|musculoskeletal pain|musculoskeletal pain
5131275|NCT03173456|emergency medicine|emergency medicine
5131276|NCT03173456|Emergency Service, Hospital|emergency service, hospital
5131277|NCT03173456|analgesics|analgesics
5131278|NCT03173456|Acetaminophen|acetaminophen
5131279|NCT03173456|Ibuprofen|ibuprofen
5131280|NCT03173456|oxycodone|oxycodone
5131281|NCT03173456|hydrocodone|hydrocodone
5131282|NCT03173456|codeine|codeine
5131283|NCT03173456|adult|adult
5131284|NCT03173443|Fiberoptic intubation|fiberoptic intubation
5131285|NCT03173443|double lumen tube|double lumen tube
5131286|NCT03173391|GKA|gka
5131287|NCT03173391|T2DM|t2dm
5131288|NCT03173391|HMS5552|hms5552
5131289|NCT03173391|monotherapy|monotherapy
5131290|NCT03173365|Hand-foot Syndrome|hand-foot syndrome
5131291|NCT03173365|Brimonidine|brimonidine
5131293|NCT03173365|palmar-plantar erythrodysesthesia syndrome|palmar-plantar erythrodysesthesia syndrome
5131294|NCT03173365|Brimonidine Tartrate|brimonidine tartrate
5131295|NCT03173352|Hemangioma|hemangioma
5131296|NCT03173339|intubation|intubation
5131297|NCT03173339|pharyngitis|pharyngitis
5131298|NCT03173339|remifentanil|remifentanil
5131299|NCT03173313|Hypothermia|hypothermia
5131300|NCT03173313|Acute Myocardial Infarction|acute myocardial infarction
5131301|NCT03173313|AMI|ami
5131302|NCT03173313|PCI|pci
5131303|NCT03173313|Therapeutic Hypothermia|therapeutic hypothermia
5131304|NCT03173300|PMM2-CDG|pmm2-cdg
5131305|NCT03173300|CDG-Ia|cdg-ia
5131320|NCT03173144|Food|food
5131321|NCT03173144|Exercise|exercise
5131322|NCT03173144|Treatment Outcome|treatment outcome
5131323|NCT03173144|Biomarkers|biomarkers
5131324|NCT03173144|Smoking|smoking
5131325|NCT03173105|Visually Impaired Persons|visually impaired persons
5131326|NCT03173105|Postural Balance|postural balance
5131327|NCT03173105|Rehabilitation|rehabilitation
5131328|NCT03173105|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5131329|NCT03173092|Drug therapy|drug therapy
5131330|NCT03173053|S. aureus|s. aureus
5131331|NCT03173053|Home Parenteral Nutrition|home parenteral nutrition
5131332|NCT03173053|Intestinal failure|intestinal failure
5131333|NCT03173053|Eradication|eradication
5131334|NCT03173053|Decolonization|decolonization
5131335|NCT03173040|Traditional Chinese medicine|traditional chinese medicine
5131336|NCT03173040|Niu Bang Zi pill|niu bang zi pill
5131337|NCT03173040|methotrexate|methotrexate
5131338|NCT03173040|active rheumatoid arthritis|active rheumatoid arthritis
5131339|NCT03173001|intestinal helminths; protozoan infections;|intestinal helminths; protozoan infections;
5131340|NCT03173001|colorectal cancer; chemotherapy; cancer pathogenesis;|colorectal cancer; chemotherapy; cancer pathogenesis;
5131341|NCT03172988|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5131342|NCT03172988|Surgery|surgery
5131343|NCT03172988|Dexamethasone|dexamethasone
5131344|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil
5131345|NCT03172988|Long-term survival|long-term survival
5131346|NCT03172975|Controlled infection|controlled infection
5131347|NCT03172975|Na-GST-1|na-gst-1
5131348|NCT03172975|Hookworm vaccine|hookworm vaccine
5131349|NCT03172936|injected lesion|injected lesion
5131350|NCT03172936|distal lesion|distal lesion
5131351|NCT03172936|abscopal activity|abscopal activity
5131352|NCT03172936|intratumoral|intratumoral
5131353|NCT03172936|checkpoint inhibitor|checkpoint inhibitor
5131354|NCT03172936|cyclic dinucleotide|cyclic dinucleotide
5131355|NCT03172936|programmed cell death|programmed cell death
5131356|NCT03172910|PER977|per977
5131357|NCT03172910|Ciraparantag|ciraparantag
5131358|NCT03172910|Whole Blood Clotting Time (WBCT)|whole blood clotting time (wbct)
5131359|NCT03172910|Rivaroxaban|rivaroxaban
5131366|NCT03172884|Pharmacokinetics|pharmacokinetics
5131367|NCT03172884|Hepatic impairment|hepatic impairment
5131368|NCT03172871|Schizophrenia|schizophrenia
5131369|NCT03172871|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
5131370|NCT03172871|Acute treatment|acute treatment
5131371|NCT03172858|cervical ripening|cervical ripening
5131372|NCT03172858|term premature rupture of membrane|term premature rupture of membrane
5131373|NCT03172858|intracervical balloon catheter|intracervical balloon catheter
5131374|NCT03172845|coronary bifurcation lesion|coronary bifurcation lesion
5131375|NCT03172845|optical coherence tomography|optical coherence tomography
5131376|NCT03172845|vulnerable plaque|vulnerable plaque
5131377|NCT03172793|telavancin|telavancin
5131378|NCT03172793|lipoglycopeptide|lipoglycopeptide
5131379|NCT03172793|MRSA|mrsa
5131380|NCT03172793|pharmacokinetics|pharmacokinetics
5131381|NCT03172767|Preterm|preterm
5131382|NCT03172767|Sensory processing|sensory processing
5131383|NCT03172767|School Readiness|school readiness
5131384|NCT03172741|Cannabis|cannabis
5131385|NCT03172715|Open reduction internal fixation|open reduction internal fixation
5131386|NCT03172715|Arthroplasty|arthroplasty
5131387|NCT03172715|Surgery|surgery
5131388|NCT03172715|Randomized controlled trial|randomized controlled trial
5131389|NCT03172663|obesity|obesity
5131390|NCT03172624|Nivolumab|nivolumab
5131391|NCT03172624|Ipilimumab|ipilimumab
5132772|NCT03163108|ventilation|ventilation
5131393|NCT03172572|minimally invasive surgical procedures|minimally invasive surgical procedures
5131394|NCT03172572|pancreas surgery|pancreas surgery
5131395|NCT03172572|pancreatoduodenectomy|pancreatoduodenectomy
5131396|NCT03172559|Stereotactic body radiotherapy|stereotactic body radiotherapy
5131397|NCT03172559|SBRT|sbrt
5131398|NCT03172559|Radiotherapy|radiotherapy
5131399|NCT03172559|Bridging therapy|bridging therapy
5131400|NCT03172559|Transplant|transplant
5131401|NCT03172546|direct oral anticoagulant|direct oral anticoagulant
5131402|NCT03172546|hemorrhagic complication|hemorrhagic complication
5131403|NCT03172546|thrombotic complication|thrombotic complication
5131404|NCT03172546|genetic polymorphisms|genetic polymorphisms
5131405|NCT03172533|anorexia nervosa|anorexia nervosa
5131406|NCT03172533|estrogen|estrogen
5131407|NCT03172533|psychotherapy|psychotherapy
5131408|NCT03172533|cortisol|cortisol
5131409|NCT03172533|appetite regulation|appetite regulation
5131410|NCT03172533|neurocognitive performance|neurocognitive performance
5131411|NCT03172533|eating disorder|eating disorder
5131412|NCT03172533|sexual hormone|sexual hormone
5131413|NCT03172520|Parotidectomy|parotidectomy
5131414|NCT03172507|Hematopoietic Stem Cells|hematopoietic stem cells
5131415|NCT03172442|Class III treatment|class iii treatment
5131416|NCT03172442|orthodontic removable traction appliance|orthodontic removable traction appliance
5131417|NCT03172442|RCT|rct
5131418|NCT03172429|pulmonary hypertension|pulmonary hypertension
5131419|NCT03172429|cerebral tissue oxygenation|cerebral tissue oxygenation
5131420|NCT03172429|disease progression|disease progression
5131421|NCT03172429|hypoxia|hypoxia
5131422|NCT03172416|Gastric Cancer|gastric cancer
5131423|NCT03172416|Unresectable Peritoneal Carcinomatosis|unresectable peritoneal carcinomatosis
5131424|NCT03172416|Oxaliplatin|oxaliplatin
5131425|NCT03172416|Pressurized intraperitoneal aerosol chemotherapy|pressurized intraperitoneal aerosol chemotherapy
5131426|NCT03172403|Cachexia|cachexia
5131427|NCT03172403|Cancer of Digestive System|cancer of digestive system
5131428|NCT03172403|Myostatin|myostatin
5131429|NCT03172403|Skeletal muscle|skeletal muscle
5131430|NCT03172390|Ascending aorta aneurysm|ascending aorta aneurysm
5131431|NCT03172390|Aortic wall shear stress|aortic wall shear stress
5131432|NCT03172390|4D phase contrast Cardiovascular Magnetic Resonance|4d phase contrast cardiovascular magnetic resonance
5131433|NCT03172390|Aortic dissection|aortic dissection
5131434|NCT03172377|adalimumab|adalimumab
5131435|NCT03172377|anti-tumor necrosis factor|anti-tumor necrosis factor
5131436|NCT03172377|anti-TNF|anti-tnf
5131437|NCT03172377|Humira|humira
5131438|NCT03172377|interval lengthening|interval lengthening
5131439|NCT03172377|dosing interval|dosing interval
5131440|NCT03172377|inflammatory bowel disease|inflammatory bowel disease
5131441|NCT03172377|antidrug antibodies|antidrug antibodies
5131442|NCT03172377|trough levels|trough levels
5131443|NCT03172377|pharmacokinetics|pharmacokinetics
5131444|NCT03172377|immunogenicity|immunogenicity
5131445|NCT03172377|cost-effectiveness|cost-effectiveness
5131446|NCT03172377|dose reduction|dose reduction
5131447|NCT03172312|Intraoperative Parathyroid Scores System|intraoperative parathyroid scores system
5131448|NCT03172312|total thyroidectomy|total thyroidectomy
5131457|NCT03172221|malaria|malaria
5131458|NCT03172221|pregnancy|pregnancy
5131459|NCT03172221|diagnosis|diagnosis
5131460|NCT03172221|low-transmission|low-transmission
5131461|NCT03172221|Plasmodium falciparum|plasmodium falciparum
5131462|NCT03172221|rapid diagnostic test|rapid diagnostic test
5131463|NCT03172195|ulcerative colitis|ulcerative colitis
5131464|NCT03172195|inflammation|inflammation
5131465|NCT03172195|immunosuppressive drugs|immunosuppressive drugs
5131466|NCT03172195|herpesvirus|herpesvirus
5131467|NCT03172195|qPCR|qpcr
5131468|NCT03172195|colonic mucosa|colonic mucosa
5131469|NCT03172156|NSCLC|nsclc
5131470|NCT03172156|stage I|stage i
5131471|NCT03172156|The next generation of high-throughput gene sequencing (NGS)|the next generation of high-throughput gene sequencing (ngs)
5131473|NCT03172143|Ileocolic|ileocolic
5131474|NCT03172143|Crohn's|crohn's
5131475|NCT03172143|Terminal ilium|terminal ilium
5131476|NCT03172143|Ileocecal|ileocecal
5131477|NCT03172130|Obstructive Sleep Apnea|obstructive sleep apnea
5131478|NCT03172130|CPAP|cpap
5131479|NCT03172091|Lung transplant|lung transplant
5131480|NCT03172091|Acute resection|acute resection
5131481|NCT03172091|Volatile Organic Compounds|volatile organic compounds
5131482|NCT03172078|advanced endoscopic procedure|advanced endoscopic procedure
5131483|NCT03172078|ERCP|ercp
5131484|NCT03172078|EUS|eus
5131485|NCT03172078|target-controlled infusion|target-controlled infusion
5131486|NCT03172078|sedation|sedation
5131487|NCT03172078|propofol|propofol
5131488|NCT03172039|hemodialysis|hemodialysis
5131490|NCT03172039|antimicrobial agents|antimicrobial agents
5131491|NCT03172039|bacterial infections|bacterial infections
5131492|NCT03172039|ambulatory care|ambulatory care
5131493|NCT03172026|Telerehabilitation|telerehabilitation
5131494|NCT03172026|Maraviroc|maraviroc
5131495|NCT03171987|lidocaine patch|lidocaine patch
5131496|NCT03171987|flurbiprofen patch|flurbiprofen patch
5131497|NCT03171987|acute back pain|acute back pain
5131498|NCT03171974|breast capsular contructure|breast capsular contructure
5131499|NCT03171961|weight loss|weight loss
5131500|NCT03171961|Diet|diet
5131501|NCT03171961|online visit|online visit
5131502|NCT03171961|clinic visit|clinic visit
5131503|NCT03171948|almond|almond
5131504|NCT03171948|weight loss|weight loss
5131505|NCT03171948|Weight maintenance|weight maintenance
5131506|NCT03171948|hypoenergetic diet|hypoenergetic diet
5131507|NCT03171922|weight loss|weight loss
5131508|NCT03171922|internet-based diet|internet-based diet
5131509|NCT03171922|online dietary coach|online dietary coach
5131510|NCT03171922|clinic visit approach|clinic visit approach
5131511|NCT03171922|Diet|diet
5131512|NCT03171792|Musculoskeletal pain|musculoskeletal pain
5131513|NCT03171792|Adolescent|adolescent
5131514|NCT03171792|Qualitative research|qualitative research
5131515|NCT03171792|Attitude|attitude
5131516|NCT03171792|Health professionals|health professionals
5131517|NCT03171740|Emergence Delirium|emergence delirium
5131518|NCT03171740|Emergence Agitation|emergence agitation
5131519|NCT03171740|premedication|premedication
5131520|NCT03171740|dexmedetomidine|dexmedetomidine
5131521|NCT03171740|midazolam|midazolam
5131522|NCT03171714|Drainage Catheter|drainage catheter
5131523|NCT03171688|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5131524|NCT03171688|cesarean|cesarean
5131525|NCT03171688|risk factors|risk factors
5131526|NCT03171675|Chronic Periodontitis|chronic periodontitis
5131527|NCT03171675|Preterm Labor|preterm labor
5131528|NCT03171675|Preterm Birth|preterm birth
5131529|NCT03171675|Interleukin-17|interleukin-17
5131530|NCT03171675|IL-17|il-17
5131531|NCT03171675|Periodontal Disease|periodontal disease
5131532|NCT03171675|Periodontitis|periodontitis
5131533|NCT03171675|Periodontal risk factors|periodontal risk factors
5131534|NCT03171675|Medical risk factors|medical risk factors
5131535|NCT03171649|rehabilitation|rehabilitation
5131536|NCT03171649|exoskeleton|exoskeleton
5131537|NCT03171649|functional electrical stimulation|functional electrical stimulation
5131538|NCT03171649|upper limb|upper limb
5131539|NCT03171649|sub-acute|sub-acute
5131540|NCT03171649|motor re-learning|motor re-learning
5131541|NCT03171623|T2DM|t2dm
5131542|NCT03171623|Diabetes|diabetes
5131543|NCT03171623|GKA|gka
5131544|NCT03171610|laparoscopic nephrectomy|laparoscopic nephrectomy
5131545|NCT03171610|Patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
5131546|NCT03171610|sufentanil|sufentanil
5131547|NCT03171610|fentanyl|fentanyl
5131548|NCT03171597|Unstable Angina|unstable angina
5131549|NCT03171597|Traditional Chinese Medicine|traditional chinese medicine
5131550|NCT03171571|eating Behavior|eating behavior
5131551|NCT03171571|Volunteers|volunteers
5131552|NCT03171545|Peer Mentoring|peer mentoring
5131553|NCT03171545|Team Training|team training
5131554|NCT03171545|Checklist|checklist
5131555|NCT03171532|ACL|acl
5131556|NCT03171519|Physical activity|physical activity
5131557|NCT03171519|Disorders of onset and maintenance of sleep|disorders of onset and maintenance of sleep
5131558|NCT03171519|non-pharmacological treatment|non-pharmacological treatment
5131559|NCT03171519|Acupuncture|acupuncture
5131560|NCT03171506|ketogenic diet|ketogenic diet
5131561|NCT03171506|carbohydrate-restricted diet|carbohydrate-restricted diet
5131562|NCT03171493|Bladder cancer, Radical cystectomy|bladder cancer, radical cystectomy
5131565|NCT03171454|hysteroscopic operation|hysteroscopic operation
5131566|NCT03171454|intrauterine balloon|intrauterine balloon
5131567|NCT03171454|adhesions|adhesions
5131568|NCT03171415|Obesity|obesity
5131569|NCT03171415|Overweight|overweight
5131570|NCT03171415|Thermogenesis|thermogenesis
5131571|NCT03171415|Fat reduction|fat reduction
5131572|NCT03171389|GIST|gist
5131573|NCT03171389|KIT secondary mutation|kit secondary mutation
5131574|NCT03171389|ponatinib|ponatinib
5131575|NCT03171376|Root canal treatment|root canal treatment
5131577|NCT03171376|Intraorifice barrier|intraorifice barrier
5131578|NCT03171363|Attention bias modification treatment|attention bias modification treatment
5131579|NCT03171363|Anxiety disorders|anxiety disorders
5131580|NCT03171363|Attention training|attention training
5131581|NCT03171337|Chronic tension-type headache|chronic tension-type headache
5131582|NCT03171337|Acupuncture|acupuncture
5131583|NCT03171337|Fu's subcutaneous needling(FSN)|fu's subcutaneous needling(fsn)
5131584|NCT03171337|fMRI|fmri
5131585|NCT03171337|Regional homogeneity (ReHo)|regional homogeneity (reho)
5131586|NCT03171246|dietary intervention|dietary intervention
5131587|NCT03171220|Neoantigen|neoantigen
5131616|NCT03171038|Telemonitoring|telemonitoring
5131617|NCT03171038|Chronic Heart Failure|chronic heart failure
5131618|NCT03171038|eHealth|ehealth
5131619|NCT03171038|Mortality|mortality
5131620|NCT03171025|Muscle Invasive|muscle invasive
5131621|NCT03171012|Muscle Stretching Exercises|muscle stretching exercises
5131622|NCT03170999|China|china
5131623|NCT03170999|Cognitive testing|cognitive testing
5131624|NCT03170999|COPD exacerbation|copd exacerbation
5131625|NCT03170999|CERT|cert
5131626|NCT03170973|Obesity|obesity
5131627|NCT03170973|Motor Activity|motor activity
5131628|NCT03170973|Fatty acids|fatty acids
5131629|NCT03170973|Lipid|lipid
5131644|NCT03170947|Rheumatoid arthritis|rheumatoid arthritis
5131645|NCT03170947|Foot|foot
5131646|NCT03170947|Insoles|insoles
5131647|NCT03170947|Quality of life|quality of life
5131648|NCT03170947|Physical Activity|physical activity
5131649|NCT03170895|FLT3-ITD (+) Acute Myeloid Leukemia (AML)|flt3-itd (+) acute myeloid leukemia (aml)
5131650|NCT03170882|Drug therapy|drug therapy
5131651|NCT03170778|Congenital Heart Disease|congenital heart disease
5131652|NCT03170778|CHD|chd
5131653|NCT03170778|Fontan|fontan
5131654|NCT03170752|RCT, Cardiovascular Risk Factors, Screening|rct, cardiovascular risk factors, screening
5131655|NCT03170739|dexmedetomidine|dexmedetomidine
5131656|NCT03170739|dopamine|dopamine
5131657|NCT03170739|surgery|surgery
5131658|NCT03170726|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
5131659|NCT03170726|Intraoperative analgesia|intraoperative analgesia
5131660|NCT03170726|Third molar tooth surgery|third molar tooth surgery
5131661|NCT03170713|Preemptive intravenous ibuprofen|preemptive intravenous ibuprofen
5131662|NCT03170713|trismus|trismus
5131663|NCT03170713|edema|edema
5131664|NCT03170713|Third molar tooth extraction|third molar tooth extraction
5131665|NCT03170713|Antiinflammatory effect|antiinflammatory effect
5131666|NCT03170700|preschool|preschool
5131667|NCT03170700|eating behaviors|eating behaviors
5131668|NCT03170700|family|family
5131669|NCT03170648|Acupuncture|acupuncture
5131670|NCT03170648|Breast Cancer|breast cancer
5131671|NCT03170635|recess, occupational therapy|recess, occupational therapy
5131672|NCT03170622|children|children
5131673|NCT03170622|paediatrics|paediatrics
5131674|NCT03170622|faecal volitile organic compounds|faecal volitile organic compounds
5131675|NCT03170622|diagnosis|diagnosis
5131676|NCT03170622|pathogenesis|pathogenesis
5131677|NCT03170583|bradycardia, pacemaker, MRI scan|bradycardia, pacemaker, mri scan
5131678|NCT03170570|recurrent cervical cancer|recurrent cervical cancer
5131679|NCT03170570|re-irradiation|re-irradiation
5131680|NCT03170570|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5131691|NCT03170453|Autism|autism
5131692|NCT03170453|Autism Spectrum Disorder|autism spectrum disorder
5131693|NCT03170453|Asperger's Syndrome|asperger's syndrome
5131694|NCT03170453|Pervasive Developmental Disorder|pervasive developmental disorder
5131695|NCT03170453|Cognition|cognition
5131696|NCT03170453|Social Cognition|social cognition
5131697|NCT03170453|Psychosocial Treatment|psychosocial treatment
5131698|NCT03170453|Cognitive Enhancement Therapy|cognitive enhancement therapy
5131699|NCT03170453|Enriched Supportive Therapy|enriched supportive therapy
5131700|NCT03170453|Therapy|therapy
5131701|NCT03170453|Psychotherapy|psychotherapy
5131702|NCT03170440|Nerve stimulation|nerve stimulation
5131703|NCT03170414|HIV|hiv
5131704|NCT03170414|Kidney Transplant|kidney transplant
5131705|NCT03170414|Liver Transplant|liver transplant
5131706|NCT03170414|Transplant|transplant
5131707|NCT03170414|HOPE Act|hope act
5131708|NCT03170375|obesity|obesity
5131709|NCT03170375|sodium|sodium
5131710|NCT03170375|DASH diet|dash diet
5131711|NCT03170375|hypertension|hypertension
5131712|NCT03170375|vascular stiffness|vascular stiffness
5131713|NCT03170375|diastolic function|diastolic function
5131714|NCT03170362|Treatment|treatment
5131715|NCT03170362|Pharmacogenetics|pharmacogenetics
5131736|NCT03170232|Danirixin|danirixin
5131737|NCT03170232|COPD|copd
5131738|NCT03170206|Lung Cancer|lung cancer
5131739|NCT03170141|CAR T|car t
5131740|NCT03170141|Gene Therapy|gene therapy
5131741|NCT03170141|GBM|gbm
5131742|NCT03170141|PD-L1|pd-l1
5131743|NCT03170141|PD1|pd1
5131744|NCT03170115|Rectal Cancer|rectal cancer
5131745|NCT03170115|Total neoadjuvant therapy|total neoadjuvant therapy
5131746|NCT03170115|Induction chemotherapy|induction chemotherapy
5131747|NCT03170115|Aspirin colorectal cancer|aspirin colorectal cancer
5131748|NCT03170102|occupational therapy|occupational therapy
5131749|NCT03170089|oral-health-awareness, Diabetes|oral-health-awareness, diabetes
5131750|NCT03170076|skin manifestations - hepatitis c virus|skin manifestations - hepatitis c virus
5131752|NCT03170063|Alpha-Synuclein|alpha-synuclein
5131753|NCT03170063|Biomarker|biomarker
5131754|NCT03170011|Cardiac rehabilitation|cardiac rehabilitation
5131755|NCT03170011|Sit to Stand|sit to stand
5131756|NCT03170011|Function|function
5131757|NCT03169985|Rosuvastatin|rosuvastatin
5131758|NCT03169985|Ezetimibe|ezetimibe
5131759|NCT03169985|Atherosclerotic plaque|atherosclerotic plaque
5131760|NCT03169985|Intravascular ultrasound|intravascular ultrasound
5131761|NCT03169959|Anti-diabetic|anti-diabetic
5131762|NCT03169959|Anti-hyperglycemic agents|anti-hyperglycemic agents
5131763|NCT03169959|Bioequivalence|bioequivalence
5445347|NCT01522235|Autonomic failure|autonomic failure
5445348|NCT01522235|Peripheral autonomic neuropathy|peripheral autonomic neuropathy
5131764|NCT03169959|Fixed-Combination Drug Product (FCDP) of saxagliptin / dapagliflozin / metformin extended-release (XR).|fixed-combination drug product (fcdp) of saxagliptin / dapagliflozin / metformin extended-release (xr).
5131765|NCT03169959|Fed-state bioequivalence (BE)|fed-state bioequivalence (be)
5131766|NCT03169959|XIGDUO® XR|xigduo® xr
5131767|NCT03169959|ONGLYZA®|onglyza®
5131768|NCT03169933|adjuvant|adjuvant
5131769|NCT03169933|androgen suppressive therapy|androgen suppressive therapy
5131770|NCT03169933|literature review|literature review
5131771|NCT03169933|phase II|phase ii
5131772|NCT03169933|prostate neoplasms|prostate neoplasms
5131773|NCT03169933|radiotherapy|radiotherapy
5131774|NCT03169907|Cardiac functions|cardiac functions
5131775|NCT03169907|Intrauterine fetal anemia|intrauterine fetal anemia
5131776|NCT03169907|Intrauterine Fetal blood transfusion|intrauterine fetal blood transfusion
5131777|NCT03169907|Myocardial performance index|myocardial performance index
5131778|NCT03169907|spatiotemporal imaging correlation|spatiotemporal imaging correlation
5131779|NCT03169868|clinical decision support|clinical decision support
5131780|NCT03169868|drug levels in blood|drug levels in blood
5131781|NCT03169868|therapeutic drug monitoring|therapeutic drug monitoring
5131782|NCT03169868|medication adherence|medication adherence
5423371|NCT01615900|Renal graft|renal graft
5131788|NCT03169855|contrast sensitivity|contrast sensitivity
5131789|NCT03169855|mesopic vision|mesopic vision
5131790|NCT03169829|Hemodialysis|hemodialysis
5131791|NCT03169829|Renal Disease|renal disease
5131792|NCT03169803|Electrical Stimulation Therapy|electrical stimulation therapy
5131793|NCT03169803|Electrodes|electrodes
5131794|NCT03169803|Parasympathetic Nervous System|parasympathetic nervous system
5131795|NCT03169803|Sympathetic Fibers|sympathetic fibers
5131796|NCT03169803|Post Ganglionic|post ganglionic
5131797|NCT03169803|Congestive Heart Failure|congestive heart failure
5131798|NCT03169803|Heart Failure|heart failure
5131799|NCT03169673|Magnetic Resonance Imaging|magnetic resonance imaging
5131800|NCT03169673|Pulmonary Function|pulmonary function
5131801|NCT03169634|Failed knee replacement|failed knee replacement
5131802|NCT03169634|loosening|loosening
5131803|NCT03169634|wear|wear
5131804|NCT03169634|reoperation|reoperation
5131808|NCT03169621|Next Generation Sequencing|next generation sequencing
5131809|NCT03169621|Metagenomics|metagenomics
5131810|NCT03169621|Endometrial receptivity|endometrial receptivity
5131811|NCT03169608|autonomic nervous system|autonomic nervous system
5131812|NCT03169608|atrial fibrillation|atrial fibrillation
5131813|NCT03169608|acute kidney injury|acute kidney injury
5131814|NCT03169608|baroreflex sensitivity|baroreflex sensitivity
5131815|NCT03169608|microcirculation|microcirculation
5131816|NCT03169608|coronary artery bypass graft|coronary artery bypass graft
5131817|NCT03169569|hemostatic powder|hemostatic powder
5131818|NCT03169569|post-ESD bleeding|post-esd bleeding
5131819|NCT03169569|antithrombotic therapy|antithrombotic therapy
5131820|NCT03169569|high risk of bleeding|high risk of bleeding
5131821|NCT03169569|endoscopic submucosal dissection|endoscopic submucosal dissection
5131822|NCT03169569|adverse event|adverse event
5131823|NCT03169556|Intubation|intubation
5131824|NCT03169556|light wand|light wand
5131825|NCT03169556|video laryngoscopy|video laryngoscopy
5131826|NCT03169556|cervical spine immobilization|cervical spine immobilization
5131827|NCT03169530|cardiovascular, alcohol, diabetes|cardiovascular, alcohol, diabetes
5131828|NCT03169517|Peripheral nerve block|peripheral nerve block
5131829|NCT03169517|laser speckle contrast imaging|laser speckle contrast imaging
5131830|NCT03169517|blood flow index|blood flow index
5131831|NCT03169504|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5131832|NCT03169504|Acupuncture Therapy|acupuncture therapy
5131833|NCT03169504|Humans|humans
5131834|NCT03169491|Sleep Apnea, Obstructive|sleep apnea, obstructive
5131835|NCT03169491|Child|child
5131836|NCT03169491|Continuous Positive Airway Pressure|continuous positive airway pressure
5131837|NCT03169491|Perioperative management|perioperative management
5131839|NCT03169491|Acoustic pharyngometry|acoustic pharyngometry
5131840|NCT03169478|hysteroscopic myomectomy|hysteroscopic myomectomy
5131841|NCT03169478|balloon dilatation|balloon dilatation
5131842|NCT03169478|adhesions|adhesions
5131843|NCT03169426|remote ischemic conditioning|remote ischemic conditioning
5131844|NCT03169426|beta-blocker|beta-blocker
5131845|NCT03169400|vascular calcification|vascular calcification
5131846|NCT03169400|haemodialysis|haemodialysis
5131847|NCT03169400|dialysis membrane|dialysis membrane
5131848|NCT03169387|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5131849|NCT03169374|Virtual Reality|virtual reality
5131850|NCT03169374|Mechanical Ventilation|mechanical ventilation
5131851|NCT03169374|Anxiety|anxiety
5131852|NCT03169309|complementary and alternative medicine|complementary and alternative medicine
5131853|NCT03169309|military|military
5131854|NCT03169309|binaural beat technology|binaural beat technology
5131855|NCT03169309|brain entrainment technology|brain entrainment technology
5131856|NCT03169309|sleep|sleep
5131857|NCT03169296|Myelodysplastic syndrome|myelodysplastic syndrome
5131858|NCT03169296|Mutations|mutations
5131859|NCT03169296|Next-generation sequencing|next-generation sequencing
5131860|NCT03169270|Exercise training|exercise training
5131861|NCT03169270|Muscle dysfunction|muscle dysfunction
5131862|NCT03169270|COPD|copd
5131863|NCT03169257|paediatric obesity|paediatric obesity
5131864|NCT03169257|cardiovascular dysfunction|cardiovascular dysfunction
5131865|NCT03169257|metabolic syndrome|metabolic syndrome
5131866|NCT03169257|adipokines|adipokines
5131867|NCT03169257|inflammation|inflammation
5131868|NCT03169257|oxidative stress|oxidative stress
5131869|NCT03169218|Adult|adult
5131870|NCT03169218|Chronic pain|chronic pain
5131876|NCT03169218|Pain/cognitive aspects|pain/cognitive aspects
5131877|NCT03169218|Physiotherapy|physiotherapy
5131878|NCT03169218|Somatosensory cortex|somatosensory cortex
5131879|NCT03169179|Physical activity|physical activity
5131880|NCT03169179|Mobile health|mobile health
5133666|NCT03157609|Thermometry|thermometry
5131882|NCT03169179|Organisational wellness|organisational wellness
5131883|NCT03169179|Occupational health|occupational health
5131884|NCT03169179|Police force|police force
5131885|NCT03169166|GnRH agonist|gnrh agonist
5131886|NCT03169166|In Vitro fertilization|in vitro fertilization
5131887|NCT03169166|Assisted Reproductive Technology|assisted reproductive technology
5131888|NCT03169166|Follicule Maturation|follicule maturation
5131889|NCT03169166|Pregnancy|pregnancy
5131890|NCT03169153|contact lenses|contact lenses
5131891|NCT03169153|lipids|lipids
5131892|NCT03169153|deposits|deposits
5131893|NCT03169140|pain management|pain management
5131894|NCT03169140|topical analgesic|topical analgesic
5131895|NCT03169140|acute low back pain|acute low back pain
5131896|NCT03169140|kinesiology tape|kinesiology tape
5131897|NCT03169127|Ibuprofen|ibuprofen
5131898|NCT03169127|Lower third molar|lower third molar
5131899|NCT03169127|Oral Surgery|oral surgery
5131900|NCT03169114|Appendicitis|appendicitis
5131901|NCT03169114|Surgery|surgery
5131902|NCT03169114|Antibiotic therapy|antibiotic therapy
5131903|NCT03169114|RIPASA Score|ripasa score
5131904|NCT03169101|Smoking Cessation|smoking cessation
5131906|NCT03169101|Cognition|cognition
5131907|NCT03169088|eating Behavior|eating behavior
5131908|NCT03169088|Volunteers|volunteers
5131909|NCT03169075|Adapted physical activity|adapted physical activity
5131910|NCT03169075|Oral targeted therapy|oral targeted therapy
5131911|NCT03169075|Advanced cancer|advanced cancer
5131912|NCT03169075|Fatigue|fatigue
5131913|NCT03169075|Quality of life|quality of life
5131914|NCT03169075|Randomized Study|randomized study
5131915|NCT03169049|nerve conduction block|nerve conduction block
5131916|NCT03169049|high frequency stimulation|high frequency stimulation
5131917|NCT03169049|handgrip|handgrip
5131918|NCT03169010|registry|registry
5131919|NCT03169010|pulmonary hypertension|pulmonary hypertension
5131920|NCT03169010|survival|survival
5131921|NCT03169010|biomarker|biomarker
5131922|NCT03169010|whole genome sequencing|whole genome sequencing
5131923|NCT03168997|Alzheimer Disease Memantine|alzheimer disease memantine
5131924|NCT03168984|Healthy Japanese subjects|healthy japanese subjects
5131925|NCT03168984|Healthy Caucasian subjects|healthy caucasian subjects
5131926|NCT03168984|UCB0942|ucb0942
5131927|NCT03168971|Cancer|cancer
5131928|NCT03168971|Anxiety|anxiety
5131929|NCT03168971|Cognitive behavior therapy|cognitive behavior therapy
5131930|NCT03168971|Elderly|elderly
5131931|NCT03168971|Caregivers|caregivers
5131932|NCT03168971|18-542|18-542
5131933|NCT03168945|Active Case Finding|active case finding
5131934|NCT03168906|Amyloidosis|amyloidosis
5131935|NCT03168906|NEOD001|neod001
5131936|NCT03168906|RAIN|rain
5131938|NCT03168867|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
5131939|NCT03168867|adolescents/young adults|adolescents/young adults
5131940|NCT03168867|e-health intervention|e-health intervention
5131941|NCT03168867|parental monitoring|parental monitoring
5131942|NCT03168854|Anopheles stephensi Mosquitoes|anopheles stephensi mosquitoes
5131943|NCT03168854|GAP3KO|gap3ko
5131944|NCT03168854|Genetically-attenuated|genetically-attenuated
5131945|NCT03168854|Malaria-Naïve Adults|malaria-naïve adults
5131946|NCT03168854|Phase 1|phase 1
5131947|NCT03168854|Plasmodium falciparum|plasmodium falciparum
5131948|NCT03168815|HFNC|hfnc
5003613|NCT03973723|NPC|npc
5131949|NCT03168815|Bronchoscopy|bronchoscopy
5131950|NCT03168815|Hypoxia|hypoxia
5131951|NCT03168815|Immunocompromised|immunocompromised
5131952|NCT03168815|Hematological malignancy|hematological malignancy
5131953|NCT03168802|Focused ultrasound Ablation|focused ultrasound ablation
5131954|NCT03168802|Radiofrequency Ablation|radiofrequency ablation
5131955|NCT03168802|Facet joint syndrome|facet joint syndrome
5131956|NCT03168802|Chronic low back pain|chronic low back pain
5131957|NCT03168789|Breathing Awareness Meditation,|breathing awareness meditation,
5131958|NCT03168776|Drug-eluting stent|drug-eluting stent
5131959|NCT03168763|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5131960|NCT03168763|Advanced Cancer|advanced cancer
5131961|NCT03168763|Videos|videos
5131962|NCT03168763|Questionnaires|questionnaires
5131963|NCT03168763|Surveys|surveys
5131964|NCT03168724|Cognition|cognition
5131965|NCT03168724|Intervention|intervention
5131966|NCT03168724|Self-management|self-management
5131967|NCT03168724|Rehabilitation|rehabilitation
5131972|NCT03168711|Glutathione|glutathione
5131973|NCT03168711|Biomarker|biomarker
5131974|NCT03168711|Oxidative stress|oxidative stress
5131975|NCT03168711|Oxidative damage|oxidative damage
5131976|NCT03168698|pregnancy|pregnancy
5131977|NCT03168698|postpartum hemorrhage|postpartum hemorrhage
5131978|NCT03168698|cesarean delivery|cesarean delivery
5131979|NCT03168698|carbetocin|carbetocin
5131980|NCT03168698|duratocin|duratocin
5131981|NCT03168698|oxytocin|oxytocin
5131982|NCT03168685|smartphones|smartphones
5131990|NCT03168633|medication adherence|medication adherence
5131991|NCT03168633|lifestyle changes|lifestyle changes
5131993|NCT03168607|OS|os
5131994|NCT03168607|PFS|pfs
5131995|NCT03168607|safety|safety
5131996|NCT03168594|chemotherapy|chemotherapy
5131997|NCT03168594|OS|os
5131998|NCT03168594|ORR|orr
5131999|NCT03168594|PFS|pfs
5132000|NCT03168594|safety|safety
5132001|NCT03168529|Acute Heart Failure|acute heart failure
5132002|NCT03168529|Observation|observation
5132003|NCT03168529|Ivabradine|ivabradine
5132004|NCT03168516|Oxygen|oxygen
5132005|NCT03168516|closed-loop automatic control|closed-loop automatic control
5132006|NCT03168516|Oxygen saturation|oxygen saturation
5132007|NCT03168516|preterm infants|preterm infants
5132008|NCT03168451|text messaging|text messaging
5132009|NCT03168438|Metastatic|metastatic
5132010|NCT03168438|Multiple Myeloma|multiple myeloma
5132011|NCT03168438|Previously Treated|previously treated
5132012|NCT03168438|T Cell Receptor|t cell receptor
5132013|NCT03168438|Cell Therapy|cell therapy
5132014|NCT03168438|Immuno-oncology|immuno-oncology
5132015|NCT03168438|SPEAR T Cell|spear t cell
5132016|NCT03168438|T Cell Therapy|t cell therapy
5132017|NCT03168438|NY-ESO-1|ny-eso-1
5132018|NCT03168425|safe opioid prescribing|safe opioid prescribing
5132019|NCT03168412|Hepatitis E|hepatitis e
5132031|NCT03168243|nutrition support, home enteral feeding|nutrition support, home enteral feeding
5132033|NCT03168217|classification|classification
5132034|NCT03168217|Cluster analysis|cluster analysis
5132035|NCT03168139|Metastatic colorectal cancer|metastatic colorectal cancer
5132036|NCT03168139|Metastatic pancreatic cancer|metastatic pancreatic cancer
5132037|NCT03168139|NOX-A12|nox-a12
5132038|NCT03168139|Olaptesed pegol|olaptesed pegol
5132039|NCT03168139|Spiegelmer|spiegelmer
5132040|NCT03168139|Pembrolizumab|pembrolizumab
5132041|NCT03168139|PD-1 inhibitor|pd-1 inhibitor
5132042|NCT03168139|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5132043|NCT03168139|CXCL12|cxcl12
5132044|NCT03168139|Tumor microenvironment|tumor microenvironment
5132045|NCT03168139|Immunotherapy|immunotherapy
5132046|NCT03168139|Checkpoint inhibition|checkpoint inhibition
5132047|NCT03168113|skin barrier function|skin barrier function
5132048|NCT03168113|microbiome|microbiome
5132049|NCT03168113|transepidermal water loss (TEWL)|transepidermal water loss (tewl)
5132050|NCT03168113|epidermal transcriptome|epidermal transcriptome
5132051|NCT03168113|epidermal lipid composition|epidermal lipid composition
5132054|NCT03168048|mobile application|mobile application
5132055|NCT03168048|radiotherapy|radiotherapy
5132056|NCT03168048|patient-care|patient-care
5132057|NCT03168048|mhealth|mhealth
5132058|NCT03168048|follow-up|follow-up
5132059|NCT03168048|patient satisfaction|patient satisfaction
5132060|NCT03168048|quality of life|quality of life
5132064|NCT03167996|South Asian|south asian
5132065|NCT03167996|Cardiovascular Risk Reduction|cardiovascular risk reduction
5132066|NCT03167996|Metabolic Disorders|metabolic disorders
5132067|NCT03167996|Lifestyle modifications|lifestyle modifications
5132068|NCT03167957|fluconazole|fluconazole
5132069|NCT03167957|fluconazole-resistant|fluconazole-resistant
5132070|NCT03167944|Mastectomy|mastectomy
5962040|NCT04283370|Randomized Controlled Trial|randomized controlled trial
5132071|NCT03167944|Seroma|seroma
5132072|NCT03167931|non-invasive brain stimulation|non-invasive brain stimulation
5132073|NCT03167931|neuromodulation|neuromodulation
5132074|NCT03167931|semantic tasks|semantic tasks
5132075|NCT03167918|calcium dobesilate|calcium dobesilate
5132076|NCT03167918|Xuefuzhuyu Decoction|xuefuzhuyu decoction
5132077|NCT03167918|pulmonary function|pulmonary function
5132082|NCT03167879|family planning|family planning
5132083|NCT03167879|safer conception|safer conception
5132084|NCT03167879|HIV|hiv
5132085|NCT03167879|serodiscordant couples|serodiscordant couples
5132086|NCT03167879|Uganda|uganda
5132087|NCT03167879|contraception|contraception
5132088|NCT03167840|falls prevention, older adults, mild cognitive impairment|falls prevention, older adults, mild cognitive impairment
5132091|NCT03167827|exercise|exercise
5132092|NCT03167827|Supplementation of Isoflavone|supplementation of isoflavone
5132093|NCT03167801|tetraplegia|tetraplegia
5132094|NCT03167801|spinal cord injury|spinal cord injury
5132095|NCT03167801|melatonin|melatonin
5132096|NCT03167801|sleep quality|sleep quality
5132097|NCT03167801|sleepiness|sleepiness
5132098|NCT03167723|Chest tube size|chest tube size
5132099|NCT03167723|Hemothorax|hemothorax
5132100|NCT03167723|Empyema|empyema
5132101|NCT03167697|Phenylketonuria|phenylketonuria
5132102|NCT03167697|Hyperphenylalaninaemia|hyperphenylalaninaemia
5132103|NCT03167697|Inherited Metabolic Disorders|inherited metabolic disorders
5132104|NCT03167671|Oswestry|oswestry
5132105|NCT03167671|SF 36|sf 36
5132106|NCT03167671|Promis Pain and Function|promis pain and function
5132107|NCT03167671|Berg Balance|berg balance
5132108|NCT03167658|Wellness|wellness
5132109|NCT03167658|Prevention|prevention
5132110|NCT03167619|Mestastic|mestastic
5132111|NCT03167619|Platinum Sensitive|platinum sensitive
5132112|NCT03167619|Advanced|advanced
5132113|NCT03167619|PARP inhibitor|parp inhibitor
5132114|NCT03167606|myPEEPS|mypeeps
5132115|NCT03167606|Mobile Intervention|mobile intervention
5132116|NCT03167606|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5132117|NCT03167606|Men who have sex with men (MSM)|men who have sex with men (msm)
5132118|NCT03167593|Lactobacillus coryniformis|lactobacillus coryniformis
5132119|NCT03167593|Flu|flu
5132120|NCT03167593|Vaccine|vaccine
5132121|NCT03167528|Pain|pain
5132140|NCT03167385|radioiodine refractory thyroid carcinoma|radioiodine refractory thyroid carcinoma
5132142|NCT03167372|N-of-1|n-of-1
5132143|NCT03167359|Psychiatry|psychiatry
5132144|NCT03167359|Radiation Therapy|radiation therapy
5132145|NCT03167346|stroke|stroke
5132146|NCT03167346|core symptoms|core symptoms
5132147|NCT03167346|public awareness|public awareness
5132148|NCT03167346|FAST|fast
5132149|NCT03167307|omega-3 fatty acids|omega-3 fatty acids
5132150|NCT03167307|eicosapentaenoic acid|eicosapentaenoic acid
5132151|NCT03167307|docosahexaenoic acid|docosahexaenoic acid
5132152|NCT03167307|antidepressants|antidepressants
5132153|NCT03167307|suicidality|suicidality
5132154|NCT03167307|cognition|cognition
5132155|NCT03167307|childhood depression|childhood depression
5132156|NCT03167307|pediatric depression|pediatric depression
5132157|NCT03167294|Aquablation|aquablation
5132158|NCT03167294|AQUABEAM|aquabeam
5132160|NCT03167294|LUTS|luts
5132161|NCT03167281|Chest tube|chest tube
5132162|NCT03167281|Thoracostomy|thoracostomy
5132163|NCT03167281|Pleural Diseases|pleural diseases
5132164|NCT03167281|Lung Neoplasms|lung neoplasms
5132165|NCT03167281|Pulmonary Embolism|pulmonary embolism
5132166|NCT03167281|Pneumothorax|pneumothorax
5132167|NCT03167281|Thoracic Surgery|thoracic surgery
5132168|NCT03167281|Deoxyribonucleases|deoxyribonucleases
5132169|NCT03167281|Fibrinolytic Agents|fibrinolytic agents
5132170|NCT03167281|Drainage|drainage
5132171|NCT03167281|Pleural Effusion|pleural effusion
5132172|NCT03167268|Lycopene|lycopene
5132173|NCT03167268|Anti EGFR therapy|anti egfr therapy
5132174|NCT03167216|chronic pain|chronic pain
5132175|NCT03167216|prostatitis|prostatitis
5132176|NCT03167216|pelvic pain|pelvic pain
5132177|NCT03167203|hESC-RPE|hesc-rpe
5132178|NCT03167203|Macular Degenerative Disease|macular degenerative disease
5132179|NCT03167190|Point of Care Ultrasound|point of care ultrasound
5132180|NCT03167151|Recurrent intermediate risk NMIBC|recurrent intermediate risk nmibc
5132181|NCT03167151|Intravesical Pembrolizumab|intravesical pembrolizumab
5132182|NCT03167151|Intravenous Pembrolizumab|intravenous pembrolizumab
5132183|NCT03167151|Phase I/II|phase i/ii
5132184|NCT03167151|Marker-lesion|marker-lesion
5141842|NCT03104530|Cadmium body burden|cadmium body burden
5132199|NCT03167073|smartphone application|smartphone application
5132200|NCT03167073|low-income women|low-income women
5132201|NCT03167073|breastfeeding|breastfeeding
5132202|NCT03167073|health education|health education
5132203|NCT03167073|health disparities|health disparities
5132204|NCT03167073|postpartum weight loss|postpartum weight loss
5132205|NCT03167034|exercise|exercise
5132206|NCT03167034|echocardiography|echocardiography
5132207|NCT03167034|right ventricular function|right ventricular function
5017973|NCT03884465|PAH|pah
5132208|NCT03167034|obstructive airway disease|obstructive airway disease
5132209|NCT03167034|emphysema|emphysema
5128574|NCT03190941|KRAS|kras
5132215|NCT03167021|Students|students
5132216|NCT03166995|Fibromyalgia,postural exercises|fibromyalgia,postural exercises
5132217|NCT03166982|Tubo-ovarian abscess|tubo-ovarian abscess
5132218|NCT03166982|Transvaginal drainage|transvaginal drainage
5132219|NCT03166982|Laparoscopic treatment|laparoscopic treatment
5132220|NCT03166956|Vitamin C|vitamin c
5132221|NCT03166956|Glutamine|glutamine
5132222|NCT03166956|Interleukin-6|interleukin-6
5132223|NCT03166956|Clinical outcomes|clinical outcomes
5132224|NCT03166930|Muscle Spasticity|muscle spasticity
5132225|NCT03166930|Muscle Stretching Exercises|muscle stretching exercises
5132226|NCT03166891|ovarian cancer, relapsed or refractory,chiauranib|ovarian cancer, relapsed or refractory,chiauranib
5132228|NCT03166878|Cancer treatment|cancer treatment
5132229|NCT03166878|Immunotherapy|immunotherapy
5132230|NCT03166878|Adoptive cell therapy|adoptive cell therapy
5132231|NCT03166878|Chimeric antigen receptor|chimeric antigen receptor
5132232|NCT03166878|Universal CAR-T|universal car-t
5132233|NCT03166865|osteoarthritis (OA)|osteoarthritis (oa)
5132234|NCT03166865|mesenchymal stem cells(MSC)|mesenchymal stem cells(msc)
5132235|NCT03166839|maternal health|maternal health
5132236|NCT03166839|statistical analysis plan|statistical analysis plan
5132237|NCT03166813|remote ischaemic preconditioning|remote ischaemic preconditioning
5132238|NCT03166813|childhood cancer|childhood cancer
5132239|NCT03166813|cardio-oncology|cardio-oncology
5132240|NCT03166813|anthracycline|anthracycline
5132241|NCT03166813|myocardial reperfusion injury|myocardial reperfusion injury
5132242|NCT03166800|mitoquinone|mitoquinone
5132243|NCT03166800|Fatigue|fatigue
5132244|NCT03166800|Multiple Sclerosis|multiple sclerosis
5132245|NCT03166748|Incomplete lower first molar|incomplete lower first molar
5132246|NCT03166748|Immature permanent molar|immature permanent molar
5132247|NCT03166748|Potassium nitrate in polycarboxylate|potassium nitrate in polycarboxylate
5132248|NCT03166748|Mineral trioxide aggregate .Mineral trioxid|mineral trioxide aggregate .mineral trioxid
5132249|NCT03166644|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
5132250|NCT03166644|Postoperative Analgesia|postoperative analgesia
5132251|NCT03166644|Postoperative Hypoxemia|postoperative hypoxemia
5132252|NCT03166566|glaucoma|glaucoma
5132253|NCT03166566|glaucoma surgery|glaucoma surgery
5132254|NCT03166566|glaucoma drainage device|glaucoma drainage device
5132255|NCT03166566|glaucoma implant|glaucoma implant
5132256|NCT03166566|blindness|blindness
5132257|NCT03166540|coffee|coffee
5132258|NCT03166540|cocoa|cocoa
5132259|NCT03166540|bioavailability|bioavailability
5132260|NCT03166540|pharmacokinetics|pharmacokinetics
5132261|NCT03166540|cardiometabolic risk factors|cardiometabolic risk factors
5132262|NCT03166540|caffeoylquinic acids|caffeoylquinic acids
5132263|NCT03166540|flavan-3-ol|flavan-3-ol
5132264|NCT03166540|caffeine|caffeine
5132265|NCT03166540|trigonelline|trigonelline
5132266|NCT03166540|diterpene|diterpene
5132267|NCT03166449|Traumatic Brain injury|traumatic brain injury
5132268|NCT03166449|Immunonutrition|immunonutrition
5132269|NCT03166384|electrosurgical bipolar sealing devices, breast cancer|electrosurgical bipolar sealing devices, breast cancer
5132270|NCT03166371|Endocrinology|endocrinology
5132271|NCT03166371|Nutrition|nutrition
5132272|NCT03166371|Aging|aging
5132273|NCT03166332|Mindfulness|mindfulness
5132274|NCT03166332|Mediterranean diet|mediterranean diet
5132275|NCT03166332|Neurodevelopment|neurodevelopment
5132276|NCT03166332|Epigenetics|epigenetics
5132277|NCT03166332|Fetal growth restriction|fetal growth restriction
5132278|NCT03166306|pulmonary vascular disease|pulmonary vascular disease
5132279|NCT03166306|pulmonary vascular imaging|pulmonary vascular imaging
5132280|NCT03166293|Cerebral Palsy|cerebral palsy
5132293|NCT03166150|Pelvic Floor Disorder|pelvic floor disorder
5132294|NCT03166150|Pelvic Floor Muscle|pelvic floor muscle
5132295|NCT03166150|Strength|strength
5132296|NCT03166150|Disability|disability
5132297|NCT03166150|Aging|aging
5132298|NCT03166150|Atrophy|atrophy
5132299|NCT03166150|Exercise|exercise
5132300|NCT03166150|Magnetic Resonance Imaging|magnetic resonance imaging
5132301|NCT03166150|Fatty Infiltration|fatty infiltration
5132305|NCT03166150|Urge Urinary Incontinence|urge urinary incontinence
5132306|NCT03166150|Mixed Urinary Incontinence|mixed urinary incontinence
5132307|NCT03166137|Warts,Laser,Cryotherapy|warts,laser,cryotherapy
5132308|NCT03166098|Psychotic Spectrum Disorders|psychotic spectrum disorders
5132309|NCT03166085|HER2-Negative|her2-negative
5132310|NCT03166085|PU-H71|pu-h71
5132311|NCT03166085|Nab-paclitaxel (Abraxane)|nab-paclitaxel (abraxane)
5132312|NCT03166085|17-093|17-093
5132313|NCT03166072|Low-vision|low-vision
5132314|NCT03166072|health related quality of life|health related quality of life
5132315|NCT03166072|visual aids|visual aids
5132316|NCT03166072|randomized controlled trial|randomized controlled trial
5132317|NCT03166059|Catheter directed thrombolysis (CDT)|catheter directed thrombolysis (cdt)
5132318|NCT03166033|Carpal Tunnel Syndrome|carpal tunnel syndrome
5132320|NCT03166033|risk factor|risk factor
5132321|NCT03166020|Serious Game|serious game
5132323|NCT03166020|Rehabilitation|rehabilitation
5132324|NCT03166020|Connected objects|connected objects
5132325|NCT03166007|Multiple Sclerosis|multiple sclerosis
5132326|NCT03166007|Neurogenic Bowel Dysfunction|neurogenic bowel dysfunction
5132327|NCT03166007|Abdominal massage|abdominal massage
5132328|NCT03165994|esophagus|esophagus
5132329|NCT03165994|gastroesophageal (GE) junction|gastroesophageal (ge) junction
5132330|NCT03165994|T1-3N0-1|t1-3n0-1
5132331|NCT03165981|Influenza vaccine|influenza vaccine
5132332|NCT03165981|fever following vaccination|fever following vaccination
5132333|NCT03165981|PCV13 vaccine|pcv13 vaccine
5132334|NCT03165981|DTaP vaccine|dtap vaccine
5132335|NCT03165981|pneumococcal vaccine|pneumococcal vaccine
5132336|NCT03165955|breast cancer|breast cancer
5132337|NCT03165955|paclitaxel|paclitaxel
5132338|NCT03165929|free gingival grafts|free gingival grafts
5132339|NCT03165929|connective tissue grafts|connective tissue grafts
5132340|NCT03165929|flurbiprofen|flurbiprofen
5132341|NCT03165890|cognition|cognition
5132342|NCT03165890|visuomotor learning|visuomotor learning
5132343|NCT03165890|airway disease|airway disease
5132344|NCT03165890|altitude|altitude
5132345|NCT03165890|prevention|prevention
5132346|NCT03165890|acetazolamide|acetazolamide
5132347|NCT03165877|GLYCEMIC INDEX|glycemic index
5132348|NCT03165877|NAFLD|nafld
5132349|NCT03165877|METABOLIC PARAMETERS|metabolic parameters
5132350|NCT03165877|SATIETY|satiety
5132351|NCT03165864|Thalassaemia, IONIS TMPRSS6-Lrx|thalassaemia, ionis tmprss6-lrx
5132352|NCT03165838|postpartum|postpartum
5132353|NCT03165838|pregnancy|pregnancy
5132354|NCT03165838|contraception|contraception
5132355|NCT03165838|RROP|rrop
5132356|NCT03165812|Sleeve Gastrectomy|sleeve gastrectomy
5132357|NCT03165812|Duodeno Jejunal Bypass|duodeno jejunal bypass
5132358|NCT03165812|Single Anastomosis|single anastomosis
5132359|NCT03165812|Intensive Medical Therapy|intensive medical therapy
5132360|NCT03165812|Diabetes Mellitus|diabetes mellitus
5132361|NCT03165786|fear of hypoglycemia|fear of hypoglycemia
5132362|NCT03165786|self-management|self-management
5132363|NCT03165786|glycemic control|glycemic control
5132364|NCT03165786|glycemic variability|glycemic variability
5132365|NCT03165760|protective mechanical ventilation|protective mechanical ventilation
5132366|NCT03165747|Probiotics|probiotics
5132367|NCT03165747|Menopausal Osteoporosis|menopausal osteoporosis
5132395|NCT03165669|pillow|pillow
5132396|NCT03165669|neck|neck
5132397|NCT03165656|Echocardiography|echocardiography
5132398|NCT03165656|right ventricular function|right ventricular function
5132399|NCT03165656|pulmonary hypertension|pulmonary hypertension
5132400|NCT03165656|disease progression|disease progression
5132401|NCT03165656|hypoxia|hypoxia
5132402|NCT03165617|Influenza vaccine|influenza vaccine
5132403|NCT03165604|Physical fitness|physical fitness
5132404|NCT03165604|Exercise|exercise
5132405|NCT03165604|Childhood Obesity|childhood obesity
5132406|NCT03165604|Information|information
5132407|NCT03165539|Postoperative|postoperative
5132408|NCT03165539|One-lung ventilation|one-lung ventilation
5132409|NCT03165539|Cerebral oximetry|cerebral oximetry
5132410|NCT03165539|Cerebral desaturation|cerebral desaturation
5132411|NCT03165513|Traditional healer|traditional healer
5132412|NCT03165513|faith healer|faith healer
5132413|NCT03165513|depression|depression
5132414|NCT03165513|mhGAP|mhgap
5132415|NCT03165513|Kenya|kenya
5132416|NCT03165500|Exodontia|exodontia
5132417|NCT03165500|Sedation|sedation
5132418|NCT03165500|Nitrous Oxide|nitrous oxide
5132419|NCT03165500|Benzodiazepines|benzodiazepines
5132420|NCT03165487|Triple Negative Breast Cancer|triple negative breast cancer
5132421|NCT03165487|microenvironment|microenvironment
5132422|NCT03165487|IORT|iort
5132423|NCT03165487|Hormone Receptor Positive, HER 2 negative|hormone receptor positive, her 2 negative
5132437|NCT03165383|Transverse Abdominis Plane (TAP) Block|transverse abdominis plane (tap) block
5132438|NCT03165383|Patient Control Analgesia (PCA)|patient control analgesia (pca)
5132439|NCT03165357|Crossfit|crossfit
5132440|NCT03165357|Sodium bicarbonate|sodium bicarbonate
5132441|NCT03165357|Physical capacity|physical capacity
5132442|NCT03165318|Pulsed electromagnetic field|pulsed electromagnetic field
5018140|NCT03883438|Surgery|surgery
5132443|NCT03165318|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5132445|NCT03165253|Helicobacter pylori infection|helicobacter pylori infection
5132446|NCT03165253|Children|children
5132447|NCT03165253|Synbiotic|synbiotic
5132448|NCT03165253|Standard Triple Therapy|standard triple therapy
5132449|NCT03165201|Liver transplantation and Biopsy|liver transplantation and biopsy
5132450|NCT03165201|Liver transplantation and LiverMultiScan|liver transplantation and livermultiscan
5132451|NCT03165175|prescription drug abuse|prescription drug abuse
5132452|NCT03165175|prescription drug misuse|prescription drug misuse
5132453|NCT03165175|risk reduction|risk reduction
5132455|NCT03165175|military|military
5132456|NCT03165175|mobile application|mobile application
5132457|NCT03165175|substance misuse|substance misuse
5132458|NCT03165175|substance abuse|substance abuse
5132459|NCT03165162|natural|natural
5132460|NCT03165162|Food Label Choices|food label choices
5132461|NCT03165136|Unexplained Recurrent Miscarriage|unexplained recurrent miscarriage
5132462|NCT03165136|First trimester abortion|first trimester abortion
5132463|NCT03165136|Hydroxychloroquine|hydroxychloroquine
5132464|NCT03165136|Antiphospholipid antibody|antiphospholipid antibody
5132465|NCT03165097|tolerability|tolerability
5132466|NCT03165097|safety|safety
5132467|NCT03165084|Self-management|self-management
5962041|NCT04283357|virtual reality|virtual reality
5132468|NCT03165084|Primary Health Care|primary health care
5132469|NCT03165084|eHealth|ehealth
5132470|NCT03165032|exercise|exercise
5132471|NCT03165032|echocardiography|echocardiography
5132472|NCT03165032|right ventricular function|right ventricular function
5132473|NCT03165032|pulmonary hypertension|pulmonary hypertension
5132474|NCT03165032|hypoxia|hypoxia
5132475|NCT03165019|high altitude illness|high altitude illness
5132476|NCT03165019|pulmonary hypertension|pulmonary hypertension
5132477|NCT03165019|sleep apnea|sleep apnea
5132484|NCT03164980|platinum sensitive|platinum sensitive
5132485|NCT03164980|recurrent|recurrent
5132486|NCT03164941|selective laser trabeculoplasty|selective laser trabeculoplasty
5132487|NCT03164941|practice|practice
5132488|NCT03164941|treatment|treatment
5132489|NCT03164941|intraocular pressure|intraocular pressure
5132490|NCT03164928|Denosumab|denosumab
5132491|NCT03164928|Pediatric GIOP|pediatric giop
5132492|NCT03164928|Glucocorticoid-induced|glucocorticoid-induced
5132493|NCT03164928|Osteoporosis|osteoporosis
5132494|NCT03164889|Chronic hepatitis B, antiviral treatment|chronic hepatitis b, antiviral treatment
5132495|NCT03164863|Neoadjuvant Chemotherapy, Triple Negative Breast Cancer|neoadjuvant chemotherapy, triple negative breast cancer
5132496|NCT03164824|Questionnaire|questionnaire
5132497|NCT03164824|Functional Rating Index|functional rating index
5132498|NCT03164824|Cross-cultural adaptation|cross-cultural adaptation
5132499|NCT03164824|Psychometric properties testing|psychometric properties testing
5132507|NCT03164746|Autism|autism
5132508|NCT03164746|Therapeutic body wraps|therapeutic body wraps
5132509|NCT03164681|sheerly|sheerly
5132510|NCT03164642|Depressive Symptoms|depressive symptoms
5132511|NCT03164642|Developmental Disabilities|developmental disabilities
5132512|NCT03164642|Early Intervention|early intervention
5132513|NCT03164642|Language Development|language development
5132514|NCT03164642|Communication|communication
5132515|NCT03164642|Maternal Empowerment|maternal empowerment
5132516|NCT03164629|BPH|bph
5132517|NCT03164629|Lower Urinary Track Infection|lower urinary track infection
5132518|NCT03164629|Urine Retention|urine retention
5142148|NCT03102437|CCM|ccm
5132528|NCT03164551|EEVA|eeva
5132529|NCT03164551|Embryo culture|embryo culture
5132530|NCT03164551|In Vitro Fertilization|in vitro fertilization
5132531|NCT03164551|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
5132532|NCT03164525|Thai version|thai version
5132533|NCT03164525|validated|validated
5132534|NCT03164525|Critical Care Pain Observation Tool|critical care pain observation tool
5132535|NCT03164525|Behavioral Pain Scale|behavioral pain scale
5132536|NCT03164525|adult ICU patients|adult icu patients
5132537|NCT03164499|Health education|health education
5132538|NCT03164499|Life style|life style
5132539|NCT03164499|Risk factors|risk factors
5132540|NCT03164499|Cardiovascular diseases|cardiovascular diseases
5132541|NCT03164499|Cognitive performance|cognitive performance
5132542|NCT03164499|Quality of life|quality of life
5132543|NCT03164473|Eosinophilic granulomatosis with polyangiitis in remission|eosinophilic granulomatosis with polyangiitis in remission
5132544|NCT03164473|double-blind randomized controlled trial|double-blind randomized controlled trial
5132545|NCT03164473|maintenance therapy|maintenance therapy
5132546|NCT03164473|rituximab versus azathioprine|rituximab versus azathioprine
5132547|NCT03164473|vasculitis remission|vasculitis remission
5132548|NCT03164473|asthma control|asthma control
5132549|NCT03164473|rhinosinusal manifestations control|rhinosinusal manifestations control
5132550|NCT03164473|glucocorticoid therapy reduction/withdrawal|glucocorticoid therapy reduction/withdrawal
5132551|NCT03164473|steroid sparing effect|steroid sparing effect
5132552|NCT03164473|damage|damage
5132553|NCT03164434|intracranial pressure|intracranial pressure
5132554|NCT03164434|cerebrospinal fluid drainage|cerebrospinal fluid drainage
5132555|NCT03164434|waveform analysis|waveform analysis
5132556|NCT03164395|atrial fibrillation|atrial fibrillation
5132557|NCT03164395|implantable cardiac defibrillator|implantable cardiac defibrillator
5132558|NCT03164395|cardioversion|cardioversion
5132559|NCT03164369|epidural block, ultrasound|epidural block, ultrasound
5132560|NCT03164356|Limb Fluid Volume Management|limb fluid volume management
5132561|NCT03164356|Prosthetic Socket Modification|prosthetic socket modification
5132562|NCT03164343|Pain Neuroscience Education|pain neuroscience education
5132563|NCT03164330|Health Care|health care
5132564|NCT03164330|Workplace Wellness|workplace wellness
5132565|NCT03164330|Preventative Health Care|preventative health care
5132566|NCT03164330|Health Costs|health costs
5132570|NCT03164317|Decision support system|decision support system
5132572|NCT03164278|Wheelchair|wheelchair
5132573|NCT03164278|Biomechanics|biomechanics
5132574|NCT03164278|Transfer|transfer
5132575|NCT03164278|Participation|participation
5132576|NCT03164278|Training|training
5132577|NCT03164265|Regulatory Dendritic Cells|regulatory dendritic cells
5132578|NCT03164252|Third molar;|third molar;
5132579|NCT03164252|Third molar surgery;|third molar surgery;
5132581|NCT03164252|Tissue Repair.|tissue repair.
5132582|NCT03164226|endothelial function|endothelial function
5132583|NCT03164226|acute coronary syndrome|acute coronary syndrome
5132584|NCT03164213|tDCS|tdcs
5132585|NCT03164213|aphasia|aphasia
5132586|NCT03164161|Pain Sensitivity|pain sensitivity
5132587|NCT03164161|Measurement|measurement
5132588|NCT03164161|Cold Pressor|cold pressor
5132589|NCT03164161|β-endorphins|β-endorphins
5132590|NCT03164161|saliva|saliva
5132591|NCT03164161|oral surgery|oral surgery
5132592|NCT03164109|Healthy Adult|healthy adult
5132593|NCT03164109|Superoxide Dismutase|superoxide dismutase
5132594|NCT03164109|Free Radical Dismutase|free radical dismutase
5132595|NCT03164109|Cardiodynamic Assessment|cardiodynamic assessment
5132596|NCT03164083|Joint Diseases|joint diseases
5132597|NCT03164083|Musculoskeletal Diseases|musculoskeletal diseases
5132598|NCT03164083|Arthritis|arthritis
5132599|NCT03164070|Osteoarthritis|osteoarthritis
5132600|NCT03164070|Flow cytometry|flow cytometry
5132601|NCT03164070|Synovial fluid|synovial fluid
5132602|NCT03164057|DNA methyltransferase inhibitors|dna methyltransferase inhibitors
5132603|NCT03164057|Acute myeloid leukemia|acute myeloid leukemia
5132604|NCT03164044|Allergy|allergy
5132605|NCT03164044|Drug allergy|drug allergy
5132606|NCT03164044|Basophil activation test|basophil activation test
5132607|NCT03164044|Flow cytometry|flow cytometry
5132608|NCT03164005|VEGF-B|vegf-b
5132609|NCT03163979|locally advanced cervical cancer; radiotherapy|locally advanced cervical cancer; radiotherapy
5132610|NCT03163953|Physical Activity|physical activity
5132611|NCT03163953|Sedentary Lifestyle|sedentary lifestyle
5132612|NCT03163953|Office Workers|office workers
5132613|NCT03163940|Laughter Yoga|laughter yoga
5132614|NCT03163940|Major Depressive Disorder|major depressive disorder
5132615|NCT03163940|Anxiety|anxiety
5132616|NCT03163940|Stress|stress
5132617|NCT03163940|Depression|depression
5132618|NCT03163940|Quality of Life|quality of life
5132619|NCT03163940|Mood Disorder|mood disorder
5132620|NCT03163914|vasopressor|vasopressor
5132621|NCT03163914|spinal anaesthesia|spinal anaesthesia
5132622|NCT03163901|traumatic brain injury|traumatic brain injury
5132623|NCT03163875|erythema|erythema
5132624|NCT03163875|wheal formation|wheal formation
5132625|NCT03163875|vascular reaction of the skin|vascular reaction of the skin
5132627|NCT03163836|Double Valve Replacement|double valve replacement
5132628|NCT03163836|Atrial Fibrillation Ablation|atrial fibrillation ablation
5132629|NCT03163797|Oropharyngeal cancer|oropharyngeal cancer
5132630|NCT03163797|integrated PET/MR|integrated pet/mr
5132631|NCT03163797|diffusion-weighted imaging|diffusion-weighted imaging
5132632|NCT03163797|perfusion-weighted imaging|perfusion-weighted imaging
5132633|NCT03163758|Ischemic stroke|ischemic stroke
5132634|NCT03163758|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5132635|NCT03163758|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5132636|NCT03163758|Brain Reorganization|brain reorganization
5132637|NCT03163732|Solid tumor|solid tumor
5018348|NCT03882281|HQP1351|hqp1351
5132638|NCT03163732|Advanced tumor|advanced tumor
5132639|NCT03163732|Profiling panel|profiling panel
5132640|NCT03163719|Seizure|seizure
5758010|NCT00291109|RTPCR|rtpcr
5132641|NCT03163719|Generalized convulsive seizure|generalized convulsive seizure
5132642|NCT03163719|Convulsions|convulsions
5132643|NCT03163719|Creatine Kinase|creatine kinase
5132644|NCT03163719|Lactate|lactate
5132645|NCT03163719|Lactacidaemia|lactacidaemia
5132646|NCT03163719|Diagnostic|diagnostic
5132647|NCT03163719|Losing consciousness|losing consciousness
5132648|NCT03163719|Epilepsy|epilepsy
5132649|NCT03163719|Epileptic generalized tonic-clonic seizure|epileptic generalized tonic-clonic seizure
5132650|NCT03163706|Schizophrenia|schizophrenia
5132651|NCT03163706|Stroop effect|stroop effect
5132652|NCT03163706|Semantic conflict|semantic conflict
5132653|NCT03163706|Response conflict|response conflict
5132654|NCT03163693|Dexmedetomidine|dexmedetomidine
5132655|NCT03163693|Cardiac Troponin I|cardiac troponin i
5132656|NCT03163693|Glycogen Phosphorylase Isoenzyme BB|glycogen phosphorylase isoenzyme bb
5132657|NCT03163680|Gastroduodenal Ulcer|gastroduodenal ulcer
5132658|NCT03163680|Marginal Ulcer|marginal ulcer
5132659|NCT03163680|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
5132660|NCT03163680|Peptic Ulcer|peptic ulcer
5132661|NCT03163667|advanced, metastatic RCC|advanced, metastatic rcc
5132664|NCT03163667|Everolimus|everolimus
5132665|NCT03163667|CBE|cbe
5132666|NCT03163667|Glutaminase Inhibitor|glutaminase inhibitor
5132667|NCT03163667|Glutaminase|glutaminase
5132668|NCT03163667|Tumor Metabolism|tumor metabolism
5132669|NCT03163667|Glutamine|glutamine
5132670|NCT03163654|multiple gingival recessions|multiple gingival recessions
5132671|NCT03163654|collagen matrix|collagen matrix
5132672|NCT03163654|connective tissue graft|connective tissue graft
5132673|NCT03163654|tunnel technique|tunnel technique
5132674|NCT03163641|Photorefractive Keratectomy, Corneal Defect|photorefractive keratectomy, corneal defect
5132675|NCT03163628|severe bacterial infection|severe bacterial infection
5132676|NCT03163628|acute infection|acute infection
5132677|NCT03163628|infection viral|infection viral
5132678|NCT03163628|biomarker combination|biomarker combination
5132679|NCT03163628|diagnostic|diagnostic
5132680|NCT03163628|child|child
5132681|NCT03163602|Peri-Implantitis|peri-implantitis
5132682|NCT03163602|Infection|infection
5132683|NCT03163602|Bone substitutes|bone substitutes
5132684|NCT03163524|family planning|family planning
5132685|NCT03163524|reproductive health|reproductive health
5132686|NCT03163524|m-health|m-health
5132687|NCT03163498|Hypertension|hypertension
5132688|NCT03163498|Exercise|exercise
5132689|NCT03163498|Sleep|sleep
5132690|NCT03163485|epilepsy|epilepsy
5132691|NCT03163485|multimodal neuromonitoring|multimodal neuromonitoring
5132692|NCT03163485|depth EEG|depth eeg
5132693|NCT03163485|microdialysis|microdialysis
5132694|NCT03163485|brain injury|brain injury
5132695|NCT03163485|brain tissue at risk|brain tissue at risk
5132696|NCT03163485|NCSE|ncse
5132697|NCT03163485|short time monitoring|short time monitoring
5132698|NCT03163485|neurologic ICU|neurologic icu
5132699|NCT03163459|mechanical thrombectomy|mechanical thrombectomy
5132700|NCT03163459|selective brain cooling|selective brain cooling
5132701|NCT03163446|Staphylococcus aureus|staphylococcus aureus
5132702|NCT03163446|bacteremia|bacteremia
5132703|NCT03163446|staphylococcal endocarditis|staphylococcal endocarditis
5132704|NCT03163433|Patient activation measure|patient activation measure
5132705|NCT03163433|Self-efficacy|self-efficacy
5132706|NCT03163433|Patient participation in research|patient participation in research
5132707|NCT03163433|Patient reported outcome measures|patient reported outcome measures
5132708|NCT03163420|Anesthetic efficacy|anesthetic efficacy
5132709|NCT03163420|Diclofenac|diclofenac
5132710|NCT03163420|Irreversible pulpitis|irreversible pulpitis
5132711|NCT03163381|first-line treatment failure|first-line treatment failure
5132712|NCT03163381|one measurable lesion|one measurable lesion
5132713|NCT03163368|metastatic tumor|metastatic tumor
5132714|NCT03163368|brain lesion|brain lesion
5132715|NCT03163368|stereotactic radiosurgery|stereotactic radiosurgery
5132717|NCT03163368|maximum tolerated dose|maximum tolerated dose
5132718|NCT03163368|dose escalation|dose escalation
5132719|NCT03163368|neurosurgical resection|neurosurgical resection
5132720|NCT03163355|pureed diet|pureed diet
5132721|NCT03163355|dysphasia|dysphasia
5132722|NCT03163342|Seasonal|seasonal
5132723|NCT03163303|Tobacco|tobacco
5132724|NCT03163303|Cigarettes|cigarettes
5132725|NCT03163303|Alcohol|alcohol
5132726|NCT03163303|Cessation|cessation
5132727|NCT03163303|Intervention|intervention
5132728|NCT03163303|Young adults|young adults
5132729|NCT03163303|Internet|internet
5132730|NCT03163303|Social media|social media
5132731|NCT03163264|obesity|obesity
5132732|NCT03163264|weight loss|weight loss
5132733|NCT03163264|weight gain|weight gain
5132734|NCT03163264|weight management|weight management
5132735|NCT03163264|primary care|primary care
5132736|NCT03163264|health coach|health coach
5132737|NCT03163251|READ-SG|read-sg
5132738|NCT03163251|Burnout|burnout
5132739|NCT03163251|Professional identity|professional identity
5132740|NCT03163251|Empathy|empathy
5132741|NCT03163251|Emotional intelligence|emotional intelligence
5132742|NCT03163238|Dexmedetomidine|dexmedetomidine
5132743|NCT03163238|Congenital Heart Disease|congenital heart disease
5132744|NCT03163238|Cardiopulmonary Bypass|cardiopulmonary bypass
5132745|NCT03163238|Interleukin|interleukin
5132746|NCT03163225|outpatient care|outpatient care
5132747|NCT03163225|emergency department visits|emergency department visits
5132748|NCT03163212|Lactoferrin/FOS Supplementation|lactoferrin/fos supplementation
5132749|NCT03163173|Healthy Adult|healthy adult
5132750|NCT03163173|Superoxide Dismutase|superoxide dismutase
5132751|NCT03163173|Absorption|absorption
5132752|NCT03163173|Metabolism|metabolism
5132753|NCT03163173|Elimination|elimination
5132754|NCT03163173|Mass Balance|mass balance
5132755|NCT03163173|Male Subjects|male subjects
5132756|NCT03163160|pelvic floor muscles|pelvic floor muscles
5132757|NCT03163160|pelvic floor myalgia|pelvic floor myalgia
5132758|NCT03163160|manual therapy|manual therapy
5132759|NCT03163160|electrolysis|electrolysis
5132760|NCT03163160|galvanic|galvanic
5132761|NCT03163147|frequency|frequency
5132762|NCT03163134|Lumbar Drain, CSF Leak|lumbar drain, csf leak
5132763|NCT03163121|Plasmodium falciparum|plasmodium falciparum
5132765|NCT03163121|PfSPZ-GA1 Vaccine|pfspz-ga1 vaccine
5132766|NCT03163121|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
5356845|NCT01917760|C-peptide|c-peptide
5132767|NCT03163121|Genetically attenuated sporozoites|genetically attenuated sporozoites
5132768|NCT03163121|Plasmodium falciparum sporozoites (PfSPZ)|plasmodium falciparum sporozoites (pfspz)
5132769|NCT03163108|controller|controller
5132770|NCT03163108|hyperoxia|hyperoxia
5132771|NCT03163108|hypoxia|hypoxia
5132786|NCT03163030|Preserved Ejection Fraction|preserved ejection fraction
5132788|NCT03163030|Vagus Nerve|vagus nerve
5132789|NCT03163030|Autonomic Regulation Therapy|autonomic regulation therapy
5132790|NCT03163017|3D Fluoroscopy|3d fluoroscopy
5132791|NCT03163004|Sedentary behavior|sedentary behavior
5132792|NCT03162978|Exercise|exercise
5132793|NCT03162978|behavior economics|behavior economics
5132794|NCT03162952|Chronic pain|chronic pain
5132795|NCT03162913|Strawberry|strawberry
5132796|NCT03162913|Cognition|cognition
5132797|NCT03162913|Gait|gait
5132798|NCT03162913|Posture|posture
5132799|NCT03162900|Glasdegib|glasdegib
5132800|NCT03162900|PF-04449913|pf-04449913
5132801|NCT03162900|Pharmacokinetics|pharmacokinetics
5132803|NCT03162900|TQT|tqt
5132804|NCT03162874|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
5132805|NCT03162874|Wearing-off|wearing-off
5132806|NCT03162874|Foliglurax|foliglurax
5132807|NCT03162874|Parkinson's Disease|parkinson's disease
5132808|NCT03162874|mGluR4 PAM|mglur4 pam
5132809|NCT03162835|Pain Neuroscience Education|pain neuroscience education
5132810|NCT03162822|Caregiver-Child Coercion|caregiver-child coercion
5132811|NCT03162822|Early Childhood Caries|early childhood caries
5132812|NCT03162809|infertility|infertility
5132813|NCT03162809|in vitro fertilization|in vitro fertilization
5132814|NCT03162809|Estradiol|estradiol
5132815|NCT03162809|Progesterone|progesterone
5132816|NCT03162783|Aldeyra|aldeyra
5132817|NCT03162770|mindfulness meditation|mindfulness meditation
5132818|NCT03162770|hemodialysis|hemodialysis
5132819|NCT03162770|quality of life|quality of life
5132820|NCT03162770|stress|stress
5132821|NCT03162718|lung cancer|lung cancer
5132822|NCT03162718|exercise|exercise
5132823|NCT03162718|pre-operative exercise program|pre-operative exercise program
5132824|NCT03162679|trauma treatment|trauma treatment
5132825|NCT03162679|Refugees|refugees
5132826|NCT03162679|Emotion regulation|emotion regulation
5132827|NCT03162679|Group therapy|group therapy
5132828|NCT03162679|randomized controlled|randomized controlled
5132829|NCT03162679|PTSD|ptsd
5132830|NCT03162653|Allopurinol|allopurinol
5132831|NCT03162653|hypothermia therapy|hypothermia therapy
5132832|NCT03162653|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5132833|NCT03162653|neonatal oxygen deficiency|neonatal oxygen deficiency
5132835|NCT03162653|perinatal asphyxia|perinatal asphyxia
5132836|NCT03162640|Early onset of cannabis use|early onset of cannabis use
5132837|NCT03162640|Addiction|addiction
5132838|NCT03162640|Time perception|time perception
5133209|NCT03160586|Anxiety|anxiety
5132851|NCT03162614|healthy volunteers|healthy volunteers
5132852|NCT03162614|Malaria|malaria
5132853|NCT03162614|malaria vaccine|malaria vaccine
5132854|NCT03162614|controlled human challenge|controlled human challenge
5132855|NCT03162614|RTS,S/AS01|rts,s/as01
5132856|NCT03162536|ARQ 531|arq 531
5132857|NCT03162536|Hematologic Malignancies|hematologic malignancies
5132859|NCT03162536|CLL|cll
5132860|NCT03162536|B-cell NHL|b-cell nhl
5132861|NCT03162536|WM|wm
5132862|NCT03162536|BTK (Bruton's tyrosine kinase)|btk (bruton's tyrosine kinase)
5132863|NCT03162536|cancer|cancer
5132864|NCT03162536|refractory|refractory
5132865|NCT03162536|relapsed|relapsed
5132866|NCT03162536|Acalabrutinib|acalabrutinib
5132867|NCT03162536|ArQule|arqule
5132868|NCT03162536|BGB-3111|bgb-3111
5132869|NCT03162536|Blood Protein Disorders|blood protein disorders
5132870|NCT03162536|Follicular Lymphoma|follicular lymphoma
5132871|NCT03162536|BTK Intolerant|btk intolerant
5132872|NCT03162536|C481|c481
5132873|NCT03162536|C481S|c481s
5132874|NCT03162536|C481S Mutation|c481s mutation
5132877|NCT03162536|DLBCL (Diffuse Large B-cell lymphoma)|dlbcl (diffuse large b-cell lymphoma)
5132879|NCT03162536|Hemorrhagic Disorders|hemorrhagic disorders
5132880|NCT03162536|Hemostatic Disorders|hemostatic disorders
5132881|NCT03162536|Ibrutinib|ibrutinib
5132882|NCT03162536|Immune System Diseases|immune system diseases
5132883|NCT03162536|Immunoproliferative Disorders|immunoproliferative disorders
5132884|NCT03162536|Leukemia|leukemia
5132885|NCT03162536|Leukemia, B-Cell|leukemia, b-cell
5132886|NCT03162536|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5132887|NCT03162536|Leukemia, Lymphoid|leukemia, lymphoid
5132888|NCT03162536|Lymphatic Diseases|lymphatic diseases
5132889|NCT03162536|Lymphoma|lymphoma
5132890|NCT03162536|Lymphoma, B-Cell|lymphoma, b-cell
5132891|NCT03162536|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5132892|NCT03162536|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5132893|NCT03162536|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5132894|NCT03162536|Lymphoproliferative Disorders|lymphoproliferative disorders
5132895|NCT03162536|Mantle Cell Lymphoma|mantle cell lymphoma
5132896|NCT03162536|Marginal zone lymphoma|marginal zone lymphoma
5132897|NCT03162536|Neoplasms|neoplasms
5132898|NCT03162536|Neoplasms by Histologic Type|neoplasms by histologic type
5132899|NCT03162536|Neoplasms, Plasma Cell|neoplasms, plasma cell
5132900|NCT03162536|NHL (Non-Hodgkin's Lymphoma)|nhl (non-hodgkin's lymphoma)
5132901|NCT03162536|ONO-4059|ono-4059
5132902|NCT03162536|Paraproteinemias|paraproteinemias
5132903|NCT03162536|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5132904|NCT03162536|Tirabrutinib|tirabrutinib
5132905|NCT03162536|Vascular Diseases|vascular diseases
5132906|NCT03162536|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5132907|NCT03162536|Zanubrutinib|zanubrutinib
5132908|NCT03162510|SOLAR regimen|solar regimen
5132909|NCT03162471|Corneal astigmatism|corneal astigmatism
5132910|NCT03162471|Cataract surgery|cataract surgery
5132911|NCT03162471|Corneal hysteresis|corneal hysteresis
5132912|NCT03162471|Corneal resistance factor|corneal resistance factor
5132913|NCT03162471|Intraocular pressure|intraocular pressure
5132914|NCT03162445|bone mineral density|bone mineral density
5132915|NCT03162445|Autism Spectrum Disorder|autism spectrum disorder
5132918|NCT03162393|brachial plexus; avulsion injury|brachial plexus; avulsion injury
5132919|NCT03162380|Bipolar Disorder|bipolar disorder
5132920|NCT03162380|occupational stress|occupational stress
5132921|NCT03162367|Burn|burn
5132922|NCT03162367|Epidermal cell suspension|epidermal cell suspension
5132923|NCT03162341|Dual-Energy Computed Tomography|dual-energy computed tomography
5132924|NCT03162341|UltraSonography|ultrasonography
5132925|NCT03162341|Gout|gout
5132926|NCT03162341|Urate deposition|urate deposition
5132927|NCT03162302|MRI|mri
5132928|NCT03162302|magnetic resonance imaging|magnetic resonance imaging
5132929|NCT03162302|fat quantification|fat quantification
5132930|NCT03162302|iron quantification|iron quantification
5132931|NCT03162289|Fasting|fasting
5132932|NCT03162289|Vegan|vegan
5132933|NCT03162276|BRCA 1/2 Carriers|brca 1/2 carriers
5132934|NCT03162276|The Work|the work
5132935|NCT03162276|RCT|rct
5132936|NCT03162276|IBSR|ibsr
5132937|NCT03162263|Ekso|ekso
5132938|NCT03162263|neuroplasticity|neuroplasticity
5132939|NCT03162263|functional recovery|functional recovery
5132940|NCT03162237|Type1 diabetes|type1 diabetes
5132941|NCT03162237|porcine islets|porcine islets
5132942|NCT03162237|treg cells|treg cells
5132943|NCT03162237|immunosuppress|immunosuppress
5132944|NCT03162237|xenotransplantation|xenotransplantation
5132945|NCT03162224|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5132946|NCT03162224|Oropharyngeal Cancer|oropharyngeal cancer
5132947|NCT03162224|HPV|hpv
5132948|NCT03162224|Human Papilloma Virus|human papilloma virus
5132949|NCT03162224|Cancer Immunotherapy|cancer immunotherapy
5132950|NCT03162224|Check point inhibitors|check point inhibitors
5132952|NCT03162224|Recurrent or Metastatic Cancer|recurrent or metastatic cancer
5132953|NCT03162224|Durvalumab|durvalumab
5132954|NCT03162224|MEDI0457|medi0457
5132955|NCT03162224|Antineoplastic agents|antineoplastic agents
5132956|NCT03162224|Neoplasms|neoplasms
5132957|NCT03162185|Neuroplasticity|neuroplasticity
5132958|NCT03162185|SSRI|ssri
5132959|NCT03162185|Motor Learning|motor learning
5132960|NCT03162172|congenital adrenal hyperplasia|congenital adrenal hyperplasia
5132961|NCT03162172|short stature|short stature
5132962|NCT03162172|growth hormone treatment|growth hormone treatment
5132963|NCT03162133|Breast Cancer|breast cancer
5132964|NCT03162133|Aromatase Inhibitor Therapy|aromatase inhibitor therapy
5132965|NCT03162133|Baduanjin Exercise|baduanjin exercise
5132970|NCT03162081|addiction|addiction
5132971|NCT03162081|cognition|cognition
5132972|NCT03162081|impulsivity|impulsivity
5132976|NCT03162068|Cushing's syndrome|cushing's syndrome
5132977|NCT03162068|Osteoporosis|osteoporosis
5132978|NCT03162068|peripheral Quantitative Computed|peripheral quantitative computed
5132979|NCT03162068|volumetric Bone Mineral Density|volumetric bone mineral density
5132980|NCT03162068|Cortical and trabecular bone|cortical and trabecular bone
5132981|NCT03162068|Bone Strength|bone strength
5132982|NCT03162055|COPD|copd
5132983|NCT03162042|Activin A|activin a
5132984|NCT03162042|Myostatin|myostatin
5132985|NCT03162042|Follistatin|follistatin
5132986|NCT03162042|Cachexia|cachexia
5132987|NCT03162042|Squamous cell carcinoma|squamous cell carcinoma
5132988|NCT03162029|CBCT|cbct
5132989|NCT03162029|Bone quality|bone quality
5132990|NCT03162029|Renal failure|renal failure
5132991|NCT03161990|DAIR|dair
5132992|NCT03161990|Transgluteal approach|transgluteal approach
5132993|NCT03161990|Posterior approach|posterior approach
5132994|NCT03161964|Hypoglycemia|hypoglycemia
5132995|NCT03161964|Impaired Awareness of Hypoglycemia|impaired awareness of hypoglycemia
5132996|NCT03161964|Propranolol|propranolol
5132997|NCT03161951|acute Infections, flow cytometry, cell activation|acute infections, flow cytometry, cell activation
5132998|NCT03161912|Diabetes|diabetes
5132999|NCT03161912|Retinal Diseases|retinal diseases
5133000|NCT03161912|Diabetic Retinopathy|diabetic retinopathy
5133001|NCT03161912|Diabetic macular edema|diabetic macular edema
5133002|NCT03161912|Retinal vein occlusion|retinal vein occlusion
5133003|NCT03161912|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
5133004|NCT03161912|Intravitreal anti-VEGF (vascular endothelial growth factor)|intravitreal anti-vegf (vascular endothelial growth factor)
5133005|NCT03161912|VEGF inhibitor|vegf inhibitor
5133006|NCT03161912|aflibercept|aflibercept
5133007|NCT03161912|real world data|real world data
5133008|NCT03161912|treatment pattern|treatment pattern
5133009|NCT03161899|thalassemia - nutrition -growth|thalassemia - nutrition -growth
5133010|NCT03161886|colon capsule endoscopy|colon capsule endoscopy
5133011|NCT03161860|Program evaluation|program evaluation
5133012|NCT03161860|Cost-effectiveness|cost-effectiveness
5133013|NCT03161860|Community participation|community participation
5133014|NCT03161860|empowerment|empowerment
5133015|NCT03161847|OPMD|opmd
5133017|NCT03161834|Circulating tumor cells|circulating tumor cells
5133018|NCT03161795|Chemical coping|chemical coping
5133019|NCT03161795|Long-term opioid therapy|long-term opioid therapy
5133020|NCT03161795|Risk factors|risk factors
5133021|NCT03161795|Predictive tools|predictive tools
5133022|NCT03161795|Frequency|frequency
5133023|NCT03161782|pain|pain
5133024|NCT03161782|exercise|exercise
5133025|NCT03161782|proprioceptive neuromuscular facilitation stretching|proprioceptive neuromuscular facilitation stretching
5133026|NCT03161782|static stretching|static stretching
5133027|NCT03161743|platelet-rich plasma|platelet-rich plasma
5133028|NCT03161743|platelet|platelet
5133029|NCT03161730|videolaryngoscope, novice|videolaryngoscope, novice
5133030|NCT03161717|electrical stimulation|electrical stimulation
5133031|NCT03161717|vaginal delivery|vaginal delivery
5133032|NCT03161678|Pharmacogenetics|pharmacogenetics
5133033|NCT03161678|Carboxylesterase 1 (CES1)|carboxylesterase 1 (ces1)
5133034|NCT03161678|Antiplatelet therapy|antiplatelet therapy
5133035|NCT03161652|diabetic retinopathy|diabetic retinopathy
5133036|NCT03161652|blindness|blindness
5133037|NCT03161652|eye|eye
5133038|NCT03161652|macular edema|macular edema
5133039|NCT03161652|prolactin|prolactin
5133040|NCT03161652|dopamine antagonists|dopamine antagonists
5133041|NCT03161652|peptide hormones|peptide hormones
5133042|NCT03161639|Pulpectomy|pulpectomy
5133043|NCT03161639|Primary teeth|primary teeth
5133044|NCT03161639|Working length|working length
5133045|NCT03161639|Apex locator|apex locator
5133046|NCT03161587|FEV1|fev1
5133047|NCT03161587|COPD|copd
5133048|NCT03161587|CAT|cat
5133049|NCT03161587|treatment modality|treatment modality
5133050|NCT03161587|FVC|fvc
5133051|NCT03161587|GOLD 2016|gold 2016
5133052|NCT03161587|mMRC|mmrc
5133053|NCT03161574|neochemotherapy|neochemotherapy
5133054|NCT03161574|CRM|crm
5133059|NCT03161457|RA|ra
5133060|NCT03161457|Moderate RA|moderate ra
5133061|NCT03161457|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5133062|NCT03161457|Severe RA|severe ra
5133063|NCT03161457|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
5133064|NCT03161457|Moderate to Severe RA|moderate to severe ra
5133065|NCT03161457|Moderate to Severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
5133066|NCT03161431|Immunotherapy|immunotherapy
5133067|NCT03161431|Chemokine receptor blockade|chemokine receptor blockade
5133068|NCT03161431|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
5133069|NCT03161405|Drug Therapy|drug therapy
5133070|NCT03161392|mammography|mammography
5133667|NCT03157609|SpotOn|spoton
5133105|NCT03161275|cerebral saturation|cerebral saturation
5133106|NCT03161275|epidural anaesthesia|epidural anaesthesia
5133107|NCT03161275|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
5133108|NCT03161275|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
5133109|NCT03161262|Text-message reminder|text-message reminder
5133110|NCT03161262|Post-operative medication|post-operative medication
5133111|NCT03161262|Behavioral Research|behavioral research
5133112|NCT03161262|Social Research|social research
5133113|NCT03161262|Short Message Service (SMS)|short message service (sms)
5133114|NCT03161249|first psychotic episode, mobile app intervention|first psychotic episode, mobile app intervention
5133115|NCT03161223|Durvalumab|durvalumab
5133116|NCT03161223|Pralatrexate|pralatrexate
5133117|NCT03161223|Romidepsin|romidepsin
5133118|NCT03161223|5-Azacitidine|5-azacitidine
5133119|NCT03161197|CKD, Dialysis, ESRD|ckd, dialysis, esrd
5133120|NCT03161197|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
5133121|NCT03161184|maternal health|maternal health
5133122|NCT03161184|community health|community health
5133123|NCT03161184|health services|health services
5133124|NCT03161184|Tanzania|tanzania
5133125|NCT03161184|evaluation|evaluation
5133126|NCT03161184|cluster randomized trial|cluster randomized trial
5133127|NCT03161158|Cardio-Renal Syndrome type 1|cardio-renal syndrome type 1
5133128|NCT03161158|Acutely decompensated chronic heart failure|acutely decompensated chronic heart failure
5133129|NCT03161158|Ultrafiltration|ultrafiltration
5133130|NCT03161067|Tetraplegia|tetraplegia
5133131|NCT03161067|Rehabilitation|rehabilitation
5133132|NCT03161067|Brain Computer Interface|brain computer interface
5129388|NCT03185832|Arrhythmia|arrhythmia
5133136|NCT03161054|Elderly non-fit patients|elderly non-fit patients
5133137|NCT03161054|Aggressive B-Cell lymphomas|aggressive b-cell lymphomas
5133138|NCT03161041|Cytoreductive surgery, HIPEC, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery|cytoreductive surgery, hipec, perioperative chemotherapy, peritoneal carcinomatosis, bevacizumab, colorectal surgery
5133147|NCT03160989|Blood pressure variability|blood pressure variability
5133148|NCT03160989|Combined physical exercise|combined physical exercise
5133149|NCT03160989|Hypertension|hypertension
5133151|NCT03160937|pain|pain
5133152|NCT03160924|Enhanced recovery after surgery|enhanced recovery after surgery
5133153|NCT03160924|ERAS|eras
5133154|NCT03160924|Fast track recovery|fast track recovery
5133155|NCT03160924|Laparoscopic gastrectomy|laparoscopic gastrectomy
5133156|NCT03160924|Gastric Cancer|gastric cancer
5133157|NCT03160911|Over-the-scope clip|over-the-scope clip
5133158|NCT03160911|endoscopic haemostasis|endoscopic haemostasis
5133168|NCT03160859|water exchange colonoscopy|water exchange colonoscopy
5133169|NCT03160859|cap|cap
5133170|NCT03160859|colonoscopy pain|colonoscopy pain
5133175|NCT03160833|HMPL453|hmpl453
5133176|NCT03160833|solid tumor|solid tumor
5133177|NCT03160833|dose escalation|dose escalation
5133178|NCT03160794|Prostate cancer|prostate cancer
5133179|NCT03160794|stereotactic ablative radiotherpy|stereotactic ablative radiotherpy
5133180|NCT03160794|PET/MR|pet/mr
5133181|NCT03160768|p16|p16
5133182|NCT03160768|T cell isolation|t cell isolation
5133183|NCT03160768|physiologic age|physiologic age
5133184|NCT03160703|Dental stain, stannous fluoride, dentifrice|dental stain, stannous fluoride, dentifrice
5133185|NCT03160690|Choroidal thickness|choroidal thickness
5133186|NCT03160690|Open Angle Glaucoma|open angle glaucoma
5133187|NCT03160690|Non penetrating deep sclerectomy|non penetrating deep sclerectomy
5133191|NCT03160664|magnetic seizure therapy|magnetic seizure therapy
5133192|NCT03160664|electroconvulsive therapy|electroconvulsive therapy
5133193|NCT03160664|bipolar mania|bipolar mania
5133194|NCT03160664|cognition|cognition
5133195|NCT03160664|randomized controlled trial|randomized controlled trial
5133196|NCT03160651|alcoholic hepatitis|alcoholic hepatitis
5133197|NCT03160651|spontaneous improvement|spontaneous improvement
5133198|NCT03160651|corticosteroids|corticosteroids
5133199|NCT03160638|Azithromycin|azithromycin
5133200|NCT03160638|Immunomodulation|immunomodulation
5133201|NCT03160638|Pharmacokinetics|pharmacokinetics
5133202|NCT03160638|Tissue degradation|tissue degradation
5133203|NCT03160638|Tissue remodelling|tissue remodelling
5133204|NCT03160612|Wheelchair|wheelchair
5133205|NCT03160612|Biomechanics|biomechanics
5133206|NCT03160612|Transfer|transfer
5133207|NCT03160612|Training|training
5133208|NCT03160586|Stuttering|stuttering
5133211|NCT03160495|Squamous cell carcinoma|squamous cell carcinoma
5133212|NCT03160495|Heterogeneity|heterogeneity
5133213|NCT03160482|Thyroid Neoplasm|thyroid neoplasm
5133214|NCT03160482|Thyroid Cancer|thyroid cancer
5133215|NCT03160482|Bethesda Classification|bethesda classification
5133216|NCT03160482|Biomarkers|biomarkers
5133217|NCT03160482|Protein convertase|protein convertase
5133218|NCT03160469|obesity|obesity
5133219|NCT03160456|upper airway|upper airway
5133220|NCT03160456|genioglossus|genioglossus
5133221|NCT03160456|CPAP|cpap
5133222|NCT03160456|electrical stimulation|electrical stimulation
5133223|NCT03160456|sleep|sleep
5133224|NCT03160456|sleep disordered breathing|sleep disordered breathing
5133225|NCT03160443|Anorexia nervosa|anorexia nervosa
5133226|NCT03160443|Bulimia|bulimia
5133227|NCT03160443|Binge eating disorders|binge eating disorders
5133228|NCT03160443|Neuropsychology|neuropsychology
5133229|NCT03160443|Neurocognition|neurocognition
5133230|NCT03160443|Daily functioning|daily functioning
5133231|NCT03160430|Chronic Kidney Failure|chronic kidney failure
5133233|NCT03160430|End-Stage Kidney Disease|end-stage kidney disease
5133234|NCT03160430|End-Stage Renal Disease|end-stage renal disease
5133235|NCT03160430|Renal Disease, End-Stage|renal disease, end-stage
5133236|NCT03160430|Renal Failure, Chronic|renal failure, chronic
5133237|NCT03160430|Renal Failure, End-Stage|renal failure, end-stage
5133238|NCT03160404|Exercise|exercise
5133239|NCT03160404|Zolpidem|zolpidem
5133240|NCT03160404|Sleep|sleep
5133241|NCT03160326|chronic kidney disease|chronic kidney disease
5133242|NCT03160326|ultrasound|ultrasound
5133243|NCT03160326|muscle loss|muscle loss
5133244|NCT03160313|Social engagement|social engagement
5133245|NCT03160313|Physical Activity|physical activity
5133246|NCT03160313|Sleep Quality|sleep quality
5133247|NCT03160313|Traumatic Brain Injury|traumatic brain injury
5133248|NCT03160313|Veteran|veteran
5133249|NCT03160287|mobile, sleep, physical activity, older adults|mobile, sleep, physical activity, older adults
5133250|NCT03160274|tumor suppressor gene|tumor suppressor gene
5133261|NCT03160196|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5133262|NCT03160196|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5133461|NCT03158935|cyclophosphamide|cyclophosphamide
5133264|NCT03160183|prospective, open label, single arm, cohort|prospective, open label, single arm, cohort
5133265|NCT03160183|non randomized, non interventional|non randomized, non interventional
5133266|NCT03160170|open lumbar spine surgery|open lumbar spine surgery
5133267|NCT03160170|operative time and efficiency|operative time and efficiency
5133268|NCT03160170|Suction-Integrated Surgical Tissue Elevator and Retractor|suction-integrated surgical tissue elevator and retractor
5133269|NCT03160144|laparoscopic resection of colorectal cancer|laparoscopic resection of colorectal cancer
5133270|NCT03160144|open lung approach|open lung approach
5133271|NCT03160131|Stroke|stroke
5133272|NCT03160131|Visual impairment|visual impairment
5133273|NCT03160131|Hemianopia|hemianopia
5133274|NCT03160131|Neuro Vision Technology|neuro vision technology
5133275|NCT03160131|Rehabilitation|rehabilitation
5133276|NCT03160079|blinatumomab|blinatumomab
5133277|NCT03160079|pembrolizumab|pembrolizumab
5133278|NCT03160079|MK-3475|mk-3475
5133279|NCT03160079|relapsed|relapsed
5133280|NCT03160079|refractory|refractory
5133281|NCT03160079|B-lineage acute lymphoblastic leukemia|b-lineage acute lymphoblastic leukemia
5133282|NCT03160079|ALL|all
5133283|NCT03160066|Psychobiotic|psychobiotic
5133284|NCT03160066|Brain-gut axis|brain-gut axis
5133285|NCT03160066|Stress|stress
5133286|NCT03160066|Cognition|cognition
5133287|NCT03160066|EEG|eeg
5133288|NCT03160001|Niclosamide|niclosamide
5133289|NCT03160001|Rheumatoid arthritis|rheumatoid arthritis
5018937|NCT03878394|depression|depression
5133290|NCT03160001|diseases activity|diseases activity
5133291|NCT03160001|Efficacy|efficacy
5133292|NCT03160001|Safety|safety
5133293|NCT03159975|Tuberculosis|tuberculosis
5133294|NCT03159975|DNA vaccine|dna vaccine
5133295|NCT03159975|Electroporation|electroporation
5133296|NCT03159975|GX-70|gx-70
5133297|NCT03159962|Rapid maxillary expansion|rapid maxillary expansion
5133298|NCT03159962|Mandibular response|mandibular response
5133299|NCT03159962|Class II malocclusion|class ii malocclusion
5133300|NCT03159962|Growing subjects|growing subjects
5133301|NCT03159949|VO2max, maximal oxygen uptake|vo2max, maximal oxygen uptake
5133302|NCT03159910|Shoulder Pain|shoulder pain
5133303|NCT03159910|Occupational Exposure|occupational exposure
5133304|NCT03159910|Clinical Trial|clinical trial
5133305|NCT03159897|advanced stage (IIB-IV)|advanced stage (iib-iv)
5133306|NCT03159897|ABVD DD-DI|abvd dd-di
5133307|NCT03159897|PET|pet
5133309|NCT03159871|C- section|c- section
5133310|NCT03159871|Suture|suture
5133311|NCT03159858|Complex Abdominal Aortic Aneurysm|complex abdominal aortic aneurysm
5133312|NCT03159845|zinc|zinc
5133313|NCT03159832|Efficacy|efficacy
5133314|NCT03159832|PK/PD study|pk/pd study
5133315|NCT03159832|Renal Insufficiency|renal insufficiency
5133316|NCT03159832|Type 2 Diabetes|type 2 diabetes
5133317|NCT03159728|Ability Care|ability care
5133318|NCT03159728|Caregiver overload|caregiver overload
5133319|NCT03159728|Family caregiver|family caregiver
5133320|NCT03159715|Internet, Behavioral Activation, Positive Psychology|internet, behavioral activation, positive psychology
5133321|NCT03159702|hematological malignancy|hematological malignancy
5133322|NCT03159702|EVOMELA|evomela
5200866|NCT02738788|airway|airway
5133323|NCT03159702|Melphalan HCl|melphalan hcl
5133324|NCT03159702|Total Body Irradiation|total body irradiation
5133325|NCT03159702|Reduced Intensity Conditioning|reduced intensity conditioning
5133326|NCT03159702|Haploidentical Transplantation|haploidentical transplantation
5133327|NCT03159702|Fludarabine|fludarabine
5133328|NCT03159702|Hematologic Diseases|hematologic diseases
5133329|NCT03159702|Neoplasms, Plasma Cell|neoplasms, plasma cell
5133330|NCT03159702|Neoplasms by Histologic Type|neoplasms by histologic type
5133331|NCT03159702|Lymphoproliferative Disorders|lymphoproliferative disorders
5133332|NCT03159676|Prostate cancer|prostate cancer
5133333|NCT03159676|Radiation therapy|radiation therapy
5133334|NCT03159676|Radiotherapy|radiotherapy
5133336|NCT03159676|Proton beam|proton beam
5133337|NCT03159676|Stereotactic ablative body radiotherapy|stereotactic ablative body radiotherapy
5133338|NCT03159676|Stereotactic body radiotherapy|stereotactic body radiotherapy
5133339|NCT03159676|SABR|sabr
5133340|NCT03159676|SBRT|sbrt
5133341|NCT03159676|Localized|localized
5133342|NCT03159676|Low risk|low risk
5133343|NCT03159676|Intermediate risk|intermediate risk
5133344|NCT03159637|Pneumoperitoneum|pneumoperitoneum
5133345|NCT03159637|Trendelenburg position|trendelenburg position
5133346|NCT03159637|intra-abdominal pressure|intra-abdominal pressure
5133347|NCT03159624|nasoseptal flap|nasoseptal flap
5133348|NCT03159624|tissue repair|tissue repair
5133349|NCT03159624|wound healing|wound healing
5133350|NCT03159624|remucosalization|remucosalization
5133351|NCT03159624|upper airway|upper airway
5133352|NCT03159624|granulation tissue|granulation tissue
5133353|NCT03159624|tissue graft|tissue graft
5133355|NCT03159598|Abdominal-based breast reconstruction|abdominal-based breast reconstruction
5133356|NCT03159598|Seroma|seroma
5133357|NCT03159585|TAEST16001|taest16001
5133358|NCT03159572|Ovarian cancer|ovarian cancer
5133359|NCT03159572|Fallopian tube cancer|fallopian tube cancer
5133360|NCT03159572|Primary peritoneal cancer|primary peritoneal cancer
5133462|NCT03158935|fludarabine|fludarabine
5133361|NCT03159572|Germline Breast Cancer Susceptibility Gene (BRCA1/2 gene)|germline breast cancer susceptibility gene (brca1/2 gene)
5133363|NCT03159520|Pain|pain
5133364|NCT03159507|Omega-3 Index|omega-3 index
5133365|NCT03159507|Cellular metabolism|cellular metabolism
5133366|NCT03159507|EPA Monoglyceride|epa monoglyceride
5133367|NCT03159507|Quality of life|quality of life
5133368|NCT03159442|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5133369|NCT03159442|Asthma|asthma
5133370|NCT03159442|AZD8871|azd8871
5133371|NCT03159442|muscarinic receptor antagonist and β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist and β2 adrenoceptor agonist (maba)
5133372|NCT03159442|Phase I|phase i
5133373|NCT03159442|Safety|safety
5133374|NCT03159442|Tolerability|tolerability
5133375|NCT03159442|Pharmacokinetics|pharmacokinetics
5133376|NCT03159442|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
5133377|NCT03159442|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
5133378|NCT03159442|Japanese|japanese
5133379|NCT03159429|Dyspnea|dyspnea
5133380|NCT03159429|Rehabilitation of olfaction|rehabilitation of olfaction
5133381|NCT03159429|Hyperventilation syndrome|hyperventilation syndrome
5133382|NCT03159390|dietary supplements|dietary supplements
5133383|NCT03159377|pulmonary nodule, CT, low dose|pulmonary nodule, ct, low dose
5133384|NCT03159364|CTL|ctl
5133385|NCT03159364|Virus CTL|virus ctl
5133386|NCT03159364|Fungus CTL|fungus ctl
5133387|NCT03159364|TB CTL|tb ctl
5133388|NCT03159325|internet|internet
5133389|NCT03159325|chronic disease management|chronic disease management
5133390|NCT03159325|technology|technology
5133391|NCT03159325|telehealth|telehealth
5133392|NCT03159325|application|application
5133393|NCT03159312|obesity,bariatric surgery,physical activity|obesity,bariatric surgery,physical activity
5133394|NCT03159299|mHealth|mhealth
5133395|NCT03159299|Hispanic/Latinos|hispanic/latinos
5133396|NCT03159299|Diabetes Self-Management Education|diabetes self-management education
5133397|NCT03159273|Dietary nitrate supplementation|dietary nitrate supplementation
5133398|NCT03159273|Cold symptoms|cold symptoms
5133399|NCT03159273|Stress|stress
5133400|NCT03159273|Immunity|immunity
5133401|NCT03159273|Exhaled nitric oxide|exhaled nitric oxide
5133402|NCT03159273|Lung function|lung function
5133415|NCT03159208|Critical Illness|critical illness
5133416|NCT03159208|Ventilation, Mechanical|ventilation, mechanical
5133417|NCT03159208|Disease Attributes|disease attributes
5133418|NCT03159208|Socioeconomic Factors|socioeconomic factors
5133419|NCT03159208|Activities of Daily LIving|activities of daily living
5133420|NCT03159208|Cognition|cognition
5133421|NCT03159195|metastatic breast cancer|metastatic breast cancer
5133422|NCT03159195|advanced breast cancer|advanced breast cancer
5133423|NCT03159195|HR+/ HER2-|hr+/ her2-
5133424|NCT03159182|Hypertrophic scarring|hypertrophic scarring
5133425|NCT03159182|Silicone Material|silicone material
5133426|NCT03159182|Pressure garments|pressure garments
5133429|NCT03159130|Pain pump catheters|pain pump catheters
5133430|NCT03159130|bariatric surgery|bariatric surgery
5133431|NCT03159130|OnQ pump|onq pump
5133432|NCT03159130|sleeve gastrectomy|sleeve gastrectomy
5133433|NCT03159130|continuous infusion catheter|continuous infusion catheter
5133434|NCT03159117|GD3 ADC (Pfizer PF-06688992)|gd3 adc (pfizer pf-06688992)
5133435|NCT03159117|Stage III Melanoma|stage iii melanoma
5133436|NCT03159117|Stage IV Melanoma|stage iv melanoma
5133437|NCT03159117|17-165|17-165
5133438|NCT03159078|Acinetobacter|acinetobacter
5133439|NCT03159078|Polymyxins|polymyxins
5133440|NCT03159078|Imipenem|imipenem
5133441|NCT03159078|Pseudomona|pseudomona
5133442|NCT03159078|Klebsiella|klebsiella
5133443|NCT03159026|Amish/Mennonite variant|amish/mennonite variant
5133444|NCT03159013|Pyrethroids|pyrethroids
5129679|NCT03184012|caries|caries
5133445|NCT03159013|Lambda-cyhalothrin|lambda-cyhalothrin
5133446|NCT03159013|Biomarkers|biomarkers
5133447|NCT03159013|Toxicokinetics|toxicokinetics
5133448|NCT03158974|External Genital Warts|external genital warts
5133449|NCT03158961|Thyroid|thyroid
5133450|NCT03158961|Thyroidectomy|thyroidectomy
5133451|NCT03158961|Transoral|transoral
5133452|NCT03158961|Endoscopic|endoscopic
5133453|NCT03158961|Surgery|surgery
5133454|NCT03158948|Sepsis|sepsis
5133455|NCT03158948|LR12|lr12
5133456|NCT03158948|TREM1|trem1
5133457|NCT03158948|TREM-1|trem-1
5133458|NCT03158935|adoptive cell therapy|adoptive cell therapy
5133459|NCT03158935|melanoma|melanoma
5133465|NCT03158935|interleukin-2|interleukin-2
5133466|NCT03158935|anti-PD-1|anti-pd-1
5133467|NCT03158935|immune checkpoint|immune checkpoint
5133468|NCT03158909|Eyemask|eyemask
5133469|NCT03158909|Earplugs|earplugs
5133470|NCT03158896|mesenchymal stem cell|mesenchymal stem cell
5133471|NCT03158896|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5133472|NCT03158896|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5133473|NCT03158896|Autologous hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
5133474|NCT03158896|Wharton's jelly|wharton's jelly
5133475|NCT03158896|umbilical cord blood|umbilical cord blood
5133476|NCT03158896|steroid refractory graft versus host disease|steroid refractory graft versus host disease
5133477|NCT03158883|Avelumab|avelumab
5133478|NCT03158883|NSCLC|nsclc
5133479|NCT03158883|Stereotactic ablative radiotherapy (SAR)|stereotactic ablative radiotherapy (sar)
5133482|NCT03158831|Drug Allergy|drug allergy
5133483|NCT03158831|Penicillin Allergy|penicillin allergy
5133484|NCT03158831|Antibiotic Allergy|antibiotic allergy
5133485|NCT03158831|Graded Drug Challenge|graded drug challenge
5133486|NCT03158792|Anticoagulation|anticoagulation
5133487|NCT03158792|Thromboprophylaxis|thromboprophylaxis
5133488|NCT03158792|Anti-Xa levels|anti-xa levels
5133489|NCT03158792|Elderly|elderly
5133490|NCT03158792|Prevention|prevention
5133491|NCT03158792|Enoxaparin|enoxaparin
5133492|NCT03158792|Low molecular weight heparin|low molecular weight heparin
5133493|NCT03158766|infection|infection
5019134|NCT03877146|Anxiety|anxiety
5133494|NCT03158766|intervertebral disc|intervertebral disc
5133495|NCT03158766|Propionibacterium acnes|propionibacterium acnes
5133503|NCT03158662|Junctional Non-Herlitz|junctional non-herlitz
5133505|NCT03158649|Prenatal well-being|prenatal well-being
5133506|NCT03158649|Mental maternal prenatal well-being|mental maternal prenatal well-being
5133507|NCT03158649|Positive Psychology|positive psychology
5133508|NCT03158649|Positive Psychology Intervention|positive psychology intervention
5133509|NCT03158649|Web-based intervention|web-based intervention
5133510|NCT03158623|total joint arthroplasty|total joint arthroplasty
5133511|NCT03158623|platelet-rich plasma|platelet-rich plasma
5133512|NCT03158623|activated collagen|activated collagen
5133513|NCT03158571|Gastric Cancer|gastric cancer
5133514|NCT03158571|gastric adenocarcinoma|gastric adenocarcinoma
5133515|NCT03158571|cancer subtypes|cancer subtypes
5133516|NCT03158571|prognosis|prognosis
5133517|NCT03158571|survival|survival
5133518|NCT03158571|molecular classification|molecular classification
5133519|NCT03158571|chemotherapy|chemotherapy
5133520|NCT03158571|immunotherapy|immunotherapy
5133522|NCT03158480|DC-CIK|dc-cik
5133523|NCT03158480|interferon|interferon
5133524|NCT03158441|MRI|mri
5133525|NCT03158441|Diffusion|diffusion
5133526|NCT03158441|DTI|dti
5133527|NCT03158415|mHealth|mhealth
5133528|NCT03158402|Inspiratory muscle training|inspiratory muscle training
5133529|NCT03158402|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5133533|NCT03158376|gabapentin|gabapentin
5133534|NCT03158376|thoracotomy|thoracotomy
5133535|NCT03158376|chronic post-thoracotomy pain|chronic post-thoracotomy pain
5133536|NCT03158376|acute post-thoracotomy pain|acute post-thoracotomy pain
5133537|NCT03158376|quality of life|quality of life
5133538|NCT03158376|neuropathic pain|neuropathic pain
5133539|NCT03158363|immobilization|immobilization
5133540|NCT03158363|fasting|fasting
5133541|NCT03158363|endotoxemia|endotoxemia
5133542|NCT03158363|LPS|lps
5133543|NCT03158363|metabolism|metabolism
5133544|NCT03158363|model of disease|model of disease
5133545|NCT03158337|Exercise|exercise
5133546|NCT03158337|Physical Activity|physical activity
5133547|NCT03158337|Brain blood flow|brain blood flow
5133548|NCT03158337|Cognition|cognition
5133549|NCT03158337|Fitness|fitness
5133550|NCT03158311|QVM149|qvm149
5133551|NCT03158311|asthma|asthma
5133552|NCT03158311|adult|adult
5133553|NCT03158259|IS|is
5133554|NCT03158259|ICH|ich
5133555|NCT03158259|rtPa|rtpa
5133556|NCT03158259|Prehospital|prehospital
5133557|NCT03158259|MSU|msu
5133558|NCT03158246|zoledronic acid|zoledronic acid
5133559|NCT03158246|Yigu|yigu
5133560|NCT03158246|Aclasta|aclasta
5133561|NCT03158246|Osteoporosis|osteoporosis
5133562|NCT03158246|Postmenopausal|postmenopausal
5133563|NCT03158246|BMD|bmd
5133564|NCT03158246|fracture|fracture
5133565|NCT03158246|Biochemical markers|biochemical markers
5133566|NCT03158233|Zika virus disease|zika virus disease
5133567|NCT03158194|Anxiety|anxiety
5133568|NCT03158194|Stress|stress
5133571|NCT03158116|tracheostomy tube|tracheostomy tube
5133572|NCT03158116|Pseudomonas aeruginosa|pseudomonas aeruginosa
5133573|NCT03158103|MEK162 (Binimetinib)|mek162 (binimetinib)
5133574|NCT03158103|Pexidartinib|pexidartinib
5133575|NCT03158103|17-056|17-056
5133576|NCT03158090|Acromegaly|acromegaly
5133577|NCT03158064|17-160|17-160
5133578|NCT03158064|durvalumab|durvalumab
5133579|NCT03158064|tremelimumab|tremelimumab
5133580|NCT03158064|MEDI4736|medi4736
5133581|NCT03158051|Hypertension|hypertension
5133582|NCT03158051|Young Adult|young adult
5133583|NCT03158051|Self-Management|self-management
5133584|NCT03158051|Health coach|health coach
5133585|NCT03158038|Trivalent|trivalent
5133586|NCT03158038|Influenza|influenza
5133587|NCT03158038|FluMist Quadrivalent|flumist quadrivalent
5133589|NCT03158038|Prevention|prevention
5133590|NCT03158038|Healthy|healthy
5133591|NCT03158038|Monovalent|monovalent
5133592|NCT03158025|Recreational sedatives|recreational sedatives
5133593|NCT03158025|Healthy participants|healthy participants
5133594|NCT03158025|Lemborexant|lemborexant
5133595|NCT03158025|E2006|e2006
5133596|NCT03158025|Zolpidem|zolpidem
5133597|NCT03158025|Suvorexant|suvorexant
5133598|NCT03157999|Older Adults|older adults
5133599|NCT03157999|Transitional Care|transitional care
5133600|NCT03157999|Caregiver|caregiver
5133601|NCT03157999|Intervention|intervention
5133602|NCT03157986|COPD|copd
5133603|NCT03157986|Balance|balance
5133604|NCT03157986|Whole Body Vibration Training|whole body vibration training
5133605|NCT03157986|pulmonary rehabilitation|pulmonary rehabilitation
5133606|NCT03157986|exercise|exercise
5133607|NCT03157973|Information Literacy|information literacy
5133608|NCT03157973|Nursing Care|nursing care
5133609|NCT03157973|Social Support|social support
5133610|NCT03157960|Fructose|fructose
5133611|NCT03157960|Uric acid|uric acid
5133612|NCT03157960|Oxidised LDL|oxidised ldl
5133613|NCT03157960|Interleukin 6|interleukin 6
5133614|NCT03157947|decision aid|decision aid
5133615|NCT03157947|focus group|focus group
5133616|NCT03157934|stroke network|stroke network
5133617|NCT03157934|acute stroke care|acute stroke care
5133618|NCT03157934|emergency medical services|emergency medical services
5133619|NCT03157934|integrated care|integrated care
5133620|NCT03157908|South Africa|south africa
5133621|NCT03157908|Retention in care|retention in care
5133622|NCT03157908|Pregnancy|pregnancy
5133623|NCT03157908|Mobile health|mobile health
5133624|NCT03157895|Foster Families|foster families
5133625|NCT03157882|pediatric|pediatric
5133626|NCT03157882|children|children
5133627|NCT03157882|Faces Pain Scale Revised|faces pain scale revised
5133628|NCT03157882|Wong Baker FACES|wong baker faces
5133629|NCT03157882|pain scales|pain scales
5133630|NCT03157882|BRIGANCE|brigance
5133631|NCT03157869|Learning, Automatism, Motor Activity, Electric Stimulation|learning, automatism, motor activity, electric stimulation
5133632|NCT03157856|Fluorescence imaging technique|fluorescence imaging technique
5133633|NCT03157856|Biopsies from resected prostate|biopsies from resected prostate
5133634|NCT03157856|Medical device|medical device
5133635|NCT03157830|Multiple Sclerosis|multiple sclerosis
5133637|NCT03157830|ocrelizumab|ocrelizumab
5133638|NCT03157830|OCREVUS|ocrevus
5133639|NCT03157830|Natalizumab|natalizumab
5133640|NCT03157830|Tysabri|tysabri
5133641|NCT03157791|simethicone|simethicone
5133642|NCT03157778|pregnenolone|pregnenolone
5133643|NCT03157778|endocannabinoid|endocannabinoid
5133644|NCT03157778|food intake|food intake
5133645|NCT03157778|type-1 cannabinoid receptor|type-1 cannabinoid receptor
5133646|NCT03157765|recurrent implantation failure|recurrent implantation failure
5133647|NCT03157765|frozen embryo transfer|frozen embryo transfer
5133648|NCT03157765|IVF|ivf
5133649|NCT03157765|endometrial scratch|endometrial scratch
5133650|NCT03157765|endometrial injury|endometrial injury
5133651|NCT03157739|Migraine|migraine
5133652|NCT03157726|benign prostatic hyperplasia|benign prostatic hyperplasia
5133653|NCT03157726|multicenter randomized control clinical trial|multicenter randomized control clinical trial
5133654|NCT03157726|transurethral plasmakinetic enucleation of prostate|transurethral plasmakinetic enucleation of prostate
5133655|NCT03157726|transurethral resection of prostate|transurethral resection of prostate
5133656|NCT03157713|Obesity|obesity
5133657|NCT03157713|Weight-loss|weight-loss
5133658|NCT03157713|Financial Incentives|financial incentives
5133659|NCT03157713|Behavioral Economics|behavioral economics
5133660|NCT03157648|Shivering temperature|shivering temperature
5133661|NCT03157622|Chronic Low Back Pain|chronic low back pain
5133662|NCT03157622|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
5133663|NCT03157622|Exposure|exposure
5133664|NCT03157622|Therapeutic processes|therapeutic processes
5133665|NCT03157622|Single-case study|single-case study
5133668|NCT03157596|disability|disability
5133669|NCT03157596|developmental disability|developmental disability
5133670|NCT03157596|special healthcare needs|special healthcare needs
5133671|NCT03157557|Treatment|treatment
5133672|NCT03157557|Sheltered Housing|sheltered housing
5133673|NCT03157544|Chronic Neck Pain|chronic neck pain
5133674|NCT03157544|Chronic Back Pain|chronic back pain
5133675|NCT03157544|non-pharmacological|non-pharmacological
5133676|NCT03157544|pain relief|pain relief
5133677|NCT03157518|Asthma|asthma
5133678|NCT03157518|obesity|obesity
5133679|NCT03157518|micorbiome|micorbiome
5133680|NCT03157518|probiotics|probiotics
5133681|NCT03157492|Adult|adult
5133682|NCT03157492|Post-lingual|post-lingual
5133683|NCT03157492|Auditory training|auditory training
5133684|NCT03157492|Communication strategies|communication strategies
5133685|NCT03157492|Speech tracking|speech tracking
5133686|NCT03157492|Speech recognition|speech recognition
5133687|NCT03157492|Quality of Life|quality of life
5133688|NCT03157479|Mechanical ventilation|mechanical ventilation
5133689|NCT03157453|Evaluation scale|evaluation scale
5133690|NCT03157453|Brain injury|brain injury
5133691|NCT03157453|Severity of Brain Injury|severity of brain injury
5133692|NCT03157453|Initial Evaluation|initial evaluation
5133693|NCT03157427|Solar Lentigo, Cryotherapy, Difluoroethane|solar lentigo, cryotherapy, difluoroethane
5133694|NCT03157388|inflammation|inflammation
5133695|NCT03157388|Macrophages|macrophages
5133696|NCT03157388|CD163|cd163
5133697|NCT03157375|IOL, IOL Rotation, Axial Rotation|iol, iol rotation, axial rotation
5133698|NCT03157349|Biofreeze|biofreeze
5133709|NCT03157336|Oxidative Damage|oxidative damage
5133711|NCT03157323|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5133712|NCT03157323|Dietary Change|dietary change
5133713|NCT03157323|Pediatric Oncology|pediatric oncology
5133714|NCT03157284|Lactobacillus, Probiotics|lactobacillus, probiotics
5133715|NCT03157219|Heart failure|heart failure
5133716|NCT03157219|Institutional level registry|institutional level registry
5133717|NCT03157219|Systolic heart failure|systolic heart failure
5133718|NCT03157219|Acute heart failure|acute heart failure
5133719|NCT03157219|Heart failure India|heart failure india
5133720|NCT03157193|Peri-Implantitis|peri-implantitis
5133721|NCT03157193|Dental Implants|dental implants
5133722|NCT03157193|Hyaluronic Acid|hyaluronic acid
5133723|NCT03157193|Clinical Trial|clinical trial
5133724|NCT03157167|Kaposi Sarcoma, KS, HIV|kaposi sarcoma, ks, hiv
5133725|NCT03157154|Haemophilia|haemophilia
5133726|NCT03157154|Atherosclerosis|atherosclerosis
5133727|NCT03157154|Atrial fibrillation|atrial fibrillation
5133728|NCT03157154|Antiplatelets|antiplatelets
5133729|NCT03157154|Anticoagulant|anticoagulant
5201368|NCT02735551|LARC|larc
5133730|NCT03157141|Ankle osteoarthritis|ankle osteoarthritis
5133731|NCT03157141|total ankle replacement|total ankle replacement
5133732|NCT03157141|ankle arthrodesis|ankle arthrodesis
5133733|NCT03157141|kinematics|kinematics
5133734|NCT03157141|kinetics|kinetics
5133735|NCT03157141|plantar pressure measurements|plantar pressure measurements
5133736|NCT03157141|functional compensatory adaptations|functional compensatory adaptations
5133737|NCT03157128|LOXO-292|loxo-292
5133738|NCT03157128|KIF5B-RET|kif5b-ret
5133739|NCT03157128|M918T|m918t
5133740|NCT03157128|CCDC6-RET|ccdc6-ret
5133741|NCT03157128|RET-PTC1|ret-ptc1
5133742|NCT03157128|NCOA4-RET|ncoa4-ret
5133743|NCT03157128|RET-PTC|ret-ptc
5133744|NCT03157128|RET-PTC3|ret-ptc3
5133745|NCT03157128|RET-PTC4|ret-ptc4
5133746|NCT03157128|PRKAR1A-RET|prkar1a-ret
5133747|NCT03157128|RET-PTC2|ret-ptc2
5133748|NCT03157128|GOLGA5-RET|golga5-ret
5133749|NCT03157128|RET-PTC5|ret-ptc5
5133750|NCT03157128|ERC1-RET|erc1-ret
5133751|NCT03157128|KTN1-RET|ktn1-ret
5133752|NCT03157128|RET-PTC8|ret-ptc8
5133753|NCT03157128|HOOK3-RET|hook3-ret
5133754|NCT03157128|PCM1-RET|pcm1-ret
5133755|NCT03157128|TRIM24-RET|trim24-ret
5133756|NCT03157128|RET-PTC6|ret-ptc6
5133757|NCT03157128|TRIM27-RET|trim27-ret
5133758|NCT03157128|TRIM33-RET|trim33-ret
5133759|NCT03157128|RET-PTC7|ret-ptc7
5133760|NCT03157128|AKAP13-RET|akap13-ret
5133761|NCT03157128|FKBP15-RET|fkbp15-ret
5133762|NCT03157128|SPECC1L-RET|specc1l-ret
5133763|NCT03157128|TBL1XR1-RET|tbl1xr1-ret
5133764|NCT03157128|BCR-RET|bcr-ret
5133765|NCT03157128|FGRF1OP-RET|fgrf1op-ret
5133766|NCT03157128|RFG8-RET|rfg8-ret
5133767|NCT03157128|RET-PTC9|ret-ptc9
5133768|NCT03157128|ACBD5-RET|acbd5-ret
5133769|NCT03157128|MYH13-RET|myh13-ret
5133770|NCT03157128|CUX1-RET|cux1-ret
5133771|NCT03157128|KIAA1468-RET|kiaa1468-ret
5133772|NCT03157128|FRMD4A-RET|frmd4a-ret
5133773|NCT03157128|SQSTM1-RET|sqstm1-ret
5133774|NCT03157128|AFAP1L2-RET|afap1l2-ret
5133775|NCT03157128|PPFIBP2-RET|ppfibp2-ret
5133776|NCT03157128|EML4-RET|eml4-ret
5133777|NCT03157128|PARD3-RET|pard3-ret
5133778|NCT03157128|G533C|g533c
5133779|NCT03157128|C609F|c609f
5133780|NCT03157128|C609G|c609g
5133781|NCT03157128|C609R|c609r
5133782|NCT03157128|C609S|c609s
5133783|NCT03157128|C609Y|c609y
5133784|NCT03157128|C611F|c611f
5133785|NCT03157128|C611G|c611g
5133786|NCT03157128|C611S|c611s
5133799|NCT03157128|C634G|c634g
5133800|NCT03157128|C634R|c634r
5133801|NCT03157128|C634S|c634s
5133802|NCT03157128|C634W|c634w
5133805|NCT03157128|E768D|e768d
5133806|NCT03157128|L790F|l790f
5133807|NCT03157128|V804L|v804l
5133808|NCT03157128|V804M|v804m
5133809|NCT03157128|A883F|a883f
5133810|NCT03157128|S891A|s891a
5133811|NCT03157128|R912P|r912p
5133812|NCT03157128|CLIP1-RET|clip1-ret
5133813|NCT03157128|Y806C|y806c
5133814|NCT03157128|RET fusion|ret fusion
5133815|NCT03157128|RET alteration|ret alteration
5133816|NCT03157128|RET mutation|ret mutation
5133817|NCT03157128|RET rearrangement|ret rearrangement
5133818|NCT03157128|RET translocation|ret translocation
5133819|NCT03157128|Neoplasms by Site|neoplasms by site
5133820|NCT03157128|Neoplasms|neoplasms
5133821|NCT03157128|Non-Small Cell Lung Cancer|non-small cell lung cancer
5133822|NCT03157128|Lung Neoplasms|lung neoplasms
5133823|NCT03157128|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5133824|NCT03157128|Cancer of Lung|cancer of lung
5133825|NCT03157128|Cancer of the Lung|cancer of the lung
5133826|NCT03157128|Lung Cancer|lung cancer
5133827|NCT03157128|Neoplasms, Lung|neoplasms, lung
5133828|NCT03157128|Neoplasms, Pulmonary|neoplasms, pulmonary
5133829|NCT03157128|Pulmonary Cancer|pulmonary cancer
5133830|NCT03157128|Pulmonary Neoplasms|pulmonary neoplasms
5133831|NCT03157128|Respiratory Tract Neoplasms|respiratory tract neoplasms
5133832|NCT03157128|Lung Diseases|lung diseases
5133833|NCT03157128|Respiratory Tract Diseases|respiratory tract diseases
5133834|NCT03157128|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5133835|NCT03157128|Bronchial Neoplasms|bronchial neoplasms
5133836|NCT03157128|Medullary Thyroid Cancer|medullary thyroid cancer
5133837|NCT03157128|Papillary Thyroid Cancer|papillary thyroid cancer
5133838|NCT03157128|Thyroid Diseases|thyroid diseases
5133839|NCT03157128|Thyroid Neoplasms|thyroid neoplasms
5133840|NCT03157128|Cancer of the Thyroid|cancer of the thyroid
5133841|NCT03157128|Cancer of Thyroid|cancer of thyroid
5133842|NCT03157128|Neoplasms, Thyroid|neoplasms, thyroid
5133843|NCT03157128|Thyroid Ademona|thyroid ademona
5133844|NCT03157128|Thyroid Cancer|thyroid cancer
5133845|NCT03157128|Thyroid Carcinoma|thyroid carcinoma
5133846|NCT03157128|Endocrine System Diseases|endocrine system diseases
5133847|NCT03157128|Endocrine Gland Neoplasms|endocrine gland neoplasms
5133848|NCT03157128|Head and Neck Neoplasms|head and neck neoplasms
5133849|NCT03157128|Thoracic Neoplasms|thoracic neoplasms
5133850|NCT03157128|CNS tumor|cns tumor
5133851|NCT03157128|Primary CNS tumor|primary cns tumor
5133852|NCT03157128|Cancer of Colon|cancer of colon
5133853|NCT03157128|Cancer of the Colon|cancer of the colon
5133854|NCT03157128|Colon Cancer|colon cancer
5133855|NCT03157128|Colon Neoplasms|colon neoplasms
5133856|NCT03157128|Colonic Cancer|colonic cancer
5133857|NCT03157128|Neoplasms, Colonic|neoplasms, colonic
5133858|NCT03157128|Malignant tumor of Breast|malignant tumor of breast
5133859|NCT03157128|Mammary Cancer|mammary cancer
5133860|NCT03157128|Mammary Carcinoma, Human|mammary carcinoma, human
5133861|NCT03157128|Mammary Neoplasm, Human|mammary neoplasm, human
5133862|NCT03157128|Neoplasms, Breast|neoplasms, breast
5133863|NCT03157128|Tumors, Breast|tumors, breast
5133864|NCT03157128|Human Mammary Carcinoma|human mammary carcinoma
5133865|NCT03157128|Malignant Neoplasm of Breast|malignant neoplasm of breast
5133866|NCT03157128|Breast Carcinoma|breast carcinoma
5133867|NCT03157128|Breast Tumors|breast tumors
5133868|NCT03157128|Cancer of the Breast|cancer of the breast
5133869|NCT03157128|Breast Neoplasms|breast neoplasms
5133870|NCT03157128|Breast Cancer|breast cancer
5133871|NCT03157128|RET Inhibitor|ret inhibitor
5133873|NCT03157128|NSCLC|nsclc
5133874|NCT03157115|Kinocardiography|kinocardiography
5133875|NCT03157115|Cardiac contractility|cardiac contractility
5133876|NCT03157115|Heart kinetic energy|heart kinetic energy
5133877|NCT03157102|children|children
5133878|NCT03157102|status asthmaticus|status asthmaticus
5133879|NCT03157102|HFNC|hfnc
5133880|NCT03157011|Primary Sjögren syndrome - Digestive symptoms|primary sjögren syndrome - digestive symptoms
5133881|NCT03156998|CARE|care
5133882|NCT03156998|Paediatric asthma|paediatric asthma
5130092|NCT03181789|IL-12|il-12
5133884|NCT03156998|Home nebulizer|home nebulizer
5133885|NCT03156959|Eating disorders|eating disorders
5133886|NCT03156959|Cognitive Behavioral Therapy|cognitive behavioral therapy
5133887|NCT03156959|Eye Movement Desensitization and Processing|eye movement desensitization and processing
5133888|NCT03156946|breastfeeding|breastfeeding
5133889|NCT03156946|mother-to-mother support|mother-to-mother support
5133890|NCT03156946|lactation consultant|lactation consultant
5133891|NCT03156946|stepped wedge cluster randomized trial|stepped wedge cluster randomized trial
5133892|NCT03156946|peer counseling|peer counseling
5133893|NCT03156907|High dosage Buprenorphine (HDB)|high dosage buprenorphine (hdb)
5133894|NCT03156907|Chronic pain|chronic pain
5133895|NCT03156907|Analgesics opioids|analgesics opioids
5133896|NCT03156907|Withdrawal symptoms|withdrawal symptoms
5133897|NCT03156894|Graft Dysfunction|graft dysfunction
5133898|NCT03156894|Primary Graft Dysfunction|primary graft dysfunction
5133899|NCT03156894|heart transplant|heart transplant
5133900|NCT03156894|heart failure|heart failure
5133901|NCT03156894|Hemodynamic parameters|hemodynamic parameters
5133902|NCT03156894|Incidence of PDG|incidence of pdg
5133903|NCT03156855|efficacy|efficacy
5133905|NCT03156855|H. pylori eradication|h. pylori eradication
5133906|NCT03156842|Hypertension|hypertension
5133907|NCT03156842|Dyslipidemia|dyslipidemia
5133908|NCT03156842|Fimasartan|fimasartan
5133909|NCT03156842|Rosuvastatin|rosuvastatin
5133910|NCT03156829|splinting|splinting
5133911|NCT03156829|steroid|steroid
5133912|NCT03156829|cortisone|cortisone
5133913|NCT03156829|trigger digit|trigger digit
5133914|NCT03156816|Myocardial Infarction|myocardial infarction
5133915|NCT03156816|STEMI|stemi
5133916|NCT03156816|Inflammation|inflammation
5133917|NCT03156816|Left ventricular remodeling|left ventricular remodeling
5133918|NCT03156816|Colchicine|colchicine
5133919|NCT03156816|CMR|cmr
5133920|NCT03156790|recombinant L-Asparaginase|recombinant l-asparaginase
5133921|NCT03156790|Spectrila®|spectrila®
5133922|NCT03156790|Lymphoblastic Leukaemia|lymphoblastic leukaemia
5133923|NCT03156790|BRALL 2014|brall 2014
5133924|NCT03156777|Gastric cancer; Circulating tumor cells; Prognosis|gastric cancer; circulating tumor cells; prognosis
5133925|NCT03156764|Qp/Qs ratio|qp/qs ratio
5133926|NCT03156764|Pediatric congenital heart disease|pediatric congenital heart disease
5133927|NCT03156751|Syphilis screening|syphilis screening
5133928|NCT03156751|antenatal care|antenatal care
5133929|NCT03156751|prenatal diagnosis|prenatal diagnosis
5133930|NCT03156751|rapid diagnosis test|rapid diagnosis test
5133931|NCT03156751|Burkina Faso|burkina faso
5133932|NCT03156751|feasibility|feasibility
5133933|NCT03156725|Iron Bioavailability|iron bioavailability
5133934|NCT03156725|hepcidin|hepcidin
5133935|NCT03156725|ferritin|ferritin
5133936|NCT03156725|iron absorption|iron absorption
5133937|NCT03156725|iron status|iron status
5133938|NCT03156712|Anemia|anemia
5133939|NCT03156712|Iron deficiency anemia|iron deficiency anemia
5133940|NCT03156712|Iron fortification|iron fortification
5133941|NCT03156712|ferrous sulfate|ferrous sulfate
5133942|NCT03156712|aspergillus oryzae|aspergillus oryzae
5133943|NCT03156712|iron supplementation|iron supplementation
5133944|NCT03156712|AUC|auc
5133945|NCT03156686|Acute Heart Failure|acute heart failure
5133946|NCT03156686|Chronic Heart Failure|chronic heart failure
5133947|NCT03156686|Home care services|home care services
5133948|NCT03156686|Cost-Benefit Analysis|cost-benefit analysis
5133949|NCT03156686|Quality of life|quality of life
5133950|NCT03156634|Patient education|patient education
5133951|NCT03156634|Internet|internet
5133952|NCT03156608|External Fetal Heart Rate Monitor|external fetal heart rate monitor
5133953|NCT03156608|Fetal Heart Rate Monitor|fetal heart rate monitor
5133954|NCT03156582|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, AFP|liver transplantation, hepatocellular carcinoma, alpha-foetoproteins, afp
5133955|NCT03156569|saliva , dental , oral health|saliva , dental , oral health
5133956|NCT03156530|Acupunture|acupunture
5133957|NCT03156530|Acupunture Therapy|acupunture therapy
5133958|NCT03156530|Acupunture Points|acupunture points
5133959|NCT03156530|Acupunture Ear|acupunture ear
5133960|NCT03156530|Postural Balance|postural balance
5133961|NCT03156517|Treatment|treatment
5133962|NCT03156517|Deep Brain Stimulation|deep brain stimulation
5133963|NCT03156517|VIM Nucleus of the Thalamus|vim nucleus of the thalamus
5133964|NCT03156517|Posterior Subthalamic Area|posterior subthalamic area
5133965|NCT03156517|Zona Incerta|zona incerta
5133966|NCT03156517|Efficacy|efficacy
5133967|NCT03156517|Safety|safety
5133968|NCT03156491|recurrent miscarriages (RM)|recurrent miscarriages (rm)
5133969|NCT03156491|recurrent pregnancy loss (RPL)|recurrent pregnancy loss (rpl)
5133970|NCT03156491|fetal-maternal interface|fetal-maternal interface
5133971|NCT03156491|decidualization|decidualization
5133972|NCT03156491|co-culture|co-culture
5133973|NCT03156491|implantation|implantation
5133974|NCT03156491|immune regulation|immune regulation
5133975|NCT03156478|Prevention|prevention
5133976|NCT03156478|Digital solutions|digital solutions
5133977|NCT03156478|Type 2 diabetes|type 2 diabetes
5133978|NCT03156478|Life style modification|life style modification
5134078|NCT03155594|DM-1|dm-1
5133981|NCT03156478|Health economics|health economics
5133982|NCT03156478|Environmental choice architecture|environmental choice architecture
5133983|NCT03156478|Socio-economic facilitators|socio-economic facilitators
5133984|NCT03156478|Socio-economic barriers|socio-economic barriers
5133985|NCT03156478|Wellbeing|wellbeing
5133986|NCT03156387|diode laser|diode laser
5133987|NCT03156387|scalpel surgery|scalpel surgery
5133988|NCT03156387|frenectomy|frenectomy
5133989|NCT03156387|postoperative complications|postoperative complications
5133990|NCT03156348|Pharmaceutical intervention|pharmaceutical intervention
5133991|NCT03156348|Older adult|older adult
5133992|NCT03156348|Internal medicine|internal medicine
5133993|NCT03156348|Adverse drug event|adverse drug event
5133994|NCT03156322|cesarean section|cesarean section
5133995|NCT03156322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
5133996|NCT03156322|patient controlled epidural analgesia|patient controlled epidural analgesia
5133997|NCT03156322|postoperative pain|postoperative pain
5356848|NCT01917747|Patient Navigator|patient navigator
5423311|NCT01616251|Egg|egg
5133998|NCT03156296|transversus abdominis plane block , Dexmedetomidine|transversus abdominis plane block , dexmedetomidine
5134000|NCT03156283|obstructive sleep apnea|obstructive sleep apnea
5134001|NCT03156283|adherence|adherence
5134002|NCT03156270|nasal valve|nasal valve
5134003|NCT03156270|nasal airway obstruction|nasal airway obstruction
5134004|NCT03156257|Microgravity Effects on Vascular Cells|microgravity effects on vascular cells
5134006|NCT03156231|airway disease|airway disease
5134007|NCT03156231|bronchitis|bronchitis
5134008|NCT03156231|emphysema|emphysema
5134009|NCT03156231|altitude|altitude
5134010|NCT03156231|prevention|prevention
5134011|NCT03156231|acetazolamide|acetazolamide
5134012|NCT03156218|PaO2/FiO2 ratio, hyperoxia, mechanical ventilation, ARDS|pao2/fio2 ratio, hyperoxia, mechanical ventilation, ards
5134013|NCT03156205|critically ill patients|critically ill patients
5134014|NCT03156205|music therapy|music therapy
5134015|NCT03156205|sleep|sleep
5134016|NCT03156205|delirium|delirium
5134017|NCT03156205|melatonin|melatonin
5134018|NCT03156205|elderly|elderly
5134019|NCT03156192|Caregivers|caregivers
5134020|NCT03156192|Family-centered care|family-centered care
5134021|NCT03156192|Music use|music use
5134022|NCT03156192|Psycho-social benefits of music|psycho-social benefits of music
5134023|NCT03156088|Predictors|predictors
5134024|NCT03156088|Sacral neuromodulation|sacral neuromodulation
5134025|NCT03156088|Outcomes|outcomes
5134026|NCT03156088|Overactive bladder|overactive bladder
5134027|NCT03156075|hip fracture, intervention, mortality, mobility|hip fracture, intervention, mortality, mobility
5134028|NCT03156036|Temozolomide|temozolomide
5134029|NCT03156036|Capecitabine|capecitabine
5134030|NCT03156036|MGMT|mgmt
5134031|NCT03156010|oculomotor testing|oculomotor testing
5134034|NCT03155971|Drug-Coated Balloon|drug-coated balloon
5134035|NCT03155971|Main Coronary Artery|main coronary artery
5134036|NCT03155971|De Novo Lesion|de novo lesion
5134037|NCT03155919|taurine|taurine
5134038|NCT03155919|triathletes|triathletes
5134039|NCT03155919|oxidative stress|oxidative stress
5134040|NCT03155919|chocolate milk|chocolate milk
5134041|NCT03155906|Chronic hepatitis C|chronic hepatitis c
5134042|NCT03155906|Opiate Substitution Treatment|opiate substitution treatment
5134043|NCT03155906|Integrated Delivery of Health Care|integrated delivery of health care
5134044|NCT03155906|Substance Abuse Treatment Centers|substance abuse treatment centers
5134045|NCT03155841|Prevention|prevention
5134046|NCT03155841|Internet|internet
5134047|NCT03155841|Adolescence|adolescence
5134048|NCT03155841|LGBT|lgbt
5134049|NCT03155841|Sexuality|sexuality
5134050|NCT03155828|PCOS, OSA, CPAP|pcos, osa, cpap
5962042|NCT04283357|pes planus|pes planus
5134051|NCT03155763|kidney transplantation|kidney transplantation
5134052|NCT03155763|implantation biopsy|implantation biopsy
5134053|NCT03155763|histology|histology
5134054|NCT03155763|allograft function|allograft function
5134055|NCT03155763|allograft survival|allograft survival
5134056|NCT03155750|insomnia|insomnia
5134057|NCT03155737|Knee Osteoarthritis|knee osteoarthritis
5134058|NCT03155685|antipsychotic|antipsychotic
5134059|NCT03155685|palliative care|palliative care
5134060|NCT03155659|Fish|fish
5134061|NCT03155659|Polyunsaturated fatty acids|polyunsaturated fatty acids
5134062|NCT03155659|Mortality|mortality
5134063|NCT03155659|CHNS|chns
5134064|NCT03155659|NHANES|nhanes
5134065|NCT03155646|TAP block|tap block
5134066|NCT03155646|Dexmedetomidine|dexmedetomidine
5134067|NCT03155646|Clonidine|clonidine
5134068|NCT03155633|Marathon, runners, biomarkers, recovery|marathon, runners, biomarkers, recovery
5134069|NCT03155594|Diabetes|diabetes
5134070|NCT03155594|Diabetes Mellitus|diabetes mellitus
5134071|NCT03155594|Diabetes Type 1|diabetes type 1
5134072|NCT03155594|Diabetes Type 2|diabetes type 2
5134073|NCT03155594|CGM|cgm
5134074|NCT03155594|Continuous Glucose Monitoring|continuous glucose monitoring
5134075|NCT03155594|Inpatient|inpatient
5134076|NCT03155594|Outpatient|outpatient
5134077|NCT03155594|Transition of care|transition of care
5134083|NCT03155555|General endotracheal anaesthesia|general endotracheal anaesthesia
5134085|NCT03155542|gene polymorphisms|gene polymorphisms
5134086|NCT03155542|Colorectal cancer|colorectal cancer
5134097|NCT03155503|SUVN-911|suvn-911
5134098|NCT03155503|Depression|depression
5134099|NCT03155503|single dose|single dose
5134100|NCT03155503|multiple dose|multiple dose
5134101|NCT03155503|alpha4 beta2 receptor|alpha4 beta2 receptor
5134102|NCT03155503|first in human|first in human
5134103|NCT03155503|safety|safety
5134104|NCT03155503|pharmacokinetics|pharmacokinetics
5134150|NCT03155204|inhalation|inhalation
5134151|NCT03155204|LABA|laba
5134152|NCT03155204|corticosteroid|corticosteroid
5134153|NCT03155191|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5134154|NCT03155191|Leukemia|leukemia
5134155|NCT03155191|Lymphoblastic|lymphoblastic
5134156|NCT03155191|TBI-1501|tbi-1501
5134157|NCT03155191|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
5134158|NCT03155191|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
5143736|NCT03093337|Parenthood|parenthood
5134168|NCT03155139|prevalence|prevalence
5134169|NCT03155139|primary aldosteronism|primary aldosteronism
5134170|NCT03155139|hypertension|hypertension
5134171|NCT03155139|nationwide|nationwide
5134172|NCT03155126|shock|shock
5134173|NCT03155126|acute kidney injury|acute kidney injury
5134174|NCT03155126|crystalloid|crystalloid
5134175|NCT03155113|Chronic infection|chronic infection
5134177|NCT03155113|DAA therapy|daa therapy
5134178|NCT03155113|immune response|immune response
5134179|NCT03155087|T2DM|t2dm
5134180|NCT03155087|genetic polymorphism|genetic polymorphism
5134181|NCT03155087|diabetic nephropathy|diabetic nephropathy
5134182|NCT03155035|deworming|deworming
5134184|NCT03155022|ST-elevation myocardial infarction|st-elevation myocardial infarction
5134185|NCT03154996|Gliomas|gliomas
5134186|NCT03154996|Recurrent|recurrent
5134187|NCT03154996|Chronic Convection|chronic convection
5134188|NCT03154996|High Grade Gliomas|high grade gliomas
5134189|NCT03154983|Mesylate Apatinib|mesylate apatinib
5134190|NCT03154983|The First-line Treatment|the first-line treatment
5134191|NCT03154983|Metastatic Gastric Cancer|metastatic gastric cancer
5134192|NCT03154970|Physical Therapy Specialty|physical therapy specialty
5134193|NCT03154931|PTSD|ptsd
5134194|NCT03154931|CBT|cbt
5134195|NCT03154931|CFT|cft
5134196|NCT03154931|compassion|compassion
5134197|NCT03154931|shame|shame
5134198|NCT03154931|guilty|guilty
5134199|NCT03154931|self-criticism|self-criticism
5134200|NCT03154879|Heart arrest|heart arrest
5134201|NCT03154879|Hypothermia|hypothermia
5134202|NCT03154879|EEG|eeg
5134203|NCT03154879|Prognosis|prognosis
5134204|NCT03154866|Lactobacillus kefiri LKF01 DSM32079|lactobacillus kefiri lkf01 dsm32079
5134205|NCT03154866|Microbial Colonization|microbial colonization
5134206|NCT03154853|Electromyography,Excessive Foot Pronation,exercise,neurology,physical therapy|electromyography,excessive foot pronation,exercise,neurology,physical therapy
5134207|NCT03154814|ulinastatin|ulinastatin
5134208|NCT03154814|cardiopulmonary bypass|cardiopulmonary bypass
5134209|NCT03154814|cardiac surgery|cardiac surgery
5134210|NCT03154788|Falls prevention|falls prevention
5134211|NCT03154788|Community-Based Participatory Research|community-based participatory research
5134212|NCT03154749|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5134213|NCT03154749|Triple-Negative Breast Cancer|triple-negative breast cancer
5134214|NCT03154736|CVD|cvd
5134215|NCT03154736|FDRCV|fdrcv
5134216|NCT03154736|Developing countries|developing countries
5134217|NCT03154736|Rcih countries|rcih countries
5134218|NCT03154710|Web-mediated follow up|web-mediated follow up
5134219|NCT03154710|Lymphoma|lymphoma
5134220|NCT03154710|Personalized medicine|personalized medicine
5134221|NCT03154684|Autonomy|autonomy
5134222|NCT03154684|Rehabilitation|rehabilitation
5134223|NCT03154684|Falls|falls
5134224|NCT03154684|Quality of life|quality of life
5134225|NCT03154684|Senior|senior
5134226|NCT03154671|older adult;|older adult;
5134227|NCT03154671|comprehensive geriatric assessment|comprehensive geriatric assessment
5134228|NCT03154671|chemotherapy|chemotherapy
5134234|NCT03154632|Ultrasound|ultrasound
5134235|NCT03154593|Prevalence|prevalence
5134236|NCT03154541|Chronic Rhinosinusitis (CRS), Cystic Fibrosis related CRS|chronic rhinosinusitis (crs), cystic fibrosis related crs
5134237|NCT03154515|Respiratory Tract Infections|respiratory tract infections
5134238|NCT03154515|Acute Respiratory Viral Infection|acute respiratory viral infection
5134239|NCT03154502|Sodium intake|sodium intake
5134240|NCT03154502|Urinary sodium excretion|urinary sodium excretion
5134245|NCT03154398|evaluation of thyroid function in diabetes patients|evaluation of thyroid function in diabetes patients
5134247|NCT03154346|Baseline|baseline
5143838|NCT03092817|HIV|hiv
5134248|NCT03154346|Project Baseline|project baseline
5134249|NCT03154346|Baseline Study|baseline study
5134250|NCT03154346|Project Baseline Study|project baseline study
5134251|NCT03154346|Health Study|health study
5134252|NCT03154346|Baseline Health Study|baseline health study
5134253|NCT03154333|Epidermolysis|epidermolysis
5134254|NCT03154333|bullosa|bullosa
5134255|NCT03154333|simplex|simplex
5134256|NCT03154333|EBS|ebs
5134257|NCT03154281|Breast|breast
5134258|NCT03154281|Ovarian|ovarian
5134259|NCT03154268|Gestational weight gain|gestational weight gain
5134260|NCT03154268|Chinese pregnant women|chinese pregnant women
5134261|NCT03154268|Retrospective longitudinal study|retrospective longitudinal study
5134263|NCT03154268|IOM guideline|iom guideline
5134264|NCT03154268|Adverse outcome|adverse outcome
5134265|NCT03154268|Model|model
5134266|NCT03154255|Obesity|obesity
5134267|NCT03154255|Paediatric|paediatric
5134268|NCT03154255|Mediterranean diet|mediterranean diet
5134269|NCT03154255|Gamification|gamification
5134270|NCT03154255|Insulin-resistance|insulin-resistance
5134271|NCT03154242|non small cell lung cancer|non small cell lung cancer
5134272|NCT03154242|NSCLC|nsclc
5134282|NCT03154151|9/11 survivor|9/11 survivor
5134284|NCT03154138|hemiplegia|hemiplegia
5134285|NCT03154138|rehabilitation|rehabilitation
5134286|NCT03154138|prismatic adaptation|prismatic adaptation
5134287|NCT03154138|postural imbalance|postural imbalance
5134288|NCT03154138|posture|posture
5134289|NCT03154138|spatial cognition|spatial cognition
5134290|NCT03154099|CIRCI|circi
5134291|NCT03154086|REarranged during Transfection|rearranged during transfection
5134292|NCT03154073|Exercise|exercise
5134293|NCT03154073|Physical activity|physical activity
5134294|NCT03154073|Blood glucose|blood glucose
5134295|NCT03154073|Sleep|sleep
5134296|NCT03154060|Flash glucose monitoring|flash glucose monitoring
5134297|NCT03154060|Accuracy|accuracy
5134298|NCT03154060|Precision|precision
5134299|NCT03154034|Stress echocardiography|stress echocardiography
5134300|NCT03154034|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5134301|NCT03154034|ergospirometry|ergospirometry
5134302|NCT03154021|Gingival Index|gingival index
5134303|NCT03154021|Plaque Index|plaque index
5134304|NCT03154021|Bleeding|bleeding
5134305|NCT03154021|Pocket Depth|pocket depth
5134311|NCT03153995|expander|expander
5134312|NCT03153982|HNSCC|hnscc
5134317|NCT03153930|sedentary behavior|sedentary behavior
5134318|NCT03153930|youth|youth
5134319|NCT03153930|moderating factors|moderating factors
5134320|NCT03153930|metabolic outcomes|metabolic outcomes
5134321|NCT03153917|shift work|shift work
5134322|NCT03153917|melatonin|melatonin
5134323|NCT03153917|sleep|sleep
5134324|NCT03153904|anxiety|anxiety
5134325|NCT03153904|depression|depression
5134326|NCT03153904|trauma|trauma
5134327|NCT03153904|behavior problems|behavior problems
5134328|NCT03153904|evidence-based treatments|evidence-based treatments
5134329|NCT03153904|manualized treatments|manualized treatments
5134330|NCT03153904|cognitive-behavioral therapy|cognitive-behavioral therapy
5134331|NCT03153904|youth|youth
5134332|NCT03153904|mental health|mental health
5134333|NCT03153891|environment|environment
5134334|NCT03153891|nature|nature
5134335|NCT03153878|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
5134336|NCT03153878|Benefit-risk|benefit-risk
5134337|NCT03153878|Ischemic heart disease|ischemic heart disease
5134338|NCT03153878|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
5134339|NCT03153878|Antithrombotic|antithrombotic
5134340|NCT03153878|Anticoagulant|anticoagulant
5134341|NCT03153878|People's Republic of China|people's republic of china
5134342|NCT03153878|Multicenter Studies|multicenter studies
5134343|NCT03153839|Children|children
5134344|NCT03153839|Babies|babies
5134345|NCT03153839|Infant|infant
5134346|NCT03153839|Swimming pool|swimming pool
5134347|NCT03153839|Aquatic physical activity|aquatic physical activity
5134348|NCT03153839|Motor development|motor development
5134349|NCT03153839|Neurodevelopment|neurodevelopment
5134350|NCT03153826|COPD Exacerbation|copd exacerbation
5134351|NCT03153826|Muscle atrophy|muscle atrophy
5134352|NCT03153826|Inflammation|inflammation
5134353|NCT03153826|Oxidative stress|oxidative stress
5765612|NCT00260988|Dalteparin|dalteparin
5134355|NCT03153813|knee osteoarthritis|knee osteoarthritis
5134357|NCT03153813|capsaicin|capsaicin
5134358|NCT03153787|implantation failure|implantation failure
5134359|NCT03153787|fertility|fertility
5134360|NCT03153787|microbiome|microbiome
5134361|NCT03153787|Assisted reproduction|assisted reproduction
5134362|NCT03153774|Sarcopenia|sarcopenia
5134363|NCT03153774|Heart failure (HF)|heart failure (hf)
5134364|NCT03153774|The trans aortic valvular implantation (TAVI)|the trans aortic valvular implantation (tavi)
5134365|NCT03153748|Treatment strategy|treatment strategy
5134366|NCT03153735|Hyaluronic acid|hyaluronic acid
5134367|NCT03153735|Small Penis|small penis
5134368|NCT03153735|Penile Enhancement|penile enhancement
5134369|NCT03153722|pediatric|pediatric
5134370|NCT03153722|hospital discharge|hospital discharge
5134371|NCT03153722|quality improvement|quality improvement
5134372|NCT03153722|transition of care|transition of care
5134373|NCT03153709|Pregnancy rates|pregnancy rates
5134374|NCT03153709|pharmacokinetic interactions|pharmacokinetic interactions
5134388|NCT03153644|Medical conditions|medical conditions
5134389|NCT03153644|Birth control methods|birth control methods
5134390|NCT03153644|Intrauterine Devices|intrauterine devices
5134391|NCT03153644|Physicians, Primary Care|physicians, primary care
5134392|NCT03153644|Long-acting reversible contraceptives (LARC)|long-acting reversible contraceptives (larc)
5134393|NCT03153540|Aphasia|aphasia
5134394|NCT03153540|Agrammatism|agrammatism
5134395|NCT03153540|Frontotemporal Dementia|frontotemporal dementia
5134396|NCT03153540|Tauopathies|tauopathies
5134397|NCT03153540|Neurodegenerative Diseases|neurodegenerative diseases
5134398|NCT03153540|Language Disorders|language disorders
5134399|NCT03153540|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5134400|NCT03153514|CLL|cll
5134401|NCT03153488|ADHD|adhd
5134402|NCT03153488|Methylphenidate|methylphenidate
5134403|NCT03153488|Amphetamine|amphetamine
5134404|NCT03153488|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5134405|NCT03153488|Treatment|treatment
5134406|NCT03153475|Revision knee surgery, implant replacement|revision knee surgery, implant replacement
5134407|NCT03153449|complex primary, deformity, ligamentous laxity|complex primary, deformity, ligamentous laxity
5134408|NCT03153410|Pancreas vaccine|pancreas vaccine
5134409|NCT03153410|immunotherapy|immunotherapy
5134410|NCT03153410|antibody|antibody
5134411|NCT03153410|PD-1|pd-1
5134412|NCT03153410|IMC-CS4|imc-cs4
5134413|NCT03153410|Pembrolizumab|pembrolizumab
5134414|NCT03153410|GVAX|gvax
5134415|NCT03153410|Borderline Resectable|borderline resectable
5134416|NCT03153397|trauma|trauma
5134417|NCT03153397|brain|brain
5134418|NCT03153397|neurological|neurological
5134419|NCT03153397|injury|injury
5134420|NCT03153397|enteral|enteral
5134421|NCT03153397|tube|tube
5134422|NCT03153397|feeding|feeding
5134423|NCT03153397|nutrition|nutrition
5134424|NCT03153384|Diagnosis|diagnosis
5134425|NCT03153384|Blood Culture|blood culture
5134426|NCT03153371|Alzheimer's disease|alzheimer's disease
5134427|NCT03153371|Young-onset|young-onset
5134428|NCT03153371|variant|variant
5134429|NCT03153371|visuospatial|visuospatial
5134430|NCT03153371|language|language
5134431|NCT03153371|apraxia|apraxia
5134432|NCT03153371|control|control
5134433|NCT03153371|dementia|dementia
5134434|NCT03153371|memory|memory
5134435|NCT03153371|MRI|mri
5134436|NCT03153371|neurology|neurology
5134437|NCT03153371|neuropsychology|neuropsychology
5134438|NCT03153371|brain|brain
5134439|NCT03153358|EGFR mutation icotinib SBRT|egfr mutation icotinib sbrt
5134440|NCT03153306|Albumin|albumin
5134441|NCT03153293|LHON,G11778A mutation, rAAV2-ND4，gene therapy|lhon,g11778a mutation, raav2-nd4，gene therapy
5134442|NCT03153254|Upper extremity|upper extremity
5134443|NCT03153254|Rehabilitation|rehabilitation
5134444|NCT03153254|Robot assisted therapy|robot assisted therapy
5134445|NCT03153254|Robotics|robotics
5134446|NCT03153254|Devices|devices
5134447|NCT03153254|Orthosis|orthosis
5134448|NCT03153228|E-cigarettes|e-cigarettes
5134449|NCT03153202|Ibrutinib|ibrutinib
5134450|NCT03153202|Pembrolizumab|pembrolizumab
5134451|NCT03153202|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5134452|NCT03153202|Mantle Cell Lymphoma|mantle cell lymphoma
5134453|NCT03153189|PA,menatal health,QOL|pa,menatal health,qol
5134454|NCT03153176|physical activity|physical activity
5134455|NCT03153176|physical fitness|physical fitness
5134456|NCT03153176|eating habits|eating habits
5134457|NCT03153176|sedentary behavior|sedentary behavior
5134458|NCT03153176|sleep quality|sleep quality
5134459|NCT03153176|satisfaction personal|satisfaction personal
5134460|NCT03153176|school health|school health
5134461|NCT03153176|adolescent|adolescent
5134462|NCT03153150|Oral anticoagulant|oral anticoagulant
5134463|NCT03153150|Factor Xa inhibitors|factor xa inhibitors
5134464|NCT03153150|Direct thrombin inhibitor|direct thrombin inhibitor
5134470|NCT03153098|physical activity|physical activity
5134471|NCT03153098|intervention|intervention
5134472|NCT03153098|behaviour change|behaviour change
5134473|NCT03153098|inactive adults|inactive adults
5134474|NCT03153098|behaviour change techniques|behaviour change techniques
5134478|NCT03153085|Recurrent Melanoma|recurrent melanoma
5134480|NCT03153085|HF10|hf10
5134481|NCT03153085|HSV-1|hsv-1
5134482|NCT03153085|Oncolytic virus|oncolytic virus
5134483|NCT03153085|Oncolytic viral immunotherapy|oncolytic viral immunotherapy
5134484|NCT03153085|Ipilimumab|ipilimumab
5134485|NCT03153085|Intratumoral administration|intratumoral administration
5134486|NCT03153085|canerpaturev|canerpaturev
5134487|NCT03153059|gut microbiota|gut microbiota
5134488|NCT03153059|stool frequency|stool frequency
5134489|NCT03153046|prebiotics|prebiotics
5134490|NCT03153046|cognitive impairment|cognitive impairment
5134491|NCT03153046|weight gain|weight gain
5134492|NCT03153033|Wheelchair propulsion|wheelchair propulsion
5134493|NCT03153033|Shoulder|shoulder
5134494|NCT03153033|Biomechanics|biomechanics
5134495|NCT03152994|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5134496|NCT03152994|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5134497|NCT03152994|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
5134498|NCT03152994|platelet-lymphocyte ratio|platelet-lymphocyte ratio
5134499|NCT03152994|lymphocyte-monocyte ratio|lymphocyte-monocyte ratio
5134500|NCT03152968|FMS|fms
5134501|NCT03152955|trigeminal neuralgia|trigeminal neuralgia
5134502|NCT03152955|nerve block|nerve block
5134503|NCT03152929|Surgery|surgery
5134504|NCT03152929|Breast|breast
5134505|NCT03152929|Pectoral Never Block|pectoral never block
5134506|NCT03152929|Paravertebral Block|paravertebral block
5134507|NCT03152929|Analgesia|analgesia
5134508|NCT03152929|Mastectomy|mastectomy
5134509|NCT03152916|subtalar joint|subtalar joint
5134510|NCT03152916|arthrodesis|arthrodesis
5134511|NCT03152916|3d printing|3d printing
5134512|NCT03152903|Recombinant BCG vaccine|recombinant bcg vaccine
5134513|NCT03152903|Category 1 pulmonary tuberculosis|category 1 pulmonary tuberculosis
5134514|NCT03152903|Recurrence|recurrence
5134515|NCT03152903|Efficacy|efficacy
5134516|NCT03152890|Insulin|insulin
5134517|NCT03152890|Liver transplantation|liver transplantation
5134518|NCT03152890|Hyperglycemia|hyperglycemia
5134519|NCT03152825|myocardial ischaemia|myocardial ischaemia
5134520|NCT03152825|myocardial viability|myocardial viability
5134521|NCT03152825|coronary chronic total occlusions|coronary chronic total occlusions
5134522|NCT03152825|cardiac magnetic resonance|cardiac magnetic resonance
5134523|NCT03152825|stress CMR|stress cmr
5134524|NCT03152799|remote ischaemic conditioning|remote ischaemic conditioning
5134525|NCT03152799|remote ischemic conditioning|remote ischemic conditioning
5134526|NCT03152799|cerebral infarction|cerebral infarction
5134527|NCT03152799|ischaemia reperfusion injury|ischaemia reperfusion injury
5134528|NCT03152799|ischemia reperfusion injury|ischemia reperfusion injury
5134529|NCT03152799|anterior circulation stroke|anterior circulation stroke
5134530|NCT03152799|mechanical thrombectomy|mechanical thrombectomy
5134531|NCT03152773|MRI Catheterization|mri catheterization
5134532|NCT03152773|Real-time MRI|real-time mri
5134533|NCT03152760|Alcoholism|alcoholism
5134534|NCT03152760|Healthy Volunteers|healthy volunteers
5134535|NCT03152760|Craving|craving
5134536|NCT03152760|Gut|gut
5134537|NCT03152734|Elderly patients, Mortality, morbidity, post-intervention|elderly patients, mortality, morbidity, post-intervention
5134538|NCT03152721|accelerometry|accelerometry
5134539|NCT03152721|home based|home based
5134540|NCT03152721|motor complications|motor complications
5134541|NCT03152721|Parkinson KinetiGraph|parkinson kinetigraph
5134542|NCT03152721|Registry|registry
5134543|NCT03152682|glucose|glucose
5134544|NCT03152682|glucose homeostasis|glucose homeostasis
5134548|NCT03152656|Familial hypercholesterolemia|familial hypercholesterolemia
5134549|NCT03152656|total cholesterol|total cholesterol
5134550|NCT03152656|low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
5134551|NCT03152656|tendon xanthomas|tendon xanthomas
5134552|NCT03152656|premature atherosclerosis|premature atherosclerosis
5134553|NCT03152643|Cumulative live birth rates|cumulative live birth rates
5134554|NCT03152643|cleavage-stage embryo transfer|cleavage-stage embryo transfer
5134555|NCT03152643|blastocyst transfer|blastocyst transfer
5134556|NCT03152630|lncRNAs|lncrnas
5134557|NCT03152630|Alzheimer's disease|alzheimer's disease
5134558|NCT03152630|vascular dementia|vascular dementia
5134559|NCT03152617|bariatric surgery|bariatric surgery
5134560|NCT03152617|gastric bypass|gastric bypass
5134566|NCT03152591|hyperandrogenism|hyperandrogenism
5134567|NCT03152591|insulin resistance|insulin resistance
5134569|NCT03152591|obesity|obesity
5134570|NCT03152552|Diabetes mellitus|diabetes mellitus
5134571|NCT03152552|LIK066|lik066
5134572|NCT03152552|Obesity|obesity
5134573|NCT03152552|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5134574|NCT03152552|Heart Failure (HF)|heart failure (hf)
5134575|NCT03152552|Hypertension|hypertension
5134576|NCT03152552|Renal dysfunction|renal dysfunction
5134577|NCT03152552|Adult-onset diabetes|adult-onset diabetes
5134578|NCT03152552|Noninsulin-dependent diabetes mellitus (NIDDM)|noninsulin-dependent diabetes mellitus (niddm)
5134579|NCT03152552|High blood sugar|high blood sugar
5134580|NCT03152500|IOL|iol
5134581|NCT03152500|Stability|stability
5134582|NCT03152500|FEMTIS IOL|femtis iol
5134583|NCT03152500|Acrysof IOL|acrysof iol
5134584|NCT03152500|FLACS|flacs
5134585|NCT03152500|Capsulotomy|capsulotomy
5134586|NCT03152487|endoscopic ultrasound|endoscopic ultrasound
5134587|NCT03152487|celiac plexus neurolysis|celiac plexus neurolysis
5134588|NCT03152487|radiofrequency ablation|radiofrequency ablation
5134589|NCT03152487|pancreatic cancer|pancreatic cancer
5134590|NCT03152461|Viscoelastic testing|viscoelastic testing
5134592|NCT03152461|Quantra|quantra
5134593|NCT03152461|Hemostasis|hemostasis
5134594|NCT03152448|Prolaris|prolaris
5134595|NCT03152448|Prostate Cancer|prostate cancer
5134596|NCT03152409|Aspirin|aspirin
5134597|NCT03152409|Treatment|treatment
5134598|NCT03152409|Salicylic acid|salicylic acid
5134599|NCT03152409|anti-inflammatory|anti-inflammatory
5134600|NCT03152396|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
5134601|NCT03152396|cardiovascular risk factors|cardiovascular risk factors
5134602|NCT03152396|blood pressure|blood pressure
5134603|NCT03152396|LDL-cholesterol|ldl-cholesterol
5134604|NCT03152396|total-cholesterol|total-cholesterol
5134605|NCT03152396|HDL-cholesterol|hdl-cholesterol
5134606|NCT03152396|hemoglobin A1C|hemoglobin a1c
5134607|NCT03152396|tobacco cessation|tobacco cessation
5134608|NCT03152396|patient satisfaction|patient satisfaction
5134609|NCT03152383|Autism Spectrum Disorder|autism spectrum disorder
5134610|NCT03152383|Behavioral Research|behavioral research
5134611|NCT03152383|Psychology|psychology
5134612|NCT03152383|Cognitive Disorders|cognitive disorders
5134613|NCT03152370|E7046|e7046
5134614|NCT03152370|Radiotherapy/Chemoradiotherapy|radiotherapy/chemoradiotherapy
5134615|NCT03152370|Neoadjuvant therapy|neoadjuvant therapy
5134616|NCT03152370|Rectal cancer|rectal cancer
5134617|NCT03152357|osteoarthritis|osteoarthritis
5134618|NCT03152357|total knee arthroplasty|total knee arthroplasty
5134620|NCT03152357|TKR|tkr
5134621|NCT03152357|patient specific|patient specific
5134622|NCT03152357|Conformis|conformis
5134623|NCT03152344|Fall|fall
5134624|NCT03152344|Balance control|balance control
5134625|NCT03152344|Screening test|screening test
5134626|NCT03152344|Oxygen|oxygen
5134627|NCT03152344|Skeletal muscle mass|skeletal muscle mass
5134628|NCT03152331|Neurofeedback|neurofeedback
5134629|NCT03152318|Malignant Glioma|malignant glioma
5134630|NCT03152318|Brain Tumor|brain tumor
5134631|NCT03152318|Glioblastoma|glioblastoma
5134632|NCT03152305|Migraine|migraine
5134633|NCT03152305|Intracranial pressure|intracranial pressure
5134634|NCT03152305|Headache|headache
5134635|NCT03152253|Tobacco, Smoking, Text Message|tobacco, smoking, text message
5134636|NCT03152240|Acute Coronary Syndrome|acute coronary syndrome
5134637|NCT03152240|Primary Angioplasty|primary angioplasty
5134638|NCT03152240|Gender|gender
5134639|NCT03152214|Transition out of military|transition out of military
5134640|NCT03152188|Hepatic Encephalopathy|hepatic encephalopathy
5134641|NCT03152188|Cirrhosis|cirrhosis
5134642|NCT03152188|Liver|liver
5134643|NCT03152188|Openbiome|openbiome
5134644|NCT03152188|FMT Capsule|fmt capsule
5134645|NCT03152188|Placebo|placebo
5134646|NCT03152175|Memory Reconsolidation|memory reconsolidation
5134647|NCT03152175|Propranolol|propranolol
5134648|NCT03152175|Police officers|police officers
5134649|NCT03152175|911 operators|911 operators
5134650|NCT03152175|Efficacy|efficacy
5134651|NCT03152175|Cost-effectiveness|cost-effectiveness
5134652|NCT03152162|osteoarthritis|osteoarthritis
5134653|NCT03152162|patient-specific|patient-specific
5134654|NCT03152162|knee replacement|knee replacement
5134655|NCT03152162|TKA|tka
5134656|NCT03152162|knee arthroplasty|knee arthroplasty
5134657|NCT03152162|total knee replacement|total knee replacement
5134658|NCT03152162|posterior stabilized|posterior stabilized
5130813|NCT03176732|Sleep Apnea|sleep apnea
5130859|NCT03176485|HCC|hcc
5134666|NCT03152071|Robot|robot
5134667|NCT03152045|communication between adolescent patients and their clinician|communication between adolescent patients and their clinician
5134668|NCT03152032|employment service|employment service
5134669|NCT03152032|vocational counseling|vocational counseling
5765613|NCT00260988|Anti Xa|anti xa
5134670|NCT03152032|employment outcome|employment outcome
5134671|NCT03152032|schizophrenia|schizophrenia
5134672|NCT03152032|bipolar|bipolar
5134673|NCT03152032|occupational therapy in mental health|occupational therapy in mental health
5134778|NCT03151265|Range of Movement|range of movement
5134683|NCT03151954|nasal epithelium stem cells|nasal epithelium stem cells
5134684|NCT03151954|Hippo-YAP pathway|hippo-yap pathway
5134686|NCT03151954|differentiation|differentiation
5134687|NCT03151863|Dexmedetomidine|dexmedetomidine
5134688|NCT03151863|Opioids|opioids
5134689|NCT03151863|Palliative Care|palliative care
5134690|NCT03151863|Elderly people|elderly people
5134691|NCT03151863|Nursing care|nursing care
5134692|NCT03151863|Analgesia|analgesia
5134693|NCT03151863|Sedation|sedation
5134694|NCT03151863|Anxiolysis|anxiolysis
5134695|NCT03151863|Intranasal|intranasal
5134696|NCT03151850|fungal|fungal
5134697|NCT03151850|mucosa|mucosa
5134698|NCT03151850|diversity|diversity
5134699|NCT03151850|Basidiomycete|basidiomycete
5134700|NCT03151837|Diabetes|diabetes
5134709|NCT03151798|Exercise|exercise
5134710|NCT03151798|Weight loss diet|weight loss diet
5134712|NCT03151785|Schools|schools
5134713|NCT03151785|Education|education
5134714|NCT03151785|Lifesaver|lifesaver
5134715|NCT03151733|SILS|sils
5134716|NCT03151733|colorectal cancer|colorectal cancer
5134717|NCT03151694|childhood obesity|childhood obesity
5134718|NCT03151694|body weight|body weight
5134719|NCT03151694|nutritional risk|nutritional risk
5134725|NCT03151603|Uva Ursi|uva ursi
5134726|NCT03151603|fosfomycin|fosfomycin
5134727|NCT03151603|uncomplicated urinary tract infection of women|uncomplicated urinary tract infection of women
5134728|NCT03151564|Diseases of liver|diseases of liver
5134729|NCT03151564|Colon carcinoma|colon carcinoma
5134730|NCT03151564|Colorectal carcinoma|colorectal carcinoma
5134731|NCT03151564|Liver metastases|liver metastases
5134732|NCT03151564|Computed tomography|computed tomography
5134734|NCT03151564|Reduced radiation doses|reduced radiation doses
5134735|NCT03151538|Pedography|pedography
5134736|NCT03151538|Exercise|exercise
5134737|NCT03151538|Play Training|play training
5134738|NCT03151538|Pes Planus|pes planus
5134739|NCT03151538|Femoral Anteversion|femoral anteversion
5134740|NCT03151512|MRI|mri
5134741|NCT03151512|distortion correction|distortion correction
5134742|NCT03151512|Magnetic Resonance Imaging|magnetic resonance imaging
5134743|NCT03151512|prostheses|prostheses
5134744|NCT03151447|Breast Cancer|breast cancer
5134745|NCT03151447|Anti-PD1 Antibody|anti-pd1 antibody
5134746|NCT03151447|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5134747|NCT03151434|VATS|vats
5134748|NCT03151434|pain|pain
5134749|NCT03151421|air quality feedback|air quality feedback
5134750|NCT03151421|second-hand smoke|second-hand smoke
5134751|NCT03151421|passive smoking|passive smoking
5134752|NCT03151421|exposure to second-hand smoke|exposure to second-hand smoke
5134753|NCT03151421|second-hand smoke exposure prevention|second-hand smoke exposure prevention
5134754|NCT03151408|AML|aml
5134755|NCT03151395|COPD|copd
5134756|NCT03151395|AECOPD|aecopd
5134757|NCT03151395|GOLD (Global Initiative for Chronic Obstructive Lung Disease)|gold (global initiative for chronic obstructive lung disease)
5134758|NCT03151395|Asia Pacific|asia pacific
5134759|NCT03151382|Alzheimer Disease|alzheimer disease
5020340|NCT03870113|E6/E7 protein|e6/e7 protein
5134760|NCT03151382|Cognitive Function|cognitive function
5134761|NCT03151382|tandospirone|tandospirone
5134762|NCT03151304|MDS|mds
5134763|NCT03151291|cancer cachexia|cancer cachexia
5134764|NCT03151291|WB-EMS|wb-ems
5134765|NCT03151291|skeletal muscle mass|skeletal muscle mass
5134766|NCT03151291|exercise|exercise
5134767|NCT03151291|nutrition|nutrition
5134768|NCT03151291|dietary supplements|dietary supplements
5134769|NCT03151278|Fluoroscopy|fluoroscopy
5134770|NCT03151278|Ablation|ablation
5134771|NCT03151278|Three dimensional|three dimensional
5134772|NCT03151278|Atrial arrhythmia|atrial arrhythmia
5134773|NCT03151278|Radiation|radiation
5134774|NCT03151265|Functional Outcome Measures|functional outcome measures
5130912|NCT03176238|everolimus|everolimus
5134776|NCT03151265|ViMove|vimove
5134777|NCT03151265|Low Back Pain|low back pain
5134779|NCT03151265|Muscle Activity|muscle activity
5134780|NCT03151265|ThermaCare|thermacare
5134781|NCT03151226|obstructive sleep apnea screen negative|obstructive sleep apnea screen negative
5134782|NCT03151226|respiratory depression|respiratory depression
5134783|NCT03151226|cesarean section|cesarean section
5134784|NCT03151200|Amblyopia treatment|amblyopia treatment
5134785|NCT03151161|chemotherapy|chemotherapy
5134786|NCT03151161|maintenance therapy|maintenance therapy
5134787|NCT03151161|icotinib|icotinib
5134788|NCT03151148|allogeneic targeted microbiome transplant (TMT)|allogeneic targeted microbiome transplant (tmt)
5134789|NCT03151148|dysbiosis in AD|dysbiosis in ad
5134790|NCT03151148|Staphylococcus aureus colonized skin|staphylococcus aureus colonized skin
5134791|NCT03151148|antimicrobial peptides (AMPs)|antimicrobial peptides (amps)
5134792|NCT03151148|randomized trial|randomized trial
5134793|NCT03151135|Energy metabolism|energy metabolism
5134794|NCT03151109|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
5134795|NCT03151109|glenoid bone loss|glenoid bone loss
5134796|NCT03151083|Health Technology|health technology
5134797|NCT03151083|Internet-Based Psychotherapy|internet-based psychotherapy
5134798|NCT03151083|self-care|self-care
5134799|NCT03151083|Primary Care|primary care
5134800|NCT03151083|Mental Health|mental health
5134801|NCT03151057|Idelalisib|idelalisib
5134802|NCT03151057|Zydelig|zydelig
5134803|NCT03151057|allo transplant|allo transplant
5134804|NCT03151057|PI3K inhibitor|pi3k inhibitor
5134805|NCT03151057|post transplant maintenance therapy|post transplant maintenance therapy
5134806|NCT03151044|epirubicin|epirubicin
5134807|NCT03151044|high-dose|high-dose
5134808|NCT03151044|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5134809|NCT03151044|medium/high-risk|medium/high-risk
5134810|NCT03151031|balance|balance
5134811|NCT03151031|college students|college students
5962043|NCT04283357|exercise|exercise
5134812|NCT03151031|star excursion balance test|star excursion balance test
5134813|NCT03151018|coronary artery disease|coronary artery disease
5134814|NCT03151018|percutaneous coronary intervention|percutaneous coronary intervention
5134815|NCT03151018|zotarolimus-eluting stents|zotarolimus-eluting stents
5134816|NCT03151005|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5134817|NCT03151005|Overweight|overweight
5134818|NCT03151005|Obesity|obesity
5134819|NCT03151005|GLP-1 Agonist|glp-1 agonist
5134820|NCT03151005|Oral contraceptives (OCs)|oral contraceptives (ocs)
5134821|NCT03151005|Metformin|metformin
5134822|NCT03151005|Reproductive Disorders|reproductive disorders
5134823|NCT03151005|Cardiovascular risk factor|cardiovascular risk factor
5134824|NCT03151005|Lipid Metabolism|lipid metabolism
5134825|NCT03150992|Feasibility|feasibility
5134826|NCT03150992|Elemental Diet|elemental diet
5134827|NCT03150992|Quality of life|quality of life
5134828|NCT03150992|Palliative|palliative
5134829|NCT03150992|Nutrition|nutrition
5134830|NCT03150992|Ovarian|ovarian
5134831|NCT03150992|Peritoneal|peritoneal
5134832|NCT03150992|Advanced|advanced
5134833|NCT03150992|Metastatic|metastatic
5134834|NCT03150992|Bowel obstruction|bowel obstruction
5134835|NCT03150992|Inoperable|inoperable
5134836|NCT03150979|Stroke|stroke
5134837|NCT03150979|Assistive devices|assistive devices
5134838|NCT03150979|Gait|gait
5134839|NCT03150979|Rehabilitation|rehabilitation
5134840|NCT03150979|Clinical trial|clinical trial
5134841|NCT03150966|Multiple sclerosis|multiple sclerosis
5134842|NCT03150966|Nanocurcumin|nanocurcumin
5134843|NCT03150966|MicroRNAs|micrornas
5134844|NCT03150966|Th17 cells|th17 cells
5134845|NCT03150966|Treg cells|treg cells
5134846|NCT03150953|anesthesia|anesthesia
5134848|NCT03150953|thermoregulation|thermoregulation
5134849|NCT03150862|Adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms|adult glioblastoma, adult gian cell glioblastoma, adult gliosarcoma, glioma neoplasms
5134850|NCT03150862|recurrent adult brain tumor|recurrent adult brain tumor
5134851|NCT03150862|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site|neoplasms, central nervous system neoplasms, neoplasms by histologic type, neoplasms by site
5134852|NCT03150862|astrocytoma|astrocytoma
5134853|NCT03150862|neuroepithelial|neuroepithelial
5134854|NCT03150862|neuroectodermal tumors|neuroectodermal tumors
5134855|NCT03150862|germ cell and embryonal|germ cell and embryonal
5134856|NCT03150862|antineoplastic agents|antineoplastic agents
5134857|NCT03150862|glandular and epithelial|glandular and epithelial
5134858|NCT03150862|nerve tissue, nervous system diseases|nerve tissue, nervous system diseases
5134859|NCT03150862|temozolomide|temozolomide
5134860|NCT03150862|BGB-290|bgb-290
5134861|NCT03150862|alkylating, alkylating agents|alkylating, alkylating agents
5134862|NCT03150862|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
5134863|NCT03150862|Poly(ADP-ribose) polymerase inhibitors|poly(adp-ribose) polymerase inhibitors
5134864|NCT03150862|enzyme inhibitors|enzyme inhibitors
5134865|NCT03150836|bladder cancer|bladder cancer
5134866|NCT03150836|urothelial|urothelial
5134867|NCT03150823|Direct current|direct current
5134868|NCT03150823|Galvanic current|galvanic current
5134869|NCT03150823|Handgrip Force|handgrip force
5134870|NCT03150823|Palmar Grip|palmar grip
5134871|NCT03150823|Dynamometry|dynamometry
5134872|NCT03150823|Miofeedback|miofeedback
5134970|NCT03150160|efficacy|efficacy
5134873|NCT03150810|Ovarian cancer|ovarian cancer
5134874|NCT03150810|Triple negative breast cancer|triple negative breast cancer
5134875|NCT03150810|Small cell lung cancer|small cell lung cancer
5134876|NCT03150810|Prostate cancer,|prostate cancer,
5134877|NCT03150810|Gastric cancer|gastric cancer
5134878|NCT03150810|neoplasms|neoplasms
5134879|NCT03150810|temozolomide|temozolomide
5134880|NCT03150810|BGB-290|bgb-290
5134881|NCT03150810|antineoplastic agents|antineoplastic agents
5134882|NCT03150810|alkylating, alkylating agents,|alkylating, alkylating agents,
5134883|NCT03150810|Poly (ADP-ribose) polymerase inhibitors|poly (adp-ribose) polymerase inhibitors
5134884|NCT03150810|enzyme inhibitors|enzyme inhibitors
5134885|NCT03150797|UCSF|ucsf
5134886|NCT03150797|UCLA|ucla
5134887|NCT03150797|melatonin|melatonin
5134888|NCT03150797|migraine|migraine
5134889|NCT03150797|headache|headache
5134890|NCT03150784|Motor Learning|motor learning
5134891|NCT03150784|Coordination|coordination
5134892|NCT03150784|Children|children
5134893|NCT03150784|Motor Skills Disorders|motor skills disorders
5134894|NCT03150784|Movement|movement
5134895|NCT03150758|Erectile Disfunction|erectile disfunction
5134896|NCT03150758|Urinary Function|urinary function
5134897|NCT03150706|POLE mutation|pole mutation
5134898|NCT03150706|mismatch repair deficient|mismatch repair deficient
5134899|NCT03150706|Avelumab|avelumab
5134900|NCT03150680|SYNTAX score|syntax score
5134901|NCT03150680|SNPs|snps
5134902|NCT03150680|Genetics|genetics
5134903|NCT03150680|Pharmacogenetics|pharmacogenetics
5134908|NCT03150654|diabetic retinopathy|diabetic retinopathy
5134909|NCT03150654|laser pan-retinal photocoagulation|laser pan-retinal photocoagulation
5134910|NCT03150641|Maternal blood loss|maternal blood loss
5006644|NCT03954925|ACL|acl
5134911|NCT03150641|Cesarean delivery|cesarean delivery
5134912|NCT03150641|Delayed cord clamping|delayed cord clamping
5134913|NCT03150641|Neonatal health|neonatal health
5134914|NCT03150576|Triple negative breast cancer|triple negative breast cancer
5134915|NCT03150576|germline BRCA|germline brca
5134916|NCT03150576|platinum and PARP inhibitor|platinum and parp inhibitor
5134917|NCT03150576|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5134918|NCT03150576|olaparib|olaparib
5134919|NCT03150563|Stretching|stretching
5134920|NCT03150563|Stretching sensation|stretching sensation
5134921|NCT03150563|Isokinetic dynamometry|isokinetic dynamometry
5134922|NCT03150563|Stretching load.|stretching load.
5134923|NCT03150550|Mindfulness|mindfulness
5134924|NCT03150550|Alcohol|alcohol
5134925|NCT03150550|Alcohol Use Disorder|alcohol use disorder
5134926|NCT03150550|Relapse|relapse
5134927|NCT03150550|Relapse Prevention|relapse prevention
5134928|NCT03150550|Cognitive-behavioral therapy|cognitive-behavioral therapy
5134929|NCT03150537|jet injector|jet injector
5134930|NCT03150537|influenza vaccine|influenza vaccine
5134931|NCT03150537|immune response|immune response
5134932|NCT03150524|stroke|stroke
5134933|NCT03150524|RCVS|rcvs
5134934|NCT03150498|Food Effect|food effect
5134935|NCT03150498|Pharmacokinetics|pharmacokinetics
5134936|NCT03150472|Dental Instruments|dental instruments
5134937|NCT03150472|Dental Technology|dental technology
5134938|NCT03150446|laparoscopy|laparoscopy
5134939|NCT03150446|ureteral catheterization|ureteral catheterization
5134940|NCT03150420|calciphylaxis|calciphylaxis
5134941|NCT03150420|calcific uremic arteriolopathy, calcinosis|calcific uremic arteriolopathy, calcinosis
5134942|NCT03150420|calcium metabolism disorders|calcium metabolism disorders
5134943|NCT03150420|metabolic diseases|metabolic diseases
5134944|NCT03150420|sodium thiosulfate|sodium thiosulfate
5134945|NCT03150342|CZT scanner|czt scanner
5134946|NCT03150342|myocardial perfusion imaging|myocardial perfusion imaging
5134947|NCT03150342|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5134948|NCT03150303|Periprocedural period|periprocedural period
5134949|NCT03150303|Anticoagulant treatment|anticoagulant treatment
5134950|NCT03150303|Thromboembolic events|thromboembolic events
5134951|NCT03150303|Bleeding events|bleeding events
5134952|NCT03150264|lung protective ventilation strategies|lung protective ventilation strategies
5134953|NCT03150264|obesity|obesity
5134954|NCT03150225|andropause|andropause
5134955|NCT03150225|depressive symptoms|depressive symptoms
5134956|NCT03150225|stress|stress
5134957|NCT03150225|abdominal Obesity|abdominal obesity
5134958|NCT03150225|testosterone|testosterone
5134959|NCT03150225|erectile dysfunction|erectile dysfunction
5134960|NCT03150186|second hand smoke|second hand smoke
5134961|NCT03150186|passive smoking|passive smoking
5134962|NCT03150186|airborne nicotine|airborne nicotine
5134963|NCT03150186|private settings|private settings
5134964|NCT03150186|outdoors|outdoors
5134965|NCT03150173|opioid use disorder, syringe exchange, HIV risk reduction|opioid use disorder, syringe exchange, hiv risk reduction
5134966|NCT03150160|travoprost|travoprost
5134967|NCT03150160|brinzolamide 1%/brimonidine 0.2%|brinzolamide 1%/brimonidine 0.2%
5134968|NCT03150160|normal tension glaucoma|normal tension glaucoma
5134969|NCT03150160|intraocular pressure|intraocular pressure
5862713|NCT00001541|Cytokines|cytokines
5134977|NCT03150134|Acute Myeloid Leukemia|acute myeloid leukemia
5134978|NCT03150134|transplantation|transplantation
5134979|NCT03150134|allogeneic transplantation|allogeneic transplantation
5134980|NCT03150134|immunosuppressive agents|immunosuppressive agents
5134981|NCT03150082|GR37547|gr37547
5134982|NCT03150082|Cross-over|cross-over
5134983|NCT03150082|Bioequivalence|bioequivalence
5134984|NCT03150082|Ciprofloxacin|ciprofloxacin
5134985|NCT03150069|Pregnancy|pregnancy
5134986|NCT03150056|abiraterone|abiraterone
5134987|NCT03150056|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5134988|NCT03150056|androgen receptor targeted therapy|androgen receptor targeted therapy
5134989|NCT03150056|RP2D|rp2d
5134990|NCT03150056|enzalutamide|enzalutamide
5134991|NCT03150056|GSK525762|gsk525762
5134992|NCT03150043|Hemoglobin|hemoglobin
5134993|NCT03150043|Cesarean delivery|cesarean delivery
5134994|NCT03150004|Acute myeloid leukemia|acute myeloid leukemia
5134995|NCT03150004|AML|aml
5134996|NCT03150004|salvage chemotherapy|salvage chemotherapy
5134997|NCT03150004|CLAG-M|clag-m
5134998|NCT03150004|relapse acute myeloid leukemia|relapse acute myeloid leukemia
5134999|NCT03150004|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5135004|NCT03149978|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
5135005|NCT03149978|treatment effect prediction|treatment effect prediction
5135007|NCT03149913|below the knee artery|below the knee artery
5135008|NCT03149913|endovascular|endovascular
5135009|NCT03149913|drug coated balloon|drug coated balloon
5135010|NCT03149913|critical limb ischemia|critical limb ischemia
5135011|NCT03149848|Tuberculosis|tuberculosis
5135012|NCT03149848|Human Immunodeficiency Virus|human immunodeficiency virus
5135013|NCT03149848|Rifabutin|rifabutin
5135014|NCT03149848|Drug-drug interaction|drug-drug interaction
5962044|NCT04283357|balance|balance
5135015|NCT03149848|Cabotegravir|cabotegravir
5135016|NCT03149809|Urinary incontinence|urinary incontinence
5135017|NCT03149809|Parkinson disease|parkinson disease
5135018|NCT03149809|Overactive urinary bladder|overactive urinary bladder
5135019|NCT03149809|Nocturia|nocturia
5135020|NCT03149757|Treatment Adherence|treatment adherence
5135021|NCT03149757|Alcohol or Drugs|alcohol or drugs
5135022|NCT03149757|Behavioral|behavioral
5135023|NCT03149757|Internet|internet
5135024|NCT03149757|Adolescents|adolescents
5135025|NCT03149757|Young Adults|young adults
5135026|NCT03149757|Social Support|social support
5135027|NCT03149718|Pharmacy|pharmacy
5135028|NCT03149718|Intervention|intervention
5135029|NCT03149718|Medication Adherence|medication adherence
5135030|NCT03149705|Ischemic stroke, stroke, bio-collection, Imaging markers, biomarkers, clinical outcomes|ischemic stroke, stroke, bio-collection, imaging markers, biomarkers, clinical outcomes
5135034|NCT03149653|lipid emulsion|lipid emulsion
5135035|NCT03149653|olive oil|olive oil
5135036|NCT03149653|fish oil|fish oil
5135037|NCT03149653|intestinal failure|intestinal failure
5135038|NCT03149653|home parenteral nutrition|home parenteral nutrition
5135039|NCT03149640|Prevention|prevention
5135040|NCT03149640|inhaled amikacin|inhaled amikacin
5135041|NCT03149640|placebo|placebo
5135042|NCT03149614|mobilization|mobilization
5135043|NCT03149614|resonant oscillation|resonant oscillation
5135044|NCT03149575|Glioma|glioma
5135045|NCT03149575|Glioblastoma|glioblastoma
5135046|NCT03149575|Glioblastoma multiforme|glioblastoma multiforme
5135048|NCT03149575|brain tumor|brain tumor
5135049|NCT03149575|brain cancer|brain cancer
5135050|NCT03149575|recurrent brain tumor|recurrent brain tumor
5135051|NCT03149575|recurrent brain cancer|recurrent brain cancer
5135052|NCT03149575|refractory brain tumor|refractory brain tumor
5135053|NCT03149575|refractory brain cancer|refractory brain cancer
5135054|NCT03149575|recurrent GBM|recurrent gbm
5135055|NCT03149575|refractory GBM|refractory gbm
5135056|NCT03149575|recurrent glioma|recurrent glioma
5135057|NCT03149575|refractory glioma|refractory glioma
5135058|NCT03149575|recurrent glioblastoma|recurrent glioblastoma
5135059|NCT03149575|refractory glioblastoma|refractory glioblastoma
5135060|NCT03149575|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5135061|NCT03149575|refractory glioblastoma multiforme|refractory glioblastoma multiforme
5135062|NCT03149575|failed temodar|failed temodar
5135063|NCT03149575|failed temozolomide|failed temozolomide
5135064|NCT03149575|temodar refractory|temodar refractory
5135065|NCT03149575|temozolomide refractory|temozolomide refractory
5135066|NCT03149575|failed avastin|failed avastin
5135067|NCT03149575|avastin refractory|avastin refractory
5135068|NCT03149575|failed bevacizumab|failed bevacizumab
5135069|NCT03149575|bevacizumab refractory|bevacizumab refractory
5135070|NCT03149575|avastin failure|avastin failure
5135071|NCT03149575|bevacizumab failure|bevacizumab failure
5135072|NCT03149575|STAR-3|star-3
5135073|NCT03149549|cancer|cancer
5135074|NCT03149549|solid tumor|solid tumor
5135075|NCT03149549|PROCLAIM|proclaim
5135076|NCT03149549|CX-2009|cx-2009
5135077|NCT03149549|PROBODY™ Therapeutic|probody™ therapeutic
5135078|NCT03149549|Drug Conjugate|drug conjugate
5135090|NCT03149523|kidney cancer|kidney cancer
5135091|NCT03149523|liver cancer|liver cancer
5135092|NCT03149523|immunological tumor microenvironment|immunological tumor microenvironment
5135093|NCT03149523|tumor microenvironment heterogeneity|tumor microenvironment heterogeneity
5144625|NCT03087812|kidney|kidney
5135098|NCT03149458|dance|dance
5135099|NCT03149432|mirror therapy|mirror therapy
5135100|NCT03149432|amputation|amputation
5135101|NCT03149432|phantom pain|phantom pain
5135102|NCT03149419|postmenopause|postmenopause
5135103|NCT03149419|paroxetine|paroxetine
5135104|NCT03149419|endothelial dysfunction|endothelial dysfunction
5135105|NCT03149419|blood pressure|blood pressure
5135106|NCT03149419|heart rate variability|heart rate variability
5135107|NCT03149419|sleep quality|sleep quality
5135108|NCT03149419|perceived stress|perceived stress
5135109|NCT03149419|sleepiness|sleepiness
5135113|NCT03149328|Home Dialysis|home dialysis
5135114|NCT03149328|Person-Centred Care|person-centred care
5135115|NCT03149328|Patient-Reported Outcome Measures|patient-reported outcome measures
5135116|NCT03149328|Process Evaluation|process evaluation
5135117|NCT03149328|Educational Support|educational support
5135118|NCT03149328|Electronic Patient-Reported Outcome Measures|electronic patient-reported outcome measures
5135119|NCT03149328|Patient-Reported Experience Measures|patient-reported experience measures
5135120|NCT03149302|Manual therapy|manual therapy
5135121|NCT03149302|Sensorimotor exercises|sensorimotor exercises
5135122|NCT03149302|Balance exercises|balance exercises
5135123|NCT03149302|Cervical mobilization|cervical mobilization
5135124|NCT03149302|Specific neck muscle exercises|specific neck muscle exercises
5135125|NCT03149263|botulinum toxin|botulinum toxin
5135126|NCT03149263|anxiety reduction|anxiety reduction
5135127|NCT03149263|pain reduction|pain reduction
5135128|NCT03149263|medical clowns|medical clowns
5135129|NCT03149263|distraction|distraction
5135130|NCT03149250|Aggregometry|aggregometry
5135131|NCT03149237|Mozambique|mozambique
5135132|NCT03149237|Couples-based services|couples-based services
5135133|NCT03149237|HIV/AIDS|hiv/aids
5135134|NCT03149237|Ante-natal Care|ante-natal care
5135135|NCT03149198|Fibromyalgia, pilates, exercises|fibromyalgia, pilates, exercises
5135136|NCT03149185|prostate cancer|prostate cancer
5135137|NCT03149185|advanced prostate cancer|advanced prostate cancer
5135138|NCT03149185|technology based|technology based
5135139|NCT03149146|Clinical Decision Making|clinical decision making
5135140|NCT03149146|Myanmar Physical therapists|myanmar physical therapists
5135141|NCT03149146|Educational workshop|educational workshop
5135142|NCT03149133|Biomechanics|biomechanics
5135143|NCT03149133|Strength training|strength training
5135144|NCT03149133|Elastography|elastography
5135145|NCT03149133|Ultrasound|ultrasound
5135146|NCT03149120|Metastatic|metastatic
5135147|NCT03149120|Unresectable|unresectable
5135148|NCT03149120|anthracycline|anthracycline
5135149|NCT03149120|chemotherapy|chemotherapy
5135150|NCT03149120|systemic therapy|systemic therapy
5135151|NCT03149107|Prodrome, CHR, Schizophrenia, prevention, N-acetylcysteine|prodrome, chr, schizophrenia, prevention, n-acetylcysteine
5135152|NCT03149094|Self-Management|self-management
5135153|NCT03149094|mHealth|mhealth
5135154|NCT03149042|FFR|ffr
5135155|NCT03149042|Fractional Flow Reserve|fractional flow reserve
5135156|NCT03149042|Atherosclerosis|atherosclerosis
5135157|NCT03149042|Coronary|coronary
5135158|NCT03149042|stenosis|stenosis
5135159|NCT03149029|Metastatic Melanoma|metastatic melanoma
5135160|NCT03149003|Glioblastoma (GBM)|glioblastoma (gbm)
5135161|NCT03149003|Wilms Tumor 1 (WT1)|wilms tumor 1 (wt1)
5135162|NCT03149003|Cancer Vaccines|cancer vaccines
5020786|NCT03866902|obesity|obesity
5135163|NCT03149003|Neoplasms|neoplasms
5135164|NCT03149003|Astrocytoma|astrocytoma
5135165|NCT03149003|Glioma|glioma
5135166|NCT03149003|Brain Cancer|brain cancer
5135167|NCT03149003|Brain Tumor|brain tumor
5135168|NCT03149003|Bevacizumab|bevacizumab
5131306|NCT03173287|Hepatic fibrosis|hepatic fibrosis
5135169|NCT03148990|Double Viral Vaccine Measles and Rubella|double viral vaccine measles and rubella
5135171|NCT03148977|Matrix Metalloproteinases|matrix metalloproteinases
5135173|NCT03148951|NLR|nlr
5135174|NCT03148951|Postoperative pain|postoperative pain
5135175|NCT03148938|DAM|dam
5135176|NCT03148938|multiple sclerosis|multiple sclerosis
5135177|NCT03148938|MSFC|msfc
5135178|NCT03148938|application|application
5135179|NCT03148938|mobile|mobile
5135180|NCT03148925|nicotine vaccine|nicotine vaccine
5135181|NCT03148925|smoking vaccine|smoking vaccine
5135182|NCT03148925|smoking cessation|smoking cessation
5135183|NCT03148925|SELA-070|sela-070
5135184|NCT03148899|Sleep Apnea|sleep apnea
5135185|NCT03148899|Oxytocin Nasal Spray|oxytocin nasal spray
5135186|NCT03148886|Physical activity|physical activity
5135187|NCT03148860|Psoriatic Arthritis|psoriatic arthritis
5135188|NCT03148860|Ustekinumab|ustekinumab
5135189|NCT03148860|Methotrexate|methotrexate
5135190|NCT03148860|DAS28|das28
5135191|NCT03148834|Acute Myocardial Infarction Reperfusion Injury|acute myocardial infarction reperfusion injury
5135192|NCT03148821|pressure ulcer|pressure ulcer
5135193|NCT03148821|pressure sore|pressure sore
5135194|NCT03148821|patient positioning|patient positioning
5135195|NCT03148769|Bloodstream infections, epidemiology|bloodstream infections, epidemiology
5135196|NCT03148678|Emotional reactivity|emotional reactivity
5135197|NCT03148678|Cognitive flexibility|cognitive flexibility
5135198|NCT03148665|Oral Cancer|oral cancer
5135199|NCT03148665|Head and Neck Cancer|head and neck cancer
5135200|NCT03148639|auditory hallucination|auditory hallucination
5135201|NCT03148639|schizophrenia|schizophrenia
5135202|NCT03148639|treatment-resistant|treatment-resistant
5135203|NCT03148639|psychotherapy|psychotherapy
5135204|NCT03148639|virtual reality|virtual reality
5135205|NCT03148639|avatar|avatar
5135206|NCT03148626|mindfulness curriculum|mindfulness curriculum
5135207|NCT03148600|Ileoanal pouch, pelvic floor exercise|ileoanal pouch, pelvic floor exercise
5135208|NCT03148587|abortion|abortion
5135209|NCT03148587|medical abortion|medical abortion
5135210|NCT03148587|mifepristone|mifepristone
5135211|NCT03148587|pregnancy test|pregnancy test
5135212|NCT03148548|VTE|vte
5135213|NCT03148548|thrombophilia screening|thrombophilia screening
5135214|NCT03148548|patients|patients
5135215|NCT03148548|risk factors|risk factors
5135216|NCT03148548|post-thrombotic syndrome|post-thrombotic syndrome
5135217|NCT03148496|abdominal surgery|abdominal surgery
5135218|NCT03148496|wound complication|wound complication
5135219|NCT03148483|Pregnancy outcome|pregnancy outcome
5135220|NCT03148483|Feasibility|feasibility
5135221|NCT03148483|Milk Fortification|milk fortification
5135222|NCT03148483|Periodontitis|periodontitis
5135223|NCT03148483|Pregnant women|pregnant women
5135224|NCT03148483|Periodontal Therapy|periodontal therapy
5135225|NCT03148470|theta burst stimulation|theta burst stimulation
5135226|NCT03148470|Language switching|language switching
5135227|NCT03148470|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5135228|NCT03148457|Stroke|stroke
5135229|NCT03148457|Direct oral anticoagulation|direct oral anticoagulation
5135230|NCT03148457|Apixaban|apixaban
5135231|NCT03148457|Dabigatran|dabigatran
5135232|NCT03148457|Rivaroxaban|rivaroxaban
5135233|NCT03148457|Edoxaban|edoxaban
5135234|NCT03148457|Therapy initiation|therapy initiation
5135235|NCT03148457|Major bleeding|major bleeding
5135236|NCT03148457|Atrial fibrillation|atrial fibrillation
5135237|NCT03148379|Total Knee Replacement|total knee replacement
5135238|NCT03148366|Self Efficacy|self efficacy
5135239|NCT03148353|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain|ultrasonography, corticosteroid, subacromial impingement syndrome, shoulder pain
5135240|NCT03148249|Randomized control trial|randomized control trial
5135241|NCT03148249|Charles Bonnet syndrome|charles bonnet syndrome
5135242|NCT03148249|visual hallucinations|visual hallucinations
5135243|NCT03148249|age related macular degeneration|age related macular degeneration
5135244|NCT03148249|patient education|patient education
5135245|NCT03148223|Dysmenorrhea|dysmenorrhea
5135246|NCT03148223|acupuncture|acupuncture
5135247|NCT03148223|auriculotherapy|auriculotherapy
5135248|NCT03148197|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5135249|NCT03148197|Graft-versus-host-disease|graft-versus-host-disease
5135250|NCT03148197|Acute Myeloid Leukemia|acute myeloid leukemia
5135251|NCT03148184|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
5135252|NCT03148184|60 years old or younger|60 years old or younger
5135253|NCT03148184|outcomes|outcomes
5135254|NCT03148171|Pre-Exposure Prophylaxis (PrEP); Retention in PrEP Care|pre-exposure prophylaxis (prep); retention in prep care
5020940|NCT03865979|ICH|ich
5135255|NCT03148158|Bladder Cancer|bladder cancer
5135256|NCT03148158|Flexible cystoscopy|flexible cystoscopy
5135257|NCT03148158|Diagnosis|diagnosis
5135258|NCT03148132|Retinopathy of Prematurity|retinopathy of prematurity
5135259|NCT03148132|VEGF|vegf
5135260|NCT03148132|Bevacizumab|bevacizumab
5135261|NCT03148132|Ranibizumab|ranibizumab
5135262|NCT03148093|Metastatic Colorectal Cancer|metastatic colorectal cancer
5135263|NCT03148093|Registry|registry
5135264|NCT03148093|Patient Reported Outcomes|patient reported outcomes
5135265|NCT03148093|Treatment Patterns|treatment patterns
5135266|NCT03148093|Prescription Use|prescription use
5135267|NCT03148067|Risk Factors|risk factors
5135268|NCT03148067|Incidence|incidence
5135269|NCT03148067|Epidemiology|epidemiology
5135270|NCT03148054|Anastomosis|anastomosis
5135271|NCT03148054|Colon|colon
5135272|NCT03148054|CT|ct
5135273|NCT03148054|Endoscopy|endoscopy
5135274|NCT03148054|Enema|enema
5135275|NCT03148054|Detection leak|detection leak
5135276|NCT03148054|Anastomotic leak|anastomotic leak
5135277|NCT03147989|MultiHance|multihance
5135278|NCT03147989|MRI|mri
5135279|NCT03147989|CNS|cns
5135280|NCT03147989|Gadobenate Dimeglumine|gadobenate dimeglumine
5135281|NCT03147963|therapy|therapy
5135282|NCT03147963|breast cancer|breast cancer
5135283|NCT03147963|docetaxel|docetaxel
5135284|NCT03147963|metastasis|metastasis
5135285|NCT03147950|Prone-Flexed Position|prone-flexed position
5135286|NCT03147950|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
5135287|NCT03147950|Clavien-Dindo Classification Score|clavien-dindo classification score
5135288|NCT03147911|Stroke or systemic embolism|stroke or systemic embolism
5135289|NCT03147911|CHA2DS2-VASc score|cha2ds2-vasc score
5135290|NCT03147898|Whooping cough|whooping cough
5135291|NCT03147898|Pertussis|pertussis
5135292|NCT03147807|Carbapenems de-escalation, rapid diagnostic test,|carbapenems de-escalation, rapid diagnostic test,
5135293|NCT03147807|Carbapenem-antimicrobial de-escalation-rapid diagnostic test|carbapenem-antimicrobial de-escalation-rapid diagnostic test
5135294|NCT03147781|auriculotherapy, human milk, breastfeeding, lactogenesis|auriculotherapy, human milk, breastfeeding, lactogenesis
5135296|NCT03147768|Pancreatic Sealing|pancreatic sealing
5135297|NCT03147768|Hemostasis|hemostasis
5135298|NCT03147768|Pancreatic Tumors|pancreatic tumors
5135299|NCT03147768|Pancreatic Resection|pancreatic resection
5135300|NCT03147768|Pancreatic leakage|pancreatic leakage
5135301|NCT03147768|LTW|ltw
5135302|NCT03147755|stroke|stroke
5135303|NCT03147742|ruxolitinib|ruxolitinib
5135304|NCT03147742|acute or chronic steroid-refractory GVHD|acute or chronic steroid-refractory gvhd
5135305|NCT03147742|hematopoietic stem cell transplantation (allo-HSCT)|hematopoietic stem cell transplantation (allo-hsct)
5135306|NCT03147729|Radiofrequency|radiofrequency
5135307|NCT03147729|Anal incontinence|anal incontinence
5135308|NCT03147729|Fecal incontinence|fecal incontinence
5135309|NCT03147729|Women sexual function|women sexual function
5135310|NCT03147729|Sexuality|sexuality
5135311|NCT03147703|Microbiota|microbiota
5135312|NCT03147703|Food timing|food timing
5135313|NCT03147703|Obesity|obesity
5135314|NCT03147690|Solid Organ Injury|solid organ injury
5135315|NCT03147677|Type 2 diabetic nephropathy|type 2 diabetic nephropathy
5135316|NCT03147677|Alfacalcidol|alfacalcidol
5135317|NCT03147664|pompe disease|pompe disease
5135318|NCT03147664|exercise capacity|exercise capacity
5135319|NCT03147664|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5135320|NCT03147651|Cystic fibrosis|cystic fibrosis
5135321|NCT03147651|exercise capacity|exercise capacity
5135322|NCT03147651|non-cystic fibrosis|non-cystic fibrosis
5135323|NCT03147651|bronchiectasis|bronchiectasis
5135324|NCT03147625|Aged|aged
5962045|NCT04283357|performance|performance
5135325|NCT03147625|Independent living|independent living
5135326|NCT03147625|Health Promotion|health promotion
5135327|NCT03147625|Residence Characteristics|residence characteristics
5135328|NCT03147625|Elderly-only household|elderly-only household
5135329|NCT03147599|Mebeverine|mebeverine
5135330|NCT03147599|Incontinence|incontinence
5135331|NCT03147599|Orthotopic Neobladder|orthotopic neobladder
5135332|NCT03147586|Immune Nutrition|immune nutrition
5135333|NCT03147586|Morbidity|morbidity
5135334|NCT03147573|Hypertension|hypertension
5135335|NCT03147573|Blood pressure monitoring|blood pressure monitoring
5135336|NCT03147560|Immunogenicity|immunogenicity
5135337|NCT03147560|Safety|safety
5135338|NCT03147560|Sabin IPV|sabin ipv
5135339|NCT03147560|bOPV|bopv
5135340|NCT03147508|Diagnostics, clinical criteria, clincal reasoning, neck pain|diagnostics, clinical criteria, clincal reasoning, neck pain
5135341|NCT03147456|bariatric|bariatric
5135342|NCT03147456|obesity|obesity
5135343|NCT03147456|protein supplements|protein supplements
5135344|NCT03147443|traditional Chinese medicine|traditional chinese medicine
5135345|NCT03147443|Drugs, Chinese Herbal|drugs, chinese herbal
5135346|NCT03147443|N-of-1 trials|n-of-1 trials
5135347|NCT03147443|sputum|sputum
5135348|NCT03147443|symptoms|symptoms
5135349|NCT03147443|individualized treatment|individualized treatment
5135350|NCT03147443|stable bronchiectasis|stable bronchiectasis
5135351|NCT03147391|Atrial Fibrillation|atrial fibrillation
5135352|NCT03147391|Left Atrial Appendage Closure|left atrial appendage closure
5135353|NCT03147391|LAmbre device|lambre device
5135354|NCT03147391|Stroke|stroke
5135355|NCT03147352|Fasciitis|fasciitis
5135356|NCT03147352|Gangrene|gangrene
5135357|NCT03147352|Fasciitis, Necrotizing|fasciitis, necrotizing
5135358|NCT03147352|Soft Tissue Infections|soft tissue infections
5136156|NCT03141827|Lipoprotein|lipoprotein
5135359|NCT03147352|Fournier's Gangrene|fournier's gangrene
5135360|NCT03147352|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
5135370|NCT03147352|Necrosis/surgery|necrosis/surgery
5135372|NCT03147352|Risk Factors|risk factors
5135373|NCT03147352|Bacterial Infections|bacterial infections
5135374|NCT03147352|Infection|infection
5135375|NCT03147352|Skin Diseases, Bacterial|skin diseases, bacterial
5135376|NCT03147352|Observational study|observational study
5135377|NCT03147352|Biological markers|biological markers
5135378|NCT03147352|Endothelium|endothelium
5135379|NCT03147352|suPAR|supar
5135381|NCT03147352|syndecan-1|syndecan-1
5135382|NCT03147352|sE-selectin|se-selectin
5135383|NCT03147352|VE-cadherin|ve-cadherin
5135384|NCT03147352|protein C|protein c
5135385|NCT03147352|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5135386|NCT03147352|HBOT|hbot
5135387|NCT03147339|AGEs( Advanced glycation end products)|ages( advanced glycation end products)
5135388|NCT03147313|extracorporeal shock wave|extracorporeal shock wave
5135389|NCT03147313|microsurgical nerve coaptation|microsurgical nerve coaptation
5135390|NCT03147313|nerve regeneration|nerve regeneration
5135391|NCT03147300|Low back pain|low back pain
5135392|NCT03147300|Model of care|model of care
5135393|NCT03147300|Primary health care|primary health care
5135394|NCT03147300|Implementation|implementation
5135395|NCT03147300|Patient-rated outcome|patient-rated outcome
5135396|NCT03147300|Clinician-rated outcome|clinician-rated outcome
5135397|NCT03147300|Cost-effectiveness|cost-effectiveness
5135398|NCT03147287|Breast Cancer|breast cancer
5135399|NCT03147274|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5135401|NCT03147222|fragility fracture|fragility fracture
5135402|NCT03147222|dementia|dementia
5135403|NCT03147222|intervention|intervention
5135404|NCT03147157|tacrolimus|tacrolimus
5135405|NCT03147157|histocompatibility antigens|histocompatibility antigens
5135406|NCT03147131|Total Hip Arthroplasty|total hip arthroplasty
5135407|NCT03147131|Short Stem|short stem
5135408|NCT03147131|DEXA|dexa
5135409|NCT03147118|trapeziometacarpal arthritis|trapeziometacarpal arthritis
5135410|NCT03147105|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation|chronic progressive multiple sclerosis, mobility, arm ergometry, rehabilitation
5135411|NCT03147079|obesity|obesity
5135412|NCT03147079|pregnancy|pregnancy
5135413|NCT03147079|lifestyle|lifestyle
5135414|NCT03147079|gestational weight gain|gestational weight gain
5135415|NCT03147079|weight of offspring|weight of offspring
5135416|NCT03147079|antenatal care|antenatal care
5135417|NCT03147079|health behavior|health behavior
5135418|NCT03147079|physical activity|physical activity
5135419|NCT03147079|diet|diet
5135420|NCT03147079|programme evaluation|programme evaluation
5135421|NCT03147079|costs and costs analysis|costs and costs analysis
5135422|NCT03147066|Dezocine|dezocine
5135423|NCT03147066|CRBD|crbd
5135424|NCT03147066|General anesthesia|general anesthesia
5135425|NCT03147066|Urinary catheter|urinary catheter
5135426|NCT03147040|Lobular|lobular
5135427|NCT03147040|Metastatic or incurable locally advanced cancer|metastatic or incurable locally advanced cancer
5135428|NCT03147040|Disease progression on endocrine therapy in advanced setting|disease progression on endocrine therapy in advanced setting
5135429|NCT03147027|ischemic cardiomyopathy|ischemic cardiomyopathy
5962046|NCT04283344|Food Security|food security
5135430|NCT03147027|prophylactic ablation|prophylactic ablation
5135431|NCT03147014|Echocardiography|echocardiography
5135432|NCT03147014|Congenital Heart Disease|congenital heart disease
5135433|NCT03147014|Maternal hyperoxygenation|maternal hyperoxygenation
5135434|NCT03147001|Endurance exercise|endurance exercise
5135435|NCT03147001|Dietary protein|dietary protein
5135436|NCT03146975|Beta-defensins|beta-defensins
5135437|NCT03146975|Chronic periodontitis|chronic periodontitis
5135438|NCT03146975|Diabetes mellitus|diabetes mellitus
5135439|NCT03146975|Non-surgical periodontal therapy|non-surgical periodontal therapy
5135440|NCT03146897|Food Aid, Malnutrition, RUSF, FBF, Supplementary Food|food aid, malnutrition, rusf, fbf, supplementary food
5135441|NCT03146845|Diabetic Foot Ulcer|diabetic foot ulcer
5135442|NCT03146845|Pressure Ulcer|pressure ulcer
5135443|NCT03146845|Leg Ulcer|leg ulcer
5135444|NCT03146819|osteoarthritis|osteoarthritis
5135445|NCT03146819|osteoarthritis knee|osteoarthritis knee
5131607|NCT03171116|obestatin|obestatin
5135471|NCT03146663|cancer of the ovary|cancer of the ovary
5135472|NCT03146637|Activated CIK|activated cik
5135473|NCT03146637|MUC1/CEA/EpCAM/GPC3|muc1/cea/epcam/gpc3
5135474|NCT03146637|Bispecfic antibody|bispecfic antibody
5135475|NCT03146637|liver cancer|liver cancer
5135476|NCT03146598|Foot deformity|foot deformity
5135477|NCT03146598|Orthopaedic management|orthopaedic management
5135478|NCT03146598|prevention|prevention
5135479|NCT03146598|side pole static ankle foot orthosis|side pole static ankle foot orthosis
5135480|NCT03146585|Glycocalyx|glycocalyx
5135481|NCT03146559|Cross education|cross education
5135483|NCT03146520|Syndecan 2|syndecan 2
5135491|NCT03146455|geographic|geographic
5135492|NCT03146455|Blood Transfusion|blood transfusion
5135493|NCT03146442|increased dietary protein|increased dietary protein
5135494|NCT03146442|breakfast|breakfast
5135495|NCT03146442|weight management|weight management
5135496|NCT03146442|satiety|satiety
5135497|NCT03146442|glucose control|glucose control
5135498|NCT03146442|fMRI|fmri
5135499|NCT03146442|cognitive performance|cognitive performance
5135500|NCT03146442|memory|memory
5135501|NCT03146442|attention|attention
5135502|NCT03146442|executive function|executive function
5135503|NCT03146442|structural MRI|structural mri
5135504|NCT03146442|sleep quality|sleep quality
5135505|NCT03146403|HSV|hsv
5135506|NCT03146403|Herpes|herpes
5135507|NCT03146403|Genital Herpes|genital herpes
5135508|NCT03146403|Vaccine|vaccine
5135509|NCT03146390|biofilms|biofilms
5135510|NCT03146390|essential oils|essential oils
5135511|NCT03146390|microscopy, confocal|microscopy, confocal
5135512|NCT03146390|mouthwashes|mouthwashes
5135513|NCT03146364|Virtual Reality|virtual reality
5135514|NCT03146351|preterm|preterm
5135515|NCT03146351|infant|infant
5135516|NCT03146351|physiotherapy|physiotherapy
5135517|NCT03146338|Anti-EGFR|anti-egfr
5135518|NCT03146338|Hypomagnesemia|hypomagnesemia
5135519|NCT03146338|Magnesium-rich mineral water|magnesium-rich mineral water
5135520|NCT03146338|Metastatic colorectal or head and neck cancers|metastatic colorectal or head and neck cancers
5135521|NCT03146325|H. pylori infection|h. pylori infection
5135522|NCT03146312|gene expression|gene expression
5135523|NCT03146312|gene array|gene array
5135524|NCT03146312|epigenetics|epigenetics
5135525|NCT03146312|DNA methylation|dna methylation
5135527|NCT03146260|Sperm retreival|sperm retreival
5135528|NCT03146260|Azoospermia|azoospermia
5135529|NCT03146260|FSH|fsh
5135530|NCT03146260|LH|lh
5135531|NCT03146208|Growth differentiation factor-15|growth differentiation factor-15
5135532|NCT03146208|Dipeptidyl-peptidase inhibitors (DPP4 -I)|dipeptidyl-peptidase inhibitors (dpp4 -i)
5135533|NCT03146208|Coronroy artery diseases|coronroy artery diseases
5131733|NCT03170258|EEG|eeg
5135538|NCT03146182|C-reactive protein|c-reactive protein
5135540|NCT03146182|Community-acquired pneumonia|community-acquired pneumonia
5135541|NCT03146182|Antibiotic stewardship|antibiotic stewardship
5135542|NCT03146156|obesity|obesity
5135543|NCT03146156|overweight|overweight
5135544|NCT03146156|lifestyle intervention|lifestyle intervention
5135545|NCT03146156|fetal growth/adiposity|fetal growth/adiposity
5135546|NCT03146156|Mediterranean diet|mediterranean diet
5135547|NCT03146117|PET CT|pet ct
5135548|NCT03146091|Antibiotics|antibiotics
5135549|NCT03146052|Colon cleansing|colon cleansing
5135550|NCT03146013|HTLV|htlv
5135551|NCT03146013|Confirmatory|confirmatory
5135552|NCT03146013|Supplemental|supplemental
5135553|NCT03146013|Blot|blot
5135554|NCT03146013|HTLV-I|htlv-i
5135555|NCT03146013|HTLV-II|htlv-ii
5135556|NCT03145987|Cognitive functioning|cognitive functioning
5135559|NCT03145974|respiratory failure|respiratory failure
5135560|NCT03145974|mechanical ventilation|mechanical ventilation
5135561|NCT03145961|Breast cancer early stage|breast cancer early stage
5135562|NCT03145961|circulating tumour DNA|circulating tumour dna
5135563|NCT03145961|pembrolizumab|pembrolizumab
5135564|NCT03145961|targeted therapy|targeted therapy
5135565|NCT03145961|randomised clinical trial|randomised clinical trial
5135566|NCT03145961|phase II|phase ii
5135567|NCT03145961|mutation screening|mutation screening
5135568|NCT03145961|intermediate endpoint|intermediate endpoint
5135569|NCT03145948|Tolerability|tolerability
5135570|NCT03145948|Psoriasis|psoriasis
5135571|NCT03145948|Pharmacokinetics|pharmacokinetics
5135572|NCT03145948|Safety|safety
5135573|NCT03145948|Healthy Volunteers|healthy volunteers
5135574|NCT03145909|Cancer|cancer
5135575|NCT03145909|Metastatic|metastatic
5135576|NCT03145909|Prolactin Receptor (PRLR)|prolactin receptor (prlr)
5135577|NCT03145909|Breast cancer|breast cancer
5135578|NCT03145909|Colorectal cancer|colorectal cancer
5135579|NCT03145909|Adrenocortical carcinoma,|adrenocortical carcinoma,
5135595|NCT03145805|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5135596|NCT03145766|Rabies virus|rabies virus
5135597|NCT03145753|HIV testing program|hiv testing program
5135598|NCT03145753|HCV testing program|hcv testing program
5135599|NCT03145753|education|education
5135600|NCT03145727|Chemotherapy|chemotherapy
5135601|NCT03145727|nausea|nausea
5135602|NCT03145727|vomiting|vomiting
5135603|NCT03145727|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5135604|NCT03145714|POCD|pocd
5135605|NCT03145714|Elderly|elderly
5135608|NCT03145675|Anticoagulation|anticoagulation
5135609|NCT03145675|Enoxaparin|enoxaparin
5135610|NCT03145675|Dose|dose
5135611|NCT03145649|Breast milk|breast milk
5135612|NCT03145649|Hormone|hormone
5135613|NCT03145649|Infant growth|infant growth
5135614|NCT03145649|Gestational diabetes mellitus|gestational diabetes mellitus
5135615|NCT03145636|Obesity|obesity
5135616|NCT03145636|Bariatric surgery|bariatric surgery
5135617|NCT03145636|Vagal blocking|vagal blocking
5135618|NCT03145636|vBloc therapy|vbloc therapy
5135619|NCT03145636|Vagus Nerve|vagus nerve
5135620|NCT03145636|Percent excess weight loss|percent excess weight loss
5135621|NCT03145636|Percent total body weight loss|percent total body weight loss
5135622|NCT03145597|facings|facings
5135623|NCT03145597|veneers|veneers
5135624|NCT03145597|laminates|laminates
5135625|NCT03145597|existing|existing
5135626|NCT03145597|restorations|restorations
5135627|NCT03145597|esthetics|esthetics
5135628|NCT03145597|dental|dental
5135629|NCT03145584|Total Knee Arthroplasty|total knee arthroplasty
5135630|NCT03145584|Physiotherapy|physiotherapy
5135631|NCT03145558|Tirapazamine, embolization, TACE, Hepatocellular carcinoma|tirapazamine, embolization, tace, hepatocellular carcinoma
5135632|NCT03145493|Drainage, Suction|drainage, suction
5135633|NCT03145493|tranexamic acid|tranexamic acid
5135634|NCT03145480|leukemia|leukemia
5135635|NCT03145480|richter|richter
5135636|NCT03145467|Migraine|migraine
5135637|NCT03145467|Paracetamol|paracetamol
5135638|NCT03145467|Zolmitriptan|zolmitriptan
5135639|NCT03145467|Emergency services|emergency services
5135640|NCT03145454|Pain|pain
5135641|NCT03145454|children|children
5135642|NCT03145454|emergency|emergency
5135643|NCT03145454|electroencephalography|electroencephalography
5135644|NCT03145454|heart rate|heart rate
5135645|NCT03145454|skin conductance|skin conductance
5135646|NCT03145454|pupillary diameter|pupillary diameter
5135647|NCT03145415|pudendal nerve block|pudendal nerve block
5135648|NCT03145415|hypospadias|hypospadias
5135654|NCT03145376|elderly|elderly
5135655|NCT03145350|NAFLD|nafld
5135656|NCT03145350|Fat intake|fat intake
5135657|NCT03145350|Sugar intake|sugar intake
5135855|NCT03144024|Cardiac Valve Annulus Repair|cardiac valve annulus repair
5136265|NCT03141073|Metformin|metformin
5135658|NCT03145311|Repetitive transcranial magnetic stimulation, Drug Induced Tardive Syndrome|repetitive transcranial magnetic stimulation, drug induced tardive syndrome
5135659|NCT03145298|HPAH (heritable)|hpah (heritable)
5135660|NCT03145298|IPAH (idiopathic)|ipah (idiopathic)
5135661|NCT03145298|PAH-CTD (connective tissue diseases)|pah-ctd (connective tissue diseases)
5135662|NCT03145298|PAH-HIV (human immunodeficiency virus)|pah-hiv (human immunodeficiency virus)
5135663|NCT03145285|Abiraterone Acetate|abiraterone acetate
5135664|NCT03145285|Cushing Syndrome|cushing syndrome
5135665|NCT03145285|Adrenocortical Carcinoma|adrenocortical carcinoma
5135666|NCT03145272|Pharmacogenomics|pharmacogenomics
5135667|NCT03145272|Pharmacokinetics|pharmacokinetics
5135668|NCT03145272|Oxycodone|oxycodone
5135669|NCT03145246|intrabony defect|intrabony defect
5135670|NCT03145246|periodontal regeneration|periodontal regeneration
5135671|NCT03145233|physiotherapy|physiotherapy
5135672|NCT03145220|EA-230|ea-230
5135673|NCT03145220|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5135674|NCT03145220|Acute Kidney Injury|acute kidney injury
5135675|NCT03145220|Interleukin-6|interleukin-6
5135676|NCT03145220|Safety|safety
5135677|NCT03145220|Tolerability|tolerability
5135678|NCT03145220|Phase II|phase ii
5135679|NCT03145220|Randomized clinical trial|randomized clinical trial
5135680|NCT03145155|continuum of care|continuum of care
5135681|NCT03145155|maternal|maternal
5135682|NCT03145155|newborn|newborn
5135683|NCT03145155|child health|child health
5135684|NCT03145155|noncommunicable diseases|noncommunicable diseases
5135685|NCT03145142|Near-Infrared Spectroscopy|near-infrared spectroscopy
5135686|NCT03145129|Intraocular pressure|intraocular pressure
5049113|NCT03691870|AVM|avm
5135688|NCT03145129|CPAP|cpap
5135689|NCT03145090|bone scintigraphy|bone scintigraphy
5135690|NCT03145090|knee arthroplasty|knee arthroplasty
5135691|NCT03145090|spect-ct|spect-ct
5135692|NCT03145090|quantification|quantification
5135693|NCT03145077|Head and Neck Cancer|head and neck cancer
5135694|NCT03145077|Osteoradionecrosis|osteoradionecrosis
5135695|NCT03145077|ORN|orn
5135696|NCT03145077|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
5135697|NCT03145077|DCE-MRI|dce-mri
5135698|NCT03145077|Questionnaires|questionnaires
5135699|NCT03145077|Surveys|surveys
5135700|NCT03145064|relapsed/refractory non-GCB type|relapsed/refractory non-gcb type
5135701|NCT03145051|saline solution|saline solution
5135702|NCT03145051|minerals|minerals
5135703|NCT03145051|cystic fibrosis|cystic fibrosis
5135704|NCT03145051|chronic rhinosinusitis|chronic rhinosinusitis
5135705|NCT03145051|nasal irrigation|nasal irrigation
5135706|NCT03145012|Cancer|cancer
5135707|NCT03145012|Immunity|immunity
5135708|NCT03145012|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5135709|NCT03145012|Ranitidine|ranitidine
5135710|NCT03144999|Dry AMD|dry amd
5135711|NCT03144999|Dry Age-related Macular Degeneration|dry age-related macular degeneration
5135712|NCT03144999|Gene Therapy|gene therapy
5135713|NCT03144999|Complement|complement
5135714|NCT03144999|Intravitreal Injection|intravitreal injection
5135715|NCT03144999|Geographic Atrophy|geographic atrophy
5135716|NCT03144999|Drusen|drusen
5135717|NCT03144999|Membrane Attack Complex|membrane attack complex
5135718|NCT03144999|CD59|cd59
5135719|NCT03144934|HPV|hpv
5135720|NCT03144921|Early-stage Dementia|early-stage dementia
5135721|NCT03144921|Early-stage Alzheimer's disease|early-stage alzheimer's disease
5135722|NCT03144921|Care partner|care partner
5135723|NCT03144921|Caregivers|caregivers
5135724|NCT03144921|Caregiving|caregiving
5135725|NCT03144869|type 1 diabetes mellitus|type 1 diabetes mellitus
5135726|NCT03144869|physical activity|physical activity
5135727|NCT03144869|children|children
5135728|NCT03144869|constant glucose monitoring|constant glucose monitoring
5135729|NCT03144856|Biliary Tract Cancer|biliary tract cancer
5135730|NCT03144856|Second line thrapy|second line thrapy
5135731|NCT03144856|Apatinib|apatinib
5135732|NCT03144843|Gastric cancer|gastric cancer
5135733|NCT03144843|Peritoneal metastasis|peritoneal metastasis
5135734|NCT03144843|Paclitaxol|paclitaxol
5135735|NCT03144843|Apatinib|apatinib
5135736|NCT03144843|Second-line chemotherapy|second-line chemotherapy
5135737|NCT03144817|hemodialysis|hemodialysis
5135738|NCT03144817|fluid overload|fluid overload
5131873|NCT03169218|Humans|humans
5135741|NCT03144817|dialysate sodium lowering|dialysate sodium lowering
5135743|NCT03144765|taTME|tatme
5135744|NCT03144765|Transanal|transanal
5135745|NCT03144765|Rectal cancer|rectal cancer
5135746|NCT03144765|Colorectal|colorectal
5135747|NCT03144765|Total mesorectal excision|total mesorectal excision
5135748|NCT03144765|TME|tme
5135749|NCT03144687|Myelofibrosis|myelofibrosis
5135750|NCT03144687|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5135751|NCT03144687|itacitinib|itacitinib
5135752|NCT03144687|ruxolitinib|ruxolitinib
5135753|NCT03144674|Marginal zone lymphoma|marginal zone lymphoma
5135754|NCT03144674|phosphatidylinositol 3-kinase (PI3K)δ inhibitor|phosphatidylinositol 3-kinase (pi3k)δ inhibitor
5135756|NCT03144661|hepatocellular carcinoma|hepatocellular carcinoma
5135757|NCT03144661|cholangiocarcinoma|cholangiocarcinoma
5135758|NCT03144661|esophageal|esophageal
5135759|NCT03144661|nasopharyngeal|nasopharyngeal
5135760|NCT03144661|serous ovarian|serous ovarian
5135761|NCT03144661|solid tumors|solid tumors
5135762|NCT03144661|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
5135763|NCT03144661|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5135764|NCT03144635|Direct Acting Antivirals|direct acting antivirals
5135765|NCT03144635|Grazoprevir|grazoprevir
5135766|NCT03144635|Elbasvir|elbasvir
5135767|NCT03144622|(4S)-4-(3-[18F]fluoropropyl-)-L-glutamate|(4s)-4-(3-[18f]fluoropropyl-)-l-glutamate
5135768|NCT03144622|18F-FSPG|18f-fspg
5135769|NCT03144622|PET/CT|pet/ct
5135770|NCT03144622|system xC-transporter|system xc-transporter
5135771|NCT03144609|mechanical ventilation, obesity, oral-surgical procedures|mechanical ventilation, obesity, oral-surgical procedures
5135772|NCT03144583|CART19|cart19
5135773|NCT03144570|ICU, encephalitis, meningo-encephalitis, seizures|icu, encephalitis, meningo-encephalitis, seizures
5135774|NCT03144557|Education|education
5135775|NCT03144557|COPD|copd
5135776|NCT03144557|Inhalation Devices|inhalation devices
5135777|NCT03144544|Similarity|similarity
5135778|NCT03144544|Diversity|diversity
5135779|NCT03144531|School-age child|school-age child
5135780|NCT03144518|Positive Affect|positive affect
5135781|NCT03144518|Positive Mood|positive mood
5135782|NCT03144518|Influenza Vaccination|influenza vaccination
5135783|NCT03144518|Vaccination|vaccination
5962047|NCT04283344|Hunger|hunger
5021479|NCT03862872|Borage oil|borage oil
5135784|NCT03144518|Randomised Controlled Trial|randomised controlled trial
5135785|NCT03144505|Type 2 Diabetes|type 2 diabetes
5135786|NCT03144505|Exercise|exercise
5002810|NCT03978325|Surgery|surgery
5135787|NCT03144505|High Intensity Interval Training|high intensity interval training
5135788|NCT03144505|Glycemic Control|glycemic control
5135791|NCT03144453|Curare|curare
5135792|NCT03144453|Robotic surgery|robotic surgery
5135793|NCT03144440|ZEPATIER|zepatier
5135794|NCT03144427|albumin|albumin
5135795|NCT03144427|resuscitation|resuscitation
5135796|NCT03144427|burns|burns
5135797|NCT03144427|shock|shock
5135798|NCT03144427|fluid creep|fluid creep
5135799|NCT03144401|cesarean section|cesarean section
5135800|NCT03144401|Misoprostol|misoprostol
5135801|NCT03144401|sublingual|sublingual
5135802|NCT03144401|uterotonics|uterotonics
5135803|NCT03144323|Intraoral elastics|intraoral elastics
5135804|NCT03144258|congenital heart defects|congenital heart defects
5135805|NCT03144258|systemic microcirculation|systemic microcirculation
5135806|NCT03144258|laser Doppler perfusion imaging|laser doppler perfusion imaging
5135807|NCT03144258|cardiac corrective surgery|cardiac corrective surgery
5135808|NCT03144245|AML|aml
5135809|NCT03144245|treatment|treatment
5135810|NCT03144245|relapsed|relapsed
5135811|NCT03144245|refractory|refractory
5135812|NCT03144245|phase 1|phase 1
5135813|NCT03144219|intracranial pressure|intracranial pressure
5135814|NCT03144219|transcranial Doppler|transcranial doppler
5135815|NCT03144219|jugular compression|jugular compression
5135816|NCT03144219|cerebral compliance|cerebral compliance
5135817|NCT03144193|topical treatment|topical treatment
5135818|NCT03144193|wrinkles|wrinkles
5135819|NCT03144193|extracellular matrix|extracellular matrix
5135820|NCT03144180|pregnant|pregnant
5135821|NCT03144180|third trimester|third trimester
5135822|NCT03144180|umbilical cord blood collection|umbilical cord blood collection
5135823|NCT03144154|Cancer|cancer
5135824|NCT03144154|Fatigue|fatigue
5135825|NCT03144154|Hypnosis|hypnosis
5135826|NCT03144154|Self-hypnosis|self-hypnosis
5135827|NCT03144154|Self-care|self-care
5135828|NCT03144154|Emotional distress|emotional distress
5135829|NCT03144154|Cancer survivors|cancer survivors
5135830|NCT03144128|vitamin D|vitamin d
5135831|NCT03144128|muscle|muscle
5135832|NCT03144128|metabolism|metabolism
5135833|NCT03144128|cancer cachexia|cancer cachexia
5135834|NCT03144115|oxytocin|oxytocin
5135835|NCT03144115|sex hormone|sex hormone
5135836|NCT03144115|verbal reward|verbal reward
5135837|NCT03144115|mate selection|mate selection
5135838|NCT03144115|metaphorical language|metaphorical language
5135840|NCT03144089|Obstructive sleep apnea|obstructive sleep apnea
5135841|NCT03144089|Mask ventilation|mask ventilation
5135842|NCT03144089|Upper airway obstruction|upper airway obstruction
5135844|NCT03144076|India|india
5135845|NCT03144076|health insurance|health insurance
5135846|NCT03144076|RSBY|rsby
5135847|NCT03144076|free health insurance|free health insurance
5135848|NCT03144076|inpatient insurance|inpatient insurance
5135849|NCT03144076|wealth transfer|wealth transfer
5135850|NCT03144063|Disease Activity|disease activity
5135851|NCT03144063|SLEDAI-2K|sledai-2k
5135852|NCT03144024|Tricuspid Regurgitation|tricuspid regurgitation
5135853|NCT03144024|Insufficiency, Tricuspid Valve|insufficiency, tricuspid valve
5135854|NCT03144024|Valvular Annuloplasty|valvular annuloplasty
5135856|NCT03144011|acute kidney injury, cardiosurgery|acute kidney injury, cardiosurgery
5135857|NCT03143985|TEW-7197|tew-7197
5135858|NCT03143985|Pomalidomide|pomalidomide
5135859|NCT03143972|Dexmedetomidine|dexmedetomidine
5135860|NCT03143972|Remifentanil|remifentanil
5135861|NCT03143972|Pharmacodynamics|pharmacodynamics
5135862|NCT03143972|Interaction|interaction
5135863|NCT03143946|neuroendocrine tumor|neuroendocrine tumor
5135864|NCT03143946|vitamin|vitamin
5135865|NCT03143946|diet|diet
5135866|NCT03143933|propofol, BIS, general anesthesia|propofol, bis, general anesthesia
5135867|NCT03143920|hyperbaric oxygen|hyperbaric oxygen
5135868|NCT03143920|inflammation|inflammation
5135869|NCT03143920|chronic disease|chronic disease
5135870|NCT03143920|urinary bladder|urinary bladder
5135871|NCT03143920|urinary tract infection|urinary tract infection
5135872|NCT03143920|recurrent urinary tract infection|recurrent urinary tract infection
5135873|NCT03143920|painful bladder syndrome|painful bladder syndrome
5135874|NCT03143920|chronic pain|chronic pain
5135875|NCT03143920|hypoxia|hypoxia
5135878|NCT03143907|Group Therapy|group therapy
5135879|NCT03143894|Breast Cancer|breast cancer
5135880|NCT03143894|Cognition|cognition
5135881|NCT03143894|Fatigue|fatigue
5135882|NCT03143894|Cancer-related Cognitive Impairment|cancer-related cognitive impairment
5135883|NCT03143894|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5135884|NCT03143868|acute exercise|acute exercise
5135885|NCT03143868|resistance exercise|resistance exercise
5135886|NCT03143868|aerobic exercise|aerobic exercise
5135887|NCT03143868|appetite|appetite
5135888|NCT03143868|energy intake|energy intake
5135889|NCT03143855|oxycodone|oxycodone
5135890|NCT03143855|lorcaserin|lorcaserin
5135891|NCT03143855|Belviq|belviq
5962048|NCT04283344|Rural|rural
5135892|NCT03143842|VNS|vns
5135893|NCT03143842|accelerate learning|accelerate learning
5135894|NCT03143842|memory|memory
5135896|NCT03143829|symptom self-management|symptom self-management
5135897|NCT03143829|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5135898|NCT03143816|diabetes|diabetes
5135899|NCT03143816|time in range|time in range
5135900|NCT03143816|inhaled insulin|inhaled insulin
5135901|NCT03143816|continuous glucose monitoring|continuous glucose monitoring
5135902|NCT03143816|type 1 diabetes|type 1 diabetes
5135903|NCT03143816|hypoglycemia|hypoglycemia
5135904|NCT03143816|post prandial hypergylcemia|post prandial hypergylcemia
5135905|NCT03143790|Erectile Function|erectile function
5135906|NCT03143790|Prostatectomy|prostatectomy
5135907|NCT03143790|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5135908|NCT03143790|IIEF-5|iief-5
5135909|NCT03143777|physiotherapy|physiotherapy
5135910|NCT03143777|rehabilitation|rehabilitation
5135911|NCT03143777|critical care|critical care
5135912|NCT03143777|seating|seating
5135913|NCT03143738|regional anesthesia|regional anesthesia
5135914|NCT03143738|knee replacement|knee replacement
5135915|NCT03143738|pain treatment|pain treatment
5135916|NCT03143738|rehabilitation|rehabilitation
5135917|NCT03143686|Severe symptomatic Aortic Stenosis|severe symptomatic aortic stenosis
5135918|NCT03143673|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
5135919|NCT03143660|obesity|obesity
5135920|NCT03143608|GERD|gerd
5135921|NCT03143608|Hiatal hernia repair|hiatal hernia repair
5135922|NCT03143608|Transoral Incision less fundoplication|transoral incision less fundoplication
5135923|NCT03143595|Preexisting cognitive impairment|preexisting cognitive impairment
5135924|NCT03143595|Elderly|elderly
5135925|NCT03143595|Outcomes|outcomes
5135926|NCT03143556|renal transplant|renal transplant
5135927|NCT03143556|magnetic ureteral stent|magnetic ureteral stent
5135928|NCT03143556|Black-Star®|black-star®
5135929|NCT03143543|cocaine disorder|cocaine disorder
5135930|NCT03143543|opioid disorder|opioid disorder
5135931|NCT03143543|lorcaserin|lorcaserin
5135932|NCT03143543|MRI|mri
5135933|NCT03143543|fMRI|fmri
5135934|NCT03143530|Ropivacaine|ropivacaine
5135935|NCT03143517|Inflammatory Bowel Diseases|inflammatory bowel diseases
5135936|NCT03143517|Irritable Bowel Syndrome|irritable bowel syndrome
5135937|NCT03143517|Ulcerative Colitis|ulcerative colitis
5135938|NCT03143517|Crohn Disease|crohn disease
5132089|NCT03167827|pelvic floor|pelvic floor
5135941|NCT03143426|Junior surgeons|junior surgeons
5135942|NCT03143426|Complication|complication
5135943|NCT03143426|Conversion|conversion
5135944|NCT03143413|Salivary glands ultrasonography|salivary glands ultrasonography
5135945|NCT03143413|Systemic sclerosis|systemic sclerosis
5135946|NCT03143413|Gougerot Sjogren syndrome|gougerot sjogren syndrome
5135947|NCT03143413|Sicca syndrome|sicca syndrome
5135948|NCT03143400|Probiotics|probiotics
5135949|NCT03143400|Galenic form|galenic form
5135950|NCT03143400|Digestive tract|digestive tract
5135951|NCT03143400|Intestinal microbiota|intestinal microbiota
5135952|NCT03143400|Lactobacillus salivarius|lactobacillus salivarius
5135953|NCT03143361|aortic valve stenosis|aortic valve stenosis
5135954|NCT03143361|heart valves|heart valves
5135955|NCT03143361|heart surgery|heart surgery
5135956|NCT03143335|Breast; Reconstruction; BAD; Implant; ADM|breast; reconstruction; bad; implant; adm
5135957|NCT03143322|Bone-only metastases|bone-only metastases
5135958|NCT03143322|solid tumors|solid tumors
5135959|NCT03143322|SBRT|sbrt
5135960|NCT03143283|suicide|suicide
5135961|NCT03143283|lethal means|lethal means
5135962|NCT03143283|counseling|counseling
5135963|NCT03143283|youth|youth
5135964|NCT03143283|parents|parents
5135965|NCT03143283|firearms|firearms
5135966|NCT03143283|medication|medication
5135967|NCT03143283|suicidal|suicidal
5135968|NCT03143283|emergency department|emergency department
5135969|NCT03143270|nivolumab|nivolumab
5135970|NCT03143270|deb-TACE|deb-tace
5135971|NCT03143270|17-087|17-087
5135972|NCT03143218|Malaria|malaria
5135973|NCT03143218|Seasonal vaccination|seasonal vaccination
5135974|NCT03143218|Seasonal chemoprevention|seasonal chemoprevention
5135975|NCT03143192|DME, Micropulse Laser, Anti-VEGF|dme, micropulse laser, anti-vegf
5135976|NCT03143140|Ablation Techniques|ablation techniques
5021692|NCT03861676|brachytherapy|brachytherapy
5135977|NCT03143101|FluMist Quadrivalent|flumist quadrivalent
5135978|NCT03143101|Trivalent|trivalent
5135979|NCT03143101|Influenza|influenza
5135980|NCT03143101|Vaccine|vaccine
5135981|NCT03143101|Prevention|prevention
5135982|NCT03143088|Blood pressure|blood pressure
5135983|NCT03143088|Medical clown|medical clown
5135984|NCT03143088|Pediatric|pediatric
5135985|NCT03143062|National Early Warning Score|national early warning score
5135986|NCT03143062|Rapid response system|rapid response system
5135987|NCT03143049|Pomalidomide|pomalidomide
5135988|NCT03143036|daratumumab|daratumumab
5135989|NCT03142971|Shock waves|shock waves
5135990|NCT03142971|Greater trochanteric pain syndrome|greater trochanteric pain syndrome
5135991|NCT03142932|smoking|smoking
5135992|NCT03142919|Mood Disorder|mood disorder
5135994|NCT03142919|Endotoxin|endotoxin
5135996|NCT03142919|CRP|crp
5135997|NCT03142906|preoperative, perioperative, point-of-care ultrasound|preoperative, perioperative, point-of-care ultrasound
5135998|NCT03142893|testosterone|testosterone
5135999|NCT03142893|cortisol|cortisol
5136000|NCT03142880|marginally hyperbaric|marginally hyperbaric
5136001|NCT03142880|ropivacaine|ropivacaine
5136002|NCT03142880|cesarean|cesarean
5136003|NCT03142867|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5136004|NCT03142867|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
5136005|NCT03142867|Prevalence|prevalence
5136006|NCT03142867|Coronary Artery Disease|coronary artery disease
5136007|NCT03142867|PDFF|pdff
5136008|NCT03142854|bowel preparation|bowel preparation
5136009|NCT03142854|colonoscopy|colonoscopy
5136010|NCT03142854|predictive model|predictive model
5136011|NCT03142841|Depression|depression
5136012|NCT03142841|Burden|burden
5136013|NCT03142841|Problem Solving Ability|problem solving ability
5136014|NCT03142841|Caregivers|caregivers
5136015|NCT03142841|Stroke|stroke
5136016|NCT03142841|Veterans|veterans
5136017|NCT03142828|chlorhexidine, dental implant, in-situ drug delivery,|chlorhexidine, dental implant, in-situ drug delivery,
5136018|NCT03142815|Coronary Artery Bypass Graft (CABG), Arterial stiffness|coronary artery bypass graft (cabg), arterial stiffness
5136019|NCT03142802|Testicular cancer|testicular cancer
5136020|NCT03142802|low-dose CT|low-dose ct
5136021|NCT03142802|CT scan|ct scan
5136022|NCT03142789|Pain|pain
5136023|NCT03142789|Total knee arthroplasty|total knee arthroplasty
5136024|NCT03142789|Regional anesthesia|regional anesthesia
5136025|NCT03142776|clarithromycin|clarithromycin
5136026|NCT03142776|photodynamic therapy|photodynamic therapy
5136027|NCT03142776|Antimicrobial therapy|antimicrobial therapy
5136028|NCT03142776|Periodontal pocket|periodontal pocket
5136029|NCT03142724|HV|hv
5136030|NCT03142698|hepatic steatosis|hepatic steatosis
5136031|NCT03142698|MRImaging|mrimaging
5136032|NCT03142685|NEC|nec
5136033|NCT03142685|Bowel Ultrasound|bowel ultrasound
5136034|NCT03142685|CHD|chd
5136035|NCT03142672|Postoperative pain|postoperative pain
5136036|NCT03142672|child|child
5136037|NCT03142672|pulpotomy|pulpotomy
5136038|NCT03142672|general anesthesia|general anesthesia
5136043|NCT03142516|Clinical Trial, Phase II|clinical trial, phase ii
5136044|NCT03142516|Elderly|elderly
5136045|NCT03142516|Aged|aged
5136046|NCT03142516|Disease-Free Survival|disease-free survival
5136047|NCT03142516|Safety|safety
5136048|NCT03142516|Tolerability|tolerability
5136049|NCT03142516|Chemotherapy regimen|chemotherapy regimen
5136050|NCT03142516|Monoclonal antibody|monoclonal antibody
5136051|NCT03142516|FOLFIRI|folfiri
5136052|NCT03142516|Panitumumab|panitumumab
5136053|NCT03142516|RAS/BRAF Wild-type|ras/braf wild-type
5136054|NCT03142503|psoriatic arthritis|psoriatic arthritis
5136055|NCT03142503|psoriasis|psoriasis
5136056|NCT03142503|body composition|body composition
5136057|NCT03142503|DXA measurements|dxa measurements
5136058|NCT03142503|spondyloarthritis|spondyloarthritis
5136068|NCT03142477|Reiki|reiki
5136069|NCT03142477|Laying-on-of-Hands|laying-on-of-hands
5136070|NCT03142477|Spiritual Therapies|spiritual therapies
5136071|NCT03142464|saline solution|saline solution
5136072|NCT03142464|laparoscopy|laparoscopy
5136073|NCT03142464|cholecystectomy|cholecystectomy
5136074|NCT03142464|outcomes|outcomes
5136075|NCT03142412|Lupus|lupus
5136076|NCT03142412|SLE|sle
5136077|NCT03142412|Systemic Lupus Erythematosus|systemic lupus erythematosus
5136078|NCT03142399|heart failure|heart failure
5136079|NCT03142399|cardiac reabilitation|cardiac reabilitation
5765905|NCT00259974|Rituximab|rituximab
5136080|NCT03142399|nutritional status|nutritional status
5136081|NCT03142399|quality of life|quality of life
5136082|NCT03142399|milk protein|milk protein
5136083|NCT03142386|geriatric oncology|geriatric oncology
5136084|NCT03142386|pain|pain
5136085|NCT03142386|osteopathic manipulative treatment|osteopathic manipulative treatment
5136087|NCT03142373|heart rate variability|heart rate variability
5136088|NCT03142373|autonomic nervous system|autonomic nervous system
5136089|NCT03142373|osteopathic manipulative treatment|osteopathic manipulative treatment
5136090|NCT03142373|skin conductance|skin conductance
5136091|NCT03142347|remote endarterectomy|remote endarterectomy
5136092|NCT03142347|DCB balloon|dcb balloon
5136093|NCT03142334|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5136094|NCT03142334|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5136095|NCT03142334|Adjuvant|adjuvant
5136096|NCT03142308|Satisfaction|satisfaction
5136097|NCT03142308|Training program|training program
5136098|NCT03142308|Egypt|egypt
5136099|NCT03142308|Cross-sectional|cross-sectional
5136100|NCT03142308|Multi-center|multi-center
5136101|NCT03142295|Urine transfusion|urine transfusion
5136102|NCT03142295|Recurrent urinary tract infection|recurrent urinary tract infection
5136103|NCT03142295|Urinary microbiota|urinary microbiota
5136104|NCT03142282|maintenance treatment|maintenance treatment
5136105|NCT03142243|Tennis|tennis
5136106|NCT03142243|Asymmetry|asymmetry
5136107|NCT03142243|Morphological|morphological
5136108|NCT03142230|feeding tube|feeding tube
5136109|NCT03142230|gastric|gastric
5136110|NCT03142230|newborn infant|newborn infant
5136111|NCT03142230|nursing|nursing
5136112|NCT03142230|pain|pain
5136113|NCT03142191|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5136114|NCT03142191|Pulmonary Fibrosis|pulmonary fibrosis
5136115|NCT03142191|CC-90001|cc-90001
5136116|NCT03142191|Safety|safety
5136117|NCT03142191|Efficacy|efficacy
5136118|NCT03142191|IPF|ipf
5136119|NCT03142191|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5136120|NCT03142178|osteoarthritis|osteoarthritis
5136121|NCT03142178|pain|pain
5136122|NCT03142178|knee|knee
5136130|NCT03142139|Observational study; DTaP-IPV-Hib; Atopic Dermatitis; AD; Heterologous immunity; Non-specific effects; Non-targeted effects; Immunization;|observational study; dtap-ipv-hib; atopic dermatitis; ad; heterologous immunity; non-specific effects; non-targeted effects; immunization;
5136131|NCT03142113|optimization|optimization
5136132|NCT03142113|adalimumab|adalimumab
5136133|NCT03142087|balance|balance
5136134|NCT03142087|brain tumor|brain tumor
5136135|NCT03142087|virtual reality|virtual reality
5136136|NCT03142074|Improve diagnosis|improve diagnosis
5136137|NCT03142009|Community-Based Participatory Research|community-based participatory research
5136138|NCT03141996|vibration|vibration
5136139|NCT03141996|stroke|stroke
5136140|NCT03141996|activities of daily living|activities of daily living
5136141|NCT03141983|ESRD|esrd
5136142|NCT03141983|End-Stage Kidney Disease|end-stage kidney disease
5136143|NCT03141970|Proteinuria Hypoproteinemia Edema Hypoalbuminemia Prednisone|proteinuria hypoproteinemia edema hypoalbuminemia prednisone
5136144|NCT03141957|Aging|aging
5136145|NCT03141957|Hypermetabolism|hypermetabolism
5136146|NCT03141944|non motor symptoms|non motor symptoms
5136147|NCT03141931|Nutraceutical supplement|nutraceutical supplement
5136148|NCT03141905|patient safety|patient safety
5136165|NCT03141775|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
5136166|NCT03141762|Falls|falls
5136167|NCT03141762|Intensive care|intensive care
5136168|NCT03141736|Infant|infant
5136169|NCT03141736|Newborn|newborn
5136170|NCT03141736|Preterm|preterm
5136171|NCT03141736|Hypothermia|hypothermia
5136172|NCT03141736|Kangaroo|kangaroo
5136173|NCT03141736|Plastic|plastic
5136174|NCT03141736|Bag|bag
5136175|NCT03141723|Infant|infant
5136176|NCT03141723|Newborn|newborn
5136177|NCT03141723|Preterm|preterm
5136178|NCT03141723|Hypothermia|hypothermia
5136179|NCT03141723|Kangaroo|kangaroo
5136180|NCT03141723|Plastic|plastic
5136181|NCT03141723|Bag|bag
5136182|NCT03141697|Carbon Dioxide|carbon dioxide
5136183|NCT03141697|Coloboscopy|coloboscopy
5136184|NCT03141671|Prostate Cancer|prostate cancer
5136185|NCT03141658|TS-134|ts-134
5136186|NCT03141658|ketamine|ketamine
5136187|NCT03141658|fMRI|fmri
5136188|NCT03141619|cerebral oximetry|cerebral oximetry
5136189|NCT03141619|near-infrared spectroscopy|near-infrared spectroscopy
5136190|NCT03141619|neurocognitive|neurocognitive
5136191|NCT03141619|post-ICU syndrome|post-icu syndrome
5136192|NCT03141593|adherence to medication|adherence to medication
5136193|NCT03141593|electronic monitoring|electronic monitoring
5136194|NCT03141567|Lymphangiogenesis|lymphangiogenesis
5136195|NCT03141567|Heart Failure|heart failure
5136196|NCT03141541|low back pain|low back pain
5136197|NCT03141541|cognitive behavioural therapy|cognitive behavioural therapy
5136198|NCT03141541|randomised controlled trial|randomised controlled trial
5136199|NCT03141528|Self-learning|self-learning
5136200|NCT03141528|Instructor-led learning|instructor-led learning
5136201|NCT03141528|Long-term retention|long-term retention
5136202|NCT03141515|lung ultrasound|lung ultrasound
5136203|NCT03141515|recruitment maneuver|recruitment maneuver
5136204|NCT03141515|atelectasis|atelectasis
5136205|NCT03141515|children|children
5136206|NCT03141502|tension wound|tension wound
5136207|NCT03141502|skin stretching device|skin stretching device
5136208|NCT03141502|skin grafting|skin grafting
5136209|NCT03141476|Surgery|surgery
5136210|NCT03141476|Obesity|obesity
5136211|NCT03141476|Drug|drug
5136212|NCT03141476|Antibiotics|antibiotics
5136213|NCT03141476|Cefuroxime|cefuroxime
5136214|NCT03141463|Therapeutic vaccination|therapeutic vaccination
5136215|NCT03141372|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
5136216|NCT03141372|Urinary Retention|urinary retention
5136217|NCT03141372|Backfill Void Trial|backfill void trial
5136218|NCT03141372|Autofill Void Trial|autofill void trial
5136219|NCT03141346|mother|mother
5136220|NCT03141346|infant|infant
5136221|NCT03141346|nutrition|nutrition
5136222|NCT03141346|sugar|sugar
5136223|NCT03141346|obesity|obesity
5136224|NCT03141346|growth|growth
5136225|NCT03141307|Neonatal screening|neonatal screening
5136226|NCT03141307|Biobank|biobank
5136227|NCT03141307|Broad Consent|broad consent
5136228|NCT03141294|tracheostomy，fascia，force gauge|tracheostomy，fascia，force gauge
5136229|NCT03141281|aging|aging
5136230|NCT03141281|cognitive ability|cognitive ability
5136231|NCT03141281|IADL|iadl
5136232|NCT03141281|driving|driving
5136233|NCT03141281|financial fraud|financial fraud
5136234|NCT03141281|perception|perception
5136235|NCT03141281|attention|attention
5136236|NCT03141281|memory|memory
5136237|NCT03141255|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
5136238|NCT03141242|Advance Care Planning|advance care planning
5136239|NCT03141242|Group Medial Visit|group medial visit
5136240|NCT03141242|Shared Medical Appointment|shared medical appointment
5136241|NCT03141229|MBSR|mbsr
5136242|NCT03141229|Children|children
5136243|NCT03141229|Teacher|teacher
5136246|NCT03141229|Classroom behavior|classroom behavior
5136247|NCT03141190|stress, surgery, mindfulness, feasibility|stress, surgery, mindfulness, feasibility
5136248|NCT03141125|Erythrocyte sedimentation rate|erythrocyte sedimentation rate
5136249|NCT03141125|Modified Rodnan Skin Score|modified rodnan skin score
5136250|NCT03141125|B-cell Activating Factor|b-cell activating factor
5136251|NCT03141125|soluble-CD40Ligand|soluble-cd40ligand
5136252|NCT03141125|Procollagen Type-1 N-terminal Propeptide|procollagen type-1 n-terminal propeptide
5136253|NCT03141125|Scleroderma|scleroderma
5136254|NCT03141099|OHCA|ohca
5136255|NCT03141099|Hemodynamic|hemodynamic
5136256|NCT03141099|TTM|ttm
5136257|NCT03141099|post-rescusitation care|post-rescusitation care
5136258|NCT03141099|Blood pressure targets|blood pressure targets
5136259|NCT03141099|Oxygenation targets|oxygenation targets
5136260|NCT03141086|shift work disorder|shift work disorder
5136261|NCT03141073|GKA|gka
5136262|NCT03141073|T2DM|t2dm
5136263|NCT03141073|HMS5552|hms5552
5136264|NCT03141073|Add-on therapy|add-on therapy
5136266|NCT03141047|Sexual trauma, Lifespan Integration|sexual trauma, lifespan integration
5136267|NCT03141008|Ketosis|ketosis
5136268|NCT03141008|NAFLD|nafld
5136269|NCT03141008|Obesity|obesity
5136270|NCT03140995|Exercise|exercise
5136271|NCT03140995|Sleep|sleep
5136272|NCT03140982|propofol|propofol
5136273|NCT03140982|pharmacology|pharmacology
5136274|NCT03140982|anesthesic induction|anesthesic induction
5136275|NCT03140982|drug titration|drug titration
5136276|NCT03140969|CEP290|cep290
5136277|NCT03140969|p.Cys998X|p.cys998x
5136278|NCT03140969|c.2991+1655A>G|c.2991+1655a>g
5136279|NCT03140969|RNA therapy|rna therapy
5136280|NCT03140969|Antisense oligonucleotide|antisense oligonucleotide
5136281|NCT03140969|Leber's congenital amaurosis|leber's congenital amaurosis
5136282|NCT03140943|carfilzomib|carfilzomib
5136283|NCT03140917|Liver function|liver function
5136284|NCT03140917|Future liver remnant|future liver remnant
5136285|NCT03140917|Chemotherapy|chemotherapy
5136286|NCT03140891|preterm infant|preterm infant
5136287|NCT03140891|respiratory distress syndrome|respiratory distress syndrome
5136288|NCT03140891|nasal high frequence oscillation ventilation|nasal high frequence oscillation ventilation
5136289|NCT03140865|Alzheimer's|alzheimer's
5136290|NCT03140865|observational|observational
5136291|NCT03140865|prediabetes|prediabetes
5136292|NCT03140865|mild cognitive impairment|mild cognitive impairment
5136293|NCT03140774|Ebola vaccine|ebola vaccine
5136294|NCT03140774|immunogenicity|immunogenicity
5136295|NCT03140774|persistence|persistence
5136296|NCT03140722|anemia|anemia
5136297|NCT03140722|kidney|kidney
5136298|NCT03140722|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
5136299|NCT03140722|CKD|ckd
5136301|NCT03140722|renal|renal
5136302|NCT03140722|vadadustat|vadadustat
5136303|NCT03140722|AKB-6548|akb-6548
5136304|NCT03140722|hypoxia-inducible factor|hypoxia-inducible factor
5136305|NCT03140722|HIF|hif
5136306|NCT03140722|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5136307|NCT03140722|HIF-PHI|hif-phi
5136308|NCT03140722|hyporesponder|hyporesponder
5136309|NCT03140722|hyporesponsive|hyporesponsive
5136310|NCT03140722|epoetin alfa|epoetin alfa
5136311|NCT03140722|hemoglobin|hemoglobin
5136312|NCT03140722|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5136313|NCT03140722|ESA|esa
5136314|NCT03140709|Salivary|salivary
5136315|NCT03140709|Oxytocin|oxytocin
5136316|NCT03140709|Induction|induction
5136317|NCT03140709|Labor|labor
5136318|NCT03140657|Ankylosing spondylitis, Nanocurcumin, MicroRNA, Th17 cells|ankylosing spondylitis, nanocurcumin, microrna, th17 cells
5136319|NCT03140644|thoracic sarcoidosis|thoracic sarcoidosis
5136320|NCT03140644|ultra-low dose computed tomography|ultra-low dose computed tomography
5136321|NCT03140644|Magnetic resonance imaging using Ultrashort echo time|magnetic resonance imaging using ultrashort echo time
5136322|NCT03140631|atrial fibrillation|atrial fibrillation
5136323|NCT03140631|catheter ablation|catheter ablation
5136324|NCT03140631|protamine sulfate|protamine sulfate
5136325|NCT03140631|anticoagulation reversal|anticoagulation reversal
5136326|NCT03140618|single-system-design|single-system-design
5136327|NCT03140618|mixed methods|mixed methods
5136328|NCT03140618|psychiatric inpatient care|psychiatric inpatient care
5136329|NCT03140618|work environment|work environment
5136330|NCT03140618|rebuilding|rebuilding
5136331|NCT03140579|recruitment|recruitment
5136332|NCT03140579|lung homogeneity|lung homogeneity
5136333|NCT03140579|airway pressure release ventilation|airway pressure release ventilation
5136334|NCT03140566|heart failure|heart failure
5136335|NCT03140566|acute decompensated heart failure|acute decompensated heart failure
5136336|NCT03140566|congestion|congestion
5136337|NCT03140566|inferior vena cava|inferior vena cava
5136338|NCT03140553|Neoadjuvant Treatment|neoadjuvant treatment
5136339|NCT03140553|HER2-Positive Breast Cancer|her2-positive breast cancer
5136340|NCT03140540|Fluid management|fluid management
5136341|NCT03140540|goal-directed therapy|goal-directed therapy
5132526|NCT03164551|GERI+|geri+
5136342|NCT03140540|transesophageal echocardiography|transesophageal echocardiography
5136343|NCT03140514|Urine chemokine monitoring|urine chemokine monitoring
5136345|NCT03140488|Pitocin|pitocin
5136346|NCT03140488|BMI|bmi
5136347|NCT03140475|Metacognition|metacognition
5136348|NCT03140475|Mousetracking|mousetracking
5136349|NCT03140475|EEG|eeg
5136350|NCT03140475|Event related potentials|event related potentials
5136351|NCT03140475|Frequency analysis|frequency analysis
5136352|NCT03140475|Depression|depression
5136353|NCT03140462|Tacrolimus|tacrolimus
5136354|NCT03140462|Pharmacokinetics|pharmacokinetics
5136355|NCT03140462|Genetic polymorphisms|genetic polymorphisms
5136356|NCT03140449|Tuberous sclerosis complex|tuberous sclerosis complex
5136357|NCT03140449|facial angiofibroma|facial angiofibroma
5136358|NCT03140449|rapamycin|rapamycin
5136359|NCT03140449|calcitriol|calcitriol
5136360|NCT03140436|stain removal efficacy, air polishing powder|stain removal efficacy, air polishing powder
5136361|NCT03140423|MRSA|mrsa
5136362|NCT03140423|healthcare-associated infections|healthcare-associated infections
5136363|NCT03140423|mupirocin|mupirocin
5136364|NCT03140423|iodophor|iodophor
5136365|NCT03140423|resistance|resistance
5136366|NCT03140410|Staphylococci|staphylococci
5136367|NCT03140410|Blood-stream infections|blood-stream infections
5136368|NCT03140410|Linezolid|linezolid
5136369|NCT03140397|Bioavailability|bioavailability
5136370|NCT03140397|Pharmacokinetics|pharmacokinetics
5136371|NCT03140397|8-prenylnaringenin|8-prenylnaringenin
5136372|NCT03140397|6-prenylnaringenin|6-prenylnaringenin
5136373|NCT03140397|Prenylflavonoids|prenylflavonoids
5136374|NCT03140397|PBMC|pbmc
5136375|NCT03140371|Enteral feeding|enteral feeding
5136376|NCT03140371|Oral nutritional supplements|oral nutritional supplements
5136377|NCT03140371|Peptide-based feed|peptide-based feed
5136378|NCT03140371|Hydrolysed feed|hydrolysed feed
5136379|NCT03140371|Semi-elemental feed|semi-elemental feed
5136380|NCT03140345|Hemodialysis|hemodialysis
5136381|NCT03140345|Microcirculation|microcirculation
5136382|NCT03140345|Traditional Chinese Medicine|traditional chinese medicine
5136383|NCT03140345|Hemodialysis vascular access|hemodialysis vascular access
5136384|NCT03140319|Fibroblast|fibroblast
5136385|NCT03140319|Cell transplantation|cell transplantation
5136386|NCT03140306|Computed tomography|computed tomography
5136387|NCT03140306|Model based iterative reconstruction|model based iterative reconstruction
5136388|NCT03140306|Low dose CT|low dose ct
5136389|NCT03140293|Chorionic villus sampling|chorionic villus sampling
5136390|NCT03140293|Pain|pain
5136391|NCT03140293|Anxiety|anxiety
5136392|NCT03140280|Black raspberries|black raspberries
5136393|NCT03140280|MDS|mds
5136394|NCT03140280|Myelodysplastic Syndromes|myelodysplastic syndromes
5136395|NCT03140280|hypomethylating effects|hypomethylating effects
5136410|NCT03140176|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5136412|NCT03140098|Collagen membrane|collagen membrane
5136413|NCT03140098|Cardiac surgery|cardiac surgery
5136414|NCT03140098|Postoperative complication|postoperative complication
5136415|NCT03140072|Asthma, Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), AZD9898|asthma, single ascending dose (sad), multiple ascending dose (mad), azd9898
5136416|NCT03140059|surgical procedure|surgical procedure
5136417|NCT03140059|residual pockets|residual pockets
5136418|NCT03140059|agressive periodontitis|agressive periodontitis
5136419|NCT03140059|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
5136420|NCT03140020|aneurysm|aneurysm
5136421|NCT03140020|cognition|cognition
5136422|NCT03140020|functional connectivity|functional connectivity
5136423|NCT03140020|frontal lobe function|frontal lobe function
5136424|NCT03140020|neuropsychological testing|neuropsychological testing
5136425|NCT03140020|coiling|coiling
5136426|NCT03140020|clipping|clipping
5136427|NCT03140007|ERCP|ercp
5136428|NCT03140007|cholangioscopy|cholangioscopy
5136429|NCT03139994|occlusion|occlusion
5136430|NCT03139994|pain|pain
5136431|NCT03139981|eczema|eczema
5136432|NCT03139955|Feasibility Study|feasibility study
5136433|NCT03139955|Pre/Post-Operative Patient Monitoring|pre/post-operative patient monitoring
5136434|NCT03139955|Continuous Patient Monitoring|continuous patient monitoring
5136435|NCT03139955|Patient Deterioration Identification|patient deterioration identification
5136436|NCT03139955|Bodytrak|bodytrak
5136437|NCT03139955|National Early Warning System|national early warning system
5136438|NCT03139955|Patient Safety|patient safety
5136439|NCT03139942|Endoscopy|endoscopy
5136440|NCT03139942|Colonoscopy|colonoscopy
5136441|NCT03139942|Hyperspectral imaging|hyperspectral imaging
5136442|NCT03139942|Tissue classification|tissue classification
5136443|NCT03139942|Tissue autofluorescence|tissue autofluorescence
5136444|NCT03139942|Advanced imaging techniques|advanced imaging techniques
5136445|NCT03139916|Glioblastoma|glioblastoma
5136446|NCT03139903|Seckel Syndrome|seckel syndrome
5136447|NCT03139903|Microcephalic Osteodysplastic Primordial Dwarfism Type II|microcephalic osteodysplastic primordial dwarfism type ii
5136448|NCT03139864|Type 1 diabetes|type 1 diabetes
5136449|NCT03139864|Control|control
5136450|NCT03139864|Physical activity|physical activity
5132626|NCT03163862|IVF|ivf
5136452|NCT03139864|Hormonal regulation|hormonal regulation
5136453|NCT03139851|Solid tumor|solid tumor
5136454|NCT03139851|Breast cancer|breast cancer
5136455|NCT03139851|Metastatic cancer|metastatic cancer
5136456|NCT03139851|Pembrolizumab|pembrolizumab
5136457|NCT03139851|Metronomic cyclophosphamide|metronomic cyclophosphamide
5136458|NCT03139838|Palliative Care|palliative care
5136459|NCT03139838|Pragmatic Clinical Trial|pragmatic clinical trial
5136465|NCT03139812|corneal epithelial permeability|corneal epithelial permeability
5136466|NCT03139812|contact lens-related adverse events|contact lens-related adverse events
5136467|NCT03139734|Sacral Nerve Modulation|sacral nerve modulation
5136469|NCT03139708|Cycloplegics|cycloplegics
5136470|NCT03139630|HIV, Dyslipidemia|hiv, dyslipidemia
5136471|NCT03139630|Dyslipidemia|dyslipidemia
5136472|NCT03139630|Protease Inhibitor|protease inhibitor
5136473|NCT03139630|Ritonavir|ritonavir
5136474|NCT03139630|PCSK9|pcsk9
5136475|NCT03139630|Observational|observational
5136476|NCT03139617|Fascia Iliaca Block|fascia iliaca block
5136477|NCT03139617|Femoral 3-in-1 block|femoral 3-in-1 block
5136478|NCT03139617|Fracture femur|fracture femur
5136479|NCT03139617|Spinal anesthesia|spinal anesthesia
5136485|NCT03139565|Influenza|influenza
5136486|NCT03139565|Solid Organ Transplant|solid organ transplant
5136494|NCT03139526|Craniopharyngioma|craniopharyngioma
5136495|NCT03139526|Children|children
5136496|NCT03139526|Social participation|social participation
5136497|NCT03139526|Life-H questionnaire|life-h questionnaire
5136498|NCT03139487|Anticoagulant Adverse Reaction|anticoagulant adverse reaction
5136499|NCT03139487|Cancer-associated Thrombosis|cancer-associated thrombosis
5136500|NCT03139487|Low molecular weight heparin|low molecular weight heparin
5136501|NCT03139487|Direct oral anticoagulant|direct oral anticoagulant
5136505|NCT03139396|inlay bridge, tub shaped design|inlay bridge, tub shaped design
5136506|NCT03139383|postoperative nausea|postoperative nausea
5136507|NCT03139383|postoperative vomiting|postoperative vomiting
5136508|NCT03139383|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5136509|NCT03139344|metabolism|metabolism
5136510|NCT03139344|exercise|exercise
5136512|NCT03139344|secondary health conditions|secondary health conditions
5136513|NCT03139344|quality of life|quality of life
5136514|NCT03139305|glucagon|glucagon
5136515|NCT03139266|cystic fibrosis|cystic fibrosis
5136516|NCT03139266|mindfulness|mindfulness
5136517|NCT03139266|cognitive behavioral therapy|cognitive behavioral therapy
5136518|NCT03139266|UPLIFT|uplift
5136519|NCT03139266|anxiety|anxiety
5136520|NCT03139266|depression|depression
5136521|NCT03139266|web based intervention|web based intervention
5136522|NCT03139253|Helicobacter Pylori Infection|helicobacter pylori infection
5136523|NCT03139253|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
5136524|NCT03139253|Triple Therapy|triple therapy
5136525|NCT03139201|silicone hydrogel soft contact lens|silicone hydrogel soft contact lens
5136526|NCT03139188|Cancer|cancer
5136527|NCT03139188|incurable pathologies|incurable pathologies
5136528|NCT03139188|palliative care|palliative care
5136529|NCT03139162|Home Care Services|home care services
5136530|NCT03139162|Aging|aging
5136531|NCT03139162|Frailty|frailty
5136532|NCT03139162|Complexity|complexity
5136533|NCT03139162|Nursing|nursing
5136534|NCT03139149|conservative treatment|conservative treatment
5136535|NCT03139149|laparoscopic adhesiolysis|laparoscopic adhesiolysis
5136536|NCT03139149|strangulation|strangulation
5136537|NCT03139071|coffee consumption|coffee consumption
5136538|NCT03139071|cardiovascular diseases|cardiovascular diseases
5136539|NCT03139071|coronary artery calcium|coronary artery calcium
5136540|NCT03139071|subclinical atherosclerosis|subclinical atherosclerosis
5136541|NCT03139019|Diabetes prevention|diabetes prevention
5136542|NCT03139019|Weight loss|weight loss
5136543|NCT03139019|Lifestyle change|lifestyle change
5136544|NCT03138967|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
5136545|NCT03138967|Bladder cancer|bladder cancer
5136546|NCT03138967|Outpatient bladder procedures|outpatient bladder procedures
5136547|NCT03138967|Outpatient cystoscopy procedure|outpatient cystoscopy procedure
5136548|NCT03138967|Transurethral resection of the bladder|transurethral resection of the bladder
5136549|NCT03138967|TURB|turb
5136550|NCT03138967|Rocuronium|rocuronium
5136551|NCT03138967|Rocuronium Bromide|rocuronium bromide
5136552|NCT03138967|Zemuron|zemuron
5136553|NCT03138967|Sugammadex|sugammadex
5136554|NCT03138967|Neostigmine|neostigmine
5136558|NCT03138928|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
5136559|NCT03138928|XEN45 gel stent|xen45 gel stent
5136560|NCT03138915|clinically significant portal hypertension|clinically significant portal hypertension
5136561|NCT03138915|hepatic venous pressure gradient|hepatic venous pressure gradient
5136563|NCT03138889|NKTR-214|nktr-214
5369143|NCT01861106|Peripheral Blood Stem Cell|peripheral blood stem cell
5136564|NCT03138889|Metastatic Urothelial Bladder Cancer|metastatic urothelial bladder cancer
5136565|NCT03138889|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5136566|NCT03138889|Pembrolizumab|pembrolizumab
5136567|NCT03138889|Keytruda®|keytruda®
5136568|NCT03138889|Melanoma|melanoma
5136569|NCT03138889|Bladder|bladder
5136572|NCT03138889|HNSCC|hnscc
5136573|NCT03138889|Bempegaldesleukin|bempegaldesleukin
5136574|NCT03138889|bempeg|bempeg
5136575|NCT03138850|intravenous sedation|intravenous sedation
5136576|NCT03138850|esophagogastroduodenalscopy|esophagogastroduodenalscopy
5136577|NCT03138850|upper airway|upper airway
5136578|NCT03138850|mandibular advancement device|mandibular advancement device
5136579|NCT03138850|high flow nasal cannula|high flow nasal cannula
5136580|NCT03138837|Bladder cancer|bladder cancer
5136581|NCT03138837|Magnetic Resonance Imaging|magnetic resonance imaging
5136582|NCT03138837|Bladder Cancer Superficial|bladder cancer superficial
5136583|NCT03138824|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
5136584|NCT03138824|TURBT|turbt
5136585|NCT03138824|Recurrence|recurrence
5136586|NCT03138824|Progression|progression
5136587|NCT03138811|asthma|asthma
5136588|NCT03138811|allergen bronchoprovocation|allergen bronchoprovocation
5136589|NCT03138811|pharmacodynamics|pharmacodynamics
5136590|NCT03138811|pharmacokinetics|pharmacokinetics
5136592|NCT03138811|tolerability|tolerability
5136593|NCT03138798|Labor|labor
5136594|NCT03138798|Second stage|second stage
5136595|NCT03138798|Dental device|dental device
5136596|NCT03138746|hyperbaric oxygenation|hyperbaric oxygenation
5136597|NCT03138746|insulin sensitivity|insulin sensitivity
5136598|NCT03138746|human|human
5136599|NCT03138746|inflammation|inflammation
5136600|NCT03138655|Drug therapy|drug therapy
5136601|NCT03138642|mucosal melanoma|mucosal melanoma
5136602|NCT03138642|radiotherapy|radiotherapy
5136603|NCT03138616|Gestational diabetes mellitus|gestational diabetes mellitus
5136604|NCT03138616|vitamin D|vitamin d
5136605|NCT03138616|postpartum|postpartum
5136606|NCT03138603|surgery|surgery
5136607|NCT03138603|heart disease|heart disease
5136608|NCT03138603|metoprolol|metoprolol
5136609|NCT03138603|myocardial injury|myocardial injury
5136610|NCT03138590|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5136611|NCT03138590|accelerate learning|accelerate learning
5136612|NCT03138590|memory|memory
5136613|NCT03138564|Nursing|nursing
5136614|NCT03138564|Nephrology|nephrology
5136615|NCT03138564|Behavioral Research|behavioral research
5136616|NCT03138564|Social Research|social research
5136617|NCT03138551|Sensory Food Aversions|sensory food aversions
5136621|NCT03138512|localized; resected; adjuvant|localized; resected; adjuvant
5136622|NCT03138473|SYNTAX Score|syntax score
5136623|NCT03138473|residual SYNTAX score|residual syntax score
5136624|NCT03138473|SYNTAX Revascularization Index|syntax revascularization index
5136625|NCT03138447|insulin|insulin
5136626|NCT03138447|basal|basal
5136627|NCT03138447|titration|titration
5136628|NCT03138447|digital health|digital health
5136629|NCT03138434|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5136630|NCT03138434|4D flow MRI|4d flow mri
5136631|NCT03138434|DCE-MRI|dce-mri
5136632|NCT03138434|T1 and T2 mapping|t1 and t2 mapping
5136633|NCT03138408|Ovarian cancer|ovarian cancer
5136634|NCT03138408|Endometrial cancer|endometrial cancer
5136635|NCT03138408|SC-004|sc-004
5136636|NCT03138408|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5136637|NCT03138408|ABBV-181|abbv-181
5136638|NCT03138395|acute myeloid leukemia|acute myeloid leukemia
5136639|NCT03138395|myelodysplastic syndrome|myelodysplastic syndrome
5136640|NCT03138395|relapse|relapse
5136642|NCT03138395|droplet digital|droplet digital
5136643|NCT03138395|polymerase chain reaction|polymerase chain reaction
5136644|NCT03138382|obesity|obesity
5136645|NCT03138382|metabolic syndrome|metabolic syndrome
5136646|NCT03138356|Type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin XR, fixed-dose combination, healthy subjects, crossover, cohorts.|type 2 diabetes mellitus, saxagliptin, dapagliflozin, metformin xr, fixed-dose combination, healthy subjects, crossover, cohorts.
5136647|NCT03138304|decision making|decision making
5136648|NCT03138304|heuristics|heuristics
5136649|NCT03138226|uterus, transplantation, infertility, twin|uterus, transplantation, infertility, twin
5136650|NCT03138213|pancreaticoduodenectomy|pancreaticoduodenectomy
5136651|NCT03138213|surgical outcome|surgical outcome
5136652|NCT03138200|Transfusion|transfusion
5136653|NCT03138200|ScvO2|scvo2
5136654|NCT03138200|Hemoglobin|hemoglobin
5136655|NCT03138187|spontaneous physical activity|spontaneous physical activity
5136656|NCT03138187|caloric intake|caloric intake
5136657|NCT03138174|Blood Glucose Monitor System Accuracy|blood glucose monitor system accuracy
5136658|NCT03138161|cancer immunotherapy, combination chemo-/immunotherapy|cancer immunotherapy, combination chemo-/immunotherapy
5136659|NCT03138148|intensive care|intensive care
5136660|NCT03138135|PrEP|prep
5136661|NCT03138135|HIV prevention|hiv prevention
5136662|NCT03138135|Risk reduction|risk reduction
5136663|NCT03138135|STI prevention|sti prevention
5136664|NCT03138135|Home HIV testing|home hiv testing
5008520|NCT03943316|Ascites|ascites
5136665|NCT03138135|HIV testing|hiv testing
5136666|NCT03138135|STI testing|sti testing
5136667|NCT03138109|non-cardiac surgery|non-cardiac surgery
5136668|NCT03138109|major adverse cardiac event|major adverse cardiac event
5136669|NCT03138083|Mesenchymal-epithelial transition factor (MET) inhibitor|mesenchymal-epithelial transition factor (met) inhibitor
5136671|NCT03138044|Ipsilateral Liver Lobe Devascularization|ipsilateral liver lobe devascularization
5136672|NCT03138044|Alcohol Treatment|alcohol treatment
5136673|NCT03138044|CILDAT|cildat
5136674|NCT03138031|Percutaneuos Ethanol alcohol injection|percutaneuos ethanol alcohol injection
5136675|NCT03138005|Emergency Care, Prehospital|emergency care, prehospital
5136676|NCT03138005|Resuscitation|resuscitation
5136677|NCT03138005|Oxygen|oxygen
5136678|NCT03138005|Cardiac Arrest|cardiac arrest
5136679|NCT03138005|Heart Arrest|heart arrest
5136680|NCT03137992|COPD|copd
5136681|NCT03137979|Periodontitis|periodontitis
5136682|NCT03137979|Gingiva mesenchymal stem cells|gingiva mesenchymal stem cells
5136683|NCT03137966|Diabetes mellitus, foot ulcer, deferoxamine|diabetes mellitus, foot ulcer, deferoxamine
5136691|NCT03137927|whooping cough|whooping cough
5136692|NCT03137914|orthognathic surgery|orthognathic surgery
5136694|NCT03137914|osteoarthritis|osteoarthritis
5136695|NCT03137875|Tuberculosis|tuberculosis
5136697|NCT03137875|MDR-TB|mdr-tb
5136698|NCT03137875|LIPA|lipa
5136699|NCT03137875|filter paper|filter paper
5136700|NCT03137875|slides|slides
5136701|NCT03137875|MTBDR Plus|mtbdr plus
5136702|NCT03137849|Yoga|yoga
5136703|NCT03137849|Hypertension|hypertension
5136704|NCT03137849|Post-Menopausal Women|post-menopausal women
5136705|NCT03137849|Heart Rate Variability|heart rate variability
5022381|NCT03857594|High-Risk|high-risk
5136706|NCT03137823|diagnosis, tonsillitis, streptococcus, GABHS|diagnosis, tonsillitis, streptococcus, gabhs
5136707|NCT03137784|asthma,|asthma,
5136708|NCT03137784|NVA237,|nva237,
5136709|NCT03137784|glycopyrronium bromide|glycopyrronium bromide
5136710|NCT03137784|allergic asthma,|allergic asthma,
5136711|NCT03137784|allergy triggered asthma,|allergy triggered asthma,
5136712|NCT03137784|reactive asthma,|reactive asthma,
5136713|NCT03137784|asthma attack,|asthma attack,
5136714|NCT03137784|difficulty breathing|difficulty breathing
5136715|NCT03137745|Thromboelastography, chemotherapy,hyperthermic|thromboelastography, chemotherapy,hyperthermic
5136716|NCT03137693|histologically proven|histologically proven
5136717|NCT03137693|invasive adenocarcinoma of breast|invasive adenocarcinoma of breast
5136718|NCT03137693|node negative (N0)|node negative (n0)
5136719|NCT03137693|breast-conserving surgery|breast-conserving surgery
5136720|NCT03137693|negative for Her-2 amplification|negative for her-2 amplification
5136721|NCT03137693|estrogen receptor (ER) positive|estrogen receptor (er) positive
5136722|NCT03137693|progesterone receptor (PR) positive|progesterone receptor (pr) positive
5136723|NCT03137680|Arteriovenous Fistula|arteriovenous fistula
5136724|NCT03137680|Pre-operative Exercise|pre-operative exercise
5136725|NCT03137680|Fistula Maturation|fistula maturation
5136726|NCT03137667|Influenza Vaccination Rates|influenza vaccination rates
5136727|NCT03137654|Cognitive Training|cognitive training
5136728|NCT03137654|Emotion Processing|emotion processing
5136729|NCT03137641|occupational exposure|occupational exposure
5136730|NCT03137641|antineoplastic drugs|antineoplastic drugs
5136731|NCT03137641|biomonitoring|biomonitoring
5136732|NCT03137628|general anesthesia,mechanical ventilation,colectomy|general anesthesia,mechanical ventilation,colectomy
5136733|NCT03137589|Telemedicine|telemedicine
5136734|NCT03137576|Awake Thoracic Surgery, Erector Spinae Plane Block|awake thoracic surgery, erector spinae plane block
5136735|NCT03137563|Women|women
5136736|NCT03137563|25-65 years|25-65 years
5136737|NCT03137537|Lymphoma|lymphoma
5136738|NCT03137537|Abnormal resting heart rate|abnormal resting heart rate
5136739|NCT03137537|Autonomic imbalance|autonomic imbalance
5136740|NCT03137537|Cancer survivorship|cancer survivorship
5136741|NCT03137524|Fan or Air Therapy|fan or air therapy
5136742|NCT03137511|Public Health|public health
5136743|NCT03137511|General Medicine|general medicine
5136744|NCT03137511|Dermatology|dermatology
5136745|NCT03137498|renal colic|renal colic
5136746|NCT03137498|lidocaine|lidocaine
5136750|NCT03137485|endoscopic discectomy|endoscopic discectomy
5136751|NCT03137485|open discectomy|open discectomy
5136752|NCT03137485|comparative study|comparative study
5136753|NCT03137485|Translaminar|translaminar
5136754|NCT03137485|surgery|surgery
5136755|NCT03137472|TMS, CRPS, Sham|tms, crps, sham
5136756|NCT03137459|Transtheoretical Model (TTM)|transtheoretical model (ttm)
5136757|NCT03137446|Intravenous fluid resuscitation|intravenous fluid resuscitation
5136758|NCT03137446|Septic shock|septic shock
5136759|NCT03137446|Severe sepsis|severe sepsis
5136760|NCT03137446|Fluid restriction|fluid restriction
5136761|NCT03137433|Weight loss|weight loss
5136762|NCT03137433|Cardiometabolic|cardiometabolic
5136763|NCT03137433|Meal-replacement therapy|meal-replacement therapy
5136764|NCT03137407|heel pain|heel pain
5136768|NCT03137368|ovarian function suppression/ablation|ovarian function suppression/ablation
5136769|NCT03137368|breast cancer|breast cancer
5136770|NCT03137368|Exemestane|exemestane
5962049|NCT04283344|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
5136771|NCT03137368|Tamoxifen|tamoxifen
5136772|NCT03137368|CYP2D6*10 mutations|cyp2d6*10 mutations
5136773|NCT03137355|Leigh Syndrome|leigh syndrome
5136774|NCT03137355|Leigh Disease|leigh disease
5136775|NCT03137355|Leigh's Necrotizing Encephalopathy|leigh's necrotizing encephalopathy
5136776|NCT03137355|Subacute Necrotizing Encephalomyelopathy|subacute necrotizing encephalomyelopathy
5136777|NCT03137355|Subacute Necrotizing Encephalomyopathy|subacute necrotizing encephalomyopathy
5136785|NCT03137290|Sugammadex|sugammadex
5136786|NCT03137277|Colonoscopy|colonoscopy
5136787|NCT03137277|ADR|adr
5136788|NCT03137277|Adenoma detection rate|adenoma detection rate
5136789|NCT03137277|colonoscopic imaging feature improvement|colonoscopic imaging feature improvement
5136790|NCT03137277|Olympus colonoscopes|olympus colonoscopes
5136791|NCT03137264|T790M mutation|t790m mutation
5136792|NCT03137264|EGFR epidermal growth factor receptor|egfr epidermal growth factor receptor
5136793|NCT03137264|non-invasive testing|non-invasive testing
5136794|NCT03137264|lung cancer|lung cancer
5136795|NCT03137251|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5136796|NCT03137251|TENS|tens
5136797|NCT03137251|Analgesia|analgesia
5136798|NCT03137251|Labour pain|labour pain
5136799|NCT03137251|Physical therapy modality|physical therapy modality
5136800|NCT03137238|Self-motion perception|self-motion perception
5136801|NCT03137238|Optic flow|optic flow
5136802|NCT03137238|Vestibular system|vestibular system
5136803|NCT03137238|Multisensory integration|multisensory integration
5136804|NCT03137238|Parkinson's disease|parkinson's disease
5136805|NCT03137212|Percutaneous Coronary Intervention|percutaneous coronary intervention
5136806|NCT03137212|STEMI|stemi
5136807|NCT03137212|Thrombosis|thrombosis
5136808|NCT03137199|stem cell|stem cell
5136809|NCT03137199|mesenchymal stem cell|mesenchymal stem cell
5136810|NCT03137199|lung|lung
5136811|NCT03137199|asthma|asthma
5136812|NCT03137186|Metformin, prostate cancer|metformin, prostate cancer
5136813|NCT03137147|pediatric|pediatric
5136814|NCT03137147|children|children
5136815|NCT03137147|adolescent|adolescent
5136816|NCT03137147|sleep|sleep
5136817|NCT03137147|pain|pain
5136818|NCT03137147|cognitive-behavioral therapy|cognitive-behavioral therapy
5136819|NCT03137121|nausea|nausea
5136820|NCT03137121|vomiting|vomiting
5136821|NCT03137121|olanzapine|olanzapine
5136822|NCT03137082|Alcohol Use Disorder|alcohol use disorder
5136823|NCT03137082|Guanfacine|guanfacine
5136824|NCT03137082|Stress|stress
5136825|NCT03137082|Craving|craving
5136826|NCT03137082|Gender|gender
5136827|NCT03137082|Relapse|relapse
5136828|NCT03137056|Hemodialysis|hemodialysis
5136829|NCT03137056|Membrane|membrane
5136830|NCT03137056|Albumin|albumin
5136831|NCT03137056|Proteomics|proteomics
5136832|NCT03137043|GINA guidelines|gina guidelines
5136833|NCT03137043|Prevalence|prevalence
5136834|NCT03137043|Mepolizumab|mepolizumab
5136835|NCT03137043|severe asthma|severe asthma
5136836|NCT03137043|Spain|spain
5136837|NCT03137030|Abuse deterrent formulation|abuse deterrent formulation
5136838|NCT03137030|Hydrocodone|hydrocodone
5136839|NCT03137030|Analgesics, Opioid|analgesics, opioid
5136840|NCT03137030|Narcotics|narcotics
5136841|NCT03137017|Abuse deterrent formulation|abuse deterrent formulation
5136842|NCT03137017|Hydrocodone|hydrocodone
5136843|NCT03137017|Analgesics, Opioid|analgesics, opioid
5136844|NCT03137017|Narcotics|narcotics
5136845|NCT03136991|Oral myeloperoxidase inhibitor|oral myeloperoxidase inhibitor
5136846|NCT03136978|Macrophages|macrophages
5136847|NCT03136978|Macrophages, Peritoneal|macrophages, peritoneal
5136848|NCT03136978|Endometriosis|endometriosis
5136891|NCT03136588|Information and Communication Technology|information and communication technology
5136892|NCT03136588|Adherence|adherence
5136893|NCT03136588|Kidney transplantation|kidney transplantation
5136894|NCT03136523|NSCLC|nsclc
5136895|NCT03136523|SCLC|sclc
5136896|NCT03136523|MOLECULAR BIOMARKERS|molecular biomarkers
5136897|NCT03136523|EGFR|egfr
5136898|NCT03136523|PD-L1|pd-l1
5136899|NCT03136523|ALK|alk
5136900|NCT03136523|KRAS|kras
5136901|NCT03136458|contrast media|contrast media
5136902|NCT03136458|nephropathy|nephropathy
5136903|NCT03136458|ischemic preconditioning|ischemic preconditioning
5136906|NCT03136432|Cerebral Palsy|cerebral palsy
5136907|NCT03136432|Functional Exercise Capacity|functional exercise capacity
5136908|NCT03136432|Quality of Life|quality of life
5136909|NCT03136419|microbiota|microbiota
5136910|NCT03136419|innate immunity|innate immunity
5136911|NCT03136393|nutrition|nutrition
5136912|NCT03136393|pregnancy|pregnancy
5136913|NCT03136393|birth weight|birth weight
5136914|NCT03136380|healthy Japanese subjects|healthy japanese subjects
5136915|NCT03136380|CXCR2 inhibitor|cxcr2 inhibitor
5136916|NCT03136380|Danirixin|danirixin
5136917|NCT03136367|encounter decision aids|encounter decision aids
5136918|NCT03136367|shared decision making|shared decision making
5136919|NCT03136367|socioeconomic status|socioeconomic status
5136927|NCT03136315|ultra endurance|ultra endurance
5136936|NCT03136250|Muscle Energy Techniques|muscle energy techniques
5136937|NCT03136250|Autogenic Inhibition|autogenic inhibition
5136938|NCT03136250|Reciprocal Inhibition|reciprocal inhibition
5136939|NCT03136250|Stretching|stretching
5136940|NCT03136250|Range of Motion|range of motion
5136941|NCT03136250|Muscle Strength|muscle strength
5136942|NCT03136250|VAS|vas
5136943|NCT03136250|Neck Disability Index|neck disability index
5136944|NCT03136250|NDI|ndi
5136945|NCT03136224|circumcision|circumcision
5136946|NCT03136224|Thermocautery|thermocautery
5136947|NCT03136224|Clamp|clamp
5136948|NCT03136224|Surgical Circumcision|surgical circumcision
5136949|NCT03136198|Heart Failure|heart failure
5136950|NCT03136198|Acute Heart Failure|acute heart failure
5136951|NCT03136198|Pulmonary Edema|pulmonary edema
5136952|NCT03136198|Lung ultrasound|lung ultrasound
5136953|NCT03136198|Extra vascular lung water|extra vascular lung water
5136954|NCT03136198|B-lines|b-lines
5136958|NCT03136159|cesarean section|cesarean section
5136959|NCT03136159|wound healing|wound healing
5136960|NCT03136159|silver-containing dressing|silver-containing dressing
5136961|NCT03136120|Ipratropium bromide|ipratropium bromide
5136962|NCT03136120|Cryobiopsy|cryobiopsy
5136963|NCT03136120|TBCB|tbcb
5136965|NCT03136120|Transbronchial cryobiopsy|transbronchial cryobiopsy
5136966|NCT03136120|Interstitial lung disease|interstitial lung disease
5136972|NCT03136081|Candidiasis|candidiasis
5136973|NCT03136081|Candidemia|candidemia
5136974|NCT03136081|Bacteremia|bacteremia
5136975|NCT03136081|Immunoparalysis|immunoparalysis
5136976|NCT03136055|NEC|nec
5136980|NCT03135990|Virtual Reality|virtual reality
5136981|NCT03135990|Exposure Therapy|exposure therapy
5022612|NCT03856190|Fasting|fasting
5136982|NCT03135990|Cognitive Behavioral Therapy|cognitive behavioral therapy
5136983|NCT03135990|Extinction Learning|extinction learning
5136984|NCT03135964|NPWT|npwt
5136985|NCT03135964|foam|foam
5136986|NCT03135964|gauze|gauze
5136987|NCT03135951|Breast Cancer|breast cancer
5136988|NCT03135951|Pharmacokinetics|pharmacokinetics
5136989|NCT03135951|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
5136990|NCT03135951|Early Stage Breast Cancer|early stage breast cancer
5136991|NCT03135951|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
5136992|NCT03135912|Tinea Pedis|tinea pedis
5136993|NCT03135912|Athlete's Foot|athlete's foot
5136994|NCT03135886|HIV|hiv
5136995|NCT03135886|HIV Testing|hiv testing
5136996|NCT03135886|Hepatitis C Virus Testing|hepatitis c virus testing
5136997|NCT03135886|Opioid Use Disorder Treatment|opioid use disorder treatment
5136998|NCT03135886|Substance Use Disorders Treatment|substance use disorders treatment
5136999|NCT03135886|Hepatitis C Virus|hepatitis c virus
5137000|NCT03135886|Practice Coaching|practice coaching
5137001|NCT03135860|Inhaled Nitric Oxide|inhaled nitric oxide
5137002|NCT03135860|COPD|copd
5137003|NCT03135860|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5137004|NCT03135860|Idopathic Pulmonary Fibrosis|idopathic pulmonary fibrosis
5137005|NCT03135860|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
5137006|NCT03135808|MRI|mri
5137007|NCT03135808|Imaging,|imaging,
5137008|NCT03135808|Anatomy|anatomy
5137009|NCT03135808|Tissue|tissue
5137010|NCT03135808|Colorectal|colorectal
5137011|NCT03135808|Sigmoid|sigmoid
5137012|NCT03135808|Colon|colon
5137013|NCT03135808|Pathology|pathology
5137014|NCT03135795|sufentanil|sufentanil
5137015|NCT03135795|DNA methylation|dna methylation
5137016|NCT03135769|avelumab|avelumab
5137017|NCT03135769|PDL1|pdl1
5137018|NCT03135769|Gestational Trophoblastic Neoplasias|gestational trophoblastic neoplasias
5137019|NCT03135769|GTN|gtn
5137020|NCT03135769|Hydatiform mole|hydatiform mole
5137021|NCT03135769|hCG|hcg
5137022|NCT03135717|Chronic kidney disease|chronic kidney disease
5137023|NCT03135717|Enteral nutrition|enteral nutrition
5137024|NCT03135717|Oral nutritional supplements|oral nutritional supplements
5137025|NCT03135717|Parenteral nutrition|parenteral nutrition
5137026|NCT03135717|Refeeding|refeeding
5137027|NCT03135717|Wasting|wasting
5137028|NCT03135652|Radiotherapy|radiotherapy
5137029|NCT03135652|Colorectal Cancer|colorectal cancer
5137030|NCT03135652|Liver Metastases|liver metastases
5137031|NCT03135639|tACS|tacs
5137032|NCT03135639|transcranial alternating current stimulation|transcranial alternating current stimulation
5137033|NCT03135639|stimulation|stimulation
5137034|NCT03135639|healthy control|healthy control
5137035|NCT03135639|alpha oscillations|alpha oscillations
5137036|NCT03135639|heart rate variability|heart rate variability
5137037|NCT03135626|Pulpotomy|pulpotomy
5137038|NCT03135626|Primary molars|primary molars
5137039|NCT03135613|Knee tumor|knee tumor
5137045|NCT03135587|Knee|knee
5137046|NCT03135587|Loading|loading
5137047|NCT03135587|Kinematics|kinematics
5137048|NCT03135522|Chronic cough|chronic cough
5137049|NCT03135522|Refractory cough|refractory cough
5137050|NCT03135522|Chronic refractory cough|chronic refractory cough
5137051|NCT03135522|Zinc|zinc
5137052|NCT03135522|Zinc acetate|zinc acetate
5137053|NCT03135509|Healthy Subjects|healthy subjects
5137054|NCT03135509|CC-220 Capsules|cc-220 capsules
5137055|NCT03135509|Relative Bioavailability|relative bioavailability
5137056|NCT03135509|Phase 1|phase 1
5137057|NCT03135470|pain|pain
5137058|NCT03135470|ambulatory surgery|ambulatory surgery
5137059|NCT03135470|oxycodone|oxycodone
5137060|NCT03135470|adverse effect|adverse effect
5137061|NCT03135444|Screening|screening
5137062|NCT03135444|Shared Decision Making|shared decision making
5137063|NCT03135418|Virtual Reality|virtual reality
5137064|NCT03135392|Breast Cancer|breast cancer
5137065|NCT03135392|sensation recovery|sensation recovery
5137067|NCT03135366|Tuberculosis|tuberculosis
5137068|NCT03135366|TB|tb
5137069|NCT03135366|Adherence|adherence
5137070|NCT03135366|Mobile Health|mobile health
5137071|NCT03135366|mHealth|mhealth
5137072|NCT03135366|Behavior change|behavior change
5137073|NCT03135366|Social and Behavior Change Communication (SBCC)|social and behavior change communication (sbcc)
5137074|NCT03135366|Drug-Resistance|drug-resistance
5137075|NCT03135366|Keheala|keheala
5137076|NCT03135275|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
5137077|NCT03135275|Multivessel coronary disease|multivessel coronary disease
5022718|NCT03855540|ECG monitoring|ecg monitoring
5137078|NCT03135275|Immediate complete coronary revascularization|immediate complete coronary revascularization
5137079|NCT03135275|Staged complete coronary revascularization|staged complete coronary revascularization
5137080|NCT03135275|Percutaneous coronary intervention|percutaneous coronary intervention
5137081|NCT03135275|Biodegradable-polymer everolimus-eluting stent|biodegradable-polymer everolimus-eluting stent
5137083|NCT03135236|Family education|family education
5137084|NCT03135236|Young adults|young adults
5137085|NCT03135236|Down syndrome|down syndrome
5137086|NCT03135236|sexuality|sexuality
5137087|NCT03135223|Physical activity|physical activity
5137088|NCT03135145|Single Event Multilevel Lower Extremity Orthopedic Surgery (SEMLS)|single event multilevel lower extremity orthopedic surgery (semls)
5137089|NCT03135145|Physical Therapy|physical therapy
5137090|NCT03135145|Gait Training|gait training
5137091|NCT03135145|Functional Walking|functional walking
5137092|NCT03135145|Selective Dorsal Rhizotomy (SDR)|selective dorsal rhizotomy (sdr)
5137093|NCT03135132|High visceral fat|high visceral fat
5137094|NCT03135132|Low calorie diet|low calorie diet
5137095|NCT03135132|Mild weight loss|mild weight loss
5137096|NCT03135132|Metabolomics|metabolomics
5137097|NCT03135132|Metabolites|metabolites
5137098|NCT03135132|Acylcarnitines|acylcarnitines
5137099|NCT03135093|synergies|synergies
5137100|NCT03135093|upper limb|upper limb
5137101|NCT03135093|vision|vision
5137102|NCT03135067|HIV self-testing|hiv self-testing
5137103|NCT03135067|female sex workers|female sex workers
5137104|NCT03135067|partner testing|partner testing
5137105|NCT03135067|couples testing|couples testing
5137106|NCT03135067|transactional sex|transactional sex
5137107|NCT03135054|FLT3-ITD (+) AML; Quizartinib, Omacetaxine mepesuccinate|flt3-itd (+) aml; quizartinib, omacetaxine mepesuccinate
5137108|NCT03135041|Prebiotics|prebiotics
5137109|NCT03135041|Microbiome|microbiome
5137110|NCT03135041|Glucose metabolism|glucose metabolism
5137111|NCT03134976|Salvage surgery|salvage surgery
5137112|NCT03134976|Head and neck cancer|head and neck cancer
5137113|NCT03134976|Wound healing|wound healing
5137114|NCT03134976|Hypothyroidism|hypothyroidism
5137115|NCT03134976|Levothyroxine|levothyroxine
5137116|NCT03134937|Gastric Ultrasound|gastric ultrasound
5137117|NCT03134937|Gastric Distension|gastric distension
5137118|NCT03134937|Gastric Volume|gastric volume
5137119|NCT03134937|Gastric Fluid Volume|gastric fluid volume
5137120|NCT03134937|High-flow oxygen therapy|high-flow oxygen therapy
5137121|NCT03134937|HFHHNO|hfhhno
5137122|NCT03134937|Healthy volunteer|healthy volunteer
5137123|NCT03134924|Bacterial Vaginosis|bacterial vaginosis
5137124|NCT03134885|suicide|suicide
5137125|NCT03134885|suicidal conducts|suicidal conducts
5137126|NCT03134885|post discharge monitoring system|post discharge monitoring system
5137127|NCT03134872|PD-1|pd-1
5137128|NCT03134872|PD-L1|pd-l1
5137129|NCT03134872|SHR-1210|shr-1210
5137130|NCT03134872|Carboplatin|carboplatin
5137131|NCT03134872|Pemetrexed|pemetrexed
5137132|NCT03134859|motor development|motor development
5137133|NCT03134846|Intraoperative fluorescence imaging|intraoperative fluorescence imaging
5146610|NCT03076099|Dexmedetomidine|dexmedetomidine
5137134|NCT03134846|Cetuximab-IRDye800CW|cetuximab-irdye800cw
5137135|NCT03134846|Molecular imaging|molecular imaging
5137136|NCT03134833|HIV|hiv
5137137|NCT03134833|STI|sti
5137138|NCT03134833|Mental Health|mental health
5137139|NCT03134833|Substance Use|substance use
5137140|NCT03134833|Peer Support|peer support
5137141|NCT03134820|Low molecular weight heparins|low molecular weight heparins
5137142|NCT03134820|Procoagulants|procoagulants
5137143|NCT03134820|Phospholipid-dependent Microparticles|phospholipid-dependent microparticles
5137144|NCT03134794|neuroeconomics|neuroeconomics
5137145|NCT03134794|multiple sclerosis|multiple sclerosis
5137146|NCT03134794|educational intervention|educational intervention
5137147|NCT03134794|traffic light system|traffic light system
5137148|NCT03134794|aversion to ambiguity|aversion to ambiguity
5137149|NCT03134794|risk|risk
5137150|NCT03134794|outcomes|outcomes
5137151|NCT03134794|knowledge|knowledge
5137152|NCT03134794|action|action
5137153|NCT03134794|gaps|gaps
5137154|NCT03134794|disease modifying agents|disease modifying agents
5137155|NCT03134755|Asthma|asthma
5137156|NCT03134755|Children|children
5137157|NCT03134755|Stress|stress
5137162|NCT03134729|Serratus Block, Pain Management, lung lobectomy|serratus block, pain management, lung lobectomy
5137163|NCT03134690|Poor ovarian response gonadotropins antagonist|poor ovarian response gonadotropins antagonist
5137165|NCT03134677|General anesthesia|general anesthesia
5137180|NCT03134586|Ileocolonoscopy|ileocolonoscopy
5137181|NCT03134586|Bowel Ultrasound|bowel ultrasound
5137182|NCT03134586|diagnostic imaging|diagnostic imaging
5137183|NCT03134573|Relapsing Remitting Multiple Sclerosis (RRMS),|relapsing remitting multiple sclerosis (rrms),
5137184|NCT03134573|Clinically isolated Syndrome (CIS),|clinically isolated syndrome (cis),
5137185|NCT03134573|Secondary Progressive Multiple Sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
5137186|NCT03134560|vein display instrument|vein display instrument
5137187|NCT03134560|pediatric|pediatric
5137188|NCT03134560|vein access|vein access
5137189|NCT03134560|vein cannulation|vein cannulation
5137190|NCT03134547|emergence agitation|emergence agitation
5137191|NCT03134547|sevoflurane|sevoflurane
5137192|NCT03134547|children|children
5137193|NCT03134534|lobectomy|lobectomy
5137194|NCT03134534|robot-assisted thoracoscopic surgery|robot-assisted thoracoscopic surgery
5137195|NCT03134534|lung cancer|lung cancer
5137196|NCT03134521|bone and joint infection|bone and joint infection
5137197|NCT03134521|daptomycin|daptomycin
5137198|NCT03134521|population pharmacokinetics|population pharmacokinetics
5137199|NCT03134521|Glycoprotein-P (PgP)|glycoprotein-p (pgp)
5137200|NCT03134482|in vitro maturation (IVM)|in vitro maturation (ivm)
5137201|NCT03134482|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5137202|NCT03134482|ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
5137203|NCT03134482|assisted reproductive technology (ART)|assisted reproductive technology (art)
5137204|NCT03134430|Regional nerve block|regional nerve block
5137205|NCT03134430|cancer recurrence|cancer recurrence
5137206|NCT03134404|RAMP|ramp
5137207|NCT03134404|Rapid Access|rapid access
5137208|NCT03134404|Metastasis to Bone|metastasis to bone
5137209|NCT03134404|Cancer|cancer
5137210|NCT03134378|Helicobacter pylori|helicobacter pylori
5137211|NCT03134378|triple therapy|triple therapy
5137212|NCT03134378|eradication|eradication
5137213|NCT03134365|meal ingestion|meal ingestion
5137214|NCT03134365|palatability|palatability
5137215|NCT03134365|postprandial responses|postprandial responses
5137216|NCT03134365|hedonic response|hedonic response
5137217|NCT03134352|subacute|subacute
5137218|NCT03134339|nicotine, smoking|nicotine, smoking
5137225|NCT03134196|Herpes Zoster Ophthalmicus|herpes zoster ophthalmicus
5137226|NCT03134196|Zoster Eye Disease Study|zoster eye disease study
5137227|NCT03134196|Varicella Zoster Virus|varicella zoster virus
5137228|NCT03134196|Zoster|zoster
5137229|NCT03134196|Shingles|shingles
5137231|NCT03134183|dilation and evacuation|dilation and evacuation
5137232|NCT03134183|abortion|abortion
5137233|NCT03134183|second trimester|second trimester
5137234|NCT03134183|mifepristone|mifepristone
5137235|NCT03134183|misoprostol|misoprostol
5137236|NCT03134170|pharmacist|pharmacist
5137237|NCT03134170|diabetes|diabetes
5137238|NCT03134170|Preventative Care|preventative care
5137239|NCT03134170|Quality of Life|quality of life
5137240|NCT03134157|Leiomyoma simvastatin infertility|leiomyoma simvastatin infertility
5137241|NCT03134144|Exoskeleton|exoskeleton
5137242|NCT03134144|Manual materials handling|manual materials handling
5137243|NCT03134144|Musculoskeletal disorders|musculoskeletal disorders
5137245|NCT03134144|Standing work|standing work
5137246|NCT03134144|Muscle activity|muscle activity
5137247|NCT03134118|Thymoma|thymoma
5137248|NCT03134118|Phase II|phase ii
5137249|NCT03134118|nivolumab|nivolumab
5137250|NCT03134118|Thymic carcinoma|thymic carcinoma
5137251|NCT03134079|Taste Test|taste test
5137252|NCT03134079|Spices|spices
5137253|NCT03134079|Reduced sugar|reduced sugar
5137254|NCT03134079|Food liking|food liking
5137255|NCT03134053|hypertrophy scar|hypertrophy scar
5137256|NCT03134053|burn|burn
5137257|NCT03134040|Incentives|incentives
5137258|NCT03134040|Motivation|motivation
5137265|NCT03133897|dexamethasone|dexamethasone
5137267|NCT03133897|inpatient|inpatient
5137268|NCT03133897|paediatrics|paediatrics
5137269|NCT03133884|chronic tension-type headache|chronic tension-type headache
5137270|NCT03133884|acupuncture|acupuncture
5137271|NCT03133884|Deqi|deqi
5137272|NCT03133845|delirium|delirium
5137273|NCT03133845|elderly|elderly
5137274|NCT03133845|lumbar|lumbar
5137275|NCT03133845|surgery|surgery
5137276|NCT03133832|Schistosomiasis haematobium|schistosomiasis haematobium
5137277|NCT03133832|Praziquantel|praziquantel
5137278|NCT03133832|A randomized controlled trial|a randomized controlled trial
5137279|NCT03133806|Percutaneous Occlusion|percutaneous occlusion
5137280|NCT03133793|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5137281|NCT03133767|Normal saline|normal saline
5137282|NCT03133767|Lactated ringers|lactated ringers
5137283|NCT03133767|Emergency department|emergency department
5137284|NCT03133741|GIP|gip
5137285|NCT03133741|GIP receptor antagonist|gip receptor antagonist
5137286|NCT03133728|EID HIV|eid hiv
5137287|NCT03133728|Early Infant Diagnosis|early infant diagnosis
5137288|NCT03133728|Point of Care|point of care
5137289|NCT03133728|Infant|infant
5137290|NCT03133728|HIV|hiv
5137291|NCT03133715|robot-assisted|robot-assisted
5137292|NCT03133689|Alcohol|alcohol
5137293|NCT03133689|Coronary heart disease|coronary heart disease
5137294|NCT03133689|Ischemic heart disease|ischemic heart disease
5137295|NCT03133689|Cardiovascular health|cardiovascular health
5137296|NCT03133689|Individual participant data meta-analysis|individual participant data meta-analysis
5137297|NCT03133689|Longitudinal|longitudinal
5137298|NCT03133676|Osteoarthritis|osteoarthritis
5137299|NCT03133676|Arthritis|arthritis
5137300|NCT03133676|Joint Disease|joint disease
5137301|NCT03133676|Osteoarthritis, Knee|osteoarthritis, knee
5137302|NCT03133663|electrocardiogram|electrocardiogram
5137303|NCT03133663|premature|premature
5137304|NCT03133663|resuscitation|resuscitation
5137305|NCT03133650|Vascular-Targeted Photodynamic Therapy (VTP)|vascular-targeted photodynamic therapy (vtp)
5137306|NCT03133650|15-319|15-319
5137307|NCT03133624|unruptured intracranial aneurysms|unruptured intracranial aneurysms
5137308|NCT03133624|rupture risk|rupture risk
5137309|NCT03133624|computational fluid dynamic|computational fluid dynamic
5137310|NCT03133624|high resolution magnetic resonance images|high resolution magnetic resonance images
5137311|NCT03133624|gene|gene
5137312|NCT03133624|multi dimensional prediction model|multi dimensional prediction model
5137313|NCT03133624|clinical features|clinical features
5137314|NCT03133624|risk factors|risk factors
5137315|NCT03133624|registry study|registry study
5137316|NCT03133624|china|china
5137317|NCT03133624|biomarkers|biomarkers
5137318|NCT03133611|Speech disorder|speech disorder
5137319|NCT03133611|Acoustic analysis|acoustic analysis
5137320|NCT03133611|Dysarthria|dysarthria
5137321|NCT03133598|Un-ruptured intracranial aneurysm|un-ruptured intracranial aneurysm
5137322|NCT03133598|Interventional therapy and craniotomy|interventional therapy and craniotomy
5137323|NCT03133598|Prospective cohort study|prospective cohort study
5137324|NCT03133598|China|china
5137325|NCT03133546|NSCLC|nsclc
5137326|NCT03133546|EGFR|egfr
5137327|NCT03133546|TKI|tki
5137328|NCT03133546|EGFRm|egfrm
5137329|NCT03133546|T790M|t790m
5137330|NCT03133533|robot-assisted|robot-assisted
5137331|NCT03133520|Respiratory failure|respiratory failure
5137332|NCT03133520|immuncompromise patients|immuncompromise patients
5137333|NCT03133520|high flow oxygen|high flow oxygen
5137334|NCT03133507|cancer|cancer
5137335|NCT03133507|salivary alpha amylase|salivary alpha amylase
5137336|NCT03133507|pain|pain
5137337|NCT03133507|positive affect|positive affect
5137338|NCT03133507|emotion regulation strategies|emotion regulation strategies
5137339|NCT03133481|Adductor Canal Block|adductor canal block
5137340|NCT03133481|Femoral Canal Block|femoral canal block
5137341|NCT03133468|AJM347|ajm347
5137342|NCT03133468|pharmacokinetics|pharmacokinetics
5137346|NCT03133429|carotid artery|carotid artery
5137347|NCT03133429|stroke|stroke
5137348|NCT03133429|stent|stent
5137349|NCT03133416|rotator cuff tendinopathy|rotator cuff tendinopathy
5137350|NCT03133416|rotator cuff tear|rotator cuff tear
5137351|NCT03133416|platelet-rich plasma|platelet-rich plasma
5137352|NCT03133416|physiotherapy|physiotherapy
5137353|NCT03133416|exercise|exercise
5137354|NCT03133377|Early activity and mobilization, rehabilitation, intensive care|early activity and mobilization, rehabilitation, intensive care
5137363|NCT03133286|Ovarian|ovarian
5137364|NCT03133286|Pancreas|pancreas
5137365|NCT03133286|Pancreatic|pancreatic
5137366|NCT03133286|Prostate|prostate
5137367|NCT03133286|Rectal|rectal
5137368|NCT03133286|Renal|renal
5137369|NCT03133286|Kidney|kidney
5137370|NCT03133286|Stomach|stomach
5137371|NCT03133286|Testicular|testicular
5137372|NCT03133286|Uterine|uterine
5137373|NCT03133286|Cancer|cancer
5137374|NCT03133286|Radiation Therapy|radiation therapy
5137375|NCT03133286|Radiation Treatment|radiation treatment
5137376|NCT03133273|Colorectal Cancer Metastatic|colorectal cancer metastatic
5137377|NCT03133273|Chemosensitivity|chemosensitivity
5137378|NCT03133221|NHL|nhl
5137379|NCT03133221|indolent NHL|indolent nhl
5137380|NCT03133221|Zydelig|zydelig
5137381|NCT03133221|Idelalisib|idelalisib
5137382|NCT03133221|B-cell NHL|b-cell nhl
5137383|NCT03133221|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5137384|NCT03133221|Maintenance|maintenance
5137385|NCT03133221|Transformed B-cell Non-Hodgkin's lymphoma|transformed b-cell non-hodgkin's lymphoma
5137386|NCT03133221|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5137387|NCT03133208|sepsis|sepsis
5137388|NCT03133208|sepsis associated encephalopathy|sepsis associated encephalopathy
5137389|NCT03133208|sepsis associated delirium|sepsis associated delirium
5137390|NCT03133208|altered mental status|altered mental status
5137391|NCT03133195|Terriparatide, bone fracture healing, PFNA|terriparatide, bone fracture healing, pfna
5137392|NCT03133169|Thalassemia|thalassemia
5137393|NCT03133169|Glutamine/glutamate ratio|glutamine/glutamate ratio
5137394|NCT03133169|Pulmonary hypertension|pulmonary hypertension
5137395|NCT03133156|Exercise|exercise
5137396|NCT03133156|Training|training
5137397|NCT03133156|Type 2 Diabetes|type 2 diabetes
5137398|NCT03133156|Mellitus|mellitus
5137399|NCT03133143|Cognitive Function|cognitive function
5137400|NCT03133143|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5137401|NCT03133143|Computers, Digital|computers, digital
5137403|NCT03133130|Scar prevention|scar prevention
5137404|NCT03133130|siRNA|sirna
5137405|NCT03133091|PIEB|pieb
5137406|NCT03133091|PCEA|pcea
5137407|NCT03133091|LEVOBUPIVACAINE|levobupivacaine
5137408|NCT03133078|Side Hop|side hop
5137409|NCT03133078|Forward Hop|forward hop
5137410|NCT03133078|Step test|step test
5137411|NCT03133078|Vertical Jump|vertical jump
5137412|NCT03133052|cognitive control training|cognitive control training
5137413|NCT03133052|aMCI|amci
5137414|NCT03133052|MRI|mri
5137415|NCT03133052|RCT|rct
5137416|NCT03133026|obstructive Jaundice|obstructive jaundice
5137417|NCT03133026|Self Expandable Metal Stents (SEMS)|self expandable metal stents (sems)
5137418|NCT03133026|Cholangitis|cholangitis
5137419|NCT03133000|Recurrent abdominal wall hernia|recurrent abdominal wall hernia
5137420|NCT03133000|Incisional hernia|incisional hernia
5137421|NCT03132987|quadriceps strength|quadriceps strength
5137422|NCT03132987|quadriceps voluntary activation|quadriceps voluntary activation
5137423|NCT03132987|progressive strength program|progressive strength program
5137424|NCT03132961|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5137425|NCT03132961|Electrocochleography|electrocochleography
5137426|NCT03132961|Infrasound|infrasound
5137427|NCT03132948|ALL Cancer Patients|all cancer patients
5137428|NCT03132948|Quality of Life|quality of life
5137429|NCT03132948|Fitness|fitness
5137430|NCT03132935|Non-STEMI Acute Coronary Syndrome|non-stemi acute coronary syndrome
5137431|NCT03132935|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5137432|NCT03132935|Telemedicine|telemedicine
5137433|NCT03132922|Cell Therapy|cell therapy
5137434|NCT03132922|T Cell Therapy|t cell therapy
5137435|NCT03132922|SPEAR T Cell|spear t cell
5137436|NCT03132922|MAGE-A4|mage-a4
5137437|NCT03132922|Immuno-oncology|immuno-oncology
5137438|NCT03132922|Metastatic|metastatic
5137439|NCT03132922|Urothelial Cancer|urothelial cancer
5137440|NCT03132922|Previously Treated|previously treated
5137441|NCT03132922|T Cell Receptor|t cell receptor
5137442|NCT03132922|Squamous, adenosquamous, adenocarcinoma or large cell NSCLC|squamous, adenosquamous, adenocarcinoma or large cell nsclc
5137443|NCT03132922|Squamous or adenocarcinoma esophageal cancer|squamous or adenocarcinoma esophageal cancer
5137444|NCT03132922|Sarcoma|sarcoma
5137445|NCT03132922|Melanoma|melanoma
5137446|NCT03132922|Bladder|bladder
5137465|NCT03132714|Antimicrobial therapy|antimicrobial therapy
5137466|NCT03132714|Photodynamic therapy|photodynamic therapy
5137467|NCT03132714|Low-level laser therapy|low-level laser therapy
5137473|NCT03132649|Three dimensional visualization|three dimensional visualization
5137474|NCT03132649|Operation strategy|operation strategy
5137475|NCT03132597|stress|stress
5137476|NCT03132597|anxiety|anxiety
5137477|NCT03132597|depression|depression
5137478|NCT03132597|quality of life|quality of life
5137479|NCT03132597|Mindfulness|mindfulness
5137480|NCT03132584|Non Hodgkin Lymphoma|non hodgkin lymphoma
5137481|NCT03132571|Schizophrenia|schizophrenia
5137482|NCT03132571|Diabetes|diabetes
5137493|NCT03132428|Premature and term-near-term neonates|premature and term-near-term neonates
5137494|NCT03132415|Prevention & Control|prevention & control
5137495|NCT03132415|Internet|internet
5137496|NCT03132415|Adolescents|adolescents
5137497|NCT03132415|Young adults|young adults
5137498|NCT03132402|Elisa|elisa
5137499|NCT03132402|Plasmodium Falciparum|plasmodium falciparum
5137500|NCT03132389|Sexual assault|sexual assault
5137501|NCT03132389|Sexually transmitted diseases|sexually transmitted diseases
5137502|NCT03132389|Chlamydia trachomatis|chlamydia trachomatis
5137503|NCT03132389|Mycoplasma genitalium|mycoplasma genitalium
5137504|NCT03132389|Neisseria gonorrhoeae|neisseria gonorrhoeae
5137505|NCT03132389|Hepatitis B and C|hepatitis b and c
5137507|NCT03132389|Syphilis|syphilis
5137508|NCT03132389|Follow up visits after sexual assault|follow up visits after sexual assault
5137509|NCT03132324|Sickle cell disease (SCD)|sickle cell disease (scd)
5137510|NCT03132324|sickle cell SS|sickle cell ss
5137511|NCT03132324|lysine demethylase 1 (LSD1) inhibition|lysine demethylase 1 (lsd1) inhibition
5137512|NCT03132311|yellow fever vaccine|yellow fever vaccine
5137513|NCT03132311|hiv|hiv
5137514|NCT03132272|ADAsorb apheresis|adasorb apheresis
5137515|NCT03132272|Globaffin adsorber|globaffin adsorber
5137516|NCT03132272|Agonistic Autoantibodies|agonistic autoantibodies
5137517|NCT03132272|Immunoadsorption|immunoadsorption
5137518|NCT03132272|Alzheimer Dementia|alzheimer dementia
5137519|NCT03132259|Dexmedethomidine|dexmedethomidine
5137520|NCT03132246|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5137521|NCT03132246|Infection|infection
5137522|NCT03132246|Biofilm Assay|biofilm assay
5137523|NCT03132233|Migraine|migraine
5004478|NCT03968419|MPR|mpr
5137524|NCT03132233|Prevention|prevention
5137525|NCT03132233|Prophylaxis|prophylaxis
5137526|NCT03132233|Ketone bodies|ketone bodies
5137527|NCT03132233|Beta-hydroxybutyrate|beta-hydroxybutyrate
5137528|NCT03132233|Double-blind|double-blind
5137529|NCT03132233|Randomised|randomised
5137530|NCT03132233|Placebo controlled|placebo controlled
5137531|NCT03132233|Mitochondrial functioning|mitochondrial functioning
5137532|NCT03132233|Energy metabolism|energy metabolism
5137533|NCT03132233|Intervention|intervention
5137534|NCT03132233|Dietary Supplement|dietary supplement
5137535|NCT03132220|critical care nurses|critical care nurses
5137536|NCT03132220|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5137537|NCT03132220|Burn-out Syndrome|burn-out syndrome
5137538|NCT03132220|Post-traumatic Stress Disorder|post-traumatic stress disorder
5137539|NCT03132220|Cognitive Behavioral Therapy|cognitive behavioral therapy
5137540|NCT03132207|Oral Health|oral health
5137541|NCT03132207|Pregnancy|pregnancy
5137542|NCT03132207|Prevention|prevention
5137543|NCT03132207|adverse pregnancy outcomes|adverse pregnancy outcomes
5137544|NCT03132181|Empagliflozin|empagliflozin
5137545|NCT03132181|Diabetes|diabetes
5137546|NCT03132181|Systemic vascular resistance|systemic vascular resistance
5137547|NCT03132181|Cardiac output|cardiac output
5137548|NCT03132181|Blood pressure|blood pressure
5137549|NCT03132168|cystectomy|cystectomy
5137550|NCT03132168|urology|urology
5137551|NCT03132168|surgery|surgery
5137552|NCT03132129|Type 2 diabetes|type 2 diabetes
5137553|NCT03132129|Diabetic cardiomyopathy|diabetic cardiomyopathy
5137949|NCT03129178|Nitrate|nitrate
5137559|NCT03132103|Oral vitamin D3|oral vitamin d3
5137560|NCT03132051|carpal tunnel syndrome|carpal tunnel syndrome
5137561|NCT03132025|Metastatic Colorectal Cancer|metastatic colorectal cancer
5137562|NCT03132025|Apatinib|apatinib
5137563|NCT03132025|Capecitabine|capecitabine
5137564|NCT03131999|VEGF-D|vegf-d
5137565|NCT03131999|Imatinib mesylate|imatinib mesylate
5137566|NCT03131999|Sirolimus|sirolimus
5137571|NCT03131908|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
5137572|NCT03131908|Metastatic Melanoma|metastatic melanoma
5137573|NCT03131908|GSK2633771|gsk2633771
5137574|NCT03131908|Pembrolizumab|pembrolizumab
5137575|NCT03131908|Keytruda|keytruda
5137576|NCT03131908|MK-3475|mk-3475
5137577|NCT03131908|SCH-900475|sch-900475
5137578|NCT03131895|Drug therapy|drug therapy
5137579|NCT03131882|trigger finger|trigger finger
5137581|NCT03131882|ultrasound guided|ultrasound guided
5137582|NCT03131882|hyaluronic acid|hyaluronic acid
5137583|NCT03131856|Geriatrics|geriatrics
5137584|NCT03131856|Nutritional risk|nutritional risk
5137585|NCT03131856|Multi-disciplinary intervention|multi-disciplinary intervention
5137586|NCT03131856|Randomized Controlled Trial|randomized controlled trial
5137587|NCT03131843|skin infection|skin infection
5137588|NCT03131843|vaccination|vaccination
5137589|NCT03131843|children|children
5137590|NCT03131843|alcohol swab|alcohol swab
5137591|NCT03131843|skin preparation|skin preparation
5137592|NCT03131804|Aerobic|aerobic
5137593|NCT03131804|Intradialytic|intradialytic
5137594|NCT03131804|Cardio-metabolic markers|cardio-metabolic markers
5137595|NCT03131804|Dialysis Adequacy|dialysis adequacy
5137596|NCT03131804|Quality of Life|quality of life
5137597|NCT03131804|Cost Effectiveness|cost effectiveness
5137598|NCT03131791|Extracorporeal Shock Wave|extracorporeal shock wave
5137599|NCT03131791|Spasticity in stokes|spasticity in stokes
5137600|NCT03131791|Botulinum toxin|botulinum toxin
5137601|NCT03131752|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5137602|NCT03131752|muscle strength|muscle strength
5137603|NCT03131752|physical activity|physical activity
5137604|NCT03131739|Resilience|resilience
5137605|NCT03131739|Alaska Native|alaska native
5137606|NCT03131739|Community Based Participatory Research|community based participatory research
5137607|NCT03131739|Culture and Community Factors|culture and community factors
5137608|NCT03131739|Protective Factors|protective factors
5137609|NCT03131739|Risk Factors|risk factors
5137610|NCT03131726|simvastatin|simvastatin
5137611|NCT03131726|diclofenac|diclofenac
5137612|NCT03131713|Mohs micrographic surgery|mohs micrographic surgery
5137613|NCT03131713|pain|pain
5137614|NCT03131713|functional status|functional status
5137615|NCT03131700|RPH101|rph101
5137616|NCT03131700|RPH-101|rph-101
5137617|NCT03131700|Biosimilar|biosimilar
5137618|NCT03131700|Bevacizumab|bevacizumab
5137619|NCT03131700|Safety|safety
5137620|NCT03131674|Somatic tinnitus|somatic tinnitus
5137621|NCT03131635|Developmental|developmental
5137622|NCT03131596|Intrauterine Adhesion|intrauterine adhesion
5137623|NCT03131596|Hysteroscopy|hysteroscopy
5137624|NCT03131596|Intrauterine balloon|intrauterine balloon
5137625|NCT03131596|Reformation|reformation
5137626|NCT03131596|Prevention|prevention
5962050|NCT04283344|Food expenditures|food expenditures
5137627|NCT03131583|SHR4640 Febuxostat Colchicine pharmacodynamics|shr4640 febuxostat colchicine pharmacodynamics
5137628|NCT03131570|Psoriasis|psoriasis
5137629|NCT03131570|Chronic Plaque Psoriasis|chronic plaque psoriasis
5137630|NCT03131570|Secukinumab|secukinumab
5137632|NCT03131544|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5137633|NCT03131544|MRI|mri
5137634|NCT03131544|Prostate|prostate
5137635|NCT03131544|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5137636|NCT03131544|Nocturia|nocturia
5137637|NCT03131544|Incomplete bladder emptying|incomplete bladder emptying
5137638|NCT03131479|renal function|renal function
5137639|NCT03131479|sodium-glucose co-transporter|sodium-glucose co-transporter
5137640|NCT03131479|pharmacokinetics|pharmacokinetics
5137641|NCT03131479|decreased renal function|decreased renal function
5137642|NCT03131479|decreased kidney function|decreased kidney function
5137643|NCT03131479|kidney disease|kidney disease
5137644|NCT03131479|urinary glucose excretion|urinary glucose excretion
5137645|NCT03131479|UGE|uge
5137646|NCT03131466|Trigeminal Neuralgia|trigeminal neuralgia
5137647|NCT03131466|Pulsed Radiofrequency|pulsed radiofrequency
5137648|NCT03131466|Gasserian Ganglion|gasserian ganglion
5138150|NCT03127800|Hypercapnia|hypercapnia
5137661|NCT03131427|Genetic Testing|genetic testing
5137662|NCT03131375|dexmedetomidine|dexmedetomidine
5137663|NCT03131375|emergence delirium|emergence delirium
5137664|NCT03131375|anesthesia|anesthesia
5137665|NCT03131375|propofol|propofol
5137666|NCT03131375|children|children
5137667|NCT03131362|COPD|copd
5137668|NCT03131323|delineate the prevalence of abnormal nasal finding in wheezy child|delineate the prevalence of abnormal nasal finding in wheezy child
5137669|NCT03131297|anal fistulas|anal fistulas
5137670|NCT03131297|evaluation of radiofrequency|evaluation of radiofrequency
5137671|NCT03131271|Percutaneous coronary intervention|percutaneous coronary intervention
5137672|NCT03131271|Femoral arterial catheter|femoral arterial catheter
5137673|NCT03131271|Pain|pain
5137674|NCT03131271|Cold application|cold application
5137675|NCT03131271|Nursing|nursing
5137676|NCT03131206|Non-small cell lung cancer|non-small cell lung cancer
5137677|NCT03131206|NSCLC|nsclc
5137678|NCT03131206|ALK|alk
5137679|NCT03131206|RET|ret
5137680|NCT03131206|alectinib|alectinib
5137681|NCT03131206|Thyroid cancer|thyroid cancer
5137682|NCT03131154|reproxalap|reproxalap
5137683|NCT03131128|Mindfulness-based intervention|mindfulness-based intervention
5137684|NCT03131128|Weight loss|weight loss
5137685|NCT03131128|Workplace health promotion|workplace health promotion
5137686|NCT03131128|Obesity|obesity
5137687|NCT03131063|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5137688|NCT03131063|Sepsis|sepsis
5137689|NCT03131063|Antibiotics|antibiotics
5137690|NCT03131063|Pharmacokinetic|pharmacokinetic
5137691|NCT03131063|Intensive Care Unit|intensive care unit
5137692|NCT03131050|Scopolamine|scopolamine
5137693|NCT03131037|immunotherapy|immunotherapy
5137694|NCT03131037|immuno-oncology|immuno-oncology
5137695|NCT03131037|tumor vaccine|tumor vaccine
5137696|NCT03131024|anthracyclines|anthracyclines
5137697|NCT03130998|smoking cessation|smoking cessation
5137698|NCT03130998|depression|depression
5137699|NCT03130998|mental health|mental health
5137700|NCT03130998|mood management|mood management
5137701|NCT03130998|primary care|primary care
5137702|NCT03130998|screening|screening
5137703|NCT03130998|brief intervention|brief intervention
5137704|NCT03130998|referral to treatment|referral to treatment
5137705|NCT03130985|microRNA|microrna
5137706|NCT03130985|biomarker|biomarker
5137707|NCT03130946|breast neoplasms|breast neoplasms
5137708|NCT03130946|Ultrasonography, Interventional|ultrasonography, interventional
5137709|NCT03130946|Biopsy, Large-Core Needle|biopsy, large-core needle
5137710|NCT03130946|Biopsy, Fine-Needle|biopsy, fine-needle
5137711|NCT03130933|third molar|third molar
5137712|NCT03130933|oral surgical procedures|oral surgical procedures
5137713|NCT03130933|antibiotic prophylaxis|antibiotic prophylaxis
5137714|NCT03130933|placebo effect|placebo effect
5137715|NCT03130920|preconditioning, resection|preconditioning, resection
5137716|NCT03130894|trimethylamine-N-oxide|trimethylamine-n-oxide
5137717|NCT03130894|type2 Diabetes|type2 diabetes
5023357|NCT03851653|continuous positive airway pressure|continuous positive airway pressure
5137718|NCT03130894|enzyme flavin monooxygenase 3 polymorphisms|enzyme flavin monooxygenase 3 polymorphisms
5137719|NCT03130855|pediatric patients|pediatric patients
5137720|NCT03130855|articaine local anesthesia|articaine local anesthesia
5137721|NCT03130829|NSCLC|nsclc
5137723|NCT03130829|Fucoidan|fucoidan
5137724|NCT03130816|Umbilical cord blood transplantation|umbilical cord blood transplantation
5137725|NCT03130816|Cytokine changes|cytokine changes
5137726|NCT03130764|Non-small Cell Lung Cancer|non-small cell lung cancer
5137727|NCT03130712|immunotherapy|immunotherapy
5137728|NCT03130712|GPC3-CART|gpc3-cart
5137729|NCT03130712|HCC|hcc
5137730|NCT03130699|Diabetes|diabetes
5137731|NCT03130699|mHealth|mhealth
5137732|NCT03130699|Medical Assistant|medical assistant
5137733|NCT03130699|Automated|automated
5137734|NCT03130699|Adaptive Feedback|adaptive feedback
5137735|NCT03130699|Self-Management Support|self-management support
5137736|NCT03130699|Hispanics|hispanics
5137737|NCT03130699|HbA1c|hba1c
5137738|NCT03130699|Cyberinfrastructure|cyberinfrastructure
5137739|NCT03130699|Federally-Qualified Health Centers|federally-qualified health centers
5137740|NCT03130699|Cost-Effectiveness|cost-effectiveness
5137741|NCT03130699|T2DM|t2dm
5137742|NCT03130699|Pay-for-Performance|pay-for-performance
5137743|NCT03130699|Medication Adherence|medication adherence
5137744|NCT03130699|LDL-C|ldl-c
5137745|NCT03130699|Systolic Blood Pressure|systolic blood pressure
5137746|NCT03130699|Text Messaging|text messaging
5137747|NCT03130673|hip fracture|hip fracture
5137748|NCT03130673|trochanteric fracure|trochanteric fracure
5137749|NCT03130673|subtrocantheric fracture|subtrocantheric fracture
5137750|NCT03130673|femoral head fracture|femoral head fracture
5137753|NCT03130660|Central Line Complication|central line complication
5137754|NCT03130634|CPT-11(irinotecan)|cpt-11(irinotecan)
5137755|NCT03130634|silymarin|silymarin
5137756|NCT03130634|GI toxicity|gi toxicity
5137757|NCT03130608|liver disease|liver disease
5137758|NCT03130608|transplant|transplant
5137759|NCT03130608|muscle wasting|muscle wasting
5137760|NCT03130608|breathing exercise|breathing exercise
5137761|NCT03130595|accelerometry|accelerometry
5137762|NCT03130595|Parkinson Kinetigraph|parkinson kinetigraph
5137763|NCT03130582|high-dose etoposide,autologous peripheral blood stem cell transplantation|high-dose etoposide,autologous peripheral blood stem cell transplantation
5137764|NCT03130569|Risk Assessment|risk assessment
5137765|NCT03130569|Personal Genomic Testing|personal genomic testing
5137766|NCT03130569|Skin Cancer|skin cancer
5137767|NCT03130569|Primary Care|primary care
5137768|NCT03130556|Glasdegib|glasdegib
5137769|NCT03130556|PF-04449913|pf-04449913
5137770|NCT03130556|Pharmacokinetics|pharmacokinetics
5137771|NCT03130556|Bioavailability|bioavailability
5137772|NCT03130543|Brief resolved unexplained event|brief resolved unexplained event
5137773|NCT03130530|robotic|robotic
5137774|NCT03130530|colorectal|colorectal
5137775|NCT03130530|surgery|surgery
5137776|NCT03130517|hemolysis,newborn|hemolysis,newborn
5137777|NCT03130478|long-acting injectable antipsychotic|long-acting injectable antipsychotic
5137789|NCT03130426|Diet|diet
5137790|NCT03130426|Exercise|exercise
5137791|NCT03130426|Lifestyle|lifestyle
5137792|NCT03130413|Ambu Aura Gain|ambu aura gain
5137793|NCT03130413|Air-Q intubating laryngeal airway|air-q intubating laryngeal airway
5137794|NCT03130413|Paediatric surgery|paediatric surgery
5137795|NCT03130400|Knee|knee
5137796|NCT03130400|Gait|gait
5137797|NCT03130400|Injuries|injuries
5137798|NCT03130400|Arthritis|arthritis
5137799|NCT03130387|Hytsteroscopy|hytsteroscopy
5137800|NCT03130374|mesenchymal stem cells|mesenchymal stem cells
5133904|NCT03156855|safety|safety
5137801|NCT03130374|Tracheal Stenosis|tracheal stenosis
5137802|NCT03130374|Laryngeal Stenosis|laryngeal stenosis
5137804|NCT03130309|Knee|knee
5137805|NCT03130309|Replacement|replacement
5137806|NCT03130309|Mobile-bearing|mobile-bearing
5137807|NCT03130309|unicompartmental prosthesis|unicompartmental prosthesis
5137808|NCT03130296|HIV infection|hiv infection
5137809|NCT03130296|Fc receptor polymorphism (FcR)|fc receptor polymorphism (fcr)
5137810|NCT03130283|Acute patients|acute patients
5137811|NCT03130283|Exacerbated chronic patients|exacerbated chronic patients
5137812|NCT03130270|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5137813|NCT03130270|disease-free survival|disease-free survival
5137814|NCT03130270|adverse reaction|adverse reaction
5137815|NCT03130257|blood pressure measurement|blood pressure measurement
5137816|NCT03130231|Delirium β2-microspheres|delirium β2-microspheres
5137817|NCT03130179|Bioequivalence|bioequivalence
5137818|NCT03130166|Postoperative pain|postoperative pain
5137819|NCT03130166|Postoperative recovery|postoperative recovery
5137820|NCT03130166|Intracorporeal anastomosis|intracorporeal anastomosis
5137821|NCT03130166|Robotic right colectomy|robotic right colectomy
5137822|NCT03130114|Mortality|mortality
5137823|NCT03130114|Infant|infant
5137824|NCT03130114|Antibiotics|antibiotics
5137825|NCT03130114|Linear Growth|linear growth
5137826|NCT03130101|Type 1 Diabetes|type 1 diabetes
5137827|NCT03130101|Exercise|exercise
5137828|NCT03130101|Basal insulin|basal insulin
5137829|NCT03130101|CSII|csii
5137830|NCT03130101|OmniPod|omnipod
5137831|NCT03130101|CGM|cgm
5137832|NCT03130088|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5137833|NCT03130088|Resuscitation Registry|resuscitation registry
5137834|NCT03130088|EuReCa TWO|eureca two
5137835|NCT03130062|Resistance Exercise|resistance exercise
5137836|NCT03130062|Functional Fitness|functional fitness
5126539|NCT03203525|Doxil|doxil
5137837|NCT03130062|Actigraphy|actigraphy
5137838|NCT03130062|Primary Sjögren Syndrome|primary sjögren syndrome
5137839|NCT03130049|Peripheral nerve block|peripheral nerve block
5137840|NCT03130049|Ultrasound|ultrasound
5137843|NCT03129984|mandibular movements|mandibular movements
5137844|NCT03129958|NECK PAIN, OFFICE WORKERS|neck pain, office workers
5137845|NCT03129945|Obstetric Labor, Premature|obstetric labor, premature
5137846|NCT03129945|Tocolytic Agents|tocolytic agents
5137847|NCT03129932|gluten|gluten
5137848|NCT03129932|adipokine|adipokine
5137849|NCT03129932|obesity|obesity
5137850|NCT03129932|diet|diet
5137851|NCT03129906|Fibromyalgia; non-celiac gluten sensitivity|fibromyalgia; non-celiac gluten sensitivity
5137852|NCT03129880|Voice disorder|voice disorder
5137853|NCT03129880|Hoarseness|hoarseness
5137854|NCT03129880|Phonation Disorders|phonation disorders
5137855|NCT03129880|Speech Disorders|speech disorders
5137856|NCT03129854|prostate cancer|prostate cancer
5137858|NCT03129854|cryotherapy|cryotherapy
5137859|NCT03129854|ADT|adt
5137860|NCT03129841|weight loss|weight loss
5137861|NCT03129841|dietary pattern|dietary pattern
5137862|NCT03129841|late dinner|late dinner
5137863|NCT03129841|early dinner|early dinner
5137864|NCT03129828|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5137865|NCT03129828|Ibrutinib|ibrutinib
5137866|NCT03129828|Bortezomib|bortezomib
5137867|NCT03129815|extubation|extubation
5137868|NCT03129815|pediatric resuscitation|pediatric resuscitation
5137869|NCT03129815|reintubation|reintubation
5137870|NCT03129815|failures of extubation.|failures of extubation.
5137871|NCT03129802|extubation|extubation
5137872|NCT03129802|pediatric resuscitation|pediatric resuscitation
5137873|NCT03129802|reintubation|reintubation
5137874|NCT03129802|failures of extubation.|failures of extubation.
5137875|NCT03129802|Respiratory Insufficiency|respiratory insufficiency
5137876|NCT03129763|SPY-ICG Angiography|spy-icg angiography
5137877|NCT03129763|Tissue Expander|tissue expander
5137878|NCT03129763|Capsule Pressure|capsule pressure
5137879|NCT03129763|Blood Supply|blood supply
5137880|NCT03129724|Kidney Neoplasms|kidney neoplasms
5137881|NCT03129724|Kidney|kidney
5137882|NCT03129724|Neoplasms|neoplasms
5137883|NCT03129724|TKI|tki
5137884|NCT03129724|Axitinib|axitinib
5137885|NCT03129724|VEGF|vegf
5137886|NCT03129724|mTORi|mtori
5137887|NCT03129685|Hepatocellular carcinoma|hepatocellular carcinoma
5137888|NCT03129685|Devascularization|devascularization
5137889|NCT03129672|allograft|allograft
5137890|NCT03129672|distal tibia sarcoma|distal tibia sarcoma
5137891|NCT03129659|Coronary CT Angiography|coronary ct angiography
5137892|NCT03129659|High-sensitivity Troponin|high-sensitivity troponin
5137893|NCT03129659|Diagnosis|diagnosis
5137894|NCT03129620|Ampicillin|ampicillin
5137895|NCT03129607|POPF|popf
5137896|NCT03129607|Classification system|classification system
5137897|NCT03129581|obesity, diet, sleep activity|obesity, diet, sleep activity
5342965|NCT01981343|Gallbladder motility|gallbladder motility
5137898|NCT03129555|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
5137899|NCT03129555|Non-vitamin K Antagonist Oral Anticoagulants|non-vitamin k antagonist oral anticoagulants
5134005|NCT03156244|PROMIS|promis
5137941|NCT03129217|Diaphragm function|diaphragm function
5137942|NCT03129217|Acute respiratory failure|acute respiratory failure
5137943|NCT03129217|Weaning|weaning
5137944|NCT03129204|intensive care unit|intensive care unit
5137945|NCT03129204|critical care|critical care
5137946|NCT03129204|family|family
5137947|NCT03129204|caregiver|caregiver
5137948|NCT03129204|actigraphy|actigraphy
5134126|NCT03155399|Stroke|stroke
5137967|NCT03128996|Reduced Intensity|reduced intensity
5137968|NCT03128996|Familial HLA mismatched|familial hla mismatched
5137969|NCT03128905|Colchicine|colchicine
5137970|NCT03128905|Corticoids|corticoids
5137971|NCT03128905|Prednisone|prednisone
5137981|NCT03128801|Stabilization Exercise|stabilization exercise
5137982|NCT03128801|Exercise Therapy|exercise therapy
5137983|NCT03128801|Exercise Movement|exercise movement
5137984|NCT03128801|Exercise Movement Tecniques|exercise movement tecniques
5137985|NCT03128801|Pain|pain
5137986|NCT03128801|Disability|disability
5137987|NCT03128788|epidurography epidural pressure patient posture|epidurography epidural pressure patient posture
5137988|NCT03128749|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5137989|NCT03128749|Mindfulness Based Intervention|mindfulness based intervention
5137990|NCT03128749|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5137991|NCT03128749|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5137992|NCT03128749|Neuropsychology|neuropsychology
5137993|NCT03128749|Childhood Maltreatment|childhood maltreatment
5137994|NCT03128723|Acne|acne
5137995|NCT03128710|Survey|survey
5137996|NCT03128710|Focus Group|focus group
5137997|NCT03128710|Treatment Preferences|treatment preferences
5137998|NCT03128697|Obesity|obesity
5137999|NCT03128697|Satiety quotient|satiety quotient
5138000|NCT03128697|Appetite control|appetite control
5138001|NCT03128697|Weight loss|weight loss
5138002|NCT03128697|Satiety phenotype|satiety phenotype
5138003|NCT03128697|Functional food|functional food
5138004|NCT03128684|lentils|lentils
5138005|NCT03128684|satiety|satiety
5138006|NCT03128684|appetite|appetite
5138007|NCT03128684|food intake|food intake
5138008|NCT03128684|24-hour energy intake|24-hour energy intake
5138009|NCT03128671|intensive care unit|intensive care unit
5138010|NCT03128671|critical care|critical care
5138011|NCT03128671|mechanical ventilation|mechanical ventilation
5138012|NCT03128671|confusion|confusion
5138013|NCT03128671|polysomnography|polysomnography
5138014|NCT03128671|delirium|delirium
5138015|NCT03128671|adult|adult
5138016|NCT03128658|Trauma induced coagulopathy|trauma induced coagulopathy
5138017|NCT03128554|Not Ready to Quit|not ready to quit
5138018|NCT03128554|Primary Care|primary care
5138019|NCT03128554|Tobacco|tobacco
5138020|NCT03128554|Reduce to Quit|reduce to quit
5138021|NCT03128554|Smoking Reduction|smoking reduction
5138025|NCT03128502|GCF|gcf
5138026|NCT03128502|pentraxin-3|pentraxin-3
5138027|NCT03128489|Safety|safety
5138028|NCT03128489|Infanrix™-IPV/Hib|infanrix™-ipv/hib
5138029|NCT03128489|Immunogenicity|immunogenicity
5138030|NCT03128489|Indian infants|indian infants
5138031|NCT03128489|Combined vaccine|combined vaccine
5138032|NCT03128463|Age-Related Macular Degeneration|age-related macular degeneration
5138033|NCT03128463|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5138034|NCT03128463|Pathological Myopia|pathological myopia
5138035|NCT03128463|Conbercept|conbercept
5138036|NCT03128450|Parkinson Disease|parkinson disease
5138037|NCT03128450|Neural stem cell|neural stem cell
5138038|NCT03128450|Nasal delivery|nasal delivery
5138039|NCT03128437|Anxiety|anxiety
5138040|NCT03128437|Young Adults|young adults
5138041|NCT03128437|Health Behaviors|health behaviors
5138042|NCT03128411|Leukemia, Chronic Myelogenous|leukemia, chronic myelogenous
5138043|NCT03128398|Gastroparesis|gastroparesis
5138044|NCT03128385|Upper limb neurorehabilitation|upper limb neurorehabilitation
5138045|NCT03128385|Neurological rehabilitation|neurological rehabilitation
5138046|NCT03128385|Upper extremity|upper extremity
5138047|NCT03128281|Malignant Neoplasms of Female Genital Organs|malignant neoplasms of female genital organs
5138048|NCT03128281|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5138049|NCT03128281|Robotic gynecologic surgery|robotic gynecologic surgery
5138050|NCT03128281|AirSeal® Insufflation System|airseal® insufflation system
5138051|NCT03128281|AIS|ais
5138052|NCT03128281|Conventional Insufflation System|conventional insufflation system
5138053|NCT03128281|CIS|cis
5138054|NCT03128281|Questionnaires|questionnaires
5138055|NCT03128281|Surveys|surveys
5138056|NCT03128255|Fusion|fusion
5138057|NCT03128255|Hybrid Imaging|hybrid imaging
5138058|NCT03128255|Mapping|mapping
5138059|NCT03128255|Iodine|iodine
5138060|NCT03128255|Ultrasound|ultrasound
5138061|NCT03128242|oxytocin|oxytocin
5138062|NCT03128242|attention bias|attention bias
5138063|NCT03128242|attention training|attention training
5138064|NCT03128242|eye-tracking|eye-tracking
5138065|NCT03128203|Oxytocin|oxytocin
5138074|NCT03128177|non-dipping blood pressure|non-dipping blood pressure
5138075|NCT03128177|obstructive sleep apnea|obstructive sleep apnea
5138076|NCT03128151|NMB (Neuromuscular Blockade)|nmb (neuromuscular blockade)
5138077|NCT03128151|Anesthesia|anesthesia
5138078|NCT03128151|Curarization|curarization
5138079|NCT03128151|TOFr (train of four)|tofr (train of four)
5138080|NCT03128151|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
5138081|NCT03128151|Monitorization|monitorization
5138082|NCT03128112|Parental perception, obesity, overweight|parental perception, obesity, overweight
5138083|NCT03128099|Social Skills|social skills
5138084|NCT03128099|Social attention|social attention
5138085|NCT03128099|Virtual reality|virtual reality
5138086|NCT03128099|Eye tracking|eye tracking
5138087|NCT03128073|Heart failure, Cardio-Renal Syndrome|heart failure, cardio-renal syndrome
5138088|NCT03128047|pediatric cancer|pediatric cancer
5138089|NCT03128047|brain tumor|brain tumor
5138090|NCT03128047|glioblastoma|glioblastoma
5138091|NCT03128047|high grade brain tumor|high grade brain tumor
5138092|NCT03128047|malignant brain tumor|malignant brain tumor
5138093|NCT03128047|recurrent brain tumor|recurrent brain tumor
5138094|NCT03128021|Depression|depression
5138095|NCT03128021|fMRI|fmri
5138096|NCT03128021|Escitalopram|escitalopram
5138097|NCT03128021|Lexapro|lexapro
5138098|NCT03128021|Randomized Clinical Trial|randomized clinical trial
5138099|NCT03128021|Levomilnacipran|levomilnacipran
5138100|NCT03128021|Fetzima|fetzima
5138101|NCT03127995|Breast Cancer pT1-3, pN0-N3, M0|breast cancer pt1-3, pn0-n3, m0
5138102|NCT03127995|Lymph Node Irradiation|lymph node irradiation
5138103|NCT03127982|Anxiety Depression Emotion PTSD Randomized Clinical Trial|anxiety depression emotion ptsd randomized clinical trial
5138104|NCT03127969|Rheumatoid hand|rheumatoid hand
5138105|NCT03127969|Fluidotherapy|fluidotherapy
5138106|NCT03127969|Rehabilitation|rehabilitation
5138107|NCT03127943|lidocaine, mandible|lidocaine, mandible
5138108|NCT03127930|Cognitive Impairment|cognitive impairment
5138109|NCT03127930|Memory loss|memory loss
5138110|NCT03127930|Caregivers|caregivers
5138111|NCT03127930|Medication adherence|medication adherence
5138112|NCT03127930|Medication compliance|medication compliance
5138113|NCT03127930|Medication management|medication management
5138114|NCT03127930|Problem solving|problem solving
5138115|NCT03127930|Quality of Life|quality of life
5138116|NCT03127930|Health resource utilization|health resource utilization
5138117|NCT03127930|Community dwelling|community dwelling
5138118|NCT03127917|Gait Speed|gait speed
5138119|NCT03127917|Cognitive Function|cognitive function
5138120|NCT03127904|Varicose ulcer|varicose ulcer
5138121|NCT03127904|Compressive therapy|compressive therapy
5138122|NCT03127904|Venous ulcer|venous ulcer
5138123|NCT03127904|Chronic venous disease|chronic venous disease
5138124|NCT03127891|pranayama yoga|pranayama yoga
5138125|NCT03127878|Exercise|exercise
5138126|NCT03127878|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5138127|NCT03127878|Activities of Daily Living|activities of daily living
5138128|NCT03127878|Upper Extremity|upper extremity
5138129|NCT03127878|Motor Activity|motor activity
5138130|NCT03127839|Exercise|exercise
5138131|NCT03127839|Pain Neuroscience Education|pain neuroscience education
5138132|NCT03127839|Physical Therapy|physical therapy
5138133|NCT03127839|Subacromial Pain|subacromial pain
5138134|NCT03127839|Rotator Cuff|rotator cuff
5138135|NCT03127826|Low Back Pain|low back pain
5138136|NCT03127826|Risk-Stratified Care|risk-stratified care
5138137|NCT03127813|glaucoma|glaucoma
5138138|NCT03127813|OSA|osa
5138139|NCT03127813|apnoea|apnoea
5138140|NCT03127813|intraocular|intraocular
5138141|NCT03127813|CPAP|cpap
5138142|NCT03127813|airway|airway
5138143|NCT03127813|pressure|pressure
5138144|NCT03127813|blindness|blindness
5138145|NCT03127800|Obstructive Sleep Apnoea|obstructive sleep apnoea
5138146|NCT03127800|Morphine sulphate|morphine sulphate
5138147|NCT03127800|Sleep Disordered Breathing|sleep disordered breathing
5138148|NCT03127800|Central Sleep Apnoea|central sleep apnoea
5138149|NCT03127800|Hypoxaemia|hypoxaemia
5138151|NCT03127800|Cheyne-Stokes Respiration|cheyne-stokes respiration
5138152|NCT03127800|Analgesia|analgesia
5138153|NCT03127800|Respiration|respiration
5138154|NCT03127800|Apnoea-Hypopnea Index|apnoea-hypopnea index
5138155|NCT03127800|Oxygen Desaturation Index|oxygen desaturation index
5138160|NCT03127774|Heated Cisplatin|heated cisplatin
5138161|NCT03127761|Multiple Myeloma|multiple myeloma
5138162|NCT03127748|ventricular septal defect,transcatheter closure|ventricular septal defect,transcatheter closure
5138163|NCT03127735|Phase 1|phase 1
5138164|NCT03127735|mIDH1|midh1
5138165|NCT03127735|IDH1 mutation|idh1 mutation
5138166|NCT03127735|mIDH1 inhibitor|midh1 inhibitor
5138167|NCT03127709|17-199|17-199
5138168|NCT03127709|histiocytosis|histiocytosis
5023772|NCT03849170|coping skills|coping skills
5138169|NCT03127696|Fecal Microbiota Transplant|fecal microbiota transplant
5138170|NCT03127631|Androgen Deprivation Therapy|androgen deprivation therapy
5138171|NCT03127553|salt intake|salt intake
5138172|NCT03127553|functional food|functional food
5138173|NCT03127553|low-salt bread|low-salt bread
5138174|NCT03127553|blood pressure|blood pressure
5138175|NCT03127514|Randomized|randomized
5138176|NCT03127514|Double-blind|double-blind
5138177|NCT03127514|Placebo-controlled|placebo-controlled
5138178|NCT03127514|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5138179|NCT03127514|Sodium Phenylbutyrate|sodium phenylbutyrate
5138180|NCT03127514|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
5138181|NCT03127475|Parkinson's disease|parkinson's disease
5138182|NCT03127475|freezing of gait|freezing of gait
5138183|NCT03127475|electrophysiology|electrophysiology
5138184|NCT03127475|magnetic resonance image|magnetic resonance image
5138185|NCT03127475|direct current stimulation|direct current stimulation
5138186|NCT03127423|Hybrid ablation|hybrid ablation
5138187|NCT03127423|Thoracoscope|thoracoscope
5138188|NCT03127397|antiretroviral therapy|antiretroviral therapy
5138189|NCT03127397|HIV/AIDS|hiv/aids
5138190|NCT03127397|ART adherence|art adherence
5138191|NCT03127371|Nitrous Oxide|nitrous oxide
5138192|NCT03127371|Abscess|abscess
5138193|NCT03127371|Incision and drainage|incision and drainage
5138194|NCT03127358|Addiction|addiction
5138195|NCT03127358|Sustained Viral Response|sustained viral response
5138196|NCT03127358|Adherence|adherence
5138197|NCT03127358|Adverse Effects|adverse effects
5138198|NCT03127358|Direct Acting Antiviral Agent|direct acting antiviral agent
5138199|NCT03127358|Chronic Hepatitis C|chronic hepatitis c
5138200|NCT03127358|Resistance Development|resistance development
5138201|NCT03127358|Methadone Clinic|methadone clinic
5138202|NCT03127358|Primary Care|primary care
5138203|NCT03127358|Directly Observed Therapy|directly observed therapy
5138204|NCT03127358|Randomized Controlled Trial|randomized controlled trial
5138205|NCT03127358|Resistance|resistance
5138206|NCT03127358|Reinfection|reinfection
5138207|NCT03127358|Treatment Outcome|treatment outcome
5138208|NCT03127358|Patient Navigation|patient navigation
5138209|NCT03127358|Multi-Site|multi-site
5138210|NCT03127358|Liver Disease|liver disease
5138211|NCT03127358|Intervention|intervention
5138212|NCT03127332|Treatment care planning|treatment care planning
5138213|NCT03127306|Pain|pain
5138214|NCT03127306|Behavioural Pain Scale|behavioural pain scale
5138215|NCT03127306|BPS|bps
5138216|NCT03127306|NRS|nrs
5138217|NCT03127306|Delirium|delirium
5138218|NCT03127306|CAM-ICU|cam-icu
5138219|NCT03127280|urinary tract infections|urinary tract infections
5138220|NCT03127280|postoperative voiding dysfunction|postoperative voiding dysfunction
5138221|NCT03127280|foley removal|foley removal
5138222|NCT03127280|patient satisfaction|patient satisfaction
5138223|NCT03127267|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5138224|NCT03127267|ALS|als
5138225|NCT03127267|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5138226|NCT03127267|Lou Gehrig's disease|lou gehrig's disease
5138227|NCT03127267|Charcot's disease|charcot's disease
5138228|NCT03127267|Motor Neuron disease|motor neuron disease
5138229|NCT03127267|MND|mnd
5138230|NCT03127254|Video Narrative|video narrative
5138231|NCT03127241|Assistive devices|assistive devices
5138232|NCT03127241|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5138233|NCT03127241|Upper limbs|upper limbs
5138234|NCT03127241|Robotic devices|robotic devices
5138235|NCT03127228|Laser|laser
5138236|NCT03127202|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5138237|NCT03127150|Chylous leakage|chylous leakage
5138238|NCT03127150|Diagnostic criteria|diagnostic criteria
5138239|NCT03127150|Pancreas surgery|pancreas surgery
5138240|NCT03127150|Therapy|therapy
5138241|NCT03127098|locally advanced or metastatic|locally advanced or metastatic
5138242|NCT03127098|carcinoembryonic antigen (CEA)-expressing|carcinoembryonic antigen (cea)-expressing
5138243|NCT03127098|CEA|cea
5138244|NCT03127098|carcinoembryonic antigen|carcinoembryonic antigen
5138245|NCT03127072|colorectal cancer|colorectal cancer
5138246|NCT03127072|liver metastasis|liver metastasis
5138247|NCT03127072|Radiofrequency Ablation|radiofrequency ablation
5138248|NCT03127072|chemotherapy|chemotherapy
5138346|NCT03126500|Frailty|frailty
5138258|NCT03126942|Cost Estimates|cost estimates
5138261|NCT03126942|Dental Implants|dental implants
5138262|NCT03126942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5138263|NCT03126942|Denture Retention|denture retention
5138264|NCT03126942|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5138265|NCT03126942|Oral Health-Related Quality of Life|oral health-related quality of life
5138267|NCT03126942|Patient Acceptance of Health Care|patient acceptance of health care
5138268|NCT03126942|Quality of Healthcare|quality of healthcare
5138269|NCT03126942|Quality of Life|quality of life
5138270|NCT03126942|Patient Satisfaction|patient satisfaction
5138271|NCT03126942|Single implant overdenture|single implant overdenture
5138272|NCT03126929|disorders of consciousness|disorders of consciousness
5138273|NCT03126929|Vegetative state|vegetative state
5138274|NCT03126929|Minimally conscious state|minimally conscious state
5138275|NCT03126929|Emergence from MCS|emergence from mcs
5138276|NCT03126929|Coma Recovery Scale-Revised|coma recovery scale-revised
5138277|NCT03126890|Pharmacokinetics,adverse events|pharmacokinetics,adverse events
5138279|NCT03126890|Therapeutic drug monitoring|therapeutic drug monitoring
5138280|NCT03126890|Myelosuppression|myelosuppression
5138281|NCT03126890|Lactic acidosis|lactic acidosis
5138282|NCT03126890|Peripheral neuropathy|peripheral neuropathy
5138283|NCT03126864|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
5138284|NCT03126864|Acute Myeloid Leukemia|acute myeloid leukemia
5138286|NCT03126864|Relapsed or Refractory CD33-Positive|relapsed or refractory cd33-positive
5138287|NCT03126864|CD33-CAR-T cells|cd33-car-t cells
5138288|NCT03126864|Fludarabine|fludarabine
5138289|NCT03126864|Fludarabine phosphate|fludarabine phosphate
5138290|NCT03126864|Fludara|fludara
5138291|NCT03126864|Cyclophosphamide|cyclophosphamide
5138292|NCT03126864|Cytoxan|cytoxan
5138293|NCT03126864|Neosar|neosar
5138294|NCT03126838|diaphragm|diaphragm
5138295|NCT03126838|ultrasound|ultrasound
5138296|NCT03126838|dysfunction|dysfunction
5138297|NCT03126838|cardiac surgery|cardiac surgery
5138298|NCT03126838|weaning|weaning
5138299|NCT03126812|Primary stage 4|primary stage 4
5138300|NCT03126812|Neo adjuvant|neo adjuvant
5138301|NCT03126786|Diabetes Mellitus|diabetes mellitus
5138302|NCT03126786|Diabetic Retinopathy|diabetic retinopathy
5138303|NCT03126786|Microneedle|microneedle
5138304|NCT03126786|Mircoinjection|mircoinjection
5138305|NCT03126786|Triamcinolone|triamcinolone
5138306|NCT03126786|Choroid|choroid
5138307|NCT03126786|Choroid Injection|choroid injection
5138308|NCT03126786|Aflibercept|aflibercept
5138309|NCT03126786|Suprachoroidal|suprachoroidal
5138315|NCT03126734|Down Syndrome|down syndrome
5138316|NCT03126734|Acceptance|acceptance
5138317|NCT03126734|Commitment|commitment
5138318|NCT03126734|Concience of influence|concience of influence
5138319|NCT03126721|drug interaction|drug interaction
5138320|NCT03126721|PF-06751979|pf-06751979
5138321|NCT03126721|oral midazolam|oral midazolam
5138322|NCT03126695|Abnormal hemoglobin (called hemoglobin S or sickle hemoglobin) in the red blood cells|abnormal hemoglobin (called hemoglobin s or sickle hemoglobin) in the red blood cells
5138323|NCT03126695|Thrombotic cardiovascular events|thrombotic cardiovascular events
5138324|NCT03126695|Acute coronary syndrome|acute coronary syndrome
5138325|NCT03126695|P2Y12 platelet inhibitor|p2y12 platelet inhibitor
5138326|NCT03126695|Brilinta|brilinta
5138327|NCT03126682|Wellbutrin|wellbutrin
5138328|NCT03126682|Electroconvulsive therapy|electroconvulsive therapy
5138329|NCT03126682|Right Unilateral Ultra Brief|right unilateral ultra brief
5138330|NCT03126669|Hyperbaric oxygen|hyperbaric oxygen
5138331|NCT03126669|multitasking performance|multitasking performance
5138332|NCT03126669|cognitive funcitons|cognitive funcitons
5138333|NCT03126656|testosterone|testosterone
5138334|NCT03126656|chronic heart failure|chronic heart failure
5138341|NCT03126513|G-POEM|g-poem
5138342|NCT03126513|Safety|safety
5138343|NCT03126513|Efficacy|efficacy
5138344|NCT03126500|Malnutrition|malnutrition
5138345|NCT03126500|Disease-related malnutrition|disease-related malnutrition
5138370|NCT03126292|Primary care|primary care
5138371|NCT03126292|Children|children
5138372|NCT03126292|Development|development
5138373|NCT03126279|Osteoarthritis|osteoarthritis
5138374|NCT03126279|Pain|pain
5138375|NCT03126279|Postoperative Pain|postoperative pain
5138376|NCT03126253|childhood anemia, socioeconomic status|childhood anemia, socioeconomic status
5138377|NCT03126227|AR101|ar101
5138378|NCT03126227|Characterized Peanut Allergen|characterized peanut allergen
5138379|NCT03126227|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5138380|NCT03126227|OIT (oral immunotherapy)|oit (oral immunotherapy)
5138381|NCT03126227|Peanut Allergy|peanut allergy
5138382|NCT03126227|Peanut-Allergic Children|peanut-allergic children
5138383|NCT03126227|Desensitization|desensitization
5138384|NCT03126227|ARC007|arc007
5138385|NCT03126227|Characterized Oral Desensitization Immunotherapy (CODIT™)|characterized oral desensitization immunotherapy (codit™)
5147811|NCT03068754|ALS|als
5138390|NCT03126201|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5138391|NCT03126201|disease progression|disease progression
5138392|NCT03126175|conservative treatment, treatment outcome|conservative treatment, treatment outcome
5138393|NCT03126162|minimally invasive gynecologic surgery|minimally invasive gynecologic surgery
5138394|NCT03126162|same-day discharge|same-day discharge
5138395|NCT03126162|bladder testing|bladder testing
5138396|NCT03126136|Fetal heart rate abnormalities|fetal heart rate abnormalities
5138397|NCT03126136|Pregnancy|pregnancy
5138398|NCT03126136|Epidural analgesia|epidural analgesia
5138399|NCT03126136|Pulse pressure|pulse pressure
5138400|NCT03126123|Anal condylomatosis|anal condylomatosis
5138401|NCT03126123|surgery|surgery
5138402|NCT03126123|acetic acid|acetic acid
5138403|NCT03126123|dysplastic areas|dysplastic areas
5138420|NCT03126058|enhanced recovery after surgery|enhanced recovery after surgery
5138421|NCT03126058|colorectal cancer|colorectal cancer
5138423|NCT03126045|Post lumbar puncture headache|post lumbar puncture headache
5138424|NCT03126045|Atraumatic needle|atraumatic needle
5138425|NCT03126045|Haematology|haematology
5138426|NCT03126032|Sepsis|sepsis
5138427|NCT03126032|SIRS|sirs
5138428|NCT03126032|Glycocalyx|glycocalyx
5138429|NCT03126032|Glycocheck™-System|glycocheck™-system
5138430|NCT03126032|Infection|infection
5138431|NCT03126019|Follicular lymphoma|follicular lymphoma
5138432|NCT03126019|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5138433|NCT03126019|phosphatidylinositol 3-kinase (PI3K) δ inhibitor|phosphatidylinositol 3-kinase (pi3k) δ inhibitor
5138434|NCT03125993|obesity; brisk walking|obesity; brisk walking
5138435|NCT03125928|Atezolizumab|atezolizumab
5138436|NCT03125928|PD-L1|pd-l1
5138537|NCT03125330|Leadership strengths|leadership strengths
5138443|NCT03125889|Tissue resection|tissue resection
5138445|NCT03125863|Image-guided|image-guided
5138446|NCT03125863|BPH|bph
5138447|NCT03125863|Aquablation|aquablation
5138448|NCT03125863|AQUABEAM|aquabeam
5138449|NCT03125863|LUTS|luts
5138450|NCT03125863|Tissue resection|tissue resection
5138451|NCT03125863|Robotics|robotics
5138452|NCT03125850|knowledge|knowledge
5138453|NCT03125850|psychology|psychology
5138454|NCT03125811|Isopropyl alcohol|isopropyl alcohol
5138455|NCT03125811|Zofran|zofran
5138456|NCT03125811|antiemetics|antiemetics
5138457|NCT03125798|video-assisted thoracic surgery|video-assisted thoracic surgery
5138458|NCT03125798|LigaSure|ligasure
5138459|NCT03125798|mediastinal lymph node dissection|mediastinal lymph node dissection
5138460|NCT03125785|congenital cataract, contact lens|congenital cataract, contact lens
5138461|NCT03125772|coronary artery disease|coronary artery disease
5138462|NCT03125772|diabetes mellitus|diabetes mellitus
5138463|NCT03125772|everolimus|everolimus
5138464|NCT03125772|paclitaxel stents|paclitaxel stents
5138465|NCT03125759|Ischemic Stroke|ischemic stroke
5138466|NCT03125759|Omentin|omentin
5138467|NCT03125733|Endoscopy, Digestive system|endoscopy, digestive system
5138468|NCT03125733|Natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
5138469|NCT03125733|Therapeutic|therapeutic
5138470|NCT03125733|Complications|complications
5138471|NCT03125720|cardiac resynchronization therapy|cardiac resynchronization therapy
5138472|NCT03125720|chronic heart failure|chronic heart failure
5138473|NCT03125720|image fusion-guided implantation|image fusion-guided implantation
5138474|NCT03125720|SPECT|spect
5138475|NCT03125720|venogram|venogram
5138476|NCT03125681|remote ischemic conditioning|remote ischemic conditioning
5138477|NCT03125681|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
5138478|NCT03125655|cytokines|cytokines
5138479|NCT03125642|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5138480|NCT03125642|Mature B-cell Lymphomas|mature b-cell lymphomas
5138481|NCT03125642|Follicular Lymphoma|follicular lymphoma
5138482|NCT03125642|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5138483|NCT03125642|Mantle Cell Lymphoma|mantle cell lymphoma
5138484|NCT03125642|Burkitt's/Burkitt's like|burkitt's/burkitt's like
5138485|NCT03125642|Mature T-Cell Lymphoma|mature t-cell lymphoma
5138486|NCT03125616|Prematurity|prematurity
5138487|NCT03125616|Vaccination|vaccination
5138488|NCT03125603|Immunotherapy|immunotherapy
5138489|NCT03125603|Anti-PD-(L)-1|anti-pd-(l)-1
5138490|NCT03125603|Anti-CTLA-4|anti-ctla-4
5138491|NCT03125590|Osteoporosis, osteopenia, test-retest, validity, PEQ, questionnaire, facilitators, barriers, exercise, physical activity|osteoporosis, osteopenia, test-retest, validity, peq, questionnaire, facilitators, barriers, exercise, physical activity
5138492|NCT03125577|4S CAR-T|4s car-t
5138493|NCT03125577|CD19|cd19
5138494|NCT03125577|CD20|cd20
5138495|NCT03125577|CD22|cd22
5138496|NCT03125577|CD38|cd38
5147922|NCT03068039|MRI|mri
5138498|NCT03125577|B cell leukemia|b cell leukemia
5138499|NCT03125577|B-ALL|b-all
5138500|NCT03125577|CD70|cd70
5138501|NCT03125577|CD30|cd30
5138502|NCT03125551|Dietary supplements|dietary supplements
5138503|NCT03125551|Bleeding tendency|bleeding tendency
5138504|NCT03125538|Motor Imagery|motor imagery
5138505|NCT03125538|Amputation|amputation
5138506|NCT03125538|Functional rehabilitation|functional rehabilitation
5138507|NCT03125538|Locomotion|locomotion
5138508|NCT03125538|Phantom-limb pain|phantom-limb pain
5138509|NCT03125525|migraine|migraine
5138510|NCT03125525|transcutaneous|transcutaneous
5138511|NCT03125525|supraorbital|supraorbital
5138512|NCT03125525|nerve|nerve
5138513|NCT03125525|stimulation|stimulation
5138514|NCT03125512|Sleep Apnea Syndromes|sleep apnea syndromes
5138515|NCT03125512|Positional sleep apnea|positional sleep apnea
5138516|NCT03125512|CPAP|cpap
5138517|NCT03125512|Night Shift|night shift
5138518|NCT03125486|subcutaneous Belimumab|subcutaneous belimumab
5138519|NCT03125486|Individual Patient Compassionate Use|individual patient compassionate use
5138520|NCT03125486|SLE|sle
5138521|NCT03125486|GSK1550188|gsk1550188
5138522|NCT03125447|Prematurely born children|prematurely born children
5138523|NCT03125447|Attention function|attention function
5138524|NCT03125447|Posture|posture
5138532|NCT03125330|Coaching|coaching
5138533|NCT03125330|Professional coaching|professional coaching
5138534|NCT03125330|Emergency physicians|emergency physicians
5138535|NCT03125330|Emergency medicine|emergency medicine
5138536|NCT03125330|Goal attainment|goal attainment
5138538|NCT03125330|Well-being|well-being
5138539|NCT03125330|Burnout|burnout
5138540|NCT03125330|Adult level of development|adult level of development
5138541|NCT03125330|Group coaching|group coaching
5138542|NCT03125330|Instructor|instructor
5138543|NCT03125330|Assistant professor|assistant professor
5138544|NCT03125330|Academic faculty|academic faculty
5138545|NCT03125330|Subject-Object Interview|subject-object interview
5138546|NCT03125304|Endometriosis|endometriosis
5138547|NCT03125304|acupuncture|acupuncture
5138548|NCT03125304|pain|pain
5138549|NCT03125304|dysmenorrhea|dysmenorrhea
5138550|NCT03125291|Substance Use and Abuse|substance use and abuse
5138551|NCT03125291|Risky Sexual Behavior|risky sexual behavior
5138552|NCT03125291|Behavior Problems|behavior problems
5138553|NCT03125291|Academic Achievement|academic achievement
5138554|NCT03125265|nutrition|nutrition
5138555|NCT03125265|hemodialysis|hemodialysis
5138556|NCT03125265|mortality|mortality
5138557|NCT03125265|omega 3|omega 3
5138558|NCT03125252|Delirium|delirium
5138559|NCT03125252|Reanimation|reanimation
5138560|NCT03125252|Conversational hypnosis|conversational hypnosis
5138561|NCT03125239|Refractory Adult Acute Myeloid Leukemia|refractory adult acute myeloid leukemia
5138562|NCT03125239|Relapsed Adult Acute Myeloid Leukemia|relapsed adult acute myeloid leukemia
5138563|NCT03125187|Sodium Heparin|sodium heparin
5138564|NCT03125187|Intravenous administration|intravenous administration
5138565|NCT03125187|Pharmacokinetics|pharmacokinetics
5138566|NCT03125187|Coagulation factor|coagulation factor
5138567|NCT03125174|sputum|sputum
5138568|NCT03125174|bronchiectasis|bronchiectasis
5138569|NCT03125174|lung disease|lung disease
5138570|NCT03125161|colorectal cancer|colorectal cancer
5138571|NCT03125161|liver metastasis|liver metastasis
5138572|NCT03125161|hepatic arterial infusion|hepatic arterial infusion
5138573|NCT03125161|chemotherapy|chemotherapy
5138574|NCT03125161|target therapy|target therapy
5138575|NCT03125161|conversional resection rates|conversional resection rates
5138576|NCT03125083|Skin restricted lupus|skin restricted lupus
5138577|NCT03125083|Psychiatric disorders|psychiatric disorders
5138578|NCT03125083|Inflammation|inflammation
5138579|NCT03125083|Kynurenine pathway|kynurenine pathway
5138580|NCT03124667|adherence|adherence
5138581|NCT03124667|cognition|cognition
5138582|NCT03124667|exercise|exercise
5138583|NCT03124667|aging|aging
5138584|NCT03124667|brain training|brain training
5138585|NCT03124667|cognitive training|cognitive training
5138586|NCT03124667|executive function|executive function
5138587|NCT03124641|Hypothermic oxygenated machine perfusion|hypothermic oxygenated machine perfusion
5138588|NCT03124641|Orthotopic liver transplantation|orthotopic liver transplantation
5138589|NCT03124641|Extended criteria donation|extended criteria donation
5138590|NCT03124641|Donation after brain death|donation after brain death
5138591|NCT03124641|HOPE|hope
5138592|NCT03124563|Exercise|exercise
5138593|NCT03124563|Health Behavior|health behavior
5138594|NCT03124563|Aging|aging
5138595|NCT03124550|Caregivers|caregivers
5138596|NCT03124550|Exercise|exercise
5138597|NCT03124550|Behavior Change|behavior change
5138598|NCT03124537|Physical Exercise|physical exercise
5138599|NCT03124537|Behavior Change|behavior change
5138600|NCT03124524|estradiol valerate/dienogest|estradiol valerate/dienogest
5138601|NCT03124524|ethinylestradiol/ drospirenone|ethinylestradiol/ drospirenone
5138602|NCT03124524|pelvic pain|pelvic pain
5138603|NCT03124524|primary dysmenorrhea|primary dysmenorrhea
5138604|NCT03124524|uterine artery doppler indices|uterine artery doppler indices
5138605|NCT03124498|Hepatocellular Carcinoma, Autologous Cytokine-Induced Killer|hepatocellular carcinoma, autologous cytokine-induced killer
5138606|NCT03124459|CMT1 / CMTX|cmt1 / cmtx
5138607|NCT03124446|mindfulness, meditation, emerging adults, young adults, undergraduate students, stress, health|mindfulness, meditation, emerging adults, young adults, undergraduate students, stress, health
5138608|NCT03124433|prostate cancer|prostate cancer
5138609|NCT03124433|prostatectomy, retropubic|prostatectomy, retropubic
5138610|NCT03124433|Androgen Receptor Antagonists|androgen receptor antagonists
5138611|NCT03124420|Helicobacter Infection|helicobacter infection
5138612|NCT03124420|Eradication therapy|eradication therapy
5138613|NCT03124420|Antibiotics|antibiotics
5138614|NCT03124381|Acne|acne
5138615|NCT03124368|factor D|factor d
5138617|NCT03124368|alternative pathway|alternative pathway
5138618|NCT03124368|complement mediated disease|complement mediated disease
5138619|NCT03124368|idiopathic MPGN|idiopathic mpgn
5138620|NCT03124368|MPGN Type I|mpgn type i
5138621|NCT03124368|MPGN Type II|mpgn type ii
5138622|NCT03124368|MPGN Type III|mpgn type iii
5138623|NCT03124368|Primary MPGN|primary mpgn
5138625|NCT03124368|Mesangiocapillary Glomerulonephritis|mesangiocapillary glomerulonephritis
5138626|NCT03124355|vagal stimulation|vagal stimulation
5138627|NCT03124355|POTS|pots
5138628|NCT03124355|galantamine|galantamine
5138629|NCT03124355|pyridostigmine|pyridostigmine
5138630|NCT03124238|massage|massage
5138631|NCT03124212|mutation carrier|mutation carrier
5138632|NCT03124212|blood relative|blood relative
5138633|NCT03124212|genetic testing|genetic testing
5138634|NCT03124212|family-based cohort|family-based cohort
5138635|NCT03124199|Eradication|eradication
5138636|NCT03124199|Helicobacter pylori|helicobacter pylori
5138637|NCT03124199|rifaximin|rifaximin
5138638|NCT03124199|therapy|therapy
5138639|NCT03124199|standard triple therapy|standard triple therapy
5138640|NCT03124186|motor recovery|motor recovery
5138641|NCT03124186|neuroplasticity|neuroplasticity
5138642|NCT03124186|subacute|subacute
5138643|NCT03124186|human|human
5138644|NCT03124186|sensory|sensory
5138645|NCT03124186|nerve stimulation|nerve stimulation
5138646|NCT03124173|fMRI|fmri
5138647|NCT03124173|cingulate cortex|cingulate cortex
5138648|NCT03124173|adaptation|adaptation
5138649|NCT03124173|frontal cortex|frontal cortex
5138650|NCT03124160|Healthy Women|healthy women
5138651|NCT03124160|Female Contraception|female contraception
5138653|NCT03124147|motor recovery|motor recovery
5138654|NCT03124147|neuroplasticity|neuroplasticity
5138655|NCT03124147|chronic|chronic
5138656|NCT03124147|human|human
5138657|NCT03124147|noninvasive brain stimulation|noninvasive brain stimulation
5138658|NCT03124147|neuromodulation|neuromodulation
5138659|NCT03124108|Elafibranor|elafibranor
5138660|NCT03124108|Primary Biliary Cholangitis|primary biliary cholangitis
5138661|NCT03124108|Alkaline phosphatase|alkaline phosphatase
5138662|NCT03124095|physical exercise|physical exercise
5138663|NCT03124095|combined training|combined training
5138664|NCT03124095|physical activity|physical activity
5138665|NCT03124095|physical fitness|physical fitness
5138666|NCT03124056|Extracorporeal photopheresis|extracorporeal photopheresis
5138667|NCT03124056|Biomarker of response|biomarker of response
5138668|NCT03124056|Steroid resistant|steroid resistant
5138669|NCT03124030|direct oral anticoagulant|direct oral anticoagulant
5138670|NCT03124030|oral anticoagulant therapy|oral anticoagulant therapy
5138671|NCT03124030|dental extraction|dental extraction
5138672|NCT03124030|bleeding complication|bleeding complication
5138673|NCT03124030|atrial fibrillation|atrial fibrillation
5138674|NCT03124030|deep venous thrombosis|deep venous thrombosis
5138675|NCT03124004|direct oral anticoagulant|direct oral anticoagulant
5138676|NCT03124004|oral anticoagulant therapy|oral anticoagulant therapy
5138677|NCT03124004|periodontal disease|periodontal disease
5138678|NCT03124004|periodontal debridement|periodontal debridement
5138679|NCT03124004|ultrasonic periodontal debridement|ultrasonic periodontal debridement
5138680|NCT03124004|ultrasonic scaling|ultrasonic scaling
5138681|NCT03124004|periodontal scaling|periodontal scaling
5138682|NCT03124004|subgingival scaling|subgingival scaling
5138683|NCT03123978|castration resistant prostate cancer|castration resistant prostate cancer
5138684|NCT03123965|Special Access Scheme|special access scheme
5138685|NCT03123965|Expanded Access|expanded access
5138686|NCT03123965|Pre-approval Access|pre-approval access
5138687|NCT03123965|Compassionate Use|compassionate use
5138688|NCT03123965|Special Access Program|special access program
5138689|NCT03123965|Named Patient Basis|named patient basis
5138690|NCT03123952|Expanded Access|expanded access
5138691|NCT03123952|Pre-approval Access|pre-approval access
5138692|NCT03123952|Compassionate Use|compassionate use
5138693|NCT03123952|Special Access Program|special access program
5138694|NCT03123952|Named Patient Basis|named patient basis
5138695|NCT03123952|Special Access Scheme|special access scheme
5138696|NCT03123939|ALL|all
5138697|NCT03123939|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5138698|NCT03123939|CTL019|ctl019
5138705|NCT03123874|expressed human milk|expressed human milk
5138706|NCT03123874|bacterial communities|bacterial communities
5138707|NCT03123874|microbiome|microbiome
5138708|NCT03123874|breast pump|breast pump
5138709|NCT03123874|bacterial growth|bacterial growth
5138710|NCT03123861|Pelvic Organ Prolapse|pelvic organ prolapse
5138711|NCT03123861|postoperative gluteal pain|postoperative gluteal pain
5138712|NCT03123861|opioid use|opioid use
5138713|NCT03123835|Achalasia|achalasia
5138714|NCT03123835|Fistula|fistula
5138715|NCT03123835|Obesity|obesity
5138716|NCT03123835|POEM|poem
5138717|NCT03123835|GERD|gerd
5138718|NCT03123835|endoscopic|endoscopic
5138719|NCT03123835|treatments|treatments
5138720|NCT03123835|post bariatric surger weight gain|post bariatric surger weight gain
5138721|NCT03123835|endoluminal|endoluminal
5138722|NCT03123835|Bariatric Surgery|bariatric surgery
5138723|NCT03123835|Barretts|barretts
5138724|NCT03123809|Diabetes Mellitus|diabetes mellitus
5138725|NCT03123809|gastroparesis|gastroparesis
5138726|NCT03123809|gastric electrical stimulation|gastric electrical stimulation
5138727|NCT03123809|pyloroplasty|pyloroplasty
5138733|NCT03123783|Nivolumab|nivolumab
5138734|NCT03123783|APX005M|apx005m
5138738|NCT03123770|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5138740|NCT03123744|Palbociclib|palbociclib
5138741|NCT03123744|Cyclin Pathway|cyclin pathway
5138742|NCT03123744|kinase inhibitor|kinase inhibitor
5138743|NCT03123731|physical activity|physical activity
5138744|NCT03123731|diet|diet
5138745|NCT03123731|mHealth|mhealth
5138746|NCT03123731|Fitbit|fitbit
5138747|NCT03123731|neurocognition|neurocognition
5138748|NCT03123731|text messaging|text messaging
5138749|NCT03123718|methotrexate|methotrexate
5138753|NCT03123627|Cytomegalovirus, Seropositive|cytomegalovirus, seropositive
5138754|NCT03123614|Photorefractive keratectomy|photorefractive keratectomy
5766106|NCT00258934|Influenza|influenza
5138755|NCT03123601|Nursing home|nursing home
5138756|NCT03123601|Falls|falls
5138757|NCT03123601|Dysphasia|dysphasia
5138758|NCT03123601|Choking|choking
5138759|NCT03123601|Dehydration|dehydration
5138760|NCT03123588|Essential thrombocythemia|essential thrombocythemia
5138761|NCT03123588|hydroxyurea-resistant|hydroxyurea-resistant
5138762|NCT03123588|hydroxyurea-intolerant|hydroxyurea-intolerant
5138763|NCT03123588|ruxolitinib|ruxolitinib
5138764|NCT03123588|anagrelide|anagrelide
5138765|NCT03123562|Cerebral palsy|cerebral palsy
5138766|NCT03123562|Stem cells|stem cells
5138767|NCT03123562|Neonatal icterus|neonatal icterus
5138768|NCT03123536|high risk|high risk
5138769|NCT03123536|complication|complication
5138770|NCT03123536|Ultrasonography|ultrasonography
5138771|NCT03123510|probiotics|probiotics
5138772|NCT03123510|prebiotics|prebiotics
5138773|NCT03123510|synbiotics|synbiotics
5138774|NCT03123510|obesity|obesity
5138775|NCT03123497|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5138776|NCT03123484|beta-elemene|beta-elemene
5138777|NCT03123471|Plaque Psoriasis|plaque psoriasis
5138778|NCT03123471|Scalp|scalp
5138779|NCT03123471|Double-Blind|double-blind
5138780|NCT03123471|Efficacy|efficacy
5138781|NCT03123471|Safety|safety
5138782|NCT03123471|CC-10004|cc-10004
5138783|NCT03123471|Apremilast|apremilast
5138784|NCT03123471|Otezla|otezla
5138785|NCT03123471|Itch|itch
5138786|NCT03123471|Head|head
5138787|NCT03123458|MSC|msc
5138788|NCT03123458|GVHDs|gvhds
5138789|NCT03123458|transplantation|transplantation
5138790|NCT03123445|endostar|endostar
5138791|NCT03123432|immunomodulating nutrients|immunomodulating nutrients
5138792|NCT03123406|cinacalcet|cinacalcet
5138793|NCT03123406|secondary hyperparathyroidism|secondary hyperparathyroidism
5138794|NCT03123406|calcimimetics|calcimimetics
5138795|NCT03123406|CKD-MBD|ckd-mbd
5138796|NCT03123393|Drug therapy|drug therapy
5138797|NCT03123315|hysterectomy|hysterectomy
5138798|NCT03123315|ureter|ureter
5138799|NCT03123302|MRI scan, sedation, epilepsia|mri scan, sedation, epilepsia
5138800|NCT03123289|PET/CT|pet/ct
5138801|NCT03123289|68Gallium Citrate|68gallium citrate
5138802|NCT03123289|Orthopedic Hardware infection|orthopedic hardware infection
5138803|NCT03123250|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5138804|NCT03123250|AQUABEAM|aquabeam
5138805|NCT03123250|Aquablation|aquablation
5138806|NCT03123250|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5138807|NCT03123224|Caregiver|caregiver
5138808|NCT03123224|Caregiving|caregiving
5138809|NCT03123224|TBI|tbi
5138810|NCT03123224|dementia|dementia
5138811|NCT03123224|Alzheimer's disease|alzheimer's disease
5138812|NCT03123224|physical exercise|physical exercise
5138813|NCT03123224|physical activity|physical activity
5138814|NCT03123224|psychosocial|psychosocial
5138815|NCT03123224|caregiver skills training|caregiver skills training
5138816|NCT03123211|Expanded Access|expanded access
5138817|NCT03123211|Pre-approval Access|pre-approval access
5138818|NCT03123211|Compassionate Use|compassionate use
5138819|NCT03123211|Special Access Program|special access program
5138820|NCT03123211|Named Patient Basis|named patient basis
5138821|NCT03123211|Special Access Scheme|special access scheme
5138822|NCT03123198|borderline personality disorder, dialectical behavior therapy, suicidal behaviors|borderline personality disorder, dialectical behavior therapy, suicidal behaviors
5138823|NCT03123172|co2 gap|co2 gap
5138824|NCT03123172|PPV|ppv
5138825|NCT03123172|resuscitation|resuscitation
5138826|NCT03123172|liver transplantation|liver transplantation
5138827|NCT03123146|Cognitive Behavioral Therapy|cognitive behavioral therapy
5138828|NCT03123107|Vitamin C|vitamin c
5138829|NCT03123107|Postoperative atrial fibrillation|postoperative atrial fibrillation
5138830|NCT03123107|coronary artery bypass graft|coronary artery bypass graft
5138831|NCT03123107|ascorbic acid|ascorbic acid
5138837|NCT03123055|invasive bladder cancer|invasive bladder cancer
5138838|NCT03123055|Transitional Cell Carcinoma|transitional cell carcinoma
5138840|NCT03123055|second line therapy|second line therapy
5138841|NCT03123055|monoclonal antibody|monoclonal antibody
5138842|NCT03123055|combination therapy|combination therapy
5138844|NCT03123055|pembrolizumab|pembrolizumab
5138845|NCT03123055|checkpoint inhibitor|checkpoint inhibitor
5138846|NCT03123055|Phase 2|phase 2
5138847|NCT03123055|Urothelial Carcinoma|urothelial carcinoma
5138848|NCT03123055|Vofatamab|vofatamab
5138849|NCT03123042|Sentinel lymph node|sentinel lymph node
5138850|NCT03123042|Early gastric cancer|early gastric cancer
5138851|NCT03123042|Non-curative endoscopic resection|non-curative endoscopic resection
5138852|NCT03123029|Expanded Access|expanded access
5138853|NCT03123029|Pre-approval Access|pre-approval access
5138854|NCT03123029|Compassionate Use|compassionate use
5138855|NCT03123029|Special Access Program|special access program
5138856|NCT03123029|Named Patient Basis|named patient basis
5138857|NCT03123029|Special Access Scheme|special access scheme
5138858|NCT03123016|Vitiligo|vitiligo
5138859|NCT03123003|Bone age,|bone age,
5138860|NCT03123003|Height prediction|height prediction
5138861|NCT03123003|Growth|growth
5138862|NCT03122938|lactoferrin|lactoferrin
5138863|NCT03122938|Iron Metabolism|iron metabolism
5138864|NCT03122938|iron-deficiency anemia|iron-deficiency anemia
5138865|NCT03122938|pregnant women|pregnant women
5138866|NCT03122938|fetal development|fetal development
5138867|NCT03122912|fish oil|fish oil
5138868|NCT03122899|SI-BONE|si-bone
5138869|NCT03122899|sacroiliac joint|sacroiliac joint
5138870|NCT03122899|degenerative sacroiliitis|degenerative sacroiliitis
5138871|NCT03122899|sacroiliac joint disruption|sacroiliac joint disruption
5138872|NCT03122899|iFuse|ifuse
5138873|NCT03122860|SM04690|sm04690
5138874|NCT03122860|Wnt pathway inhibitor|wnt pathway inhibitor
5138875|NCT03122860|osteoarthritis|osteoarthritis
5138876|NCT03122860|Samumed|samumed
5138877|NCT03122834|Heart Failure|heart failure
5138878|NCT03122834|Genetic Polymorphism|genetic polymorphism
5138879|NCT03122834|RAAS|raas
5138880|NCT03122834|Cardiac Fibrosis|cardiac fibrosis
5138881|NCT03122834|Remodeling|remodeling
5138882|NCT03122808|Tachysystole|tachysystole
5138883|NCT03122808|Excessive Uterine Activity|excessive uterine activity
5138884|NCT03122769|Metformin|metformin
5138885|NCT03122769|Heart Failure|heart failure
5138886|NCT03122769|Organic cation transporter|organic cation transporter
5138887|NCT03122769|Pharmacogenetics|pharmacogenetics
5138888|NCT03122769|Pharmacokinetics|pharmacokinetics
5138889|NCT03122769|Positron Emission Tomography|positron emission tomography
5138890|NCT03122756|Intravenous Dexamethasone|intravenous dexamethasone
5138891|NCT03122756|Spinal Anesthesia|spinal anesthesia
5138892|NCT03122756|Post-cesarean Section Pain|post-cesarean section pain
5138893|NCT03122730|Cardiac surgery|cardiac surgery
5138894|NCT03122730|Cardiopulmonary bypass|cardiopulmonary bypass
5138895|NCT03122730|Epoprostenol|epoprostenol
5138896|NCT03122717|Non-Small Cell Lung Cancer|non-small cell lung cancer
5138897|NCT03122665|Nefopam|nefopam
5138898|NCT03122665|Pharmacokinetics|pharmacokinetics
5138899|NCT03122665|Shivering,|shivering,
5138900|NCT03122665|Thermoregulation|thermoregulation
5138901|NCT03122665|Anesthesia|anesthesia
5138902|NCT03122652|Radiologically Isolated Syndrome|radiologically isolated syndrome
5138903|NCT03122626|stroke|stroke
5138907|NCT03122626|healthcare-recreation partnership|healthcare-recreation partnership
5138908|NCT03122626|randomized controlled pilot trial|randomized controlled pilot trial
5138909|NCT03122626|mixed methods|mixed methods
5138911|NCT03122587|Brain Stimulation|brain stimulation
5138912|NCT03122587|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
5138913|NCT03122587|Substance Use|substance use
5138914|NCT03122574|aromatherapy|aromatherapy
5138915|NCT03122574|pediatric|pediatric
5138916|NCT03122574|venipuncture|venipuncture
5138917|NCT03122574|lavender|lavender
5138918|NCT03122574|pain management|pain management
5138919|NCT03122548|stomach cancer|stomach cancer
5138920|NCT03122548|gastric cancer|gastric cancer
5138921|NCT03122548|esophageal cancer|esophageal cancer
5138922|NCT03122548|digestive system diseases|digestive system diseases
5138923|NCT03122548|gastrointestinal diseases|gastrointestinal diseases
5138924|NCT03122548|stomach diseases|stomach diseases
5138925|NCT03122535|Femtosecond LASIK (FS--LASIK)|femtosecond lasik (fs--lasik)
5138926|NCT03122535|Visual acuity|visual acuity
5138927|NCT03122535|Refractive errors|refractive errors
5138928|NCT03122535|Side-cut angles|side-cut angles
5138929|NCT03122522|unresectable|unresectable
5138930|NCT03122522|III or stage IV|iii or stage iv
5138939|NCT03122496|Durvalumab (Medi4736)|durvalumab (medi4736)
5138940|NCT03122496|Tremelimumab|tremelimumab
5138941|NCT03122496|Image Guided Stereotactic Body Radiotherapy (SBRT)|image guided stereotactic body radiotherapy (sbrt)
5138943|NCT03122470|TRUS biopsy|trus biopsy
5138944|NCT03122470|Pelvic MRI|pelvic mri
5138945|NCT03122457|Actinic Keratosis|actinic keratosis
5138946|NCT03122366|single nucleotide polymorphisms|single nucleotide polymorphisms
5138947|NCT03122366|Toll-like receptor-4|toll-like receptor-4
5138948|NCT03122340|Acute Coronary Syndrome|acute coronary syndrome
5138949|NCT03122340|Polyprenols|polyprenols
5138950|NCT03122340|Cholesterol|cholesterol
5138951|NCT03122314|paracetamol|paracetamol
5138952|NCT03122314|dexketoprofen|dexketoprofen
5138953|NCT03122314|emergency department|emergency department
5138954|NCT03122314|musculoskeletal pain|musculoskeletal pain
5138955|NCT03122275|Adherence|adherence
5138956|NCT03122275|Directive Counseling|directive counseling
5138957|NCT03122262|Antiretroviral Agents, first-line antiretroviral therapy|antiretroviral agents, first-line antiretroviral therapy
5138958|NCT03122262|dolutegravir|dolutegravir
5138959|NCT03122262|Tenofovir alafenamide|tenofovir alafenamide
5138960|NCT03122249|Palliative care|palliative care
5138961|NCT03122249|Symptom management|symptom management
5138962|NCT03122249|Self-management|self-management
5138963|NCT03122249|Rural area|rural area
5138964|NCT03122249|eHealth|ehealth
5138965|NCT03122249|telehealth|telehealth
5138967|NCT03122158|major depressive disorder|major depressive disorder
5138968|NCT03122158|anxiety disorders|anxiety disorders
5138969|NCT03122158|adolescent|adolescent
5138970|NCT03122158|child|child
5138971|NCT03122145|healthy|healthy
5138972|NCT03122145|volunteer|volunteer
5138973|NCT03122132|Hepatitis C Infection|hepatitis c infection
5138974|NCT03122132|Ombitasvir/Paritaprevir/Ritonavir+dasabuvir|ombitasvir/paritaprevir/ritonavir+dasabuvir
5138975|NCT03122119|Sacroiliac|sacroiliac
5138976|NCT03122119|Joint Injection|joint injection
5138977|NCT03122119|Platelet Rich Plasma|platelet rich plasma
5138978|NCT03122119|Ultrasound|ultrasound
5138979|NCT03122119|Low Back Pain|low back pain
5138980|NCT03122093|pediatric|pediatric
5138981|NCT03122093|dietary treatment|dietary treatment
5138982|NCT03122093|celiac disease|celiac disease
5138983|NCT03122093|T1D|t1d
5138984|NCT03122080|acupuncture|acupuncture
5138985|NCT03122080|insomnia|insomnia
5138986|NCT03122080|depression|depression
5138987|NCT03122080|antidepressants|antidepressants
5138988|NCT03122067|oxytocin|oxytocin
5138989|NCT03122067|social cognition|social cognition
5138990|NCT03122067|fMRI|fmri
5138991|NCT03122067|empathy|empathy
5138992|NCT03122054|Laparoscopic Cholecystectomy, Delayed Cholecystectomy|laparoscopic cholecystectomy, delayed cholecystectomy
5138993|NCT03122041|metformin intolerance|metformin intolerance
5138994|NCT03122041|PCOS|pcos
5138995|NCT03122041|Sitagliptin|sitagliptin
5138996|NCT03122041|beta cell function|beta cell function
5138997|NCT03122028|LAmbre|lambre
5138998|NCT03122002|Ischemic Stroke|ischemic stroke
5138999|NCT03122002|Cerebral Infarction|cerebral infarction
5139000|NCT03122002|Cerebrovascular Disorders|cerebrovascular disorders
5139001|NCT03121950|dementia|dementia
5139002|NCT03121924|oocyte denudation|oocyte denudation
5139003|NCT03121924|preincubation|preincubation
5139004|NCT03121924|icsi|icsi
5139009|NCT03121911|Expiratory Flow Limitation|expiratory flow limitation
5139010|NCT03121911|Ventilatory Efficiency|ventilatory efficiency
5139011|NCT03121911|Inflammatory Markers|inflammatory markers
5139012|NCT03121911|Heart Rate Variability|heart rate variability
5139014|NCT03121859|interferential current therapy|interferential current therapy
5139015|NCT03121859|Chronic neck pain|chronic neck pain
5139016|NCT03121846|Apatinib|apatinib
5139017|NCT03121846|Soft Tissue Sarcoma|soft tissue sarcoma
5139018|NCT03121833|Endostar|endostar
5139019|NCT03121833|Soft Tissue Sarcoma|soft tissue sarcoma
5139020|NCT03121833|Chemotherapy|chemotherapy
5139021|NCT03121807|home parenteral nutrition|home parenteral nutrition
5139022|NCT03121794|ultrasonography|ultrasonography
5139023|NCT03121794|Intraosseous Vascular access|intraosseous vascular access
5139024|NCT03121794|humerus|humerus
5139025|NCT03121794|anatomic landmark|anatomic landmark
5139026|NCT03121768|Prognostic Model|prognostic model
5139027|NCT03121768|Bladder Cancer|bladder cancer
5139028|NCT03121768|Superficial Bladder Cancer|superficial bladder cancer
5139029|NCT03121768|Recurrence|recurrence
5139030|NCT03121768|Progression|progression
5139031|NCT03121768|BCG|bcg
5139032|NCT03121742|Suicide|suicide
5139033|NCT03121729|enhanced recovery after surgery|enhanced recovery after surgery
5139034|NCT03121729|gastric cancer|gastric cancer
5139035|NCT03121664|Drug drug interaction, CYP3A4, itraconazole|drug drug interaction, cyp3a4, itraconazole
5139036|NCT03121651|Mobile technology|mobile technology
5139037|NCT03121651|Reinforcement-learning|reinforcement-learning
5139038|NCT03121651|Medication management|medication management
5139039|NCT03121638|Varicella Vaccine|varicella vaccine
5139040|NCT03121638|Herpes Zoster Vaccine|herpes zoster vaccine
5139041|NCT03121612|RDS|rds
5139042|NCT03121573|near infrared spectroscopy, NIRS, duloxetine|near infrared spectroscopy, nirs, duloxetine
5139043|NCT03121560|Hysteroscopy|hysteroscopy
5139044|NCT03121560|Saline infusion hysterosonography|saline infusion hysterosonography
5139045|NCT03121534|Hematopoietic/Lymphoid Cancer|hematopoietic/lymphoid cancer
5139046|NCT03121534|Richter's transformation|richter's transformation
5139047|NCT03121534|RT|rt
5139048|NCT03121534|Blinatumomab|blinatumomab
5139049|NCT03121534|Dexamethasone|dexamethasone
5139050|NCT03121534|Decadron|decadron
5139051|NCT03121521|statins liver enzymes melatonin|statins liver enzymes melatonin
5207761|NCT02696499|Itch|itch
5139052|NCT03121430|peripheral arterial disease|peripheral arterial disease
5139053|NCT03121430|Drug eluting peripheral vascular stent system|drug eluting peripheral vascular stent system
5139054|NCT03121430|primary patency|primary patency
5139055|NCT03121378|Hip Joint Alloplasty|hip joint alloplasty
5139056|NCT03121378|Bone Cements|bone cements
5139057|NCT03121378|Impedance Aggregometry|impedance aggregometry
5139058|NCT03121378|Platelet Activation|platelet activation
5139059|NCT03121365|Digital literacy|digital literacy
5139060|NCT03121365|Reading|reading
5139061|NCT03121352|Carboplatin|carboplatin
5139062|NCT03121352|Nab-Paclitaxel|nab-paclitaxel
5139063|NCT03121352|Pembrolizumab|pembrolizumab
5139064|NCT03121326|Sarcopenia|sarcopenia
5139065|NCT03121326|Aging|aging
5139066|NCT03121326|Biomarkers|biomarkers
5139067|NCT03121326|Metabolomics|metabolomics
5139068|NCT03121313|Tegafur-uracil|tegafur-uracil
5139069|NCT03121313|distant metastasis|distant metastasis
5139070|NCT03121313|oral cavity cancer|oral cavity cancer
5139071|NCT03121261|levobupivacaine|levobupivacaine
5139072|NCT03121261|nerve fibers|nerve fibers
5139073|NCT03121261|clonidine|clonidine
5139074|NCT03121248|Accelerated radiotherapy|accelerated radiotherapy
5139075|NCT03121248|Older women|older women
5139076|NCT03121248|Hypo-fractonation|hypo-fractonation
5139077|NCT03121235|aspergillosis|aspergillosis
5139078|NCT03121235|mycosis|mycosis
5139079|NCT03121235|neutropenia|neutropenia
5139080|NCT03121235|hematologic diseases|hematologic diseases
5139081|NCT03121235|AsperGenius PCR|aspergenius pcr
5139082|NCT03121235|Ambisome|ambisome
5139083|NCT03121235|Voriconazole|voriconazole
5139084|NCT03121196|Social deprivation|social deprivation
5139085|NCT03121196|Adverse perinatal outcomes|adverse perinatal outcomes
5139086|NCT03121183|Cardiology|cardiology
5139087|NCT03121183|Device Removal|device removal
5139088|NCT03121183|Pacemaker|pacemaker
5139089|NCT03121183|Defibrillators|defibrillators
5139090|NCT03121183|Catheterization|catheterization
5139091|NCT03121183|Laser Therapy|laser therapy
5139092|NCT03121183|Cost-Benefit Analysis|cost-benefit analysis
5139093|NCT03121170|primary dysmenorrhea|primary dysmenorrhea
5139094|NCT03121170|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5139095|NCT03121170|traditional Chinese medicine|traditional chinese medicine
5139098|NCT03121157|Medication adherence|medication adherence
5139099|NCT03121157|eHealth|ehealth
5139100|NCT03121118|Mild Cognitive Impairment|mild cognitive impairment
5139101|NCT03121118|Amyvid|amyvid
5139102|NCT03121118|Amyloid Imaging|amyloid imaging
5139103|NCT03121118|PET Brain Scan|pet brain scan
5139104|NCT03121118|Amyloid Plaque|amyloid plaque
5139105|NCT03121118|Ethics|ethics
5139106|NCT03121118|Results disclosure|results disclosure
5139107|NCT03121105|Idiopathic Inflammatory demyelinating disorders of the central nervous system|idiopathic inflammatory demyelinating disorders of the central nervous system
5139108|NCT03121105|Multiple Sclerosis|multiple sclerosis
5139109|NCT03121105|Neuromyelitis Optica|neuromyelitis optica
5139110|NCT03121105|MRI|mri
5139111|NCT03121105|pahtological|pahtological
5139112|NCT03121079|Interferon-alpha|interferon-alpha
5139113|NCT03121079|Relapse|relapse
5139114|NCT03121079|prevention|prevention
5139115|NCT03121079|hematopietic stem cell transplantation|hematopietic stem cell transplantation
5139116|NCT03121079|acute myeloid leukemia|acute myeloid leukemia
5139117|NCT03121066|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5139118|NCT03121066|Non invasive brain stimulation|non invasive brain stimulation
5139119|NCT03121066|Theta Burst Protocol|theta burst protocol
5139120|NCT03121066|Brain connectivity|brain connectivity
5139121|NCT03121066|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5139122|NCT03121066|Parietal cortex|parietal cortex
5139123|NCT03121053|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5139124|NCT03121053|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5139125|NCT03121040|Vespa amino acid mixture (VAAM®)|vespa amino acid mixture (vaam®)
5139126|NCT03121040|Young athletes|young athletes
5139127|NCT03121040|Nutrition|nutrition
5139128|NCT03121040|lactic acid accumulation|lactic acid accumulation
5139129|NCT03121040|Anaerobic metabolism|anaerobic metabolism
5139130|NCT03121040|ATP|atp
5139131|NCT03121040|Sports damage|sports damage
5139132|NCT03121027|Anemia|anemia
5139133|NCT03121027|Ever married women|ever married women
5139134|NCT03121027|Economic inequality|economic inequality
5139135|NCT03121027|Diabetes|diabetes
5139136|NCT03121027|Maternity|maternity
5139139|NCT03120988|lavage|lavage
5139140|NCT03120988|Platelet Poor Plasma (PPP)|platelet poor plasma (ppp)
5139141|NCT03120975|Anti-Infective Agents|anti-infective agents
5139142|NCT03120975|Decision Support Systems, Clinical|decision support systems, clinical
5139143|NCT03120975|Quality Improvement|quality improvement
5139144|NCT03120949|Rheumatoid Arthritis|rheumatoid arthritis
5139145|NCT03120949|moderate|moderate
5139146|NCT03120949|severe|severe
5139147|NCT03120949|subcutaneous|subcutaneous
5139148|NCT03120949|Olokizumab|olokizumab
5139149|NCT03120949|open-label|open-label
5139150|NCT03120936|Adherence|adherence
5139151|NCT03120936|Transgender|transgender
5139152|NCT03120936|PrEP|prep
5139153|NCT03120936|HIV Prevention|hiv prevention
5139154|NCT03120936|Truvada|truvada
5139155|NCT03120936|HIV Risk Reduction|hiv risk reduction
5139156|NCT03120923|subacromial injection|subacromial injection
5139157|NCT03120871|Beta cell failure|beta cell failure
5139158|NCT03120871|Puberty|puberty
5139159|NCT03120871|Microbiome|microbiome
5139160|NCT03120871|Insulin Sensitivity|insulin sensitivity
5139161|NCT03120858|motor imagery|motor imagery
5139162|NCT03120858|kinesthetic imagery|kinesthetic imagery
5139163|NCT03120858|reliability|reliability
5139164|NCT03120858|Turkish version|turkish version
5139165|NCT03120845|Pain,|pain,
5139166|NCT03120845|one-visit|one-visit
5139167|NCT03120845|two visits|two visits
5139168|NCT03120819|exercise|exercise
5139169|NCT03120819|fatigue|fatigue
5139170|NCT03120819|physical activity|physical activity
5139171|NCT03120754|ERAS|eras
5139172|NCT03120754|Peritoneal drainage|peritoneal drainage
5139173|NCT03120754|Primary Closure|primary closure
5139174|NCT03120741|Healthcare Quality|healthcare quality
5139175|NCT03120728|Emergency contraception|emergency contraception
5139176|NCT03120728|Contraceptive vaginal ring|contraceptive vaginal ring
5139177|NCT03120728|NuvaRing|nuvaring
5139178|NCT03120728|Contraception|contraception
5139179|NCT03120715|low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
5139180|NCT03120715|frozen embryo transfer (FET)|frozen embryo transfer (fet)
5139181|NCT03120715|pregnancy|pregnancy
5139182|NCT03120689|VITOM|vitom
5139183|NCT03120689|Adult learners|adult learners
5139184|NCT03120689|Medical students|medical students
5139185|NCT03120689|Residents|residents
5139186|NCT03120689|Vaginal surgery|vaginal surgery
5139187|NCT03120689|Medical education|medical education
5139188|NCT03120676|Relapsed|relapsed
5139189|NCT03120676|Refractory|refractory
5139190|NCT03120676|Atezolizumab|atezolizumab
5139191|NCT03120676|17-191|17-191
5139192|NCT03120663|antimicrobials|antimicrobials
5139193|NCT03120663|pharmacokinetics|pharmacokinetics
5139194|NCT03120663|augmented renal clearance|augmented renal clearance
5139195|NCT03120663|non critically ill|non critically ill
5139196|NCT03120637|Methylene Blue|methylene blue
5139197|NCT03120637|Septic Shock|septic shock
5139198|NCT03120637|Vasoplegia|vasoplegia
5139199|NCT03120637|Cirrhosis|cirrhosis
5139200|NCT03120611|Exercise|exercise
5139201|NCT03120611|Hemodialysis|hemodialysis
5139202|NCT03120611|Virtual Reality|virtual reality
5139203|NCT03120598|preparation strategies|preparation strategies
5139204|NCT03120598|implementation strategies|implementation strategies
5139205|NCT03120598|sustainment strategies|sustainment strategies
5139206|NCT03120585|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
5139207|NCT03120585|fluid restriction|fluid restriction
5139208|NCT03120572|Respiratory muscle strength|respiratory muscle strength
5139209|NCT03120572|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
5139210|NCT03120572|Functional capacity|functional capacity
5139211|NCT03120559|Gingivitis|gingivitis
5139212|NCT03120559|SMS|sms
5139213|NCT03120559|Dental floss|dental floss
5139214|NCT03120559|behavior change|behavior change
5139215|NCT03120559|HAPA|hapa
5024825|NCT03842956|Wound healing|wound healing
5139216|NCT03120546|cervical spine motion|cervical spine motion
5139217|NCT03120546|video laryngoscope|video laryngoscope
5139218|NCT03120546|rigid video stylet|rigid video stylet
5139219|NCT03120533|iontophoresis|iontophoresis
5139220|NCT03120533|treprostinil|treprostinil
5139221|NCT03120507|in-hospital cardiac arrest|in-hospital cardiac arrest
5139222|NCT03120507|IHCA|ihca
5139223|NCT03120507|quality of life|quality of life
5139224|NCT03120507|QoL|qol
5139225|NCT03120507|patient-reported outcomes|patient-reported outcomes
5139226|NCT03120494|HIV prevention, high risk MSM, sero-discordant couples, PrEP|hiv prevention, high risk msm, sero-discordant couples, prep
5139227|NCT03120468|alcohol, alcohol dependence, addiction, alcohol use disorder|alcohol, alcohol dependence, addiction, alcohol use disorder
5139228|NCT03120455|weight loss|weight loss
5139229|NCT03120455|Almond|almond
5139230|NCT03120455|Pistachio|pistachio
5139231|NCT03120455|hypoenergetic diet|hypoenergetic diet
5139232|NCT03120455|Nut|nut
5139233|NCT03120442|postoperative delirium|postoperative delirium
5139234|NCT03120442|total knee arthroplasty|total knee arthroplasty
5139235|NCT03120442|propofol|propofol
5139238|NCT03120442|inflammatory response|inflammatory response
5139239|NCT03120442|interleukins|interleukins
5139241|NCT03120429|lean fish|lean fish
5139243|NCT03120429|Diet|diet
5139244|NCT03120364|Herpes Zoster Vaccine|herpes zoster vaccine
5139245|NCT03120364|Prevention of Herpes Zoster|prevention of herpes zoster
5139246|NCT03120338|Child and Adolescent|child and adolescent
5139247|NCT03120338|Randomised Controlled Trial|randomised controlled trial
5139248|NCT03120338|Paediatrics|paediatrics
5139249|NCT03120338|DAWBA|dawba
5139250|NCT03120338|eHealth Services|ehealth services
5139251|NCT03120312|outcome|outcome
5139252|NCT03120286|OBESITY|obesity
5139253|NCT03120286|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5139254|NCT03120286|Polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5139255|NCT03120260|Caloric Restriction|caloric restriction
5139256|NCT03120260|weight loss|weight loss
5139257|NCT03120260|sleep|sleep
5139258|NCT03120221|Pregnancy|pregnancy
5139259|NCT03120221|Iodine deficiency|iodine deficiency
5139260|NCT03120221|Thyroid|thyroid
5139261|NCT03120208|Postpartum psychological disorders|postpartum psychological disorders
5139262|NCT03120208|immediate postpartum hemorrhage.|immediate postpartum hemorrhage.
5139263|NCT03120182|aspirin|aspirin
5139264|NCT03120182|bleeding risk|bleeding risk
5139265|NCT03120182|intracranial bleeding|intracranial bleeding
5139266|NCT03120182|burr-hole drainage|burr-hole drainage
5139267|NCT03120182|chronic subdural hematoma|chronic subdural hematoma
5139268|NCT03120182|anticoagulation|anticoagulation
5139269|NCT03120169|COPD|copd
5139270|NCT03120169|exercise|exercise
5139271|NCT03120169|training|training
5139272|NCT03120169|cycling|cycling
5139273|NCT03120169|treadmill|treadmill
5139274|NCT03120169|walking|walking
5139275|NCT03120169|pulmonary rehabilitation|pulmonary rehabilitation
5139276|NCT03120156|sensomotoric insoles|sensomotoric insoles
5139277|NCT03120156|postural control|postural control
5139278|NCT03120156|proprioceptive insoles|proprioceptive insoles
5139279|NCT03120156|insoles|insoles
5139280|NCT03120143|Small-sided ball games|small-sided ball games
5139281|NCT03120143|Aging|aging
5139282|NCT03120143|Muscle mass|muscle mass
5139283|NCT03120143|Health|health
5139284|NCT03120143|Training|training
5139285|NCT03120143|Protein intake|protein intake
5139286|NCT03120143|Physical function|physical function
5139287|NCT03120143|Physiological adaptations|physiological adaptations
5139288|NCT03120130|Phase I,|phase i,
5139289|NCT03120117|Midurethral Slings|midurethral slings
5139290|NCT03120078|Ultrasound|ultrasound
5139291|NCT03120065|adherence|adherence
5139292|NCT03120013|Transcranial direct current stimulation|transcranial direct current stimulation
5139293|NCT03120013|Transcranial magnetic stimulation|transcranial magnetic stimulation
5139294|NCT03120013|Spinocerebellar ataxia|spinocerebellar ataxia
5139295|NCT03120013|Cerebellar ataxia|cerebellar ataxia
5139296|NCT03120000|DLBCL|dlbcl
5139297|NCT03119987|Red cell Distribution Width|red cell distribution width
5139298|NCT03119987|Risk|risk
5139299|NCT03119987|Mortality|mortality
5139300|NCT03119987|Hemorrhage|hemorrhage
5139304|NCT03119961|Amyloid Amyloid Plaque|amyloid amyloid plaque
5139305|NCT03119961|Tau Protein|tau protein
5139306|NCT03119961|Sonication|sonication
5139307|NCT03119948|Muscle spasticity|muscle spasticity
5139308|NCT03119948|Botulinum toxin|botulinum toxin
5139309|NCT03119935|ambu bag, ventilation, tidal volume|ambu bag, ventilation, tidal volume
5139310|NCT03119922|major sickle cell disease (SCD)|major sickle cell disease (scd)
5139311|NCT03119922|children|children
5139312|NCT03119922|pneumococcal preventive measures|pneumococcal preventive measures
5139313|NCT03119909|fMRI|fmri
5024961|NCT03842111|programs|programs
5139314|NCT03119909|cingulate cortex|cingulate cortex
5139315|NCT03119909|adaptation|adaptation
5139316|NCT03119909|frontal cortex|frontal cortex
5139317|NCT03119896|chronic pain|chronic pain
5139318|NCT03119896|self-management|self-management
5139319|NCT03119896|pain management|pain management
5139320|NCT03119896|doctor patient communication|doctor patient communication
5139321|NCT03119896|primary care|primary care
5139322|NCT03119883|Myeloma|myeloma
5139323|NCT03119883|Metabolism|metabolism
5139324|NCT03119883|Glutamine|glutamine
5139325|NCT03119870|fMRI|fmri
5139327|NCT03119870|behavior|behavior
5139328|NCT03119870|cingulate cortex|cingulate cortex
5139329|NCT03119857|Non-metastatic Prostate Cancer|non-metastatic prostate cancer
5139330|NCT03119831|chlorhexidine|chlorhexidine
5139331|NCT03119831|alcohol|alcohol
5139332|NCT03119831|C31G|c31g
5139333|NCT03119831|Mouthrinses|mouthrinses
5139334|NCT03119831|Early postsurgical wound healing|early postsurgical wound healing
5139335|NCT03119818|ESRD|esrd
5139336|NCT03119818|hemodialysis|hemodialysis
5139337|NCT03119818|phosphate|phosphate
5139339|NCT03119818|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5139351|NCT03119792|Community Intervention|community intervention
5139353|NCT03119792|Cardiovascular Health|cardiovascular health
5139355|NCT03119792|Colombia|colombia
5139356|NCT03119779|pulpotomy|pulpotomy
5139357|NCT03119779|deep caries|deep caries
5139358|NCT03119779|permanent molars|permanent molars
5139359|NCT03119779|MTA|mta
5139366|NCT03119714|sputum eosinophils|sputum eosinophils
5139367|NCT03119701|Patients Surviving Open Surgery|patients surviving open surgery
5139368|NCT03119701|Ruptured Abdominal Aortic Aneurysm|ruptured abdominal aortic aneurysm
5139370|NCT03119675|Hyperopia|hyperopia
5139371|NCT03119675|Anisometropia|anisometropia
5139372|NCT03119675|Amblyopia Risk Factors|amblyopia risk factors
5139373|NCT03119675|Risk Factors|risk factors
5139374|NCT03119675|Smartphone Application (App)|smartphone application (app)
5139375|NCT03119675|Photoscreening|photoscreening
5139376|NCT03119675|Vision Screening|vision screening
5139377|NCT03119675|Mobile Vision Screening|mobile vision screening
5139378|NCT03119662|Acute kidney injury (AKI)|acute kidney injury (aki)
5139379|NCT03119662|Acute kidney injury network (AKIN)|acute kidney injury network (akin)
5139380|NCT03119662|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
5139381|NCT03119662|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
5139382|NCT03119662|Endovascular Aneurysm Repair (EVAR)|endovascular aneurysm repair (evar)
5139383|NCT03119662|Iodixanol|iodixanol
5139384|NCT03119662|Non-enhanced computed tomography (NECT)|non-enhanced computed tomography (nect)
5139385|NCT03119662|Serum creatinine (SCr)|serum creatinine (scr)
5139386|NCT03119623|Heart Failure|heart failure
5139387|NCT03119623|Endothelial function|endothelial function
5139388|NCT03119623|Brachial Artery Reactivity Test|brachial artery reactivity test
5139389|NCT03119623|Sacubitril/Valsartan|sacubitril/valsartan
5139390|NCT03119623|Enalapril|enalapril
5139391|NCT03119623|HFREF|hfref
5139392|NCT03119597|low mood, depression|low mood, depression
5139395|NCT03119571|Cardiac arrest|cardiac arrest
5139396|NCT03119571|Ventricular fibrillation|ventricular fibrillation
5139397|NCT03119571|coronary artery disease|coronary artery disease
5139398|NCT03119545|intervention|intervention
5139399|NCT03119545|support program|support program
5139400|NCT03119545|family centered|family centered
5139401|NCT03119545|parental death|parental death
5139402|NCT03119519|NSCLC|nsclc
5139403|NCT03119519|Oligometastases|oligometastases
5139404|NCT03119519|radiotherapy|radiotherapy
5139405|NCT03119493|Metabolic syndrome X|metabolic syndrome x
5139406|NCT03119493|Autonomic nervous system|autonomic nervous system
5139407|NCT03119493|Aerobic exercise|aerobic exercise
5139408|NCT03119493|Exercise|exercise
5139409|NCT03119493|Heart rate|heart rate
5139410|NCT03119480|Acute Kidney Injury|acute kidney injury
5139411|NCT03119480|Electronic alerts|electronic alerts
5139417|NCT03119402|transcranial direct current stimulation|transcranial direct current stimulation
5139419|NCT03119389|Non-sterile glove use|non-sterile glove use
5139420|NCT03119376|peer review|peer review
5139421|NCT03119376|online tool|online tool
5139422|NCT03119376|Randomized Controlled Trial|randomized controlled trial
5139432|NCT03119337|male circumcision, text-based follow-up, Zimbabwe,|male circumcision, text-based follow-up, zimbabwe,
5139433|NCT03119324|Biomodulation|biomodulation
5139435|NCT03119324|Temporomandibular Joint Disorders|temporomandibular joint disorders
5139436|NCT03119324|Pain management|pain management
5139437|NCT03119285|ovarian cancer|ovarian cancer
5139439|NCT03119285|BRCA2|brca2
5139440|NCT03119285|BROCA|broca
5139441|NCT03119246|beta testing|beta testing
5139442|NCT03119246|assessment battery|assessment battery
5139444|NCT03119207|ICU|icu
5139445|NCT03119168|screening|screening
5139446|NCT03119168|adenoma detection rate|adenoma detection rate
5139447|NCT03119168|simethicone|simethicone
5139448|NCT03119155|Congenital Heart Disease|congenital heart disease
5139449|NCT03119155|Echocardiography|echocardiography
5139450|NCT03119155|Diagnosis|diagnosis
5139451|NCT03119129|prevention|prevention
5139452|NCT03119129|health disparities|health disparities
5139453|NCT03119129|Native Hawaiians and other Pacific Islanders|native hawaiians and other pacific islanders
5139454|NCT03119116|Stroke Prevention in NVAF patients|stroke prevention in nvaf patients
5139455|NCT03119103|respiratory pattern|respiratory pattern
5139456|NCT03119103|sensor data|sensor data
5139457|NCT03119103|bed sheet|bed sheet
5139458|NCT03119103|pressure|pressure
5139459|NCT03119103|respiration rate|respiration rate
5139460|NCT03119090|biomarkers|biomarkers
5139461|NCT03119090|Fontan operation|fontan operation
5139462|NCT03119090|Single ventricle|single ventricle
5139463|NCT03119090|congenital heart disease|congenital heart disease
5139464|NCT03119077|PCOS|pcos
5139465|NCT03119051|mild cognitive impairment|mild cognitive impairment
5139466|NCT03119038|total hip|total hip
5139476|NCT03119012|Dual antiplatelet therapy|dual antiplatelet therapy
5139477|NCT03119012|P2Y12 receptor inhibitor|p2y12 receptor inhibitor
5139478|NCT03119012|Coronary artery disease|coronary artery disease
5139480|NCT03118986|vomiting|vomiting
5139481|NCT03118986|children|children
5139482|NCT03118986|adolescents|adolescents
5139483|NCT03118986|bone marrow transplant|bone marrow transplant
5139484|NCT03118986|supportive care|supportive care
5139485|NCT03118934|contact lenses|contact lenses
5139486|NCT03118934|presbyopia|presbyopia
5139487|NCT03118934|multifocal|multifocal
5139488|NCT03118908|Succinate|succinate
5139489|NCT03118908|B complex vitamins|b complex vitamins
5139490|NCT03118908|menopause|menopause
5139491|NCT03118882|Breast cancer screening|breast cancer screening
5139492|NCT03118882|Colorectal Cancer screening|colorectal cancer screening
5139493|NCT03118882|Primary prevention|primary prevention
5139494|NCT03118882|Lifestyles|lifestyles
5139495|NCT03118882|Teachable moment|teachable moment
5139496|NCT03118869|Asthma|asthma
5139497|NCT03118869|B2 adrenergic receptors|b2 adrenergic receptors
5139498|NCT03118869|Polymorphism|polymorphism
5139499|NCT03118804|Weaning|weaning
5139500|NCT03118804|Mechanical ventilation|mechanical ventilation
5139501|NCT03118804|Electrical impedance tomography|electrical impedance tomography
5139502|NCT03118804|Tidal distribution|tidal distribution
5139503|NCT03118778|Stress Ulcer Prevention|stress ulcer prevention
5139504|NCT03118726|LARC|larc
5139505|NCT03118726|New Mexico|new mexico
5139506|NCT03118726|Contraception|contraception
5139507|NCT03118713|Metformin|metformin
5139508|NCT03118713|Ipragliflozin|ipragliflozin
5139509|NCT03118713|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5139510|NCT03118713|ASP1941|asp1941
5139511|NCT03118713|Glimepiride|glimepiride
5139512|NCT03118687|Immune system|immune system
5139513|NCT03118674|Interventional, Open-label, PCT, Hepatitis C|interventional, open-label, pct, hepatitis c
5139514|NCT03118648|upper limb|upper limb
5139515|NCT03118648|functional recovery|functional recovery
5148920|NCT03062254|PSMA|psma
5139520|NCT03118635|Sedentary behavior|sedentary behavior
5139521|NCT03118635|Low-income|low-income
5139522|NCT03118609|Caregivers|caregivers
5139523|NCT03118609|Chronic Pain|chronic pain
5139524|NCT03118596|intubation|intubation
5139525|NCT03118596|tracheal|tracheal
5139526|NCT03118596|airway device|airway device
5139527|NCT03118596|supra-glottic airway device|supra-glottic airway device
5139528|NCT03118596|fibreoptic scope|fibreoptic scope
5139529|NCT03118570|Osteogenesis Imperfecta|osteogenesis imperfecta
5139530|NCT03118570|Brittle Bone Disease|brittle bone disease
5139531|NCT03118557|pelvic floor|pelvic floor
5139532|NCT03118557|strengthening|strengthening
5139533|NCT03118557|Stress|stress
5139534|NCT03118557|urinary|urinary
5139535|NCT03118557|incontinence|incontinence
5139536|NCT03118544|Chronic Total Occlusion|chronic total occlusion
5139537|NCT03118544|Coronary Artery Disease|coronary artery disease
5139538|NCT03118544|Percutaneous Coronary Intervention|percutaneous coronary intervention
5139539|NCT03118544|CTO|cto
5139540|NCT03118544|PCI|pci
5139541|NCT03118531|Long Lesion|long lesion
5139542|NCT03118531|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
5139543|NCT03118531|Major Adverse Cardiac Events (MACE)|major adverse cardiac events (mace)
5139544|NCT03118531|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5139545|NCT03118531|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5139546|NCT03118531|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5139547|NCT03118531|Target Vessel Failure (TVF)|target vessel failure (tvf)
5139548|NCT03118531|Target Lesion Failure (TLF)|target lesion failure (tlf)
5139549|NCT03118531|Stent Thrombosis (ST)|stent thrombosis (st)
5139550|NCT03118479|IHH|ihh
5139551|NCT03118479|KS|ks
5139552|NCT03118479|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
5139553|NCT03118479|GnRH deficiency|gnrh deficiency
5139554|NCT03118466|AML|aml
5139555|NCT03118453|Musculoskeletal pain/*therapy|musculoskeletal pain/*therapy
5135584|NCT03145896|IBD|ibd
5139556|NCT03118453|Behavioral medicine|behavioral medicine
5139557|NCT03118453|Physical therapy|physical therapy
5139558|NCT03118453|Cost-benefit analyses|cost-benefit analyses
5139559|NCT03118453|Treatment outcome|treatment outcome
5139560|NCT03118453|Adults|adults
5139561|NCT03118440|Fluoroscopy|fluoroscopy
5139562|NCT03118440|Pacemaker|pacemaker
5139563|NCT03118440|Three dimensional|three dimensional
5139564|NCT03118440|Radiation|radiation
5139565|NCT03118440|Imaging|imaging
5139566|NCT03118427|Fluoroscopy|fluoroscopy
5139567|NCT03118427|Pacemaker|pacemaker
5139568|NCT03118427|Three dimensional|three dimensional
5139569|NCT03118427|Radiation|radiation
5139570|NCT03118427|Imaging|imaging
5139571|NCT03118414|Balance|balance
5139572|NCT03118414|Cognition|cognition
5139573|NCT03118414|Exercise|exercise
5139574|NCT03118362|Burns|burns
5139575|NCT03118362|Critically ill|critically ill
5139576|NCT03118362|Acid-Base status|acid-base status
5139577|NCT03118349|CA19-9 Positive Malignancies|ca19-9 positive malignancies
5139578|NCT03118323|willingness topay|willingness topay
5139580|NCT03118323|health economic|health economic
5139581|NCT03118323|preference-based measures|preference-based measures
5139582|NCT03118310|Reduction of liver fat|reduction of liver fat
5139583|NCT03118297|Etonogestrel Implant|etonogestrel implant
5139584|NCT03118284|Foley catheter|foley catheter
5139585|NCT03118271|lumbar disc herniation|lumbar disc herniation
5139587|NCT03118271|spinal manipulation|spinal manipulation
5139588|NCT03118271|lumbar surgery|lumbar surgery
5139589|NCT03118258|Vaginal HPV self-sampling|vaginal hpv self-sampling
5139590|NCT03118258|Pap test smear|pap test smear
5139591|NCT03118258|cervical cancer screening|cervical cancer screening
5139592|NCT03118258|deprivation|deprivation
5139593|NCT03118258|sexual and reproductive health|sexual and reproductive health
5139594|NCT03118258|Precariousness|precariousness
5139595|NCT03118232|Nursing Homes|nursing homes
5139596|NCT03118232|Health Facilities|health facilities
5139597|NCT03118232|Infections|infections
5139598|NCT03118232|Readmissions|readmissions
5139599|NCT03118232|Multi-Drug resistance|multi-drug resistance
5139600|NCT03118232|Antibiotic Use|antibiotic use
5139601|NCT03118219|assisted reproductive technology|assisted reproductive technology
5139602|NCT03118219|embryo transfer|embryo transfer
5139603|NCT03118219|online intervention|online intervention
5139604|NCT03118219|rct|rct
5139605|NCT03118206|Lumbar spinal stenosis|lumbar spinal stenosis
5139606|NCT03118206|spinal manipulation|spinal manipulation
5139607|NCT03118206|physical therapy|physical therapy
5139608|NCT03118206|surgery|surgery
5139609|NCT03118193|depression|depression
5139610|NCT03118193|antidepressant|antidepressant
5139611|NCT03118193|resistance|resistance
5139612|NCT03118167|Acrylamide|acrylamide
5139613|NCT03118167|Tea polyphenols|tea polyphenols
5139618|NCT03118141|preimplantation genetic screening|preimplantation genetic screening
5139619|NCT03118141|single embryo transfer|single embryo transfer
5139620|NCT03118141|frozen embryo transfer|frozen embryo transfer
5139621|NCT03118141|cumulative live birth rate|cumulative live birth rate
5139622|NCT03118128|Acute Lymphoblastic Leukemia (ALL), ABCB1, Metformin|acute lymphoblastic leukemia (all), abcb1, metformin
5139623|NCT03118115|bioimpedance|bioimpedance
5139624|NCT03118115|thrombosis|thrombosis
5139625|NCT03118115|free flap|free flap
5139626|NCT03118115|microsurgerie|microsurgerie
5139627|NCT03118115|breast reconstruction|breast reconstruction
5139628|NCT03118089|Oral nutritional supplements|oral nutritional supplements
5139629|NCT03118050|exercise|exercise
5139630|NCT03118050|bed rest|bed rest
5139631|NCT03118050|muscle|muscle
5139632|NCT03118050|nutrition|nutrition
5139633|NCT03118050|amino acids|amino acids
5139634|NCT03118037|Radiofrequency Ablation|radiofrequency ablation
5139637|NCT03118024|catecholamine restriction|catecholamine restriction
5139638|NCT03118011|Tobacco use, withdrawal symptoms|tobacco use, withdrawal symptoms
5139639|NCT03117985|HIV reservoirs|hiv reservoirs
5139640|NCT03117985|HIV persistence|hiv persistence
5139641|NCT03117985|Viral rebound|viral rebound
5139642|NCT03117972|Metastatic colorectal cancer|metastatic colorectal cancer
5139643|NCT03117972|Biomarker|biomarker
5139644|NCT03117972|Chemotherapy intensification|chemotherapy intensification
5139645|NCT03117972|Syndecan1|syndecan1
5139647|NCT03117972|CD138|cd138
5139648|NCT03117946|immunomonitoring|immunomonitoring
5139649|NCT03117946|immune checkpoint|immune checkpoint
5139650|NCT03117946|chemoradiation|chemoradiation
5139651|NCT03117946|T cells|t cells
5139652|NCT03117933|BRCA1/2 mutation|brca1/2 mutation
5139653|NCT03117933|Platinum resistance|platinum resistance
5139654|NCT03117920|Refractory pancreatic cancer|refractory pancreatic cancer
5139655|NCT03117920|Minnelide|minnelide
5139656|NCT03117920|Minnelide002|minnelide002
5139657|NCT03117920|2017-000126-36|2017-000126-36
5139658|NCT03117881|Multiple Sclerosis|multiple sclerosis
5139659|NCT03117881|Yoga|yoga
5139660|NCT03117881|Pilates|pilates
5139661|NCT03117881|Telerehabilitation|telerehabilitation
5139662|NCT03117881|Physical activity|physical activity
5139663|NCT03117842|Female entertainment workers|female entertainment workers
5139664|NCT03117842|mHealth|mhealth
5139665|NCT03117842|HIV testing|hiv testing
5139666|NCT03117842|Cambodia|cambodia
5139667|NCT03117816|deep molecular remission of MR4 or better|deep molecular remission of mr4 or better
5139668|NCT03117803|Aneurysm, Intracranial|aneurysm, intracranial
5139669|NCT03117803|Registries|registries
5139670|NCT03117803|Multicenter Studies|multicenter studies
5139671|NCT03117803|People's Republic of China|people's republic of china
5139672|NCT03117790|elderly|elderly
5139673|NCT03117790|surgery|surgery
5139674|NCT03117790|analgesia|analgesia
5139675|NCT03117790|dexmedetomidine|dexmedetomidine
5139676|NCT03117790|sleep quality|sleep quality
5139677|NCT03117751|Leukemia|leukemia
5139678|NCT03117751|Lymphoma|lymphoma
5139679|NCT03117751|Pediatric|pediatric
5139680|NCT03117751|B-Cell|b-cell
5139681|NCT03117751|T-Cell|t-cell
5139682|NCT03117725|oxidative stress|oxidative stress
5139683|NCT03117725|antioxidants|antioxidants
5139684|NCT03117725|diminished ovarian reserve|diminished ovarian reserve
5139685|NCT03117712|cerebral blood supply|cerebral blood supply
5139686|NCT03117712|cardiopulmonary bypass|cardiopulmonary bypass
5139687|NCT03117712|open-heart cardiac surgery|open-heart cardiac surgery
5139688|NCT03117699|Hemiplegia|hemiplegia
5139689|NCT03117699|transport device|transport device
5139690|NCT03117673|right ventricular systolic pressure (RVSP)|right ventricular systolic pressure (rvsp)
5139691|NCT03117673|Transesophageal echocardiography|transesophageal echocardiography
5139697|NCT03117608|aMAT|amat
5139698|NCT03117608|PRP|prp
5139699|NCT03117595|Single Shot Spinal|single shot spinal
5139700|NCT03117595|Intrathecal narcotics|intrathecal narcotics
5139701|NCT03117595|Morphine|morphine
5139702|NCT03117595|Fentanyl|fentanyl
5139703|NCT03117595|Labour Analgesia|labour analgesia
5139704|NCT03117582|C. diff|c. diff
5139705|NCT03117582|CDI|cdi
5139706|NCT03117582|Clostridium Difficile Infection|clostridium difficile infection
5139707|NCT03117582|Diarrhea|diarrhea
5139708|NCT03117582|Fecal microbiota transplantation|fecal microbiota transplantation
5139709|NCT03117582|FMT|fmt
5139710|NCT03117543|Screening|screening
5139711|NCT03117530|minocycline|minocycline
5139712|NCT03117530|brain inflammation|brain inflammation
5139713|NCT03117530|microglia|microglia
5139714|NCT03117530|cognition|cognition
5139715|NCT03117517|PCOS|pcos
5139716|NCT03117504|Stress urinary incontinence|stress urinary incontinence
5139719|NCT03117491|Inferior alveolar nerve block|inferior alveolar nerve block
5139720|NCT03117491|local anesthesia|local anesthesia
5139721|NCT03117491|molar|molar
5139722|NCT03117491|pulpitis|pulpitis
5139723|NCT03117452|schizophrenia|schizophrenia
5139724|NCT03117452|visual processing|visual processing
5139725|NCT03117452|cognitive training|cognitive training
5139726|NCT03117452|visual training|visual training
5139727|NCT03117426|Symfony Extended Range of Vision IOL|symfony extended range of vision iol
5139728|NCT03117426|AT LISA tri 839MP IOL|at lisa tri 839mp iol
5139729|NCT03117426|Trifocal IOL|trifocal iol
5139730|NCT03117426|Extended depth of focus IOLs|extended depth of focus iols
5139731|NCT03117413|Cochlear implantation|cochlear implantation
5139732|NCT03117413|Deafness|deafness
5139733|NCT03117413|Auditory cortex|auditory cortex
5139734|NCT03117413|Auditory plasticity|auditory plasticity
5139735|NCT03117413|Tinnitus|tinnitus
5139736|NCT03117361|multiple myeloma|multiple myeloma
5139737|NCT03117361|plitidepsin|plitidepsin
5139738|NCT03117361|Aplidin|aplidin
5139739|NCT03117348|Enteral Nutrition|enteral nutrition
5139740|NCT03117348|Digestive System Neoplasms|digestive system neoplasms
5139741|NCT03117348|Randomized Controlled Trial|randomized controlled trial
5139742|NCT03117348|Clinical Outcomes|clinical outcomes
5139743|NCT03117335|Non-small Cell Lung Cancer|non-small cell lung cancer
5139744|NCT03117335|Sulijia|sulijia
5139745|NCT03117335|Recombinant endostatin|recombinant endostatin
5139746|NCT03117335|Vinorelbine|vinorelbine
5139747|NCT03117335|Cisplatin|cisplatin
5139748|NCT03117322|cerebral palsy|cerebral palsy
5139749|NCT03117322|children|children
5139750|NCT03117322|chronic constipation|chronic constipation
5139751|NCT03117322|synbiotic|synbiotic
5139752|NCT03117322|prebiotics|prebiotics
5139753|NCT03117322|probiotics|probiotics
5139754|NCT03117322|agave inulin|agave inulin
5139755|NCT03117322|microbiota|microbiota
5139756|NCT03117309|Nivolumab|nivolumab
5139757|NCT03117309|Ipilimumab|ipilimumab
5139758|NCT03117309|OPDIVO|opdivo
5139759|NCT03117309|IgG1 kappa immunoglobulin|igg1 kappa immunoglobulin
5139760|NCT03117296|physical therapy|physical therapy
5139761|NCT03117296|occupational therapy|occupational therapy
5139762|NCT03117296|tAVR|tavr
5139763|NCT03117283|Laparoscopic surgery|laparoscopic surgery
5139764|NCT03117283|Radical total gastrectomy|radical total gastrectomy
5139765|NCT03117283|Bursectomy|bursectomy
5139766|NCT03117283|Advanced posterior gastric wall cancer|advanced posterior gastric wall cancer
5139767|NCT03117257|Lobaplatin|lobaplatin
5139768|NCT03117257|head and neck cancer|head and neck cancer
5139769|NCT03117257|chronic-chemotherapy|chronic-chemotherapy
5139770|NCT03117231|osteoarthritis|osteoarthritis
5139771|NCT03117231|elderly|elderly
5139772|NCT03117231|musculoskeletal pain|musculoskeletal pain
5139774|NCT03117192|zinc supplementation|zinc supplementation
5139775|NCT03117192|immunity|immunity
5139776|NCT03117192|thalassemia|thalassemia
5139777|NCT03117166|lidocaine implantation ICD|lidocaine implantation icd
5139778|NCT03117140|Brachial Plexus Block|brachial plexus block
5139779|NCT03117140|Clonidine|clonidine
5139780|NCT03117140|Dexamethasone|dexamethasone
5139781|NCT03117140|Buprenorphine|buprenorphine
5139782|NCT03117114|colonoscopy|colonoscopy
5139783|NCT03117114|polyp|polyp
5139784|NCT03117114|resection|resection
5139785|NCT03117101|Tolerability Pharmacokinetics|tolerability pharmacokinetics
5139786|NCT03117088|Standardized handover|standardized handover
5139787|NCT03117088|Online-based|online-based
5139788|NCT03117088|SOFA-Score|sofa-score
5139790|NCT03117088|ISBAR3|isbar3
5139791|NCT03117075|cancer pain, wearable device|cancer pain, wearable device
5139792|NCT03117036|lymphoma|lymphoma
5139793|NCT03117036|cohort|cohort
5139794|NCT03117036|serum|serum
5139795|NCT03117036|cell-free DNA|cell-free dna
5139796|NCT03117023|dexmedetomidine|dexmedetomidine
5139797|NCT03117023|sleep deprivation|sleep deprivation
5139798|NCT03117023|gastric cancer|gastric cancer
5006638|NCT03954977|Neonate|neonate
5139799|NCT03117023|middle-aged and elderly patient|middle-aged and elderly patient
5139800|NCT03117010|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5139801|NCT03116997|neuromuscular blockade|neuromuscular blockade
5139802|NCT03116997|sugammadex|sugammadex
5139803|NCT03116997|SUG|sug
5139804|NCT03116997|neostigmine|neostigmine
5139805|NCT03116997|NEO/GLYCO|neo/glyco
5139806|NCT03116997|17-207|17-207
5139807|NCT03116984|Hepatocellular Carcinoma|hepatocellular carcinoma
5139808|NCT03116984|external- beam radiotherapy (EBRT)|external- beam radiotherapy (ebrt)
5139809|NCT03116984|transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5139810|NCT03116971|M3814, Small Cell Lung Cancer (SCLC), Deoxyribonucleic acid-dependent protein kinase inhibitor, Chemotherapy|m3814, small cell lung cancer (sclc), deoxyribonucleic acid-dependent protein kinase inhibitor, chemotherapy
5139811|NCT03116958|CPAP compliance|cpap compliance
5139812|NCT03116958|Telemedicine integrated platform|telemedicine integrated platform
5139814|NCT03116958|Cost-effectiveness|cost-effectiveness
5139815|NCT03116945|PET/CT|pet/ct
5139816|NCT03116945|68Gallium Citrate|68gallium citrate
5139817|NCT03116945|Hepatocellular carcinoma|hepatocellular carcinoma
5139818|NCT03116932|HIV prevention, high risk MSM, PrEP|hiv prevention, high risk msm, prep
5139819|NCT03116919|nutrition|nutrition
5139820|NCT03116919|Potatoes|potatoes
5139821|NCT03116919|endothelial function|endothelial function
5139822|NCT03116919|feeding trial|feeding trial
5139823|NCT03116880|Aorta, Abdominal/surgery|aorta, abdominal/surgery
5139824|NCT03116880|Endovascular Procedures|endovascular procedures
5139825|NCT03116854|Acute Coronary Syndrome|acute coronary syndrome
5139826|NCT03116854|Beta Blockers|beta blockers
5139827|NCT03116854|Prognosis|prognosis
5139828|NCT03116828|epilepsy|epilepsy
5139829|NCT03116828|seizures|seizures
5139830|NCT03116828|partial on-set seizures|partial on-set seizures
5139831|NCT03116815|blood pressure|blood pressure
5139832|NCT03116815|monitoring|monitoring
5139833|NCT03116815|hypertension|hypertension
5139834|NCT03116815|patient reported outcomes|patient reported outcomes
5139838|NCT03116750|mechanical thrombectomy|mechanical thrombectomy
5139839|NCT03116737|AOM|aom
5139840|NCT03116724|catheterization, central venous|catheterization, central venous
5139841|NCT03116724|jugular veins|jugular veins
5139842|NCT03116724|echocardiography, transesophageal|echocardiography, transesophageal
5139843|NCT03116672|pain|pain
5139844|NCT03116672|Diclofenac|diclofenac
5139845|NCT03116672|NSAID|nsaid
5139846|NCT03116672|Ketorolac|ketorolac
5139847|NCT03116646|mastication|mastication
5139848|NCT03116646|cerebral palsy|cerebral palsy
5139849|NCT03116646|family|family
5139850|NCT03116633|lung cancer|lung cancer
5139851|NCT03116633|biopsy|biopsy
5139852|NCT03116620|mastication|mastication
5139853|NCT03116620|children with neuromuscular disorders|children with neuromuscular disorders
5139854|NCT03116607|User satisfaction|user satisfaction
5139855|NCT03116607|Readmission|readmission
5139856|NCT03116607|Emergency department|emergency department
5139857|NCT03116607|Pharmaceutical intervention|pharmaceutical intervention
5139858|NCT03116594|Herpes Zoster Vaccine|herpes zoster vaccine
5139859|NCT03116594|Prevention of Herpes Zoster|prevention of herpes zoster
5139860|NCT03116581|Perceptual Decision|perceptual decision
5139861|NCT03116581|Social Cognition|social cognition
5139862|NCT03116581|Motivation|motivation
5139863|NCT03116568|IBD|ibd
5139864|NCT03116568|Meconium|meconium
5139865|NCT03116568|Pregnancy|pregnancy
5139866|NCT03116568|Microbiota|microbiota
5139867|NCT03116568|Newborn|newborn
5139868|NCT03116555|Apatinib|apatinib
5139869|NCT03116555|Irinotecan|irinotecan
5139870|NCT03116555|Second-line|second-line
5139871|NCT03116555|Metastatic Gastric Adenocarcinoma|metastatic gastric adenocarcinoma
5139872|NCT03116529|Neoadjuvant|neoadjuvant
5139873|NCT03116529|Soft Tissue Sarcoma|soft tissue sarcoma
5139874|NCT03116529|Immunotherapy|immunotherapy
5139875|NCT03116529|Checkpoint Inhibitor|checkpoint inhibitor
5139876|NCT03116529|PD-1 (Programmed Cell Death Protein 1)|pd-1 (programmed cell death protein 1)
5139877|NCT03116529|PD-L1 (Programmed Death Ligand 1)|pd-l1 (programmed death ligand 1)
5139878|NCT03116529|CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4)|ctla-4 (cytotoxic t-lymphocyte-associated protein 4)
5139879|NCT03116529|Radiotherapy|radiotherapy
5139881|NCT03116529|Tremelimumab|tremelimumab
5139882|NCT03116529|Surgery|surgery
5139883|NCT03116529|Radiation|radiation
5139884|NCT03116529|Combined|combined
5139885|NCT03116529|Preoperative|preoperative
5139886|NCT03116503|Suicide|suicide
5139887|NCT03116490|morbidity|morbidity
5139888|NCT03116490|mortality|mortality
5139889|NCT03116490|hip fracture|hip fracture
5139890|NCT03116490|anesthesia type|anesthesia type
5139891|NCT03116490|POSSUM|possum
5139892|NCT03116451|foot health|foot health
5139893|NCT03116451|nurses|nurses
5139894|NCT03116451|work well-being|work well-being
5139895|NCT03116438|Coronary Artery Disease|coronary artery disease
5139896|NCT03116438|Nuclear Stress Test|nuclear stress test
5139897|NCT03116438|CT Angiography|ct angiography
5139898|NCT03116438|Angiography|angiography
5962051|NCT04283331|refractive surgery; PRK; LASIK|refractive surgery; prk; lasik
5962052|NCT04283318|starvation|starvation
5139899|NCT03116425|Precision Medicine|precision medicine
5139900|NCT03116425|Functional Neuroimaging|functional neuroimaging
5139901|NCT03116425|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5139902|NCT03116425|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5139903|NCT03116425|Monocentric|monocentric
5139904|NCT03116425|Comparative balanced, randomized|comparative balanced, randomized
5139905|NCT03116425|double-blind cross-over 3 Arms Study|double-blind cross-over 3 arms study
5139906|NCT03116412|Malignant melanoma|malignant melanoma
5139907|NCT03116412|Follow up|follow up
5139908|NCT03116412|Radiology|radiology
5139909|NCT03116412|Survival|survival
5139913|NCT03116373|Posture|posture
5139914|NCT03116373|Physiology|physiology
5139915|NCT03116373|Head|head
5139916|NCT03116373|Intubation|intubation
5139917|NCT03116373|Intratracheal methods|intratracheal methods
5139918|NCT03116334|Obesity|obesity
5139920|NCT03116334|executive functioning|executive functioning
5139921|NCT03116334|general cognitive ability|general cognitive ability
5139922|NCT03116334|twin study|twin study
5139923|NCT03116334|heritability|heritability
5139924|NCT03116334|cognition|cognition
5139925|NCT03116334|GCTA|gcta
5139926|NCT03116243|migrant and seasonal head start|migrant and seasonal head start
5139927|NCT03116243|early childhood education|early childhood education
5139928|NCT03116243|head start|head start
5139929|NCT03116230|Knee pathology|knee pathology
5139930|NCT03116217|renal function|renal function
5139931|NCT03116217|post natal|post natal
5139932|NCT03116217|peptidome|peptidome
5139933|NCT03116204|Dependency|dependency
5139934|NCT03116204|FRC department|frc department
5139935|NCT03116204|scale validation|scale validation
5139936|NCT03116204|validity|validity
5139937|NCT03116204|reliability|reliability
5139938|NCT03116178|Fluid therapy|fluid therapy
5139939|NCT03116178|oximetry|oximetry
5139940|NCT03116178|thromboelastography|thromboelastography
5139941|NCT03116178|intraoperative/method|intraoperative/method
5139942|NCT03116178|monitoring|monitoring
5139943|NCT03116139|Computed tomography scan|computed tomography scan
5139944|NCT03116139|Ventilation-perfusion lung scan|ventilation-perfusion lung scan
5139945|NCT03116139|Acute kidney injury|acute kidney injury
5139946|NCT03116139|Pulmonary embolism|pulmonary embolism
5139947|NCT03116139|Contrast-induced nephropathy|contrast-induced nephropathy
5139948|NCT03116113|XLRP|xlrp
5139949|NCT03116113|Ophthalmology|ophthalmology
5139950|NCT03116113|Gene Therapy|gene therapy
5139951|NCT03116113|Retinitis Pigmentosa GTPase Regulator (RPGR)|retinitis pigmentosa gtpase regulator (rpgr)
5139952|NCT03116113|AAV8|aav8
5139953|NCT03116087|Postmenopausal women|postmenopausal women
5139954|NCT03116061|Multimorbidity|multimorbidity
5139955|NCT03116061|Family Medicine|family medicine
5139956|NCT03116061|decompensation|decompensation
5139957|NCT03116061|predictive value|predictive value
5139958|NCT03116022|menopause|menopause
5139959|NCT03116022|sexual dysfunction|sexual dysfunction
5139960|NCT03116022|coital pain|coital pain
5139961|NCT03116022|vagina|vagina
5139962|NCT03116009|Obesity|obesity
5139963|NCT03116009|Pregnancy|pregnancy
5139964|NCT03116009|Diabetes Mellitus|diabetes mellitus
5139965|NCT03116009|Perinatal Outcomes|perinatal outcomes
5139966|NCT03115957|Parenteral Nutrition|parenteral nutrition
5139967|NCT03115957|Digestive System Neoplasms|digestive system neoplasms
5139968|NCT03115957|Randomized Controlled Trials|randomized controlled trials
5139969|NCT03115957|Clinical Outcomes|clinical outcomes
5139970|NCT03115957|Postoperative Period|postoperative period
5139971|NCT03115905|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
5139972|NCT03115905|Emergency Medical Services|emergency medical services
5139973|NCT03115905|Registry Study|registry study
5139974|NCT03115905|China|china
5139975|NCT03115866|Healthy Diet|healthy diet
5139976|NCT03115866|Fruits and Vegetables|fruits and vegetables
5139977|NCT03115866|Metabolome|metabolome
5139978|NCT03115866|Microbiome|microbiome
5139979|NCT03115866|Young Adults|young adults
5139980|NCT03115788|Thermal|thermal
5139981|NCT03115788|ipad|ipad
5139982|NCT03115788|game|game
5139983|NCT03115762|ASKB1202|askb1202
5139984|NCT03115749|Crohn's disease|crohn's disease
5139985|NCT03115749|ulcerative colitis|ulcerative colitis
5139986|NCT03115749|mesenchymal stem cells|mesenchymal stem cells
5139987|NCT03115749|intestinal inflammation|intestinal inflammation
5139989|NCT03115736|Hepatitis B|hepatitis b
5139990|NCT03115736|Renal dysfunction|renal dysfunction
5139991|NCT03115736|tenofovir alafenamide|tenofovir alafenamide
5139992|NCT03115723|Hospitalization|hospitalization
5139993|NCT03115723|Health Care Economics and Organizations|health care economics and organizations
5139994|NCT03115710|Keratoconus|keratoconus
5139995|NCT03115710|Prevalence|prevalence
5139996|NCT03115671|Phosphatidylserine|phosphatidylserine
5139997|NCT03115671|Omega-3|omega-3
5139998|NCT03115606|videolaryngoscope|videolaryngoscope
5139999|NCT03115606|Fastrach LMA|fastrach lma
5140000|NCT03115606|cervical motion|cervical motion
5140001|NCT03115593|hysteroscopy|hysteroscopy
5140002|NCT03115593|pipette|pipette
5011964|NCT03921554|AGS|ags
5140003|NCT03115593|biopsy|biopsy
5140004|NCT03115593|endometrial cancer|endometrial cancer
5140005|NCT03115541|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5140006|NCT03115541|deep vein thrombosis|deep vein thrombosis
5140007|NCT03115541|pulmonary embolus|pulmonary embolus
5140008|NCT03115541|esophageal resection|esophageal resection
5140009|NCT03115541|incidence|incidence
5140010|NCT03115528|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5140011|NCT03115528|Medical oncologists|medical oncologists
5140012|NCT03115528|Palliative care physicians|palliative care physicians
5140013|NCT03115528|Questionnaire|questionnaire
5140014|NCT03115528|Survey|survey
5140015|NCT03115515|Thyroid Stimulating Hormone|thyroid stimulating hormone
5140016|NCT03115489|seizure|seizure
5140017|NCT03115489|glutamate activation|glutamate activation
5140018|NCT03115489|N-Methyl D-Aspartate|n-methyl d-aspartate
5140019|NCT03115489|gamma-aminobutyric acid receptor|gamma-aminobutyric acid receptor
5140021|NCT03115463|Neonatal Resuscitation|neonatal resuscitation
5140022|NCT03115463|Prematurity|prematurity
5140023|NCT03115463|Oxygen|oxygen
5140024|NCT03115450|External ventricular drain (EVD)|external ventricular drain (evd)
5140025|NCT03115450|Placement of Bolt|placement of bolt
5140026|NCT03115437|Body mass|body mass
5140027|NCT03115437|Running-related injury|running-related injury
5140028|NCT03115437|Sports injury prevention|sports injury prevention
5140029|NCT03115437|Impact forces|impact forces
5140030|NCT03115437|Epidemiology|epidemiology
5140031|NCT03115437|Running biomechanics|running biomechanics
5140032|NCT03115437|Sports footwear|sports footwear
5140033|NCT03115437|Shoe cushioning|shoe cushioning
5140034|NCT03115424|Weight Loss|weight loss
5140035|NCT03115424|Bariatric Surgery|bariatric surgery
5140036|NCT03115398|Fitness Tracker|fitness tracker
5140037|NCT03115398|Activity Monitoring|activity monitoring
5140038|NCT03115398|Chemotherapy|chemotherapy
5140039|NCT03115398|Radiation Therapy|radiation therapy
5140040|NCT03115398|Chemoradiotherapy|chemoradiotherapy
5140041|NCT03115359|Chronic Low Back Pain|chronic low back pain
5140042|NCT03115359|Opioid Therapy|opioid therapy
5140043|NCT03115359|Chronic Pain|chronic pain
5140044|NCT03115359|Mindfulness Meditation|mindfulness meditation
5025761|NCT03837522|Kidney transplantation|kidney transplantation
5140045|NCT03115359|Cognitive Behavioral Therapy|cognitive behavioral therapy
5140046|NCT03115359|Opioid-treated Chronic Low Back Pain|opioid-treated chronic low back pain
5140047|NCT03115359|CLBP|clbp
5140048|NCT03115307|Insemination|insemination
5140049|NCT03115307|Luteal phase support|luteal phase support
5140050|NCT03115307|Gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
5140051|NCT03115307|Triptorelin|triptorelin
5140052|NCT03115268|social support|social support
5140053|NCT03115255|retinopathy of prematurity|retinopathy of prematurity
5140054|NCT03115255|ranibizumab|ranibizumab
5140055|NCT03115255|vascular endothelial growth factor|vascular endothelial growth factor
5140056|NCT03115229|Obesity|obesity
5140057|NCT03115229|Overweight|overweight
5140058|NCT03115229|Physical Activity|physical activity
5140059|NCT03115229|Nutrition|nutrition
5140060|NCT03115229|Nursing|nursing
5140061|NCT03115203|muscle skin|muscle skin
5140062|NCT03115203|IRM 3 tesla|irm 3 tesla
5140063|NCT03115138|Biopsy|biopsy
5140064|NCT03115125|B lymphocyte|b lymphocyte
5140065|NCT03115086|Bile Acid Synthesis Disorder|bile acid synthesis disorder
5140066|NCT03115086|Zellweger Spectrum Disorder|zellweger spectrum disorder
5140067|NCT03115086|Peroxisomal Disorder|peroxisomal disorder
5140068|NCT03115086|Cholic Acid|cholic acid
5140069|NCT03115086|Cholbam|cholbam
5140070|NCT03115086|Kolbam|kolbam
5140071|NCT03115086|The Replace Registry|the replace registry
5140072|NCT03115073|Vulvovaginal candidiasis|vulvovaginal candidiasis
5140073|NCT03115073|Candiplus|candiplus
5140074|NCT03115073|Clotrimazole|clotrimazole
5140075|NCT03115073|Safety|safety
5140076|NCT03115073|Tolerability|tolerability
5140077|NCT03115073|Clinical efficacy|clinical efficacy
5140078|NCT03115034|carotid stenosis|carotid stenosis
5140079|NCT03115034|melatonin|melatonin
5140080|NCT03115034|vascular injury|vascular injury
5140081|NCT03115034|ischemia reperfusion|ischemia reperfusion
5140082|NCT03114995|Tirofiban|tirofiban
5356849|NCT01917734|severe acute malnutrition|severe acute malnutrition
5140083|NCT03114995|Resistance to antiplatelet agents|resistance to antiplatelet agents
5140084|NCT03114982|Prevention of varicella|prevention of varicella
5140085|NCT03114982|Varicella-zoster vaccine|varicella-zoster vaccine
5140086|NCT03114969|Overall error|overall error
5140087|NCT03114969|Error rate|error rate
5140088|NCT03114969|Critical error|critical error
5140089|NCT03114969|COPD|copd
5140090|NCT03114969|ELLIPTA|ellipta
5140091|NCT03114969|Dry powder inhaler|dry powder inhaler
5140092|NCT03114943|prevention of varicella|prevention of varicella
5140093|NCT03114943|Varicella-zoster vaccine|varicella-zoster vaccine
5140094|NCT03114917|Suicide|suicide
5140095|NCT03114917|Self-harm|self-harm
5140096|NCT03114917|Psychosis|psychosis
5140097|NCT03114917|Community|community
5140098|NCT03114917|Suicide Prevention|suicide prevention
5962053|NCT04283318|healthy people|healthy people
5140100|NCT03114917|CARMS|carms
5140101|NCT03114917|Randomised controlled trial|randomised controlled trial
5140102|NCT03114891|post-traumatic stress|post-traumatic stress
5140103|NCT03114891|depression|depression
5140104|NCT03114865|bone marrow|bone marrow
5140105|NCT03114865|bone marrow transplant|bone marrow transplant
5140106|NCT03114865|allogeneic|allogeneic
5140107|NCT03114865|tacrolimus|tacrolimus
5140108|NCT03114865|cyclophosphamide|cyclophosphamide
5140109|NCT03114865|Blinatumomab|blinatumomab
5140110|NCT03114839|Lactobacillus casei strain Shirota|lactobacillus casei strain shirota
5140111|NCT03114839|Yakult|yakult
5140112|NCT03114839|IntelliCap|intellicap
5140113|NCT03114761|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5140114|NCT03114761|Internal Herniation|internal herniation
5140115|NCT03114761|Computed Tomography|computed tomography
5140116|NCT03114748|deep brain stimulation|deep brain stimulation
5140117|NCT03114748|EEG|eeg
5140118|NCT03114709|Mindfulness|mindfulness
5140119|NCT03114709|Exercise|exercise
5140120|NCT03114709|Physical activity|physical activity
5140124|NCT03114709|Pilot|pilot
5140125|NCT03114670|Leukemia|leukemia
5140126|NCT03114670|Leukemia, Myeloid|leukemia, myeloid
5140127|NCT03114670|Recurrence|recurrence
5140128|NCT03114670|Neoplasms by Histologic Type|neoplasms by histologic type
5140129|NCT03114670|Disease Attributes|disease attributes
5140130|NCT03114670|Cyclophosphamide|cyclophosphamide
5140131|NCT03114670|Fludarabine|fludarabine
5140132|NCT03114670|CD123|cd123
5140133|NCT03114670|Chimeric Antigen Receptor modified T-cells|chimeric antigen receptor modified t-cells
5140134|NCT03114631|dendritic cells, pancreatic cancer, immunotherapy|dendritic cells, pancreatic cancer, immunotherapy
5140135|NCT03114566|transplant donor|transplant donor
5140136|NCT03114566|HLA typed|hla typed
5140141|NCT03114553|clinical decision support|clinical decision support
5140147|NCT03114501|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5140148|NCT03114501|Head and Neck Cancer|head and neck cancer
5140150|NCT03114501|Questionnaires|questionnaires
5140151|NCT03114501|Surveys|surveys
5140152|NCT03114462|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
5140153|NCT03114462|Squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
5140154|NCT03114462|Stereotactic hypofractionated radioablation|stereotactic hypofractionated radioablation
5140155|NCT03114462|HYDRA|hydra
5140156|NCT03114462|Questionnaires|questionnaires
5140157|NCT03114462|Surveys|surveys
5140158|NCT03114423|EMDR|emdr
5140159|NCT03114423|Psychotherapy|psychotherapy
5140160|NCT03114423|Substance Use Disorders|substance use disorders
5140161|NCT03114423|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
5140162|NCT03114371|Prader-Willi syndrome|prader-willi syndrome
5140163|NCT03114371|Oxytocin|oxytocin
5140164|NCT03114371|Behavioural troubles|behavioural troubles
5140165|NCT03114358|De-escalation|de-escalation
5140166|NCT03114358|Carbapenems|carbapenems
5140167|NCT03114358|Antimicrobial stewardship|antimicrobial stewardship
5140168|NCT03114345|Pressure ulcer|pressure ulcer
5140169|NCT03114345|Interface pressure|interface pressure
5140170|NCT03114345|Pressure mapping device|pressure mapping device
5140171|NCT03114345|Monitoring|monitoring
5140172|NCT03114345|Microvascularization|microvascularization
5140173|NCT03114319|TNO155|tno155
5140174|NCT03114319|SHP2|shp2
5140175|NCT03114319|advanced solid tumor|advanced solid tumor
5140176|NCT03114319|NSCLC|nsclc
5140177|NCT03114319|HNSCC|hnscc
5140178|NCT03114319|Colorectal cancer (CRC)|colorectal cancer (crc)
5140179|NCT03114319|Esophageal SCC|esophageal scc
5140180|NCT03114319|EGFR|egfr
5140181|NCT03114319|GIST|gist
5140182|NCT03114319|PTPN11|ptpn11
5140183|NCT03114319|cancers with a mass|cancers with a mass
5140184|NCT03114319|bulky tumor|bulky tumor
5140185|NCT03114319|nodule|nodule
5140186|NCT03114319|lump|lump
5140187|NCT03114319|advanced solid malignancies|advanced solid malignancies
5140188|NCT03114306|ERAS|eras
5140189|NCT03114306|pain|pain
5140190|NCT03114306|knee arthroplasty|knee arthroplasty
5140191|NCT03114306|joint pain|joint pain
5140192|NCT03114306|regional anaesthesia|regional anaesthesia
5140193|NCT03114293|Physical activity|physical activity
5140194|NCT03114293|Mobility|mobility
5140195|NCT03114254|Recurrent|recurrent
5140196|NCT03114254|Locally advanced|locally advanced
5140197|NCT03114254|Metastatic|metastatic
5140198|NCT03114241|COPD|copd
5140199|NCT03114241|Physical activity|physical activity
5140200|NCT03114241|Endothelial function|endothelial function
5140201|NCT03114228|myeloid|myeloid
5140202|NCT03114228|leukemia|leukemia
5140203|NCT03114228|FLT3-mutated|flt3-mutated
5140204|NCT03114228|PKC412|pkc412
5140205|NCT03114228|midostaurin|midostaurin
5140206|NCT03114228|adult|adult
5140209|NCT03114228|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
5140210|NCT03114228|Acute myeloid leukemia|acute myeloid leukemia
5140211|NCT03114215|Biotin|biotin
5140212|NCT03114215|MD1003|md1003
5140213|NCT03114215|ALSFRS-R|alsfrs-r
5140214|NCT03114189|Sleep disturbance|sleep disturbance
5140215|NCT03114189|footbath|footbath
5140217|NCT03114189|care of sleep|care of sleep
5140218|NCT03114189|sleep|sleep
5140219|NCT03114150|physical activity|physical activity
5140220|NCT03114150|aging|aging
5140221|NCT03114150|learning and memory|learning and memory
5140222|NCT03114150|exercise|exercise
5140223|NCT03114150|brain|brain
5140224|NCT03114137|Sub-Saharan Africa|sub-saharan africa
5140225|NCT03114137|Sickle Cell Disease|sickle cell disease
5140226|NCT03114137|Vasculopathy|vasculopathy
5140227|NCT03114137|Nephropathy|nephropathy
5140228|NCT03114137|Pulmonary hypertension|pulmonary hypertension
5140229|NCT03114137|cardiac disease|cardiac disease
5140230|NCT03114137|hemolysis|hemolysis
5149618|NCT03057340|Dribbles|dribbles
5140236|NCT03114098|Drug Resistance|drug resistance
5140237|NCT03114098|CYP2D6|cyp2d6
5140238|NCT03114098|cytochrom P450|cytochrom p450
5140239|NCT03114072|Pregnancy|pregnancy
5140240|NCT03114072|Blue-blockers|blue-blockers
5140241|NCT03114072|Sleep quality|sleep quality
5140242|NCT03114072|Melatonin|melatonin
5140243|NCT03114059|Late Effects of Surgery|late effects of surgery
5140244|NCT03114033|Cardiac Arrest|cardiac arrest
5140245|NCT03114033|Intensive Care Unit|intensive care unit
5140246|NCT03114033|Therapeutic Mild Hypercapnia|therapeutic mild hypercapnia
5140247|NCT03114033|Normocapnia|normocapnia
5140248|NCT03114033|Mortality|mortality
5025987|NCT03836196|Prostate Cancer|prostate cancer
5140249|NCT03114033|Neurological function|neurological function
5140250|NCT03114020|Emphysema|emphysema
5140251|NCT03114020|COPD|copd
5140252|NCT03114020|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5140253|NCT03114007|Mental health problems|mental health problems
5140254|NCT03114007|Substance misuse|substance misuse
5140255|NCT03114007|Psychosocial difficulties|psychosocial difficulties
5140256|NCT03114007|Youth|youth
5140257|NCT03113994|Spinal Cord Injury|spinal cord injury
5140258|NCT03113994|Osteoporosis|osteoporosis
5140259|NCT03113994|Cardiometabolic Syndrome|cardiometabolic syndrome
5140260|NCT03113916|Culturally-tailored|culturally-tailored
5140261|NCT03113916|Weight Loss|weight loss
5140262|NCT03113916|Diabetes|diabetes
5140263|NCT03113916|Women|women
5140264|NCT03113916|Hispanic|hispanic
5140265|NCT03113916|Obesity|obesity
5140266|NCT03113903|Pain|pain
5140267|NCT03113903|psychophysics|psychophysics
5140268|NCT03113903|Nociception|nociception
5140269|NCT03113903|Sensitivity|sensitivity
5140270|NCT03113903|Senses|senses
5140271|NCT03113903|Phenotyping|phenotyping
5140272|NCT03113903|Questionnaire|questionnaire
5140273|NCT03113903|Anxiety|anxiety
5140274|NCT03113903|Depression|depression
5140275|NCT03113903|Catastrophizing|catastrophizing
5140276|NCT03113890|pharmacogenetic testing|pharmacogenetic testing
5140277|NCT03113890|genomic|genomic
5140278|NCT03113890|assay|assay
5140279|NCT03113890|PTSD|ptsd
5140280|NCT03113890|pharmacodynamic|pharmacodynamic
5140281|NCT03113890|pharmacokinetic|pharmacokinetic
5140282|NCT03113890|psychiatric disorders|psychiatric disorders
5140283|NCT03113864|Vision|vision
5140284|NCT03113864|Eye Health|eye health
5140285|NCT03113864|Lutein|lutein
5140286|NCT03113864|Carotenoids|carotenoids
5140287|NCT03113838|Drug-Induced Liver Injury|drug-induced liver injury
5140288|NCT03113825|breast carcinoma|breast carcinoma
5140289|NCT03113825|DCIS|dcis
5140290|NCT03113786|Discectomy|discectomy
5140291|NCT03113786|Lumbar discectomy|lumbar discectomy
5140292|NCT03113786|Protruding disc|protruding disc
5140293|NCT03113747|Allogeneic adipose-derived stem cells|allogeneic adipose-derived stem cells
5140294|NCT03113747|burn wounds|burn wounds
5140295|NCT03113747|wound healing|wound healing
5140296|NCT03113747|regeneration|regeneration
5140297|NCT03113747|repair|repair
5140298|NCT03113747|skin tissue engineering|skin tissue engineering
5140299|NCT03113708|heparin|heparin
5140300|NCT03113708|heparin antagonists|heparin antagonists
5140301|NCT03113708|cardiac surgery|cardiac surgery
5140302|NCT03113708|active clotting time|active clotting time
5140303|NCT03113695|Richter's Syndrome|richter's syndrome
5140318|NCT03113591|total hip arthroplasty|total hip arthroplasty
5140319|NCT03113591|minimal invasive|minimal invasive
5140320|NCT03113578|Balloon enteroscopy|balloon enteroscopy
5140321|NCT03113578|colonoscopy|colonoscopy
5140322|NCT03113578|polyps|polyps
5140323|NCT03113461|cognitive impairment|cognitive impairment
5140324|NCT03113461|sleep apnea|sleep apnea
5140325|NCT03113461|positive airway pressure therapy|positive airway pressure therapy
5140326|NCT03113448|capsaicin|capsaicin
5140327|NCT03113448|neuropathic pain|neuropathic pain
5140328|NCT03113448|diabetic neuropathy|diabetic neuropathy
5140329|NCT03113448|topical lotion|topical lotion
5140330|NCT03113435|CO2 gap|co2 gap
5140337|NCT03113422|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
5140338|NCT03113422|Monoclonal Antibody|monoclonal antibody
5140339|NCT03113409|Outpatient detoxification|outpatient detoxification
5140340|NCT03113409|Opioid dependence|opioid dependence
5140341|NCT03113409|Naltrexone|naltrexone
5140342|NCT03113409|Vivitrol|vivitrol
5012287|NCT03919318|AH Plus|ah plus
5140343|NCT03113409|Buprenorphine|buprenorphine
5140344|NCT03113383|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
5140442|NCT03112889|GSDV|gsdv
5140345|NCT03113383|Endovascular Aneurysm Repair|endovascular aneurysm repair
5140346|NCT03113383|Stent-Graft|stent-graft
5140347|NCT03113370|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5140348|NCT03113370|tobacco use|tobacco use
5140349|NCT03113370|postpartum|postpartum
5140350|NCT03113357|myofascial release|myofascial release
5140351|NCT03113357|cervicogenic headache|cervicogenic headache
5140352|NCT03113357|pain intensity|pain intensity
5140353|NCT03113357|exercise therapy|exercise therapy
5140354|NCT03113357|pressure pain threshold|pressure pain threshold
5140355|NCT03113331|Intrauterine growth restriction|intrauterine growth restriction
5140356|NCT03113331|Preterm birth|preterm birth
5140357|NCT03113331|Birth defect|birth defect
5140358|NCT03113331|Infant growth|infant growth
5140359|NCT03113331|Neurodevelopmental outcomes|neurodevelopmental outcomes
5140360|NCT03113318|Pulmonary neoplasm|pulmonary neoplasm
5140361|NCT03113318|Metastasis|metastasis
5140362|NCT03113318|colorectal neoplasm|colorectal neoplasm
5140363|NCT03113305|Gastric bypass|gastric bypass
5140364|NCT03113305|Morbid obesity|morbid obesity
5140365|NCT03113305|Food choice|food choice
5140366|NCT03113305|Ingestive behaviour|ingestive behaviour
5140367|NCT03113292|physical therapy|physical therapy
5140368|NCT03113292|therapeutic exercises|therapeutic exercises
5140369|NCT03113292|low back pain|low back pain
5140370|NCT03113266|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5140371|NCT03113266|Metastatic|metastatic
5140372|NCT03113266|Advanced|advanced
5140373|NCT03113266|Bladder Urothelial Carcinoma|bladder urothelial carcinoma
5140374|NCT03113253|Tranexamic Acid|tranexamic acid
5140375|NCT03113253|Burn|burn
5140376|NCT03113253|Surgery|surgery
5140377|NCT03113253|Excision|excision
5140378|NCT03113240|Glutamin|glutamin
5140379|NCT03113240|Enteral Nutrition|enteral nutrition
5140380|NCT03113240|Intensive Care Unit|intensive care unit
5140381|NCT03113240|Intestinal Permeability|intestinal permeability
5140382|NCT03113227|induction of labor|induction of labor
5140383|NCT03113227|Bishop score|bishop score
5140384|NCT03113227|posterior cervical angle|posterior cervical angle
5140385|NCT03113227|cervical length|cervical length
5140386|NCT03113201|Depression|depression
5140387|NCT03113201|Collaborative care|collaborative care
5140388|NCT03113201|Care manager|care manager
5140389|NCT03113201|Anxiety|anxiety
5140390|NCT03113201|Psychiatry|psychiatry
5140391|NCT03113201|Consultation-liaison|consultation-liaison
5140392|NCT03113201|General practitioner|general practitioner
5140399|NCT03113162|HSCT|hsct
5140400|NCT03113149|Physical Therapy Modalities|physical therapy modalities
5140401|NCT03113149|Recovery of Function|recovery of function
5140402|NCT03113149|Predictive Value of Tests|predictive value of tests
5140403|NCT03113149|Cohort Studies|cohort studies
5140404|NCT03113123|Adherence|adherence
5140405|NCT03113123|Prevention|prevention
5140406|NCT03113123|Tenofovir|tenofovir
5140407|NCT03113123|Emtricitabine|emtricitabine
5140408|NCT03113123|Antiretroviral|antiretroviral
5140409|NCT03113123|Prophylaxis|prophylaxis
5140410|NCT03113123|Men who have sex with men|men who have sex with men
5140411|NCT03113110|Empagliflozin|empagliflozin
5140412|NCT03113110|SGLT-2 Inhibition|sglt-2 inhibition
5140413|NCT03113110|Glucose Metabolism|glucose metabolism
5140414|NCT03113084|Sodium Heparin|sodium heparin
5140415|NCT03113084|Pharmacokinetics|pharmacokinetics
5140416|NCT03113084|Coagulation factor|coagulation factor
5140417|NCT03113058|HBV infection,γδT cells,Adoptive treatment|hbv infection,γδt cells,adoptive treatment
5140418|NCT03113032|total knee replacement|total knee replacement
5140419|NCT03113032|sensorimotor training|sensorimotor training
5140420|NCT03113032|pre-surgery exercise|pre-surgery exercise
5149818|NCT03056079|aflibercept|aflibercept
5140424|NCT03112993|spine surgery|spine surgery
5140425|NCT03112993|neuromuscular blockade|neuromuscular blockade
5140426|NCT03112993|sugammadex|sugammadex
5140427|NCT03112993|elderly|elderly
5140428|NCT03112993|reversal|reversal
5140429|NCT03112993|neostigmine|neostigmine
5140430|NCT03112993|recovery|recovery
5140431|NCT03112980|Aortic Valve Stenosis|aortic valve stenosis
5140432|NCT03112980|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5140433|NCT03112980|Surgical aortic valve replacement|surgical aortic valve replacement
5140434|NCT03112980|Low to intermediate operative risk|low to intermediate operative risk
5140435|NCT03112915|postoperative pain|postoperative pain
5140436|NCT03112915|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5140437|NCT03112915|Quadratus lumborum block|quadratus lumborum block
5140438|NCT03112915|transversus abdominis plan block|transversus abdominis plan block
5140439|NCT03112889|McArdle Disease|mcardle disease
5140440|NCT03112889|McArdle's Disease|mcardle's disease
5140441|NCT03112889|Glycogen Storage Disease Type V|glycogen storage disease type v
5140448|NCT03112889|Glycogen Storage Disorder|glycogen storage disorder
5140450|NCT03112876|older age|older age
5962054|NCT04283318|obese|obese
5962055|NCT04283318|Type 2 diabetes mellitus|type 2 diabetes mellitus
5140451|NCT03112876|atopic dermatitis|atopic dermatitis
5140452|NCT03112876|acne|acne
5140453|NCT03112876|smoker|smoker
5140454|NCT03112850|Crossover design|crossover design
5140455|NCT03112850|Randomized controlled trial|randomized controlled trial
5140456|NCT03112850|Aural rehabilitation intervention|aural rehabilitation intervention
5140457|NCT03112798|tracheal intubation|tracheal intubation
5140458|NCT03112798|Macintosh blade|macintosh blade
5140459|NCT03112798|Miller blade|miller blade
5140461|NCT03112785|Arthroplasty|arthroplasty
5140462|NCT03112785|Stem|stem
5140463|NCT03112785|Outcome|outcome
5140464|NCT03112746|child|child
5140465|NCT03112746|goal|goal
5140466|NCT03112746|intervention|intervention
5140467|NCT03112746|motor skills disorder|motor skills disorder
5140468|NCT03112746|occupational therapy|occupational therapy
5140469|NCT03112655|diagnosis|diagnosis
5140470|NCT03112655|sensitivity|sensitivity
5140471|NCT03112655|specificity|specificity
5140472|NCT03112655|therapeutic outcome|therapeutic outcome
5140473|NCT03112655|cerebrospinal fluid|cerebrospinal fluid
5140479|NCT03112603|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
5140480|NCT03112603|Chronic GvHD (cGvHD)|chronic gvhd (cgvhd)
5140481|NCT03112603|steroid-refractory|steroid-refractory
5140482|NCT03112603|ruxolitinib|ruxolitinib
5140483|NCT03112603|Janus kinase inhibitor|janus kinase inhibitor
5140484|NCT03112590|Histologically confirmed HER2 positive breast cancer|histologically confirmed her2 positive breast cancer
5140485|NCT03112590|Unresectable breast cancer|unresectable breast cancer
5140486|NCT03112590|Locally advanced breast cancer|locally advanced breast cancer
5140487|NCT03112590|Metastatic breast cancer|metastatic breast cancer
5140488|NCT03112590|Clinical stage 2-3 early stage breast cancer|clinical stage 2-3 early stage breast cancer
5140489|NCT03112564|Endotracheal intubation|endotracheal intubation
5140490|NCT03112564|muscle relaxants|muscle relaxants
5140491|NCT03112564|inhalational anesthesia|inhalational anesthesia
5140492|NCT03112538|insulin pump|insulin pump
5140493|NCT03112538|basal bolus insulin|basal bolus insulin
5140494|NCT03112525|rivaroxaban|rivaroxaban
5140495|NCT03112525|apixaban|apixaban
5140496|NCT03112525|cytochrome|cytochrome
5140497|NCT03112525|anticoagulant|anticoagulant
5140499|NCT03112525|polymorphism|polymorphism
5140500|NCT03112525|genotyping|genotyping
5140501|NCT03112525|phenotyping|phenotyping
5140502|NCT03112512|optimal positive end-expiratory pressure determination|optimal positive end-expiratory pressure determination
5140503|NCT03112512|Electrical impedance tomography|electrical impedance tomography
5140504|NCT03112499|Acute Kidney Injury|acute kidney injury
5140505|NCT03112499|PCNL|pcnl
5140506|NCT03112499|mini-PCNL|mini-pcnl
5140507|NCT03112499|RIRS|rirs
5140508|NCT03112499|urine biomarkers|urine biomarkers
5140509|NCT03112486|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5140510|NCT03112486|neurological outcome|neurological outcome
5140511|NCT03112486|prognostication|prognostication
5140512|NCT03112486|cerebral performance category|cerebral performance category
5140513|NCT03112486|hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
5140514|NCT03112486|biomarkers|biomarkers
5140515|NCT03112460|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5140516|NCT03112447|medial epicondyle humerus|medial epicondyle humerus
5140517|NCT03112447|absorbable cartilage nail|absorbable cartilage nail
5140519|NCT03112408|cerebellar lesion|cerebellar lesion
5140520|NCT03112408|saccadic adaptation|saccadic adaptation
5140521|NCT03112408|spatial localization|spatial localization
5140522|NCT03112408|visuo spatial perception|visuo spatial perception
5140528|NCT03112369|Substance Use|substance use
5140529|NCT03112356|infectious endocarditis|infectious endocarditis
5140530|NCT03112356|prosthetic valve infection|prosthetic valve infection
5140531|NCT03112356|implantable cardiac device infection|implantable cardiac device infection
5140532|NCT03112356|99mTc-Leukoscan® scintigraphy|99mtc-leukoscan® scintigraphy
5140533|NCT03112343|ICT based clinical trial|ict based clinical trial
5140534|NCT03112343|Contract research organization (CRO)|contract research organization (cro)
5140535|NCT03112343|eCRF|ecrf
5140736|NCT03111342|Anesthesia|anesthesia
5140547|NCT03112304|adolescents|adolescents
5140548|NCT03112304|anxiety|anxiety
5140549|NCT03112304|depression|depression
5140550|NCT03112304|trauma|trauma
5140551|NCT03112304|behavior problems|behavior problems
5140552|NCT03112304|evidence-based treatments|evidence-based treatments
5140553|NCT03112304|manualized|manualized
5140554|NCT03112304|cognitive-behavioral therapy|cognitive-behavioral therapy
5140555|NCT03112304|mental health|mental health
5140556|NCT03112291|anti-microbial agents|anti-microbial agents
5140557|NCT03112291|apexification|apexification
5140558|NCT03112291|dental pulp|dental pulp
5140559|NCT03112291|endodontics|endodontics
5140560|NCT03112291|root canal therapy|root canal therapy
5140561|NCT03112291|dental trauma|dental trauma
5140562|NCT03112278|tooth erosion|tooth erosion
5140563|NCT03112278|Computer-Aided Design|computer-aided design
5140564|NCT03112278|occlusal veneers|occlusal veneers
5140565|NCT03112278|dental veneers|dental veneers
5140566|NCT03112265|anxiety|anxiety
5140567|NCT03112265|depression|depression
5140568|NCT03112265|trauma|trauma
5012520|NCT03918096|vaccin|vaccin
5140569|NCT03112265|behavior problems|behavior problems
5140570|NCT03112265|evidence-based treatments|evidence-based treatments
5140571|NCT03112265|manualized treatments|manualized treatments
5140572|NCT03112265|cognitive-behavioral therapy|cognitive-behavioral therapy
5140573|NCT03112265|youth|youth
5140574|NCT03112265|mental health|mental health
5140575|NCT03112265|self-regulation|self-regulation
5140576|NCT03112265|neuroimaging|neuroimaging
5140577|NCT03112252|Immunotherapy|immunotherapy
5140578|NCT03112239|Asthma|asthma
5140579|NCT03112239|Photobiomodulation|photobiomodulation
5140580|NCT03112239|Resistance Training|resistance training
5140581|NCT03112226|cognitive impairment|cognitive impairment
5140582|NCT03112226|menopause|menopause
5140583|NCT03112226|estrogen|estrogen
5140584|NCT03112226|functional MRI|functional mri
5140585|NCT03112226|executive function|executive function
5140586|NCT03112226|endothelial function|endothelial function
5140587|NCT03112226|arterial stiffness|arterial stiffness
5140588|NCT03112200|Subchondroplasty|subchondroplasty
5140589|NCT03112200|Arthroscopy|arthroscopy
5140590|NCT03112200|Bone Substitute Material|bone substitute material
5140591|NCT03112200|Subchondral Bone Defect|subchondral bone defect
5140592|NCT03112200|AccuFill|accufill
5140593|NCT03112200|Bone Marrow Lesion|bone marrow lesion
5140594|NCT03112200|Knee Replacement|knee replacement
5140595|NCT03112200|Knee Replacement Alternative|knee replacement alternative
5140597|NCT03112187|iron deficiency anemia|iron deficiency anemia
5140598|NCT03112187|iron supplements|iron supplements
5140599|NCT03112187|Pakistan|pakistan
5140600|NCT03112187|Liposomal iron|liposomal iron
5140601|NCT03112174|PCYC|pcyc
5140602|NCT03112174|MCL|mcl
5140603|NCT03112174|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5140604|NCT03112174|NHL|nhl
5140605|NCT03112174|ibrutinib|ibrutinib
5140606|NCT03112174|venetoclax|venetoclax
5140607|NCT03112174|Pharmacyclics|pharmacyclics
5140608|NCT03112122|Bone Marrow Edema|bone marrow edema
5140609|NCT03112122|Mesenchymal Stem Cells|mesenchymal stem cells
5140610|NCT03112096|Tau|tau
5140611|NCT03112096|neurodegeneration|neurodegeneration
5140612|NCT03112096|positron emission tomography|positron emission tomography
5140620|NCT03112083|docosahexaenoic acid|docosahexaenoic acid
5140622|NCT03112044|Transplant|transplant
5140623|NCT03112044|Hepatitis C|hepatitis c
5140624|NCT03112044|DAAs|daas
5140625|NCT03112044|Epclusa|epclusa
5140626|NCT03112031|Tamoxifen|tamoxifen
5140627|NCT03112031|Cryptococcal meningitis|cryptococcal meningitis
5140628|NCT03112031|Cryptococcus neoformans|cryptococcus neoformans
5150012|NCT03054701|PFP|pfp
5140647|NCT03111953|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5140648|NCT03111953|Biliopancreatic Diversion|biliopancreatic diversion
5356850|NCT01917734|severe wasting|severe wasting
5140649|NCT03111927|Nutrition, Brain Development, Cognition, Heathy Infants|nutrition, brain development, cognition, heathy infants
5140650|NCT03111901|pembrolizumab|pembrolizumab
5140651|NCT03111901|IL-2|il-2
5140652|NCT03111901|interleukin-2|interleukin-2
5140653|NCT03111901|MK-3475|mk-3475
5140654|NCT03111875|Hypothermia|hypothermia
5140655|NCT03111875|Intraoperative warming|intraoperative warming
5140656|NCT03111875|non-cardiac surgery|non-cardiac surgery
5140657|NCT03111875|myocardial injury|myocardial injury
5140658|NCT03111849|COPD|copd
5140659|NCT03111849|Sarcopenia|sarcopenia
5140660|NCT03111849|Prevalence|prevalence
5140661|NCT03111849|Mortality|mortality
5140662|NCT03111849|Malnutrition|malnutrition
5140663|NCT03111849|Nutritional assessment|nutritional assessment
5140664|NCT03111849|Body composition|body composition
5140665|NCT03111849|Pulmonary cachexia|pulmonary cachexia
5140666|NCT03111810|Corticosteroids|corticosteroids
5140667|NCT03111810|Prednisolone|prednisolone
5140668|NCT03111810|11 beta-Hydroxysteroid dehydrogenase1 inhibitor|11 beta-hydroxysteroid dehydrogenase1 inhibitor
5140669|NCT03111810|Iatrogenic Cushing's disease|iatrogenic cushing's disease
5140670|NCT03111810|AZD4017|azd4017
5140671|NCT03111784|Fish Consumption, Fatty acid composition, Lipid Profile, Tocopherol, Sociodemographics|fish consumption, fatty acid composition, lipid profile, tocopherol, sociodemographics
5140672|NCT03111771|Cancer|cancer
5140673|NCT03111771|Cachexia|cachexia
5140674|NCT03111771|Myosteatosis|myosteatosis
5140675|NCT03111771|Mitochondrial activity|mitochondrial activity
5140676|NCT03111771|Upper aerodigestive pathways|upper aerodigestive pathways
5140677|NCT03111771|Lipotoxicity|lipotoxicity
5140685|NCT03111693|Epicardial fat|epicardial fat
5140686|NCT03111693|Obesity|obesity
5140687|NCT03111693|Cardiovascular risks markers|cardiovascular risks markers
5140688|NCT03111693|Metabolic syndrome|metabolic syndrome
5140689|NCT03111693|Low dose computed tomography|low dose computed tomography
5140690|NCT03111667|Marijuana|marijuana
5140691|NCT03111667|Motivational Enhancement Therapy|motivational enhancement therapy
5962056|NCT04283318|glucose metabolism|glucose metabolism
5140692|NCT03111667|Adolescents|adolescents
5140693|NCT03111615|Aromatase inhibitors|aromatase inhibitors
5140694|NCT03111615|Luminal Breast Cancer neoadjuvant hormone therapy|luminal breast cancer neoadjuvant hormone therapy
5140695|NCT03111602|polyphenols|polyphenols
5140696|NCT03111602|pregnant|pregnant
5140697|NCT03111602|fetal ductal constriction|fetal ductal constriction
5140698|NCT03111602|prostaglandin E2|prostaglandin e2
5140699|NCT03111589|Sickle Cell Disease|sickle cell disease
5140700|NCT03111589|Heme oxidase-1 (HO-1)|heme oxidase-1 (ho-1)
5140701|NCT03111537|cigarette|cigarette
5140702|NCT03111537|smoking|smoking
5140703|NCT03111537|e-cigarette|e-cigarette
5140704|NCT03111537|nicotine replacement therapy|nicotine replacement therapy
5140705|NCT03111537|nrt|nrt
5140706|NCT03111537|tobacco|tobacco
5140707|NCT03111524|stuttering|stuttering
5140708|NCT03111524|children who stutter|children who stutter
5140709|NCT03111524|peer attitudes|peer attitudes
5140710|NCT03111524|classroom-based intervention|classroom-based intervention
5140711|NCT03111524|teasing|teasing
5140712|NCT03111524|bullying|bullying
5140713|NCT03111498|Vacuum assisted delivery|vacuum assisted delivery
5140714|NCT03111498|technical skills|technical skills
5140715|NCT03111498|training|training
5140716|NCT03111459|endograft repair,|endograft repair,
5140717|NCT03111433|Type 1 Diabetes mellitus|type 1 diabetes mellitus
5140718|NCT03111433|Coenzyme Q10|coenzyme q10
5140719|NCT03111433|endothelial dysfunction|endothelial dysfunction
5140720|NCT03111433|pediatric patients|pediatric patients
5140721|NCT03111407|primary total knee arthroplasty|primary total knee arthroplasty
5140722|NCT03111394|MS|ms
5140723|NCT03111394|23andMe|23andme
5140724|NCT03111394|MRI|mri
5140725|NCT03111394|Genome-wide association studies|genome-wide association studies
5140726|NCT03111368|eus-fna|eus-fna
5136685|NCT03137940|tDCS|tdcs
5140734|NCT03111342|Intrauterine contraception|intrauterine contraception
5140735|NCT03111342|Pain|pain
5140737|NCT03111342|LNG-IUD|lng-iud
5140738|NCT03111342|nulligravida|nulligravida
5140863|NCT03110757|Schistosomiasis|schistosomiasis
5140739|NCT03111329|Gastric residuals assessment|gastric residuals assessment
5140740|NCT03111329|Prematurity|prematurity
5140745|NCT03111316|Cervical Ripening|cervical ripening
5140746|NCT03111316|Induction of Labor|induction of labor
5140747|NCT03111290|Facial recognition|facial recognition
5140748|NCT03111277|neuropathic pain|neuropathic pain
5140749|NCT03111264|Overweight|overweight
5140750|NCT03111264|Obesity|obesity
5140751|NCT03111264|Prevention|prevention
5140752|NCT03111264|Children|children
5140753|NCT03111264|Childcare|childcare
5140754|NCT03111264|Physical Activity|physical activity
5140755|NCT03111264|Nutrition|nutrition
5140756|NCT03111264|Wellness|wellness
5140757|NCT03111264|Environment|environment
5140758|NCT03111264|Intervention|intervention
5140759|NCT03111264|Feeding|feeding
5140760|NCT03111238|Autologous|autologous
5140761|NCT03111238|Bone Marrow-derived Mononuclear Cells (BM-MNCs)|bone marrow-derived mononuclear cells (bm-mncs)
5140762|NCT03111238|Advanced Therapy Medicinal Product (ATMP)|advanced therapy medicinal product (atmp)
5140763|NCT03111238|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
5140764|NCT03111238|Revascularization|revascularization
5140765|NCT03111238|Angiogenesis|angiogenesis
5140766|NCT03111238|Vasculogenesis|vasculogenesis
5140767|NCT03111238|Arteriogenesis|arteriogenesis
5140768|NCT03111212|Acute respiratory distress syndrome|acute respiratory distress syndrome
5140769|NCT03111199|Low back pain|low back pain
5140770|NCT03111199|Analgesia|analgesia
5140771|NCT03111199|Physical therapy|physical therapy
5140772|NCT03111186|oxycodone|oxycodone
5140773|NCT03111186|ibuprofen|ibuprofen
5140774|NCT03111186|acetaminophen|acetaminophen
5140775|NCT03111186|soft-tissue hand surgery|soft-tissue hand surgery
5140776|NCT03111186|carpal tunnel release|carpal tunnel release
5140777|NCT03111186|Dupuytren contracture release|dupuytren contracture release
5140778|NCT03111186|Trigger digit release|trigger digit release
5140779|NCT03111186|Ganglion cyst removal|ganglion cyst removal
5140780|NCT03111186|De Quervain's release|de quervain's release
5140781|NCT03111173|ECG|ecg
5140782|NCT03111173|Fetus|fetus
5140783|NCT03111173|R peak extraction|r peak extraction
5140784|NCT03111160|Small-incision lenticule extraction|small-incision lenticule extraction
5140785|NCT03111160|femtosecond laser|femtosecond laser
5140786|NCT03111160|lower laser energy level|lower laser energy level
5140787|NCT03111160|early visual recovery|early visual recovery
5140788|NCT03111134|abdominal wound closure techniques|abdominal wound closure techniques
5140789|NCT03111134|layered closure|layered closure
5140790|NCT03111134|component separation technique|component separation technique
5140791|NCT03111121|deeply anesthetized|deeply anesthetized
5140792|NCT03111121|ideal surgical exposure|ideal surgical exposure
5140793|NCT03111121|muscle relaxation|muscle relaxation
5140794|NCT03111121|Adults|adults
5140795|NCT03111069|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
5140796|NCT03111069|Pelvic and Abdominal Rhabdomyosarcoma|pelvic and abdominal rhabdomyosarcoma
5140797|NCT03111069|Undifferentiated Sarcomas|undifferentiated sarcomas
5140798|NCT03111069|Unresectable or Refractory|unresectable or refractory
5140799|NCT03111069|Abdominal tumors|abdominal tumors
5140800|NCT03111069|Hyperthermic intra-peritoneal chemotherapy|hyperthermic intra-peritoneal chemotherapy
5140801|NCT03111069|HIPEC|hipec
5140802|NCT03111069|Abdominal surgery|abdominal surgery
5140803|NCT03111069|Doxorubicin|doxorubicin
5140804|NCT03111069|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5140805|NCT03111069|Adriamycin PFS|adriamycin pfs
5140806|NCT03111069|Adriamycin RDF|adriamycin rdf
5140807|NCT03111069|Adriamycin|adriamycin
5140808|NCT03111069|Rubex|rubex
5766208|NCT00258635|Allergy|allergy
5140809|NCT03111069|Intra-operative radiation|intra-operative radiation
5140810|NCT03111069|IORT|iort
5140811|NCT03111069|Brachytherapy|brachytherapy
5140812|NCT03111043|computed tomography|computed tomography
5140813|NCT03111043|Sudden cardiac arrest|sudden cardiac arrest
5140814|NCT03111043|Cardiac computed tomography|cardiac computed tomography
5140815|NCT03111043|Diagnostic accuracy|diagnostic accuracy
5140816|NCT03111043|Clinical outcome|clinical outcome
5140817|NCT03111017|muscle sympathetic nerve activity|muscle sympathetic nerve activity
5140818|NCT03111017|exercise tolerance|exercise tolerance
5140819|NCT03111017|exercise training|exercise training
5140823|NCT03111004|integrated care|integrated care
5140824|NCT03111004|MAST framework|mast framework
5140825|NCT03111004|organizational change|organizational change
5140826|NCT03111004|social care|social care
5140827|NCT03111004|elderly patients|elderly patients
5140828|NCT03110991|Depression|depression
5140829|NCT03110991|Depressive symptoms|depressive symptoms
5140837|NCT03110887|Dynamic prediction model|dynamic prediction model
5140838|NCT03110822|Ruxolitinib|ruxolitinib
5140839|NCT03110822|Steroids|steroids
5140840|NCT03110822|Lenalidomide|lenalidomide
5140841|NCT03110822|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5140843|NCT03110809|brown|brown
5140844|NCT03110809|fat|fat
5140845|NCT03110809|weight|weight
5140846|NCT03110809|loss|loss
5140847|NCT03110783|Bioseal as an Adjunct to Sutured Dural Repair|bioseal as an adjunct to sutured dural repair
5140848|NCT03110783|elective posterior fossa|elective posterior fossa
5140849|NCT03110783|supratentorial procedure|supratentorial procedure
5140850|NCT03110770|Flavivirus|flavivirus
5140851|NCT03110770|Zika|zika
5140852|NCT03110770|Vaccine|vaccine
5140853|NCT03110770|Physiological Effects of Drugs|physiological effects of drugs
5140854|NCT03110770|Immunologic Factors|immunologic factors
5140855|NCT03110770|Virus-like Particles|virus-like particles
5140856|NCT03110770|Zika vaccine|zika vaccine
5140857|NCT03110757|AP 10-701|ap 10-701
5140858|NCT03110757|healthy adults|healthy adults
5140859|NCT03110757|Immunogenicity|immunogenicity
5140860|NCT03110757|Phase Ib|phase ib
5140861|NCT03110757|Reactogenicity|reactogenicity
5140862|NCT03110757|Safety|safety
5140864|NCT03110757|Sm-TSP-2/Alhydrogel®|sm-tsp-2/alhydrogel®
5140865|NCT03110718|robotic rehabilitation|robotic rehabilitation
5140866|NCT03110718|muscle vibration|muscle vibration
5140867|NCT03110718|combined approach|combined approach
5140868|NCT03110679|osteoarthritis|osteoarthritis
5140869|NCT03110679|autologous bone marrow concentrate|autologous bone marrow concentrate
5140870|NCT03110666|knee osteoarthritis ,|knee osteoarthritis ,
5140871|NCT03110666|bone marrow aspirate|bone marrow aspirate
5140872|NCT03110666|injections|injections
5140873|NCT03110627|Single-chamber ICD (implantable cardioverter-defibrillator)|single-chamber icd (implantable cardioverter-defibrillator)
5140874|NCT03110627|Cardiac Arrhythmias|cardiac arrhythmias
5140875|NCT03110627|Atrial fibrillation|atrial fibrillation
5140876|NCT03110627|Atrial flutter|atrial flutter
5140877|NCT03110627|Stroke|stroke
5140878|NCT03110614|COPD|copd
5140879|NCT03110614|acute|acute
5140880|NCT03110614|exacerbation|exacerbation
5140881|NCT03110614|lung ultrasound|lung ultrasound
5140882|NCT03110588|metastatic prostate cancer|metastatic prostate cancer
5140883|NCT03110588|castration-resistant prostate cancer|castration-resistant prostate cancer
5140884|NCT03110588|PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)|pace (prednisone, abiraterone, cabazitaxel, and enzalutamide)
5140885|NCT03110575|TNX-102 SL|tnx-102 sl
5140886|NCT03110575|Bedtime|bedtime
5140887|NCT03110575|Sublingual|sublingual
5140888|NCT03110575|3-month|3-month
5140889|NCT03110575|Safety|safety
5140890|NCT03110575|Efficacy|efficacy
5140891|NCT03110575|PTSD|ptsd
5140896|NCT03110536|Burnout syndrome|burnout syndrome
5140897|NCT03110536|Triage|triage
5140898|NCT03110536|Nurse|nurse
5140899|NCT03110536|Emergency Department|emergency department
5140900|NCT03110536|Romania|romania
5140901|NCT03110497|Cervical cancer|cervical cancer
5140902|NCT03110497|Image guided Brachytherapy|image guided brachytherapy
5140903|NCT03110497|single application|single application
5140904|NCT03110471|Cognitive impairment|cognitive impairment
5140905|NCT03110471|antipsychotics|antipsychotics
5140906|NCT03110471|antidepressants|antidepressants
5767490|NCT00254111|stiffness|stiffness
5140907|NCT03110458|Acute unilateral vestibulopathy, AUV|acute unilateral vestibulopathy, auv
5140909|NCT03110419|Frailty|frailty
5140910|NCT03110419|Multicomponent training|multicomponent training
5140911|NCT03110419|Physical exercise|physical exercise
5140912|NCT03110419|Functional capacity|functional capacity
5140913|NCT03110419|Complexity|complexity
5140914|NCT03110419|Physical Therapy|physical therapy
5140915|NCT03110406|renal transplant recipients|renal transplant recipients
5140916|NCT03110406|exercise|exercise
5140917|NCT03110406|heart rate variability|heart rate variability
5140918|NCT03110406|Cardiovascular mortality|cardiovascular mortality
5140919|NCT03110393|Obese|obese
5140920|NCT03110393|Laryngeal Mask Airway|laryngeal mask airway
5140921|NCT03110393|Anaesthesia|anaesthesia
5140923|NCT03110354|ALL|all
5140924|NCT03110354|Enhancer of zeste homolog (EZH) inhibitor|enhancer of zeste homolog (ezh) inhibitor
5140925|NCT03110354|DS-3201b|ds-3201b
5140926|NCT03110315|Multiple Sclerosis|multiple sclerosis
5140927|NCT03110315|Fatigue|fatigue
5140928|NCT03110315|Insomnia|insomnia
5140929|NCT03110315|Suvorexant|suvorexant
5136926|NCT03136315|athlete|athlete
5140936|NCT03110302|In home therapy|in home therapy
5140937|NCT03110302|Prolonged Exposure|prolonged exposure
5140938|NCT03110289|Fecal microbiota transplantation|fecal microbiota transplantation
5140939|NCT03110250|Familial Hypercholesterolemia|familial hypercholesterolemia
5140940|NCT03110250|registry|registry
5140942|NCT03110250|Lipid lowering therapy|lipid lowering therapy
5140943|NCT03110224|Subchondroplasty|subchondroplasty
5140944|NCT03110224|Bone Marrow Lesion|bone marrow lesion
5140945|NCT03110224|Arthroscopy|arthroscopy
5140946|NCT03110224|Bone Substitute Material|bone substitute material
5140947|NCT03110224|AccuFill|accufill
5140948|NCT03110224|Subchondral Bone Defect|subchondral bone defect
5140949|NCT03110198|Mesalazine|mesalazine
5140950|NCT03110198|Ulcerative Colitis(UC)|ulcerative colitis(uc)
5140951|NCT03110198|Enema|enema
5140952|NCT03110172|Osteoarthritis|osteoarthritis
5140953|NCT03110172|Depression|depression
5140954|NCT03110172|Pain|pain
5140955|NCT03110159|Photodynamic therapy|photodynamic therapy
5140956|NCT03110159|Prevention|prevention
5140957|NCT03110159|Actinic Keratosis|actinic keratosis
5140958|NCT03110159|Skin Cancer|skin cancer
5140959|NCT03110159|Non-melanoma Skin Cancer|non-melanoma skin cancer
5140960|NCT03110159|Sun Damaged Skin|sun damaged skin
5140961|NCT03110159|Solid Organ Transplant|solid organ transplant
5140962|NCT03110159|PDT|pdt
5140963|NCT03110133|Clostridium Difficile Infection|clostridium difficile infection
5140964|NCT03110133|CP101|cp101
5140965|NCT03110133|Crestovo|crestovo
5140966|NCT03110133|FMT|fmt
5140967|NCT03110133|CDI|cdi
5140968|NCT03110133|C. difficile|c. difficile
5140970|NCT03110133|Recurrent Clostridium Difficile Infection|recurrent clostridium difficile infection
5140971|NCT03110133|Recurrent C. diff|recurrent c. diff
5140972|NCT03110133|Recurrent CDI|recurrent cdi
5140973|NCT03110133|Finch|finch
5140974|NCT03110133|Fecal transplant|fecal transplant
5140975|NCT03110133|Fecal microbiota transplant|fecal microbiota transplant
5140976|NCT03110133|rCDI|rcdi
5140977|NCT03110133|Finch Therapeutics|finch therapeutics
5140978|NCT03110068|microvascular invasion|microvascular invasion
5140979|NCT03110068|serum biomarker|serum biomarker
5140980|NCT03110068|radiological feature|radiological feature
5140981|NCT03110068|pathological differentiation|pathological differentiation
5140982|NCT03110003|Neuraxial epidural techniques|neuraxial epidural techniques
5140983|NCT03110003|Combined spinal epidural|combined spinal epidural
5140984|NCT03110003|Epidural volume extension|epidural volume extension
5140985|NCT03110003|Transient Neurologic Symptoms (TNS)|transient neurologic symptoms (tns)
5140986|NCT03109977|17-059|17-059
5140987|NCT03109977|Zr-DFO-pertuzumab|zr-dfo-pertuzumab
5140988|NCT03109951|Type 2 diabetes|type 2 diabetes
5140989|NCT03109951|colonoscopy|colonoscopy
5140990|NCT03109951|hypoglycemia|hypoglycemia
5140991|NCT03109951|hyperglycemia|hyperglycemia
5140992|NCT03109951|polyethylene glycol|polyethylene glycol
5140993|NCT03109925|PAE|pae
5140994|NCT03109925|embolization|embolization
5140995|NCT03109925|non-surgical|non-surgical
5140996|NCT03109925|prostate artery embolization|prostate artery embolization
5140997|NCT03109925|radio-opaque embolic|radio-opaque embolic
5141000|NCT03109886|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5141001|NCT03109886|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5141002|NCT03109886|Child-Pugh Class A|child-pugh class a
5141003|NCT03109860|Chronic neuropathic pain|chronic neuropathic pain
5141004|NCT03109834|Weight Management Programs|weight management programs
5141005|NCT03109834|Weight loss stabilization|weight loss stabilization
5141006|NCT03109834|Cardiometabolic risk|cardiometabolic risk
5141007|NCT03109821|Exercise Therapy|exercise therapy
5141008|NCT03109821|Rehabilitation|rehabilitation
5141009|NCT03109782|Spinal Cord Injury|spinal cord injury
5141010|NCT03109782|Spine Surgery|spine surgery
5141011|NCT03109782|Patient Registry|patient registry
5141012|NCT03109782|Trauma|trauma
5141013|NCT03109743|HIV treatment|hiv treatment
5141014|NCT03109743|Adherence Group Treatment|adherence group treatment
5141015|NCT03109717|Treatment Resistant Depression|treatment resistant depression
5141016|NCT03109704|scapular kinematics|scapular kinematics
5141017|NCT03109704|thoracic spine|thoracic spine
5141018|NCT03109704|thrust manipulation|thrust manipulation
5141019|NCT03109652|total knee replacement arthroplasty|total knee replacement arthroplasty
5141020|NCT03109652|total knee arthroplasty|total knee arthroplasty
5141021|NCT03109652|tranexamic acid|tranexamic acid
5141022|NCT03109652|oral tranexamic acid|oral tranexamic acid
5141023|NCT03109652|transfusion|transfusion
5141024|NCT03109652|blood loss|blood loss
5141025|NCT03109639|EUS|eus
5141026|NCT03109639|FNA|fna
5141027|NCT03109639|FNB|fnb
5141028|NCT03109639|Core Histology|core histology
5137040|NCT03135613|Microwave|microwave
5137041|NCT03135613|Gait|gait
5141029|NCT03109626|DHA, replacement, treatment, brain PET-FDG, ataxia|dha, replacement, treatment, brain pet-fdg, ataxia
5141030|NCT03109613|Positive end-expiratory pressure|positive end-expiratory pressure
5141031|NCT03109613|PEEP|peep
5141032|NCT03109613|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5141052|NCT03109470|Early Rheumatoid Arthritis|early rheumatoid arthritis
5141053|NCT03109470|Observational|observational
5141054|NCT03109470|Canadian|canadian
5141055|NCT03109457|Hepatitis C Virus|hepatitis c virus
5141056|NCT03109457|Oral squamous cell carcinoma|oral squamous cell carcinoma
5141057|NCT03109444|Hip Growth Chart|hip growth chart
5141058|NCT03109431|HIV Treatment Continuum|hiv treatment continuum
5141059|NCT03109431|HIV Disease Progression|hiv disease progression
5141060|NCT03109431|Mental Health|mental health
5141061|NCT03109431|Substance Use|substance use
5141062|NCT03109431|ARV Adherence|arv adherence
5141063|NCT03109431|Retention in Care|retention in care
5141064|NCT03109431|STI|sti
5141065|NCT03109418|Ketamine|ketamine
5141066|NCT03109418|Postoperative morbidity|postoperative morbidity
5141067|NCT03109353|Photopheresis|photopheresis
5141068|NCT03109353|5-aminolevulinic acid|5-aminolevulinic acid
5141069|NCT03109353|Extracorporeal Circulation|extracorporeal circulation
5141070|NCT03109340|abdominal obesity|abdominal obesity
5141071|NCT03109340|walking|walking
5141072|NCT03109340|aerobic exercise|aerobic exercise
5141073|NCT03109314|amblyopia|amblyopia
5141074|NCT03109314|donepezil|donepezil
5141075|NCT03109314|perceptual learning|perceptual learning
5141076|NCT03109314|crowding|crowding
5141077|NCT03109314|contrast sensitivity|contrast sensitivity
5141078|NCT03109314|visual acuity|visual acuity
5141079|NCT03109301|Mesenchymal Neoplasm|mesenchymal neoplasm
5141080|NCT03109301|Neurofibromatosis 1|neurofibromatosis 1
5141081|NCT03109301|Plexiform Neurofibromas|plexiform neurofibromas
5141087|NCT03109184|Dating violence prevention|dating violence prevention
5141088|NCT03109184|Adolescent boys|adolescent boys
5141089|NCT03109184|Middle school|middle school
5141090|NCT03109184|Web-based prevention|web-based prevention
5141091|NCT03109171|Endoscopy|endoscopy
5141092|NCT03109171|Lasers|lasers
5141093|NCT03109171|Fiber Optic Technology|fiber optic technology
5141094|NCT03109171|Bronchoscopy|bronchoscopy
5141095|NCT03109171|Esthesiometer|esthesiometer
5141096|NCT03109171|Mechanoreceptors|mechanoreceptors
5141097|NCT03109171|Diagnosis|diagnosis
5141098|NCT03109171|Reflex|reflex
5141099|NCT03109171|Reproducibility of Results|reproducibility of results
5141100|NCT03109171|Reliability of Results|reliability of results
5141101|NCT03109171|Validity of Results|validity of results
5141102|NCT03109171|Sensory Thresholds|sensory thresholds
5141103|NCT03109158|squamous cell carcinoma|squamous cell carcinoma
5141104|NCT03109158|head|head
5141105|NCT03109158|neck|neck
5141106|NCT03109145|Shared decision making|shared decision making
5141107|NCT03109145|Knowledge|knowledge
5141108|NCT03109145|Patient portal|patient portal
5141109|NCT03109145|Secure messaging|secure messaging
5141110|NCT03109119|genomic instability|genomic instability
5141111|NCT03109119|Sevoflurane|sevoflurane
5141112|NCT03109119|General anaesthesia|general anaesthesia
5141113|NCT03109106|MICU|micu
5141114|NCT03109106|CICU|cicu
5141115|NCT03109106|PCT - Procalcitonin|pct - procalcitonin
5141116|NCT03109106|B·R·A·H·M·S PCT sensitive Kryptor®|b·r·a·h·m·s pct sensitive kryptor®
5141117|NCT03109106|Antibiotic initiation|antibiotic initiation
5141118|NCT03109106|Antibiotic de-escalation|antibiotic de-escalation
5141119|NCT03109093|ALL|all
5141120|NCT03109093|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5141121|NCT03109093|MRD positive|mrd positive
5141122|NCT03109093|minimal residual disease|minimal residual disease
5141123|NCT03109093|blinatumomab|blinatumomab
5141124|NCT03109067|Cholesterol, HDL, Postprandial Period, Polymorphism, Genetic|cholesterol, hdl, postprandial period, polymorphism, genetic
5141125|NCT03109054|Melatonin|melatonin
5141126|NCT03109054|Anxiety|anxiety
5141127|NCT03109041|Whipple|whipple
5141128|NCT03109041|brachytherapy|brachytherapy
5141129|NCT03109041|CivaSheet|civasheet
5141130|NCT03109041|CivaTech Oncology|civatech oncology
5141131|NCT03109041|radiation|radiation
5141132|NCT03109041|intraoperative radiation|intraoperative radiation
5141134|NCT03109041|resectable pancreatic cancer|resectable pancreatic cancer
5141135|NCT03109041|Pd-103|pd-103
5141136|NCT03109015|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5141137|NCT03109015|sunitinib|sunitinib
5141138|NCT03109015|Sutent|sutent
5141139|NCT03109015|cardiopulmonary function|cardiopulmonary function
5141140|NCT03108976|Autism|autism
5141141|NCT03108976|Sensori-motor learning|sensori-motor learning
5141142|NCT03108976|Development|development
5141143|NCT03108976|Neuroimaging|neuroimaging
5141144|NCT03108872|Anticoagulants|anticoagulants
5141145|NCT03108872|Atrial Appendage|atrial appendage
5141147|NCT03108846|Alzheimer's Disease|alzheimer's disease
5141148|NCT03108846|Agitation|agitation
5141149|NCT03108807|Emergency Department|emergency department
5141150|NCT03108807|Medical patients|medical patients
5141151|NCT03108807|D-dimer|d-dimer
5141152|NCT03108807|National Early Warning Score|national early warning score
5141154|NCT03108807|30-days mortality|30-days mortality
5141155|NCT03108807|Mortality|mortality
5141158|NCT03108781|Behavioral Psychiatric symptoms|behavioral psychiatric symptoms
5141159|NCT03108781|Treatment|treatment
5141160|NCT03108755|ASP7713|asp7713
5141161|NCT03108729|epilepsy|epilepsy
5141162|NCT03108729|Partial-onset seizures|partial-onset seizures
5141163|NCT03108729|Focal epilepsy|focal epilepsy
5141164|NCT03108729|Focal seizures|focal seizures
5141165|NCT03108729|Partial onset seizures|partial onset seizures
5141166|NCT03108729|Pediatric|pediatric
5141167|NCT03108729|Partial seizures|partial seizures
5141168|NCT03108703|RCC|rcc
5141169|NCT03108703|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5141170|NCT03108703|SBRT|sbrt
5141171|NCT03108703|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
5141172|NCT03108703|SABR|sabr
5141173|NCT03108690|Therapeutic drug monitoring|therapeutic drug monitoring
5141174|NCT03108690|Continuous infusion|continuous infusion
5141175|NCT03108690|Beta-lactam|beta-lactam
5141176|NCT03108690|Antibiotics|antibiotics
5141177|NCT03108690|Bacteraemia|bacteraemia
5141178|NCT03108677|RNA profiling|rna profiling
5141179|NCT03108677|Exosome|exosome
5141180|NCT03108677|Lung Metastases|lung metastases
5141181|NCT03108677|Osteosarcoma|osteosarcoma
5141182|NCT03108664|SYL1001|syl1001
5141183|NCT03108664|siRNA|sirna
5141184|NCT03108625|children|children
5141185|NCT03108625|adolescent|adolescent
5141186|NCT03108612|diagnostic accuracy|diagnostic accuracy
5141187|NCT03108612|upper limb|upper limb
5141188|NCT03108599|Health Promotion|health promotion
5141189|NCT03108599|Injury Prevention|injury prevention
5141190|NCT03108599|Safety|safety
5141191|NCT03108599|Wellbeing|wellbeing
5141192|NCT03108599|Physical Activity|physical activity
5141193|NCT03108599|Sleep|sleep
5141194|NCT03108599|Whole Body Vibration|whole body vibration
5141195|NCT03108599|Self-Monitoring|self-monitoring
5141196|NCT03108586|restorations|restorations
5141197|NCT03108586|diagnosis|diagnosis
5141198|NCT03108586|secondary caries|secondary caries
5141199|NCT03108586|treatment decision|treatment decision
5141200|NCT03108560|sublobar resection|sublobar resection
5141201|NCT03108560|lobectomy|lobectomy
5141202|NCT03108547|Sarcoidosis|sarcoidosis
5141203|NCT03108547|Scalp hair cortisol and testosterone|scalp hair cortisol and testosterone
5141204|NCT03108547|Fatigue|fatigue
5141205|NCT03108547|Biomarker|biomarker
5141206|NCT03108547|Psychological distress|psychological distress
5141207|NCT03108521|DPP - 4; GLP1R ; gene polymorphism research; diabetes|dpp - 4; glp1r ; gene polymorphism research; diabetes
5141208|NCT03108495|LN-145|ln-145
5141209|NCT03108495|Cell Therapy|cell therapy
5141210|NCT03108495|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
5141211|NCT03108495|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
5141212|NCT03108495|Cellular Immuno-therapy|cellular immuno-therapy
5141213|NCT03108495|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5141214|NCT03108495|TIL|til
5141215|NCT03108495|IL-2|il-2
5141216|NCT03108495|Pembrolizumab|pembrolizumab
5141217|NCT03108482|Acute Pain|acute pain
5141218|NCT03108482|Post-surgical Pain|post-surgical pain
5141219|NCT03108482|Bunionectomy|bunionectomy
5141220|NCT03108482|Co-crystal|co-crystal
5141221|NCT03108482|Tramadol|tramadol
5141222|NCT03108482|Celecoxib|celecoxib
5141223|NCT03108469|migraine|migraine
5141224|NCT03108456|atherectomy|atherectomy
5141225|NCT03108456|CAD|cad
5141226|NCT03108456|severe calcium|severe calcium
5141227|NCT03108456|orbital atherectomy|orbital atherectomy
5141228|NCT03108456|minimum stent area|minimum stent area
5141229|NCT03108404|predictive score|predictive score
5141230|NCT03108378|Gadolinium|gadolinium
5141231|NCT03108378|Bone|bone
5141232|NCT03108378|Skin|skin
5141233|NCT03108300|efficacy|efficacy
5141234|NCT03108300|propranolol hydrochloride|propranolol hydrochloride
5141235|NCT03108300|sts|sts
5141236|NCT03108274|Midazolam|midazolam
5141237|NCT03108274|Fexofenadine|fexofenadine
5141238|NCT03108274|Mycophenolate Mofetil|mycophenolate mofetil
5141239|NCT03108248|transarterial chemoembolization|transarterial chemoembolization
5141240|NCT03108248|stent|stent
5141241|NCT03108248|irradiation|irradiation
5141242|NCT03108248|survival|survival
5141243|NCT03108248|decompensation|decompensation
5141244|NCT03108248|tumor response|tumor response
5141245|NCT03108222|chronic kidney disease|chronic kidney disease
5141246|NCT03108222|CKD|ckd
5141247|NCT03108222|renal failure|renal failure
5141248|NCT03108222|phosphorus|phosphorus
5141249|NCT03108222|phosphate|phosphate
5141250|NCT03108222|intestinal absorption|intestinal absorption
5141251|NCT03108196|bladder cancer， neobladder, detaenial sigmoid, ileal|bladder cancer， neobladder, detaenial sigmoid, ileal
5141253|NCT03108157|DONOR EGGS|donor eggs
5141254|NCT03108157|ENDOMETRIAL SCRATCH|endometrial scratch
5141255|NCT03108157|PIPELLE|pipelle
5141256|NCT03108157|ONGOING PREGNANCY|ongoing pregnancy
5150605|NCT03050944|Adiponectin|adiponectin
5141261|NCT03108144|brief intervention|brief intervention
5137244|NCT03134144|Posture|posture
5141265|NCT03108118|Acute respiratory failure|acute respiratory failure
5141266|NCT03108118|Weaning|weaning
5141267|NCT03108092|Drug Utilization Review|drug utilization review
5141268|NCT03108092|Older people|older people
5141269|NCT03108092|Health economics|health economics
5141270|NCT03108079|Urologic Injuries|urologic injuries
5141271|NCT03108079|Urologic Diseases|urologic diseases
5141272|NCT03108079|Bladder Infection|bladder infection
5141273|NCT03108079|Urinary Tract Infections|urinary tract infections
5141274|NCT03108079|Mucosal Inflammation|mucosal inflammation
5141275|NCT03108079|Mucosal Infection|mucosal infection
5141276|NCT03108079|Bladder Injury|bladder injury
5141277|NCT03108079|Catheter Related Infections|catheter related infections
5141278|NCT03108079|Catheter Complications|catheter complications
5141279|NCT03108079|Catheter Infection|catheter infection
5141280|NCT03108079|Indwelling Catheter|indwelling catheter
5141281|NCT03108079|Pelvic Floor Disorders|pelvic floor disorders
5141282|NCT03108079|Urinary Incontinence|urinary incontinence
5141283|NCT03108053|urinary stones|urinary stones
5141284|NCT03108053|semirigid ureteroscopy|semirigid ureteroscopy
5141285|NCT03108053|guidewire|guidewire
5141286|NCT03108027|QVM149,|qvm149,
5141287|NCT03108027|asthma,|asthma,
5141288|NCT03108027|allergic asthma,|allergic asthma,
5141289|NCT03108027|allergy triggered asthma,|allergy triggered asthma,
5141290|NCT03108027|reactive asthma,|reactive asthma,
5141291|NCT03108027|asthma attack,|asthma attack,
5141292|NCT03108027|difficulty breathing|difficulty breathing
5141293|NCT03107962|NK/T cell lymphoma|nk/t cell lymphoma
5141294|NCT03107962|immunotherapy|immunotherapy
5141295|NCT03107962|clinical trial|clinical trial
5141297|NCT03107962|PFS|pfs
5141298|NCT03107962|OS|os
5141299|NCT03107949|Diaphragm atrophy|diaphragm atrophy
5141300|NCT03107949|VIDD|vidd
5141301|NCT03107949|weaning failure|weaning failure
5141302|NCT03107949|SBT|sbt
5141303|NCT03107923|Myocardial fibrosis|myocardial fibrosis
5141304|NCT03107923|Aortic Valve Stenosis|aortic valve stenosis
5141305|NCT03107923|TAVI|tavi
5141306|NCT03107923|Outcome|outcome
5141307|NCT03107897|TAVR|tavr
5141308|NCT03107897|elevated frailty score|elevated frailty score
5141309|NCT03107897|Transcatheter Valve Replacement|transcatheter valve replacement
5141310|NCT03107884|Insulin Resistance|insulin resistance
5141311|NCT03107884|Muscle Atrophy|muscle atrophy
5141312|NCT03107884|Metformin|metformin
5141313|NCT03107884|Muscle Loss|muscle loss
5141314|NCT03107884|Inactivity-induced muscle loss|inactivity-induced muscle loss
5141315|NCT03107884|older adults|older adults
5141316|NCT03107871|valganciclovir|valganciclovir
5141317|NCT03107845|CBT|cbt
5141318|NCT03107845|Psychometric Feedback|psychometric feedback
5141319|NCT03107845|Clinical Support Tools|clinical support tools
5141320|NCT03107845|Personalized Mental Health|personalized mental health
5141321|NCT03107819|Plasma metabolomics|plasma metabolomics
5141322|NCT03107819|Urinary metabolomics|urinary metabolomics
5141323|NCT03107819|Metabonomics|metabonomics
5141324|NCT03107819|Biomarker discovery|biomarker discovery
5027197|NCT03828682|once daily|once daily
5141325|NCT03107806|acute coronary syndromes|acute coronary syndromes
5141326|NCT03107806|hyperglycemia|hyperglycemia
5141327|NCT03107806|hypoglycemia|hypoglycemia
5141328|NCT03107806|continuous glucose monitoring|continuous glucose monitoring
5141329|NCT03107741|Metabolic Syndrome|metabolic syndrome
5141330|NCT03107741|Waist circumference|waist circumference
5141331|NCT03107741|Blood pressure|blood pressure
5141332|NCT03107741|Triglyceride|triglyceride
5141333|NCT03107741|HDL cholesterol|hdl cholesterol
5141334|NCT03107728|orthotics|orthotics
5141335|NCT03107728|high-energy lower extremity trauma|high-energy lower extremity trauma
5141336|NCT03107728|physical therapy|physical therapy
5141337|NCT03107728|bracing|bracing
5141348|NCT03107663|PET/CT|pet/ct
5141349|NCT03107663|Imaging|imaging
5141350|NCT03107663|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
5141351|NCT03107663|CD8 + T Cells|cd8 + t cells
5141352|NCT03107663|Standard of Care|standard of care
5141353|NCT03107637|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
5141354|NCT03107637|transesophageal echocardiography|transesophageal echocardiography
5141355|NCT03107637|cardiac source of embolism|cardiac source of embolism
5141356|NCT03107637|ischemic stroke|ischemic stroke
5141357|NCT03107598|spinal anesthesia|spinal anesthesia
5141358|NCT03107598|neonatal outcome|neonatal outcome
5141359|NCT03107598|Caesarean Section|caesarean section
5141360|NCT03107585|cervical plexus block|cervical plexus block
5141361|NCT03107585|thyroidectomy|thyroidectomy
5141362|NCT03107585|opioid consumption|opioid consumption
5150707|NCT03050398|CDK|cdk
5141364|NCT03107559|epidural analgesia|epidural analgesia
5141365|NCT03107559|labor|labor
5141371|NCT03107520|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5141372|NCT03107520|Lumason|lumason
5141373|NCT03107520|developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
5141379|NCT03107507|Neurodevelopmental Abnormality|neurodevelopmental abnormality
5141380|NCT03107481|Acetaminophen|acetaminophen
5141381|NCT03107481|Hydromorphone|hydromorphone
5141382|NCT03107481|Emergency Department|emergency department
5141383|NCT03107481|Narcotics|narcotics
5141384|NCT03107481|Analgesics, Opioid|analgesics, opioid
5141385|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic
5141386|NCT03107468|Non-surgical treatment|non-surgical treatment
5141387|NCT03107468|Acupuncture|acupuncture
5141388|NCT03107468|Chuna|chuna
5141389|NCT03107468|Physiotherapy|physiotherapy
5141390|NCT03107468|Epidural steroid injection|epidural steroid injection
5141391|NCT03107455|MitraClip|mitraclip
5141392|NCT03107455|Acute mitral regurgitation|acute mitral regurgitation
5141393|NCT03107455|Acute myocardial infarction|acute myocardial infarction
5141394|NCT03107442|Arterial stiffness|arterial stiffness
5141395|NCT03107442|Markers of Inflammation|markers of inflammation
5141396|NCT03107442|Exercise|exercise
5141397|NCT03107442|Physical fitness|physical fitness
5141398|NCT03107442|Cardiovascular risk|cardiovascular risk
5141399|NCT03107442|Autoimmune diseases|autoimmune diseases
5141400|NCT03107429|Trendelenburg|trendelenburg
5141401|NCT03107429|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5141402|NCT03107429|POVL|povl
5141403|NCT03107416|Bumetanide|bumetanide
5141404|NCT03107416|Diuretic|diuretic
5141405|NCT03107416|Transarterial Embolization (TAE)|transarterial embolization (tae)
5141406|NCT03107416|17-141|17-141
5141407|NCT03107403|dreams bereavement|dreams bereavement
5141408|NCT03107403|emotional|emotional
5141409|NCT03107403|regulation|regulation
5141410|NCT03107403|bereavement|bereavement
5141411|NCT03107338|Pre-emptive analgesia; Dexketoprofen trometamol|pre-emptive analgesia; dexketoprofen trometamol
5141413|NCT03107208|type 1 diabetes|type 1 diabetes
5141414|NCT03107208|children|children
5141415|NCT03107208|continuous glucose monitoring|continuous glucose monitoring
5141416|NCT03107182|HPV- positive HNSCC|hpv- positive hnscc
5141417|NCT03107182|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5141418|NCT03107156|Treatment care planning|treatment care planning
5141419|NCT03107143|Pressure ulcer prevention|pressure ulcer prevention
5141420|NCT03107143|Pressure injury|pressure injury
5141421|NCT03107091|Terlipressin|terlipressin
5141422|NCT03107091|Terlipressin acetate|terlipressin acetate
5141423|NCT03107065|Sweating|sweating
5141424|NCT03107026|Binge eating Disorder|binge eating disorder
5141425|NCT03107026|dasotraline|dasotraline
5141426|NCT03107013|Mass Balance|mass balance
5141427|NCT03107013|Phase 1|phase 1
5141534|NCT03106480|HIV|hiv
5141480|NCT03106727|Maternal and Child Health|maternal and child health
5141481|NCT03106727|Integrated Care|integrated care
5141482|NCT03106727|Malawi|malawi
5141484|NCT03106714|persistence|persistence
5141485|NCT03106714|body fluids|body fluids
5141486|NCT03106688|PET imaging|pet imaging
5141487|NCT03106688|Cannabinoid receptor|cannabinoid receptor
5141488|NCT03106688|Opioid receptor|opioid receptor
5141489|NCT03106688|Addiction|addiction
5141490|NCT03106688|fMRI imaging|fmri imaging
5141491|NCT03106675|HIFU|hifu
5141492|NCT03106675|MR-HIFU|mr-hifu
5141493|NCT03106675|MRgFUs|mrgfus
5141494|NCT03106675|MRI-intervention|mri-intervention
5141495|NCT03106675|Palliation|palliation
5141496|NCT03106662|Mesenchymal stem cell|mesenchymal stem cell
5141497|NCT03106662|haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5141498|NCT03106662|graft-versus-host disease|graft-versus-host disease
5141499|NCT03106662|engraftment|engraftment
5141500|NCT03106636|Preschool-aged|preschool-aged
5141501|NCT03106636|Foster children|foster children
5141502|NCT03106636|child welfare|child welfare
5141503|NCT03106636|Fostercare|fostercare
5141504|NCT03106636|Parent training|parent training
5141505|NCT03106636|early adversity|early adversity
5141506|NCT03106636|curriculum based|curriculum based
5141507|NCT03106636|early intervention|early intervention
5141508|NCT03106636|preschool|preschool
5141509|NCT03106636|foster placement disruptions|foster placement disruptions
5141510|NCT03106636|manualized intervention|manualized intervention
5141511|NCT03106636|group based intervention|group based intervention
5141512|NCT03106636|high-risk children|high-risk children
5141513|NCT03106610|Bladder cancer|bladder cancer
5141514|NCT03106610|Cancer of urothelium|cancer of urothelium
5141515|NCT03106610|Transitional cell carcinoma|transitional cell carcinoma
5141516|NCT03106610|Carcinoma in situ|carcinoma in situ
5141517|NCT03106610|Nivolumab|nivolumab
5141525|NCT03106584|Glucosamine|glucosamine
5141526|NCT03106584|WOMAC|womac
5141527|NCT03106584|Osteoarthritis|osteoarthritis
5141528|NCT03106571|Phase 1 clinical trial|phase 1 clinical trial
5141529|NCT03106506|Implants|implants
5141530|NCT03106506|Conjunctive tissue graft|conjunctive tissue graft
5141531|NCT03106506|Prospective study|prospective study
5141532|NCT03106480|Pre-diabetes|pre-diabetes
5141533|NCT03106480|Diabetes Mellitus|diabetes mellitus
5141540|NCT03106480|Pre-Hypertension|pre-hypertension
5141542|NCT03106467|appendectomy|appendectomy
5141543|NCT03106467|laparoscopic|laparoscopic
5141544|NCT03106467|single port|single port
5141545|NCT03106467|randomized|randomized
5141553|NCT03106389|misoprostol|misoprostol
5141554|NCT03106389|transcervical balloon catheter|transcervical balloon catheter
5141555|NCT03106389|second trimester|second trimester
5141556|NCT03106389|induced abortion|induced abortion
5141557|NCT03106337|Thyroid|thyroid
5141558|NCT03106337|Follicular Neoplasms|follicular neoplasms
5141559|NCT03106337|Bethesda System|bethesda system
5141560|NCT03106337|Elastography|elastography
5141561|NCT03106337|Doppler ultrasound|doppler ultrasound
5141562|NCT03106337|Thyroidectomy|thyroidectomy
5141569|NCT03106298|Iron Deficiency|iron deficiency
5141570|NCT03106298|Fibroblast Growth Factor 23|fibroblast growth factor 23
5141571|NCT03106298|Phosphate|phosphate
5141572|NCT03106259|FURESTEM-RA|furestem-ra
5141573|NCT03106246|Extracellular vesicles|extracellular vesicles
5141574|NCT03106246|Autoimmunity|autoimmunity
5141575|NCT03106246|Beta-cell injury|beta-cell injury
5141576|NCT03106233|Breast reconstruction|breast reconstruction
5141577|NCT03106233|Perforator flap|perforator flap
5141578|NCT03106233|Microsurgery|microsurgery
5141579|NCT03106168|Extraction|extraction
5141580|NCT03106168|Local Anesthetic|local anesthetic
5141581|NCT03106168|Mepivacaine|mepivacaine
5141582|NCT03106168|Mandibular Molar|mandibular molar
5141583|NCT03106142|intervention, improvement strategy|intervention, improvement strategy
5141584|NCT03106116|Coronary Heart Disease|coronary heart disease
5141585|NCT03106116|Ventricular Function|ventricular function
5141586|NCT03106116|Vascular Endothelium|vascular endothelium
5141587|NCT03106116|Counterpulsation, External|counterpulsation, external
5141589|NCT03106103|cystitis|cystitis
5141590|NCT03106103|prophylactic antibiotics|prophylactic antibiotics
5141591|NCT03106103|bacteriuria|bacteriuria
5141592|NCT03106090|survivorship care plan|survivorship care plan
5141593|NCT03106090|head and neck cancer|head and neck cancer
5141594|NCT03106090|survivorship|survivorship
5141595|NCT03106051|Arthritis|arthritis
5141596|NCT03106051|Psoriatic|psoriatic
5141597|NCT03106051|Observational|observational
5141598|NCT03106051|Apremilast|apremilast
5141599|NCT03106038|contrast agent|contrast agent
5141600|NCT03106038|ureter imaging|ureter imaging
5141601|NCT03106038|intraoperative monitoring|intraoperative monitoring
5141602|NCT03106038|intraoperative procedures|intraoperative procedures
5141603|NCT03106038|near infrared fluorescence|near infrared fluorescence
5141604|NCT03106038|minimally invasive|minimally invasive
5141605|NCT03105973|jail|jail
5141606|NCT03105973|prison|prison
5141607|NCT03105973|technology|technology
5141608|NCT03105973|depression|depression
5141610|NCT03105947|lipids|lipids
5141611|NCT03105947|dietary fats|dietary fats
5141612|NCT03105921|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
5027444|NCT03827200|Ascites|ascites
5141613|NCT03105921|Irreversible electroporation|irreversible electroporation
5141614|NCT03105921|Interventional radiology|interventional radiology
5141615|NCT03105895|Incisional hernia|incisional hernia
5141616|NCT03105895|Mesh prevention|mesh prevention
5141617|NCT03105895|Mesh augmentation|mesh augmentation
5141618|NCT03105882|Spinal Cord Injury|spinal cord injury
5141619|NCT03105882|SCI|sci
5141620|NCT03105882|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
5141621|NCT03105869|repeatability|repeatability
5141622|NCT03105869|positron emission tomography (PET)|positron emission tomography (pet)
5141623|NCT03105869|fluorocholine|fluorocholine
5141624|NCT03105856|Mass screening|mass screening
5141625|NCT03105856|Vaccination|vaccination
5141626|NCT03105856|Mexico|mexico
5141627|NCT03105843|Asthma|asthma
5141628|NCT03105843|Cough|cough
5141629|NCT03105843|Eucapneic Voluntary Hyperventilation|eucapneic voluntary hyperventilation
5141630|NCT03105843|Hypertonic Saline|hypertonic saline
5141631|NCT03105817|Asymmetric cellulose triacetate|asymmetric cellulose triacetate
5141632|NCT03105817|Biocompatibility|biocompatibility
5141633|NCT03105817|Hemodiafiltration on-line|hemodiafiltration on-line
5141634|NCT03105817|Convective volume|convective volume
5141635|NCT03105817|Adequacy|adequacy
5141642|NCT03105752|Volunteers|volunteers
5141643|NCT03105752|Informed consent|informed consent
5141644|NCT03105752|Comprehension|comprehension
5141645|NCT03105752|Language tests|language tests
5141646|NCT03105726|End Stage Heart Failure|end stage heart failure
5141647|NCT03105726|New York Heart Association functional class III or IV|new york heart association functional class iii or iv
5141648|NCT03105726|Heart transplantation|heart transplantation
5141649|NCT03105726|Ventricular assisted devices|ventricular assisted devices
5141650|NCT03105726|Cardiogenic shock|cardiogenic shock
5141651|NCT03105713|Checklist|checklist
5141652|NCT03105713|Patient Checklist|patient checklist
5141654|NCT03105713|Safety|safety
5141655|NCT03105713|Patient Involvement|patient involvement
5141662|NCT03105687|mHealth|mhealth
5141663|NCT03105687|SMS reminders|sms reminders
5141664|NCT03105687|adherence|adherence
5141665|NCT03105687|antihypertensive drugs|antihypertensive drugs
5141666|NCT03105687|pharmacists|pharmacists
5141667|NCT03105687|cost-effectiveness|cost-effectiveness
5141668|NCT03105674|analgesia|analgesia
5141669|NCT03105674|peri-anal procedure|peri-anal procedure
5141670|NCT03105674|peri-anal block|peri-anal block
5141671|NCT03105674|anal surgery|anal surgery
5141672|NCT03105635|Community Resources|community resources
5141673|NCT03105635|Health Navigator|health navigator
5141674|NCT03105622|Exercise|exercise
5141675|NCT03105622|Screen|screen
5141676|NCT03105622|Music|music
5141677|NCT03105622|Energy compensation|energy compensation
5141678|NCT03105622|Adolescents|adolescents
5141679|NCT03105622|Running+screen|running+screen
5141680|NCT03105622|Running+music|running+music
5141681|NCT03105622|Running without stimulus (control condition)|running without stimulus (control condition)
5141682|NCT03105609|hyperspectral imaging, Ranibizumab|hyperspectral imaging, ranibizumab
5141683|NCT03105583|Medication beliefs|medication beliefs
5141684|NCT03105583|Information desire|information desire
5141685|NCT03105583|Vitamin deficiencies|vitamin deficiencies
5141686|NCT03105570|breast neoplasms|breast neoplasms
5141687|NCT03105570|Mastectomy, Subcutaneous|mastectomy, subcutaneous
5141688|NCT03105570|Areola|areola
5141689|NCT03105557|Prematurely born newborns|prematurely born newborns
5141690|NCT03105557|Urine|urine
5141691|NCT03105557|Collecting device|collecting device
5141692|NCT03105544|simulation-based training|simulation-based training
5141693|NCT03105544|obstetric ultrasound|obstetric ultrasound
5141694|NCT03105544|intrauterine growth restriction|intrauterine growth restriction
5141695|NCT03105544|ultrasound simulation|ultrasound simulation
5141696|NCT03105531|primary aldosteronism|primary aldosteronism
5141697|NCT03105531|hypertension|hypertension
5141698|NCT03105531|screening|screening
5141699|NCT03105531|secondary hypertension|secondary hypertension
5141700|NCT03105518|assisted reproduction|assisted reproduction
5141701|NCT03105518|postoperative pain|postoperative pain
5141702|NCT03105518|opioid|opioid
5141703|NCT03105492|Prenatal Testing|prenatal testing
5141704|NCT03105479|vancomycin|vancomycin
5141705|NCT03105479|children|children
5141706|NCT03105479|cadazolid|cadazolid
5141707|NCT03105479|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5141708|NCT03105466|Corneal Transplantation|corneal transplantation
5141709|NCT03105466|Xenotransplantation|xenotransplantation
5141710|NCT03105466|Bioegineered cornea|bioegineered cornea
5141711|NCT03105453|Assisted reproductive technologies|assisted reproductive technologies
5141712|NCT03105453|Microbiome|microbiome
5141713|NCT03105440|breast cancer|breast cancer
5141714|NCT03105440|lymphedema|lymphedema
5141715|NCT03105440|pain|pain
5027570|NCT03826498|CP|cp
5141716|NCT03105440|range of motion|range of motion
5141717|NCT03105440|technologic innovation|technologic innovation
5141718|NCT03105440|rehabilitation|rehabilitation
5141719|NCT03105414|Mechanical ventilation|mechanical ventilation
5141720|NCT03105414|Pediatrics|pediatrics
5141721|NCT03105414|Cross infection|cross infection
5141722|NCT03105414|Intensive care|intensive care
5141723|NCT03105414|Diagnosis|diagnosis
5141724|NCT03105375|Potassium competitive acid blocker|potassium competitive acid blocker
5141725|NCT03105375|X842|x842
5141726|NCT03105375|Gastroesophageal reflux disease|gastroesophageal reflux disease
5141727|NCT03105375|Esophagitis|esophagitis
5141728|NCT03105375|Intragastric pH|intragastric ph
5141729|NCT03105375|Acid inhibition|acid inhibition
5141731|NCT03105310|Hepatitis D|hepatitis d
5141732|NCT03105310|Ezetimibe|ezetimibe
5141733|NCT03105310|Pegylated interferon|pegylated interferon
5141734|NCT03105297|Nasal dilator strip|nasal dilator strip
5141735|NCT03105297|Sleep disordered breathing|sleep disordered breathing
5141736|NCT03105284|stem cell|stem cell
5141737|NCT03105284|liposuction|liposuction
5141738|NCT03105284|regenerative medicine|regenerative medicine
5141739|NCT03105245|electroconvulsive therapy|electroconvulsive therapy
5141740|NCT03105245|anaesthesia|anaesthesia
5141741|NCT03105206|lowl pole renal calculus|lowl pole renal calculus
5141742|NCT03105206|anatomical parameters|anatomical parameters
5141751|NCT03105167|TLIF|tlif
5141752|NCT03105141|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
5141753|NCT03105141|Remote ischemic conditioning|remote ischemic conditioning
5141754|NCT03105141|Stroke|stroke
5141755|NCT03105128|Crohn's Disease (CD)|crohn's disease (cd)
5141756|NCT03105128|Risankizumab|risankizumab
5141757|NCT03105128|ABBV-066|abbv-066
5141758|NCT03105128|BI 655066|bi 655066
5141759|NCT03105115|fentanyl|fentanyl
5141760|NCT03105115|dexmedetomidine|dexmedetomidine
5141761|NCT03105102|risankizumab|risankizumab
5141762|NCT03105102|ABBV-066|abbv-066
5141763|NCT03105102|BI 655066|bi 655066
5141764|NCT03105050|access|access
5141765|NCT03105050|policy|policy
5141766|NCT03105024|specific phobia|specific phobia
5141767|NCT03105024|height phobia|height phobia
5141768|NCT03105024|exposure|exposure
5141769|NCT03105024|virtual reality|virtual reality
5141781|NCT03104959|N-acetyl cysteine|n-acetyl cysteine
5141782|NCT03104959|alcohol|alcohol
5141783|NCT03104933|Proadrenomedullin|proadrenomedullin
5141784|NCT03104933|Copeptin|copeptin
5141785|NCT03104933|Vasopressors|vasopressors
5141786|NCT03104933|Septic Shock|septic shock
5141787|NCT03104920|ERAS|eras
5141788|NCT03104920|Time to ready for discharge|time to ready for discharge
5141789|NCT03104907|IPSS|ipss
5141790|NCT03104907|Quality of Life|quality of life
5141791|NCT03104907|DAN-PSS|dan-pss
5141792|NCT03104907|Complications|complications
5141793|NCT03104907|Prostate cancer|prostate cancer
5141794|NCT03104881|stroke|stroke
5141795|NCT03104855|cystic fibrosis|cystic fibrosis
5141796|NCT03104855|vitamin d catabolism|vitamin d catabolism
5141797|NCT03104816|Acetaminophen po|acetaminophen po
5141798|NCT03104816|Acetaminophen IV|acetaminophen iv
5141799|NCT03104816|Pain management|pain management
5141800|NCT03104816|minimally invasive lumbar fusions|minimally invasive lumbar fusions
5141801|NCT03104816|Ofirmev|ofirmev
5141802|NCT03104816|Analgesics|analgesics
5141803|NCT03104816|Opioid|opioid
5141804|NCT03104816|Pain|pain
5141805|NCT03104816|Postoperative|postoperative
5141806|NCT03104816|Spinal|spinal
5141807|NCT03104764|labial frenulum|labial frenulum
5141808|NCT03104764|surgery|surgery
5141809|NCT03104764|scalpel technique|scalpel technique
5141810|NCT03104764|Er:YAG laser|er:yag laser
5141811|NCT03104751|Complex Congenital Heart Defect|complex congenital heart defect
5141812|NCT03104751|Infants|infants
5141817|NCT03104712|glycemic index|glycemic index
5141818|NCT03104699|Antibodies|antibodies
5141819|NCT03104699|Immunologic effects|immunologic effects
5141820|NCT03104699|Physiological Effects of Drugs|physiological effects of drugs
5141821|NCT03104673|Molecular signature|molecular signature
5141822|NCT03104673|Thailand-Myanmar border|thailand-myanmar border
5141823|NCT03104621|preservative-free, tafluprost|preservative-free, tafluprost
5141824|NCT03104595|EC-18, febrile neutropenia, breast cancer, chemotherapy|ec-18, febrile neutropenia, breast cancer, chemotherapy
5141825|NCT03104582|ERCP|ercp
5141826|NCT03104582|PTBD|ptbd
5141827|NCT03104582|EBD|ebd
5141828|NCT03104582|Cholangitis|cholangitis
5141829|NCT03104582|Complication|complication
5141830|NCT03104582|Klatskin tumor|klatskin tumor
5141831|NCT03104569|ERCP|ercp
5141832|NCT03104569|Contrast agent|contrast agent
5141833|NCT03104569|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
5141834|NCT03104569|Cholangitis|cholangitis
5141835|NCT03104569|Nonionic|nonionic
5141836|NCT03104543|survivor|survivor
5141837|NCT03104543|undertreatment|undertreatment
5141838|NCT03104543|adherence|adherence
5141839|NCT03104543|self-efficacy|self-efficacy
5141840|NCT03104530|Crab|crab
5141841|NCT03104530|Brown meat|brown meat
5141844|NCT03104530|Zinc|zinc
5141845|NCT03104530|Selenium|selenium
5141846|NCT03104530|Creatinine|creatinine
5141847|NCT03104530|B2-Microglobulin|b2-microglobulin
5141876|NCT03104400|Arthritis|arthritis
5141877|NCT03104400|Psoriasis|psoriasis
5141878|NCT03104400|Anti-inflammatory|anti-inflammatory
5141879|NCT03104400|Joint disease|joint disease
5141880|NCT03104400|Musculoskeletal disease|musculoskeletal disease
5141881|NCT03104400|Anti-Rheumatic|anti-rheumatic
5141882|NCT03104387|Air pollution|air pollution
5141883|NCT03104387|Diesel exhaust|diesel exhaust
5141884|NCT03104387|Ultrafine particles|ultrafine particles
5141885|NCT03104387|Vascular function|vascular function
5141886|NCT03104387|Endothelium function|endothelium function
5141887|NCT03104387|Heart rate variability|heart rate variability
5141888|NCT03104387|DNA damage|dna damage
5141889|NCT03104374|Arthritis|arthritis
5141890|NCT03104374|Psoriasis|psoriasis
5141891|NCT03104374|Anti-Rheumatic|anti-rheumatic
5141892|NCT03104374|Anti-inflammatory|anti-inflammatory
5141893|NCT03104374|Joint disease|joint disease
5141894|NCT03104374|Musculoskeletal disease|musculoskeletal disease
5141895|NCT03104361|intersitial cystitis|intersitial cystitis
5141896|NCT03104361|Bladder pain syndrome|bladder pain syndrome
5141897|NCT03104361|Intravesical treatment|intravesical treatment
5141899|NCT03104348|Primary care|primary care
5141900|NCT03104335|soft tissue sarcoma|soft tissue sarcoma
5141901|NCT03104335|advanced|advanced
5141902|NCT03104335|apatinib|apatinib
5141903|NCT03104335|tyrosine-kinase inhibitors|tyrosine-kinase inhibitors
5141904|NCT03104322|digital health|digital health
5141905|NCT03104322|home spirometry|home spirometry
5141906|NCT03104322|patient reported outcome measure|patient reported outcome measure
5141907|NCT03104322|e-health|e-health
5141908|NCT03104322|pirfenidone|pirfenidone
5141909|NCT03104322|nintedanib|nintedanib
5141910|NCT03104322|FVC|fvc
5141911|NCT03104322|antifibrotic|antifibrotic
5141912|NCT03104296|NIRS|nirs
5141913|NCT03104296|Griffiths Mental Development Scales|griffiths mental development scales
5141914|NCT03104296|prematurity|prematurity
5141915|NCT03104283|apatinib|apatinib
5141916|NCT03104283|gastric cancer|gastric cancer
5141917|NCT03104283|elderly patients|elderly patients
5141918|NCT03104270|Elotuzumab, Multiple Myeloma, Phase 2|elotuzumab, multiple myeloma, phase 2
5141919|NCT03104257|Healthy Control, Cannabis, Dependence|healthy control, cannabis, dependence
5141920|NCT03104244|concussion|concussion
5141921|NCT03104244|subconcussive impacts|subconcussive impacts
5141922|NCT03104244|brain function|brain function
5141923|NCT03104244|football|football
5141924|NCT03104231|atrial fibrillation|atrial fibrillation
5141925|NCT03104231|oral anticoagulantion|oral anticoagulantion
5141926|NCT03104231|stroke prevention|stroke prevention
5141927|NCT03104231|education|education
5141928|NCT03104231|e-medicine|e-medicine
5141935|NCT03104192|frail elderly|frail elderly
5141936|NCT03104192|telemedicine|telemedicine
5141937|NCT03104192|obesity|obesity
5141938|NCT03104192|rural health|rural health
5141939|NCT03104192|health promotion|health promotion
5141940|NCT03104192|weight loss|weight loss
5141941|NCT03104127|Lower-limb robotic device|lower-limb robotic device
5141942|NCT03104127|Gait|gait
5141946|NCT03104127|Blood pressure|blood pressure
5141947|NCT03104127|Blood velocity|blood velocity
5141948|NCT03104127|Aerobic fitness|aerobic fitness
5141949|NCT03104127|Strength|strength
5141950|NCT03104101|PTNS|ptns
5141951|NCT03104101|Neuromodulation|neuromodulation
5141952|NCT03104101|TPTNS|tptns
5141957|NCT03104075|Elderly|elderly
5141958|NCT03104049|Parkinson's Disease|parkinson's disease
5141959|NCT03104049|Neuromuscular taping|neuromuscular taping
5141960|NCT03104049|Trunk|trunk
5141961|NCT03104049|Posture|posture
5141962|NCT03104049|Kinematic|kinematic
5141963|NCT03104049|rehabilitation|rehabilitation
5141964|NCT03104036|Feacal bacterial transplantation|feacal bacterial transplantation
5141965|NCT03104036|Left-sided ulcerative colitis|left-sided ulcerative colitis
5141966|NCT03103997|Liver|liver
5141968|NCT03103997|Biopsy|biopsy
5141969|NCT03103997|Heparin|heparin
5141970|NCT03103984|Obesity|obesity
5141971|NCT03103984|Liver transplantation|liver transplantation
5141972|NCT03103984|weight loss diet|weight loss diet
5141973|NCT03103984|immunosuppression|immunosuppression
5141974|NCT03103958|probiotic|probiotic
5141975|NCT03103958|metagenomic|metagenomic
5141976|NCT03103958|constipation|constipation
5141977|NCT03103945|Atrial Fibrillation|atrial fibrillation
5141978|NCT03103945|Atrial Arrhythmia|atrial arrhythmia
5141979|NCT03103945|Arrhythmias, Cardiac|arrhythmias, cardiac
5141980|NCT03103945|Cardiac Diseases|cardiac diseases
5141981|NCT03103945|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
5141982|NCT03103945|Electrophysiology|electrophysiology
5141983|NCT03103945|Remote Magnetic Navigation|remote magnetic navigation
5141984|NCT03103945|Contact Detection System|contact detection system
5141985|NCT03103932|biomarkers|biomarkers
5141986|NCT03103932|heart failure|heart failure
5141987|NCT03103932|hospital admission|hospital admission
5141988|NCT03103919|Parkinson´s Disease|parkinson´s disease
5141989|NCT03103919|Kinesia-360™|kinesia-360™
5141990|NCT03103919|Kinesia-ONE™|kinesia-one™
5141991|NCT03103919|Biosensor|biosensor
5141992|NCT03103880|Patient Adherence|patient adherence
5141993|NCT03103880|Mobile Applications|mobile applications
5141994|NCT03103880|Mobile Health|mobile health
5141995|NCT03103854|Exercise|exercise
5141996|NCT03103854|Secondary Prevention|secondary prevention
5141997|NCT03103854|Diabetes|diabetes
5141998|NCT03103854|Rehabilitation|rehabilitation
5141999|NCT03103841|Children|children
5142000|NCT03103815|Amyotrophic lateral sclerosis, survival, adverse event|amyotrophic lateral sclerosis, survival, adverse event
5142001|NCT03103763|Elderly|elderly
5142002|NCT03103763|Anticoagulation|anticoagulation
5142003|NCT03103763|Risk Assessment|risk assessment
5142004|NCT03103750|Vitamin D|vitamin d
5142005|NCT03103737|Well-being|well-being
5142006|NCT03103737|Information and communication technologies|information and communication technologies
5142007|NCT03103737|Hospital|hospital
5142008|NCT03103711|Virtual reality|virtual reality
5142009|NCT03103711|Well-being|well-being
5142010|NCT03103711|Hospital|hospital
5142011|NCT03103698|analgesia per-operative|analgesia per-operative
5142021|NCT03103542|Immune Tolerance Induction|immune tolerance induction
5142022|NCT03103490|PET/MR|pet/mr
5142023|NCT03103425|New onset seizures|new onset seizures
5142025|NCT03103386|fermented rye bran|fermented rye bran
5142026|NCT03103386|H. pylori infections|h. pylori infections
5142027|NCT03103386|non-communicable diseases|non-communicable diseases
5142028|NCT03103373|Echocardiography|echocardiography
5142029|NCT03103373|anesthesia|anesthesia
5142030|NCT03103373|general surgery|general surgery
5142031|NCT03103347|EEG|eeg
5142032|NCT03103347|Parkinson Disease|parkinson disease
5142033|NCT03103347|Beta Oscillations|beta oscillations
5142034|NCT03103308|Cancer|cancer
5142035|NCT03103308|Exercise|exercise
5142036|NCT03103308|Physical Function|physical function
5142037|NCT03103295|tissue engineering,|tissue engineering,
5142038|NCT03103295|regeneration,|regeneration,
5142039|NCT03103295|repair,|repair,
5142040|NCT03103295|traumatic bone defects,|traumatic bone defects,
5142041|NCT03103295|regenerative therapy|regenerative therapy
5142042|NCT03103269|Overweight|overweight
5142043|NCT03103269|Obesity|obesity
5142044|NCT03103269|Prevention|prevention
5013953|NCT03909724|TAS-102|tas-102
5142045|NCT03103269|Diet|diet
5142050|NCT03103269|Barriers|barriers
5142051|NCT03103269|Perceptions|perceptions
5142052|NCT03103269|Environment|environment
5142053|NCT03103269|Eating Disorder|eating disorder
5142054|NCT03103269|Self efficacy|self efficacy
5142055|NCT03103243|Lupus|lupus
5142056|NCT03103243|SLE|sle
5142057|NCT03103243|Erythematosus|erythematosus
5142058|NCT03103230|Motor evoked potentials|motor evoked potentials
5142059|NCT03103230|aphasia|aphasia
5142060|NCT03103230|prognosis|prognosis
5142061|NCT03103230|stroke|stroke
5142062|NCT03103204|Obesity|obesity
5142063|NCT03103204|Periodontitis|periodontitis
5142064|NCT03103204|Therapeutics|therapeutics
5142065|NCT03103204|Chlorhexidine|chlorhexidine
5142066|NCT03103152|Prostate Cancer|prostate cancer
5142067|NCT03103152|Active Surveillance|active surveillance
5142068|NCT03103152|Chemo-prevention|chemo-prevention
5142069|NCT03103126|pedometer-determined walking|pedometer-determined walking
5142070|NCT03103126|resistance exercise|resistance exercise
5142071|NCT03103100|Local anesthetic|local anesthetic
5142072|NCT03103100|Labor epidural|labor epidural
5142073|NCT03103074|botulinum toxin|botulinum toxin
5142074|NCT03103061|Computed Tomography|computed tomography
5142075|NCT03102996|Alkali|alkali
5142076|NCT03102996|Graft|graft
5142077|NCT03102996|Acid base|acid base
5142078|NCT03102996|Metabolic acidosis|metabolic acidosis
5142079|NCT03102996|Chronic kidney disease|chronic kidney disease
5142080|NCT03102983|MRI, Functional|mri, functional
5142081|NCT03102970|COPD, Pain, Exacerbation|copd, pain, exacerbation
5142082|NCT03102918|Cannabidiol|cannabidiol
5142083|NCT03102879|mesenchymal stem cells|mesenchymal stem cells
5142084|NCT03102879|regenerative procedures|regenerative procedures
5142085|NCT03102879|tissue engineering|tissue engineering
5142086|NCT03102879|regenerative endodontic|regenerative endodontic
5142087|NCT03102879|scaffold|scaffold
5142088|NCT03102879|cell encapsulation|cell encapsulation
5142089|NCT03102879|dental pulp|dental pulp
5142090|NCT03102879|pulp regeneration|pulp regeneration
5142091|NCT03102879|plasma-derived biomaterial|plasma-derived biomaterial
5142092|NCT03102879|allogenic stem cells|allogenic stem cells
5142093|NCT03102879|mesenchymal stromal cells|mesenchymal stromal cells
5142094|NCT03102879|adult stem cells|adult stem cells
5142095|NCT03102879|umbilical cord stem cells|umbilical cord stem cells
5142096|NCT03102840|Carriage|carriage
5142097|NCT03102840|Immunogenicity|immunogenicity
5142098|NCT03102840|Pneumococcal conjugate vaccine 13 (PCV 13)|pneumococcal conjugate vaccine 13 (pcv 13)
5142099|NCT03102840|Children|children
5142100|NCT03102840|Pneumococcus|pneumococcus
5142101|NCT03102775|poverty|poverty
5142102|NCT03102775|unemployment|unemployment
5142103|NCT03102775|cluster-randomized|cluster-randomized
5142104|NCT03102775|family-project|family-project
5142105|NCT03102762|Erectile dysfunction|erectile dysfunction
5142106|NCT03102762|Botulinum toxin A|botulinum toxin a
5142107|NCT03102762|Botox|botox
5142108|NCT03102749|Airways|airways
5142109|NCT03102749|asthma|asthma
5142110|NCT03102749|overweight|overweight
5142111|NCT03102736|depression|depression
5142112|NCT03102736|ketamine|ketamine
5142121|NCT03102697|bariatric surgery|bariatric surgery
5142122|NCT03102684|e-cigarette|e-cigarette
5142123|NCT03102684|electronic cigarette|electronic cigarette
5142124|NCT03102684|passive exposure|passive exposure
5142125|NCT03102684|secondhand exposure|secondhand exposure
5142126|NCT03102684|smoking|smoking
5142127|NCT03102684|respiratory system|respiratory system
5142128|NCT03102619|Wireless monitoring|wireless monitoring
5142129|NCT03102619|Postoperative complications|postoperative complications
5142130|NCT03102619|Vital parameters|vital parameters
5142131|NCT03102619|Continuous monitoring|continuous monitoring
5142136|NCT03102580|Shared Decision Making|shared decision making
5142137|NCT03102554|Exome Sequencing|exome sequencing
5142138|NCT03102502|Coronary Heart Disease|coronary heart disease
5142139|NCT03102502|Atherosclerosis|atherosclerosis
5770969|NCT00240643|aspirin|aspirin
5142140|NCT03102502|Vascular Endothelium|vascular endothelium
5142141|NCT03102502|Counterpulsation, External|counterpulsation, external
5142142|NCT03102463|Insulin sensitivity|insulin sensitivity
5142144|NCT03102463|Insulin resistance|insulin resistance
5142145|NCT03102463|Milk derived hydrolysate|milk derived hydrolysate
5142146|NCT03102463|Hyperinsulinemic-euglycaemic clamp|hyperinsulinemic-euglycaemic clamp
5142244|NCT03101800|Ulcerative Colitis|ulcerative colitis
5142154|NCT03102385|blood donation|blood donation
5142156|NCT03102385|donor retention|donor retention
5142158|NCT03102372|VLCD|vlcd
5142159|NCT03102372|exercise|exercise
5142160|NCT03102372|Protein|protein
5142161|NCT03102372|Obesity|obesity
5142162|NCT03102346|cardiorespiratory fitness|cardiorespiratory fitness
5142163|NCT03102346|coronary artery disease|coronary artery disease
5142164|NCT03102346|cardiac rehabilitation|cardiac rehabilitation
5962057|NCT04283318|Type 1 diabetes mellitus|type 1 diabetes mellitus
5142165|NCT03102346|remote control|remote control
5142166|NCT03102346|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
5962058|NCT04283305|approach bias|approach bias
5142173|NCT03102307|Targeted axillary dissection|targeted axillary dissection
5142174|NCT03102307|Sentinel node biopsy|sentinel node biopsy
5151410|NCT03045640|ECD|ecd
5142175|NCT03102307|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5142176|NCT03102255|Nasotracheal intubation|nasotracheal intubation
5142177|NCT03102229|Activity Monitoring|activity monitoring
5142178|NCT03102229|Chemotherapy|chemotherapy
5142179|NCT03102229|Radiotherapy|radiotherapy
5142180|NCT03102164|heart failure|heart failure
5142181|NCT03102164|decompensation|decompensation
5142182|NCT03102125|heart transplant, acute graft rejection, chronic graft rejection|heart transplant, acute graft rejection, chronic graft rejection
5142183|NCT03102112|Glioma APT MRI|glioma apt mri
5142184|NCT03102073|Reading speed|reading speed
5142185|NCT03102047|microsatellite stable|microsatellite stable
5142186|NCT03102047|MSS|mss
5142187|NCT03102047|durvalumab|durvalumab
5142188|NCT03102047|NSABP|nsabp
5142189|NCT03102008|Transdiagnostic Treatment|transdiagnostic treatment
5142190|NCT03102008|Emotional Disorders|emotional disorders
5142191|NCT03102008|Adolescence|adolescence
5142192|NCT03102008|Psychotherapy|psychotherapy
5142193|NCT03101995|Treatment|treatment
5142194|NCT03101995|Locally advanced cervical cancer|locally advanced cervical cancer
5142195|NCT03101995|Renal failure|renal failure
5142196|NCT03101995|Gemcitabine|gemcitabine
5142197|NCT03101969|language|language
5142198|NCT03101969|scheduled|scheduled
5142199|NCT03101969|appointment|appointment
5142200|NCT03101956|Spine Manipulation|spine manipulation
5142201|NCT03101943|Sugar|sugar
5142202|NCT03101943|Sweetened|sweetened
5142203|NCT03101943|Beverages|beverages
5142204|NCT03101891|Amnioinfusion|amnioinfusion
5142205|NCT03101891|Fetal therapy|fetal therapy
5142206|NCT03101891|Bilateral Renal Agenesis|bilateral renal agenesis
5142207|NCT03101891|Fetal Renal Failure|fetal renal failure
5142208|NCT03101891|Lower Urinary Tract Obstruction (LUTO)|lower urinary tract obstruction (luto)
5142209|NCT03101891|Anhydramnios|anhydramnios
5142210|NCT03101878|Healthy Volunteers, IONIS AGT-Lrx|healthy volunteers, ionis agt-lrx
5142211|NCT03101865|Type 1 diabetes|type 1 diabetes
5142212|NCT03101865|Artificial Pancreas|artificial pancreas
5142213|NCT03101865|Closed-loop glucose control|closed-loop glucose control
5142214|NCT03101865|Very young children|very young children
5142215|NCT03101865|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5142216|NCT03101865|Continuous glucose monitoring|continuous glucose monitoring
5138066|NCT03128203|Resting-state|resting-state
5142221|NCT03101852|antiretroviral|antiretroviral
5142222|NCT03101852|Africa|africa
5142223|NCT03101852|ready-to-use food|ready-to-use food
5142224|NCT03101852|outpatient care|outpatient care
5142225|NCT03101839|AZD4785|azd4785
5142226|NCT03101839|KRAS|kras
5142227|NCT03101839|KRAS mutations|kras mutations
5142228|NCT03101839|Non-small cell lung cancer|non-small cell lung cancer
5142229|NCT03101839|Advanced solid tumours|advanced solid tumours
5142230|NCT03101826|Polyvagal Theory|polyvagal theory
5142231|NCT03101826|Respiratory Sinus Arrhythmia|respiratory sinus arrhythmia
5142232|NCT03101826|Heart rate|heart rate
5142233|NCT03101826|Social Behavior|social behavior
5142234|NCT03101826|Arginine Vasopressin|arginine vasopressin
5142235|NCT03101826|Dichotic Listening Tests|dichotic listening tests
5142236|NCT03101826|Oxytocin|oxytocin
5142237|NCT03101826|Hyperacusis|hyperacusis
5142238|NCT03101826|Affect|affect
5142239|NCT03101826|Auditory perception|auditory perception
5142240|NCT03101826|Sound spectrography|sound spectrography
5142241|NCT03101800|Azathioprine|azathioprine
5142242|NCT03101800|Allopurinol|allopurinol
5142243|NCT03101800|Antimetabolites|antimetabolites
5142245|NCT03101787|ECPR|ecpr
5142246|NCT03101787|Extracorporeal CardioPulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
5142247|NCT03101787|OHCA|ohca
5142248|NCT03101787|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5142249|NCT03101787|CPR|cpr
5142250|NCT03101787|CardioPulmonary Resuscitation|cardiopulmonary resuscitation
5142251|NCT03101787|ECMO|ecmo
5142252|NCT03101787|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5142253|NCT03101787|Refractory Cardiac Arrest|refractory cardiac arrest
5142254|NCT03101774|inspiratory muscle training|inspiratory muscle training
5142255|NCT03101722|presbycusis|presbycusis
5142256|NCT03101722|tinnitus|tinnitus
5142257|NCT03101722|cognitive impairment|cognitive impairment
5142258|NCT03101722|Huperzine A|huperzine a
5142259|NCT03101722|age-related hearing impairment|age-related hearing impairment
5142260|NCT03101696|coronary angiography|coronary angiography
5142261|NCT03101696|coronary conductance|coronary conductance
5142262|NCT03101696|hyperemia|hyperemia
5142263|NCT03101696|regadenoson|regadenoson
5142264|NCT03101696|fractional flow reserve|fractional flow reserve
5142265|NCT03101696|coronary flow reserve|coronary flow reserve
5142266|NCT03101696|index of microcirculatory resistance|index of microcirculatory resistance
5142267|NCT03101631|Elderly population with cancer|elderly population with cancer
5142268|NCT03101631|Toxicity risk|toxicity risk
5142269|NCT03101631|Mortality risk|mortality risk
5142270|NCT03101631|Frailty conditions in elderly population|frailty conditions in elderly population
5423372|NCT01615900|Teleconsultation|teleconsultation
5142283|NCT03101579|Pemetrexed|pemetrexed
5142284|NCT03101540|Major Depressive Disorder,|major depressive disorder,
5142285|NCT03101540|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
5142286|NCT03101540|PUFA|pufa
5142287|NCT03101540|Pregnancy|pregnancy
5142288|NCT03101540|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
5142289|NCT03101540|cytokine|cytokine
5142290|NCT03101540|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5142291|NCT03101527|Major Depressive Disorder|major depressive disorder
5142292|NCT03101527|omega-3 polyunsaturated fatty acid|omega-3 polyunsaturated fatty acid
5142293|NCT03101527|PUFA|pufa
5142294|NCT03101527|Pregnancy|pregnancy
5142295|NCT03101527|eicosapentaenoic acid (EPA) supplementation|eicosapentaenoic acid (epa) supplementation
5142296|NCT03101514|head and neck|head and neck
5142297|NCT03101514|tumor|tumor
5142298|NCT03101514|radiotherapy|radiotherapy
5142299|NCT03101514|mucositis|mucositis
5142300|NCT03101514|toxicity|toxicity
5142301|NCT03101514|Kanglaite injection|kanglaite injection
5142302|NCT03101488|KN035|kn035
5142303|NCT03101488|phase 1|phase 1
5142304|NCT03101475|Colorectal Cancer|colorectal cancer
5142305|NCT03101475|Liver Metastases|liver metastases
5142306|NCT03101475|Durvalumab|durvalumab
5142307|NCT03101475|Tremelimumab|tremelimumab
5028100|NCT03823417|Bleeding|bleeding
5142308|NCT03101436|Insulin Resistance|insulin resistance
5142309|NCT03101436|Extra Virgin Olive Oil|extra virgin olive oil
5142310|NCT03101436|Red Wine|red wine
5142311|NCT03101436|Diet|diet
5142312|NCT03101436|Microbiota|microbiota
5142313|NCT03101423|thalassemia|thalassemia
5142314|NCT03101423|transplantation|transplantation
5142315|NCT03101423|chimerism|chimerism
5142316|NCT03101423|donor ymphocytes|donor ymphocytes
5142317|NCT03101410|Gluten|gluten
5142318|NCT03101410|sport performance|sport performance
5142319|NCT03101397|serum KL-6|serum kl-6
5142320|NCT03101397|pulmonary function test|pulmonary function test
5142321|NCT03101397|CT score|ct score
5142322|NCT03101397|evaluation|evaluation
5142323|NCT03101358|cutaneous metastases|cutaneous metastases
5142326|NCT03101358|skin metastasis|skin metastasis
5142327|NCT03101306|cervix, radiotherapy, magnetic resonance imaging|cervix, radiotherapy, magnetic resonance imaging
5142328|NCT03101293|Drug therapy|drug therapy
5142329|NCT03101267|Cedar pollinosis|cedar pollinosis
5142330|NCT03101267|ASP4070|asp4070
5142331|NCT03101267|DNA plasmid vaccine|dna plasmid vaccine
5142332|NCT03101254|Melanoma|melanoma
5142333|NCT03101241|Essential Tremor|essential tremor
5142334|NCT03101241|Movement Disorders|movement disorders
5142335|NCT03101241|thalamocortical dysrhythmias|thalamocortical dysrhythmias
5142336|NCT03101228|Physical Activity|physical activity
5142337|NCT03101228|Metabolic Syndrome|metabolic syndrome
5142338|NCT03101228|Insulin Sensitivity|insulin sensitivity
5142339|NCT03101228|Cardiovascular Risk Factor|cardiovascular risk factor
5142340|NCT03101228|Sedentary Lifestyle|sedentary lifestyle
5142341|NCT03101228|Accelerometry|accelerometry
5142342|NCT03101189|safety|safety
5142343|NCT03101189|Japanese|japanese
5142344|NCT03101189|pharmacokinetics|pharmacokinetics
5142345|NCT03101176|multiparametric ultrasound|multiparametric ultrasound
5142346|NCT03101176|prostate cancer|prostate cancer
5142347|NCT03101176|contrast ultrasound|contrast ultrasound
5142349|NCT03101176|radical prostatectomy|radical prostatectomy
5142350|NCT03101150|Maternal vitamin D|maternal vitamin d
5142351|NCT03101150|Deficiency|deficiency
5142352|NCT03101150|Insufficiency|insufficiency
5142353|NCT03101150|Pregnancy|pregnancy
5142354|NCT03101150|Pre-eclampsia|pre-eclampsia
5142355|NCT03101150|IUGR|iugr
5142356|NCT03101124|Hemostasis, Surgical|hemostasis, surgical
5142357|NCT03101124|Tranexamic Acid|tranexamic acid
5142358|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents
5142359|NCT03101124|Administration, Cutaneous|administration, cutaneous
5142360|NCT03101124|Administration, Intravenous|administration, intravenous
5151595|NCT03044431|Breathlessness|breathlessness
5142364|NCT03101072|point-of-care randomization|point-of-care randomization
5142365|NCT03101059|Tracheal|tracheal
5142366|NCT03101059|Bronchial|bronchial
5142367|NCT03101059|Tracheobronchiomegaly|tracheobronchiomegaly
5142368|NCT03101059|Collapse|collapse
5142369|NCT03101059|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5142370|NCT03101059|Computer Tomography|computer tomography
5142371|NCT03101059|Impedance Tomography|impedance tomography
5142372|NCT03101046|Docetaxel|docetaxel
5142373|NCT03101046|Cabazitaxel|cabazitaxel
5142374|NCT03101033|Herniated lumbar disc|herniated lumbar disc
5142375|NCT03101033|Epidural neuroplasty|epidural neuroplasty
5142376|NCT03101033|Epidural injection|epidural injection
5142377|NCT03101020|Visceral Manipulation|visceral manipulation
5142378|NCT03101007|Comparative study|comparative study
5142379|NCT03101007|Knee Prosthesis|knee prosthesis
5142380|NCT03101007|Prosthesis Design|prosthesis design
5142381|NCT03101007|Treatment Outcome|treatment outcome
5142382|NCT03101007|Follow-up studies|follow-up studies
5142383|NCT03101007|Arthroplast, Replacement, Knee/methods|arthroplast, replacement, knee/methods
5962059|NCT04283305|virtual reality|virtual reality
5142384|NCT03100981|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5142385|NCT03100981|Internet-delivered|internet-delivered
5142387|NCT03100981|Prostate cancer|prostate cancer
5142388|NCT03100981|Survivors|survivors
5142389|NCT03100981|Depression|depression
5142391|NCT03100981|Stress|stress
5142392|NCT03100838|Proton Pump Inhibitor|proton pump inhibitor
5142393|NCT03100838|Bioequivalence|bioequivalence
5142394|NCT03100838|Drug-Drug Interaction|drug-drug interaction
5142395|NCT03100838|Modified Release|modified release
5142396|NCT03100838|Nifedipine|nifedipine
5142397|NCT03100825|QVM149,|qvm149,
5142398|NCT03100825|Asthma,|asthma,
5142399|NCT03100825|Japanese,|japanese,
5142400|NCT03100825|Allergic asthma,|allergic asthma,
5142401|NCT03100825|Allergy triggered asthma,|allergy triggered asthma,
5142402|NCT03100825|Reactive asthma,|reactive asthma,
5142403|NCT03100825|Asthma attack,|asthma attack,
5142404|NCT03100825|Difficulty breathing|difficulty breathing
5142405|NCT03100812|Hypertensive|hypertensive
5142406|NCT03100812|Hypertension|hypertension
5142407|NCT03100812|Filipino|filipino
5142408|NCT03100799|Osteoarthritis|osteoarthritis
5142409|NCT03100799|Senescence|senescence
5142410|NCT03100799|Magnetic resonance imaging|magnetic resonance imaging
5142411|NCT03100799|Arthroscopy|arthroscopy
5142412|NCT03100799|Arthrocentesis|arthrocentesis
5142413|NCT03100799|Biomarker|biomarker
5142414|NCT03100786|Tuberculosis|tuberculosis
5142415|NCT03100786|tuberculous meningitis|tuberculous meningitis
5142416|NCT03100786|drug induced liver injury|drug induced liver injury
5142417|NCT03100786|dexamethasone|dexamethasone
5142418|NCT03100786|LTA4H|lta4h
5142419|NCT03100786|host genotype|host genotype
5142420|NCT03100786|personalized medicine|personalized medicine
5142421|NCT03100773|alpha-amylases|alpha-amylases
5142422|NCT03100773|child|child
5142423|NCT03100773|cortisol|cortisol
5142424|NCT03100773|dental anxiety|dental anxiety
5138259|NCT03126942|Complete Denture|complete denture
5142429|NCT03100773|quality of life|quality of life
5142430|NCT03100773|saliva|saliva
5142431|NCT03100734|Observational|observational
5142432|NCT03100734|Biosimilar|biosimilar
5142433|NCT03100734|Etanercept|etanercept
5142434|NCT03100734|Benepali|benepali
5142435|NCT03100734|Enbrel|enbrel
5142436|NCT03100721|Education|education
5142437|NCT03100721|Neuroscience|neuroscience
5142438|NCT03100721|Chronic pain|chronic pain
5142439|NCT03100721|Musculoskeletal pain|musculoskeletal pain
5142440|NCT03100721|Primary care|primary care
5142441|NCT03100656|psychopathology|psychopathology
5142442|NCT03100656|treatment|treatment
5142443|NCT03100656|epoxide hydrolases|epoxide hydrolases
5142444|NCT03100656|polyunsaturated fatty acids|polyunsaturated fatty acids
5142445|NCT03100656|eicosanoids|eicosanoids
5342966|NCT01981343|A-F Betafood|a-f betafood
5342967|NCT01981343|Betaine|betaine
5142446|NCT03100643|HIV/AIDS, mHealth, intervention development, African American men|hiv/aids, mhealth, intervention development, african american men
5142447|NCT03100617|Family caregiver|family caregiver
5142448|NCT03100604|middle ear pressure|middle ear pressure
5142449|NCT03100604|sevoflurane|sevoflurane
5142450|NCT03100604|desflurane|desflurane
5142451|NCT03100578|PANCREAS|pancreas
5142452|NCT03100578|ENDOSCOPIC INTERVENTION|endoscopic intervention
5142453|NCT03100578|PLASTIC STENT|plastic stent
5142454|NCT03100578|SELF EXPANDING METALLIC STENT|self expanding metallic stent
5142455|NCT03100578|ENDOSCOPIC TRANSMURAL DRAINAGE|endoscopic transmural drainage
5142475|NCT03100474|tremor|tremor
5142476|NCT03100474|Parkinson's|parkinson's
5142477|NCT03100474|movement|movement
5142478|NCT03100474|neuropathic|neuropathic
5142479|NCT03100474|pain|pain
5142480|NCT03100461|Cancer Screening|cancer screening
5142481|NCT03100461|Colon Cancer|colon cancer
5142482|NCT03100461|Colon Cancer Screening|colon cancer screening
5142483|NCT03100409|Cervical cancer|cervical cancer
5142484|NCT03100383|gestational diabetes|gestational diabetes
5142485|NCT03100383|Type2 Diabetes|type2 diabetes
5142486|NCT03100331|neuropsychological outcomes|neuropsychological outcomes
5142487|NCT03100331|HIV/AIDS|hiv/aids
5142488|NCT03100331|international adoption|international adoption
5142489|NCT03100331|perinatal infection|perinatal infection
5142490|NCT03100292|primary bariatric surgery|primary bariatric surgery
5142491|NCT03100292|morbid obesity|morbid obesity
5142492|NCT03100292|South Korea|south korea
5142493|NCT03100292|sleeve gastrectomy|sleeve gastrectomy
5142494|NCT03100292|Roux-en Y gastric bypass|roux-en y gastric bypass
5142495|NCT03100279|cognitive behavioral therapy|cognitive behavioral therapy
5142496|NCT03100279|treatment mediators|treatment mediators
5142497|NCT03100279|trajectories of change|trajectories of change
5142498|NCT03100253|Rheumatoid Arthritis|rheumatoid arthritis
5142499|NCT03100253|Tocilizumab|tocilizumab
5142500|NCT03100253|anti-TNF treatment|anti-tnf treatment
5142501|NCT03100201|robotic-assisted rehabilitation|robotic-assisted rehabilitation
5142502|NCT03100201|humeral fracture|humeral fracture
5142503|NCT03100201|randomised controlled study|randomised controlled study
5142504|NCT03100188|peritoneal dialysis|peritoneal dialysis
5142505|NCT03100188|incremental peritoneal dialysis|incremental peritoneal dialysis
5142506|NCT03100188|quality of life|quality of life
5142507|NCT03100188|end stage renal disease|end stage renal disease
5142508|NCT03100188|adequacy|adequacy
5142509|NCT03100162|probiotics|probiotics
5142510|NCT03100162|metabolic syndrome|metabolic syndrome
5142511|NCT03100162|obesity|obesity
5142512|NCT03100162|microbiome|microbiome
5142514|NCT03100136|[11C]PF-06809247|[11c]pf-06809247
5142515|NCT03100136|Reliability|reliability
5142516|NCT03100136|Scan, Safety|scan, safety
5142517|NCT03100110|Brain-Computer Interface|brain-computer interface
5142518|NCT03100110|Brain-Machine Interface|brain-machine interface
5142519|NCT03100110|Prefrontal Cortex|prefrontal cortex
5142520|NCT03100084|Preeclampsia|preeclampsia
5142521|NCT03100084|Diabetes in Pregnancy|diabetes in pregnancy
5142522|NCT03100084|Fetal Growth Restriction|fetal growth restriction
5142523|NCT03100084|Reduced Fetal Movements|reduced fetal movements
5142524|NCT03100058|Obesity|obesity
5142525|NCT03100058|Overweight|overweight
5142539|NCT03100032|Spinal Fusion|spinal fusion
5142540|NCT03100032|Lumbar Interbody Fusion|lumbar interbody fusion
5142541|NCT03100032|Autologous Stem Cell Therapy|autologous stem cell therapy
5142542|NCT03100032|Bone Graft|bone graft
5142543|NCT03100032|Demineralized Bone Matrix|demineralized bone matrix
5771178|NCT00239252|Hepatitis C|hepatitis c
5142544|NCT03100032|Polyetheretherketone (PEEK) cage|polyetheretherketone (peek) cage
5142545|NCT03100019|Resveratrol|resveratrol
5142546|NCT03100019|Cerebral blood flow|cerebral blood flow
5142547|NCT03100019|Cognition|cognition
5142548|NCT03099993|Unilateral cerebral palsy|unilateral cerebral palsy
5142550|NCT03099993|electromyography|electromyography
5142551|NCT03099993|constraint-induced therapy|constraint-induced therapy
5142552|NCT03099993|muscle activation|muscle activation
5142553|NCT03099993|upper limb|upper limb
5142554|NCT03099993|child|child
5142555|NCT03099941|Low Back Pain, Mechanical, Biofeedback, Pain, Chronic|low back pain, mechanical, biofeedback, pain, chronic
5142556|NCT03099902|Asthma|asthma
5142557|NCT03099902|Wheezing|wheezing
5142558|NCT03099902|GSTP1|gstp1
5142559|NCT03099902|TNFa|tnfa
5142560|NCT03099902|Secondhand smoking|secondhand smoking
5142561|NCT03099902|Passive smoking|passive smoking
5142562|NCT03099902|Intrauterine smoking|intrauterine smoking
5142563|NCT03099850|Chronic Pancreatitis|chronic pancreatitis
5142564|NCT03099850|Data management|data management
5142565|NCT03099850|Regulatory compliance|regulatory compliance
5142566|NCT03099850|Protocol monitoring|protocol monitoring
5142567|NCT03099772|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5142568|NCT03099759|Vitamin D Dosing Regimens|vitamin d dosing regimens
5142569|NCT03099759|Blood Serum 25(OH)D3 Levels|blood serum 25(oh)d3 levels
5142570|NCT03099746|chronically critically ill|chronically critically ill
5142571|NCT03099746|surrogate decision maker|surrogate decision maker
5142572|NCT03099707|Treatment|treatment
5142574|NCT03099707|South Africa|south africa
5142575|NCT03099694|NRDS|nrds
5142576|NCT03099694|nHFOV|nhfov
5142577|NCT03099694|nCPAP|ncpap
5142578|NCT03099694|preterm infants|preterm infants
5142579|NCT03099655|Heart Failure|heart failure
5142580|NCT03099655|Cardiac Pacing|cardiac pacing
5142581|NCT03099655|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5142582|NCT03099655|Left Ventricular Lead|left ventricular lead
5142583|NCT03099642|lumbar puncture|lumbar puncture
5142584|NCT03099642|Point of care ultrasound|point of care ultrasound
5142585|NCT03099642|children|children
5142586|NCT03099629|Inspiratory muscle training|inspiratory muscle training
5142587|NCT03099629|Diaphragmatic surface electromyography|diaphragmatic surface electromyography
5142588|NCT03099629|Respiratory muscle strength|respiratory muscle strength
5142589|NCT03099629|Functional capacity|functional capacity
5142590|NCT03099616|propofol|propofol
5142591|NCT03099616|CLADS|clads
5142592|NCT03099616|Desflurane|desflurane
5142593|NCT03099616|Obesity|obesity
5142594|NCT03099564|Pembrolizumab|pembrolizumab
5142595|NCT03099564|Y90 Radioembolization|y90 radioembolization
5142596|NCT03099564|KEYTRUDA®|keytruda®
5142597|NCT03099564|TheraSphere®|therasphere®
5142598|NCT03099564|PD-1|pd-1
5142599|NCT03099564|IgG4/kappa isotype|igg4/kappa isotype
5142600|NCT03099551|Plaque|plaque
5142601|NCT03099551|oral hygiene|oral hygiene
5142602|NCT03099551|gingivitis|gingivitis
5142603|NCT03099551|sonic toothbrush|sonic toothbrush
5142604|NCT03099551|manual toothbrush|manual toothbrush
5142605|NCT03099538|Ixekizumab|ixekizumab
5142606|NCT03099538|Bullous Pemphigoid|bullous pemphigoid
5142607|NCT03099538|Pemphigoid|pemphigoid
5142608|NCT03099538|IL17|il17
5142609|NCT03099538|IL-17|il-17
5142610|NCT03099538|Interleukin 17|interleukin 17
5142611|NCT03099512|Patellofemoral pain|patellofemoral pain
5142612|NCT03099512|foot deformity|foot deformity
5142613|NCT03099512|foot pronation|foot pronation
5142614|NCT03099512|short foot exercise|short foot exercise
5142615|NCT03099473|electroacupuncture|electroacupuncture
5142616|NCT03099473|trochlear nerve palsy|trochlear nerve palsy
5142617|NCT03099473|eyeball movement|eyeball movement
5142618|NCT03099473|diplopia|diplopia
5142619|NCT03099473|ocular motility disorder|ocular motility disorder
5142620|NCT03099460|electroacupuncture|electroacupuncture
5142621|NCT03099460|abducens nerve palsy|abducens nerve palsy
5142622|NCT03099460|eyeball movement|eyeball movement
5142623|NCT03099460|diplopia|diplopia
5142624|NCT03099460|ocular motility disorder|ocular motility disorder
5142625|NCT03099447|electroacupuncture|electroacupuncture
5142626|NCT03099447|oculomotor nerve palsy|oculomotor nerve palsy
5142627|NCT03099447|rehabilitation|rehabilitation
5142628|NCT03099447|diplopia|diplopia
5142629|NCT03099447|ocular motility disorder|ocular motility disorder
5142630|NCT03099434|Live Donor Transplant, Social Media, Education, Advocacy, Live Donor|live donor transplant, social media, education, advocacy, live donor
5142631|NCT03099421|Benign prostatic obstruction|benign prostatic obstruction
5142632|NCT03099421|benign prostatic enlargement|benign prostatic enlargement
5142633|NCT03099421|benign prostatic hyperplasia|benign prostatic hyperplasia
5142634|NCT03099421|prostatic artery embolization|prostatic artery embolization
5142635|NCT03099421|Quality of Life|quality of life
5142636|NCT03099421|IPSS|ipss
5142637|NCT03099421|DAN-PSS|dan-pss
5142638|NCT03099421|Complications|complications
5142639|NCT03099408|Recurrence|recurrence
5142640|NCT03099408|Lactobacillus Vaginal Suppositories|lactobacillus vaginal suppositories
5142641|NCT03099395|myocardial infarction|myocardial infarction
5142642|NCT03099369|Peripheral Artery Disease|peripheral artery disease
5142643|NCT03099369|Peripheral Arterial Disease|peripheral arterial disease
5142644|NCT03099369|Exercise|exercise
5142645|NCT03099369|Step Count|step count
5142646|NCT03099369|Fitness Monitor|fitness monitor
5142647|NCT03099369|Mobile Health|mobile health
5142648|NCT03099369|Walking Ability|walking ability
5142649|NCT03099369|Quality of Life|quality of life
5142652|NCT03099343|diet|diet
5142653|NCT03099343|tailored messaging|tailored messaging
5142654|NCT03099343|mobile application|mobile application
5142655|NCT03099317|Knee Osteoarthritis|knee osteoarthritis
5142656|NCT03099317|Sinew Acupuncture|sinew acupuncture
5142657|NCT03099317|Pain|pain
5142658|NCT03099304|Vitiligo|vitiligo
5142659|NCT03099304|depigmenting disorder|depigmenting disorder
5142660|NCT03099304|topical JAK inhibitor|topical jak inhibitor
5142661|NCT03099278|hepatitis D|hepatitis d
5142662|NCT03099278|Ezetimibe|ezetimibe
5142663|NCT03099278|HDV RNA|hdv rna
5142664|NCT03099161|Advanced Solid Tumor|advanced solid tumor
5142665|NCT03099161|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5142666|NCT03099161|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5142667|NCT03099161|PD1|pd1
5142668|NCT03099161|PD-1|pd-1
5142669|NCT03099161|PDL1|pdl1
5142670|NCT03099161|PD-L1|pd-l1
5142671|NCT03099109|TIM-3|tim-3
5142672|NCT03099109|PD-L1|pd-l1
5142673|NCT03099096|SB240563|sb240563
5142674|NCT03099096|Mepolizumab|mepolizumab
5142675|NCT03099096|self-administration|self-administration
5142676|NCT03099096|eosinophilic asthma|eosinophilic asthma
5142677|NCT03099096|autoinjector|autoinjector
5142678|NCT03099083|Psoriasis|psoriasis
5142679|NCT03099083|Adalimumab|adalimumab
5142680|NCT03099083|Humira|humira
5142681|NCT03099083|Korea|korea
5142682|NCT03099070|Stress|stress
5142683|NCT03099070|Fasting|fasting
5142684|NCT03099070|Migraine|migraine
5142685|NCT03099031|Ottawa score|ottawa score
5142686|NCT03099031|tinzaparin|tinzaparin
5142687|NCT03099031|low-molecular weight heparin|low-molecular weight heparin
5142688|NCT03099031|anticoagulants|anticoagulants
5142689|NCT03099031|venous thrombosis|venous thrombosis
5142690|NCT03099031|thromboembolism|thromboembolism
5142691|NCT03099031|hemostatic disorders|hemostatic disorders
5142692|NCT03099031|vascular disease|vascular disease
5142693|NCT03099031|neoplasms|neoplasms
5142694|NCT03099031|breast neoplasms|breast neoplasms
5142695|NCT03099031|lung neoplasms|lung neoplasms
5142696|NCT03099031|prostatic neoplasms|prostatic neoplasms
5142697|NCT03099031|colorectal neoplasms|colorectal neoplasms
5142698|NCT03099031|genital neoplasms|genital neoplasms
5142699|NCT03099031|urogenital neoplasms|urogenital neoplasms
5142700|NCT03099031|intestinal neoplasms|intestinal neoplasms
5142701|NCT03099031|digestive system neoplasms|digestive system neoplasms
5142702|NCT03099031|lymphoma|lymphoma
5142703|NCT03099031|leukemia|leukemia
5142704|NCT03099031|multiple myeloma|multiple myeloma
5142705|NCT03099031|lymphoproliferative disorders|lymphoproliferative disorders
5142706|NCT03099031|myeloproliferative disorders|myeloproliferative disorders
5142707|NCT03099031|lymphatic disease|lymphatic disease
5142708|NCT03099018|GAS|gas
5142709|NCT03099018|pharyngitis|pharyngitis
5142710|NCT03099018|children|children
5142711|NCT03099018|RADT|radt
5142712|NCT03099005|neuropathic pain|neuropathic pain
5142713|NCT03099005|human immunovirus|human immunovirus
5142714|NCT03099005|vaporized cannabis|vaporized cannabis
5142715|NCT03098979|Chronic Heart Failure|chronic heart failure
5142716|NCT03098979|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5142717|NCT03098953|Ocular Installation|ocular installation
5142719|NCT03098927|Spinal Cord Injury|spinal cord injury
5142720|NCT03098927|Motor Function Improvement|motor function improvement
5142721|NCT03098914|Pathogen|pathogen
5142722|NCT03098914|Mortality|mortality
5142723|NCT03098914|Community-acquired Pneumonia|community-acquired pneumonia
5142724|NCT03098914|Risk factors|risk factors
5142725|NCT03098901|TTR Amyloidosis|ttr amyloidosis
5142726|NCT03098901|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5142727|NCT03098901|Ventricular arrhythmia|ventricular arrhythmia
5028622|NCT03820700|Anxiety|anxiety
5142728|NCT03098901|Cardiac Conduction Disturbances|cardiac conduction disturbances
5142729|NCT03098888|side effects|side effects
5142730|NCT03098888|decision making|decision making
5142731|NCT03098888|indications|indications
5142732|NCT03098888|risk factors|risk factors
5142733|NCT03098862|Ebola Virus|ebola virus
5142734|NCT03098862|Genome-Wide Association Study|genome-wide association study
5142735|NCT03098862|Liberia|liberia
5142736|NCT03098862|Ebola Survivors|ebola survivors
5142737|NCT03098862|Ebola Contacts|ebola contacts
5142738|NCT03098849|Buteyko-based breathing technique training|buteyko-based breathing technique training
5142739|NCT03098836|metastatic|metastatic
5142740|NCT03098836|castrate resistant|castrate resistant
5142741|NCT03098797|Barth Syndrome|barth syndrome
5142742|NCT03098797|elamipretide|elamipretide
5142743|NCT03098797|MTP-131|mtp-131
5142744|NCT03098797|Stealth|stealth
5142745|NCT03098797|Stealth BT|stealth bt
5142746|NCT03098797|BTHS|bths
5142747|NCT03098784|airport environment|airport environment
5142748|NCT03098784|Air France|air france
5142749|NCT03098784|flightline employees|flightline employees
5142754|NCT03098758|peritoneal washing|peritoneal washing
5142756|NCT03098758|CEA|cea
5142757|NCT03098758|BER-EP4|ber-ep4
5142764|NCT03098732|Fibrinolytic Agents|fibrinolytic agents
5142765|NCT03098732|Plasminogen|plasminogen
5142766|NCT03098693|Serodiscordant|serodiscordant
5142767|NCT03098693|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5142768|NCT03098693|Self-testing|self-testing
5142769|NCT03098693|Tanzania|tanzania
5142770|NCT03098680|Adverse reactions|adverse reactions
5142771|NCT03098680|Cardiovascular|cardiovascular
5142772|NCT03098680|Translation|translation
5142773|NCT03098680|Modelling|modelling
5142774|NCT03098680|Pharmacokinetics|pharmacokinetics
5142775|NCT03098680|Pharmacodynamics|pharmacodynamics
5142776|NCT03098654|Human Immunodeficiency Virus|human immunodeficiency virus
5142777|NCT03098654|Community Health Services|community health services
5142778|NCT03098654|Chronic Disease|chronic disease
5142779|NCT03098654|Integrated Delivery of Health Care|integrated delivery of health care
5142780|NCT03098654|Tanzania|tanzania
5142781|NCT03098589|Adult T-cell Leukemia Lymphoma|adult t-cell leukemia lymphoma
5142782|NCT03098589|Teratogenicity|teratogenicity
5142783|NCT03098589|Myelosuppression|myelosuppression
5142784|NCT03098589|Haemorrhage|haemorrhage
5142785|NCT03098589|Infection|infection
5142786|NCT03098589|Thromboembolism|thromboembolism
5142787|NCT03098589|Hypersensitivity|hypersensitivity
5142788|NCT03098589|Tumor lysis syndrome|tumor lysis syndrome
5142789|NCT03098589|Peripheral neuropathy|peripheral neuropathy
5142790|NCT03098589|Ischaemic heart disease|ischaemic heart disease
5142791|NCT03098589|Cardiac failure|cardiac failure
5142792|NCT03098589|Arrhythmia|arrhythmia
5142793|NCT03098589|Renal failure|renal failure
5142794|NCT03098589|Interstitial lung disease|interstitial lung disease
5142795|NCT03098589|Hepatic disorder|hepatic disorder
5142796|NCT03098589|Hypothyroidism|hypothyroidism
5142797|NCT03098589|Gastrointestinal perforation|gastrointestinal perforation
5142798|NCT03098589|Orthostatic hypotension|orthostatic hypotension
5142799|NCT03098589|Convulsion|convulsion
5142800|NCT03098589|Somnolence|somnolence
5142801|NCT03098589|Confusion|confusion
5142802|NCT03098589|Fatigue|fatigue
5142803|NCT03098589|Dizziness|dizziness
5142804|NCT03098589|Blurred vision|blurred vision
5142805|NCT03098589|Second primary cancer|second primary cancer
5142806|NCT03098589|Cataract|cataract
5142807|NCT03098589|Revlimid capsules|revlimid capsules
5142808|NCT03098576|advanced|advanced
5142809|NCT03098576|metastatic solid tumors|metastatic solid tumors
5142810|NCT03098563|Clinical Trial|clinical trial
5142811|NCT03098563|Phase II|phase ii
5142812|NCT03098550|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5142813|NCT03098550|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
5142814|NCT03098550|Pancreatic Cancer (PAC)|pancreatic cancer (pac)
5142815|NCT03098524|Cardiac surgery|cardiac surgery
5142816|NCT03098524|Mechanical ventilation|mechanical ventilation
5142817|NCT03098524|Cardiopulmonary bypass|cardiopulmonary bypass
5142818|NCT03098524|Pneumonia|pneumonia
5142819|NCT03098524|Atelectasis|atelectasis
5142820|NCT03098511|Neurological Determination of Death|neurological determination of death
5142821|NCT03098511|Determination of Death|determination of death
5142822|NCT03098511|CT-Perfusion scan|ct-perfusion scan
5142823|NCT03098511|Ancillary Test|ancillary test
5142824|NCT03098511|Organ Donation|organ donation
5142825|NCT03098498|periodontitis|periodontitis
5142826|NCT03098498|scaling|scaling
5142827|NCT03098498|attachment gain|attachment gain
5962060|NCT04283305|training|training
5142828|NCT03098498|air polishing|air polishing
5142829|NCT03098498|periodontal lesion|periodontal lesion
5142830|NCT03098459|Delirium|delirium
5142831|NCT03098459|Cognitive Impairment|cognitive impairment
5142832|NCT03098459|Alzheimer's Disease|alzheimer's disease
5142833|NCT03098459|Encephalopathy|encephalopathy
5142834|NCT03098459|Trauma|trauma
5142835|NCT03098459|Polytrauma|polytrauma
5142836|NCT03098459|ICU|icu
5142837|NCT03098459|Critical Illness|critical illness
5142838|NCT03098459|Traumatic Brain Injury|traumatic brain injury
5142839|NCT03098459|INSIGHT-ICU|insight-icu
5142840|NCT03098459|INSIGHT|insight
5142841|NCT03098459|Intracerebral hemorrhage|intracerebral hemorrhage
5772045|NCT00236418|Prophylaxis|prophylaxis
5142842|NCT03098459|Subarachnoid hemorrhage|subarachnoid hemorrhage
5142843|NCT03098459|Neurotrauma|neurotrauma
5142844|NCT03098459|Neuropsychology|neuropsychology
5142850|NCT03098459|Neuropsychology Dysfunction|neuropsychology dysfunction
5142851|NCT03098459|Inflammation|inflammation
5142852|NCT03098459|Neuroinflammation|neuroinflammation
5142853|NCT03098459|Inflammatory Mechanisms|inflammatory mechanisms
5142854|NCT03098459|Burn|burn
5142855|NCT03098459|Critically Injured|critically injured
5142856|NCT03098459|Injury|injury
5142857|NCT03098459|Head Injury|head injury
5142858|NCT03098459|Long-term Cognitive Impairment|long-term cognitive impairment
5142859|NCT03098459|ICU-related Dementia|icu-related dementia
5142860|NCT03098459|Employment|employment
5142861|NCT03098459|Return to Work|return to work
5142862|NCT03098394|Rapid turnaround test|rapid turnaround test
5142863|NCT03098394|RTAT|rtat
5142864|NCT03098394|Gonorrhea|gonorrhea
5142865|NCT03098394|Chlamydia|chlamydia
5142866|NCT03098394|STI|sti
5142867|NCT03098368|Parkinson's disease|parkinson's disease
5142868|NCT03098368|Rotigotine transdermal patch|rotigotine transdermal patch
5142869|NCT03098368|Nocturnal hypokinesia|nocturnal hypokinesia
5142870|NCT03098355|CART|cart
5142871|NCT03098355|CD19|cd19
5142872|NCT03098355|CD22|cd22
5142873|NCT03098355|Interleukin-2|interleukin-2
5142874|NCT03098342|Onychomycosis|onychomycosis
5142875|NCT03098342|photodynamic therapy|photodynamic therapy
5142876|NCT03098342|methylene blue|methylene blue
5142877|NCT03098342|amorolfine, nail lacquer|amorolfine, nail lacquer
5142878|NCT03098342|Asians|asians
5142879|NCT03098329|Screening|screening
5142880|NCT03098329|men|men
5142881|NCT03098329|expedited treatment|expedited treatment
5142882|NCT03098316|Cross sectional studies|cross sectional studies
5142883|NCT03098316|Metabolomics|metabolomics
5142884|NCT03098316|Glaucoma|glaucoma
5142885|NCT03098316|Low tension glaucoma|low tension glaucoma
5142886|NCT03098316|Ophthalmologic surgical procedures|ophthalmologic surgical procedures
5142887|NCT03098290|GermanVasc|germanvasc
5142888|NCT03098290|Peripheral Arterial Disease|peripheral arterial disease
5142889|NCT03098290|IDOMENEO|idomeneo
5142890|NCT03098290|Routine Data|routine data
5142891|NCT03098290|Registry Data|registry data
5142892|NCT03098290|Data Validity|data validity
5142893|NCT03098199|Antimullerian Hormone|antimullerian hormone
5142894|NCT03098199|In vitro fertilization|in vitro fertilization
5142895|NCT03098199|Medications|medications
5142896|NCT03098199|Dosing|dosing
5142897|NCT03098186|Medication adherence|medication adherence
5142898|NCT03098186|mHealth|mhealth
5142899|NCT03098173|Early colonoscopy|early colonoscopy
5142900|NCT03098173|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
5142901|NCT03098173|Rebleeding|rebleeding
5142902|NCT03098160|Immunotherapy|immunotherapy
5142903|NCT03098160|Hypoxia|hypoxia
5142904|NCT03098160|Evofosfamide|evofosfamide
5142905|NCT03098160|Ipilimumab|ipilimumab
5142906|NCT03098160|TH-302|th-302
5142907|NCT03098069|Kangaroo Mother Care|kangaroo mother care
5142908|NCT03098069|Low Birth Weight|low birth weight
5142909|NCT03098069|Implementation research|implementation research
5142910|NCT03098043|Hypothermic machine perfusion|hypothermic machine perfusion
5142911|NCT03098043|Donation after circulatory death|donation after circulatory death
5142912|NCT03098043|Extended criteria liver grafts|extended criteria liver grafts
5142913|NCT03098030|Dinutuximab|dinutuximab
5142914|NCT03098030|Irinotecan|irinotecan
5142915|NCT03098030|Topotecan|topotecan
5142916|NCT03097991|Coparenting Unmarried African-American Prenatal|coparenting unmarried african-american prenatal
5142917|NCT03097913|nasotracheal intubation|nasotracheal intubation
5142918|NCT03097913|video-stylet|video-stylet
5142919|NCT03097913|nasal cavity injury|nasal cavity injury
5142920|NCT03097900|Postoperative Ileus|postoperative ileus
5142921|NCT03097900|Caffeine Citrate|caffeine citrate
5142922|NCT03097887|Omega Loop Gastric Bypass|omega loop gastric bypass
5142923|NCT03097887|Reflux|reflux
5142924|NCT03097887|Mini Gastric Bypass|mini gastric bypass
5142925|NCT03097874|anorexia|anorexia
5142926|NCT03097874|anorexia nervosa|anorexia nervosa
5142927|NCT03097874|eating disorder|eating disorder
5142928|NCT03097874|weight|weight
5142929|NCT03097874|eating|eating
5142930|NCT03097874|weight loss|weight loss
5142931|NCT03097874|family based treatment|family based treatment
5142932|NCT03097874|FBT|fbt
5142933|NCT03097874|family treatment|family treatment
5142934|NCT03097874|therapy|therapy
5142935|NCT03097874|Maudsley method|maudsley method
5142936|NCT03097783|hyaluronic acid, midface|hyaluronic acid, midface
5142937|NCT03097757|Ultrasound|ultrasound
5142938|NCT03097757|Forearm Fracture Reduction|forearm fracture reduction
5142939|NCT03097757|Pediatric Emergency Department|pediatric emergency department
5142942|NCT03097731|interleukin-10|interleukin-10
5142943|NCT03097731|inflammatory bowel disease|inflammatory bowel disease
5142944|NCT03097692|cardiac preconditioning|cardiac preconditioning
5142945|NCT03097692|open heart surgery|open heart surgery
5142946|NCT03097692|createnine|createnine
5142947|NCT03097692|inflammation|inflammation
5142948|NCT03097653|breast cancer screening|breast cancer screening
5142949|NCT03097653|mammography|mammography
5142950|NCT03097653|decision-aid|decision-aid
5142951|NCT03097653|informed choice|informed choice
5142952|NCT03097653|National Cancer Screening Program|national cancer screening program
5142953|NCT03097627|Indocyanine Green|indocyanine green
5142954|NCT03097627|Near-infrared imaging|near-infrared imaging
5142955|NCT03097575|Lung lesions|lung lesions
5142956|NCT03097575|Navigational bronchoscopy|navigational bronchoscopy
5142957|NCT03097575|Near infrared imaging|near infrared imaging
5142958|NCT03097575|Lymphadenectomy|lymphadenectomy
5142964|NCT03097562|surgery|surgery
5142965|NCT03097549|urinary incontinence|urinary incontinence
5142966|NCT03097549|urgency urinary incontinence|urgency urinary incontinence
5142967|NCT03097549|mixed urinary incontinence|mixed urinary incontinence
5142968|NCT03097549|smartphone application|smartphone application
5142969|NCT03097549|ehealth|ehealth
5142970|NCT03097549|mhealth|mhealth
5142971|NCT03097549|randomized controlled trial|randomized controlled trial
5142972|NCT03097549|self management|self management
5142973|NCT03097549|treatment|treatment
5142974|NCT03097536|Blood Sugar|blood sugar
5142975|NCT03097523|NSBRI|nsbri
5142976|NCT03097510|Perceived stress|perceived stress
5142977|NCT03097510|Leadership|leadership
5142978|NCT03097510|Transcendental Meditation|transcendental meditation
5142979|NCT03097497|Chronic Non-specific Low-Back Pain|chronic non-specific low-back pain
5142980|NCT03097497|Chronic Low-Back Pain|chronic low-back pain
5142981|NCT03097497|Physiotherapy|physiotherapy
5142982|NCT03097497|Therapeutic Exercise|therapeutic exercise
5142983|NCT03097497|Primary Care|primary care
5142984|NCT03097497|Transverse Abdominal Muscle|transverse abdominal muscle
5142985|NCT03097458|Counselling for Families|counselling for families
5142986|NCT03097458|Parental cancer|parental cancer
5142987|NCT03097458|Psychological distress and adjustment|psychological distress and adjustment
5142988|NCT03097445|Smoking|smoking
5142989|NCT03097445|Nicotine|nicotine
5142990|NCT03097445|Nicotine Replacement Therapy|nicotine replacement therapy
5142991|NCT03097445|Nicotine Patch|nicotine patch
5142992|NCT03097445|Mass Distribution|mass distribution
5142993|NCT03097445|Tobacco Control|tobacco control
5142994|NCT03097445|Cancer Prevention|cancer prevention
5142995|NCT03097445|Randomized Controlled Trial|randomized controlled trial
5142996|NCT03097419|non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
5142997|NCT03097419|myocardial infarction|myocardial infarction
5142998|NCT03097419|remote ischemic conditioning|remote ischemic conditioning
5142999|NCT03097419|ischemic conditioning|ischemic conditioning
5143000|NCT03097419|sphygmomanometer|sphygmomanometer
5143001|NCT03097419|metabolomics|metabolomics
5143002|NCT03097380|Healthy volunteer study|healthy volunteer study
5143003|NCT03097367|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
5143004|NCT03097367|urinary incontinence|urinary incontinence
5143005|NCT03097367|prostate cancer|prostate cancer
5143006|NCT03097367|bladder neck level|bladder neck level
5143007|NCT03097367|urodynamics|urodynamics
5143008|NCT03097354|alcohol use|alcohol use
5143009|NCT03097354|consumption measure|consumption measure
5143010|NCT03097354|Composite International Diagnostic Interview (CIDI)|composite international diagnostic interview (cidi)
5143011|NCT03097354|internet survey|internet survey
5143012|NCT03097354|standardized assessment|standardized assessment
5143013|NCT03097328|Renal Cell Carcinoma|renal cell carcinoma
5143014|NCT03097315|Uveitis|uveitis
5143015|NCT03097315|UME|ume
5143016|NCT03097315|Posterior Uveitis|posterior uveitis
5143017|NCT03097315|Anterior Uveitis|anterior uveitis
5143018|NCT03097315|Intermediate Uveitis|intermediate uveitis
5143019|NCT03097315|Panuveitis|panuveitis
5143020|NCT03097315|Non-infectious Uveitis|non-infectious uveitis
5143021|NCT03097315|Triamcinolone|triamcinolone
5143022|NCT03097315|Choroid|choroid
5143023|NCT03097315|Choroidal Injection|choroidal injection
5143024|NCT03097315|Suprachoroidal|suprachoroidal
5143025|NCT03097315|Microneedle|microneedle
5143026|NCT03097315|Microinjection|microinjection
5143027|NCT03097302|laser-assisted keratotomy|laser-assisted keratotomy
5143028|NCT03097302|anterior astigmatism|anterior astigmatism
5143029|NCT03097302|posterior astigmatism|posterior astigmatism
5143030|NCT03097302|total corneal refractive power|total corneal refractive power
5143031|NCT03097302|nomogram|nomogram
5143032|NCT03097289|Healthy Adults|healthy adults
5143034|NCT03097250|Neuropsychology|neuropsychology
5143035|NCT03097250|MRI|mri
5143036|NCT03097198|Juvenile|juvenile
5143037|NCT03097198|Traditional Chinese Medicine|traditional chinese medicine
5143038|NCT03097198|Plum-blossom needle|plum-blossom needle
5143039|NCT03097185|pancreatitis|pancreatitis
5143040|NCT03097185|islet cell|islet cell
5143041|NCT03097172|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5143042|NCT03097172|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5143043|NCT03097172|Cardiac MRI|cardiac mri
5143055|NCT03097107|saroglitazar magnesium|saroglitazar magnesium
5143057|NCT03097094|Dog allergy|dog allergy
5143058|NCT03097094|Can f 5|can f 5
5143059|NCT03097094|Male dog|male dog
5143060|NCT03097094|Female dog|female dog
5143061|NCT03097094|Allergen components|allergen components
5143062|NCT03097055|Stroke|stroke
5143063|NCT03097055|Acupuncture|acupuncture
5143064|NCT03097055|antiinflammatory|antiinflammatory
5143065|NCT03097055|NIHSS|nihss
5143072|NCT03097016|Severe|severe
5143073|NCT03097003|Proriasis|proriasis
5143074|NCT03097003|Real-life management|real-life management
5143075|NCT03097003|Observational|observational
5143076|NCT03097003|Otezla|otezla
5143077|NCT03097003|CC-10004|cc-10004
5143078|NCT03097003|Apremilast|apremilast
5143079|NCT03097003|Belgium|belgium
5143080|NCT03097003|OTELO|otelo
5143081|NCT03096990|Psoriatic Arthritis|psoriatic arthritis
5143082|NCT03096990|Observational|observational
5143083|NCT03096990|Otezla|otezla
5143084|NCT03096990|Apremilast|apremilast
5143085|NCT03096990|Real-Life management|real-life management
5143086|NCT03096990|Belgium|belgium
5143087|NCT03096990|APOLO|apolo
5143088|NCT03096990|CC-10004|cc-10004
5143089|NCT03096977|Hand dexterity|hand dexterity
5143090|NCT03096977|Multiple sclerosis|multiple sclerosis
5143091|NCT03096977|Nine Holes Peg|nine holes peg
5143092|NCT03096964|Elderly training|elderly training
5143093|NCT03096964|Pole walking|pole walking
5143094|NCT03096964|Locomotor Rehabilitation Index|locomotor rehabilitation index
5143095|NCT03096964|Self-selected speed of walking|self-selected speed of walking
5143096|NCT03096964|Recovery|recovery
5143097|NCT03096938|cell-free DNA|cell-free dna
5143098|NCT03096938|methylation|methylation
5143099|NCT03096938|markers|markers
5143100|NCT03096938|cancer|cancer
5143101|NCT03096938|screening|screening
5143102|NCT03096925|non-cardiac chest pain|non-cardiac chest pain
5143103|NCT03096925|anxiety|anxiety
5143104|NCT03096912|CDK4 inhibitor|cdk4 inhibitor
5143105|NCT03096912|LEE011|lee011
5143106|NCT03096912|ribociclib|ribociclib
5143107|NCT03096912|liposarcoma dedifferentiated|liposarcoma dedifferentiated
5143108|NCT03096912|liposarcoma well differentiated|liposarcoma well differentiated
5143109|NCT03096886|Cognitive Behavioral Therapy|cognitive behavioral therapy
5143110|NCT03096886|Computer-Assisted Cognitive Behavioral Therapy|computer-assisted cognitive behavioral therapy
5143111|NCT03096886|Computer-Augmented Cognitive Behavioral Therapy|computer-augmented cognitive behavioral therapy
5143112|NCT03096886|CBT|cbt
5143113|NCT03096886|Computer-Assisted CBT|computer-assisted cbt
5143114|NCT03096886|Computer-Augmented CBT|computer-augmented cbt
5143125|NCT03096834|Migraine|migraine
5143126|NCT03096834|attack|attack
5143127|NCT03096834|headache|headache
5143128|NCT03096834|episodic|episodic
5143129|NCT03096834|aura|aura
5143130|NCT03096834|AMG 334|amg 334
5143131|NCT03096834|CGRP receptor agonist|cgrp receptor agonist
5143132|NCT03096834|erenumab|erenumab
5143137|NCT03096795|MEDI3506|medi3506
5143138|NCT03096795|Safety|safety
5143139|NCT03096795|Tolerability|tolerability
5143140|NCT03096795|Pharmacokinetics|pharmacokinetics
5143141|NCT03096795|Immunogenicity|immunogenicity
5143142|NCT03096756|Oral Formulation|oral formulation
5143143|NCT03096756|Food Effect|food effect
5143144|NCT03096756|Superoxide Dismutase|superoxide dismutase
5143145|NCT03096756|Single Ascending Dose|single ascending dose
5143146|NCT03096756|GC4702|gc4702
5143147|NCT03096756|Bioavailability|bioavailability
5143148|NCT03096756|Pharmacokinetics|pharmacokinetics
5143149|NCT03096756|Active Comparator|active comparator
5143154|NCT03096691|cervical pessary|cervical pessary
5143155|NCT03096691|preterm labor|preterm labor
5143156|NCT03096691|Cervical insufficiency|cervical insufficiency
5143157|NCT03096678|Left Bundle Branch Block|left bundle branch block
5143158|NCT03096678|Regional/Globle cardiac function|regional/globle cardiac function
5143159|NCT03096678|Mechanical asynchrony|mechanical asynchrony
5143160|NCT03096678|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5143161|NCT03096678|Outcome|outcome
5143162|NCT03096678|Cardiovascular events|cardiovascular events
5143163|NCT03096665|venous blood|venous blood
5143164|NCT03096665|arterial blood|arterial blood
5143165|NCT03096665|capillary blood|capillary blood
5143166|NCT03096652|gynecologic cancer - panniculectomy|gynecologic cancer - panniculectomy
5143168|NCT03096639|VIDD|vidd
5143169|NCT03096639|Weaning failure|weaning failure
5143170|NCT03096626|Depression|depression
5143171|NCT03096613|heart failure|heart failure
5143172|NCT03096613|Subclinical Hypothyroidism|subclinical hypothyroidism
5143173|NCT03096613|levothyroxine|levothyroxine
5143174|NCT03096613|6-minute walk test|6-minute walk test
5143175|NCT03096600|spine|spine
5143176|NCT03096587|XP Endo Finisher|xp endo finisher
5143177|NCT03096587|ultrasonic activated irrigation|ultrasonic activated irrigation
5143178|NCT03096587|postoperative pain|postoperative pain
5143179|NCT03096574|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5143180|NCT03096574|Maternal vaccination|maternal vaccination
5143181|NCT03096574|Attitudes|attitudes
5143184|NCT03096548|Tattoo|tattoo
5143185|NCT03096496|Quality of life|quality of life
5143186|NCT03096496|acute promyelocytic leukemia|acute promyelocytic leukemia
5143188|NCT03096457|leishmaniasis|leishmaniasis
5143189|NCT03096457|L.braziliensis|l.braziliensis
5143190|NCT03096457|paromomycin cream|paromomycin cream
5143191|NCT03096457|intralesional pentamidine|intralesional pentamidine
5143192|NCT03096457|leishmaniasis local therapy|leishmaniasis local therapy
5143193|NCT03096431|whole-brain radiation therapy|whole-brain radiation therapy
5143194|NCT03096431|sterotactic radiosurgery|sterotactic radiosurgery
5143195|NCT03096431|cognitive rehabilitation|cognitive rehabilitation
5143196|NCT03096431|physical activity|physical activity
5143198|NCT03096379|CD|cd
5143199|NCT03096379|MRE|mre
5143200|NCT03096379|ileocecal|ileocecal
5143201|NCT03096366|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5143202|NCT03096353|NALOXONE|naloxone
5143203|NCT03096353|fMRI|fmri
5143204|NCT03096353|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5143205|NCT03096340|SN-38|sn-38
5143206|NCT03096340|irinotecan|irinotecan
5143207|NCT03096327|Quality of Life|quality of life
5143208|NCT03096327|Asthma control test|asthma control test
5143209|NCT03096327|Montelukast|montelukast
5143210|NCT03096327|Asthma|asthma
5143211|NCT03096314|ARDS|ards
5143212|NCT03096314|Vitamin D|vitamin d
5143213|NCT03096301|temporomandibular disorder|temporomandibular disorder
5143214|NCT03096301|photobiomodulation|photobiomodulation
5143215|NCT03096301|pain|pain
5143216|NCT03096275|Mycophenolate mofetil|mycophenolate mofetil
5143217|NCT03096275|Methotrexate|methotrexate
5143218|NCT03096275|cyclophosphamide|cyclophosphamide
5143224|NCT03096249|oxytocin|oxytocin
5143225|NCT03096249|emotion recognition|emotion recognition
5143226|NCT03096249|emotion processing|emotion processing
5143227|NCT03096249|social salience|social salience
5143228|NCT03096249|face processing|face processing
5143229|NCT03096249|Electroencephalography (EEG)|electroencephalography (eeg)
5143230|NCT03096210|Maxillar sinus|maxillar sinus
5143231|NCT03096210|Titanium-Prepared Platelet Rich Fibrin|titanium-prepared platelet rich fibrin
5143232|NCT03096210|Allograft|allograft
5143233|NCT03096210|implant|implant
5143234|NCT03096197|Spinal Cord injury (SCI)|spinal cord injury (sci)
5143235|NCT03096197|Transcutaneous lumbosacral stimulation (TLS)|transcutaneous lumbosacral stimulation (tls)
5143236|NCT03096197|Exoskeleton-Assisted Walking (EAW)|exoskeleton-assisted walking (eaw)
5143237|NCT03096184|head and neck cancer|head and neck cancer
5143238|NCT03096184|Apatinib|apatinib
5143239|NCT03096184|Tegafur Gimeracil Oteracil|tegafur gimeracil oteracil
5143240|NCT03096171|Stress|stress
5143241|NCT03096171|Well-being|well-being
5143242|NCT03096171|Positive Psychology|positive psychology
5143243|NCT03096158|Coronary artery bypass grafting|coronary artery bypass grafting
5143244|NCT03096158|Cardiorespiratory rehabilitation|cardiorespiratory rehabilitation
5143245|NCT03096158|Functional electrical stimulation|functional electrical stimulation
5143246|NCT03096158|Inspiratory muscle training|inspiratory muscle training
5143247|NCT03096158|Aerobic training|aerobic training
5143248|NCT03096158|Isometric handgrip training|isometric handgrip training
5143249|NCT03096158|Functional capacity|functional capacity
5143250|NCT03096158|Endothelial function|endothelial function
5143251|NCT03096158|Cardiac function|cardiac function
5143252|NCT03096145|tobacco|tobacco
5143253|NCT03096145|quitlines|quitlines
5143254|NCT03096145|social support|social support
5143255|NCT03096145|mobile support|mobile support
5143257|NCT03096132|Overweight|overweight
5143258|NCT03096132|Overeating|overeating
5143259|NCT03096132|Body Mass Index|body mass index
5143260|NCT03096132|Treatment|treatment
5143261|NCT03096132|Intervention|intervention
5143262|NCT03096132|Family Based Therapy|family based therapy
5143263|NCT03096132|Weight|weight
5143264|NCT03096132|Children|children
5143265|NCT03096119|blood pressure monitoring, home|blood pressure monitoring, home
5143266|NCT03096119|Asia|asia
5143267|NCT03096093|Pancreatic|pancreatic
5143268|NCT03096093|Late stage cancer|late stage cancer
5143269|NCT03096093|Immunotherapy|immunotherapy
5143270|NCT03096093|Phase I|phase i
5143271|NCT03096093|Vaccination|vaccination
5143272|NCT03096080|ARPKD|arpkd
5143273|NCT03096080|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
5143274|NCT03096080|Pediatric Polycystic Kidney|pediatric polycystic kidney
5143275|NCT03096080|Tesevatinib|tesevatinib
5143276|NCT03096080|Polycystic Kidney Disease|polycystic kidney disease
5143277|NCT03096041|auriculotherapy|auriculotherapy
5143278|NCT03096041|aromatase inhibitors|aromatase inhibitors
5143279|NCT03096041|adjuvant treatment|adjuvant treatment
5143280|NCT03096028|maternal nutrition|maternal nutrition
5962061|NCT04283266|probiotics|probiotics
5143281|NCT03096028|neurocognitive development|neurocognitive development
5143282|NCT03096028|brain volume|brain volume
5143283|NCT03096002|PreDiabetes, Lifestyle intervention, Exercise Behavior, Adherence|prediabetes, lifestyle intervention, exercise behavior, adherence
5143284|NCT03095989|mindfulness|mindfulness
5143285|NCT03095976|Guided Tissue Regeneration,|guided tissue regeneration,
5143286|NCT03095976|Amnion-Chorion,|amnion-chorion,
5143287|NCT03095976|Intrabony defects,|intrabony defects,
5143288|NCT03095976|furcation|furcation
5143289|NCT03095950|Spin|spin
5143290|NCT03095950|Misleading reporting|misleading reporting
5143291|NCT03095950|Misleading interpretation|misleading interpretation
5143292|NCT03095950|Misleading extrapolation|misleading extrapolation
5143293|NCT03095950|Randomized controlled trials|randomized controlled trials
5143294|NCT03095950|Patients|patients
5143295|NCT03095924|Spin|spin
5143296|NCT03095924|Misleading reporting|misleading reporting
5143297|NCT03095924|Misleading interpretation|misleading interpretation
5143298|NCT03095924|Misleading extrapolation|misleading extrapolation
5143299|NCT03095924|Randomized controlled trials|randomized controlled trials
5143300|NCT03095924|Patients|patients
5143301|NCT03095911|Spin|spin
5143302|NCT03095911|Misleading reporting|misleading reporting
5143303|NCT03095911|Misleading interpretation|misleading interpretation
5143304|NCT03095911|Misleading extrapolation|misleading extrapolation
5143305|NCT03095911|Randomized controlled trials|randomized controlled trials
5143306|NCT03095911|Patients|patients
5143307|NCT03095898|Colonoscopy|colonoscopy
5143308|NCT03095898|Acupuncture|acupuncture
5143309|NCT03095885|Urine Oxalate|urine oxalate
5143310|NCT03095885|Nephrolithiasis|nephrolithiasis
5143311|NCT03095885|Kidney Stones|kidney stones
5143312|NCT03095885|Hyperoxaluria|hyperoxaluria
5143313|NCT03095885|Enteric Hyperoxaluria|enteric hyperoxaluria
5143314|NCT03095885|urological Diseases|urological diseases
5143315|NCT03095885|Kidney Diseases|kidney diseases
5143316|NCT03095885|Dietary Oxalate|dietary oxalate
5143317|NCT03095885|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
5143318|NCT03095885|Oxalate Absorption|oxalate absorption
5143319|NCT03095872|photodamaged skin|photodamaged skin
5143320|NCT03095872|wound healing|wound healing
5143321|NCT03095872|CO2 laser|co2 laser
5143322|NCT03095820|Community|community
5143323|NCT03095820|Depressive Symptoms|depressive symptoms
5143324|NCT03095820|Mental Health Program|mental health program
5143325|NCT03095820|Older adults|older adults
5143326|NCT03095768|Lifestyle|lifestyle
5143327|NCT03095768|Nutrition|nutrition
5143328|NCT03095768|Cooking|cooking
5143329|NCT03095742|Microdialysis|microdialysis
5143330|NCT03095742|Cerebral metabolism|cerebral metabolism
5143331|NCT03095742|Cardiac arrest|cardiac arrest
5143332|NCT03095742|Intravenous|intravenous
5143333|NCT03095742|Neurological prognosis|neurological prognosis
5143334|NCT03095716|Carbon dioxide pneumoperitoneum|carbon dioxide pneumoperitoneum
5143335|NCT03095716|Intraperitoneal pressure|intraperitoneal pressure
5143336|NCT03095716|Post-operative recovery|post-operative recovery
5143337|NCT03095716|Laparoscopic Humidification System|laparoscopic humidification system
5143338|NCT03095703|Sirolimus|sirolimus
5143339|NCT03095703|Intestinal adenomas|intestinal adenomas
5143340|NCT03095690|Osteoporosis|osteoporosis
5143341|NCT03095690|Parkinson|parkinson
5143342|NCT03095690|HR-pQCT|hr-pqct
5143343|NCT03095690|bone microstructure|bone microstructure
5143344|NCT03095690|fracture risk|fracture risk
5143345|NCT03095677|dynamic apnea|dynamic apnea
5143355|NCT03095638|Conventional tablets|conventional tablets
5143356|NCT03095625|Sepsis|sepsis
5143357|NCT03095625|Bleeding disorder|bleeding disorder
5143358|NCT03095625|Viscoelastic tests|viscoelastic tests
5143359|NCT03095599|Influenza|influenza
5143360|NCT03095599|Vaccine|vaccine
5143361|NCT03095586|Spin|spin
5143362|NCT03095586|Misleading reporting|misleading reporting
5143363|NCT03095586|Misleading interpretation|misleading interpretation
5143364|NCT03095586|Misleading extrapolation|misleading extrapolation
5143365|NCT03095586|Randomized controlled trials|randomized controlled trials
5143366|NCT03095586|Patients|patients
5143367|NCT03095573|Celiac disease|celiac disease
5143368|NCT03095573|Enteropathy associated T cell lymphoma|enteropathy associated t cell lymphoma
5143369|NCT03095573|Refractory celiac disease|refractory celiac disease
5143370|NCT03095573|Small bowel adenocarcinoma|small bowel adenocarcinoma
5143371|NCT03095534|Occupational Therapy|occupational therapy
5143372|NCT03095534|Aging in place|aging in place
5143373|NCT03095534|Activities of daily living|activities of daily living
5143374|NCT03095534|Community program|community program
5143378|NCT03095521|no less therapeutic efficacy|no less therapeutic efficacy
5143380|NCT03095508|ANTI-ANGIN FORMULA|anti-angin formula
5143381|NCT03095508|Sore Throat|sore throat
5143382|NCT03095508|no less therapeutic efficacy|no less therapeutic efficacy
5143390|NCT03095482|Arachnophobia (fear of spiders)|arachnophobia (fear of spiders)
5143391|NCT03095482|Ophidophobia (fear of snakes)|ophidophobia (fear of snakes)
5143392|NCT03095482|Claustrophobia (fear of tightly enclosed spaces)|claustrophobia (fear of tightly enclosed spaces)
5369144|NCT01861106|Immunodeficiency|immunodeficiency
5010111|NCT03933410|KB195|kb195
5143393|NCT03095482|Germaphobia (fear of germs, dirtiness, and contamination)|germaphobia (fear of germs, dirtiness, and contamination)
5143394|NCT03095456|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5143395|NCT03095456|Low Peak Inspiratory Flow Rate (PIFR)|low peak inspiratory flow rate (pifr)
5143396|NCT03095443|Delirium|delirium
5143397|NCT03095443|Critical Illness|critical illness
5143398|NCT03095443|Music Therapy|music therapy
5143399|NCT03095430|Trauma|trauma
5143400|NCT03095430|General Anesthesia|general anesthesia
5143401|NCT03095430|Surgical Pleth Index|surgical pleth index
5143402|NCT03095430|Entropy|entropy
5143403|NCT03095417|Delirium|delirium
5143404|NCT03095417|Alzheimer's Disease|alzheimer's disease
5143405|NCT03095417|Aging|aging
5143406|NCT03095417|Exercise Therapy|exercise therapy
5143407|NCT03095417|Cognitive Training|cognitive training
5143408|NCT03095378|gingival recession|gingival recession
5143409|NCT03095339|Burkina Faso|burkina faso
5143410|NCT03095339|Community-based randomized controlled trial|community-based randomized controlled trial
5143411|NCT03095339|Cysticercosis|cysticercosis
5143412|NCT03095339|Implementation Research|implementation research
5143413|NCT03095339|Effectiveness|effectiveness
5143414|NCT03095313|Transcatheter Aortic Valve Replacement (TAVR).|transcatheter aortic valve replacement (tavr).
5143415|NCT03095313|Surgical bioprosthetic aortic valve replacement|surgical bioprosthetic aortic valve replacement
5143416|NCT03095300|Prone Position|prone position
5143417|NCT03095300|High-flow oxygen therapy|high-flow oxygen therapy
5143418|NCT03095287|Factor VIII|factor viii
5143419|NCT03095287|von Willebrand Factor|von willebrand factor
5143420|NCT03095287|Plasma-derived|plasma-derived
5143421|NCT03095287|Inhibitors|inhibitors
5143422|NCT03095287|Immune tolerance induction|immune tolerance induction
5143423|NCT03095287|ITI|iti
5143424|NCT03095287|Antibodies|antibodies
5143425|NCT03095287|Hemophilia A|hemophilia a
5143426|NCT03095261|Cardiovascular Disease|cardiovascular disease
5143427|NCT03095261|Cardiac Rehabilitation|cardiac rehabilitation
5143428|NCT03095261|Financial Incentives|financial incentives
5143429|NCT03095261|Outpatient (Phase II) Cardiac Rehabilitation Exercise Adherence|outpatient (phase ii) cardiac rehabilitation exercise adherence
5143430|NCT03095235|keratoconus|keratoconus
5143431|NCT03095235|cornea ectasia|cornea ectasia
5143432|NCT03095183|Posterior oropharynx exam|posterior oropharynx exam
5143433|NCT03095183|Pediatric|pediatric
5143434|NCT03095183|Tongue Depressor|tongue depressor
5143435|NCT03095183|Flavored Tongue Depressor|flavored tongue depressor
5143436|NCT03095144|pyloromyotomy|pyloromyotomy
5143437|NCT03095144|spinal anaesthesia|spinal anaesthesia
5143438|NCT03095144|surgical outcomes|surgical outcomes
5143439|NCT03095144|general anaesthesia|general anaesthesia
5143440|NCT03095144|infants|infants
5143441|NCT03095131|Heart Spectrum Blood Pressure MonitorHeart Spectrum|heart spectrum blood pressure monitorheart spectrum
5143442|NCT03095079|endostar|endostar
5143443|NCT03095079|dacarbazine|dacarbazine
5143444|NCT03095079|cisplatin|cisplatin
5143445|NCT03095066|aggression|aggression
5143446|NCT03095066|agitation|agitation
5143447|NCT03095066|irritability|irritability
5143448|NCT03095066|non-penetrating brain injury|non-penetrating brain injury
5143449|NCT03095066|traumatic brain injury|traumatic brain injury
5143450|NCT03095066|TBI|tbi
5143451|NCT03095066|AVP-786|avp-786
5143452|NCT03095053|morphological score|morphological score
5143453|NCT03095053|preimplantation genetic testing|preimplantation genetic testing
5143454|NCT03095053|frozen embryo transfer|frozen embryo transfer
5143455|NCT03095053|blastocyst|blastocyst
5143456|NCT03095027|contact lens, silicone hydrogel, daily disposable, visual acuity|contact lens, silicone hydrogel, daily disposable, visual acuity
5143457|NCT03095001|bevacizumab|bevacizumab
5143458|NCT03095001|Intraperitoneal administration|intraperitoneal administration
5143459|NCT03095001|Ovarian Cancer|ovarian cancer
5143460|NCT03095001|Peritoneal Adhesion|peritoneal adhesion
5143461|NCT03094962|Kinematics|kinematics
5143462|NCT03094962|MRI Scans|mri scans
5143463|NCT03094962|CT Scan, Single-Photon Emission|ct scan, single-photon emission
5143464|NCT03094962|finger interphalangeal joint|finger interphalangeal joint
5143465|NCT03094949|microwave ablation|microwave ablation
5143466|NCT03094949|partial nephrectomy|partial nephrectomy
5143467|NCT03094910|Raynaud Phenomenon|raynaud phenomenon
5143468|NCT03094910|Hand and Arm Vibration Syndrome|hand and arm vibration syndrome
5143469|NCT03094910|Autonomic Imbalance|autonomic imbalance
5143470|NCT03094910|Thermography|thermography
5772346|NCT00234962|Lopinavir|lopinavir
5143471|NCT03094897|Breast Neoplasms,Prostatic Neoplasms|breast neoplasms,prostatic neoplasms
5143472|NCT03094858|Smartphone, sedentary behavior, smartphone intervention|smartphone, sedentary behavior, smartphone intervention
5143473|NCT03094832|ARQ 092|arq 092
5143474|NCT03094832|ArQule|arqule
5143476|NCT03094832|PIK3CA|pik3ca
5143477|NCT03094832|Overgrowth|overgrowth
5143478|NCT03094832|Congenital malformations|congenital malformations
5143479|NCT03094832|Miransertib|miransertib
5143480|NCT03094832|MOSAIC|mosaic
5143481|NCT03094793|abnormal EEGs (AIC)|abnormal eegs (aic)
5143482|NCT03094767|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5962062|NCT04283266|constipation|constipation
5143483|NCT03094767|Heart Rate Variability|heart rate variability
5143484|NCT03094767|Rehabilitation|rehabilitation
5143485|NCT03094767|Hemoglobin Glycated|hemoglobin glycated
5143486|NCT03094715|Mechanical thrombectomy|mechanical thrombectomy
5143487|NCT03094715|Endovascular thrombectomy|endovascular thrombectomy
5143488|NCT03094689|Physical activity|physical activity
5143489|NCT03094689|Muscle pain|muscle pain
5143490|NCT03094689|Cryotherapy|cryotherapy
5143491|NCT03094676|Massage|massage
5143492|NCT03094676|Autonomic nervous system|autonomic nervous system
5143499|NCT03094650|virtual reality|virtual reality
5143500|NCT03094650|rehabilitation dose|rehabilitation dose
5143501|NCT03094650|motor rehabilitation|motor rehabilitation
5143502|NCT03094624|Amusia|amusia
5143503|NCT03094624|Audition|audition
5143504|NCT03094624|Short-term memory|short-term memory
5143505|NCT03094624|Emotions|emotions
5143507|NCT03094624|MEG|meg
5143508|NCT03094624|MRI|mri
5143509|NCT03094585|Healthy nurses|healthy nurses
5143510|NCT03094572|spinal cord circuitry|spinal cord circuitry
5143511|NCT03094572|hemiplegia|hemiplegia
5143512|NCT03094572|rhythmic task|rhythmic task
5143513|NCT03094559|peripheral arterial disease|peripheral arterial disease
5143514|NCT03094546|subjective cognitive decline|subjective cognitive decline
5143515|NCT03094546|Alzheimer's disease, dementia|alzheimer's disease, dementia
5143516|NCT03094546|dietary supplement|dietary supplement
5143517|NCT03094546|polyamine|polyamine
5143518|NCT03094546|prevention|prevention
5143519|NCT03094546|treatment|treatment
5143520|NCT03094546|lifestyle|lifestyle
5143521|NCT03094546|memory|memory
5143522|NCT03094546|autophagy|autophagy
5143523|NCT03094533|Anesthesia, intravenous|anesthesia, intravenous
5143524|NCT03094533|Anesthesia, inhalation|anesthesia, inhalation
5143525|NCT03094533|propofol|propofol
5143526|NCT03094533|sevoflurane|sevoflurane
5143527|NCT03094533|glucose|glucose
5143528|NCT03094468|terbinafine nail solution|terbinafine nail solution
5143529|NCT03094468|nail fungal infection|nail fungal infection
5143530|NCT03094468|topical antifungal drug|topical antifungal drug
5143531|NCT03094455|Tele-rehabilitation|tele-rehabilitation
5143532|NCT03094455|Action Observation|action observation
5143533|NCT03094455|Mirror neurons|mirror neurons
5143534|NCT03094455|ICT|ict
5143535|NCT03094442|Quality of Recovery|quality of recovery
5143536|NCT03094442|Minimally Invasive Sacrocolpopexy|minimally invasive sacrocolpopexy
5143537|NCT03094442|Dexamethasone|dexamethasone
5143538|NCT03094377|Multisensory stimulation; motor recovery|multisensory stimulation; motor recovery
5143539|NCT03094364|Constraint-induced movement therapy|constraint-induced movement therapy
5143540|NCT03094364|video game|video game
5143541|NCT03094364|virtual reality|virtual reality
5143542|NCT03094364|upper extremity|upper extremity
5143543|NCT03094364|CI therapy|ci therapy
5143544|NCT03094364|rehabilitation|rehabilitation
5143545|NCT03094364|hemiparesis|hemiparesis
5143546|NCT03094364|MS|ms
5143547|NCT03094364|multiple sclerosis|multiple sclerosis
5143548|NCT03094364|progressive multiple sclerosis|progressive multiple sclerosis
5143549|NCT03094364|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5143550|NCT03094364|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5143551|NCT03094364|motor|motor
5143552|NCT03094364|physical therapy|physical therapy
5143553|NCT03094364|physiotherapy|physiotherapy
5143554|NCT03094364|occupational therapy|occupational therapy
5143555|NCT03094364|arm|arm
5143556|NCT03094364|hand|hand
5143557|NCT03094351|robot assisted esophagectomy|robot assisted esophagectomy
5143558|NCT03094351|minimally invasive esophagectomy|minimally invasive esophagectomy
5143559|NCT03094351|esophageal cancer|esophageal cancer
5143560|NCT03094338|Psychology, Educational [F02.784.629]|psychology, educational [f02.784.629]
5143561|NCT03094325|Septal Myectomy|septal myectomy
5143562|NCT03094312|SEEG|seeg
5143563|NCT03094312|ISD|isd
5143564|NCT03094312|cognitive disorder|cognitive disorder
5143565|NCT03094312|epilepsy surgery|epilepsy surgery
5143566|NCT03094286|HIV|hiv
5143567|NCT03094286|HIV with cancer patient|hiv with cancer patient
5143568|NCT03094286|D006678|d006678
5143569|NCT03094273|Melanocytic neoplasm|melanocytic neoplasm
5143576|NCT03094247|Ready-to-use therapeutic foods|ready-to-use therapeutic foods
5143577|NCT03094247|Omega-3 fatty acids|omega-3 fatty acids
5143579|NCT03094195|post-herpetic neuralgia|post-herpetic neuralgia
5143580|NCT03094195|neuropathic pain|neuropathic pain
5143581|NCT03094195|angiotensin II type 2 receptor antagonist|angiotensin ii type 2 receptor antagonist
5143582|NCT03094195|dose ranging|dose ranging
5143583|NCT03094130|Spin|spin
5143584|NCT03094130|Misleading reporting|misleading reporting
5143585|NCT03094130|Misleading interpretation|misleading interpretation
5143586|NCT03094130|Misleading extrapolation|misleading extrapolation
5143587|NCT03094130|phase I/II trials|phase i/ii trials
5143588|NCT03094130|non-randomized trials|non-randomized trials
5143589|NCT03094130|Patients|patients
5143590|NCT03094117|Spin|spin
5143591|NCT03094117|Misleading reporting|misleading reporting
5143592|NCT03094117|Misleading interpretation|misleading interpretation
5139412|NCT03119402|Reading|reading
5143596|NCT03094117|Patients|patients
5010311|NCT03932396|POCT|poct
5143597|NCT03094104|Spin|spin
5143598|NCT03094104|Misleading reporting|misleading reporting
5143599|NCT03094104|Misleading interpretation|misleading interpretation
5143600|NCT03094104|Misleading extrapolation|misleading extrapolation
5143601|NCT03094104|phase I/II trials|phase i/ii trials
5143602|NCT03094104|non-randomized trials|non-randomized trials
5143603|NCT03094104|Patients|patients
5143604|NCT03094091|Spin|spin
5143605|NCT03094091|Misleading reporting|misleading reporting
5143606|NCT03094091|Misleading interpretation|misleading interpretation
5143607|NCT03094091|Misleading extrapolation|misleading extrapolation
5143608|NCT03094091|phase I/II trials|phase i/ii trials
5143609|NCT03094091|non-randomized trials|non-randomized trials
5143610|NCT03094091|Patients|patients
5143611|NCT03094078|Spin|spin
5143612|NCT03094078|Misleading reporting|misleading reporting
5143613|NCT03094078|Misleading interpretation|misleading interpretation
5143614|NCT03094078|Misleading extrapolation|misleading extrapolation
5143615|NCT03094078|Animal studies|animal studies
5143616|NCT03094078|Cell culture studies|cell culture studies
5143617|NCT03094078|Pre-clinical studies|pre-clinical studies
5143618|NCT03094065|Spin|spin
5143619|NCT03094065|Misleading reporting|misleading reporting
5143620|NCT03094065|Misleading interpretation|misleading interpretation
5143621|NCT03094065|Misleading extrapolation|misleading extrapolation
5143622|NCT03094065|Animal studies|animal studies
5143623|NCT03094065|Cell culture studies|cell culture studies
5143624|NCT03094065|Pre-clinical studies|pre-clinical studies
5143625|NCT03094052|neratinib|neratinib
5143626|NCT03094052|trastuzumab|trastuzumab
5143627|NCT03094052|crofelemer|crofelemer
5143628|NCT03094026|Hematologic cancers|hematologic cancers
5143629|NCT03094026|Hematopoietic cell transplantation|hematopoietic cell transplantation
5143630|NCT03094026|cognitive training|cognitive training
5143631|NCT03094026|genetic knowledge|genetic knowledge
5143632|NCT03094026|genetic attitude|genetic attitude
5143633|NCT03094026|adult cancer survivors|adult cancer survivors
5143634|NCT03094013|psycho-social factors, psychological symptoms|psycho-social factors, psychological symptoms
5143635|NCT03094000|Bulimia Nervosa|bulimia nervosa
5143636|NCT03094000|Binge-Eating|binge-eating
5143637|NCT03094000|Self monitoring|self monitoring
5143638|NCT03094000|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5143639|NCT03094000|Mindfulness|mindfulness
5143641|NCT03093987|Critical Care Ultrasound|critical care ultrasound
5143642|NCT03093987|Lactate|lactate
5143643|NCT03093987|Mortality|mortality
5143644|NCT03093987|Prognosis|prognosis
5143645|NCT03093935|Post-Stroke|post-stroke
5143646|NCT03093935|Neuromodulation|neuromodulation
5143647|NCT03093935|Axillary nerve|axillary nerve
5143648|NCT03093935|Peripheral Nerve Stimulation|peripheral nerve stimulation
5143649|NCT03093922|Gemcitabine|gemcitabine
5143650|NCT03093922|Atezolizumab|atezolizumab
5143651|NCT03093922|Cisplatin|cisplatin
5143652|NCT03093922|16-1621|16-1621
5143653|NCT03093909|Solid Tumors and Pulmonary Metastases|solid tumors and pulmonary metastases
5143654|NCT03093909|aerosol gemcitabine|aerosol gemcitabine
5143655|NCT03093909|aerosol GCB|aerosol gcb
5143656|NCT03093909|Lung metastases|lung metastases
5143657|NCT03093909|osteosarcoma|osteosarcoma
5143658|NCT03093896|almonds|almonds
5143659|NCT03093896|cereal snack|cereal snack
5143660|NCT03093870|Neoplasms|neoplasms
5152898|NCT03036371|Memory|memory
5143673|NCT03093779|Visual Learning|visual learning
5143674|NCT03093766|Aetiology|aetiology
5143675|NCT03093740|hemodialysis|hemodialysis
5143676|NCT03093740|renal failure|renal failure
5143677|NCT03093740|kidney transplant|kidney transplant
5143678|NCT03093714|Cystic Fibrosis|cystic fibrosis
5143679|NCT03093636|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5143680|NCT03093636|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5143681|NCT03093636|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
5143682|NCT03093636|Insulin Pen|insulin pen
5143683|NCT03093636|inControl Advice|incontrol advice
5143684|NCT03093636|Decision Support System (DSS)|decision support system (dss)
5143685|NCT03093623|physical activity|physical activity
5143686|NCT03093623|abstain from smoking|abstain from smoking
5143687|NCT03093623|human papillomavirus (HPV)|human papillomavirus (hpv)
5143688|NCT03093623|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5143689|NCT03093558|adherence|adherence
5143690|NCT03093558|quality of life|quality of life
5143691|NCT03093558|health literacy|health literacy
5143692|NCT03093545|rabies|rabies
5143693|NCT03093545|obese|obese
5143694|NCT03093545|immunoglobulin|immunoglobulin
5143695|NCT03093545|rabies vaccine|rabies vaccine
5143696|NCT03093545|post-exposure|post-exposure
5143697|NCT03093545|immunogenicity|immunogenicity
5139517|NCT03118635|Summer|summer
5143702|NCT03093506|Randomized controlled trial|randomized controlled trial
5143703|NCT03093506|Human volunteers|human volunteers
5143704|NCT03093506|Mitochondrial function|mitochondrial function
5143705|NCT03093506|Cognitive performance|cognitive performance
5962063|NCT04283266|FOS|fos
5143706|NCT03093467|Internet|internet
5015683|NCT03899350|Treatment Efficacy|treatment efficacy
5143707|NCT03093467|Mental Health|mental health
5143708|NCT03093441|High-intensity interval training|high-intensity interval training
5143709|NCT03093441|cardiometabolic|cardiometabolic
5143710|NCT03093441|physical performance|physical performance
5143711|NCT03093441|psychosocial adaptation|psychosocial adaptation
5143712|NCT03093428|Prostate Cancer|prostate cancer
5143713|NCT03093415|Hepatitis C|hepatitis c
5143715|NCT03093415|People Who Inject Drugs|people who inject drugs
5143716|NCT03093415|PWID|pwid
5143717|NCT03093415|Medication Assisted Therapy|medication assisted therapy
5143719|NCT03093415|Needle Exchange Program|needle exchange program
5143720|NCT03093402|JBT-101 (also known as lenabasum)|jbt-101 (also known as lenabasum)
5143721|NCT03093402|efficacy|efficacy
5143722|NCT03093402|musculoskeletal disease|musculoskeletal disease
5143723|NCT03093402|randomized trial|randomized trial
5143724|NCT03093376|Anxiety|anxiety
5143725|NCT03093376|Effortful Control|effortful control
5143726|NCT03093376|Preschool|preschool
5143727|NCT03093376|ERN|ern
5143728|NCT03093350|Breast Cancer|breast cancer
5143729|NCT03093350|Tumor Associated Antigen Specific T cells|tumor associated antigen specific t cells
5143730|NCT03093337|Neuromotor sequelae|neuromotor sequelae
5144906|NCT03085992|trust|trust
5143820|NCT03092908|calcium oxalate|calcium oxalate
5143821|NCT03092908|nephrolithiasis|nephrolithiasis
5143822|NCT03092908|Mature vinegar|mature vinegar
5143823|NCT03092908|prophylaxis|prophylaxis
5143824|NCT03092869|Feet|feet
5143825|NCT03092869|Ankle|ankle
5143826|NCT03092869|Balance|balance
5143827|NCT03092869|Manual Therapy|manual therapy
5143828|NCT03092869|Older Adult|older adult
5143829|NCT03092830|SCC|scc
5143830|NCT03092830|BCC|bcc
5143831|NCT03092830|DNA|dna
5143832|NCT03092830|RNA|rna
5143845|NCT03092791|Drug Therapy|drug therapy
5143846|NCT03092778|Cryoablation|cryoablation
5143847|NCT03092778|Radiology|radiology
5143848|NCT03092765|E6011|e6011
5143849|NCT03092765|Ursodeoxycholic acid|ursodeoxycholic acid
5143850|NCT03092765|Japan|japan
5143851|NCT03092726|ASP8062|asp8062
5143852|NCT03092726|Fibromyalgia|fibromyalgia
5143853|NCT03092713|Cognitive Rehabilitation|cognitive rehabilitation
5143854|NCT03092713|Supported employment|supported employment
5143855|NCT03092713|Mild and moderate TBI|mild and moderate tbi
5143856|NCT03092713|Return to work|return to work
5143857|NCT03092713|Randomized Controlled Trial|randomized controlled trial
5143858|NCT03092687|Mental Illness|mental illness
5143859|NCT03092687|Aging|aging
5143860|NCT03092687|Normal Development|normal development
5143861|NCT03092661|Oxygen saturation|oxygen saturation
5143862|NCT03092661|Pulse oximetry|pulse oximetry
5143863|NCT03092661|Neonate|neonate
5143864|NCT03092661|Infant|infant
5143865|NCT03092622|Exercise Therapy|exercise therapy
5143866|NCT03092609|Attentional Bias to Threat|attentional bias to threat
5143867|NCT03092596|HIV infection|hiv infection
5143868|NCT03092596|drug abuse|drug abuse
5143869|NCT03092596|substance use|substance use
5143870|NCT03092596|alcohol abuse|alcohol abuse
5143871|NCT03092596|screening|screening
5143872|NCT03092596|treatment|treatment
5143873|NCT03092596|primary care|primary care
5143874|NCT03092596|motivational interviewing|motivational interviewing
5143875|NCT03092570|Motor learning|motor learning
5143876|NCT03092570|stroke|stroke
5143877|NCT03092570|tDCS|tdcs
5143878|NCT03092570|upper limb|upper limb
5143879|NCT03092531|HIV|hiv
5143880|NCT03092531|ART Adherence|art adherence
5143881|NCT03092531|Adolescents|adolescents
5143891|NCT03092466|femoral nerve block|femoral nerve block
5143892|NCT03092466|elderly patient|elderly patient
5143893|NCT03092466|cognitive impairment|cognitive impairment
5143894|NCT03092466|hip fracture|hip fracture
5143895|NCT03092466|regional anesthesia|regional anesthesia
5143896|NCT03092440|Medical Education|medical education
5143897|NCT03092440|simulation|simulation
5143898|NCT03092440|serious game|serious game
5143899|NCT03092440|validity|validity
5143900|NCT03092401|Liver transplantation|liver transplantation
5143901|NCT03092401|Hepatopulmonary Syndrome|hepatopulmonary syndrome
5143902|NCT03092401|Liver Cirrhosis|liver cirrhosis
5143903|NCT03092388|Sleep-Disordered Breathing|sleep-disordered breathing
5143904|NCT03092388|Heart Failure|heart failure
5143905|NCT03092388|Leg Fluid Shift|leg fluid shift
5143908|NCT03092362|persistent atrial fibrillation|persistent atrial fibrillation
5143909|NCT03092362|Heart rate variability|heart rate variability
5143911|NCT03092336|Peripheral Arterial Disease, training|peripheral arterial disease, training
5143912|NCT03092310|Artificial Pancreas|artificial pancreas
5143914|NCT03092271|suicide attempt|suicide attempt
5143915|NCT03092271|self harm|self harm
5143916|NCT03092271|depression|depression
5143917|NCT03092193|Naproxen|naproxen
5143918|NCT03092193|Association of naproxen-esomeprazole|association of naproxen-esomeprazole
5143919|NCT03092193|High pressure liquid chromatography|high pressure liquid chromatography
5143920|NCT03092193|Cytochrome P450|cytochrome p450
5143921|NCT03092180|Dermatomyositis|dermatomyositis
5962064|NCT04283227|OTL-200|otl-200
5962065|NCT04283227|Cryopreserved formulation|cryopreserved formulation
5015799|NCT03898544|TKA|tka
5143922|NCT03092180|Immunomodulation|immunomodulation
5143923|NCT03092180|Immunosuppressive agents|immunosuppressive agents
5143924|NCT03092180|Myositis|myositis
5143925|NCT03092180|Polymyositis|polymyositis
5143926|NCT03092180|Necrotizing myopathies|necrotizing myopathies
5143927|NCT03092180|Antisynthetase syndrome|antisynthetase syndrome
5143928|NCT03092128|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
5143929|NCT03092128|Imatinib|imatinib
5143930|NCT03092128|Pharmacogenetics|pharmacogenetics
5143931|NCT03092128|Pharmacokinetics|pharmacokinetics
5143932|NCT03092128|Precision medicine|precision medicine
5143933|NCT03092128|Somatic and germ-line mutations|somatic and germ-line mutations
5143934|NCT03092115|Men who have sex with men (MSM)|men who have sex with men (msm)
5143935|NCT03092115|mHealth|mhealth
5143936|NCT03092115|antiretroviral therapy (ART)|antiretroviral therapy (art)
5143937|NCT03092115|native android app|native android app
5143938|NCT03092089|Sonothrombolysis, STEMI, PPCI, Microbubbles|sonothrombolysis, stemi, ppci, microbubbles
5143939|NCT03092076|pharmacokinetics|pharmacokinetics
5143940|NCT03092076|antiplatelet effects|antiplatelet effects
5143941|NCT03092076|single nucleotide polymorphism (SNP)|single nucleotide polymorphism (snp)
5143942|NCT03092024|Systemic Sclerosis|systemic sclerosis
5143943|NCT03092024|Scleroderma|scleroderma
5143944|NCT03092024|Hand|hand
5143945|NCT03092024|Intervention|intervention
5143946|NCT03092024|Exercise|exercise
5143947|NCT03091985|Breastshield|breastshield
5143948|NCT03091985|Breastpump|breastpump
5143949|NCT03091985|Breastfeeding|breastfeeding
5143950|NCT03091972|Persistent Atrial Fibrillation|persistent atrial fibrillation
5143951|NCT03091972|Linear ablation|linear ablation
5143952|NCT03091972|Catheter ablation|catheter ablation
5143953|NCT03091972|Contact force|contact force
5143954|NCT03091946|Oatmeal; Post-prandial glycemic response ; Post-prandial insulin response; Post-prandial hunger|oatmeal; post-prandial glycemic response ; post-prandial insulin response; post-prandial hunger
5143955|NCT03091933|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5143956|NCT03091933|relapsed hematopoietic malignancy|relapsed hematopoietic malignancy
5143957|NCT03091933|HLA matched donor|hla matched donor
5143958|NCT03091933|minor histocompatibilty antigen (MiHA)|minor histocompatibilty antigen (miha)
5143959|NCT03091907|Necrotizing enterocolitis|necrotizing enterocolitis
5143960|NCT03091907|Followup|followup
5143961|NCT03091907|Neurodevelopmental impairments|neurodevelopmental impairments
5143962|NCT03091907|Growth impairments|growth impairments
5143963|NCT03091907|Gut function|gut function
5143964|NCT03091907|Behavioural impairments|behavioural impairments
5143965|NCT03091894|Dexmedetomidine|dexmedetomidine
5143966|NCT03091894|Sleep|sleep
5143967|NCT03091894|Endoscopy|endoscopy
5143968|NCT03091894|Propofol|propofol
5143969|NCT03091881|Granisetron|granisetron
5143970|NCT03091881|Spinal induced hypotension|spinal induced hypotension
5143971|NCT03091790|ventral hernia|ventral hernia
5143972|NCT03091790|mesh|mesh
5143973|NCT03091777|bacterial vaginosis|bacterial vaginosis
5143974|NCT03091777|vaginal infection|vaginal infection
5143976|NCT03091764|NMIBC|nmibc
5143977|NCT03091764|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5143978|NCT03091764|Patient reported outcome|patient reported outcome
5143979|NCT03091764|Symptom burden|symptom burden
5143980|NCT03091764|Questionnaire|questionnaire
5143981|NCT03091751|Factor IX (FIX)|factor ix (fix)
5143982|NCT03091738|sleep|sleep
5143983|NCT03091725|Obesity|obesity
5143984|NCT03091725|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
5143985|NCT03091725|Very low calorie diet|very low calorie diet
5143986|NCT03091725|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
5143987|NCT03091712|Degludec|degludec
5143988|NCT03091712|MIDS|mids
5143989|NCT03091712|Mobile Insulin Dosing System|mobile insulin dosing system
5143990|NCT03091712|Glooko|glooko
5143991|NCT03091712|Tresiba|tresiba
5143992|NCT03091712|Tresiba® U-200 FlexTouch®|tresiba® u-200 flextouch®
5143993|NCT03091699|Smoking|smoking
5143994|NCT03091699|Nicotine|nicotine
5143995|NCT03091699|Exercise|exercise
5143996|NCT03091699|Cognition|cognition
5143997|NCT03091686|Sedentary Behaviour|sedentary behaviour
5143998|NCT03091686|Health Behaviour Change|health behaviour change
5143999|NCT03091686|Health Action Process Approach|health action process approach
5144000|NCT03091686|Intervention|intervention
5144001|NCT03091686|Prolonged Sitting|prolonged sitting
5144002|NCT03091686|Light Intensity Physical Activity|light intensity physical activity
5144003|NCT03091686|Motivational Factors|motivational factors
5144005|NCT03091686|Diabetes|diabetes
5144006|NCT03091686|Self-Efficacy|self-efficacy
5144007|NCT03091686|Risk Perception|risk perception
5144008|NCT03091686|Outcome Expectancies|outcome expectancies
5144009|NCT03091647|Chinese women|chinese women
5144010|NCT03091647|Cancer-related fatigue|cancer-related fatigue
5144011|NCT03091647|Acupressure|acupressure
5144012|NCT03091634|Xue-Fu-Zhu-Yu Capsule|xue-fu-zhu-yu capsule
5144013|NCT03091634|Qi Stagnation and Blood Stasis syndrome|qi stagnation and blood stasis syndrome
5962066|NCT04283227|Gene therapy|gene therapy
5962067|NCT04283227|MLD|mld
5015935|NCT03897582|amoxicillin|amoxicillin
5144014|NCT03091634|National Center for Complementary and Integrative Health|national center for complementary and integrative health
5144015|NCT03091621|Deep Vein Thrombosis|deep vein thrombosis
5144016|NCT03091621|pulmonary embolism|pulmonary embolism
5144017|NCT03091608|Drug-Induced Liver Injury|drug-induced liver injury
5144018|NCT03091582|Psychological Therapy|psychological therapy
5144019|NCT03091556|Drug-Induced Liver Injury|drug-induced liver injury
5144020|NCT03091530|Throwing|throwing
5144021|NCT03091530|Sleeper Stretch|sleeper stretch
5144022|NCT03091530|Balloon Blow|balloon blow
5144023|NCT03091530|GIRD (Glenohumeral internal rotation deficit)|gird (glenohumeral internal rotation deficit)
5144024|NCT03091517|Online lifestyle modification|online lifestyle modification
5144025|NCT03091517|Self-management|self-management
5144026|NCT03091517|HbA1c|hba1c
5144027|NCT03091439|Osteomyelitis|osteomyelitis
5144028|NCT03091439|dalbavancin|dalbavancin
5144029|NCT03091439|antibiotic|antibiotic
5144030|NCT03091400|Memory Disorders|memory disorders
5144031|NCT03091400|Multiple Sclerosis|multiple sclerosis
5144032|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride
5144033|NCT03091387|neonates, extubation|neonates, extubation
5144034|NCT03091361|Bacterial imaging|bacterial imaging
5144035|NCT03091361|PPV|ppv
5144036|NCT03091361|Chronic wounds|chronic wounds
5144037|NCT03091309|Inflammatory Bowel Diseases|inflammatory bowel diseases
5144038|NCT03091309|Medication Adherence|medication adherence
5144039|NCT03091309|Crohn Disease|crohn disease
5144040|NCT03091309|Ulcerative Colitis|ulcerative colitis
5144041|NCT03091309|Pregnancy|pregnancy
5144046|NCT03091270|motor functional cortex|motor functional cortex
5144047|NCT03091270|ZOOMit-fMRI|zoomit-fmri
5144048|NCT03091270|BOLD-fMRI|bold-fmri
5144049|NCT03091257|Multiple Myeloma|multiple myeloma
5144050|NCT03091244|Drug-Induced Liver Injury|drug-induced liver injury
5144051|NCT03091218|Drug-Induced Liver Injury|drug-induced liver injury
5144052|NCT03091192|Papillary Renal Cell Cancer|papillary renal cell cancer
5144053|NCT03091192|AZD6094|azd6094
5144054|NCT03091192|Savolitinib|savolitinib
5144055|NCT03091179|airway management|airway management
5144056|NCT03091179|high flow nasal oxygen|high flow nasal oxygen
5144057|NCT03091179|high flow nasal cannula|high flow nasal cannula
5144058|NCT03091179|THRIVE|thrive
5773359|NCT00229879|cardiac|cardiac
5144059|NCT03091140|Parathyroidectomy|parathyroidectomy
5144060|NCT03091140|Muscular Functional Characteristics|muscular functional characteristics
5144061|NCT03091140|Parathyroid Glands|parathyroid glands
5144062|NCT03091114|fractures, risk prediction|fractures, risk prediction
5144063|NCT03091101|keratoconus|keratoconus
5144064|NCT03091101|corneal innervation|corneal innervation
5144065|NCT03091101|scleral contact lenses|scleral contact lenses
5144066|NCT03091075|Rotator Cuff Tear|rotator cuff tear
5144067|NCT03091075|Rotator Cuff|rotator cuff
5144068|NCT03091075|Anabolic Steroid|anabolic steroid
5144069|NCT03091075|Testosterone|testosterone
5144070|NCT03091075|Oxandrolone|oxandrolone
5144071|NCT03091049|coronary|coronary
5144072|NCT03091049|catheterization|catheterization
5144073|NCT03091049|transradial|transradial
5144074|NCT03091049|anesthesia|anesthesia
5144075|NCT03091036|Chronic|chronic
5144076|NCT03091036|Complex|complex
5144077|NCT03091023|Endometrial receptivity|endometrial receptivity
5144078|NCT03091023|Transcriptomic|transcriptomic
5144079|NCT03091023|Single cell|single cell
5144080|NCT03091023|Endometrial fluid|endometrial fluid
5144081|NCT03090997|resveratrol, vitamin C, antioxidant therapy, antioxidant capacity|resveratrol, vitamin c, antioxidant therapy, antioxidant capacity
5144082|NCT03090984|Hemodialysis|hemodialysis
5144083|NCT03090984|Coagulation activation|coagulation activation
5144084|NCT03090958|technology|technology
5144085|NCT03090958|app|app
5144086|NCT03090958|YMSM|ymsm
5144087|NCT03090958|HIV|hiv
5144088|NCT03090945|Endoscopy|endoscopy
5144089|NCT03090945|GI Bleeding|gi bleeding
5144090|NCT03090945|Pediatrics|pediatrics
5144091|NCT03090945|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
5144092|NCT03090945|Gastro Intestinal Bleeding|gastro intestinal bleeding
5144093|NCT03090906|volume gain|volume gain
5144094|NCT03090906|soft tissue augmentation|soft tissue augmentation
5144095|NCT03090906|dental implants|dental implants
5144096|NCT03090906|histology|histology
5144097|NCT03090880|Low-molecular-weight Heparin|low-molecular-weight heparin
5144098|NCT03090880|Tinzaparin|tinzaparin
5144099|NCT03090867|Clinical Practice Guideline|clinical practice guideline
5144100|NCT03090867|Critical care|critical care
5144101|NCT03090867|Family-centered care|family-centered care
5139813|NCT03116958|Standard management|standard management
5144102|NCT03090867|Professional-family relations|professional-family relations
5144103|NCT03090867|Family nursing|family nursing
5144104|NCT03090867|Anxiety|anxiety
5144105|NCT03090867|Depression|depression
5144106|NCT03090867|Participation in care|participation in care
5144107|NCT03090854|Alzheimer's Disease|alzheimer's disease
5144108|NCT03090854|Cognition|cognition
5144109|NCT03090854|Cholinergic target|cholinergic target
5144110|NCT03090841|Cytomegalovirus Congenital|cytomegalovirus congenital
5962068|NCT04283227|late juvenile|late juvenile
5010715|NCT03929666|XP|xp
5144111|NCT03090841|Non-invasive diagnosis|non-invasive diagnosis
5144112|NCT03090841|Omics|omics
5144113|NCT03090841|Biomarkers|biomarkers
5144114|NCT03090828|economic evaluation|economic evaluation
5144115|NCT03090828|e health|e health
5144116|NCT03090815|Circulating Tumor DNA|circulating tumor dna
5144117|NCT03090815|Prognostic|prognostic
5144118|NCT03090815|Molecular tests|molecular tests
5144119|NCT03090802|Human Immunodeficiency Virus|human immunodeficiency virus
5144120|NCT03090802|resilience|resilience
5144121|NCT03090802|adolescent mothers|adolescent mothers
5144122|NCT03090802|Sub-Saharan Africa|sub-saharan africa
5144123|NCT03090802|intimate partner violence|intimate partner violence
5144124|NCT03090802|postpartum period|postpartum period
5144125|NCT03090789|Friedreich Ataxia|friedreich ataxia
5144378|NCT03089359|Unspecific symptoms|unspecific symptoms
5144126|NCT03090789|Neuro-degenerative disease|neuro-degenerative disease
5144127|NCT03090698|osteoarthritis|osteoarthritis
5144128|NCT03090698|knee|knee
5144129|NCT03090698|treatment|treatment
5144130|NCT03090685|Chikungunya Fever|chikungunya fever
5144131|NCT03090685|Pain|pain
5144132|NCT03090685|Mobility Limitation|mobility limitation
5144133|NCT03090685|Auriculotherapy|auriculotherapy
5144134|NCT03090685|Complementary Therapies|complementary therapies
5153296|NCT03034070|MRI|mri
5144135|NCT03090685|Physical Therapy|physical therapy
5144136|NCT03090672|Arthritis|arthritis
5144137|NCT03090672|Degenerative|degenerative
5144138|NCT03090672|Tendinosis|tendinosis
5144139|NCT03090672|Jont disease|jont disease
5144140|NCT03090672|Low back pain|low back pain
5144141|NCT03090659|multiple myeloma|multiple myeloma
5144142|NCT03090659|BCMA|bcma
5144143|NCT03090659|CAR-T|car-t
5144144|NCT03090646|social behavioral|social behavioral
5144145|NCT03090646|living donor kidney transplant|living donor kidney transplant
5144146|NCT03090646|follow-up|follow-up
5144147|NCT03090646|health utilization|health utilization
5144148|NCT03090646|incentives|incentives
5144149|NCT03090633|Fetoscopy|fetoscopy
5144150|NCT03090633|Fetal surgery|fetal surgery
5144151|NCT03090633|Fetal spina bifida|fetal spina bifida
5144152|NCT03090594|Cryoprobe|cryoprobe
5144153|NCT03090594|Bronchoscopy|bronchoscopy
5144154|NCT03090594|Acute cellular rejection|acute cellular rejection
5144155|NCT03090581|Graft Rejection/diagnosis|graft rejection/diagnosis
5144156|NCT03090581|Lung Transplantation|lung transplantation
5144157|NCT03090581|Cryoprobe|cryoprobe
5144158|NCT03090555|adhesive capsulitis|adhesive capsulitis
5144159|NCT03090555|clinical trial|clinical trial
5144160|NCT03090555|manipulation|manipulation
5144161|NCT03090529|Exercise training|exercise training
5144162|NCT03090529|Ambulatory blood pressure|ambulatory blood pressure
5144163|NCT03090529|Resistant Hypertension|resistant hypertension
5144164|NCT03090529|Nitric Oxide|nitric oxide
5030092|NCT03810898|radioligand|radioligand
5144165|NCT03090516|Ginkgo biloba dispersible tablets|ginkgo biloba dispersible tablets
5144166|NCT03090516|Alzheimer's|alzheimer's
5144167|NCT03090503|Antipsychotic agents|antipsychotic agents
5144168|NCT03090503|Treatment|treatment
5144169|NCT03090503|Effectiveness|effectiveness
5144170|NCT03090503|Aripiprazole|aripiprazole
5144171|NCT03090503|Risperidone|risperidone
5144172|NCT03090490|Treatment|treatment
5144173|NCT03090490|Maintenance|maintenance
5144174|NCT03090464|Type 2 diabetes mellitus|type 2 diabetes mellitus
5144175|NCT03090464|Digital disease management|digital disease management
5144176|NCT03090464|T2DM|t2dm
5144177|NCT03090464|Hyperglycemia|hyperglycemia
5144178|NCT03090464|Diabetes mellitus|diabetes mellitus
5144179|NCT03090451|Insulin|insulin
5144180|NCT03090451|Glucose Clamp|glucose clamp
5144181|NCT03090451|Glucose Tracer|glucose tracer
5144182|NCT03090451|Artificial Pancreas|artificial pancreas
5144183|NCT03090451|Exercise|exercise
5144184|NCT03090451|Aerobic|aerobic
5144185|NCT03090399|Goal Directed Fluid Therapy|goal directed fluid therapy
5144186|NCT03090373|Catheter|catheter
5144187|NCT03090373|UTI's|uti's
5144188|NCT03090360|Healthy babies|healthy babies
5144189|NCT03090360|Infant formula|infant formula
5144190|NCT03090360|Growth|growth
5144191|NCT03090334|beta-d-glucan|beta-d-glucan
5144192|NCT03090334|abdominal candidiasis|abdominal candidiasis
5144193|NCT03090321|fitness|fitness
5144194|NCT03090321|health|health
5144195|NCT03090321|activity|activity
5144196|NCT03090321|heart risk|heart risk
5144197|NCT03090321|wellness|wellness
5144198|NCT03090282|mechanical treatment|mechanical treatment
5144199|NCT03090282|implant|implant
5144200|NCT03090269|cocaine|cocaine
5962069|NCT04283201|lifestyle modification|lifestyle modification
5144201|NCT03090269|methylphenidate|methylphenidate
5144202|NCT03090269|psychostimulant|psychostimulant
5144203|NCT03090269|ADHD|adhd
5144204|NCT03090269|effective dose|effective dose
5144206|NCT03090269|crack|crack
5144207|NCT03090256|Trifocal IOL|trifocal iol
5144208|NCT03090243|Glaucoma|glaucoma
5144209|NCT03090243|Intraocular pressure|intraocular pressure
5144210|NCT03090243|Colonoscopy|colonoscopy
5144211|NCT03090243|Virtual Colonoscopy|virtual colonoscopy
5144212|NCT03090243|Valsalva|valsalva
5010853|NCT03928717|Africa|africa
5144213|NCT03090230|Descending Thoracic Aorta|descending thoracic aorta
5144215|NCT03090230|Transection|transection
5144216|NCT03090230|Traumatic Injury of the Descending Thoracic Aorta|traumatic injury of the descending thoracic aorta
5144217|NCT03090217|Radiotherapy|radiotherapy
5144218|NCT03090217|Brachytherapy|brachytherapy
5144219|NCT03090217|Physiotherapy|physiotherapy
5144220|NCT03090217|Vaginal dilators|vaginal dilators
5144221|NCT03090217|Pelvic floor exercises|pelvic floor exercises
5144222|NCT03090217|Vaginal Stenosis|vaginal stenosis
5144223|NCT03090204|strain|strain
5144224|NCT03090204|myocarditic deformation imaging|myocarditic deformation imaging
5144225|NCT03090204|right ventricle (RV)|right ventricle (rv)
5144226|NCT03090204|systolic RV function|systolic rv function
5144227|NCT03090204|preload dependence|preload dependence
5144228|NCT03090204|contractility|contractility
5144229|NCT03090204|intermittent hemodialysis (HDI)|intermittent hemodialysis (hdi)
5144230|NCT03090165|Triple Negative Breast Neoplasms|triple negative breast neoplasms
5144231|NCT03090165|ribociclib|ribociclib
5144232|NCT03090165|LEE011|lee011
5144233|NCT03090165|CDK 4/6 inhibitor|cdk 4/6 inhibitor
5144234|NCT03090165|bicalutamide|bicalutamide
5144235|NCT03090152|Total Hip Replacement|total hip replacement
5144236|NCT03090152|Total Hip Arthroplasty|total hip arthroplasty
5144237|NCT03090139|Drug therapy|drug therapy
5144238|NCT03090113|Stroke|stroke
5144239|NCT03090113|Embolic Stroke|embolic stroke
5144240|NCT03090113|Shuxuetong|shuxuetong
5144241|NCT03090113|Recurrence|recurrence
5144242|NCT03090113|Symptomatic New Cerebral Infarction|symptomatic new cerebral infarction
5144243|NCT03090113|Asymptomatic New Cerebral Infarction|asymptomatic new cerebral infarction
5144244|NCT03090087|Diameter of retinal arteries|diameter of retinal arteries
5144245|NCT03090087|Adenosine|adenosine
5144246|NCT03090087|Hypoxia|hypoxia
5144247|NCT03090035|HCV genotype 2, HCV genotype 3, IL-28B, PEG-INF.|hcv genotype 2, hcv genotype 3, il-28b, peg-inf.
5144248|NCT03090009|Peri-implant Mucositis|peri-implant mucositis
5144249|NCT03090009|NSAID|nsaid
5144250|NCT03090009|Microbiome|microbiome
5144251|NCT03090009|16s Ribosomal Pyro-sequencing|16s ribosomal pyro-sequencing
5144252|NCT03089996|piezocision|piezocision
5144253|NCT03089996|corticotomy|corticotomy
5144254|NCT03089996|Gingival Crevicular Fluid|gingival crevicular fluid
5144255|NCT03089983|prison|prison
5144256|NCT03089957|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5144257|NCT03089957|Critical Illness|critical illness
5144258|NCT03089957|Randomized Controlled Trial|randomized controlled trial
5144259|NCT03089957|Ulinastatin|ulinastatin
5144260|NCT03089944|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5144261|NCT03089944|Glecaprevir|glecaprevir
5144262|NCT03089944|Pibrentasvir|pibrentasvir
5144263|NCT03089944|Treatment Naïve|treatment naïve
5144264|NCT03089944|Cirrhosis|cirrhosis
5144265|NCT03089944|Compensated Cirrhosis|compensated cirrhosis
5144266|NCT03089944|Genotype (GT) 1-6|genotype (gt) 1-6
5144267|NCT03089944|Pangenotypic|pangenotypic
5144268|NCT03089944|Chronic Hepatitis C Virus (HCV)|chronic hepatitis c virus (hcv)
5144269|NCT03089879|Immunogenicity, Vaccine|immunogenicity, vaccine
5144270|NCT03089879|Immunologic Memory|immunologic memory
5144271|NCT03089879|GMMA|gmma
5144272|NCT03089879|Shigella Vaccines|shigella vaccines
5144273|NCT03089879|Shigellosis|shigellosis
5144274|NCT03089879|Dysentery, Bacillary|dysentery, bacillary
5144275|NCT03089879|Healthy Volunteers|healthy volunteers
5144276|NCT03089879|Safety|safety
5144277|NCT03089879|Bacteria|bacteria
5144278|NCT03089879|Clinical Trials, Phase 1|clinical trials, phase 1
5144279|NCT03089879|Shigella sonnei|shigella sonnei
5144280|NCT03089866|Central nervous System|central nervous system
5144281|NCT03089866|Memory functions|memory functions
5144282|NCT03089866|Executive functions|executive functions
5144283|NCT03089866|Cognitive impairment|cognitive impairment
5144284|NCT03089853|COPD|copd
5144285|NCT03089853|pulmonary rehabilitation|pulmonary rehabilitation
5144286|NCT03089853|telehealth|telehealth
5144287|NCT03089853|smart|smart
5144288|NCT03089853|technology|technology
5144289|NCT03089853|NEMS|nems
5144290|NCT03089853|acute exacerbation|acute exacerbation
5144291|NCT03089840|normothermic perfusion|normothermic perfusion
5144292|NCT03089840|liver transplantation|liver transplantation
5144293|NCT03089827|Memory|memory
5144294|NCT03089814|tissue oxygen saturation, ischemic conditioning|tissue oxygen saturation, ischemic conditioning
5144295|NCT03089801|health care access|health care access
5144296|NCT03089801|eHealth|ehealth
5144297|NCT03089801|telehealth|telehealth
5144298|NCT03089775|Contact|contact
5144299|NCT03089775|Treatment|treatment
5144300|NCT03089775|Prevention|prevention
5144301|NCT03089775|BBI-2000|bbi-2000
5144302|NCT03089775|Dermatitis|dermatitis
5144306|NCT03089736|depression|depression
5144307|NCT03089736|anxiety|anxiety
5962070|NCT04283201|type 2 diabetes|type 2 diabetes
5144308|NCT03089736|health|health
5144309|NCT03089736|catastrophizing|catastrophizing
5144310|NCT03089723|carpometacarpal joint ostearthritis|carpometacarpal joint ostearthritis
5144311|NCT03089723|hyaluronic acid|hyaluronic acid
5016316|NCT03894969|Safety|safety
5144312|NCT03089723|Rhizarthrosis|rhizarthrosis
5144313|NCT03089697|N-Rephasin SAL200|n-rephasin sal200
5144314|NCT03089697|Methicillin-Sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
5144315|NCT03089697|Methicillin Resistant Staphylococcus Aureus|methicillin resistant staphylococcus aureus
5144316|NCT03089684|NHANES|nhanes
5144317|NCT03089684|Folate|folate
5144318|NCT03089684|Folic Acid|folic acid
5144319|NCT03089671|Vitamin B|vitamin b
5144320|NCT03089671|5% Dextrose in Water|5% dextrose in water
5144321|NCT03089671|Cystoscopy|cystoscopy
5144322|NCT03089671|Ureter|ureter
5144323|NCT03089658|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
5144324|NCT03089658|Expanded Access Program|expanded access program
5144325|NCT03089658|Temporary Authorisation for Use|temporary authorisation for use
5144326|NCT03089658|Avelumab|avelumab
5144327|NCT03089632|gluten-free diet|gluten-free diet
5144328|NCT03089632|gluten sensitivity|gluten sensitivity
5144329|NCT03089632|dyspepsia|dyspepsia
5144333|NCT03089619|Alveolar bone|alveolar bone
5144334|NCT03089619|Bone resorption|bone resorption
5144335|NCT03089619|dental implants|dental implants
5144336|NCT03089593|Thermic Effect of Food|thermic effect of food
5144337|NCT03089593|Energy Expenditure|energy expenditure
5144339|NCT03089567|Silver diamine Fluoride|silver diamine fluoride
5144340|NCT03089567|Streptococcus mutans|streptococcus mutans
5144341|NCT03089567|Caries prevention|caries prevention
5144342|NCT03089567|Fluoride|fluoride
5144345|NCT03089528|Diabetes Mellitus|diabetes mellitus
5144346|NCT03089528|Intubation|intubation
5144347|NCT03089528|Anesthesia|anesthesia
5144348|NCT03089515|World Trade Center|world trade center
5144349|NCT03089515|World Trade Center Survivors|world trade center survivors
5144350|NCT03089502|Exercise|exercise
5144351|NCT03089502|Cardiac Rehabilitation|cardiac rehabilitation
5144352|NCT03089502|Breast Caner|breast caner
5144353|NCT03089502|Left Ventricular Dysfunction|left ventricular dysfunction
5144354|NCT03089502|Trastuzumab|trastuzumab
5144355|NCT03089502|Anthracyclines|anthracyclines
5144356|NCT03089489|Primary graft dysfunction|primary graft dysfunction
5144357|NCT03089489|Lung transplantation|lung transplantation
5144358|NCT03089489|Surfactant Protein|surfactant protein
5144359|NCT03089489|inflammation|inflammation
5144360|NCT03089476|Prevention|prevention
5144361|NCT03089476|Predictors|predictors
5144362|NCT03089463|Diabetes|diabetes
5144363|NCT03089463|Diabetic Foot|diabetic foot
5144364|NCT03089463|Biomechanics|biomechanics
5144365|NCT03089463|Stratification|stratification
5144366|NCT03089463|Diabetes Complications|diabetes complications
5144367|NCT03089463|Diabetes; Neuropathic (Manifestation)|diabetes; neuropathic (manifestation)
5144368|NCT03089463|Risk Factors|risk factors
5144369|NCT03089463|Prospective Studies|prospective studies
5144370|NCT03089424|low back pain, photobiomodulation therapy, LLLT|low back pain, photobiomodulation therapy, lllt
5144371|NCT03089411|myeloma multiple|myeloma multiple
5144372|NCT03089411|newly diagnosed|newly diagnosed
5144373|NCT03089398|Hybrid Coronary Revascularization|hybrid coronary revascularization
5144374|NCT03089398|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5144375|NCT03089398|Percutaneous Coronary Intervention|percutaneous coronary intervention
5144376|NCT03089372|Erectile Dysfunction|erectile dysfunction
5144377|NCT03089372|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
5144379|NCT03089359|Soluvent urokinase plasminogen activator receptor|soluvent urokinase plasminogen activator receptor
5144381|NCT03089359|Emergency Medical Services|emergency medical services
5144382|NCT03089346|Imaging|imaging
5144383|NCT03089346|Bronchial Remodeling|bronchial remodeling
5144384|NCT03089320|HIV, Heavy drinking, Alcohol Abuse, AIDS|hiv, heavy drinking, alcohol abuse, aids
5144385|NCT03089307|Erectile Dysfunction|erectile dysfunction
5144386|NCT03089307|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
5144387|NCT03089294|Erectile Dysfunction|erectile dysfunction
5144388|NCT03089294|Low intensity extracorporeal shock wave treatment|low intensity extracorporeal shock wave treatment
5144393|NCT03089255|Thrombophylaxis|thrombophylaxis
5144394|NCT03089255|Deep Venous Thrombosis|deep venous thrombosis
5144395|NCT03089255|Pulmonary Embolism|pulmonary embolism
5144396|NCT03089255|Lower Leg Trauma|lower leg trauma
5144397|NCT03089229|Topical Cream|topical cream
5144398|NCT03089229|Novel|novel
5144399|NCT03089190|Appetite|appetite
5144400|NCT03089190|Satiety|satiety
5144401|NCT03089190|Energy intake|energy intake
5144402|NCT03089190|Hunger|hunger
5144403|NCT03089190|Peptide|peptide
5144404|NCT03089190|Encapsulation|encapsulation
5144405|NCT03089177|Randomized Controlled Trial|randomized controlled trial
5144411|NCT03089177|Cancer Prevention|cancer prevention
5144412|NCT03089177|Neighborhood|neighborhood
5144413|NCT03089151|Pilot Randomized Controlled Trial|pilot randomized controlled trial
5144414|NCT03089151|Community Garden|community garden
5144415|NCT03089151|Health Behavior Change|health behavior change
5144416|NCT03089151|Physical Activity|physical activity
5144417|NCT03089151|Diet|diet
5144418|NCT03089151|Obesity|obesity
5962071|NCT04283201|prevention|prevention
5962072|NCT04283201|Ukraine|ukraine
5011103|NCT03926910|PLR|plr
5144419|NCT03089151|Neighborhood|neighborhood
5144420|NCT03089151|Microbiome|microbiome
5144421|NCT03089151|Inflammatory biomarkers|inflammatory biomarkers
5144422|NCT03089125|Lung Cancer|lung cancer
5144423|NCT03089099|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5144424|NCT03089099|circulating tumor cells|circulating tumor cells
5144425|NCT03089099|Prognosis|prognosis
5144426|NCT03089099|Liquid biopsy|liquid biopsy
5144427|NCT03089086|meningococcal B vaccine|meningococcal b vaccine
5144428|NCT03089086|herd immunity|herd immunity
5144429|NCT03089086|adolescents|adolescents
5144430|NCT03089086|young adults|young adults
5144431|NCT03089086|south australia|south australia
5144432|NCT03089060|Fingertip Amputation|fingertip amputation
5144433|NCT03089060|Fingertip Regeneration|fingertip regeneration
5144434|NCT03089060|Infection|infection
5144435|NCT03089060|Occlusive Dressings|occlusive dressings
5144436|NCT03089060|Pediatric Surgery|pediatric surgery
5144437|NCT03089060|Silicone Finger Cap|silicone finger cap
5144438|NCT03089021|neck pain,|neck pain,
5144439|NCT03088982|Family Medicine|family medicine
5144440|NCT03088982|multimorbidity|multimorbidity
5144441|NCT03088982|prevention|prevention
5144442|NCT03088969|Chronic Low Back Pain|chronic low back pain
5144443|NCT03088969|Function|function
5144444|NCT03088969|Self-efficacy|self-efficacy
5144445|NCT03088969|Return to work|return to work
5144446|NCT03088969|Questionnaire|questionnaire
5144447|NCT03088956|Longitudinal|longitudinal
5144448|NCT03088956|Caregiver|caregiver
5144449|NCT03088956|Cognitive assessments|cognitive assessments
5144450|NCT03088956|Behavioral assessments|behavioral assessments
5144451|NCT03088956|Functional assessments|functional assessments
5144452|NCT03088904|Inactivated influenza vaccine quadrivalent|inactivated influenza vaccine quadrivalent
5144453|NCT03088904|Live, attenuated influenza vaccine quadrivalent|live, attenuated influenza vaccine quadrivalent
5144454|NCT03088904|Monozygotic twins|monozygotic twins
5144455|NCT03088904|Dizygotic twins|dizygotic twins
5144456|NCT03088904|Adults|adults
5144457|NCT03088904|Adolescents|adolescents
5144458|NCT03088891|altitude training|altitude training
5144459|NCT03088891|antioxidants|antioxidants
5144460|NCT03088891|oxidative stress|oxidative stress
5144461|NCT03088891|elite athletes|elite athletes
5144462|NCT03088891|inflammation|inflammation
5144464|NCT03088878|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5144465|NCT03088878|Small lymphocytic lymphoma|small lymphocytic lymphoma
5144466|NCT03088878|Mantle cell lymphoma|mantle cell lymphoma
5144467|NCT03088878|Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)|receptor tyrosine kinase-like orphan receptor 1 (ror1)
5144468|NCT03088878|Bruton Tyrosine Kinase (BTK)|bruton tyrosine kinase (btk)
5144469|NCT03088774|Low back pain|low back pain
5144470|NCT03088761|tracheal tube|tracheal tube
5144471|NCT03088761|cuff pressure|cuff pressure
5144472|NCT03088748|total knee arthroplasty|total knee arthroplasty
5144473|NCT03088722|Contraceptive implant|contraceptive implant
5144474|NCT03088722|Task sharing|task sharing
5144475|NCT03088722|Nigeria|nigeria
5144476|NCT03088709|NHL|nhl
5144477|NCT03088709|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5144478|NCT03088709|Haploidentical|haploidentical
5144479|NCT03088709|Bone Marrow Transplant|bone marrow transplant
5144480|NCT03088709|Stem Cell Transplant|stem cell transplant
5144481|NCT03088709|Acute Myeloid Leukemia|acute myeloid leukemia
5144482|NCT03088709|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5144483|NCT03088709|Myelodysplastic Syndrome|myelodysplastic syndrome
5144484|NCT03088709|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5144485|NCT03088709|GVHD|gvhd
5144486|NCT03088696|laparoscopic|laparoscopic
5144487|NCT03088696|acupuncture|acupuncture
5144488|NCT03088683|sleeve gastrectomy|sleeve gastrectomy
5144489|NCT03088683|liver retractor|liver retractor
5144490|NCT03088683|nathanson|nathanson
5144491|NCT03088683|reveel|reveel
5144492|NCT03088683|liver trauma|liver trauma
5144493|NCT03088657|Cohort study|cohort study
5144494|NCT03088657|early-onset mood disorders|early-onset mood disorders
5144495|NCT03088618|Nasal obstruction|nasal obstruction
5144496|NCT03088618|Septal deformity|septal deformity
5144497|NCT03088618|Septoplasty|septoplasty
5144498|NCT03088618|TnR Mesh|tnr mesh
5144499|NCT03088618|polycaprolactone|polycaprolactone
5144506|NCT03088553|Solid organ transplantation (heart, kidney or liver)|solid organ transplantation (heart, kidney or liver)
5144508|NCT03088540|Current Smoker|current smoker
5144509|NCT03088540|Stage IIIB|stage iiib
5144510|NCT03088540|Stage IIIC|stage iiic
5144511|NCT03088540|Stage IV|stage iv
5144512|NCT03088540|PD-L1|pd-l1
5144513|NCT03088514|Hypertension|hypertension
5144514|NCT03088514|Left Ventricular Hypertrophy|left ventricular hypertrophy
5144515|NCT03088514|Endothelial Dysfunction|endothelial dysfunction
5144516|NCT03088514|Nitrate|nitrate
5144517|NCT03088501|Birth cohort, follow-up, IVRS|birth cohort, follow-up, ivrs
5144518|NCT03088488|25-OH vitamin D|25-oh vitamin d
5144519|NCT03088488|RANKL|rankl
5962073|NCT04283201|Rural|rural
5144520|NCT03088488|Osteoprotogerin|osteoprotogerin
5144521|NCT03088488|TNF-α|tnf-α
5144522|NCT03088462|Bipolar Disorder|bipolar disorder
5144523|NCT03088462|Smartphone|smartphone
5144524|NCT03088462|Behavior Therapy|behavior therapy
5144529|NCT03088449|Anti-TNF|anti-tnf
5144530|NCT03088449|PANTS|pants
5144531|NCT03088449|Biosimilars|biosimilars
5144532|NCT03088436|MRI|mri
5144533|NCT03088436|Breast|breast
5144534|NCT03088423|MRI|mri
5144535|NCT03088423|Stereotactic body radiation therapy|stereotactic body radiation therapy
5144536|NCT03088384|Post Traumatic Stress Disorder|post traumatic stress disorder
5144537|NCT03088384|PTSD|ptsd
5144538|NCT03088384|Combat Trauma|combat trauma
5144539|NCT03088371|Total knee replacement|total knee replacement
5144540|NCT03088371|Psoas Sciatic block|psoas sciatic block
5144541|NCT03088371|Epidural anaesthesia|epidural anaesthesia
5144542|NCT03088345|Fontan Palliation Surgery|fontan palliation surgery
5144543|NCT03088345|Post-Operative Care|post-operative care
5144548|NCT03088241|randomized clinical trial|randomized clinical trial
5144549|NCT03088241|low level viremia|low level viremia
5144550|NCT03088241|lesotho|lesotho
5144551|NCT03088241|resource-limited setting|resource-limited setting
5144552|NCT03088241|ART first-line failure|art first-line failure
5144553|NCT03088215|Trigger Point Pain, Myofascial|trigger point pain, myofascial
5144554|NCT03088215|shock-waves|shock-waves
5144555|NCT03088215|extracorporeal shock-wave treatment (ESWT)|extracorporeal shock-wave treatment (eswt)
5144556|NCT03088215|pain|pain
5144557|NCT03088215|trigger point|trigger point
5144558|NCT03088215|referred pain|referred pain
5144565|NCT03088189|maternal nutrition|maternal nutrition
5144566|NCT03088189|periconceptional|periconceptional
5144567|NCT03088189|neurocognitive development|neurocognitive development
5144568|NCT03088176|Melanoma|melanoma
5144569|NCT03088176|BRAF inhibitor|braf inhibitor
5144570|NCT03088176|Intratumoral injection|intratumoral injection
5144571|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec
5144572|NCT03088176|MEK inhibitor|mek inhibitor
5144573|NCT03088176|dabrafenib|dabrafenib
5144574|NCT03088176|trametinib|trametinib
5144575|NCT03088150|Hepatic resection|hepatic resection
5144576|NCT03088150|Liver surgery|liver surgery
5144577|NCT03088150|Thermal ablation|thermal ablation
5144578|NCT03088150|Radiofrequency ablation|radiofrequency ablation
5144579|NCT03088150|Microwave ablation|microwave ablation
5144581|NCT03088150|MWA|mwa
5144582|NCT03088137|in vitro fertilization|in vitro fertilization
5144583|NCT03088111|Anthim®|anthim®
5144584|NCT03088111|Obiltoxaximab|obiltoxaximab
5144585|NCT03088111|anthrax|anthrax
5144586|NCT03088111|anti-toxin|anti-toxin
5144587|NCT03088098|left atrial appendage occlusion|left atrial appendage occlusion
5144588|NCT03088098|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5144589|NCT03088098|atrial fibrillation|atrial fibrillation
5144590|NCT03088072|Edoxaban|edoxaban
5144591|NCT03088072|WATCHMAN device|watchman device
5144592|NCT03088020|CCHS|cchs
5144593|NCT03088020|PHOX2B|phox2b
5144594|NCT03088020|Paired-like Homeobox gene PHOX2B|paired-like homeobox gene phox2b
5144595|NCT03088020|autonomic nervous system dysregulation|autonomic nervous system dysregulation
5144596|NCT03088020|control of breathing|control of breathing
5144597|NCT03088020|Hirschsprung disease|hirschsprung disease
5144598|NCT03088020|neural crest tumors|neural crest tumors
5144599|NCT03088020|neuroblastoma|neuroblastoma
5144600|NCT03088020|ganglioneuroma|ganglioneuroma
5144601|NCT03088020|ganglioneuroblastoma|ganglioneuroblastoma
5144602|NCT03088020|artificial ventilation|artificial ventilation
5144603|NCT03088020|diaphragm pacing|diaphragm pacing
5144604|NCT03088007|Intellectual Deficiency|intellectual deficiency
5144605|NCT03088007|cognitive, adaptive|cognitive, adaptive
5144606|NCT03088007|behavioral and academic profile|behavioral and academic profile
5144610|NCT03087942|renal impairment|renal impairment
5144611|NCT03087903|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5144612|NCT03087903|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
5144613|NCT03087890|Microbial drug resistance|microbial drug resistance
5144614|NCT03087890|Beta-lactamase|beta-lactamase
5144615|NCT03087890|Cotrimoxazole|cotrimoxazole
5144616|NCT03087890|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5144617|NCT03087890|Tanzania|tanzania
5144618|NCT03087864|esophageal cancer|esophageal cancer
5144619|NCT03087864|PD-L1 inhibition|pd-l1 inhibition
5144620|NCT03087864|chemoradiation|chemoradiation
5144621|NCT03087851|Denosumab|denosumab
5144993|NCT03085511|PYY (3-36) peptide|pyy (3-36) peptide
5144627|NCT03087812|durability of flexible endoscopes|durability of flexible endoscopes
5144628|NCT03087773|Biomarker|biomarker
5144629|NCT03087773|Heart failure|heart failure
5144630|NCT03087773|SGLT-2 inhibitor|sglt-2 inhibitor
5144631|NCT03087773|Empagliflozin|empagliflozin
5144632|NCT03087773|Randomized controlled trial|randomized controlled trial
5144633|NCT03087734|Prostheses and Implants|prostheses and implants
5144634|NCT03087721|Metabolic Syndrome|metabolic syndrome
5144635|NCT03087721|Exercise Training|exercise training
5144636|NCT03087721|Interval Training|interval training
5144637|NCT03087721|Skeletal Muscle|skeletal muscle
5144638|NCT03087721|Risk Factors|risk factors
5144639|NCT03087721|Insulin Resistance|insulin resistance
5016657|NCT03892369|FGF21|fgf21
5144640|NCT03087695|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5144641|NCT03087695|EBV DNA|ebv dna
5144642|NCT03087695|Chemoradiotherapy|chemoradiotherapy
5144648|NCT03087656|ERCP|ercp
5144649|NCT03087643|Flow-mediated dilation|flow-mediated dilation
5144650|NCT03087643|Passive limb movement|passive limb movement
5144651|NCT03087604|epidural catheter placement|epidural catheter placement
5144652|NCT03087578|overactive bladder, acupuncture|overactive bladder, acupuncture
5144653|NCT03087526|Non Invasive Prenatal Diagnosis (NIPD)|non invasive prenatal diagnosis (nipd)
5144654|NCT03087526|Circulating Fetal Trophoblastic Cells (CFTC)|circulating fetal trophoblastic cells (cftc)
5144655|NCT03087526|Huntington's Disease|huntington's disease
5144656|NCT03087526|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
5144657|NCT03087526|Fragile X syndrome|fragile x syndrome
5144658|NCT03087526|Spinocerebellar Ataxia type 1|spinocerebellar ataxia type 1
5144659|NCT03087526|Spinocerebellar Ataxia type 2|spinocerebellar ataxia type 2
5144660|NCT03087526|Spinocerebellar Ataxia type 3|spinocerebellar ataxia type 3
5144661|NCT03087500|Down Syndrome|down syndrome
5144662|NCT03087500|Typically Developing Participants|typically developing participants
5144663|NCT03087500|Children|children
5144664|NCT03087500|Adolescents|adolescents
5144665|NCT03087500|Adults|adults
5144666|NCT03087448|ALK rearranged|alk rearranged
5144667|NCT03087448|Stage IIIB NSCLC|stage iiib nsclc
5144668|NCT03087448|Stage IV NSCLC|stage iv nsclc
5144669|NCT03087448|ROS-1 rearranged NSCLC|ros-1 rearranged nsclc
5144675|NCT03087370|CXCR4 Mutation|cxcr4 mutation
5144676|NCT03087370|Primary immunodeficiency disorder|primary immunodeficiency disorder
5144677|NCT03087370|Warts|warts
5144678|NCT03087370|Hypogammaglobulinemia|hypogammaglobulinemia
5144679|NCT03087370|Infections|infections
5144680|NCT03087370|Myelokathexis|myelokathexis
5144681|NCT03087370|Human papillomavirus (HPV)|human papillomavirus (hpv)
5144682|NCT03087370|Neutropenia|neutropenia
5144683|NCT03087370|Herpes|herpes
5144684|NCT03087344|Postprandial liver and spleen stiffness measurements|postprandial liver and spleen stiffness measurements
5144685|NCT03087344|Transient elastography|transient elastography
5144686|NCT03087344|Cirrhosis|cirrhosis
5144687|NCT03087344|Acoustic radiation force impulse|acoustic radiation force impulse
5144688|NCT03087318|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
5144689|NCT03087318|Overweight and moderate obesity|overweight and moderate obesity
5144690|NCT03087318|Sport prescription|sport prescription
5144691|NCT03087318|Physical activity|physical activity
5144692|NCT03087305|Interventional Pulmonary|interventional pulmonary
5144693|NCT03087305|EBUS-TBNA|ebus-tbna
5144694|NCT03087305|Lung cancer staging|lung cancer staging
5144695|NCT03087292|blood flow restriction|blood flow restriction
5144696|NCT03087292|resistance training|resistance training
5144697|NCT03087292|coronary heart disease|coronary heart disease
5144698|NCT03087240|Disease Activity Score 28 (DAS28)|disease activity score 28 (das28)
5144699|NCT03087240|Health Assessment Questionnaire (HAQ)|health assessment questionnaire (haq)
5144700|NCT03087240|Dental Scaling|dental scaling
5144701|NCT03087240|Dental Polishing|dental polishing
5144702|NCT03087240|Oral Health|oral health
5144703|NCT03087240|Gingival Crevicular Fluid|gingival crevicular fluid
5144704|NCT03087240|Inflammatory Cytokine Profile|inflammatory cytokine profile
5144705|NCT03087240|Biofilm|biofilm
5144706|NCT03087240|Oral Microbiome|oral microbiome
5140422|NCT03113032|neuromuscular|neuromuscular
5144711|NCT03087227|antineoplastic agents/*adverse events|antineoplastic agents/*adverse events
5144713|NCT03087227|disease management|disease management
5144714|NCT03087201|Chronic tic disorders|chronic tic disorders
5144715|NCT03087201|Tourette syndrome|tourette syndrome
5144716|NCT03087149|vitamin D|vitamin d
5144717|NCT03087149|supplementation|supplementation
5144718|NCT03087149|hydroxyvitamin D|hydroxyvitamin d
5144719|NCT03087149|pretrem infants|pretrem infants
5144720|NCT03087149|osteopenia|osteopenia
5144721|NCT03087136|multiple sclerosis|multiple sclerosis
5144722|NCT03087136|pediatric|pediatric
5144723|NCT03087123|single-case design|single-case design
5144724|NCT03087123|children|children
5144725|NCT03087123|health equity|health equity
5144726|NCT03087123|mobile health|mobile health
5144728|NCT03087058|Treatment of Hyperkalemia|treatment of hyperkalemia
5144729|NCT03087058|Hyperkalemia|hyperkalemia
5144730|NCT03087058|Potassium|potassium
5144731|NCT03087058|Chronic Kidney Disease|chronic kidney disease
5144732|NCT03087032|Liraglutide|liraglutide
5144733|NCT03087032|Insulin Glargine|insulin glargine
5144734|NCT03087032|Prandial Insulin|prandial insulin
5144735|NCT03087019|adenoid cystic carcinoma|adenoid cystic carcinoma
5144739|NCT03086967|cervical ripening|cervical ripening
5144740|NCT03086967|double lumen catheter|double lumen catheter
5144741|NCT03086954|CD19 positive lymphoma|cd19 positive lymphoma
5144742|NCT03086915|neuromuscular blockade|neuromuscular blockade
5144743|NCT03086915|muscle relaxation|muscle relaxation
5144744|NCT03086915|muscle relaxant|muscle relaxant
5144745|NCT03086902|Ablation; Cryo Energy; Radofrequency Ablation|ablation; cryo energy; radofrequency ablation
5144746|NCT03086863|electroacupuncture|electroacupuncture
5962074|NCT04283188|Dialectical behavior therapy|dialectical behavior therapy
5144747|NCT03086863|randomized controlled trial|randomized controlled trial
5144748|NCT03086824|Bone Metastasis|bone metastasis
5030791|NCT03806764|CMV|cmv
5144749|NCT03086811|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity|feeding interaction, infant eating habits, hunger satiety cues, childhood obesity
5144750|NCT03086798|Magill forceps|magill forceps
5144751|NCT03086798|cuff inflation|cuff inflation
5144752|NCT03086798|Nasotracheal Intubation|nasotracheal intubation
5144753|NCT03086746|Remodeling|remodeling
5144754|NCT03086733|Lung Cancer|lung cancer
5144755|NCT03086733|Non small cell lung cancer|non small cell lung cancer
5144756|NCT03086733|Metformin|metformin
5144757|NCT03086733|Pre-operative treatment|pre-operative treatment
5144758|NCT03086733|Neoadjuvant treatments|neoadjuvant treatments
5144759|NCT03086733|Cancer|cancer
5144760|NCT03086733|Phase II|phase ii
5144761|NCT03086720|Adhesive system|adhesive system
5144762|NCT03086720|Controlled clinical trial|controlled clinical trial
5144763|NCT03086720|Dental restoration|dental restoration
5144764|NCT03086720|Noncarious cervical lesions|noncarious cervical lesions
5144765|NCT03086720|Dental restoration failure|dental restoration failure
5144766|NCT03086720|Sodium hypochlorite|sodium hypochlorite
5144767|NCT03086707|nasal mucociliary clearance|nasal mucociliary clearance
5144768|NCT03086707|saccharine transit time|saccharine transit time
5144769|NCT03086694|oromaxillofacial surgery|oromaxillofacial surgery
5144770|NCT03086694|nasotracheal intubation|nasotracheal intubation
5144771|NCT03086694|stroke volume variation|stroke volume variation
5144772|NCT03086681|Cervical carcinoma|cervical carcinoma
5144773|NCT03086681|endostar|endostar
5144774|NCT03086681|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5144775|NCT03086668|Nasotracheal Intubation|nasotracheal intubation
5144776|NCT03086668|jaw thrust|jaw thrust
5144777|NCT03086668|hook-finger|hook-finger
5144778|NCT03086655|biological markers|biological markers
5144779|NCT03086655|monitoring device|monitoring device
5144780|NCT03086655|wireless technology|wireless technology
5144781|NCT03086642|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5144782|NCT03086642|locally advanced pancreas cancer|locally advanced pancreas cancer
5144783|NCT03086642|metastatic pancreatic cancer|metastatic pancreatic cancer
5144784|NCT03086642|metastatic pancreas cancer|metastatic pancreas cancer
5144785|NCT03086642|refractory|refractory
5144786|NCT03086642|refractory pancreatic cancer|refractory pancreatic cancer
5144787|NCT03086642|refractory pancreas cancer|refractory pancreas cancer
5144788|NCT03086642|T-Vec|t-vec
5144789|NCT03086642|T Vec|t vec
5144790|NCT03086616|DIPG|dipg
5144791|NCT03086616|CED|ced
5144792|NCT03086616|glioma|glioma
5144793|NCT03086590|Body composition|body composition
5144794|NCT03086590|Ultrasound|ultrasound
5144795|NCT03086590|Chronic Pulmonary Obstructive Disease|chronic pulmonary obstructive disease
5144796|NCT03086590|Respiratory muscles|respiratory muscles
5144797|NCT03086564|HCC|hcc
5144798|NCT03086564|ADCC|adcc
5144799|NCT03086564|TACE|tace
5144805|NCT03086525|Chronic pain|chronic pain
5144806|NCT03086525|Psychological factors|psychological factors
5144807|NCT03086525|Musculoskeletal pain|musculoskeletal pain
5144808|NCT03086525|Prognosis|prognosis
5144809|NCT03086499|pectus excavatum|pectus excavatum
5144810|NCT03086486|Tuberculosis|tuberculosis
5144811|NCT03086486|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
5144812|NCT03086486|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
5144813|NCT03086486|Drug-Resistant Tuberculosis|drug-resistant tuberculosis
5144814|NCT03086486|Pretomanid|pretomanid
5144815|NCT03086486|PA-824|pa-824
5144816|NCT03086486|Bedaquiline|bedaquiline
5144817|NCT03086486|Linezolid|linezolid
5144818|NCT03086486|NC-007|nc-007
5144819|NCT03086486|TB Alliance|tb alliance
5144820|NCT03086486|pre-XDR-TB|pre-xdr-tb
5144821|NCT03086486|Sirturo|sirturo
5144822|NCT03086473|caffeine|caffeine
5144823|NCT03086473|intubation|intubation
5144824|NCT03086473|hemodynamics|hemodynamics
5144825|NCT03086473|mechanical ventilation|mechanical ventilation
5144826|NCT03086473|cardiac output|cardiac output
5144827|NCT03086473|near infrared spectroscopy|near infrared spectroscopy
5153993|NCT03029585|ovarian carcinoma|ovarian carcinoma
5144831|NCT03086434|Prevention of substance use|prevention of substance use
5144832|NCT03086421|Childhood cancer|childhood cancer
5144833|NCT03086421|Social functioning|social functioning
5144834|NCT03086421|Social development|social development
5144839|NCT03086395|relapsed|relapsed
5144840|NCT03086395|refractory|refractory
5144841|NCT03086382|Lacosamide|lacosamide
5144842|NCT03086382|Syrup|syrup
5144843|NCT03086382|Bioequivalence|bioequivalence
5144844|NCT03086382|Tablet|tablet
5144845|NCT03086343|Musculoskeletal Disease|musculoskeletal disease
5144846|NCT03086343|Arthritis|arthritis
5144847|NCT03086343|Joint Disease|joint disease
5144848|NCT03086343|Anti-inflammatory agents|anti-inflammatory agents
5144849|NCT03086343|Antirheumatic agents|antirheumatic agents
5030888|NCT03806270|Midazolam|midazolam
5144850|NCT03086317|Pulmonary Medicine|pulmonary medicine
5144851|NCT03086317|Therapy Evaluation|therapy evaluation
5144852|NCT03086304|postoperative intestinal obstruction;TEAS|postoperative intestinal obstruction;teas
5144853|NCT03086265|airway management|airway management
5144854|NCT03086265|high flow nasal oxygen high flow nasal cannula THRIVE|high flow nasal oxygen high flow nasal cannula thrive
5144855|NCT03086265|high flow nasal cannula THRIVE|high flow nasal cannula thrive
5144856|NCT03086265|THRIVE|thrive
5144857|NCT03086239|Advanced, Recurrent Small Cell Lung Cancer|advanced, recurrent small cell lung cancer
5144858|NCT03086239|Small Cell Lung Cancer|small cell lung cancer
5144859|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine
5144860|NCT03086239|Cancer|cancer
5144861|NCT03086226|Mycetoma Fosravuconazole Itraconazole Surgery Sudan|mycetoma fosravuconazole itraconazole surgery sudan
5144862|NCT03086213|nonintubated uniport thoracoscopic surgery|nonintubated uniport thoracoscopic surgery
5144863|NCT03086213|paravertebral nerve block|paravertebral nerve block
5144864|NCT03086213|intercostal nerve block|intercostal nerve block
5144865|NCT03086213|peripheral solitary pulmonary nodule|peripheral solitary pulmonary nodule
5144866|NCT03086200|PrEP|prep
5144994|NCT03085511|Ghrelin|ghrelin
5144867|NCT03086200|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5144868|NCT03086200|Text messaging|text messaging
5144869|NCT03086200|Truvada|truvada
5144870|NCT03086200|Motivational interviewing|motivational interviewing
5144871|NCT03086200|Transgender|transgender
5144872|NCT03086200|Gender Non-conforming|gender non-conforming
5144873|NCT03086187|weight bearing|weight bearing
5144874|NCT03086187|muscle unloading|muscle unloading
5144875|NCT03086187|bone loss|bone loss
5144876|NCT03086187|arterial adaptation|arterial adaptation
5144877|NCT03086187|muscular adaptation|muscular adaptation
5144878|NCT03086174|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5144879|NCT03086174|advanced|advanced
5144880|NCT03086174|melanoma|melanoma
5144881|NCT03086174|kidney cancer|kidney cancer
5144883|NCT03086122|Erectile Dysfunction|erectile dysfunction
5144884|NCT03086122|CPAP treatment|cpap treatment
5144885|NCT03086122|Endothelial Dysfunction|endothelial dysfunction
5144886|NCT03086122|Cardiovascular risk|cardiovascular risk
5144887|NCT03086109|prevalence|prevalence
5144888|NCT03086109|Bone Degenerative Disease|bone degenerative disease
5144889|NCT03086083|Traumatic memories|traumatic memories
5144890|NCT03086083|comparative study|comparative study
5144891|NCT03086083|single session|single session
5144892|NCT03086083|EMDR|emdr
5144893|NCT03086083|Beck inventory|beck inventory
5144894|NCT03086070|omeprazole|omeprazole
5144895|NCT03086070|placebo|placebo
5144896|NCT03086070|treatment|treatment
5144897|NCT03086070|adults|adults
5144902|NCT03086005|Metformin|metformin
5144903|NCT03085992|rectal cancer|rectal cancer
5144904|NCT03085992|FOLFOXIRI|folfoxiri
5144905|NCT03085992|bevacizumab|bevacizumab
5144907|NCT03085966|central memory T cell|central memory t cell
5144908|NCT03085966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5144909|NCT03085953|Psychological health|psychological health
5144910|NCT03085953|Well-being|well-being
5144911|NCT03085953|Employee|employee
5144912|NCT03085927|music therapy|music therapy
5144913|NCT03085927|neoplasms|neoplasms
5144914|NCT03085927|play|play
5144915|NCT03085927|children|children
5144916|NCT03085927|parents|parents
5144917|NCT03085914|solid tumors|solid tumors
5144918|NCT03085914|colorectal cancer|colorectal cancer
5144919|NCT03085914|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5144920|NCT03085914|non-small cell lung cancer|non-small cell lung cancer
5144921|NCT03085914|PD-1|pd-1
5144922|NCT03085914|PD-L1|pd-l1
5144923|NCT03085914|epacadostat|epacadostat
5144924|NCT03085914|IDO inhibitor|ido inhibitor
5144925|NCT03085888|Cancer Screening|cancer screening
5144926|NCT03085888|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5144927|NCT03085888|Deep Sequencing|deep sequencing
5144928|NCT03085888|Circulating cell-free tumor DNA|circulating cell-free tumor dna
5144929|NCT03085875|Weight Change|weight change
5144930|NCT03085875|Healthy Pregnancy|healthy pregnancy
5144931|NCT03085875|Physiologic Sensors|physiologic sensors
5144932|NCT03085862|Ultrasonography|ultrasonography
5144933|NCT03085862|Extravascular lung water|extravascular lung water
5144934|NCT03085862|PaO2/FiO2 ratio|pao2/fio2 ratio
5144935|NCT03085836|Drug Therapy|drug therapy
5144937|NCT03085797|Nasal Polyps|nasal polyps
5144938|NCT03085797|Mepolizumab|mepolizumab
5144939|NCT03085797|Phase 3|phase 3
5144940|NCT03085797|Parallel group|parallel group
5144941|NCT03085797|Efficacy|efficacy
5144942|NCT03085758|Early Septic Shock|early septic shock
5144943|NCT03085745|Writer's cramp|writer's cramp
5144944|NCT03085745|Sensorimotor plasticity|sensorimotor plasticity
5144945|NCT03085745|TMS|tms
5144946|NCT03085745|Afferent inhibition|afferent inhibition
5144947|NCT03085745|Motor mapping|motor mapping
5144948|NCT03085745|Sensory mapping|sensory mapping
5144949|NCT03085745|adaptive sensorimotor synergies|adaptive sensorimotor synergies
5144950|NCT03085745|fine motor control|fine motor control
5144951|NCT03085732|saline irrigation|saline irrigation
5144952|NCT03085732|abdominal hysterectomy|abdominal hysterectomy
5144953|NCT03085732|postoperative infectious morbidities|postoperative infectious morbidities
5144954|NCT03085732|gastrointestinal disturbances|gastrointestinal disturbances
5144955|NCT03085719|Head and Neck Cancer|head and neck cancer
5144956|NCT03085680|Curcumin, physical function, cognitive function|curcumin, physical function, cognitive function
5144957|NCT03085667|Left atrial appendage occluder|left atrial appendage occluder
5144958|NCT03085667|Watchman device|watchman device
5144959|NCT03085667|Atrial fibrillation|atrial fibrillation
5144960|NCT03085667|atrial natriureitc peptide|atrial natriureitc peptide
5144961|NCT03085667|brain natriuretic peptide|brain natriuretic peptide
5144962|NCT03085654|multiple doses|multiple doses
5144963|NCT03085654|oxytocin|oxytocin
5144964|NCT03085654|trait anxiety|trait anxiety
5144965|NCT03085641|High flow oxygen therapy|high flow oxygen therapy
5144966|NCT03085628|social sharing|social sharing
5144967|NCT03085628|social reward|social reward
5144968|NCT03085628|functional magnetic resonance imaging|functional magnetic resonance imaging
5144969|NCT03085628|reward circuit|reward circuit
5144970|NCT03085589|elderly|elderly
5144971|NCT03085589|telemedicine|telemedicine
5144972|NCT03085589|obesity|obesity
5144973|NCT03085589|rural health|rural health
5144974|NCT03085589|health promotion|health promotion
5144975|NCT03085576|Atrial Fibrillation|atrial fibrillation
5144976|NCT03085576|Anticoagulation|anticoagulation
5144977|NCT03085576|Stroke|stroke
5144978|NCT03085576|Vitamin K antagonist|vitamin k antagonist
5144979|NCT03085576|Cardioversion|cardioversion
5144980|NCT03085576|INR (International Normalized Ratio)|inr (international normalized ratio)
5144981|NCT03085550|diabetic foot ulcer|diabetic foot ulcer
5144982|NCT03085550|diabetes mellitus|diabetes mellitus
5144983|NCT03085550|fat grafting|fat grafting
5144984|NCT03085550|platelet rich plasma|platelet rich plasma
5144985|NCT03085550|wound healing|wound healing
5144986|NCT03085537|home monitoring|home monitoring
5144987|NCT03085537|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
5144988|NCT03085511|Egg breakfast|egg breakfast
5144989|NCT03085511|Weight loss|weight loss
5144990|NCT03085511|Satiety|satiety
5144991|NCT03085511|Insulin|insulin
5145002|NCT03085485|CFTR|cftr
5145003|NCT03085485|ivacaftor|ivacaftor
5145004|NCT03085485|topic trial|topic trial
5145005|NCT03085472|intracerebral hemrrohage|intracerebral hemrrohage
5145006|NCT03085472|stroke|stroke
5145007|NCT03085472|China|china
5145008|NCT03085472|hematoma|hematoma
5145009|NCT03085472|CT|ct
5145010|NCT03085472|predictor|predictor
5145011|NCT03085472|prognosis|prognosis
5145012|NCT03085472|outcome|outcome
5145013|NCT03085420|Burns|burns
5145014|NCT03085420|Pediatrics|pediatrics
5145015|NCT03085420|Cardiac Arrhythmia|cardiac arrhythmia
5145016|NCT03085394|Morbid Obesity|morbid obesity
5145017|NCT03085394|Sleeve gastrectomy|sleeve gastrectomy
5145018|NCT03085368|breast cancer|breast cancer
5145019|NCT03085368|her-2 positive|her-2 positive
5145020|NCT03085368|lapatinib|lapatinib
5145021|NCT03085368|herceptin|herceptin
5145022|NCT03085355|neck pain|neck pain
5145023|NCT03085342|liver|liver
5145024|NCT03085342|fibrosis|fibrosis
5145025|NCT03085342|MRI|mri
5145026|NCT03085329|bubble nasal continuous positive airway pressure|bubble nasal continuous positive airway pressure
5145027|NCT03085329|respiratory support|respiratory support
5154220|NCT03028337|XRT|xrt
5145028|NCT03085290|dry eye syndrome|dry eye syndrome
5145029|NCT03085290|serum eye drops|serum eye drops
5145030|NCT03085277|Bovine colostrum|bovine colostrum
5145031|NCT03085277|Preterm formula|preterm formula
5145032|NCT03085277|Very preterm infants|very preterm infants
5145033|NCT03085277|Enteral feeding|enteral feeding
5145034|NCT03085225|Advanced tumor|advanced tumor
5145035|NCT03085225|Pretreated tumor|pretreated tumor
5145036|NCT03085225|Soft Tissue Sarcomas|soft tissue sarcomas
5145037|NCT03085225|Ovarian Carcinomas|ovarian carcinomas
5145038|NCT03085225|Phase Ib|phase ib
5145039|NCT03085225|Circulating DNA|circulating dna
5145040|NCT03085199|gastric cancer|gastric cancer
5145041|NCT03085199|laparoscopic gastrectomy|laparoscopic gastrectomy
5145042|NCT03085199|laparoscopic reinforcement suture (LARS)|laparoscopic reinforcement suture (lars)
5145043|NCT03085173|CAR T Cells Targeting CD19|car t cells targeting cd19
5145044|NCT03085173|EGFRt/19-28z/4-1BBL|egfrt/19-28z/4-1bbl
5145045|NCT03085173|16-1570|16-1570
5145046|NCT03085147|Tongue|tongue
5145047|NCT03085147|Mouth|mouth
5145048|NCT03085147|Fluorescent PARP1 Binding Imaging Agent|fluorescent parp1 binding imaging agent
5145049|NCT03085147|PARPi-FL|parpi-fl
5145050|NCT03085147|15-336|15-336
5145051|NCT03085121|extramedullary|extramedullary
5145052|NCT03085121|intramedullary|intramedullary
5145053|NCT03085121|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
5145054|NCT03085069|PD-1|pd-1
5145055|NCT03085069|PD-L1|pd-l1
5145056|NCT03085069|shr-1210|shr-1210
5145057|NCT03085056|Trametinib|trametinib
5145058|NCT03085056|Paclitaxel|paclitaxel
5145059|NCT03085056|15-055|15-055
5145060|NCT03085030|infertility|infertility
5145061|NCT03085030|IVF|ivf
5145062|NCT03085030|ICSI|icsi
5145063|NCT03085030|poor responders in IVF/ICSI cycles|poor responders in ivf/icsi cycles
5145064|NCT03085030|antioxidant|antioxidant
5145065|NCT03085004|Pancreatic cyst|pancreatic cyst
5145066|NCT03085004|EUS-FNA|eus-fna
5145067|NCT03085004|Chemotherapy|chemotherapy
5011745|NCT03922971|EGD|egd
5145068|NCT03085004|Endoscopic ultrasound-guided fine needle infusion|endoscopic ultrasound-guided fine needle infusion
5145069|NCT03085004|paclitaxel|paclitaxel
5145070|NCT03085004|gemcitabine|gemcitabine
5145071|NCT03085004|cyst ablation|cyst ablation
5145072|NCT03084952|safety|safety
5145073|NCT03084952|pharmacokynetics|pharmacokynetics
5145074|NCT03084952|leishmaniasis treatment|leishmaniasis treatment
5145075|NCT03084913|dietary treatment|dietary treatment
5145076|NCT03084887|Tissue Expansion Devices|tissue expansion devices
5145077|NCT03084887|Tissue Expansion|tissue expansion
5145078|NCT03084887|common complications|common complications
5145079|NCT03084887|intervention study|intervention study
5145080|NCT03084874|COPD|copd
5145081|NCT03084874|Physical Activity|physical activity
5145082|NCT03084874|Sedentary behaviour|sedentary behaviour
5145083|NCT03084874|Hospitalization|hospitalization
5145084|NCT03084848|brain/cognitive measures|brain/cognitive measures
5145085|NCT03084848|condition|condition
5145086|NCT03084848|inhibitor control|inhibitor control
5145087|NCT03084848|training at adolescence|training at adolescence
5145088|NCT03084835|tobacco|tobacco
5145089|NCT03084835|smoking|smoking
5145090|NCT03084835|low dose computed tomography|low dose computed tomography
5140832|NCT03110991|App|app
5145091|NCT03084835|lung screening|lung screening
5145092|NCT03084835|text messaging|text messaging
5145093|NCT03084783|dexamethasone|dexamethasone
5145094|NCT03084783|HSV encephalitis|hsv encephalitis
5145095|NCT03084770|NF-PNEN|nf-pnen
5145096|NCT03084731|Microbiota|microbiota
5145097|NCT03084731|Complementary Food|complementary food
5145098|NCT03084692|caregiver|caregiver
5145099|NCT03084692|lung cancer|lung cancer
5145100|NCT03084692|yoga|yoga
5145101|NCT03084692|resistance exercise|resistance exercise
5145102|NCT03084679|Heart Failure|heart failure
5145103|NCT03084679|Hypertrophy|hypertrophy
5145104|NCT03084679|Fibrosis|fibrosis
5145105|NCT03084679|Magnetic Resonance|magnetic resonance
5145106|NCT03084653|Trocar entery|trocar entery
5145107|NCT03084653|Surgery, Laparoscopic|surgery, laparoscopic
5145108|NCT03084627|tailored dietary advice|tailored dietary advice
5145109|NCT03084627|nutrient adequacy|nutrient adequacy
5145110|NCT03084627|dietary modifications|dietary modifications
5145111|NCT03084614|Infectious Diseases|infectious diseases
5145112|NCT03084614|Dendritic Cells|dendritic cells
5145113|NCT03084614|Pathogens|pathogens
5145119|NCT03084497|Development|development
5145123|NCT03084458|Increasing daily physical activity|increasing daily physical activity
5145124|NCT03084445|Brominated Flame Retardants (BFRs)|brominated flame retardants (bfrs)
5145125|NCT03084445|Phthalates|phthalates
5145126|NCT03084445|pregnant women|pregnant women
5145127|NCT03084445|newborn|newborn
5145128|NCT03084445|Heavy Metals|heavy metals
5145129|NCT03084445|Volatile Organic Compounds|volatile organic compounds
5145130|NCT03084432|caffeine|caffeine
5145131|NCT03084432|bone mineral content|bone mineral content
5145132|NCT03084419|Rheumatoid Arthritis|rheumatoid arthritis
5145133|NCT03084419|Interstitial Lung Disease|interstitial lung disease
5145134|NCT03084419|RA-ILD|ra-ild
5145135|NCT03084419|Abatacept|abatacept
5145136|NCT03084406|Substance Abuse|substance abuse
5145137|NCT03084406|Implementation Science|implementation science
5145139|NCT03084393|non-cardiac surgery|non-cardiac surgery
5145140|NCT03084393|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5145141|NCT03084354|pelvic floor|pelvic floor
5145142|NCT03084354|women's experiences|women's experiences
5145143|NCT03084354|bladder care|bladder care
5145144|NCT03084354|pregnancy|pregnancy
5145146|NCT03084354|postpartum|postpartum
5145147|NCT03084341|Elasticity|elasticity
5145148|NCT03084341|Electric Stimulation|electric stimulation
5145149|NCT03084341|Muscle Stretching Exercises|muscle stretching exercises
5145150|NCT03084315|smoking|smoking
5145151|NCT03084315|electronic cigarettes|electronic cigarettes
5145152|NCT03084315|nicotine|nicotine
5145153|NCT03084302|sedentary behavior|sedentary behavior
5145154|NCT03084302|physical activity|physical activity
5145155|NCT03084276|meal ingestion|meal ingestion
5145156|NCT03084276|meal composition|meal composition
5145157|NCT03084276|postprandial responses|postprandial responses
5145158|NCT03084276|hedonic sensations|hedonic sensations
5145159|NCT03084276|homeostatic sensations|homeostatic sensations
5145160|NCT03084276|new composition|new composition
5145164|NCT03084198|Bioartificial Liver|bioartificial liver
5145165|NCT03084198|Acute Liver Failure|acute liver failure
5145166|NCT03084185|decompensation|decompensation
5145168|NCT03084185|metabolomics|metabolomics
5145169|NCT03084185|portal hypertension|portal hypertension
5145170|NCT03084133|Therapeutic education strategy|therapeutic education strategy
5145171|NCT03084107|Elder care|elder care
5145172|NCT03084107|Active aging|active aging
5145173|NCT03084107|Intelligent Care Facilities for Elders|intelligent care facilities for elders
5145174|NCT03084094|Fibromyalgia|fibromyalgia
5145175|NCT03084094|tDCS|tdcs
5145176|NCT03084081|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5145177|NCT03084081|Cryotherapy|cryotherapy
5962075|NCT04283162|calcium dobesilate|calcium dobesilate
5145178|NCT03084081|Thermoablation|thermoablation
5145179|NCT03084081|Thermocoagulation|thermocoagulation
5145180|NCT03084081|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
5145181|NCT03084042|emotional impairments|emotional impairments
5145182|NCT03084042|cognitive impairments|cognitive impairments
5145183|NCT03084029|oxytocin|oxytocin
5145184|NCT03084029|fMRI|fmri
5145185|NCT03084029|empathy|empathy
5145186|NCT03083964|Middle aged women|middle aged women
5145187|NCT03083964|35-64yrs|35-64yrs
5145188|NCT03083964|BMI= >30|bmi= >30
5145189|NCT03083951|Complete mesocolon excision|complete mesocolon excision
5145190|NCT03083951|Sigmoid cancer|sigmoid cancer
5145191|NCT03083951|Colorectal cancer|colorectal cancer
5145192|NCT03083938|Pancreatoduodenectomy|pancreatoduodenectomy
5145193|NCT03083938|Omentum|omentum
5145194|NCT03083938|Wrapping|wrapping
5145195|NCT03083938|Roll-up|roll-up
5145196|NCT03083938|Whipple|whipple
5145197|NCT03083912|Malnutrition|malnutrition
5145198|NCT03083912|Disability|disability
5145199|NCT03083912|Oral Nutritional Supplementation|oral nutritional supplementation
5145200|NCT03083899|Diabetes|diabetes
5145201|NCT03083899|Organization|organization
5145202|NCT03083899|Out-patient control|out-patient control
5145203|NCT03083873|LN-145|ln-145
5145204|NCT03083873|Cell Therapy|cell therapy
5145205|NCT03083873|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
5145206|NCT03083873|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
5145207|NCT03083873|Cellular Immuno-therapy|cellular immuno-therapy
5145208|NCT03083873|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5145220|NCT03083808|PD-1|pd-1
5145221|NCT03083808|PD-L1 Inhibitor|pd-l1 inhibitor
5145222|NCT03083808|Pembrolizumab|pembrolizumab
5145223|NCT03083808|Docetaxel|docetaxel
5145224|NCT03083808|Pemetrexed|pemetrexed
5145225|NCT03083808|Gemcitabine|gemcitabine
5145226|NCT03083795|Social relationships|social relationships
5145227|NCT03083795|Vulnerable connections|vulnerable connections
5145228|NCT03083795|Diabetes Distress|diabetes distress
5145229|NCT03083795|Support group|support group
5145230|NCT03083782|Apixaban|apixaban
5145231|NCT03083782|Cyclosporine|cyclosporine
5145232|NCT03083782|Tacrolimus|tacrolimus
5145233|NCT03083782|Cytochrome P450 CYP3A4|cytochrome p450 cyp3a4
5145234|NCT03083782|Permeability Glycoprotein P-gp|permeability glycoprotein p-gp
5145235|NCT03083782|Breast cancer resistance protein BCRP|breast cancer resistance protein bcrp
5145236|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors
5145237|NCT03083782|Anticoagulants|anticoagulants
5145238|NCT03083782|Enzyme Inhibitors|enzyme inhibitors
5145239|NCT03083769|tacrolimus|tacrolimus
5145240|NCT03083769|genetic variants|genetic variants
5145241|NCT03083769|side effects|side effects
5145242|NCT03083743|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5145243|NCT03083743|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5145244|NCT03083743|Bronchial Neoplasms|bronchial neoplasms
5145245|NCT03083743|Lung Neoplasms|lung neoplasms
5145246|NCT03083743|Thoracic Neoplasms|thoracic neoplasms
5145247|NCT03083743|Neoplasms|neoplasms
5145248|NCT03083743|Lung Diseases|lung diseases
5154389|NCT03027479|muscle energy|muscle energy
5145253|NCT03083743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5145254|NCT03083743|Physiological Effects of Drugs|physiological effects of drugs
5145259|NCT03083691|Nivolumab|nivolumab
5145260|NCT03083691|Ipilimumab|ipilimumab
5145262|NCT03083678|Afatinib|afatinib
5145267|NCT03083652|physiotherapy|physiotherapy
5145268|NCT03083652|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5145269|NCT03083652|exercise capacity|exercise capacity
5145270|NCT03083639|Drug Therapy|drug therapy
5145271|NCT03083626|Chronic pain|chronic pain
5145272|NCT03083626|Narcotic abuse|narcotic abuse
5145273|NCT03083626|Opioid related disorders|opioid related disorders
5145274|NCT03083626|Opiate substitution treatment|opiate substitution treatment
5145275|NCT03083626|Buprenorphine|buprenorphine
5145276|NCT03083626|Pregabalin|pregabalin
5145277|NCT03083626|Methadone|methadone
5145278|NCT03083613|Raltitrexed|raltitrexed
5145279|NCT03083613|Paclitaxel|paclitaxel
5145280|NCT03083613|chemotherapy|chemotherapy
5215247|NCT02650674|SDS|sds
5145281|NCT03083613|Gastric cancer|gastric cancer
5145282|NCT03083613|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5145283|NCT03083600|protein hydrolysates|protein hydrolysates
5145284|NCT03083600|HbA1c|hba1c
5145285|NCT03083600|prediabetes|prediabetes
5145286|NCT03083574|Hematology|hematology
5145287|NCT03083574|Chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
5145288|NCT03083574|Extracorporeal photopheresis|extracorporeal photopheresis
5145289|NCT03083574|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5145290|NCT03083574|Donor lymphocyte infusion|donor lymphocyte infusion
5145291|NCT03083522|Cold Hypersensitivity|cold hypersensitivity
5145292|NCT03083522|Korean medicine|korean medicine
5145293|NCT03083522|Ojeok-san|ojeok-san
5145294|NCT03083522|Cold intolerance|cold intolerance
5145295|NCT03083418|AECOPD|aecopd
5145296|NCT03083418|EDP|edp
5145297|NCT03083418|Neural Respiratory Drive|neural respiratory drive
5145298|NCT03083418|Surface EMGdi|surface emgdi
5145299|NCT03083392|DIVA|diva
5145300|NCT03083392|sinusitis|sinusitis
5145301|NCT03083392|maxillary|maxillary
5145302|NCT03083379|Incentive spirometry|incentive spirometry
5145303|NCT03083379|EzPAP|ezpap
5145304|NCT03083379|Electrical impedance tomography|electrical impedance tomography
5145305|NCT03083366|spinal cord injury|spinal cord injury
5145306|NCT03083366|Neurogenic|neurogenic
5145307|NCT03083366|bladder|bladder
5145308|NCT03083366|electrical stimulation|electrical stimulation
5145309|NCT03083366|neuromodulation|neuromodulation
5145310|NCT03083353|nicotine|nicotine
5145311|NCT03083353|craving|craving
5145312|NCT03083353|virtual reality cue exposure|virtual reality cue exposure
5145313|NCT03083353|smoking relapse|smoking relapse
5145314|NCT03083353|immersive video environment|immersive video environment
5145315|NCT03083353|extinction enhancer|extinction enhancer
5145316|NCT03083301|Cardiac resynchronisation|cardiac resynchronisation
5145317|NCT03083223|patient positioning|patient positioning
5145318|NCT03083223|lung diseases|lung diseases
5145319|NCT03083223|oxygenation|oxygenation
5145320|NCT03083223|hemodynamic parameters|hemodynamic parameters
5145321|NCT03083223|vital signs|vital signs
5145322|NCT03083197|Scrub Typhus|scrub typhus
5145323|NCT03083197|Antibiotic Resistance|antibiotic resistance
5145324|NCT03083184|Hemodialysis|hemodialysis
5145327|NCT03083184|interdialytic lock solution|interdialytic lock solution
5145328|NCT03083184|preventing tunnelled catheter infection|preventing tunnelled catheter infection
5145329|NCT03083171|Adrecizumab|adrecizumab
5145330|NCT03083171|Adrenomedullin|adrenomedullin
5145331|NCT03083171|Healthy volunteers|healthy volunteers
5145333|NCT03083171|Monoclonal recombinant antibody|monoclonal recombinant antibody
5145334|NCT03083132|freezing of gait|freezing of gait
5145335|NCT03083067|AECOPD|aecopd
5145336|NCT03083067|air pollution|air pollution
5145337|NCT03083067|COPD|copd
5145338|NCT03083067|salvational Intervention|salvational intervention
5145339|NCT03083041|SHR-1210|shr-1210
5145340|NCT03083041|Apatinib|apatinib
5145341|NCT03083041|NSCLC|nsclc
5145342|NCT03083028|Ankle Fracture|ankle fracture
5145343|NCT03083015|regeneration, MTA apexification and TAP|regeneration, mta apexification and tap
5145344|NCT03083015|revascularization|revascularization
5145345|NCT03082963|atrial fibrillation|atrial fibrillation
5145346|NCT03082963|ablation|ablation
5145347|NCT03082950|hpv prevalence|hpv prevalence
5145348|NCT03082950|recurrence rate|recurrence rate
5145355|NCT03082911|early detection|early detection
5145356|NCT03082911|participation|participation
5145357|NCT03082872|Reduction, Fracture|reduction, fracture
5145358|NCT03082859|Exercise|exercise
5145359|NCT03082859|Interval Training|interval training
5145360|NCT03082859|Glycaemic Control|glycaemic control
5145361|NCT03082859|Type 2 Diabetes|type 2 diabetes
5145362|NCT03082846|malignant glioma|malignant glioma
5145363|NCT03082846|intensity modulated radiation therapy|intensity modulated radiation therapy
5145364|NCT03082846|simultaneous integrated boost|simultaneous integrated boost
5145365|NCT03082846|hypofractionation|hypofractionation
5145366|NCT03082846|temozolomide|temozolomide
5145367|NCT03082846|maximum tolerated dose|maximum tolerated dose
5145368|NCT03082807|Caloric Restriction|caloric restriction
5145369|NCT03082807|Diet|diet
5145370|NCT03082807|Exercise|exercise
5145371|NCT03082807|Obesity|obesity
5145372|NCT03082807|Overweight|overweight
5145373|NCT03082807|Sedentary lifestyle|sedentary lifestyle
5145374|NCT03082807|weight loss|weight loss
5145375|NCT03082807|Men|men
5145376|NCT03082794|Dietary Formulations|dietary formulations
5145377|NCT03082794|Lifestyle|lifestyle
5215311|NCT02650401|Sarcoma|sarcoma
5145378|NCT03082794|Obesity|obesity
5145379|NCT03082794|Overweight|overweight
5031442|NCT03802669|PCR|pcr
5145380|NCT03082794|weight loss|weight loss
5145381|NCT03082781|Diet|diet
5145382|NCT03082781|Exercise|exercise
5145383|NCT03082781|Obesity|obesity
5145384|NCT03082781|Overweight|overweight
5145385|NCT03082781|Weight loss|weight loss
5145386|NCT03082768|HV|hv
5145387|NCT03082742|diuretics|diuretics
5145388|NCT03082742|furosemide|furosemide
5145389|NCT03082742|hydrochlorothiazide|hydrochlorothiazide
5145390|NCT03082742|CKD-MBD|ckd-mbd
5145391|NCT03082742|HRpQCT|hrpqct
5145392|NCT03082742|parathyroid hormone|parathyroid hormone
5145393|NCT03082716|cardioplegia|cardioplegia
5145394|NCT03082716|myocardial protection|myocardial protection
5145395|NCT03082716|custodiol|custodiol
5145396|NCT03082716|htk|htk
5145397|NCT03082677|Ixazomib|ixazomib
5145398|NCT03082677|Graft-versus-Host Disease|graft-versus-host disease
5145399|NCT03082677|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5145400|NCT03082677|16-076|16-076
5145401|NCT03082651|Running injuries, footwear, alternating load|running injuries, footwear, alternating load
5145402|NCT03082612|Behavioral research|behavioral research
5145403|NCT03082612|Social research|social research
5145404|NCT03082612|Spirituality|spirituality
5145405|NCT03082612|Late stage cancer|late stage cancer
5145406|NCT03082547|Headache|headache
5145407|NCT03082547|Neuropsychological tests|neuropsychological tests
5145408|NCT03082547|Myofascial trigger points|myofascial trigger points
5145409|NCT03082547|electrophysiology|electrophysiology
5145410|NCT03082534|Head and Neck Cancer|head and neck cancer
5145412|NCT03082534|Keytruda®|keytruda®
5145413|NCT03082534|Cetuximab|cetuximab
5145414|NCT03082534|Erbitux®|erbitux®
5145415|NCT03082534|Recurrent|recurrent
5145416|NCT03082534|Metastatic|metastatic
5145417|NCT03082534|PD-1|pd-1
5145418|NCT03082534|PD-L1|pd-l1
5145419|NCT03082534|non-EBV related Nasopharynx|non-ebv related nasopharynx
5145420|NCT03082521|After hours care; Primary care; Antibiotics; Action Research|after hours care; primary care; antibiotics; action research
5145421|NCT03082508|Algisyl|algisyl
5145422|NCT03082508|Heart Failure|heart failure
5145423|NCT03082508|Dilated Cardiomyopathy|dilated cardiomyopathy
5145424|NCT03082508|Alginate Hydrogel|alginate hydrogel
5145425|NCT03082508|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5145426|NCT03082508|Congestive Heart Failure|congestive heart failure
5145427|NCT03082495|Exercise|exercise
5145428|NCT03082495|Cancer|cancer
5145433|NCT03082495|Physical Fitness|physical fitness
5145434|NCT03082482|Smoking Cessation|smoking cessation
5145435|NCT03082482|HIV|hiv
5145436|NCT03082482|AIDS|aids
5145437|NCT03082469|Severe acute pancreatitis|severe acute pancreatitis
5145438|NCT03082469|Haemodynamic monitoring|haemodynamic monitoring
5145439|NCT03082469|Cytokine removal|cytokine removal
5145440|NCT03082469|Vasopressor dependency index|vasopressor dependency index
5145441|NCT03082456|molecuiar breast imaging|molecuiar breast imaging
5145442|NCT03082456|MBI|mbi
5145443|NCT03082456|breast cancer|breast cancer
5145446|NCT03082456|recall rate|recall rate
5145447|NCT03082456|diagnostic accuracy|diagnostic accuracy
5145448|NCT03082456|breast echo|breast echo
5145449|NCT03082456|female population|female population
5145450|NCT03082443|Cardiac rehabilitation|cardiac rehabilitation
5145451|NCT03082443|psychology|psychology
5145452|NCT03082443|nutrition|nutrition
5145453|NCT03082443|stress|stress
5145454|NCT03082443|quality of life|quality of life
5145455|NCT03082417|Bone Fracture|bone fracture
5145456|NCT03082417|75 years old|75 years old
5145457|NCT03082417|Elderly|elderly
5145458|NCT03082417|Older adults|older adults
5145459|NCT03082417|Pain scale|pain scale
5145460|NCT03082417|Pain documentation|pain documentation
5145461|NCT03082417|Analgesics|analgesics
5145462|NCT03082417|Acetaminophen|acetaminophen
5145463|NCT03082417|Opioid|opioid
5145464|NCT03082417|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5145465|NCT03082417|Emergency Department|emergency department
5145466|NCT03082404|Chronic kidney disease|chronic kidney disease
5145467|NCT03082404|Inspiratory muscle training|inspiratory muscle training
5145468|NCT03082391|Ventral Hernia Repair|ventral hernia repair
5145469|NCT03082391|Heavyweight Mesh|heavyweight mesh
5145470|NCT03082391|Mediumweight Mesh|mediumweight mesh
5145471|NCT03082365|oral findings or oral manifestations|oral findings or oral manifestations
5145472|NCT03082365|pre-dialysis or end stage renal disease|pre-dialysis or end stage renal disease
5145473|NCT03082326|shock|shock
5145474|NCT03082326|critical care ultrasound|critical care ultrasound
5145475|NCT03082326|hemodynamics|hemodynamics
5145476|NCT03082326|lung pathology|lung pathology
5145477|NCT03082326|epidemic|epidemic
5145478|NCT03082326|prognosis|prognosis
5145479|NCT03082313|infant|infant
5145480|NCT03082313|leg movement|leg movement
5145481|NCT03082313|wearable sensors|wearable sensors
5145482|NCT03082313|early intervention|early intervention
5145483|NCT03082300|ASP8273|asp8273
5145484|NCT03082300|Epidermal growth factor receptor (EGFR) mutations|epidermal growth factor receptor (egfr) mutations
5145485|NCT03082300|naquotinib|naquotinib
5145486|NCT03082300|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5145487|NCT03082300|Bioequivalence|bioequivalence
5145488|NCT03082261|Failed Back Surgery Syndrome|failed back surgery syndrome
5145489|NCT03082261|Radiculopathy|radiculopathy
5145490|NCT03082261|Post Laminectomy Syndrome|post laminectomy syndrome
5145491|NCT03082248|Low Back Pain|low back pain
5145492|NCT03082248|Surgery|surgery
5145493|NCT03082248|Lumbar Spine|lumbar spine
5145494|NCT03082248|Physical Therapy Modalities|physical therapy modalities
5145495|NCT03082248|Rehabilitation|rehabilitation
5145496|NCT03082235|Healthy participants|healthy participants
5145497|NCT03082235|E6742|e6742
5145498|NCT03082235|pharmacokinetics|pharmacokinetics
5145499|NCT03082222|partial onset seizures with or without secondary generalization|partial onset seizures with or without secondary generalization
5145500|NCT03082209|Solid Tumors|solid tumors
5145501|NCT03082209|Hematologic Malignancies|hematologic malignancies
5145502|NCT03082209|Cancer|cancer
5145503|NCT03082209|non-Hodgkin lymphoma|non-hodgkin lymphoma
5145504|NCT03082209|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5145505|NCT03082209|colorectal cancer (CRC)|colorectal cancer (crc)
5145506|NCT03082209|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5145507|NCT03082196|sodium fluoride|sodium fluoride
5145508|NCT03082196|povidone iodine|povidone iodine
5145511|NCT03082170|robotic surgery for base of tongue|robotic surgery for base of tongue
5145512|NCT03082170|soft palate surgery|soft palate surgery
5145513|NCT03082170|post operative swallowing evaluation|post operative swallowing evaluation
5145514|NCT03082170|dysphagia|dysphagia
5145515|NCT03082131|Gut Microbiota|gut microbiota
5145516|NCT03082131|Glycemic Response|glycemic response
5145517|NCT03082131|Resistant Starch|resistant starch
5145518|NCT03082131|Fiber|fiber
5145519|NCT03082092|Knee|knee
5145520|NCT03082092|Pain|pain
5145521|NCT03082092|Recovery|recovery
5145522|NCT03082092|Steroid|steroid
5145523|NCT03082092|Replacement|replacement
5145524|NCT03082092|Arthroplasty|arthroplasty
5145525|NCT03082079|GIST|gist
5145526|NCT03082079|ESD|esd
5145527|NCT03082066|bone access|bone access
5145529|NCT03082066|resuscitation|resuscitation
5145530|NCT03082066|infusion|infusion
5145531|NCT03082066|volume therapy|volume therapy
5145532|NCT03082066|emergency|emergency
5145533|NCT03082027|ultrasonography|ultrasonography
5145534|NCT03082027|carpal tunnel syndrome|carpal tunnel syndrome
5145535|NCT03082014|Hypertension|hypertension
5145536|NCT03082014|Cerebrovascular Reactivity|cerebrovascular reactivity
5145537|NCT03082014|Blood Pressure Variability|blood pressure variability
5145539|NCT03082001|Pain|pain
5145540|NCT03082001|ELBW|elbw
5145541|NCT03081988|Esophageal Cancer|esophageal cancer
5145542|NCT03081988|chemoradiotherapy response|chemoradiotherapy response
5145543|NCT03081988|molecular factors|molecular factors
5145544|NCT03081975|adenoma detection rate|adenoma detection rate
5145545|NCT03081975|narrow band imaging|narrow band imaging
5145546|NCT03081949|peripartum cardiomyopathy|peripartum cardiomyopathy
5145547|NCT03081949|Ventricular remodelling|ventricular remodelling
5145548|NCT03081949|Survival|survival
5145549|NCT03081949|Selenium|selenium
5145550|NCT03081949|Oxidative stress|oxidative stress
5145551|NCT03081949|Nigeria|nigeria
5145552|NCT03081923|Immunotherapy|immunotherapy
5145553|NCT03081923|Durvalumab|durvalumab
5145554|NCT03081923|Tremelimumab|tremelimumab
5145555|NCT03081923|Combination therapy|combination therapy
5145556|NCT03081923|Testicular cancer|testicular cancer
5145557|NCT03081910|Autologous CAR T cells|autologous car t cells
5145558|NCT03081910|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
5145559|NCT03081910|T-non-Hodgkin Lymphoma|t-non-hodgkin lymphoma
5145560|NCT03081910|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
5145561|NCT03081884|Prostate cancer|prostate cancer
5145562|NCT03081884|Metastatic cancer|metastatic cancer
5145563|NCT03081884|Urogenital disorders|urogenital disorders
5145564|NCT03081884|Oncology|oncology
5145565|NCT03081884|Radiology|radiology
5145566|NCT03081858|NMIBC|nmibc
5145567|NCT03081858|Paclitaxel|paclitaxel
5145568|NCT03081858|Antineoplastic Agents|antineoplastic agents
5145569|NCT03081832|Prader-Willi|prader-willi
5145570|NCT03081832|Oxytocin|oxytocin
5145571|NCT03081832|Communication skills|communication skills
5145572|NCT03081832|Oral skills|oral skills
5145573|NCT03081832|Brain activity|brain activity
5145574|NCT03081832|Hormonal disease|hormonal disease
5145575|NCT03081806|Phase 3|phase 3
5145576|NCT03081806|Efficacy|efficacy
5145577|NCT03081806|Safety|safety
5145578|NCT03081806|Osteoarthritis, Knee|osteoarthritis, knee
5145579|NCT03081793|postoperative monitoring|postoperative monitoring
5145580|NCT03081793|plethysmography|plethysmography
5145581|NCT03081793|monitoring|monitoring
5145582|NCT03081780|AML|aml
5145583|NCT03081767|PET/CT|pet/ct
5145584|NCT03081767|digital PET/CT|digital pet/ct
5145585|NCT03081715|esophageal cancer|esophageal cancer
5145586|NCT03081715|immune checkpoint|immune checkpoint
5145587|NCT03081715|PD-1|pd-1
5145588|NCT03081715|CRISPER|crisper
5145589|NCT03081715|autologous cell infusion|autologous cell infusion
5145590|NCT03081676|Maturity-Onset Diabetes of the Young, Type 3|maturity-onset diabetes of the young, type 3
5145591|NCT03081676|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
5145592|NCT03081676|Glucagon-like-peptide 1|glucagon-like-peptide 1
5145593|NCT03081676|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
5145594|NCT03081676|Glimepiride|glimepiride
5145595|NCT03081676|Sulphonylurea|sulphonylurea
5145596|NCT03081676|Glucose clamp|glucose clamp
5145597|NCT03081676|Hepatocyte nuclear factor 1 alpha|hepatocyte nuclear factor 1 alpha
5145598|NCT03081663|total knee arthroplasty|total knee arthroplasty
5145599|NCT03081663|quadriceps sparing mid-vastus|quadriceps sparing mid-vastus
5145600|NCT03081663|medial para-patellar|medial para-patellar
5145601|NCT03081624|preterm|preterm
5145602|NCT03081624|neurological status|neurological status
5145603|NCT03081624|School Readiness|school readiness
5145604|NCT03081585|fmri|fmri
5145605|NCT03081585|neuronal reward processing|neuronal reward processing
5145606|NCT03081585|hormonal satiety signalling|hormonal satiety signalling
5145607|NCT03081585|fasting|fasting
5145610|NCT03081533|Healthy Aging|healthy aging
5145611|NCT03081533|Family Health|family health
5145612|NCT03081533|Exercise|exercise
5145613|NCT03081533|Dance Therapy|dance therapy
5145614|NCT03081507|Muslim Americans|muslim americans
5145615|NCT03081507|Patient Navigation|patient navigation
5145616|NCT03081507|Breast Cancer|breast cancer
5145617|NCT03081507|Cervical Cancer|cervical cancer
5145619|NCT03081494|MCC|mcc
5145620|NCT03081494|immunotherapy|immunotherapy
5145621|NCT03081494|regorafenib|regorafenib
5145622|NCT03081494|CRC|crc
5145623|NCT03081494|MMS|mms
5145624|NCT03081494|CMS4|cms4
5145625|NCT03081494|ElevatION:CRC-102|elevation:crc-102
5145626|NCT03081481|Intraprostatic|intraprostatic
5145627|NCT03081481|MRI lesion|mri lesion
5145628|NCT03081481|Prostate biopsies|prostate biopsies
5145629|NCT03081468|Optical coherence tomography|optical coherence tomography
5145630|NCT03081468|Pupillometry|pupillometry
5145631|NCT03081468|Automated|automated
5356851|NCT01917734|facility-based care|facility-based care
5145638|NCT03081351|Extended retroperitoneal lymphadenectomy, Nerve plexus clearance, Survival benefit|extended retroperitoneal lymphadenectomy, nerve plexus clearance, survival benefit
5145639|NCT03081338|ALS, MND, Care, Patient journey|als, mnd, care, patient journey
5145640|NCT03081325|uRM|urm
5145641|NCT03081325|RIF|rif
5145642|NCT03081325|Th1|th1
5145643|NCT03081325|Th2|th2
5145644|NCT03081325|Treg|treg
5145645|NCT03081325|lymphocyte immunotherapy|lymphocyte immunotherapy
5145646|NCT03081312|Family Cancer Caregivers,|family cancer caregivers,
5145648|NCT03081312|Burden of Care|burden of care
5145649|NCT03081312|Quality of Life|quality of life
5145650|NCT03081273|Antimicrobial susceptibility|antimicrobial susceptibility
5145651|NCT03081273|Biofilm formation|biofilm formation
5145652|NCT03081273|Bone and joint infection|bone and joint infection
5145653|NCT03081273|Corynebacterium spp|corynebacterium spp
5145654|NCT03081273|Osteoblast|osteoblast
5145655|NCT03081273|Outcome|outcome
5145656|NCT03081273|Prosthetic joint infection|prosthetic joint infection
5145657|NCT03081260|Total Knee Arthroplasty|total knee arthroplasty
5145658|NCT03081260|Patella|patella
5145659|NCT03081260|Resurfacing|resurfacing
5145660|NCT03081260|IKS score|iks score
5145661|NCT03081234|Hormone receptor-positive|hormone receptor-positive
5145662|NCT03081234|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
5145663|NCT03081234|HER2-negative|her2-negative
5145664|NCT03081234|Intermediate risk early breast cancer|intermediate risk early breast cancer
5145665|NCT03081234|Adjuvant|adjuvant
5145666|NCT03081234|Ribociclib|ribociclib
5145667|NCT03081234|LEE011|lee011
5145668|NCT03081234|CDK4/6 inhibitor|cdk4/6 inhibitor
5145669|NCT03081234|Endocrine therapy|endocrine therapy
5145670|NCT03081234|Phase III|phase iii
5145671|NCT03081234|breast carcinoma|breast carcinoma
5145672|NCT03081234|breast cancer|breast cancer
5145673|NCT03081208|IVF|ivf
5145674|NCT03081208|ICSI|icsi
5145675|NCT03081195|child behavior|child behavior
5145676|NCT03081195|intervention|intervention
5145677|NCT03081195|multiple family group|multiple family group
5145678|NCT03081195|Sub Saharan Africa|sub saharan africa
5145679|NCT03081195|caregivers|caregivers
5145680|NCT03081156|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5145681|NCT03081156|exercise intolerance|exercise intolerance
5145682|NCT03081156|dynamic hyperinflation|dynamic hyperinflation
5145683|NCT03081117|HIV-Associated Neurocognitive Disorder (HAND)|hiv-associated neurocognitive disorder (hand)
5145684|NCT03081117|Intranasal|intranasal
5145685|NCT03081052|Heart and Lung transplantation surgery|heart and lung transplantation surgery
5031825|NCT03800303|treatment|treatment
5145686|NCT03081052|Pulmonary vasodilation therapy|pulmonary vasodilation therapy
5145687|NCT03081039|cholangiocarcinoma|cholangiocarcinoma
5145688|NCT03081039|gemcitabine|gemcitabine
5145689|NCT03081039|carboplatin|carboplatin
5145690|NCT03081039|cisplatin|cisplatin
5145691|NCT03081026|surgery|surgery
5145692|NCT03081026|ages 6-16|ages 6-16
5145693|NCT03081013|adolescents|adolescents
5145694|NCT03081013|social norms|social norms
5145695|NCT03080974|irreversible electroporation|irreversible electroporation
5145696|NCT03080974|Nivolumab|nivolumab
5145697|NCT03080961|Barrier cream|barrier cream
5145698|NCT03080922|Acute Myeloid Leukemia|acute myeloid leukemia
5145699|NCT03080922|Relapsed|relapsed
5145700|NCT03080922|Refractory|refractory
5145701|NCT03080922|hematopoietic stem cell|hematopoietic stem cell
5145702|NCT03080909|Satiety|satiety
5145703|NCT03080909|Nutrient|nutrient
5145704|NCT03080909|Appetite|appetite
5145705|NCT03080909|Encapsulation|encapsulation
5145706|NCT03080909|Lipid|lipid
5145707|NCT03080909|Amino acid|amino acid
5145708|NCT03080909|Probiotic bacteria|probiotic bacteria
5145709|NCT03080870|Art intervention|art intervention
5145710|NCT03080870|Quality of Life|quality of life
5145711|NCT03080870|Well-being|well-being
5145712|NCT03080870|Physical performance|physical performance
5145714|NCT03080870|Older adults|older adults
5145715|NCT03080831|Maintenance Fluid Therapy|maintenance fluid therapy
5145717|NCT03080792|stem cell transplantation|stem cell transplantation
5145718|NCT03080792|exercise|exercise
5145719|NCT03080792|high intensity interval training|high intensity interval training
5145720|NCT03080792|resistance training|resistance training
5017776|NCT03885713|Infliximab|infliximab
5145721|NCT03080792|physical fitness|physical fitness
5145722|NCT03080792|cancer|cancer
5145723|NCT03080753|Sphinkeeper|sphinkeeper
5145724|NCT03080753|Intersphincteric implants|intersphincteric implants
5145725|NCT03080753|Gatekeeper|gatekeeper
5145727|NCT03080714|Glaucoma|glaucoma
5145728|NCT03080714|Retinal Disease|retinal disease
5145729|NCT03080701|Behavioral: Automated Mailing|behavioral: automated mailing
5145730|NCT03080675|Aging population|aging population
5145731|NCT03080649|dental caries, Er:YAG laser, rotary bur|dental caries, er:yag laser, rotary bur
5145732|NCT03080636|Post-exercise hypotension|post-exercise hypotension
5145733|NCT03080636|Aerobic Exercise|aerobic exercise
5145734|NCT03080636|Resistance Exercise|resistance exercise
5145735|NCT03080636|Autonomic Stress|autonomic stress
5145736|NCT03080636|Heart Rate Variability|heart rate variability
5145737|NCT03080636|Sex difference|sex difference
5145738|NCT03080610|Post-Dural Puncture Headache [C10.228.140.546.699.124]|post-dural puncture headache [c10.228.140.546.699.124]
5145739|NCT03080610|Blood Patch, Epidural [E02.319.267.530.580.300.145]|blood patch, epidural [e02.319.267.530.580.300.145]
5145740|NCT03080584|acupuncture|acupuncture
5145741|NCT03080584|IVF|ivf
5145742|NCT03080584|AMH|amh
5145743|NCT03080584|ovarian reserve|ovarian reserve
5145744|NCT03080558|Indocyanine green fluorescence|indocyanine green fluorescence
5145745|NCT03080558|Rectal vascularisation|rectal vascularisation
5145746|NCT03080558|Vaginal vascularisation|vaginal vascularisation
5145747|NCT03080558|Laparoscopic surgery|laparoscopic surgery
5145748|NCT03080558|Rectal shaving|rectal shaving
5145749|NCT03080558|Recto vaginal node|recto vaginal node
5145750|NCT03080558|Deep Endometriosis|deep endometriosis
5145751|NCT03080532|Microbiome|microbiome
5145752|NCT03080532|Mediterranean diet|mediterranean diet
5145753|NCT03080519|renal artery stenosis|renal artery stenosis
5145754|NCT03080519|balloon angioplasty|balloon angioplasty
5145755|NCT03080519|stents|stents
5145756|NCT03080493|Abortion|abortion
5145757|NCT03080493|Osmotic dilators|osmotic dilators
5145758|NCT03080493|Gabapentin|gabapentin
5145759|NCT03080493|Text message|text message
5145760|NCT03080480|Chronic Granulomatous Disease|chronic granulomatous disease
5145761|NCT03080480|Severe Infection|severe infection
5145762|NCT03080480|PPARγ|pparγ
5145763|NCT03080480|Pioglitazone|pioglitazone
5145764|NCT03080480|phagocytes|phagocytes
5145765|NCT03080467|Trauma|trauma
5145766|NCT03080467|Laceration|laceration
5145767|NCT03080467|Suture|suture
5145768|NCT03080467|Cosmesis|cosmesis
5145769|NCT03080467|Ethyl-2-Cyanoacrylate|ethyl-2-cyanoacrylate
5145770|NCT03080467|Tissue adhesive|tissue adhesive
5145771|NCT03080467|Lip lacerations|lip lacerations
5145772|NCT03080467|Skalp lacerations|skalp lacerations
5145773|NCT03080467|Facial injuries|facial injuries
5145774|NCT03080454|stroke|stroke
5145775|NCT03080454|CVA|cva
5145776|NCT03080454|Spasticity|spasticity
5145777|NCT03080454|hemiparesis|hemiparesis
5145778|NCT03080454|rehabilitation|rehabilitation
5145779|NCT03080454|trans-spinal direct current stimulation (tsDCS)|trans-spinal direct current stimulation (tsdcs)
5145780|NCT03080454|non-invasive stimulation|non-invasive stimulation
5145781|NCT03080428|Breast cancer|breast cancer
5145782|NCT03080428|ER-positive|er-positive
5145783|NCT03080428|Her-2 negative|her-2 negative
5145784|NCT03080428|genomic test|genomic test
5145785|NCT03080402|Anterior Cruciate Ligament|anterior cruciate ligament
5145786|NCT03080402|ACL injury|acl injury
5145787|NCT03080402|Injury prevention|injury prevention
5145788|NCT03080402|Perturbation training|perturbation training
5145789|NCT03080402|Risk factors|risk factors
5145790|NCT03080389|overactive bladder|overactive bladder
5145791|NCT03080389|overactive detrusor|overactive detrusor
5145792|NCT03080389|urgency-frequency|urgency-frequency
5145793|NCT03080389|urinary tract infection|urinary tract infection
5145794|NCT03080376|Exercise|exercise
5145795|NCT03080376|Web-based intervention|web-based intervention
5145796|NCT03080363|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
5145797|NCT03080363|Quadratus Lumborum Block|quadratus lumborum block
5145798|NCT03080363|bupivacaine|bupivacaine
5145799|NCT03080363|lidocaine|lidocaine
5145800|NCT03080350|Fentanyl|fentanyl
5145801|NCT03080350|Transmucosal administration|transmucosal administration
5145802|NCT03080350|Endovenous administration|endovenous administration
5145803|NCT03080350|Pain therapy|pain therapy
5145804|NCT03080350|Mountain emergency medicine|mountain emergency medicine
5145805|NCT03080324|Fentanyl|fentanyl
5145806|NCT03080324|Transmucosal administration|transmucosal administration
5145807|NCT03080324|Endovenous administration|endovenous administration
5145808|NCT03080324|Pain therapy|pain therapy
5145809|NCT03080311|Bcl-2/Bcl-xL dual inhibitor|bcl-2/bcl-xl dual inhibitor
5145810|NCT03080272|individual patient|individual patient
5145811|NCT03080259|ADHD|adhd
5145812|NCT03080259|Stimulant Misuse|stimulant misuse
5145813|NCT03080259|Stimulant Diversion|stimulant diversion
5145814|NCT03080233|stroke|stroke
5145815|NCT03080233|Validation|validation
5145816|NCT03080233|Clinical decision support tool|clinical decision support tool
5962076|NCT04283162|mild to moderate non-proliferative diabetic retinopathy|mild to moderate non-proliferative diabetic retinopathy
5145817|NCT03080207|Lower Extremity Lymphedema|lower extremity lymphedema
5145819|NCT03080207|Complex Decongestive Physiotherapy|complex decongestive physiotherapy
5145820|NCT03080207|Low Level Laser|low level laser
5145821|NCT03080207|Platelet rich plasma|platelet rich plasma
5145829|NCT03080168|inpatients|inpatients
5145830|NCT03080168|Actigraphy|actigraphy
5145831|NCT03080168|implicit associations|implicit associations
5145832|NCT03080168|risk factors|risk factors
5145833|NCT03080129|Liver cirrhosis|liver cirrhosis
5145834|NCT03080129|Sarcopenia|sarcopenia
5145835|NCT03080129|Microbiome|microbiome
5145836|NCT03080116|Randomized|randomized
5145837|NCT03080116|Placebo-controlled|placebo-controlled
5145838|NCT03080116|Neoadjuvant|neoadjuvant
5145839|NCT03080116|Androgen deprivation|androgen deprivation
5145840|NCT03080116|Antiandrogen|antiandrogen
5145841|NCT03080116|Radical Prostatectomy|radical prostatectomy
5145842|NCT03080103|Acute Appendicitis|acute appendicitis
5145843|NCT03080103|Uncomplicated Acute Appendicitis|uncomplicated acute appendicitis
5145844|NCT03080103|Appendectomy|appendectomy
5145845|NCT03080103|Conservative Treatment|conservative treatment
5145852|NCT03080038|Sepsis|sepsis
5145853|NCT03080038|Shock|shock
5145854|NCT03080038|Septic Shock|septic shock
5145855|NCT03080038|Fluid Therapy|fluid therapy
5145856|NCT03080038|Resuscitation|resuscitation
5145857|NCT03080038|Pediatrics|pediatrics
5145858|NCT03080038|Emergency Medicine|emergency medicine
5145859|NCT03080038|Critical Care|critical care
5145860|NCT03080025|CBCT® (Cognitively Based Compassion-Training)|cbct® (cognitively based compassion-training)
5145861|NCT03080025|Psychobiological Evaluation|psychobiological evaluation
5145862|NCT03080025|Real Time Social Interaction|real time social interaction
5145863|NCT03080025|Eye-Tracking|eye-tracking
5145864|NCT03080025|Heart Rate Variability|heart rate variability
5145865|NCT03080025|IL-6|il-6
5145866|NCT03080025|IL-1b|il-1b
5145867|NCT03080025|Cortisol|cortisol
5145868|NCT03080025|Alpha-Amylase|alpha-amylase
5145869|NCT03080025|Randomised Controlled Trial|randomised controlled trial
5145870|NCT03080025|Compassion|compassion
5145871|NCT03080025|Empathy|empathy
5145872|NCT03080025|Relationship Quality|relationship quality
5145873|NCT03080025|Interpersonal Relations|interpersonal relations
5145874|NCT03080025|Stress|stress
5145875|NCT03079986|Pancreatic surgery|pancreatic surgery
5773360|NCT00229866|newborn|newborn
5145876|NCT03079986|Chylous ascites|chylous ascites
5145877|NCT03079973|Calcipotriene|calcipotriene
5145878|NCT03079960|Parkinson|parkinson
5145880|NCT03079960|Deep Brain Stimulation|deep brain stimulation
5145881|NCT03079960|LFP|lfp
5145882|NCT03079960|Local Field Potentials|local field potentials
5145883|NCT03079960|EEG|eeg
5145884|NCT03079960|Electroencephalogram|electroencephalogram
5145885|NCT03079947|Circulating DNA|circulating dna
5032034|NCT03799003|melanoma|melanoma
5145886|NCT03079947|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5145887|NCT03079947|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5145888|NCT03079947|prognosis|prognosis
5145889|NCT03079934|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
5145890|NCT03079934|Optical coherence tomography|optical coherence tomography
5145891|NCT03079934|strut coverage|strut coverage
5145892|NCT03079934|acute coronary syndrome|acute coronary syndrome
5145893|NCT03079921|Islet Graft Function|islet graft function
5145894|NCT03079921|Islet Cell transplantation|islet cell transplantation
5145895|NCT03079921|Auto-islet transplantation|auto-islet transplantation
5145896|NCT03079921|Intra-hepatic islets|intra-hepatic islets
5145897|NCT03079921|Extra-hepatic islets|extra-hepatic islets
5145898|NCT03079908|Laparoscopy|laparoscopy
5145899|NCT03079908|Surgery|surgery
5145900|NCT03079908|Training|training
5145901|NCT03079908|Virtual reality|virtual reality
5145902|NCT03079908|Simulation|simulation
5145903|NCT03079908|Robotic Surgery|robotic surgery
5145904|NCT03079908|Da Vinci|da vinci
5145905|NCT03079895|Depression|depression
5145906|NCT03079895|internet|internet
5145907|NCT03079895|Cognitive Behavioral Therapy|cognitive behavioral therapy
5145908|NCT03079895|CBT|cbt
5145909|NCT03079895|computer|computer
5145910|NCT03079895|Primary Care|primary care
5145911|NCT03079895|Psychiatry|psychiatry
5145912|NCT03079895|treatment|treatment
5145913|NCT03079895|self-help|self-help
5145914|NCT03079895|managed care|managed care
5145915|NCT03079882|Ultrasound|ultrasound
5145916|NCT03079882|Viscoelasticity|viscoelasticity
5145917|NCT03079882|Viscoelastic Response (VisR) Ultrasound|viscoelastic response (visr) ultrasound
5145918|NCT03079856|Emerging adults|emerging adults
5145919|NCT03079856|Drugs|drugs
5145920|NCT03079856|HIV|hiv
5145921|NCT03079856|Risky Sex Behaviors|risky sex behaviors
5145922|NCT03079830|aortic valve surgery|aortic valve surgery
5145940|NCT03079687|Ovarian Neoplasms|ovarian neoplasms
5145942|NCT03079687|Ovarian Disease|ovarian disease
5145943|NCT03079687|fallopean tube cancer|fallopean tube cancer
5145944|NCT03079687|primary peritoneal cancer|primary peritoneal cancer
5145945|NCT03079687|epithelial ovarian cancer|epithelial ovarian cancer
5145946|NCT03079687|PARP inhibitors|parp inhibitors
5145947|NCT03079687|Poly (ADP-ribose) polymerase inhibitors.|poly (adp-ribose) polymerase inhibitors.
5145948|NCT03079674|transient Ischemic Attack|transient ischemic attack
5145949|NCT03079674|minor Stroke|minor stroke
5145950|NCT03079674|non-disabling ischemic cerebrovascular events|non-disabling ischemic cerebrovascular events
5145952|NCT03079674|epidemiology|epidemiology
5145953|NCT03079674|prognosis|prognosis
5145954|NCT03079661|pollution|pollution
5145955|NCT03079661|ozone|ozone
5145956|NCT03079661|Copd|copd
5145957|NCT03079661|particles|particles
5145958|NCT03079648|Angelica gigas N. extract|angelica gigas n. extract
5145959|NCT03079648|Hyperlipidemia|hyperlipidemia
5145960|NCT03079648|Clinical Trial|clinical trial
5145961|NCT03079596|gastric cancer|gastric cancer
5145962|NCT03079596|ERAS (early recovery after surgery)|eras (early recovery after surgery)
5145963|NCT03079596|laparoscopic total gastrectomy|laparoscopic total gastrectomy
5145964|NCT03079557|Adolescent|adolescent
5145965|NCT03079557|Injections, intraperitoneal|injections, intraperitoneal
5145966|NCT03079557|Endoscopy|endoscopy
5145967|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a
5145968|NCT03079557|OnabotulinumtoxinA|onabotulinumtoxina
5145969|NCT03079518|iron deficiency|iron deficiency
5145970|NCT03079518|HFREF|hfref
5145971|NCT03079518|FGF23|fgf23
5145972|NCT03079518|ferric carboxymaltose|ferric carboxymaltose
5145973|NCT03079479|Arthoplasty|arthoplasty
5145974|NCT03079479|Gait|gait
5145975|NCT03079479|muscle strenght|muscle strenght
5145976|NCT03079479|Quality of life|quality of life
5145977|NCT03079466|Sleep apnea|sleep apnea
5145978|NCT03079466|Elderly|elderly
5145979|NCT03079466|CPAP|cpap
5145980|NCT03079453|Dexamethasone|dexamethasone
5145981|NCT03079453|Tonsillectomy|tonsillectomy
5145982|NCT03079453|Uvula|uvula
5145983|NCT03079453|Edema|edema
5145984|NCT03079453|Uvula edema|uvula edema
5145985|NCT03079453|Post-tonsillectomy|post-tonsillectomy
5145986|NCT03079440|Neuroendocrine tumors|neuroendocrine tumors
5145987|NCT03079440|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5145988|NCT03079440|Capecitabine|capecitabine
5145989|NCT03079440|Temozolomide|temozolomide
5145990|NCT03079427|Cholangiocarcinoma|cholangiocarcinoma
5145991|NCT03079427|Adjuvant chemotherapy|adjuvant chemotherapy
5145992|NCT03079414|Sudden Cardiac Death|sudden cardiac death
5145993|NCT03079414|Cardiac Arrhythmia|cardiac arrhythmia
5145994|NCT03079414|Electrophysiology Study|electrophysiology study
5145995|NCT03079414|Genetics|genetics
5032144|NCT03798301|T-cell|t-cell
5145996|NCT03079401|biventricular conversion|biventricular conversion
5145997|NCT03079375|cross sectional|cross sectional
5145998|NCT03079375|medication review|medication review
5145999|NCT03079375|readmissions|readmissions
5146000|NCT03079375|follow-up|follow-up
5146001|NCT03079336|Randomized controlled design development|randomized controlled design development
5146002|NCT03079336|Translational Research|translational research
5146003|NCT03079336|Psychological Interventions|psychological interventions
5146004|NCT03079336|Contextual Model of Psychotherapy|contextual model of psychotherapy
5146009|NCT03079310|spinal cord stimulation|spinal cord stimulation
5146010|NCT03079310|gait analysis|gait analysis
5146011|NCT03079310|whole-body kinematics|whole-body kinematics
5146026|NCT03079258|offspring health|offspring health
5146027|NCT03079258|maternal health|maternal health
5146028|NCT03079245|Neonatal ICU|neonatal icu
5146029|NCT03079245|antimicrobial stewardship|antimicrobial stewardship
5146030|NCT03079232|Optical biopsy|optical biopsy
5146031|NCT03079232|Skin cancer|skin cancer
5146032|NCT03079232|Diagnostic performance|diagnostic performance
5146033|NCT03079206|hazelnut|hazelnut
5146034|NCT03079206|allergens|allergens
5146035|NCT03079206|basophile-activation-test|basophile-activation-test
5146037|NCT03079206|allergy|allergy
5146038|NCT03079193|post thyroidectomy|post thyroidectomy
5146039|NCT03079193|laryngeoscopic examination|laryngeoscopic examination
5146040|NCT03079180|Tendon|tendon
5146041|NCT03079180|Ageing|ageing
5146042|NCT03079180|Training|training
5146043|NCT03079180|Achilles tendon|achilles tendon
5146044|NCT03079180|Patella tendon|patella tendon
5146045|NCT03079180|Skeletal muscle|skeletal muscle
5146046|NCT03079180|Adaptation|adaptation
5146047|NCT03079180|Triceps Surae|triceps surae
5146048|NCT03079180|Quadriceps|quadriceps
5146049|NCT03079115|Atorvastatin|atorvastatin
5146050|NCT03079089|Allogenic cell stem transplant|allogenic cell stem transplant
5146051|NCT03079089|Sequential chemotherapy|sequential chemotherapy
5146052|NCT03079089|Haploidentical transplant|haploidentical transplant
5146053|NCT03079076|Postoperative Analgesia|postoperative analgesia
5146054|NCT03079076|Ultrasound guided thoracolumbar interfascial plane block|ultrasound guided thoracolumbar interfascial plane block
5146055|NCT03079024|Cognitive Training|cognitive training
5146056|NCT03079024|First Episode Psychosis|first episode psychosis
5146061|NCT03078998|Obstetric Brachial Plexus Palsy|obstetric brachial plexus palsy
5146062|NCT03078998|Human Computer Interaction|human computer interaction
5146063|NCT03078998|Leap Motion|leap motion
5146064|NCT03078998|Video Game Based Rehabilitation|video game based rehabilitation
5146065|NCT03078985|real-time MRI|real-time mri
5146066|NCT03078985|electrophysiology study|electrophysiology study
5146067|NCT03078985|atrial flutter ablation|atrial flutter ablation
5146068|NCT03078985|active tracking|active tracking
5146069|NCT03078946|Cardiac surgery|cardiac surgery
5146071|NCT03078946|dexmedetomidine|dexmedetomidine
5146072|NCT03078946|morphine|morphine
5146073|NCT03078946|midazolam|midazolam
5146075|NCT03078907|daily life|daily life
5146076|NCT03078907|physical activity|physical activity
5146077|NCT03078907|actigraphy|actigraphy
5146078|NCT03078907|PAH-SYMPACT|pah-sympact
5146079|NCT03078894|Zika|zika
5146080|NCT03078894|Dengue|dengue
5146081|NCT03078894|Chikagunya|chikagunya
5146082|NCT03078894|Peru|peru
5146083|NCT03078829|gender identity|gender identity
5146084|NCT03078829|trans female|trans female
5146085|NCT03078829|GnRH agonists|gnrh agonists
5146086|NCT03078829|QTc interval|qtc interval
5146089|NCT03078777|Pharmacokinetics|pharmacokinetics
5146090|NCT03078764|Mobile health (mHealth)|mobile health (mhealth)
5146103|NCT03078738|OMT-28|omt-28
5146104|NCT03078738|Atrial Fibrillation|atrial fibrillation
5146105|NCT03078738|SAD|sad
5146106|NCT03078738|MAD|mad
5146107|NCT03078738|First-in-Man|first-in-man
5146108|NCT03078738|Cardiovascular|cardiovascular
5146109|NCT03078725|gestational diabetes|gestational diabetes
5146110|NCT03078725|glyburide|glyburide
5146111|NCT03078725|metformin|metformin
5146112|NCT03078725|failure rate|failure rate
5146115|NCT03078712|Capillary Refill Time|capillary refill time
5146116|NCT03078712|Fluid Responsiveness|fluid responsiveness
5146117|NCT03078712|Mortality|mortality
5146119|NCT03078699|Thymic tumor|thymic tumor
5146120|NCT03078699|Stereotactic body radiotherapy|stereotactic body radiotherapy
5146121|NCT03078686|Stem Cells,PRP, tSVF,cSVF,Alopecia Areata,Scarring Alopecia|stem cells,prp, tsvf,csvf,alopecia areata,scarring alopecia
5146122|NCT03078673|Cross country poling, motor skill, strength training|cross country poling, motor skill, strength training
5146123|NCT03078634|Irritable bowel syndrome|irritable bowel syndrome
5146124|NCT03078634|Constipation|constipation
5146125|NCT03078634|Functional dyspepsia|functional dyspepsia
5146126|NCT03078634|Multi-disciplinary treatment|multi-disciplinary treatment
5146127|NCT03078621|stem cells|stem cells
5146128|NCT03078608|anxiety|anxiety
5146129|NCT03078608|quality of life|quality of life
5146130|NCT03078608|mindfulness|mindfulness
5146131|NCT03078608|meditation|meditation
5146132|NCT03078608|depression|depression
5146138|NCT03078582|PNH|pnh
5146139|NCT03078569|Poor responders|poor responders
5146140|NCT03078556|FDC|fdc
5146141|NCT03078556|Lamivudine|lamivudine
5146142|NCT03078556|Bio-equivalence|bio-equivalence
5146143|NCT03078556|Dolutegravir|dolutegravir
5146145|NCT03078530|GWI|gwi
5146146|NCT03078530|IBS|ibs
5146147|NCT03078530|Irritable Bowel Syndrome|irritable bowel syndrome
5146148|NCT03078530|Gulf War Illness|gulf war illness
5146149|NCT03078530|Probiotics|probiotics
5146150|NCT03078517|I-gel|i-gel
5146151|NCT03078517|Laryngeal mask airway protector|laryngeal mask airway protector
5146152|NCT03078491|type 1 diabetes|type 1 diabetes
5146153|NCT03078491|geriatrics|geriatrics
5146154|NCT03078491|older adults|older adults
5146155|NCT03078491|technology|technology
5146156|NCT03078491|CGM|cgm
5146157|NCT03078491|clinical decision support|clinical decision support
5146158|NCT03078491|hypoglycemia|hypoglycemia
5146159|NCT03078439|very preterm birth|very preterm birth
5146160|NCT03078439|developmental disorders|developmental disorders
5146161|NCT03078439|health problems|health problems
5146162|NCT03078439|prospective population-based cohort|prospective population-based cohort
5146163|NCT03078426|Lung|lung
5146164|NCT03078426|MRI|mri
5146165|NCT03078426|CT|ct
5146166|NCT03078426|Usual interstitial pneumonia|usual interstitial pneumonia
5146167|NCT03078426|Ultra-short echo time|ultra-short echo time
5146168|NCT03078413|Mustard Procedure|mustard procedure
5146169|NCT03078374|Reduced anti-coagulation, mechanical circulatory support.|reduced anti-coagulation, mechanical circulatory support.
5146170|NCT03078361|cancer screening|cancer screening
5146171|NCT03078361|colon|colon
5146172|NCT03078348|cancer screening|cancer screening
5146173|NCT03078335|Late onset sepsis|late onset sepsis
5146174|NCT03078335|glove based care|glove based care
5146175|NCT03078335|NICU|nicu
5146180|NCT03078309|cannabis|cannabis
5146181|NCT03078309|THC|thc
5146182|NCT03078309|CBD|cbd
5146183|NCT03078309|electrophysiology|electrophysiology
5146184|NCT03078309|visual functions|visual functions
5146185|NCT03078309|eye|eye
5146186|NCT03078309|retina|retina
5146187|NCT03078270|social anxiety|social anxiety
5146188|NCT03078270|botulinum toxin|botulinum toxin
5146189|NCT03078270|botox|botox
5146190|NCT03078257|Platelet Activities|platelet activities
5146191|NCT03078257|light aggregometry|light aggregometry
5146192|NCT03078257|VerifyNow P2Y12-assay|verifynow p2y12-assay
5146193|NCT03078257|peripheral vein|peripheral vein
5146194|NCT03078257|peripheral artery|peripheral artery
5146195|NCT03078257|intracoronary artery|intracoronary artery
5146196|NCT03078257|tirofiban|tirofiban
5146197|NCT03078257|antiplatelet thrombolysin|antiplatelet thrombolysin
5146198|NCT03078218|Pulse oximetry|pulse oximetry
5146199|NCT03078218|Asymptomatic newborns|asymptomatic newborns
5146202|NCT03078192|right heart catheterization for evaluation of PAH or other cardiac or pulmonary disease|right heart catheterization for evaluation of pah or other cardiac or pulmonary disease
5146203|NCT03078179|Probiotic|probiotic
5146205|NCT03078179|Care, dental|care, dental
5146206|NCT03078166|Cardiac Failure|cardiac failure
5146207|NCT03078166|Congestive Heart Failure|congestive heart failure
5146208|NCT03078166|Heart Decompensation|heart decompensation
5146209|NCT03078166|Heart Failure, Congestive|heart failure, congestive
5146210|NCT03078166|Heart Failure, Left-Sided|heart failure, left-sided
5146211|NCT03078166|Heart Failure, Right-Sided|heart failure, right-sided
5146212|NCT03078166|Left-Sided Heart Failure|left-sided heart failure
5146213|NCT03078166|Myocardial Failure|myocardial failure
5146214|NCT03078166|Right-Sided Heart Failure|right-sided heart failure
5146215|NCT03078166|Outcomes|outcomes
5146216|NCT03078166|Co-morbidities|co-morbidities
5146217|NCT03078166|Biomarkers|biomarkers
5146218|NCT03078101|Empagliflozin|empagliflozin
5146219|NCT03078101|SGLT-2 Inhibiton and RAS in CKD|sglt-2 inhibiton and ras in ckd
5146220|NCT03078075|Methamphetamine|methamphetamine
5146221|NCT03078075|Methamphetamine Use Disorder|methamphetamine use disorder
5146222|NCT03078075|Naltrexone|naltrexone
5146223|NCT03078075|Bupropion|bupropion
5146224|NCT03078075|Vivitrol®|vivitrol®
5146225|NCT03078062|Spinal anesthesia|spinal anesthesia
5146226|NCT03078062|Motor block|motor block
5146227|NCT03078062|Sensory block|sensory block
5146228|NCT03078062|Dexamethasone|dexamethasone
5146229|NCT03078036|HER2-ve metastatic breast cancer|her2-ve metastatic breast cancer
5146230|NCT03078036|gBRCA, sBRCA and HRR gene mutations|gbrca, sbrca and hrr gene mutations
5146231|NCT03078023|EoE|eoe
5146232|NCT03078010|Antibiotic|antibiotic
5146233|NCT03078010|piperacillin-tazobactam|piperacillin-tazobactam
5146234|NCT03078010|cefepime|cefepime
5146235|NCT03078010|aztreonam|aztreonam
5146236|NCT03078010|17-097|17-097
5146237|NCT03077997|Diabetes|diabetes
5146238|NCT03077997|Diabetes distress|diabetes distress
5146239|NCT03077971|Carers of People with Multiple Sclerosis|carers of people with multiple sclerosis
5146240|NCT03077971|Carer Strain|carer strain
5146241|NCT03077971|Acceptance and Commitment Therapy|acceptance and commitment therapy
5146242|NCT03077945|biofeedback|biofeedback
5146243|NCT03077945|heart rate variability|heart rate variability
5146244|NCT03077945|HRV|hrv
5146245|NCT03077945|psychophysiology|psychophysiology
5146246|NCT03077945|reappraisal|reappraisal
5146247|NCT03077945|cognitive reappraisal|cognitive reappraisal
5142157|NCT03102372|FFM|ffm
5146248|NCT03077945|arousal reappraisal|arousal reappraisal
5146249|NCT03077945|woman|woman
5146250|NCT03077945|women|women
5146251|NCT03077945|female|female
5146252|NCT03077945|smoker|smoker
5146253|NCT03077945|relapse|relapse
5146254|NCT03077945|cigarette|cigarette
5146255|NCT03077945|craving|craving
5146256|NCT03077945|self regulation|self regulation
5146257|NCT03077945|emotion regulation|emotion regulation
5146258|NCT03077945|stress response|stress response
5146259|NCT03077945|cognitive behavioral intervention|cognitive behavioral intervention
5146260|NCT03077945|respiratory sinus arrhythmia|respiratory sinus arrhythmia
5146261|NCT03077945|smoking cessation intervention|smoking cessation intervention
5146262|NCT03077919|Posttraumatic Stress Disorder|posttraumatic stress disorder
5146263|NCT03077919|Generalized Anxiety Disorder|generalized anxiety disorder
5146264|NCT03077919|Depression|depression
5146265|NCT03077919|Distress|distress
5146266|NCT03077919|Alcohol Use|alcohol use
5146267|NCT03077919|Pain|pain
5146268|NCT03077906|Gastroœsophageal Reflux|gastroœsophageal reflux
5146269|NCT03077906|Sleeve Gastrectomy|sleeve gastrectomy
5146270|NCT03077880|implant insertion|implant insertion
5146271|NCT03077880|bone resorption|bone resorption
5155447|NCT03020589|UNC|unc
5146273|NCT03077867|sinus lift|sinus lift
5146274|NCT03077867|synthetic hydroxyapatite|synthetic hydroxyapatite
5146275|NCT03077867|bone graft|bone graft
5146276|NCT03077854|Lung Cancer|lung cancer
5146277|NCT03077854|Radiotherapy|radiotherapy
5146278|NCT03077854|Biomarkers|biomarkers
5146279|NCT03077854|Radiation Lung Injury|radiation lung injury
5146280|NCT03077854|Quality of Life|quality of life
5146281|NCT03077841|Malignant neoplasm of breast|malignant neoplasm of breast
5146282|NCT03077841|Breast cancer|breast cancer
5146283|NCT03077841|Radiation therapy|radiation therapy
5146285|NCT03077841|External beam radiation therapy|external beam radiation therapy
5146286|NCT03077841|Shorter course|shorter course
5146287|NCT03077841|Questionnaires|questionnaires
5146288|NCT03077841|Surveys|surveys
5146289|NCT03077802|Seldinger technique|seldinger technique
5146290|NCT03077802|Modified Seldinger technique|modified seldinger technique
5146291|NCT03077802|Complication|complication
5146292|NCT03077802|Success rate|success rate
5146293|NCT03077789|visual acuity|visual acuity
5146294|NCT03077789|prognosis epidemiology|prognosis epidemiology
5146295|NCT03077763|nitrite|nitrite
5146296|NCT03077763|haemoglobin|haemoglobin
5146297|NCT03077763|normoxia|normoxia
5146298|NCT03077763|hypoxia|hypoxia
5146299|NCT03077763|vasodilatation|vasodilatation
5146300|NCT03077763|blood|blood
5146301|NCT03077750|viral skin disease|viral skin disease
5146302|NCT03077737|Treatment access|treatment access
5146303|NCT03077737|Treatment utilization|treatment utilization
5146304|NCT03077737|Smoking cessation|smoking cessation
5146305|NCT03077737|Low income|low income
5146306|NCT03077737|Electronic health record system|electronic health record system
5146307|NCT03077737|Electronic referral|electronic referral
5146308|NCT03077724|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5146309|NCT03077724|tobacco use|tobacco use
5146310|NCT03077724|pregnancy|pregnancy
5146311|NCT03077698|Endometrial cancer|endometrial cancer
5146312|NCT03077698|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
5146319|NCT03077685|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5146320|NCT03077685|pancreatic cancer|pancreatic cancer
5146321|NCT03077672|Mitochondrial DNA|mitochondrial dna
5146322|NCT03077672|Lactate|lactate
5146323|NCT03077672|Mortality|mortality
5146324|NCT03077672|Emergency Department|emergency department
5146325|NCT03077672|Intensive Care Unit|intensive care unit
5146326|NCT03077672|Triage|triage
5146327|NCT03077672|Organ Dysfunction|organ dysfunction
5146328|NCT03077672|Biomarker|biomarker
5146329|NCT03077672|Prognosis|prognosis
5146330|NCT03077659|prostate cancer|prostate cancer
5146331|NCT03077659|prostatic neoplasms|prostatic neoplasms
5146332|NCT03077659|genital neoplasms, male|genital neoplasms, male
5146333|NCT03077659|urogenital neoplasms|urogenital neoplasms
5146334|NCT03077659|prostatic diseases|prostatic diseases
5146335|NCT03077646|firearm|firearm
5146336|NCT03077646|gun|gun
5146337|NCT03077646|safety|safety
5146338|NCT03077646|pediatric|pediatric
5146339|NCT03077646|inpatient|inpatient
5146340|NCT03077633|Cerclage|cerclage
5146341|NCT03077633|Cervical shortening|cervical shortening
5146342|NCT03077633|Twins|twins
5146343|NCT03077633|Progesterone|progesterone
5146344|NCT03077568|internet|internet
5146345|NCT03077568|web-based|web-based
5146346|NCT03077568|behavior change|behavior change
5146347|NCT03077568|stress-management|stress-management
5146348|NCT03077555|quick starting contraception|quick starting contraception
5146349|NCT03077542|Peripheral Blood Stem Cells|peripheral blood stem cells
5146350|NCT03077542|Host-Donor Chimerism|host-donor chimerism
5146351|NCT03077542|Graft Versus Host Disease|graft versus host disease
5146352|NCT03077542|Haploidentical|haploidentical
5146353|NCT03077542|Donor Apheresis|donor apheresis
5146354|NCT03077503|Hemodynamic response|hemodynamic response
5146355|NCT03077503|Skull pins application|skull pins application
5146356|NCT03077503|Dexmedetomidine|dexmedetomidine
5146368|NCT03077399|lateropulsion|lateropulsion
5146370|NCT03077399|Pusher syndrome|pusher syndrome
5146371|NCT03077386|patient navigator|patient navigator
5146372|NCT03077386|community health navigator|community health navigator
5146373|NCT03077386|multi-morbidity|multi-morbidity
5146374|NCT03077386|primary care|primary care
5146375|NCT03077386|social determinants of health|social determinants of health
5146376|NCT03077373|systolic blood pressure|systolic blood pressure
5146377|NCT03077373|physical activity|physical activity
5146378|NCT03077373|sedentary time|sedentary time
5146380|NCT03077347|Schizophrenia|schizophrenia
5146381|NCT03077347|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5146382|NCT03077347|tDCS|tdcs
5146383|NCT03077347|Cognitive Control|cognitive control
5146384|NCT03077347|fMRI|fmri
5146385|NCT03077347|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5146386|NCT03077308|Auditory ERP, Visual ERP, EEG|auditory erp, visual erp, eeg
5146387|NCT03077282|Prasaprohyai extract, Healthy volunteers|prasaprohyai extract, healthy volunteers
5146388|NCT03077269|burn|burn
5146389|NCT03077269|coagulation|coagulation
5146390|NCT03077269|inflammation|inflammation
5146391|NCT03077256|Ankle Arthrodesis|ankle arthrodesis
5146392|NCT03077256|Cellular Allograft|cellular allograft
5146400|NCT03077217|covert hepatic encephalopathy|covert hepatic encephalopathy
5146401|NCT03077217|low-dose rifaximin|low-dose rifaximin
5146402|NCT03077204|Total cervical vertebrectomy|total cervical vertebrectomy
5146403|NCT03077204|Partial cervical vertebrectomy|partial cervical vertebrectomy
5146404|NCT03077204|Failed previous fusion|failed previous fusion
5146405|NCT03077204|Spinal stenosis|spinal stenosis
5146406|NCT03077204|Tumor|tumor
5146407|NCT03077204|Decompression of the spinal cord|decompression of the spinal cord
5146408|NCT03077204|Pseudoarthrosis|pseudoarthrosis
5146409|NCT03077204|Curvatures|curvatures
5146410|NCT03077204|Deformities|deformities
5146511|NCT03076528|exergame|exergame
5146417|NCT03077178|Functional Impact|functional impact
5146418|NCT03077178|Elderly Patient|elderly patient
5146419|NCT03077178|Geriatrics|geriatrics
5146420|NCT03077152|copd, aecopd, antibiotic use|copd, aecopd, antibiotic use
5146421|NCT03077126|elastography|elastography
5146422|NCT03077126|ultrasound|ultrasound
5146423|NCT03077126|prostate|prostate
5773468|NCT00229463|genetic|genetic
5146424|NCT03077126|cancer screening|cancer screening
5146425|NCT03077113|lung cancer|lung cancer
5146426|NCT03077113|radiation therapy|radiation therapy
5146428|NCT03077048|Ketosteril|ketosteril
5146429|NCT03077048|keto-acids|keto-acids
5146430|NCT03077048|ketoanalogues|ketoanalogues
5146431|NCT03077048|Chronic kidney disease|chronic kidney disease
5146432|NCT03077035|ICDAS|icdas
5146433|NCT03077035|DIAGNOdent|diagnodent
5146434|NCT03077035|glass ionomer sealant|glass ionomer sealant
5146435|NCT03077035|resin-based sealant|resin-based sealant
5146436|NCT03077035|pit and fissure sealants|pit and fissure sealants
5146437|NCT03077035|effectiveness of preventing caries|effectiveness of preventing caries
5146438|NCT03076983|Ventilation Monitoring|ventilation monitoring
5146439|NCT03076983|Electrical Impedance Tomography|electrical impedance tomography
5146440|NCT03076931|Voice|voice
5146441|NCT03076931|Biomarker|biomarker
5146442|NCT03076931|Airway Reconstruction|airway reconstruction
5146443|NCT03076918|PDT, Methyl Aminolevulinate, Light Emitting Textile|pdt, methyl aminolevulinate, light emitting textile
5146444|NCT03076892|PDT|pdt
5146445|NCT03076892|Methyl Aminolevulinate|methyl aminolevulinate
5146446|NCT03076892|light emitting textile|light emitting textile
5146447|NCT03076879|Cervical Cancer|cervical cancer
5146448|NCT03076879|Pap smear|pap smear
5146449|NCT03076879|Screening|screening
5146450|NCT03076879|Beliefs|beliefs
5146451|NCT03076879|Attitude|attitude
5146452|NCT03076879|Nursing|nursing
5146453|NCT03076840|hamstring tightness|hamstring tightness
5146454|NCT03076801|Choral Singing|choral singing
5146455|NCT03076801|Music|music
5146456|NCT03076801|Quality of Life|quality of life
5146457|NCT03076801|Psychosocial Stress|psychosocial stress
5146461|NCT03076788|cardiac remodeling|cardiac remodeling
5146462|NCT03076788|athletes|athletes
5146463|NCT03076775|Betamethasone|betamethasone
5146464|NCT03076775|Late preterm|late preterm
5146465|NCT03076775|Steroids|steroids
5146466|NCT03076762|interstitial cystitis|interstitial cystitis
5146467|NCT03076762|pain|pain
5146468|NCT03076762|intravesical injection|intravesical injection
5146469|NCT03076762|therapy|therapy
5146470|NCT03076762|bladder|bladder
5146471|NCT03076749|Betalactam|betalactam
5146472|NCT03076749|Decision tree|decision tree
5146473|NCT03076749|Drug hypersensitivity|drug hypersensitivity
5146474|NCT03076749|Logistic regression|logistic regression
5146475|NCT03076749|Predictive modelling|predictive modelling
5146476|NCT03076710|spine surgery|spine surgery
5146477|NCT03076710|post-operative pain|post-operative pain
5146478|NCT03076710|patient controlled analgesia|patient controlled analgesia
5146479|NCT03076710|Exparel®|exparel®
5146480|NCT03076710|bupivacaine|bupivacaine
5146481|NCT03076697|fundus photography|fundus photography
5146482|NCT03076697|smartphone-based photography|smartphone-based photography
5146483|NCT03076671|Palliative Care|palliative care
5146484|NCT03076671|Supportive Care|supportive care
5146485|NCT03076671|Movement Disorders|movement disorders
5146486|NCT03076671|Brain Disease|brain disease
5146487|NCT03076671|Neurodegeneration|neurodegeneration
5146488|NCT03076671|Parkinson's Disease|parkinson's disease
5146489|NCT03076671|Alzheimer's Disease|alzheimer's disease
5146494|NCT03076619|pregnancy induced hypertension|pregnancy induced hypertension
5146495|NCT03076619|ophthalmoscopy|ophthalmoscopy
5146496|NCT03076593|geriatric|geriatric
5146504|NCT03076541|Restless legs syndrome|restless legs syndrome
5146505|NCT03076541|Periodic leg movements|periodic leg movements
5146506|NCT03076541|Heart rate|heart rate
5146507|NCT03076541|Heart rate variability|heart rate variability
5146508|NCT03076541|Microarousals|microarousals
5146509|NCT03076541|Autonomic nervous system activity|autonomic nervous system activity
5146510|NCT03076528|exercise|exercise
5146512|NCT03076528|hemodialysis|hemodialysis
5146514|NCT03076502|ctDNA|ctdna
5146515|NCT03076502|Gastrointestinal Cancer|gastrointestinal cancer
5146516|NCT03076502|ROS|ros
5146517|NCT03076502|Hepatobiliary Pancreatic Cancer|hepatobiliary pancreatic cancer
5146518|NCT03076476|Coronary Stent|coronary stent
5146519|NCT03076476|PCI|pci
5146520|NCT03076476|BVS|bvs
5146521|NCT03076476|Index of microcirculatory resistance|index of microcirculatory resistance
5146522|NCT03076463|Polyphenols|polyphenols
5146523|NCT03076463|Metabolic syndrome|metabolic syndrome
5146524|NCT03076463|Cardiometabolic risk|cardiometabolic risk
5146525|NCT03076463|Grape pomace|grape pomace
5146526|NCT03076463|Postprandial glucose|postprandial glucose
5146527|NCT03076463|Insulin resistance|insulin resistance
5146528|NCT03076463|Obesity|obesity
5146529|NCT03076450|Acute respiratory distress syndrome, ARDS|acute respiratory distress syndrome, ards
5216683|NCT02641873|mCRC|mcrc
5146530|NCT03076450|Point-of-care lung ultrasound,POC-LUS|point-of-care lung ultrasound,poc-lus
5146531|NCT03076450|Pressure-volume curve, PVC|pressure-volume curve, pvc
5146532|NCT03076450|Positive end-expiratory pressure, PEEP|positive end-expiratory pressure, peep
5146533|NCT03076450|Ultrasound re-aeration score, US-RAS|ultrasound re-aeration score, us-ras
5146534|NCT03076411|Dyspepsia|dyspepsia
5146535|NCT03076411|Observational trial|observational trial
5146536|NCT03076411|Enzyme therapy|enzyme therapy
5146537|NCT03076411|Pepsin|pepsin
5146538|NCT03076385|VAL-506440|val-506440
5146539|NCT03076385|H10N8 antigen mRNA|h10n8 antigen mrna
5146540|NCT03076385|Influenza vaccine|influenza vaccine
5146541|NCT03076372|Cancer|cancer
5146542|NCT03076372|Oncology|oncology
5146543|NCT03076372|Phase I|phase i
5146544|NCT03076372|Gemcitabine|gemcitabine
5146545|NCT03076372|Carboplatin|carboplatin
5146546|NCT03076372|MM-310|mm-310
5146547|NCT03076372|EphA2|epha2
5146548|NCT03076372|Ephrin A2|ephrin a2
5146549|NCT03076372|Solid tumors|solid tumors
5146550|NCT03076372|urothelial carcinoma|urothelial carcinoma
5146551|NCT03076372|gastric carcinoma|gastric carcinoma
5146552|NCT03076372|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5146553|NCT03076372|ovarian cancer|ovarian cancer
5146554|NCT03076372|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5146555|NCT03076372|prostate adenocarcinoma|prostate adenocarcinoma
5146556|NCT03076372|non-small cell lung cancer|non-small cell lung cancer
5146557|NCT03076372|small cell lung cancer|small cell lung cancer
5146558|NCT03076372|triple negative breast cancer|triple negative breast cancer
5146559|NCT03076372|endometrial carcinoma|endometrial carcinoma
5146560|NCT03076372|soft tissue sarcoma|soft tissue sarcoma
5146561|NCT03076372|Merrimack|merrimack
5146562|NCT03076320|Modified diallyl disulfide oxide (M-DDO)|modified diallyl disulfide oxide (m-ddo)
5146563|NCT03076320|Pirfenidone (PFD)|pirfenidone (pfd)
5146581|NCT03076216|brachytherapy|brachytherapy
5146582|NCT03076216|gemcitabine|gemcitabine
5146583|NCT03076216|nab-paclitaxel|nab-paclitaxel
5146584|NCT03076216|Abraxane|abraxane
5146585|NCT03076190|psychology|psychology
5146586|NCT03076190|pain|pain
5146587|NCT03076190|surgery|surgery
5146588|NCT03076190|treatment|treatment
5146591|NCT03076177|knee osteoarthritis, kinesio taping, knee function, pain|knee osteoarthritis, kinesio taping, knee function, pain
5146592|NCT03076164|erlotinib|erlotinib
5146593|NCT03076164|trametinib|trametinib
5146595|NCT03076151|Transplantation|transplantation
5146596|NCT03076151|Kidney|kidney
5146597|NCT03076151|pharmacokinetic|pharmacokinetic
5146598|NCT03076151|bayesian estimators|bayesian estimators
5146599|NCT03076138|Gene-activated matrix|gene-activated matrix
5146600|NCT03076138|Bone substitute|bone substitute
5146601|NCT03076138|Bone grafting|bone grafting
5146602|NCT03076138|Dental implantation|dental implantation
5146603|NCT03076138|gene therapy|gene therapy
5146604|NCT03076138|plasmid DNA|plasmid dna
5146605|NCT03076138|VEGF gene|vegf gene
5146606|NCT03076138|octacalcium phosphate|octacalcium phosphate
5146607|NCT03076125|Primary Stroke Prevention, Risk Factors for Stroke|primary stroke prevention, risk factors for stroke
5146608|NCT03076112|Ipragliflozin|ipragliflozin
5146609|NCT03076112|Sitagliptin|sitagliptin
5146613|NCT03076099|post-operative hypertension|post-operative hypertension
5146616|NCT03076073|Patellar tendon|patellar tendon
5146617|NCT03076073|obesity|obesity
5146618|NCT03076060|Ketogenic Diet|ketogenic diet
5146619|NCT03076060|Very low calories diet|very low calories diet
5146620|NCT03076060|ketone bodies|ketone bodies
5146621|NCT03075995|lapatinib|lapatinib
5146622|NCT03075995|steady state plasma concentration|steady state plasma concentration
5146623|NCT03075995|high-fat breakfast|high-fat breakfast
5146624|NCT03075969|Chronic myeloid leukemia; quality of life|chronic myeloid leukemia; quality of life
5146629|NCT03075917|Allergic rhinitis|allergic rhinitis
5146630|NCT03075865|intermaxillary fixation|intermaxillary fixation
5773469|NCT00229463|gene|gene
5146631|NCT03075865|maxillo-mandibular fixation|maxillo-mandibular fixation
5146632|NCT03075852|Heads-up display, NGENUITY, Vitreoretinal surgery|heads-up display, ngenuity, vitreoretinal surgery
5146633|NCT03075800|Assertive Community Treatment (ACT) Only|assertive community treatment (act) only
5146634|NCT03075800|Assertive Community Treatment (ACT) + Illness Management and Recovery (IMR)|assertive community treatment (act) + illness management and recovery (imr)
5146635|NCT03075787|Obstructive sleep apnea|obstructive sleep apnea
5146636|NCT03075787|Heart rate|heart rate
5146637|NCT03075787|Heart rate variability|heart rate variability
5146638|NCT03075787|Microarousals|microarousals
5146639|NCT03075787|Autonomic nervous system activity|autonomic nervous system activity
5146640|NCT03075761|Venous thromboembolism|venous thromboembolism
5146641|NCT03075761|Deep Vein Thrombosis|deep vein thrombosis
5146642|NCT03075761|Lower Extremity|lower extremity
5146643|NCT03075761|Blood clot|blood clot
5146644|NCT03075761|Anticoagulation|anticoagulation
5146645|NCT03075761|Physical Activity|physical activity
5146646|NCT03075761|Fitbit|fitbit
5146647|NCT03075761|Post-thrombotic syndrome|post-thrombotic syndrome
5146648|NCT03075761|Post-phlebitic syndrome|post-phlebitic syndrome
5146649|NCT03075761|Thrombosis|thrombosis
5146650|NCT03075748|Vascular|vascular
5146652|NCT03075748|Graft|graft
5146653|NCT03075735|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5146654|NCT03075735|DNA-repair|dna-repair
5146655|NCT03075735|BRCA1|brca1
5146656|NCT03075735|BRCA2|brca2
5146658|NCT03075735|PALB2|palb2
5146659|NCT03075709|Clinical Pathway|clinical pathway
5146660|NCT03075709|CPW|cpw
5146661|NCT03075709|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5146662|NCT03075709|COPD|copd
5146663|NCT03075709|Protocol|protocol
5146664|NCT03075709|Adherence|adherence
5146665|NCT03075709|Readmission|readmission
5146666|NCT03075709|Length of Stay|length of stay
5146667|NCT03075709|Cost|cost
5146668|NCT03075683|Cognitive behavioural therapy|cognitive behavioural therapy
5146669|NCT03075683|Non-pharmacological treatment|non-pharmacological treatment
5146670|NCT03075683|Internet mediated|internet mediated
5146671|NCT03075579|ADHD, cortisol, α-amylase, actometer|adhd, cortisol, α-amylase, actometer
5146672|NCT03075566|coronary artery disease|coronary artery disease
5146673|NCT03075566|risk factors|risk factors
5146674|NCT03075566|inflammation|inflammation
5146675|NCT03075566|biomarkers|biomarkers
5146676|NCT03075566|atherosclerosis|atherosclerosis
5146677|NCT03075540|Latinas|latinas
5146678|NCT03075527|Mesothelioma|mesothelioma
5146679|NCT03075514|ketogenic|ketogenic
5146680|NCT03075501|drug cues|drug cues
5146681|NCT03075475|Child|child
5146682|NCT03075475|Adolescent|adolescent
5146683|NCT03075475|Mental Health|mental health
5146684|NCT03075475|Randomized Controlled Trial|randomized controlled trial
5146685|NCT03075462|PARP inhibitor|parp inhibitor
5146686|NCT03075462|VEGFR inhibitor|vegfr inhibitor
5146687|NCT03075462|Combination therapy|combination therapy
5146688|NCT03075462|Ovarian Cancer|ovarian cancer
5146689|NCT03075462|Triple Negative Breast Cancer|triple negative breast cancer
5146690|NCT03075436|Sanitation|sanitation
5146691|NCT03075436|Hygiene|hygiene
5146692|NCT03075436|Public Health|public health
5146695|NCT03075436|Demand-side sanitation and hygiene|demand-side sanitation and hygiene
5146696|NCT03075436|Mental well-being|mental well-being
5146697|NCT03075436|Water insecurity|water insecurity
5146698|NCT03075436|Sanitation insecurity|sanitation insecurity
5146699|NCT03075436|Collective efficacy|collective efficacy
5146700|NCT03075410|ascending dose|ascending dose
5146701|NCT03075410|Pharmacokinetics|pharmacokinetics
5146702|NCT03075410|GSK3036656|gsk3036656
5146704|NCT03075410|Safety|safety
5146705|NCT03075397|HIV-1|hiv-1
5146706|NCT03075397|Colo-rectal transmission|colo-rectal transmission
5146707|NCT03075397|seminal plasma|seminal plasma
5146812|NCT03074734|asthma|asthma
5146708|NCT03075384|computer-assisted navigation system|computer-assisted navigation system
5146709|NCT03075332|Detraining|detraining
5146710|NCT03075332|Physical aptitude|physical aptitude
5146711|NCT03075332|HIV|hiv
5146712|NCT03075280|ERCP|ercp
5146713|NCT03075280|ERAS|eras
5146714|NCT03075280|complication|complication
5146715|NCT03075280|fatigue|fatigue
5146716|NCT03075280|high carbohydrate diet|high carbohydrate diet
5146718|NCT03075254|Fatigue|fatigue
5146719|NCT03075241|Sleep Disturbances|sleep disturbances
5146720|NCT03075241|Alzheimer Disease|alzheimer disease
5146721|NCT03075241|Insomnia|insomnia
5146722|NCT03075241|Z-Drugs|z-drugs
5146723|NCT03075241|Treatment|treatment
5146724|NCT03075228|microbiota|microbiota
5146725|NCT03075228|small intestine|small intestine
5146726|NCT03075228|metabolic disease|metabolic disease
5146727|NCT03075202|Schizophrenia|schizophrenia
5146728|NCT03075202|Smoking|smoking
5146729|NCT03075202|E-cigarette|e-cigarette
5146730|NCT03075189|Frailty|frailty
5146731|NCT03075189|geriatric|geriatric
5216959|NCT02640365|cancer|cancer
5146732|NCT03075189|hospitalized|hospitalized
5146733|NCT03075189|enrichment|enrichment
5146734|NCT03075189|whey protein|whey protein
5146735|NCT03075189|protein intake|protein intake
5146736|NCT03075189|sarcopenia|sarcopenia
5146737|NCT03075189|dietary counseling|dietary counseling
5146738|NCT03075176|Photorefractive keratectomy|photorefractive keratectomy
5146739|NCT03075176|Laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
5146740|NCT03075163|PONV|ponv
5146741|NCT03075163|Nausea|nausea
5146742|NCT03075163|Vomiting|vomiting
5146743|NCT03075163|Acupressure|acupressure
5146744|NCT03075137|ischemic stroke|ischemic stroke
5146745|NCT03075137|external counter pulsation|external counter pulsation
5146746|NCT03075137|mRS|mrs
5146747|NCT03075124|Coronary Artery Disease|coronary artery disease
5146748|NCT03075124|external counter pulsation|external counter pulsation
5146749|NCT03075124|major adverse cardiovascular events|major adverse cardiovascular events
5146750|NCT03075098|Colposcopy|colposcopy
5146751|NCT03075098|oral epithelial dysplasia|oral epithelial dysplasia
5146752|NCT03075098|diagnostic accuracy|diagnostic accuracy
5146753|NCT03075072|Brain metastases|brain metastases
5146754|NCT03075072|Brain metastasis|brain metastasis
5146755|NCT03075072|Lung cancer|lung cancer
5146756|NCT03075072|Melanoma|melanoma
5146757|NCT03075072|Breast cancer|breast cancer
5146758|NCT03075072|Kidney cancer|kidney cancer
5146759|NCT03075072|Renal cell carcinoma|renal cell carcinoma
5146760|NCT03075072|Stereotactic radiation|stereotactic radiation
5146761|NCT03075072|Stereotactic radiosurgery|stereotactic radiosurgery
5146763|NCT03075072|Stereotactic|stereotactic
5146764|NCT03075072|Whole brain radiation|whole brain radiation
5146765|NCT03075072|WBRT|wbrt
5146766|NCT03075072|Hippocampal avoidance|hippocampal avoidance
5146767|NCT03075072|Hippocampal sparing|hippocampal sparing
5146768|NCT03075072|Hippocampal|hippocampal
5146769|NCT03075072|Hippocampus|hippocampus
5146770|NCT03075072|Radiation|radiation
5146771|NCT03075072|Quality of Life|quality of life
5146772|NCT03075072|Neurocognitive|neurocognitive
5146773|NCT03075072|Neurocognition|neurocognition
5146774|NCT03075072|Survival|survival
5146775|NCT03075072|Salvage|salvage
5146776|NCT03075072|MDASI|mdasi
5146777|NCT03075072|Chemotherapy|chemotherapy
5146778|NCT03075072|Recurrence|recurrence
5146779|NCT03075046|Blue Light Emitting Diode|blue light emitting diode
5146780|NCT03075046|Women|women
5146781|NCT03075033|Shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.|shikani optical stylet, rigid optical stylets, awake, fiber-optic intubation, and cervical spine injury.
5146782|NCT03075007|Alzheimer Disease|alzheimer disease
5146783|NCT03075007|Aging|aging
5146784|NCT03075007|Dementia|dementia
5146785|NCT03075007|PET|pet
5146786|NCT03074994|Tranexamic acid|tranexamic acid
5146787|NCT03074994|Peri-articular injection|peri-articular injection
5146788|NCT03074994|Intraarticular injection|intraarticular injection
5146789|NCT03074994|Total knee arthroplasty|total knee arthroplasty
5146790|NCT03074994|Blood loss|blood loss
5146791|NCT03074955|Hypotension|hypotension
5146811|NCT03074734|COPD|copd
5146813|NCT03074734|SHS health effect|shs health effect
5146814|NCT03074708|Three-Dimensional Image|three-dimensional image
5146815|NCT03074708|Three Dimensional Printing|three dimensional printing
5146816|NCT03074682|Resuscitation|resuscitation
5146817|NCT03074669|Anxiety symptoms/disorders (OCD, PTSD, GAD, SAD, Panic)|anxiety symptoms/disorders (ocd, ptsd, gad, sad, panic)
5146818|NCT03074656|infliximab|infliximab
5146819|NCT03074656|therapeutic drug monitoring|therapeutic drug monitoring
5146820|NCT03074656|anti drug antibodies|anti drug antibodies
5146821|NCT03074656|TDM|tdm
5146822|NCT03074604|Brain Injuries|brain injuries
5146823|NCT03074604|Neurological Injury|neurological injury
5146824|NCT03074604|Stroke|stroke
5146825|NCT03074604|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5146826|NCT03074604|Postoperative Delirium|postoperative delirium
5146827|NCT03074604|Coronary Artery Disease|coronary artery disease
5146828|NCT03074604|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5146829|NCT03074604|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5146830|NCT03074604|Bypass surgery|bypass surgery
5146831|NCT03074604|Beating Heart Coronary Artery Bypass|beating heart coronary artery bypass
5146832|NCT03074604|Off-Pump Coronary Artery Bypass|off-pump coronary artery bypass
5146833|NCT03074591|Iron deficiency|iron deficiency
5146834|NCT03074591|Heart failure|heart failure
5146835|NCT03074578|sleep|sleep
5146836|NCT03074578|verbal abuse|verbal abuse
5146837|NCT03074578|polysomnography|polysomnography
5146838|NCT03074578|perception|perception
5146839|NCT03074578|neuropsychological tests|neuropsychological tests
5146840|NCT03074565|Sanative Therapy|sanative therapy
5146841|NCT03074565|Ultrasonic Therapy|ultrasonic therapy
5146842|NCT03074565|Deep Scaling|deep scaling
5146843|NCT03074565|Hand Scaling|hand scaling
5146844|NCT03074552|probiotics|probiotics
5146845|NCT03074552|VAP|vap
5146846|NCT03074552|microbiome|microbiome
5146847|NCT03074552|trauma|trauma
5146848|NCT03074552|infections|infections
5146849|NCT03074500|Kinesio taping|kinesio taping
5146850|NCT03074500|lateral epicondylitis|lateral epicondylitis
5146851|NCT03074500|tennis elbow|tennis elbow
5146852|NCT03074500|treatment|treatment
5146853|NCT03074487|Spinal cord ischemia|spinal cord ischemia
5146854|NCT03074487|Postoperative|postoperative
5146855|NCT03074487|Thoracoabdominal Aneurysm|thoracoabdominal aneurysm
5146856|NCT03074487|Monitoring|monitoring
5146857|NCT03074474|use of mesh|use of mesh
5146858|NCT03074461|Rectal Cancer|rectal cancer
5146859|NCT03074461|Low Anterior Resection|low anterior resection
5146860|NCT03074461|Coloplasty Pouch|coloplasty pouch
5146861|NCT03074461|Side-to-end Anastomosis|side-to-end anastomosis
5146862|NCT03074461|Continence|continence
5146863|NCT03074461|Quality of Life|quality of life
5146864|NCT03074448|Colonoscopy|colonoscopy
5146865|NCT03074448|Intestinal Cleaning|intestinal cleaning
5146866|NCT03074448|Picoprep|picoprep
5146867|NCT03074448|Aquanet|aquanet
5146868|NCT03074422|Functional neurosurgery|functional neurosurgery
5146869|NCT03074422|Pain management|pain management
5146870|NCT03074422|Hypnosis|hypnosis
5146871|NCT03074422|Stereotaxy|stereotaxy
5155992|NCT03016754|SCD|scd
5146873|NCT03074422|Essential tremor|essential tremor
5146874|NCT03074422|Dystonia|dystonia
5146875|NCT03074422|Invasive monitoring of epilepsy|invasive monitoring of epilepsy
5146876|NCT03074409|Oxytocin|oxytocin
5146877|NCT03074344|Dry Eye Syndrome|dry eye syndrome
5142651|NCT03099343|salt|salt
5146882|NCT03074305|drug-eluting stent|drug-eluting stent
5146883|NCT03074305|drug-eluting balloon|drug-eluting balloon
5146884|NCT03074305|bioresorbable scaffold|bioresorbable scaffold
5146885|NCT03074279|Epilepsy|epilepsy
5146886|NCT03074279|SUDEP|sudep
5146887|NCT03074279|case-control study|case-control study
5146888|NCT03074279|risks factors|risks factors
5146889|NCT03074240|Truncal block|truncal block
5146890|NCT03074240|Surgical anesthesia|surgical anesthesia
5146891|NCT03074240|Postoperative pain control|postoperative pain control
5146892|NCT03074214|copeptin|copeptin
5146893|NCT03074214|myocardial infarct size|myocardial infarct size
5146894|NCT03074214|prognosis|prognosis
5033001|NCT03792763|SLiM CRAB|slim crab
5146895|NCT03074214|ST-elevation myocardial infarction|st-elevation myocardial infarction
5146896|NCT03074214|percutaneous coronary intervention|percutaneous coronary intervention
5146897|NCT03074201|ERCP, choledocholithiasis, cholangioscopy|ercp, choledocholithiasis, cholangioscopy
5146898|NCT03074188|oral findings or oral manifestation|oral findings or oral manifestation
5146899|NCT03074188|pre-dialysis stage or end stage renal disease|pre-dialysis stage or end stage renal disease
5146900|NCT03074136|photodynamic therapy|photodynamic therapy
5146901|NCT03074136|diode laser|diode laser
5146902|NCT03074136|immature permanent teeth|immature permanent teeth
5146903|NCT03074136|endodontic therapy|endodontic therapy
5146904|NCT03074123|cosyntropin stimulation test|cosyntropin stimulation test
5146905|NCT03074123|low-dose|low-dose
5146906|NCT03074110|Inhalation Anaesthetics, Sevoflurane|inhalation anaesthetics, sevoflurane
5146907|NCT03074110|Carbon Dioxide|carbon dioxide
5146908|NCT03074110|Hyperventilation|hyperventilation
5146911|NCT03074097|Rectus sheath block, Postoperative pain,TNF alpha and IL-6|rectus sheath block, postoperative pain,tnf alpha and il-6
5146913|NCT03074084|adult|adult
5146914|NCT03074084|emergency department|emergency department
5146915|NCT03074084|electronic nose|electronic nose
5146916|NCT03074084|celiac disease|celiac disease
5146917|NCT03074071|Disambiguation, Depression, Burnout|disambiguation, depression, burnout
5146918|NCT03074045|Intrauterine|intrauterine
5146919|NCT03074045|Birth control|birth control
5146920|NCT03073993|nasogastric|nasogastric
5146921|NCT03073993|orogastric|orogastric
5146922|NCT03073993|nutrition|nutrition
5146923|NCT03073993|preterm|preterm
5146924|NCT03073993|feeding tube|feeding tube
5146925|NCT03073993|insertion|insertion
5146926|NCT03073993|episodes|episodes
5146927|NCT03073993|bradycardia|bradycardia
5146928|NCT03073993|desaturation|desaturation
5146929|NCT03073980|in vitro fertilization|in vitro fertilization
5146930|NCT03073980|oocyte retrieval|oocyte retrieval
5146931|NCT03073980|acetaminophen|acetaminophen
5146932|NCT03073980|postoperative pain control|postoperative pain control
5146933|NCT03073954|Health Behavior|health behavior
5146934|NCT03073954|Executive function|executive function
5146935|NCT03073954|Working-memory training|working-memory training
5146936|NCT03073954|Feasibility|feasibility
5146937|NCT03073954|Impulsivity|impulsivity
5146938|NCT03073941|Knee arthroplasty|knee arthroplasty
5146939|NCT03073941|Knee function|knee function
5146940|NCT03073941|Total knee replacement|total knee replacement
5146941|NCT03073941|Persona total knee system|persona total knee system
5146942|NCT03073941|NexGen total knee system|nexgen total knee system
5146943|NCT03073928|Nerve block|nerve block
5146944|NCT03073928|Diaphragm function|diaphragm function
5146945|NCT03073889|Aneurysm Clipping|aneurysm clipping
5146946|NCT03073889|Scalp nerve block|scalp nerve block
5146947|NCT03073889|Scalp infiltration|scalp infiltration
5146948|NCT03073889|Ropivacaine|ropivacaine
5146952|NCT03073863|LDL Cholesterol|ldl cholesterol
5146953|NCT03073863|Statin intensity|statin intensity
5146954|NCT03073863|post hoc analysis|post hoc analysis
5146955|NCT03073863|Achieved LDL Cholesterol level|achieved ldl cholesterol level
5146956|NCT03073811|protein supplementation|protein supplementation
5146957|NCT03073811|older adults|older adults
5146958|NCT03073811|nutrition perihabilitation|nutrition perihabilitation
5146959|NCT03073811|perioperative optimization|perioperative optimization
5146960|NCT03073811|Veterans|veterans
5146961|NCT03073798|Lung Disease|lung disease
5146962|NCT03073798|Breathing Difficulty|breathing difficulty
5146963|NCT03073798|Smoking|smoking
5146964|NCT03073798|Mucociliary|mucociliary
5146965|NCT03073746|Google|google
5146966|NCT03073746|Knowledge Panels|knowledge panels
5146967|NCT03073746|Health Search|health search
5146968|NCT03073746|Online|online
5146969|NCT03073746|Internet|internet
5146970|NCT03073746|Smartphone|smartphone
5146971|NCT03073746|Tablet|tablet
5146972|NCT03073746|Digital|digital
5146973|NCT03073746|Mobile|mobile
5146975|NCT03073746|Differential diagnosis|differential diagnosis
5033107|NCT03791905|PET|pet
5146977|NCT03073746|Anxiety|anxiety
5142755|NCT03098758|CK20|ck20
5146983|NCT03073694|Peritoneal Surface Disease|peritoneal surface disease
5146984|NCT03073694|mitomycin-c|mitomycin-c
5146985|NCT03073694|melphalan|melphalan
5146986|NCT03073694|Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC)|cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (crs-hipec)
5146987|NCT03073694|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5146988|NCT03073681|cataract|cataract
5146989|NCT03073655|shoulder pain|shoulder pain
5146990|NCT03073655|shoulder function|shoulder function
5146991|NCT03073642|Hydrotherapy|hydrotherapy
5146992|NCT03073642|Pain education|pain education
5146993|NCT03073577|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5146994|NCT03073577|Islet Transplantation|islet transplantation
5146995|NCT03073577|Diabetes|diabetes
5146996|NCT03073577|Diabetes Treatment|diabetes treatment
5146997|NCT03073564|Dyspnea|dyspnea
5146998|NCT03073564|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5146999|NCT03073564|Positive-Pressure Respiration|positive-pressure respiration
5147000|NCT03073525|Stage IIIb|stage iiib
5147001|NCT03073525|Stage IV|stage iv
5147002|NCT03073525|Ovarian Cancer|ovarian cancer
5147003|NCT03073525|Cervical Cancer|cervical cancer
5147004|NCT03073525|Uterine Cancer|uterine cancer
5147005|NCT03073525|Immunotherapy|immunotherapy
5147006|NCT03073447|Myocardial infarction|myocardial infarction
5147007|NCT03073447|Women|women
5147008|NCT03073447|Young|young
5147015|NCT03073356|Positron emission tomography|positron emission tomography
5147016|NCT03073356|Echocardiography|echocardiography
5147017|NCT03073356|Right sided heart catheterization|right sided heart catheterization
5147018|NCT03073317|Preterm Infants|preterm infants
5147019|NCT03073317|Premature Birth|premature birth
5147020|NCT03073317|Placenta growth factor|placenta growth factor
5147021|NCT03073317|Prenatal Care|prenatal care
5147022|NCT03073317|PERINATAL MORTALITY|perinatal mortality
5147023|NCT03073317|Pre-Eclampsia|pre-eclampsia
5147024|NCT03073304|isolated limb perfusion|isolated limb perfusion
5147025|NCT03073291|cannabis|cannabis
5147026|NCT03073291|commerce|commerce
5147027|NCT03073265|DOAC|doac
5147028|NCT03073265|apixaban|apixaban
5147029|NCT03073265|IVD|ivd
5147030|NCT03073239|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5147031|NCT03073239|Bulbar disfunction|bulbar disfunction
5147032|NCT03073239|Rik factors ALS|rik factors als
5147033|NCT03073200|children|children
5147034|NCT03073200|psoriasis treatment|psoriasis treatment
5147035|NCT03073200|adolescents|adolescents
5147036|NCT03073187|Asthma|asthma
5147037|NCT03073187|Sleep|sleep
5147038|NCT03073187|Adolescents|adolescents
5147039|NCT03073187|Urban|urban
5147040|NCT03073187|Intervention|intervention
5147041|NCT03073187|High school|high school
5147042|NCT03073174|dietary intake|dietary intake
5147043|NCT03073174|nutritional supplements|nutritional supplements
5147044|NCT03073174|sanative therapy|sanative therapy
5147045|NCT03073174|healing|healing
5147046|NCT03073174|flavonoids|flavonoids
5147047|NCT03073174|tea|tea
5147048|NCT03073161|flavonoids|flavonoids
5147049|NCT03073161|tea|tea
5147050|NCT03073161|dietary intake|dietary intake
5147051|NCT03073161|nutritional supplements|nutritional supplements
5147052|NCT03073161|periodontal disease|periodontal disease
5147053|NCT03073161|healing|healing
5147054|NCT03073161|sanative therapy|sanative therapy
5147055|NCT03073096|axillary nodal dissection|axillary nodal dissection
5147056|NCT03073096|groin nodal dissection|groin nodal dissection
5147057|NCT03073083|autograft|autograft
5147058|NCT03073070|diabetic children|diabetic children
5147059|NCT03073070|RBC lifespan|rbc lifespan
5147060|NCT03073044|Quality of life|quality of life
5147061|NCT03073044|psychosocial and psychological problems|psychosocial and psychological problems
5147062|NCT03073005|ventricular assist device (VAD)|ventricular assist device (vad)
5147063|NCT03073005|heart failure|heart failure
5147064|NCT03073005|simulation|simulation
5147065|NCT03072966|Distress|distress
5147066|NCT03072966|Exercise|exercise
5147067|NCT03072966|Wearable device|wearable device
5147068|NCT03072966|Smartphone|smartphone
5147073|NCT03072888|acute pain|acute pain
5147074|NCT03072888|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5147075|NCT03072888|Anesthesia Recovery Period|anesthesia recovery period
5147076|NCT03072875|Suicidality|suicidality
5147077|NCT03072875|Collaborative Assessment and Management of Suicidality|collaborative assessment and management of suicidality
5147078|NCT03072875|Technology|technology
5147079|NCT03072875|Suicide Prevention|suicide prevention
5147080|NCT03072875|Suicide Intervention|suicide intervention
5147082|NCT03072849|Pediatrics|pediatrics
5147089|NCT03072823|depression|depression
5147090|NCT03072810|Positive psychology|positive psychology
5147091|NCT03072810|Wellbeing|wellbeing
5147092|NCT03072810|Chronic pain|chronic pain
5147093|NCT03072810|Mindfulness|mindfulness
5147094|NCT03072797|Atherosclerosis|atherosclerosis
5147095|NCT03072797|Longitudinal|longitudinal
5147096|NCT03072797|Biomarker|biomarker
5147097|NCT03072797|Coronary angiography|coronary angiography
5147098|NCT03072797|Follow-up|follow-up
5147099|NCT03072797|Metabolomics|metabolomics
5147100|NCT03072797|Risk factor|risk factor
5147101|NCT03072758|Male partner involvement|male partner involvement
5147102|NCT03072745|Cognitive Impairment|cognitive impairment
5147103|NCT03072732|Heart Failure|heart failure
5147104|NCT03072732|Hemodialysis|hemodialysis
5147105|NCT03072706|hip replacement|hip replacement
5147106|NCT03072706|acetabulum|acetabulum
5147107|NCT03072706|anteversion|anteversion
5147108|NCT03072706|position|position
5147109|NCT03072706|guide|guide
5147110|NCT03072667|prematurity|prematurity
5147111|NCT03072667|bowel atresia|bowel atresia
5147112|NCT03072667|necrotizing entercolitis|necrotizing entercolitis
5147113|NCT03072667|parenteral nutrition associated liver disease (PNALD)|parenteral nutrition associated liver disease (pnald)
5147114|NCT03072667|intestinal failure|intestinal failure
5147115|NCT03072667|parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
5019040|NCT03877653|PNS|pns
5147116|NCT03072667|fish oil|fish oil
5147117|NCT03072641|Probiotics|probiotics
5147118|NCT03072641|Epigenetics|epigenetics
5147119|NCT03072641|Microbiota|microbiota
5147120|NCT03072628|nicotine|nicotine
5147121|NCT03072628|sympathetic nerve activity|sympathetic nerve activity
5147122|NCT03072628|oxidative stress|oxidative stress
5147123|NCT03072602|Racial differences|racial differences
5147124|NCT03072576|Diagnosis|diagnosis
5147125|NCT03072576|Xpert MTB/RIF|xpert mtb/rif
5147126|NCT03072576|Ultra Xpert MTB/RIF|ultra xpert mtb/rif
5147127|NCT03072550|fungal nail|fungal nail
5147128|NCT03072550|toenail fungus|toenail fungus
5147129|NCT03072537|growth|growth
5147130|NCT03072537|BMI|bmi
5147131|NCT03072537|obesity|obesity
5147132|NCT03072537|childhood|childhood
5147133|NCT03072537|adolescence|adolescence
5147134|NCT03072537|development|development
5147135|NCT03072524|pre-hospital stroke scale test|pre-hospital stroke scale test
5147136|NCT03072524|severe hemiparesis|severe hemiparesis
5147137|NCT03072524|large vessel occlusion|large vessel occlusion
5147138|NCT03072524|mechanical thrombectomy|mechanical thrombectomy
5147139|NCT03072485|aging|aging
5147140|NCT03072472|Colorectal Cancer|colorectal cancer
5147141|NCT03072472|Endoscopy|endoscopy
5147142|NCT03072472|Screening|screening
5147143|NCT03072472|Colonic Adenoma|colonic adenoma
5147144|NCT03072472|Adenoma Detection Rate|adenoma detection rate
5147145|NCT03072472|Endocuff|endocuff
5147146|NCT03072472|Endocuff Vision|endocuff vision
5147147|NCT03072446|Uterine Fibroid|uterine fibroid
5147148|NCT03072446|Embolization|embolization
5147149|NCT03072446|symptoms|symptoms
5147150|NCT03072446|Gel-Beads|gel-beads
5147151|NCT03072433|child malnutrition|child malnutrition
5147152|NCT03072433|child development|child development
5147153|NCT03072433|counseling|counseling
5147154|NCT03072420|MRI, fingers compression|mri, fingers compression
5147155|NCT03072381|CLE|cle
5147156|NCT03072381|epicondylosis|epicondylosis
5147157|NCT03072381|platelet rich plasma|platelet rich plasma
5147159|NCT03072381|ultrasound|ultrasound
5147160|NCT03072381|shear wave ultrasound|shear wave ultrasound
5147161|NCT03072381|tendinopathy|tendinopathy
5147162|NCT03072381|elbow|elbow
5147163|NCT03072381|tenis elbow|tenis elbow
5147164|NCT03072381|plasma|plasma
5147165|NCT03072381|plasma injection|plasma injection
5147166|NCT03072381|tendinosis|tendinosis
5147167|NCT03072381|tendinitis|tendinitis
5147168|NCT03072355|fatigue|fatigue
5147169|NCT03072355|resistance test|resistance test
5147170|NCT03072316|breast cancer|breast cancer
5147171|NCT03072316|mastectomy|mastectomy
5147172|NCT03072316|deep inferior perforator flap reconstruction|deep inferior perforator flap reconstruction
5147173|NCT03072316|post mastectomy radiotherapy|post mastectomy radiotherapy
5147174|NCT03072303|Brittle Bone|brittle bone
5147175|NCT03072303|Osteogenesis Imperfecta|osteogenesis imperfecta
5147176|NCT03072303|BBD|bbd
5147177|NCT03072303|OI|oi
5147178|NCT03072303|Congenital Abnormalities|congenital abnormalities
5147179|NCT03072303|Congenital Bone Disorder|congenital bone disorder
5147180|NCT03072303|Lobstein Syndrome|lobstein syndrome
5147181|NCT03072277|DHA|dha
5156282|NCT03015129|Durvalumab|durvalumab
5147182|NCT03072277|Docosa Hexaenoic Acid|docosa hexaenoic acid
5147183|NCT03072277|Omega 3 fatty acid|omega 3 fatty acid
5147184|NCT03072277|Birth Outcome|birth outcome
5147185|NCT03072277|Birth Size|birth size
5147186|NCT03072277|Gestational Age|gestational age
5147187|NCT03072277|DASII|dasii
5772345|NCT00234962|HAART|haart
5147188|NCT03072277|Prenatal and Postnatal Supplementation|prenatal and postnatal supplementation
5147189|NCT03072277|Randomized Controlled Trial|randomized controlled trial
5147190|NCT03072277|Neurodevelopment|neurodevelopment
5147191|NCT03072277|Pregnancy|pregnancy
5147192|NCT03072277|Lactation|lactation
5147193|NCT03072264|Generalized Anxiety Disorder, GAD, mindfulness, anxiety|generalized anxiety disorder, gad, mindfulness, anxiety
5147194|NCT03072238|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
5147195|NCT03072225|herbal medicine|herbal medicine
5147196|NCT03072225|stroke|stroke
5147197|NCT03072225|vulnerable plaques of carotid artery|vulnerable plaques of carotid artery
5147199|NCT03072212|Stroke|stroke
5147200|NCT03072212|Cerebral vascular accident|cerebral vascular accident
5147201|NCT03072212|Uganda|uganda
5147202|NCT03072199|Rituximab|rituximab
5147203|NCT03072199|B cells|b cells
5147204|NCT03072160|Anti-PD1/PDL1|anti-pd1/pdl1
5147205|NCT03072160|Vaccine Therapy|vaccine therapy
5147206|NCT03072160|TKI-Naive|tki-naive
5147207|NCT03072134|Glioma|glioma
5147208|NCT03072134|Glioblastoma|glioblastoma
5147209|NCT03072134|Astrocytoma|astrocytoma
5962077|NCT04283162|cluster-randomized controlled trial|cluster-randomized controlled trial
5147210|NCT03072134|Brain Cancer|brain cancer
5147211|NCT03072134|New Diagnosed Glioma|new diagnosed glioma
5147212|NCT03072134|Temozolomide|temozolomide
5147213|NCT03072134|Radiation|radiation
5147214|NCT03072134|Neural Stem Cells|neural stem cells
5147215|NCT03072134|Virotherapy|virotherapy
5147216|NCT03072134|Adenovirus|adenovirus
5147217|NCT03072134|Oncolytic virotherapy|oncolytic virotherapy
5147218|NCT03072121|coronary artery disease|coronary artery disease
5147219|NCT03072121|revascularization|revascularization
5147220|NCT03072121|Shexiang Baoxin Pill|shexiang baoxin pill
5147221|NCT03072095|Colorectal Neoplasms|colorectal neoplasms
5147222|NCT03072095|Colonic Neoplasms|colonic neoplasms
5147223|NCT03072095|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5147224|NCT03072095|Digestive System Neoplasms|digestive system neoplasms
5147225|NCT03072095|Neoplasms|neoplasms
5147226|NCT03072095|Digestive System Diseases|digestive system diseases
5147227|NCT03072095|Gastrointestinal Diseases|gastrointestinal diseases
5147228|NCT03072095|Colonic Diseases|colonic diseases
5147229|NCT03072095|Rectal Diseases|rectal diseases
5147230|NCT03072082|coronary artery disease|coronary artery disease
5147231|NCT03072082|revascularization|revascularization
5147232|NCT03072082|Danlou Tablet|danlou tablet
5147233|NCT03072043|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5147234|NCT03072043|TP53 mutant myelodysplastic syndrome|tp53 mutant myelodysplastic syndrome
5147235|NCT03072043|MDS/myeloproliferative neoplasm (MPN)|mds/myeloproliferative neoplasm (mpn)
5147236|NCT03072043|chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5147237|NCT03072043|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5147238|NCT03072030|Ebola Virus Disease|ebola virus disease
5147239|NCT03072030|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
5147240|NCT03072030|Vaccines|vaccines
5774259|NCT00225537|hbv|hbv
5147241|NCT03072030|GP protein, Ebola virus|gp protein, ebola virus
5147242|NCT03072030|Ebola Virus Vaccines|ebola virus vaccines
5147243|NCT03072004|Leprosy|leprosy
5147244|NCT03072004|Neuropathy|neuropathy
5147245|NCT03072004|LLLT|lllt
5147246|NCT03071991|preinsicional bupivacain|preinsicional bupivacain
5147247|NCT03071991|laparoscopic bariatric surgery|laparoscopic bariatric surgery
5147248|NCT03071991|postoperative pain|postoperative pain
5147249|NCT03071978|Heart Failure|heart failure
5147250|NCT03071978|LV-fusion pacing|lv-fusion pacing
5147251|NCT03071978|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5147252|NCT03071952|Heart Failure|heart failure
5147253|NCT03071952|Chronotropic Incompetence|chronotropic incompetence
5147254|NCT03071952|Rate Response|rate response
5147255|NCT03071952|Exercise Test|exercise test
5147256|NCT03071874|Meningioma|meningioma
5147257|NCT03071861|darbepoetin|darbepoetin
5147258|NCT03071861|Brain Diseases|brain diseases
5147259|NCT03071835|Stem Cells|stem cells
5147260|NCT03071835|Cardiovascular|cardiovascular
5147261|NCT03071835|Quality of Life|quality of life
5147262|NCT03071835|Cardiomyopathy|cardiomyopathy
5147263|NCT03071822|PTCLs|ptcls
5147264|NCT03071809|Solid tumor|solid tumor
5147265|NCT03071809|carcinoma|carcinoma
5147266|NCT03071809|sarcoma|sarcoma
5147267|NCT03071809|stage I|stage i
5147268|NCT03071809|stage II|stage ii
5147269|NCT03071809|stage III|stage iii
5147270|NCT03071770|Healthy Volunteers|healthy volunteers
5147271|NCT03071770|Japanese|japanese
5147272|NCT03071770|Caucasian|caucasian
5147273|NCT03071757|Solid Tumors|solid tumors
5147274|NCT03071757|Cancer|cancer
5147275|NCT03071757|Metastatic Solid Tumors|metastatic solid tumors
5147276|NCT03071757|Advanced Solid Tumors|advanced solid tumors
5147277|NCT03071757|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5147278|NCT03071757|Ovarian cancer|ovarian cancer
5147279|NCT03071757|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5147280|NCT03071757|Gastric cancer|gastric cancer
5147281|NCT03071757|Mesothelioma|mesothelioma
5147282|NCT03071757|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5147283|NCT03071757|Cholangiocarcinoma|cholangiocarcinoma
5147285|NCT03071757|Melanoma|melanoma
5147286|NCT03071757|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5147287|NCT03071757|2'-Deoxy-2'-[18F]Fluoro-9-β-DArabinofuranosylguanine (18F-AraG)|2'-deoxy-2'-[18f]fluoro-9-β-darabinofuranosylguanine (18f-arag)
5147289|NCT03071731|COPD|copd
5147290|NCT03071731|sit-to-stand|sit-to-stand
5147291|NCT03071731|responsiveness|responsiveness
5147292|NCT03071731|bronchodilation|bronchodilation
5147293|NCT03071718|cardiovascular diseases|cardiovascular diseases
5147294|NCT03071718|gut microbiota|gut microbiota
5147295|NCT03071718|Mediterranean diet|mediterranean diet
5147296|NCT03071705|NSCLC|nsclc
5147297|NCT03071705|metformin|metformin
5147298|NCT03071705|metformin plus TKI|metformin plus tki
5147299|NCT03071705|EGFR positive status|egfr positive status
5147300|NCT03071666|Nepal|nepal
5147301|NCT03071666|South Asia|south asia
5147302|NCT03071666|Nutrition|nutrition
5147303|NCT03071666|Pregnancy|pregnancy
5147304|NCT03071666|Neurodevelopment|neurodevelopment
5147305|NCT03071666|Growth|growth
5147306|NCT03071653|Cardiomyopathy|cardiomyopathy
5147307|NCT03071653|Left Cardiac Sympathetic Denervation|left cardiac sympathetic denervation
5147309|NCT03071640|elderly|elderly
5147310|NCT03071640|radiotherapy|radiotherapy
5147311|NCT03071640|geriatric assessment|geriatric assessment
5147320|NCT03071614|Misleading reporting|misleading reporting
5147321|NCT03071614|Misleading interpretation|misleading interpretation
5147322|NCT03071614|Misleading extrapolation|misleading extrapolation
5147323|NCT03071614|Animal studies|animal studies
5147324|NCT03071614|Cell culture studies|cell culture studies
5147325|NCT03071614|Pre-clinical studies|pre-clinical studies
5147326|NCT03071601|Laceration|laceration
5147327|NCT03071601|Suture|suture
5147328|NCT03071601|Topical anesthesia|topical anesthesia
5147329|NCT03071601|Lidocaine|lidocaine
5147330|NCT03071575|measles|measles
5147331|NCT03071575|rubella|rubella
5147332|NCT03071575|immunogenicity|immunogenicity
5147333|NCT03071575|congenital rubella syndrome|congenital rubella syndrome
5147334|NCT03071575|measles-rubella vaccine|measles-rubella vaccine
5147335|NCT03071562|HIV|hiv
5147336|NCT03071562|Cognitive impairment|cognitive impairment
5147337|NCT03071562|Aging|aging
5147338|NCT03071562|Physical Activity|physical activity
5147339|NCT03071562|Exercise|exercise
5147340|NCT03071562|Yoga|yoga
5147341|NCT03071562|Neuroplasticity|neuroplasticity
5147342|NCT03071549|Acne vulgaris|acne vulgaris
5147343|NCT03071549|Chemical peeling|chemical peeling
5147344|NCT03071549|Dermoscopy|dermoscopy
5147350|NCT03071497|Iron-deficiency|iron-deficiency
5147351|NCT03071497|Anemia|anemia
5147352|NCT03071497|Iron-deficiency Anemia|iron-deficiency anemia
5147353|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin
5147359|NCT03071419|fathers|fathers
5774459|NCT00224601|HNPCC|hnpcc
5147360|NCT03071406|Merkel cell carcinoma (MCC)|merkel cell carcinoma (mcc)
5147361|NCT03071406|Metastatic|metastatic
5147362|NCT03071406|Metastasis|metastasis
5147363|NCT03071406|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5147364|NCT03071406|Immunology|immunology
5147365|NCT03071406|Antibody|antibody
5147366|NCT03071406|Nivolumab|nivolumab
5147367|NCT03071406|Ipilimumab|ipilimumab
5147368|NCT03071406|Metastatic skin cancer|metastatic skin cancer
5147369|NCT03071406|Cutaneous|cutaneous
5147370|NCT03071393|acute intermittent hypoxia|acute intermittent hypoxia
5147371|NCT03071393|walking|walking
5147372|NCT03071393|breathing|breathing
5147373|NCT03071393|standing|standing
5147374|NCT03071393|sitting|sitting
5147375|NCT03071393|spinal cord injury|spinal cord injury
5147376|NCT03071367|Airway Management|airway management
5147377|NCT03071367|Medical students|medical students
5147378|NCT03071367|Intratracheal intubation|intratracheal intubation
5147379|NCT03071367|Educational Technology|educational technology
5147380|NCT03071354|ICU-acquired weakness|icu-acquired weakness
5147381|NCT03071341|MPS I; Hurler Syndrome|mps i; hurler syndrome
5147382|NCT03071315|Economic evaluation|economic evaluation
5147383|NCT03071315|Heroin dependence|heroin dependence
5147384|NCT03071315|Compulsory treatment|compulsory treatment
5147385|NCT03071315|Methadone treatment|methadone treatment
5147386|NCT03071315|Vietnam|vietnam
5147387|NCT03071315|East and Southeast Asia|east and southeast asia
5147388|NCT03071315|Cost-effectiveness|cost-effectiveness
5147389|NCT03071302|Keratoconus,Corneal Dystrophies, corneal Tomography, topography|keratoconus,corneal dystrophies, corneal tomography, topography
5147390|NCT03071263|Treatment of Hyperkalemia|treatment of hyperkalemia
5147391|NCT03071263|Hyperkalemia|hyperkalemia
5147392|NCT03071263|Potassium|potassium
5147393|NCT03071263|Chronic Kidney Disease|chronic kidney disease
5147394|NCT03071263|Hypertension|hypertension
5147395|NCT03071263|Resistant Hypertension|resistant hypertension
5147396|NCT03071263|Spironolactone|spironolactone
5147397|NCT03071237|infrapyloric artery|infrapyloric artery
5147398|NCT03071237|gastric cancer|gastric cancer
5147399|NCT03071224|AD|ad
5147400|NCT03071224|HV|hv
5212688|NCT02665104|TCD|tcd
5147401|NCT03071211|pelvic organ prolapse|pelvic organ prolapse
5147402|NCT03071211|urinary catheters|urinary catheters
5147403|NCT03071198|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5147404|NCT03071185|free flap|free flap
5147405|NCT03071185|nerve block|nerve block
5147406|NCT03071185|elective reconstructive surgery|elective reconstructive surgery
5147407|NCT03071185|free fibular|free fibular
5147408|NCT03071185|anterolateral thigh flaps|anterolateral thigh flaps
5147409|NCT03071159|Flash Glucose Monitoring|flash glucose monitoring
5147410|NCT03071159|Usability|usability
5147411|NCT03071159|Metabolic control|metabolic control
5147412|NCT03071055|Macular Degeneration|macular degeneration
5147414|NCT03071055|Wet AMD|wet amd
5147415|NCT03071055|Lucentis|lucentis
5147416|NCT03071029|family planning|family planning
5147417|NCT03071029|reproductive health|reproductive health
5147418|NCT03071029|abortion|abortion
5147419|NCT03071029|health providers|health providers
5147420|NCT03071016|T2D,|t2d,
5147421|NCT03071016|Type 2 Diabetes,|type 2 diabetes,
5147422|NCT03071016|T2DM|t2dm
5147423|NCT03071003|Pharmacokinetics|pharmacokinetics
5147424|NCT03071003|Healthy Volunteer Study|healthy volunteer study
5147425|NCT03070990|Enfortumab vedotin|enfortumab vedotin
5147426|NCT03070990|ASG-22CE|asg-22ce
5147427|NCT03070990|ASG-22ME|asg-22me
5147428|NCT03070990|Metastatic Urothelial Cancer|metastatic urothelial cancer
5147429|NCT03070977|Interprofessional education|interprofessional education
5147430|NCT03070977|Training unit|training unit
5147431|NCT03070977|Psychiatry|psychiatry
5147432|NCT03070977|Patient reported outcome|patient reported outcome
5147433|NCT03070951|Uterine Fibroid|uterine fibroid
5147434|NCT03070951|Leiomyomata|leiomyomata
5147435|NCT03070951|Heavy Menstrual Bleeding|heavy menstrual bleeding
5147436|NCT03070951|HMB|hmb
5147437|NCT03070951|Heavy Uterine Bleeding|heavy uterine bleeding
5147438|NCT03070951|Menorrhagia|menorrhagia
5147439|NCT03070951|OBE2109 + Add-back|obe2109 + add-back
5147440|NCT03070938|Chronic wounds|chronic wounds
5147441|NCT03070938|Acute Wounds|acute wounds
5147442|NCT03070938|PHMB|phmb
5147443|NCT03070938|Wound Management|wound management
5147444|NCT03070938|Bioburden|bioburden
5147445|NCT03070938|Collagen|collagen
5147446|NCT03070925|Antimicrobial|antimicrobial
5147447|NCT03070925|Collagen|collagen
5147448|NCT03070925|Bioburden|bioburden
5147449|NCT03070925|Biofilm|biofilm
5147450|NCT03070925|PHMB|phmb
5147451|NCT03070925|Chronic wounds|chronic wounds
5147452|NCT03070925|Acute wounds|acute wounds
5147453|NCT03070912|mechanical circulatory support|mechanical circulatory support
5147454|NCT03070912|bleeding, acquired von willebrand disease|bleeding, acquired von willebrand disease
5147455|NCT03070912|acquired von willebrand disease|acquired von willebrand disease
5147456|NCT03070899|Uterine Fibroid|uterine fibroid
5147457|NCT03070899|Leiomyomata|leiomyomata
5147458|NCT03070899|Heavy Menstrual Bleeding|heavy menstrual bleeding
5147459|NCT03070899|HMB|hmb
5217816|NCT02635321|MRI|mri
5147460|NCT03070899|Heavy Uterine Bleeding|heavy uterine bleeding
5147461|NCT03070899|Menorrhagia|menorrhagia
5147462|NCT03070899|OBE2109 + Add-back|obe2109 + add-back
5147463|NCT03070873|Quality of life|quality of life
5147464|NCT03070873|Vaginal mesh|vaginal mesh
5147465|NCT03070873|Mesh complications|mesh complications
5147466|NCT03070860|Low Grade Chronic vascular and skin Inflammation|low grade chronic vascular and skin inflammation
5147467|NCT03070860|Molecular vascular and skin Calcification|molecular vascular and skin calcification
5147468|NCT03070860|Calcium Score|calcium score
5147469|NCT03070847|tranexamic acid|tranexamic acid
5147470|NCT03070847|rhinoplasty|rhinoplasty
5147471|NCT03070847|bleeding reduction|bleeding reduction
5147472|NCT03070821|neurofeedback|neurofeedback
5147473|NCT03070821|real-time functional MRI|real-time functional mri
5147474|NCT03070821|parahippocampus|parahippocampus
5147475|NCT03070808|obesity|obesity
5147476|NCT03070808|voice|voice
5147477|NCT03070795|post-operative ileus|post-operative ileus
5147478|NCT03070795|early feeding|early feeding
5147479|NCT03070795|delayed feeding|delayed feeding
5147480|NCT03070782|IONIS-APO(a)-LRx|ionis-apo(a)-lrx
5147481|NCT03070782|AKCEA-APO(a)-LRx|akcea-apo(a)-lrx
5147482|NCT03070782|Dyslipidemia|dyslipidemia
5147483|NCT03070782|Dyslipoproteinemia|dyslipoproteinemia
5147484|NCT03070782|Hyperlipidemia|hyperlipidemia
5147485|NCT03070782|Hyperlipoproteinemia|hyperlipoproteinemia
5147486|NCT03070782|Hyperlipoproteinemia(a)|hyperlipoproteinemia(a)
5147487|NCT03070782|Hyperlipoproteinemia a|hyperlipoproteinemia a
5147488|NCT03070782|Lipoprotein|lipoprotein
5147489|NCT03070782|Lipoprotein(a)|lipoprotein(a)
5147490|NCT03070782|Lipoprotein a|lipoprotein a
5147491|NCT03070782|Lp(a)|lp(a)
5147492|NCT03070782|Lp a|lp a
5147493|NCT03070756|auto-CPAP|auto-cpap
5147494|NCT03070756|forced oscillation technique|forced oscillation technique
5147495|NCT03070756|obstructive sleep apnea|obstructive sleep apnea
5147496|NCT03070743|basilar invagination|basilar invagination
5147498|NCT03070743|surgery|surgery
5147499|NCT03070743|restoration technique|restoration technique
5147500|NCT03070730|Tachycardia|tachycardia
5147501|NCT03070730|orthostatic symptoms|orthostatic symptoms
5147505|NCT03070691|Nevoid Basal Cell Carcinoma Syndrome|nevoid basal cell carcinoma syndrome
5147506|NCT03070691|NBCCS, Gorlin syndrome|nbccs, gorlin syndrome
5147514|NCT03070652|attachment|attachment
5147515|NCT03070652|bonding psychological|bonding psychological
5147516|NCT03070626|General Surgery|general surgery
5147517|NCT03070626|Carbohydrates|carbohydrates
5147518|NCT03070626|Perioperative|perioperative
5147519|NCT03070613|Colonoscopy|colonoscopy
5147520|NCT03070613|Fluorescence guided surgery|fluorescence guided surgery
5147521|NCT03070600|PrEP|prep
5147522|NCT03070574|Lynch Syndrome|lynch syndrome
5147523|NCT03070574|Chemoprevention|chemoprevention
5147524|NCT03070574|Mesalazine|mesalazine
5147525|NCT03070574|5-ASA|5-asa
5147526|NCT03070535|APOE E4; cognition; metabolic markers; beta-amyloid|apoe e4; cognition; metabolic markers; beta-amyloid
5147527|NCT03070496|Myocardial infarction|myocardial infarction
5147528|NCT03070496|bio-collection|bio-collection
5147529|NCT03070496|Imaging markers|imaging markers
5147530|NCT03070496|biomarkers|biomarkers
5147531|NCT03070496|STEMI|stemi
5147532|NCT03070496|clinical outcomes|clinical outcomes
5147533|NCT03070457|bariatric surgery|bariatric surgery
5147534|NCT03070457|sleeve gastrectomy|sleeve gastrectomy
5147535|NCT03070457|eras|eras
5147536|NCT03070444|Essix retainer|essix retainer
5147537|NCT03070444|Cuspid-to-cuspid retainer|cuspid-to-cuspid retainer
5147538|NCT03070431|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
5147540|NCT03070418|DCS|dcs
5147541|NCT03070418|Boyd and Griffin Classification|boyd and griffin classification
5147542|NCT03070405|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5147543|NCT03070405|4-Aminosalicylic Acid|4-aminosalicylic acid
5147544|NCT03070405|Tuberculosis|tuberculosis
5147545|NCT03070405|HIV|hiv
5147546|NCT03070392|Melanoma|melanoma
5147547|NCT03070392|Uveal Cancer|uveal cancer
5147548|NCT03070392|IMCgp100|imcgp100
5147549|NCT03070392|Immunotherapy|immunotherapy
5147550|NCT03070366|Oligometastasis|oligometastasis
5147551|NCT03070366|stereotactic irradiation|stereotactic irradiation
5147552|NCT03070353|Cirrhosis|cirrhosis
5147553|NCT03070353|AKI|aki
5147554|NCT03070353|Albumin|albumin
5147555|NCT03070353|Dextran|dextran
5147556|NCT03070340|mastectomy|mastectomy
5147557|NCT03070340|breast MRI|breast mri
5147558|NCT03070340|contrast enhanced mammography|contrast enhanced mammography
5147559|NCT03070340|CEDM|cedm
5147560|NCT03070340|17-045|17-045
5147561|NCT03070327|B-cell Maturation Antigen (BCMA)|b-cell maturation antigen (bcma)
5147562|NCT03070327|Targeted EGFRt/BCMA-41BBz|targeted egfrt/bcma-41bbz
5774460|NCT00224601|Diagnosis|diagnosis
5147563|NCT03070327|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
5147564|NCT03070327|Lenalidomide|lenalidomide
5147565|NCT03070327|17-025|17-025
5147566|NCT03070314|Echinacea|echinacea
5147567|NCT03070314|bioavailability|bioavailability
5147568|NCT03070314|children|children
5147572|NCT03070288|RGB|rgb
5147573|NCT03070288|red-green-blue|red-green-blue
5147574|NCT03070288|rhinitis|rhinitis
5147575|NCT03070288|allergic rhinitis|allergic rhinitis
5147576|NCT03070288|nasal mucosa|nasal mucosa
5147577|NCT03070275|surgical implant placement|surgical implant placement
5147578|NCT03070275|crestal bone|crestal bone
5147579|NCT03070275|mucosa thickness|mucosa thickness
5147580|NCT03070275|stem cells|stem cells
5147581|NCT03070275|fibrin glue|fibrin glue
5147582|NCT03070275|collagen fleece|collagen fleece
5147583|NCT03070262|esophageal cancer|esophageal cancer
5147584|NCT03070262|caffeic acid|caffeic acid
5147585|NCT03070249|Emergency Department|emergency department
5147586|NCT03070236|Breast Cancer|breast cancer
5147587|NCT03070184|Racial differences|racial differences
5147588|NCT03070158|Premature Infant|premature infant
5147589|NCT03070158|Mother-Infant Interaction|mother-infant interaction
5147590|NCT03070158|Acoustic stimulation/methods|acoustic stimulation/methods
5147591|NCT03070158|Touch|touch
5147592|NCT03070158|Visual Stimulation|visual stimulation
5147593|NCT03070158|Vestibule, Labyrinth/physiology|vestibule, labyrinth/physiology
5147594|NCT03070145|Prostate Cancer|prostate cancer
5147600|NCT03070015|Weight Loss|weight loss
5147601|NCT03070015|Obesity|obesity
5147602|NCT03070015|Overweight|overweight
5147603|NCT03069989|Tolerability|tolerability
5147604|NCT03069989|IPF|ipf
5147605|NCT03069989|PET imaging|pet imaging
5147606|NCT03069989|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5147607|NCT03069989|Safety|safety
5147608|NCT03069989|Pharmacokinetics|pharmacokinetics
5147617|NCT03069911|Parkinsonism|parkinsonism
5147618|NCT03069911|Depression|depression
5156701|NCT03012724|TMS|tms
5147632|NCT03069846|non-invasive diagnostics|non-invasive diagnostics
5147633|NCT03069781|estrogen|estrogen
5147634|NCT03069768|Nicotine addiction|nicotine addiction
5147635|NCT03069768|Cigarette smoking|cigarette smoking
5147636|NCT03069768|Smoking cessation|smoking cessation
5147637|NCT03069768|Quit smoking|quit smoking
5147642|NCT03069742|Breast Cancer Prevention|breast cancer prevention
5147643|NCT03069742|Risk Assessment|risk assessment
5147644|NCT03069742|Chemoprevention|chemoprevention
5147645|NCT03069742|Decision Making|decision making
5147654|NCT03069664|Pancreatic Cancer|pancreatic cancer
5147655|NCT03069664|Pancreatic Duct Stricture|pancreatic duct stricture
5147656|NCT03069664|Endoscopic treatment|endoscopic treatment
5147657|NCT03069638|sedation|sedation
5147658|NCT03069638|pediatrics|pediatrics
5147659|NCT03069638|intranasal sedation|intranasal sedation
5147660|NCT03069638|dexmedetomidine|dexmedetomidine
5147661|NCT03069638|dinitrous oxide|dinitrous oxide
5147662|NCT03069638|intra-articular joint injection|intra-articular joint injection
5147663|NCT03069625|Cystic Fibrosis|cystic fibrosis
5147664|NCT03069625|Exercise Testing|exercise testing
5147665|NCT03069625|Muscular strength|muscular strength
5147666|NCT03069625|Pediatrics|pediatrics
5147667|NCT03069625|Quality of life|quality of life
5147668|NCT03069612|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5147669|NCT03069612|working memory|working memory
5147670|NCT03069612|gamma oscillations|gamma oscillations
5147671|NCT03069612|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5147672|NCT03069573|Eosinophilic Esophagitis|eosinophilic esophagitis
5147673|NCT03069573|Gastroesophageal Reflux|gastroesophageal reflux
5147674|NCT03069573|Diagnose|diagnose
5147675|NCT03069573|Biomarker|biomarker
5147676|NCT03069560|suicide attempt|suicide attempt
5147677|NCT03069560|SMS monitoring|sms monitoring
5147678|NCT03069560|Phone|phone
5147679|NCT03069560|Prevention control|prevention control
5147680|NCT03069560|tertiary healthcare|tertiary healthcare
5147681|NCT03069534|MDR-TB|mdr-tb
5147682|NCT03069534|rhIL-2|rhil-2
5147683|NCT03069534|immunotherapy|immunotherapy
5147684|NCT03069495|Allergy|allergy
5147685|NCT03069495|Asthma|asthma
5062277|NCT03609970|UVR|uvr
5147686|NCT03069495|Urticaria|urticaria
5147687|NCT03069482|Smoking|smoking
5147688|NCT03069482|mHealth|mhealth
5147689|NCT03069482|Serious Mental Illness|serious mental illness
5218161|NCT02633683|RLS|rls
5147690|NCT03069482|Acceptance and Commitment Therapy|acceptance and commitment therapy
5147691|NCT03069482|US DHHS Clinical Practice Guidelines|us dhhs clinical practice guidelines
5147692|NCT03069469|CSF1R|csf1r
5147693|NCT03069469|Breast cancer|breast cancer
5147694|NCT03069469|Prostate cancer|prostate cancer
5147695|NCT03069469|NSCLC|nsclc
5147696|NCT03069469|DTGCT|dtgct
5147697|NCT03069469|PVNS|pvns
5147698|NCT03069456|sevoflurane|sevoflurane
5147699|NCT03069456|Bistpectral index|bistpectral index
5147700|NCT03069456|Anesthetic Depth Monitoring System|anesthetic depth monitoring system
5147701|NCT03069456|population pharmacodynamics|population pharmacodynamics
5147702|NCT03069443|Isometric handgrip training|isometric handgrip training
5147703|NCT03069443|home training|home training
5147704|NCT03069443|older adults|older adults
5147705|NCT03069443|Hypertension|hypertension
5147706|NCT03069417|HIV|hiv
5147707|NCT03069417|Medication adherence|medication adherence
5147708|NCT03069417|PMTCT|pmtct
5147709|NCT03069417|Depression|depression
5147710|NCT03069391|exercise|exercise
5147711|NCT03069391|exergame|exergame
5147720|NCT03069365|Pibrentasvir|pibrentasvir
5147721|NCT03069365|Hepatitis C Virus Genotype|hepatitis c virus genotype
5147722|NCT03069365|Compensated cirrhosis|compensated cirrhosis
5147723|NCT03069365|Non-cirrhotic|non-cirrhotic
5147724|NCT03069365|Interferon (IFN)|interferon (ifn)
5147725|NCT03069365|Treatment naïve|treatment naïve
5147726|NCT03069365|Sofosbuvir (SOF)|sofosbuvir (sof)
5147727|NCT03069365|Pegylated interferon (pegIFN)|pegylated interferon (pegifn)
5147728|NCT03069365|Ribavirin (RBV)|ribavirin (rbv)
5147734|NCT03069326|Ruxolitinib|ruxolitinib
5147735|NCT03069326|Thalidomide|thalidomide
5147736|NCT03069326|16-1498|16-1498
5147737|NCT03069313|Aromatase Inhibitor|aromatase inhibitor
5147740|NCT03069313|Musculoskeletal symptoms|musculoskeletal symptoms
5147742|NCT03069261|Breast reconstruction|breast reconstruction
5147743|NCT03069261|Autologous tissue flaps|autologous tissue flaps
5147744|NCT03069261|Indocyanine green angiography|indocyanine green angiography
5147745|NCT03069261|Breast cancer|breast cancer
5147746|NCT03069235|HIV|hiv
5147747|NCT03069235|Breast Feeding|breast feeding
5147748|NCT03069222|diffusion tensor imaging|diffusion tensor imaging
5147749|NCT03069196|Prevalence|prevalence
5147750|NCT03069196|Incidence|incidence
5147751|NCT03069196|Type 1 diabetes and its Micro-vascular complications|type 1 diabetes and its micro-vascular complications
5147752|NCT03069196|Type 1 diabetes and its Macro-vascular complications|type 1 diabetes and its macro-vascular complications
5147753|NCT03069196|Type 1 Diabetes and its complications in India|type 1 diabetes and its complications in india
5147754|NCT03069183|Fascia Iliaca Block|fascia iliaca block
5147755|NCT03069183|Total Hip Arthroplasty|total hip arthroplasty
5147756|NCT03069183|Total Hip Replacement|total hip replacement
5147757|NCT03069183|Ultrasound|ultrasound
5147758|NCT03069144|Psoriasis|psoriasis
5147759|NCT03069144|Topical|topical
5147766|NCT03069079|dental health|dental health
5147767|NCT03069079|neutrophil defect|neutrophil defect
5147768|NCT03069079|periodontitis|periodontitis
5147769|NCT03069066|In-stent restenosis|in-stent restenosis
5147770|NCT03069066|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
5147772|NCT03069066|Drug-eluting stent|drug-eluting stent
5147773|NCT03069066|Coronary angiography|coronary angiography
5147774|NCT03069066|Scoring balloon|scoring balloon
5147775|NCT03069040|cervical cancer|cervical cancer
5147776|NCT03069040|NSRH|nsrh
5147777|NCT03069040|RH|rh
5147778|NCT03069040|urine flow mechanics|urine flow mechanics
5147779|NCT03069040|anorectal dynamics|anorectal dynamics
5147780|NCT03069027|Nasal surgery|nasal surgery
5147781|NCT03069027|external nasal nerve block|external nasal nerve block
5147782|NCT03069027|postoperative agitation|postoperative agitation
5147783|NCT03069001|HCV treatment|hcv treatment
5147784|NCT03068988|bone marrow stem cells|bone marrow stem cells
5147785|NCT03068988|rotator cuff lesion|rotator cuff lesion
5147786|NCT03068936|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5147787|NCT03068936|Intensity modulated radiotherapy|intensity modulated radiotherapy
5147788|NCT03068936|Cisplatin|cisplatin
5147789|NCT03068923|Blood clot|blood clot
5147790|NCT03068923|Deep Vein Thrombosis|deep vein thrombosis
5147791|NCT03068923|Pulmonary Embolism|pulmonary embolism
5147792|NCT03068923|Lower Extremity|lower extremity
5147793|NCT03068923|Upper Extremity|upper extremity
5147794|NCT03068923|Cerebral sinus|cerebral sinus
5147795|NCT03068923|Renal vein|renal vein
5147796|NCT03068923|Portal vein|portal vein
5147797|NCT03068923|thrombin|thrombin
5147798|NCT03068923|fibrinolysis|fibrinolysis
5147799|NCT03068923|coagulation|coagulation
5962078|NCT04283149|Nearsightedness|nearsightedness
5147800|NCT03068923|anticoagulation|anticoagulation
5147801|NCT03068923|Post trombotic syndrome|post trombotic syndrome
5147802|NCT03068923|Post pulmonary embolism syndrome|post pulmonary embolism syndrome
5369145|NCT01861106|Myelodysplasia|myelodysplasia
5147803|NCT03068923|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5147804|NCT03068910|Hyperandrogenism|hyperandrogenism
5147805|NCT03068910|Polycystic ovary syndrome|polycystic ovary syndrome
5147806|NCT03068910|Puberty|puberty
5147807|NCT03068845|non-maturing arteriovenous fistula|non-maturing arteriovenous fistula
5147808|NCT03068845|stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
5147809|NCT03068845|drug-eluting balloon|drug-eluting balloon
5147812|NCT03068728|bilateral chronic rhino sinusitis|bilateral chronic rhino sinusitis
5147815|NCT03068689|Partial nephrectomy, RIPC, Reperfusion Injury|partial nephrectomy, ripc, reperfusion injury
5147817|NCT03068676|Anxiety|anxiety
5147818|NCT03068676|Internet-delivered|internet-delivered
5147819|NCT03068676|CBT|cbt
5147820|NCT03068676|Primary Care|primary care
5147821|NCT03068663|lung cancer|lung cancer
5147822|NCT03068663|intestinal microbiota|intestinal microbiota
5147823|NCT03068663|lung microbiota|lung microbiota
5147824|NCT03068663|surgery|surgery
5147825|NCT03068663|chemotherapy|chemotherapy
5147826|NCT03068585|PAD|pad
5147827|NCT03068585|CLI|cli
5147828|NCT03068585|stage 2a-3 of Pokrovsky-Fonteine|stage 2a-3 of pokrovsky-fonteine
5356852|NCT01917734|community-based care|community-based care
5147829|NCT03068572|minimal change esophageal reflux disease diagnosis|minimal change esophageal reflux disease diagnosis
5147830|NCT03068572|Linked Color imaging|linked color imaging
5147831|NCT03068572|non-erosive reflux disease|non-erosive reflux disease
5147833|NCT03068533|DH, dentin hypersensitivity, chronic periodontitis|dh, dentin hypersensitivity, chronic periodontitis
5147834|NCT03068520|PET|pet
5147835|NCT03068520|MRI|mri
5147836|NCT03068520|BRAIN METASTASIS|brain metastasis
5147839|NCT03068507|Perioperative|perioperative
5147840|NCT03068507|functional capability|functional capability
5147841|NCT03068507|Prehabilitation|prehabilitation
5147842|NCT03068507|thoracoscopic lobectomy|thoracoscopic lobectomy
5147843|NCT03068507|Lung Cancer|lung cancer
5147844|NCT03068494|Coronary Bifurcation Lesion|coronary bifurcation lesion
5147845|NCT03068494|2nd generation drug-eluting stent|2nd generation drug-eluting stent
5147846|NCT03068442|Carotid artery|carotid artery
5147847|NCT03068442|MRI|mri
5147848|NCT03068442|PET|pet
5147849|NCT03068442|Intraplaque hemorrhage|intraplaque hemorrhage
5147850|NCT03068429|obsessive-compulsive disorder|obsessive-compulsive disorder
5147851|NCT03068429|fear conditioning|fear conditioning
5147852|NCT03068429|functional neuroimaging|functional neuroimaging
5147853|NCT03068429|sertraline|sertraline
5147854|NCT03068403|CEUS Perfusion|ceus perfusion
5147855|NCT03068403|Rectal Cancer|rectal cancer
5147856|NCT03068403|Tumor Perfusion|tumor perfusion
5143570|NCT03094273|Biopsy|biopsy
5147873|NCT03068299|Rural population|rural population
5147874|NCT03068273|Hospitalization|hospitalization
5147875|NCT03068260|caesarean section|caesarean section
5147876|NCT03068260|postoperative pain|postoperative pain
5147877|NCT03068260|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
5147878|NCT03068260|reduction of opioid consumption|reduction of opioid consumption
5147879|NCT03068208|Methylene blue|methylene blue
5147880|NCT03068208|photodynamic therapy|photodynamic therapy
5147881|NCT03068208|primary cutaneous localized amyloidosis|primary cutaneous localized amyloidosis
5147882|NCT03068208|lichen amyloidosis|lichen amyloidosis
5147884|NCT03068195|microwave|microwave
5147885|NCT03068195|ablation technique|ablation technique
5147886|NCT03068182|Exercise ,Autonomic cardiac function ,Adult subjects|exercise ,autonomic cardiac function ,adult subjects
5147887|NCT03068169|remote ECG|remote ecg
5147888|NCT03068169|atrial fibrillation|atrial fibrillation
5147889|NCT03068169|cardiac rehabilitation|cardiac rehabilitation
5147890|NCT03068169|cardiac resynchronization therapy|cardiac resynchronization therapy
5147891|NCT03068169|supraventricular tachycardia|supraventricular tachycardia
5147892|NCT03068156|308-nm excimer laser|308-nm excimer laser
5342968|NCT01981343|Ejection fraction|ejection fraction
5147893|NCT03068156|primary localized cutaneous amyloidosis|primary localized cutaneous amyloidosis
5147894|NCT03068156|lichen amyloidosis|lichen amyloidosis
5147895|NCT03068156|Asians|asians
5147896|NCT03068130|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5147897|NCT03068130|Pulmonary Hypertension|pulmonary hypertension
5147898|NCT03068130|PH|ph
5147899|NCT03068130|PAH|pah
5147900|NCT03068130|Bardoxolone methyl|bardoxolone methyl
5147901|NCT03068130|6-minute walk distance|6-minute walk distance
5147902|NCT03068130|CDDO-ME|cddo-me
5147903|NCT03068130|RTA 402|rta 402
5147904|NCT03068130|LARIAT|lariat
5147905|NCT03068130|CATALYST|catalyst
5147906|NCT03068130|RANGER|ranger
5147907|NCT03068117|Specialist Palliative Care|specialist palliative care
5147912|NCT03068117|Mesothelioma|mesothelioma
5147917|NCT03068091|Interstitial Lung Disease|interstitial lung disease
5147918|NCT03068091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5147919|NCT03068065|Liraglutide|liraglutide
5147920|NCT03068065|Metformin|metformin
5147921|NCT03068065|Gliclazide|gliclazide
5147923|NCT03068039|blood glucose|blood glucose
5147924|NCT03068039|porridge|porridge
5147925|NCT03068039|breakfast|breakfast
5147926|NCT03068039|satiety|satiety
5147927|NCT03068039|plasma peptides|plasma peptides
5147928|NCT03068026|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5147929|NCT03068026|Non-invasive ventilation|non-invasive ventilation
5147930|NCT03068013|CALM|calm
5147931|NCT03068013|Depression|depression
5147932|NCT03068013|Demoralization|demoralization
5147933|NCT03068013|Cancer|cancer
5147934|NCT03068013|Spirituality|spirituality
5147935|NCT03068013|Psychotherapy|psychotherapy
5147936|NCT03068013|Quality of Life|quality of life
5147937|NCT03068013|Anxiety|anxiety
5147938|NCT03068013|Post-Traumatic Growth|post-traumatic growth
5147939|NCT03068000|Martial arts|martial arts
5147940|NCT03068000|Judo|judo
5147941|NCT03068000|Motor skills|motor skills
5147942|NCT03068000|Physical fitness|physical fitness
5147943|NCT03068000|Cardiovascular parameters|cardiovascular parameters
5147944|NCT03068000|Quality of life|quality of life
5147945|NCT03068000|Physical Activity|physical activity
5147946|NCT03067974|ketamine|ketamine
5147947|NCT03067974|pediatric|pediatric
5147948|NCT03067974|procedural sedation|procedural sedation
5147949|NCT03067961|Enteric fever|enteric fever
5147954|NCT03067961|Typhoid toxin|typhoid toxin
5147955|NCT03067922|Mastectomy|mastectomy
5147956|NCT03067922|Pain|pain
5147957|NCT03067922|Severity|severity
5147958|NCT03067922|Life quality|life quality
5147959|NCT03067896|spinal block|spinal block
5147960|NCT03067896|stress response|stress response
5147961|NCT03067896|dexmedetomidine|dexmedetomidine
5147962|NCT03067896|intrathecally|intrathecally
5147963|NCT03067870|Stem cells|stem cells
5147964|NCT03067870|Rheumatoid arthritis|rheumatoid arthritis
5147965|NCT03067831|stem cells|stem cells
5147966|NCT03067818|arm|arm
5147967|NCT03067818|rehabilitation|rehabilitation
5147968|NCT03067818|non-invasive brain stimulation|non-invasive brain stimulation
5147969|NCT03067818|transcranial magnetic stimulation|transcranial magnetic stimulation
5147970|NCT03067818|upper extremity|upper extremity
5147971|NCT03067805|Oxytocin effect|oxytocin effect
5147972|NCT03067805|romantic jealousy|romantic jealousy
5147973|NCT03067805|Arousal Rating|arousal rating
5147974|NCT03067805|Jealousy Rating|jealousy rating
5147975|NCT03067792|inoperable gastric cancer|inoperable gastric cancer
5147976|NCT03067792|palliative chemotherapy|palliative chemotherapy
5147977|NCT03067740|appendicectomy|appendicectomy
5147978|NCT03067740|children|children
5147979|NCT03067740|local anesthetics|local anesthetics
5147980|NCT03067740|laparoscopy|laparoscopy
5147981|NCT03067740|peritoneum|peritoneum
5147982|NCT03067675|no known ocular pathology|no known ocular pathology
5147983|NCT03067623|Thin endometrium|thin endometrium
5147984|NCT03067623|Endometrial thickness|endometrial thickness
5147985|NCT03067584|Familial cancer|familial cancer
5147986|NCT03067584|Genetic predisposition|genetic predisposition
5147987|NCT03067584|Heritable disease|heritable disease
5147988|NCT03067584|Cancer risk|cancer risk
5147989|NCT03067584|Genome analysis|genome analysis
5147990|NCT03067584|Genetic modifiers|genetic modifiers
5147991|NCT03067584|Next generation sequencing (NGS)|next generation sequencing (ngs)
5147992|NCT03067584|Genetic counseling|genetic counseling
5147993|NCT03067584|DNA|dna
5147994|NCT03067558|Pneumonia|pneumonia
5147995|NCT03067558|Diagnostics|diagnostics
5147996|NCT03067558|Childhood|childhood
5147997|NCT03067558|Respiratory rate|respiratory rate
5147998|NCT03067558|Ethiopia|ethiopia
5147999|NCT03067506|Drug Therapy|drug therapy
5148000|NCT03067454|early mobilisation|early mobilisation
5148001|NCT03067454|metacarpal fracture|metacarpal fracture
5148002|NCT03067454|operation|operation
5148003|NCT03067441|hyperlipidemia|hyperlipidemia
5148004|NCT03067441|cholesterol|cholesterol
5148005|NCT03067441|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5148006|NCT03067441|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5148007|NCT03067441|ASCVD|ascvd
5148008|NCT03067441|HeFH|hefh
5148722|NCT03063437|capsule|capsule
5148012|NCT03067415|Glaucoma, Primary Open Angle|glaucoma, primary open angle
5148013|NCT03067415|Ocular hypertension|ocular hypertension
5148014|NCT03067415|CKD-351|ckd-351
5148015|NCT03067402|Myocardial Infarction|myocardial infarction
5148266|NCT03066258|nAMD|namd
5148016|NCT03067402|Physiological Stress Test|physiological stress test
5148017|NCT03067402|Nuclear Image Perfusion|nuclear image perfusion
5148018|NCT03067402|Angioplasty|angioplasty
5148019|NCT03067402|Coronary Artery Bypass Graft|coronary artery bypass graft
5148020|NCT03067402|Percutaneous Coronary Intervention|percutaneous coronary intervention
5148021|NCT03067402|Angina|angina
5148022|NCT03067402|Ischemia|ischemia
5148023|NCT03067376|Absorption, distribution, metabolism, and excretion (ADME)|absorption, distribution, metabolism, and excretion (adme)
5148024|NCT03067376|Metabolism|metabolism
5148025|NCT03067376|Metabolite Profiling|metabolite profiling
5148026|NCT03067376|Excretion|excretion
5148027|NCT03067350|voriconazole|voriconazole
5148028|NCT03067350|pharmacogenetics|pharmacogenetics
5148029|NCT03067350|pharmacokinetics|pharmacokinetics
5148030|NCT03067350|therapeutic drug monitoring|therapeutic drug monitoring
5148031|NCT03067337|Stainless Steel Crowns|stainless steel crowns
5148032|NCT03067337|Zirconia Crowns|zirconia crowns
5148033|NCT03067337|Aesthetic restorations|aesthetic restorations
5148034|NCT03067324|Islet Transplantation|islet transplantation
5148035|NCT03067298|pregnancy|pregnancy
5148036|NCT03067298|screening|screening
5148037|NCT03067298|doppler|doppler
5148038|NCT03067298|markers|markers
5148040|NCT03067298|sFlt-1|sflt-1
5148041|NCT03067298|placenta|placenta
5148042|NCT03067272|Permanent contraception|permanent contraception
5148043|NCT03067272|Birth control|birth control
5148044|NCT03067259|eldery patients|eldery patients
5148045|NCT03067259|cognitive impairment|cognitive impairment
5148046|NCT03067246|Supraglottic device|supraglottic device
5148047|NCT03067246|Fibre optic scope|fibre optic scope
5148048|NCT03067246|Endotracheal intubation|endotracheal intubation
5148049|NCT03067220|outpatients|outpatients
5148050|NCT03067220|general surgery|general surgery
5148051|NCT03067220|virtual clinic|virtual clinic
5148052|NCT03067220|patient satisfaction|patient satisfaction
5148053|NCT03067207|mindfulness meditation|mindfulness meditation
5148054|NCT03067207|Adolescent|adolescent
5148055|NCT03067207|eHealth|ehealth
5148056|NCT03067207|randomized trial|randomized trial
5148057|NCT03067194|Osteoarthritis Hand|osteoarthritis hand
5148058|NCT03067155|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5148059|NCT03067155|CMV reactivation|cmv reactivation
5148060|NCT03067129|Chronic Hepatitis C Virus|chronic hepatitis c virus
5148061|NCT03067129|Glecaprevir|glecaprevir
5148062|NCT03067129|Pibrentasvir|pibrentasvir
5148063|NCT03067129|Pharmacokinetic|pharmacokinetic
5148064|NCT03067129|Treatment naïve|treatment naïve
5148065|NCT03067129|Treatment experienced|treatment experienced
5148066|NCT03067129|Interferon (IFN)|interferon (ifn)
5148067|NCT03067129|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
5148068|NCT03067129|Ribavirin (RBV)|ribavirin (rbv)
5148069|NCT03067129|sofosbuvir|sofosbuvir
5148070|NCT03067129|Non-cirrhotic cirrhosis|non-cirrhotic cirrhosis
5148071|NCT03067129|Compensated (Child-Pugh A) cirrhosis|compensated (child-pugh a) cirrhosis
5148072|NCT03067116|balance, postural|balance, postural
5148073|NCT03067116|fall risk|fall risk
5148074|NCT03067116|anthropometrics|anthropometrics
5148075|NCT03067116|blood pressure|blood pressure
5148076|NCT03067116|SpO2|spo2
5148077|NCT03067116|heart rate|heart rate
5148078|NCT03067116|heart rate variability|heart rate variability
5148079|NCT03067116|stance width|stance width
5148080|NCT03067103|Adenotonsillectomy|adenotonsillectomy
5148081|NCT03067103|pain|pain
5148082|NCT03067103|topic analgesia|topic analgesia
5148083|NCT03067103|child|child
5148084|NCT03067077|SMILE|smile
5148085|NCT03067077|LASIK|lasik
5148086|NCT03067077|Myopia|myopia
5148087|NCT03067077|Wavefront-guided|wavefront-guided
5148088|NCT03067012|Oncometabolic surgery|oncometabolic surgery
5148089|NCT03067012|Long limb uncut Roux-en-Y gastrojejunostomy|long limb uncut roux-en-y gastrojejunostomy
5148090|NCT03067012|Obesity|obesity
5148091|NCT03067012|Diabetes|diabetes
5148092|NCT03067012|Early gastric cancer|early gastric cancer
5148093|NCT03066986|Venom anaphylaxis|venom anaphylaxis
5148094|NCT03066986|Myrmecia piluosa|myrmecia piluosa
5148095|NCT03066986|Immunological adjuvant|immunological adjuvant
5148096|NCT03066986|Immunotherapy|immunotherapy
5148097|NCT03066986|Jack jumper ant|jack jumper ant
5148098|NCT03066973|breath exercises|breath exercises
5148099|NCT03066973|labor pain|labor pain
5148100|NCT03066973|labor duration|labor duration
5148102|NCT03066960|radiofrequency neurotomy|radiofrequency neurotomy
5148103|NCT03066960|zygapophyseal joint|zygapophyseal joint
5148104|NCT03066934|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5148105|NCT03066934|Nasal high flow|nasal high flow
5148106|NCT03066934|Respiratory Failure|respiratory failure
5148107|NCT03066934|Childhood|childhood
5148108|NCT03066921|Lactic acid bacteria|lactic acid bacteria
5148109|NCT03066921|dyslipidemia uremic toxins|dyslipidemia uremic toxins
5148110|NCT03066921|Hemodialysis|hemodialysis
5148111|NCT03066908|Chronic Rhinosinusitis|chronic rhinosinusitis
5148112|NCT03066882|Caloric Restriction|caloric restriction
5148113|NCT03066882|Diet|diet
5148114|NCT03066882|Obesity|obesity
5148115|NCT03066882|Overweight|overweight
5148116|NCT03066882|Sedentary Lifestyle|sedentary lifestyle
5148117|NCT03066882|Weight loss|weight loss
5148118|NCT03066882|Women|women
5148119|NCT03066856|BRCA genes|brca genes
5148120|NCT03066856|Mutation carriers|mutation carriers
5148121|NCT03066856|IGF-I|igf-i
5148122|NCT03066856|Diet|diet
5148123|NCT03066817|Vitamin D|vitamin d
5148124|NCT03066817|Deficiency|deficiency
5148125|NCT03066817|Insufficiency|insufficiency
5148126|NCT03066817|Bone turnover|bone turnover
5148127|NCT03066817|Bone healing|bone healing
5148128|NCT03066817|Polytrauma|polytrauma
5148129|NCT03066804|Cardiovascular Diseases|cardiovascular diseases
5148130|NCT03066804|Heart Failure|heart failure
5148131|NCT03066804|Heart failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5148132|NCT03066804|NT-proBNP|nt-probnp
5148133|NCT03066804|6 MWT|6 mwt
5148134|NCT03066804|KCCQ|kccq
5148135|NCT03066804|SF-36|sf-36
5148136|NCT03066804|NYHA Class|nyha class
5148137|NCT03066804|LCZ696|lcz696
5148138|NCT03066804|Enalapril|enalapril
5148139|NCT03066804|Valsartan|valsartan
5148140|NCT03066804|Angiotensin-Converting Enzyme Inhibitors (ACEi)|angiotensin-converting enzyme inhibitors (acei)
5148141|NCT03066804|Angiotensin II Type 1 Receptor Blockers (ARB)|angiotensin ii type 1 receptor blockers (arb)
5148267|NCT03066258|wet AMD|wet amd
5148142|NCT03066804|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
5148143|NCT03066778|Extensive stage small cell lung cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
5848822|NCT00033163|Hepatitis B Virus|hepatitis b virus
5148145|NCT03066778|Programmed cell death-ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
5148147|NCT03066778|PDL1|pdl1
5148148|NCT03066726|Biophysical profile|biophysical profile
5143975|NCT03091777|BV|bv
5148153|NCT03066726|Fetal growth restriction|fetal growth restriction
5148154|NCT03066726|Pulsatility index|pulsatility index
5148155|NCT03066726|Estimated gestational age|estimated gestational age
5148156|NCT03066726|Doppler|doppler
5148157|NCT03066648|Acute Myeloid Leukemia|acute myeloid leukemia
5148158|NCT03066648|Myelodysplastic syndromes|myelodysplastic syndromes
5148159|NCT03066635|Nerve block|nerve block
5148160|NCT03066635|Ganglia, Parasympathetic|ganglia, parasympathetic
5148161|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a
5148162|NCT03066635|Injection|injection
5148163|NCT03066609|Plaque psoriasis|plaque psoriasis
5148164|NCT03066609|Secukinumab|secukinumab
5148165|NCT03066609|Skin condition|skin condition
5148166|NCT03066609|skin disease|skin disease
5148167|NCT03066609|itching|itching
5148168|NCT03066609|psoriasis vulgaris|psoriasis vulgaris
5148169|NCT03066609|immune-mediated systemic disease|immune-mediated systemic disease
5148170|NCT03066609|skin lesions|skin lesions
5148171|NCT03066609|scaly patches|scaly patches
5148172|NCT03066609|papules|papules
5148173|NCT03066609|psoriasis|psoriasis
5148174|NCT03066583|meniscus repair|meniscus repair
5148175|NCT03066583|platelet rich plasma|platelet rich plasma
5148176|NCT03066570|Graded Exposure|graded exposure
5148177|NCT03066570|Quality of Life|quality of life
5148178|NCT03066570|Physical Activity|physical activity
5148179|NCT03066570|Anxiety|anxiety
5148180|NCT03066557|Hepatocellular Carcinoma|hepatocellular carcinoma
5148181|NCT03066557|Apatinib|apatinib
5148182|NCT03066544|migraine|migraine
5148183|NCT03066544|responder|responder
5148184|NCT03066544|non-responder|non-responder
5148185|NCT03066544|treatment|treatment
5148186|NCT03066531|ACT|act
5148187|NCT03066531|CBT obesity|cbt obesity
5148188|NCT03066531|Eating disorders|eating disorders
5148189|NCT03066531|Health psychology|health psychology
5148190|NCT03066518|melatonin|melatonin
5148191|NCT03066518|sleep|sleep
5148192|NCT03066518|dementia|dementia
5148193|NCT03066518|cognition|cognition
5148194|NCT03066492|Tertiary Care Center|tertiary care center
5148195|NCT03066492|Patient Readmission|patient readmission
5148196|NCT03066492|Health Services Research|health services research
5148197|NCT03066492|Hospital Readmissions|hospital readmissions
5148198|NCT03066466|Acute Myeloid Leukemia|acute myeloid leukemia
5148199|NCT03066466|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5774461|NCT00224601|Coloscopy|coloscopy
5148200|NCT03066466|Myelodysplastic Syndrome|myelodysplastic syndrome
5148201|NCT03066466|BMT|bmt
5148202|NCT03066466|Matched unrelated donor transplant|matched unrelated donor transplant
5148203|NCT03066466|Graft versus Host Disease|graft versus host disease
5148204|NCT03066466|GVHD|gvhd
5148205|NCT03066453|cystic fibrosis, tobramycin, antibiotic courses, FEV1|cystic fibrosis, tobramycin, antibiotic courses, fev1
5148206|NCT03066440|diabetic ketoacidosis|diabetic ketoacidosis
5148207|NCT03066440|fluid management|fluid management
5148208|NCT03066440|hyperchloremia|hyperchloremia
5148215|NCT03066414|internal jugular vein|internal jugular vein
5148216|NCT03066414|ultrasound|ultrasound
5148217|NCT03066414|ultrasonography|ultrasonography
5148218|NCT03066414|echography|echography
5148219|NCT03066401|hyperferritinemia|hyperferritinemia
5148220|NCT03066401|dysmetabolic hyperferritinemia|dysmetabolic hyperferritinemia
5148221|NCT03066401|obese|obese
5148222|NCT03066401|blood withdrawal|blood withdrawal
5148223|NCT03066401|respiratory variations|respiratory variations
5148224|NCT03066401|inferior vena cava|inferior vena cava
5148225|NCT03066401|internal jugular vein|internal jugular vein
5148226|NCT03066401|ultrasound|ultrasound
5148227|NCT03066401|ultrasonography|ultrasonography
5148228|NCT03066401|echography|echography
5148229|NCT03066388|fluid|fluid
5148230|NCT03066388|fluid responsiveness|fluid responsiveness
5148231|NCT03066388|pulse pressure|pulse pressure
5148232|NCT03066388|noninvasive monitoring|noninvasive monitoring
5148233|NCT03066388|pulse pressure variations|pulse pressure variations
5148234|NCT03066388|volume expansion|volume expansion
5148235|NCT03066388|SIRS|sirs
5148236|NCT03066388|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5148237|NCT03066375|vena cava|vena cava
5148238|NCT03066375|fluid|fluid
5148239|NCT03066375|sepsis|sepsis
5148240|NCT03066375|echocardiography|echocardiography
5148241|NCT03066375|ultrasound|ultrasound
5148242|NCT03066375|ultrasonography|ultrasonography
5148243|NCT03066375|collapsibility index|collapsibility index
5148244|NCT03066375|circulatory failure|circulatory failure
5148245|NCT03066375|irregular cardiac rhythm|irregular cardiac rhythm
5148246|NCT03066375|fluid responsiveness|fluid responsiveness
5148251|NCT03066310|Urine|urine
5148252|NCT03066310|DNA biomarker|dna biomarker
5144045|NCT03091270|gliomas|gliomas
5148253|NCT03066310|Diagnosis|diagnosis
5148254|NCT03066297|Clinical stage IA non-small cell lung cancer|clinical stage ia non-small cell lung cancer
5148255|NCT03066297|Lobectomy|lobectomy
5148256|NCT03066297|Segmentectomy|segmentectomy
5148257|NCT03066297|Wedge resection|wedge resection
5148258|NCT03066297|Sublobar resection|sublobar resection
5148259|NCT03066297|Limited resection|limited resection
5148260|NCT03066284|Children|children
5148261|NCT03066284|Adolescents|adolescents
5148262|NCT03066284|Parents|parents
5148263|NCT03066284|Insulin Pump Therapy|insulin pump therapy
5148264|NCT03066271|Aerobic exercise|aerobic exercise
5148265|NCT03066271|Lung Cancer|lung cancer
5148268|NCT03066258|gene therapy|gene therapy
5034349|NCT03784638|pain|pain
5148269|NCT03066245|Aneurysmal bone cysts|aneurysmal bone cysts
5148270|NCT03066245|PLGA|plga
5148271|NCT03066245|Platelet Lysate|platelet lysate
5148272|NCT03066245|Bone marrow|bone marrow
5148273|NCT03066245|Mesenchymal stem cells|mesenchymal stem cells
5148274|NCT03066232|Delirium|delirium
5148275|NCT03066232|Dementia|dementia
5148276|NCT03066232|Physical function|physical function
5148285|NCT03066167|Cancer of the gastro-esophageal junction|cancer of the gastro-esophageal junction
5148286|NCT03066167|Watson score|watson score
5148287|NCT03066167|Ogilvie score|ogilvie score
5148288|NCT03066167|Goldschmid score|goldschmid score
5148289|NCT03066167|Validation|validation
5148290|NCT03066167|Quality of Life|quality of life
5148291|NCT03066154|High risk prostate cancer|high risk prostate cancer
5148292|NCT03066154|>T2cN+M0|>t2cn+m0
5148293|NCT03066128|Task shifting|task shifting
5148294|NCT03066128|HIV care|hiv care
5148295|NCT03066115|Cerebral blood flow|cerebral blood flow
5148296|NCT03066115|Cyclooxygenase|cyclooxygenase
5148297|NCT03066115|Nitric oxide synthase|nitric oxide synthase
5148298|NCT03066115|Reactive Oxygen Species|reactive oxygen species
5148299|NCT03066102|sensorimotor system|sensorimotor system
5148300|NCT03066102|scapular joint position sense|scapular joint position sense
5148301|NCT03066102|fatigue|fatigue
5148302|NCT03066089|FBS,HbA1C, PPBS|fbs,hba1c, ppbs
5148303|NCT03066050|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5148304|NCT03066050|Mitral Valve Disease|mitral valve disease
5148305|NCT03066050|Moderate Mitral Regurgitation|moderate mitral regurgitation
5148306|NCT03066050|Severe Mitral Regurgitation|severe mitral regurgitation
5148307|NCT03066037|regional-anaesthesiological infiltration|regional-anaesthesiological infiltration
5148308|NCT03066037|block series|block series
5148309|NCT03066037|invasive pain treatment|invasive pain treatment
5148310|NCT03066011|mold-active triazoles|mold-active triazoles
5148311|NCT03065972|kidney disease|kidney disease
5148312|NCT03065972|vascular access|vascular access
5148313|NCT03065972|graft|graft
5148314|NCT03065972|fistula|fistula
5148315|NCT03065972|hemodialysis|hemodialysis
5148316|NCT03065972|dialysis|dialysis
5148317|NCT03065959|CK-2127107|ck-2127107
5148318|NCT03065959|Mobility Limitation|mobility limitation
5148319|NCT03065959|Phase 1b|phase 1b
5148320|NCT03065959|skeletal muscle fatigue|skeletal muscle fatigue
5148321|NCT03065946|Therapeutic hypothermia|therapeutic hypothermia
5148322|NCT03065946|Electroencephalogram|electroencephalogram
5148323|NCT03065946|Neuron-Specific Enolase|neuron-specific enolase
5148324|NCT03065946|Return of Spontaneous Circulation|return of spontaneous circulation
5148325|NCT03065946|S-100B|s-100b
5148326|NCT03065933|mania|mania
5148327|NCT03065933|clonidine|clonidine
5148328|NCT03065933|bipolar disorder|bipolar disorder
5148329|NCT03065894|stratified care|stratified care
5148330|NCT03065894|psychologically informed practice|psychologically informed practice
5148331|NCT03065894|matched care|matched care
5148332|NCT03065868|gastric polyp|gastric polyp
5148333|NCT03065868|Helicobacter pylori eradication|helicobacter pylori eradication
5148334|NCT03065855|laparoscopic mesorectal excision|laparoscopic mesorectal excision
5148335|NCT03065855|rectal cancer|rectal cancer
5148336|NCT03065855|urinary distention|urinary distention
5148337|NCT03065842|Stigma|stigma
5148338|NCT03065842|Pregnancy|pregnancy
5148339|NCT03065842|Abortion|abortion
5148340|NCT03065842|Contraception|contraception
5148341|NCT03065842|Adolescence|adolescence
5148342|NCT03065829|caregiver|caregiver
5148343|NCT03065829|chronically critically ill|chronically critically ill
5148344|NCT03065777|single file.|single file.
5148345|NCT03065777|ONE ENDO.|one endo.
5148346|NCT03065777|F6 SkyTaper.|f6 skytaper.
5148347|NCT03065777|ProTaper Universal.|protaper universal.
5148348|NCT03065777|irreversible pulpitis.|irreversible pulpitis.
5148349|NCT03065777|postoperative pain.|postoperative pain.
5148350|NCT03065764|Pembrolizumab|pembrolizumab
5148351|NCT03065764|89Zirconium|89zirconium
5157370|NCT03008187|AML|aml
5148353|NCT03065738|knee arthroplasty|knee arthroplasty
5148354|NCT03065712|Breast Cancer|breast cancer
5148355|NCT03065712|PET/CT|pet/ct
5148356|NCT03065712|FES|fes
5148357|NCT03065712|18F Fluoroestradiol|18f fluoroestradiol
5148358|NCT03065712|Breast|breast
5148359|NCT03065699|Medical device|medical device
5148360|NCT03065699|Liver dialysis|liver dialysis
5148361|NCT03065699|Haemofilter|haemofilter
5148362|NCT03065699|ACLF|aclf
5148363|NCT03065686|Cleft Lip and Palate|cleft lip and palate
5148365|NCT03065686|WES|wes
5148366|NCT03065673|Tooth bleaching|tooth bleaching
5148367|NCT03065673|Tooth sensitivity|tooth sensitivity
5148368|NCT03065660|Missed miscarriage|missed miscarriage
5148369|NCT03065660|Mifepristone|mifepristone
5148370|NCT03065660|Misoprostol|misoprostol
5148371|NCT03065660|Medical management|medical management
5148372|NCT03065647|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5148373|NCT03065647|Cardiac Arrest|cardiac arrest
5148374|NCT03065647|Heart Arrest|heart arrest
5148375|NCT03065647|Sudden Cardiac Arrest|sudden cardiac arrest
5148376|NCT03065647|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5148377|NCT03065647|Extracorporeal Cardiopulmonary Resuscitation|extracorporeal cardiopulmonary resuscitation
5148378|NCT03065647|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5148379|NCT03065647|CPR|cpr
5148380|NCT03065647|ECPR|ecpr
5148381|NCT03065647|ECMO|ecmo
5148382|NCT03065647|Emergency Medical Services|emergency medical services
5148383|NCT03065647|EMS|ems
5148384|NCT03065647|OHCA|ohca
5148385|NCT03065621|Breast|breast
5148386|NCT03065595|Ophiocephalus striatus|ophiocephalus striatus
5148387|NCT03065595|IGF-1|igf-1
5148388|NCT03065595|hypoalbuminemia|hypoalbuminemia
5148389|NCT03065595|MNA score|mna score
5148390|NCT03065595|elderly|elderly
5148391|NCT03065543|Hyperlipidemias|hyperlipidemias
5148392|NCT03065543|Secondary prevention|secondary prevention
5148393|NCT03065543|high risk patients|high risk patients
5148394|NCT03065543|very high risk patients|very high risk patients
5148395|NCT03065530|Dexmedetomidine|dexmedetomidine
5148396|NCT03065530|Butorphanol tartrate|butorphanol tartrate
5148397|NCT03065530|Analgesia|analgesia
5148398|NCT03065530|Breastfeeding|breastfeeding
5148399|NCT03065530|Relative infant dose|relative infant dose
5148400|NCT03065517|Criminal Justice|criminal justice
5148401|NCT03065517|Juvenile Delinquency|juvenile delinquency
5148402|NCT03065491|Red yeast rice|red yeast rice
5148403|NCT03065491|Phytosterols|phytosterols
5148404|NCT03065491|L-Tyrosol|l-tyrosol
5148406|NCT03065491|LDL-cholesterol|ldl-cholesterol
5148407|NCT03065491|Endothelial function|endothelial function
5148408|NCT03065478|Peripheral Neuropathy|peripheral neuropathy
5148409|NCT03065478|Chemotherapy induced|chemotherapy induced
5148410|NCT03065478|CIPN|cipn
5148411|NCT03065465|Upper GI hemorrhage|upper gi hemorrhage
5148412|NCT03065465|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
5774462|NCT00224601|Chromoscopy|chromoscopy
5148413|NCT03065465|Diverticular Hemorrhage|diverticular hemorrhage
5148414|NCT03065465|Ulcers|ulcers
5148415|NCT03065400|Myelofibrosis|myelofibrosis
5148416|NCT03065400|Acute Leukemia|acute leukemia
5148417|NCT03065361|Chronic Kidney Disease|chronic kidney disease
5148418|NCT03065361|Handgrip Strength|handgrip strength
5148419|NCT03065361|Fine Motor Skills|fine motor skills
5148420|NCT03065361|Sensitivity|sensitivity
5148421|NCT03065348|prehabilitation|prehabilitation
5148422|NCT03065348|nutrition|nutrition
5148423|NCT03065348|hydration|hydration
5148424|NCT03065348|cystectomy and urinary diversion|cystectomy and urinary diversion
5148425|NCT03065348|regional anesthesia|regional anesthesia
5148426|NCT03065348|cognition|cognition
5148427|NCT03065335|Magnetic Resonance Imaging|magnetic resonance imaging
5148428|NCT03065335|Magnetoencephalography|magnetoencephalography
5148429|NCT03065335|Major Depressive Disorder|major depressive disorder
5148430|NCT03065335|Ketamine|ketamine
5148431|NCT03065335|Neuropharmacology|neuropharmacology
5148432|NCT03065322|PCOS|pcos
5148433|NCT03065322|OSA|osa
5148434|NCT03065296|Behavior|behavior
5148435|NCT03065296|education|education
5148436|NCT03065296|medical residents|medical residents
5148437|NCT03065296|knowledge|knowledge
5148438|NCT03065296|confidence|confidence
5148439|NCT03065296|skills assessment|skills assessment
5148440|NCT03065257|EMR|emr
5148441|NCT03065257|ESD|esd
5148442|NCT03065257|Resection|resection
5148443|NCT03065257|STER|ster
5148444|NCT03065257|EFTR|eftr
5148445|NCT03065257|Submucosal dissection|submucosal dissection
5148446|NCT03065257|Endoscopic resection|endoscopic resection
5148447|NCT03065244|Kawasaki disease|kawasaki disease
5148448|NCT03065218|Thyroid|thyroid
5148449|NCT03065218|sestamibi|sestamibi
5148450|NCT03065192|Gene Therapy|gene therapy
5148451|NCT03065192|PD|pd
5148452|NCT03065192|Parkinson's Disease|parkinson's disease
5148453|NCT03065192|Aromatic L- Amino Acid Decarboxylase|aromatic l- amino acid decarboxylase
5148454|NCT03065192|AADC|aadc
5020380|NCT03869905|Remission|remission
5148455|NCT03065192|AAV2-AADC|aav2-aadc
5148458|NCT03065192|Gene Transfer|gene transfer
5148459|NCT03065192|MRI|mri
5148460|NCT03065192|PET|pet
5148461|NCT03065192|VY-AADC01|vy-aadc01
5148462|NCT03065153|Torso|torso
5148463|NCT03065153|Trunk|trunk
5148464|NCT03065088|Exercise|exercise
5148465|NCT03065088|Feasibility Studies|feasibility studies
5148466|NCT03065088|Healthy Lifestyle|healthy lifestyle
5148467|NCT03065088|Health Promotion|health promotion
5148468|NCT03065088|Health Behavior|health behavior
5148469|NCT03065088|Aging|aging
5148470|NCT03065088|Activities of Daily Living|activities of daily living
5148474|NCT03065062|Neoplasms|neoplasms
5148475|NCT03065062|Endometrial Cancer|endometrial cancer
5148476|NCT03065049|Physical Activity|physical activity
5148477|NCT03065049|Peer-facilitation|peer-facilitation
5148478|NCT03065049|Methadone Maintenance Therapy|methadone maintenance therapy
5148479|NCT03065036|Primary Open Angle Glaucoma|primary open angle glaucoma
5148480|NCT03065036|POAG|poag
5148481|NCT03065023|Advanced tumor|advanced tumor
5148482|NCT03065023|Intratumoral injection|intratumoral injection
5148483|NCT03065023|Intralesional injection|intralesional injection
5148484|NCT03064997|prebiotic|prebiotic
5148485|NCT03064997|pediatric patients|pediatric patients
5148486|NCT03064997|health status|health status
5148487|NCT03064997|intestine permeability|intestine permeability
5148488|NCT03064971|Quitline|quitline
5148489|NCT03064971|culturally specific|culturally specific
5148490|NCT03064958|glucose regulation|glucose regulation
5148491|NCT03064958|lipids|lipids
5148492|NCT03064958|Immune markers|immune markers
5148493|NCT03064958|Endothelium, Vascular|endothelium, vascular
5148494|NCT03064945|Livia TENS|livia tens
5148495|NCT03064945|safety and efficacy|safety and efficacy
5148496|NCT03064945|menstruating women|menstruating women
5148497|NCT03064919|hunger and fullness|hunger and fullness
5148498|NCT03064919|regulation of energy intake|regulation of energy intake
5148499|NCT03064919|energy compensation|energy compensation
5148500|NCT03064919|nutrition knowledge|nutrition knowledge
5148501|NCT03064906|T1D, Omnipod|t1d, omnipod
5148502|NCT03064880|Thoracic surgery|thoracic surgery
5148503|NCT03064880|Fluid responsiveness|fluid responsiveness
5148504|NCT03064880|Hemodynamics|hemodynamics
5148505|NCT03064880|Oxidative stress|oxidative stress
5148506|NCT03064880|Goal-directed fluid therapy|goal-directed fluid therapy
5148507|NCT03064867|venetoclax|venetoclax
5148508|NCT03064867|rituximab|rituximab
5148509|NCT03064867|ifosfamide|ifosfamide
5148510|NCT03064867|carboplatin|carboplatin
5148511|NCT03064867|etoposide|etoposide
5148512|NCT03064854|PDR001|pdr001
5148513|NCT03064854|immunotherapy|immunotherapy
5148514|NCT03064854|Non-small cell lung cancer|non-small cell lung cancer
5148515|NCT03064854|lung|lung
5148516|NCT03064854|NSCLC|nsclc
5148517|NCT03064802|BioBurst|bioburst
5148518|NCT03064802|Spinal Fusion|spinal fusion
5148519|NCT03064802|Cellular Allograft|cellular allograft
5148520|NCT03064789|Candidiases|candidiases
5148526|NCT03064750|Preoperative Care|preoperative care
5148527|NCT03064724|smoking|smoking
5148528|NCT03064724|tobacco use|tobacco use
5148529|NCT03064724|Asian|asian
5148530|NCT03064724|patients|patients
5148531|NCT03064724|provider advice|provider advice
5148532|NCT03064724|digital health intervention|digital health intervention
5148533|NCT03064685|Pyogenic Liver abscess|pyogenic liver abscess
5148534|NCT03064685|Liver transplantation|liver transplantation
5148535|NCT03064685|Biliary disease|biliary disease
5148536|NCT03064659|Postoperative pulmonary complications|postoperative pulmonary complications
5148537|NCT03064659|Driving Pressure|driving pressure
5148538|NCT03064659|Limitation of Expiratory Flow|limitation of expiratory flow
5148539|NCT03064659|Cardiac Surgery|cardiac surgery
5148540|NCT03064659|Cardio-pulmonary bypass|cardio-pulmonary bypass
5148541|NCT03064646|ORGAN PRESERVATION|organ preservation
5148542|NCT03064646|WATCH AND WAIT|watch and wait
5148543|NCT03064646|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
5148544|NCT03064633|Dexamethasone|dexamethasone
5148545|NCT03064633|Dexmedetomidine|dexmedetomidine
5148546|NCT03064633|Transversus abdominis plane block|transversus abdominis plane block
5148547|NCT03064633|Local anesthetic adjuvants|local anesthetic adjuvants
5148548|NCT03064633|postoperative pain|postoperative pain
5148549|NCT03064620|PCV effects|pcv effects
5148550|NCT03064620|S. pneumoniae carriage|s. pneumoniae carriage
5148551|NCT03064620|S. aureus carriage|s. aureus carriage
5148552|NCT03064620|Indirect vaccination effects|indirect vaccination effects
5148553|NCT03064620|Palestinian-Israeli Collaborative Research (PICR)|palestinian-israeli collaborative research (picr)
5148554|NCT03064607|Neonates|neonates
5148555|NCT03064607|biomarkers|biomarkers
5148556|NCT03064607|EXIT procedure|exit procedure
5148557|NCT03064607|Cesarean Section|cesarean section
5148558|NCT03064581|Cervical Cancer|cervical cancer
5148559|NCT03064581|Screening|screening
5148561|NCT03064581|Pacific Islander Americans|pacific islander americans
5356853|NCT01917734|Madhya Pradesh|madhya pradesh
5369146|NCT01861106|Haploidentical|haploidentical
5962079|NCT04283149|Phakic intraocular lens (IOL)|phakic intraocular lens (iol)
5020508|NCT03869034|PD-1 Inhibitor|pd-1 inhibitor
5148562|NCT03064568|Myomectomy, Misoprostol, Vasopressin, Blood loss|myomectomy, misoprostol, vasopressin, blood loss
5148571|NCT03064503|cardiac function|cardiac function
5148573|NCT03064477|Unified Protocol|unified protocol
5148574|NCT03064477|Transdiagnostic approach|transdiagnostic approach
5148575|NCT03064477|Public health|public health
5148576|NCT03064464|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5148577|NCT03064451|persistent atrial fibrillation - ablation procedure|persistent atrial fibrillation - ablation procedure
5148578|NCT03064373|S. aureus|s. aureus
5148579|NCT03064373|carriage|carriage
5148580|NCT03064373|mother-neonatal transmission|mother-neonatal transmission
5148581|NCT03064373|microbiome|microbiome
5148582|NCT03064347|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5148584|NCT03064347|Nutrient|nutrient
5148585|NCT03064321|cognitive behavioral treatment|cognitive behavioral treatment
5148586|NCT03064308|Frailty|frailty
5148587|NCT03064308|Surgery|surgery
5148588|NCT03064308|Physical function|physical function
5148589|NCT03064308|Cognitive function|cognitive function
5148590|NCT03064308|Quality of life|quality of life
5148591|NCT03064308|Exercise|exercise
5148592|NCT03064308|Rehabilitation|rehabilitation
5148593|NCT03064308|Delirium|delirium
5148594|NCT03064308|Morbidity|morbidity
5148595|NCT03064308|Mortality|mortality
5148596|NCT03064308|Length of stay|length of stay
5148597|NCT03064308|Well-being|well-being
5148598|NCT03064308|Elderly|elderly
5148599|NCT03064308|Older surgical patient|older surgical patient
5148600|NCT03064308|Radical prostatectomy|radical prostatectomy
5148601|NCT03064308|Radical cystectomy|radical cystectomy
5148602|NCT03064308|Radical cystoprostatectomy|radical cystoprostatectomy
5148603|NCT03064308|Aortic Aneurysm Repair|aortic aneurysm repair
5148604|NCT03064308|Major Cavity Surgery|major cavity surgery
5148605|NCT03064308|Abdominal Surgery|abdominal surgery
5148606|NCT03064308|Recovery|recovery
5148607|NCT03064308|Nephrectomy|nephrectomy
5148608|NCT03064269|CNS B cell acute lymphocytic leukemia|cns b cell acute lymphocytic leukemia
5148609|NCT03064256|Exercisy therapy|exercisy therapy
5148610|NCT03064256|Hypertension|hypertension
5148611|NCT03064256|Physiopathology|physiopathology
5148612|NCT03064256|Heart rate|heart rate
5148613|NCT03064256|Nonlinear dynamics|nonlinear dynamics
5148614|NCT03064217|Clinical crown lengthening|clinical crown lengthening
5148615|NCT03064217|intraoral imaging|intraoral imaging
5148616|NCT03064217|Emax crown|emax crown
5148617|NCT03064191|intra-canal medications|intra-canal medications
5148618|NCT03064178|periodontal therapy|periodontal therapy
5148619|NCT03064178|anticipated pain|anticipated pain
5148620|NCT03064178|experienced pain|experienced pain
5148621|NCT03064178|pain medication use|pain medication use
5148622|NCT03064139|physical activity|physical activity
5148623|NCT03064139|gait|gait
5148624|NCT03064139|biomechanics|biomechanics
5219201|NCT02628223|SLT|slt
5148625|NCT03064139|mindfulness|mindfulness
5148626|NCT03064126|Artery|artery
5148627|NCT03064126|Atherosclerosis|atherosclerosis
5148628|NCT03064126|Arterial|arterial
5148629|NCT03064126|Peripheral|peripheral
5148630|NCT03064126|Plaque|plaque
5148631|NCT03064126|Angioplasty|angioplasty
5148632|NCT03064126|PTA|pta
5148633|NCT03064113|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5148634|NCT03064087|Self-Sampling|self-sampling
5148635|NCT03064087|HPV Testing|hpv testing
5148636|NCT03064087|Diagnostic Test Accuracy|diagnostic test accuracy
5148637|NCT03064087|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5148638|NCT03064087|Urine|urine
5148639|NCT03064087|Cervical Cancer Screening|cervical cancer screening
5148640|NCT03064048|Argininosuccinate Lyase Deficiency|argininosuccinate lyase deficiency
5148641|NCT03064048|Urea Cycle Disorder|urea cycle disorder
5148642|NCT03064022|weight gain|weight gain
5148643|NCT03064022|head circumference|head circumference
5148644|NCT03064022|length|length
5148645|NCT03064022|neurodevelopment|neurodevelopment
5148646|NCT03063983|osteosarcoma|osteosarcoma
5148647|NCT03063983|metastatic|metastatic
5148648|NCT03063983|metronomic therapy|metronomic therapy
5148649|NCT03063970|Upper extremity|upper extremity
5148650|NCT03063970|Rehabilitation|rehabilitation
5148651|NCT03063931|Breast cancer|breast cancer
5148652|NCT03063931|Mastectomy|mastectomy
5148653|NCT03063931|Pain|pain
5148654|NCT03063931|Anxiety and Depression|anxiety and depression
5148655|NCT03063931|Cognition|cognition
5148656|NCT03063931|Quality of life|quality of life
5148657|NCT03063905|Opioid related disorders|opioid related disorders
5148658|NCT03063905|Narcotic abuse|narcotic abuse
5148659|NCT03063879|hepatitis C|hepatitis c
5148660|NCT03063879|renal failure|renal failure
5148661|NCT03063879|sofosbuvir|sofosbuvir
5148662|NCT03063879|daclatasvir|daclatasvir
5148663|NCT03063840|hepatocellular carcinoma|hepatocellular carcinoma
5148664|NCT03063840|microwave ablation|microwave ablation
5962080|NCT04283149|ICL|icl
5148665|NCT03063840|liver cancer|liver cancer
5034821|NCT03781661|CCTA|ccta
5148667|NCT03063801|Blood products transfusion|blood products transfusion
5962081|NCT04283149|Toric ICL|toric icl
5962082|NCT04283149|EVO|evo
5020668|NCT03867656|CTX|ctx
5148668|NCT03063762|Renal Cell Carcinoma|renal cell carcinoma
5148669|NCT03063762|RO6874281|ro6874281
5148670|NCT03063762|Atezolizumab|atezolizumab
5148671|NCT03063762|Bevacizumab|bevacizumab
5148672|NCT03063723|Chronic Hepatitis C|chronic hepatitis c
5148673|NCT03063723|Monocytes|monocytes
5148674|NCT03063723|Nk cells|nk cells
5148675|NCT03063723|direct-acting antiviral agents|direct-acting antiviral agents
5148676|NCT03063697|Carvedilol SR Cap|carvedilol sr cap
5148677|NCT03063697|Essential hypertension|essential hypertension
5148678|NCT03063697|Chronic stable angina|chronic stable angina
5148679|NCT03063697|Congestive heart failure|congestive heart failure
5148686|NCT03063645|Healthy volunteer|healthy volunteer
5148687|NCT03063645|AC-1202|ac-1202
5148688|NCT03063645|AC-SD-01|ac-sd-01
5148689|NCT03063645|Pharacokinetic|pharacokinetic
5148690|NCT03063645|ketone body|ketone body
5148691|NCT03063554|Endoscopy|endoscopy
5148692|NCT03063554|Pancreatic Cancer|pancreatic cancer
5148693|NCT03063554|Bile duct|bile duct
5148694|NCT03063554|Periampullary|periampullary
5148695|NCT03063554|ERCP|ercp
5148696|NCT03063554|Biliary drainage|biliary drainage
5148697|NCT03063554|Biliary obstruction|biliary obstruction
5148698|NCT03063554|EUSBD|eusbd
5148699|NCT03063554|TEUS|teus
5148700|NCT03063554|EUS|eus
5148701|NCT03063554|Endoscopic Ultrasound|endoscopic ultrasound
5148702|NCT03063528|Pregnancy|pregnancy
5148703|NCT03063528|Weight|weight
5148704|NCT03063528|Gestational weight gain|gestational weight gain
5148705|NCT03063528|Stress reduction|stress reduction
5148706|NCT03063528|Exercise|exercise
5148707|NCT03063515|Insulin secretion|insulin secretion
5148708|NCT03063450|anti PD-L1|anti pd-l1
5148709|NCT03063450|nivolumab|nivolumab
5148710|NCT03063450|immunotherapy|immunotherapy
5148711|NCT03063450|RECIST|recist
5148712|NCT03063450|quality of life|quality of life
5148713|NCT03063450|survival|survival
5148714|NCT03063450|immune checkpoint inhibition|immune checkpoint inhibition
5148715|NCT03063437|vancomycin resistant enterococcus|vancomycin resistant enterococcus
5148716|NCT03063437|VRE|vre
5148717|NCT03063437|decolonization|decolonization
5148718|NCT03063437|VRE colonization|vre colonization
5148719|NCT03063437|fecal microbiota transplantation|fecal microbiota transplantation
5148720|NCT03063437|FMT|fmt
5148721|NCT03063437|FMT capsule|fmt capsule
5148723|NCT03063437|antimicrobial resistance|antimicrobial resistance
5148724|NCT03063437|antibiotic resistance|antibiotic resistance
5148725|NCT03063437|MDRO|mdro
5148726|NCT03063437|multidrug-resistant organism|multidrug-resistant organism
5148727|NCT03063437|OpenBiome|openbiome
5148728|NCT03063424|isocapnic voluntary hyperventilation|isocapnic voluntary hyperventilation
5148729|NCT03063424|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
5148730|NCT03063424|exercise induced bronchoconstriction|exercise induced bronchoconstriction
5148731|NCT03063424|exercise challenge cycle ergometer|exercise challenge cycle ergometer
5148732|NCT03063411|Maths reasoning|maths reasoning
5148733|NCT03063411|Working memory|working memory
5148734|NCT03063411|Executive Functions|executive functions
5148735|NCT03063411|Cognitive Control|cognitive control
5148736|NCT03063411|Academic Skills|academic skills
5148737|NCT03063411|Randomised Control Trial|randomised control trial
5148738|NCT03063385|Adolescents|adolescents
5148739|NCT03063385|Parents|parents
5148740|NCT03063385|Web-based|web-based
5148741|NCT03063385|Puerto Rico|puerto rico
5148742|NCT03063385|Latino|latino
5148743|NCT03063385|Sexual communication|sexual communication
5148744|NCT03063385|Stigma|stigma
5148745|NCT03063385|Randomized controlled trial|randomized controlled trial
5148747|NCT03063385|Intercourse|intercourse
5148748|NCT03063385|Sexual behavior|sexual behavior
5148749|NCT03063385|HIV/AIDS|hiv/aids
5148750|NCT03063372|Pomegranate|pomegranate
5148751|NCT03063372|Burnout|burnout
5148752|NCT03063372|Psychological Distress|psychological distress
5148753|NCT03063372|Antioxidant|antioxidant
5148754|NCT03063359|traumatic pain|traumatic pain
5148755|NCT03063359|children|children
5148756|NCT03063359|fentanyl|fentanyl
5148757|NCT03063359|intranasal use|intranasal use
5148758|NCT03063333|spinal cord injury|spinal cord injury
5148759|NCT03063333|hypnosis|hypnosis
5148760|NCT03063333|pain|pain
5148761|NCT03063333|pain catastrophizing|pain catastrophizing
5148762|NCT03063333|coping|coping
5148763|NCT03063307|Tooth, Deciduous|tooth, deciduous
5148764|NCT03063307|Dental Caries|dental caries
5148765|NCT03063307|Glass Ionomer Cements|glass ionomer cements
5148766|NCT03063307|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5148767|NCT03063307|Cariostatic Agents|cariostatic agents
5148768|NCT03063307|Fluorides|fluorides
5148769|NCT03063294|Coordination, Administrative|coordination, administrative
5148770|NCT03063294|Coaching|coaching
5148771|NCT03063294|Primary Care|primary care
5148772|NCT03063294|Quality Improvement|quality improvement
5962083|NCT04283149|EVO+|evo+
5148773|NCT03063281|ficolin-2|ficolin-2
5148774|NCT03063281|anti-ficolin-2 antibodies|anti-ficolin-2 antibodies
5148775|NCT03063281|lupus nephritis|lupus nephritis
5148776|NCT03063281|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5148777|NCT03063281|biomarker|biomarker
5148778|NCT03063281|ficolin-3|ficolin-3
5148784|NCT03063268|Electronic Medical Records (EMR)|electronic medical records (emr)
5148785|NCT03063268|Electronic Health Records (EHR)|electronic health records (ehr)
5148786|NCT03063268|Informed Consent Form|informed consent form
5148787|NCT03063268|Interactive Consent|interactive consent
5148788|NCT03063268|Health Record Data|health record data
5148789|NCT03063242|Sargramostim|sargramostim
5148790|NCT03063229|Insulin Pump Therapy|insulin pump therapy
5148791|NCT03063229|Islet Cell Transplant|islet cell transplant
5148792|NCT03063229|Energy Expenditure|energy expenditure
5148793|NCT03063177|chronic thoracic pain|chronic thoracic pain
5148794|NCT03063177|spine stiffness|spine stiffness
5148795|NCT03063177|spinal manipulation|spinal manipulation
5148796|NCT03063177|spinal manipulative therapy|spinal manipulative therapy
5148797|NCT03063164|Femtosecond laser|femtosecond laser
5148799|NCT03063164|Intralase IFS150|intralase ifs150
5148800|NCT03063164|LASIK|lasik
5148801|NCT03063138|Diabetic foot ulcer|diabetic foot ulcer
5148802|NCT03063138|Measurement|measurement
5148803|NCT03063138|Wound healing|wound healing
5148804|NCT03063138|Measurement device|measurement device
5148805|NCT03063138|Three-dimensional measurements|three-dimensional measurements
5148806|NCT03063125|radical cystectomy|radical cystectomy
5148807|NCT03063125|hypogonadism|hypogonadism
5148808|NCT03063008|Lumbar spine; Fusion; Titanium; PEEK|lumbar spine; fusion; titanium; peek
5148809|NCT03062930|stroke|stroke
5148810|NCT03062930|hemiparesis|hemiparesis
5148811|NCT03062930|lesion hemisphere|lesion hemisphere
5148812|NCT03062930|ipsilesional deficits|ipsilesional deficits
5148813|NCT03062930|contralesional deficits|contralesional deficits
5148814|NCT03062930|rehabilitation|rehabilitation
5148815|NCT03062930|remediation|remediation
5148816|NCT03062930|paretic arm|paretic arm
5148817|NCT03062904|healthy|healthy
5148818|NCT03062904|respiratory system|respiratory system
5148819|NCT03062904|ventilation|ventilation
5148820|NCT03062904|paradoxical effect|paradoxical effect
5148821|NCT03062904|methacholine|methacholine
5148822|NCT03062904|bronchodilator|bronchodilator
5148823|NCT03062904|NEP|nep
5148824|NCT03062904|EFL|efl
5148825|NCT03062865|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5219465|NCT02626975|MRI|mri
5148826|NCT03062865|TNF-alpha inhibitors|tnf-alpha inhibitors
5148827|NCT03062852|Medication Errors/prevention & control|medication errors/prevention & control
5148828|NCT03062852|Nursing Staff, Hospital/organization & administration|nursing staff, hospital/organization & administration
5148829|NCT03062852|Drug Therapy/nursing|drug therapy/nursing
5148830|NCT03062852|Safety Management|safety management
5148831|NCT03062852|Medication Systems, Hospital/organization & administration|medication systems, hospital/organization & administration
5148832|NCT03062826|OCT|oct
5148833|NCT03062826|STEMI|stemi
5148834|NCT03062813|Hepatitis B virus, tacrolimus,membranous nephropathy|hepatitis b virus, tacrolimus,membranous nephropathy
5148835|NCT03062800|thalidomide|thalidomide
5148836|NCT03062800|pemetrexed|pemetrexed
5148837|NCT03062800|nsclc|nsclc
5148838|NCT03062800|maintenance treatment|maintenance treatment
5148839|NCT03062722|microsurgical treatment|microsurgical treatment
5148840|NCT03062722|pain|pain
5148841|NCT03062722|dexterity|dexterity
5148842|NCT03062722|Phalen sign|phalen sign
5148843|NCT03062722|functional status|functional status
5148844|NCT03062709|tobacco cessation|tobacco cessation
5148845|NCT03062709|bronchiolitis|bronchiolitis
5148846|NCT03062709|pneumonia|pneumonia
5148847|NCT03062709|pediatric|pediatric
5148848|NCT03062709|environmental tobacco smoke|environmental tobacco smoke
5148849|NCT03062709|secondhand tobacco smoke|secondhand tobacco smoke
5148850|NCT03062709|thirdhand tobacco smoke|thirdhand tobacco smoke
5148851|NCT03062709|tobacco smoke|tobacco smoke
5148852|NCT03062709|asthma|asthma
5148853|NCT03062709|reactive airway disease|reactive airway disease
5148854|NCT03062709|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5148855|NCT03062683|lactate|lactate
5148856|NCT03062683|syncope|syncope
5148857|NCT03062644|Open Total or Subtotal Abdominal Hysterectomy|open total or subtotal abdominal hysterectomy
5148858|NCT03062631|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
5148859|NCT03062631|Lambert-Eaton Myasthenic Syndrome|lambert-eaton myasthenic syndrome
5148860|NCT03062631|3,4 DAP|3,4 dap
5148861|NCT03062631|3,4 Diaminopyridine|3,4 diaminopyridine
5148862|NCT03062592|incretin|incretin
5148863|NCT03062592|insulin|insulin
5148864|NCT03062592|glucose|glucose
5148867|NCT03062566|biomarkers|biomarkers
5356854|NCT01917734|India|india
5148868|NCT03062566|point-of-care analysis|point-of-care analysis
5148869|NCT03062540|PTSD|ptsd
5148870|NCT03062540|Military-related PTSD|military-related ptsd
5148871|NCT03062527|Nutrition|nutrition
5144646|NCT03087656|Ceftriaxone|ceftriaxone
5148874|NCT03062527|Moderate Glycemic Index|moderate glycemic index
5148876|NCT03062527|Running|running
5148877|NCT03062449|L-Serine, Alzheimer's Disease, AD, Memory,|l-serine, alzheimer's disease, ad, memory,
5148878|NCT03062436|CML, treatment free remission|cml, treatment free remission
5962084|NCT04283149|Visian|visian
5148879|NCT03062410|Health Related Quality of Life|health related quality of life
5148880|NCT03062410|Routine clinical practice|routine clinical practice
5148881|NCT03062410|Electronic Patient Reported Outcome|electronic patient reported outcome
5148882|NCT03062410|EORTC QLQ-C30|eortc qlq-c30
5148883|NCT03062410|Pazopanib|pazopanib
5148884|NCT03062410|Sunitinib|sunitinib
5148885|NCT03062410|Tyrosine Kinase Inhibitor anti-VEGF|tyrosine kinase inhibitor anti-vegf
5148886|NCT03062410|Patient Reported Outcome|patient reported outcome
5148887|NCT03062410|Supportive Care|supportive care
5148888|NCT03062410|Quality of Life|quality of life
5148889|NCT03062384|brain|brain
5148890|NCT03062384|health|health
5148891|NCT03062358|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5148892|NCT03062358|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5148893|NCT03062358|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
5148894|NCT03062358|PD1|pd1
5148895|NCT03062358|PD-1|pd-1
5148896|NCT03062358|PDL1|pdl1
5148897|NCT03062358|PD-L1|pd-l1
5148898|NCT03062358|PDL2|pdl2
5148899|NCT03062345|Stroke|stroke
5148900|NCT03062345|Virtual Reality Therapy|virtual reality therapy
5148901|NCT03062345|Rehabilitation|rehabilitation
5148902|NCT03062345|Upper Extremity|upper extremity
5148903|NCT03062345|Arm|arm
5148904|NCT03062345|Telerehabilitation|telerehabilitation
5148905|NCT03062319|anticoagulant|anticoagulant
5148906|NCT03062319|antiplatelet|antiplatelet
5148907|NCT03062306|Cerebral Oxygenation|cerebral oxygenation
5148908|NCT03062306|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5148909|NCT03062306|Chest Compression|chest compression
5148910|NCT03062293|Lumbo-pelvic muscles|lumbo-pelvic muscles
5148911|NCT03062293|Rehabilitation|rehabilitation
5148912|NCT03062293|Exercise|exercise
5148913|NCT03062293|Low back pain|low back pain
5148914|NCT03062293|Functional Re-adaptive Exercise Device|functional re-adaptive exercise device
5148915|NCT03062280|Extension study|extension study
5148916|NCT03062267|mhealth|mhealth
5148917|NCT03062267|texting intervention|texting intervention
5148918|NCT03062267|mobile health|mobile health
5774753|NCT00223483|Receptors|receptors
5148919|NCT03062267|mobile mental health|mobile mental health
5148926|NCT03062228|pregnancy|pregnancy
5148927|NCT03062228|supine|supine
5148928|NCT03062228|small for gestational age|small for gestational age
5148929|NCT03062215|Culturally adapted psychotherapy|culturally adapted psychotherapy
5148930|NCT03062215|Internet-delivered treatment|internet-delivered treatment
5148931|NCT03062215|Depression|depression
5148932|NCT03062215|Latin America|latin america
5148933|NCT03062202|Depression|depression
5148934|NCT03062202|Anxiety|anxiety
5148935|NCT03062202|Online interventions|online interventions
5148936|NCT03062202|CBT|cbt
5148937|NCT03062202|IAPT|iapt
5148938|NCT03062176|Heart failure|heart failure
5148939|NCT03062176|End-stage renal disease|end-stage renal disease
5148940|NCT03062176|Interleukin-1|interleukin-1
5148941|NCT03062176|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
5148942|NCT03062176|Metabolomics|metabolomics
5148943|NCT03062176|Lipidomics|lipidomics
5148944|NCT03062176|Chronic kidney disease|chronic kidney disease
5148945|NCT03062137|bronchoscopy|bronchoscopy
5148946|NCT03062137|saturation|saturation
5148947|NCT03062124|SpyGlass|spyglass
5148948|NCT03062124|Pancreatoscopy|pancreatoscopy
5148949|NCT03062111|Laser Enucleation of Prostate (LEP)|laser enucleation of prostate (lep)
5148950|NCT03062111|Transurethral Resection of Prostate (TURP)|transurethral resection of prostate (turp)
5148951|NCT03062072|normoglycemia|normoglycemia
5148952|NCT03062072|cancer|cancer
5148953|NCT03062072|chemotherapy|chemotherapy
5148954|NCT03062072|Hyperglycemia Drug Induced|hyperglycemia drug induced
5148955|NCT03062046|Atrial Fibrillation|atrial fibrillation
5148956|NCT03062020|Preterm Birth|preterm birth
5148957|NCT03062020|Asymptomatic high-risk women|asymptomatic high-risk women
5148958|NCT03062020|QUIPP|quipp
5148959|NCT03062020|Quantitative fetal fibronectin|quantitative fetal fibronectin
5148960|NCT03062020|Cervical length|cervical length
5148961|NCT03061968|acupressure|acupressure
5148962|NCT03061968|very-low- birth-weight premature|very-low- birth-weight premature
5148963|NCT03061968|body weight|body weight
5148964|NCT03061968|behavioral state|behavioral state
5148965|NCT03061968|developmental status|developmental status
5148966|NCT03061903|total hip arthroplasty|total hip arthroplasty
5148967|NCT03061903|direct anterior approach|direct anterior approach
5148968|NCT03061903|wound complication|wound complication
5148969|NCT03061890|children's environmental health|children's environmental health
5148970|NCT03061890|prematurity|prematurity
5148976|NCT03061890|neurodevelopment|neurodevelopment
5148978|NCT03061877|Rheumatoid arthritis|rheumatoid arthritis
5148979|NCT03061877|Anxiety|anxiety
5148980|NCT03061877|Depression|depression
5148981|NCT03061825|Aneurysm|aneurysm
5148982|NCT03061825|Aortic Aneurysm|aortic aneurysm
5148983|NCT03061825|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5148984|NCT03061825|Iliac Aneurysm|iliac aneurysm
5148985|NCT03061825|Vascular Diseases|vascular diseases
5962085|NCT04283136|Phase 1|phase 1
5148986|NCT03061825|Cardiovascular Diseases|cardiovascular diseases
5148987|NCT03061825|Aortic Diseases|aortic diseases
5148993|NCT03061760|Prostate cancer|prostate cancer
5148994|NCT03061760|Incontinence|incontinence
5148995|NCT03061760|Radical prostatectomy|radical prostatectomy
5148996|NCT03061760|Urge urinary incontinence|urge urinary incontinence
5148997|NCT03061734|Migraine Disorders|migraine disorders
5148998|NCT03061734|Headache Disorders|headache disorders
5148999|NCT03061734|Migraine with Aura|migraine with aura
5149000|NCT03061734|Migraine without Aura|migraine without aura
5149001|NCT03061721|NASH|nash
5149002|NCT03061721|NAFLD|nafld
5149003|NCT03061721|Saroglitazar|saroglitazar
5149004|NCT03061669|heart failure|heart failure
5149005|NCT03061669|pulmonary hypertension|pulmonary hypertension
5149006|NCT03061669|right heart catheterization|right heart catheterization
5149007|NCT03061591|Turmeric|turmeric
5149008|NCT03061591|Curcumin|curcumin
5149009|NCT03061591|colorectal polyps|colorectal polyps
5149010|NCT03061591|colorectal neoplasia|colorectal neoplasia
5149011|NCT03061591|mutyh mutation|mutyh mutation
5149012|NCT03061591|apc mutation|apc mutation
5149013|NCT03061578|Tear Film|tear film
5149014|NCT03061578|Hyperspectral imaging|hyperspectral imaging
5149015|NCT03061578|Low Humidity Environmental Exposure Chamber|low humidity environmental exposure chamber
5149016|NCT03061565|erythropoietin|erythropoietin
5149017|NCT03061565|traumatic brain injury|traumatic brain injury
5149018|NCT03061539|Immunogenic signature|immunogenic signature
5149023|NCT03061513|lactate|lactate
5149024|NCT03061513|glutathione|glutathione
5149025|NCT03061500|Proadrenomedullin|proadrenomedullin
5149026|NCT03061500|Sepsis|sepsis
5149027|NCT03061500|Intraabdominal Infections|intraabdominal infections
5149028|NCT03061500|prognosis|prognosis
5149029|NCT03061474|Mild Cognitive Impairment|mild cognitive impairment
5149030|NCT03061474|Alzheimer's Disease|alzheimer's disease
5149031|NCT03061474|Nicotinamide|nicotinamide
5149032|NCT03061474|Niacinamide|niacinamide
5149033|NCT03061474|Niacin|niacin
5149034|NCT03061474|Nicotinic Acids|nicotinic acids
5149035|NCT03061474|Vitamin|vitamin
5149036|NCT03061474|Neurodegenerative Diseases|neurodegenerative diseases
5149037|NCT03061474|Tauopathies|tauopathies
5149038|NCT03061474|Dementia|dementia
5149039|NCT03061461|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5149040|NCT03061461|ESWT|eswt
5149041|NCT03061461|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
5149042|NCT03061461|rESWT|reswt
5149043|NCT03061461|Diabetes|diabetes
5149044|NCT03061435|Vulvar Cancer|vulvar cancer
5149045|NCT03061435|Cervical Cancer|cervical cancer
5149046|NCT03061435|Vulvar Dysplasia|vulvar dysplasia
5149047|NCT03061435|Cervical Dysplasia|cervical dysplasia
5149048|NCT03061435|Anal Cancer|anal cancer
5149049|NCT03061435|Anal Dysplasia|anal dysplasia
5149051|NCT03061357|activity tracker|activity tracker
5035263|NCT03778996|SM-88|sm-88
5149052|NCT03061357|behavior change|behavior change
5149053|NCT03061318|Fine Needle Aspiration, Genetic Classifier|fine needle aspiration, genetic classifier
5149054|NCT03061279|Medial Malleolus fractures|medial malleolus fractures
5149055|NCT03061279|headless screws|headless screws
5149056|NCT03061279|headed screws|headed screws
5149057|NCT03061266|type 2 diabetes mellitus, application, e-health education|type 2 diabetes mellitus, application, e-health education
5149058|NCT03061253|Electronic Cigarettes|electronic cigarettes
5149059|NCT03061253|Laser Doppler Flowmetry|laser doppler flowmetry
5149060|NCT03061253|Ultrasound|ultrasound
5149061|NCT03061253|Nicotine Replacement Therapy|nicotine replacement therapy
5149062|NCT03061240|Internet of Things|internet of things
5149063|NCT03061136|Cognition|cognition
5149064|NCT03061136|Gamma oscillations|gamma oscillations
5149065|NCT03061136|EEG|eeg
5149066|NCT03061136|Executive function|executive function
5149067|NCT03061136|Benzodiazepine|benzodiazepine
5149068|NCT03061136|GABA|gaba
5149069|NCT03061097|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
5149070|NCT03061084|Spina Bifida, Neurogenic bladder, Myelomeningocele|spina bifida, neurogenic bladder, myelomeningocele
5149071|NCT03061071|Positional Sleep Apnea|positional sleep apnea
5149072|NCT03061071|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
5149073|NCT03061071|POSA|posa
5149074|NCT03061071|OSA|osa
5149076|NCT03061071|Sleep Apnea|sleep apnea
5149078|NCT03061019|myofunctional therapy|myofunctional therapy
5149079|NCT03061019|adenotonsillectomy|adenotonsillectomy
5149080|NCT03061019|randomized controlled trial|randomized controlled trial
5149081|NCT03060993|Cannabis|cannabis
5149082|NCT03060993|Marijuana|marijuana
5149083|NCT03060967|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression|motivation, instrumental tasks, food-related stimuli, size/time discrimination, major depression
5149084|NCT03060928|Rotator Cuff Tear|rotator cuff tear
5149085|NCT03060928|Artelon®|artelon®
5149086|NCT03060915|Actigraphy|actigraphy
5149087|NCT03060915|Polysomnography|polysomnography
5149088|NCT03060915|Obstructive Sleep Apnea|obstructive sleep apnea
5149089|NCT03060889|Cesarean section|cesarean section
5149090|NCT03060889|placenta previa|placenta previa
5149091|NCT03060889|Tranexamic acid|tranexamic acid
5149092|NCT03060876|shoulder fractures|shoulder fractures
5149093|NCT03060876|humeral fractures|humeral fractures
5149094|NCT03060876|operative therapy|operative therapy
5149095|NCT03060876|conservative therapy|conservative therapy
5149096|NCT03060876|range of motion, articular|range of motion, articular
5149097|NCT03060876|quality of life|quality of life
5149098|NCT03060876|proximal|proximal
5149099|NCT03060863|children|children
5149104|NCT03060824|Osmolality|osmolality
5149105|NCT03060824|Sodium|sodium
5149106|NCT03060824|CABG|cabg
5149107|NCT03060824|Cardiovascular Diseases|cardiovascular diseases
5149108|NCT03060824|Cardiopulmonary bypass|cardiopulmonary bypass
5149109|NCT03060772|Pulmonary Medicine|pulmonary medicine
5149110|NCT03060772|Oxidative Stress|oxidative stress
5149111|NCT03060772|Pioglitazone|pioglitazone
5149112|NCT03060772|Immunology|immunology
5149113|NCT03060772|Addictive/Compulsive Behavior|addictive/compulsive behavior
5149114|NCT03060759|Multiple Sclerosis|multiple sclerosis
5149115|NCT03060759|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5149120|NCT03060694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5149121|NCT03060668|Critical Illness|critical illness
5149122|NCT03060668|Indirect Calorimetry|indirect calorimetry
5149123|NCT03060668|Dietary Proteins|dietary proteins
5149124|NCT03060655|PLGA-Mg|plga-mg
5149125|NCT03060655|fracture|fracture
5149126|NCT03060655|fixation|fixation
5149127|NCT03060655|union|union
5149128|NCT03060642|Microenvironment|microenvironment
5149129|NCT03060642|Microbiome|microbiome
5149130|NCT03060642|Screening|screening
5149131|NCT03060642|Barrett Esophagus|barrett esophagus
5149132|NCT03060642|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5149133|NCT03060603|Erythropoietin|erythropoietin
5149134|NCT03060603|Endometrium|endometrium
5149135|NCT03060603|Doppler Ultrasonography|doppler ultrasonography
5774754|NCT00223470|pain|pain
5149136|NCT03060590|sarcopenia, uremic toxins|sarcopenia, uremic toxins
5149137|NCT03060564|shoulder|shoulder
5149138|NCT03060564|orthopaedics|orthopaedics
5149139|NCT03060525|Deaf|deaf
5149140|NCT03060525|American Sign Language|american sign language
5149141|NCT03060525|Overweight|overweight
5149142|NCT03060525|Obese|obese
5149143|NCT03060512|Opioid Induced constipation,|opioid induced constipation,
5149144|NCT03060512|constipation,|constipation,
5149145|NCT03060512|laxative,|laxative,
5149146|NCT03060512|bowel movement,|bowel movement,
5149147|NCT03060512|Movantik,|movantik,
5149148|NCT03060512|Naloxegol|naloxegol
5149149|NCT03060499|Thyroidectomy|thyroidectomy
5149150|NCT03060499|Myocardial Function|myocardial function
5149151|NCT03060499|Thyroid gland|thyroid gland
5149152|NCT03060499|Heart|heart
5149153|NCT03060473|PPROM|pprom
5149154|NCT03060473|Azithromycin|azithromycin
5149155|NCT03060473|Erythromycin|erythromycin
5149160|NCT03060408|Fluid Therapy|fluid therapy
5149161|NCT03060408|Laparoscopy|laparoscopy
5149162|NCT03060369|Tissue Perfusion|tissue perfusion
5149163|NCT03060369|Noninvasive Monitoring|noninvasive monitoring
5149164|NCT03060369|Near-infrared spectroscopy|near-infrared spectroscopy
5149165|NCT03060369|CareGuide|careguide
5149166|NCT03060317|Disorders of consciousness|disorders of consciousness
5149167|NCT03060317|validation studies|validation studies
5149168|NCT03060317|coma|coma
5149169|NCT03060317|vegetative state|vegetative state
5149170|NCT03060304|tamoxifen|tamoxifen
5149171|NCT03060304|thin endometrium|thin endometrium
5149172|NCT03060304|frozen embryo transfer|frozen embryo transfer
5149173|NCT03060304|pregnancy rate|pregnancy rate
5149174|NCT03060291|Family Check-up|family check-up
5149175|NCT03060278|smoking cessation, food pantry|smoking cessation, food pantry
5149176|NCT03060265|multimodal analgesia|multimodal analgesia
5149177|NCT03060265|paracetamol|paracetamol
5149178|NCT03060265|cesarean section|cesarean section
5149179|NCT03060252|Drug-Induced Liver Injury|drug-induced liver injury
5149180|NCT03060239|Parkinson Disease|parkinson disease
5149181|NCT03060239|Near infrared Spectroscopy|near infrared spectroscopy
5149182|NCT03060239|REM sleep behaviour disorder|rem sleep behaviour disorder
5149183|NCT03060239|Supplementary motor area|supplementary motor area
5149184|NCT03060213|Well-Being|well-being
5149185|NCT03060213|e-Health|e-health
5149186|NCT03060213|Randomized Controlled Trial|randomized controlled trial
5149187|NCT03060213|Self-Efficacy|self-efficacy
5149188|NCT03060213|Interpersonal well-being|interpersonal well-being
5149189|NCT03060213|Community well-being|community well-being
5149190|NCT03060213|Occupational well-being|occupational well-being
5149191|NCT03060213|Physical well-being|physical well-being
5149192|NCT03060213|Psychological well-being|psychological well-being
5149193|NCT03060213|Economic well-being|economic well-being
5149194|NCT03060200|depression|depression
5149195|NCT03060200|treatment|treatment
5149197|NCT03060200|online|online
5149198|NCT03060200|app|app
5149199|NCT03060161|Health promotion|health promotion
5149200|NCT03060161|Healthy Diet|healthy diet
5149201|NCT03060161|Exercise|exercise
5149202|NCT03060148|Heart failure|heart failure
5149203|NCT03060148|Spinal cord stimulation|spinal cord stimulation
5149204|NCT03060109|Traumatic brain injury|traumatic brain injury
5149205|NCT03060109|Head injury|head injury
5149206|NCT03060031|Oxytocin|oxytocin
5149207|NCT03060005|Sjögren's syndrome|sjögren's syndrome
5149208|NCT03060005|meibomian gland dysfunction|meibomian gland dysfunction
5149209|NCT03060005|dry eye disease|dry eye disease
5149210|NCT03059940|Smoking Cessation|smoking cessation
5149211|NCT03059940|Low Dose computed tomography|low dose computed tomography
5149212|NCT03059940|LDCT|ldct
5149213|NCT03059940|Quitline|quitline
5149214|NCT03059940|Questionnaires|questionnaires
5149215|NCT03059940|Surveys|surveys
5149216|NCT03059940|Counseling|counseling
5149217|NCT03059940|Smoking cessation drugs|smoking cessation drugs
5149219|NCT03059940|Nicotine replacement therapy|nicotine replacement therapy
5149221|NCT03059940|Nicotine Patch|nicotine patch
5149222|NCT03059927|Cruciate retaining|cruciate retaining
5149223|NCT03059927|Anterior stabilized|anterior stabilized
5149224|NCT03059927|Posterior stabilized|posterior stabilized
5149225|NCT03059927|Posterior cruciate ligament|posterior cruciate ligament
5149226|NCT03059927|Degenerative knee joint disease|degenerative knee joint disease
5149227|NCT03059927|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
5149228|NCT03059927|Kinematic radiostereometry|kinematic radiostereometry
5149229|NCT03059901|Physical Activity|physical activity
5149230|NCT03059901|Latina Women|latina women
5149231|NCT03059901|Minority Health|minority health
5149232|NCT03059901|Mobile Technology|mobile technology
5149233|NCT03059901|Social Support|social support
5149234|NCT03059875|Breastcancer|breastcancer
5149235|NCT03059875|Standardized Geriatric Evaluation|standardized geriatric evaluation
5149236|NCT03059875|Onco-Geriatric Filter|onco-geriatric filter
5149237|NCT03059862|immunity|immunity
5149238|NCT03059862|Aryl-hydrocarbon receptor|aryl-hydrocarbon receptor
5149239|NCT03059862|immune homeostasis|immune homeostasis
5149240|NCT03059862|microbiota|microbiota
5149241|NCT03059862|tryptophan|tryptophan
5149242|NCT03059836|n3 PUFA|n3 pufa
5149243|NCT03059823|Solid tumors|solid tumors
5149244|NCT03059823|Metastatic cancer|metastatic cancer
5149245|NCT03059745|Cholecystitis|cholecystitis
5149246|NCT03059745|Cholelithiasis|cholelithiasis
5149247|NCT03059732|Gastric cancer|gastric cancer
5149248|NCT03059732|Thailand|thailand
5149249|NCT03059732|Japan|japan
5149250|NCT03059719|safety|safety
5149251|NCT03059719|pharmacokinetics|pharmacokinetics
5149252|NCT03059719|pharmacodynamics|pharmacodynamics
5149253|NCT03059693|Eczema|eczema
5149254|NCT03059693|Topical|topical
5149257|NCT03059667|Small Cell Lun cancer|small cell lun cancer
5149258|NCT03059667|IFCT|ifct
5149259|NCT03059667|immune therapy|immune therapy
5149260|NCT03059654|Percutaneous tracheostomy|percutaneous tracheostomy
5149261|NCT03059654|surgical tracheostomy|surgical tracheostomy
5149262|NCT03059654|airway ultrasound|airway ultrasound
5149263|NCT03059654|intensive care|intensive care
5149264|NCT03059641|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
5149265|NCT03059641|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
5149266|NCT03059641|liquid biopsy|liquid biopsy
5149267|NCT03059641|EGFR Gene mutation|egfr gene mutation
5149268|NCT03059589|food anaphylaxis|food anaphylaxis
5149269|NCT03059589|peanut anaphylaxis|peanut anaphylaxis
5149270|NCT03059589|food oral immunotherapy|food oral immunotherapy
5149271|NCT03059589|food allergy|food allergy
5149272|NCT03059589|food allergy treatment|food allergy treatment
5149273|NCT03059576|Chronobiology|chronobiology
5149274|NCT03059576|Circadian rhythms|circadian rhythms
5149275|NCT03059576|Heritability|heritability
5149276|NCT03059576|Twins|twins
5149277|NCT03059563|Varenicline|varenicline
5149278|NCT03059563|Positron Emission Tomography|positron emission tomography
5149279|NCT03059563|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5149280|NCT03059563|Methamphetamine Abuse|methamphetamine abuse
5149281|NCT03059550|cardiac rehabilitation|cardiac rehabilitation
5149282|NCT03059550|prediabetes|prediabetes
5149283|NCT03059524|microRNA|microrna
5149284|NCT03059498|PECS I and II|pecs i and ii
5149285|NCT03059498|PECS blocks|pecs blocks
5149286|NCT03059485|Leukemia|leukemia
5158301|NCT03002454|MDP|mdp
5149292|NCT03059459|Air Pollution|air pollution
5149295|NCT03059433|adolescent|adolescent
5149296|NCT03059433|health|health
5149297|NCT03059433|social network|social network
5149298|NCT03059420|CFEOM (Congenital Fibrosis of Extraocular Muscles)|cfeom (congenital fibrosis of extraocular muscles)
5149299|NCT03059420|CCDD (Congenital Cranial Dysinnervation Disorders)|ccdd (congenital cranial dysinnervation disorders)
5149300|NCT03059420|DRS (Duane Retraction Syndrome)|drs (duane retraction syndrome)
5149301|NCT03059420|DRRS (Duane Radial Ray Syndrome)|drrs (duane radial ray syndrome)
5149302|NCT03059420|Strabismus|strabismus
5149303|NCT03059420|MGJWS (Marcus Gunn Jaw Winking Syndrome)|mgjws (marcus gunn jaw winking syndrome)
5149304|NCT03059420|HGP (Horizontal Gaze Palsy)|hgp (horizontal gaze palsy)
5149305|NCT03059420|HGPPS (Horizontal Gaze Palsy with Progressive Scoliosis)|hgpps (horizontal gaze palsy with progressive scoliosis)
5149306|NCT03059420|Moebius|moebius
5149307|NCT03059394|reliability|reliability
5070583|NCT03558191|PD-1|pd-1
5149308|NCT03059394|validity|validity
5149309|NCT03059394|measurement error|measurement error
5149310|NCT03059381|adolescent epilepsy participants|adolescent epilepsy participants
5149311|NCT03059381|partial seizures|partial seizures
5149312|NCT03059381|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
5149313|NCT03059342|spastic diplegic CP|spastic diplegic cp
5149314|NCT03059342|self-care|self-care
5149315|NCT03059342|functional mobility|functional mobility
5149316|NCT03059342|multilevel surgery|multilevel surgery
5149317|NCT03059329|adult epilepsy participants|adult epilepsy participants
5149318|NCT03059329|partial seizures|partial seizures
5149319|NCT03059329|primary generalized Tonic-clonic seizures|primary generalized tonic-clonic seizures
5149320|NCT03059316|controlled hypotension, perfusion|controlled hypotension, perfusion
5149321|NCT03059290|post operative pain|post operative pain
5149322|NCT03059290|Post operative flare ups|post operative flare ups
5149323|NCT03059290|Post endodontic pain|post endodontic pain
5149324|NCT03059290|Post endodontic flare ups|post endodontic flare ups
5149325|NCT03059290|Necrotic teeth|necrotic teeth
5149326|NCT03059290|Non vital teeth|non vital teeth
5149327|NCT03059290|Neolix file|neolix file
5149328|NCT03059290|Single rotating file|single rotating file
5149329|NCT03059290|Protaper next file|protaper next file
5149330|NCT03059290|Multiple rotating file|multiple rotating file
5149331|NCT03059290|Single visit|single visit
5149332|NCT03059277|Diabetic Macular Edema|diabetic macular edema
5149333|NCT03059277|Diabetes|diabetes
5220072|NCT02623595|safety|safety
5149334|NCT03059277|reduced treatment frequency|reduced treatment frequency
5149335|NCT03059251|CLL, obinutuzumab, treatment|cll, obinutuzumab, treatment
5149336|NCT03059238|Pain control|pain control
5149337|NCT03059238|TACE|tace
5149338|NCT03059238|Opioids|opioids
5149339|NCT03059238|NSAIDs|nsaids
5149340|NCT03059225|Stroke|stroke
5149341|NCT03059225|Aphasia|aphasia
5149342|NCT03059225|rTMS|rtms
5149343|NCT03059225|Functional MRI|functional mri
5149344|NCT03059225|Speech training|speech training
5149345|NCT03059212|working memory|working memory
5149346|NCT03059212|parkinson's disease|parkinson's disease
5149347|NCT03059199|Prospective/Retrospective|prospective/retrospective
5149348|NCT03059173|Polycystic ovary syndrome|polycystic ovary syndrome
5149349|NCT03059173|Reproductive medicine|reproductive medicine
5149350|NCT03059160|Rett syndrome, Triheptanoic acid, Walking, EEG|rett syndrome, triheptanoic acid, walking, eeg
5149351|NCT03059134|Overactive bladder|overactive bladder
5149352|NCT03059134|Pharmacotherapy|pharmacotherapy
5149353|NCT03059134|Adverse event|adverse event
5149355|NCT03059121|Lipodystrophy|lipodystrophy
5149356|NCT03059043|Phakic Intraocular Lenses|phakic intraocular lenses
5149357|NCT03059043|viscoelastic|viscoelastic
5149358|NCT03059030|Thrombocytopenia|thrombocytopenia
5149359|NCT03059030|cirrhosis|cirrhosis
5149360|NCT03059030|Therasphere®|therasphere®
5149361|NCT03059030|Y90|y90
5149362|NCT03059030|Radioembolization|radioembolization
5149363|NCT03059004|physical therapy|physical therapy
5149364|NCT03058965|AD|ad
5149365|NCT03058965|HV|hv
5149366|NCT03058965|PSP|psp
5149367|NCT03058952|pain management|pain management
5149368|NCT03058952|fatigue|fatigue
5149369|NCT03058952|mindfulness|mindfulness
5149370|NCT03058952|Gulf War|gulf war
5149371|NCT03058939|Breast Cancer|breast cancer
5149372|NCT03058939|Breast Cancer Stage II|breast cancer stage ii
5149373|NCT03058939|Breast Cancer Stage III|breast cancer stage iii
5149374|NCT03058939|Paclitaxel|paclitaxel
5149375|NCT03058939|Taxol|taxol
5149376|NCT03058926|Chronic Pancreatitis|chronic pancreatitis
5149377|NCT03058926|Diabetes|diabetes
5149381|NCT03058926|Regulatory compliance|regulatory compliance
5149383|NCT03058900|Fecal Microbiota Transplantation|fecal microbiota transplantation
5149384|NCT03058900|FMT|fmt
5149385|NCT03058900|Randomized Controlled Trial|randomized controlled trial
5149386|NCT03058900|Intestinal microbiome|intestinal microbiome
5149387|NCT03058900|RCT|rct
5149388|NCT03058900|Faecal microbiota transplantation|faecal microbiota transplantation
5356855|NCT01917721|Kawasaki disease|kawasaki disease
5149394|NCT03058874|Hypertension|hypertension
5149395|NCT03058874|Arterial Stifness|arterial stifness
5149396|NCT03058874|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5149397|NCT03058848|Phenylketonuria|phenylketonuria
5149398|NCT03058848|PKU|pku
5149399|NCT03058848|Metabolism|metabolism
5149400|NCT03058848|Metabolic|metabolic
5149401|NCT03058848|Control|control
5149402|NCT03058848|Acceptability|acceptability
5149403|NCT03058835|HIV|hiv
5149404|NCT03058835|Truvada|truvada
5149405|NCT03058796|stroke|stroke
5149406|NCT03058796|rehabilitation|rehabilitation
5149407|NCT03058796|Hemipelegia|hemipelegia
5149408|NCT03058770|chronic stroke, sensorimotor retraining|chronic stroke, sensorimotor retraining
5149409|NCT03058692|Immunogenicity|immunogenicity
5149410|NCT03058692|Influenza Vaccine|influenza vaccine
5149411|NCT03058692|M-001 vaccine|m-001 vaccine
5149412|NCT03058692|Reactogenicity|reactogenicity
5149413|NCT03058692|Safety|safety
5962086|NCT04283136|Padsevonil|padsevonil
5149414|NCT03058679|diet|diet
5149415|NCT03058679|specific carbohydrate diet|specific carbohydrate diet
5149416|NCT03058679|Mediterranean style diet|mediterranean style diet
5149417|NCT03058679|randomized controlled trial|randomized controlled trial
5149418|NCT03058666|Aerosol|aerosol
5149419|NCT03058666|surfactant|surfactant
5149420|NCT03058666|calfactant|calfactant
5149421|NCT03058666|Infasurf|infasurf
5149422|NCT03058666|Respiratory Distress Syndrome|respiratory distress syndrome
5149423|NCT03058666|RDS|rds
5149424|NCT03058666|Premature|premature
5149425|NCT03058666|Neonates|neonates
5149426|NCT03058614|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5149427|NCT03058614|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5149428|NCT03058575|Microbiome|microbiome
5149429|NCT03058575|Gut|gut
5149430|NCT03058575|Skin|skin
5149431|NCT03058575|Fiber|fiber
5149432|NCT03058575|Starch|starch
5149433|NCT03058549|Expectant parents|expectant parents
5149434|NCT03058549|Relationship education|relationship education
5342969|NCT01981343|Ejection rate|ejection rate
5149435|NCT03058536|twin short cervix pessary progesterone preterm birth|twin short cervix pessary progesterone preterm birth
5149436|NCT03058523|Flavour|flavour
5149437|NCT03058523|Infants|infants
5149438|NCT03058523|Taste|taste
5149439|NCT03058523|Pregnancy|pregnancy
5149440|NCT03058523|Programming|programming
5149441|NCT03058523|Fruit|fruit
5149442|NCT03058523|Vegetables|vegetables
5149443|NCT03058523|Bitter profile|bitter profile
5149444|NCT03058523|Food preferences|food preferences
5149445|NCT03058510|bifurcation lesion|bifurcation lesion
5149446|NCT03058510|atherectomy|atherectomy
5149447|NCT03058510|calcification|calcification
5149448|NCT03058510|stent|stent
5149449|NCT03058445|Central venous catheter|central venous catheter
5149450|NCT03058445|MMode echocardiography|mmode echocardiography
5149451|NCT03058406|Sarcoma, Soft Tissue|sarcoma, soft tissue
5149452|NCT03058406|Halaven Injection|halaven injection
5149453|NCT03058406|E7389|e7389
5149454|NCT03058341|postoperative pain|postoperative pain
5149455|NCT03058341|propofol|propofol
5149456|NCT03058341|TIVA|tiva
5149457|NCT03058328|Inflammation/physiopathology, Immune System/immunology,|inflammation/physiopathology, immune system/immunology,
5149458|NCT03058328|Neuroimmunomodulation/physiology, General Surgery|neuroimmunomodulation/physiology, general surgery
5149459|NCT03058328|Heart Rate/physiology*Vagus Nerve/physiology*|heart rate/physiology*vagus nerve/physiology*
5149460|NCT03058315|Physical activity|physical activity
5149461|NCT03058315|Disease perception|disease perception
5149462|NCT03058315|Pain beliefs|pain beliefs
5149463|NCT03058315|Disability|disability
5149464|NCT03058315|Advice|advice
5149465|NCT03058289|Neoplasm|neoplasm
5149466|NCT03058289|Malignancy|malignancy
5149467|NCT03058289|Intratumoral|intratumoral
5149468|NCT03058289|Intralesional|intralesional
5149469|NCT03058289|anti-PD-1 antibodies|anti-pd-1 antibodies
5149470|NCT03058289|Immuno therapy|immuno therapy
5149471|NCT03058289|Dose escalation|dose escalation
5149472|NCT03058289|Platinum|platinum
5149473|NCT03058289|Intensity Therapeutics|intensity therapeutics
5149474|NCT03058289|INT230-6|int230-6
5149475|NCT03058289|Cisplatin|cisplatin
5149476|NCT03058289|Vinblastine|vinblastine
5149478|NCT03058289|Vinca|vinca
5149479|NCT03058289|Keytruda|keytruda
5149480|NCT03058289|Pembrolizumab|pembrolizumab
5149481|NCT03058289|CTLA-4|ctla-4
5149482|NCT03058289|Carcinoma|carcinoma
5149483|NCT03058276|rTMS|rtms
5149484|NCT03058276|AAT|aat
5149485|NCT03058276|Alcohol-Dependence|alcohol-dependence
5149486|NCT03058276|Relapses|relapses
5149487|NCT03058224|Pain, Symptom Severity|pain, symptom severity
5149495|NCT03058224|FSS|fss
5149496|NCT03058224|PGIC|pgic
5149497|NCT03058224|Quality of life|quality of life
5149498|NCT03058211|Pneumococcal pneumonia|pneumococcal pneumonia
5149499|NCT03058211|Acute cardiovascular events|acute cardiovascular events
5149500|NCT03058198|Glioma|glioma
5149501|NCT03058198|PET|pet
5149502|NCT03058198|EGFR vIII|egfr viii
5149503|NCT03058198|Multimodal neuronavigation|multimodal neuronavigation
5149504|NCT03058198|Molecular pathology|molecular pathology
5149505|NCT03058198|PET-CT|pet-ct
5149506|NCT03058198|Neuronavigation|neuronavigation
5149507|NCT03058185|Lamin A/C|lamin a/c
5149508|NCT03058185|Emerin|emerin
5149509|NCT03058146|Exercise|exercise
5149510|NCT03058146|Fitness|fitness
5149511|NCT03058146|Physical Activity|physical activity
5149512|NCT03058146|Cognitive Aging|cognitive aging
5149513|NCT03058146|Cerebral Blood Flow|cerebral blood flow
5149514|NCT03058146|Brain Imaging|brain imaging
5149515|NCT03058146|Unsupervised Intervention|unsupervised intervention
5149516|NCT03058146|Mobile Health|mobile health
5149517|NCT03058146|Free-living exercise intervention|free-living exercise intervention
5149518|NCT03058133|fMRI, perception, face-voice processing|fmri, perception, face-voice processing
5149519|NCT03058107|Nutrition Therapy|nutrition therapy
5149520|NCT03058081|COPD|copd
5149521|NCT03058081|Exercise|exercise
5149522|NCT03058081|High Flow Nasal|high flow nasal
5149523|NCT03058081|Muscle Oxygenation|muscle oxygenation
5962087|NCT04283136|Bioavailability|bioavailability
5149524|NCT03058081|Pulmonary Rehabilitation|pulmonary rehabilitation
5149525|NCT03058042|Urinary Incontinence, Stress|urinary incontinence, stress
5149526|NCT03058042|Pelvic Floor; Exercise|pelvic floor; exercise
5149527|NCT03058042|Physical Therapy Modalities|physical therapy modalities
5149528|NCT03058003|balance, postural|balance, postural
5149529|NCT03058003|postural equilibrium|postural equilibrium
5149530|NCT03058003|chronic pain|chronic pain
5149531|NCT03058003|Chronic nonspecific low back pain|chronic nonspecific low back pain
5149532|NCT03058003|Fibromyalgia|fibromyalgia
5149533|NCT03058003|Cervicogenic headache|cervicogenic headache
5149534|NCT03058003|Chronic tension type headache|chronic tension type headache
5149535|NCT03058003|Irritable bowel syndrome|irritable bowel syndrome
5149536|NCT03058003|Whiplash associated disorder|whiplash associated disorder
5149537|NCT03058003|Temporomandibular disorder|temporomandibular disorder
5149538|NCT03057990|Pyrimethamine|pyrimethamine
5149539|NCT03057990|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5149540|NCT03057990|Refractory|refractory
5149541|NCT03057990|Relapsed|relapsed
5149542|NCT03057938|Alzheimer|alzheimer
5149543|NCT03057938|Subjective Cognitive Decline|subjective cognitive decline
5149544|NCT03057938|Florbetaben|florbetaben
5149545|NCT03057925|thyroid nodule|thyroid nodule
5149546|NCT03057925|microwave ablation|microwave ablation
5149547|NCT03057912|Cervical intraepithelial neoplasiaⅠ|cervical intraepithelial neoplasiaⅰ
5149548|NCT03057912|TALEN|talen
5149549|NCT03057912|CRISPR/Cas9|crispr/cas9
5149550|NCT03057899|Herbal medicine|herbal medicine
5149551|NCT03057899|phytotherapy|phytotherapy
5149552|NCT03057899|testosterone|testosterone
5149553|NCT03057873|protein|protein
5149554|NCT03057873|fiber|fiber
5149555|NCT03057873|weight loss|weight loss
5149556|NCT03057873|fat loss|fat loss
5149557|NCT03057821|hydrogen peroxide|hydrogen peroxide
5149558|NCT03057821|Propionibacterium Acnes|propionibacterium acnes
5149559|NCT03057821|shoulder arthroplasty|shoulder arthroplasty
5149560|NCT03057808|Pregnancy|pregnancy
5149561|NCT03057808|Postpartum|postpartum
5149562|NCT03057782|Pain|pain
5149563|NCT03057782|Sedation|sedation
5149564|NCT03057782|Surgery|surgery
5149565|NCT03057769|ERCP, post-ERCP pancreatitis, indomethacin, epinephrine|ercp, post-ercp pancreatitis, indomethacin, epinephrine
5149566|NCT03057756|Multi-drug Resistant Tuberculosis|multi-drug resistant tuberculosis
5149567|NCT03057756|short course regimen protocol|short course regimen protocol
5149568|NCT03057730|acellular dermal matrix|acellular dermal matrix
5149569|NCT03057704|Propofol|propofol
5149570|NCT03057704|lidocaine|lidocaine
5149571|NCT03057704|pain|pain
5149572|NCT03057691|Acute Coronary Syndrome|acute coronary syndrome
5149573|NCT03057691|Depression|depression
5149574|NCT03057691|Anxiety|anxiety
5149575|NCT03057691|Percutaneous Coronary Intervention|percutaneous coronary intervention
5158587|NCT03000712|biostar|biostar
5149579|NCT03057600|African ancestry|african ancestry
5149580|NCT03057600|African American|african american
5149581|NCT03057600|CB-839|cb-839
5149582|NCT03057600|Glutaminase Inhibitor|glutaminase inhibitor
5149583|NCT03057600|Glutaminase|glutaminase
5149586|NCT03057600|Glutamine|glutamine
5149587|NCT03057561|CAD|cad
5149588|NCT03057548|Atrial Fibrillation|atrial fibrillation
5149589|NCT03057548|Long-Standing Atrial Fibrillation|long-standing atrial fibrillation
5149590|NCT03057548|Posterior Left Atrial Wall Ablation|posterior left atrial wall ablation
5149591|NCT03057535|Exercise|exercise
5149592|NCT03057535|Sodium Bicarbonate|sodium bicarbonate
5356856|NCT01917721|doxycycline|doxycycline
5149593|NCT03057535|Ventilatory equivalent for carbon dioxide|ventilatory equivalent for carbon dioxide
5149594|NCT03057522|Run|run
5149595|NCT03057522|Cadence|cadence
5149596|NCT03057522|Home exercise|home exercise
5149597|NCT03057509|Carcinoid Tumors|carcinoid tumors
5149598|NCT03057470|Diabetes|diabetes
5149599|NCT03057470|Exercise|exercise
5149600|NCT03057470|Insulin|insulin
5149601|NCT03057444|resistant starch type III|resistant starch type iii
5149602|NCT03057444|butyrate-producing gut bacteria|butyrate-producing gut bacteria
5149603|NCT03057444|diabetes mellitus type 2|diabetes mellitus type 2
5149604|NCT03057444|prediabetes|prediabetes
5149605|NCT03057431|kidney stones|kidney stones
5149606|NCT03057431|hydrochlorothiazide|hydrochlorothiazide
5149607|NCT03057405|intra-operative navigation|intra-operative navigation
5149608|NCT03057405|3D virtual planning|3d virtual planning
5149609|NCT03057405|intra-operative cone beam computed tomography (CBCT)|intra-operative cone beam computed tomography (cbct)
5149610|NCT03057392|immersion|immersion
5149611|NCT03057392|ultrafiltration|ultrafiltration
5149612|NCT03057392|dialysis|dialysis
5149613|NCT03057379|HPV vaccine|hpv vaccine
5149614|NCT03057379|Immunization registry|immunization registry
5149615|NCT03057379|Reminder recall|reminder recall
5149616|NCT03057366|Drug therapy|drug therapy
5149913|NCT03055377|youth|youth
5149619|NCT03057275|Threatened Premature Labor|threatened premature labor
5149620|NCT03057275|Abdominal Fetal ECG|abdominal fetal ecg
5149621|NCT03057262|temporomandibular joint disorders|temporomandibular joint disorders
5149622|NCT03057262|disc displacement with reduction|disc displacement with reduction
5149623|NCT03057262|anterior repositioning splint|anterior repositioning splint
5149625|NCT03057249|Thermography|thermography
5149626|NCT03057249|Perfusion|perfusion
5149627|NCT03057249|Imaging|imaging
5149628|NCT03057236|psychological, behavioral, psychosocial, antiviral, liver|psychological, behavioral, psychosocial, antiviral, liver
5149629|NCT03057223|3D printing|3d printing
5149630|NCT03057223|patient-specific titanium plate|patient-specific titanium plate
5149631|NCT03057223|mandibular malignancy|mandibular malignancy
5149632|NCT03057223|dento-maxillofacial deformity|dento-maxillofacial deformity
5342970|NCT01981343|Ultrasound|ultrasound
5149633|NCT03057223|orthognathic surgery|orthognathic surgery
5149634|NCT03057223|mandibular reconstruction|mandibular reconstruction
5149635|NCT03057210|Exercise|exercise
5149636|NCT03057210|Massage|massage
5149637|NCT03057210|Post-exercise recovery|post-exercise recovery
5149638|NCT03057210|Athletic performance|athletic performance
5149642|NCT03057171|Helicobacter pylori|helicobacter pylori
5149643|NCT03057171|long non-coding RNA|long non-coding rna
5149644|NCT03057171|THRIL|thril
5149645|NCT03057171|PACER|pacer
5149646|NCT03057171|cagA|caga
5149647|NCT03057158|OAB|oab
5149648|NCT03057158|Insulin resistance|insulin resistance
5149649|NCT03057158|diabetes|diabetes
5149650|NCT03057158|pre-diabetes|pre-diabetes
5149651|NCT03057145|Solid Tumor|solid tumor
5149652|NCT03057093|NSTEMI, ECG|nstemi, ecg
5149653|NCT03057067|Embolization, Therapeutic|embolization, therapeutic
5149654|NCT03057067|Pelvis|pelvis
5149655|NCT03056976|Overdenture|overdenture
5149656|NCT03056976|Dental implant|dental implant
5149657|NCT03056976|Complete denture|complete denture
5149658|NCT03056976|Cost analysis|cost analysis
5149659|NCT03056963|Guided Imagery|guided imagery
5149660|NCT03056950|Blood Flow Restriciton|blood flow restriciton
5149661|NCT03056950|Occlusion training|occlusion training
5149662|NCT03056950|Distal radius fracture|distal radius fracture
5149663|NCT03056911|ozone therapy|ozone therapy
5149664|NCT03056911|percutaneous treatment|percutaneous treatment
5149665|NCT03056911|Oswestry Disability Index (ODI)|oswestry disability index (odi)
5149666|NCT03056911|Visual analog Scale (VAS)|visual analog scale (vas)
5149667|NCT03056911|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
5149668|NCT03056911|cervical|cervical
5149669|NCT03056898|eicosapentaenoic acid|eicosapentaenoic acid
5149670|NCT03056898|EPA|epa
5149671|NCT03056898|docosahexaenoic acid|docosahexaenoic acid
5149672|NCT03056898|DHA|dha
5149673|NCT03056898|omega-3 index|omega-3 index
5149674|NCT03056885|one-lung ventilation|one-lung ventilation
5149678|NCT03056885|thoracic surgery|thoracic surgery
5149679|NCT03056859|Operator satisfaction with device|operator satisfaction with device
5149680|NCT03056846|probiotic|probiotic
5149681|NCT03056846|gastrointestinal|gastrointestinal
5149682|NCT03056846|stress|stress
5149683|NCT03056846|student|student
5149684|NCT03056820|tracheal intubation|tracheal intubation
5149685|NCT03056807|tolerable apneic time|tolerable apneic time
5149686|NCT03056807|bariatric surgery|bariatric surgery
5149687|NCT03056807|gastric band surgery|gastric band surgery
5149688|NCT03056807|intubation|intubation
5149689|NCT03056794|pyruvate|pyruvate
5149690|NCT03056794|pyruvate dehydrogenase|pyruvate dehydrogenase
5149691|NCT03056794|PDC|pdc
5149692|NCT03056794|PDCD|pdcd
5149693|NCT03056755|advanced breast cancer|advanced breast cancer
5149694|NCT03056755|PIK3CA|pik3ca
5149695|NCT03056755|CDK 4/6 inhibitor|cdk 4/6 inhibitor
5149696|NCT03056755|fulvestrant|fulvestrant
5149697|NCT03056755|letrozole|letrozole
5149699|NCT03056755|HER-negative|her-negative
5149700|NCT03056755|post menopausal|post menopausal
5149701|NCT03056755|pre-menopausal|pre-menopausal
5149702|NCT03056755|aromatase inhibitor|aromatase inhibitor
5149703|NCT03056755|endocrine treatment|endocrine treatment
5149704|NCT03056755|AI|ai
5149705|NCT03056755|ET|et
5149706|NCT03056716|thoracic surgery|thoracic surgery
5149707|NCT03056716|silastic drains|silastic drains
5149708|NCT03056716|conventional drains|conventional drains
5149709|NCT03056690|ASP0819|asp0819
5149710|NCT03056690|Fibromyalgia|fibromyalgia
5149711|NCT03056677|Whey protein|whey protein
5149712|NCT03056677|Dietary supplementation|dietary supplementation
5149713|NCT03056677|Glucose|glucose
5149714|NCT03056677|GLP-1|glp-1
5149715|NCT03056677|Satiety|satiety
5149716|NCT03056651|heart failure|heart failure
5149717|NCT03056651|day care|day care
5149718|NCT03056651|prognosis|prognosis
5149723|NCT03056625|lactating women|lactating women
5149724|NCT03056625|13C2-retinol isotope dilution|13c2-retinol isotope dilution
5149725|NCT03056625|vitamin A liver store|vitamin a liver store
5149726|NCT03056599|in vivo drug sensitivity|in vivo drug sensitivity
5149727|NCT03056599|personalized medicine|personalized medicine
5149728|NCT03056599|precision oncology|precision oncology
5149729|NCT03056599|in vivo oncology|in vivo oncology
5149730|NCT03056599|soft tissue sarcoma|soft tissue sarcoma
5149731|NCT03056599|chemotherapy|chemotherapy
5149732|NCT03056599|microinjection|microinjection
5149733|NCT03056599|microdosing|microdosing
5149734|NCT03056573|TAVI|tavi
5962088|NCT04283136|Food effect|food effect
5021838|NCT03860857|PET|pet
5149735|NCT03056573|Valvular heart disease|valvular heart disease
5149736|NCT03056573|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5149737|NCT03056534|Primary Total Hip Arthroplasty|primary total hip arthroplasty
5149738|NCT03056534|Non-Inflammatory Arthritis|non-inflammatory arthritis
5149739|NCT03056534|Degenerative Joint Disease|degenerative joint disease
5149740|NCT03056534|R3 Delta Ceramic Acetabular Insert|r3 delta ceramic acetabular insert
5149741|NCT03056508|diet|diet
5149742|NCT03056508|nutrition|nutrition
5149743|NCT03056508|aerobic exercise|aerobic exercise
5149744|NCT03056508|cognition|cognition
5149745|NCT03056508|grey matter|grey matter
5149746|NCT03056508|cerebral blood flow|cerebral blood flow
5149747|NCT03056508|neural activity|neural activity
5149748|NCT03056508|resting state connectivity|resting state connectivity
5149749|NCT03056482|cannabis|cannabis
5149750|NCT03056482|haloperidol|haloperidol
5149751|NCT03056482|ondansetron|ondansetron
5149752|NCT03056482|hyperemesis|hyperemesis
5149753|NCT03056482|cyclic vomiting syndrome|cyclic vomiting syndrome
5149754|NCT03056469|patient-reported outcomes|patient-reported outcomes
5149755|NCT03056469|supportive care|supportive care
5149756|NCT03056469|clinical practice|clinical practice
5149757|NCT03056469|hematological cancer|hematological cancer
5445349|NCT01522222|cardiopulmonary bypass surgery|cardiopulmonary bypass surgery
5445350|NCT01522222|CABG|cabg
5149758|NCT03056430|MRI, Neuroplasticity, Balance, Spatial orientation, Hippocampus, Slacklining|mri, neuroplasticity, balance, spatial orientation, hippocampus, slacklining
5149759|NCT03056417|chronic pain|chronic pain
5149760|NCT03056417|telomere|telomere
5149761|NCT03056417|telomerase|telomerase
5149762|NCT03056417|life style|life style
5149763|NCT03056391|knowlesi malaria|knowlesi malaria
5149764|NCT03056391|paracetamol|paracetamol
5149765|NCT03056391|renal function|renal function
5149766|NCT03056391|haemolysis|haemolysis
5149767|NCT03056391|oxidative stress|oxidative stress
5149768|NCT03056365|Detoxification|detoxification
5149769|NCT03056365|Outpatient|outpatient
5149770|NCT03056365|Advanced Nursing|advanced nursing
5149771|NCT03056365|Health Services|health services
5149772|NCT03056339|B-Lymphoid Malignancies|b-lymphoid malignancies
5149773|NCT03056339|Relapsed/Refractory|relapsed/refractory
5149774|NCT03056339|Acute lymphocytic leukemia|acute lymphocytic leukemia
5149775|NCT03056339|ALL|all
5149776|NCT03056339|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5149777|NCT03056339|CLL|cll
5149778|NCT03056339|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5149779|NCT03056339|NHL|nhl
5149780|NCT03056339|(CAR).CD19-CD28-zeta-2A-iCasp9-IL15-transduced cord blood natural killer cells|(car).cd19-cd28-zeta-2a-icasp9-il15-transduced cord blood natural killer cells
5149781|NCT03056339|CB-NK cells|cb-nk cells
5149782|NCT03056339|Fludarabine|fludarabine
5149783|NCT03056339|Fludarabine phosphate|fludarabine phosphate
5149784|NCT03056339|Fludara|fludara
5149785|NCT03056339|Cyclophosphamide|cyclophosphamide
5149786|NCT03056339|Cytoxan|cytoxan
5149787|NCT03056339|Neosar|neosar
5149788|NCT03056339|AP1903|ap1903
5149789|NCT03056339|Mesna|mesna
5149790|NCT03056339|Mesnex|mesnex
5149791|NCT03056313|Delivery, Obstetric|delivery, obstetric
5149792|NCT03056313|Uterine Contraction|uterine contraction
5149793|NCT03056313|Cervix Uteri|cervix uteri
5149795|NCT03056274|Ursodeoxycholic acid|ursodeoxycholic acid
5149796|NCT03056274|Outcomes|outcomes
5149797|NCT03056261|Combined general-epidural anesthesia intestinal recovery|combined general-epidural anesthesia intestinal recovery
5149798|NCT03056235|Atrophic acne scar|atrophic acne scar
5149799|NCT03056209|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|mitochondrial dna trnaleu(uur) m.3243a<g mutation
5149805|NCT03056144|spinal muscular atrophy|spinal muscular atrophy
5149806|NCT03056144|total body vibration|total body vibration
5149807|NCT03056144|children|children
5149808|NCT03056118|OPTIMA-C|optima-c
5149809|NCT03056105|Well-being, affiliation, inflammation|well-being, affiliation, inflammation
5149810|NCT03056092|ranibizumab|ranibizumab
5149811|NCT03056092|aqueous cytokine|aqueous cytokine
5149812|NCT03056092|age related macular degeneration|age related macular degeneration
5149813|NCT03056092|diabetic macular edema|diabetic macular edema
5149814|NCT03056092|retinal vein occlusion|retinal vein occlusion
5149820|NCT03056053|insomnia|insomnia
5149821|NCT03055975|Bacteria|bacteria
5149822|NCT03055975|Root canal treatment|root canal treatment
5149823|NCT03055975|Endodontics|endodontics
5149824|NCT03055962|Healthy Participants|healthy participants
5149825|NCT03055962|E2609|e2609
5149826|NCT03055962|Pharmacokinetics|pharmacokinetics
5149827|NCT03055962|Japan|japan
5149828|NCT03055949|early rehabilitation|early rehabilitation
5149829|NCT03055949|early mobilization|early mobilization
5149830|NCT03055949|surgical intensive care unit|surgical intensive care unit
5149831|NCT03055884|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5149832|NCT03055884|accelerated learning|accelerated learning
5149833|NCT03055884|memory|memory
5149834|NCT03055871|Behavioural: Family physical activity habit|behavioural: family physical activity habit
5149835|NCT03055858|PDA, ADO II AS|pda, ado ii as
5149836|NCT03055832|iLux|ilux
5149837|NCT03055832|LipiFlow|lipiflow
5149838|NCT03055832|dry eye|dry eye
5962089|NCT04283123|Assistive Technology|assistive technology
5149839|NCT03055832|Meibomian Gland Dysfunction|meibomian gland dysfunction
5149840|NCT03055832|evaporative dry eye|evaporative dry eye
5149841|NCT03055819|Brow Lift|brow lift
5149842|NCT03055819|Brow Ptosis|brow ptosis
5149844|NCT03055806|Sexual Dysfunction|sexual dysfunction
5149845|NCT03055806|IX-01|ix-01
5149846|NCT03055741|Alzheimer's disease|alzheimer's disease
5149847|NCT03055728|streptococcal infections|streptococcal infections
5774854|NCT00222963|Adolescents|adolescents
5149848|NCT03055728|rapid strep testing|rapid strep testing
5149849|NCT03055728|rapid antigen detection test|rapid antigen detection test
5149850|NCT03055715|NSCLC|nsclc
5149851|NCT03055715|Radiotherapy|radiotherapy
5149852|NCT03055715|young DEGRO|young degro
5149853|NCT03055715|tumor volume|tumor volume
5149854|NCT03055715|lung cancer|lung cancer
5149855|NCT03055715|radiochemotherapy|radiochemotherapy
5149856|NCT03055715|prognostic factors|prognostic factors
5149857|NCT03055702|Short Message Service|short message service
5445351|NCT01522222|PEEP|peep
5149858|NCT03055702|appointment reminder|appointment reminder
5149859|NCT03055702|Attendance rate|attendance rate
5149860|NCT03055689|Colonoscopy|colonoscopy
5149861|NCT03055689|Educational intervention|educational intervention
5149862|NCT03055676|Pancreaticoduodenectomy|pancreaticoduodenectomy
5149863|NCT03055676|Time of drain removal|time of drain removal
5149864|NCT03055624|prostate artery embolization (PAE)|prostate artery embolization (pae)
5149865|NCT03055624|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5149866|NCT03055624|lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5149867|NCT03055611|Blood Coagulation Disorder|blood coagulation disorder
5149868|NCT03055611|Hematologic Diseases|hematologic diseases
5149869|NCT03055611|Coagulation Protein Disorder|coagulation protein disorder
5149870|NCT03055611|Hemorrhagic Disorder|hemorrhagic disorder
5149871|NCT03055611|Genetic Diseases, Inborn|genetic diseases, inborn
5149872|NCT03055585|Wolbachia; Ae. aegypti; Indonesia; Dengue; Cluster-randomised trial|wolbachia; ae. aegypti; indonesia; dengue; cluster-randomised trial
5149873|NCT03055572|Rhinitis|rhinitis
5149874|NCT03055572|Chronic Rhinosinusitis|chronic rhinosinusitis
5149875|NCT03055572|Olfactory Training|olfactory training
5149876|NCT03055559|Iron, Hemoglobin, Feritin, erytrocyty. transferin|iron, hemoglobin, feritin, erytrocyty. transferin
5149877|NCT03055546|oxytocin|oxytocin
5149878|NCT03055546|emotion regulation|emotion regulation
5149879|NCT03055533|Behavioral|behavioral
5149880|NCT03055533|Social|social
5149881|NCT03055533|Headsprout reading program|headsprout reading program
5149882|NCT03055520|schizophrenia|schizophrenia
5149883|NCT03055520|cognition|cognition
5149884|NCT03055520|arithmetic training|arithmetic training
5149885|NCT03055520|Kumon method|kumon method
5149894|NCT03055481|neonatal jaundice|neonatal jaundice
5149895|NCT03055481|phototherapy|phototherapy
5149896|NCT03055481|neonate|neonate
5149897|NCT03055429|Prisoners|prisoners
5149898|NCT03055429|End-of-life care|end-of-life care
5149899|NCT03055429|Geriatric care|geriatric care
5149900|NCT03055429|Palliative care|palliative care
5149901|NCT03055429|Hospice care|hospice care
5149902|NCT03055416|Overweight|overweight
5149903|NCT03055416|Obesity|obesity
5145647|NCT03081312|Needs|needs
5149904|NCT03055416|Physical Activity|physical activity
5149905|NCT03055416|African-American Men|african-american men
5149906|NCT03055416|mHealth|mhealth
5149907|NCT03055416|Mobile Health|mobile health
5149908|NCT03055390|hyoscine butylbromide|hyoscine butylbromide
5149909|NCT03055390|progress of labor|progress of labor
5149910|NCT03055390|duration of labor|duration of labor
5149911|NCT03055377|cannabis|cannabis
5149912|NCT03055377|marijuana|marijuana
5149919|NCT03055351|Exercise motivation|exercise motivation
5149920|NCT03055351|Psychological well-being|psychological well-being
5149921|NCT03055351|Healthy living|healthy living
5149922|NCT03055351|Physical activity|physical activity
5149923|NCT03055351|Autonomy support|autonomy support
5149924|NCT03055351|Self-determination theory|self-determination theory
5149925|NCT03055338|Schizophrenia, acute episode|schizophrenia, acute episode
5149926|NCT03055338|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
5149927|NCT03055338|Mental Disorders|mental disorders
5149928|NCT03055247|Chronic granulomatous disease X-linked|chronic granulomatous disease x-linked
5149929|NCT03055247|Ibuprofen|ibuprofen
5149930|NCT03055247|Mobilization regimen|mobilization regimen
5149931|NCT03055247|Gene Therapy|gene therapy
5149932|NCT03055234|Oral treprostinil|oral treprostinil
5149933|NCT03055234|6-Minute Walk Distance|6-minute walk distance
5149935|NCT03055234|sickle cell|sickle cell
5149936|NCT03055221|Remodulin|remodulin
5149937|NCT03055221|6-Minute Walk Test|6-minute walk test
5149938|NCT03055208|Glioblastoma|glioblastoma
5149939|NCT03055208|Radiosurgery|radiosurgery
5149940|NCT03055208|Gamma Knife|gamma knife
5149946|NCT03055182|Isokinetic|isokinetic
5149947|NCT03055182|oxygenation|oxygenation
5149948|NCT03055182|deoxygenation|deoxygenation
5149949|NCT03055182|aerobic metabolism|aerobic metabolism
5149950|NCT03055169|hyperglycemia|hyperglycemia
5149951|NCT03055169|Multiple Organ Failure|multiple organ failure
5149952|NCT03055169|biobank|biobank
5149953|NCT03055169|diabetes|diabetes
5149954|NCT03055156|Sleep Apnea|sleep apnea
5149955|NCT03055156|Insomnia|insomnia
5149956|NCT03055156|sleep disorders|sleep disorders
5149957|NCT03055156|sleep environment|sleep environment
5149958|NCT03055156|core body temperature|core body temperature
5149959|NCT03055117|Shoulder pain|shoulder pain
5149960|NCT03055117|Physiotherapy|physiotherapy
5149961|NCT03055117|Rehabilitation|rehabilitation
5149962|NCT03055117|Exercise|exercise
5149963|NCT03055104|severe malnutrition|severe malnutrition
5149964|NCT03055104|Critically Ill|critically ill
5149965|NCT03055104|refeeding syndrome|refeeding syndrome
5149966|NCT03055104|guideline|guideline
5149967|NCT03055065|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
5149968|NCT03055000|Mosquito-Borne Diseases|mosquito-borne diseases
5149969|NCT03055000|Universal Mosquito Vaccine|universal mosquito vaccine
5149970|NCT03055000|Mosquito Transmission|mosquito transmission
5149971|NCT03055000|Vector Borne Viruses|vector borne viruses
5149972|NCT03055000|Vaccine|vaccine
5149973|NCT03054974|Stroke|stroke
5149974|NCT03054974|Traditional Chinese Medicine|traditional chinese medicine
5149975|NCT03054974|Rehabilitation|rehabilitation
5149976|NCT03054961|epilepsy|epilepsy
5149977|NCT03054961|cytochrome oxidase redox state|cytochrome oxidase redox state
5149978|NCT03054961|childhood epilepsy|childhood epilepsy
5149979|NCT03054961|partial epilepsy|partial epilepsy
5149980|NCT03054961|NIRS|nirs
5149981|NCT03054961|near-infrared spectroscopy|near-infrared spectroscopy
5149982|NCT03054961|regional cerebral oxygen saturation|regional cerebral oxygen saturation
5149983|NCT03054935|Energy Expenditure|energy expenditure
5149984|NCT03054935|Body Composition|body composition
5149985|NCT03054935|Food Intake|food intake
5149986|NCT03054896|Richter Syndrome|richter syndrome
5149987|NCT03054883|Mantle Cell Lymphoma|mantle cell lymphoma
5149988|NCT03054883|minimal residual disease|minimal residual disease
5149989|NCT03054883|cytosine arabinoside|cytosine arabinoside
5149990|NCT03054870|pulmonary ventilation|pulmonary ventilation
5149991|NCT03054870|ventilation scintigraphy|ventilation scintigraphy
5149992|NCT03054844|Intranasal|intranasal
5149993|NCT03054844|Pain|pain
5149994|NCT03054844|Lidocaine|lidocaine
5149995|NCT03054844|Midazolam|midazolam
5149996|NCT03054844|Emergency department|emergency department
5149997|NCT03054766|Laser Photocoagulation|laser photocoagulation
5149998|NCT03054766|Ranibizumab|ranibizumab
5149999|NCT03054766|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5150000|NCT03054766|Vascular Endothecial Growth Factor|vascular endothecial growth factor
5150001|NCT03054753|Abduction brace|abduction brace
5150002|NCT03054753|Compliance|compliance
5150003|NCT03054753|Rotator cuff tear|rotator cuff tear
5150004|NCT03054753|Rotator cuff repair|rotator cuff repair
5150005|NCT03054740|Vapocoolant applied prior to IV access|vapocoolant applied prior to iv access
5150006|NCT03054727|Post Thrombotic Syndrome|post thrombotic syndrome
5150007|NCT03054727|Venous Thromboembolism|venous thromboembolism
5150008|NCT03054727|Incidence|incidence
5150009|NCT03054727|Risk factors|risk factors
5150010|NCT03054727|Venous ulcer|venous ulcer
5150011|NCT03054701|Patellofemoral pain|patellofemoral pain
5150028|NCT03054480|Intradermal Botulinum Toxin A|intradermal botulinum toxin a
5150029|NCT03054441|Upper limb|upper limb
5150030|NCT03054441|Inertial sensors|inertial sensors
5150031|NCT03054415|neuronal-glial-epithelial unit, anorectal function|neuronal-glial-epithelial unit, anorectal function
5150032|NCT03054376|Immobilization|immobilization
5150033|NCT03054376|Angiogenesis|angiogenesis
5150034|NCT03054376|Skeletal muscle|skeletal muscle
5150035|NCT03054376|Exercise training|exercise training
5150036|NCT03054376|Vascular function|vascular function
5150037|NCT03054363|Metastatic Breast Cancer|metastatic breast cancer
5150038|NCT03054363|Tucatinib|tucatinib
5150039|NCT03054363|Palbociclib|palbociclib
5150040|NCT03054363|Letrozole|letrozole
5150041|NCT03054363|HR-positive|hr-positive
5150042|NCT03054363|HER2-positive|her2-positive
5150043|NCT03054363|ER-positive|er-positive
5150044|NCT03054363|PR-positive|pr-positive
5150045|NCT03054363|HER2-targeted therapy|her2-targeted therapy
5150046|NCT03054363|CDK4/6 inhibitor|cdk4/6 inhibitor
5150048|NCT03054363|Ibrance|ibrance
5150049|NCT03054350|Anemia|anemia
5150050|NCT03054350|kidney|kidney
5150051|NCT03054350|dialysis dependent chronic kidney disease|dialysis dependent chronic kidney disease
5150052|NCT03054350|CKD|ckd
5150053|NCT03054350|DD|dd
5150054|NCT03054350|renal|renal
5150055|NCT03054350|vadadustat|vadadustat
5150056|NCT03054350|AKB-6548|akb-6548
5150057|NCT03054350|hypoxia-inducible factor|hypoxia-inducible factor
5150058|NCT03054350|Akebia (AKB)|akebia (akb)
5150059|NCT03054350|hypoxia-inducible factor (HIF)|hypoxia-inducible factor (hif)
5150060|NCT03054350|HIF|hif
5150061|NCT03054350|prolyl-hydroxylase inhibitor (PHI)|prolyl-hydroxylase inhibitor (phi)
5150062|NCT03054350|PHI|phi
5150063|NCT03054350|Japan|japan
5150064|NCT03054350|Japanese|japanese
5150065|NCT03054337|Anemia|anemia
5150066|NCT03054337|kidney|kidney
5423320|NCT01616212|Treatment Efficacy|treatment efficacy
5022112|NCT03859206|medical|medical
5150067|NCT03054337|non-dialysis dependent chronic kidney disease|non-dialysis dependent chronic kidney disease
5150068|NCT03054337|CKD|ckd
5150069|NCT03054337|NDD-CKD|ndd-ckd
5150070|NCT03054337|renal|renal
5150071|NCT03054337|vadadustat|vadadustat
5150072|NCT03054337|AKB-6548|akb-6548
5150073|NCT03054337|hypoxia-inducible factor|hypoxia-inducible factor
5150074|NCT03054337|hypoxia-inducible factor (HIF)|hypoxia-inducible factor (hif)
5150075|NCT03054337|HIF|hif
5150076|NCT03054337|prolyl-hydroxylase inhibitor (PHI)|prolyl-hydroxylase inhibitor (phi)
5150077|NCT03054337|PHI|phi
5150078|NCT03054337|Japan|japan
5150079|NCT03054337|Japanese|japanese
5150080|NCT03054337|Akebia (AKB)|akebia (akb)
5150081|NCT03054324|Cardiovascular Diseases|cardiovascular diseases
5150082|NCT03054324|Fractional Flow Reserve|fractional flow reserve
5150083|NCT03054324|Ischemic Heart Disease|ischemic heart disease
5150084|NCT03054324|CT Angiogram|ct angiogram
5150085|NCT03054285|Seizures|seizures
5150086|NCT03054285|Traumatic Brain Injury|traumatic brain injury
5150087|NCT03054285|Prophylaxis|prophylaxis
5150088|NCT03054285|Levetiracetam|levetiracetam
5150089|NCT03054272|High-fidelity simulation|high-fidelity simulation
5150090|NCT03054272|Eye-tracking|eye-tracking
5150091|NCT03054272|Difficult intubation|difficult intubation
5150092|NCT03054233|spinal anesthesia|spinal anesthesia
5150093|NCT03054233|spinal-bone contact|spinal-bone contact
5150094|NCT03054233|caesarian section|caesarian section
5150095|NCT03054233|crossed leg sitting position|crossed leg sitting position
5150096|NCT03054194|Healthy participants|healthy participants
5150097|NCT03054194|E2730|e2730
5150098|NCT03054194|Pharmacokinetics|pharmacokinetics
5150099|NCT03054181|Observational|observational
5150100|NCT03054181|Infection|infection
5150101|NCT03054181|Utilisation|utilisation
5150102|NCT03054181|Safety|safety
5150103|NCT03054181|Tolerability|tolerability
5150104|NCT03054181|Infusion|infusion
5150105|NCT03054181|chronic|chronic
5150106|NCT03054168|Protein Synthesis|protein synthesis
5150107|NCT03054168|Hypertrophy|hypertrophy
5150108|NCT03054168|Testosterone|testosterone
5150109|NCT03054155|hidradenitis suppurativa|hidradenitis suppurativa
5150110|NCT03054155|hidradenitis|hidradenitis
5150111|NCT03054155|laser|laser
5150112|NCT03054103|ketamine|ketamine
5150113|NCT03054103|midazolam|midazolam
5150114|NCT03054103|sedation|sedation
5150115|NCT03054090|Cardiovascular Diseases|cardiovascular diseases
5150116|NCT03054090|Primary Care|primary care
5150117|NCT03054077|pre-procedural anxiety|pre-procedural anxiety
5150118|NCT03054077|children|children
5150119|NCT03054077|pediatric sedation|pediatric sedation
5150120|NCT03054051|HIV prevention|hiv prevention
5150121|NCT03054051|Preadolescence|preadolescence
5150122|NCT03054051|Mobile phone game|mobile phone game
5150124|NCT03054012|CAD-CAM software|cad-cam software
5150125|NCT03054012|accuracy|accuracy
5150126|NCT03054012|head and neck region|head and neck region
5150127|NCT03054012|mandibular reconstruction|mandibular reconstruction
5150128|NCT03053999|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5150129|NCT03053999|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
5150130|NCT03053999|Hyperparathyroidism|hyperparathyroidism
5150131|NCT03053999|HPTH|hpth
5150132|NCT03053999|PNET|pnet
5150133|NCT03053999|Biomarkers|biomarkers
5150134|NCT03053999|Parathyroidectomy|parathyroidectomy
5150135|NCT03053999|Genome sequencing|genome sequencing
5150136|NCT03053999|Data review|data review
5150137|NCT03053973|COPD|copd
5150138|NCT03053973|airway inflammation|airway inflammation
5150139|NCT03053973|airway remodeling|airway remodeling
5150140|NCT03053973|health-related auality of life|health-related auality of life
5150141|NCT03053973|forced expiratory volume 1 second|forced expiratory volume 1 second
5150142|NCT03053947|Intranasal Ketamine|intranasal ketamine
5150143|NCT03053947|Pain Management|pain management
5150144|NCT03053934|Online counselling|online counselling
5150145|NCT03053921|gingival recession|gingival recession
5150146|NCT03053921|Zuchellis technique,|zuchellis technique,
5150147|NCT03053921|placental membrane|placental membrane
5150148|NCT03053908|Orexin|orexin
5150149|NCT03053908|Core Body Temperature|core body temperature
5150150|NCT03053882|mouth wash , green tea , peppermint , bad breath|mouth wash , green tea , peppermint , bad breath
5150151|NCT03053856|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5150152|NCT03053856|Adjuvant pembrolizumab|adjuvant pembrolizumab
5150153|NCT03053843|Atrial fibrillation|atrial fibrillation
5150154|NCT03053843|Mediterranean Diet|mediterranean diet
5150155|NCT03053843|Extra Virgin Olive Oil|extra virgin olive oil
5150156|NCT03053843|Ablation|ablation
5150157|NCT03053830|Ketamine|ketamine
5150158|NCT03053830|Major Depressive Disorder|major depressive disorder
5150159|NCT03053804|MR/PET|mr/pet
5150160|NCT03053804|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5962090|NCT04283123|Informal Caregivers|informal caregivers
5150161|NCT03053791|Deep brain stimulation|deep brain stimulation
5150163|NCT03053791|Spinal cord injury|spinal cord injury
5150164|NCT03053791|SCI|sci
5150165|NCT03053791|Paraplegia|paraplegia
5150166|NCT03053791|Mesencephalic locomotor region|mesencephalic locomotor region
5150168|NCT03053791|Pedunculopontine nucleus|pedunculopontine nucleus
5150169|NCT03053791|PPN|ppn
5150170|NCT03053778|Readmission|readmission
5150171|NCT03053778|Early follow-up|early follow-up
5774953|NCT00222560|fitness|fitness
5150172|NCT03053778|Heart valves|heart valves
5150173|NCT03053778|Heart valve surgery|heart valve surgery
5150174|NCT03053739|Systemic sclerosis, Associated Pulmonary Arterial Hypertension|systemic sclerosis, associated pulmonary arterial hypertension
5150175|NCT03053726|Variable Frequency Stimulation|variable frequency stimulation
5150176|NCT03053713|Mediterranean diet pattern|mediterranean diet pattern
5150177|NCT03053713|nutrition|nutrition
5150178|NCT03053713|diet intervention|diet intervention
5150179|NCT03053713|disease activity|disease activity
5150180|NCT03053713|intestinal microbiome|intestinal microbiome
5150181|NCT03053713|inflammatory bowel disease|inflammatory bowel disease
5150182|NCT03053700|Rosacea, Bromonidine, intensed pulse light|rosacea, bromonidine, intensed pulse light
5150183|NCT03053661|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5150184|NCT03053661|cancer-specific immunity|cancer-specific immunity
5150185|NCT03053661|cancer immunology|cancer immunology
5150186|NCT03053661|cancer-testis antigens|cancer-testis antigens
5150187|NCT03053661|human papilloma virus|human papilloma virus
5150188|NCT03053661|immune modulatory cells|immune modulatory cells
5150189|NCT03053648|Insomnia|insomnia
5150190|NCT03053648|Randomized controlled trial|randomized controlled trial
5150191|NCT03053648|Acupressure|acupressure
5150192|NCT03053648|Self-help|self-help
5150193|NCT03053635|Photodynamic Therapy|photodynamic therapy
5150194|NCT03053635|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5150195|NCT03053635|Urothelial carcinoma|urothelial carcinoma
5150196|NCT03053635|Ta bladder cancer|ta bladder cancer
5150197|NCT03053635|T1 bladder cancer|t1 bladder cancer
5150198|NCT03053635|Refractory to BCG|refractory to bcg
5150199|NCT03053609|gastroesophageal reflux|gastroesophageal reflux
5150201|NCT03053609|bradycardia|bradycardia
5150202|NCT03053609|desaturation|desaturation
5150203|NCT03053609|impedance|impedance
5150204|NCT03053596|HCC|hcc
5150205|NCT03053596|LifePearl|lifepearl
5150206|NCT03053583|larynx, laryngoscopy|larynx, laryngoscopy
5150207|NCT03053583|vocal cords, laryngoscopy|vocal cords, laryngoscopy
5150208|NCT03053583|airway|airway
5150209|NCT03053583|pediatric|pediatric
5150210|NCT03053570|Cryoballoon|cryoballoon
5150211|NCT03053570|Contact Force|contact force
5150212|NCT03053570|Persistent Atrial Fibrillation|persistent atrial fibrillation
5150217|NCT03053544|metformin|metformin
5150218|NCT03053544|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5150219|NCT03053518|Type 2 Diabetes|type 2 diabetes
5150220|NCT03053518|Hyperglycemia|hyperglycemia
5150221|NCT03053518|Personal Nutrition Project|personal nutrition project
5150227|NCT03053492|Video Games|video games
5150228|NCT03053479|surgery|surgery
5150229|NCT03053479|native tissue prolapse repair|native tissue prolapse repair
5150230|NCT03053479|laparoscopic sacrocolpopexy|laparoscopic sacrocolpopexy
5150231|NCT03053479|vaginal mesh|vaginal mesh
5150232|NCT03053466|Advanced Solid Tumor|advanced solid tumor
5150233|NCT03053466|Relapsed Solid Tumor|relapsed solid tumor
5150234|NCT03053466|Recurrent Solid Tumor|recurrent solid tumor
5150235|NCT03053453|Total Knee Replacement Arthroplasty|total knee replacement arthroplasty
5150236|NCT03053427|Restless Legs Syndrome|restless legs syndrome
5150237|NCT03053427|ASP8825|asp8825
5150238|NCT03053427|Gabapentin enacarbil|gabapentin enacarbil
5150239|NCT03053401|Quadriceps muscle strength|quadriceps muscle strength
5150240|NCT03053401|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5150241|NCT03053401|Femoral nerve block|femoral nerve block
5150242|NCT03053401|Adductor Canal block|adductor canal block
5150243|NCT03053401|Saphenous nerve block in the Adductor Canal|saphenous nerve block in the adductor canal
5150244|NCT03053401|Pediatrics|pediatrics
5150245|NCT03053401|Postoperative analgesia|postoperative analgesia
5150246|NCT03053401|Ultrasound guided nerve block|ultrasound guided nerve block
5150250|NCT03053310|surgery|surgery
5150251|NCT03053310|curative intent|curative intent
5150252|NCT03053310|geriatric assessment|geriatric assessment
5150253|NCT03053310|30-day postoperative morbidity|30-day postoperative morbidity
5150254|NCT03053297|EGFR|egfr
5150255|NCT03053297|EGFR mutation|egfr mutation
5150256|NCT03053297|EGFRm|egfrm
5150257|NCT03053297|EGFR-TKI|egfr-tki
5150258|NCT03053297|Health care resource utilization|health care resource utilization
5150259|NCT03053297|Health-Related Quality of Life|health-related quality of life
5150260|NCT03053297|Locally advanced or metastatic lung cancer|locally advanced or metastatic lung cancer
5150261|NCT03053297|NSCLC|nsclc
5150262|NCT03053297|Non-Small Cell Lung Cancer|non-small cell lung cancer
5150263|NCT03053297|Observational study|observational study
5150264|NCT03053297|Osimertinib|osimertinib
5150265|NCT03053297|Personalized medicine|personalized medicine
5150266|NCT03053297|PRO|pro
5150267|NCT03053297|Patient Reported Outcome|patient reported outcome
5150268|NCT03053297|Resistance|resistance
5150269|NCT03053297|T790M|t790m
5022325|NCT03858023|balance|balance
5150270|NCT03053297|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5150271|NCT03053297|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5150272|NCT03053297|Bronchial Neoplasms|bronchial neoplasms
5150273|NCT03053297|Lung Neoplasms|lung neoplasms
5150274|NCT03053297|Respiratory Tract Neoplasms|respiratory tract neoplasms
5150275|NCT03053297|Thoracic neoplasms, Neoplasms by site|thoracic neoplasms, neoplasms by site
5150276|NCT03053297|Lung diseases|lung diseases
5150277|NCT03053297|Respiratory Tract diseases|respiratory tract diseases
5150278|NCT03053297|Cancer Chemotherapy|cancer chemotherapy
5150279|NCT03053297|Combination Chemotherapy|combination chemotherapy
5150280|NCT03053297|Immunotherapy|immunotherapy
5150281|NCT03053297|Radiation|radiation
5150285|NCT03053245|Collaborative Care Model|collaborative care model
5150286|NCT03053245|Intensive Care Unit|intensive care unit
5150287|NCT03053193|breast cancer|breast cancer
5150289|NCT03053193|stage II|stage ii
5150290|NCT03053193|stage III|stage iii
5150291|NCT03053180|Paritaprevir|paritaprevir
5150292|NCT03053180|Dasabuvir|dasabuvir
5150293|NCT03053180|Ombitasvir|ombitasvir
5150294|NCT03053180|Ritonavir|ritonavir
5150295|NCT03053180|Ribavirin free|ribavirin free
5150296|NCT03053180|Chronic Hepatitis C genotype 1b (GT1b)|chronic hepatitis c genotype 1b (gt1b)
5150297|NCT03053180|Cirrhosis|cirrhosis
5150298|NCT03053180|Compensated liver cirrhosis|compensated liver cirrhosis
5150299|NCT03053180|Hepatitis|hepatitis
5150300|NCT03053167|Raltitrexed|raltitrexed
5150301|NCT03053167|Irinotecan|irinotecan
5150302|NCT03053167|Second-line Treatment|second-line treatment
5150303|NCT03053167|Advanced Colorectal Cancer(ACC)|advanced colorectal cancer(acc)
5150304|NCT03053154|Pelvic Inclination|pelvic inclination
5150305|NCT03053154|Sit to Stand|sit to stand
5150306|NCT03053154|Stroke|stroke
5150307|NCT03053154|Anterior pelvic tilt|anterior pelvic tilt
5150308|NCT03053154|Posterior pelvic tilt|posterior pelvic tilt
5150313|NCT03053089|MPS I; Hurler Syndrome|mps i; hurler syndrome
5150314|NCT03053076|cord blood mononuclear cells|cord blood mononuclear cells
5150316|NCT03053076|effect|effect
5150317|NCT03053076|neonates|neonates
5150318|NCT03053037|apical size|apical size
5150319|NCT03053037|root canal treatment success|root canal treatment success
5150320|NCT03053037|micro biome analysis|micro biome analysis
5150324|NCT03052946|fecal incontinence, anorectal manometry, bulking agents|fecal incontinence, anorectal manometry, bulking agents
5150332|NCT03052894|neuromuscular blockade|neuromuscular blockade
5150333|NCT03052894|monitoring device|monitoring device
5150335|NCT03052855|Suicidal behaviour|suicidal behaviour
5150336|NCT03052855|Cerebral metabolites|cerebral metabolites
5150337|NCT03052855|MRI|mri
5150338|NCT03052855|Inflammatory markers|inflammatory markers
5150339|NCT03052803|coronary stenosis|coronary stenosis
5150340|NCT03052803|fractional flow reserve|fractional flow reserve
5150341|NCT03052751|UCB7665|ucb7665
5150342|NCT03052751|Myasthenia Gravis|myasthenia gravis
5150343|NCT03052738|central nervous system (brain or spinal) tumor|central nervous system (brain or spinal) tumor
5150344|NCT03052712|Disorders of socio-emotional|disorders of socio-emotional
5150345|NCT03052712|Alzheimer|alzheimer
5150346|NCT03052712|frontal temporal dementia|frontal temporal dementia
5150347|NCT03052712|Parkinson|parkinson
5150348|NCT03052712|Huntington|huntington
5150349|NCT03052712|traumatic brain injury|traumatic brain injury
5150350|NCT03052712|stroke|stroke
5150351|NCT03052712|focal lesions|focal lesions
5150352|NCT03052699|Complications; Cesarean Section|complications; cesarean section
5150353|NCT03052686|Uterine rupture|uterine rupture
5150354|NCT03052673|ketamine|ketamine
5150355|NCT03052673|fentanyl|fentanyl
5150356|NCT03052673|postoperative pain|postoperative pain
5150357|NCT03052660|Midazolam|midazolam
5150358|NCT03052660|Anxiety|anxiety
5150359|NCT03052660|Clinical trial|clinical trial
5445352|NCT01522209|CRLM|crlm
5150360|NCT03052660|Patient Satisfaction|patient satisfaction
5150361|NCT03052647|dermaclip|dermaclip
5150362|NCT03052647|subcuticular|subcuticular
5150363|NCT03052647|cesarean section|cesarean section
5150364|NCT03052647|staples|staples
5150365|NCT03052647|adhesive latch|adhesive latch
5150366|NCT03052647|rousseau|rousseau
5150367|NCT03052608|ALK; anaplastic lymphoma kinase; Non-Small-Cell Lung cancer; NSCLC|alk; anaplastic lymphoma kinase; non-small-cell lung cancer; nsclc
5150368|NCT03052556|cystic Fibrosis|cystic fibrosis
5150369|NCT03052556|cervical cancer|cervical cancer
5150370|NCT03052556|screening|screening
5150371|NCT03052556|human papilloma virus (HPV)|human papilloma virus (hpv)
5150372|NCT03052556|pap smear test|pap smear test
5150373|NCT03052517|Asthma, QAW039|asthma, qaw039
5150374|NCT03052465|Motility|motility
5150375|NCT03052413|thinning hair|thinning hair
5150376|NCT03052413|female pattern hair loss|female pattern hair loss
5150377|NCT03052400|type 2 diabetes mellitus|type 2 diabetes mellitus
5150378|NCT03052400|insulin resistance|insulin resistance
5150379|NCT03052400|mifepristone|mifepristone
5962091|NCT04283123|Occupational Therapy|occupational therapy
5150380|NCT03052400|glucocorticoids|glucocorticoids
5150381|NCT03052374|Video-Feedback Interaction Guidance|video-feedback interaction guidance
5150382|NCT03052374|Depressed Mothers and their Infants|depressed mothers and their infants
5150383|NCT03052361|Children|children
5150384|NCT03052361|emergency department|emergency department
5150385|NCT03052361|ondansetron|ondansetron
5150386|NCT03052348|Topical Antibiotics|topical antibiotics
5150387|NCT03052348|Fusidic Acid|fusidic acid
5150388|NCT03052348|Atopic Dermatitis|atopic dermatitis
5150389|NCT03052348|Eczema|eczema
5150390|NCT03052335|colorectal cancer|colorectal cancer
5150391|NCT03052335|screening|screening
5150392|NCT03052335|colon capsule|colon capsule
5150393|NCT03052335|colonoscopy|colonoscopy
5150394|NCT03052283|Cystic fibrosis|cystic fibrosis
5150395|NCT03052283|Abdomen|abdomen
5150396|NCT03052283|Pancreas|pancreas
5150397|NCT03052283|Liver|liver
5150399|NCT03052283|Symptom Score|symptom score
5150400|NCT03052283|Patient reported outcome measure (PROM)|patient reported outcome measure (prom)
5150401|NCT03052257|Glaucoma|glaucoma
5150402|NCT03052257|Disease management|disease management
5150403|NCT03052257|Smart bottle|smart bottle
5150404|NCT03052244|tDCS (trans cranial direct current stimulation)|tdcs (trans cranial direct current stimulation)
5150405|NCT03052244|Visual illusion|visual illusion
5150406|NCT03052244|Neuropathic pain|neuropathic pain
5150407|NCT03052244|Spinal cord Injury|spinal cord injury
5150408|NCT03052231|adherence|adherence
5150409|NCT03052231|cystic fibrosis|cystic fibrosis
5150410|NCT03052218|children|children
5150411|NCT03052218|pain|pain
5150412|NCT03052218|Cytochrome P450 CYP2D6 genotype|cytochrome p450 cyp2d6 genotype
5150413|NCT03052218|Cytochrome P450 CYP2D6 phenotype|cytochrome p450 cyp2d6 phenotype
5150414|NCT03052218|Pupillometry|pupillometry
5150415|NCT03052205|ILLUMINATE-101|illuminate-101
5150416|NCT03052205|melanoma|melanoma
5150417|NCT03052127|Uveal melanoma|uveal melanoma
5150424|NCT03052114|Craniocerebral Injury|craniocerebral injury
5150426|NCT03052101|PLCH|plch
5150427|NCT03052101|Air travel|air travel
5150428|NCT03052101|pneumothorax|pneumothorax
5150429|NCT03052101|pleurodesis|pleurodesis
5150431|NCT03052075|Parathyroidectomy|parathyroidectomy
5150432|NCT03052075|Bone mineral density|bone mineral density
5150433|NCT03052075|BMD|bmd
5150434|NCT03052075|Data Review|data review
5150435|NCT03052049|Prostate Artery Embolization|prostate artery embolization
5150436|NCT03052036|Acute Coronary Syndrome|acute coronary syndrome
5150437|NCT03052023|dual approach|dual approach
5150438|NCT03052023|laparoscopic hernioplasty|laparoscopic hernioplasty
5150439|NCT03052010|HIV-1 serodiscordant couples|hiv-1 serodiscordant couples
5150440|NCT03052010|PrEP as Bridge to ART|prep as bridge to art
5150441|NCT03051919|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5150442|NCT03051919|reinforcement|reinforcement
5150443|NCT03051919|leak|leak
5150444|NCT03051906|Carcinoma, squamous cell|carcinoma, squamous cell
5150445|NCT03051906|Head and Neck Neoplasms|head and neck neoplasms
5150446|NCT03051906|Radiotherapy|radiotherapy
5150447|NCT03051906|Immunotherapy|immunotherapy
5150448|NCT03051880|Epidermal Growth Factor|epidermal growth factor
5150449|NCT03051854|Violence|violence
5150450|NCT03051854|Children|children
5150451|NCT03051854|Prevalence|prevalence
5150453|NCT03051854|Prevention|prevention
5150454|NCT03051828|fencing, cancer|fencing, cancer
5150455|NCT03051815|obstructive sleep apnea|obstructive sleep apnea
5150456|NCT03051802|Endoscopy|endoscopy
5150457|NCT03051802|HDR Brachytherapy|hdr brachytherapy
5150458|NCT03051802|navigation|navigation
5150459|NCT03051789|Menstrual hygiene management|menstrual hygiene management
5150460|NCT03051789|Sexual and Reproductive Health|sexual and reproductive health
5150461|NCT03051789|Adolescent schoolgirls|adolescent schoolgirls
5150462|NCT03051789|School dropoout|school dropoout
5150463|NCT03051789|sub-Saharan Africa|sub-saharan africa
5150464|NCT03051789|Kenya|kenya
5150465|NCT03051776|Compression garments|compression garments
5150466|NCT03051776|Kinesio Taping|kinesio taping
5150467|NCT03051776|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
5150468|NCT03051763|pulmonary hypertension|pulmonary hypertension
5150469|NCT03051763|commercial air travel|commercial air travel
5150470|NCT03051750|Breast Cancer-Related Lymphedema|breast cancer-related lymphedema
5150471|NCT03051750|Complex Physical Therapy|complex physical therapy
5150472|NCT03051750|Pressotherapy|pressotherapy
5150473|NCT03051750|Kinesio Taping|kinesio taping
5150474|NCT03051750|Physiotherapy|physiotherapy
5150475|NCT03051750|Manual Lymph Drainage|manual lymph drainage
5150476|NCT03051750|Multilayer Bandage|multilayer bandage
5150477|NCT03051750|TTDL questionnaire|ttdl questionnaire
5150478|NCT03051737|Multi-scale|multi-scale
5150479|NCT03051737|Prediction|prediction
5150480|NCT03051737|Patient Flow|patient flow
5150481|NCT03051737|Emergency Department|emergency department
5150482|NCT03051737|Hospitalization|hospitalization
5150483|NCT03051737|Ile-de-France|ile-de-france
5150484|NCT03051724|OSA|osa
5150485|NCT03051724|CPAP management|cpap management
5150486|NCT03051724|Telemedicine|telemedicine
5150487|NCT03051698|C1-inhibitor|c1-inhibitor
5150488|NCT03051698|house dust mite|house dust mite
5150489|NCT03051698|complement system|complement system
5150490|NCT03051672|Breast Cancer|breast cancer
5022536|NCT03856710|Mesh|mesh
5150491|NCT03051659|Breast Cancer|breast cancer
5150492|NCT03051646|Exercise|exercise
5150493|NCT03051646|Time to Exhaustion|time to exhaustion
5150494|NCT03051620|Bone turnover markers|bone turnover markers
5150495|NCT03051620|Alendronate|alendronate
5150496|NCT03051620|Drug Holiday|drug holiday
5150497|NCT03051607|Motor Fluctuations|motor fluctuations
5150498|NCT03051607|Off time|off time
5150499|NCT03051607|On time|on time
5150500|NCT03051607|Dyskinesia|dyskinesia
5150501|NCT03051581|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5150502|NCT03051581|Positron-Emission Tomography|positron-emission tomography
5150503|NCT03051581|Prognosis|prognosis
5150504|NCT03051568|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5150505|NCT03051568|Positron-Emission Tomography|positron-emission tomography
5150506|NCT03051568|Prognosis|prognosis
5150507|NCT03051555|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
5150705|NCT03050398|letrozole|letrozole
5150508|NCT03051555|Positron-Emission Tomography|positron-emission tomography
5150509|NCT03051555|Prognosis|prognosis
5150510|NCT03051542|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
5150511|NCT03051542|Positron-Emission Tomography|positron-emission tomography
5150512|NCT03051542|Prognosis|prognosis
5150513|NCT03051451|Hydrochloride of Metformin / Fluoxetine|hydrochloride of metformin / fluoxetine
5150514|NCT03051451|Placebo|placebo
5150515|NCT03051451|Obesity|obesity
5150516|NCT03051425|Probiotics|probiotics
5150517|NCT03051425|Immune function|immune function
5150518|NCT03051425|Natural killer cell activity|natural killer cell activity
5150519|NCT03051425|Interleukin-12|interleukin-12
5150520|NCT03051425|Interferon-gamma|interferon-gamma
5150521|NCT03051425|Immunoglobulin|immunoglobulin
5150522|NCT03051399|Constipation|constipation
5150523|NCT03051399|Gastrointestinal symptoms of discomfort|gastrointestinal symptoms of discomfort
5150524|NCT03051399|Quality of life|quality of life
5150525|NCT03051399|Saccharomyces cerevisiae|saccharomyces cerevisiae
5150527|NCT03051360|aortic valve stenosis|aortic valve stenosis
5150528|NCT03051360|PCSK9 inhibitor|pcsk9 inhibitor
5150529|NCT03051308|Parathyroid cell viability|parathyroid cell viability
5150530|NCT03051308|Ischemia|ischemia
5150531|NCT03051308|Parathyroid allotransplantation|parathyroid allotransplantation
5150532|NCT03051308|Vitamin D Receptor|vitamin d receptor
5150533|NCT03051308|Calcium Sensing Receptor|calcium sensing receptor
5150534|NCT03051295|Communication Barriers|communication barriers
5150535|NCT03051295|Persuasive Communication|persuasive communication
5150536|NCT03051295|Risk|risk
5150537|NCT03051269|Electroporation|electroporation
5150538|NCT03051269|Calcium|calcium
5150539|NCT03051269|Head and Neck cancer|head and neck cancer
5150540|NCT03051256|REL-1017|rel-1017
5150541|NCT03051256|d-Methadone|d-methadone
5150542|NCT03051256|Methadone|methadone
5150543|NCT03051256|Depression|depression
5150544|NCT03051256|Refractory Depression|refractory depression
5150546|NCT03051256|Adjunctive Treatment|adjunctive treatment
5150547|NCT03051256|NMDA Receptor Antagonist|nmda receptor antagonist
5150548|NCT03051256|Excitatory Amino Acid Antagonist|excitatory amino acid antagonist
5150549|NCT03051256|Glutamate Antagonist|glutamate antagonist
5150550|NCT03051230|Blood Coagulation Disorders|blood coagulation disorders
5150551|NCT03051230|Cell-Derived Microparticles|cell-derived microparticles
5150552|NCT03051230|Superovulation|superovulation
5150553|NCT03051230|Fertilization in Vitro|fertilization in vitro
5150554|NCT03051230|Biomarkers|biomarkers
5150555|NCT03051217|Psoriasis|psoriasis
5150556|NCT03051217|PSO|pso
5150557|NCT03051217|Chronic plaque psoriasis|chronic plaque psoriasis
5150558|NCT03051217|Certolizumb Pegol|certolizumb pegol
5150559|NCT03051217|Cimzia|cimzia
5445353|NCT01522209|Primovist MRI|primovist mri
5150560|NCT03051217|Generalized pustular psoriasis and erythrodermic psoriasis|generalized pustular psoriasis and erythrodermic psoriasis
5150561|NCT03051191|atherosclerotic cardiovascular diseases|atherosclerotic cardiovascular diseases
5150562|NCT03051191|nonischemic heart failure|nonischemic heart failure
5150563|NCT03051191|cancer|cancer
5150564|NCT03051165|Cardiovascular Disease|cardiovascular disease
5150565|NCT03051165|Pulmonary Medicine|pulmonary medicine
5150566|NCT03051165|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
5150567|NCT03051139|Implementation Science|implementation science
5775143|NCT00221741|Mortality|mortality
5150568|NCT03051139|Low Tidal Volume Ventilation (LTVV)|low tidal volume ventilation (ltvv)
5150569|NCT03051126|Parathyroid disease|parathyroid disease
5150570|NCT03051126|Parathyroid Tissue Bank|parathyroid tissue bank
5150571|NCT03051126|Database|database
5150572|NCT03051126|Blood samples|blood samples
5150573|NCT03051100|hyperlididemia|hyperlididemia
5150574|NCT03051100|LDL|ldl
5150575|NCT03051100|cholesterol|cholesterol
5150576|NCT03051074|Anxiety|anxiety
5150577|NCT03051074|Floating|floating
5150578|NCT03051061|Atrial Fibrillation|atrial fibrillation
5150579|NCT03051061|Coronary Heart Disease|coronary heart disease
5150580|NCT03051061|antithrombotic treatment|antithrombotic treatment
5150581|NCT03051061|clinical prognosis|clinical prognosis
5150582|NCT03051048|Acute Myocardial Infarction|acute myocardial infarction
5962092|NCT04283123|Toileting|toileting
5423321|NCT01616199|PX-866|px-866
5150583|NCT03051035|non-hematological malignancies|non-hematological malignancies
5150584|NCT03051035|non-squamous|non-squamous
5150585|NCT03051035|squamous|squamous
5150586|NCT03051035|BRAF|braf
5150587|NCT03051035|KRAS|kras
5150588|NCT03051035|NRAS|nras
5150589|NCT03051022|Bupivacaine|bupivacaine
5150590|NCT03051022|adjuvant|adjuvant
5150591|NCT03051022|regional anesthesia|regional anesthesia
5150592|NCT03051022|dexamethasone|dexamethasone
5150593|NCT03051022|morphine|morphine
5150594|NCT03050983|Respiratory Compromise|respiratory compromise
5150595|NCT03050970|minor head trauma|minor head trauma
5150596|NCT03050970|child|child
5150597|NCT03050970|age less than 2 years|age less than 2 years
5150598|NCT03050970|Clinically-important traumatic brain injury (ciTBI)|clinically-important traumatic brain injury (citbi)
5150599|NCT03050970|Computed tomography scan|computed tomography scan
5150600|NCT03050970|Radiation exposure from CT scans|radiation exposure from ct scans
5150601|NCT03050944|Fertility|fertility
5150602|NCT03050944|Infertility|infertility
5150603|NCT03050944|Dietary Patterns|dietary patterns
5150607|NCT03050944|Assisted Reproduction|assisted reproduction
5150608|NCT03050944|In Vitro Fertilization|in vitro fertilization
5150612|NCT03050931|Electrical Impedance Tomography|electrical impedance tomography
5150614|NCT03050931|Epilepsy|epilepsy
5150615|NCT03050879|Stomach Neoplasms|stomach neoplasms
5150616|NCT03050879|Indocyanine Green Tracer|indocyanine green tracer
5150617|NCT03050879|Laparoscopic Gastrectomy|laparoscopic gastrectomy
5150618|NCT03050879|Lymph Node Dissection|lymph node dissection
5150619|NCT03050866|Androgen Receptor|androgen receptor
5150620|NCT03050866|AR-V7|ar-v7
5150621|NCT03050866|Predictive Factor|predictive factor
5150622|NCT03050814|Anti-PDL1 Antibody|anti-pdl1 antibody
5150623|NCT03050814|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
5150624|NCT03050814|Mismatch Repair Deficiency|mismatch repair deficiency
5150625|NCT03050814|Progression Free Survival|progression free survival
5150626|NCT03050814|Adenovirus Based, CEA-Targeting Vaccine|adenovirus based, cea-targeting vaccine
5150634|NCT03050762|Thyroid disease|thyroid disease
5150635|NCT03050762|Parathyroid disease|parathyroid disease
5150636|NCT03050762|Adrenal disease|adrenal disease
5150637|NCT03050762|Data Review|data review
5150638|NCT03050762|Database|database
5150639|NCT03050736|Glioma|glioma
5150640|NCT03050736|Glioblastoma|glioblastoma
5150641|NCT03050736|Glioblastoma multiforme|glioblastoma multiforme
5150643|NCT03050736|brain tumor|brain tumor
5150644|NCT03050736|brain cancer|brain cancer
5150645|NCT03050632|working memory|working memory
5150646|NCT03050632|adherence|adherence
5150647|NCT03050606|Exercise Therapy|exercise therapy
5150648|NCT03050606|Exercise Movement Techniques|exercise movement techniques
5150649|NCT03050606|Pilates-Based Exercises|pilates-based exercises
5150650|NCT03050606|Cost-effectiveness|cost-effectiveness
5150651|NCT03050593|HFpEF|hfpef
5150652|NCT03050593|HFrEF|hfref
5150653|NCT03050580|Abused women|abused women
5150654|NCT03050580|treatment group|treatment group
5150655|NCT03050580|family violence|family violence
5150656|NCT03050567|Microemboli|microemboli
5150657|NCT03050554|cancer|cancer
5150658|NCT03050554|Non-Small Cell Lung Cancer|non-small cell lung cancer
5150659|NCT03050554|SBRT|sbrt
5150660|NCT03050554|Avelumab|avelumab
5150661|NCT03050554|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5150662|NCT03050554|radiation|radiation
5150663|NCT03050554|NSCLC|nsclc
5150664|NCT03050554|PD-1|pd-1
5150665|NCT03050554|PD-L1|pd-l1
5150666|NCT03050554|Immunotherapy|immunotherapy
5150667|NCT03050554|Lung|lung
5150668|NCT03050541|MDMA|mdma
5150669|NCT03050541|adult|adult
5150670|NCT03050528|Acceptance and Commitment Therapy|acceptance and commitment therapy
5150671|NCT03050528|Exercise|exercise
5150672|NCT03050528|Psychology|psychology
5150673|NCT03050528|Psychological therapy|psychological therapy
5150674|NCT03050528|Physiotherapy|physiotherapy
5150675|NCT03050528|Physical therapy|physical therapy
5150676|NCT03050502|Hemothorax|hemothorax
5150677|NCT03050502|Management|management
5150678|NCT03050489|CABG|cabg
5150679|NCT03050489|Off-Pump CABG|off-pump cabg
5150680|NCT03050489|On-Pump CABG|on-pump cabg
5150681|NCT03050489|ischemic-reperfusion injury during CABG|ischemic-reperfusion injury during cabg
5150682|NCT03050489|comparison of On- and Off- Pump CABG|comparison of on- and off- pump cabg
5150683|NCT03050489|Ischemic Heart Disease|ischemic heart disease
5150684|NCT03050489|Myocardial ischemia-reperfusion and myeloperoxidase|myocardial ischemia-reperfusion and myeloperoxidase
5150685|NCT03050489|Myocardial ischemia-reperfusion biomarkers|myocardial ischemia-reperfusion biomarkers
5150686|NCT03050476|side-effects|side-effects
5150687|NCT03050476|heart-lung machine|heart-lung machine
5150688|NCT03050476|alkaline phosphatase|alkaline phosphatase
5150689|NCT03050437|Failed in First Line EGFR-TKI|failed in first line egfr-tki
5150690|NCT03050437|EGFR Activating Mutation|egfr activating mutation
5150691|NCT03050437|Pemetrexed|pemetrexed
5150692|NCT03050424|COPD|copd
5150693|NCT03050424|Iron|iron
5962093|NCT04283071|Upper limb function|upper limb function
5022754|NCT03855410|youth|youth
5150694|NCT03050424|Exercise Capacity|exercise capacity
5150695|NCT03050424|Non-anaemic iron deficiency|non-anaemic iron deficiency
5150696|NCT03050411|Non Small Cell Lung Cancer|non small cell lung cancer
5150697|NCT03050411|EGFR-TKI resistance|egfr-tki resistance
5150698|NCT03050411|Apatinib|apatinib
5150699|NCT03050411|anti-angiogenesis drugs|anti-angiogenesis drugs
5150700|NCT03050398|HR-positive|hr-positive
5150701|NCT03050398|HER2-negative|her2-negative
5150702|NCT03050398|Advanced breast cancer|advanced breast cancer
5150703|NCT03050398|LEE011|lee011
5150704|NCT03050398|ribociclib|ribociclib
5150711|NCT03050398|CDK4/6 inhibitor|cdk4/6 inhibitor
5150712|NCT03050398|Phase III|phase iii
5150713|NCT03050398|Phase IIIb|phase iiib
5150714|NCT03050398|ER-positive|er-positive
5150715|NCT03050398|PR-positive|pr-positive
5150718|NCT03050398|Men|men
5150720|NCT03050359|Drug therapy|drug therapy
5150721|NCT03050359|Gastrointestinal Diseases|gastrointestinal diseases
5150722|NCT03050359|Digestive System Diseases|digestive system diseases
5150723|NCT03050359|Lansoprazole|lansoprazole
5150724|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents
5150725|NCT03050359|Gastrointestinal Agents|gastrointestinal agents
5150726|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors
5150727|NCT03050359|Enzyme Inhibitors|enzyme inhibitors
5150728|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5150729|NCT03050346|Magnetic Resonance Imaging|magnetic resonance imaging
5150730|NCT03050346|Coronary Artery Disease|coronary artery disease
5150731|NCT03050346|Apnea|apnea
5150732|NCT03050346|Hyperventilation|hyperventilation
5150733|NCT03050346|BOLD|bold
5150734|NCT03050346|Breathing Maneuvers|breathing maneuvers
5150737|NCT03050320|Exercise in the workplace|exercise in the workplace
5150739|NCT03050268|Familial cancer|familial cancer
5150740|NCT03050268|Genetic predisposition|genetic predisposition
5150741|NCT03050268|Heritable disease|heritable disease
5150742|NCT03050268|Cancer risk|cancer risk
5150743|NCT03050268|Genome analysis|genome analysis
5150744|NCT03050268|Genetic modifiers|genetic modifiers
5150745|NCT03050268|Next generation sequencing (NGS)|next generation sequencing (ngs)
5150746|NCT03050268|Genetic counseling|genetic counseling
5150747|NCT03050268|DNA|dna
5150748|NCT03050255|supplemental oxygen|supplemental oxygen
5150749|NCT03050255|walking capacity|walking capacity
5150750|NCT03050255|exercise capacity|exercise capacity
5150751|NCT03050255|endurance shuttle walk test|endurance shuttle walk test
5150752|NCT03050190|CART therapy|cart therapy
5150753|NCT03050190|4SCAR19|4scar19
5150754|NCT03050190|CD19|cd19
5150755|NCT03050190|B cell leukemia|b cell leukemia
5150756|NCT03050190|B-ALL|b-all
5150757|NCT03050177|Bioequivalence Study|bioequivalence study
5150758|NCT03050138|Postthrombotic Syndrome|postthrombotic syndrome
5150759|NCT03050138|Venous Thrombosis|venous thrombosis
5150760|NCT03050138|Quality of Life|quality of life
5150761|NCT03050138|Hemorrhage|hemorrhage
5150762|NCT03050138|Recurrence|recurrence
5150763|NCT03050112|MacNew questionnaire|macnew questionnaire
5150764|NCT03050112|Quality of life|quality of life
5150768|NCT03050034|Wireless monitoring system|wireless monitoring system
5150769|NCT03050034|Acute Medicine|acute medicine
5150770|NCT03050034|Poly-pathological patients|poly-pathological patients
5150771|NCT03050034|Internal Medicine core competencies|internal medicine core competencies
5150772|NCT03050034|Acute Complex Care Model|acute complex care model
5150773|NCT03050021|Delirium|delirium
5150774|NCT03050021|Intensive care unit|intensive care unit
5150775|NCT03050008|Cataract Surgery|cataract surgery
5150776|NCT03049995|effectiveness; imaging; prognosis; stress echocardiography|effectiveness; imaging; prognosis; stress echocardiography
5150777|NCT03049982|Oral appliance therapy|oral appliance therapy
5150778|NCT03049969|Working Memory|working memory
5150779|NCT03049969|Cognitive Training|cognitive training
5150780|NCT03049969|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5150781|NCT03049956|Ocular Vestibular Evoked Myogenic Potentials|ocular vestibular evoked myogenic potentials
5150782|NCT03049943|low level laser therapy|low level laser therapy
5150783|NCT03049943|hyposalivation|hyposalivation
5150784|NCT03049930|Burns|burns
5150785|NCT03049930|Ketamine|ketamine
5150786|NCT03049930|Anesthesia|anesthesia
5150787|NCT03049917|financial incentive|financial incentive
5150788|NCT03049917|pediatric HIV testing|pediatric hiv testing
5150789|NCT03049904|Indian, North America|indian, north america
5150790|NCT03049904|Male, Two-Spirit|male, two-spirit
5150791|NCT03049904|HIV Prevention|hiv prevention
5150792|NCT03049904|MSM|msm
5150793|NCT03049891|Antiretroviral Therapy|antiretroviral therapy
5150794|NCT03049891|Retention|retention
5150795|NCT03049891|Loss to Follow Up|loss to follow up
5150796|NCT03049878|postoperative pain|postoperative pain
5150797|NCT03049878|paracetamol|paracetamol
5150798|NCT03049878|codeine|codeine
5150799|NCT03049878|tooth extractions|tooth extractions
5150800|NCT03049878|analgesia|analgesia
5150801|NCT03049878|premedication|premedication
5150802|NCT03049826|nutrient|nutrient
5150803|NCT03049800|Recent onset psychotic illness|recent onset psychotic illness
5962094|NCT04283071|Kinematic assessment|kinematic assessment
5962095|NCT04283045|ASD|asd
5150804|NCT03049800|Healthy controls|healthy controls
5150805|NCT03049800|Cognitive training|cognitive training
5150806|NCT03049800|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
5150807|NCT03049800|Prisma 3T Magnetic Resonance Imaging|prisma 3t magnetic resonance imaging
5150809|NCT03049787|home exercise|home exercise
5150810|NCT03049787|adhesive capsulitis|adhesive capsulitis
5150811|NCT03049748|Heart-Assist Devices, Self-care, Quality of Life|heart-assist devices, self-care, quality of life
5150812|NCT03049709|central blood pressure|central blood pressure
5150813|NCT03049709|measurement|measurement
5159777|NCT02992847|Dentate nucleus|dentate nucleus
5150820|NCT03049696|Behaviour Modification|behaviour modification
5150821|NCT03049696|Surgical Outcomes|surgical outcomes
5150822|NCT03049696|Quality of Life|quality of life
5150823|NCT03049683|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5150824|NCT03049670|Safety Issue|safety issue
5150825|NCT03049644|chronic lower back pain|chronic lower back pain
5150826|NCT03049644|Manual Therapy|manual therapy
5150827|NCT03049644|Mechanical Diagnosis and Treatment|mechanical diagnosis and treatment
5150828|NCT03049631|Pre-diabetes|pre-diabetes
5150829|NCT03049631|red raspberry|red raspberry
5150830|NCT03049631|fructooligosaccharide|fructooligosaccharide
5150831|NCT03049631|metagenomics|metagenomics
5150832|NCT03049631|polyphenol bioavailability|polyphenol bioavailability
5150833|NCT03049631|glycemic response|glycemic response
5150834|NCT03049631|insulin response|insulin response
5150835|NCT03049605|Neuropathies laser and magnetic therapy|neuropathies laser and magnetic therapy
5150839|NCT03049566|Bleeding|bleeding
5150840|NCT03049566|Adverse Cardiac Events|adverse cardiac events
5150841|NCT03049566|Adherence, Medication|adherence, medication
5150843|NCT03049566|Acetylsalicylic acid|acetylsalicylic acid
5150844|NCT03049553|Cervical screening|cervical screening
5150845|NCT03049553|Human papillomavirus (HPV)|human papillomavirus (hpv)
5150846|NCT03049553|Cytology|cytology
5150847|NCT03049553|HPV-test|hpv-test
5150848|NCT03049553|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5150849|NCT03049527|Chronic Kidney Disease|chronic kidney disease
5150850|NCT03049527|Unknown Origin|unknown origin
5150851|NCT03049514|Thrombolysis|thrombolysis
5150852|NCT03049514|Recanalization|recanalization
5150853|NCT03049514|Dynamic retinal angiography|dynamic retinal angiography
5150854|NCT03049501|Alzheimer's caregivers|alzheimer's caregivers
5150855|NCT03049501|Technology-based intervention|technology-based intervention
5150856|NCT03049501|Culturally-tailored intervention|culturally-tailored intervention
5150857|NCT03049488|Immune Response|immune response
5150858|NCT03049488|Respiratory Syncytial Virus|respiratory syncytial virus
5150859|NCT03049488|Vaccine-Mediated Protection|vaccine-mediated protection
5150860|NCT03049488|Neutralizing Antibody|neutralizing antibody
5150861|NCT03049488|Antibody Response|antibody response
5150862|NCT03049475|Pain|pain
5150863|NCT03049475|Cell Free DNA|cell free dna
5150864|NCT03049475|Inflammatory Markers|inflammatory markers
5150865|NCT03049475|Microparticles|microparticles
5150866|NCT03049475|NETosis|netosis
5150871|NCT03049449|Gene Therapy|gene therapy
5150872|NCT03049449|Adoptive T Cell Therapy|adoptive t cell therapy
5150873|NCT03049449|T-cell infusion|t-cell infusion
5150874|NCT03049449|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5150875|NCT03049436|Physical activity|physical activity
5150876|NCT03049436|cancer|cancer
5150877|NCT03049436|chemotherapy|chemotherapy
5150878|NCT03049436|daily care unit|daily care unit
5150879|NCT03049410|Cystectomy|cystectomy
5150880|NCT03049332|Quality of Life|quality of life
5150881|NCT03049306|Obstructive sleep apnea|obstructive sleep apnea
5150882|NCT03049306|CPAP|cpap
5150883|NCT03049306|Propranolol|propranolol
5150884|NCT03049306|Metabolism|metabolism
5150886|NCT03049267|acne inversa|acne inversa
5150887|NCT03049241|Children|children
5150888|NCT03049241|Neuromuscular fatigue|neuromuscular fatigue
5150889|NCT03049241|Muscle group|muscle group
5150890|NCT03049241|Magnetic Nerve stimulation|magnetic nerve stimulation
5150891|NCT03049241|Muscle length|muscle length
5150892|NCT03049241|Stiffness|stiffness
5150893|NCT03049241|prepubertal children|prepubertal children
5150894|NCT03049241|adults|adults
5150895|NCT03049228|Spectrum Analysis|spectrum analysis
5150896|NCT03049228|Mitochondria|mitochondria
5150897|NCT03049228|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5150898|NCT03049228|Respirometry|respirometry
5150899|NCT03049228|Human|human
5150900|NCT03049228|Heart|heart
5150901|NCT03049150|Urine|urine
5150902|NCT03049150|Mass Spectometry|mass spectometry
5150903|NCT03049150|Observational|observational
5150904|NCT03049098|Eye-tracking|eye-tracking
5150905|NCT03049098|High Fidelity Simulation Training|high fidelity simulation training
5159879|NCT02992067|breast cancer|breast cancer
5150907|NCT03049085|OPCAB|opcab
5150909|NCT03049085|Aspirin|aspirin
5150910|NCT03049020|pelvic organ prolapse|pelvic organ prolapse
5150911|NCT03049020|sacrocolpopexy|sacrocolpopexy
5150912|NCT03049020|pelvic floor ultrasound|pelvic floor ultrasound
5150913|NCT03048994|Glutamine|glutamine
5150914|NCT03048994|Severe sepsis|severe sepsis
5150915|NCT03048916|dysphagia|dysphagia
5150916|NCT03048916|stroke|stroke
5150917|NCT03048916|magnetic resonance imaging|magnetic resonance imaging
5150918|NCT03048916|videofluoroscopy|videofluoroscopy
5150919|NCT03048903|Gastrointestinal dysfunction|gastrointestinal dysfunction
5150920|NCT03048903|sepsis|sepsis
5150921|NCT03048903|trauma|trauma
5150922|NCT03048227|TIDM|tidm
5150923|NCT03048227|Type1diabetes|type1diabetes
5150924|NCT03048227|Implantable Pump|implantable pump
5150925|NCT03048227|CGM|cgm
5150926|NCT03048175|C-reactive protein|c-reactive protein
5150927|NCT03048175|Systemic inflammation|systemic inflammation
5150928|NCT03048175|Third molar|third molar
5150929|NCT03048175|Wisdom tooth|wisdom tooth
5150930|NCT03048123|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5150931|NCT03048123|Transarterial Chemoembolization|transarterial chemoembolization
5150932|NCT03048123|Large and unresectable HCC|large and unresectable hcc
5150933|NCT03047902|Adolescent Smoking Cessation Asthma Carbon Monoxide.|adolescent smoking cessation asthma carbon monoxide.
5150934|NCT03047798|centella asiatica|centella asiatica
5150935|NCT03047798|bamboo salt|bamboo salt
5150936|NCT03047798|magnolia bark|magnolia bark
5150937|NCT03047798|gingivitis|gingivitis
5150938|NCT03047798|dental plaque|dental plaque
5150958|NCT03049124|Feasibility trial|feasibility trial
5150960|NCT03049124|Chemoradiation|chemoradiation
5150961|NCT03049111|Der F (House Dust Mite)|der f (house dust mite)
5150962|NCT03049007|bereavement|bereavement
5150963|NCT03049007|natural grief|natural grief
5150964|NCT03049007|prolonged grief|prolonged grief
5150965|NCT03049007|complicated grief|complicated grief
5150966|NCT03048981|Thrombocyte aggregation|thrombocyte aggregation
5150967|NCT03048981|Fish oil|fish oil
5150968|NCT03048981|Alternative medicine|alternative medicine
5150969|NCT03048981|Point of care testing|point of care testing
5150970|NCT03048981|Coagulation monitoring|coagulation monitoring
5150971|NCT03048968|Exoskeleton Device|exoskeleton device
5150972|NCT03048968|elderly|elderly
5150973|NCT03048968|stroke|stroke
5150974|NCT03048942|Breast cancer|breast cancer
5150975|NCT03048942|HER2 negative|her2 negative
5150976|NCT03048942|Cabazitaxel|cabazitaxel
5150977|NCT03048942|Paclitaxel|paclitaxel
5150978|NCT03048942|Chemotherapy|chemotherapy
5150979|NCT03048890|PAD|pad
5150980|NCT03048877|Radioactive iodine-refractory|radioactive iodine-refractory
5150981|NCT03048877|differentiated thyroid cancer|differentiated thyroid cancer
5150982|NCT03048877|Apatinib|apatinib
5150983|NCT03048877|anti-angiogenesis drugs|anti-angiogenesis drugs
5150984|NCT03048864|Metabolic Screening|metabolic screening
5150985|NCT03048864|24 hour urine|24 hour urine
5150986|NCT03048851|Cerebral palsy|cerebral palsy
5150987|NCT03048851|sensory electrical stimulation|sensory electrical stimulation
5150988|NCT03048851|virtual reality constraint-induced therapy|virtual reality constraint-induced therapy
5150989|NCT03048812|Dental implant|dental implant
5150990|NCT03048812|Mandibular overdenture|mandibular overdenture
5150991|NCT03048812|Cross-over study|cross-over study
5150992|NCT03048786|Peer mentoring|peer mentoring
5150993|NCT03048786|social support|social support
5150994|NCT03048786|text messaging|text messaging
5150995|NCT03048786|smoking cessation|smoking cessation
5150996|NCT03048773|shockwave therapy|shockwave therapy
5150997|NCT03048773|knee osteoarthritis|knee osteoarthritis
5150998|NCT03048760|MRI scan|mri scan
5150999|NCT03048760|Organs at Risk|organs at risk
5151000|NCT03048708|Bariatric surgery|bariatric surgery
5151001|NCT03048708|Leptin|leptin
5151002|NCT03048708|Thyroid function tests|thyroid function tests
5151003|NCT03048617|Primary Mitochondrial Disease|primary mitochondrial disease
5151005|NCT03048617|Myopathy|myopathy
5151006|NCT03048617|exercise intolerance|exercise intolerance
5151007|NCT03048617|muscle pain|muscle pain
5151018|NCT03048552|substance-induced|substance-induced
5151019|NCT03048552|substance abuse|substance abuse
5151020|NCT03048552|substance addiction|substance addiction
5151021|NCT03048552|substance dependence|substance dependence
5151022|NCT03048552|substance use disorders|substance use disorders
5151023|NCT03048539|Endoscopic surgery|endoscopic surgery
5151024|NCT03048539|Thyroidectomy|thyroidectomy
5151025|NCT03048539|Quality of life|quality of life
5151026|NCT03048513|Melioidosis|melioidosis
5151027|NCT03048513|Head and Neck|head and neck
5151028|NCT03048513|Clinical|clinical
5151029|NCT03048474|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
5151031|NCT03048448|Fevipiprant,|fevipiprant,
5151033|NCT03048448|pharmacokinetics|pharmacokinetics
5151034|NCT03048435|Cervical Cancer|cervical cancer
5151035|NCT03048435|Patient Reported Outcomes|patient reported outcomes
5151036|NCT03048435|Radiation Therapy|radiation therapy
5151037|NCT03048435|EORTC QLQ-CX24|eortc qlq-cx24
5151038|NCT03048435|Quality of Life|quality of life
5151039|NCT03048383|Facial paralysis|facial paralysis
5151040|NCT03048383|Facial synkinesis|facial synkinesis
5151041|NCT03048383|Botulinum toxin|botulinum toxin
5151042|NCT03048344|acute promyelocytic leukemia|acute promyelocytic leukemia
5151044|NCT03048344|arsenic trioxide|arsenic trioxide
5962096|NCT04283045|autism|autism
5151045|NCT03048331|Functional Electrical Stimulation|functional electrical stimulation
5151046|NCT03048331|Tetraplegia|tetraplegia
5151047|NCT03048331|Reconstructive Hand Surgery|reconstructive hand surgery
5151048|NCT03048292|Embolectomy|embolectomy
5151049|NCT03048292|Embolus|embolus
5151050|NCT03048292|Thrombectomy|thrombectomy
5151051|NCT03048292|Thrombolysis|thrombolysis
5151052|NCT03048292|Thrombus|thrombus
5151053|NCT03048292|Mobile|mobile
5151054|NCT03048292|Interventional|interventional
5151055|NCT03048292|Neurointervention|neurointervention
5151056|NCT03048292|Stroke|stroke
5151057|NCT03048292|Ischemic|ischemic
5151058|NCT03048292|Acute|acute
5151059|NCT03048292|Endovascular|endovascular
5151060|NCT03048292|Cerebrovascular|cerebrovascular
5151061|NCT03048292|Clot|clot
5445354|NCT01522209|CEIOUS|ceious
5151062|NCT03048292|Stent Retriever|stent retriever
5151063|NCT03048292|Tissue Plasminogen Activator|tissue plasminogen activator
5151064|NCT03048292|Drip and Ship|drip and ship
5151065|NCT03048292|Mothership|mothership
5151066|NCT03048292|Trip and Treat|trip and treat
5151067|NCT03048279|Multiple Endocrine Neoplasia Syndromes|multiple endocrine neoplasia syndromes
5151068|NCT03048279|MEN1|men1
5151069|NCT03048279|MEN2|men2
5151070|NCT03048279|Relatives|relatives
5151071|NCT03048279|Database|database
5151072|NCT03048279|Questionnaires|questionnaires
5151073|NCT03048279|Surveys|surveys
5151074|NCT03048266|Multiple endocrine neoplasia|multiple endocrine neoplasia
5151075|NCT03048266|MEN1|men1
5673414|NCT00608335|Echinocandin|echinocandin
5151076|NCT03048266|Aggressive pancreatic neuroendocrine tumors|aggressive pancreatic neuroendocrine tumors
5151077|NCT03048266|PNET|pnet
5151078|NCT03048266|Non-aggressive pancreatic neuroendocrine tumors|non-aggressive pancreatic neuroendocrine tumors
5151079|NCT03048266|Metabolomics|metabolomics
5151080|NCT03048266|Genetics|genetics
5151081|NCT03048266|Biomarkers|biomarkers
5151082|NCT03048240|Glioblastoma|glioblastoma
5151083|NCT03048214|Nerve block; Infraclavicular; Acute pain|nerve block; infraclavicular; acute pain
5151091|NCT03048149|hazelnut allergy|hazelnut allergy
5151092|NCT03048071|Contegra|contegra
5151093|NCT03048071|Homograft|homograft
5151094|NCT03048045|chronic periodontitis|chronic periodontitis
5151095|NCT03048045|aggressive periodontitis|aggressive periodontitis
5151096|NCT03048045|supportive periodontal treatment|supportive periodontal treatment
5151097|NCT03048032|acute heart failure|acute heart failure
5151098|NCT03048032|right ventricular failure|right ventricular failure
5151099|NCT03048032|cardiac biomarkers|cardiac biomarkers
5151100|NCT03048032|echocardiography|echocardiography
5151101|NCT03048032|diagnosis|diagnosis
5151102|NCT03048032|prognosis|prognosis
5151103|NCT03047980|SWS|sws
5151108|NCT03047915|Emergency department (ED)|emergency department (ed)
5151109|NCT03047876|cardiac|cardiac
5151110|NCT03047876|aortic arch surgery|aortic arch surgery
5151111|NCT03047876|Brain vascular reactivity|brain vascular reactivity
5151112|NCT03047876|neonates|neonates
5151113|NCT03047876|infants|infants
5151114|NCT03047863|Epidermal Growth Factor|epidermal growth factor
5151115|NCT03047850|Sternotomy|sternotomy
5151116|NCT03047837|Colorectal cancer|colorectal cancer
5151117|NCT03047837|aspirin|aspirin
5151118|NCT03047837|metformin|metformin
5151119|NCT03047837|chemoprevention|chemoprevention
5151120|NCT03047785|Myocardial Infarction|myocardial infarction
5151121|NCT03047785|Highly sensitive troponin|highly sensitive troponin
5151122|NCT03047785|Hospital population|hospital population
5151123|NCT03047785|99th percentile|99th percentile
5151124|NCT03047785|Upper limit of normal|upper limit of normal
5151125|NCT03047720|bedwetting|bedwetting
5151126|NCT03047707|ultrasound elastography|ultrasound elastography
5151127|NCT03047707|S-Shearwave|s-shearwave
5151128|NCT03047707|liver|liver
5151129|NCT03047707|fibrosis|fibrosis
5151130|NCT03047694|Lexico-semantic stimulation|lexico-semantic stimulation
5151131|NCT03047694|tactile tablet|tactile tablet
5151132|NCT03047642|biomarker|biomarker
5151133|NCT03047642|low and middle income countries|low and middle income countries
5151134|NCT03047642|fever|fever
5151135|NCT03047642|antimicrobial resistance|antimicrobial resistance
5151136|NCT03047642|diagnostic|diagnostic
5151137|NCT03047629|non-motor symptoms|non-motor symptoms
5151138|NCT03047603|Hepatocellular carcinoma|hepatocellular carcinoma
5151139|NCT03047603|Protein induced by vitamin K absence or antagonist-II|protein induced by vitamin k absence or antagonist-ii
5151141|NCT03047603|Des-γ-carboxy prothrombin|des-γ-carboxy prothrombin
5151143|NCT03047603|Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein|lens culinaris agglutinin-reactive fraction of alpha-fetoprotein-fetoprotein
5151144|NCT03047590|exercise behavior|exercise behavior
5151145|NCT03047590|exercise prescription|exercise prescription
5151146|NCT03047590|affect-based exercise|affect-based exercise
5151147|NCT03047590|affect-guided exercise|affect-guided exercise
5151148|NCT03047590|self-paced exercise|self-paced exercise
5151149|NCT03047590|self-selected exercise|self-selected exercise
5151150|NCT03047577|Brief intervention|brief intervention
5151151|NCT03047577|Alcohol|alcohol
5151152|NCT03047577|Alcohol use disorder|alcohol use disorder
5151153|NCT03047577|Intensive care unit|intensive care unit
5151154|NCT03047577|Critically ill|critically ill
5151155|NCT03047577|Audit|audit
5151156|NCT03047564|Total Knee Arthroplasty|total knee arthroplasty
5151157|NCT03047564|Total Knee Replacement|total knee replacement
5151158|NCT03047564|Outcome|outcome
5151159|NCT03047564|Metal ion concentration|metal ion concentration
5151160|NCT03047564|Results|results
5151161|NCT03047551|Abortion, induced|abortion, induced
5151162|NCT03047551|Ultrasonography|ultrasonography
5037505|NCT03764527|Coartem|coartem
5151163|NCT03047551|Health Services accessibility|health services accessibility
5151164|NCT03047551|Pragmatic Clinical Trial|pragmatic clinical trial
5151165|NCT03047551|Randomized controlled trial as topic|randomized controlled trial as topic
5151166|NCT03047538|Arterial hypertension|arterial hypertension
5151167|NCT03047538|Dyslipidemia|dyslipidemia
5151168|NCT03047538|Blood pressure control|blood pressure control
5151169|NCT03047538|Fixed combination|fixed combination
5151170|NCT03047525|cytokine-induced killer cell|cytokine-induced killer cell
5151171|NCT03047525|dendritic and cytokine-induced killer cells|dendritic and cytokine-induced killer cells
5151172|NCT03047512|Depression in adolescents|depression in adolescents
5151173|NCT03047512|Mental Health|mental health
5151174|NCT03047512|E-mental health|e-mental health
5151175|NCT03047512|Prevention and Early intervention|prevention and early intervention
5151176|NCT03047486|insulin pump|insulin pump
5151177|NCT03047486|continuous glucose monitoring sensor|continuous glucose monitoring sensor
5151178|NCT03047486|predictive low glucose suspend|predictive low glucose suspend
5151179|NCT03047473|newly diagnosed|newly diagnosed
5151180|NCT03047460|motor evoked potential|motor evoked potential
5151181|NCT03047460|somatosensory evoked potentials|somatosensory evoked potentials
5151182|NCT03047460|biomarker|biomarker
5151183|NCT03047395|ABBV-066|abbv-066
5151184|NCT03047395|BI 655066|bi 655066
5151185|NCT03047369|leukodystrophy|leukodystrophy
5151186|NCT03047369|white matter disease|white matter disease
5151187|NCT03047369|leukoencephalopathy|leukoencephalopathy
5151189|NCT03047369|demyelinating|demyelinating
5151190|NCT03047369|mdbp|mdbp
5151191|NCT03047343|pulmonary artery strapping|pulmonary artery strapping
5151192|NCT03047330|menopause|menopause
5151193|NCT03047330|sleep fragmentation|sleep fragmentation
5151194|NCT03047330|leuprolide|leuprolide
5151195|NCT03047330|adipokine|adipokine
5151197|NCT03047330|leptin|leptin
5151201|NCT03047226|mismatch repair|mismatch repair
5151202|NCT03047226|microsatellite instability|microsatellite instability
5151203|NCT03047226|next-generation sequencing|next-generation sequencing
5151204|NCT03047226|immunohistochemistry|immunohistochemistry
5151205|NCT03047200|Diabetes Mellitus|diabetes mellitus
5151206|NCT03047200|Hypoglycemia|hypoglycemia
5151207|NCT03047200|Hyperglycemia|hyperglycemia
5151208|NCT03047200|Type 1 Diabetes|type 1 diabetes
5151209|NCT03047200|Islet Cell Transplantation|islet cell transplantation
5151210|NCT03047174|Head and Neck Neoplasms, Radio(chemo)therapy|head and neck neoplasms, radio(chemo)therapy
5151211|NCT03047161|magnetocardiography|magnetocardiography
5151213|NCT03047122|Breast|breast
5151214|NCT03047122|ultrasonography|ultrasonography
5151215|NCT03047109|Ephedrine|ephedrine
5151216|NCT03047109|Phenylephrine|phenylephrine
5151217|NCT03047109|Spinal Hypotension|spinal hypotension
5151218|NCT03047109|Cesarean Section|cesarean section
5151219|NCT03047109|Maternal Cardiodynamics|maternal cardiodynamics
5151220|NCT03047083|Retrospective|retrospective
5151221|NCT03047083|Non-interventional Study|non-interventional study
5151222|NCT03047083|FMS-like tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
5151223|NCT03047044|lumbar fusion surgery|lumbar fusion surgery
5151224|NCT03047044|Patient Controlled Analgesia|patient controlled analgesia
5151225|NCT03047044|Optimizing Basal Infusion Mode|optimizing basal infusion mode
5151226|NCT03047018|Nutrition|nutrition
5151227|NCT03046992|EGFR|egfr
5151228|NCT03046992|Non-Small Cell Lung Cancer|non-small cell lung cancer
5151229|NCT03046992|T790M|t790m
5151230|NCT03046992|Brain Metastasis|brain metastasis
5151231|NCT03046979|apatinib|apatinib
5151232|NCT03046979|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5151233|NCT03046953|Lymphoma|lymphoma
5151234|NCT03046927|Type 1 diabetes|type 1 diabetes
5151235|NCT03046927|vitamin D|vitamin d
5151236|NCT03046927|honeymoon phase|honeymoon phase
5151241|NCT03046849|next-generation sequencing|next-generation sequencing
5151242|NCT03046849|germline mutation|germline mutation
5151244|NCT03046836|Oxytocin|oxytocin
5151245|NCT03046836|Aggression|aggression
5151246|NCT03046836|Alcohol|alcohol
5151247|NCT03046771|falls|falls
5151248|NCT03046771|readmissions|readmissions
5151249|NCT03046771|emergency department visits|emergency department visits
5151250|NCT03046771|transitions of care|transitions of care
5151252|NCT03046732|Kidney Transplant Education|kidney transplant education
5151253|NCT03046732|Transplant Readiness|transplant readiness
5151254|NCT03046732|Living Donor Kidney Transplant|living donor kidney transplant
5151255|NCT03046732|Chronic Kidney Disease|chronic kidney disease
5151256|NCT03046732|End Stage Kidney Disease|end stage kidney disease
5151257|NCT03046732|Renal Replacement Therapy|renal replacement therapy
5151258|NCT03046719|bupivacaine|bupivacaine
5962097|NCT04283045|JASPER|jasper
5151259|NCT03046719|intravitreal|intravitreal
5151260|NCT03046719|analgesia|analgesia
5151261|NCT03046719|silicone oil removal|silicone oil removal
5151262|NCT03046719|retinal detachment|retinal detachment
5151263|NCT03046719|subconjunctival|subconjunctival
5151264|NCT03046706|voice rest|voice rest
5151265|NCT03046706|laryngeal surgery|laryngeal surgery
5151266|NCT03046706|glottic polyp|glottic polyp
5151267|NCT03046706|glottic cyst|glottic cyst
5151268|NCT03046693|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
5151269|NCT03046693|pattern electroretinography|pattern electroretinography
5151270|NCT03046693|citicoline|citicoline
5151271|NCT03046693|retinal ganglion cell|retinal ganglion cell
5151272|NCT03046693|visual field|visual field
5151273|NCT03046667|Beta glucans|beta glucans
5151275|NCT03046667|SCFA|scfa
5151276|NCT03046667|Calprotectin|calprotectin
5151277|NCT03046667|Microbiota|microbiota
5151278|NCT03046667|Hydrogene|hydrogene
5151279|NCT03046667|Methane|methane
5151280|NCT03046667|Metabolomics|metabolomics
5151281|NCT03046667|Stool volume|stool volume
5151282|NCT03046667|Stool frequency|stool frequency
5151283|NCT03046641|Caloric Restriction|caloric restriction
5151284|NCT03046641|Dietary Formulations|dietary formulations
5151285|NCT03046641|Exercise|exercise
5151286|NCT03046641|Men|men
5151287|NCT03046615|EEG electrodes|eeg electrodes
5151288|NCT03046563|acupressure|acupressure
5151289|NCT03046563|abdominal massage|abdominal massage
5151290|NCT03046563|constipation|constipation
5151291|NCT03046563|stroke patients|stroke patients
5151292|NCT03046563|Traditional Chinese medicine|traditional chinese medicine
5151293|NCT03046524|Parathyroid Carcinoma|parathyroid carcinoma
5151793|NCT03043378|Surveys|surveys
5151298|NCT03046485|self-management strategies|self-management strategies
5151299|NCT03046485|low-vision rehabilitation|low-vision rehabilitation
5151300|NCT03046485|IVI|ivi
5151301|NCT03046472|thorax curve angle|thorax curve angle
5151302|NCT03046459|cytokines|cytokines
5151303|NCT03046459|interleukin-2|interleukin-2
5151304|NCT03046459|Safety Issues|safety issues
5151305|NCT03046446|Osteoarthritis|osteoarthritis
5151306|NCT03046446|Knee|knee
5151307|NCT03046446|Pain|pain
5151308|NCT03046446|Steroid|steroid
5151309|NCT03046446|Intra-articular|intra-articular
5151310|NCT03046446|Injection|injection
5151311|NCT03046433|children|children
5151312|NCT03046433|asthma|asthma
5151313|NCT03046433|China|china
5151314|NCT03046394|prosthetic feet|prosthetic feet
5151315|NCT03046394|gait pattern|gait pattern
5151316|NCT03046394|one leg standing|one leg standing
5151317|NCT03046394|walking speed|walking speed
5151318|NCT03046342|Gastroenteritis, Polymerase chain reaction|gastroenteritis, polymerase chain reaction
5151319|NCT03046329|patient care planning|patient care planning
5151320|NCT03046316|Therapeutics|therapeutics
5151321|NCT03046303|ERAS,gastric cancer|eras,gastric cancer
5151322|NCT03046264|central blood pressure|central blood pressure
5151323|NCT03046264|measurement|measurement
5151324|NCT03046264|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
5151325|NCT03046186|Gastric sleeve|gastric sleeve
5151326|NCT03046186|Gastric bypass|gastric bypass
5151327|NCT03046160|PPT|ppt
5151328|NCT03046160|Scapula|scapula
5151329|NCT03046160|Intervention|intervention
5151330|NCT03046160|Manual therapy|manual therapy
5151331|NCT03046160|mobilization|mobilization
5151336|NCT03046095|Muscle Hypertrophy|muscle hypertrophy
5151337|NCT03046095|Muscle Atrophy|muscle atrophy
5151338|NCT03046095|Resistance Training|resistance training
5151339|NCT03046095|Immobilization|immobilization
5151340|NCT03046069|Triple therapy|triple therapy
5151341|NCT03046069|COPD|copd
5151342|NCT03046069|DCE|dce
5151343|NCT03046069|Qualitative|qualitative
5151344|NCT03046004|breast cancer|breast cancer
5151345|NCT03046004|screening|screening
5151346|NCT03046004|decision aid|decision aid
5151347|NCT03046004|informed choice|informed choice
5151348|NCT03046004|decisional conflict|decisional conflict
5151349|NCT03045965|Salpingectomy|salpingectomy
5151350|NCT03045965|Hysterectomy|hysterectomy
5151351|NCT03045965|Ovarian cancer|ovarian cancer
5151352|NCT03045952|Multicenter study|multicenter study
5151353|NCT03045952|microwave|microwave
5151354|NCT03045939|cervical ripening|cervical ripening
5151355|NCT03045939|labor induction|labor induction
5151356|NCT03045939|double balloon device|double balloon device
5151357|NCT03045939|cervical ripening device|cervical ripening device
5151358|NCT03045939|unfavorable cervix|unfavorable cervix
5151359|NCT03045913|Observational registry|observational registry
5151360|NCT03045913|All-comers open label registry|all-comers open label registry
5151361|NCT03045913|Genoss DES|genoss des
5151362|NCT03045913|Multicenter|multicenter
5151363|NCT03045913|Stenting|stenting
5151364|NCT03045913|Coronary Artery Disease|coronary artery disease
5151365|NCT03045913|Coronary revascularization|coronary revascularization
5151366|NCT03045913|Percutaneous Coronary Intervention|percutaneous coronary intervention
5151367|NCT03045887|repeat dose|repeat dose
5151368|NCT03045887|GSK2292767|gsk2292767
5151369|NCT03045887|smoke|smoke
5151370|NCT03045887|tolerability|tolerability
5151371|NCT03045887|safety|safety
5151372|NCT03045887|dry powder inhalation|dry powder inhalation
5151373|NCT03045887|pharmacokinetics|pharmacokinetics
5151374|NCT03045887|single dose|single dose
5445355|NCT01522196|SCD|scd
5151375|NCT03045848|Observational registry|observational registry
5151376|NCT03045848|All-comers open label registry|all-comers open label registry
5151377|NCT03045848|Drug coated stent|drug coated stent
5151378|NCT03045848|Multicenter|multicenter
5151379|NCT03045848|Stenting|stenting
5151380|NCT03045848|Coronary Artery Disease|coronary artery disease
5151381|NCT03045848|Coronary revascularization|coronary revascularization
5151382|NCT03045848|Percutaneous Coronary Intervention|percutaneous coronary intervention
5356857|NCT01917721|coronary artery aneurysm|coronary artery aneurysm
5151383|NCT03045835|laparoscopic cholecystectomy BASKA mask Endotracheal tube|laparoscopic cholecystectomy baska mask endotracheal tube
5151384|NCT03045822|Bioimpedance analysis|bioimpedance analysis
5151385|NCT03045822|implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
5151386|NCT03045822|pacemakers|pacemakers
5151387|NCT03045809|Syndromic management|syndromic management
5151388|NCT03045809|Point of care testing|point of care testing
5151389|NCT03045783|gastric varices|gastric varices
5151390|NCT03045783|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
5151391|NCT03045731|kidney transplantation|kidney transplantation
5151392|NCT03045731|ultrasound|ultrasound
5151393|NCT03045731|mathematical model|mathematical model
5151991|NCT03042377|Retreatment|retreatment
5151394|NCT03045718|Horticultural Therapy|horticultural therapy
5151395|NCT03045718|Dementia|dementia
5151396|NCT03045718|Randomized Controlled Trial|randomized controlled trial
5151397|NCT03045718|Elderly|elderly
5151398|NCT03045718|Prevention|prevention
5151399|NCT03045692|drug dosing, eGFR, CCr|drug dosing, egfr, ccr
5151400|NCT03045679|Roux-en Y gastric bypass|roux-en y gastric bypass
5151401|NCT03045679|One-anastomosis gastric bypass|one-anastomosis gastric bypass
5151402|NCT03045679|Mini-gastric bypass|mini-gastric bypass
5151403|NCT03045679|metabolic surgery|metabolic surgery
5151404|NCT03045653|Breast Cancer|breast cancer
5151405|NCT03045653|high dose Tamoxifen|high dose tamoxifen
5151418|NCT03045601|Echocardiography, Stress|echocardiography, stress
5151419|NCT03045510|Decitabine Myelodysplastic syndrome|decitabine myelodysplastic syndrome
5151420|NCT03045484|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5151421|NCT03045484|Oral Mucositis Pain|oral mucositis pain
5151422|NCT03045484|Oxycodone|oxycodone
5151423|NCT03045458|one stage dental implant|one stage dental implant
5151424|NCT03045458|two stage dental implant|two stage dental implant
5151425|NCT03045458|Interleukin-1β|interleukin-1β
5151427|NCT03045445|dual energy|dual energy
5151428|NCT03045445|low dose|low dose
5151429|NCT03045432|Stroke|stroke
5151430|NCT03045432|Hemiplegia|hemiplegia
5151431|NCT03045432|Rotator Cuff Injury|rotator cuff injury
5151433|NCT03045419|gadoxetic acid|gadoxetic acid
5151434|NCT03045419|CT|ct
5151435|NCT03045393|Neoadjuvant|neoadjuvant
5151436|NCT03045393|Breast Cancer|breast cancer
5151437|NCT03045393|Folate Receptor Alpha|folate receptor alpha
5151438|NCT03045393|FRa|fra
5151439|NCT03045393|TNBC|tnbc
5151440|NCT03045393|Triple Negative Breast Cancer|triple negative breast cancer
5151441|NCT03045393|Preoperative|preoperative
5151442|NCT03045393|Presurgery|presurgery
5151443|NCT03045393|Mirvetuximab Soravtansine|mirvetuximab soravtansine
5151444|NCT03045393|IMGN853|imgn853
5151445|NCT03045367|Metamorphopsia|metamorphopsia
5151446|NCT03045367|Epiretinal membrane|epiretinal membrane
5151447|NCT03045367|Vitrectomy|vitrectomy
5151448|NCT03045354|children|children
5151449|NCT03045354|dietary carbohydrates|dietary carbohydrates
5151450|NCT03045354|satiety|satiety
5151451|NCT03045354|appetite|appetite
5151452|NCT03045354|blood glucose|blood glucose
5151453|NCT03045354|solanum tuberosum|solanum tuberosum
5151455|NCT03045354|breakfast|breakfast
5151456|NCT03045276|Spina Bifida|spina bifida
5151457|NCT03045276|Kidney Transplant|kidney transplant
5151458|NCT03045263|ASD|asd
5151459|NCT03045237|Pregnancy|pregnancy
5151460|NCT03045237|Physical activity|physical activity
5151461|NCT03045237|Newborn|newborn
5151462|NCT03045237|Depressive Symptoms|depressive symptoms
5151463|NCT03045237|Dietary habits|dietary habits
5151464|NCT03045237|Healthy lifestyles|healthy lifestyles
5151465|NCT03045224|PAD, PTA, mortality, morbidity, amputation rate, quality of life|pad, pta, mortality, morbidity, amputation rate, quality of life
5151466|NCT03045224|Percutaneous transluminal angioplasty (PTA), Stenting, balloon angioplasty|percutaneous transluminal angioplasty (pta), stenting, balloon angioplasty
5151467|NCT03045198|cystic fibrosis|cystic fibrosis
5151468|NCT03045185|Non Vital teeth|non vital teeth
5151469|NCT03045185|Traumatised teeth|traumatised teeth
5151470|NCT03045185|Immature teeth|immature teeth
5151471|NCT03045185|Regenerative Endodontics|regenerative endodontics
5151472|NCT03045172|Lichen Sclerosus|lichen sclerosus
5151473|NCT03045172|Platelet Rich Plasma|platelet rich plasma
5151474|NCT03045172|Vulvar|vulvar
5151475|NCT03045172|Vulva|vulva
5151476|NCT03045159|deployment cycle|deployment cycle
5023581|NCT03850132|Cancer|cancer
5151477|NCT03045159|military family|military family
5151478|NCT03045159|prevention|prevention
5151479|NCT03045159|stress|stress
5151480|NCT03045159|military child|military child
5151481|NCT03045159|parenting|parenting
5151482|NCT03045159|coparenting|coparenting
5151483|NCT03045146|Acute Ischemic Stroke, Thrombectomy|acute ischemic stroke, thrombectomy
5151484|NCT03045133|Postoperative pain|postoperative pain
5151485|NCT03045133|Postoperative nausea and vomiting|postoperative nausea and vomiting
5151486|NCT03045133|Quality of recovery|quality of recovery
5151487|NCT03045133|QoR-40|qor-40
5151488|NCT03045133|Total intravenous anesthesia|total intravenous anesthesia
5151489|NCT03045107|right colon|right colon
5151490|NCT03045107|laparoscopic right colectomy|laparoscopic right colectomy
5160468|NCT02988466|Burkitt's lymphoma|burkitt's lymphoma
5151491|NCT03045107|intracorporeal anastomosis|intracorporeal anastomosis
5151492|NCT03045107|extracorporeal anastomosis|extracorporeal anastomosis
5151493|NCT03045107|hospital stay|hospital stay
5151494|NCT03045107|quality of life|quality of life
5151496|NCT03045094|pediatric|pediatric
5151497|NCT03045094|intubation|intubation
5151498|NCT03045094|neck movement|neck movement
5151499|NCT03045055|Acute ischemic stroke|acute ischemic stroke
5151500|NCT03045055|Endovascular treatment|endovascular treatment
5151501|NCT03045055|Remote ischemic conditioning|remote ischemic conditioning
5151502|NCT03045042|Pompe|pompe
5151503|NCT03045042|microRNA|microrna
5151504|NCT03045042|biomarker|biomarker
5151505|NCT03045042|muscle MRI|muscle mri
5151506|NCT03045042|glycogenosis|glycogenosis
5151507|NCT03045029|PAH|pah
5151508|NCT03045029|Oral Treprostiinil|oral treprostiinil
5151509|NCT03045029|Orenitram|orenitram
5151510|NCT03045016|Acute stress Disorder|acute stress disorder
5151511|NCT03045016|Post Traumatic Stress Disorder|post traumatic stress disorder
5151512|NCT03045016|Prevention|prevention
5151513|NCT03045016|trauma|trauma
5151514|NCT03045016|prazosin|prazosin
5151515|NCT03045003|Resilience, Supportive Care, Psychosocial Care, Nursing|resilience, supportive care, psychosocial care, nursing
5151516|NCT03044990|Acute coronary syndrome|acute coronary syndrome
5151517|NCT03044990|renal insufficiency|renal insufficiency
5151518|NCT03044990|mortality|mortality
5151519|NCT03044977|3-Iodobenzylguanidine|3-iodobenzylguanidine
5151520|NCT03044977|dose-response relationship, radiation|dose-response relationship, radiation
5151521|NCT03044977|theranostic|theranostic
5151522|NCT03044977|radionuclide|radionuclide
5151523|NCT03044977|MIBG|mibg
5151524|NCT03044977|DOTA|dota
5151525|NCT03044964|Angina, Chest Pain|angina, chest pain
5151526|NCT03044951|atrial fibrillation|atrial fibrillation
5151527|NCT03044951|cryoablation|cryoablation
5151528|NCT03044951|irrigated radiofrequency ablation|irrigated radiofrequency ablation
5151529|NCT03044951|pulmonary vein isolation|pulmonary vein isolation
5151530|NCT03044938|Asthma|asthma
5151531|NCT03044938|Salbutamol|salbutamol
5151532|NCT03044938|Exercise|exercise
5151533|NCT03044938|Heart Rate|heart rate
5151534|NCT03044938|Blood pressure|blood pressure
5151535|NCT03044925|persistent atrial fibrillation|persistent atrial fibrillation
5151536|NCT03044925|remote magnetic navigation|remote magnetic navigation
5151537|NCT03044925|cryoablation|cryoablation
5151538|NCT03044899|Surgery|surgery
5151539|NCT03044899|Complications|complications
5151540|NCT03044899|Mortality|mortality
5151541|NCT03044886|Vitamin D|vitamin d
5151542|NCT03044821|Neural Tube Defect|neural tube defect
5151543|NCT03044795|homologous recombination deficiency|homologous recombination deficiency
5151544|NCT03044795|veliparib|veliparib
5151545|NCT03044795|PARP inhibitor|parp inhibitor
5151546|NCT03044795|biomarker|biomarker
5151547|NCT03044769|Congenital Lung Anomalies|congenital lung anomalies
5151548|NCT03044756|GnRH antagonist|gnrh antagonist
5151549|NCT03044756|Pituitary downregulation|pituitary downregulation
5151550|NCT03044756|IVF|ivf
5151551|NCT03044756|ICSI|icsi
5151552|NCT03044743|PD-1|pd-1
5151553|NCT03044743|CRISPR Cas9|crispr cas9
5151555|NCT03044743|advanced stage malignancies|advanced stage malignancies
5151556|NCT03044717|Nutrition Education|nutrition education
5151557|NCT03044717|Cardiology Fellows|cardiology fellows
5151558|NCT03044652|Vulvovaginal Dryness|vulvovaginal dryness
5151559|NCT03044626|Nivolumab|nivolumab
5151560|NCT03044626|Radiotherapy|radiotherapy
5151561|NCT03044600|Parathyroid disease|parathyroid disease
5151562|NCT03044600|Hyperparathyroidism|hyperparathyroidism
5151563|NCT03044600|Chart review|chart review
5151564|NCT03044600|MEN1-negative|men1-negative
5151565|NCT03044600|HRPT2 mutations|hrpt2 mutations
5151566|NCT03044587|Biliary Tract Cancer|biliary tract cancer
5151567|NCT03044587|NaI-IRI|nai-iri
5151568|NCT03044574|venous thromboembolism|venous thromboembolism
5151569|NCT03044574|deep vein thrombosis|deep vein thrombosis
5151570|NCT03044574|pulmonary embolism|pulmonary embolism
5151571|NCT03044574|prevention|prevention
5962098|NCT04283045|JasPEER|jaspeer
5151572|NCT03044574|intermittent pneumatic compression|intermittent pneumatic compression
5151573|NCT03044574|sequential pneumatic compression|sequential pneumatic compression
5151574|NCT03044574|surgery|surgery
5151575|NCT03044574|elastic compression|elastic compression
5151576|NCT03044574|low-molecular weight heparin|low-molecular weight heparin
5151577|NCT03044574|prophylaxis|prophylaxis
5151578|NCT03044535|quality of life|quality of life
5151579|NCT03044535|mechanical circulatory support|mechanical circulatory support
5151580|NCT03044509|Immunodiagnostics tests|immunodiagnostics tests
5151581|NCT03044509|TB exposure|tb exposure
5151582|NCT03044509|Latent TB|latent tb
5151583|NCT03044509|TB disease|tb disease
5151584|NCT03044509|Biomarkers|biomarkers
5151585|NCT03044496|NIR Spectroscopy|nir spectroscopy
5151586|NCT03044496|Nerve Blockade|nerve blockade
5151587|NCT03044496|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
5151588|NCT03044483|Sepsis|sepsis
5151589|NCT03044483|Microcirculatory function|microcirculatory function
5151590|NCT03044444|performance|performance
5151591|NCT03044444|polyphenols|polyphenols
5151608|NCT03044392|Programmed Intermittent Epidural Bolus|programmed intermittent epidural bolus
5151610|NCT03044392|Pain|pain
5151611|NCT03044353|echocardiography (ECHO)|echocardiography (echo)
5151612|NCT03044353|skin biopsy|skin biopsy
5151613|NCT03044353|monoclonal anti-serum amyloid p component antibody (anti-SAP mAb)|monoclonal anti-serum amyloid p component antibody (anti-sap mab)
5151614|NCT03044353|Amyloidosis|amyloidosis
5151615|NCT03044353|cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
5151616|NCT03044353|biomarkers|biomarkers
5151617|NCT03044353|cardiac functional measures|cardiac functional measures
5151618|NCT03044353|left ventricular mass|left ventricular mass
5151626|NCT03044223|pseudomonas aeruginosa|pseudomonas aeruginosa
5151627|NCT03044223|critically ill patient|critically ill patient
5151628|NCT03044223|sepsis|sepsis
5151629|NCT03044223|monocyte|monocyte
5151630|NCT03044223|macrophage|macrophage
5151631|NCT03044223|cytokine|cytokine
5151632|NCT03044223|severity of disease|severity of disease
5151633|NCT03044210|Rest energetic cost measured by indirect calorimetry|rest energetic cost measured by indirect calorimetry
5151634|NCT03044210|Hormonal axis|hormonal axis
5151635|NCT03044210|Mitochondrial oxidative phosphorylation|mitochondrial oxidative phosphorylation
5151636|NCT03044210|Basal metabolism|basal metabolism
5151637|NCT03044197|prostate cancer|prostate cancer
5151638|NCT03044197|magnetic resonance imaging|magnetic resonance imaging
5151639|NCT03044197|transperineal biopsy|transperineal biopsy
5151640|NCT03044197|target lesion|target lesion
5151641|NCT03044197|fusion biopsy|fusion biopsy
5151642|NCT03044184|Tranexamic Acid|tranexamic acid
5151643|NCT03044184|Antifibrinolytic|antifibrinolytic
5151644|NCT03044158|tuberculosis|tuberculosis
5151645|NCT03044158|implementation science|implementation science
5151646|NCT03044158|point-of-care|point-of-care
5151647|NCT03044158|diagnostics|diagnostics
5151648|NCT03044158|GeneXpert|genexpert
5151649|NCT03044158|Uganda|uganda
5151650|NCT03044145|Cultural Competence|cultural competence
5151651|NCT03044145|Patient-Clinician communication|patient-clinician communication
5151652|NCT03044132|Diabetic Foot Ulcer|diabetic foot ulcer
5151653|NCT03044132|DFU|dfu
5151654|NCT03044132|Lower Extremity Wound|lower extremity wound
5151655|NCT03044132|Skin Substitute|skin substitute
5151656|NCT03044106|hamstrings|hamstrings
5151657|NCT03044106|flexibility|flexibility
5151658|NCT03044106|strength|strength
5151659|NCT03044106|pain pressure threshold|pain pressure threshold
5151660|NCT03044106|lllt|lllt
5151661|NCT03044106|photobiomodulation|photobiomodulation
5151662|NCT03044106|cranial reflex|cranial reflex
5151663|NCT03044106|cranial laser reflex technique|cranial laser reflex technique
5151664|NCT03044106|CLRT|clrt
5151665|NCT03044080|Walking Disorder|walking disorder
5151666|NCT03044080|Stroke|stroke
5151667|NCT03044080|Botulinum Toxin|botulinum toxin
5151668|NCT03044080|Spasticity|spasticity
5151669|NCT03044067|Chronic pain|chronic pain
5151670|NCT03044067|Fibromyalgia|fibromyalgia
5151671|NCT03044067|Pain neuroscience education|pain neuroscience education
5151672|NCT03044067|Exercise|exercise
5151673|NCT03044054|HIFU|hifu
5151674|NCT03044041|Blood loss|blood loss
5151676|NCT03044041|Total knee arthroplasty|total knee arthroplasty
5151677|NCT03044041|Topical administration|topical administration
5151683|NCT03043976|Physical activity|physical activity
5151684|NCT03043976|Steps count|steps count
5151685|NCT03043950|mCRC|mcrc
5151686|NCT03043950|First line|first line
5151687|NCT03043950|Panitumumab|panitumumab
5151688|NCT03043950|mCCS Prognostic Score|mccs prognostic score
5151689|NCT03043950|Prognosis|prognosis
5151690|NCT03043950|Ras wild type|ras wild type
5151691|NCT03043924|hypothalamus|hypothalamus
5151692|NCT03043924|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5151696|NCT03043911|sepsis|sepsis
5151697|NCT03043872|Carcinoma, Small Cell Lung|carcinoma, small cell lung
5151698|NCT03043872|Oat Cell Carcinoma of Lung|oat cell carcinoma of lung
5151699|NCT03043872|Oat Cell Lung Cancer|oat cell lung cancer
5151700|NCT03043872|Small Cell Cancer Of The Lung|small cell cancer of the lung
5151701|NCT03043872|Small Cell Lung Cancer|small cell lung cancer
5151702|NCT03043846|Treat to Target approach|treat to target approach
5151703|NCT03043820|raloxifene|raloxifene
5151704|NCT03043820|selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
5151705|NCT03043820|schizophrenia|schizophrenia
5151706|NCT03043820|psychosis|psychosis
5151707|NCT03043820|cognition|cognition
5151708|NCT03043820|negative symptoms|negative symptoms
5160664|NCT02987400|AGMT|agmt
5151716|NCT03043768|Autonomic|autonomic
5151717|NCT03043768|Diagnosis|diagnosis
5151718|NCT03043768|Pilomotor|pilomotor
5151719|NCT03043768|Alpha-synuclein|alpha-synuclein
5151720|NCT03043768|Axon-reflex|axon-reflex
5151721|NCT03043768|Peripheral nerve fibers|peripheral nerve fibers
5151722|NCT03043729|neoadjuvant|neoadjuvant
5151723|NCT03043729|MRI-defined T3|mri-defined t3
5151724|NCT03043729|mFOLFOX6|mfolfox6
5151726|NCT03043690|menopause|menopause
5151727|NCT03043690|ammonium succinate|ammonium succinate
5151732|NCT03043651|Pulmonary Hypertension|pulmonary hypertension
5151734|NCT03043651|6-Minute Walk Test|6-minute walk test
5151735|NCT03043651|Oral Treprostinil|oral treprostinil
5151736|NCT03043638|multiple adjacent gingival recessions|multiple adjacent gingival recessions
5151737|NCT03043638|platelet rich plasma|platelet rich plasma
5151738|NCT03043638|acellular dermal matrix|acellular dermal matrix
5151739|NCT03043638|coronally advanced flap|coronally advanced flap
5151740|NCT03043638|gingival recession|gingival recession
5151741|NCT03043638|root coverage|root coverage
5151742|NCT03043638|clinical attachment level|clinical attachment level
5151743|NCT03043625|Neck pain|neck pain
5151744|NCT03043625|visceral manipulation|visceral manipulation
5151745|NCT03043625|functional dyspepsia|functional dyspepsia
5151746|NCT03043625|electromyography|electromyography
5151747|NCT03043625|pain|pain
5151748|NCT03043612|Ureteroscopy for urolithiasis|ureteroscopy for urolithiasis
5151749|NCT03043599|Thoracic|thoracic
5151750|NCT03043599|Radiotherapy|radiotherapy
5151751|NCT03043599|Platinum Based Chemotherapy|platinum based chemotherapy
5151752|NCT03043599|Immunotherapy|immunotherapy
5151753|NCT03043599|Ipilimumab|ipilimumab
5151754|NCT03043599|Nivolumab|nivolumab
5151755|NCT03043599|Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)|extensive-stage disease small cell lung cancer (ed-sclc)
5151756|NCT03043586|Acromegaly|acromegaly
5151757|NCT03043560|depression|depression
5151758|NCT03043560|anhedonia|anhedonia
5151759|NCT03043560|reward|reward
5151760|NCT03043547|nal-IRI|nal-iri
5151761|NCT03043547|5-Fluorouracil|5-fluorouracil
5151762|NCT03043508|Genetic mutation|genetic mutation
5151763|NCT03043508|MEN1|men1
5151764|NCT03043508|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5151765|NCT03043508|PNET|pnet
5151766|NCT03043508|Chart review|chart review
5151767|NCT03043508|Questionnaire|questionnaire
5151768|NCT03043508|Survey|survey
5151769|NCT03043495|dexamethasone|dexamethasone
5151770|NCT03043495|supraclavicular brachial plexus block|supraclavicular brachial plexus block
5151771|NCT03043495|ultrasound|ultrasound
5151772|NCT03043482|VS-105|vs-105
5151773|NCT03043482|Renal Insufficiency, Chronic|renal insufficiency, chronic
5151774|NCT03043482|Secondary hyperparathyroidism|secondary hyperparathyroidism
5151775|NCT03043469|dysfunctional breathing|dysfunctional breathing
5151776|NCT03043443|sleep|sleep
5151777|NCT03043443|Alcohol dependence|alcohol dependence
5151778|NCT03043443|Melatonin|melatonin
5151779|NCT03043417|Stigma|stigma
5151780|NCT03043417|Primary Health Care|primary health care
5151781|NCT03043417|Recovery|recovery
5151782|NCT03043391|Pediatric Malignant Glioma|pediatric malignant glioma
5151783|NCT03043391|PVSRIPO|pvsripo
5151784|NCT03043391|Pro00071228|pro00071228
5151785|NCT03043391|Eric Thompson|eric thompson
5151786|NCT03043391|Darell Bigner|darell bigner
5151787|NCT03043391|Oncolytic Poliovirus|oncolytic poliovirus
5151788|NCT03043391|Daniel Landi|daniel landi
5151789|NCT03043378|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
5151790|NCT03043378|Non-malignant pain|non-malignant pain
5151791|NCT03043378|Supportive care|supportive care
5151792|NCT03043378|Questionnaires|questionnaires
5151810|NCT03043326|MSM and transgender women|msm and transgender women
5151814|NCT03043300|Travelers' diarrhea|travelers' diarrhea
5151815|NCT03043300|Intestinal microbiota|intestinal microbiota
5151816|NCT03043300|Antibiotic resistance|antibiotic resistance
5151817|NCT03043300|Antibiotics|antibiotics
5151818|NCT03043300|Gastrointestinal disorders|gastrointestinal disorders
5151819|NCT03043300|Infectious diseases|infectious diseases
5151820|NCT03043300|International Travel|international travel
5151821|NCT03043300|Travel Medicine|travel medicine
5151822|NCT03043300|Resistome|resistome
5151823|NCT03043300|Microbiome|microbiome
5151824|NCT03043261|CHF|chf
5151825|NCT03043248|TRK-700|trk-700
5151826|NCT03043248|PK|pk
5151827|NCT03043248|Digoxin|digoxin
5151828|NCT03043248|Midazolam|midazolam
5151829|NCT03043248|Drug-Drug interaction|drug-drug interaction
5151830|NCT03043248|P-glycoprotein|p-glycoprotein
5151831|NCT03043248|CYP3A4|cyp3a4
5151832|NCT03043248|MDR1|mdr1
5151833|NCT03043248|pharmacokinetics|pharmacokinetics
5151834|NCT03043248|multidrug resistance 1|multidrug resistance 1
5151835|NCT03043222|prostate artery embolization|prostate artery embolization
5151836|NCT03043222|Prostatic Urethral Lift, Urolift|prostatic urethral lift, urolift
5151837|NCT03043222|Minimally invasive|minimally invasive
5151838|NCT03043222|non-surgical|non-surgical
5151839|NCT03043222|maintenance of sexual function|maintenance of sexual function
5151840|NCT03043222|complications of TURP , surgery|complications of turp , surgery
5151841|NCT03043183|gastric cancer|gastric cancer
5151842|NCT03043183|Enhanced recovery after surgery|enhanced recovery after surgery
5151843|NCT03043170|Adults|adults
5151844|NCT03043170|Emergency Department|emergency department
5151845|NCT03043170|Haemodynamics|haemodynamics
5151846|NCT03043170|Resuscitation|resuscitation
5151847|NCT03043170|Shock|shock
5151848|NCT03043170|Uscom|uscom
5151849|NCT03043131|Cardiopulmonary bypass prime|cardiopulmonary bypass prime
5151850|NCT03043131|Plasma Lyte - A|plasma lyte - a
5151851|NCT03043131|Ringer;s lactate|ringer;s lactate
5151852|NCT03043131|Acidosis|acidosis
5151853|NCT03043118|Eating Behaviors|eating behaviors
5151854|NCT03043118|Preschool|preschool
5151855|NCT03043118|Vegetable Intake|vegetable intake
5151856|NCT03043105|Multicentric Castleman's Disease|multicentric castleman's disease
5151857|NCT03043105|Thalidomide, cyclophosphamide and prednisone (TCP regimen)|thalidomide, cyclophosphamide and prednisone (tcp regimen)
5151858|NCT03043105|Efficacy|efficacy
5151859|NCT03043105|Safety|safety
5151860|NCT03043092|ultrasound, transcranial Doppler, arterial diseases|ultrasound, transcranial doppler, arterial diseases
5151861|NCT03043066|Chronic Periodontitis|chronic periodontitis
5151862|NCT03043066|TRAP-5b|trap-5b
5151863|NCT03043066|Non-surgical periodontal therapy|non-surgical periodontal therapy
5151864|NCT03043066|Systemic antibiotics|systemic antibiotics
5151865|NCT03043053|weight loss|weight loss
5151866|NCT03043053|body mass index|body mass index
5151867|NCT03043053|oxytocin|oxytocin
5151868|NCT03043053|magnetic resonance imaging|magnetic resonance imaging
5151869|NCT03043040|suicide, attempted|suicide, attempted
5151870|NCT03043040|prevention|prevention
5151871|NCT03043040|telemedicine|telemedicine
5151872|NCT03042988|supine hypertension|supine hypertension
5151873|NCT03042988|autonomic failure|autonomic failure
5151874|NCT03042988|heat stress|heat stress
5151875|NCT03042988|orthostatic hypotension|orthostatic hypotension
5151885|NCT03042936|Children|children
5151886|NCT03042936|Teens|teens
5151887|NCT03042936|Adolescents|adolescents
5151888|NCT03042936|Type 2 diabetes|type 2 diabetes
5151889|NCT03042936|Impaired glucose tolerance|impaired glucose tolerance
5151890|NCT03042936|Exercise|exercise
5151891|NCT03042936|Nutrition|nutrition
5151892|NCT03042936|Education|education
5151893|NCT03042923|Intestinal permeability|intestinal permeability
5151894|NCT03042884|Benign Neoplasms|benign neoplasms
5151895|NCT03042884|In Situ Neoplasms|in situ neoplasms
5151896|NCT03042884|Malignant Neoplasms of Independent (Primary) Multiple Sites|malignant neoplasms of independent (primary) multiple sites
5151897|NCT03042884|Wearable exercise trackers|wearable exercise trackers
5151898|NCT03042884|Questionnaires|questionnaires
5151899|NCT03042884|Surveys|surveys
5151900|NCT03042871|PM-CNV ,Ranibizumab, Dosing Strategy|pm-cnv ,ranibizumab, dosing strategy
5151903|NCT03042858|inguinal hernia|inguinal hernia
5151904|NCT03042832|Leadership|leadership
5151905|NCT03042832|Organizational Climate|organizational climate
5151906|NCT03042832|Implementation|implementation
5151907|NCT03042832|Implementation Climate|implementation climate
5151908|NCT03042832|Motivational Interviewing|motivational interviewing
5151909|NCT03042832|Fidelity|fidelity
5151910|NCT03042806|Physical Activity|physical activity
5151911|NCT03042806|Questionnaire|questionnaire
5151913|NCT03042793|vaccination|vaccination
5151915|NCT03042793|peptide vaccine|peptide vaccine
5151916|NCT03042793|cancer vaccine|cancer vaccine
5151917|NCT03042793|immunotherapy|immunotherapy
5151918|NCT03042780|Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs)|gastroenteropancreatic neuroendocrine carcinomas (gep-necs)
5151919|NCT03042780|Metastatic|metastatic
5151920|NCT03042780|High grade|high grade
5151921|NCT03042780|Pancreas|pancreas
5151922|NCT03042780|Neuroendocrine carcinoma of gastrointestinal tract|neuroendocrine carcinoma of gastrointestinal tract
5151923|NCT03042754|LAM|lam
5151924|NCT03042754|XpertMTB/RIF|xpertmtb/rif
5151931|NCT03042676|prophylaxis of GVHD|prophylaxis of gvhd
5151932|NCT03042663|stellate ganglion block|stellate ganglion block
5151933|NCT03042663|arterial cannula|arterial cannula
5151934|NCT03042663|ischemia|ischemia
5151935|NCT03042663|septic shock|septic shock
5151936|NCT03042611|Gastric Cancer|gastric cancer
5151937|NCT03042611|Gastric Adenocarcinoma|gastric adenocarcinoma
5151938|NCT03042611|Gastro-esophageal Cancer|gastro-esophageal cancer
5151939|NCT03042611|Gastro-esophageal junction Cancer|gastro-esophageal junction cancer
5151940|NCT03042611|Stomach Cancer|stomach cancer
5151942|NCT03042611|Oncology|oncology
5151943|NCT03042611|Antiangiogenesis|antiangiogenesis
5151944|NCT03042611|Metastatic|metastatic
5151945|NCT03042598|Safe Apneic Period|safe apneic period
5151946|NCT03042598|Emergency Intubation|emergency intubation
5151947|NCT03042598|Biphasic Cuirass Ventilation (BCV)|biphasic cuirass ventilation (bcv)
5151948|NCT03042598|Non-invasive ventilation|non-invasive ventilation
5962099|NCT04283032|Prostate Cancer|prostate cancer
5151949|NCT03042598|Peri-intubation Hemodynamic instability|peri-intubation hemodynamic instability
5151950|NCT03042598|desaturation|desaturation
5151951|NCT03042598|waveform capnography|waveform capnography
5151952|NCT03042598|Patient safety|patient safety
5151954|NCT03042585|NHL|nhl
5151955|NCT03042585|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5151956|NCT03042585|Relapsed Non-Hodgkin Lymphoma|relapsed non-hodgkin lymphoma
5151957|NCT03042585|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
5151958|NCT03042585|autologous stem cell transplantation|autologous stem cell transplantation
5151959|NCT03042572|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5151960|NCT03042572|Severe Limb Ischemia (SLI)|severe limb ischemia (sli)
5151961|NCT03042572|Peripheral Artery Disease (PAD)|peripheral artery disease (pad)
5151962|NCT03042572|Peripheral Artery Occlusive Disease (PAOD)|peripheral artery occlusive disease (paod)
5151963|NCT03042572|Cardiovascular disease|cardiovascular disease
5151964|NCT03042572|Mesenchymal stromal cell (MSC)|mesenchymal stromal cell (msc)
5151965|NCT03042572|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
5151966|NCT03042494|Prebiotic|prebiotic
5151967|NCT03042494|Gut microbiota|gut microbiota
5151968|NCT03042494|Dietary fiber|dietary fiber
5151969|NCT03042494|Gastrointestinal tolerance|gastrointestinal tolerance
5151970|NCT03042481|chronic hepatitis B|chronic hepatitis b
5151971|NCT03042481|entecavir|entecavir
5151972|NCT03042481|tenofovir|tenofovir
5151973|NCT03042481|off-therapy|off-therapy
5151974|NCT03042481|relapse|relapse
5151975|NCT03042442|pancreatic cancer|pancreatic cancer
5151976|NCT03042442|cachexia|cachexia
5151977|NCT03042442|perineural invasion|perineural invasion
5151978|NCT03042442|pain|pain
5151979|NCT03042442|diabetes|diabetes
5151980|NCT03042429|neuroblastoma|neuroblastoma
5151981|NCT03042429|chemotherapy|chemotherapy
5151982|NCT03042429|autologous stem cell transplantation|autologous stem cell transplantation
5151983|NCT03042429|radiotherapy|radiotherapy
5151984|NCT03042429|mIBG|mibg
5151985|NCT03042429|tumor resection|tumor resection
5151986|NCT03042416|18F-DOPA PET/CT|18f-dopa pet/ct
5151987|NCT03042403|hemodynamics|hemodynamics
5151988|NCT03042403|physiotherapy|physiotherapy
5151989|NCT03042403|breath stacking|breath stacking
5151990|NCT03042377|Endodontics|endodontics
5151992|NCT03042377|Postoperative Pain|postoperative pain
5151993|NCT03042377|Visual Analogue Pain Scale|visual analogue pain scale
5151994|NCT03042364|Endometrium, Cytokines, Endometrial secretion, Implantation, Endometrial scratching|endometrium, cytokines, endometrial secretion, implantation, endometrial scratching
5151995|NCT03042351|Urinary Incontinence|urinary incontinence
5151996|NCT03042351|Pelvic Floor|pelvic floor
5151997|NCT03042325|Drug therapy|drug therapy
5151998|NCT03042299|Drug therapy|drug therapy
5151999|NCT03042286|statin|statin
5152000|NCT03042286|myalgia|myalgia
5152001|NCT03042286|myopathy|myopathy
5152002|NCT03042286|adverse drug reactions (ADRs)|adverse drug reactions (adrs)
5147738|NCT03069313|Breast Cancer|breast cancer
5152005|NCT03042260|trimethoprim, sulfamethoxazole drug combination|trimethoprim, sulfamethoxazole drug combination
5152006|NCT03042260|Infection|infection
5152007|NCT03042260|Prophylaxis|prophylaxis
5152008|NCT03042234|Obesity|obesity
5152009|NCT03042234|Exercise|exercise
5152010|NCT03042234|Fat oxidation|fat oxidation
5152011|NCT03042234|Adolescent|adolescent
5152012|NCT03042234|Insulin resistance|insulin resistance
5160963|NCT02985645|sinus augmentation|sinus augmentation
5152019|NCT03042169|survival|survival
5152020|NCT03042169|quality of life|quality of life
5152021|NCT03042143|Acute respiratory distress syndrome|acute respiratory distress syndrome
5152022|NCT03042143|Human umbilical cord-derived mesenchymal stem cells|human umbilical cord-derived mesenchymal stem cells
5152023|NCT03042104|Stenosis|stenosis
5152024|NCT03042104|Heart Disease|heart disease
5152025|NCT03042104|Valve|valve
5152026|NCT03042104|Tricuspid|tricuspid
5152027|NCT03042104|Aortic Valve|aortic valve
5152028|NCT03042104|Asymptomatic|asymptomatic
5152029|NCT03042078|Fluoroscopy|fluoroscopy
5152030|NCT03042078|Ablation|ablation
5152031|NCT03042078|Three dimensional|three dimensional
5152032|NCT03042078|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5152033|NCT03042078|Radiation|radiation
5152034|NCT03042065|pediatrics|pediatrics
5152035|NCT03042065|asthma|asthma
5152036|NCT03042065|nebulization|nebulization
5152037|NCT03042065|vibrating mesh|vibrating mesh
5152038|NCT03042065|salbutamol|salbutamol
5152039|NCT03042065|Efficiency|efficiency
5152040|NCT03042013|ASP8273|asp8273
5152041|NCT03042013|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5152042|NCT03042013|EGFR mutations|egfr mutations
5152043|NCT03042013|Oncology|oncology
5152044|NCT03042000|rectal cancer|rectal cancer
5152045|NCT03042000|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5152046|NCT03042000|circulating tumor DNA|circulating tumor dna
5152047|NCT03042000|local recurrence|local recurrence
5152048|NCT03042000|long-term survival|long-term survival
5152049|NCT03041987|Cohort studies|cohort studies
5152050|NCT03041987|Prognosis|prognosis
5152051|NCT03041974|Red Blood Cell Transfusion|red blood cell transfusion
5152052|NCT03041974|Cell-Derived Microparticles|cell-derived microparticles
5152053|NCT03041961|Vascular function|vascular function
5152054|NCT03041961|Endothelial function|endothelial function
5152055|NCT03041961|(Poly)phenols|(poly)phenols
5152056|NCT03041948|Inguinal hernia|inguinal hernia
5152057|NCT03041948|Caudal nerve block|caudal nerve block
5152058|NCT03041948|Ilioinguinal nerve block|ilioinguinal nerve block
5152059|NCT03041948|Pain|pain
5152060|NCT03041935|Testicle|testicle
5152061|NCT03041935|Pain|pain
5152062|NCT03041935|Orchiopexy|orchiopexy
5152063|NCT03041935|Caudal nerve block|caudal nerve block
5152064|NCT03041935|Ilioinguinal nerve block|ilioinguinal nerve block
5152065|NCT03041922|Elastography|elastography
5152066|NCT03041922|Buttocks|buttocks
5152067|NCT03041922|Ultrasound|ultrasound
5152068|NCT03041922|Soft tissue|soft tissue
5152069|NCT03041870|PET-fMRI|pet-fmri
5152070|NCT03041870|dominance|dominance
5152071|NCT03041870|5HT transporter|5ht transporter
5152072|NCT03041857|Videofluoroscopy|videofluoroscopy
5152073|NCT03041857|GMK Sphere|gmk sphere
5152074|NCT03041857|GMK PS Fixed Bearing|gmk ps fixed bearing
5152075|NCT03041857|GMK UC Mobile Bearing|gmk uc mobile bearing
5152076|NCT03041844|therapeutic ultrasound|therapeutic ultrasound
5152077|NCT03041844|quality of life|quality of life
5152083|NCT03041818|cerebral palsy|cerebral palsy
5152084|NCT03041818|horseback riding|horseback riding
5152085|NCT03041805|venous thromboembolism|venous thromboembolism
5152086|NCT03041805|deep vein thrombosis|deep vein thrombosis
5152087|NCT03041805|pulmonary embolism|pulmonary embolism
5152088|NCT03041805|varicose veins|varicose veins
5152089|NCT03041805|surgery|surgery
5152090|NCT03041805|endovenous laser treatment|endovenous laser treatment
5152095|NCT03041766|Schistosomiasis|schistosomiasis
5152096|NCT03041766|Recombinant vaccine|recombinant vaccine
5152097|NCT03041766|rSm14|rsm14
5152098|NCT03041766|GLA-SE|gla-se
5152099|NCT03041766|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
5152100|NCT03041766|Phase II Clinical Trial|phase ii clinical trial
5152101|NCT03041766|Senegal|senegal
5152102|NCT03041753|stroke|stroke
5152103|NCT03041753|thrombolysis|thrombolysis
5152104|NCT03041753|metalloproteinases|metalloproteinases
5152105|NCT03041753|blood brain barrier|blood brain barrier
5152106|NCT03041740|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5152107|NCT03041740|Neonates|neonates
5152108|NCT03041714|Essential Tremor|essential tremor
5152109|NCT03041714|Cervical Dystonia|cervical dystonia
5152110|NCT03041714|Hand Dystonia|hand dystonia
5152111|NCT03041714|Neurophysiology|neurophysiology
5152112|NCT03041714|Dystonic Tremor|dystonic tremor
5152113|NCT03041701|ERMS|erms
5152114|NCT03041701|ARMS|arms
5152115|NCT03041701|Monoclonal Antibody|monoclonal antibody
5152127|NCT03041623|IIPs|iips
5152128|NCT03041558|healthy relationships|healthy relationships
5152129|NCT03041558|interpersonal relations|interpersonal relations
5152135|NCT03041519|Fluoroscopy|fluoroscopy
5152136|NCT03041519|Ablation|ablation
5152137|NCT03041519|Three dimensional|three dimensional
5152138|NCT03041519|Ventricular arrhythmias|ventricular arrhythmias
5152139|NCT03041519|Radiation|radiation
5152140|NCT03041506|Shoulder dislocation reduction|shoulder dislocation reduction
5152141|NCT03041506|Ultrasound guided interscalene block (ISCB)|ultrasound guided interscalene block (iscb)
5152142|NCT03041506|Sedation|sedation
5152143|NCT03041493|Electronic Cigarettes|electronic cigarettes
5152144|NCT03041493|17-071|17-071
5152145|NCT03041480|chronic periodontitis|chronic periodontitis
5152146|NCT03041480|lipids|lipids
5152147|NCT03041480|Lp-PLA2|lp-pla2
5152148|NCT03041402|non-invasive ventilation|non-invasive ventilation
5152149|NCT03041402|Pressure Support Ventilation|pressure support ventilation
5152150|NCT03041402|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5152151|NCT03041402|patient-ventilator interaction|patient-ventilator interaction
5152152|NCT03041402|ventilator performance|ventilator performance
5152153|NCT03041402|asynchrony|asynchrony
5152154|NCT03041389|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
5152155|NCT03041350|Emergency Medical Services|emergency medical services
5152156|NCT03041350|Smartphone|smartphone
5152157|NCT03041350|Survival|survival
5152159|NCT03041324|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5152160|NCT03041324|Hunter syndrome|hunter syndrome
5152161|NCT03041324|Gene Editing|gene editing
5152162|NCT03041324|Gene therapy|gene therapy
5152163|NCT03041324|Zinc Finger|zinc finger
5152164|NCT03041324|ZFN|zfn
5152165|NCT03041324|SB-913|sb-913
5152166|NCT03041324|Rare|rare
5152167|NCT03041324|Genetic|genetic
5152168|NCT03041324|DNA|dna
5152169|NCT03041324|Sangamo|sangamo
5152170|NCT03041324|Genome editing|genome editing
5152171|NCT03041324|Champions|champions
5152172|NCT03041324|Hunter|hunter
5152173|NCT03041324|Gene Specific Targeted Insertion|gene specific targeted insertion
5152174|NCT03041311|Small Cell Lung Cancer|small cell lung cancer
5152176|NCT03041311|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5152177|NCT03041246|pelvic floor|pelvic floor
5152178|NCT03041207|ventilator associated infection|ventilator associated infection
5152179|NCT03041207|ventilator associated pneumonia|ventilator associated pneumonia
5152180|NCT03041207|ventilator associated tracheitis|ventilator associated tracheitis
5152181|NCT03041207|Lower respiratory infection|lower respiratory infection
5152182|NCT03041181|Nivolumab|nivolumab
5152183|NCT03041181|BMS-936558-01|bms-936558-01
5152184|NCT03041181|Anti-PD-1 Antibody|anti-pd-1 antibody
5152185|NCT03041181|Docetaxel|docetaxel
5152186|NCT03041181|Pemetrexed|pemetrexed
5152187|NCT03041181|Gemcitabine|gemcitabine
5152188|NCT03041142|Obesity|obesity
5152189|NCT03041142|Cardiovascular risk factors|cardiovascular risk factors
5152190|NCT03041142|Interdisciplinary intervention|interdisciplinary intervention
5153093|NCT03035175|neonates|neonates
5152198|NCT03041025|Systemic Sclerosis|systemic sclerosis
5152200|NCT03041025|Phase IIA|phase iia
5152201|NCT03041025|GSK2330811|gsk2330811
5152202|NCT03041025|Pharmacodynamics|pharmacodynamics
5152203|NCT03041025|Pharmacokinetics|pharmacokinetics
5152204|NCT03041025|Proof of mechanism study|proof of mechanism study
5152205|NCT03041012|HIV-1|hiv-1
5152206|NCT03041012|Latency Reversal Agent|latency reversal agent
5152207|NCT03041012|Immunotherapy|immunotherapy
5152222|NCT03040960|infection|infection
5152223|NCT03040960|wound infection|wound infection
5152224|NCT03040960|surgical wound infection|surgical wound infection
5152225|NCT03040960|Staphylococcal infections|staphylococcal infections
5152226|NCT03040960|wound and injuries|wound and injuries
5152227|NCT03040960|postoperative complications|postoperative complications
5152228|NCT03040960|Gram-positive bacterial infections|gram-positive bacterial infections
5152229|NCT03040960|bacterial infections|bacterial infections
5152230|NCT03040895|Parenting practices|parenting practices
5152231|NCT03040856|Omega 3|omega 3
5152232|NCT03040856|Supplements|supplements
5152233|NCT03040856|Alpha Linolenic Acid|alpha linolenic acid
5152234|NCT03040843|documentation|documentation
5152235|NCT03040843|altered mental status|altered mental status
5152236|NCT03040843|definition|definition
5152237|NCT03040843|clinically|clinically
5152238|NCT03040804|hidradenitis suppurativa|hidradenitis suppurativa
5152240|NCT03040804|radiotherapy|radiotherapy
5152241|NCT03040791|prostate cancer|prostate cancer
5152242|NCT03040778|MRONJ|mronj
5152243|NCT03040778|BRONJ|bronj
5152244|NCT03040765|Osteoporosis|osteoporosis
5152245|NCT03040765|Beta-Thalassemia Major|beta-thalassemia major
5152246|NCT03040765|Denosumab|denosumab
5152247|NCT03040765|Zoledronic Acid|zoledronic acid
5152248|NCT03040739|O'ARM|o'arm
5152249|NCT03040700|coronary artery disease|coronary artery disease
5152250|NCT03040700|surgery|surgery
5152251|NCT03040700|angina|angina
5152252|NCT03040700|myocardial ischemia|myocardial ischemia
5152253|NCT03040700|non-invasive testing|non-invasive testing
5152254|NCT03040687|ETEC|etec
5152255|NCT03040687|Escherichia coli|escherichia coli
5152257|NCT03040687|challenge|challenge
5152258|NCT03040687|CS6|cs6
5152259|NCT03040687|B7A|b7a
5152260|NCT03040674|Shortness of breath|shortness of breath
5152261|NCT03040674|Breathlessness|breathlessness
5152262|NCT03040674|Cellular therapy|cellular therapy
5152263|NCT03040674|Platelet rich plasma|platelet rich plasma
5152264|NCT03040674|Quality of life|quality of life
5152265|NCT03040674|Pulmonary function|pulmonary function
5152266|NCT03040622|WATCHMAN|watchman
5152267|NCT03040622|Left Atrial Appendage Closure|left atrial appendage closure
5152268|NCT03040622|Thrombosis|thrombosis
5152269|NCT03040622|Platelet Function|platelet function
5038610|NCT03757364|Nail Psoriasis|nail psoriasis
5152270|NCT03040609|Profound Multiple Intellectual Disabilities|profound multiple intellectual disabilities
5152271|NCT03040609|Visual-Behavioral Scale|visual-behavioral scale
5152272|NCT03040596|vocal fold nodules|vocal fold nodules
5152273|NCT03040596|inhaled steroid|inhaled steroid
5152274|NCT03040596|steroid|steroid
5152275|NCT03040596|children|children
5152276|NCT03040596|nodules|nodules
5152277|NCT03040583|Primary Sjögren's syndrome (PSS)|primary sjögren's syndrome (pss)
5152278|NCT03040583|auto-immune diseases|auto-immune diseases
5152279|NCT03040557|plantar fasciitis|plantar fasciitis
5152280|NCT03040557|shoes|shoes
5152281|NCT03040557|insoles|insoles
5152282|NCT03040557|pain|pain
5152283|NCT03040557|foot|foot
5152284|NCT03040544|minimally invasive surgery|minimally invasive surgery
5152285|NCT03040544|video-based trainer|video-based trainer
5152286|NCT03040544|laparoscopic|laparoscopic
5152287|NCT03040544|simulation training|simulation training
5152288|NCT03040544|surgical education|surgical education
5152289|NCT03040531|glucocorticoid|glucocorticoid
5152290|NCT03040531|genistein|genistein
5152291|NCT03040531|alendronate|alendronate
5152292|NCT03040518|Behaviour change|behaviour change
5152293|NCT03040518|Male obesity|male obesity
5152294|NCT03040518|SMS|sms
5152297|NCT03040466|ureteroscopy|ureteroscopy
5152298|NCT03040466|flexible ureteroscope|flexible ureteroscope
5152299|NCT03040466|randomized controlled trial|randomized controlled trial
5152300|NCT03040453|Irreversible electroporation|irreversible electroporation
5152301|NCT03040453|Microwave ablation|microwave ablation
5152302|NCT03040427|F-18 florbetapir|f-18 florbetapir
5152305|NCT03040427|Early detection|early detection
5152306|NCT03040414|Hybrid closed loop|hybrid closed loop
5152307|NCT03040414|Closed loop|closed loop
5152308|NCT03040414|Artificial pancreas|artificial pancreas
5152309|NCT03040401|CMML|cmml
5152310|NCT03040401|Ceplene|ceplene
5152311|NCT03040401|Interleukin-2|interleukin-2
5152312|NCT03040388|Electroconvulsive therapy|electroconvulsive therapy
5152313|NCT03040388|Depressive Disorder|depressive disorder
5152314|NCT03040388|Magnetic Resonance Imaging|magnetic resonance imaging
5152315|NCT03040388|Hippocampus|hippocampus
5152316|NCT03040388|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5152317|NCT03040388|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5152318|NCT03040388|Blood-Brain Barrier|blood-brain barrier
5152319|NCT03040349|primary care|primary care
5152320|NCT03040349|greece|greece
5152321|NCT03040349|cyprus|cyprus
5152322|NCT03040349|tobacco use treatment|tobacco use treatment
5152323|NCT03040349|evidence-based guidelines|evidence-based guidelines
5152324|NCT03040336|surgery|surgery
5152325|NCT03040336|prehabilitation|prehabilitation
5152326|NCT03040336|exercise therapy|exercise therapy
5152327|NCT03040336|nutrition support|nutrition support
5152328|NCT03040297|Weaning from mechanical ventilation|weaning from mechanical ventilation
5152329|NCT03040297|tracheostomized patients|tracheostomized patients
5673415|NCT00608335|Candidiasis|candidiasis
5152330|NCT03040297|Tracheal gas insufflation|tracheal gas insufflation
5152331|NCT03040284|noninvasive monitoring|noninvasive monitoring
5152332|NCT03040284|intracranial pressure|intracranial pressure
5152333|NCT03040284|cochlear electrophysiology|cochlear electrophysiology
5152334|NCT03040284|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
5152335|NCT03040284|cerebrovascular disorders|cerebrovascular disorders
5152336|NCT03040284|brain diseases|brain diseases
5152337|NCT03040271|School-based intervention|school-based intervention
5152338|NCT03040258|School-based intervention|school-based intervention
5152339|NCT03040245|Emergency physician|emergency physician
5152340|NCT03040245|Whiplash Book|whiplash book
5152341|NCT03040245|Whiplash trauma|whiplash trauma
5152342|NCT03040245|Fears|fears
5152343|NCT03040245|Beliefs|beliefs
5152344|NCT03040193|Lignocaine|lignocaine
5152345|NCT03040180|Neoplasms|neoplasms
5152346|NCT03040180|Neoplasms, primary|neoplasms, primary
5152347|NCT03040180|Cancer|cancer
5152348|NCT03040180|Colorectal cancer|colorectal cancer
5152349|NCT03040180|rectal cancer|rectal cancer
5152350|NCT03040180|rectal cancer, locally advanced|rectal cancer, locally advanced
5152351|NCT03040180|Electrochemotherapy|electrochemotherapy
5152352|NCT03040180|Electroporation|electroporation
5152353|NCT03040180|Neoadjuvant therapy|neoadjuvant therapy
5152354|NCT03040180|Antineoplastic, antibodies|antineoplastic, antibodies
5152355|NCT03040180|Bleomycin|bleomycin
5152356|NCT03040180|Pathologic processes|pathologic processes
5152358|NCT03040154|Filipino|filipino
5152359|NCT03040102|Advanced Cancer|advanced cancer
5152360|NCT03040063|aneurysm, poplietl artery, acute limb ischemia|aneurysm, poplietl artery, acute limb ischemia
5152361|NCT03040024|Anesthesiology|anesthesiology
5152362|NCT03040011|Vaginal Surgery|vaginal surgery
5152363|NCT03040011|Pelvic Organ Prolapse|pelvic organ prolapse
5152364|NCT03040011|Postoperative Pain|postoperative pain
5152367|NCT03039946|Fluid therapy|fluid therapy
5152368|NCT03039946|Hemodynamic flow monitoring|hemodynamic flow monitoring
5152369|NCT03039946|Closed-loop system|closed-loop system
5152370|NCT03039946|Goal-directed fluid therapy|goal-directed fluid therapy
5152371|NCT03039946|Anesthesiology|anesthesiology
5152373|NCT03039907|Replacement|replacement
5152374|NCT03039894|school-based, evaluation, interrupted time series|school-based, evaluation, interrupted time series
5152375|NCT03039881|Minute ventilation, ExSpiron monitor|minute ventilation, exspiron monitor
5152376|NCT03039855|Mitral|mitral
5152377|NCT03039855|Regurgitation|regurgitation
5152378|NCT03039855|Heart valve|heart valve
5152379|NCT03039855|Transcatheter|transcatheter
5152380|NCT03039855|Transapical|transapical
5152381|NCT03039855|Functional|functional
5152382|NCT03039855|Degenerative|degenerative
5152383|NCT03039855|TMVR|tmvr
5152384|NCT03039842|dextromethorphan; memantine; treatment response|dextromethorphan; memantine; treatment response
5152385|NCT03039790|Drug Therapy|drug therapy
5152386|NCT03039686|muscular dystrophy|muscular dystrophy
5152387|NCT03039686|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
5152389|NCT03039673|interleukin-2|interleukin-2
5152390|NCT03039673|low-dose interleukin-2|low-dose interleukin-2
5152391|NCT03039608|esophageal stricture|esophageal stricture
5152392|NCT03039608|endoscopic submucosal dissection|endoscopic submucosal dissection
5152393|NCT03039608|prevention|prevention
5152394|NCT03039595|Early rectal cancer|early rectal cancer
5152395|NCT03039595|Ploidy|ploidy
5152396|NCT03039595|Tumour:stroma ratio|tumour:stroma ratio
5152397|NCT03039582|perineal tear|perineal tear
5152398|NCT03039582|bidigital palpation|bidigital palpation
5152399|NCT03039582|perineal ultrasound|perineal ultrasound
5152400|NCT03039582|post partum diagnostics|post partum diagnostics
5152401|NCT03039569|Type 2 diabetes patients|type 2 diabetes patients
5152402|NCT03039569|Diabetes self-management|diabetes self-management
5152403|NCT03039569|Cardiovascular diseases awareness|cardiovascular diseases awareness
5152404|NCT03039569|Home food environment|home food environment
5152405|NCT03039569|Text message|text message
5152406|NCT03039530|Postpartum Depression|postpartum depression
5152407|NCT03039530|Cognitive Behavioral Therapy|cognitive behavioral therapy
5152408|NCT03039530|Public Health|public health
5152409|NCT03039530|Mother|mother
5152410|NCT03039530|Infant|infant
5152411|NCT03039530|Emotion|emotion
5152412|NCT03039517|Adaptive Compression Therapy Delivery System|adaptive compression therapy delivery system
5152413|NCT03039504|Succinates|succinates
5152414|NCT03039504|Dietary supplement|dietary supplement
5152415|NCT03039491|pneumococcal vaccination|pneumococcal vaccination
5152416|NCT03039465|Indwelling Trachea-oesophageal Prosthesis|indwelling trachea-oesophageal prosthesis
5152417|NCT03039465|Voice Rehabilitation|voice rehabilitation
5152418|NCT03039465|Total Laryngectomy|total laryngectomy
5152419|NCT03039374|OASI|oasi
5152420|NCT03039374|Faecal incontinence|faecal incontinence
5152421|NCT03039374|Obstetric anal sphincter injury|obstetric anal sphincter injury
5152422|NCT03039374|MRI|mri
5152423|NCT03039348|Breast Cancer Female|breast cancer female
5152424|NCT03039348|Mastectomy|mastectomy
5152425|NCT03039348|Breast Reconstruction|breast reconstruction
5152426|NCT03039348|questionnaire|questionnaire
5152427|NCT03039309|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5152428|NCT03039296|Low back pain|low back pain
5152429|NCT03039296|Facet joints|facet joints
5152430|NCT03039296|Endoscopic rhizotomy|endoscopic rhizotomy
5152437|NCT03039257|vitamin a|vitamin a
5152438|NCT03039244|Photochemotherapy|photochemotherapy
5152439|NCT03039244|Photosensitizing agents|photosensitizing agents
5152440|NCT03039244|Smokers|smokers
5152441|NCT03039231|PTSD|ptsd
5152442|NCT03039218|erectile dysfunction|erectile dysfunction
5152443|NCT03039218|shockwave|shockwave
5152444|NCT03039218|Dornier|dornier
5152445|NCT03039205|Platelet aggregation|platelet aggregation
5152446|NCT03039205|Adenosine|adenosine
5152447|NCT03039205|Coronary artery disease|coronary artery disease
5152448|NCT03039205|Kidney dysfunction|kidney dysfunction
5152449|NCT03039205|Ticagrelor|ticagrelor
5152450|NCT03039205|Clopidogrel|clopidogrel
5152451|NCT03039127|Hyperthermia|hyperthermia
5152452|NCT03039127|Laser Coagulation|laser coagulation
5152453|NCT03039127|Laser Therapy|laser therapy
5152454|NCT03039127|Induced|induced
5152455|NCT03039114|Follicular lymphoma|follicular lymphoma
5152456|NCT03039114|relapsed|relapsed
5152457|NCT03039114|refractory|refractory
5152458|NCT03039114|non-Hodgkin lymphoma|non-hodgkin lymphoma
5152459|NCT03039114|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5152460|NCT03039101|allergen|allergen
5152465|NCT03039062|malignant tumor patients|malignant tumor patients
5152466|NCT03039049|GnRH agonist trigger|gnrh agonist trigger
5152468|NCT03039049|Luteal phase support|luteal phase support
5152469|NCT03039049|Mid-luteal GnRH agonist|mid-luteal gnrh agonist
5152470|NCT03039036|Labor Induction|labor induction
5152471|NCT03039036|Early Amniotomy|early amniotomy
5038879|NCT03755557|hayfever|hayfever
5152472|NCT03039036|Foley catheter|foley catheter
5152474|NCT03039023|choline|choline
5152475|NCT03039023|eggs|eggs
5152476|NCT03039023|gastrointestinal microbiome|gastrointestinal microbiome
5152477|NCT03039023|healthy volunteers|healthy volunteers
5152485|NCT03038958|Local Anaesthetic|local anaesthetic
5152486|NCT03038958|spinal anesthesia|spinal anesthesia
5152487|NCT03038958|Knee arthroscopy|knee arthroscopy
5152488|NCT03038945|Laparoscopy|laparoscopy
5152489|NCT03038945|Hysterectomy|hysterectomy
5152490|NCT03038945|Suture Techniques|suture techniques
5152491|NCT03038932|whole genome sequencing (WGS)|whole genome sequencing (wgs)
5152492|NCT03038919|prolonged mechanical ventilation|prolonged mechanical ventilation
5152493|NCT03038919|critically ill patients|critically ill patients
5152494|NCT03038919|anabolic steroid|anabolic steroid
5152495|NCT03038893|Ultrasonography|ultrasonography
5152496|NCT03038893|Point-of-care systems|point-of-care systems
5152497|NCT03038893|Deep venous thrombosis|deep venous thrombosis
5152498|NCT03038893|Hospitalization|hospitalization
5152499|NCT03038776|vaccine|vaccine
5152500|NCT03038750|Healthy Volunteers|healthy volunteers
5152501|NCT03038750|Genetic Risk Markers for Cardiovascular Disease|genetic risk markers for cardiovascular disease
5152502|NCT03038750|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5152503|NCT03038750|Coronary Disease|coronary disease
5152504|NCT03038750|Hypertension|hypertension
5152505|NCT03038750|Venous Thromboses|venous thromboses
5152506|NCT03038750|Venous Thromboembolism|venous thromboembolism
5152507|NCT03038750|Coronary Heart Disease|coronary heart disease
5152508|NCT03038750|Coronary Artery Disease|coronary artery disease
5152510|NCT03038737|polyamide|polyamide
5152511|NCT03038737|PEEK|peek
5152512|NCT03038737|partial denture|partial denture
5152513|NCT03038724|HIV testing|hiv testing
5152514|NCT03038698|spirometry|spirometry
5152515|NCT03038698|normative values|normative values
5152516|NCT03038698|health|health
5152517|NCT03038698|south africa|south africa
5152518|NCT03038698|children|children
5152519|NCT03038685|Secondary prevention|secondary prevention
5152520|NCT03038685|Web-based intervention|web-based intervention
5152521|NCT03038685|Strokecoach|strokecoach
5152522|NCT03038646|Pharmacokinetics|pharmacokinetics
5152523|NCT03038646|Food Effect|food effect
5152525|NCT03038620|Visceral|visceral
5152526|NCT03038620|Cardiovascular Disease|cardiovascular disease
5152527|NCT03038620|Fat|fat
5152528|NCT03038594|Burns|burns
5152529|NCT03038594|Growth Hormone|growth hormone
5152530|NCT03038594|Lean Body Mass|lean body mass
5152531|NCT03038594|Strength|strength
5152532|NCT03038594|Exercise Endurance|exercise endurance
5152533|NCT03038581|Deep wrist injury|deep wrist injury
5152534|NCT03038581|Self inflicted|self inflicted
5152535|NCT03038581|Traumatic wrist injury|traumatic wrist injury
5152536|NCT03038568|colorectal liver metastases|colorectal liver metastases
5152537|NCT03038568|CT scan|ct scan
5152538|NCT03038568|17-010|17-010
5152539|NCT03038555|Medical staff|medical staff
5152540|NCT03038555|preeclampsia|preeclampsia
5152541|NCT03038555|cohort study|cohort study
5152542|NCT03038555|further effect|further effect
5152543|NCT03038529|low back pain , Ozone|low back pain , ozone
5152544|NCT03038503|refractory septic shock|refractory septic shock
5152545|NCT03038503|catecholamine resistance septic shock|catecholamine resistance septic shock
5152546|NCT03038503|terlipressin|terlipressin
5152547|NCT03038503|methylene blue|methylene blue
5152548|NCT03038477|Borderline Resectable Pancreatic Ductal Adenocarcinoma|borderline resectable pancreatic ductal adenocarcinoma
5152549|NCT03038477|Durvalumab|durvalumab
5152550|NCT03038399|Duchenne muscular dystrophy|duchenne muscular dystrophy
5152551|NCT03038399|vamorolone|vamorolone
5152552|NCT03038347|cross-cultural competencies|cross-cultural competencies
5152553|NCT03038347|internet-based training|internet-based training
5152554|NCT03038347|cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
5152555|NCT03038347|psychotherapy training|psychotherapy training
5152556|NCT03038347|competence training|competence training
5152557|NCT03038321|BCG Cystitis|bcg cystitis
5152558|NCT03038321|Bladder Cancer|bladder cancer
5152559|NCT03038321|Levofloxacin|levofloxacin
5152560|NCT03038321|Solifenacin|solifenacin
5152561|NCT03038321|Lornoxicam|lornoxicam
5152562|NCT03038308|ropinirole|ropinirole
5152563|NCT03038308|hyperprolactinemia|hyperprolactinemia
5152564|NCT03038308|prolactin|prolactin
5152565|NCT03038295|Retinopathy of Prematurity|retinopathy of prematurity
5152567|NCT03038295|ROP|rop
5152568|NCT03038269|Robotics|robotics
5152569|NCT03038269|Upper Extremity|upper extremity
5152570|NCT03038256|High Risk Rectal Cancer|high risk rectal cancer
5152571|NCT03038256|Total neoadjuvant chemoradiotherapy|total neoadjuvant chemoradiotherapy
5152572|NCT03038256|Lengthening interval between radiotherapy and surgery|lengthening interval between radiotherapy and surgery
5152573|NCT03038243|Shigella|shigella
5152574|NCT03038243|vaccine|vaccine
5152575|NCT03038243|shigellosis|shigellosis
5152576|NCT03038243|dysentery|dysentery
5152577|NCT03038243|whole cell|whole cell
5152578|NCT03038230|human bispecific full length IgG antibody, CLEC12A, CD3|human bispecific full length igg antibody, clec12a, cd3
5152579|NCT03038230|MCLA-117|mcla-117
5152580|NCT03038230|First in Human|first in human
5152581|NCT03038230|Antibodies, Bispecific|antibodies, bispecific
5152582|NCT03038230|Immunologic Factors|immunologic factors
5152583|NCT03038230|relapsed, refractory patient|relapsed, refractory patient
5152584|NCT03038230|AML, minimal residual disease (MRD)|aml, minimal residual disease (mrd)
5152585|NCT03038230|Acute Myelogenous Leukemia|acute myelogenous leukemia
5153194|NCT03034707|prolactin|prolactin
5152586|NCT03038230|Acute Myeloid Leukemia|acute myeloid leukemia
5152587|NCT03038230|CD34+CD38|cd34+cd38
5152588|NCT03038230|T-cell recruiting|t-cell recruiting
5152589|NCT03038217|rectal cancer|rectal cancer
5152590|NCT03038217|neoajuvant chemoradiation|neoajuvant chemoradiation
5152591|NCT03038217|circulating tumor DNA|circulating tumor dna
5152592|NCT03038204|Papillary muscles approximation|papillary muscles approximation
5152593|NCT03038178|Mycobacterium Infections, Nontuberculous|mycobacterium infections, nontuberculous
5152594|NCT03038178|Mycobacteria, Atypical|mycobacteria, atypical
5152595|NCT03038178|Amikacin|amikacin
5152596|NCT03038178|Inhalation|inhalation
5152597|NCT03038165|Hemodialysis|hemodialysis
5152598|NCT03038165|Intradialytic hypertension|intradialytic hypertension
5152599|NCT03038165|Hemodynamics changes|hemodynamics changes
5152600|NCT03038139|forward head posture|forward head posture
5152601|NCT03038139|postural correction|postural correction
5152602|NCT03038139|spinal muscles|spinal muscles
5152603|NCT03038126|chronic kidney disease|chronic kidney disease
5152604|NCT03038126|patient safety|patient safety
5152605|NCT03038126|home telehealth|home telehealth
5152606|NCT03038061|Diaphragm|diaphragm
5152607|NCT03038061|EIT|eit
5152608|NCT03038061|Laparoscopy|laparoscopy
5152609|NCT03038009|Coronary Artery Bypass Graft|coronary artery bypass graft
5152610|NCT03038009|Dual Antiplatelet Therapy|dual antiplatelet therapy
5152611|NCT03038009|Gastrointestinal|gastrointestinal
5152612|NCT03038009|Mucosal Injury|mucosal injury
5152613|NCT03038009|Proton Pump Inhibitor|proton pump inhibitor
5152614|NCT03037996|anesthesia|anesthesia
5152615|NCT03037996|satisfaction|satisfaction
5152616|NCT03037983|Schizophrenia|schizophrenia
5152617|NCT03037983|Transcranial magnetic stimulation|transcranial magnetic stimulation
5962100|NCT04283032|Biomarkers|biomarkers
5152618|NCT03037983|Electroencephalography|electroencephalography
5152619|NCT03037944|Adenomyosis|adenomyosis
5152620|NCT03037944|Contraceptive pills|contraceptive pills
5152621|NCT03037944|Levonorgestrel-releasing Intrauterine System|levonorgestrel-releasing intrauterine system
5152622|NCT03037918|Gut Microbiota|gut microbiota
5152623|NCT03037918|High Fat Diets|high fat diets
5152624|NCT03037918|Probiotics|probiotics
5152625|NCT03037918|Glycaemic Control|glycaemic control
5152626|NCT03037853|Atlas|atlas
5152627|NCT03037853|Full human Body|full human body
5152628|NCT03037853|MRI|mri
5152629|NCT03037840|RF EMF|rf emf
5152630|NCT03037840|In Vivo|in vivo
5152631|NCT03037840|tumor specific frequencies|tumor specific frequencies
5152632|NCT03037827|endovenous laser ablation|endovenous laser ablation
5152633|NCT03037827|radial fiber|radial fiber
5152634|NCT03037827|linear endovenous energy density|linear endovenous energy density
5152635|NCT03037827|1470 nm|1470 nm
5152636|NCT03037827|occlusion rate|occlusion rate
5152637|NCT03037814|restorative materials|restorative materials
5152638|NCT03037814|primary teeth|primary teeth
5152639|NCT03037814|children|children
5152640|NCT03037788|Excessive sweating|excessive sweating
5152641|NCT03037775|tobacco|tobacco
5152642|NCT03037775|cardiovascular system|cardiovascular system
5152643|NCT03037775|sympathetic nervous system|sympathetic nervous system
5152644|NCT03037684|neuropathic pain|neuropathic pain
5152645|NCT03037684|chronic postoperative pain|chronic postoperative pain
5152646|NCT03037671|Malglycemia|malglycemia
5152647|NCT03037658|physical activity|physical activity
5152648|NCT03037658|walking|walking
5152649|NCT03037658|incentive|incentive
5152650|NCT03037658|step count|step count
5152651|NCT03037645|CLL|cll
5152652|NCT03037645|hematological diseases|hematological diseases
5152653|NCT03037645|relapsed|relapsed
5152654|NCT03037645|cancer|cancer
5152655|NCT03037645|malignancy|malignancy
5152656|NCT03037645|SNS-062|sns-062
5152657|NCT03037645|B-lymphoid|b-lymphoid
5152658|NCT03037645|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5152659|NCT03037645|small lymphocytic lymphoma|small lymphocytic lymphoma
5148352|NCT03065738|reduction osteotomy|reduction osteotomy
5152661|NCT03037645|Waldenström's macrogloulinemia|waldenström's macrogloulinemia
5152662|NCT03037645|mantle cell lymphoma|mantle cell lymphoma
5152663|NCT03037645|SLL|sll
5152664|NCT03037645|LPL|lpl
5152665|NCT03037645|WM|wm
5152666|NCT03037645|MCL|mcl
5152667|NCT03037645|refractory|refractory
5152668|NCT03037645|DLBCL-ABC|dlbcl-abc
5152669|NCT03037645|DLBCL|dlbcl
5152670|NCT03037645|follicular lymphoma|follicular lymphoma
5152671|NCT03037645|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5152672|NCT03037645|CLL/SLL|cll/sll
5152673|NCT03037645|MZL|mzl
5152674|NCT03037645|marginal zone lymphoma|marginal zone lymphoma
5152675|NCT03037593|Pregnancy|pregnancy
5152676|NCT03037593|Gestational Diabetes|gestational diabetes
5152677|NCT03037580|Pulmonary Hypertension|pulmonary hypertension
5152678|NCT03037580|6-Minute Walk Test|6-minute walk test
5152679|NCT03037580|HFpEF|hfpef
5152680|NCT03037580|Oral Treprostinil|oral treprostinil
5152681|NCT03037554|Skin Temperature|skin temperature
5152682|NCT03037554|Hot Flashes|hot flashes
5152683|NCT03037554|Sleep Disturbance|sleep disturbance
5152684|NCT03037541|Wake Forest|wake forest
5152685|NCT03037541|Actinic Keratosis|actinic keratosis
5152686|NCT03037541|Cryosurgery|cryosurgery
5152687|NCT03037541|Cream|cream
5152691|NCT03037502|Latino men|latino men
5152695|NCT03037424|Cyroprecipitate|cyroprecipitate
5152696|NCT03037424|Fibrinogen|fibrinogen
5152697|NCT03037424|Cardiac Surgery|cardiac surgery
5152698|NCT03037411|Atherosclerosis|atherosclerosis
5152699|NCT03037411|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
5152700|NCT03037411|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
5152701|NCT03037411|Stenting|stenting
5152702|NCT03037411|Paclitaxel|paclitaxel
5152703|NCT03037411|Health Economics|health economics
5152704|NCT03037385|RET Lung|ret lung
5152705|NCT03037385|RET Thyroid|ret thyroid
5152706|NCT03037385|RET fusion|ret fusion
5152707|NCT03037385|RET alteration|ret alteration
5152708|NCT03037385|RET mutation|ret mutation
5152709|NCT03037385|RET positive|ret positive
5152710|NCT03037385|RET inhibitor|ret inhibitor
5152711|NCT03037385|RET altered|ret altered
5152712|NCT03037385|RET rearrangement|ret rearrangement
5152713|NCT03037385|RET NSCLC|ret nsclc
5152714|NCT03037385|RET medullary thyroid cancer|ret medullary thyroid cancer
5152715|NCT03037385|RET-rearranged NSCLC|ret-rearranged nsclc
5152716|NCT03037385|RET-rearranged thyroid|ret-rearranged thyroid
5152717|NCT03037385|M918T|m918t
5152718|NCT03037385|TRIM33-RET|trim33-ret
5152719|NCT03037385|RET fusion lung cancer|ret fusion lung cancer
5152720|NCT03037385|RET fusion thyroid cancer|ret fusion thyroid cancer
5152721|NCT03037385|lung cancer mutation|lung cancer mutation
5152722|NCT03037385|BLU 667|blu 667
5152723|NCT03037385|RET tyrosine kinase|ret tyrosine kinase
5152724|NCT03037385|RET gene mutation|ret gene mutation
5152725|NCT03037385|RET kinase|ret kinase
5152726|NCT03037385|RET MTC|ret mtc
5152727|NCT03037385|advanced lung cancer|advanced lung cancer
5152728|NCT03037385|advanced non small cell lung cancer|advanced non small cell lung cancer
5152729|NCT03037385|metastatic lung cancer|metastatic lung cancer
5152730|NCT03037385|KIF5B-RET|kif5b-ret
5152731|NCT03037385|CCDC6-RET|ccdc6-ret
5152732|NCT03037385|NCOA4-RET|ncoa4-ret
5152733|NCT03037385|advance solid tumor|advance solid tumor
5152734|NCT03037385|V804L|v804l
5152735|NCT03037385|V804M|v804m
5152736|NCT03037385|thyroid cancer RET inhibitor|thyroid cancer ret inhibitor
5152738|NCT03037385|RET PTC|ret ptc
5152739|NCT03037385|rearranged during transfection|rearranged during transfection
5152740|NCT03037385|RET-PTC1|ret-ptc1
5152741|NCT03037385|RET-PTC|ret-ptc
5152742|NCT03037385|RET-PTC3|ret-ptc3
5152743|NCT03037385|RET-PTC4|ret-ptc4
5152744|NCT03037385|PRKAR1A-RET|prkar1a-ret
5152745|NCT03037385|RET-PTC2|ret-ptc2
5152746|NCT03037385|GOLGA5-RET|golga5-ret
5152747|NCT03037385|RET-PTC5|ret-ptc5
5152748|NCT03037385|ERC1-RET|erc1-ret
5152749|NCT03037385|KTN1-RET|ktn1-ret
5152750|NCT03037385|RET-PTC8|ret-ptc8
5152751|NCT03037385|HOOK3-RET|hook3-ret
5152752|NCT03037385|PCM1-RET|pcm1-ret
5152753|NCT03037385|TRIM24-RET|trim24-ret
5152754|NCT03037385|RET-PTC6|ret-ptc6
5152755|NCT03037385|TRIM27-RET|trim27-ret
5152756|NCT03037385|RET-PTC7|ret-ptc7
5152757|NCT03037385|AKAP13-RET|akap13-ret
5152758|NCT03037385|FKBP15-RET|fkbp15-ret
5152759|NCT03037385|SPECC1L-RET|specc1l-ret
5152760|NCT03037385|TBL1XR1-RET|tbl1xr1-ret
5152761|NCT03037385|BCR-RET|bcr-ret
5152762|NCT03037385|FGRF1OP-RET|fgrf1op-ret
5152763|NCT03037385|RFG8-RET|rfg8-ret
5152764|NCT03037372|adults|adults
5152765|NCT03037372|antiretroviral therapy|antiretroviral therapy
5152766|NCT03037359|PID|pid
5152767|NCT03037333|echocardiogram|echocardiogram
5152768|NCT03037333|Electrocardiogram: Electrical Alternans|electrocardiogram: electrical alternans
5152769|NCT03037333|fluoroscopy|fluoroscopy
5152770|NCT03037229|Myocardial Infarction|myocardial infarction
5152771|NCT03037229|Ischemia|ischemia
5152772|NCT03037229|Myocardial Ischemia|myocardial ischemia
5152774|NCT03037229|Cardiovascular Diseases|cardiovascular diseases
5152775|NCT03037229|Vascular Diseases|vascular diseases
5152776|NCT03037216|Exercise|exercise
5152777|NCT03037164|INTERCEPT|intercept
5152778|NCT03037164|Red Blood Cells|red blood cells
5152779|NCT03037164|RBC|rbc
5152780|NCT03037164|Pathogen Inactivation|pathogen inactivation
5152781|NCT03037164|Zika|zika
5152782|NCT03037164|Cerus|cerus
5152783|NCT03037164|Pathogen Reduction|pathogen reduction
5152784|NCT03037151|Safety|safety
5152785|NCT03037151|Efficacy|efficacy
5152786|NCT03037151|grazoprevir|grazoprevir
5152787|NCT03037151|elbasvir|elbasvir
5152788|NCT03037151|compensated cirrhosis|compensated cirrhosis
5152789|NCT03037151|genotype 1 (GT1)|genotype 1 (gt1)
5152790|NCT03037151|genotype 6 (GT6)|genotype 6 (gt6)
5152791|NCT03037151|hepatitis virus C (HCV)|hepatitis virus c (hcv)
5152792|NCT03037151|human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5152793|NCT03037138|postdialysis washed-out|postdialysis washed-out
5152794|NCT03037099|Glycemic index|glycemic index
5152795|NCT03037099|dietary intakes|dietary intakes
5152796|NCT03037086|NSCLC|nsclc
5152797|NCT03037073|Duloxetine|duloxetine
5152798|NCT03037073|Succinylcholine|succinylcholine
5152799|NCT03037073|Postoperative Myalgia|postoperative myalgia
5152800|NCT03037073|Microlaryngoscopy|microlaryngoscopy
5152801|NCT03037060|Alcohol use, problem|alcohol use, problem
5152802|NCT03037021|Sickle Cell Disease|sickle cell disease
5152803|NCT03037021|Needs Assessment|needs assessment
5152804|NCT03037021|Barriers to care|barriers to care
5152805|NCT03037021|Access to care|access to care
5152806|NCT03037021|Primary care|primary care
5152807|NCT03037008|perineal sonography|perineal sonography
5152808|NCT03037008|male sling|male sling
5152809|NCT03037008|post prostatectomy incontinence|post prostatectomy incontinence
5152810|NCT03037008|ultrasonography|ultrasonography
5152811|NCT03036956|subclinical hypothyroidism in pregnancy|subclinical hypothyroidism in pregnancy
5152812|NCT03036904|venetoclax|venetoclax
5152813|NCT03036904|dose-adjusted EPOCH-R|dose-adjusted epoch-r
5152814|NCT03036904|aggressive B-Cell lymphoma|aggressive b-cell lymphoma
5152815|NCT03036904|Lymphoma|lymphoma
5152816|NCT03036904|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5152817|NCT03036904|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5152818|NCT03036904|Double hit lymphoma|double hit lymphoma
5152819|NCT03036891|Gastroparesis|gastroparesis
5152820|NCT03036891|Opioid-Induced|opioid-induced
5152821|NCT03036891|Delayed Gastric Emptying|delayed gastric emptying
5152822|NCT03036878|Osteochondral|osteochondral
5152823|NCT03036878|Marrow Stimulation|marrow stimulation
5152824|NCT03036878|ReNu|renu
5152825|NCT03036865|Healthy participants|healthy participants
5152826|NCT03036865|BOS161721|bos161721
5152827|NCT03036865|Pharmacokinetics|pharmacokinetics
5152828|NCT03036865|Pharmacodynamics|pharmacodynamics
5152829|NCT03036826|renal replacement therapy|renal replacement therapy
5152830|NCT03036787|Premature Baby|premature baby
5152831|NCT03036787|motor development|motor development
5152832|NCT03036787|cognitive development|cognitive development
5019319|NCT03876301|Factor VIII Protein|factor viii protein
5152833|NCT03036774|Gastric contents|gastric contents
5152834|NCT03036774|Ultrasound|ultrasound
5152835|NCT03036774|Diabetes|diabetes
5152836|NCT03036761|Auriculotherapy|auriculotherapy
5152837|NCT03036696|Retention|retention
5152838|NCT03036696|Lactation|lactation
5152839|NCT03036696|Human milk|human milk
5152840|NCT03036696|Pregnancy|pregnancy
5152856|NCT03036605|dexamethasone|dexamethasone
5152857|NCT03036605|bupivacaine|bupivacaine
5152858|NCT03036605|nasal surgery|nasal surgery
5152859|NCT03036605|nasal packing|nasal packing
5152860|NCT03036592|Glucose tolerance test, MTNR1B, nutrigenomics, food timing|glucose tolerance test, mtnr1b, nutrigenomics, food timing
5152861|NCT03036579|CAD/CAM|cad/cam
5152862|NCT03036579|Ceramic|ceramic
5152863|NCT03036579|Crown|crown
5152864|NCT03036553|Chronic pain|chronic pain
5152865|NCT03036553|Psychological factors|psychological factors
5152866|NCT03036553|Musculoskeletal pain|musculoskeletal pain
5152867|NCT03036553|Prognosis|prognosis
5152868|NCT03036540|upper limb thrombosis, midline catheter|upper limb thrombosis, midline catheter
5152869|NCT03036527|Bladder|bladder
5152870|NCT03036527|Sexual Function|sexual function
5152871|NCT03036514|numeric rating scale|numeric rating scale
5152872|NCT03036514|opioid side effects|opioid side effects
5152877|NCT03036462|intravenous iron|intravenous iron
5152878|NCT03036462|systolic heart failure|systolic heart failure
5152879|NCT03036462|iron deficiency|iron deficiency
5152880|NCT03036462|morbidity|morbidity
5152881|NCT03036462|mortality|mortality
5152882|NCT03036449|Medication errors|medication errors
5152883|NCT03036449|Patient safety|patient safety
5152884|NCT03036436|Cancer|cancer
5152885|NCT03036436|EHealth|ehealth
5152886|NCT03036436|Cancer Survivor|cancer survivor
5152887|NCT03036436|Rehabilitation|rehabilitation
5152888|NCT03036410|Hearing Aid Usage (monaural, binaural)|hearing aid usage (monaural, binaural)
5152889|NCT03036410|Cochlear Implant Usage (monaural, binaural)|cochlear implant usage (monaural, binaural)
5152890|NCT03036410|Hearing Aid and Cochlear Implant Usage (monaural)|hearing aid and cochlear implant usage (monaural)
5152893|NCT03036397|Fear|fear
5152894|NCT03036384|scheduled cesarean delivery|scheduled cesarean delivery
5152902|NCT03036371|Aerobic Exercise|aerobic exercise
5152903|NCT03036332|aerobic interval training|aerobic interval training
5152904|NCT03036332|biomarkers|biomarkers
5152905|NCT03036306|scar|scar
5152906|NCT03036306|nefopam|nefopam
5152907|NCT03036306|cicatrix|cicatrix
5152917|NCT03036267|health disparity|health disparity
5152918|NCT03036267|motivational interviewing|motivational interviewing
5152919|NCT03036267|African American adults|african american adults
5152920|NCT03036267|Federally Qualified Health Centers|federally qualified health centers
5152921|NCT03036267|adherence|adherence
5152922|NCT03036267|health beliefs|health beliefs
5152923|NCT03036267|self-management|self-management
5152924|NCT03036267|asthma control|asthma control
5152925|NCT03036254|Diabetes Mellitus|diabetes mellitus
5152926|NCT03036254|Cognition|cognition
5152927|NCT03036241|drug-eluting balloon,|drug-eluting balloon,
5152928|NCT03036241|target lesion revascularization (TLR)|target lesion revascularization (tlr)
5152929|NCT03036241|restenosis|restenosis
5152930|NCT03036228|Solid tumours|solid tumours
5152931|NCT03036202|epinephrine|epinephrine
5152932|NCT03036163|Tuberculosis|tuberculosis
5152936|NCT03036137|Tinnitus|tinnitus
5152937|NCT03036137|Electroencephalogram|electroencephalogram
5152938|NCT03036137|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5152939|NCT03036124|HFrEF|hfref
5152940|NCT03036124|Heart Failure (HF)|heart failure (hf)
5152941|NCT03036124|Cardiovascular Events (CV)|cardiovascular events (cv)
5152942|NCT03036124|Phase III outcome trial|phase iii outcome trial
5152943|NCT03036085|postoperative pain|postoperative pain
5152944|NCT03036085|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5152945|NCT03036085|opioids|opioids
5152946|NCT03036085|bupivacaine|bupivacaine
5152947|NCT03036085|liposomal bupivacaine|liposomal bupivacaine
5152959|NCT03035968|physiotherapy|physiotherapy
5152960|NCT03035955|Rosacea|rosacea
5152961|NCT03035955|Wake Forest|wake forest
5152962|NCT03035955|Demodex|demodex
5152963|NCT03035955|Finacea Gel|finacea gel
5152964|NCT03035942|Intrathecal morphine|intrathecal morphine
5152965|NCT03035942|Nausea and vomiting|nausea and vomiting
5152966|NCT03035942|Quality of recovery|quality of recovery
5152967|NCT03035942|Patient satisfaction|patient satisfaction
5152968|NCT03035942|Pruritus|pruritus
5152969|NCT03035942|Postoperative pain|postoperative pain
5152970|NCT03035916|transversus abdominal plane block|transversus abdominal plane block
5152971|NCT03035916|epidural anesthesia|epidural anesthesia
5152972|NCT03035916|stress response|stress response
5152973|NCT03035916|anesthetic recovery|anesthetic recovery
5152974|NCT03035890|NSCLC|nsclc
5152975|NCT03035890|Lung Cancer|lung cancer
5152976|NCT03035890|Non Small Cell Lung Cancer|non small cell lung cancer
5152977|NCT03035877|Antisocial Behavior|antisocial behavior
5152978|NCT03035877|Alcohol Abuse|alcohol abuse
5152979|NCT03035877|Drug Abuse|drug abuse
5962101|NCT04283032|PSA|psa
5962102|NCT04283032|MMPm|mmpm
5152980|NCT03035877|Young Adults|young adults
5152981|NCT03035864|Ocular discomfort after cataract and refractive surgery|ocular discomfort after cataract and refractive surgery
5152982|NCT03035864|cataract surgery|cataract surgery
5152983|NCT03035864|refractive surgery|refractive surgery
5152984|NCT03035851|Alzheimer Disease|alzheimer disease
5152985|NCT03035851|Dementia|dementia
5152986|NCT03035851|Exercise|exercise
5152987|NCT03035851|Physical Activity|physical activity
5152988|NCT03035851|Brain blood flow|brain blood flow
5152989|NCT03035851|Cognition|cognition
5152990|NCT03035851|Fitness|fitness
5152991|NCT03035812|Bicarbonate|bicarbonate
5152992|NCT03035773|Oncology|oncology
5153009|NCT03035721|Body composition|body composition
5153010|NCT03035695|Trauma|trauma
5153011|NCT03035695|Scalp injuries|scalp injuries
5153012|NCT03035695|Profused Bleeding|profused bleeding
5153013|NCT03035695|Accident|accident
5153014|NCT03035656|Pain|pain
5153015|NCT03035656|analgesic|analgesic
5153016|NCT03035656|spinal fusion|spinal fusion
5153017|NCT03035630|Avelumab|avelumab
5153018|NCT03035630|Sunitinib|sunitinib
5153019|NCT03035630|MSB0010718C|msb0010718c
5153020|NCT03035630|Sutent|sutent
5153021|NCT03035630|IgG1 antibody|igg1 antibody
5153022|NCT03035630|Anti-PD-L1|anti-pd-l1
5153023|NCT03035630|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5153024|NCT03035617|Bupivacaine|bupivacaine
5153029|NCT03035565|Heart Failure|heart failure
5153030|NCT03035565|Cognition in Heart Failure|cognition in heart failure
5153031|NCT03035552|Congenital heart disease (CCHD)|congenital heart disease (cchd)
5153032|NCT03035552|Non-Nutritive Suck|non-nutritive suck
5153033|NCT03035539|Rehabilitation|rehabilitation
5153034|NCT03035513|Continuous spikes|continuous spikes
5153035|NCT03035513|Epilepsy|epilepsy
5153036|NCT03035513|Nervous system disease|nervous system disease
5153037|NCT03035513|Neuronal plasticity|neuronal plasticity
5153038|NCT03035513|Diffusion MRI|diffusion mri
5153039|NCT03035513|Functional MRI|functional mri
5153040|NCT03035513|waves during slow sleep (CSWS)|waves during slow sleep (csws)
5153042|NCT03035474|Quality Improvement|quality improvement
5153043|NCT03035461|diagnosis annoucement|diagnosis annoucement
5153044|NCT03035461|patient's feelings|patient's feelings
5153053|NCT03035435|fast-track rehabilitation|fast-track rehabilitation
5153054|NCT03035435|fast-track surgery|fast-track surgery
5153055|NCT03035422|Allogenic cell stem transplant, Sequential chemotherapy Haploidentical transplant|allogenic cell stem transplant, sequential chemotherapy haploidentical transplant
5153056|NCT03035383|Large thyroid|large thyroid
5153057|NCT03035383|purse string suture|purse string suture
5153058|NCT03035383|thyroidectomy|thyroidectomy
5153059|NCT03035370|Pertussis|pertussis
5153060|NCT03035370|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
5153061|NCT03035370|Vaccine|vaccine
5153062|NCT03035370|Viaskin PT|viaskin pt
5153063|NCT03035357|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5153064|NCT03035357|Prostate cancer|prostate cancer
5153065|NCT03035357|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5153066|NCT03035357|Daratumumab|daratumumab
5153067|NCT03035357|Biomarker response|biomarker response
5153068|NCT03035305|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
5153069|NCT03035305|Lipid-based nutrient supplement|lipid-based nutrient supplement
5153070|NCT03035305|Children|children
5153071|NCT03035305|Mali|mali
5153083|NCT03035201|Memory|memory
5153084|NCT03035201|Mild Cognitive Impairment|mild cognitive impairment
5153085|NCT03035201|Alzheimer's Disease|alzheimer's disease
5153086|NCT03035201|Cognition|cognition
5153087|NCT03035188|resectable|resectable
5153088|NCT03035175|Residences|residences
5153089|NCT03035175|Video Laryngoscopy|video laryngoscopy
5153090|NCT03035175|Intubations|intubations
5153091|NCT03035175|Neonatal|neonatal
5153092|NCT03035175|NICU|nicu
5153094|NCT03035175|Medical Education|medical education
5153095|NCT03035162|dual tDCS|dual tdcs
5153096|NCT03035162|physical rehabilitation|physical rehabilitation
5153097|NCT03035162|lower limb functions|lower limb functions
5153098|NCT03035149|Obesity|obesity
5153099|NCT03035149|Metabolic Syndrome|metabolic syndrome
5153100|NCT03035149|Dyspnea|dyspnea
5153101|NCT03035149|Pulmonary Function|pulmonary function
5153102|NCT03035149|Exercise Capacity|exercise capacity
5153103|NCT03035136|polyps|polyps
5153104|NCT03035123|Heart Failure|heart failure
5153105|NCT03035123|Therapeutic education|therapeutic education
5153106|NCT03035123|Quality of life|quality of life
5153107|NCT03035071|Minimal-invasive esophagectomy|minimal-invasive esophagectomy
5153108|NCT03035071|Esophageal resection|esophageal resection
5153109|NCT03035071|Hybrid esophagectomy|hybrid esophagectomy
5153110|NCT03035058|Drug therapy|drug therapy
5153111|NCT03035032|Leuprolide acetate|leuprolide acetate
5153112|NCT03035032|Prostate cancer|prostate cancer
5153113|NCT03035019|anxiety|anxiety
5153114|NCT03035019|behavioral app|behavioral app
5153115|NCT03035006|Hepatocellular carcinoma|hepatocellular carcinoma
5153116|NCT03035006|Portal vein tumor thrombosis|portal vein tumor thrombosis
5153117|NCT03035006|TLC388|tlc388
5153118|NCT03035006|Chemoradiotherapy|chemoradiotherapy
5153119|NCT03035006|Lipotecan|lipotecan
5153120|NCT03034993|Healthcare for homeless|healthcare for homeless
5153121|NCT03034993|Text messages|text messages
5153122|NCT03034993|Primary care visits|primary care visits
5153123|NCT03034993|Medication adherence|medication adherence
5153124|NCT03034993|Inpatient admissions|inpatient admissions
5153125|NCT03034967|HCRU exacerbations|hcru exacerbations
5153126|NCT03034967|SGRQ|sgrq
5153127|NCT03034967|CXCR2 antagonist|cxcr2 antagonist
5153128|NCT03034967|GSK1325756|gsk1325756
5153129|NCT03034967|Danirixin|danirixin
5153130|NCT03034967|COPD|copd
5153131|NCT03034941|Obesity|obesity
5153132|NCT03034941|PCOS|pcos
5153133|NCT03034941|Infertility|infertility
5153134|NCT03034941|Liraglutide|liraglutide
5153135|NCT03034941|Metformin|metformin
5153136|NCT03034941|IVF|ivf
5153137|NCT03034915|Vilanterol|vilanterol
5153138|NCT03034915|COPD|copd
5153139|NCT03034915|HRQoL|hrqol
5153140|NCT03034915|Salmeterol|salmeterol
5153141|NCT03034915|Umeclidinium|umeclidinium
5153142|NCT03034889|Anesthesia|anesthesia
5153143|NCT03034889|Children|children
5153144|NCT03034889|General Anesthesia|general anesthesia
5153145|NCT03034889|Neurocognitive Outcome|neurocognitive outcome
5153146|NCT03034876|"Acute Kidney Injury, diagnosis, children, shock"|"acute kidney injury, diagnosis, children, shock"
5153147|NCT03034863|Family Caregivers|family caregivers
5153148|NCT03034863|Spouse Caregivers|spouse caregivers
5153149|NCT03034863|Veterans|veterans
5153150|NCT03034863|Suicide|suicide
5153151|NCT03034863|Clinical Trial|clinical trial
5153152|NCT03034863|Military Families|military families
5153153|NCT03034863|Military Psychology|military psychology
5153154|NCT03034850|cytoreductive surgery|cytoreductive surgery
5445356|NCT01522183|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5153155|NCT03034850|hyperthermic intraperitoneal peroperative chemotherapy|hyperthermic intraperitoneal peroperative chemotherapy
5153156|NCT03034850|platelet function|platelet function
5153157|NCT03034850|thrombin generation|thrombin generation
5153158|NCT03034850|thromboelastometry|thromboelastometry
5153159|NCT03034824|diode laser|diode laser
5153161|NCT03034824|Aggressive Periodontitis|aggressive periodontitis
5153162|NCT03034824|Clinical periodontal parameters|clinical periodontal parameters
5153163|NCT03034824|Gingival crevicular fluid cytokines levels|gingival crevicular fluid cytokines levels
5153164|NCT03034811|Noninflammatory degenerative joint disease|noninflammatory degenerative joint disease
5153166|NCT03034811|Avascular necrosis|avascular necrosis
5153167|NCT03034811|Traumatic arthritis|traumatic arthritis
5153168|NCT03034811|Partial knee arthroplasty|partial knee arthroplasty
5673416|NCT00608322|Sepsis|sepsis
5153169|NCT03034811|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5153170|NCT03034772|neovascular|neovascular
5153171|NCT03034772|wet|wet
5153172|NCT03034772|age-related|age-related
5153173|NCT03034772|macular degeneration|macular degeneration
5153174|NCT03034772|dorzolamide|dorzolamide
5153175|NCT03034772|timolol|timolol
5153176|NCT03034759|continuous glucose monitoring|continuous glucose monitoring
5153177|NCT03034746|alzheimer's disease, physical activity, cognitive training|alzheimer's disease, physical activity, cognitive training
5153178|NCT03034733|Arthroplasty|arthroplasty
5153187|NCT03034720|Depression|depression
5153188|NCT03034720|Anxiety|anxiety
5153189|NCT03034707|biotin pharmacokinetic|biotin pharmacokinetic
5153190|NCT03034707|biotinylated assay|biotinylated assay
5153191|NCT03034707|hormone measurement|hormone measurement
5153192|NCT03034707|thyroid|thyroid
5153193|NCT03034707|parathyroid|parathyroid
5153195|NCT03034668|Botanical Supplement|botanical supplement
5153196|NCT03034668|Performance-Enhancing Supplement|performance-enhancing supplement
5153197|NCT03034655|Vestibular rehabilitation|vestibular rehabilitation
5153198|NCT03034655|Falls in elderly|falls in elderly
5153199|NCT03034655|Computerized dynamic posturography|computerized dynamic posturography
5153200|NCT03034655|Mobile posturography|mobile posturography
5153201|NCT03034642|Apoptosis|apoptosis
5153203|NCT03034642|Human|human
5153204|NCT03034642|Mice, inbred strains|mice, inbred strains
5153205|NCT03034642|Macrophages, Alveolar|macrophages, alveolar
5153206|NCT03034642|MicroRNAs|micrornas
5153207|NCT03034642|Streptococcus pneumoniae|streptococcus pneumoniae
5153208|NCT03034642|Fluticasone|fluticasone
5153209|NCT03034616|Primary ovarian insufficiency|primary ovarian insufficiency
5153210|NCT03034616|In-vivo activation|in-vivo activation
5153211|NCT03034551|Adherence|adherence
5153212|NCT03034551|Financial Incentives|financial incentives
5153213|NCT03034551|Remote Monitoring|remote monitoring
5153214|NCT03034551|Self-Weighing|self-weighing
5153215|NCT03034551|Behavioral Economics|behavioral economics
5153216|NCT03034551|Telehealth|telehealth
5153217|NCT03034551|mobile health (mHealth)|mobile health (mhealth)
5153218|NCT03034551|Smartphone App|smartphone app
5153219|NCT03034551|Wellth App|wellth app
5153220|NCT03034486|Glaucoma|glaucoma
5153221|NCT03034473|locally advanced rectal cancer|locally advanced rectal cancer
5153222|NCT03034473|translational research|translational research
5153223|NCT03034473|Biomarker|biomarker
5153224|NCT03034447|Asthma|asthma
5153225|NCT03034447|Obstructive Sleep Apnea|obstructive sleep apnea
5153226|NCT03034447|Children|children
5153227|NCT03034447|Teenagers|teenagers
5153228|NCT03034408|Impulsivity|impulsivity
5153229|NCT03034408|Nalmefene|nalmefene
5153230|NCT03034408|Baclofen|baclofen
5153231|NCT03034395|Melanoma|melanoma
5153232|NCT03034395|cT2N0M0|ct2n0m0
5153233|NCT03034382|morphine|morphine
5153234|NCT03034382|nalbuphine|nalbuphine
5153235|NCT03034382|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5153236|NCT03034382|ultrasound guided interscalene block|ultrasound guided interscalene block
5153237|NCT03034369|Integration|integration
5153238|NCT03034369|Primary Care|primary care
5153239|NCT03034369|Behavioral Health|behavioral health
5153240|NCT03034369|Health Care Reform|health care reform
5153241|NCT03034369|Medical Home|medical home
5153242|NCT03034369|Accountable Care Organization|accountable care organization
5153243|NCT03034356|Schizophrenia|schizophrenia
5153244|NCT03034343|Mindfulness|mindfulness
5153245|NCT03034343|Internet program|internet program
5153246|NCT03034343|Depression|depression
5153247|NCT03034343|Cost-effectiveness|cost-effectiveness
5153248|NCT03034330|informal care|informal care
5153249|NCT03034330|empowerment|empowerment
5153250|NCT03034330|family-focused intervention|family-focused intervention
5153251|NCT03034330|stroke rehabilitation|stroke rehabilitation
5153252|NCT03034317|Diaphragm Pacing|diaphragm pacing
5153253|NCT03034304|MASCT-I，DC，T cell|masct-i，dc，t cell
5153254|NCT03034304|Advanced solid tumors|advanced solid tumors
5153255|NCT03034304|Bladder Cancer|bladder cancer
5153256|NCT03034304|Soft Tissue Sarcoma|soft tissue sarcoma
5153257|NCT03034291|Cocoa|cocoa
5153258|NCT03034291|obesity|obesity
5153259|NCT03034291|HOMA-IR|homa-ir
5153260|NCT03034291|BMI|bmi
5153261|NCT03034291|Quality of life|quality of life
5153262|NCT03034278|opioid use|opioid use
5153263|NCT03034265|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine|hypertension; exosome; angiotensin; sodium channel; kidney; aldosterone; renin; urine
5153264|NCT03034226|Hypoglycemia-Associated Autonomic Failure (HAAF)|hypoglycemia-associated autonomic failure (haaf)
5153265|NCT03034213|mesh|mesh
5153266|NCT03034200|Pheochromocytoma-paraganglioma|pheochromocytoma-paraganglioma
5153267|NCT03034200|ONC201|onc201
5153268|NCT03034187|Acute toxicity|acute toxicity
5153269|NCT03034187|Late toxicity|late toxicity
5162136|NCT02978456|QCA guided PCI|qca guided pci
5153271|NCT03034174|tigecycline|tigecycline
5153272|NCT03034174|pharmacokinetics|pharmacokinetics
5153273|NCT03034148|Coronary artery disease|coronary artery disease
5153274|NCT03034148|Atherothrombosis|atherothrombosis
5153275|NCT03034148|Thrombin generation|thrombin generation
5153276|NCT03034148|Platelet Acetyl Coenzyme A carboxylase phosphorylation|platelet acetyl coenzyme a carboxylase phosphorylation
5153277|NCT03034109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5153278|NCT03034109|Stroke|stroke
5153279|NCT03034109|Electric Stimulation Therapy|electric stimulation therapy
5153280|NCT03034109|Prefrontal Cortex|prefrontal cortex
5153281|NCT03034109|Electroencephalography|electroencephalography
5153282|NCT03034109|Cognition|cognition
5153283|NCT03034109|Neurological Rehabilitation|neurological rehabilitation
5153284|NCT03034109|Memory|memory
5153285|NCT03034109|Working Memory|working memory
5153286|NCT03034109|Attention|attention
5153287|NCT03034109|Concentration|concentration
5153288|NCT03034109|Short-Term Memory|short-term memory
5153289|NCT03034109|Planning|planning
5153290|NCT03034109|Executive Function|executive function
5153390|NCT03033420|Smartphone|smartphone
5153295|NCT03034083|healthy marriage and relationship education|healthy marriage and relationship education
5153297|NCT03034070|MRI sequences|mri sequences
5153298|NCT03034070|prostate cancer|prostate cancer
5153299|NCT03034070|cancer|cancer
5153300|NCT03034070|staging|staging
5153301|NCT03034070|bone metastasis|bone metastasis
5153302|NCT03034070|node metastasis|node metastasis
5153303|NCT03034031|Traumatic Brain Injury|traumatic brain injury
5153304|NCT03034031|Children|children
5153305|NCT03034031|Pediatric|pediatric
5153306|NCT03034031|MRI|mri
5153307|NCT03034031|fMRI|fmri
5153308|NCT03034031|Cognition|cognition
5153309|NCT03034031|DTI|dti
5153310|NCT03034031|Longitudinal|longitudinal
5153311|NCT03034031|Connectivity|connectivity
5153312|NCT03034031|DAI|dai
5153313|NCT03034031|Neuropsychology|neuropsychology
5153314|NCT03034031|Rehabilitation|rehabilitation
5153315|NCT03034018|insomnia|insomnia
5153316|NCT03034018|hot flashes|hot flashes
5153317|NCT03034018|menopause|menopause
5153318|NCT03034018|suvorexant|suvorexant
5153319|NCT03034018|belsomra|belsomra
5153320|NCT03034005|Inhaled corticosteroids|inhaled corticosteroids
5153321|NCT03034005|Airway hyper-responsiveness|airway hyper-responsiveness
5153322|NCT03034005|Airway smooth muscle|airway smooth muscle
5153323|NCT03034005|sodium-potassium pump|sodium-potassium pump
5153324|NCT03033966|Cerebral Oximetry|cerebral oximetry
5153325|NCT03033966|Cerebral Venous Thrombosis|cerebral venous thrombosis
5153326|NCT03033966|Decompressive Craniectomy|decompressive craniectomy
5153327|NCT03033927|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
5153328|NCT03033927|FOLFIRINOX|folfirinox
5153329|NCT03033927|gem/nab-P chemotherapy|gem/nab-p chemotherapy
5153330|NCT03033927|17-042|17-042
5153337|NCT03033901|Veterans|veterans
5153338|NCT03033901|Comparative Effectiveness Research|comparative effectiveness research
5153339|NCT03033901|Diagnosis|diagnosis
5153340|NCT03033836|transgender women|transgender women
5153341|NCT03033823|Alcoholism|alcoholism
5153342|NCT03033823|Delirium|delirium
5153343|NCT03033823|Magnesium Deficiency|magnesium deficiency
5153344|NCT03033797|assitive technology|assitive technology
5153345|NCT03033797|virtual reality games|virtual reality games
5153346|NCT03033797|intellectual disability|intellectual disability
5153347|NCT03033797|augmentative and alternative communication|augmentative and alternative communication
5153348|NCT03033784|Neuroscience|neuroscience
5153349|NCT03033758|comorbidities|comorbidities
5153350|NCT03033732|opioid agonist treatment|opioid agonist treatment
5153351|NCT03033732|pragmatic|pragmatic
5153352|NCT03033732|prescription opioid use|prescription opioid use
5153353|NCT03033732|patient engagement|patient engagement
5153354|NCT03033719|Colorectal Surgery|colorectal surgery
5153355|NCT03033719|Geriatrics|geriatrics
5153356|NCT03033719|Digestive Oncology|digestive oncology
5153357|NCT03033719|Colon cancer|colon cancer
5153358|NCT03033719|Elderly patients|elderly patients
5153359|NCT03033719|Laparoscopy|laparoscopy
5153360|NCT03033719|Laparotomy|laparotomy
5153361|NCT03033719|Morbidity|morbidity
5153362|NCT03033667|perioperative fasting|perioperative fasting
5153363|NCT03033667|free fatty acids|free fatty acids
5153364|NCT03033667|coronary bypass grfting|coronary bypass grfting
5153365|NCT03033589|Pain control|pain control
5445357|NCT01522183|aHUS|ahus
5153366|NCT03033589|Anterior Cruciate Ligament (ACL_ Reconstruction)|anterior cruciate ligament (acl_ reconstruction)
5153367|NCT03033589|Regional Anesthesia|regional anesthesia
5153368|NCT03033550|HPV vaccination|hpv vaccination
5153369|NCT03033550|Cervical cancer screening|cervical cancer screening
5153370|NCT03033550|Primary care setting|primary care setting
5153371|NCT03033550|Primary prevention of cervical cancer|primary prevention of cervical cancer
5153372|NCT03033550|Secondary prevention of cervical cancer|secondary prevention of cervical cancer
5153373|NCT03033550|Mobile health information|mobile health information
5162247|NCT02977923|Anxiety|anxiety
5153378|NCT03033511|first-line chemotherapy|first-line chemotherapy
5153379|NCT03033511|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5153380|NCT03033511|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
5153381|NCT03033485|Picolinamide|picolinamide
5153382|NCT03033485|PET/CT|pet/ct
5153383|NCT03033485|Diagnosis|diagnosis
5153384|NCT03033485|Melanoma|melanoma
5153385|NCT03033459|breast feeding|breast feeding
5153386|NCT03033459|motivational interviewing|motivational interviewing
5153387|NCT03033420|Unipolar disorder|unipolar disorder
5153388|NCT03033420|Bipolar disorder|bipolar disorder
5153389|NCT03033420|Randomized controlled trial|randomized controlled trial
5153391|NCT03033420|Re-admission|re-admission
5153392|NCT03033420|CBT|cbt
5153393|NCT03033394|Penicillins|penicillins
5153394|NCT03033394|Drug Monitoring|drug monitoring
5153395|NCT03033394|Pharmacokinetics|pharmacokinetics
5153396|NCT03033381|Children|children
5153397|NCT03033381|Inguinal hernia|inguinal hernia
5153398|NCT03033381|Testis|testis
5153399|NCT03033381|Doppler ultrasonography|doppler ultrasonography
5153400|NCT03033368|immunological outcome|immunological outcome
5153401|NCT03033368|virologic outcomes|virologic outcomes
5153402|NCT03033368|HIV-1 infected adolescents|hiv-1 infected adolescents
5153403|NCT03033368|EFV switch to RPV|efv switch to rpv
5153404|NCT03033368|Rilpivirine pharmacokinetic|rilpivirine pharmacokinetic
5153405|NCT03033368|neuropsychiatric adverse events|neuropsychiatric adverse events
5153535|NCT03032601|PET Scan|pet scan
5356858|NCT01917708|non malignant conditions|non malignant conditions
5153406|NCT03033355|Neurogenic Bladder, Detrusor Overactivity, Botox, fMRI, neurogenic detrusor overactivity|neurogenic bladder, detrusor overactivity, botox, fmri, neurogenic detrusor overactivity
5153408|NCT03033316|Multiple Myeloma|multiple myeloma
5153409|NCT03033316|Liposomal Dexamethasone|liposomal dexamethasone
5153410|NCT03033316|Targeted Drug Delivery|targeted drug delivery
5153411|NCT03033303|Hu3F8|hu3f8
5153412|NCT03033303|GM-CSF|gm-csf
5153413|NCT03033303|Isotretinoin|isotretinoin
5153414|NCT03033303|16-1643|16-1643
5153415|NCT03033290|Qi-tonifying regimen|qi-tonifying regimen
5153416|NCT03033290|immune-modulation|immune-modulation
5153417|NCT03033290|gut microbiota|gut microbiota
5153418|NCT03033251|COPD exacerbation|copd exacerbation
5153419|NCT03033251|Work of breathing|work of breathing
5153420|NCT03033251|Non invasive ventilation|non invasive ventilation
5153421|NCT03033251|High Flow Oxygen Cannula|high flow oxygen cannula
5153422|NCT03033225|Pancrease|pancrease
5153423|NCT03033225|Cancer|cancer
5153424|NCT03033225|Photodynamic Therapy|photodynamic therapy
5153425|NCT03033225|Pancreatic|pancreatic
5153426|NCT03033225|Tumor|tumor
5153427|NCT03033225|unresectable|unresectable
5153428|NCT03033199|Gut microbiota|gut microbiota
5153429|NCT03033199|Immune thrombocytopenia|immune thrombocytopenia
5153430|NCT03033186|Everolimus|everolimus
5153431|NCT03033186|Long term site effects|long term site effects
5153432|NCT03033186|Dried Blood Spot|dried blood spot
5153433|NCT03033186|Therapeutic Drug Monitoring|therapeutic drug monitoring
5153434|NCT03033160|Estrogen|estrogen
5153435|NCT03033160|Hematuria|hematuria
5153436|NCT03033121|growth hormone|growth hormone
5153437|NCT03033121|children|children
5153438|NCT03033121|metabolism|metabolism
5153439|NCT03033095|TNF inhibitor|tnf inhibitor
5153440|NCT03033095|Etanercept|etanercept
5153441|NCT03033095|Spondyloarthritis|spondyloarthritis
5153442|NCT03033095|Biomarkers analysis|biomarkers analysis
5153443|NCT03033095|Personnalized medicine|personnalized medicine
5153444|NCT03033056|fear-conditioning|fear-conditioning
5153445|NCT03033056|behavioral avoidance|behavioral avoidance
5153446|NCT03033056|anxiety disorders|anxiety disorders
5153447|NCT03033056|fMRI|fmri
5153448|NCT03033043|aortic|aortic
5153449|NCT03033043|dissection|dissection
5153450|NCT03033043|type B|type b
5153451|NCT03033043|thoracic|thoracic
5153452|NCT03033030|Ultrasound|ultrasound
5153453|NCT03033030|Digital Breast Tomosynthesis|digital breast tomosynthesis
5153454|NCT03033030|Cancer Detection rate|cancer detection rate
5153455|NCT03033030|Sensitivity|sensitivity
5153456|NCT03033030|Specificity|specificity
5153457|NCT03033030|Breast density|breast density
5153458|NCT03033017|HIV|hiv
5153459|NCT03032991|Gestational diabetes|gestational diabetes
5153460|NCT03032991|Neurodevelopment|neurodevelopment
5153461|NCT03032991|Placenta|placenta
5153462|NCT03032991|Gut microbiota|gut microbiota
5153463|NCT03032991|Protectins|protectins
5153464|NCT03032991|MFSD2a|mfsd2a
5153465|NCT03032991|AdipoRon|adiporon
5153466|NCT03032965|atrial fibrillation|atrial fibrillation
5153467|NCT03032965|ablation|ablation
5153468|NCT03032965|adenosine|adenosine
5153469|NCT03032952|RCT|rct
5153473|NCT03032952|Depressive symptoms|depressive symptoms
5153474|NCT03032952|Anxious symptoms|anxious symptoms
5153475|NCT03032952|Students|students
5153476|NCT03032952|Mental health|mental health
5153477|NCT03032926|Anxiety|anxiety
5153479|NCT03032913|Pancreatic|pancreatic
5153480|NCT03032913|Cancer|cancer
5153481|NCT03032913|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
5153482|NCT03032913|Adenocarcinoma|adenocarcinoma
5153483|NCT03032913|Ductal|ductal
5153484|NCT03032913|Exosome|exosome
5153485|NCT03032900|Major lung resection|major lung resection
5153486|NCT03032900|Right Ventricular Dysfunction|right ventricular dysfunction
5153487|NCT03032900|2D Strain|2d strain
5153488|NCT03032887|hygiene|hygiene
5153489|NCT03032887|prenatal care|prenatal care
5153490|NCT03032887|postnatal care|postnatal care
5153491|NCT03032874|Colorectal cancer|colorectal cancer
5153492|NCT03032874|Polyps|polyps
5153493|NCT03032874|Colonoscopy|colonoscopy
5153494|NCT03032874|Rectal bleeding|rectal bleeding
5153495|NCT03032874|Nigeria|nigeria
5153496|NCT03032861|Orange juice|orange juice
5153497|NCT03032861|Microbiota|microbiota
5153498|NCT03032861|Prebiotic|prebiotic
5153499|NCT03032861|Flavanones|flavanones
5153500|NCT03032861|Bioavailability|bioavailability
5153501|NCT03032835|Calciphylaxis|calciphylaxis
5153502|NCT03032835|Warfarin|warfarin
5153503|NCT03032835|Dialysis|dialysis
5153504|NCT03032822|Opioid consumption|opioid consumption
5153505|NCT03032822|postdischarge|postdischarge
5153506|NCT03032822|cystectomy|cystectomy
5153507|NCT03032744|Pediatric|pediatric
5153508|NCT03032744|School Based Health Center|school based health center
5153509|NCT03032731|Physical activity|physical activity
5153510|NCT03032731|Diet|diet
5153511|NCT03032731|Health Behavior|health behavior
5153512|NCT03032705|Restorations|restorations
5153513|NCT03032705|Composite|composite
5153514|NCT03032679|pain, acute, chronic, knee arthroplasty|pain, acute, chronic, knee arthroplasty
5153515|NCT03032666|Thalassemia|thalassemia
5153516|NCT03032666|HCV|hcv
5153517|NCT03032666|Sofosbuvir|sofosbuvir
5153518|NCT03032666|Ledipasvir|ledipasvir
5153519|NCT03032653|ankle, fracture, rehabilitation, weightbearing, early, late|ankle, fracture, rehabilitation, weightbearing, early, late
5153520|NCT03032640|Glucose|glucose
5153521|NCT03032640|Sweet taste receptors|sweet taste receptors
5153522|NCT03032640|Artificial sweeteners|artificial sweeteners
5153523|NCT03032601|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5153524|NCT03032601|Acute Fulminating|acute fulminating
5153525|NCT03032601|Sclerosis|sclerosis
5153526|NCT03032601|FDG|fdg
5153527|NCT03032601|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
5153528|NCT03032601|18F-FDG|18f-fdg
5153529|NCT03032601|18FDG|18fdg
5153530|NCT03032601|2-Fluoro-2-deoxy-D-glucose|2-fluoro-2-deoxy-d-glucose
5153531|NCT03032601|2-Fluoro-2-deoxyglucose|2-fluoro-2-deoxyglucose
5153532|NCT03032601|Fludeoxyglucose F 18|fludeoxyglucose f 18
5153533|NCT03032601|Fluorine-18-fluorodeoxyglucose|fluorine-18-fluorodeoxyglucose
5153534|NCT03032601|Fluorodeoxyglucose F 18|fluorodeoxyglucose f 18
5153536|NCT03032601|Tomography, Positron-Emission|tomography, positron-emission
5153537|NCT03032601|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5153538|NCT03032601|fMRI|fmri
5153539|NCT03032601|PET-MRI|pet-mri
5153540|NCT03032601|Acetylcysteine|acetylcysteine
5153541|NCT03032601|N-acetyl cysteine|n-acetyl cysteine
5153542|NCT03032601|NAC|nac
5153543|NCT03032601|Oral supplements|oral supplements
5153544|NCT03032575|HIV|hiv
5153545|NCT03032562|respiratory muscle strength|respiratory muscle strength
5153546|NCT03032562|sleep-disordered breathing|sleep-disordered breathing
5153547|NCT03032562|neuromuscular disease|neuromuscular disease
5153548|NCT03032562|chronic-obstructive pulmonary disease|chronic-obstructive pulmonary disease
5153549|NCT03032497|Brain Computer Interface|brain computer interface
5153550|NCT03032497|Electroencephalogram (EEG)|electroencephalogram (eeg)
5153551|NCT03032497|Chronic Pain|chronic pain
5153552|NCT03032471|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5153553|NCT03032471|Delayed cerebral ischemia|delayed cerebral ischemia
5153554|NCT03032471|Cognitive Impairment|cognitive impairment
5153555|NCT03032471|Montreal Cognitive Assessment|montreal cognitive assessment
5153556|NCT03032471|MoCA|moca
5153557|NCT03032471|Cognitive Deterioration|cognitive deterioration
5153558|NCT03032458|Shock Wave Lithotripsy|shock wave lithotripsy
5153559|NCT03032458|Ketorolac|ketorolac
5153560|NCT03032458|Xylocaine Gel|xylocaine gel
5153561|NCT03032458|Pethidine|pethidine
5153562|NCT03032445|Body Water/physiology|body water/physiology
5039932|NCT03749174|Radial fracture|radial fracture
5153563|NCT03032445|Hyponatremia/etiology|hyponatremia/etiology
5153564|NCT03032445|Physical Exertion/physiology|physical exertion/physiology
5153565|NCT03032445|Running/physiology|running/physiology
5153566|NCT03032445|Sodium/blood|sodium/blood
5153567|NCT03032445|Ethanol|ethanol
5153586|NCT03032276|Safe motherhood|safe motherhood
5153587|NCT03032276|Newborn survival|newborn survival
5153588|NCT03032276|Community|community
5153589|NCT03032276|Cluster Randomized Trial|cluster randomized trial
5153590|NCT03032237|Protein intake|protein intake
5153591|NCT03032237|Older adults|older adults
5153592|NCT03032237|Protein-rich|protein-rich
5153593|NCT03032237|Acceptance|acceptance
5153594|NCT03032237|Liking|liking
5153597|NCT03032224|sarcopenia|sarcopenia
5153598|NCT03032224|Dysphagia|dysphagia
5153599|NCT03032224|Surgery|surgery
5153605|NCT03032185|electrical stimulation therapy|electrical stimulation therapy
5153606|NCT03032185|women's health|women's health
5153607|NCT03032133|Total Knee Arthroplasty|total knee arthroplasty
5153608|NCT03032133|Total Knee Replacement|total knee replacement
5153609|NCT03032133|Outcome|outcome
5153610|NCT03032133|Results|results
5153611|NCT03032133|Pain|pain
5153612|NCT03032107|Breast Cancer|breast cancer
5153613|NCT03032094|Gingival Recession|gingival recession
5153614|NCT03032055|sickle cell desease|sickle cell desease
5153615|NCT03032055|vaso occlusive crisis|vaso occlusive crisis
5153616|NCT03032055|acute chest syndrome|acute chest syndrome
5153617|NCT03032055|Validation of predictif score of acute chest syndrome|validation of predictif score of acute chest syndrome
5153618|NCT03032042|intestinal microbiome|intestinal microbiome
5153619|NCT03032042|soil-transmitted helminths|soil-transmitted helminths
5153620|NCT03032042|mass drug administration|mass drug administration
5153621|NCT03032016|VOD|vod
5153622|NCT03032016|Defibrotide|defibrotide
5153623|NCT03032016|Defitelio|defitelio
5153624|NCT03032016|Registry|registry
5153625|NCT03032016|SOS|sos
5153626|NCT03031990|Yoga|yoga
5153627|NCT03031990|Oocyte cryopreservation|oocyte cryopreservation
5153628|NCT03031990|In-vitro fertilization|in-vitro fertilization
5153629|NCT03031951|Former athletes|former athletes
5153630|NCT03031951|Body composition|body composition
5153631|NCT03031951|Adaptive thermogenesis|adaptive thermogenesis
5153632|NCT03031951|Physical activity|physical activity
5153633|NCT03031951|Energy expenditure|energy expenditure
5153634|NCT03031951|Sedentary behavior|sedentary behavior
5153635|NCT03031951|Fat mass|fat mass
5153636|NCT03031951|Abdominal fat mass|abdominal fat mass
5153637|NCT03031951|Nutrition|nutrition
5153638|NCT03031951|Behavior modification|behavior modification
5153639|NCT03031938|Exposure in utero in tanezumab program|exposure in utero in tanezumab program
5153640|NCT03031925|Annexin A2|annexin a2
5153641|NCT03031925|biomarker|biomarker
5153642|NCT03031821|Prostate Cancer|prostate cancer
5153643|NCT03031821|ADT|adt
5153644|NCT03031821|Metabolic Syndrome|metabolic syndrome
5153645|NCT03031821|Androgen Deprivation Therapy|androgen deprivation therapy
5153646|NCT03031821|Phase III|phase iii
5153647|NCT03031821|Phase 3|phase 3
5153648|NCT03031821|Randomized|randomized
5153649|NCT03031795|intrauterine device|intrauterine device
5153650|NCT03031782|JIA, JPsA, ERA, Secukinumab, ILAR|jia, jpsa, era, secukinumab, ilar
5153651|NCT03031756|Air polishing|air polishing
5153652|NCT03031743|rotavirus vaccine|rotavirus vaccine
5153653|NCT03031743|human microbiome|human microbiome
5153654|NCT03031743|fecal microbiome|fecal microbiome
5153655|NCT03031743|vaccine immunogenicity|vaccine immunogenicity
5153656|NCT03031743|Rotarix|rotarix
5153657|NCT03031743|immune response, mucosal|immune response, mucosal
5153658|NCT03031665|GABA|gaba
5153659|NCT03031665|Depression|depression
5153660|NCT03031665|Stress|stress
5153661|NCT03031665|Androgens|androgens
5153662|NCT03031652|pain|pain
5153663|NCT03031652|axial length|axial length
5153664|NCT03031652|anterior chamber depth|anterior chamber depth
5153665|NCT03031652|intraocular pressure|intraocular pressure
5153668|NCT03031613|intraocular pressure|intraocular pressure
5962103|NCT04283032|Quality of Life|quality of life
5153669|NCT03031613|intracerebral pressure|intracerebral pressure
5153670|NCT03031587|Thermometric MRI|thermometric mri
5153671|NCT03031587|Myocardium|myocardium
5153672|NCT03031574|Serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
5153674|NCT03031509|Nonunion Fracture of limb|nonunion fracture of limb
5153675|NCT03031496|Cross-over|cross-over
5153676|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide
5153677|NCT03031496|Amiloride hydrochloride|amiloride hydrochloride
5153678|NCT03031496|Phase I|phase i
5153679|NCT03031496|GSK3542503|gsk3542503
5153680|NCT03031496|Bioequivalence|bioequivalence
5153681|NCT03031496|FTIH|ftih
5153682|NCT03031470|Liver Transplant|liver transplant
5153683|NCT03031470|Ischemia-reperfusion injury|ischemia-reperfusion injury
5153684|NCT03031470|Early allograft dysfunction|early allograft dysfunction
5153685|NCT03031444|colorectal liver metastasis|colorectal liver metastasis
5153686|NCT03031444|preoperative|preoperative
5153687|NCT03031444|chemotherapy|chemotherapy
5153688|NCT03031444|targeted therapy|targeted therapy
5153689|NCT03031431|Hypothermia|hypothermia
5153690|NCT03031431|Infant Warmer|infant warmer
5153691|NCT03031340|Spinal fusion|spinal fusion
5153692|NCT03031340|pregabalin|pregabalin
5153693|NCT03031340|Spinal fusion surgeries|spinal fusion surgeries
5153694|NCT03031340|two or more vertebrae|two or more vertebrae
5153791|NCT03030820|inflammation|inflammation
5149287|NCT03059472|physical activity|physical activity
5153699|NCT03031314|Wound Healing|wound healing
5153700|NCT03031314|Hip Replacement|hip replacement
5153701|NCT03031288|gastroesophageal reflux|gastroesophageal reflux
5153702|NCT03031288|swallow|swallow
5153703|NCT03031288|feeding bottle|feeding bottle
5153704|NCT03031288|cardiorespiratory|cardiorespiratory
5153705|NCT03031288|apnoea|apnoea
5153706|NCT03031288|preterm|preterm
5153707|NCT03031288|impedance-pH-metry|impedance-ph-metry
5153708|NCT03031275|extracorporeal circulation|extracorporeal circulation
5153709|NCT03031275|critical care outcomes|critical care outcomes
5153710|NCT03031236|Early Childhood Development (ECD)|early childhood development (ecd)
5153711|NCT03031236|Psychosocial stimulation|psychosocial stimulation
5153712|NCT03031236|Cognition|cognition
5153713|NCT03031236|Parenting|parenting
5153714|NCT03031236|Malnutrition|malnutrition
5153715|NCT03031236|Bangladesh|bangladesh
5153716|NCT03031236|Childhood Maltreatment|childhood maltreatment
5153717|NCT03031223|Spinal cord injuries|spinal cord injuries
5153718|NCT03031223|low-level laser therapy|low-level laser therapy
5153719|NCT03031210|Non-severe community-acquired pneumonia|non-severe community-acquired pneumonia
5153720|NCT03031210|Amoxicillin treatment|amoxicillin treatment
5153721|NCT03031210|Twice daily antibiotic regimen|twice daily antibiotic regimen
5153722|NCT03031197|adherence|adherence
5153723|NCT03031197|adolescent|adolescent
5153724|NCT03031197|HIV/AIDS|hiv/aids
5153725|NCT03031197|Vietnam|vietnam
5153726|NCT03031184|Agitation|agitation
5153727|NCT03031184|Agitated behaviours|agitated behaviours
5153728|NCT03031184|Alzheimer's Disease|alzheimer's disease
5153729|NCT03031171|community engagement, navigation, cancer screening|community engagement, navigation, cancer screening
5153730|NCT03031132|Protein-rich breakfast|protein-rich breakfast
5153731|NCT03031132|Breakfast Skipping|breakfast skipping
5153732|NCT03031132|Young Adults|young adults
5153733|NCT03031132|Breakfast|breakfast
5153734|NCT03031132|Food form|food form
5153736|NCT03031132|Ghrelin|ghrelin
5153738|NCT03031132|Sleep|sleep
5153739|NCT03031119|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5153740|NCT03031106|Patient-reported outcomes, Health-related QoL, Internet-based tool|patient-reported outcomes, health-related qol, internet-based tool
5153741|NCT03031093|aerosol therapy|aerosol therapy
5153742|NCT03031093|pulmonary scintigraphy|pulmonary scintigraphy
5153743|NCT03031093|upper airways anatomy|upper airways anatomy
5153744|NCT03031093|High Flow Nasal Cannula|high flow nasal cannula
5153745|NCT03031080|Collagenase, Night-splinting, Dupuytrens, Contracture|collagenase, night-splinting, dupuytrens, contracture
5153746|NCT03031067|Donors and donation|donors and donation
5153747|NCT03031067|Extended criteria donor|extended criteria donor
5153748|NCT03031067|Organ perfusion and preservation|organ perfusion and preservation
5153749|NCT03031067|Liver transplantation|liver transplantation
5153750|NCT03031067|Kidney transplantation|kidney transplantation
5153751|NCT03031067|Preservation injury|preservation injury
5153752|NCT03031067|Ischemia reperfusion injury|ischemia reperfusion injury
5153753|NCT03031054|Hydrodissection|hydrodissection
5153754|NCT03031054|hyaluronic acid|hyaluronic acid
5153755|NCT03031041|Hydrodissection|hydrodissection
5153756|NCT03031041|short-axis|short-axis
5153757|NCT03031041|long-axis|long-axis
5153758|NCT03031028|refractory epilepsy,|refractory epilepsy,
5153759|NCT03031028|ketogenic diet|ketogenic diet
5153760|NCT03031028|classic ketogenic diet|classic ketogenic diet
5153761|NCT03031028|seizure rate|seizure rate
5153762|NCT03031028|efficacy|efficacy
5153763|NCT03031028|epilepsy|epilepsy
5153764|NCT03031015|Reduction, Fracture|reduction, fracture
5153765|NCT03031002|exposure|exposure
5153766|NCT03031002|spider phobia|spider phobia
5153767|NCT03031002|generalization|generalization
5153768|NCT03031002|extinction|extinction
5153769|NCT03030976|CD19|cd19
5153770|NCT03030976|CAR-T|car-t
5153771|NCT03030976|SLE|sle
5153772|NCT03030963|Equal ratio ventilation(ERV)|equal ratio ventilation(erv)
5153773|NCT03030963|Peak inspiratory pressure(PIP)|peak inspiratory pressure(pip)
5153775|NCT03030963|Posterior lumbar interbody fusion(PLIF)|posterior lumbar interbody fusion(plif)
5153776|NCT03030963|Prone position|prone position
5153777|NCT03030924|suicide|suicide
5153778|NCT03030885|Radiopharmaceutical (131I-MIP-1095)|radiopharmaceutical (131i-mip-1095)
5153779|NCT03030885|16-1110|16-1110
5153780|NCT03030846|pregnancy|pregnancy
5153781|NCT03030846|pelvic floor muscles|pelvic floor muscles
5153782|NCT03030846|Lumbo-pelvic pain|lumbo-pelvic pain
5153783|NCT03030846|Stabilization exercises|stabilization exercises
5153784|NCT03030846|abdominal muscles thickness|abdominal muscles thickness
5153785|NCT03030846|Multifidus muscles thickness|multifidus muscles thickness
5153786|NCT03030846|Multifidus muscles cross section area|multifidus muscles cross section area
5153787|NCT03030820|cirrhosis|cirrhosis
5153789|NCT03030820|oral health|oral health
5153790|NCT03030820|gingivitis|gingivitis
5153798|NCT03030768|Fertility|fertility
5153799|NCT03030768|mHealth|mhealth
5153800|NCT03030768|Pregnancy|pregnancy
5153801|NCT03030716|antinutrients|antinutrients
5153802|NCT03030716|tannins|tannins
5153803|NCT03030716|proanthocyanidins|proanthocyanidins
5153804|NCT03030716|salivary proline-rich proteins|salivary proline-rich proteins
5153805|NCT03030703|Phytic acid|phytic acid
5153806|NCT03030703|Cystatin|cystatin
5153807|NCT03030703|Salivary proline-rich protein|salivary proline-rich protein
5153808|NCT03030703|antinutrient|antinutrient
5153809|NCT03030690|Proximal Dental Caries|proximal dental caries
5153810|NCT03030690|Glass Carbomer|glass carbomer
5153811|NCT03030690|Hydroxyapatite Enhanced Glass Ionomer|hydroxyapatite enhanced glass ionomer
5153812|NCT03030690|Primary Teeth|primary teeth
5153813|NCT03030677|pecs block|pecs block
5153814|NCT03030677|breast surgery|breast surgery
5153815|NCT03030677|ultrasound guidence|ultrasound guidence
5153816|NCT03030664|constipation|constipation
5153817|NCT03030664|Lactobacillus reuteri|lactobacillus reuteri
5153818|NCT03030664|probiotics|probiotics
5153819|NCT03030651|Breastfeeding|breastfeeding
5153820|NCT03030651|Education and support|education and support
5153821|NCT03030651|Ethiopia|ethiopia
5153822|NCT03030651|Timely initiation of breastfeeding|timely initiation of breastfeeding
5153823|NCT03030625|Prostate Cancer|prostate cancer
5153824|NCT03030625|VMAT|vmat
5153825|NCT03030625|Dominant Intraprostatic Lesion|dominant intraprostatic lesion
5153826|NCT03030625|Intensity modulated radiotherapy|intensity modulated radiotherapy
5153827|NCT03030586|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
5153828|NCT03030573|Bile duct injury|bile duct injury
5153829|NCT03030573|Bile duct defect|bile duct defect
5153830|NCT03030573|Round ligament|round ligament
5153831|NCT03030573|Reconstruction|reconstruction
5153832|NCT03030508|biomarks|biomarks
5153833|NCT03030508|colorectal cancer|colorectal cancer
5153834|NCT03030508|capecitabine|capecitabine
5153835|NCT03030508|gene polymorphism|gene polymorphism
5153836|NCT03030495|Ischemic Heart Disease|ischemic heart disease
5153837|NCT03030495|Stable angina|stable angina
5153838|NCT03030495|Fractional flow reserve|fractional flow reserve
5153839|NCT03030495|Index of Microcirculatory Resistance|index of microcirculatory resistance
5153840|NCT03030495|Coronary Flow Reserve|coronary flow reserve
5153841|NCT03030495|Intravascular Imaging|intravascular imaging
5153843|NCT03030482|intensive care|intensive care
5153844|NCT03030482|mechanical ventilation|mechanical ventilation
5153845|NCT03030482|touch massage|touch massage
5153846|NCT03030456|whole body vibration|whole body vibration
5153847|NCT03030456|Oxidative Stress|oxidative stress
5153848|NCT03030456|Aged|aged
5153849|NCT03030456|Biochemical profile|biochemical profile
5153850|NCT03030456|muscle strength|muscle strength
5153851|NCT03030456|flexibility|flexibility
5153852|NCT03030443|Pain management|pain management
5153853|NCT03030443|Nitrous|nitrous
5153854|NCT03030417|Topoisomerase I Inhibitor|topoisomerase i inhibitor
5153855|NCT03030417|Epithelial-Mesenchymal Transition|epithelial-mesenchymal transition
5153856|NCT03030417|Pharmacodynamics|pharmacodynamics
5153857|NCT03030417|DNA Damage|dna damage
5153858|NCT03030417|Pharmacokinetics|pharmacokinetics
5153864|NCT03030391|Camp|camp
5153865|NCT03030391|Radiation Absorbed Dose|radiation absorbed dose
5153866|NCT03030391|Compartmental Analysis|compartmental analysis
5153867|NCT03030365|Orientation, Disorientation.|orientation, disorientation.
5153868|NCT03030352|Child Mental Health|child mental health
5153869|NCT03030352|Parenting|parenting
5153870|NCT03030352|Autonomy Support|autonomy support
5153871|NCT03030352|How-to Parenting Program|how-to parenting program
5153872|NCT03030352|Randomized Controlled Trial|randomized controlled trial
5153873|NCT03030352|Primary Prevention|primary prevention
5153874|NCT03030352|Parental Mental Health|parental mental health
5153875|NCT03030352|Child Well-Being|child well-being
5153876|NCT03030339|Vitamin A status|vitamin a status
5153877|NCT03030339|infant|infant
5153878|NCT03030339|dietary assessment|dietary assessment
5153879|NCT03030339|retinol isotope dilution|retinol isotope dilution
5153886|NCT03030248|Clostridium difficile|clostridium difficile
5153887|NCT03030248|metabolomics|metabolomics
5153888|NCT03030248|vancomycin|vancomycin
5153894|NCT03030222|SGLT-2 inhibitors|sglt-2 inhibitors
5153895|NCT03030209|pancreatectomy|pancreatectomy
5153896|NCT03030209|diabetes mellitus|diabetes mellitus
5153898|NCT03030157|urothelial cancer|urothelial cancer
5153899|NCT03030157|bladder cancer|bladder cancer
5153900|NCT03030157|nephroureterectomy|nephroureterectomy
5153901|NCT03030131|IFCT|ifct
5153902|NCT03030131|neodjuvant|neodjuvant
5153903|NCT03030131|immune therapy|immune therapy
5153904|NCT03030131|Non small cell lung cancer|non small cell lung cancer
5153905|NCT03030118|hydroxychloroquine|hydroxychloroquine
5153906|NCT03030105|Cognition|cognition
5153907|NCT03030105|Dementia|dementia
5153908|NCT03030105|Phosphodiesterase Type 4D|phosphodiesterase type 4d
5153909|NCT03030105|PDE4D|pde4d
5153918|NCT03030053|Polyphenols|polyphenols
5153919|NCT03030053|Cognition|cognition
5153920|NCT03030053|Aging|aging
5153921|NCT03030040|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5153922|NCT03030040|self-help|self-help
5153923|NCT03030040|healthcare staff|healthcare staff
5153924|NCT03030027|Intergeneration|intergeneration
5153925|NCT03030027|Reappraisal|reappraisal
5153926|NCT03030027|Caregiving|caregiving
5153927|NCT03030001|mesothelin|mesothelin
5153928|NCT03030001|PD-1|pd-1
5153929|NCT03030001|CAR T|car t
5153930|NCT03030001|solid tumor|solid tumor
5153931|NCT03029988|adenocarcinoma, Colorectal Carcinoma, liver metastases|adenocarcinoma, colorectal carcinoma, liver metastases
5153932|NCT03029975|beef|beef
5153933|NCT03029975|protein|protein
5153934|NCT03029975|resistance training|resistance training
5153935|NCT03029975|strength|strength
5153936|NCT03029975|performance|performance
5153941|NCT03029949|chronic dizziness|chronic dizziness
5153942|NCT03029949|persistent postural-perceptual dizziness|persistent postural-perceptual dizziness
5153943|NCT03029949|acceptance and commitment therapy|acceptance and commitment therapy
5153944|NCT03029949|behavior therapy|behavior therapy
5153945|NCT03029949|vestibular rehabilitation|vestibular rehabilitation
5153946|NCT03029936|obesity|obesity
5153947|NCT03029936|asthma|asthma
5153948|NCT03029936|diaphragm excursion|diaphragm excursion
5153949|NCT03029936|pulmonary function test|pulmonary function test
5153950|NCT03029923|smoking|smoking
5153951|NCT03029923|depression|depression
5153952|NCT03029923|Behavioral Activation|behavioral activation
5153953|NCT03029910|Eccentric exercise|eccentric exercise
5153954|NCT03029910|Whole body vibration|whole body vibration
5153955|NCT03029910|Cryotherapy|cryotherapy
5153956|NCT03029884|thalamic pain|thalamic pain
5153957|NCT03029884|chronic pain|chronic pain
5153958|NCT03029884|spinal cord injury|spinal cord injury
5153959|NCT03029884|phantom limb|phantom limb
5153960|NCT03029871|lung cancer|lung cancer
5153961|NCT03029871|adenovirus|adenovirus
5153962|NCT03029871|gene therapy|gene therapy
5153963|NCT03029871|SBRT|sbrt
5153964|NCT03029793|Esophageal Cancer|esophageal cancer
5153965|NCT03029793|Prediction|prediction
5153966|NCT03029793|Biomarker|biomarker
5153967|NCT03029793|MRI-DWI|mri-dwi
5153968|NCT03029793|PET-CT|pet-ct
5153969|NCT03029767|Hypertension|hypertension
5153970|NCT03029767|Anthropometry|anthropometry
5153971|NCT03029767|Aerobic exercise|aerobic exercise
5153972|NCT03029767|Resistance exercise|resistance exercise
5153973|NCT03029728|Angioedema, Hereditary|angioedema, hereditary
5153974|NCT03029728|Biomarker|biomarker
5153975|NCT03029715|Sleeve gastrectomy|sleeve gastrectomy
5153976|NCT03029715|TIVA|tiva
5153977|NCT03029702|Gestational diabetes|gestational diabetes
5153978|NCT03029702|Diabetes in pregnancy|diabetes in pregnancy
5153979|NCT03029702|Insulin resistance|insulin resistance
5153980|NCT03029702|Insulin secretion deficiency|insulin secretion deficiency
5153981|NCT03029689|HIV infection|hiv infection
5153982|NCT03029689|Gut microbiome|gut microbiome
5153983|NCT03029689|Raltegravir|raltegravir
5153984|NCT03029689|Raltegravir intensification|raltegravir intensification
5153985|NCT03029689|Bacterial richness|bacterial richness
5153986|NCT03029676|spinal anesthesia, TURBT, POCD, premedication|spinal anesthesia, turbt, pocd, premedication
5775242|NCT00221377|tube|tube
5153987|NCT03029663|bladder cancer|bladder cancer
5162841|NCT02974868|alopecia areata|alopecia areata
5154001|NCT03029520|Herofill carrier-based obturation|herofill carrier-based obturation
5154009|NCT03029494|oxidative stress|oxidative stress
5154011|NCT03029468|Cognitive behavioral therapy|cognitive behavioral therapy
5154012|NCT03029468|Chronic pain|chronic pain
5154013|NCT03029468|Sickle cell disease|sickle cell disease
5154014|NCT03029468|Mobile phone app|mobile phone app
5154015|NCT03029468|Mental health|mental health
5154016|NCT03029468|Behavioral intervention|behavioral intervention
5154017|NCT03029468|Behavioral health|behavioral health
5154018|NCT03029442|Spinal Cord Injury|spinal cord injury
5154019|NCT03029442|Denosumab|denosumab
5154020|NCT03029442|Osteoporosis|osteoporosis
5154021|NCT03029442|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
5154025|NCT03029390|Prediabetes|prediabetes
5154026|NCT03029390|hyperglycemia|hyperglycemia
5154027|NCT03029390|Impaired Fasting Glucose|impaired fasting glucose
5154028|NCT03029390|Metformin|metformin
5154029|NCT03029390|Berberine|berberine
5154030|NCT03029390|glucose intolerance|glucose intolerance
5154031|NCT03029377|CFS|cfs
5154032|NCT03029377|Stress|stress
5154033|NCT03029377|Norepinephrine Transporter (NET)|norepinephrine transporter (net)
5154034|NCT03029377|Norepinephrine (NE)|norepinephrine (ne)
5154035|NCT03029377|Healthy Controls|healthy controls
5154036|NCT03029377|Fatigue|fatigue
5154037|NCT03029364|Maximal Fat Oxidation|maximal fat oxidation
5154038|NCT03029364|Exercise|exercise
5154042|NCT03029364|Body composition|body composition
5154043|NCT03029351|albuminuria|albuminuria
5154044|NCT03029351|GLP-1 Receptor Agonist|glp-1 receptor agonist
5154045|NCT03029351|Type 2 Diabetes|type 2 diabetes
5154046|NCT03029338|lymphoma|lymphoma
5154047|NCT03029338|non-hodgkin|non-hodgkin
5154048|NCT03029338|B-cell|b-cell
5154049|NCT03029338|CD19 CAR T cells|cd19 car t cells
5154050|NCT03029338|refractory|refractory
5154051|NCT03029338|relapse|relapse
5154052|NCT03029312|whole body vibration|whole body vibration
5154053|NCT03029312|Muscle function|muscle function
5154054|NCT03029312|Physical activity|physical activity
5154055|NCT03029312|bone density|bone density
5154056|NCT03029286|Breast Cancer|breast cancer
5154057|NCT03029286|Breast Density|breast density
5154058|NCT03029247|Anemia|anemia
5154059|NCT03029247|Daprodustat|daprodustat
5154060|NCT03029247|Blood pressure|blood pressure
5154061|NCT03029247|ESA|esa
5154062|NCT03029247|CKD|ckd
5154063|NCT03029208|Daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, ESRD|daprodustat, recombinant human erythropoietin, darbepoetin, anemia, chronic kidney disease, dialysis, esrd
5154064|NCT03029195|cleft lip and palate|cleft lip and palate
5154065|NCT03029195|nasoalveolar molding|nasoalveolar molding
5154066|NCT03029195|Egyptian infants|egyptian infants
5154067|NCT03029195|quantitative analysis|quantitative analysis
5154068|NCT03029182|Exercise|exercise
5154069|NCT03029182|Cancer|cancer
5154070|NCT03029182|Obesity|obesity
5154071|NCT03029169|Supraventricular Arrhythmia|supraventricular arrhythmia
5154072|NCT03029169|Septic shock|septic shock
5154073|NCT03029169|Propafenone|propafenone
5154074|NCT03029169|Amiodarone|amiodarone
5154075|NCT03029169|Intensive Care|intensive care
5154076|NCT03029156|Asthma|asthma
5154077|NCT03029156|Aeroneb|aeroneb
5154078|NCT03029156|Aerogen|aerogen
5154079|NCT03029156|Bronchodilator|bronchodilator
5154080|NCT03029143|Drug Therapy|drug therapy
5154081|NCT03029130|vesicovaginal fistula|vesicovaginal fistula
5154082|NCT03029130|urinary catheter|urinary catheter
5154088|NCT03029104|Pellucid marginal degeneration|pellucid marginal degeneration
5154089|NCT03029104|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
5154090|NCT03029104|Diurnal fluctuation post-radial keratotomy|diurnal fluctuation post-radial keratotomy
5154091|NCT03029104|Terrien's marginal degeneration|terrien's marginal degeneration
5154093|NCT03029078|fecal microbiota transplant|fecal microbiota transplant
5154094|NCT03029078|eradicate|eradicate
5154095|NCT03029078|colonization|colonization
5154097|NCT03029078|GRE|gre
5154098|NCT03029078|bacteria|bacteria
5154099|NCT03029065|lung Adenocarcinoma with brain (meningeal) metastasis|lung adenocarcinoma with brain (meningeal) metastasis
5154100|NCT03029039|Platelet|platelet
5154101|NCT03029039|severe sepsis|severe sepsis
5154102|NCT03029039|inflammation|inflammation
5154103|NCT03029039|S. aureus|s. aureus
5154104|NCT03029039|biomarkers|biomarkers
5154105|NCT03029026|Cardiac amyloidosis|cardiac amyloidosis
5154106|NCT03029026|Aortic stenosis|aortic stenosis
5154107|NCT03029026|DPD scintigraphy|dpd scintigraphy
5154108|NCT03028987|Quadrivalent, inactivated influenza vaccine|quadrivalent, inactivated influenza vaccine
5154109|NCT03028987|Quadrivalent, live, attenuated influenza vaccine|quadrivalent, live, attenuated influenza vaccine
5154110|NCT03028987|Identical twin adults|identical twin adults
5154111|NCT03028974|Inactivated influenza vaccine|inactivated influenza vaccine
5154112|NCT03028974|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5154113|NCT03028974|Young children|young children
5154114|NCT03028974|Adults|adults
5154115|NCT03028922|creos xenogain|creos xenogain
5154116|NCT03028909|Influenza A|influenza a
5154117|NCT03028909|MEDI8852|medi8852
5154118|NCT03028896|LMA Flexible|lma flexible
5154119|NCT03028870|Osteoarthritis|osteoarthritis
5154120|NCT03028870|Pain|pain
5154121|NCT03028870|Osteoarthritis Knee|osteoarthritis knee
5154122|NCT03028844|Neonate|neonate
5154123|NCT03028844|preterm|preterm
5154124|NCT03028844|pain|pain
5154125|NCT03028844|music|music
5154126|NCT03028844|EEG|eeg
5154127|NCT03028844|venepuncture|venepuncture
5154128|NCT03028805|Informatics|informatics
5154129|NCT03028805|COPD|copd
5154130|NCT03028805|quality improvement|quality improvement
5154131|NCT03028792|attention training, youth, latino|attention training, youth, latino
5962104|NCT04283019|Cannabidiol|cannabidiol
5154132|NCT03028779|Outpatient,fast-track, arthroplasty, Total knee arthroplasty (TKA), Total hip Arthroplasty (THA)|outpatient,fast-track, arthroplasty, total knee arthroplasty (tka), total hip arthroplasty (tha)
5154133|NCT03028714|University|university
5154134|NCT03028714|College|college
5154135|NCT03028714|University students|university students
5154136|NCT03028714|Health education|health education
5154137|NCT03028714|Educational techonology|educational techonology
5154138|NCT03028714|Internet|internet
5154139|NCT03028714|Nutrition knowledge|nutrition knowledge
5154140|NCT03028714|Eating behaviour|eating behaviour
5154141|NCT03028714|Diet|diet
5154142|NCT03028714|Physical Activity|physical activity
5154143|NCT03028714|Weight gain prevention|weight gain prevention
5154144|NCT03028701|Formoterol|formoterol
5154145|NCT03028701|Budesonide|budesonide
5154146|NCT03028701|Dry powder inhalation|dry powder inhalation
5154147|NCT03028701|Discair|discair
5154148|NCT03028701|COPD|copd
5154149|NCT03028662|Alcohol Dependence|alcohol dependence
5154150|NCT03028662|Brain Connectivity|brain connectivity
5154151|NCT03028662|Inhibition|inhibition
5154152|NCT03028649|β-hydroxy-β-methylbutyric acid|β-hydroxy-β-methylbutyric acid
5154153|NCT03028649|Sport supplements|sport supplements
5154154|NCT03028649|Training support|training support
5154155|NCT03028649|Adaptation|adaptation
5154156|NCT03028636|fecal incontinence|fecal incontinence
5154157|NCT03028636|bowel control|bowel control
5154158|NCT03028636|accidental bowel leakage|accidental bowel leakage
5154159|NCT03028636|medical device|medical device
5154160|NCT03028636|women's health|women's health
5154161|NCT03028636|vaginal insert|vaginal insert
5154162|NCT03028636|pessary|pessary
5154163|NCT03028636|incontinence|incontinence
5154164|NCT03028636|bowel continence|bowel continence
5154165|NCT03028636|pump|pump
5154166|NCT03028597|Hypertension|hypertension
5154167|NCT03028597|Medication Adherence|medication adherence
5154168|NCT03028597|Values Affirmation|values affirmation
5154169|NCT03028597|African Americans|african americans
5154170|NCT03028584|BrCa|brca
5154171|NCT03028584|PrCa|prca
5154172|NCT03028584|CRCa|crca
5154173|NCT03028558|Electronic Cigarettes|electronic cigarettes
5154174|NCT03028558|Healthy Volunteers|healthy volunteers
5154175|NCT03028558|E-Cigarettes Smokers|e-cigarettes smokers
5154179|NCT03028545|bipolar disorders|bipolar disorders
5154180|NCT03028545|personality disorders|personality disorders
5154181|NCT03028532|Healthy Volunteers|healthy volunteers
5154183|NCT03028532|Anti-doping|anti-doping
5154184|NCT03028532|Athletes|athletes
5154185|NCT03028532|Men's Health|men's health
5154186|NCT03028480|Exacerbation|exacerbation
5154187|NCT03028480|Mepolizumab|mepolizumab
5154188|NCT03028480|NUCALA|nucala
5154189|NCT03028467|GSK3196165|gsk3196165
5154190|NCT03028467|Active Rheumatoid Arthritis|active rheumatoid arthritis
5154191|NCT03028467|Methotrexate|methotrexate
5154192|NCT03028467|Monoclonal Antibody|monoclonal antibody
5154193|NCT03028467|Efficacy|efficacy
5154194|NCT03028467|Electrocardiogram|electrocardiogram
5154195|NCT03028467|Tolerability|tolerability
5154196|NCT03028467|Pharmacokinetics|pharmacokinetics
5154197|NCT03028467|Japanese Subjects|japanese subjects
5154198|NCT03028441|Chikungunya|chikungunya
5154199|NCT03028441|Immunogenicity|immunogenicity
5154200|NCT03028441|Measles|measles
5154201|NCT03028441|Vaccine|vaccine
5154202|NCT03028428|Osteoarthritis|osteoarthritis
5154203|NCT03028428|Stem Cell|stem cell
5154204|NCT03028428|Knee|knee
5154205|NCT03028428|Mesenchymal Stem Cell|mesenchymal stem cell
5154206|NCT03028389|elderly patients|elderly patients
5154207|NCT03028389|non-cardiac surgery|non-cardiac surgery
5154208|NCT03028389|ischemic preconditioning|ischemic preconditioning
5154209|NCT03028389|delirium|delirium
5154210|NCT03028376|biomarker|biomarker
5154211|NCT03028376|point-of-care analysis|point-of-care analysis
5154212|NCT03028337|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
5154213|NCT03028337|Solid tumor malignancy|solid tumor malignancy
5154214|NCT03028337|Radiographic evidence of spine metastasis|radiographic evidence of spine metastasis
5154215|NCT03028337|Spine radiosurgery|spine radiosurgery
5154216|NCT03028337|Radiation therapy|radiation therapy
5154217|NCT03028337|Radiotherapy|radiotherapy
5154218|NCT03028337|Questionnaires|questionnaires
5154219|NCT03028337|Surveys|surveys
5154221|NCT03028285|succinate|succinate
5154222|NCT03028285|arginine|arginine
5154223|NCT03028285|vasodilation|vasodilation
5154224|NCT03028285|peripheral vascular disease|peripheral vascular disease
5154225|NCT03028272|tympanic membrane perforation|tympanic membrane perforation
5154226|NCT03028233|physical activity|physical activity
5154227|NCT03028233|healthy eating|healthy eating
5154228|NCT03028233|weight|weight
5154229|NCT03028233|families|families
5154230|NCT03028233|Community Health Worker|community health worker
5154231|NCT03028233|childhood obesity|childhood obesity
5154232|NCT03028233|built environment|built environment
5154233|NCT03028220|Type 1 Diabetes|type 1 diabetes
5154234|NCT03028220|Hypoglycemia|hypoglycemia
5154235|NCT03028207|EPI-Scan-II Study|epi-scan-ii study
5026323|NCT03834168|Race|race
5154236|NCT03028207|COPD|copd
5154237|NCT03028207|Epidemiology|epidemiology
5154238|NCT03028207|Spain|spain
5154239|NCT03028207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5154240|NCT03028207|Prevalence|prevalence
5154241|NCT03028207|Cross-sectional|cross-sectional
5154242|NCT03028194|Pre-eclampsia|pre-eclampsia
5154243|NCT03028194|Eclampsia|eclampsia
5154244|NCT03028194|Postpartum uterine curettage|postpartum uterine curettage
5154245|NCT03028181|smoke|smoke
5154246|NCT03028181|acute pancreatitis|acute pancreatitis
5154247|NCT03028181|pro/antioxidant status|pro/antioxidant status
5154248|NCT03028181|pro-inflammatory factors|pro-inflammatory factors
5154249|NCT03028181|lipid profile|lipid profile
5154250|NCT03028181|exocrine functions of pancreas|exocrine functions of pancreas
5154252|NCT03028168|Breathing Techniques|breathing techniques
5154253|NCT03028168|Heart Failure and Preserved Ejection Fraction|heart failure and preserved ejection fraction
5154254|NCT03028129|Tuberculosis|tuberculosis
5154255|NCT03028129|Primary prevention|primary prevention
5154256|NCT03028129|Prisoners|prisoners
5154257|NCT03028129|Controlled Clinical Trial|controlled clinical trial
5154258|NCT03028129|Isoniazid|isoniazid
5154259|NCT03028116|vaccine|vaccine
5154260|NCT03028116|1 phase|1 phase
5154261|NCT03028116|safety|safety
5154262|NCT03028077|ultrafiltered red ginseng|ultrafiltered red ginseng
5154263|NCT03028077|hydrolyzed ginseng|hydrolyzed ginseng
5154264|NCT03028077|acute respiratory illness|acute respiratory illness
5154265|NCT03028077|clinical trial|clinical trial
5154266|NCT03028038|Platelet-rich plasma|platelet-rich plasma
5154267|NCT03028038|Rapid maxillary expansion|rapid maxillary expansion
5154268|NCT03028038|Buccal bone thickness|buccal bone thickness
5154269|NCT03028038|Alveolar bone loss|alveolar bone loss
5154270|NCT03028038|Alveolar bone resorption|alveolar bone resorption
5154271|NCT03028025|radial artery occlusion|radial artery occlusion
5163135|NCT02972983|Bacteremia|bacteremia
5154277|NCT03028025|hemostasis band|hemostasis band
5154278|NCT03028025|potassium ferrate|potassium ferrate
5154279|NCT03028025|percutaneous coronary intervention|percutaneous coronary intervention
5154280|NCT03028012|Trigger Point Injections|trigger point injections
5154281|NCT03028012|steroid|steroid
5154282|NCT03028012|nsaid|nsaid
5154283|NCT03027999|Rituximab|rituximab
5154284|NCT03027999|tight monitoring|tight monitoring
5154285|NCT03027960|cardio-renal|cardio-renal
5154286|NCT03027947|Phantom Limb Pain|phantom limb pain
5154287|NCT03027947|Lower-Limb Amputation|lower-limb amputation
5154288|NCT03027947|Electrodes|electrodes
5154289|NCT03027947|Stimulation|stimulation
5154291|NCT03027947|Sensation|sensation
5154292|NCT03027882|Reliability|reliability
5154293|NCT03027882|Validity|validity
5154294|NCT03027882|Functional Testing|functional testing
5154295|NCT03027856|Percutaneous intervention (PCI)|percutaneous intervention (pci)
5154296|NCT03027856|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5154297|NCT03027856|Bifurcation lesion|bifurcation lesion
5154298|NCT03027856|Bioresorbable stents (BRS)|bioresorbable stents (brs)
5154299|NCT03027843|low ovarian reserve|low ovarian reserve
5154300|NCT03027843|growth hormone|growth hormone
5154301|NCT03027843|embryo quality|embryo quality
5154302|NCT03027843|live birth|live birth
5154303|NCT03027843|clinical pregnancy|clinical pregnancy
5154304|NCT03027830|Provisional side-branch intervention strategy|provisional side-branch intervention strategy
5154305|NCT03027830|iFR|ifr
5154306|NCT03027830|Pilot study|pilot study
5154307|NCT03027817|Prone positioning|prone positioning
5154308|NCT03027817|Non-invasive Cardiac Output Monitoring|non-invasive cardiac output monitoring
5154309|NCT03027791|Biosensors|biosensors
5154310|NCT03027791|Virtual Reality|virtual reality
5154311|NCT03027791|Dietary Sodium|dietary sodium
5154312|NCT03027778|arterial stiffness|arterial stiffness
5154313|NCT03027778|hemodialysis|hemodialysis
5154314|NCT03027778|intradialytic pedalling exercise|intradialytic pedalling exercise
5154315|NCT03027778|carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
5154316|NCT03027778|chronic kidney disease|chronic kidney disease
5154317|NCT03027778|hemodynamics|hemodynamics
5154318|NCT03027778|augmentation index|augmentation index
5154319|NCT03027752|carotid endaretectomy|carotid endaretectomy
5154320|NCT03027713|NAVA: neurally adjusted ventilatory assist|nava: neurally adjusted ventilatory assist
5154321|NCT03027713|Diaphragm electromyographic activity|diaphragm electromyographic activity
5154322|NCT03027713|Weaning|weaning
5154323|NCT03027687|Smoking|smoking
5154324|NCT03027687|EMA|ema
5154325|NCT03027687|ERPs|erps
5154326|NCT03027687|tDCS|tdcs
5154327|NCT03027687|Cigarette consumption|cigarette consumption
5154328|NCT03027687|Inhibitory control|inhibitory control
5154329|NCT03027687|Reward processing|reward processing
5154330|NCT03027687|Tobacco addiction|tobacco addiction
5154331|NCT03027687|Craving|craving
5154332|NCT03027687|electrophysiological|electrophysiological
5154333|NCT03027674|Raynaud Phenomena|raynaud phenomena
5154334|NCT03027674|System; Sclerosis|system; sclerosis
5154335|NCT03027674|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5962105|NCT04283006|lymphoid hematological malignancies|lymphoid hematological malignancies
5154336|NCT03027674|Ultrasound|ultrasound
5154337|NCT03027674|sildenafil|sildenafil
5154338|NCT03027674|Nifedipine|nifedipine
5154339|NCT03027661|para-cervical block|para-cervical block
5154340|NCT03027661|laparoscopic hysterectomy|laparoscopic hysterectomy
5154341|NCT03027648|levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
5154342|NCT03027648|adenomyosis|adenomyosis
5154343|NCT03027635|diuretic resistant ascites|diuretic resistant ascites
5154344|NCT03027635|Paracentesis|paracentesis
5154346|NCT03027635|Peritoneal tunnelated catheter|peritoneal tunnelated catheter
5149934|NCT03055234|PH|ph
5154348|NCT03027622|pericoronitis|pericoronitis
5154349|NCT03027622|third molar|third molar
5154350|NCT03027609|Pseudomonas aeruginosa|pseudomonas aeruginosa
5154351|NCT03027609|pneumonia|pneumonia
5154352|NCT03027570|Exergame|exergame
5154353|NCT03027570|Cellular apps|cellular apps
5154354|NCT03027570|Smartphone|smartphone
5154355|NCT03027570|Overweight|overweight
5154356|NCT03027570|Obesity|obesity
5154357|NCT03027570|Children|children
5154358|NCT03027570|Physical activity|physical activity
5154359|NCT03027570|Fitness|fitness
5154360|NCT03027570|Motivation|motivation
5154361|NCT03027570|BMI|bmi
5154362|NCT03027557|Primary Hyperparathyroidism|primary hyperparathyroidism
5154363|NCT03027557|Parathyroid Adenoma|parathyroid adenoma
5154364|NCT03027557|Parathyroid Hyperplasia|parathyroid hyperplasia
5154365|NCT03027557|Cinacalcet|cinacalcet
5154366|NCT03027557|Denosumab|denosumab
5154367|NCT03027557|Drug Therapy|drug therapy
5154374|NCT03027531|reproductive health, condoms, sexually transmitted diseases, contraception|reproductive health, condoms, sexually transmitted diseases, contraception
5154377|NCT03027505|RUTF|rutf
5154378|NCT03027505|Children|children
5154379|NCT03027505|Burkina Faso|burkina faso
5154380|NCT03027492|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
5154381|NCT03027492|gynaecological disorders|gynaecological disorders
5154382|NCT03027492|gluten-free diet|gluten-free diet
5154383|NCT03027479|weight loss|weight loss
5154384|NCT03027479|ovarian cancer|ovarian cancer
5154385|NCT03027479|endometrial cancer|endometrial cancer
5226212|NCT02585973|AZD1775|azd1775
5154386|NCT03027479|energy metabolism|energy metabolism
5154387|NCT03027479|Body mass index|body mass index
5154388|NCT03027479|obesity|obesity
5154591|NCT03026244|Prebiotics|prebiotics
5154391|NCT03027466|Phone Application|phone application
5154396|NCT03027427|Screening|screening
5154397|NCT03027427|Heritable Gastric Malignancy|heritable gastric malignancy
5154398|NCT03027427|Molecular Profiling|molecular profiling
5154399|NCT03027427|Molecular Alterations|molecular alterations
5154400|NCT03027414|Anxiety|anxiety
5154401|NCT03027414|Startle|startle
5154402|NCT03027414|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5154403|NCT03027414|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5154404|NCT03027414|Working Memory|working memory
5154405|NCT03027401|Genetic Testing|genetic testing
5154406|NCT03027401|Tumor Profiling|tumor profiling
5154407|NCT03027401|Biorepository|biorepository
5154408|NCT03027388|Brain Tumor|brain tumor
5154409|NCT03027388|Blood Brain Barrier|blood brain barrier
5154410|NCT03027388|Pharmacokinetics|pharmacokinetics
5154411|NCT03027388|Pharmacodynamics|pharmacodynamics
5154412|NCT03027375|chronic heart failure|chronic heart failure
5154413|NCT03027375|traditional Chinese medicine|traditional chinese medicine
5154414|NCT03027375|Qishen granules|qishen granules
5154415|NCT03027336|dyslipidemia|dyslipidemia
5154416|NCT03027336|dietary supplement|dietary supplement
5154417|NCT03027323|undifferentiated hypotension|undifferentiated hypotension
5154418|NCT03027323|central venous cannulation|central venous cannulation
5154419|NCT03027310|Dystonic Tremor|dystonic tremor
5154420|NCT03027310|Essential Tremor|essential tremor
5154421|NCT03027310|Parkinsonism|parkinsonism
5040846|NCT03743662|18-400|18-400
5154422|NCT03027310|Voice Tremor|voice tremor
5154423|NCT03027310|Parkinson's Disease|parkinson's disease
5154425|NCT03027258|Mobile health technology|mobile health technology
5154426|NCT03027245|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5154427|NCT03027245|peripheral neuropathy|peripheral neuropathy
5154428|NCT03027245|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5154429|NCT03027245|eribulin|eribulin
5154430|NCT03027232|infection|infection
5154433|NCT03027154|diagnostic test|diagnostic test
5154434|NCT03027154|children|children
5154435|NCT03027154|diagnosis of tuberculosis|diagnosis of tuberculosis
5154436|NCT03027141|Face Transplant|face transplant
5154437|NCT03027128|Phase 1|phase 1
5154438|NCT03027128|Metastatic|metastatic
5154439|NCT03027128|Locally Advanced|locally advanced
5154440|NCT03027128|Cancer|cancer
5154441|NCT03027128|Cell Therapy|cell therapy
5154442|NCT03027102|allogenic double negative T cells|allogenic double negative t cells
5154443|NCT03027102|DNT cells|dnt cells
5154444|NCT03027089|Aspergillus-specific IgG|aspergillus-specific igg
5154445|NCT03027076|prostatitis|prostatitis
5154446|NCT03027076|chronic prostatitis|chronic prostatitis
5154447|NCT03027076|chronic pelvic pain syndrome|chronic pelvic pain syndrome
5154448|NCT03027076|interstitial cystitis|interstitial cystitis
5154449|NCT03027076|painful bladder syndrome|painful bladder syndrome
5154450|NCT03027076|bladder pain syndrome|bladder pain syndrome
5154451|NCT03027076|biomarkers|biomarkers
5154452|NCT03027076|biological markers|biological markers
5154453|NCT03027076|bacteria|bacteria
5154454|NCT03027076|microbiome|microbiome
5154455|NCT03027076|inflammation|inflammation
5154456|NCT03027063|Speckle tracking echocardiography|speckle tracking echocardiography
5154457|NCT03027050|periodontitis|periodontitis
5154458|NCT03027050|Growth factors|growth factors
5154459|NCT03027050|Periodontal healing|periodontal healing
5154460|NCT03027024|Intraocular Lens|intraocular lens
5154461|NCT03027024|trifocal|trifocal
5154462|NCT03027024|cataract|cataract
5154463|NCT03027024|PhysIOL|physiol
5154465|NCT03026998|External beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
5154466|NCT03026985|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5154467|NCT03026985|Ultrasonography|ultrasonography
5154468|NCT03026985|Intensive Care Units|intensive care units
5154470|NCT03026972|Tolerance|tolerance
5154471|NCT03026946|Alitretinoin|alitretinoin
5154472|NCT03026946|Cyclosporine A|cyclosporine a
5154473|NCT03026946|Hand eczema|hand eczema
5154474|NCT03026920|Fracture|fracture
5154475|NCT03026920|outcome|outcome
5154476|NCT03026920|pelvic|pelvic
5154477|NCT03026920|acetabular|acetabular
5154478|NCT03026907|Alitretinoin|alitretinoin
5154479|NCT03026907|Azathioprine|azathioprine
5154480|NCT03026907|Hand eczema|hand eczema
5154481|NCT03026881|PARP inhibitor|parp inhibitor
5154482|NCT03026881|VEGFR inhibitor|vegfr inhibitor
5154483|NCT03026881|Combination therapy|combination therapy
5154484|NCT03026881|Gastric cancer|gastric cancer
5154485|NCT03026868|acetabular|acetabular
5775243|NCT00221377|cuff|cuff
5154486|NCT03026868|quadrilateral surface plate|quadrilateral surface plate
5154487|NCT03026855|Autologous PRP|autologous prp
5154488|NCT03026855|Non-healing ulcer|non-healing ulcer
5154496|NCT03026790|Opioid partial agonists|opioid partial agonists
5154497|NCT03026790|Health care delivery|health care delivery
5154498|NCT03026790|Back pain|back pain
5154499|NCT03026790|Osteoarthritis|osteoarthritis
5154500|NCT03026790|Veterans health|veterans health
5154502|NCT03026764|total hip replacement|total hip replacement
5154503|NCT03026764|outpatient Surgery|outpatient surgery
5154504|NCT03026764|satisfaction|satisfaction
5154505|NCT03026764|arthroplasty|arthroplasty
5154506|NCT03026725|tooth sensitivity|tooth sensitivity
5154507|NCT03026725|tri calcium phosphate|tri calcium phosphate
5154508|NCT03026725|at-home whitening|at-home whitening
5154509|NCT03026712|Robotic therapy|robotic therapy
5154511|NCT03026712|non invasive electrical stimulation|non invasive electrical stimulation
5154512|NCT03026712|ArmeoPower|armeopower
5154513|NCT03026712|interhemispheric balance|interhemispheric balance
5154514|NCT03026699|Brain|brain
5154515|NCT03026699|Nervous system|nervous system
5154516|NCT03026699|Neuro-oncology|neuro-oncology
5154517|NCT03026699|Caregivers|caregivers
5154518|NCT03026699|Cancer patient|cancer patient
5154519|NCT03026699|Family caregivers|family caregivers
5154520|NCT03026699|Brain tumors|brain tumors
5154521|NCT03026699|Quality of life|quality of life
5154522|NCT03026699|Stress|stress
5154523|NCT03026699|Social support|social support
5154524|NCT03026699|Feasibility|feasibility
5154525|NCT03026699|Electronic Social Network Assessment Program (eSNAP)|electronic social network assessment program (esnap)
5154526|NCT03026660|Moringa Oleifera|moringa oleifera
5154527|NCT03026634|Sleep-Disordered Breathing|sleep-disordered breathing
5154528|NCT03026634|Heart Failure|heart failure
5154529|NCT03026634|Heart Transplantation|heart transplantation
5154530|NCT03026569|orange juice|orange juice
5154531|NCT03026569|chronic hepatitis C|chronic hepatitis c
5154532|NCT03026569|biochemical markers|biochemical markers
5154533|NCT03026569|oxidative stress|oxidative stress
5154534|NCT03026569|nutritional status|nutritional status
5154535|NCT03026569|antioxidants|antioxidants
5154536|NCT03026517|Phenformin|phenformin
5154537|NCT03026517|Dabrafenib|dabrafenib
5154538|NCT03026517|Trametinib|trametinib
5154539|NCT03026517|BRAF|braf
5154540|NCT03026517|15-318|15-318
5154541|NCT03026478|oral lichen planus|oral lichen planus
5154542|NCT03026478|betamethasone|betamethasone
5154543|NCT03026478|clobetasol|clobetasol
5154544|NCT03026478|orabase|orabase
5154545|NCT03026439|mild COPD|mild copd
5154546|NCT03026439|early COPD|early copd
5154547|NCT03026439|six-min walk test|six-min walk test
5154548|NCT03026439|computed tomography|computed tomography
5154549|NCT03026439|emphysema|emphysema
5154550|NCT03026439|airway disease|airway disease
5154551|NCT03026439|peripheral muscle mass|peripheral muscle mass
5154552|NCT03026439|Saint George's Respiratory Questionnaire|saint george's respiratory questionnaire
5154553|NCT03026426|Depression|depression
5154554|NCT03026426|Chronic diseases|chronic diseases
5154555|NCT03026426|Mobile technology|mobile technology
5154556|NCT03026426|Clinical trial|clinical trial
5154557|NCT03026413|atrial fibrillation|atrial fibrillation
5962106|NCT04283006|CAR T-cell therapy|car t-cell therapy
5154558|NCT03026413|pulmonary vein isolation|pulmonary vein isolation
5154559|NCT03026413|Contact Force|contact force
5154560|NCT03026413|antrum|antrum
5154561|NCT03026387|Suicidal behavior|suicidal behavior
5154562|NCT03026387|Suicide attempt|suicide attempt
5154563|NCT03026387|Emergency department|emergency department
5154564|NCT03026387|Psychometrics|psychometrics
5154565|NCT03026387|Neuropsychological tests|neuropsychological tests
5154566|NCT03026387|Suicidal ideation|suicidal ideation
5154567|NCT03026374|psychosocial support|psychosocial support
5154568|NCT03026374|resilience|resilience
5154569|NCT03026374|metastatic breast cancer|metastatic breast cancer
5154570|NCT03026374|survival|survival
5154598|NCT03026140|MSI tumors|msi tumors
5154599|NCT03026140|MSS tumors|mss tumors
5154600|NCT03026140|short-term immunotherapy|short-term immunotherapy
5154601|NCT03026140|surgical resection|surgical resection
5154602|NCT03026140|nivolumab|nivolumab
5154603|NCT03026140|ipilimumab|ipilimumab
5154604|NCT03026127|Suicide|suicide
5154605|NCT03026127|Middle-aged and Older Adults|middle-aged and older adults
5154606|NCT03026127|Cognitive Reappraisal|cognitive reappraisal
5154607|NCT03026127|Emotion Regulation|emotion regulation
5154608|NCT03026088|Chronic Heart Failure|chronic heart failure
5154609|NCT03026088|Bisoprolol|bisoprolol
5154610|NCT03026088|Heart rate control|heart rate control
5154615|NCT03026023|Heart Transplant|heart transplant
5154616|NCT03026023|Cardiac Transplant|cardiac transplant
5154617|NCT03026023|Hepatitis C|hepatitis c
5154618|NCT03026023|Zepatier|zepatier
5154619|NCT03025971|Severe Aortic Stenosis and/or severe aortic regurgitation|severe aortic stenosis and/or severe aortic regurgitation
5154620|NCT03025919|Advanced glycation end-product|advanced glycation end-product
5154621|NCT03025919|Glycosuria|glycosuria
5154622|NCT03025893|Sunitinib|sunitinib
5154623|NCT03025893|Lomustine|lomustine
5154624|NCT03025893|High-dose|high-dose
5154625|NCT03025893|Intermittent|intermittent
5154626|NCT03025880|Advanced Breast Cancer|advanced breast cancer
5154627|NCT03025880|Pembrolizumab|pembrolizumab
5154628|NCT03025880|HER2-negative|her2-negative
5154629|NCT03025828|Membranous nephropathy|membranous nephropathy
5154630|NCT03025828|adrenocorticotropic hormone|adrenocorticotropic hormone
5154631|NCT03025828|ACTH|acth
5154632|NCT03025828|proteinuria|proteinuria
5154633|NCT03025828|glomerulonephritis|glomerulonephritis
5154634|NCT03025815|Infant, Premature|infant, premature
5154635|NCT03025802|Molecular diagnosis|molecular diagnosis
5154636|NCT03025802|Pathogen identification|pathogen identification
5154637|NCT03025802|Sepsis|sepsis
5154638|NCT03025802|Bacteremia|bacteremia
5154639|NCT03025802|Rapid diagnostics|rapid diagnostics
5154640|NCT03025789|T.b gambiense|t.b gambiense
5154641|NCT03025789|HAT|hat
5154642|NCT03025789|outpatients|outpatients
5154643|NCT03025763|Craniosynostosis|craniosynostosis
5154644|NCT03025763|Bone|bone
5154645|NCT03025763|Birth Defect|birth defect
5154646|NCT03025763|Congenital Anomaly|congenital anomaly
5154647|NCT03025763|Malformation|malformation
5154648|NCT03025763|Genetics|genetics
5154649|NCT03025763|Genomics|genomics
5154650|NCT03025763|Skull|skull
5154651|NCT03025763|Human|human
5154652|NCT03025763|Mouse|mouse
5154653|NCT03025763|Imaging|imaging
5154654|NCT03025763|Cell Biology|cell biology
5154655|NCT03025763|Induced Pluripotent Stem Cells|induced pluripotent stem cells
5154656|NCT03025763|System Biology|system biology
5154657|NCT03025737|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5154658|NCT03025737|Ventricular Remodeling|ventricular remodeling
5154659|NCT03025711|Advanced HER2+ breast cancer|advanced her2+ breast cancer
5154660|NCT03025711|Pertuzumab|pertuzumab
5154661|NCT03025711|Trastuzumab emtansine|trastuzumab emtansine
5154662|NCT03025711|Compassionate use|compassionate use
5154663|NCT03025711|Early access program|early access program
5154664|NCT03025711|Effectiveness|effectiveness
5154665|NCT03025711|Safety|safety
5154666|NCT03025698|Eltrombopag|eltrombopag
5154667|NCT03025698|hATG|hatg
5154669|NCT03025698|previously untreated or relapsed severe aplastic anemia|previously untreated or relapsed severe aplastic anemia
5154670|NCT03025698|recurrent aplastic anemia|recurrent aplastic anemia
5154671|NCT03025698|Severe aplastic anemia|severe aplastic anemia
5154672|NCT03025698|Pharmacokinetics|pharmacokinetics
5154673|NCT03025698|Immunosuppressive therapy|immunosuppressive therapy
5154674|NCT03025698|ETB115|etb115
5154675|NCT03025685|Percutaneous Coronary Intervention|percutaneous coronary intervention
5154676|NCT03025685|Coronary Artery Disease|coronary artery disease
5154677|NCT03025685|Wire|wire
5154678|NCT03025685|Coronary stenting|coronary stenting
5154679|NCT03025659|pediatric|pediatric
5154680|NCT03025659|congenital heart disease|congenital heart disease
5154684|NCT03025633|PEARL|pearl
5154691|NCT03025594|Paralytic sellfish toxins|paralytic sellfish toxins
5154692|NCT03025594|Gonyautoxin|gonyautoxin
5154693|NCT03025594|Post surgery pain management|post surgery pain management
5154694|NCT03025594|total knee arthroplasty|total knee arthroplasty
5154695|NCT03025568|nylon|nylon
5154696|NCT03025568|polyamide|polyamide
5154697|NCT03025568|denture base|denture base
5154698|NCT03025555|nylon|nylon
5154699|NCT03025555|polyamide|polyamide
5154700|NCT03025555|PEEK|peek
5154701|NCT03025555|partial denture|partial denture
5154702|NCT03025542|Psoriasis|psoriasis
5154703|NCT03025542|Chronic Plaque Psoriasis|chronic plaque psoriasis
5154704|NCT03025542|Bimekizumab|bimekizumab
5154705|NCT03025490|Capnography|capnography
5154706|NCT03025490|Electrophysiology|electrophysiology
5154707|NCT03025477|Intraperitoneal|intraperitoneal
5154708|NCT03025477|Intravenous|intravenous
5154709|NCT03025477|Completeness of cytoreduction score|completeness of cytoreduction score
5154710|NCT03025477|Carboplatin|carboplatin
5154711|NCT03025477|Epirubicin|epirubicin
5154712|NCT03025477|Paclitaxel|paclitaxel
5154713|NCT03025477|Cisplatin|cisplatin
5154714|NCT03025451|nutrition|nutrition
5154719|NCT03025451|community support|community support
5154720|NCT03025451|cardiovascular disease|cardiovascular disease
5154722|NCT03025451|hypertension|hypertension
5154723|NCT03025451|dyslipidemia|dyslipidemia
5154724|NCT03025451|cholesterol|cholesterol
5154725|NCT03025451|overweight|overweight
5154726|NCT03025451|obesity|obesity
5154727|NCT03025451|lifestyle|lifestyle
5154728|NCT03025438|angiosarcoma|angiosarcoma
5154729|NCT03025438|Cytology|cytology
5154730|NCT03025438|liver|liver
5154731|NCT03025438|cancer|cancer
5154732|NCT03025412|Achilles Tendon|achilles tendon
5154733|NCT03025412|Endoscopy|endoscopy
5154734|NCT03025412|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5154735|NCT03025412|Exercise therapy|exercise therapy
5154736|NCT03025399|tang wang prescription|tang wang prescription
5154737|NCT03025360|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5154738|NCT03025360|NTRK1|ntrk1
5154739|NCT03025360|NTRK2|ntrk2
5154740|NCT03025360|NTRK3|ntrk3
5154741|NCT03025360|Fusion Positive|fusion positive
5154742|NCT03025321|Cocaine|cocaine
5154743|NCT03025321|tDCS|tdcs
5154744|NCT03025321|EMA|ema
5154745|NCT03025321|Inhibitory control|inhibitory control
5154746|NCT03025321|Reward processing|reward processing
5154747|NCT03025321|Addiction|addiction
5154748|NCT03025321|dlPFC|dlpfc
5154750|NCT03025321|cognitive control|cognitive control
5154751|NCT03025243|computer aided design , dental implants , accuracy|computer aided design , dental implants , accuracy
5154752|NCT03025204|Regeneration Procedures|regeneration procedures
5154753|NCT03025204|Intrabony Defects|intrabony defects
5154754|NCT03025204|Cronic Periodontitis|cronic periodontitis
5154755|NCT03025191|incarceration|incarceration
5154756|NCT03025191|HIV|hiv
5154757|NCT03025152|Hou Gu Mi Xi|hou gu mi xi
5154758|NCT03025152|Shen Ling Bai Zhu San|shen ling bai zhu san
5154759|NCT03025152|radical gastrectomy|radical gastrectomy
5154760|NCT03025152|gastric cancer|gastric cancer
5154761|NCT03025152|traditional Chinese medicine|traditional chinese medicine
5154762|NCT03025152|randomized controlled trial|randomized controlled trial
5154763|NCT03025139|breast cancer|breast cancer
5154764|NCT03025139|younger women|younger women
5154765|NCT03025139|education|education
5154766|NCT03025139|mindfulness meditation|mindfulness meditation
5154767|NCT03025139|depression|depression
5154768|NCT03025139|cancer survivor|cancer survivor
5154769|NCT03025074|Liver Disease|liver disease
5154770|NCT03025074|Obesity|obesity
5154771|NCT03025074|Hepatitis|hepatitis
5154772|NCT03025074|HIV|hiv
5154773|NCT03025074|Hepatology|hepatology
5154774|NCT03025061|Breath pattern|breath pattern
5154775|NCT03025061|Children|children
5154776|NCT03025061|Repeatability|repeatability
5154777|NCT03025035|BRCA-mutation|brca-mutation
5154778|NCT03025035|Immune checkpoint inhibition|immune checkpoint inhibition
5154779|NCT03025035|Immunotherapy|immunotherapy
5154780|NCT03025035|Advanced BRCA-mutated breast cancer|advanced brca-mutated breast cancer
5154781|NCT03024957|morphine|morphine
5154782|NCT03024957|dexmedetomidine|dexmedetomidine
5154783|NCT03024957|immune system|immune system
5154784|NCT03024944|Diabetes Mellitus|diabetes mellitus
5154785|NCT03024944|Alzheimer's Disease|alzheimer's disease
5154786|NCT03024944|Dementia|dementia
5154787|NCT03024944|THK|thk
5154788|NCT03024918|monochorionic|monochorionic
5154789|NCT03024918|placental sharing|placental sharing
5154790|NCT03024892|Fluorenscent image guided surgery|fluorenscent image guided surgery
5154791|NCT03024892|indocyanide green|indocyanide green
5154792|NCT03024892|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5154793|NCT03024892|common bile duct injury|common bile duct injury
5154794|NCT03024879|Motilin|motilin
5154795|NCT03024879|Erythromycin|erythromycin
5154796|NCT03024879|Food intake|food intake
5154797|NCT03024853|Best Possible Self|best possible self
5154798|NCT03024853|Positive Intervention|positive intervention
5154799|NCT03024853|Optimism|optimism
5154800|NCT03024840|Propofol|propofol
5154801|NCT03024840|Neurocognitive Disorders|neurocognitive disorders
5154802|NCT03024840|Liver transplantation|liver transplantation
5154803|NCT03024840|Pediatrics|pediatrics
5154804|NCT03024840|Brain Injuries|brain injuries
5154805|NCT03024827|Infantile Spasms|infantile spasms
5154806|NCT03024827|Lennox Gastaut Syndrome|lennox gastaut syndrome
5154807|NCT03024827|Doose Syndrome|doose syndrome
5154808|NCT03024827|Continuous Spike Wave in Sleep|continuous spike wave in sleep
5154809|NCT03024827|Landau-Kleffner Syndrome|landau-kleffner syndrome
5154810|NCT03024827|Dravet Syndrome|dravet syndrome
5154811|NCT03024827|Malignant Migrating Partial Seizures of Infancy (MMPSI)|malignant migrating partial seizures of infancy (mmpsi)
5154812|NCT03024788|Glycosylated haemoglobin|glycosylated haemoglobin
5154813|NCT03024788|advanced glycation end products|advanced glycation end products
5154819|NCT03024749|Spinal Arteriovenous Fistula|spinal arteriovenous fistula
5154820|NCT03024723|Obese patient|obese patient
5154821|NCT03024723|nasal CPAP|nasal cpap
5154822|NCT03024710|Stunting|stunting
5154823|NCT03024710|complementary feeding Index|complementary feeding index
5154824|NCT03024710|Bangladesh|bangladesh
5154825|NCT03024697|Breast surgery|breast surgery
5154826|NCT03024697|Pectoral plane block|pectoral plane block
5154827|NCT03024697|PECs|pecs
5154828|NCT03024697|Local anaesthesia infusion|local anaesthesia infusion
5154829|NCT03024697|Analgesia|analgesia
5154830|NCT03024684|Hepatocellular carcinoma|hepatocellular carcinoma
5154831|NCT03024684|statin|statin
5154832|NCT03024684|curative ablation|curative ablation
5154833|NCT03024658|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
5154834|NCT03024658|Positive end expiratory pressure|positive end expiratory pressure
5154835|NCT03024658|morbidly obese|morbidly obese
5154836|NCT03024658|laparoscopic bariatric surgery|laparoscopic bariatric surgery
5154837|NCT03024645|Postpartum Depression|postpartum depression
5154838|NCT03024645|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5154839|NCT03024645|Prevention|prevention
5154840|NCT03024645|Web-Based Psychological Intervention|web-based psychological intervention
5154841|NCT03024593|Cyberchondria|cyberchondria
5154842|NCT03024593|health-related internet use|health-related internet use
5154843|NCT03024593|pathological health anxiety|pathological health anxiety
5154844|NCT03024580|Megestrol Acetate|megestrol acetate
5041290|NCT03740789|ALT|alt
5154845|NCT03024580|Steroid, Receptors|steroid, receptors
5154846|NCT03024567|Calorimetry|calorimetry
5154847|NCT03024567|Blood pressure|blood pressure
5154848|NCT03024567|Immunophenotyping|immunophenotyping
5154849|NCT03024567|Gut microbial composition|gut microbial composition
5154850|NCT03024554|aortic aneurysm involving iliac arteries|aortic aneurysm involving iliac arteries
5154851|NCT03024554|abdominal aortic aneurysm|abdominal aortic aneurysm
5154853|NCT03024554|Multilayer Flow Modulator|multilayer flow modulator
5154854|NCT03024554|Multilayer Stent|multilayer stent
5154855|NCT03024528|Pain|pain
5154856|NCT03024528|CPOT|cpot
5154857|NCT03024528|ICU Delirium|icu delirium
5154858|NCT03024528|Critical Care Pain Observation Tool|critical care pain observation tool
5154859|NCT03024528|NRS|nrs
5154860|NCT03024528|Behaviour|behaviour
5154861|NCT03024528|Critical care|critical care
5154862|NCT03024528|Intensive Care|intensive care
5154863|NCT03024502|vulvovaginal candidiasis|vulvovaginal candidiasis
5154864|NCT03024502|EPPAF mucoadhesive gel|eppaf mucoadhesive gel
5154865|NCT03024502|clotrimazol|clotrimazol
5154866|NCT03024489|Phase I/II|phase i/ii
5154867|NCT03024476|behavioral intervention|behavioral intervention
5154868|NCT03024476|prespecified medication algorithm|prespecified medication algorithm
5154869|NCT03024476|bluetooth-equipped sphygmomanometer|bluetooth-equipped sphygmomanometer
5154870|NCT03024463|Breast Neoplasm; Internal Lymph Node; Sentinel Lymph Node Biospy|breast neoplasm; internal lymph node; sentinel lymph node biospy
5154871|NCT03024450|Gastric cancer|gastric cancer
5154872|NCT03024450|HER2|her2
5154873|NCT03024450|trastuzumab|trastuzumab
5154874|NCT03024450|prognosis|prognosis
5154875|NCT03024437|PD-L1 inhibitor|pd-l1 inhibitor
5154876|NCT03024359|Obesity|obesity
5154877|NCT03024359|Brown adipose tissue|brown adipose tissue
5154881|NCT03024333|Swallowing Sound|swallowing sound
5154882|NCT03024333|Acoustic Analysis|acoustic analysis
5154883|NCT03024307|Pharmaceutical Care|pharmaceutical care
5154884|NCT03024307|Medication Adherence|medication adherence
5154885|NCT03024307|Direct Costs|direct costs
5154886|NCT03024281|Aspergillus|aspergillus
5154887|NCT03024281|Antifungal susceptibility|antifungal susceptibility
5154888|NCT03024281|Azole resistance|azole resistance
5154889|NCT03024255|sweat gland disease|sweat gland disease
5154890|NCT03024255|sweating|sweating
5154891|NCT03024255|underarm|underarm
5154892|NCT03024229|Transplantation;perfusion machine|transplantation;perfusion machine
5154893|NCT03024190|stroke|stroke
5154894|NCT03024190|spasticity|spasticity
5154895|NCT03024190|Kinesiotaping|kinesiotaping
5154896|NCT03024190|sonography|sonography
5154897|NCT03024190|exercise|exercise
5154898|NCT03024177|Human rhinovirus|human rhinovirus
5154899|NCT03024177|HRV|hrv
5154900|NCT03024177|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5154901|NCT03024177|HSCT|hsct
5154902|NCT03024177|Antiviral|antiviral
5154903|NCT03024177|vapendavir|vapendavir
5154904|NCT03024177|Allogeneic|allogeneic
5154905|NCT03024177|Autologous|autologous
5154906|NCT03024164|youth; etiology; prognosis; recurrence; biomarkers|youth; etiology; prognosis; recurrence; biomarkers
5154907|NCT03024125|lean mass|lean mass
5154908|NCT03024125|postmenopausal|postmenopausal
5154909|NCT03024125|protein|protein
5154910|NCT03024099|hippotherapy Gross Motor Function Functional performance.|hippotherapy gross motor function functional performance.
5154911|NCT03024060|Actinic Keratosis|actinic keratosis
5154912|NCT03024021|therapeutic hypothermia|therapeutic hypothermia
5154913|NCT03024021|targeted temperature management|targeted temperature management
5154914|NCT03024021|neurological outcome|neurological outcome
5154915|NCT03024021|post-cardiac arrest syndrome|post-cardiac arrest syndrome
5154916|NCT03024008|Critical Gap|critical gap
5154917|NCT03024008|Comminuted Fracture|comminuted fracture
5154918|NCT03024008|Extra-Articular|extra-articular
5154919|NCT03023930|Opioid Use Disorder|opioid use disorder
5154920|NCT03023917|jaundice,complication|jaundice,complication
5154921|NCT03023891|glucocorticoids|glucocorticoids
5154922|NCT03023891|efficacy|efficacy
5154923|NCT03023891|metabolic toxicity|metabolic toxicity
5154924|NCT03023865|Long gap esophageal atresia|long gap esophageal atresia
5154925|NCT03023839|Delirium|delirium
5154926|NCT03023839|Trauma|trauma
5154927|NCT03023839|Injury|injury
5154928|NCT03023839|restraints|restraints
5154929|NCT03023761|Endodontic retreatments|endodontic retreatments
5154930|NCT03023761|Low level laser|low level laser
5154931|NCT03023761|Pain|pain
5154932|NCT03023748|activated vitamin D treatment|activated vitamin d treatment
5154933|NCT03023709|Quadrivalent inactivated influenza vaccine|quadrivalent inactivated influenza vaccine
5154934|NCT03023709|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
5154935|NCT03023709|Adults with obstructive sleep apnea|adults with obstructive sleep apnea
5154936|NCT03023696|C5 Palsy|c5 palsy
5154937|NCT03023683|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5154938|NCT03023683|Children and young adults|children and young adults
5154939|NCT03023670|Lung|lung
5154940|NCT03023670|Cardiopulmonary Bypass|cardiopulmonary bypass
5154941|NCT03023670|Pediatric|pediatric
5154942|NCT03023670|Cardiac surgery|cardiac surgery
5154943|NCT03023657|arousal|arousal
5154944|NCT03023657|Consciousness Disorders|consciousness disorders
5154945|NCT03023657|vegetative state|vegetative state
5154946|NCT03023657|minimally conscious state|minimally conscious state
5154947|NCT03023644|Congenital Heart Disease|congenital heart disease
5154948|NCT03023644|Neurodevelopmental Disorders|neurodevelopmental disorders
5154949|NCT03023644|Children|children
5154950|NCT03023644|Executive Function|executive function
5154951|NCT03023644|Working Memory|working memory
5154952|NCT03023644|Cognitive interventions|cognitive interventions
5154953|NCT03023644|Infant Open Heart Surgery|infant open heart surgery
5154954|NCT03023618|[G09.330.380]|[g09.330.380]
5154955|NCT03023605|Pulmonary embolism|pulmonary embolism
5154956|NCT03023605|Adherence to practice guidelines|adherence to practice guidelines
5154957|NCT03023605|Age-adjusted D-dimer|age-adjusted d-dimer
5154958|NCT03023605|Clinical prediction rules|clinical prediction rules
5154959|NCT03023605|Elderly patients|elderly patients
5154960|NCT03023592|Sjogren's Syndrome|sjogren's syndrome
5154961|NCT03023592|Iguratimod|iguratimod
5154962|NCT03023566|Dotarem|dotarem
5154963|NCT03023566|MRI|mri
5154964|NCT03023566|pediatric|pediatric
5154965|NCT03023566|safety|safety
5154966|NCT03023566|efficacy|efficacy
5154967|NCT03023553|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
5154968|NCT03023553|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5154969|NCT03023553|Nasopharyngeal swabs|nasopharyngeal swabs
5154972|NCT03023540|Peripheral neuropathy|peripheral neuropathy
5154973|NCT03023540|PXT3003|pxt3003
5154974|NCT03023527|Refractory|refractory
5154975|NCT03023527|Relapsed|relapsed
5154976|NCT03023527|Nivolumab|nivolumab
5154977|NCT03023514|Oocyte donation|oocyte donation
5154978|NCT03023514|IVF|ivf
5154979|NCT03023514|Lipoic acid|lipoic acid
5154980|NCT03023514|Implantation rate|implantation rate
5154981|NCT03023514|Endometrial receptivity|endometrial receptivity
5154982|NCT03023488|flexible ureteroscopy|flexible ureteroscopy
5154983|NCT03023488|blood flow|blood flow
5154984|NCT03023436|Stomach Neoplasms|stomach neoplasms
5154985|NCT03023436|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
5154986|NCT03023410|Revision TKA|revision tka
5154987|NCT03023410|Instability|instability
5154988|NCT03023410|Stiffness|stiffness
5154989|NCT03023410|Aseptic Loosening|aseptic loosening
5154990|NCT03023410|Polyethylene Wear|polyethylene wear
5154991|NCT03023410|Malrotation|malrotation
5154992|NCT03023410|Soft Tissue Imbalance|soft tissue imbalance
5154993|NCT03023397|E-cig smokers|e-cig smokers
5154994|NCT03023384|Acute Myeloid Leukemia|acute myeloid leukemia
5154995|NCT03023384|Chemotherapy|chemotherapy
5154996|NCT03023384|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5154997|NCT03023384|Developing country|developing country
5154998|NCT03023384|Clinical network|clinical network
5154999|NCT03023371|Registry; cohort study; IgG4-related disease|registry; cohort study; igg4-related disease
5155000|NCT03023358|peripheral T cell lymphoma|peripheral t cell lymphoma
5155001|NCT03023345|cancer|cancer
5155002|NCT03023345|prostate|prostate
5155003|NCT03023345|PSA|psa
5155004|NCT03023345|biopsies|biopsies
5155007|NCT03023332|Biofeedback|biofeedback
5155008|NCT03023332|Resourcefulness|resourcefulness
5155009|NCT03023332|Self-Management|self-management
5155010|NCT03023293|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5155011|NCT03023293|irisin|irisin
5155012|NCT03023241|BPS/IC|bps/ic
5155013|NCT03023241|OAB|oab
5155014|NCT03023228|Diabetes mellitus|diabetes mellitus
5155015|NCT03023228|Hyperglycemia|hyperglycemia
5155016|NCT03023228|Inpatient|inpatient
5155017|NCT03023228|self-management education|self-management education
5155018|NCT03023215|Meditation|meditation
5155019|NCT03023215|Breast Biopsy|breast biopsy
5155020|NCT03023215|Stereotactic Breast Biopsy|stereotactic breast biopsy
5155021|NCT03023215|SBB|sbb
5155022|NCT03023215|Guided meditation|guided meditation
5155023|NCT03023215|Focused breathing|focused breathing
5155024|NCT03023215|Electroencephalogram|electroencephalogram
5155025|NCT03023215|EEG|eeg
5155026|NCT03023215|Heart rate|heart rate
5155027|NCT03023215|HR|hr
5155028|NCT03023215|Questionnaires|questionnaires
5155029|NCT03023215|Surveys|surveys
5155030|NCT03023189|Upper digestive bleeding|upper digestive bleeding
5155031|NCT03023189|Haemorrhage|haemorrhage
5155032|NCT03023189|Cirrhosis|cirrhosis
5155033|NCT03023189|Antifibrinolytic|antifibrinolytic
5155034|NCT03023189|Tranexamic acid|tranexamic acid
5155035|NCT03023189|Emergency|emergency
5155036|NCT03023176|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
5155037|NCT03023176|Child identical twins|child identical twins
5155038|NCT03023176|Child fraternal twins|child fraternal twins
5155039|NCT03023163|autonomic dysreflexia|autonomic dysreflexia
5155040|NCT03023163|baroreceptor integrity|baroreceptor integrity
5155041|NCT03023163|sympathetic integrity|sympathetic integrity
5155042|NCT03023163|vagal integrity|vagal integrity
5155043|NCT03023163|autonomic integrity|autonomic integrity
5155044|NCT03023163|arterial stiffness|arterial stiffness
5155045|NCT03023163|cognitive function|cognitive function
5155046|NCT03023163|traumatic brain injury|traumatic brain injury
5155047|NCT03023163|cerebral blood flow|cerebral blood flow
5155048|NCT03023163|white matter hyperintensities|white matter hyperintensities
5155049|NCT03023163|cerebral vascular resistance index|cerebral vascular resistance index
5155050|NCT03023137|prevention|prevention
5155051|NCT03023137|carbohydrate|carbohydrate
5155052|NCT03023137|exercise|exercise
5155053|NCT03023137|neonatal hypoglycemia|neonatal hypoglycemia
5155054|NCT03023111|Cutaneous leishmaniasis|cutaneous leishmaniasis
5155055|NCT03023111|miltefosine|miltefosine
5155056|NCT03023111|cytokines|cytokines
5155057|NCT03023111|treatment|treatment
5155058|NCT03023098|Restenosis|restenosis
5155059|NCT03023098|Drug-eluting balloon|drug-eluting balloon
5155060|NCT03023098|Vein graft|vein graft
5155061|NCT03023059|L-DOPA|l-dopa
5155062|NCT03023059|GPR143|gpr143
5155063|NCT03023059|PEDF|pedf
5155064|NCT03023059|VEGF|vegf
5155065|NCT03023033|PMTCT|pmtct
5155066|NCT03023033|MNCH|mnch
5155067|NCT03023020|Dual Antiplatelet Therapy|dual antiplatelet therapy
5155068|NCT03022994|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
5155069|NCT03022994|eosinophils|eosinophils
5155075|NCT03022825|BCG|bcg
5155076|NCT03022825|bladder cancer|bladder cancer
5155077|NCT03022825|immunotherapy|immunotherapy
5155078|NCT03022825|interleukin-15|interleukin-15
5155079|NCT03022825|intravesical|intravesical
5155080|NCT03022825|non-muscle invasive|non-muscle invasive
5155081|NCT03022825|NMIBC|nmibc
5155082|NCT03022812|Neck pain|neck pain
5155083|NCT03022812|Rehabilitation|rehabilitation
5155084|NCT03022812|Exercise Therapy|exercise therapy
5155085|NCT03022812|Internet|internet
5155086|NCT03022799|FAF1|faf1
5155087|NCT03022799|Fas (TNFRSF6)-associated factor 1|fas (tnfrsf6)-associated factor 1
5155088|NCT03022799|FAF1 inhibitor|faf1 inhibitor
5155089|NCT03022799|KM-819|km-819
5155090|NCT03022786|Dermatitis|dermatitis
5155091|NCT03022760|Exhaustion Disorder|exhaustion disorder
5155092|NCT03022682|ethnicity|ethnicity
5155093|NCT03022682|inflammation|inflammation
5155094|NCT03022669|mobile health|mobile health
5155099|NCT03022630|palliative care|palliative care
5155100|NCT03022630|cirrhosis|cirrhosis
5155101|NCT03022630|liver disease|liver disease
5155102|NCT03022630|hepatology|hepatology
5155103|NCT03022630|end of life care|end of life care
5155104|NCT03022630|supportive care|supportive care
5155105|NCT03022565|Uveal Melanoma|uveal melanoma
5775244|NCT00221377|children|children
5155106|NCT03022552|Myocardial Infarction|myocardial infarction
5155107|NCT03022552|Women|women
5155108|NCT03022552|Platelets|platelets
5155109|NCT03022552|Blood Collection|blood collection
5155110|NCT03022552|Genomics|genomics
5155111|NCT03022526|Pregnant|pregnant
5155112|NCT03022526|Analgesia|analgesia
5155113|NCT03022526|Labor analgesia|labor analgesia
5155114|NCT03022526|Epidural|epidural
5150611|NCT03050944|IVF|ivf
5155117|NCT03022513|fibromyalgia|fibromyalgia
5155118|NCT03022513|synovitis|synovitis
5155119|NCT03022487|Sudden Cardiac Death (SCD)|sudden cardiac death (scd)
5155120|NCT03022487|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5155121|NCT03022487|electrophysiological|electrophysiological
5155122|NCT03022487|EP|ep
5155123|NCT03022487|Ischaemic cardiomyopathy|ischaemic cardiomyopathy
5155124|NCT03022487|Ventricular Arrhythmia|ventricular arrhythmia
5155125|NCT03022487|ICD|icd
5155126|NCT03022474|Childhood obesity|childhood obesity
5155127|NCT03022461|Heart Failure|heart failure
5155128|NCT03022461|Ventricular Dysfunction|ventricular dysfunction
5155129|NCT03022461|Cardiomyopathies|cardiomyopathies
5155130|NCT03022461|Heart Disease|heart disease
5155131|NCT03022461|Cardiovascular Disease|cardiovascular disease
5155132|NCT03022461|Heart-assist Devices|heart-assist devices
5155133|NCT03022461|Thoratec Corporation|thoratec corporation
5155134|NCT03022448|soft tissue sarcomas (STS)|soft tissue sarcomas (sts)
5155135|NCT03022448|trabectedin|trabectedin
5155136|NCT03022448|metastatic STS patients|metastatic sts patients
5155137|NCT03022448|overall survival|overall survival
5155138|NCT03022435|Inactivated influenza vaccine|inactivated influenza vaccine
5155139|NCT03022435|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5155140|NCT03022435|Adult and elderly identical twins|adult and elderly identical twins
5155141|NCT03022435|Adult fraternal twins|adult fraternal twins
5155142|NCT03022422|Trivalent, inactivated influenza vaccine|trivalent, inactivated influenza vaccine
5155143|NCT03022422|High-Dose trivalent, inactivated influenza vaccine|high-dose trivalent, inactivated influenza vaccine
5155144|NCT03022422|Adult and elderly identical twins|adult and elderly identical twins
5155145|NCT03022422|Adult fraternal twins|adult fraternal twins
5155149|NCT03022396|Inactivated influenza vaccine|inactivated influenza vaccine
5155150|NCT03022396|Identical twins|identical twins
5155151|NCT03022396|Fraternal twins|fraternal twins
5155152|NCT03022396|High-Dose influenza vaccine|high-dose influenza vaccine
5155153|NCT03022396|Elderly twins|elderly twins
5155154|NCT03022396|Child twins|child twins
5155155|NCT03022396|Inactivated influenza vaccine, high-dose|inactivated influenza vaccine, high-dose
5155156|NCT03022383|no known ocular pathology|no known ocular pathology
5155157|NCT03022370|informal settlements|informal settlements
5155158|NCT03022370|poverty|poverty
5155159|NCT03022344|DD2 plaque study|dd2 plaque study
5155160|NCT03022344|Coronary plaque|coronary plaque
5155161|NCT03022344|Type-2 diabetes mellitus|type-2 diabetes mellitus
5155162|NCT03022331|Idiopathic aortitis|idiopathic aortitis
5155163|NCT03022331|Isolated aortitis|isolated aortitis
5155164|NCT03022331|Vasculitis|vasculitis
5155165|NCT03022318|GPR143|gpr143
5155166|NCT03022318|PEDF|pedf
5155167|NCT03022318|VEGF|vegf
5155168|NCT03022318|LDOPA|ldopa
5155169|NCT03022305|Hip alignment|hip alignment
5155170|NCT03022305|Hip misalignment|hip misalignment
5155171|NCT03022305|Shoulder function|shoulder function
5155172|NCT03022305|Shoulder rotation|shoulder rotation
5155173|NCT03022305|Athletic shoulder injuries|athletic shoulder injuries
5155174|NCT03022305|Athletic hip alignment|athletic hip alignment
5155175|NCT03022305|Hip and shoulder alignment|hip and shoulder alignment
5155176|NCT03022305|Hip joint|hip joint
5155177|NCT03022305|Hip joint alignment|hip joint alignment
5155178|NCT03022305|Hip joint misalignment|hip joint misalignment
5155179|NCT03022279|Pediatric|pediatric
5155180|NCT03022279|post-operative pain prevention|post-operative pain prevention
5155181|NCT03022279|Anesthesia, Infiltration|anesthesia, infiltration
5155182|NCT03022279|Nerve Blockade|nerve blockade
5155183|NCT03022266|Adherence|adherence
5155184|NCT03022266|CleverCap® Lite BLE C035|clevercap® lite ble c035
5155185|NCT03022266|Smartphone App|smartphone app
5155186|NCT03022266|Telehealth|telehealth
5155187|NCT03022266|Digital Health|digital health
5155188|NCT03022266|Mobile Phone App|mobile phone app
5155189|NCT03022266|Behavioral Economics|behavioral economics
5155190|NCT03022266|Aspirin|aspirin
5155191|NCT03022266|Wellth App|wellth app
5155192|NCT03022253|PDA|pda
5155193|NCT03022253|Platelets|platelets
5155194|NCT03022227|cochlear implant ;|cochlear implant ;
5155195|NCT03022214|Dietary supplementation|dietary supplementation
5155196|NCT03022214|Exercise|exercise
5155197|NCT03022214|Increase Resilience|increase resilience
5155198|NCT03022214|Oxidative Stress|oxidative stress
5155199|NCT03022214|Efficacy|efficacy
5155200|NCT03022201|Motilitone|motilitone
5155201|NCT03022188|pancreatic incidentaloma|pancreatic incidentaloma
5775245|NCT00221364|Trachoma|trachoma
5155202|NCT03022188|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5155203|NCT03022188|EUS-guided fine-needle aspiration|eus-guided fine-needle aspiration
5155204|NCT03022188|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
5155206|NCT03022175|Tolerability|tolerability
5155207|NCT03022175|Pharmacokinetics|pharmacokinetics
5155208|NCT03022162|Neuropathic Pain, Paclitaxel, CIPN|neuropathic pain, paclitaxel, cipn
5155218|NCT03022045|Generalized Pustular Psoriasis|generalized pustular psoriasis
5155219|NCT03022045|Erythrodermic Psoriasis|erythrodermic psoriasis
5155220|NCT03022045|risankizumab|risankizumab
5155221|NCT03022045|Japanese|japanese
5155222|NCT03022032|Gynecologic cancer|gynecologic cancer
5155223|NCT03022019|autologous cell suspension grafting|autologous cell suspension grafting
5155224|NCT03022019|vitiligo|vitiligo
5155225|NCT03022019|non-segmental|non-segmental
5155226|NCT03022019|ReNovaCell|renovacell
5155227|NCT03021967|incurable pathologies|incurable pathologies
5155228|NCT03021967|palliative care|palliative care
5155229|NCT03021954|platelet rich plasma|platelet rich plasma
5155230|NCT03021954|pelvic floor disorders|pelvic floor disorders
5155231|NCT03021954|primipara|primipara
5155232|NCT03021941|Gaucher Disease|gaucher disease
5155233|NCT03021941|Enzyme Replacement Therapy|enzyme replacement therapy
5155234|NCT03021928|Stroke|stroke
5155235|NCT03021928|Atrial Fibrillation|atrial fibrillation
5155236|NCT03021928|Anticoagulation|anticoagulation
5155237|NCT03021928|NOAC|noac
5155238|NCT03021889|HIV / AIDS|hiv / aids
5155239|NCT03021889|Dyslipidemia|dyslipidemia
5155240|NCT03021889|Adolescents|adolescents
5155241|NCT03021889|Nutritional Therapy|nutritional therapy
5155242|NCT03021863|Dissemination|dissemination
5155243|NCT03021863|Tone|tone
5155244|NCT03021863|Survey reminders|survey reminders
5155245|NCT03021863|Questionnaires|questionnaires
5155246|NCT03021850|Pliability|pliability
5155247|NCT03021850|Cryotherapy|cryotherapy
5155248|NCT03021850|Hot temperature|hot temperature
5155249|NCT03021850|Hyperthermia, induced|hyperthermia, induced
5155250|NCT03021850|Randomized Controlled Trial|randomized controlled trial
5155251|NCT03021850|Hamstring muscles|hamstring muscles
5155252|NCT03021850|Muscle stretching exercises|muscle stretching exercises
5155253|NCT03021824|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5155254|NCT03021824|ARDS|ards
5155255|NCT03021824|Acute Lung Injury|acute lung injury
5155256|NCT03021824|ALI|ali
5155257|NCT03021824|Mechanical Ventilation|mechanical ventilation
5155258|NCT03021824|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5155259|NCT03021824|Neuromuscular Blockade|neuromuscular blockade
5155260|NCT03021824|Vasodilator Agents|vasodilator agents
5155261|NCT03021824|Prone Position|prone position
5155262|NCT03021824|ECMO|ecmo
5155263|NCT03021824|Acute Respiratory Failure|acute respiratory failure
5155264|NCT03021798|Sarcopenia|sarcopenia
5155265|NCT03021798|Sarcopenic Obesity|sarcopenic obesity
5155266|NCT03021798|observational study|observational study
5155267|NCT03021798|6-minute walking distance|6-minute walking distance
5155268|NCT03021798|400 meters walking test|400 meters walking test
5155269|NCT03021798|Patient Reported Outcomes|patient reported outcomes
5155273|NCT03021785|TK001|tk001
5155274|NCT03021772|Neostigmine|neostigmine
5155275|NCT03021772|Dexamethasone|dexamethasone
5155276|NCT03021772|Intravenous Local Anesthesia|intravenous local anesthesia
5155277|NCT03021746|African-American|african-american
5155278|NCT03021720|Uterine fibroid embolization|uterine fibroid embolization
5155279|NCT03021720|Uterine artery embolization|uterine artery embolization
5155280|NCT03021720|Arterial access|arterial access
5155281|NCT03021720|Radial access|radial access
5155282|NCT03021720|Interventional radiology|interventional radiology
5155283|NCT03021720|Quality of life|quality of life
5155284|NCT03021720|Patient Satisfaction|patient satisfaction
5155285|NCT03021720|Patient centered care|patient centered care
5155286|NCT03021720|Uterine fibroid|uterine fibroid
5155287|NCT03021655|Youth|youth
5155288|NCT03021655|Randomized controlled trial|randomized controlled trial
5155289|NCT03021655|Adventure-based training|adventure-based training
5155290|NCT03021655|WhatsApp|whatsapp
5155291|NCT03021642|Healthy volunteer|healthy volunteer
5155292|NCT03021642|Tepotinib|tepotinib
5155293|NCT03021642|Mesenchymal-epithelial transition factor|mesenchymal-epithelial transition factor
5155294|NCT03021642|Translocated promoter region|translocated promoter region
5155295|NCT03021616|energy drink|energy drink
5155296|NCT03021616|qtc interval|qtc interval
5227351|NCT02579096|CKD|ckd
5155297|NCT03021616|clotting time|clotting time
5155298|NCT03021616|thorough qt study|thorough qt study
5155299|NCT03021603|Hope|hope
5155300|NCT03021603|psychotherapy|psychotherapy
5155301|NCT03021603|palliative|palliative
5155303|NCT03021590|Helicobacter pylori|helicobacter pylori
5155304|NCT03021590|Helicobacter Infections|helicobacter infections
5155305|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors
5155306|NCT03021590|sequential therapy|sequential therapy
5155307|NCT03021590|Clarithromycin|clarithromycin
5155308|NCT03021590|Tinidazole|tinidazole
5155309|NCT03021577|orbital atherectomy system|orbital atherectomy system
5155310|NCT03021577|rotational atherectomy|rotational atherectomy
5155311|NCT03021577|Fractional flow reserve|fractional flow reserve
5155312|NCT03021577|coronary flow reserve|coronary flow reserve
5155313|NCT03021577|index of microcirculatory resistance (IMR)|index of microcirculatory resistance (imr)
5155314|NCT03021551|oxygen|oxygen
5155315|NCT03021551|desaturation|desaturation
5155316|NCT03021551|obesity|obesity
5155317|NCT03021538|Cardiopulmonary Bypass|cardiopulmonary bypass
5155318|NCT03021538|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5155319|NCT03021538|Primary Graft Dysfunction|primary graft dysfunction
5155320|NCT03021538|Hemorrhage|hemorrhage
5155321|NCT03021538|Mechanical Ventilator|mechanical ventilator
5155322|NCT03021525|Goal-directed therapy|goal-directed therapy
5962107|NCT04283006|CD20/CD22|cd20/cd22
5155323|NCT03021525|postoperative morbidity|postoperative morbidity
5155324|NCT03021525|haemodynamic optimisation|haemodynamic optimisation
5155325|NCT03021525|individualised medicine|individualised medicine
5155326|NCT03021525|Pulse pressure variation|pulse pressure variation
5155327|NCT03021525|Cardiac output|cardiac output
5155328|NCT03021499|lupus nephritis|lupus nephritis
5155329|NCT03021499|calcineurin inhibitors|calcineurin inhibitors
5155330|NCT03021499|voclosporin|voclosporin
5155334|NCT03021434|Water Supply/standards|water supply/standards
5155335|NCT03021434|Water microbiology|water microbiology
5155336|NCT03021434|India|india
5155337|NCT03021434|Hand disinfection|hand disinfection
5155338|NCT03021434|Escherichia coli Infections/prevention & control|escherichia coli infections/prevention & control
5155339|NCT03021434|Hygiene|hygiene
5155340|NCT03021434|Health behavior|health behavior
5155341|NCT03021434|Drinking water|drinking water
5155342|NCT03021434|Informational intervention|informational intervention
5155343|NCT03021421|Total knee arthroplasty|total knee arthroplasty
5155344|NCT03021421|unilateral spinal anaesthesia|unilateral spinal anaesthesia
5155345|NCT03021421|psoas compartment block|psoas compartment block
5155346|NCT03021421|sciatic nerve block|sciatic nerve block
5155347|NCT03021421|haemodynamic effects|haemodynamic effects
5155348|NCT03021343|Atrial fibrillation|atrial fibrillation
5155349|NCT03021343|Colchicine|colchicine
5155350|NCT03021343|Cardiac surgery|cardiac surgery
5155351|NCT03021304|SB240563|sb240563
5155352|NCT03021304|self-administration|self-administration
5155353|NCT03021304|Mepolizumab|mepolizumab
5155354|NCT03021304|safety syringe|safety syringe
5155355|NCT03021304|Eosinophilic asthma|eosinophilic asthma
5155356|NCT03021278|Tactile acuity|tactile acuity
5155357|NCT03021278|Chronic pain|chronic pain
5155358|NCT03021278|Two-point discrimination|two-point discrimination
5155359|NCT03021278|Point-to-point test|point-to-point test
5155360|NCT03021278|Two-point estimation|two-point estimation
5155361|NCT03021278|Body image|body image
5155362|NCT03021239|Ramp Test|ramp test
5155363|NCT03021239|Continuous Flow -Left Ventricular Assist Device (CF-LVAD)|continuous flow -left ventricular assist device (cf-lvad)
5155365|NCT03021226|Health Behavior|health behavior
5155366|NCT03021174|CIPN|cipn
5155367|NCT03021174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5155368|NCT03021161|probiotic|probiotic
5155369|NCT03021148|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
5155370|NCT03021148|self-reported|self-reported
5155371|NCT03021122|Medication errors|medication errors
5155372|NCT03021122|Resuscitation|resuscitation
5155373|NCT03021122|Drugs|drugs
5155374|NCT03021122|Pediatrics|pediatrics
5155375|NCT03021122|Biomedical technology|biomedical technology
5155376|NCT03021109|ultrasound|ultrasound
5155377|NCT03021109|pediatrics|pediatrics
5155378|NCT03021109|gastroenteritis|gastroenteritis
5155379|NCT03021083|Lumbar multi-level fusions|lumbar multi-level fusions
5155380|NCT03021083|Patient Controlled Analgesia|patient controlled analgesia
5155381|NCT03021083|Fentanyl|fentanyl
5155382|NCT03021083|Opioid Analgesia|opioid analgesia
5155483|NCT03020407|Mortality|mortality
5155387|NCT03021070|Conditional cash transfer|conditional cash transfer
5155388|NCT03021070|Maternal and child health|maternal and child health
5155389|NCT03021070|Cluster randomized trial|cluster randomized trial
5155390|NCT03021031|Parkinson's Disease|parkinson's disease
5155391|NCT03021018|Epilepsy|epilepsy
5155392|NCT03021018|Brivaracetam|brivaracetam
5155393|NCT03021018|Epilepsy Monitoring Unit|epilepsy monitoring unit
5155394|NCT03021018|Increased seizure activity|increased seizure activity
5155400|NCT03020875|Acetaminophen|acetaminophen
5155401|NCT03020875|Pain management|pain management
5155402|NCT03020862|Dietary nitrate|dietary nitrate
5155403|NCT03020862|Physical performance|physical performance
5155404|NCT03020862|Blood pressure|blood pressure
5155405|NCT03020862|Nitrite|nitrite
5155406|NCT03020862|Exercise|exercise
5155407|NCT03020849|hypofibrinogenemia|hypofibrinogenemia
5155419|NCT03020745|Pharmacodynamics|pharmacodynamics
5155420|NCT03020745|Efficacy|efficacy
5155421|NCT03020745|Chronic Hepatitis B|chronic hepatitis b
5155422|NCT03020745|GSK3389404|gsk3389404
5155423|NCT03020732|growth factor|growth factor
5155424|NCT03020732|mucogingival surgery|mucogingival surgery
5155425|NCT03020732|gingival recession|gingival recession
5155426|NCT03020719|Growth Parameters|growth parameters
5155427|NCT03020719|Cystic Fibrosis|cystic fibrosis
5155428|NCT03020706|magnesium sulphate|magnesium sulphate
5155429|NCT03020706|neostigmine|neostigmine
5155430|NCT03020693|electrostimulation|electrostimulation
5155431|NCT03020693|exercise program|exercise program
5155432|NCT03020667|Cigarette|cigarette
5155433|NCT03020667|IQOS|iqos
5155434|NCT03020667|Nicotine-containing product|nicotine-containing product
5155435|NCT03020667|Tobacco|tobacco
5155436|NCT03020641|low pressure pneumoperitoneum|low pressure pneumoperitoneum
5155437|NCT03020641|standard pressure pneumoperitoneum|standard pressure pneumoperitoneum
5155438|NCT03020641|laparoscopy cholecystectomy|laparoscopy cholecystectomy
5155439|NCT03020628|Influenza Vaccines|influenza vaccines
5155440|NCT03020628|Vaccines, Inactivated|vaccines, inactivated
5155441|NCT03020628|Cell Culture-Derived|cell culture-derived
5155442|NCT03020615|Sickle cell|sickle cell
5155443|NCT03020615|Hydroxyurea|hydroxyurea
5155444|NCT03020615|Infants|infants
5155445|NCT03020589|Renal Transplant|renal transplant
5155446|NCT03020589|Tacrolimus|tacrolimus
5155448|NCT03020589|Phase IV|phase iv
5155449|NCT03020550|GERD|gerd
5155450|NCT03020550|Galvanic Skin Response|galvanic skin response
5155451|NCT03020550|Heart Rate Variability|heart rate variability
5155452|NCT03020537|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
5155453|NCT03020537|Young children|young children
5155455|NCT03020511|Modern grains|modern grains
5155456|NCT03020511|ancient grains|ancient grains
5155457|NCT03020511|immunologic response|immunologic response
5155458|NCT03020511|microbiota|microbiota
5155459|NCT03020498|Inactivated influenza vaccine|inactivated influenza vaccine
5155460|NCT03020498|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5155461|NCT03020498|Child identical twins and non-twins|child identical twins and non-twins
5155462|NCT03020498|Young and elderly non-twin adults|young and elderly non-twin adults
5155463|NCT03020472|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5155464|NCT03020472|Children|children
5155465|NCT03020459|macular holes|macular holes
5155466|NCT03020433|Stroke|stroke
5155467|NCT03020433|rehab|rehab
5155468|NCT03020433|rehabilitation|rehabilitation
5155469|NCT03020433|paresis|paresis
5155470|NCT03020433|paralysis|paralysis
5155475|NCT03020433|TMS|tms
5155476|NCT03020433|transcranial magnetic stimulation|transcranial magnetic stimulation
5155477|NCT03020433|CIMT|cimt
5155478|NCT03020433|constraint induced movement therapy|constraint induced movement therapy
5155479|NCT03020433|MRI|mri
5155480|NCT03020407|Septic Shock|septic shock
5155481|NCT03020407|Inferior vene cava diameter|inferior vene cava diameter
5155482|NCT03020407|Resuscitation|resuscitation
5155484|NCT03020394|COPD Exacerbation|copd exacerbation
5155485|NCT03020394|Noninvasive Positive Ventilation|noninvasive positive ventilation
5155486|NCT03020394|Invasive Positive Ventilation|invasive positive ventilation
5155488|NCT03020394|High flow nasal cannula|high flow nasal cannula
5155489|NCT03020342|HCC|hcc
5155490|NCT03020342|chimera DNA|chimera dna
5155491|NCT03020342|circulating DNA|circulating dna
5155492|NCT03020342|biomarker|biomarker
5155493|NCT03020329|Induction Chemotherapy|induction chemotherapy
5155494|NCT03020329|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5155495|NCT03020329|Chemoradiotherapy|chemoradiotherapy
5155496|NCT03020290|femoropopliteal artery|femoropopliteal artery
5155497|NCT03020290|interwoven nitinol stent|interwoven nitinol stent
5775246|NCT00221364|Chlamydia|chlamydia
5155498|NCT03020290|self-expanding-endovascular|self-expanding-endovascular
5155499|NCT03020290|TASC C and TASC D|tasc c and tasc d
5155500|NCT03020290|Peripheral Arterial Disease|peripheral arterial disease
5155501|NCT03020264|Type 2 Diabetes|type 2 diabetes
5155505|NCT03020251|preoperative rehabilitation program|preoperative rehabilitation program
5155507|NCT03020251|lung cancer resection|lung cancer resection
5155508|NCT03020212|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5155509|NCT03020212|High altitude|high altitude
5155510|NCT03020212|Oxygen|oxygen
5155511|NCT03020212|long-term oxygen therapy|long-term oxygen therapy
5155512|NCT03020212|pulmonary hypertension|pulmonary hypertension
5155513|NCT03020212|chronic hypoxemia|chronic hypoxemia
5155515|NCT03020134|pharmacokinetics|pharmacokinetics
5155516|NCT03020134|Danoprevir/r|danoprevir/r
5155517|NCT03020134|Ravidasvir|ravidasvir
5155518|NCT03020095|Ravidasvir|ravidasvir
5155519|NCT03020095|HCV GT1|hcv gt1
5155520|NCT03020095|SVR12|svr12
5155521|NCT03020095|Danoprevir/r|danoprevir/r
5155522|NCT03020082|Danoprevir|danoprevir
5155523|NCT03020082|non-cirrhotic|non-cirrhotic
5155524|NCT03020082|Chinese HCV G1|chinese hcv g1
5155525|NCT03020082|SVR12|svr12
5155526|NCT03020069|Type 1 Diabetes|type 1 diabetes
5155527|NCT03020069|Adolescents|adolescents
5155528|NCT03020069|Glucose Monitoring|glucose monitoring
5155529|NCT03020056|cataract surgery|cataract surgery
5155530|NCT03020056|socioeconomic status|socioeconomic status
5155531|NCT03020056|quality of life|quality of life
5155532|NCT03020056|rural area|rural area
5155533|NCT03020056|China|china
5155534|NCT03020056|randomized controlled trial|randomized controlled trial
5155535|NCT03020030|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5155536|NCT03020004|Danoprevir|danoprevir
5155537|NCT03020004|SVR12|svr12
5155538|NCT03020004|Chinese HCV G1|chinese hcv g1
5155539|NCT03020004|non-cirrhotic|non-cirrhotic
5155540|NCT03019991|pharmacokinetics,Danoprevir|pharmacokinetics,danoprevir
5155541|NCT03019926|systemic lupus erythematosus|systemic lupus erythematosus
5155542|NCT03019926|observance|observance
5155543|NCT03019926|hydroxychloroquine dosage|hydroxychloroquine dosage
5155544|NCT03019926|risk factors of non-observance|risk factors of non-observance
5155545|NCT03019926|SLICC score|slicc score
5155546|NCT03019926|SLEDAI score|sledai score
5155547|NCT03019913|Skeletal muscle|skeletal muscle
5155548|NCT03019861|Ayurveda|ayurveda
5155549|NCT03019861|IBS|ibs
5155550|NCT03019861|Complementary medicine|complementary medicine
5155551|NCT03019861|nutritional counseling|nutritional counseling
5155552|NCT03019848|Redox and pro-inflammatory status|redox and pro-inflammatory status
5155553|NCT03019835|mivacurium|mivacurium
5155554|NCT03019835|neostigmine|neostigmine
5155555|NCT03019835|antagonism|antagonism
5155556|NCT03019783|Endothelial function|endothelial function
5155557|NCT03019770|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5155558|NCT03019770|HIV|hiv
5155559|NCT03019770|Decision Aid|decision aid
5155560|NCT03019770|Shared Decision Making|shared decision making
5155561|NCT03019744|Functional Electrical Stimulation|functional electrical stimulation
5155562|NCT03019744|Cerebrovascular accident|cerebrovascular accident
5155563|NCT03019744|Stroke|stroke
5155564|NCT03019744|Electromyography|electromyography
5155565|NCT03019731|Tics|tics
5155566|NCT03019731|Behavioral therapy|behavioral therapy
5155567|NCT03019731|Neurologic Examination|neurologic examination
5164427|NCT02964520|A/T neurofeedback|a/t neurofeedback
5155574|NCT03019705|health-related internet use|health-related internet use
5155575|NCT03019705|pathological health anxiety|pathological health anxiety
5155576|NCT03019705|ambulatory assessment|ambulatory assessment
5155577|NCT03019666|MM|mm
5155578|NCT03019666|NHL|nhl
5155579|NCT03019666|NK Cell|nk cell
5155580|NCT03019666|NK Cells|nk cells
5155581|NCT03019601|HIV|hiv
5155582|NCT03019601|PMTCT|pmtct
5155583|NCT03019588|PD1|pd1
5155584|NCT03019588|PD-1|pd-1
5155585|NCT03019588|PDL1|pdl1
5155587|NCT03019562|postoperative pain|postoperative pain
5155588|NCT03019523|caffeine|caffeine
5155589|NCT03019523|mental performance|mental performance
5155590|NCT03019523|reaction time|reaction time
5155591|NCT03019523|focus|focus
5155592|NCT03019497|PTSD|ptsd
5155593|NCT03019497|Related Problems|related problems
5155594|NCT03019497|Therapy|therapy
5155595|NCT03019497|Traumatic Event|traumatic event
5155596|NCT03019497|Quality of Life|quality of life
5155597|NCT03019497|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5155598|NCT03019497|Major depression|major depression
5155599|NCT03019497|Sleep disorders|sleep disorders
5155600|NCT03019497|Pain|pain
5155601|NCT03019497|Stressors|stressors
5155602|NCT03019497|Social support|social support
5155603|NCT03019497|Substance use disorder|substance use disorder
5155604|NCT03019497|Anxiety disorder|anxiety disorder
5155605|NCT03019484|Self-efficacy|self-efficacy
5155606|NCT03019484|Self Efficacy|self efficacy
5155607|NCT03019484|Nurses's Role|nurses's role
5155608|NCT03019484|Professional Role|professional role
5155610|NCT03019484|Breast Feeding|breast feeding
5155611|NCT03019458|prospective randomized trial|prospective randomized trial
5155612|NCT03019419|sporadic ALS|sporadic als
5155613|NCT03019419|perampanel|perampanel
5155614|NCT03019393|non-transferrin bound iron (NTBI)|non-transferrin bound iron (ntbi)
5155615|NCT03019393|Red meat|red meat
5155616|NCT03019393|Non-transferrin bound iron (NTBI) in serum|non-transferrin bound iron (ntbi) in serum
5155622|NCT03019354|high flow oxygen|high flow oxygen
5155623|NCT03019354|pulmonary atelectasis|pulmonary atelectasis
5155624|NCT03019354|intravenous general anesthesia|intravenous general anesthesia
5155625|NCT03019341|Nausea|nausea
5155626|NCT03019341|Vomiting|vomiting
5155627|NCT03019341|Non-ionic contrast media|non-ionic contrast media
5155628|NCT03019341|Side effect|side effect
5155629|NCT03019328|peanut allergy|peanut allergy
5155630|NCT03019328|food allergens|food allergens
5155631|NCT03019328|atopic dermatitis|atopic dermatitis
5155632|NCT03019328|eczema|eczema
5155633|NCT03019328|infant food allergy testing|infant food allergy testing
5155634|NCT03019328|skin prick testing|skin prick testing
5155635|NCT03019328|peanut IgE|peanut ige
5155636|NCT03019328|early peanut introduction|early peanut introduction
5155637|NCT03019328|food allergy prevention|food allergy prevention
5155638|NCT03019315|Ovarian Cancer|ovarian cancer
5155639|NCT03019315|Chemotherapy|chemotherapy
5155640|NCT03019315|Response Rate|response rate
5155641|NCT03019315|Survival|survival
5155642|NCT03019250|Colostrum|colostrum
5155643|NCT03019250|Critical Care Outcomes|critical care outcomes
5155644|NCT03019250|Intensive Care Unit|intensive care unit
5155645|NCT03019250|Inflammation|inflammation
5155646|NCT03019250|Infection|infection
5155647|NCT03019250|mortality|mortality
5155648|NCT03019224|Tooth whitening|tooth whitening
5155649|NCT03019224|Dentifrice|dentifrice
5155650|NCT03019224|Sensitivity|sensitivity
5155651|NCT03019211|Physical Therapy Modalities|physical therapy modalities
5155652|NCT03019211|Accidental Fall|accidental fall
5155653|NCT03019211|Elderly|elderly
5155654|NCT03019211|Hydrotherapy|hydrotherapy
5155655|NCT03019211|Nursing Home|nursing home
5155656|NCT03019198|Tranexamic Acid|tranexamic acid
5155657|NCT03019198|Blood loss|blood loss
5155658|NCT03019198|Tranfusion|tranfusion
5155659|NCT03019185|Alport Syndrome|alport syndrome
5155660|NCT03019185|Bardoxolone methyl|bardoxolone methyl
5155661|NCT03019185|CDDO-ME|cddo-me
5155662|NCT03019185|RTA 402|rta 402
5155663|NCT03019146|Prehabilitation|prehabilitation
5155664|NCT03019133|Heart rate|heart rate
5155665|NCT03019133|Blood pressure variability|blood pressure variability
5027937|NCT03824418|Dysplasia|dysplasia
5155666|NCT03019094|overactive bladder|overactive bladder
5155667|NCT03019094|urge urinary incontinence|urge urinary incontinence
5155668|NCT03019094|urgency frequency|urgency frequency
5155669|NCT03019068|recruitment potential|recruitment potential
5155670|NCT03019068|prediction|prediction
5155671|NCT03019068|databases|databases
5155675|NCT03019042|mild gastrointestinal disorders|mild gastrointestinal disorders
5155676|NCT03019042|traditional Chinese medicine|traditional chinese medicine
5155677|NCT03019042|randomized controlled trial|randomized controlled trial
5155678|NCT03019029|Peripheral Nerve Amyloidosis|peripheral nerve amyloidosis
5155679|NCT03019003|Head and Neck Cancer|head and neck cancer
5155680|NCT03018964|Single incision|single incision
5155681|NCT03018964|Solo surgery|solo surgery
5155682|NCT03018951|frailty, assessement|frailty, assessement
5155683|NCT03018938|mid mixture insulin analog|mid mixture insulin analog
5155684|NCT03018938|basal insulin analog|basal insulin analog
5155689|NCT03018912|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5155691|NCT03018912|Complex Sleep Disorders|complex sleep disorders
5155692|NCT03018912|Predictive Analytics|predictive analytics
5155693|NCT03018912|Screening|screening
5155694|NCT03018912|Therapy Outcomes|therapy outcomes
5155695|NCT03018899|paravertebral block|paravertebral block
5155696|NCT03018899|ultrasound|ultrasound
5155697|NCT03018899|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5155698|NCT03018899|postoperative pain|postoperative pain
5155699|NCT03018873|remote ischemic preconditioning|remote ischemic preconditioning
5155700|NCT03018873|acute myocardial infarction|acute myocardial infarction
5155701|NCT03018860|Active second stage|active second stage
5155702|NCT03018860|Neonatal morbidity|neonatal morbidity
5155703|NCT03018860|Operative delivery|operative delivery
5155704|NCT03018860|Labor|labor
5155705|NCT03018834|Acute Myocarditis|acute myocarditis
5155706|NCT03018834|ANAKINRA|anakinra
5155707|NCT03018808|Eosinophilia|eosinophilia
5155708|NCT03018808|COPD prevalence|copd prevalence
5155709|NCT03018808|Primary care subjects|primary care subjects
5155710|NCT03018795|peri-implantitis|peri-implantitis
5155711|NCT03018795|Surgical regenerative treatment|surgical regenerative treatment
5155712|NCT03018795|ozone therapy|ozone therapy
5155713|NCT03018730|Fabry disease|fabry disease
5155714|NCT03018730|Enzyme-Replacement Therapy|enzyme-replacement therapy
5155715|NCT03018730|pegunigalsidase alfa|pegunigalsidase alfa
5155716|NCT03018730|PRX-102|prx-102
5155717|NCT03018730|alpha galactosidase-A|alpha galactosidase-a
5155718|NCT03018704|alcoholism|alcoholism
5155719|NCT03018704|treatment|treatment
5155720|NCT03018652|COPD|copd
5155721|NCT03018652|Ig|ig
5155722|NCT03018652|IPRAC|iprac
5155723|NCT03018652|outpatient|outpatient
5155724|NCT03018626|Non-germinal b-cell-like|non-germinal b-cell-like
5155725|NCT03018626|R-ACVBP|r-acvbp
5155726|NCT03018626|DA-EPOCH-R|da-epoch-r
5155727|NCT03018613|Chronic Functional Constipation|chronic functional constipation
5155728|NCT03018613|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
5155729|NCT03018613|Fecal Microbiota Transplantation|fecal microbiota transplantation
5155730|NCT03018600|prednisone, autoimmune disease|prednisone, autoimmune disease
5155731|NCT03018509|JTE-451|jte-451
5155732|NCT03018509|psoriasis|psoriasis
5155733|NCT03018470|COPD|copd
5155734|NCT03018470|Non invasive ventilation|non invasive ventilation
5155735|NCT03018470|NIV|niv
5155736|NCT03018470|Acute exacerbation COPD|acute exacerbation copd
5155737|NCT03018470|AECOPD|aecopd
5155738|NCT03018470|Telemonitoring|telemonitoring
5155739|NCT03018457|Trabecular microarchitecture|trabecular microarchitecture
5155740|NCT03018457|alveolar bone|alveolar bone
5155741|NCT03018457|osseointegration|osseointegration
5155742|NCT03018457|dental implant|dental implant
5155743|NCT03018431|Lung ultrasonography|lung ultrasonography
5155744|NCT03018431|Chest CT scan|chest ct scan
5155745|NCT03018431|ventilator-associated pneumonia|ventilator-associated pneumonia
5155746|NCT03018431|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
5155747|NCT03018431|antibiotic stewardship|antibiotic stewardship
5155748|NCT03018418|Anal Cancer|anal cancer
5155749|NCT03018379|Obesity|obesity
5155750|NCT03018379|Body composition|body composition
5155751|NCT03018379|energy expenditure|energy expenditure
5155752|NCT03018379|sedentarity|sedentarity
5155753|NCT03018379|dietary behaviors|dietary behaviors
5155754|NCT03018366|estrogen|estrogen
5155755|NCT03018366|premenopause|premenopause
5155756|NCT03018366|menopause|menopause
5155757|NCT03018366|amenorrhea|amenorrhea
5155758|NCT03018353|Hepatitis C, Chronic|hepatitis c, chronic
5155759|NCT03018353|Jail|jail
5155760|NCT03018353|Patient Navigation|patient navigation
5155761|NCT03018353|Incarcerated Population|incarcerated population
5155762|NCT03018353|HCV|hcv
5155763|NCT03018353|Sofosbuvir/Velpatasvir|sofosbuvir/velpatasvir
5155764|NCT03018353|Hepatitis C|hepatitis c
5155765|NCT03018288|Malignant Gliomas|malignant gliomas
5155766|NCT03018288|Immunotherapy|immunotherapy
5423213|NCT01616667|Recovery of Function/physiology|recovery of function/physiology
5962108|NCT04282980|Gastrointestinal Stromal Tumors,GIST,DCC-2618,Ripretinib|gastrointestinal stromal tumors,gist,dcc-2618,ripretinib
5155778|NCT03018236|substance use disorders|substance use disorders
5155780|NCT03018236|N-acetylcysteine|n-acetylcysteine
5155781|NCT03018236|randomized controlled trial|randomized controlled trial
5155782|NCT03018223|Acute leukemia in CR|acute leukemia in cr
5155783|NCT03018223|Chronic myeloid leukemia|chronic myeloid leukemia
5155784|NCT03018223|Non-Hodgkin lymphoma in high risk|non-hodgkin lymphoma in high risk
5155785|NCT03018223|Graft vs. Host Disease|graft vs. host disease
5155787|NCT03018223|Hematopoietic cell transplant (HCT)|hematopoietic cell transplant (hct)
5155788|NCT03018197|Personal Health Record|personal health record
5155789|NCT03018197|Medication Knowledge|medication knowledge
5155790|NCT03018197|Anticoagulants|anticoagulants
5155791|NCT03018197|Patient Engagement|patient engagement
5155793|NCT03018184|CCSA|ccsa
5155794|NCT03018184|Contractile Cross Sectional Area|contractile cross sectional area
5155795|NCT03018184|Strength|strength
5155796|NCT03018171|clonidine, spinal injections|clonidine, spinal injections
5155797|NCT03018132|perinatal mental health|perinatal mental health
5155798|NCT03018106|Female sexual disorder|female sexual disorder
5155799|NCT03018106|Aging|aging
5155800|NCT03018106|Menopause|menopause
5155801|NCT03018106|Obstetrics/Gynecology|obstetrics/gynecology
5155802|NCT03018106|Female urogenital disorder|female urogenital disorder
5673417|NCT00608322|Severe sepsis|severe sepsis
5155803|NCT03018093|Relapsed or refractory acute lymphoblastic leukemia|relapsed or refractory acute lymphoblastic leukemia
5155804|NCT03018093|Anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
5155805|NCT03018054|moderate active ulcerative colitis|moderate active ulcerative colitis
5155806|NCT03018054|Japanese|japanese
5155807|NCT03018041|Kidney transplantation|kidney transplantation
5155808|NCT03018041|Renal transplantation|renal transplantation
5155809|NCT03018041|Omega-3 fatty acids|omega-3 fatty acids
5155810|NCT03018041|Marine n-3 fatty acids|marine n-3 fatty acids
5155811|NCT03018041|Fatty acids|fatty acids
5155812|NCT03018041|Inflammation|inflammation
5155813|NCT03018041|Interstitial fibrosis|interstitial fibrosis
5155814|NCT03018041|Glomerular filtration rate|glomerular filtration rate
5155815|NCT03018041|Renal function|renal function
5155816|NCT03018041|Allograft function|allograft function
5155817|NCT03018041|Proteinuria|proteinuria
5155818|NCT03018041|Blood pressure|blood pressure
5155819|NCT03018041|Heart rate variability|heart rate variability
5155820|NCT03018041|Lipids|lipids
5155821|NCT03018041|Blood glucose|blood glucose
5155822|NCT03018041|Body mass index|body mass index
5155823|NCT03018041|Fatty acid composition|fatty acid composition
5155824|NCT03018041|Gas chromatography|gas chromatography
5155825|NCT03018041|Interventional study|interventional study
5155826|NCT03018041|Allograft biopsy|allograft biopsy
5155840|NCT03017911|Complications|complications
5155842|NCT03017911|Infection|infection
5155843|NCT03017898|FiLaC|filac
5155844|NCT03017898|Fistula Laser Closure|fistula laser closure
5155845|NCT03017898|Laser Coagulation|laser coagulation
5155846|NCT03017872|HIV, second-line|hiv, second-line
5155847|NCT03017794|Radiotherapy|radiotherapy
5155848|NCT03017794|Chromogranin A|chromogranin a
5155849|NCT03017794|Neuroendocrine differentiation|neuroendocrine differentiation
5155850|NCT03017781|Bipolar|bipolar
5155851|NCT03017781|High-Risk Off-Spring|high-risk off-spring
5155852|NCT03017781|Psychosocial Functioning|psychosocial functioning
5155853|NCT03017768|Acute tryptophan depletion, esophageal sensitivity,|acute tryptophan depletion, esophageal sensitivity,
5155854|NCT03017716|Inflammatory back pain|inflammatory back pain
5155855|NCT03017716|gluten-free diet|gluten-free diet
5155856|NCT03017716|celiac disease|celiac disease
5155857|NCT03017716|non-celiac wheat sensitivity|non-celiac wheat sensitivity
5155858|NCT03017703|Endothelial dysfunction|endothelial dysfunction
5155859|NCT03017703|Insulin resistance|insulin resistance
5155860|NCT03017703|Type 2 diabetes|type 2 diabetes
5155861|NCT03017703|Mineralocorticoid blocker|mineralocorticoid blocker
5155862|NCT03017625|COPD|copd
5155863|NCT03017625|Cardiovascular Disease|cardiovascular disease
5155864|NCT03017625|Platelets|platelets
5155865|NCT03017625|Inflammation|inflammation
5155866|NCT03017612|Presbyopia|presbyopia
5042492|NCT03733379|Probiotic|probiotic
5155867|NCT03017573|Immunological biomarkers|immunological biomarkers
5155868|NCT03017573|molecular profil|molecular profil
5155869|NCT03017573|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
5155870|NCT03017560|Breast Cancer|breast cancer
5155871|NCT03017560|Chemotherapy|chemotherapy
5155872|NCT03017560|Verbal Memory|verbal memory
5155873|NCT03017560|Processing Speed|processing speed
5155874|NCT03017534|Patient-Therapist Interaction|patient-therapist interaction
5155875|NCT03017534|Non-Specific Effects|non-specific effects
5155876|NCT03017534|Manual Therapy|manual therapy
5155879|NCT03017521|Refractory solid tumors|refractory solid tumors
5155881|NCT03017508|Cross-over study|cross-over study
5155882|NCT03017508|Riluzole|riluzole
5155883|NCT03017508|Double-blind study|double-blind study
5155884|NCT03017508|Speech task|speech task
5155885|NCT03017508|Social Anxiety Disorder|social anxiety disorder
5155886|NCT03017495|food-drug interaction|food-drug interaction
5155887|NCT03017495|drug-drug interaction|drug-drug interaction
5155888|NCT03017495|pharmacokinetics|pharmacokinetics
5155889|NCT03017469|Resilience|resilience
5155890|NCT03017469|Workplace Stress|workplace stress
5155891|NCT03017469|Occupational Fatigue|occupational fatigue
5155892|NCT03017469|Compassion Fatigue|compassion fatigue
5155893|NCT03017469|Peer Support|peer support
5155894|NCT03017469|Self-Care|self-care
5155895|NCT03017469|Employee Assistance|employee assistance
5155896|NCT03017456|Survivorship|survivorship
5155897|NCT03017456|Prostate Cancer|prostate cancer
5155898|NCT03017456|Survivorship Care Plan|survivorship care plan
5155899|NCT03017443|Weight Loss|weight loss
5155901|NCT03017443|Overweight|overweight
5155902|NCT03017391|palliative care|palliative care
5155903|NCT03017391|palliative medicine|palliative medicine
5155904|NCT03017391|palliative|palliative
5155905|NCT03017378|influenza vector|influenza vector
5155906|NCT03017378|tuberculosis|tuberculosis
5155907|NCT03017378|vaccine|vaccine
5155908|NCT03017365|Motor Control|motor control
5155909|NCT03017365|Balance|balance
5155910|NCT03017352|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5155911|NCT03017352|Exenatide|exenatide
5155912|NCT03017352|Incretins|incretins
5155913|NCT03017352|GLP-1|glp-1
5155914|NCT03017352|Insulin|insulin
5155915|NCT03017339|Low Lever Laser Therapy|low lever laser therapy
5155916|NCT03017339|Exercise Therapy|exercise therapy
5155917|NCT03017339|Chronic Pain|chronic pain
5155918|NCT03017287|Glucose blood measurements, glucometer, BGM, Diabetes App|glucose blood measurements, glucometer, bgm, diabetes app
5155919|NCT03017274|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
5155920|NCT03017274|celiac disease|celiac disease
5155921|NCT03017274|abdominal ultrasonography;|abdominal ultrasonography;
5155922|NCT03017261|Osteoarthritis|osteoarthritis
5155923|NCT03017261|Arthroplasty|arthroplasty
5155924|NCT03017261|Robotic Surgery|robotic surgery
5155925|NCT03017261|Knee|knee
5155926|NCT03017248|pain|pain
5155927|NCT03017248|ketamine|ketamine
5155928|NCT03017248|morphine|morphine
5155929|NCT03017248|analgesia|analgesia
5155930|NCT03017248|emergency|emergency
5155931|NCT03017144|non-technical skills (NTS)|non-technical skills (nts)
5155932|NCT03017144|human factors|human factors
5155933|NCT03017144|team work|team work
5155934|NCT03017144|Crew Resource Management / Crisis Resource Management (CRM)|crew resource management / crisis resource management (crm)
5155935|NCT03017144|technical skills (TS)|technical skills (ts)
5155936|NCT03017144|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5155937|NCT03017144|Advanced cardiac life support|advanced cardiac life support
5155938|NCT03017079|Semi-solidification|semi-solidification
5155939|NCT03017079|caloric debt|caloric debt
5155940|NCT03017079|enteral nutrition|enteral nutrition
5155941|NCT03017079|critical illness|critical illness
5155942|NCT03017066|Ultrasonography|ultrasonography
5155943|NCT03017066|Child|child
5155944|NCT03017066|Preoperative period|preoperative period
5155945|NCT03017053|Neck dissection|neck dissection
5155946|NCT03017053|Survival|survival
5155947|NCT03017053|Early oral cancer|early oral cancer
5155948|NCT03017053|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
5155949|NCT03017027|human-animal interaction|human-animal interaction
5155950|NCT03017014|Crohn's Disease|crohn's disease
5155951|NCT03017014|Adalimumab|adalimumab
5155952|NCT03017014|Humira®|humira®
5155953|NCT03016988|Mantle cell lymphoma|mantle cell lymphoma
5155954|NCT03016988|Bortezomib|bortezomib
5155955|NCT03016988|Fludarabine|fludarabine
5155956|NCT03016988|Cytarabine|cytarabine
5155957|NCT03016975|Edwards Cardioband|edwards cardioband
5155958|NCT03016975|Mitral Valve|mitral valve
5155959|NCT03016975|Transcatheter|transcatheter
5155960|NCT03016975|Mitral repair|mitral repair
5155961|NCT03016975|Functional mitral regurgitation|functional mitral regurgitation
5155962|NCT03016975|Secondary mitral regurgitation|secondary mitral regurgitation
5155963|NCT03016975|Annuloplasty|annuloplasty
5155964|NCT03016936|Metabolic equivalents (METs)|metabolic equivalents (mets)
5155965|NCT03016936|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
5155966|NCT03016936|Noncardiac surgery|noncardiac surgery
5155967|NCT03016936|Cardiovascular Mortality|cardiovascular mortality
5155968|NCT03016923|cerebral palsy|cerebral palsy
5155969|NCT03016923|hemiplegia|hemiplegia
5155971|NCT03016923|grasping|grasping
5155972|NCT03016897|ALS|als
5155973|NCT03016897|neurodegenerative|neurodegenerative
5156582|NCT03013504|phase III|phase iii
5155997|NCT03016741|cognitive function|cognitive function
5155998|NCT03016741|hormonal therapy|hormonal therapy
5155999|NCT03016741|cancer survivorship|cancer survivorship
5156000|NCT03016741|dementia|dementia
5156001|NCT03016741|cognitive dysfunction|cognitive dysfunction
5156002|NCT03016741|mild cognitive impairment|mild cognitive impairment
5156003|NCT03016728|exercise|exercise
5156004|NCT03016728|physical activity|physical activity
5156005|NCT03016728|pilot study|pilot study
5156006|NCT03016728|randomized controlled trial|randomized controlled trial
5156007|NCT03016728|cancer|cancer
5156008|NCT03016728|adolescent and young adult|adolescent and young adult
5156009|NCT03016728|AYA|aya
5156010|NCT03016715|Epidermolysis bullosa simplex|epidermolysis bullosa simplex
5156011|NCT03016676|Spinal Manipulation|spinal manipulation
5156012|NCT03016676|Postural Instability|postural instability
5156013|NCT03016676|Quality of Life|quality of life
5156014|NCT03016650|Acetaminophen|acetaminophen
5156015|NCT03016650|Ibuprofen|ibuprofen
5156016|NCT03016637|endoscopic ultrasonography|endoscopic ultrasonography
5156017|NCT03016637|EUS-FNA|eus-fna
5156023|NCT03016572|Suicide|suicide
5156024|NCT03016572|Adolescent|adolescent
5156025|NCT03016572|Intervention|intervention
5156026|NCT03016572|Crisis|crisis
5156027|NCT03016572|Follow-Up|follow-up
5156028|NCT03016559|releasing muscle|releasing muscle
5156029|NCT03016559|quadratus lumborum|quadratus lumborum
5156030|NCT03016559|hip angle|hip angle
5156031|NCT03016546|Pregnancy|pregnancy
5156032|NCT03016533|Dolutegravir|dolutegravir
5156033|NCT03016533|Continued access study|continued access study
5156034|NCT03016533|HIV-1|hiv-1
5156035|NCT03016533|ABC/DTG/3TC|abc/dtg/3tc
5156036|NCT03016533|Pediatric|pediatric
5156037|NCT03016507|intraocular pressure|intraocular pressure
5156038|NCT03016507|phacoemulsification|phacoemulsification
5156039|NCT03016507|cataract|cataract
5156040|NCT03016468|Oral Treprostinil|oral treprostinil
5156041|NCT03016468|Remodulin|remodulin
5156042|NCT03016468|Selexipag|selexipag
5156053|NCT03016390|Cardiac Implantable Electronic Device|cardiac implantable electronic device
5156054|NCT03016390|Pacemaker|pacemaker
5156055|NCT03016390|Automatic Implantable Cardioverter-Defibrillator (AICD)|automatic implantable cardioverter-defibrillator (aicd)
5156056|NCT03016390|Electromagnetic interference (EMI)|electromagnetic interference (emi)
5156057|NCT03016390|Keyless access system|keyless access system
5156058|NCT03016390|Keyless entry system|keyless entry system
5156068|NCT03016351|Hypertension|hypertension
5156069|NCT03016351|Exercise|exercise
5156070|NCT03016351|African Americans|african americans
5156071|NCT03016351|Arterial Function|arterial function
5156072|NCT03016351|Arterial Stiffness|arterial stiffness
5156073|NCT03016286|Whole body vibration|whole body vibration
5156074|NCT03016286|Bone myoregulation reflex|bone myoregulation reflex
5156075|NCT03016286|H-reflex|h-reflex
5156077|NCT03016260|Anti TNF|anti tnf
5156078|NCT03016260|Infliximab|infliximab
5156079|NCT03016260|Adalimumab|adalimumab
5156080|NCT03016260|Etanercept|etanercept
5156081|NCT03016260|Golimumab|golimumab
5156082|NCT03016260|Certolizumab Pegol|certolizumab pegol
5156083|NCT03016260|Infliximab biosimilar|infliximab biosimilar
5156084|NCT03016260|Etanercept biosimilar|etanercept biosimilar
5156085|NCT03016260|Methotrexate|methotrexate
5156086|NCT03016247|magnetic resonance imaging, trust, reward|magnetic resonance imaging, trust, reward
5156087|NCT03016234|intraocular pressure|intraocular pressure
5156088|NCT03016234|trendelenburg position|trendelenburg position
5156089|NCT03016234|pneumoperitoneum|pneumoperitoneum
5156090|NCT03016221|local skin responses|local skin responses
5156091|NCT03016221|hyperemia|hyperemia
5156092|NCT03016221|thermal sensation|thermal sensation
5156093|NCT03016221|topical warming ointments|topical warming ointments
5156094|NCT03016221|topical cooling ointments|topical cooling ointments
5156095|NCT03016221|skin perfusion|skin perfusion
5156096|NCT03016221|subjective thermal sensation|subjective thermal sensation
5156097|NCT03016221|muscle tissue oxygenation|muscle tissue oxygenation
5156098|NCT03016221|skin temperature|skin temperature
5156099|NCT03016221|skin redness|skin redness
5156100|NCT03016221|erythema|erythema
5156101|NCT03016143|phase II|phase ii
5156102|NCT03016143|split|split
5156103|NCT03016143|vaccine|vaccine
5156104|NCT03016130|leukemia|leukemia
5156105|NCT03016130|myelodysplastic|myelodysplastic
5156106|NCT03016130|myeloid|myeloid
5156107|NCT03016130|lymphoblastic|lymphoblastic
5156108|NCT03016130|diet|diet
5156109|NCT03016130|infection|infection
5156110|NCT03016130|hematopoietic|hematopoietic
5156111|NCT03016130|stem cell|stem cell
5156112|NCT03016130|transplant|transplant
5156113|NCT03016104|magnetic seizure therapy|magnetic seizure therapy
5156114|NCT03016104|electroconvulsive therapy|electroconvulsive therapy
5156115|NCT03016104|bipolar mania|bipolar mania
5156116|NCT03016104|cognition|cognition
5156117|NCT03016104|controlled trial|controlled trial
5156118|NCT03016052|ABMT|abmt
5156119|NCT03016052|social anxiety|social anxiety
5156120|NCT03016052|generalized anxiety|generalized anxiety
5356859|NCT01917708|blood and marrow transplant|blood and marrow transplant
5156121|NCT03016026|ERAS,Laparoscopy,Distal Gastrectomy,Safety,Effectiveness|eras,laparoscopy,distal gastrectomy,safety,effectiveness
5156122|NCT03016000|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5156123|NCT03016000|Thalidomide|thalidomide
5156124|NCT03016000|Maintenance|maintenance
5156125|NCT03015987|Diode laser|diode laser
5156126|NCT03015987|asymptomatic pulp|asymptomatic pulp
5156127|NCT03015987|Laser activated irrigation|laser activated irrigation
5156128|NCT03015987|continuous ultrasonic activation|continuous ultrasonic activation
5156129|NCT03015987|post obturation pain|post obturation pain
5156130|NCT03015935|Obesity, Morbid|obesity, morbid
5156131|NCT03015883|Squamous Cell Carcinoma|squamous cell carcinoma
5028483|NCT03821441|IPV|ipv
5156132|NCT03015883|Alpha emitting radiation|alpha emitting radiation
5156133|NCT03015883|Skin Cancer|skin cancer
5156134|NCT03015883|Carcinoma, Squamous|carcinoma, squamous
5156135|NCT03015883|HNSCC|hnscc
5156136|NCT03015870|vocal dysfunction|vocal dysfunction
5156137|NCT03015870|voice|voice
5156138|NCT03015870|vocal folds|vocal folds
5228366|NCT02573831|labor|labor
5156139|NCT03015870|vocal aging|vocal aging
5156140|NCT03015844|MIBG|mibg
5156141|NCT03015844|131I-MIBG|131i-mibg
5156142|NCT03015844|relapsed|relapsed
5156143|NCT03015844|neuroblastoma|neuroblastoma
5156144|NCT03015844|pheochromocytoma|pheochromocytoma
5156145|NCT03015831|Atrial fibrillation|atrial fibrillation
5156146|NCT03015831|Cardiac surgery|cardiac surgery
5156147|NCT03015831|Colchicine|colchicine
5156155|NCT03015753|Randomized controlled trial|randomized controlled trial
5156156|NCT03015727|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5156157|NCT03015727|Induction chemotherapy|induction chemotherapy
5156159|NCT03015727|chemoradiotherapy|chemoradiotherapy
5156160|NCT03015701|Unresectable|unresectable
5156161|NCT03015688|Biomarkers|biomarkers
5156162|NCT03015662|Quality of Life|quality of life
5156163|NCT03015662|Fatigue|fatigue
5156164|NCT03015662|Anxiety|anxiety
5156165|NCT03015662|Physical Therapy Modalities|physical therapy modalities
5156166|NCT03015662|Pain|pain
5156167|NCT03015649|breast cancer|breast cancer
5156168|NCT03015649|neoadjuvant treatment|neoadjuvant treatment
5156169|NCT03015649|surgical guidance system|surgical guidance system
5156170|NCT03015636|Cognitive Behaviour Therapy|cognitive behaviour therapy
5156171|NCT03015636|Psychological Intervention|psychological intervention
5156172|NCT03015623|Mesenchymal stromal cells|mesenchymal stromal cells
5156173|NCT03015623|MSC|msc
5156174|NCT03015623|Stem cells|stem cells
5156175|NCT03015623|Mesenchymal stem cells|mesenchymal stem cells
5156182|NCT03015597|Smoking, Tobacco|smoking, tobacco
5156183|NCT03015597|Smoking Cessation|smoking cessation
5156184|NCT03015597|Opiate Addiction|opiate addiction
5156185|NCT03015597|Opiate Dependence|opiate dependence
5156186|NCT03015597|Contingency Management|contingency management
5156187|NCT03015571|heterotopic gastric mucosa|heterotopic gastric mucosa
5156188|NCT03015571|cervical inlet patch|cervical inlet patch
5156189|NCT03015571|narrow band imaging|narrow band imaging
5156190|NCT03015571|endoscopy|endoscopy
5156191|NCT03015558|Drug Resistance|drug resistance
5156192|NCT03015558|Neuropathic Pain|neuropathic pain
5156193|NCT03015558|opercular-insular cortex|opercular-insular cortex
5156194|NCT03015558|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5156195|NCT03015545|Muscle Stiffness|muscle stiffness
5156196|NCT03015545|Ultrasound elastography|ultrasound elastography
5156197|NCT03015545|H-reflex|h-reflex
5156198|NCT03015545|Whole body vibration|whole body vibration
5156199|NCT03015545|blood perfusion|blood perfusion
5156200|NCT03015532|knee|knee
5156201|NCT03015532|knee replacement|knee replacement
5156202|NCT03015532|arthroplasty|arthroplasty
5156203|NCT03015532|joint replacement|joint replacement
5156204|NCT03015532|knee pain|knee pain
5156207|NCT03015519|albiglutide|albiglutide
5156208|NCT03015519|safety|safety
5156209|NCT03015519|pediatric|pediatric
5156210|NCT03015519|efficacy|efficacy
5156211|NCT03015493|Neck pain|neck pain
5156212|NCT03015493|Neurodynamics|neurodynamics
5156213|NCT03015493|Spinal manipulative therapy|spinal manipulative therapy
5156214|NCT03015480|Mobile Application|mobile application
5156215|NCT03015480|Chronic Kidney Disease|chronic kidney disease
5156216|NCT03015480|Diabetes Mellitus|diabetes mellitus
5156217|NCT03015480|Albuminuria|albuminuria
5156218|NCT03015480|Diet|diet
5156219|NCT03015467|acute pancreatitis|acute pancreatitis
5156220|NCT03015467|intestinal mucosal barrier|intestinal mucosal barrier
5156221|NCT03015467|Fecal Microbiota Transplantation|fecal microbiota transplantation
5156222|NCT03015454|InSight|insight
5156223|NCT03015454|Dascena|dascena
5156224|NCT03015441|Healthy subjects|healthy subjects
5156225|NCT03015441|Probiotics|probiotics
5156226|NCT03015441|Breath test|breath test
5156227|NCT03015441|Dihydrogen|dihydrogen
5156228|NCT03015441|Methane|methane
5156229|NCT03015441|Intestinal gas production|intestinal gas production
5156230|NCT03015441|Gut microbiota|gut microbiota
5156231|NCT03015428|Family caregivers|family caregivers
5156232|NCT03015428|training programme|training programme
5156233|NCT03015428|dementia|dementia
5156234|NCT03015415|elbow|elbow
5156235|NCT03015415|posttraumatic stiffness|posttraumatic stiffness
5156236|NCT03015415|elbow contractures|elbow contractures
5156237|NCT03015415|stiff elbow|stiff elbow
5156238|NCT03015415|dynamic orthoses|dynamic orthoses
5156239|NCT03015415|Dynamic splint|dynamic splint
5156240|NCT03015415|Rehabilitation|rehabilitation
5156241|NCT03015415|Splint|splint
5156242|NCT03015415|Effectiveness of bracing|effectiveness of bracing
5962109|NCT04282967|Exercise|exercise
5156243|NCT03015376|epithelial ovarian cancer|epithelial ovarian cancer
5156244|NCT03015376|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
5962110|NCT04282967|Breast Cancer Survivor|breast cancer survivor
5156245|NCT03015376|next-generation sequencing|next-generation sequencing
5156246|NCT03015376|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5156247|NCT03015363|Hypertension|hypertension
5156249|NCT03015363|Vital signs|vital signs
5156250|NCT03015350|blood sevoflurane concentration|blood sevoflurane concentration
5156251|NCT03015350|blood desflurane concentration|blood desflurane concentration
5156252|NCT03015350|one lung ventilation|one lung ventilation
5156253|NCT03015311|Blood pressure control|blood pressure control
5156254|NCT03015298|gastric cancer|gastric cancer
5156255|NCT03015298|Simultaneous PET/MRI|simultaneous pet/mri
5156256|NCT03015298|PET/CT|pet/ct
5156257|NCT03015272|minimally-verbal|minimally-verbal
5156258|NCT03015272|children|children
5156259|NCT03015272|intervention|intervention
5156260|NCT03015272|singing|singing
5156261|NCT03015272|music|music
5156262|NCT03015259|bioequivalence|bioequivalence
5156263|NCT03015233|Lactate|lactate
5156264|NCT03015233|Acute Abdominal Pain|acute abdominal pain
5156265|NCT03015233|Acute Abdomen|acute abdomen
5156266|NCT03015233|Strong Ion Gap|strong ion gap
5156267|NCT03015233|Renal Colic|renal colic
5156268|NCT03015233|Emergency Department|emergency department
5156269|NCT03015233|Emergency|emergency
5156270|NCT03015233|Surgery|surgery
5156271|NCT03015233|Stewart|stewart
5156272|NCT03015194|LVOT (left ventricular outflow tract, obstruction)|lvot (left ventricular outflow tract, obstruction)
5156273|NCT03015194|Transcatheter Mitral Valve Implantation|transcatheter mitral valve implantation
5156274|NCT03015194|Transcatheter Heart Valve|transcatheter heart valve
5156275|NCT03015194|Mitral Valve Regurgitation|mitral valve regurgitation
5156276|NCT03015194|Mitral Valve Stenosis|mitral valve stenosis
5156287|NCT03015129|16-1491|16-1491
5156288|NCT03015116|photobiomodulation|photobiomodulation
5156289|NCT03015116|plantar fasciitis|plantar fasciitis
5156290|NCT03015090|COPD|copd
5156291|NCT03015090|CYP1A2|cyp1a2
5156292|NCT03015090|Theophylline|theophylline
5156293|NCT03015077|Glutamine|glutamine
5156294|NCT03015051|Bronchiolitis|bronchiolitis
5156295|NCT03015051|High flow nasal cannula|high flow nasal cannula
5156296|NCT03015051|Oxygen therapy|oxygen therapy
5156297|NCT03015025|Acenocoumarol|acenocoumarol
5042832|NCT03731455|Electrode|electrode
5156298|NCT03015025|Cytochrome P450|cytochrome p450
5156299|NCT03015025|Pharmacogenetics|pharmacogenetics
5156300|NCT03015025|Algorithm|algorithm
5156301|NCT03015025|CYP2C9|cyp2c9
5156302|NCT03015025|VKORC1|vkorc1
5156303|NCT03015025|CYP4F2|cyp4f2
5156304|NCT03015025|P450 oxidoreductase (POR)|p450 oxidoreductase (por)
5156305|NCT03015012|Nutrigenomics|nutrigenomics
5156306|NCT03015012|Genetics|genetics
5156307|NCT03015012|Overweight|overweight
5156308|NCT03015012|Obesity|obesity
5156309|NCT03015012|Transplantation|transplantation
5156310|NCT03015012|Nutrition|nutrition
5156311|NCT03015012|Dietetics|dietetics
5156312|NCT03015012|BMI|bmi
5156313|NCT03015012|Body Composition|body composition
5156314|NCT03014999|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5156319|NCT03014947|Humira®|humira®
5156320|NCT03014934|Aspergillosis|aspergillosis
5156321|NCT03014934|IA|ia
5156322|NCT03014908|Type 1 diabetes|type 1 diabetes
5156323|NCT03014908|1H-NMR spectroscopy|1h-nmr spectroscopy
5156324|NCT03014908|Metabolomics|metabolomics
5156325|NCT03014908|Pediatrics|pediatrics
5156326|NCT03014895|E3112|e3112
5156327|NCT03014895|Pharmacokinetics|pharmacokinetics
5156328|NCT03014895|Japanese|japanese
5156329|NCT03014869|COPD Exacerbation|copd exacerbation
5156330|NCT03014869|High Flow Oxygen|high flow oxygen
5156331|NCT03014869|Noninvasive Positive Ventilation|noninvasive positive ventilation
5156332|NCT03014869|moderate|moderate
5156333|NCT03014856|Metabolic syndrome|metabolic syndrome
5156334|NCT03014856|Metabolomics|metabolomics
5156335|NCT03014856|NMR spectroscopy|nmr spectroscopy
5156336|NCT03014843|Esophagal sensitivity, GERD, endogenous opiods|esophagal sensitivity, gerd, endogenous opiods
5156337|NCT03014791|Epidemiology|epidemiology
5156338|NCT03014791|Ethnicity|ethnicity
5156339|NCT03014791|Age|age
5156340|NCT03014791|Weight|weight
5156341|NCT03014791|Hypertensive|hypertensive
5156342|NCT03014791|Cardiac Output|cardiac output
5156343|NCT03014791|Peripheral Vascular Resistance|peripheral vascular resistance
5156344|NCT03014791|Arterial Stiffness|arterial stiffness
5156345|NCT03014791|Healthy Volunteers|healthy volunteers
5156346|NCT03014791|Endothelial function|endothelial function
5156347|NCT03014791|Arterial Structure|arterial structure
5156348|NCT03014791|Left ventricular mass/function|left ventricular mass/function
5156349|NCT03014765|endothelial dysfunction|endothelial dysfunction
5156350|NCT03014765|perioperative stress|perioperative stress
5156351|NCT03014765|cardiovascular complications|cardiovascular complications
5156352|NCT03014765|inflammatory markers|inflammatory markers
5156353|NCT03014739|Elastography|elastography
5156354|NCT03014739|Musculoskeletal System|musculoskeletal system
5156355|NCT03014726|reduced urine flow rate|reduced urine flow rate
5156356|NCT03014726|low peak flow rate|low peak flow rate
5156357|NCT03014726|urinary tract infections|urinary tract infections
5156358|NCT03014713|Dexmedetomidine|dexmedetomidine
5156359|NCT03014713|Dezocine|dezocine
5156360|NCT03014713|Flubiprofen|flubiprofen
5156361|NCT03014713|Analgesia|analgesia
5156362|NCT03014713|Colorectal Surgery|colorectal surgery
5156371|NCT03014661|pollinosis, quality of life, specific immunotherapy|pollinosis, quality of life, specific immunotherapy
5156372|NCT03014635|glabellar lines, frown lines|glabellar lines, frown lines
5156373|NCT03014622|glabellar lines, frown lines|glabellar lines, frown lines
5156374|NCT03014609|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5156375|NCT03014609|cardiovascular risk|cardiovascular risk
5156376|NCT03014609|inflammation|inflammation
5156377|NCT03014609|oxidative stress|oxidative stress
5156583|NCT03013504|efficacy|efficacy
5156378|NCT03014609|peripheral muscle function|peripheral muscle function
5156379|NCT03014570|behavior,|behavior,
5156380|NCT03014570|apathy|apathy
5156381|NCT03014570|mood|mood
5156382|NCT03014570|function|function
5156383|NCT03014570|cognition|cognition
5156384|NCT03014557|atrial fibrillation|atrial fibrillation
5156385|NCT03014557|left atrial appendage closure|left atrial appendage closure
5156386|NCT03014557|WATCHMAN|watchman
5156387|NCT03014518|Adolescent|adolescent
5156388|NCT03014518|Biological Markers|biological markers
5156389|NCT03014518|Biomarkers|biomarkers
5156390|NCT03014518|Biomarkers for suicidality|biomarkers for suicidality
5156391|NCT03014518|Blood brain barrier|blood brain barrier
5156392|NCT03014518|Clinical predictors|clinical predictors
5156393|NCT03014518|Cytokine|cytokine
5156394|NCT03014518|Feeling suicidal|feeling suicidal
5156395|NCT03014518|Inflammation|inflammation
5156396|NCT03014518|Inflammatory marker|inflammatory marker
5156397|NCT03014518|Inpatient discharge|inpatient discharge
5156398|NCT03014518|Interleukin-1 beta|interleukin-1 beta
5156399|NCT03014518|IL-1ß|il-1ß
5156400|NCT03014518|Interleukin-6|interleukin-6
5156401|NCT03014518|IL-6|il-6
5156402|NCT03014518|Kynurenic acid|kynurenic acid
5156403|NCT03014518|Kynurenine pathway|kynurenine pathway
5156404|NCT03014518|Neuroinflammation|neuroinflammation
5156405|NCT03014518|Novel marker|novel marker
5156406|NCT03014518|Peripheral blood biomarkers|peripheral blood biomarkers
5156407|NCT03014518|Picolinic acid|picolinic acid
5156408|NCT03014518|Plasma biomarker|plasma biomarker
5156409|NCT03014518|Psychiatric inpatient|psychiatric inpatient
5156410|NCT03014518|S100B|s100b
5156411|NCT03014518|Serum biomarker|serum biomarker
5156412|NCT03014518|Stress|stress
5156413|NCT03014518|Suicide|suicide
5156414|NCT03014518|Suicidal behavior|suicidal behavior
5156415|NCT03014518|Suicidal risk|suicidal risk
5156416|NCT03014518|Tumor necrosis factor alpha|tumor necrosis factor alpha
5156417|NCT03014518|TNF-α|tnf-α
5156418|NCT03014505|Cirrhosis|cirrhosis
5156419|NCT03014505|Fecal Microbiota Transplantation|fecal microbiota transplantation
5156420|NCT03014505|Intestinal flora|intestinal flora
5156421|NCT03014505|Intestinal mucosal barrier|intestinal mucosal barrier
5156422|NCT03014505|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
5156423|NCT03014401|stem cell|stem cell
5156424|NCT03014401|knee pain|knee pain
5156425|NCT03014401|osteoarthritis|osteoarthritis
5156426|NCT03014401|arthritis|arthritis
5156427|NCT03014401|ADSC|adsc
5156428|NCT03014401|fat stem cell|fat stem cell
5156429|NCT03014349|Glaucoma|glaucoma
5156430|NCT03014349|Ocular hypertension|ocular hypertension
5156431|NCT03014336|co2 removal, anesthesia|co2 removal, anesthesia
5156432|NCT03014323|insulin sensitivity|insulin sensitivity
5156433|NCT03014323|African American|african american
5156434|NCT03014323|obese|obese
5156435|NCT03014310|A/H5N8|a/h5n8
5156436|NCT03014310|Adjuvants|adjuvants
5156438|NCT03014310|Inactivated|inactivated
5156439|NCT03014310|Influenza|influenza
5156440|NCT03014310|MF59|mf59
5156441|NCT03014310|Monovalent|monovalent
5156442|NCT03014284|Tissue collection|tissue collection
5156443|NCT03014284|colonoscopic surgical procedures|colonoscopic surgical procedures
5156444|NCT03014258|Biology|biology
5156445|NCT03014258|falciparum|falciparum
5156446|NCT03014258|Immunity|immunity
5156447|NCT03014258|Infections|infections
5156448|NCT03014258|Malaria|malaria
5156449|NCT03014258|Pf|pf
5156450|NCT03014258|Plasmodium|plasmodium
5156451|NCT03014258|Systems|systems
5156452|NCT03014232|sustained low-efficiency diafiltration (SLED-f)|sustained low-efficiency diafiltration (sled-f)
5156453|NCT03014232|high cut-off dialyzer|high cut-off dialyzer
5156454|NCT03014232|cytokines|cytokines
5156455|NCT03014180|Heart failure, CRT|heart failure, crt
5156456|NCT03014167|transmission interruption|transmission interruption
5156464|NCT03014154|asthma|asthma
5156465|NCT03014154|physical exercise|physical exercise
5156466|NCT03014128|musculoskeletal disorders|musculoskeletal disorders
5156467|NCT03014128|upper extremity|upper extremity
5156468|NCT03014128|work|work
5156469|NCT03014128|surgical instruments|surgical instruments
5156470|NCT03014115|arachidonic|arachidonic
5156471|NCT03014115|docosahexaenoic acid|docosahexaenoic acid
5156472|NCT03014115|infant formula|infant formula
5156473|NCT03014089|mRNA-1325|mrna-1325
5156474|NCT03014089|Zika vaccine|zika vaccine
5156475|NCT03014063|sepsis|sepsis
5156476|NCT03014063|septic shock|septic shock
5156477|NCT03014063|vasopressin|vasopressin
5156479|NCT03014050|physical activity|physical activity
5156480|NCT03014050|fitness|fitness
5156481|NCT03014050|cognition|cognition
5156482|NCT03014050|mood|mood
5156483|NCT03014050|depression|depression
5156484|NCT03014050|anxiety|anxiety
5156485|NCT03014050|sleep quality|sleep quality
5156486|NCT03014050|tremor|tremor
5156487|NCT03014050|gait|gait
5156488|NCT03014037|Orthopedics|orthopedics
5156489|NCT03014024|Distal Radius Fracture|distal radius fracture
5156490|NCT03014024|Low Level Laser Therapy|low level laser therapy
5156491|NCT03013985|Blood glucose|blood glucose
5156492|NCT03013972|ColoRectal Cancer|colorectal cancer
5156493|NCT03013972|Adjuvant Chemotherapy|adjuvant chemotherapy
5156494|NCT03013972|Cancer-related Fatigue|cancer-related fatigue
5156495|NCT03013972|Brief fatigue inventory (BFI)|brief fatigue inventory (bfi)
5156496|NCT03013972|Functional Assessment of Cancer Therapy-General 7 (FACT-G7)|functional assessment of cancer therapy-general 7 (fact-g7)
5156497|NCT03013920|upper urinary tract cancer|upper urinary tract cancer
5156498|NCT03013920|confocal laser endomicroscopy|confocal laser endomicroscopy
5156499|NCT03013920|urothelial carcinoma|urothelial carcinoma
5156500|NCT03013907|Hypertension|hypertension
5156501|NCT03013907|Coping|coping
5156502|NCT03013907|Relaxing|relaxing
5156503|NCT03013894|bladder neoplasm|bladder neoplasm
5156504|NCT03013894|urothelium carcinoma|urothelium carcinoma
5156505|NCT03013894|confocal laser endomicroscopy|confocal laser endomicroscopy
5156506|NCT03013881|UB-921|ub-921
5156507|NCT03013881|anti-HER2 monoclonal antibody|anti-her2 monoclonal antibody
5156508|NCT03013881|breast neoplasm|breast neoplasm
5156509|NCT03013881|breast cancer|breast cancer
5156510|NCT03013881|Herceptin|herceptin
5156511|NCT03013881|Trastuzumab|trastuzumab
5156512|NCT03013881|HER2|her2
5156513|NCT03013855|Digital rectal exam|digital rectal exam
5156514|NCT03013855|Colon cancer screening|colon cancer screening
5156517|NCT03013842|fetal oximetry|fetal oximetry
5156518|NCT03013842|fetal heart rate|fetal heart rate
5156519|NCT03013842|pulse oximetry|pulse oximetry
5156520|NCT03013842|near infrared spectroscopy|near infrared spectroscopy
5156521|NCT03013829|Kidney Paired Donation|kidney paired donation
5156522|NCT03013777|Familial dysautonomia|familial dysautonomia
5156523|NCT03013699|diet|diet
5156524|NCT03013699|nutrition|nutrition
5156525|NCT03013699|survival|survival
5156526|NCT03013699|recurrence|recurrence
5156527|NCT03013699|cruciferous|cruciferous
5156528|NCT03013699|dark leafy greens|dark leafy greens
5156529|NCT03013673|leishmaniasis, visceral, neglected, HIV, co-infection, asymptomatic, Ethiopia|leishmaniasis, visceral, neglected, hiv, co-infection, asymptomatic, ethiopia
5156530|NCT03013647|actinic keratosis|actinic keratosis
5156531|NCT03013647|field cancerization|field cancerization
5156532|NCT03013647|photodynamic therapy|photodynamic therapy
5156533|NCT03013647|daylight photodynamic therapy|daylight photodynamic therapy
5156534|NCT03013634|dexmedetomidine|dexmedetomidine
5156535|NCT03013621|Renal Failure|renal failure
5156536|NCT03013621|Renal Insufficiency|renal insufficiency
5156537|NCT03013621|Acute Renal Failure|acute renal failure
5156538|NCT03013621|Acute Renal Injury|acute renal injury
5156539|NCT03013621|Kidney Failure|kidney failure
5156540|NCT03013621|Kidney Insufficiency|kidney insufficiency
5156541|NCT03013621|Acute Kidney Failure|acute kidney failure
5156542|NCT03013621|Acute Kidney Injury|acute kidney injury
5156543|NCT03013621|Ventricular dysfunction|ventricular dysfunction
5156544|NCT03013621|Venous congestion|venous congestion
5156545|NCT03013621|Renal function|renal function
5156546|NCT03013621|Kidney function|kidney function
5156547|NCT03013621|Venous heart failure|venous heart failure
5156548|NCT03013608|Nail bed injury|nail bed injury
5156549|NCT03013608|Nail bed injuries|nail bed injuries
5156550|NCT03013608|Nail|nail
5156551|NCT03013608|Children|children
5156562|NCT03013543|POMC deficiency obesity|pomc deficiency obesity
5156563|NCT03013543|LepR deficiency obesity|lepr deficiency obesity
5156564|NCT03013543|Bardet-Biedl syndrome|bardet-biedl syndrome
5156565|NCT03013543|Alström Syndrome|alström syndrome
5156566|NCT03013543|Smith-Magenis Syndrome|smith-magenis syndrome
5156567|NCT03013530|Intensive care unit|intensive care unit
5156568|NCT03013530|Triage and Therapy.|triage and therapy.
5156569|NCT03013530|Advance Directives (AD).|advance directives (ad).
5156570|NCT03013530|Simulation model of real situations. (hypothetical scenario)|simulation model of real situations. (hypothetical scenario)
5156571|NCT03013530|Intensivist physician.|intensivist physician.
5156573|NCT03013517|food allergy|food allergy
5156574|NCT03013517|viaskin|viaskin
5156575|NCT03013517|peanut|peanut
5156576|NCT03013517|epicutaneous|epicutaneous
5156577|NCT03013504|randomized|randomized
5156578|NCT03013504|double-blind|double-blind
5156579|NCT03013504|parallel group|parallel group
5156580|NCT03013504|equivalence|equivalence
5156581|NCT03013504|multicentre|multicentre
5156584|NCT03013504|safety|safety
5156585|NCT03013504|pharmacokinetics|pharmacokinetics
5156586|NCT03013504|HD201|hd201
5156587|NCT03013504|docetaxel|docetaxel
5156588|NCT03013504|Herceptin|herceptin
5156589|NCT03013504|HER2 positive|her2 positive
5156590|NCT03013504|breast cancer|breast cancer
5156591|NCT03013504|early breast cancer|early breast cancer
5156592|NCT03013491|cancer|cancer
5156593|NCT03013491|checkpoint inhibitor|checkpoint inhibitor
5156594|NCT03013491|monotherapy|monotherapy
5156595|NCT03013491|combination|combination
5156596|NCT03013491|PD-L1|pd-l1
5156597|NCT03013491|CTLA-4|ctla-4
5156598|NCT03013491|solid tumor|solid tumor
5156599|NCT03013491|lymphoma|lymphoma
5156600|NCT03013491|BRAF|braf
5156601|NCT03013491|PROCLAIM|proclaim
5156602|NCT03013491|CX-072|cx-072
5156603|NCT03013491|PROCLAIM-CX-072|proclaim-cx-072
5156604|NCT03013374|protein accretion|protein accretion
5156605|NCT03013374|body composition|body composition
5156606|NCT03013361|ropivacaine, bupivacaine|ropivacaine, bupivacaine
5156607|NCT03013335|Clear-cell|clear-cell
5156608|NCT03013335|Nivolumab|nivolumab
5156609|NCT03013335|Renal cell carcinoma|renal cell carcinoma
5156610|NCT03013335|Immunotherapy|immunotherapy
5156611|NCT03013309|Hybrid|hybrid
5156612|NCT03013309|Implementation|implementation
5156613|NCT03013309|Effectiveness|effectiveness
5156614|NCT03013309|Parent training|parent training
5156615|NCT03013309|Fidelity|fidelity
5156616|NCT03013309|Cost-Effectiveness|cost-effectiveness
5156617|NCT03013309|Primary Care|primary care
5156619|NCT03013296|GIP receptor antagonist|gip receptor antagonist
5156620|NCT03013270|Rehabilitation|rehabilitation
5156621|NCT03013270|Exercise|exercise
5156622|NCT03013270|Training|training
5156623|NCT03013257|Relapsed Graves' disease|relapsed graves' disease
5156624|NCT03013257|High Intensity Focused Ultrasound|high intensity focused ultrasound
5156625|NCT03013257|RAI|rai
5156626|NCT03013244|prevention|prevention
5156627|NCT03013244|eating disorder|eating disorder
5156628|NCT03013244|men|men
5156629|NCT03013244|intervention|intervention
5156630|NCT03013244|muscle dysmorphia|muscle dysmorphia
5156631|NCT03013244|peer-led|peer-led
5156632|NCT03013231|ACL Reconstruction|acl reconstruction
5156633|NCT03013231|Return to Sport|return to sport
5156634|NCT03013231|Resilience|resilience
5156635|NCT03013218|Neoplasms|neoplasms
5156636|NCT03013218|CD47|cd47
5156637|NCT03013218|SIRPα|sirpα
5156638|NCT03013218|ALX148|alx148
5156639|NCT03013205|adhesive capsulitis|adhesive capsulitis
5156640|NCT03013153|Rectal Cancer|rectal cancer
5156641|NCT03013153|Inferior Mesenteric Artery|inferior mesenteric artery
5156642|NCT03013153|Ligation|ligation
5156643|NCT03013153|Apical Lymph Nodes|apical lymph nodes
5156644|NCT03013153|Laparoscopy|laparoscopy
5156645|NCT03013153|IMA Types|ima types
5156646|NCT03013140|Anesthesia, Obstetric|anesthesia, obstetric
5156647|NCT03013140|fluid therapy|fluid therapy
5156648|NCT03013140|cesarean section|cesarean section
5156649|NCT03013140|spinal anesthesia|spinal anesthesia
5156650|NCT03013127|Osteogenic Sarcoma|osteogenic sarcoma
5156652|NCT03013127|Sarcoma, Osteogenic|sarcoma, osteogenic
5156653|NCT03013127|Pembrolizumab|pembrolizumab
5156654|NCT03013127|Immunotherapy|immunotherapy
5156655|NCT03013114|Bortezomib Immune thrombocytopenia|bortezomib immune thrombocytopenia
5156656|NCT03013101|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5156657|NCT03013101|advanced|advanced
5156658|NCT03013101|metastatic|metastatic
5156659|NCT03013101|melanoma|melanoma
5156660|NCT03013088|Chronic|chronic
5156661|NCT03013088|Occlusion|occlusion
5156662|NCT03013088|CTO|cto
5156663|NCT03013023|Behavioral and Transaction Interventions|behavioral and transaction interventions
5156664|NCT03013023|Parents' Biopsychosocial Well-being|parents' biopsychosocial well-being
5156665|NCT03013023|Preterm Infants|preterm infants
5156666|NCT03013023|Sleep|sleep
5156667|NCT03013023|Salivary cortisol|salivary cortisol
5156668|NCT03013010|Randomized|randomized
5156669|NCT03013010|Open Label|open label
5156670|NCT03013010|Multicenter|multicenter
5156671|NCT03012984|elderly|elderly
5156672|NCT03012984|surgery|surgery
5156673|NCT03012984|analgesia|analgesia
5156674|NCT03012984|dexmedetomidine|dexmedetomidine
5156675|NCT03012984|delirium|delirium
5156676|NCT03012971|Elderly|elderly
5156677|NCT03012971|Surgery|surgery
5156678|NCT03012971|Analgesia|analgesia
5156679|NCT03012971|Dexmedetomidine|dexmedetomidine
5156680|NCT03012971|Long-term outcome|long-term outcome
5156681|NCT03012945|Elderly|elderly
5156682|NCT03012945|Cancer surgery|cancer surgery
5156683|NCT03012945|Epidural anesthesia and analgesia|epidural anesthesia and analgesia
5156684|NCT03012945|Long-term survival|long-term survival
5156685|NCT03012945|Quality of life|quality of life
5156686|NCT03012919|active decision support system|active decision support system
5156687|NCT03012919|goal directed therapy|goal directed therapy
5156688|NCT03012919|Lidco|lidco
5156689|NCT03012919|vascular surgery|vascular surgery
5156690|NCT03012919|hemodynamic optimization|hemodynamic optimization
5156788|NCT03012061|Asthma|asthma
5156691|NCT03012893|ultrasonography to identify C7 spinous process|ultrasonography to identify c7 spinous process
5156692|NCT03012867|criticall illness|criticall illness
5156693|NCT03012867|enteral nutrition|enteral nutrition
5156694|NCT03012854|Esophageal achalasia|esophageal achalasia
5156695|NCT03012854|Peroral endoscopic myotomy|peroral endoscopic myotomy
5156697|NCT03012815|gabapentin|gabapentin
5156698|NCT03012815|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
5156699|NCT03012815|benzodiazepine|benzodiazepine
5156700|NCT03012815|symptom-triggered|symptom-triggered
5156702|NCT03012724|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5156703|NCT03012724|MDD|mdd
5156704|NCT03012724|Major Depressive Disorder|major depressive disorder
5156705|NCT03012659|contraceptive counseling|contraceptive counseling
5156706|NCT03012659|cluster randomized trial|cluster randomized trial
5156707|NCT03012659|provider counseling training|provider counseling training
5156708|NCT03012646|Treprostinil|treprostinil
5156709|NCT03012646|PH|ph
5156710|NCT03012646|COPD|copd
5156711|NCT03012646|6 Minute Walk Test|6 minute walk test
5156712|NCT03012633|hyperfibrinolysis, Lysis Timer|hyperfibrinolysis, lysis timer
5156713|NCT03012607|PrEP|prep
5156714|NCT03012594|Small bowel motility disorder|small bowel motility disorder
5156715|NCT03012594|Slow intestinal motility|slow intestinal motility
5156716|NCT03012594|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
5156717|NCT03012555|Sickle Cell Disease|sickle cell disease
5156718|NCT03012555|Vitamin D|vitamin d
5156720|NCT03012529|Double-blind|double-blind
5156721|NCT03012529|Clinical Trial|clinical trial
5156722|NCT03012529|Veterans|veterans
5156723|NCT03012529|Diabetes|diabetes
5156724|NCT03012516|Physical Therapy Specialty|physical therapy specialty
5156725|NCT03012516|Exercise Test|exercise test
5156726|NCT03012516|Prescriptions|prescriptions
5156727|NCT03012516|Counseling|counseling
5156728|NCT03012516|Primary Health Care|primary health care
5156729|NCT03012516|Exercise|exercise
5156730|NCT03012490|Remote monitoring|remote monitoring
5156731|NCT03012477|Triple-negative metastatic breast cancer|triple-negative metastatic breast cancer
5156732|NCT03012451|Stress|stress
5156733|NCT03012451|Insecurity|insecurity
5156734|NCT03012451|Mental Health|mental health
5156735|NCT03012438|Near infrared fluorescence|near infrared fluorescence
5156736|NCT03012438|ICG|icg
5156737|NCT03012438|Parathyroid gland|parathyroid gland
5156738|NCT03012425|Cognitive Behavioral Therapy|cognitive behavioral therapy
5156739|NCT03012425|Acupuncture|acupuncture
5156740|NCT03012425|17-001|17-001
5156741|NCT03012386|CD36|cd36
5156742|NCT03012386|Endothelial dysfunction|endothelial dysfunction
5156743|NCT03012386|African Americans|african americans
5156744|NCT03012373|methadone|methadone
5156745|NCT03012373|heroin|heroin
5156746|NCT03012373|acupuncture|acupuncture
5156747|NCT03012360|Infectiology|infectiology
5156748|NCT03012360|Biology of infectious agents|biology of infectious agents
5156749|NCT03012360|Hygiene|hygiene
5156751|NCT03012360|Critical Care|critical care
5156752|NCT03012308|Myocardial Dysfunction|myocardial dysfunction
5156753|NCT03012308|left ventricular|left ventricular
5156754|NCT03012308|mitral valve doppler|mitral valve doppler
5156755|NCT03012308|mitral ring doppler|mitral ring doppler
5156756|NCT03012308|ultrasound signs|ultrasound signs
5156757|NCT03012308|lung edema|lung edema
5156758|NCT03012295|Genetic Testing|genetic testing
5156759|NCT03012295|Chinese Population|chinese population
5156760|NCT03012256|Cardio-Respiratory Disease Management|cardio-respiratory disease management
5156761|NCT03012256|Chronic Disease Management|chronic disease management
5156762|NCT03012256|Cluster-randomized Trial|cluster-randomized trial
5156763|NCT03012256|Multi-component Intervention|multi-component intervention
5156764|NCT03012256|DIVERT Scale|divert scale
5156765|NCT03012256|Frail Elderly|frail elderly
5156766|NCT03012256|Interprofessional Care|interprofessional care
5156767|NCT03012256|Pragmatic Trial|pragmatic trial
5156768|NCT03012256|Targeted Intervention|targeted intervention
5156769|NCT03012256|Home Care|home care
5156770|NCT03012204|Cerebrovascular Disease|cerebrovascular disease
5156771|NCT03012204|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5156772|NCT03012178|Mitral Regurgitation|mitral regurgitation
5156773|NCT03012178|Mitral valve Surgery|mitral valve surgery
5156774|NCT03012178|MRI|mri
5156775|NCT03012165|ADX-102|adx-102
5156776|NCT03012165|Allergic Conjunctivitis|allergic conjunctivitis
5156777|NCT03012152|Oncoplastic surgery|oncoplastic surgery
5156778|NCT03012152|Standard conservative surgery|standard conservative surgery
5156779|NCT03012152|Patient satisfaction|patient satisfaction
5156780|NCT03012152|Margin Status|margin status
5156781|NCT03012113|Adipose tissue|adipose tissue
5156782|NCT03012113|Type 2 Diabetes|type 2 diabetes
5156783|NCT03012074|diabetes, mHealth, mobile health technology|diabetes, mhealth, mobile health technology
5156784|NCT03012061|Respiratory|respiratory
5156785|NCT03012061|Efficacy|efficacy
5156786|NCT03012061|Umeclidinium bromide|umeclidinium bromide
5156787|NCT03012061|Parallel|parallel
5156789|NCT03012061|Dry powder inhaler|dry powder inhaler
5156790|NCT03012048|water treatment|water treatment
5156791|NCT03012035|psychotherapy|psychotherapy
5156792|NCT03012035|exposition|exposition
5156793|NCT03012035|spider fear|spider fear
5156794|NCT03012035|expectation|expectation
5156795|NCT03012022|Healthy Volunteers|healthy volunteers
5156796|NCT03012022|Congestive Heart Failure|congestive heart failure
5156797|NCT03012022|Cardiomyopathies|cardiomyopathies
5156798|NCT03012022|Heart Failure|heart failure
5156799|NCT03012022|Risk Factors|risk factors
5156800|NCT03012009|Bowen's Disease|bowen's disease
5156801|NCT03012009|Superficial Basal Cel Carcinoma|superficial basal cel carcinoma
5043370|NCT03728049|Point-of-care test|point-of-care test
5156802|NCT03012009|Non melanoma skin cancer|non melanoma skin cancer
5156803|NCT03012009|Photodynamic therapy|photodynamic therapy
5156804|NCT03012009|PDT|pdt
5156805|NCT03012009|CO2 laser|co2 laser
5156806|NCT03012009|Laser assisted drug delivery|laser assisted drug delivery
5156807|NCT03012009|Carbon dioxide laser|carbon dioxide laser
5156808|NCT03012009|Laser assisted photodynamic therapy|laser assisted photodynamic therapy
5156809|NCT03011983|Magnetoencephalography (MEG)|magnetoencephalography (meg)
5156810|NCT03011983|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5156811|NCT03011892|Atopic dermatitis|atopic dermatitis
5156812|NCT03011892|eczema|eczema
5156813|NCT03011892|pruritus|pruritus
5156814|NCT03011892|Janus kinase (JAK) inhibitors|janus kinase (jak) inhibitors
5156815|NCT03011840|Patient education handout|patient education handout
5156816|NCT03011840|Patient satisfaction|patient satisfaction
5156824|NCT03011684|Fertility Preservation|fertility preservation
5156826|NCT03011671|Malignant Glioma of Brain|malignant glioma of brain
5156827|NCT03011671|Acetazolamide|acetazolamide
5156828|NCT03011671|Temozolomide|temozolomide
5156829|NCT03011619|Depression|depression
5156830|NCT03011619|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5156831|NCT03011606|prostate|prostate
5156832|NCT03011606|ablation|ablation
5156833|NCT03011606|focal|focal
5156834|NCT03011606|cancer|cancer
5156835|NCT03011580|Vitamin D|vitamin d
5156836|NCT03011567|Postpartum|postpartum
5156837|NCT03011541|Stem Cells|stem cells
5156838|NCT03011541|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
5156839|NCT03011541|BMSC|bmsc
5156840|NCT03011541|Mesenchymal Stem Cells|mesenchymal stem cells
5156841|NCT03011541|MSC|msc
5156842|NCT03011541|Eye Disease|eye disease
5156843|NCT03011541|Ophthalmology|ophthalmology
5156844|NCT03011541|Ophthalmic Disease|ophthalmic disease
5156845|NCT03011541|Retina|retina
5156846|NCT03011541|Retinal Disease|retinal disease
5156847|NCT03011541|Macular Degeneration|macular degeneration
5156848|NCT03011541|Age Related Macular Degeneration|age related macular degeneration
5156849|NCT03011541|Myopic Macular Degeneration|myopic macular degeneration
5156850|NCT03011541|Geographic Atrophy|geographic atrophy
5156851|NCT03011541|Dry Macular Degeneration|dry macular degeneration
5156852|NCT03011541|Wet Macular Degeneration|wet macular degeneration
5156853|NCT03011541|Retinal Atrophy|retinal atrophy
5152388|NCT03039686|DMD|dmd
5156861|NCT03011541|Cone-Rod Dystrophy|cone-rod dystrophy
5156862|NCT03011541|Maculopathy|maculopathy
5156863|NCT03011541|Optic Nerve Disease|optic nerve disease
5156864|NCT03011541|Optic Atrophy|optic atrophy
5156865|NCT03011541|Optic Neuropathy|optic neuropathy
5156866|NCT03011541|Ischemic Optic Neuropathy|ischemic optic neuropathy
5156867|NCT03011541|Optic Nerve Damage|optic nerve damage
5156868|NCT03011541|Optic Nerve Compression|optic nerve compression
5156869|NCT03011541|Compressive Optic Neuropathy|compressive optic neuropathy
5156870|NCT03011541|Devics Syndrome|devics syndrome
5156871|NCT03011541|Ushers Syndrome|ushers syndrome
5156872|NCT03011541|Neuromyelitis Optica|neuromyelitis optica
5156873|NCT03011541|Dominant Optic Atrophy|dominant optic atrophy
5156874|NCT03011541|Kjers Optic Atrophy|kjers optic atrophy
5156875|NCT03011541|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5156876|NCT03011541|Blindness|blindness
5156877|NCT03011541|Vision Loss|vision loss
5156878|NCT03011541|Retina Atrophy|retina atrophy
5156879|NCT03011437|linked color imaging|linked color imaging
5156880|NCT03011437|Helicobacter Pylori|helicobacter pylori
5156881|NCT03011424|Liver resection|liver resection
5156882|NCT03011424|post hepatectomy liver failure|post hepatectomy liver failure
5156883|NCT03011424|liver dialysis|liver dialysis
5156884|NCT03011424|encephalopathy|encephalopathy
5156885|NCT03011424|mortality|mortality
5156886|NCT03011411|methods, qualitative research|methods, qualitative research
5156887|NCT03011372|Myeloid neoplasm|myeloid neoplasm
5156888|NCT03011372|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
5156889|NCT03011372|FGFR1 rearrangement|fgfr1 rearrangement
5156891|NCT03011372|eosinophilia|eosinophilia
5156892|NCT03011372|eosinophilic syndrome|eosinophilic syndrome
5156893|NCT03011372|Lymphoid neoplasm|lymphoid neoplasm
5156894|NCT03011359|Colon resection|colon resection
5156895|NCT03011359|Patient Controlled Analgesia|patient controlled analgesia
5156896|NCT03011359|Optimizing Basal Infusion Mode|optimizing basal infusion mode
5156897|NCT03011346|Aortic valve stenosis|aortic valve stenosis
5156898|NCT03011346|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5043454|NCT03727672|CRP|crp
5156899|NCT03011346|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5156900|NCT03011346|Randomized controlled trial|randomized controlled trial
5156901|NCT03011320|ovarian cancer|ovarian cancer
5156902|NCT03011320|specimen collection|specimen collection
5423214|NCT01616641|rheumatoid arthritis|rheumatoid arthritis
5156903|NCT03011268|Tumor Necrosis Factor-alpha/antagonists & inhibitors|tumor necrosis factor-alpha/antagonists & inhibitors
5156904|NCT03011268|Infliximab|infliximab
5156905|NCT03011268|Adalimumab|adalimumab
5156906|NCT03011268|Golimumab|golimumab
5156907|NCT03011268|Recurrence|recurrence
5156908|NCT03011255|Esophageal cancer|esophageal cancer
5156909|NCT03011255|Peptide specific CTL|peptide specific ctl
5156910|NCT03011255|Radiation|radiation
5156911|NCT03011242|Psoriatic Arthritis|psoriatic arthritis
5156912|NCT03011242|US|us
5156913|NCT03011242|DC-STAMP|dc-stamp
5156914|NCT03011242|Osteoclast Precursor (OCPs)|osteoclast precursor (ocps)
5156915|NCT03011203|glycogen storage disease type IIIa|glycogen storage disease type iiia
5156916|NCT03011203|exercise|exercise
5156917|NCT03011203|ketone esters|ketone esters
5156918|NCT03011203|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5156919|NCT03011190|Terapia Iconica|terapia iconica
5156920|NCT03011190|BPD|bpd
5156921|NCT03011190|adolescence|adolescence
5156922|NCT03011190|suicide|suicide
5156923|NCT03011164|Running|running
5156924|NCT03011164|Gait velocity|gait velocity
5156925|NCT03011164|Kinematics|kinematics
5156926|NCT03011151|pediatric|pediatric
5156927|NCT03011151|critical illness|critical illness
5156928|NCT03011151|surgery|surgery
5156929|NCT03011151|gastrointestinal dysfunction|gastrointestinal dysfunction
5156930|NCT03011151|gastric emptying|gastric emptying
5156931|NCT03011151|epithelial barrier|epithelial barrier
5156932|NCT03011151|nutrition|nutrition
5156933|NCT03011138|knee|knee
5156934|NCT03011138|gait velocity|gait velocity
5156935|NCT03011138|kinematic parameters|kinematic parameters
5156936|NCT03011112|Osteoarthritis, Knee|osteoarthritis, knee
5156937|NCT03011112|WOMAC|womac
5156938|NCT03011112|gait|gait
5156939|NCT03011112|kinematics|kinematics
5156940|NCT03011086|Autoantibodies, Oral Submucous Fibrosis|autoantibodies, oral submucous fibrosis
5156941|NCT03011060|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5156945|NCT03011060|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5156946|NCT03011047|endoscopic, trans-antral, subciliary|endoscopic, trans-antral, subciliary
5156947|NCT03011021|Autoimmune Diabetes|autoimmune diabetes
5156948|NCT03011021|Umbilical Cord Blood Regulatory T Lymphocyte|umbilical cord blood regulatory t lymphocyte
5156949|NCT03011021|Liraglutide|liraglutide
5156950|NCT03010995|electronic cigarette|electronic cigarette
5156951|NCT03010995|endothelial function|endothelial function
5156952|NCT03010969|Endothelial dysfunction|endothelial dysfunction
5156953|NCT03010969|Surgery|surgery
5156954|NCT03010969|Pulmonary function|pulmonary function
5156955|NCT03010969|Blood glucose level|blood glucose level
5156956|NCT03010969|Patient-related outcomes|patient-related outcomes
5156957|NCT03010956|Arterial stiffness|arterial stiffness
5156958|NCT03010956|Endothelial glycocalyx|endothelial glycocalyx
5156959|NCT03010956|Coronary flow reserve|coronary flow reserve
5156960|NCT03010943|virtual reality|virtual reality
5156961|NCT03010943|glioma surgery|glioma surgery
5156962|NCT03010943|awake craniotomy|awake craniotomy
5156963|NCT03010943|brain tumor|brain tumor
5156964|NCT03010943|glioma|glioma
5156965|NCT03010943|neurosurgery|neurosurgery
5156966|NCT03010917|Alcohol Dependence|alcohol dependence
5156967|NCT03010917|Fish Oil|fish oil
5156968|NCT03010891|Preterm infant|preterm infant
5156969|NCT03010891|Stress|stress
5156970|NCT03010891|Salivary DHEA|salivary dhea
5156971|NCT03010891|Salivary cortisol|salivary cortisol
5156972|NCT03010891|Actigraphy|actigraphy
5156973|NCT03010878|yoga|yoga
5156974|NCT03010878|chronic pain|chronic pain
5156975|NCT03010878|occupational therapy|occupational therapy
5156976|NCT03010878|self-management|self-management
5156977|NCT03010865|HDAC inhibitors|hdac inhibitors
5156978|NCT03010865|Inflammation|inflammation
5156979|NCT03010852|Bariatric Surgery|bariatric surgery
5156980|NCT03010852|Spirometry Monitoring|spirometry monitoring
5156981|NCT03010761|addiction|addiction
5156982|NCT03010761|betel-quid|betel-quid
5156983|NCT03010761|drug therapy|drug therapy
5156986|NCT03010748|Chinese population|chinese population
5156987|NCT03010748|corneal curvature|corneal curvature
5156988|NCT03010748|corneal thickness|corneal thickness
5156989|NCT03010748|higher order aberrations|higher order aberrations
5156990|NCT03010735|Kidney Failure, Chronic|kidney failure, chronic
5156991|NCT03010735|Probiotics|probiotics
5156992|NCT03010735|Uremic toxins|uremic toxins
5156993|NCT03010735|Gastrointestinal Microbiome|gastrointestinal microbiome
5156994|NCT03010709|Aneurysmal Subarachnoid Haemorrhage|aneurysmal subarachnoid haemorrhage
5156995|NCT03010709|Delayed Ischaemic Neurological Deficit|delayed ischaemic neurological deficit
5156996|NCT03010709|Induced Hypertension|induced hypertension
5156997|NCT03010709|Partial Brain Tissue Oxygen Tension|partial brain tissue oxygen tension
5156998|NCT03010709|Cerebral Microdialysis|cerebral microdialysis
5156999|NCT03010696|Kidney Failure, Chronic|kidney failure, chronic
5157000|NCT03010696|Uremic toxins|uremic toxins
5157001|NCT03010696|Gastrointestinal Microbiome|gastrointestinal microbiome
5157002|NCT03010696|Metabolomics|metabolomics
5157011|NCT03010618|temporomandibular joint|temporomandibular joint
5157012|NCT03010618|dental caries|dental caries
5157013|NCT03010618|occlusion|occlusion
5157014|NCT03010605|physical therapy post total knee replacement|physical therapy post total knee replacement
5157015|NCT03010605|range of motion|range of motion
5157016|NCT03010605|goniometry|goniometry
5157017|NCT03010592|Lung volume reduction treatment|lung volume reduction treatment
5157018|NCT03010592|Endobronchial cryotherapy|endobronchial cryotherapy
5157019|NCT03010592|Microvesicles|microvesicles
5157020|NCT03010579|Anemia|anemia
5157021|NCT03010579|Lymphoma|lymphoma
5157022|NCT03010579|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5157023|NCT03010579|Erythropoietin|erythropoietin
5157024|NCT03010566|Lung volume reduction coil|lung volume reduction coil
5157025|NCT03010566|Lung Microbiome|lung microbiome
5157026|NCT03010527|Chronic plaque psoriasis|chronic plaque psoriasis
5157027|NCT03010527|Psoriasis|psoriasis
5157028|NCT03010527|Bimekizumab|bimekizumab
5157029|NCT03010488|Chronotherapy|chronotherapy
5157030|NCT03010488|Light Therapy|light therapy
5157031|NCT03010462|Stroke|stroke
5157032|NCT03010462|rTMS|rtms
5157033|NCT03010462|Motor rehabilitation|motor rehabilitation
5157034|NCT03010449|Lung volume reduction treatment|lung volume reduction treatment
5157035|NCT03010449|Autologous blood instillation|autologous blood instillation
5157036|NCT03010449|Intra-bronchial valve (IBV)|intra-bronchial valve (ibv)
5157037|NCT03010449|Endobronchial valve|endobronchial valve
5157038|NCT03010423|Non-obstructive coronary artery disease|non-obstructive coronary artery disease
5157039|NCT03010423|Nicorandil|nicorandil
5157041|NCT03010332|Cytomegalovirus|cytomegalovirus
5157042|NCT03010332|Cytomegalovirus Viremia|cytomegalovirus viremia
5157043|NCT03010332|Cytomegalovirus Infection|cytomegalovirus infection
5157044|NCT03010332|CMV Infection|cmv infection
5157045|NCT03010332|Hematopoietic Cell Transplant|hematopoietic cell transplant
5145167|NCT03084185|deficit|deficit
5157046|NCT03010332|Solid Organ Transplant|solid organ transplant
5157047|NCT03010332|Human Immunodeficiency Virus|human immunodeficiency virus
5157048|NCT03010332|Cytomegalovirus Disease|cytomegalovirus disease
5157049|NCT03010332|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5157051|NCT03010332|CMV syndrome|cmv syndrome
5157052|NCT03010332|Cytomegalovirus syndrome|cytomegalovirus syndrome
5157053|NCT03010332|CMV disease|cmv disease
5157054|NCT03010332|CMV viremia|cmv viremia
5157055|NCT03010332|allogeneic|allogeneic
5157056|NCT03010332|third-party|third-party
5157057|NCT03010293|Antimicrobial therapy|antimicrobial therapy
5157058|NCT03010293|Debridement|debridement
5157059|NCT03010293|Osteomyelitis|osteomyelitis
5157060|NCT03010293|Muscular flap|muscular flap
5157061|NCT03010293|Pressure ulcer|pressure ulcer
5157062|NCT03010293|Treatment failure|treatment failure
5157063|NCT03010293|Vacuum-assisted closure therapy|vacuum-assisted closure therapy
5157064|NCT03010267|DP-R213|dp-r213
5157065|NCT03010241|Diabetes Distal Symmetric Polyneuropathy|diabetes distal symmetric polyneuropathy
5157066|NCT03010241|Chinese medicine|chinese medicine
5157067|NCT03010228|VLA15|vla15
5157068|NCT03010228|Lyme Borreliosis|lyme borreliosis
5157069|NCT03010228|Multivalent Recombinant OspA Vaccine|multivalent recombinant ospa vaccine
5157070|NCT03010215|Minimally Invasive Surgery|minimally invasive surgery
5157071|NCT03010215|Percutaneous distal osteotomy|percutaneous distal osteotomy
5157072|NCT03010215|Distal Metatarsal Minimally-invasive Osteotomy (DMMO)|distal metatarsal minimally-invasive osteotomy (dmmo)
5157073|NCT03010215|Percutaneous Tenotomy|percutaneous tenotomy
5157074|NCT03010215|Forefoot|forefoot
5157861|NCT03004690|outbreaks|outbreaks
5157075|NCT03010215|Metatarsal bones|metatarsal bones
5157076|NCT03010202|immune thrombocytopenia|immune thrombocytopenia
5157077|NCT03010202|rituximab|rituximab
5157078|NCT03010202|thrombocytopenia|thrombocytopenia
5157079|NCT03010189|Cluster headache|cluster headache
5157080|NCT03010189|Actigraphy|actigraphy
5157081|NCT03010189|Pupillometry|pupillometry
5157082|NCT03010163|pedometer|pedometer
5157083|NCT03010163|walking|walking
5157084|NCT03010163|taxi driver|taxi driver
5157085|NCT03010163|16-1659|16-1659
5157086|NCT03010111|Latent Tuberculosis|latent tuberculosis
5157087|NCT03010111|Interferons|interferons
5157088|NCT03010111|Tuberculosis|tuberculosis
5157089|NCT03010111|Healthcare|healthcare
5157090|NCT03010098|POCD|pocd
5157099|NCT03010020|Rectal Chlamydia|rectal chlamydia
5157100|NCT03010020|Personalized Cognitive Counseling|personalized cognitive counseling
5157101|NCT03010007|Influenza|influenza
5157102|NCT03010007|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5157103|NCT03010007|Viral Transmission|viral transmission
5157105|NCT03009981|Degarelix|degarelix
5157106|NCT03009981|Apalutamide|apalutamide
5157107|NCT03009981|Abiraterone Acetate|abiraterone acetate
5157108|NCT03009981|Radical Prostatectomy|radical prostatectomy
5157109|NCT03009981|Bicalutamide|bicalutamide
5157110|NCT03009981|Leuprolide|leuprolide
5029544|NCT03814655|Dental implants|dental implants
5157112|NCT03009942|nitric oxide|nitric oxide
5157113|NCT03009942|arginase|arginase
5157114|NCT03009942|loading|loading
5157115|NCT03009890|elderly|elderly
5157116|NCT03009890|intra articular|intra articular
5157118|NCT03009864|Diabetic Kidney Disease|diabetic kidney disease
5157119|NCT03009864|TCM|tcm
5157120|NCT03009864|RCT|rct
5157121|NCT03009825|Trauma exposure|trauma exposure
5157122|NCT03009825|Psychological distress|psychological distress
5157123|NCT03009825|Emotion regulation|emotion regulation
5157124|NCT03009825|Mindfulness|mindfulness
5157125|NCT03009825|Eating pathology|eating pathology
5157126|NCT03009799|adenoviral conjunctivis|adenoviral conjunctivis
5157127|NCT03009799|iota-carrageenan|iota-carrageenan
5157128|NCT03009773|subacute stroke|subacute stroke
5157129|NCT03009773|multitasking rehabilitation|multitasking rehabilitation
5157130|NCT03009773|walking|walking
5157131|NCT03009747|rectal cancer|rectal cancer
5157132|NCT03009747|anterior resection syndrome|anterior resection syndrome
5157133|NCT03009747|sphincter-preserving surgery|sphincter-preserving surgery
5157134|NCT03009708|Allograft|allograft
5157135|NCT03009708|Cytomegalovirus|cytomegalovirus
5157136|NCT03009708|Platelets|platelets
5157137|NCT03009708|Hematopoietic stem cells|hematopoietic stem cells
5157138|NCT03009708|Graft Versus Host Disease (GVH)|graft versus host disease (gvh)
5157139|NCT03009708|Hemostasis|hemostasis
5157140|NCT03009708|Adaptive immunity|adaptive immunity
5157141|NCT03009708|Innate immunity|innate immunity
5157142|NCT03009708|Post graft follow up|post graft follow up
5157143|NCT03009695|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5157144|NCT03009695|Obesity|obesity
5157145|NCT03009695|Food Craving|food craving
5157146|NCT03009695|Appetite/Satiety Hormones|appetite/satiety hormones
5157147|NCT03009695|fMRI|fmri
5157148|NCT03009695|Intestinal microbiota|intestinal microbiota
5157149|NCT03009695|Physical activity|physical activity
5157150|NCT03009669|pleth variability index|pleth variability index
5157151|NCT03009669|stroke volume variation|stroke volume variation
5157153|NCT03009669|intraoperative|intraoperative
5157154|NCT03009669|intestinal tumor|intestinal tumor
5157157|NCT03009656|Focal Neurological Deficits|focal neurological deficits
5157158|NCT03009656|Diagnostic|diagnostic
5157159|NCT03009643|Nitric Oxide|nitric oxide
5157160|NCT03009643|hypoxemia|hypoxemia
5157161|NCT03009643|aortic surgery|aortic surgery
5157162|NCT03009630|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
5157163|NCT03009630|Radiofrequency ablation(RFA)|radiofrequency ablation(rfa)
5157164|NCT03009630|Peripheral lung cancer|peripheral lung cancer
5157165|NCT03009617|adolescents|adolescents
5157166|NCT03009617|web-based health education|web-based health education
5157167|NCT03009617|eHealth literacy|ehealth literacy
5157168|NCT03009591|Hemophilia|hemophilia
5157169|NCT03009591|Elbow|elbow
5157170|NCT03009591|Arthropathy|arthropathy
5157171|NCT03009591|Joint pain|joint pain
5157172|NCT03009591|Range of motion|range of motion
5157173|NCT03009591|Myofascial techniques|myofascial techniques
5157174|NCT03009591|Safety patients|safety patients
5157175|NCT03009591|Quality of life|quality of life
5157176|NCT03009591|Functionality|functionality
5157177|NCT03009565|coronary artery disease|coronary artery disease
5157178|NCT03009565|human gut microbiota|human gut microbiota
5157179|NCT03009565|microbiome|microbiome
5157180|NCT03009552|speckle tracking echocardiography|speckle tracking echocardiography
5157181|NCT03009552|strain|strain
5157182|NCT03009552|strain rate|strain rate
5157183|NCT03009552|torsion|torsion
5157214|NCT03009344|Japan|japan
5157215|NCT03009331|Postoperative pulmonary dysfunction|postoperative pulmonary dysfunction
5157216|NCT03009331|Postoperative pulmonary complication|postoperative pulmonary complication
5157217|NCT03009331|Recruitment manouver|recruitment manouver
5157218|NCT03009331|Prone position|prone position
5157219|NCT03009318|Glioma|glioma
5157220|NCT03009318|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5157221|NCT03009318|Methionine|methionine
5157222|NCT03009318|PET/CT|pet/ct
5157226|NCT03009279|blood pressure|blood pressure
5157227|NCT03009279|fasting plasma glucose|fasting plasma glucose
5157228|NCT03009279|thyroid stimulating hormone|thyroid stimulating hormone
5157229|NCT03009253|Neoadjuvant therapy|neoadjuvant therapy
5157230|NCT03009253|Pancreatic Cancer|pancreatic cancer
5157231|NCT03009227|colon cancer|colon cancer
5157232|NCT03009227|lymph node dissection|lymph node dissection
5157233|NCT03009227|D3 lymph node dissection|d3 lymph node dissection
5157234|NCT03009214|solid epithelial cancer|solid epithelial cancer
5962111|NCT04282967|Prostate Cancer Survivor|prostate cancer survivor
5157235|NCT03009214|CD44v6|cd44v6
5157236|NCT03009214|c-Met|c-met
5157237|NCT03009214|VEGFR-2|vegfr-2
5157238|NCT03009214|RON|ron
5157239|NCT03009214|receptor tyrosine kinase|receptor tyrosine kinase
5157240|NCT03009188|Axenfeld-Rieger syndrom, genetic findings|axenfeld-rieger syndrom, genetic findings
5157241|NCT03009136|Perennial Allergic Rhinitis|perennial allergic rhinitis
5157242|NCT03009136|Herbal Medicine|herbal medicine
5157243|NCT03009136|Korean Medicine|korean medicine
5023478|NCT03850730|HHT|hht
5157244|NCT03009136|So-Cheong-Ryong-Tang|so-cheong-ryong-tang
5157245|NCT03009123|cohort study|cohort study
5157246|NCT03009123|prostate cancer|prostate cancer
5157247|NCT03009123|population-based study|population-based study
5157248|NCT03009123|benign prostatic hypertrophy|benign prostatic hypertrophy
5157249|NCT03009097|Chronic periodontitis|chronic periodontitis
5157250|NCT03009097|atorvastatin|atorvastatin
5157251|NCT03009097|intrabony defect|intrabony defect
5157252|NCT03009071|Neck Pain|neck pain
5157253|NCT03009071|Disability Evaluation|disability evaluation
5157254|NCT03009071|Costs and Cost Analysis|costs and cost analysis
5157255|NCT03009071|Doin Exercise Therapy|doin exercise therapy
5157256|NCT03009071|Acupuncture|acupuncture
5157257|NCT03009058|Unresectable cancer|unresectable cancer
5157258|NCT03009058|pancreatic|pancreatic
5157259|NCT03009058|melanoma|melanoma
5157260|NCT03009058|breast|breast
5157261|NCT03009058|lung|lung
5157262|NCT03009058|colorectal|colorectal
5157263|NCT03009058|cholangio|cholangio
5157264|NCT03009058|sarcoma|sarcoma
5157265|NCT03009045|bone and joint infection|bone and joint infection
5157266|NCT03009045|osteomyelitis|osteomyelitis
5157267|NCT03009045|tedizolid|tedizolid
5157268|NCT03009032|HIV|hiv
5157269|NCT03009032|immunologic recovery|immunologic recovery
5157270|NCT03009032|microbiota|microbiota
5157278|NCT03009006|Root canal treatment|root canal treatment
5157279|NCT03008967|Total Knee Arthroplasty|total knee arthroplasty
5157280|NCT03008967|Total Hip Arthroplasty|total hip arthroplasty
5157281|NCT03008967|Rehabilitation|rehabilitation
5157282|NCT03008954|weight loss|weight loss
5157283|NCT03008954|body composition|body composition
5157284|NCT03008954|glycemic control|glycemic control
5157285|NCT03008954|satiety|satiety
5157286|NCT03008941|HIV|hiv
5157287|NCT03008941|microbiota|microbiota
5157288|NCT03008941|inflammation|inflammation
5157289|NCT03008941|fecal microbiota restoration|fecal microbiota restoration
5157290|NCT03008915|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5157292|NCT03008915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5157293|NCT03008889|Repetitive Self-Injurious Behavior|repetitive self-injurious behavior
5157311|NCT03008759|Dentifrice|dentifrice
5157312|NCT03008720|functional electrical simulation|functional electrical simulation
5157313|NCT03008707|Laparoscopic peritoneal lavage|laparoscopic peritoneal lavage
5157314|NCT03008707|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
5157315|NCT03008707|complicated acute diverticulitis|complicated acute diverticulitis
5157317|NCT03008694|PET/CT|pet/ct
5157318|NCT03008642|Polycythemia|polycythemia
5157319|NCT03008642|CO-Rebreathing|co-rebreathing
5157320|NCT03008642|red cell mass determination|red cell mass determination
5157321|NCT03008642|myeloproliferative neoplasms|myeloproliferative neoplasms
5157322|NCT03008603|CT-guided minimally invasive procedures|ct-guided minimally invasive procedures
5157323|NCT03008603|Robot|robot
5157324|NCT03008590|Pain management|pain management
5157325|NCT03008590|Naltrexone|naltrexone
5157326|NCT03008590|Controlled clinical trials, randomized|controlled clinical trials, randomized
5157327|NCT03008512|Liver Neoplasms|liver neoplasms
5157328|NCT03008512|Antineoplastic Agents|antineoplastic agents
5157329|NCT03008512|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5157330|NCT03008512|Genexol-PM|genexol-pm
5157331|NCT03008512|Neoplasms by Site|neoplasms by site
5157332|NCT03008512|Sorafenib|sorafenib
5157333|NCT03008512|Liver Diseases|liver diseases
5157334|NCT03008512|Digestive System Neoplasms|digestive system neoplasms
5157335|NCT03008499|Metastatic colorectal cancer|metastatic colorectal cancer
5157336|NCT03008499|High-activity natural killer|high-activity natural killer
5157337|NCT03008447|E2006|e2006
5157338|NCT03008447|postural stability|postural stability
5157339|NCT03008447|auditory awakening threshold|auditory awakening threshold
5157340|NCT03008447|cognitive performance|cognitive performance
5157341|NCT03008447|healthy participants|healthy participants
5157342|NCT03008434|yoga|yoga
5157343|NCT03008434|Traumatic Brain Injury|traumatic brain injury
5157344|NCT03008408|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5157345|NCT03008408|Endometrial carcinoma|endometrial carcinoma
5157346|NCT03008408|Advanced or Recurrent|advanced or recurrent
5157347|NCT03008408|Endometrioid and mixed endometrioid tumors|endometrioid and mixed endometrioid tumors
5157348|NCT03008408|Ribociclib|ribociclib
5157349|NCT03008408|LEE011|lee011
5157350|NCT03008408|Everolimus|everolimus
5157351|NCT03008408|Afinitor|afinitor
5157352|NCT03008408|Zortress|zortress
5157353|NCT03008408|RAD001|rad001
5157354|NCT03008408|Letrozole|letrozole
5157355|NCT03008408|Femara|femara
5157356|NCT03008382|Interstitial Cystitis|interstitial cystitis
5157357|NCT03008382|Pelvic Pain|pelvic pain
5157358|NCT03008343|Irreversible Electroporation|irreversible electroporation
5157359|NCT03008343|NK Immunotherapy|nk immunotherapy
5157360|NCT03008343|Recurrent Liver Carcinoma|recurrent liver carcinoma
5157361|NCT03008330|Metastatic tongue cancer|metastatic tongue cancer
5157362|NCT03008330|High-activity natural killer|high-activity natural killer
5962112|NCT04282928|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5157363|NCT03008304|Metastatic pancreatic cancer|metastatic pancreatic cancer
5157364|NCT03008304|High-activity natural killer Immunotherapy|high-activity natural killer immunotherapy
5157365|NCT03008265|Fascial dehiscence|fascial dehiscence
5157366|NCT03008265|Mortality|mortality
5157367|NCT03008252|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
5157665|NCT03006042|bupivacaine|bupivacaine
5157372|NCT03008174|tracheostomy|tracheostomy
5157373|NCT03008174|quality of life|quality of life
5157374|NCT03008174|speaking valve|speaking valve
5157376|NCT03008174|mechanically ventilated patients|mechanically ventilated patients
5157377|NCT03008161|GAIM|gaim
5157378|NCT03008161|amyloid|amyloid
5157379|NCT03008161|anti-aBeta|anti-abeta
5157380|NCT03008161|anti-tau|anti-tau
5157387|NCT03008109|EGFR-TKI|egfr-tki
5157396|NCT03008070|Digestive System Diseases|digestive system diseases
5157397|NCT03008070|IVA337|iva337
5157398|NCT03008057|vitamin D|vitamin d
5157399|NCT03008057|YKL40|ykl40
5157400|NCT03008057|PAI-1|pai-1
5157401|NCT03008057|RAGE|rage
5157402|NCT03008057|AGEs|ages
5157403|NCT03008057|glyoxalase enzyme|glyoxalase enzyme
5157404|NCT03008057|TNF-alpha|tnf-alpha
5157405|NCT03008057|IL-6|il-6
5157406|NCT03008057|Diabetes|diabetes
5157407|NCT03007992|Breast cancer|breast cancer
5157408|NCT03007992|Vinorelbine|vinorelbine
5157409|NCT03007992|Metronomic chemotherapy|metronomic chemotherapy
5157410|NCT03007953|Palliative Care|palliative care
5157411|NCT03007953|Supportive Care|supportive care
5157412|NCT03007940|Implementation Strategies|implementation strategies
5157413|NCT03007940|Sustainability|sustainability
5157414|NCT03007940|Integrated Services|integrated services
5157415|NCT03007927|pain|pain
5157416|NCT03007927|hernia repair|hernia repair
5157417|NCT03007927|Dexamethasone|dexamethasone
5157418|NCT03007914|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5157419|NCT03007914|Medicine, Chinese Traditional|medicine, chinese traditional
5157420|NCT03007914|Humans|humans
5157421|NCT03007914|Treatment Outcome|treatment outcome
5157422|NCT03007888|IPX203 (carbidopa-levodopa) Extended-Release capsules|ipx203 (carbidopa-levodopa) extended-release capsules
5157423|NCT03007875|Metastatic lung cancer|metastatic lung cancer
5157424|NCT03007875|High-activity natural killer|high-activity natural killer
5157425|NCT03007836|Metastatic Nasopharyngeal Cancer|metastatic nasopharyngeal cancer
5157426|NCT03007836|High-activity natural killer|high-activity natural killer
5157427|NCT03007823|Metastatic Melanoma|metastatic melanoma
5157428|NCT03007823|High-activity natural killer|high-activity natural killer
5157429|NCT03007784|Consciousness|consciousness
5157430|NCT03007784|Disorder of consciousness|disorder of consciousness
5157431|NCT03007784|Minimally conscious state|minimally conscious state
5157432|NCT03007784|Vegetative state|vegetative state
5157433|NCT03007784|Exit-MCS|exit-mcs
5157434|NCT03007784|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5157435|NCT03007784|CRS-R|crs-r
5157436|NCT03007784|EEG|eeg
5157437|NCT03007784|Cognitive ERPs|cognitive erps
5157438|NCT03007758|Hernia repair|hernia repair
5157439|NCT03007758|Robotic hernia repair|robotic hernia repair
5157440|NCT03007758|Open hernia repair|open hernia repair
5775444|NCT00220493|RITALIN|ritalin
5157441|NCT03007758|Incisional hernia|incisional hernia
5157442|NCT03007745|Continuous positive airway pressure|continuous positive airway pressure
5157443|NCT03007628|magnetic seizure therapy|magnetic seizure therapy
5157444|NCT03007628|electroconvulsive therapy|electroconvulsive therapy
5157445|NCT03007628|controlled trial|controlled trial
5157446|NCT03007602|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5157447|NCT03007602|Aerobic exercise|aerobic exercise
5157448|NCT03007602|Quality of Life|quality of life
5157449|NCT03007602|Muscle Strength|muscle strength
5157450|NCT03007602|Depression|depression
5157451|NCT03007602|exercise capacity|exercise capacity
5157452|NCT03007602|dyspnea|dyspnea
5157453|NCT03007602|anxiety|anxiety
5157454|NCT03007602|fatigue|fatigue
5157455|NCT03007602|pulmonary functions|pulmonary functions
5157456|NCT03007589|erythema|erythema
5157457|NCT03007589|persistent pigment darkening|persistent pigment darkening
5157458|NCT03007589|sunburn|sunburn
5157459|NCT03007589|suntan|suntan
5157460|NCT03007563|Diagnosis|diagnosis
5157461|NCT03007563|Cell Phones|cell phones
5157462|NCT03007563|Infant, Newborn|infant, newborn
5157463|NCT03007550|Gastric cancer|gastric cancer
5157464|NCT03007550|Laparoscopic total gastrectomy|laparoscopic total gastrectomy
5157465|NCT03007550|Open total gastrectomy|open total gastrectomy
5157466|NCT03007537|Erythropoietin|erythropoietin
5157467|NCT03007537|Cardiac Surgery Associated-acute Kidney Injury|cardiac surgery associated-acute kidney injury
5423215|NCT01616641|bite force|bite force
5157486|NCT03007459|Drive for leanness|drive for leanness
5157489|NCT03007446|Conversion Surgery|conversion surgery
5157490|NCT03007446|unresectable gastric cancer|unresectable gastric cancer
5157491|NCT03007433|gastric emptying|gastric emptying
5157492|NCT03007433|functional dyspepsia|functional dyspepsia
5157493|NCT03007433|non invasive imaging|non invasive imaging
5157494|NCT03007433|MRI|mri
5962113|NCT04282928|Severe viral Pneumonia|severe viral pneumonia
5029909|NCT03812068|Development|development
5157495|NCT03007433|gamma scintigraphy|gamma scintigraphy
5157496|NCT03007433|gastroparesis|gastroparesis
5157497|NCT03007407|microsatellite stable|microsatellite stable
5157498|NCT03007407|MSS|mss
5157499|NCT03007407|durvalumab|durvalumab
5157500|NCT03007407|tremelimumab|tremelimumab
5157501|NCT03007407|mCRC|mcrc
5157502|NCT03007407|NSABP|nsabp
5157504|NCT03007342|Amoxicillin|amoxicillin
5157505|NCT03007342|clavulanic acid|clavulanic acid
5157506|NCT03007342|Periapical periodontitis|periapical periodontitis
5157507|NCT03007342|Post-operative pain|post-operative pain
5157514|NCT03007264|cold atmospheric plasma|cold atmospheric plasma
5157515|NCT03007264|pain|pain
5157516|NCT03007264|bacteria|bacteria
5157517|NCT03007264|skin parameters|skin parameters
5157518|NCT03007186|Blood glucose monitoring|blood glucose monitoring
5157519|NCT03007186|Glucose tolerance|glucose tolerance
5157520|NCT03007186|HbA1C|hba1c
5157521|NCT03007186|Insulin|insulin
5157522|NCT03007186|Betamethasone|betamethasone
5157523|NCT03007173|umbilical pilonidal sinus|umbilical pilonidal sinus
5157524|NCT03007082|endovascular treatment|endovascular treatment
5157525|NCT03007082|mechanical thrombectomy|mechanical thrombectomy
5157526|NCT03007082|stent retriever|stent retriever
5157527|NCT03007082|human|human
5157528|NCT03007056|high flow nasal cannula|high flow nasal cannula
5157529|NCT03007056|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5157530|NCT03007056|noninvasive ventilatory support|noninvasive ventilatory support
5157531|NCT03007056|newborn developmental care|newborn developmental care
5157532|NCT03007056|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5157533|NCT03007056|weaning|weaning
5157534|NCT03007056|pain|pain
5157535|NCT03007056|length of stay|length of stay
5157536|NCT03007004|Systemic aclerosis|systemic aclerosis
5157537|NCT03007004|digital ulcer|digital ulcer
5157538|NCT03007004|botulinum toxin|botulinum toxin
5157539|NCT03006991|methotrexate, Juvenile Idiopathic Arthritis|methotrexate, juvenile idiopathic arthritis
5157540|NCT03006965|Hemophilia|hemophilia
5157541|NCT03006965|Hemophilia A|hemophilia a
5157542|NCT03006965|Factor VIII|factor viii
5157543|NCT03006965|Advate|advate
5157544|NCT03006965|Antithrombotic factor|antithrombotic factor
5157545|NCT03006965|Pharmacokinetic dosing|pharmacokinetic dosing
5157546|NCT03006965|Hemarthrosis|hemarthrosis
5157547|NCT03006965|myPKFiT|mypkfit
5157548|NCT03006926|hepatocellular carcinoma|hepatocellular carcinoma
5157549|NCT03006926|E7080|e7080
5157550|NCT03006926|lenvatinib|lenvatinib
5157551|NCT03006926|pembrolizumab|pembrolizumab
5157552|NCT03006926|Japan|japan
5157553|NCT03006913|Genetic counseling modes|genetic counseling modes
5157565|NCT03006848|Osteosarcoma|osteosarcoma
5157566|NCT03006848|PD-L1|pd-l1
5157567|NCT03006848|Immunotherapy|immunotherapy
5166431|NCT02952300|rotation|rotation
5157583|NCT03006575|Locoregional recurrence|locoregional recurrence
5157584|NCT03006575|Postoperative recurrence|postoperative recurrence
5157585|NCT03006549|Emergency Manual|emergency manual
5157586|NCT03006549|Crisis Checklist|crisis checklist
5157587|NCT03006523|donor intrauterine insemination|donor intrauterine insemination
5157588|NCT03006523|insemination volume|insemination volume
5157589|NCT03006523|Live Birth Rates|live birth rates
5157590|NCT03006523|donor sperm|donor sperm
5157591|NCT03006510|inpatient diabetes|inpatient diabetes
5157592|NCT03006510|hypoglycemia|hypoglycemia
5157593|NCT03006497|neck|neck
5157594|NCT03006497|motor control|motor control
5157595|NCT03006497|motor learning|motor learning
5157596|NCT03006484|Cardiac arrest|cardiac arrest
5157597|NCT03006484|Inhospital Cardiac Arrest|inhospital cardiac arrest
5157598|NCT03006484|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5157599|NCT03006471|Prediabetes|prediabetes
5157600|NCT03006471|Prehypertension|prehypertension
5157601|NCT03006471|Variability of blood pressure|variability of blood pressure
5157602|NCT03006471|ABPM|abpm
5157603|NCT03006471|Dapagliflozin|dapagliflozin
5157604|NCT03006471|SGLT2|sglt2
5157605|NCT03006432|OESOPHAGO-GASTRIC CARCINOMA|oesophago-gastric carcinoma
5157606|NCT03006419|kidney transplantation|kidney transplantation
5157607|NCT03006419|induction|induction
5157608|NCT03006419|thymoglobulin|thymoglobulin
5157609|NCT03006419|basiliximab|basiliximab
5157610|NCT03006419|acute rejection|acute rejection
5157611|NCT03006419|graft loss|graft loss
5157612|NCT03006406|endometriosis|endometriosis
5157613|NCT03006406|long term GnRH-a|long term gnrh-a
5157617|NCT03006354|high frequency oscillatory ventilation|high frequency oscillatory ventilation
5157618|NCT03006354|newborn|newborn
5157619|NCT03006354|noninvasive ventilation|noninvasive ventilation
5157620|NCT03006354|transient tachypnea of the newborn|transient tachypnea of the newborn
5157621|NCT03006328|weight gain|weight gain
5962114|NCT04282915|Primary care|primary care
5157622|NCT03006328|weight loss|weight loss
5157623|NCT03006315|multiple myeloma|multiple myeloma
5157624|NCT03006315|garmin vivofit|garmin vivofit
5157625|NCT03006302|pancreatic cancer|pancreatic cancer
5157626|NCT03006302|vaccine|vaccine
5157627|NCT03006302|immunotherapy|immunotherapy
5157628|NCT03006302|MK-3475|mk-3475
5157629|NCT03006302|PD-1|pd-1
5157630|NCT03006302|IDO|ido
5157638|NCT03006250|Respiratory Complications|respiratory complications
5157639|NCT03006224|secondary smoking|secondary smoking
5157640|NCT03006224|one lung ventilation|one lung ventilation
5157641|NCT03006224|arterial oxygen tension|arterial oxygen tension
5157642|NCT03006224|lobectomy|lobectomy
5157643|NCT03006211|nitrogen protoxide|nitrogen protoxide
5157644|NCT03006211|oxygen|oxygen
5157645|NCT03006211|corneal endothelial|corneal endothelial
5157646|NCT03006211|pediatric|pediatric
5157647|NCT03006107|Irreversible pulpitis|irreversible pulpitis
5157648|NCT03006107|Post endodontic pain|post endodontic pain
5157649|NCT03006107|Symptomatic pulpitis pain|symptomatic pulpitis pain
5157650|NCT03006107|Single visit RCT pain|single visit rct pain
5157651|NCT03006107|Root canal treatment flare up|root canal treatment flare up
5166529|NCT02951338|Exercise|exercise
5157655|NCT03006094|questionnaire|questionnaire
5157656|NCT03006094|hip|hip
5157657|NCT03006094|pain|pain
5157658|NCT03006081|Retinal nonperfusion|retinal nonperfusion
5157659|NCT03006081|Aflibercept|aflibercept
5157660|NCT03006068|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5157661|NCT03006068|Upadacitinib (ABT-494)|upadacitinib (abt-494)
5157662|NCT03006068|Long Term Extension (LTE)|long term extension (lte)
5157663|NCT03006068|Safety|safety
5157664|NCT03006068|Efficacy|efficacy
5157666|NCT03006042|local anaesthetics|local anaesthetics
5157667|NCT03006042|cesarean section|cesarean section
5157668|NCT03006042|transversus abdominis plane block|transversus abdominis plane block
5157669|NCT03006042|toxicity|toxicity
5157670|NCT03006042|ultrasound guidance|ultrasound guidance
5157671|NCT03006042|QTc interval|qtc interval
5157672|NCT03006003|Osteoporosis|osteoporosis
5157673|NCT03006003|Raloxifene|raloxifene
5157674|NCT03006003|Central nervous disorders|central nervous disorders
5157675|NCT03005990|Sleep disturbance|sleep disturbance
5157676|NCT03005990|Body composition|body composition
5157677|NCT03005990|Energy metabolism|energy metabolism
5157678|NCT03005990|Exercise training|exercise training
5157679|NCT03005990|Community-dwelling elderly|community-dwelling elderly
5157680|NCT03005977|Urodynamics|urodynamics
5157681|NCT03005977|Pyridium pad test|pyridium pad test
5157682|NCT03005977|Cough stress test|cough stress test
5157683|NCT03005977|Pelvic organ prolapse|pelvic organ prolapse
5157684|NCT03005938|Cerebral Palsy|cerebral palsy
5157685|NCT03005938|Spinal Manipulation|spinal manipulation
5157686|NCT03005938|Muscle Spasticity|muscle spasticity
5157687|NCT03005938|Manual Dexterity|manual dexterity
5157688|NCT03005912|Speech Comprehension|speech comprehension
5157689|NCT03005912|Telephony|telephony
5157690|NCT03005912|VoIP|voip
5157691|NCT03005886|Periodontitis|periodontitis
5157692|NCT03005886|Periodontal-systemic disease|periodontal-systemic disease
5157693|NCT03005886|Cardiovascular diseases|cardiovascular diseases
5157694|NCT03005886|Gingival crevicular fluid|gingival crevicular fluid
5157695|NCT03005886|Acute myocardial infarction|acute myocardial infarction
5157696|NCT03005886|Neopterin|neopterin
5157697|NCT03005886|Vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
5157698|NCT03005873|osteoarthritis of the knee|osteoarthritis of the knee
5157699|NCT03005873|TLC599|tlc599
5157700|NCT03005873|Dexamethasone|dexamethasone
5157701|NCT03005873|DSP|dsp
5157702|NCT03005834|Atherosclerotic cardiovascular diseases, cancers|atherosclerotic cardiovascular diseases, cancers
5157703|NCT03005821|pediatric massage|pediatric massage
5157704|NCT03005821|Tuina therapy|tuina therapy
5157705|NCT03005821|acute diarrhea|acute diarrhea
5157706|NCT03005808|appendectomy, pediatrics, nerve block, abdominal wall|appendectomy, pediatrics, nerve block, abdominal wall
5157707|NCT03005795|cervical dysplasia|cervical dysplasia
5157708|NCT03005795|colposcopy|colposcopy
5157709|NCT03005795|anxiety|anxiety
5157710|NCT03005795|music|music
5157711|NCT03005795|mozart|mozart
5157712|NCT03005795|randomized controlled trial|randomized controlled trial
5157713|NCT03005769|persistence|persistence
5157714|NCT03005769|long-acting injectable antipsychotic|long-acting injectable antipsychotic
5157715|NCT03005769|adherence|adherence
5157716|NCT03005743|Cervical cancer|cervical cancer
5157717|NCT03005743|Brachytherapy|brachytherapy
5157718|NCT03005743|Conventional planning|conventional planning
5157719|NCT03005743|MR based Brachytherapy|mr based brachytherapy
5157720|NCT03005717|submental|submental
5157721|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate
5157725|NCT03005704|Acetylsalicylic acid|acetylsalicylic acid
5157726|NCT03005704|Platelet transfusion|platelet transfusion
5157727|NCT03005704|Reversal|reversal
5157728|NCT03005691|metabolite|metabolite
5157729|NCT03005691|central sensitization|central sensitization
5157730|NCT03005691|whiplash|whiplash
5157731|NCT03005678|glucocorticoids, steroids, osteoporosis|glucocorticoids, steroids, osteoporosis
5157732|NCT03005665|optic nerve sheath diameter|optic nerve sheath diameter
5157733|NCT03005665|acetazolamide|acetazolamide
5157734|NCT03005652|Subjective Cognitive Decline|subjective cognitive decline
5157735|NCT03005652|Mental Health|mental health
5157736|NCT03005652|Meditation|meditation
5157737|NCT03005652|Health Education|health education
5157738|NCT03005613|Pelvic organ prolapse|pelvic organ prolapse
5157739|NCT03005613|Sacrospinous ligament fixation|sacrospinous ligament fixation
5157740|NCT03005613|Ischial spine fascia fixation|ischial spine fascia fixation
5157741|NCT03005613|Clinical outcome|clinical outcome
5356860|NCT01917695|Bulky cervical cancers|bulky cervical cancers
5157742|NCT03005600|Screening, diagnosis, risk stratification, ethnic|screening, diagnosis, risk stratification, ethnic
5157743|NCT03005574|Severe Mental Illness|severe mental illness
5166624|NCT02950818|self-care|self-care
5157744|NCT03005574|Cognitive Remediation|cognitive remediation
5157745|NCT03005574|Employment|employment
5157746|NCT03005548|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5157747|NCT03005548|Pain Postoperative|pain postoperative
5157748|NCT03005548|Thoracotomy|thoracotomy
5157749|NCT03005509|Quality improvement|quality improvement
5157750|NCT03005509|Injury|injury
5157751|NCT03005509|Injuries|injuries
5157752|NCT03005483|GABAPENTIN POSTOPERATIVE PAIN CHILD|gabapentin postoperative pain child
5157753|NCT03005470|Prehypertension|prehypertension
5157754|NCT03005470|Hypertension|hypertension
5157755|NCT03005470|Blood pressure|blood pressure
5157756|NCT03005470|Intervention|intervention
5157757|NCT03005470|Lifestyle|lifestyle
5157758|NCT03005470|Blood pressure monitoring|blood pressure monitoring
5157759|NCT03005470|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5157760|NCT03005470|Text Messages|text messages
5157761|NCT03005470|High blood pressure|high blood pressure
5157762|NCT03005444|liver cirrhosis|liver cirrhosis
5157763|NCT03005444|Transjugular Intrahepatic Portosystemic Stent Shunt|transjugular intrahepatic portosystemic stent shunt
5157764|NCT03005444|Anticoagulation|anticoagulation
5157765|NCT03005444|Survival|survival
5157766|NCT03005444|Additional decompensation|additional decompensation
5157767|NCT03005431|Parenting|parenting
5157768|NCT03005431|Training|training
5157769|NCT03005431|Support|support
5157770|NCT03005431|On-line|on-line
5157771|NCT03005431|Stress|stress
5157772|NCT03005405|Dental Caries|dental caries
5157773|NCT03005405|Primary tooth|primary tooth
5157774|NCT03005405|Ionomer Sealants|ionomer sealants
5157775|NCT03005405|Glass Ionomer Restoration|glass ionomer restoration
5157776|NCT03005392|Cancer|cancer
5157777|NCT03005392|Physical therapy|physical therapy
5157778|NCT03005392|Cardiorespiratory fitness|cardiorespiratory fitness
5157779|NCT03005379|FMT|fmt
5157780|NCT03005379|recurrent c. difficile|recurrent c. difficile
5157781|NCT03005379|infectious disease|infectious disease
5157782|NCT03005379|intestine|intestine
5157783|NCT03005379|clinical trial|clinical trial
5157784|NCT03005379|gastrointestinal|gastrointestinal
5157785|NCT03005379|prevention|prevention
5157786|NCT03005379|randomized|randomized
5157787|NCT03005379|diarrhea|diarrhea
5157788|NCT03005379|fecal microbiota therapy|fecal microbiota therapy
5157789|NCT03005366|Atrial fibrillation|atrial fibrillation
5157790|NCT03005366|vernakalant|vernakalant
5157791|NCT03005366|flecainide|flecainide
5157792|NCT03005366|cardioversion|cardioversion
5157793|NCT03005301|electroacupuncture instrument|electroacupuncture instrument
5157794|NCT03005288|type 2 diabetes|type 2 diabetes
5157795|NCT03005288|obesity|obesity
5157796|NCT03005288|DXA|dxa
5157797|NCT03005288|MRI|mri
5157798|NCT03005236|Kidney transplant|kidney transplant
5157799|NCT03005236|Tacrolimus|tacrolimus
5157800|NCT03005236|Envarsus|envarsus
5157801|NCT03005236|Older adult|older adult
5157802|NCT03005236|Elderly|elderly
5157803|NCT03005158|High-sensitivity cardiac troponin I|high-sensitivity cardiac troponin i
5157804|NCT03005158|Myocardial infarction|myocardial infarction
5157805|NCT03005158|Acute coronary syndrome|acute coronary syndrome
5157806|NCT03005158|Cluster-randomized trial|cluster-randomized trial
5157807|NCT03005132|GBM; Integrative Analysis; WES|gbm; integrative analysis; wes
5157808|NCT03004989|Qualitative study|qualitative study
5157809|NCT03004989|Musculoskeletal Disorders|musculoskeletal disorders
5157810|NCT03004989|Return to Work Programme|return to work programme
5157811|NCT03004976|hematopoietic stem cells|hematopoietic stem cells
5157812|NCT03004976|umbilical cord blood|umbilical cord blood
5157813|NCT03004976|stroke|stroke
5157814|NCT03004976|ischemic stroke|ischemic stroke
5157815|NCT03004963|Peritoneal Dialysis|peritoneal dialysis
5157821|NCT03004911|quality of life|quality of life
5157822|NCT03004872|birth experience|birth experience
5157823|NCT03004872|postpartum depression|postpartum depression
5157824|NCT03004872|PTSD|ptsd
5157825|NCT03004872|pain during labor|pain during labor
5157826|NCT03004872|pain during cesarean delivery|pain during cesarean delivery
5157827|NCT03004872|non-elective induction of labor|non-elective induction of labor
5157828|NCT03004872|unplanned surgery for urgent/emergent cesarean delivery|unplanned surgery for urgent/emergent cesarean delivery
5157829|NCT03004872|postpartum hemorrhage|postpartum hemorrhage
5157830|NCT03004859|atrial fibrillation|atrial fibrillation
5157831|NCT03004859|screening|screening
5157832|NCT03004859|electrocardiogram|electrocardiogram
5157833|NCT03004859|community pharmacy|community pharmacy
5157834|NCT03004859|Germany|germany
5157835|NCT03004846|Vehicle- controlled|vehicle- controlled
5157836|NCT03004846|GSK2981278|gsk2981278
5157837|NCT03004846|Plaque psoriasis|plaque psoriasis
5157838|NCT03004820|Minor Ischemic Stroke|minor ischemic stroke
5157839|NCT03004820|Transient Ischemic Attack|transient ischemic attack
5157840|NCT03004820|Remote Ischemic Conditioning|remote ischemic conditioning
5157841|NCT03004807|Nutrition|nutrition
5157842|NCT03004807|Aging|aging
5157843|NCT03004807|Multivitamin|multivitamin
5157844|NCT03004781|parenting intervention|parenting intervention
5157845|NCT03004781|externalizing behavior|externalizing behavior
5157846|NCT03004781|emotion coaching practices|emotion coaching practices
5157847|NCT03004781|self-efficacy beliefs|self-efficacy beliefs
5157849|NCT03004742|metabolomics|metabolomics
5157850|NCT03004742|oxidative stress|oxidative stress
5157851|NCT03004729|Allergy|allergy
5157852|NCT03004729|Atopic Dermatitis|atopic dermatitis
5157853|NCT03004729|Immunoglobulin E (IgE)|immunoglobulin e (ige)
5157854|NCT03004729|CMPA|cmpa
5157855|NCT03004703|Interleukin 6|interleukin 6
5157856|NCT03004703|Tocilizumab|tocilizumab
5157857|NCT03004703|Acute coronary syndrome|acute coronary syndrome
5157858|NCT03004703|STEMI|stemi
5157859|NCT03004703|Inflammation|inflammation
5157860|NCT03004690|biosafety|biosafety
5157862|NCT03004690|clinic|clinic
5157863|NCT03004690|personal protective equipment|personal protective equipment
5157864|NCT03004690|ergonomics|ergonomics
5157865|NCT03004690|error rates|error rates
5157866|NCT03004664|Latinos|latinos
5157867|NCT03004664|Low Income|low income
5157868|NCT03004664|Self Management|self management
5157869|NCT03004664|Education|education
5157870|NCT03004664|Cultural Competence|cultural competence
5157871|NCT03004638|Atherosclerosis|atherosclerosis
5157872|NCT03004638|Cardiovascular Disease|cardiovascular disease
5157873|NCT03004638|CAD|cad
5157874|NCT03004638|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
5157875|NCT03004612|prediabetes|prediabetes
5157876|NCT03004599|Valvular Heart Disease|valvular heart disease
5157877|NCT03004599|Critical Aortic Stenosis|critical aortic stenosis
5157878|NCT03004599|Severe Aortic Stenosis|severe aortic stenosis
5157879|NCT03004599|High Risk|high risk
5157880|NCT03004599|Aortic Valve Replacement|aortic valve replacement
5157881|NCT03004599|Cardiovascular Disease|cardiovascular disease
5157882|NCT03004599|Aortic Stenosis|aortic stenosis
5157883|NCT03004599|Heart Valve Therapy|heart valve therapy
5157884|NCT03004599|Transcatheter|transcatheter
5157885|NCT03004599|Transfemoral|transfemoral
5157886|NCT03004599|TAVI|tavi
5157887|NCT03004599|TAVR|tavr
5157888|NCT03004599|ACURATE neo™ Aortic Bioprosthesis|acurate neo™ aortic bioprosthesis
5157889|NCT03004599|ACURATE TF™ Transfemoral Delivery System|acurate tf™ transfemoral delivery system
5157890|NCT03004586|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
5157891|NCT03004586|Lung cancer|lung cancer
5157892|NCT03004586|Ultrasound-guided transbronchial needle aspiration|ultrasound-guided transbronchial needle aspiration
5157893|NCT03004586|EBUS-TBNA|ebus-tbna
5157894|NCT03004586|25-gauge needle|25-gauge needle
5157895|NCT03004586|22-gauge needle|22-gauge needle
5157896|NCT03004573|Parkinson Disease|parkinson disease
5157897|NCT03004573|emotional recognition|emotional recognition
5157898|NCT03004573|Deep Brain Stimulation|deep brain stimulation
5157899|NCT03004560|Bariatric|bariatric
5157900|NCT03004560|standard laparoscopic surgery|standard laparoscopic surgery
5157901|NCT03004560|minimally invasive|minimally invasive
5157902|NCT03004560|scars|scars
5157903|NCT03004560|psychology|psychology
5157904|NCT03004534|Breast Cancer|breast cancer
5157905|NCT03004534|Breast Carcinoma|breast carcinoma
5157906|NCT03004534|Breast Tumours|breast tumours
5157907|NCT03004534|Early Breast Cancer|early breast cancer
5157908|NCT03004521|Lithium|lithium
5157909|NCT03004521|Quetiapine|quetiapine
5153375|NCT03033511|Cancer|cancer
5157914|NCT03004508|DNA cell maintenance|dna cell maintenance
5157915|NCT03004482|NICU|nicu
5157916|NCT03004482|Recorded video images|recorded video images
5157917|NCT03004482|physiological disorders|physiological disorders
5157918|NCT03004456|Phlebotomy|phlebotomy
5157919|NCT03004456|Pain|pain
5157920|NCT03004456|Distress|distress
5157921|NCT03004443|Psychiatry|psychiatry
5157922|NCT03004430|Mantra|mantra
5157923|NCT03004430|Meditation|meditation
5157924|NCT03004391|Shared decision making|shared decision making
5157925|NCT03004391|Follow-up|follow-up
5157926|NCT03004378|obesity|obesity
5157927|NCT03004378|adolescent|adolescent
5157928|NCT03004378|tracking device|tracking device
5157929|NCT03004378|fitbit|fitbit
5157930|NCT03004326|DIV|div
5157931|NCT03004326|CSS|css
5157932|NCT03004326|EGPA|egpa
5157933|NCT03004326|HSP|hsp
5157934|NCT03004326|GPA|gpa
5157935|NCT03004326|MPA|mpa
5157936|NCT03004326|PAN|pan
5157937|NCT03004326|Wegeners|wegeners
5157938|NCT03004313|migraine|migraine
5157939|NCT03004300|maxillary expansion|maxillary expansion
5157940|NCT03004300|adenotonsillar hypertrophy|adenotonsillar hypertrophy
5157941|NCT03004300|airway volume|airway volume
5157942|NCT03004261|cytomegalovirus infection|cytomegalovirus infection
5157943|NCT03004261|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5157944|NCT03004261|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5157945|NCT03004248|glabellar lines, frown lines|glabellar lines, frown lines
5157946|NCT03004209|Erythropoietin|erythropoietin
5157947|NCT03004209|Autoimmune encephalitis|autoimmune encephalitis
5157948|NCT03004196|White Spot Lesion|white spot lesion
5157950|NCT03004196|Chlorhexidine|chlorhexidine
5157951|NCT03004196|Streptococcus Mutans|streptococcus mutans
5157952|NCT03004196|Fixed Orthodontic Treatment|fixed orthodontic treatment
5157953|NCT03004170|HIV|hiv
5157954|NCT03004170|Motivational Interviewing|motivational interviewing
5157955|NCT03004170|Telephone|telephone
5157956|NCT03004170|Telehealth|telehealth
5157957|NCT03004170|Risky Sex|risky sex
5157958|NCT03004170|Unprotected Sex|unprotected sex
5157959|NCT03004170|Condoms|condoms
5157960|NCT03004170|Older Adults|older adults
5157961|NCT03004157|infant|infant
5157962|NCT03004157|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5157963|NCT03004157|hemodynamics|hemodynamics
5157964|NCT03004157|chest compressions|chest compressions
5157965|NCT03004105|Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma|malignant neoplasm of respiratory and intrathoracic organ carcinoma
5157966|NCT03004105|Advanced Lung Cancer|advanced lung cancer
5157967|NCT03004105|Recurrent Nonsmall Cell Lung Cancer|recurrent nonsmall cell lung cancer
5157968|NCT03004105|Selumetinib|selumetinib
5157969|NCT03004105|AZD6244|azd6244
5157970|NCT03004105|Durvalumab|durvalumab
5157971|NCT03004105|MEDI4736|medi4736
5157972|NCT03004092|bis(methylthio)gliotoxin|bis(methylthio)gliotoxin
5157973|NCT03004092|lateral flow device|lateral flow device
5157974|NCT03004092|JF5|jf5
5157975|NCT03004092|Galactomannan|galactomannan
5157976|NCT03004092|Invasive aspergillosis|invasive aspergillosis
5157977|NCT03004053|Reflectance Confocal Microscopy|reflectance confocal microscopy
5157978|NCT03004053|Normal Oral Tissue|normal oral tissue
5157979|NCT03004053|16-1652|16-1652
5157980|NCT03004027|health behaviour change|health behaviour change
5157981|NCT03004027|implementation intention|implementation intention
5157982|NCT03004027|if then plan|if then plan
5157983|NCT03004027|skin condition|skin condition
5157984|NCT03004027|visible difference|visible difference
5157985|NCT03004027|self help|self help
5157986|NCT03004014|sleep endoscopy|sleep endoscopy
5157987|NCT03004014|sedation|sedation
5157988|NCT03004001|Severe proteinuria|severe proteinuria
5157989|NCT03004001|Dyslipidemia|dyslipidemia
5157990|NCT03003975|Ablation|ablation
5157991|NCT03003975|Cryoballoon|cryoballoon
5157992|NCT03003975|Achieve|achieve
5157993|NCT03003962|NSCLC|nsclc
5157994|NCT03003962|PD-L1|pd-l1
5157995|NCT03003962|Durvalumab (MEDI4736)|durvalumab (medi4736)
5157996|NCT03003962|OS|os
5157997|NCT03003949|perimenopause|perimenopause
5157998|NCT03003949|menopause transition|menopause transition
5157999|NCT03003949|estrogen|estrogen
5158000|NCT03003949|stress|stress
5158001|NCT03003949|mood|mood
5158002|NCT03003936|Glucose tolerance|glucose tolerance
5158003|NCT03003936|MTNR1B|mtnr1b
5158004|NCT03003936|nutrigenomics|nutrigenomics
5158005|NCT03003936|Food timing|food timing
5158006|NCT03003923|Vegetable intake|vegetable intake
5158007|NCT03003923|Taste exposures|taste exposures
5158008|NCT03003923|Educational intervention|educational intervention
5158009|NCT03003923|Preschool children|preschool children
5158010|NCT03003923|Healthy eating intervention|healthy eating intervention
5158011|NCT03003910|Best Possible Self|best possible self
5158019|NCT03003871|randomized controled clinical trial|randomized controled clinical trial
5158020|NCT03003871|oral health promotion|oral health promotion
5158022|NCT03003858|hyaluronic acid|hyaluronic acid
5158023|NCT03003858|pediatrics|pediatrics
5158024|NCT03003858|medical devices|medical devices
5158025|NCT03003806|Insulin pump treatment|insulin pump treatment
5158026|NCT03003806|Type 1 diabetes|type 1 diabetes
5158027|NCT03003806|Pump setting advisor|pump setting advisor
5158028|NCT03003689|Scaling and Root Planing|scaling and root planing
5158029|NCT03003689|Er:YAG|er:yag
5158030|NCT03003663|Fall Prevention|fall prevention
5158031|NCT03003663|Interrupted Time-Series Study|interrupted time-series study
5158032|NCT03003663|Patient Safety|patient safety
5158033|NCT03003663|Patient-Centered Care|patient-centered care
5158034|NCT03003663|Patient Monitoring|patient monitoring
5158035|NCT03003663|Health Care Technology|health care technology
5158036|NCT03003663|Mobile Applications|mobile applications
5158037|NCT03003663|Bedside Monitor|bedside monitor
5158038|NCT03003663|Mechanical Fall|mechanical fall
5158039|NCT03003650|Severe Symptomatic Aortic Valve Stenosis|severe symptomatic aortic valve stenosis
5158040|NCT03003624|Incisions|incisions
5158041|NCT03003624|microdissection needle|microdissection needle
5158042|NCT03003598|Intraocular pressure|intraocular pressure
5158043|NCT03003598|videolaryngoscope|videolaryngoscope
5158044|NCT03003598|direct laryngoscope|direct laryngoscope
5158045|NCT03003585|intraocular pressure|intraocular pressure
5166935|NCT02949011|Flu|flu
5158047|NCT03003585|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5158048|NCT03003572|Sjögren's syndrome|sjögren's syndrome
5158049|NCT03003572|Immunoglobulin E|immunoglobulin e
5158050|NCT03003572|Anti-Ro/SSA|anti-ro/ssa
5158051|NCT03003572|Autoimmune disease|autoimmune disease
5158052|NCT03003572|Biomarker|biomarker
5158053|NCT03003559|COPD Exacerbation|copd exacerbation
5158054|NCT03003559|High Flow Oxygen|high flow oxygen
5158055|NCT03003559|Nasal Cannula|nasal cannula
5158056|NCT03003559|mild|mild
5158057|NCT03003533|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5158058|NCT03003533|Blood Coagulation Disorders|blood coagulation disorders
5158059|NCT03003533|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5158060|NCT03003533|Coagulation Protein Disorders|coagulation protein disorders
5158061|NCT03003533|Factor VIII (FVIII)|factor viii (fviii)
5158062|NCT03003533|Factor VIII (FVIII) Deficiency|factor viii (fviii) deficiency
5158063|NCT03003533|Factor VIII (FVIII) Gene|factor viii (fviii) gene
5158064|NCT03003533|Factor VIII (FVIII) Protein|factor viii (fviii) protein
5158065|NCT03003533|Genetic Diseases, Inborn|genetic diseases, inborn
5158066|NCT03003533|Genetic Diseases, X-Linked|genetic diseases, x-linked
5158067|NCT03003533|Gene Therapy|gene therapy
5158068|NCT03003533|Gene Transfer|gene transfer
5158069|NCT03003533|Hematologic Diseases|hematologic diseases
5158070|NCT03003533|Hemorrhagic Disorders|hemorrhagic disorders
5158071|NCT03003533|Recombinant|recombinant
5158072|NCT03003533|Vector|vector
5158073|NCT03003520|Lymphoma|lymphoma
5158074|NCT03003520|Diffuse-large B-Cell Lymphoma|diffuse-large b-cell lymphoma
5158075|NCT03003520|Durvalumab|durvalumab
5158076|NCT03003520|Anti-PD-L1 Antibody|anti-pd-l1 antibody
5158077|NCT03003520|MEDI4736|medi4736
5158078|NCT03003520|Immune Checkpoint|immune checkpoint
5158079|NCT03003520|Rituximab|rituximab
5158080|NCT03003520|Cyclophosphamide|cyclophosphamide
5158081|NCT03003520|Doxorubicin|doxorubicin
5158082|NCT03003520|Vincristine|vincristine
5158083|NCT03003520|Prednisone/Prednisolone|prednisone/prednisolone
5158084|NCT03003520|Lenalidomide|lenalidomide
5158085|NCT03003507|Hyperglycemia|hyperglycemia
5158086|NCT03003507|Fructose|fructose
5158087|NCT03003507|Diabetes mellitus|diabetes mellitus
5158088|NCT03003507|Enteral Nutrition|enteral nutrition
5158089|NCT03003507|Glycemic Variability|glycemic variability
5158090|NCT03003468|Anti-PD-1|anti-pd-1
5158091|NCT03003468|Pembrolizumab|pembrolizumab
5158092|NCT03003468|Imprime PGG|imprime pgg
5158093|NCT03003468|MK-3475|mk-3475
5158094|NCT03003455|Nasotracheal Intubation|nasotracheal intubation
5158095|NCT03003442|Multivitamin/mineral|multivitamin/mineral
5158096|NCT03003442|Exercise|exercise
5158097|NCT03003442|Fatigue|fatigue
5158098|NCT03003442|Stress|stress
5158099|NCT03003442|Arousal|arousal
5158100|NCT03003442|Energy expenditure|energy expenditure
5158101|NCT03003442|Recovery biomarkers|recovery biomarkers
5158102|NCT03003442|Cognition|cognition
5158103|NCT03003429|Heart rate variability|heart rate variability
5153582|NCT03032302|TBI|tbi
5158105|NCT03003429|Autonomic dysfunction|autonomic dysfunction
5158106|NCT03003403|mHealth|mhealth
5158107|NCT03003403|Digital Health|digital health
5158108|NCT03003403|Primary Care|primary care
5158109|NCT03003403|Pragmatic Clinical Trial|pragmatic clinical trial
5158110|NCT03003403|Behavior Change|behavior change
5158111|NCT03003403|Weight Management|weight management
5158112|NCT03003390|child|child
5158113|NCT03003390|critical illness|critical illness
5158114|NCT03003390|venous thromboembolism|venous thromboembolism
5158115|NCT03003390|enoxaparin|enoxaparin
5158116|NCT03003390|thrombin generation|thrombin generation
5158117|NCT03003377|Sevoflurane|sevoflurane
5158118|NCT03003377|Remifentanil|remifentanil
5158119|NCT03003377|Laryngeal mask supreme|laryngeal mask supreme
5158120|NCT03003377|laryngeal mask proseal|laryngeal mask proseal
5158121|NCT03003351|Fistula|fistula
5158122|NCT03003351|Cohort Study|cohort study
5158123|NCT03003338|chronic HCV Genotype 1b infection|chronic hcv genotype 1b infection
5158124|NCT03003338|HCV RNA|hcv rna
5158125|NCT03003338|OBV/PTV/r in combination with DSV|obv/ptv/r in combination with dsv
5158126|NCT03003338|neuropsychiatric manifestations|neuropsychiatric manifestations
5158127|NCT03003325|low risk of thrombosis|low risk of thrombosis
5158128|NCT03003325|Interferon|interferon
5158129|NCT03003312|Urolithiasis|urolithiasis
5158130|NCT03003312|Uyghur|uyghur
5158131|NCT03003312|Prevalence|prevalence
5158132|NCT03003312|Associated factors|associated factors
5158133|NCT03003312|Children|children
5158134|NCT03003299|Sapien 3|sapien 3
5158135|NCT03003299|Partner 3|partner 3
5775445|NCT00220493|PASAT|pasat
5158136|NCT03003299|cardiovascular disease|cardiovascular disease
5158137|NCT03003299|heart disease|heart disease
5158138|NCT03003299|aortic stenosis|aortic stenosis
5158139|NCT03003299|SAVR|savr
5158140|NCT03003299|TAVR|tavr
5158141|NCT03003299|failing surgical valve|failing surgical valve
5158142|NCT03003299|failing bioprosthetic valve|failing bioprosthetic valve
5158143|NCT03003299|failing valve|failing valve
5158144|NCT03003286|Contingency Behavior Management|contingency behavior management
5158154|NCT03003286|intervention|intervention
5158155|NCT03003221|Parent training|parent training
5158156|NCT03003221|Dental care|dental care
5158157|NCT03003169|surgery|surgery
5158158|NCT03003169|breast cancer|breast cancer
5962115|NCT04282915|Stigma|stigma
5158159|NCT03003169|quality of life|quality of life
5158160|NCT03003156|magnetic seizure therapy|magnetic seizure therapy
5158161|NCT03003156|schizophrenia|schizophrenia
5158162|NCT03003156|controlled trial|controlled trial
5158163|NCT03003156|cognition|cognition
5158164|NCT03003130|Hyaluronic acid|hyaluronic acid
5158165|NCT03003130|Comparative study|comparative study
5158167|NCT03003117|Infant|infant
5158168|NCT03003117|Diet|diet
5158169|NCT03003117|Growth|growth
5158170|NCT03003117|Breastfeeding|breastfeeding
5158171|NCT03003117|Complementary feeding|complementary feeding
5158172|NCT03003117|Pregnancy|pregnancy
5158173|NCT03003117|Body mass index|body mass index
5158174|NCT03003117|Social disadvantage|social disadvantage
5158175|NCT03003117|Randomized controlled trial|randomized controlled trial
5158176|NCT03003117|Education|education
5158177|NCT03003117|Food vouchers|food vouchers
5158178|NCT03003104|Skin diseases|skin diseases
5158179|NCT03003104|rosacea|rosacea
5158180|NCT03003078|Pancreatic cancer|pancreatic cancer
5158181|NCT03003078|Pancreas|pancreas
5158182|NCT03003078|metastases|metastases
5158183|NCT03003078|pancreatic tumour|pancreatic tumour
5158184|NCT03003078|unresectable|unresectable
5158185|NCT03003078|locally advanced|locally advanced
5158186|NCT03003078|implantable|implantable
5158187|NCT03003078|radiographic|radiographic
5158188|NCT03003078|device|device
5158189|NCT03003078|Phosphorous-32|phosphorous-32
5158190|NCT03003078|OncoSil™|oncosil™
5158191|NCT03003078|brachytherapy|brachytherapy
5158192|NCT03003078|FOLFIRINOX|folfirinox
5158193|NCT03003078|gemcitabine|gemcitabine
5158194|NCT03003078|nab-paclitaxel|nab-paclitaxel
5158195|NCT03003078|Abraxane|abraxane
5158196|NCT03003065|Inoperable cholangiocarcinoma|inoperable cholangiocarcinoma
5158197|NCT03003065|Photodynamic therapy|photodynamic therapy
5158198|NCT03003065|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5158199|NCT03003052|dental implants|dental implants
5158200|NCT03003052|edentulous|edentulous
5158201|NCT03003052|dental hygiene|dental hygiene
5158202|NCT03003052|evidence-based dentistry|evidence-based dentistry
5158203|NCT03003039|GB241|gb241
5158204|NCT03003039|Rituximab|rituximab
5158205|NCT03003039|B-cell Lymphoma|b-cell lymphoma
5158206|NCT03003026|motor learning|motor learning
5158207|NCT03003026|participation|participation
5158208|NCT03003013|Odontogenic cysts|odontogenic cysts
5158209|NCT03003013|Bone substitutes materials|bone substitutes materials
5158210|NCT03003013|SYMBIOS®|symbios®
5158211|NCT03003013|Platelets rich fibrin (PRF)|platelets rich fibrin (prf)
5158212|NCT03003013|Bone regeneration|bone regeneration
5158213|NCT03002974|Gout|gout
5158214|NCT03002974|Interleukin 1 receptor antagonist|interleukin 1 receptor antagonist
5158215|NCT03002974|IL-1 receptor antagonist|il-1 receptor antagonist
5158217|NCT03002896|Caregivers|caregivers
5158218|NCT03002896|Pep-pal|pep-pal
5158219|NCT03002896|Pep-Pal + Treatment as Usual|pep-pal + treatment as usual
5158220|NCT03002896|Treatment as Usual|treatment as usual
5158221|NCT03002857|Laryngeal Mask Airway|laryngeal mask airway
5158222|NCT03002857|Urologic Surgical Procedure|urologic surgical procedure
5158223|NCT03002831|CIK|cik
5158224|NCT03002831|Chemotherapy|chemotherapy
5158225|NCT03002831|Pancreatic Cancer|pancreatic cancer
5158226|NCT03002818|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
5158227|NCT03002818|Genotype 1|genotype 1
5158228|NCT03002818|Paritaprevir|paritaprevir
5158229|NCT03002818|Ritonavir|ritonavir
5158230|NCT03002818|ombitasvir|ombitasvir
5158231|NCT03002818|Dasabuvir|dasabuvir
5158232|NCT03002818|Sustained Virological Response|sustained virological response
5158233|NCT03002805|Phase I|phase i
5158234|NCT03002805|CBT-1®|cbt-1®
5158235|NCT03002805|Doxorubicin|doxorubicin
5158236|NCT03002805|Sarcoma|sarcoma
5158237|NCT03002792|anesthesia|anesthesia
5158238|NCT03002792|neurodevelopment|neurodevelopment
5158239|NCT03002792|dental caries|dental caries
5158240|NCT03002753|OCD|ocd
5158241|NCT03002753|obsessive-compulsive disorder|obsessive-compulsive disorder
5158242|NCT03002753|cognitive therapy|cognitive therapy
5167123|NCT02947724|laparoscopy|laparoscopy
5158243|NCT03002753|metacognitive therapy|metacognitive therapy
5158244|NCT03002753|cognitive restructuring|cognitive restructuring
5158245|NCT03002753|detached mindfulness|detached mindfulness
5158246|NCT03002753|comparison|comparison
5158247|NCT03002753|Germany|germany
5158248|NCT03002753|Muenster|muenster
5158249|NCT03002753|Christoph-Dornier-Stiftung|christoph-dornier-stiftung
5158250|NCT03002753|metacognition|metacognition
5158251|NCT03002727|Colorectal cancer|colorectal cancer
5158253|NCT03002727|Colorectal cancer stem cells|colorectal cancer stem cells
5158254|NCT03002714|Resistance Training|resistance training
5158255|NCT03002714|Psychological Stress|psychological stress
5158256|NCT03002714|Aging|aging
5158257|NCT03002714|Hypertension|hypertension
5158258|NCT03002714|Autonomic Nervous System|autonomic nervous system
5158259|NCT03002701|Prevention|prevention
5158260|NCT03002701|Critical care|critical care
5158261|NCT03002701|Delirium|delirium
5158262|NCT03002701|Nurse|nurse
5158264|NCT03002675|Adipose tissue|adipose tissue
5158265|NCT03002675|Type 2 diabetes|type 2 diabetes
5158266|NCT03002649|Dermatomyositis|dermatomyositis
5158267|NCT03002649|Tofacitinib|tofacitinib
5158268|NCT03002649|Refractory dermatomyositis|refractory dermatomyositis
5158269|NCT03002636|Obesity|obesity
5158270|NCT03002636|Anesthesia Complications|anesthesia complications
5158271|NCT03002636|Body Mass Index (BMI)|body mass index (bmi)
5158272|NCT03002623|Dual Inhibitor of HDAC and P13K Signaling|dual inhibitor of hdac and p13k signaling
5158273|NCT03002623|HDAC2|hdac2
5158274|NCT03002623|EGFR/RAS/RAF/MEK/ERK Signaling Pathway Inhibition|egfr/ras/raf/mek/erk signaling pathway inhibition
5158275|NCT03002584|IBS, population|ibs, population
5158276|NCT03002558|Hypertension|hypertension
5158277|NCT03002558|Continuous Positive Airway Pressure|continuous positive airway pressure
5158278|NCT03002558|Obstructive Sleep Apnea|obstructive sleep apnea
5158279|NCT03002558|Cardiovascular Diseases|cardiovascular diseases
5158280|NCT03002545|Magnesium|magnesium
5158281|NCT03002545|Type II diabetes|type ii diabetes
5158282|NCT03002545|magnesium-sensitive genes|magnesium-sensitive genes
5158283|NCT03002532|Breast cancer|breast cancer
5158284|NCT03002532|Brain metastasis|brain metastasis
5158285|NCT03002532|Whole brain radiotherapy|whole brain radiotherapy
5158286|NCT03002532|Hippocampal avoidance|hippocampal avoidance
5158287|NCT03002532|Neurocognitive function|neurocognitive function
5158288|NCT03002532|intracranial failure|intracranial failure
5158289|NCT03002506|ceftolozane|ceftolozane
5158290|NCT03002506|tazobactam|tazobactam
5158291|NCT03002493|Rifampicin|rifampicin
5158292|NCT03002493|Pharmacokinetics|pharmacokinetics
5158293|NCT03002493|Eribulin Mesylate|eribulin mesylate
5158294|NCT03002493|E7389|e7389
5158295|NCT03002493|Advanced Solid Tumors|advanced solid tumors
5158296|NCT03002493|Tumors|tumors
5158297|NCT03002454|99mTc Pertechnetate|99mtc pertechnetate
5158298|NCT03002454|Sodium Pertechnetate|sodium pertechnetate
5158299|NCT03002454|Technetium|technetium
5158300|NCT03002454|Molybdenum|molybdenum
5158302|NCT03002454|neutron activation|neutron activation
5158303|NCT03002402|asthma|asthma
5158304|NCT03002402|insomnia|insomnia
5158305|NCT03002402|cognitive-behavioral treatment|cognitive-behavioral treatment
5158306|NCT03002389|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5158307|NCT03002389|COPD|copd
5158308|NCT03002389|emphysema|emphysema
5158309|NCT03002389|MRI|mri
5158310|NCT03002389|hyper polarized gas MRI|hyper polarized gas mri
5158311|NCT03002363|autism|autism
5158312|NCT03002363|audiology|audiology
5158313|NCT03002363|video modeling|video modeling
5158314|NCT03002363|testing compliance|testing compliance
5158315|NCT03002350|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
5158316|NCT03002350|Optically induced dielectrophoresis (ODEP)|optically induced dielectrophoresis (odep)
5153774|NCT03030963|Blood loss|blood loss
5158322|NCT03002324|Childhood Vaccination|childhood vaccination
5158324|NCT03002324|Health Belief Model|health belief model
5158325|NCT03002311|Bioinformatics|bioinformatics
5158326|NCT03002311|Electronic pharmacology|electronic pharmacology
5158327|NCT03002311|Mobile health|mobile health
5158328|NCT03002311|Electronic health|electronic health
5158329|NCT03002311|Adherence|adherence
5158330|NCT03002311|Digital health|digital health
5158331|NCT03002311|Health information technology|health information technology
5158332|NCT03002311|mHealth|mhealth
5158333|NCT03002311|eHealth|ehealth
5158334|NCT03002259|cardiac surgery|cardiac surgery
5158335|NCT03002233|TRK-820|trk-820
5158336|NCT03002233|Hemodialysis|hemodialysis
5158337|NCT03002233|Uremic Pruritus|uremic pruritus
5158338|NCT03002194|rhytides|rhytides
5158339|NCT03002194|wrinkle|wrinkle
5158340|NCT03002142|Alzheimer|alzheimer
5158341|NCT03002142|Hearing loss|hearing loss
5158342|NCT03002142|Cognition|cognition
5158343|NCT03002142|Quality of life|quality of life
5158344|NCT03002142|Hearing aids|hearing aids
5158350|NCT03002090|Chinese medicine|chinese medicine
5158351|NCT03002090|BaZhen KeLi|bazhen keli
5158352|NCT03002064|Esophagus squamous carcinoma|esophagus squamous carcinoma
5158353|NCT03002064|First-line chemotherapy|first-line chemotherapy
5158354|NCT03002064|Docetaxel|docetaxel
5158355|NCT03002064|Cisplatin|cisplatin
5158356|NCT03002064|5-fluorouracil|5-fluorouracil
5158357|NCT03002038|neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
5158358|NCT03002038|azathioprine|azathioprine
5158360|NCT03002038|clinical trial|clinical trial
5158361|NCT03002038|annual relapse rate|annual relapse rate
5158362|NCT03002038|expanded disability status scale|expanded disability status scale
5158363|NCT03002012|cryptococcal antigen|cryptococcal antigen
5158364|NCT03002012|preemptive treatment|preemptive treatment
5158365|NCT03002012|CRAG+|crag+
5158366|NCT03002012|sertraline|sertraline
5158367|NCT03002012|fluconazole|fluconazole
5158368|NCT03002012|randomized clinical trial|randomized clinical trial
5158370|NCT03001999|Diabetes|diabetes
5158371|NCT03001999|Positive Psychology|positive psychology
5158372|NCT03001999|Physical Activity|physical activity
5158373|NCT03001986|effectiveness|effectiveness
5158378|NCT03001973|Lupus nephritis|lupus nephritis
5030865|NCT03806426|FAP|fap
5158379|NCT03001973|Patient survival|patient survival
5158380|NCT03001973|Renal survival|renal survival
5158381|NCT03001947|IgA nephropathy|iga nephropathy
5158382|NCT03001947|All-cause mortality|all-cause mortality
5158383|NCT03001947|Cardiovascular mortality|cardiovascular mortality
5158384|NCT03001947|A composite renal outcome|a composite renal outcome
5158385|NCT03001934|Nephrotic syndrome|nephrotic syndrome
5158386|NCT03001934|Treatment response|treatment response
5158387|NCT03001934|Renal function|renal function
5158388|NCT03001921|Hemodialysis|hemodialysis
5158389|NCT03001921|Patient survival|patient survival
5158390|NCT03001921|Quality of life|quality of life
5158391|NCT03001921|Hemodialysis access|hemodialysis access
5158392|NCT03001908|shoulder|shoulder
5158393|NCT03001908|mobilization|mobilization
5158394|NCT03001908|electromyography|electromyography
5158395|NCT03001908|imaging ultrasound|imaging ultrasound
5158396|NCT03001804|Multiple Myeloma|multiple myeloma
5158397|NCT03001804|Revlimid|revlimid
5158398|NCT03001804|Lenalidomide|lenalidomide
5158399|NCT03001804|Non-transplantable|non-transplantable
5158400|NCT03001791|CO2 laser|co2 laser
5158401|NCT03001791|thermal damage zone|thermal damage zone
5158402|NCT03001791|Er:YAG laser|er:yag laser
5158403|NCT03001778|Physical Activity|physical activity
5158404|NCT03001778|Older Adults|older adults
5158405|NCT03001778|Independent Living Facilities|independent living facilities
5158406|NCT03001778|Multimedia technology|multimedia technology
5158407|NCT03001752|post-extraction dental implant|post-extraction dental implant
5158408|NCT03001752|immediate dental implant|immediate dental implant
5158409|NCT03001752|open flap|open flap
5158410|NCT03001752|flapless|flapless
5158411|NCT03001752|bone grafting|bone grafting
5158412|NCT03001752|CT Cone Beam|ct cone beam
5158413|NCT03001687|hepcidin|hepcidin
5158414|NCT03001687|sepsis|sepsis
5158415|NCT03001687|surgery|surgery
5158416|NCT03001687|vitamin D|vitamin d
5158417|NCT03001661|Propess|propess
5158418|NCT03001661|Dilapan-S|dilapan-s
5158419|NCT03001661|Dinoprostone|dinoprostone
5158420|NCT03001661|Labour|labour
5158421|NCT03001661|Induction|induction
5158422|NCT03001661|Child birth|child birth
5153880|NCT03030339|breast milk intake|breast milk intake
5158436|NCT03001466|Cataract|cataract
5158437|NCT03001466|Urea-loaded NPs|urea-loaded nps
5158438|NCT03001466|TEM examination|tem examination
5158439|NCT03001453|Exparel|exparel
5158440|NCT03001453|total hip replacement|total hip replacement
5158441|NCT03001453|bupivacaine|bupivacaine
5158442|NCT03001440|REMS|rems
5158443|NCT03001440|Smoking cessation|smoking cessation
5158444|NCT03001440|WELLBUTRIN|wellbutrin
5158445|NCT03001440|ZYBAN|zyban
5158446|NCT03001440|Neuropsychiatric adverse events|neuropsychiatric adverse events
5158447|NCT03001388|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
5167326|NCT02946385|booster|booster
5158454|NCT03001336|Thyroid|thyroid
5158455|NCT03001336|Diabetes Mellitus|diabetes mellitus
5158456|NCT03001297|atherosclerosis; acute coronary syndrome; MEDI5884|atherosclerosis; acute coronary syndrome; medi5884
5158457|NCT03001271|Angiotensin-(1-7)|angiotensin-(1-7)
5158458|NCT03001271|Renin-angiotensin System|renin-angiotensin system
5158459|NCT03001271|Autonomic Nervous System|autonomic nervous system
5158460|NCT03001245|adolescents|adolescents
5158461|NCT03001245|depression|depression
5158462|NCT03001245|psychotherapy|psychotherapy
5158463|NCT03001245|interpersonal therapy|interpersonal therapy
5158464|NCT03001232|Movement-oriented Dementia Care|movement-oriented dementia care
5158465|NCT03001232|QoL|qol
5158466|NCT03001232|ADL|adl
5158467|NCT03001232|Nursing Home|nursing home
5158468|NCT03001193|Primary slow progress|primary slow progress
5158469|NCT03001193|Prolonged latent phase|prolonged latent phase
5158470|NCT03001193|Labor arrest|labor arrest
5158471|NCT03001180|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
5158474|NCT03001180|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
5158475|NCT03001180|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5158476|NCT03001180|Biomarkers|biomarkers
5158477|NCT03001180|GLA|gla
5158478|NCT03001180|KLA|kla
5158479|NCT03001180|KHE|khe
5158480|NCT03001180|GSD|gsd
5158484|NCT03001141|MultiPoint Pacing|multipoint pacing
5158485|NCT03001141|Heart Failure|heart failure
5158486|NCT03001141|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5158487|NCT03001141|Quadripolar pacing|quadripolar pacing
5158488|NCT03001115|Adalimumab|adalimumab
5158489|NCT03001115|Safety|safety
5158490|NCT03001115|Hidradenitis Suppurativa|hidradenitis suppurativa
5158491|NCT03001115|Korean participants|korean participants
5158492|NCT03001102|Preoperative Care|preoperative care
5158493|NCT03001102|Baths|baths
5962116|NCT04282915|Developing countries|developing countries
5158494|NCT03001102|Chlorhexidine|chlorhexidine
5158495|NCT03001102|Soaps|soaps
5158496|NCT03001102|Povidone-Iodine|povidone-iodine
5158497|NCT03001102|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5158498|NCT03001102|Surgical Wound Infection|surgical wound infection
5158499|NCT03001089|Neonatology|neonatology
5158500|NCT03001089|Endocrinology|endocrinology
5158501|NCT03001076|hyperlididemia|hyperlididemia
5158502|NCT03001076|LDL|ldl
5158503|NCT03001076|cholesterol|cholesterol
5158504|NCT03001076|statin intolerance|statin intolerance
5158505|NCT03001037|Functional Outcome Measures|functional outcome measures
5158506|NCT03001037|Wearable Sensors|wearable sensors
5158507|NCT03001037|ViMove|vimove
5158508|NCT03001037|Low Back Pain|low back pain
5158509|NCT03001037|Range of Movement|range of movement
5158510|NCT03001037|Muscle Activity|muscle activity
5158511|NCT03000998|HPV|hpv
5158512|NCT03000998|Cancer|cancer
5158513|NCT03000985|schizophrenia|schizophrenia
5158514|NCT03000985|psychoeducation program|psychoeducation program
5158515|NCT03000985|family caregiver|family caregiver
5158516|NCT03000985|relapse|relapse
5158517|NCT03000985|medication adherence|medication adherence
5158518|NCT03000985|burden|burden
5158519|NCT03000972|Augmentation|augmentation
5158520|NCT03000972|PET-CT|pet-ct
5158521|NCT03000972|Positron Emission Tomography|positron emission tomography
5158522|NCT03000972|Fluorine-18|fluorine-18
5158523|NCT03000946|Pancreatectomy|pancreatectomy
5158524|NCT03000946|Somatostatin analogue|somatostatin analogue
5158532|NCT03000907|obese|obese
5158533|NCT03000907|elderly|elderly
5158534|NCT03000907|physical exercise|physical exercise
5158535|NCT03000894|cognitive-behavioral therapy for insomnia|cognitive-behavioral therapy for insomnia
5158536|NCT03000894|insomnia|insomnia
5158537|NCT03000894|mood disorder|mood disorder
5158538|NCT03000868|Colonic Polyps|colonic polyps
5158539|NCT03000868|Endoscopic Mucosal Resection|endoscopic mucosal resection
5158540|NCT03000868|Colonoscopy|colonoscopy
5158541|NCT03000855|Malignant biliary obstruction|malignant biliary obstruction
5158542|NCT03000855|EUS - guided choledocho-duodenostomy|eus - guided choledocho-duodenostomy
5158543|NCT03000855|ERCP with covered metallic stents|ercp with covered metallic stents
5158544|NCT03000842|autonomic control|autonomic control
5167428|NCT02945748|pediatric|pediatric
5158545|NCT03000842|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
5158546|NCT03000842|transauricular vagal nerve stimulation|transauricular vagal nerve stimulation
5158547|NCT03000829|Code blue|code blue
5158548|NCT03000829|Code team|code team
5158549|NCT03000829|Crisis team leadership|crisis team leadership
5673418|NCT00608322|Septic shock|septic shock
5158550|NCT03000829|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5158551|NCT03000829|Telemedicine|telemedicine
5158552|NCT03000829|Simulation|simulation
5158553|NCT03000829|Mock code|mock code
5158554|NCT03000829|In-hospital cardiac arrest|in-hospital cardiac arrest
5158555|NCT03000790|Anterior disc displacement|anterior disc displacement
5158556|NCT03000790|TMD therapy|tmd therapy
5158557|NCT03000790|internal derangement|internal derangement
5158558|NCT03000790|Lingual Ring|lingual ring
5158559|NCT03000777|melatonin|melatonin
5158560|NCT03000777|zinc|zinc
5158561|NCT03000777|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5158562|NCT03000777|Chronic Fatigue Syndrome|chronic fatigue syndrome
5158563|NCT03000777|sleep|sleep
5158564|NCT03000777|pain|pain
5158565|NCT03000764|Skin biopsy|skin biopsy
5158566|NCT03000764|Radiotherapy|radiotherapy
5158567|NCT03000764|RNA biomarker|rna biomarker
5158568|NCT03000764|HSP biomarker|hsp biomarker
5158569|NCT03000764|Exon junction array|exon junction array
5158570|NCT03000764|Gene expression|gene expression
5158571|NCT03000764|Radiosensitivity prediction|radiosensitivity prediction
5158573|NCT03000751|CT exam|ct exam
5158574|NCT03000751|ionizing radiation|ionizing radiation
5158575|NCT03000751|medical imaging|medical imaging
5158576|NCT03000751|cat scan|cat scan
5158577|NCT03000751|radiation|radiation
5158578|NCT03000738|CD16- monocyte/CD16+ monocyte ratio|cd16- monocyte/cd16+ monocyte ratio
5158579|NCT03000738|CytoDiff flow cytometric system|cytodiff flow cytometric system
5158580|NCT03000738|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5158581|NCT03000738|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5158582|NCT03000738|prognosis|prognosis
5158583|NCT03000712|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
5158584|NCT03000712|osteoarthritis|osteoarthritis
5158585|NCT03000712|degenerative arthritis|degenerative arthritis
5158586|NCT03000712|kyung hee university hospital|kyung hee university hospital
5158588|NCT03000712|Rbio|rbio
5158589|NCT03000712|Osteoarthritis, Knee|osteoarthritis, knee
5158590|NCT03000712|High tibial osteotomy|high tibial osteotomy
5158591|NCT03000712|Joint Diseases|joint diseases
5158592|NCT03000699|cognitive bias modification|cognitive bias modification
5158593|NCT03000699|interpretation bias|interpretation bias
5158594|NCT03000699|suicidal ideation|suicidal ideation
5158595|NCT03000699|depression|depression
5158596|NCT03000686|GSK2586881, Acute hypoxia, Exercise|gsk2586881, acute hypoxia, exercise
5158597|NCT03000660|Amyloidosis|amyloidosis
5158598|NCT03000660|AL Amyloidosis|al amyloidosis
5158599|NCT03000660|Amyloid Light Chain Amylodosis|amyloid light chain amylodosis
5158600|NCT03000660|ABT-199|abt-199
5158601|NCT03000660|Venetoclax|venetoclax
5158602|NCT03000647|Pelvic floor muscle exercise|pelvic floor muscle exercise
5158603|NCT03000647|Supervision|supervision
5158604|NCT03000647|Physiotherapy|physiotherapy
5031034|NCT03805334|sleep|sleep
5158605|NCT03000621|MicroRNA|microrna
5158606|NCT03000621|miR-122|mir-122
5158607|NCT03000621|Diagnosis|diagnosis
5158608|NCT03000621|Prognosis|prognosis
5158609|NCT03000595|eczema|eczema
5158610|NCT03000569|Parkinson|parkinson
5158611|NCT03000543|vitamin A|vitamin a
5158612|NCT03000543|vitamin A isotope|vitamin a isotope
5158613|NCT03000543|Inflammation|inflammation
5158614|NCT03000530|Depression|depression
5158615|NCT03000517|levofloxacin|levofloxacin
5158616|NCT03000517|multi-drug resistant TB|multi-drug resistant tb
5158620|NCT03000465|intra-abdominal insufflation|intra-abdominal insufflation
5158621|NCT03000465|intra-abdominal pressures|intra-abdominal pressures
5158622|NCT03000465|abdominal compliance|abdominal compliance
5158623|NCT03000452|Multiple Myeloma|multiple myeloma
5158625|NCT03000452|Durvalumab|durvalumab
5158626|NCT03000452|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5158627|NCT03000439|systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5158628|NCT03000439|Xeljanz|xeljanz
5158629|NCT03000439|Tofacitinib|tofacitinib
5158630|NCT03000439|sJIA|sjia
5158631|NCT03000439|CP-690 550|cp-690 550
5158632|NCT03000426|Low level laser therapy|low level laser therapy
5158633|NCT03000387|Nicotine Replacement Therapy|nicotine replacement therapy
5158634|NCT03000387|Smoking Cessation|smoking cessation
5158635|NCT03000387|Randomized Clinical Trial|randomized clinical trial
5158636|NCT03000387|Nicotine Patch|nicotine patch
5158637|NCT03000387|Abstinence|abstinence
5158638|NCT03000387|Placebo|placebo
5158639|NCT03000387|Double blind|double blind
5158640|NCT03000361|Colonoscopy|colonoscopy
5158641|NCT03000361|motorized spiral endoscopy|motorized spiral endoscopy
5158642|NCT03000361|adenoma detection rate|adenoma detection rate
5158643|NCT03000348|Exacerbation|exacerbation
5158644|NCT03000348|CF|cf
5158645|NCT03000348|Lung disease|lung disease
5158646|NCT03000348|Lung infection|lung infection
5158647|NCT03000348|Gram negative|gram negative
5158648|NCT03000348|Bacterial Infection|bacterial infection
5231462|NCT02555839|Imnovid|imnovid
5158649|NCT03000348|pneumonia|pneumonia
5158650|NCT03000348|bronchitis|bronchitis
5158651|NCT03000335|microRNA|microrna
5158652|NCT03000335|relapse|relapse
5158653|NCT03000335|blood|blood
5158654|NCT03000335|in vitro diagnostics|in vitro diagnostics
5158655|NCT03000335|prediction|prediction
5158656|NCT03000335|lab test|lab test
5158657|NCT03000296|autologous|autologous
5158658|NCT03000296|lymphoablation|lymphoablation
5158659|NCT03000296|hematopoetic stem cell transplant|hematopoetic stem cell transplant
5158660|NCT03000296|immune system|immune system
5158661|NCT03000296|Bone marrow transplant|bone marrow transplant
5158662|NCT03000283|Conivaptan|conivaptan
5158663|NCT03000270|Infarct Size|infarct size
5158664|NCT03000270|Impella|impella
5158665|NCT03000270|Unloading|unloading
5158666|NCT03000270|Left Ventricle|left ventricle
5158667|NCT03000270|PPCI|ppci
5158668|NCT03000270|STEMI|stemi
5158669|NCT03000257|Cancer|cancer
5158670|NCT03000257|Advanced Solid Tumors|advanced solid tumors
5158671|NCT03000257|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5158672|NCT03000257|Triple negative breast cancer|triple negative breast cancer
5158676|NCT03000257|Small cell lung cancer|small cell lung cancer
5158678|NCT03000257|Cholangiocarcinoma|cholangiocarcinoma
5158679|NCT03000257|Merkel cell carcinoma|merkel cell carcinoma
5158680|NCT03000257|Head and neck cancer|head and neck cancer
5158683|NCT03000205|Dextrose prolotherapy|dextrose prolotherapy
5158684|NCT03000205|patients|patients
5158685|NCT03000192|Survivorship|survivorship
5158686|NCT03000192|Cancer|cancer
5158687|NCT03000192|Recovery|recovery
5158688|NCT03000192|Self-management|self-management
5158689|NCT03000192|Cohort|cohort
5158690|NCT03000179|small bowel cancer, small bowel carcinoma|small bowel cancer, small bowel carcinoma
5158691|NCT03000127|testosterone|testosterone
5158692|NCT03000127|multiple sclerosis|multiple sclerosis
5158693|NCT03000127|fatigue|fatigue
5158694|NCT03000114|Collagenase injection|collagenase injection
5158695|NCT03000114|percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
5158696|NCT03000101|Biomarkers|biomarkers
5158697|NCT03000101|Colitis|colitis
5158698|NCT03000101|Colitis, Ulcerative|colitis, ulcerative
5158699|NCT03000101|Colonic Diseases|colonic diseases
5158700|NCT03000101|Crohn Disease|crohn disease
5158701|NCT03000101|Digestive System Diseases|digestive system diseases
5158702|NCT03000101|Fruit|fruit
5158703|NCT03000101|Fruit and Vegetable Juices|fruit and vegetable juices
5158704|NCT03000101|Gastroenteritis|gastroenteritis
5158705|NCT03000101|Gastrointestinal Diseases|gastrointestinal diseases
5158706|NCT03000101|Humans|humans
5158707|NCT03000101|Hydrolysable Tannins|hydrolysable tannins
5158708|NCT03000101|Inflammation|inflammation
5962117|NCT04282915|Mental health|mental health
5158709|NCT03000101|Inflammatory Bowel Disease|inflammatory bowel disease
5158710|NCT03000101|Intestinal Diseases|intestinal diseases
5158711|NCT03000101|Punicaceae|punicaceae
5158712|NCT03000075|BI 655066|bi 655066
5158713|NCT03000075|ABBV-066|abbv-066
5158714|NCT03000075|risankizumab|risankizumab
5158715|NCT03000062|overweight, general practice|overweight, general practice
5158716|NCT03000049|sepsis|sepsis
5158717|NCT03000049|septic shock|septic shock
5158718|NCT03000049|blood cultures|blood cultures
5158724|NCT03000023|Hepatitis C|hepatitis c
5158725|NCT03000023|Patient-Reported Outcomes|patient-reported outcomes
5158726|NCT03000023|DAA Treatment|daa treatment
5158727|NCT03000023|Qualitative|qualitative
5158728|NCT03000023|Mixed methods|mixed methods
5158729|NCT03000010|Wound Vac|wound vac
5158730|NCT03000010|Neuromuscular Scoliosis|neuromuscular scoliosis
5158731|NCT03000010|Posterior Spinal Fusion|posterior spinal fusion
5158732|NCT02999997|Physical therapy modalities|physical therapy modalities
5158733|NCT02999997|Dual-task performance|dual-task performance
5158734|NCT02999997|Parkinson's disease|parkinson's disease
5158735|NCT02999997|Active music therapy|active music therapy
5158736|NCT02999997|Physical activity|physical activity
5158737|NCT02999971|circuit class therapy|circuit class therapy
5158738|NCT02999971|ICF model|icf model
5158739|NCT02999971|aquatic therapy|aquatic therapy
5158740|NCT02999971|neuro-rehabilitation|neuro-rehabilitation
5158741|NCT02999945|preterm infants|preterm infants
5158742|NCT02999945|SGA infants|sga infants
5158743|NCT02999945|IUGR infants|iugr infants
5158744|NCT02999945|growth|growth
5158745|NCT02999945|body composition|body composition
5158746|NCT02999945|metabolomics|metabolomics
5158747|NCT02999945|microbiome|microbiome
5158748|NCT02999945|adiposity markers|adiposity markers
5158749|NCT02999945|metabolic programming|metabolic programming
5158755|NCT02999854|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5158756|NCT02999854|Graft-versus-host disease|graft-versus-host disease
5158757|NCT02999854|Immune reconstitution|immune reconstitution
5158758|NCT02999854|Alloreactive T-cells|alloreactive t-cells
5158759|NCT02999854|Photodynamic treatment|photodynamic treatment
5158760|NCT02999854|Hematologic malignancy|hematologic malignancy
5158761|NCT02999854|Transplant-related mortality|transplant-related mortality
5158763|NCT02999854|GRFS|grfs
5158764|NCT02999854|GVHD|gvhd
5158765|NCT02999841|Visceral fat|visceral fat
5158766|NCT02999828|safety|safety
5158767|NCT02999828|immune persistence|immune persistence
5158768|NCT02999815|Tetanus|tetanus
5158769|NCT02999802|Nutrient Sensing|nutrient sensing
5158770|NCT02999802|Exercise|exercise
5158771|NCT02999802|Elderly|elderly
5158772|NCT02999789|Asthma/drug therapy|asthma/drug therapy
5158775|NCT02999789|Communication Barriers|communication barriers
5158776|NCT02999776|Plaques Psoriasis|plaques psoriasis
5158778|NCT02999776|Laser microporation|laser microporation
5158779|NCT02999763|lipolysis|lipolysis
5158780|NCT02999763|fat reduction|fat reduction
5158781|NCT02999763|circumference reduction|circumference reduction
5158782|NCT02999737|Platelet Rich Plasma|platelet rich plasma
5158783|NCT02999737|PRP|prp
5158784|NCT02999737|Hair loss|hair loss
5158785|NCT02999737|Alopecia|alopecia
5158786|NCT02999737|Hypotrichosis|hypotrichosis
5158787|NCT02999737|Hair diseases|hair diseases
5158788|NCT02999698|Psoriasis|psoriasis
5158789|NCT02999698|Hidradenitis|hidradenitis
5158790|NCT02999698|Psychological impact|psychological impact
5158791|NCT02999698|Quality of life|quality of life
5158792|NCT02999659|pupillometry|pupillometry
5158793|NCT02999659|autonomous nerve system|autonomous nerve system
5158794|NCT02999646|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5158795|NCT02999646|cancer|cancer
5158796|NCT02999646|HNSCC|hnscc
5158797|NCT02999646|immunotherapy|immunotherapy
5158798|NCT02999646|MVX-ONCO-1|mvx-onco-1
5158799|NCT02999607|Transcranial direct current stimulation|transcranial direct current stimulation
5158800|NCT02999607|Positron emission tomography|positron emission tomography
5158801|NCT02999529|Chemotherapy|chemotherapy
5158802|NCT02999529|Oncology|oncology
5158803|NCT02999503|adhd treatment|adhd treatment
5158804|NCT02999503|nutrition|nutrition
5158805|NCT02999477|Breast Cancer|breast cancer
5158806|NCT02999464|stroke|stroke
5158807|NCT02999464|qigong|qigong
5158808|NCT02999464|randomized controlled trial|randomized controlled trial
5158809|NCT02999464|body-mind exercise|body-mind exercise
5158810|NCT02999464|balance|balance
5158811|NCT02999464|quality of life|quality of life
5158812|NCT02999464|wellbeing|wellbeing
5158813|NCT02999412|Integrated Healthcare System|integrated healthcare system
5158814|NCT02999412|Inappropriate Prescribing|inappropriate prescribing
5158815|NCT02999412|Pragmatic Clinical Trial|pragmatic clinical trial
5158816|NCT02999412|Crossover Design|crossover design
5158817|NCT02999412|Randomised Controlled Trial|randomised controlled trial
5158818|NCT02999399|Smoker|smoker
5158819|NCT02999399|Former smoker|former smoker
5158820|NCT02999386|stress, hyperglycemia, inflammatory markers, trauma, HbA1c|stress, hyperglycemia, inflammatory markers, trauma, hba1c
5158821|NCT02999386|interleukin-6|interleukin-6
5158828|NCT02999347|Gynecologic Surgery Procedures|gynecologic surgery procedures
5158829|NCT02999334|Group healthcare models|group healthcare models
5158831|NCT02999334|Prenatal care|prenatal care
5158832|NCT02999334|Perinatal health|perinatal health
5158833|NCT02999334|CenteringPregnancy|centeringpregnancy
5158834|NCT02999334|sub-Saharan Africa|sub-saharan africa
5158835|NCT02999334|Malawi|malawi
5158836|NCT02999334|Tanzania|tanzania
5158837|NCT02999334|Pregnancy|pregnancy
5158838|NCT02999308|haemophilia|haemophilia
5158839|NCT02999308|prophylaxis|prophylaxis
5158840|NCT02999308|children|children
5158842|NCT02999282|tDCS|tdcs
5158843|NCT02999282|Rehabilitation|rehabilitation
5158844|NCT02999269|electroconvulsive therapy|electroconvulsive therapy
5158845|NCT02999269|MRI|mri
5158846|NCT02999269|major depressive disorder|major depressive disorder
5158850|NCT02999256|Anthocyanins|anthocyanins
5158851|NCT02999256|Exercise|exercise
5158852|NCT02999256|Calorie Restrictive Mimetic|calorie restrictive mimetic
5158853|NCT02999230|Cavities|cavities
5158854|NCT02999217|iron isomaltoside|iron isomaltoside
5158855|NCT02999217|plasma ferritin|plasma ferritin
5158856|NCT02999217|haemoglobin|haemoglobin
5158857|NCT02999217|colorectal cancer|colorectal cancer
5158858|NCT02999165|Breastfeeding|breastfeeding
5158859|NCT02999165|CPAP|cpap
5158860|NCT02999165|Humidified High Flow Nasal Cannula Oxygen|humidified high flow nasal cannula oxygen
5158861|NCT02999165|preterm neonate|preterm neonate
5158862|NCT02999152|Bio-markers|bio-markers
5158863|NCT02999152|Radiation|radiation
5158864|NCT02999152|Appropriate therapeutic strategy|appropriate therapeutic strategy
5158865|NCT02999152|Total Body Irradiation|total body irradiation
5158866|NCT02999152|Partial Body Irradiation|partial body irradiation
5158867|NCT02999139|Injury|injury
5158868|NCT02999139|Prevention|prevention
5158874|NCT02999113|non-technical skills|non-technical skills
5158875|NCT02999113|patient safety|patient safety
5158876|NCT02999113|medical education|medical education
5158877|NCT02999100|oxytocin|oxytocin
5158878|NCT02999100|non-pregnant|non-pregnant
5158879|NCT02999100|pregnant|pregnant
5158880|NCT02999100|Postpartum Hemorrhage|postpartum hemorrhage
5158881|NCT02999087|Head and Neck cancer|head and neck cancer
5158882|NCT02999087|Immunotherapy|immunotherapy
5158883|NCT02999074|exercise|exercise
5158884|NCT02999074|resistance training|resistance training
5158885|NCT02999074|aerobic training|aerobic training
5158886|NCT02999074|breast cancer|breast cancer
5158887|NCT02999074|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5158888|NCT02999074|fatigue|fatigue
5158889|NCT02999074|quality of life|quality of life
5158890|NCT02999074|tumor response|tumor response
5158891|NCT02999061|pre-term children|pre-term children
5158892|NCT02999048|panax notoginseng saponins|panax notoginseng saponins
5158893|NCT02999048|hypertensive intracerebral hemorrhage|hypertensive intracerebral hemorrhage
5158894|NCT02999048|hematoma|hematoma
5158895|NCT02999048|neurological function|neurological function
5158896|NCT02999035|ocular surface sensitivity|ocular surface sensitivity
5158897|NCT02999022|bone fractures|bone fractures
5158898|NCT02999022|bony callus|bony callus
5158899|NCT02999022|fractures, bone|fractures, bone
5158900|NCT02999022|lithium|lithium
5158901|NCT02999022|lithium carbonate|lithium carbonate
5158902|NCT02999022|osteogenesis|osteogenesis
5158903|NCT02999022|bone development|bone development
5158904|NCT02999022|fracture healing|fracture healing
5158905|NCT02999022|fracture repair|fracture repair
5158906|NCT02998970|Cardiovascular Disease|cardiovascular disease
5158907|NCT02998970|Type 2 Diabetes|type 2 diabetes
5158908|NCT02998970|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5158909|NCT02998957|Acupuncture|acupuncture
5158910|NCT02998957|TENS|tens
5158911|NCT02998957|Physiotherapy|physiotherapy
5158912|NCT02998931|Glutamin|glutamin
5158913|NCT02998931|Enteral Nutrition|enteral nutrition
5158914|NCT02998931|Intensive Care Unit|intensive care unit
5158915|NCT02998931|Critical Care Outcomes|critical care outcomes
5158916|NCT02998931|inflammatory|inflammatory
5158917|NCT02998931|Immune System|immune system
5158918|NCT02998918|Inflammation|inflammation
5158919|NCT02998918|HDL|hdl
5158920|NCT02998918|Anti-inflammatory|anti-inflammatory
5158921|NCT02998918|Supplementation|supplementation
5158922|NCT02998918|Curcumin|curcumin
5158925|NCT02998918|I-cam|i-cam
5158926|NCT02998918|atherosclerosis|atherosclerosis
5158927|NCT02998918|cardiovascular disease|cardiovascular disease
5158928|NCT02998918|atherogenesis|atherogenesis
5158929|NCT02998918|antioxidant|antioxidant
5158930|NCT02998918|resveratrol|resveratrol
5158931|NCT02998918|quercetin|quercetin
5158932|NCT02998892|Sedentary Behavior|sedentary behavior
5158933|NCT02998866|Cryoballoon Pulmonary Vein Isolation|cryoballoon pulmonary vein isolation
5158934|NCT02998866|Esophageal Effects|esophageal effects
5158935|NCT02998853|Non culprit|non culprit
5158936|NCT02998853|STEMI PCI|stemi pci
5158937|NCT02998853|angio QFR|angio qfr
5158939|NCT02998853|Staged procedure|staged procedure
5158940|NCT02998840|elevated blood pressure|elevated blood pressure
5158941|NCT02998814|fissure sealant|fissure sealant
5158942|NCT02998814|etch and rinse|etch and rinse
5158943|NCT02998814|self etch|self etch
5158944|NCT02998788|heart failure|heart failure
5158945|NCT02998788|risk factor|risk factor
5158946|NCT02998788|cardiovascular disease|cardiovascular disease
5158947|NCT02998788|lifestyle behavior|lifestyle behavior
5158948|NCT02998775|in vitro protein binding|in vitro protein binding
5158949|NCT02998775|hepatic impairment|hepatic impairment
5158950|NCT02998775|renal impairment|renal impairment
5158951|NCT02998762|major depression|major depression
5158955|NCT02998762|long term follow up|long term follow up
5158956|NCT02998736|Colon|colon
5158957|NCT02998723|Basic Life Support|basic life support
5158958|NCT02998723|Education, Medical|education, medical
5158959|NCT02998723|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5158960|NCT02998723|Learning|learning
5775446|NCT00220493|COGNITION|cognition
5158961|NCT02998697|Systolic Heart Failure|systolic heart failure
5158962|NCT02998697|Anemia|anemia
5158963|NCT02998697|Iron Deficiency|iron deficiency
5158964|NCT02998684|Autism|autism
5158965|NCT02998684|Adolescent|adolescent
5158966|NCT02998684|Social skills|social skills
5158967|NCT02998671|Acne, inflammatory acne, efficacy, safety, PK|acne, inflammatory acne, efficacy, safety, pk
5158968|NCT02998658|Laparoscopy|laparoscopy
5158969|NCT02998658|Barbed sutures|barbed sutures
5158970|NCT02998658|Hysterectomy|hysterectomy
5158971|NCT02998645|severe acquired aplastic anemia|severe acquired aplastic anemia
5158972|NCT02998645|SAA|saa
5158973|NCT02998645|first line|first line
5158974|NCT02998645|eltrombopag|eltrombopag
5158975|NCT02998645|cyclosporine|cyclosporine
5158976|NCT02998645|h-ATG|h-atg
5158977|NCT02998645|severe aplastic anemia|severe aplastic anemia
5158978|NCT02998645|aplastic anemia|aplastic anemia
5158979|NCT02998593|Semen parameters Male infertility oligospermia Traditional Medicine|semen parameters male infertility oligospermia traditional medicine
5158980|NCT02998580|late-life depression|late-life depression
5158981|NCT02998580|treatment resistance|treatment resistance
5158982|NCT02998515|supplemental oxygen|supplemental oxygen
5158983|NCT02998515|concentrator|concentrator
5158984|NCT02998515|endurance shuttle walk test|endurance shuttle walk test
5158985|NCT02998502|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5158986|NCT02998502|Anxiety|anxiety
5158987|NCT02998502|Pediatrics|pediatrics
5158988|NCT02998489|enteral nutrition|enteral nutrition
5158989|NCT02998489|infant,premature|infant,premature
5158990|NCT02998489|feeding method|feeding method
5158991|NCT02998476|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5158992|NCT02998476|relapsed|relapsed
5158993|NCT02998476|refractory|refractory
5158994|NCT02998476|non-Hodgkin lymphoma|non-hodgkin lymphoma
5158995|NCT02998476|phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor|phosphatidylinositol 3-kinase δ (pi3kδ) inhibitor
5158996|NCT02998476|Bruton's tyrosine kinase (BTK)|bruton's tyrosine kinase (btk)
5158997|NCT02998463|Skin-to-skin|skin-to-skin
5158998|NCT02998463|Kangaroo Care|kangaroo care
5158999|NCT02998463|Kangaroo Mother Care|kangaroo mother care
5159000|NCT02998450|Sickle Cell Disease|sickle cell disease
5159001|NCT02998450|Sickle Beta 0 Thalassemia|sickle beta 0 thalassemia
5159002|NCT02998424|propofol|propofol
5159003|NCT02998424|pupillary diameter|pupillary diameter
5159004|NCT02998411|anti-infectives|anti-infectives
5159005|NCT02998411|adults|adults
5159006|NCT02998411|pharmacokinetic|pharmacokinetic
5159007|NCT02998411|pharmacodynamic end-points|pharmacodynamic end-points
5159008|NCT02998411|clinical cure|clinical cure
5159009|NCT02998398|Biosimilar|biosimilar
5159010|NCT02998385|salivary glands|salivary glands
5159011|NCT02998385|sinus carcinoma|sinus carcinoma
5159012|NCT02998385|radiochemotherapy concomitant|radiochemotherapy concomitant
5159013|NCT02998385|cisplatin|cisplatin
5159014|NCT02998385|protontherapy|protontherapy
5159015|NCT02998346|Nutrition|nutrition
5159016|NCT02998346|CRRT|crrt
5159017|NCT02998346|CVVH|cvvh
5159018|NCT02998346|citrate|citrate
5159019|NCT02998346|anticoagulation|anticoagulation
5159020|NCT02998346|caloric uptake|caloric uptake
5159021|NCT02998333|Instability|instability
5159022|NCT02998333|Ankle|ankle
5159023|NCT02998333|Surgical stabilization|surgical stabilization
5159024|NCT02998281|cerebral palsy|cerebral palsy
5159036|NCT02998177|Gut microbiome|gut microbiome
5159037|NCT02998177|Gut microbiota|gut microbiota
5159038|NCT02998177|Peripheral nerve block|peripheral nerve block
5159039|NCT02998177|Axillary brachial plexus block|axillary brachial plexus block
5159042|NCT02998112|fecal microbiota transplantation|fecal microbiota transplantation
5159043|NCT02998112|Ulcerative colitis|ulcerative colitis
5159044|NCT02998099|Healthy Volunteers|healthy volunteers
5159045|NCT02998099|Rivipansel|rivipansel
5159046|NCT02998060|Robot|robot
5159047|NCT02998060|Spinal Fusion|spinal fusion
5159048|NCT02998060|Spine|spine
5159049|NCT02998060|Navigation|navigation
5159050|NCT02998060|Freehand|freehand
5159056|NCT02997995|Estrogen Receptor Positive Tumor|estrogen receptor positive tumor
5159057|NCT02997995|PD-1|pd-1
5159058|NCT02997995|Neoadjuvant|neoadjuvant
5775447|NCT00220493|ATTENTION|attention
5159059|NCT02997995|Immune-attractants|immune-attractants
5159060|NCT02997995|lymphocytes activation|lymphocytes activation
5159061|NCT02997982|Alzheimer's Disease|alzheimer's disease
5159062|NCT02997982|Herpes Simplex Virus|herpes simplex virus
5031546|NCT03801941|Low back pain|low back pain
5159063|NCT02997982|HSV|hsv
5159064|NCT02997982|Antiviral Drugs|antiviral drugs
5159065|NCT02997969|HIV|hiv
5159066|NCT02997943|Obesity|obesity
5159067|NCT02997943|Weight Loss|weight loss
5159068|NCT02997943|Diet|diet
5159069|NCT02997943|Physical Activity|physical activity
5159070|NCT02997943|Mobile Health|mobile health
5159071|NCT02997904|lice comb|lice comb
5159072|NCT02997904|human head lice infestations|human head lice infestations
5159073|NCT02997904|combing solution|combing solution
5159074|NCT02997891|cognition|cognition
5159075|NCT02997891|hip replacement|hip replacement
5159076|NCT02997891|physical activity|physical activity
5159077|NCT02997891|quality of life|quality of life
5159776|NCT02992847|MRI|mri
5159078|NCT02997891|psychological distress|psychological distress
5159079|NCT02997878|autoimmune|autoimmune
5159080|NCT02997878|AiH|aih
5159081|NCT02997878|PSC|psc
5159082|NCT02997878|liver disease|liver disease
5159083|NCT02997878|cholangitis|cholangitis
5159084|NCT02997865|heart failure|heart failure
5159085|NCT02997865|depressive disorder, major|depressive disorder, major
5159086|NCT02997865|cognitive therapy|cognitive therapy
5159087|NCT02997865|self-care|self-care
5159088|NCT02997852|human-animal interaction|human-animal interaction
5159089|NCT02997787|adenomyosis|adenomyosis
5159090|NCT02997787|leiomyoma|leiomyoma
5159091|NCT02997787|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
5159092|NCT02997787|platelet to lymphocyte ratio|platelet to lymphocyte ratio
5159093|NCT02997748|acute kidney injury|acute kidney injury
5159094|NCT02997748|cardiac surgery|cardiac surgery
5159095|NCT02997748|Remote ischemic preconditioning|remote ischemic preconditioning
5159096|NCT02997748|[TIMP-2]*[IGFBP7]|[timp-2]*[igfbp7]
5159097|NCT02997735|Secondhand Smoke|secondhand smoke
5159098|NCT02997735|Nicotine Replacement Therapy|nicotine replacement therapy
5159099|NCT02997735|Clinical Decision Support|clinical decision support
5159100|NCT02997735|Tobacco quitline|tobacco quitline
5159101|NCT02997722|ketamine|ketamine
5159102|NCT02997722|suicide|suicide
5159103|NCT02997709|Prostate Cancer|prostate cancer
5159104|NCT02997709|Circulating Tumor Cells|circulating tumor cells
5159105|NCT02997709|CTCs|ctcs
5159106|NCT02997709|Androgen Deprivation Therapy|androgen deprivation therapy
5159107|NCT02997709|ADT|adt
5159108|NCT02997670|Cardiac resynchronization pacing therapy|cardiac resynchronization pacing therapy
5159109|NCT02997644|patient education|patient education
5159110|NCT02997644|orthopaedic surgery|orthopaedic surgery
5159111|NCT02997644|post-surgical pain|post-surgical pain
5159112|NCT02997644|chronic opioid use|chronic opioid use
5159113|NCT02997631|Pain Management|pain management
5159114|NCT02997631|Distraction Therapy|distraction therapy
5159115|NCT02997631|Robot Based Distraction|robot based distraction
5159116|NCT02997631|MEDi|medi
5159117|NCT02997605|low disease activity|low disease activity
5159118|NCT02997605|remission|remission
5159119|NCT02997566|Autonomic Nervous System|autonomic nervous system
5154572|NCT03026348|RSV|rsv
5159126|NCT02997553|Optonuclear probe|optonuclear probe
5159127|NCT02997553|Surgery|surgery
5159128|NCT02997540|female breast lesion|female breast lesion
5159129|NCT02997540|ultrasound examination|ultrasound examination
5159130|NCT02997514|Solution focused coaching|solution focused coaching
5159131|NCT02997514|Self determination|self determination
5159132|NCT02997488|videolaryngoscope|videolaryngoscope
5159133|NCT02997475|Bulimia Nervosa|bulimia nervosa
5159134|NCT02997475|Bulimia|bulimia
5159135|NCT02997475|fMRI|fmri
5159136|NCT02997475|Emotion Regulation|emotion regulation
5159137|NCT02997475|Response Inhibition|response inhibition
5159138|NCT02997462|Monocyte|monocyte
5159139|NCT02997462|Oxidative Stress|oxidative stress
5159140|NCT02997462|Endothelial Function|endothelial function
5159141|NCT02997462|Congestive Heart Failure|congestive heart failure
5159142|NCT02997449|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5168037|NCT02941926|Phase IIIb|phase iiib
5159146|NCT02997423|Biomarker|biomarker
5159147|NCT02997423|Cytochrome C Oxidase|cytochrome c oxidase
5159148|NCT02997423|Newly diagnosed|newly diagnosed
5159149|NCT02997410|Ozone|ozone
5159150|NCT02997371|Traumatic brain injury|traumatic brain injury
5159151|NCT02997371|Microdialysis|microdialysis
5159152|NCT02997371|Interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
5159153|NCT02997371|Magnetic Resonance Imaging|magnetic resonance imaging
5159154|NCT02997371|Positron Emission Tomography|positron emission tomography
5159155|NCT02997345|PPROM|pprom
5159156|NCT02997319|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5159157|NCT02997319|Insulin Resistance|insulin resistance
5159158|NCT02997319|Shift Work|shift work
5159159|NCT02997319|Circadian Rhythms|circadian rhythms
5159160|NCT02997319|MTNR1B|mtnr1b
5159161|NCT02997306|Moh's Surgery|moh's surgery
5159162|NCT02997306|Erythema|erythema
5159163|NCT02997306|Face|face
5159164|NCT02997306|Simple Interrupted Sutures|simple interrupted sutures
5159165|NCT02997306|Running Sutures|running sutures
5159166|NCT02997306|Image Processing|image processing
5962118|NCT04282889|ROTEM|rotem
5962119|NCT04282889|Rotational Thromboelastometry|rotational thromboelastometry
5159167|NCT02997280|acute graft-versus-host disease|acute graft-versus-host disease
5159168|NCT02997280|chronic graft-versus-host disease|chronic graft-versus-host disease
5159169|NCT02997280|Steroid-refractory GVHD|steroid-refractory gvhd
5159170|NCT02997280|ruxolitinib|ruxolitinib
5159171|NCT02997280|JAK inhibitors|jak inhibitors
5159172|NCT02997254|atrial fibrillation|atrial fibrillation
5159173|NCT02997254|ablation|ablation
5159174|NCT02997254|abnormal heart rhythm|abnormal heart rhythm
5159175|NCT02997241|Colonic Neoplasms|colonic neoplasms
5159176|NCT02997241|recurrence|recurrence
5159177|NCT02997215|intravenous lidocaine|intravenous lidocaine
5159178|NCT02997215|postoperative pain management|postoperative pain management
5159179|NCT02997202|Gilteritinib|gilteritinib
5159180|NCT02997202|ASP2215|asp2215
5159181|NCT02997202|Safety and Efficacy|safety and efficacy
5159182|NCT02997202|Acute Myeloid Leukemia|acute myeloid leukemia
5159183|NCT02997150|Idiopathic nephrotic syndrome-child-steroid dependant-IL2|idiopathic nephrotic syndrome-child-steroid dependant-il2
5159184|NCT02997150|Safety|safety
5159185|NCT02997150|Efficacy|efficacy
5159186|NCT02997137|Chronic psychological distress|chronic psychological distress
5159187|NCT02997137|Chronic exhaustion conditions|chronic exhaustion conditions
5159188|NCT02997137|Perceived Stress Questionnaire 30 (PSQ30)|perceived stress questionnaire 30 (psq30)
5159189|NCT02997137|Stress management|stress management
5159190|NCT02997137|Dietary supplement|dietary supplement
5159191|NCT02997124|Alveolar bone grafting|alveolar bone grafting
5159192|NCT02997124|delirium|delirium
5159193|NCT02997124|early ambulation|early ambulation
5159194|NCT02997098|Hepatectomy|hepatectomy
5159195|NCT02997085|Pain|pain
5159196|NCT02997085|Virtual Reality|virtual reality
5159197|NCT02997085|Opioid|opioid
5159198|NCT02997085|Prescription pain reliever|prescription pain reliever
5159199|NCT02997085|Treatment|treatment
5159200|NCT02997072|electrical impedance tomography|electrical impedance tomography
5159201|NCT02997072|high frequency jet ventilation|high frequency jet ventilation
5159202|NCT02997072|drive pressure|drive pressure
5159203|NCT02997059|Crohn disease|crohn disease
5159204|NCT02997059|Candida|candida
5159205|NCT02997059|ASCA|asca
5159206|NCT02997046|Ferumoxytol|ferumoxytol
5159208|NCT02997046|fistula|fistula
5159209|NCT02997046|graft|graft
5159210|NCT02997046|kidney transplant|kidney transplant
5159211|NCT02997046|angiography|angiography
5159212|NCT02997046|arteriovenous|arteriovenous
5159213|NCT02997033|Bone|bone
5159214|NCT02997033|Sex steroids|sex steroids
5159215|NCT02997033|Body composition|body composition
5159217|NCT02997007|tDCS|tdcs
5159218|NCT02997007|Mild Cognitive Impairment|mild cognitive impairment
5159219|NCT02997007|fMRI|fmri
5159220|NCT02997007|Healthy ageing|healthy ageing
5159221|NCT02996955|Low Back Pain|low back pain
5159222|NCT02996955|Social Support|social support
5159223|NCT02996955|Illness Perceptions|illness perceptions
5159224|NCT02996955|Activity Advice|activity advice
5159225|NCT02996942|haemophilia, joint disease, quality of life|haemophilia, joint disease, quality of life
5159226|NCT02996903|Cardiac Computed Tomography (CT) Angiography (CCTA)|cardiac computed tomography (ct) angiography (ccta)
5159227|NCT02996903|coronary artery disease|coronary artery disease
5159228|NCT02996903|malignancy induction|malignancy induction
5159229|NCT02996903|radiation dose|radiation dose
5159230|NCT02996903|dose saving techniques|dose saving techniques
5159231|NCT02996903|effective dose|effective dose
5159232|NCT02996864|college students|college students
5159233|NCT02996864|physical activity|physical activity
5159234|NCT02996864|sleep behaviors|sleep behaviors
5159235|NCT02996864|diet|diet
5159236|NCT02996851|Fibrinolytic Agents|fibrinolytic agents
5159238|NCT02996851|Norway|norway
5159239|NCT02996851|Registries|registries
5159240|NCT02996812|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
5159241|NCT02996812|Non-insulinoma pancreatogenous hypoglycemia syndrome|non-insulinoma pancreatogenous hypoglycemia syndrome
5159242|NCT02996812|Late dumping syndrome|late dumping syndrome
5159243|NCT02996773|high-risk malignancies|high-risk malignancies
5159244|NCT02996773|Lymphoma|lymphoma
5159245|NCT02996773|Haploidentical|haploidentical
5159246|NCT02996773|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
5159247|NCT02996773|Post-transplant|post-transplant
5159248|NCT02996773|myeloablative (MAC)|myeloablative (mac)
5159249|NCT02996773|reduced intensity conditioning (RIC)|reduced intensity conditioning (ric)
5159250|NCT02996773|haploidentical hematopoietic cell transplantation (HHCT)|haploidentical hematopoietic cell transplantation (hhct)
5159251|NCT02996773|Leukemia|leukemia
5232312|NCT02550561|IC|ic
5159252|NCT02996747|bone tumors|bone tumors
5159253|NCT02996747|chondroma|chondroma
5159254|NCT02996747|chondrosarcoma|chondrosarcoma
5159255|NCT02996734|bone tumors|bone tumors
5159256|NCT02996734|giant cell tumor|giant cell tumor
5159257|NCT02996734|treatment|treatment
5159258|NCT02996708|Telemedicine|telemedicine
5159259|NCT02996708|Health economics|health economics
5159260|NCT02996695|Chloroquine Chemoprophylaxis|chloroquine chemoprophylaxis
5159261|NCT02996695|Efficacy|efficacy
5159262|NCT02996695|Immunogenicity|immunogenicity
5031810|NCT03800368|Aerobic|aerobic
5159263|NCT02996695|Malaria|malaria
5159264|NCT02996695|Placebo|placebo
5159265|NCT02996695|Plasmodium falciparum Sporozoites|plasmodium falciparum sporozoites
5159266|NCT02996695|Safety|safety
5159267|NCT02996695|Tolerability|tolerability
5159268|NCT02996682|Communicable Diseases|communicable diseases
5159269|NCT02996682|Hepatitis|hepatitis
5159270|NCT02996682|Hepatitis C|hepatitis c
5159271|NCT02996682|Virus Diseases|virus diseases
5159272|NCT02996682|Liver Diseases|liver diseases
5159273|NCT02996682|Digestive System Diseases|digestive system diseases
5159274|NCT02996682|Hepatitis, Viral, Human|hepatitis, viral, human
5159275|NCT02996682|Velpatasvir|velpatasvir
5159276|NCT02996682|RNA Virus Infections|rna virus infections
5159277|NCT02996682|Ribavirin|ribavirin
5159278|NCT02996682|Sofosbuvir|sofosbuvir
5159279|NCT02996682|Antiviral Agents|antiviral agents
5159280|NCT02996682|Antimetabolites|antimetabolites
5159281|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5159282|NCT02996682|Anti-Infective Agents|anti-infective agents
5159283|NCT02996682|Decompensated Cirrhosis|decompensated cirrhosis
5159284|NCT02996643|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5159285|NCT02996643|Brace Treatment|brace treatment
5159286|NCT02996643|Ultrasound Imaging|ultrasound imaging
5159287|NCT02996630|LVOTO|lvoto
5159288|NCT02996630|Fallot|fallot
5159289|NCT02996630|Great Arteries Transposition|great arteries transposition
5159290|NCT02996617|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
5159291|NCT02996617|Lymphomas Non-Hodgkin's T-Cell|lymphomas non-hodgkin's t-cell
5159292|NCT02996617|PEG-rhG-CSF|peg-rhg-csf
5159293|NCT02996617|Neutropenia|neutropenia
5159294|NCT02996604|acupuncture|acupuncture
5159295|NCT02996604|functional dyspepsia|functional dyspepsia
5159296|NCT02996604|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5159297|NCT02996591|Nerve Block|nerve block
5159298|NCT02996591|General Anesthesia|general anesthesia
5159299|NCT02996591|Spinal Anesthesia|spinal anesthesia
5159300|NCT02996591|Pain|pain
5159301|NCT02996591|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5159302|NCT02996578|Cognition|cognition
5159303|NCT02996578|Cacao|cacao
5159304|NCT02996578|Flavan-3-ols|flavan-3-ols
5159305|NCT02996578|Blood Pressure|blood pressure
5159306|NCT02996578|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5159307|NCT02996578|Memory|memory
5159308|NCT02996565|Clinic care|clinic care
5159309|NCT02996565|Team-based care|team-based care
5159310|NCT02996565|Medication Therapy Management (MTM)|medication therapy management (mtm)
5159311|NCT02996565|Telehealth|telehealth
5159312|NCT02996565|Cluster-randomized|cluster-randomized
5159315|NCT02996552|Tricuspid annulus dilation|tricuspid annulus dilation
5159316|NCT02996552|mitral valve regurgitation|mitral valve regurgitation
5159317|NCT02996526|vocal cord palsy dysfunction thoracic surgery complication|vocal cord palsy dysfunction thoracic surgery complication
5159319|NCT02996513|Retinol Isotope Dilution|retinol isotope dilution
5159320|NCT02996513|Nigeria|nigeria
5159321|NCT02996513|Preschool children|preschool children
5159322|NCT02996513|Malaria|malaria
5159323|NCT02996513|Inflammation|inflammation
5159324|NCT02996474|Pembrolizumab|pembrolizumab
5159325|NCT02996474|Decitabine|decitabine
5159326|NCT02996474|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
5159327|NCT02996461|Zika Infection|zika infection
5159328|NCT02996461|Immune Response|immune response
5159329|NCT02996461|Flavivirus|flavivirus
5159330|NCT02996461|Arthropod-Borne Virus|arthropod-borne virus
5159333|NCT02996448|Staphylococcus Aureus|staphylococcus aureus
5159334|NCT02996448|Candida Albicans|candida albicans
5159335|NCT02996448|RNA Transcriptome|rna transcriptome
5159336|NCT02996396|AAA, Aortoiliac Aneurysm|aaa, aortoiliac aneurysm
5159337|NCT02996383|arthroplasty|arthroplasty
5159338|NCT02996370|esthetic|esthetic
5159339|NCT02996370|inter-implant papilla|inter-implant papilla
5159340|NCT02996370|soft tissue tickness|soft tissue tickness
5159341|NCT02996370|crestal bone loss|crestal bone loss
5159342|NCT02996370|second stage surgery|second stage surgery
5159343|NCT02996357|Incontinence-associated dermatitis|incontinence-associated dermatitis
5159344|NCT02996357|Risk factor|risk factor
5159345|NCT02996357|Intensive care unit|intensive care unit
5159346|NCT02996357|Prevention|prevention
5159347|NCT02996331|Ulcer|ulcer
5159348|NCT02996331|Pressure Ulcer|pressure ulcer
5159349|NCT02996331|Pathologic Processes|pathologic processes
5159350|NCT02996331|Skin Ulcer|skin ulcer
5159351|NCT02996331|Skin Diseases|skin diseases
5159352|NCT02996292|Crowding|crowding
5159353|NCT02996292|Self ligating|self ligating
5159354|NCT02996292|CBCT|cbct
5159355|NCT02996292|RCT|rct
5159356|NCT02996279|Neonate|neonate
5159357|NCT02996279|Chorioamnionitis|chorioamnionitis
5159358|NCT02996279|S100A12|s100a12
5159359|NCT02996266|Targeted Temperature Management|targeted temperature management
5159360|NCT02996175|Behavior|behavior
5159361|NCT02996175|Sleep|sleep
5159362|NCT02996175|Problems|problems
5159363|NCT02996175|Intervention|intervention
5962120|NCT04282889|NATEM|natem
5962121|NCT04282889|TRUE-NATEM|true-natem
5159364|NCT02996162|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5159365|NCT02996162|Chronic Lung Disease|chronic lung disease
5159366|NCT02996162|Prematurity|prematurity
5159367|NCT02996084|Imaging research|imaging research
5159368|NCT02995980|breast cancer screening|breast cancer screening
5159369|NCT02995980|dense breasts|dense breasts
5159370|NCT02995980|dual-energy contrast-enhanced digital mammography|dual-energy contrast-enhanced digital mammography
5159371|NCT02995954|Combination therapy|combination therapy
5159375|NCT02995941|classification|classification
5159376|NCT02995941|irritability|irritability
5159378|NCT02995941|intensity|intensity
5159379|NCT02995941|intervention|intervention
5159380|NCT02995928|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5159381|NCT02995928|Decompressive Craniectomy|decompressive craniectomy
5159382|NCT02995928|Cerebral Aneurysm|cerebral aneurysm
5159383|NCT02995837|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5159384|NCT02995837|Cerebral Blood Flow|cerebral blood flow
5159385|NCT02995837|Neurocognition|neurocognition
5159390|NCT02995785|Simulation|simulation
5159391|NCT02995733|asthma|asthma
5159392|NCT02995733|African Americans|african americans
5159393|NCT02995733|Hispanics|hispanics
5159394|NCT02995707|Thalidomide NTDT|thalidomide ntdt
5159395|NCT02995681|COPD|copd
5159396|NCT02995681|Falls|falls
5159397|NCT02995681|Balance training|balance training
5159398|NCT02995642|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5159399|NCT02995642|Carotid Stenosis|carotid stenosis
5159400|NCT02995642|Atherosclerosis|atherosclerosis
5159401|NCT02995642|Angiogenesis|angiogenesis
5159402|NCT02995642|Inflammation|inflammation
5159403|NCT02995642|Macrophages|macrophages
5159404|NCT02995642|Positron-Emission Tomography|positron-emission tomography
5159405|NCT02995642|Computerized tomography|computerized tomography
5159406|NCT02995642|Magnetic Resonance Imaging|magnetic resonance imaging
5159407|NCT02995642|(18F)FPP(RGD)2|(18f)fpp(rgd)2
5159408|NCT02995616|Robot-Assisted Gait Training|robot-assisted gait training
5159409|NCT02995616|Guidance force|guidance force
5159410|NCT02995616|Stroke|stroke
5159411|NCT02995616|Energy Consumption|energy consumption
5159412|NCT02995616|Cardiorespiratory Load|cardiorespiratory load
5159413|NCT02995603|Radiotherapy|radiotherapy
5159414|NCT02995603|Rotation|rotation
5159415|NCT02995564|Social Skills|social skills
5159416|NCT02995564|Asperger's|asperger's
5159417|NCT02995564|High-functioning autism|high-functioning autism
5154880|NCT03024333|Dysphagia|dysphagia
5159420|NCT02995551|Knee Injuries|knee injuries
5159421|NCT02995551|Arthroscopy|arthroscopy
5159422|NCT02995551|Exercise|exercise
5159423|NCT02995551|Young adults|young adults
5159424|NCT02995551|Treatment Outcome|treatment outcome
5159426|NCT02995512|myocardial infarction|myocardial infarction
5159427|NCT02995512|colchicine|colchicine
5159428|NCT02995512|anti-inflammatory|anti-inflammatory
5159429|NCT02995499|ASA-PS classification|asa-ps classification
5159430|NCT02995499|inter-rater reliability|inter-rater reliability
5159431|NCT02995499|general surgery|general surgery
5159432|NCT02995473|Psoriasis|psoriasis
5159433|NCT02995460|Exercise Therapy|exercise therapy
5159434|NCT02995447|propofol|propofol
5159435|NCT02995447|electroencephalogram|electroencephalogram
5159436|NCT02995434|Virtual Reality|virtual reality
5159437|NCT02995434|Cancer Survivorship|cancer survivorship
5159438|NCT02995434|Pain Management|pain management
5159440|NCT02995434|Chronic Pain Management|chronic pain management
5159441|NCT02995434|Adjunctive Pain Management|adjunctive pain management
5159442|NCT02995408|resiliency training|resiliency training
5159444|NCT02995408|Autism Spectrum Disorders|autism spectrum disorders
5159445|NCT02995369|Sealants|sealants
5159446|NCT02995369|Dryshield|dryshield
5159447|NCT02995369|Cotton roll|cotton roll
5159448|NCT02995369|Isolation|isolation
5159449|NCT02995369|Efficiency|efficiency
5159450|NCT02995369|Preference|preference
5159451|NCT02995356|Ectopic pregnancy|ectopic pregnancy
5159452|NCT02995356|Axonemal Dynein Heavy Chain 5|axonemal dynein heavy chain 5
5159453|NCT02995356|Creatine Kinase|creatine kinase
5159454|NCT02995356|Cervical fluid|cervical fluid
5673419|NCT00608283|Kidney transplant|kidney transplant
5159455|NCT02995330|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5159456|NCT02995330|Bone Marrow Transplantation|bone marrow transplantation
5159457|NCT02995317|Aged|aged
5159458|NCT02995317|Gait|gait
5159459|NCT02995317|Postural Balance|postural balance
5159460|NCT02995317|Accelerometry|accelerometry
5159461|NCT02995317|Physical Activity|physical activity
5159462|NCT02995265|Exoskeleton|exoskeleton
5159463|NCT02995265|Stroke|stroke
5159464|NCT02995265|Walking|walking
5159465|NCT02995265|Rehabilitation|rehabilitation
5159466|NCT02995187|Apatinib|apatinib
5159467|NCT02995187|Third-line and Later Therapy|third-line and later therapy
5159468|NCT02995187|Small Cell Lung Cancer|small cell lung cancer
5159469|NCT02995174|amblyopia|amblyopia
5159470|NCT02995174|fixation stability|fixation stability
5159471|NCT02995174|perceptual learning|perceptual learning
5159472|NCT02995083|osteoarthritis|osteoarthritis
5962122|NCT04282889|Coagulation|coagulation
5032008|NCT03799146|eHealth|ehealth
5159473|NCT02995057|Microneedles|microneedles
5159480|NCT02995005|hepatitis B|hepatitis b
5159481|NCT02995005|tenofovir|tenofovir
5159486|NCT02994927|ANCA-associated vasculitis|anca-associated vasculitis
5159487|NCT02994927|complement|complement
5159488|NCT02994927|vasculitis|vasculitis
5159489|NCT02994927|C5aR|c5ar
5159490|NCT02994927|avacopan|avacopan
5159491|NCT02994927|CCX168|ccx168
5159492|NCT02994927|MPA|mpa
5159493|NCT02994927|GPA|gpa
5159494|NCT02994914|Breast Cancer|breast cancer
5159495|NCT02994914|Onco Geriatric Evaluation|onco geriatric evaluation
5159496|NCT02994914|Radiotherapy|radiotherapy
5159497|NCT02994914|Hypo fractionated radiotherapy|hypo fractionated radiotherapy
5159498|NCT02994914|Normo fractionated radiotherapy|normo fractionated radiotherapy
5159499|NCT02994914|Large hypo fractionated radiotherapy|large hypo fractionated radiotherapy
5159500|NCT02994901|Sarcopenia|sarcopenia
5159501|NCT02994901|Geriatrics|geriatrics
5159502|NCT02994901|Biomarker|biomarker
5046097|NCT03711058|P13K|p13k
5159503|NCT02994836|Crohn's Disease|crohn's disease
5159504|NCT02994836|Inflammatory bowel disease|inflammatory bowel disease
5159505|NCT02994836|Anti-TNF discontinuation|anti-tnf discontinuation
5159506|NCT02994836|Ulcerative colitis|ulcerative colitis
5159507|NCT02994810|Breastfeeding|breastfeeding
5159508|NCT02994810|Orientation|orientation
5159509|NCT02994797|salivary glands|salivary glands
5159510|NCT02994797|ultrasonography|ultrasonography
5159511|NCT02994797|elastometry|elastometry
5159512|NCT02994797|elastography|elastography
5159513|NCT02994771|Lymphedema, Breast cancer|lymphedema, breast cancer
5159514|NCT02994758|Prostate|prostate
5159515|NCT02994758|bladder|bladder
5159516|NCT02994758|renal|renal
5159517|NCT02994758|NGS|ngs
5159518|NCT02994758|DSRT|dsrt
5159519|NCT02994758|drug screening|drug screening
5159520|NCT02994758|sequencing|sequencing
5159521|NCT02994758|personalised medicine|personalised medicine
5159522|NCT02994693|Barrett's Esophagus|barrett's esophagus
5159523|NCT02994693|Natural History|natural history
5159524|NCT02994693|Device|device
5159525|NCT02994693|OCT|oct
5159526|NCT02994693|Capsule|capsule
5159527|NCT02994693|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
5159528|NCT02994680|Air Pollution|air pollution
5159529|NCT02994680|Liquefied Petroleum Gas|liquefied petroleum gas
5159530|NCT02994680|Cookstove|cookstove
5159535|NCT02994641|patient discharge|patient discharge
5159536|NCT02994641|costs and cost analysis|costs and cost analysis
5159537|NCT02994641|length of stay|length of stay
5159538|NCT02994641|hospital mortality|hospital mortality
5159539|NCT02994628|oxidative stress|oxidative stress
5159540|NCT02994628|immune function|immune function
5159541|NCT02994628|muscle damage|muscle damage
5159542|NCT02994628|carbohydrate|carbohydrate
5159543|NCT02994628|polyphenols|polyphenols
5159544|NCT02994628|cycling|cycling
5159547|NCT02994602|Healthy Men|healthy men
5159548|NCT02994602|Male Contraception|male contraception
5159549|NCT02994602|Healthy Women|healthy women
5159550|NCT02994602|Transfer|transfer
5159551|NCT02994602|Transference|transference
5159552|NCT02994602|Gel|gel
5159565|NCT02994420|Cholecystokinin|cholecystokinin
5159566|NCT02994420|Magnetic Resonance Imaging|magnetic resonance imaging
5159567|NCT02994381|Healthy Male Adults|healthy male adults
5159569|NCT02994381|RPC1063|rpc1063
5159570|NCT02994368|retinal degeneration|retinal degeneration
5159571|NCT02994368|eye|eye
5159572|NCT02994368|REP-1 gene|rep-1 gene
5775552|NCT00219830|Walking|walking
5159573|NCT02994355|Family planning clinics|family planning clinics
5159574|NCT02994355|Implementation Science|implementation science
5159575|NCT02994355|Systems Analysis and Improvement Approach (SAIA)|systems analysis and improvement approach (saia)
5159576|NCT02994342|vaginal dryness|vaginal dryness
5159577|NCT02994342|vaginal gel|vaginal gel
5159578|NCT02994342|colostrum|colostrum
5159579|NCT02994342|vaginal atrophy|vaginal atrophy
5159580|NCT02994329|HIV testing|hiv testing
5159581|NCT02994329|Linkage to care|linkage to care
5159582|NCT02994303|Fabry disease|fabry disease
5159583|NCT02994303|Fabry nephropathy|fabry nephropathy
5159584|NCT02994303|end-stage renal disease|end-stage renal disease
5159585|NCT02994303|Anderson-Fabry disease|anderson-fabry disease
5159586|NCT02994303|Fabry's disease|fabry's disease
5159587|NCT02994277|"Artificial Pancreas"|"artificial pancreas"
5159588|NCT02994277|"control System"|"control system"
5159589|NCT02994277|"Closed loop"|"closed loop"
5159590|NCT02994277|diabetes|diabetes
5159591|NCT02994277|"T1DM"|"t1dm"
5159592|NCT02994277|"pump"|"pump"
5159593|NCT02994277|algorithm|algorithm
5159594|NCT02994277|CGM|cgm
5962123|NCT04282889|liver transplantation|liver transplantation
5159595|NCT02994199|Active video gaming|active video gaming
5159596|NCT02994199|Energy expenditure|energy expenditure
5159597|NCT02994186|cognitive function|cognitive function
5159598|NCT02994186|obesity|obesity
5159599|NCT02994186|bariatric surgery|bariatric surgery
5159600|NCT02994186|metabolic surgery|metabolic surgery
5159601|NCT02994160|peripheral nerve|peripheral nerve
5159602|NCT02994160|intraneural electrode|intraneural electrode
5159603|NCT02994160|hand amputation|hand amputation
5032128|NCT03798379|exercise|exercise
5159604|NCT02994160|forearm amputation|forearm amputation
5159605|NCT02994108|Human Papillomavirus|human papillomavirus
5159606|NCT02994108|Men Who Have Sex with Men|men who have sex with men
5159607|NCT02994082|Rural health|rural health
5159608|NCT02994082|Veterans|veterans
5159609|NCT02994082|Smokeless tobacco cessation|smokeless tobacco cessation
5159610|NCT02994069|Cisplatin|cisplatin
5159611|NCT02994069|Squamous Cell|squamous cell
5159612|NCT02994069|Carcinoma|carcinoma
5159613|NCT02994030|Duchenne Disease|duchenne disease
5159614|NCT02994030|Biomarker|biomarker
5159615|NCT02994017|cystic fibrosis|cystic fibrosis
5159616|NCT02994017|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5159617|NCT02994017|prognostic|prognostic
5159618|NCT02994004|Hospital, medical decision-making, role conflict, f-MRI|hospital, medical decision-making, role conflict, f-mri
5159619|NCT02993978|Pediatric radiotherapy|pediatric radiotherapy
5159620|NCT02993926|Drug Therapy|drug therapy
5159621|NCT02993887|Caregiver|caregiver
5159622|NCT02993887|Technology Dependent Children|technology dependent children
5159623|NCT02993887|Resourcefulness|resourcefulness
5159624|NCT02993887|Mindfulness|mindfulness
5159625|NCT02993874|Ergonemic resources|ergonemic resources
5159626|NCT02993874|Walking capacity|walking capacity
5159627|NCT02993874|Peripheral artery disease|peripheral artery disease
5159628|NCT02993861|Epilepsy|epilepsy
5159629|NCT02993861|Obese|obese
5159630|NCT02993848|Scapula|scapula
5159631|NCT02993848|Fracture|fracture
5159632|NCT02993796|Krabbe disease|krabbe disease
5159633|NCT02993796|globoid cell leukodystrophy|globoid cell leukodystrophy
5159634|NCT02993796|galactosylceramide lipidosis|galactosylceramide lipidosis
5159635|NCT02993796|sphingolipidosis|sphingolipidosis
5159636|NCT02993783|Drug Therapy|drug therapy
5159637|NCT02993757|Dengue Fever|dengue fever
5159638|NCT02993757|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5159639|NCT02993757|Human Papillomavirus Disease|human papillomavirus disease
5159640|NCT02993757|CYD Dengue Vaccine|cyd dengue vaccine
5155074|NCT03022916|jublia|jublia
5159641|NCT02993757|Dengvaxia®|dengvaxia®
5159642|NCT02993757|Gardasil®|gardasil®
5159643|NCT02993744|preterm birth|preterm birth
5159650|NCT02993731|Digestive System Neoplasms|digestive system neoplasms
5159651|NCT02993731|Endocrine Gland Neoplasms|endocrine gland neoplasms
5159652|NCT02993731|Pancreatic Neoplasms|pancreatic neoplasms
5159653|NCT02993731|Adenocarcinoma|adenocarcinoma
5159654|NCT02993731|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5159655|NCT02993731|Neoplasms by Histologic Type|neoplasms by histologic type
5159656|NCT02993731|Digestive System Diseases|digestive system diseases
5159657|NCT02993731|Pancreatic Diseases|pancreatic diseases
5159658|NCT02993731|Endocrine System Diseases|endocrine system diseases
5159659|NCT02993731|Albumin-Bound Paclitaxel|albumin-bound paclitaxel
5159660|NCT02993731|Gemcitabine|gemcitabine
5159661|NCT02993692|direct laryngoscopy|direct laryngoscopy
5159662|NCT02993692|fiberopitc bronchoscopy|fiberopitc bronchoscopy
5159663|NCT02993692|nasotracheal intubation|nasotracheal intubation
5159664|NCT02993640|vasopressin|vasopressin
5159665|NCT02993640|nitroglycerine|nitroglycerine
5159666|NCT02993640|portal pressure|portal pressure
5159667|NCT02993640|portal flow|portal flow
5159668|NCT02993627|obesity|obesity
5159670|NCT02993627|body weight|body weight
5159671|NCT02993601|Heart Failure|heart failure
5159672|NCT02993601|Edema|edema
5159673|NCT02993601|Oedema|oedema
5159674|NCT02993601|Decompensated Heartfailure|decompensated heartfailure
5159675|NCT02993588|Melatonin|melatonin
5159676|NCT02993588|IVF/ICSI|ivf/icsi
5159677|NCT02993588|Poor ovarian response|poor ovarian response
5159678|NCT02993575|Pharmacokinetics|pharmacokinetics
5159679|NCT02993575|Flucloxacillin|flucloxacillin
5159680|NCT02993575|Continuous infusion|continuous infusion
5159683|NCT02993562|Resting Energy Expenditure|resting energy expenditure
5159685|NCT02993562|Insulin response|insulin response
5159686|NCT02993562|Body Composition|body composition
5159691|NCT02993510|microfracture|microfracture
5159692|NCT02993510|enhanced marrow stimulation|enhanced marrow stimulation
5159693|NCT02993510|articular cartilage|articular cartilage
5159694|NCT02993510|Autologous Matrix-Induced Chondrogenesis|autologous matrix-induced chondrogenesis
5159695|NCT02993510|Chondro-Gide®|chondro-gide®
5159696|NCT02993510|knee surgery|knee surgery
5159697|NCT02993510|AMIC|amic
5159698|NCT02993458|dietary patterns|dietary patterns
5159699|NCT02993458|blood pressure|blood pressure
5159700|NCT02993458|adolescents|adolescents
5159701|NCT02993458|dietary sodium|dietary sodium
5159702|NCT02993393|Simulation Training [I02.903.847]|simulation training [i02.903.847]
5159703|NCT02993393|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
5159704|NCT02993380|Olive oil|olive oil
5159705|NCT02993380|Erythrocyte membrane fatty acid contents|erythrocyte membrane fatty acid contents
5962124|NCT04282863|Uterine Leiomyoma|uterine leiomyoma
5159706|NCT02993380|Oleic acid|oleic acid
5159707|NCT02993367|Butylphthalide Soft Capsules|butylphthalide soft capsules
5159708|NCT02993367|VCIND|vcind
5159709|NCT02993367|fMRI|fmri
5159713|NCT02993224|thalassemia|thalassemia
5159714|NCT02993224|TDT|tdt
5159715|NCT02993224|transfusion-dependent|transfusion-dependent
5159716|NCT02993224|non-transfusion-dependent|non-transfusion-dependent
5159717|NCT02993224|NTDT|ntdt
5159718|NCT02993211|Bladder cancer|bladder cancer
5159719|NCT02993211|Transurethral resection|transurethral resection
5159720|NCT02993211|En bloc resection|en bloc resection
5159721|NCT02993211|TURBT|turbt
5159722|NCT02993185|pregnancy|pregnancy
5159723|NCT02993185|adolescents|adolescents
5159724|NCT02993185|sexually transmitted diseases|sexually transmitted diseases
5159725|NCT02993185|decision making|decision making
5159726|NCT02993185|prevention education|prevention education
5159727|NCT02993107|AR101|ar101
5159728|NCT02993107|Characterized Peanut Allergen|characterized peanut allergen
5159729|NCT02993107|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5159730|NCT02993107|OIT (oral immunotherapy)|oit (oral immunotherapy)
5159731|NCT02993107|Peanut Allergy|peanut allergy
5159732|NCT02993107|Allergy|allergy
5159733|NCT02993107|Peanut-Allergic Children|peanut-allergic children
5159734|NCT02993107|Peanut-Allergic Adults|peanut-allergic adults
5159735|NCT02993107|Desensitization|desensitization
5159736|NCT02993107|PALISADE|palisade
5159737|NCT02993094|breast cancer|breast cancer
5159738|NCT02993094|advanced triple negative|advanced triple negative
5159739|NCT02993094|ixazomib|ixazomib
5159740|NCT02993094|carboplatin|carboplatin
5159741|NCT02993094|CARIXA|carixa
5159742|NCT02993094|Study Group of Medical Tumor Therapy (AGMT)|study group of medical tumor therapy (agmt)
5159743|NCT02993081|YAG laser|yag laser
5159744|NCT02993042|Rehabilitation|rehabilitation
5159745|NCT02993042|Robot-assisted gait training|robot-assisted gait training
5159747|NCT02993029|osteoarthritis|osteoarthritis
5159748|NCT02993029|celecoxib|celecoxib
5159749|NCT02992977|Vaccine, neoantigen|vaccine, neoantigen
5159750|NCT02992951|Infection|infection
5159751|NCT02992951|Surgical Site Infection|surgical site infection
5159752|NCT02992951|Dialkylcarbamoylchloride|dialkylcarbamoylchloride
5159753|NCT02992938|Opioid hyperalgesia|opioid hyperalgesia
5159754|NCT02992938|Acetazolamide|acetazolamide
5159755|NCT02992938|Remifentanil|remifentanil
5159757|NCT02992925|Adsorbed Diphteria-purified Pertussis-Tetanus-Inactivate poliovirus combined vaccine|adsorbed diphteria-purified pertussis-tetanus-inactivate poliovirus combined vaccine
5159760|NCT02992899|stress disorders, post-traumatic|stress disorders, post-traumatic
5159761|NCT02992899|posttraumatic stress disorder|posttraumatic stress disorder
5159762|NCT02992899|PTSD|ptsd
5159763|NCT02992899|vagal nerve|vagal nerve
5159764|NCT02992886|elderly patients|elderly patients
5159765|NCT02992886|rectal cancer|rectal cancer
5159766|NCT02992886|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5159767|NCT02992886|comprehensive geriatric assessment|comprehensive geriatric assessment
5159768|NCT02992860|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5159769|NCT02992860|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5159770|NCT02992860|hypomethylating agent (HMA) treatment|hypomethylating agent (hma) treatment
5159771|NCT02992860|leukemic stem cell|leukemic stem cell
5159772|NCT02992860|CD123|cd123
5159773|NCT02992860|immunotherapy|immunotherapy
5159774|NCT02992847|Multiple sclerosis|multiple sclerosis
5159775|NCT02992847|Gadolinium based contrast agent|gadolinium based contrast agent
5159778|NCT02992821|Hand-held|hand-held
5159779|NCT02992821|Ultrasound|ultrasound
5159780|NCT02992821|Diagnosis|diagnosis
5159781|NCT02992821|Carotid artery stenosis|carotid artery stenosis
5159783|NCT02992808|Ovarian stimulation|ovarian stimulation
5159784|NCT02992808|Androgenic profile|androgenic profile
5159785|NCT02992808|Follicular fluid|follicular fluid
5159786|NCT02992808|Recombinant gonadotropins|recombinant gonadotropins
5159787|NCT02992808|human menopausal gonadotropin|human menopausal gonadotropin
5159788|NCT02992769|Breast Cancer|breast cancer
5159789|NCT02992769|Nomogram|nomogram
5159790|NCT02992769|Ultrasound|ultrasound
5159791|NCT02992769|Axillary Metastases|axillary metastases
5159792|NCT02992743|Previously treated|previously treated
5159793|NCT02992743|Metastatic|metastatic
5159794|NCT02992743|Cell Therapy|cell therapy
5159795|NCT02992743|T Cell Therapy|t cell therapy
5159796|NCT02992743|Sarcoma|sarcoma
5159797|NCT02992743|NY-ESO-1|ny-eso-1
5159798|NCT02992743|Immuno-oncology|immuno-oncology
5159799|NCT02992743|T Cell Receptor|t cell receptor
5159800|NCT02992730|Medication Adherence|medication adherence
5159801|NCT02992665|Calcium ionophore|calcium ionophore
5159802|NCT02992665|Fertilization|fertilization
5159803|NCT02992665|Sperm|sperm
5159804|NCT02992665|Oocyte|oocyte
5159805|NCT02992665|ICSI|icsi
5159806|NCT02992639|High visceral fat|high visceral fat
5159807|NCT02992639|Liver enzymes|liver enzymes
5159808|NCT02992639|Aminotransferase|aminotransferase
5159809|NCT02992639|Mild calorie restriction|mild calorie restriction
5159810|NCT02992600|non-cardiac surgery|non-cardiac surgery
5159811|NCT02992600|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5159812|NCT02992574|Post-Mastectomy Radiation|post-mastectomy radiation
5962125|NCT04282863|robot-assisted (RM)|robot-assisted (rm)
5159813|NCT02992574|Node Negative|node negative
5159814|NCT02992574|Early breast Cancer|early breast cancer
5159815|NCT02992561|Aggression|aggression
5159816|NCT02992561|Violence|violence
5159817|NCT02992561|Post-conflict reconstruction|post-conflict reconstruction
5159818|NCT02992561|Demobilization|demobilization
5046422|NCT03709108|Exercise|exercise
5159819|NCT02992561|Traumatized offenders|traumatized offenders
5159820|NCT02992548|chronic kidney disease|chronic kidney disease
5159821|NCT02992548|pravastatin|pravastatin
5159822|NCT02992548|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
5159823|NCT02992483|multiple myeloma|multiple myeloma
5159824|NCT02992483|lymphoma|lymphoma
5159825|NCT02992483|dlbcl|dlbcl
5159826|NCT02992431|patient care planning|patient care planning
5159827|NCT02992431|primary health care|primary health care
5159828|NCT02992431|comorbidity|comorbidity
5159829|NCT02992418|Dengue Fever|dengue fever
5159830|NCT02992418|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5159831|NCT02992418|CYD Dengue Vaccine|cyd dengue vaccine
5159832|NCT02992418|Degavaxia®|degavaxia®
5159833|NCT02992392|Tear film|tear film
5159834|NCT02992392|Lipid layer|lipid layer
5159835|NCT02992392|Liposic|liposic
5159836|NCT02992392|Tears Naturale Forte|tears naturale forte
5159837|NCT02992379|Anterior disc displacement|anterior disc displacement
5159838|NCT02992379|Stabilizing splint|stabilizing splint
5159839|NCT02992366|socket shield|socket shield
5159840|NCT02992366|volumetric tissue alteration|volumetric tissue alteration
5159841|NCT02992366|immediate implant|immediate implant
5159842|NCT02992353|VATS|vats
5159843|NCT02992353|NSCLC|nsclc
5159844|NCT02992353|recurrence rate|recurrence rate
5159845|NCT02992288|Chronic Heart Failure|chronic heart failure
5159850|NCT02992223|Aggressive B-cell non-Hodgkin Lymphoma|aggressive b-cell non-hodgkin lymphoma
5159851|NCT02992223|Relapsed|relapsed
5159852|NCT02992223|Refractory|refractory
5159853|NCT02992223|Zevalin|zevalin
5159854|NCT02992223|Y90 Ibritumomab Tiuxetan|y90 ibritumomab tiuxetan
5159855|NCT02992223|Autologous stem cell transplant|autologous stem cell transplant
5159856|NCT02992223|BEAM|beam
5159858|NCT02992210|CAR|car
5159859|NCT02992210|chimeric antigen receptor|chimeric antigen receptor
5159860|NCT02992210|adoptive T cell transfer|adoptive t cell transfer
5159861|NCT02992197|Rotavirus|rotavirus
5159862|NCT02992197|Oral vaccines|oral vaccines
5159863|NCT02992197|Vaccine underperformance|vaccine underperformance
5159864|NCT02992197|Vaccine shedding|vaccine shedding
5159865|NCT02992184|HCV|hcv
5159866|NCT02992184|Genedrive|genedrive
5159867|NCT02992184|Point of Care|point of care
5159868|NCT02992119|safety|safety
5159869|NCT02992119|immunogenicity|immunogenicity
5159870|NCT02992106|Maternal Obesity|maternal obesity
5159871|NCT02992106|Endothelial Dysfunction|endothelial dysfunction
5159872|NCT02992106|Childhood Obesity|childhood obesity
5159873|NCT02992093|Polycystic ovary syndrome|polycystic ovary syndrome
5159874|NCT02992093|Metabonomics|metabonomics
5159875|NCT02992093|Traditional Chinese medicine syndromes|traditional chinese medicine syndromes
5160270|NCT02989493|Relapse|relapse
5159882|NCT02992028|Rotator cuff repair|rotator cuff repair
5159883|NCT02992028|Vitamin C|vitamin c
5159884|NCT02992028|postoperative pain|postoperative pain
5159885|NCT02991989|Home-based exercise|home-based exercise
5159886|NCT02991989|Exercise snacking|exercise snacking
5159887|NCT02991989|Protein|protein
5159888|NCT02991989|Yogurt|yogurt
5159889|NCT02991976|Normobaric hyperoxia|normobaric hyperoxia
5159890|NCT02991976|Cerebral oxygenation|cerebral oxygenation
5159891|NCT02991976|Near-infrared spectroscopy|near-infrared spectroscopy
5159892|NCT02991976|Carotid endarterectomy|carotid endarterectomy
5159893|NCT02991976|TIVA|tiva
5159894|NCT02991924|endobronchial ultrasound|endobronchial ultrasound
5159895|NCT02991924|EBUS-TBNA|ebus-tbna
5159896|NCT02991924|lung cancer|lung cancer
5159897|NCT02991924|staging|staging
5159898|NCT02991911|metastatic, prostate cancer|metastatic, prostate cancer
5159899|NCT02991898|CML|cml
5159900|NCT02991898|MDS|mds
5159901|NCT02991898|CLL|cll
5159902|NCT02991898|ALL|all
5159903|NCT02991898|AML|aml
5159904|NCT02991872|Persistence|persistence
5159905|NCT02991872|Purified chicken-embryo cell rabies vaccine|purified chicken-embryo cell rabies vaccine
5159906|NCT02991872|Rabies Virus Neutralizing Antibody (RVNA)|rabies virus neutralizing antibody (rvna)
5159907|NCT02991872|Immunogenicity|immunogenicity
5159908|NCT02991872|Post-Exposure Prophylaxis (PEP)|post-exposure prophylaxis (pep)
5159909|NCT02991872|Rabipur|rabipur
5159910|NCT02991859|Dose-response|dose-response
5159911|NCT02991859|AMP challenge|amp challenge
5159912|NCT02991859|cortisol suppression|cortisol suppression
5159913|NCT02991859|dose escalation|dose escalation
5159914|NCT02991859|therapeutic index|therapeutic index
5159915|NCT02991846|chronic graft-versus-host disease cGVHD|chronic graft-versus-host disease cgvhd
5159916|NCT02991846|Hematopoietic stem cell transplantation HSCT|hematopoietic stem cell transplantation hsct
5159917|NCT02991846|NIH consensus criteria|nih consensus criteria
5159918|NCT02991846|GITMO|gitmo
5159919|NCT02991833|fecal incontinence|fecal incontinence
5159920|NCT02991833|care product|care product
5159921|NCT02991833|bowel incontinence|bowel incontinence
5159922|NCT02991807|PTEN|pten
5159923|NCT02991807|PTEN Gene Mutation|pten gene mutation
5159924|NCT02991807|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
5159925|NCT02991807|Autism|autism
5159926|NCT02991807|Intellectual Disability|intellectual disability
5159927|NCT02991807|Neurocognition|neurocognition
5159928|NCT02991807|Afinitor|afinitor
5159929|NCT02991807|Everolimus|everolimus
5159930|NCT02991807|RAD001|rad001
5159931|NCT02991794|prostatectomy|prostatectomy
5159932|NCT02991794|laparoscopy|laparoscopy
5159933|NCT02991794|3D visualization|3d visualization
5159934|NCT02991794|learning curve|learning curve
5159935|NCT02991794|anastomosis|anastomosis
5159936|NCT02991742|nephropathy|nephropathy
5159937|NCT02991742|catheterization|catheterization
5159938|NCT02991742|contrast media|contrast media
5159939|NCT02991742|ioxaglate|ioxaglate
5159940|NCT02991742|iodixanol|iodixanol
5159941|NCT02991742|high risk|high risk
5159942|NCT02991742|prevention|prevention
5159943|NCT02991729|Decision aid|decision aid
5159944|NCT02991703|Arterial stiffness|arterial stiffness
5159945|NCT02991703|pulse wave velocity|pulse wave velocity
5159946|NCT02991703|Sphygmocor|sphygmocor
5159947|NCT02991703|applanation tonometry|applanation tonometry
5159949|NCT02991703|children|children
5159950|NCT02991703|EPIPAGE cohort|epipage cohort
5159954|NCT02991677|exercise|exercise
5159955|NCT02991677|neuropathy|neuropathy
5159956|NCT02991664|glass ionomer cement|glass ionomer cement
5159957|NCT02991664|composite resin|composite resin
5159958|NCT02991651|RXR agonist IRX4204 erlotinib|rxr agonist irx4204 erlotinib
5159959|NCT02991599|Hepatitis B, Vaccine|hepatitis b, vaccine
5159960|NCT02991599|Immunogenicity|immunogenicity
5159961|NCT02991599|methadone maintenance treatment|methadone maintenance treatment
5159962|NCT02991599|Randomized Controlled Trial|randomized controlled trial
5159963|NCT02991586|Emotional Instability|emotional instability
5159964|NCT02991586|Family Therapy|family therapy
5159965|NCT02991586|BPD|bpd
5159966|NCT02991586|DBT|dbt
5159967|NCT02991560|physiotherapy|physiotherapy
5159971|NCT02991534|Health Behavior [F01.145.488]|health behavior [f01.145.488]
5159972|NCT02991534|Women [M01.975]|women [m01.975]
5159973|NCT02991534|Patient Satisfaction [N05.715.360.600]|patient satisfaction [n05.715.360.600]
5159974|NCT02991534|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
5159975|NCT02991534|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
5160368|NCT02989038|smoker|smoker
5159976|NCT02991534|Health Educators [M01.526.485.410]|health educators [m01.526.485.410]
5159977|NCT02991534|Cardiovascular Diseases [C14]|cardiovascular diseases [c14]
5159978|NCT02991534|Hypertension [C14.907.489]|hypertension [c14.907.489]
5159979|NCT02991534|Hyperlipidemias [C18.452.584.500.500]|hyperlipidemias [c18.452.584.500.500]
5159980|NCT02991534|Dyslipidemias [C18.452.584.500]|dyslipidemias [c18.452.584.500]
5159981|NCT02991534|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
5159982|NCT02991534|Diabetes Mellitus [C18.452.394.750]|diabetes mellitus [c18.452.394.750]
5159983|NCT02991534|Tobacco Use Disorder [C25.775.912]|tobacco use disorder [c25.775.912]
5159984|NCT02991534|Overweight [C23.888.144.699]|overweight [c23.888.144.699]
5159985|NCT02991508|Adrecizumab|adrecizumab
5159986|NCT02991508|Phase 1 clinical trial|phase 1 clinical trial
5159987|NCT02991508|Adrenomedullin|adrenomedullin
5159988|NCT02991508|Healthy volunteers|healthy volunteers
5159989|NCT02991508|Monoclonal recombinant antibody|monoclonal recombinant antibody
5159990|NCT02991495|Epidemic response|epidemic response
5159991|NCT02991482|MPM|mpm
5159992|NCT02991456|malignant glioma|malignant glioma
5159993|NCT02991456|temozolomide|temozolomide
5159994|NCT02991456|temodar|temodar
5159995|NCT02991456|radiation|radiation
5159996|NCT02991456|emesis|emesis
5159997|NCT02991456|nausea|nausea
5159998|NCT02991456|vomiting|vomiting
5159999|NCT02991456|chemotherapy|chemotherapy
5160000|NCT02991456|Affronti|affronti
5160001|NCT02991456|Peters|peters
5160002|NCT02991456|00076418|00076418
5160003|NCT02991430|migraine headache, episodic|migraine headache, episodic
5160004|NCT02991378|preschool children|preschool children
5160005|NCT02991378|emotional disorders/problems|emotional disorders/problems
5160006|NCT02991378|stress related disorders/problems|stress related disorders/problems
5160007|NCT02991378|early intervention|early intervention
5160008|NCT02991352|Vascular Malformations|vascular malformations
5160009|NCT02991352|Image Guidance|image guidance
5160010|NCT02991339|Dexamethasone|dexamethasone
5160011|NCT02991339|Liver Dysfunction|liver dysfunction
5160012|NCT02991339|Hepatectomy|hepatectomy
5160013|NCT02991339|Bilirubinaemia|bilirubinaemia
5160014|NCT02991339|Jaundice|jaundice
5160015|NCT02991326|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5160016|NCT02991326|Temporomandibular Disorder|temporomandibular disorder
5160017|NCT02991300|focal defect|focal defect
5160018|NCT02991300|focal lesion|focal lesion
5160019|NCT02991300|chondral lesion|chondral lesion
5160020|NCT02991300|osteochondral lesion|osteochondral lesion
5160021|NCT02991274|T790M|t790m
5160022|NCT02991274|EGFR (Epidermal Growth Factor Receptor) mutation|egfr (epidermal growth factor receptor) mutation
5160023|NCT02991274|NSCLC|nsclc
5160024|NCT02991196|Advanced colorectal cancer|advanced colorectal cancer
5160025|NCT02991196|DNA mismatch repair (MMR)|dna mismatch repair (mmr)
5160026|NCT02991196|MMR-proficient Subjects|mmr-proficient subjects
5160027|NCT02991196|TRAIL-R2 (DR5) Antibody|trail-r2 (dr5) antibody
5160028|NCT02991183|Caregivers|caregivers
5160029|NCT02991183|Acceptance and Commitment Therapy|acceptance and commitment therapy
5160030|NCT02991170|myocardial infarction|myocardial infarction
5160031|NCT02991170|ventricular arrhythmia|ventricular arrhythmia
5160032|NCT02991170|radiofrequency ablation|radiofrequency ablation
5160033|NCT02991170|Coronary Artery Bypass Grafts|coronary artery bypass grafts
5160034|NCT02991157|cerebral vasospasm|cerebral vasospasm
5160035|NCT02991157|nimodipine|nimodipine
5160036|NCT02991144|Gene Transfer|gene transfer
5160037|NCT02991144|OTC Deficiency|otc deficiency
5160038|NCT02991144|Urea Cycle Disorder|urea cycle disorder
5160039|NCT02991131|Acute bacterial skin infection|acute bacterial skin infection
5160040|NCT02991131|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
5160041|NCT02991131|Abscess|abscess
5160042|NCT02991131|Cellulitis|cellulitis
5160043|NCT02991131|Erysipelas|erysipelas
5160044|NCT02991131|Wound infection|wound infection
5356861|NCT01917695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5160045|NCT02991131|Methicillin resistant Staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
5160046|NCT02991118|hyperlipidemia|hyperlipidemia
5160047|NCT02991118|cholesterol|cholesterol
5160048|NCT02991118|familial hypercholesterolemia|familial hypercholesterolemia
5160049|NCT02991118|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5160050|NCT02991118|ASCVD|ascvd
5160051|NCT02991118|HeFH|hefh
5160053|NCT02991105|Malignancy|malignancy
5160060|NCT02991079|Health education|health education
5160061|NCT02991079|Physical activity|physical activity
5160062|NCT02991079|Information and Communication Technologies|information and communication technologies
5160063|NCT02991066|Acute promyelocytic leukemia|acute promyelocytic leukemia
5160064|NCT02991066|Coagulopathy|coagulopathy
5160065|NCT02991066|Microparticles|microparticles
5160067|NCT02991053|Intra-operative anesthesia|intra-operative anesthesia
5160068|NCT02991053|Pediatric patient|pediatric patient
5160167|NCT02990377|Emergency Department|emergency department
5160071|NCT02991027|no known ocular pathology|no known ocular pathology
5160072|NCT02991014|music intervention|music intervention
5160073|NCT02991014|heart rate variability|heart rate variability
5160074|NCT02991014|frequency modulation|frequency modulation
5160075|NCT02991014|pain perception|pain perception
5160076|NCT02991014|cold pressor test (CPT)|cold pressor test (cpt)
5160077|NCT02991001|Hydrodissection|hydrodissection
5160078|NCT02990988|Blood donation|blood donation
5160079|NCT02990988|Iron repletion|iron repletion
5160081|NCT02990975|Intra-operative anesthesia|intra-operative anesthesia
5160082|NCT02990975|Pediatric patient|pediatric patient
5160083|NCT02990975|Transversus Abdominis Plane Block|transversus abdominis plane block
5160084|NCT02990962|perineural injection|perineural injection
5160085|NCT02990962|ultrasound-guided|ultrasound-guided
5160086|NCT02990962|dextrose|dextrose
5160087|NCT02990962|steroid|steroid
5160088|NCT02990936|hea and neck squamous cell carcinoma|hea and neck squamous cell carcinoma
5160089|NCT02990936|tumor growth|tumor growth
5160090|NCT02990936|predictive markers|predictive markers
5160091|NCT02990936|tumoral kinetics|tumoral kinetics
5160092|NCT02990910|respiratory adverse events|respiratory adverse events
5160093|NCT02990910|adenotonsillectomy|adenotonsillectomy
5160094|NCT02990910|opioid analgesia|opioid analgesia
5160095|NCT02990910|children|children
5160096|NCT02990897|Medical informatics|medical informatics
5160097|NCT02990897|Quality of care|quality of care
5160098|NCT02990897|Referral|referral
5160099|NCT02990884|Intra-operative anesthesia and analgesia|intra-operative anesthesia and analgesia
5160100|NCT02990884|ilioinguinal / iliohyogogastric nerve block|ilioinguinal / iliohyogogastric nerve block
5046720|NCT03707145|nutrition|nutrition
5160101|NCT02990884|Pediatric patient|pediatric patient
5160102|NCT02990819|Immunodeficiencies|immunodeficiencies
5160103|NCT02990819|Immune dysregulation syndromes|immune dysregulation syndromes
5160104|NCT02990793|PTSD|ptsd
5160105|NCT02990793|Concussion|concussion
5160106|NCT02990793|TBI|tbi
5160107|NCT02990793|TMS|tms
5160108|NCT02990741|atrial fibrillation|atrial fibrillation
5160109|NCT02990741|automated ECG system|automated ecg system
5160110|NCT02990728|Endometrial Cancer.Mirena®|endometrial cancer.mirena®
5160111|NCT02990715|average risk CRC screening|average risk crc screening
5160112|NCT02990715|Non compliant patients for CRC screening|non compliant patients for crc screening
5160113|NCT02990715|Counterindicated patients for colonoscopy|counterindicated patients for colonoscopy
5160114|NCT02990702|Infraclavicular block|infraclavicular block
5160115|NCT02990702|Retroclavicular block|retroclavicular block
5160116|NCT02990702|Ultrasound|ultrasound
5160117|NCT02990676|Cognition|cognition
5160118|NCT02990676|Computerised cognitive training|computerised cognitive training
5160119|NCT02990676|Feasibility study|feasibility study
5160120|NCT02990676|Huntington's disease|huntington's disease
5160121|NCT02990676|Translational|translational
5160122|NCT02990663|Pragmatic|pragmatic
5160123|NCT02990663|Primary Care|primary care
5160124|NCT02990663|Chronotherapy|chronotherapy
5160125|NCT02990663|Administrative Data|administrative data
5160126|NCT02990663|Stroke|stroke
5160127|NCT02990663|Myocardial Infarction|myocardial infarction
5160128|NCT02990663|Congestive Heart Failure|congestive heart failure
5160129|NCT02990663|Glaucoma|glaucoma
5160130|NCT02990663|Dementia|dementia
5160131|NCT02990663|Hip Fracture|hip fracture
5160132|NCT02990637|Olive leaf extract|olive leaf extract
5160133|NCT02990637|Cardiovascular health|cardiovascular health
5160134|NCT02990637|Cholesterol|cholesterol
5160135|NCT02990624|psoriasis|psoriasis
5160136|NCT02990624|photochemotherapy|photochemotherapy
5160137|NCT02990624|atherosclerosis|atherosclerosis
5160138|NCT02990624|metabolic syndrome|metabolic syndrome
5160139|NCT02990624|cardiovascular risk|cardiovascular risk
5160140|NCT02990598|Hydroxyurea|hydroxyurea
5160141|NCT02990572|Amish|amish
5160142|NCT02990572|Mennonite|mennonite
5160143|NCT02990559|Iron repletion|iron repletion
5160144|NCT02990559|Blood donation|blood donation
5160145|NCT02990559|Transfusion|transfusion
5160151|NCT02990468|Xerostomia|xerostomia
5160157|NCT02990442|rTMS|rtms
5160158|NCT02990442|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5160159|NCT02990442|Brain Stimulation|brain stimulation
5160160|NCT02990429|hypothermia|hypothermia
5160161|NCT02990429|Shivering|shivering
5160162|NCT02990429|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5160163|NCT02990429|Warming|warming
5160164|NCT02990429|General anesthesia|general anesthesia
5160165|NCT02990377|Opioid Analgesics|opioid analgesics
5160166|NCT02990377|Opioid Safety|opioid safety
5160171|NCT02990377|mHealth|mhealth
5160172|NCT02990364|Circumcision|circumcision
5160173|NCT02990364|Analgesia|analgesia
5160174|NCT02990364|Controlled Clinical Trial|controlled clinical trial
5160175|NCT02990325|ABX464, HIV infection|abx464, hiv infection
5160176|NCT02990299|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5160177|NCT02990299|Medication Adherence|medication adherence
5160178|NCT02990299|Telemedicine|telemedicine
5160179|NCT02990299|Community Health Workers|community health workers
5160180|NCT02990299|Pharmacists|pharmacists
5160181|NCT02990299|Mobile Health|mobile health
5160182|NCT02990286|Non specific intertitial pneumonia|non specific intertitial pneumonia
5160183|NCT02990286|interstitial pneumonia with autoimmune feature|interstitial pneumonia with autoimmune feature
5160184|NCT02990286|connective tissue disease|connective tissue disease
5160185|NCT02990286|rituximab|rituximab
5160186|NCT02990286|Mycophenolate Mofetil|mycophenolate mofetil
5160187|NCT02990286|pulmonary fibrosis|pulmonary fibrosis
5160188|NCT02990247|Asthma|asthma
5160189|NCT02990247|Exacerbations|exacerbations
5160190|NCT02990247|Telemonitoring|telemonitoring
5160191|NCT02990247|Biomarkers|biomarkers
5160192|NCT02990234|Capsular Repair|capsular repair
5160193|NCT02990234|FAI|fai
5160194|NCT02990234|Hip|hip
5160195|NCT02990221|Field Cancerization|field cancerization
5160196|NCT02990208|Diaphragmatic Breathing|diaphragmatic breathing
5160197|NCT02990208|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5160198|NCT02990182|Yellow Fever Vaccine|yellow fever vaccine
5160199|NCT02990182|Immunity, Humoral|immunity, humoral
5160200|NCT02990182|Immunity, Cellular|immunity, cellular
5160201|NCT02990182|children|children
5160202|NCT02990156|Coils|coils
5160203|NCT02990091|TBI|tbi
5160204|NCT02990091|DHA|dha
5160205|NCT02990091|omega-3 highly unsaturated fatty acids|omega-3 highly unsaturated fatty acids
5160206|NCT02990091|synaptamide|synaptamide
5160207|NCT02990078|TBI|tbi
5160208|NCT02990078|CVR|cvr
5160209|NCT02990078|Hypercapnia|hypercapnia
5160210|NCT02990078|fNIRS|fnirs
5160211|NCT02990065|PROTEIN SUPPLEMENTATION|protein supplementation
5160212|NCT02990065|NUTRITIONAL STATUS|nutritional status
5160213|NCT02990039|physical activity|physical activity
5160214|NCT02990039|sedentary time|sedentary time
5160215|NCT02990039|feasibility study|feasibility study
5160216|NCT02990039|accelerometer|accelerometer
5160217|NCT02989987|PTSD|ptsd
5160218|NCT02989987|Shame|shame
5160219|NCT02989987|Narrative Exposure Therapy|narrative exposure therapy
5160220|NCT02989987|Sexual and gender based violence (SGBV)|sexual and gender based violence (sgbv)
5160221|NCT02989987|DR Congo|dr congo
5160222|NCT02989974|Survivorship Care|survivorship care
5160223|NCT02989974|Caregiving|caregiving
5160224|NCT02989948|Endovascular|endovascular
5160225|NCT02989935|respiratory muscle|respiratory muscle
5160226|NCT02989935|bronchodilator|bronchodilator
5160227|NCT02989896|Perfusion index|perfusion index
5160228|NCT02989896|Peripheral nerve block success|peripheral nerve block success
5160229|NCT02989896|older age|older age
5160230|NCT02989883|achalasia|achalasia
5160231|NCT02989883|POEM|poem
5160232|NCT02989883|outcome|outcome
5160233|NCT02989870|Liver Disease|liver disease
5160234|NCT02989870|Child-Pugh Class A|child-pugh class a
5160235|NCT02989870|Child-Pugh Class B7|child-pugh class b7
5160236|NCT02989857|IDH1|idh1
5160237|NCT02989831|diabetic neuropathy|diabetic neuropathy
5160238|NCT02989831|foot ulcers|foot ulcers
5160239|NCT02989831|random vibration|random vibration
5160240|NCT02989831|vibration perception threshold|vibration perception threshold
5160241|NCT02989831|mechanical noise|mechanical noise
5160246|NCT02989792|pain|pain
5160247|NCT02989753|Prevention|prevention
5160248|NCT02989740|Diabetes Mellitus|diabetes mellitus
5160249|NCT02989740|Thincap fibroatheroma|thincap fibroatheroma
5160250|NCT02989740|Optical Coherence Tomography|optical coherence tomography
5160251|NCT02989740|Fractional Flow Reserve|fractional flow reserve
5160252|NCT02989701|Plerixafor|plerixafor
5160253|NCT02989675|pediatric|pediatric
5160254|NCT02989675|critical illness|critical illness
5160255|NCT02989675|Malawi|malawi
5160265|NCT02989493|Stress|stress
5160266|NCT02989493|Norepinephrine|norepinephrine
5160267|NCT02989493|Doxazosin|doxazosin
5160268|NCT02989493|Anxiety|anxiety
5160269|NCT02989493|Startle Potentiation|startle potentiation
5160271|NCT02989493|Adrenergic Antagonists|adrenergic antagonists
5160272|NCT02989493|Surrogate Endpoint|surrogate endpoint
5160273|NCT02989480|Cardiomyopathy|cardiomyopathy
5160274|NCT02989441|Perfusion Index|perfusion index
5160275|NCT02989441|Hemodynamics|hemodynamics
5160276|NCT02989441|Anesthesia|anesthesia
5160277|NCT02989441|Stroke Volume|stroke volume
5160278|NCT02989415|Anesthesia|anesthesia
5160279|NCT02989415|Mechanical Ventilation|mechanical ventilation
5160280|NCT02989415|Robotic Surgery|robotic surgery
5160281|NCT02989415|Postoperative Pulmonary Complications|postoperative pulmonary complications
5160282|NCT02989402|Alzheimer, Rivastigmine|alzheimer, rivastigmine
5673420|NCT00608283|Live donor transplant|live donor transplant
5160283|NCT02989363|deep brain surgery and complex back surgery|deep brain surgery and complex back surgery
5160284|NCT02989337|Hyperemesis Gravidarum|hyperemesis gravidarum
5160285|NCT02989337|Inflammatory adhesion molecules|inflammatory adhesion molecules
5160286|NCT02989337|Dehydration|dehydration
5160287|NCT02989311|Iron absorption|iron absorption
5160288|NCT02989311|Iron deficiency|iron deficiency
5160289|NCT02989311|Hepcidin|hepcidin
5160290|NCT02989311|Stable isotopes|stable isotopes
5160291|NCT02989311|Anemia|anemia
5160292|NCT02989311|Infants|infants
5160293|NCT02989298|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
5160294|NCT02989298|Residual renal function|residual renal function
5160295|NCT02989298|Peritoneum function|peritoneum function
5160296|NCT02989298|Peritonitis rate|peritonitis rate
5160297|NCT02989298|Technical survival|technical survival
5160298|NCT02989298|Patient survival|patient survival
5160300|NCT02989285|HIV-associated neurocognitive disorder (HAND)|hiv-associated neurocognitive disorder (hand)
5160301|NCT02989285|Neurology|neurology
5160302|NCT02989285|Latent HIV|latent hiv
5160303|NCT02989285|HIV Reservoirs|hiv reservoirs
5160304|NCT02989259|apatinib|apatinib
5160305|NCT02989259|advanced head and neck cancer|advanced head and neck cancer
5160306|NCT02989259|non-squamous|non-squamous
5160307|NCT02989246|pediatrics|pediatrics
5160308|NCT02989246|ventilator weaning|ventilator weaning
5160309|NCT02989220|Miscarriage|miscarriage
5160310|NCT02989207|Glaucoma|glaucoma
5160311|NCT02989207|Trabeculectomy|trabeculectomy
5160312|NCT02989207|Glaucoma drainage implant|glaucoma drainage implant
5160313|NCT02989207|Africa and Africa-Caribbean|africa and africa-caribbean
5160314|NCT02989168|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5160315|NCT02989168|hypoxemia|hypoxemia
5160316|NCT02989168|oxygen|oxygen
5160317|NCT02989142|interpregnancy|interpregnancy
5160318|NCT02989142|pregnancy-induced hypertension|pregnancy-induced hypertension
5046927|NCT03705780|diagnose|diagnose
5160319|NCT02989142|gestational diabetes mellitus|gestational diabetes mellitus
5160320|NCT02989142|caesarean section|caesarean section
5160321|NCT02989142|large-for-gestational-age|large-for-gestational-age
5160322|NCT02989129|Polyneuropathies and Other Disorders of the Peripheral Nervous System|polyneuropathies and other disorders of the peripheral nervous system
5160323|NCT02989129|Chemotherapy Induced Neuropathic Pain|chemotherapy induced neuropathic pain
5160324|NCT02989129|CINP|cinp
5160325|NCT02989129|Quercetin|quercetin
5160326|NCT02989129|Questionnaires|questionnaires
5160327|NCT02989129|Surveys|surveys
5160328|NCT02989116|Learning|learning
5160329|NCT02989116|Executive functions|executive functions
5160330|NCT02989116|Cognitive control|cognitive control
5160331|NCT02989116|Prefrontal Cortex|prefrontal cortex
5160332|NCT02989116|Typically developing children|typically developing children
5160333|NCT02989116|Genotype|genotype
5160334|NCT02989116|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5160335|NCT02989116|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
5160336|NCT02989116|Inhibition|inhibition
5160337|NCT02989116|Working Memory|working memory
5160338|NCT02989116|Metacognition|metacognition
5160339|NCT02989116|Mindfulness|mindfulness
5160340|NCT02989116|Preterm children|preterm children
5160341|NCT02989116|Developmental Psychology|developmental psychology
5160342|NCT02989116|Developmental cognitive neuroscience|developmental cognitive neuroscience
5160343|NCT02989116|Touch screen tablet|touch screen tablet
5160344|NCT02989116|Adaptive training|adaptive training
5160345|NCT02989103|Hyperthyroidism|hyperthyroidism
5160347|NCT02989103|Mortality|mortality
5160348|NCT02989090|Patient Engagement|patient engagement
5160349|NCT02989090|Defibrillators|defibrillators
5160350|NCT02989090|Health Records, Personal|health records, personal
5160351|NCT02989090|Patient Portal|patient portal
5160352|NCT02989077|combined coronary and cerebral ischemia|combined coronary and cerebral ischemia
5160354|NCT02989064|T Cell Therapy|t cell therapy
5160355|NCT02989064|SPEAR T Cell|spear t cell
5160356|NCT02989064|MAGE-A10|mage-a10
5160357|NCT02989064|Immuno-oncology|immuno-oncology
5160358|NCT02989064|Metastatic|metastatic
5160359|NCT02989064|Urothelial Cancer|urothelial cancer
5160360|NCT02989064|Previously Treated|previously treated
5160361|NCT02989064|T Cell Receptor|t cell receptor
5160362|NCT02989064|Inoperable|inoperable
5160363|NCT02989064|Advanced|advanced
5160364|NCT02989064|Cancer|cancer
5160365|NCT02989064|Bladder|bladder
5160366|NCT02989064|Head and neck|head and neck
5160367|NCT02989064|Melanoma|melanoma
5160369|NCT02989038|young adult|young adult
5160370|NCT02989038|adolescent|adolescent
5160371|NCT02988999|D-allulose or erythritol|d-allulose or erythritol
5160372|NCT02988986|mTOR|mtor
5160373|NCT02988986|Tamoxifen|tamoxifen
5160374|NCT02988986|Breast Cancer|breast cancer
5160375|NCT02988973|Roxadustat|roxadustat
5160376|NCT02988973|Anemia|anemia
5160377|NCT02988973|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
5160378|NCT02988973|ASP1517|asp1517
5160379|NCT02988960|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5342973|NCT01981317|Obsessive Compulsive Disorder|obsessive compulsive disorder
5160380|NCT02988960|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5160381|NCT02988960|Advanced solid tumor|advanced solid tumor
5160383|NCT02988960|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5160384|NCT02988960|Cutaneous melanoma|cutaneous melanoma
5160385|NCT02988947|Knee Arthroplasty|knee arthroplasty
5160386|NCT02988947|Hypnosis|hypnosis
5160387|NCT02988947|Pain Neuroscience Education|pain neuroscience education
5160388|NCT02988947|Pain|pain
5160389|NCT02988947|Catastrophizing|catastrophizing
5160390|NCT02988947|Optimism|optimism
5160391|NCT02988947|Distress|distress
5160392|NCT02988947|Hope|hope
5160393|NCT02988947|Self-Efficacy|self-efficacy
5160394|NCT02988895|Brachytherapy|brachytherapy
5160395|NCT02988895|Wet AMD|wet amd
5160396|NCT02988869|COPD|copd
5160397|NCT02988869|Tiotropium|tiotropium
5160398|NCT02988869|Formoterol|formoterol
5160399|NCT02988843|GCT|gct
5160400|NCT02988830|Subcutaneous stimulation|subcutaneous stimulation
5160401|NCT02988804|endoscopic endonasal transsphenoidal surgery|endoscopic endonasal transsphenoidal surgery
5160402|NCT02988804|laryngeal mask|laryngeal mask
5160403|NCT02988765|vulvar cancer|vulvar cancer
5160404|NCT02988765|inguinal lymph node|inguinal lymph node
5160405|NCT02988765|lymph node status|lymph node status
5160406|NCT02988765|cytology|cytology
5160407|NCT02988765|core biopsy|core biopsy
5160408|NCT02988726|Neurofibroma|neurofibroma
5160409|NCT02988726|Schwannoma|schwannoma
5160410|NCT02988713|stimulation|stimulation
5160411|NCT02988713|chronic pain|chronic pain
5160412|NCT02988713|back pain|back pain
5160413|NCT02988713|leg pain|leg pain
5160414|NCT02988687|fatigue|fatigue
5160415|NCT02988687|quality of life|quality of life
5160416|NCT02988687|depression|depression
5160417|NCT02988687|cognitive function|cognitive function
5160418|NCT02988687|growth hormone|growth hormone
5160419|NCT02988687|traumatic brain injury|traumatic brain injury
5160420|NCT02988674|Adalimumab|adalimumab
5160421|NCT02988674|Ankylosing spondylitis|ankylosing spondylitis
5160422|NCT02988674|Psoriatic arthritis|psoriatic arthritis
5160423|NCT02988674|Spondylarthritis|spondylarthritis
5160424|NCT02988674|Humira®|humira®
5160425|NCT02988661|Autoimmunity|autoimmunity
5160426|NCT02988661|Immune System Disorders|immune system disorders
5160427|NCT02988648|Metastatic Breast Cancer|metastatic breast cancer
5160428|NCT02988635|Early Palliative Care|early palliative care
5160429|NCT02988635|Simultaneous Care|simultaneous care
5160430|NCT02988635|Chemotherapy|chemotherapy
5160431|NCT02988635|Quality of Life|quality of life
5160432|NCT02988596|Concussion|concussion
5160433|NCT02988596|Rehabilitation|rehabilitation
5160434|NCT02988583|silicone oil|silicone oil
5160435|NCT02988583|emulsification|emulsification
5160436|NCT02988583|retinal detachment surgery|retinal detachment surgery
5160437|NCT02988557|cerebral palsy|cerebral palsy
5160438|NCT02988557|gait|gait
5160439|NCT02988557|slope|slope
5160440|NCT02988557|electromyography|electromyography
5160441|NCT02988544|Single blastocyst embryo transfer|single blastocyst embryo transfer
5160442|NCT02988544|Artificial Shrinkage|artificial shrinkage
5160443|NCT02988544|Clinical pregnancy rate|clinical pregnancy rate
5160444|NCT02988544|Cell free|cell free
5160446|NCT02988531|MRI|mri
5160447|NCT02988531|Attenuation|attenuation
5160448|NCT02988531|Correction|correction
5160449|NCT02988531|Cardiovascular|cardiovascular
5160450|NCT02988531|coronary|coronary
5160451|NCT02988531|disease|disease
5160452|NCT02988518|Psychiatry|psychiatry
5160453|NCT02988518|Bipolar disorder|bipolar disorder
5160454|NCT02988518|Memory complaints|memory complaints
5160456|NCT02988518|Cognitive remediation|cognitive remediation
5160457|NCT02988518|Working memory|working memory
5160458|NCT02988466|Acute Leukemias|acute leukemias
5160459|NCT02988466|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5160460|NCT02988466|Acute lymphoblastic leukemia (ALL)/lymphoma|acute lymphoblastic leukemia (all)/lymphoma
5160461|NCT02988466|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|biphenotypic/undifferentiated/prolymphocytic leukemias
5160462|NCT02988466|Myelodysplastic syndrome|myelodysplastic syndrome
5160463|NCT02988466|Chronic myelogenous leukemia|chronic myelogenous leukemia
5160464|NCT02988466|Minimal Residual Disease (MRD) positive leukemia|minimal residual disease (mrd) positive leukemia
5160465|NCT02988466|Leukemia or Myelodysplastic Syndromes (MDS) in aplasia|leukemia or myelodysplastic syndromes (mds) in aplasia
5160466|NCT02988466|Myeloproliferative neoplasms/myelofibrosis|myeloproliferative neoplasms/myelofibrosis
5160558|NCT02988089|Antimicrobial susceptibility testing (AST)|antimicrobial susceptibility testing (ast)
5160475|NCT02988453|mentalization-based treatment|mentalization-based treatment
5160476|NCT02988453|conduct disorder|conduct disorder
5160477|NCT02988453|adolescents|adolescents
5160492|NCT02988414|Sepsis|sepsis
5160493|NCT02988414|Infection|infection
5160494|NCT02988414|Culture|culture
5160495|NCT02988414|Sequencing|sequencing
5160496|NCT02988414|Non-invasive|non-invasive
5160497|NCT02988414|NGS|ngs
5160498|NCT02988375|insomnia|insomnia
5233720|NCT02541929|DHA|dha
5160499|NCT02988375|depression|depression
5160500|NCT02988375|digital CBTI|digital cbti
5160501|NCT02988375|online CBTI|online cbti
5160502|NCT02988336|difficult intubation|difficult intubation
5160503|NCT02988336|thyromental height|thyromental height
5160504|NCT02988323|sport concussion|sport concussion
5160505|NCT02988323|cervical spine|cervical spine
5160506|NCT02988323|vestibular rehabilitation|vestibular rehabilitation
5160507|NCT02988323|exercise|exercise
5160508|NCT02988323|rehabilitation|rehabilitation
5160509|NCT02988323|children|children
5160510|NCT02988323|youth|youth
5160511|NCT02988310|Limb Loss|limb loss
5160512|NCT02988310|Gait Characteristics|gait characteristics
5160513|NCT02988284|Gait variability|gait variability
5160514|NCT02988258|Ex vivo gene therapy|ex vivo gene therapy
5160515|NCT02988258|T cell receptor transduction|t cell receptor transduction
5160516|NCT02988258|Immunotherapy|immunotherapy
5160517|NCT02988258|Allogeneic Haematopoietic Stem Cell Transplantation|allogeneic haematopoietic stem cell transplantation
5160518|NCT02988258|CMV|cmv
5160519|NCT02988232|Work Related Chronic Low Back Pain|work related chronic low back pain
5160520|NCT02988232|Korean Medicine|korean medicine
5160521|NCT02988232|Sogyeonghwalhyeol-tang|sogyeonghwalhyeol-tang
5160522|NCT02988219|cardiac arrhythmia|cardiac arrhythmia
5160523|NCT02988219|epidural anesthesia|epidural anesthesia
5160524|NCT02988219|combined anesthesia|combined anesthesia
5160525|NCT02988219|general anesthesia|general anesthesia
5160526|NCT02988219|NSS|nss
5160527|NCT02988219|radical nephrectomy|radical nephrectomy
5160528|NCT02988219|extraperitoneal|extraperitoneal
5160529|NCT02988193|clinical reasoning artificial intelligence|clinical reasoning artificial intelligence
5160530|NCT02988193|poorly controlled hypertension|poorly controlled hypertension
5160531|NCT02988167|Spontaneous Breathing Trial (SBT)|spontaneous breathing trial (sbt)
5160532|NCT02988167|Extubation Decision Support Tool|extubation decision support tool
5160533|NCT02988167|Extubation|extubation
5160534|NCT02988167|Extubation Readiness|extubation readiness
5160535|NCT02988154|Medical education|medical education
5160536|NCT02988154|simulation|simulation
5160537|NCT02988154|neurosurgical education|neurosurgical education
5160538|NCT02988154|Simulation laboratory|simulation laboratory
5160539|NCT02988154|Ventricular drain|ventricular drain
5160540|NCT02988128|Embolization Device|embolization device
5160541|NCT02988128|Flow Diverter|flow diverter
5160542|NCT02988128|Intra saccular device|intra saccular device
5160543|NCT02988128|Vascular Reconstruction Device|vascular reconstruction device
5160544|NCT02988128|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
5160545|NCT02988128|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
5160546|NCT02988115|hyperlipidemia|hyperlipidemia
5160547|NCT02988115|cholesterol|cholesterol
5160548|NCT02988115|familial hypercholesterolemia|familial hypercholesterolemia
5160549|NCT02988115|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5160550|NCT02988115|ASCVD|ascvd
5160551|NCT02988115|HeFH|hefh
5160552|NCT02988115|LDL|ldl
5160553|NCT02988115|statin intolerence|statin intolerence
5160554|NCT02988102|S100B, NSE|s100b, nse
5160555|NCT02988102|moderate brain trauma|moderate brain trauma
5160556|NCT02988102|mild brain trauma|mild brain trauma
5160557|NCT02988089|Helicobacter Pylori Infection|helicobacter pylori infection
5160559|NCT02988076|database|database
5160560|NCT02988076|probability|probability
5160561|NCT02988076|response|response
5160562|NCT02988076|depression|depression
5160563|NCT02988076|medication|medication
5160564|NCT02988076|quantitative|quantitative
5160565|NCT02988076|electroencephalogram|electroencephalogram
5160567|NCT02988063|Polidocanol Endovenous Microfoam|polidocanol endovenous microfoam
5160568|NCT02988050|Epilepsy Surgery|epilepsy surgery
5160569|NCT02988050|Conscious sedation|conscious sedation
5160570|NCT02988011|type 2 diabetes|type 2 diabetes
5160571|NCT02988011|gastric by-pass surgery|gastric by-pass surgery
5160572|NCT02988011|low calorie diet|low calorie diet
5160573|NCT02988011|glucose metabolism|glucose metabolism
5160574|NCT02987998|Pembrolizumab|pembrolizumab
5160575|NCT02987998|Chemoradiation|chemoradiation
5160576|NCT02987985|Opioid-sparing|opioid-sparing
5160578|NCT02987959|TAK-228|tak-228
5160579|NCT02987959|MLN0128|mln0128
5160580|NCT02987959|mTOR|mtor
5160581|NCT02987933|Chronic Pain|chronic pain
5160582|NCT02987933|fMRI|fmri
5160583|NCT02987933|DTI|dti
5160584|NCT02987894|TAVI|tavi
5160585|NCT02987894|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5160586|NCT02987894|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
5160587|NCT02987894|Transfemoral access|transfemoral access
5160588|NCT02987894|Aortic valve regurgitation|aortic valve regurgitation
5160589|NCT02987868|Somatostatin|somatostatin
5160590|NCT02987868|Thyroid Hormone|thyroid hormone
5160591|NCT02987868|Growth Hormone|growth hormone
5160592|NCT02987842|Mild cognitive impairment|mild cognitive impairment
5160593|NCT02987842|Alzhiemer's disease|alzhiemer's disease
5160594|NCT02987842|Neurofeedback|neurofeedback
5233868|NCT02541006|FVC|fvc
5160595|NCT02987842|EEG|eeg
5160596|NCT02987803|Patient Engagement|patient engagement
5160597|NCT02987803|Public Reporting|public reporting
5160598|NCT02987803|Quality Measurement|quality measurement
5160599|NCT02987790|Intensive care|intensive care
5160600|NCT02987790|Sepsis|sepsis
5160601|NCT02987790|Biomarkers|biomarkers
5160602|NCT02987790|C-reactive Protein|c-reactive protein
5160603|NCT02987790|Antimicrobial|antimicrobial
5160604|NCT02987790|Systemic infection|systemic infection
5160605|NCT02987764|Premature|premature
5160606|NCT02987764|Birth weight|birth weight
5160607|NCT02987725|Adolescence|adolescence
5160608|NCT02987725|Autonomic Nervous System|autonomic nervous system
5160609|NCT02987725|Hypnosis|hypnosis
5160610|NCT02987725|Pain|pain
5160611|NCT02987725|Sickle Cell Disease|sickle cell disease
5160612|NCT02987712|Thromboelastography|thromboelastography
5160613|NCT02987699|Hepatocellular Carcinoma|hepatocellular carcinoma
5160614|NCT02987699|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5160615|NCT02987699|optimal dose|optimal dose
5160616|NCT02987686|Topical Infliximab|topical infliximab
5160617|NCT02987686|Cornea|cornea
5160618|NCT02987686|Keratolysis|keratolysis
5160619|NCT02987673|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
5160620|NCT02987673|Sleeve Gastrectomy|sleeve gastrectomy
5160621|NCT02987673|Gastro-esophageal sphincter function|gastro-esophageal sphincter function
5160622|NCT02987634|gingivitis|gingivitis
5160623|NCT02987634|dental implant|dental implant
5160624|NCT02987634|mouthwash|mouthwash
5160625|NCT02987595|intervention|intervention
5160626|NCT02987595|lignans|lignans
5160627|NCT02987595|whole-grain|whole-grain
5160628|NCT02987582|mental health|mental health
5160629|NCT02987582|mindfulness|mindfulness
5160630|NCT02987582|shame|shame
5160631|NCT02987569|Home Parenteral Nutrition|home parenteral nutrition
5160632|NCT02987569|HPN|hpn
5160633|NCT02987569|Total Parenteral Nutrition|total parenteral nutrition
5160634|NCT02987569|TPN|tpn
5160635|NCT02987569|mConnect|mconnect
5160636|NCT02987569|SBS|sbs
5160637|NCT02987569|short bowel disorder|short bowel disorder
5160638|NCT02987569|telehealth|telehealth
5160639|NCT02987569|telemedicine|telemedicine
5160640|NCT02987543|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5160641|NCT02987543|homologous recombination repair (HRR)|homologous recombination repair (hrr)
5160642|NCT02987530|primary infection|primary infection
5160643|NCT02987517|running|running
5160644|NCT02987517|vertical load rates|vertical load rates
5160645|NCT02987517|cadence|cadence
5160646|NCT02987517|footstrike|footstrike
5160647|NCT02987504|Cancer|cancer
5160648|NCT02987504|Solid tumor|solid tumor
5160649|NCT02987504|Phase 1|phase 1
5160650|NCT02987491|exercise|exercise
5160651|NCT02987478|Vitamin D following intra cytoplasmic sperm injection|vitamin d following intra cytoplasmic sperm injection
5160652|NCT02987452|exercise|exercise
5160653|NCT02987452|resistant hypertension|resistant hypertension
5160654|NCT02987452|blood pressure|blood pressure
5160655|NCT02987439|COPD|copd
5160656|NCT02987439|Exacerbation|exacerbation
5160657|NCT02987439|Rehabilitation|rehabilitation
5160658|NCT02987413|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5160659|NCT02987400|DLBCL|dlbcl
5160660|NCT02987400|GA-101|ga-101
5160661|NCT02987400|ABT-199|abt-199
5160662|NCT02987400|relapsed DLBCL|relapsed dlbcl
5160962|NCT02985645|CGF|cgf
5160668|NCT02987387|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
5160669|NCT02987387|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
5160673|NCT02987374|Influenza Vaccine|influenza vaccine
5160677|NCT02987296|Colorectal Cancer|colorectal cancer
5160678|NCT02987296|Surgery|surgery
5160679|NCT02987296|Arginine depletion|arginine depletion
5160680|NCT02987296|Immune system dysfunction|immune system dysfunction
5160805|NCT02986464|Pediatric, Pediatrics|pediatric, pediatrics
5160681|NCT02987296|Arginine Supplementation|arginine supplementation
5160682|NCT02987270|mass screen and treat|mass screen and treat
5160683|NCT02987270|malaria|malaria
5160684|NCT02987270|asymptomatic infections|asymptomatic infections
5160685|NCT02987270|transmission reduction|transmission reduction
5160686|NCT02987270|infectious reservoir|infectious reservoir
5160687|NCT02987270|kenya|kenya
5160688|NCT02987257|Therapeutics|therapeutics
5160689|NCT02987257|Management|management
5160690|NCT02987257|Cyclosporine|cyclosporine
5160691|NCT02987257|Etanercept|etanercept
5160692|NCT02987257|Supportive Care|supportive care
5160693|NCT02987257|Immunopathogenesis|immunopathogenesis
5160694|NCT02987257|Genetics|genetics
5160695|NCT02987257|Adverse Drug Reaction|adverse drug reaction
5673421|NCT00608244|Tacrolimus|tacrolimus
5160696|NCT02987244|Chidamide, T Cell Non-Hodgkin's Lymphoma|chidamide, t cell non-hodgkin's lymphoma
5160697|NCT02987218|POCD|pocd
5160698|NCT02987218|subarachnoid hemorrhage|subarachnoid hemorrhage
5160699|NCT02987218|Propofol|propofol
5160700|NCT02987218|Desflurane|desflurane
5160701|NCT02987192|spinal anesthesia|spinal anesthesia
5160702|NCT02987192|anticoagulation|anticoagulation
5160703|NCT02987192|minimally invasive|minimally invasive
5160704|NCT02987192|Cesarean Section|cesarean section
5160705|NCT02987192|Maternal|maternal
5160712|NCT02987153|Kyphoplasty|kyphoplasty
5160713|NCT02987153|Spinal metastases|spinal metastases
5160714|NCT02987153|IORT|iort
5160715|NCT02987153|Intraoperative radiation therapy|intraoperative radiation therapy
5160716|NCT02987153|Pain management|pain management
5160717|NCT02987140|Parkinson's disease|parkinson's disease
5160718|NCT02987140|freezing of gait|freezing of gait
5160719|NCT02987140|context-dependency|context-dependency
5160720|NCT02987140|transcranial magnetic stimulation|transcranial magnetic stimulation
5160721|NCT02987140|visual cues|visual cues
5160722|NCT02987062|Atrial Fibrillation|atrial fibrillation
5160723|NCT02987062|Non-vitamin K Oral Anticoagulants|non-vitamin k oral anticoagulants
5160724|NCT02987062|Vitamin K Antagonists|vitamin k antagonists
5160725|NCT02987062|ROCKET-AF|rocket-af
5160726|NCT02987062|RE-LY|re-ly
5160727|NCT02987062|ARISTOTLE|aristotle
5160728|NCT02987049|heart disease, cardiac rehabilitation|heart disease, cardiac rehabilitation
5160729|NCT02987036|nebulizer technologies, lung mechanics, beta-agonistic drug|nebulizer technologies, lung mechanics, beta-agonistic drug
5160730|NCT02987023|infertility, uterus, transplantation|infertility, uterus, transplantation
5160731|NCT02986997|epidural anesthesia|epidural anesthesia
5160732|NCT02986997|prone position|prone position
5160733|NCT02986997|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5160734|NCT02986984|Diabetes|diabetes
5160735|NCT02986984|Chronic kidney disease|chronic kidney disease
5160736|NCT02986984|Progression|progression
5160737|NCT02986984|Genomics|genomics
5160738|NCT02986984|Transcriptomics|transcriptomics
5160739|NCT02986971|Contraceptive implant|contraceptive implant
5160740|NCT02986945|Depressive symptoms|depressive symptoms
5160741|NCT02986945|resiliency|resiliency
5160742|NCT02986945|Health Promotion|health promotion
5160743|NCT02986945|minority health|minority health
5160744|NCT02986945|text-messaging app|text-messaging app
5160745|NCT02986945|participatory technology development|participatory technology development
5160746|NCT02986932|Blood-Brain Barrier|blood-brain barrier
5160747|NCT02986919|Malignant peripheral Nerve Sheath Tumors (MPNST); Neurofibromatosis sarcoma|malignant peripheral nerve sheath tumors (mpnst); neurofibromatosis sarcoma
5160748|NCT02986906|ulnar neuropathy at elbow|ulnar neuropathy at elbow
5160749|NCT02986906|Dextrose|dextrose
5160750|NCT02986906|perineural injection|perineural injection
5160751|NCT02986893|Multiple Sclerosis|multiple sclerosis
5160752|NCT02986893|Diet|diet
5160753|NCT02986893|Clinical Trial|clinical trial
5160754|NCT02986854|Meningococcal disease|meningococcal disease
5160759|NCT02986828|Hydrodissection|hydrodissection
5160760|NCT02986737|TAVI|tavi
5160761|NCT02986737|Aortic Stenosis|aortic stenosis
5160762|NCT02986737|Transcatether Aortic Valve Implantation|transcatether aortic valve implantation
5160763|NCT02986724|Drug therapy|drug therapy
5160764|NCT02986698|intrauterine transfusion|intrauterine transfusion
5160765|NCT02986698|in utero human stem cell transplantation|in utero human stem cell transplantation
5160766|NCT02986685|Refractory reflux esophagitis|refractory reflux esophagitis
5160767|NCT02986685|Rabeprazole|rabeprazole
5160768|NCT02986685|trimebutine maleate|trimebutine maleate
5160769|NCT02986672|ADHD|adhd
5160770|NCT02986672|omega 3|omega 3
5160771|NCT02986672|children|children
5160772|NCT02986672|nutrition|nutrition
5160773|NCT02986672|MUFA|mufa
5160776|NCT02986672|Calanus|calanus
5160780|NCT02986633|Biventricular Pacing|biventricular pacing
5160781|NCT02986568|Ontogenetic surgery|ontogenetic surgery
5160783|NCT02986568|PMMR|pmmr
5160784|NCT02986568|LEER|leer
5160785|NCT02986555|Stress|stress
5160786|NCT02986555|Virtual Reality|virtual reality
5160787|NCT02986555|Motion sickness|motion sickness
5160788|NCT02986555|Visual Fatigue|visual fatigue
5160789|NCT02986555|Biofeedback|biofeedback
5160790|NCT02986542|newborns,femoral artery, catheterization|newborns,femoral artery, catheterization
5160791|NCT02986490|Mental disorders|mental disorders
5160792|NCT02986490|Antipsychotic agents|antipsychotic agents
5160793|NCT02986490|Magnesium|magnesium
5160794|NCT02986490|Cardiovascular risk factor|cardiovascular risk factor
5160795|NCT02986490|Metabolic syndrome|metabolic syndrome
5160796|NCT02986464|Virtual reality|virtual reality
5160797|NCT02986464|Immersive distraction|immersive distraction
5160798|NCT02986464|Virtual world|virtual world
5160799|NCT02986464|Virtual environment|virtual environment
5160800|NCT02986464|Procedural pain|procedural pain
5160801|NCT02986464|Acute pain|acute pain
5160802|NCT02986464|Pain Management|pain management
5160803|NCT02986464|Children, Child|children, child
5160804|NCT02986464|Kid, Kids|kid, kids
5160806|NCT02986464|Young children|young children
5160807|NCT02986464|Burns|burns
5160808|NCT02986464|Burn injuries|burn injuries
5160809|NCT02986464|Burn unit|burn unit
5160810|NCT02986464|Hydrotherapy|hydrotherapy
5160811|NCT02986464|Burn dressing|burn dressing
5160812|NCT02986464|Non-pharmacological|non-pharmacological
5160813|NCT02986464|Clinical Research|clinical research
5160814|NCT02986464|Nursing Practice|nursing practice
5160815|NCT02986438|Cocaine|cocaine
5160816|NCT02986438|Addiction|addiction
5160817|NCT02986438|rTMS|rtms
5160818|NCT02986438|fMRI|fmri
5160819|NCT02986425|Drug Utilization Review|drug utilization review
5160820|NCT02986425|Older people|older people
5160821|NCT02986399|fast track|fast track
5160822|NCT02986386|Dental Occlusion|dental occlusion
5160823|NCT02986386|Oral Health|oral health
5160824|NCT02986386|Mastication|mastication
5160825|NCT02986386|Dementia|dementia
5160826|NCT02986386|Psychological health|psychological health
5160827|NCT02986373|risankizumab|risankizumab
5160828|NCT02986373|ABBV-066|abbv-066
5160829|NCT02986373|BI655066|bi655066
5160830|NCT02986334|chronic|chronic
5160831|NCT02986334|low back|low back
5160832|NCT02986334|back|back
5160833|NCT02986334|pain|pain
5160834|NCT02986334|brain|brain
5160836|NCT02986321|anti-inflammatory respiratory drug|anti-inflammatory respiratory drug
5160837|NCT02986321|PDE4 inhibitor|pde4 inhibitor
5160842|NCT02986295|BioMime, Ultimaster, Ischemic heart disease, DES|biomime, ultimaster, ischemic heart disease, des
5160843|NCT02986282|ankle - brachial index|ankle - brachial index
5160844|NCT02986269|Respiratory Function|respiratory function
5160845|NCT02986269|Patient Positioning|patient positioning
5160846|NCT02986269|anesthesia|anesthesia
5160847|NCT02986256|telemedicine|telemedicine
5160848|NCT02986230|Cancer prevention|cancer prevention
5160849|NCT02986230|Clinical Decision Support|clinical decision support
5160850|NCT02986230|Rural Health|rural health
5160851|NCT02986230|Shared Decision Making|shared decision making
5160852|NCT02986204|implant removal|implant removal
5160853|NCT02986204|Nexplanon|nexplanon
5160854|NCT02986204|Implanon|implanon
5160855|NCT02986204|contraception|contraception
5160856|NCT02986204|ENG|eng
5160857|NCT02986191|gingival graft|gingival graft
5160858|NCT02986191|free gingival graft|free gingival graft
5160859|NCT02986191|coronally advanced flap|coronally advanced flap
5160860|NCT02986191|reduced keratinized gingiva|reduced keratinized gingiva
5160861|NCT02986178|Glioblastoma|glioblastoma
5160862|NCT02986178|Glioma|glioma
5160863|NCT02986178|PVSRIPO|pvsripo
5160864|NCT02986178|Duke|duke
5160865|NCT02986178|Pro00077024|pro00077024
5160866|NCT02986178|Randazzo|randazzo
5160867|NCT02986178|Brain tumor|brain tumor
5160868|NCT02986178|Bigner|bigner
5160869|NCT02986178|Istari|istari
5160870|NCT02986165|Platelet Aggregation|platelet aggregation
5160871|NCT02986152|PTSD|ptsd
5160872|NCT02986152|anxiety|anxiety
5160873|NCT02986152|depression|depression
5160874|NCT02986152|distress|distress
5160875|NCT02986152|fear|fear
5160876|NCT02986152|coping|coping
5160877|NCT02986152|support|support
5160878|NCT02986152|caregiver|caregiver
5160879|NCT02986152|oncology|oncology
5160880|NCT02986152|app|app
5160881|NCT02986152|mobile app|mobile app
5160882|NCT02986126|Depression|depression
5160883|NCT02986126|Resilience|resilience
5160884|NCT02986126|Minority health|minority health
5160885|NCT02986126|Community-based participatory research|community-based participatory research
5156315|NCT03014999|Spinal Cord Injury|spinal cord injury
5160886|NCT02986126|Lesbian, gay, bisexual, transgender, and intersex (LGBTI) health|lesbian, gay, bisexual, transgender, and intersex (lgbti) health
5160887|NCT02986126|Racial / ethnic health disparities|racial / ethnic health disparities
5160888|NCT02986126|Patient-centered outcomes research|patient-centered outcomes research
5160889|NCT02986126|Comparative-effectiveness research|comparative-effectiveness research
5160892|NCT02986100|Clovis|clovis
5160893|NCT02986100|Clovis Oncology|clovis oncology
5160894|NCT02986100|PARP inhibitor|parp inhibitor
5160895|NCT02986100|Absorption|absorption
5160896|NCT02986100|Metabolism|metabolism
5160897|NCT02986100|Excretion|excretion
5160898|NCT02986048|proton beam|proton beam
5160899|NCT02986048|registry|registry
5160900|NCT02986048|radiation|radiation
5160901|NCT02986048|cancer|cancer
5160902|NCT02986022|Self-efficacy|self-efficacy
5160903|NCT02986022|optimism|optimism
5160904|NCT02986022|altruism|altruism
5160905|NCT02986022|goal setting|goal setting
5160906|NCT02986009|emotion management|emotion management
5160907|NCT02986009|positive and negative affect|positive and negative affect
5160908|NCT02986009|satisfaction with parent-child relationship|satisfaction with parent-child relationship
5160909|NCT02986009|subjective happiness|subjective happiness
5160910|NCT02986009|family harmony|family harmony
5775835|NCT00218166|tiagabine|tiagabine
5160911|NCT02985996|Preventative Medicine|preventative medicine
5160912|NCT02985996|Infectious Diseases|infectious diseases
5160913|NCT02985996|Sexually Transmitted Diseases|sexually transmitted diseases
5160914|NCT02985983|Brodalumab|brodalumab
5160915|NCT02985983|KHK4827|khk4827
5160916|NCT02985983|Axial Spondyloarthritis|axial spondyloarthritis
5160917|NCT02985970|crush induction, RSI|crush induction, rsi
5160918|NCT02985944|colorectal cancer|colorectal cancer
5160919|NCT02985944|Colon polyp|colon polyp
5160920|NCT02985944|Colonoscopy|colonoscopy
5160921|NCT02985944|Adenoma detection rate|adenoma detection rate
5160922|NCT02985905|Zinc supplementation|zinc supplementation
5160923|NCT02985905|Thiol|thiol
5160924|NCT02985905|Glutathione peroxidase|glutathione peroxidase
5160925|NCT02985905|Sulfhydryl oxidase|sulfhydryl oxidase
5160926|NCT02985892|Physical therapy|physical therapy
5160927|NCT02985892|Muscle Stretching Exercises|muscle stretching exercises
5160928|NCT02985892|Low Back pain|low back pain
5160929|NCT02985879|PSP|psp
5160930|NCT02985879|Steele-Richardson-Olszewski syndrome|steele-richardson-olszewski syndrome
5160931|NCT02985879|tauopathy|tauopathy
5160932|NCT02985866|Artificial Pancreas|artificial pancreas
5160933|NCT02985866|Closed Loop Control|closed loop control
5160934|NCT02985866|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5160935|NCT02985866|inControl Diabetes Management Platform|incontrol diabetes management platform
5160936|NCT02985840|ondansetron|ondansetron
5160937|NCT02985840|dexamethasone|dexamethasone
5160938|NCT02985814|COPD Asthma Overlap|copd asthma overlap
5160939|NCT02985775|CMV-specific T cell|cmv-specific t cell
5160940|NCT02985775|haploidentical stem cell transplantation|haploidentical stem cell transplantation
5160941|NCT02985775|immunologic response|immunologic response
5160942|NCT02985775|acute GVHD|acute gvhd
5160943|NCT02985762|bupivacaine|bupivacaine
5160944|NCT02985762|exparel|exparel
5160945|NCT02985762|analgesic|analgesic
5160946|NCT02985762|lumbar spine|lumbar spine
5160947|NCT02985749|Autism Spectrum Disorders|autism spectrum disorders
5160948|NCT02985749|Pervasive Developmental Disorder|pervasive developmental disorder
5160949|NCT02985749|ASD|asd
5160950|NCT02985749|PDD|pdd
5160951|NCT02985749|Oxytocin|oxytocin
5160952|NCT02985749|Syntocinon|syntocinon
5160953|NCT02985749|Social Impairment|social impairment
5160954|NCT02985749|Treatment|treatment
5160955|NCT02985671|Postural Low Back Pain|postural low back pain
5160956|NCT02985671|Mechanical Low Back Pain|mechanical low back pain
5160957|NCT02985671|Low Back Pain|low back pain
5160958|NCT02985671|acetaminophen|acetaminophen
5160959|NCT02985671|caffeine|caffeine
5160960|NCT02985671|orphenadrine|orphenadrine
5160961|NCT02985671|diclofenac sodium|diclofenac sodium
5160972|NCT02985515|Intranasal Steroid Irrigation|intranasal steroid irrigation
5160973|NCT02985515|Olfactory Neuroplasticity|olfactory neuroplasticity
5160974|NCT02985515|Olfactory training|olfactory training
5160975|NCT02985502|Quality of Life|quality of life
5160976|NCT02985502|Diabetes Mellitus|diabetes mellitus
5160977|NCT02985502|Pancreatectomy|pancreatectomy
5160978|NCT02985476|Electronic health records|electronic health records
5160979|NCT02985476|Health records personal|health records personal
5160980|NCT02985437|wound healing|wound healing
5160981|NCT02985437|Bovine Lung Surfactant|bovine lung surfactant
5160982|NCT02985437|SATOSU|satosu
5160983|NCT02985385|Congenital Lethal Malformations|congenital lethal malformations
5160984|NCT02985359|Program impact evaluation|program impact evaluation
5160985|NCT02985359|Malawi|malawi
5160986|NCT02985359|Lipid-based nutrient supplements|lipid-based nutrient supplements
5160987|NCT02985359|Social behavior change communication|social behavior change communication
5160988|NCT02985359|Childhood stunting|childhood stunting
5160989|NCT02985346|Idiopathic pulmonary hemosiderosis|idiopathic pulmonary hemosiderosis
5160993|NCT02985320|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
5160996|NCT02985320|immunogenicity|immunogenicity
5160999|NCT02985294|Quantitative Sensory Testing|quantitative sensory testing
5161000|NCT02985294|Multiple Excitability Measures|multiple excitability measures
5161001|NCT02985294|Threshold Tracking|threshold tracking
5161002|NCT02985281|direct acting antiviral drugs, chronic hepatitis C virus infection|direct acting antiviral drugs, chronic hepatitis c virus infection
5161008|NCT02985255|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5161009|NCT02985255|Tongue Malignancy|tongue malignancy
5161010|NCT02985255|Squamous Cell Carcinoma|squamous cell carcinoma
5161011|NCT02985203|lung cancer|lung cancer
5161012|NCT02985203|vinorelbine|vinorelbine
5161013|NCT02985203|metronomic chemotherapy|metronomic chemotherapy
5161014|NCT02985190|Azacitidine|azacitidine
5161015|NCT02985190|MDS|mds
5161016|NCT02985190|Systemic auto-immune and inflammatory disorders|systemic auto-immune and inflammatory disorders
5161017|NCT02985177|Children|children
5161018|NCT02985177|Musculoskeletal injury|musculoskeletal injury
5161019|NCT02985177|Emergency department|emergency department
5161020|NCT02985177|Analgesia|analgesia
5161021|NCT02985177|Opioids|opioids
5161022|NCT02985164|Anesthesiology( H02.403.066 )|anesthesiology( h02.403.066 )
5161023|NCT02985164|Radiation Protection( N06.850.810.425)|radiation protection( n06.850.810.425)
5161024|NCT02985164|Cholangiopancreatography, Endoscopic Retrograde(D002760 )|cholangiopancreatography, endoscopic retrograde(d002760 )
5161025|NCT02985151|Scar|scar
5161026|NCT02985151|Carbon Dioxide Laser|carbon dioxide laser
5161027|NCT02985151|Laser Ablation|laser ablation
5161028|NCT02985125|Pancreas|pancreas
5161029|NCT02985125|5-FU|5-fu
5161030|NCT02985125|Gemcitabine|gemcitabine
5161031|NCT02985125|LEE011|lee011
5161032|NCT02985125|Everolimus|everolimus
5161033|NCT02985125|Refractory|refractory
5161034|NCT02985125|Chemotherapy|chemotherapy
5161035|NCT02985086|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection|term premature rupture of membranes, antibiotic prophylaxis, chorioamnionitis, endometritis, neonatal infection
5161036|NCT02985060|Therapeutic hypothermia|therapeutic hypothermia
5161037|NCT02985047|Brief admission|brief admission
5161038|NCT02985047|admission|admission
5161039|NCT02985047|deliberate self-harm|deliberate self-harm
5161040|NCT02985047|self-harm|self-harm
5161041|NCT02985034|HCC|hcc
5161042|NCT02985034|RFA|rfa
5161043|NCT02985034|Liver tumor|liver tumor
5047712|NCT03700827|Abdominal Fat|abdominal fat
5161044|NCT02985008|Shock, IVBP, ECMO, In hospital death|shock, ivbp, ecmo, in hospital death
5161049|NCT02984956|Hypotension|hypotension
5161050|NCT02984956|Pleth variability index|pleth variability index
5161051|NCT02984956|Hip Fracture|hip fracture
5161052|NCT02984956|Spinal anesthesia|spinal anesthesia
5161055|NCT02984917|anterior transversalis fascia repair; preperitoneal repair|anterior transversalis fascia repair; preperitoneal repair
5161056|NCT02984904|Fusarium Infection|fusarium infection
5161057|NCT02984904|Corneal ulcer|corneal ulcer
5161059|NCT02984904|Epidemiology|epidemiology
5161060|NCT02984891|Intravascular ultrasound|intravascular ultrasound
5161061|NCT02984891|Optical coherence tomography|optical coherence tomography
5161062|NCT02984865|transversus plane block|transversus plane block
5161063|NCT02984865|opioid|opioid
5161064|NCT02984865|nalbuphine|nalbuphine
5161065|NCT02984865|gastrointestinal surgery|gastrointestinal surgery
5161066|NCT02984865|elderly patient|elderly patient
5161067|NCT02984865|rectus sheath block|rectus sheath block
5161068|NCT02984865|Peritoneal dialysis|peritoneal dialysis
5161069|NCT02984839|intra-abdominal surgery|intra-abdominal surgery
5161070|NCT02984839|neuromuscular blocking agent|neuromuscular blocking agent
5161071|NCT02984839|post-anesthesia care unit|post-anesthesia care unit
5161072|NCT02984787|Gastric Cancer|gastric cancer
5161073|NCT02984787|3D|3d
5161074|NCT02984787|2D|2d
5161075|NCT02984774|Endometriosis|endometriosis
5161076|NCT02984774|Infertility|infertility
5161077|NCT02984774|Telomerase activity|telomerase activity
5161078|NCT02984761|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
5161079|NCT02984761|Respiratory Tract Neoplasms|respiratory tract neoplasms
5161080|NCT02984761|Thoracic Neoplasms|thoracic neoplasms
5161081|NCT02984761|Neoplasms by Site|neoplasms by site
5161082|NCT02984761|Neoplasms|neoplasms
5161083|NCT02984761|Lung Diseases|lung diseases
5161084|NCT02984761|Respiratory Tract Diseases|respiratory tract diseases
5161085|NCT02984761|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5161086|NCT02984761|Bronchial Neoplasms|bronchial neoplasms
5161087|NCT02984761|Radiosurgery|radiosurgery
5161088|NCT02984761|Radiotherapy|radiotherapy
5161089|NCT02984761|Radiotherapy, Image-Guided|radiotherapy, image-guided
5161090|NCT02984761|Lung Neoplasms|lung neoplasms
5161091|NCT02984748|cochlear implants|cochlear implants
5161092|NCT02984748|hearing loss|hearing loss
5161093|NCT02984735|chewing|chewing
5169983|NCT02929017|IPF|ipf
5161094|NCT02984735|cerebral palsy|cerebral palsy
5161095|NCT02984735|chewing disorders|chewing disorders
5161096|NCT02984735|gross motor function|gross motor function
5161097|NCT02984722|PCOS|pcos
5161098|NCT02984722|metformin|metformin
5161099|NCT02984670|Cognitive therapy|cognitive therapy
5161100|NCT02984670|Behavior therapy|behavior therapy
5161101|NCT02984670|Moderation|moderation
5161102|NCT02984670|Mediation|mediation
5161103|NCT02984657|Hypoxemia|hypoxemia
5161104|NCT02984657|Reverse Trendelenburg|reverse trendelenburg
5161105|NCT02984592|premature ejaculation|premature ejaculation
5161106|NCT02984592|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
5161107|NCT02984592|premature ejaculation diagnostic tools|premature ejaculation diagnostic tools
5161108|NCT02984566|Primary liver cancer|primary liver cancer
5161109|NCT02984566|Secondary liver cancer|secondary liver cancer
5161110|NCT02984566|Kilovoltage Intrafraction Monitoring|kilovoltage intrafraction monitoring
5161111|NCT02984566|Stereotactic Ablative Body Radiation|stereotactic ablative body radiation
5161112|NCT02984553|accelerometry|accelerometry
5161113|NCT02984553|aerobic fitness|aerobic fitness
5161114|NCT02984553|metabolic thresholds|metabolic thresholds
5161115|NCT02984553|moderate to vigorous physical activity|moderate to vigorous physical activity
5161116|NCT02984501|radiochemotherapy|radiochemotherapy
5161117|NCT02984501|neoadjuvant therapy|neoadjuvant therapy
5161118|NCT02984488|necrotic teeth|necrotic teeth
5161119|NCT02984488|single visit|single visit
5161120|NCT02984488|multiple visits|multiple visits
5161121|NCT02984488|protaper next|protaper next
5161122|NCT02984475|Beta Thalassemia|beta thalassemia
5161123|NCT02984475|Metformin|metformin
5161124|NCT02984475|Oxidative stress|oxidative stress
5161125|NCT02984475|Iron overload|iron overload
5161126|NCT02984475|Liver function|liver function
5161127|NCT02984462|percutaneous|percutaneous
5161128|NCT02984462|non-fixed|non-fixed
5161129|NCT02984462|Akin ;|akin ;
5161130|NCT02984462|osteotomy|osteotomy
5161131|NCT02984449|cardiac rehabilitation|cardiac rehabilitation
5161132|NCT02984449|surgical complications|surgical complications
5161133|NCT02984449|quality of life|quality of life
5161134|NCT02984449|preoperative|preoperative
5161135|NCT02984449|cardiac surgery|cardiac surgery
5161136|NCT02984423|Ovarian Cancer|ovarian cancer
5161137|NCT02984423|BRCA mutations|brca mutations
5161138|NCT02984410|T1-T2, N0 oropharyngeal carcinoma|t1-t2, n0 oropharyngeal carcinoma
5161143|NCT02984384|Trauma|trauma
5161144|NCT02984384|Blood clot|blood clot
5161145|NCT02984384|Venous Thromboembolism|venous thromboembolism
5161146|NCT02984384|Pulmonary Embolism|pulmonary embolism
5161147|NCT02984384|Deep Vein Thrombosis|deep vein thrombosis
5161148|NCT02984384|Thromboprophylaxis|thromboprophylaxis
5047850|NCT03699826|neuromodulation|neuromodulation
5161149|NCT02984384|Blood clot prevention|blood clot prevention
5161150|NCT02984384|trauma patients|trauma patients
5161151|NCT02984371|atrial fibrillation|atrial fibrillation
5161152|NCT02984371|ganglionated plexi|ganglionated plexi
5161153|NCT02984371|ischemic heart disease|ischemic heart disease
5161154|NCT02984293|Atorvastatin|atorvastatin
5161155|NCT02984293|LILRB5|lilrb5
5161156|NCT02984293|Statin intolerance|statin intolerance
5161157|NCT02984254|knee|knee
5161158|NCT02984254|knee osteoarthritis|knee osteoarthritis
5161159|NCT02984254|Bracing|bracing
5161160|NCT02984254|patellofemoral osteoarthritis|patellofemoral osteoarthritis
5161161|NCT02984189|Physical Exercise|physical exercise
5161162|NCT02984189|Physical Therapy|physical therapy
5161163|NCT02984189|Physical Performance|physical performance
5161164|NCT02984189|Critical Power|critical power
5161165|NCT02984189|Respiratory Muscle|respiratory muscle
5161166|NCT02984176|Simethicone|simethicone
5161167|NCT02984176|Laparoscopies|laparoscopies
5161168|NCT02984176|Pain|pain
5161169|NCT02984163|cancer|cancer
5161170|NCT02984163|exercise|exercise
5161171|NCT02984137|Lewy body disease|lewy body disease
5161172|NCT02984137|REM Sleep Behavior Disorder|rem sleep behavior disorder
5161173|NCT02984137|Parkinson disease|parkinson disease
5161174|NCT02984137|Imaging|imaging
5161175|NCT02984137|Bio-markers|bio-markers
5161176|NCT02984137|Prospective cohort|prospective cohort
5161177|NCT02984111|Coronary artery bypass|coronary artery bypass
5161178|NCT02984111|Erythropoietin|erythropoietin
5161179|NCT02984111|Inflammation|inflammation
5161180|NCT02984111|IL-6|il-6
5161181|NCT02984111|Reperfusion injury|reperfusion injury
5161182|NCT02984111|YKL- 40|ykl- 40
5161183|NCT02984098|procedural pain, 40% Dextrose, heel lance|procedural pain, 40% dextrose, heel lance
5161184|NCT02984085|RDEB|rdeb
5161185|NCT02984085|Stem cells|stem cells
5161186|NCT02984085|Gene therapy|gene therapy
5161187|NCT02984046|Acute bronchiolitis|acute bronchiolitis
5161189|NCT02984046|CC16|cc16
5161190|NCT02984046|SP-D|sp-d
5161191|NCT02984046|sRAGE|srage
5161192|NCT02984046|Severity|severity
5161193|NCT02984046|Biomarkers|biomarkers
5161194|NCT02983994|asthma, devices|asthma, devices
5161195|NCT02983968|Oncology|oncology
5161196|NCT02983968|Hepatology|hepatology
5161197|NCT02983968|Public Health|public health
5161198|NCT02983968|Liver|liver
5161199|NCT02983942|ketogenic diet|ketogenic diet
5161200|NCT02983942|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
5161201|NCT02983942|chemotherapy|chemotherapy
5161202|NCT02983916|Adhesions|adhesions
5161203|NCT02983916|Adhesiolysis|adhesiolysis
5161204|NCT02983916|chronic pain|chronic pain
5161205|NCT02983916|post-operative complications|post-operative complications
5161206|NCT02983916|anti-adhesion barrier|anti-adhesion barrier
5161208|NCT02983916|shared decision making|shared decision making
5161209|NCT02983851|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
5161210|NCT02983851|Invasive mechanical ventilation|invasive mechanical ventilation
5161212|NCT02983838|BDNF|bdnf
5161213|NCT02983838|major depressive disorder|major depressive disorder
5161214|NCT02983838|cognitive decline|cognitive decline
5161215|NCT02983825|CPAP|cpap
5161216|NCT02983825|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5775836|NCT00218166|baclofen|baclofen
5161217|NCT02983825|Ventilator Induced Lung Injury|ventilator induced lung injury
5161218|NCT02983825|V/Q mismatch|v/q mismatch
5161219|NCT02983799|BRCA, ovarian, platinum, chemotherapy|brca, ovarian, platinum, chemotherapy
5161220|NCT02983760|Pulmonary embolism|pulmonary embolism
5161221|NCT02983747|Platelet Rich Plasma|platelet rich plasma
5161222|NCT02983747|Intervertebral Disk Injection Therapy|intervertebral disk injection therapy
5161223|NCT02983747|Low Back Pain|low back pain
5161224|NCT02983747|Ultrasound Guided|ultrasound guided
5161225|NCT02983747|Degenerative Spinal Disease|degenerative spinal disease
5161226|NCT02983734|Gulf War|gulf war
5161227|NCT02983734|D-cycloserine|d-cycloserine
5161228|NCT02983734|Neuroinflammation|neuroinflammation
5161229|NCT02983734|Cognition|cognition
5161230|NCT02983734|Memory|memory
5161231|NCT02983708|Neuroregeneration|neuroregeneration
5161232|NCT02983708|G-CSF|g-csf
5161233|NCT02983708|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
5161234|NCT02983708|Cerebral palsy|cerebral palsy
5161235|NCT02983682|Anesthetics, Local|anesthetics, local
5161236|NCT02983682|Lidocaine|lidocaine
5161237|NCT02983682|Pediatrics|pediatrics
5161238|NCT02983682|Children|children
5161239|NCT02983682|Adolescents|adolescents
5161240|NCT02983669|Thymus Plant|thymus plant
5161241|NCT02983669|Multiflotriol [Supplementary Concept]|multiflotriol [supplementary concept]
5161242|NCT02983669|Zataria multiflora|zataria multiflora
5161243|NCT02983669|Complementary Therapies|complementary therapies
5161244|NCT02983669|Herbal Medicine|herbal medicine
5161245|NCT02983669|Medicine, traditional|medicine, traditional
5161246|NCT02983656|Vaccine Safety|vaccine safety
5161247|NCT02983643|Skeletal Muscle Index|skeletal muscle index
5161248|NCT02983643|Visceral Adipose Tissue|visceral adipose tissue
5161249|NCT02983643|Metabolic Syndrome|metabolic syndrome
5161250|NCT02983604|Exemestane|exemestane
5161251|NCT02983604|Aromasin|aromasin
5161252|NCT02983604|Fulvestrant|fulvestrant
5161253|NCT02983604|Faslodex|faslodex
5161254|NCT02983604|Breast Cancer|breast cancer
5161255|NCT02983604|HER 2-|her 2-
5161256|NCT02983604|Estrogen receptor positive|estrogen receptor positive
5161257|NCT02983565|Long-term oxygen therapy|long-term oxygen therapy
5161258|NCT02983565|Intelligent oxygen therapy system|intelligent oxygen therapy system
5161259|NCT02983565|Auto-titrating oxygen system|auto-titrating oxygen system
5161260|NCT02983552|Amblyopia|amblyopia
5161261|NCT02983539|sarcomas|sarcomas
5161262|NCT02983539|immunocytochemistry|immunocytochemistry
5161263|NCT02983539|circulating tumor cells|circulating tumor cells
5161264|NCT02983526|short stem|short stem
5161265|NCT02983513|Early intervention|early intervention
5161266|NCT02983513|Brain Development|brain development
5161267|NCT02983513|Neurodevelopment|neurodevelopment
5161268|NCT02983500|Patient Reported Outcome (PRO)|patient reported outcome (pro)
5161269|NCT02983487|Bordetella Pertussis|bordetella pertussis
5161270|NCT02983487|Whooping Cough|whooping cough
5161271|NCT02983487|vaccine|vaccine
5161272|NCT02983461|urinary incontinence|urinary incontinence
5161273|NCT02983461|pelvic floor dysfunction|pelvic floor dysfunction
5161274|NCT02983435|Osteopathic Treatment|osteopathic treatment
5161275|NCT02983435|Postural control|postural control
5161276|NCT02983435|Neuromuscular activation|neuromuscular activation
5161277|NCT02983435|Physiotherapy|physiotherapy
5161278|NCT02983409|computerized tomography|computerized tomography
5161279|NCT02983409|Urinary Calculi|urinary calculi
5161280|NCT02983409|Patient admission|patient admission
5161281|NCT02983409|Pain|pain
5161282|NCT02983396|RELF method|relf method
5161283|NCT02983396|Medical device|medical device
5161284|NCT02983396|Admission delay|admission delay
5161285|NCT02983383|Varicocele|varicocele
5161286|NCT02983383|TAP block|tap block
5161287|NCT02983383|spinal anesthesia|spinal anesthesia
5161288|NCT02983357|Shoulder Arthroplasty|shoulder arthroplasty
5161289|NCT02983357|glenohumeral arthritis|glenohumeral arthritis
5161290|NCT02983344|fascia iliaca compartment block|fascia iliaca compartment block
5161292|NCT02983266|Hyperadrenergia|hyperadrenergia
5161293|NCT02983266|Inflammatory stress|inflammatory stress
5161294|NCT02983214|Cilostazol|cilostazol
5170130|NCT02928354|Asthma|asthma
5161295|NCT02983214|Clopidogrel|clopidogrel
5161296|NCT02983214|Peripheral Artery Disease|peripheral artery disease
5161297|NCT02983201|Orthopedic Pain Syndromes|orthopedic pain syndromes
5161298|NCT02983201|Thumbtack Intra-dermal Needle|thumbtack intra-dermal needle
5161299|NCT02983201|Filiform needle|filiform needle
5161300|NCT02983201|Acupuncture|acupuncture
5161301|NCT02983188|Schizophrenia|schizophrenia
5161302|NCT02983188|Berberine|berberine
5161311|NCT02983136|Implementation|implementation
5161313|NCT02983136|Surgery|surgery
5161314|NCT02983123|Acute MI|acute mi
5234724|NCT02535364|ALL|all
5161315|NCT02983123|Acute myocardial infarction cardiac troponin|acute myocardial infarction cardiac troponin
5161316|NCT02983123|High-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
5161317|NCT02983123|0/1-hour algorithm|0/1-hour algorithm
5161318|NCT02983123|Outpatient clinic|outpatient clinic
5161319|NCT02983123|Cardiac troponin|cardiac troponin
5161320|NCT02983123|Chest pain|chest pain
5161321|NCT02983110|Hormones, Transgender|hormones, transgender
5161322|NCT02983097|lymphoma|lymphoma
5161324|NCT02983097|recurrence|recurrence
5161325|NCT02983097|progress|progress
5161326|NCT02983097|progressive|progressive
5161327|NCT02983097|b-cell lymphoma|b-cell lymphoma
5161328|NCT02983097|chemotherapy|chemotherapy
5161329|NCT02983097|immunotherapy|immunotherapy
5161330|NCT02983097|IMiD|imid
5161331|NCT02983097|Salvage chemotherapy|salvage chemotherapy
5161332|NCT02983097|peripheral stem cell mobilization|peripheral stem cell mobilization
5161333|NCT02983097|lenalidomide|lenalidomide
5161334|NCT02983097|Rituximab|rituximab
5161335|NCT02983097|CD20|cd20
5161336|NCT02983097|Cytarabine|cytarabine
5161337|NCT02983097|Ara-C|ara-c
5161338|NCT02983097|platinum-based chemotherapy|platinum-based chemotherapy
5161339|NCT02983097|Cisplatin|cisplatin
5161340|NCT02983097|Carboplatin|carboplatin
5161341|NCT02983097|Cisplatinum|cisplatinum
5161342|NCT02983097|Carboplatinum|carboplatinum
5161343|NCT02983097|Dexamethasone|dexamethasone
5161344|NCT02983084|Orthodontic wires|orthodontic wires
5161345|NCT02983084|Root resorption|root resorption
5161346|NCT02983071|Breast Cancer|breast cancer
5161347|NCT02983071|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5161348|NCT02983071|HER2-Negative|her2-negative
5161349|NCT02983071|HR-Positive|hr-positive
5161351|NCT02983071|HER2-|her2-
5161352|NCT02983071|HER2 -ve|her2 -ve
5161353|NCT02983071|HER2 +ve|her2 +ve
5161354|NCT02983045|NKTR-214|nktr-214
5161355|NCT02983045|Bempegaldesleukin|bempegaldesleukin
5161356|NCT02983045|Nivolumab|nivolumab
5161357|NCT02983045|Ipilimumab|ipilimumab
5161358|NCT02983045|Paclitaxel|paclitaxel
5161359|NCT02983045|Carboplatin|carboplatin
5161360|NCT02983045|Cisplatin|cisplatin
5161361|NCT02983045|Pemetrexed|pemetrexed
5161362|NCT02983045|Melanoma|melanoma
5161363|NCT02983045|Renal Cell Carcinoma|renal cell carcinoma
5161364|NCT02983045|Non Small Cell Lung Cancer|non small cell lung cancer
5161365|NCT02983045|Urothelial Carcinoma|urothelial carcinoma
5161366|NCT02983045|Triple Negative Breast Cancer|triple negative breast cancer
5161367|NCT02983045|Colorectal Cancer|colorectal cancer
5161368|NCT02983045|Metastatic|metastatic
5161369|NCT02983045|Advanced|advanced
5161370|NCT02983045|Immunotherapy|immunotherapy
5161371|NCT02983045|Anti-PD-1|anti-pd-1
5161372|NCT02983045|anti-CTLA-4|anti-ctla-4
5161373|NCT02983032|Caregivers|caregivers
5161374|NCT02983032|Insomnia|insomnia
5161375|NCT02983019|influenza|influenza
5161376|NCT02983019|flu|flu
5161377|NCT02983019|acute respiratory viral infection|acute respiratory viral infection
5161378|NCT02983019|ARVI|arvi
5161379|NCT02983019|acute upper respiratory infection|acute upper respiratory infection
5161380|NCT02983019|AURI|auri
5161381|NCT02983006|TRAIL-DR5|trail-dr5
5161382|NCT02983006|DS-8273a|ds-8273a
5161383|NCT02983006|Immunoglobulin gamma-1 (IgG1)|immunoglobulin gamma-1 (igg1)
5161384|NCT02983006|Cell mediated cytotoxicity (ADCC)|cell mediated cytotoxicity (adcc)
5161385|NCT02983006|Complement dependent cytotoxicity (CDC)|complement dependent cytotoxicity (cdc)
5161386|NCT02983006|DR5|dr5
5161387|NCT02983006|Immunoglobulin G4 (IgG4)|immunoglobulin g4 (igg4)
5161388|NCT02983006|Monoclonal antibody|monoclonal antibody
5161389|NCT02983006|Programmed Cell Death 1 (PD-1)|programmed cell death 1 (pd-1)
5161390|NCT02982993|hepatitis C virus|hepatitis c virus
5161391|NCT02982993|linkage-to-care|linkage-to-care
5161392|NCT02982993|World Trade Center Health Program cohort|world trade center health program cohort
5161393|NCT02982993|Baby Boomer|baby boomer
5161394|NCT02982993|risk factors for hepatitis C virus infection|risk factors for hepatitis c virus infection
5161395|NCT02982967|child|child
5161396|NCT02982967|physical activity|physical activity
5161397|NCT02982967|irisin|irisin
5161399|NCT02982941|Neuroblastoma|neuroblastoma
5161400|NCT02982941|Rhabdomyosarcoma|rhabdomyosarcoma
5161401|NCT02982941|Osteosarcoma|osteosarcoma
5161402|NCT02982941|Ewing Sarcoma|ewing sarcoma
5161404|NCT02982941|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5161405|NCT02982941|pediatric|pediatric
5161406|NCT02982928|Obesity|obesity
5161407|NCT02982928|Bariatrics|bariatrics
5161408|NCT02982928|Acetaminophen|acetaminophen
5161409|NCT02982928|robot-assisted or laparoscopic bariatric surgery|robot-assisted or laparoscopic bariatric surgery
5161410|NCT02982928|Pharmacokinetics|pharmacokinetics
5161411|NCT02982902|Immunotherapy|immunotherapy
5161412|NCT02982902|T-Cell Therapy|t-cell therapy
5161413|NCT02982902|Lymphoproliferative Disorder|lymphoproliferative disorder
5673422|NCT00608244|Pharmacokinetics|pharmacokinetics
5234827|NCT02534415|Palate|palate
5161414|NCT02982889|Analytical, Diagnostic,Therapeutic Technique and Equipment|analytical, diagnostic,therapeutic technique and equipment
5161415|NCT02982889|Anesthesia and Analgesia|anesthesia and analgesia
5161416|NCT02982876|Silicone Airway stent|silicone airway stent
5161417|NCT02982876|Metallic Airway stent|metallic airway stent
5161418|NCT02982850|Atrial Fibrillation|atrial fibrillation
5161419|NCT02982850|Valvular Insufficiency|valvular insufficiency
5161420|NCT02982850|Valvular Stenosis|valvular stenosis
5161421|NCT02982824|Children|children
5161422|NCT02982824|IQ|iq
5161423|NCT02982824|Idiopathic epilepsy|idiopathic epilepsy
5161424|NCT02982824|Magnesium supplementation|magnesium supplementation
5161425|NCT02982824|Seizure control|seizure control
5161426|NCT02982824|Chalfont score|chalfont score
5161427|NCT02982811|Activity-based|activity-based
5161428|NCT02982811|Client-centred|client-centred
5161429|NCT02982811|Rehabilitation|rehabilitation
5161430|NCT02982811|Quality of life|quality of life
5161431|NCT02982772|Nicotine Replacement|nicotine replacement
5161432|NCT02982772|Smoking|smoking
5161433|NCT02982772|HIV|hiv
5161434|NCT02982746|Head and neck cancer|head and neck cancer
5161435|NCT02982746|Person Centred Care|person centred care
5161436|NCT02982746|Health related quality of life|health related quality of life
5161437|NCT02982746|EORTC QLQ-C30|eortc qlq-c30
5161438|NCT02982746|EORTC QLQ-C35|eortc qlq-c35
5161439|NCT02982720|cholangiocarcinoma|cholangiocarcinoma
5161440|NCT02982720|Pembrolizumab|pembrolizumab
5161441|NCT02982720|MK-3475|mk-3475
5161442|NCT02982720|Sylatron|sylatron
5161443|NCT02982720|peginterferon alfa-2b|peginterferon alfa-2b
5161444|NCT02982694|MSI|msi
5161445|NCT02982694|colorectal|colorectal
5161446|NCT02982694|chemotherapy|chemotherapy
5161447|NCT02982694|Bevacizumab|bevacizumab
5161448|NCT02982694|Atezolizumab|atezolizumab
5161449|NCT02982681|Periodontal disease|periodontal disease
5161450|NCT02982681|Platelet rich fibrin|platelet rich fibrin
5161451|NCT02982668|severe stroke|severe stroke
5161452|NCT02982668|Acute Stroke|acute stroke
5161453|NCT02982668|Enteral Feeding|enteral feeding
5161454|NCT02982668|Mortality|mortality
5161455|NCT02982668|Disability|disability
5161456|NCT02982668|Clinical trial|clinical trial
5161457|NCT02982655|Severe Stroke|severe stroke
5161458|NCT02982655|Acute Stroke|acute stroke
5161459|NCT02982655|Antihypertension|antihypertension
5161460|NCT02982655|mortality|mortality
5161461|NCT02982655|disability|disability
5161462|NCT02982655|clinical trial|clinical trial
5161463|NCT02982629|Glaucoma|glaucoma
5161464|NCT02982629|Eye Care|eye care
5161465|NCT02982629|Community Outreach|community outreach
5161466|NCT02982577|Xerostomia|xerostomia
5161467|NCT02982577|Pilocarpine|pilocarpine
5161468|NCT02982577|Quality of life|quality of life
5161469|NCT02982564|Exercise|exercise
5161470|NCT02982564|Physical Functioning|physical functioning
5161471|NCT02982564|Hispanic|hispanic
5161472|NCT02982538|posttraumatic stress symptoms|posttraumatic stress symptoms
5161473|NCT02982538|implementation|implementation
5161474|NCT02982538|dissemination|dissemination
5161475|NCT02982538|PTSD|ptsd
5161476|NCT02982525|Mussels|mussels
5161477|NCT02982525|Dietary Intervention|dietary intervention
5161478|NCT02982525|Long-term intervention|long-term intervention
5161479|NCT02982525|Vitamin D status|vitamin d status
5161480|NCT02982525|Selenium|selenium
5161481|NCT02982525|Iodine|iodine
5161482|NCT02982525|Vitamin B12|vitamin b12
5161483|NCT02982525|Omega-3 index|omega-3 index
5161484|NCT02982512|Potential local fields|potential local fields
5161485|NCT02982512|Subthalamic neuronal activity|subthalamic neuronal activity
5161486|NCT02982499|glaucoma|glaucoma
5161487|NCT02982499|Leber optic neuropathy|leber optic neuropathy
5161488|NCT02982499|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
5161489|NCT02982486|nivolumab|nivolumab
5161490|NCT02982486|ipilimumab|ipilimumab
5161491|NCT02982486|immunotherapy|immunotherapy
5161492|NCT02982486|PD-1 inhibitor|pd-1 inhibitor
5161493|NCT02982486|sarcoma|sarcoma
5161494|NCT02982460|Rotator cuff tendinopathy|rotator cuff tendinopathy
5161495|NCT02982460|Eccentric exercise|eccentric exercise
5161496|NCT02982460|Isoinertial training|isoinertial training
5161498|NCT02982434|atrial fibrillation|atrial fibrillation
5161499|NCT02982434|botulinum toxin|botulinum toxin
5161509|NCT02982395|superficial bladder cancer|superficial bladder cancer
5161511|NCT02982395|Transitional cell carcinoma|transitional cell carcinoma
5161512|NCT02982382|Low Back Pain|low back pain
5161513|NCT02982382|Musculoskeletal Manipulations|musculoskeletal manipulations
5161514|NCT02982382|Neurophysiology|neurophysiology
5161515|NCT02982382|Education|education
5161516|NCT02982317|Neuraxial anesthesia|neuraxial anesthesia
5161517|NCT02982317|Obstetrics|obstetrics
5161518|NCT02982317|Ultrasound|ultrasound
5161519|NCT02982252|Power mobility|power mobility
5161520|NCT02982252|Wheelchair skills training|wheelchair skills training
5161521|NCT02982252|Older adults|older adults
5161522|NCT02982226|Plantar Fasciitis|plantar fasciitis
5161523|NCT02982226|Jogger's Heel|jogger's heel
5161524|NCT02982226|ReNu|renu
5161525|NCT02982213|Newest Vital Sign|newest vital sign
5161526|NCT02982213|Anxiety|anxiety
5161527|NCT02982213|Health literacy|health literacy
5161528|NCT02982213|Neuraxial Analgesia|neuraxial analgesia
5161529|NCT02982213|Epidural catheter placement|epidural catheter placement
5161530|NCT02982213|Pregnancy|pregnancy
5161531|NCT02982213|Parturients|parturients
5161532|NCT02982213|Pain Catastrophizing Scale|pain catastrophizing scale
5161533|NCT02982213|STAI questionnaire|stai questionnaire
5161534|NCT02982213|Companion|companion
5161535|NCT02982200|Embolization Device|embolization device
5161536|NCT02982200|Medina|medina
5161537|NCT02982200|Rupture Intracranial Aneurysm|rupture intracranial aneurysm
5161538|NCT02982200|Unrupture Intracranial Aneurysm|unrupture intracranial aneurysm
5161539|NCT02982187|HANDIHALER|handihaler
5161540|NCT02982187|ELLIPTA|ellipta
5161541|NCT02982187|TURBUHALER|turbuhaler
5161542|NCT02982187|DISKUS|diskus
5161543|NCT02982187|COPD|copd
5161544|NCT02982187|critical error|critical error
5161545|NCT02982187|inhaler preference|inhaler preference
5161546|NCT02982174|no known ocular pathology|no known ocular pathology
5161547|NCT02982161|Third Molar Tooth Extraction|third molar tooth extraction
5161548|NCT02982148|sentinel lymph node biopsy|sentinel lymph node biopsy
5161549|NCT02982148|methylene blue|methylene blue
5161550|NCT02982148|intradermal injection|intradermal injection
5161551|NCT02982148|subcutaneous injection|subcutaneous injection
5161552|NCT02982135|hemorrhagic moyamoya disease|hemorrhagic moyamoya disease
5161553|NCT02982135|bypass|bypass
5161554|NCT02982135|indirect bypass|indirect bypass
5161555|NCT02982083|Rheumatoid arthritis|rheumatoid arthritis
5161556|NCT02982083|Raloxifene|raloxifene
5161557|NCT02982083|Disease activity|disease activity
5161558|NCT02982070|psychological well-being, academic success|psychological well-being, academic success
5161559|NCT02982044|blood flow|blood flow
5161560|NCT02982044|endothelial function|endothelial function
5161561|NCT02982044|shear stress|shear stress
5161562|NCT02982031|Ultrasound-guided lumbar plexus blockade|ultrasound-guided lumbar plexus blockade
5161563|NCT02982031|Shamrock technique|shamrock technique
5161564|NCT02982031|Paramedian transverse scan|paramedian transverse scan
5161565|NCT02982031|USG LPB|usg lpb
5161566|NCT02982031|USGRA|usgra
5161567|NCT02982005|KHK4827 (brodalumab)|khk4827 (brodalumab)
5161568|NCT02981979|Takayasu Arteritis|takayasu arteritis
5161569|NCT02981979|Leflunomide|leflunomide
5161570|NCT02981953|Valtech Cardio|valtech cardio
5161571|NCT02981953|Cardioband|cardioband
5161572|NCT02981953|Tricuspid|tricuspid
5161573|NCT02981940|Brain Tumor|brain tumor
5161574|NCT02981914|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5161575|NCT02981914|B-cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
5161576|NCT02981914|Acute Myeloid Leukemia|acute myeloid leukemia
5161577|NCT02981914|Myelodysplastic Syndromes|myelodysplastic syndromes
5161578|NCT02981914|pembrolizumab|pembrolizumab
5161579|NCT02981875|reading eye movement|reading eye movement
5161580|NCT02981862|HPV infection|hpv infection
5161581|NCT02981862|Blood sample|blood sample
5161582|NCT02981862|Biopsy|biopsy
5161583|NCT02981836|live attenuated varicella vaccine|live attenuated varicella vaccine
5161584|NCT02981836|protective effect|protective effect
5161585|NCT02981836|safety|safety
5161586|NCT02981836|immunogenicity|immunogenicity
5161587|NCT02981836|child|child
5161588|NCT02981810|TONSILLAR COBLATION|tonsillar coblation
5161589|NCT02981797|symptomatic bone metastasis|symptomatic bone metastasis
5161590|NCT02981797|metastatic|metastatic
5161598|NCT02981706|Arteriovenous Fistula (AVF)|arteriovenous fistula (avf)
5161599|NCT02981706|Arteriovenous Graft (AVG)|arteriovenous graft (avg)
5161600|NCT02981680|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery|remote ischemic preconditioning; transient limb ischemia; acute kidney injury; coronary artery bypass graft surgery
5161601|NCT02981641|Pancreatic cancer|pancreatic cancer
5161602|NCT02981641|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
5161603|NCT02981641|Concurrent Chemoradiotherapy (CCRT)|concurrent chemoradiotherapy (ccrt)
5161604|NCT02981602|Hepatitis|hepatitis
5161607|NCT02981576|Spinal Cord Injury|spinal cord injury
5161608|NCT02981576|Mesenchymal Stem Cells|mesenchymal stem cells
5161609|NCT02981563|engagement|engagement
5161610|NCT02981563|psychiatric in-patient care|psychiatric in-patient care
5161611|NCT02981563|mental health nursing|mental health nursing
5161612|NCT02981563|quality interactions|quality interactions
5161613|NCT02981550|Infection|infection
5161614|NCT02981524|Colorectal Neoplasms|colorectal neoplasms
5161615|NCT02981524|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5161616|NCT02981524|Digestive System Neoplasms|digestive system neoplasms
5161617|NCT02981524|Neoplasms by Site|neoplasms by site
5161618|NCT02981524|Neoplasms|neoplasms
5161619|NCT02981524|Digestive System Diseases|digestive system diseases
5161620|NCT02981524|Gastrointestinal Diseases|gastrointestinal diseases
5161621|NCT02981524|Intestinal Diseases|intestinal diseases
5161622|NCT02981524|Rectal Diseases|rectal diseases
5161623|NCT02981524|Colonic Diseases|colonic diseases
5161624|NCT02981498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5161625|NCT02981498|Sorafenib|sorafenib
5161626|NCT02981485|Fat Grafting, Breast Cancer Lymphedema|fat grafting, breast cancer lymphedema
5161627|NCT02981459|bladder pain|bladder pain
5161628|NCT02981459|urinary frequency|urinary frequency
5161629|NCT02981459|urinary urgency|urinary urgency
5161630|NCT02981459|mirabegron|mirabegron
5161631|NCT02981407|Red Blood Cell Transfusion|red blood cell transfusion
5161632|NCT02981407|Anemia|anemia
5161633|NCT02981407|Heart Disease|heart disease
5161634|NCT02981407|Cardiovascular Disease|cardiovascular disease
5161635|NCT02981381|sTMS|stms
5161636|NCT02981381|NeoSync|neosync
5161637|NCT02981381|NEST|nest
5161638|NCT02981381|synchronous|synchronous
5161639|NCT02981381|non-invasive neuromodulation|non-invasive neuromodulation
5161641|NCT02981381|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5161642|NCT02981381|PTSD|ptsd
5161643|NCT02981381|EEG|eeg
5161644|NCT02981381|Depression|depression
5161645|NCT02981368|Diagnostic|diagnostic
5161646|NCT02981368|Imaging|imaging
5161647|NCT02981368|2301|2301
5161648|NCT02981368|PET/CT|pet/ct
5161649|NCT02981368|PyL|pyl
5161650|NCT02981368|PSMA|psma
5161651|NCT02981368|radical prostatectomy|radical prostatectomy
5161652|NCT02981368|metastatic prostate cancer|metastatic prostate cancer
5161653|NCT02981368|recurrent prostate cancer|recurrent prostate cancer
5161654|NCT02981355|BST-CarGel|bst-cargel
5161655|NCT02981355|Microfracture|microfracture
5161656|NCT02981355|Cartilage Lesion, Chondral Lesion|cartilage lesion, chondral lesion
5161657|NCT02981355|Femoral condyle|femoral condyle
5161658|NCT02981355|Bone Marrow Stimulation|bone marrow stimulation
5161659|NCT02981355|Cartilage Repair|cartilage repair
5161660|NCT02981355|Tear of Articular Cartilage of Knee, Current|tear of articular cartilage of knee, current
5161661|NCT02981342|pancreatic cancer|pancreatic cancer
5161662|NCT02981329|Metformin|metformin
5161663|NCT02981329|Sickle Cell Anemia|sickle cell anemia
5161664|NCT02981329|Sickle Cell Disease|sickle cell disease
5161665|NCT02981329|Hemoglobinopathies|hemoglobinopathies
5161666|NCT02981329|Hemoglobin Disorder|hemoglobin disorder
5161667|NCT02981329|Blood Disease|blood disease
5161668|NCT02981329|Hemoglobin Disease; Sickle-Cell, Thalassemia|hemoglobin disease; sickle-cell, thalassemia
5161669|NCT02981329|Hemoglobin Disease|hemoglobin disease
5161670|NCT02981277|Bronchoscopy|bronchoscopy
5161671|NCT02981277|Lignocaine|lignocaine
5161672|NCT02981264|Bronchoscopy|bronchoscopy
5161673|NCT02981264|Lignocaine|lignocaine
5161674|NCT02981264|Endobronchial Ultrasound|endobronchial ultrasound
5161675|NCT02981251|Hypertension|hypertension
5161676|NCT02981251|Uncontrolled blood pressure|uncontrolled blood pressure
5157091|NCT03010098|narcotrend|narcotrend
5161700|NCT02981004|Aortic valve disease, patient prosthesis mismatch|aortic valve disease, patient prosthesis mismatch
5161701|NCT02980965|breast cancer|breast cancer
5161702|NCT02980965|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5161703|NCT02980965|endocrine therapy|endocrine therapy
5161704|NCT02980965|concurrent|concurrent
5161705|NCT02980887|Pulmonary arterial hypertension|pulmonary arterial hypertension
5161707|NCT02980874|ME|me
5161708|NCT02980874|Central Subfield Thickness|central subfield thickness
5161709|NCT02980874|OCT|oct
5161710|NCT02980874|Optical Coherence Tomography|optical coherence tomography
5161711|NCT02980874|Cystoid Macular Edema|cystoid macular edema
5161712|NCT02980874|Subretinal Fluid|subretinal fluid
5161713|NCT02980874|Eylea|eylea
5161714|NCT02980874|Aflibercept|aflibercept
5161715|NCT02980874|Anti-VEGF|anti-vegf
5161716|NCT02980874|Suprachoroidal|suprachoroidal
5161717|NCT02980861|Gastric Cancer|gastric cancer
5161718|NCT02980861|Splenic Hilum Lymph Nodes Dissection|splenic hilum lymph nodes dissection
5161719|NCT02980861|Gastrectomy|gastrectomy
5161720|NCT02980848|digital mammography|digital mammography
5161721|NCT02980848|digital breast tomosynthesis|digital breast tomosynthesis
5161722|NCT02980848|breast magnetic resonance imaging|breast magnetic resonance imaging
5161723|NCT02980848|screening|screening
5161724|NCT02980848|breast density|breast density
5161725|NCT02980848|breast imaging|breast imaging
5161726|NCT02980848|pre-operative magnetic resonance imaging|pre-operative magnetic resonance imaging
5161727|NCT02980796|Brain|brain
5161728|NCT02980796|MRI|mri
5161729|NCT02980796|Exercise|exercise
5161730|NCT02980796|Rehabilitation|rehabilitation
5161731|NCT02980796|TMS|tms
5161732|NCT02980770|Obstructive Sleep Apnea|obstructive sleep apnea
5161733|NCT02980770|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5161734|NCT02980770|Hypercapnia|hypercapnia
5161735|NCT02980770|Post-Op Complication|post-op complication
5161736|NCT02980770|Acid-Base Imbalance|acid-base imbalance
5161737|NCT02980744|Stroke|stroke
5161738|NCT02980744|Sedentary behaviour|sedentary behaviour
5161739|NCT02980744|Intervention|intervention
5161740|NCT02980731|Relapsed CLL|relapsed cll
5161741|NCT02980731|Refractory CLL|refractory cll
5161742|NCT02980731|17p deletion|17p deletion
5161743|NCT02980731|TP53 gene|tp53 gene
5161744|NCT02980731|B-Cell receptor inhibitor (BCRi)|b-cell receptor inhibitor (bcri)
5161745|NCT02980731|European Organization of Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30)|european organization of research and treatment of cancer quality of life core questionnaire (eortc qlq-c30)
5161746|NCT02980731|Overall response rate (ORR)|overall response rate (orr)
5161747|NCT02980731|Duration of overall response (Dor)|duration of overall response (dor)
5161748|NCT02980731|Complete remission rate (CR + CRi)|complete remission rate (cr + cri)
5157194|NCT03009526|Malaria|malaria
5161755|NCT02980653|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5161757|NCT02980653|Head and neck cancer|head and neck cancer
5161758|NCT02980640|Multiple Sclerosis|multiple sclerosis
5161759|NCT02980640|Treatment|treatment
5161760|NCT02980640|Quality of Life|quality of life
5161761|NCT02980640|Symptoms|symptoms
5161762|NCT02980627|Eating Disorders|eating disorders
5161763|NCT02980627|Diabulimia|diabulimia
5161764|NCT02980627|ED-T1DM|ed-t1dm
5161765|NCT02980627|Type 1 Diabetes|type 1 diabetes
5161766|NCT02980627|Mobile Technology|mobile technology
5161767|NCT02980627|Acceptance and Commitment Therapy|acceptance and commitment therapy
5161768|NCT02980614|phase-contrast MRI|phase-contrast mri
5161769|NCT02980614|blood flow|blood flow
5161770|NCT02980614|velocity mapping|velocity mapping
5161771|NCT02980614|Quantitative MRI|quantitative mri
5161772|NCT02980614|Cardiac imaging|cardiac imaging
5161773|NCT02980614|Tetralogy of Fallot|tetralogy of fallot
5161774|NCT02980601|Traumatic Defect|traumatic defect
5161775|NCT02980601|Chronic Wounds|chronic wounds
5161776|NCT02980575|COPD|copd
5161777|NCT02980575|Music|music
5161779|NCT02980562|Bowel preparation|bowel preparation
5161780|NCT02980562|Ascorbic acid|ascorbic acid
5161781|NCT02980562|Bisacodyl|bisacodyl
5161782|NCT02980562|Polyethylene glycol|polyethylene glycol
5161783|NCT02980536|NSCLC|nsclc
5161784|NCT02980536|TKI|tki
5161785|NCT02980536|Mutation|mutation
5161786|NCT02980536|Liquid Biopsy|liquid biopsy
5161787|NCT02980497|mouthrinse|mouthrinse
5161788|NCT02980497|plaque|plaque
5161789|NCT02980497|gingivitis|gingivitis
5161790|NCT02980497|gum bleeding|gum bleeding
5161791|NCT02980484|rTMS|rtms
5161792|NCT02980458|Healthy|healthy
5161793|NCT02980458|Bioequivalence|bioequivalence
5161794|NCT02980458|Deferiprone|deferiprone
5161795|NCT02980445|Myopia|myopia
5161796|NCT02980445|Outdoor time|outdoor time
5161797|NCT02980445|Children|children
5161798|NCT02980445|Intervention|intervention
5161799|NCT02980445|Prevention|prevention
5161800|NCT02980432|vestibular|vestibular
5161801|NCT02980432|spatial orientation|spatial orientation
5161802|NCT02980432|vision|vision
5161803|NCT02980432|optokinetic|optokinetic
5161804|NCT02980406|FODMAP|fodmap
5161805|NCT02980406|Irritable bowel syndrome|irritable bowel syndrome
5161806|NCT02980406|Gastric accommodation|gastric accommodation
5161807|NCT02980406|Gastric motility|gastric motility
5161808|NCT02980406|brain-gut axis|brain-gut axis
5161809|NCT02980393|congenital heart disease|congenital heart disease
5161810|NCT02980393|smart mobile technology|smart mobile technology
5161811|NCT02980393|children|children
5161812|NCT02980393|adolescents|adolescents
5161813|NCT02980393|lifestyle counselling|lifestyle counselling
5161814|NCT02980393|nutrition|nutrition
5161815|NCT02980393|physical activity|physical activity
5161816|NCT02980380|non-invasive brain computer interface|non-invasive brain computer interface
5161817|NCT02980380|communication|communication
5161818|NCT02980380|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5161819|NCT02980380|complete locked-in state|complete locked-in state
5161820|NCT02980367|Anterior Cruciate Ligament|anterior cruciate ligament
5161821|NCT02980367|ACL|acl
5161822|NCT02980367|Anterior Cruciate Ligament deficiency|anterior cruciate ligament deficiency
5161823|NCT02980367|ACL deficiency|acl deficiency
5161824|NCT02980367|ACLD|acld
5161825|NCT02980367|Anterior Cruciate Ligament reconstruction|anterior cruciate ligament reconstruction
5161826|NCT02980367|ACL reconstruction|acl reconstruction
5161827|NCT02980367|Anterior Cruciate Ligament physiotherapy|anterior cruciate ligament physiotherapy
5161828|NCT02980367|Anterior Cruciate Ligament rehabilitation|anterior cruciate ligament rehabilitation
5161829|NCT02980367|ACL physiotherapy|acl physiotherapy
5161830|NCT02980367|ACL rehabilitation|acl rehabilitation
5161831|NCT02980367|Anterior Cruciate Ligament management|anterior cruciate ligament management
5161832|NCT02980367|ACL management|acl management
5161833|NCT02980354|endothelial progenitor cells, ischaemic stroke, aging|endothelial progenitor cells, ischaemic stroke, aging
5161834|NCT02980341|Oncology|oncology
5161835|NCT02980341|HER3|her3
5161836|NCT02980341|Antibody drug conjugate|antibody drug conjugate
5161837|NCT02980341|Developmental Phase I/II|developmental phase i/ii
5161838|NCT02980328|Overactive bladder|overactive bladder
5161839|NCT02980328|Urinary incontinence|urinary incontinence
5161840|NCT02980328|Low-level light therapy|low-level light therapy
5161841|NCT02980315|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5157271|NCT03009032|prebiotics|prebiotics
5161842|NCT02980315|EBV related cancers|ebv related cancers
5161843|NCT02980302|Mental retardation MR|mental retardation mr
5161848|NCT02980276|Diabetes|diabetes
5161849|NCT02980276|Pregnancy|pregnancy
5161850|NCT02980263|Kawasaki disease|kawasaki disease
5161851|NCT02980263|Coronary artery aneurysm|coronary artery aneurysm
5161852|NCT02980263|mucocutaneous lymph node syndrome|mucocutaneous lymph node syndrome
5161853|NCT02980263|lymph node syndrome|lymph node syndrome
5161854|NCT02980263|canakinumab|canakinumab
5161855|NCT02980263|intravenous immunoglobulin naïve (IVIG-naïve)|intravenous immunoglobulin naïve (ivig-naïve)
5161856|NCT02980263|intravenous immunoglobulin refractory (IVIG-refractory)|intravenous immunoglobulin refractory (ivig-refractory)
5161857|NCT02980263|pediatric|pediatric
5161858|NCT02980250|feeding intolerance|feeding intolerance
5161859|NCT02980250|premature infant|premature infant
5161861|NCT02980237|Office workers|office workers
5161862|NCT02980237|Quality of life|quality of life
5161863|NCT02980237|e-Learning|e-learning
5161864|NCT02980237|Occupational health|occupational health
5161865|NCT02980211|Alveolar Bone|alveolar bone
5161866|NCT02980211|Alveolar Ridge|alveolar ridge
5161867|NCT02980211|Bone Resorption|bone resorption
5161868|NCT02980211|Bone Grafting|bone grafting
5161869|NCT02980211|Barrier Membrane|barrier membrane
5161870|NCT02980172|triage|triage
5161871|NCT02980120|Eating Disorders|eating disorders
5048641|NCT03694782|nature|nature
5161872|NCT02980120|Anorexia Nervosa|anorexia nervosa
5161873|NCT02980120|Bulimia Nervosa|bulimia nervosa
5161874|NCT02980094|aging|aging
5161875|NCT02980094|nutrients|nutrients
5161876|NCT02980094|milk|milk
5161877|NCT02980094|dietary supplementation|dietary supplementation
5161878|NCT02980055|connective tissue graft|connective tissue graft
5161879|NCT02980055|transplantation|transplantation
5161880|NCT02980055|collagen|collagen
5161881|NCT02980055|autologous|autologous
5161882|NCT02980055|gingiva|gingiva
5161883|NCT02980029|Resectable Tumors|resectable tumors
5161884|NCT02980003|contrast media|contrast media
5161885|NCT02980003|contrast-induced acute kidney injury (AKI)|contrast-induced acute kidney injury (aki)
5161886|NCT02980003|contrast-induced nephropathy (CIN)|contrast-induced nephropathy (cin)
5161887|NCT02979990|infertility|infertility
5161889|NCT02979951|Observational Study|observational study
5161890|NCT02979951|Non-Interventional Study|non-interventional study
5161891|NCT02979951|Registries|registries
5161892|NCT02979951|Prospective|prospective
5161893|NCT02979951|Monitored|monitored
5161894|NCT02979951|Multicentric|multicentric
5161895|NCT02979951|International|international
5161896|NCT02979951|Fosfomycin|fosfomycin
5161897|NCT02979951|Infectofos|infectofos
5161898|NCT02979951|Fomicyt|fomicyt
5161899|NCT02979951|Bacterial Infections|bacterial infections
5161900|NCT02979951|Gram-Negative Bacterial Infections|gram-negative bacterial infections
5161901|NCT02979951|Gram-Positive Bacterial Infections|gram-positive bacterial infections
5161902|NCT02979951|Bone Diseases, Infectious|bone diseases, infectious
5161903|NCT02979951|Osteomyelitis|osteomyelitis
5161904|NCT02979951|Central Nervous System Bacterial Infections|central nervous system bacterial infections
5161905|NCT02979951|Meningitis, Bacterial|meningitis, bacterial
5161906|NCT02979951|Encephalitis|encephalitis
5161907|NCT02979951|Brain Abscess|brain abscess
5161908|NCT02979951|Urinary Tract Infections|urinary tract infections
5161909|NCT02979951|Respiratory Tract Infections|respiratory tract infections
5161910|NCT02979951|Pneumonia, Bacterial|pneumonia, bacterial
5161911|NCT02979951|Skin Diseases, Bacterial|skin diseases, bacterial
5161912|NCT02979951|Soft Tissue Infections|soft tissue infections
5161913|NCT02979951|Intraabdominal Infections|intraabdominal infections
5161914|NCT02979951|Sepsis|sepsis
5161915|NCT02979951|Bacteremia|bacteremia
5161916|NCT02979951|Endocarditis, Bacterial|endocarditis, bacterial
5161917|NCT02979951|Treatment Outcome|treatment outcome
5161918|NCT02979951|Clinical Efficacy|clinical efficacy
5161919|NCT02979951|Microbiological Efficacy|microbiological efficacy
5161920|NCT02979951|Safety|safety
5161921|NCT02979925|neuropathic pain|neuropathic pain
5161922|NCT02979925|TMS|tms
5161923|NCT02979925|nerve injury|nerve injury
5161924|NCT02979925|transcutaneous magnetic stimulation|transcutaneous magnetic stimulation
5161925|NCT02979912|Persistent corneal epithelial defect|persistent corneal epithelial defect
5161926|NCT02979912|Platelet Lysate|platelet lysate
5161927|NCT02979899|angiosarcoma|angiosarcoma
5162049|NCT02978924|3D motion capture|3d motion capture
5161928|NCT02979886|single nucleotide polymorphism,GnRH receptor, IVF|single nucleotide polymorphism,gnrh receptor, ivf
5161932|NCT02979847|persistent atrial fibrillation|persistent atrial fibrillation
5161933|NCT02979847|catheter ablation|catheter ablation
5161934|NCT02979847|epicardial mapping and ablation|epicardial mapping and ablation
5161935|NCT02979834|fetal movement|fetal movement
5161936|NCT02979834|placenta site|placenta site
5161937|NCT02979834|body mass index|body mass index
5161938|NCT02979834|maternal education|maternal education
5161939|NCT02979821|pan-HER inhibitor|pan-her inhibitor
5161940|NCT02979782|cardiac surgery|cardiac surgery
5161941|NCT02979782|neurological outcome|neurological outcome
5862714|NCT00001541|Inflammatory Mediators|inflammatory mediators
5161959|NCT02979639|Herpes Zoster|herpes zoster
5161960|NCT02979639|Reactogenicity|reactogenicity
5161961|NCT02979639|Quality of life|quality of life
5161962|NCT02979639|Shingles|shingles
5161963|NCT02979626|hospitalization|hospitalization
5161964|NCT02979626|intensive care unit|intensive care unit
5161965|NCT02979626|school absenteeism|school absenteeism
5161966|NCT02979626|work absenteeism|work absenteeism
5161967|NCT02979600|Oral immunotherapy|oral immunotherapy
5161968|NCT02979600|Oral tolerance induction|oral tolerance induction
5161969|NCT02979574|acupuncture|acupuncture
5161970|NCT02979574|pain|pain
5161971|NCT02979574|chronic pain|chronic pain
5161972|NCT02979574|pain management|pain management
5161973|NCT02979574|16-1579|16-1579
5161974|NCT02979561|Dabigatran etexilate|dabigatran etexilate
5161975|NCT02979561|Recurrence of DVT|recurrence of dvt
5161976|NCT02979561|Pulmonary Embolism|pulmonary embolism
5161977|NCT02979561|Warfarin|warfarin
5161978|NCT02979548|Aprepitant|aprepitant
5161979|NCT02979535|Dengue Fever|dengue fever
5161980|NCT02979535|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5161981|NCT02979535|Human Papillomavirus Disease|human papillomavirus disease
5161982|NCT02979535|CYD Dengue Vaccine|cyd dengue vaccine
5161983|NCT02979535|Dengvaxia®|dengvaxia®
5161984|NCT02979535|Cervarix®|cervarix®
5161985|NCT02979522|Drug therapy, pediatric Hodgkin disease, frontline Hodgkin disease, advanced stage Hodgkin disease, pediatric lymphoma|drug therapy, pediatric hodgkin disease, frontline hodgkin disease, advanced stage hodgkin disease, pediatric lymphoma
5161986|NCT02979496|immune|immune
5161987|NCT02979496|citrus|citrus
5161988|NCT02979470|advanced colon cancer|advanced colon cancer
5161989|NCT02979470|advanced rectum cancer|advanced rectum cancer
5161990|NCT02979470|circulating tumor cells|circulating tumor cells
5161991|NCT02979470|immune response|immune response
5161992|NCT02979470|mutations|mutations
5161993|NCT02979457|telephone consultation, patient involvement|telephone consultation, patient involvement
5161994|NCT02979431|RSV, Lower Respiratory Tract Infection, pediattric patients|rsv, lower respiratory tract infection, pediattric patients
5161995|NCT02979418|Water insecurity|water insecurity
5161996|NCT02979340|Cystic Fibrosis Liver Disease|cystic fibrosis liver disease
5161997|NCT02979340|Pancreatic Insufficiency|pancreatic insufficiency
5161998|NCT02979275|acute kidney injury|acute kidney injury
5161999|NCT02979275|cardiopulmonary bypass|cardiopulmonary bypass
5162000|NCT02979275|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5162001|NCT02979275|tissue hypoxia|tissue hypoxia
5162002|NCT02979249|Interventional|interventional
5162003|NCT02979249|open-label|open-label
5162005|NCT02979249|XLP|xlp
5162006|NCT02979249|porphyria|porphyria
5162007|NCT02979197|High blood pressure|high blood pressure
5162008|NCT02979197|Systolic blood pressure|systolic blood pressure
5162009|NCT02979197|Diastolic blood pressure|diastolic blood pressure
5162010|NCT02979197|Antihypertensive|antihypertensive
5162011|NCT02979184|Lymphedema, Obstructive Sleep Apnea , Intensive Decongestive Physiotherapy|lymphedema, obstructive sleep apnea , intensive decongestive physiotherapy
5162012|NCT02979119|Hemophilia|hemophilia
5162013|NCT02979119|Children, ,|children, ,
5162014|NCT02979119|Inhibitors,|inhibitors,
5162015|NCT02979119|Prophylaxis|prophylaxis
5162016|NCT02979119|Long-term outcome|long-term outcome
5162032|NCT02979028|complication|complication
5162441|NCT02976987|cervix|cervix
5162033|NCT02978989|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5162034|NCT02978989|Solo surgery|solo surgery
5162035|NCT02978989|Camera holder|camera holder
5162036|NCT02978989|Cholecystitis|cholecystitis
5162037|NCT02978976|RDS|rds
5162038|NCT02978976|Doppler on fetal pulmonary artery|doppler on fetal pulmonary artery
5162039|NCT02978963|Excessive worry|excessive worry
5162040|NCT02978963|Worry|worry
5162041|NCT02978963|Adolescents|adolescents
5162042|NCT02978963|Intolerance of uncertainty|intolerance of uncertainty
5162043|NCT02978950|duplex ultrasound|duplex ultrasound
5162044|NCT02978950|trauma|trauma
5162045|NCT02978950|venous thromboembolism|venous thromboembolism
5162046|NCT02978950|prevention|prevention
5162047|NCT02978924|spinal cord|spinal cord
5162048|NCT02978924|tsDCS|tsdcs
5162050|NCT02978924|EMG|emg
5162051|NCT02978911|RMI|rmi
5162052|NCT02978898|Follicular Lymphoma|follicular lymphoma
5162053|NCT02978898|flow cytometry|flow cytometry
5162054|NCT02978898|CD180|cd180
5162055|NCT02978898|Toll-like receptor|toll-like receptor
5162056|NCT02978898|lymphoproliferative disease|lymphoproliferative disease
5162057|NCT02978885|Acute lung injury|acute lung injury
5162058|NCT02978885|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5162059|NCT02978885|Whipple procedures|whipple procedures
5162060|NCT02978885|pancreatico-duodenectomies|pancreatico-duodenectomies
5162061|NCT02978872|Cardiac surgery|cardiac surgery
5162062|NCT02978872|Quantra|quantra
5162063|NCT02978872|Viscoelastic testing|viscoelastic testing
5162064|NCT02978872|Coagulation|coagulation
5162065|NCT02978859|MGCD516|mgcd516
5162066|NCT02978859|Sarcoma|sarcoma
5162067|NCT02978859|Liposarcoma|liposarcoma
5162068|NCT02978859|Unresectable Liposarcoma|unresectable liposarcoma
5162069|NCT02978859|Metastatic Liposarcoma|metastatic liposarcoma
5162070|NCT02978859|Sitravatinib|sitravatinib
5162071|NCT02978833|Gluteus Medius Tendinosis|gluteus medius tendinosis
5162072|NCT02978820|scientific exercise approach to scoliosis|scientific exercise approach to scoliosis
5162073|NCT02978820|core stabilization training|core stabilization training
5162074|NCT02978820|bracing|bracing
5162075|NCT02978820|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5162076|NCT02978794|stroke, clinical pathway, medical care|stroke, clinical pathway, medical care
5162077|NCT02978781|Tremor|tremor
5162078|NCT02978768|dementia|dementia
5162079|NCT02978768|Tai Chi|tai chi
5162080|NCT02978768|mental training|mental training
5162081|NCT02978768|cognitive rehabilitation|cognitive rehabilitation
5162082|NCT02978742|Eating Disorders|eating disorders
5162083|NCT02978742|Bulimia Nervosa|bulimia nervosa
5162084|NCT02978742|Binge Eating Disorder|binge eating disorder
5162085|NCT02978742|App|app
5162086|NCT02978742|Smartphone|smartphone
5162087|NCT02978742|Self-Help|self-help
5162088|NCT02978742|Coaching|coaching
5162089|NCT02978742|Recovery Record|recovery record
5162090|NCT02978742|Mobile Phone|mobile phone
5162091|NCT02978742|Cognitive Behavioral Therapy|cognitive behavioral therapy
5162092|NCT02978729|Telemedicine|telemedicine
5162093|NCT02978729|Counseling, Genetic|counseling, genetic
5162094|NCT02978716|Breast Cancer|breast cancer
5162095|NCT02978716|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5162096|NCT02978716|Triple Negative Breast Cancer|triple negative breast cancer
5162097|NCT02978716|Metastatic|metastatic
5162098|NCT02978677|brain tumors|brain tumors
5162099|NCT02978677|proton radiotherapy|proton radiotherapy
5162100|NCT02978677|photon radiotherapy|photon radiotherapy
5162107|NCT02978638|Spinal cord injury|spinal cord injury
5162108|NCT02978638|Bladder capacity|bladder capacity
5162109|NCT02978638|Electrical stimulation|electrical stimulation
5162110|NCT02978638|Continence|continence
5162111|NCT02978638|Urodynamics|urodynamics
5162112|NCT02978612|Colorectal Neoplasms|colorectal neoplasms
5162113|NCT02978586|PSMA|psma
5162114|NCT02978586|PET/MRI|pet/mri
5162115|NCT02978573|First MTP Joint|first mtp joint
5162116|NCT02978573|Hallux Rigidus|hallux rigidus
5162117|NCT02978573|Hallux Limitus|hallux limitus
5162118|NCT02978573|Cartilage Replacement|cartilage replacement
5162119|NCT02978573|Osteoarthritis|osteoarthritis
5162120|NCT02978573|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
5162121|NCT02978573|Big Toe Pain|big toe pain
5162122|NCT02978547|Resectable pancreatic ductal adenocarcinoma|resectable pancreatic ductal adenocarcinoma
5162123|NCT02978547|PDAC|pdac
5162124|NCT02978547|Metformin|metformin
5162125|NCT02978534|pregnant|pregnant
5162126|NCT02978534|quetiapine|quetiapine
5162127|NCT02978534|bipolar|bipolar
5162128|NCT02978534|women|women
5162129|NCT02978534|female|female
5162130|NCT02978534|postpartum|postpartum
5162131|NCT02978534|seroquel|seroquel
5162132|NCT02978534|perinatal|perinatal
5162133|NCT02978534|manic-depressive|manic-depressive
5162134|NCT02978469|Habitual Physical Activity (HPA); Sedentary Behavior;|habitual physical activity (hpa); sedentary behavior;
5162135|NCT02978456|IVUS guided PCI|ivus guided pci
5163435|NCT02971072|innovation|innovation
5162145|NCT02978443|Yervoy|yervoy
5162146|NCT02978430|Fluid therapy|fluid therapy
5162147|NCT02978430|Anesthesiology|anesthesiology
5162148|NCT02978430|Major surgery|major surgery
5162149|NCT02978430|Goal-directed fluid therapy|goal-directed fluid therapy
5162150|NCT02978430|Fluid responsiveness|fluid responsiveness
5162151|NCT02978430|Closed-loop system|closed-loop system
5162152|NCT02978417|Medication-assisted treatment|medication-assisted treatment
5162153|NCT02978417|Drug Court|drug court
5162154|NCT02978417|Pilot study|pilot study
5162155|NCT02978417|Opioid dependence|opioid dependence
5162156|NCT02978417|Criminal justice|criminal justice
5162157|NCT02978404|radiosurgery|radiosurgery
5162158|NCT02978404|PD-1|pd-1
5162159|NCT02978404|Nivolumab|nivolumab
5162160|NCT02978326|Postpartum Care|postpartum care
5162161|NCT02978287|Calcium sensing receptor|calcium sensing receptor
5162162|NCT02978287|Parathyroid cell viability|parathyroid cell viability
5162163|NCT02978287|Parathyroid allotransplantation|parathyroid allotransplantation
5162164|NCT02978287|Transporting solution|transporting solution
5162165|NCT02978235|Multiple Myeloma|multiple myeloma
5162166|NCT02978235|Relapsed/Refractory|relapsed/refractory
5162167|NCT02978235|Lymphoma|lymphoma
5162168|NCT02978235|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5162169|NCT02978235|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5162170|NCT02978235|DLBCL|dlbcl
5162171|NCT02978235|Mantle Cell Lymphoma|mantle cell lymphoma
5162172|NCT02978235|MCL|mcl
5162173|NCT02978235|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5162174|NCT02978235|PTCL|ptcl
5162175|NCT02978235|TAS4464|tas4464
5162176|NCT02978235|NEDD8|nedd8
5162177|NCT02978235|NAE inhibitor|nae inhibitor
5162178|NCT02978235|Neoplasms|neoplasms
5162179|NCT02978235|Hematologic Diseases|hematologic diseases
5162180|NCT02978235|Myeloma|myeloma
5162181|NCT02978157|Helicobacter pylori|helicobacter pylori
5162182|NCT02978157|Eradication rate|eradication rate
5162183|NCT02978157|Rescue treatment|rescue treatment
5162184|NCT02978144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5162185|NCT02978131|TUBERCULOSIS|tuberculosis
5162186|NCT02978131|Sensitivity and Specificity|sensitivity and specificity
5162187|NCT02978131|Polymerase Chain Reaction|polymerase chain reaction
5162188|NCT02978131|Immunohistochemistry|immunohistochemistry
5162189|NCT02978131|Histochemistry|histochemistry
5162190|NCT02978131|Paraformaldehyde and paraffin embedded tissues|paraformaldehyde and paraffin embedded tissues
5162191|NCT02978053|Bright light|bright light
5162192|NCT02978053|Sleepiness|sleepiness
5162193|NCT02978053|Sleep|sleep
5162194|NCT02978053|Psychomotor vigilance|psychomotor vigilance
5162202|NCT02978027|motivational interviewing|motivational interviewing
5162203|NCT02978027|brief alcohol intervention in primary care|brief alcohol intervention in primary care
5162204|NCT02978014|Prostate|prostate
5162205|NCT02978014|Radiotherapy|radiotherapy
5162206|NCT02978014|Obturator|obturator
5162207|NCT02978014|Toxicity|toxicity
5162208|NCT02978014|Bowel|bowel
5162209|NCT02978014|Urinary|urinary
5162210|NCT02978014|Sexual|sexual
5162211|NCT02978014|PROM|prom
5162212|NCT02978014|EPIC|epic
5162213|NCT02977988|Mindfulness|mindfulness
5162214|NCT02977988|Women|women
5162215|NCT02977988|Relapse prevention|relapse prevention
5162216|NCT02977988|Clinical trial|clinical trial
5162217|NCT02977988|Substance use disorder|substance use disorder
5162218|NCT02977988|Ethnically diverse|ethnically diverse
5162219|NCT02977988|Underserved|underserved
5162220|NCT02977988|Health disparities|health disparities
5162221|NCT02977988|Stress|stress
5162222|NCT02977988|Addiction|addiction
5162223|NCT02977988|Latina/Hispanic|latina/hispanic
5162224|NCT02977988|African American|african american
5162225|NCT02977988|Treatment retention|treatment retention
5162226|NCT02977988|Residential treatment|residential treatment
5162227|NCT02977988|Brain Imaging|brain imaging
5162228|NCT02977975|Irritable bowel syndrome|irritable bowel syndrome
5162229|NCT02977975|The human microbiome|the human microbiome
5162230|NCT02977975|Microbiota|microbiota
5162231|NCT02977975|Gut microbiota|gut microbiota
5162232|NCT02977975|Probiotics|probiotics
5162233|NCT02977975|Sauerkraut|sauerkraut
5162234|NCT02977949|SERM|serm
5162235|NCT02977949|Season|season
5162236|NCT02977949|Variation|variation
5162237|NCT02977949|Vitamin D|vitamin d
5162239|NCT02977923|Immersive distraction|immersive distraction
5162240|NCT02977923|Oculus rift|oculus rift
5162241|NCT02977923|Virtual world|virtual world
5162242|NCT02977923|Virtual environment|virtual environment
5162243|NCT02977923|Procedural pain|procedural pain
5162244|NCT02977923|Procedural anxiety|procedural anxiety
5162245|NCT02977923|Acute pain|acute pain
5162246|NCT02977923|Pain management|pain management
5162248|NCT02977923|Children, Child|children, child
5162249|NCT02977923|Kid, Kids|kid, kids
5162250|NCT02977923|Pediatric, Pediatrics|pediatric, pediatrics
5162251|NCT02977923|Young children|young children
5162252|NCT02977923|Burns|burns
5162253|NCT02977923|Burn injuries|burn injuries
5162254|NCT02977923|Burn unit|burn unit
5162255|NCT02977923|Physiotherapy|physiotherapy
5162256|NCT02977923|Physical therapy|physical therapy
5162257|NCT02977923|Burn dressing|burn dressing
5162258|NCT02977923|Dressing change|dressing change
5162259|NCT02977923|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
5162260|NCT02977923|Clinical Research|clinical research
5162261|NCT02977923|Nursing Practice|nursing practice
5162262|NCT02977923|Trauma|trauma
5162263|NCT02977897|Diarrhea|diarrhea
5162264|NCT02977897|Immunosuppression|immunosuppression
5162265|NCT02977897|Post-transplantation|post-transplantation
5162266|NCT02977897|Octreotide|octreotide
5162267|NCT02977897|Mycophenolate Mofetil|mycophenolate mofetil
5162268|NCT02977897|Fecal Calprotectin|fecal calprotectin
5162269|NCT02977884|nutrition|nutrition
5162270|NCT02977884|exercise|exercise
5162271|NCT02977884|stress|stress
5162272|NCT02977884|cardiovascular disease|cardiovascular disease
5162273|NCT02977884|diabetes|diabetes
5162274|NCT02977884|hypertension|hypertension
5162275|NCT02977884|dyslipidemia|dyslipidemia
5162276|NCT02977884|cholesterol|cholesterol
5162277|NCT02977884|overweight|overweight
5162278|NCT02977884|obesity|obesity
5162279|NCT02977884|lifestyle|lifestyle
5162280|NCT02977871|Cesarean section|cesarean section
5162281|NCT02977871|operating time|operating time
5162282|NCT02977871|bladder|bladder
5162283|NCT02977871|urinary retention|urinary retention
5162284|NCT02977845|dypsnea|dypsnea
5162285|NCT02977845|fatigue|fatigue
5162286|NCT02977845|anxiety|anxiety
5162287|NCT02977845|Qigong|qigong
5162288|NCT02977845|Lung cancer|lung cancer
5162289|NCT02977832|LUTS|luts
5162290|NCT02977832|Iresine celosia|iresine celosia
5162291|NCT02977832|Odyliresin|odyliresin
5162292|NCT02977832|medical therapy|medical therapy
5162294|NCT02977728|MTBI|mtbi
5162295|NCT02977728|olfaction|olfaction
5162296|NCT02977728|acute|acute
5162297|NCT02977715|Democratic Republic of the Congo|democratic republic of the congo
5162298|NCT02977715|IMVAMUNE|imvamune
5162299|NCT02977715|Modified Vaccinia Ankara (MVA)|modified vaccinia ankara (mva)
5162300|NCT02977715|Monkeypox|monkeypox
5162301|NCT02977715|Orthopoxvirus|orthopoxvirus
5162302|NCT02977715|Vaccine|vaccine
5162303|NCT02977715|Vaccinia virus|vaccinia virus
5162304|NCT02977689|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
5162305|NCT02977689|R-2-Hydroxyglutarate (2-HG)|r-2-hydroxyglutarate (2-hg)
5423216|NCT01616641|grip strenght|grip strenght
5162306|NCT02977689|Gene encoding UDP-glucuronosyltransferase (UGT1A1)|gene encoding udp-glucuronosyltransferase (ugt1a1)
5162307|NCT02977689|Glioblastoma (GBM)|glioblastoma (gbm)
5162308|NCT02977689|IDH305|idh305
5162309|NCT02977689|IDHR132 mutations|idhr132 mutations
5162310|NCT02977689|Astrocytoma|astrocytoma
5162311|NCT02977689|Oligodendroglioma|oligodendroglioma
5162312|NCT02977689|Oligoastrocytoma|oligoastrocytoma
5162313|NCT02977689|IDH1 R132H|idh1 r132h
5162315|NCT02977637|hht|hht
5162316|NCT02977637|hereditary|hereditary
5162317|NCT02977637|hemorrhagic|hemorrhagic
5162318|NCT02977637|telangiectasia|telangiectasia
5162319|NCT02977637|feraheme|feraheme
5162320|NCT02977585|continous positive airway pressure|continous positive airway pressure
5162321|NCT02977585|helmet|helmet
5162322|NCT02977585|non invasive|non invasive
5162323|NCT02977585|positive end expiratory pressure|positive end expiratory pressure
5162324|NCT02977585|severe bronchiolitis|severe bronchiolitis
5162325|NCT02977585|pediatric intensive care unit|pediatric intensive care unit
5162326|NCT02977572|Non-invasive ventilation,|non-invasive ventilation,
5162327|NCT02977572|continuous positive airway pressure|continuous positive airway pressure
5162328|NCT02977572|cardiogenic pulmonary oedema,|cardiogenic pulmonary oedema,
5162329|NCT02977572|acute respiratory failure|acute respiratory failure
5162330|NCT02977559|Laryngeal Tube Suction Ambu AuraGain Leak Pressure|laryngeal tube suction ambu auragain leak pressure
5162331|NCT02977546|Hemodynamics|hemodynamics
5162333|NCT02977546|Pulse contour analysis|pulse contour analysis
5162334|NCT02977546|Heart failure|heart failure
5162335|NCT02977546|Swan Ganz Catheterization|swan ganz catheterization
5162336|NCT02977546|Pulmonary artery Catheter|pulmonary artery catheter
5162337|NCT02977468|triple negative breast cancer|triple negative breast cancer
5162338|NCT02977468|Pembrolizumab|pembrolizumab
5162339|NCT02977468|IORT|iort
5162344|NCT02977429|Tumor|tumor
5162345|NCT02977429|Abdominal infection|abdominal infection
5162346|NCT02977429|Hemodynamics|hemodynamics
5162347|NCT02977429|Pcv-aCO2|pcv-aco2
5162348|NCT02977429|Early Goal-directed Therapy (EGDT)|early goal-directed therapy (egdt)
5162349|NCT02977416|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5162350|NCT02977416|fat oxidation|fat oxidation
5162351|NCT02977416|exercise|exercise
5162357|NCT02977351|Periodontopathogenic microorganisms|periodontopathogenic microorganisms
5162358|NCT02977351|Non-surgical periodontal treatment|non-surgical periodontal treatment
5162359|NCT02977325|Physical activity level|physical activity level
5162360|NCT02977325|Personal efficacy|personal efficacy
5162361|NCT02977325|Knee osteoarthritis|knee osteoarthritis
5162362|NCT02977325|Self-management|self-management
5162363|NCT02977325|Self-care|self-care
5162364|NCT02977325|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
5162365|NCT02977273|Meal size|meal size
5162366|NCT02977260|Meal size|meal size
5162367|NCT02977247|SoftVue|softvue
5162368|NCT02977247|Dense Breast Tissue|dense breast tissue
5162369|NCT02977247|Breast Screening|breast screening
5162370|NCT02977247|Abnormal Breast|abnormal breast
5162371|NCT02977247|Normal Breast|normal breast
5162372|NCT02977247|Breast Imaging|breast imaging
5162373|NCT02977247|Breast Biopsy|breast biopsy
5162374|NCT02977247|Mammography|mammography
5162375|NCT02977247|Tomosynthesis|tomosynthesis
5162376|NCT02977247|Automated Breast Ultrasound|automated breast ultrasound
5162377|NCT02977247|Breast Cancer|breast cancer
5162378|NCT02977247|Breast Carcinoma|breast carcinoma
5162379|NCT02977247|Breast Tumors|breast tumors
5162380|NCT02977247|Mammary Carcinoma|mammary carcinoma
5162381|NCT02977247|Malignant Breast Tumor|malignant breast tumor
5162382|NCT02977247|Mammary Neoplasm|mammary neoplasm
5162383|NCT02977247|Mammary Cancer|mammary cancer
5162384|NCT02977247|ABUS|abus
5162385|NCT02977247|AWBUS|awbus
5162386|NCT02977247|Breast Tomography|breast tomography
5162387|NCT02977247|ATUS|atus
5162388|NCT02977247|ABTUS|abtus
5162389|NCT02977247|Mammogram|mammogram
5162390|NCT02977247|3D Mammogram|3d mammogram
5162391|NCT02977247|3D ABUS|3d abus
5162392|NCT02977247|3D Breast Ultrasound|3d breast ultrasound
5162393|NCT02977247|DBT|dbt
5162394|NCT02977247|FFDM|ffdm
5162395|NCT02977247|Digital Mammography|digital mammography
5162396|NCT02977247|Breast Ultrasound|breast ultrasound
5162400|NCT02977247|Asymptomatic|asymptomatic
5162401|NCT02977247|Delphinus|delphinus
5162402|NCT02977247|Delphinus Medical Technologies|delphinus medical technologies
5162403|NCT02977247|Diagnostic Breast Imaging|diagnostic breast imaging
5162404|NCT02977221|corticotomy|corticotomy
5162405|NCT02977221|piezocision|piezocision
5162406|NCT02977221|piezosurgery|piezosurgery
5162407|NCT02977221|acceleration of tooth movement|acceleration of tooth movement
5162408|NCT02977221|crowded anterior teeth|crowded anterior teeth
5162409|NCT02977208|Gabapentin|gabapentin
5162410|NCT02977208|OCT2|oct2
5162411|NCT02977208|OCTN1|octn1
5162412|NCT02977208|Pharmacogenetics|pharmacogenetics
5162413|NCT02977208|Pharmacokinetics|pharmacokinetics
5162414|NCT02977208|Polymorphisms|polymorphisms
5162418|NCT02977156|Injectable lesion|injectable lesion
5162419|NCT02977156|Intra-tumoral injection|intra-tumoral injection
5162420|NCT02977143|fluid responsiveness|fluid responsiveness
5162421|NCT02977143|central venous pressure|central venous pressure
5162422|NCT02977143|positive end-expiratory pressure|positive end-expiratory pressure
5162423|NCT02977143|robot surgery|robot surgery
5162424|NCT02977117|magnesium|magnesium
5162425|NCT02977117|ectopic calcification|ectopic calcification
5162426|NCT02977117|chronic kidney disease - mineral and bone disorder|chronic kidney disease - mineral and bone disorder
5162427|NCT02977117|serum calcification propensity|serum calcification propensity
5162428|NCT02977091|short stature|short stature
5162429|NCT02977091|fitness|fitness
5162430|NCT02977091|children|children
5162431|NCT02977078|Inhaler|inhaler
5162432|NCT02977065|Dyslipidemia|dyslipidemia
5162433|NCT02977065|CETP Inhibitors|cetp inhibitors
5162434|NCT02977065|Hyperlipidemia|hyperlipidemia
5162435|NCT02977052|Melanoma|melanoma
5162437|NCT02977052|Nivolumab|nivolumab
5162438|NCT02977052|Neo-adjuvant|neo-adjuvant
5162439|NCT02976987|Colvir|colvir
5162440|NCT02976987|high grade squamous intraepithelial lesions|high grade squamous intraepithelial lesions
5162442|NCT02976974|chronic pain|chronic pain
5162443|NCT02976974|central sensitization|central sensitization
5162444|NCT02976974|function|function
5162445|NCT02976974|force|force
5162446|NCT02976974|ultrasonography|ultrasonography
5162447|NCT02976961|Information|information
5162448|NCT02976961|Empowerment|empowerment
5162450|NCT02976922|microbiome|microbiome
5162451|NCT02976922|probiotics|probiotics
5162452|NCT02976883|Hypoxia|hypoxia
5162453|NCT02976883|HX4|hx4
5162454|NCT02976883|PET CT|pet ct
5162455|NCT02976883|Radiotherapy|radiotherapy
5162456|NCT02976870|Hydronephrosis|hydronephrosis
5162457|NCT02976870|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
5162458|NCT02976857|refractory diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
5162459|NCT02976857|anti-CD19 chimeric antigen receptor T-cell|anti-cd19 chimeric antigen receptor t-cell
5162460|NCT02976844|optimal balloon volume|optimal balloon volume
5162461|NCT02976844|positive end-expiratory pressure|positive end-expiratory pressure
5162462|NCT02976831|Plaque psoriasis vulgaris|plaque psoriasis vulgaris
5162463|NCT02976792|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5162464|NCT02976792|Acute Kidney Injury|acute kidney injury
5162465|NCT02976792|early acute kidney injury detection|early acute kidney injury detection
5162466|NCT02976792|Nephrocheck™|nephrocheck™
5162467|NCT02976792|Renal Resistive Index|renal resistive index
5162468|NCT02976766|Neuroprotection|neuroprotection
5162469|NCT02976766|Clinical trial|clinical trial
5162470|NCT02976766|Traditional Chinese medicine|traditional chinese medicine
5162471|NCT02976766|Axonal loss|axonal loss
5162472|NCT02976766|Jiaogulan|jiaogulan
5162473|NCT02976766|Gynostemma pentaphyllum|gynostemma pentaphyllum
5162474|NCT02976766|Optical coherence tomography|optical coherence tomography
5162475|NCT02976753|Blood Coagulation Disorders|blood coagulation disorders
5162476|NCT02976753|Hematologic Diseases|hematologic diseases
5162477|NCT02976753|Coagulation Protein Disorders|coagulation protein disorders
5162478|NCT02976753|Hemorrhagic Disorders|hemorrhagic disorders
5162479|NCT02976753|Genetic Diseases, Inborn|genetic diseases, inborn
5162480|NCT02976740|lung cancer|lung cancer
5162481|NCT02976740|SBRT|sbrt
5162482|NCT02976740|rhGM-CSF|rhgm-csf
5162483|NCT02976740|Thymosin Alpha 1|thymosin alpha 1
5162484|NCT02976727|Vitamin D|vitamin d
5162485|NCT02976727|Calcipotriol|calcipotriol
5162486|NCT02976727|Ablative fractional laser|ablative fractional laser
5162487|NCT02976727|Actinic keratosis|actinic keratosis
5162488|NCT02976727|Photodynamic therapy|photodynamic therapy
5162489|NCT02976714|Cystic Fibrosis|cystic fibrosis
5162490|NCT02976714|Lung disease|lung disease
5162491|NCT02976714|DNA methylation|dna methylation
5162492|NCT02976714|Predictive biomarkers|predictive biomarkers
5162493|NCT02976701|STEMI|stemi
5162494|NCT02976701|acute coronary syndrome|acute coronary syndrome
5162496|NCT02976701|microvascular resistance index|microvascular resistance index
5162497|NCT02976701|Left ventricular function|left ventricular function
5162498|NCT02976688|Endstage renal Disease|endstage renal disease
5162499|NCT02976688|Hemodialysis|hemodialysis
5162500|NCT02976649|Morbid obesity|morbid obesity
5162501|NCT02976649|Bariatric surgery|bariatric surgery
5162502|NCT02976649|Multi-dimensional score|multi-dimensional score
5162503|NCT02976636|Obesity treatment|obesity treatment
5162504|NCT02976636|Parenting training|parenting training
5162505|NCT02976636|Parenting style|parenting style
5049280|NCT03690635|tunneling technique|tunneling technique
5162506|NCT02976636|Family-based behavioral therapy|family-based behavioral therapy
5162507|NCT02976623|metrics|metrics
5162508|NCT02976623|feedback|feedback
5162509|NCT02976623|ultrasound-guided|ultrasound-guided
5162510|NCT02976623|procedural skills|procedural skills
5162511|NCT02976610|hemolysis|hemolysis
5423217|NCT01616641|oral health|oral health
5162512|NCT02976597|Abdominal surgery, pain, local, transversus abdominus block.|abdominal surgery, pain, local, transversus abdominus block.
5162514|NCT02976584|Cardiac Surgery|cardiac surgery
5162515|NCT02976584|Seizure|seizure
5162516|NCT02976584|Tranexamic acid|tranexamic acid
5162517|NCT02976558|CAM|cam
5162518|NCT02976558|allogenic Stem Cell Transplantation|allogenic stem cell transplantation
5162519|NCT02976558|Graft-Versus-Host Disease|graft-versus-host disease
5162520|NCT02976558|Depression|depression
5162521|NCT02976558|Quality of Life|quality of life
5162522|NCT02976558|Acupuncture|acupuncture
5162523|NCT02976558|Traditional chinese Medicine|traditional chinese medicine
5035278|NCT03778918|IBD|ibd
5162524|NCT02976558|Integrative medicine|integrative medicine
5162525|NCT02976558|Complementary and Alternative Medicine|complementary and alternative medicine
5162526|NCT02976558|Music therapy TaKeTiNa|music therapy taketina
5162527|NCT02976558|Clown theatrical performance|clown theatrical performance
5162528|NCT02976558|Humour|humour
5162529|NCT02976558|Chemotherapy side effects|chemotherapy side effects
5162530|NCT02976558|Psycho neuro immune system|psycho neuro immune system
5162531|NCT02976558|GvHD|gvhd
5162532|NCT02976558|PNEIS|pneis
5162533|NCT02976558|CMV|cmv
5162535|NCT02976558|holistic medicine|holistic medicine
5162536|NCT02976532|Electromagnetic tracking|electromagnetic tracking
5162537|NCT02976532|Internal rotation gait|internal rotation gait
5164024|NCT02967198|Ablation|ablation
5162538|NCT02976532|Femoral derotation osteotomy|femoral derotation osteotomy
5162539|NCT02976480|Irrigation|irrigation
5162540|NCT02976454|Obesity treatment|obesity treatment
5162541|NCT02976454|Primary care|primary care
5162542|NCT02976454|Guided Self-Help|guided self-help
5162543|NCT02976428|knee soft tissue balancing|knee soft tissue balancing
5162544|NCT02976428|sensor-guided|sensor-guided
5162545|NCT02976428|range of motion|range of motion
5162546|NCT02976415|Cardiac Surgery|cardiac surgery
5162547|NCT02976415|Physiotherapy|physiotherapy
5162548|NCT02976415|In-Bed Cycling|in-bed cycling
5162549|NCT02976415|Mechanical Ventilation|mechanical ventilation
5162550|NCT02976415|Cycle Ergometry|cycle ergometry
5162551|NCT02976415|Early Mobilization|early mobilization
5162552|NCT02976415|Rehabilitation|rehabilitation
5162553|NCT02976415|Critical Care|critical care
5162554|NCT02976415|Intensive Care Unit|intensive care unit
5162555|NCT02976389|Supplemental Nutrition Assistance Program|supplemental nutrition assistance program
5162556|NCT02976389|Food insecurity|food insecurity
5162557|NCT02976389|fruit and vegetable|fruit and vegetable
5162558|NCT02976389|healthy diet|healthy diet
5162559|NCT02976376|Myocardial infarction|myocardial infarction
5162560|NCT02976376|e-Health|e-health
5162561|NCT02976376|mHealth|mhealth
5162562|NCT02976376|mobile phones|mobile phones
5162563|NCT02976376|smartphone|smartphone
5162564|NCT02976376|follow-up|follow-up
5162565|NCT02976363|Radiotherapy|radiotherapy
5162566|NCT02976363|Respiratory muscles|respiratory muscles
5162567|NCT02976363|Neoplasms|neoplasms
5162568|NCT02976363|Breast|breast
5162569|NCT02976350|Heart failure|heart failure
5162570|NCT02976350|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5162571|NCT02976350|GH deficiency|gh deficiency
5162572|NCT02976350|Testosterone deficiency|testosterone deficiency
5162573|NCT02976350|Low- T3 syndrome|low- t3 syndrome
5162574|NCT02976350|Multiple Hormone Deficiencies|multiple hormone deficiencies
5162575|NCT02976337|Central sensitization|central sensitization
5162576|NCT02976337|Endogenous opioids|endogenous opioids
5162577|NCT02976337|Humans|humans
5162578|NCT02976337|Latent sensitization|latent sensitization
5162579|NCT02976337|Mandibular third molar extraction|mandibular third molar extraction
5162580|NCT02976337|Naloxone|naloxone
5162581|NCT02976337|Pain|pain
5162582|NCT02976337|Pressure algometry|pressure algometry
5162583|NCT02976337|Randomized controlled trial|randomized controlled trial
5162584|NCT02976337|Secondary hyperalgesia|secondary hyperalgesia
5162585|NCT02976337|Target controlled infusion|target controlled infusion
5162586|NCT02976311|inflammatory reaction|inflammatory reaction
5162587|NCT02976311|IL-6|il-6
5162588|NCT02976311|TNF|tnf
5162589|NCT02976311|Misgav Ladach technique|misgav ladach technique
5162590|NCT02976311|Pfannenstiel-Kerr technique|pfannenstiel-kerr technique
5162591|NCT02976311|cesarean delivery|cesarean delivery
5162592|NCT02976311|cesarean technique|cesarean technique
5162594|NCT02976298|supplementary motor area|supplementary motor area
5162595|NCT02976285|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5162596|NCT02976285|patch augmentation|patch augmentation
5162597|NCT02976272|Bortezomib regimen|bortezomib regimen
5162598|NCT02976272|patients with multiple myeloma|patients with multiple myeloma
5162599|NCT02976233|Acute Respiratory Failure|acute respiratory failure
5162600|NCT02976233|Non Invasive Ventilation|non invasive ventilation
5162601|NCT02976233|Ultrasound|ultrasound
5162602|NCT02976233|Diaphragm Thickening|diaphragm thickening
5162603|NCT02976168|Cognitive functioning|cognitive functioning
5162604|NCT02976168|Brain tissue oxygenation|brain tissue oxygenation
5162605|NCT02976168|cerebral perfusion|cerebral perfusion
5162606|NCT02976168|head down tilt|head down tilt
5162607|NCT02976155|critically ill, intensive care, enteral nutrition|critically ill, intensive care, enteral nutrition
5776113|NCT00216541|transfusion|transfusion
5236354|NCT02525146|HIV|hiv
5162608|NCT02976142|gastric cancer, metastatic|gastric cancer, metastatic
5162609|NCT02976142|positive wash cytology|positive wash cytology
5162610|NCT02976142|neoadjuvant intraperitoneal immunotherapy|neoadjuvant intraperitoneal immunotherapy
5162611|NCT02976116|Fruquintinib|fruquintinib
5162612|NCT02976116|NSCLC|nsclc
5162613|NCT02976116|1st line|1st line
5162614|NCT02976103|recovery|recovery
5162615|NCT02976103|pain|pain
5962126|NCT04282863|conventional lapatoscopic myomectomy (LM)|conventional lapatoscopic myomectomy (lm)
5162616|NCT02976103|surgical drains|surgical drains
5162617|NCT02976077|social cognition|social cognition
5162618|NCT02976077|cognitive remediation|cognitive remediation
5162619|NCT02976077|emotions|emotions
5162620|NCT02976077|theory of mind|theory of mind
5162621|NCT02976077|attributions|attributions
5162622|NCT02976077|social perception|social perception
5162623|NCT02976064|physical activity|physical activity
5162624|NCT02976064|lifestyle|lifestyle
5162625|NCT02976064|adaptive case management|adaptive case management
5162626|NCT02976064|telemedicine|telemedicine
5162627|NCT02976064|integrated care|integrated care
5162635|NCT02975986|Nephrolithiasis, Uric Acid|nephrolithiasis, uric acid
5162636|NCT02975986|Fatty Acid|fatty acid
5162637|NCT02975973|tDCS|tdcs
5162638|NCT02975973|cognitive control|cognitive control
5162639|NCT02975973|EEG|eeg
5162640|NCT02975973|gamma oscillations|gamma oscillations
5162641|NCT02975960|systemic sclerosis|systemic sclerosis
5162642|NCT02975960|adipose derived stem cell|adipose derived stem cell
5162643|NCT02975960|stromal vascular fraction|stromal vascular fraction
5162644|NCT02975960|digital ulcer|digital ulcer
5162645|NCT02975960|gangrene|gangrene
5162646|NCT02975934|CRPC|crpc
5162647|NCT02975934|PARP inhibitor|parp inhibitor
5162648|NCT02975934|PARPi|parpi
5162649|NCT02975934|BRCA|brca
5162650|NCT02975934|ATM|atm
5162651|NCT02975934|HRD|hrd
5162652|NCT02975934|TRITON|triton
5162653|NCT02975934|homologous recombination|homologous recombination
5162654|NCT02975934|DNA repair|dna repair
5162655|NCT02975934|DNA defect|dna defect
5162656|NCT02975934|DNA anomaly|dna anomaly
5162657|NCT02975934|germline|germline
5162658|NCT02975934|somatic|somatic
5162659|NCT02975934|mCRPC|mcrpc
5162660|NCT02975921|Pleural Effusion|pleural effusion
5162661|NCT02975921|Thoracentesis|thoracentesis
5162662|NCT02975921|Pleural Cavity|pleural cavity
5162663|NCT02975921|Pleurodesis|pleurodesis
5162664|NCT02975921|Tunneled Pleural Catheter|tunneled pleural catheter
5162665|NCT02975908|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5162666|NCT02975908|epidemiology|epidemiology
5162667|NCT02975908|clinical features|clinical features
5162668|NCT02975908|management|management
5162669|NCT02975908|prognosis|prognosis
5162670|NCT02975869|Leukemia|leukemia
5162671|NCT02975869|Acute Myeloid Leukemia|acute myeloid leukemia
5162672|NCT02975856|Anthocyanins|anthocyanins
5162673|NCT02975856|Bioavailability|bioavailability
5162674|NCT02975856|Flavonoids|flavonoids
5162675|NCT02975856|Port wine|port wine
5162676|NCT02975856|Red wine|red wine
5162677|NCT02975817|pediatric, intraoperative, neurosurgery, inadvertent|pediatric, intraoperative, neurosurgery, inadvertent
5162678|NCT02975804|cerebral palsy|cerebral palsy
5162679|NCT02975804|video games|video games
5162680|NCT02975804|postural control|postural control
5162681|NCT02975804|balance|balance
5162682|NCT02975804|children|children
5162683|NCT02975791|Airway Obstruction|airway obstruction
5162684|NCT02975778|80 years old|80 years old
5162685|NCT02975765|corticotomy|corticotomy
5162686|NCT02975765|minimally invasive|minimally invasive
5162687|NCT02975765|piezosurgery|piezosurgery
5162688|NCT02975765|piezocision|piezocision
5162689|NCT02975765|pain|pain
5162690|NCT02975765|discomfort|discomfort
5162691|NCT02975739|Intratumoral|intratumoral
5162692|NCT02975739|Tongue|tongue
5162693|NCT02975739|Microspheres|microspheres
5162694|NCT02975726|Liver Cirrhosis|liver cirrhosis
5162695|NCT02975726|Refractory ascites|refractory ascites
5162696|NCT02975726|PD catheter|pd catheter
5162697|NCT02975713|P4,ART,IVF,FSH,LH,AMH|p4,art,ivf,fsh,lh,amh
5162698|NCT02975700|PLX3397|plx3397
5162699|NCT02975700|Kit-mutant Melanoma|kit-mutant melanoma
5162700|NCT02975700|Unresectable or Metastatic KIT-mutated Melanoma|unresectable or metastatic kit-mutated melanoma
5162701|NCT02975700|Developmental Phase I/II|developmental phase i/ii
5162702|NCT02975687|Acute|acute
5162703|NCT02975687|Leukemia|leukemia
5162704|NCT02975687|Lymphoid|lymphoid
5162705|NCT02975687|CD19|cd19
5162706|NCT02975687|Refractory|refractory
5162707|NCT02975635|Patients' Preferences|patients' preferences
5162708|NCT02975596|educational intervention|educational intervention
5162709|NCT02975583|Atherosclerosis|atherosclerosis
5903594|NCT00342433|Androgens|androgens
5162710|NCT02975557|Brimonidine|brimonidine
5162711|NCT02975557|Dry Eye|dry eye
5162712|NCT02975557|oGVHD|ogvhd
5162714|NCT02975544|social and emotional competence|social and emotional competence
5162715|NCT02975544|healthy lifestyles|healthy lifestyles
5162716|NCT02975544|children|children
5162717|NCT02975544|educational programme|educational programme
5162718|NCT02975531|Pompage|pompage
5162719|NCT02975479|Hay fever|hay fever
5162720|NCT02975479|Pollen allergy|pollen allergy
5162721|NCT02975479|Allergic rhinitis|allergic rhinitis
5162722|NCT02975440|Vilaprisan|vilaprisan
5162723|NCT02975440|PK|pk
5162724|NCT02975440|rifampicin|rifampicin
5162725|NCT02975440|midazolam,|midazolam,
5162726|NCT02975440|CYP3A4 induction|cyp3a4 induction
5162727|NCT02975440|drug-drug interaction|drug-drug interaction
5962127|NCT04282785|meropenem|meropenem
5162729|NCT02975427|Abdominal bioelectrical impedance analysis|abdominal bioelectrical impedance analysis
5162730|NCT02975427|Anthropometry|anthropometry
5162731|NCT02975427|Insulin resistance|insulin resistance
5162732|NCT02975362|Acupuncture Treatment; Motor Dysfunction; Stroke Patients|acupuncture treatment; motor dysfunction; stroke patients
5162734|NCT02975349|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5162735|NCT02975349|Bruton's Tyrosine Kinase inhibitor|bruton's tyrosine kinase inhibitor
5162736|NCT02975336|Systemic Lupus Erythematosus|systemic lupus erythematosus
5162737|NCT02975336|M2951|m2951
5162738|NCT02975336|Placebo|placebo
5162739|NCT02975336|Dose response|dose response
5162740|NCT02975336|Oral Corticosteroids|oral corticosteroids
5162741|NCT02975336|Safety|safety
5162742|NCT02975336|Efficacy|efficacy
5162743|NCT02975336|Autoimmune And Inflammatory Disorders|autoimmune and inflammatory disorders
5162744|NCT02975323|hepatic venous pressure gradient|hepatic venous pressure gradient
5162745|NCT02975323|liver disease|liver disease
5162746|NCT02975323|US Doppler waveform|us doppler waveform
5162747|NCT02975323|Cirrhosis|cirrhosis
5162748|NCT02975297|smoking|smoking
5162749|NCT02975297|pre-diabetes|pre-diabetes
5162750|NCT02975297|overweight|overweight
5162751|NCT02975297|exenatide|exenatide
5162752|NCT02975297|GLP-1 agonists|glp-1 agonists
5162753|NCT02975284|bronchial thermoplasty|bronchial thermoplasty
5162754|NCT02975284|long term|long term
5162755|NCT02975284|interventional bronchoscopy|interventional bronchoscopy
5162757|NCT02975258|Asthma|asthma
5162758|NCT02975258|Adiposity|adiposity
5162759|NCT02975258|Lung disease|lung disease
5162760|NCT02975258|Weight|weight
5162761|NCT02975258|Fat|fat
5162762|NCT02975258|Obese|obese
5162763|NCT02975245|Male infertility|male infertility
5162764|NCT02975245|Germ cells|germ cells
5162765|NCT02975245|Chemotherapy|chemotherapy
5162766|NCT02975245|Sperm|sperm
5162767|NCT02975232|nutrition disparities|nutrition disparities
5162768|NCT02975232|SNAP population|snap population
5162769|NCT02975232|behavioral economics|behavioral economics
5162770|NCT02975232|retail setting|retail setting
5162771|NCT02975232|point of purchase education|point of purchase education
5162772|NCT02975232|pediatric obesity|pediatric obesity
5162773|NCT02975232|rural population|rural population
5162774|NCT02975232|fruit and vegetable purchases|fruit and vegetable purchases
5162775|NCT02975232|fruit and vegetable consumption|fruit and vegetable consumption
5162776|NCT02975193|Parkinsons Disease|parkinsons disease
5162777|NCT02975193|Cognition|cognition
5162778|NCT02975167|Induction of labor|induction of labor
5162779|NCT02975167|mechanical cervical ripening|mechanical cervical ripening
5162780|NCT02975167|patient satisfaction|patient satisfaction
5162781|NCT02975167|outpatient|outpatient
5162782|NCT02975167|cost savings|cost savings
5162783|NCT02975154|osteoarthritis|osteoarthritis
5162784|NCT02975154|microcurrent|microcurrent
5162785|NCT02975154|knee|knee
5162786|NCT02975154|electrotherapy|electrotherapy
5162787|NCT02975141|Palliative Chemotherapy|palliative chemotherapy
5162788|NCT02975141|Afatinib|afatinib
5162789|NCT02975141|Gemcitabine|gemcitabine
5162790|NCT02975141|nab-paclitaxel|nab-paclitaxel
5162791|NCT02975141|pancreatic cancer|pancreatic cancer
5162792|NCT02975128|Minimal invasive|minimal invasive
5162793|NCT02975128|Biopsy|biopsy
5162794|NCT02975089|Frailty|frailty
5162795|NCT02975089|nutrition education|nutrition education
5162796|NCT02975089|designed dishware|designed dishware
5162797|NCT02975089|balanced diet|balanced diet
5162798|NCT02975089|multiple dietary components|multiple dietary components
5162799|NCT02975076|Sanchitongshu|sanchitongshu
5162800|NCT02975076|Acute Minor Stroke|acute minor stroke
5162801|NCT02975076|Transient Ischemic Attack|transient ischemic attack
5162802|NCT02975063|Exclusive breastfeeding|exclusive breastfeeding
5162803|NCT02975024|mandibular vestibuloplasty|mandibular vestibuloplasty
5162804|NCT02975024|wound healing|wound healing
5162805|NCT02975024|microcirculation|microcirculation
5162806|NCT02975024|Laser Speckle Contrast Imager|laser speckle contrast imager
5162807|NCT02975024|Mucograft|mucograft
5162808|NCT02975024|strip gingival graft|strip gingival graft
5162809|NCT02975011|Magnetic Resonance Imaging|magnetic resonance imaging
5776531|NCT00214435|Adherence|adherence
5162810|NCT02975011|Patient Satisfaction|patient satisfaction
5162811|NCT02975011|Numeric Rating Scale|numeric rating scale
5162812|NCT02974998|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5162813|NCT02974998|HIV Testing and Counseling (HTC)|hiv testing and counseling (htc)
5162814|NCT02974998|Sexually Transmitted Infections (STIs)|sexually transmitted infections (stis)
5162815|NCT02974998|Substance Abuse|substance abuse
5162816|NCT02974998|Gender Based Violence|gender based violence
5162817|NCT02974998|Gang Violence|gang violence
5162818|NCT02974998|Victimization|victimization
5162819|NCT02974998|Linkage to Care|linkage to care
5162820|NCT02974998|Sexual Risk|sexual risk
5162821|NCT02974998|Out-of-school Adolescents|out-of-school adolescents
5162822|NCT02974998|Young Women|young women
5162828|NCT02974985|WIZDOM|wizdom
5162829|NCT02974985|Midface lift|midface lift
5162830|NCT02974985|Midface augmentation|midface augmentation
5162831|NCT02974933|apatinib|apatinib
5162832|NCT02974933|pemetrexed|pemetrexed
5162833|NCT02974933|NSCLC|nsclc
5162834|NCT02974907|Dry Eye Syndrome|dry eye syndrome
5162835|NCT02974907|Dry Eye|dry eye
5162836|NCT02974907|DES|des
5162837|NCT02974868|Phase 2|phase 2
5162838|NCT02974868|randomized|randomized
5162839|NCT02974868|double-blind|double-blind
5162840|NCT02974868|placebo|placebo
5162845|NCT02974868|janus kinase|janus kinase
5162846|NCT02974868|moderate|moderate
5162847|NCT02974868|severe|severe
5162848|NCT02974855|hemophilia|hemophilia
5162849|NCT02974829|Chronic Hepatitis B|chronic hepatitis b
5162850|NCT02974816|Glooko|glooko
5162851|NCT02974816|Mobile health application|mobile health application
5162852|NCT02974816|Insulin treated|insulin treated
5162853|NCT02974816|Type 2 Diabetes|type 2 diabetes
5162854|NCT02974816|Remote patient monitoring|remote patient monitoring
5162855|NCT02974816|Certified diabetes educator|certified diabetes educator
5162856|NCT02974816|mHealth Advantage|mhealth advantage
5162857|NCT02974816|Population health|population health
5162858|NCT02974790|echocardiography|echocardiography
5162859|NCT02974790|training|training
5162860|NCT02974790|emergency department|emergency department
5162861|NCT02974790|circulatory failure|circulatory failure
5162862|NCT02974751|Aquablation|aquablation
5162863|NCT02974751|AQUABEAM|aquabeam
5162864|NCT02974751|BPH|bph
5162865|NCT02974751|LUTS|luts
5162866|NCT02974725|NSCLC|nsclc
5162867|NCT02974725|Melanoma|melanoma
5162868|NCT02974725|NRAS|nras
5162869|NCT02974725|KRAS|kras
5162870|NCT02974725|BRAF|braf
5162871|NCT02974725|LXH254|lxh254
5162872|NCT02974725|LTT462|ltt462
5162873|NCT02974725|Trametinib|trametinib
5162874|NCT02974725|Ribocliclib|ribocliclib
5162875|NCT02974725|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5162876|NCT02974725|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5162877|NCT02974725|lung cancer|lung cancer
5162878|NCT02974725|lung adenocarcinoma|lung adenocarcinoma
5162879|NCT02974725|Large-cell lung carcinoma|large-cell lung carcinoma
5162880|NCT02974725|Non small cell lung carcinoma|non small cell lung carcinoma
5162881|NCT02974725|Non small cell lung cancer|non small cell lung cancer
5162882|NCT02974725|Large cell lung carcinoma|large cell lung carcinoma
5162883|NCT02974725|Large cell lung cancer|large cell lung cancer
5162884|NCT02974725|squamous cell lung carcinoma|squamous cell lung carcinoma
5162885|NCT02974712|Arterial blood gases|arterial blood gases
5162886|NCT02974712|MAP|map
5162887|NCT02974712|HR|hr
5162888|NCT02974673|Spinal Cord Injury|spinal cord injury
5162889|NCT02974673|Genito sexuals disorders|genito sexuals disorders
5162890|NCT02974673|Ejaculatory test|ejaculatory test
5162895|NCT02974634|Ileostomy|ileostomy
5162896|NCT02974608|Placental|placental
5162897|NCT02974608|Fetal Loss|fetal loss
5162898|NCT02974608|Observational|observational
5162899|NCT02974608|Antenatal|antenatal
5162900|NCT02974608|Infection|infection
5162901|NCT02974595|Study of pathogenesis of patients affected with autoinflammatory diseases|study of pathogenesis of patients affected with autoinflammatory diseases
5162902|NCT02974595|This Includes the Clinical, Immunological , Genetic, and Metabolic Characteristi|this includes the clinical, immunological , genetic, and metabolic characteristi
5162903|NCT02974595|Collection of Clinical and Laboratory Outcome Data|collection of clinical and laboratory outcome data
5162904|NCT02974595|Evaluation of Characteristics/Disease Manifestations|evaluation of characteristics/disease manifestations
5162905|NCT02974582|Cigarette|cigarette
5162906|NCT02974582|Behaviors|behaviors
5162907|NCT02974582|Attitudes|attitudes
5162908|NCT02974582|Beliefs|beliefs
5162909|NCT02974569|adolescents|adolescents
5162910|NCT02974569|young adults|young adults
5162911|NCT02974543|tinnitus|tinnitus
5162912|NCT02974517|time-lapes|time-lapes
5162913|NCT02974517|IVF/ICSI|ivf/icsi
5162914|NCT02974517|pregnancy outcome|pregnancy outcome
5162915|NCT02974491|hemodialysis|hemodialysis
5776532|NCT00214435|MEMS caps|mems caps
5162916|NCT02974491|diabetes mellitus|diabetes mellitus
5162917|NCT02974491|apple juice|apple juice
5162918|NCT02974491|potassium|potassium
5162919|NCT02974478|orange juice consumption|orange juice consumption
5162920|NCT02974478|glucose homeostasis|glucose homeostasis
5162921|NCT02974478|antioxidative status|antioxidative status
5162922|NCT02974465|Brain injuries|brain injuries
5162923|NCT02974465|upper extremity|upper extremity
5162924|NCT02974465|biofeedback|biofeedback
5162925|NCT02974465|electromyography|electromyography
5158346|NCT03002090|anemia|anemia
5162932|NCT02974322|Mongersen|mongersen
5162933|NCT02974322|Adolescent|adolescent
5162934|NCT02974322|Pediatric|pediatric
5162935|NCT02974322|Children|children
5162936|NCT02974309|Youth|youth
5162937|NCT02974309|Diabetes Management|diabetes management
5162938|NCT02974309|Sleep|sleep
5162939|NCT02974283|Normobaric hyperoxia|normobaric hyperoxia
5162940|NCT02974283|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
5164125|NCT02966353|anemia|anemia
5962128|NCT04282785|cefotaxime|cefotaxime
5162953|NCT02974166|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5162954|NCT02974166|Rigid Splint|rigid splint
5162955|NCT02974166|Speech Therapy|speech therapy
5162956|NCT02974127|intracranial benign meningioma|intracranial benign meningioma
5162957|NCT02974127|radiosurgery|radiosurgery
5162958|NCT02974127|large meningioma|large meningioma
5162959|NCT02974127|critical site|critical site
5162960|NCT02974127|multisession radiosurgery|multisession radiosurgery
5162961|NCT02974101|Spinal cord stimulation|spinal cord stimulation
5162962|NCT02974101|AdaptiveStim|adaptivestim
5162963|NCT02974062|Position sense|position sense
5162964|NCT02974062|Lumbar stabilization exercise|lumbar stabilization exercise
5162965|NCT02974049|Ivermectin|ivermectin
5162966|NCT02974049|Albendazole|albendazole
5162967|NCT02974049|Diethylcarbamazine|diethylcarbamazine
5162968|NCT02974036|Patient education|patient education
5162969|NCT02974036|Osteoarthritis|osteoarthritis
5162970|NCT02974036|Primary health care|primary health care
5162971|NCT02974010|d-cycloserine|d-cycloserine
5162972|NCT02974010|lurasidone|lurasidone
5162973|NCT02974010|ketamine|ketamine
5162974|NCT02974010|randomized controlled trial|randomized controlled trial
5162975|NCT02973984|Anticoagulant Treatments|anticoagulant treatments
5162976|NCT02973984|Multidimensional Prognostic Index (MPI)|multidimensional prognostic index (mpi)
5162977|NCT02973984|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
5162978|NCT02973984|Frailty|frailty
5162979|NCT02973984|Elderly|elderly
5162980|NCT02973984|Atrial Fibrillation|atrial fibrillation
5162981|NCT02973971|Blood cell biomarkers, peripheral circulating biomarkers|blood cell biomarkers, peripheral circulating biomarkers
5162982|NCT02973958|Penis|penis
5162983|NCT02973958|Pain|pain
5162984|NCT02973958|Ketorolac|ketorolac
5162985|NCT02973958|Circumcision|circumcision
5162986|NCT02973945|Pulmonary Rehabilitation|pulmonary rehabilitation
5162987|NCT02973945|High Flow Nasal Cannula|high flow nasal cannula
5162988|NCT02973945|The Venturi Mask|the venturi mask
5162989|NCT02973945|Exercise capacity|exercise capacity
5162990|NCT02973945|Aerobic capacity|aerobic capacity
5162991|NCT02973945|HFNC|hfnc
5162992|NCT02973932|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
5162993|NCT02973932|obsessive-compulsive disorder|obsessive-compulsive disorder
5162994|NCT02973932|internet-based|internet-based
5162995|NCT02973893|Chronic Venous Leg Ulcer|chronic venous leg ulcer
5162996|NCT02973880|Steroid/antibiotic associated treatment|steroid/antibiotic associated treatment
5162997|NCT02973880|Phaco-emulsification|phaco-emulsification
5162998|NCT02973880|Cataract extraction|cataract extraction
5162999|NCT02973867|Bone mineral density|bone mineral density
5163000|NCT02973867|Myokines|myokines
5163001|NCT02973867|Adipokines|adipokines
5163002|NCT02973815|family meals|family meals
5163003|NCT02973815|home food availability|home food availability
5163004|NCT02973802|Graves Disease|graves disease
5163005|NCT02973802|Phase 1|phase 1
5163018|NCT02973750|high-grade serous cancer|high-grade serous cancer
5163019|NCT02973750|stage III cancer|stage iii cancer
5163020|NCT02973750|stage IV cancer|stage iv cancer
5163021|NCT02973724|Extubation|extubation
5163022|NCT02973724|Remifentanil|remifentanil
5163023|NCT02973724|Laryngomicrosurgery|laryngomicrosurgery
5163024|NCT02973685|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5163025|NCT02973685|Transarterial Chemoembolization|transarterial chemoembolization
5163026|NCT02973685|BCLC A/B|bclc a/b
5163027|NCT02973672|Fluorescence|fluorescence
5163028|NCT02973672|Surgery|surgery
5163029|NCT02973672|Cancer|cancer
5163030|NCT02973672|SGM-101|sgm-101
5163031|NCT02973672|Near Infrared|near infrared
5163032|NCT02973672|Immunophotodetection|immunophotodetection
5163033|NCT02973646|chronic hepatitis b|chronic hepatitis b
5163034|NCT02973646|peginterferon alfa-2b|peginterferon alfa-2b
5163035|NCT02973646|interferon gene mutation|interferon gene mutation
5163036|NCT02973646|interferon receptor|interferon receptor
5163037|NCT02973633|Heart Failure|heart failure
5163038|NCT02973633|Remodeling|remodeling
5163043|NCT02973594|beta-1 adrenergic receptor signaling|beta-1 adrenergic receptor signaling
5163044|NCT02973594|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
5163045|NCT02973594|HCN4 inhibition|hcn4 inhibition
5163046|NCT02973594|beta-1 adrenergic receptor blocker|beta-1 adrenergic receptor blocker
5163047|NCT02973594|gene expression|gene expression
5163048|NCT02973581|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5163049|NCT02973581|General Anaesthesia (GA),|general anaesthesia (ga),
5163050|NCT02973581|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
5163051|NCT02973581|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5163052|NCT02973581|Peribulbar Block (PBB)|peribulbar block (pbb)
5163053|NCT02973581|Topical Analgesia (TA)|topical analgesia (ta)
5163054|NCT02973581|Oculocardiac reflex (OCR)|oculocardiac reflex (ocr)
5163055|NCT02973581|Postoperative nausea nad vomiting (PONV)|postoperative nausea nad vomiting (ponv)
5163057|NCT02973581|metamizol|metamizol
5163059|NCT02973542|Ethosuximide|ethosuximide
5163060|NCT02973542|Pain|pain
5163061|NCT02973529|Percutaneous intervention (PCI)|percutaneous intervention (pci)
5962129|NCT04282785|piperacillin/tazobactam|piperacillin/tazobactam
5163062|NCT02973529|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5163063|NCT02973529|Bifurcation lesion|bifurcation lesion
5163064|NCT02973529|Bioresorbable stents (BRS)|bioresorbable stents (brs)
5163065|NCT02973503|Hepatitis C|hepatitis c
5163066|NCT02973503|Genotype 1B|genotype 1b
5163067|NCT02973503|Non Severe Fibrosis|non severe fibrosis
5163068|NCT02973503|Treatment Naïve|treatment naïve
5163069|NCT02973503|8 Weeks of Treatment|8 weeks of treatment
5163070|NCT02973503|Elbasvir/Grazoprevir Combination|elbasvir/grazoprevir combination
5163071|NCT02973490|ESD;Transanal Tube Drainage;Colorectal Tumor|esd;transanal tube drainage;colorectal tumor
5163072|NCT02973438|Spinal Cord Injuries|spinal cord injuries
5163073|NCT02973438|Obesity|obesity
5163074|NCT02973438|Insulin Resistance|insulin resistance
5163075|NCT02973438|Intermittent hypoxia|intermittent hypoxia
5163076|NCT02973425|mHealth, Smoking cessation,|mhealth, smoking cessation,
5163078|NCT02973399|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
5163079|NCT02973399|Hsp90|hsp90
5163080|NCT02973399|Ibrutinib|ibrutinib
5163081|NCT02973386|Local advanced|local advanced
5163082|NCT02973386|High Risk|high risk
5163083|NCT02973386|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5163084|NCT02973373|MRI|mri
5163085|NCT02973373|Chest|chest
5163086|NCT02973373|Apnea|apnea
5163087|NCT02973347|Enteral Feeding|enteral feeding
5163088|NCT02973347|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5163089|NCT02973347|Mechanical Ventilation|mechanical ventilation
5163090|NCT02973347|Pediatric Intensive Care Unit|pediatric intensive care unit
5163091|NCT02973347|Critical Illness|critical illness
5163092|NCT02973334|sweeteners|sweeteners
5163093|NCT02973334|sugar|sugar
5163094|NCT02973334|stress response|stress response
5163095|NCT02973295|NAFLD;|nafld;
5163096|NCT02973295|Fibroscan|fibroscan
5163097|NCT02973295|Silymarin|silymarin
5163098|NCT02973256|Meningioma grade II|meningioma grade ii
5163099|NCT02973256|Meningioma grade III|meningioma grade iii
5163100|NCT02973243|early warning scoring|early warning scoring
5163101|NCT02973243|respiration rate|respiration rate
5163102|NCT02973243|acute care teams|acute care teams
5163103|NCT02973243|NEWS|news
5163104|NCT02973243|CREWS|crews
5163105|NCT02973230|Pregnancy, Ectopic|pregnancy, ectopic
5163106|NCT02973230|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5163107|NCT02973230|Pregnancy, Tubal|pregnancy, tubal
5163108|NCT02973217|Hyperthermia, Induced|hyperthermia, induced
5163109|NCT02973217|Laser Coagulation|laser coagulation
5163110|NCT02973217|Laser Therapy|laser therapy
5163111|NCT02973204|tumor DNA|tumor dna
5163112|NCT02973204|circulating tumor cells|circulating tumor cells
5163113|NCT02973204|biopsy|biopsy
5163114|NCT02973191|Leukemia|leukemia
5163115|NCT02973191|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
5163116|NCT02973191|JCAR015|jcar015
5163117|NCT02973152|Type I Thyroplasty|type i thyroplasty
5163118|NCT02973152|Reinnervation|reinnervation
5163124|NCT02973074|iron deficiency|iron deficiency
5163125|NCT02973074|patient blood management|patient blood management
5163126|NCT02973074|anemia|anemia
5163127|NCT02973048|Cesarean delivery|cesarean delivery
5163128|NCT02973048|Spinal anesthesia|spinal anesthesia
5163129|NCT02973048|Local anesthetics|local anesthetics
5163130|NCT02973009|The Sleeve Gastrectomy (SG)|the sleeve gastrectomy (sg)
5163131|NCT02973009|bariatric surgery|bariatric surgery
5163132|NCT02973009|laparoscopy|laparoscopy
5445358|NCT01522183|Thrombotic Microangiopathy|thrombotic microangiopathy
5163133|NCT02973009|systematic closure of the epigastric|systematic closure of the epigastric
5163140|NCT02972931|HIV infection|hiv infection
5163141|NCT02972931|low HIV reservoir|low hiv reservoir
5163142|NCT02972931|functional cure|functional cure
5163143|NCT02972905|pharmacokinetics|pharmacokinetics
5163144|NCT02972905|GSK2269557|gsk2269557
5163145|NCT02972905|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
5163146|NCT02972905|tolerability|tolerability
5163148|NCT02972905|ELLIPTA|ellipta
5163149|NCT02972879|trigger finger|trigger finger
5163150|NCT02972879|Therapeutic Modalities|therapeutic modalities
5163151|NCT02972879|Corticosteroid Injection|corticosteroid injection
5163152|NCT02972879|non-surgical treatment|non-surgical treatment
5163153|NCT02972879|physical therapy|physical therapy
5163154|NCT02972840|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5163155|NCT02972840|Acalabrutinib|acalabrutinib
5163156|NCT02972840|Mantle Cell Lymphoma|mantle cell lymphoma
5163157|NCT02972840|ACE-LY-308|ace-ly-308
5163158|NCT02972840|Treatment naive|treatment naive
5163159|NCT02972840|non-Hodgkins Lymphoma|non-hodgkins lymphoma
5163160|NCT02972840|Bendomustine|bendomustine
5163161|NCT02972840|Rituximab|rituximab
5163162|NCT02972814|Troponin|troponin
5163163|NCT02972814|Point of care test|point of care test
5163164|NCT02972814|myocardial infarction|myocardial infarction
5163165|NCT02972801|Spermatogonial stem cells|spermatogonial stem cells
5163166|NCT02972801|Testis|testis
5163167|NCT02972801|Fertility|fertility
5163168|NCT02972801|Infertility|infertility
5163169|NCT02972801|Oncofertility|oncofertility
5163170|NCT02972762|depth of anesthesia\postoperation delirium|depth of anesthesia\postoperation delirium
5163171|NCT02972736|Radiation dose|radiation dose
5163172|NCT02972736|percutaneous coronary intervention|percutaneous coronary intervention
5163173|NCT02972736|Coronary|coronary
5163174|NCT02972736|Interventional radiology|interventional radiology
5163175|NCT02972736|Electrophysiology|electrophysiology
5163176|NCT02972723|Metformin Therapy in HCV|metformin therapy in hcv
5163177|NCT02972684|Cardiopulmonary Bypass|cardiopulmonary bypass
5163178|NCT02972684|Hemorrhage|hemorrhage
5163179|NCT02972684|blood transfusion|blood transfusion
5163180|NCT02972684|Point-of-care test|point-of-care test
5163181|NCT02972684|health economics|health economics
5163183|NCT02972658|Alzheimer's Disease|alzheimer's disease
5163184|NCT02972658|Dementia|dementia
5163185|NCT02972658|Brain Diseases|brain diseases
5163186|NCT02972658|Neurodegenerative Diseases|neurodegenerative diseases
5163187|NCT02972658|Central Nervous System Diseases|central nervous system diseases
5163188|NCT02972658|Nervous System Diseases|nervous system diseases
5163189|NCT02972658|Mental Disorders|mental disorders
5163190|NCT02972658|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5163191|NCT02972658|Tauopathies|tauopathies
5163192|NCT02972658|Memory|memory
5163193|NCT02972658|Amyloid|amyloid
5163194|NCT02972632|Drug Therapy|drug therapy
5163195|NCT02972619|Blood Pressure|blood pressure
5163196|NCT02972619|Lipids|lipids
5163197|NCT02972619|Cardiovascular|cardiovascular
5163198|NCT02972619|Health Services|health services
5163199|NCT02972619|Hypertension|hypertension
5163201|NCT02972606|Peripheral Neuropathy|peripheral neuropathy
5163202|NCT02972606|Chronic Pain|chronic pain
5163203|NCT02972606|Qualitative Research|qualitative research
5163204|NCT02972567|probiotics|probiotics
5163205|NCT02972567|metabolic syndrome|metabolic syndrome
5163206|NCT02972567|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5163207|NCT02972528|DFU|dfu
5163208|NCT02972528|Diabetic Foot Ulcer|diabetic foot ulcer
5163209|NCT02972528|Diabetes|diabetes
5163210|NCT02972528|Platelet Rich Plasma|platelet rich plasma
5163211|NCT02972515|Smoking|smoking
5163212|NCT02972515|Smoking cessation|smoking cessation
5163213|NCT02972515|Multiple behaviors|multiple behaviors
5163214|NCT02972515|mHealth|mhealth
5163215|NCT02972515|Mobile Application|mobile application
5163216|NCT02972502|Metoclopramide (Reglan)|metoclopramide (reglan)
5163217|NCT02972502|Haloperidol (Haldol)|haloperidol (haldol)
5163218|NCT02972476|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5163219|NCT02972463|Gastrointestinal|gastrointestinal
5163220|NCT02972463|Microbiome|microbiome
5163221|NCT02972463|Inflammation|inflammation
5163222|NCT02972437|GAS in oral cavity|gas in oral cavity
5163223|NCT02972424|pelvic fracture|pelvic fracture
5163224|NCT02972424|healing|healing
5163225|NCT02972424|teriparatide|teriparatide
5163226|NCT02972398|treatment resistant depression|treatment resistant depression
5163227|NCT02972398|N-Acetyl Cysteine|n-acetyl cysteine
5163228|NCT02972398|inflammation mediators|inflammation mediators
5163229|NCT02972398|oxidative stress|oxidative stress
5163230|NCT02972398|brain imaging|brain imaging
5163231|NCT02972385|warfarin|warfarin
5050127|NCT03684603|Sleep|sleep
5163232|NCT02972385|blood clotting|blood clotting
5163233|NCT02972372|esophageal cancer|esophageal cancer
5163239|NCT02972359|RSD (reflex sympathetic dystrophy)|rsd (reflex sympathetic dystrophy)
5163240|NCT02972294|iron isomaltoside|iron isomaltoside
5163241|NCT02972294|tranexamic acid|tranexamic acid
5163242|NCT02972203|Mindfulness|mindfulness
5163243|NCT02972203|primary care|primary care
5163244|NCT02972203|self-control|self-control
5163245|NCT02972203|self-regulation|self-regulation
5163246|NCT02972203|adherence|adherence
5163251|NCT02972164|Childhood obesity|childhood obesity
5163252|NCT02972164|Lifestyle|lifestyle
5163253|NCT02972164|Prevention|prevention
5163254|NCT02972164|Intervention|intervention
5163255|NCT02972164|Behavioural psychology|behavioural psychology
5163256|NCT02972138|Sickle-cells Disease|sickle-cells disease
5163257|NCT02972138|bisphosphonates|bisphosphonates
5163258|NCT02972138|Vitamine D|vitamine d
5163260|NCT02972125|Bioequivalence|bioequivalence
5163261|NCT02972125|Dry Syrup|dry syrup
5163262|NCT02972073|Low back pain|low back pain
5163268|NCT02972008|Aortic stenosis|aortic stenosis
5163269|NCT02972008|Transaortic valve replacement|transaortic valve replacement
5163270|NCT02972008|stroke|stroke
5163271|NCT02972008|Epigenetic|epigenetic
5163272|NCT02971969|gene therapy|gene therapy
5163273|NCT02971969|Hemophilia B|hemophilia b
5163274|NCT02971956|Esophageal Cancer|esophageal cancer
5163275|NCT02971917|Chest radiography|chest radiography
5163276|NCT02971917|Image improvements|image improvements
5163277|NCT02971917|Image Reconstruction|image reconstruction
5163278|NCT02971917|Preprocessing|preprocessing
5163280|NCT02971904|newborn|newborn
5163281|NCT02971904|prematurity|prematurity
5163282|NCT02971904|preterm|preterm
5163283|NCT02971904|human milk|human milk
5163284|NCT02971904|human milk analyzer|human milk analyzer
5163285|NCT02971904|neonatology|neonatology
5163286|NCT02971904|neonatal intensive care unit|neonatal intensive care unit
5163287|NCT02971904|low birth weight|low birth weight
5163288|NCT02971865|Cognitive Behavior Therapy|cognitive behavior therapy
5163289|NCT02971865|Chiropractic|chiropractic
5163290|NCT02971865|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5163291|NCT02971865|Primary care shared visit|primary care shared visit
5163292|NCT02971852|Hypnosis|hypnosis
5163293|NCT02971852|Anesthesia|anesthesia
5163294|NCT02971852|Suggestion|suggestion
5163295|NCT02971852|Thermography|thermography
5163296|NCT02971826|Stroke|stroke
5163297|NCT02971826|thrombectomy|thrombectomy
5163298|NCT02971826|REVIVETM SE|revivetm se
5163299|NCT02971826|MRI|mri
5163300|NCT02971826|Computed Tomography|computed tomography
5163301|NCT02971813|cardiac rehabilitation|cardiac rehabilitation
5163302|NCT02971813|social media|social media
5163303|NCT02971813|adherence|adherence
5163304|NCT02971813|motivation|motivation
5163305|NCT02971800|sodium fluorescein|sodium fluorescein
5163306|NCT02971800|ureteral efflux|ureteral efflux
5163307|NCT02971800|laparoscopic hysterectomy|laparoscopic hysterectomy
5163308|NCT02971774|stroke|stroke
5163309|NCT02971774|botulinum toxin injection|botulinum toxin injection
5163310|NCT02971774|daily life|daily life
5163311|NCT02971735|cognitive style|cognitive style
5163312|NCT02971735|e-learning|e-learning
5163313|NCT02971735|mobile technology|mobile technology
5163314|NCT02971735|randomized controlled trial|randomized controlled trial
5163315|NCT02971735|otolaryngology-head and neck surgery|otolaryngology-head and neck surgery
5163316|NCT02971722|GLP-1 receptor agonist|glp-1 receptor agonist
5163317|NCT02971657|Staphylococcus aureus phenotypic characterization|staphylococcus aureus phenotypic characterization
5163318|NCT02971657|Antibiotic resistance|antibiotic resistance
5163319|NCT02971657|Orthopedic device related infections|orthopedic device related infections
5163320|NCT02971657|Phenotypic characterization|phenotypic characterization
5163321|NCT02971631|Dumping syndrome|dumping syndrome
5163322|NCT02971631|Gastrectomy|gastrectomy
5163323|NCT02971631|GLP-1|glp-1
5163324|NCT02971631|Insulin|insulin
5163325|NCT02971618|dapagliflozin,|dapagliflozin,
5163326|NCT02971618|Russia,|russia,
5163327|NCT02971618|retrospective study,|retrospective study,
5163328|NCT02971618|diabetes mellitus type 2|diabetes mellitus type 2
5163329|NCT02971579|ERCP|ercp
5163330|NCT02971579|biliary diseases|biliary diseases
5163331|NCT02971579|Pancreatic diseases|pancreatic diseases
5163332|NCT02971579|outcome|outcome
5163333|NCT02971579|Quality|quality
5163334|NCT02971579|Training|training
5163335|NCT02971566|feeding intolerance|feeding intolerance
5163339|NCT02971540|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5163340|NCT02971540|General Anaesthesia (GA),|general anaesthesia (ga),
5163341|NCT02971540|Numerical Rating Scale (NRS)|numerical rating scale (nrs)
5163342|NCT02971540|Adequacy of Anaesthesia (AoA|adequacy of anaesthesia (aoa
5163343|NCT02971540|Spectral Entropy (SE)|spectral entropy (se)
5163344|NCT02971540|Local Anesthetic (LA)|local anesthetic (la)
5163346|NCT02971488|PWID|pwid
5163347|NCT02971488|Linkage-to-care|linkage-to-care
5445359|NCT01522183|TMA|tma
5163348|NCT02971475|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
5163349|NCT02971475|Endoscopic Retrograde Cholangiopancreatography(ERCP)|endoscopic retrograde cholangiopancreatography(ercp)
5163350|NCT02971475|chronic pancreatitis|chronic pancreatitis
5163351|NCT02971475|pain relief|pain relief
5163352|NCT02971462|stroke|stroke
5163353|NCT02971462|Vertebrobasilar atherosclerosis|vertebrobasilar atherosclerosis
5163354|NCT02971462|remote ischemic conditioning|remote ischemic conditioning
5163355|NCT02971449|Village Healthcare Team|village healthcare team
5163356|NCT02971449|mHealth|mhealth
5163357|NCT02971449|Telemedicine|telemedicine
5163358|NCT02971423|infection|infection
5158751|NCT02999906|PAH|pah
5163360|NCT02971345|Hepatocellular carcinoma|hepatocellular carcinoma
5163361|NCT02971345|main portal vein tumor thrombus|main portal vein tumor thrombus
5163362|NCT02971345|endovascular brachytherapy|endovascular brachytherapy
5163365|NCT02971306|alcoholic hepatitis|alcoholic hepatitis
5163366|NCT02971306|alcoholic liver disease|alcoholic liver disease
5163367|NCT02971306|jaundice|jaundice
5163368|NCT02971306|ascites|ascites
5163369|NCT02971306|regeneration|regeneration
5163370|NCT02971293|AZD8871|azd8871
5163371|NCT02971293|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
5163372|NCT02971293|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
5163373|NCT02971293|inhaled long-acting bronchodilator|inhaled long-acting bronchodilator
5163374|NCT02971293|pharmacokinetics|pharmacokinetics
5163375|NCT02971293|safety|safety
5163376|NCT02971293|tolerability|tolerability
5163377|NCT02971293|efficacy|efficacy
5163378|NCT02971293|Phase IIa|phase iia
5163379|NCT02971293|Muscarinic receptor antagonist β2 adrenoceptor agonist (MABA)|muscarinic receptor antagonist β2 adrenoceptor agonist (maba)
5163380|NCT02971267|heart failure|heart failure
5163381|NCT02971267|cardiomyopathy|cardiomyopathy
5163382|NCT02971267|myocarditis|myocarditis
5163383|NCT02971254|cognitive functions|cognitive functions
5163384|NCT02971254|anaesthesia recovery|anaesthesia recovery
5163385|NCT02971254|sevoflurane|sevoflurane
5163386|NCT02971254|desflurane|desflurane
5163387|NCT02971241|Integeneration|integeneration
5163388|NCT02971241|Mobile technology|mobile technology
5163389|NCT02971241|Chronic disease management|chronic disease management
5163390|NCT02971241|Diabetes self-management|diabetes self-management
5163391|NCT02971228|glucagon|glucagon
5163392|NCT02971228|T1DM|t1dm
5163393|NCT02971228|Bionic Pancreas|bionic pancreas
5163394|NCT02971228|diabetes|diabetes
5163395|NCT02971228|iLet|ilet
5163396|NCT02971228|iPhone|iphone
5163397|NCT02971228|Beta Bionics|beta bionics
5163398|NCT02971228|Anti-hypoglycemia|anti-hypoglycemia
5163399|NCT02971228|Glucagon Analog|glucagon analog
5163400|NCT02971202|o-glcnacylation|o-glcnacylation
5163401|NCT02971202|hexosamine|hexosamine
5163402|NCT02971163|Syncope|syncope
5163403|NCT02971163|Shared Decision-Making|shared decision-making
5163404|NCT02971163|Emergency Medicine|emergency medicine
5163405|NCT02971163|Decision Aid|decision aid
5163411|NCT02971124|Cognitive Performance|cognitive performance
5163412|NCT02971124|Meaningful Play|meaningful play
5163413|NCT02971124|Screening test|screening test
5163414|NCT02971124|Dementia|dementia
5163415|NCT02971085|low-risk prostate cancer|low-risk prostate cancer
5163416|NCT02971085|active surveillance|active surveillance
5163417|NCT02971085|pathologic reclassification|pathologic reclassification
5163418|NCT02971072|address|address
5163419|NCT02971072|atrophic|atrophic
5163420|NCT02971072|base|base
5163421|NCT02971072|clinical|clinical
5163422|NCT02971072|cost|cost
5163423|NCT02971072|data|data
5163424|NCT02971072|disability|disability
5163425|NCT02971072|effectiveness|effectiveness
5163426|NCT02971072|attention|attention
5163427|NCT02971072|biofeedback|biofeedback
5163428|NCT02971072|electrical stimulation|electrical stimulation
5163429|NCT02971072|electromyography|electromyography
5163430|NCT02971072|exercise|exercise
5163431|NCT02971072|exertion|exertion
5163432|NCT02971072|health care service utilization|health care service utilization
5163433|NCT02971072|improved|improved
5163434|NCT02971072|injection of therapeutic agent|injection of therapeutic agent
5163436|NCT02971072|intervention|intervention
5163437|NCT02971072|knowledge|knowledge
5163438|NCT02971072|local anesthetics|local anesthetics
5163439|NCT02971072|measures|measures
5163440|NCT02971072|modeling|modeling
5163442|NCT02971072|motor control|motor control
5163443|NCT02971072|muscle|muscle
5163444|NCT02971072|neuroadaptation|neuroadaptation
5163445|NCT02971072|neurophysiology|neurophysiology
5163446|NCT02971072|novel|novel
5163447|NCT02971072|outcome|outcome
5163448|NCT02971072|outcome measure|outcome measure
5163449|NCT02971072|pain inhibition|pain inhibition
5163450|NCT02971072|patients|patients
5163451|NCT02971072|pattern|pattern
5163452|NCT02971072|programs|programs
5163453|NCT02971072|public health relevance|public health relevance
5163454|NCT02971072|rehabilitation strategy|rehabilitation strategy
5163455|NCT02971072|relating to nervous system|relating to nervous system
5163456|NCT02971072|reporting|reporting
5163457|NCT02971072|research|research
5163458|NCT02971072|rotator cuff|rotator cuff
5163459|NCT02971072|shoulder|shoulder
5163460|NCT02971072|staging|staging
5163461|NCT02971072|strength training|strength training
5163462|NCT02971072|success|success
5163463|NCT02971072|systematic review|systematic review
5163464|NCT02971072|techniques|techniques
5163465|NCT02971072|testing|testing
5163466|NCT02971072|time|time
5163467|NCT02971072|training|training
5163471|NCT02971059|Elderly|elderly
5163472|NCT02971059|Phenylalanine|phenylalanine
5163473|NCT02971059|Healthy|healthy
5163474|NCT02971046|healthy children|healthy children
5163475|NCT02971046|protein|protein
5163476|NCT02971046|glutathione|glutathione
5163477|NCT02971046|protein requirement|protein requirement
5163478|NCT02971033|hepatitis C virus|hepatitis c virus
5163479|NCT02971033|antiviral treatment|antiviral treatment
5163480|NCT02971033|viral entry inhibitor|viral entry inhibitor
5163481|NCT02971033|mathematical modeling|mathematical modeling
5163482|NCT02970994|Linear growth and neurodevelopment outcome|linear growth and neurodevelopment outcome
5163483|NCT02970994|< 34 weeks|< 34 weeks
5163484|NCT02970981|Monoclonal antibody|monoclonal antibody
5163485|NCT02970981|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
5163486|NCT02970981|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
5163487|NCT02970981|Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4)|cytotoxic t lymphocyte-associated antigen 4 (ctla-4)
5163488|NCT02970981|Antigen|antigen
5163489|NCT02970929|Schizophrenia|schizophrenia
5163490|NCT02970916|metastatic colorectal cancer|metastatic colorectal cancer
5163491|NCT02970916|FOLFIRI|folfiri
5163492|NCT02970916|aflibercept|aflibercept
5163493|NCT02970916|oxaliplatin|oxaliplatin
5163494|NCT02970916|ACE polymorphisms|ace polymorphisms
5163495|NCT02970890|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
5163496|NCT02970890|Phototherapy|phototherapy
5163497|NCT02970890|Low-level laser therapy|low-level laser therapy
5163498|NCT02970890|Light-emitting diodes|light-emitting diodes
5163499|NCT02970877|Fecal microbiota transplant|fecal microbiota transplant
5163500|NCT02970877|Intestinal microbiome|intestinal microbiome
5163501|NCT02970877|Oral microbiome|oral microbiome
5163502|NCT02970877|Mucosa associated microbiome|mucosa associated microbiome
5036286|NCT03772210|tDCS|tdcs
5163503|NCT02970877|Appetite|appetite
5163504|NCT02970877|Metabolome|metabolome
5163505|NCT02970877|Depression|depression
5163506|NCT02970877|Anxiety|anxiety
5163507|NCT02970864|Nerve regeneration|nerve regeneration
5163508|NCT02970864|Peripheral nerve injury|peripheral nerve injury
5163509|NCT02970864|Nerve conduits|nerve conduits
5163510|NCT02970864|Sensory nerve transection|sensory nerve transection
5163511|NCT02970851|Endothelin receptor antagonist (ERA)|endothelin receptor antagonist (era)
5163512|NCT02970851|pulmonary artery hypertension (PAH),|pulmonary artery hypertension (pah),
5163513|NCT02970851|18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT)|18f-2-fluoro-2-deoxy-d-glucose (18f-fdg) positron emission tomography/computed tomography (pet/ct)
5163514|NCT02970851|Rubidium-82 (82Rb) PET/CT|rubidium-82 (82rb) pet/ct
5163515|NCT02970838|Formula diet|formula diet
5163516|NCT02970825|exercise medicine|exercise medicine
5163517|NCT02970825|youth|youth
5163518|NCT02970825|adolescents|adolescents
5163519|NCT02970825|students|students
5163520|NCT02970721|bipolar disorder|bipolar disorder
5163521|NCT02970721|adverse outcomes|adverse outcomes
5163522|NCT02970721|readmission|readmission
5163523|NCT02970721|polytherapy|polytherapy
5163524|NCT02970695|insomnia|insomnia
5163525|NCT02970695|older people|older people
5163526|NCT02970695|auriculotherapy|auriculotherapy
5163527|NCT02970669|Heart failure with reduced left ventricular ejection fraction (LVEF)|heart failure with reduced left ventricular ejection fraction (lvef)
5163528|NCT02970669|Cardiac dysfunction|cardiac dysfunction
5163529|NCT02970669|Heart muscle dysfunction|heart muscle dysfunction
5163530|NCT02970669|Left ventricular (LV) dilation|left ventricular (lv) dilation
5163531|NCT02970669|Left ventricular hypertrophy|left ventricular hypertrophy
5163532|NCT02970669|HF|hf
5163533|NCT02970669|AHF|ahf
5163534|NCT02970669|CHF|chf
5163537|NCT02970669|congestive heart failure|congestive heart failure
5163538|NCT02970669|congestive cardiac failure|congestive cardiac failure
5163539|NCT02970669|Heart failure|heart failure
5163540|NCT02970669|HReEF|hreef
5163541|NCT02970669|Physical Activity|physical activity
5163542|NCT02970669|Actigraphy|actigraphy
5163543|NCT02970669|Home sleep test|home sleep test
5163544|NCT02970669|wake|wake
5163545|NCT02970643|Olanzapine|olanzapine
5163546|NCT02970643|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5163547|NCT02970643|Moderate risk|moderate risk
5163548|NCT02970630|prophylaxis|prophylaxis
5163549|NCT02970591|FODMAPS|fodmaps
5163550|NCT02970591|carbohydrates|carbohydrates
5163551|NCT02970591|metabolomics|metabolomics
5163552|NCT02970591|microbiota|microbiota
5163553|NCT02970565|Family Nurture Intervention|family nurture intervention
5163554|NCT02970565|Martha G. Welch MD|martha g. welch md
5163555|NCT02970565|Randomized Control Trial|randomized control trial
5163556|NCT02970565|Pre-school Intervention|pre-school intervention
5163557|NCT02970565|Preschool Intervention|preschool intervention
5163558|NCT02970565|Multiple Family Group Intervention|multiple family group intervention
5163559|NCT02970565|Emotional Connection|emotional connection
5163560|NCT02970565|Co-regulation|co-regulation
5163561|NCT02970552|PreTerm Birth|preterm birth
5163568|NCT02970513|Escherichia coli|escherichia coli
5163569|NCT02970513|Microbiota|microbiota
5163570|NCT02970513|Colorectal cancer|colorectal cancer
5163571|NCT02970513|Psychiatric disorders|psychiatric disorders
5163572|NCT02970513|Personality traits|personality traits
5163573|NCT02970500|Cognitive impairment|cognitive impairment
5163574|NCT02970500|Methylphenidate|methylphenidate
5163575|NCT02970500|Cancer-related cognitive impairment|cancer-related cognitive impairment
5163576|NCT02970500|Mixed method|mixed method
5163577|NCT02970500|Phase II study|phase ii study
5163578|NCT02970500|Breast cancer|breast cancer
5163579|NCT02970487|cataract|cataract
5163580|NCT02970461|personal health record|personal health record
5163581|NCT02970461|gamification|gamification
5163582|NCT02970461|chronic patient care|chronic patient care
5163586|NCT02970435|surgery|surgery
5163587|NCT02970435|video discharge instructions|video discharge instructions
5163588|NCT02970422|Survey|survey
5163589|NCT02970422|Priorities|priorities
5163590|NCT02970422|Activities|activities
5163591|NCT02970422|Participation|participation
5163592|NCT02970357|Evaluation|evaluation
5163593|NCT02970357|Therapeutic education|therapeutic education
5163594|NCT02970357|Type 1 Diabetes|type 1 diabetes
5163595|NCT02970357|Children|children
5163596|NCT02970344|Coping Skills Training|coping skills training
5163597|NCT02970344|Diabetes Education|diabetes education
5163598|NCT02970318|CLL|cll
5163599|NCT02970318|BTK|btk
5163600|NCT02970318|Bruton Tyrosine Kinase|bruton tyrosine kinase
5163601|NCT02970318|acalabrutinib|acalabrutinib
5163602|NCT02970318|ACP-196|acp-196
5163603|NCT02970279|Behavioural activation|behavioural activation
5163604|NCT02970279|Psychotherapy, group|psychotherapy, group
5163605|NCT02970279|Depression|depression
5163606|NCT02970279|Depressive disorder|depressive disorder
5163607|NCT02970266|Leber Congenital Amaurosis|leber congenital amaurosis
5962130|NCT04282785|Drug Monitoring|drug monitoring
5962131|NCT04282785|Antibiotics|antibiotics
5036384|NCT03771547|ERCP|ercp
5163608|NCT02970266|Genetic Decryption|genetic decryption
5163609|NCT02970266|The genotype-phenotype correlations|the genotype-phenotype correlations
5163610|NCT02970266|Ethnicity families|ethnicity families
5163611|NCT02970240|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5163612|NCT02970240|inflammation|inflammation
5163613|NCT02970240|oxidative status|oxidative status
5163614|NCT02970227|heart failure|heart failure
5163615|NCT02970227|cardiomyopathies|cardiomyopathies
5163616|NCT02970227|myocarditis|myocarditis
5163617|NCT02970214|heart failure|heart failure
5163618|NCT02970214|heart disease|heart disease
5163619|NCT02970214|cardiovascular disease|cardiovascular disease
5163620|NCT02970214|metabolic risk|metabolic risk
5163621|NCT02970214|comorbidities|comorbidities
5163622|NCT02970201|eHealth|ehealth
5163623|NCT02970201|mHealth|mhealth
5163624|NCT02970201|Hemodialysis|hemodialysis
5163625|NCT02970201|Adherence|adherence
5163626|NCT02970201|Electronic intervention|electronic intervention
5163627|NCT02970201|ESRD|esrd
5163628|NCT02970201|Nephrology|nephrology
5163629|NCT02970188|time restricted feeding|time restricted feeding
5163630|NCT02970188|endothelial function|endothelial function
5163631|NCT02970188|arterial stiffness|arterial stiffness
5163632|NCT02970188|intermittent fasting|intermittent fasting
5163633|NCT02970175|Terlipressin|terlipressin
5163634|NCT02970162|LEMS|lems
5163635|NCT02970136|Increased Screening Uptake|increased screening uptake
5164831|NCT02961816|Busulfan|busulfan
5163645|NCT02970071|Echocardiography|echocardiography
5163646|NCT02970006|spinal cord stimulation|spinal cord stimulation
5163647|NCT02970006|virtual reality|virtual reality
5163653|NCT02969967|upper extremity|upper extremity
5163654|NCT02969967|orthosis|orthosis
5163655|NCT02969967|SaeboFlex|saeboflex
5163656|NCT02969941|Parkinson Disease|parkinson disease
5163657|NCT02969941|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5163658|NCT02969941|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5163659|NCT02969928|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
5163660|NCT02969928|Clarithromycin|clarithromycin
5163661|NCT02969928|Amoxicillin|amoxicillin
5163662|NCT02969928|Metronidazole|metronidazole
5163667|NCT02969902|Procedural pain|procedural pain
5163668|NCT02969902|Phlebotomy|phlebotomy
5163669|NCT02969902|Distraction|distraction
5163670|NCT02969902|Hand-held computer|hand-held computer
5163671|NCT02969902|Children|children
5163672|NCT02969889|Airtraq|airtraq
5163673|NCT02969889|Intubating laryngeal mask airway|intubating laryngeal mask airway
5163674|NCT02969889|BMI>35|bmi>35
5163675|NCT02969863|bionic pancreas|bionic pancreas
5163676|NCT02969850|vitamin D supplementation|vitamin d supplementation
5163677|NCT02969850|calcium supplementation|calcium supplementation
5163682|NCT02969837|Dexamethasone (E-KRd)|dexamethasone (e-krd)
5163683|NCT02969824|Sport Injury|sport injury
5163684|NCT02969824|Concussion|concussion
5163685|NCT02969824|Active Recovery|active recovery
5163686|NCT02969785|Postural control|postural control
5163687|NCT02969785|Physiotherapy|physiotherapy
5163688|NCT02969785|Sports injuries|sports injuries
5163689|NCT02969785|Low back pain|low back pain
5163690|NCT02969785|training|training
5163691|NCT02969759|Bioenergetics|bioenergetics
5163692|NCT02969759|Protein Metabolism|protein metabolism
5163693|NCT02969759|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
5163694|NCT02969746|activated charcoal, direct oral anticoagulant|activated charcoal, direct oral anticoagulant
5163695|NCT02969733|postoperative analgesia|postoperative analgesia
5163696|NCT02969733|PainMatcher|painmatcher
5163697|NCT02969707|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5163698|NCT02969707|functional MRI|functional mri
5163699|NCT02969707|Fibromyalgia|fibromyalgia
5163700|NCT02969707|Hypnosis|hypnosis
5163701|NCT02969707|Pain Assessment|pain assessment
5163702|NCT02969694|addiction|addiction
5163703|NCT02969694|hypersexuality|hypersexuality
5163704|NCT02969694|psychostimulants|psychostimulants
5163705|NCT02969668|opioid substitution treatment|opioid substitution treatment
5163706|NCT02969668|interferon-free direct acting antivirals|interferon-free direct acting antivirals
5163707|NCT02969668|hepatitis c therapy|hepatitis c therapy
5163709|NCT02969655|Efficacy|efficacy
5163710|NCT02969655|Daprodustat|daprodustat
5163711|NCT02969655|Chronic kidney disease|chronic kidney disease
5163712|NCT02969616|lumbar, fusion, DDD, Trinity Elite|lumbar, fusion, ddd, trinity elite
5163713|NCT02969603|PET/MRI|pet/mri
5163714|NCT02969603|muscular activity|muscular activity
5163715|NCT02969603|11C-acetate|11c-acetate
5163716|NCT02969590|Contraception|contraception
5163717|NCT02969590|Mucus|mucus
5163718|NCT02969590|Cervix|cervix
5163719|NCT02969590|progestin|progestin
5163720|NCT02969590|hormones|hormones
5163721|NCT02969577|Androgen deprivation therapy|androgen deprivation therapy
5163723|NCT02969564|prostate cancer|prostate cancer
5163724|NCT02969564|bone metastases|bone metastases
5163725|NCT02969564|PET/MRI|pet/mri
5163726|NCT02969525|Psoriatic Arthritis|psoriatic arthritis
5962132|NCT04282772|Ectopic Eruption|ectopic eruption
5163728|NCT02969525|Bimekizumab|bimekizumab
5163729|NCT02969512|Patient education|patient education
5163730|NCT02969512|Advanced hip osteoarthritis|advanced hip osteoarthritis
5163731|NCT02969512|Online education|online education
5163732|NCT02969512|Computer-assisted instruction|computer-assisted instruction
5163733|NCT02969512|e-learning|e-learning
5163734|NCT02969512|Older adult|older adult
5163735|NCT02969499|Electroconvulsive Therapy|electroconvulsive therapy
5163736|NCT02969499|Dementia|dementia
5163737|NCT02969473|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5163738|NCT02969473|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5163739|NCT02969473|docetaxel|docetaxel
5163740|NCT02969473|cisplatin|cisplatin
5163741|NCT02969473|5-fluorouracil|5-fluorouracil
5163742|NCT02969447|Retained Placenta|retained placenta
5163743|NCT02969447|Second trimester medical termination|second trimester medical termination
5163744|NCT02969447|Third stage labor|third stage labor
5163745|NCT02969447|Oxytocin|oxytocin
5163747|NCT02969395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5163748|NCT02969395|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5163749|NCT02969395|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
5163750|NCT02969395|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5163751|NCT02969395|Cardiac Implantable Electronic Device (CIED)|cardiac implantable electronic device (cied)
5163752|NCT02969382|Schizophrenia|schizophrenia
5163753|NCT02969369|Parkinson's Disease Psychosis|parkinson's disease psychosis
5163754|NCT02969304|Tecfidera|tecfidera
5163755|NCT02969304|Off-label|off-label
5163756|NCT02969304|Utilization|utilization
5163757|NCT02969278|vulvar cancer|vulvar cancer
5163758|NCT02969278|sentinel node biopsy|sentinel node biopsy
5163759|NCT02969278|inguino-femoral lymphadenectomy|inguino-femoral lymphadenectomy
5163760|NCT02969278|18F FDG- PET/TC|18f fdg- pet/tc
5163761|NCT02969278|guidelines|guidelines
5163762|NCT02969278|preoperative imaging|preoperative imaging
5163763|NCT02969265|Drug therapy|drug therapy
5163764|NCT02969226|mechanical ventilation|mechanical ventilation
5163765|NCT02969226|weaning|weaning
5163766|NCT02969226|critically ill|critically ill
5163767|NCT02969226|spontaneous breathing trial|spontaneous breathing trial
5163768|NCT02969226|screening|screening
5163769|NCT02969226|invasive ventilation|invasive ventilation
5163770|NCT02969226|SBT technique|sbt technique
5159145|NCT02997423|Glioblastoma Multiforme|glioblastoma multiforme
5163771|NCT02969213|Electronic management of epilepsy|electronic management of epilepsy
5163772|NCT02969213|biological etiology|biological etiology
5163773|NCT02969213|Chinese children|chinese children
5163775|NCT02969200|Nephropathy|nephropathy
5163776|NCT02969200|Measured GFR|measured gfr
5163777|NCT02969200|Enzyme replacement therapy|enzyme replacement therapy
5423218|NCT01616641|quality of life|quality of life
5423219|NCT01616628|Incentives|incentives
5163778|NCT02969161|PMTCT (Prevention of Mother-to-Child Transmission)|pmtct (prevention of mother-to-child transmission)
5163779|NCT02969161|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
5163780|NCT02969161|Loss to follow-up (LTF)|loss to follow-up (ltf)
5163781|NCT02969161|Option B+ (B+)|option b+ (b+)
5163782|NCT02969161|ART (antiretroviral therapy)|art (antiretroviral therapy)
5163783|NCT02969148|Laparoscopic|laparoscopic
5163784|NCT02969148|Bursectomy|bursectomy
5163785|NCT02969148|D2 lymphadenectomy|d2 lymphadenectomy
5163786|NCT02969148|Gastric Cancer|gastric cancer
5163787|NCT02969122|gastric cancer|gastric cancer
5163788|NCT02969122|peritoneal cytology|peritoneal cytology
5163789|NCT02969083|UTUC|utuc
5163790|NCT02969083|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
5163791|NCT02969083|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5163792|NCT02969083|Adjuvant chemotherapy|adjuvant chemotherapy
5163793|NCT02969083|Radical nephroureterectomy|radical nephroureterectomy
5163794|NCT02969057|Lipidemic Response|lipidemic response
5163795|NCT02969031|communication|communication
5163796|NCT02969018|plaque psoriasis|plaque psoriasis
5163797|NCT02969005|radiopaque localizer grid|radiopaque localizer grid
5163798|NCT02969005|methylene blue|methylene blue
5163799|NCT02969005|reduce radiation exposure|reduce radiation exposure
5163800|NCT02968979|Cachexia|cachexia
5163801|NCT02968979|Non-Small Cell Lung cancer|non-small cell lung cancer
5163802|NCT02968979|Anorexia|anorexia
5163803|NCT02968979|Malnutrition|malnutrition
5163804|NCT02968940|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
5163805|NCT02968940|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
5163806|NCT02968940|Immunotherapy|immunotherapy
5163807|NCT02968940|Hypofractionated Radiotherapy (HFRT)|hypofractionated radiotherapy (hfrt)
5163808|NCT02968940|Isocitrate dehydrogenase (IDH)|isocitrate dehydrogenase (idh)
5163809|NCT02968940|Glioma|glioma
5163810|NCT02968914|Asthma|asthma
5163811|NCT02968914|Chronic Obstructive pulmonary Disease|chronic obstructive pulmonary disease
5163812|NCT02968914|Pharmacokinetics|pharmacokinetics
5163813|NCT02968914|Healthy volunteers|healthy volunteers
5163814|NCT02968875|endurance training|endurance training
5163815|NCT02968875|BDNF analysis|bdnf analysis
5163816|NCT02968875|cognitive function|cognitive function
5163817|NCT02968875|physiological abilities|physiological abilities
5163819|NCT02968823|Postoperative Pain|postoperative pain
5163820|NCT02968823|Anesthesia|anesthesia
5163821|NCT02968823|Oral Surgery|oral surgery
5163822|NCT02968784|Prostate Cancer|prostate cancer
5163823|NCT02968784|MRgFUS|mrgfus
5163824|NCT02968784|ExAblate|exablate
5163825|NCT02968784|Focused Ultrasound|focused ultrasound
5163826|NCT02968771|Coronary artery disease|coronary artery disease
5163827|NCT02968771|Cardiac perfusion SPECT|cardiac perfusion spect
5163831|NCT02968745|Canadian Occupational Performance Measure|canadian occupational performance measure
5163832|NCT02968706|High Flow Nasal Cannula|high flow nasal cannula
5163833|NCT02968706|Colonoscopy|colonoscopy
5163834|NCT02968706|Obesity|obesity
5163835|NCT02968654|Blood Transfusion|blood transfusion
5163836|NCT02968654|Brain Injury|brain injury
5163837|NCT02968654|Outcome|outcome
5163838|NCT02968654|Hemoglobin|hemoglobin
5163839|NCT02968615|fiber|fiber
5163840|NCT02968615|lean protein|lean protein
5163841|NCT02968615|loss weight|loss weight
5163842|NCT02968589|Tele-rehabilitation|tele-rehabilitation
5163843|NCT02968589|Function|function
5163844|NCT02968589|Quality of life|quality of life
5163845|NCT02968589|Exercise|exercise
5163846|NCT02968589|Occupational Therapy|occupational therapy
5163847|NCT02968589|Physiotherapy|physiotherapy
5163848|NCT02968589|Caregiver burden|caregiver burden
5163849|NCT02968576|healthy volunteers|healthy volunteers
5163850|NCT02968576|pharmacokinetics|pharmacokinetics
5163851|NCT02968537|Alcohol use disorders|alcohol use disorders
5163852|NCT02968537|inhibition|inhibition
5163854|NCT02968537|cortisol|cortisol
5163855|NCT02968537|Training|training
5163856|NCT02968537|clinical outcome measures|clinical outcome measures
5163857|NCT02968498|Blood glucose level|blood glucose level
5163858|NCT02968498|Oral intake|oral intake
5163859|NCT02968498|Lactulose|lactulose
5163860|NCT02968498|Healthy volunteers|healthy volunteers
5163861|NCT02968485|advanced solid tumor|advanced solid tumor
5163862|NCT02968485|Protein Kinase MEK inhibitor (MEKi)|protein kinase mek inhibitor (meki)
5163863|NCT02968485|Safety|safety
5163864|NCT02968485|Pharmacokinetics|pharmacokinetics
5163865|NCT02968472|4s CAR-T19|4s car-t19
5163866|NCT02968472|B cell leukemia|b cell leukemia
5163867|NCT02968472|B-ALL|b-all
5163871|NCT02968446|Valchlor|valchlor
5163872|NCT02968446|Vitamin D|vitamin d
5159237|NCT02996851|Adverse effects|adverse effects
5163875|NCT02968381|tobacco|tobacco
5163876|NCT02968381|smoking|smoking
5163877|NCT02968381|imagery|imagery
5163878|NCT02968342|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
5163879|NCT02968212|Mycobacterium avium Complex|mycobacterium avium complex
5163880|NCT02968212|Clofazimine|clofazimine
5163881|NCT02968186|Mass Screening|mass screening
5163882|NCT02968186|Counseling|counseling
5163883|NCT02968186|Primary Health Care|primary health care
5163884|NCT02968173|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5163885|NCT02968173|RSV hospitalization|rsv hospitalization
5163886|NCT02968173|Palivizumab|palivizumab
5163887|NCT02968173|Immunoprophylaxis|immunoprophylaxis
5163888|NCT02968173|Chronic lung disease (CLD) of prematurity|chronic lung disease (cld) of prematurity
5163889|NCT02968147|atrial fibrillation|atrial fibrillation
5163890|NCT02968147|catheter ablation|catheter ablation
5163891|NCT02968147|general anaesthesia|general anaesthesia
5163892|NCT02968082|MVD|mvd
5163893|NCT02968082|Scopolamine|scopolamine
5163894|NCT02968082|Microvascular Decompression|microvascular decompression
5163895|NCT02968056|atrial fibrillation|atrial fibrillation
5163896|NCT02968056|radiofrequency ablation|radiofrequency ablation
5163897|NCT02968043|physiotherapeutic scoliosis specific exercise|physiotherapeutic scoliosis specific exercise
5163898|NCT02968030|Aged|aged
5163899|NCT02968030|Postural balance|postural balance
5163900|NCT02968030|Muscle strength|muscle strength
5163901|NCT02967991|EUS|eus
5163902|NCT02967991|Biopsy|biopsy
5163903|NCT02967991|Liver|liver
5163904|NCT02967991|FNA|fna
5163905|NCT02967991|FNB|fnb
5163906|NCT02967978|risk factors|risk factors
5163907|NCT02967978|Calcium isotopes|calcium isotopes
5163908|NCT02967978|calcium turnover|calcium turnover
5163909|NCT02967978|DXA|dxa
5163910|NCT02967965|clinical confounders|clinical confounders
5163911|NCT02967965|myocardial infarction size|myocardial infarction size
5163912|NCT02967965|determinants of myocardial infarct injury|determinants of myocardial infarct injury
5163913|NCT02967952|out-of-hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
5163914|NCT02967952|supraglottic airway (SGA)|supraglottic airway (sga)
5163915|NCT02967952|endotracheal intubation (ETI)|endotracheal intubation (eti)
5163916|NCT02967952|emergency medical system (EMS)|emergency medical system (ems)
5163917|NCT02967952|Supraglottic Airway Versus Endotracheal tube (SAVE)|supraglottic airway versus endotracheal tube (save)
5163918|NCT02967926|common bile duct stone|common bile duct stone
5163919|NCT02967926|cholangioscopy|cholangioscopy
5163920|NCT02967926|SpyGlass|spyglass
5163921|NCT02967926|non-fluoroscopic|non-fluoroscopic
5163922|NCT02967913|Cesarean delivery|cesarean delivery
5962133|NCT04282772|Eruption Failure|eruption failure
5036701|NCT03769636|Quality of life|quality of life
5163923|NCT02967913|Obstetrical delivery|obstetrical delivery
5163924|NCT02967913|PFDI-20|pfdi-20
5163925|NCT02967913|UDI-6|udi-6
5163926|NCT02967913|Bladder flap|bladder flap
5164025|NCT02967198|Percutaneous biopsy|percutaneous biopsy
5163928|NCT02967874|Knee Osteoarthritis|knee osteoarthritis
5163929|NCT02967874|Intra-articular Administration|intra-articular administration
5163930|NCT02967874|Liposuction|liposuction
5163931|NCT02967861|chronic periodontitis|chronic periodontitis
5163932|NCT02967861|Nuclear factor-kappa B|nuclear factor-kappa b
5163933|NCT02967861|Pranayama|pranayama
5163934|NCT02967861|Peroxisome proliferator - activated receptor gamma|peroxisome proliferator - activated receptor gamma
5163935|NCT02967861|Red complex microorganisms|red complex microorganisms
5163936|NCT02967848|Radiotherapy|radiotherapy
5163937|NCT02967848|Mebrofenin|mebrofenin
5163938|NCT02967848|Liver|liver
5163939|NCT02967848|Cancer|cancer
5163940|NCT02967848|SPECT|spect
5163941|NCT02967770|Metastatic|metastatic
5163942|NCT02967770|Pancreas|pancreas
5163943|NCT02967770|Cancer|cancer
5163944|NCT02967705|Pain Management|pain management
5163945|NCT02967705|Chronic Pain|chronic pain
5163946|NCT02967705|Health Services|health services
5163947|NCT02967705|Occupational Health|occupational health
5163948|NCT02967692|Spartalizumab (PDR001)|spartalizumab (pdr001)
5163949|NCT02967692|dabrafenib|dabrafenib
5163950|NCT02967692|trametinib|trametinib
5163951|NCT02967692|melanoma|melanoma
5163952|NCT02967692|immunotherapy|immunotherapy
5163953|NCT02967692|PD 1 inhibitor|pd 1 inhibitor
5163954|NCT02967692|anti PD1|anti pd1
5163955|NCT02967692|PD-1|pd-1
5050970|NCT03679949|THC|thc
5163956|NCT02967692|anti-PD-1|anti-pd-1
5163957|NCT02967692|combination treatment|combination treatment
5163958|NCT02967692|malignant skin cancer|malignant skin cancer
5163959|NCT02967692|skin cancer|skin cancer
5163960|NCT02967692|BRAF V600|braf v600
5163961|NCT02967692|unresectable BRAF V600 mutated melanoma|unresectable braf v600 mutated melanoma
5163962|NCT02967692|metastatic BRAF V600 mutated melanoma|metastatic braf v600 mutated melanoma
5163963|NCT02967679|Neuropathy|neuropathy
5163964|NCT02967679|Demyelinating polyradiculoneuropathy|demyelinating polyradiculoneuropathy
5163965|NCT02967640|Ketamine|ketamine
5163966|NCT02967640|Analgesics|analgesics
5163967|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
5163968|NCT02967640|Receptors, Glutamate|receptors, glutamate
5163970|NCT02967601|shivering, cesarean section, anxiety, STAI|shivering, cesarean section, anxiety, stai
5163971|NCT02967588|Medication adherence|medication adherence
5163972|NCT02967588|Behavioural intervention|behavioural intervention
5163973|NCT02967588|Acute coronary syndrome|acute coronary syndrome
5163974|NCT02967588|Medication beliefs|medication beliefs
5163975|NCT02967588|Implementation intentions|implementation intentions
5163976|NCT02967575|cervical total disc replacement (cTDR)|cervical total disc replacement (ctdr)
5163977|NCT02967536|cognitive function|cognitive function
5163978|NCT02967536|microglia|microglia
5163979|NCT02967536|neuroinflammation|neuroinflammation
5163980|NCT02967523|Hepatocellular carcinoma|hepatocellular carcinoma
5163981|NCT02967523|DEB-TACE|deb-tace
5163982|NCT02967497|Chemotherapy|chemotherapy
5163983|NCT02967497|Herbal medicine|herbal medicine
5163984|NCT02967497|Lung cancer|lung cancer
5163985|NCT02967484|Acupuncture|acupuncture
5163986|NCT02967484|Hypertension|hypertension
5163987|NCT02967484|Second prevention of Stroke|second prevention of stroke
5163988|NCT02967484|Efficacy|efficacy
5163990|NCT02967484|Study protocol|study protocol
5163991|NCT02967471|ARDS|ards
5163992|NCT02967458|prostate cancer|prostate cancer
5163993|NCT02967458|prostate ultrasound|prostate ultrasound
5163994|NCT02967458|subharmonic imaging|subharmonic imaging
5163995|NCT02967458|prostate biopsy|prostate biopsy
5163996|NCT02967432|Staphylococcus aureus|staphylococcus aureus
5163997|NCT02967432|Staphylococcal colonization|staphylococcal colonization
5163998|NCT02967432|Staphylococcal infection|staphylococcal infection
5163999|NCT02967432|Mupirocin|mupirocin
5164000|NCT02967432|Mupirocin-resistance|mupirocin-resistance
5164001|NCT02967419|Repeated Implantation Failure; TWEAK;Fn14;JAK/STAT3;Indoleamine 2,3-dioxygenase|repeated implantation failure; tweak;fn14;jak/stat3;indoleamine 2,3-dioxygenase
5164002|NCT02967406|Lifestyle modification|lifestyle modification
5164003|NCT02967406|Primary prevention|primary prevention
5164004|NCT02967406|Community-based intervention|community-based intervention
5164005|NCT02967406|Randomized control trial|randomized control trial
5164006|NCT02967328|Reticulated Platelets|reticulated platelets
5164007|NCT02967328|Immune Thrombocytopenia|immune thrombocytopenia
5164009|NCT02967289|colon|colon
5164010|NCT02967289|cancer|cancer
5164011|NCT02967289|stage 3|stage 3
5164012|NCT02967289|high-risk|high-risk
5164013|NCT02967289|mFolfirinox|mfolfirinox
5164014|NCT02967289|mFolfox6|mfolfox6
5164015|NCT02967289|adjuvant|adjuvant
5164016|NCT02967276|Metformin|metformin
5164017|NCT02967276|Dexamethasone|dexamethasone
5164018|NCT02967276|Multiple Myeloma|multiple myeloma
5164019|NCT02967263|Acute Kidney Injury|acute kidney injury
5962134|NCT04282772|Impacted Teeth|impacted teeth
5164020|NCT02967263|Proteinosis|proteinosis
5164021|NCT02967263|Epidemiology|epidemiology
5164022|NCT02967263|Risk factors|risk factors
5164023|NCT02967198|Fusion|fusion
5164030|NCT02967107|colorectal cancer|colorectal cancer
5164031|NCT02967107|polypectomy|polypectomy
5164032|NCT02967107|colonoscopy|colonoscopy
5164033|NCT02967081|Pulpitis|pulpitis
5164034|NCT02967081|Biomarker|biomarker
5164035|NCT02967081|Diagnostic|diagnostic
5164036|NCT02967081|Dentinal fluid|dentinal fluid
5164037|NCT02967068|CSS|css
5164038|NCT02967068|EGPA|egpa
5164039|NCT02967068|GCA|gca
5164040|NCT02967068|GPA|gpa
5164041|NCT02967068|MPA|mpa
5164042|NCT02967068|PAN|pan
5164043|NCT02967068|TAK|tak
5164044|NCT02967068|HSP|hsp
5164045|NCT02966951|osteoarthrosis|osteoarthrosis
5164046|NCT02966951|knee|knee
5164047|NCT02966951|adipose tissue|adipose tissue
5164048|NCT02966951|stem cells|stem cells
5164049|NCT02966951|cell therapy|cell therapy
5164050|NCT02966925|Vulvovaginal dryness|vulvovaginal dryness
5164051|NCT02966886|Surgical Management|surgical management
5164052|NCT02966873|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5164053|NCT02966873|Addiction|addiction
5164054|NCT02966873|Alcohol Use Disorder|alcohol use disorder
5164055|NCT02966873|Cognitive Behavioral Therapy|cognitive behavioral therapy
5164056|NCT02966873|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
5164057|NCT02966847|Video assisted thoracoscopy|video assisted thoracoscopy
5164058|NCT02966847|Cone beam computed tomography|cone beam computed tomography
5164065|NCT02966821|Surufatinib|surufatinib
5164066|NCT02966821|Biliary Tract Cancer|biliary tract cancer
5164067|NCT02966821|Second-line|second-line
5164068|NCT02966795|glecaprevir|glecaprevir
5164069|NCT02966795|pibrentasvir|pibrentasvir
5164070|NCT02966795|compensated cirrhosis|compensated cirrhosis
5164071|NCT02966795|non-cirrhotic|non-cirrhotic
5164072|NCT02966795|interferon (IFN)|interferon (ifn)
5164073|NCT02966795|pegylated interferon (pegIFN)|pegylated interferon (pegifn)
5164074|NCT02966795|ribavirin (RBV)|ribavirin (rbv)
5164075|NCT02966795|sofosbuvir (SOF)|sofosbuvir (sof)
5164076|NCT02966795|Sustained Virologic Response 12 weeks post dosing (SVR12)|sustained virologic response 12 weeks post dosing (svr12)
5164077|NCT02966795|Chronic|chronic
5164078|NCT02966795|Genotype 5 or 6 Infection|genotype 5 or 6 infection
5164088|NCT02966730|follicular lymphoma|follicular lymphoma
5164090|NCT02966730|FLIPP|flipp
5164091|NCT02966730|16-396|16-396
5164092|NCT02966717|Rituximab|rituximab
5164093|NCT02966717|Mesenchymal stem cells|mesenchymal stem cells
5164094|NCT02966717|primary nephrotic syndrome|primary nephrotic syndrome
5164095|NCT02966717|chronic kidney disease|chronic kidney disease
5164096|NCT02966678|Glaucoma, Dychromatopsia|glaucoma, dychromatopsia
5164098|NCT02966652|Hypogonadism|hypogonadism
5164099|NCT02966652|Primary|primary
5164100|NCT02966652|Secondary|secondary
5164101|NCT02966652|Androgen deficiency|androgen deficiency
5164102|NCT02966626|Pragmatic, Sodium-Glucose Transporter 2 inhibitor, Malaysia|pragmatic, sodium-glucose transporter 2 inhibitor, malaysia
5164103|NCT02966574|Whole body MRI|whole body mri
5164104|NCT02966574|Breastcancer|breastcancer
5164105|NCT02966561|Pulmonary Rehabilitation|pulmonary rehabilitation
5164106|NCT02966561|Physical Activity|physical activity
5164107|NCT02966561|Behaviour Change|behaviour change
5164108|NCT02966561|Pedometer|pedometer
5164109|NCT02966522|Thalidoide|thalidoide
5164110|NCT02966483|Rectal cancer|rectal cancer
5164111|NCT02966483|Laparoscopic surgery|laparoscopic surgery
5164112|NCT02966483|Total mesorectal excision|total mesorectal excision
5164113|NCT02966483|Transanal|transanal
5164114|NCT02966483|Multicentre randomised clinical trial|multicentre randomised clinical trial
5164115|NCT02966470|surgical outcomes|surgical outcomes
5164116|NCT02966457|hematological infection, decolonization|hematological infection, decolonization
5164117|NCT02966418|Hypoxic preconditioning|hypoxic preconditioning
5164118|NCT02966418|Carotid artery stenosis|carotid artery stenosis
5164119|NCT02966418|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
5164120|NCT02966392|Cuff pressure|cuff pressure
5164121|NCT02966392|Ventilator associated pneumonia|ventilator associated pneumonia
5164122|NCT02966392|Respiratory tract infections|respiratory tract infections
5164123|NCT02966379|Electroacoustic stimulation|electroacoustic stimulation
5164124|NCT02966353|Ruxolitinib|ruxolitinib
5164126|NCT02966353|Primary Myelofibrosis|primary myelofibrosis
5164127|NCT02966353|PMF|pmf
5164128|NCT02966353|Post-Polycythemia Vera-Myelofibrosis|post-polycythemia vera-myelofibrosis
5164129|NCT02966353|PPV-MF|ppv-mf
5164130|NCT02966353|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5164131|NCT02966353|PET-MF|pet-mf
5164132|NCT02966340|Alcoholism|alcoholism
5164133|NCT02966340|Prazosin|prazosin
5164134|NCT02966340|Startle Potentiation|startle potentiation
5164135|NCT02966340|Norepinephrine|norepinephrine
5164136|NCT02966340|Anxiety|anxiety
5164137|NCT02966340|Fear|fear
5164138|NCT02966340|Stress|stress
5164139|NCT02966314|Angioedema|angioedema
5164140|NCT02966314|Idiopathic Angioedema|idiopathic angioedema
5164141|NCT02966314|IAE|iae
5164142|NCT02966301|c GvHD|c gvhd
5164143|NCT02966301|Arsenic Trioxyde|arsenic trioxyde
5164144|NCT02966301|Hematology|hematology
5164145|NCT02966275|glucagon|glucagon
5164146|NCT02966275|continuous glucose monitorering (CGM)|continuous glucose monitorering (cgm)
5164147|NCT02966275|artificial pancreas|artificial pancreas
5164148|NCT02966275|hypoglycemia|hypoglycemia
5164149|NCT02966275|post-bariatric hypoglycemia|post-bariatric hypoglycemia
5164150|NCT02966275|bionic pancreas|bionic pancreas
5164151|NCT02966275|bariatric surgery|bariatric surgery
5164155|NCT02966158|Aerobic Interval Training|aerobic interval training
5164156|NCT02966158|Fitness|fitness
5164157|NCT02966158|Endothelial Function|endothelial function
5164158|NCT02966158|Cognition|cognition
5164159|NCT02966145|CBD|cbd
5164160|NCT02966145|CBS|cbs
5164161|NCT02966145|CBGD|cbgd
5164162|NCT02966145|PSP|psp
5164163|NCT02966145|nfvPPA|nfvppa
5164164|NCT02966145|oPSP|opsp
5164165|NCT02966145|vPSP|vpsp
5164166|NCT02966145|o/vPSP|o/vpsp
5164167|NCT02966145|Corticobasal Degeneration|corticobasal degeneration
5164168|NCT02966145|Corticobasal Syndrome|corticobasal syndrome
5164169|NCT02966145|Cortocal-basal Ganglionic Degeneration|cortocal-basal ganglionic degeneration
5164170|NCT02966145|Progressive Supranuclear Palsy|progressive supranuclear palsy
5164175|NCT02966145|Neuroimaging|neuroimaging
5164176|NCT02966145|MRI|mri
5164177|NCT02966145|PET|pet
5164178|NCT02966145|Tau|tau
5164179|NCT02966145|Oculomotor|oculomotor
5164180|NCT02966145|Retinal Imaging|retinal imaging
5164181|NCT02966132|Asian American|asian american
5164182|NCT02966132|Immigrant Health|immigrant health
5164183|NCT02966132|Digital Health Intervention|digital health intervention
5164184|NCT02966132|Federally Qualified Health Centers|federally qualified health centers
5164185|NCT02966119|stroke|stroke
5164186|NCT02966119|intracranial hemorrhage|intracranial hemorrhage
5164187|NCT02966119|intracerebral hemorrhage|intracerebral hemorrhage
5164188|NCT02966119|antithrombotic drugs|antithrombotic drugs
5164189|NCT02966119|brain microbleeds|brain microbleeds
5164195|NCT02966080|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5164196|NCT02966080|intravenous heparin|intravenous heparin
5164197|NCT02966067|Microneedles|microneedles
5164198|NCT02966067|Dental Anaesthesia|dental anaesthesia
5164199|NCT02966041|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5164200|NCT02966041|PONV|ponv
5164201|NCT02966041|CSICU|csicu
5164202|NCT02966041|post-cardiac surgery|post-cardiac surgery
5164203|NCT02966041|cardiac intensive care unit|cardiac intensive care unit
5164204|NCT02966028|CAC|cac
5164205|NCT02966028|calcium|calcium
5164206|NCT02966028|ESRD|esrd
5164207|NCT02966028|calcification|calcification
5164208|NCT02966028|cardiovascular|cardiovascular
5164209|NCT02966028|heart|heart
5164210|NCT02966028|kidney|kidney
5164211|NCT02966028|hemodialysis|hemodialysis
5164212|NCT02966028|Agatston|agatston
5164213|NCT02965989|nursery care|nursery care
5164214|NCT02965989|nursery infection|nursery infection
5164215|NCT02965989|online learning|online learning
5164216|NCT02965950|breast cancer|breast cancer
5164217|NCT02965950|TP53|tp53
5164218|NCT02965950|cyclophosphamide|cyclophosphamide
5164219|NCT02965937|Attentively embracing story|attentively embracing story
5164220|NCT02965937|story-centred care|story-centred care
5164221|NCT02965937|heart rate variability|heart rate variability
5164222|NCT02965937|cognitive function|cognitive function
5164223|NCT02965911|UDCA, Fenofibrate|udca, fenofibrate
5164224|NCT02965898|chronic pancreatitis|chronic pancreatitis
5164225|NCT02965898|vitamin d|vitamin d
5164226|NCT02965898|pancreatitis|pancreatitis
5164227|NCT02965898|Pancreatic stellate cell|pancreatic stellate cell
5164228|NCT02965898|rct|rct
5164229|NCT02965885|Phase I|phase i
5164230|NCT02965885|Solid Tumors|solid tumors
5164231|NCT02965885|Pharmacokinetics|pharmacokinetics
5164232|NCT02965885|Pharmacodynamics|pharmacodynamics
5164233|NCT02965885|MTD|mtd
5164234|NCT02965885|TAS116|tas116
5164235|NCT02965885|HSP90 Inhibitor|hsp90 inhibitor
5164236|NCT02965885|Neoplasms|neoplasms
5164237|NCT02965885|HER2 positive MBC|her2 positive mbc
5164238|NCT02965885|NSCLC EGFR|nsclc egfr
5164239|NCT02965885|NSCLC ALK positive|nsclc alk positive
5164240|NCT02965872|Postural Balance|postural balance
5164241|NCT02965859|Chronic Hepatitis B|chronic hepatitis b
5164242|NCT02965846|EDE|ede
5164243|NCT02965846|evaporative dry eye|evaporative dry eye
5164244|NCT02965833|Contact lens induced dryness|contact lens induced dryness
5164245|NCT02965820|Contact lens induced dryness|contact lens induced dryness
5164246|NCT02965807|Bronchial Thermoplasty|bronchial thermoplasty
5164247|NCT02965807|moderate asthma|moderate asthma
5164248|NCT02965807|China|china
5164249|NCT02965794|surgery|surgery
5164250|NCT02965794|bowel|bowel
5164251|NCT02965794|rectum|rectum
5164252|NCT02965794|cancer|cancer
5164253|NCT02965794|nutrition|nutrition
5164254|NCT02965755|Metastatic Breast Cancer|metastatic breast cancer
5164255|NCT02965755|Breast Cancer|breast cancer
5164256|NCT02965755|Molecular profiling|molecular profiling
5164257|NCT02965755|Personalized medicine|personalized medicine
5164259|NCT02965742|DMS|dms
5164260|NCT02965742|DMS Imaging|dms imaging
5164261|NCT02965742|STRATOS|stratos
5164262|NCT02965742|Horizon A|horizon a
5164263|NCT02965742|QDR4500A|qdr4500a
5164264|NCT02965729|behavior goals|behavior goals
5164265|NCT02965729|self-monitoring|self-monitoring
5164266|NCT02965729|pedometer|pedometer
5164267|NCT02965729|physical activity|physical activity
5164268|NCT02965690|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5164269|NCT02965690|TKR|tkr
5164270|NCT02965690|Knee kinematics|knee kinematics
5164271|NCT02965690|Dynamic RSA|dynamic rsa
5164272|NCT02965690|Fluoroscopy|fluoroscopy
5159644|NCT02993744|corticosteroids|corticosteroids
5164273|NCT02965690|Roentgen Fluoroscopic Stereophotogrammetric Analysis|roentgen fluoroscopic stereophotogrammetric analysis
5051245|NCT03677947|insight|insight
5164274|NCT02965677|drug eluting balloon|drug eluting balloon
5164275|NCT02965677|Femoral Popliteal Artery|femoral popliteal artery
5164276|NCT02965651|embodied conversational agent|embodied conversational agent
5164277|NCT02965651|virtual patient agent|virtual patient agent
5238362|NCT02512575|AZD9567|azd9567
5164279|NCT02965651|mindfulness based stress reduction|mindfulness based stress reduction
5164280|NCT02965651|nutrition|nutrition
5164281|NCT02965638|LHH|lhh
5164282|NCT02965612|Grass Allergy|grass allergy
5164283|NCT02965612|Allergic Rhinitis|allergic rhinitis
5164284|NCT02965612|Allergic Asthma|allergic asthma
5164285|NCT02965612|Paediatric|paediatric
5164286|NCT02965599|pharmacodynamics|pharmacodynamics
5164287|NCT02965599|tolerability|tolerability
5164288|NCT02965599|GSK3117391|gsk3117391
5164289|NCT02965599|safety|safety
5164290|NCT02965599|efficacy|efficacy
5164291|NCT02965599|rheumatoid arthritis|rheumatoid arthritis
5164292|NCT02965599|pharmacokinetics|pharmacokinetics
5164293|NCT02965547|Ischemic Preconditioning|ischemic preconditioning
5164294|NCT02965547|dynamic cerebral autoregulation|dynamic cerebral autoregulation
5164295|NCT02965534|night vision|night vision
5164296|NCT02965534|mesopic visual acuity|mesopic visual acuity
5164297|NCT02965534|aberrometry|aberrometry
5164298|NCT02965534|mesopic spectacle correction|mesopic spectacle correction
5164299|NCT02965534|night myopia|night myopia
5164300|NCT02965508|Home-bound|home-bound
5164301|NCT02965508|home-based primary care|home-based primary care
5164302|NCT02965495|Osteoarthritis|osteoarthritis
5164303|NCT02965482|methacholine, airway hyperresponsiveness|methacholine, airway hyperresponsiveness
5164304|NCT02965417|Resistance to anti-EGFR monoclonal antibodies|resistance to anti-egfr monoclonal antibodies
5164305|NCT02965417|Mutation of ECD-EGFR|mutation of ecd-egfr
5164306|NCT02965404|live attenuated varicella vaccine|live attenuated varicella vaccine
5164307|NCT02965404|safety|safety
5164308|NCT02965404|adult|adult
5164309|NCT02965404|adolescent|adolescent
5164310|NCT02965404|child|child
5164311|NCT02965391|Circulating Tumor DNA|circulating tumor dna
5164312|NCT02965391|Half time|half time
5164313|NCT02965391|Lung cancer|lung cancer
5164314|NCT02965391|Surgery|surgery
5164315|NCT02965391|Surveillance|surveillance
5164316|NCT02965339|Vasoplegia|vasoplegia
5164317|NCT02965339|endothelial dysfunction|endothelial dysfunction
5164318|NCT02965339|extracorporeal circulation|extracorporeal circulation
5164319|NCT02965339|cardiac surgery|cardiac surgery
5164320|NCT02965300|Pulmonary lesion|pulmonary lesion
5164321|NCT02965300|Volatile Organic Compositions(VOCs)|volatile organic compositions(vocs)
5164322|NCT02965248|Locally advanced colorectal cancer|locally advanced colorectal cancer
5164323|NCT02965248|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5164324|NCT02965222|blastocyst|blastocyst
5164325|NCT02965222|pregnancy rate|pregnancy rate
5164326|NCT02965209|endoscopy|endoscopy
5164327|NCT02965209|small bowel endoscopy|small bowel endoscopy
5164328|NCT02965209|motorized spiral endoscopy|motorized spiral endoscopy
5164329|NCT02965209|spiral endoscopy|spiral endoscopy
5164330|NCT02965144|long-term survivors, high-grade glioma|long-term survivors, high-grade glioma
5164331|NCT02965079|extracorporeal CO2 removal|extracorporeal co2 removal
5164332|NCT02965079|registry|registry
5164333|NCT02965079|COPD and ARDS|copd and ards
5164334|NCT02965079|CEDIT on behalf of APHP|cedit on behalf of aphp
5164335|NCT02965040|ASP1517|asp1517
5164336|NCT02965040|Normal renal function|normal renal function
5164337|NCT02965040|Dialysis|dialysis
5164338|NCT02965040|Roxadustat|roxadustat
5164339|NCT02965040|Metabolites|metabolites
5164340|NCT02965040|Pharmacokinetics|pharmacokinetics
5164341|NCT02965040|Impaired renal function|impaired renal function
5164342|NCT02965027|Chronic Headache|chronic headache
5164343|NCT02965027|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5164344|NCT02965027|Iraq/Afghanistan Veteran|iraq/afghanistan veteran
5164345|NCT02965014|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5164346|NCT02965014|Sexually transmitted infections (STI)|sexually transmitted infections (sti)
5164347|NCT02965014|mHealth|mhealth
5164348|NCT02965014|Substance abuse|substance abuse
5164349|NCT02965014|Violence|violence
5164350|NCT02965014|Victimization|victimization
5164351|NCT02965014|Sexual Risk|sexual risk
5164352|NCT02965001|Molecular Imaging|molecular imaging
5164353|NCT02965001|uPAR-PET/CT|upar-pet/ct
5164354|NCT02965001|Head and neck cancer|head and neck cancer
5164355|NCT02965001|curative intended radiotherapy|curative intended radiotherapy
5164356|NCT02964949|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
5164357|NCT02964949|High Creatinine Clearance|high creatinine clearance
5164358|NCT02964949|Developmental Phase III|developmental phase iii
5164359|NCT02964949|Anticoagulant Naïve|anticoagulant naïve
5164360|NCT02964936|Anemia|anemia
5164361|NCT02964936|Non-dialysis chronic kidney disease|non-dialysis chronic kidney disease
5164362|NCT02964936|Roxadustat|roxadustat
5164363|NCT02964936|ASP1517|asp1517
5164364|NCT02964923|Genetic polymorphism|genetic polymorphism
5159746|NCT02993029|99Tc-MDP|99tc-mdp
5051348|NCT03677258|anti-age therapy|anti-age therapy
5164368|NCT02964923|Cannabinoid Receptor Type 1|cannabinoid receptor type 1
5164370|NCT02964897|justice involvement|justice involvement
5903595|NCT00342433|Serum|serum
5903596|NCT00342433|Tissue|tissue
5164371|NCT02964897|Homeless|homeless
5164372|NCT02964897|Vulnerable Populations|vulnerable populations
5164373|NCT02964897|Linkage to care|linkage to care
5164374|NCT02964897|Veterans|veterans
5164375|NCT02964884|Neurofibromatosis Type 1|neurofibromatosis type 1
5164376|NCT02964884|Learning Disability|learning disability
5164377|NCT02964884|Reading Disability|reading disability
5164378|NCT02964884|NF1|nf1
5164379|NCT02964871|Long-term care facility|long-term care facility
5164380|NCT02964871|Elderly|elderly
5164381|NCT02964858|Radiation Dose|radiation dose
5164382|NCT02964858|Optimization|optimization
5164383|NCT02964858|NHL|nhl
5164384|NCT02964858|DLBCL|dlbcl
5164385|NCT02964858|R-CHOP|r-chop
5164386|NCT02964832|Basic Cardiac Life Support, Education, Feedback|basic cardiac life support, education, feedback
5164387|NCT02964793|Fetal Growth Restriction|fetal growth restriction
5164388|NCT02964793|Customised Fetal Weight Reference|customised fetal weight reference
5164389|NCT02964793|Estimated fetal Weight|estimated fetal weight
5164390|NCT02964793|Symphysis Fundal Height|symphysis fundal height
5164392|NCT02964767|HIV-Tb co infection|hiv-tb co infection
5164393|NCT02964767|CD4 Cell|cd4 cell
5164394|NCT02964741|Episodic Migraine|episodic migraine
5164395|NCT02964741|Headache|headache
5164396|NCT02964741|Opioid|opioid
5164397|NCT02964689|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5164398|NCT02964689|KRAS mutations|kras mutations
5164399|NCT02964689|Binimetinib|binimetinib
5164400|NCT02964689|Pemetrexed|pemetrexed
5164401|NCT02964689|Cisplatin|cisplatin
5164402|NCT02964689|Phase IB trial|phase ib trial
5164403|NCT02964624|Osteoarthritis|osteoarthritis
5164404|NCT02964624|biomarkers|biomarkers
5164405|NCT02964624|HMGB1|hmgb1
5164406|NCT02964624|knee|knee
5164407|NCT02964598|Adolescent|adolescent
5164408|NCT02964598|Population-based|population-based
5164409|NCT02964598|Social jetlag|social jetlag
5164410|NCT02964598|Intervention|intervention
5164411|NCT02964598|Bright light|bright light
5164412|NCT02964598|Motivation|motivation
5164413|NCT02964598|Circadian regulation|circadian regulation
5164414|NCT02964598|Behavioral change|behavioral change
5164415|NCT02964585|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5164416|NCT02964585|Endothelial Cells|endothelial cells
5164417|NCT02964585|Cellular Biomarker|cellular biomarker
5164418|NCT02964585|Endothelial Dysfunction|endothelial dysfunction
5164419|NCT02964585|CD34+|cd34+
5164420|NCT02964585|Impaired renal function|impaired renal function
5164421|NCT02964546|direct oral anticoagulants|direct oral anticoagulants
5164422|NCT02964546|atrial fibrillation|atrial fibrillation
5164423|NCT02964546|renal function|renal function
5164424|NCT02964546|ckd-epi|ckd-epi
5164425|NCT02964546|plasmatic concentration|plasmatic concentration
5164426|NCT02964520|trait anxiety|trait anxiety
5164434|NCT02964481|genetics|genetics
5164435|NCT02964481|RYR1|ryr1
5164436|NCT02964481|CAC-NA1S|cac-na1s
5164437|NCT02964481|hyperthermia|hyperthermia
5164438|NCT02964468|Rectal Cancer|rectal cancer
5164439|NCT02964468|IMRT|imrt
5164440|NCT02964468|Radiation Dose Escalation|radiation dose escalation
5164441|NCT02964455|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5164442|NCT02964455|Chemoradiotherapy|chemoradiotherapy
5164443|NCT02964455|Docetaxel|docetaxel
5164444|NCT02964455|Nedaplatin|nedaplatin
5164445|NCT02964455|Twice weekly|twice weekly
5164446|NCT02964416|supratentorial craniotomy|supratentorial craniotomy
5164447|NCT02964416|extubation response|extubation response
5164448|NCT02964416|emergence|emergence
5164449|NCT02964416|tramadol|tramadol
5164450|NCT02964403|COX-2|cox-2
5164451|NCT02964403|ERCP|ercp
5164452|NCT02964403|Pancreatitis|pancreatitis
5164453|NCT02964390|CTEPH|cteph
5164454|NCT02964390|balloon pulmonary angioplasty|balloon pulmonary angioplasty
5164455|NCT02964377|Pediatric|pediatric
5164456|NCT02964377|muscle disease|muscle disease
5164457|NCT02964377|Duchenne muscular dystrophy|duchenne muscular dystrophy
5164458|NCT02964377|cardiomyopathy|cardiomyopathy
5164459|NCT02964364|TAKAYASU ARTERITIS|takayasu arteritis
5164460|NCT02964351|MicroRNA|microrna
5164461|NCT02964351|Prostate Carcinoma|prostate carcinoma
5164462|NCT02964351|PET-MR|pet-mr
5962135|NCT04282733|Mindfulness|mindfulness
5037252|NCT03766347|NMOSD|nmosd
5164463|NCT02964325|hypoproliferative thrombocytopenia|hypoproliferative thrombocytopenia
5164464|NCT02964325|hematologic malignancies|hematologic malignancies
5164465|NCT02964325|thrombocytopenia|thrombocytopenia
5164466|NCT02964325|platelet therapy|platelet therapy
5164467|NCT02964325|apheresis|apheresis
5159847|NCT02992275|Hip|hip
5164469|NCT02964312|nasal valve collapse|nasal valve collapse
5164470|NCT02964312|absorbable nasal implant|absorbable nasal implant
5164471|NCT02964299|Gastrointestinal endoscopy|gastrointestinal endoscopy
5164472|NCT02964299|Moderate sedation|moderate sedation
5164473|NCT02964299|Airway management|airway management
5164474|NCT02964286|Cancer|cancer
5164475|NCT02964286|Acupressure|acupressure
5164476|NCT02964286|Hematopoietic Cell Growth Factors|hematopoietic cell growth factors
5164477|NCT02964273|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5164478|NCT02964273|ADPKD|adpkd
5164479|NCT02964273|Tolvaptan|tolvaptan
5164480|NCT02964273|Renal cysts|renal cysts
5164481|NCT02964273|Chronic Kidney Disease|chronic kidney disease
5164482|NCT02964273|Genetic Kidney Disease|genetic kidney disease
5164483|NCT02964260|HCC; Embolization; Ablation; simultaneously; sequentially|hcc; embolization; ablation; simultaneously; sequentially
5164484|NCT02964234|Mammography Screening|mammography screening
5164485|NCT02964234|Latinas|latinas
5164486|NCT02964234|Breast cancer disparities|breast cancer disparities
5164487|NCT02964208|Atrial Fibrillation|atrial fibrillation
5164488|NCT02964208|Thromboembolism|thromboembolism
5164489|NCT02964208|Stroke|stroke
5164490|NCT02964208|ACP|acp
5164491|NCT02964208|Left Atrial Appendage|left atrial appendage
5164492|NCT02964208|Cardiac Plug|cardiac plug
5164493|NCT02964208|Amulet|amulet
5164494|NCT02964208|Amplatzer|amplatzer
5164495|NCT02964156|RA|ra
5164496|NCT02964156|Insole|insole
5164497|NCT02964156|Forefoot|forefoot
5164498|NCT02964156|Walking Ability|walking ability
5164499|NCT02964156|Pain|pain
5164500|NCT02964117|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5164501|NCT02964091|Hepatitis C Virus|hepatitis c virus
5164502|NCT02964091|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
5164503|NCT02964091|Efficacy|efficacy
5164504|NCT02964078|Kidney Disease|kidney disease
5164505|NCT02964078|Metastatic|metastatic
5164506|NCT02964078|Antibody|antibody
5164507|NCT02964065|Influenza Vaccines|influenza vaccines
5164508|NCT02964065|LAIV|laiv
5164509|NCT02964039|stroke|stroke
5164510|NCT02964039|rehabilitation|rehabilitation
5164511|NCT02964039|gait|gait
5164512|NCT02964026|pulmonary artery catheter|pulmonary artery catheter
5164513|NCT02964026|Swan-Ganz catheter|swan-ganz catheter
5164514|NCT02964013|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5164515|NCT02964013|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5164516|NCT02964013|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
5164517|NCT02964013|PD-1|pd-1
5164518|NCT02964013|PDL1|pdl1
5164519|NCT02964013|PD-L1|pd-l1
5164520|NCT02964013|PD-L2|pd-l2
5164521|NCT02964000|Pain|pain
5164522|NCT02964000|Low level laser therapy|low level laser therapy
5164523|NCT02964000|Sham|sham
5164524|NCT02964000|Chronic Pain|chronic pain
5164525|NCT02964000|Opioid|opioid
5164526|NCT02964000|Physical activity|physical activity
5164527|NCT02964000|Quality of sleep|quality of sleep
5164529|NCT02963961|Delirium|delirium
5164530|NCT02963961|Cognition|cognition
5164531|NCT02963961|Prehabilitation|prehabilitation
5164532|NCT02963961|Neuroplasticity|neuroplasticity
5164533|NCT02963909|Adjuvant|adjuvant
5164534|NCT02963909|Alum|alum
5164535|NCT02963909|Inactivated|inactivated
5164536|NCT02963909|Purified|purified
5164537|NCT02963909|Vaccine|vaccine
5164538|NCT02963909|Virus|virus
5164539|NCT02963909|Zika|zika
5164540|NCT02963896|vestibular rehabilitation|vestibular rehabilitation
5164541|NCT02963883|ScVO2|scvo2
5164542|NCT02963883|Post operative red cell transfusion|post operative red cell transfusion
5164543|NCT02963870|Cognitive behavioral|cognitive behavioral
5164544|NCT02963870|security plan|security plan
5164545|NCT02963870|suicidal Recidivism in adolescents|suicidal recidivism in adolescents
5164546|NCT02963857|breast surgery|breast surgery
5164547|NCT02963857|acute pain|acute pain
5164548|NCT02963857|regional anesthesia|regional anesthesia
5164549|NCT02963831|Oncos-102|oncos-102
5164550|NCT02963831|Durvalumab|durvalumab
5164551|NCT02963831|Peritoneal|peritoneal
5164552|NCT02963831|Cyclophosphamide|cyclophosphamide
5164553|NCT02963818|Brief intervention|brief intervention
5164554|NCT02963818|Harm reduction|harm reduction
5164555|NCT02963818|Young adult|young adult
5164556|NCT02963818|College Student|college student
5164557|NCT02963805|Children|children
5164558|NCT02963805|Physical activity|physical activity
5164559|NCT02963805|Physical competence|physical competence
5962136|NCT04282733|Stress|stress
5164560|NCT02963805|Obesity|obesity
5164561|NCT02963805|School|school
5164562|NCT02963805|Health|health
5164563|NCT02963805|Fundamental movement skills|fundamental movement skills
5030994|NCT03805620|BDNF|bdnf
5164564|NCT02963792|Professionalism|professionalism
5164565|NCT02963792|Burnout prevention|burnout prevention
5164566|NCT02963792|Resiliency|resiliency
5164567|NCT02963792|Student education|student education
5164569|NCT02963753|Hyperemesis gravidarum|hyperemesis gravidarum
5164570|NCT02963753|gestational diabetes mellitus|gestational diabetes mellitus
5164571|NCT02963753|oral glucose tolerance test|oral glucose tolerance test
5164572|NCT02963740|breast cancer survivor|breast cancer survivor
5164573|NCT02963740|weight loss program|weight loss program
5164574|NCT02963727|osteoarthrosis|osteoarthrosis
5164575|NCT02963727|Knee|knee
5164576|NCT02963727|Wharton Jelly|wharton jelly
5164577|NCT02963714|Hepatitis B, Vaccine|hepatitis b, vaccine
5164578|NCT02963714|Randomized Controlled Trial|randomized controlled trial
5164579|NCT02963714|Hemodialysis|hemodialysis
5164580|NCT02963714|Immunogenicity|immunogenicity
5164581|NCT02963662|obesity|obesity
5164582|NCT02963662|bariatric surgery|bariatric surgery
5238732|NCT02510261|FAP|fap
5164583|NCT02963662|gut hormones|gut hormones
5164584|NCT02963662|inflammatory adipokine|inflammatory adipokine
5164585|NCT02963649|Drug-eluting angioplasty balloon, Drug coated angioplasty balloon, Experimental, percutaneous transluminal angioplasty (PTA)|drug-eluting angioplasty balloon, drug coated angioplasty balloon, experimental, percutaneous transluminal angioplasty (pta)
5164586|NCT02963636|family medicine group|family medicine group
5164587|NCT02963636|pharmacists|pharmacists
5164588|NCT02963636|primary health care|primary health care
5164589|NCT02963636|pharmaceutical services|pharmaceutical services
5164590|NCT02963636|interprofessional relations|interprofessional relations
5164591|NCT02963623|fibtem|fibtem
5164592|NCT02963623|total knee replacement|total knee replacement
5164593|NCT02963584|chronic total occlusion|chronic total occlusion
5164594|NCT02963584|decision aid|decision aid
5164595|NCT02963506|AS|as
5164596|NCT02963506|Ankylosing Spondylitis|ankylosing spondylitis
5164597|NCT02963506|Bimekizumab|bimekizumab
5164598|NCT02963493|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
5164599|NCT02963467|multiple inert gas elimination technique|multiple inert gas elimination technique
5164601|NCT02963467|pulmonary disorder|pulmonary disorder
5164602|NCT02963441|Diabetic Retinopathy|diabetic retinopathy
5164603|NCT02963441|Macular Edema|macular edema
5164604|NCT02963415|Subjective memory complaint|subjective memory complaint
5164605|NCT02963363|Breast cancer|breast cancer
5164606|NCT02963363|HER2+|her2+
5164607|NCT02963363|Adapted physical activity|adapted physical activity
5164608|NCT02963363|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5164609|NCT02963337|remifentanil|remifentanil
5164610|NCT02963337|combined spinal-epidural analgesia|combined spinal-epidural analgesia
5164611|NCT02963337|multiparous|multiparous
5164612|NCT02963272|Heart failure|heart failure
5164613|NCT02963272|ST2|st2
5164614|NCT02963272|fibrosis|fibrosis
5164615|NCT02963246|mindfulness|mindfulness
5164616|NCT02963246|quality of life|quality of life
5164617|NCT02963246|Bowel Disease|bowel disease
5164618|NCT02963207|colorectal polyp|colorectal polyp
5164619|NCT02963207|colorectal lesion|colorectal lesion
5164620|NCT02963207|Modified Sano's Classification|modified sano's classification
5164621|NCT02963207|NICE classification|nice classification
5164622|NCT02963207|NBI|nbi
5164623|NCT02963207|PIVI guidelines|pivi guidelines
5164624|NCT02963207|SSA/P|ssa/p
5164625|NCT02963207|sessile serrated adenoma|sessile serrated adenoma
5164626|NCT02963207|sessile serrated polyp|sessile serrated polyp
5164632|NCT02963181|Anti-hypertensive agents|anti-hypertensive agents
5164633|NCT02963155|prostate, metastatic|prostate, metastatic
5164634|NCT02963142|Intensive care|intensive care
5164635|NCT02963142|Extra-corporeal membrane oxygenation (ECMO)|extra-corporeal membrane oxygenation (ecmo)
5164636|NCT02963142|Severe Respiratory Infections|severe respiratory infections
5164637|NCT02963142|Sequencing|sequencing
5164638|NCT02963142|Metagenome|metagenome
5164639|NCT02963142|Diagnosis|diagnosis
5164640|NCT02963129|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5164641|NCT02963129|Epistaxis|epistaxis
5164642|NCT02963116|Pharmacokinetics (PK)|pharmacokinetics (pk)
5164643|NCT02963116|Bioavailability (BA)|bioavailability (ba)
5164644|NCT02963116|Safety|safety
5164645|NCT02963116|Tolerability|tolerability
5164646|NCT02963116|Healthy Volunteers|healthy volunteers
5164647|NCT02963103|Tacrolimus|tacrolimus
5051662|NCT03675152|spondylolysis|spondylolysis
5164648|NCT02963103|Kidney transplantation|kidney transplantation
5164649|NCT02963090|SCLC|sclc
5164650|NCT02963090|small cell lung cancer|small cell lung cancer
5164651|NCT02963090|lung cancer|lung cancer
5164652|NCT02963090|topotecan|topotecan
5164653|NCT02963090|pembrolizumab|pembrolizumab
5164654|NCT02963064|Immunodeficiency|immunodeficiency
5164655|NCT02963064|Pediatric|pediatric
5164656|NCT02963064|SCID|scid
5164657|NCT02963064|Bone Marrow Transplantation|bone marrow transplantation
5164658|NCT02963064|GVHD|gvhd
5164659|NCT02963064|Stem Cells|stem cells
5164660|NCT02963064|Chimerism|chimerism
5164661|NCT02963064|Transplant|transplant
5164663|NCT02963051|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
5962137|NCT04282733|pain scores|pain scores
5164664|NCT02963051|neuroendocrine prostate cancer (NEPC)|neuroendocrine prostate cancer (nepc)
5164665|NCT02963051|adenocarcinoma castrate-resistant prostate cancer (CRPC)|adenocarcinoma castrate-resistant prostate cancer (crpc)
5164667|NCT02963051|Disulfiram|disulfiram
5164668|NCT02962999|Ketamine|ketamine
5164669|NCT02962999|One lung ventilation|one lung ventilation
5164670|NCT02962999|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5164671|NCT02962986|vasopressor|vasopressor
5164672|NCT02962986|blood pressure|blood pressure
5164673|NCT02962986|cesarean section|cesarean section
5164674|NCT02962986|spinal anesthesia|spinal anesthesia
5164675|NCT02962973|Advanced heart failure|advanced heart failure
5164676|NCT02962973|Total artificial heart|total artificial heart
5164677|NCT02962947|Melanoma|melanoma
5164678|NCT02962947|Propanolol|propanolol
5164679|NCT02962947|Betablockers|betablockers
5164680|NCT02962908|broad|broad
5164681|NCT02962908|universal|universal
5164682|NCT02962908|vaccine|vaccine
5164683|NCT02962908|influenza|influenza
5164684|NCT02962908|peptide|peptide
5164685|NCT02962908|Tcell|tcell
5164686|NCT02962908|UNISEC|unisec
5164687|NCT02962895|Sjogren|sjogren
5164688|NCT02962895|VAY736|vay736
5164689|NCT02962895|ianalumab|ianalumab
5164690|NCT02962843|Behavior Problem|behavior problem
5164691|NCT02962843|Social Competence|social competence
5164692|NCT02962843|Student|student
5164693|NCT02962843|Children|children
5164694|NCT02962830|fetal pain|fetal pain
5164695|NCT02962830|fetal analgesia|fetal analgesia
5164696|NCT02962804|kidney|kidney
5164697|NCT02962804|renal cell|renal cell
5164698|NCT02962804|cancer|cancer
5164699|NCT02962804|metastatic|metastatic
5164700|NCT02962804|recurrent|recurrent
5164701|NCT02962791|symptomatic heart failure|symptomatic heart failure
5164702|NCT02962778|treatment-resistant|treatment-resistant
5164703|NCT02962739|healthy volunteers|healthy volunteers
5164704|NCT02962726|Anorexia|anorexia
5164705|NCT02962726|Depression|depression
5164706|NCT02962726|Microbiome|microbiome
5164711|NCT02962700|continuous haemofiltration|continuous haemofiltration
5164712|NCT02962700|intermittent haemodialysis|intermittent haemodialysis
5164713|NCT02962687|Veterans|veterans
5164714|NCT02962687|Cognitive impairments|cognitive impairments
5164715|NCT02962687|Nursing care management|nursing care management
5164716|NCT02962687|Videoconferencing|videoconferencing
5164718|NCT02962648|IDA|ida
5164719|NCT02962622|Neurocognition|neurocognition
5164720|NCT02962622|Exercise|exercise
5164721|NCT02962622|Metabolism|metabolism
5164722|NCT02962622|Hispanic women|hispanic women
5164723|NCT02962609|Feeding|feeding
5164724|NCT02962609|preterm infant|preterm infant
5164725|NCT02962609|physiological characteristics|physiological characteristics
5164726|NCT02962609|position|position
5164727|NCT02962609|ESL|esl
5164728|NCT02962609|ESU|esu
5164729|NCT02962557|ventilatory depression|ventilatory depression
5164730|NCT02962544|Femtosecond|femtosecond
5164740|NCT02962492|Ketogenesis|ketogenesis
5164741|NCT02962492|Type 1 Diabetes|type 1 diabetes
5164743|NCT02962492|ketones|ketones
5164744|NCT02962492|exenatide/Bydureon|exenatide/bydureon
5164752|NCT02962388|efficacy|efficacy
5164753|NCT02962388|safety|safety
5164754|NCT02962375|orange pomace fiber|orange pomace fiber
5164755|NCT02962375|glycemic response|glycemic response
5164756|NCT02962297|Vitamin E, Non Diabetic|vitamin e, non diabetic
5164757|NCT02962271|Musculoskeletal Ultrasound|musculoskeletal ultrasound
5164758|NCT02962271|Psoriatic Arthritis|psoriatic arthritis
5164759|NCT02962271|Enthesopathy|enthesopathy
5164760|NCT02962245|Ulcerative Colitis|ulcerative colitis
5164761|NCT02962245|Berberine|berberine
5164762|NCT02962232|drug eluting balloon|drug eluting balloon
5164763|NCT02962232|arterial vasculature below the knee|arterial vasculature below the knee
5164764|NCT02962219|oesophagectomy|oesophagectomy
5164765|NCT02962193|ADL|adl
5164766|NCT02962193|Bariatric surgery|bariatric surgery
5164767|NCT02962193|Daily participation|daily participation
5164768|NCT02962180|derma-rolling system, vitiligo|derma-rolling system, vitiligo
5164769|NCT02962167|measles virus|measles virus
5164770|NCT02962167|recurrent medulloblastoma|recurrent medulloblastoma
5164771|NCT02962167|recurrent ATRT|recurrent atrt
5164772|NCT02962154|Invasive Coronary Angiography|invasive coronary angiography
5164773|NCT02962154|Myocardial Infarction|myocardial infarction
5164774|NCT02962154|Major Depressive Disorder|major depressive disorder
5164775|NCT02962154|Bipolar I Disorder|bipolar i disorder
5164776|NCT02962154|Bipolar II Disorder|bipolar ii disorder
5164777|NCT02962154|Mental Stress|mental stress
5962138|NCT04282733|patient satisfaction|patient satisfaction
5164778|NCT02962141|drug eluting balloon, Arteriovenous Fistulae|drug eluting balloon, arteriovenous fistulae
5164779|NCT02962089|Protein-energy wasting|protein-energy wasting
5164780|NCT02962089|Hemodialysis patients|hemodialysis patients
5164781|NCT02962089|Microbiota|microbiota
5164782|NCT02962089|Branched chain amino acids|branched chain amino acids
5164783|NCT02962089|Undernutrition|undernutrition
5164784|NCT02962089|Malnutrition|malnutrition
5164785|NCT02962089|Renal failure|renal failure
5164786|NCT02962089|Dialysis|dialysis
5164787|NCT02962089|Protein|protein
5164788|NCT02962089|Appetite|appetite
5164789|NCT02962089|Body composition|body composition
5164790|NCT02962089|Energy expenditure|energy expenditure
5164791|NCT02962063|Durvalumab|durvalumab
5164792|NCT02962063|Anti-PD-L1 Antibody|anti-pd-l1 antibody
5164793|NCT02962063|16-1405|16-1405
5164794|NCT02962011|Cesarean, incision, suture,|cesarean, incision, suture,
5164795|NCT02961998|hepatocellular carcinoma|hepatocellular carcinoma
5164796|NCT02961998|sorafenib|sorafenib
5164797|NCT02961998|celecoxib|celecoxib
5164798|NCT02961972|vegetarianism|vegetarianism
5164799|NCT02961972|Hyperhomocysteinemia|hyperhomocysteinemia
5164800|NCT02961972|vegan vegetarian|vegan vegetarian
5164801|NCT02961933|hypoxemia|hypoxemia
5164802|NCT02961933|intubation|intubation
5164803|NCT02961933|apneic oxygenation|apneic oxygenation
5164807|NCT02961894|Atherectomy|atherectomy
5238985|NCT02509039|CC-122|cc-122
5164808|NCT02961894|Atherosclerosis|atherosclerosis
5164809|NCT02961868|Renal Artery Obstruction|renal artery obstruction
5164810|NCT02961868|Carotid Artery Diseases|carotid artery diseases
5164811|NCT02961868|Genetic Association Studies|genetic association studies
5164812|NCT02961829|Dendritic Cell vaccination using|dendritic cell vaccination using
5164813|NCT02961829|antiretroviral intensification|antiretroviral intensification
5164814|NCT02961829|Auranofin|auranofin
5164815|NCT02961829|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5164816|NCT02961829|residual viral replication|residual viral replication
5164817|NCT02961829|HIV sanctuaries|hiv sanctuaries
5164818|NCT02961829|HIV latency|hiv latency
5164819|NCT02961816|Lymphoma|lymphoma
5164820|NCT02961816|Refractory/Relapsed Lymphoma|refractory/relapsed lymphoma
5164821|NCT02961816|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5164822|NCT02961816|Hodgkin's lymphoma|hodgkin's lymphoma
5164823|NCT02961816|T-cell Lymphoma|t-cell lymphoma
5164824|NCT02961816|Palifermin|palifermin
5164825|NCT02961816|Kepivance|kepivance
5164826|NCT02961816|Panobinostat|panobinostat
5164828|NCT02961816|Gemcitabine|gemcitabine
5164829|NCT02961816|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5164830|NCT02961816|Gemzar|gemzar
5164832|NCT02961816|Busulfex|busulfex
5164833|NCT02961816|Myleran|myleran
5164834|NCT02961816|Melphalan|melphalan
5164835|NCT02961816|Alkeran|alkeran
5164836|NCT02961816|Rituximab|rituximab
5164837|NCT02961816|Rituxan|rituxan
5164838|NCT02961816|Dexamethasone|dexamethasone
5164839|NCT02961816|Decadron|decadron
5164840|NCT02961816|Caphosol|caphosol
5164841|NCT02961816|Glutamine|glutamine
5164842|NCT02961816|Enterex|enterex
5164843|NCT02961816|Glutapak-10|glutapak-10
5164844|NCT02961816|NutreStore|nutrestore
5164845|NCT02961816|Resource|resource
5164846|NCT02961816|GlutaSolve|glutasolve
5164847|NCT02961816|Sympt-X G.I.|sympt-x g.i.
5164848|NCT02961816|Sympt-X|sympt-x
5164849|NCT02961816|Pyridoxine|pyridoxine
5164850|NCT02961816|G-CSF|g-csf
5164851|NCT02961816|Filgrastim|filgrastim
5164852|NCT02961816|Neupogen|neupogen
5164853|NCT02961816|Stem cell transplant|stem cell transplant
5164855|NCT02961803|MD1003|md1003
5164856|NCT02961803|Adrenomyeloneuropathy|adrenomyeloneuropathy
5164858|NCT02961803|Adrenoleukodystrophy|adrenoleukodystrophy
5164859|NCT02961803|Biotin|biotin
5164860|NCT02961803|2MWT|2mwt
5164861|NCT02961803|Two-minute walk test|two-minute walk test
5164862|NCT02961803|TW25|tw25
5164863|NCT02961803|Timed 25-Foot Walk|timed 25-foot walk
5164864|NCT02961764|Critical Pathways|critical pathways
5164865|NCT02961764|Health Facilities|health facilities
5164866|NCT02961764|Clinical Protocols|clinical protocols
5164867|NCT02961764|Patient Satisfaction|patient satisfaction
5164868|NCT02961764|Absenteeism|absenteeism
5051900|NCT03673800|addiction|addiction
5164869|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents
5164870|NCT02961764|Quality of Life|quality of life
5164871|NCT02961764|Economics, Medical|economics, medical
5164872|NCT02961764|Health Resources|health resources
5164873|NCT02961764|Health resource utilization|health resource utilization
5164874|NCT02961764|Acute bacterial skin and skin structure infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
5164875|NCT02961751|Ciprofloxacin-susceptibility|ciprofloxacin-susceptibility
5164876|NCT02961751|Efficacy|efficacy
5164877|NCT02961751|Gyrase A Assay|gyrase a assay
5164878|NCT02961751|Neisseria gonorrhoeae|neisseria gonorrhoeae
5164879|NCT02961647|Hemodynamic stress test|hemodynamic stress test
5164880|NCT02961647|Surgical intervention|surgical intervention
5164881|NCT02961634|onychomycosis|onychomycosis
5164882|NCT02961634|nail|nail
5164883|NCT02961595|Oral polio vaccine|oral polio vaccine
5164884|NCT02961595|Inactivated polio vaccine|inactivated polio vaccine
5164885|NCT02961595|Enterovirus|enterovirus
5164886|NCT02961595|Type 1 diabetes|type 1 diabetes
5164887|NCT02961595|Autoantibody|autoantibody
5164888|NCT02961582|Sacral neuromodulation|sacral neuromodulation
5164889|NCT02961582|Constipation|constipation
5164890|NCT02961582|Slow-transit constipation|slow-transit constipation
5164891|NCT02961582|Surgery|surgery
5164892|NCT02961582|Colorectal surgery|colorectal surgery
5164893|NCT02961582|Cost-effectiveness|cost-effectiveness
5164894|NCT02961582|Quality of life|quality of life
5164895|NCT02961556|AJG555|ajg555
5164896|NCT02961556|Constipation|constipation
5164897|NCT02961556|Phase 3|phase 3
5164898|NCT02961556|Pediatric participants|pediatric participants
5164899|NCT02961491|MIBG|mibg
5164900|NCT02961491|Azedra|azedra
5164901|NCT02961491|Rare neuroendocrine tumors|rare neuroendocrine tumors
5164902|NCT02961491|Iobenguane I 131|iobenguane i 131
5164903|NCT02961491|Progenics|progenics
5164904|NCT02961465|Sacral neuromodulation|sacral neuromodulation
5164905|NCT02961465|Constipation|constipation
5164907|NCT02961465|Surgery|surgery
5164908|NCT02961465|Colorectal surgery|colorectal surgery
5673424|NCT00608218|Asthma|asthma
5164909|NCT02961465|Cost-effectiveness|cost-effectiveness
5164910|NCT02961465|Quality of life|quality of life
5164911|NCT02961387|Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.|tracheal stenosis, hydrogen generator, hydrogen-oxygen, dyspnea.
5164912|NCT02961361|dexmedetomidine|dexmedetomidine
5164913|NCT02961361|coracoid|coracoid
5164914|NCT02961361|brachial plexus block|brachial plexus block
5164915|NCT02961348|Oral anticoagulants (NOAC)|oral anticoagulants (noac)
5164917|NCT02961309|marijuana|marijuana
5164918|NCT02961309|tobacco cigarette|tobacco cigarette
5164919|NCT02961309|smoking|smoking
5164920|NCT02961296|Helicobacter Pylori|helicobacter pylori
5164921|NCT02961283|BRAF Kinases|braf kinases
5164922|NCT02961283|PIK3CA protein, human|pik3ca protein, human
5164923|NCT02961244|Surgical Site Infection|surgical site infection
5164924|NCT02961244|normothermia|normothermia
5164925|NCT02961244|hypothermia|hypothermia
5164926|NCT02961244|prewarming|prewarming
5164927|NCT02961231|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5164928|NCT02961231|Herd immunity|herd immunity
5164929|NCT02961231|Reduced dosing schedule|reduced dosing schedule
5164930|NCT02961218|Sickle cell disease|sickle cell disease
5164931|NCT02961218|hemoglobinopathy|hemoglobinopathy
5164932|NCT02961218|pediatric|pediatric
5164933|NCT02961166|IVIG|ivig
5164934|NCT02961166|ARDS|ards
5164935|NCT02961166|ECMO|ecmo
5164936|NCT02961140|Outcome|outcome
5164937|NCT02961127|tissue factor pathway inhibitor|tissue factor pathway inhibitor
5164938|NCT02961114|Prostatitis, Chronic|prostatitis, chronic
5164939|NCT02961114|Nocturia|nocturia
5164940|NCT02961114|BPH With Urinary Obstruction|bph with urinary obstruction
5164941|NCT02961101|relapsed or refractory|relapsed or refractory
5164942|NCT02961101|malignancies|malignancies
5164943|NCT02961101|decitabine|decitabine
5164944|NCT02961101|anti-PD-1 antibody|anti-pd-1 antibody
5164945|NCT02961101|chemotherapy|chemotherapy
5164946|NCT02961088|Systematic review and meta-analysis|systematic review and meta-analysis
5164947|NCT02961088|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5164948|NCT02961088|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5164949|NCT02961088|Clinical practice guidelines|clinical practice guidelines
5164950|NCT02961088|Glycemic index|glycemic index
5164951|NCT02961088|Pasta|pasta
5164952|NCT02961088|Glycemic load|glycemic load
5164953|NCT02961088|Body weight|body weight
5164954|NCT02961088|Cardiovascular risk factors|cardiovascular risk factors
5164955|NCT02961088|Cardiovascular disease|cardiovascular disease
5164956|NCT02961062|ocular pain|ocular pain
5164957|NCT02961062|photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
5164958|NCT02961062|SAF312|saf312
5164959|NCT02961062|corneal epithelial defect|corneal epithelial defect
5164960|NCT02961036|Surveys and Questionnaires|surveys and questionnaires
5164961|NCT02961010|school based prevention, child sexual and domestic abuse|school based prevention, child sexual and domestic abuse
5164962|NCT02960997|epidermolysis bullosa simplex|epidermolysis bullosa simplex
5164963|NCT02960958|Rheumatoid arthritis|rheumatoid arthritis
5164964|NCT02960958|Metabolomics|metabolomics
5164965|NCT02960958|urine|urine
5164966|NCT02960932|Hemiplegic|hemiplegic
5164967|NCT02960932|Child|child
5164968|NCT02960932|Elastography|elastography
5164969|NCT02960932|paralysis|paralysis
5164970|NCT02960893|Ataxia|ataxia
5164972|NCT02960893|Spinocerebellar Ataxia|spinocerebellar ataxia
5164973|NCT02960880|Rivaroxaban, Phenprocoumon, retrospective cohort study, Non-Valvular Atrial fibrillation, NVAF|rivaroxaban, phenprocoumon, retrospective cohort study, non-valvular atrial fibrillation, nvaf
5164974|NCT02960867|paediatric|paediatric
5164975|NCT02960867|kidney|kidney
5164976|NCT02960815|influenza vaccine|influenza vaccine
5164977|NCT02960815|Transplantation|transplantation
5164978|NCT02960815|imiquimod|imiquimod
5164979|NCT02960815|HIV infection|hiv infection
5164980|NCT02960815|immunogenicity|immunogenicity
5164983|NCT02960789|Dehydration|dehydration
5164984|NCT02960789|Children|children
5164985|NCT02960789|Measurement|measurement
5164986|NCT02960776|Body Weight|body weight
5164987|NCT02960776|Habitual sleep|habitual sleep
5164988|NCT02960763|Comparative Effectiveness Research|comparative effectiveness research
5164989|NCT02960763|Pragmatic Clinical Trials|pragmatic clinical trials
5164990|NCT02960763|Patient-Centered Outcomes Research|patient-centered outcomes research
5164991|NCT02960750|workplace|workplace
5164992|NCT02960750|sedentary behavior|sedentary behavior
5164993|NCT02960750|physical activity|physical activity
5164994|NCT02960750|physical risk factors|physical risk factors
5164995|NCT02960750|mental well-being|mental well-being
5164996|NCT02960750|presenteeism|presenteeism
5164997|NCT02960750|work productivity|work productivity
5164998|NCT02960750|activity-related energy expenditures|activity-related energy expenditures
5164999|NCT02960737|Dysphagia|dysphagia
5165000|NCT02960737|Stroke|stroke
5165001|NCT02960737|Intervention|intervention
5165002|NCT02960737|Oral screen|oral screen
5165003|NCT02960737|Incidence|incidence
5165004|NCT02960724|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
5165005|NCT02960724|Oropharyngeal cancer|oropharyngeal cancer
5165007|NCT02960724|Positron Emission Tomography|positron emission tomography
5165008|NCT02960698|cognitive impulsivity|cognitive impulsivity
5165009|NCT02960698|IRM|irm
5165010|NCT02960698|Tourette Syndrome|tourette syndrome
5165011|NCT02960672|KL-6|kl-6
5165012|NCT02960672|disease progression|disease progression
5165013|NCT02960672|predict|predict
5165014|NCT02960672|biomarkers|biomarkers
5165015|NCT02960672|MMP-7|mmp-7
5165016|NCT02960659|Diabetes|diabetes
5165017|NCT02960659|Metformin|metformin
5165018|NCT02960659|Glucose|glucose
5165019|NCT02960620|Humanitarian Device Exemption|humanitarian device exemption
5165020|NCT02960620|Liver Disease|liver disease
5165021|NCT02960620|HDE #980006|hde #980006
5165022|NCT02960594|Immunotherapy|immunotherapy
5165023|NCT02960594|Human Telomerase Reverse Transcriptase (hTERT)|human telomerase reverse transcriptase (htert)
5165024|NCT02960594|Breast Neoplasms|breast neoplasms
5165025|NCT02960594|Lung Neoplasms|lung neoplasms
5165026|NCT02960594|Pancreatic Neoplasms|pancreatic neoplasms
5165027|NCT02960594|High Risk of Relapse|high risk of relapse
5423220|NCT01616628|Fruit|fruit
5165028|NCT02960594|Post Definitive Surgery|post definitive surgery
5165029|NCT02960594|Post Adjuvant Therapy|post adjuvant therapy
5165030|NCT02960594|No Evidence of Disease|no evidence of disease
5165031|NCT02960568|primaquine|primaquine
5165032|NCT02960568|metabolism|metabolism
5165033|NCT02960568|malaria|malaria
5165034|NCT02960568|hypnozoite|hypnozoite
5165035|NCT02960568|vivax|vivax
5165036|NCT02960568|CYP2D6|cyp2d6
5165037|NCT02960568|active duty personnel|active duty personnel
5165038|NCT02960542|lifestyle intervention|lifestyle intervention
5165039|NCT02960542|weight-loss|weight-loss
5165040|NCT02960503|sickle cell disease|sickle cell disease
5165041|NCT02960503|pulmonary complications|pulmonary complications
5165042|NCT02960503|reduced FEV1|reduced fev1
5165043|NCT02960503|azithromycin|azithromycin
5165044|NCT02960503|lung function|lung function
5165047|NCT02960477|Shoulder pain|shoulder pain
5165048|NCT02960477|Shoulder surgery|shoulder surgery
5165049|NCT02960477|Pain neuroscience education|pain neuroscience education
5165050|NCT02960477|Chronic pain|chronic pain
5165051|NCT02960464|Parkinson Disease|parkinson disease
5165052|NCT02960464|Depression|depression
5165053|NCT02960464|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5165054|NCT02960464|Neuromodulation|neuromodulation
5165055|NCT02960451|prodrome|prodrome
5165056|NCT02960451|cognitive behavioral therapy|cognitive behavioral therapy
5165057|NCT02960451|family focused therapy|family focused therapy
5165058|NCT02960438|E6011|e6011
5165059|NCT02960438|rheumatoid arthritis|rheumatoid arthritis
5165060|NCT02960373|Dried fruit|dried fruit
5165061|NCT02960373|Glycemic Index|glycemic index
5165062|NCT02960373|Catalytic dose|catalytic dose
5165063|NCT02960373|Glycemic response|glycemic response
5165064|NCT02960373|Fructose|fructose
5165065|NCT02960373|Postprandial|postprandial
5165066|NCT02960373|Randomized clinical trial|randomized clinical trial
5165067|NCT02960373|Carbohydrate metabolism|carbohydrate metabolism
5165068|NCT02960334|Screening|screening
5165069|NCT02960334|Silent Atrial Fibrillation|silent atrial fibrillation
5165070|NCT02960334|Undertreated Atrial Fibrillation|undertreated atrial fibrillation
5165071|NCT02960334|Actionable Atrial Fibrillation|actionable atrial fibrillation
5165072|NCT02960334|MyDiagnostick|mydiagnostick
5165073|NCT02960334|Opportunistic Screening|opportunistic screening
5165074|NCT02960334|Preoperative Consultation|preoperative consultation
5165075|NCT02960334|OAC|oac
5165076|NCT02960334|VKA|vka
5165077|NCT02960334|NOAC|noac
5165078|NCT02960321|myocardial injury|myocardial injury
5165079|NCT02960321|high-sensitivity troponin I|high-sensitivity troponin i
5165080|NCT02960321|periprocedural myocardial infarction|periprocedural myocardial infarction
5165081|NCT02960269|rural health|rural health
5165082|NCT02960269|telehealth|telehealth
5165083|NCT02960269|physiotherapy|physiotherapy
5165084|NCT02960269|interprofessional|interprofessional
5165085|NCT02960243|Deep Brain Stimulation|deep brain stimulation
5165086|NCT02960243|Laryngeal Motor Cortex|laryngeal motor cortex
5165087|NCT02960243|Essential Voice Tremor|essential voice tremor
5165088|NCT02960243|Essential Tremor|essential tremor
5165089|NCT02960230|peptide vaccine|peptide vaccine
5165090|NCT02960230|immunotherapy|immunotherapy
5165091|NCT02960230|DIPG|dipg
5165092|NCT02960230|vaccine|vaccine
5165093|NCT02960204|cirrhosis|cirrhosis
5165094|NCT02960204|Portal Hypertension|portal hypertension
5037904|NCT03761979|Osteopenia|osteopenia
5165095|NCT02960204|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5165096|NCT02960204|Liver cirrhosis|liver cirrhosis
5165097|NCT02960152|periodontitis|periodontitis
5165098|NCT02960113|cesarean section|cesarean section
5165099|NCT02960113|acupressure point p6|acupressure point p6
5165100|NCT02960113|scopolamine patch|scopolamine patch
5165101|NCT02960100|Cancer prevention|cancer prevention
5165102|NCT02960100|HPV|hpv
5165103|NCT02960100|Human papillomavirus vaccine|human papillomavirus vaccine
5165105|NCT02960074|Hypersensitivity Peanut|hypersensitivity peanut
5165106|NCT02960074|Peanut Allergy|peanut allergy
5165107|NCT02960074|Donor Feces Infusion|donor feces infusion
5165108|NCT02960074|Fecal Transplant|fecal transplant
5165109|NCT02960074|Fecal Transplantation|fecal transplantation
5165110|NCT02960074|Intestinal Microbiota Transfer|intestinal microbiota transfer
5165111|NCT02960074|Fecal Microbiota Transplantation|fecal microbiota transplantation
5165112|NCT02960074|Food allergy|food allergy
5165113|NCT02960061|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5165114|NCT02960061|gastric cancer|gastric cancer
5165115|NCT02960061|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5165116|NCT02960048|Anterior disc displacement|anterior disc displacement
5165117|NCT02960048|TMD therapy|tmd therapy
5165118|NCT02960048|internal derangement|internal derangement
5165119|NCT02960048|occlusal splint|occlusal splint
5165120|NCT02960048|anterior repositioning splint|anterior repositioning splint
5165121|NCT02960035|Mardird sonographic enthesis index|mardird sonographic enthesis index
5165122|NCT02960035|Spondyloarthropathy|spondyloarthropathy
5165123|NCT02960035|Ultrasonics|ultrasonics
5165124|NCT02960035|Etanercept|etanercept
5423221|NCT01616628|Vegetables|vegetables
5165125|NCT02960022|prostate cancer|prostate cancer
5165126|NCT02960022|prednisone|prednisone
5165128|NCT02960022|enzalutamide|enzalutamide
5165129|NCT02960022|Xtandi|xtandi
5165130|NCT02960022|abiraterone acetate|abiraterone acetate
5165225|NCT02959567|cervix|cervix
5165131|NCT02959944|chronic graft versus host disease|chronic graft versus host disease
5165133|NCT02959944|PCYC1140IM|pcyc1140im
5165134|NCT02959944|1140|1140
5165135|NCT02959944|Ibrutinib|ibrutinib
5165136|NCT02959944|GVHD|gvhd
5165137|NCT02959944|Steroid dependent|steroid dependent
5165138|NCT02959944|refractory|refractory
5165139|NCT02959944|chronic|chronic
5165140|NCT02959944|PCI32765|pci32765
5165141|NCT02959944|IMBRUVICA|imbruvica
5165142|NCT02959944|Pharmacyclics|pharmacyclics
5165143|NCT02959944|PCYC|pcyc
5165144|NCT02959944|graft versus host disease|graft versus host disease
5165145|NCT02959944|immunology|immunology
5165146|NCT02959944|new onset graft versus host disease|new onset graft versus host disease
5165147|NCT02959944|INTEGRATE|integrate
5165148|NCT02959944|Corticosteroids|corticosteroids
5165149|NCT02959944|prednisone|prednisone
5165151|NCT02959905|Metastatic Melanoma|metastatic melanoma
5165152|NCT02959905|Colorectal Cancer|colorectal cancer
5165153|NCT02959905|neoantigen|neoantigen
5165154|NCT02959892|Drug therapy|drug therapy
5165155|NCT02959879|FOLFOX|folfox
5165156|NCT02959879|FOLFIRINOX|folfirinox
5165157|NCT02959853|Hypogonadism|hypogonadism
5165158|NCT02959853|Severe obesity|severe obesity
5165159|NCT02959827|Hypothyroidism,|hypothyroidism,
5165160|NCT02959827|children,|children,
5165161|NCT02959827|iodinated contrast agents,|iodinated contrast agents,
5165162|NCT02959827|retrospective cohort,|retrospective cohort,
5165163|NCT02959827|database|database
5165164|NCT02959814|Fractional Flow Reserve|fractional flow reserve
5165165|NCT02959814|Quantitative Coronary Analysis|quantitative coronary analysis
5165166|NCT02959814|Stable coronary artery disease|stable coronary artery disease
5165167|NCT02959814|Angina pectoris|angina pectoris
5165168|NCT02959801|Deep Venous Thrombosis|deep venous thrombosis
5165169|NCT02959801|Percutaneous Mechanical Thrombectomy|percutaneous mechanical thrombectomy
5165170|NCT02959788|Heart rate variability|heart rate variability
5165171|NCT02959775|Hepatitis B vaccination|hepatitis b vaccination
5165172|NCT02959775|Immunogenicity|immunogenicity
5165173|NCT02959775|Randomized controlled trial|randomized controlled trial
5165174|NCT02959775|Drug abuse|drug abuse
5165175|NCT02959762|G01 [Biological Sciences]|g01 [biological sciences]
5165176|NCT02959762|G02.513 [Nutrition]|g02.513 [nutrition]
5165177|NCT02959762|G06.696.259 [Child Nutrition]|g06.696.259 [child nutrition]
5165178|NCT02959762|G07.553.481.398.571 [Obesity]|g07.553.481.398.571 [obesity]
5165179|NCT02959762|G06 [Biochemical Phenomena, Metabolism, and Nutrition]|g06 [biochemical phenomena, metabolism, and nutrition]
5165180|NCT02959762|G12.392.617 [Insulin Resistance]|g12.392.617 [insulin resistance]
5165181|NCT02959762|G06.696.259.500 [Adolescent Nutrition]|g06.696.259.500 [adolescent nutrition]
5165182|NCT02959762|A06 [Endocrine System]|a06 [endocrine system]
5165183|NCT02959762|A07 [Cardiovascular System]|a07 [cardiovascular system]
5165184|NCT02959762|C18.452.297.681 [Obesity in Diabetes]|c18.452.297.681 [obesity in diabetes]
5165185|NCT02959762|C18.452.555 [Insulin Resistance]|c18.452.555 [insulin resistance]
5165186|NCT02959762|C18 [Nutritional and Metabolic Diseases]|c18 [nutritional and metabolic diseases]
5962139|NCT04282733|Perceived Stress Scale|perceived stress scale
5962140|NCT04282733|MBSR|mbsr
5165187|NCT02959762|C18.452.494 [Hyperlipidemia]|c18.452.494 [hyperlipidemia]
5165188|NCT02959762|C18.452.460 [Hyperglycemia]|c18.452.460 [hyperglycemia]
5165189|NCT02959762|C14 [Cardiovascular Diseases]|c14 [cardiovascular diseases]
5165190|NCT02959762|D11.786.875.844 [Vitamin K 2]|d11.786.875.844 [vitamin k 2]
5165191|NCT02959762|D02.806.550.750 [Vitamin K 2]|d02.806.550.750 [vitamin k 2]
5165192|NCT02959762|E02.293 [Diet Therapy]|e02.293 [diet therapy]
5165193|NCT02959762|E02 [Therapeutics]|e02 [therapeutics]
5673425|NCT00608218|ciclesonide|ciclesonide
5165194|NCT02959762|F04.096.544.215.508.428 [Primary Prevention]|f04.096.544.215.508.428 [primary prevention]
5165195|NCT02959762|N01.224.425.525 [Nutritional Status]|n01.224.425.525 [nutritional status]
5165197|NCT02959749|EGFR T790M Resistant Mutation|egfr t790m resistant mutation
5165198|NCT02959749|Docetaxel|docetaxel
5165199|NCT02959749|Bevacizumab|bevacizumab
5165200|NCT02959749|Non Small Cell Lung|non small cell lung
5165201|NCT02959736|Vegetative State (VS)|vegetative state (vs)
5165202|NCT02959736|Minimally Conscious State (MCS)|minimally conscious state (mcs)
5165203|NCT02959736|Brain Injuries|brain injuries
5165204|NCT02959723|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5165205|NCT02959723|BMPR2|bmpr2
5165206|NCT02959723|Inflammation|inflammation
5165207|NCT02959710|Healthy volunteers|healthy volunteers
5165208|NCT02959710|AC-1202|ac-1202
5165209|NCT02959710|AC-1204|ac-1204
5165210|NCT02959710|Pharmacokinetic|pharmacokinetic
5165211|NCT02959710|ketone body|ketone body
5165212|NCT02959697|Blepharoptosis|blepharoptosis
5165213|NCT02959697|Ptosis|ptosis
5165214|NCT02959697|Surgery|surgery
5165215|NCT02959697|Pain Reduction|pain reduction
5165216|NCT02959697|Anesthetic|anesthetic
5165217|NCT02959697|Local Anesthetic|local anesthetic
5165218|NCT02959697|Subconjunctival|subconjunctival
5173944|NCT02905240|APS|aps
5165219|NCT02959593|Primary open-angle glaucoma|primary open-angle glaucoma
5165220|NCT02959593|retinal capillary blood flow|retinal capillary blood flow
5165221|NCT02959593|visual stimulation|visual stimulation
5165222|NCT02959580|Granulomatous|granulomatous
5165223|NCT02959580|Mastitis|mastitis
5165224|NCT02959580|topical steroids|topical steroids
5165229|NCT02959554|Metastatic|metastatic
5165230|NCT02959554|RCC|rcc
5165231|NCT02959541|Leukovorin|leukovorin
5165232|NCT02959476|Postoperative pain|postoperative pain
5165233|NCT02959476|Postsurgical pain|postsurgical pain
5165234|NCT02959450|Nutritional Intervention in Oropharyngeal Dysphagia|nutritional intervention in oropharyngeal dysphagia
5165235|NCT02959437|Solid tumors|solid tumors
5165236|NCT02959437|NSCLC|nsclc
5165237|NCT02959437|CRC|crc
5165238|NCT02959359|Chronic hepatitis C|chronic hepatitis c
5165239|NCT02959359|Hepatocellular Carcinoma|hepatocellular carcinoma
5165240|NCT02959359|Direct-acting antiviral (DAA)|direct-acting antiviral (daa)
5165241|NCT02959359|Recurrence|recurrence
5165242|NCT02959346|Minimal invasive thoracoscopic surgery|minimal invasive thoracoscopic surgery
5165243|NCT02959346|Pain control|pain control
5165244|NCT02959346|Acupuncture|acupuncture
5165245|NCT02959346|Randomized controlled trial|randomized controlled trial
5165246|NCT02959307|Depression|depression
5165247|NCT02959307|Major Depressive Disorder|major depressive disorder
5165248|NCT02959307|Major Depressive Episode|major depressive episode
5165249|NCT02959294|TBI|tbi
5165250|NCT02959294|mTBI|mtbi
5165251|NCT02959294|Concussion, Brain|concussion, brain
5165252|NCT02959294|Loss Consciousness, Traumatic|loss consciousness, traumatic
5165253|NCT02959294|Headaches|headaches
5165254|NCT02959242|glaucoma, follow-up intervals, treatment efficiency|glaucoma, follow-up intervals, treatment efficiency
5165255|NCT02959229|Late onset sepsis|late onset sepsis
5165256|NCT02959229|Bovine Lactoferrin|bovine lactoferrin
5165257|NCT02959216|Aerobic Exercise|aerobic exercise
5165258|NCT02959203|Central Venous Catheter|central venous catheter
5165259|NCT02959203|Ultrasound|ultrasound
5165260|NCT02959203|Chest X-ray|chest x-ray
5165261|NCT02959203|Pneumothorax|pneumothorax
5165262|NCT02959190|prevention|prevention
5165263|NCT02959190|prophylaxis|prophylaxis
5165264|NCT02959190|headache|headache
5165268|NCT02959112|pancreatitis after ERCP|pancreatitis after ercp
5165269|NCT02959112|epinephrine|epinephrine
5165270|NCT02959112|papilla|papilla
5165271|NCT02959112|rectal indomethacin|rectal indomethacin
5165272|NCT02959099|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5165273|NCT02959099|Atherosclerotic plaque morphology|atherosclerotic plaque morphology
5165274|NCT02959099|Coronary Computed Tomographic Angiography (CCTA)|coronary computed tomographic angiography (ccta)
5165275|NCT02959099|Gender disparities|gender disparities
5165276|NCT02959086|Epidemiology|epidemiology
5165277|NCT02959086|Shanghai|shanghai
5165278|NCT02959086|Cancer|cancer
5165279|NCT02959086|Adolescents|adolescents
5165280|NCT02959086|Children|children
5165281|NCT02959073|Symptom recording|symptom recording
5165283|NCT02959047|PCSK9 inhibition|pcsk9 inhibition
5165284|NCT02959047|LDL cholesterol|ldl cholesterol
5165285|NCT02959021|weight loss|weight loss
5165286|NCT02959021|behavioral|behavioral
5165287|NCT02959021|primary care|primary care
5165288|NCT02959021|lifestyle|lifestyle
5165289|NCT02958995|Drug Therapy|drug therapy
5165290|NCT02958982|RP3128|rp3128
5165291|NCT02958982|Phase 1|phase 1
5165292|NCT02958982|Healthy volunteers|healthy volunteers
5165293|NCT02958969|venous thromboembolism|venous thromboembolism
5165294|NCT02958969|multiple myeloma|multiple myeloma
5165295|NCT02958969|anticoagulation|anticoagulation
5165296|NCT02958956|Drug Therapy|drug therapy
5165297|NCT02958943|atrial fibrillation|atrial fibrillation
5165298|NCT02958943|stroke|stroke
5165299|NCT02958943|computerized decision support|computerized decision support
5165300|NCT02958904|Sexuality|sexuality
5165301|NCT02958904|Spinal cord injuries|spinal cord injuries
5165303|NCT02958904|depression|depression
5165304|NCT02958865|Mayo score|mayo score
5165305|NCT02958852|Breast Cancer|breast cancer
5165306|NCT02958852|Endocrine Treatment|endocrine treatment
5165307|NCT02958852|Atorvastatin|atorvastatin
5165308|NCT02958852|Mechanisms of Resistance|mechanisms of resistance
5165310|NCT02958852|Fulvestrant|fulvestrant
5165311|NCT02958852|Circulating Tumor Cells|circulating tumor cells
5165312|NCT02958852|Statins and Endocrine Treatment|statins and endocrine treatment
5165313|NCT02958852|Tumor Marker Expression|tumor marker expression
5165314|NCT02958852|ER+ Metastatic Breast Cancer|er+ metastatic breast cancer
5165315|NCT02958852|Circulating Tumor DNA|circulating tumor dna
5165316|NCT02958852|Cholesterol|cholesterol
5165317|NCT02958839|Atrial fibrillation|atrial fibrillation
5165318|NCT02958839|Fibroblast Growth factor 23|fibroblast growth factor 23
5165319|NCT02958800|Deprescribing|deprescribing
5165320|NCT02958800|Single patient open label trial|single patient open label trial
5165321|NCT02958800|Long-term care|long-term care
5165322|NCT02958761|knee arthrosis|knee arthrosis
5165323|NCT02958761|platelet-derived growth factors|platelet-derived growth factors
5165324|NCT02958735|exercise|exercise
5165325|NCT02958735|cognition|cognition
5165326|NCT02958735|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5165327|NCT02958735|insulin-like growth factor 1|insulin-like growth factor 1
5165328|NCT02958735|cortisol|cortisol
5165329|NCT02958683|Optoelectronic plethysmography|optoelectronic plethysmography
5165330|NCT02958683|Structure light plethysmography|structure light plethysmography
5165331|NCT02958683|Respiratory Function Tests|respiratory function tests
5165332|NCT02958657|Platelet function|platelet function
5165333|NCT02958657|Autonomic Nervous System|autonomic nervous system
5165334|NCT02958657|Multiplate® (Multiple Electrode Aggregometry - MEA)|multiplate® (multiple electrode aggregometry - mea)
5165335|NCT02958657|VerifyNow®|verifynow®
5165336|NCT02958644|synbiotic|synbiotic
5165337|NCT02958644|obesity|obesity
5165338|NCT02958644|body mass index|body mass index
5165339|NCT02958644|microbiota|microbiota
5165340|NCT02958605|Children|children
5165341|NCT02958605|resuscitation|resuscitation
5165342|NCT02958605|smartphone|smartphone
5165343|NCT02958592|shear-wave elastography|shear-wave elastography
5165344|NCT02958592|hepatic fibrosis|hepatic fibrosis
5165345|NCT02958592|liver tumor|liver tumor
5165346|NCT02958566|Pain control|pain control
5165347|NCT02958566|Post-operative pain|post-operative pain
5165348|NCT02958566|Narcotic|narcotic
5165349|NCT02958566|Non-narcotic|non-narcotic
5165350|NCT02958566|Side effect|side effect
5165351|NCT02958566|Toxicity|toxicity
5165352|NCT02958553|Lower Extremity Limb Loss|lower extremity limb loss
5165353|NCT02958553|Prosthesis Use|prosthesis use
5165354|NCT02958540|Prophylaxis|prophylaxis
5165355|NCT02958527|Effexor|effexor
5165356|NCT02958527|Depression|depression
5165357|NCT02958527|Depressed state|depressed state
5165358|NCT02958514|IPL|ipl
5165359|NCT02958514|MGD|mgd
5165360|NCT02958501|Vitamin D|vitamin d
5165361|NCT02958501|Inflammatory Bowel Diseases|inflammatory bowel diseases
5165362|NCT02958488|34 to 36 Weeks Preterm Neonates|34 to 36 weeks preterm neonates
5165363|NCT02958488|Respiratory Distress Syndrom|respiratory distress syndrom
5165364|NCT02958488|High Flow Nasal Cannula|high flow nasal cannula
5165365|NCT02958436|Safety|safety
5165366|NCT02958436|Tolerability|tolerability
5165367|NCT02958436|Pharmacokinetics|pharmacokinetics
5165368|NCT02958436|REGN3500|regn3500
5165369|NCT02958410|CD30|cd30
5165370|NCT02958410|CAR-T|car-t
5165371|NCT02958397|Myeloid Malignancies|myeloid malignancies
5165372|NCT02958397|CAR-T|car-t
5165374|NCT02958384|Myeloid Malignancies|myeloid malignancies
5165375|NCT02958384|CAR-T|car-t
5165376|NCT02958384|LeY|ley
5165377|NCT02958371|Functional magnetic resonance imaging|functional magnetic resonance imaging
5165378|NCT02958371|Taste|taste
5165379|NCT02958371|Feeding behavior|feeding behavior
5165380|NCT02958371|Choice behavior|choice behavior
5165381|NCT02958358|pulmonary hypertension|pulmonary hypertension
5165382|NCT02958358|ambrisentan|ambrisentan
5165383|NCT02958358|PET imaging|pet imaging
5165384|NCT02958358|CT/PET|ct/pet
5165385|NCT02958332|video games|video games
5165386|NCT02958306|cleft lip repair|cleft lip repair
5165387|NCT02958306|cheiloplasty|cheiloplasty
5165388|NCT02958306|PRP|prp
5165389|NCT02958306|platelet rich plasma|platelet rich plasma
5165390|NCT02958280|Exercise|exercise
5165391|NCT02958280|Smartphone|smartphone
5165392|NCT02958267|knee osteoarthritis|knee osteoarthritis
5165393|NCT02958267|regenerative medicine|regenerative medicine
5165394|NCT02958267|orthobiologics|orthobiologics
5165395|NCT02958267|cellular therapy|cellular therapy
5165396|NCT02958254|hamstring|hamstring
5165397|NCT02958254|ultrasonography|ultrasonography
5165398|NCT02958254|validation|validation
5165399|NCT02958254|magnetic resonance imaging|magnetic resonance imaging
5165400|NCT02958254|muscle thickness|muscle thickness
5165401|NCT02958241|spondylolisthesis|spondylolisthesis
5165402|NCT02958241|Lumbar spine|lumbar spine
5165404|NCT02958228|Positive Affect|positive affect
5165405|NCT02958228|Mental Imagery|mental imagery
5165406|NCT02958228|Cognitive Bias Modification|cognitive bias modification
5165407|NCT02958228|Cognitive Control Training|cognitive control training
5165408|NCT02958215|Orthostatic|orthostatic
5165409|NCT02958215|Cesarean section|cesarean section
5165410|NCT02958215|Pregnant|pregnant
5165411|NCT02958215|Phenyephrine|phenyephrine
5165412|NCT02958215|Hypotension|hypotension
5165413|NCT02958202|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5165415|NCT02958202|Dystrophin|dystrophin
5165416|NCT02958202|BMN 044|bmn 044
5165417|NCT02958202|PRO044|pro044
5165418|NCT02958202|BioMarin|biomarin
5165419|NCT02958189|Twitter|twitter
5165420|NCT02958189|social support|social support
5165421|NCT02958189|internet intervention|internet intervention
5165422|NCT02958189|sedentary lifestyle|sedentary lifestyle
5165423|NCT02958189|walking|walking
5165424|NCT02958189|behavior change|behavior change
5165425|NCT02958163|Hepatocellular cancer|hepatocellular cancer
5165426|NCT02958163|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5165427|NCT02958163|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5165428|NCT02958111|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5166023|NCT02954679|Stimulants|stimulants
5165430|NCT02958111|Capecitabine|capecitabine
5165431|NCT02958098|myocardial infarction|myocardial infarction
5165432|NCT02958098|stroke|stroke
5165433|NCT02958098|dilated cardiomyopathy|dilated cardiomyopathy
5165434|NCT02958098|systolic heart failure|systolic heart failure
5165435|NCT02958098|atrial fibrillation|atrial fibrillation
5165436|NCT02958098|aortic dissection|aortic dissection
5165437|NCT02958098|wearable devices|wearable devices
5165438|NCT02958098|genomic sequencing|genomic sequencing
5165439|NCT02958072|Malleoli ulcers|malleoli ulcers
5165440|NCT02958072|Diabetes|diabetes
5165441|NCT02958072|Healing|healing
5165442|NCT02958072|Dressing|dressing
5165443|NCT02958072|LeucoPatch|leucopatch
5165444|NCT02958059|ERCP|ercp
5165445|NCT02958059|prophylaxis|prophylaxis
5165446|NCT02958059|antibiotics|antibiotics
5165447|NCT02958059|infection|infection
5165448|NCT02958059|cholangitis|cholangitis
5165449|NCT02958020|cohort, osteoporosis, bone mineral density, Chinese|cohort, osteoporosis, bone mineral density, chinese
5165450|NCT02957981|BRCA1|brca1
5165451|NCT02957981|BRCA2|brca2
5165453|NCT02957981|Hereditary Cancer|hereditary cancer
5052639|NCT03669627|Fluad|fluad
5165454|NCT02957981|Prostate Cancer|prostate cancer
5165455|NCT02957981|Male Breast Cancer|male breast cancer
5165457|NCT02957955|Heart failure|heart failure
5165458|NCT02957942|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5165459|NCT02957942|Spasmodic dysphonia|spasmodic dysphonia
5165460|NCT02957942|Dystonia|dystonia
5165461|NCT02957877|Anticoagulation|anticoagulation
5165462|NCT02957877|Anti-Xa activity|anti-xa activity
5165463|NCT02957877|Low-molecular weight heparin|low-molecular weight heparin
5165464|NCT02957877|Unfractionated heparin|unfractionated heparin
5165465|NCT02957838|Transferrin Receptor|transferrin receptor
5165466|NCT02957838|Type 2 Diabetes|type 2 diabetes
5165467|NCT02957838|Stearic Acid (C18:0)|stearic acid (c18:0)
5165468|NCT02957838|Mitochondrial Morphology|mitochondrial morphology
5165469|NCT02957838|Crossover Study|crossover study
5165470|NCT02957812|Gait|gait
5165471|NCT02957812|Balance Control|balance control
5165472|NCT02957812|Orthotics|orthotics
5165473|NCT02957799|Pregnancy|pregnancy
5165474|NCT02957799|Home Healthcare Visits|home healthcare visits
5165475|NCT02957799|Community Health Workers|community health workers
5165476|NCT02957799|Infants|infants
5165481|NCT02957747|Women Veterans|women veterans
5165482|NCT02957747|Sexual Trauma|sexual trauma
5165483|NCT02957734|Vertical dimension of occlusion|vertical dimension of occlusion
5165484|NCT02957734|Direct composite restorations|direct composite restorations
5165485|NCT02957734|Indirect composite restorations|indirect composite restorations
5165486|NCT02957734|Tooth wear|tooth wear
5165487|NCT02957734|Failure|failure
5165488|NCT02957734|Quality of Life|quality of life
5165489|NCT02957695|frontal brain lesions|frontal brain lesions
5165490|NCT02957695|neurofeedback|neurofeedback
5165491|NCT02957695|cognitive functions|cognitive functions
5165495|NCT02957630|Estetrol (E4)|estetrol (e4)
5165496|NCT02957630|Drospirenone (DRSP)|drospirenone (drsp)
5165497|NCT02957630|Ethinylestradiol (EE)|ethinylestradiol (ee)
5165498|NCT02957630|Levonorgestrel (LNG)|levonorgestrel (lng)
5165499|NCT02957630|Oral contraceptive|oral contraceptive
5165500|NCT02957630|Prevention of pregnancy|prevention of pregnancy
5165501|NCT02957630|Hemostasis|hemostasis
5165502|NCT02957630|Metabolism|metabolism
5165503|NCT02957617|Neuropathic Pain From Lumbosacral Radiculopathy|neuropathic pain from lumbosacral radiculopathy
5165504|NCT02957604|Pregnancy; Cardiovascular Diseases; High serum cholesterol; FH; ASCVD|pregnancy; cardiovascular diseases; high serum cholesterol; fh; ascvd
5165505|NCT02957591|Depression|depression
5165506|NCT02957591|probiotic supplementation|probiotic supplementation
5165507|NCT02957591|Adjuvant Therapy|adjuvant therapy
5165508|NCT02957591|Gut microbiome|gut microbiome
5165509|NCT02957591|Psychological functioning|psychological functioning
5165510|NCT02957591|Brain imaging|brain imaging
5165512|NCT02957591|Sleep|sleep
5165513|NCT02957279|sepsis|sepsis
5165514|NCT02957279|exosomes|exosomes
5165515|NCT02957279|dendritic cell|dendritic cell
5165516|NCT02957188|Eicosapentaenoic acid|eicosapentaenoic acid
5165517|NCT02957188|Arachidonic acid|arachidonic acid
5165518|NCT02957188|Metabolism|metabolism
5165519|NCT02957188|Healthy aging|healthy aging
5165520|NCT02957084|difficult laryngoscopy|difficult laryngoscopy
5165521|NCT02957084|neck circumference|neck circumference
5165522|NCT02957084|sternomental distance|sternomental distance
5165523|NCT02957084|thyromental distance|thyromental distance
5165524|NCT02957084|hyomental distance|hyomental distance
5165525|NCT02957084|thyrosternal distance|thyrosternal distance
5165526|NCT02956889|Carcinoma, Basal Cell|carcinoma, basal cell
5165527|NCT02956889|Vismodegib|vismodegib
5165528|NCT02956889|Radiotherapy|radiotherapy
5423222|NCT01616602|patients|patients
5165529|NCT02956824|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5165530|NCT02956824|Sacro-iliac joints|sacro-iliac joints
5165531|NCT02956824|Pelvis|pelvis
5165532|NCT02956824|Erosion|erosion
5165533|NCT02956824|Fat deposit|fat deposit
5165534|NCT02956824|Subchondral sclerosis|subchondral sclerosis
5165535|NCT02956824|Bone marrow edema|bone marrow edema
5165536|NCT02956824|Axial spondyloarthritis|axial spondyloarthritis
5165537|NCT02956759|diabetic retinopathy|diabetic retinopathy
5165538|NCT02956759|Pan-retinal photocoagulation|pan-retinal photocoagulation
5165539|NCT02956759|proliferative|proliferative
5165540|NCT02956759|non-proliferative|non-proliferative
5165541|NCT02956733|inexpensive, fasciotomy|inexpensive, fasciotomy
5165542|NCT02956694|Aged|aged
5165543|NCT02956694|Cognitive impairment|cognitive impairment
5165544|NCT02956694|Neurocognitive Disorders|neurocognitive disorders
5165545|NCT02956694|Shared decision making|shared decision making
5165546|NCT02956694|Distance learning|distance learning
5165547|NCT02956694|Primary care|primary care
5165548|NCT02956694|Decision support tool|decision support tool
5165549|NCT02956694|Patient decision aid|patient decision aid
5165550|NCT02956252|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
5165551|NCT02956252|spinal anesthesia|spinal anesthesia
5165552|NCT02956252|general anesthesia|general anesthesia
5165553|NCT02956252|cholecystectomy|cholecystectomy
5165554|NCT02956161|Sleep|sleep
5165555|NCT02956161|Auditory stimulations|auditory stimulations
5052830|NCT03668379|HIV|hiv
5165556|NCT02956161|Slow oscillations|slow oscillations
5165557|NCT02957578|Tympanostomy Tube|tympanostomy tube
5165558|NCT02957578|Ventilation Tube|ventilation tube
5165559|NCT02957578|Grommet|grommet
5165560|NCT02957578|Otitis Media|otitis media
5165561|NCT02957578|Middle Ear Effusion|middle ear effusion
5165562|NCT02957565|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5165563|NCT02957565|Questionnaires|questionnaires
5165564|NCT02957565|Surveys|surveys
5165565|NCT02957565|Videos|videos
5165566|NCT02957565|Advanced Cancer|advanced cancer
5165567|NCT02957539|motivation|motivation
5165568|NCT02957539|patient incentives|patient incentives
5165569|NCT02957513|Diabetes|diabetes
5165570|NCT02957513|Uncontrolled|uncontrolled
5165571|NCT02957513|Chronic Disease|chronic disease
5165572|NCT02957513|Chronic Conditions|chronic conditions
5165573|NCT02957513|Medically Underserved Areas|medically underserved areas
5165574|NCT02957513|African Americans|african americans
5165575|NCT02957513|Health Coaching|health coaching
5165576|NCT02957513|Health Education|health education
5165577|NCT02957513|Text Messaging|text messaging
5165578|NCT02957513|Text Messages|text messages
5165579|NCT02957513|Mobile Health|mobile health
5165580|NCT02957474|Healthy Volunteers|healthy volunteers
5165581|NCT02957474|Pharmacokinetics|pharmacokinetics
5165582|NCT02957474|Food Effect|food effect
5165583|NCT02957474|Proton Pump|proton pump
5165584|NCT02957474|GED-0301|ged-0301
5165585|NCT02957474|Mongersen|mongersen
5165586|NCT02957461|Concussion|concussion
5165587|NCT02957461|Mild Traumatic Brain Injury|mild traumatic brain injury
5165588|NCT02957461|Sport Related Concussion|sport related concussion
5165589|NCT02957422|milk|milk
5165590|NCT02957422|brain aging|brain aging
5165591|NCT02957422|antioxidant|antioxidant
5165592|NCT02957422|glutathione|glutathione
5165593|NCT02957422|dietary intervention|dietary intervention
5165594|NCT02957422|brain imaging|brain imaging
5165595|NCT02957409|Heart failure|heart failure
5962141|NCT04282707|Endoscopic submucosal dissection, defect closure|endoscopic submucosal dissection, defect closure
5032135|NCT03798340|stroke|stroke
5165596|NCT02957409|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5165597|NCT02957409|HFrEF|hfref
5165598|NCT02957383|Sleep, Melatonin|sleep, melatonin
5165599|NCT02957383|Circadian Rhythm|circadian rhythm
5165600|NCT02957383|Temperature|temperature
5165601|NCT02957383|screen illumination|screen illumination
5165602|NCT02957344|health communication|health communication
5165603|NCT02957344|Zika virus|zika virus
5165604|NCT02957344|legislation|legislation
5165605|NCT02957344|vaccination|vaccination
5165606|NCT02957344|Child Care|child care
5165607|NCT02957305|misoprostol|misoprostol
5165608|NCT02957305|miscarriage|miscarriage
5165609|NCT02957266|cervical cancer|cervical cancer
5165610|NCT02957266|interstitial brachytherapy|interstitial brachytherapy
5165611|NCT02957266|gemcitabine|gemcitabine
5165612|NCT02957266|volumetric arc therapy|volumetric arc therapy
5165613|NCT02957253|Quality of care|quality of care
5165614|NCT02957253|Health related quality of life|health related quality of life
5165615|NCT02957253|Nurse-led clinic|nurse-led clinic
5165616|NCT02957253|Health economics|health economics
5165617|NCT02957240|Forearm [A01.378.800.585]|forearm [a01.378.800.585]
5165618|NCT02957240|Radius [A02.835.232.087.090.700]|radius [a02.835.232.087.090.700]
5165619|NCT02957240|Motor Skills [F02.808.260]|motor skills [f02.808.260]
5165620|NCT02957240|Task Performance and Analysis [F02.808.600]|task performance and analysis [f02.808.600]
5165621|NCT02957240|Casts, Surgical [E07.858.442.660.430.500]|casts, surgical [e07.858.442.660.430.500]
5165622|NCT02957240|Splints [E07.858.690.725.430.750]|splints [e07.858.690.725.430.750]
5165623|NCT02957240|motor representation techniques|motor representation techniques
5165624|NCT02957240|mirror therapy|mirror therapy
5165625|NCT02957240|Women [M01.975]|women [m01.975]
5165626|NCT02957227|Alzheimer's disease|alzheimer's disease
5165627|NCT02957227|Frontotemporal Dementia|frontotemporal dementia
5165628|NCT02957227|Lewy Body Dementia|lewy body dementia
5165629|NCT02957227|Diagnosis|diagnosis
5165630|NCT02957175|Immunophenotyping|immunophenotyping
5165631|NCT02957175|Perioperative Care|perioperative care
5165632|NCT02957175|Innate Immunity|innate immunity
5165633|NCT02957175|Cardiac Surgical Procedures|cardiac surgical procedures
5165634|NCT02957136|Respiratory Tract Infections|respiratory tract infections
5165635|NCT02957136|Influenza, Human|influenza, human
5165636|NCT02957136|Common Cold|common cold
5165637|NCT02957136|Viral Infection|viral infection
5165638|NCT02957136|Pathology, Molecular|pathology, molecular
5165639|NCT02957136|Molecular Diagnostics|molecular diagnostics
5165640|NCT02957136|Diagnostic Testing|diagnostic testing
5165641|NCT02957136|Clinical Microbiology|clinical microbiology
5165642|NCT02957136|Polymerase Chain Reaction|polymerase chain reaction
5165643|NCT02957136|Antibiotic Stewardship|antibiotic stewardship
5165644|NCT02957136|Antimicrobial Use|antimicrobial use
5165645|NCT02957136|Emergency Department|emergency department
5165646|NCT02957136|Emergency Room|emergency room
5165647|NCT02957123|macrophages M2 type|macrophages m2 type
5165648|NCT02957123|cytokines|cytokines
5165649|NCT02957123|intranasal administration|intranasal administration
5165650|NCT02957123|neuroprotection|neuroprotection
5165651|NCT02957123|neuroregeneration|neuroregeneration
5165652|NCT02957123|organic brain syndrome|organic brain syndrome
5165653|NCT02957123|neurocognitive disorders|neurocognitive disorders
5165654|NCT02957097|Gabapentin|gabapentin
5165655|NCT02957097|acute pain|acute pain
5165656|NCT02957058|Colonoscopy|colonoscopy
5165657|NCT02957058|Endoscopic Mucosal Resection|endoscopic mucosal resection
5165658|NCT02957058|Adenoma Recurrence|adenoma recurrence
5165659|NCT02957058|EMR defect thermal ablation|emr defect thermal ablation
5165660|NCT02956993|peripheral artery disease|peripheral artery disease
5165662|NCT02956993|vonapanitase|vonapanitase
5165663|NCT02956993|critical limb ischemia|critical limb ischemia
5165664|NCT02956993|CLI|cli
5165665|NCT02956993|tibial artery|tibial artery
5165672|NCT02956993|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
5165673|NCT02956993|CELA1|cela1
5165674|NCT02956993|PRT-201|prt-201
5165675|NCT02956980|type 1 interferons|type 1 interferons
5165676|NCT02956980|children|children
5165677|NCT02956980|gender|gender
5165678|NCT02956980|pubertal status|pubertal status
5165679|NCT02956980|sex difference|sex difference
5165680|NCT02956967|Non-Interventional Study|non-interventional study
5165681|NCT02956954|Enzyme replacement therapy|enzyme replacement therapy
5165682|NCT02956941|Academic performance|academic performance
5165683|NCT02956941|Behaviour change communication|behaviour change communication
5165684|NCT02956941|Nutritional status|nutritional status
5165685|NCT02956941|School children|school children
5165686|NCT02956941|Ethiopia|ethiopia
5165687|NCT02956915|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5165688|NCT02956915|SAPIEN-3 prostheses|sapien-3 prostheses
5165689|NCT02956915|Length of stay|length of stay
5165690|NCT02956915|Aortic stenosis|aortic stenosis
5165691|NCT02956837|Vaccines|vaccines
5165692|NCT02956837|Respiratory Syncytial Viruses|respiratory syncytial viruses
5165693|NCT02956837|Safety|safety
5962142|NCT04282655|breast milk|breast milk
5165694|NCT02956837|Reactogenicity|reactogenicity
5962143|NCT04282655|milk warming|milk warming
5165695|NCT02956837|Ranking of Formulations|ranking of formulations
5165696|NCT02956837|Immunogenicity|immunogenicity
5165697|NCT02956811|Type 2 Diabetes|type 2 diabetes
5165698|NCT02956811|Left Ventricular Hypertrophy|left ventricular hypertrophy
5165699|NCT02956811|Dapagliflozin|dapagliflozin
5165700|NCT02956798|Renal Cell, Stereotactic ablative body radiotherapy (SAbR), Pazopanib, Oligo-mets|renal cell, stereotactic ablative body radiotherapy (sabr), pazopanib, oligo-mets
5165701|NCT02956785|Propess|propess
5165702|NCT02956707|neonates|neonates
5165703|NCT02956707|cardiopulmonary bypass|cardiopulmonary bypass
5165704|NCT02956707|adrenal insufficiency|adrenal insufficiency
5165705|NCT02956707|congenital heart disease|congenital heart disease
5165706|NCT02956668|tDCS|tdcs
5165707|NCT02956668|Visual field|visual field
5165708|NCT02956668|Stroke|stroke
5165710|NCT02956590|dyslipidemia|dyslipidemia
5165711|NCT02956590|obesity|obesity
5165712|NCT02956590|pitavastatin|pitavastatin
5165713|NCT02956590|lipids|lipids
5165714|NCT02956577|Global Longitudinal Strain (GLS)|global longitudinal strain (gls)
5165715|NCT02956577|Coronary Flow Velocity Reserve (CFVR)|coronary flow velocity reserve (cfvr)
5165716|NCT02956577|Cardiac dysfunction|cardiac dysfunction
5165717|NCT02956577|Microcirculation|microcirculation
5165718|NCT02956577|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
5165719|NCT02956577|Type 1 Diabetes|type 1 diabetes
5165720|NCT02956577|Type 2 Diabetes|type 2 diabetes
5165822|NCT02955862|Cryptococcal antigenemia|cryptococcal antigenemia
5165734|NCT02956473|Breast Cancer|breast cancer
5165735|NCT02956447|Kisspeptin|kisspeptin
5165736|NCT02956447|Hyperprolactinemia|hyperprolactinemia
5165737|NCT02956408|Obesity|obesity
5165738|NCT02956408|Pediatrics|pediatrics
5165739|NCT02956408|Vitamin D deficiency|vitamin d deficiency
5165740|NCT02956395|adaptive case management approach|adaptive case management approach
5165741|NCT02956395|Transitional Care|transitional care
5165742|NCT02956395|multimorbidity|multimorbidity
5165743|NCT02956382|Ibrutinib|ibrutinib
5165744|NCT02956382|Venetoclax|venetoclax
5165745|NCT02956382|Follicular|follicular
5165746|NCT02956382|Refractory|refractory
5165747|NCT02956382|Relapsed|relapsed
5165748|NCT02956382|Lymphoma|lymphoma
5165749|NCT02956343|Atrial fibrillation|atrial fibrillation
5165750|NCT02956343|cardiovascular App|cardiovascular app
5165751|NCT02956343|Rhythm monitoring|rhythm monitoring
5165752|NCT02956343|Stroke prevention|stroke prevention
5165753|NCT02956330|RVO|rvo
5165754|NCT02956330|ME|me
5052955|NCT03667664|Nutrition|nutrition
5165755|NCT02956330|Central Subfield Thickness|central subfield thickness
5165756|NCT02956330|OCT|oct
5165757|NCT02956330|Optical Coherence Tomography|optical coherence tomography
5165758|NCT02956330|Cystoid Macular Edema|cystoid macular edema
5165759|NCT02956330|Subretinal Fluid|subretinal fluid
5165760|NCT02956330|Eylea|eylea
5165761|NCT02956330|Aflibercept|aflibercept
5165762|NCT02956330|Anti-VEGF|anti-vegf
5165763|NCT02956291|glioma|glioma
5165764|NCT02956291|brain tumor|brain tumor
5165765|NCT02956291|brain metastasis|brain metastasis
5165766|NCT02956278|allopurinol|allopurinol
5165767|NCT02956239|cervical precancer|cervical precancer
5165768|NCT02956239|screening|screening
5165769|NCT02956239|treatment|treatment
5165770|NCT02956239|thermo-coagulation|thermo-coagulation
5165771|NCT02956239|thermal ablation|thermal ablation
5165772|NCT02956239|Reducing overtreatment|reducing overtreatment
5165774|NCT02956213|air filter|air filter
5165775|NCT02956213|indoor air quality|indoor air quality
5165776|NCT02956213|respiratory symptoms|respiratory symptoms
5165777|NCT02956213|emphysema|emphysema
5165778|NCT02956213|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5165779|NCT02956213|tobacco use|tobacco use
5165780|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride
5165781|NCT02956200|Intravenous thrombolysis|intravenous thrombolysis
5165782|NCT02956200|Mechanical thrombectomy|mechanical thrombectomy
5165783|NCT02956200|Acute ischemic stroke|acute ischemic stroke
5165784|NCT02956096|tDCS|tdcs
5165785|NCT02956096|Stroke|stroke
5165786|NCT02956096|Autonomic Modulation|autonomic modulation
5165787|NCT02956070|dental bleaching|dental bleaching
5165788|NCT02956070|antiinflammatory|antiinflammatory
5165789|NCT02956070|tooth sensitivity|tooth sensitivity
5165798|NCT02956018|children|children
5165799|NCT02955979|acute renal insufficiency|acute renal insufficiency
5165800|NCT02955979|Iodinated Contrast Agents|iodinated contrast agents
5165801|NCT02955979|pediatric|pediatric
5165802|NCT02955966|Aspergillosis|aspergillosis
5165803|NCT02955966|Haematological malignancy|haematological malignancy
5165804|NCT02955966|18F-FDG PET/CT|18f-fdg pet/ct
5165805|NCT02955966|Biomarkers|biomarkers
5165806|NCT02955940|Solid tumors|solid tumors
5165807|NCT02955940|ruxolitinib|ruxolitinib
5165808|NCT02955940|regorafenib|regorafenib
5165809|NCT02955940|capecitabine|capecitabine
5165810|NCT02955927|Myopia control,ortho-k, atropine eye drops, children|myopia control,ortho-k, atropine eye drops, children
5165811|NCT02955914|Optimism|optimism
5165812|NCT02955914|Pessimism|pessimism
5165813|NCT02955914|Recovery|recovery
5165814|NCT02955914|Elective Cardiac surgery|elective cardiac surgery
5165815|NCT02955901|Randomized controlled trial|randomized controlled trial
5165816|NCT02955901|Colonoscopy|colonoscopy
5165817|NCT02955901|Colon Disease|colon disease
5165818|NCT02955901|Low residue diet|low residue diet
5165819|NCT02955901|Colon preparation|colon preparation
5165820|NCT02955875|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5165821|NCT02955875|Pharmaceutical Services|pharmaceutical services
5165823|NCT02955862|Cryptococcal meningitis|cryptococcal meningitis
5165824|NCT02955862|HIV/AIDS|hiv/aids
5165825|NCT02955849|glaucoma|glaucoma
5165827|NCT02955849|China|china
5165829|NCT02955836|Patient Safety|patient safety
5165830|NCT02955836|Quality indicator|quality indicator
5165831|NCT02955836|Information system|information system
5165832|NCT02955836|Nursing|nursing
5165833|NCT02955836|Healthcare Quality|healthcare quality
5165834|NCT02955836|Quality measurement|quality measurement
5165835|NCT02955823|B cell Lymphoma|b cell lymphoma
5165836|NCT02955823|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5165837|NCT02955823|Elderly patients|elderly patients
5165838|NCT02955810|Newly Diagnosed|newly diagnosed
5165839|NCT02955810|Treatment Naiive|treatment naiive
5165840|NCT02955797|Meningitis|meningitis
5165841|NCT02955797|Meningococcal Meningitis|meningococcal meningitis
5165842|NCT02955797|MenACYW conjugate vaccine|menacyw conjugate vaccine
5165843|NCT02955797|Nimenrix®|nimenrix®
5165844|NCT02955797|Menjugate®|menjugate®
5165845|NCT02955771|photodynamic therapy(PDT)|photodynamic therapy(pdt)
5165846|NCT02955771|stenting|stenting
5165847|NCT02955771|Hilar Cholangiocarcinoma|hilar cholangiocarcinoma
5165848|NCT02955771|Deuteporfin|deuteporfin
5165849|NCT02955719|Collaborative Care|collaborative care
5165850|NCT02955719|Depression|depression
5165852|NCT02955719|Mild Cognitive Impairment|mild cognitive impairment
5165853|NCT02955719|Integrated Care Pathway|integrated care pathway
5165854|NCT02955693|Pharmacokinetics|pharmacokinetics
5165855|NCT02955693|Healthy volunteers|healthy volunteers
5165856|NCT02955693|Monomethylfumarate|monomethylfumarate
5165857|NCT02955693|Dimethyl fumarate|dimethyl fumarate
5165858|NCT02955693|Fumaderm®|fumaderm®
5165859|NCT02955693|Ethyl fumarate|ethyl fumarate
5165860|NCT02955680|emergence delirium|emergence delirium
5165861|NCT02955680|emergence time|emergence time
5165862|NCT02955680|bispectral index|bispectral index
5165863|NCT02955667|invivo microscopy|invivo microscopy
5165864|NCT02955667|colposcopy|colposcopy
5165865|NCT02955667|cervical precancer and cancer|cervical precancer and cancer
5053046|NCT03667157|Intravenous|intravenous
5165866|NCT02955641|Laser peripheral iridotomy|laser peripheral iridotomy
5165867|NCT02955641|topical anti-inflammatory drops|topical anti-inflammatory drops
5165868|NCT02955602|PBC|pbc
5165869|NCT02955602|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
5165870|NCT02955576|Psoriasis|psoriasis
5165871|NCT02955563|decision making for incapacitated patients|decision making for incapacitated patients
5165872|NCT02955563|intensive care|intensive care
5165873|NCT02955563|surrogate decision making|surrogate decision making
5165874|NCT02955563|patient centered care|patient centered care
5165875|NCT02955563|Palliative Care|palliative care
5165876|NCT02955563|End of Life|end of life
5165877|NCT02955563|Quality of Communication|quality of communication
5165879|NCT02955563|Depression|depression
5165880|NCT02955550|Multiple Myeloma|multiple myeloma
5165881|NCT02955550|Plasma Cell Myeloma|plasma cell myeloma
5165882|NCT02955550|Plasma Cell Neoplasm|plasma cell neoplasm
5165883|NCT02955550|Relapsed/refractory Myeloma|relapsed/refractory myeloma
5165884|NCT02955550|PNK-007|pnk-007
5165885|NCT02955550|Recombinant Human IL-2 (RHIL-2)|recombinant human il-2 (rhil-2)
5165886|NCT02955550|Human IL-2|human il-2
5165887|NCT02955550|Bone Marrow Transplant|bone marrow transplant
5165888|NCT02955537|Hypertension|hypertension
5165889|NCT02955537|mHealth|mhealth
5165890|NCT02955485|Ankle|ankle
5165891|NCT02955485|Instability|instability
5165892|NCT02955485|Prediction|prediction
5165893|NCT02955472|Neuralgia, Postherpetic|neuralgia, postherpetic
5165894|NCT02955472|Postherpetic Neuralgia|postherpetic neuralgia
5165895|NCT02955472|Diabetic Neuropathies|diabetic neuropathies
5165896|NCT02955472|Diabetic Neuralgia|diabetic neuralgia
5165897|NCT02955472|Diabetic Polyneuropathy|diabetic polyneuropathy
5165898|NCT02955472|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5165899|NCT02955472|Neuralgia|neuralgia
5165900|NCT02955472|Neuropathic Pain|neuropathic pain
5165901|NCT02955472|Pregabalin|pregabalin
5165902|NCT02955472|Pharmacokinetics|pharmacokinetics
5165903|NCT02955472|Bioequivalent|bioequivalent
5165904|NCT02955459|Healthy volunteers|healthy volunteers
5165905|NCT02955459|Pharmacokinetics|pharmacokinetics
5165906|NCT02955446|Refractory Tumors|refractory tumors
5165907|NCT02955446|Advanced Solid Tumors|advanced solid tumors
5165908|NCT02955433|Rideshare|rideshare
5165909|NCT02955433|Digital transportation network|digital transportation network
5165910|NCT02955433|Missed appointment|missed appointment
5165911|NCT02955420|Autoantibodies|autoantibodies
5165912|NCT02955420|Heart Failure|heart failure
5165913|NCT02955420|Fatigue Syndrome, Chronic|fatigue syndrome, chronic
5165914|NCT02955420|Idiopathic Pulmonary Hypertension|idiopathic pulmonary hypertension
5165915|NCT02955420|Cardiomyopathies|cardiomyopathies
5165916|NCT02955394|ER+/Her2 - breast cancer|er+/her2 - breast cancer
5165917|NCT02955394|Preoperative Fulvestrant|preoperative fulvestrant
5165918|NCT02955394|Enzalutamide|enzalutamide
5165919|NCT02955368|DP-R212|dp-r212
5165920|NCT02955329|THC|thc
5165921|NCT02955329|Tobacco|tobacco
5165922|NCT02955329|Vaping|vaping
5165932|NCT02955251|Advanced solid tumor|advanced solid tumor
5165933|NCT02955251|Nivolumab|nivolumab
5165934|NCT02955251|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5165935|NCT02955251|Non-squamous NSCLC|non-squamous nsclc
5165936|NCT02955251|Ovarian cancer|ovarian cancer
5165937|NCT02955238|Intervention|intervention
5165938|NCT02955238|Cardiovascular Disease|cardiovascular disease
5165939|NCT02955238|CVD|cvd
5165940|NCT02955238|Diabetes|diabetes
5165943|NCT02955238|Medication Adherence|medication adherence
5165944|NCT02955238|Risk Factors|risk factors
5165945|NCT02955238|T2D|t2d
5165951|NCT02955212|Rheumatoid Arthritis|rheumatoid arthritis
5423223|NCT01616602|presenting|presenting
5423224|NCT01616602|elective|elective
5165952|NCT02955212|Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)|conventional synthetic disease-modifying anti-rheumatic drugs (csdmards)
5165953|NCT02955212|ABT-494|abt-494
5165954|NCT02955134|central blinded histological assessment|central blinded histological assessment
5165955|NCT02955134|traditional Chinese medicine intervention|traditional chinese medicine intervention
5165956|NCT02955134|biological specimen banks|biological specimen banks
5165957|NCT02955121|Cytochrome P-450 CYP2C19|cytochrome p-450 cyp2c19
5165958|NCT02955121|Pharmacogenetics|pharmacogenetics
5165959|NCT02955121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5165960|NCT02955121|Percutaneous Coronary Intervention|percutaneous coronary intervention
5165967|NCT02955056|Weber B|weber b
5165968|NCT02955043|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5165969|NCT02955043|Fatigue|fatigue
5165970|NCT02955043|Insomnia|insomnia
5165971|NCT02955043|Depression|depression
5165972|NCT02955043|Behavioral Intervention|behavioral intervention
5165973|NCT02955017|obesity|obesity
5165974|NCT02955017|children|children
5165975|NCT02955017|adolescents|adolescents
5165976|NCT02955017|new technology|new technology
5165977|NCT02955017|mobile health|mobile health
5165978|NCT02955017|chronic disease|chronic disease
5165979|NCT02955004|silent brain embolism|silent brain embolism
5165980|NCT02955004|atrial fibrillation|atrial fibrillation
5165981|NCT02955004|cardioversion|cardioversion
5165982|NCT02954965|graduate student|graduate student
5165983|NCT02954965|burnout|burnout
5165984|NCT02954965|stress|stress
5165985|NCT02954965|mood|mood
5165986|NCT02954939|lupus nephritis|lupus nephritis
5165987|NCT02954939|lymphocyte subsets|lymphocyte subsets
5165988|NCT02954939|cytokines|cytokines
5165989|NCT02954939|mycophenolate mofetil|mycophenolate mofetil
5165990|NCT02954939|cyclophosphamide|cyclophosphamide
5165991|NCT02954900|Breast Cancer Prevention|breast cancer prevention
5165992|NCT02954900|Risk Assessment|risk assessment
5165993|NCT02954900|Chemoprevention|chemoprevention
5165994|NCT02954900|Decision Making|decision making
5165995|NCT02954887|GWP42003-P|gwp42003-p
5165996|NCT02954887|Cannabidiol|cannabidiol
5165997|NCT02954848|Drug therapy|drug therapy
5165998|NCT02954809|fatigue|fatigue
5165999|NCT02954809|sleep disturbances|sleep disturbances
5166000|NCT02954809|circadian activity rhythms|circadian activity rhythms
5166001|NCT02954783|Prostate cancer|prostate cancer
5166002|NCT02954783|Localized|localized
5166003|NCT02954783|Exercise|exercise
5166004|NCT02954783|Physical activity|physical activity
5166005|NCT02954783|Natural killer cells|natural killer cells
5166006|NCT02954783|Immune cells|immune cells
5166007|NCT02954757|uterine adenomyosis|uterine adenomyosis
5166008|NCT02954744|uterine fibroid|uterine fibroid
5166009|NCT02954731|Cognitive Behavior Therapy|cognitive behavior therapy
5166010|NCT02954731|Negative Affect|negative affect
5166011|NCT02954731|Unified Protocol|unified protocol
5166012|NCT02954731|Session Tracking|session tracking
5166013|NCT02954731|Mechanisms of Change in Psychotherapy|mechanisms of change in psychotherapy
5166014|NCT02954718|activity performance|activity performance
5166015|NCT02954718|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5166016|NCT02954718|virtual reality|virtual reality
5166017|NCT02954679|Psychoactive Substances Consumption|psychoactive substances consumption
5166018|NCT02954679|Substance-related Disorder|substance-related disorder
5240485|NCT02500641|Humans|humans
5166019|NCT02954679|Off label-use|off label-use
5166020|NCT02954679|Cognitive Enhancement|cognitive enhancement
5166021|NCT02954679|Students|students
5166022|NCT02954679|Doping|doping
5166031|NCT02954666|ganglionated plexi|ganglionated plexi
5166032|NCT02954666|anterior right ganglionated plexus|anterior right ganglionated plexus
5166033|NCT02954666|syncope|syncope
5166034|NCT02954653|relapsed|relapsed
5166035|NCT02954653|refractory|refractory
5166036|NCT02954653|acute myeloid leukemia|acute myeloid leukemia
5166038|NCT02954627|Osteoarthritis|osteoarthritis
5166039|NCT02954627|Obesity|obesity
5962144|NCT04282642|Insomnia|insomnia
5032584|NCT03795454|MEG|meg
5166040|NCT02954627|Liraglutide 3 mg|liraglutide 3 mg
5166041|NCT02954627|Liraglutide|liraglutide
5166042|NCT02954627|Ultrasound|ultrasound
5166043|NCT02954601|Oral Insulin|oral insulin
5166044|NCT02954601|DM T2 (Diabetes Mellitus Type 2)|dm t2 (diabetes mellitus type 2)
5166045|NCT02954562|anxiety|anxiety
5166046|NCT02954562|fMRI|fmri
5166047|NCT02954562|emotion regulation|emotion regulation
5166048|NCT02954549|vitamin D deficiency, genomics, vitamin D supplementation|vitamin d deficiency, genomics, vitamin d supplementation
5166049|NCT02954536|pembrolizumab|pembrolizumab
5166050|NCT02954536|trastuzumab|trastuzumab
5166051|NCT02954536|capecitabine|capecitabine
5166052|NCT02954536|cisplatin|cisplatin
5166053|NCT02954536|Stage IV|stage iv
5166054|NCT02954536|HER2-positive|her2-positive
5166057|NCT02954536|Oxaliplatin|oxaliplatin
5166058|NCT02954536|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
5166320|NCT02953054|DMTS|dmts
5166067|NCT02954445|BCMA|bcma
5166068|NCT02954445|CAR-T|car-t
5166069|NCT02954432|transcranial Direct Current Stimulation|transcranial direct current stimulation
5166071|NCT02954432|non-invasive brain stimulation|non-invasive brain stimulation
5166072|NCT02954419|IgA Nephropathy|iga nephropathy
5166073|NCT02954419|Biomarker|biomarker
5166074|NCT02954406|Drug Therapy|drug therapy
5166075|NCT02954393|Periodontal disease|periodontal disease
5166076|NCT02954393|Metronidazole|metronidazole
5166077|NCT02954393|Amoxicillin|amoxicillin
5166078|NCT02954393|Scaling and root planing|scaling and root planing
5166079|NCT02954393|Healing phase|healing phase
5166081|NCT02954354|Baloxavir Marboxil|baloxavir marboxil
5166082|NCT02954354|Oseltamivir|oseltamivir
5166083|NCT02954354|Tamiflu®|tamiflu®
5166084|NCT02954302|Delayed gastric emptying|delayed gastric emptying
5166085|NCT02954302|pancreaticoduodenectomy|pancreaticoduodenectomy
5166086|NCT02954289|modifiable risk factors|modifiable risk factors
5166087|NCT02954289|lifestyle|lifestyle
5166088|NCT02954289|nutrition|nutrition
5166089|NCT02954289|weight control|weight control
5166090|NCT02954289|dietary intervention|dietary intervention
5166091|NCT02954289|health promotion|health promotion
5166092|NCT02954289|patient-partner outcomes|patient-partner outcomes
5166093|NCT02954289|survivorship|survivorship
5166094|NCT02954289|prostate cancer outcomes|prostate cancer outcomes
5166095|NCT02954276|safety|safety
5166096|NCT02954263|Multiple ascending dose (MAD)|multiple ascending dose (mad)
5166097|NCT02954237|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5166098|NCT02954237|Anticoagulant|anticoagulant
5166099|NCT02954237|Warfarin|warfarin
5166100|NCT02954237|Stroke|stroke
5166101|NCT02954224|sleep apnea, delirium|sleep apnea, delirium
5166102|NCT02954211|rTMS|rtms
5166103|NCT02954211|noninvasive brain stimulation|noninvasive brain stimulation
5166104|NCT02954211|physical therapy|physical therapy
5166105|NCT02954185|Shoulder Pain|shoulder pain
5166106|NCT02954146|Veterans|veterans
5166107|NCT02954146|Posttraumatic Stress Disorder|posttraumatic stress disorder
5166108|NCT02954146|Anger|anger
5166109|NCT02954146|Behavioral Health|behavioral health
5166110|NCT02954146|Mobile Health Technology|mobile health technology
5166111|NCT02954133|Alignment phase|alignment phase
5166112|NCT02954133|Photobiomodulation|photobiomodulation
5166113|NCT02954133|Orthodontic treatment|orthodontic treatment
5166114|NCT02954133|Malocclusion|malocclusion
5166115|NCT02954133|OrthoPulse™|orthopulse™
5166116|NCT02954133|Invisalign|invisalign
5166117|NCT02954120|8- hydroxy -2´- deoxyguanosine|8- hydroxy -2´- deoxyguanosine
5166118|NCT02954120|Malondialdehyde|malondialdehyde
5166119|NCT02954120|Total antioxidant status|total antioxidant status
5166120|NCT02954120|Oxidative stres|oxidative stres
5166121|NCT02954068|Oxytocin|oxytocin
5166122|NCT02954055|locally advanced|locally advanced
5166123|NCT02954055|metastatic|metastatic
5166124|NCT02954055|breast cancer|breast cancer
5166136|NCT02953990|Pregnancy|pregnancy
5166137|NCT02953990|Self-Management|self-management
5166138|NCT02953990|Yoga|yoga
5166139|NCT02953951|blood transfusion|blood transfusion
5166140|NCT02953951|free hemoglobin|free hemoglobin
5166141|NCT02953951|nitric oxide|nitric oxide
5166142|NCT02953951|endothelium-dependent vasodilatation|endothelium-dependent vasodilatation
5166143|NCT02953951|peripheral artery tonometry|peripheral artery tonometry
5166144|NCT02953951|cardiac surgery.|cardiac surgery.
5166153|NCT02953925|primary health care|primary health care
5166154|NCT02953925|village doctor|village doctor
5166155|NCT02953925|township hospital|township hospital
5166156|NCT02953925|community health center|community health center
5166157|NCT02953912|Rotation|rotation
5166158|NCT02953912|Reciprocation|reciprocation
5166159|NCT02953912|single file|single file
5166160|NCT02953912|postoperative pain|postoperative pain
5166161|NCT02953912|Reciproc|reciproc
5166162|NCT02953912|One Shape|one shape
5166163|NCT02953912|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
5166164|NCT02953899|Internet|internet
5962145|NCT04282642|Cognitive training|cognitive training
5166165|NCT02953899|Contingency Management|contingency management
5166166|NCT02953899|Gambling Disorder|gambling disorder
5166167|NCT02953899|Rural|rural
5166168|NCT02953886|Caries|caries
5166169|NCT02953886|Cavity|cavity
5166170|NCT02953886|Silver Diamine Fluoride (SDF)|silver diamine fluoride (sdf)
5166171|NCT02953886|HOMINGS|homings
5166174|NCT02953834|insulin regulation in pregnancy|insulin regulation in pregnancy
5166175|NCT02953834|kisspeptin|kisspeptin
5166176|NCT02953808|GSK2315698|gsk2315698
5166177|NCT02953808|Dose-ascending|dose-ascending
5166178|NCT02953808|Systemic amyloidosis|systemic amyloidosis
5166179|NCT02953782|Colorectal Neoplasms, Hu5F9-G4, CD47, cetuximab|colorectal neoplasms, hu5f9-g4, cd47, cetuximab
5166180|NCT02953756|Brain metastases|brain metastases
5166181|NCT02953756|Cognition|cognition
5166182|NCT02953756|Radiosurgery|radiosurgery
5166183|NCT02953756|Stereotactic radiosurgery|stereotactic radiosurgery
5166184|NCT02953756|Gamma Knife Radiosurgery|gamma knife radiosurgery
5166185|NCT02953756|Quality of Life|quality of life
5166187|NCT02953756|Anxiety|anxiety
5166188|NCT02953756|Depression|depression
5166189|NCT02953743|E7080|e7080
5166191|NCT02953743|Pharmacokinetic study|pharmacokinetic study
5166192|NCT02953743|Chinese participants|chinese participants
5166193|NCT02953743|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5166194|NCT02953717|Brain metastases|brain metastases
5166195|NCT02953717|Cognition|cognition
5166196|NCT02953717|Radiosurgery|radiosurgery
5166197|NCT02953717|Gamma Knife Radiosurgery|gamma knife radiosurgery
5166198|NCT02953717|Stereotactic radiosurgery|stereotactic radiosurgery
5166199|NCT02953717|Whole Brain Radiation Therapy|whole brain radiation therapy
5166200|NCT02953717|Quality of Life|quality of life
5166201|NCT02953717|Fatigue|fatigue
5166202|NCT02953717|Anxiety|anxiety
5166203|NCT02953717|Depression|depression
5166204|NCT02953704|Myelofibrosis|myelofibrosis
5166205|NCT02953704|essential thrombocythemia|essential thrombocythemia
5166206|NCT02953704|clinical characteristics|clinical characteristics
5166207|NCT02953704|disease burden|disease burden
5166208|NCT02953704|patient-reported outcomes|patient-reported outcomes
5166209|NCT02953691|perioperative|perioperative
5166210|NCT02953691|surgery|surgery
5166211|NCT02953691|pain|pain
5166212|NCT02953691|anxiety|anxiety
5166213|NCT02953691|post operative cognitive dysfunction|post operative cognitive dysfunction
5166214|NCT02953691|cognition|cognition
5166215|NCT02953678|Graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
5166216|NCT02953678|acute GVHD|acute gvhd
5166217|NCT02953678|steroid-refractory|steroid-refractory
5166218|NCT02953678|ruxolitinib|ruxolitinib
5166219|NCT02953678|Janus kinase inhibitor|janus kinase inhibitor
5166220|NCT02953665|Parkinson's Disease, Liraglutide|parkinson's disease, liraglutide
5166221|NCT02953665|Antidiabetic agents|antidiabetic agents
5166222|NCT02953665|GLP-1 agonists|glp-1 agonists
5166223|NCT02953665|Insulin resistance|insulin resistance
5166224|NCT02953626|pilot RCT|pilot rct
5166327|NCT02953028|Snoring|snoring
5166230|NCT02953613|coronary artery disease|coronary artery disease
5166231|NCT02953613|atherosclerosis|atherosclerosis
5166232|NCT02953587|Obesity|obesity
5166233|NCT02953587|Bariatric Surgery|bariatric surgery
5166234|NCT02953574|geriatric nursing|geriatric nursing
5166235|NCT02953548|GWP42003-P|gwp42003-p
5166236|NCT02953548|Cannabidiol|cannabidiol
5166237|NCT02953522|Polymorphism|polymorphism
5166238|NCT02953522|Folate|folate
5166239|NCT02953522|Oxidative stress|oxidative stress
5166240|NCT02953522|Overweight and Obesity|overweight and obesity
5166247|NCT02953496|peripheral artery disease|peripheral artery disease
5166249|NCT02953496|vonapanitase|vonapanitase
5166250|NCT02953496|claudication|claudication
5166251|NCT02953496|superficial femoral artery|superficial femoral artery
5166253|NCT02953496|popliteal artery|popliteal artery
5166254|NCT02953496|stenosis|stenosis
5166255|NCT02953496|elastase|elastase
5166256|NCT02953496|chymotrypsin-like elastase 1|chymotrypsin-like elastase 1
5166257|NCT02953496|CELA1|cela1
5166258|NCT02953496|PRT-201|prt-201
5166259|NCT02953483|Ex Vivo lung perfusion|ex vivo lung perfusion
5166260|NCT02953470|chronic pain|chronic pain
5166261|NCT02953470|community-dwelling|community-dwelling
5166262|NCT02953470|older adults|older adults
5776828|NCT00212901|Diabetes|diabetes
5166263|NCT02953470|physical activity|physical activity
5166264|NCT02953470|physiotherapy|physiotherapy
5166265|NCT02953470|behavioural medicine|behavioural medicine
5166266|NCT02953470|biopsychosocial|biopsychosocial
5166267|NCT02953470|exercise|exercise
5166268|NCT02953470|independency|independency
5166269|NCT02953470|everyday activities|everyday activities
5166270|NCT02953470|self-efficacy|self-efficacy
5166271|NCT02953470|quality of life|quality of life
5166272|NCT02953470|pain-related beliefs|pain-related beliefs
5166273|NCT02953470|pain-related disability|pain-related disability
5166274|NCT02953431|Asthma|asthma
5166275|NCT02953431|Obesity|obesity
5166276|NCT02953353|Obesity|obesity
5166277|NCT02953353|Feeding behavior|feeding behavior
5166278|NCT02953353|Transcranial direct current stimulation|transcranial direct current stimulation
5166279|NCT02953353|Weight loss|weight loss
5166280|NCT02953340|Neutropenia|neutropenia
5166281|NCT02953340|Breast Cancer|breast cancer
5166282|NCT02953340|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
5166283|NCT02953340|Early Stage Breast Cancer|early stage breast cancer
5166284|NCT02953340|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
5166285|NCT02953327|Non-Specific Effect of Vaccine|non-specific effect of vaccine
5166286|NCT02953327|Middle aged|middle aged
5166287|NCT02953327|Immunity, heterologous|immunity, heterologous
5166288|NCT02953301|Cutaneous T-Cell Lymphoma (CTLC)|cutaneous t-cell lymphoma (ctlc)
5166289|NCT02953301|Maintenance|maintenance
5166290|NCT02953301|resminostat|resminostat
5166291|NCT02953301|4SC|4sc
5166292|NCT02953301|HDAC|hdac
5166293|NCT02953301|Mycosis Fungoides|mycosis fungoides
5166294|NCT02953301|Sézary Syndrome|sézary syndrome
5166295|NCT02953262|Diabetes Mellitus|diabetes mellitus
5166296|NCT02953262|Personal Health Records|personal health records
5166297|NCT02953262|Patient Outcome Assessment|patient outcome assessment
5166298|NCT02953262|Mental Health|mental health
5166299|NCT02953184|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5166300|NCT02953184|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5166301|NCT02953184|breast cancer|breast cancer
5166302|NCT02953171|Irritable Bowel Syndrome|irritable bowel syndrome
5166303|NCT02953171|The human microbiome|the human microbiome
5166304|NCT02953171|Microbiota|microbiota
5166305|NCT02953171|Gut microbiota|gut microbiota
5166306|NCT02953171|Probiotics|probiotics
5166307|NCT02953171|Sauerkraut|sauerkraut
5166308|NCT02953106|Asthma|asthma
5166309|NCT02953106|Rhinitis|rhinitis
5166310|NCT02953106|Dymista|dymista
5166311|NCT02953106|allergy|allergy
5166312|NCT02953093|acarbose|acarbose
5166313|NCT02953093|aging|aging
5166314|NCT02953054|Pain|pain
5166315|NCT02953054|Bunionectomy|bunionectomy
5166316|NCT02953054|Dexmedetomidine|dexmedetomidine
5166317|NCT02953054|Transdermal|transdermal
5166318|NCT02953054|Patch|patch
5166319|NCT02953054|Postoperative|postoperative
5166321|NCT02953028|Continuous Positive Airway Pressure|continuous positive airway pressure
5166322|NCT02953028|Mandibular Advancing Splint|mandibular advancing splint
5166323|NCT02953028|Efficacy|efficacy
5166324|NCT02953028|Compliance|compliance
5166325|NCT02953028|Health related quality of life|health related quality of life
5166326|NCT02953028|Randomized Controlled Trial|randomized controlled trial
5166328|NCT02953028|Mandibular Advancing Appliance|mandibular advancing appliance
5166329|NCT02953028|Mandibular Advancing Device|mandibular advancing device
5166330|NCT02953028|Humans|humans
5166331|NCT02953028|Quality of Life|quality of life
5166332|NCT02953028|Sleep Apnea, Obstructive|sleep apnea, obstructive
5166333|NCT02953015|Chronic Migraine|chronic migraine
5166334|NCT02953015|Manipulative treatments|manipulative treatments
5166335|NCT02953015|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5166336|NCT02952989|MSI-high|msi-high
5166338|NCT02952989|PD-L1|pd-l1
5166339|NCT02952976|open abdomen|open abdomen
5166340|NCT02952976|Damage control|damage control
5166341|NCT02952976|Abdominal Compartment Syndrome|abdominal compartment syndrome
5166342|NCT02952950|Intra Oral Vacuum|intra oral vacuum
5166343|NCT02952950|protein content breastmilk|protein content breastmilk
5166344|NCT02952937|Neuralgia, Postherpetic|neuralgia, postherpetic
5166345|NCT02952937|Postherpetic Neuralgia|postherpetic neuralgia
5166346|NCT02952937|Diabetic Neuropathies|diabetic neuropathies
5166347|NCT02952937|Diabetic Neuralgia|diabetic neuralgia
5166348|NCT02952937|Diabetic Polyneuropathy|diabetic polyneuropathy
5166349|NCT02952937|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5166350|NCT02952937|Neuralgia|neuralgia
5166351|NCT02952937|Neuropathic Pain|neuropathic pain
5166352|NCT02952937|Pregabalin|pregabalin
5166353|NCT02952937|Pharmacokinetics|pharmacokinetics
5166354|NCT02952937|Bioequivalent|bioequivalent
5166355|NCT02952898|solar keratoses|solar keratoses
5166356|NCT02952872|Computerized Brief Intervention|computerized brief intervention
5166357|NCT02952833|Inactivated|inactivated
5166358|NCT02952833|Phase I|phase i
5166359|NCT02952833|placebo-controlled|placebo-controlled
5166360|NCT02952833|Vaccine|vaccine
5166361|NCT02952833|ZIKA|zika
5166362|NCT02952820|insomnia|insomnia
5166363|NCT02952794|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
5166364|NCT02952794|endoscopic mucosal band ligation (EMBL)|endoscopic mucosal band ligation (embl)
5166365|NCT02952781|ECG Monitoring|ecg monitoring
5166366|NCT02952781|Palpitations|palpitations
5166367|NCT02952716|carbon monoxide poisoning|carbon monoxide poisoning
5166368|NCT02952716|delayed encephalopathy|delayed encephalopathy
5166369|NCT02952638|Lipids|lipids
5166370|NCT02952638|lysophosphatidic acid|lysophosphatidic acid
5166371|NCT02952638|Lysophospholipids|lysophospholipids
5166372|NCT02952638|phosphatidylcholine|phosphatidylcholine
5166373|NCT02952638|lysophosphatidylcholine|lysophosphatidylcholine
5166374|NCT02952638|autotaxin|autotaxin
5166375|NCT02952638|dietary|dietary
5962146|NCT04282642|Sleep|sleep
5166376|NCT02952625|PET/MRI|pet/mri
5166377|NCT02952599|Non-interventional Study|non-interventional study
5166378|NCT02952599|Real World Evidence|real world evidence
5962147|NCT04282642|Cognition|cognition
5166379|NCT02952599|Patients with Acute VTE treated with Edoxaban|patients with acute vte treated with edoxaban
5166380|NCT02952599|Efficacy/Safety|efficacy/safety
5166381|NCT02952560|Ultrasound|ultrasound
5166382|NCT02952560|Computed Tomography|computed tomography
5166383|NCT02952560|Oral cavity size|oral cavity size
5166384|NCT02952560|The Mallampati classification|the mallampati classification
5166385|NCT02952534|CRPC|crpc
5166386|NCT02952534|PARP inhibitor|parp inhibitor
5166387|NCT02952534|PARPi|parpi
5166388|NCT02952534|BRCA|brca
5166390|NCT02952534|HRD|hrd
5166391|NCT02952534|TRITON|triton
5166392|NCT02952534|homologous recombination|homologous recombination
5166393|NCT02952534|DNA repair|dna repair
5166394|NCT02952534|DNA defect|dna defect
5166395|NCT02952534|DNA anomaly|dna anomaly
5166396|NCT02952534|BARD1|bard1
5166398|NCT02952534|CDK12|cdk12
5166399|NCT02952534|CHEK2|chek2
5166400|NCT02952534|FANCA|fanca
5166401|NCT02952534|NBN|nbn
5166402|NCT02952534|PALB2|palb2
5166403|NCT02952534|RAD51|rad51
5166404|NCT02952534|RAD51B|rad51b
5166405|NCT02952534|RAD51C|rad51c
5166406|NCT02952534|RAD51D|rad51d
5166407|NCT02952534|RAD54L|rad54l
5166408|NCT02952534|germline|germline
5166409|NCT02952534|somatic|somatic
5166410|NCT02952534|mCRPC|mcrpc
5166411|NCT02952495|Alcohol Consumption|alcohol consumption
5166412|NCT02952495|Older Adults|older adults
5166413|NCT02952482|adrenoleukodystrophy|adrenoleukodystrophy
5166414|NCT02952482|C26:0-lyso-PC|c26:0-lyso-pc
5166415|NCT02952469|Positron-Emission Tomography|positron-emission tomography
5166416|NCT02952469|(68Ga)Glu-urea-Lys(Ahx)-HBED-CC|(68ga)glu-urea-lys(ahx)-hbed-cc
5166417|NCT02952469|(68Ga)PSMA-HBED-CC|(68ga)psma-hbed-cc
5166418|NCT02952469|Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))|glu-nh-co-nh-lys-(ahx)-((68)ga(hbed-cc))
5166419|NCT02952469|(68)Ga-PSMA|(68)ga-psma
5166420|NCT02952469|68Ga-PSMA-11|68ga-psma-11
5166421|NCT02952456|SUDEP|sudep
5166422|NCT02952456|Epilepsy|epilepsy
5053591|NCT03663673|Dermatitis|dermatitis
5166423|NCT02952456|Qualitative research|qualitative research
5166424|NCT02952456|Risks associated with epilepsy|risks associated with epilepsy
5166425|NCT02952456|Epilepsy-related deaths|epilepsy-related deaths
5166426|NCT02952391|cognition|cognition
5166427|NCT02952391|cholinergic system|cholinergic system
5166428|NCT02952365|LASIK, Ingrowth, Tissue sealant|lasik, ingrowth, tissue sealant
5166429|NCT02952300|irreversible pulpitis|irreversible pulpitis
5166430|NCT02952300|reciprocation|reciprocation
5166433|NCT02952300|wave one|wave one
5166434|NCT02952300|neolix|neolix
5166435|NCT02952261|Printing, Three-dimensional|printing, three-dimensional
5166436|NCT02952209|Alveolar Ridge Preservation|alveolar ridge preservation
5166437|NCT02952209|Xenograft bone graft|xenograft bone graft
5166438|NCT02952209|Collagen membrane|collagen membrane
5166439|NCT02952196|Amphetamine|amphetamine
5166440|NCT02952196|Cannabinoids|cannabinoids
5166441|NCT02952183|Autonomic nerve monitoring|autonomic nerve monitoring
5166442|NCT02952183|Nerve-sparing surgery|nerve-sparing surgery
5166443|NCT02952131|IBD,Crohn's,Ulcerative Bowel; Diverticulitis;IBS;UC|ibd,crohn's,ulcerative bowel; diverticulitis;ibs;uc
5166444|NCT02952105|cardiac arrest|cardiac arrest
5166445|NCT02952105|identify of electrocardiac rhythm|identify of electrocardiac rhythm
5166446|NCT02952105|ventricuar fibrillation|ventricuar fibrillation
5166447|NCT02952105|defibrillation|defibrillation
5166448|NCT02952092|ASP1517|asp1517
5166449|NCT02952092|Renal anemia|renal anemia
5166450|NCT02952092|Hemodialysis|hemodialysis
5166451|NCT02952092|Roxadustat|roxadustat
5166452|NCT02952053|Myofascial Trigger Points|myofascial trigger points
5166453|NCT02952053|Dry needling|dry needling
5166454|NCT02952053|Myotonometry|myotonometry
5166455|NCT02952040|ASP1517|asp1517
5166456|NCT02952040|Pharmacokinetics|pharmacokinetics
5166457|NCT02952040|Drug-drug interaction|drug-drug interaction
5166458|NCT02952001|Uveitis|uveitis
5166459|NCT02952001|UME|ume
5166460|NCT02952001|Posterior Uveitis|posterior uveitis
5166461|NCT02952001|Anterior Uveitis|anterior uveitis
5166462|NCT02952001|Intermediate Uveitis|intermediate uveitis
5166463|NCT02952001|Panuveitis|panuveitis
5166464|NCT02952001|Non-infectious Uveitis|non-infectious uveitis
5166465|NCT02952001|Triamcinolone|triamcinolone
5166466|NCT02952001|Choroid|choroid
5166467|NCT02952001|Choroidal Injection|choroidal injection
5166468|NCT02952001|Suprachoroidal|suprachoroidal
5166469|NCT02952001|Microneedle|microneedle
5166470|NCT02952001|Microinjection|microinjection
5166471|NCT02951949|atherosclerosis, endogenous estrogens, age|atherosclerosis, endogenous estrogens, age
5166472|NCT02951897|circulating tumor cells|circulating tumor cells
5166473|NCT02951897|lung adenocarcinoma|lung adenocarcinoma
5166474|NCT02951897|treatment|treatment
5166475|NCT02951897|early diagnosis|early diagnosis
5166476|NCT02951884|Aspiration|aspiration
5166477|NCT02951884|Bupivacaine|bupivacaine
5166478|NCT02951884|Epinephrine|epinephrine
5166479|NCT02951884|Marcaine|marcaine
5166481|NCT02951884|Shin Bone|shin bone
5166482|NCT02951871|Follicular lymphoma; death, rituximab, treatment related toxicity|follicular lymphoma; death, rituximab, treatment related toxicity
5166483|NCT02951858|Alcohol,Smoking,and Substance Use Involvement Screening Test|alcohol,smoking,and substance use involvement screening test
5166484|NCT02951858|Brief Intervention|brief intervention
5166485|NCT02951858|Substance Use|substance use
5166486|NCT02951858|Primary Medical and Health Care Institution|primary medical and health care institution
5166487|NCT02951793|intensive care unit|intensive care unit
5166488|NCT02951793|delirium|delirium
5166489|NCT02951793|substance withdrawal|substance withdrawal
5166490|NCT02951767|anti-PD-L1|anti-pd-l1
5166491|NCT02951767|PD-L1|pd-l1
5166492|NCT02951767|MPDL3280A|mpdl3280a
5166493|NCT02951767|PD-1|pd-1
5166494|NCT02951767|bladder cancer|bladder cancer
5166495|NCT02951767|atezolizumab|atezolizumab
5166496|NCT02951767|Tecentriq|tecentriq
5166497|NCT02951754|ADHD|adhd
5166498|NCT02951754|Adults|adults
5166499|NCT02951754|treatment|treatment
5166500|NCT02951754|Methylphenidate|methylphenidate
5166503|NCT02951624|Exercise|exercise
5166504|NCT02951624|Breaking prolonged sitting|breaking prolonged sitting
5166505|NCT02951624|physical activity|physical activity
5166506|NCT02951572|Noninvasive Ventilation|noninvasive ventilation
5166507|NCT02951572|Physical activity|physical activity
5166508|NCT02951520|Patients|patients
5166509|NCT02951481|Clostridium difficile.|clostridium difficile.
5166510|NCT02951481|Antimicrobial Stewardship.|antimicrobial stewardship.
5166511|NCT02951481|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
5166512|NCT02951442|Arterial stiffness|arterial stiffness
5166513|NCT02951442|Klotho-FGF23|klotho-fgf23
5166514|NCT02951403|elbow arthroscopy|elbow arthroscopy
5166515|NCT02951403|DASH|dash
5166516|NCT02951403|elbow locking|elbow locking
5166517|NCT02951403|elbow osteoarthritis|elbow osteoarthritis
5166518|NCT02951390|Surveillance|surveillance
5166519|NCT02951390|Colorectal cancer|colorectal cancer
5166520|NCT02951390|Colonoscopy|colonoscopy
5166521|NCT02951390|Adenoma|adenoma
5166522|NCT02951390|Chromoendoscopy|chromoendoscopy
5166523|NCT02951377|mechanical diagnosis therapy (MDT)|mechanical diagnosis therapy (mdt)
5166524|NCT02951377|physical therapy|physical therapy
5166525|NCT02951377|steroid injection|steroid injection
5166526|NCT02951377|exercise|exercise
5166528|NCT02951338|Physical activity|physical activity
5166545|NCT02951273|cerebral blood flow|cerebral blood flow
5166546|NCT02951273|cerebral oxygenation|cerebral oxygenation
5166547|NCT02951273|CO2 reactivity|co2 reactivity
5166548|NCT02951273|duplex ultrasound|duplex ultrasound
5166549|NCT02951273|general anaesthesia|general anaesthesia
5166550|NCT02951273|mesenteric traction syndrome|mesenteric traction syndrome
5166551|NCT02951273|near-infrared spectroscopy|near-infrared spectroscopy
5166552|NCT02951273|upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
5166553|NCT02951234|coronary artery lesions|coronary artery lesions
5166554|NCT02951234|intravenous immunoglobulin|intravenous immunoglobulin
5166555|NCT02951234|Kawasaki disease|kawasaki disease
5166556|NCT02951234|randomized clinical trial|randomized clinical trial
5166559|NCT02951130|PPHN|pphn
5166561|NCT02951117|lymphoid malignancies|lymphoid malignancies
5166562|NCT02951117|Next generation sequencing|next generation sequencing
5166563|NCT02951117|Refractory Multiple Myeloma|refractory multiple myeloma
5166564|NCT02951117|Relapsed Multiple Myeloma|relapsed multiple myeloma
5166565|NCT02951052|Long-acting cabotegravir|long-acting cabotegravir
5166566|NCT02951052|Virologic failure|virologic failure
5166567|NCT02951052|long-acting rilpivirine|long-acting rilpivirine
5166568|NCT02951052|Antiretroviral|antiretroviral
5166569|NCT02951039|Non valvular Atrial Fibrillation|non valvular atrial fibrillation
5166570|NCT02951039|Non-interventional Study|non-interventional study
5166571|NCT02951039|Efficacy/Safety|efficacy/safety
5166572|NCT02951039|Real World Evidence|real world evidence
5166573|NCT02951026|knee|knee
5166574|NCT02951026|osteoarthritis|osteoarthritis
5166575|NCT02951026|intra-articular injection|intra-articular injection
5166576|NCT02951026|SM04690|sm04690
5166577|NCT02951000|thyroidectomy|thyroidectomy
5166578|NCT02951000|postoperative pain|postoperative pain
5166579|NCT02951000|wound healing|wound healing
5166580|NCT02950987|Li-Fraumeni Syndrome (LFS)|li-fraumeni syndrome (lfs)
5166581|NCT02950987|Cancer Predisposition Syndromes|cancer predisposition syndromes
5166582|NCT02950987|LFS|lfs
5166583|NCT02950974|sterofundin|sterofundin
5166584|NCT02950974|resuscitation|resuscitation
5166585|NCT02950974|normal saline|normal saline
5166586|NCT02950974|chloride|chloride
5166587|NCT02950974|fluid|fluid
5166588|NCT02950974|SID|sid
5166589|NCT02950974|pH|ph
5166590|NCT02950974|osmolality|osmolality
5166591|NCT02950974|urine|urine
5166603|NCT02950909|Therapeutic exercise|therapeutic exercise
5166604|NCT02950909|Chronic pain|chronic pain
5166605|NCT02950909|Neck extensors|neck extensors
5166606|NCT02950883|Cystic Fibrosis|cystic fibrosis
5166607|NCT02950883|Hypertonic Saline|hypertonic saline
5166608|NCT02950883|Inhaled Saline|inhaled saline
5166609|NCT02950883|Digestive System Diseases|digestive system diseases
5166610|NCT02950883|Genetic Diseases, Inborn|genetic diseases, inborn
5166611|NCT02950883|Lung Diseases|lung diseases
5166612|NCT02950883|Pancreatic Diseases|pancreatic diseases
5166613|NCT02950883|Pathologic Processes|pathologic processes
5962148|NCT04282642|Polysomnography|polysomnography
5039562|NCT03751280|CBT|cbt
5166614|NCT02950883|Respiratory Tract Diseases|respiratory tract diseases
5166615|NCT02950883|Computed Tomography (CT)|computed tomography (ct)
5166616|NCT02950844|Atrial fibrillation|atrial fibrillation
5166617|NCT02950844|Electrogram|electrogram
5166618|NCT02950844|Ablation|ablation
5166619|NCT02950844|Drivers|drivers
5166620|NCT02950831|Chronic Pain|chronic pain
5166621|NCT02950831|BurstDR|burstdr
5166622|NCT02950831|spinal cord stimulation|spinal cord stimulation
5166623|NCT02950831|Accelerometry|accelerometry
5166628|NCT02950818|risk factors for heart disease|risk factors for heart disease
5166629|NCT02950805|AZD5634|azd5634
5166630|NCT02950805|Mucociliary Clearance|mucociliary clearance
5166631|NCT02950805|Safety|safety
5166632|NCT02950805|Tolerability|tolerability
5166633|NCT02950805|Pharmacokinetic|pharmacokinetic
5166634|NCT02950805|Cystic Fibrosis|cystic fibrosis
5166635|NCT02950805|Cross-Over Study|cross-over study
5166636|NCT02950792|Non-Small Cell Lung Cancer|non-small cell lung cancer
5166637|NCT02950792|NSCLC|nsclc
5166638|NCT02950766|Kidney Cancer|kidney cancer
5166639|NCT02950753|Elevated Serum Lactate|elevated serum lactate
5166640|NCT02950753|Serum lactate|serum lactate
5166641|NCT02950753|Ringer's Lactate|ringer's lactate
5166642|NCT02950753|Lactated Ringer's|lactated ringer's
5166643|NCT02950753|Hyperlactatemia|hyperlactatemia
5166644|NCT02950740|malnutrition|malnutrition
5166645|NCT02950727|orthognathic surgery|orthognathic surgery
5166646|NCT02950727|bicortical screws|bicortical screws
5166647|NCT02950727|monocortical plates|monocortical plates
5166648|NCT02950675|Burn patient|burn patient
5166649|NCT02950675|Developmental Disabilities|developmental disabilities
5166650|NCT02950675|Body function|body function
5166651|NCT02950675|Participation|participation
5166652|NCT02950675|Quality of Life|quality of life
5166653|NCT02950675|longitudinal study|longitudinal study
5166654|NCT02950636|Epilepsy|epilepsy
5166655|NCT02950610|Electronic nose|electronic nose
5053829|NCT03661892|Opioid|opioid
5166656|NCT02950610|Non invasive diagnosis of NAFLD|non invasive diagnosis of nafld
5166657|NCT02950610|NAFLD|nafld
5166658|NCT02950610|exhaled breath analysis|exhaled breath analysis
5166659|NCT02950610|Volatile organic compounds|volatile organic compounds
5166660|NCT02950545|astigmatism, contact lens, driving|astigmatism, contact lens, driving
5166661|NCT02950532|Posterior ligamentous complex|posterior ligamentous complex
5166662|NCT02950532|Thoracolumbar fractures|thoracolumbar fractures
5166663|NCT02950532|Interspinous distance|interspinous distance
5166664|NCT02950532|Local kyphosis|local kyphosis
5166665|NCT02950506|Interictal|interictal
5166666|NCT02950506|Cognitive|cognitive
5166667|NCT02950506|Dysfunction|dysfunction
5166668|NCT02950506|tDCS|tdcs
5166669|NCT02950506|transcranial direct current stimulation|transcranial direct current stimulation
5166670|NCT02950480|Mastectomy|mastectomy
5166675|NCT02950454|Progressive Multiple Sclerosis|progressive multiple sclerosis
5166676|NCT02950454|Rehabilitation|rehabilitation
5166677|NCT02950454|Exercise|exercise
5166678|NCT02950441|Nicotinamide Riboside|nicotinamide riboside
5166679|NCT02950441|Nicotinamide Adenine Dinucleotide|nicotinamide adenine dinucleotide
5166680|NCT02950441|Skeletal muscle|skeletal muscle
5166681|NCT02950441|Metabolism|metabolism
5166682|NCT02950428|TAVI|tavi
5166683|NCT02950428|Aortic Stenosis|aortic stenosis
5166684|NCT02950428|transcatether Aortic Valve Implantation|transcatether aortic valve implantation
5166685|NCT02950389|PMMA|pmma
5166686|NCT02950389|on-line HFR|on-line hfr
5166687|NCT02950389|free light chains|free light chains
5166688|NCT02950389|toxins|toxins
5166689|NCT02950389|removal|removal
5166690|NCT02950389|hemodialysis|hemodialysis
5166691|NCT02950376|synthetic drugs|synthetic drugs
5166692|NCT02950376|virtual reality|virtual reality
5166693|NCT02950376|addiction evaluation|addiction evaluation
5166694|NCT02950376|physiological data|physiological data
5166695|NCT02950376|eye movement index|eye movement index
5166696|NCT02950363|Depression|depression
5166697|NCT02950363|Suicide|suicide
5776829|NCT00212901|Proteinuria|proteinuria
5166698|NCT02950363|Anxiety disorder|anxiety disorder
5166699|NCT02950363|Burn out|burn out
5166700|NCT02950363|Sleep quality|sleep quality
5166701|NCT02950363|Stress|stress
5166702|NCT02950350|Cervical cancer|cervical cancer
5166703|NCT02950350|Precision medicine|precision medicine
5166704|NCT02950350|Individualized treatment|individualized treatment
5166705|NCT02950350|Surgical staging|surgical staging
5166706|NCT02950337|Unbiopsied Early Stage Non Small Cell Lung Cancer|unbiopsied early stage non small cell lung cancer
5166707|NCT02950324|Prehabilitation|prehabilitation
5166708|NCT02950324|Oesophago-gastric|oesophago-gastric
5166709|NCT02950324|Cancer|cancer
5166710|NCT02950324|Neo-adjuvant|neo-adjuvant
5166711|NCT02950324|Exercise|exercise
5166712|NCT02950324|Cardiopulmonary exercise test|cardiopulmonary exercise test
5166713|NCT02950324|Insulin resistance|insulin resistance
5166714|NCT02950298|Pompe|pompe
5166715|NCT02950298|Glycogen Storage Disease II|glycogen storage disease ii
5166716|NCT02950298|Telemedicine|telemedicine
5166717|NCT02950298|Duke University Medical Center|duke university medical center
5962149|NCT04282642|Actigraphy|actigraphy
5962150|NCT04282642|Older Adults|older adults
5039636|NCT03750864|Stigma|stigma
5166718|NCT02950259|Breast Cancer|breast cancer
5166719|NCT02950259|Early Stage Breast Cancer|early stage breast cancer
5166720|NCT02950259|Male breast cancer|male breast cancer
5166721|NCT02950259|IRX-2|irx-2
5166722|NCT02950259|Immunotherapy|immunotherapy
5166723|NCT02950259|Triple Negative Breast Cancer|triple negative breast cancer
5166724|NCT02950233|postoperative pain|postoperative pain
5166725|NCT02950233|VATS|vats
5166726|NCT02950233|activities of daily living|activities of daily living
5166727|NCT02950233|quality of life|quality of life
5166728|NCT02950194|mesh|mesh
5166729|NCT02950194|rectus diastasis|rectus diastasis
5166730|NCT02950194|panniculectomy|panniculectomy
5166731|NCT02950194|abdominoplasty|abdominoplasty
5166732|NCT02950168|Diagnostic procedures|diagnostic procedures
5166733|NCT02950168|Interventional procedures|interventional procedures
5166734|NCT02950168|Planned or unplanned|planned or unplanned
5166735|NCT02950168|Edoxaban-treated population|edoxaban-treated population
5166737|NCT02950142|decision support|decision support
5166738|NCT02950142|laboratory test|laboratory test
5166739|NCT02950142|primary care|primary care
5166740|NCT02950129|pelvic girdle dysfunction|pelvic girdle dysfunction
5166741|NCT02950103|solid tumor|solid tumor
5166742|NCT02950103|phase II|phase ii
5166743|NCT02950103|phosphoethanolamine|phosphoethanolamine
5166744|NCT02950090|Knee symptoms|knee symptoms
5166745|NCT02950090|physical activity|physical activity
5166746|NCT02950090|Fitbit|fitbit
5166747|NCT02950090|Accelerometer|accelerometer
5166748|NCT02950090|remote coaching|remote coaching
5166749|NCT02950064|BRCA|brca
5166750|NCT02950064|BRCA1|brca1
5166751|NCT02950064|BRCA2|brca2
5166752|NCT02950064|Pancreatic cancer|pancreatic cancer
5166753|NCT02950064|Ovarian cancer|ovarian cancer
5166754|NCT02950064|Castrate resistant prostate cancer|castrate resistant prostate cancer
5166755|NCT02950064|Triple negative breast cancer|triple negative breast cancer
5166756|NCT02950064|Breast cancer|breast cancer
5166757|NCT02950064|DNA repair mutation-positive solid tumors|dna repair mutation-positive solid tumors
5166758|NCT02950051|CLL|cll
5166759|NCT02950038|Lung Cancer, Nonsmall Cell|lung cancer, nonsmall cell
5166760|NCT02950038|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5166761|NCT02950038|NSCLC|nsclc
5166762|NCT02950038|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5166763|NCT02950038|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5166764|NCT02950038|Ibrutinib|ibrutinib
5166765|NCT02950038|PCI-32765|pci-32765
5166766|NCT02950038|Imbruvica|imbruvica
5166767|NCT02950038|Nivolumab|nivolumab
5166768|NCT02950038|BMS-936558|bms-936558
5166769|NCT02950038|Opdivo|opdivo
5166770|NCT02950012|Healthy|healthy
5166771|NCT02950012|Bloating|bloating
5166772|NCT02950012|Abdominal Discomfort|abdominal discomfort
5166773|NCT02950012|Gas|gas
5166774|NCT02950012|Probiotic|probiotic
5166775|NCT02950012|Bacillus Subtillis|bacillus subtillis
5166776|NCT02949999|Calcineurin inhibitor|calcineurin inhibitor
5166777|NCT02949999|Voclosporin|voclosporin
5166778|NCT02949973|lupus nephritis|lupus nephritis
5166779|NCT02949973|calcineurin inhibitors|calcineurin inhibitors
5166780|NCT02949973|voclosporin|voclosporin
5166781|NCT02949960|Eczema|eczema
5166782|NCT02949960|Dermatitis|dermatitis
5166783|NCT02949960|Skin Diseases|skin diseases
5166784|NCT02949960|Skin Diseases, Genetic|skin diseases, genetic
5166785|NCT02949960|Dermatitis, Atopic|dermatitis, atopic
5166786|NCT02949960|Skin Diseases, Eczematous|skin diseases, eczematous
5166787|NCT02949960|Hypersensitivity|hypersensitivity
5166788|NCT02949960|Immune System Diseases|immune system diseases
5166789|NCT02949947|Malignant Neoplasms of Mesothelial and Soft Tissue|malignant neoplasms of mesothelial and soft tissue
5166790|NCT02949947|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5166791|NCT02949947|GIST|gist
5166792|NCT02949947|Iron-deficiency anemia|iron-deficiency anemia
5166793|NCT02949947|Ferric Carboxymaltose|ferric carboxymaltose
5166794|NCT02949947|Injectafer|injectafer
5166795|NCT02949947|Iron supplement|iron supplement
5166796|NCT02949947|Health Questionnaire|health questionnaire
5166797|NCT02949947|Survey|survey
5166798|NCT02949908|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5166799|NCT02949908|Rebif|rebif
5166800|NCT02949908|Treatment Satisfaction Questionnaire for Medication Version II|treatment satisfaction questionnaire for medication version ii
5166801|NCT02949908|Multiple Sclerosis International Quality of Life Questionnaire|multiple sclerosis international quality of life questionnaire
5166802|NCT02949882|Diarrhea|diarrhea
5166803|NCT02949882|Constipation|constipation
5166804|NCT02949882|Elderly|elderly
5166805|NCT02949882|Nursing Homes|nursing homes
5166806|NCT02949882|Probiotics|probiotics
5166807|NCT02949882|Bowel Habits|bowel habits
5166808|NCT02949830|RNAi therapeutic|rnai therapeutic
5166809|NCT02949830|Porphyria|porphyria
5166810|NCT02949830|AIP|aip
5166811|NCT02949830|Heme/Haem Arginate|heme/haem arginate
5962151|NCT04282629|Milrinone|milrinone
5166812|NCT02949817|upper limb function|upper limb function
5166813|NCT02949817|multi-IMU (inertial measurement unit) sensors|multi-imu (inertial measurement unit) sensors
5033287|NCT03790995|QoL|qol
5166814|NCT02949817|Melbourne Assessment of Unilateral Upper Limb Function (MUUL-2)|melbourne assessment of unilateral upper limb function (muul-2)
5166815|NCT02949791|cisplatin|cisplatin
5166816|NCT02949791|HIPEC|hipec
5166817|NCT02949791|Intra abdominal pressure|intra abdominal pressure
5166818|NCT02949791|tissue drug concentration|tissue drug concentration
5166819|NCT02949713|HIV|hiv
5166820|NCT02949713|infant feeding|infant feeding
5166821|NCT02949713|mHealth|mhealth
5166822|NCT02949713|behavioural intervention|behavioural intervention
5166823|NCT02949700|metformin|metformin
5166824|NCT02949700|head and neck cancer|head and neck cancer
5166825|NCT02949687|ileal interposition|ileal interposition
5166826|NCT02949687|metabolic surgery|metabolic surgery
5166827|NCT02949687|diabetes|diabetes
5166828|NCT02949687|intra abdominal selective denervation|intra abdominal selective denervation
5166829|NCT02949648|Electronic cigarette|electronic cigarette
5166831|NCT02949635|Patient readmission|patient readmission
5166832|NCT02949635|Geriatric Assessment|geriatric assessment
5166833|NCT02949635|Mortality|mortality
5166834|NCT02949622|Metabolic syndrome|metabolic syndrome
5166835|NCT02949622|Mediterranean diet|mediterranean diet
5166836|NCT02949622|Stress|stress
5166837|NCT02949622|quality of life|quality of life
5166838|NCT02949622|psychological factors|psychological factors
5166839|NCT02949609|stroke|stroke
5166840|NCT02949609|mirror therapy|mirror therapy
5166841|NCT02949609|neurorehabilitation|neurorehabilitation
5166842|NCT02949596|quality of sexual life|quality of sexual life
5166843|NCT02949596|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5166844|NCT02949596|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5166845|NCT02949583|DENTAL PLAQUE|dental plaque
5054031|NCT03660475|naltrexone|naltrexone
5166846|NCT02949583|MEDICINAL PLANTS|medicinal plants
5166847|NCT02949583|GINGIVITIS|gingivitis
5166848|NCT02949505|Prehabilitation|prehabilitation
5166849|NCT02949505|liver transplant|liver transplant
5166850|NCT02949505|functional capacity|functional capacity
5166851|NCT02949505|exercise|exercise
5166852|NCT02949492|Liver|liver
5166853|NCT02949492|Transplant|transplant
5166854|NCT02949492|Immunosuppression|immunosuppression
5166855|NCT02949479|sex offenses|sex offenses
5166856|NCT02949466|knee osteoarthritis|knee osteoarthritis
5166857|NCT02949466|triamcinolone|triamcinolone
5166858|NCT02949466|therapeutic effects|therapeutic effects
5166859|NCT02949453|suicide|suicide
5166860|NCT02949453|prevention|prevention
5166861|NCT02949440|Laparoscopic right Hemicolectomy|laparoscopic right hemicolectomy
5166862|NCT02949440|Caudal-to-cranial Approach|caudal-to-cranial approach
5166863|NCT02949427|Microbiome|microbiome
5166864|NCT02949427|Mycobiome|mycobiome
5166865|NCT02949427|Virome|virome
5166866|NCT02949427|Pediatric leukemia|pediatric leukemia
5166867|NCT02949427|Pediatric bone marrow transplantation|pediatric bone marrow transplantation
5166869|NCT02949414|Stenosis|stenosis
5166870|NCT02949414|Trachea|trachea
5166871|NCT02949414|Transplant|transplant
5166872|NCT02949401|Virtual Reality|virtual reality
5166873|NCT02949401|Stress Inoculation|stress inoculation
5166874|NCT02949401|Procedure|procedure
5166875|NCT02949349|Systemic Lupus Erythematosus|systemic lupus erythematosus
5166876|NCT02949349|Lupus Nephritis|lupus nephritis
5166877|NCT02949349|Mycophenolate Mofetil|mycophenolate mofetil
5166878|NCT02949349|Azathioprine|azathioprine
5166879|NCT02949349|Maintenance Therapy|maintenance therapy
5166880|NCT02949349|Prednisolone|prednisolone
5166881|NCT02949349|Serum albumin|serum albumin
5166882|NCT02949349|Serum creatinine|serum creatinine
5166883|NCT02949349|Spot urine protein/creatinine ratio|spot urine protein/creatinine ratio
5166884|NCT02949323|children|children
5166885|NCT02949323|renal stone|renal stone
5166886|NCT02949323|metabolic evaluation|metabolic evaluation
5166887|NCT02949323|Mutational analysis|mutational analysis
5166888|NCT02949297|abdominal|abdominal
5166889|NCT02949297|aortic|aortic
5166890|NCT02949297|aneurysm|aneurysm
5166891|NCT02949271|epidural analgesia|epidural analgesia
5166892|NCT02949258|gastric cancer|gastric cancer
5166893|NCT02949258|Borrmann type 4|borrmann type 4
5166894|NCT02949258|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5166895|NCT02949258|Intra-arterial administration|intra-arterial administration
5166896|NCT02949245|Spine|spine
5166897|NCT02949245|Surgery|surgery
5166898|NCT02949245|Prospective Studies|prospective studies
5166899|NCT02949245|Deformity|deformity
5166900|NCT02949245|Neurologic deficit|neurologic deficit
5166901|NCT02949180|Atrial fibrillation|atrial fibrillation
5166902|NCT02949180|Rhythm monitoring|rhythm monitoring
5166903|NCT02949180|Cardiovascular App|cardiovascular app
5166904|NCT02949180|m-health|m-health
5166905|NCT02949167|Nurse-led follow-up after breast cancer|nurse-led follow-up after breast cancer
5166906|NCT02949115|Red beetroot|red beetroot
5166907|NCT02949115|Dietary Nitrate|dietary nitrate
5166908|NCT02949115|Polyphenols|polyphenols
5166909|NCT02949115|Endothelial Function|endothelial function
5166910|NCT02949115|High-Fat Meal|high-fat meal
5166911|NCT02949115|Overweight|overweight
5166912|NCT02949115|Obesity|obesity
5166913|NCT02949115|Aging|aging
5962152|NCT04282629|Vasospasm|vasospasm
5166914|NCT02949115|Cardiometabolic|cardiometabolic
5166916|NCT02949089|tolerability|tolerability
5166917|NCT02949089|rising multiple doses|rising multiple doses
5166918|NCT02949089|ACH04|ach04
5166919|NCT02949089|adult|adult
5166920|NCT02949089|male|male
5166921|NCT02949063|school lunch|school lunch
5166922|NCT02949063|occupational therapy|occupational therapy
5166923|NCT02949024|Diabetes mellitus|diabetes mellitus
5166924|NCT02949024|Diabetic retinopathy|diabetic retinopathy
5166925|NCT02949024|Microneedle|microneedle
5166926|NCT02949024|Microinjection|microinjection
5166927|NCT02949024|Triamcinolone|triamcinolone
5166928|NCT02949024|Choroid|choroid
5166929|NCT02949024|Choroid Injection|choroid injection
5166930|NCT02949024|Aflibercept|aflibercept
5166931|NCT02949024|Suprachoroidal|suprachoroidal
5166932|NCT02949011|Tamiflu®|tamiflu®
5166933|NCT02949011|Influenza|influenza
5166934|NCT02949011|Oseltamivir|oseltamivir
5166936|NCT02949011|S-033188|s-033188
5166937|NCT02948985|Metastatic colorectal cancer|metastatic colorectal cancer
5166938|NCT02948985|Cetuximab|cetuximab
5166939|NCT02948985|CTCs|ctcs
5166940|NCT02948985|ct DNA|ct dna
5166941|NCT02948972|deep infiltrating endometriosis|deep infiltrating endometriosis
5175483|NCT02894411|MRI|mri
5166942|NCT02948972|endometriosis surgery|endometriosis surgery
5166943|NCT02948972|In vitro fertilization|in vitro fertilization
5166944|NCT02948946|lung cancer|lung cancer
5054130|NCT03659812|Spermatozoa|spermatozoa
5166945|NCT02948946|pancreatic cancer|pancreatic cancer
5166946|NCT02948933|Dengue Fever|dengue fever
5166947|NCT02948933|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5166948|NCT02948933|Dengvaxia®|dengvaxia®
5166949|NCT02948920|ephedrine|ephedrine
5166950|NCT02948920|core temperature|core temperature
5166951|NCT02948920|tympanic temperature|tympanic temperature
5166952|NCT02948920|heat loss|heat loss
5166953|NCT02948920|spinal anesthesia|spinal anesthesia
5166954|NCT02948920|neuraxial|neuraxial
5166955|NCT02948920|hypothermia|hypothermia
5166956|NCT02948920|shivering|shivering
5166957|NCT02948881|Osteoporosis|osteoporosis
5166958|NCT02948881|bisphosphonates|bisphosphonates
5166959|NCT02948881|bone|bone
5166960|NCT02948855|Long non-coding RNA（LncRNA）|long non-coding rna（lncrna）
5166961|NCT02948855|Thymoma|thymoma
5166962|NCT02948855|Autoimmune disease|autoimmune disease
5166963|NCT02948855|Notch2 Signaling pathway|notch2 signaling pathway
5166964|NCT02948855|Regulatory B cell（Breg）|regulatory b cell（breg）
5166965|NCT02948829|Drug therapy|drug therapy
5166966|NCT02948803|intervention|intervention
5166967|NCT02948803|mHealth|mhealth
5166968|NCT02948803|physical activity|physical activity
5166969|NCT02948803|active transport|active transport
5166970|NCT02948803|smartphone|smartphone
5166971|NCT02948803|application|application
5166972|NCT02948764|breast cancer|breast cancer
5166973|NCT02948764|vacuum-assisted biopsy|vacuum-assisted biopsy
5166974|NCT02948764|pathological complete response|pathological complete response
5166975|NCT02948712|distress|distress
5166976|NCT02948712|survivorship|survivorship
5166977|NCT02948712|transition period|transition period
5166978|NCT02948699|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5166979|NCT02948699|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5166980|NCT02948699|nutrition support|nutrition support
5166981|NCT02948699|nutrition assessment|nutrition assessment
5166982|NCT02948686|dentin bonding agents|dentin bonding agents
5166983|NCT02948686|tooth sensitivity|tooth sensitivity
5166984|NCT02948686|composite resin restoration|composite resin restoration
5166985|NCT02948673|type 2 diabetes|type 2 diabetes
5166986|NCT02948673|mitochondrial reactive oxygen species production|mitochondrial reactive oxygen species production
5166987|NCT02948673|oxidative stress|oxidative stress
5166988|NCT02948673|antioxidant treatment|antioxidant treatment
5166989|NCT02948673|glutathione supplementation|glutathione supplementation
5166990|NCT02948647|obesity|obesity
5166991|NCT02948647|fatty liver|fatty liver
5166992|NCT02948647|sugar|sugar
5166993|NCT02948647|PNPLA3|pnpla3
5166994|NCT02948621|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
5777021|NCT00211926|vaccine|vaccine
5166995|NCT02948621|Excess weight loss|excess weight loss
5166996|NCT02948621|Quality of life|quality of life
5166997|NCT02948608|spondyloarthropathy|spondyloarthropathy
5166998|NCT02948608|ankylosing spondylitis|ankylosing spondylitis
5166999|NCT02948608|spinal diseases|spinal diseases
5167000|NCT02948608|spondylitis|spondylitis
5167001|NCT02948608|spondylarthritis|spondylarthritis
5167002|NCT02948608|psoriasis|psoriasis
5167003|NCT02948608|uveitis|uveitis
5167004|NCT02948608|joint diseases|joint diseases
5167005|NCT02948582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5167006|NCT02948582|COPD|copd
5167007|NCT02948582|Emphysema|emphysema
5167008|NCT02948582|Chronic bronchitis|chronic bronchitis
5167009|NCT02948569|Obesity|obesity
5167010|NCT02948569|Hyperlipidemia|hyperlipidemia
5167011|NCT02948569|Impaired fasting glucose|impaired fasting glucose
5167012|NCT02948569|Insulin resistance|insulin resistance
5167013|NCT02948569|Hypertension|hypertension
5167014|NCT02948504|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
5167015|NCT02948504|Small aneurysms|small aneurysms
5167016|NCT02948504|Risk of rupture|risk of rupture
5167017|NCT02948504|Natural history|natural history
5167018|NCT02948504|Endovascular Coiling|endovascular coiling
5167019|NCT02948504|Surgical clipping|surgical clipping
5167020|NCT02948491|Complementary Therapies|complementary therapies
5167021|NCT02948491|Neonate Intensive Care Units (NICU)|neonate intensive care units (nicu)
5167022|NCT02948491|Child Development|child development
5167023|NCT02948491|Infants Premature|infants premature
5167024|NCT02948478|precariousness|precariousness
5167025|NCT02948478|care pathways|care pathways
5054227|NCT03659292|Pancreatic cancer|pancreatic cancer
5167026|NCT02948465|Neutrophil Extracellular Traps|neutrophil extracellular traps
5167027|NCT02948452|anorexia nervosa|anorexia nervosa
5167028|NCT02948452|anxiety|anxiety
5167029|NCT02948452|reward|reward
5167030|NCT02948452|recurrence|recurrence
5167031|NCT02948452|magnetic resonance imaging|magnetic resonance imaging
5167032|NCT02948439|pregnancy|pregnancy
5167033|NCT02948439|cardiovascular|cardiovascular
5167034|NCT02948439|nervous system|nervous system
5167035|NCT02948439|exercise|exercise
5167036|NCT02948426|Immunotherapy|immunotherapy
5167037|NCT02948426|Adoptive Cell Therapy|adoptive cell therapy
5167038|NCT02948426|Carcinomatosis|carcinomatosis
5167039|NCT02948426|CA125|ca125
5167040|NCT02948413|Traumatic Stress|traumatic stress
5167041|NCT02948413|Oncology|oncology
5167042|NCT02948413|Lymphoma|lymphoma
5167043|NCT02948413|Leukemia|leukemia
5167044|NCT02948335|Microbial communities|microbial communities
5167045|NCT02948335|Hospital environment|hospital environment
5167046|NCT02948335|Disinfection|disinfection
5167047|NCT02948335|Adenosine triphosphate measures|adenosine triphosphate measures
5167048|NCT02948335|Bioburden|bioburden
5167049|NCT02948322|Acromegaly,|acromegaly,
5167050|NCT02948322|water retention|water retention
5167051|NCT02948322|myocardial fibrosis|myocardial fibrosis
5167052|NCT02948322|left ventricular hypertrophy|left ventricular hypertrophy
5167053|NCT02948322|left ventricular dysfunction|left ventricular dysfunction
5167054|NCT02948309|Primary diagnosis|primary diagnosis
5167055|NCT02948309|Relapse|relapse
5167056|NCT02948257|Vessel closure|vessel closure
5167057|NCT02948257|Antegrade access|antegrade access
5167058|NCT02948257|Femoral arteriotomy|femoral arteriotomy
5167059|NCT02948257|Peripheral endovascular interventions|peripheral endovascular interventions
5167060|NCT02948244|fshd|fshd
5167061|NCT02948244|creatine monohydrate|creatine monohydrate
5167062|NCT02948244|children|children
5167063|NCT02948244|pediatrics|pediatrics
5167064|NCT02948244|Facio-Scapulo-Humeral Dystrophy|facio-scapulo-humeral dystrophy
5167065|NCT02948205|Infertility, TU-LESS, 3D laparoscopy|infertility, tu-less, 3d laparoscopy
5167066|NCT02948192|Preterm Delivery|preterm delivery
5167067|NCT02948192|Preterm Birth|preterm birth
5167068|NCT02948192|Vaginal Microbiome|vaginal microbiome
5167069|NCT02948192|Microbiome|microbiome
5167070|NCT02948192|Gut Microbiome|gut microbiome
5167071|NCT02948192|African American|african american
5167072|NCT02948192|Metabolomics|metabolomics
5167073|NCT02948192|Pregnancy|pregnancy
5167074|NCT02948166|remote endarterectomy|remote endarterectomy
5167075|NCT02948166|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
5167076|NCT02948140|Subdiaphragmatic infarction|subdiaphragmatic infarction
5167077|NCT02948088|Tenosynovial Giant Cell Tumors|tenosynovial giant cell tumors
5167078|NCT02948088|Disease registry|disease registry
5167079|NCT02948088|Routine clinical practice|routine clinical practice
5167080|NCT02948088|Real World Evidence|real world evidence
5167082|NCT02948062|Newborn Screening|newborn screening
5167083|NCT02948049|Accelerometer|accelerometer
5167084|NCT02948049|Spinal Cord Stimulator|spinal cord stimulator
5167085|NCT02948049|Peripheral Nerve Stimulator|peripheral nerve stimulator
5167086|NCT02948049|Physical Function|physical function
5167087|NCT02947997|Healthy Volunteers|healthy volunteers
5167088|NCT02947984|sphenoid region|sphenoid region
5167089|NCT02947984|parasellar area|parasellar area
5167090|NCT02947984|photon radiation therapy|photon radiation therapy
5167091|NCT02947984|proton radiation therapy|proton radiation therapy
5167092|NCT02947971|Device|device
5167093|NCT02947971|OFDI|ofdi
5167094|NCT02947971|Tethered Capsule Endomicroscopy|tethered capsule endomicroscopy
5167095|NCT02947958|teleconsultation|teleconsultation
5167096|NCT02947958|urology|urology
5167097|NCT02947958|primary care|primary care
5167098|NCT02947958|tertiary care|tertiary care
5167099|NCT02947932|acute pancreatitis|acute pancreatitis
5167100|NCT02947932|post-ERCP|post-ercp
5167101|NCT02947932|endoscopy|endoscopy
5167102|NCT02947919|Perioperative Period|perioperative period
5167103|NCT02947919|Music|music
5167104|NCT02947906|Gait|gait
5167105|NCT02947906|Loading|loading
5167106|NCT02947906|Multiple Sclerosis|multiple sclerosis
5167107|NCT02947906|Plantar Pressure|plantar pressure
5167108|NCT02947893|Nilotinib in Alzheimer's disease|nilotinib in alzheimer's disease
5167109|NCT02947880|autism, Bumetanide|autism, bumetanide
5167110|NCT02947854|Vaccine|vaccine
5167111|NCT02947854|Photochemical Internalisation|photochemical internalisation
5167112|NCT02947854|Immune Response|immune response
5167113|NCT02947854|Peptide vaccine|peptide vaccine
5167114|NCT02947854|Anti cancer vaccine|anti cancer vaccine
5167115|NCT02947828|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5167116|NCT02947828|Polyneuropathies, Diabetic|polyneuropathies, diabetic
5167117|NCT02947750|Hypertension|hypertension
5167118|NCT02947750|Kidney Disorder|kidney disorder
5167119|NCT02947750|Nephrology|nephrology
5167120|NCT02947750|Physiology|physiology
5167121|NCT02947737|Skin graft|skin graft
5167122|NCT02947724|chocolate cyst|chocolate cyst
5167131|NCT02947685|breast cancer|breast cancer
5167132|NCT02947685|malignant tumor of the breast|malignant tumor of the breast
5167133|NCT02947685|HER2+|her2+
5167135|NCT02947685|metastatic breast cancer|metastatic breast cancer
5167136|NCT02947659|Body mass index|body mass index
5167137|NCT02947659|Academic stress|academic stress
5167138|NCT02947659|Musculoskeletal disorders|musculoskeletal disorders
5167139|NCT02947607|Human gut microbiome|human gut microbiome
5167140|NCT02947607|Colorectal cancer|colorectal cancer
5167141|NCT02947607|Colorectal adenoma|colorectal adenoma
5167142|NCT02947607|Gut bacteria|gut bacteria
5167143|NCT02947607|Metagenomics|metagenomics
5167144|NCT02947607|Metatranscriptomics|metatranscriptomics
5167145|NCT02947581|subarachnoid neurocysticercosis|subarachnoid neurocysticercosis
5167146|NCT02947581|albendazole|albendazole
5167147|NCT02947581|praziquantel|praziquantel
5167148|NCT02947568|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5167149|NCT02947568|Chronic Kidney Disease|chronic kidney disease
5167150|NCT02947568|Diabetes Mellitus|diabetes mellitus
5167151|NCT02947568|Cross-sectional|cross-sectional
5167152|NCT02947555|diabetes mellitus|diabetes mellitus
5167153|NCT02947555|atherosclerosis|atherosclerosis
5167155|NCT02947555|lens autofluorescence|lens autofluorescence
5167156|NCT02947529|Hemiarthroplasty|hemiarthroplasty
5167157|NCT02947529|Intramedullary nail|intramedullary nail
5167158|NCT02947529|Tranexamic acid|tranexamic acid
5167159|NCT02947529|Transfusion|transfusion
5167160|NCT02947516|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
5167161|NCT02947516|liver|liver
5167162|NCT02947516|biopsy|biopsy
5167163|NCT02947516|pain|pain
5167164|NCT02947503|Gestational Diabetes|gestational diabetes
5167165|NCT02947503|Insulin Resistance|insulin resistance
5167166|NCT02947503|Metformin|metformin
5167167|NCT02947503|Hyperinsulinaemia|hyperinsulinaemia
5167168|NCT02947503|Prevention of Complications|prevention of complications
5167169|NCT02947503|Long Term Study|long term study
5167170|NCT02947503|Mother and Child|mother and child
5167171|NCT02947503|Health Benefits|health benefits
5167172|NCT02947490|Blood pressure monitoring|blood pressure monitoring
5167173|NCT02947490|self BP monitoring|self bp monitoring
5167174|NCT02947490|self BP management|self bp management
5167175|NCT02947438|Renal anemia|renal anemia
5167176|NCT02947438|Haemodialysis|haemodialysis
5167177|NCT02947438|Maintenance phase|maintenance phase
5167178|NCT02947412|sleeve gastrectomy|sleeve gastrectomy
5167179|NCT02947412|long-term follow-up|long-term follow-up
5167180|NCT02947412|gastroesophageal reflux disease after sleeve|gastroesophageal reflux disease after sleeve
5167181|NCT02947412|revisional surgery|revisional surgery
5167182|NCT02947399|Thyroid|thyroid
5167183|NCT02947399|I-124|i-124
5167184|NCT02947399|Thyroid hormone Withdrawal|thyroid hormone withdrawal
5167185|NCT02947373|brain tumor|brain tumor
5167186|NCT02947373|children|children
5167187|NCT02947321|Radiofrequency ablation|radiofrequency ablation
5167188|NCT02947308|Anxiety|anxiety
5167189|NCT02947308|Depression|depression
5167190|NCT02947243|Virtual reality|virtual reality
5167191|NCT02947243|Immersive distraction|immersive distraction
5167192|NCT02947243|Oculus rift|oculus rift
5167193|NCT02947243|Virtual world|virtual world
5167194|NCT02947243|Virtual environment|virtual environment
5167195|NCT02947243|Procedural pain|procedural pain
5167196|NCT02947243|Procedural anxiety|procedural anxiety
5167197|NCT02947243|Acute pain|acute pain
5167198|NCT02947243|Pain management|pain management
5167199|NCT02947243|Anxiety|anxiety
5167200|NCT02947243|Children, Child|children, child
5167201|NCT02947243|Kid, Kids|kid, kids
5167202|NCT02947243|Pediatric, Pediatrics|pediatric, pediatrics
5167203|NCT02947243|Young children|young children
5167204|NCT02947243|Burns|burns
5167205|NCT02947243|Burn injuries|burn injuries
5167206|NCT02947243|Burn unit|burn unit
5167207|NCT02947243|Physiotherapy|physiotherapy
5167208|NCT02947243|Physical therapy|physical therapy
5167209|NCT02947243|Burn dressing|burn dressing
5167210|NCT02947243|Dressing change|dressing change
5167211|NCT02947243|Non-pharmacological, nonpharmacological|non-pharmacological, nonpharmacological
5167212|NCT02947243|Clinical Research|clinical research
5167213|NCT02947243|Nursing Practice|nursing practice
5167222|NCT02947204|Bronchiolitis|bronchiolitis
5167223|NCT02947204|Length of Hospital Stay|length of hospital stay
5167224|NCT02947204|Clinical Trial|clinical trial
5167225|NCT02947204|Oxygen Saturation Monitoring|oxygen saturation monitoring
5167226|NCT02947152|HKT288|hkt288
5167227|NCT02947152|CDH6|cdh6
5167229|NCT02947152|maytansine|maytansine
5167230|NCT02947152|epithelial ovarian cancer|epithelial ovarian cancer
5167231|NCT02947152|renal cell carcinoma|renal cell carcinoma
5167232|NCT02947152|RCC|rcc
5167233|NCT02947126|cystic fibrosis|cystic fibrosis
5167234|NCT02947126|mucociliary clearance|mucociliary clearance
5167235|NCT02947126|CFTR|cftr
5167236|NCT02947113|cancer|cancer
5167237|NCT02947100|Sickle Cell Disease|sickle cell disease
5167238|NCT02947100|omega-3 fatty acids|omega-3 fatty acids
5167239|NCT02947100|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
5167240|NCT02947100|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
5167241|NCT02947087|Islet autotransplantation|islet autotransplantation
5167242|NCT02947087|Alpha1 anti trypsin|alpha1 anti trypsin
5167243|NCT02947074|Yoga|yoga
5167244|NCT02947074|Meditation|meditation
5167245|NCT02947074|Glutathione|glutathione
5167246|NCT02947074|Catecholamine|catecholamine
5167247|NCT02947074|polysomnography|polysomnography
5162513|NCT02976584|EEG|eeg
5862715|NCT00001541|Wegener's Granulomatosis|wegener's granulomatosis
5167248|NCT02947061|Advanced Breast Cancer,first treatment, S1, Capecitabine|advanced breast cancer,first treatment, s1, capecitabine
5167249|NCT02947035|thyroid cancer|thyroid cancer
5167250|NCT02947035|thyroid nodule|thyroid nodule
5167251|NCT02947035|thyroidectomy|thyroidectomy
5167252|NCT02947035|personalized medicine|personalized medicine
5167253|NCT02947022|gadolinium|gadolinium
5167254|NCT02947022|deposition|deposition
5167256|NCT02947022|Extremity Pain|extremity pain
5167257|NCT02947022|Skin Pain|skin pain
5167258|NCT02947022|Chest Wall Pain|chest wall pain
5167259|NCT02946944|Pulmonary Embolism|pulmonary embolism
5167260|NCT02946944|sildenafil|sildenafil
5167261|NCT02946944|oral anticoagulation therapy|oral anticoagulation therapy
5167262|NCT02946918|levothyroxine|levothyroxine
5167263|NCT02946853|Atrial Fibrillation|atrial fibrillation
5167265|NCT02946853|AV Junction Ablation|av junction ablation
5167266|NCT02946853|LVESV|lvesv
5167267|NCT02946827|FODMAPs diet|fodmaps diet
5167268|NCT02946827|micro-macro nutrients intake|micro-macro nutrients intake
5167269|NCT02946827|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
5167270|NCT02946814|essential oils|essential oils
5167271|NCT02946814|microscope, colfocal|microscope, colfocal
5167272|NCT02946814|dental plaque|dental plaque
5167273|NCT02946801|Biofilms|biofilms
5167274|NCT02946801|essential oils|essential oils
5167275|NCT02946801|alcohol|alcohol
5167276|NCT02946801|microscopy, confocal|microscopy, confocal
5167277|NCT02946801|mouthwashes|mouthwashes
5167278|NCT02946775|septicemia|septicemia
5167279|NCT02946775|bacteremia|bacteremia
5167280|NCT02946775|pneumonia|pneumonia
5167281|NCT02946775|meningitis|meningitis
5167282|NCT02946762|HIV|hiv
5167283|NCT02946762|TB|tb
5167284|NCT02946762|Antiretroviral Treatment|antiretroviral treatment
5167285|NCT02946762|Anti-tuberculosis Treatment|anti-tuberculosis treatment
5167286|NCT02946762|HIV Counselling and Testing|hiv counselling and testing
5167287|NCT02946762|Treatment as Prevention|treatment as prevention
5167288|NCT02946749|Scar pregnancy|scar pregnancy
5167289|NCT02946749|Placenta planting abnormal disease|placenta planting abnormal disease
5167290|NCT02946749|Early diagnosis|early diagnosis
5167291|NCT02946749|Individualized treatment|individualized treatment
5167292|NCT02946736|Sleep|sleep
5167293|NCT02946736|Physical Health|physical health
5167294|NCT02946736|Psychological Health|psychological health
5167295|NCT02946736|Well-Being|well-being
5167296|NCT02946736|Employee|employee
5167297|NCT02946736|Actigraphy|actigraphy
5167298|NCT02946710|Alzheimer disease|alzheimer disease
5167299|NCT02946710|Alzheimer's disease, biomarkers|alzheimer's disease, biomarkers
5167300|NCT02946710|p75NTR-ECD|p75ntr-ecd
5167301|NCT02946697|Chinese|chinese
5167302|NCT02946697|cancer survivors|cancer survivors
5167303|NCT02946697|Quality of Life|quality of life
5167304|NCT02946697|Social Support|social support
5167305|NCT02946658|COPD, Emphysema|copd, emphysema
5167306|NCT02946619|Chinese breast cancer survivors|chinese breast cancer survivors
5167307|NCT02946619|expressive writing|expressive writing
5167308|NCT02946554|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
5167309|NCT02946554|ACLF|aclf
5167310|NCT02946541|DA-1229|da-1229
5167311|NCT02946541|evogliptin|evogliptin
5167312|NCT02946541|DPP-IV inhibitor|dpp-iv inhibitor
5167313|NCT02946541|Suganon|suganon
5167314|NCT02946541|DPP-4 inhibitor|dpp-4 inhibitor
5167315|NCT02946515|Pediatrics|pediatrics
5167316|NCT02946489|cannabis|cannabis
5167317|NCT02946489|mindfulness based relapse prevention|mindfulness based relapse prevention
5167318|NCT02946489|motivational enhancement therapy|motivational enhancement therapy
5167319|NCT02946437|severe SAH|severe sah
5167320|NCT02946437|prevention of vasospasm and/ or brain oedema|prevention of vasospasm and/ or brain oedema
5167321|NCT02946437|Sevoflurane|sevoflurane
5167322|NCT02946437|Postconditioning|postconditioning
5167323|NCT02946411|Hyperglycemia|hyperglycemia
5167324|NCT02946385|meningococcal disease|meningococcal disease
5167325|NCT02946385|meningitis|meningitis
5167331|NCT02946372|internal limiting membrane (ILM)|internal limiting membrane (ilm)
5167332|NCT02946372|vitrectomy|vitrectomy
5167333|NCT02946372|autologous transplantation|autologous transplantation
5167334|NCT02946346|Human papillomaviruses|human papillomaviruses
5167335|NCT02946346|Clearance|clearance
5167336|NCT02946346|Kinetics|kinetics
5167337|NCT02946346|Ecology|ecology
5167338|NCT02946346|Bacterial vaginosis|bacterial vaginosis
5167339|NCT02946346|Immune response|immune response
5167340|NCT02946346|Microbiota|microbiota
5167341|NCT02946333|Multiple Myeloma|multiple myeloma
5167342|NCT02946333|autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
5167343|NCT02946333|QoLMMBuS|qolmmbus
5167344|NCT02946333|healthcare costs|healthcare costs
5167345|NCT02946320|PCI, bioabsorbable scaffold|pci, bioabsorbable scaffold
5167346|NCT02946281|self-management|self-management
5167347|NCT02946281|health behavior|health behavior
5167348|NCT02946281|cardiac disease|cardiac disease
5167349|NCT02946281|habits|habits
5167350|NCT02946281|lifestyle|lifestyle
5167351|NCT02946255|Psychosis|psychosis
5167352|NCT02946255|Psychosis NOS|psychosis nos
5167353|NCT02946255|Schizophrenia|schizophrenia
5167354|NCT02946255|Hospital discharge|hospital discharge
5167355|NCT02946255|Inpatient psychiatry|inpatient psychiatry
5167356|NCT02946190|Acellular pertussis vaccines Genetically-detoxified pertussis toxin Adolescents|acellular pertussis vaccines genetically-detoxified pertussis toxin adolescents
5167362|NCT02946151|Epilepsy|epilepsy
5167363|NCT02946151|Seizure monitoring|seizure monitoring
5167364|NCT02946151|Electroencephalography|electroencephalography
5167365|NCT02946138|Hepatocellular Carcinoma|hepatocellular carcinoma
5167366|NCT02946138|carbon-ion radiotherapy|carbon-ion radiotherapy
5167368|NCT02946138|immunotherapy|immunotherapy
5167369|NCT02946086|motor skill learning, visuo-spatial attention|motor skill learning, visuo-spatial attention
5167370|NCT02946047|HIV|hiv
5167371|NCT02946047|ART|art
5167372|NCT02946047|Antiretroviral|antiretroviral
5167373|NCT02946047|Therapy|therapy
5167374|NCT02946047|Reservoir|reservoir
5167375|NCT02946047|Cure|cure
5167376|NCT02946034|CKD|ckd
5167377|NCT02946034|HCV|hcv
5167378|NCT02946021|Lymphedema|lymphedema
5167379|NCT02946021|Cancer|cancer
5167380|NCT02946021|Head Cancer|head cancer
5167381|NCT02946021|Neck Cancer|neck cancer
5167382|NCT02945982|Portal Hypertension|portal hypertension
5167383|NCT02945982|Fuzheng Huayu|fuzheng huayu
5167384|NCT02945982|Hepatitis B|hepatitis b
5167385|NCT02945969|dietary sodium|dietary sodium
5167386|NCT02945969|albuminuria|albuminuria
5167387|NCT02945969|chronic kidney disease|chronic kidney disease
5167388|NCT02945956|Portal Hypertension|portal hypertension
5167389|NCT02945956|Fuzheng Huayu|fuzheng huayu
5167390|NCT02945956|Hepatitis B|hepatitis b
5167391|NCT02945930|Enbucrilate|enbucrilate
5167392|NCT02945930|Esophageal and Gastric Varices|esophageal and gastric varices
5167393|NCT02945930|Endoscopy|endoscopy
5167394|NCT02945930|Safety|safety
5167395|NCT02945930|Efficacy|efficacy
5167396|NCT02945891|mass screening|mass screening
5167397|NCT02945891|coverage|coverage
5167398|NCT02945891|self-sampling|self-sampling
5167399|NCT02945891|clinical validity|clinical validity
5167400|NCT02945878|radiotherapy, oral mucositis,oral mucosa protection|radiotherapy, oral mucositis,oral mucosa protection
5167401|NCT02945839|Migraine|migraine
5167402|NCT02945839|emergency department|emergency department
5167403|NCT02945826|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
5167404|NCT02945826|positron emission tomography|positron emission tomography
5167405|NCT02945826|glioblastoma multiforme|glioblastoma multiforme
5167406|NCT02945813|Prostate Cancer|prostate cancer
5167407|NCT02945813|Prostate Cancer after Prostatectomy|prostate cancer after prostatectomy
5167408|NCT02945813|Phase II Trial|phase ii trial
5167409|NCT02945813|Salvage Radiotherapy|salvage radiotherapy
5167410|NCT02945813|Metformin|metformin
5167411|NCT02945800|relapsed|relapsed
5167412|NCT02945800|refractory|refractory
5167413|NCT02945800|soft tissue|soft tissue
5167414|NCT02945800|bones and joints|bones and joints
5167415|NCT02945800|non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
5167416|NCT02945800|pediatric|pediatric
5777815|NCT00208650|transplant|transplant
5167417|NCT02945787|Spanish speaking|spanish speaking
5167418|NCT02945787|self-help|self-help
5167419|NCT02945787|tobacco abstinence|tobacco abstinence
5167420|NCT02945787|public health|public health
5167421|NCT02945787|Forever Free|forever free
5167422|NCT02945787|Stop Smoking for Good|stop smoking for good
5167423|NCT02945774|PET|pet
5167424|NCT02945774|MRI|mri
5167425|NCT02945774|Inflammation|inflammation
5962153|NCT04282629|Delayed Cerebral Ischemia|delayed cerebral ischemia
5167426|NCT02945774|Microglia|microglia
5167427|NCT02945774|FEPPA|feppa
5167435|NCT02945735|MDD|mdd
5167436|NCT02945735|major depressive disorder|major depressive disorder
5167437|NCT02945735|attention bias modification treatment|attention bias modification treatment
5167438|NCT02945722|Hemodialysis|hemodialysis
5167439|NCT02945722|S. Aureus|s. aureus
5167440|NCT02945722|Decolonization|decolonization
5167441|NCT02945722|Persistent carriage|persistent carriage
5167442|NCT02945709|PTSD|ptsd
5167443|NCT02945709|attention training|attention training
5167444|NCT02945709|cognitive bias modification|cognitive bias modification
5167445|NCT02945696|nerve block|nerve block
5167446|NCT02945696|laparoscopy|laparoscopy
5167447|NCT02945696|anesthesia|anesthesia
5167448|NCT02945683|atopic dermatitis, probiotics, vitamin D3, L. reuteri|atopic dermatitis, probiotics, vitamin d3, l. reuteri
5167449|NCT02945644|obstructive sleep apnea|obstructive sleep apnea
5167450|NCT02945644|trazodone|trazodone
5167451|NCT02945644|positive airway pressure|positive airway pressure
5167452|NCT02945644|adherence|adherence
5167453|NCT02945631|HPV|hpv
5167454|NCT02945631|Induction Chemotherapy|induction chemotherapy
5167455|NCT02945631|De-Intensified Chemoradiotherapy|de-intensified chemoradiotherapy
5167456|NCT02945631|Oropharynx Cancer|oropharynx cancer
5167457|NCT02945618|cryotherapy|cryotherapy
5167458|NCT02945618|physical therapy|physical therapy
5167459|NCT02945592|Hemispatial Neglect|hemispatial neglect
5167460|NCT02945592|cueing|cueing
5167461|NCT02945592|egocentric-allocentric|egocentric-allocentric
5167462|NCT02945592|early rehabilitation|early rehabilitation
5167463|NCT02945592|parietal tDCS|parietal tdcs
5167464|NCT02945540|Gestational diabetes|gestational diabetes
5167465|NCT02945540|Patient education|patient education
5167466|NCT02945540|Patient Satisfaction|patient satisfaction
5167467|NCT02945514|Healthy|healthy
5167468|NCT02945514|Diet|diet
5167469|NCT02945514|Microbiome|microbiome
5167470|NCT02945514|Personalized|personalized
5167471|NCT02945514|Custom|custom
5167472|NCT02945475|functional magnetic resonance imaging|functional magnetic resonance imaging
5167473|NCT02945475|eating behavior|eating behavior
5167474|NCT02945475|sugar|sugar
5167475|NCT02945475|fructose|fructose
5167476|NCT02945449|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
5167477|NCT02945449|Erectile Dysfunction|erectile dysfunction
5167478|NCT02945449|Diabetes|diabetes
5167479|NCT02945449|safety|safety
5167480|NCT02945397|Return to work|return to work
5167481|NCT02945397|Work rehabilitation|work rehabilitation
5167482|NCT02945397|Sick-leave|sick-leave
5167483|NCT02945384|family well-being|family well-being
5167484|NCT02945332|exercise|exercise
5167485|NCT02945332|activity|activity
5167486|NCT02945332|behavior|behavior
5167487|NCT02945306|Sleep Disordered Breathing|sleep disordered breathing
5167488|NCT02945306|Adenotonsillectomy|adenotonsillectomy
5167489|NCT02945306|Child|child
5167490|NCT02945293|Pain|pain
5167491|NCT02945293|Elderly|elderly
5167492|NCT02945293|Aged|aged
5167493|NCT02945293|Opioid|opioid
5167494|NCT02945293|Cognition|cognition
5167495|NCT02945293|Side-effects|side-effects
5167497|NCT02945293|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
5167498|NCT02945293|Older|older
5167499|NCT02945280|apixaban|apixaban
5167500|NCT02945280|factor Xa inhibitors|factor xa inhibitors
5167501|NCT02945280|antithrombotic agent|antithrombotic agent
5167502|NCT02945280|deep vein thrombosis|deep vein thrombosis
5167503|NCT02945280|upper extremity|upper extremity
5167504|NCT02945267|Pancreatic Cancer|pancreatic cancer
5167505|NCT02945267|Unresectable|unresectable
5167506|NCT02945267|Maintenance Treatment|maintenance treatment
5167507|NCT02945254|sleep onset latency|sleep onset latency
5167508|NCT02945254|sleep quality|sleep quality
5167509|NCT02945254|insomnia|insomnia
5167510|NCT02945228|Genotype 2|genotype 2
5167511|NCT02945228|Paritaprevir|paritaprevir
5167512|NCT02945228|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5167513|NCT02945228|Ritonavir|ritonavir
5167514|NCT02945228|Ombitasvir|ombitasvir
5167515|NCT02945189|Pregnancy|pregnancy
5167516|NCT02945176|Boston Keratoprosthesis|boston keratoprosthesis
5167524|NCT02945072|Child Behavior|child behavior
5167525|NCT02945072|Problem Behavior|problem behavior
5167526|NCT02945072|postoperative behaviour problems|postoperative behaviour problems
5167527|NCT02945059|Liver regeneration|liver regeneration
5167528|NCT02945059|portal vein embolization|portal vein embolization
5167529|NCT02945059|gelatin powder|gelatin powder
5167530|NCT02945059|liver surgery|liver surgery
5167531|NCT02945059|hepatectomy|hepatectomy
5167532|NCT02945033|Pi3k mutation|pi3k mutation
5167533|NCT02945033|Aspirin|aspirin
5167534|NCT02944968|Interventional|interventional
5167535|NCT02944968|Radiofrequency Ablation|radiofrequency ablation
5167536|NCT02944968|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5167537|NCT02944929|Spastic hemiparesis|spastic hemiparesis
5167538|NCT02944929|Stroke|stroke
5167539|NCT02944929|Self-rehabilitation|self-rehabilitation
5167540|NCT02944929|Botulinum Toxin Injections|botulinum toxin injections
5167541|NCT02944903|audit|audit
5167542|NCT02944903|Lung cancer|lung cancer
5167543|NCT02944903|screening practice|screening practice
5167544|NCT02944903|Egypt|egypt
5167545|NCT02944851|Blood donors|blood donors
5167546|NCT02944851|blood donation|blood donation
5167547|NCT02944851|traumatic blood loss|traumatic blood loss
5167548|NCT02944851|Trauma|trauma
5167549|NCT02944838|older adults|older adults
5962154|NCT04282616|exercise|exercise
5167550|NCT02944838|physical activity|physical activity
5167551|NCT02944838|built environment|built environment
5167552|NCT02944825|Urolithiasis|urolithiasis
5167554|NCT02944786|Chronic pain|chronic pain
5167555|NCT02944786|Adolescents|adolescents
5167556|NCT02944786|School nurse|school nurse
5167558|NCT02944773|facilitated tucking|facilitated tucking
5167559|NCT02944773|position|position
5167560|NCT02944773|weight|weight
5167561|NCT02944773|stress|stress
5167562|NCT02944747|Gestational age, Preterm birth, LMP, Bangladesh|gestational age, preterm birth, lmp, bangladesh
5167563|NCT02944734|Candesartan|candesartan
5167564|NCT02944734|Amlodipine|amlodipine
5167565|NCT02944734|Hypertension|hypertension
5167566|NCT02944734|Vascular Diseases|vascular diseases
5167567|NCT02944734|Cardiovascular Diseases|cardiovascular diseases
5167568|NCT02944734|Antihypertensive Agents|antihypertensive agents
5167569|NCT02944734|Vasodilator Agents|vasodilator agents
5167570|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5167571|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
5167572|NCT02944734|Calcium Channel Blockers|calcium channel blockers
5167573|NCT02944721|Neuropathic Pain|neuropathic pain
5167574|NCT02944708|maintenance chemotherapy|maintenance chemotherapy
5167575|NCT02944695|audit|audit
5167576|NCT02944695|infection control|infection control
5167577|NCT02944695|bronchoscopy unit|bronchoscopy unit
5167578|NCT02944695|Egypt|egypt
5167579|NCT02944682|Obstetrics|obstetrics
5167580|NCT02944682|Pregnancy Outcomes|pregnancy outcomes
5167581|NCT02944682|Pediatrics|pediatrics
5167582|NCT02944682|Atherosclerosis|atherosclerosis
5167583|NCT02944682|Cancer|cancer
5167584|NCT02944682|Cardiovascular Disease|cardiovascular disease
5167585|NCT02944682|Public Health|public health
5167586|NCT02944682|Environmental Air Pollutants|environmental air pollutants
5167587|NCT02944656|Perioperative pain|perioperative pain
5167588|NCT02944656|Outpatient surgery|outpatient surgery
5167589|NCT02944656|Obstetrics/gynecology|obstetrics/gynecology
5167590|NCT02944656|Pain management|pain management
5167591|NCT02944630|quality of life|quality of life
5167592|NCT02944630|psychotherapy|psychotherapy
5167593|NCT02944630|psoriasis|psoriasis
5167594|NCT02944630|treatments|treatments
5167595|NCT02944578|Cancer|cancer
5167597|NCT02944578|Oncology|oncology
5167598|NCT02944578|Infectious Diseases|infectious diseases
5167599|NCT02944578|HPV|hpv
5167600|NCT02944578|Preventive Medicine|preventive medicine
5167601|NCT02944539|Mitochondrial DNA copy number|mitochondrial dna copy number
5167602|NCT02944539|Gastric cancer|gastric cancer
5167603|NCT02944526|suprascapular nerve|suprascapular nerve
5167604|NCT02944500|Brain|brain
5167605|NCT02944500|Liraglutide|liraglutide
5167607|NCT02944487|safety|safety
5167608|NCT02944487|pharmacokinetics|pharmacokinetics
5167609|NCT02944474|Pharmacokinetics|pharmacokinetics
5167610|NCT02944474|Safety|safety
5167611|NCT02944448|Osteoarthritis|osteoarthritis
5167612|NCT02944448|Hip|hip
5167613|NCT02944448|Knee|knee
5167614|NCT02944448|CR845|cr845
5167615|NCT02944448|Analgesic|analgesic
5167616|NCT02944448|Kappa opioid|kappa opioid
5167617|NCT02944448|difelikefalin|difelikefalin
5167618|NCT02944435|Glutaminase Inhibitor|glutaminase inhibitor
5167619|NCT02944435|Glutaminase|glutaminase
5167620|NCT02944435|CB-839|cb-839
5167621|NCT02944396|metastatic|metastatic
5167622|NCT02944396|non-small cell lung cancer|non-small cell lung cancer
5167623|NCT02944396|Eastern Cooperative Oncology Group (ECOG)|eastern cooperative oncology group (ecog)
5167624|NCT02944396|veliparib|veliparib
5167625|NCT02944396|nivolumab|nivolumab
5167626|NCT02944396|Platinum Doublet Chemotherapy|platinum doublet chemotherapy
5167627|NCT02944396|carboplatin|carboplatin
5167628|NCT02944396|paclitaxel|paclitaxel
5167629|NCT02944396|pemetrexed|pemetrexed
5167630|NCT02944396|Response Evaluation Criteria In Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
5167631|NCT02944396|Common Terminology Criteria for Adverse Events (CTCAE)|common terminology criteria for adverse events (ctcae)
5167731|NCT02943902|immunogenicity|immunogenicity
5167632|NCT02944396|Poly (ADP) ribose polymerase (PARP)|poly (adp) ribose polymerase (parp)
5167633|NCT02944396|Immuno Oncology|immuno oncology
5167634|NCT02944396|Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)|metastatic or advanced non-small cell lung cancer (nsclc)
5167635|NCT02944383|Hypertriglycerides|hypertriglycerides
5167636|NCT02944344|breast cancer|breast cancer
5167637|NCT02944344|stage 4|stage 4
5167638|NCT02944344|metastatic|metastatic
5167639|NCT02944344|hospice|hospice
5167640|NCT02944344|palliative care|palliative care
5167641|NCT02944344|end of life|end of life
5167642|NCT02944344|advance directive|advance directive
5167643|NCT02944344|oncology|oncology
5167644|NCT02944344|caregiver|caregiver
5167645|NCT02944344|provider|provider
5167646|NCT02944344|coping|coping
5167647|NCT02944344|support|support
5167648|NCT02944344|online|online
5054874|NCT03654989|Foot Ulcer|foot ulcer
5167649|NCT02944331|Steam ablation|steam ablation
5167650|NCT02944331|Endothermal ablation|endothermal ablation
5167651|NCT02944331|Varicose vein treatment|varicose vein treatment
5034150|NCT03785925|mUC|muc
5167652|NCT02944331|Venous insufficiency|venous insufficiency
5167653|NCT02944331|Saphenous vein reflux|saphenous vein reflux
5167654|NCT02944331|Recurrent varicosity|recurrent varicosity
5167655|NCT02944318|Physical Activity|physical activity
5167656|NCT02944318|Healthy Lifestyle|healthy lifestyle
5167657|NCT02944318|Academic performance|academic performance
5167658|NCT02944292|Intra-abdominal pressure|intra-abdominal pressure
5167659|NCT02944292|Intra-abdominal hypertension|intra-abdominal hypertension
5167660|NCT02944266|post general anaesthesia induced|post general anaesthesia induced
5167661|NCT02944253|Diet, Reducing|diet, reducing
5167662|NCT02944253|Hunger|hunger
5167663|NCT02944253|Appetite Regulation|appetite regulation
5167664|NCT02944253|Ketogenic Diet|ketogenic diet
5167665|NCT02944253|Caloric Restriction|caloric restriction
5167666|NCT02944253|Weight Loss|weight loss
5167667|NCT02944253|Ketosis|ketosis
5167668|NCT02944214|Hyperuricemia|hyperuricemia
5167669|NCT02944214|Renal Function|renal function
5167670|NCT02944214|Chronic kidney disease|chronic kidney disease
5167671|NCT02944214|Febuxostat|febuxostat
5167672|NCT02944214|Benzbromarone|benzbromarone
5167673|NCT02944201|carvedilol|carvedilol
5167674|NCT02944201|biomarkers|biomarkers
5167675|NCT02944201|autonomic nerves|autonomic nerves
5167676|NCT02944188|enhanced recovery after surgery|enhanced recovery after surgery
5167677|NCT02944188|right hemicolectomy|right hemicolectomy
5167679|NCT02944162|CD33|cd33
5167680|NCT02944162|CAR-NK|car-nk
5167681|NCT02944136|cancer|cancer
5167682|NCT02944136|stepped collaborative care intervention|stepped collaborative care intervention
5167683|NCT02944136|depression|depression
5167684|NCT02944136|quality of life|quality of life
5167685|NCT02944136|stress|stress
5167686|NCT02944136|dyadic function|dyadic function
5167687|NCT02944136|spousal or intimate caregiver|spousal or intimate caregiver
5167689|NCT02944123|Newer oral P2Y12 receptor inhibitors|newer oral p2y12 receptor inhibitors
5167690|NCT02944123|Acute coronary syndrome|acute coronary syndrome
5167691|NCT02944097|Bioavailability|bioavailability
5167692|NCT02944097|Pharmacokinetics|pharmacokinetics
5167693|NCT02944097|trans-resveratrol|trans-resveratrol
5167694|NCT02944097|trans-epsilon-viniferin|trans-epsilon-viniferin
5167695|NCT02944097|Vineatrol 30|vineatrol 30
5167696|NCT02944084|Bioavailability|bioavailability
5167697|NCT02944084|Pharmacokinetics|pharmacokinetics
5167698|NCT02944084|Rice bran extract|rice bran extract
5167699|NCT02944084|Vitamin E|vitamin e
5167700|NCT02944084|Gamma-oryzanol|gamma-oryzanol
5167701|NCT02944084|Ferulic acid|ferulic acid
5167702|NCT02944071|femoropopliteal artery lesions|femoropopliteal artery lesions
5167703|NCT02944071|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5167704|NCT02944071|Peripheral Artery Disease|peripheral artery disease
5167705|NCT02944071|Drug-coated Balloon|drug-coated balloon
5167706|NCT02944058|Multiloc|multiloc
5167707|NCT02944058|Philos|philos
5167708|NCT02944058|Locking plate|locking plate
5167709|NCT02944058|Straight nail|straight nail
5167710|NCT02944058|Randomized controlled trial|randomized controlled trial
5167711|NCT02944058|3 and 4 part fractures|3 and 4 part fractures
5167712|NCT02944019|Nonvalvular Atrial Fibrillation|nonvalvular atrial fibrillation
5167713|NCT02944019|Post Authorisation Safety Study|post authorisation safety study
5167714|NCT02944019|Safety|safety
5167715|NCT02944019|Real World Evidence|real world evidence
5167716|NCT02944006|MRI|mri
5167717|NCT02943993|Post-Authorisation Safety Study|post-authorisation safety study
5167718|NCT02943993|Real World Evidence|real world evidence
5167719|NCT02943993|Edoxaban|edoxaban
5167720|NCT02943993|Efficacy/Safety|efficacy/safety
5167721|NCT02943980|Intraoperative nerve monitoring, airway management|intraoperative nerve monitoring, airway management
5167722|NCT02943967|Refractive Surgical Procedures|refractive surgical procedures
5167723|NCT02943967|Photorefractive Keratectomy|photorefractive keratectomy
5167724|NCT02943967|Aberrometry|aberrometry
5167725|NCT02943954|Fractional Flow Reserve|fractional flow reserve
5167726|NCT02943915|Spinal Cord|spinal cord
5167727|NCT02943915|Injury|injury
5167728|NCT02943915|Exoskeleton|exoskeleton
5167729|NCT02943915|Ekso|ekso
5167730|NCT02943915|Rehabilitation|rehabilitation
5167736|NCT02943876|risk score|risk score
5167737|NCT02943876|accuracy of risk perception|accuracy of risk perception
5167738|NCT02943876|self-help|self-help
5167739|NCT02943876|psychological distress|psychological distress
5167740|NCT02943850|stem cells|stem cells
5167741|NCT02943850|growth factor|growth factor
5167742|NCT02943850|ALS|als
5167743|NCT02943824|brachytherapy|brachytherapy
5167744|NCT02943824|machine learning|machine learning
5167745|NCT02943824|treatment planning|treatment planning
5167746|NCT02943824|Low-Dose-Rate brachytherapy|low-dose-rate brachytherapy
5167747|NCT02943811|endometrial cancer|endometrial cancer
5167748|NCT02943811|survival|survival
5167749|NCT02943811|uterine manipulator|uterine manipulator
5167750|NCT02943798|Pulmonary Large Cell Neuroendocrine Carcinoma,chemotherapy|pulmonary large cell neuroendocrine carcinoma,chemotherapy
5167755|NCT02943746|Standard Protein Diet|standard protein diet
5167756|NCT02943746|High Protein Diet|high protein diet
5167757|NCT02943746|Growth|growth
5962155|NCT04282616|rehabilitation|rehabilitation
5085238|NCT03465735|Venous|venous
5167758|NCT02943746|Body Composition|body composition
5167759|NCT02943746|Extremely Low Birth Weight|extremely low birth weight
5167760|NCT02943746|Human Milk Derived Fortifier|human milk derived fortifier
5167761|NCT02943746|Protein|protein
5167762|NCT02943746|Targeted Fortification|targeted fortification
5167763|NCT02943746|Human Milk Diet|human milk diet
5167764|NCT02943746|Prematurity|prematurity
5167765|NCT02943733|Pancreatic neuroendocrine tumors (pNETs)|pancreatic neuroendocrine tumors (pnets)
5167766|NCT02943733|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
5167767|NCT02943733|pNETs|pnets
5167768|NCT02943733|NETs|nets
5167769|NCT02943707|liver diseases|liver diseases
5167770|NCT02943707|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5167771|NCT02943694|TaTME|tatme
5167772|NCT02943694|Complications|complications
5167773|NCT02943694|Instrument|instrument
5167774|NCT02943642|MF|mf
5167775|NCT02943642|CTCL|ctcl
5167776|NCT02943642|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5167777|NCT02943616|Absorb GT1 BVS|absorb gt1 bvs
5167778|NCT02943616|BVS|bvs
5167779|NCT02943616|Bioabsorbable|bioabsorbable
5167780|NCT02943616|Myocardial ischemia|myocardial ischemia
5167781|NCT02943616|Stent thrombosis|stent thrombosis
5167782|NCT02943616|Stents|stents
5167783|NCT02943603|mFOLFOX6|mfolfox6
5167784|NCT02943603|pembrolizumab|pembrolizumab
5167785|NCT02943590|Cancer Treatment Related to Heart Failure|cancer treatment related to heart failure
5167786|NCT02943551|Pediatrics|pediatrics
5167787|NCT02943551|Respiratory disease|respiratory disease
5167788|NCT02943551|antibiotic use|antibiotic use
5167789|NCT02943538|Crohn's Disease|crohn's disease
5167790|NCT02943538|Colitis, Ulcerative|colitis, ulcerative
5167791|NCT02943538|Telemedicine|telemedicine
5167792|NCT02943525|vaginal packing|vaginal packing
5167793|NCT02943525|pelvic organ prolapse|pelvic organ prolapse
5167794|NCT02943525|pain and satisfaction|pain and satisfaction
5167795|NCT02943486|Mesenchymal stromal cells|mesenchymal stromal cells
5167796|NCT02943486|Fitostimoline|fitostimoline
5167797|NCT02943486|MSC derivatives|msc derivatives
5167799|NCT02943473|Smoldering multiple myeloma|smoldering multiple myeloma
5167800|NCT02943473|myeloma|myeloma
5167801|NCT02943473|smoldering|smoldering
5167802|NCT02943473|ibrutinib|ibrutinib
5167803|NCT02943408|Veterans|veterans
5167804|NCT02943408|mental health|mental health
5167805|NCT02943408|Patient-Centered Care|patient-centered care
5167806|NCT02943382|MGD|mgd
5167807|NCT02943382|Autologous Serum|autologous serum
5167808|NCT02943382|Meibomian gland dysfunction|meibomian gland dysfunction
5167809|NCT02943382|Dry eye disease|dry eye disease
5167810|NCT02943382|FAB|fab
5167811|NCT02943382|Fingerprick autologous blood|fingerprick autologous blood
5167814|NCT02943369|P2Y12 receptor antagonist|p2y12 receptor antagonist
5167815|NCT02943369|acute myocardial infarction|acute myocardial infarction
5167817|NCT02943330|Cytokines|cytokines
5167818|NCT02943330|Hemodialysis|hemodialysis
5167819|NCT02943330|Interferon treatment|interferon treatment
5167820|NCT02943330|Hepatitis C|hepatitis c
5167821|NCT02943304|Pregnancy|pregnancy
5167822|NCT02943304|Fetal Development|fetal development
5167823|NCT02943304|Child Development|child development
5167824|NCT02943304|Developmental Disabilities|developmental disabilities
5167825|NCT02943304|Zika Virus Infection|zika virus infection
5167826|NCT02943291|Exercise therapy|exercise therapy
5167827|NCT02943291|Adipose tissue|adipose tissue
5167828|NCT02943291|Mitochondria|mitochondria
5167829|NCT02943291|Oxidative Phosphorylation|oxidative phosphorylation
5167830|NCT02943265|Care Coordination|care coordination
5167831|NCT02943252|apatinib|apatinib
5167835|NCT02943213|Chlorpromazine|chlorpromazine
5167836|NCT02943213|Hydrochloride|hydrochloride
5167837|NCT02943213|Chlorpromazine Hydrochloride|chlorpromazine hydrochloride
5167838|NCT02943213|Bioavailability|bioavailability
5167839|NCT02943213|Variability|variability
5167840|NCT02943213|Variable|variable
5167841|NCT02943213|Absorption|absorption
5167842|NCT02943213|USL Pharma|usl pharma
5167844|NCT02943213|Healthy|healthy
5167845|NCT02943213|South Africa|south africa
5167847|NCT02943213|Anti-Psychotic|anti-psychotic
5167850|NCT02943109|patient portal|patient portal
5167851|NCT02943109|Health Information Technology|health information technology
5167852|NCT02943109|Electronic Health Records|electronic health records
5167853|NCT02943109|Inpatient Care|inpatient care
5167854|NCT02943109|Outpatient Care|outpatient care
5167855|NCT02943109|Patient Engagement|patient engagement
5167858|NCT02943031|bile duct tumor|bile duct tumor
5167859|NCT02943031|individualized precise treatment programs|individualized precise treatment programs
5167860|NCT02943018|ultrasound anovaginal distance, observer variation|ultrasound anovaginal distance, observer variation
5167861|NCT02942979|Facilitation|facilitation
5167862|NCT02942979|Implementation|implementation
5167863|NCT02942979|Homelessness|homelessness
5167864|NCT02942979|Substance Use Disorder|substance use disorder
5167865|NCT02942979|Mental Illness|mental illness
5167866|NCT02942979|Co-Occurring Disorders|co-occurring disorders
5167867|NCT02942979|Veterans|veterans
5962156|NCT04282616|exercise testing|exercise testing
5167868|NCT02942979|Primary Care|primary care
5167869|NCT02942966|Angioplasty|angioplasty
5167870|NCT02942966|Below the Knee|below the knee
5167871|NCT02942966|PAD|pad
5167872|NCT02942966|Critical Limb Ischemia|critical limb ischemia
5167873|NCT02942966|Lesion|lesion
5167874|NCT02942966|Claudication|claudication
5167875|NCT02942953|Pacemaker, Artificial|pacemaker, artificial
5167876|NCT02942953|Diaphragmatic pacing|diaphragmatic pacing
5167877|NCT02942927|Polypharmacy|polypharmacy
5167878|NCT02942927|Multimorbidity|multimorbidity
5167879|NCT02942927|Randomized Control Trial|randomized control trial
5167880|NCT02942927|Drug Discontinuation|drug discontinuation
5167881|NCT02942927|Patient Preference|patient preference
5167882|NCT02942927|eHealth|ehealth
5167883|NCT02942901|PET-CT|pet-ct
5167884|NCT02942901|pulmonary metstasectomy|pulmonary metstasectomy
5167885|NCT02942888|Mild Cognitive Impairment|mild cognitive impairment
5167886|NCT02942888|MCI|mci
5167887|NCT02942888|NAD|nad
5167888|NCT02942888|nicotinamide riboside|nicotinamide riboside
5167889|NCT02942888|aging|aging
5167890|NCT02942875|upper limb|upper limb
5167891|NCT02942875|mirror therapy|mirror therapy
5167892|NCT02942875|rehabilitation|rehabilitation
5167893|NCT02942875|subacute|subacute
5167894|NCT02942849|Bemfola|bemfola
5167895|NCT02942849|r-hFSH|r-hfsh
5167896|NCT02942849|Oocytes|oocytes
5167897|NCT02942849|Pregnancy|pregnancy
5167898|NCT02942849|OHSS|ohss
5167899|NCT02942836|Respiration Rate Detection|respiration rate detection
5167900|NCT02942823|obesity|obesity
5167901|NCT02942823|child|child
5167902|NCT02942823|primary prevention|primary prevention
5167903|NCT02942823|serious game|serious game
5167904|NCT02942823|nutrition|nutrition
5167906|NCT02942823|psychosocial|psychosocial
5167907|NCT02942823|stress|stress
5167908|NCT02942823|knowledge|knowledge
5167909|NCT02942823|diet|diet
5167910|NCT02942823|energy density|energy density
5167911|NCT02942823|beverages|beverages
5167912|NCT02942823|food pyramide|food pyramide
5167913|NCT02942732|Vitamin D|vitamin d
5167914|NCT02942732|Glucose|glucose
5167915|NCT02942732|HbA1C|hba1c
5167916|NCT02942732|Insulin resistance|insulin resistance
5167917|NCT02942732|Blood lipids|blood lipids
5167918|NCT02942693|Apatinib|apatinib
5167919|NCT02942693|Particle therapy|particle therapy
5167920|NCT02942680|coronary artery bypass grafting|coronary artery bypass grafting
5167921|NCT02942641|Urethral catheter|urethral catheter
5167922|NCT02942641|clean intermittent catheterization|clean intermittent catheterization
5167923|NCT02942641|UTI|uti
5167924|NCT02942641|pain|pain
5167925|NCT02942641|quality of life|quality of life
5167926|NCT02942641|hematuria|hematuria
5167927|NCT02942641|cloudy urine|cloudy urine
5167928|NCT02942589|Portion Size|portion size
5167929|NCT02942563|Local Advanced Rectal Cancer|local advanced rectal cancer
5167930|NCT02942563|Total Neoadjuvant Therapy|total neoadjuvant therapy
5167931|NCT02942563|FOLFOXIRI|folfoxiri
5167932|NCT02942498|behavior, cognitive|behavior, cognitive
5167933|NCT02942472|clinical pregnancy rate after embryo transfer|clinical pregnancy rate after embryo transfer
5167934|NCT02942459|music therapy|music therapy
5167935|NCT02942459|double-blinded|double-blinded
5167936|NCT02942459|Randomized Controlled study (RCT)|randomized controlled study (rct)
5168036|NCT02941926|CDK4/6|cdk4/6
5167937|NCT02942459|Schizophrenia, negative symptoms|schizophrenia, negative symptoms
5167938|NCT02942407|Renal dialysis|renal dialysis
5167939|NCT02942329|humanized anti-PD-1 monoclonal antibody|humanized anti-pd-1 monoclonal antibody
5167940|NCT02942329|apatinib|apatinib
5167941|NCT02942329|Gastric Neoplasms|gastric neoplasms
5167942|NCT02942329|Gastric Cancer|gastric cancer
5167943|NCT02942329|Cancer of Stomach|cancer of stomach
5167944|NCT02942329|Hepatocellular Carcinoma|hepatocellular carcinoma
5167945|NCT02942329|Liver Cancer, Adult|liver cancer, adult
5167946|NCT02942329|Liver Cell Carcinoma|liver cell carcinoma
5167947|NCT02942316|Heart Rate|heart rate
5167948|NCT02942316|Reflex, Pupillary|reflex, pupillary
5055232|NCT03653247|Drug: Busulfan|drug: busulfan
5167949|NCT02942316|Monitoring, Intraoperative|monitoring, intraoperative
5167950|NCT02942303|Botulinum Toxin, Rejuvenation, Brow lift, Eyebrow.|botulinum toxin, rejuvenation, brow lift, eyebrow.
5167951|NCT02942290|Higher-Risk (HR) Myelodysplastic Syndromes (MDS)|higher-risk (hr) myelodysplastic syndromes (mds)
5167952|NCT02942290|Pharmacokinetic|pharmacokinetic
5167953|NCT02942290|Venetoclax|venetoclax
5167954|NCT02942290|Azacitidine|azacitidine
5167955|NCT02942290|Acute Myelogenous Leukemia|acute myelogenous leukemia
5167956|NCT02942290|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5167957|NCT02942290|Treatment-Naïve Higher-Risk|treatment-naïve higher-risk
5167958|NCT02942277|Malaria|malaria
5167959|NCT02942277|Reactogenicity|reactogenicity
5167960|NCT02942277|Antibody|antibody
5167961|NCT02942277|Direct Skin Feed|direct skin feed
5167962|NCT02942277|Mosquito|mosquito
5167963|NCT02942264|Brain Tumor|brain tumor
5167964|NCT02942264|Glioblastoma|glioblastoma
5167965|NCT02942264|Relapse|relapse
5167966|NCT02942264|Randomized|randomized
5167967|NCT02942264|Temodar|temodar
5167969|NCT02942251|big data analytics|big data analytics
5167970|NCT02942238|CME|cme
5167971|NCT02942238|Right hemi Colon cancer|right hemi colon cancer
5167973|NCT02942238|laparoscopy|laparoscopy
5167974|NCT02942225|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5167975|NCT02942225|metabolomics|metabolomics
5167976|NCT02942225|neuropsychological deficits|neuropsychological deficits
5167977|NCT02942225|pathway analysis|pathway analysis
5167978|NCT02942212|Smoking Cessation|smoking cessation
5167979|NCT02942212|Nicotine patch|nicotine patch
5167980|NCT02942212|Nicoderm Committed Quitters|nicoderm committed quitters
5167981|NCT02942212|CQ|cq
5167982|NCT02942212|Nicoderm CQ|nicoderm cq
5167983|NCT02942212|Questionnaires|questionnaires
5167984|NCT02942212|Surveys|surveys
5167985|NCT02942212|Interviews|interviews
5167986|NCT02942212|Breath tests|breath tests
5167987|NCT02942173|CD45RA-depletion|cd45ra-depletion
5167988|NCT02942173|TCR-alpha/beta depletion|tcr-alpha/beta depletion
5167989|NCT02942173|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5167990|NCT02942121|surgery education|surgery education
5167991|NCT02942121|radical cystectomy|radical cystectomy
5167992|NCT02942121|cystectomy|cystectomy
5167993|NCT02942121|muscle-invasive bladder cancer|muscle-invasive bladder cancer
5167994|NCT02942108|piezolectric surgery|piezolectric surgery
5167995|NCT02942108|conventional surgery|conventional surgery
5167996|NCT02942108|lower third molars|lower third molars
5167997|NCT02942095|Advanced Solid Tumors|advanced solid tumors
5167998|NCT02942095|Metastatic cancer|metastatic cancer
5167999|NCT02942095|Ixazomib|ixazomib
5168000|NCT02942095|MLN9708|mln9708
5168001|NCT02942095|Erlotinib|erlotinib
5168002|NCT02942095|Erlotinib hydrochloride|erlotinib hydrochloride
5168004|NCT02942095|CP358774|cp358774
5168005|NCT02942095|Tarceva|tarceva
5168006|NCT02942043|Malignant pleural effusion|malignant pleural effusion
5168007|NCT02942043|Bevacizumab|bevacizumab
5168008|NCT02942017|Moderate Postpartum Depression|moderate postpartum depression
5168009|NCT02942017|SAGE-547|sage-547
5168010|NCT02942004|Severe Postpartum Depression|severe postpartum depression
5168011|NCT02942004|SAGE-547|sage-547
5168012|NCT02941991|Stargardt's Macular Dystrophy|stargardt's macular dystrophy
5168013|NCT02941991|Retinal Diseases|retinal diseases
5168014|NCT02941991|Macular Degeneration|macular degeneration
5168015|NCT02941991|fundus flavimaculatus|fundus flavimaculatus
5168016|NCT02941991|hESC-RPE|hesc-rpe
5168017|NCT02941991|ASP7316|asp7316
5168018|NCT02941991|juvenile macular dystrophy|juvenile macular dystrophy
5168019|NCT02941991|SMD|smd
5168020|NCT02941978|atrial fibrillation|atrial fibrillation
5168021|NCT02941978|oral anticoagulation|oral anticoagulation
5168022|NCT02941978|motivational intervention|motivational intervention
5168023|NCT02941978|adherence|adherence
5168024|NCT02941978|treatment gaps|treatment gaps
5168025|NCT02941939|high intensity interval training|high intensity interval training
5168026|NCT02941939|hyperbaric oxygen|hyperbaric oxygen
5168027|NCT02941926|HR-positive HER2-negative|hr-positive her2-negative
5168028|NCT02941926|advanced breast cancer|advanced breast cancer
5168029|NCT02941926|LEE011|lee011
5168030|NCT02941926|ribociclib|ribociclib
5168031|NCT02941926|letrozole|letrozole
5168032|NCT02941926|goserelin|goserelin
5168033|NCT02941926|CDK|cdk
5168034|NCT02941926|CDK4|cdk4
5168035|NCT02941926|CDK6|cdk6
5168042|NCT02941926|men with advanced breast cancer|men with advanced breast cancer
5168046|NCT02941887|Gingivitis|gingivitis
5168047|NCT02941887|Periodontitis|periodontitis
5168048|NCT02941887|Down's Syndrome|down's syndrome
5168049|NCT02941874|IRAP|irap
5168050|NCT02941874|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
5168051|NCT02941874|Diagnostic biomarker|diagnostic biomarker
5168052|NCT02941874|Type 2 diabetes|type 2 diabetes
5168053|NCT02941861|Hepatocellular carcinoma|hepatocellular carcinoma
5168054|NCT02941861|Cholangiocarcinoma|cholangiocarcinoma
5168055|NCT02941861|Recurrence|recurrence
5168056|NCT02941835|pre-operative radiotherapy|pre-operative radiotherapy
5168061|NCT02941770|Adolescents|adolescents
5168062|NCT02941770|Overweight|overweight
5168063|NCT02941770|Obesity|obesity
5168064|NCT02941770|Weight Loss|weight loss
5168065|NCT02941770|Physical activity consultation|physical activity consultation
5168066|NCT02941770|Cardiorespiratory fitness|cardiorespiratory fitness
5168067|NCT02941770|Endothelial structure|endothelial structure
5168068|NCT02941770|Endothelial function|endothelial function
5168069|NCT02941757|Mediterranean Diet|mediterranean diet
5168070|NCT02941757|Firefighters|firefighters
5168071|NCT02941757|workplace|workplace
5168072|NCT02941757|Intervention|intervention
5168073|NCT02941757|obesity|obesity
5168074|NCT02941757|Randomized Control Trial|randomized control trial
5168075|NCT02941744|nivolumab|nivolumab
5168076|NCT02941744|ipilimumab|ipilimumab
5168077|NCT02941744|low fixed dose|low fixed dose
5168078|NCT02941744|adjuvant therapy|adjuvant therapy
5168079|NCT02941744|Melanoma|melanoma
5168080|NCT02941718|Smoking|smoking
5168081|NCT02941718|Smoking cessation|smoking cessation
5168082|NCT02941718|Nicotine|nicotine
5168083|NCT02941705|stem cell research|stem cell research
5168084|NCT02941640|Laparoscopic appendectomy|laparoscopic appendectomy
5168085|NCT02941640|Endoloop|endoloop
5168086|NCT02941640|Stapler|stapler
5168087|NCT02941640|Hem-o-lok clip|hem-o-lok clip
5168088|NCT02941640|DS clip|ds clip
5168089|NCT02941601|Thoracic Neoplasms|thoracic neoplasms
5168090|NCT02941601|Lung Diseases|lung diseases
5168091|NCT02941601|Lung Cancer|lung cancer
5168092|NCT02941601|Respiratory Tract Diseases|respiratory tract diseases
5168093|NCT02941601|Respiratory Tract Neoplasms|respiratory tract neoplasms
5168094|NCT02941601|Antineoplastic Agents|antineoplastic agents
5168095|NCT02941601|Monoclonal Antibodies|monoclonal antibodies
5168096|NCT02941562|rectal cancer, radiotherapy|rectal cancer, radiotherapy
5168097|NCT02941536|Circulating Tumor Cells|circulating tumor cells
5168098|NCT02941536|Stereotactic Radiosurgery|stereotactic radiosurgery
5168099|NCT02941497|Stress, Psychological|stress, psychological
5168100|NCT02941497|Obesity|obesity
5168101|NCT02941497|Physical Activity|physical activity
5168102|NCT02941497|Fruit|fruit
5168103|NCT02941497|Vegetables|vegetables
5168104|NCT02941497|Social Marketing|social marketing
5168105|NCT02941497|Peer Influence|peer influence
5168106|NCT02941497|Community-Based Participatory Research|community-based participatory research
5168107|NCT02941471|Constipation|constipation
5168108|NCT02941471|Neuromodulation|neuromodulation
5168109|NCT02941471|Interferential|interferential
5168110|NCT02941471|Transabdominal|transabdominal
5168111|NCT02941445|DPP4-inhibitors|dpp4-inhibitors
5168112|NCT02941419|Platelet lysate|platelet lysate
5168113|NCT02941419|Critical limb ischemia|critical limb ischemia
5168114|NCT02941419|Peripheral arterial disease|peripheral arterial disease
5168115|NCT02941406|Retina|retina
5168116|NCT02941406|Perimetry|perimetry
5168117|NCT02941393|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia|internal tocodynamometry, external tocodynamometry, cesarean section, labor, newborn, vacuum extraction, dystocia
5168118|NCT02941380|coronary artery bypass grafting|coronary artery bypass grafting
5168119|NCT02941380|cardiopulmonary bypass|cardiopulmonary bypass
5168120|NCT02941380|Cerebral oxidative stress|cerebral oxidative stress
5168121|NCT02941380|Cerebral inflammatory stress|cerebral inflammatory stress
5168122|NCT02941380|Cerebral hemodynamics|cerebral hemodynamics
5168123|NCT02941380|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5168124|NCT02941341|Bemfola|bemfola
5168125|NCT02941341|r-hFSH|r-hfsh
5168126|NCT02941341|ART|art
5168127|NCT02941341|Oocytes|oocytes
5168128|NCT02941341|OHSS|ohss
5168129|NCT02941341|Pregnancy|pregnancy
5168130|NCT02941328|SMA, SMN1, Kugelberg-Welander|sma, smn1, kugelberg-welander
5168131|NCT02941315|Cardiomyopathy|cardiomyopathy
5168132|NCT02941315|Heart Failure|heart failure
5168133|NCT02941315|Cardiac Magnetic Resonance|cardiac magnetic resonance
5168134|NCT02941302|gliomas|gliomas
5168135|NCT02941302|biological boundary|biological boundary
5168142|NCT02941211|cervical dilation|cervical dilation
5168143|NCT02941211|balloon catheter|balloon catheter
5168144|NCT02941172|Brown adipose tissue|brown adipose tissue
5168145|NCT02941172|Cannabinoid receptor|cannabinoid receptor
5168146|NCT02941172|PET imaging|pet imaging
5168147|NCT02941172|Metabolism|metabolism
5168148|NCT02941120|Cartilage defect|cartilage defect
5168149|NCT02941120|Knee|knee
5168150|NCT02941120|ACT (Autologous chondrocyte implantation)|act (autologous chondrocyte implantation)
5168151|NCT02941120|NOVOCART® Inject|novocart® inject
5168152|NCT02941107|Aboriginal|aboriginal
5168153|NCT02941107|Rotavirus|rotavirus
5168154|NCT02941107|Vaccine|vaccine
5168155|NCT02941107|Diarrhoea|diarrhoea
5168156|NCT02941081|iron supplement|iron supplement
5168157|NCT02941068|severe sepsis|severe sepsis
5168158|NCT02941068|intra-abdominal perforation|intra-abdominal perforation
5168159|NCT02941068|surgical intensive care unit|surgical intensive care unit
5168160|NCT02941068|fungal infection|fungal infection
5777816|NCT00208650|cardiac|cardiac
5055457|NCT03651778|GHB|ghb
5168161|NCT02941068|prophylactic anti-fungal treatment|prophylactic anti-fungal treatment
5168162|NCT02941055|Diet|diet
5168163|NCT02941055|Inflammation|inflammation
5168164|NCT02941055|Metabolomics|metabolomics
5168165|NCT02941029|Radiation|radiation
5168166|NCT02941029|Chemotherapy|chemotherapy
5168167|NCT02941003|Early stage lung adenocarcinoma|early stage lung adenocarcinoma
5168168|NCT02941003|Intraoperative frozen section|intraoperative frozen section
5168169|NCT02941003|Diagnostic criteria|diagnostic criteria
5168170|NCT02940977|Circulating tumor cell|circulating tumor cell
5168171|NCT02940977|Epithelial to mesenchymal transition|epithelial to mesenchymal transition
5168172|NCT02940977|Prostate specific antigen (PSA)|prostate specific antigen (psa)
5168173|NCT02940977|Partin table|partin table
5168174|NCT02940925|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5168175|NCT02940925|induction chemotherapy|induction chemotherapy
5168176|NCT02940912|Parkinson disease|parkinson disease
5168177|NCT02940912|Insomnia|insomnia
5168178|NCT02940912|Sleep disorders|sleep disorders
5168179|NCT02940912|Polysomnography|polysomnography
5168180|NCT02940912|Apomorphine|apomorphine
5168181|NCT02940912|Multiple sleep latency test|multiple sleep latency test
5168182|NCT02940912|Parkinson Disease Sleep Scale 2 (PDSS-2)|parkinson disease sleep scale 2 (pdss-2)
5168183|NCT02940873|severe hypoglycemia|severe hypoglycemia
5168184|NCT02940873|impaired awareness of hypoglycemia|impaired awareness of hypoglycemia
5168185|NCT02940873|type 1 diabetes mellitus|type 1 diabetes mellitus
5168186|NCT02940873|cognitive behavioral therapy|cognitive behavioral therapy
5168187|NCT02940873|structured education|structured education
5168188|NCT02940847|ultrasound-guided technique|ultrasound-guided technique
5168189|NCT02940847|blind technique|blind technique
5168190|NCT02940847|medial brachial cutaneous nerve block|medial brachial cutaneous nerve block
5168191|NCT02940847|intercostobrachial nerve block|intercostobrachial nerve block
5168192|NCT02940821|Tooth Whitening|tooth whitening
5168193|NCT02940808|Caffeine|caffeine
5168194|NCT02940808|EEG|eeg
5168195|NCT02940808|Theta/beta ratio|theta/beta ratio
5168196|NCT02940808|Eye-blink rates|eye-blink rates
5168197|NCT02940808|Cognitive control|cognitive control
5168198|NCT02940808|Emotional Stroop|emotional stroop
5168199|NCT02940808|Global/local congruency|global/local congruency
5168200|NCT02940808|N-Back|n-back
5168201|NCT02940808|Prefrontal Cortex|prefrontal cortex
5168202|NCT02940795|breast feeding|breast feeding
5168203|NCT02940795|fructose|fructose
5168204|NCT02940769|depression|depression
5168205|NCT02940769|insomnia|insomnia
5168206|NCT02940769|light|light
5168207|NCT02940769|cortisol|cortisol
5168208|NCT02940769|melatonin|melatonin
5168209|NCT02940756|Malaria, efficacy, safety, ACT, DR Congo|malaria, efficacy, safety, act, dr congo
5168210|NCT02940743|Hemodialysis|hemodialysis
5168211|NCT02940704|Reciproc|reciproc
5168212|NCT02940704|One Shape|one shape
5168213|NCT02940704|reciprocation|reciprocation
5168214|NCT02940704|continuous rotation|continuous rotation
5168215|NCT02940704|irreversible pulpitis|irreversible pulpitis
5168216|NCT02940704|postoperative pain|postoperative pain
5168221|NCT02940652|Laryngeal mask,MRI|laryngeal mask,mri
5168222|NCT02940626|Pneumonia|pneumonia
5168223|NCT02940626|S. aureus|s. aureus
5168224|NCT02940626|Mechanically ventilated|mechanically ventilated
5168225|NCT02940613|Rapid response|rapid response
5168226|NCT02940613|Eating Disorders|eating disorders
5168227|NCT02940613|Cognitive Behavior Therapy|cognitive behavior therapy
5168228|NCT02940613|Bulimia Nervosa|bulimia nervosa
5168229|NCT02940613|Binge Eating Disorder|binge eating disorder
5168230|NCT02940613|Purging Disorder|purging disorder
5168231|NCT02940600|normothermic perfusion|normothermic perfusion
5168232|NCT02940600|old donors|old donors
5168233|NCT02940600|extended criteria grafts|extended criteria grafts
5168235|NCT02940587|Non Healing Wound|non healing wound
5168237|NCT02940574|Autism Spectrum Disorders|autism spectrum disorders
5168238|NCT02940548|non-dipper hypertension|non-dipper hypertension
5168240|NCT02940548|middle-aged|middle-aged
5168241|NCT02940548|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5168242|NCT02940548|arterial stiffness|arterial stiffness
5168243|NCT02940548|nifedipine gastrointestinal therapeutic system (GITS)|nifedipine gastrointestinal therapeutic system (gits)
5168244|NCT02940483|Ependymoma|ependymoma
5168245|NCT02940457|tDCS|tdcs
5168246|NCT02940457|MCI|mci
5168247|NCT02940457|Working Memory|working memory
5168248|NCT02940457|fNIRS|fnirs
5168249|NCT02940418|Diabetes Mellitus|diabetes mellitus
5168250|NCT02940418|Type 1|type 1
5168251|NCT02940418|Adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
5055571|NCT03651323|Stroke|stroke
5168252|NCT02940405|Ketorolac Premedication|ketorolac premedication
5168253|NCT02940405|Anesthetic Efficiency|anesthetic efficiency
5168254|NCT02940405|Post-Endodontic Pain|post-endodontic pain
5168255|NCT02940405|Post-operative pain|post-operative pain
5168256|NCT02940405|Irreversible Pulpitis|irreversible pulpitis
5168257|NCT02940405|Oral premedication|oral premedication
5168259|NCT02940340|infective endocarditis|infective endocarditis
5168260|NCT02940340|systemic microcirculation|systemic microcirculation
5168261|NCT02940327|ECMO|ecmo
5168262|NCT02940327|PPHN|pphn
5168263|NCT02940327|Pulmonary Hypertension of the Newborn|pulmonary hypertension of the newborn
5168264|NCT02940327|Markers of inflammation|markers of inflammation
5168265|NCT02940327|Mi-Ecmo|mi-ecmo
5168266|NCT02940249|Polyphenol|polyphenol
5168267|NCT02940249|Apple|apple
5168268|NCT02940249|Fruit|fruit
5168269|NCT02940249|Hyperglycaemia|hyperglycaemia
5168270|NCT02940249|Metabolic|metabolic
5168271|NCT02940197|overweight|overweight
5168272|NCT02940197|Caloric Restriction|caloric restriction
5168273|NCT02940184|Physiology|physiology
5168274|NCT02940171|burns|burns
5168275|NCT02940171|critically ill|critically ill
5168276|NCT02940171|surgery outcome|surgery outcome
5168277|NCT02940171|mortality|mortality
5168278|NCT02940158|lentils|lentils
5168279|NCT02940158|diabetes|diabetes
5168280|NCT02940158|glycemia|glycemia
5168281|NCT02940158|insulin|insulin
5168282|NCT02940158|glucose|glucose
5168283|NCT02940145|inflammatory biomarkers|inflammatory biomarkers
5168284|NCT02940145|Interleukines|interleukines
5168285|NCT02940145|resistance training|resistance training
5168286|NCT02940145|phase angle|phase angle
5168287|NCT02940145|oxidative stress|oxidative stress
5168288|NCT02940106|oocyte cryopreservation|oocyte cryopreservation
5962157|NCT04282603|Adipose tissue|adipose tissue
5168289|NCT02940106|closed vitrification|closed vitrification
5168290|NCT02940106|open vitrification|open vitrification
5168291|NCT02940067|prehabilitation|prehabilitation
5168292|NCT02940067|pancreatectomy|pancreatectomy
5168293|NCT02940067|nutrition|nutrition
5168294|NCT02940067|exercise|exercise
5168295|NCT02940054|Early diagnosis|early diagnosis
5168296|NCT02940041|Diagnosis|diagnosis
5168297|NCT02940041|Sonography|sonography
5168298|NCT02940041|Magnetic Ressonance|magnetic ressonance
5168299|NCT02940015|Quality Control|quality control
5168300|NCT02940015|Urine|urine
5168301|NCT02940015|Tissue|tissue
5168302|NCT02940015|Normal|normal
5168303|NCT02940002|Plaque form psoriasis vulgaris|plaque form psoriasis vulgaris
5168304|NCT02939989|Chronic Hepatitis C (HCV)|chronic hepatitis c (hcv)
5168305|NCT02939989|HCV Genotype 1 (HCV GT1)|hcv genotype 1 (hcv gt1)
5168306|NCT02939989|HCV Genotype 2 (HCV GT2)|hcv genotype 2 (hcv gt2)
5168307|NCT02939989|HCV Genotype 3 (HCV GT3)|hcv genotype 3 (hcv gt3)
5168308|NCT02939989|HCV Genotype 4 (HCV GT4)|hcv genotype 4 (hcv gt4)
5168309|NCT02939989|HCV Genotype 5 (HCV GT5)|hcv genotype 5 (hcv gt5)
5168310|NCT02939989|HCV Genotype 6 (HCV GT6)|hcv genotype 6 (hcv gt6)
5168311|NCT02939989|Compensated Cirrhosis|compensated cirrhosis
5168312|NCT02939989|Non-cirrhotics|non-cirrhotics
5168313|NCT02939989|Virologic failure|virologic failure
5168314|NCT02939989|Hepatitis C Virus Infection|hepatitis c virus infection
5168315|NCT02939976|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5168316|NCT02939963|weaning|weaning
5168317|NCT02939963|mechanical ventilation|mechanical ventilation
5168318|NCT02939963|work of breathing|work of breathing
5168319|NCT02939963|automatic tube compensation|automatic tube compensation
5168320|NCT02939963|pressure support ventilation|pressure support ventilation
5168321|NCT02939911|Residual neuromuscular blockade|residual neuromuscular blockade
5168323|NCT02939872|BVS|bvs
5168324|NCT02939872|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5168325|NCT02939872|Dual Antiplatelet Therapy|dual antiplatelet therapy
5168326|NCT02939859|Multiple Sclerosis|multiple sclerosis
5168327|NCT02939859|Demyelinating Diseases|demyelinating diseases
5168328|NCT02939859|Nervous System Diseases|nervous system diseases
5168329|NCT02939859|Autoimmune Disorders|autoimmune disorders
5168330|NCT02939846|Safety|safety
5168331|NCT02939846|Solid tumor|solid tumor
5168332|NCT02939846|Trametinib|trametinib
5168333|NCT02939846|Pharmacokinetics|pharmacokinetics
5168349|NCT02939755|Collaborative care intervention|collaborative care intervention
5168351|NCT02939755|Depression|depression
5168352|NCT02939755|Palliative care|palliative care
5168353|NCT02939755|Quality of life|quality of life
5168354|NCT02939755|Fatigue|fatigue
5168355|NCT02939755|Pain|pain
5168356|NCT02939742|preterm premature rupture of membranes|preterm premature rupture of membranes
5168357|NCT02939742|complications of prematurity|complications of prematurity
5168358|NCT02939742|neonatal morbidity|neonatal morbidity
5168359|NCT02939742|respiratory distress syndrome|respiratory distress syndrome
5168360|NCT02939742|antenatal corticosteroids|antenatal corticosteroids
5168361|NCT02939742|betamethasone|betamethasone
5168362|NCT02939729|prehabilitation|prehabilitation
5168363|NCT02939729|physiotherapy|physiotherapy
5168365|NCT02939729|thoracic|thoracic
5168366|NCT02939729|preoperative|preoperative
5168367|NCT02939716|small bowel|small bowel
5168368|NCT02939716|bloating|bloating
5168369|NCT02939716|flow|flow
5168370|NCT02939703|Adipose tissue|adipose tissue
5168371|NCT02939703|calorimetry|calorimetry
5168372|NCT02939703|energy expenditure|energy expenditure
5168373|NCT02939703|microbiome|microbiome
5168374|NCT02939690|Catheter|catheter
5168375|NCT02939690|Umbilical vein|umbilical vein
5168376|NCT02939690|Neonate|neonate
5168377|NCT02939664|banded gastric bypass|banded gastric bypass
5168378|NCT02939664|weight loss|weight loss
5168381|NCT02939638|Plant-based diet|plant-based diet
5168382|NCT02939638|Obesity|obesity
5168383|NCT02939638|Insulin sensitivity|insulin sensitivity
5168384|NCT02939638|Intracellular lipid|intracellular lipid
5168385|NCT02939638|Postprandial metabolism|postprandial metabolism
5168386|NCT02939638|Vegan diet|vegan diet
5168387|NCT02939638|Beta-cell function|beta-cell function
5168388|NCT02939612|Stress management|stress management
5168389|NCT02939612|App|app
5168400|NCT02939586|Sleep, Sleep apnoea, Haemodialysis, Haemodiafiltration, end stage kidney disease|sleep, sleep apnoea, haemodialysis, haemodiafiltration, end stage kidney disease
5168401|NCT02939560|Autism Spectrum Disorder|autism spectrum disorder
5168402|NCT02939560|Autism|autism
5168403|NCT02939560|Depressive|depressive
5168404|NCT02939560|Depression|depression
5168405|NCT02939547|intravenous|intravenous
5168406|NCT02939547|cyclodextrin|cyclodextrin
5168407|NCT02939547|compassionate|compassionate
5168408|NCT02939547|Trappsol|trappsol
5168409|NCT02939534|Parkinson's disease|parkinson's disease
5168410|NCT02939534|autoimmunity|autoimmunity
5168411|NCT02939521|Pincer Nail|pincer nail
5168412|NCT02939521|Surgery|surgery
5168413|NCT02939508|Acute lower gastrointestinal dysfunction|acute lower gastrointestinal dysfunction
5168414|NCT02939508|Colon-originated lesions|colon-originated lesions
5168415|NCT02939508|Critical patient|critical patient
5041588|NCT03739372|WES|wes
5168416|NCT02939508|Colonoscopic decompression|colonoscopic decompression
5168417|NCT02939508|Anticholinergic drugs|anticholinergic drugs
5168418|NCT02939495|Premature Ejaculation|premature ejaculation
5168419|NCT02939495|Erectile Dysfunction|erectile dysfunction
5168420|NCT02939495|DAP-SPEED|dap-speed
5176917|NCT02885389|CNV|cnv
5168421|NCT02939495|Dapoxetine|dapoxetine
5168422|NCT02939495|Sildenafil|sildenafil
5168423|NCT02939469|Sympathetic Nerve Activity|sympathetic nerve activity
5168424|NCT02939469|Skin Sympathetic Nerve Activity|skin sympathetic nerve activity
5168425|NCT02939456|prostate|prostate
5168426|NCT02939456|cancer|cancer
5168427|NCT02939456|MRI|mri
5168428|NCT02939417|Laminate veneers|laminate veneers
5168429|NCT02939417|Grape seed extract|grape seed extract
5168430|NCT02939417|Emax|emax
5168431|NCT02939417|collagen cross-linking agent|collagen cross-linking agent
5168432|NCT02939404|Energy Intake|energy intake
5168433|NCT02939404|Energy Expenditure|energy expenditure
5168435|NCT02939404|Cold Exposure|cold exposure
5168436|NCT02939378|ketogenic diet|ketogenic diet
5168437|NCT02939378|recurrent glioblastoma|recurrent glioblastoma
5168438|NCT02939378|chemotherapy|chemotherapy
5168439|NCT02939352|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5168440|NCT02939352|Magnetic Resonance Imaging|magnetic resonance imaging
5168441|NCT02939352|MRI, Functional|mri, functional
5168442|NCT02939339|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5168443|NCT02939313|alcohol|alcohol
5168444|NCT02939313|addiction|addiction
5168445|NCT02939313|cTBS|ctbs
5168446|NCT02939300|Leptomeningeal Metastases|leptomeningeal metastases
5168447|NCT02939287|autologous|autologous
5168448|NCT02939287|myeloma|myeloma
5168449|NCT02939287|transplant|transplant
5168450|NCT02939209|Rotator cuff repair|rotator cuff repair
5168451|NCT02939209|Interscalene block|interscalene block
5168452|NCT02939209|Hydromorphone|hydromorphone
5168453|NCT02939209|Pain|pain
5168454|NCT02939209|Rebound pain|rebound pain
5168455|NCT02939209|Acromioplasty|acromioplasty
5168456|NCT02939183|Multiple Myeloma|multiple myeloma
5168457|NCT02939157|Diagnostic Ultrasound|diagnostic ultrasound
5168458|NCT02939157|Primary Care|primary care
5168459|NCT02939131|Cognitive Behavioral Therapy|cognitive behavioral therapy
5168460|NCT02939131|Medication Management|medication management
5168461|NCT02939092|Gingival Bleeding on probing|gingival bleeding on probing
5168462|NCT02939079|Multiple Sclerosis|multiple sclerosis
5168463|NCT02939079|Fingolimod|fingolimod
5168464|NCT02939079|Fish Oil|fish oil
5168465|NCT02939053|Bioimpedance spectroscopy|bioimpedance spectroscopy
5168466|NCT02939040|positive activities intervention|positive activities intervention
5168467|NCT02939040|peri-operative|peri-operative
5168469|NCT02938988|Periodontal Diseases|periodontal diseases
5168470|NCT02938988|Down Syndrome|down syndrome
5168471|NCT02938975|malaria|malaria
5168472|NCT02938975|personal protection|personal protection
5168473|NCT02938975|permethrin treated clothing|permethrin treated clothing
5168474|NCT02938975|insect repellents|insect repellents
5168475|NCT02938975|army personnel|army personnel
5168476|NCT02938975|cluster randomised trial|cluster randomised trial
5168477|NCT02938949|Myocardial Infarction|myocardial infarction
5168478|NCT02938949|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
5168479|NCT02938949|proprotein convertase subtilisin kexin 9, human|proprotein convertase subtilisin kexin 9, human
5168480|NCT02938949|alirocumab|alirocumab
5168481|NCT02938910|Primary hyperaldosteronism|primary hyperaldosteronism
5168482|NCT02938910|Secondary hyperaldosteronism|secondary hyperaldosteronism
5168483|NCT02938910|Cardiac fibrosis|cardiac fibrosis
5168484|NCT02938910|magnetic resonance imaging|magnetic resonance imaging
5168485|NCT02938897|Telehealth|telehealth
5168486|NCT02938897|Weight loss|weight loss
5168487|NCT02938897|Diet quality|diet quality
5168488|NCT02938897|Behavioral counseling|behavioral counseling
5168489|NCT02938871|synbiotic|synbiotic
5168490|NCT02938871|infections|infections
5168491|NCT02938871|probiotics|probiotics
5168492|NCT02938871|liver transplantation|liver transplantation
5168493|NCT02938832|cardiovascular disease, diet, diabetes|cardiovascular disease, diet, diabetes
5168494|NCT02938819|upper limbs|upper limbs
5168495|NCT02938819|physiotherapy|physiotherapy
5168496|NCT02938793|cancer, malignancy|cancer, malignancy
5168497|NCT02938780|Behavioral economics|behavioral economics
5168498|NCT02938780|Breast cancer survivors|breast cancer survivors
5168499|NCT02938780|nutrition|nutrition
5168500|NCT02938780|physical activity|physical activity
5168501|NCT02938767|peritoneal dialysis|peritoneal dialysis
5168502|NCT02938767|carotid intima-media thickness|carotid intima-media thickness
5168503|NCT02938767|coronary flow reserve|coronary flow reserve
5168504|NCT02938767|cardiovascular mortality|cardiovascular mortality
5168505|NCT02938754|Hemiparesis|hemiparesis
5168506|NCT02938754|Functional independence|functional independence
5168507|NCT02938754|Virtual Rehabilitation|virtual rehabilitation
5168508|NCT02938741|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5168509|NCT02938741|lymphoblastic lymphoma|lymphoblastic lymphoma
5962158|NCT04282603|Skeletal Muscle|skeletal muscle
5962159|NCT04282603|Physical Function|physical function
5034993|NCT03780569|GBM|gbm
5168510|NCT02938741|stem-cell transplant|stem-cell transplant
5168511|NCT02938741|T-cell lymphoma|t-cell lymphoma
5168513|NCT02938728|AntiPD1|antipd1
5168514|NCT02938702|Active surveillance|active surveillance
5168515|NCT02938650|nitrolipid|nitrolipid
5168516|NCT02938650|microbiome|microbiome
5168517|NCT02938650|inflammation|inflammation
5168518|NCT02938650|cytokine|cytokine
5168519|NCT02938598|maternal depression|maternal depression
5423225|NCT01616602|colonoscopy.|colonoscopy.
5168520|NCT02938598|pediatric-based maternal depression screening|pediatric-based maternal depression screening
5168521|NCT02938598|maternal health services|maternal health services
5168522|NCT02938546|Non-small-cell lung cancer|non-small-cell lung cancer
5168523|NCT02938546|18F-FDG PET/CT|18f-fdg pet/ct
5168524|NCT02938546|treatment response assessment|treatment response assessment
5168525|NCT02938520|Antiretroviral agent|antiretroviral agent
5168526|NCT02938520|Maintenance|maintenance
5168527|NCT02938520|rilpivirine|rilpivirine
5168528|NCT02938520|dolutegravir|dolutegravir
5168539|NCT02938520|Long-Acting Intramuscular Cabotegravir|long-acting intramuscular cabotegravir
5168541|NCT02938520|cabotegravir|cabotegravir
5168542|NCT02938520|abacavir|abacavir
5168543|NCT02938507|Overactive bladder, Incontinence|overactive bladder, incontinence
5168544|NCT02938481|colon cancer, lymph node, extent of bowel resection|colon cancer, lymph node, extent of bowel resection
5168545|NCT02938455|Hyperalgesia|hyperalgesia
5168546|NCT02938455|Opioids|opioids
5168547|NCT02938455|Postoperative pain|postoperative pain
5168548|NCT02938455|DNA methylation|dna methylation
5168549|NCT02938429|congenital|congenital
5168550|NCT02938390|Nipple Sparing Mastectomy|nipple sparing mastectomy
5168551|NCT02938390|Ultrasound|ultrasound
5168552|NCT02938351|Collaborative care intervention|collaborative care intervention
5168553|NCT02938351|kidney transplant|kidney transplant
5168554|NCT02938325|Electroencephalogram|electroencephalogram
5168555|NCT02938325|awareness|awareness
5168556|NCT02938286|Fractional laser|fractional laser
5168557|NCT02938286|Topical anesthesia|topical anesthesia
5168558|NCT02938286|Drug delivery|drug delivery
5168560|NCT02938286|Er:YAG laser|er:yag laser
5168561|NCT02938247|Malnutrition|malnutrition
5168562|NCT02938247|Geriatric subjects|geriatric subjects
5168563|NCT02938247|Nursing home|nursing home
5168564|NCT02938234|Malnutrition|malnutrition
5168565|NCT02938234|Geriatric subjects|geriatric subjects
5168566|NCT02938234|Nursing home|nursing home
5168567|NCT02938221|TeleStroke|telestroke
5168568|NCT02938221|HINTS|hints
5168569|NCT02938221|Diagnosis|diagnosis
5168570|NCT02938221|Telemedicine|telemedicine
5055930|NCT03649308|Skin graft|skin graft
5168571|NCT02938221|Acute Vestibular Syndrome|acute vestibular syndrome
5168572|NCT02938169|low back pain|low back pain
5168573|NCT02938169|surface EMG|surface emg
5168574|NCT02938169|exercise|exercise
5168575|NCT02938156|Hemophilia|hemophilia
5168576|NCT02938143|Jumpers knee|jumpers knee
5168577|NCT02938143|Patellar Tendinopathy|patellar tendinopathy
5168578|NCT02938143|Jumping Athletes|jumping athletes
5168579|NCT02938143|UTE MRI|ute mri
5168580|NCT02938143|Exercise Therapy|exercise therapy
5168581|NCT02938143|NBA|nba
5168582|NCT02938117|obesity|obesity
5168583|NCT02938117|eccentric exercise|eccentric exercise
5168584|NCT02938117|body composition|body composition
5168585|NCT02938117|training program|training program
5168586|NCT02938091|Hispanics|hispanics
5168587|NCT02938091|Single nucleotide polymorphism|single nucleotide polymorphism
5168588|NCT02938091|Hepatic lipase|hepatic lipase
5168589|NCT02938052|Heart Failure|heart failure
5168590|NCT02938052|Positive Psychology|positive psychology
5168591|NCT02938052|Adherence to Health Behaviors|adherence to health behaviors
5168592|NCT02938039|laryngeal airways|laryngeal airways
5168593|NCT02938039|infants|infants
5168594|NCT02938039|neonates|neonates
5168595|NCT02938039|children|children
5168596|NCT02938039|anesthetized|anesthetized
5168597|NCT02938000|aerobic training|aerobic training
5168598|NCT02938000|stroke|stroke
5168599|NCT02938000|exercise|exercise
5168600|NCT02938000|stroke recovery|stroke recovery
5168601|NCT02937974|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5168602|NCT02937974|Xuebijing|xuebijing
5168603|NCT02937948|Locally advanced|locally advanced
5168604|NCT02937922|Exercise|exercise
5168605|NCT02937922|Endothelium|endothelium
5168606|NCT02937922|Hypertension|hypertension
5168607|NCT02937922|Endothelial progenitor cell|endothelial progenitor cell
5168608|NCT02937922|Endothelial microparticle|endothelial microparticle
5168609|NCT02937909|woundcare community nursing competence|woundcare community nursing competence
5168610|NCT02937883|Daily Activities|daily activities
5168616|NCT02937740|Hypogonadism|hypogonadism
5168617|NCT02937714|Teachers|teachers
5168618|NCT02937714|mental health literacy|mental health literacy
5168619|NCT02937714|school mental health promotion|school mental health promotion
5168620|NCT02937688|Parkinson's disease|parkinson's disease
5962160|NCT04282564|CO-OP|co-op
5168621|NCT02937688|Deep Brain Stimulation|deep brain stimulation
5168622|NCT02937675|small molecule inhibitor of protein translation|small molecule inhibitor of protein translation
5168625|NCT02937649|Obesity|obesity
5168626|NCT02937649|Bariatric surgery|bariatric surgery
5168627|NCT02937649|Sleeve gastrectomy|sleeve gastrectomy
5168628|NCT02937649|Staple-line Leak|staple-line leak
5168629|NCT02937649|Bougie|bougie
5168630|NCT02937649|Calibration|calibration
5168631|NCT02937597|proficiency based progression|proficiency based progression
5168632|NCT02937597|feedback|feedback
5168633|NCT02937597|computer based assessment|computer based assessment
5168634|NCT02937597|non technical skills|non technical skills
5168635|NCT02937597|deteriorating patient|deteriorating patient
5168636|NCT02937597|ISBAR|isbar
5168637|NCT02937571|Carfilzomib|carfilzomib
5168638|NCT02937571|Lenalidomide|lenalidomide
5168639|NCT02937571|Dexamethasone|dexamethasone
5168640|NCT02937571|15-326|15-326
5168641|NCT02937558|hypoglycemia|hypoglycemia
5168642|NCT02937532|Fear of falling|fear of falling
5168643|NCT02937532|Fear avoidance behavior|fear avoidance behavior
5168644|NCT02937532|cognitive behavioral therapy|cognitive behavioral therapy
5168645|NCT02937532|Rehabilitation|rehabilitation
5168646|NCT02937519|Chronomodulated Chemotherapy|chronomodulated chemotherapy
5168647|NCT02937519|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5168648|NCT02937519|Advanced Nasopharyngeal Cancer|advanced nasopharyngeal cancer
5168649|NCT02937506|propofol|propofol
5168650|NCT02937506|colonoscopy|colonoscopy
5168651|NCT02937506|patient satisfaction|patient satisfaction
5168652|NCT02937480|stroke|stroke
5168653|NCT02937480|physical activity|physical activity
5168654|NCT02937480|task performance|task performance
5168655|NCT02937480|clinical protocol|clinical protocol
5168656|NCT02937467|SWE|swe
5168657|NCT02937467|diagnosis|diagnosis
5168658|NCT02937454|Acute Heart Failure|acute heart failure
5168659|NCT02937454|Iron Deficiency|iron deficiency
5168660|NCT02937441|C10.228.140.187|c10.228.140.187
5168661|NCT02937428|vaccination|vaccination
5168662|NCT02937428|pain|pain
5168663|NCT02937428|fear|fear
5168664|NCT02937428|psychological intervention|psychological intervention
5168665|NCT02937415|carbon monoxide|carbon monoxide
5168666|NCT02937415|oxidative stress|oxidative stress
5168668|NCT02937415|cigarette smoking|cigarette smoking
5168669|NCT02937415|pulmonary function test|pulmonary function test
5168670|NCT02937350|chronic kidney disease|chronic kidney disease
5168671|NCT02937350|vitamin d catabolism|vitamin d catabolism
5243645|NCT02482415|Family|family
5168672|NCT02937311|Taping, stroke|taping, stroke
5168673|NCT02937311|rehabilitation|rehabilitation
5168674|NCT02937311|shoulder pain|shoulder pain
5168675|NCT02937311|electrical stimulation|electrical stimulation
5168676|NCT02937298|Diet Induced Thermogenesis|diet induced thermogenesis
5168677|NCT02937298|Obesity|obesity
5168678|NCT02937298|Energy balance|energy balance
5168679|NCT02937298|Energy expenditure|energy expenditure
5168680|NCT02937298|berries|berries
5168681|NCT02937298|Sea Buckthorn|sea buckthorn
5168682|NCT02937298|Wild garlic|wild garlic
5168683|NCT02937272|TGF Beta|tgf beta
5168684|NCT02937233|Zika|zika
5168685|NCT02937233|Vaccine|vaccine
5168686|NCT02937233|ZPIV|zpiv
5168689|NCT02937194|Early childhood caries (ECC)|early childhood caries (ecc)
5168690|NCT02937194|Oral health promotion|oral health promotion
5168691|NCT02937194|Randomized controlled trial|randomized controlled trial
5168692|NCT02937142|Behavior Therapy|behavior therapy
5168693|NCT02937142|Cognitive Therapy|cognitive therapy
5168694|NCT02937142|Adolescents|adolescents
5168695|NCT02937142|Psychotherapy, Group|psychotherapy, group
5168696|NCT02937129|Infrared tympanic thermometer|infrared tympanic thermometer
5168697|NCT02937129|Axillary thermometer|axillary thermometer
5168698|NCT02937129|Mercury glass thermometer|mercury glass thermometer
5168699|NCT02937129|Adult emergency department|adult emergency department
5168700|NCT02937103|Leukemia|leukemia
5168701|NCT02937103|Myeloid|myeloid
5168702|NCT02937103|CD123|cd123
5168703|NCT02937103|CAR-T|car-t
5168704|NCT02937090|Polycystic Ovary Syndrome|polycystic ovary syndrome
5168705|NCT02937090|Intestinal Microbiota|intestinal microbiota
5168706|NCT02937077|etiology|etiology
5168707|NCT02937038|Urine Biomarkers|urine biomarkers
5168708|NCT02937038|Child Nutrition|child nutrition
5168709|NCT02937038|Hydration|hydration
5168710|NCT02937038|Parent Nutrition Habits|parent nutrition habits
5168711|NCT02937025|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5168712|NCT02937025|Stroke|stroke
5168713|NCT02937025|Left Atrial Appendage Closure|left atrial appendage closure
5168714|NCT02937025|Intervention|intervention
5168715|NCT02937012|Primary Biliary Cirrhosis|primary biliary cirrhosis
5168716|NCT02937012|Primary Biliary Cholangitis|primary biliary cholangitis
5168717|NCT02937012|Bezafibrate|bezafibrate
5168718|NCT02937012|Ursodeoxycholic acid|ursodeoxycholic acid
5168719|NCT02936973|simple obesity|simple obesity
5168720|NCT02936973|catgut implantation|catgut implantation
5168721|NCT02936934|Adverse Drug Reaction|adverse drug reaction
5168722|NCT02936934|Morphine|morphine
5168723|NCT02936934|Oxycodone|oxycodone
5168724|NCT02936934|Abdominal hysterectomy|abdominal hysterectomy
5168725|NCT02936921|Toxoplasma gondii|toxoplasma gondii
5962161|NCT04282564|executive functions|executive functions
5168726|NCT02936921|Toxoplasmosis|toxoplasmosis
5168727|NCT02936921|congenital|congenital
5168728|NCT02936921|prenatal|prenatal
5168729|NCT02936921|screening|screening
5168730|NCT02936921|treatment|treatment
5168731|NCT02936921|diagnosis|diagnosis
5168732|NCT02936908|Neuromuscular Diseases|neuromuscular diseases
5168733|NCT02936908|Muscular dystrophy|muscular dystrophy
5168734|NCT02936908|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5168735|NCT02936908|Acute respiratory failure|acute respiratory failure
5168736|NCT02936908|respiratory care|respiratory care
5168737|NCT02936908|mechanical ventilation|mechanical ventilation
5168739|NCT02936908|Intensive Care Unit|intensive care unit
5168740|NCT02936908|Critical Care|critical care
5168741|NCT02936908|Survival|survival
5168742|NCT02936882|ultrasonography|ultrasonography
5168743|NCT02936882|aspiration|aspiration
5168744|NCT02936882|emergency|emergency
5168746|NCT02936882|antrum|antrum
5168747|NCT02936843|Pain|pain
5168748|NCT02936843|Inflammation|inflammation
5168749|NCT02936843|Diabetes Mellitus|diabetes mellitus
5168750|NCT02936843|Adult|adult
5168751|NCT02936843|Neuropathy|neuropathy
5168752|NCT02936817|HRCT|hrct
5168753|NCT02936817|High Resolution Computed Tomography scans|high resolution computed tomography scans
5168754|NCT02936817|Functional Respiratory Imaging|functional respiratory imaging
5168755|NCT02936817|CT scan|ct scan
5168756|NCT02936817|Computed Tomography|computed tomography
5168757|NCT02936817|COPD|copd
5168758|NCT02936817|sputum producing COPD patients|sputum producing copd patients
5168759|NCT02936817|Aerobika® device|aerobika® device
5168760|NCT02936804|early stage lung cancer|early stage lung cancer
5168761|NCT02936804|LDCT screening|ldct screening
5168762|NCT02936804|lung resection|lung resection
5168763|NCT02936804|electromagnetic navigation bronchoscopy|electromagnetic navigation bronchoscopy
5168764|NCT02936804|peripheral biomarker|peripheral biomarker
5168765|NCT02936791|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5168766|NCT02936791|ADPKD|adpkd
5168767|NCT02936791|PKD biomarkers|pkd biomarkers
5168768|NCT02936791|Kidney Institute|kidney institute
5168769|NCT02936791|University of Kansas Medical Center|university of kansas medical center
5168770|NCT02936778|Short-term medical and psychosocial functioning|short-term medical and psychosocial functioning
5168771|NCT02936713|flatulence|flatulence
5168772|NCT02936713|gas|gas
5168773|NCT02936713|probiotics|probiotics
5168774|NCT02936713|fermented milk|fermented milk
5168775|NCT02936713|diet|diet
5168776|NCT02936713|functional gastrointestinal disorders|functional gastrointestinal disorders
5168777|NCT02936700|Psychiatry|psychiatry
5168778|NCT02936700|Suicide|suicide
5168779|NCT02936700|Randomized controlled trial|randomized controlled trial
5168780|NCT02936700|ACT|act
5168781|NCT02936700|fMRI|fmri
5168782|NCT02936687|blood flow|blood flow
5168783|NCT02936687|magnetic resonance imaging|magnetic resonance imaging
5168784|NCT02936687|insulin|insulin
5168785|NCT02936687|vasodilation|vasodilation
5168786|NCT02936661|postpartum hemorrhage， cesarean section， tranexamic acid|postpartum hemorrhage， cesarean section， tranexamic acid
5168787|NCT02936648|Hepatitis C|hepatitis c
5168788|NCT02936635|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5168789|NCT02936635|ALS|als
5168790|NCT02936635|tirasemtiv|tirasemtiv
5168791|NCT02936609|healthcare access|healthcare access
5168792|NCT02936609|healthcare utilization|healthcare utilization
5168793|NCT02936609|preventive services|preventive services
5168794|NCT02936609|cancer survivors|cancer survivors
5168795|NCT02936531|evoked response potential|evoked response potential
5168796|NCT02936531|ERP|erp
5168797|NCT02936531|Brain Network Activation|brain network activation
5168798|NCT02936531|BNA|bna
5168799|NCT02936531|Biomarker|biomarker
5168800|NCT02936518|ankyloglossia|ankyloglossia
5168801|NCT02936518|breastfeeding|breastfeeding
5168802|NCT02936518|lip tie|lip tie
5168803|NCT02936505|chronic lung allograft dysfunction|chronic lung allograft dysfunction
5168804|NCT02936505|cyclosporin|cyclosporin
5168805|NCT02936505|tacrolimus|tacrolimus
5168806|NCT02936505|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5168807|NCT02936505|Restrictive Allograft Syndrome|restrictive allograft syndrome
5168808|NCT02936505|CLAD|clad
5168809|NCT02936492|Phase I|phase i
5168810|NCT02936492|Healthy volunteers|healthy volunteers
5168811|NCT02936466|Psychiatry|psychiatry
5168812|NCT02936466|Randomized controlled trial|randomized controlled trial
5168813|NCT02936466|Bipolar disorder|bipolar disorder
5168814|NCT02936466|Serious game|serious game
5168815|NCT02936466|Compliance|compliance
5168816|NCT02936466|Psychoeducation|psychoeducation
5168817|NCT02936453|Spinal Cord Injury|spinal cord injury
5168818|NCT02936453|Epidural Electrical Stimulation|epidural electrical stimulation
5168819|NCT02936453|Robot-assisted|robot-assisted
5168820|NCT02936440|acute kidney injury|acute kidney injury
5168821|NCT02936440|intensive care unit|intensive care unit
5168822|NCT02936440|bioelectrical impedance analysis|bioelectrical impedance analysis
5168828|NCT02936388|uveal melanoma|uveal melanoma
5168829|NCT02936388|liver metastasis|liver metastasis
5168830|NCT02936388|chemoembolisation|chemoembolisation
5168831|NCT02936388|radioembolisation|radioembolisation
5168833|NCT02936375|nephritis|nephritis
5168834|NCT02936375|iguratimod|iguratimod
5168835|NCT02936362|Bread|bread
5168836|NCT02936362|Microbiome|microbiome
5168837|NCT02936362|Blood tests|blood tests
5168838|NCT02936362|Sourdough bread|sourdough bread
5168839|NCT02936362|Dietary intervention|dietary intervention
5168840|NCT02936349|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5168841|NCT02936349|Pulmonary Arteriovenous Malformation (PAVM)|pulmonary arteriovenous malformation (pavm)
5168842|NCT02936349|Transthoracic Contrast Echocardiogram (TTCE)|transthoracic contrast echocardiogram (ttce)
5168843|NCT02936323|SCLC small cell lung cancer|sclc small cell lung cancer
5168844|NCT02936323|pancreatic neuroendocrine NET|pancreatic neuroendocrine net
5168845|NCT02936323|GI neuroendocrine NET|gi neuroendocrine net
5168846|NCT02936310|stress|stress
5168847|NCT02936310|mindfulness|mindfulness
5168848|NCT02936310|Mindful Living With Stress Intervention|mindful living with stress intervention
5168849|NCT02936310|nurse|nurse
5168850|NCT02936310|HIV/AIDS|hiv/aids
5168851|NCT02936271|Radiofrequency Ablation|radiofrequency ablation
5168852|NCT02936271|Sclerotherapy|sclerotherapy
5168853|NCT02936271|Vasculera|vasculera
5168854|NCT02936219|complementary feeding|complementary feeding
5168855|NCT02936219|breast milk|breast milk
5168856|NCT02936219|formula feeding|formula feeding
5168857|NCT02936219|combined feeding|combined feeding
5168858|NCT02936219|preterm infants|preterm infants
5168859|NCT02936219|body composition|body composition
5168860|NCT02936206|proliferation Index|proliferation index
5168861|NCT02936206|Tamoxifen|tamoxifen
5168862|NCT02936206|Fulvestrant|fulvestrant
5168863|NCT02936206|cyclinD1|cyclind1
5168864|NCT02936206|Breast cancer|breast cancer
5168865|NCT02936180|Rheumatoid arthritis|rheumatoid arthritis
5168866|NCT02936180|Flu vaccine|flu vaccine
5168867|NCT02936180|Influenza|influenza
5168868|NCT02936167|Ringer Lactate|ringer lactate
5168869|NCT02936167|Plasmalyte|plasmalyte
5168870|NCT02936167|Perioperative Period|perioperative period
5164097|NCT02966652|Male|male
5168871|NCT02936141|homeless, mental disorders, attendance|homeless, mental disorders, attendance
5168872|NCT02936102|Phase I|phase i
5168873|NCT02936102|FAZ053|faz053
5168874|NCT02936102|PDR001|pdr001
5168875|NCT02936102|Checkpoint inhibitor|checkpoint inhibitor
5168876|NCT02936102|PD-L1|pd-l1
5168877|NCT02936102|PD-1|pd-1
5168878|NCT02936063|Head and neck surgery|head and neck surgery
5168879|NCT02936063|Scar cosmesis|scar cosmesis
5168880|NCT02936063|Surgical staples|surgical staples
5168881|NCT02936063|Sutures|sutures
5168882|NCT02936063|Patient satisfaction|patient satisfaction
5168883|NCT02936050|Echocardiography|echocardiography
5168884|NCT02936050|Telemedicine|telemedicine
5168885|NCT02936050|Nurses|nurses
5168886|NCT02936050|Decision support|decision support
5168887|NCT02936050|eHealth|ehealth
5168893|NCT02935998|schizophrenia|schizophrenia
5168894|NCT02935998|agitation|agitation
5168895|NCT02935998|ziprasidone|ziprasidone
5168896|NCT02935985|spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5168897|NCT02935985|point-of-care bio-markers|point-of-care bio-markers
5168898|NCT02935985|multicenter|multicenter
5168899|NCT02935985|Emergency Department|emergency department
5168900|NCT02935985|Romania|romania
5168901|NCT02935972|prostate biopsy, analgesia, anesthesia, pain, prostate cancer|prostate biopsy, analgesia, anesthesia, pain, prostate cancer
5168902|NCT02935946|pharyngeal swallow, NICU, intervention, thickening|pharyngeal swallow, nicu, intervention, thickening
5168903|NCT02935920|PRO, follow up|pro, follow up
5168904|NCT02935894|oxygenated lipids|oxygenated lipids
5168905|NCT02935894|metabolic profiling|metabolic profiling
5168906|NCT02935894|sphingoid bases|sphingoid bases
5168907|NCT02935894|ceramides|ceramides
5168908|NCT02935894|endocannabinoids|endocannabinoids
5168909|NCT02935894|non-invasive sampling|non-invasive sampling
5168910|NCT02935868|Saliva|saliva
5168911|NCT02935855|Diabetic patients|diabetic patients
5168912|NCT02935855|nondiabetic patients|nondiabetic patients
5168913|NCT02935842|Parkinson's Disease|parkinson's disease
5168914|NCT02935842|Word Retrieval|word retrieval
5168915|NCT02935842|Apraxia Symptoms|apraxia symptoms
5168916|NCT02935842|Dysarthria|dysarthria
5168917|NCT02935829|energy intake|energy intake
5168918|NCT02935829|blood glucose|blood glucose
5168919|NCT02935829|carob flour|carob flour
5168920|NCT02935790|unresectable|unresectable
5168921|NCT02935790|melanoma|melanoma
5168922|NCT02935777|Pomegranate extract|pomegranate extract
5168923|NCT02935777|cognitive function|cognitive function
5168924|NCT02935777|cognition|cognition
5168925|NCT02935777|polyphenols|polyphenols
5168927|NCT02935738|prednisolone|prednisolone
5168928|NCT02935738|anti-sperm antibodies|anti-sperm antibodies
5168929|NCT02935738|sperm penetration assay|sperm penetration assay
5168930|NCT02935712|Safety|safety
5168931|NCT02935712|Tolerability|tolerability
5168932|NCT02935712|AZD8601|azd8601
5168933|NCT02935712|Type II Diabetes|type ii diabetes
5168934|NCT02935582|Topical|topical
5168935|NCT02935582|Real-world|real-world
5168936|NCT02935582|Local standard of care|local standard of care
5168937|NCT02935582|Non-interventional|non-interventional
5168938|NCT02935582|Calcipotriol|calcipotriol
5168939|NCT02935569|Alopecia|alopecia
5168940|NCT02935569|Radiotherapy|radiotherapy
5168941|NCT02935556|Post Partum Pre-eclampsia|post partum pre-eclampsia
5168942|NCT02935517|Color vision deficiency|color vision deficiency
5168943|NCT02935517|Color vision defects|color vision defects
5168944|NCT02935517|Vision disorders|vision disorders
5168945|NCT02935517|Sensation disorders|sensation disorders
5168946|NCT02935517|Neurologic manifestations|neurologic manifestations
5168947|NCT02935517|Nervous system diseases|nervous system diseases
5168949|NCT02935517|Signs and symptoms|signs and symptoms
5168950|NCT02935504|Depression|depression
5168951|NCT02935504|Pregnancy|pregnancy
5168952|NCT02935504|Postpartum|postpartum
5168953|NCT02935491|TAVI|tavi
5168954|NCT02935491|Aortic stenosis|aortic stenosis
5168955|NCT02935491|aortic stiffness|aortic stiffness
5168956|NCT02935491|calcifications|calcifications
5168957|NCT02935491|CT-scan|ct-scan
5168958|NCT02935491|Vascular impedance|vascular impedance
5168959|NCT02935478|bariatric surgery|bariatric surgery
5168960|NCT02935478|minimally invasive|minimally invasive
5168961|NCT02935478|Embolization|embolization
5168962|NCT02935478|ghrelin|ghrelin
5168963|NCT02935478|gastric artery embolization|gastric artery embolization
5168964|NCT02935452|Self-management|self-management
5168965|NCT02935452|Supportive self-management|supportive self-management
5168966|NCT02935452|Normalisation process theory|normalisation process theory
5168967|NCT02935452|Social networks|social networks
5168968|NCT02935439|Mobile Phone|mobile phone
5168969|NCT02935439|Self-efficacy|self-efficacy
5168970|NCT02935439|Quality of Life|quality of life
5168971|NCT02935439|Knowledge|knowledge
5168972|NCT02935439|Feasibility|feasibility
5168973|NCT02935426|cyanoacrylate|cyanoacrylate
5168974|NCT02935426|sutures|sutures
5168975|NCT02935400|porphyria|porphyria
5168976|NCT02935400|biomarkers|biomarkers
5168977|NCT02935387|Very early rheumatoid arthritis|very early rheumatoid arthritis
5168978|NCT02935374|children|children
5168979|NCT02935374|intestinal microbiome|intestinal microbiome
5168980|NCT02935374|microbiota|microbiota
5168984|NCT02935374|macrolide|macrolide
5168985|NCT02935322|Prevention|prevention
5168987|NCT02935309|transrectal|transrectal
5168988|NCT02935309|carcinoma|carcinoma
5168989|NCT02935270|Stroke|stroke
5168990|NCT02935270|Neglect|neglect
5168991|NCT02935270|Rehabilitation|rehabilitation
5168992|NCT02935244|Epidemiology|epidemiology
5168993|NCT02935244|Staphylococcus aureus|staphylococcus aureus
5168994|NCT02935244|Prospective observational|prospective observational
5168995|NCT02935244|Surgical site or wound infection|surgical site or wound infection
5168996|NCT02935231|minimal cessation advice|minimal cessation advice
5168997|NCT02935231|proactive|proactive
5168998|NCT02935231|nicotine replacement therapy|nicotine replacement therapy
5168999|NCT02935231|smoking hotspots|smoking hotspots
5169000|NCT02935192|seasonal influenza|seasonal influenza
5169001|NCT02935192|vaccine|vaccine
5169002|NCT02935153|CD22|cd22
5169003|NCT02935153|CAR-T|car-t
5169004|NCT02935153|Leukemia|leukemia
5169005|NCT02935153|Lymphoma|lymphoma
5169006|NCT02935127|absorbable sutures|absorbable sutures
5169007|NCT02935114|Tooth Bleaching|tooth bleaching
5169008|NCT02935114|Tooth Bleaching Agents|tooth bleaching agents
5169009|NCT02935114|Tooth Whitening|tooth whitening
5169010|NCT02935114|Hydrogen Peroxide|hydrogen peroxide
5169011|NCT02935114|Carbamide Peroxide|carbamide peroxide
5169012|NCT02935101|glucocorticoids|glucocorticoids
5169013|NCT02935101|craving|craving
5169014|NCT02935101|Heroin|heroin
5169015|NCT02935101|Cocaine|cocaine
5169016|NCT02935101|dependency|dependency
5169018|NCT02935088|Percutaneous coronary intervention|percutaneous coronary intervention
5169019|NCT02935062|Speech|speech
5169020|NCT02935062|Speech Therapy|speech therapy
5169021|NCT02935062|Speech Sound Disorders|speech sound disorders
5169022|NCT02935062|Phonological Disorders|phonological disorders
5169023|NCT02935062|Auditory Perception|auditory perception
5169024|NCT02935010|Helicobacter pylori|helicobacter pylori
5169025|NCT02935010|Bismuth quadruple therapy|bismuth quadruple therapy
5169026|NCT02935010|Tailored therapy|tailored therapy
5169027|NCT02935010|Empiric therapy|empiric therapy
5169028|NCT02935010|clarithromycin susceptibility|clarithromycin susceptibility
5169033|NCT02934984|Pancreatic Cancer|pancreatic cancer
5169034|NCT02934984|recurrence|recurrence
5169035|NCT02934984|DNA|dna
5169036|NCT02934958|Colon Cancer Screening|colon cancer screening
5169037|NCT02934945|Budesonide/formoterol|budesonide/formoterol
5169038|NCT02934945|Typical asthma|typical asthma
5169039|NCT02934945|Cough variant asthma|cough variant asthma
5169040|NCT02934919|Nalmefene|nalmefene
5169041|NCT02934919|Impulse control disorders|impulse control disorders
5169042|NCT02934919|Parkinson's disease|parkinson's disease
5169043|NCT02934919|Tolerance|tolerance
5169044|NCT02934919|Efficacy|efficacy
5169045|NCT02934906|Neonatal Alloimmune Thrombocytopenia|neonatal alloimmune thrombocytopenia
5169046|NCT02934906|pregnancy|pregnancy
5169047|NCT02934906|human platelet allogantigen|human platelet allogantigen
5169048|NCT02934906|asian|asian
5169049|NCT02934906|Chinese|chinese
5169050|NCT02934880|adapted physical activity, cognitive functions|adapted physical activity, cognitive functions
5169051|NCT02934854|Creatine Transporter Deficiency (CTD)|creatine transporter deficiency (ctd)
5169052|NCT02934854|Guanidinoacetate Methyltransferase Deficiency (GAMT)|guanidinoacetate methyltransferase deficiency (gamt)
5169053|NCT02934854|Arginine: Glycine Amidinotransferase Deficiency (AGAT)|arginine: glycine amidinotransferase deficiency (agat)
5169054|NCT02934854|Biomarker|biomarker
5169056|NCT02934815|breast cancer|breast cancer
5169057|NCT02934815|supportive-expressive group therapy|supportive-expressive group therapy
5169058|NCT02934815|emotion regulation|emotion regulation
5169059|NCT02934815|social support|social support
5169063|NCT02934789|heavy menstrual bleeding|heavy menstrual bleeding
5169064|NCT02934789|quality of life|quality of life
5169066|NCT02934776|prostate cancer|prostate cancer
5169068|NCT02934750|pursed lip breathing|pursed lip breathing
5169069|NCT02934750|interstitial lund disease|interstitial lund disease
5169070|NCT02934750|exercise physiology|exercise physiology
5169071|NCT02934737|Obesity|obesity
5169072|NCT02934737|Diabetes Mellitus|diabetes mellitus
5169073|NCT02934724|HPV vaccines|hpv vaccines
5169074|NCT02934724|HPV-6|hpv-6
5169075|NCT02934724|HPV-11|hpv-11
5169076|NCT02934724|HPV-16|hpv-16
5169077|NCT02934724|HPV-18|hpv-18
5169078|NCT02934724|Gardasil|gardasil
5169079|NCT02934711|Multimorbidity|multimorbidity
5673427|NCT00608218|Alvesco|alvesco
5169083|NCT02934685|radiotherapy|radiotherapy
5169084|NCT02934646|Robotics|robotics
5169085|NCT02934646|Upper Extremity|upper extremity
5169086|NCT02934633|injury|injury
5169087|NCT02934633|child|child
5169088|NCT02934633|cars|cars
5169089|NCT02934633|pedestrians|pedestrians
5169090|NCT02934633|child safety|child safety
5169091|NCT02934633|interactive|interactive
5169092|NCT02934633|computer|computer
5169093|NCT02934633|prevention|prevention
5169094|NCT02934633|internet|internet
5169095|NCT02934633|CD-ROM|cd-rom
5169100|NCT02934607|Asthma|asthma
5169101|NCT02934607|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5169103|NCT02934607|Symbicort|symbicort
5169104|NCT02934607|Pressurized metered-dose inhaler|pressurized metered-dose inhaler
5169105|NCT02934607|Relative bioavailability|relative bioavailability
5169106|NCT02934607|Crossover|crossover
5169107|NCT02934607|AstraZeneca|astrazeneca
5169108|NCT02934607|Safety|safety
5169109|NCT02934607|Activated charcoal|activated charcoal
5169110|NCT02934607|AeroChamber Plus Flow-Vu spacer device|aerochamber plus flow-vu spacer device
5169111|NCT02934568|Ribociclib|ribociclib
5169112|NCT02934568|LEE011|lee011
5169113|NCT02934542|Laparoscope holder|laparoscope holder
5169114|NCT02934542|Colon resection|colon resection
5169115|NCT02934542|Right hemicolectomy|right hemicolectomy
5169116|NCT02934542|Left hemicolectomy|left hemicolectomy
5169117|NCT02934542|Sigmoid resection|sigmoid resection
5169118|NCT02934542|Anti-reflux|anti-reflux
5169119|NCT02934542|Hiatal hernia|hiatal hernia
5169123|NCT02934503|Chemotherapy|chemotherapy
5169124|NCT02934503|PD-L1|pd-l1
5169125|NCT02934503|Thoracic radiotherapy|thoracic radiotherapy
5169126|NCT02934503|PD-1|pd-1
5169127|NCT02934503|MK-3475|mk-3475
5169128|NCT02934477|Myelofibrosis|myelofibrosis
5169328|NCT02933060|intravenous fluid|intravenous fluid
5169129|NCT02934477|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5169130|NCT02934477|Medicare|medicare
5169131|NCT02934438|nitric oxide|nitric oxide
5169132|NCT02934438|Neo40 supplement,|neo40 supplement,
5169133|NCT02934438|exercise tolerance|exercise tolerance
5169134|NCT02934425|Pork|pork
5169135|NCT02934425|Refined carbohydrates|refined carbohydrates
5169136|NCT02934425|Satiety|satiety
5169137|NCT02934425|Glucose|glucose
5169138|NCT02934425|Insulin|insulin
5169139|NCT02934425|Breakfast|breakfast
5169140|NCT02934425|Lipoprotein lipids|lipoprotein lipids
5169141|NCT02934399|dynamic hormone diagnostics|dynamic hormone diagnostics
5169142|NCT02934399|adrenal insufficiency|adrenal insufficiency
5169143|NCT02934399|congenital adrenal hyperplasia|congenital adrenal hyperplasia
5169144|NCT02934399|primary hyperaldosteronism|primary hyperaldosteronism
5169145|NCT02934399|cushing syndrome|cushing syndrome
5169146|NCT02934399|growth hormone deficiency|growth hormone deficiency
5169147|NCT02934399|acromegaly|acromegaly
5169148|NCT02934360|Lung Cancer|lung cancer
5169149|NCT02934360|Breast Cancer|breast cancer
5169150|NCT02934360|cell free DNA|cell free dna
5169151|NCT02934360|biomarker|biomarker
5169152|NCT02934347|Intubation, Back-up position; Glottis, View|intubation, back-up position; glottis, view
5169153|NCT02934334|major depression|major depression
5169154|NCT02934334|major depressive episode|major depressive episode
5169155|NCT02934334|biomarkers|biomarkers
5169156|NCT02934334|relapse|relapse
5169157|NCT02934334|near term relapse|near term relapse
5169158|NCT02934334|m-health|m-health
5169159|NCT02934321|Erythritol|erythritol
5169160|NCT02934321|Satiety Response|satiety response
5169161|NCT02934321|Ghrelin|ghrelin
5169162|NCT02934295|Rubeola|rubeola
5169163|NCT02934269|Healthy subjects|healthy subjects
5169164|NCT02934269|Safety|safety
5169165|NCT02934269|CC-90006|cc-90006
5169166|NCT02934269|Phase 1|phase 1
5169167|NCT02934269|Tolerability|tolerability
5169168|NCT02934256|Neurofibromatosis Type 2|neurofibromatosis type 2
5169173|NCT02934243|Risk factors|risk factors
5169175|NCT02934204|DLBCL|dlbcl
5169176|NCT02934204|methotrexate|methotrexate
5169177|NCT02934204|temozolomide|temozolomide
5169178|NCT02934191|Tonsillectomy|tonsillectomy
5169179|NCT02934191|Post-operative complications|post-operative complications
5169180|NCT02934191|Post-operative pain|post-operative pain
5169181|NCT02934178|shigellosis|shigellosis
5777817|NCT00208637|Maori|maori
5169186|NCT02934178|Gastrointestinal Diseases|gastrointestinal diseases
5169187|NCT02934178|Digestive System Diseases|digestive system diseases
5169189|NCT02934165|child safety|child safety
5169190|NCT02934165|injury|injury
5169191|NCT02934165|computer|computer
5169192|NCT02934165|prevention|prevention
5169193|NCT02934165|internet|internet
5169194|NCT02934152|Gastroesophageal reflux disease|gastroesophageal reflux disease
5169195|NCT02934152|Helicobacter pylori|helicobacter pylori
5169196|NCT02934139|N91115|n91115
5169197|NCT02934139|Cavosonstat|cavosonstat
5169198|NCT02934139|Healthy Volunteer|healthy volunteer
5169199|NCT02934113|weight loss|weight loss
5169200|NCT02934113|text messaging|text messaging
5169201|NCT02934113|workplace|workplace
5169202|NCT02934113|participatory approach|participatory approach
5056606|NCT03645382|DM|dm
5169203|NCT02934113|health care workers|health care workers
5169204|NCT02934100|Calcaneal spur|calcaneal spur
5169205|NCT02934100|Heel spur|heel spur
5169206|NCT02934100|ESWT|eswt
5169207|NCT02934100|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5169208|NCT02934100|ultrasound therapy|ultrasound therapy
5169209|NCT02934100|electric field diathermy|electric field diathermy
5169210|NCT02934100|skanlab 25 bodywave|skanlab 25 bodywave
5169211|NCT02934100|sham laser therapy|sham laser therapy
5169212|NCT02934087|snare technique|snare technique
5169213|NCT02934087|cannulation of contralateral gate|cannulation of contralateral gate
5169214|NCT02934087|endovascular|endovascular
5169215|NCT02934087|aneurysm|aneurysm
5169217|NCT02934087|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5169218|NCT02934074|Limb Loss|limb loss
5169219|NCT02934074|Gait Variability|gait variability
5169220|NCT02934074|Phantom Sensation|phantom sensation
5169221|NCT02934074|Phantom Pain|phantom pain
5169222|NCT02934074|Peripheral Sensation|peripheral sensation
5169223|NCT02934061|Acute low back pain|acute low back pain
5169224|NCT02934022|Maraviroc|maraviroc
5169225|NCT02934022|HAART regimen|haart regimen
5169226|NCT02934022|Immunologic response|immunologic response
5169231|NCT02933957|Vascular Evaluation|vascular evaluation
5169232|NCT02933957|influencing factor|influencing factor
5169233|NCT02933957|She Minority population|she minority population
5169234|NCT02933944|locally recurrent|locally recurrent
5169235|NCT02933918|Probiotics|probiotics
5169236|NCT02933918|Nasal Irrigation|nasal irrigation
5169237|NCT02933918|Healthy Volunteers|healthy volunteers
5169243|NCT02933788|cardiovascular disease|cardiovascular disease
5169244|NCT02933788|atherosclerosis|atherosclerosis
5169245|NCT02933723|influenza vaccine|influenza vaccine
5169246|NCT02933723|nursing home|nursing home
5169247|NCT02933723|influenza|influenza
5169248|NCT02933723|vaccination|vaccination
5169249|NCT02933723|immunity|immunity
5169250|NCT02933723|cell-mediated immunity|cell-mediated immunity
5169251|NCT02933723|humoral immunity|humoral immunity
5169252|NCT02933710|Japanese encephalitis|japanese encephalitis
5169253|NCT02933710|IMOJEV®|imojev®
5169254|NCT02933710|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5169255|NCT02933697|Atrial Fibrillation|atrial fibrillation
5169256|NCT02933697|Kidney disease|kidney disease
5169257|NCT02933697|Anticoagulation|anticoagulation
5169258|NCT02933671|suprainguinal fascia iliaca (SIFI)|suprainguinal fascia iliaca (sifi)
5169259|NCT02933671|nerve block|nerve block
5169260|NCT02933645|Insulin|insulin
5169261|NCT02933645|Intranasal|intranasal
5169262|NCT02933645|Glucose/metabolism|glucose/metabolism
5169263|NCT02933645|Glucose homeostasis|glucose homeostasis
5169264|NCT02933632|Osteoarthritis|osteoarthritis
5169265|NCT02933632|Physiotherapy|physiotherapy
5169266|NCT02933632|Rehabilitation|rehabilitation
5169267|NCT02933632|Clinical Trials|clinical trials
5169268|NCT02933632|Accelerated rehabilitation|accelerated rehabilitation
5169269|NCT02933632|Hip Replacement Arthroplasty|hip replacement arthroplasty
5169270|NCT02933554|bariatric surgery|bariatric surgery
5169271|NCT02933554|minimally invasive|minimally invasive
5169272|NCT02933554|Embolization|embolization
5169274|NCT02933554|ghrelin|ghrelin
5169275|NCT02933554|gastric artery embolization|gastric artery embolization
5169276|NCT02933515|yoga|yoga
5169277|NCT02933515|occupational therapy|occupational therapy
5169278|NCT02933515|stroke|stroke
5169291|NCT02933320|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
5169292|NCT02933320|BI-1206|bi-1206
5035820|NCT03775083|PEP|pep
5169293|NCT02933320|CD32b|cd32b
5169294|NCT02933294|uniportal|uniportal
5169295|NCT02933294|lung cancer|lung cancer
5169296|NCT02933294|VATS|vats
5169297|NCT02933268|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5169298|NCT02933268|Polycystic Kidney Disease|polycystic kidney disease
5169299|NCT02933268|ADPKD|adpkd
5169300|NCT02933268|Water|water
5169301|NCT02933268|Vasopressin|vasopressin
5169302|NCT02933268|Dietary|dietary
5169308|NCT02933242|Cancer|cancer
5169309|NCT02933216|Cesarean Scar Diverticula|cesarean scar diverticula
5169310|NCT02933177|Dementia|dementia
5169311|NCT02933177|Alzheimer disease|alzheimer disease
5169312|NCT02933177|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5169313|NCT02933177|non-drug intervention|non-drug intervention
5169314|NCT02933138|Lipoprotein Lipase|lipoprotein lipase
5169315|NCT02933138|Hypertriglyceridemia|hypertriglyceridemia
5169316|NCT02933138|Triglycerides|triglycerides
5169317|NCT02933138|Lipolysis|lipolysis
5169318|NCT02933138|Multifactorial Chylomicronemia|multifactorial chylomicronemia
5169319|NCT02933125|substance abuse|substance abuse
5169320|NCT02933125|group psychotherapy|group psychotherapy
5169321|NCT02933125|family therapy|family therapy
5169322|NCT02933125|longitudinal study|longitudinal study
5169323|NCT02933125|child and adolescent|child and adolescent
5169324|NCT02933112|Oral appliance therapy|oral appliance therapy
5169325|NCT02933086|Pregnant|pregnant
5169326|NCT02933086|Low Back Pain|low back pain
5169327|NCT02933086|Postural Control|postural control
5169329|NCT02933060|headache|headache
5169330|NCT02933047|Hysterectomy|hysterectomy
5169331|NCT02933047|Patient satisfaction|patient satisfaction
5169332|NCT02933047|Rehabilitation|rehabilitation
5169333|NCT02933047|Laparoscopy|laparoscopy
5169334|NCT02933047|Return to work|return to work
5169335|NCT02933047|Exercise|exercise
5169344|NCT02933021|MGUS|mgus
5169346|NCT02933008|biofeedback|biofeedback
5169347|NCT02933008|injury prevention|injury prevention
5169348|NCT02933008|virtual reality|virtual reality
5169349|NCT02932995|Optical Coherence Tomography|optical coherence tomography
5169350|NCT02932995|Drug-Eluting Stent|drug-eluting stent
5169351|NCT02932982|primary care|primary care
5169352|NCT02932982|chest pain|chest pain
5169353|NCT02932982|dyspnea|dyspnea
5169355|NCT02932956|GPC3|gpc3
5169356|NCT02932956|Glypican|glypican
5169357|NCT02932956|Liver cancer|liver cancer
5169358|NCT02932930|QLB|qlb
5169359|NCT02932930|Abdominoplasty|abdominoplasty
5169360|NCT02932930|Quadratus lumborum block|quadratus lumborum block
5169361|NCT02932904|Drug therapy|drug therapy
5169362|NCT02932865|azoospermia|azoospermia
5169363|NCT02932865|male fertility|male fertility
5169364|NCT02932865|MD-TESE|md-tese
5169365|NCT02932865|miRNA|mirna
5169366|NCT02932865|piRNA|pirna
5169367|NCT02932865|male infertility|male infertility
5169368|NCT02932852|stem cell|stem cell
5169369|NCT02932852|mesenchymal|mesenchymal
5169370|NCT02932852|ADASc|adasc
5169371|NCT02932852|transplantation|transplantation
5169372|NCT02932852|cornea|cornea
5169373|NCT02932852|corneal defects|corneal defects
5169374|NCT02932852|keratoconus|keratoconus
5169375|NCT02932852|scaffold|scaffold
5169376|NCT02932852|lamina|lamina
5169377|NCT02932839|Epilepsy surgery|epilepsy surgery
5169378|NCT02932839|Micro-electrode arrays|micro-electrode arrays
5169379|NCT02932839|Single-neuron recordings|single-neuron recordings
5169380|NCT02932839|Electrocorticography|electrocorticography
5169381|NCT02932826|Autoimmune Diabetes|autoimmune diabetes
5169382|NCT02932826|Umbilical Cord Blood Cell|umbilical cord blood cell
5169388|NCT02932800|microbiota|microbiota
5169389|NCT02932800|Blood Circulation|blood circulation
5169390|NCT02932774|SAR|sar
5169391|NCT02932774|seasonal allergic rhinitis|seasonal allergic rhinitis
5169392|NCT02932774|hay fever|hay fever
5169393|NCT02932774|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5169394|NCT02932761|cesarean scar diverticula|cesarean scar diverticula
5169395|NCT02932761|vaginal repair|vaginal repair
5169396|NCT02932761|GnRHa|gnrha
5169397|NCT02932722|Propofol|propofol
5169398|NCT02932722|Sevoflurane|sevoflurane
5169399|NCT02932722|Preconditioning|preconditioning
5169400|NCT02932709|Emergency|emergency
5169401|NCT02932709|follow-up|follow-up
5169402|NCT02932709|nurse|nurse
5169403|NCT02932709|phone|phone
5169404|NCT02932709|suicide attempts|suicide attempts
5169405|NCT02932683|Resuscitation|resuscitation
5169406|NCT02932683|Neonatal|neonatal
5169407|NCT02932683|Education|education
5169408|NCT02932644|Rheumatoid Arthritis|rheumatoid arthritis
5169409|NCT02932644|Cardiovascular event|cardiovascular event
5169410|NCT02932644|Cardiovascular mortality|cardiovascular mortality
5962162|NCT04282564|stroke|stroke
5169411|NCT02932644|Vitamin D|vitamin d
5169412|NCT02932631|hemiparesis|hemiparesis
5169413|NCT02932631|STROKE|stroke
5169414|NCT02932631|neural plasticity|neural plasticity
5169415|NCT02932631|PHYSICAL THERAPY|physical therapy
5169416|NCT02932605|Schizophrenia|schizophrenia
5169417|NCT02932605|Cannabidiol|cannabidiol
5169418|NCT02932605|Magnetic Resonance Spectroscopy (1H-MRS)|magnetic resonance spectroscopy (1h-mrs)
5169419|NCT02932605|Microglia|microglia
5169420|NCT02932566|Heart failure|heart failure
5169421|NCT02932566|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5169422|NCT02932566|Myocardial fibrosis|myocardial fibrosis
5169423|NCT02932566|Extracellular volume fraction (ECV)|extracellular volume fraction (ecv)
5169424|NCT02932566|Interstitial fibrosis|interstitial fibrosis
5169425|NCT02932553|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5169426|NCT02932553|variant angina|variant angina
5169427|NCT02932553|moderate coronary artery disease|moderate coronary artery disease
5169428|NCT02932553|vasospastic angina|vasospastic angina
5169429|NCT02932527|cannabis|cannabis
5169435|NCT02932488|PET-MR|pet-mr
5169436|NCT02932488|5-HT1B receptor|5-ht1b receptor
5169437|NCT02932488|Sumatriptan|sumatriptan
5169438|NCT02932488|phMRI|phmri
5169439|NCT02932488|[11C]AZ10419369|[11c]az10419369
5169440|NCT02932436|empagliflozin|empagliflozin
5169441|NCT02932436|diastolic function|diastolic function
5169442|NCT02932436|poorly controlled type 2 diabetes mellitus|poorly controlled type 2 diabetes mellitus
5169443|NCT02932423|Sugar-sweetened beverage|sugar-sweetened beverage
5169444|NCT02932423|Overweight|overweight
5169445|NCT02932423|Obese|obese
5169446|NCT02932423|Sugar|sugar
5169447|NCT02932423|Water|water
5169448|NCT02932397|Ambulatory surgery|ambulatory surgery
5169449|NCT02932397|Perioperative outcomes|perioperative outcomes
5169450|NCT02932397|General anesthesia under desflurane|general anesthesia under desflurane
5169451|NCT02932397|Prevention of coughing|prevention of coughing
5169452|NCT02932397|Propofol|propofol
5169453|NCT02932384|HIV|hiv
5169454|NCT02932384|Black/African American|black/african american
5169455|NCT02932384|Men|men
5169456|NCT02932384|Gay/bisexual|gay/bisexual
5169457|NCT02932384|Los Angeles|los angeles
5169458|NCT02932371|Cardiac output|cardiac output
5169459|NCT02932358|Intensive care units|intensive care units
5169460|NCT02932358|Delirium|delirium
5169461|NCT02932358|Cross infection|cross infection
5169462|NCT02932358|Mortality|mortality
5169463|NCT02932358|Length of stay|length of stay
5169464|NCT02932358|Burnout, Professional|burnout, professional
5169465|NCT02932358|Depression|depression
5169466|NCT02932358|Anxiety|anxiety
5169467|NCT02932345|EGFR mutation; non-small-cell lung cancer;|egfr mutation; non-small-cell lung cancer;
5169469|NCT02932332|oxygen|oxygen
5169470|NCT02932332|breathing therapies|breathing therapies
5169471|NCT02932319|induction of labour|induction of labour
5169472|NCT02932319|nulliparous|nulliparous
5169473|NCT02932319|prolonged pregnancy|prolonged pregnancy
5169474|NCT02932319|foley catheter|foley catheter
5169475|NCT02932319|vaginal birth|vaginal birth
5169476|NCT02932280|Recurrent|recurrent
5169477|NCT02932280|Refractory Disease|refractory disease
5169478|NCT02932280|Neratinib|neratinib
5169479|NCT02932280|16-878|16-878
5169480|NCT02932267|Acne|acne
5169481|NCT02932267|Dark skin|dark skin
5169482|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs
5169483|NCT02932254|Rocuronium|rocuronium
5169484|NCT02932254|Sugammadex sodium|sugammadex sodium
5169485|NCT02932254|Magnesium|magnesium
5169486|NCT02932254|Neuromuscular block, antagonism|neuromuscular block, antagonism
5169487|NCT02932215|mobile health device|mobile health device
5169488|NCT02932215|substance abuse treatment|substance abuse treatment
5169489|NCT02932215|quality of life|quality of life
5169490|NCT02932215|lorcaserin|lorcaserin
5169491|NCT02932202|Obesity|obesity
5169492|NCT02932202|Pregnancy|pregnancy
5169493|NCT02932202|Weight Gain|weight gain
5169494|NCT02932189|Mechanical Ventilator Weaning|mechanical ventilator weaning
5169495|NCT02932189|Respiratory Muscle Training|respiratory muscle training
5169496|NCT02932189|Mortality Rate|mortality rate
5169497|NCT02932176|Arteries|arteries
5169498|NCT02932163|Chronic low back pain|chronic low back pain
5169499|NCT02932163|disability|disability
5169500|NCT02932163|endurance|endurance
5169502|NCT02932150|HBV|hbv
5169503|NCT02932137|SLE,IL-2|sle,il-2
5169504|NCT02932124|German Resuscitation Registry|german resuscitation registry
5169505|NCT02932124|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5169506|NCT02932124|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5169507|NCT02932124|mechanical chest compression devices|mechanical chest compression devices
5169508|NCT02932111|IBS|ibs
5169509|NCT02932111|Osteopathic manipulative treatment|osteopathic manipulative treatment
5169510|NCT02932111|pain|pain
5169511|NCT02932085|Transcranial magnetic stimulation|transcranial magnetic stimulation
5169512|NCT02932085|Magnetic resonance imaging|magnetic resonance imaging
5169513|NCT02932085|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5169514|NCT02932059|Metamemory|metamemory
5169515|NCT02932059|Schizophrenia|schizophrenia
5169516|NCT02932059|Aging|aging
5169517|NCT02932059|Learning|learning
5169518|NCT02932059|Judgement of learning|judgement of learning
5169519|NCT02932059|Sentence construction strategy|sentence construction strategy
5169520|NCT02932046|eating disorders|eating disorders
5169521|NCT02932046|anorexia nervosa|anorexia nervosa
5169522|NCT02932046|appetite|appetite
5169523|NCT02932020|disc herniation|disc herniation
5169524|NCT02932020|spinal stenosis|spinal stenosis
5169525|NCT02932007|persistent|persistent
5169526|NCT02931994|dental floss|dental floss
5169527|NCT02931994|gingival embrasure|gingival embrasure
5169528|NCT02931994|oral hygiene|oral hygiene
5169529|NCT02931981|DKK4|dkk4
5169530|NCT02931981|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5169531|NCT02931981|Biomarker|biomarker
5169532|NCT02931968|Monolithic Zirconia|monolithic zirconia
5169533|NCT02931968|Implant supported prosthesis|implant supported prosthesis
5169534|NCT02931968|Fixed partial denture|fixed partial denture
5169535|NCT02931955|allergy|allergy
5169536|NCT02931955|insect venom|insect venom
5169537|NCT02931955|pollen|pollen
5169538|NCT02931955|systems biology|systems biology
5169539|NCT02931942|AA|aa
5169540|NCT02931916|smart-phone|smart-phone
5169541|NCT02931916|assessment|assessment
5169542|NCT02931916|chronic ankle instability|chronic ankle instability
5169543|NCT02931903|implant supported restorations|implant supported restorations
5169544|NCT02931903|IPS Emax (lithium disilicate glass-ceramic)|ips emax (lithium disilicate glass-ceramic)
5169545|NCT02931903|Vita Enamic (hybrid dental ceramic)|vita enamic (hybrid dental ceramic)
5169546|NCT02931903|implant survival|implant survival
5169547|NCT02931903|peri-implant tissue response|peri-implant tissue response
5169548|NCT02931890|gastric cancer|gastric cancer
5169549|NCT02931890|radiotherapy|radiotherapy
5169550|NCT02931890|chemoradiotherapy|chemoradiotherapy
5169551|NCT02931877|Sevoflurane|sevoflurane
5169552|NCT02931877|Propofol|propofol
5169553|NCT02931877|Cardiac valvular surgery|cardiac valvular surgery
5169554|NCT02931877|Cardiopulmonary bypass|cardiopulmonary bypass
5169555|NCT02931877|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5169556|NCT02931825|high risk|high risk
5169557|NCT02931825|surveillance|surveillance
5169558|NCT02931825|screening|screening
5169559|NCT02931825|colonoscopy|colonoscopy
5169560|NCT02931812|cirrhosis|cirrhosis
5169561|NCT02931812|reward system|reward system
5169562|NCT02931812|taste sensitivity|taste sensitivity
5169563|NCT02931812|chronic renal failure|chronic renal failure
5169564|NCT02931799|Colitis, Ulcerative|colitis, ulcerative
5169565|NCT02931799|Crohn Disease|crohn disease
5169567|NCT02931799|Gastroenterology|gastroenterology
5169568|NCT02931799|Quality Improvement|quality improvement
5169569|NCT02931799|Post-Discharge|post-discharge
5169570|NCT02931786|core body temperature|core body temperature
5169571|NCT02931786|magnetic resonance imaging|magnetic resonance imaging
5169572|NCT02931786|propofol|propofol
5169573|NCT02931786|ketofol|ketofol
5169574|NCT02931773|Diabetes Autonomic Cardiovascular|diabetes autonomic cardiovascular
5169575|NCT02931747|Bacopa Monnieri|bacopa monnieri
5169576|NCT02931747|Working memory|working memory
5169577|NCT02931747|Cognitive processing|cognitive processing
5169578|NCT02931747|Student|student
5169579|NCT02931721|Azospermia|azospermia
5673523|NCT00607945|glucose control|glucose control
5169587|NCT02931695|post partum|post partum
5169596|NCT02931656|Gestational Diabetes|gestational diabetes
5169597|NCT02931643|Spices|spices
5169598|NCT02931643|Functional food|functional food
5169599|NCT02931643|Cardiometabolic risk|cardiometabolic risk
5169600|NCT02931643|Metabolic syndrome|metabolic syndrome
5169601|NCT02931643|Inflammation|inflammation
5169602|NCT02931643|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
5169603|NCT02931643|Acute|acute
5169604|NCT02931643|miRNA|mirna
5169605|NCT02931630|Whey protein|whey protein
5169606|NCT02931630|Dietary fibers|dietary fibers
5169607|NCT02931630|Wheat bran|wheat bran
5169608|NCT02931630|Arabinoxylan|arabinoxylan
5169609|NCT02931630|Postprandial lipaemia|postprandial lipaemia
5169610|NCT02931630|Body composition|body composition
5169611|NCT02931630|Blood pressure|blood pressure
5169612|NCT02931630|Metabolic rate|metabolic rate
5169613|NCT02931630|Insulin sensitivity|insulin sensitivity
5169614|NCT02931630|Metabolic syndrome|metabolic syndrome
5169615|NCT02931604|sinus wash|sinus wash
5169616|NCT02931604|sinus lavage|sinus lavage
5169617|NCT02931604|Sinusitis|sinusitis
5169618|NCT02931591|Small for gestational age|small for gestational age
5169619|NCT02931591|insulin sensitivity|insulin sensitivity
5169620|NCT02931591|IGF-1 response|igf-1 response
5169621|NCT02931591|growth hormone treatment|growth hormone treatment
5169622|NCT02931578|glycemic index|glycemic index
5169623|NCT02931552|Breast cancer|breast cancer
5169624|NCT02931552|Latinas|latinas
5169625|NCT02931552|Peer support counselor|peer support counselor
5169626|NCT02931552|Spanish speaking|spanish speaking
5169627|NCT02931552|Community based|community based
5169628|NCT02931552|Rural|rural
5169629|NCT02931526|Tigecycline|tigecycline
5169630|NCT02931526|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5169631|NCT02931526|Pharmacokinetics|pharmacokinetics
5169632|NCT02931500|machine learning|machine learning
5169633|NCT02931500|cohort study|cohort study
5169634|NCT02931474|Growth Hormone|growth hormone
5169635|NCT02931474|Traumatic Brain Injury|traumatic brain injury
5169636|NCT02931474|Insomnia|insomnia
5169637|NCT02931474|Polysomnography|polysomnography
5169638|NCT02931474|NREM Sleep|nrem sleep
5169639|NCT02931461|endobronchial transbronchial needle aspiration lung cancer procore|endobronchial transbronchial needle aspiration lung cancer procore
5169640|NCT02931448|Device assessment|device assessment
5169641|NCT02931435|Genicular Radiofrequency Ablation|genicular radiofrequency ablation
5169642|NCT02931435|Knee Arthroplasty, Total|knee arthroplasty, total
5169644|NCT02931422|financial incentive|financial incentive
5169645|NCT02931422|pediatric HIV testing|pediatric hiv testing
5169646|NCT02931409|Positive end-expiratory pressure|positive end-expiratory pressure
5169647|NCT02931409|Static pulmonary compliance|static pulmonary compliance
5169648|NCT02931409|Lung Protective Ventilation|lung protective ventilation
5169649|NCT02931409|Radical cystectomy and urinary diversion|radical cystectomy and urinary diversion
5169650|NCT02931409|Postoperative pulmonary complications|postoperative pulmonary complications
5169651|NCT02931409|Procalcitonin|procalcitonin
5169652|NCT02931383|Liraglutide|liraglutide
5169653|NCT02931383|Liraglutide 3 mg|liraglutide 3 mg
5169654|NCT02931383|Osteoarthritis|osteoarthritis
5169655|NCT02931383|Obesity|obesity
5169656|NCT02931383|Ultrasound|ultrasound
5169657|NCT02931370|Osteoarthritis|osteoarthritis
5169658|NCT02931370|Obesity|obesity
5169659|NCT02931370|Ultrasound|ultrasound
5169660|NCT02931370|Liraglutide|liraglutide
5169661|NCT02931370|Liraglutide 3mg|liraglutide 3mg
5169662|NCT02931357|Treatment of teething in infants|treatment of teething in infants
5169663|NCT02931344|Osteoarthrtis|osteoarthrtis
5169664|NCT02931344|Obesity|obesity
5169665|NCT02931344|Liraglutide 3 mg|liraglutide 3 mg
5169666|NCT02931344|Liraglutide|liraglutide
5169667|NCT02931344|Biomarkers|biomarkers
5169668|NCT02931318|Organ donation|organ donation
5169669|NCT02931318|brain death|brain death
5169670|NCT02931318|public opinion|public opinion
5169671|NCT02931305|Epimedium prenylflavonoids|epimedium prenylflavonoids
5169672|NCT02931305|Osteoporosis|osteoporosis
5169673|NCT02931305|Cardiovascular diseases|cardiovascular diseases
5169674|NCT02931305|Phase 1|phase 1
5169675|NCT02931305|safety|safety
5169676|NCT02931305|tolerability|tolerability
5169682|NCT02931214|Healthy Subjects|healthy subjects
5164827|NCT02961816|LBH589B|lbh589b
5169683|NCT02931214|Pharmacokinetics|pharmacokinetics
5169684|NCT02931214|Pharmacodynamics|pharmacodynamics
5169685|NCT02931201|Positron-Emission Tomography|positron-emission tomography
5169686|NCT02931201|Prognosis|prognosis
5169687|NCT02931188|Vascular Diseases|vascular diseases
5169688|NCT02931188|Lipids|lipids
5169689|NCT02931188|Cholesteryl Ester Transfer Protein (CETP) Inhibition|cholesteryl ester transfer protein (cetp) inhibition
5169690|NCT02931188|Anacetrapib|anacetrapib
5169691|NCT02931188|Cardiovascular Disease|cardiovascular disease
5169692|NCT02931188|Cholesterol|cholesterol
5169693|NCT02931175|ACTH gel|acth gel
5169694|NCT02931175|Non-Infectious Uveitis|non-infectious uveitis
5169695|NCT02931175|ACTHAR|acthar
5169696|NCT02931175|Posterior Uveitis|posterior uveitis
5169697|NCT02931175|Intermediate Uveitis|intermediate uveitis
5169698|NCT02931175|Pan Uveitis|pan uveitis
5169699|NCT02931175|Uveitis|uveitis
5169700|NCT02931149|platelet-rich plasma|platelet-rich plasma
5169701|NCT02931149|endoscopic mucosal resection|endoscopic mucosal resection
5169702|NCT02931149|endoscopic submucosal dissection|endoscopic submucosal dissection
5169703|NCT02931110|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5169704|NCT02931110|follicular lymphoma (FL)|follicular lymphoma (fl)
5169705|NCT02931110|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5169706|NCT02931110|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
5169707|NCT02931110|Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)|chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
5169708|NCT02931110|Multiple myeloma (MM)|multiple myeloma (mm)
5169709|NCT02931097|Parkinson's disease|parkinson's disease
5169710|NCT02931097|Deep brain stimulation|deep brain stimulation
5169711|NCT02931097|Mesencephalic locomotor region|mesencephalic locomotor region
5169712|NCT02931058|Knee-extension exercise|knee-extension exercise
5169713|NCT02931058|Quadriceps exercise|quadriceps exercise
5169714|NCT02931058|Knee osteoarthritis|knee osteoarthritis
5169715|NCT02931058|Exercise adherence|exercise adherence
5169716|NCT02931058|Dose-response relationship|dose-response relationship
5169717|NCT02931058|Prehabilitation|prehabilitation
5169718|NCT02931045|extracellular vesicles|extracellular vesicles
5169719|NCT02931045|inflammation|inflammation
5169720|NCT02931045|thrombosis|thrombosis
5169721|NCT02931045|antiplatelet drugs|antiplatelet drugs
5169722|NCT02931032|nano receptor|nano receptor
5169723|NCT02931032|oral microbiology|oral microbiology
5169724|NCT02931032|dental caries|dental caries
5169725|NCT02931032|periodontal disease|periodontal disease
5169726|NCT02931019|fiberoptic|fiberoptic
5169727|NCT02931019|intubation|intubation
5169729|NCT02930954|NSCLC, EGFR, Bim, mutation abundance|nsclc, egfr, bim, mutation abundance
5169735|NCT02930928|Anaesthesia|anaesthesia
5169736|NCT02930928|Anthropometry|anthropometry
5087515|NCT03451539|ICU|icu
5169737|NCT02930928|Body weight and measures|body weight and measures
5169738|NCT02930928|Development|development
5169739|NCT02930928|Emergency treatment|emergency treatment
5169740|NCT02930928|Patient safety|patient safety
5169741|NCT02930915|Head and Neck Cancer|head and neck cancer
5169742|NCT02930915|Radiotherapy|radiotherapy
5169743|NCT02930889|Therapeutic Embolization|therapeutic embolization
5169744|NCT02930889|Prostatic Artery Embolization|prostatic artery embolization
5169745|NCT02930876|sarcopenia|sarcopenia
5169746|NCT02930876|cancer|cancer
5169747|NCT02930876|chemotherapy|chemotherapy
5169748|NCT02930876|palliative care|palliative care
5169749|NCT02930876|resistance training|resistance training
5169750|NCT02930733|Postoperative Analgesia|postoperative analgesia
5169751|NCT02930733|Ultrasound guided serratus plane block|ultrasound guided serratus plane block
5169752|NCT02930720|TAUS|taus
5169753|NCT02930720|breathing protocols and cough|breathing protocols and cough
5169754|NCT02930720|pelvic floor displacement|pelvic floor displacement
5169755|NCT02930720|women|women
5169756|NCT02930720|SUI|sui
5169757|NCT02930707|magnesium sulfate|magnesium sulfate
5169758|NCT02930707|postoperative pain|postoperative pain
5169759|NCT02930707|TAP block|tap block
5169760|NCT02930707|total abdominal hysterectomy|total abdominal hysterectomy
5169761|NCT02930655|Fabry disease|fabry disease
5169762|NCT02930655|lucerastat|lucerastat
5169763|NCT02930642|Mindfulness|mindfulness
5169764|NCT02930642|Obesity|obesity
5169765|NCT02930642|Food insecurity|food insecurity
5169766|NCT02930642|Delay discounting|delay discounting
5169767|NCT02930629|Recovery Period, Anesthesia|recovery period, anesthesia
5169768|NCT02930629|Neuromuscular Monitoring|neuromuscular monitoring
5169769|NCT02930603|Developmental Disabilities|developmental disabilities
5169770|NCT02930603|Body function and body structure|body function and body structure
5245076|NCT02473822|LCA|lca
5169771|NCT02930603|Participation|participation
5169772|NCT02930603|Life activities|life activities
5169773|NCT02930603|Quality of Life|quality of life
5169774|NCT02930577|treatment adherence|treatment adherence
5169775|NCT02930577|outpatient treatment|outpatient treatment
5169776|NCT02930577|drug dependence|drug dependence
5169777|NCT02930525|apnea|apnea
5169778|NCT02930525|children|children
5169779|NCT02930525|hypercarbia|hypercarbia
5169780|NCT02930525|procedural sedation|procedural sedation
5169781|NCT02930525|HFNC|hfnc
5169782|NCT02930512|Bone mineral density|bone mineral density
5169783|NCT02930512|Osteoporosis|osteoporosis
5169784|NCT02930512|Parkinson's disease|parkinson's disease
5169785|NCT02930512|Bone turnover markers|bone turnover markers
5169787|NCT02930486|Injury|injury
5169788|NCT02930486|Ankle|ankle
5169789|NCT02930486|Fracture|fracture
5169790|NCT02930486|Weber C|weber c
5169791|NCT02930473|Psychotherapy|psychotherapy
5169792|NCT02930473|Nursing|nursing
5169793|NCT02930473|Nursing Care|nursing care
5169794|NCT02930473|Nursing Model|nursing model
5169795|NCT02930473|Randomised Controlled Trial|randomised controlled trial
5169796|NCT02930434|Vitamin D|vitamin d
5169797|NCT02930434|cholecalciferol|cholecalciferol
5169798|NCT02930434|Antarctica|antarctica
5169799|NCT02930434|Chile|chile
5169800|NCT02930434|cathelicidin|cathelicidin
5169801|NCT02930434|bone metabolism|bone metabolism
5169802|NCT02930434|cardiovascular risk|cardiovascular risk
5169803|NCT02930421|mild COPD|mild copd
5169804|NCT02930421|Exercise training|exercise training
5169805|NCT02930421|Six minute walking distance|six minute walking distance
5169806|NCT02930421|Quality of life|quality of life
5169807|NCT02930421|Saint George Respiratory Questionnaire (SGRQ)|saint george respiratory questionnaire (sgrq)
5169808|NCT02930395|Concussion|concussion
5169809|NCT02930395|Professional rugby players|professional rugby players
5169810|NCT02930395|S100B|s100b
5169811|NCT02930330|Exercise|exercise
5169812|NCT02930330|Interval training|interval training
5169813|NCT02930330|Blood platelets|blood platelets
5169814|NCT02930330|Platelet function tests|platelet function tests
5169815|NCT02930330|Physical fitness|physical fitness
5169816|NCT02930330|Rehabilitation|rehabilitation
5169817|NCT02930304|tennis elbow|tennis elbow
5169818|NCT02930304|pain|pain
5169819|NCT02930304|shock wave|shock wave
5169820|NCT02930304|kinesio taping|kinesio taping
5169821|NCT02930252|Self-expandable metal stent|self-expandable metal stent
5169822|NCT02930252|strictures|strictures
5169823|NCT02930252|biliary|biliary
5169824|NCT02930239|ACL-reconstruction|acl-reconstruction
5169825|NCT02930239|Gait rehabilitation|gait rehabilitation
5169826|NCT02930239|Anti Gravity treadmill|anti gravity treadmill
5169827|NCT02930239|ACL-rehabilitation|acl-rehabilitation
5169828|NCT02930213|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
5169829|NCT02930213|minimally conscious state|minimally conscious state
5170526|NCT02925936|Radiation|radiation
5169830|NCT02930213|circadian rhythms|circadian rhythms
5962163|NCT04282564|single-case experimental designs|single-case experimental designs
5169831|NCT02930213|free-running period|free-running period
5169832|NCT02930200|Smoking Cessation|smoking cessation
5169833|NCT02930200|Smartphone Based Smoking Cessation|smartphone based smoking cessation
5169834|NCT02930187|Rheumatoid arthritis, remission, ultrasound|rheumatoid arthritis, remission, ultrasound
5169835|NCT02930161|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5169836|NCT02930161|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5169838|NCT02930161|Succinic acid|succinic acid
5169839|NCT02930148|mHealth|mhealth
5169840|NCT02930148|adolescents|adolescents
5169841|NCT02930148|quasi-experimental study|quasi-experimental study
5169842|NCT02930148|apps|apps
5169843|NCT02930148|lifestyles|lifestyles
5169844|NCT02930148|lifestyles knowledge|lifestyles knowledge
5169845|NCT02930148|dietary behaviour|dietary behaviour
5169846|NCT02930148|physical activity|physical activity
5169847|NCT02930148|sleeping behaviour|sleeping behaviour
5169848|NCT02930135|Indirect Pulp Capping, Young Permanent Molars|indirect pulp capping, young permanent molars
5169849|NCT02930070|sepsis|sepsis
5169850|NCT02930070|qSOFA|qsofa
5169851|NCT02930070|SOFA|sofa
5169852|NCT02930070|diagnostic accuracy|diagnostic accuracy
5169853|NCT02930057|lumbar dorsal root ganglion|lumbar dorsal root ganglion
5169854|NCT02930057|transforaminal epidural steroid injection|transforaminal epidural steroid injection
5169855|NCT02930057|chronic lumbosacral radicular pain|chronic lumbosacral radicular pain
5169856|NCT02930057|pulsed radiofrequency treatment|pulsed radiofrequency treatment
5169857|NCT02930057|betamethasone|betamethasone
5169858|NCT02930057|dorsal root ganglion|dorsal root ganglion
5169859|NCT02930044|Emergency department|emergency department
5169860|NCT02930044|Insulin|insulin
5169861|NCT02930044|Adult|adult
5169862|NCT02930031|muscle injury|muscle injury
5169863|NCT02930031|exercise|exercise
5169864|NCT02930031|redox status|redox status
5169865|NCT02930031|immune cells|immune cells
5169866|NCT02930018|Acute Ischemic Stroke|acute ischemic stroke
5778635|NCT00204113|balance|balance
5169867|NCT02930018|Endovascular Thrombectomy|endovascular thrombectomy
5169868|NCT02930018|Neuroprotection|neuroprotection
5169869|NCT02930018|Tat-NR2B9c|tat-nr2b9c
5169870|NCT02930018|NA-1|na-1
5169871|NCT02930005|Psychotic|psychotic
5169872|NCT02930005|Schizophrenia|schizophrenia
5169873|NCT02930005|Schizoaffective|schizoaffective
5169874|NCT02930005|Bipolar|bipolar
5169875|NCT02929979|PTSD|ptsd
5169876|NCT02929979|Alcohol Use Disorder|alcohol use disorder
5169877|NCT02929979|Cognitive Training|cognitive training
5169878|NCT02929979|Veterans|veterans
5169879|NCT02929953|premature birth|premature birth
5169880|NCT02929953|risk factor|risk factor
5169881|NCT02929953|type 1 diabetes mellitus|type 1 diabetes mellitus
5169882|NCT02929953|seasonality|seasonality
5169884|NCT02929953|enteral feeding|enteral feeding
5169885|NCT02929953|immunomodulating medications|immunomodulating medications
5169886|NCT02929953|early onset|early onset
5169887|NCT02929927|PDT|pdt
5169888|NCT02929914|Carious dentin|carious dentin
5169889|NCT02929914|Photodynamic Therapy|photodynamic therapy
5169890|NCT02929888|ST-segment elevacion myocardial infarction, platelets|st-segment elevacion myocardial infarction, platelets
5169891|NCT02929836|Ablation Linear Lesions|ablation linear lesions
5169892|NCT02929797|pancreatic cancer|pancreatic cancer
5169893|NCT02929784|Hemiplegic Shoulder Pain|hemiplegic shoulder pain
5169894|NCT02929784|transcranial Direct Current Stimulation|transcranial direct current stimulation
5169895|NCT02929784|Stroke|stroke
5169896|NCT02929771|Virtual Reality|virtual reality
5169897|NCT02929771|Subcutaneous Port Sampling|subcutaneous port sampling
5169898|NCT02929771|Pain|pain
5169899|NCT02929771|Children|children
5169900|NCT02929745|immunology, genetics|immunology, genetics
5169901|NCT02929667|Fluoxetine|fluoxetine
5169902|NCT02929641|Optical Enhancement technology|optical enhancement technology
5169903|NCT02929641|coloractal polyp prediction|coloractal polyp prediction
5169904|NCT02929602|prescribing|prescribing
5169905|NCT02929602|effectiveness|effectiveness
5169906|NCT02929602|dental|dental
5169907|NCT02929602|opioid|opioid
5169908|NCT02929602|analgesic|analgesic
5169909|NCT02929576|metastatic|metastatic
5169910|NCT02929576|triple negative|triple negative
5169911|NCT02929550|Cardiovascular disease|cardiovascular disease
5169912|NCT02929550|Costs|costs
5169913|NCT02929550|Guidelines|guidelines
5169914|NCT02929550|Lipids|lipids
5169915|NCT02929550|Myocardial infarction|myocardial infarction
5169916|NCT02929537|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5169917|NCT02929537|registration research|registration research
5169918|NCT02929537|Medicine, Chinese Traditional|medicine, chinese traditional
5169919|NCT02929524|Ketamine|ketamine
5169920|NCT02929524|Intranasal administration|intranasal administration
5169921|NCT02929524|Pediatric nursing|pediatric nursing
5169922|NCT02929498|GSK2879552|gsk2879552
5169923|NCT02929498|Revised International Prognostic Scoring System (IPSS-R)|revised international prognostic scoring system (ipss-r)
5169924|NCT02929498|azacitidine|azacitidine
5169925|NCT02929498|hypomethylating agents|hypomethylating agents
5169926|NCT02929498|myelodysplastic syndrome|myelodysplastic syndrome
5169928|NCT02929472|Physical Fitness|physical fitness
5169929|NCT02929472|Intervention|intervention
5169930|NCT02929472|Children and Adolescents|children and adolescents
5169931|NCT02929459|Gut Microbiota|gut microbiota
5169932|NCT02929459|Riboflavin|riboflavin
5169933|NCT02929459|Vitamin B2|vitamin b2
5169935|NCT02929459|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
5169936|NCT02929446|mobilisation|mobilisation
5169937|NCT02929446|physiotherapy|physiotherapy
5169938|NCT02929433|disability|disability
5169939|NCT02929433|pain|pain
5169940|NCT02929433|Rotator Cuff Tear|rotator cuff tear
5169941|NCT02929433|rehabilitation|rehabilitation
5169942|NCT02929433|range of motion (ROM)|range of motion (rom)
5169943|NCT02929420|Multicenter|multicenter
5169944|NCT02929420|randomized|randomized
5169945|NCT02929420|open|open
5169946|NCT02929420|parallel controlled|parallel controlled
5169947|NCT02929394|Histologically proven locally advanced or metastatic high grade STS (excluding histologies insensitive to chemotherapy such as ASPS, PECOMA subtypes)|histologically proven locally advanced or metastatic high grade sts (excluding histologies insensitive to chemotherapy such as asps, pecoma subtypes)
5057432|NCT03639961|leading|leading
5169948|NCT02929381|Narrow Band Imaging|narrow band imaging
5169949|NCT02929381|Colorectal Cancer Screening|colorectal cancer screening
5169950|NCT02929381|Colonoscopy|colonoscopy
5169951|NCT02929381|Responsive Insertion Technology|responsive insertion technology
5169952|NCT02929381|Near Focus|near focus
5169953|NCT02929368|PICC-Line|picc-line
5169954|NCT02929355|Carotid atherosclerosis|carotid atherosclerosis
5169955|NCT02929355|duplex ultrasonography|duplex ultrasonography
5169956|NCT02929355|diabetes|diabetes
5169957|NCT02929355|vascular events|vascular events
5169958|NCT02929277|farm children|farm children
5169959|NCT02929277|non-farm children|non-farm children
5169960|NCT02929264|Healthy volunteer|healthy volunteer
5169961|NCT02929264|Experimental hyperalgesia|experimental hyperalgesia
5169977|NCT02929108|hospice|hospice
5169978|NCT02929108|caregiver|caregiver
5169979|NCT02929082|magnetic resonance force|magnetic resonance force
5169980|NCT02929069|Minority Stress|minority stress
5169981|NCT02929017|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5169982|NCT02929017|Fibrosis|fibrosis
5169984|NCT02929017|Caregivers|caregivers
5169985|NCT02929017|Pulmonary|pulmonary
5169986|NCT02929017|Palliative|palliative
5169987|NCT02929017|end of life|end of life
5169988|NCT02929017|Idiopathic|idiopathic
5169989|NCT02929004|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5169990|NCT02929004|Local vibration training|local vibration training
5169991|NCT02929004|Ligamentoplasty|ligamentoplasty
5169992|NCT02929004|Anterior cruciate ligament|anterior cruciate ligament
5169993|NCT02929004|Corticospinal excitability|corticospinal excitability
5169994|NCT02929004|Elastography|elastography
5169995|NCT02929004|Knee extensor muscles|knee extensor muscles
5169996|NCT02929004|Readaptation|readaptation
5169997|NCT02928991|Acquired aplastic anemia|acquired aplastic anemia
5169998|NCT02928991|Inherited bone marrow failure|inherited bone marrow failure
5169999|NCT02928978|Premalignant Breast Disease|premalignant breast disease
5170001|NCT02928978|ADH|adh
5170002|NCT02928978|DCIS|dcis
5170003|NCT02928978|LCIS|lcis
5170004|NCT02928978|Breast Cancer Prevention|breast cancer prevention
5170005|NCT02928978|Ruxolitinib|ruxolitinib
5170006|NCT02928965|psychosis|psychosis
5170007|NCT02928965|schizophrenia|schizophrenia
5170008|NCT02928965|negative symptoms|negative symptoms
5170009|NCT02928965|minocycline|minocycline
5170010|NCT02928952|Mindfulness|mindfulness
5170011|NCT02928939|multimorbidity|multimorbidity
5170012|NCT02928939|multiple chronic conditions|multiple chronic conditions
5170013|NCT02928939|drug-drug interactions|drug-drug interactions
5170014|NCT02928939|drug-disease interactions|drug-disease interactions
5170015|NCT02928939|polypharmacy|polypharmacy
5170016|NCT02928939|Oral anticoagulants|oral anticoagulants
5170017|NCT02928939|Steroids|steroids
5170018|NCT02928913|sedentary|sedentary
5170019|NCT02928913|non-sedentary|non-sedentary
5170020|NCT02928913|populations|populations
5170021|NCT02928900|Adolescents|adolescents
5170022|NCT02928900|Clinical training|clinical training
5170023|NCT02928900|HIV care and treatment|hiv care and treatment
5170024|NCT02928900|Africa|africa
5170025|NCT02928861|Positron-Emission Tomography|positron-emission tomography
5170027|NCT02928835|Total knee arthroplasty|total knee arthroplasty
5170028|NCT02928835|Knee flexion|knee flexion
5170029|NCT02928835|Dynamic orthosis|dynamic orthosis
5170030|NCT02928822|stroke|stroke
5170031|NCT02928822|broca's aphasia|broca's aphasia
5170032|NCT02928822|priming|priming
5170033|NCT02928822|Intensive language-action therapy|intensive language-action therapy
5170034|NCT02928822|Rehabilitation gaming system|rehabilitation gaming system
5170035|NCT02928809|temporomandibular joint|temporomandibular joint
5170036|NCT02928809|temporomandibular disorder|temporomandibular disorder
5170037|NCT02928809|muscle fatigue|muscle fatigue
5170038|NCT02928809|low-level laser therapy|low-level laser therapy
5170039|NCT02928796|Attentional capacity|attentional capacity
5170040|NCT02928796|Working memory|working memory
5170041|NCT02928796|Simulation-based training|simulation-based training
5170042|NCT02928796|Eye-tracking|eye-tracking
5170043|NCT02928796|Visual attention|visual attention
5170044|NCT02928796|Psychophysiological measurement|psychophysiological measurement
5170045|NCT02928796|Surgical simulation|surgical simulation
5170046|NCT02928796|Computer-based simulation|computer-based simulation
5170047|NCT02928783|Home-based cardiac rehabilitation|home-based cardiac rehabilitation
5170048|NCT02928783|Quality of Medical Care|quality of medical care
5170049|NCT02928783|Heart Failure|heart failure
5170050|NCT02928757|Care coordination|care coordination
5170051|NCT02928757|Complex care kids Ontario|complex care kids ontario
5170052|NCT02928757|Technology-dependent|technology-dependent
5170053|NCT02928757|Quality of life|quality of life
5170054|NCT02928744|Resistance|resistance
5170055|NCT02928744|Forced oscillations|forced oscillations
5170056|NCT02928744|Dyspnea|dyspnea
5170057|NCT02928731|Cancer|cancer
5170058|NCT02928731|Quality of life|quality of life
5170059|NCT02928731|Child|child
5170060|NCT02928718|Post-ERCP pancreatitis|post-ercp pancreatitis
5170061|NCT02928718|Genetic variation|genetic variation
5170062|NCT02928705|analgesia|analgesia
5170063|NCT02928705|prehospital|prehospital
5170064|NCT02928705|telemedicine|telemedicine
5170065|NCT02928705|ambulance|ambulance
5170066|NCT02928705|opioids|opioids
5170067|NCT02928705|teleconsultation|teleconsultation
5170068|NCT02928705|tele-emergency medical services|tele-emergency medical services
5170069|NCT02928705|adverse events|adverse events
5170070|NCT02928705|prehospital emergency medical service physician|prehospital emergency medical service physician
5170071|NCT02928692|Minocycline|minocycline
5170072|NCT02928692|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5170073|NCT02928692|Postoperative delirium|postoperative delirium
5170074|NCT02928679|Magnetic resonance imaging|magnetic resonance imaging
5170075|NCT02928679|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5170076|NCT02928679|Liraglutide 3 mg|liraglutide 3 mg
5170077|NCT02928679|Liraglutide|liraglutide
5170078|NCT02928679|Obesity|obesity
5170079|NCT02928679|Osteoarthritis|osteoarthritis
5170080|NCT02928666|decision-support|decision-support
5170081|NCT02928666|ontology|ontology
5170082|NCT02928666|computer-interpretable guidelines|computer-interpretable guidelines
5170083|NCT02928666|comorbidities|comorbidities
5170084|NCT02928653|energy intake|energy intake
5170085|NCT02928653|energy expenditure|energy expenditure
5170086|NCT02928653|appetite|appetite
5170087|NCT02928614|Osteoarthritis|osteoarthritis
5170088|NCT02928614|Obesity|obesity
5170089|NCT02928614|Liraglutide 3 mg|liraglutide 3 mg
5170090|NCT02928614|Liraglutide|liraglutide
5170091|NCT02928614|Biomarkers|biomarkers
5170092|NCT02928575|Glioblastoma|glioblastoma
5170093|NCT02928575|Sunitinib|sunitinib
5170094|NCT02928575|Temozolomide|temozolomide
5170095|NCT02928575|Radiation Therapy,|radiation therapy,
5170096|NCT02928575|MGMT|mgmt
5170097|NCT02928575|Biomarkers|biomarkers
5170098|NCT02928549|interviews|interviews
5170099|NCT02928549|16-1378|16-1378
5170100|NCT02928523|Autologous Fecal Microbiota Transplantation|autologous fecal microbiota transplantation
5170101|NCT02928497|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5170102|NCT02928497|Left atrial appendage|left atrial appendage
5170103|NCT02928484|Functional dyspepsia|functional dyspepsia
5170104|NCT02928484|Abdominal pain|abdominal pain
5170105|NCT02928484|Flatulence|flatulence
5170106|NCT02928484|Probiotics|probiotics
5170107|NCT02928484|Bifidobacterium|bifidobacterium
5170108|NCT02928484|Lactobacillus|lactobacillus
5170109|NCT02928471|Liraglutide|liraglutide
5170110|NCT02928471|Liraglutide 3 mg|liraglutide 3 mg
5170111|NCT02928471|Osteoarthritis|osteoarthritis
5170112|NCT02928471|Obesity|obesity
5170113|NCT02928471|Magnetic resonance imaging|magnetic resonance imaging
5170114|NCT02928471|Computed tomography|computed tomography
5170115|NCT02928471|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5170116|NCT02928445|Dementia with Lewy bodies|dementia with lewy bodies
5170117|NCT02928445|dementia|dementia
5170118|NCT02928445|RVT-101|rvt-101
5170119|NCT02928445|intepirdine|intepirdine
5170120|NCT02928445|Lewy bodies|lewy bodies
5170121|NCT02928432|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5170122|NCT02928432|Abiraterone acetate|abiraterone acetate
5170123|NCT02928432|Steroids Switch|steroids switch
5170124|NCT02928393|Stroke|stroke
5170125|NCT02928393|Motor impairment|motor impairment
5170126|NCT02928393|Stroke recovery|stroke recovery
5170127|NCT02928393|Middle cerebral artery stroke|middle cerebral artery stroke
5170128|NCT02928393|Fugl Meyer|fugl meyer
5170129|NCT02928393|Fugl-Meyer Motor Scale (FMMS)|fugl-meyer motor scale (fmms)
5170131|NCT02928354|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5170132|NCT02928354|Healthy volunteers|healthy volunteers
5170133|NCT02928354|Pharmacokinetics (PK)|pharmacokinetics (pk)
5170134|NCT02928354|Bioavailability|bioavailability
5170135|NCT02928354|AZD7594|azd7594
5170136|NCT02928354|Safety|safety
5170137|NCT02928354|Tolerability|tolerability
5170138|NCT02928328|craniofacial pain|craniofacial pain
5170139|NCT02928328|masticatory muscle|masticatory muscle
5170146|NCT02928237|cancer liver|cancer liver
5170147|NCT02928237|chronic abdominal pain|chronic abdominal pain
5170148|NCT02928237|VAS|vas
5170149|NCT02928237|VDS|vds
5170150|NCT02928237|HAM-D|ham-d
5170151|NCT02928237|BPI|bpi
5170152|NCT02928237|analgesia|analgesia
5170153|NCT02928224|Colorectal cancer|colorectal cancer
5170154|NCT02928224|BRAF|braf
5170155|NCT02928224|BRAFV600E|brafv600e
5170156|NCT02928198|Tomography, Optical Coherence|tomography, optical coherence
5170157|NCT02928198|Percutaneous Coronary Intervention|percutaneous coronary intervention
5170158|NCT02928198|Cardiac Catheterization|cardiac catheterization
5170159|NCT02928198|Coronary Biovascular Scaffold|coronary biovascular scaffold
5170160|NCT02928185|training manuals|training manuals
5170161|NCT02928185|patients and caregivers|patients and caregivers
5170162|NCT02928185|16-1334|16-1334
5170173|NCT02928159|Low Pulse Amplitude ECT|low pulse amplitude ect
5170174|NCT02928159|LAP|lap
5170175|NCT02928159|LAP-ST|lap-st
5170176|NCT02928159|ECT|ect
5170177|NCT02928159|Mood disorders|mood disorders
5170178|NCT02928159|Psychotic disorders|psychotic disorders
5170179|NCT02928146|TAPP|tapp
5170180|NCT02928146|TEP|tep
5170181|NCT02928146|Lichtenstein|lichtenstein
5170182|NCT02928146|syntethic mesh|syntethic mesh
5170183|NCT02928146|hernioplasty|hernioplasty
5170184|NCT02928133|Non-vitamin K antagonist oral anticoagulant (NOAC)|non-vitamin k antagonist oral anticoagulant (noac)
5170185|NCT02928133|Congenital heart disease|congenital heart disease
5170186|NCT02928133|Atrial fibrillation|atrial fibrillation
5170187|NCT02928133|Atrial tachyarrhythmia|atrial tachyarrhythmia
5170188|NCT02928133|Thromboembolism|thromboembolism
5170189|NCT02928094|refractory angina|refractory angina
5170190|NCT02928094|myocardial ischemia|myocardial ischemia
5170191|NCT02928094|angiogenesis|angiogenesis
5170192|NCT02928068|telehealth|telehealth
5170203|NCT02928016|carbohydrate counting method|carbohydrate counting method
5170204|NCT02928016|protein|protein
5170205|NCT02928016|fat|fat
5170206|NCT02928016|glucose|glucose
5170207|NCT02928016|type 1 diabetes|type 1 diabetes
5170208|NCT02928003|Lung surgery|lung surgery
5170209|NCT02927977|dry needling|dry needling
5170210|NCT02927977|exercise|exercise
5170211|NCT02927977|manual therapy|manual therapy
5170212|NCT02927951|Diabetes Mellitus|diabetes mellitus
5170213|NCT02927951|Peripheral Neuropathy|peripheral neuropathy
5170214|NCT02927951|Diabetic Pain|diabetic pain
5170215|NCT02927899|Tomato-Soy-Arugula|tomato-soy-arugula
5170222|NCT02927860|sleep|sleep
5170223|NCT02927860|exercise|exercise
5170224|NCT02927860|activity|activity
5170225|NCT02927821|Adult Day Care Centers|adult day care centers
5170226|NCT02927821|Caregivers|caregivers
5170227|NCT02927808|Motivational Interviewing|motivational interviewing
5170229|NCT02927808|LDL target|ldl target
5170230|NCT02927808|Medication adherence|medication adherence
5170231|NCT02927782|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
5170233|NCT02927756|Non-Hodgkin Lymphoma Transformed Recurrent|non-hodgkin lymphoma transformed recurrent
5170234|NCT02927756|Discordant Lymphomas|discordant lymphomas
5170236|NCT02927756|Follicular Lymphoma|follicular lymphoma
5170237|NCT02927756|Aggressive Lymphoma|aggressive lymphoma
5170238|NCT02927730|Retained placenta, surgical hysteroscopy, residua|retained placenta, surgical hysteroscopy, residua
5170239|NCT02927717|Grade 3b Follicular Lymphoma|grade 3b follicular lymphoma
5170240|NCT02927717|2016 WHO Criteria|2016 who criteria
5170241|NCT02927717|Front-line treatment|front-line treatment
5170242|NCT02927717|Rituximab|rituximab
5170243|NCT02927704|Aggressive Periodontitis|aggressive periodontitis
5170244|NCT02927704|monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
5170245|NCT02927704|gingival crevicular fluid|gingival crevicular fluid
5170246|NCT02927704|enzyme-linked immunosorbent assay|enzyme-linked immunosorbent assay
5170247|NCT02927691|Rehabilitation|rehabilitation
5170248|NCT02927691|Parkinson's disease|parkinson's disease
5170249|NCT02927691|Swallowing|swallowing
5170250|NCT02927691|Cough|cough
5170251|NCT02927691|Dysphagia|dysphagia
5170252|NCT02927691|Dystussia|dystussia
5170253|NCT02927678|Diabetic foot|diabetic foot
5170254|NCT02927678|Osteomyelitis|osteomyelitis
5170255|NCT02927678|Antibiotic treatment|antibiotic treatment
5170256|NCT02927678|White Blood Cell SPECT/CT|white blood cell spect/ct
5170257|NCT02927665|Weight Loss|weight loss
5170258|NCT02927613|Home mechanical ventilation|home mechanical ventilation
5170274|NCT02927574|systematic review|systematic review
5170275|NCT02927574|meta-analysis|meta-analysis
5170276|NCT02927574|Paclitaxel|paclitaxel
5170277|NCT02927522|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5170278|NCT02927522|Donepezil|donepezil
5170279|NCT02927522|Hip replacement|hip replacement
5170280|NCT02927522|Knee replacement|knee replacement
5170281|NCT02927522|Postoperative delirium|postoperative delirium
5170286|NCT02927483|Venous Insufficiency|venous insufficiency
5170287|NCT02927470|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5170288|NCT02927457|Cutaneous Lupus Erythematosus-CLE|cutaneous lupus erythematosus-cle
5170289|NCT02927457|Spleen Tyrosine Kinase-SYK|spleen tyrosine kinase-syk
5170290|NCT02927457|Photoprovocation-PV|photoprovocation-pv
5170291|NCT02927457|GSK2646264|gsk2646264
5170292|NCT02927431|Anti-inflammatory|anti-inflammatory
5170293|NCT02927431|Danirixin|danirixin
5170294|NCT02927431|Influenza|influenza
5170295|NCT02927431|Hospitalized patients|hospitalized patients
5170296|NCT02927405|gabapentin|gabapentin
5170297|NCT02927405|TAP block|tap block
5170308|NCT02927353|Bioequivalence, Biosimilarity, Pharmacokinetics, adalimumab|bioequivalence, biosimilarity, pharmacokinetics, adalimumab
5170309|NCT02927340|Lung Cancer|lung cancer
5170310|NCT02927288|PTSD, mTBI|ptsd, mtbi
5170311|NCT02927262|Acute myeloid leukemia|acute myeloid leukemia
5170312|NCT02927262|First Complete Remission|first complete remission
5170313|NCT02927262|gilteritinib|gilteritinib
5170314|NCT02927262|FLT3/ITD|flt3/itd
5170317|NCT02927236|Non-Invasive Brain Stimulation|non-invasive brain stimulation
5170318|NCT02927236|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5170319|NCT02927210|Healthy Men|healthy men
5170320|NCT02927210|Male Contraception|male contraception
5170321|NCT02927210|Androgen|androgen
5170322|NCT02927210|Dimethandrolone|dimethandrolone
5170323|NCT02927171|Skilled Nursing Facility|skilled nursing facility
5170324|NCT02927171|Post-Acute Care|post-acute care
5170325|NCT02927171|Older Adults|older adults
5170326|NCT02927171|Physical Function|physical function
5170327|NCT02927171|Rehabilitation|rehabilitation
5170328|NCT02927132|Drinking, Alcohol|drinking, alcohol
5170329|NCT02927119|thyroglobulin|thyroglobulin
5170330|NCT02927119|iodine|iodine
5170331|NCT02927119|pregnancy|pregnancy
5170332|NCT02927106|leukemia|leukemia
5170333|NCT02927106|myeloid|myeloid
5170334|NCT02927106|genomics|genomics
5170335|NCT02927080|FSHD|fshd
5170336|NCT02927041|hemodynamic transesophageal echocardiography|hemodynamic transesophageal echocardiography
5170337|NCT02927028|energy availability|energy availability
5170338|NCT02927028|walnuts|walnuts
5170339|NCT02926989|Isotonic|isotonic
5170340|NCT02926989|Hypotonic|hypotonic
5170341|NCT02926989|Intravenous fluids|intravenous fluids
5170342|NCT02926976|Schizophrenia|schizophrenia
5170343|NCT02926963|Chronic Granulomatous Disease, Nox2, p22phox, iPS cells|chronic granulomatous disease, nox2, p22phox, ips cells
5170344|NCT02926911|Ductal Carcinoma|ductal carcinoma
5170345|NCT02926898|seizure|seizure
5170346|NCT02926898|tonic clonic|tonic clonic
5170347|NCT02926898|epilepsy|epilepsy
5170348|NCT02926898|myoclonic|myoclonic
5170349|NCT02926898|encephalopathy|encephalopathy
5170350|NCT02926885|liver|liver
5170351|NCT02926885|laparoscopy|laparoscopy
5170352|NCT02926885|Bariatric Surgery|bariatric surgery
5170353|NCT02926885|Esophagogastric Junction|esophagogastric junction
5170354|NCT02926885|obesity|obesity
5170355|NCT02926872|Screening|screening
5170356|NCT02926872|Hepatic Injury|hepatic injury
5170357|NCT02926872|Pediatric Patients|pediatric patients
5170358|NCT02926846|Peritoneal dialysis|peritoneal dialysis
5170359|NCT02926846|Lavage|lavage
5170360|NCT02926820|Huntington disease|huntington disease
5170361|NCT02926820|cognitive rehabilitation|cognitive rehabilitation
5170362|NCT02926820|cognitive dysfunction|cognitive dysfunction
5170363|NCT02926807|Atopic Dermatitis|atopic dermatitis
5170364|NCT02926807|Vascular Inflammation|vascular inflammation
5170365|NCT02926807|Coronary Atherosclerosis|coronary atherosclerosis
5170366|NCT02926807|Ascending aorta|ascending aorta
5170367|NCT02926807|Pet scan|pet scan
5170368|NCT02926768|Cancer|cancer
5170369|NCT02926768|Non Small Cell Lung Cancer|non small cell lung cancer
5170370|NCT02926768|EGFR sensitivity mutation|egfr sensitivity mutation
5170371|NCT02926768|T790M|t790m
5170372|NCT02926768|NSCLC|nsclc
5170373|NCT02926768|epidermal growth factor receptor|epidermal growth factor receptor
5170374|NCT02926768|EGFR|egfr
5170375|NCT02926768|EGFR inhibitor|egfr inhibitor
5170376|NCT02926755|Intra Venous Ultrasound (IVUS)|intra venous ultrasound (ivus)
5170377|NCT02926755|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5170378|NCT02926755|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
5170379|NCT02926755|Acute Myocardial Infarction|acute myocardial infarction
5170380|NCT02926755|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5170381|NCT02926755|Angiography|angiography
5170382|NCT02926742|Thrombolysis|thrombolysis
5170383|NCT02926742|Ultrasound Thrombolysis|ultrasound thrombolysis
5170384|NCT02926742|Pulmonary Embolism|pulmonary embolism
5170385|NCT02926742|Saddle PE|saddle pe
5170386|NCT02926742|Submassive PE|submassive pe
5170387|NCT02926742|Massive PE|massive pe
5170388|NCT02926742|Bilateral PE|bilateral pe
5170389|NCT02926729|Breast Cancer|breast cancer
5170390|NCT02926716|Stomach neoplasm|stomach neoplasm
5170391|NCT02926716|Endoscopy|endoscopy
5170392|NCT02926716|Narrow band imaging|narrow band imaging
5170393|NCT02926703|seizure|seizure
5170394|NCT02926703|lactate|lactate
5170395|NCT02926703|creatine kinase|creatine kinase
5170396|NCT02926677|PTSD|ptsd
5170397|NCT02926677|Child Trauma|child trauma
5170398|NCT02926677|Cue-Centered Treatment|cue-centered treatment
5170399|NCT02926677|Trauma-Focused Cognitive-Behavioral Therapy|trauma-focused cognitive-behavioral therapy
5170400|NCT02926677|fNIRs|fnirs
5170402|NCT02926677|TF-CBT|tf-cbt
5170403|NCT02926677|Posttraumatic stress|posttraumatic stress
5170404|NCT02926677|NIRX|nirx
5170405|NCT02926625|Unspecific fever|unspecific fever
5170406|NCT02926625|Ethiopia|ethiopia
5170407|NCT02926625|iCCM|iccm
5170408|NCT02926625|CHW|chw
5170409|NCT02926625|HEW|hew
5170410|NCT02926599|High Fidelity Simulation|high fidelity simulation
5170411|NCT02926586|RUNX1-RUNX1T1|runx1-runx1t1
5170412|NCT02926586|CBFβ-MYH11|cbfβ-myh11
5170413|NCT02926586|fludarabine|fludarabine
5170414|NCT02926586|cytarabine|cytarabine
5170415|NCT02926573|oral cavity|oral cavity
5170416|NCT02926573|oropharynx|oropharynx
5170417|NCT02926573|hypopharynx and larynx|hypopharynx and larynx
5170418|NCT02926560|Chronic inflammatory rheumatism|chronic inflammatory rheumatism
5170419|NCT02926547|proteomics|proteomics
5170420|NCT02926534|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5170421|NCT02926534|smoking|smoking
5170422|NCT02926534|prevalence|prevalence
5170423|NCT02926534|cross-sectional study|cross-sectional study
5170424|NCT02926534|Kazakhstan|kazakhstan
5170425|NCT02926521|nerve block catheter|nerve block catheter
5170426|NCT02926521|catheter fixation|catheter fixation
5170427|NCT02926521|catheter dressing|catheter dressing
5170428|NCT02926508|Reading|reading
5170429|NCT02926508|Learning|learning
5170430|NCT02926508|Cognition|cognition
5170431|NCT02926482|Evidence-based practice implementation|evidence-based practice implementation
5170432|NCT02926482|Buprenorphine|buprenorphine
5170433|NCT02926482|Addiction treatment|addiction treatment
5170434|NCT02926482|Extended-release naltrexone|extended-release naltrexone
5170435|NCT02926482|Addiction|addiction
5170436|NCT02926469|Virtual Reality|virtual reality
5170437|NCT02926469|Analgesia|analgesia
5170438|NCT02926469|Immersive Virtual Reality|immersive virtual reality
5170439|NCT02926469|VR|vr
5170440|NCT02926469|Labor|labor
5170441|NCT02926469|Pain|pain
5170442|NCT02926443|Shoulder|shoulder
5170443|NCT02926443|Motor control|motor control
5170444|NCT02926443|Usual physiotherapy care|usual physiotherapy care
5170445|NCT02926443|Supervised exercise program|supervised exercise program
5170446|NCT02926404|Sagittal alignment|sagittal alignment
5170447|NCT02926404|Surgical planning|surgical planning
5170448|NCT02926404|Patient-specific|patient-specific
5170449|NCT02926404|Adult Spinal Deformity|adult spinal deformity
5170450|NCT02926352|LLLT|lllt
5170451|NCT02926352|LLLS|llls
5170452|NCT02926352|Low-Level Laser Stimulation|low-level laser stimulation
5170453|NCT02926352|Low-Level Laser Therapy|low-level laser therapy
5170454|NCT02926352|Low-Level Light Therapy|low-level light therapy
5673524|NCT00607945|insulin sensitivity|insulin sensitivity
5170463|NCT02926352|Fear of public speaking|fear of public speaking
5170464|NCT02926352|Anxiety sensitivity|anxiety sensitivity
5170465|NCT02926352|Cytochrome oxidase|cytochrome oxidase
5170466|NCT02926352|Memory consolidation|memory consolidation
5170467|NCT02926352|Cognitive enhancer|cognitive enhancer
5170468|NCT02926326|Healthy Male volunteers|healthy male volunteers
5170470|NCT02926313|Specialized seating|specialized seating
5170471|NCT02926313|Pressure ulcers|pressure ulcers
5170472|NCT02926300|crohn's disease|crohn's disease
5170473|NCT02926300|stem cell therapy|stem cell therapy
5170474|NCT02926300|inflammatory bowel disease|inflammatory bowel disease
5170475|NCT02926300|hUCB-MSC|hucb-msc
5170476|NCT02926300|UCB-MSC|ucb-msc
5170477|NCT02926300|Umbilical cord Blood|umbilical cord blood
5170478|NCT02926300|Rheumatoid Arthritis|rheumatoid arthritis
5170479|NCT02926300|RA|ra
5170480|NCT02926300|Stem cell|stem cell
5170481|NCT02926300|Cell therapy|cell therapy
5170482|NCT02926300|Furestem|furestem
5170483|NCT02926300|Mesenchymal stem cell|mesenchymal stem cell
5170484|NCT02926300|MSC|msc
5170485|NCT02926287|prolapse surgery|prolapse surgery
5170486|NCT02926287|ambulatory surgery|ambulatory surgery
5170487|NCT02926274|whole blood|whole blood
5170488|NCT02926274|trauma|trauma
5170489|NCT02926274|transfusion|transfusion
5170490|NCT02926274|coagulopathy|coagulopathy
5170491|NCT02926248|Arthrofibrosis|arthrofibrosis
5170492|NCT02926235|Total Knee Arthroplasty|total knee arthroplasty
5170493|NCT02926209|colonoscopy|colonoscopy
5170494|NCT02926209|adenoma|adenoma
5170496|NCT02926209|crc screening|crc screening
5170497|NCT02926196|ER-Negative|er-negative
5170498|NCT02926196|PR-Negative|pr-negative
5170499|NCT02926196|HER2-Negative|her2-negative
5170500|NCT02926144|Intratracheal intubation|intratracheal intubation
5170501|NCT02926144|videolaryngoscope|videolaryngoscope
5170503|NCT02926131|stick test|stick test
5170504|NCT02926118|Glucose|glucose
5170505|NCT02926118|Continuous glucose monitor|continuous glucose monitor
5170506|NCT02926118|Glycemic load|glycemic load
5170507|NCT02926118|Dietary intervention|dietary intervention
5170508|NCT02926066|Aromatic L-amino acid decarboxylase (AADC)|aromatic l-amino acid decarboxylase (aadc)
5170509|NCT02926014|Dysphagia|dysphagia
5170510|NCT02926014|Lingual Tonsil Hypertrophy|lingual tonsil hypertrophy
5170511|NCT02926014|Lingual Tonsil Enlargement|lingual tonsil enlargement
5170512|NCT02926001|Taxes|taxes
5170513|NCT02926001|Beverages/economics|beverages/economics
5170514|NCT02926001|Carbonated Beverages/economics|carbonated beverages/economics
5170515|NCT02926001|Diet, Food and Nutrition/economics|diet, food and nutrition/economics
5170516|NCT02926001|Economics|economics
5170517|NCT02926001|Energy Intake|energy intake
5170518|NCT02926001|Risk Factors|risk factors
5170519|NCT02925988|Critically ill|critically ill
5170520|NCT02925988|High risk neonates|high risk neonates
5170525|NCT02925936|Radiography|radiography
5170527|NCT02925936|Diagnostic imaging|diagnostic imaging
5170533|NCT02925858|Ketamine|ketamine
5170534|NCT02925858|Cardiac surgery|cardiac surgery
5170535|NCT02925858|Pain|pain
5170536|NCT02925832|Deep topical fornix nerve block Anesthesia|deep topical fornix nerve block anesthesia
5170537|NCT02925832|Ropivacaine|ropivacaine
5170538|NCT02925832|Bupivacaine|bupivacaine
5170539|NCT02925832|Anaesthesia|anaesthesia
5170540|NCT02925832|Eye surgery blocks|eye surgery blocks
5170541|NCT02925832|Phacoemulsification|phacoemulsification
5170542|NCT02925819|Mitral regurgitation|mitral regurgitation
5170543|NCT02925819|Mitral stenosis|mitral stenosis
5170544|NCT02925819|Mitral valve repair deterioration|mitral valve repair deterioration
5170545|NCT02925819|Bioprosthesis degeneration|bioprosthesis degeneration
5170546|NCT02925780|Enamel defects|enamel defects
5170547|NCT02925780|Fluorosis|fluorosis
5170548|NCT02925780|Icon|icon
5170549|NCT02925780|Resin infiltration|resin infiltration
5170550|NCT02925741|bed linens|bed linens
5170551|NCT02925728|Finger-Food|finger-food
5170552|NCT02925702|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5170553|NCT02925702|Radium-223|radium-223
5170562|NCT02925624|pulmonary vein isolation|pulmonary vein isolation
5170563|NCT02925624|implantable loop recorder|implantable loop recorder
5170564|NCT02925611|Postoperative delirium|postoperative delirium
5170565|NCT02925611|spine surgery|spine surgery
5170566|NCT02925611|isoflurane|isoflurane
5170567|NCT02925611|desflurane|desflurane
5170568|NCT02925598|Laringeal masks|laringeal masks
5170569|NCT02925598|Cholecystectomy, Laparascopic|cholecystectomy, laparascopic
5170570|NCT02925598|Intubation, intratracheal|intubation, intratracheal
5170571|NCT02925572|pediatric obesity|pediatric obesity
5170572|NCT02925572|eccentric exercise|eccentric exercise
5170573|NCT02925572|body composition|body composition
5170574|NCT02925572|training program|training program
5170575|NCT02925559|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5170576|NCT02925559|Glycemic Variability|glycemic variability
5170577|NCT02925559|Dapagliflozin|dapagliflozin
5170578|NCT02925559|Gliclazide MR|gliclazide mr
5170579|NCT02925559|Continuous Glucose Monitoring|continuous glucose monitoring
5170580|NCT02925559|Mean Amplitude of Glycemic Excursions|mean amplitude of glycemic excursions
5170582|NCT02925546|Healthy|healthy
5170583|NCT02925546|Pharmacokinetics|pharmacokinetics
5170584|NCT02925546|Phase I|phase i
5170585|NCT02925546|GSK2798745|gsk2798745
5170586|NCT02925546|Tablet|tablet
5170587|NCT02925533|Bladder Cancer|bladder cancer
5170588|NCT02925533|Urothelial Cancer|urothelial cancer
5170589|NCT02925520|Cholestasis|cholestasis
5170590|NCT02925494|Uterine Fibroids|uterine fibroids
5170591|NCT02925494|Elagolix|elagolix
5170592|NCT02925494|Heavy Menstrual Bleeding|heavy menstrual bleeding
5170593|NCT02925494|Elagolix Sodium|elagolix sodium
5170594|NCT02925494|Elagolix plus Norethindrone Acetate|elagolix plus norethindrone acetate
5170595|NCT02925481|Yoga|yoga
5170596|NCT02925481|PTSD|ptsd
5170597|NCT02925481|mental health|mental health
5170598|NCT02925481|stillbirth|stillbirth
5170599|NCT02925468|orthodontics|orthodontics
5170600|NCT02925455|Hemiplegia|hemiplegia
5170601|NCT02925455|Functional Electrical Stimulation|functional electrical stimulation
5170602|NCT02925455|Video Games|video games
5170603|NCT02925455|Occupational Therapy|occupational therapy
5170604|NCT02925442|Unilateral Knee Arthroplasty|unilateral knee arthroplasty
5170605|NCT02925442|Radiofrequency Ablation|radiofrequency ablation
5170606|NCT02925442|Genicular|genicular
5170607|NCT02925442|RFA|rfa
5170608|NCT02925442|C-RFA|c-rfa
5170609|NCT02925442|t-RFA|t-rfa
5170610|NCT02925442|total knee replacement|total knee replacement
5170611|NCT02925364|magnetic resonance imaging|magnetic resonance imaging
5170612|NCT02925364|central pain processing|central pain processing
5170613|NCT02925364|anatomical MRI|anatomical mri
5170614|NCT02925364|fMRI|fmri
5170615|NCT02925325|Major depressive disorder|major depressive disorder
5170616|NCT02925325|Music therapy|music therapy
5170617|NCT02925325|Residual symptoms|residual symptoms
5170618|NCT02925286|gambling prevention|gambling prevention
5170619|NCT02925286|workplace policy|workplace policy
5170620|NCT02925273|dementia|dementia
5170628|NCT02925221|Kidney Disease|kidney disease
5170629|NCT02925221|ADPKD-Related Outcome|adpkd-related outcome
5170630|NCT02925221|Quality of Life|quality of life
5170631|NCT02925195|Vitamin D|vitamin d
5170632|NCT02925195|cardiovascular disease|cardiovascular disease
5170634|NCT02925195|genetics|genetics
5170635|NCT02925195|pharmacogenetics|pharmacogenetics
5170636|NCT02925195|blood pressure|blood pressure
5170637|NCT02925195|biomarkers|biomarkers
5170638|NCT02925169|Subglottis, cricoid, airway shape, CT imaging|subglottis, cricoid, airway shape, ct imaging
5170639|NCT02925156|Activity Energy Expenditure|activity energy expenditure
5170640|NCT02925156|Doubly Labeled Water|doubly labeled water
5170641|NCT02925156|Physical Activity|physical activity
5170642|NCT02925156|Obesity|obesity
5170643|NCT02925156|Diabetes|diabetes
5170644|NCT02925156|Cardiovascular Disease|cardiovascular disease
5043868|NCT03725163|ACT|act
5170645|NCT02925156|Adiponectin|adiponectin
5170646|NCT02925156|Leptin|leptin
5170647|NCT02925156|Ghrelin|ghrelin
5170648|NCT02925143|Residual nerve blockade|residual nerve blockade
5170649|NCT02925143|Neuromuscular monitoring|neuromuscular monitoring
5170650|NCT02925143|Residual curarization|residual curarization
5170651|NCT02925143|Neuromuscular blocking agents|neuromuscular blocking agents
5170662|NCT02925039|Rehabilitation|rehabilitation
5170663|NCT02925039|Geriatric|geriatric
5170664|NCT02925013|Omega 3|omega 3
5170665|NCT02925013|Lipids|lipids
5170666|NCT02925013|Pregnancy|pregnancy
5170667|NCT02925000|Advanced Malignancy|advanced malignancy
5170668|NCT02925000|lymphoma|lymphoma
5170669|NCT02925000|TLC178|tlc178
5170670|NCT02924948|Endoscopic ultrasonography|endoscopic ultrasonography
5170671|NCT02924922|renal cell carcinoma|renal cell carcinoma
5170672|NCT02924922|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
5170673|NCT02924922|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
5170674|NCT02924922|nephron sparing surgery|nephron sparing surgery
5170675|NCT02924922|warm ischemia time|warm ischemia time
5170676|NCT02924922|renal function loss|renal function loss
5170677|NCT02924870|health education|health education
5170678|NCT02924792|Intraosseous access|intraosseous access
5170679|NCT02924740|stress urinary incontinence|stress urinary incontinence
5170680|NCT02924740|quality of life|quality of life
5170681|NCT02924740|pelvic floor muscle training|pelvic floor muscle training
5170682|NCT02924740|pelvic floor muscle exercises|pelvic floor muscle exercises
5170683|NCT02924740|vaginal tampon training|vaginal tampon training
5170684|NCT02924727|Spontaneous AMI|spontaneous ami
5170685|NCT02924727|HF hospitalization|hf hospitalization
5170686|NCT02924727|outpatient HF|outpatient hf
5170687|NCT02924727|LV systolic dysfunction|lv systolic dysfunction
5170688|NCT02924727|pulmonary congestion|pulmonary congestion
5170689|NCT02924727|STEMI|stemi
5170690|NCT02924727|NSTEMI|nstemi
5170691|NCT02924727|randomized clinical trial|randomized clinical trial
5170692|NCT02924727|LCZ696|lcz696
5170693|NCT02924727|ramipril|ramipril
5170694|NCT02924714|GIST|gist
5170695|NCT02924701|prognosis|prognosis
5170704|NCT02924675|neuropathic pain, ent cancer, pregabalin|neuropathic pain, ent cancer, pregabalin
5170705|NCT02924649|Brain injury|brain injury
5170706|NCT02924649|Early mobilisation|early mobilisation
5170707|NCT02924649|Consciousness|consciousness
5170708|NCT02924649|Cerebral blood flow|cerebral blood flow
5170709|NCT02924649|Blood pressure|blood pressure
5170710|NCT02924636|C-section|c-section
5170711|NCT02924636|Instrumental delivery|instrumental delivery
5170712|NCT02924636|Pregnancy complications|pregnancy complications
5170714|NCT02924636|Neonatal complications|neonatal complications
5170715|NCT02924584|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence|hormonal receptor positive, human epidermal growth factor receptor 2 negative, breast cancer, aromatse inhibitor, overall survival, prevalence
5170716|NCT02924558|Egg|egg
5170717|NCT02924558|Protein|protein
5170718|NCT02924558|Unsaturated fatty acids|unsaturated fatty acids
5170719|NCT02924558|Triglycerides|triglycerides
5170720|NCT02924558|Insulin sensitivity|insulin sensitivity
5170721|NCT02924558|Lipid triad|lipid triad
5170722|NCT02924506|cervical arthroplasty|cervical arthroplasty
5170723|NCT02924493|Endometriosis|endometriosis
5170724|NCT02924493|IBS|ibs
5170725|NCT02924493|Irritable bowel syndrome|irritable bowel syndrome
5170726|NCT02924493|low FODMAP diet|low fodmap diet
5170727|NCT02924493|FODMAPs|fodmaps
5170728|NCT02924493|visceral syndrome|visceral syndrome
5170729|NCT02924493|fermentable carbohydrates|fermentable carbohydrates
5170730|NCT02924493|visceral hypersensitivity|visceral hypersensitivity
5170731|NCT02924493|cross organ effect|cross organ effect
5170732|NCT02924480|invasive bladder cancer|invasive bladder cancer
5170733|NCT02924480|cystectomy|cystectomy
5170734|NCT02924480|high grade bladder cancer|high grade bladder cancer
5170735|NCT02924467|reminder systems|reminder systems
5170736|NCT02924467|Influenza vaccines|influenza vaccines
5170737|NCT02924454|metoprolol|metoprolol
5170738|NCT02924454|lipid emulsion|lipid emulsion
5170739|NCT02924454|pharmacodynamics|pharmacodynamics
5170740|NCT02924454|pharmacokinetics|pharmacokinetics
5170741|NCT02924441|Mammogram|mammogram
5170742|NCT02924441|Pain Management|pain management
5170743|NCT02924441|Lidocaine|lidocaine
5170744|NCT02924428|Acne|acne
5170746|NCT02924402|B-cell Prolymphocytic Leukemia|b-cell prolymphocytic leukemia
5778935|NCT00202397|riluzole|riluzole
5170747|NCT02924402|Transformed Lymphoma|transformed lymphoma
5170748|NCT02924402|Burkitt's Lymphoma|burkitt's lymphoma
5170749|NCT02924402|Mantle Cell Lymphoma|mantle cell lymphoma
5170750|NCT02924402|Hairy Cell Leukemia|hairy cell leukemia
5170751|NCT02924402|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
5170752|NCT02924402|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5170753|NCT02924402|Variant Hairy Cell Leukemia|variant hairy cell leukemia
5170754|NCT02924402|Splenic B-cell Lymphoma/Leukemia|splenic b-cell lymphoma/leukemia
5170755|NCT02924402|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5962164|NCT04282564|transfer of knowledge|transfer of knowledge
5170756|NCT02924402|Extranodal Marginal Zone Lymphoma (MALT)|extranodal marginal zone lymphoma (malt)
5170757|NCT02924402|MALT Lymphoma|malt lymphoma
5170758|NCT02924402|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
5170759|NCT02924402|Follicular Lymphoma|follicular lymphoma
5170760|NCT02924402|In Situ Follicular Neoplasia|in situ follicular neoplasia
5170761|NCT02924402|Duodenal-type Follicular Lymphoma|duodenal-type follicular lymphoma
5170762|NCT02924402|Large B-cell Lymphoma with IRF4 rearrangement|large b-cell lymphoma with irf4 rearrangement
5170763|NCT02924402|Primary Cutaneous Follicle Center Lymphoma|primary cutaneous follicle center lymphoma
5170764|NCT02924402|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5170765|NCT02924402|DLBCL|dlbcl
5170766|NCT02924402|T-cell/Histiocyte-Rich Large B-cell Lymphoma|t-cell/histiocyte-rich large b-cell lymphoma
5170767|NCT02924402|Primary Cutaneous DLBCL, leg type|primary cutaneous dlbcl, leg type
5170768|NCT02924402|EBV-positive DLBCL, NOS|ebv-positive dlbcl, nos
5170769|NCT02924402|EBV-positive Mucocutaneous Ulcer|ebv-positive mucocutaneous ulcer
5170770|NCT02924402|DLBCL Associated with Chronic Inflammation|dlbcl associated with chronic inflammation
5170771|NCT02924402|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
5170772|NCT02924402|Primary Mediastinal (Thymic) Large B-cell Lymphoma|primary mediastinal (thymic) large b-cell lymphoma
5170773|NCT02924402|Intravascular Large B-cell Lymphoma|intravascular large b-cell lymphoma
5170774|NCT02924402|ALK+ Large B-cell Lymphoma|alk+ large b-cell lymphoma
5170775|NCT02924402|Plasmablastic Lymphoma|plasmablastic lymphoma
5170776|NCT02924402|Primary Effusion Lymphoma|primary effusion lymphoma
5170777|NCT02924402|HHV8+ DLBCL|hhv8+ dlbcl
5170778|NCT02924402|Burkitt-like Lymphoma with 11q Aberration|burkitt-like lymphoma with 11q aberration
5170779|NCT02924402|High-grade B-cell Lymphoma|high-grade b-cell lymphoma
5170780|NCT02924402|B-cell Lymphoma, unclassifiable|b-cell lymphoma, unclassifiable
5170781|NCT02924402|Post-transplant Lymphoproliferative Disorder|post-transplant lymphoproliferative disorder
5170782|NCT02924402|PTLD|ptld
5170783|NCT02924402|CLL|cll
5170784|NCT02924402|SLL|sll
5170785|NCT02924402|High-grade Lymphoma|high-grade lymphoma
5170786|NCT02924402|Richter's Transformation|richter's transformation
5170787|NCT02924376|Cholangiocarcinoma|cholangiocarcinoma
5170788|NCT02924376|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
5170789|NCT02924376|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5170790|NCT02924376|FGF/FGFR alterations|fgf/fgfr alterations
5170791|NCT02924363|Cardiac Magnetic Resonance|cardiac magnetic resonance
5170792|NCT02924363|Mitra Clip|mitra clip
5170793|NCT02924363|Mitral Valve|mitral valve
5170794|NCT02924337|QT/QTC interval|qt/qtc interval
5170795|NCT02924337|Hypoglycemic Agents|hypoglycemic agents
5170796|NCT02924337|Imeglimin|imeglimin
5170797|NCT02924337|Healthy Volunteers|healthy volunteers
5170798|NCT02924324|local Injection|local injection
5170799|NCT02924324|pain Medication|pain medication
5170800|NCT02924324|propofol|propofol
5170801|NCT02924324|ropivacaine|ropivacaine
5170803|NCT02924311|Diabetic Macular Edema|diabetic macular edema
5170804|NCT02924272|Drug Therapy|drug therapy
5170805|NCT02924259|muscle soreness|muscle soreness
5170806|NCT02924259|pain|pain
5170807|NCT02924259|myofascial release|myofascial release
5170808|NCT02924246|immunity|immunity
5170809|NCT02924246|vaccination|vaccination
5170810|NCT02924246|milk|milk
5170811|NCT02924233|Squamous|squamous
5170812|NCT02924233|Non-Small Cell Lung Cancer|non-small cell lung cancer
5170813|NCT02924233|NSCLC|nsclc
5170814|NCT02924207|diabetes mellitus|diabetes mellitus
5170815|NCT02924181|pulmonary vein isolation|pulmonary vein isolation
5170816|NCT02924181|contact force sensing catheter|contact force sensing catheter
5170817|NCT02924142|Kennedy classification for edentulous ridge|kennedy classification for edentulous ridge
5170818|NCT02924129|Chronic Pain|chronic pain
5170819|NCT02924129|Back Pain|back pain
5170820|NCT02924129|Leg Pain|leg pain
5170821|NCT02924129|Pain|pain
5170822|NCT02924129|Neurologic Manifestations|neurologic manifestations
5170823|NCT02924129|Nervous System Diseases|nervous system diseases
5170824|NCT02924129|Signs and Symptoms|signs and symptoms
5170825|NCT02924129|SCS|scs
5170826|NCT02924129|Closed Loop|closed loop
5170827|NCT02924116|insomnia|insomnia
5170828|NCT02924116|sleep|sleep
5170829|NCT02924116|Bioboosti|bioboosti
5170831|NCT02924116|device|device
5170832|NCT02924103|acute rhinosinusitis|acute rhinosinusitis
5170833|NCT02924103|staphylococcus aureus|staphylococcus aureus
5170834|NCT02924103|nasal vestibule|nasal vestibule
5170835|NCT02924103|contamination|contamination
5170840|NCT02924090|Electroconvulsive therapy|electroconvulsive therapy
5170841|NCT02924090|Depression|depression
5170842|NCT02924090|Anesthesia|anesthesia
5170843|NCT02924090|Nervous System Diseases|nervous system diseases
5170844|NCT02924090|Mental Disorders|mental disorders
5170845|NCT02924090|Electroencephalography|electroencephalography
5170846|NCT02924090|Cerebral Metabolism|cerebral metabolism
5170847|NCT02924038|low-grade glioma|low-grade glioma
5170848|NCT02924038|glioma|glioma
5170849|NCT02924038|immunotherapy|immunotherapy
5170850|NCT02924038|vaccine|vaccine
5170851|NCT02924038|WHO grade II|who grade ii
5170852|NCT02924012|post exercise hypotension|post exercise hypotension
5170853|NCT02924012|exercise|exercise
5170854|NCT02924012|video games|video games
5170855|NCT02923999|HIV|hiv
5170856|NCT02923999|MAB|mab
5170857|NCT02923999|PLANT|plant
5170858|NCT02923986|Liposomal Grb-2 treatment of Ph+ CML|liposomal grb-2 treatment of ph+ cml
5170859|NCT02923986|Liposomal Grb-2 with Das for Ph+ CML|liposomal grb-2 with das for ph+ cml
5170860|NCT02923986|Liposomal Grb-2 treatment of Ph+ AML|liposomal grb-2 treatment of ph+ aml
5170861|NCT02923986|Liposomal Grb-2 with Das for Ph+ AML|liposomal grb-2 with das for ph+ aml
5170862|NCT02923986|Liposomal Grb-2 treatment of Ph+ MDS|liposomal grb-2 treatment of ph+ mds
5170863|NCT02923986|Liposomal Grb-2 with Das for Ph+ MDS|liposomal grb-2 with das for ph+ mds
5170864|NCT02923947|Pharmacokinetics,|pharmacokinetics,
5170865|NCT02923947|Renal impairment,|renal impairment,
5170866|NCT02923947|Safety assessments,|safety assessments,
5170867|NCT02923947|Solid tumours,|solid tumours,
5170868|NCT02923947|EGFRm+|egfrm+
5170869|NCT02923947|EGFRm+/T790M+ inhibitor|egfrm+/t790m+ inhibitor
5170870|NCT02923908|Palatability|palatability
5170871|NCT02923908|Pediatrics|pediatrics
5170872|NCT02923908|Facial Recognition|facial recognition
5170873|NCT02923908|Taste|taste
5170874|NCT02923908|Facial Expressions|facial expressions
5170875|NCT02923882|Low-birth-weight|low-birth-weight
5170876|NCT02923882|Model kitchen|model kitchen
5170877|NCT02923882|Improved cookstove|improved cookstove
5170878|NCT02923869|Levobupivacaine|levobupivacaine
5170879|NCT02923869|Bupivacaine|bupivacaine
5170880|NCT02923869|Nerve Block|nerve block
5170881|NCT02923869|Cleft Palate|cleft palate
5170882|NCT02923856|Helicobacter pylori|helicobacter pylori
5170883|NCT02923856|Antibiotic resistance|antibiotic resistance
5170884|NCT02923856|Sequencing|sequencing
5170885|NCT02923843|frailty|frailty
5170886|NCT02923843|comprehensive geriatric assessment|comprehensive geriatric assessment
5170887|NCT02923817|spinal cord injury|spinal cord injury
5170888|NCT02923817|autologous transplants|autologous transplants
5170889|NCT02923817|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
5170890|NCT02923804|steatosis|steatosis
5170891|NCT02923804|NAFL|nafl
5170892|NCT02923804|NAFLD|nafld
5170893|NCT02923804|Polyunsaturated fatty acids|polyunsaturated fatty acids
5170894|NCT02923804|omega-3|omega-3
5170895|NCT02923804|EPA|epa
5170896|NCT02923804|DHA|dha
5170897|NCT02923804|fish oil|fish oil
5170901|NCT02923700|platelet rich plasma|platelet rich plasma
5170902|NCT02923700|intra-articular injection|intra-articular injection
5170903|NCT02923700|leukocytes|leukocytes
5170904|NCT02923687|Ketorolac|ketorolac
5170905|NCT02923687|Root canal treatment|root canal treatment
5170906|NCT02923687|Pain|pain
5166037|NCT02954653|AML|aml
5170908|NCT02923661|single implant|single implant
5170909|NCT02923635|Oncoplastic breast surgery|oncoplastic breast surgery
5170910|NCT02923635|Standard Wide Local Excision|standard wide local excision
5170911|NCT02923596|Keloid|keloid
5170912|NCT02923570|proton-beam radiation therapy (PBRT)|proton-beam radiation therapy (pbrt)
5171507|NCT02920476|lung|lung
5170913|NCT02923570|intensity-modulated radiation therapy (IMRT)|intensity-modulated radiation therapy (imrt)
5170914|NCT02923570|16-1416|16-1416
5170915|NCT02923544|Uterine Manipulator|uterine manipulator
5170916|NCT02923544|Yukio's Uterine Manipulating Instrument (YUMI)|yukio's uterine manipulating instrument (yumi)
5170917|NCT02923544|16-1397|16-1397
5170918|NCT02923518|Heart Screening|heart screening
5170919|NCT02923518|Master Athletes|master athletes
5170920|NCT02923518|Cardiovascular Disease|cardiovascular disease
5170921|NCT02923479|Rehabilitation|rehabilitation
5170922|NCT02923479|Robotics|robotics
5170923|NCT02923466|refractory solid tumor|refractory solid tumor
5170924|NCT02923427|laryngeal mask Supreme|laryngeal mask supreme
5170925|NCT02923427|i-gel|i-gel
5170926|NCT02923427|laparoscopic gynecological surgery|laparoscopic gynecological surgery
5170927|NCT02923414|Cardioversion|cardioversion
5170928|NCT02923401|Exercise|exercise
5170929|NCT02923401|Biomarkers|biomarkers
5170930|NCT02923401|Breast cancer high risk|breast cancer high risk
5170931|NCT02923401|Treadmill|treadmill
5170938|NCT02923362|GERD|gerd
5170939|NCT02923362|Reflux|reflux
5170940|NCT02923362|Acid Reflux|acid reflux
5170941|NCT02923362|Heartburn|heartburn
5170942|NCT02923362|Regurgitation|regurgitation
5170943|NCT02923362|Laryngopharyngeal Reflux|laryngopharyngeal reflux
5170944|NCT02923362|Hiatal Hernia|hiatal hernia
5170946|NCT02923362|LINX|linx
5170947|NCT02923362|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
5170948|NCT02923362|Antireflux Surgery|antireflux surgery
5170949|NCT02923362|Nissen|nissen
5170950|NCT02923349|Solid tumor|solid tumor
5170951|NCT02923349|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
5170952|NCT02923349|ovarian cancer|ovarian cancer
5170953|NCT02923349|renal cell carcinoma|renal cell carcinoma
5170954|NCT02923349|melanoma|melanoma
5170955|NCT02923349|non-small cell lung cancer|non-small cell lung cancer
5170956|NCT02923349|OX40|ox40
5170957|NCT02923349|immunoglobulin G monoclonal antibody|immunoglobulin g monoclonal antibody
5170958|NCT02923336|liver cirrhosis|liver cirrhosis
5044229|NCT03722849|ATP|atp
5170959|NCT02923336|variceal bleeding|variceal bleeding
5170960|NCT02923336|non selective beta blockers|non selective beta blockers
5170961|NCT02923323|Neurocognitive Function|neurocognitive function
5170962|NCT02923323|MRI|mri
5170963|NCT02923323|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
5170964|NCT02923323|Sleep|sleep
5170965|NCT02923297|parkinson|parkinson
5170966|NCT02923297|alpha-synuclein|alpha-synuclein
5170967|NCT02923297|GALIG|galig
5170968|NCT02923297|quantitative PCR (polymerase chain reaction)|quantitative pcr (polymerase chain reaction)
5170969|NCT02923271|Driving|driving
5170970|NCT02923271|Teens|teens
5170971|NCT02923271|Texting|texting
5170972|NCT02923271|Cellphone|cellphone
5170973|NCT02923271|DriveID|driveid
5170974|NCT02923271|Motor vehicle accident|motor vehicle accident
5170975|NCT02923258|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5170976|NCT02923258|concurrent chemotherapy|concurrent chemotherapy
5170977|NCT02923258|High-Risk|high-risk
5170978|NCT02923232|Contact lens; Accommodation; Visual performance|contact lens; accommodation; visual performance
5170979|NCT02923219|Facial Rejuvenation|facial rejuvenation
5170980|NCT02923219|Adipose-Derived Stem Cells|adipose-derived stem cells
5170981|NCT02923206|apheresis|apheresis
5170982|NCT02923206|pregnancy|pregnancy
5170983|NCT02923206|pre-eclampsia|pre-eclampsia
5170984|NCT02923206|PE|pe
5170985|NCT02923206|sFlt-1|sflt-1
5170986|NCT02923206|Pre-term|pre-term
5170987|NCT02923167|CP|cp
5170988|NCT02923167|Cerebral Palsy|cerebral palsy
5170989|NCT02923167|Robotic|robotic
5170990|NCT02923167|Hand|hand
5170991|NCT02923167|Rehabilitation|rehabilitation
5170992|NCT02923154|NASH|nash
5170993|NCT02923141|substance use|substance use
5170994|NCT02923141|trauma|trauma
5170995|NCT02923141|HIV|hiv
5170996|NCT02923141|viral load|viral load
5170997|NCT02923141|women|women
5170998|NCT02923115|Venous thromboembolism|venous thromboembolism
5170999|NCT02923115|VTE|vte
5171000|NCT02923115|Pulmonary embolism|pulmonary embolism
5171001|NCT02923115|PE|pe
5171002|NCT02923115|Acute Submassive Pulmonary Embolism|acute submassive pulmonary embolism
5171003|NCT02923102|Recovery|recovery
5171004|NCT02923102|Muscle soreness|muscle soreness
5171005|NCT02923102|Lemon Verbena|lemon verbena
5171006|NCT02923089|Diabetes|diabetes
5171007|NCT02923089|Lentils|lentils
5171008|NCT02923089|Pulses|pulses
5171009|NCT02923089|Postprandial glycemia|postprandial glycemia
5171010|NCT02923076|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5171016|NCT02922998|CD64 antigens|cd64 antigens
5171017|NCT02922998|Biomarkers|biomarkers
5171018|NCT02922998|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5171020|NCT02922998|Interferon-gamma|interferon-gamma
5171021|NCT02922998|C-reactive protein|c-reactive protein
5171022|NCT02922998|lipopolysaccharide-binding protein|lipopolysaccharide-binding protein
5171023|NCT02922998|procalcitonin|procalcitonin
5171024|NCT02922998|Cytokines|cytokines
5171025|NCT02922998|Patients|patients
5171026|NCT02922998|Human|human
5171027|NCT02922998|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5171028|NCT02922998|Sepsis|sepsis
5171029|NCT02922998|Infection|infection
5171030|NCT02922998|Antibiotics|antibiotics
5171031|NCT02922998|Intensive Care Units|intensive care units
5171032|NCT02922998|Point-of-Care Systems|point-of-care systems
5171033|NCT02922998|Bedside Testing|bedside testing
5171041|NCT02922959|Telephone intervention|telephone intervention
5171042|NCT02922959|secondary prevention|secondary prevention
5171043|NCT02922959|naloxone|naloxone
5171044|NCT02922946|entinostat|entinostat
5171045|NCT02922946|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5171047|NCT02922933|entinostat|entinostat
5171048|NCT02922933|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5171049|NCT02922933|HDAC|hdac
5171050|NCT02922868|Cystoscopy|cystoscopy
5171051|NCT02922868|EndoSheath|endosheath
5171052|NCT02922868|Infection Control|infection control
5171053|NCT02922868|Bacteriuria|bacteriuria
5171054|NCT02922842|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5171055|NCT02922829|Food Insecurity|food insecurity
5171056|NCT02922829|Nutrition|nutrition
5171057|NCT02922816|Carbapenem-resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
5171058|NCT02922816|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
5171059|NCT02922816|Multidrug Resistant Organism (MDRO)|multidrug resistant organism (mdro)
5171060|NCT02922816|Fecal Microbiota Transplant (FMT)|fecal microbiota transplant (fmt)
5171061|NCT02922816|Renal Transplant|renal transplant
5171062|NCT02922816|Colonization|colonization
5171063|NCT02922816|Infection|infection
5171064|NCT02922816|Antibiotic Resistance|antibiotic resistance
5171065|NCT02922816|Resistome|resistome
5171066|NCT02922816|Multidrug Resistant (MDR) Pseudomonas|multidrug resistant (mdr) pseudomonas
5171067|NCT02922790|smoker|smoker
5171068|NCT02922790|smoking|smoking
5171069|NCT02922790|cigarette|cigarette
5962165|NCT04282564|sens of self efficacy|sens of self efficacy
5171070|NCT02922790|cessation|cessation
5171071|NCT02922790|DNA|dna
5171072|NCT02922790|DNA damage|dna damage
5171073|NCT02922790|blood draw|blood draw
5171074|NCT02922790|feedback|feedback
5171075|NCT02922790|cellular|cellular
5171077|NCT02922790|tobacco smoke|tobacco smoke
5171078|NCT02922764|Solid malignancy|solid malignancy
5171079|NCT02922764|Lymphoma|lymphoma
5171080|NCT02922764|Solid tumor|solid tumor
5171081|NCT02922764|Melanoma|melanoma
5171082|NCT02922764|Non-small cell lung cancer|non-small cell lung cancer
5171083|NCT02922764|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
5171084|NCT02922764|NSCLC|nsclc
5171085|NCT02922764|EOC|eoc
5171086|NCT02922764|LXR|lxr
5171087|NCT02922764|ApoE|apoe
5171088|NCT02922764|Small cell lung cancer|small cell lung cancer
5171089|NCT02922764|SCLC|sclc
5171090|NCT02922764|High-grade neuroendocrine tumors|high-grade neuroendocrine tumors
5171091|NCT02922764|HG-NET|hg-net
5171099|NCT02922738|Clinical Knowledge Systems, Decision support, Dermatology|clinical knowledge systems, decision support, dermatology
5171100|NCT02922738|Technology Assessment|technology assessment
5171101|NCT02922673|human endotoxemia|human endotoxemia
5171102|NCT02922673|LPS|lps
5171103|NCT02922673|acetylsalicylic acid|acetylsalicylic acid
5171104|NCT02922673|placebo|placebo
5171105|NCT02922673|endotoxin tolerance|endotoxin tolerance
5171106|NCT02922660|Ambulatory surgery|ambulatory surgery
5171107|NCT02922660|Ophthalmic|ophthalmic
5171108|NCT02922660|Inhalation anesthesia|inhalation anesthesia
5171109|NCT02922660|Desflurane|desflurane
5171110|NCT02922660|Total intravenous anesthesia|total intravenous anesthesia
5171111|NCT02922634|postoperative health outcomes|postoperative health outcomes
5171112|NCT02922634|older surgical patients|older surgical patients
5171113|NCT02922634|delirium|delirium
5171114|NCT02922608|Education, Medical|education, medical
5171115|NCT02922543|Multiple Myeloma|multiple myeloma
5171116|NCT02922543|Teratogenicity|teratogenicity
5171117|NCT02922543|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
5171118|NCT02922543|Neutropenia and infection|neutropenia and infection
5171119|NCT02922543|Venous thromboembolism|venous thromboembolism
5171120|NCT02922543|Allergic reactions|allergic reactions
5171121|NCT02922543|Diarrhoea or constipation|diarrhoea or constipation
5171122|NCT02922543|Peripheral neuropathy|peripheral neuropathy
5171123|NCT02922543|Cardiac failure|cardiac failure
5171124|NCT02922543|Arrhythmia|arrhythmia
5171125|NCT02922543|Renal failure|renal failure
5171126|NCT02922543|Myocardial infarction|myocardial infarction
5171127|NCT02922543|Interstitial lung disease|interstitial lung disease
5171128|NCT02922543|Tumour lysis syndrome|tumour lysis syndrome
5171129|NCT02922517|biomarkers|biomarkers
5171130|NCT02922517|echocardiography|echocardiography
5171131|NCT02922517|MRI imaging|mri imaging
5171132|NCT02922517|nuclear medicine|nuclear medicine
5171133|NCT02922504|First trimester abortion|first trimester abortion
5171134|NCT02922504|Surgical abortion|surgical abortion
5171135|NCT02922504|Music intervention|music intervention
5171136|NCT02922504|Local anesthesia|local anesthesia
5171138|NCT02922439|chronic disease|chronic disease
5171139|NCT02922439|multimorbidity|multimorbidity
5171140|NCT02922439|chronic disease self-management|chronic disease self-management
5171141|NCT02922439|tailored information|tailored information
5171142|NCT02922439|mobile applications|mobile applications
5171143|NCT02922426|ALKS 3831|alks 3831
5171144|NCT02922426|Samidorphan|samidorphan
5171145|NCT02922426|Olanzapine|olanzapine
5171146|NCT02922413|Porphyria|porphyria
5171147|NCT02922413|Heme|heme
5171148|NCT02922400|Autism|autism
5171149|NCT02922400|Traumatic Brain Injury|traumatic brain injury
5171150|NCT02922400|Schizophrenia|schizophrenia
5171151|NCT02922400|Virtual-Reality Social Cognition Training|virtual-reality social cognition training
5171152|NCT02922387|varenicline|varenicline
5171153|NCT02922387|COPD|copd
5171154|NCT02922387|asthma|asthma
5171155|NCT02922387|pneumonia|pneumonia
5171156|NCT02922387|smoking cessation|smoking cessation
5171157|NCT02922374|acute severe colitis|acute severe colitis
5171158|NCT02922374|corticosteroids|corticosteroids
5171159|NCT02922374|UCEIS|uceis
5171160|NCT02922374|fecal calprotectin|fecal calprotectin
5171161|NCT02922348|premature ovarian failure|premature ovarian failure
5171162|NCT02922348|hormone replacement|hormone replacement
5171163|NCT02922335|Antisocial Behavior|antisocial behavior
5171164|NCT02922335|Mental Illness|mental illness
5171165|NCT02922335|Emerging Adulthood|emerging adulthood
5171166|NCT02922335|Criminal Behavior|criminal behavior
5171167|NCT02922335|Serious Mental Illness|serious mental illness
5171168|NCT02922322|Mat Pilates|mat pilates
5171169|NCT02922322|Chronic Nonspecific low back pain|chronic nonspecific low back pain
5171170|NCT02922322|Quality of life|quality of life
5171171|NCT02922322|Disability|disability
5171172|NCT02922322|transverse abdominal muscle|transverse abdominal muscle
5171173|NCT02922283|T cell response|t cell response
5171174|NCT02922283|Interleukin 2|interleukin 2
5171175|NCT02922283|PET scan|pet scan
5171176|NCT02922283|Ipilimumab|ipilimumab
5171177|NCT02922283|Pembrolizumab|pembrolizumab
5171178|NCT02922283|Nivolumab|nivolumab
5044414|NCT03721510|HIV|hiv
5171179|NCT02922270|peritoneal dialysis: outcome|peritoneal dialysis: outcome
5171180|NCT02922270|peritoneal dialysis: complications|peritoneal dialysis: complications
5171181|NCT02922270|peritoneal dialysis: technique|peritoneal dialysis: technique
5171182|NCT02922270|peritoneal dialysis: peritonitis|peritoneal dialysis: peritonitis
5171183|NCT02922244|herbal products|herbal products
5171184|NCT02922244|reduction of radiation-induced dermatitis|reduction of radiation-induced dermatitis
5171185|NCT02922244|breast cancer|breast cancer
5171186|NCT02922244|radiotherapy|radiotherapy
5171187|NCT02922218|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5171188|NCT02922218|Enzalutamide|enzalutamide
5171189|NCT02922218|Biomarkers|biomarkers
5171190|NCT02922192|Anti-inflammatory|anti-inflammatory
5171191|NCT02922192|Biologics|biologics
5171192|NCT02922192|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
5171193|NCT02922192|BBCIC|bbcic
5171194|NCT02922179|Insulin|insulin
5171195|NCT02922179|Diabetes|diabetes
5171196|NCT02922179|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
5171197|NCT02922179|BBCIC|bbcic
5171198|NCT02922179|Descriptive analysis|descriptive analysis
5171199|NCT02922153|CryoAnalgesia|cryoanalgesia
5171200|NCT02922153|Thoracotomy|thoracotomy
5171201|NCT02922153|FEV1|fev1
5171202|NCT02922153|VAS|vas
5171203|NCT02922140|pharmaceutical care service, clinical pharmacist|pharmaceutical care service, clinical pharmacist
5171204|NCT02922140|Cardiac rehabilitation unit|cardiac rehabilitation unit
5171205|NCT02922140|Acute coronary syndrome|acute coronary syndrome
5171206|NCT02922140|patient education and counselling|patient education and counselling
5171207|NCT02922127|Ulipristal Acetate (UPA)|ulipristal acetate (upa)
5171208|NCT02922127|Breast Cancer|breast cancer
5171209|NCT02922127|Combined Oral Contraceptive (COC)|combined oral contraceptive (coc)
5171210|NCT02922114|Ultrasonography|ultrasonography
5171211|NCT02922114|Clinical assesment|clinical assesment
5171212|NCT02922114|joint abnormalities|joint abnormalities
5171213|NCT02922088|Vein Graft Failure|vein graft failure
5171214|NCT02922088|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5171215|NCT02922088|Vascular Grafts|vascular grafts
5171216|NCT02922088|Saphenous Vein Grafts|saphenous vein grafts
5171217|NCT02922088|Vein Graft Disease|vein graft disease
5171218|NCT02922088|Vein Graft Treatment|vein graft treatment
5171219|NCT02922088|Vein Graft Handling|vein graft handling
5171220|NCT02922075|gingival recession|gingival recession
5171221|NCT02922075|immediate implant and provisional placement|immediate implant and provisional placement
5171222|NCT02922075|bone graft|bone graft
5171235|NCT02921997|influenza|influenza
5171236|NCT02921997|monovalent|monovalent
5171237|NCT02921997|pH1N1|ph1n1
5171238|NCT02921997|vaccines|vaccines
5171239|NCT02921984|Salivary Gland Tumors|salivary gland tumors
5171240|NCT02921984|Head and Neck Cancer|head and neck cancer
5171241|NCT02921984|concurrent chemotherapy|concurrent chemotherapy
5171242|NCT02921984|genetic testing|genetic testing
5171243|NCT02921958|Parents of children with disabilities|parents of children with disabilities
5171244|NCT02921932|Physiotherapy|physiotherapy
5171245|NCT02921932|Inspiratory Muscle Training|inspiratory muscle training
5171246|NCT02921932|Perioperative Medicine|perioperative medicine
5171247|NCT02921932|Postoperative outcomes|postoperative outcomes
5171248|NCT02921932|Preoperative nutrition|preoperative nutrition
5171249|NCT02921932|Elderly, frail|elderly, frail
5171250|NCT02921906|Insulin|insulin
5171251|NCT02921906|Glucose|glucose
5171252|NCT02921906|Incretin|incretin
5171253|NCT02921906|GLP-1|glp-1
5171254|NCT02921906|Food|food
5171255|NCT02921867|ultrasound|ultrasound
5171256|NCT02921867|radiology|radiology
5171257|NCT02921867|simulation|simulation
5171258|NCT02921867|abdominal ultrasound|abdominal ultrasound
5171259|NCT02921867|medical education|medical education
5171260|NCT02921841|Adolescents|adolescents
5171261|NCT02921841|HIV prevention|hiv prevention
5171262|NCT02921841|computerized intervention|computerized intervention
5171263|NCT02921841|mental health treatment|mental health treatment
5171264|NCT02921828|Pomalyst|pomalyst
5171265|NCT02921828|Teratogenicity|teratogenicity
5171266|NCT02921828|bone marrow suppression|bone marrow suppression
5171267|NCT02921828|thromboembolism|thromboembolism
5171268|NCT02921828|peripheral neuropathy|peripheral neuropathy
5171269|NCT02921828|infection|infection
5171270|NCT02921828|tumour lysis syndrome|tumour lysis syndrome
5171271|NCT02921828|somnolence|somnolence
5171272|NCT02921828|depressed level of consciousness|depressed level of consciousness
5171273|NCT02921828|confusion|confusion
5171275|NCT02921828|dizziness|dizziness
5171276|NCT02921828|acute renal failure|acute renal failure
5171277|NCT02921828|heart failure|heart failure
5171278|NCT02921828|arrhythmia|arrhythmia
5171279|NCT02921828|interstitial pneumonia|interstitial pneumonia
5171280|NCT02921828|hypersensitivity|hypersensitivity
5171281|NCT02921828|hepatic function disorder|hepatic function disorder
5171282|NCT02921828|jaundice|jaundice
5962166|NCT04282551|oligosaccharides|oligosaccharides
5171283|NCT02921815|Leukemia|leukemia
5171284|NCT02921815|Acute Myeloid Leukemia|acute myeloid leukemia
5171285|NCT02921815|Revlimid|revlimid
5171286|NCT02921802|Teratogenicity|teratogenicity
5171287|NCT02921802|Thrombocytopenia and haemorrhage|thrombocytopenia and haemorrhage
5171288|NCT02921802|Neutropenia and infection|neutropenia and infection
5171289|NCT02921802|Venous thromboembolism|venous thromboembolism
5171290|NCT02921802|Allergic reactions|allergic reactions
5171291|NCT02921802|Diarrhoea or constipation|diarrhoea or constipation
5171292|NCT02921802|Peripheral neuropathy|peripheral neuropathy
5171293|NCT02921802|Cardiac failure|cardiac failure
5171294|NCT02921802|Arrhythmia|arrhythmia
5171295|NCT02921802|Renal failure|renal failure
5171296|NCT02921802|Myocardial infarction|myocardial infarction
5171297|NCT02921802|Interstitial lung disease|interstitial lung disease
5171298|NCT02921802|Tumour lysis syndrome|tumour lysis syndrome
5171299|NCT02921802|Transformation from myelodysplastic syndrome to acute myeloid leukemia|transformation from myelodysplastic syndrome to acute myeloid leukemia
5171300|NCT02921789|Bleselumab|bleselumab
5171301|NCT02921789|ASKP1240|askp1240
5171302|NCT02921789|Efficacy and Safety|efficacy and safety
5171303|NCT02921776|Vidatalk|vidatalk
5171305|NCT02921776|Augmentative and Alternative Communication|augmentative and alternative communication
5171306|NCT02921776|iPad|ipad
5171307|NCT02921776|Android|android
5171508|NCT02920476|metastatic|metastatic
5171308|NCT02921776|Mechanical ventilation|mechanical ventilation
5171309|NCT02921776|Patient Communication|patient communication
5171310|NCT02921776|Critical Illness|critical illness
5171311|NCT02921750|wound reduction wound healing, venous ulcers|wound reduction wound healing, venous ulcers
5171315|NCT02921724|cancer|cancer
5171316|NCT02921724|oral drug|oral drug
5171317|NCT02921724|sunitinib|sunitinib
5171318|NCT02921724|capecitabine|capecitabine
5171319|NCT02921724|mobile app|mobile app
5171320|NCT02921659|nicotinamide riboside|nicotinamide riboside
5171321|NCT02921659|aging|aging
5171322|NCT02921659|arterial stiffness|arterial stiffness
5171323|NCT02921659|endothelial dysfunction|endothelial dysfunction
5171324|NCT02921646|energetic expenditure|energetic expenditure
5171325|NCT02921633|Immunization|immunization
5171326|NCT02921633|Behavioural insights|behavioural insights
5171327|NCT02921633|Children|children
5171328|NCT02921620|Gastrointestinal symptoms|gastrointestinal symptoms
5171329|NCT02921620|Diarrhea|diarrhea
5171330|NCT02921620|Abdominal pain|abdominal pain
5171331|NCT02921581|Dose painting|dose painting
5171332|NCT02921581|18F-FDG|18f-fdg
5171333|NCT02921581|Positron emission tomography|positron emission tomography
5171334|NCT02921581|Radiotherapy|radiotherapy
5171335|NCT02921555|RCT (randomized controlled trial)|rct (randomized controlled trial)
5171336|NCT02921529|Postoperative recovery|postoperative recovery
5171337|NCT02921529|colon surgery|colon surgery
5171338|NCT02921516|Adolescence|adolescence
5171339|NCT02921516|Adherence|adherence
5171340|NCT02921477|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5171341|NCT02921477|bosutinib|bosutinib
5171343|NCT02921438|Cardiovascular Diseases|cardiovascular diseases
5171344|NCT02921438|Heart Diseases|heart diseases
5171345|NCT02921438|Myocardial Ischemia|myocardial ischemia
5171346|NCT02921438|NSTE ACS|nste acs
5171347|NCT02921438|NSTEMI|nstemi
5171348|NCT02921438|Unstable Angina Pectoris|unstable angina pectoris
5171349|NCT02921438|Coronary Artery Disease|coronary artery disease
5171350|NCT02921425|lifestyle|lifestyle
5171351|NCT02921425|patient health record|patient health record
5171352|NCT02921425|Veterans|veterans
5171353|NCT02921425|prediabetes|prediabetes
5171354|NCT02921373|perfluorocarbon imaging|perfluorocarbon imaging
5171355|NCT02921373|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5171356|NCT02921373|cancer immunotherapy|cancer immunotherapy
5171357|NCT02921373|prostate cancer|prostate cancer
5171359|NCT02921360|thrombolytic therapy|thrombolytic therapy
5171360|NCT02921360|tissue plasminogen activator|tissue plasminogen activator
5171361|NCT02921360|aspirin|aspirin
5171362|NCT02921321|MRI|mri
5171363|NCT02921321|Muscular Dystrophy|muscular dystrophy
5171364|NCT02921321|Cardiac|cardiac
5171365|NCT02921321|Late gadolinium enhancement|late gadolinium enhancement
5171366|NCT02921308|Prematurity|prematurity
5171367|NCT02921308|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5171368|NCT02921308|MRI|mri
5171369|NCT02921308|PFT|pft
5171370|NCT02921308|Emphysema|emphysema
5171371|NCT02921282|genes|genes
5171372|NCT02921282|cues|cues
5171373|NCT02921282|reward|reward
5171374|NCT02921282|smoking|smoking
5171376|NCT02921230|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
5171377|NCT02921230|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
5171378|NCT02921230|stenting|stenting
5171379|NCT02921230|paclitaxel|paclitaxel
5171380|NCT02921217|Cardiovascular diseases|cardiovascular diseases
5171381|NCT02921217|abdominal visceral fat|abdominal visceral fat
5171382|NCT02921217|subcutaneous body fat|subcutaneous body fat
5171383|NCT02921217|body weight|body weight
5171384|NCT02921217|waist circumference|waist circumference
5171385|NCT02921217|lipid profile|lipid profile
5171386|NCT02921217|insulin resistance|insulin resistance
5171387|NCT02921217|glucose metabolism|glucose metabolism
5171388|NCT02921217|blood pressure|blood pressure
5171389|NCT02921217|inflammation|inflammation
5171390|NCT02921217|adiponectin|adiponectin
5171391|NCT02921217|leptin|leptin
5171392|NCT02921217|metabolomics|metabolomics
5171393|NCT02921217|cardiovascular risk factor|cardiovascular risk factor
5171394|NCT02921204|Vitamin D|vitamin d
5171395|NCT02921204|Calcium|calcium
5171396|NCT02921204|Phytic Acid|phytic acid
5171397|NCT02921204|body weight|body weight
5171398|NCT02921191|recombinant human granulocyte colony-stimulating factors|recombinant human granulocyte colony-stimulating factors
5171399|NCT02921191|G-CSFs|g-csfs
5171400|NCT02921191|biosimilar|biosimilar
5171401|NCT02921191|biologics|biologics
5171402|NCT02921191|High Neutropenia Risk Chemotherapy|high neutropenia risk chemotherapy
5171403|NCT02921191|Biologic and Biosimilars Collective Intelligence Consortium|biologic and biosimilars collective intelligence consortium
5171404|NCT02921191|bbcic|bbcic
5171405|NCT02921165|tooth extraction|tooth extraction
5171406|NCT02921165|tooth socket healing|tooth socket healing
5171407|NCT02921165|hypertension|hypertension
5171408|NCT02921165|rinses|rinses
5171409|NCT02921139|Hepatocellular Carcinoma|hepatocellular carcinoma
5171410|NCT02921139|Transcatheter Arterial Chemoembolization (TACE)|transcatheter arterial chemoembolization (tace)
5171411|NCT02921139|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
5171412|NCT02921113|suPAR|supar
5171413|NCT02921113|Acute Kidney Injury|acute kidney injury
5171414|NCT02921113|On-Pump Cardiac Surgery|on-pump cardiac surgery
5171415|NCT02921113|Biomarker|biomarker
5171416|NCT02921048|Eicosapentaenoic Acid|eicosapentaenoic acid
5171417|NCT02921048|Docosahexaenoic Acid|docosahexaenoic acid
5171418|NCT02921048|Ambient Air Pollution|ambient air pollution
5779042|NCT00202033|referred to|referred to
5171419|NCT02921035|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5171420|NCT02921035|Interferon beta-1a|interferon beta-1a
5171421|NCT02921035|Rebif®|rebif®
5171422|NCT02921035|Morisky Medication Adherence Scale|morisky medication adherence scale
5171423|NCT02921022|Gemcitabine|gemcitabine
5171424|NCT02921022|Nab-paclitaxel|nab-paclitaxel
5171425|NCT02921022|PEGPH20|pegph20
5171426|NCT02921022|Rivaroxaban|rivaroxaban
5171427|NCT02921022|thromboembolic event (TE)|thromboembolic event (te)
5171428|NCT02921022|16-1066|16-1066
5171429|NCT02920996|NSCLC|nsclc
5171431|NCT02920996|Non-small cell lung cancer|non-small cell lung cancer
5171432|NCT02920996|MET mutation|met mutation
5171433|NCT02920996|NTRK rearrangement|ntrk rearrangement
5171434|NCT02920996|NTRK|ntrk
5171435|NCT02920996|targeted therapy|targeted therapy
5171436|NCT02920996|MET exon 14|met exon 14
5171437|NCT02920996|NTRK1|ntrk1
5171438|NCT02920996|NTRK2|ntrk2
5171439|NCT02920996|NTRK3|ntrk3
5171440|NCT02920996|merestinib|merestinib
5171441|NCT02920996|LY2801653|ly2801653
5171442|NCT02920918|Systolic Heart Failure|systolic heart failure
5171443|NCT02920918|Canagliflozin|canagliflozin
5171444|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate
5171445|NCT02920918|Type 2 Diabetes|type 2 diabetes
5171446|NCT02920918|SGLT2 inhibitor|sglt2 inhibitor
5171447|NCT02920918|DPPIV inhibitor|dppiv inhibitor
5171448|NCT02920866|Functional strength integration|functional strength integration
5171449|NCT02920866|Rehabilitation|rehabilitation
5171450|NCT02920866|Hip arthroplasty|hip arthroplasty
5171451|NCT02920866|Physical function|physical function
5171452|NCT02920866|Muscle performance|muscle performance
5171453|NCT02920866|Movement compensations|movement compensations
5171454|NCT02920853|chronic pain|chronic pain
5171455|NCT02920827|HIV Infections|hiv infections
5171456|NCT02920827|HIV seronegativity|hiv seronegativity
5171457|NCT02920801|saxagliptin|saxagliptin
5171458|NCT02920801|endothelial progenitor cell|endothelial progenitor cell
5171459|NCT02920801|flow-mediated dilation|flow-mediated dilation
5171460|NCT02920788|Rehabilitation|rehabilitation
5171461|NCT02920788|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5171462|NCT02920749|anaesthesia|anaesthesia
5171463|NCT02920749|costs|costs
5171464|NCT02920749|recovery profiles|recovery profiles
5171465|NCT02920723|Sleep Apnea Syndromes|sleep apnea syndromes
5171466|NCT02920723|Sleep Apnea, Obstructives|sleep apnea, obstructives
5171467|NCT02920723|Training|training
5171468|NCT02920684|Early rehabilitation|early rehabilitation
5171469|NCT02920684|Mechanical ventilation|mechanical ventilation
5171470|NCT02920684|Physiotherapy|physiotherapy
5171471|NCT02920658|NAVS Naphthalan|navs naphthalan
5171472|NCT02920658|Betamethasone dipropionate|betamethasone dipropionate
5171475|NCT02920645|AVM|avm
5171476|NCT02920645|intracerebral hemorrhage|intracerebral hemorrhage
5171477|NCT02920645|arterio-venous malformation|arterio-venous malformation
5171478|NCT02920645|AVICH|avich
5171479|NCT02920632|Parkinson|parkinson
5171480|NCT02920632|Cognitive training|cognitive training
5171481|NCT02920632|Cognitive rehabilitation|cognitive rehabilitation
5171482|NCT02920632|Brain networks|brain networks
5171483|NCT02920619|ultrasound|ultrasound
5171484|NCT02920619|muscle|muscle
5171485|NCT02920606|pulpotomy|pulpotomy
5171486|NCT02920606|pulpitis|pulpitis
5171487|NCT02920606|mature tooth|mature tooth
5171488|NCT02920606|tricalcium silicate|tricalcium silicate
5171489|NCT02920593|Vitamin D; hypertensive disorders of pregnancy|vitamin d; hypertensive disorders of pregnancy
5171490|NCT02920580|Subarachnoid hemorrhage|subarachnoid hemorrhage
5171491|NCT02920580|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5171492|NCT02920580|Global cerebral anoxia/cardiac arrest|global cerebral anoxia/cardiac arrest
5171493|NCT02920580|Meningitis/Encephalitis/Cerebral abscess|meningitis/encephalitis/cerebral abscess
5171494|NCT02920580|Seizure|seizure
5171495|NCT02920580|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
5171496|NCT02920580|Ischemic Stroke|ischemic stroke
5171497|NCT02920580|Brain tumor|brain tumor
5171498|NCT02920554|gallbladder cancer|gallbladder cancer
5171499|NCT02920554|bisegmentectomy|bisegmentectomy
5171500|NCT02920515|epidemiology|epidemiology
5171501|NCT02920515|treatment|treatment
5171502|NCT02920515|molecular pathological mechanism|molecular pathological mechanism
5171503|NCT02920515|environmental disrupting chemicals|environmental disrupting chemicals
5171504|NCT02920489|severity of labor pain|severity of labor pain
5171505|NCT02920489|individualized administration|individualized administration
5171506|NCT02920489|neuraxial labor analgesia|neuraxial labor analgesia
5171509|NCT02920476|carcinoma|carcinoma
5171510|NCT02920463|Anti-Infective agents|anti-infective agents
5171511|NCT02920463|Antimicrobial stewardship|antimicrobial stewardship
5171512|NCT02920463|Empirical antibiotic therapy|empirical antibiotic therapy
5171513|NCT02920463|De-escalation|de-escalation
5171514|NCT02920463|Critical care|critical care
5171515|NCT02920450|lung|lung
5171516|NCT02920450|carcinoma|carcinoma
5171517|NCT02920437|dietary salt|dietary salt
5171518|NCT02920437|24 hour urinary sodium excretion|24 hour urinary sodium excretion
5171519|NCT02920437|blood pressure|blood pressure
5171520|NCT02920437|hypertension|hypertension
5171521|NCT02920346|Neonatal Systemic lupus erythematosus|neonatal systemic lupus erythematosus
5171522|NCT02920346|Sjogren's syndrome|sjogren's syndrome
5171523|NCT02920346|Fetal Atrioventricular Block|fetal atrioventricular block
5171524|NCT02920346|Fetal Heart Block|fetal heart block
5171525|NCT02920333|stroke|stroke
5059072|NCT03629678|mhealth|mhealth
5171526|NCT02920333|transcraniel direct current stimulation|transcraniel direct current stimulation
5171527|NCT02920333|repetitive transcraniel magnetic stimulation|repetitive transcraniel magnetic stimulation
5171528|NCT02920333|rehabilitation|rehabilitation
5171529|NCT02920333|lower extremities|lower extremities
5171530|NCT02920307|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5171531|NCT02920307|total extraperitoneoscopic hernia repair|total extraperitoneoscopic hernia repair
5171532|NCT02920307|transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
5171533|NCT02920307|inguinal hernia|inguinal hernia
5171534|NCT02920307|laparoscopy|laparoscopy
5171535|NCT02920307|hernia repair|hernia repair
5171536|NCT02920307|herniorraphy|herniorraphy
5171537|NCT02920307|laparoscopic surgery|laparoscopic surgery
5171538|NCT02920294|probiotics, microbiota, ileostoma|probiotics, microbiota, ileostoma
5171539|NCT02920268|dance-intervention|dance-intervention
5171540|NCT02920268|yoga|yoga
5171541|NCT02920268|adolescents|adolescents
5171542|NCT02920268|recurrent abdominal pain|recurrent abdominal pain
5171543|NCT02920242|Travelers|travelers
5171544|NCT02920242|diarrhea|diarrhea
5171545|NCT02920242|rifaximin|rifaximin
5171546|NCT02920242|equivalence|equivalence
5171547|NCT02920229|68Ga-PSMA|68ga-psma
5171548|NCT02920229|HBED-PET/CT|hbed-pet/ct
5171549|NCT02920229|biochemical relapse|biochemical relapse
5171550|NCT02920229|prostate cancer|prostate cancer
5171551|NCT02920229|radically treated|radically treated
5171552|NCT02920216|Head and Neck Neoplasms|head and neck neoplasms
5171553|NCT02920216|Recurrence|recurrence
5171554|NCT02920216|Indocyanine Green|indocyanine green
5171555|NCT02920216|Salvage surgery|salvage surgery
5171556|NCT02920203|Sudden unexpected death|sudden unexpected death
5171557|NCT02920203|young subjects|young subjects
5171558|NCT02920203|molecular genetic autopsy|molecular genetic autopsy
5171559|NCT02920203|sequencing|sequencing
5171560|NCT02920138|Obesity|obesity
5171561|NCT02920138|intraabdominal pressure|intraabdominal pressure
5171562|NCT02920138|cerebral oxymeter|cerebral oxymeter
5171563|NCT02920138|sleeve gastrectomy|sleeve gastrectomy
5171564|NCT02920138|laparoscopy|laparoscopy
5171565|NCT02920125|Vascular disease|vascular disease
5171566|NCT02920112|Obesity|obesity
5171567|NCT02920112|Bariatric Surgery|bariatric surgery
5171569|NCT02920112|Cognitive Therapy|cognitive therapy
5171570|NCT02920112|Binge eating|binge eating
5171571|NCT02920099|Nutrition literacy|nutrition literacy
5171572|NCT02920073|Microbiota|microbiota
5171573|NCT02920073|anorexia nervosa|anorexia nervosa
5171574|NCT02920073|under nutrition|under nutrition
5171575|NCT02920073|inpatients|inpatients
5171576|NCT02920073|enteral nutrition|enteral nutrition
5171578|NCT02920047|Fimasartan|fimasartan
5171579|NCT02920008|AML, acute myeloid leukemia, guadecitabine, SGI-110, Phase 3|aml, acute myeloid leukemia, guadecitabine, sgi-110, phase 3
5171580|NCT02919982|Anticoagulant|anticoagulant
5171581|NCT02919982|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5171582|NCT02919982|Registries|registries
5171583|NCT02919969|Anal Cancer|anal cancer
5171584|NCT02919956|Single Ventricle|single ventricle
5171585|NCT02919956|Fontan|fontan
5171586|NCT02919904|prostate cancer|prostate cancer
5171587|NCT02919904|sleep|sleep
5171588|NCT02919904|androgen deprivation therapy|androgen deprivation therapy
5171589|NCT02919891|intra-epidermal nerve fibre density|intra-epidermal nerve fibre density
5171590|NCT02919891|IENFD|ienfd
5171591|NCT02919891|Chronic Pain|chronic pain
5171592|NCT02919891|Post-mastectomy|post-mastectomy
5171593|NCT02919891|Post-mastectomy pain syndrome|post-mastectomy pain syndrome
5171594|NCT02919891|PMPS|pmps
5171595|NCT02919891|Chronic Post-Surgical Pain|chronic post-surgical pain
5171596|NCT02919891|CPSP|cpsp
5171597|NCT02919891|Mastectomy|mastectomy
5171598|NCT02919813|mindfulness group therapy|mindfulness group therapy
5171599|NCT02919813|vulvodynia|vulvodynia
5171600|NCT02919813|vulvar pain|vulvar pain
5171601|NCT02919787|Neoadjuvant treatment|neoadjuvant treatment
5171602|NCT02919761|persistant disease activity|persistant disease activity
5171603|NCT02919748|dementia|dementia
5171604|NCT02919748|cognitive decline|cognitive decline
5171605|NCT02919748|choral singing|choral singing
5171606|NCT02919748|health education program|health education program
5171607|NCT02919748|randomized controlled trial|randomized controlled trial
5171608|NCT02919735|Alopecia|alopecia
5171609|NCT02919735|Hair|hair
5171610|NCT02919735|Chemotherapy|chemotherapy
5171611|NCT02919735|Cancer|cancer
5171612|NCT02919722|Music therapy|music therapy
5171613|NCT02919722|sensorimotor cortex|sensorimotor cortex
5171614|NCT02919722|brain injury|brain injury
5171642|NCT02919475|Rheumatoid Arthritis|rheumatoid arthritis
5171643|NCT02919462|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5171644|NCT02919462|advanced stage IIIB|advanced stage iiib
5171645|NCT02919462|high Thymidylate Synthase expression|high thymidylate synthase expression
5171646|NCT02919462|Treatment|treatment
5171647|NCT02919462|Chemotherapy Naïve Patients|chemotherapy naïve patients
5171648|NCT02919462|stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer|stage iiib-iv non-squamous non-small cell lung cancer
5171649|NCT02919462|Cisplatin and Pemetrexed|cisplatin and pemetrexed
5171650|NCT02919462|Cisplatin and Oral Vinorelbine|cisplatin and oral vinorelbine
5171651|NCT02919449|Lung Cancer Measles Nivolumab Opdivo|lung cancer measles nivolumab opdivo
5171652|NCT02919384|Embryonic development|embryonic development
5171653|NCT02919384|blastocyst stage|blastocyst stage
5171654|NCT02919345|Dapagliflozin|dapagliflozin
5171655|NCT02919345|Glibenclamide|glibenclamide
5171656|NCT02919345|Endothelial Function|endothelial function
5171657|NCT02919345|Vascular Endothelial Cells|vascular endothelial cells
5171658|NCT02919345|Flow Mediated Dilation|flow mediated dilation
5171659|NCT02919267|One lung ventilation|one lung ventilation
5171660|NCT02919267|Lung collapse|lung collapse
5171661|NCT02919267|Bronchial blocker|bronchial blocker
5171662|NCT02919267|Double lumen tube|double lumen tube
5171663|NCT02919267|video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
5171664|NCT02919267|VATS|vats
5171665|NCT02919267|DLT|dlt
5171666|NCT02919267|Thoracic surgery|thoracic surgery
5171667|NCT02919267|Video-assisted|video-assisted
5171668|NCT02919241|dental anxiety|dental anxiety
5171669|NCT02919241|cognitive therapy|cognitive therapy
5171694|NCT02919163|cerebral oxygen metabolism|cerebral oxygen metabolism
5171695|NCT02919163|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5171696|NCT02919163|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5171697|NCT02919163|heart rate variability|heart rate variability
5171698|NCT02919163|blood pressure|blood pressure
5171699|NCT02919163|affect|affect
5171700|NCT02919163|mood|mood
5171701|NCT02919163|respiration|respiration
5171702|NCT02919163|systematic randomized cross-over study|systematic randomized cross-over study
5171703|NCT02919163|systemic physiology|systemic physiology
5171704|NCT02919163|electro-dermal activity|electro-dermal activity
5171705|NCT02919163|pulse-respiratory quotient|pulse-respiratory quotient
5171706|NCT02919150|Myofascial Trigger Points|myofascial trigger points
5171707|NCT02919150|Myotonometry|myotonometry
5171708|NCT02919150|Isokinetic Dynamometry|isokinetic dynamometry
5171709|NCT02919150|Assessment|assessment
5171710|NCT02919150|Reliability|reliability
5171711|NCT02919137|cerebral oxygen metabolism|cerebral oxygen metabolism
5171712|NCT02919137|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5171713|NCT02919137|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5171714|NCT02919137|heart rate variability|heart rate variability
5171715|NCT02919137|blood pressure|blood pressure
5171716|NCT02919137|affect|affect
5171717|NCT02919137|mood|mood
5171718|NCT02919137|respiration|respiration
5171719|NCT02919137|systematic randomized cross-over study|systematic randomized cross-over study
5171720|NCT02919137|systemic physiology|systemic physiology
5171721|NCT02919137|electro-dermal activity|electro-dermal activity
5171722|NCT02919137|pulse-respiratory quotient|pulse-respiratory quotient
5171723|NCT02919124|Coronary artery bypass grafting|coronary artery bypass grafting
5171724|NCT02919124|Anastomosis|anastomosis
5962167|NCT04282525|ECMO|ecmo
5044970|NCT03717974|telemedecine|telemedecine
5171725|NCT02919124|Ultrasonography|ultrasonography
5171726|NCT02919059|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5171727|NCT02919059|DM|dm
5171728|NCT02919046|neuroblastoma|neuroblastoma
5171729|NCT02919046|CAR-T|car-t
5171730|NCT02919033|randomized controlled trial|randomized controlled trial
5171731|NCT02919033|telemedicine|telemedicine
5171732|NCT02919033|hypertension|hypertension
5171733|NCT02919033|primary care|primary care
5171734|NCT02919033|medication adherence|medication adherence
5171735|NCT02919020|Proprioceptive Neuromuscular Facilitation (PNF )|proprioceptive neuromuscular facilitation (pnf )
5171736|NCT02919020|resistance exercise|resistance exercise
5171737|NCT02918968|enzalutamide|enzalutamide
5171738|NCT02918968|Xtandi|xtandi
5171739|NCT02918968|Prostate Cancer|prostate cancer
5171740|NCT02918955|head and neck cancer|head and neck cancer
5171741|NCT02918955|radiotherapy|radiotherapy
5171742|NCT02918955|chemotherapy|chemotherapy
5171743|NCT02918955|neck dissection|neck dissection
5171744|NCT02918955|surgery|surgery
5171745|NCT02918955|quality of life|quality of life
5171746|NCT02918955|toxicity|toxicity
5171747|NCT02918955|oropharyngeal cancer|oropharyngeal cancer
5171748|NCT02918955|laryngeal cancer|laryngeal cancer
5171749|NCT02918955|hypopharyngeal cancer|hypopharyngeal cancer
5171750|NCT02918929|First-in-human|first-in-human
5171751|NCT02918929|Single Ascending Dose|single ascending dose
5171752|NCT02918929|Multiple Ascending Dose|multiple ascending dose
5171753|NCT02918890|Pediatric|pediatric
5171754|NCT02918890|HABIT|habit
5171755|NCT02918890|CIMT|cimt
5171756|NCT02918890|Cerebral Palsy|cerebral palsy
5171757|NCT02918890|Hemiplegia|hemiplegia
5171758|NCT02918890|Children|children
5171759|NCT02918890|Therapy|therapy
5171760|NCT02918877|Volatile Anesthetics|volatile anesthetics
5171761|NCT02918877|Intravenous Anesthetics|intravenous anesthetics
5171762|NCT02918877|Inflammatory Lung Injury|inflammatory lung injury
5171763|NCT02918877|Postoperative Pulmonary Complications|postoperative pulmonary complications
5171764|NCT02918877|Cardiac Surgery|cardiac surgery
5171765|NCT02918877|Cardiopulmonary Bypass|cardiopulmonary bypass
5171766|NCT02918864|Autism Spectrum Disorder|autism spectrum disorder
5171767|NCT02918864|Oxytocin|oxytocin
5171768|NCT02918864|Social Skills|social skills
5171769|NCT02918864|Social cognitive skills|social cognitive skills
5171770|NCT02918864|Cognitive Behavioral Intervention|cognitive behavioral intervention
5171771|NCT02918864|Combination treatment|combination treatment
5171772|NCT02918864|Syntocinon|syntocinon
5171773|NCT02918864|NETT (Nonverbal communication, Emotion recognition, Theory of mind Training)|nett (nonverbal communication, emotion recognition, theory of mind training)
5171774|NCT02918864|emotion recognition|emotion recognition
5171775|NCT02918864|theory of mind|theory of mind
5171776|NCT02918838|HIV|hiv
5171777|NCT02918838|Antiretroviral (ARV)|antiretroviral (arv)
5171778|NCT02918838|co-trimoxazole|co-trimoxazole
5171779|NCT02918838|SMS|sms
5171780|NCT02918838|Lottery incentive|lottery incentive
5171781|NCT02918838|mobile health|mobile health
5171782|NCT02918838|Uganda|uganda
5171783|NCT02918838|Youth|youth
5171784|NCT02918825|schizophrenia|schizophrenia
5171785|NCT02918825|clinical trial|clinical trial
5171786|NCT02918825|olanzapine|olanzapine
5171787|NCT02918825|paliperidone|paliperidone
5171788|NCT02918812|Hysterosalpingography|hysterosalpingography
5171789|NCT02918812|Pain relief|pain relief
5171790|NCT02918812|Infertility|infertility
5171791|NCT02918812|Intracervical block|intracervical block
5171792|NCT02918812|Diclofenac|diclofenac
5171793|NCT02918786|oxygen therapy|oxygen therapy
5171794|NCT02918786|continuous positive airway pressure|continuous positive airway pressure
5171795|NCT02918786|extubation|extubation
5171796|NCT02918773|Pediatrics|pediatrics
5171797|NCT02918773|Emergency Medicine|emergency medicine
5171798|NCT02918773|Ear infection|ear infection
5171799|NCT02918760|Gabapentin, chronic pelvic pain.|gabapentin, chronic pelvic pain.
5171800|NCT02918734|Anterior Cruciate Ligament|anterior cruciate ligament
5171802|NCT02918721|Hyaluronic Acid, Nasolabial Fold, Lidocaine|hyaluronic acid, nasolabial fold, lidocaine
5171803|NCT02918708|vaccination|vaccination
5171804|NCT02918708|immunisation|immunisation
5171805|NCT02918708|pneumococcal|pneumococcal
5171806|NCT02918708|conjugate|conjugate
5171807|NCT02918695|Geriatric assessment|geriatric assessment
5171808|NCT02918695|Fit and frail elderly|fit and frail elderly
5171809|NCT02918695|Geriatric oncology|geriatric oncology
5171810|NCT02918656|Cochrane|cochrane
5171811|NCT02918656|Abstract|abstract
5171813|NCT02918656|Understanding|understanding
5171815|NCT02918643|Potentially Inappropriate Medications|potentially inappropriate medications
5171816|NCT02918630|E-cigarettes|e-cigarettes
5171817|NCT02918630|Schizophrenia|schizophrenia
5171818|NCT02918617|dentin hypersensitivity|dentin hypersensitivity
5171819|NCT02918617|nanohydroxyapatite|nanohydroxyapatite
5171820|NCT02918617|calcium sodium phosphosilicate|calcium sodium phosphosilicate
5171821|NCT02918617|toothpaste|toothpaste
5171822|NCT02918617|tooth cream|tooth cream
5171823|NCT02918604|peripheral vein access|peripheral vein access
5962168|NCT04282525|cerebral autoregulation|cerebral autoregulation
5045084|NCT03717324|Frailty|frailty
5171824|NCT02918604|infrared|infrared
5171825|NCT02918604|pediatric|pediatric
5171826|NCT02918578|Physical Inactivity|physical inactivity
5171827|NCT02918578|Behavior Change|behavior change
5171828|NCT02918526|Laryngeal masks|laryngeal masks
5171829|NCT02918513|Wellness|wellness
5171830|NCT02918513|Mental Wellness|mental wellness
5171831|NCT02918513|Well-Being|well-being
5171832|NCT02918500|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
5171833|NCT02918500|Nicotine Replacement Therapy (NRT)|nicotine replacement therapy (nrt)
5171835|NCT02918435|Pediatric practices|pediatric practices
5171836|NCT02918422|Diet Intervention|diet intervention
5171837|NCT02918422|Metabolic Syndrome|metabolic syndrome
5171838|NCT02918422|Feeding Study|feeding study
5171839|NCT02918422|Prediabetes|prediabetes
5171840|NCT02918396|Atrial Fibrillation|atrial fibrillation
5171841|NCT02918396|Atrial Fibrosis|atrial fibrosis
5171842|NCT02918396|Late Gadolinium Enhancement Magnetic Resonance Imaging|late gadolinium enhancement magnetic resonance imaging
5171843|NCT02918396|Computational Modeling|computational modeling
5171844|NCT02918396|Rotor Anchor Sites|rotor anchor sites
5171845|NCT02918370|Alcohol Use Disorder|alcohol use disorder
5171846|NCT02918370|Bipolar Disorder|bipolar disorder
5171847|NCT02918370|Mood|mood
5171848|NCT02918370|Alcohol Craving|alcohol craving
5171849|NCT02918370|Aripiprazole|aripiprazole
5171850|NCT02918344|calcium phosphate paste|calcium phosphate paste
5171853|NCT02918292|Haploidentical Bone Marrow|haploidentical bone marrow
5171854|NCT02918292|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5171855|NCT02918292|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
5171856|NCT02918292|Antithymocyte Globulin (ATG)|antithymocyte globulin (atg)
5171857|NCT02918266|Drug Therapy|drug therapy
5171858|NCT02918253|High dose-rate brachytherapy|high dose-rate brachytherapy
5171859|NCT02918227|Ejaculation|ejaculation
5171860|NCT02918227|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5171861|NCT02918227|Prostate|prostate
5171862|NCT02918214|Septic Shock|septic shock
5171863|NCT02918214|echocardiography|echocardiography
5171864|NCT02918214|diastolic dysfunction|diastolic dysfunction
5171865|NCT02918214|Transthoracic|transthoracic
5171866|NCT02918214|Transesophageal|transesophageal
5171867|NCT02918214|hyperkinesia|hyperkinesia
5171868|NCT02918214|prognosis|prognosis
5171869|NCT02918201|Administration, topical|administration, topical
5171870|NCT02918201|Tranexamic Acid|tranexamic acid
5171871|NCT02918201|Postoperative Care|postoperative care
5171872|NCT02918201|Bandages|bandages
5171873|NCT02918201|Occlusive Dressings|occlusive dressings
5171874|NCT02918175|mHealth|mhealth
5171875|NCT02918162|pembrolizumab|pembrolizumab
5171876|NCT02918162|adenocarcinoma|adenocarcinoma
5171877|NCT02918162|gastric cancer|gastric cancer
5171878|NCT02918162|Locoregional gastric adenocarcinoma|locoregional gastric adenocarcinoma
5171879|NCT02918162|Locoregional GE junction adenocarcinoma|locoregional ge junction adenocarcinoma
5171880|NCT02918149|Ultrasonography|ultrasonography
5171881|NCT02918149|Infant|infant
5171882|NCT02918149|Newborn|newborn
5171883|NCT02918149|Lumbar puncture|lumbar puncture
5171884|NCT02918149|Spinal puncture|spinal puncture
5171885|NCT02918149|Cerebrospinal fluid|cerebrospinal fluid
5171886|NCT02918123|Psoriasis|psoriasis
5171887|NCT02918123|Plaque psoriasis|plaque psoriasis
5171888|NCT02918123|Stem cell|stem cell
5171889|NCT02918123|Cell therapy|cell therapy
5171890|NCT02918123|Furestem|furestem
5171891|NCT02918123|Mesenchymal stem cell|mesenchymal stem cell
5171892|NCT02918123|MSC|msc
5171893|NCT02918123|Umbilical cord blood|umbilical cord blood
5171894|NCT02918123|hUCB-MSC|hucb-msc
5171895|NCT02918123|UCB-MSC|ucb-msc
5171896|NCT02918097|Cost effectiveness|cost effectiveness
5171897|NCT02918097|Bipolar disorder|bipolar disorder
5171914|NCT02918045|Tooth Extraction|tooth extraction
5171915|NCT02918045|Surgical Hemostasis|surgical hemostasis
5171916|NCT02918045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5171917|NCT02918045|Chitosan|chitosan
5171918|NCT02918032|Jordans anomaly|jordans anomaly
5171919|NCT02918032|neutral lipid storage disease|neutral lipid storage disease
5171920|NCT02918032|triglyceride deposit cardiovasculopathy|triglyceride deposit cardiovasculopathy
5171921|NCT02918032|ATGL gene|atgl gene
5171922|NCT02918032|CGI-58 gene|cgi-58 gene
5171923|NCT02918032|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
5171924|NCT02918032|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
5171925|NCT02917993|non-small cell lung cancer|non-small cell lung cancer
5171926|NCT02917993|locally advanced|locally advanced
5171927|NCT02917993|metastatic|metastatic
5171928|NCT02917993|epidermal growth factor receptor (EGFR) inhibition|epidermal growth factor receptor (egfr) inhibition
5171929|NCT02917993|Janus kinase inhibition|janus kinase inhibition
5171930|NCT02917980|structural Heart Diseases|structural heart diseases
5171931|NCT02917980|surgical treatment|surgical treatment
5171932|NCT02917980|interventional treatment|interventional treatment
5171933|NCT02917980|hybrid treatment|hybrid treatment
5962169|NCT04282512|Nutrition|nutrition
5962170|NCT04282512|Blood pressure|blood pressure
5171944|NCT02917928|carnosine, type 2 diabetes, cardiovascular factors|carnosine, type 2 diabetes, cardiovascular factors
5171946|NCT02917915|Emphysema|emphysema
5171947|NCT02917915|Chronic Bronchitis|chronic bronchitis
5171948|NCT02917915|Pulmonary rehabilitation|pulmonary rehabilitation
5171949|NCT02917915|Lung Diseases, Obstructive|lung diseases, obstructive
5171950|NCT02917902|student-run free clinic|student-run free clinic
5171951|NCT02917902|food supply|food supply
5171952|NCT02917902|food insecure|food insecure
5171953|NCT02917902|medically uninsured|medically uninsured
5171954|NCT02917902|medically underserved|medically underserved
5171955|NCT02917889|Caffeine|caffeine
5171956|NCT02917889|Autonomic Nervous System|autonomic nervous system
5171957|NCT02917889|Recovery|recovery
5171958|NCT02917889|Aerobic exercise|aerobic exercise
5171965|NCT02917863|Hypothyroidism|hypothyroidism
5171966|NCT02917863|Microbiota|microbiota
5171967|NCT02917863|Thyroid hormone|thyroid hormone
5171968|NCT02917863|L-Thyroxine|l-thyroxine
5171969|NCT02917863|Celiac disease|celiac disease
5171970|NCT02917850|stroke|stroke
5171971|NCT02917850|gait|gait
5171972|NCT02917850|hip flexors|hip flexors
5171973|NCT02917850|paresis|paresis
5171974|NCT02917850|hemiplegia|hemiplegia
5171975|NCT02917798|Genetic Testing|genetic testing
5171976|NCT02917798|16-919|16-919
5171977|NCT02917772|tailored immuno therapy|tailored immuno therapy
5171978|NCT02917772|Nivolumab|nivolumab
5171979|NCT02917772|Ipilimumab|ipilimumab
5171980|NCT02917772|boost|boost
5171981|NCT02917759|liver cancer|liver cancer
5171982|NCT02917759|biliary tract cancer|biliary tract cancer
5171983|NCT02917759|cholangiocarcinoma|cholangiocarcinoma
5171984|NCT02917759|hepatocellular carcinoma|hepatocellular carcinoma
5171985|NCT02917759|liver tumor|liver tumor
5171986|NCT02917759|biliary tumor|biliary tumor
5171987|NCT02917759|hepatoma|hepatoma
5171988|NCT02917759|liver mass|liver mass
5171989|NCT02917746|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5171990|NCT02917746|Imiquimod|imiquimod
5171991|NCT02917746|Treatment|treatment
5171992|NCT02917746|Predictive biomarkers|predictive biomarkers
5171993|NCT02917720|TKI discontinuation|tki discontinuation
5171998|NCT02917681|intrathecal|intrathecal
5172000|NCT02917668|Hyperoxia|hyperoxia
5172001|NCT02917668|Hypercapnia|hypercapnia
5172002|NCT02917668|Postoperative complications|postoperative complications
5172003|NCT02917668|Cardiac surgical procedures|cardiac surgical procedures
5172004|NCT02917655|Education|education
5172005|NCT02917655|Quality of Life|quality of life
5172006|NCT02917655|Osteoarthritis|osteoarthritis
5172007|NCT02917655|Metabolic Syndrome|metabolic syndrome
5172008|NCT02917642|bacterial infection|bacterial infection
5172009|NCT02917642|endotoxin|endotoxin
5172010|NCT02917642|passive ultrasonic irrigation|passive ultrasonic irrigation
5172011|NCT02917642|root canal treatment|root canal treatment
5172012|NCT02917590|Spinal cord injury|spinal cord injury
5172013|NCT02917590|dual-task obstacle crossing|dual-task obstacle crossing
5172014|NCT02917564|Choroidal effusions|choroidal effusions
5172015|NCT02917564|Trabeculectomy|trabeculectomy
5172016|NCT02917551|Bacteremia, duration, non-critically ill, non-ICU|bacteremia, duration, non-critically ill, non-icu
5172017|NCT02917525|Calcium metabolism|calcium metabolism
5172018|NCT02917525|Matrix Gla Protein|matrix gla protein
5172019|NCT02917525|Vitamin K2|vitamin k2
5172020|NCT02917486|ExtraCorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5172021|NCT02917486|patient in intensive care|patient in intensive care
5172022|NCT02917486|pharmacokinetic modeling|pharmacokinetic modeling
5172023|NCT02917473|Medical skin examination|medical skin examination
5172024|NCT02917473|Skin Self Examination|skin self examination
5172025|NCT02917473|Sun protection|sun protection
5172027|NCT02917460|Pediatric|pediatric
5172028|NCT02917460|Genomic|genomic
5172029|NCT02917460|Precision medicine|precision medicine
5172030|NCT02917460|Biorepository|biorepository
5172031|NCT02917447|PTSD|ptsd
5172032|NCT02917447|Women Veterans|women veterans
5172033|NCT02917447|Online intervention|online intervention
5172034|NCT02917434|Obesity|obesity
5172035|NCT02917434|Psoriatic arthritis|psoriatic arthritis
5172036|NCT02917434|Psoriasis|psoriasis
5172037|NCT02917434|Metabolic syndrome|metabolic syndrome
5172038|NCT02917434|Cardiovascular disease|cardiovascular disease
5172039|NCT02917395|hypertrophic cardiomyopathy, disopyramide,|hypertrophic cardiomyopathy, disopyramide,
5172040|NCT02917369|LCLC; Integrative Analysis; Metastasis|lclc; integrative analysis; metastasis
5172041|NCT02917356|Healing touch|healing touch
5172042|NCT02917356|Faith Healing|faith healing
5172043|NCT02917356|Pain|pain
5172044|NCT02917356|Joint stiffness|joint stiffness
5172045|NCT02917356|Functional status|functional status
5172046|NCT02917356|Mental health|mental health
5172047|NCT02917356|Osteoarthritis|osteoarthritis
5172048|NCT02917304|Quadrivalent Influenza Vaccines|quadrivalent influenza vaccines
5172049|NCT02917291|Trauma Spinal Cord|trauma spinal cord
5172050|NCT02917291|Thoracic Acute Spinal Cord Injury|thoracic acute spinal cord injury
5172051|NCT02917291|Neurosurgery|neurosurgery
5172052|NCT02917291|Cell Therapy|cell therapy
5172054|NCT02917291|HC016 adipose mesenchymal stem cell|hc016 adipose mesenchymal stem cell
5045285|NCT03715946|OPSCC|opscc
5172055|NCT02917291|SPINE|spine
5172056|NCT02917265|vagus nerve stimulation|vagus nerve stimulation
5172057|NCT02917265|systemic lupus erythematosus|systemic lupus erythematosus
5172058|NCT02917213|acute myocardial infarction|acute myocardial infarction
5172059|NCT02917213|cardiac embolism|cardiac embolism
5172060|NCT02917213|intracardiac fluid dynamics|intracardiac fluid dynamics
5172061|NCT02917213|silent brain infarct|silent brain infarct
5172062|NCT02917213|intracardiac blood stasis|intracardiac blood stasis
5172063|NCT02917174|asthma|asthma
5172064|NCT02917174|m-health|m-health
5172065|NCT02917174|asthma control|asthma control
5172066|NCT02917174|self-management|self-management
5172067|NCT02917161|Prostate|prostate
5172068|NCT02917161|Prostatic Neoplams|prostatic neoplams
5172069|NCT02917161|Therapeutic Embolization|therapeutic embolization
5172070|NCT02917161|Prostatectomy|prostatectomy
5172071|NCT02917122|Parkinson disease|parkinson disease
5172072|NCT02917122|transcranial direct current stimulation|transcranial direct current stimulation
5172073|NCT02917122|depression|depression
5172074|NCT02917122|dopamine transporter|dopamine transporter
5172075|NCT02917122|single photon emission computerized tomography|single photon emission computerized tomography
5172076|NCT02917083|chimeric antigen receptors|chimeric antigen receptors
5172077|NCT02917083|immunotherapy|immunotherapy
5172078|NCT02917083|CAR T-cells|car t-cells
5172079|NCT02917083|lymphoma|lymphoma
5172080|NCT02917083|Cyclophosphamide|cyclophosphamide
5172081|NCT02917083|fludarabine|fludarabine
5172082|NCT02917070|Consanguinity-associated kidney diseases|consanguinity-associated kidney diseases
5172083|NCT02917070|Turkey population|turkey population
5172084|NCT02917044|Atrial Fibrillation|atrial fibrillation
5172092|NCT02917005|breast cancer|breast cancer
5172093|NCT02917005|hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
5172094|NCT02917005|palbociclib|palbociclib
5172095|NCT02917005|premenopausal|premenopausal
5172096|NCT02916992|spontaneous pneumothorax|spontaneous pneumothorax
5172097|NCT02916992|familial pneumothorax|familial pneumothorax
5172098|NCT02916992|Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome
5172099|NCT02916992|prevalence|prevalence
5172100|NCT02916992|FLCN mutation|flcn mutation
5172101|NCT02916992|Lung cysts|lung cysts
5172103|NCT02916992|inherited disease|inherited disease
5172104|NCT02916992|genetic disease|genetic disease
5172105|NCT02916992|primary pneumothorax|primary pneumothorax
5172106|NCT02916992|CAT scan|cat scan
5172107|NCT02916992|CT scan|ct scan
5172108|NCT02916940|sprains of the proximal interphalangeal joints of the long fingers|sprains of the proximal interphalangeal joints of the long fingers
5172109|NCT02916940|Diprophos|diprophos
5172110|NCT02916927|ketamine|ketamine
5172111|NCT02916927|emergency department|emergency department
5172112|NCT02916914|preterm|preterm
5172113|NCT02916914|feeding|feeding
5172114|NCT02916914|oral transition|oral transition
5172115|NCT02916901|Dyslipidemia|dyslipidemia
5172116|NCT02916901|CKD-519|ckd-519
5172117|NCT02916901|CETP inhibitor|cetp inhibitor
5172118|NCT02916901|ABPM|abpm
5172119|NCT02916888|Atopic dermatitis|atopic dermatitis
5172120|NCT02916888|Topical corticosteroid|topical corticosteroid
5172121|NCT02916888|Pediatric|pediatric
5172122|NCT02916888|Eczema|eczema
5172123|NCT02916888|Quality of life|quality of life
5172124|NCT02916875|Shared decision Making|shared decision making
5172125|NCT02916875|Follow-up|follow-up
5172130|NCT02916849|Accidental Falls|accidental falls
5172131|NCT02916849|Prevention & Control|prevention & control
5172132|NCT02916849|Exercise|exercise
5172134|NCT02916849|Aged|aged
5172135|NCT02916849|Aged 80 and over|aged 80 and over
5172136|NCT02916849|Smartphone|smartphone
5172137|NCT02916849|Computers|computers
5172138|NCT02916849|Computers handheld|computers handheld
5172139|NCT02916849|Motivation|motivation
5172140|NCT02916849|Postural balance|postural balance
5172141|NCT02916849|Health behaviour|health behaviour
5172142|NCT02916849|mHealth|mhealth
5172143|NCT02916849|eHealth|ehealth
5172144|NCT02916810|transcranial magnetic stimulation|transcranial magnetic stimulation
5172145|NCT02916810|schizophrenia|schizophrenia
5172147|NCT02916797|Feedback|feedback
5172148|NCT02916797|Physical Therapy|physical therapy
5172149|NCT02916784|Sit-to-stand|sit-to-stand
5172150|NCT02916784|Walking devices|walking devices
5172151|NCT02916771|Smoldering Multiple Myeloma|smoldering multiple myeloma
5172152|NCT02916758|older adults|older adults
5172153|NCT02916758|community mobility|community mobility
5172154|NCT02916758|wellness|wellness
5172155|NCT02916758|isolation|isolation
5172156|NCT02916745|Non-small cell lung cancer|non-small cell lung cancer
5172157|NCT02916745|NSCLC|nsclc
5172158|NCT02916745|lung cancer|lung cancer
5172159|NCT02916745|lung carcinoma|lung carcinoma
5172160|NCT02916745|lung metastasis|lung metastasis
5172161|NCT02916732|asymptomatics|asymptomatics
5172162|NCT02916732|microcephaly|microcephaly
5962171|NCT04282512|Sodium bicarbonate|sodium bicarbonate
5172163|NCT02916732|abnormalities|abnormalities
5172164|NCT02916719|neo-adjuvant radiotherapy|neo-adjuvant radiotherapy
5172165|NCT02916719|breast cancer|breast cancer
5172167|NCT02916693|Mirabegron|mirabegron
5172168|NCT02916693|Overactive Bladder|overactive bladder
5172169|NCT02916693|Erectile Dysfunction|erectile dysfunction
5172170|NCT02916693|Beta 3 agonist|beta 3 agonist
5172171|NCT02916680|Pancreatic islet transplantation|pancreatic islet transplantation
5172172|NCT02916641|Fuzhenghuayu|fuzhenghuayu
5172173|NCT02916628|smoking cessation|smoking cessation
5172174|NCT02916628|group counseling|group counseling
5172175|NCT02916628|acupressure|acupressure
5172176|NCT02916628|serotonin|serotonin
5172177|NCT02916628|depressive symptoms|depressive symptoms
5172178|NCT02916628|resilience|resilience
5172179|NCT02916537|prostate cancer|prostate cancer
5172180|NCT02916537|prostate specific membrane antigen|prostate specific membrane antigen
5172181|NCT02916537|prostate neoplasms|prostate neoplasms
5172182|NCT02916537|metastatic prostate cancer|metastatic prostate cancer
5172183|NCT02916537|prostatic hyperplasia|prostatic hyperplasia
5172184|NCT02916524|Aphasia|aphasia
5172185|NCT02916524|Bilingualism|bilingualism
5172186|NCT02916524|Language therapy|language therapy
5172187|NCT02916524|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5172188|NCT02916524|Speech-language pathology|speech-language pathology
5779263|NCT00200863|alertness|alertness
5172189|NCT02916498|chronic neuropathic pain in the low back and legs|chronic neuropathic pain in the low back and legs
5172190|NCT02916498|subperception spinal cord stimulation|subperception spinal cord stimulation
5172191|NCT02916485|bioresorbable scaffold|bioresorbable scaffold
5172192|NCT02916485|vascular restoration therapy|vascular restoration therapy
5172193|NCT02916472|AYA|aya
5172194|NCT02916472|exercise|exercise
5172195|NCT02916472|cancer|cancer
5172196|NCT02916472|cybercycling|cybercycling
5172197|NCT02916407|Anesthesia|anesthesia
5172198|NCT02916407|Agitation|agitation
5172199|NCT02916407|Extubation|extubation
5172200|NCT02916316|Lymphoma|lymphoma
5172201|NCT02916316|Large B-Cell|large b-cell
5172202|NCT02916316|Cardiotoxicity|cardiotoxicity
5172203|NCT02916303|Schizophrenia|schizophrenia
5172204|NCT02916303|Psychosis|psychosis
5172205|NCT02916303|Effectiveness|effectiveness
5172206|NCT02916290|Fuzhenghuayu|fuzhenghuayu
5172207|NCT02916264|scalp block, surgical peth index|scalp block, surgical peth index
5172208|NCT02916160|Chronic Heart failure|chronic heart failure
5172209|NCT02916160|Sleep Apnea Syndrome|sleep apnea syndrome
5172210|NCT02916160|Continuous Positive Airways Pressure|continuous positive airways pressure
5172211|NCT02916160|SACUBITRIL - VALSARTAN|sacubitril - valsartan
5172212|NCT02916108|Concussion|concussion
5172213|NCT02916108|Mild traumatic brain injury|mild traumatic brain injury
5172214|NCT02916108|EEG|eeg
5172215|NCT02916082|Cervical length|cervical length
5172216|NCT02916082|Prolonged pregnancy|prolonged pregnancy
5172217|NCT02916082|Vaginal birth|vaginal birth
5172218|NCT02916069|Spectroscopy|spectroscopy
5172219|NCT02916069|Transcranial Doppler|transcranial doppler
5172220|NCT02916069|Bispectral index|bispectral index
5172221|NCT02916069|Cardiac surgery|cardiac surgery
5172222|NCT02916056|Alzheimer's disease|alzheimer's disease
5172223|NCT02916056|RAGE|rage
5172224|NCT02916056|ADAS-cog|adas-cog
5172225|NCT02916056|CDR-sb|cdr-sb
5172226|NCT02916043|acute kidney injury|acute kidney injury
5172227|NCT02916043|cardiovascular surgery|cardiovascular surgery
5172228|NCT02916043|mortality|mortality
5172229|NCT02916030|Vitamin D|vitamin d
5172230|NCT02916030|Stroke|stroke
5172231|NCT02916030|Parathormone|parathormone
5172232|NCT02916017|Humira|humira
5167264|NCT02946853|CRT|crt
5172234|NCT02916017|Non-infectious Intermediate-, Posterior-, or Pan-uveitis|non-infectious intermediate-, posterior-, or pan-uveitis
5172235|NCT02916004|Analgesia|analgesia
5172236|NCT02916004|Pain measurement|pain measurement
5172237|NCT02916004|Nociception|nociception
5172240|NCT02916004|Pupillometry|pupillometry
5172241|NCT02916004|Critical care|critical care
5172242|NCT02916004|Sedation|sedation
5172243|NCT02915991|Coronary catheterization|coronary catheterization
5172244|NCT02915991|Instantaneous wave free ratio (iFR)|instantaneous wave free ratio (ifr)
5172245|NCT02915991|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5172246|NCT02915991|automated co-registration|automated co-registration
5172247|NCT02915939|Family caregiving|family caregiving
5172248|NCT02915939|Institutionalization|institutionalization
5172249|NCT02915939|Residential long-term care|residential long-term care
5172250|NCT02915939|Placement|placement
5172251|NCT02915939|Psychosocial support|psychosocial support
5172252|NCT02915939|Dementia|dementia
5172253|NCT02915939|Caregivers|caregivers
5172254|NCT02915939|Nursing homes|nursing homes
5172255|NCT02915939|Assisted Living Facilities|assisted living facilities
5172256|NCT02915939|Long-Term Care|long-term care
5172257|NCT02915939|Intervention Study|intervention study
5172258|NCT02915939|Psychosocial Support Systems|psychosocial support systems
5172259|NCT02915939|Social Support|social support
5172261|NCT02915900|In vitro fertilization|in vitro fertilization
5172262|NCT02915887|neck pain|neck pain
5172263|NCT02915887|chronic|chronic
5172264|NCT02915887|taping|taping
5172265|NCT02915887|kinematics|kinematics
5038766|NCT03756220|Sepsis|sepsis
5172266|NCT02915887|motion analysis|motion analysis
5172267|NCT02915887|physiotherapy|physiotherapy
5172268|NCT02915861|immune responses|immune responses
5172269|NCT02915861|vaccines|vaccines
5172270|NCT02915848|deep brain stimulation|deep brain stimulation
5172271|NCT02915848|local field potential|local field potential
5172272|NCT02915848|kinematic analysis|kinematic analysis
5172273|NCT02915835|Scleroderma|scleroderma
5172274|NCT02915835|Digital Ulcer|digital ulcer
5172275|NCT02915809|Influenza Vaccines|influenza vaccines
5172276|NCT02915796|Endothelial progenitor cell|endothelial progenitor cell
5172277|NCT02915796|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5172280|NCT02915770|Moderate dilatation of common bile duct|moderate dilatation of common bile duct
5172281|NCT02915757|Depression|depression
5172282|NCT02915757|EDOR test|edor test
5172283|NCT02915757|Electrodermal hyporeactivity|electrodermal hyporeactivity
5172284|NCT02915744|Breast Cancer Brain Metastases (BCBM)|breast cancer brain metastases (bcbm)
5172285|NCT02915744|Carcinoma|carcinoma
5172286|NCT02915731|Vitamin A stores|vitamin a stores
5172287|NCT02915731|Stable isotope dilution|stable isotope dilution
5172288|NCT02915731|Multiple vitamin A interventions|multiple vitamin a interventions
5172289|NCT02915718|dilated cardiomyopathy|dilated cardiomyopathy
5172290|NCT02915718|immunoadsorption|immunoadsorption
5172291|NCT02915692|Foley|foley
5172292|NCT02915692|CAUTI|cauti
5172293|NCT02915692|ERASE CAUTI|erase cauti
5172294|NCT02915679|Suicidal behavior|suicidal behavior
5172295|NCT02915679|psychological and social pain|psychological and social pain
5172296|NCT02915679|physical pain|physical pain
5172297|NCT02915679|pain perception|pain perception
5172298|NCT02915666|Melanoma, skin|melanoma, skin
5172299|NCT02915627|Antishock Garment|antishock garment
5172300|NCT02915614|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5172301|NCT02915614|pulmonary rehabilitation|pulmonary rehabilitation
5172302|NCT02915614|exercise training|exercise training
5172303|NCT02915614|skeletal muscle biopsy|skeletal muscle biopsy
5172304|NCT02915562|rehabilitation|rehabilitation
5172305|NCT02915562|exercise|exercise
5172306|NCT02915562|outcome measurement|outcome measurement
5172307|NCT02915549|premature infant|premature infant
5172308|NCT02915549|early progressive feeding|early progressive feeding
5172309|NCT02915536|iodine excess|iodine excess
5172310|NCT02915536|thyroid disease|thyroid disease
5172311|NCT02915536|children|children
5172312|NCT02915536|tolerable upper intake level|tolerable upper intake level
5172313|NCT02915523|Ovarian Cancer|ovarian cancer
5172314|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5172315|NCT02915523|Entinostat|entinostat
5172316|NCT02915523|Solid tumor|solid tumor
5172317|NCT02915523|Avelumab|avelumab
5172318|NCT02915523|SNDX-275|sndx-275
5172319|NCT02915523|Ovarian Neoplasms|ovarian neoplasms
5172320|NCT02915523|Ovarian Diseases|ovarian diseases
5172321|NCT02915523|Fallopian Tube Cancer|fallopian tube cancer
5172322|NCT02915523|Peritoneal Cancer|peritoneal cancer
5172323|NCT02915497|Prolonged Exposure Therapy|prolonged exposure therapy
5172324|NCT02915484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5172325|NCT02915484|Apathy|apathy
5172326|NCT02915484|Stroke|stroke
5172327|NCT02915484|Empathy|empathy
5172328|NCT02915484|Electric Stimulation Therapy|electric stimulation therapy
5172329|NCT02915484|Depression|depression
5172330|NCT02915484|Anhedonia|anhedonia
5172331|NCT02915484|Prefrontal Cortex|prefrontal cortex
5172332|NCT02915484|Electroencephalography|electroencephalography
5172453|NCT02915042|dexmedetomidine|dexmedetomidine
5172335|NCT02915484|Neurological Rehabilitation|neurological rehabilitation
5172336|NCT02915484|Brain Diseases|brain diseases
5172337|NCT02915484|Cerebrovascular Disorders|cerebrovascular disorders
5172338|NCT02915471|Adolescent|adolescent
5172339|NCT02915471|Online Peer Support|online peer support
5172340|NCT02915471|Managing Cancer|managing cancer
5172341|NCT02915471|Mentor|mentor
5172342|NCT02915458|Weaning|weaning
5172343|NCT02915458|Mechanical ventilation|mechanical ventilation
5172344|NCT02915458|synchrosqueezing transform|synchrosqueezing transform
5172345|NCT02915445|EpCAM CAR-T, solid tumors, cancer immunotherapy|epcam car-t, solid tumors, cancer immunotherapy
5172346|NCT02915432|Anti PD-1|anti pd-1
5172347|NCT02915432|JS001|js001
5172348|NCT02915432|Gastric Adenocarcinoma|gastric adenocarcinoma
5172349|NCT02915432|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5172350|NCT02915432|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5172351|NCT02915432|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5172352|NCT02915432|Simon's Two Stage|simon's two stage
5172353|NCT02915432|ORR|orr
5172354|NCT02915393|Chronic Gastritis|chronic gastritis
5172355|NCT02915393|Qi Deficiency Constitution|qi deficiency constitution
5172356|NCT02915393|Next Generation Sequencing|next generation sequencing
5172357|NCT02915393|Proteomics|proteomics
5172358|NCT02915393|Metabonomics|metabonomics
5962172|NCT04282499|Hypertension|hypertension
5172359|NCT02915367|HIV/AIDS|hiv/aids
5172360|NCT02915367|adherence|adherence
5172361|NCT02915367|women|women
5962173|NCT04282499|Cardiac Disease|cardiac disease
5172362|NCT02915367|real time monitoring|real time monitoring
5172363|NCT02915367|risk|risk
5172365|NCT02915367|mHealth|mhealth
5172366|NCT02915315|blood pressure|blood pressure
5172367|NCT02915315|Hypertrophy|hypertrophy
5172368|NCT02915315|Left Ventricular|left ventricular
5172369|NCT02915315|arterial Stiffness|arterial stiffness
5172370|NCT02915315|Proteinuria|proteinuria
5172371|NCT02915315|baPWV|bapwv
5172372|NCT02915315|ambulatory Blood Pressure|ambulatory blood pressure
5172373|NCT02915302|Influenza|influenza
5172374|NCT02915302|Influenza virus vaccine|influenza virus vaccine
5172375|NCT02915302|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
5172376|NCT02915289|Caesarean section|caesarean section
5172377|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate
5172378|NCT02915276|Blastocyst|blastocyst
5172379|NCT02915276|Human|human
5172380|NCT02915276|DNA|dna
5172381|NCT02915276|Blastocentesis|blastocentesis
5172382|NCT02915263|Diabetes Complications|diabetes complications
5172383|NCT02915263|Diabetes Mellitus|diabetes mellitus
5172384|NCT02915263|Diabetic Neuropathies|diabetic neuropathies
5172385|NCT02915263|IGIV-C|igiv-c
5172386|NCT02915263|Immune Globulin Injection (Human), 10% Caprylate/Chromatography|immune globulin injection (human), 10% caprylate/chromatography
5172387|NCT02915263|Gamunex-C|gamunex-c
5172388|NCT02915237|Veterans|veterans
5172389|NCT02915237|Gulf War Illness|gulf war illness
5172390|NCT02915237|Gulf War Veterans's Illness|gulf war veterans's illness
5172391|NCT02915237|Gulf War Veterans' Medically Unexplained Illnesses|gulf war veterans' medically unexplained illnesses
5172392|NCT02915211|Epilepsy|epilepsy
5172393|NCT02915211|Glut|glut
5172394|NCT02915211|Ketogenic|ketogenic
5172395|NCT02915211|Glucose|glucose
5172396|NCT02915198|Metformin|metformin
5172397|NCT02915198|Atherosclerosis|atherosclerosis
5172398|NCT02915198|Prediabetic State|prediabetic state
5172399|NCT02915198|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5172400|NCT02915198|Coronary Artery Disease|coronary artery disease
5172401|NCT02915198|Peripheral Arterial Disease|peripheral arterial disease
5172402|NCT02915198|Cerebrovascular Disorders|cerebrovascular disorders
5172403|NCT02915185|exercise|exercise
5172404|NCT02915185|rehabilitation|rehabilitation
5172405|NCT02915185|recovery of function|recovery of function
5172406|NCT02915185|transcranial magnetic stimulation|transcranial magnetic stimulation
5172407|NCT02915185|transcranial direct-current stimulation|transcranial direct-current stimulation
5172408|NCT02915172|Advanced Cancer|advanced cancer
5172409|NCT02915172|Malignant neoplasm of breast|malignant neoplasm of breast
5172410|NCT02915172|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
5172411|NCT02915172|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
5172412|NCT02915172|Malignant neoplasms of eye brain and other parts of central nervous system|malignant neoplasms of eye brain and other parts of central nervous system
5172413|NCT02915172|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5172414|NCT02915172|Malignant neoplasms of ill-defined secondary and unspecified sites|malignant neoplasms of ill-defined secondary and unspecified sites
5172415|NCT02915172|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5172416|NCT02915172|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5172417|NCT02915172|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5172418|NCT02915172|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
5172419|NCT02915172|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
5172420|NCT02915172|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
5172421|NCT02915172|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
5172422|NCT02915172|Lenvatinib|lenvatinib
5172423|NCT02915172|E7080|e7080
5172424|NCT02915172|Lenvima|lenvima
5172425|NCT02915172|Capecitabine|capecitabine
5172426|NCT02915172|Xeloda|xeloda
5172427|NCT02915146|eczema|eczema
5172428|NCT02915146|phototherapy|phototherapy
5172429|NCT02915146|uva1|uva1
5172430|NCT02915146|uvb|uvb
5172431|NCT02915146|adults|adults
5172432|NCT02915146|children|children
5172433|NCT02915133|high myopia|high myopia
5172434|NCT02915133|myopia foveoschisis|myopia foveoschisis
5172435|NCT02915133|macular buckling|macular buckling
5172436|NCT02915120|Knee pain|knee pain
5172437|NCT02915120|osteoarthritis|osteoarthritis
5172438|NCT02915120|genicular nerve|genicular nerve
5172439|NCT02915120|ultrasonography|ultrasonography
5172440|NCT02915120|pulsed radiofrequency|pulsed radiofrequency
5172441|NCT02915107|drug eluting stents|drug eluting stents
5172442|NCT02915107|coronary vascular healing|coronary vascular healing
5172443|NCT02915068|patient-provider communication|patient-provider communication
5172444|NCT02915068|Electronic Health Records|electronic health records
5172445|NCT02915068|Provider education|provider education
5172446|NCT02915055|Analgesic efficacy|analgesic efficacy
5172447|NCT02915055|knee arthroplasty|knee arthroplasty
5172448|NCT02915055|Opioid consumption|opioid consumption
5172449|NCT02915055|Pain Medicine|pain medicine
5172450|NCT02915055|Narcotics|narcotics
5172451|NCT02915055|Multimodal Analgesia|multimodal analgesia
5172452|NCT02915042|Pain|pain
5172454|NCT02915042|postoperative|postoperative
5172455|NCT02915029|Native American|native american
5060049|NCT03623620|Mindfulness|mindfulness
5172456|NCT02915029|Community Health Representative|community health representative
5172457|NCT02915029|Home base|home base
5172458|NCT02915029|Diabetes|diabetes
5172459|NCT02915029|Point of care testing|point of care testing
5172460|NCT02915029|Patient Activation Measure|patient activation measure
5172461|NCT02915029|Patient preferences|patient preferences
5172462|NCT02915003|health care navigation|health care navigation
5172463|NCT02915003|health literacy|health literacy
5172464|NCT02915003|Affordable Care Act|affordable care act
5172465|NCT02914977|Relapsed|relapsed
5172466|NCT02914977|Refractory|refractory
5172467|NCT02914964|Fatigue|fatigue
5172468|NCT02914964|Quality of Life|quality of life
5172469|NCT02914964|Diet|diet
5172470|NCT02914951|Autism|autism
5172471|NCT02914951|Irritability|irritability
5172472|NCT02914951|Disruptive Behavior|disruptive behavior
5172473|NCT02914951|Aggression|aggression
5172474|NCT02914951|Behavior Therapy|behavior therapy
5172475|NCT02914951|Cognitive Behavioral Therapy|cognitive behavioral therapy
5172476|NCT02914951|Intellectual Disability|intellectual disability
5172477|NCT02914951|Cognitive Impairment|cognitive impairment
5172478|NCT02914925|CIT|cit
5172479|NCT02914925|ArmeoSpring|armeospring
5172480|NCT02914925|TMS|tms
5172481|NCT02914899|Chinese Taxi Drivers|chinese taxi drivers
5172482|NCT02914899|16-949|16-949
5172483|NCT02914886|Diabetes|diabetes
5172484|NCT02914886|Lipoatrophy|lipoatrophy
5172485|NCT02914886|children|children
5172486|NCT02914886|adolescents|adolescents
5172487|NCT02914886|adults|adults
5172488|NCT02914886|insulin therapy|insulin therapy
5172489|NCT02914873|prostate cancer|prostate cancer
5172490|NCT02914873|active surveillance|active surveillance
5172491|NCT02914873|standardised treatment triggers|standardised treatment triggers
5172492|NCT02914873|MRI|mri
5172493|NCT02914873|randomized|randomized
5172494|NCT02914821|consumption|consumption
5172495|NCT02914821|decision making|decision making
5172496|NCT02914821|policy|policy
5172497|NCT02914821|sweetened beverages|sweetened beverages
5172498|NCT02914821|taxes|taxes
5172499|NCT02914821|Diet, Food, and Nutrition|diet, food, and nutrition
5172500|NCT02914769|Depression|depression
5172501|NCT02914769|Ayahuasca|ayahuasca
5172502|NCT02914769|Psychedelics|psychedelics
5172503|NCT02914743|Oral health|oral health
5172504|NCT02914743|Diabetes|diabetes
5172505|NCT02914743|Interprofessionalism|interprofessionalism
5172506|NCT02914743|Periodontal disease|periodontal disease
5172507|NCT02914730|diabetes|diabetes
5172508|NCT02914730|insulin|insulin
5172509|NCT02914730|medication adherence|medication adherence
5172510|NCT02914717|golimumab|golimumab
5172511|NCT02914691|Type 2 diabetes|type 2 diabetes
5172512|NCT02914691|Diabetic Nephropathy|diabetic nephropathy
5172513|NCT02914691|Proteomics|proteomics
5172514|NCT02914691|Albuminuria|albuminuria
5172515|NCT02914691|SGLT2 inhibitor|sglt2 inhibitor
5172516|NCT02914678|Emergency Medical Services|emergency medical services
5172517|NCT02914678|Analgesics|analgesics
5172518|NCT02914665|Heart failure|heart failure
5172519|NCT02914665|diuresis|diuresis
5172520|NCT02914665|dropsy|dropsy
5172521|NCT02914665|congestion|congestion
5172522|NCT02914665|elamipretide|elamipretide
5172523|NCT02914665|MTP-131|mtp-131
5172524|NCT02914665|Bendavia™|bendavia™
5172525|NCT02914652|Congenital Heart Disease|congenital heart disease
5172526|NCT02914652|Ventricular Septal Defect|ventricular septal defect
5172527|NCT02914652|Beta-2-agonists|beta-2-agonists
5172529|NCT02914652|Follow-up|follow-up
5172530|NCT02914626|Glaucoma, Neovascular|glaucoma, neovascular
5172531|NCT02914626|Ranibizumab|ranibizumab
5172532|NCT02914626|Intraocular pressure|intraocular pressure
5172533|NCT02914626|anti-VEGF|anti-vegf
5172534|NCT02914626|intravitreal injection|intravitreal injection
5172535|NCT02914483|Myocardial Infarction|myocardial infarction
5172536|NCT02914483|Women|women
5172537|NCT02914483|Stress Management|stress management
5172538|NCT02914470|advanced|advanced
5172539|NCT02914431|Personalized Titanium Plate|personalized titanium plate
5172540|NCT02914431|Orthognathic Surgery|orthognathic surgery
5172541|NCT02914431|Maxilla Repositioning|maxilla repositioning
5172542|NCT02914431|Accuracy|accuracy
5423226|NCT01616589|Fragile X syndrome|fragile x syndrome
5172543|NCT02914431|Computer-aided Design and Manufacturing|computer-aided design and manufacturing
5172544|NCT02914431|Patient Specified Implants (PSI)|patient specified implants (psi)
5172545|NCT02914418|transcranial magnetic stimulation|transcranial magnetic stimulation
5172546|NCT02914418|Spinal Cord Injuries|spinal cord injuries
5172547|NCT02914418|Muscle Spasticity|muscle spasticity
5172549|NCT02914418|Spinal Cord|spinal cord
5172550|NCT02914418|Spinal Cord Diseases|spinal cord diseases
5172551|NCT02914405|131-I-mIBG therapy|131-i-mibg therapy
5172552|NCT02914405|ch14.18/CHO|ch14.18/cho
5172553|NCT02914405|Nivolumab|nivolumab
5172554|NCT02914392|case control study|case control study
5172555|NCT02914392|Environmental Factors|environmental factors
5172556|NCT02914392|Fetal Congenital Heart Disease|fetal congenital heart disease
5172557|NCT02914366|Ambroxol|ambroxol
5172558|NCT02914366|Dementia|dementia
5172559|NCT02914366|Parkinson's disease|parkinson's disease
5172560|NCT02914366|Disease modifying treatment|disease modifying treatment
5172561|NCT02914366|Pharmacological Chaperone|pharmacological chaperone
5172563|NCT02914353|Factor X!a|factor x!a
5172564|NCT02914353|anticoagulant|anticoagulant
5172565|NCT02914353|thromboembolism|thromboembolism
5172566|NCT02914353|venous thromboembolism|venous thromboembolism
5172567|NCT02914353|embolism and thrombosis|embolism and thrombosis
5172568|NCT02914353|enzyme inhibitors|enzyme inhibitors
5172569|NCT02914353|hematologic agent|hematologic agent
5172570|NCT02914327|CLL|cll
5172571|NCT02914327|Leukemia, Chronic Lymphocytic|leukemia, chronic lymphocytic
5172572|NCT02914327|Hsp90|hsp90
5172573|NCT02914327|BTK|btk
5172574|NCT02914327|Ibrutinib|ibrutinib
5172575|NCT02914314|epilepsy|epilepsy
5172576|NCT02914314|refractory partial seizures|refractory partial seizures
5172577|NCT02914249|Orange juice|orange juice
5172578|NCT02914249|Low-calorie diet|low-calorie diet
5172579|NCT02914249|Body composition|body composition
5172580|NCT02914249|Weight-loss|weight-loss
5172581|NCT02914249|Metabolic biomarkers|metabolic biomarkers
5172582|NCT02914249|Obese|obese
5172583|NCT02914236|Nasal valve|nasal valve
5172584|NCT02914236|Nasal airway obstruction|nasal airway obstruction
5172585|NCT02914210|TKR|tkr
5172586|NCT02914210|TKA|tka
5172587|NCT02914210|Knee|knee
5172588|NCT02914210|Surgery|surgery
5172589|NCT02914210|Replacement|replacement
5172590|NCT02914210|Rehabilitation|rehabilitation
5172591|NCT02914210|Virtual|virtual
5172592|NCT02914210|Physical Therapy|physical therapy
5172593|NCT02914210|Telerehabilitation|telerehabilitation
5172594|NCT02914197|Decision|decision
5172595|NCT02914197|Mammography|mammography
5172596|NCT02914197|Informed Choice|informed choice
5172597|NCT02914197|Full Information|full information
5172598|NCT02914197|Decision Aid|decision aid
5172599|NCT02914197|Self-efficacy|self-efficacy
5172600|NCT02914197|Shared decision making|shared decision making
5172601|NCT02914197|Over-detection|over-detection
5172602|NCT02914197|Over-diagnosis|over-diagnosis
5172603|NCT02914184|Safety|safety
5172604|NCT02914184|Healthy infants|healthy infants
5172605|NCT02914184|Immunogenicity|immunogenicity
5172606|NCT02914184|Human Rotavirus (HRV)|human rotavirus (hrv)
5172607|NCT02914171|Myopathic right ventricle|myopathic right ventricle
5172608|NCT02914158|breast cancer|breast cancer
5172609|NCT02914158|ovarian function suppression (OFS)|ovarian function suppression (ofs)
5172610|NCT02914158|aromatase inhibitors（AIs）|aromatase inhibitors（ais）
5172611|NCT02914158|tamoxifen（TAM）|tamoxifen（tam）
5172612|NCT02914119|Residual nerve blockade|residual nerve blockade
5172613|NCT02914119|Neuromuscular monitoring|neuromuscular monitoring
5172614|NCT02914119|Residual curarization|residual curarization
5172615|NCT02914119|Neuromuscular blocking agents|neuromuscular blocking agents
5172616|NCT02914106|Neuroactive steroids|neuroactive steroids
5172617|NCT02914106|Acute Ischemic Stroke|acute ischemic stroke
5172618|NCT02914106|Patients|patients
5172619|NCT02914093|Hypercapnia|hypercapnia
5172620|NCT02914093|Physiotherapy|physiotherapy
5172621|NCT02914093|Inspiratory Muscle Training|inspiratory muscle training
5172622|NCT02914067|Pediatric brain tumors|pediatric brain tumors
5172623|NCT02914067|Cognitive deficits|cognitive deficits
5172624|NCT02914067|Resting state functional connectivity|resting state functional connectivity
5172625|NCT02914067|NIH toolbox|nih toolbox
5172628|NCT02914041|Kyphosis wall distance|kyphosis wall distance
5172629|NCT02914041|elderly|elderly
5172630|NCT02914028|TAP block|tap block
5172631|NCT02914028|subacute pain|subacute pain
5172632|NCT02914028|inguinal herniography|inguinal herniography
5172633|NCT02913937|ultrasonic irrigation|ultrasonic irrigation
5172634|NCT02913937|pain|pain
5172635|NCT02913937|healing|healing
5172636|NCT02913937|apical periodontitis|apical periodontitis
5172637|NCT02913924|Marijuana|marijuana
5172638|NCT02913924|Treatment|treatment
5172639|NCT02913911|feedback|feedback
5172640|NCT02913898|learning|learning
5172641|NCT02913872|Spirometry|spirometry
5172642|NCT02913872|Exhaled Nitric Oxide|exhaled nitric oxide
5172643|NCT02913872|Primary Care|primary care
5172645|NCT02913859|hormone-sensitive|hormone-sensitive
5172646|NCT02913859|metastasis|metastasis
5172647|NCT02913846|denutrition|denutrition
5172648|NCT02913846|hospital length of stay|hospital length of stay
5172649|NCT02913846|patient's autonomy|patient's autonomy
5172650|NCT02913833|Pain|pain
5172651|NCT02913833|Hospital length of stay|hospital length of stay
5172652|NCT02913833|Revalidation unit|revalidation unit
5172653|NCT02913781|Polar body removal|polar body removal
5962174|NCT04282499|Excercise|excercise
5172654|NCT02913781|ICSI|icsi
5172655|NCT02913781|Fertilization failure|fertilization failure
5962175|NCT04282486|Willebrand disease|willebrand disease
5172656|NCT02913742|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
5172657|NCT02913729|breast cancer|breast cancer
5172658|NCT02913703|Ghrelin|ghrelin
5172659|NCT02913690|Hemodialysis|hemodialysis
5172660|NCT02913690|Tocotrienol|tocotrienol
5172661|NCT02913690|Vitamin E|vitamin e
5172662|NCT02913677|feeding intolerance|feeding intolerance
5172663|NCT02913677|minimal enteral nutrition|minimal enteral nutrition
5172664|NCT02913677|very low birth weight|very low birth weight
5172665|NCT02913677|preterm infant|preterm infant
5172666|NCT02913664|Dementia|dementia
5172667|NCT02913664|Alzheimer's Disease|alzheimer's disease
5172668|NCT02913664|Cognitive Function|cognitive function
5172669|NCT02913664|Blood Pressure|blood pressure
5172670|NCT02913664|Cholesterol|cholesterol
5172671|NCT02913664|Physical Activity|physical activity
5172672|NCT02913664|Exercise|exercise
5172673|NCT02913664|Magnetic Resonance Imaging|magnetic resonance imaging
5172674|NCT02913651|Idiopathic hypersomnia|idiopathic hypersomnia
5172675|NCT02913651|heart rate variability|heart rate variability
5172689|NCT02913508|Drug therapy|drug therapy
5172692|NCT02913469|Morphine，Ticagrelor，STEMI，PCI|morphine，ticagrelor，stemi，pci
5172693|NCT02913417|uveal melanoma|uveal melanoma
5172694|NCT02913417|liver metastases|liver metastases
5172695|NCT02913391|noninvasive ventilation|noninvasive ventilation
5172696|NCT02913391|myocardial revascularization|myocardial revascularization
5172697|NCT02913391|pulmonary atelectasis|pulmonary atelectasis
5172698|NCT02913391|hypoxia|hypoxia
5172699|NCT02913391|positive end-expiratory pressure|positive end-expiratory pressure
5172700|NCT02913391|coronary artery bypass grafting|coronary artery bypass grafting
5172701|NCT02913391|extracorporeal circulation|extracorporeal circulation
5172702|NCT02913365|Haemoptysis|haemoptysis
5172703|NCT02913365|Hemoptysis|hemoptysis
5172704|NCT02913365|Airway bleeding|airway bleeding
5172705|NCT02913365|Pulmonary hemorrhage|pulmonary hemorrhage
5172706|NCT02913339|screening|screening
5172707|NCT02913339|telemedicine|telemedicine
5172708|NCT02913339|risk assessment|risk assessment
5172709|NCT02913339|prevention|prevention
5172710|NCT02913300|Lignocaine|lignocaine
5172719|NCT02913248|periodontitis|periodontitis
5172720|NCT02913248|saliva|saliva
5172721|NCT02913248|bacteria|bacteria
5172722|NCT02913235|biofilm|biofilm
5172723|NCT02913235|saliva|saliva
5172724|NCT02913235|bacteria|bacteria
5172725|NCT02913235|oral hygiene|oral hygiene
5172726|NCT02913222|femoroacetabular impingement|femoroacetabular impingement
5172727|NCT02913222|labral tear|labral tear
5172728|NCT02913222|rehabilitation|rehabilitation
5172729|NCT02913183|acute stroke|acute stroke
5172730|NCT02913183|young health plasma|young health plasma
5172731|NCT02913183|efficacy|efficacy
5172732|NCT02913183|safety|safety
5172733|NCT02913105|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5172734|NCT02913105|NASH|nash
5172735|NCT02913105|Fatty liver disease|fatty liver disease
5172736|NCT02913014|Antiarrhythmic Agents|antiarrhythmic agents
5172737|NCT02913014|Catheter Ablation, electric|catheter ablation, electric
5172738|NCT02913014|Cardiac Arrhythmias|cardiac arrhythmias
5172739|NCT02913014|Anti-Arrhythmia Drugs|anti-arrhythmia drugs
5172740|NCT02913001|Diet|diet
5172741|NCT02913001|glycemic index|glycemic index
5172742|NCT02913001|glycemic load|glycemic load
5172743|NCT02913001|Acne Vulgaris|acne vulgaris
5172744|NCT02912988|Subfertility|subfertility
5172745|NCT02912988|In-vitro fertilization|in-vitro fertilization
5172746|NCT02912988|Letrozole|letrozole
5172747|NCT02912949|Bispecific Antibody IgG1, HER2, HER3|bispecific antibody igg1, her2, her3
5172748|NCT02912949|MCLA-128|mcla-128
5172749|NCT02912949|Antibodies, Bispecific|antibodies, bispecific
5172750|NCT02912949|Immunologic Factors|immunologic factors
5172751|NCT02912949|NRG1 fusion|nrg1 fusion
5172753|NCT02912949|Solid tumor|solid tumor
5172754|NCT02912949|Pancreatic cancer|pancreatic cancer
5172755|NCT02912949|PDAC|pdac
5172756|NCT02912949|Non-small cell lung cancer|non-small cell lung cancer
5172757|NCT02912949|NSCLC|nsclc
5172758|NCT02912949|zenocutuzumab|zenocutuzumab
5172759|NCT02912936|medium chain triglyceride|medium chain triglyceride
5172761|NCT02912936|coconut oil|coconut oil
5172762|NCT02912936|MRI|mri
5172763|NCT02912936|PET|pet
5172764|NCT02912936|ketones|ketones
5172765|NCT02912923|Stroke|stroke
5172766|NCT02912923|Rehabilitation Robotics|rehabilitation robotics
5172767|NCT02912923|Bimanual|bimanual
5172768|NCT02912923|Compensatory Movements|compensatory movements
5172770|NCT02912923|Kinematics|kinematics
5172771|NCT02912923|Reaching|reaching
5172772|NCT02912923|Trunk|trunk
5172773|NCT02912897|EBV-CTL|ebv-ctl
5172774|NCT02912897|Multiple sclerosis|multiple sclerosis
5172775|NCT02912897|cellular therapy|cellular therapy
5172776|NCT02912871|subthalamotomy|subthalamotomy
5172777|NCT02912871|motor features|motor features
5172778|NCT02912871|deep brain stimulation|deep brain stimulation
5172779|NCT02912832|Diagnosis|diagnosis
5172780|NCT02912806|Knee Arthroplasty|knee arthroplasty
5172781|NCT02912806|Total knee replacement|total knee replacement
5172782|NCT02912806|Knee osteoarthritis|knee osteoarthritis
5172783|NCT02912806|Patient-Outcomes Measurement Program|patient-outcomes measurement program
5172784|NCT02912806|Surgical Registries|surgical registries
5172785|NCT02912806|Shared Decision Making|shared decision making
5172884|NCT02911805|Exercise|exercise
5172786|NCT02912806|Patient Reported Outcomes|patient reported outcomes
5172787|NCT02912806|Patient Experience|patient experience
5172788|NCT02912806|Cohort Studies|cohort studies
5172789|NCT02912767|lower-extremity lymphedema|lower-extremity lymphedema
5172790|NCT02912767|16-1001|16-1001
5172791|NCT02912702|Pegaspargase|pegaspargase
5172792|NCT02912702|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5172793|NCT02912702|Epstein Barr virus|epstein barr virus
5172794|NCT02912702|initial treatment|initial treatment
5172795|NCT02912689|COPD|copd
5172796|NCT02912689|Non-invasive ventilation|non-invasive ventilation
5172797|NCT02912689|NAVA|nava
5172798|NCT02912676|Cancer|cancer
5172799|NCT02912676|Thioguanine|thioguanine
5172800|NCT02912676|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5172801|NCT02912676|6 Mercaptopurine|6 mercaptopurine
5172802|NCT02912676|Maintenance Therapy of Leukemia|maintenance therapy of leukemia
5172803|NCT02912676|Denmark|denmark
5172804|NCT02912676|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5172805|NCT02912650|ibuprofen|ibuprofen
5172806|NCT02912650|acetaminophen|acetaminophen
5172807|NCT02912650|pain|pain
5172808|NCT02912650|molar extraction|molar extraction
5172809|NCT02912624|Physical Examination|physical examination
5172810|NCT02912624|Diagnostic Imaging|diagnostic imaging
5172811|NCT02912624|Ultrasonography|ultrasonography
5172812|NCT02912624|Hemodynamics|hemodynamics
5172813|NCT02912624|Patient Outcome Assessment|patient outcome assessment
5172814|NCT02912624|Mortality|mortality
5172815|NCT02912585|colostrum|colostrum
5172816|NCT02912572|Endometrial Cancer|endometrial cancer
5172817|NCT02912546|Stroke, Acute|stroke, acute
5172818|NCT02912468|Nasal polyposis, Chronic rhinosinusitis, Intranasal corticosteroids, Dupilumab, Human monoclonal antibody|nasal polyposis, chronic rhinosinusitis, intranasal corticosteroids, dupilumab, human monoclonal antibody
5172819|NCT02912455|Post-Bariatric Surgery|post-bariatric surgery
5172820|NCT02912455|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5172821|NCT02912442|thyroid|thyroid
5172822|NCT02912442|infertility|infertility
5172823|NCT02912442|autoimmunity|autoimmunity
5172824|NCT02912442|pregnancy loss|pregnancy loss
5172825|NCT02912442|autoantibodies|autoantibodies
5172826|NCT02912364|Eslicarbazepine|eslicarbazepine
5172827|NCT02912364|Carbamazepine|carbamazepine
5172828|NCT02912364|cognition|cognition
5172829|NCT02912351|Total Knee Arthroplasty|total knee arthroplasty
5172830|NCT02912351|Total Knee Replacement|total knee replacement
5172831|NCT02912351|Revision Knee Arthroplasty|revision knee arthroplasty
5172832|NCT02912338|Sarcopenic obesity|sarcopenic obesity
5172833|NCT02912338|Body composition|body composition
5172834|NCT02912338|Physical function|physical function
5172835|NCT02912338|quality of life|quality of life
5172836|NCT02912338|long term care|long term care
5172837|NCT02912312|Breast cancer|breast cancer
5172838|NCT02912312|hypofractionation|hypofractionation
5172839|NCT02912312|radiation therapy|radiation therapy
5172840|NCT02912312|regional nodal irradiation|regional nodal irradiation
5172841|NCT02912273|Geriatric assessment|geriatric assessment
5172842|NCT02912247|tumor necrosis factor-a blocker|tumor necrosis factor-a blocker
5172843|NCT02912247|pharmacokinetics|pharmacokinetics
5172844|NCT02912247|safety|safety
5172845|NCT02912169|Alzheimer's Disease|alzheimer's disease
5172846|NCT02912169|Alzheimer's|alzheimer's
5172847|NCT02912169|Stem cell|stem cell
5172848|NCT02912169|Adipose-derived stem cells|adipose-derived stem cells
5172849|NCT02912169|ASC|asc
5172850|NCT02912169|ADSC|adsc
5172851|NCT02912156|Pharmacokinetic|pharmacokinetic
5172852|NCT02912130|Exercise|exercise
5172853|NCT02912130|Nutrition|nutrition
5172854|NCT02912130|Sarcopenia|sarcopenia
5172855|NCT02912130|Healthy Ageing|healthy ageing
5172856|NCT02912130|Elderly|elderly
5172857|NCT02912130|Muscular Hypertrophy|muscular hypertrophy
5172858|NCT02912104|primary ovarian insufficiency|primary ovarian insufficiency
5172859|NCT02912104|premature ovarian failure|premature ovarian failure
5172860|NCT02912104|Infertility|infertility
5172861|NCT02912104|human amniotic epithelial cells transplantation|human amniotic epithelial cells transplantation
5172862|NCT02912052|Perioperative Chemotherapy|perioperative chemotherapy
5172863|NCT02912052|Postoperative Chemotherapy|postoperative chemotherapy
5172864|NCT02912052|Colon Cancer|colon cancer
5172865|NCT02912052|Resectable Liver Metastasis|resectable liver metastasis
5172866|NCT02912000|Dental Health Services|dental health services
5172867|NCT02912000|Sugar-Sweetened Beverages|sugar-sweetened beverages
5172868|NCT02912000|Tobacco control|tobacco control
5172869|NCT02912000|Pediatrics|pediatrics
5172870|NCT02912000|Parents|parents
5172871|NCT02911974|fine needle biopsy|fine needle biopsy
5172872|NCT02911974|EUS|eus
5172873|NCT02911974|solid pancreatic mass|solid pancreatic mass
5172874|NCT02911896|physical function|physical function
5172875|NCT02911896|critical care|critical care
5172876|NCT02911857|Canakinumab,|canakinumab,
5172877|NCT02911857|interleukin-1|interleukin-1
5039394|NCT03752359|obesity|obesity
5172878|NCT02911857|Periodic Fevers Syndrome|periodic fevers syndrome
5172879|NCT02911857|TRAPS|traps
5172880|NCT02911857|HIDS|hids
5172881|NCT02911857|crFMF|crfmf
5172882|NCT02911857|auto-inflammatory diseases|auto-inflammatory diseases
5172883|NCT02911857|extension study|extension study
5172885|NCT02911805|Retinal Degeneration|retinal degeneration
5172886|NCT02911805|Neuropharmacology|neuropharmacology
5172887|NCT02911805|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5172888|NCT02911805|Biometry|biometry
5172889|NCT02911805|Immunochemistry|immunochemistry
5172890|NCT02911805|Molecular Biology|molecular biology
5172891|NCT02911805|Neurosciences|neurosciences
5172892|NCT02911805|Ophthalmology|ophthalmology
5172893|NCT02911792|hyperfiltering|hyperfiltering
5172894|NCT02911792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5172895|NCT02911766|Periodontal Index|periodontal index
5172896|NCT02911727|Cesarean section|cesarean section
5172897|NCT02911727|Postnatal Care|postnatal care
5172898|NCT02911714|Kidney Transplantation|kidney transplantation
5172899|NCT02911714|Delayed Graft Function|delayed graft function
5172900|NCT02911714|Acute Allograft Rejection|acute allograft rejection
5172901|NCT02911714|Acute Kidney Injury|acute kidney injury
5172902|NCT02911597|Ketamine|ketamine
5172903|NCT02911597|Naltrexone|naltrexone
5172904|NCT02911597|Treatment-Resistant|treatment-resistant
5172906|NCT02911545|Atrial fibrillation|atrial fibrillation
5172907|NCT02911545|Anticoagulation|anticoagulation
5172908|NCT02911545|Cardioversion|cardioversion
5172909|NCT02911532|pterygium|pterygium
5172910|NCT02911532|tissue engineering|tissue engineering
5172911|NCT02911532|atretoblepharia|atretoblepharia
5172912|NCT02911519|Schizophrenia|schizophrenia
5172913|NCT02911519|Patient Education|patient education
5172914|NCT02911493|sedentary time|sedentary time
5172915|NCT02911493|number of steps/day|number of steps/day
5172916|NCT02911493|mobility|mobility
5172917|NCT02911493|disability|disability
5172918|NCT02911428|Ebola|ebola
5172919|NCT02911428|Ebola Virus Vaccines|ebola virus vaccines
5172920|NCT02911428|Haemorrhagic Fever|haemorrhagic fever
5172921|NCT02911428|Ebola Infection|ebola infection
5172922|NCT02911428|GP protein, Ebola virus|gp protein, ebola virus
5172923|NCT02911415|Ebola|ebola
5172924|NCT02911415|Ebola Virus Vaccines|ebola virus vaccines
5172925|NCT02911415|Haemorrhagic Fever|haemorrhagic fever
5172926|NCT02911415|Ebola Infection|ebola infection
5172927|NCT02911415|GP protein, Ebola virus|gp protein, ebola virus
5172928|NCT02911311|conbercept|conbercept
5172929|NCT02911311|anti-VEGF agent|anti-vegf agent
5172930|NCT02911311|panretinal photocoagulation|panretinal photocoagulation
5172931|NCT02911285|Alcohol|alcohol
5172932|NCT02911285|PTSD|ptsd
5172933|NCT02911285|Trauma|trauma
5172934|NCT02911285|Veteran|veteran
5172935|NCT02911285|Substance|substance
5172936|NCT02911285|Drug|drug
5172937|NCT02911285|Post Traumatic Stress Disorder|post traumatic stress disorder
5172938|NCT02911285|Military|military
5172939|NCT02911272|Partograph|partograph
5172940|NCT02911272|Best action line|best action line
5172941|NCT02911272|Prolonged labour prevention|prolonged labour prevention
5172942|NCT02911207|chronic ill patients|chronic ill patients
5172943|NCT02911207|Emotion management skill|emotion management skill
5172944|NCT02911207|Quality of Life|quality of life
5172945|NCT02911181|BIVA measurement|biva measurement
5172946|NCT02911181|SNAQ score|snaq score
5172948|NCT02911168|ANESTHESIA RECOVERY PERIOD|anesthesia recovery period
5172949|NCT02911168|PAIN MANAGEMENT|pain management
5172950|NCT02911155|Cohort Study|cohort study
5172951|NCT02911155|Radiation|radiation
5172952|NCT02911155|Occupation|occupation
5172953|NCT02911142|Treatment Naive|treatment naive
5172954|NCT02911142|Immune Modulatory|immune modulatory
5172955|NCT02911142|Chemotherapy|chemotherapy
5172956|NCT02911142|AIDS-Related Lymphoma|aids-related lymphoma
5172958|NCT02911129|Chronic Stroke|chronic stroke
5172959|NCT02911129|Neglect|neglect
5172960|NCT02911129|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5172961|NCT02911129|Visual and Motor Integration|visual and motor integration
5172962|NCT02911129|Visual Fields|visual fields
5172963|NCT02911116|Panuveitis|panuveitis
5172964|NCT02911116|Intermediate Uveitis|intermediate uveitis
5172965|NCT02911116|Uveitis|uveitis
5172966|NCT02911103|Electrophysiology|electrophysiology
5172967|NCT02911103|Neurosurgery|neurosurgery
5172968|NCT02911103|Dystonia|dystonia
5172969|NCT02911103|Deep Brain Stimulation|deep brain stimulation
5172970|NCT02911090|Endometriosis|endometriosis
5172973|NCT02911077|Bacteria|bacteria
5172974|NCT02911064|Questionnaires|questionnaires
5172976|NCT02911064|Benign neoplasms|benign neoplasms
5172977|NCT02911064|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5962176|NCT04282460|Chinese traditional medicine|chinese traditional medicine
5172978|NCT02911064|Inpatient rehabilitation therapy|inpatient rehabilitation therapy
5172979|NCT02911038|Complete denture|complete denture
5172980|NCT02911038|PMMA|pmma
5172981|NCT02911038|Stereolithography|stereolithography
5172982|NCT02911025|epilepsy|epilepsy
5172983|NCT02911025|sleep|sleep
5172984|NCT02911025|antiepileptic drugs|antiepileptic drugs
5172985|NCT02910986|Mammography|mammography
5172986|NCT02910986|Breast Density|breast density
5172987|NCT02910986|Hispanic|hispanic
5172989|NCT02910960|fine needle biopsy|fine needle biopsy
5172990|NCT02910960|EUS|eus
5172991|NCT02910960|solid pancreatic mass|solid pancreatic mass
5172992|NCT02910934|Indoor Residual Spray|indoor residual spray
5172993|NCT02910934|IRS|irs
5172994|NCT02910934|Insecticide Treated Net|insecticide treated net
5172995|NCT02910934|LLIN|llin
5172996|NCT02910934|ITN|itn
5172997|NCT02910934|Long lasting insecticidal net|long lasting insecticidal net
5172998|NCT02910921|Migraine|migraine
5172999|NCT02910921|Prediction|prediction
5173000|NCT02910921|Forecast|forecast
5173001|NCT02910921|App|app
5173002|NCT02910921|Fitbit|fitbit
5173003|NCT02910921|Individual|individual
5173004|NCT02910921|Algorithm|algorithm
5173005|NCT02910921|Machine Learning|machine learning
5173006|NCT02910921|Mayo Clinic|mayo clinic
5173007|NCT02910921|Allergan|allergan
5173008|NCT02910921|Second Opinion|second opinion
5173009|NCT02910908|Elderly|elderly
5173010|NCT02910908|ESRD prognosis|esrd prognosis
5173011|NCT02910908|help decision making dialysis therapeutic project|help decision making dialysis therapeutic project
5173012|NCT02910882|Pancreas Cancer|pancreas cancer
5173013|NCT02910882|Unresectable|unresectable
5173014|NCT02910882|Chemoradiation|chemoradiation
5173015|NCT02910882|PEGPH20|pegph20
5173016|NCT02910843|rectal cancer|rectal cancer
5173017|NCT02910843|Neoadjuvant treatment|neoadjuvant treatment
5173018|NCT02910843|Regorafenib|regorafenib
5173019|NCT02910843|Capecitabine|capecitabine
5173020|NCT02910843|locally advanced rectal cancer|locally advanced rectal cancer
5173021|NCT02910843|Phase Ib trial|phase ib trial
5173022|NCT02910804|GBM|gbm
5173023|NCT02910804|GRPR|grpr
5173024|NCT02910804|IRDye800|irdye800
5173025|NCT02910804|NIRF|nirf
5173026|NCT02910804|surgery|surgery
5173027|NCT02910726|indocyanine green fluorescent dye|indocyanine green fluorescent dye
5173028|NCT02910726|Technetium lymphoscintigraphy|technetium lymphoscintigraphy
5173029|NCT02910726|sentinel lymph node biopsy|sentinel lymph node biopsy
5173030|NCT02910726|16-1003|16-1003
5173031|NCT02910687|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
5173032|NCT02910687|Elderly|elderly
5173033|NCT02910687|Frailty|frailty
5173034|NCT02910687|Prognostic value|prognostic value
5173035|NCT02910661|Kidney Transplantation|kidney transplantation
5173036|NCT02910648|healthy|healthy
5173037|NCT02910648|BMI|bmi
5173038|NCT02910648|weight loss|weight loss
5173039|NCT02910648|sleep|sleep
5173040|NCT02910648|healthy sleeper|healthy sleeper
5173041|NCT02910648|overweight|overweight
5173042|NCT02910648|obese|obese
5173043|NCT02910635|Thorough QTc, Therapeutic dose, supra therapeutic dose|thorough qtc, therapeutic dose, supra therapeutic dose
5173044|NCT02910622|breast|breast
5173045|NCT02910622|ovarian|ovarian
5173046|NCT02910622|cancer|cancer
5173047|NCT02910609|preterm|preterm
5173048|NCT02910609|patent ductus arterioles|patent ductus arterioles
5173049|NCT02910609|treatment|treatment
5173050|NCT02910557|CTCAE - Common Terminology Criteria for Adverse Events|ctcae - common terminology criteria for adverse events
5173051|NCT02910557|eCRF - electronic case report form|ecrf - electronic case report form
5173052|NCT02910557|ECOG - Eastern Cooperative Oncology Group|ecog - eastern cooperative oncology group
5173053|NCT02910557|EDC - electronic data capture|edc - electronic data capture
5173054|NCT02910557|GM-CSF - human granulocyte macrophage colony-stimulating factor|gm-csf - human granulocyte macrophage colony-stimulating factor
5173055|NCT02910557|HCP - health care provider|hcp - health care provider
5173056|NCT02910557|HSV-1 - herpes simplex virus type 1|hsv-1 - herpes simplex virus type 1
5173057|NCT02910557|ICF - informed consent form|icf - informed consent form
5173058|NCT02910557|ICP - infected cell protein|icp - infected cell protein
5173059|NCT02910557|IEC - Independent Ethics Committee|iec - independent ethics committee
5862716|NCT00001539|Borrelia Burgdorferi|borrelia burgdorferi
5173060|NCT02910557|IRB - Institutional Review Board|irb - institutional review board
5173061|NCT02910557|MedDRA - Medical Dictionary for Regulatory Activities|meddra - medical dictionary for regulatory activities
5173062|NCT02910557|PFU - plaque-forming unit|pfu - plaque-forming unit
5173063|NCT02910557|qPCR - quantitative polymerase chain reaction|qpcr - quantitative polymerase chain reaction
5173064|NCT02910557|SmPC - Summary of Product Characteristics|smpc - summary of product characteristics
5173065|NCT02910557|USPI - United States Prescribing Information|uspi - united states prescribing information
5173067|NCT02910531|Kidney stone|kidney stone
5173068|NCT02910531|Alpha lipoic acid|alpha lipoic acid
5173069|NCT02910479|Body Temperature|body temperature
5173070|NCT02910479|Thermometers|thermometers
5173071|NCT02910453|Pulmonary lobectomy|pulmonary lobectomy
5173072|NCT02910453|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
5173073|NCT02910453|Opto-electronic plethysmography|opto-electronic plethysmography
5173074|NCT02910453|Posterolateral thoracotomy|posterolateral thoracotomy
5173076|NCT02910427|potassium and magnesium-enriched salt|potassium and magnesium-enriched salt
5173077|NCT02910427|neurological performance|neurological performance
5173078|NCT02910414|Renal Denervation|renal denervation
5173079|NCT02910414|Alcohol|alcohol
5173080|NCT02910388|conization|conization
5173081|NCT02910388|LLETZ|lletz
5173082|NCT02910388|loop excision|loop excision
5173083|NCT02910388|randomized controlled trial|randomized controlled trial
5173084|NCT02910388|colposcopy|colposcopy
5173085|NCT02910388|direct colposcopic vision|direct colposcopic vision
5173086|NCT02910388|intraoperative colposcopy|intraoperative colposcopy
5173087|NCT02910375|golimumab|golimumab
5173088|NCT02910375|drug monitoring|drug monitoring
5173089|NCT02910375|home based care|home based care
5173090|NCT02910349|valvular hear disease|valvular hear disease
5173091|NCT02910349|echocardiography|echocardiography
5173092|NCT02910349|magnetic resonance|magnetic resonance
5173093|NCT02910349|global longitudinal strain|global longitudinal strain
5173094|NCT02910349|T1 relaxation time|t1 relaxation time
5173095|NCT02910310|Uterine Balloon Tamponade|uterine balloon tamponade
5173096|NCT02910297|cannabidiol|cannabidiol
5173097|NCT02910297|Dravet Syndrome|dravet syndrome
5173098|NCT02910297|Lennox Gastaut Syndrome|lennox gastaut syndrome
5173100|NCT02910284|Herpes|herpes
5173101|NCT02910284|Genital Herpes|genital herpes
5173102|NCT02910258|myelofibrosis|myelofibrosis
5173103|NCT02910258|pegylated interferon|pegylated interferon
5173104|NCT02910245|Therapeutic Drug Monitoring|therapeutic drug monitoring
5173105|NCT02910245|Mercaptopurine (6-MP)|mercaptopurine (6-mp)
5173106|NCT02910245|Thiopurine|thiopurine
5173107|NCT02910245|Efficacy|efficacy
5173108|NCT02910232|Rice starch|rice starch
5173109|NCT02910232|Porous composite|porous composite
5173110|NCT02910232|Biomaterial|biomaterial
5173111|NCT02910232|Bone regeneration|bone regeneration
5173112|NCT02910232|Clinical trial|clinical trial
5173113|NCT02910232|Hydroxyapatite|hydroxyapatite
5173114|NCT02910219|HER2|her2
5173115|NCT02910219|pertuzumab|pertuzumab
5173116|NCT02910219|trastuzumab|trastuzumab
5173117|NCT02910219|docetaxel|docetaxel
5173118|NCT02910219|paclitaxel|paclitaxel
5173119|NCT02910219|carboplatin|carboplatin
5173120|NCT02910219|crofelemer|crofelemer
5173121|NCT02910219|chemotherapy induced diarrhea|chemotherapy induced diarrhea
5173122|NCT02910206|etomidate|etomidate
5173123|NCT02910206|propofol|propofol
5173124|NCT02910193|alcoholism|alcoholism
5173125|NCT02910193|genetics|genetics
5173126|NCT02910193|functional MRI|functional mri
5173127|NCT02910193|structural MRI|structural mri
5173128|NCT02910193|first-degree relatives|first-degree relatives
5173129|NCT02910180|Tissue Repository|tissue repository
5173130|NCT02910180|Cerebrovascular Diseases|cerebrovascular diseases
5173131|NCT02910180|Stroke|stroke
5173132|NCT02910180|Aneurysm|aneurysm
5173133|NCT02910180|Arteriovenous malformation|arteriovenous malformation
5173134|NCT02910180|Fistula|fistula
5173135|NCT02910180|Intracranial Stenosis|intracranial stenosis
5173136|NCT02910180|Treatment|treatment
5173137|NCT02910180|Registry|registry
5173138|NCT02910180|Outcomes|outcomes
5173139|NCT02910141|Type 2 diabetes|type 2 diabetes
5173140|NCT02910141|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5173141|NCT02910141|Meta-analysis|meta-analysis
5173142|NCT02910141|Insulin pump therapy|insulin pump therapy
5173143|NCT02910141|Multiple daily insulin injections|multiple daily insulin injections
5173144|NCT02910102|RVT-101|rvt-101
5173145|NCT02910102|intepirdine|intepirdine
5173146|NCT02910102|Alzheimer's disease|alzheimer's disease
5173147|NCT02910102|Dementia with Lewy bodies|dementia with lewy bodies
5173148|NCT02910102|Lewy body dementia|lewy body dementia
5173149|NCT02910102|Parkinson's Disease Dementia|parkinson's disease dementia
5173150|NCT02910089|Diabetes Mellitus Type 2|diabetes mellitus type 2
5173151|NCT02910063|Relapsed/Refractory Aggressive B-Cell Non Hodgkin Lymphoma|relapsed/refractory aggressive b-cell non hodgkin lymphoma
5173152|NCT02910063|Blinatumomab|blinatumomab
5173153|NCT02910063|Leukemia|leukemia
5173154|NCT02910063|Standard of Care|standard of care
5173156|NCT02910063|Cancer|cancer
5173157|NCT02910063|Chemotherapy|chemotherapy
5173158|NCT02910050|androgen receptor|androgen receptor
5173159|NCT02910050|bicalutamide|bicalutamide
5173160|NCT02910050|aromatase inhibitors|aromatase inhibitors
5173161|NCT02910050|advanced breast cancer|advanced breast cancer
5173163|NCT02910050|anastrozole|anastrozole
5173164|NCT02910050|exemestane|exemestane
5173165|NCT02910037|metagenomic next-generation sequencing|metagenomic next-generation sequencing
5173166|NCT02910037|microbiological diagnosis|microbiological diagnosis
5173167|NCT02910037|bacterial infections|bacterial infections
5173168|NCT02910037|viral infections|viral infections
5173169|NCT02910037|fungal infections|fungal infections
5173170|NCT02910037|parasitic infections|parasitic infections
5173171|NCT02909998|Biomarkers|biomarkers
5173172|NCT02909998|Genetic|genetic
5173173|NCT02909998|Chronic arthritis|chronic arthritis
5173174|NCT02909998|Treatment|treatment
5173175|NCT02909985|Infrared|infrared
5962177|NCT04282434|Adaptive immunity|adaptive immunity
5173176|NCT02909985|Dark Adaptation|dark adaptation
5173177|NCT02909985|Vision|vision
5173178|NCT02909985|Scotopic Threshold Response|scotopic threshold response
5962178|NCT04282434|DNA methylome|dna methylome
5173179|NCT02909985|Transient Receptor Potential (TRP) Channels|transient receptor potential (trp) channels
5173180|NCT02909985|Human|human
5173181|NCT02909959|sulforaphane|sulforaphane
5173383|NCT02908750|osimertinib|osimertinib
5173182|NCT02909959|glucoraphanin|glucoraphanin
5173183|NCT02909959|physiologic effects of drugs|physiologic effects of drugs
5173184|NCT02909946|multidrug-resistant organisms|multidrug-resistant organisms
5173185|NCT02909946|nursing home|nursing home
5173186|NCT02909946|post-acute care|post-acute care
5173187|NCT02909946|long-term care|long-term care
5173188|NCT02909946|infection control|infection control
5173189|NCT02909920|Telerehabilitation|telerehabilitation
5173190|NCT02909920|Physiotherapy|physiotherapy
5173191|NCT02909920|Surgery|surgery
5173192|NCT02909920|Telemedicine|telemedicine
5173193|NCT02909894|Sedentary behaviour|sedentary behaviour
5173194|NCT02909894|Postprandial glycaemic response|postprandial glycaemic response
5173195|NCT02909881|polysaccharide|polysaccharide
5173196|NCT02909881|oxidation|oxidation
5173197|NCT02909881|endurance exercise|endurance exercise
5173198|NCT02909855|children|children
5173199|NCT02909855|psychological predictors|psychological predictors
5173200|NCT02909855|side-effects|side-effects
5173201|NCT02909855|vaccination|vaccination
5173202|NCT02909842|influenza|influenza
5173203|NCT02909842|vaccine|vaccine
5173204|NCT02909842|probiotic|probiotic
5173205|NCT02909842|immune response|immune response
5173206|NCT02909829|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5173207|NCT02909829|Artificial Pancreas|artificial pancreas
5173208|NCT02909829|Closed-Loop Delivery|closed-loop delivery
5173209|NCT02909829|Insulin|insulin
5173210|NCT02909829|Adolescent|adolescent
5173211|NCT02909829|Missed Bolus|missed bolus
5173212|NCT02909803|glucose|glucose
5173213|NCT02909803|glycemic index|glycemic index
5173214|NCT02909803|lentil|lentil
5173215|NCT02909803|polyphenols|polyphenols
5173216|NCT02909803|metabolites|metabolites
5173217|NCT02909803|bioavailability|bioavailability
5173218|NCT02909777|Lymphoma|lymphoma
5173219|NCT02909777|Neuroblastoma|neuroblastoma
5173220|NCT02909777|Brain Tumor|brain tumor
5173221|NCT02909777|Solid Tumor|solid tumor
5173222|NCT02909764|Salty taste|salty taste
5173223|NCT02909764|Psychophysics|psychophysics
5173224|NCT02909764|Genetics|genetics
5173225|NCT02909764|Diet|diet
5173226|NCT02909764|Age|age
5173227|NCT02909725|Physical activity|physical activity
5173228|NCT02909725|Sedentary time|sedentary time
5173229|NCT02909725|Pregnancy|pregnancy
5173230|NCT02909725|Pregnant women|pregnant women
5173231|NCT02909725|Weight gain|weight gain
5173232|NCT02909712|Sub-Saharan Africa|sub-saharan africa
5173233|NCT02909712|Dihydroartemisinin|dihydroartemisinin
5173234|NCT02909712|Piperaquine|piperaquine
5173235|NCT02909712|Sulphadoxine-Pyrimethamine|sulphadoxine-pyrimethamine
5173236|NCT02909712|Antimalarials|antimalarials
5173237|NCT02909686|Gulf War Syndrome|gulf war syndrome
5173238|NCT02909686|Chronic Multisymptom Illnesses|chronic multisymptom illnesses
5173239|NCT02909686|Medically Unexplained Illnesses|medically unexplained illnesses
5173240|NCT02909673|adolescent behavior|adolescent behavior
5173241|NCT02909673|intimate partner violence|intimate partner violence
5173242|NCT02909673|youth risk behavior|youth risk behavior
5173243|NCT02909673|violence prevention|violence prevention
5173244|NCT02909673|teen dating violence|teen dating violence
5173245|NCT02909621|OsteoArthritis; FLEXOFYTOL®; Curcuma; biomarkers|osteoarthritis; flexofytol®; curcuma; biomarkers
5173246|NCT02909556|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5173247|NCT02909556|TAVI|tavi
5173248|NCT02909556|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
5173249|NCT02909556|Transfemoral access|transfemoral access
5173250|NCT02909530|Endoscopic ultrasound-guided fine needle biopsy|endoscopic ultrasound-guided fine needle biopsy
5173251|NCT02909530|Olympus EZ Shot 3Plus|olympus ez shot 3plus
5173252|NCT02909530|Olympus EZ Shot 2|olympus ez shot 2
5173253|NCT02909452|entinostat|entinostat
5173254|NCT02909452|pembrolizumab|pembrolizumab
5173255|NCT02909452|solid tumor|solid tumor
5168322|NCT02939872|DAPT|dapt
5173256|NCT02909452|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5173257|NCT02909426|Screening|screening
5173258|NCT02909426|Digital mammography|digital mammography
5173259|NCT02909426|Ultrasonography|ultrasonography
5173260|NCT02909426|Sensitivity|sensitivity
5173261|NCT02909426|Specificity|specificity
5173262|NCT02909413|desflurane|desflurane
5173263|NCT02909413|sevoflurane|sevoflurane
5173264|NCT02909400|mitochondrial|mitochondrial
5173265|NCT02909400|oxidative phosphorylation (oxphos)|oxidative phosphorylation (oxphos)
5173267|NCT02909400|MIDD|midd
5173268|NCT02909400|KH176|kh176
5173269|NCT02909400|Proof of Concept|proof of concept
5173270|NCT02909387|Epilepsy|epilepsy
5173271|NCT02909387|Seizure Disorder|seizure disorder
5173272|NCT02909374|Implementation|implementation
5173273|NCT02909374|fall prevention|fall prevention
5173274|NCT02909374|balance training|balance training
5173275|NCT02909348|Neoplasms|neoplasms
5173276|NCT02909348|Melanoma|melanoma
5173277|NCT02909348|Immunotherapy|immunotherapy
5173278|NCT02909348|Biomarkers|biomarkers
5091754|NCT03425136|HIV|hiv
5173279|NCT02909309|Propofol|propofol
5173280|NCT02909309|Deep Sedation|deep sedation
5173281|NCT02909309|Anoxia|anoxia
5173282|NCT02909309|Hypercapnia|hypercapnia
5173283|NCT02909231|Patient Outcome Assessment|patient outcome assessment
5173582|NCT02907476|Walking|walking
5173284|NCT02909218|HIV/AIDS, Swaziland|hiv/aids, swaziland
5173285|NCT02909205|child|child
5173286|NCT02909205|gastrostomy|gastrostomy
5173287|NCT02909205|supportive care|supportive care
5173288|NCT02909205|educational program|educational program
5173289|NCT02909192|Parkinson's Disease|parkinson's disease
5173290|NCT02909192|Excessive Daytime Sleepiness|excessive daytime sleepiness
5173291|NCT02909192|Circadian Rhythms|circadian rhythms
5173292|NCT02909192|Light Therapy|light therapy
5173293|NCT02909179|Community Health Workers, mHealth, mobile phones, ANC, PNC, essential newborn care|community health workers, mhealth, mobile phones, anc, pnc, essential newborn care
5173294|NCT02909153|Triferic|triferic
5173295|NCT02909153|ferric pyrophosphate citrate (FPC)|ferric pyrophosphate citrate (fpc)
5173296|NCT02909153|peritoneal dialysis|peritoneal dialysis
5173297|NCT02909153|anemia|anemia
5173298|NCT02909153|chronic kidney disease|chronic kidney disease
5173299|NCT02909127|deglutition|deglutition
5173300|NCT02909127|deglutition disorders|deglutition disorders
5173301|NCT02909127|pediatric dysphagia|pediatric dysphagia
5173302|NCT02909127|swallowing|swallowing
5173303|NCT02909114|stereotactic boday radiotherapy, oligometastases|stereotactic boday radiotherapy, oligometastases
5173304|NCT02909101|Working memory|working memory
5173305|NCT02909101|cognitive training|cognitive training
5173306|NCT02909101|HIV|hiv
5173307|NCT02909101|substance abuse|substance abuse
5173308|NCT02909088|stuttering|stuttering
5173309|NCT02909088|childhood onset fluency disorder|childhood onset fluency disorder
5173310|NCT02909088|ecopipam|ecopipam
5173311|NCT02909075|PET/CT|pet/ct
5173312|NCT02909075|MRI|mri
5173313|NCT02909075|Assess Thymic Function|assess thymic function
5173314|NCT02909075|16-1244|16-1244
5173315|NCT02909062|Electronic Activity Monitoring (EAM)|electronic activity monitoring (eam)
5173316|NCT02909062|16-493|16-493
5173317|NCT02909049|Prostate Biopsy|prostate biopsy
5173318|NCT02909049|Local Anesthesia|local anesthesia
5173319|NCT02909049|Pain|pain
5173320|NCT02909049|Biopsy of prostate|biopsy of prostate
5173321|NCT02909036|Melphalan|melphalan
5173322|NCT02909036|Autologous Hematopoietic Progenitor Cell Transplant|autologous hematopoietic progenitor cell transplant
5173323|NCT02909036|High Dose Therapy|high dose therapy
5173324|NCT02909036|16-875|16-875
5173325|NCT02909023|Hepatitis B Virus|hepatitis b virus
5173326|NCT02909023|Elispot test|elispot test
5173327|NCT02909023|T cellular immune response|t cellular immune response
5173328|NCT02908984|unilateral headache|unilateral headache
5173329|NCT02908984|cervical pain|cervical pain
5173330|NCT02908984|neck pain|neck pain
5173331|NCT02908984|rehabilitation|rehabilitation
5173332|NCT02908984|structural brain changes|structural brain changes
5173333|NCT02908984|surface based volumetry|surface based volumetry
5173334|NCT02908984|diffusion tensor imaging|diffusion tensor imaging
5173335|NCT02908984|functional brain changes|functional brain changes
5173336|NCT02908971|soy based formula|soy based formula
5173337|NCT02908971|overweight|overweight
5173338|NCT02908971|adrenarche,|adrenarche,
5173339|NCT02908971|gonadarache|gonadarache
5173340|NCT02908945|Ketamine|ketamine
5173341|NCT02908945|Anesthesia|anesthesia
5173342|NCT02908945|EEG|eeg
5173343|NCT02908945|NeuroSENSE|neurosense
5173344|NCT02908945|Pain|pain
5173345|NCT02908919|Colonoscopy|colonoscopy
5173346|NCT02908919|Picosulfate sodium|picosulfate sodium
5173347|NCT02908919|Polyethylene glycol|polyethylene glycol
5173348|NCT02908919|Magnesium citrate|magnesium citrate
5173349|NCT02908919|Ascorbic acid|ascorbic acid
5173350|NCT02908919|SPMC (solution picosulfate + magnesium citrate)|spmc (solution picosulfate + magnesium citrate)
5173351|NCT02908919|PEGA (Polyethylene glycol + ascorbic acid)|pega (polyethylene glycol + ascorbic acid)
5173352|NCT02908880|MANTA|manta
5173353|NCT02908880|Arterial Closure Device|arterial closure device
5173354|NCT02908880|Large Bore Closure Device|large bore closure device
5173355|NCT02908867|Sexuality|sexuality
5173357|NCT02908867|Complementary Therapies|complementary therapies
5173358|NCT02908867|Medicinal plants|medicinal plants
5173359|NCT02908854|Spices|spices
5173360|NCT02908854|Herbs|herbs
5173361|NCT02908854|Vegetables|vegetables
5173362|NCT02908854|National School Lunch Program|national school lunch program
5173363|NCT02908854|High school|high school
5181437|NCT02855580|child|child
5173364|NCT02908828|Biological Products/therapeutic use|biological products/therapeutic use
5173365|NCT02908828|Copepoda|copepoda
5173366|NCT02908828|Dietary Supplements|dietary supplements
5173367|NCT02908828|Fish Oils|fish oils
5173368|NCT02908828|Fatty Acids, Omega-3|fatty acids, omega-3
5173369|NCT02908828|Oxygen Consumption|oxygen consumption
5173370|NCT02908828|Calanus|calanus
5173371|NCT02908828|Maximal oxygen uptake|maximal oxygen uptake
5173372|NCT02908828|Zooplankton|zooplankton
5173373|NCT02908789|Photochemotherapy|photochemotherapy
5173374|NCT02908763|Chronic Hepatitis B|chronic hepatitis b
5962179|NCT04282434|RNA-sequencing|rna-sequencing
5173375|NCT02908763|Peginterferon Alpha|peginterferon alpha
5173376|NCT02908750|oncology|oncology
5173377|NCT02908750|cancer|cancer
5173378|NCT02908750|non small cell lung cancer|non small cell lung cancer
5173379|NCT02908750|anticancer drug|anticancer drug
5173380|NCT02908750|lung neoplasms|lung neoplasms
5173381|NCT02908750|pharmacokinetics|pharmacokinetics
5173382|NCT02908750|AZD9291|azd9291
5173384|NCT02908750|fexofenadine|fexofenadine
5173385|NCT02908750|TAGRISSO™|tagrisso™
5173386|NCT02908750|EGFR genes|egfr genes
5173387|NCT02908724|Familial cardiomyopathies|familial cardiomyopathies
5173388|NCT02908724|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5173389|NCT02908724|Left ventricular hypertrophy|left ventricular hypertrophy
5173390|NCT02908659|intensive care unit|intensive care unit
5173391|NCT02908659|patient's monitoring|patient's monitoring
5173392|NCT02908659|respiratory rate|respiratory rate
5173393|NCT02908633|open angle glaucoma|open angle glaucoma
5173394|NCT02908633|canaloplasty|canaloplasty
5173395|NCT02908633|migs|migs
5173396|NCT02908633|abic|abic
5173397|NCT02908594|Nursing|nursing
5173398|NCT02908594|ESRD|esrd
5173399|NCT02908594|hemodialysis|hemodialysis
5173400|NCT02908594|intradialytic exercise|intradialytic exercise
5173401|NCT02908594|depression|depression
5173402|NCT02908594|fatigue|fatigue
5173403|NCT02908594|Quality Of Life|quality of life
5173404|NCT02908594|self-efficacy|self-efficacy
5173405|NCT02908594|resilience|resilience
5173406|NCT02908568|mandibular stretching, trigeminocardiac reflex|mandibular stretching, trigeminocardiac reflex
5173407|NCT02908555|type 1 diabetes|type 1 diabetes
5173408|NCT02908555|adolescents|adolescents
5173409|NCT02908555|sleep|sleep
5173410|NCT02908490|Arthritis, Rheumatoid|arthritis, rheumatoid
5173411|NCT02908490|Atherosclerosis|atherosclerosis
5173412|NCT02908464|Cardiac Surgery|cardiac surgery
5173413|NCT02908464|Delirium|delirium
5173414|NCT02908464|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5173415|NCT02908451|Cancer|cancer
5173416|NCT02908451|Antibody Drug Conjugate|antibody drug conjugate
5173417|NCT02908451|AbGn-107|abgn-107
5173418|NCT02908451|Adenocarcinoma|adenocarcinoma
5173419|NCT02908451|Gastric|gastric
5173420|NCT02908451|Colorectal|colorectal
5173421|NCT02908451|Pancreatic|pancreatic
5173422|NCT02908451|biliary|biliary
5173423|NCT02908451|cholangiocarcinoma|cholangiocarcinoma
5173424|NCT02908451|gallbladder|gallbladder
5173425|NCT02908451|ampullary carcinomas|ampullary carcinomas
5173426|NCT02908412|Nerve Block|nerve block
5173427|NCT02908412|Spectrophotometry|spectrophotometry
5173428|NCT02908412|Bupivacaine|bupivacaine
5173429|NCT02908412|Spinal Surgery|spinal surgery
5173430|NCT02908412|Blood Loss, Surgical|blood loss, surgical
5173431|NCT02908386|Head and neck tumors|head and neck tumors
5173432|NCT02908386|Proton|proton
5173433|NCT02908386|Photon|photon
5173434|NCT02908386|replanning timing|replanning timing
5173435|NCT02908373|risk management|risk management
5173436|NCT02908373|nursing home|nursing home
5173437|NCT02908373|elderly|elderly
5173438|NCT02908373|care|care
5173439|NCT02908360|Double positive lymphocyte T F prausnitzii|double positive lymphocyte t f prausnitzii
5173440|NCT02908347|Plaque psoriasis|plaque psoriasis
5173441|NCT02908347|chronic|chronic
5173442|NCT02908347|moderate|moderate
5173443|NCT02908347|severe|severe
5173444|NCT02908347|Plaque|plaque
5173445|NCT02908308|Induced hypothermia|induced hypothermia
5173446|NCT02908308|Mild induced hypothermia|mild induced hypothermia
5173447|NCT02908308|Therapeutic hypothermia|therapeutic hypothermia
5173448|NCT02908308|Cardiac arrest|cardiac arrest
5173449|NCT02908308|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5173450|NCT02908308|Mortality|mortality
5173451|NCT02908308|Neurological function|neurological function
5173452|NCT02908308|Randomised clinical trial|randomised clinical trial
5173453|NCT02908282|tear film|tear film
5173454|NCT02908282|omega-3 fatty acids|omega-3 fatty acids
5173455|NCT02908282|eye drops|eye drops
5173456|NCT02908269|Influenza|influenza
5173457|NCT02908269|Fluzone® Quadrivalent, Influenza Vaccine (2016-2017 formulation)|fluzone® quadrivalent, influenza vaccine (2016-2017 formulation)
5173458|NCT02908269|Fluzone® High-Dose, Influenza Vaccine (2016-2017 formulation)|fluzone® high-dose, influenza vaccine (2016-2017 formulation)
5173460|NCT02908256|delta PP|delta pp
5173461|NCT02908256|vascular filling|vascular filling
5173462|NCT02908243|Hemophilia|hemophilia
5173463|NCT02908243|Primary prophylaxis|primary prophylaxis
5173464|NCT02908243|Pettersson Score|pettersson score
5173465|NCT02908243|Joint function study|joint function study
5173466|NCT02908243|Comorbidity|comorbidity
5173467|NCT02908217|Polymyalgia Rheumatica|polymyalgia rheumatica
5173468|NCT02908217|Tocilizumab|tocilizumab
5173469|NCT02908217|Glucocorticoid|glucocorticoid
5173470|NCT02908204|superficial esophageal squamous cell carcinoma|superficial esophageal squamous cell carcinoma
5173471|NCT02908204|efficacy|efficacy
5173472|NCT02908204|survival|survival
5173473|NCT02908178|ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
5173474|NCT02908178|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5173475|NCT02908087|Diabetes Type 1|diabetes type 1
5962180|NCT04282434|Network analysis|network analysis
5173476|NCT02908087|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
5173477|NCT02908087|Liraglutide|liraglutide
5173478|NCT02908087|GLP-1 Analogue|glp-1 analogue
5173479|NCT02908087|Early diagnosis|early diagnosis
5173480|NCT02908074|Hypogonadotropic|hypogonadotropic
5173481|NCT02908074|hypogonadism|hypogonadism
5173482|NCT02908074|testosterone|testosterone
5173483|NCT02908061|Mesh Placement|mesh placement
5173879|NCT02905578|Abraxane|abraxane
5173484|NCT02908061|Radical Cystectomy|radical cystectomy
5173485|NCT02908061|16-1285|16-1285
5173486|NCT02908048|liver cancer|liver cancer
5173487|NCT02908048|cholangiocarcinoma (CCA)|cholangiocarcinoma (cca)
5173488|NCT02908048|cirrhosis|cirrhosis
5173489|NCT02908048|hepatitis|hepatitis
5173490|NCT02908048|bile duct cancer|bile duct cancer
5173491|NCT02908048|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5173492|NCT02908048|hepatobiliary carcinoma|hepatobiliary carcinoma
5173493|NCT02908048|hepatoma|hepatoma
5173494|NCT02908048|liver mass|liver mass
5173495|NCT02907983|Menopause|menopause
5173496|NCT02907983|Post-menopausal|post-menopausal
5173497|NCT02907970|Cervical cancer|cervical cancer
5173498|NCT02907970|Screening|screening
5173499|NCT02907970|Barriers|barriers
5173500|NCT02907931|hemodynamics|hemodynamics
5173501|NCT02907931|ultrasonography|ultrasonography
5173502|NCT02907879|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5173503|NCT02907879|Ultrasound perfusion imaging|ultrasound perfusion imaging
5173504|NCT02907879|cerebral hypoperfusion|cerebral hypoperfusion
5173505|NCT02907879|vasospasm|vasospasm
5173506|NCT02907879|DIND|dind
5173507|NCT02907879|infarction|infarction
5173508|NCT02907827|complete remission|complete remission
5173509|NCT02907827|cfDNA|cfdna
5173510|NCT02907827|DW-MRI|dw-mri
5173511|NCT02907827|surveillance|surveillance
5173512|NCT02907814|Uveitis|uveitis
5173513|NCT02907814|Optical Coherence Tomography|optical coherence tomography
5173514|NCT02907801|congenital muscular torticollis|congenital muscular torticollis
5173515|NCT02907801|infants|infants
5173516|NCT02907801|perception-action approach|perception-action approach
5173517|NCT02907788|Cystic fibrosis|cystic fibrosis
5173518|NCT02907788|Neutrophils|neutrophils
5173520|NCT02907788|Inflammation|inflammation
5173521|NCT02907788|Lung disease|lung disease
5173522|NCT02907788|PRAGMA|pragma
5173523|NCT02907762|Endovascular|endovascular
5173524|NCT02907762|EVAR|evar
5173525|NCT02907762|Neck Angulation|neck angulation
5173526|NCT02907710|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5173527|NCT02907710|endostar|endostar
5173528|NCT02907710|chemoradiotherapy|chemoradiotherapy
5173529|NCT02907697|HIV/AIDS|hiv/aids
5173530|NCT02907697|adherence|adherence
5173531|NCT02907697|substance use|substance use
5173532|NCT02907697|HIV care continuum|hiv care continuum
5173533|NCT02907684|Cardiovascular disease|cardiovascular disease
5173534|NCT02907684|Non alcoholic fatty liver|non alcoholic fatty liver
5173535|NCT02907684|Diabetes|diabetes
5173536|NCT02907684|Almonds|almonds
5173537|NCT02907684|Endothelium-dependent vasodilation|endothelium-dependent vasodilation
5173538|NCT02907684|Fecal short chain fatty acids (SCFAs)|fecal short chain fatty acids (scfas)
5173539|NCT02907684|Snacking|snacking
5173540|NCT02907671|carpal tunnel injection|carpal tunnel injection
5173541|NCT02907671|corticosteroid|corticosteroid
5173542|NCT02907671|ultrasound-guided|ultrasound-guided
5173543|NCT02907671|musculoskeletal ultrasound|musculoskeletal ultrasound
5173544|NCT02907658|Internet Use Disorder|internet use disorder
5173545|NCT02907658|Internet Gaming Disorder|internet gaming disorder
5173546|NCT02907658|Cognitive-Behavioral Intervention|cognitive-behavioral intervention
5173547|NCT02907658|Indicated Prevention|indicated prevention
5173548|NCT02907658|Adolescents|adolescents
5173549|NCT02907658|Internet Addiction|internet addiction
5173550|NCT02907632|Metoclopramide|metoclopramide
5173551|NCT02907632|Pro kinetic|pro kinetic
5173552|NCT02907632|Gastroesophageal Reflux|gastroesophageal reflux
5173553|NCT02907632|Premature Infant|premature infant
5173554|NCT02907632|Low Birth Weight|low birth weight
5173555|NCT02907632|Kangaroo Mother Care Method|kangaroo mother care method
5173556|NCT02907619|Duchenne muscular dystrophy, myostatin, open-label|duchenne muscular dystrophy, myostatin, open-label
5173557|NCT02907606|Non-small-cell Lung Cancer|non-small-cell lung cancer
5173558|NCT02907606|circulating tumor DNA|circulating tumor dna
5173560|NCT02907593|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5173561|NCT02907593|Pulmonary|pulmonary
5173562|NCT02907593|Surfactant|surfactant
5173563|NCT02907593|Steroids|steroids
5173564|NCT02907593|Extremely low gestational age|extremely low gestational age
5173566|NCT02907580|vaccination|vaccination
5173567|NCT02907554|Preconditioning|preconditioning
5173568|NCT02907554|Tissue and organ procurement|tissue and organ procurement
5173569|NCT02907554|Cyclosporine A|cyclosporine a
5173570|NCT02907554|Kidney transplantation|kidney transplantation
5173571|NCT02907554|Delayed graft function|delayed graft function
5173572|NCT02907541|eLearning|elearning
5173573|NCT02907541|Quality Improvement Methods|quality improvement methods
5173574|NCT02907541|Knowledge Transfer|knowledge transfer
5173575|NCT02907541|Impact of learning|impact of learning
5046950|NCT03705676|Cortical movement preparation|cortical movement preparation
5046952|NCT03705650|Disease detection|disease detection
5046953|NCT03705650|Medicare aged patients|medicare aged patients
5046954|NCT03705650|routine physical examination|routine physical examination
5173576|NCT02907515|single implant retained mandibular overdenture|single implant retained mandibular overdenture
5173577|NCT02907489|post operative pain|post operative pain
5173578|NCT02907489|triple antibiotic paste|triple antibiotic paste
5173579|NCT02907489|intracanal medication|intracanal medication
5173580|NCT02907476|Vagal-gamma amino-butyric acid (GABA)|vagal-gamma amino-butyric acid (gaba)
5173581|NCT02907476|Yoga|yoga
5173583|NCT02907463|Aortic Valve Replacement|aortic valve replacement
5173584|NCT02907463|Aortic Stenosis|aortic stenosis
5173585|NCT02907463|EDWARDS INTUITY Elite|edwards intuity elite
5173586|NCT02907463|Rapid deployment valves|rapid deployment valves
5173587|NCT02907437|Minocycline|minocycline
5173588|NCT02907437|Negative symptoms|negative symptoms
5173589|NCT02907437|Cognitive symptoms|cognitive symptoms
5173590|NCT02907437|Inflammation|inflammation
5173591|NCT02907411|Quadrivas|quadrivas
5173592|NCT02907411|Veins|veins
5173593|NCT02907411|Lipedema|lipedema
5173594|NCT02907411|Lymphedema|lymphedema
5173595|NCT02907398|Neurostimulation|neurostimulation
5173596|NCT02907398|Hypoglossal nerve|hypoglossal nerve
5173597|NCT02907398|Tongue|tongue
5173598|NCT02907398|Upper airway stimulation|upper airway stimulation
5173599|NCT02907398|Surgery|surgery
5173600|NCT02907385|Rectal Cancer|rectal cancer
5173601|NCT02907385|Low Anterior Resection|low anterior resection
5173602|NCT02907385|LifeSeal|lifeseal
5173603|NCT02907385|Surgical Sealant|surgical sealant
5173604|NCT02907372|cognitive dysfunctions|cognitive dysfunctions
5173605|NCT02907372|cognitive complaints|cognitive complaints
5173606|NCT02907372|metastatic prostate cancer|metastatic prostate cancer
5173607|NCT02907372|new generations of hormone-therapy|new generations of hormone-therapy
5173608|NCT02907333|Condom use|condom use
5173609|NCT02907333|Human Papillomavirus|human papillomavirus
5173610|NCT02907333|Conization|conization
5173611|NCT02907307|LactiSal|lactisal
5173612|NCT02907307|Vaginal therapy|vaginal therapy
5173613|NCT02907294|PDE10 inhibitor|pde10 inhibitor
5173614|NCT02907294|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
5173615|NCT02907294|Huntington's disease|huntington's disease
5173616|NCT02907294|psychiatric disorders|psychiatric disorders
5061464|NCT03614962|Cognitive|cognitive
5173617|NCT02907281|Multiple sclerosis,|multiple sclerosis,
5173618|NCT02907281|MS,|ms,
5173619|NCT02907281|Optical coherence tomography|optical coherence tomography
5173620|NCT02907281|OCT,|oct,
5173621|NCT02907281|RRMS|rrms
5173622|NCT02907268|botulinum toxin type A, intradermal|botulinum toxin type a, intradermal
5173623|NCT02907255|Pulse oximetry|pulse oximetry
5173624|NCT02907255|vital signs monitoring|vital signs monitoring
5173625|NCT02907255|wireless notification of clinicians|wireless notification of clinicians
5173626|NCT02907255|respiratory monitoring system|respiratory monitoring system
5173627|NCT02907242|stillbirth|stillbirth
5173628|NCT02907242|cerebroplacental ratio|cerebroplacental ratio
5173629|NCT02907242|fetal growth restriction|fetal growth restriction
5173630|NCT02907216|Healthy Japanese infants|healthy japanese infants
5173631|NCT02907216|Safety|safety
5173632|NCT02907216|Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) vaccine|diphtheria, tetanus, pertussis and inactivated poliovirus (dpt-ipv) vaccine
5173633|NCT02907216|Vaccination|vaccination
5173634|NCT02907216|Oral HRV liquid vaccine|oral hrv liquid vaccine
5173635|NCT02907216|Immunogenicity|immunogenicity
5173636|NCT02907190|pulses|pulses
5173637|NCT02907190|beans|beans
5173638|NCT02907190|blood glucose|blood glucose
5173639|NCT02907190|insulin|insulin
5173640|NCT02907112|meat intake|meat intake
5173641|NCT02907112|meat analogues|meat analogues
5173642|NCT02907112|LDL Cholesterol|ldl cholesterol
5173643|NCT02907112|HDL Cholesterol|hdl cholesterol
5173644|NCT02907060|prolonged pregnancy|prolonged pregnancy
5173645|NCT02907060|mechanical cervical ripening|mechanical cervical ripening
5173646|NCT02906995|pharmacokinetics|pharmacokinetics
5173647|NCT02906995|nicotine absorption|nicotine absorption
5173648|NCT02906982|Periodontal diseases|periodontal diseases
5173649|NCT02906982|Periodontitis|periodontitis
5173650|NCT02906982|Gingivitis|gingivitis
5173651|NCT02906982|Teeth Whitening|teeth whitening
5173652|NCT02906982|Dental Plaque Index|dental plaque index
5779266|NCT00200850|Breathing|breathing
5173663|NCT02906878|Intensive Care|intensive care
5173665|NCT02906878|Platelets prophylactic transfusion|platelets prophylactic transfusion
5173666|NCT02906839|cardiovascular risk|cardiovascular risk
5173667|NCT02906839|risk of atrial fibrillation recurrence|risk of atrial fibrillation recurrence
5173668|NCT02906839|sleep apnea syndrome|sleep apnea syndrome
5173669|NCT02906839|atrial fibrillation|atrial fibrillation
5173670|NCT02906826|Airway clearance technique|airway clearance technique
5962181|NCT04282408|scoliosis|scoliosis
5962182|NCT04282408|spinal deformity|spinal deformity
5962183|NCT04282395|Self-management|self-management
5962184|NCT04282395|Church setting|church setting
5962185|NCT04282395|African Americans|african americans
5962186|NCT04282395|Health disparities|health disparities
5962187|NCT04282382|Transfusion, Pediatric, Patient Blood Management|transfusion, pediatric, patient blood management
5047059|NCT03705104|App|app
5173671|NCT02906826|Positive expiratory pressure technique|positive expiratory pressure technique
5173672|NCT02906826|Adherence|adherence
5173673|NCT02906813|Drug Therapy|drug therapy
5173674|NCT02906800|cisplatin|cisplatin
5173675|NCT02906800|head and neck cancer|head and neck cancer
5173677|NCT02906787|Smoking Cessation|smoking cessation
5173678|NCT02906787|Weight Loss|weight loss
5173679|NCT02906761|asthma, aspirin|asthma, aspirin
5173680|NCT02906748|parathyroid autografting|parathyroid autografting
5173681|NCT02906748|thyroidectomy|thyroidectomy
5173682|NCT02906748|survival rate|survival rate
5173683|NCT02906748|hypoparathyroidism|hypoparathyroidism
5173684|NCT02906722|Nebulized colistin|nebulized colistin
5173685|NCT02906722|Intravenous colistin|intravenous colistin
5173686|NCT02906722|ventilator-associated pneumonia|ventilator-associated pneumonia
5173687|NCT02906722|multidrug resistance|multidrug resistance
5173688|NCT02906722|Gram-negative bacteria|gram-negative bacteria
5173689|NCT02906683|Urinary Incontinence|urinary incontinence
5173690|NCT02906683|Urinary Incontinence, Stress|urinary incontinence, stress
5173691|NCT02906683|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5173692|NCT02906670|Epithelial malignancies|epithelial malignancies
5173693|NCT02906657|Medication Reconciliation|medication reconciliation
5173694|NCT02906657|Adverse Drug Event|adverse drug event
5173696|NCT02906657|patient pharmaceutical record|patient pharmaceutical record
5173697|NCT02906644|Nicotine addiction|nicotine addiction
5173698|NCT02906644|Cigarette smoking|cigarette smoking
5173699|NCT02906644|Smoking cessation|smoking cessation
5173700|NCT02906644|lorcaserin|lorcaserin
5173701|NCT02906644|Belviq|belviq
5173702|NCT02906644|Nicotine patches|nicotine patches
5173703|NCT02906631|encephalitis,|encephalitis,
5173704|NCT02906631|neurologic outcomes of all-cause encephalitis in intensive care unit|neurologic outcomes of all-cause encephalitis in intensive care unit
5173705|NCT02906631|outcome, intensive care unit|outcome, intensive care unit
5173706|NCT02906553|Nitric Oxide|nitric oxide
5173707|NCT02906553|Cognition|cognition
5173708|NCT02906527|Cardiology|cardiology
5173709|NCT02906527|Oral anticoagulants|oral anticoagulants
5173710|NCT02906527|Risk and Benefit analysis|risk and benefit analysis
5173711|NCT02906527|Health insurance databases|health insurance databases
5173712|NCT02906527|Safety|safety
5173713|NCT02906527|Elderly|elderly
5173714|NCT02906514|Hydroxyethyl Starch|hydroxyethyl starch
5173715|NCT02906514|Cardiac surgery|cardiac surgery
5173716|NCT02906514|Priming of cardiopulmonary bypass|priming of cardiopulmonary bypass
5173717|NCT02906501|Risperidone|risperidone
5173718|NCT02906501|ADHD|adhd
5173720|NCT02906501|IGT|igt
5173721|NCT02906501|CNP|cnp
5173722|NCT02906501|Executive functions|executive functions
5173723|NCT02906488|Quality of life|quality of life
5173724|NCT02906475|Dermatitis, atopic|dermatitis, atopic
5173725|NCT02906475|prevention and control|prevention and control
5173726|NCT02906475|Infant|infant
5173727|NCT02906475|Skin care|skin care
5173728|NCT02906475|randomized controlled trial|randomized controlled trial
5173729|NCT02906462|Leonetti French law|leonetti french law
5173730|NCT02906462|Palliative care|palliative care
5173731|NCT02906449|concussion, mild head injury, mindfulness|concussion, mild head injury, mindfulness
5173732|NCT02906436|Lung transplantation|lung transplantation
5173733|NCT02906436|ExVivo reconditionning|exvivo reconditionning
5173734|NCT02906423|Quality of Life|quality of life
5173735|NCT02906423|Patient-Centered Care|patient-centered care
5173736|NCT02906423|Patient Outcome Assessment|patient outcome assessment
5173737|NCT02906384|hippocampus avoidance|hippocampus avoidance
5173738|NCT02906384|volumetric modulated arc therapy|volumetric modulated arc therapy
5173739|NCT02906384|functional MRI|functional mri
5173740|NCT02906384|hopkins Verbal Learning Test|hopkins verbal learning test
5173741|NCT02906384|prophylactic cranial irradiation|prophylactic cranial irradiation
5173742|NCT02906345|Septic shock|septic shock
5173743|NCT02906345|Fresh frozen plasma|fresh frozen plasma
5173744|NCT02906306|Older adults|older adults
5173745|NCT02906306|Occupational Therapy|occupational therapy
5173746|NCT02906306|Self-Efficacy|self-efficacy
5173747|NCT02906306|Psychological Well-being|psychological well-being
5173748|NCT02906280|EBUS-TBNA|ebus-tbna
5173749|NCT02906241|African Americans|african americans
5173750|NCT02906241|prostate cancer|prostate cancer
5173751|NCT02906241|Minority|minority
5173752|NCT02906241|Racial /Ethnic disparity|racial /ethnic disparity
5173753|NCT02906241|Cancer care|cancer care
5173754|NCT02906241|patient-physician communication|patient-physician communication
5173755|NCT02906241|cancer clinical trial accrual|cancer clinical trial accrual
5173756|NCT02906228|non-ionizing radiation|non-ionizing radiation
5173757|NCT02906215|mHealth|mhealth
5173758|NCT02906215|implementation|implementation
5173759|NCT02906215|PrEP|prep
5173761|NCT02906163|EGFR mutation positive|egfr mutation positive
5173762|NCT02906163|Thymosin Alpha 1|thymosin alpha 1
5173763|NCT02906163|Tyrosine Kinase inhibitor|tyrosine kinase inhibitor
5173764|NCT02906163|Thymalfasin|thymalfasin
5173765|NCT02906163|Non Small Cell Lung Cancer|non small cell lung cancer
5962188|NCT04282369|respiratory distress, newborn, noninvasive ventilation|respiratory distress, newborn, noninvasive ventilation
5047271|NCT03703882|DMD|dmd
5173767|NCT02906150|Thymosin Alpha 1|thymosin alpha 1
5173768|NCT02906150|Non-Small Cell Lung Cancer|non-small cell lung cancer
5173769|NCT02906150|Thymalfasin|thymalfasin
5173770|NCT02906124|hypercholesterolaemia|hypercholesterolaemia
5173771|NCT02906124|Lipid lowering therapies|lipid lowering therapies
5173772|NCT02906124|Pregnancy|pregnancy
5173773|NCT02906111|Estriol|estriol
5173774|NCT02906111|Prolapse|prolapse
5173775|NCT02906111|Quality of life|quality of life
5173776|NCT02906111|Vaginal health|vaginal health
5173777|NCT02906111|Vaginal surgery|vaginal surgery
5173778|NCT02906098|Gingivitis|gingivitis
5173779|NCT02906098|Adolescents|adolescents
5173780|NCT02906098|Oral hygiene|oral hygiene
5173781|NCT02906098|Oral health behavior|oral health behavior
5173782|NCT02906098|Periodontal infection control|periodontal infection control
5173783|NCT02906085|[C10.228.140.546.399.750.250]|[c10.228.140.546.399.750.250]
5173784|NCT02906072|Obesity|obesity
5173785|NCT02906072|Body fat|body fat
5173786|NCT02906072|Plant-based diet|plant-based diet
5173787|NCT02906072|Plant-based meal replacement|plant-based meal replacement
5173788|NCT02906059|RAS|ras
5173789|NCT02906059|KRAS|kras
5173790|NCT02906059|NRAS|nras
5173791|NCT02906059|BRAF|braf
5173792|NCT02906059|Mutated|mutated
5173793|NCT02906059|Wee1 inhibitor|wee1 inhibitor
5173794|NCT02906046|SCA 3|sca 3
5173795|NCT02906046|Ataxic Gait|ataxic gait
5173796|NCT02906033|Surgical Procedures, Operative|surgical procedures, operative
5173797|NCT02906033|Operating Rooms|operating rooms
5173798|NCT02906033|Quality of Life|quality of life
5173799|NCT02906033|Surgery-related anxiety|surgery-related anxiety
5173800|NCT02905994|Leukemia|leukemia
5173801|NCT02905981|IRIDA|irida
5173802|NCT02905981|Triferic|triferic
5173803|NCT02905981|soluble ferric pyrophosphate|soluble ferric pyrophosphate
5061687|NCT03613298|DIE|die
5173804|NCT02905981|Shohl's solution|shohl's solution
5173805|NCT02905968|Anastomotic leak|anastomotic leak
5173806|NCT02905968|Low rectal cancer|low rectal cancer
5173807|NCT02905929|sedentary behavior|sedentary behavior
5173808|NCT02905929|standing|standing
5173809|NCT02905929|sitting|sitting
5173810|NCT02905929|inclinometer|inclinometer
5173811|NCT02905864|Liraglutide|liraglutide
5173812|NCT02905864|Liraglutide 3 mg|liraglutide 3 mg
5173813|NCT02905864|Osteoarthritis|osteoarthritis
5173814|NCT02905864|Obesity|obesity
5173815|NCT02905799|Osteoarthritis|osteoarthritis
5173816|NCT02905799|Knee|knee
5173817|NCT02905799|Resveratrol|resveratrol
5173818|NCT02905799|Oral Treatment|oral treatment
5173819|NCT02905799|Pain|pain
5173820|NCT02905799|Trial|trial
5173821|NCT02905786|General Practice|general practice
5173822|NCT02905786|Nurse practitioner|nurse practitioner
5173823|NCT02905786|Natriuretic peptides|natriuretic peptides
5173824|NCT02905786|Clinical audit|clinical audit
5173825|NCT02905773|Intensity|intensity
5173826|NCT02905760|Acute Myocardial Infarction|acute myocardial infarction
5173827|NCT02905760|Right ventricular infarction|right ventricular infarction
5173828|NCT02905760|Diuretic|diuretic
5173829|NCT02905760|Fluid Expansion|fluid expansion
5173830|NCT02905747|Exercise Therapy|exercise therapy
5173831|NCT02905747|Musculoskeletal Pain|musculoskeletal pain
5173832|NCT02905747|Knee osteoarthritis|knee osteoarthritis
5173833|NCT02905747|Physical Therapy Modalities|physical therapy modalities
5173834|NCT02905734|Nicotine replacement therapy|nicotine replacement therapy
5173835|NCT02905734|Tobacco|tobacco
5173836|NCT02905708|normothermia|normothermia
5173837|NCT02905708|hypothermia|hypothermia
5173838|NCT02905695|Post-partum Perineal pain|post-partum perineal pain
5173839|NCT02905695|Episiotomy|episiotomy
5173840|NCT02905695|First-degree tear|first-degree tear
5173841|NCT02905669|distensibility|distensibility
5173842|NCT02905669|impedance planimetry|impedance planimetry
5173843|NCT02905669|esophagus|esophagus
5173844|NCT02905669|esophago-gastric junction|esophago-gastric junction
5173845|NCT02905669|pylorus|pylorus
5173846|NCT02905656|quitline|quitline
5173847|NCT02905656|nicotine replacement therapy|nicotine replacement therapy
5173848|NCT02905656|tobacco intervention|tobacco intervention
5173849|NCT02905656|smokers not ready to quit|smokers not ready to quit
5173850|NCT02905643|Pseudoprogression|pseudoprogression
5173851|NCT02905643|Brain Cancer|brain cancer
5173852|NCT02905630|coronary flow reserve|coronary flow reserve
5173853|NCT02905630|angina|angina
5173854|NCT02905630|exercise training|exercise training
5173855|NCT02905617|Breast Augmentation|breast augmentation
5173856|NCT02905617|Breast Revision-Augmentation|breast revision-augmentation
5173857|NCT02905604|rTMS|rtms
5173858|NCT02905604|negative symptoms|negative symptoms
5173859|NCT02905604|intermittent theta burst|intermittent theta burst
5962189|NCT04282356|ovarian cancer|ovarian cancer
5173860|NCT02905604|iTBS|itbs
5173861|NCT02905604|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5173863|NCT02905604|dmPFC|dmpfc
5173864|NCT02905604|NIRS|nirs
5173865|NCT02905591|pharmacological ascorbate|pharmacological ascorbate
5173866|NCT02905591|ascorbic acid|ascorbic acid
5173867|NCT02905591|radiation|radiation
5047278|NCT03703856|AD|ad
5173868|NCT02905591|chemotherapy|chemotherapy
5173869|NCT02905591|carboplatin|carboplatin
5173870|NCT02905591|paclitaxel|paclitaxel
5173871|NCT02905578|Ascorbate|ascorbate
5173872|NCT02905578|Vitamin C|vitamin c
5173873|NCT02905578|Pharmacological ascorbate|pharmacological ascorbate
5173874|NCT02905578|Pharmacologic ascorbate|pharmacologic ascorbate
5173875|NCT02905578|Ascorbic Acid|ascorbic acid
5173876|NCT02905578|gemcitabine|gemcitabine
5173877|NCT02905578|nab-paclitaxel|nab-paclitaxel
5173878|NCT02905578|Gemzar|gemzar
5173880|NCT02905565|Multicenter|multicenter
5173881|NCT02905565|Randomized|randomized
5173882|NCT02905565|Double-Blind|double-blind
5173883|NCT02905565|Placebo-Controlled|placebo-controlled
5173884|NCT02905565|Add-On to Standard-of-Care|add-on to standard-of-care
5173885|NCT02905565|Safety|safety
5173886|NCT02905565|Efficacy|efficacy
5173887|NCT02905552|Myelodysplastic syndrome (myelodysplasia)|myelodysplastic syndrome (myelodysplasia)
5173888|NCT02905552|Infection|infection
5173889|NCT02905552|Risk Factors|risk factors
5173890|NCT02905539|Iron|iron
5173891|NCT02905539|anemia|anemia
5173892|NCT02905539|phosphorus|phosphorus
5173893|NCT02905539|FGF-23|fgf-23
5173894|NCT02905526|Reproductive health|reproductive health
5173895|NCT02905513|Reproductive health|reproductive health
5173896|NCT02905500|Disability-Adjusted Life Years|disability-adjusted life years
5173897|NCT02905500|Epidemiology|epidemiology
5173898|NCT02905500|Public Health|public health
5173899|NCT02905487|Gestational Diabetes Mellitus|gestational diabetes mellitus
5173900|NCT02905487|Obesity|obesity
5173901|NCT02905487|Adipocytokin|adipocytokin
5173902|NCT02905474|chronic kidney disease, mobile applications, mHealth, medication reconciliation, self-management|chronic kidney disease, mobile applications, mhealth, medication reconciliation, self-management
5173903|NCT02905461|Reproductive health|reproductive health
5173904|NCT02905448|Obesity|obesity
5173905|NCT02905448|Body composition|body composition
5173906|NCT02905448|Atherosclerosis|atherosclerosis
5173907|NCT02905448|Insulin resistance|insulin resistance
5173908|NCT02905448|Hyperuricemia|hyperuricemia
5173909|NCT02905435|burns|burns
5173910|NCT02905435|autografts|autografts
5173911|NCT02905435|humans|humans
5173912|NCT02905435|biodegradable polyurethane|biodegradable polyurethane
5173913|NCT02905435|dermal matrix|dermal matrix
5173914|NCT02905435|synthetic|synthetic
5173915|NCT02905422|physical activity|physical activity
5173916|NCT02905422|sleep|sleep
5173917|NCT02905422|nutrition|nutrition
5173918|NCT02905422|Soldier|soldier
5173919|NCT02905422|prevention|prevention
5173920|NCT02905422|remote monitoring|remote monitoring
5173921|NCT02905422|mobile technology|mobile technology
5173922|NCT02905396|small fiber neuropathy|small fiber neuropathy
5173923|NCT02905396|spinal cord stimulation|spinal cord stimulation
5173924|NCT02905396|treatment|treatment
5173925|NCT02905396|pain|pain
5173926|NCT02905370|Home Health|home health
5173927|NCT02905370|Rehabilitation|rehabilitation
5173928|NCT02905370|High Intensity|high intensity
5173929|NCT02905370|Hospital Associated Deconditioning|hospital associated deconditioning
5173930|NCT02905370|Functional Mobility|functional mobility
5173931|NCT02905370|Physical Function|physical function
5173932|NCT02905357|Myocardial Infarction|myocardial infarction
5173933|NCT02905357|Women|women
5173934|NCT02905357|Imaging|imaging
5173935|NCT02905305|cochlear implants|cochlear implants
5173936|NCT02905305|Dexamethasone|dexamethasone
5173937|NCT02905305|combined device|combined device
5173938|NCT02905279|spider phobia|spider phobia
5173939|NCT02905279|animal phobia|animal phobia
5173940|NCT02905279|exposure therapy|exposure therapy
5173941|NCT02905279|biofeedback|biofeedback
5173942|NCT02905279|relaxation training|relaxation training
5173943|NCT02905240|Autologous Protein Solution|autologous protein solution
5173945|NCT02905240|intra-articular injection|intra-articular injection
5173946|NCT02905240|osteoarthritis|osteoarthritis
5173947|NCT02905227|Adult smokers|adult smokers
5173948|NCT02905227|Asthma|asthma
5173949|NCT02905227|Healthy volunteers|healthy volunteers
5173950|NCT02905188|hepatocellular carcinoma|hepatocellular carcinoma
5173951|NCT02905188|GPC3-CAR T cells|gpc3-car t cells
5173952|NCT02905188|GPC3-positive hepatocellular carcinoma|gpc3-positive hepatocellular carcinoma
5173953|NCT02905175|rheumatoid arthritis|rheumatoid arthritis
5173954|NCT02905175|Porphyromonas gingivalis|porphyromonas gingivalis
5173955|NCT02905149|Oncological|oncological
5173956|NCT02905149|Surgery|surgery
5173957|NCT02905149|Breast|breast
5173958|NCT02905149|Reconstruction|reconstruction
5173959|NCT02905136|autoantibodies|autoantibodies
5173960|NCT02905136|neuronal synaptic receptors|neuronal synaptic receptors
5173961|NCT02905136|autoimmune encephalitis|autoimmune encephalitis
5174089|NCT02904265|acetazolamide|acetazolamide
5173962|NCT02905110|Malignant Neoplasms, Brain|malignant neoplasms, brain
5173963|NCT02905110|medulloblastoma|medulloblastoma
5173964|NCT02905110|ependymoma|ependymoma
5173965|NCT02905110|Atypical Teratoid Rhabdoid Tumor (ATRT)|atypical teratoid rhabdoid tumor (atrt)
5173966|NCT02905097|Knee arthroplasty, Total|knee arthroplasty, total
5962190|NCT04282356|intraperitoneal|intraperitoneal
5040662|NCT03744676|NHL|nhl
5173967|NCT02905097|Knee replacement, Total|knee replacement, total
5173968|NCT02905097|Survival rate|survival rate
5173969|NCT02905097|Osseointegration|osseointegration
5173971|NCT02905071|mental health|mental health
5173972|NCT02905071|well-being at work|well-being at work
5173973|NCT02905071|screening|screening
5173974|NCT02905071|psychosocial risk|psychosocial risk
5173975|NCT02905071|psychometrics|psychometrics
5173976|NCT02905071|questionnaire|questionnaire
5173977|NCT02905071|job stress|job stress
5173978|NCT02905032|Afib|afib
5173979|NCT02905032|Atrial fib|atrial fib
5173980|NCT02905032|Shared|shared
5173981|NCT02905032|Decision|decision
5173982|NCT02905032|Making|making
5173983|NCT02905032|Aid|aid
5173984|NCT02905032|AF|af
5173985|NCT02905006|Psoriasis|psoriasis
5173986|NCT02905006|Chronic Plaque Psoriasis|chronic plaque psoriasis
5173987|NCT02905006|Bimekizumab|bimekizumab
5173988|NCT02904980|Quiet eye training|quiet eye training
5173989|NCT02904980|Visual Attention|visual attention
5173990|NCT02904954|Lung neoplasms|lung neoplasms
5173991|NCT02904954|Bronchial Neoplasms|bronchial neoplasms
5173992|NCT02904954|Carcinoma, bronchogenic|carcinoma, bronchogenic
5173993|NCT02904954|Neoplasms|neoplasms
5173994|NCT02904954|Neoplasms by site|neoplasms by site
5173995|NCT02904954|Respiratory Tract Diseases|respiratory tract diseases
5173996|NCT02904954|Respiratory Tract Neoplasms|respiratory tract neoplasms
5173997|NCT02904954|Thoracic Neoplasms|thoracic neoplasms
5173998|NCT02904941|Children|children
5173999|NCT02904941|Skin Transplantation|skin transplantation
5174000|NCT02904941|Amniotic Membrane|amniotic membrane
5174001|NCT02904902|efficacy|efficacy
5174002|NCT02904902|safety|safety
5174003|NCT02904902|adalimumab|adalimumab
5174004|NCT02904902|japanese participants|japanese participants
5174005|NCT02904850|Non-small cell lung cancer|non-small cell lung cancer
5174006|NCT02904850|locally advanced or metastatic|locally advanced or metastatic
5174007|NCT02904850|erlotinib monotherapy|erlotinib monotherapy
5174008|NCT02904837|Randomized clinical trial|randomized clinical trial
5174009|NCT02904837|Parkinson's disease|parkinson's disease
5174010|NCT02904837|Mental practice|mental practice
5174011|NCT02904837|Gait|gait
5174012|NCT02904824|adipose tissue|adipose tissue
5174013|NCT02904824|adult stem cells|adult stem cells
5174014|NCT02904824|vocal cord paralysis|vocal cord paralysis
5174015|NCT02904811|Chlamydia trachomatis|chlamydia trachomatis
5174016|NCT02904811|Pelvic inflammatory disease|pelvic inflammatory disease
5174017|NCT02904798|sunscreen|sunscreen
5174018|NCT02904798|photoprotection|photoprotection
5174019|NCT02904798|visible light|visible light
5174020|NCT02904746|follow-up|follow-up
5174021|NCT02904746|mental health appointment|mental health appointment
5174022|NCT02904720|Vitamin D; Pregnancy|vitamin d; pregnancy
5174023|NCT02904707|Skin Graft|skin graft
5174024|NCT02904668|chronic pain|chronic pain
5174025|NCT02904642|SMS reminder|sms reminder
5174026|NCT02904642|incentive|incentive
5174027|NCT02904642|mobile phone|mobile phone
5174028|NCT02904642|Immunization|immunization
5174029|NCT02904590|IBD|ibd
5174030|NCT02904590|Infection|infection
5174031|NCT02904577|Indolent B-Cell Lymphomas|indolent b-cell lymphomas
5174032|NCT02904577|prospective collection|prospective collection
5174033|NCT02904564|drug delivery|drug delivery
5174034|NCT02904564|Idiopathic Guttate Hypomelanosis|idiopathic guttate hypomelanosis
5174035|NCT02904551|prospective study|prospective study
5174036|NCT02904551|free gingival graft|free gingival graft
5174037|NCT02904551|keratinized gingiva|keratinized gingiva
5174038|NCT02904551|dental implant|dental implant
5174059|NCT02904421|spinal deformity|spinal deformity
5174060|NCT02904421|vitamin D|vitamin d
5174061|NCT02904421|bone health|bone health
5174062|NCT02904408|quality of life|quality of life
5174063|NCT02904408|psychotherapy|psychotherapy
5174064|NCT02904408|hidradenitis|hidradenitis
5174065|NCT02904408|treatments|treatments
5174066|NCT02904356|OCD|ocd
5174067|NCT02904356|TMS|tms
5174068|NCT02904356|Neuromodulation|neuromodulation
5174069|NCT02904356|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5174070|NCT02904356|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5174071|NCT02904356|Imaging|imaging
5174072|NCT02904343|hemodialysis machine|hemodialysis machine
5174073|NCT02904343|quality|quality
5174074|NCT02904343|safety|safety
5174075|NCT02904343|domestic|domestic
5174077|NCT02904304|Treatment|treatment
5174585|NCT02900937|Stents|stents
5174083|NCT02904278|Mobile Application Intervention|mobile application intervention
5174084|NCT02904278|Teen Pocket PATH® [TPP]|teen pocket path® [tpp]
5174085|NCT02904278|Adherence|adherence
5174086|NCT02904278|Medical Management|medical management
5174087|NCT02904265|continuous spike wave in sleep|continuous spike wave in sleep
5174088|NCT02904265|Landau-Kleffner syndrome|landau-kleffner syndrome
5962191|NCT04282356|chemotherapy|chemotherapy
5174090|NCT02904265|diazepam|diazepam
5174091|NCT02904252|Transient elastography|transient elastography
5174092|NCT02904252|Fibrotest|fibrotest
5174093|NCT02904239|Multidetector Computed Tomography|multidetector computed tomography
5174094|NCT02904239|Incidental cardiac findings|incidental cardiac findings
5174095|NCT02904239|Thoracic high-pitch Computed Tomography|thoracic high-pitch computed tomography
5174096|NCT02904239|Management guidelines|management guidelines
5174098|NCT02904226|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
5174099|NCT02904226|JTX-2011|jtx-2011
5174100|NCT02904226|Anti-PD-1|anti-pd-1
5174101|NCT02904226|Nivolumab|nivolumab
5174102|NCT02904226|ICONIC|iconic
5174103|NCT02904226|Immunotherapy|immunotherapy
5174104|NCT02904226|Immuno-oncology|immuno-oncology
5174105|NCT02904226|Cancer|cancer
5174106|NCT02904226|Solid Tumor|solid tumor
5174107|NCT02904226|Dose Escalation|dose escalation
5174108|NCT02904226|Dose Expansion|dose expansion
5174109|NCT02904226|Anti-CTLA-4|anti-ctla-4
5174110|NCT02904226|Ipilimumab|ipilimumab
5174111|NCT02904226|Pembrolizumab|pembrolizumab
5174112|NCT02904213|vaccine|vaccine
5174113|NCT02904213|ComBe Five|combe five
5174114|NCT02904213|Vietnam|vietnam
5174115|NCT02904213|pentavalent|pentavalent
5174116|NCT02904135|Circulating Tumor Cells|circulating tumor cells
5174117|NCT02904070|Threat of|threat of
5174118|NCT02904044|School|school
5174119|NCT02904044|Sport|sport
5174120|NCT02904044|Injuries|injuries
5174121|NCT02904005|Suicide|suicide
5174122|NCT02904005|Prediction|prediction
5174123|NCT02904005|Prospective study|prospective study
5174124|NCT02904005|Suicide attempt|suicide attempt
5174125|NCT02904005|Risk management|risk management
5174126|NCT02903992|Frail Elderly|frail elderly
5174127|NCT02903992|sarcopenia|sarcopenia
5174128|NCT02903966|Tolerability|tolerability
5174129|NCT02903966|GSK2982772|gsk2982772
5174130|NCT02903966|Safety|safety
5174131|NCT02903966|Pharmacokinetics|pharmacokinetics
5174132|NCT02903966|RIP1 kinase inhibitor|rip1 kinase inhibitor
5174133|NCT02903966|Ulcerative colitis|ulcerative colitis
5174134|NCT02903966|Pharmacodynamics|pharmacodynamics
5174150|NCT02903901|Delirium|delirium
5174154|NCT02903862|Cognition|cognition
5174155|NCT02903862|Caregiver Burden|caregiver burden
5174156|NCT02903862|Depression|depression
5174160|NCT02903797|Endometrial hyperplasia|endometrial hyperplasia
5174161|NCT02903797|Irisin|irisin
5174162|NCT02903797|fibronectin type III domain containing 5|fibronectin type iii domain containing 5
5174163|NCT02903797|FNDC5 (fibronectin type III domain containing )|fndc5 (fibronectin type iii domain containing )
5174164|NCT02903771|Cantrixil|cantrixil
5174165|NCT02903771|Intraperitoneal|intraperitoneal
5174166|NCT02903719|Phrenic|phrenic
5174167|NCT02903719|Nerve block|nerve block
5174168|NCT02903719|Postoperative shoulder pain|postoperative shoulder pain
5174169|NCT02903719|Liver resection|liver resection
5174170|NCT02903706|gold miners|gold miners
5174171|NCT02903706|plasmodium carriers|plasmodium carriers
5174172|NCT02903706|artemisinine resistance|artemisinine resistance
5174173|NCT02903680|Relapse Prevention|relapse prevention
5174174|NCT02903680|Children|children
5174175|NCT02903667|bone grafting|bone grafting
5174176|NCT02903667|implantology|implantology
5174177|NCT02903667|oral surgery|oral surgery
5174178|NCT02903628|myopia|myopia
5174179|NCT02903615|glucose|glucose
5174180|NCT02903615|inflammation|inflammation
5174181|NCT02903602|sharing histories|sharing histories
5174182|NCT02903602|autobiographical memory|autobiographical memory
5174183|NCT02903602|health behavior|health behavior
5174184|NCT02903602|narrative communication|narrative communication
5174185|NCT02903602|community health workers|community health workers
5174186|NCT02903602|global health|global health
5174187|NCT02903602|maternal and child health|maternal and child health
5174188|NCT02903602|stunting|stunting
5174189|NCT02903537|Multiple Sclerosis|multiple sclerosis
5174190|NCT02903537|Dendritic Cells|dendritic cells
5174191|NCT02903537|Immune Tolerance|immune tolerance
5174192|NCT02903537|Myelin Proteins|myelin proteins
5174193|NCT02903537|Tolerogenic dendritic cells|tolerogenic dendritic cells
5174194|NCT02903511|Metformin|metformin
5174195|NCT02903511|total kidney volume|total kidney volume
5174196|NCT02903511|glomerular filtration rate|glomerular filtration rate
5174197|NCT02903498|disease control survival|disease control survival
5174199|NCT02903472|microbiome|microbiome
5174200|NCT02903472|metabolome|metabolome
5174201|NCT02903472|GI|gi
5174202|NCT02903472|UTI|uti
5174203|NCT02903472|DNA|dna
5174204|NCT02903472|genomics|genomics
5174205|NCT02903472|infections|infections
5174206|NCT02903472|tetraplegic|tetraplegic
5174207|NCT02903472|paraplegic|paraplegic
5174208|NCT02903459|Central Fat|central fat
5174209|NCT02903459|Subcutaneous Fat|subcutaneous fat
5174210|NCT02903459|Lumbar Lordosis Degree|lumbar lordosis degree
5174211|NCT02903459|Cellulite|cellulite
5174212|NCT02903433|Avocado|avocado
5174213|NCT02903433|Cardiovascular disease|cardiovascular disease
5174214|NCT02903407|Ventilators, Mechanical|ventilators, mechanical
5174215|NCT02903407|Intensive Care Units|intensive care units
5169273|NCT02933554|NASH|nash
5174216|NCT02903407|Deep Sedation|deep sedation
5174217|NCT02903381|Smoldering Multiple Myeloma|smoldering multiple myeloma
5174218|NCT02903368|Prostate Cancer|prostate cancer
5174220|NCT02903342|Febrile illness|febrile illness
5174221|NCT02903342|Children|children
5174222|NCT02903316|Fluid responsiveness|fluid responsiveness
5174223|NCT02903316|Perioperative|perioperative
5174224|NCT02903316|Extra systoles|extra systoles
5174225|NCT02903316|Coronary artery bypass|coronary artery bypass
5174226|NCT02903316|Systolic arterial pressure|systolic arterial pressure
5174227|NCT02903264|Gestational Diabetes Mellitus|gestational diabetes mellitus
5174228|NCT02903264|Obesity|obesity
5174229|NCT02903264|Periodontal Disease|periodontal disease
5174230|NCT02903251|Oxytocin|oxytocin
5174231|NCT02903251|Administration, Intranasal|administration, intranasal
5174232|NCT02903251|Ethanol|ethanol
5174233|NCT02903238|placebo|placebo
5174234|NCT02903238|pain|pain
5174235|NCT02903238|osteoarthritis|osteoarthritis
5174236|NCT02903225|Heart rate variability|heart rate variability
5174237|NCT02903225|Systolic heart failure|systolic heart failure
5174238|NCT02903225|Physical exercise|physical exercise
5174239|NCT02903225|Parasympathetic indexes|parasympathetic indexes
5174240|NCT02903212|Apoptotic cells|apoptotic cells
5174241|NCT02903199|Whey Protein|whey protein
5174242|NCT02903199|Postprandial Glycaemia|postprandial glycaemia
5174243|NCT02903199|Appetite Response|appetite response
5174244|NCT02903186|infants|infants
5174245|NCT02903186|minorities|minorities
5174246|NCT02903186|overfeeding|overfeeding
5174247|NCT02903186|WIC program|wic program
5174248|NCT02903186|feeding practices|feeding practices
5174249|NCT02903186|breastfeeding|breastfeeding
5174250|NCT02903173|respiratory depression|respiratory depression
5174251|NCT02903173|postpartum|postpartum
5174252|NCT02903173|neuraxial morphine|neuraxial morphine
5779478|NCT00199888|antibody|antibody
5174253|NCT02903173|cesarean delivery|cesarean delivery
5174254|NCT02903160|Castration resistant|castration resistant
5174255|NCT02903160|Prostate cancer|prostate cancer
5174256|NCT02903160|Metastatic|metastatic
5174257|NCT02903160|First-line|first-line
5174258|NCT02903160|Treatment naive|treatment naive
5174259|NCT02903160|Rapidly cycling|rapidly cycling
5174260|NCT02903160|Non-cross resistant|non-cross resistant
5174262|NCT02903121|Unscheduled bleeding|unscheduled bleeding
5174263|NCT02903121|Long acting contraception|long acting contraception
5174264|NCT02903095|Single ascending dose|single ascending dose
5174265|NCT02903082|Myeloid-Derivated suppressive cell|myeloid-derivated suppressive cell
5174266|NCT02903082|Sepsis|sepsis
5174267|NCT02903082|Inflammatory Response Syndrome, Systemic|inflammatory response syndrome, systemic
5174268|NCT02903069|newly diagnosed|newly diagnosed
5174269|NCT02903069|malignant glioma|malignant glioma
5174270|NCT02903069|WHO Grade 4|who grade 4
5174271|NCT02903069|WHO Grade IV|who grade iv
5174272|NCT02903069|marizomib|marizomib
5174273|NCT02903069|MRZ|mrz
5174274|NCT02903069|TMZ|tmz
5174275|NCT02903069|RT|rt
5174276|NCT02903069|brain cancer|brain cancer
5174277|NCT02903069|proteasome inhibitor|proteasome inhibitor
5174278|NCT02903069|radiation|radiation
5174279|NCT02903069|temozolomide|temozolomide
5174280|NCT02903069|temodar|temodar
5174281|NCT02903069|chemotherapy|chemotherapy
5174282|NCT02903069|concurrent|concurrent
5174283|NCT02903069|adjuvant|adjuvant
5174284|NCT02903069|Optune|optune
5174285|NCT02903069|Novocure|novocure
5174286|NCT02903069|NovoTTF|novottf
5174287|NCT02903056|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5174288|NCT02903056|Diffusion Spectrum Imaging|diffusion spectrum imaging
5174289|NCT02903056|Susceptibility weighted imaging|susceptibility weighted imaging
5174290|NCT02903056|Magnetic Resonance Imaging|magnetic resonance imaging
5174291|NCT02903043|MicroRNAs|micrornas
5174292|NCT02903043|Angiogenesis|angiogenesis
5174293|NCT02903043|Skeletal muscle|skeletal muscle
5174294|NCT02903043|COPD|copd
5174295|NCT02903030|Gastrointestinal Microbiome|gastrointestinal microbiome
5174296|NCT02902991|liquid biopsy, breast cancer,circulating tumor biomarker|liquid biopsy, breast cancer,circulating tumor biomarker
5174297|NCT02902978|E6130|e6130
5174298|NCT02902978|Japanese healthy adult male participants|japanese healthy adult male participants
5174299|NCT02902978|Phase 1|phase 1
5174300|NCT02902978|Pharmacokinetics|pharmacokinetics
5174301|NCT02902965|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5174302|NCT02902965|Bortezomib|bortezomib
5174303|NCT02902965|Dexamethasone|dexamethasone
5174304|NCT02902965|Ibrutinib|ibrutinib
5174305|NCT02902939|Immune Suppression, Inflammatory Response, Cardiac Surgery|immune suppression, inflammatory response, cardiac surgery
5174306|NCT02902913|platelet reactivity|platelet reactivity
5174307|NCT02902913|phenolic|phenolic
5174308|NCT02902913|extra virgin olive oil|extra virgin olive oil
5174309|NCT02902913|cyclooxygenase|cyclooxygenase
5174310|NCT02902913|oleocanthal|oleocanthal
5174311|NCT02902913|oxylipin|oxylipin
5174312|NCT02902900|Multiple Myeloma|multiple myeloma
5174313|NCT02902900|Pomalidomide|pomalidomide
5174314|NCT02902900|Efficacy|efficacy
5174315|NCT02902835|Buprenorphine treatment|buprenorphine treatment
5174316|NCT02902835|Incarceration|incarceration
5174317|NCT02902835|Linkage Intervention|linkage intervention
5174318|NCT02902835|Opioid use disorder|opioid use disorder
5174320|NCT02902822|non-melanoma skin cancer|non-melanoma skin cancer
5174322|NCT02902822|app|app
5174323|NCT02902822|cliccailneo|cliccailneo
5174324|NCT02902809|open-label study|open-label study
5174325|NCT02902809|tralokinumab|tralokinumab
5174326|NCT02902809|subcutaneous|subcutaneous
5174327|NCT02902809|inadequately controlled asthma|inadequately controlled asthma
5174328|NCT02902809|asthma|asthma
5174329|NCT02902809|medium to high-dose of inhaled corticosteroid|medium to high-dose of inhaled corticosteroid
5174330|NCT02902809|long-acting β2-agonist|long-acting β2-agonist
5174331|NCT02902770|Pain|pain
5174332|NCT02902770|Lidocaine|lidocaine
5174333|NCT02902770|Ketorolac|ketorolac
5174336|NCT02902705|White adipose tissue|white adipose tissue
5174337|NCT02902705|chronic kidney disease|chronic kidney disease
5174338|NCT02902705|uremia|uremia
5174339|NCT02902705|adipocytes|adipocytes
5174340|NCT02902692|brief|brief
5174341|NCT02902692|mindfulness|mindfulness
5174342|NCT02902666|Bioequivalence|bioequivalence
5174343|NCT02902666|Paracetamol 1000 mg/codeine 30 mg|paracetamol 1000 mg/codeine 30 mg
5174344|NCT02902666|Co-efferalgan 500 mg/30 mg|co-efferalgan 500 mg/30 mg
5174345|NCT02902653|misoprostol|misoprostol
5174346|NCT02902653|dinoprostonal|dinoprostonal
5174347|NCT02902653|induction|induction
5174348|NCT02902614|embryo biopsy|embryo biopsy
5174349|NCT02902614|preimplantation genetic testing|preimplantation genetic testing
5174350|NCT02902614|animal pole|animal pole
5174351|NCT02902614|vegetal pole|vegetal pole
5174352|NCT02902614|day 3 embryo biopsy|day 3 embryo biopsy
5174353|NCT02902614|embryo implantation|embryo implantation
5174354|NCT02902614|Blastomeres|blastomeres
5174355|NCT02902588|Blood-Brain Barrier|blood-brain barrier
5174356|NCT02902588|Magnetic Resonance Imaging|magnetic resonance imaging
5174357|NCT02902588|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5174358|NCT02902588|Indocyanine green|indocyanine green
5174359|NCT02902575|Stomach Neoplasms|stomach neoplasms
5174360|NCT02902575|Laparoscopy|laparoscopy
5174361|NCT02902575|Advanced Gastric Cancer|advanced gastric cancer
5174362|NCT02902575|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5174363|NCT02902549|Optical Coherence Tomography|optical coherence tomography
5174364|NCT02902549|Fluorescence Imaging|fluorescence imaging
5174365|NCT02902549|Sidestream Darkfield Microscopy|sidestream darkfield microscopy
5174366|NCT02902549|Laser Speckle Contrast Imaging|laser speckle contrast imaging
5174367|NCT02902536|Myasthenia Gravis|myasthenia gravis
5174368|NCT02902510|yoga|yoga
5174369|NCT02902510|function|function
5174370|NCT02902510|Parkinson's disease|parkinson's disease
5174371|NCT02902510|gait|gait
5174372|NCT02902510|balance|balance
5174373|NCT02902458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5174374|NCT02902458|primary prevention|primary prevention
5174375|NCT02902458|psychological follow-up|psychological follow-up
5174376|NCT02902458|anxiety|anxiety
5174377|NCT02902458|depression|depression
5174378|NCT02902458|quality of life|quality of life
5174379|NCT02902445|Vaccine|vaccine
5174380|NCT02902445|Polymorphism|polymorphism
5174381|NCT02902432|endostar|endostar
5174382|NCT02902432|cisplatin|cisplatin
5174383|NCT02902393|Fibrinolysis|fibrinolysis
5174385|NCT02902367|mobility|mobility
5174386|NCT02902367|exercise|exercise
5174387|NCT02902367|walking capacity|walking capacity
5174388|NCT02902367|fat mass|fat mass
5174389|NCT02902367|muscles|muscles
5174390|NCT02902341|Nutrition Therapy|nutrition therapy
5174391|NCT02902315|Muscle soreness|muscle soreness
5174392|NCT02902315|Free radicals|free radicals
5174393|NCT02902315|Ascorbic acid|ascorbic acid
5174394|NCT02902315|Alpha-Tocopherol|alpha-tocopherol
5174395|NCT02902315|Cryotherapy|cryotherapy
5174396|NCT02902315|Exercise tolerance|exercise tolerance
5174397|NCT02902315|Resistance training|resistance training
5174398|NCT02902302|Bioequivalence|bioequivalence
5174399|NCT02902302|Ibuprofen 400 mg/5 ml|ibuprofen 400 mg/5 ml
5174400|NCT02902302|Moment 400 mg coated tablet|moment 400 mg coated tablet
5174401|NCT02902302|Oral Suspension|oral suspension
5174402|NCT02902289|Bioequivalence|bioequivalence
5174403|NCT02902289|Ibuprofen 200 mg/5 ml|ibuprofen 200 mg/5 ml
5174404|NCT02902289|Moment 200 mg coated tablet|moment 200 mg coated tablet
5174405|NCT02902289|Oral Suspension|oral suspension
5174406|NCT02902276|plasma citrulline|plasma citrulline
5174407|NCT02902276|lipopolysaccharide|lipopolysaccharide
5174408|NCT02902276|critically ill|critically ill
5174409|NCT02902276|Hospitalization in an Intensive Care Unit|hospitalization in an intensive care unit
5174410|NCT02902263|Telemedecine|telemedecine
5174411|NCT02902263|Thrombolysis|thrombolysis
5174412|NCT02902250|Vertebroplasty|vertebroplasty
5174413|NCT02902250|Core decompression|core decompression
5174414|NCT02902250|Osteoporosis|osteoporosis
5174415|NCT02902211|ankle foot orthosis|ankle foot orthosis
5174416|NCT02902211|biomechanics|biomechanics
5174417|NCT02902211|mobility|mobility
5174418|NCT02902185|Chidamide|chidamide
5174419|NCT02902185|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5174420|NCT02902185|HIV-1 Reservoir|hiv-1 reservoir
5174421|NCT02902185|Chronic HIV infections|chronic hiv infections
5174422|NCT02902185|HIV Eradication|hiv eradication
5174423|NCT02902185|Antiretroviral Therapy|antiretroviral therapy
5174425|NCT02902159|Low Mood|low mood
5174426|NCT02902159|Mental Health|mental health
5174427|NCT02902159|Peer Support|peer support
5174428|NCT02902159|Online|online
5174429|NCT02902133|cerebrospinal fluid leak|cerebrospinal fluid leak
5174430|NCT02902107|Low Dose Rate Brachytherapy|low dose rate brachytherapy
5174431|NCT02902107|CivaSheet|civasheet
5174432|NCT02902107|16-605|16-605
5174433|NCT02902042|Unresectable or metastatic BRAF V600 mutant melanoma|unresectable or metastatic braf v600 mutant melanoma
5174434|NCT02902042|Encorafenib, binimetinib, pembrolizumab|encorafenib, binimetinib, pembrolizumab
5174435|NCT02902029|unresectable stage IIIB, IIIC, IV melanoma|unresectable stage iiib, iiic, iv melanoma
5174436|NCT02902016|PPARgamma|ppargamma
5174437|NCT02902016|Lactose intolerance|lactose intolerance
5174438|NCT02902016|Lactase|lactase
5174439|NCT02901990|mumps|mumps
5174440|NCT02901990|immunity|immunity
5174441|NCT02901990|cohort study|cohort study
5174442|NCT02901990|children|children
5174443|NCT02901990|vaccine|vaccine
5174444|NCT02901977|Hypertension|hypertension
5174445|NCT02901977|Blood pressure|blood pressure
5174446|NCT02901977|Hemostasis|hemostasis
5174447|NCT02901977|Endothelial function|endothelial function
5174448|NCT02901951|Hepatitis B surface antigen antibody|hepatitis b surface antigen antibody
5779479|NCT00199888|Iodine 124|iodine 124
5174458|NCT02901912|fecal enzymatic activity|fecal enzymatic activity
5174459|NCT02901886|Rheumatoid Arthritis|rheumatoid arthritis
5174460|NCT02901886|Smoking Cessation|smoking cessation
5174461|NCT02901886|Disease Activity|disease activity
5174462|NCT02901886|Clinical Prevention|clinical prevention
5174463|NCT02901808|NOMI|nomi
5174468|NCT02901730|laser peripheral iridoplasty|laser peripheral iridoplasty
5174470|NCT02901678|skelatal open bite, posterior intrusion|skelatal open bite, posterior intrusion
5174476|NCT02901600|DMBT1 expression|dmbt1 expression
5174477|NCT02901600|Colorectal cancer|colorectal cancer
5174478|NCT02901548|BCG refractory CIS|bcg refractory cis
5174479|NCT02901548|Urothelial CIS of bladder|urothelial cis of bladder
5174480|NCT02901548|Carcinoma in situ (CIS)|carcinoma in situ (cis)
5174481|NCT02901548|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
5174482|NCT02901548|Medi4736|medi4736
5174483|NCT02901548|Durvalumab|durvalumab
5174484|NCT02901548|CIS of the bladder|cis of the bladder
5174485|NCT02901548|Bladder cancer|bladder cancer
5174486|NCT02901548|BCG Vaccine|bcg vaccine
5174487|NCT02901548|Bladder diseases|bladder diseases
5174586|NCT02900937|Angioplasty|angioplasty
5174488|NCT02901548|Urothelial diseases|urothelial diseases
5174489|NCT02901535|telemedicine|telemedicine
5174490|NCT02901535|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5174491|NCT02901535|Primary Health care|primary health care
5174492|NCT02901535|spirometry|spirometry
5174493|NCT02901522|telemedicine|telemedicine
5174494|NCT02901522|asthma control test|asthma control test
5174495|NCT02901522|Primary Health care|primary health care
5174496|NCT02901522|spirometry|spirometry
5174497|NCT02901509|Chikungunya|chikungunya
5174498|NCT02901509|Quality of Life|quality of life
5174499|NCT02901483|Head and Neck|head and neck
5174500|NCT02901457|Body Image|body image
5174501|NCT02901418|chronic hepatitis B|chronic hepatitis b
5174502|NCT02901418|mother to child transmission|mother to child transmission
5174503|NCT02901418|interruption|interruption
5174504|NCT02901418|hepatitis B immunoglobulin|hepatitis b immunoglobulin
5174505|NCT02901418|pregnancy|pregnancy
5174506|NCT02901418|HBsAg|hbsag
5174507|NCT02901418|newborns|newborns
5174508|NCT02901405|sarcoma|sarcoma
5174509|NCT02901405|infection|infection
5174510|NCT02901405|negative pressure|negative pressure
5174511|NCT02901392|Male Urethral Slings|male urethral slings
5174512|NCT02901392|Artificial Urinary Sphincter|artificial urinary sphincter
5174513|NCT02901392|Prostatectomy|prostatectomy
5174514|NCT02901392|Radiotherapy|radiotherapy
5174515|NCT02901379|atorvastatin|atorvastatin
5174516|NCT02901379|myocardial edema|myocardial edema
5174517|NCT02901379|Follistatin-like 1|follistatin-like 1
5174518|NCT02901379|FSTL1|fstl1
5174519|NCT02901379|atorvastatin 80mg|atorvastatin 80mg
5174520|NCT02901379|coronary artery bypass surgery|coronary artery bypass surgery
5174521|NCT02901366|Mass balance|mass balance
5174522|NCT02901340|Borderline idiopathic isolated oligohydramnios|borderline idiopathic isolated oligohydramnios
5174523|NCT02901340|Fetal renal artery doppler indices|fetal renal artery doppler indices
5174524|NCT02901340|neonatal outcomes|neonatal outcomes
5174525|NCT02901340|Maternal hydration|maternal hydration
5174526|NCT02901327|Lumbar Stabilisation Exercise|lumbar stabilisation exercise
5174527|NCT02901327|Treadmill Walk|treadmill walk
5174528|NCT02901327|Multifidus Muscle Activation|multifidus muscle activation
5174529|NCT02901327|Pain Intensity|pain intensity
5174530|NCT02901327|Functional Disability|functional disability
5174531|NCT02901288|pulmonary tuberculosis|pulmonary tuberculosis
5174532|NCT02901288|shortened regimen|shortened regimen
5174533|NCT02901288|clinical trial|clinical trial
5048033|NCT03698929|cholesterol|cholesterol
5174534|NCT02901275|Clinical Trial, Phase II|clinical trial, phase ii
5174536|NCT02901262|continuous EEG|continuous eeg
5174537|NCT02901249|Cost effectiveness|cost effectiveness
5174538|NCT02901249|Unipolar Depression|unipolar depression
5174539|NCT02901249|Major Depression Disorder|major depression disorder
5174540|NCT02901249|Quality of life disorder|quality of life disorder
5174541|NCT02901236|trabeculectomy|trabeculectomy
5174542|NCT02901236|glaucoma|glaucoma
5174543|NCT02901236|filtration surgery|filtration surgery
5174544|NCT02901236|wound healing|wound healing
5174545|NCT02901236|angiogenesis|angiogenesis
5174546|NCT02901236|mitomycin|mitomycin
5062440|NCT03608904|Stroke|stroke
5174547|NCT02901236|vascular endothelial growth factor inhibition|vascular endothelial growth factor inhibition
5174548|NCT02901223|Oncoplastic breast surgery|oncoplastic breast surgery
5174549|NCT02901223|oncological safety|oncological safety
5174550|NCT02901223|patient satisfaction|patient satisfaction
5174551|NCT02901210|Recta prolapse|recta prolapse
5174552|NCT02901210|Intraoperative bleeding|intraoperative bleeding
5174553|NCT02901210|mucosal cauterization|mucosal cauterization
5174554|NCT02901197|capnography|capnography
5174555|NCT02901171|Smoking cessation|smoking cessation
5174556|NCT02901171|Acceptance and Commitment Therapy|acceptance and commitment therapy
5174557|NCT02901171|Smartphone|smartphone
5174566|NCT02901093|Sensorineural complications|sensorineural complications
5174568|NCT02901093|Imaging|imaging
5174569|NCT02901093|Cone Beam CT|cone beam ct
5174570|NCT02901067|Fibrinolysis|fibrinolysis
5174571|NCT02901015|schizophrenia|schizophrenia
5174572|NCT02901002|Complex Regional Pain Syndromes|complex regional pain syndromes
5174573|NCT02901002|Pain|pain
5174574|NCT02901002|Spontaneous sensations|spontaneous sensations
5174575|NCT02901002|interoception|interoception
5174576|NCT02900989|Psychiatry|psychiatry
5174577|NCT02900989|Pediatrics|pediatrics
5174578|NCT02900989|Suicide|suicide
5174579|NCT02900963|Nutrition|nutrition
5174580|NCT02900963|Head and Neck Cancer|head and neck cancer
5174581|NCT02900950|cancer|cancer
5174582|NCT02900950|resection margin|resection margin
5174583|NCT02900950|pathology|pathology
5174584|NCT02900950|pancreas|pancreas
5174587|NCT02900937|Coronary Vessels|coronary vessels
5174588|NCT02900937|Coronary Artery Disease|coronary artery disease
5174589|NCT02900937|Angina Pectoris|angina pectoris
5174590|NCT02900937|Myocardial Ischemia|myocardial ischemia
5174591|NCT02900937|Myocardial Infarction|myocardial infarction
5174592|NCT02900937|Myocardial Revascularization|myocardial revascularization
5174594|NCT02900924|PVD|pvd
5174595|NCT02900924|SFA stent|sfa stent
5174596|NCT02900911|head and neck cancer|head and neck cancer
5174597|NCT02900911|dysphagia|dysphagia
5174598|NCT02900911|rehabilitation|rehabilitation
5174599|NCT02900911|radiation therapy|radiation therapy
5174600|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents
5174601|NCT02900820|Primary Health Care|primary health care
5174602|NCT02900820|Drug Resistance, Microbial|drug resistance, microbial
5174603|NCT02900820|Respiratory Tract Infections|respiratory tract infections
5174604|NCT02900781|Arthroplasty|arthroplasty
5174605|NCT02900781|Physical Therapy|physical therapy
5174606|NCT02900768|Bone Marrow Transplantation|bone marrow transplantation
5174607|NCT02900768|Exercise|exercise
5174608|NCT02900768|Rehabilitation|rehabilitation
5174609|NCT02900768|Cancer|cancer
5174610|NCT02900755|Electroencephalography|electroencephalography
5174611|NCT02900755|Perampanel|perampanel
5174612|NCT02900742|lung cancer|lung cancer
5174613|NCT02900742|traditional Chinese medicine|traditional chinese medicine
5174614|NCT02900742|maintenance therapy|maintenance therapy
5174615|NCT02900742|chemotherapy|chemotherapy
5174616|NCT02900677|Pancreatic Cancer|pancreatic cancer
5174617|NCT02900677|Fatigue|fatigue
5174618|NCT02900677|Nutrition|nutrition
5174619|NCT02900677|Quality of Life|quality of life
5174629|NCT02900638|mentoring|mentoring
5174630|NCT02900638|children|children
5174631|NCT02900638|cardiovascular health|cardiovascular health
5174632|NCT02900612|dyslipidemias,|dyslipidemias,
5174633|NCT02900612|aging|aging
5174634|NCT02900612|water aerobics training|water aerobics training
5174635|NCT02900612|resistance aquatic training|resistance aquatic training
5174636|NCT02900612|lipid profile|lipid profile
5174637|NCT02900599|HIV|hiv
5174638|NCT02900599|Behavior|behavior
5174639|NCT02900547|Systolic Heart Failure|systolic heart failure
5174640|NCT02900547|medical algorithm decision support system|medical algorithm decision support system
5174641|NCT02900534|grief|grief
5174642|NCT02900534|depression|depression
5174643|NCT02900534|bereavement|bereavement
5174655|NCT02900417|sitagliptin|sitagliptin
5174656|NCT02900378|sacubitril/valsartan|sacubitril/valsartan
5174657|NCT02900378|enalapril|enalapril
5174658|NCT02900378|physical activity|physical activity
5174659|NCT02900378|actigraphy|actigraphy
5174660|NCT02900378|sleep|sleep
5174661|NCT02900378|heart failure|heart failure
5174662|NCT02900378|reduced ejection fraction|reduced ejection fraction
5174663|NCT02900378|randomized controlled trial|randomized controlled trial
5962192|NCT04282356|surgery|surgery
5962193|NCT04282356|HIPEC|hipec
5174664|NCT02900378|accelerometry|accelerometry
5174665|NCT02900365|trauma|trauma
5174667|NCT02900365|lensectomy|lensectomy
5174668|NCT02900365|time|time
5174669|NCT02900365|early|early
5174670|NCT02900365|late|late
5174675|NCT02900352|Alcohol Intoxication|alcohol intoxication
5174676|NCT02900352|Drinking Behaviors|drinking behaviors
5174677|NCT02900352|Anticonvulsants|anticonvulsants
5174678|NCT02900339|MRI|mri
5174679|NCT02900339|Sequence optimization|sequence optimization
5174680|NCT02900339|Healthy volunteers|healthy volunteers
5174681|NCT02900326|Exercise capacity|exercise capacity
5174682|NCT02900326|Mindfulness|mindfulness
5174683|NCT02900326|Quality of life|quality of life
5174684|NCT02900313|acute kidney injury|acute kidney injury
5174685|NCT02900313|cardiac surgery|cardiac surgery
5174686|NCT02900313|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
5174687|NCT02900313|renal replacement therapy|renal replacement therapy
5174688|NCT02900313|renal recovery|renal recovery
5174689|NCT02900313|serum hyperphosphatemia|serum hyperphosphatemia
5174690|NCT02900287|Survival|survival
5174691|NCT02900287|Cancer|cancer
5174692|NCT02900248|Biomarkers|biomarkers
5174693|NCT02900248|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5174694|NCT02900248|Neoplasms|neoplasms
5174695|NCT02900248|Myelodysplastic Syndromes|myelodysplastic syndromes
5174696|NCT02900235|Healthy|healthy
5174697|NCT02900209|Influenza|influenza
5174698|NCT02900209|Exacerbations|exacerbations
5174699|NCT02900196|Probiotics|probiotics
5174700|NCT02900196|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
5174701|NCT02900196|Gastro-Intestinal disorders|gastro-intestinal disorders
5174702|NCT02900196|Helicobacter pylori|helicobacter pylori
5174703|NCT02900170|Rivaroxaban, Acute Kidney Injury|rivaroxaban, acute kidney injury
5174709|NCT02900118|Bone metastasis|bone metastasis
5174710|NCT02900118|PET-CT|pet-ct
5174711|NCT02900118|whole-body MRI|whole-body mri
5174712|NCT02900092|postmenopausal|postmenopausal
5174713|NCT02900092|women|women
5174714|NCT02900092|depression|depression
5174715|NCT02900079|malaria|malaria
5174716|NCT02900079|rapid diagnostic test|rapid diagnostic test
5174717|NCT02900079|travel|travel
5174718|NCT02900079|fever|fever
5174719|NCT02900079|self care|self care
5174720|NCT02900066|fever|fever
5174721|NCT02900066|traveler|traveler
5174722|NCT02900066|arbovirus|arbovirus
5174723|NCT02900066|rickettsia|rickettsia
5174724|NCT02900066|malaria|malaria
5174725|NCT02900066|filter paper|filter paper
5174726|NCT02900066|diagnosis|diagnosis
5174727|NCT02900001|myocardial infarction|myocardial infarction
5174728|NCT02900001|invasive strategy|invasive strategy
5174729|NCT02900001|elderly|elderly
5174730|NCT02900001|deferred|deferred
5174731|NCT02899988|IL-23|il-23
5174732|NCT02899988|dermatology|dermatology
5174733|NCT02899975|Validation|validation
5174734|NCT02899975|Information and Fitness Software|information and fitness software
5174735|NCT02899975|Elderly|elderly
5174736|NCT02899975|WeTakeCare|wetakecare
5174737|NCT02899949|dapagliflozin|dapagliflozin
5174738|NCT02899949|type 2 diabetes|type 2 diabetes
5174739|NCT02899949|real-world data|real-world data
5174740|NCT02899936|Mass drug administration|mass drug administration
5174741|NCT02899936|Safety Data|safety data
5174742|NCT02899897|echocardiography|echocardiography
5174743|NCT02899884|Drug Therapy|drug therapy
5174744|NCT02899871|joint pain|joint pain
5174745|NCT02899858|Thoracic spinal cord injury|thoracic spinal cord injury
5174746|NCT02899858|Paralysis|paralysis
5174747|NCT02899858|ASIA A|asia a
5174748|NCT02899858|Device|device
5174749|NCT02899832|children|children
5174750|NCT02899832|spasms|spasms
5174751|NCT02899819|pesticides|pesticides
5174752|NCT02899819|exposure|exposure
5174753|NCT02899819|in utero|in utero
5174754|NCT02899806|Video Information|video information
5174755|NCT02899806|Satisfaction|satisfaction
5174756|NCT02899806|Anxiety|anxiety
5174757|NCT02899806|Epidural Analgesia|epidural analgesia
5174758|NCT02899806|Comprehension|comprehension
5174759|NCT02899806|delivery|delivery
5174760|NCT02899767|transfusion dependency|transfusion dependency
5174761|NCT02899767|transfusion intensity|transfusion intensity
5174762|NCT02899767|prognosis|prognosis
5174763|NCT02899767|chemotherapy|chemotherapy
5174767|NCT02899741|Medically intractable epilepsy, Omega-3|medically intractable epilepsy, omega-3
5174768|NCT02899689|Labor|labor
5174769|NCT02899689|Foley|foley
5174770|NCT02899689|Dilapan|dilapan
5962194|NCT04282317|Gastroparesis|gastroparesis
5174771|NCT02899689|Cervical Dilators|cervical dilators
5174772|NCT02899689|Induction|induction
5174773|NCT02899650|Delayed Onset Muscle Soreness|delayed onset muscle soreness
5174774|NCT02899650|Eccentric exercise|eccentric exercise
5174775|NCT02899650|Masters athlete|masters athlete
5174776|NCT02899637|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5174777|NCT02899637|Rehabilitation|rehabilitation
5174778|NCT02899637|Non-invasive brain stimulation|non-invasive brain stimulation
5174779|NCT02899637|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5174780|NCT02899611|Epilepsy|epilepsy
5174781|NCT02899585|Palliative care|palliative care
5169837|NCT02930161|Methionine|methionine
5174782|NCT02899546|Peripherally Inserted Central Catheter|peripherally inserted central catheter
5174784|NCT02899546|Radiology|radiology
5174785|NCT02899533|PAH|pah
5174786|NCT02899533|Pulmonary hypertension|pulmonary hypertension
5174787|NCT02899507|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5174788|NCT02899507|Prophylactic antibiotics|prophylactic antibiotics
5174789|NCT02899468|TBI|tbi
5174790|NCT02899468|Virtual Reality|virtual reality
5174791|NCT02899455|Hypertension|hypertension
5174792|NCT02899455|Hyperlipidemia|hyperlipidemia
5174793|NCT02899442|cardiovascular risk|cardiovascular risk
5174893|NCT02898441|low-dose CT|low-dose ct
5174794|NCT02899442|Occupational Health|occupational health
5174795|NCT02899442|night work|night work
5174796|NCT02899442|Public Health|public health
5174797|NCT02899442|Preventive Health Services|preventive health services
5174798|NCT02899416|cardiovascular risk|cardiovascular risk
5174799|NCT02899416|young adulthood|young adulthood
5174800|NCT02899403|Cognitive Tasks|cognitive tasks
5174801|NCT02899403|Mild Cognitive Impairment|mild cognitive impairment
5174802|NCT02899403|Neurophysiological Correlates|neurophysiological correlates
5174803|NCT02899403|Healthy Volunteers|healthy volunteers
5174804|NCT02899377|PET/CT|pet/ct
5174805|NCT02899377|Primary Sjögren's Syndrome|primary sjögren's syndrome
5174806|NCT02899377|Magnetic resonance imaging|magnetic resonance imaging
5174807|NCT02899377|11^C-MET|11^c-met
5174808|NCT02899377|18^F-FDG|18^f-fdg
5174809|NCT02899364|Sodium thiosulfate|sodium thiosulfate
5174810|NCT02899364|STEMI|stemi
5174811|NCT02899364|Infarct size|infarct size
5174812|NCT02899364|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5174813|NCT02899364|Hydrogen sulfide|hydrogen sulfide
5174814|NCT02899286|Acute myeloid leukemia|acute myeloid leukemia
5174815|NCT02899286|AML|aml
5174816|NCT02899286|pegylated recombinant human arginase|pegylated recombinant human arginase
5174817|NCT02899286|PEG-BCT-100|peg-bct-100
5174818|NCT02899273|Early Childhood Caries|early childhood caries
5174819|NCT02899273|eye-tracking|eye-tracking
5174820|NCT02899273|children|children
5174821|NCT02899273|dentistry|dentistry
5174822|NCT02899273|face perception|face perception
5174823|NCT02899247|composite resin|composite resin
5174824|NCT02899247|surface sealant|surface sealant
5174825|NCT02899234|Nicotine|nicotine
5174826|NCT02899234|Electronic Cigarette|electronic cigarette
5174827|NCT02899195|Unresectable Mesothelioma|unresectable mesothelioma
5174828|NCT02899195|Durvalumab|durvalumab
5174829|NCT02899195|Anti-Programmed Death-Ligand 1 Antibody|anti-programmed death-ligand 1 antibody
5174830|NCT02899169|Acute promyelocytic leukemia|acute promyelocytic leukemia
5174831|NCT02899169|Realgar-Indigo Naturalis Formula|realgar-indigo naturalis formula
5174832|NCT02899169|All-trans Retinoic Acid|all-trans retinoic acid
5174833|NCT02899091|Alzheimer's disease|alzheimer's disease
5174834|NCT02899091|Mesenchymal Stem cells|mesenchymal stem cells
5174835|NCT02899052|Multiple Myeloma|multiple myeloma
5174836|NCT02899052|Refractory myeloma|refractory myeloma
5174837|NCT02899052|Relapsed myeloma|relapsed myeloma
5174838|NCT02899052|Relapsed or Refractory|relapsed or refractory
5174839|NCT02899026|Glucocorticosteroids|glucocorticosteroids
5174840|NCT02899026|Sirukumab|sirukumab
5174841|NCT02899026|Prednisone|prednisone
5174842|NCT02899026|Polymyalgia Rheumatica|polymyalgia rheumatica
5174843|NCT02899013|Perianal Lesions|perianal lesions
5174844|NCT02898987|HIV|hiv
5174845|NCT02898987|Hepatitis C|hepatitis c
5174846|NCT02898987|Comorbidities|comorbidities
5174850|NCT02898909|femtosecond laser-assisted cataract surgery|femtosecond laser-assisted cataract surgery
5174852|NCT02898844|dieting|dieting
5174853|NCT02898844|dyads|dyads
5174854|NCT02898844|psychological well-being|psychological well-being
5174855|NCT02898844|weight loss|weight loss
5174856|NCT02898844|cortisol|cortisol
5174857|NCT02898792|sensitivity, opioid|sensitivity, opioid
5174858|NCT02898753|GSD-II|gsd-ii
5174859|NCT02898753|Pompe Disease|pompe disease
5174860|NCT02898753|Glycogen Storage Diseases|glycogen storage diseases
5174861|NCT02898753|GAA|gaa
5174862|NCT02898740|Parkinson's disease|parkinson's disease
5174863|NCT02898740|exercise therapy|exercise therapy
5174864|NCT02898740|quality of life|quality of life
5174865|NCT02898701|Motor Learning|motor learning
5174866|NCT02898701|Dose of Motor Practice|dose of motor practice
5174867|NCT02898701|Postural Control|postural control
5174868|NCT02898701|Serial Reaction Time Task|serial reaction time task
5174869|NCT02898701|Retention|retention
5174870|NCT02898701|Transfer|transfer
5174871|NCT02898701|Overpractice|overpractice
5174872|NCT02898701|Overtraining|overtraining
5174873|NCT02898701|Overlearning|overlearning
5174878|NCT02898662|inhaled|inhaled
5174879|NCT02898662|TLR9 agonist|tlr9 agonist
5174880|NCT02898662|withdrawal design|withdrawal design
5174881|NCT02898662|loss of control|loss of control
5174882|NCT02898532|Children, ADHD, target shooting sport|children, adhd, target shooting sport
5174883|NCT02898506|Diabetes Type 1|diabetes type 1
5174884|NCT02898506|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
5174885|NCT02898506|Liraglutide|liraglutide
5174886|NCT02898506|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
5174887|NCT02898506|GLP-1 Analogue|glp-1 analogue
5174888|NCT02898506|Dysglycemia|dysglycemia
5174889|NCT02898506|Prevention|prevention
5174890|NCT02898493|Validation of questionnaire|validation of questionnaire
5174891|NCT02898493|Quality of life|quality of life
5174892|NCT02898441|lung cancer screening|lung cancer screening
5174894|NCT02898441|high-risk population|high-risk population
5174896|NCT02898415|Liver Transplantation|liver transplantation
5174897|NCT02898415|AFP|afp
5174898|NCT02898415|Mortality|mortality
5174899|NCT02898415|Competing risk|competing risk
5174900|NCT02898415|Selection criteria|selection criteria
5174901|NCT02898415|Recurrence|recurrence
5174902|NCT02898376|spa care|spa care
5174903|NCT02898376|randomised controlled trial|randomised controlled trial
5174904|NCT02898376|pentoxifylline/tocopherol combination|pentoxifylline/tocopherol combination
5174905|NCT02898376|late sequelae|late sequelae
5174906|NCT02898376|radiotherapy|radiotherapy
5174907|NCT02898363|Care of disabled population|care of disabled population
5174908|NCT02898363|Mental retardation|mental retardation
5174909|NCT02898363|Cancer screening|cancer screening
5174910|NCT02898363|Cancer prevention|cancer prevention
5174911|NCT02898324|Bullying|bullying
5174912|NCT02898324|KiVa program|kiva program
5174913|NCT02898324|Primary school students|primary school students
5174914|NCT02898311|CAD-CAM|cad-cam
5174915|NCT02898311|composite dental resin|composite dental resin
5174916|NCT02898311|Immediate dental implant loading|immediate dental implant loading
5174917|NCT02898259|Lenalidomide|lenalidomide
5174918|NCT02898259|Ixazomib|ixazomib
5174919|NCT02898259|Rituximab|rituximab
5174920|NCT02898246|heart failure|heart failure
5174921|NCT02898246|fear of physical activity|fear of physical activity
5174922|NCT02898246|motor activity|motor activity
5174923|NCT02898233|depression|depression
5174924|NCT02898233|internet-based|internet-based
5174925|NCT02898233|treatment|treatment
5174926|NCT02898233|low-level light therapy|low-level light therapy
5174928|NCT02898233|deprexis|deprexis
5174929|NCT02898194|Surrogate Decision-making|surrogate decision-making
5174930|NCT02898194|Health Care|health care
5174931|NCT02898194|Medical Decisions|medical decisions
5174932|NCT02898194|End of Life Care|end of life care
5174933|NCT02898168|stroke|stroke
5174934|NCT02898168|Rehabilitation|rehabilitation
5174935|NCT02898168|WalkAide (WA)|walkaide (wa)
5174936|NCT02898168|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
5174937|NCT02898155|Avoidable hospitalizations|avoidable hospitalizations
5174938|NCT02898155|primary care|primary care
5174939|NCT02898155|geographicvariation|geographicvariation
5174940|NCT02898142|Postprandial test|postprandial test
5174941|NCT02898142|Metabolic syndrime|metabolic syndrime
5174942|NCT02898142|HTG|htg
5174943|NCT02898129|chronic respiratory diseases|chronic respiratory diseases
5174944|NCT02898129|housing|housing
5174945|NCT02898129|lung function test|lung function test
5174946|NCT02898116|ALK-rearranged|alk-rearranged
5174947|NCT02898116|ALK-positive|alk-positive
5174952|NCT02898116|Durvalumab|durvalumab
5174953|NCT02898116|MEDI4736|medi4736
5174954|NCT02898116|ALK|alk
5174955|NCT02898090|Quality indicators|quality indicators
5174956|NCT02898090|Appropriateness|appropriateness
5174957|NCT02898090|Oral anticoagulant prescriptions|oral anticoagulant prescriptions
5174958|NCT02898090|Development and validation|development and validation
5174959|NCT02898090|Hospital information system|hospital information system
5174960|NCT02898090|Information Storage and Retrieval|information storage and retrieval
5174961|NCT02898090|Natural Language Processing|natural language processing
5174965|NCT02898051|heparin low-molecular-weight;pharmacokinetics|heparin low-molecular-weight;pharmacokinetics
5174966|NCT02898012|Glioblastoma Multiforme|glioblastoma multiforme
5174967|NCT02898012|temozolomide|temozolomide
5174968|NCT02898012|bevacizumab|bevacizumab
5174969|NCT02897973|Spinal loads|spinal loads
5174970|NCT02897973|Trunk muscle force|trunk muscle force
5174971|NCT02897973|Computational modeling|computational modeling
5174972|NCT02897973|Unilateral lower limb amputation|unilateral lower limb amputation
5174973|NCT02897960|wheezing|wheezing
5174974|NCT02897960|bronchiolitis|bronchiolitis
5174975|NCT02897960|respiratory sound algorithm|respiratory sound algorithm
5174976|NCT02897947|Lumbosacral Region|lumbosacral region
5174977|NCT02897947|Surgery|surgery
5174978|NCT02897947|Registries|registries
5174979|NCT02897895|Lung transplantation in end-stage lung diseases|lung transplantation in end-stage lung diseases
5174980|NCT02897843|Electroconvulsive Therapy|electroconvulsive therapy
5174981|NCT02897843|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5174982|NCT02897843|cognition|cognition
5174983|NCT02897817|Methotrexate|methotrexate
5174984|NCT02897817|Treatment adherence|treatment adherence
5174985|NCT02897804|multiphase optimization strategy|multiphase optimization strategy
5174986|NCT02897804|college students|college students
5174987|NCT02897778|entinostat|entinostat
5174988|NCT02897778|solid tumor|solid tumor
5174989|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5174990|NCT02897765|Checkpoint Inhibitor|checkpoint inhibitor
5175380|NCT02895113|Thromboxane|thromboxane
5174991|NCT02897765|Immunotherapy|immunotherapy
5174992|NCT02897765|Personal Vaccine|personal vaccine
5174994|NCT02897765|Poly-ICLC|poly-iclc
5174995|NCT02897765|Peptide|peptide
5174996|NCT02897752|stroke|stroke
5174997|NCT02897752|Rehabilitation|rehabilitation
5174998|NCT02897752|WalkAide (WA)|walkaide (wa)
5174999|NCT02897752|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
5175000|NCT02897713|mechanical ventilation|mechanical ventilation
5175001|NCT02897713|enteral nutrition|enteral nutrition
5175002|NCT02897713|feeding intolerance|feeding intolerance
5175003|NCT02897700|Chemotherapy|chemotherapy
5175004|NCT02897700|Safety|safety
5175005|NCT02897700|Tolerability|tolerability
5175006|NCT02897700|Efficacy|efficacy
5175007|NCT02897687|Autism Spectrum Disorder|autism spectrum disorder
5175008|NCT02897687|Social Skills|social skills
5175009|NCT02897687|Social Media|social media
5175010|NCT02897674|palm oil|palm oil
5175011|NCT02897674|lipid profile|lipid profile
5175012|NCT02897661|fecal microbiota transplantation|fecal microbiota transplantation
5175013|NCT02897661|enteral nutrition|enteral nutrition
5175014|NCT02897622|Eating disorders|eating disorders
5175015|NCT02897622|severe and enduring|severe and enduring
5175016|NCT02897622|quality of life|quality of life
5175017|NCT02897622|case management|case management
5175018|NCT02897609|Beta-lactamine|beta-lactamine
5175019|NCT02897609|β-lactamine|β-lactamine
5175020|NCT02897570|ghrelin|ghrelin
5175021|NCT02897570|breakfast meal|breakfast meal
5175022|NCT02897570|P-300|p-300
5175023|NCT02897531|Ileocolic, stapled, laparoscopy, right hemicolectomy|ileocolic, stapled, laparoscopy, right hemicolectomy
5175024|NCT02897518|Videolaryngoscopes|videolaryngoscopes
5175025|NCT02897518|Intubation|intubation
5175026|NCT02897505|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
5175027|NCT02897466|ventilator-associated pneumonia|ventilator-associated pneumonia
5175028|NCT02897466|Multidrug-resistant bacteria|multidrug-resistant bacteria
5175029|NCT02897440|Femoral Neck Fracture|femoral neck fracture
5175030|NCT02897440|Hip Arthroplasty|hip arthroplasty
5175031|NCT02897440|Repairing of soft tissue|repairing of soft tissue
5175032|NCT02897401|urinary N'Nitrosonornicotine|urinary n'nitrosonornicotine
5175033|NCT02897401|nicotine|nicotine
5175034|NCT02897401|electronic cigarette|electronic cigarette
5175035|NCT02897401|nicotine remplacement treatment|nicotine remplacement treatment
5175036|NCT02897362|ADHD|adhd
5175037|NCT02897362|Sleep|sleep
5175038|NCT02897362|Adolescents|adolescents
5175039|NCT02897362|Neurocognition|neurocognition
5175040|NCT02897362|Polysomnography|polysomnography
5779480|NCT00199875|antibody|antibody
5175045|NCT02897284|Mindfulness-based|mindfulness-based
5175046|NCT02897284|Self-care|self-care
5175047|NCT02897284|Health workers|health workers
5175048|NCT02897284|Epigenetics|epigenetics
5175049|NCT02897271|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
5175050|NCT02897258|Dialysis|dialysis
5175051|NCT02897258|Thrombosis|thrombosis
5175052|NCT02897258|Haemorrhage|haemorrhage
5175053|NCT02897245|Myelogenous|myelogenous
5175055|NCT02897245|BCR-ABL Positive|bcr-abl positive
5175056|NCT02897232|Human Papillomavirus Vaccine|human papillomavirus vaccine
5175057|NCT02897232|HPV|hpv
5175058|NCT02897232|Patient Acceptance|patient acceptance
5175059|NCT02897232|Physician Comfort|physician comfort
5175060|NCT02897232|Male Vaccination|male vaccination
5175061|NCT02897232|HPV Associated Cancers|hpv associated cancers
5175062|NCT02897219|SGLT2 inhibitor|sglt2 inhibitor
5175063|NCT02897219|ASP1941|asp1941
5175064|NCT02897219|type 1 diabetes mellitus|type 1 diabetes mellitus
5175065|NCT02897206|Acute pancreatitis|acute pancreatitis
5175066|NCT02897206|Antibiotic prophylaxis|antibiotic prophylaxis
5175067|NCT02897206|Imipenem-cilastatin|imipenem-cilastatin
5175068|NCT02897206|Infected pancreatic necrosis|infected pancreatic necrosis
5175069|NCT02897206|Infection|infection
5175070|NCT02897206|Organ failure|organ failure
5175071|NCT02897180|tuberculosis|tuberculosis
5175072|NCT02897180|latent tuberculosis infection|latent tuberculosis infection
5175073|NCT02897180|Food supplement|food supplement
5175074|NCT02897180|Mycobacterium manresensis|mycobacterium manresensis
5175075|NCT02897180|Nyaditum resae|nyaditum resae
5175076|NCT02897180|Efficacy trial|efficacy trial
5175081|NCT02897141|HIV|hiv
5175082|NCT02897141|Health Management App|health management app
5175083|NCT02897141|HIV symptoms|hiv symptoms
5175084|NCT02897128|Sarcoma|sarcoma
5175085|NCT02897128|Radiation|radiation
5175086|NCT02897128|Wound healing|wound healing
5175087|NCT02897115|Axial Spondyloarthritis|axial spondyloarthritis
5175088|NCT02897115|Humira|humira
5175089|NCT02897089|universal adhesive|universal adhesive
5175090|NCT02897089|fissure sealants|fissure sealants
5175091|NCT02897089|retention|retention
5175092|NCT02897063|midodrine|midodrine
5175093|NCT02897063|droxidopa|droxidopa
5175094|NCT02897063|splanchnic circulation|splanchnic circulation
5175095|NCT02897037|Bivalirudin|bivalirudin
5175096|NCT02897037|Acute myocardial infarction|acute myocardial infarction
5048573|NCT03695133|loneliness|loneliness
5175097|NCT02897037|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5175098|NCT02897024|Cerebral Palsy|cerebral palsy
5175099|NCT02897024|Motor Impairments|motor impairments
5175100|NCT02896985|Patient Reported Outcome 2 (PRO 2)|patient reported outcome 2 (pro 2)
5175101|NCT02896985|C-Reactive Protein (CRP)|c-reactive protein (crp)
5175102|NCT02896985|Adalimumab|adalimumab
5175103|NCT02896985|Harvey Bradshaw Index (HBI)|harvey bradshaw index (hbi)
5175104|NCT02896985|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
5175105|NCT02896985|Anti-Adalimumab Antibody (AAA)|anti-adalimumab antibody (aaa)
5175106|NCT02896972|vitrectomy|vitrectomy
5175107|NCT02896972|macular hole retinal detachment|macular hole retinal detachment
5175108|NCT02896972|high myopia|high myopia
5175109|NCT02896920|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
5175110|NCT02896920|Humira®|humira®
5175111|NCT02896920|Canada|canada
5175112|NCT02896816|Parkinson's|parkinson's
5175113|NCT02896803|Pancreatic Cancer|pancreatic cancer
5175114|NCT02896803|Chemotherapy|chemotherapy
5175115|NCT02896790|Cancer|cancer
5175116|NCT02896790|Oral Therapy|oral therapy
5175117|NCT02896790|Compliance|compliance
5175118|NCT02896790|Anthropology|anthropology
5175119|NCT02896790|Psychology|psychology
5175120|NCT02896777|pH|ph
5175121|NCT02896777|IVF|ivf
5175122|NCT02896777|live birth rate|live birth rate
5175123|NCT02896751|CPAP|cpap
5175124|NCT02896751|Noninvasive Ventilation Mask|noninvasive ventilation mask
5175125|NCT02896725|Venous leg ulcer|venous leg ulcer
5175126|NCT02896725|Acellular skin substitutes|acellular skin substitutes
5175127|NCT02896725|Keratin dressings|keratin dressings
5175128|NCT02896699|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5175129|NCT02896699|diffusion of innovation|diffusion of innovation
5175130|NCT02896699|men who have sex with men|men who have sex with men
5175131|NCT02896699|LGBT|lgbt
5175132|NCT02896699|African American|african american
5175133|NCT02896699|Black|black
5175134|NCT02896699|HIV|hiv
5175135|NCT02896699|network analysis|network analysis
5175136|NCT02896699|network intervention|network intervention
5175137|NCT02896686|Ileostomy closure|ileostomy closure
5175138|NCT02896686|Polypropylene Mesh|polypropylene mesh
5175141|NCT02896673|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5175142|NCT02896673|electrical impedance tomography (EIT)|electrical impedance tomography (eit)
5175143|NCT02896673|tidal volume (TV)|tidal volume (tv)
5175144|NCT02896673|transpulmonary pressure (TPP)|transpulmonary pressure (tpp)
5175145|NCT02896621|Sleep Apnea|sleep apnea
5175146|NCT02896621|Hypertension|hypertension
5175147|NCT02896621|Chlortalidone|chlortalidone
5175148|NCT02896621|Diastolic function|diastolic function
5175149|NCT02896569|resurfacing|resurfacing
5175150|NCT02896569|ablation|ablation
5175151|NCT02896556|image analysis|image analysis
5175152|NCT02896543|dendritic cells|dendritic cells
5175153|NCT02896543|P-selectin|p-selectin
5175154|NCT02896504|Chemobrain|chemobrain
5175155|NCT02896504|Chemotherapy|chemotherapy
5175156|NCT02896504|Hormonal Therapy|hormonal therapy
5175157|NCT02896504|Neuroimaging|neuroimaging
5175158|NCT02896465|Children|children
5175159|NCT02896465|Diarrhea|diarrhea
5175160|NCT02896465|Human milk oligosaccharides|human milk oligosaccharides
5175161|NCT02896439|Traumatic|traumatic
5175162|NCT02896439|Acetabular|acetabular
5175163|NCT02896426|Parent training|parent training
5175164|NCT02896426|Preschoolers|preschoolers
5175165|NCT02896426|Behavior problems|behavior problems
5175166|NCT02896426|Oppositional Defiant Disorder|oppositional defiant disorder
5175167|NCT02896426|ODD|odd
5175168|NCT02896426|Conduct Disorder|conduct disorder
5175169|NCT02896426|CD|cd
5175170|NCT02896426|Children|children
5175171|NCT02896426|Parenting|parenting
5175172|NCT02896426|Collaborative Problem Solving|collaborative problem solving
5175173|NCT02896426|CPS|cps
5175174|NCT02896426|Disruptive behavior|disruptive behavior
5175175|NCT02896348|Hemiparesis|hemiparesis
5175176|NCT02896348|Stroke|stroke
5175177|NCT02896348|Rehabilitation|rehabilitation
5175178|NCT02896348|Home-based|home-based
5175179|NCT02896335|Recurrent Brain metastases|recurrent brain metastases
5175180|NCT02896283|wound healing|wound healing
5175181|NCT02896283|low-level laser therapy|low-level laser therapy
5175182|NCT02896283|gingival recession|gingival recession
5175183|NCT02896270|idiopathic podocytopathies|idiopathic podocytopathies
5175184|NCT02896270|Neprology|neprology
5175185|NCT02896257|Quality Improvement|quality improvement
5175186|NCT02896257|Quality Enhancement Research Initiatives|quality enhancement research initiatives
5175187|NCT02896257|QuERI|queri
5175188|NCT02896257|Interventional|interventional
5175189|NCT02896257|Multicenter|multicenter
5175190|NCT02896257|Inhaled corticosteroids|inhaled corticosteroids
5175191|NCT02896257|Pneumonia|pneumonia
5175192|NCT02896257|Safety|safety
5175193|NCT02896257|De-implementation|de-implementation
5175194|NCT02896257|Respiratory Tract Diseases|respiratory tract diseases
5175195|NCT02896257|Lung Diseases|lung diseases
5962195|NCT04282317|functional MRI|functional mri
5962196|NCT04282317|Gastric MRI|gastric mri
5175196|NCT02896257|Lung Diseases, Obstructive|lung diseases, obstructive
5175197|NCT02896257|Pulmonary Diseases, Chronic Obstructive COPD|pulmonary diseases, chronic obstructive copd
5175198|NCT02896244|Clostridium difficile|clostridium difficile
5175199|NCT02896244|Clostridium difficile infection|clostridium difficile infection
5175200|NCT02896244|antibiotics|antibiotics
5175201|NCT02896244|antibiotics associated diarrhea|antibiotics associated diarrhea
5175203|NCT02896244|microbiota|microbiota
5175204|NCT02896218|Vancomycin|vancomycin
5175205|NCT02896218|Critically Ill|critically ill
5175206|NCT02896218|Pharmacist|pharmacist
5175207|NCT02896218|Population Pharmacokinetic|population pharmacokinetic
5175208|NCT02896218|Bayesian Methods|bayesian methods
5175211|NCT02896179|Multiple sclerosis|multiple sclerosis
5175212|NCT02896179|Gait rehabilitation|gait rehabilitation
5175213|NCT02896179|Quality of life|quality of life
5175214|NCT02896179|Virtual reality|virtual reality
5175215|NCT02896179|Cognitive deficit|cognitive deficit
5175216|NCT02896179|Robot assisted gait training|robot assisted gait training
5175217|NCT02896166|nsclc and stage I and microwave ablation|nsclc and stage i and microwave ablation
5175218|NCT02896140|Type 2 diabetes|type 2 diabetes
5175219|NCT02896140|Obesity|obesity
5175220|NCT02896140|Nutrition|nutrition
5175221|NCT02896140|Dairy|dairy
5175222|NCT02896127|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
5175223|NCT02896127|Axial spondyloarthritis|axial spondyloarthritis
5175224|NCT02896101|Mild to moderate|mild to moderate
5175225|NCT02896075|delayed onset muscle soreness|delayed onset muscle soreness
5175226|NCT02896075|laughter|laughter
5175227|NCT02896049|neoplasms|neoplasms
5175228|NCT02896049|hyperthermia|hyperthermia
5175229|NCT02896036|Laparoscopic Entry|laparoscopic entry
5175230|NCT02896036|Veress Needle|veress needle
5175231|NCT02896036|Intraperitoneal insufflation|intraperitoneal insufflation
5175232|NCT02896036|Time|time
5175233|NCT02896036|Complications|complications
5175234|NCT02896023|predictors|predictors
5175235|NCT02896023|ovarian reserve|ovarian reserve
5175236|NCT02896023|infertile women|infertile women
5175237|NCT02896010|Mobile Health|mobile health
5175238|NCT02895997|mental fatigue|mental fatigue
5175239|NCT02895997|critical care|critical care
5175240|NCT02895984|Social network analysis|social network analysis
5175241|NCT02895984|Brief Motivational Interviewing|brief motivational interviewing
5175242|NCT02895984|College Students|college students
5175243|NCT02895971|Venous Thromboembolism|venous thromboembolism
5175244|NCT02895971|professional Practices|professional practices
5175245|NCT02895906|22q11.2 DS|22q11.2 ds
5175246|NCT02895880|Communication Tool|communication tool
5175247|NCT02895880|Cancer Survivors|cancer survivors
5175248|NCT02895880|Increase Statin|increase statin
5175249|NCT02895880|16-1128|16-1128
5175250|NCT02895854|Low risk prostate cancer|low risk prostate cancer
5175251|NCT02895854|Intermediate risk prostate cancer|intermediate risk prostate cancer
5175252|NCT02895854|Low dose-rate brachytherapy|low dose-rate brachytherapy
5175253|NCT02895854|Hypofractionated|hypofractionated
5175254|NCT02895854|Robotic external beam radiation|robotic external beam radiation
5175255|NCT02895854|Quality of life|quality of life
5175256|NCT02895841|oncology|oncology
5175257|NCT02895841|bone marrow transplant|bone marrow transplant
5175258|NCT02895841|sickle cell disease|sickle cell disease
5175259|NCT02895802|down syndrome|down syndrome
5175260|NCT02895789|spinal muscular atrophy|spinal muscular atrophy
5175261|NCT02895789|oxidative capacity|oxidative capacity
5175262|NCT02895789|exercise tolerance|exercise tolerance
5175263|NCT02895789|mitochondrial myopathy|mitochondrial myopathy
5175264|NCT02895789|SMA|sma
5175265|NCT02895789|six minute walk test|six minute walk test
5175266|NCT02895789|neuromuscular disease|neuromuscular disease
5175267|NCT02895789|ambulation|ambulation
5175268|NCT02895789|exercise|exercise
5175269|NCT02895789|mitochondria|mitochondria
5175270|NCT02895789|cycle ergometry|cycle ergometry
5175271|NCT02895789|near infrared spectroscopy|near infrared spectroscopy
5175272|NCT02895763|QUALITY OF LIFE|quality of life
5175273|NCT02895763|NEUROMUSCULAR DISEASES|neuromuscular diseases
5175274|NCT02895750|diabetes type 2|diabetes type 2
5175275|NCT02895750|Metformin|metformin
5175276|NCT02895750|chronic kidney disease|chronic kidney disease
5175277|NCT02895750|CKD|ckd
5175278|NCT02895737|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device|aortic stenosis, transcatheter aortic valve replacement, stroke, ischemic infarction, cerebral embolic protection device
5175279|NCT02895724|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5175280|NCT02895724|secondary lymphedema|secondary lymphedema
5175281|NCT02895698|Cupping|cupping
5175282|NCT02895698|Dry cupping|dry cupping
5175283|NCT02895698|Myofascial trigger points|myofascial trigger points
5175284|NCT02895685|Simulation|simulation
5175285|NCT02895685|Self-regulated training|self-regulated training
5175286|NCT02895685|Education|education
5175287|NCT02895685|Open surgery|open surgery
5175288|NCT02895685|Dyad training|dyad training
5175289|NCT02895659|fluid management|fluid management
5175290|NCT02895659|critical illness|critical illness
5175291|NCT02895659|hemodynamics|hemodynamics
5175292|NCT02895659|buffered infusates|buffered infusates
5175293|NCT02895633|MR imaging|mr imaging
5175294|NCT02895633|Diffusion weighted imaging|diffusion weighted imaging
5175295|NCT02895633|MR proton spectroscopy|mr proton spectroscopy
5175296|NCT02895633|CT perfusion|ct perfusion
5175297|NCT02895633|Contrast enhanced ultrasound|contrast enhanced ultrasound
5175299|NCT02895568|Resistance|resistance
5175300|NCT02895568|Republic of Chard|republic of chard
5175302|NCT02895503|Stage IA Non-Small Cell Lung Carcinoma|stage ia non-small cell lung carcinoma
5175303|NCT02895503|Stage IB Non-Small Cell Lung Carcinoma|stage ib non-small cell lung carcinoma
5175304|NCT02895503|Stage IIA Non-Small Cell Lung Carcinoma|stage iia non-small cell lung carcinoma
5175305|NCT02895503|Stage IIB Non-Small Cell Lung Carcinoma|stage iib non-small cell lung carcinoma
5175306|NCT02895503|Stage IIIA Non-Small Cell Lung Cancer|stage iiia non-small cell lung cancer
5175307|NCT02895503|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
5175308|NCT02895503|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5175309|NCT02895451|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
5175310|NCT02895451|Physical capacity|physical capacity
5175311|NCT02895451|Adherence|adherence
5175312|NCT02895451|Behavioral medicine|behavioral medicine
5175313|NCT02895438|Gluten-Sensitive|gluten-sensitive
5175314|NCT02895438|Diet, Gluten-Free|diet, gluten-free
5175315|NCT02895438|Irritable Bowel Syndrome|irritable bowel syndrome
5175316|NCT02895438|non Coeliac Gluten sensitivity|non coeliac gluten sensitivity
5175317|NCT02895438|children|children
5175318|NCT02895425|Renal Transplant|renal transplant
5175319|NCT02895386|Hypertension|hypertension
5175320|NCT02895386|High Blood Pressure|high blood pressure
5175321|NCT02895386|Systolic Blood Pressure|systolic blood pressure
5175322|NCT02895386|Uncontrolled Hypertension|uncontrolled hypertension
5175323|NCT02895386|Essential Hypertension|essential hypertension
5175324|NCT02895386|Resistant Hypertension|resistant hypertension
5175325|NCT02895386|Vascular Disease|vascular disease
5175326|NCT02895373|platelet inhibition|platelet inhibition
5175327|NCT02895373|alprostadil|alprostadil
5175328|NCT02895373|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5175329|NCT02895373|bleeding|bleeding
5175330|NCT02895373|thromboembolic|thromboembolic
5175331|NCT02895334|CHD|chd
5175332|NCT02895334|Congenital Heart Disease|congenital heart disease
5175333|NCT02895321|nano-hydroxyapatite|nano-hydroxyapatite
5175334|NCT02895321|potassium nitrate|potassium nitrate
5175335|NCT02895308|compliance|compliance
5175336|NCT02895295|Medicare Part D|medicare part d
5175337|NCT02895295|decision support|decision support
5175338|NCT02895295|prescription drugs|prescription drugs
5175339|NCT02895295|expert recommendation|expert recommendation
5175340|NCT02895295|health insurance choice|health insurance choice
5175341|NCT02895282|Obesity|obesity
5175342|NCT02895282|Chronobiology|chronobiology
5175343|NCT02895282|Circadian|circadian
5175344|NCT02895269|Complementary Alternative Providers|complementary alternative providers
5175345|NCT02895269|Collaborative Shared Care|collaborative shared care
5175346|NCT02895269|Primary Health Care Providers|primary health care providers
5175347|NCT02895269|Psychosis|psychosis
5175348|NCT02895230|Androgen-deprivation therapy|androgen-deprivation therapy
5175349|NCT02895230|Prostate cancer|prostate cancer
5175350|NCT02895230|Nationwide population-based cohort|nationwide population-based cohort
5175351|NCT02895230|Myocardial infarction|myocardial infarction
5175352|NCT02895230|Ischemic stroke|ischemic stroke
5175353|NCT02895217|Energy expenditure|energy expenditure
5175354|NCT02895217|Food intake|food intake
5175356|NCT02895217|aquacycling|aquacycling
5175357|NCT02895204|Fermented Maillard reacted whey protein|fermented maillard reacted whey protein
5175358|NCT02895204|Natural killer cell activity|natural killer cell activity
5175359|NCT02895204|Immune function|immune function
5175360|NCT02895204|Pre-albumin|pre-albumin
5175361|NCT02895204|Interleukin-12|interleukin-12
5175362|NCT02895178|Breast cancer|breast cancer
5175363|NCT02895178|Survivors|survivors
5175364|NCT02895178|Exercise|exercise
5175365|NCT02895165|breast neoplasms|breast neoplasms
5175366|NCT02895165|fertility preservation|fertility preservation
5175367|NCT02895165|pregnancy|pregnancy
5175368|NCT02895152|COPD|copd
5175369|NCT02895152|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5175370|NCT02895152|Pulmonary Rehabilitation|pulmonary rehabilitation
5175371|NCT02895152|Activity Monitors|activity monitors
5175372|NCT02895152|Fitbit|fitbit
5175373|NCT02895152|Fitness Tracker|fitness tracker
5175374|NCT02895139|Additive Manufacture|additive manufacture
5175375|NCT02895139|Orthotic Insole|orthotic insole
5175376|NCT02895126|vulnerable family|vulnerable family
5175377|NCT02895113|Aspirin|aspirin
5175378|NCT02895113|Diabetes|diabetes
5175379|NCT02895113|Renal function|renal function
5175381|NCT02895100|ulcerative colitis|ulcerative colitis
5175382|NCT02895100|inflammatory bowel disease|inflammatory bowel disease
5175383|NCT02895100|PROPEL|propel
5175384|NCT02895100|Propel Study|propel study
5175385|NCT02895087|diurnal variation|diurnal variation
5175386|NCT02895087|stress|stress
5175387|NCT02895074|femtosecond laser-assisted cataract surgery (FLACS)|femtosecond laser-assisted cataract surgery (flacs)
5962197|NCT04282317|Brain MRI|brain mri
5094182|NCT03410134|MTA|mta
5175388|NCT02895074|subfoveal choroidal thickness (SFCT)|subfoveal choroidal thickness (sfct)
5175389|NCT02895074|conventional phacoemulsification surgery (CPS)|conventional phacoemulsification surgery (cps)
5175390|NCT02895009|Coronary Disease|coronary disease
5175391|NCT02895009|Radial artery occlusion|radial artery occlusion
5175392|NCT02895009|transradial coronary intervention|transradial coronary intervention
5175394|NCT02894996|anesthesia|anesthesia
5175395|NCT02894996|fluid responsiveness|fluid responsiveness
5175396|NCT02894996|hemodynamic|hemodynamic
5175397|NCT02894983|wrist fracture|wrist fracture
5175398|NCT02894983|colles fracture|colles fracture
5175399|NCT02894983|non-operative|non-operative
5175400|NCT02894983|rehabilitation|rehabilitation
5175401|NCT02894944|Pancreatic cancer|pancreatic cancer
5175402|NCT02894944|Adenovirus|adenovirus
5175403|NCT02894944|Gene therapy|gene therapy
5175404|NCT02894931|macrophage atherogenicity|macrophage atherogenicity
5175405|NCT02894931|dietary interventions|dietary interventions
5175406|NCT02894931|sugars|sugars
5175407|NCT02894931|amino acids|amino acids
5175408|NCT02894931|artificial sweeteners|artificial sweeteners
5175409|NCT02894931|atherosclerosis|atherosclerosis
5175410|NCT02894892|Electron Microscopy|electron microscopy
5175411|NCT02894892|Helicobacter pylori|helicobacter pylori
5175412|NCT02894892|Bismuth|bismuth
5175413|NCT02894879|Postoperative pulmonary complications|postoperative pulmonary complications
5175414|NCT02894866|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5175415|NCT02894866|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5175416|NCT02894840|GPO Tri Fluvac Vaccine|gpo tri fluvac vaccine
5175417|NCT02894840|Tri Fluvac Vaccine|tri fluvac vaccine
5175418|NCT02894814|Self administration|self administration
5175419|NCT02894814|Medication|medication
5175420|NCT02894814|Inpatient|inpatient
5175421|NCT02894814|Self-care|self-care
5175422|NCT02894814|Self-management|self-management
5779786|NCT00198588|amputation|amputation
5175423|NCT02894814|Medical patients|medical patients
5175424|NCT02894749|hybrid rooms|hybrid rooms
5175425|NCT02894749|cone-beam computed tomography|cone-beam computed tomography
5175426|NCT02894723|Hypertension,|hypertension,
5175427|NCT02894723|Nitric Oxide|nitric oxide
5175428|NCT02894723|L-Arginine|l-arginine
5175429|NCT02894723|Arterial Stiffness|arterial stiffness
5175430|NCT02894723|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
5175431|NCT02894710|postoperative pain|postoperative pain
5175432|NCT02894710|intravenous lidocaine|intravenous lidocaine
5175433|NCT02894710|chronic post-surgical pain|chronic post-surgical pain
5175434|NCT02894710|remifentanil|remifentanil
5175435|NCT02894710|patient controlled analgesia|patient controlled analgesia
5175436|NCT02894710|morphine consumption|morphine consumption
5175437|NCT02894710|ENT surgery|ent surgery
5175438|NCT02894632|MRI|mri
5175439|NCT02894632|Motion|motion
5175440|NCT02894632|Respiratory movement|respiratory movement
5175441|NCT02894632|Artifacts correction|artifacts correction
5175442|NCT02894619|urinary incontinence|urinary incontinence
5175443|NCT02894619|anal incontinence|anal incontinence
5175444|NCT02894619|sexuality|sexuality
5175445|NCT02894619|quality of life|quality of life
5175446|NCT02894606|Kidney Transplant|kidney transplant
5175447|NCT02894606|Immunology|immunology
5175448|NCT02894593|Antiplaque agents|antiplaque agents
5175449|NCT02894593|chemical plaque control|chemical plaque control
5175450|NCT02894593|oral hygiene|oral hygiene
5175451|NCT02894593|essential oils|essential oils
5175452|NCT02894593|alcohol|alcohol
5175453|NCT02894593|mouthwash|mouthwash
5175454|NCT02894541|Dyslipidemia|dyslipidemia
5175455|NCT02894541|CKD-519|ckd-519
5175456|NCT02894541|CETP inhibitor|cetp inhibitor
5175457|NCT02894541|Food Drug Interaction|food drug interaction
5175458|NCT02894528|Alveolar ridge|alveolar ridge
5175459|NCT02894528|guided bone regeneration|guided bone regeneration
5175460|NCT02894528|bone grafts|bone grafts
5175461|NCT02894502|Self-care|self-care
5175462|NCT02894502|Motivational interviewing|motivational interviewing
5175463|NCT02894502|Heart failure|heart failure
5175464|NCT02894502|Caregivers|caregivers
5175465|NCT02894476|satisfaction with care|satisfaction with care
5175466|NCT02894476|outpatient care|outpatient care
5175467|NCT02894476|self-reported health status|self-reported health status
5175468|NCT02894476|alcohol dependence|alcohol dependence
5175469|NCT02894476|opioid dependence|opioid dependence
5175470|NCT02894463|dental care|dental care
5175471|NCT02894463|emeno|emeno
5175472|NCT02894463|abuse|abuse
5175473|NCT02894450|Atrial fibrillation|atrial fibrillation
5175474|NCT02894450|oral anticoagulant|oral anticoagulant
5175475|NCT02894450|bioassay|bioassay
5175476|NCT02894450|elderly subject|elderly subject
5175477|NCT02894437|prevention|prevention
5175478|NCT02894437|organization|organization
5175479|NCT02894437|pressure ulcers|pressure ulcers
5175480|NCT02894424|Inner limiting membrane|inner limiting membrane
5962198|NCT04282304|Behavioral intervention|behavioral intervention
5175481|NCT02894424|Microperimetry|microperimetry
5175482|NCT02894424|surgical's dye|surgical's dye
5175484|NCT02894411|Excyclotorsion|excyclotorsion
5175485|NCT02894398|HR+|hr+
5175486|NCT02894398|HER2-|her2-
5175487|NCT02894398|Locally advanced (inoperable or metastatic) Breast Cancer|locally advanced (inoperable or metastatic) breast cancer
5175488|NCT02894398|Palbociclib|palbociclib
5175489|NCT02894398|Aromatase inhibitor or fulvestrant|aromatase inhibitor or fulvestrant
5170633|NCT02925195|MESA|mesa
5862717|NCT00001539|Lyme Borreliosis|lyme borreliosis
5175490|NCT02894398|Pre-/perimenopausal receiving LHRH agonist / ovarian ablation|pre-/perimenopausal receiving lhrh agonist / ovarian ablation
5175491|NCT02894398|Postmenopausal|postmenopausal
5175492|NCT02894372|Oral spray|oral spray
5175493|NCT02894372|Topical sprays|topical sprays
5175494|NCT02894372|Faringomoss|faringomoss
5175495|NCT02894372|Local phytotherapy|local phytotherapy
5175496|NCT02894359|Cervical spine|cervical spine
5175497|NCT02894359|Musculoskeletal imagery|musculoskeletal imagery
5175498|NCT02894359|computer modelling of cervical spine|computer modelling of cervical spine
5175499|NCT02894359|ConeBeam.|conebeam.
5175500|NCT02894346|Motivation|motivation
5175501|NCT02894346|Teachers|teachers
5175502|NCT02894346|Physical activity|physical activity
5175503|NCT02894346|School|school
5175504|NCT02894333|Parkinson's disease|parkinson's disease
5175505|NCT02894333|Action-effect prediction|action-effect prediction
5175506|NCT02894333|Sensory attenuation|sensory attenuation
5175507|NCT02894333|Voluntary action|voluntary action
5175508|NCT02894320|Parkinson's disease|parkinson's disease
5175509|NCT02894320|Voluntary action|voluntary action
5175510|NCT02894320|Action-effect preactivation|action-effect preactivation
5175511|NCT02894320|Action-effect prediction|action-effect prediction
5175512|NCT02894307|Mechanical prosthesis|mechanical prosthesis
5175513|NCT02894307|Rivaroxaban|rivaroxaban
5175514|NCT02894294|malaria|malaria
5175515|NCT02894294|chemoprevention|chemoprevention
5175516|NCT02894294|season|season
5175517|NCT02894294|anemia|anemia
5175518|NCT02894294|impact|impact
5175519|NCT02894294|coverage|coverage
5175520|NCT02894294|children|children
5175521|NCT02894281|Pupillary light reflex|pupillary light reflex
5175522|NCT02894281|Multiple sclerosis|multiple sclerosis
5175523|NCT02894190|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
5175524|NCT02894190|Adherence|adherence
5175525|NCT02894190|Beliefs|beliefs
5175526|NCT02894190|Development|development
5175527|NCT02894190|Validation|validation
5175528|NCT02894177|E02.880.820.950|e02.880.820.950
5175529|NCT02894164|Cystatin C|cystatin c
5175530|NCT02894164|Creatinine|creatinine
5175531|NCT02894164|Glomerular Filtration Rate|glomerular filtration rate
5175532|NCT02894125|Chronic Low Back Pain|chronic low back pain
5175533|NCT02894125|Old subject|old subject
5175534|NCT02894125|SPA Therapy|spa therapy
5175535|NCT02894125|Pain|pain
5175536|NCT02894125|Function|function
5175537|NCT02894125|Expectations|expectations
5175538|NCT02894125|Fears|fears
5175539|NCT02894112|endothelial dependent vasodilation|endothelial dependent vasodilation
5175540|NCT02894112|blood flow|blood flow
5175541|NCT02894112|blood glucose|blood glucose
5175542|NCT02894112|triglycerides|triglycerides
5175543|NCT02894112|non-fat milk|non-fat milk
5175544|NCT02894112|dairy|dairy
5175545|NCT02894099|Aged|aged
5175546|NCT02894099|Sedentary Behaviour|sedentary behaviour
5175547|NCT02894099|Blood Glucose|blood glucose
5175548|NCT02894099|Insulin|insulin
5175549|NCT02894099|Inflammatory markers|inflammatory markers
5175550|NCT02894086|acute appendicitis|acute appendicitis
5175551|NCT02894086|ambulatory appendicectomy|ambulatory appendicectomy
5175552|NCT02894073|obese patients|obese patients
5175553|NCT02894073|peripheral venous catheter|peripheral venous catheter
5175554|NCT02894060|Cardiovascular events|cardiovascular events
5175555|NCT02894047|calcium-sensitive receptor|calcium-sensitive receptor
5175556|NCT02894034|optic nerve sheath|optic nerve sheath
5175557|NCT02894034|meningeal hemorrhage|meningeal hemorrhage
5175558|NCT02894034|early phase|early phase
5175559|NCT02894034|prognostic|prognostic
5175560|NCT02894021|padding|padding
5175561|NCT02894021|lymphoceles|lymphoceles
5175562|NCT02894021|prevention|prevention
5175564|NCT02893995|Subcutaneous Treprostinil|subcutaneous treprostinil
5175565|NCT02893995|Remodulin|remodulin
5175566|NCT02893995|6 Minute Walk Test|6 minute walk test
5175567|NCT02893969|Physical Activity|physical activity
5175568|NCT02893969|Rest|rest
5175569|NCT02893956|Echocardiography|echocardiography
5175570|NCT02893956|postural support|postural support
5175571|NCT02893956|preterm neonate|preterm neonate
5175572|NCT02893904|Propofol|propofol
5175573|NCT02893904|Sevoflurane|sevoflurane
5175574|NCT02893904|Bispectral Index|bispectral index
5175575|NCT02893904|Children|children
5175576|NCT02893904|Electroencephalographic signs|electroencephalographic signs
5175577|NCT02893891|Obesity|obesity
5175578|NCT02893891|Bariatric medicine|bariatric medicine
5175579|NCT02893891|Sleeve gastric resection|sleeve gastric resection
5175580|NCT02893891|Gastric plication|gastric plication
5175581|NCT02893891|Intragastric ballon|intragastric ballon
5175582|NCT02893891|Body composition|body composition
5175583|NCT02893891|Adipokines|adipokines
5175584|NCT02893891|Ghrelin|ghrelin
5962199|NCT04282304|Severe obesity|severe obesity
5175585|NCT02893891|Bone mineral density|bone mineral density
5175586|NCT02893891|Quality of life|quality of life
5175587|NCT02893878|Seasonal influenza vaccines|seasonal influenza vaccines
5175588|NCT02893878|Passive Enhanced Safety surveillance|passive enhanced safety surveillance
5175589|NCT02893878|England|england
5175590|NCT02893878|Pilot study|pilot study
5175591|NCT02893865|Apnea syndrome|apnea syndrome
5175592|NCT02893865|Coronary artery disease|coronary artery disease
5175594|NCT02893865|Continuous positive airway pressure|continuous positive airway pressure
5175595|NCT02893865|Endothelial dysfunction|endothelial dysfunction
5175596|NCT02893839|Allergy|allergy
5175597|NCT02893839|cross-reactivity|cross-reactivity
5175598|NCT02893839|oral allergy syndrome|oral allergy syndrome
5175599|NCT02893839|potato|potato
5175600|NCT02893839|sensitization|sensitization
5175601|NCT02893826|Aneurysm|aneurysm
5175602|NCT02893826|Ruptured|ruptured
5175603|NCT02893826|nimodipine|nimodipine
5175604|NCT02893826|subarachnoid hemorrhage|subarachnoid hemorrhage
5175605|NCT02893800|assistive technology|assistive technology
5175606|NCT02893800|dementia care|dementia care
5175607|NCT02893800|tracking technology|tracking technology
5175608|NCT02893800|locating systems|locating systems
5175609|NCT02893800|user experience|user experience
5175610|NCT02893787|Speckle Tracking|speckle tracking
5175611|NCT02893787|Anthracyclines|anthracyclines
5175612|NCT02893787|Chilhood cancers|chilhood cancers
5175613|NCT02893787|Myocardial function|myocardial function
5175614|NCT02893787|Echocardiography|echocardiography
5175615|NCT02893761|breast cancer|breast cancer
5175616|NCT02893761|survival|survival
5175617|NCT02893761|prognosis factors|prognosis factors
5175618|NCT02893748|colon|colon
5175619|NCT02893748|polyps|polyps
5175620|NCT02893748|cancer|cancer
5175621|NCT02893748|screening|screening
5175622|NCT02893735|Clinical Trial|clinical trial
5175623|NCT02893735|Composite resin|composite resin
5175624|NCT02893722|ivf ,atosiban,repeated implantation failure,RCT|ivf ,atosiban,repeated implantation failure,rct
5175625|NCT02893683|Paris Visual Learning Test|paris visual learning test
5175626|NCT02893683|visual memory|visual memory
5175627|NCT02893683|criterion validity|criterion validity
5175628|NCT02893657|MELD score|meld score
5175629|NCT02893657|hemodynamics|hemodynamics
5175630|NCT02893657|liver abnormalities|liver abnormalities
5175631|NCT02893566|overweight|overweight
5175632|NCT02893566|body mass index|body mass index
5175633|NCT02893566|university students|university students
5175634|NCT02893566|physical activity|physical activity
5175635|NCT02893566|sedentary behavior|sedentary behavior
5175636|NCT02893566|body composition|body composition
5175637|NCT02893566|Mi Band|mi band
5175638|NCT02893514|Drug Use|drug use
5175639|NCT02893488|dolutegravir|dolutegravir
5175640|NCT02893488|abacavir|abacavir
5175641|NCT02893488|relative bioavailability|relative bioavailability
5175642|NCT02893488|palatability|palatability
5175643|NCT02893488|GSK2619619|gsk2619619
5175644|NCT02893488|palatability questionnaire|palatability questionnaire
5175645|NCT02893488|lamivudine|lamivudine
5175646|NCT02893488|pediatric|pediatric
5175647|NCT02893488|calcium|calcium
5175648|NCT02893488|dispersible tablet|dispersible tablet
5175649|NCT02893462|data warehousing|data warehousing
5175650|NCT02893462|data aggregation|data aggregation
5175651|NCT02893462|data mining|data mining
5175652|NCT02893449|Parkinson|parkinson
5175653|NCT02893449|SAS-SR|sas-sr
5175654|NCT02893449|Social adaptation|social adaptation
5175655|NCT02893449|Patients suffering from Parkinson's disease|patients suffering from parkinson's disease
5175656|NCT02893423|Ropivacaine|ropivacaine
5175657|NCT02893423|C-Section Analgesia|c-section analgesia
5175658|NCT02893423|Tap Block|tap block
5175659|NCT02893358|Allisartan Isoproxil|allisartan isoproxil
5175660|NCT02893358|left ventricular hypertrophy|left ventricular hypertrophy
5175661|NCT02893358|large arterial stiffness|large arterial stiffness
5175662|NCT02893358|microalbuminuria|microalbuminuria
5175663|NCT02893345|Self Care (Rehabilitation)|self care (rehabilitation)
5175664|NCT02893345|Community Participation|community participation
5175665|NCT02893345|Patient-Centered Outcomes Research|patient-centered outcomes research
5175666|NCT02893345|Informatics, Clinical|informatics, clinical
5175667|NCT02893319|Infant Feeding|infant feeding
5175668|NCT02893319|Infant Growth|infant growth
5175669|NCT02893306|Type1 Diabetes Mellitus|type1 diabetes mellitus
5175670|NCT02893306|Multipotent stromal cell|multipotent stromal cell
5175671|NCT02893306|Mesenchymal stem cell|mesenchymal stem cell
5175672|NCT02893306|Insulin|insulin
5175673|NCT02893306|Pancreatic reserve|pancreatic reserve
5175674|NCT02893306|Disease progression|disease progression
5175675|NCT02893267|Stroke|stroke
5175676|NCT02893267|Shoulder Pain|shoulder pain
5175677|NCT02893267|Electrical stimulation|electrical stimulation
5175678|NCT02893267|Neuromuscular stimulation|neuromuscular stimulation
5175679|NCT02893267|Intramuscular stimulation|intramuscular stimulation
5175680|NCT02893267|Physical Therapy|physical therapy
5175872|NCT02892123|HER2|her2
5175681|NCT02893254|ankylosing spondylitis, tumor necrosis factor-α inhibitors|ankylosing spondylitis, tumor necrosis factor-α inhibitors
5175682|NCT02893228|forced expiratory volume in 1 second|forced expiratory volume in 1 second
5175683|NCT02893228|forced vital capacity|forced vital capacity
5175684|NCT02893228|peak expiratory flow rate|peak expiratory flow rate
5175685|NCT02893228|interscalene block|interscalene block
5175686|NCT02893228|diaphragmatic paresis|diaphragmatic paresis
5175687|NCT02893202|PTSD|ptsd
5175688|NCT02893202|Equine assisted activities|equine assisted activities
5175689|NCT02893202|quality of life|quality of life
5175690|NCT02893189|CD19+|cd19+
5175691|NCT02893189|allogeneic transplant|allogeneic transplant
5175692|NCT02893189|relapse|relapse
5175693|NCT02893176|Lung Transplant|lung transplant
5175694|NCT02893176|Macitentan|macitentan
5175695|NCT02893176|CLAD|clad
5175696|NCT02893176|BOS|bos
5175697|NCT02893176|bronchiolitis obliterans|bronchiolitis obliterans
5175698|NCT02893176|chronic lung allograft dysfunction|chronic lung allograft dysfunction
5175699|NCT02893176|Organ Rejection|organ rejection
5175700|NCT02893163|Metabolic Syndrome|metabolic syndrome
5175701|NCT02893163|Cancer Risk|cancer risk
5175702|NCT02893163|Lifestyle Interventions|lifestyle interventions
5175703|NCT02893163|Primary Care|primary care
5175704|NCT02893163|Behavioural Change|behavioural change
5175705|NCT02893150|Mindful Eating|mindful eating
5175706|NCT02893150|Overweight|overweight
5175707|NCT02893150|Primary Care|primary care
5175708|NCT02893150|Randomized Clinical Trial|randomized clinical trial
5175709|NCT02893137|Tumour treating fields|tumour treating fields
5175710|NCT02893137|Optune|optune
5175711|NCT02893137|Craniectomy|craniectomy
5175712|NCT02893137|TTFields|ttfields
5175713|NCT02893124|chronic hepatitis B|chronic hepatitis b
5175714|NCT02893111|neuromyelitis optica spectrum disorders|neuromyelitis optica spectrum disorders
5175715|NCT02893111|Bortezomib|bortezomib
5175716|NCT02893111|Velcade|velcade
5175717|NCT02893111|Proteasome inhibitor|proteasome inhibitor
5175718|NCT02893072|Diabetes, Gestational|diabetes, gestational
5175719|NCT02893072|Nutrition Therapy|nutrition therapy
5175720|NCT02893046|care pathway|care pathway
5175721|NCT02893046|hospital- private network|hospital- private network
5175722|NCT02893046|early consultation|early consultation
5175723|NCT02893033|Dysphagia|dysphagia
5175724|NCT02893033|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5175725|NCT02893033|Stroke|stroke
5175726|NCT02893020|Emotional experience and burnout in physicians|emotional experience and burnout in physicians
5175727|NCT02892994|therapeutic ultrasound|therapeutic ultrasound
5175728|NCT02892968|Regional Anesthesia Ultrasound guided|regional anesthesia ultrasound guided
5175729|NCT02892968|Emergency Department|emergency department
5063814|NCT03600532|experimental pain|experimental pain
5175730|NCT02892968|Knowledge to Practice Intervention|knowledge to practice intervention
5175731|NCT02892955|Heart Failure|heart failure
5175732|NCT02892955|LVAS|lvas
5175733|NCT02892955|Ventricular Dysfunction|ventricular dysfunction
5175734|NCT02892955|Cardiomyopathy|cardiomyopathy
5175735|NCT02892955|Heart Disease|heart disease
5175736|NCT02892955|Cardiovascular Disease|cardiovascular disease
5175737|NCT02892955|Heart-assist devices|heart-assist devices
5175738|NCT02892955|Thoratec Corporation|thoratec corporation
5175739|NCT02892942|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5175740|NCT02892942|Estradiol|estradiol
5175741|NCT02892942|Embryo implantation|embryo implantation
5175742|NCT02892942|Endometrial receptivity|endometrial receptivity
5175743|NCT02892942|Fertility preservation|fertility preservation
5175744|NCT02892929|Motivational Interviewing|motivational interviewing
5175745|NCT02892929|Hypertension|hypertension
5175746|NCT02892929|Nursing|nursing
5175747|NCT02892929|Randomized Controlled Trial|randomized controlled trial
5175748|NCT02892929|Life Style|life style
5175749|NCT02892916|Post-operative cognitive dysfunction (POCD)|post-operative cognitive dysfunction (pocd)
5175750|NCT02892916|Delirium|delirium
5175751|NCT02892916|Ketamine|ketamine
5175752|NCT02892916|Elective orthopaedic surgery|elective orthopaedic surgery
5175753|NCT02892903|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
5175754|NCT02892903|Pressure wire (PW)|pressure wire (pw)
5175755|NCT02892903|Coronary angiography|coronary angiography
5175756|NCT02892877|Complete Hydatidiform mole|complete hydatidiform mole
5175757|NCT02892877|Partial Hydatidiform mole|partial hydatidiform mole
5175758|NCT02892877|Invasive mole|invasive mole
5175759|NCT02892877|Choriocarcinoma|choriocarcinoma
5175760|NCT02892877|Post-molar neoplasia|post-molar neoplasia
5175761|NCT02892877|Placental Site Trophoblastic Tumor (PSTT)|placental site trophoblastic tumor (pstt)
5175762|NCT02892877|Epithelioid Trophoblastic Tumor (ETT)|epithelioid trophoblastic tumor (ett)
5175763|NCT02892877|hCG follow-up|hcg follow-up
5175764|NCT02892864|Bell's Palsy|bell's palsy
5175765|NCT02892864|Peripheral facial palsy|peripheral facial palsy
5175766|NCT02892851|STN-DBS|stn-dbs
5175767|NCT02892851|Craving|craving
5175768|NCT02892851|Cocaine addiction|cocaine addiction
5175769|NCT02892838|mobile bearing knee prosthesis|mobile bearing knee prosthesis
5175770|NCT02892825|Music|music
5175771|NCT02892825|cataract surgery|cataract surgery
5175772|NCT02892825|topical anaesthesia|topical anaesthesia
5175773|NCT02892825|anxiety|anxiety
5175774|NCT02892825|hypertension|hypertension
5175775|NCT02892799|NICOM device|nicom device
5175776|NCT02892786|circulating tumor cell|circulating tumor cell
5175777|NCT02892786|CellSearch™ method|cellsearch™ method
5175779|NCT02892773|electrical impedance tomography|electrical impedance tomography
5175780|NCT02892773|incentive spirometry|incentive spirometry
5175781|NCT02892773|EzPAP|ezpap
5175782|NCT02892773|lung volume|lung volume
5175783|NCT02892773|atelectasis|atelectasis
5175784|NCT02892773|positive airway pressure|positive airway pressure
5175785|NCT02892773|pulmonary complication|pulmonary complication
5175786|NCT02892773|abdominal surgery|abdominal surgery
5175787|NCT02892773|end-expiratory lung volume|end-expiratory lung volume
5175788|NCT02892747|Chronic Heart Failure (CHF)|chronic heart failure (chf)
5175789|NCT02892747|Dietetics education|dietetics education
5175790|NCT02892747|Malnutrition|malnutrition
5175791|NCT02892721|CT Colonography|ct colonography
5175792|NCT02892721|Virtual colonoscopy|virtual colonoscopy
5175793|NCT02892721|Colorectal cancer|colorectal cancer
5175794|NCT02892721|Colon cancer|colon cancer
5175795|NCT02892721|Training|training
5175796|NCT02892708|supratentorial gliomas|supratentorial gliomas
5175797|NCT02892708|surgery|surgery
5175798|NCT02892708|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5175799|NCT02892708|elderly|elderly
5175800|NCT02892630|Immune Thrombocytopenia|immune thrombocytopenia
5175801|NCT02892630|Pregnancy|pregnancy
5175802|NCT02892617|Modic 1|modic 1
5175803|NCT02892617|low back pain|low back pain
5175804|NCT02892604|Type 1 diabetes|type 1 diabetes
5175805|NCT02892604|artificial pancreas|artificial pancreas
5175806|NCT02892604|closed-loop insulin infusion|closed-loop insulin infusion
5175807|NCT02892565|systemic lupus erythematosus|systemic lupus erythematosus
5175808|NCT02892565|antiphospholipid syndrome|antiphospholipid syndrome
5175809|NCT02892565|antiphospholipid antibodies|antiphospholipid antibodies
5175810|NCT02892513|Colorectal Surgery|colorectal surgery
5175811|NCT02892513|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5175812|NCT02892487|Quality of life|quality of life
5175813|NCT02892487|Radiotherapy|radiotherapy
5175814|NCT02892487|Dysphagia|dysphagia
5175815|NCT02892487|Oral cavity|oral cavity
5175816|NCT02892487|Oropharynx|oropharynx
5175817|NCT02892487|Hypopharynx|hypopharynx
5175818|NCT02892487|Larynx|larynx
5175819|NCT02892487|Swallowing rehabilitation|swallowing rehabilitation
5175820|NCT02892487|Toxicity|toxicity
5175821|NCT02892474|Coronary Arteriosclerosis|coronary arteriosclerosis
5175822|NCT02892474|Hybrid Coronary Revascularization|hybrid coronary revascularization
5175823|NCT02892474|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5175824|NCT02892461|Anemia, Iron-Deficiency|anemia, iron-deficiency
5175825|NCT02892461|Cesarean Section|cesarean section
5175826|NCT02892461|Umbilical Cord Milking|umbilical cord milking
5175827|NCT02892461|Randomized Controlled Trial|randomized controlled trial
5175828|NCT02892409|Drug Therapy|drug therapy
5175829|NCT02892344|Phase III, blinded, QMF149, Mometasone furoate (MF), mild asthma, Adolescent, adult|phase iii, blinded, qmf149, mometasone furoate (mf), mild asthma, adolescent, adult
5175830|NCT02892331|exercise|exercise
5175831|NCT02892331|insulin resistance|insulin resistance
5175832|NCT02892331|mitochondrial function|mitochondrial function
5175833|NCT02892331|arterial stiffness|arterial stiffness
5175834|NCT02892331|exercise intensity|exercise intensity
5175835|NCT02892331|fitness|fitness
5175836|NCT02892305|Pancreaticoduodenectomy|pancreaticoduodenectomy
5175837|NCT02892305|Hepatectomy|hepatectomy
5175838|NCT02892305|Liver ablation|liver ablation
5175839|NCT02892305|Whipple|whipple
5175840|NCT02892279|Microneurography|microneurography
5175841|NCT02892279|Air pollution|air pollution
5175842|NCT02892266|Transplant recipients|transplant recipients
5175843|NCT02892266|Adolescents|adolescents
5175844|NCT02892266|Post-Traumatic Stress Symptoms (PTSS)|post-traumatic stress symptoms (ptss)
5175845|NCT02892266|Transplant Recipient and Family Impact(s)|transplant recipient and family impact(s)
5175846|NCT02892253|postoperative hypocalcemia|postoperative hypocalcemia
5175847|NCT02892253|near infrared imaging|near infrared imaging
5175848|NCT02892253|parathyroid autofluorescence|parathyroid autofluorescence
5175849|NCT02892227|bedside echography|bedside echography
5175850|NCT02892162|atrial fibrillation|atrial fibrillation
5175851|NCT02892162|catheter ablation|catheter ablation
5175852|NCT02892149|AKB-6548|akb-6548
5175853|NCT02892149|Chronic kidney disease|chronic kidney disease
5175854|NCT02892149|anemia|anemia
5175856|NCT02892149|chronic renal insufficiency|chronic renal insufficiency
5175857|NCT02892149|renal impairment|renal impairment
5175858|NCT02892149|erythropoietin|erythropoietin
5175859|NCT02892149|kidney|kidney
5175860|NCT02892149|renal|renal
5175861|NCT02892149|oral anemia treatment|oral anemia treatment
5175862|NCT02892149|hemoglobin|hemoglobin
5175863|NCT02892149|hypoxia-inducible factor|hypoxia-inducible factor
5175864|NCT02892149|HIF|hif
5175865|NCT02892149|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5175866|NCT02892149|HIF-PHI|hif-phi
5175867|NCT02892149|efficacy|efficacy
5175868|NCT02892149|safety|safety
5175869|NCT02892149|Phase 3|phase 3
5175870|NCT02892149|cardiovascular|cardiovascular
5175873|NCT02892123|Bispecific antibody|bispecific antibody
5175874|NCT02892123|Biparatopic antibody|biparatopic antibody
5175875|NCT02892123|Immunotherapy|immunotherapy
5175876|NCT02892123|Breast cancer|breast cancer
5175877|NCT02892123|Gastroesophageal adenocarcinoma (GEA)|gastroesophageal adenocarcinoma (gea)
5175878|NCT02892123|Gastric cancer|gastric cancer
5175879|NCT02892123|Gastroesophageal junction (GEJ) cancer|gastroesophageal junction (gej) cancer
5175880|NCT02892123|Ovarian cancer|ovarian cancer
5175881|NCT02892123|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5175882|NCT02892123|Chemotherapy|chemotherapy
5175883|NCT02892123|Paclitaxel|paclitaxel
5175884|NCT02892123|Capecitabine|capecitabine
5175885|NCT02892123|Vinorelbine|vinorelbine
5175886|NCT02892110|Marijuana use|marijuana use
5175887|NCT02892110|Varenicline/Chantix|varenicline/chantix
5175888|NCT02892110|Motivational enhancement therapy|motivational enhancement therapy
5175889|NCT02892097|tDCS|tdcs
5175890|NCT02892097|neglect|neglect
5175891|NCT02892097|paresis|paresis
5175892|NCT02892097|transcranial direct current stimulation|transcranial direct current stimulation
5175893|NCT02892097|rehabilitation|rehabilitation
5175894|NCT02892084|Chronic Stroke ( > 6 months)|chronic stroke ( > 6 months)
5175895|NCT02892084|non-invasive brain stimulation|non-invasive brain stimulation
5175896|NCT02892084|rehabilitation|rehabilitation
5175897|NCT02892084|walking|walking
5175898|NCT02892084|kinetics|kinetics
5175899|NCT02892045|neuromuscular block|neuromuscular block
5175900|NCT02892045|monitoring|monitoring
5175901|NCT02892019|indacaterol acetate, asthma, GINA 2015, pediatrics|indacaterol acetate, asthma, gina 2015, pediatrics
5175902|NCT02891993|Cancer Care|cancer care
5175903|NCT02891980|Ebola|ebola
5175904|NCT02891980|Immunogenicity|immunogenicity
5175905|NCT02891980|Marburg|marburg
5175906|NCT02891980|Omics|omics
5175907|NCT02891980|Zaire|zaire
5175908|NCT02891954|Glucosuria|glucosuria
5175909|NCT02891954|SGLT2 inhibitors|sglt2 inhibitors
5175910|NCT02891954|Canagliflozin|canagliflozin
5175911|NCT02891954|FGF23|fgf23
5175912|NCT02891954|Parathyroid hormone|parathyroid hormone
5175913|NCT02891954|1,25-Dihydroxyvitamin D|1,25-dihydroxyvitamin d
5175914|NCT02891954|Glucagon|glucagon
5175915|NCT02891954|Ketone bodies|ketone bodies
5175916|NCT02891954|Uric acid|uric acid
5175917|NCT02891954|Pharmacogenomics|pharmacogenomics
5175918|NCT02891928|Type 2 diabetes|type 2 diabetes
5175919|NCT02891928|Diabetic neuropathy|diabetic neuropathy
5175920|NCT02891928|Disorders of equilibrium|disorders of equilibrium
5175921|NCT02891928|"Rocker sole shoes"|"rocker sole shoes"
5175922|NCT02891928|Walking|walking
5175923|NCT02891915|Antimicrobial|antimicrobial
5175924|NCT02891915|Beta-Lactam|beta-lactam
5175925|NCT02891915|Pneumonia|pneumonia
5175926|NCT02891915|Short Course|short course
5175927|NCT02891915|Standard Course|standard course
5175928|NCT02891915|Therapy|therapy
5175929|NCT02891876|direct pulp capping, biodentine|direct pulp capping, biodentine
5175930|NCT02891863|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5175931|NCT02891837|L-citrulline|l-citrulline
5175932|NCT02891837|pediatric|pediatric
5175933|NCT02891837|Lung Injury|lung injury
5175934|NCT02891837|Bypass|bypass
5175935|NCT02891837|Heart Defects|heart defects
5175936|NCT02891837|Clinical Sequelae|clinical sequelae
5175937|NCT02891824|PD-L1|pd-l1
5175938|NCT02891824|Atezolizumab|atezolizumab
5175939|NCT02891824|Randomized, double blinded|randomized, double blinded
5175940|NCT02891824|first or second late relapse|first or second late relapse
5175941|NCT02891824|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma|progressive non-mucinous epithelial ovarian cancer, primary peritoneal adenocarcinoma and / or fallopian-tube adenocarcinoma
5175942|NCT02891824|progression-free survival|progression-free survival
5175943|NCT02891811|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5175944|NCT02891811|carfilzomib|carfilzomib
5175945|NCT02891811|thalidomide|thalidomide
5175946|NCT02891811|lenalidomide|lenalidomide
5175947|NCT02891811|dexamethasone|dexamethasone
5175948|NCT02891811|transplant ineligible|transplant ineligible
5175949|NCT02891811|induction therapy|induction therapy
5175950|NCT02891811|maintenance|maintenance
5175951|NCT02891811|Study Group of Medical Tumour Therapy (AGMT)|study group of medical tumour therapy (agmt)
5175952|NCT02891798|analgesia,|analgesia,
5175953|NCT02891798|buprenorphine|buprenorphine
5175954|NCT02891798|clonidine|clonidine
5175955|NCT02891798|dexamethasone|dexamethasone
5175956|NCT02891798|bupivacaine|bupivacaine
5175957|NCT02891798|nerve block|nerve block
5175958|NCT02891733|Expression of the Neurotensin|expression of the neurotensin
5175959|NCT02891733|Neurotensin|neurotensin
5175960|NCT02891668|Basal Metabolic rate|basal metabolic rate
5175961|NCT02891668|Quality of life|quality of life
5175962|NCT02891668|Resting energy expenditure|resting energy expenditure
5175963|NCT02891668|Insulin resistance|insulin resistance
5175964|NCT02891668|Cognitive Function|cognitive function
5175965|NCT02891668|Body Composition|body composition
5175966|NCT02891642|malignancy|malignancy
5175967|NCT02891642|Pleural Effusion|pleural effusion
5042751|NCT03731923|MRI|mri
5175968|NCT02891642|Pleural Neoplasms|pleural neoplasms
5175969|NCT02891642|Ascites|ascites
5175970|NCT02891616|Melanoma|melanoma
5175972|NCT02891616|18F-FDG|18f-fdg
5175973|NCT02891616|PET/CT|pet/ct
5175974|NCT02891616|PET/MR|pet/mr
5175975|NCT02891577|intra abdominal hypertension|intra abdominal hypertension
5175976|NCT02891577|shock|shock
5175977|NCT02891577|critically ill|critically ill
5175978|NCT02891564|therapeutic video games, mobile interventions|therapeutic video games, mobile interventions
5175979|NCT02891551|Leukemia|leukemia
5175980|NCT02891551|Chronic|chronic
5175981|NCT02891551|Acute|acute
5175982|NCT02891551|Observational|observational
5175984|NCT02891551|OCEAN|ocean
5175985|NCT02891551|Netherlands|netherlands
5175986|NCT02891551|azacitidine|azacitidine
5175987|NCT02891538|EGCG|egcg
5175988|NCT02891538|Green Tea|green tea
5175989|NCT02891538|Colon Cancer|colon cancer
5175990|NCT02891512|Magnetic Fields|magnetic fields
5175991|NCT02891512|Pain|pain
5175992|NCT02891512|Paresthesia|paresthesia
5175993|NCT02891512|Visual Analogue Scale|visual analogue scale
5175994|NCT02891499|Miniscrews|miniscrews
5175995|NCT02891499|Mini-implants|mini-implants
5175996|NCT02891499|Temporal anchorage devices|temporal anchorage devices
5175997|NCT02891499|Bone screws|bone screws
5175998|NCT02891499|Stability|stability
5175999|NCT02891499|Displacement|displacement
5176000|NCT02891499|Low-level laser therapy|low-level laser therapy
5176001|NCT02891499|Cone-beam computed tomography|cone-beam computed tomography
5176002|NCT02891499|Resonance frequency analysis|resonance frequency analysis
5176003|NCT02891499|Orthodontic|orthodontic
5176004|NCT02891499|Orthodontic miniscrew implant|orthodontic miniscrew implant
5176005|NCT02891486|spinal surgery, surgical site infection|spinal surgery, surgical site infection
5176006|NCT02891473|Posture|posture
5176007|NCT02891473|Pain|pain
5176008|NCT02891473|Muscle stretching|muscle stretching
5176009|NCT02891473|Mézières method|mézières method
5780173|NCT00196625|Ritonavir|ritonavir
5253092|NCT02428036|HF10|hf10
5176010|NCT02891473|Camptocormia|camptocormia
5176011|NCT02891473|Trunk control|trunk control
5176012|NCT02891460|Mitomycin C|mitomycin c
5176013|NCT02891460|MMC|mmc
5176014|NCT02891460|NMIBC|nmibc
5176015|NCT02891460|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5176016|NCT02891460|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
5176017|NCT02891460|Drug retention|drug retention
5176018|NCT02891460|Urinary Bladder Neoplasms|urinary bladder neoplasms
5176019|NCT02891460|Urologic Neoplasms|urologic neoplasms
5176020|NCT02891460|Urinary Bladder Diseases|urinary bladder diseases
5176021|NCT02891460|Urologic Diseases|urologic diseases
5176022|NCT02891434|Duchenne muscular dystrophy|duchenne muscular dystrophy
5176023|NCT02891434|motor learning|motor learning
5176024|NCT02891434|motor abilities|motor abilities
5176025|NCT02891395|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5176026|NCT02891395|imatinib Mesylate|imatinib mesylate
5176027|NCT02891395|Nilotinib|nilotinib
5176028|NCT02891382|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5176029|NCT02891382|Weight Loss|weight loss
5176030|NCT02891382|Financial Incentives|financial incentives
5176031|NCT02891382|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5176032|NCT02891356|Adiponectin|adiponectin
5176033|NCT02891356|Bone remodelling markers|bone remodelling markers
5176034|NCT02891343|Cognitive Function|cognitive function
5176035|NCT02891343|Hypoxia|hypoxia
5176036|NCT02891343|Neurophysiological Function|neurophysiological function
5176037|NCT02891343|Effect of Alzheimer Disease symptomatic drugs|effect of alzheimer disease symptomatic drugs
5176038|NCT02891343|Healthy Subjects|healthy subjects
5176039|NCT02891330|Roux-en-Y Gastric ByPass|roux-en-y gastric bypass
5176040|NCT02891304|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5176041|NCT02891291|optical coherence tomography|optical coherence tomography
5176042|NCT02891278|Leukemia|leukemia
5176043|NCT02891278|Sertraline|sertraline
5176044|NCT02891278|Cytosine Arabinoside|cytosine arabinoside
5176045|NCT02891278|Relapsed AML|relapsed aml
5176046|NCT02891278|Refractory AML|refractory aml
5176047|NCT02891239|laser treatment|laser treatment
5176048|NCT02891226|inflammatory bowel disease|inflammatory bowel disease
5176049|NCT02891226|IL-23|il-23
5176050|NCT02891226|biologic|biologic
5176051|NCT02891187|Postoperative Care|postoperative care
5176052|NCT02891187|Telephone follow-up|telephone follow-up
5176053|NCT02891187|Healthcare Value|healthcare value
5176054|NCT02891174|ibuprofen|ibuprofen
5176055|NCT02891174|acetaminophen|acetaminophen
5176056|NCT02891174|blood pressure|blood pressure
5176057|NCT02891174|post-partum|post-partum
5962200|NCT04282304|Weight loss|weight loss
5176058|NCT02891174|pain control|pain control
5176059|NCT02891174|pre-eclampsia|pre-eclampsia
5176060|NCT02891174|gestational hypertension|gestational hypertension
5176061|NCT02891161|durvalumab|durvalumab
5176062|NCT02891161|MEDI4736|medi4736
5176063|NCT02891161|anti-PD-L1|anti-pd-l1
5176064|NCT02891135|"WHO 'Treat all Antiretroviral Guidelines"|"who 'treat all antiretroviral guidelines"
5962201|NCT04282304|Bariatric surgery|bariatric surgery
5049754|NCT03687346|fMRI|fmri
5176065|NCT02891135|Simplified Algorithm for Treatment Eligibility (SLATE)|simplified algorithm for treatment eligibility (slate)
5176066|NCT02891096|respiratory complications|respiratory complications
5176067|NCT02891096|respiratory muscle strength|respiratory muscle strength
5176068|NCT02891096|discriminator|discriminator
5176069|NCT02891083|adjuvant chemotherapy|adjuvant chemotherapy
5176070|NCT02891083|adjuvant radiotherapy|adjuvant radiotherapy
5176071|NCT02891083|lymph node metastasis|lymph node metastasis
5176072|NCT02891083|surgery|surgery
5176073|NCT02891083|squamous cell carcinoma|squamous cell carcinoma
5176074|NCT02891070|Cranial Surgery|cranial surgery
5176075|NCT02891070|Cerebrospinal Fluid Leak|cerebrospinal fluid leak
5176076|NCT02891070|Tisseel|tisseel
5176077|NCT02891031|Rhus|rhus
5176079|NCT02891031|Herbal medicine|herbal medicine
5176080|NCT02891031|Uric acid|uric acid
5176081|NCT02890966|SHR4640 pharmacokinetics pharmacodynamics|shr4640 pharmacokinetics pharmacodynamics
5176082|NCT02890927|Geriatric Nursing|geriatric nursing
5176083|NCT02890927|Geriatric co-management|geriatric co-management
5176084|NCT02890927|Geriatric team|geriatric team
5176085|NCT02890901|Escherichia coli|escherichia coli
5176086|NCT02890901|Bloodstream infections|bloodstream infections
5176087|NCT02890901|Severity|severity
5176089|NCT02890901|Host factors|host factors
5176090|NCT02890901|Microbiology|microbiology
5176091|NCT02890888|small vessel disease of the brain|small vessel disease of the brain
5176092|NCT02890888|hyperbaric oxygen|hyperbaric oxygen
5176093|NCT02890888|functional connectivity MRI|functional connectivity mri
5176094|NCT02890875|ethanol lock|ethanol lock
5176095|NCT02890875|parenteral nutrition|parenteral nutrition
5176096|NCT02890862|Kinematics|kinematics
5176097|NCT02890862|Activity of Daily living|activity of daily living
5176098|NCT02890862|3D motion analysis|3d motion analysis
5176099|NCT02890836|Blood pressure|blood pressure
5176100|NCT02890836|Hypertension|hypertension
5176101|NCT02890836|White coat hypertension|white coat hypertension
5780376|NCT00195624|SAA|saa
5176113|NCT02890797|chest ultrasound|chest ultrasound
5176114|NCT02890771|Turmeric|turmeric
5176115|NCT02890771|Chronic periodontitis|chronic periodontitis
5176116|NCT02890758|Natural Killer Cell|natural killer cell
5176117|NCT02890758|ALT-803|alt-803
5176123|NCT02890706|Pulmonary embolism (PE)|pulmonary embolism (pe)
5176124|NCT02890706|Dual-Energy CT (DECT)|dual-energy ct (dect)
5176125|NCT02890706|Subtraction imaging|subtraction imaging
5176126|NCT02890693|gestational diabetes mellitus|gestational diabetes mellitus
5176127|NCT02890693|randomized controlled trial|randomized controlled trial
5176128|NCT02890693|lifestyle intervention|lifestyle intervention
5176129|NCT02890693|cardiovascular|cardiovascular
5176130|NCT02890693|metabolic|metabolic
5176131|NCT02890693|mental health|mental health
5176132|NCT02890693|depression|depression
5176133|NCT02890693|physical activity|physical activity
5176134|NCT02890693|dietary intervention|dietary intervention
5176135|NCT02890680|platelet-rich fibrin|platelet-rich fibrin
5176136|NCT02890680|third molar|third molar
5176137|NCT02890680|bone regeneration|bone regeneration
5176138|NCT02890667|Cancer|cancer
5176139|NCT02890667|incidence|incidence
5176140|NCT02890667|health insurance data|health insurance data
5176141|NCT02890667|algorithms|algorithms
5176142|NCT02890654|Teenagers|teenagers
5176143|NCT02890654|Multidisciplinary approach|multidisciplinary approach
5176144|NCT02890654|Pain|pain
5176145|NCT02890654|Surgery|surgery
5176146|NCT02890641|focal cortical dysplasia|focal cortical dysplasia
5176147|NCT02890641|malformation of cortical development|malformation of cortical development
5176148|NCT02890641|hemimegalencephaly|hemimegalencephaly
5176149|NCT02890628|Thai-Myanmar border|thai-myanmar border
5176152|NCT02890589|Acute coronary syndrome|acute coronary syndrome
5176153|NCT02890589|ST (Software Test) -elevation|st (software test) -elevation
5176154|NCT02890576|cochlear implant|cochlear implant
5176155|NCT02890576|telemedicine|telemedicine
5176156|NCT02890576|new organization of patient monitoring|new organization of patient monitoring
5176157|NCT02890563|Varicose veins|varicose veins
5176158|NCT02890563|Compression stockings|compression stockings
5176159|NCT02890563|Sclerotherapy|sclerotherapy
5176160|NCT02890563|Radiofrequency ablation|radiofrequency ablation
5176161|NCT02890550|Ciliopathy|ciliopathy
5176162|NCT02890550|Retinitis pigmentosa|retinitis pigmentosa
5176163|NCT02890550|ALMS1 gene|alms1 gene
5176164|NCT02890537|Osteonecrosis|osteonecrosis
5176165|NCT02890537|Femoral Head|femoral head
5176166|NCT02890537|Hip|hip
5176167|NCT02890537|Orthopedics|orthopedics
5176168|NCT02890537|Bone|bone
5176169|NCT02890537|Musculoskeletal Disorders|musculoskeletal disorders
5176170|NCT02890524|aphthous stomatitis|aphthous stomatitis
5176171|NCT02890524|night guard|night guard
5176172|NCT02890524|inflammatory cytokine|inflammatory cytokine
5176176|NCT02890446|attentional focus|attentional focus
5176177|NCT02890446|upper extremity|upper extremity
5176179|NCT02890446|stroke|stroke
5176180|NCT02890394|Neck Pain|neck pain
5176181|NCT02890394|Suboccipital inhibition|suboccipital inhibition
5176182|NCT02890394|Physical Therapy|physical therapy
5962202|NCT04282291|Analgesia|analgesia
5049867|NCT03686332|Atezolizumab|atezolizumab
5049868|NCT03686293|Glucose tolerance|glucose tolerance
5049869|NCT03686293|Gut microbiota|gut microbiota
5049870|NCT03686293|Microbial richness|microbial richness
5049871|NCT03686293|Gastric emptying|gastric emptying
5049872|NCT03686293|Metabolomics|metabolomics
5049913|NCT03685929|Tissue|tissue
5176183|NCT02890368|CD47|cd47
5176184|NCT02890368|SIRPa|sirpa
5176185|NCT02890368|Immunotherapy|immunotherapy
5176186|NCT02890368|Checkpoint inhibitor|checkpoint inhibitor
5176187|NCT02890342|Organic Acidemia|organic acidemia
5176188|NCT02890342|Inborn Errors of Metabolism|inborn errors of metabolism
5176189|NCT02890290|Frail Elderly|frail elderly
5176190|NCT02890290|Diet, Food, and Nutrition|diet, food, and nutrition
5176191|NCT02890290|physical function|physical function
5176192|NCT02890290|marine protein hydrolysates|marine protein hydrolysates
5176193|NCT02890290|protein intake|protein intake
5176194|NCT02890290|seafood intake|seafood intake
5176195|NCT02890290|ageing|ageing
5176196|NCT02890290|old|old
5176199|NCT02890264|End stage renal disease|end stage renal disease
5176200|NCT02890264|Dialysis|dialysis
5176201|NCT02890251|Infant|infant
5176202|NCT02890251|Premature|premature
5176203|NCT02890251|Diseases|diseases
5176204|NCT02890238|Sildenafil Citrate|sildenafil citrate
5176205|NCT02890238|Induction of Ovulation|induction of ovulation
5176206|NCT02890238|Pregnancy Rate|pregnancy rate
5176207|NCT02890225|stones|stones
5176208|NCT02890225|external physical vibration lithecbole|external physical vibration lithecbole
5176209|NCT02890212|Major depression, selenium, placebo, sertraline|major depression, selenium, placebo, sertraline
5176210|NCT02890186|narcotrend|narcotrend
5176211|NCT02890186|propofol|propofol
5176212|NCT02890186|remifentanil|remifentanil
5176213|NCT02890186|closed-loop of target controlled infusion|closed-loop of target controlled infusion
5176214|NCT02890173|Essential hypertension|essential hypertension
5176215|NCT02890173|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5176216|NCT02890173|Esaxerenone|esaxerenone
5176217|NCT02890173|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5176218|NCT02890160|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5176219|NCT02890147|SADs|sads
5176220|NCT02890147|Healthy Volunteers|healthy volunteers
5176221|NCT02890147|Molecular profiles|molecular profiles
5176222|NCT02890147|Omics Techniques|omics techniques
5176223|NCT02890134|SADs|sads
5176224|NCT02890134|Molecular Reclassification|molecular reclassification
5176225|NCT02890121|SADs|sads
5176226|NCT02890121|Molecular Reclassification|molecular reclassification
5176227|NCT02890108|High-Intensity Sweeteners|high-intensity sweeteners
5176228|NCT02890108|Non-Nutritive Sweeteners|non-nutritive sweeteners
5176229|NCT02890108|Artificial sweeteners|artificial sweeteners
5176230|NCT02890108|Glucose intolerance|glucose intolerance
5176231|NCT02890082|Breast cancer|breast cancer
5176232|NCT02890082|fertility|fertility
5176233|NCT02890082|chemotherapy|chemotherapy
5176234|NCT02890069|PDR001|pdr001
5176235|NCT02890069|CRC|crc
5176236|NCT02890069|TNBC|tnbc
5176237|NCT02890069|NSCLC|nsclc
5176239|NCT02890069|Immunomodulation|immunomodulation
5176240|NCT02890069|Biomarkers|biomarkers
5176241|NCT02890069|Bayesian logistic regression model|bayesian logistic regression model
5176242|NCT02890056|sugar-sweetened beverage consumption|sugar-sweetened beverage consumption
5176243|NCT02890056|water consumption|water consumption
5176244|NCT02890056|dietary behaviors|dietary behaviors
5176245|NCT02890056|youth|youth
5176246|NCT02890043|spine|spine
5176247|NCT02890043|robot-assisted surgery|robot-assisted surgery
5176248|NCT02890043|pedicle screw|pedicle screw
5176249|NCT02890030|Cisplatin-based therapy|cisplatin-based therapy
5176250|NCT02890030|Ototoxicity|ototoxicity
5176251|NCT02890030|Neurotoxicity|neurotoxicity
5176252|NCT02890017|outpatient surgery|outpatient surgery
5176253|NCT02890017|urology medico-economic|urology medico-economic
5176254|NCT02890017|hotel|hotel
5176255|NCT02890004|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5176256|NCT02890004|Neurointensive care|neurointensive care
5176257|NCT02890004|Observational registry|observational registry
5176258|NCT02889991|Myofascial pain.|myofascial pain.
5176259|NCT02889991|Myofascial trigger point.|myofascial trigger point.
5176260|NCT02889991|Infraspinatus muscle.|infraspinatus muscle.
5176261|NCT02889991|Deep dry needling.|deep dry needling.
5176262|NCT02889991|Local twitch response.|local twitch response.
5176263|NCT02889991|Fascial mechanotransduction.|fascial mechanotransduction.
5176264|NCT02889991|Needle grasp.|needle grasp.
5176265|NCT02889991|Myofascial fibrosis.|myofascial fibrosis.
5176266|NCT02889991|Elastography.|elastography.
5176267|NCT02889978|Cancer Screening|cancer screening
5962203|NCT04282291|Abdominal surgery|abdominal surgery
5962204|NCT04282252|fluid therapy|fluid therapy
5962205|NCT04282226|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
5962206|NCT04282226|functional magnetic resonance imaging|functional magnetic resonance imaging
5962207|NCT04282226|visceral pain|visceral pain
5962208|NCT04282226|oesophageal stimulation|oesophageal stimulation
5962209|NCT04282187|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5962210|NCT04282187|Other Hematopoietic|other hematopoietic
5176268|NCT02889978|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5176269|NCT02889978|Deep Sequencing|deep sequencing
5176270|NCT02889978|Circulating cell-free tumor DNA|circulating cell-free tumor dna
5176271|NCT02889965|Multiple sclerosis|multiple sclerosis
5176272|NCT02889965|Pharmacoepidemiology|pharmacoepidemiology
5176273|NCT02889965|Disease modifying drugs|disease modifying drugs
5176275|NCT02889952|postoperative hypocalcemia|postoperative hypocalcemia
5176276|NCT02889952|near infrared imaging|near infrared imaging
5176277|NCT02889952|parathyroid autofluorescence|parathyroid autofluorescence
5176278|NCT02889939|rehabilitation|rehabilitation
5176279|NCT02889939|recovery of function|recovery of function
5176280|NCT02889939|environment|environment
5176281|NCT02889900|ovarian cancer|ovarian cancer
5176282|NCT02889887|Preterm|preterm
5176283|NCT02889887|Sensory Processing|sensory processing
5176284|NCT02889887|Motor Development|motor development
5176285|NCT02889874|Radiation therapy|radiation therapy
5176286|NCT02889874|omission|omission
5176287|NCT02889874|non-inferiority|non-inferiority
5176288|NCT02889874|breast cancer|breast cancer
5176289|NCT02889861|Uveal melanoma|uveal melanoma
5176290|NCT02889861|Cutaneous melanoma|cutaneous melanoma
5176291|NCT02889835|Class II|class ii
5176292|NCT02889835|molar and premolar|molar and premolar
5176293|NCT02889835|resin composite|resin composite
5176294|NCT02889835|adult|adult
5176300|NCT02889783|urodynamics|urodynamics
5176301|NCT02889783|urethral sensation|urethral sensation
5176302|NCT02889783|urethral pain|urethral pain
5176303|NCT02889757|tuberculosis|tuberculosis
5176304|NCT02889757|acetylcysteine|acetylcysteine
5176305|NCT02889757|hepatotoxicity|hepatotoxicity
5176306|NCT02889744|Temperature|temperature
5176307|NCT02889744|Hypothermia|hypothermia
5176309|NCT02889744|Oxygen|oxygen
5176310|NCT02889744|Prognosis|prognosis
5176311|NCT02889731|Suicide|suicide
5176312|NCT02889731|Heights|heights
5176313|NCT02889731|Suicide hot spots|suicide hot spots
5176314|NCT02889731|Bridges|bridges
5176315|NCT02889705|Ultrasonography|ultrasonography
5176316|NCT02889705|echotexture|echotexture
5176317|NCT02889705|K value|k value
5176318|NCT02889705|SCM muscles|scm muscles
5176319|NCT02889705|CMT infants|cmt infants
5176320|NCT02889692|lung cancer|lung cancer
5176321|NCT02889692|traditional Chinese medicine|traditional chinese medicine
5176322|NCT02889692|maintenance therapy|maintenance therapy
5176323|NCT02889692|targeted therapy|targeted therapy
5176324|NCT02889679|Colonoscopy|colonoscopy
5176325|NCT02889679|Polypectomy|polypectomy
5176326|NCT02889666|relapsed|relapsed
5176327|NCT02889666|non-small cell lung cancer|non-small cell lung cancer
5176328|NCT02889666|cisplatin|cisplatin
5176329|NCT02889666|carboplatin|carboplatin
5176330|NCT02889666|oxaliplatin|oxaliplatin
5176331|NCT02889666|docetaxel|docetaxel
5176332|NCT02889666|gemcitabine|gemcitabine
5176333|NCT02889640|Educational Achievement|educational achievement
5176334|NCT02889640|Individualized Tutoring|individualized tutoring
5176335|NCT02889640|Mathematics|mathematics
5176336|NCT02889640|Academic Mismatch|academic mismatch
5176337|NCT02889640|Achievement Gap|achievement gap
5176338|NCT02889627|Fecal Microbiota Transplantation|fecal microbiota transplantation
5176339|NCT02889627|Gut microbiota|gut microbiota
5176340|NCT02889627|Brain-gut axis|brain-gut axis
5176341|NCT02889627|Epilepsy|epilepsy
5176342|NCT02889588|Refractive Surgery|refractive surgery
5176343|NCT02889588|higher order aberrations|higher order aberrations
5176344|NCT02889562|apixaban|apixaban
5176345|NCT02889562|anticoagulant|anticoagulant
5176346|NCT02889562|CABG|cabg
5176347|NCT02889562|thrombosis|thrombosis
5176348|NCT02889562|fibrillation|fibrillation
5176349|NCT02889536|parastomal hernia|parastomal hernia
5176350|NCT02889536|ostomy|ostomy
5176351|NCT02889536|qualitative|qualitative
5176352|NCT02889536|phenomenological-hermeneutic research|phenomenological-hermeneutic research
5176353|NCT02889536|symptoms|symptoms
5176354|NCT02889536|parastomal bulging|parastomal bulging
5176355|NCT02889523|Front line therapy|front line therapy
5176356|NCT02889523|Age-adjusted International Prognostic Index (aa-IPI) >1|age-adjusted international prognostic index (aa-ipi) >1
5176357|NCT02889523|60 to 80 years|60 to 80 years
5176361|NCT02889497|vaccine|vaccine
5176362|NCT02889497|safety|safety
5176363|NCT02889497|immunogenicity|immunogenicity
5176364|NCT02889458|Chinese|chinese
5176365|NCT02889458|Breast Cancer|breast cancer
5176366|NCT02889458|Women|women
5176367|NCT02889419|Multiple Sclerosis|multiple sclerosis
5176368|NCT02889419|Disability|disability
5176369|NCT02889419|Underwear|underwear
5176370|NCT02889419|Urinary catheter|urinary catheter
5176371|NCT02889419|Self-catheterisation|self-catheterisation
5176372|NCT02889380|Infertility|infertility
5176373|NCT02889380|Cetrotide|cetrotide
5176374|NCT02889380|Assisted reproductive technology (ART)|assisted reproductive technology (art)
5176375|NCT02889341|Docosahexanoic Acid,|docosahexanoic acid,
5176376|NCT02889341|DNA fragmentation|dna fragmentation
5176377|NCT02889341|male fertility|male fertility
5176378|NCT02889341|Sperm parameters improvements|sperm parameters improvements
5176380|NCT02889315|treprostinil|treprostinil
5176382|NCT02889315|implantable device|implantable device
5176383|NCT02889315|quality of life|quality of life
5176384|NCT02889289|traumatic brain injury|traumatic brain injury
5176385|NCT02889289|virtual reality|virtual reality
5176386|NCT02889289|Xbox kinect|xbox kinect
5176387|NCT02889289|balance|balance
5176388|NCT02889250|geriatric|geriatric
5176389|NCT02889250|depression|depression
5176390|NCT02889250|deep brain stimulation|deep brain stimulation
5176391|NCT02889250|subcallosal cingulate|subcallosal cingulate
5176392|NCT02889237|Fracture healing|fracture healing
5176393|NCT02889237|Calcium supplementation|calcium supplementation
5176394|NCT02889237|Vitamin D supplementation|vitamin d supplementation
5176395|NCT02889237|HR-pQCT|hr-pqct
5176396|NCT02889224|Obesity|obesity
5176397|NCT02889224|Cortisol|cortisol
5176398|NCT02889224|Hydrocortisone|hydrocortisone
5176399|NCT02889224|Endocannabinoïds|endocannabinoïds
5176400|NCT02889198|web-based tool|web-based tool
5176401|NCT02889198|child, preschool|child, preschool
5176402|NCT02889198|nutrition|nutrition
5176403|NCT02889198|implementation|implementation
5176404|NCT02889198|child care|child care
5064598|NCT03595293|Treatment Outcome|treatment outcome
5176405|NCT02889185|Optical Coherence Tomography|optical coherence tomography
5176406|NCT02889185|Retinal camera|retinal camera
5176407|NCT02889159|photoaging|photoaging
5176408|NCT02889146|Intensive Care Units|intensive care units
5176409|NCT02889146|Physical Therapy Specialty|physical therapy specialty
5176410|NCT02889146|Critical illness|critical illness
5176411|NCT02889146|Muscle weakness|muscle weakness
5176412|NCT02889146|Bed rest|bed rest
5176413|NCT02889133|Iron deficiency|iron deficiency
5176414|NCT02889133|Transfusion|transfusion
5176415|NCT02889133|Blood donation|blood donation
5176416|NCT02889120|Drug advice by phone|drug advice by phone
5176417|NCT02889120|Teleprescription|teleprescription
5176418|NCT02889120|Medical call centre|medical call centre
5176419|NCT02889120|Out of hours call|out of hours call
5176420|NCT02889081|birth cohort|birth cohort
5176421|NCT02889081|prenatal|prenatal
5176422|NCT02889081|skin barrier|skin barrier
5176423|NCT02889081|atopic dermatitis|atopic dermatitis
5176424|NCT02889081|key nutritional factors|key nutritional factors
5176426|NCT02889016|PANDAS|pandas
5176427|NCT02888951|Diabetes|diabetes
5176428|NCT02888951|Diabetes Mellitus|diabetes mellitus
5176429|NCT02888951|Gastric Ultrasound|gastric ultrasound
5176430|NCT02888951|Preoperative fasting|preoperative fasting
5176431|NCT02888951|Empty Stomach|empty stomach
5176432|NCT02888951|Gastric Diabetes|gastric diabetes
5176433|NCT02888912|glass ionomer cement|glass ionomer cement
5176434|NCT02888912|composite resin|composite resin
5176435|NCT02888886|systemic inflammation|systemic inflammation
5176436|NCT02888873|composite resin|composite resin
5176437|NCT02888873|Clinical trial|clinical trial
5176438|NCT02888873|FDI (World Dental Federation) criteria|fdi (world dental federation) criteria
5176439|NCT02888860|genetic susceptibility|genetic susceptibility
5176440|NCT02888860|candida infection|candida infection
5176441|NCT02888860|colonization|colonization
5176442|NCT02888847|post bleaching teeth sensitivity|post bleaching teeth sensitivity
5176443|NCT02888834|elderly|elderly
5176444|NCT02888834|adverse drug reactions|adverse drug reactions
5176445|NCT02888834|hospitalized subjects|hospitalized subjects
5176446|NCT02888834|community-dwelling|community-dwelling
5176447|NCT02888808|gastroesophageal reflux disease|gastroesophageal reflux disease
5176449|NCT02888808|Nigeria|nigeria
5176450|NCT02888808|obesity|obesity
5176451|NCT02888795|hypertonic dextrose prolotherapy|hypertonic dextrose prolotherapy
5176452|NCT02888795|osteoarthritis|osteoarthritis
5176453|NCT02888769|Coronary artery disease|coronary artery disease
5176454|NCT02888769|Text messages|text messages
5176455|NCT02888769|Blood pressure|blood pressure
5176456|NCT02888769|Lifestyle|lifestyle
5176457|NCT02888769|Risk factors|risk factors
5176458|NCT02888756|Immunotherapy|immunotherapy
5176459|NCT02888756|mRNA|mrna
5176460|NCT02888756|Lentivirus infection|lentivirus infection
5176461|NCT02888756|Virus disease|virus disease
5176462|NCT02888756|Sexually transmitted disease|sexually transmitted disease
5176463|NCT02888756|Immunodeficiency syndrome|immunodeficiency syndrome
5176464|NCT02888730|cystic fibrosis|cystic fibrosis
5176465|NCT02888730|chronic rhinosinusitis|chronic rhinosinusitis
5176466|NCT02888730|Lung Diseases|lung diseases
5176467|NCT02888730|tobramycin|tobramycin
5176468|NCT02888730|nebulized sonic aerosol therapy|nebulized sonic aerosol therapy
5176469|NCT02888704|Atopic dermatitis|atopic dermatitis
5176470|NCT02888704|Mesenchymal stem cells|mesenchymal stem cells
5176471|NCT02888678|ASPIRES|aspires
5176575|NCT02887820|TEG|teg
5176472|NCT02888652|Coronary Heart Disease|coronary heart disease
5176473|NCT02888652|PCI|pci
5176474|NCT02888652|Anti-Platelet Agents|anti-platelet agents
5176475|NCT02888613|mini-lumbotomy|mini-lumbotomy
5176476|NCT02888613|mini-laparotomy|mini-laparotomy
5176477|NCT02888613|retroperitoneal approach|retroperitoneal approach
5176478|NCT02888613|transperitoneal approach|transperitoneal approach
5176479|NCT02888613|abdominal aortic surgery|abdominal aortic surgery
5050226|NCT03683966|Chaperone therapy|chaperone therapy
5050227|NCT03683966|Migalastat|migalastat
5050228|NCT03683966|Pharmacological adherence|pharmacological adherence
5050229|NCT03683953|mesenchymal stem cells|mesenchymal stem cells
5050230|NCT03683953|safety|safety
5050231|NCT03683953|effect|effect
5176480|NCT02888535|primary immunodeficiency|primary immunodeficiency
5176481|NCT02888535|secondary immunodeficiency|secondary immunodeficiency
5176482|NCT02888535|intensive care unit|intensive care unit
5176483|NCT02888535|infection|infection
5176484|NCT02888535|adult|adult
5176485|NCT02888509|depression|depression
5176486|NCT02888509|anxiety disorder|anxiety disorder
5176487|NCT02888509|bipolar disorder|bipolar disorder
5176488|NCT02888509|Magnetic Resonance Imaging|magnetic resonance imaging
5176489|NCT02888483|physical activity|physical activity
5176490|NCT02888483|energy expenditure|energy expenditure
5176491|NCT02888457|nasopharyngeal carriage|nasopharyngeal carriage
5176492|NCT02888457|Streptococcus pneumoniae|streptococcus pneumoniae
5176493|NCT02888457|acute otitis media|acute otitis media
5176494|NCT02888457|day-care centers|day-care centers
5176495|NCT02888431|pH|ph
5176496|NCT02888431|base deficit|base deficit
5176497|NCT02888431|lactate values|lactate values
5176498|NCT02888431|venous blood samples|venous blood samples
5176501|NCT02888418|safety|safety
5176502|NCT02888418|immunogenicity|immunogenicity
5176503|NCT02888405|Body Composition|body composition
5176504|NCT02888366|breast cancer|breast cancer
5176505|NCT02888366|breath test|breath test
5176506|NCT02888366|Menssana|menssana
5176507|NCT02888366|Ancillary|ancillary
5176509|NCT02888366|Rapid Point-of-care|rapid point-of-care
5176510|NCT02888366|Inflatable Bag|inflatable bag
5176511|NCT02888353|Magnetic Resonance Imaging and Pacemakers ICD|magnetic resonance imaging and pacemakers icd
5176512|NCT02888340|Acupuncture|acupuncture
5176513|NCT02888340|Emergency Department|emergency department
5176514|NCT02888340|Pain|pain
5176515|NCT02888314|mHealth|mhealth
5176516|NCT02888314|Pokemon Go|pokemon go
5176517|NCT02888288|adolescent|adolescent
5176518|NCT02888288|adolescence|adolescence
5176519|NCT02888288|HIV/AIDS|hiv/aids
5176520|NCT02888288|mental health|mental health
5176521|NCT02888288|cognitive behavioral therapy|cognitive behavioral therapy
5176522|NCT02888262|Bipolar disorder|bipolar disorder
5176523|NCT02888262|Blood|blood
5176524|NCT02888262|Smartphone|smartphone
5176525|NCT02888262|Brain imaging|brain imaging
5176526|NCT02888262|Cognition|cognition
5176527|NCT02888262|Neuropsychology|neuropsychology
5176528|NCT02888249|Tobacco withdrawal|tobacco withdrawal
5176529|NCT02888249|Autonomic Agents|autonomic agents
5176530|NCT02888236|Psoriasis|psoriasis
5176531|NCT02888080|pulmonary sarcoidosis|pulmonary sarcoidosis
5176532|NCT02888080|sarcoidosis|sarcoidosis
5176533|NCT02888080|canakinumab|canakinumab
5176534|NCT02888080|autoimmune diseases|autoimmune diseases
5176535|NCT02888080|granulomas|granulomas
5176536|NCT02888080|inflammation|inflammation
5176537|NCT02888080|lung function testing|lung function testing
5176538|NCT02888080|immunosuppressive agents|immunosuppressive agents
5176539|NCT02888080|interleukin|interleukin
5176540|NCT02888080|interleukin-1Beta|interleukin-1beta
5176541|NCT02888080|[F-18]FDG-PET/CT|[f-18]fdg-pet/ct
5176542|NCT02888080|respiratory|respiratory
5176543|NCT02888080|pulmonary|pulmonary
5176544|NCT02888080|steroids|steroids
5176545|NCT02888080|corticosteroids|corticosteroids
5176546|NCT02888080|lung diseases|lung diseases
5176548|NCT02888041|Cervical ripening|cervical ripening
5176549|NCT02888041|Pregnancy|pregnancy
5176550|NCT02888041|Vaginal Administration|vaginal administration
5176551|NCT02888028|Remote ICD follow-up|remote icd follow-up
5176552|NCT02888028|HRQoL|hrqol
5176553|NCT02888028|Health related Quality of Life|health related quality of life
5176554|NCT02888028|Depression|depression
5176555|NCT02888028|anxiety|anxiety
5176556|NCT02888028|device acceptance|device acceptance
5176557|NCT02888028|telemedicine|telemedicine
5176558|NCT02888028|telemonitoring|telemonitoring
5176559|NCT02887989|Virtual Reality|virtual reality
5176560|NCT02887989|Non-Opioid Pain Management|non-opioid pain management
5176561|NCT02887976|Prostate Cancer|prostate cancer
5176562|NCT02887976|Castrate Resistant Prostate Cancer (CRPC)|castrate resistant prostate cancer (crpc)
5176563|NCT02887976|metastatic|metastatic
5176564|NCT02887976|castrate resistant|castrate resistant
5176565|NCT02887963|Iron Deficiency|iron deficiency
5176566|NCT02887963|Iron Deficiency Anemia|iron deficiency anemia
5176567|NCT02887963|Pregnant Women|pregnant women
5176568|NCT02887963|Gestation|gestation
5176569|NCT02887963|China|china
5176570|NCT02887963|Epidemiology|epidemiology
5176571|NCT02887872|stroke|stroke
5962211|NCT04282161|Peripheral Vascular Disease|peripheral vascular disease
5962212|NCT04282161|Critical Limb Ischemia|critical limb ischemia
5962213|NCT04282161|Superficial Femoral Artery Stenosis|superficial femoral artery stenosis
5962214|NCT04282161|Atherosclerosis|atherosclerosis
5962215|NCT04282161|Arteriosclerosis|arteriosclerosis
5962216|NCT04282161|Vascular Diseases|vascular diseases
5176572|NCT02887872|upper extremity function|upper extremity function
5176573|NCT02887872|rehabilitation|rehabilitation
5962217|NCT04282161|Arterial Disease Occlusive|arterial disease occlusive
5176574|NCT02887820|ECMO|ecmo
5176576|NCT02887807|Cardiac arrest|cardiac arrest
5176577|NCT02887807|Shockable|shockable
5176578|NCT02887807|Cyclosporine|cyclosporine
5176579|NCT02887794|pitch discrimination|pitch discrimination
5176580|NCT02887794|auditory processing disorders|auditory processing disorders
5176581|NCT02887794|auditory perception|auditory perception
5176582|NCT02887794|auditory-verbal hallucinations|auditory-verbal hallucinations
5176583|NCT02887794|theory of mind|theory of mind
5176584|NCT02887729|Polycystic disease|polycystic disease
5176585|NCT02887703|ataxia|ataxia
5176586|NCT02887703|balance training|balance training
5176587|NCT02887703|vibrotactile biofeedback|vibrotactile biofeedback
5176588|NCT02887703|sensory augmentation|sensory augmentation
5176589|NCT02887703|cerebellar ataxia|cerebellar ataxia
5176590|NCT02887690|MPL|mpl
5176591|NCT02887690|prosthetic limb|prosthetic limb
5176592|NCT02887690|upper extremity|upper extremity
5176593|NCT02887690|prosthesis|prosthesis
5176594|NCT02887677|Dapagliflozin|dapagliflozin
5176595|NCT02887677|Arterial Stiffness|arterial stiffness
5176596|NCT02887677|Aortic Pressure|aortic pressure
5176597|NCT02887651|cerebrale metastases|cerebrale metastases
5176598|NCT02887651|radiotherapy|radiotherapy
5176599|NCT02887651|surgery|surgery
5176600|NCT02887651|complete surgical resection|complete surgical resection
5176601|NCT02887651|resection|resection
5176602|NCT02887651|cavity boost radiation therapy|cavity boost radiation therapy
5176603|NCT02887651|observation|observation
5176604|NCT02887638|posture, sit|posture, sit
5176605|NCT02887586|Auricular Needling|auricular needling
5176606|NCT02887586|Mechanism Study|mechanism study
5176607|NCT02887586|Anorexia|anorexia
5176608|NCT02887586|Cancer|cancer
5176609|NCT02887573|Bowel preparation|bowel preparation
5176610|NCT02887573|Colorectal polyps|colorectal polyps
5176611|NCT02887573|Colon capsule endoscopy|colon capsule endoscopy
5176613|NCT02887560|Pulmonary transplantation|pulmonary transplantation
5176614|NCT02887560|Strain|strain
5176615|NCT02887560|isovolumic acceleration (IVA)|isovolumic acceleration (iva)
5176616|NCT02887495|scleroderma|scleroderma
5176617|NCT02887495|biorepository|biorepository
5176618|NCT02887482|DNA|dna
5176619|NCT02887482|Vaccine|vaccine
5176620|NCT02887469|Hyponatremia|hyponatremia
5176621|NCT02887469|Hypertonic saline|hypertonic saline
5176622|NCT02887469|Treatment|treatment
5176623|NCT02887469|Osmotic demyelination syndrome|osmotic demyelination syndrome
5176624|NCT02887430|foot reflexology|foot reflexology
5176625|NCT02887430|pain intensity|pain intensity
5176626|NCT02887430|health-related quality of life|health-related quality of life
5176627|NCT02887417|platelet activation|platelet activation
5176628|NCT02887391|hemodialysis|hemodialysis
5176629|NCT02887391|nutritional status|nutritional status
5176630|NCT02887378|bronchial biopsy|bronchial biopsy
5176631|NCT02887365|colon cancer|colon cancer
5176632|NCT02887365|MSI-L|msi-l
5176633|NCT02887365|MSS|mss
5176634|NCT02887365|Tegafur-Uracil|tegafur-uracil
5176635|NCT02887365|Low-Level Microsatellite-Instability|low-level microsatellite-instability
5176636|NCT02887339|Informed Consent|informed consent
5176637|NCT02887339|Research donation request|research donation request
5176638|NCT02887339|Effective Communication|effective communication
5176639|NCT02887313|Rectal cancer|rectal cancer
5176640|NCT02887313|Neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
5176641|NCT02887300|Quality of Health Care|quality of health care
5176642|NCT02887300|Psychological Stress|psychological stress
5176643|NCT02887300|Burnout|burnout
5176644|NCT02887300|Health Care Professional|health care professional
5176645|NCT02887300|Mantra Meditation|mantra meditation
5176646|NCT02887300|Health Care Economics|health care economics
5176647|NCT02887274|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5176648|NCT02887274|Sepsis|sepsis
5176649|NCT02887274|Severe Sepsis|severe sepsis
5176650|NCT02887274|Septic shock|septic shock
5176651|NCT02887274|Multiple organ failure|multiple organ failure
5176652|NCT02887261|Power Port|power port
5176653|NCT02887248|nab-paclitaxel|nab-paclitaxel
5176654|NCT02887248|gemcitabine|gemcitabine
5176655|NCT02887222|Epidural|epidural
5176656|NCT02887222|Labor analgesia|labor analgesia
5176657|NCT02887222|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5176658|NCT02887196|Breast Cancer|breast cancer
5176659|NCT02887183|Heart failure|heart failure
5176660|NCT02887183|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
5176661|NCT02887183|HFrEF|hfref
5176662|NCT02887183|NT-proBNP|nt-probnp
5176663|NCT02887183|Cardiac remodeling|cardiac remodeling
5176664|NCT02887183|sacubitril/valsartan|sacubitril/valsartan
5176665|NCT02887183|KCCQ|kccq
5176666|NCT02887183|biomarkers|biomarkers
5176667|NCT02887170|Adolescent|adolescent
5176668|NCT02887170|Lost to contact|lost to contact
5176669|NCT02887170|Recurrence|recurrence
5176670|NCT02887170|Long-term outcome|long-term outcome
5176671|NCT02887131|Subtalar arthritis|subtalar arthritis
5176672|NCT02887131|Subtalar instability|subtalar instability
5176673|NCT02887118|Erythrocytes|erythrocytes
5176674|NCT02887118|Sickle Cell Disease|sickle cell disease
5176675|NCT02887092|health determinants|health determinants
5176676|NCT02887092|epidemiology|epidemiology
5176677|NCT02887092|maintaining autonomy|maintaining autonomy
5176678|NCT02887092|psychology|psychology
5176679|NCT02887092|osteoarthritis|osteoarthritis
5176680|NCT02887092|perceived health|perceived health
5176682|NCT02887053|Healthy subjects|healthy subjects
5176683|NCT02887040|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
5176684|NCT02887040|Antineoplaston therapy|antineoplaston therapy
5176685|NCT02887040|Radiation|radiation
5176686|NCT02887014|bowel preparation|bowel preparation
5176687|NCT02887014|colonoscopy|colonoscopy
5176688|NCT02887014|inpatients|inpatients
5176689|NCT02887014|cathartics|cathartics
5176690|NCT02887001|cost study|cost study
5176691|NCT02887001|clinical pharmacist|clinical pharmacist
5176692|NCT02886988|Botulinum toxin type A, scar|botulinum toxin type a, scar
5176693|NCT02886975|Renal Insufficiency, Chronic|renal insufficiency, chronic
5176694|NCT02886975|Diet, Protein-Restricted|diet, protein-restricted
5176695|NCT02886936|transtibial amputees|transtibial amputees
5176696|NCT02886910|Chorioamnionitis|chorioamnionitis
5176697|NCT02886910|Early onset neonatal sepsis|early onset neonatal sepsis
5176698|NCT02886910|Antibiotics|antibiotics
5780581|NCT00194441|outcome|outcome
5176699|NCT02886910|Clinical observation|clinical observation
5176700|NCT02886897|Refractory solid tumors|refractory solid tumors
5176701|NCT02886897|Dendritic and Cytokine-induced killer cell|dendritic and cytokine-induced killer cell
5176702|NCT02886897|Anti-PD-1 antibody|anti-pd-1 antibody
5176703|NCT02886897|Combination immunotherapy|combination immunotherapy
5176704|NCT02886884|Diabetes|diabetes
5176705|NCT02886884|Endothelial dysfunction|endothelial dysfunction
5176706|NCT02886884|Stem cells|stem cells
5176707|NCT02886858|Depression|depression
5176708|NCT02886858|Moods disorders|moods disorders
5176709|NCT02886858|electroconvulsive therapy|electroconvulsive therapy
5176710|NCT02886845|SNP,Breast Neoplasms|snp,breast neoplasms
5176711|NCT02886832|Prostate Health|prostate health
5176712|NCT02886819|Whole body vibration|whole body vibration
5176713|NCT02886819|Tonic vibration reflex|tonic vibration reflex
5176714|NCT02886819|Bone myoregulation reflex|bone myoregulation reflex
5176716|NCT02886806|remifentanil|remifentanil
5176717|NCT02886806|propofol|propofol
5176718|NCT02886767|skin to skin contact|skin to skin contact
5176719|NCT02886754|Clinical Communication|clinical communication
5176720|NCT02886754|ISBAR|isbar
5176721|NCT02886754|Simulation|simulation
5176722|NCT02886754|Performance|performance
5176723|NCT02886754|Non technical skills|non technical skills
5176724|NCT02886754|Proficiency|proficiency
5176725|NCT02886741|campaign|campaign
5176726|NCT02886741|surgical site infection|surgical site infection
5176727|NCT02886741|orthopedic surgery|orthopedic surgery
5176728|NCT02886741|quality improvement|quality improvement
5176729|NCT02886741|infection control|infection control
5176730|NCT02886650|Paediatrics|paediatrics
5176731|NCT02886650|epilepsy surgery|epilepsy surgery
5176732|NCT02886650|genetic mutation|genetic mutation
5176733|NCT02886650|focal seizures|focal seizures
5176734|NCT02886637|A baumannii infection|a baumannii infection
5176735|NCT02886637|Immunosuppression|immunosuppression
5176736|NCT02886637|prognosis|prognosis
5176737|NCT02886637|immune function|immune function
5176738|NCT02886585|Brain Metastases|brain metastases
5176739|NCT02886559|demethylating agent|demethylating agent
5176740|NCT02886559|chidamide|chidamide
5176741|NCT02886533|Major haemorrhage|major haemorrhage
5176742|NCT02886533|Oral anticoagulation|oral anticoagulation
5176743|NCT02886533|Antiplatelet drugs|antiplatelet drugs
5176744|NCT02886533|Gastrointestinal bleeding|gastrointestinal bleeding
5176745|NCT02886533|Intracranial haemorrhage|intracranial haemorrhage
5176746|NCT02886520|Urinary incontinence|urinary incontinence
5176747|NCT02886520|Materials|materials
5176748|NCT02886520|Surgery|surgery
5176750|NCT02886520|Polyvinylidene fluoride|polyvinylidene fluoride
5176751|NCT02886520|Polypropylene|polypropylene
5176752|NCT02886481|thyroidectomy|thyroidectomy
5064971|NCT03592966|Anthocyanins|anthocyanins
5176753|NCT02886481|Electrophysiologic|electrophysiologic
5176754|NCT02886481|vocal cord movement|vocal cord movement
5176755|NCT02886429|dexmedetomidine|dexmedetomidine
5176756|NCT02886429|bupivacaine|bupivacaine
5176757|NCT02886429|Ultrasound guided paravertebral block|ultrasound guided paravertebral block
5176758|NCT02886429|pain|pain
5176759|NCT02886429|post-thoracotomy|post-thoracotomy
5176760|NCT02886416|HIV infection|hiv infection
5176761|NCT02886390|remote ischemic conditioning|remote ischemic conditioning
5176762|NCT02886390|r-tPA thrombolytic therapy|r-tpa thrombolytic therapy
5176763|NCT02886351|Moderate Sedation|moderate sedation
5176764|NCT02886351|Pediatric Dentistry|pediatric dentistry
5176765|NCT02886351|Anxiety|anxiety
5176766|NCT02886299|Fibrates|fibrates
5176767|NCT02886299|Statins|statins
5176768|NCT02886299|Hemodialysis|hemodialysis
5176769|NCT02886299|Dyslipidemia|dyslipidemia
5176770|NCT02886299|Improved Oxidative Stress|improved oxidative stress
5176771|NCT02886299|Egypt|egypt
5176772|NCT02886273|Sudden Cardiac Arrest|sudden cardiac arrest
5176773|NCT02886273|Out-of-hospital|out-of-hospital
5177279|NCT02882867|Prospective|prospective
5176774|NCT02886273|Ventricular fibrillation|ventricular fibrillation
5176775|NCT02886273|Classification|classification
5176776|NCT02886273|Mechanisms|mechanisms
5176777|NCT02886273|Biomarkers|biomarkers
5176778|NCT02886234|HIV|hiv
5176779|NCT02886234|Mindfulness|mindfulness
5176780|NCT02886234|Adherence behaviors|adherence behaviors
5176781|NCT02886234|Stress|stress
5176782|NCT02886234|Depression|depression
5176783|NCT02886221|Hallux Valgus|hallux valgus
5176784|NCT02886221|Reverdin-Isham Osteotomy|reverdin-isham osteotomy
5176785|NCT02886221|Minimally Invasive Surgery|minimally invasive surgery
5176786|NCT02886221|Percutaneous Distal Osteotomy|percutaneous distal osteotomy
5176787|NCT02886221|First Ray|first ray
5176788|NCT02886221|Forefoot|forefoot
5176789|NCT02886182|chronic hepatitis B|chronic hepatitis b
5176790|NCT02886182|pregnancy|pregnancy
5176791|NCT02886182|Cellular immune response|cellular immune response
5176792|NCT02886182|Clinical implications|clinical implications
5176793|NCT02886169|Sacha Inchi|sacha inchi
5176794|NCT02886169|High-fat meal|high-fat meal
5176795|NCT02886169|Postprandial inflammatory responses|postprandial inflammatory responses
5176796|NCT02886156|OSA|osa
5176810|NCT02886104|resection|resection
5176811|NCT02886104|ablation|ablation
5176813|NCT02886091|Shaving|shaving
5176814|NCT02886091|Ears|ears
5176815|NCT02886091|Cryosurgery|cryosurgery
5176816|NCT02886091|Hypertrophic scars|hypertrophic scars
5176817|NCT02886065|Myeloma|myeloma
5176818|NCT02886052|Cognitive behavior therapy|cognitive behavior therapy
5176819|NCT02886052|Internet treatment|internet treatment
5176820|NCT02886052|Self-help treatment|self-help treatment
5176821|NCT02886052|Insomnia|insomnia
5176822|NCT02886052|ICBT|icbt
5176823|NCT02886052|CBT-i|cbt-i
5176824|NCT02886052|Bereavement|bereavement
5176825|NCT02886039|Cardiorespiratory arrest|cardiorespiratory arrest
5176826|NCT02886039|Neurologic outcome|neurologic outcome
5176827|NCT02886039|Electroencephalogram|electroencephalogram
5176828|NCT02886039|Somatosensory evoked potential|somatosensory evoked potential
5176829|NCT02886039|Synek classification|synek classification
5176830|NCT02886039|Cerebral performance category|cerebral performance category
5176831|NCT02886039|Hypothermia|hypothermia
5176832|NCT02886026|Laser|laser
5176833|NCT02886026|Bladder cancer|bladder cancer
5176834|NCT02886026|Treatment|treatment
5176835|NCT02886026|Outpatient|outpatient
5176836|NCT02886026|TUR-BT|tur-bt
5176837|NCT02886013|prevalence|prevalence
5176838|NCT02885974|Celecoxib|celecoxib
5176839|NCT02885974|Bladder Cancer|bladder cancer
5176840|NCT02885909|type 2 diabetes|type 2 diabetes
5176841|NCT02885909|inpatient|inpatient
5176842|NCT02885909|glucose control|glucose control
5176843|NCT02885909|continue glucose monitor|continue glucose monitor
5176844|NCT02885896|Call center|call center
5176845|NCT02885896|nurses|nurses
5176846|NCT02885896|pediatrics|pediatrics
5176847|NCT02885896|standardized messages|standardized messages
5176848|NCT02885896|family counseling|family counseling
5176849|NCT02885870|biomarker|biomarker
5176850|NCT02885870|spinal cord disease|spinal cord disease
5176851|NCT02885870|resonance imaging|resonance imaging
5176852|NCT02885870|electrophysiology|electrophysiology
5176853|NCT02885831|Abduction splint|abduction splint
5176854|NCT02885831|Pubo-femoral distance|pubo-femoral distance
5176855|NCT02885792|Schizophrenia|schizophrenia
5176856|NCT02885792|Cardiovascular disease|cardiovascular disease
5176857|NCT02885792|Premature mortality|premature mortality
5176858|NCT02885792|Arteriosclerosis|arteriosclerosis
5176859|NCT02885792|Risk factor|risk factor
5176860|NCT02885792|Intervention|intervention
5176861|NCT02885792|Treatment|treatment
5176862|NCT02885792|Somatic morbidity|somatic morbidity
5176873|NCT02885753|colorectal|colorectal
5176874|NCT02885753|cancer|cancer
5176876|NCT02885753|hepatic|hepatic
5176877|NCT02885701|postoperative dressing|postoperative dressing
5176878|NCT02885701|postoperative splint|postoperative splint
5176879|NCT02885701|mini-open carpal tunnel release|mini-open carpal tunnel release
5176880|NCT02885688|Septic Shock|septic shock
5176881|NCT02885688|Sepsis|sepsis
5176882|NCT02885688|Standard of care|standard of care
5176883|NCT02885688|Liquid nutrition|liquid nutrition
5176884|NCT02885688|Metabolic support|metabolic support
5176885|NCT02885688|Enteral nutrition|enteral nutrition
5176886|NCT02885688|Insulin Drip|insulin drip
5176887|NCT02885688|Glucose Drip|glucose drip
5176888|NCT02885662|Primary aldosteronism|primary aldosteronism
5176889|NCT02885662|Hypertension|hypertension
5176890|NCT02885662|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5176891|NCT02885662|Developmental Phase III|developmental phase iii
5176892|NCT02885636|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5176893|NCT02885636|Pulmonary Hypertension|pulmonary hypertension
5176894|NCT02885597|Juanbi Pill|juanbi pill
5176895|NCT02885597|Methotrexate|methotrexate
5176896|NCT02885597|Active|active
5176897|NCT02885597|Rheumatoid Arthritis|rheumatoid arthritis
5176898|NCT02885584|Mechanical ventilation|mechanical ventilation
5176899|NCT02885558|Receptors, Calcium Channel Blocker|receptors, calcium channel blocker
5176900|NCT02885532|alcohol|alcohol
5176901|NCT02885519|Vocational Rehabilitation|vocational rehabilitation
5176902|NCT02885519|Common Mental Disorders|common mental disorders
5176903|NCT02885519|Return to Work|return to work
5176904|NCT02885519|Mental Health Services|mental health services
5176905|NCT02885519|Psychological Stress|psychological stress
5176906|NCT02885519|Adjustment Disorder|adjustment disorder
5176907|NCT02885519|Burnout|burnout
5176908|NCT02885519|Integration|integration
5176909|NCT02885519|Cognitive Behavior Therapy|cognitive behavior therapy
5176911|NCT02885467|Total Knee Arthroplasty|total knee arthroplasty
5176912|NCT02885441|Inflammation|inflammation
5176913|NCT02885389|Infantile spasms|infantile spasms
5176914|NCT02885389|West syndrome|west syndrome
5176915|NCT02885389|variant|variant
5176916|NCT02885389|mutation|mutation
5176918|NCT02885389|sequencing|sequencing
5176919|NCT02885376|Mucositis|mucositis
5176920|NCT02885337|Frail Elderly|frail elderly
5176921|NCT02885337|Arthroplasty|arthroplasty
5176922|NCT02885337|Frailty|frailty
5176923|NCT02885324|High Grade Glioma|high grade glioma
5176924|NCT02885324|Cabozantinib|cabozantinib
5176926|NCT02885324|Children|children
5176927|NCT02885324|AA|aa
5176928|NCT02885311|Drinking|drinking
5176929|NCT02885311|Excessive drinking|excessive drinking
5176930|NCT02885311|Alcohol use disorders|alcohol use disorders
5176931|NCT02885311|Primary Care|primary care
5176932|NCT02885285|Parkinson's disease|parkinson's disease
5176933|NCT02885285|fatigue|fatigue
5176934|NCT02885285|anxiety|anxiety
5176935|NCT02885285|depression|depression
5176936|NCT02885285|exercise|exercise
5176937|NCT02885246|Panama|panama
5176938|NCT02885246|Influenza B|influenza b
5176939|NCT02885246|Influenza A|influenza a
5172166|NCT02916719|MRI|mri
5176940|NCT02885246|Strain circulation|strain circulation
5176942|NCT02885233|Fall Prevention|fall prevention
5176943|NCT02885233|Multiple Sclerosis|multiple sclerosis
5176944|NCT02885233|Web-based education|web-based education
5176945|NCT02885233|Self-efficacy|self-efficacy
5176946|NCT02885207|Limbic encephalitis|limbic encephalitis
5176947|NCT02885207|anti-neuronal antibodies|anti-neuronal antibodies
5176948|NCT02885194|Parkinson Disease|parkinson disease
5176949|NCT02885194|Pain|pain
5176950|NCT02885194|Deep Brain Stimulation|deep brain stimulation
5176951|NCT02885194|Laser-Evoked Potentials|laser-evoked potentials
5176952|NCT02885168|vasoreactivity|vasoreactivity
5176953|NCT02885168|recombinant activated protein C|recombinant activated protein c
5176954|NCT02885116|NHF|nhf
5176955|NCT02885116|pulmonary hypertension|pulmonary hypertension
5176956|NCT02885103|NHF|nhf
5176957|NCT02885103|nasal highflow|nasal highflow
5176958|NCT02885038|Platelet Transfusion|platelet transfusion
5176959|NCT02885025|hypersensitivity|hypersensitivity
5176960|NCT02885025|antioxidants|antioxidants
5176961|NCT02884999|trauma|trauma
5176962|NCT02884999|bleeding|bleeding
5176963|NCT02884999|coagulopathy|coagulopathy
5176964|NCT02884999|guidelines compliance|guidelines compliance
5176965|NCT02884999|recommendation|recommendation
5176966|NCT02884999|transfusion|transfusion
5176967|NCT02884986|Etoricoxib|etoricoxib
5176968|NCT02884986|Spinal anaesthesia|spinal anaesthesia
5176969|NCT02884986|Postoperative pain|postoperative pain
5176970|NCT02884973|congenital heart|congenital heart
5176971|NCT02884973|NIRS|nirs
5176972|NCT02884960|Uterine Fibroids|uterine fibroids
5176973|NCT02884960|Embolization|embolization
5176974|NCT02884947|Brain Neoplasms|brain neoplasms
5176975|NCT02884947|Magnetic Resonance Imaging|magnetic resonance imaging
5176976|NCT02884947|Neurosurgery|neurosurgery
5176977|NCT02884934|venous thromboembolism|venous thromboembolism
5176978|NCT02884934|recurrent venous thromboembolism|recurrent venous thromboembolism
5177105|NCT02884154|Subepithelial tumor|subepithelial tumor
5176979|NCT02884934|anticoagulant-related bleeding|anticoagulant-related bleeding
5176980|NCT02884921|Postoperative pain|postoperative pain
5176981|NCT02884921|Dental treatment|dental treatment
5176982|NCT02884921|Paracetamol|paracetamol
5176983|NCT02884895|Intubating Laryngeal Tube Suction|intubating laryngeal tube suction
5176984|NCT02884895|Blind intubation|blind intubation
5176985|NCT02884882|Stroke Basal Ganglia|stroke basal ganglia
5176986|NCT02884882|Emotional change|emotional change
5176987|NCT02884869|Blind intubation,|blind intubation,
5176988|NCT02884869|Laryngeal Mask Airway|laryngeal mask airway
5176989|NCT02884856|color|color
5176990|NCT02884856|dentistry|dentistry
5176991|NCT02884856|gender|gender
5176992|NCT02884843|Laryngeal Tube|laryngeal tube
5176993|NCT02884843|blind intubation|blind intubation
5176994|NCT02884843|fiberoptic|fiberoptic
5176995|NCT02884804|Postpartum Hemorrhage|postpartum hemorrhage
5176996|NCT02884804|Immature platelet|immature platelet
5176997|NCT02884791|FGF21|fgf21
5176998|NCT02884791|Fibroblast growth factor|fibroblast growth factor
5176999|NCT02884791|fructose|fructose
5177000|NCT02884778|pain|pain
5177001|NCT02884778|monitoring|monitoring
5177002|NCT02884778|anesthesia|anesthesia
5177003|NCT02884765|mandibular condyle|mandibular condyle
5177004|NCT02884765|subcondylar|subcondylar
5177005|NCT02884765|mandible|mandible
5177006|NCT02884765|fracture|fracture
5177007|NCT02884700|Legionella|legionella
5177008|NCT02884700|Legionnaires' disease|legionnaires' disease
5177009|NCT02884700|Diagnosis|diagnosis
5177010|NCT02884700|Prognosis|prognosis
5177011|NCT02884674|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5177012|NCT02884674|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5177013|NCT02884648|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5177014|NCT02884648|Ovarian Cancer|ovarian cancer
5177015|NCT02884648|Fallopian tube cancer|fallopian tube cancer
5177016|NCT02884648|Primary peritoneal cancer|primary peritoneal cancer
5177017|NCT02884648|Bevacizumab|bevacizumab
5177019|NCT02884648|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5177020|NCT02884648|rhuMab-VEGF|rhumab-vegf
5177021|NCT02884635|Methotrexate|methotrexate
5177022|NCT02884635|ASP1707|asp1707
5177023|NCT02884635|Rheumatoid arthritis|rheumatoid arthritis
5177024|NCT02884622|Lung disease|lung disease
5177025|NCT02884622|Epigenetics|epigenetics
5177026|NCT02884622|DNA methylation|dna methylation
5177027|NCT02884622|Modifier genes|modifier genes
5177028|NCT02884596|Inferior alveolar nerve block|inferior alveolar nerve block
5177029|NCT02884596|irreversible pulpitis|irreversible pulpitis
5177030|NCT02884596|selective serotonin reuptake inhibitor antidepressants|selective serotonin reuptake inhibitor antidepressants
5177031|NCT02884583|Food allergy|food allergy
5177032|NCT02884583|asthma|asthma
5177033|NCT02884583|Predictive factor|predictive factor
5177034|NCT02884583|Exacerbation|exacerbation
5177035|NCT02884583|Prevalence|prevalence
5177036|NCT02884570|Tracheotomy|tracheotomy
5177037|NCT02884570|Anxiety|anxiety
5177038|NCT02884570|Depression|depression
5177039|NCT02884570|Back Home|back home
5177040|NCT02884518|dopamine receptor occupancy|dopamine receptor occupancy
5177041|NCT02884518|antipsychotics|antipsychotics
5177042|NCT02884518|positron emission tomography|positron emission tomography
5177043|NCT02884492|inflammation|inflammation
5177044|NCT02884492|aging|aging
5177045|NCT02884492|mild cognitive impairment|mild cognitive impairment
5177046|NCT02884453|gastrooesophageal carcinoma|gastrooesophageal carcinoma
5177047|NCT02884427|Direct current|direct current
5177048|NCT02884427|Dynamometry|dynamometry
5177049|NCT02884427|Hand strength|hand strength
5177050|NCT02884427|Electrotherapy|electrotherapy
5177051|NCT02884427|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5177052|NCT02884414|Knee Pathology|knee pathology
5177053|NCT02884375|Elderly|elderly
5177054|NCT02884375|Cancer|cancer
5177055|NCT02884375|Geriatric assessment|geriatric assessment
5177056|NCT02884375|Treatment|treatment
5177057|NCT02884375|Epidemiology|epidemiology
5177058|NCT02884362|melanoma clinical biological database|melanoma clinical biological database
5177059|NCT02884349|Computer aided orthopaedic surgery|computer aided orthopaedic surgery
5177060|NCT02884349|Implant orientation|implant orientation
5177061|NCT02884349|Range of motion|range of motion
5177062|NCT02884310|Remifentanil|remifentanil
5177063|NCT02884310|Heart Rate Variability|heart rate variability
5177064|NCT02884310|Pupil dilation|pupil dilation
5177065|NCT02884310|SPI|spi
5177066|NCT02884284|breast cancer|breast cancer
5177067|NCT02884284|database|database
5177068|NCT02884271|CPR|cpr
5177069|NCT02884271|cardiac arrest|cardiac arrest
5177070|NCT02884271|operating room|operating room
5177071|NCT02884258|Assisted Reproductive Technology|assisted reproductive technology
5177072|NCT02884258|Obesity|obesity
5177073|NCT02884258|Bariatric Surgery|bariatric surgery
5177074|NCT02884258|Infertility|infertility
5177075|NCT02884258|Fertility Preservation|fertility preservation
5177076|NCT02884245|Fertility|fertility
5177077|NCT02884245|Reproductive processes|reproductive processes
5177078|NCT02884245|In vitro fertilization|in vitro fertilization
5177079|NCT02884245|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5177080|NCT02884245|Estrogens|estrogens
5177081|NCT02884245|Follicule Stimulating Hormon|follicule stimulating hormon
5177082|NCT02884219|Early treatment|early treatment
5177083|NCT02884219|Expectative treatment|expectative treatment
5177084|NCT02884219|Patent ductus arteriosus|patent ductus arteriosus
5177085|NCT02884219|Preterm|preterm
5177086|NCT02884206|heart failure|heart failure
5177087|NCT02884206|cognition|cognition
5177088|NCT02884206|positron emission tomography|positron emission tomography
5177089|NCT02884206|magnetic resonance imaging|magnetic resonance imaging
5177090|NCT02884206|LCZ696|lcz696
5177091|NCT02884206|valsartan|valsartan
5177092|NCT02884206|Chronic heart failure|chronic heart failure
5177093|NCT02884206|CHF|chf
5177094|NCT02884193|Cooling|cooling
5177095|NCT02884193|Cryotherapy|cryotherapy
5177096|NCT02884193|isometric Strength|isometric strength
5177097|NCT02884193|Palmar Grip|palmar grip
5177100|NCT02884180|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5177101|NCT02884180|Revision|revision
5177102|NCT02884154|Endoscopic ultrasonography|endoscopic ultrasonography
5177103|NCT02884154|Biopsy|biopsy
5177104|NCT02884154|Gastrointestinal tract|gastrointestinal tract
5177106|NCT02884141|Renal Artery Obstruction|renal artery obstruction
5177107|NCT02884141|Carotid Artery Diseases|carotid artery diseases
5177108|NCT02884141|Genetic Association Studies|genetic association studies
5177109|NCT02884102|genetic sequencing|genetic sequencing
5177110|NCT02884102|relapsed|relapsed
5177111|NCT02884076|Hemorrhoids|hemorrhoids
5177112|NCT02884076|Sodergren score|sodergren score
5177113|NCT02884076|Validation|validation
5177115|NCT02884063|PGD|pgd
5177116|NCT02884063|free embryo DNA|free embryo dna
5177117|NCT02884063|NGS|ngs
5177118|NCT02884037|NAFLD|nafld
5177119|NCT02884037|Rifaximin|rifaximin
5177120|NCT02884037|Endotoxin and Homeostatic Model Assessment|endotoxin and homeostatic model assessment
5177121|NCT02884024|obesity|obesity
5177122|NCT02884024|inflammation|inflammation
5177123|NCT02884024|cancer risk|cancer risk
5177124|NCT02884011|Chronic antihypertensives|chronic antihypertensives
5177125|NCT02884011|Septic shock|septic shock
5177126|NCT02884011|Vasopressor|vasopressor
5177127|NCT02884011|Vasopressor dosing|vasopressor dosing
5177128|NCT02883998|home-based physical therapy|home-based physical therapy
5177129|NCT02883998|outpatient physical therapy|outpatient physical therapy
5177130|NCT02883998|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5177131|NCT02883998|PT (Physical Therapy)|pt (physical therapy)
5177132|NCT02883998|osteoarthritis|osteoarthritis
5177133|NCT02883972|Immunization|immunization
5177134|NCT02883972|Behavioural insights|behavioural insights
5177135|NCT02883972|Children|children
5177136|NCT02883959|critically ill|critically ill
5177137|NCT02883959|mechanical ventilation|mechanical ventilation
5177138|NCT02883959|pain|pain
5177139|NCT02883959|nursing|nursing
5177140|NCT02883959|music|music
5177141|NCT02883842|Coronary artery disease|coronary artery disease
5177142|NCT02883842|Diabetes|diabetes
5177143|NCT02883842|Text messages|text messages
5177144|NCT02883777|Kidney Transplantation|kidney transplantation
5177145|NCT02883777|Low Glycemic Index|low glycemic index
5177146|NCT02883777|High Protein|high protein
5177147|NCT02883764|eicosapentaenoic acid|eicosapentaenoic acid
5177149|NCT02883764|docosahexaenoic acid|docosahexaenoic acid
5177150|NCT02883764|DHA|dha
5177151|NCT02883764|omega-3 index|omega-3 index
5177152|NCT02883751|diabetes mellitus|diabetes mellitus
5177153|NCT02883751|amputation stumps|amputation stumps
5177154|NCT02883751|diabetic foot|diabetic foot
5177155|NCT02883751|phototherapy|phototherapy
5177156|NCT02883751|clinical trial|clinical trial
5177157|NCT02883725|Esophageal atresia|esophageal atresia
5177158|NCT02883712|epilepsy|epilepsy
5177159|NCT02883712|pharmacoresistant|pharmacoresistant
5177160|NCT02883712|antiepileptic drug|antiepileptic drug
5177161|NCT02883712|pharmacokinetic|pharmacokinetic
5177162|NCT02883712|pharmacodynamic|pharmacodynamic
5177163|NCT02883712|pharmacogenetic|pharmacogenetic
5177164|NCT02883699|Breast cancer|breast cancer
5177165|NCT02883699|Prostate cancer|prostate cancer
5177166|NCT02883699|Exercise prescription|exercise prescription
5177167|NCT02883699|High intensity interval training|high intensity interval training
5177168|NCT02883699|Daily undulating periodization training|daily undulating periodization training
5065445|NCT03590067|pediatric|pediatric
5177169|NCT02883699|Aerobic training|aerobic training
5177170|NCT02883699|Resistance training|resistance training
5177171|NCT02883699|Physical fitness|physical fitness
5177172|NCT02883699|Exercise|exercise
5177173|NCT02883686|Perinatal Depression|perinatal depression
5177174|NCT02883686|Postpartum Depression|postpartum depression
5177175|NCT02883686|Pregnancy|pregnancy
5177176|NCT02883686|Peer-delivered|peer-delivered
5177177|NCT02883686|Task-sharing|task-sharing
5177179|NCT02883660|genetics|genetics
5177180|NCT02883660|Antidepressants|antidepressants
5177181|NCT02883647|chronic hepatitis b, nucleos(t)ide analog|chronic hepatitis b, nucleos(t)ide analog
5177182|NCT02883634|Back pain|back pain
5177183|NCT02883634|spinal manipulation|spinal manipulation
5177184|NCT02883621|upper endoscopy|upper endoscopy
5177185|NCT02883621|cap assisted endoscopy|cap assisted endoscopy
5177186|NCT02883621|esophagus|esophagus
5177187|NCT02883608|Papilla|papilla
5177188|NCT02883608|major duodenal papilla|major duodenal papilla
5177189|NCT02883608|ampulla of vater|ampulla of vater
5177190|NCT02883595|thymosin alpha 1; sepsis; monocyte; pharmacokinetics|thymosin alpha 1; sepsis; monocyte; pharmacokinetics
5177191|NCT02883582|asthma ,hydrogen|asthma ,hydrogen
5177192|NCT02883569|Low back pain|low back pain
5177193|NCT02883569|Intervertebral Disc Degeneration|intervertebral disc degeneration
5177194|NCT02883569|Spinal stenosis|spinal stenosis
5781176|NCT00189579|Paclitaxel|paclitaxel
5177195|NCT02883569|Comparative Effectiveness Research|comparative effectiveness research
5177196|NCT02883569|Cost-Benefit Analysis|cost-benefit analysis
5177197|NCT02883556|Carcinoma|carcinoma
5177198|NCT02883556|Squamous Cell|squamous cell
5177199|NCT02883556|Skin|skin
5177200|NCT02883556|pembrolizumab|pembrolizumab
5177201|NCT02883556|Programmed Cell Death 1 Ligand 1|programmed cell death 1 ligand 1
5177202|NCT02883517|cell-free circulating DNA;|cell-free circulating dna;
5177203|NCT02883517|digital PCR|digital pcr
5177204|NCT02883517|liquid biopsy|liquid biopsy
5177205|NCT02883504|E/e' ratio|e/e' ratio
5177206|NCT02883504|Doppler echocardiography, filling pressure|doppler echocardiography, filling pressure
5177207|NCT02883504|Left Ventricular end-Diastolic Pressure|left ventricular end-diastolic pressure
5177208|NCT02883465|diaphragmatic dysfunction|diaphragmatic dysfunction
5177209|NCT02883465|mechanical ventilation weaning|mechanical ventilation weaning
5177210|NCT02883465|failure extubation rate|failure extubation rate
5177211|NCT02883439|MP29-02|mp29-02
5177212|NCT02883426|H3N2v Influenza Viruses|h3n2v influenza viruses
5177213|NCT02883413|Adolescents|adolescents
5177214|NCT02883413|Cognitive Flexibility|cognitive flexibility
5177215|NCT02883413|Behavioral Flexibility|behavioral flexibility
5177216|NCT02883387|DIEP flap|diep flap
5177217|NCT02883387|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
5177218|NCT02883374|cephalic and cervical adenocystic Carcinoma|cephalic and cervical adenocystic carcinoma
5177219|NCT02883374|Chidamide|chidamide
5177220|NCT02883309|Hemodialysis|hemodialysis
5177221|NCT02883309|Skeletal muscle|skeletal muscle
5177222|NCT02883309|Exercise|exercise
5177223|NCT02883309|Rehabilitation|rehabilitation
5177224|NCT02883309|Disability Evaluation|disability evaluation
5177225|NCT02883257|Major Depression|major depression
5177226|NCT02883257|Major Depressive Disorder|major depressive disorder
5177227|NCT02883257|Persistent Depressive Disorder|persistent depressive disorder
5177228|NCT02883257|Cognitive Behavioral Therapy|cognitive behavioral therapy
5177229|NCT02883257|Biomarkers|biomarkers
5177230|NCT02883218|immunosuppression|immunosuppression
5177231|NCT02883218|community-acquired sepsis|community-acquired sepsis
5177232|NCT02883218|mortality|mortality
5177233|NCT02883192|Cesarean section|cesarean section
5177234|NCT02883192|spinal anesthesia|spinal anesthesia
5177235|NCT02883192|hypotension|hypotension
5177236|NCT02883192|ondansetron|ondansetron
5177237|NCT02883153|Zirconium-89|zirconium-89
5177239|NCT02883153|imaging|imaging
5177240|NCT02883153|girentuximab|girentuximab
5177241|NCT02883140|Sialography|sialography
5177242|NCT02883140|Cone-beam CT|cone-beam ct
5177243|NCT02883140|MRI sialography|mri sialography
5177244|NCT02883140|non tumor salivary symptoms|non tumor salivary symptoms
5177245|NCT02883127|Motivational Interviewing|motivational interviewing
5177247|NCT02883127|Carbohydrates|carbohydrates
5177248|NCT02883127|Psychosocial factors|psychosocial factors
5177249|NCT02883114|PF-06648671|pf-06648671
5177251|NCT02883114|CYP3A|cyp3a
5177252|NCT02883114|drug interaction|drug interaction
5177253|NCT02883088|Optical coherence tomograhpy|optical coherence tomograhpy
5177254|NCT02883088|registry|registry
5177255|NCT02883088|Coronary artery disease|coronary artery disease
5177256|NCT02883036|tigecycline|tigecycline
5177257|NCT02883036|treatment|treatment
5177258|NCT02883036|mitochondrial biogenesis|mitochondrial biogenesis
5177259|NCT02883036|metabolic characteristics|metabolic characteristics
5177260|NCT02883023|Bleomycin|bleomycin
5177261|NCT02883023|Electroporation|electroporation
5177262|NCT02883010|Surgical incision|surgical incision
5177263|NCT02883010|surgical complication|surgical complication
5177264|NCT02883010|NPWT|npwt
5177265|NCT02883010|negative pressure|negative pressure
5177266|NCT02883010|colorectal surgery|colorectal surgery
5177267|NCT02883010|dehisced|dehisced
5177268|NCT02882971|chronic pain|chronic pain
5177269|NCT02882971|rating scale|rating scale
5177270|NCT02882958|Radiology|radiology
5177271|NCT02882932|peritonitis|peritonitis
5177272|NCT02882932|solutions|solutions
5177273|NCT02882932|normal saline|normal saline
5177274|NCT02882932|infection|infection
5177275|NCT02882932|peritoneal lavage|peritoneal lavage
5177276|NCT02882906|Stroke|stroke
5177277|NCT02882906|Pain|pain
5177278|NCT02882906|Shoulder|shoulder
5177280|NCT02882867|Epidemiology|epidemiology
5177281|NCT02882867|Track and Field|track and field
5177282|NCT02882841|AIEC (Adherent and Invasive Escherichia Coli)|aiec (adherent and invasive escherichia coli)
5177283|NCT02882841|Mucosal Healing|mucosal healing
5177284|NCT02882841|Non-invasive biomarkers|non-invasive biomarkers
5177286|NCT02882802|anger|anger
5177287|NCT02882802|aggression|aggression
5177288|NCT02882763|Early intervention|early intervention
5177289|NCT02882763|ECCE|ecce
5177290|NCT02882763|Intervention study|intervention study
5177291|NCT02882763|Child development|child development
5177292|NCT02882763|At-risk families|at-risk families
5177293|NCT02882763|Psychosocial stress|psychosocial stress
5177294|NCT02882763|Prevention|prevention
5177335|NCT02882607|unintended pregnancy|unintended pregnancy
5177336|NCT02882607|Malawi|malawi
5177337|NCT02882607|adolescent women|adolescent women
5177338|NCT02882607|community|community
5177339|NCT02882607|rural|rural
5177340|NCT02882581|Metformin|metformin
5177341|NCT02882581|Pharmacokinetics|pharmacokinetics
5177342|NCT02882581|Organic cation transporter|organic cation transporter
5177343|NCT02882581|Multidrug and toxin extrusion|multidrug and toxin extrusion
5177344|NCT02882581|Pharmacogenetics|pharmacogenetics
5177345|NCT02882581|positron emission tomography|positron emission tomography
5177383|NCT02882503|Radiofrequency ablation|radiofrequency ablation
5177384|NCT02882503|Pancreas|pancreas
5177385|NCT02882490|Tourette syndrome|tourette syndrome
5177386|NCT02882464|gingival recession|gingival recession
5177387|NCT02882464|mucogingival surgery|mucogingival surgery
5177388|NCT02882451|bile duct|bile duct
5177389|NCT02882451|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5177390|NCT02882451|pinaverium bromide|pinaverium bromide
5177391|NCT02882425|selexipag|selexipag
5177392|NCT02882425|bioavailability|bioavailability
5177393|NCT02882412|effectiveness|effectiveness
5177394|NCT02882412|buprenorphine/naloxone|buprenorphine/naloxone
5177395|NCT02882412|iatrogenic opioid dependence|iatrogenic opioid dependence
5177396|NCT02882399|athletes|athletes
5177397|NCT02882334|Focal Dystonia|focal dystonia
5177398|NCT02882334|Writer's cramp|writer's cramp
5177399|NCT02882269|locally advanced colon cancer|locally advanced colon cancer
5177400|NCT02882269|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5177401|NCT02882256|laceration|laceration
5177402|NCT02882256|urinary tract infection|urinary tract infection
5177403|NCT02882256|minor head injury|minor head injury
5177404|NCT02882256|concussion|concussion
5177405|NCT02882217|Double-blind|double-blind
5177406|NCT02882217|Randomized|randomized
5177407|NCT02882217|Dose-escalating|dose-escalating
5177408|NCT02882217|Placebo-controlled|placebo-controlled
5177409|NCT02882217|Phase I|phase i
5177410|NCT02882217|Healthy volunteers|healthy volunteers
5177411|NCT02882217|Bronchial asthma|bronchial asthma
5177412|NCT02882217|Histamine glutarimide|histamine glutarimide
5177413|NCT02882217|EURRUS|eurrus
5177414|NCT02882191|contraception|contraception
5177415|NCT02882178|Prostate cancer|prostate cancer
5177416|NCT02882178|cabazitaxel|cabazitaxel
5177417|NCT02882178|consensus|consensus
5177418|NCT02882178|conformity|conformity
5172548|NCT02914418|Pain|pain
5177420|NCT02882178|conditions of use|conditions of use
5177421|NCT02882165|COPD|copd
5177422|NCT02882165|Early Intervention|early intervention
5177423|NCT02882165|Risk|risk
5177424|NCT02882165|Stratification|stratification
5177425|NCT02882152|Analgesia|analgesia
5177426|NCT02882152|Nerve Block|nerve block
5177427|NCT02882152|Pain, Postoperative|pain, postoperative
5177428|NCT02882139|Electrical storm|electrical storm
5177429|NCT02882126|PAH|pah
5177430|NCT02882126|Subcutaneous Treprostinil|subcutaneous treprostinil
5177431|NCT02882126|Remodulin|remodulin
5177432|NCT02882126|6 Minute Walk Test|6 minute walk test
5177433|NCT02882100|influenza|influenza
5177434|NCT02882100|vaccine|vaccine
5177435|NCT02882100|vaccination|vaccination
5177436|NCT02882100|nursing home|nursing home
5177437|NCT02882100|cluster randomized trial|cluster randomized trial
5177438|NCT02882100|respiratory-related hospitalization|respiratory-related hospitalization
5177439|NCT02882061|neck pain|neck pain
5177440|NCT02882061|physical examination|physical examination
5177441|NCT02882061|thoracic manipulation|thoracic manipulation
5177442|NCT02882048|Opioid addiction|opioid addiction
5177443|NCT02882048|Opioid weaning|opioid weaning
5177444|NCT02882035|pain|pain
5177445|NCT02882035|patient comfort|patient comfort
5177446|NCT02882022|Eustachian tube dysfunction|eustachian tube dysfunction
5177447|NCT02882022|Audiometry|audiometry
5177448|NCT02881996|appendicitis|appendicitis
5177449|NCT02881996|pain|pain
5177450|NCT02881996|perforation|perforation
5177451|NCT02881983|alcohol use disorder|alcohol use disorder
5177452|NCT02881983|emotion processing|emotion processing
5177453|NCT02881983|abstinence|abstinence
5177454|NCT02881983|sympathetic system|sympathetic system
5177455|NCT02881983|parasympathetic system|parasympathetic system
5177456|NCT02881957|critical illness|critical illness
5177457|NCT02881957|craniocerebral trauma|craniocerebral trauma
5177458|NCT02881957|intracranial aneurysm|intracranial aneurysm
5177459|NCT02881957|spinal cord injuries|spinal cord injuries
5177460|NCT02881957|seizures|seizures
5177461|NCT02881957|meningitis|meningitis
5177462|NCT02881957|stroke|stroke
5177463|NCT02881957|vitamin d deficiency|vitamin d deficiency
5177464|NCT02881957|cholecalciferol|cholecalciferol
5177465|NCT02881957|intracranial hemorrhages|intracranial hemorrhages
5177466|NCT02881944|Gulf War Illness|gulf war illness
5177467|NCT02881944|Diet|diet
5177468|NCT02881944|IBS|ibs
5177469|NCT02881944|FODMAP|fodmap
5177470|NCT02881931|Huntington's disease|huntington's disease
5177471|NCT02881931|functional rating scale|functional rating scale
5177472|NCT02881931|cognitive pre-testing|cognitive pre-testing
5177473|NCT02881931|patient reported outcome (PRO)|patient reported outcome (pro)
5177474|NCT02881931|HDGEC participant at Pre-Manifest stage|hdgec participant at pre-manifest stage
5177475|NCT02881931|HDGEC participant at Early-Manifest stage|hdgec participant at early-manifest stage
5177577|NCT02881086|Nelarabine|nelarabine
5177476|NCT02881931|Corresponding HDGEC participant companion|corresponding hdgec participant companion
5177477|NCT02881892|CAPD|capd
5177478|NCT02881892|Peritoneal solute transport rate|peritoneal solute transport rate
5177479|NCT02881892|Dialysis adequacy|dialysis adequacy
5177480|NCT02881866|Air hunger|air hunger
5177481|NCT02881866|Work/effort|work/effort
5177482|NCT02881866|Aerosolized|aerosolized
5177483|NCT02881866|Hypercapnia|hypercapnia
5177484|NCT02881866|Resistive load|resistive load
5177485|NCT02881866|Nebulised|nebulised
5177486|NCT02881853|healthy|healthy
5177487|NCT02881853|atopic|atopic
5177491|NCT02881827|Salivary glands|salivary glands
5177492|NCT02881814|Lung ultrasound|lung ultrasound
5177493|NCT02881814|Chest physiotherapy|chest physiotherapy
5177494|NCT02881814|Decision-making process|decision-making process
5177495|NCT02881814|Diagnostic|diagnostic
5177496|NCT02881801|accelerometry|accelerometry
5177497|NCT02881775|TMS|tms
5177498|NCT02881775|rTMS|rtms
5177499|NCT02881775|corticospinal|corticospinal
5177500|NCT02881775|quadriceps|quadriceps
5177501|NCT02881762|hepatitis C virus (HCV)|hepatitis c virus (hcv)
5177502|NCT02881762|Maraviroc|maraviroc
5177503|NCT02881762|Human immunodeficiency virus (HCV)|human immunodeficiency virus (hcv)
5177504|NCT02881671|genetic|genetic
5177505|NCT02881671|congenital atrioventricular block|congenital atrioventricular block
5177506|NCT02881671|progressive Cardiac Conduction Disease|progressive cardiac conduction disease
5177507|NCT02881658|Plant sterols|plant sterols
5177508|NCT02881658|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5177509|NCT02881658|Phytosterols|phytosterols
5177510|NCT02881658|Soya Beverage|soya beverage
5177511|NCT02881645|Intensive care units|intensive care units
5177512|NCT02881645|Nursing Care|nursing care
5177513|NCT02881645|Critical incidents|critical incidents
5177514|NCT02881645|Best practices|best practices
5177515|NCT02881619|Tooth bleaching|tooth bleaching
5177516|NCT02881593|Operating in Minimally Invasive|operating in minimally invasive
5177517|NCT02881567|Multiple Sclerosis|multiple sclerosis
5177518|NCT02881567|Daclizumab|daclizumab
5177519|NCT02881567|Tysabri-Switch|tysabri-switch
5177520|NCT02881528|Type 1 Diabetes|type 1 diabetes
5177521|NCT02881528|Juvenile Diabetes|juvenile diabetes
5177522|NCT02881502|granulocyte activation|granulocyte activation
5177524|NCT02881502|severe asthma|severe asthma
5177525|NCT02881437|Primary Immunodeficiency|primary immunodeficiency
5177526|NCT02881437|SubCutaneous Immunoglobulins|subcutaneous immunoglobulins
5177527|NCT02881424|Familiarity|familiarity
5177528|NCT02881424|Recollection|recollection
5177529|NCT02881424|Face Recognition|face recognition
5177530|NCT02881424|Alcohol dependence|alcohol dependence
5065789|NCT03588078|Azacitidine|azacitidine
5177531|NCT02881424|Social cognition|social cognition
5177532|NCT02881411|self-soft tissue therapy|self-soft tissue therapy
5177533|NCT02881411|trigger points|trigger points
5177534|NCT02881411|feasibility study|feasibility study
5177535|NCT02881398|Mobile Health|mobile health
5177536|NCT02881398|Telemedicine|telemedicine
5177537|NCT02881398|Pocket-Echocardiography|pocket-echocardiography
5177538|NCT02881385|Synchrony|synchrony
5177539|NCT02881385|Pressure Support Ventilation|pressure support ventilation
5177540|NCT02881372|oral food desensitization|oral food desensitization
5177541|NCT02881372|food elimination|food elimination
5177542|NCT02881372|food reintroduction|food reintroduction
5177543|NCT02881346|Psoriasis vulgaris|psoriasis vulgaris
5177544|NCT02881346|Plaque|plaque
5177545|NCT02881346|Topical|topical
5177546|NCT02881346|Calcipotriol|calcipotriol
5177547|NCT02881346|Foam|foam
5177548|NCT02881346|Spray|spray
5177551|NCT02881255|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5177552|NCT02881255|subcutaneous ICD|subcutaneous icd
5177553|NCT02881255|transvenous ICD|transvenous icd
5177554|NCT02881255|inherited arrhythmia syndrome|inherited arrhythmia syndrome
5177555|NCT02881203|breast cancer|breast cancer
5177556|NCT02881203|radiation|radiation
5177557|NCT02881203|DIBH|dibh
5177558|NCT02881203|cardiac toxicity|cardiac toxicity
5177559|NCT02881177|oxytocin|oxytocin
5177560|NCT02881177|tolerability|tolerability
5177561|NCT02881177|HIV|hiv
5177562|NCT02881177|men who have sex with men (MSM)|men who have sex with men (msm)
5177563|NCT02881177|addiction|addiction
5177564|NCT02881164|Glycemia|glycemia
5177565|NCT02881164|Satiety|satiety
5177566|NCT02881164|Insulin|insulin
5177567|NCT02881164|Breakfast|breakfast
5177568|NCT02881164|Low glycemic index|low glycemic index
5177569|NCT02881164|High glycemic index|high glycemic index
5177570|NCT02881151|Deep brain stimulation|deep brain stimulation
5177571|NCT02881151|DBS|dbs
5177572|NCT02881151|Central thalamus|central thalamus
5177573|NCT02881151|TBI|tbi
5177574|NCT02881151|Traumatic brain injury|traumatic brain injury
5177575|NCT02881086|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5177576|NCT02881086|Lymphoblastic lymphoma|lymphoblastic lymphoma
5177579|NCT02881086|MRD|mrd
5177580|NCT02881086|PEG-Asparaginase|peg-asparaginase
5177581|NCT02881086|Rituximab|rituximab
5177582|NCT02881073|Placental Growth Factor|placental growth factor
5177583|NCT02881073|Maternal Morbidity|maternal morbidity
5177584|NCT02881073|Neonatal Morbidity|neonatal morbidity
5177585|NCT02881073|Pre-eclampsia|pre-eclampsia
5177586|NCT02881073|Heath Economics|heath economics
5177588|NCT02881060|Ethanol|ethanol
5177589|NCT02881034|Anemia|anemia
5177608|NCT02880956|Early dementia|early dementia
5177609|NCT02880956|Tauopathies|tauopathies
5177615|NCT02880917|Attention|attention
5177616|NCT02880917|Memory (short and long-term)|memory (short and long-term)
5177617|NCT02880917|Conflict monitoring tasks|conflict monitoring tasks
5177618|NCT02880917|Verbal fluency|verbal fluency
5177636|NCT02880865|vaccine|vaccine
5177637|NCT02880852|Systemic Lupus Erythematosus|systemic lupus erythematosus
5177638|NCT02880852|Belimumab|belimumab
5177639|NCT02880852|Pharmacodynamics|pharmacodynamics
5177640|NCT02880852|safety tolerability|safety tolerability
5177641|NCT02880852|Pharmacokinetics|pharmacokinetics
5177642|NCT02880852|Chinese subjects|chinese subjects
5177643|NCT02880800|Analgesia, Patient-Controlled|analgesia, patient-controlled
5177644|NCT02880800|Analgesics, Opioid|analgesics, opioid
5177645|NCT02880800|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5177646|NCT02880774|Temporomandibular Joint Disorders|temporomandibular joint disorders
5177647|NCT02880774|Mandibular Movement|mandibular movement
5177648|NCT02880774|Músculoesqueléticas Manipulations|músculoesqueléticas manipulations
5177649|NCT02880774|Modalities of Physiotherapy.|modalities of physiotherapy.
5177650|NCT02880761|hemodialysis|hemodialysis
5177651|NCT02880761|chronic renal failure|chronic renal failure
5177652|NCT02880761|arteriovenous fistulae|arteriovenous fistulae
5177653|NCT02880748|Water exchange colonoscopy|water exchange colonoscopy
5177654|NCT02880748|Adenoma miss rate|adenoma miss rate
5177655|NCT02880748|Polyps|polyps
5177656|NCT02880735|Myotonic Dystrophy|myotonic dystrophy
5177657|NCT02880735|Noninvasive Ventilation|noninvasive ventilation
5177658|NCT02880735|Respiratory Failure|respiratory failure
5177663|NCT02880696|Time Perception|time perception
5177664|NCT02880696|Tactile Perception|tactile perception
5177665|NCT02880696|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5177666|NCT02880683|Electrical Stimulation Therapy|electrical stimulation therapy
5177667|NCT02880683|Parasympathetic Nervous System|parasympathetic nervous system
5177669|NCT02880683|Post Ganglionic|post ganglionic
5177670|NCT02880683|Congestive Heart Failure|congestive heart failure
5177671|NCT02880683|Heart Failure|heart failure
5177672|NCT02880670|Rheumatoid|rheumatoid
5177673|NCT02880657|superoxide dismutase|superoxide dismutase
5177674|NCT02880657|melon concentrate|melon concentrate
5177675|NCT02880657|oxidative stress|oxidative stress
5177676|NCT02880657|physical training|physical training
5177677|NCT02880644|Central retinal vein occlusion|central retinal vein occlusion
5177678|NCT02880644|OCT-A|oct-a
5177679|NCT02880644|CRVO|crvo
5177680|NCT02880540|Adolescent|adolescent
5177681|NCT02880540|Bariatric|bariatric
5177682|NCT02880540|Obesity|obesity
5177683|NCT02880540|Pain|pain
5177684|NCT02880540|Opiate-sparing|opiate-sparing
5177685|NCT02880514|Frontal Sinus|frontal sinus
5177686|NCT02880514|Balloon Dilation|balloon dilation
5177687|NCT02880475|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
5177688|NCT02880462|schizophrenia|schizophrenia
5177689|NCT02880462|sulforaphane|sulforaphane
5177690|NCT02880423|salpingectomy|salpingectomy
5177691|NCT02880423|cesarean section|cesarean section
5177692|NCT02880423|tubal ligation|tubal ligation
5177693|NCT02880423|morbidity|morbidity
5177694|NCT02880410|Glioblastoma|glioblastoma
5177695|NCT02880410|NeuroBlate|neuroblate
5177696|NCT02880410|LITT|litt
5177697|NCT02880410|Quality of Life|quality of life
5177698|NCT02880397|Anti-inflammatory agents, antimicrobials, Periodontitis|anti-inflammatory agents, antimicrobials, periodontitis
5177699|NCT02880371|Advanced Solid Tumors|advanced solid tumors
5177700|NCT02880371|Pembrolizumab|pembrolizumab
5177701|NCT02880371|ARRY-382|arry-382
5177702|NCT02880371|CSF-1R|csf-1r
5177703|NCT02880371|CSF1R|csf1r
5177704|NCT02880371|cfms|cfms
5177705|NCT02880332|Chronic pain|chronic pain
5177706|NCT02880332|Endogenous Pain Processing|endogenous pain processing
5177707|NCT02880332|Central sensitization|central sensitization
5177708|NCT02880332|Pain neuroscience education|pain neuroscience education
5177709|NCT02880319|Bone Cancer|bone cancer
5177710|NCT02880293|transplant conditioning|transplant conditioning
5177711|NCT02880293|KIR/HLA based haploidentical donor selection|kir/hla based haploidentical donor selection
5177712|NCT02880293|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5177713|NCT02880254|body mass index change|body mass index change
5177714|NCT02880254|weight loss|weight loss
5177715|NCT02880254|patient compliance|patient compliance
5177716|NCT02880202|Massage Therapy|massage therapy
5177717|NCT02880202|Hospice|hospice
5177718|NCT02880202|Integrative Medicine|integrative medicine
5177719|NCT02880202|Palliative Care|palliative care
5177720|NCT02880202|Caregivers|caregivers
5177721|NCT02880189|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5177722|NCT02880189|NASH with Fibrosis|nash with fibrosis
5177723|NCT02880189|Intragastric Balloon|intragastric balloon
5177724|NCT02880189|Orbera|orbera
5177725|NCT02880189|Orbera Intragastric Balloon|orbera intragastric balloon
5177726|NCT02880176|Behavioral Economics|behavioral economics
5177727|NCT02880176|Financial Incentives|financial incentives
5177728|NCT02880176|Bladder Cancer|bladder cancer
5177729|NCT02880176|Ambulation|ambulation
5177730|NCT02880176|Surgical Co-Morbidity|surgical co-morbidity
5177731|NCT02880176|Fitbit|fitbit
5177732|NCT02880176|Mobile Health|mobile health
5177733|NCT02880176|Radical Cystectomy|radical cystectomy
5177734|NCT02880150|elite climbers|elite climbers
5177735|NCT02880150|near infrared spectroscopy|near infrared spectroscopy
5177736|NCT02880124|Isotope Labeling, Stable|isotope labeling, stable
5177737|NCT02880124|Exercise, Physical|exercise, physical
5177738|NCT02880124|Calorimetry, Indirect|calorimetry, indirect
5177739|NCT02880124|Athletic Performance|athletic performance
5177740|NCT02880124|Sugar Maple|sugar maple
5177741|NCT02880111|Malignant Brain Tumor|malignant brain tumor
5177742|NCT02880111|patient sputum|patient sputum
5177743|NCT02880098|Neonatology|neonatology
5177744|NCT02880098|Troponin T|troponin t
5177745|NCT02880098|Standards|standards
5177746|NCT02880059|Sleep Apnea, Aneurysm, Subarachnoid Hemorrhage, Blood Pressure.|sleep apnea, aneurysm, subarachnoid hemorrhage, blood pressure.
5177747|NCT02880046|immune response|immune response
5177748|NCT02880046|T lymphocyte|t lymphocyte
5177749|NCT02880046|PD-1/PDL-1 pathway|pd-1/pdl-1 pathway
5177750|NCT02880033|Parkinson's disease|parkinson's disease
5177751|NCT02880033|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5177752|NCT02880033|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
5177753|NCT02880033|ex vivo model for oxidative stress|ex vivo model for oxidative stress
5177754|NCT02880033|iron metabolism and chelation|iron metabolism and chelation
5177755|NCT02880007|Pulsed dose-rate brachytherapy|pulsed dose-rate brachytherapy
5177756|NCT02880007|3D dosimetry|3d dosimetry
5177757|NCT02880007|Prospective Studies|prospective studies
5177758|NCT02880007|Radiotherapy Dosage|radiotherapy dosage
5177759|NCT02880007|Uterine Cervical Neoplasms/radiotherapy|uterine cervical neoplasms/radiotherapy
5177760|NCT02880007|Brachytherapy/methods|brachytherapy/methods
5177761|NCT02879968|serum squamous cell carcinoma antigen|serum squamous cell carcinoma antigen
5177763|NCT02879968|Head and Neck Cancer|head and neck cancer
5177764|NCT02879955|Glucagon-Like Peptide 1|glucagon-like peptide 1
5177765|NCT02879955|Carbohydrates|carbohydrates
5177766|NCT02879955|Gastric bypass|gastric bypass
5177767|NCT02879955|Bariatric Surgery|bariatric surgery
5177768|NCT02879955|Overweight|overweight
5177769|NCT02879942|Placental volume|placental volume
5177770|NCT02879942|First-trimester screening|first-trimester screening
5177771|NCT02879942|Ultrasound|ultrasound
5177772|NCT02879942|Preeclampsia|preeclampsia
5177773|NCT02879942|Intrauterine growth restriction|intrauterine growth restriction
5177774|NCT02879942|Biochemical markers|biochemical markers
5177787|NCT02879864|fatigue|fatigue
5177788|NCT02879864|tiredness|tiredness
5177789|NCT02879864|luxo therapy|luxo therapy
5177790|NCT02879864|therapy by light|therapy by light
5177791|NCT02879851|ultrasound|ultrasound
5177792|NCT02879851|Koelis system|koelis system
5177793|NCT02879851|MRI|mri
5177794|NCT02879851|gold grain|gold grain
5177795|NCT02879825|Ventricular Premature Complexes|ventricular premature complexes
5177796|NCT02879812|Transplantation Surgery|transplantation surgery
5177797|NCT02879812|Nephrology|nephrology
5177798|NCT02879812|Organ and Tissue Transplantation|organ and tissue transplantation
5177799|NCT02879799|Family-centered care|family-centered care
5177800|NCT02879799|Family-integrated care|family-integrated care
5177801|NCT02879799|Neonatal intensive care unit|neonatal intensive care unit
5177803|NCT02879799|Infant|infant
5177804|NCT02879773|Respiratory Function Tests|respiratory function tests
5177805|NCT02879773|Computed tomography|computed tomography
5177806|NCT02879773|Thoracic surgical procedures|thoracic surgical procedures
5177807|NCT02879773|Diagnosis|diagnosis
5177808|NCT02879760|Lung|lung
5177809|NCT02879760|Cancer|cancer
5177810|NCT02879760|Chemotherapy|chemotherapy
5177811|NCT02879760|Oncolytic virus|oncolytic virus
5177812|NCT02879760|Immunotherapy|immunotherapy
5177813|NCT02879760|Pembrolizumab|pembrolizumab
5177814|NCT02879760|Keytruda|keytruda
5177815|NCT02879747|treatment|treatment
5177816|NCT02879747|growth hormone|growth hormone
5177817|NCT02879747|childhood|childhood
5177818|NCT02879747|short stature|short stature
5177819|NCT02879734|peritoneal dialysis|peritoneal dialysis
5177820|NCT02879734|laparoscopy|laparoscopy
5177821|NCT02879734|omentum|omentum
5177822|NCT02879721|Gastrointestinal|gastrointestinal
5177823|NCT02879708|Social Accountability|social accountability
5177824|NCT02879708|Healthcare Quality|healthcare quality
5177825|NCT02879708|Health System Strengthening|health system strengthening
5177826|NCT02879708|Child Health|child health
5177827|NCT02879708|Childhood pneumonia|childhood pneumonia
5177828|NCT02879708|Childhood diarrhea|childhood diarrhea
5177830|NCT02879682|brain metastases|brain metastases
5177831|NCT02879682|nTMS|ntms
5177832|NCT02879630|pharmacokinetics|pharmacokinetics
5177833|NCT02879630|acyclovir|acyclovir
5177834|NCT02879604|cognitive remediation, cost-effectiveness analysis|cognitive remediation, cost-effectiveness analysis
5962218|NCT04282161|lower extremity arterial disease|lower extremity arterial disease
5177835|NCT02879552|Upper blepharoplasty|upper blepharoplasty
5177836|NCT02879552|brassiere sutures|brassiere sutures
5177837|NCT02879552|tarsal platform show|tarsal platform show
5177838|NCT02879552|eyeshadow space|eyeshadow space
5177839|NCT02879552|brow fat span|brow fat span
5177840|NCT02879539|cochlear implants, power consumption,|cochlear implants, power consumption,
5177841|NCT02879526|Relapse/Refratory Peripheral T Cell Lymphoma|relapse/refratory peripheral t cell lymphoma
5177842|NCT02879526|Chidamide|chidamide
5177843|NCT02879526|Cyclophosphamide、Prednisone、Thalidomide(CPT)|cyclophosphamide、prednisone、thalidomide(cpt)
5177855|NCT02879461|SURGERY|surgery
5177856|NCT02879461|REHABILITATION|rehabilitation
5177857|NCT02879448|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5177858|NCT02879448|Left Atrial Appendage|left atrial appendage
5177859|NCT02879409|HbA1c variability|hba1c variability
5177860|NCT02879409|Diabetes Mellitus Type 2|diabetes mellitus type 2
5177861|NCT02879409|Diabetes microvascular complications|diabetes microvascular complications
5177862|NCT02879409|Diabetes macrovascular complications|diabetes macrovascular complications
5177863|NCT02879396|Older adults|older adults
5177864|NCT02879396|Avoidable admissions|avoidable admissions
5177865|NCT02879396|Assisted living home|assisted living home
5177866|NCT02879396|Emergency service calls|emergency service calls
5177867|NCT02879396|Heading Assisted Living Facilities|heading assisted living facilities
5177868|NCT02879383|Type 2 Diabetes, Revita System, DMR|type 2 diabetes, revita system, dmr
5177875|NCT02879357|palliative care|palliative care
5177876|NCT02879331|pulmonary emphysema|pulmonary emphysema
5177877|NCT02879331|coils|coils
5177878|NCT02879331|cycloergometry|cycloergometry
5177879|NCT02879331|lung volume reduction|lung volume reduction
5177887|NCT02879292|Pyloric stenosis spinal anesthesia postoperative pain|pyloric stenosis spinal anesthesia postoperative pain
5177888|NCT02879279|Stroke|stroke
5177889|NCT02879279|Upper limb|upper limb
5177890|NCT02879279|Robotic rehabilitation|robotic rehabilitation
5177891|NCT02879266|Dengue Vaccine|dengue vaccine
5172975|NCT02911064|Surveys|surveys
5177893|NCT02879188|total knee arthroplasty|total knee arthroplasty
5177894|NCT02879188|physical therapy|physical therapy
5177895|NCT02879188|arthroplasty, replacement, knee|arthroplasty, replacement, knee
5177896|NCT02879149|Ankle Fusions|ankle fusions
5177897|NCT02879149|AUGMENT® Bone Graft|augment® bone graft
5177898|NCT02879149|Autologous Bone Graft|autologous bone graft
5177899|NCT02879149|arthritis|arthritis
5177900|NCT02879149|ankle pain|ankle pain
5177901|NCT02879149|foot pain|foot pain
5177902|NCT02879149|hindfoot fracture|hindfoot fracture
5177903|NCT02879149|ankle fracture|ankle fracture
5177904|NCT02879136|Gait|gait
5177905|NCT02879136|Balance|balance
5177907|NCT02879110|Sulforaphane|sulforaphane
5177908|NCT02879110|clinic trial|clinic trial
5177909|NCT02879110|Autism Spectrum Disorder|autism spectrum disorder
5177910|NCT02879110|Efficacy|efficacy
5177911|NCT02879110|Safety|safety
5177912|NCT02879110|Mechanism|mechanism
5177913|NCT02879032|Treadmill Scores|treadmill scores
5177914|NCT02879032|Coronary Angiogram|coronary angiogram
5177915|NCT02879032|Coronary Artery Disease|coronary artery disease
5177916|NCT02879006|Chinese herbal therapy|chinese herbal therapy
5177917|NCT02879006|Oral immunotherapy|oral immunotherapy
5177918|NCT02879006|Food allergy|food allergy
5177919|NCT02879006|Omalizumab|omalizumab
5177920|NCT02878928|Pharmacogenetic testing|pharmacogenetic testing
5177921|NCT02878928|PGx|pgx
5177922|NCT02878928|Depression|depression
5177923|NCT02878928|Neuropsychiatric diseases|neuropsychiatric diseases
5177924|NCT02878928|IDgenetix|idgenetix
5177925|NCT02878928|AltheaDx|altheadx
5177926|NCT02878902|emergency|emergency
5177927|NCT02878902|coordination|coordination
5177928|NCT02878902|dialysis|dialysis
5177929|NCT02878824|Neurophysiology|neurophysiology
5177930|NCT02878824|Autonomic|autonomic
5177931|NCT02878824|Sensory|sensory
5177932|NCT02878824|Child|child
5177933|NCT02878824|Ethnicity|ethnicity
5177934|NCT02878824|Environment|environment
5177935|NCT02878811|heart failure|heart failure
5177936|NCT02878811|prospective|prospective
5177937|NCT02878811|cohort|cohort
5177938|NCT02878785|AML|aml
5177939|NCT02878746|Mirror therapy|mirror therapy
5177940|NCT02878746|Proprioception|proprioception
5177941|NCT02878746|Rehabilitation|rehabilitation
5177942|NCT02878746|Stroke|stroke
5177943|NCT02878746|Hemiplegia|hemiplegia
5177944|NCT02878720|ischemic stroke|ischemic stroke
5177945|NCT02878720|hemorrhagic chronic|hemorrhagic chronic
5177946|NCT02878720|non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
5177947|NCT02878720|robot-assisted rehabilitation|robot-assisted rehabilitation
5177948|NCT02878681|Diabetic Macular Edema.|diabetic macular edema.
5177949|NCT02878668|procalcitonin|procalcitonin
5177950|NCT02878668|post-operative|post-operative
5177951|NCT02878668|complication|complication
5177952|NCT02878668|CRP|crp
5177953|NCT02878655|N0 clinical and radiological|n0 clinical and radiological
5177954|NCT02878655|dissection IIb sector|dissection iib sector
5177955|NCT02878564|Schistosomiasis mansoni|schistosomiasis mansoni
5962219|NCT04282148|De novo native coronary artery long lesions|de novo native coronary artery long lesions
5044653|NCT03720080|OpenAPS|openaps
5177956|NCT02878564|HIV susceptibility|hiv susceptibility
5177957|NCT02878564|Genital immunology|genital immunology
5177958|NCT02878564|Mucosal immunology|mucosal immunology
5177959|NCT02878564|HIV entry assay|hiv entry assay
5177960|NCT02878564|Adult women|adult women
5177961|NCT02878512|Segmental Epidural|segmental epidural
5177962|NCT02878512|Regional Anesthesia for PCNL|regional anesthesia for pcnl
5177963|NCT02878499|autism|autism
5178064|NCT02878005|fiberoptic|fiberoptic
5177964|NCT02878499|autism spectrum disorder|autism spectrum disorder
5177965|NCT02878499|ASD|asd
5177966|NCT02878499|sleep|sleep
5177967|NCT02878499|Circadian|circadian
5177968|NCT02878499|Biological rhythms|biological rhythms
5177969|NCT02878499|melatonin|melatonin
5177970|NCT02878499|Cognition|cognition
5177971|NCT02878499|Behavior|behavior
5177972|NCT02878499|Longitudinal|longitudinal
5177973|NCT02878499|Longitudinal accelerated design|longitudinal accelerated design
5177974|NCT02878486|Physical activity|physical activity
5177975|NCT02878486|Alzheimer's disease|alzheimer's disease
5177976|NCT02878486|cognitive impairment|cognitive impairment
5177977|NCT02878486|sedentary behavior|sedentary behavior
5177978|NCT02878486|insulin sensitivity|insulin sensitivity
5177979|NCT02878460|HYPEROXIA|hyperoxia
5177980|NCT02878460|MECHANICAL VENTILATION|mechanical ventilation
5177981|NCT02878460|OXYGEN RESERVE INDEX|oxygen reserve index
5177982|NCT02878447|Haemoptysis|haemoptysis
5177983|NCT02878447|Radiotherapy|radiotherapy
5177984|NCT02878447|Tuberculosis|tuberculosis
5177985|NCT02878447|Aspergilloma|aspergilloma
5177986|NCT02878447|Bronchiectasis|bronchiectasis
5177987|NCT02878434|Cancer|cancer
5177988|NCT02878434|Fertility|fertility
5177989|NCT02878434|Pregnancy|pregnancy
5177990|NCT02878434|Chemotherapy|chemotherapy
5177991|NCT02878434|Radiotherapy|radiotherapy
5177992|NCT02878434|Long term|long term
5177993|NCT02878434|Follow up|follow up
5177994|NCT02878395|genomics|genomics
5177995|NCT02878395|epigenomics|epigenomics
5177996|NCT02878395|recurrence|recurrence
5177997|NCT02878382|PDT|pdt
5066224|NCT03584893|CTX|ctx
5177998|NCT02878382|skin cancer|skin cancer
5177999|NCT02878382|calcipotriol|calcipotriol
5178000|NCT02878369|fluid replacement|fluid replacement
5178001|NCT02878356|Motivational Interviewing, Clinical supervision, Education|motivational interviewing, clinical supervision, education
5178002|NCT02878330|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
5178003|NCT02878330|Preterm Infants|preterm infants
5178004|NCT02878330|Lower Respiratory Tract Infection|lower respiratory tract infection
5178005|NCT02878317|Glycosylation End Products, Advanced|glycosylation end products, advanced
5178006|NCT02878317|Skin autofluorescence|skin autofluorescence
5178007|NCT02878317|Renal Dialysis|renal dialysis
5178008|NCT02878304|Prognosis|prognosis
5178009|NCT02878304|Hand function|hand function
5178010|NCT02878304|Rehabilitation|rehabilitation
5178011|NCT02878304|Spasticity|spasticity
5178012|NCT02878304|MRI|mri
5178013|NCT02878278|Chidamide|chidamide
5178014|NCT02878278|Administration method|administration method
5178015|NCT02878265|malaria|malaria
5178016|NCT02878265|vitamin A|vitamin a
5178017|NCT02878265|Zinc|zinc
5178018|NCT02878265|Multivitamin|multivitamin
5178019|NCT02878252|COPD, Asthma, ACOS|copd, asthma, acos
5178020|NCT02878239|knee osteoarthritis|knee osteoarthritis
5178021|NCT02878239|gait|gait
5178022|NCT02878239|Kellgren-Lawrence Scores|kellgren-lawrence scores
5178023|NCT02878161|rheumatoid arthritis|rheumatoid arthritis
5178024|NCT02878161|tumor necrosis factor α inhibitor|tumor necrosis factor α inhibitor
5178026|NCT02878161|iTRAQ|itraq
5178027|NCT02878161|signal pathway|signal pathway
5178028|NCT02878148|Nephrolithiasis|nephrolithiasis
5178029|NCT02878148|Ureteral stone|ureteral stone
5178030|NCT02878148|Acute renal colic|acute renal colic
5178031|NCT02878148|Ultrasonography|ultrasonography
5178032|NCT02878148|Computed tomography|computed tomography
5178033|NCT02878148|Diagnosis|diagnosis
5178034|NCT02878122|ovarian cancer|ovarian cancer
5178035|NCT02878122|chemo resistance|chemo resistance
5178036|NCT02878122|predictive factors|predictive factors
5178037|NCT02878122|cohort study|cohort study
5178038|NCT02878122|bio bank|bio bank
5178039|NCT02878109|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5178040|NCT02878109|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5178041|NCT02878096|nocturnal polyuria|nocturnal polyuria
5178042|NCT02878083|vedolizumab,|vedolizumab,
5178043|NCT02878083|confocal endomicroscopy|confocal endomicroscopy
5178044|NCT02878083|biomarker|biomarker
5178045|NCT02878083|ULCERATIVE COLITIS|ulcerative colitis
5178046|NCT02878070|Spinal Cord Injuries|spinal cord injuries
5178047|NCT02878070|Telemedicine|telemedicine
5178048|NCT02878070|Health Behaviors|health behaviors
5178049|NCT02878057|Apatinib|apatinib
5962220|NCT04282148|ABT NG DES 48 EECSS|abt ng des 48 eecss
5178050|NCT02878057|HER-2 Negative|her-2 negative
5178051|NCT02878057|Chest wall Metastasis|chest wall metastasis
5178052|NCT02878057|Multicenter Phase II Study|multicenter phase ii study
5178053|NCT02878057|Breast cancer|breast cancer
5962221|NCT04282148|ABT-CIP-10321|abt-cip-10321
5097259|NCT03390647|E6130|e6130
5178054|NCT02878044|Shared Decision Making, Decision Aid|shared decision making, decision aid
5178055|NCT02878031|Integrated Community Case Management|integrated community case management
5178056|NCT02878031|Community Health Worker|community health worker
5178057|NCT02878031|Nigeria|nigeria
5178058|NCT02878018|Cohort Study|cohort study
5178059|NCT02878018|Children|children
5178060|NCT02878018|Henoch-Schonlein Purpura Nephritis|henoch-schonlein purpura nephritis
5178061|NCT02878018|Traditional Chinese Medicine|traditional chinese medicine
5178062|NCT02878005|Intubating Laryngeal Tube|intubating laryngeal tube
5178063|NCT02878005|blind intubation|blind intubation
5178065|NCT02877992|Infertility|infertility
5178066|NCT02877992|Tachykinin|tachykinin
5178067|NCT02877992|Kisspeptin|kisspeptin
5178068|NCT02877940|ProSeal LMA|proseal lma
5178069|NCT02877940|LTS-D|lts-d
5178070|NCT02877940|i-gel|i-gel
5178071|NCT02877914|heart failure, retrospective|heart failure, retrospective
5178072|NCT02877888|cost effectiveness|cost effectiveness
5178073|NCT02877888|fluoride varnish|fluoride varnish
5178074|NCT02877888|dental caries|dental caries
5178075|NCT02877875|anxiety|anxiety
5178076|NCT02877875|depression|depression
5178077|NCT02877875|trauma|trauma
5178078|NCT02877875|behavior problems|behavior problems
5178079|NCT02877875|evidence-based treatments|evidence-based treatments
5178080|NCT02877875|manualized treatments|manualized treatments
5178081|NCT02877875|cognitive-behavioral therapy|cognitive-behavioral therapy
5178082|NCT02877875|youth|youth
5178083|NCT02877875|mental health|mental health
5178084|NCT02877849|fMRI|fmri
5178085|NCT02877849|brain networks|brain networks
5178086|NCT02877849|biomarker|biomarker
5178087|NCT02877849|relapse|relapse
5178088|NCT02877849|alcohol|alcohol
5178089|NCT02877836|Dystonia|dystonia
5178090|NCT02877836|fMRI|fmri
5178091|NCT02877836|DTI|dti
5178092|NCT02877836|DBS|dbs
5178093|NCT02877823|Pediatric Antipsychotic Treatment|pediatric antipsychotic treatment
5178094|NCT02877823|Pediatric healthy lifestyle intervention|pediatric healthy lifestyle intervention
5178095|NCT02877823|Parent peer support|parent peer support
5178096|NCT02877784|screening|screening
5178097|NCT02877784|OPMD|opmd
5178098|NCT02877784|dysphagia|dysphagia
5178099|NCT02877784|dysarthria|dysarthria
5178100|NCT02877758|cutaneous aging|cutaneous aging
5178101|NCT02877758|skin rejuvenation|skin rejuvenation
5178102|NCT02877758|wrinkles|wrinkles
5178103|NCT02877732|Concussion|concussion
5178104|NCT02877732|Athletes|athletes
5178105|NCT02877732|Eye-tracking|eye-tracking
5178107|NCT02877706|Registry|registry
5178108|NCT02877693|ICD|icd
5178109|NCT02877693|Thoracic MRI Scan|thoracic mri scan
5178110|NCT02877693|tachycardia|tachycardia
5178111|NCT02877680|Strengths-based|strengths-based
5178112|NCT02877680|Mobile Health (mHealth)|mobile health (mhealth)
5178113|NCT02877680|Adolescence|adolescence
5178114|NCT02877680|Resilience|resilience
5178115|NCT02877680|Family|family
5178116|NCT02877667|tattoo|tattoo
5178117|NCT02877667|laser|laser
5178118|NCT02877654|Plasmatic zonulin|plasmatic zonulin
5178119|NCT02877654|Irritable Bowel Syndrome|irritable bowel syndrome
5178120|NCT02877654|Intestinal permeability|intestinal permeability
5178121|NCT02877641|Current Smoker|current smoker
5178122|NCT02877641|Former Smoker|former smoker
5178123|NCT02877628|pharmacokinetic|pharmacokinetic
5178124|NCT02877628|pharmacodynamic|pharmacodynamic
5178125|NCT02877628|tacrolimus|tacrolimus
5178126|NCT02877628|CYP3A5|cyp3a5
5178127|NCT02877628|liver transplantation|liver transplantation
5178128|NCT02877563|peripheral artery disease|peripheral artery disease
5178129|NCT02877563|contrast enhanced ultrasound|contrast enhanced ultrasound
5178130|NCT02877550|untreated Follicular lymphoma|untreated follicular lymphoma
5178131|NCT02877550|non-Hodgkin lymphoma|non-hodgkin lymphoma
5178132|NCT02877550|Obinutuzumab|obinutuzumab
5178133|NCT02877550|Gazyva|gazyva
5178134|NCT02877550|Gazyvaro|gazyvaro
5178135|NCT02877550|Venetoclax|venetoclax
5178136|NCT02877550|Venclexta|venclexta
5178137|NCT02877446|Left ventricular assist device (LVAD)|left ventricular assist device (lvad)
5178138|NCT02877446|Terminal heart failure|terminal heart failure
5178139|NCT02877446|Ventricular assist device (VAD)|ventricular assist device (vad)
5178140|NCT02877433|Small diameter implant|small diameter implant
5178141|NCT02877433|Cross-arch prostheses|cross-arch prostheses
5178142|NCT02877420|Endoscopy|endoscopy
5178143|NCT02877420|Simulation Training|simulation training
5178144|NCT02877420|Non-technical Skills|non-technical skills
5178145|NCT02877381|Tranexamic Acid|tranexamic acid
5178146|NCT02877381|Blood Transfusion|blood transfusion
5178147|NCT02877342|Injury|injury
5178148|NCT02877342|Injuries|injuries
5178149|NCT02877342|Triage|triage
5178150|NCT02877329|psychological effects|psychological effects
5178151|NCT02877290|COPD|copd
5962222|NCT04282148|Coronary artery luminal diameter|coronary artery luminal diameter
5178152|NCT02877290|NIRS|nirs
5178154|NCT02877290|Exercise|exercise
5178155|NCT02877264|Vapendavir|vapendavir
5178156|NCT02877264|Bioavailability|bioavailability
5178157|NCT02877264|Biological Availability|biological availability
5178158|NCT02877264|Volunteers|volunteers
5178159|NCT02877251|Venous Thromboembolism|venous thromboembolism
5178160|NCT02877251|Venous Thrombosis|venous thrombosis
5178161|NCT02877251|Pulmonary Thromboembolism|pulmonary thromboembolism
5178162|NCT02877251|National Registry|national registry
5178163|NCT02877251|Mexico|mexico
5178164|NCT02877251|Major Adverse Cardiovascular Events|major adverse cardiovascular events
5178165|NCT02877238|remote ischemic preconditioning|remote ischemic preconditioning
5178166|NCT02877238|sevoflurane|sevoflurane
5178167|NCT02877238|total intravenous anesthetic|total intravenous anesthetic
5178169|NCT02877212|Eltrombopag|eltrombopag
5178170|NCT02877212|Steroid refractory|steroid refractory
5178171|NCT02877212|Fc Receptor|fc receptor
5178172|NCT02877199|Hepatitis C|hepatitis c
5178178|NCT02877173|Intermittent Claudication|intermittent claudication
5178179|NCT02877121|interstitial lung disease|interstitial lung disease
5178180|NCT02877121|Respiratory Muscle Function|respiratory muscle function
5178181|NCT02877121|Neural Respiratory Drive|neural respiratory drive
5178182|NCT02877056|Colorectal adenocarcinoma|colorectal adenocarcinoma
5178183|NCT02877056|Neoadjuvant therapy|neoadjuvant therapy
5178184|NCT02877056|Endoscopy|endoscopy
5178185|NCT02877056|Endoscopic biopsy|endoscopic biopsy
5178186|NCT02877056|Biomarkers|biomarkers
5178188|NCT02876991|choline positron emission tomography|choline positron emission tomography
5178189|NCT02876991|occult recurrence|occult recurrence
5066416|NCT03583749|pharmacokinetics|pharmacokinetics
5178190|NCT02876991|prostatic adenocarcinoma|prostatic adenocarcinoma
5178191|NCT02876991|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
5178192|NCT02876952|Cardio-respiratory fitness|cardio-respiratory fitness
5178193|NCT02876952|high intensity exercise training|high intensity exercise training
5178194|NCT02876939|Hereditary Sensory Neuropathy|hereditary sensory neuropathy
5178195|NCT02876939|Autonomic Neuropathy|autonomic neuropathy
5178196|NCT02876939|Familial Dysautonomia|familial dysautonomia
5178197|NCT02876939|proprioception|proprioception
5178198|NCT02876939|motor control|motor control
5178199|NCT02876939|sensory nervous system.|sensory nervous system.
5178200|NCT02876939|HSAN III|hsan iii
5178201|NCT02876939|IKBKAP gene mutation|ikbkap gene mutation
5178202|NCT02876926|HIV testing|hiv testing
5178203|NCT02876926|Self-testing|self-testing
5178204|NCT02876926|Counseling|counseling
5178205|NCT02876926|Referral|referral
5178206|NCT02876874|Rheumatoid Arthritis|rheumatoid arthritis
5178207|NCT02876874|lymph nodes morphology|lymph nodes morphology
5178208|NCT02876874|drainage of lymphatic vessels|drainage of lymphatic vessels
5178209|NCT02876861|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5178210|NCT02876861|upper tract urothelial carcinoma|upper tract urothelial carcinoma
5178211|NCT02876848|Administrative Claims, Healthcare|administrative claims, healthcare
5178212|NCT02876848|Aromatase Inhibitors|aromatase inhibitors
5178213|NCT02876848|Breast Neoplasms|breast neoplasms
5178214|NCT02876848|Health Services for the Aged|health services for the aged
5178215|NCT02876848|Medical Informatics Applications|medical informatics applications
5178216|NCT02876848|Medication Adherence|medication adherence
5178217|NCT02876848|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5178218|NCT02876848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
5178219|NCT02876848|Telemedicine|telemedicine
5178227|NCT02876809|centenarians|centenarians
5178228|NCT02876809|geriatric|geriatric
5178229|NCT02876809|telomere length|telomere length
5178230|NCT02876809|progerin|progerin
5178231|NCT02876809|metagenome|metagenome
5178232|NCT02876809|metabolome|metabolome
5178233|NCT02876796|fractional de novo lipogenesis|fractional de novo lipogenesis
5178235|NCT02876796|pharmacodynamic|pharmacodynamic
5178236|NCT02876796|pharmacokinetic|pharmacokinetic
5178237|NCT02876705|Patterns|patterns
5178238|NCT02876705|Pain|pain
5178239|NCT02876705|Cycling|cycling
5178240|NCT02876705|Running|running
5178241|NCT02876705|Exhaustion|exhaustion
5178242|NCT02876679|Hematopoietic Stem Cell|hematopoietic stem cell
5178243|NCT02876679|Transplantation|transplantation
5178244|NCT02876679|Graft vs Host Disease|graft vs host disease
5178245|NCT02876679|Cyclophosphamide|cyclophosphamide
5178246|NCT02876679|Anti-Thymocyte Globulin|anti-thymocyte globulin
5178247|NCT02876679|GVHD prophylaxis|gvhd prophylaxis
5178248|NCT02876666|Spinal Cord Injuries|spinal cord injuries
5178249|NCT02876666|Health Behavior|health behavior
5178250|NCT02876653|Obstructive sleep apnea|obstructive sleep apnea
5178251|NCT02876653|Aging|aging
5178252|NCT02876653|Telomere length|telomere length
5178253|NCT02876614|radionuclide cisternography|radionuclide cisternography
5178254|NCT02876614|CSF leak|csf leak
5178255|NCT02876614|imaging|imaging
5178256|NCT02876601|Coagulation|coagulation
5178257|NCT02876601|Inflammation|inflammation
5178260|NCT02876588|Wrong-Patient Errors|wrong-patient errors
5178261|NCT02876588|Retract-and-Reorder Tool|retract-and-reorder tool
5178262|NCT02876562|Gingival Recession Coverage|gingival recession coverage
5178263|NCT02876549|G6PD|g6pd
5178264|NCT02876549|Primaquine|primaquine
5178265|NCT02876510|Ovarian Cancer|ovarian cancer
5178266|NCT02876510|Esophageal Cancer|esophageal cancer
5178270|NCT02876510|T-cell Therapy|t-cell therapy
5178271|NCT02876510|immunotherapy|immunotherapy
5178272|NCT02876510|adoptive cellular therapy|adoptive cellular therapy
5178273|NCT02876510|T-cell receptor|t-cell receptor
5178274|NCT02876510|cell therapy|cell therapy
5178275|NCT02876510|cytotherapy|cytotherapy
5178276|NCT02876510|IMA101|ima101
5178277|NCT02876510|atezolizumab|atezolizumab
5178278|NCT02876510|Tecentriq|tecentriq
5178279|NCT02876458|Coronary angiogram|coronary angiogram
5178280|NCT02876458|Survival rate|survival rate
5178281|NCT02876458|Neurological sequel|neurological sequel
5178282|NCT02876445|Huntington's disease|huntington's disease
5178283|NCT02876445|Caregiver|caregiver
5178284|NCT02876445|ZARIT burden scale|zarit burden scale
5178285|NCT02876419|nucleic acid polymer REP 2139 HBsAg hepatitis B hepatitis D|nucleic acid polymer rep 2139 hbsag hepatitis b hepatitis d
5178286|NCT02876367|Epidemiology|epidemiology
5178287|NCT02876354|Hemodialysis|hemodialysis
5178288|NCT02876354|Vitamin k2|vitamin k2
5178289|NCT02876354|Vascular calcifications|vascular calcifications
5178290|NCT02876341|Chronic antihypertensives|chronic antihypertensives
5178291|NCT02876341|New onset atrial fibrillation|new onset atrial fibrillation
5178292|NCT02876341|Septic shock|septic shock
5178294|NCT02876315|innate immunity|innate immunity
5178295|NCT02876315|elderly adults|elderly adults
5178296|NCT02876315|multivitamin supplement|multivitamin supplement
5178297|NCT02876315|vitamin D|vitamin d
5178298|NCT02876315|vitamin C|vitamin c
5178299|NCT02876315|zinc|zinc
5178303|NCT02876263|aortic diseases|aortic diseases
5178304|NCT02876263|aortic aneurysm|aortic aneurysm
5178305|NCT02876263|electroencephalography|electroencephalography
5178306|NCT02876263|Near-Infrared spectroscopy|near-infrared spectroscopy
5178307|NCT02876263|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
5178308|NCT02876263|Cardiopulmonary arrest|cardiopulmonary arrest
5178309|NCT02876263|Hypothermia, Induced|hypothermia, induced
5178310|NCT02876250|Lung transplantation|lung transplantation
5178311|NCT02876250|Cyclosporine|cyclosporine
5178312|NCT02876250|Postconditioning|postconditioning
5178313|NCT02876211|Renal disease|renal disease
5178314|NCT02876211|Erythropoiesis|erythropoiesis
5178315|NCT02876211|Erythropoietin stimulating agent|erythropoietin stimulating agent
5178316|NCT02876211|Iron|iron
5178317|NCT02876211|Klotho|klotho
5178319|NCT02876198|Retinal neovascularization|retinal neovascularization
5178320|NCT02876198|Anti-VEGF|anti-vegf
5178321|NCT02876198|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
5178322|NCT02876185|Glaucoma surveillance|glaucoma surveillance
5178323|NCT02876185|Orthoptist|orthoptist
5178324|NCT02876172|PTSD|ptsd
5178325|NCT02876172|psychotherapy|psychotherapy
5178326|NCT02876172|MDMA|mdma
5178327|NCT02876172|dyad|dyad
5178328|NCT02876172|cognitive behavioral therapy|cognitive behavioral therapy
5178329|NCT02876159|Vaccination|vaccination
5178330|NCT02876146|Albendazole|albendazole
5178331|NCT02876146|Benzimidazole|benzimidazole
5178332|NCT02876146|Echinococcus multilocularis|echinococcus multilocularis
5178333|NCT02876146|Alveolar echinococcosis|alveolar echinococcosis
5178334|NCT02876146|Liver Diseases|liver diseases
5178335|NCT02876055|Nerve Block/methods|nerve block/methods
5178336|NCT02876055|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
5178337|NCT02876055|Anesthetics, Local/administration & dosage|anesthetics, local/administration & dosage
5178338|NCT02876055|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
5178339|NCT02876055|Shoulder Pain/prevention & control|shoulder pain/prevention & control
5178340|NCT02875938|left middle cerebral artery|left middle cerebral artery
5178341|NCT02875938|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
5178342|NCT02875938|stroke|stroke
5178343|NCT02875925|blood coagulation|blood coagulation
5178344|NCT02875912|Family|family
5178345|NCT02875912|Care Rituals|care rituals
5178346|NCT02875912|End of Life|end of life
5178347|NCT02875912|Discordance of care|discordance of care
5178348|NCT02875860|CDH|cdh
5178349|NCT02875860|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5178350|NCT02875860|Fetal Tracheal Occlusion|fetal tracheal occlusion
5178351|NCT02875860|FETO|feto
5178352|NCT02875860|plug-unplug|plug-unplug
5178353|NCT02875860|GoldBal2|goldbal2
5178354|NCT02875860|Balloon|balloon
5178355|NCT02875860|Goldvalve Balloon|goldvalve balloon
5178356|NCT02875860|TOTAL|total
5178357|NCT02875795|linguistic|linguistic
5178358|NCT02875795|quality of life|quality of life
5178359|NCT02875782|Smoking Cessation|smoking cessation
5178360|NCT02875769|cetylpyridinium chloride|cetylpyridinium chloride
5256120|NCT02411760|MRI|mri
5178361|NCT02875769|chlorhexidine|chlorhexidine
5178362|NCT02875769|oral aerosol|oral aerosol
5178363|NCT02875769|oral splatter|oral splatter
5178364|NCT02875769|mouthwash|mouthwash
5178365|NCT02875769|microbiology|microbiology
5178366|NCT02875704|DR|dr
5178367|NCT02875704|AMD|amd
5178368|NCT02875691|disease activity|disease activity
5178369|NCT02875652|circulation tumor DNA|circulation tumor dna
5178370|NCT02875652|choroidal melanoma|choroidal melanoma
5178371|NCT02875639|Ischemic Heart Failure|ischemic heart failure
5178372|NCT02875639|coronary artery disease|coronary artery disease
5178373|NCT02875639|qi deficiency and blood stasis|qi deficiency and blood stasis
5178374|NCT02875613|Nasopharyngeal|nasopharyngeal
5178375|NCT02875613|PD-L1|pd-l1
5178376|NCT02875613|monoclonal antibody|monoclonal antibody
5178377|NCT02875613|Epstein-barr virus|epstein-barr virus
5178378|NCT02875600|chronic gastro-intestinal ischemia|chronic gastro-intestinal ischemia
5178379|NCT02875600|oxygen deficiency of the gastro-intestinal tract|oxygen deficiency of the gastro-intestinal tract
5178380|NCT02875587|OHSS|ohss
5178381|NCT02875587|Infertility|infertility
5178382|NCT02875587|Cabergoline|cabergoline
5178383|NCT02875587|Calcium gluconate|calcium gluconate
5178384|NCT02875587|IVF-ET|ivf-et
5178385|NCT02875574|Isoniazid|isoniazid
5178386|NCT02875574|Drug Resistance|drug resistance
5178387|NCT02875535|Evidence-based|evidence-based
5178388|NCT02875535|lesbian, gay, bisexual, transgender, intersex, and queer|lesbian, gay, bisexual, transgender, intersex, and queer
5178389|NCT02875535|adolescent|adolescent
5178390|NCT02875535|Suicide prevention|suicide prevention
5178391|NCT02875535|Implementation study|implementation study
5178392|NCT02875522|COPD|copd
5178393|NCT02875522|Exercise Training|exercise training
5178394|NCT02875522|Flow-Mediated Dilation|flow-mediated dilation
5178395|NCT02875522|Arterial Stiffness|arterial stiffness
5178396|NCT02875522|Echocardiography|echocardiography
5178397|NCT02875522|Cerebrovascular Physiology|cerebrovascular physiology
5178398|NCT02875470|non-surgical periodontal debridement|non-surgical periodontal debridement
5178399|NCT02875470|root planing/instrumentation|root planing/instrumentation
5178400|NCT02875470|cytokine(s)|cytokine(s)
5178401|NCT02875470|dental plaque|dental plaque
5178402|NCT02875470|microscopy, electron, scanning|microscopy, electron, scanning
5178403|NCT02875457|small cell lung cancer; apatinib; etoposide; cisplatin|small cell lung cancer; apatinib; etoposide; cisplatin
5178404|NCT02875405|postoperative|postoperative
5178405|NCT02875405|pericardiotomy|pericardiotomy
5178406|NCT02875405|prevention|prevention
5178407|NCT02875405|cardiac surgery|cardiac surgery
5178408|NCT02875405|left|left
5178409|NCT02875405|posterior|posterior
5178410|NCT02875379|Noninvasive Ventilation|noninvasive ventilation
5178411|NCT02875379|Mechanical Ventilation|mechanical ventilation
5178414|NCT02875353|Stigmata of recent hemorrhage|stigmata of recent hemorrhage
5178415|NCT02875327|SEER|seer
5178416|NCT02875327|Medicaid|medicaid
5178417|NCT02875327|Cancer|cancer
5178418|NCT02875327|Health Services Research|health services research
5178419|NCT02875327|Epidemiology|epidemiology
5178420|NCT02875301|Exercise|exercise
5178421|NCT02875301|Brain Health|brain health
5178422|NCT02875301|Dose Response|dose response
5178423|NCT02875301|Cognition|cognition
5178424|NCT02875262|intracranial aneurysm|intracranial aneurysm
5178425|NCT02875262|subarachnoid hemorrhage|subarachnoid hemorrhage
5178426|NCT02875262|stroke|stroke
5178427|NCT02875262|chelator|chelator
5178428|NCT02875249|post-antibiotic diarrhea|post-antibiotic diarrhea
5178429|NCT02875249|intestinal microbiome|intestinal microbiome
5178430|NCT02875223|Safety|safety
5178431|NCT02875223|CC-90011|cc-90011
5178432|NCT02875223|Advanced unresectable solid Tumors|advanced unresectable solid tumors
5178433|NCT02875223|R/R Non-Hodgkin's Lymphomas|r/r non-hodgkin's lymphomas
5178434|NCT02875210|Anterior Cruciate Ligament|anterior cruciate ligament
5178435|NCT02875210|A02.835.583.512.100|a02.835.583.512.100
5178436|NCT02875197|Kinetics|kinetics
5178437|NCT02875197|Biomechanics|biomechanics
5178438|NCT02875197|Amputation|amputation
5178439|NCT02875197|Prosthesis|prosthesis
5178440|NCT02875197|Transtibial|transtibial
5178441|NCT02875184|Psoriatic Arthritis|psoriatic arthritis
5178442|NCT02875184|Apremilast|apremilast
5178443|NCT02875184|CC-10004|cc-10004
5178444|NCT02875171|Anthracyclines; Cardiotoxicity; 2-D Echocardiography|anthracyclines; cardiotoxicity; 2-d echocardiography
5178445|NCT02875145|Corneal Transplantation|corneal transplantation
5178446|NCT02875145|Graft Survival|graft survival
5178447|NCT02875106|Sinus rhythm|sinus rhythm
5178448|NCT02875041|rehabilitation|rehabilitation
5178449|NCT02875041|balance|balance
5178450|NCT02875028|Coagulations|coagulations
5178451|NCT02875028|Platelets|platelets
5178452|NCT02875028|Inflammation|inflammation
5178453|NCT02875028|endotoxemia|endotoxemia
5178454|NCT02875028|vorapaxar|vorapaxar
5178455|NCT02875015|Anesthetics|anesthetics
5178456|NCT02875015|Anesthetic Effects|anesthetic effects
5178457|NCT02875015|Mid-urethral sling|mid-urethral sling
5178458|NCT02874976|sedentary lifestyle|sedentary lifestyle
5178459|NCT02874963|Diabetes|diabetes
5178460|NCT02874963|Oral Hygiene|oral hygiene
5178461|NCT02874963|Periodontal Surgery|periodontal surgery
5178462|NCT02874963|Periodontal Medicine|periodontal medicine
5178463|NCT02874950|Exercise|exercise
5178464|NCT02874937|Syncope|syncope
5178465|NCT02874937|Vasovagal|vasovagal
5178466|NCT02874937|Atomoxetine|atomoxetine
5178467|NCT02874924|Geriatrics|geriatrics
5178468|NCT02874911|Exergaming|exergaming
5178469|NCT02874911|Neurodegenerative diseases|neurodegenerative diseases
5178470|NCT02874911|Rare disease|rare disease
5178471|NCT02874911|Motor exercises|motor exercises
5052721|NCT03669133|Vitamin E|vitamin e
5052325|NCT03671434|Dissemination|dissemination
5052326|NCT03671434|Policy Training|policy training
5052327|NCT03671434|Collaboration|collaboration
5052328|NCT03671421|Graft choice|graft choice
5178472|NCT02874911|Training|training
5178473|NCT02874911|Spinocerebellar ataxia|spinocerebellar ataxia
5178474|NCT02874885|Locally-advanced rectal cancer|locally-advanced rectal cancer
5178475|NCT02874885|LARC|larc
5178476|NCT02874885|Colorectal cancer|colorectal cancer
5178478|NCT02874885|Rectosigmoid cancer|rectosigmoid cancer
5178479|NCT02874885|No known diagnosis of colorectal cancer|no known diagnosis of colorectal cancer
5178480|NCT02874885|Blood draws|blood draws
5178481|NCT02874885|Blood samples|blood samples
5178482|NCT02874885|Circulating tumor cells (CTC)|circulating tumor cells (ctc)
5178483|NCT02874885|CTC|ctc
5178484|NCT02874872|Nursing homes|nursing homes
5178485|NCT02874872|Antibiotic Stewardship|antibiotic stewardship
5178486|NCT02874872|Antibiotic Resistance|antibiotic resistance
5178487|NCT02874859|DIABETIC RETINOPATHY|diabetic retinopathy
5178488|NCT02874859|Intravitreal aflibercept|intravitreal aflibercept
5178489|NCT02874833|Depression|depression
5178490|NCT02874833|Unipolar depression|unipolar depression
5178491|NCT02874833|Bipolar affective disorder|bipolar affective disorder
5178492|NCT02874833|Exercise|exercise
5178493|NCT02874833|Internet-based intervention|internet-based intervention
5178494|NCT02874820|Imidazoline Receptor 2|imidazoline receptor 2
5178495|NCT02874820|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
5178496|NCT02874820|BU99008|bu99008
5178497|NCT02874820|[11C]-BU99008|[11c]-bu99008
5178498|NCT02874820|Radionuclide Imaging|radionuclide imaging
5178499|NCT02874820|Molecular Imaging|molecular imaging
5178500|NCT02874807|Hyponatremia|hyponatremia
5178501|NCT02874807|SGLT2 inhibitor|sglt2 inhibitor
5178502|NCT02874794|Heart Failure|heart failure
5178503|NCT02874794|Reduced Ejection Fraction|reduced ejection fraction
5178504|NCT02874794|Central Aortic Stiffness|central aortic stiffness
5178505|NCT02874794|Vascular|vascular
5178506|NCT02874794|Echocardiogram|echocardiogram
5178507|NCT02874794|Aortic Stiffness|aortic stiffness
5178508|NCT02874755|Quality of Care|quality of care
5178509|NCT02874755|Standardized Patients|standardized patients
5178511|NCT02874729|Biological Assay|biological assay
5178512|NCT02874716|Quality of Care|quality of care
5178513|NCT02874716|Standardized Patients|standardized patients
5178514|NCT02874677|Multiple sclerosis|multiple sclerosis
5178515|NCT02874677|Ventilatory threshold|ventilatory threshold
5178516|NCT02874677|Effort Reeducation|effort reeducation
5178517|NCT02874651|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5178518|NCT02874651|EB Virus|eb virus
5178519|NCT02874651|DNA|dna
5178520|NCT02874651|vascular endothecial growth factor receptor inhibitor|vascular endothecial growth factor receptor inhibitor
5178521|NCT02874651|Apatinib|apatinib
5178522|NCT02874612|Young Adults|young adults
5178523|NCT02874612|Psychosocial Functioning|psychosocial functioning
5178524|NCT02874573|Inflammation|inflammation
5178525|NCT02874573|Schizophrenia|schizophrenia
5178526|NCT02874560|CNS|cns
5178527|NCT02874560|Antipsychotic|antipsychotic
5178528|NCT02874560|Functional remission|functional remission
5178529|NCT02874560|Observational study|observational study
5178530|NCT02874560|FROGS|frogs
5178531|NCT02874560|PSP|psp
5178532|NCT02874560|Functioning|functioning
5178533|NCT02874560|Schizophrenia|schizophrenia
5178534|NCT02874508|leukocyte subpopulations|leukocyte subpopulations
5178535|NCT02874508|perioperative myocardial infarction|perioperative myocardial infarction
5178536|NCT02874508|non-cardiac surgery|non-cardiac surgery
5178537|NCT02874508|perioperative cardiovascular risk|perioperative cardiovascular risk
5178538|NCT02874495|Crohn's disease|crohn's disease
5178539|NCT02874495|Rectal Distension|rectal distension
5178541|NCT02874495|Anticipation|anticipation
5178542|NCT02874495|Painful|painful
5178543|NCT02874482|Schizophrenia|schizophrenia
5178544|NCT02874482|Change blindness|change blindness
5178545|NCT02874482|Eye tracking|eye tracking
5178546|NCT02874482|Implicit response|implicit response
5178547|NCT02874469|sudden death|sudden death
5178548|NCT02874469|post-traumatic stress disorder|post-traumatic stress disorder
5178549|NCT02874469|psychological distress|psychological distress
5178550|NCT02874469|diary|diary
5178551|NCT02874469|resuscitation|resuscitation
5178552|NCT02874456|Zyca virus|zyca virus
5178553|NCT02874352|intensive care|intensive care
5178554|NCT02874352|tracheostomy|tracheostomy
5178555|NCT02874339|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
5178556|NCT02874339|Respiratory failure|respiratory failure
5178557|NCT02874339|Hypercapnia|hypercapnia
5178558|NCT02874339|High flow nasal oxygen|high flow nasal oxygen
5178559|NCT02874339|Non invasive ventilation|non invasive ventilation
5178560|NCT02874339|Emergency department|emergency department
5178561|NCT02874326|Sandostatin LAR|sandostatin lar
5962223|NCT04282122|breast cancer|breast cancer
5962224|NCT04282122|oncology|oncology
5962225|NCT04282122|database|database
5962226|NCT04282122|radiotherapy|radiotherapy
5962227|NCT04282109|Head and neck cancer|head and neck cancer
5962228|NCT04282109|Squamous cell carcinoma|squamous cell carcinoma
5178562|NCT02874326|Somatostatin|somatostatin
5178563|NCT02874326|Octreotide|octreotide
5178564|NCT02874313|CPAP|cpap
5178565|NCT02874313|Sleep apnea|sleep apnea
5178566|NCT02874313|Diabetes|diabetes
5178567|NCT02874313|Diabetic retinopathy|diabetic retinopathy
5178568|NCT02874287|Coronary Artery Disease|coronary artery disease
5178569|NCT02874287|Hydroxychloroquine|hydroxychloroquine
5178570|NCT02874274|Corticobasal syndrome|corticobasal syndrome
5178571|NCT02874274|Dementia with Lewy Bodies|dementia with lewy bodies
5066882|NCT03580811|Alloderm|alloderm
5178572|NCT02874274|Home Visit Program (HVP)|home visit program (hvp)
5178573|NCT02874274|Multidimensional Caregiver Strain Index|multidimensional caregiver strain index
5178574|NCT02874274|Parkinson's Disease Dementia|parkinson's disease dementia
5178575|NCT02874274|Progressive Supranuclear Palsy|progressive supranuclear palsy
5178576|NCT02874222|aromatase inhibitors|aromatase inhibitors
5178577|NCT02874183|Heart Failure|heart failure
5178579|NCT02874183|CHF|chf
5178580|NCT02874183|RCT|rct
5178581|NCT02874183|Self-efficacy|self-efficacy
5178582|NCT02874183|Pharmacy|pharmacy
5178583|NCT02874183|Pharmacist|pharmacist
5178584|NCT02874183|Transition of Care|transition of care
5178585|NCT02874183|Readmission|readmission
5178586|NCT02874131|Posttraumatic Stress Disorder|posttraumatic stress disorder
5178587|NCT02874131|Major Depressive Disorder|major depressive disorder
5178588|NCT02874131|Behavioral Activation|behavioral activation
5178589|NCT02874131|Cognitive Processing Therapy|cognitive processing therapy
5178590|NCT02874131|Comorbidity|comorbidity
5178591|NCT02874131|Military|military
5178592|NCT02874105|Medical treatment|medical treatment
5178593|NCT02874105|physiotherapy|physiotherapy
5178594|NCT02874092|Methotrexate (MTX)|methotrexate (mtx)
5178595|NCT02874092|Ticagrelor|ticagrelor
5178596|NCT02874066|Hepatitis C virus|hepatitis c virus
5178597|NCT02874066|Hemodialysis|hemodialysis
5178598|NCT02874066|Direct acting antiviral agents|direct acting antiviral agents
5178599|NCT02874053|Risk Perceptions|risk perceptions
5178600|NCT02874053|Medical Tradeoffs|medical tradeoffs
5178601|NCT02874053|Regulatory Focus|regulatory focus
5178602|NCT02874053|Integral Affect|integral affect
5178603|NCT02874027|gut microbiota|gut microbiota
5178604|NCT02874027|depression|depression
5178605|NCT02874027|gut-brain axis|gut-brain axis
5178606|NCT02874027|circadian rhythm|circadian rhythm
5178607|NCT02874027|Traumatic Brain Injury|traumatic brain injury
5178608|NCT02874001|psychology|psychology
5178609|NCT02874001|caregiver support time|caregiver support time
5178611|NCT02873975|Solid tumors|solid tumors
5178612|NCT02873975|MYC amplification|myc amplification
5178613|NCT02873975|CCNE1 amplification|ccne1 amplification
5178614|NCT02873975|Rb loss|rb loss
5178615|NCT02873975|FBXW7 mutation|fbxw7 mutation
5178616|NCT02873975|BRCA1 mutation|brca1 mutation
5178617|NCT02873975|BRCA2 mutation|brca2 mutation
5178618|NCT02873975|PALB2 mutation|palb2 mutation
5178619|NCT02873975|RAD51C mutation|rad51c mutation
5178620|NCT02873975|RAD51D mutation|rad51d mutation
5178621|NCT02873975|ATR mutation|atr mutation
5178622|NCT02873975|ATM mutation|atm mutation
5178623|NCT02873975|CHK2 mutation|chk2 mutation
5178624|NCT02873975|Fanconi anemia|fanconi anemia
5178625|NCT02873962|Relapsed Ovarian Cancer|relapsed ovarian cancer
5178626|NCT02873949|immunology factors|immunology factors
5178627|NCT02873949|TREM|trem
5178628|NCT02873949|stress|stress
5178629|NCT02873923|clinical trial|clinical trial
5178630|NCT02873923|surrogate endpoints|surrogate endpoints
5178631|NCT02873923|meta analysis|meta analysis
5178632|NCT02873897|elderly|elderly
5178633|NCT02873858|elderly|elderly
5178634|NCT02873780|Pulmonary rehabilitation|pulmonary rehabilitation
5178635|NCT02873780|COPD|copd
5178636|NCT02873780|Evaluation|evaluation
5178637|NCT02873780|oxygen desaturation|oxygen desaturation
5178638|NCT02873780|exercise capacity|exercise capacity
5178639|NCT02873767|First in human|first in human
5178640|NCT02873767|Healthy volunteers|healthy volunteers
5178641|NCT02873741|Sexually Transmitted Diseases (STDs)|sexually transmitted diseases (stds)
5178642|NCT02873741|Cancer|cancer
5178643|NCT02873741|AIDS|aids
5178644|NCT02873728|chronic ulcer|chronic ulcer
5178645|NCT02873728|diabetic ulcer|diabetic ulcer
5178646|NCT02873728|venous ulcer|venous ulcer
5178647|NCT02873728|remote ischemic conditioning|remote ischemic conditioning
5178648|NCT02873715|Childhood weight control|childhood weight control
5178649|NCT02873702|Drug therapy|drug therapy
5178650|NCT02873689|Drug therapy|drug therapy
5178651|NCT02873676|prevalence; lifestyle modification; clinical outcomes|prevalence; lifestyle modification; clinical outcomes
5178652|NCT02873650|Hepatic impairment|hepatic impairment
5178653|NCT02873650|Healthy volunteers|healthy volunteers
5178654|NCT02873650|Clinical pharmacology study|clinical pharmacology study
5178655|NCT02873650|DRB436|drb436
5178656|NCT02873650|dabrafenib|dabrafenib
5178657|NCT02873650|normal hepatic function|normal hepatic function
5178658|NCT02873650|impaired hepatic function|impaired hepatic function
5066982|NCT03580174|ICF|icf
5178659|NCT02873637|total knee replacement|total knee replacement
5178660|NCT02873637|anesthesia|anesthesia
5178661|NCT02873637|catheter|catheter
5178855|NCT02872363|mammogram|mammogram
5178662|NCT02873624|Acute Kidney Injury , Laparoscopic Cholecystectomy|acute kidney injury , laparoscopic cholecystectomy
5178663|NCT02873598|Induction Chemotherapy|induction chemotherapy
5178664|NCT02873598|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5178665|NCT02873598|Dose Escalation|dose escalation
5178666|NCT02873598|Locally Advanced Pancreatic Cancer (LAPC)|locally advanced pancreatic cancer (lapc)
5178667|NCT02873598|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
5178668|NCT02873572|Online poker|online poker
5178669|NCT02873572|Casino|casino
5178670|NCT02873572|Massively Multiplayer Online Role-Playing Game (MMORPG)|massively multiplayer online role-playing game (mmorpg)
5178671|NCT02873572|Iowa Gambling Task (IGT)|iowa gambling task (igt)
5178672|NCT02873572|High Resolution Electroencephalography (HR-EEG)|high resolution electroencephalography (hr-eeg)
5178673|NCT02873559|older|older
5178674|NCT02873559|frail|frail
5178676|NCT02873559|progressive muscle training|progressive muscle training
5178677|NCT02873559|muscle training|muscle training
5178678|NCT02873559|exercise|exercise
5178679|NCT02873559|testosterone|testosterone
5178680|NCT02873520|Precision Cell Immunotherapy|precision cell immunotherapy
5178681|NCT02873520|Chemotherapy|chemotherapy
5178682|NCT02873520|Advanced Gastric Cancer|advanced gastric cancer
5178683|NCT02873507|transplantation, liver|transplantation, liver
5178684|NCT02873494|Hemodynamic monitoring|hemodynamic monitoring
5178685|NCT02873494|cardiac output|cardiac output
5178686|NCT02873494|Transthoracic echocardiography|transthoracic echocardiography
5178687|NCT02873494|Impedance cardiography|impedance cardiography
5178688|NCT02873494|Child|child
5178689|NCT02873494|Physioflow|physioflow
5178690|NCT02873494|pediatric intensive care unit|pediatric intensive care unit
5178691|NCT02873442|Precision Cell Immunotherapy|precision cell immunotherapy
5178692|NCT02873442|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5178693|NCT02873442|Advanced Liver Cancer|advanced liver cancer
5178694|NCT02873416|Precision Cell Immunotherapy|precision cell immunotherapy
5178695|NCT02873416|Chemotherapy|chemotherapy
5178696|NCT02873416|Advanced Lung Cancer|advanced lung cancer
5178697|NCT02873390|PD-1 Antibody|pd-1 antibody
5178698|NCT02873390|CAR-T Cells|car-t cells
5178699|NCT02873390|EGFR family|egfr family
5178700|NCT02873390|Advanced Malignancies|advanced malignancies
5178701|NCT02873377|Hispanics|hispanics
5173766|NCT02906150|EGFR Wild Type|egfr wild type
5178702|NCT02873377|Construction workers|construction workers
5178703|NCT02873377|Tobacco Quitline|tobacco quitline
5178704|NCT02873377|Nicotine replacement therapy|nicotine replacement therapy
5178706|NCT02873351|GPR143|gpr143
5178707|NCT02873351|PEDF|pedf
5178708|NCT02873351|VEGF|vegf
5178709|NCT02873325|ADV|adv
5178710|NCT02873325|CMV|cmv
5178711|NCT02873325|HSCT|hsct
5178712|NCT02873299|PTSD, Post Traumatic Stress Disorder|ptsd, post traumatic stress disorder
5178713|NCT02873286|RSV Vaccines|rsv vaccines
5178714|NCT02873286|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
5178715|NCT02873260|Dengue Vaccine|dengue vaccine
5178716|NCT02873234|Telemedicine|telemedicine
5178717|NCT02873234|Chinese Medicine syndrome differentiation|chinese medicine syndrome differentiation
5178718|NCT02873234|Long-term study|long-term study
5178719|NCT02873234|Relapse rate|relapse rate
5178720|NCT02873234|Suicide rate|suicide rate
5178721|NCT02873234|Antidepressants|antidepressants
5178722|NCT02873208|Alkermes|alkermes
5178723|NCT02873208|ALKS 3831|alks 3831
5178724|NCT02873208|Samidorphan|samidorphan
5178725|NCT02873208|Schizophrenia|schizophrenia
5178726|NCT02873208|Safety|safety
5178727|NCT02873182|Intraoperative monitoring|intraoperative monitoring
5178728|NCT02873182|Intraoperative neuromonitoring|intraoperative neuromonitoring
5178729|NCT02873182|Autonomic nervous system|autonomic nervous system
5178730|NCT02873182|Spine surgery|spine surgery
5178731|NCT02873182|Pelvic surgery|pelvic surgery
5178732|NCT02873182|Sexual function|sexual function
5178733|NCT02873182|Bowel function|bowel function
5178734|NCT02873182|Bladder function|bladder function
5178735|NCT02873169|Left ventricular assist device|left ventricular assist device
5178736|NCT02873169|Ventricular Arrhythmias|ventricular arrhythmias
5178737|NCT02873169|Implantable Cardioverter-defibrillator|implantable cardioverter-defibrillator
5178738|NCT02873156|E2027|e2027
5178739|NCT02873156|Healthy participants|healthy participants
5178740|NCT02873156|Pharmacokinetics|pharmacokinetics
5178741|NCT02873156|Pharmacodynamics|pharmacodynamics
5178742|NCT02873117|Benign prostate hyperplasia|benign prostate hyperplasia
5178743|NCT02873117|5 alpha reductase inhibitor|5 alpha reductase inhibitor
5178744|NCT02873117|prostate cancer|prostate cancer
5178745|NCT02873117|Symptomatic|symptomatic
5178746|NCT02873117|treated|treated
5178747|NCT02873013|prostate cancer|prostate cancer
5178748|NCT02873013|observational study|observational study
5067077|NCT03579602|BLZ-100|blz-100
5178749|NCT02873000|incentive spirometry|incentive spirometry
5178750|NCT02873000|outcome|outcome
5178751|NCT02873000|length of stay,|length of stay,
5178752|NCT02873000|hospital complication|hospital complication
5178753|NCT02873000|general internal medicine|general internal medicine
5052725|NCT03669068|Oral anticoagulants|oral anticoagulants
5052726|NCT03669068|Gastrointestinal bleeding|gastrointestinal bleeding
5178754|NCT02873000|hospital medicine|hospital medicine
5178755|NCT02873000|non-critically-ill|non-critically-ill
5178856|NCT02872363|uptake|uptake
5178756|NCT02872974|Cardiovascular diseases|cardiovascular diseases
5178757|NCT02872974|Gestational diabetes mellitus|gestational diabetes mellitus
5178758|NCT02872974|Pediatrics|pediatrics
5178759|NCT02872974|Fetal programming|fetal programming
5178760|NCT02872974|Cohort study|cohort study
5178761|NCT02872948|Non invasive prenatal testing|non invasive prenatal testing
5178762|NCT02872948|Down Syndrome|down syndrome
5178763|NCT02872948|Digital PCR|digital pcr
5178764|NCT02872922|Endothelial function|endothelial function
5178765|NCT02872922|Ultrasonic Therapy|ultrasonic therapy
5178766|NCT02872922|Vascular endothelium|vascular endothelium
5178767|NCT02872922|Nitric oxide|nitric oxide
5178768|NCT02872922|Ultrasound|ultrasound
5178769|NCT02872883|Prelabour rupture of membranes|prelabour rupture of membranes
5178770|NCT02872883|term pregnancy|term pregnancy
5178771|NCT02872883|management|management
5178772|NCT02872883|vaginal examination|vaginal examination
5178773|NCT02872883|induction of labour|induction of labour
5178774|NCT02872883|expectant management|expectant management
5178775|NCT02872870|language disorders|language disorders
5178776|NCT02872870|developmental disorders of oral and written language|developmental disorders of oral and written language
5178777|NCT02872831|Fine needle aspiration|fine needle aspiration
5178778|NCT02872818|Apoptotic signal pathway|apoptotic signal pathway
5178779|NCT02872818|Survivin|survivin
5178780|NCT02872818|Bcl-2|bcl-2
5178781|NCT02872818|Bax|bax
5178782|NCT02872818|c-Myc|c-myc
5178783|NCT02872818|Caspase-9|caspase-9
5178784|NCT02872818|endometrial hyperplasia|endometrial hyperplasia
5178785|NCT02872818|endometrium cancer|endometrium cancer
5178786|NCT02872792|cycloergometer|cycloergometer
5178787|NCT02872753|Autologous Conditioned Plasma|autologous conditioned plasma
5178788|NCT02872753|meniscectomy|meniscectomy
5178789|NCT02872753|randomized controlled trial|randomized controlled trial
5178790|NCT02872753|intra-op injection|intra-op injection
5178791|NCT02872714|Urothelial carcinoma|urothelial carcinoma
5178792|NCT02872714|fibroblast growth factor (FGF)|fibroblast growth factor (fgf)
5178793|NCT02872714|fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5178794|NCT02872714|FGF/FGFR alterations|fgf/fgfr alterations
5178795|NCT02872675|Asthma|asthma
5178796|NCT02872675|Exercise-Induced Asthma|exercise-induced asthma
5182129|NCT02851342|MEG|meg
5178797|NCT02872675|Gut Bacteria|gut bacteria
5178798|NCT02872675|Bimuno® Galactooligosaccharide|bimuno® galactooligosaccharide
5178799|NCT02872675|Pulmonary Function|pulmonary function
5178801|NCT02872675|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5178802|NCT02872675|Gut Microbiota|gut microbiota
5178803|NCT02872675|Nutritional Intervention|nutritional intervention
5178804|NCT02872675|Eucapnic Voluntary Hyperpnoea|eucapnic voluntary hyperpnoea
5178805|NCT02872675|Systemic Inflammation|systemic inflammation
5178806|NCT02872675|Systemic Immune Function|systemic immune function
5178807|NCT02872675|Regulatory T Cells|regulatory t cells
5178808|NCT02872675|TH1 Cells|th1 cells
5178809|NCT02872675|TH2 Cells|th2 cells
5178810|NCT02872675|Short-Chain Fatty Acids|short-chain fatty acids
5178811|NCT02872675|Acetate|acetate
5178812|NCT02872675|Propionate|propionate
5178813|NCT02872675|Butyrate|butyrate
5178814|NCT02872675|Metabolomics|metabolomics
5178815|NCT02872675|Airway Inflammation|airway inflammation
5178816|NCT02872675|Intestinal Permeability|intestinal permeability
5178817|NCT02872610|suicidal thoughts|suicidal thoughts
5178818|NCT02872610|suicidal ideation|suicidal ideation
5178819|NCT02872610|Internet intervention|internet intervention
5178820|NCT02872610|self-help|self-help
5178821|NCT02872571|islet of Langerhans|islet of langerhans
5178822|NCT02872571|transplantation|transplantation
5178823|NCT02872571|muscle|muscle
5178824|NCT02872506|Quality of life|quality of life
5178825|NCT02872506|Crohn's disease|crohn's disease
5178826|NCT02872506|Ileocecal resection|ileocecal resection
5178827|NCT02872506|Anti TNF|anti tnf
5178829|NCT02872493|bariatric surgery|bariatric surgery
5178830|NCT02872493|bowel length|bowel length
5178831|NCT02872480|Concussion|concussion
5178832|NCT02872480|Exercise|exercise
5178833|NCT02872467|Cocaine|cocaine
5178834|NCT02872467|Mothers|mothers
5178835|NCT02872467|Pregnant women|pregnant women
5178836|NCT02872467|Postpartum women|postpartum women
5178837|NCT02872467|Oxytocin|oxytocin
5178838|NCT02872467|Substance use disorders|substance use disorders
5178839|NCT02872467|Substance abuse|substance abuse
5178840|NCT02872467|Prenatal substance use|prenatal substance use
5781177|NCT00189579|Relapse|relapse
5178842|NCT02872454|Major Depression|major depression
5178843|NCT02872454|Text Messaging|text messaging
5178844|NCT02872454|Guided Self-Help|guided self-help
5178845|NCT02872402|gestational diabetes|gestational diabetes
5962229|NCT04282109|Nivolumab|nivolumab
5962230|NCT04282096|Micellar casein|micellar casein
5962231|NCT04282096|Bioavailibility|bioavailibility
5962232|NCT04282096|Gastric emptying|gastric emptying
5178846|NCT02872402|dietary modification|dietary modification
5178847|NCT02872402|weight loss|weight loss
5178848|NCT02872402|physical activity|physical activity
5178849|NCT02872402|breastfeeding|breastfeeding
5178850|NCT02872376|Anemia|anemia
5178851|NCT02872376|Crohn's disease|crohn's disease
5178852|NCT02872376|Ulcerative colitis|ulcerative colitis
5178853|NCT02872363|breast screening|breast screening
5178854|NCT02872363|breast cancer|breast cancer
5178857|NCT02872363|reminder|reminder
5178858|NCT02872363|text message|text message
5178859|NCT02872363|SMS|sms
5178860|NCT02872311|Vaccine|vaccine
5178861|NCT02872311|Influenza|influenza
5178862|NCT02872311|High Dose|high dose
5178863|NCT02872311|Adjuvanted|adjuvanted
5178864|NCT02872311|Recombinant|recombinant
5178865|NCT02872298|Severe|severe
5178866|NCT02872298|Refractory|refractory
5178867|NCT02872259|metastatic melanoma|metastatic melanoma
5178868|NCT02872259|advanced Non-resectable melanoma|advanced non-resectable melanoma
5178869|NCT02872181|Maternal Position|maternal position
5178870|NCT02872181|Tilt|tilt
5178871|NCT02872181|Left Uterine Displacement|left uterine displacement
5178872|NCT02872181|Cesarean Delivery|cesarean delivery
5178873|NCT02872181|Cesarean Section|cesarean section
5178874|NCT02872155|contrast-induced nephropathy|contrast-induced nephropathy
5178875|NCT02872155|renal insufficiency|renal insufficiency
5178876|NCT02872155|computed tomography|computed tomography
5178877|NCT02872129|Fibromyalgia|fibromyalgia
5178878|NCT02872129|chronic widespread pain|chronic widespread pain
5178879|NCT02872129|follow-up|follow-up
5178880|NCT02872129|pain|pain
5178881|NCT02872129|fatigue|fatigue
5178882|NCT02872129|symptoms|symptoms
5178883|NCT02872129|workability|workability
5178884|NCT02872129|physical function|physical function
5178885|NCT02872090|COPD|copd
5178886|NCT02872090|bronchodilatators|bronchodilatators
5178887|NCT02872090|autonomic nervous system|autonomic nervous system
5178888|NCT02872090|cardiovascular system|cardiovascular system
5178889|NCT02872077|AA for NAS|aa for nas
5178890|NCT02872064|Early breast cancer|early breast cancer
5178891|NCT02872064|Photodynamic therapy|photodynamic therapy
5178892|NCT02872064|PDT|pdt
5178893|NCT02872064|Visudyne|visudyne
5178894|NCT02872064|Verteporfin|verteporfin
5178895|NCT02872051|Vocational Rehabilitation|vocational rehabilitation
5178896|NCT02872051|Anxiety|anxiety
5178897|NCT02872051|Depression|depression
5178898|NCT02872051|Common Mental Disorders|common mental disorders
5178899|NCT02872051|Cognitive Behavior Therapy|cognitive behavior therapy
5178900|NCT02872051|Return to Work|return to work
5178901|NCT02872051|Mental Health Services|mental health services
5178902|NCT02872051|Integration|integration
5178903|NCT02871999|Acupuncture Therapy|acupuncture therapy
5178904|NCT02871999|Pain degree after surgery|pain degree after surgery
5178906|NCT02871973|child development|child development
5178907|NCT02871973|language|language
5178908|NCT02871947|severe asthma|severe asthma
5178909|NCT02871934|Pharmacogenetics|pharmacogenetics
5178910|NCT02871934|SLCO1B1 protein, human|slco1b1 protein, human
5178911|NCT02871934|OATP1B1 protein, human|oatp1b1 protein, human
5178912|NCT02871934|Simvastatin|simvastatin
5178913|NCT02871934|Cardiovascular disease|cardiovascular disease
5178914|NCT02871934|Cholesterol|cholesterol
5178915|NCT02871934|Statin-related myotoxicity|statin-related myotoxicity
5178916|NCT02871934|Veterans|veterans
5178917|NCT02871934|Point-of-care|point-of-care
5178918|NCT02871921|Behavioral intervention|behavioral intervention
5178919|NCT02871921|social interaction|social interaction
5178920|NCT02871921|social isolation|social isolation
5178921|NCT02871921|MRI/fMRI|mri/fmri
5178922|NCT02871921|dementia|dementia
5178923|NCT02871921|electronic pill box|electronic pill box
5178924|NCT02871921|objective IADL assessment|objective iadl assessment
5178925|NCT02871921|speech characteristics|speech characteristics
5178926|NCT02871895|sepsis|sepsis
5178927|NCT02871895|severe sepsis|severe sepsis
5178928|NCT02871895|septic shock|septic shock
5178929|NCT02871895|multiple organ failure|multiple organ failure
5178930|NCT02871869|Cinobufacini Tablets|cinobufacini tablets
5178932|NCT02871856|Screening|screening
5178933|NCT02871856|Computed tomography|computed tomography
5178934|NCT02871856|Lung cancer|lung cancer
5178935|NCT02871830|Physical activity|physical activity
5178936|NCT02871830|Walking|walking
5178937|NCT02871830|Intervention|intervention
5178938|NCT02871830|Adolescent girls|adolescent girls
5178939|NCT02871830|Randomised trial|randomised trial
5178940|NCT02871817|Near Corrected Visual Acuity|near corrected visual acuity
5178941|NCT02871817|Early Treatment Diabetes Retinopathy Study|early treatment diabetes retinopathy study
5178942|NCT02871817|Amsler Grid|amsler grid
5178943|NCT02871817|Home Monitoring|home monitoring
5962233|NCT04282083|GEP-NETs|gep-nets
5673525|NCT00607932|recurrent prostate cancer|recurrent prostate cancer
5178945|NCT02871791|Hormone receptor (HR)-positive breast cancer|hormone receptor (hr)-positive breast cancer
5178946|NCT02871765|Patient education|patient education
5178947|NCT02871765|Knowledge|knowledge
5178948|NCT02871765|Life distress|life distress
5962234|NCT04282070|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5178949|NCT02871765|Quality of life|quality of life
5178950|NCT02871752|prostate cancer|prostate cancer
5178951|NCT02871752|active surveillance|active surveillance
5178954|NCT02871752|health promotion|health promotion
5178955|NCT02871752|quality of life|quality of life
5178956|NCT02871752|mindfulness|mindfulness
5178957|NCT02871739|Communication skills training|communication skills training
5179742|NCT02866227|Candidiasis|candidiasis
5178958|NCT02871739|Shared Decision Making|shared decision making
5178959|NCT02871739|Decision making|decision making
5178960|NCT02871739|Decision Aids|decision aids
5178961|NCT02871739|lung cancer screening|lung cancer screening
5178962|NCT02871726|Prostate Cancer Detection|prostate cancer detection
5178963|NCT02871726|Prostate Biopsy|prostate biopsy
5178964|NCT02871726|Prostate Cancer|prostate cancer
5178965|NCT02871726|Transrectal Ultrasound|transrectal ultrasound
5178966|NCT02871713|quadratus lumborum block|quadratus lumborum block
5178967|NCT02871700|stroke|stroke
5178968|NCT02871700|translational rehabilitation|translational rehabilitation
5178969|NCT02871700|mirror neuron system|mirror neuron system
5178970|NCT02871700|action observation|action observation
5178971|NCT02871700|mirror therapy|mirror therapy
5178972|NCT02871700|MEG|meg
5178973|NCT02871674|Behavioural interventions|behavioural interventions
5178974|NCT02871674|Sleep difficulties|sleep difficulties
5178975|NCT02871674|Children|children
5178976|NCT02871674|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5178977|NCT02871674|Randomised controlled trial|randomised controlled trial
5178978|NCT02871674|Saudi Arabia|saudi arabia
5178979|NCT02871674|Behavioural Insomnia|behavioural insomnia
5178980|NCT02871661|vulvodynia|vulvodynia
5178981|NCT02871661|pelvic floor muscles|pelvic floor muscles
5178982|NCT02871661|kinesiotherapy|kinesiotherapy
5178983|NCT02871661|electrical therapy|electrical therapy
5178984|NCT02871661|physical therapy|physical therapy
5178985|NCT02871661|amitriptyline|amitriptyline
5178986|NCT02871661|female sexual dysfunction.|female sexual dysfunction.
5178987|NCT02871648|Healthy|healthy
5178988|NCT02871609|Biofilm|biofilm
5178989|NCT02871609|Morbidity|morbidity
5178990|NCT02871609|Ureteral Catheterization|ureteral catheterization
5178991|NCT02871570|Hepatic Impairment|hepatic impairment
5178992|NCT02871570|Rivipansel|rivipansel
5178993|NCT02871544|BNP|bnp
5178994|NCT02871544|NGAL|ngal
5178995|NCT02871544|Sepsis|sepsis
5178996|NCT02871544|Mortality|mortality
5178997|NCT02871531|retinal detachment|retinal detachment
5178998|NCT02871531|pneumatic retinopexy|pneumatic retinopexy
5178999|NCT02871531|vitrectomy|vitrectomy
5179000|NCT02871479|Atopic Dermatitis|atopic dermatitis
5179001|NCT02871479|Eczema|eczema
5179002|NCT02871453|Ischemic Stroke|ischemic stroke
5179003|NCT02871453|Motor Dysfunction|motor dysfunction
5179004|NCT02871453|Scalp Acupuncture|scalp acupuncture
5179005|NCT02871427|Lewy body dementia|lewy body dementia
5179006|NCT02871427|Dementia with Lewy bodies|dementia with lewy bodies
5179007|NCT02871427|Parkinson's disease dementia|parkinson's disease dementia
5179008|NCT02871427|Visual hallucinations|visual hallucinations
5179009|NCT02871427|REM sleep behavior disorder|rem sleep behavior disorder
5179010|NCT02871401|IPF|ipf
5179011|NCT02871401|Herpesvirus|herpesvirus
5179012|NCT02871401|Valganciclovir|valganciclovir
5179013|NCT02871388|Physical activity|physical activity
5179014|NCT02871388|Diet|diet
5179015|NCT02871388|Nutrition|nutrition
5179016|NCT02871388|Breast cancer prevention|breast cancer prevention
5179017|NCT02871388|Mammography screening|mammography screening
5179018|NCT02871375|myopia|myopia
5179019|NCT02871375|presbyopia|presbyopia
5179020|NCT02871349|Autism|autism
5179021|NCT02871349|ASD|asd
5179022|NCT02871336|Cata collection|cata collection
5179023|NCT02871336|Pancreatic cancer surgery|pancreatic cancer surgery
5179024|NCT02871323|Myelofibrosis Transformation in Essential Thrombocythemia|myelofibrosis transformation in essential thrombocythemia
5179027|NCT02871284|cancer|cancer
5179028|NCT02871284|anticancer treatment|anticancer treatment
5179029|NCT02871284|exercise|exercise
5179030|NCT02871284|physical activity|physical activity
5179031|NCT02871284|sensorimotor training|sensorimotor training
5179032|NCT02871284|chemotherapy-induced polyneuropathy|chemotherapy-induced polyneuropathy
5179033|NCT02871245|Acupuncture Therapy|acupuncture therapy
5179034|NCT02871245|Laparoscopic Surgery|laparoscopic surgery
5179035|NCT02871245|Gastrointestinal Tract Recovery of Function|gastrointestinal tract recovery of function
5179036|NCT02871193|paravertebral block|paravertebral block
5179037|NCT02871193|patient controlled analgesia|patient controlled analgesia
5179038|NCT02871193|ropivacaine|ropivacaine
5179039|NCT02871193|dexamethasone|dexamethasone
5179040|NCT02871180|Hypoglycemia|hypoglycemia
5179041|NCT02871180|Type 1 diabetes|type 1 diabetes
5179042|NCT02871167|oocyte/embryo cryopreservation|oocyte/embryo cryopreservation
5179043|NCT02871128|Hemoglobin|hemoglobin
5179044|NCT02871128|serum iron|serum iron
5179045|NCT02871128|serum ferritin|serum ferritin
5179046|NCT02871128|Hematocrit|hematocrit
5179047|NCT02871128|antioxidant|antioxidant
5179048|NCT02871115|Cancer Care|cancer care
5179049|NCT02871102|mechanical ventilation|mechanical ventilation
5179050|NCT02871102|respiratory mechanics|respiratory mechanics
5179051|NCT02871102|acute respiratory distress syndrome|acute respiratory distress syndrome
5179052|NCT02871102|positive end-expiratory pressure|positive end-expiratory pressure
5179053|NCT02871102|tidal volume|tidal volume
5179054|NCT02871089|Type 1 Diabetes|type 1 diabetes
5179055|NCT02871089|Closed-loop glucose control|closed-loop glucose control
5179056|NCT02871089|Artificial Pancreas|artificial pancreas
5179057|NCT02871089|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5179058|NCT02871089|Multiple daily injection therapy|multiple daily injection therapy
5179059|NCT02871089|New onset type 1 diabetes|new onset type 1 diabetes
5179060|NCT02871089|Residual C-Peptide secretion|residual c-peptide secretion
5179061|NCT02871089|Beta-cell function preservation|beta-cell function preservation
5179062|NCT02871089|Continuous glucose monitoring|continuous glucose monitoring
5179063|NCT02871050|Biobank|biobank
5179064|NCT02871050|biorepository|biorepository
5179065|NCT02871050|Castlebank|castlebank
5179066|NCT02871050|Castleman Disease|castleman disease
5179067|NCT02871050|CD|cd
5179068|NCT02871050|MCD|mcd
5179069|NCT02871050|iMCD|imcd
5179070|NCT02871050|Castleman|castleman
5179071|NCT02871050|Castleman's Disease|castleman's disease
5179072|NCT02871050|multicentric Castleman's disease|multicentric castleman's disease
5179073|NCT02871050|multicentric Castleman disease|multicentric castleman disease
5179074|NCT02871050|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
5179075|NCT02871024|Polymyxin B|polymyxin b
5179076|NCT02871024|Pneumonia|pneumonia
5179077|NCT02871024|Sepsis|sepsis
5179078|NCT02871024|Urinary tract infection|urinary tract infection
5179079|NCT02871011|Tinea Bronchodilator Agents|tinea bronchodilator agents
5179080|NCT02871011|Tinea Pedis|tinea pedis
5179081|NCT02871011|Nitric Oxide|nitric oxide
5179082|NCT02871011|Dermatomycoses|dermatomycoses
5179083|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
5179084|NCT02871011|Infectious|infectious
5179085|NCT02871011|Infection|infection
5179086|NCT02871011|Mycoses|mycoses
5179087|NCT02871011|Skin Diseases|skin diseases
5179088|NCT02871011|Foot Dermatoses|foot dermatoses
5179089|NCT02871011|Foot Diseases|foot diseases
5179090|NCT02871011|Pruritus|pruritus
5179091|NCT02871011|Skin Manifestations Signs and Symptoms|skin manifestations signs and symptoms
5179092|NCT02870946|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5179093|NCT02870946|Cardiogenic Shock|cardiogenic shock
5179094|NCT02870946|Renal Replacement Therapy|renal replacement therapy
5179095|NCT02870933|CD 133+|cd 133+
5179096|NCT02870933|Transepicardial with Transseptal Implantation|transepicardial with transseptal implantation
5179097|NCT02870933|CABG|cabg
5179098|NCT02870907|primary enucleation|primary enucleation
5179099|NCT02870907|retinoblastoma|retinoblastoma
5179100|NCT02870868|slow breathing|slow breathing
5179101|NCT02870868|yoga|yoga
5179102|NCT02870868|mind-body practicers|mind-body practicers
5179103|NCT02870842|ultrasonography|ultrasonography
5179104|NCT02870842|child|child
5179105|NCT02870842|perioperative period|perioperative period
5179106|NCT02870842|general anesthesia|general anesthesia
5179107|NCT02870842|lung|lung
5179108|NCT02870777|MRD|mrd
5179109|NCT02870777|Acute myeloid leukemia|acute myeloid leukemia
5179110|NCT02870764|Danshenduofensuanyan|danshenduofensuanyan
5179111|NCT02870764|Lp-PLA2|lp-pla2
5179112|NCT02870764|coronary artery disease|coronary artery disease
5179113|NCT02870764|Salvia miltiorrhiza|salvia miltiorrhiza
5179114|NCT02870751|ETEC|etec
5179115|NCT02870751|human challenge study|human challenge study
5179116|NCT02870751|heat stable toxin|heat stable toxin
5179117|NCT02870751|tourist diarrhea|tourist diarrhea
5179118|NCT02870751|diarrhea|diarrhea
5179119|NCT02870751|enterotoxigenic|enterotoxigenic
5179120|NCT02870725|chronic headaches, migraines, depression|chronic headaches, migraines, depression
5179121|NCT02870712|perineal tear of first degree|perineal tear of first degree
5179122|NCT02870712|suture|suture
5179123|NCT02870699|chemotherapy neoadjuvant|chemotherapy neoadjuvant
5179124|NCT02870686|ERCP|ercp
5179125|NCT02870686|EUS guided ERCP without fluoroscopy|eus guided ercp without fluoroscopy
5179126|NCT02870673|acupuncture|acupuncture
5179127|NCT02870673|electrical stimulation|electrical stimulation
5067489|NCT03577106|TMS|tms
5179128|NCT02870673|carpal tunnel syndrome|carpal tunnel syndrome
5179129|NCT02870608|Elastography|elastography
5179130|NCT02870556|cervical epidural, laryngectomy, pharyngocutaneous fistula|cervical epidural, laryngectomy, pharyngocutaneous fistula
5179131|NCT02870543|Bruxism|bruxism
5179132|NCT02870543|Sleep bruxism|sleep bruxism
5179133|NCT02870543|Sleep related bruxism|sleep related bruxism
5179134|NCT02870543|Homeopathy|homeopathy
5179135|NCT02870504|laser peripheral iridoplasty|laser peripheral iridoplasty
5179136|NCT02870504|treatment|treatment
5179138|NCT02870491|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5179139|NCT02870491|Oral Rehydration|oral rehydration
5179140|NCT02870491|ORS|ors
5179141|NCT02870491|Zinc|zinc
5179142|NCT02870491|Brac|brac
5179143|NCT02870491|Community Health Workers|community health workers
5179144|NCT02870491|Uganda|uganda
5179145|NCT02870465|outpatient versus operating room|outpatient versus operating room
5179146|NCT02870465|k wire infection|k wire infection
5179147|NCT02870465|closed reduction internal fixation|closed reduction internal fixation
5179148|NCT02870452|Haemophilia|haemophilia
5179149|NCT02870452|RCT|rct
5179150|NCT02870452|Pain|pain
5179151|NCT02870452|Hemarthrosis|hemarthrosis
5179152|NCT02870452|Hypnosis|hypnosis
5179744|NCT02866227|Insert|insert
5179153|NCT02870452|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5179154|NCT02870452|Quality of Life|quality of life
5179155|NCT02870452|Distress|distress
5179156|NCT02870452|Cytokines|cytokines
5179157|NCT02870426|Olfactory ensheathing cells|olfactory ensheathing cells
5179158|NCT02870413|telehealth|telehealth
5179159|NCT02870387|chronic illness|chronic illness
5179160|NCT02870387|children|children
5179161|NCT02870387|children with medical complexity|children with medical complexity
5179162|NCT02870387|medical home|medical home
5179163|NCT02870387|inpatient consultation|inpatient consultation
5179164|NCT02870335|low back|low back
5179165|NCT02870335|manual therapy|manual therapy
5179166|NCT02870335|stretching|stretching
5179167|NCT02870322|overweight|overweight
5179169|NCT02870322|lifestyle prescription|lifestyle prescription
5179170|NCT02870322|prevention|prevention
5179171|NCT02870322|physical activity|physical activity
5179172|NCT02870322|healthy eating|healthy eating
5179173|NCT02870283|Cost effectiveness|cost effectiveness
5179174|NCT02870283|Bipolar disorder|bipolar disorder
5179175|NCT02870283|Mixed episodes|mixed episodes
5179176|NCT02870283|Quality of life|quality of life
5179177|NCT02870270|saliva|saliva
5179178|NCT02870270|microflora|microflora
5179179|NCT02870270|diet|diet
5179180|NCT02870270|quality of life|quality of life
5179181|NCT02870270|oral cancer|oral cancer
5179182|NCT02870244|Melanoma|melanoma
5179183|NCT02870244|Gene Therapy|gene therapy
5179184|NCT02870244|Adoptive T-Cell Transfer|adoptive t-cell transfer
5179185|NCT02870244|IL-2|il-2
5179186|NCT02870192|Rectal Prolapse|rectal prolapse
5179187|NCT02870179|Pulse Oximetry|pulse oximetry
5179188|NCT02870179|Temperature|temperature
5179189|NCT02870179|Respiratory Rate|respiratory rate
5179190|NCT02870179|Respiratory Gases|respiratory gases
5179191|NCT02870179|This study determines the measurement accuracy of the physiological parameters|this study determines the measurement accuracy of the physiological parameters
5179192|NCT02870140|CAD|cad
5179193|NCT02870140|ACS|acs
5179194|NCT02870140|All comers|all comers
5179195|NCT02870140|PCI|pci
5179196|NCT02870114|Haemophilia|haemophilia
5179197|NCT02870114|Quality of Life|quality of life
5179198|NCT02870114|Distress|distress
5179199|NCT02870114|Hemarthrosis|hemarthrosis
5179200|NCT02870114|Pain|pain
5179201|NCT02870101|Nucleic acid amplification tests|nucleic acid amplification tests
5862718|NCT00001539|Tick-Borne Disease|tick-borne disease
5179202|NCT02870101|Neisseria gonorrhoeae infection|neisseria gonorrhoeae infection
5179203|NCT02870101|Chlamydia trachomatis infection|chlamydia trachomatis infection
5179204|NCT02870101|Sexually transmitted infection|sexually transmitted infection
5179206|NCT02870101|Rectum|rectum
5179207|NCT02870101|Gram-Negative Bacterial Infections|gram-negative bacterial infections
5179208|NCT02870101|Bacterial Infections|bacterial infections
5179209|NCT02870101|Genital Diseases, Male|genital diseases, male
5179210|NCT02870101|Genital Diseases, Female|genital diseases, female
5179211|NCT02870062|Chlorhexidine baths|chlorhexidine baths
5179212|NCT02870062|Critical patient|critical patient
5179213|NCT02870062|Healthcare associated infections|healthcare associated infections
5179214|NCT02870062|Critical care environment|critical care environment
5179215|NCT02870062|Patient colonization|patient colonization
5179216|NCT02870049|early detection|early detection
5179217|NCT02869971|Prostatic artery embolization|prostatic artery embolization
5179218|NCT02869971|Combined Therapy|combined therapy
5179219|NCT02869971|IPSS|ipss
5179220|NCT02869958|Asthma|asthma
5179221|NCT02869958|Exacerbation|exacerbation
5179222|NCT02869958|Treatment|treatment
5179223|NCT02869958|Internet|internet
5179224|NCT02869958|Emergency care|emergency care
5179225|NCT02869945|de novo untreated Parkinson Disease|de novo untreated parkinson disease
5179226|NCT02869945|genetic|genetic
5179227|NCT02869945|COMT Polymorphism|comt polymorphism
5179228|NCT02869945|gene|gene
5179229|NCT02869945|brain MRI|brain mri
5179230|NCT02869945|brain MPET|brain mpet
5179231|NCT02869841|laparotomy|laparotomy
5179232|NCT02869841|pain|pain
5179233|NCT02869841|rectus sheath block|rectus sheath block
5179234|NCT02869815|Methylene blue|methylene blue
5179238|NCT02869815|Breast Neoplasms|breast neoplasms
5179240|NCT02869802|Pancreatic Cancer|pancreatic cancer
5179241|NCT02869802|Advanced Pancreatic Ductal Adenocarcinoma|advanced pancreatic ductal adenocarcinoma
5179243|NCT02869802|Genomic Analysis|genomic analysis
5179244|NCT02869802|Molecular subtyping|molecular subtyping
5179245|NCT02869763|Ethanol|ethanol
5179246|NCT02869763|Steroid profile|steroid profile
5179247|NCT02869763|Pharmacokinetics|pharmacokinetics
5179248|NCT02869737|Point of Care Device; post traumatic coagulopathy|point of care device; post traumatic coagulopathy
5053330|NCT03665324|ECG|ecg
5179249|NCT02869724|IMV : voluntary drug intoxications|imv : voluntary drug intoxications
5179250|NCT02869724|Drug|drug
5179251|NCT02869724|Divided prescription|divided prescription
5179252|NCT02869672|safety|safety
5179253|NCT02869672|immunogenicity|immunogenicity
5179254|NCT02869672|vaccine|vaccine
5179260|NCT02869646|PTSD|ptsd
5179261|NCT02869646|acupuncture|acupuncture
5179262|NCT02869646|integrative medicine|integrative medicine
5179263|NCT02869464|Aneurysm|aneurysm
5179264|NCT02869464|Intracranial Aneurysm|intracranial aneurysm
5179265|NCT02869464|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5179266|NCT02869438|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
5179267|NCT02869399|head and neck cancer, nutritional intervention|head and neck cancer, nutritional intervention
5179268|NCT02869386|stroke|stroke
5179269|NCT02869386|prehospital|prehospital
5179270|NCT02869386|telemedicine|telemedicine
5179271|NCT02869386|thrombolysis|thrombolysis
5179272|NCT02869386|thrombectomy|thrombectomy
5179273|NCT02869386|endovascular treatment|endovascular treatment
5179274|NCT02869386|functional outcome|functional outcome
5179275|NCT02869347|recombinant C1 esterase inhibitor|recombinant c1 esterase inhibitor
5179276|NCT02869347|acute kidney injury|acute kidney injury
5179277|NCT02869347|coronary angiography|coronary angiography
5179278|NCT02869347|contrast media|contrast media
5179279|NCT02869347|Conestat alfa|conestat alfa
5179280|NCT02869347|inflammation|inflammation
5179281|NCT02869308|Cardiomyopathy|cardiomyopathy
5179282|NCT02869308|Chemotherapy|chemotherapy
5179283|NCT02869308|Left ventricular ejection fraction|left ventricular ejection fraction
5179284|NCT02869295|Metastatic Solid Tumors|metastatic solid tumors
5179285|NCT02869295|Locally Advanced Solid Tumors|locally advanced solid tumors
5179286|NCT02869256|chronic myeloid leukemia|chronic myeloid leukemia
5179287|NCT02869256|practices evaluation|practices evaluation
5179288|NCT02869243|A malignant growing astrocytoma of central nervous system|a malignant growing astrocytoma of central nervous system
5179289|NCT02869230|Breast cancer|breast cancer
5179290|NCT02869230|Non palpable breast lesions|non palpable breast lesions
5179291|NCT02869230|radioguided occult lesion localization|radioguided occult lesion localization
5179292|NCT02869217|NY-ESO-1 expressing solid tumors in HLA-A2 positive patients|ny-eso-1 expressing solid tumors in hla-a2 positive patients
5179293|NCT02869165|Postmenopausal|postmenopausal
5179294|NCT02869152|sentinel lymph node|sentinel lymph node
5179295|NCT02869152|lymphatic mapping|lymphatic mapping
5179296|NCT02869152|rectal tumor|rectal tumor
5179297|NCT02869152|rectal cancer|rectal cancer
5179298|NCT02869152|early stage|early stage
5179299|NCT02869139|Thirst|thirst
5179301|NCT02869139|Menthol|menthol
5179302|NCT02869139|Perioperative Nursing.|perioperative nursing.
5179303|NCT02869139|Recovery Room|recovery room
5174424|NCT02902159|Stress|stress
5179304|NCT02869126|99mTc-Sestamibi|99mtc-sestamibi
5179305|NCT02869126|thallium-201|thallium-201
5179306|NCT02869126|semiconductor camera|semiconductor camera
5179307|NCT02869100|magnetic resonance imaging|magnetic resonance imaging
5179308|NCT02869100|sodium fluoride positron emission tomography|sodium fluoride positron emission tomography
5179309|NCT02869074|von Willebrand disease (VWD)|von willebrand disease (vwd)
5179310|NCT02869074|von Willebrand factor (VWF)|von willebrand factor (vwf)
5179311|NCT02869074|von Willebrand factor gene|von willebrand factor gene
5067686|NCT03576014|BKV Reactivation|bkv reactivation
5179312|NCT02869074|next generation sequencing|next generation sequencing
5179313|NCT02869074|diagnosis|diagnosis
5179314|NCT02869074|VWD Spanish Cohort|vwd spanish cohort
5179315|NCT02869061|Bladder neck obstruction|bladder neck obstruction
5179316|NCT02869061|Bladder outlet obstruction|bladder outlet obstruction
5179317|NCT02869061|Benign prostatic hyperplasia|benign prostatic hyperplasia
5179318|NCT02869061|Urinary bladder neck obstruction|urinary bladder neck obstruction
5179319|NCT02869061|Bladder neck contracture|bladder neck contracture
5179320|NCT02869061|Bladder neck stricture|bladder neck stricture
5179321|NCT02869061|Bladder neck stenosis|bladder neck stenosis
5179322|NCT02869061|Transurethral resection of the prostate|transurethral resection of the prostate
5179323|NCT02869061|Prostatectomy|prostatectomy
5179324|NCT02869061|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
5179325|NCT02869061|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
5179326|NCT02869061|Adipose tissue|adipose tissue
5179327|NCT02869061|Stem cells|stem cells
5179328|NCT02869048|Biological Specimen Banks|biological specimen banks
5179329|NCT02869048|Innate Immunity|innate immunity
5179330|NCT02869048|Clinical Study|clinical study
5179331|NCT02869048|Complement system proteins|complement system proteins
5179332|NCT02869048|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5179333|NCT02869048|Neurodegenerative disease|neurodegenerative disease
5179334|NCT02869048|Motor neuron disease|motor neuron disease
5179336|NCT02869035|Serotonin|serotonin
5179338|NCT02869035|MRI|mri
5179339|NCT02869035|fMRI|fmri
5179340|NCT02869035|EEG|eeg
5179341|NCT02869035|Cortisol awakening response|cortisol awakening response
5179342|NCT02869035|Oxidative stress|oxidative stress
5962235|NCT04282057|shock wave therapy|shock wave therapy
5179343|NCT02869035|Mental health|mental health
5179745|NCT02866227|TOL-463|tol-463
5179344|NCT02869035|Prediction of treatment response|prediction of treatment response
5179345|NCT02869035|Inflammation|inflammation
5179346|NCT02869035|5-HTTLPR|5-httlpr
5179347|NCT02869035|Brain imaging|brain imaging
5179348|NCT02869035|Early life stress|early life stress
5179349|NCT02869035|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5179350|NCT02869035|Escitalopram|escitalopram
5179351|NCT02869035|Psychometrics|psychometrics
5179352|NCT02869035|Moderate depression|moderate depression
5179353|NCT02869035|Severe depression|severe depression
5179354|NCT02869035|ERP|erp
5179355|NCT02869035|rsfMRI|rsfmri
5179356|NCT02869035|11C-SB207145|11c-sb207145
5179357|NCT02869035|Sexual function|sexual function
5179358|NCT02869035|MDD|mdd
5179359|NCT02869035|Affective cognition|affective cognition
5179360|NCT02869035|Cold cognition|cold cognition
5179361|NCT02869035|Social cognition|social cognition
5179362|NCT02869035|Anxiety|anxiety
5179363|NCT02869009|stroke|stroke
5179364|NCT02869009|clopidogrel|clopidogrel
5179365|NCT02869009|antiplatelets|antiplatelets
5179366|NCT02868957|CAD|cad
5179367|NCT02868957|Digital imaging|digital imaging
5179368|NCT02868957|Prosthetic Dentistry|prosthetic dentistry
5179369|NCT02868931|self-management|self-management
5179370|NCT02868931|empowerment|empowerment
5179371|NCT02868931|treatment and education program|treatment and education program
5179372|NCT02868931|insulin pump|insulin pump
5179373|NCT02868931|diabetes education|diabetes education
5179374|NCT02868866|physical activity|physical activity
5179375|NCT02868866|nutrition|nutrition
5179376|NCT02868866|fruits and vegetables|fruits and vegetables
5179377|NCT02868866|faith-based|faith-based
5179378|NCT02868866|churches|churches
5179379|NCT02868853|diet|diet
5179380|NCT02868853|weight loss|weight loss
5179381|NCT02868853|tracking|tracking
5179382|NCT02868853|mobile|mobile
5179383|NCT02868853|calories|calories
5179384|NCT02868840|stroke|stroke
5179385|NCT02868840|Tai ji|tai ji
5179386|NCT02868840|postural balance|postural balance
5179387|NCT02868840|cognition|cognition
5179388|NCT02868827|cholecalciferol and critical illness|cholecalciferol and critical illness
5179389|NCT02868827|Mortality and cholecalciferol supplementation|mortality and cholecalciferol supplementation
5179390|NCT02868801|Pregabalin|pregabalin
5179391|NCT02868788|inflammation|inflammation
5179392|NCT02868788|insulin resistance|insulin resistance
5179393|NCT02868788|type 2 diabetes|type 2 diabetes
5179394|NCT02868788|obesity|obesity
5179395|NCT02868762|neck pain, voice disorder|neck pain, voice disorder
5179396|NCT02868749|Hyaluronic Acid|hyaluronic acid
5179397|NCT02868749|histology|histology
5179398|NCT02868749|ultrasound|ultrasound
5179399|NCT02868749|subcutaneous|subcutaneous
5179400|NCT02868749|adipose tissue|adipose tissue
5179401|NCT02868723|cerebrovascular disease|cerebrovascular disease
5179402|NCT02868723|patient management|patient management
5179403|NCT02868723|stroke management|stroke management
5179404|NCT02868723|prognosis|prognosis
5179405|NCT02868723|3D Carotid Doppler Imaging|3d carotid doppler imaging
5179406|NCT02868723|Randomization|randomization
5179407|NCT02868710|primary prevention|primary prevention
5179408|NCT02868671|mild TBI|mild tbi
5179409|NCT02868671|Post-traumatic Stress Disorders|post-traumatic stress disorders
5179410|NCT02868671|Acupuncture|acupuncture
5179411|NCT02868658|Influenza|influenza
5179412|NCT02868658|health care workers|health care workers
5179413|NCT02868658|nosocomial|nosocomial
5179414|NCT02868658|asymptomatic|asymptomatic
5179415|NCT02868658|France|france
5179416|NCT02868632|Unresectable|unresectable
5179417|NCT02868632|Locally Advanced|locally advanced
5179418|NCT02868632|Non-Metastatic|non-metastatic
5179419|NCT02868619|fMRI|fmri
5179420|NCT02868619|Deep brain stimulation|deep brain stimulation
5179421|NCT02868619|Food|food
5179422|NCT02868619|Eating|eating
5179423|NCT02868619|Reward|reward
5179424|NCT02868580|ALS|als
5179425|NCT02868580|Antiretroviral Therapy, Triumeq|antiretroviral therapy, triumeq
5673526|NCT00607906|safety|safety
5179426|NCT02868541|microorganisms|microorganisms
5179427|NCT02868541|pilgrim|pilgrim
5179428|NCT02868541|hajj|hajj
5179429|NCT02868528|advanced age women|advanced age women
5179430|NCT02868528|blastocyst culture|blastocyst culture
5179432|NCT02868528|live birth rate|live birth rate
5179433|NCT02868502|Glaucoma|glaucoma
5179434|NCT02868502|Open Angle Glaucoma|open angle glaucoma
5179435|NCT02868502|Intra Ocular Pressure|intra ocular pressure
5179436|NCT02868502|Ocular Hypotensive Drops|ocular hypotensive drops
5179437|NCT02868502|Trabeculectomy|trabeculectomy
5179438|NCT02868502|Cyclophotocoagulation|cyclophotocoagulation
5179439|NCT02868502|Glaucoma Drainage Device|glaucoma drainage device
5179441|NCT02868463|oxygen tension|oxygen tension
5179442|NCT02868463|Female Urinary Microbiome|female urinary microbiome
5179443|NCT02868463|Urinary Tract Symptoms|urinary tract symptoms
5179444|NCT02868463|Urine Oxygen Level|urine oxygen level
5179445|NCT02868398|Ulcerative Colitis|ulcerative colitis
5179446|NCT02868398|Golimumab|golimumab
5179447|NCT02868398|Deep and prolonged remission|deep and prolonged remission
5179448|NCT02868385|Schistosomiasis|schistosomiasis
5179449|NCT02868385|Schistosoma mansoni|schistosoma mansoni
5179450|NCT02868385|Bilharzia|bilharzia
5179451|NCT02868372|Cesarean section|cesarean section
5179452|NCT02868372|Betadine|betadine
5179453|NCT02868372|Wound infection|wound infection
5179454|NCT02868320|SMS|sms
5179455|NCT02868320|text messaging|text messaging
5179456|NCT02868320|diabetes self management|diabetes self management
5179457|NCT02868320|glycemic control|glycemic control
5179458|NCT02868320|mHealth|mhealth
5179459|NCT02868320|mobile health|mobile health
5179460|NCT02868320|diabetes education|diabetes education
5179461|NCT02868281|Cluster Randomization|cluster randomization
5179462|NCT02868281|Peak Expiratory Flow|peak expiratory flow
5179463|NCT02868281|Forced Expiratory Volume|forced expiratory volume
5179464|NCT02868281|Standardized Asthma Quality of Life Questionnaire|standardized asthma quality of life questionnaire
5179465|NCT02868281|Asthma Control Test|asthma control test
5179466|NCT02868268|Neuroblastoma|neuroblastoma
5179467|NCT02868255|Biobank analyses|biobank analyses
5179468|NCT02868255|Effect evaluation of the drug|effect evaluation of the drug
5179469|NCT02868255|patient-derived cells|patient-derived cells
5179470|NCT02868255|SIRPα/CD47 expression|sirpα/cd47 expression
5179471|NCT02868242|HCV genotype 1 or 4 (GT-1 or GT-4)|hcv genotype 1 or 4 (gt-1 or gt-4)
5179472|NCT02868242|Direct Acting Antiviral|direct acting antiviral
5179473|NCT02868242|Combination Therapy|combination therapy
5179474|NCT02868242|Hepatitis C, Chronic|hepatitis c, chronic
5179475|NCT02868242|Liver Diseases|liver diseases
5179476|NCT02868242|Virus Diseases|virus diseases
5179477|NCT02868177|Prevention|prevention
5179478|NCT02868151|Oral mucositis, chemo radiotherapy, vitamin c,|oral mucositis, chemo radiotherapy, vitamin c,
5179479|NCT02868138|Sickle cell disease|sickle cell disease
5179480|NCT02868138|Hydroxyurea|hydroxyurea
5179481|NCT02868138|Compliance|compliance
5179482|NCT02868125|pertrochanteric|pertrochanteric
5179483|NCT02868125|radiography|radiography
5179484|NCT02868112|Cancer Care|cancer care
5179485|NCT02868112|Palliative Care|palliative care
5179486|NCT02868112|Geriatrics|geriatrics
5179487|NCT02868112|Quality of Life|quality of life
5179488|NCT02868086|Age-related macular degeneration|age-related macular degeneration
5179489|NCT02868086|Optical coherence tomography angiography|optical coherence tomography angiography
5179490|NCT02868047|chronic pancreatitis|chronic pancreatitis
5179491|NCT02868047|endoscopic ultrasound|endoscopic ultrasound
5179492|NCT02868034|Low Back Pain|low back pain
5179493|NCT02868034|Spinal Manipulation|spinal manipulation
5179494|NCT02868034|Exercise|exercise
5179495|NCT02868021|Elderly|elderly
5179496|NCT02868021|Exercise|exercise
5179497|NCT02868008|multimodal imaging|multimodal imaging
5179498|NCT02868008|surgical risk|surgical risk
5179499|NCT02868008|arteriovenous malformations|arteriovenous malformations
5179500|NCT02867995|glaucoma drop aid|glaucoma drop aid
5179501|NCT02867982|platform switching|platform switching
5179502|NCT02867982|crestal bone remodeling|crestal bone remodeling
5179503|NCT02867982|soft tissue thickness|soft tissue thickness
5179504|NCT02867982|dental implant|dental implant
5179505|NCT02867969|Spinocerebellar ataxia|spinocerebellar ataxia
5179506|NCT02867969|Exergaming|exergaming
5179507|NCT02867969|Neurodegenerative diseases|neurodegenerative diseases
5179508|NCT02867969|Rare disease|rare disease
5179509|NCT02867969|Motor exercises|motor exercises
5179510|NCT02867969|Premanifest stage|premanifest stage
5179511|NCT02867969|Training|training
5179512|NCT02867956|Ovarian cancer|ovarian cancer
5179513|NCT02867956|Apatinib|apatinib
5179514|NCT02867956|Etoposide|etoposide
5179515|NCT02867956|Chemotherapy|chemotherapy
5179516|NCT02867943|sepsis, shock,Lactate,volume controlled ventilation|sepsis, shock,lactate,volume controlled ventilation
5179517|NCT02867930|Echocardiography|echocardiography
5179518|NCT02867930|Transesophageal|transesophageal
5179519|NCT02867930|Dexmedetomidine|dexmedetomidine
5179520|NCT02867930|Ketamine|ketamine
5179521|NCT02867930|Propofol|propofol
5179522|NCT02867917|Fibers|fibers
5179523|NCT02867917|Constipation|constipation
5179524|NCT02867891|FLT3-ITD|flt3-itd
5179526|NCT02867891|allo-HSCT|allo-hsct
5179527|NCT02867839|Gastric cancer|gastric cancer
5179528|NCT02867839|Adjuvant chemotherapy|adjuvant chemotherapy
5179529|NCT02867839|S1|s1
5179530|NCT02867839|Oxaliplatin|oxaliplatin
5179531|NCT02867839|Survival|survival
5179532|NCT02867826|Endoscopy|endoscopy
5179533|NCT02867826|Ampulla of Vater|ampulla of vater
5179534|NCT02867826|Duodenoscopy|duodenoscopy
5179535|NCT02867813|High Cholesterol|high cholesterol
5179536|NCT02867813|Treatment for high cholesterol|treatment for high cholesterol
5179537|NCT02867813|Lowering cholesterol|lowering cholesterol
5179538|NCT02867813|Lowering high cholesterol|lowering high cholesterol
5179539|NCT02867813|Hypercholesterolemia|hypercholesterolemia
5179540|NCT02867800|Sickle Cell Disease|sickle cell disease
5179541|NCT02867800|Graft Versus Host Disease|graft versus host disease
5179542|NCT02867800|Abatacept|abatacept
5179543|NCT02867800|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5179544|NCT02867787|Shoulder Joint|shoulder joint
5179545|NCT02867787|A02.835.583.748|a02.835.583.748
5179546|NCT02867774|chronic pelvic pain|chronic pelvic pain
5179547|NCT02867774|central pain amplification|central pain amplification
5179548|NCT02867774|exercise|exercise
5179549|NCT02867774|physical activity|physical activity
5179550|NCT02867761|COPD|copd
5179551|NCT02867761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5179552|NCT02867761|Pulmonary Function Tests|pulmonary function tests
5179553|NCT02867761|Current Smoker|current smoker
5179554|NCT02867761|Former Smoker|former smoker
5179555|NCT02867761|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5179556|NCT02867761|Respiratory Symptoms|respiratory symptoms
5179557|NCT02867748|tvt abbrevo , Serasis|tvt abbrevo , serasis
5179558|NCT02867735|Macular Edema|macular edema
5179559|NCT02867735|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5179560|NCT02867735|Neovascular age-related Macular Degeneration(AMD)|neovascular age-related macular degeneration(amd)
5179561|NCT02867735|Retinal Vein Occlusions(RVO)|retinal vein occlusions(rvo)
5179562|NCT02867696|Bariatric Surgery|bariatric surgery
5179563|NCT02867696|Physical Activity|physical activity
5179564|NCT02867696|Weight Management|weight management
5179565|NCT02867696|Weight Loss|weight loss
5179566|NCT02867683|vibrotactile feedback|vibrotactile feedback
5179567|NCT02867683|vestibular rehabilitation|vestibular rehabilitation
5179568|NCT02867683|balance|balance
5179569|NCT02867670|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5179570|NCT02867644|conversational hypnosis|conversational hypnosis
5179571|NCT02867644|imaging|imaging
5179572|NCT02867644|care|care
5179573|NCT02867644|breast neoplasia|breast neoplasia
5179574|NCT02867644|anxiety|anxiety
5179575|NCT02867644|pain|pain
5179576|NCT02867631|Intervention study|intervention study
5179577|NCT02867631|Maternal obesity|maternal obesity
5179578|NCT02867631|Nutrition|nutrition
5179579|NCT02867631|Maternal child health|maternal child health
5179580|NCT02867514|tobacco|tobacco
5179581|NCT02867514|craving|craving
5179582|NCT02867514|tDCS|tdcs
5179583|NCT02867514|attentional tasks|attentional tasks
5179584|NCT02867501|venous distension|venous distension
5179585|NCT02867501|venous reflux|venous reflux
5179586|NCT02867488|carotenoids|carotenoids
5179587|NCT02867488|phylloquinone|phylloquinone
5179588|NCT02867488|tocopherols|tocopherols
5179589|NCT02867488|vitamin A|vitamin a
5179590|NCT02867384|Graft vs. Host Disease|graft vs. host disease
5179591|NCT02867358|acute uncomplicated influenza|acute uncomplicated influenza
5179592|NCT02867319|safety|safety
5179593|NCT02867319|vaccine|vaccine
5179594|NCT02867306|methotrexate (MTX)|methotrexate (mtx)
5179595|NCT02867306|Pharmacokinetics|pharmacokinetics
5179596|NCT02867306|ASP1707|asp1707
5179597|NCT02867306|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5179598|NCT02867280|Sorafenib|sorafenib
5179599|NCT02867280|Microvascular invasion|microvascular invasion
5179600|NCT02867280|adjuvant therapy|adjuvant therapy
5179601|NCT02867280|hepatocellular carcinoma|hepatocellular carcinoma
5179602|NCT02867267|thymosin alpha 1; thymalfasin; sepsis; immunodepression|thymosin alpha 1; thymalfasin; sepsis; immunodepression
5179603|NCT02867254|candida|candida
5179604|NCT02867254|endodontic lesion|endodontic lesion
5179605|NCT02867254|diabetes|diabetes
5179606|NCT02867202|intrauterine balloon|intrauterine balloon
5179607|NCT02867202|Intrauterine Device Plus Foley Balloon Catheter|intrauterine device plus foley balloon catheter
5179608|NCT02867202|Asherman Syndrome|asherman syndrome
5179609|NCT02867189|anterior chamber flare|anterior chamber flare
5179610|NCT02867189|cataract|cataract
5179611|NCT02867189|intraocular pressure|intraocular pressure
5179612|NCT02867189|micro-instrument|micro-instrument
5179613|NCT02867189|photograph-based atlas|photograph-based atlas
5179614|NCT02867189|visual|visual
5179615|NCT02867189|training nurse|training nurse
5179616|NCT02867111|sperm selection|sperm selection
5179617|NCT02867111|ICSI|icsi
5179618|NCT02867111|Assisted Reproductive Techniques|assisted reproductive techniques
5179619|NCT02867098|healthy|healthy
5179622|NCT02867085|Myelodysplastic Syndromes|myelodysplastic syndromes
5179627|NCT02867007|KW-0761|kw-0761
5179628|NCT02867007|KHK2455|khk2455
5179629|NCT02867007|Metastatic Solid Tumors|metastatic solid tumors
5179630|NCT02867007|Locally Advanced Solid Tumors|locally advanced solid tumors
5179631|NCT02867007|Mogamulizumab|mogamulizumab
5179632|NCT02867007|Oncology|oncology
5179633|NCT02867007|Anti-Tumor|anti-tumor
5179634|NCT02866994|Women|women
5179635|NCT02866981|Brain Metastases|brain metastases
5179636|NCT02866955|aromatase inhibitors|aromatase inhibitors
5179637|NCT02866955|Metastases|metastases
5179638|NCT02866929|orthodontics|orthodontics
5179639|NCT02866929|periodontics|periodontics
5179640|NCT02866929|piezosurgery|piezosurgery
5179641|NCT02866929|accelerated orthodontics|accelerated orthodontics
5179642|NCT02866929|Surgically Accelerated Orthodontic Treatment|surgically accelerated orthodontic treatment
5179643|NCT02866903|Peritoneal carcinosis|peritoneal carcinosis
5179644|NCT02866903|intraperitoneal (IP) OXAliplatin|intraperitoneal (ip) oxaliplatin
5962236|NCT04282057|radiofrequency|radiofrequency
5099275|NCT03377634|RCT|rct
5179645|NCT02866903|Phase I/II dose escalation trial|phase i/ii dose escalation trial
5179646|NCT02866903|FOLFIRI Bevacizumab chemotherapy|folfiri bevacizumab chemotherapy
5179647|NCT02866890|Laryngeal Tube Suction|laryngeal tube suction
5179648|NCT02866890|seal pressure|seal pressure
5179649|NCT02866890|mechanical ventilation|mechanical ventilation
5179650|NCT02866877|augmented renal clearance|augmented renal clearance
5179651|NCT02866864|Allergen|allergen
5179652|NCT02866864|Veterinary|veterinary
5179653|NCT02866864|Allergy|allergy
5179654|NCT02866864|Animals|animals
5179655|NCT02866838|Tranexamic acid|tranexamic acid
5179656|NCT02866838|NOAC|noac
5179657|NCT02866838|Direct Oral Anticoagulant (DOAC)|direct oral anticoagulant (doac)
5179658|NCT02866838|Direct oral anticoagulants|direct oral anticoagulants
5179659|NCT02866838|Non-Vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
5179660|NCT02866825|Inflammation|inflammation
5179661|NCT02866825|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5179662|NCT02866825|Pathologic Processes|pathologic processes
5179663|NCT02866825|Organ Dysfunction|organ dysfunction
5179664|NCT02866799|Multimorbidity|multimorbidity
5179665|NCT02866799|Primary Health Care|primary health care
5179666|NCT02866799|Polypharmacy|polypharmacy
5179667|NCT02866799|Comorbidity|comorbidity
5179668|NCT02866799|Medication Adherence|medication adherence
5179669|NCT02866799|Medication Appropriateness Index|medication appropriateness index
5179670|NCT02866799|Patient-Centered Care|patient-centered care
5179671|NCT02866773|Family|family
5179672|NCT02866773|well-being|well-being
5179673|NCT02866773|Physical activity|physical activity
5179674|NCT02866773|Diet|diet
5179675|NCT02866760|Smoking Cessation|smoking cessation
5179676|NCT02866734|Diabetic Retinopathy|diabetic retinopathy
5179677|NCT02866734|Screening|screening
5179678|NCT02866734|Fee for screening|fee for screening
5179679|NCT02866734|Private practice|private practice
5179680|NCT02866721|Human Mesenchymal Stem Cells|human mesenchymal stem cells
5179681|NCT02866695|Actinic Keratosis|actinic keratosis
5179682|NCT02866695|lung transplant|lung transplant
5179683|NCT02866695|kidney transplant|kidney transplant
5179684|NCT02866643|contraceptive implant|contraceptive implant
5179685|NCT02866643|postpartum contraception|postpartum contraception
5179686|NCT02866643|breastfeeding and contraception|breastfeeding and contraception
5179687|NCT02866630|Sevoflurane|sevoflurane
5179688|NCT02866630|Desflurane|desflurane
5179689|NCT02866630|Coronary Sinus|coronary sinus
5179690|NCT02866630|Oxygenator Exhaust|oxygenator exhaust
5179691|NCT02866630|Lactate|lactate
5179692|NCT02866630|Cardiopulmonary bypass|cardiopulmonary bypass
5179693|NCT02866617|Quality of Life|quality of life
5179694|NCT02866617|Vacuum formed thermoplastic retainer|vacuum formed thermoplastic retainer
5179695|NCT02866617|Orthodontic study model|orthodontic study model
5179696|NCT02866617|3D reconstructed study model|3d reconstructed study model
5179697|NCT02866604|Traumatic brain injury|traumatic brain injury
5179698|NCT02866604|isotonic balanced fluid|isotonic balanced fluid
5179699|NCT02866591|mammography|mammography
5179700|NCT02866591|pain|pain
5179702|NCT02866591|screening|screening
5179703|NCT02866591|image quality|image quality
5179704|NCT02866591|radiology|radiology
5179705|NCT02866526|adolescents|adolescents
5179706|NCT02866526|young adults|young adults
5179707|NCT02866448|Cardiovascular disease|cardiovascular disease
5179708|NCT02866448|Flavonoid|flavonoid
5179709|NCT02866448|Isoquercetin|isoquercetin
5179710|NCT02866448|Aspirin|aspirin
5179711|NCT02866448|Platelet function|platelet function
5179712|NCT02866448|Vascular function|vascular function
5179713|NCT02866448|Blood pressure|blood pressure
5179714|NCT02866435|MRI|mri
5179715|NCT02866422|OCD|ocd
5179716|NCT02866409|dexmedetomidine|dexmedetomidine
5179717|NCT02866409|nerve block|nerve block
5257885|NCT02401672|TMS|tms
5179718|NCT02866409|anesthesia infiltration|anesthesia infiltration
5179719|NCT02866396|chronic pain|chronic pain
5179720|NCT02866396|oxycodone|oxycodone
5179721|NCT02866396|pregabalin|pregabalin
5179722|NCT02866396|lumbar spine surgery|lumbar spine surgery
5179723|NCT02866396|multimodal analgesia|multimodal analgesia
5179724|NCT02866344|Microwave ablation|microwave ablation
5179725|NCT02866344|Ablation techniques|ablation techniques
5179726|NCT02866344|Operative surgical procedures|operative surgical procedures
5179727|NCT02866344|Hepatic resection|hepatic resection
5179729|NCT02866344|Outcomes assessment|outcomes assessment
5179730|NCT02866305|primary spontaneous pneumothorax|primary spontaneous pneumothorax
5179731|NCT02866305|epidemiology|epidemiology
5179732|NCT02866305|genetics|genetics
5179733|NCT02866305|risk factors|risk factors
5179734|NCT02866292|Pelvic Floor|pelvic floor
5179735|NCT02866292|Pregnancy|pregnancy
5179736|NCT02866292|Physical Therapy Specialty|physical therapy specialty
5179737|NCT02866253|Dehydroepiandrosterone（DHEA）|dehydroepiandrosterone（dhea）
5179738|NCT02866253|DOR（Diminished Ovarian Reserve)|dor（diminished ovarian reserve)
5179739|NCT02866253|IVF(In vitro fertilization)|ivf(in vitro fertilization)
5962237|NCT04282057|adipose tissue|adipose tissue
5962238|NCT04282057|skin flaccidity|skin flaccidity
5179740|NCT02866253|BMP-15(Bone Morphogenetic Protein 15)|bmp-15(bone morphogenetic protein 15)
5179741|NCT02866227|Bacterial|bacterial
5179747|NCT02866227|Vaginitis|vaginitis
5179748|NCT02866227|Vaginoses|vaginoses
5179749|NCT02866227|Vulvovaginal|vulvovaginal
5179750|NCT02866201|Turista|turista
5179751|NCT02866175|percutaneous intervention|percutaneous intervention
5179752|NCT02866175|vitamin K antagonist|vitamin k antagonist
5179753|NCT02866149|Cancer|cancer
5179754|NCT02866149|circulating tumor biomarkers|circulating tumor biomarkers
5179755|NCT02866149|circulating tumor DNA|circulating tumor dna
5179756|NCT02866149|Circulating tumor Cell (CTC)|circulating tumor cell (ctc)
5179757|NCT02866097|integrated community case management|integrated community case management
5179758|NCT02866097|Mobile Health (mHealth)|mobile health (mhealth)
5179759|NCT02866097|rapid diagnostic test|rapid diagnostic test
5179760|NCT02866097|artemether-lumefantrine|artemether-lumefantrine
5179761|NCT02866097|amoxicillin|amoxicillin
5179762|NCT02866097|zinc|zinc
5179763|NCT02866097|oral rehydration solution (ORS)|oral rehydration solution (ors)
5179764|NCT02866097|District Health Information System 2 (DHIS2)|district health information system 2 (dhis2)
5179765|NCT02866097|iCCM-DHIS2|iccm-dhis2
5179766|NCT02866097|ZCAHRD|zcahrd
5179767|NCT02866084|vestibular migraines|vestibular migraines
5179768|NCT02866084|dizziness|dizziness
5179769|NCT02866084|migraine headache|migraine headache
5179770|NCT02866045|Subepithelial lesions|subepithelial lesions
5179771|NCT02866045|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
5179772|NCT02866006|HPV|hpv
5179773|NCT02866006|Type 16, 18|type 16, 18
5179774|NCT02866006|E6E7|e6e7
5179775|NCT02866006|Immune therapeutic vaccine|immune therapeutic vaccine
5179776|NCT02865993|cesarean section|cesarean section
5179777|NCT02865993|cesarean section complications|cesarean section complications
5179778|NCT02865993|betadine irrigation|betadine irrigation
5179779|NCT02865980|inflammation, infection|inflammation, infection
5179780|NCT02865967|Decision Support Techniques|decision support techniques
5179781|NCT02865967|Delayed Diagnosis|delayed diagnosis
5179782|NCT02865967|Natural Language Processing|natural language processing
5179783|NCT02865967|Geographic Information Systems|geographic information systems
5179784|NCT02865941|Target Fortification|target fortification
5179785|NCT02865941|Breast milk analysis|breast milk analysis
5179786|NCT02865941|Nutrition|nutrition
5179787|NCT02865941|Macronutrient intake|macronutrient intake
5179788|NCT02865941|Protein accretion|protein accretion
5179789|NCT02865915|Acne|acne
5179790|NCT02865915|Hirsutism|hirsutism
5179791|NCT02865915|Menstrual Irregularity|menstrual irregularity
5179792|NCT02865915|Alopecia|alopecia
5179793|NCT02865902|Low level laser therapy|low level laser therapy
5179794|NCT02865902|wound healing|wound healing
5179795|NCT02865902|periodontology|periodontology
5179796|NCT02865889|laparoscopic surgery|laparoscopic surgery
5179797|NCT02865889|Uterine Neoplasms|uterine neoplasms
5179798|NCT02865876|Infectious keratitis|infectious keratitis
5179799|NCT02865876|Cross-linking|cross-linking
5179800|NCT02865863|Multivitamin|multivitamin
5179801|NCT02865863|Eurycomalongifoliawater extract|eurycomalongifoliawater extract
5179802|NCT02865863|Quality of Life|quality of life
5179804|NCT02865850|vadadustat|vadadustat
5179805|NCT02865850|AKB-6548|akb-6548
5179806|NCT02865850|anemia|anemia
5179807|NCT02865850|chronic kidney disease|chronic kidney disease
5179808|NCT02865850|CKD|ckd
5179809|NCT02865850|chronic renal insufficiency|chronic renal insufficiency
5179810|NCT02865850|renal impairment|renal impairment
5179811|NCT02865850|erythropoietin|erythropoietin
5179812|NCT02865850|kidney|kidney
5179813|NCT02865850|renal|renal
5179814|NCT02865850|oral anemia treatment|oral anemia treatment
5179815|NCT02865850|hemoglobin|hemoglobin
5781277|NCT00189059|erp|erp
5179818|NCT02865850|efficacy|efficacy
5179819|NCT02865850|safety|safety
5179820|NCT02865850|phase 3|phase 3
5179821|NCT02865850|cardiovascular|cardiovascular
5179822|NCT02865837|Brachytherapy|brachytherapy
5179823|NCT02865837|Organs at Risk|organs at risk
5179824|NCT02865837|Bladder volume|bladder volume
5179825|NCT02865837|Cervical cancer|cervical cancer
5179826|NCT02865824|Colonoscopy|colonoscopy
5179827|NCT02865811|Ovarian Cancer|ovarian cancer
5179828|NCT02865798|Heart Valve Diseases|heart valve diseases
5179829|NCT02865798|Cardiovascular Diseases|cardiovascular diseases
5179830|NCT02865798|Heart Disease|heart disease
5179831|NCT02865798|Valvular Heart Diseases|valvular heart diseases
5179832|NCT02865785|recurrent implantation failure|recurrent implantation failure
5179833|NCT02865785|intralipid|intralipid
5179834|NCT02865785|uterine natural killer cells|uterine natural killer cells
5179835|NCT02865746|Steroids|steroids
5179836|NCT02865746|Pain measurement|pain measurement
5179837|NCT02865733|Remodulin®|remodulin®
5179838|NCT02865733|pulmonary vascular resistance|pulmonary vascular resistance
5179839|NCT02865733|univentricular physiology|univentricular physiology
5179840|NCT02865707|ulcerative colitis|ulcerative colitis
5179841|NCT02865707|prebiotics|prebiotics
5179842|NCT02865707|b-fructans|b-fructans
5179844|NCT02865707|oligofructose|oligofructose
5179845|NCT02865707|intestinal microbiota|intestinal microbiota
5179846|NCT02865681|Infertility|infertility
5179847|NCT02865681|Gonadotropins|gonadotropins
5179848|NCT02865681|Menopur|menopur
5179849|NCT02865681|Ovarian stimulation|ovarian stimulation
5179850|NCT02865642|Stroke|stroke
5179851|NCT02865642|Serotonin|serotonin
5179852|NCT02865642|Hand Paresis|hand paresis
5179853|NCT02865616|CDI|cdi
5179854|NCT02865616|recurrent infection|recurrent infection
5179855|NCT02865616|MET-2|met-2
5179856|NCT02865616|C. difficile|c. difficile
5179857|NCT02865590|Maxillary Sinus/surgery|maxillary sinus/surgery
5179858|NCT02865590|Bone Substitutes|bone substitutes
5179859|NCT02865590|Radiography, Panoramic|radiography, panoramic
5179860|NCT02865564|Probiotics|probiotics
5179861|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents
5179862|NCT02865564|Infant, Newborn|infant, newborn
5179863|NCT02865564|Gastrointestinal Microbiome|gastrointestinal microbiome
5179864|NCT02865564|Colic|colic
5179865|NCT02865564|Gastrointestinal Diseases|gastrointestinal diseases
5179866|NCT02865564|Body Composition|body composition
5179867|NCT02865564|Bone Density|bone density
5179868|NCT02865564|Randomized Controlled Trial|randomized controlled trial
5179869|NCT02865564|Lactobacillus reuteri|lactobacillus reuteri
5179870|NCT02865564|Pediatrics|pediatrics
5179871|NCT02865564|Feces|feces
5179872|NCT02865564|ultrasonography|ultrasonography
5179873|NCT02865564|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5179874|NCT02865564|Electric Impedance|electric impedance
5179875|NCT02865564|Surveys and Questionnaires|surveys and questionnaires
5179876|NCT02865538|Hot flashes|hot flashes
5179877|NCT02865538|Post-menopausal|post-menopausal
5179878|NCT02865525|Surveys and Questionnaires|surveys and questionnaires
5179879|NCT02865525|Patient Education as Topic|patient education as topic
5179880|NCT02865525|Medication Adherence|medication adherence
5179881|NCT02865525|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5179882|NCT02865525|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5179883|NCT02865525|Heart failure|heart failure
5179884|NCT02865512|thoracic epidural injection|thoracic epidural injection
5179885|NCT02865512|patient position|patient position
5179886|NCT02865486|Gastric emptying|gastric emptying
5179887|NCT02865486|MRI|mri
5179888|NCT02865486|lipid emulsions|lipid emulsions
5179889|NCT02865486|breath test|breath test
5179890|NCT02865486|GI peptide hormones|gi peptide hormones
5179893|NCT02865460|Chronic Pain|chronic pain
5179894|NCT02865460|Cognitive Disorders|cognitive disorders
5179895|NCT02865460|Inflammation|inflammation
5179896|NCT02865460|Neurologic manifestations|neurologic manifestations
5179897|NCT02865460|Dementia|dementia
5179898|NCT02865460|Mental Disorders|mental disorders
5179899|NCT02865460|Ubiquinol/ubiquinone|ubiquinol/ubiquinone
5179900|NCT02865460|Pathologic Processes|pathologic processes
5179901|NCT02865460|Nervous System Diseases|nervous system diseases
5179902|NCT02865460|Hormones, Hormone Substitutes, and Hormone Antagon|hormones, hormone substitutes, and hormone antagon
5179903|NCT02865460|Anti-Inflammatory Agents|anti-inflammatory agents
5179904|NCT02865460|Pharmacologic Actions|pharmacologic actions
5179905|NCT02865460|Therapeutic Uses|therapeutic uses
5179906|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs
5179907|NCT02865460|Gulf war illness|gulf war illness
5179908|NCT02865460|Chronic fatigue|chronic fatigue
5179909|NCT02865447|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5179910|NCT02865447|DEXA|dexa
5179912|NCT02865447|total hip arthroplasty|total hip arthroplasty
5179913|NCT02865447|PROFEMUR|profemur
5179915|NCT02865447|bone mineral density|bone mineral density
5179916|NCT02865447|BMD|bmd
5179917|NCT02865447|osteoarthritis|osteoarthritis
5179918|NCT02865447|THA|tha
5179919|NCT02865447|musculoskeletal disease|musculoskeletal disease
5179920|NCT02865408|Amino acids|amino acids
5179921|NCT02865408|critically-ill|critically-ill
5179922|NCT02865408|catabolic|catabolic
5179923|NCT02865408|nutrition|nutrition
5179924|NCT02865408|anabolic|anabolic
5179925|NCT02865395|Belladonna and Opium Suppositories|belladonna and opium suppositories
5179926|NCT02865382|Adenoma detection rate|adenoma detection rate
5179927|NCT02865382|Optical Enhancement Technonogy|optical enhancement technonogy
5179928|NCT02865382|Colonoscopy|colonoscopy
5179929|NCT02865369|chronic hepatitis C|chronic hepatitis c
5179930|NCT02865369|Daclatasvir|daclatasvir
5179931|NCT02865369|Asunaprevir|asunaprevir
5179932|NCT02865369|fibrosis|fibrosis
5179933|NCT02865369|transient elastography|transient elastography
5179934|NCT02865356|atopic dermatitis|atopic dermatitis
5179936|NCT02865356|children|children
5179937|NCT02865356|skin|skin
5179938|NCT02865356|topical|topical
5179939|NCT02865356|cyclosporine|cyclosporine
5179940|NCT02865343|Functional Electrical Stimulation (FES)-Rowing|functional electrical stimulation (fes)-rowing
5179941|NCT02865330|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
5179942|NCT02865330|Low Risk Prostate Cancer|low risk prostate cancer
5179943|NCT02865330|Active Surveillance|active surveillance
5179944|NCT02865304|metastatic breast cancer|metastatic breast cancer
5179945|NCT02865304|HER-2-negative|her-2-negative
5179946|NCT02865304|endostar|endostar
5179947|NCT02865252|manual therapy|manual therapy
5179948|NCT02865252|mobilization with movement|mobilization with movement
5179949|NCT02865239|Imaging, Three-Dimensional|imaging, three-dimensional
5179950|NCT02865239|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
5179951|NCT02865239|Breast Neoplasms/diagnosis*|breast neoplasms/diagnosis*
5179952|NCT02865239|Prone Position|prone position
5179953|NCT02865239|Prospective Studies|prospective studies
5179954|NCT02865226|thoracic surgery|thoracic surgery
5179955|NCT02865226|thoracotomy|thoracotomy
5179956|NCT02865213|Open bite|open bite
5179957|NCT02865213|Molar intrusion|molar intrusion
5179958|NCT02865213|Temporary anchorage devices|temporary anchorage devices
5179959|NCT02865200|Nutrition|nutrition
5179960|NCT02865200|Public Health|public health
5179961|NCT02865187|Vitamin D|vitamin d
5179962|NCT02865187|polycystic ovary syndrome|polycystic ovary syndrome
5179963|NCT02865187|polycystic ovarian syndrome|polycystic ovarian syndrome
5179964|NCT02865187|PCOS|pcos
5179965|NCT02865187|sexual dysfunction|sexual dysfunction
5179966|NCT02865187|female sexual dysfunction|female sexual dysfunction
5179967|NCT02865187|low libido|low libido
5179968|NCT02865174|Thrombin-gelatin matrix|thrombin-gelatin matrix
5179969|NCT02865174|Floseal|floseal
5179970|NCT02865174|Tranexamic Acid|tranexamic acid
5179971|NCT02865174|Total Knee Arthroplasty|total knee arthroplasty
5179972|NCT02865135|HPV Related Head and Neck|hpv related head and neck
5179973|NCT02865135|Cervical|cervical
5179974|NCT02865135|Anal Cancer|anal cancer
5179975|NCT02865109|Spinal Muscular Atrophy|spinal muscular atrophy
5179976|NCT02865109|SMA|sma
5179977|NCT02865109|SMN|smn
5179978|NCT02865109|SMNRx|smnrx
5179979|NCT02865109|ISIS-SMNRx|isis-smnrx
5179980|NCT02865109|ISIS-SMN Rx|isis-smn rx
5179981|NCT02865109|ISIS 396443|isis 396443
5179982|NCT02865109|ISIS-396443|isis-396443
5179983|NCT02865109|ENDEAR|endear
5179984|NCT02865109|IONIS-SMNRx|ionis-smnrx
5179985|NCT02865109|IONIS-SMN Rx|ionis-smn rx
5179986|NCT02865109|EMBRACE|embrace
5179987|NCT02865109|NURTURE|nurture
5179988|NCT02865109|IONIS|ionis
5179989|NCT02865109|BIOGEN|biogen
5179990|NCT02865109|SHINE|shine
5179991|NCT02865109|Nusinersen|nusinersen
5179992|NCT02865070|premature|premature
5179993|NCT02865070|wireless vitals|wireless vitals
5179994|NCT02865070|vitals monitor|vitals monitor
5179995|NCT02865044|Fatty Acids|fatty acids
5179996|NCT02865044|Fish Oil|fish oil
5179997|NCT02865044|Marine Copepod|marine copepod
5179998|NCT02865044|Fatty Acid Absorption|fatty acid absorption
5179999|NCT02865018|Neuromyelitis Optica|neuromyelitis optica
5180000|NCT02865018|Cetirizine|cetirizine
5180001|NCT02864992|lung|lung
5180002|NCT02864992|neoplasm|neoplasm
5180003|NCT02864992|cancer|cancer
5180004|NCT02864992|tumor|tumor
5180005|NCT02864992|adenocarcinoma|adenocarcinoma
5180006|NCT02864992|MET exon 14|met exon 14
5180007|NCT02864992|METex14|metex14
5180008|NCT02864992|pulmonary|pulmonary
5180009|NCT02864992|stage III|stage iii
5180010|NCT02864992|stage IV|stage iv
5180011|NCT02864992|c-Met|c-met
5180012|NCT02864992|cMET|cmet
5180013|NCT02864992|NSCLC|nsclc
5180014|NCT02864992|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5180015|NCT02864992|MET amplification|met amplification
5180016|NCT02864966|Safety study|safety study
5180017|NCT02864966|new product|new product
5180018|NCT02864966|normal healthy skin.|normal healthy skin.
5180044|NCT02864888|Diffuse, intrinsic brain stem glioma|diffuse, intrinsic brain stem glioma
5180046|NCT02864888|Radiation|radiation
5180047|NCT02864888|Antineoplaston therapy|antineoplaston therapy
5180048|NCT02864875|Trauma|trauma
5180049|NCT02864875|Coagulopathy|coagulopathy
5180050|NCT02864875|Fibrinogen|fibrinogen
5180051|NCT02864875|Fibrinogen Concentrate|fibrinogen concentrate
5180052|NCT02864875|Thromboelastometry|thromboelastometry
5180053|NCT02864875|Hypofibrinogenemia|hypofibrinogenemia
5180054|NCT02864875|Early Fibrinogen Replacement|early fibrinogen replacement
5180055|NCT02864849|Rectal cancer|rectal cancer
5180056|NCT02864849|neoadjuvant|neoadjuvant
5180057|NCT02864849|radiotherapy|radiotherapy
5180058|NCT02864849|chemotherapy|chemotherapy
5180059|NCT02864849|toxicity|toxicity
5180060|NCT02864836|Copper|copper
5180061|NCT02864836|isotopic distribution|isotopic distribution
5180062|NCT02864836|cancer|cancer
5180063|NCT02864823|Scleromalacia perforans|scleromalacia perforans
5180064|NCT02864823|Necrotizing Scleritis|necrotizing scleritis
5180065|NCT02864823|Perichondrium|perichondrium
5180066|NCT02864797|Health related quality of life|health related quality of life
5180067|NCT02864797|patient reported outcomes|patient reported outcomes
5180069|NCT02864797|e-health|e-health
5180070|NCT02864771|Ventricular Arrhythmias|ventricular arrhythmias
5180071|NCT02864771|ICD|icd
5180072|NCT02864771|Biological markers|biological markers
5180073|NCT02864745|early rehabilitation|early rehabilitation
5180074|NCT02864745|critically ill|critically ill
5180075|NCT02864745|muscle weakness|muscle weakness
5180076|NCT02864745|neuromuscular stimulation|neuromuscular stimulation
5180077|NCT02864745|functional electrical stimulation-assisted cycle ergometry|functional electrical stimulation-assisted cycle ergometry
5180078|NCT02864745|ICUAW|icuaw
5180079|NCT02864732|Low back pain|low back pain
5180080|NCT02864732|stabilization exercises|stabilization exercises
5180081|NCT02864732|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5180082|NCT02864719|Heart arrest|heart arrest
5180083|NCT02864719|Cardiac arrest|cardiac arrest
5180084|NCT02864719|Fatigue|fatigue
5180085|NCT02864706|allograft rejection|allograft rejection
5180086|NCT02864706|xenograft rejection|xenograft rejection
5180087|NCT02864706|host vs graft disease|host vs graft disease
5180088|NCT02864706|transplant|transplant
5180089|NCT02864693|Microprocessor Controlled Ankle|microprocessor controlled ankle
5180090|NCT02864693|Transtibial Amputee|transtibial amputee
5180091|NCT02864693|Pacifica LP|pacifica lp
5180092|NCT02864693|Kinnex|kinnex
5180093|NCT02864680|cannabis|cannabis
5180094|NCT02864680|magnocellular pathway|magnocellular pathway
5180095|NCT02864654|Critical lower limb ischemia|critical lower limb ischemia
5180096|NCT02864654|Atherosclerosis obliterans|atherosclerosis obliterans
5180097|NCT02864654|Diabetic angiopathies|diabetic angiopathies
5180098|NCT02864654|Thromboangiitis obliterans|thromboangiitis obliterans
5180099|NCT02864654|Ischemic ulcers|ischemic ulcers
5180100|NCT02864654|Peripheral arterial disease|peripheral arterial disease
5180101|NCT02864654|Indirect revascularisation|indirect revascularisation
5180102|NCT02864654|Intramuscular injection|intramuscular injection
5180103|NCT02864654|Ankle-brachial index|ankle-brachial index
5180104|NCT02864654|Transcutaneous oxygen tension|transcutaneous oxygen tension
5180105|NCT02864654|Stromal vascular fraction (SVF)|stromal vascular fraction (svf)
5180106|NCT02864654|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
5180107|NCT02864654|Adipose tissue|adipose tissue
5180108|NCT02864654|Stem cells|stem cells
5180109|NCT02864641|chronic kidney disease|chronic kidney disease
5180110|NCT02864641|adolescents|adolescents
5180111|NCT02864641|renal disease|renal disease
5180112|NCT02864641|CKD|ckd
5180113|NCT02864628|RSV Vaccines|rsv vaccines
5180114|NCT02864628|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
5180115|NCT02864615|renal cell carcinoma|renal cell carcinoma
5180116|NCT02864615|metastasis|metastasis
5180117|NCT02864615|stereotactic body radiation therapy|stereotactic body radiation therapy
5180118|NCT02864615|targted therapy|targted therapy
5068640|NCT03570008|women|women
5180119|NCT02864615|immune checkpoint inhibitors|immune checkpoint inhibitors
5180120|NCT02864602|Regional anesthesia|regional anesthesia
5180121|NCT02864602|Adjuvant|adjuvant
5180122|NCT02864602|Dexamethasone|dexamethasone
5180123|NCT02864589|Tourette, Tic, Tics|tourette, tic, tics
5180124|NCT02864550|Men who have sex with men|men who have sex with men
5180125|NCT02864550|Human immunodeficiency virus|human immunodeficiency virus
5180126|NCT02864550|Doxycycline|doxycycline
5180127|NCT02864550|Tetracycline|tetracycline
5180128|NCT02864537|warfarin|warfarin
5180129|NCT02864537|self-management|self-management
5180130|NCT02864537|Conventional management|conventional management
5180131|NCT02864537|Training|training
5180132|NCT02864537|TTR|ttr
5180133|NCT02864537|Complications|complications
5180134|NCT02864537|Quality of life|quality of life
5180135|NCT02864524|Physical Therapy Modalities|physical therapy modalities
5180136|NCT02864524|Exercises|exercises
5180137|NCT02864524|Musculoskeletal Manipulations|musculoskeletal manipulations
5180138|NCT02864485|Live donor liver transplantation|live donor liver transplantation
5180139|NCT02864459|Ultrasonography|ultrasonography
5180140|NCT02864459|Weaning|weaning
5180141|NCT02864433|cholera|cholera
5180142|NCT02864433|oral cholera vaccine|oral cholera vaccine
5180143|NCT02864433|diarrhea|diarrhea
5180144|NCT02864420|home hospital|home hospital
5180145|NCT02864420|acute care home|acute care home
5180146|NCT02864420|care redesign|care redesign
5180147|NCT02864420|delivery innovation|delivery innovation
5180148|NCT02864420|heart failure|heart failure
5180149|NCT02864420|pneumonia|pneumonia
5180150|NCT02864420|cellulitis|cellulitis
5180151|NCT02864420|urinary tract infections|urinary tract infections
5180152|NCT02864368|PERFORMANCE|performance
5180153|NCT02864368|Pro00034208|pro00034208
5180154|NCT02864368|Cytomegalovirus|cytomegalovirus
5180156|NCT02864342|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5180157|NCT02864342|COPD|copd
5180158|NCT02864342|Respiratory|respiratory
5180159|NCT02864342|adherence|adherence
5180160|NCT02864342|medication reminders|medication reminders
5180161|NCT02864329|Male Infertility|male infertility
5180162|NCT02864329|micro RNAs|micro rnas
5180163|NCT02864329|small interfering RNAs|small interfering rnas
5180164|NCT02864329|miRNA|mirna
5180165|NCT02864329|siRNA|sirna
5180166|NCT02864316|radiation-induced solid tumors|radiation-induced solid tumors
5180167|NCT02864316|Nivolumab|nivolumab
5180168|NCT02864316|Phase 2 study|phase 2 study
5180169|NCT02864303|Alzheimer's disease|alzheimer's disease
5180170|NCT02864303|Mild Cognitive Impairment|mild cognitive impairment
5180171|NCT02864303|Saliva|saliva
5180172|NCT02864303|Amyloid peptides|amyloid peptides
5180173|NCT02864303|Diagnosis|diagnosis
5054222|NCT03659344|Polyglactin 910|polyglactin 910
5180175|NCT02864290|Pharmacokinetics of ASP1235 (AGS62P1)|pharmacokinetics of asp1235 (ags62p1)
5180176|NCT02864290|ASP1235|asp1235
5180177|NCT02864290|Acute Myeloid Leukemia|acute myeloid leukemia
5180178|NCT02864290|ASP1235 (AGS62P1)|asp1235 (ags62p1)
5180179|NCT02864277|Gynecology|gynecology
5180180|NCT02864277|Cancer|cancer
5180181|NCT02864277|General Surgery|general surgery
5180182|NCT02864277|Recovery Quality|recovery quality
5180183|NCT02864277|Length of hospital stay|length of hospital stay
5180184|NCT02864238|electronic milestone pathway|electronic milestone pathway
5180185|NCT02864238|cardiac valve surgery|cardiac valve surgery
5180186|NCT02864186|Pain|pain
5180187|NCT02864186|Quality of life|quality of life
5180188|NCT02864186|wound healing|wound healing
5180189|NCT02864173|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5180190|NCT02864173|Postoperative cognitive decline|postoperative cognitive decline
5180191|NCT02864173|Postoperative delirium|postoperative delirium
5180192|NCT02864173|Cognitive outcome|cognitive outcome
5180193|NCT02864173|Neuropsychology|neuropsychology
5180194|NCT02864173|Genetics|genetics
5180195|NCT02864160|Language Concordance|language concordance
5180196|NCT02864160|Diabetes Self-Management|diabetes self-management
5180197|NCT02864160|Health Coaching|health coaching
5180198|NCT02864160|Latinos|latinos
5180199|NCT02864134|Optic neuritis|optic neuritis
5180200|NCT02864134|ganglion cell layer|ganglion cell layer
5180201|NCT02864121|High-risk human papillomavirus|high-risk human papillomavirus
5180202|NCT02864121|Integration of HR-HPV DNA|integration of hr-hpv dna
5180203|NCT02864121|biomarker of severity|biomarker of severity
5180204|NCT02864121|biomarker of evolution|biomarker of evolution
5180205|NCT02864095|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5180206|NCT02864095|Epinephrine|epinephrine
5180207|NCT02864095|Tranexamic acid|tranexamic acid
5180208|NCT02864082|X-linked, lamellar|x-linked, lamellar
5180209|NCT02864043|Barrett's Esophagus|barrett's esophagus
5180210|NCT02864043|Barrett's|barrett's
5180211|NCT02864043|OCT|oct
5180212|NCT02864043|VLE|vle
5180213|NCT02864030|Eribulin mesylate|eribulin mesylate
5180214|NCT02864030|Halaven|halaven
5180217|NCT02864004|Parkinson disease|parkinson disease
5180218|NCT02864004|Quality of Life|quality of life
5068741|NCT03569553|Anthrasil|anthrasil
5180219|NCT02864004|Apomorphine infusion|apomorphine infusion
5180221|NCT02863978|Neonates|neonates
5180222|NCT02863978|Cardio-respiratory maturation|cardio-respiratory maturation
5180223|NCT02863978|Neurobehavioral maturation|neurobehavioral maturation
5180224|NCT02863926|BKA|bka
5180225|NCT02863926|amputation|amputation
5180226|NCT02863926|MarrowStim|marrowstim
5180227|NCT02863926|below knee amputation|below knee amputation
5180228|NCT02863926|wound complication|wound complication
5180229|NCT02863926|vascular disease|vascular disease
5180230|NCT02863926|critical limb ischemia|critical limb ischemia
5180231|NCT02863926|peripheral artery disease|peripheral artery disease
5180232|NCT02863926|AKA|aka
5180233|NCT02863926|stem cells|stem cells
5180234|NCT02863926|bone marrow|bone marrow
5180235|NCT02863887|Weight Loss|weight loss
5180236|NCT02863887|African American|african american
5180237|NCT02863887|Community Based|community based
5180238|NCT02863887|Mobile technology|mobile technology
5180239|NCT02863887|Translational science|translational science
5180240|NCT02863874|Perineal tear|perineal tear
5180242|NCT02863874|Triclosan|triclosan
5180243|NCT02863861|Sedation|sedation
5180244|NCT02863861|Pediatric Patients|pediatric patients
5180245|NCT02863822|Functional Dyspepsia|functional dyspepsia
5180246|NCT02863822|Low FODMAP|low fodmap
5180247|NCT02863822|Dietary Modification|dietary modification
5180248|NCT02863809|Keratolysis|keratolysis
5180249|NCT02863809|Corneal Melting|corneal melting
5180250|NCT02863809|Boston KPro|boston kpro
5180251|NCT02863809|Keratoprosthesis|keratoprosthesis
5180252|NCT02863770|endosonography|endosonography
5180253|NCT02863744|mmp-8|mmp-8
5180254|NCT02863744|early stages of wound healing|early stages of wound healing
5180255|NCT02863744|wound healing marker|wound healing marker
5180256|NCT02863731|postural changes|postural changes
5180257|NCT02863731|alternating postures|alternating postures
5180258|NCT02863731|Cognitive performance|cognitive performance
5180259|NCT02863731|Height-adjustable desk|height-adjustable desk
5180260|NCT02863731|Worksite|worksite
5180262|NCT02863692|CLL|cll
5180263|NCT02863692|B-PLL|b-pll
5180264|NCT02863692|T-PLL|t-pll
5180265|NCT02863692|SLL|sll
5180266|NCT02863692|T-NK-LGL|t-nk-lgl
5180267|NCT02863692|HCL|hcl
5180268|NCT02863692|Richter´s Transformation|richter´s transformation
5180269|NCT02863679|tetracaine hydrochloride gel|tetracaine hydrochloride gel
5180270|NCT02863679|analgesia|analgesia
5180271|NCT02863679|intrauterine balloon|intrauterine balloon
5180272|NCT02863679|hysteroscope operation|hysteroscope operation
5180273|NCT02863666|Cariopulmonary, cardiac arrest|cariopulmonary, cardiac arrest
5180274|NCT02863653|social participation|social participation
5180275|NCT02863653|International Classification of Functioning|international classification of functioning
5962239|NCT04282057|aerobic exercise|aerobic exercise
5962240|NCT04282005|Metabolic Surgery|metabolic surgery
5054325|NCT03658772|EP4|ep4
5180276|NCT02863640|Senile macular degeneration|senile macular degeneration
5180277|NCT02863640|Parkinson's disease|parkinson's disease
5180278|NCT02863627|Emergencies|emergencies
5180279|NCT02863627|newborn|newborn
5180280|NCT02863627|care|care
5180283|NCT02863575|third molar extraction|third molar extraction
5180284|NCT02863575|ibuprofen|ibuprofen
5180285|NCT02863575|ibuprofen/caffeine|ibuprofen/caffeine
5180286|NCT02863575|post-surgical dental pain|post-surgical dental pain
5180287|NCT02863536|Recurrence of Bacterial Vaginosis|recurrence of bacterial vaginosis
5180288|NCT02863510|Carbon dioxide angiography|carbon dioxide angiography
5180289|NCT02863510|Renal sympathetic denervation|renal sympathetic denervation
5180290|NCT02863510|Uncontrolled hypertension|uncontrolled hypertension
5180291|NCT02863510|Chronic kidney disease|chronic kidney disease
5180292|NCT02863471|Pancreas|pancreas
5180293|NCT02863471|Adenocarcinoma|adenocarcinoma
5180294|NCT02863471|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5180295|NCT02863471|HIPEC|hipec
5180296|NCT02863471|Pancreatic surgery|pancreatic surgery
5180297|NCT02863471|Gemcitabine|gemcitabine
5180298|NCT02863458|MDS|mds
5180299|NCT02863458|AML|aml
5180300|NCT02863458|hypomethylating agents (HMA)|hypomethylating agents (hma)
5180301|NCT02863458|Surveillance Epidemiology and End Results (SEER)|surveillance epidemiology and end results (seer)
5180302|NCT02863445|Obesity|obesity
5180303|NCT02863445|Body weight|body weight
5180304|NCT02863445|Emergency contraception|emergency contraception
5180305|NCT02863445|Levonogestrel|levonogestrel
5180306|NCT02863445|Ulipristal acetate|ulipristal acetate
5180307|NCT02863406|Dust rate|dust rate
5180308|NCT02863406|Microscopic analysis|microscopic analysis
5180309|NCT02863380|Individualized Medicine|individualized medicine
5180310|NCT02863380|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5068853|NCT03569020|BMI|bmi
5180311|NCT02863380|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
5781278|NCT00189059|driving|driving
5180312|NCT02863380|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
5180313|NCT02863380|Functional Neuroimaging|functional neuroimaging
5180314|NCT02863302|Acute Myeloid Leukemia, Reflexology|acute myeloid leukemia, reflexology
5180315|NCT02863263|foam dressing|foam dressing
5180316|NCT02863263|MedifoamⓇ|medifoamⓡ
5180317|NCT02863263|BetafoamⓇ|betafoamⓡ
5180318|NCT02863263|povidone iodine|povidone iodine
5180319|NCT02863237|brain injury|brain injury
5180320|NCT02863237|mechanical ventilation|mechanical ventilation
5180321|NCT02863237|weaning|weaning
5180322|NCT02863198|unexplained infertility|unexplained infertility
5180323|NCT02863198|endometrial injury|endometrial injury
5180324|NCT02863198|pregnancy|pregnancy
5180325|NCT02863185|chronic kidney disease|chronic kidney disease
5180326|NCT02863185|pitavastatin|pitavastatin
5180327|NCT02863185|erythrocyte membrane fatty acid|erythrocyte membrane fatty acid
5180328|NCT02863172|Hereditary colorectal cancer syndrome|hereditary colorectal cancer syndrome
5180329|NCT02863172|Questionnaires|questionnaires
5180330|NCT02863172|Surveys|surveys
5180331|NCT02863172|Blood sample|blood sample
5180332|NCT02863172|Saliva sample|saliva sample
5180333|NCT02863146|locally advanced breast cancer|locally advanced breast cancer
5180334|NCT02863146|alopecia|alopecia
5180335|NCT02863146|eribulin|eribulin
5180336|NCT02863120|Bupivacaine|bupivacaine
5180337|NCT02863120|Osteoarthritis|osteoarthritis
5180338|NCT02863120|Arthritis|arthritis
5180340|NCT02863120|Ropivacaine|ropivacaine
5180341|NCT02863120|Anesthetics, Local|anesthetics, local
5180342|NCT02863120|Anesthetics|anesthetics
5180343|NCT02863107|Colon Cancer|colon cancer
5180344|NCT02863107|Rectal Cancer|rectal cancer
5180345|NCT02863107|Questionnaires|questionnaires
5180347|NCT02863107|Blood draw|blood draw
5180348|NCT02863094|schizophrenia|schizophrenia
5180349|NCT02863094|auditory hallucinations|auditory hallucinations
5180350|NCT02863094|functional magnetic resonance imaging|functional magnetic resonance imaging
5180351|NCT02863094|transcranial magnetic stimulation|transcranial magnetic stimulation
5180352|NCT02863068|Sickle cell disease|sickle cell disease
5180353|NCT02863068|sodium nitrite|sodium nitrite
5180354|NCT02863068|wound healing|wound healing
5180355|NCT02863068|Ulcer|ulcer
5180356|NCT02863055|MPM|mpm
5180357|NCT02863055|Unresectable|unresectable
5180358|NCT02863055|Phase II|phase ii
5180359|NCT02863055|Randomized|randomized
5180360|NCT02863055|Maintenance|maintenance
5180361|NCT02863029|Intestinal stem cells|intestinal stem cells
5180362|NCT02863016|dialysis|dialysis
5180363|NCT02863016|hemodiafiltration|hemodiafiltration
5180364|NCT02862990|Breast cancer|breast cancer
5180366|NCT02862964|back pain|back pain
5180367|NCT02862951|pregnancy|pregnancy
5180368|NCT02862925|fetal monitoring|fetal monitoring
5180369|NCT02862925|cesarean delivery|cesarean delivery
5962241|NCT04282005|Bariatric Surgery|bariatric surgery
5180370|NCT02862925|obstetrics|obstetrics
5180371|NCT02862925|midwifery|midwifery
5180372|NCT02862925|developing countries|developing countries
5180373|NCT02862912|Chloroprocaine|chloroprocaine
5180374|NCT02862912|cervical cerclage|cervical cerclage
5180375|NCT02862912|spinal anesthesia|spinal anesthesia
5180376|NCT02862912|Bupivacaine|bupivacaine
5180377|NCT02862873|Spinal anaesthesia|spinal anaesthesia
5180378|NCT02862821|biomarkers of psychiatric disorder|biomarkers of psychiatric disorder
5180379|NCT02862821|gambling addiction|gambling addiction
5180380|NCT02862821|high resolution-ElectroEncephaloGraphy (HR-EEG)|high resolution-electroencephalography (hr-eeg)
5180381|NCT02862808|Whole exome sequencing|whole exome sequencing
5180382|NCT02862808|Molecular diagnostic|molecular diagnostic
5180383|NCT02862808|Genetic counselling|genetic counselling
5180384|NCT02862795|colonoscopy|colonoscopy
5180385|NCT02862730|diabetes|diabetes
5180386|NCT02862730|closed-loop|closed-loop
5180387|NCT02862730|dual hormone|dual hormone
5180388|NCT02862730|exercise|exercise
5180389|NCT02862717|Cost effectiveness|cost effectiveness
5180390|NCT02862717|cost utility|cost utility
5180392|NCT02862717|hemodialysis|hemodialysis
5180394|NCT02862717|Markov model|markov model
5180395|NCT02862717|peritoneal dialysis|peritoneal dialysis
5180396|NCT02862691|toothache|toothache
5180397|NCT02862626|Diabetic children|diabetic children
5180398|NCT02862626|Mothers|mothers
5180399|NCT02862613|Precision Cells|precision cells
5180400|NCT02862613|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5180401|NCT02862613|Advanced Liver Cancer|advanced liver cancer
5180402|NCT02862600|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5180403|NCT02862600|heart failure|heart failure
5180404|NCT02862600|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5180405|NCT02862600|6 minute walk test|6 minute walk test
5180406|NCT02862600|perhexiline|perhexiline
5180407|NCT02862600|carnitine palmitoyltransferase|carnitine palmitoyltransferase
5180408|NCT02862600|mixed ion channel effects|mixed ion channel effects
5180409|NCT02862600|late sodium current inhibitor|late sodium current inhibitor
5180410|NCT02862600|calcium channel inhibition|calcium channel inhibition
5180411|NCT02862587|Precision Cells|precision cells
5180412|NCT02862587|Chemotherapy|chemotherapy
5180413|NCT02862587|Advanced Lung Cancer|advanced lung cancer
5180414|NCT02862574|Rheumatoid Arthritis|rheumatoid arthritis
5180415|NCT02862574|Tumor Necrosis Factor Inhibitor|tumor necrosis factor inhibitor
5180416|NCT02862574|TNF-IR|tnf-ir
5180417|NCT02862574|Methotrexate|methotrexate
5180418|NCT02862561|Precision Cell Immunotherapy|precision cell immunotherapy
5180419|NCT02862561|Chemotherapy|chemotherapy
5180420|NCT02862561|Advanced Malignancies|advanced malignancies
5180421|NCT02862522|uric acid|uric acid
5180422|NCT02862522|microvascular dysfunction|microvascular dysfunction
5180423|NCT02862522|inflammation|inflammation
5180424|NCT02862509|Post-frontal sinus operation chronic rhinosinusitis patients|post-frontal sinus operation chronic rhinosinusitis patients
5180425|NCT02862509|Budesonide nasal instillation|budesonide nasal instillation
5180426|NCT02862509|Vertex to floor position|vertex to floor position
5180427|NCT02862496|Hyperemesis Gravidarum|hyperemesis gravidarum
5180428|NCT02862496|Bone Health|bone health
5180429|NCT02862496|Urine N-telopeptide|urine n-telopeptide
5180430|NCT02862496|Serum calcium|serum calcium
5180431|NCT02862496|Serum parathormone|serum parathormone
5180432|NCT02862496|Serum vit D|serum vit d
5180433|NCT02862470|Lovastatin|lovastatin
5180434|NCT02862470|Vildagliptin|vildagliptin
5180435|NCT02862470|Exosome|exosome
5180436|NCT02862470|Anaplastic thyroid cancer|anaplastic thyroid cancer
5180437|NCT02862470|Proteomics|proteomics
5180438|NCT02862470|Urine|urine
5180439|NCT02862470|Biological marker|biological marker
5180440|NCT02862457|Advanced Solid Tumors|advanced solid tumors
5180441|NCT02862457|PD-1|pd-1
5180442|NCT02862457|PD1|pd1
5180443|NCT02862457|Programmed Cell Death-1|programmed cell death-1
5180444|NCT02862457|Programmed Cell Death 1|programmed cell death 1
5180445|NCT02862457|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
5180446|NCT02862457|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
5180447|NCT02862457|PDL1|pdl1
5180448|NCT02862457|PDL2|pdl2
5180449|NCT02862418|MRI|mri
5180450|NCT02862418|UTE MRI|ute mri
5180451|NCT02862418|Pulmonary|pulmonary
5180452|NCT02862405|Vision loss|vision loss
5180453|NCT02862405|Object recognition|object recognition
5180454|NCT02862405|Space recognition|space recognition
5180455|NCT02862392|Scoliosis|scoliosis
5180456|NCT02862392|Adolescent|adolescent
5180457|NCT02862392|Idiopathic scoliosis|idiopathic scoliosis
5180458|NCT02862392|Predictive factors|predictive factors
5180459|NCT02862366|myeloproliferative neoplasms|myeloproliferative neoplasms
5180460|NCT02862366|Circulating Procoagulants Microparticles|circulating procoagulants microparticles
5180461|NCT02862353|Validation new test|validation new test
5180462|NCT02862327|anaesthetic techniques|anaesthetic techniques
5180463|NCT02862327|regional anesthesia|regional anesthesia
5180464|NCT02862327|brachial plexus block|brachial plexus block
5180465|NCT02862327|Local Anesthetic|local anesthetic
5180466|NCT02862327|ropivacaine|ropivacaine
5180467|NCT02862327|analgesia|analgesia
5180468|NCT02862327|steroid|steroid
5180469|NCT02862327|dexamethasone|dexamethasone
5180470|NCT02862327|placebo|placebo
5180471|NCT02862327|adjuvant|adjuvant
5180472|NCT02862327|ultrasound guided|ultrasound guided
5180473|NCT02862314|Procalcitonin|procalcitonin
5180474|NCT02862301|Histone Deacetylases|histone deacetylases
5180475|NCT02862301|Histone Acetyltransferases|histone acetyltransferases
5180476|NCT02862223|Coagulation|coagulation
5180477|NCT02862223|Circulatory Function|circulatory function
5180478|NCT02862223|Blood Pressure|blood pressure
5180479|NCT02862223|Inflammatory response|inflammatory response
5180480|NCT02862223|Blood Glucose|blood glucose
5180481|NCT02862223|Healthy vascular function|healthy vascular function
5180483|NCT02862210|Lithium Carbonate|lithium carbonate
5180484|NCT02862145|Biosy accessible melanoma|biosy accessible melanoma
5180485|NCT02862132|VDZ: Vedolizumab|vdz: vedolizumab
5180486|NCT02862132|UC: Ulcerative colitis|uc: ulcerative colitis
5180487|NCT02862132|CD: Crohn's disease|cd: crohn's disease
5180488|NCT02862132|TDM: Therapeutic drug monitoring|tdm: therapeutic drug monitoring
5180489|NCT02862119|percutaneous coronary intervention|percutaneous coronary intervention
5180490|NCT02862119|fractional flow reserve|fractional flow reserve
5180491|NCT02862119|all cause mortality|all cause mortality
5180492|NCT02862119|myocardial infarction|myocardial infarction
5180493|NCT02862119|registry-based randomized clinical trial|registry-based randomized clinical trial
5180494|NCT02862106|Chronic Hepatitis B|chronic hepatitis b
5180495|NCT02862106|HBeAg positive|hbeag positive
5180496|NCT02862106|Therapeutic HBV Vaccine|therapeutic hbv vaccine
5180497|NCT02862106|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
5180498|NCT02862067|SGLT2|sglt2
5180499|NCT02862067|type 2 diabetes mellitus|type 2 diabetes mellitus
5180500|NCT02862067|systolic heart failure|systolic heart failure
5180501|NCT02862067|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5180502|NCT02862054|haemophagocytic lymphohistiocytosis|haemophagocytic lymphohistiocytosis
5180503|NCT02862054|splenectomy|splenectomy
5781279|NCT00189059|attention|attention
5180515|NCT02861963|Femoral Allogenic Vein Valve Conduit|femoral allogenic vein valve conduit
5180516|NCT02861963|Rehabilitation of native pulmonary arteries|rehabilitation of native pulmonary arteries
5180517|NCT02861950|hypospadias|hypospadias
5180518|NCT02861950|caudal|caudal
5180519|NCT02861950|urethrocutaneous fistula|urethrocutaneous fistula
5180520|NCT02861950|penile nerve block|penile nerve block
5180521|NCT02861911|Muscle function|muscle function
5180522|NCT02861911|Oxidative stress|oxidative stress
5180523|NCT02861911|Quality of life|quality of life
5180524|NCT02861911|Physical activities|physical activities
5180525|NCT02861898|EGFR|egfr
5180526|NCT02861898|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5180527|NCT02861898|EGFRvIII|egfrviii
5180528|NCT02861885|Colonoscopy|colonoscopy
5180529|NCT02861885|sessile serrated lesions|sessile serrated lesions
5180530|NCT02861885|chromoendoscopy|chromoendoscopy
5180531|NCT02861885|narrow band imaging|narrow band imaging
5180532|NCT02861885|Indigo Carmin®|indigo carmin®
5180533|NCT02861885|Pit pattern|pit pattern
5180534|NCT02861885|Kudo classification|kudo classification
5180535|NCT02861885|NICE classification|nice classification
5180536|NCT02861885|neoplasms by histologic type|neoplasms by histologic type
5180537|NCT02861872|Ovarian|ovarian
5180538|NCT02861872|Ovarian cancer|ovarian cancer
5180539|NCT02861872|Chemotherapy|chemotherapy
5180540|NCT02861872|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5180541|NCT02861872|pharmacokinetics|pharmacokinetics
5180553|NCT02861820|fMRI|fmri
5180554|NCT02861820|brain networks|brain networks
5180555|NCT02861820|biomarker|biomarker
5180556|NCT02861820|relapse|relapse
5180557|NCT02861820|stimulants|stimulants
5180558|NCT02861794|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5180559|NCT02861794|Total Knee Replacement (TKR)|total knee replacement (tkr)
5180560|NCT02861794|Kinematics|kinematics
5180562|NCT02861794|Knee arthroplasty|knee arthroplasty
5180563|NCT02861794|Implant stability|implant stability
5180564|NCT02861781|Bariatric surgery|bariatric surgery
5180565|NCT02861755|Depression|depression
5180566|NCT02861755|Depressive Disorder|depressive disorder
5180567|NCT02861755|Psychological Stress|psychological stress
5180568|NCT02861755|Behavioral Symptoms|behavioral symptoms
5180569|NCT02861755|Mental Disorders|mental disorders
5180570|NCT02861755|Mood Disorders|mood disorders
5180571|NCT02861729|Partial coverage restoration|partial coverage restoration
5180572|NCT02861729|Crown|crown
5180573|NCT02861729|Posterior teeth|posterior teeth
5180575|NCT02861729|Zirconia reinforced lithium silicate|zirconia reinforced lithium silicate
5180576|NCT02861729|Lithium disilicate|lithium disilicate
5180577|NCT02861729|CAD/CAM|cad/cam
5180578|NCT02861690|Esophageal Cancer|esophageal cancer
5180579|NCT02861690|nedaplatin|nedaplatin
5180580|NCT02861690|Liposomal Paclitaxel|liposomal paclitaxel
5180581|NCT02861638|Total hip replacement|total hip replacement
5180582|NCT02861638|Action observation treatment|action observation treatment
5180583|NCT02861638|Rehabilitation|rehabilitation
5180584|NCT02861638|Arthroplasty|arthroplasty
5180585|NCT02861612|peripheral nerves|peripheral nerves
5180586|NCT02861612|quadriplegia|quadriplegia
5180587|NCT02861612|nerve transfer|nerve transfer
5180588|NCT02861612|surgical procedures, operative|surgical procedures, operative
5180589|NCT02861612|hand|hand
5180590|NCT02861612|upper extremity|upper extremity
5180591|NCT02861612|quality of life|quality of life
5180592|NCT02861586|Chikungunya, infectious disease|chikungunya, infectious disease
5180593|NCT02861573|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5180594|NCT02861573|mCRPC|mcrpc
5180595|NCT02861573|PD1|pd1
5180596|NCT02861573|PD-1|pd-1
5180597|NCT02861573|PDL1|pdl1
5180598|NCT02861573|PD-L1|pd-l1
5180600|NCT02861495|upper extremity fracture|upper extremity fracture
5180601|NCT02861482|PPH, Bakri Ballon|pph, bakri ballon
5180602|NCT02861469|qualitative study, end of life, ethics, palliative care|qualitative study, end of life, ethics, palliative care
5180604|NCT02861456|Low Back Pain|low back pain
5180606|NCT02861430|colon cancer|colon cancer
5180607|NCT02861430|sentinel node|sentinel node
5180608|NCT02861404|HPV|hpv
5180609|NCT02861378|anaesthesia, dental|anaesthesia, dental
5180610|NCT02861378|lidocaine|lidocaine
5180611|NCT02861352|Zinc|zinc
5180612|NCT02861352|DNA Integrity|dna integrity
5180613|NCT02861352|Gene Expression|gene expression
5180614|NCT02861352|diet zinc|diet zinc
5180615|NCT02861352|nutrition requirements|nutrition requirements
5180616|NCT02861326|chronic periodontitis, dental scaling, periodontal pockets|chronic periodontitis, dental scaling, periodontal pockets
5180617|NCT02861300|CB-839|cb-839
5180618|NCT02861300|PIK3CA|pik3ca
5180619|NCT02861300|capecitabine|capecitabine
5180620|NCT02861248|Burn Scar|burn scar
5180621|NCT02861248|Micro-plasma Radiofrequency Therapy|micro-plasma radiofrequency therapy
5180622|NCT02861183|sodium hyaluronate|sodium hyaluronate
5180623|NCT02861183|OVT|ovt
5180624|NCT02861183|hyaluronic acid|hyaluronic acid
5180625|NCT02861170|Mindfulness|mindfulness
5180626|NCT02861170|Chronic Pain|chronic pain
5180627|NCT02861170|Chronic Hip Pain|chronic hip pain
5180628|NCT02861170|Total Hip Arthroplasty|total hip arthroplasty
5180629|NCT02861170|Disability|disability
5180630|NCT02861170|Quality of Life|quality of life
5180631|NCT02861157|Type 1 Diabetes|type 1 diabetes
5180632|NCT02861157|Adolescents|adolescents
5180633|NCT02861157|T1D|t1d
5180634|NCT02861131|Sugammadex|sugammadex
5180635|NCT02861131|Neuromuscular Blockade|neuromuscular blockade
5180636|NCT02861118|Drug Therapy|drug therapy
5180637|NCT02861092|Serious adverse event|serious adverse event
5180638|NCT02861092|bone and joint infection|bone and joint infection
5180639|NCT02861092|obesity|obesity
5180640|NCT02861092|dose adjustment|dose adjustment
5180641|NCT02861066|Mindfulness-based Intervention|mindfulness-based intervention
5180642|NCT02861066|Wellbeing|wellbeing
5180643|NCT02861066|Treatment|treatment
5180644|NCT02861027|Osteoarthritis|osteoarthritis
5180645|NCT02861027|Total hip arthroplasty|total hip arthroplasty
5180646|NCT02861027|Physiotherapy|physiotherapy
5180647|NCT02861027|Functional Electrical Stimulation|functional electrical stimulation
5180648|NCT02861001|tracheotomy|tracheotomy
5180649|NCT02861001|bronchoscopy|bronchoscopy
5180650|NCT02861001|critical care|critical care
5180651|NCT02860975|Prolonged Hypoxia|prolonged hypoxia
5180652|NCT02860975|Safety|safety
5180653|NCT02860975|Mitochondrial function|mitochondrial function
5180654|NCT02860949|Local anesthetic infiltration|local anesthetic infiltration
5180655|NCT02860949|Posterior capsular infiltration|posterior capsular infiltration
5180656|NCT02860949|Multimodal anesthesia|multimodal anesthesia
5180657|NCT02860949|Knee arthroplasty|knee arthroplasty
5180658|NCT02860949|Pain control|pain control
5180659|NCT02860949|Osteoarthritis, Knee|osteoarthritis, knee
5180660|NCT02860923|glucagon-like peptide-1|glucagon-like peptide-1
5180661|NCT02860923|exenatide|exenatide
5180662|NCT02860923|placebo|placebo
5180663|NCT02860923|multicenter trial|multicenter trial
5180664|NCT02860910|hot flashes|hot flashes
5180665|NCT02860910|postmenopause|postmenopause
5180666|NCT02860910|perimenopause|perimenopause
5180667|NCT02860832|Cyberbullying|cyberbullying
5180668|NCT02860832|Traditional bullying|traditional bullying
5180669|NCT02860832|Depression|depression
5180670|NCT02860819|Multiple relapsed/refractory testicular germ cell tumors|multiple relapsed/refractory testicular germ cell tumors
5180671|NCT02860819|PARP inhibition|parp inhibition
5180672|NCT02860819|Chemotherapy|chemotherapy
5180673|NCT02860819|Gemcitabine|gemcitabine
5180674|NCT02860819|Carboplatin|carboplatin
5180675|NCT02860793|PTK7|ptk7
5180676|NCT02860793|Acute Myeloid Leukemia|acute myeloid leukemia
5180677|NCT02860767|Prosthesis-Related Infections|prosthesis-related infections
5180678|NCT02860767|Antibiotic dosing|antibiotic dosing
5180679|NCT02860767|Reimplantation|reimplantation
5180680|NCT02860767|Knee-prothesis|knee-prothesis
5180681|NCT02860767|Hip-prothesis|hip-prothesis
5180683|NCT02860728|COPD|copd
5180684|NCT02860728|Resistance Training|resistance training
5180685|NCT02860728|Exercise Training|exercise training
5180686|NCT02860728|Dyspnea|dyspnea
5180687|NCT02860715|Safety|safety
5180688|NCT02860715|Pharmacodynamics|pharmacodynamics
5180689|NCT02860715|Dose-Limiting Toxicity (DLT)|dose-limiting toxicity (dlt)
5054777|NCT03655574|Juvenile justice|juvenile justice
5054778|NCT03655574|Motivational enhancement|motivational enhancement
5054779|NCT03655561|Lassa fever|lassa fever
5054780|NCT03655561|Lassa virus|lassa virus
5054781|NCT03655561|Nigeria|nigeria
5054782|NCT03655561|Pregnancy|pregnancy
5054783|NCT03655561|Acute kidney injury|acute kidney injury
5054796|NCT03655457|RDS|rds
5180690|NCT02860715|Immunogenicity|immunogenicity
5180691|NCT02860715|Pharmacokinetics|pharmacokinetics
5180692|NCT02860702|Single Ventricle|single ventricle
5180693|NCT02860702|Congenital Heart Defect|congenital heart defect
5180694|NCT02860689|Sexuality|sexuality
5180695|NCT02860689|Spinal cord injuries|spinal cord injuries
5180696|NCT02860689|Penile erection|penile erection
5180697|NCT02860689|erectile dysfunction|erectile dysfunction
5180698|NCT02860689|Psychological Sexual Dysfunctions|psychological sexual dysfunctions
5180699|NCT02860676|CLL|cll
5180700|NCT02860676|cancer|cancer
5180701|NCT02860676|UC-961|uc-961
5180702|NCT02860676|cirmtuzumab|cirmtuzumab
5180703|NCT02860637|Sexuality|sexuality
5180707|NCT02860624|GERD|gerd
5180708|NCT02860611|Type 1 diabetes|type 1 diabetes
5180709|NCT02860611|Type 2 diabetes|type 2 diabetes
5180710|NCT02860611|T helper 1 cytokines|t helper 1 cytokines
5180711|NCT02860598|ESAs|esas
5180712|NCT02860598|erythropoietin|erythropoietin
5180713|NCT02860598|AML|aml
5180714|NCT02860598|HSCT|hsct
5180715|NCT02860585|Metastatic breast cancer|metastatic breast cancer
5180716|NCT02860585|high-dose chemotherapy|high-dose chemotherapy
5180717|NCT02860585|autologous haematopoietic progenitor cell transplantation|autologous haematopoietic progenitor cell transplantation
5180721|NCT02860559|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5180722|NCT02860559|Severe Combined Immunodeficiency|severe combined immunodeficiency
5180723|NCT02860546|Refractory|refractory
5180724|NCT02860546|Metastatic|metastatic
5180725|NCT02860546|Colorectal cancer|colorectal cancer
5180726|NCT02860546|TAS-102|tas-102
5180727|NCT02860546|Nivolumab|nivolumab
5180728|NCT02860546|Microsatellite Stable|microsatellite stable
5180729|NCT02860546|Programmed cell death protein1 (PD 1)|programmed cell death protein1 (pd 1)
5180730|NCT02860533|Blood pressure|blood pressure
5180731|NCT02860533|smartphone App|smartphone app
5180732|NCT02860533|Hypertension|hypertension
5180733|NCT02860533|Stress testing|stress testing
5180734|NCT02860533|Prevention|prevention
5180735|NCT02860533|Cardiovascular risk factors|cardiovascular risk factors
5180736|NCT02860520|Retinitis pigmentosa:|retinitis pigmentosa:
5180737|NCT02860494|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
5180738|NCT02860494|topical everolimus|topical everolimus
5180739|NCT02860494|seamless design|seamless design
5180740|NCT02860494|dose-escalation study|dose-escalation study
5180741|NCT02860494|m-TOR inhibitor|m-tor inhibitor
5180742|NCT02860455|CO poisoning|co poisoning
5180743|NCT02860455|CO-oximetry|co-oximetry
5180744|NCT02860455|Pulse oximetry|pulse oximetry
5180745|NCT02860455|Carbon monoxide saturation (SpCO)|carbon monoxide saturation (spco)
5180746|NCT02860455|Emergency Department|emergency department
5180747|NCT02860455|Sensitivity|sensitivity
5180748|NCT02860455|Specificity|specificity
5180749|NCT02860442|Alcohol misuse|alcohol misuse
5180750|NCT02860442|Smartphone app|smartphone app
5180751|NCT02860442|Screening, Brief Intervention, Referral to Treatment (SBIRT)|screening, brief intervention, referral to treatment (sbirt)
5180752|NCT02860416|Neurology|neurology
5180753|NCT02860403|Cervical spinal cord injury|cervical spinal cord injury
5180754|NCT02860403|Motor imagery|motor imagery
5180755|NCT02860403|Magnetoencephalography|magnetoencephalography
5180756|NCT02860377|emergence agitation|emergence agitation
5180757|NCT02860377|emergence time|emergence time
5180758|NCT02860377|pediatric|pediatric
5180759|NCT02860351|subclavian vein|subclavian vein
5180760|NCT02860338|Psuedobulbar affect, PBA|psuedobulbar affect, pba
5180761|NCT02860299|patients|patients
5180762|NCT02860273|Pulmonary Rehabilitation|pulmonary rehabilitation
5180764|NCT02860273|High Flow Nasal Cannula|high flow nasal cannula
5180765|NCT02860273|HFNC|hfnc
5180766|NCT02860273|Aerobic capacity|aerobic capacity
5180767|NCT02860260|BDNF|bdnf
5180768|NCT02860247|antibiotic|antibiotic
5180769|NCT02860247|MALDI-TOF MS|maldi-tof ms
5180770|NCT02860247|susceptibility testing|susceptibility testing
5180771|NCT02860234|Rectal cancer|rectal cancer
5180772|NCT02860234|neoadjuvant|neoadjuvant
5180773|NCT02860234|radiotherapy|radiotherapy
5180774|NCT02860234|chemotherapy|chemotherapy
5180775|NCT02860234|organ preservation|organ preservation
5180776|NCT02860221|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5180777|NCT02860221|Epinephrine|epinephrine
5180778|NCT02860221|Tranexamic acid|tranexamic acid
5180779|NCT02860208|Peri-Implantitis|peri-implantitis
5962242|NCT04282005|NASH|nash
5962243|NCT04282005|Diabetes|diabetes
5962244|NCT04282005|Obesity|obesity
5962245|NCT04281979|Nondaily Smoking|nondaily smoking
5962246|NCT04281979|Craving|craving
5962247|NCT04281979|Impulsivity|impulsivity
5962248|NCT04281966|School Attendance|school attendance
5962249|NCT04281966|Welfare Dependence|welfare dependence
5962250|NCT04281966|Antisocial Behavior|antisocial behavior
5962251|NCT04281966|Third-Party Policing Partnerships|third-party policing partnerships
5054895|NCT03654872|ribotypes|ribotypes
5180780|NCT02860208|Surgical therapy|surgical therapy
5180781|NCT02860208|Follow-up|follow-up
5180782|NCT02860208|Supportive peri-implant therapy|supportive peri-implant therapy
5180783|NCT02860130|Regional Citrate Anticoagulation (RCA)|regional citrate anticoagulation (rca)
5069399|NCT03565328|NAD+/NADH ratio|nad+/nadh ratio
5180784|NCT02860130|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
5180785|NCT02860130|Acute Kidney Injury|acute kidney injury
5180786|NCT02860117|ketamine|ketamine
5180787|NCT02860117|continuous infusion|continuous infusion
5180788|NCT02860117|severe burned patients|severe burned patients
5180789|NCT02860104|microwave ablation|microwave ablation
5180791|NCT02860104|multicenter|multicenter
5180792|NCT02860091|ropivacaine infusion|ropivacaine infusion
5180793|NCT02860091|regional anesthesia|regional anesthesia
5180794|NCT02860091|paravertebral block|paravertebral block
5180795|NCT02860078|pain|pain
5180796|NCT02860078|epidural|epidural
5180797|NCT02860078|ultrasound|ultrasound
5180798|NCT02860013|Telemedicine|telemedicine
5180799|NCT02860013|Effectiveness|effectiveness
5180800|NCT02860013|Cost-effectiveness|cost-effectiveness
5180808|NCT02859935|HIV|hiv
5180809|NCT02859935|drug abuse|drug abuse
5180810|NCT02859935|MSM|msm
5180811|NCT02859935|Risk behavior|risk behavior
5180812|NCT02859935|Sexually transmitted diseases|sexually transmitted diseases
5180813|NCT02859935|Sexually transmitted infections|sexually transmitted infections
5180814|NCT02859922|Laryngeal Tube Supreme Spontaneous Ventilation|laryngeal tube supreme spontaneous ventilation
5180815|NCT02859857|Glioblastoma Multiforme|glioblastoma multiforme
5180816|NCT02859857|Solid Tumors|solid tumors
5180817|NCT02859857|Ependymoma|ependymoma
5180818|NCT02859727|APDS; PASLI; PI3Kdelta; p110delta-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency; Activated PI3Kdelta Syndrome;|apds; pasli; pi3kdelta; p110delta-activating mutation causing senescent t cells, lymphadenopathy and immunodeficiency; activated pi3kdelta syndrome;
5180819|NCT02859662|abdominal compartment syndrome|abdominal compartment syndrome
5180820|NCT02859662|abdominal aortic aneurysm|abdominal aortic aneurysm
5180821|NCT02859662|ruptured aneurysm|ruptured aneurysm
5180822|NCT02859649|working memory|working memory
5180823|NCT02859649|short term memory|short term memory
5180824|NCT02859649|gesture|gesture
5180825|NCT02859584|Acute hepatitis|acute hepatitis
5180826|NCT02859584|acute liver failure|acute liver failure
5180827|NCT02859584|adrenal dysfunction|adrenal dysfunction
5180828|NCT02859584|salivary cortisol|salivary cortisol
5180829|NCT02859584|serum free cortisol|serum free cortisol
5180830|NCT02859545|chronic pain|chronic pain
5180831|NCT02859545|pain|pain
5180832|NCT02859545|validation|validation
5180833|NCT02859545|couples|couples
5180834|NCT02859545|romantic relationships|romantic relationships
5180835|NCT02859545|emotional validation|emotional validation
5180836|NCT02859532|blood coagulation|blood coagulation
5180837|NCT02859532|Endogenous Thrombin Potential|endogenous thrombin potential
5180838|NCT02859532|rotational thromboelastometry|rotational thromboelastometry
5180839|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium
5180840|NCT02859480|Percutaneous Coronary Intervention|percutaneous coronary intervention
5180841|NCT02859480|Drug-Eluting Stents|drug-eluting stents
5180842|NCT02859480|Patient Outcome Assessment|patient outcome assessment
5180843|NCT02859480|Biomarkers|biomarkers
5180844|NCT02859480|Hyperlipidemias|hyperlipidemias
5180845|NCT02859480|Dyslipidemias|dyslipidemias
5180846|NCT02859480|Atherosclerosis|atherosclerosis
5180847|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5180848|NCT02859480|Anticholesteremic Agents|anticholesteremic agents
5180849|NCT02859480|Hypolipidemic Agents|hypolipidemic agents
5180850|NCT02859480|Lipid Regulating Agents|lipid regulating agents
5180851|NCT02859467|Physical Therapy Modalities|physical therapy modalities
5180852|NCT02859467|Exercise|exercise
5180853|NCT02859467|Electrical Stimulation Therapy|electrical stimulation therapy
5180854|NCT02859467|Bandages|bandages
5180860|NCT02859441|Intravitreal Injection|intravitreal injection
5180861|NCT02859441|Retinal Capillary Hemangioma|retinal capillary hemangioma
5180863|NCT02859415|Metastatic Colorectal Cancer|metastatic colorectal cancer
5180864|NCT02859415|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5180865|NCT02859415|Sarcoma|sarcoma
5180866|NCT02859415|ABCB4 Liver Toxicity|abcb4 liver toxicity
5180867|NCT02859415|ABCB11 Heptatoxicity|abcb11 heptatoxicity
5180868|NCT02859402|T-cell Non-Hodgkin Lymphoma|t-cell non-hodgkin lymphoma
5180869|NCT02859402|NK/T-cell Non-Hodgkin Lymphoma|nk/t-cell non-hodgkin lymphoma
5180870|NCT02859402|Relapsed, refractory|relapsed, refractory
5180871|NCT02859402|Conditioning|conditioning
5180872|NCT02859402|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5180873|NCT02859389|Leukemia|leukemia
5180874|NCT02859389|Down Syndrome|down syndrome
5180875|NCT02859389|Neurocognitive|neurocognitive
5180876|NCT02859389|Survivorship|survivorship
5180877|NCT02859389|Attention|attention
5180878|NCT02859389|Executive function|executive function
5180879|NCT02859389|Late effects|late effects
5180880|NCT02859376|Preterm infants|preterm infants
5180881|NCT02859376|Pain|pain
5180882|NCT02859376|Sucrose|sucrose
5962252|NCT04281927|wearable|wearable
5047757|NCT03700515|EPO|epo
5180883|NCT02859350|Plasmodium falciparum|plasmodium falciparum
5180884|NCT02859350|PfSPZ Vaccine|pfspz vaccine
5180885|NCT02859350|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
5180886|NCT02859350|CHMI|chmi
5180887|NCT02859350|Chloroquine|chloroquine
5180888|NCT02859350|Chemoprophylaxis|chemoprophylaxis
5180889|NCT02859350|PfSPZ-CVac|pfspz-cvac
5180890|NCT02859337|obesity|obesity
5180905|NCT02859298|Diagnostic tool|diagnostic tool
5180907|NCT02859285|Orgasm|orgasm
5180908|NCT02859285|Clitoral|clitoral
5180910|NCT02859285|Post Menopausal|post menopausal
5180911|NCT02859272|Suspension, benign hysterectomy, post operative prolapse|suspension, benign hysterectomy, post operative prolapse
5180912|NCT02859233|Spinal Puncture|spinal puncture
5180913|NCT02859233|Dural puncture|dural puncture
5180914|NCT02859233|Nursing|nursing
5180915|NCT02859220|hemodialysis|hemodialysis
5180916|NCT02859220|PTH|pth
5180917|NCT02859207|Early Alzheimer's disease|early alzheimer's disease
5180918|NCT02859207|E2609|e2609
5180919|NCT02859207|Mild and Moderate Hepatic Impairment|mild and moderate hepatic impairment
5180920|NCT02859181|Increased Metabolic Requirement|increased metabolic requirement
5180921|NCT02859168|Neck|neck
5180922|NCT02859168|Shoulder|shoulder
5180923|NCT02859168|Manual Therapies|manual therapies
5180924|NCT02859142|Varenicline|varenicline
5180925|NCT02859129|Epanova|epanova
5180926|NCT02859129|omega-3 carboxylic acids|omega-3 carboxylic acids
5180927|NCT02859129|Vascepa|vascepa
5180928|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester
5180929|NCT02859129|Crestor|crestor
5180930|NCT02859129|rosuvastatin|rosuvastatin
5180931|NCT02859116|Metabolic diseases|metabolic diseases
5180932|NCT02859077|NSCLC|nsclc
5180933|NCT02859077|BIM|bim
5180934|NCT02859077|EGFR mutation|egfr mutation
5180935|NCT02859064|radioembolization|radioembolization
5180936|NCT02859064|somatostatin analogs|somatostatin analogs
5180937|NCT02859064|carcinoid|carcinoid
5180938|NCT02859064|neuroendocrine|neuroendocrine
5180939|NCT02859064|liver-directed therapy|liver-directed therapy
5180940|NCT02859051|Cognitive Behavioral Support provided by Robot|cognitive behavioral support provided by robot
5180941|NCT02859025|Alveolar cleft|alveolar cleft
5180942|NCT02859025|Osteoplasty|osteoplasty
5180943|NCT02859025|Tissue engineering|tissue engineering
5180944|NCT02859025|Stem cells|stem cells
5180945|NCT02859025|Regenerative medicine|regenerative medicine
5180946|NCT02859025|Bone|bone
5180947|NCT02859025|Lateral ramus|lateral ramus
5180948|NCT02858999|primary plasma cell leukaemia|primary plasma cell leukaemia
5180949|NCT02858999|treatment|treatment
5180950|NCT02858960|High Flow Nasal Cannula|high flow nasal cannula
5180951|NCT02858960|COPD|copd
5180952|NCT02858960|Pulmonary rehabilitation|pulmonary rehabilitation
5180953|NCT02858960|HFNC|hfnc
5180954|NCT02858960|Oxygen|oxygen
5180955|NCT02858947|composite resin|composite resin
5180956|NCT02858947|bulk-fill|bulk-fill
5180957|NCT02858947|teeth endodontically-treated|teeth endodontically-treated
5180958|NCT02858934|Short preoperative tomotherapy|short preoperative tomotherapy
5180959|NCT02858934|Radiotherapy|radiotherapy
5180960|NCT02858921|Neoadjuvant Therapy|neoadjuvant therapy
5180961|NCT02858921|Pembrolizumab|pembrolizumab
5180962|NCT02858921|Dabrafenib|dabrafenib
5180963|NCT02858921|Trametinib|trametinib
5180964|NCT02858921|Pathological response|pathological response
5180965|NCT02858921|RECIST|recist
5180966|NCT02858921|Immune response|immune response
5180967|NCT02858921|BRAF|braf
5180968|NCT02858921|Randomised|randomised
5180969|NCT02858921|Stage IIIB/C|stage iiib/c
5180970|NCT02858921|Biomarkers, Tumour|biomarkers, tumour
5180971|NCT02858921|Biomarkers, Drug response|biomarkers, drug response
5180972|NCT02858921|Metabolic Response|metabolic response
5180986|NCT02858843|genetics|genetics
5180987|NCT02858830|FPL|fpl
5180988|NCT02858830|adipose tissue|adipose tissue
5180989|NCT02858830|diabetes|diabetes
5180990|NCT02858830|dyslipidemia|dyslipidemia
5180991|NCT02858830|metabolic|metabolic
5180992|NCT02858830|hyperinsulinemia|hyperinsulinemia
5180993|NCT02858804|mantle cell lymphoma|mantle cell lymphoma
5181000|NCT02858752|Short-term memory|short-term memory
5181001|NCT02858752|Aural Memory|aural memory
5181002|NCT02858752|Visual Memory|visual memory
5181003|NCT02858752|Child|child
5181004|NCT02858752|EEG|eeg
5181005|NCT02858726|Hemodialysis|hemodialysis
5962253|NCT04281927|electrocardiography|electrocardiography
5181006|NCT02858726|CR845|cr845
5181007|NCT02858726|Kappa opioid|kappa opioid
5181008|NCT02858726|Anti-itch|anti-itch
5181009|NCT02858726|difelikefalin|difelikefalin
5181010|NCT02858713|psoriasis|psoriasis
5181011|NCT02858700|neonatal bacterial infection|neonatal bacterial infection
5181013|NCT02858635|Suicidal behaviour|suicidal behaviour
5181014|NCT02858635|Impulsivity|impulsivity
5181015|NCT02858635|Genetics|genetics
5181016|NCT02858635|Serotonin|serotonin
5181017|NCT02858622|pediatric|pediatric
5181018|NCT02858622|renal transplant|renal transplant
5181019|NCT02858622|pain|pain
5181020|NCT02858622|dual TAB|dual tab
5181021|NCT02858583|Chest Compression|chest compression
5047869|NCT03699722|HIV|hiv
5055157|NCT03653494|phrenic block|phrenic block
5055158|NCT03653481|diet|diet
5181022|NCT02858583|Newborn|newborn
5181023|NCT02858583|Infant|infant
5181024|NCT02858583|Sustained Inflation|sustained inflation
5181025|NCT02858570|Meningococcal Vaccines|meningococcal vaccines
5181026|NCT02858570|Immunogenicity, Reactogenicity and Safety of Vaccine|immunogenicity, reactogenicity and safety of vaccine
5181027|NCT02858544|Mild traumatic brain injury|mild traumatic brain injury
5181028|NCT02858518|anticoagulant|anticoagulant
5181029|NCT02858492|efficacy|efficacy
5181030|NCT02858492|safety|safety
5181031|NCT02858492|pharmacokinetics|pharmacokinetics
5181032|NCT02858492|pharmacodynamics|pharmacodynamics
5181033|NCT02858492|Rheumatoid Arthritis|rheumatoid arthritis
5181034|NCT02858492|autoimmune|autoimmune
5181035|NCT02858453|Interstitial cystitis|interstitial cystitis
5181036|NCT02858453|Bladder pain syndrome|bladder pain syndrome
5181134|NCT02857881|keratoconus|keratoconus
5181037|NCT02858453|Painful bladder syndrome|painful bladder syndrome
5181038|NCT02858453|Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)|interstitial cystitis/bladder pain syndrome (ic/bps)
5181039|NCT02858453|AQX-1125|aqx-1125
5181041|NCT02858453|Chronic interstitial cystitis|chronic interstitial cystitis
5181042|NCT02858440|Primary dose|primary dose
5181043|NCT02858440|Reactogenicity|reactogenicity
5181044|NCT02858440|Immunogenicity|immunogenicity
5181045|NCT02858440|Booster dose|booster dose
5181046|NCT02858440|Combined vaccine|combined vaccine
5181047|NCT02858440|Russian Infants|russian infants
5181048|NCT02858440|Infanrix®-IPV/Hib|infanrix®-ipv/hib
5181049|NCT02858427|cognitive inhibition|cognitive inhibition
5181050|NCT02858427|elderly|elderly
5181051|NCT02858427|suicide attempt|suicide attempt
5181052|NCT02858427|depression|depression
5181053|NCT02858388|Otitis Media with Effusion|otitis media with effusion
5181054|NCT02858388|Exudative otitis media|exudative otitis media
5181055|NCT02858375|quality of life|quality of life
5181056|NCT02858375|botulinum toxin|botulinum toxin
5181057|NCT02858375|provoked vulvodynia|provoked vulvodynia
5181059|NCT02858362|Muscular Dystrophy|muscular dystrophy
5181060|NCT02858362|Utrophin|utrophin
5181061|NCT02858362|Duchenne|duchenne
5181062|NCT02858362|PhaseOut DMD|phaseout dmd
5181063|NCT02858336|Luteinizing Hormone (LH)|luteinizing hormone (lh)
5181064|NCT02858336|Weight Loss|weight loss
5181065|NCT02858336|Functional Hypothalamic Amenorrhea (HA)|functional hypothalamic amenorrhea (ha)
5181066|NCT02858336|Gonadotropin-Releasing Hormone (GnRH)|gonadotropin-releasing hormone (gnrh)
5181067|NCT02858336|Energy Deficiency|energy deficiency
5181068|NCT02858323|Alloimmunization|alloimmunization
5181069|NCT02858323|Refractoriness|refractoriness
5181070|NCT02858323|Corrected Count Increment|corrected count increment
5181071|NCT02858323|HLA-Compatible|hla-compatible
5181077|NCT02858297|Oral lichen planus|oral lichen planus
5181078|NCT02858297|Glucosamine|glucosamine
5181079|NCT02858297|IL-8|il-8
5181080|NCT02858258|MCL|mcl
5181081|NCT02858245|MitraClip|mitraclip
5181082|NCT02858245|Structural Heart Failure|structural heart failure
5181083|NCT02858245|Degenerative Mitral Regurgitation (DMR)|degenerative mitral regurgitation (dmr)
5181084|NCT02858245|Actigraphy|actigraphy
5181085|NCT02858232|MASCT-I|masct-i
5181086|NCT02858232|Solid Tumors|solid tumors
5181087|NCT02858219|Botulinum toxin|botulinum toxin
5181088|NCT02858219|Pain improvement|pain improvement
5181089|NCT02858206|Locally advanced esophageal cancer|locally advanced esophageal cancer
5181090|NCT02858206|Radiotherapy and nimotuzumab|radiotherapy and nimotuzumab
5181091|NCT02858206|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5181092|NCT02858154|OSA|osa
5181093|NCT02858154|obstructive sleep apnea|obstructive sleep apnea
5181094|NCT02858154|infants|infants
5181095|NCT02858154|high flow nasal cannula|high flow nasal cannula
5181096|NCT02858154|HFNC|hfnc
5181097|NCT02858141|oncogeriatric evaluation|oncogeriatric evaluation
5181098|NCT02858141|pancreatic cancer|pancreatic cancer
5181099|NCT02858141|Database|database
5181100|NCT02858102|Schizophrenia|schizophrenia
5181101|NCT02858102|Psychosis|psychosis
5181102|NCT02858102|Obesity|obesity
5181103|NCT02858102|Neurocognition|neurocognition
5181104|NCT02858102|Depression|depression
5181105|NCT02858102|Bipolar disorder|bipolar disorder
5181106|NCT02858102|Metabolomics|metabolomics
5181107|NCT02858102|Biomarkers|biomarkers
5181108|NCT02858102|Hypertension|hypertension
5181109|NCT02858102|Dyslipidemia|dyslipidemia
5181110|NCT02858102|Hyperglycemia|hyperglycemia
5181111|NCT02858102|Hypertriglyceridemia|hypertriglyceridemia
5181112|NCT02858076|Anti-VEGF|anti-vegf
5181113|NCT02858076|Vitrectomy|vitrectomy
5181114|NCT02858063|Breast cancer|breast cancer
5181115|NCT02858063|Quality Of Life|quality of life
5181116|NCT02858063|Women|women
5181117|NCT02858063|Partner|partner
5962254|NCT04281927|photoplethysmography|photoplethysmography
5181118|NCT02858011|behavior change communication|behavior change communication
5962255|NCT04281901|Otitis Media|otitis media
5962256|NCT04281901|Mastoidectomy|mastoidectomy
5181120|NCT02858011|household welfare|household welfare
5181121|NCT02858011|child nutrition status|child nutrition status
5962257|NCT04281901|Wound Healing|wound healing
5181122|NCT02857985|Myocardial Infarction|myocardial infarction
5181123|NCT02857985|MRI|mri
5181124|NCT02857985|rotational angiography|rotational angiography
5181127|NCT02857933|Gross Motor Delay|gross motor delay
5181128|NCT02857920|Vascular Endothelial Growth Factor (VEGF) antibody|vascular endothelial growth factor (vegf) antibody
5181129|NCT02857920|solid tumor|solid tumor
5181130|NCT02857920|NK Immunotherapy|nk immunotherapy
5181131|NCT02857907|Kidney transplantation|kidney transplantation
5181132|NCT02857907|Immunosuppressive treatment|immunosuppressive treatment
5181133|NCT02857894|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5181135|NCT02857881|photokeratectomy|photokeratectomy
5181136|NCT02857881|de-epithelization|de-epithelization
5181137|NCT02857868|Hepatic Impairment|hepatic impairment
5181138|NCT02857868|ABL001|abl001
5181139|NCT02857868|Child-Pugh|child-pugh
5181140|NCT02857868|healthy subjects with normal hepatic function|healthy subjects with normal hepatic function
5181141|NCT02857855|liver transplantation|liver transplantation
5181142|NCT02857855|postoperative infection|postoperative infection
5181143|NCT02857855|biliary complications|biliary complications
5181144|NCT02857855|patient survival|patient survival
5181145|NCT02857855|graft survival|graft survival
5181146|NCT02857855|supplemental oxygen|supplemental oxygen
5181147|NCT02857829|Cognition|cognition
5181148|NCT02857829|working memory|working memory
5181149|NCT02857829|nootropic|nootropic
5181150|NCT02857829|reaction time|reaction time
5181151|NCT02857829|healthy individuals|healthy individuals
5181152|NCT02857829|cognitive enhancement|cognitive enhancement
5181153|NCT02857803|Virtual Reality|virtual reality
5181154|NCT02857803|Cognitive Rehabilitation|cognitive rehabilitation
5181155|NCT02857803|Motor Rehabilitation|motor rehabilitation
5181156|NCT02857803|Ecological validity|ecological validity
5181157|NCT02857803|Personalisation|personalisation
5181158|NCT02857790|Rotablation|rotablation
5181159|NCT02857790|High speed rotational atherectomy|high speed rotational atherectomy
5181160|NCT02857790|Type IV myocardial infarction|type iv myocardial infarction
5181161|NCT02857790|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5181162|NCT02857790|CMR|cmr
5181163|NCT02857790|Percutaneous Coronary Intervention|percutaneous coronary intervention
5181164|NCT02857751|depression|depression
5181165|NCT02857751|PTSD|ptsd
5181166|NCT02857751|anxiety|anxiety
5181167|NCT02857751|surf therapy|surf therapy
5181168|NCT02857699|Quality of life|quality of life
5181169|NCT02857699|Phase I trials|phase i trials
5181172|NCT02857660|Sarcopenia|sarcopenia
5181173|NCT02857660|Obesity|obesity
5181174|NCT02857660|Whole-Body Electromyostimulation|whole-body electromyostimulation
5181175|NCT02857660|Protein Supplementation|protein supplementation
5181176|NCT02857660|community dwelling men|community dwelling men
5181177|NCT02857647|Bariatric surgery|bariatric surgery
5181178|NCT02857647|Anxiety|anxiety
5181179|NCT02857647|Nutrition knowledge|nutrition knowledge
5181180|NCT02857647|Weight loss expectations|weight loss expectations
5181181|NCT02857634|Urinary Bladder cancer|urinary bladder cancer
5181182|NCT02857634|diagnosis|diagnosis
5181183|NCT02857634|Cellvizio Dual Band|cellvizio dual band
5181184|NCT02857582|Antibiotic-induced diarrhea|antibiotic-induced diarrhea
5181185|NCT02857582|Clostridium-difficile toxin|clostridium-difficile toxin
5181186|NCT02857582|Pseudomembranous colitis|pseudomembranous colitis
5788070|NCT00155506|Niacin|niacin
5181189|NCT02857439|Trauma of the shoulder|trauma of the shoulder
5181191|NCT02857413|Radiotherapy|radiotherapy
5181192|NCT02857348|decision making|decision making
5181193|NCT02857348|heuristics|heuristics
5181194|NCT02857283|Air pollution|air pollution
5181195|NCT02857283|Air pollutant exposure|air pollutant exposure
5181196|NCT02857283|Ozone|ozone
5181200|NCT02857257|IBS|ibs
5181201|NCT02857257|Microbiota|microbiota
5181202|NCT02857244|Freezing of Gait|freezing of gait
5181203|NCT02857231|Bioimpedance spectroscopy|bioimpedance spectroscopy
5181204|NCT02857205|Hirschsprung Associated EnteroColitis (HAEC)|hirschsprung associated enterocolitis (haec)
5181205|NCT02857179|bariatric surgery|bariatric surgery
5181206|NCT02857179|follow-up|follow-up
5181207|NCT02857179|weight loss|weight loss
5181208|NCT02857179|complications|complications
5181209|NCT02857179|comorbidities evolution|comorbidities evolution
5181210|NCT02857166|JS001|js001
5181211|NCT02857166|solid tumors|solid tumors
5181212|NCT02857153|MAP|map
5181213|NCT02857153|Blood loss|blood loss
5181214|NCT02857153|Postoperative delirium|postoperative delirium
5181215|NCT02857153|Elderly patients|elderly patients
5181216|NCT02857153|Noncardiothoracic surgery|noncardiothoracic surgery
5181217|NCT02857127|Low income population|low income population
5181218|NCT02857127|Motor Activity|motor activity
5181219|NCT02857127|Primary Health Care|primary health care
5181220|NCT02857088|depression|depression
5181221|NCT02857088|emotional reactivity|emotional reactivity
5181222|NCT02857036|rhythm|rhythm
5181223|NCT02857036|depression|depression
5176238|NCT02890069|RCC|rcc
5168982|NCT02935374|amoxicillin|amoxicillin
5168983|NCT02935374|amoxicillin-clavulanate|amoxicillin-clavulanate
5168986|NCT02935309|rectum|rectum
5962258|NCT04281901|Platelet-Rich Plasma|platelet-rich plasma
5962259|NCT04281901|Extracellular Vesicles|extracellular vesicles
5181226|NCT02857023|Working memory|working memory
5181227|NCT02857023|Cogmed|cogmed
5181228|NCT02857023|Cognitive training|cognitive training
5181229|NCT02856984|Pregnancy|pregnancy
5181230|NCT02856984|Infant|infant
5181231|NCT02856971|Hinge Knee Prosthesis|hinge knee prosthesis
5181232|NCT02856971|TKA infection|tka infection
5181233|NCT02856971|rotating hinge prosthesis|rotating hinge prosthesis
5181234|NCT02856971|hinge knee arthroplasty|hinge knee arthroplasty
5181235|NCT02856945|fracture|fracture
5181236|NCT02856945|children|children
5181237|NCT02856945|knee|knee
5181238|NCT02856945|clinical criteria|clinical criteria
5181239|NCT02856945|decision making|decision making
5181240|NCT02856906|Orofacial Pain|orofacial pain
5181241|NCT02856906|Electromyography|electromyography
5181242|NCT02856906|dental occlusion|dental occlusion
5181243|NCT02856893|AZD9291|azd9291
5181244|NCT02856893|Osimertinib|osimertinib
5181245|NCT02856893|Gefitinib|gefitinib
5181246|NCT02856893|NSCLC|nsclc
5181247|NCT02856893|liquid biopsy|liquid biopsy
5181248|NCT02856893|ctDNA|ctdna
5181249|NCT02856841|epithelial ovarian cancer|epithelial ovarian cancer
5181250|NCT02856841|optimum cytoreduction|optimum cytoreduction
5181251|NCT02856815|Immuncell-LC|immuncell-lc
5181252|NCT02856815|Transarterial Chemoembolization|transarterial chemoembolization
5181253|NCT02856789|Fibrin structure|fibrin structure
5181254|NCT02856789|Coag-Lysis assay|coag-lysis assay
5181255|NCT02856789|Fibrin formation|fibrin formation
5181256|NCT02856789|Fibrinolysis|fibrinolysis
5181257|NCT02856789|TEG 5000|teg 5000
5181258|NCT02856789|TEG 6S|teg 6s
5181259|NCT02856789|Coagulo-lytic balance|coagulo-lytic balance
5181260|NCT02856789|Normal range|normal range
5181261|NCT02856789|Thromboelastography|thromboelastography
5181262|NCT02856776|Vitamin D|vitamin d
5181263|NCT02856776|Metabolomics|metabolomics
5181264|NCT02856776|Microbiota|microbiota
5181265|NCT02856776|Gene Expression|gene expression
5181266|NCT02856711|Group Prenatal Visits,CenteringPregnancy|group prenatal visits,centeringpregnancy
5181267|NCT02856698|Acute heart failure|acute heart failure
5181268|NCT02856698|morphine|morphine
5181269|NCT02856698|midazolam|midazolam
5181270|NCT02856698|in-hospital mortality|in-hospital mortality
5181271|NCT02856672|Laryngeal Tube Supreme Laryngeal Mask Airway Leak Pressure|laryngeal tube supreme laryngeal mask airway leak pressure
5181272|NCT02856620|cardiac mechanics|cardiac mechanics
5181273|NCT02856620|circulating biomarkers|circulating biomarkers
5181274|NCT02856620|frailty|frailty
5181275|NCT02856542|Psoriasis vulgaris, scalp, topical, applicator, device|psoriasis vulgaris, scalp, topical, applicator, device
5181276|NCT02856503|DCIS|dcis
5181277|NCT02856503|IBC|ibc
5181278|NCT02856503|Breast Cancer|breast cancer
5181279|NCT02856503|Invasive Breast Carcinoma|invasive breast carcinoma
5181280|NCT02856503|High Grade Ductal Carcinoma in-situ|high grade ductal carcinoma in-situ
5181281|NCT02856412|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5181282|NCT02856412|Exercise|exercise
5181283|NCT02856412|Mindfulness|mindfulness
5181284|NCT02856399|methadone|methadone
5181285|NCT02856399|cancer pain|cancer pain
5181286|NCT02856399|long term effect|long term effect
5181287|NCT02856373|Denervation|denervation
5181293|NCT02856347|PET F-DOPA|pet f-dopa
5181294|NCT02856347|18-FDOPA|18-fdopa
5181295|NCT02856334|chronic pelvic pain|chronic pelvic pain
5181296|NCT02856334|vulvodynia|vulvodynia
5181297|NCT02856334|pelvic pain|pelvic pain
5181298|NCT02856334|psychosocial factors|psychosocial factors
5181299|NCT02856334|central sensitization|central sensitization
5181300|NCT02856295|postpartum venous thromboembolism|postpartum venous thromboembolism
5181301|NCT02856295|prophylactic dose of low molecular weight heparin|prophylactic dose of low molecular weight heparin
5181302|NCT02856295|anti 10a|anti 10a
5181303|NCT02856269|Zinc|zinc
5181304|NCT02856256|Energy drink|energy drink
5181305|NCT02856256|Choroid|choroid
5181306|NCT02856230|Critical limb ischemia|critical limb ischemia
5181307|NCT02856230|bellow-the-knee angioplasty|bellow-the-knee angioplasty
5181308|NCT02856230|drug-eluting balloon|drug-eluting balloon
5181309|NCT02856165|infant|infant
5181310|NCT02856165|oxygen therapy|oxygen therapy
5181311|NCT02856165|High flow nasal canula oxygen therapy|high flow nasal canula oxygen therapy
5181312|NCT02856165|Bronchiolitis|bronchiolitis
5181313|NCT02856152|Healthy Volunteer|healthy volunteer
5181314|NCT02856139|ultra-widefield fluorescein angiography|ultra-widefield fluorescein angiography
5181315|NCT02856139|peripheral retina|peripheral retina
5181316|NCT02856139|normal eyes|normal eyes
5181317|NCT02856126|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5181318|NCT02856126|Transarterial Chemoembolization|transarterial chemoembolization
5181319|NCT02856113|Drug Therapy|drug therapy
5862719|NCT00001539|Lyme Disease|lyme disease
5862720|NCT00001535|Intracellular Immunization|intracellular immunization
5181320|NCT02856087|acute pain|acute pain
5181321|NCT02856087|postoperative|postoperative
5181322|NCT02856087|surgery|surgery
5181323|NCT02856048|GnRH agonist|gnrh agonist
5962260|NCT04281901|Cholesteatoma|cholesteatoma
5181324|NCT02856048|Ovarian reserve|ovarian reserve
5181325|NCT02856048|Fertility Preservation|fertility preservation
5181326|NCT02856048|Alkylating Agents|alkylating agents
5181327|NCT02856035|chronic stroke|chronic stroke
5181328|NCT02856035|functional MRI|functional mri
5181329|NCT02856035|functional NIRS|functional nirs
5181330|NCT02856035|motor learning|motor learning
5181331|NCT02856035|FES|fes
5181332|NCT02856035|upper extremity|upper extremity
5181333|NCT02856035|neural feedback|neural feedback
5181433|NCT02855606|TGW|tgw
5181334|NCT02856035|arm/hand functional training|arm/hand functional training
5181335|NCT02856022|electrical ilioinguinal nerve stimulation|electrical ilioinguinal nerve stimulation
5181336|NCT02856022|bladder pain syndrome|bladder pain syndrome
5181337|NCT02856022|intravesical irrigation|intravesical irrigation
5181338|NCT02855996|fatherhood|fatherhood
5181339|NCT02855996|father involvement|father involvement
5181340|NCT02855996|economic stability|economic stability
5181341|NCT02855996|co-parenting|co-parenting
5181342|NCT02855996|healthy relationships|healthy relationships
5181343|NCT02855996|father-child engagement|father-child engagement
5181344|NCT02855957|Alpha-Hemoglobin Stabilizing Protein|alpha-hemoglobin stabilizing protein
5181345|NCT02855957|alpha-Hb pool|alpha-hb pool
5181346|NCT02855957|thalassemias|thalassemias
5181347|NCT02855957|diagnostic method|diagnostic method
5181348|NCT02855957|biomarker|biomarker
5181349|NCT02855944|ovarian cancer|ovarian cancer
5181350|NCT02855944|fallopian tube cancer|fallopian tube cancer
5181351|NCT02855944|primary peritoneal cancer|primary peritoneal cancer
5181352|NCT02855944|peritoneal cancer|peritoneal cancer
5181353|NCT02855944|platinum sensitive|platinum sensitive
5181354|NCT02855944|relapsed disease|relapsed disease
5181355|NCT02855944|PARP Inhibitor|parp inhibitor
5181356|NCT02855944|PARP|parp
5181357|NCT02855944|rucaparib|rucaparib
5181358|NCT02855944|ruca|ruca
5181359|NCT02855944|homologous recombination|homologous recombination
5181360|NCT02855944|homologous recombination deficiency|homologous recombination deficiency
5181361|NCT02855944|genomic scarring|genomic scarring
5181362|NCT02855944|loss of heterozygosity|loss of heterozygosity
5181364|NCT02855944|PF-01367338|pf-01367338
5181365|NCT02855944|PF 01367338|pf 01367338
5181366|NCT02855944|CO-338-043|co-338-043
5181367|NCT02855944|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5181368|NCT02855944|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
5181369|NCT02855944|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
5181370|NCT02855944|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
5181371|NCT02855944|gynecological cancer|gynecological cancer
5181372|NCT02855944|Clovis|clovis
5181373|NCT02855944|Clovis oncology|clovis oncology
5181374|NCT02855944|ARIEL2|ariel2
5181375|NCT02855944|ARIEL 2|ariel 2
5181376|NCT02855944|ARIEL-2|ariel-2
5181377|NCT02855944|ARIEL-3|ariel-3
5181378|NCT02855944|ARIEL 3|ariel 3
5181379|NCT02855944|ARIEL3|ariel3
5181380|NCT02855944|ARIEL4|ariel4
5181381|NCT02855944|ARIEL-4|ariel-4
5181382|NCT02855944|ARIEL 4|ariel 4
5181383|NCT02855944|A4|a4
5181384|NCT02855944|advanced OC|advanced oc
5673527|NCT00607906|pharmacodynamics|pharmacodynamics
5181385|NCT02855944|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5181386|NCT02855944|platinum resistant primary ovarian cancer|platinum resistant primary ovarian cancer
5181388|NCT02855944|High grade serous|high grade serous
5181389|NCT02855944|Partially platinum sensitive|partially platinum sensitive
5181390|NCT02855918|Psychiatry|psychiatry
5181391|NCT02855918|Depressive disorder|depressive disorder
5181392|NCT02855918|Suicidal behavior|suicidal behavior
5181393|NCT02855918|Genetics|genetics
5181394|NCT02855905|Exercise|exercise
5181395|NCT02855905|Cold Temperature|cold temperature
5181396|NCT02855892|GV1001|gv1001
5181397|NCT02855892|BPH|bph
5181398|NCT02855892|Benign prostatic hyperplasia|benign prostatic hyperplasia
5181399|NCT02855788|gastric cancer|gastric cancer
5181400|NCT02855788|gastroesophageal cancer|gastroesophageal cancer
5181401|NCT02855788|metastatic|metastatic
5181402|NCT02855788|advanced|advanced
5181403|NCT02855736|Suicidal inpatients|suicidal inpatients
5181404|NCT02855736|Positive Psychology|positive psychology
5181405|NCT02855736|Gratitude|gratitude
5181406|NCT02855736|Psychological pain|psychological pain
5181407|NCT02855723|Squamous carcinoma of oral cavity and oropharynx|squamous carcinoma of oral cavity and oropharynx
5181408|NCT02855723|Sentinel lymph node|sentinel lymph node
5181409|NCT02855723|Lymph node dissection|lymph node dissection
5181410|NCT02855723|Equivalence|equivalence
5181411|NCT02855671|microcirculation|microcirculation
5176448|NCT02888808|women|women
5181418|NCT02855658|Oxidative stress|oxidative stress
5181419|NCT02855658|Immune regulation|immune regulation
5181420|NCT02855658|Gene modulation|gene modulation
5181421|NCT02855658|SS-1|ss-1
5070052|NCT03561077|Mindfulness|mindfulness
5181422|NCT02855645|Trichosanthes root|trichosanthes root
5181423|NCT02855645|Traditional Chinese Medicine|traditional chinese medicine
5181424|NCT02855645|Clinical trial|clinical trial
5181425|NCT02855632|G-CSF|g-csf
5181426|NCT02855632|adhesion reformation|adhesion reformation
5181427|NCT02855632|Asherman syndrome|asherman syndrome
5181428|NCT02855619|inspiratory muscles training programs|inspiratory muscles training programs
5181429|NCT02855619|Ventilator-induced diaphragmatic dysfunction|ventilator-induced diaphragmatic dysfunction
5181430|NCT02855619|Weaning|weaning
5181431|NCT02855619|Intensive care unit|intensive care unit
5181432|NCT02855606|Oral PrEP|oral prep
5181434|NCT02855606|Thai MSM|thai msm
5181435|NCT02855593|acupuncture|acupuncture
5181436|NCT02855580|Pharmacogenomic|pharmacogenomic
5181438|NCT02855580|psychiatry|psychiatry
5181439|NCT02855580|Obsessive Compulsive Disorder|obsessive compulsive disorder
5181440|NCT02855580|Depression|depression
5181441|NCT02855580|Anxiety|anxiety
5181442|NCT02855580|CYP2D6|cyp2d6
5181443|NCT02855580|CYP2C19|cyp2c19
5181444|NCT02855580|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5181445|NCT02855580|SSRI|ssri
5181446|NCT02855567|surgery|surgery
5181447|NCT02855567|acupuncture|acupuncture
5181448|NCT02855567|gynecology|gynecology
5181449|NCT02855567|pain|pain
5181450|NCT02855567|narcotics|narcotics
5181452|NCT02855541|Blood Glucose|blood glucose
5181453|NCT02855541|Physical Fitness|physical fitness
5181454|NCT02855541|Body Composition|body composition
5181455|NCT02855541|Lipids|lipids
5181456|NCT02855528|Tin Filter|tin filter
5181457|NCT02855528|Coronary Artery Calcium Scoring|coronary artery calcium scoring
5181458|NCT02855528|Radiation dose reduction|radiation dose reduction
5181459|NCT02855515|drug-induced sleep endoscopy|drug-induced sleep endoscopy
5181460|NCT02855515|obstructive sleep apnoea|obstructive sleep apnoea
5181461|NCT02855515|VOTE classification|vote classification
5181463|NCT02855515|BMI|bmi
5181464|NCT02855489|Condom Use|condom use
5181465|NCT02855489|HIV/STD|hiv/std
5181466|NCT02855489|Intervention|intervention
5181467|NCT02855489|Theory of Planned Behavior|theory of planned behavior
5181468|NCT02855489|Dismantling Study Design|dismantling study design
5181469|NCT02855463|Giant virus|giant virus
5181470|NCT02855463|Amoeba|amoeba
5181471|NCT02855424|stroke|stroke
5181472|NCT02855424|exercise capacity|exercise capacity
5181473|NCT02855385|Rectal bleeding, , ,|rectal bleeding, , ,
5181474|NCT02855385|Attitude|attitude
5181475|NCT02855385|Health seeking behaviour|health seeking behaviour
5181476|NCT02855385|Nigeria|nigeria
5181477|NCT02855385|Screening|screening
5181478|NCT02855385|high risk patients|high risk patients
5181479|NCT02855359|Antibodies, Monoclonal|antibodies, monoclonal
5181480|NCT02855359|SGN-19A|sgn-19a
5181481|NCT02855359|Denintuzumab Mafodotin|denintuzumab mafodotin
5181482|NCT02855359|DLBCL|dlbcl
5181483|NCT02855359|Antibody-Drug Conjugate|antibody-drug conjugate
5181484|NCT02855359|Antigens, CD19|antigens, cd19
5673528|NCT00607906|diabetes|diabetes
5181493|NCT02855359|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5181494|NCT02855359|Monomethyl auristatin F|monomethyl auristatin f
5181495|NCT02855359|Neoplasms|neoplasms
5181496|NCT02855359|Neoplasms by Histologic Type|neoplasms by histologic type
5181497|NCT02855359|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
5181498|NCT02855359|Cyclophosphamide|cyclophosphamide
5181499|NCT02855359|Doxorubicin|doxorubicin
5181500|NCT02855359|Liposomal doxorubicin|liposomal doxorubicin
5181501|NCT02855359|Prednisone|prednisone
5181502|NCT02855359|Rituximab|rituximab
5181503|NCT02855359|Vincristine|vincristine
5181504|NCT02855359|Alkylating Agents|alkylating agents
5181505|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents
5181506|NCT02855359|Antibiotic, Antineoplastic|antibiotic, antineoplastic
5181507|NCT02855359|Antimitotic Agents|antimitotic agents
5181508|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5169290|NCT02933320|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
5181510|NCT02855359|Phytogenic Antirheumatic Agents|phytogenic antirheumatic agents
5181511|NCT02855359|Glucocorticoids|glucocorticoids
5181512|NCT02855359|Drug Therapy|drug therapy
5181513|NCT02855359|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
5181514|NCT02855359|immunosuppressive agents|immunosuppressive agents
5181515|NCT02855333|Merendino procedure|merendino procedure
5181516|NCT02855333|Feasibility, Safety and QoL of the Merendino procedure|feasibility, safety and qol of the merendino procedure
5181517|NCT02855320|Biologics safety|biologics safety
5181518|NCT02855320|Rheumatoid arthritis|rheumatoid arthritis
5181519|NCT02855320|Spondyloarthritis|spondyloarthritis
5181520|NCT02855320|patient education|patient education
5181521|NCT02855320|self-management|self-management
5181522|NCT02855307|Closed-loop system|closed-loop system
5181523|NCT02855307|Artificial pancreas|artificial pancreas
5181524|NCT02855307|Exercise|exercise
5181525|NCT02855307|Hypoglycemia|hypoglycemia
5181526|NCT02855307|Insulin|insulin
5181527|NCT02855307|Type 1 diabetes|type 1 diabetes
5181528|NCT02855294|oral contraceptive pills|oral contraceptive pills
5181529|NCT02855294|Joint stability|joint stability
5181534|NCT02855229|Translational|translational
5181535|NCT02855229|Electrophysiology|electrophysiology
5181536|NCT02855216|Physiotherapy|physiotherapy
5181537|NCT02855216|Range of motion|range of motion
5181538|NCT02855216|Inhibition sub-occipital techniques|inhibition sub-occipital techniques
5181539|NCT02855190|Ga68-citrate|ga68-citrate
5048393|NCT03696420|VIM-DBS|vim-dbs
5181541|NCT02855190|PET/MR and PET/CT|pet/mr and pet/ct
5181542|NCT02855190|Periprosthetic joint infection|periprosthetic joint infection
5181543|NCT02855177|Hyperlipidemia|hyperlipidemia
5181550|NCT02855151|EUS|eus
5181551|NCT02855138|isotretinoin|isotretinoin
5181552|NCT02855138|PCOS|pcos
5181553|NCT02855138|acne vulgaris|acne vulgaris
5181554|NCT02855125|NSCLC|nsclc
5181555|NCT02855125|phase 2 study|phase 2 study
5181556|NCT02855125|TAS-114|tas-114
5181557|NCT02855125|S-1|s-1
5181558|NCT02855073|adipose-derived mesenchymal progenitor cells|adipose-derived mesenchymal progenitor cells
5181559|NCT02855073|Artz|artz
5181560|NCT02855034|child and infant|child and infant
5181561|NCT02855034|Blood samples|blood samples
5181562|NCT02855021|Dementia|dementia
5181563|NCT02855021|Cerebral metabolism|cerebral metabolism
5181564|NCT02855021|PET scan|pet scan
5181565|NCT02855008|Social Problem-Solving|social problem-solving
5181566|NCT02855008|Intellectual Disability|intellectual disability
5181567|NCT02855008|Problem Behaviors|problem behaviors
5181568|NCT02855008|Community based intervention|community based intervention
5181569|NCT02855008|Prevention|prevention
5181570|NCT02854956|phenotype|phenotype
5181571|NCT02854956|X-linked mental retardation|x-linked mental retardation
5181572|NCT02854956|neuronal networks|neuronal networks
5181573|NCT02854956|cognitive processes|cognitive processes
5181574|NCT02854930|Clinical death|clinical death
5181575|NCT02854930|state of consciousness|state of consciousness
5181576|NCT02854904|Immunomodulatory|immunomodulatory
5181577|NCT02854904|dexmedetomidine|dexmedetomidine
5181578|NCT02854904|anesthesia|anesthesia
5181579|NCT02854904|alpha-2 agonist|alpha-2 agonist
5181580|NCT02854904|arthrodesis|arthrodesis
5181581|NCT02854904|spinal fusion|spinal fusion
5181582|NCT02854904|Immune effect|immune effect
5181583|NCT02854904|double randomized clinical trials|double randomized clinical trials
5181584|NCT02854891|Effects|effects
5181585|NCT02854891|Heat|heat
5181586|NCT02854891|Light|light
5181587|NCT02854826|Frail Older Adults, Interprofessional Team|frail older adults, interprofessional team
5181588|NCT02854813|overactive bladder|overactive bladder
5181589|NCT02854813|coronary artery disease|coronary artery disease
5181590|NCT02854813|gensini score|gensini score
5181591|NCT02854800|varenicline|varenicline
5181592|NCT02854800|buprenorphine|buprenorphine
5176681|NCT02887053|MRI|mri
5181600|NCT02854735|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5181602|NCT02854735|Muscle quantification|muscle quantification
5181603|NCT02854722|deferasirox|deferasirox
5181604|NCT02854722|iron accumulation|iron accumulation
5181605|NCT02854696|Islet cell Transplantation|islet cell transplantation
5181606|NCT02854696|cost-effectiveness analysis|cost-effectiveness analysis
5181607|NCT02854696|Cost-utility analysis|cost-utility analysis
5181608|NCT02854696|Type 1 Diabetes|type 1 diabetes
5181609|NCT02854683|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
5181610|NCT02854683|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
5181611|NCT02854683|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
5181612|NCT02854683|Neurally Mediated Syncope (NMS)|neurally mediated syncope (nms)
5181613|NCT02854683|Systemic Exertion Intolerance Disease (SEID)|systemic exertion intolerance disease (seid)
5181614|NCT02854683|Orthostatic Intolerance (OI)|orthostatic intolerance (oi)
5181615|NCT02854683|Oral Rehydration Solution (ORS)|oral rehydration solution (ors)
5181616|NCT02854683|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
5181617|NCT02854670|capsaicin|capsaicin
5181618|NCT02854670|pain improvement|pain improvement
5181619|NCT02854670|provoked vulvodynia|provoked vulvodynia
5181620|NCT02854657|melanoma|melanoma
5181621|NCT02854657|skin self-examination|skin self-examination
5181622|NCT02854631|Cirrhosis|cirrhosis
5181623|NCT02854631|Prednisone|prednisone
5181624|NCT02854631|Jaundice|jaundice
5181625|NCT02854605|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5181626|NCT02854605|Fibrosis|fibrosis
5181627|NCT02854605|GS-9674|gs-9674
5181628|NCT02854592|rtPA|rtpa
5181629|NCT02854592|urokinase|urokinase
5181630|NCT02854579|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
5181631|NCT02854579|progenitor cell|progenitor cell
5181632|NCT02854579|paracrine factor|paracrine factor
5181633|NCT02854579|adipose mesenchymal stem cell|adipose mesenchymal stem cell
5181634|NCT02854579|neonate|neonate
5181635|NCT02854566|periprosthetic fracture of the femur|periprosthetic fracture of the femur
5181636|NCT02854566|hip prosthesis|hip prosthesis
5181637|NCT02854540|hyperhidrosis|hyperhidrosis
5181638|NCT02854540|palmar|palmar
5181639|NCT02854540|sweating|sweating
5181640|NCT02854540|iontophoresis|iontophoresis
5962261|NCT04281901|Regenerative Medicine|regenerative medicine
5181641|NCT02854540|sweat gland diseases|sweat gland diseases
5181642|NCT02854540|skin diseases|skin diseases
5181643|NCT02854514|endometrial -cytokines|endometrial -cytokines
5181644|NCT02854501|Homocysteine|homocysteine
5181645|NCT02854501|Preeclampsia|preeclampsia
5181646|NCT02854501|poor placentation|poor placentation
5181647|NCT02854475|skin parameters|skin parameters
5181648|NCT02854475|cholesterol|cholesterol
5181649|NCT02854475|Raman spectroscopy|raman spectroscopy
5181650|NCT02854462|Language Development|language development
5181651|NCT02854462|Shared Picture Book reading|shared picture book reading
5181652|NCT02854462|Preschoolers|preschoolers
5181653|NCT02854462|Inference making|inference making
5181654|NCT02854449|Immune Marker|immune marker
5181655|NCT02854449|Immunologic Marker|immunologic marker
5181656|NCT02854449|Radiotherapy|radiotherapy
5181657|NCT02854449|Dose Hypofractionation|dose hypofractionation
5181658|NCT02854436|Prostate cancer|prostate cancer
5181659|NCT02854436|CRPC|crpc
5181660|NCT02854436|Metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
5181661|NCT02854436|Prostate neoplasm|prostate neoplasm
5181662|NCT02854436|Galahad|galahad
5181663|NCT02854436|Niraparib|niraparib
5181664|NCT02854436|DNA anomalies|dna anomalies
5181665|NCT02854436|DNA defect|dna defect
5181666|NCT02854436|PARP inhibitor|parp inhibitor
5181667|NCT02854436|PARPi|parpi
5181668|NCT02854410|dietary sodium nitrate|dietary sodium nitrate
5181669|NCT02854410|radiotherapy|radiotherapy
5181670|NCT02854410|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5169501|NCT02932150|CHB|chb
5181680|NCT02854332|Stimulation|stimulation
5181681|NCT02854332|Motor Cortex|motor cortex
5181682|NCT02854306|Bariatric surgery|bariatric surgery
5181683|NCT02854306|Mindfulness|mindfulness
5181684|NCT02854306|Obese|obese
5181685|NCT02854293|palliative care|palliative care
5181686|NCT02854293|cancer|cancer
5181687|NCT02854293|quality of life|quality of life
5181688|NCT02854280|Hypoxia|hypoxia
5181689|NCT02854280|Brain|brain
5181690|NCT02854280|Effort|effort
5181691|NCT02854267|organ procurement|organ procurement
5181692|NCT02854267|brain death|brain death
5181693|NCT02854267|organ donation|organ donation
5181694|NCT02854267|next of kins|next of kins
5181695|NCT02854254|phlebitis|phlebitis
5181696|NCT02854254|catheter|catheter
5181697|NCT02854254|congestive heart failure|congestive heart failure
5181698|NCT02854254|dobutamine|dobutamine
5181699|NCT02854241|MRI|mri
5181700|NCT02854241|HCC|hcc
5181701|NCT02854241|surveillance|surveillance
5181702|NCT02854228|Pituitary tumor|pituitary tumor
5181703|NCT02854228|pituitary carcinoma|pituitary carcinoma
5181704|NCT02854228|acromegaly|acromegaly
5181705|NCT02854228|cushing|cushing
5181706|NCT02854228|prolactinoma|prolactinoma
5181707|NCT02854163|Secukinumab|secukinumab
5181708|NCT02854163|Neutrophils|neutrophils
5181709|NCT02854163|Vitamin D|vitamin d
5181710|NCT02854124|Melanoma|melanoma
5181711|NCT02854124|Dissemination|dissemination
5181712|NCT02854124|Initiating stem cells|initiating stem cells
5181713|NCT02854098|BHJS, constipation|bhjs, constipation
5181714|NCT02854085|Prevention of Cognitive Decline|prevention of cognitive decline
5181715|NCT02854085|Art Therapy|art therapy
5181716|NCT02854085|Music Reminiscence Activity|music reminiscence activity
5181717|NCT02854085|Elderly|elderly
5181718|NCT02854072|GV1001|gv1001
5181719|NCT02854059|Asymptomatic antibody-mediated TTP|asymptomatic antibody-mediated ttp
5181720|NCT02854046|calcific uremic arteriolopathy|calcific uremic arteriolopathy
5181721|NCT02854046|case-control study|case-control study
5181722|NCT02854046|cohort study|cohort study
5181723|NCT02854033|amyloid|amyloid
5181724|NCT02854033|plaques|plaques
5181725|NCT02854033|neuroimaging|neuroimaging
5181726|NCT02854033|biomarkers|biomarkers
5181727|NCT02854033|cognition disorder|cognition disorder
5181728|NCT02854033|early detection|early detection
5181729|NCT02854033|pre-dementia|pre-dementia
5181730|NCT02854033|dementia|dementia
5181731|NCT02854033|Alzheimer's disease|alzheimer's disease
5181732|NCT02854033|tau|tau
5181733|NCT02854020|Aircraft|aircraft
5181734|NCT02854020|Emergency|emergency
5181735|NCT02854020|First aid|first aid
5181736|NCT02854020|Cabin crew|cabin crew
5181737|NCT02854020|Burn|burn
5181738|NCT02854020|Cardiac arrest|cardiac arrest
5181739|NCT02854007|Coronary artery disease|coronary artery disease
5181740|NCT02854007|Angioplasty|angioplasty
5181741|NCT02854007|Bioresorbable coronary device|bioresorbable coronary device
5181742|NCT02854007|QALY (Quality-Adjusted Life Years)|qaly (quality-adjusted life years)
5181743|NCT02853994|DCB|dcb
5181744|NCT02853994|DEB|deb
5181745|NCT02853994|Sirolimus|sirolimus
5181746|NCT02853994|PCI|pci
5181747|NCT02853994|ISR|isr
5181748|NCT02853994|SVD|svd
5181749|NCT02853994|Restenosis|restenosis
5181750|NCT02853994|Bifurcation|bifurcation
5962262|NCT04281875|Total Thyroidectomy|total thyroidectomy
5181751|NCT02853994|CAD|cad
5181752|NCT02853994|Coronary artery|coronary artery
5181753|NCT02853968|Unlock the Cell|unlock the cell
5181754|NCT02853968|Castleman's Disease|castleman's disease
5181755|NCT02853968|CD|cd
5181756|NCT02853968|Castleman Disease|castleman disease
5181757|NCT02853968|MCD|mcd
5181758|NCT02853968|iMCD|imcd
5181759|NCT02853968|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
5181760|NCT02853968|multicentric Castleman's disease|multicentric castleman's disease
5181761|NCT02853968|multicentric Castleman disease|multicentric castleman disease
5181762|NCT02853968|idiopathic multicentric Castleman disease|idiopathic multicentric castleman disease
5181763|NCT02853929|Pertussis|pertussis
5181764|NCT02853929|Immunogenicity|immunogenicity
5181765|NCT02853929|Poliomyelitis|poliomyelitis
5181768|NCT02853929|Diptheria|diptheria
5181769|NCT02853903|solid tumor|solid tumor
5181770|NCT02853903|NK immunotherapy|nk immunotherapy
5181771|NCT02853890|Birth|birth
5181772|NCT02853890|obstetric analgesia|obstetric analgesia
5181773|NCT02853890|obstetric anesthesia|obstetric anesthesia
5181782|NCT02853838|acute viral bronchiolitis|acute viral bronchiolitis
5181783|NCT02853838|respiratory syncytial virus|respiratory syncytial virus
5181784|NCT02853838|chest physiotherapy|chest physiotherapy
5181785|NCT02853812|tinnitus|tinnitus
5181786|NCT02853812|residual inhibition|residual inhibition
5169581|NCT02931721|Male infertility|male infertility
5169582|NCT02931721|Testis|testis
5169584|NCT02931708|Heart Failure|heart failure
5169585|NCT02931708|Diaphragm|diaphragm
5169586|NCT02931708|Electrical Stimulation|electrical stimulation
5181787|NCT02853786|cochlear implant|cochlear implant
5181788|NCT02853786|language environment|language environment
5181789|NCT02853786|speech therapy assessment|speech therapy assessment
5181790|NCT02853786|LENA technology|lena technology
5181791|NCT02853773|sweeteners|sweeteners
5181792|NCT02853773|sugar|sugar
5181793|NCT02853773|EEG|eeg
5181794|NCT02853773|food viewing|food viewing
5181795|NCT02853773|food intake|food intake
5181796|NCT02853747|arterial stiffness|arterial stiffness
5181797|NCT02853747|retinal vessels|retinal vessels
5181798|NCT02853747|physical activity|physical activity
5181799|NCT02853747|children|children
5181800|NCT02853708|E. coli|e. coli
5181801|NCT02853708|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
5181802|NCT02853708|molecular epidemiology|molecular epidemiology
5181803|NCT02853708|risk factors|risk factors
5181804|NCT02853695|Hysteroscopy|hysteroscopy
5181805|NCT02853695|Diffusion|diffusion
5181806|NCT02853695|Implementation|implementation
5181807|NCT02853695|Diagnostic hysteroscopy|diagnostic hysteroscopy
5181808|NCT02853695|Operative hysteroscopy|operative hysteroscopy
5181809|NCT02853682|glycocalyx|glycocalyx
5181810|NCT02853682|capillary leak syndrome|capillary leak syndrome
5181811|NCT02853656|preterm birth|preterm birth
5181812|NCT02853656|gestation|gestation
5181813|NCT02853617|S. pneumoniae|s. pneumoniae
5181814|NCT02853617|N. meningitidis|n. meningitidis
5181815|NCT02853617|H. influenza|h. influenza
5181816|NCT02853617|B. pertussis|b. pertussis
5181817|NCT02853617|C. tetani|c. tetani
5181818|NCT02853617|MRSA|mrsa
5181819|NCT02853591|laparoscopy|laparoscopy
5181820|NCT02853591|hysterectomy|hysterectomy
5181821|NCT02853500|Liver Cancer|liver cancer
5181822|NCT02853487|Cluster headache|cluster headache
5181823|NCT02853487|actigraphy|actigraphy
5181824|NCT02853487|circadian rhythm|circadian rhythm
5181825|NCT02853461|biofilm|biofilm
5181826|NCT02853461|periprosthetic joint infection|periprosthetic joint infection
5181827|NCT02853461|hip|hip
5181828|NCT02853461|endoprothesis|endoprothesis
5181829|NCT02853461|ceramic|ceramic
5181830|NCT02853461|bearing components|bearing components
5181831|NCT02853461|sonication|sonication
5181832|NCT02853461|low grade infection|low grade infection
5181833|NCT02853461|joint aspiration|joint aspiration
5181834|NCT02853448|Plasma|plasma
5181835|NCT02853448|Serum|serum
5181836|NCT02853448|Effective Blood Draws|effective blood draws
5181837|NCT02853435|Cross-over|cross-over
5181838|NCT02853435|Gepotidacin|gepotidacin
5181839|NCT02853435|Pharmacokinetics|pharmacokinetics
5181840|NCT02853435|Relative Bioavailability|relative bioavailability
5181841|NCT02853435|non-compartmental PK analysis|non-compartmental pk analysis
5181842|NCT02853435|High shear wet granulation|high shear wet granulation
5181843|NCT02853396|internalised stigma|internalised stigma
5181844|NCT02853396|self stigma|self stigma
5181845|NCT02853396|inpatients|inpatients
5181846|NCT02853396|CBT|cbt
5181847|NCT02853396|Cognitive therapy|cognitive therapy
5181848|NCT02853383|Chronic Obstructive Pulmonary Diseases, COPD|chronic obstructive pulmonary diseases, copd
5181849|NCT02853357|Thoracic manipulation|thoracic manipulation
5181850|NCT02853357|Low back pain|low back pain
5181851|NCT02853357|Core strengthening|core strengthening
5181852|NCT02853357|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
5181853|NCT02853344|PD1|pd1
5181854|NCT02853344|PD-1|pd-1
5181855|NCT02853344|PDL1|pdl1
5181856|NCT02853344|PD-L1|pd-l1
5181857|NCT02853331|PD1|pd1
5181858|NCT02853331|PD-1|pd-1
5181859|NCT02853331|PDL1|pdl1
5181860|NCT02853331|PD-L1|pd-l1
5181861|NCT02853331|PDL2|pdl2
5181862|NCT02853331|PD-L2|pd-l2
5181863|NCT02853331|VEGFR TKI|vegfr tki
5181868|NCT02853266|Kawasaki disease|kawasaki disease
5181869|NCT02853266|non-cruzi-related antibody (NCRA)|non-cruzi-related antibody (ncra)
5181870|NCT02853253|Preterm neonates|preterm neonates
5181874|NCT02853240|botulinum toxin injection|botulinum toxin injection
5181875|NCT02853227|Telemark score, reliability|telemark score, reliability
5169677|NCT02931292|sleeve gastrectomy|sleeve gastrectomy
5169678|NCT02931292|laparoscopy|laparoscopy
5169679|NCT02931292|bariatric surgery|bariatric surgery
5169680|NCT02931292|obesity surgery|obesity surgery
5169681|NCT02931292|metabolic surgery|metabolic surgery
5181876|NCT02853214|Dysglobulinemia|dysglobulinemia
5181877|NCT02853214|Multiple Myeloma|multiple myeloma
5181879|NCT02853214|Waldenström|waldenström
5181880|NCT02853214|genetic factors|genetic factors
5181881|NCT02853214|Sequencing|sequencing
5181882|NCT02853201|Extubation|extubation
5181883|NCT02853201|Intercostal Muscles|intercostal muscles
5181884|NCT02853201|Diaphragm|diaphragm
5181885|NCT02853201|Sternocleidomastoid Muscle|sternocleidomastoid muscle
5181886|NCT02853162|Stereotactic body radiotherapy|stereotactic body radiotherapy
5181887|NCT02853162|MRI|mri
5181888|NCT02853162|Renal cell carcinoma|renal cell carcinoma
5181889|NCT02853149|Spinal Cord Injury|spinal cord injury
5181890|NCT02853149|disability|disability
5181891|NCT02853149|obesity|obesity
5181892|NCT02853149|cardiometabolic|cardiometabolic
5181893|NCT02853149|Caregiver|caregiver
5181894|NCT02853110|MRI, stereotactic body radiotherapy, hypofractionation|mri, stereotactic body radiotherapy, hypofractionation
5181895|NCT02853084|Auto-inflammatory diseases|auto-inflammatory diseases
5181896|NCT02853084|IL-1 inhibitors|il-1 inhibitors
5181897|NCT02853084|HL2351|hl2351
5181898|NCT02853084|Cryopyrin‑Associated Periodic Syndromes (CAPS)|cryopyrin‑associated periodic syndromes (caps)
5181899|NCT02853084|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
5181900|NCT02853084|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5181901|NCT02853084|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5181902|NCT02853058|stillbirth|stillbirth
5181903|NCT02853058|hemorrhage|hemorrhage
5181904|NCT02853019|Emotion|emotion
5181905|NCT02853019|motivation|motivation
5181906|NCT02853019|cognition|cognition
5181907|NCT02853019|schizophrenia|schizophrenia
5181908|NCT02853006|Cancer lung|cancer lung
5181909|NCT02853006|Fluids|fluids
5181910|NCT02853006|LungCancerTest|lungcancertest
5181911|NCT02853006|radiological anomalies|radiological anomalies
5181912|NCT02853006|non-cancerous|non-cancerous
5181913|NCT02853006|carriers|carriers
5181914|NCT02853006|Patient reference|patient reference
5181915|NCT02852993|Erythrocyte Transfusion|erythrocyte transfusion
5181916|NCT02852993|Survival|survival
5181917|NCT02852967|Skin Diseases|skin diseases
5181918|NCT02852967|Auto-Immune Diseases|auto-immune diseases
5181919|NCT02852967|Plaque|plaque
5181920|NCT02852967|Dermatology|dermatology
5181921|NCT02852954|Progesterone Induced Blocking Factor|progesterone induced blocking factor
5181922|NCT02852954|Endometrial Cancer|endometrial cancer
5181923|NCT02852941|Impedance|impedance
5181924|NCT02852941|Kidney Transplantation|kidney transplantation
5181925|NCT02852928|ILD; chILD|ild; child
5181926|NCT02852915|Colonic Neoplasms|colonic neoplasms
5181927|NCT02852915|Laparoscopic Surgery|laparoscopic surgery
5181929|NCT02852902|Bloodstream infections caused by MDR Enterobacteriaceae|bloodstream infections caused by mdr enterobacteriaceae
5181930|NCT02852902|Extended-spectrum β-lactamase-producers|extended-spectrum β-lactamase-producers
5181931|NCT02852902|Carbapenemase-producing organisms|carbapenemase-producing organisms
5181932|NCT02852902|Solid Organ Transplantation|solid organ transplantation
5181933|NCT02852902|Multidrug-resistant Enterobacteriaceae|multidrug-resistant enterobacteriaceae
5181934|NCT02852902|Anti-Infective Agents|anti-infective agents
5181935|NCT02852889|internal jugular vein distensibility,haemodynamics|internal jugular vein distensibility,haemodynamics
5181936|NCT02852876|Safety of ASP2151|safety of asp2151
5181937|NCT02852876|Phase 1|phase 1
5181938|NCT02852876|Pharmacokinetics|pharmacokinetics
5181939|NCT02852876|Healthy male subjects|healthy male subjects
5181940|NCT02852876|Tolerability|tolerability
5181941|NCT02852876|Food effect of ASP2151|food effect of asp2151
5181942|NCT02852811|Climacteric|climacteric
5181943|NCT02852811|Education|education
5182241|NCT02850536|CAR-T|car-t
5181944|NCT02852811|Mental health|mental health
5181945|NCT02852811|Menopause|menopause
5181946|NCT02852772|Cognitive impairment|cognitive impairment
5181948|NCT02852772|Microalbuminuria|microalbuminuria
5181949|NCT02852772|Chronic kidney disease|chronic kidney disease
5181950|NCT02852720|Pharmacokinetics|pharmacokinetics
5181951|NCT02852720|levobupivacaine|levobupivacaine
5181952|NCT02852720|Pregnancy|pregnancy
5181953|NCT02852720|Cesarean section|cesarean section
5181954|NCT02852720|Electrocardiography|electrocardiography
5181955|NCT02852668|elderly|elderly
5181956|NCT02852668|strength training|strength training
5181957|NCT02852668|power training|power training
5181958|NCT02852668|functional capacity|functional capacity
5181959|NCT02852668|gait biomechanics|gait biomechanics
5181960|NCT02852655|Brain Tumor|brain tumor
5181968|NCT02852603|dissection|dissection
5181969|NCT02852603|aneurysm|aneurysm
5181970|NCT02852603|thoracic aorta|thoracic aorta
5181971|NCT02852590|Observational|observational
5181973|NCT02852590|Off-Label Use|off-label use
5181974|NCT02852590|Unlicensed drug use|unlicensed drug use
5056180|NCT03647839|PD1 inhibitors|pd1 inhibitors
5181975|NCT02852590|Adverse Drug Reaction|adverse drug reaction
5181976|NCT02852590|Hospitalized Children|hospitalized children
5181977|NCT02852590|Pediatric inpatients|pediatric inpatients
5181978|NCT02852577|panic disorder|panic disorder
5181979|NCT02852577|agoraphobia|agoraphobia
5181980|NCT02852577|clonazepam|clonazepam
5181981|NCT02852577|paroxetine|paroxetine
5181982|NCT02852564|Non-Muscle|non-muscle
5181983|NCT02852564|Invasive|invasive
5181984|NCT02852564|Bladder|bladder
5181985|NCT02852564|Cancer|cancer
5181986|NCT02852564|Muscle|muscle
5181987|NCT02852564|Surgery|surgery
5181988|NCT02852564|Transurethral|transurethral
5181989|NCT02852564|Resection|resection
5181990|NCT02852564|Tumor|tumor
5181991|NCT02852564|Ethacrynic|ethacrynic
5181992|NCT02852564|Acid|acid
5181993|NCT02852564|Mitomycin|mitomycin
5181994|NCT02852564|Urine|urine
5181995|NCT02852564|NMIBC|nmibc
5181996|NCT02852512|Laparoscopic Sacrocolpopexy|laparoscopic sacrocolpopexy
5181997|NCT02852512|Robotic Assisted Sacrocolpopexy|robotic assisted sacrocolpopexy
5181998|NCT02852512|Pelvic Organ Prolapse|pelvic organ prolapse
5181999|NCT02852499|environmental epidemiology|environmental epidemiology
5182000|NCT02852499|cohort|cohort
5182001|NCT02852499|atmospheric pollutant|atmospheric pollutant
5182002|NCT02852499|chemical pollutant|chemical pollutant
5182003|NCT02852499|growth, neuro-development, respiratory health|growth, neuro-development, respiratory health
5182004|NCT02852499|big data|big data
5182005|NCT02852499|biological samples (RNA, DNA, urines ...)|biological samples (rna, dna, urines ...)
5182006|NCT02852499|e-dohad and exposome|e-dohad and exposome
5182007|NCT02852486|BCR-ABL Positive|bcr-abl positive
5182008|NCT02852486|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
5182009|NCT02852486|Imatinib|imatinib
5182010|NCT02852486|Pioglitazone|pioglitazone
5182011|NCT02852473|Continuous Positive Airway Pressure|continuous positive airway pressure
5182012|NCT02852473|Radiotherapy|radiotherapy
5182013|NCT02852473|Proton Therapy|proton therapy
5182014|NCT02852382|scalp block|scalp block
5182015|NCT02852382|local infiltration|local infiltration
5182016|NCT02852330|Voltage tomography|voltage tomography
5182017|NCT02852304|liver|liver
5182018|NCT02852304|transplant|transplant
5182019|NCT02852304|Lysosomal Acid Lipase|lysosomal acid lipase
5182020|NCT02852278|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5182021|NCT02852278|ALS|als
5182022|NCT02852278|motor neuron diseases|motor neuron diseases
5182023|NCT02852278|Progressive Muscular Atrophy|progressive muscular atrophy
5182024|NCT02852278|Primary Lateral Sclerosis|primary lateral sclerosis
5182025|NCT02852278|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5182026|NCT02852265|oral contraceptive|oral contraceptive
5182027|NCT02852265|contraceptive implant|contraceptive implant
5182028|NCT02852265|contraception|contraception
5182029|NCT02852265|adherence|adherence
5182030|NCT02852265|adverse event|adverse event
5182031|NCT02852239|Renal impairment|renal impairment
5182032|NCT02852239|Healthy volunteers|healthy volunteers
5182033|NCT02852239|Clinical pharmacology study|clinical pharmacology study
5182034|NCT02852239|DRB436|drb436
5182035|NCT02852239|dabrafenib|dabrafenib
5182036|NCT02852239|normal renal function|normal renal function
5182037|NCT02852239|impaired renal function|impaired renal function
5182038|NCT02852213|AADC|aadc
5182039|NCT02852213|gene therapy|gene therapy
5182040|NCT02852187|Intervertebral Disc Degeneration|intervertebral disc degeneration
5182041|NCT02852187|Lumbar Spinal Disease|lumbar spinal disease
5182042|NCT02852148|Wound|wound
5182043|NCT02852148|Pressure Ulcer|pressure ulcer
5182044|NCT02852148|Diabetic Foot Ulcer|diabetic foot ulcer
5182045|NCT02852148|Venous Leg Ulcer|venous leg ulcer
5182046|NCT02852148|Burn|burn
5182047|NCT02852148|Quality of Life|quality of life
5182048|NCT02852135|Laryngeal Mask Airway|laryngeal mask airway
5182049|NCT02852135|lateral position|lateral position
5182050|NCT02852135|laparoscopic surgery|laparoscopic surgery
5182051|NCT02852122|prostate cancer|prostate cancer
5182052|NCT02852122|C11 Choline PET/MR|c11 choline pet/mr
5182053|NCT02852122|staging|staging
5182054|NCT02852122|biochemical failure|biochemical failure
5182056|NCT02852096|Her2/neu|her2/neu
5182057|NCT02852096|dual paraffin blocks|dual paraffin blocks
5182058|NCT02852096|trastuzumab|trastuzumab
5182059|NCT02852070|bronchoalveolar lavage|bronchoalveolar lavage
5182060|NCT02852070|lower respiratory tract infections|lower respiratory tract infections
5182061|NCT02851979|premature newborns|premature newborns
5182062|NCT02851979|apneas prevention|apneas prevention
5182063|NCT02851979|olfactory stimulation|olfactory stimulation
5962263|NCT04281875|Intraoperative Parathyroid Identification|intraoperative parathyroid identification
5182064|NCT02851979|latin square design|latin square design
5182065|NCT02851966|Non-obstructive Azoospermia|non-obstructive azoospermia
5182066|NCT02851966|Sperm Retrieval|sperm retrieval
5182067|NCT02851966|Infertility, Male|infertility, male
5182068|NCT02851966|Semen|semen
5182069|NCT02851966|Biomarkers|biomarkers
5182070|NCT02851966|Proteomics|proteomics
5182071|NCT02851966|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5962264|NCT04281875|Near Infrared Autofluorescence|near infrared autofluorescence
5182072|NCT02851953|cervix, cervical dilation, balloon catheter|cervix, cervical dilation, balloon catheter
5182074|NCT02851940|Bleeding|bleeding
5182075|NCT02851940|Hemorrhoids|hemorrhoids
5182076|NCT02851940|Band Ligation|band ligation
5182077|NCT02851940|hypertonic saline sclerotherapy|hypertonic saline sclerotherapy
5182078|NCT02851836|attachment|attachment
5182079|NCT02851836|adolescent|adolescent
5182080|NCT02851836|picture|picture
5182081|NCT02851823|Er-YAG lasers|er-yag lasers
5182082|NCT02851823|Nd-YAG lasers|nd-yag lasers
5182083|NCT02851823|chronic periodontitis|chronic periodontitis
5182084|NCT02851823|nonsurgical periodontal debridement|nonsurgical periodontal debridement
5182085|NCT02851810|attachment|attachment
5182086|NCT02851810|oculomotor marker|oculomotor marker
5182087|NCT02851810|emotion regulation|emotion regulation
5182088|NCT02851784|hepatocellular carcinoma|hepatocellular carcinoma
5182089|NCT02851784|ablation|ablation
5182090|NCT02851784|immunotherapy|immunotherapy
5182091|NCT02851784|cytokine induced kill cell|cytokine induced kill cell
5182092|NCT02851732|Quality Improvement|quality improvement
5182093|NCT02851732|Cluster Analysis|cluster analysis
5182094|NCT02851719|Urinary Incontinence, Stress|urinary incontinence, stress
5182095|NCT02851719|Pelvic Floor|pelvic floor
5182096|NCT02851719|Exercise|exercise
5182097|NCT02851719|Patient Compliance|patient compliance
5182098|NCT02851706|Brain Tumor|brain tumor
5182100|NCT02851706|Astrocytoma|astrocytoma
5182101|NCT02851706|Brain Cancer|brain cancer
5182102|NCT02851706|Spine Cancer|spine cancer
5182103|NCT02851615|Anemia, Sickle Cell|anemia, sickle cell
5182104|NCT02851615|Self Care|self care
5182105|NCT02851615|Adolescent|adolescent
5182106|NCT02851615|Young Adult|young adult
5182107|NCT02851615|Disease Management|disease management
5182108|NCT02851615|Behavioral Activation|behavioral activation
5182109|NCT02851615|Peer Communication|peer communication
5182110|NCT02851576|Adenovirus|adenovirus
5182111|NCT02851550|liver|liver
5182112|NCT02851550|transplant|transplant
5182113|NCT02851550|Lysosomal Acid Lipase|lysosomal acid lipase
5182114|NCT02851472|TRAGI (transfusion related acute gut injury)|tragi (transfusion related acute gut injury)
5182115|NCT02851472|inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
5182116|NCT02851472|prematurity|prematurity
5182117|NCT02851472|PRBC transfusion|prbc transfusion
5182118|NCT02851472|NEC (necrotizing enterocolitis)|nec (necrotizing enterocolitis)
5182119|NCT02851472|NIRS (near infrared spectroscopy)|nirs (near infrared spectroscopy)
5182120|NCT02851472|ELGAN (extremely low gestational age neonate)|elgan (extremely low gestational age neonate)
5182121|NCT02851459|Vaccines|vaccines
5182122|NCT02851407|stem cell transplant|stem cell transplant
5182123|NCT02851407|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5182124|NCT02851407|veno-occlusive disease (VOD)|veno-occlusive disease (vod)
5182125|NCT02851407|sinosoidial obstruction syndrome (SOS)|sinosoidial obstruction syndrome (sos)
5182126|NCT02851368|Indocyanine Green|indocyanine green
5182127|NCT02851368|Fluorescence Imaging|fluorescence imaging
5182128|NCT02851342|Cognition|cognition
5182130|NCT02851329|stage IV EGFR-mutant|stage iv egfr-mutant
5182131|NCT02851329|EGFR TKIs|egfr tkis
5182132|NCT02851329|progression-free survival|progression-free survival
5182133|NCT02851329|prognosis|prognosis
5182134|NCT02851329|computed tomography|computed tomography
5182135|NCT02851290|Hypospadias|hypospadias
5182136|NCT02851290|Caudal block|caudal block
5182137|NCT02851290|Dorsal penile nerve block|dorsal penile nerve block
5182138|NCT02851290|Anesthesia|anesthesia
5182139|NCT02851290|Urethrocutaneous fistula|urethrocutaneous fistula
5182140|NCT02851290|Urethral stricture|urethral stricture
5182141|NCT02851290|Meatal stenosis|meatal stenosis
5182142|NCT02851290|Glanular dehiscence|glanular dehiscence
5182143|NCT02851277|Peanut Allergy|peanut allergy
5182144|NCT02851277|ASP0892|asp0892
5182145|NCT02851264|Early Esophageal Squamous Neoplasia|early esophageal squamous neoplasia
5182146|NCT02851264|optical enhancement technology|optical enhancement technology
5182147|NCT02851264|virtual chromoendoscopy|virtual chromoendoscopy
5182148|NCT02851251|eye disease|eye disease
5182149|NCT02851251|neonatal eye disease|neonatal eye disease
5182150|NCT02851251|newborn|newborn
5182151|NCT02851251|screening|screening
5182154|NCT02851121|Neurophysiological|neurophysiological
5182155|NCT02851121|Perception-action|perception-action
5182156|NCT02851121|Link|link
5182157|NCT02851108|falciparum malaria|falciparum malaria
5182158|NCT02851108|sub saharan|sub saharan
5182159|NCT02851108|africa|africa
5182160|NCT02851108|elimination disorder|elimination disorder
5169962|NCT02929264|fMRI|fmri
5169963|NCT02929225|bacterial translocation;micro-inflammation;hemodialysis|bacterial translocation;micro-inflammation;hemodialysis
5169964|NCT02929212|Gastric Bypass|gastric bypass
5169965|NCT02929212|Meal Texture|meal texture
5169966|NCT02929212|Meal Number|meal number
5169967|NCT02929212|GLP-1|glp-1
5169968|NCT02929212|Glucose|glucose
5170000|NCT02928978|ALH|alh
5182161|NCT02851082|Training Program|training program
5182162|NCT02851082|Endurance|endurance
5182163|NCT02851082|Von Willebrand factor|von willebrand factor
5102218|NCT03359252|stent|stent
5056410|NCT03646227|Carbapenem-resistant enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
5056411|NCT03646227|Carbapenem-resistant Pseudomonas aeruginosa (CRPA)|carbapenem-resistant pseudomonas aeruginosa (crpa)
5056412|NCT03646227|Klebsiella pneumoniae|klebsiella pneumoniae
5056413|NCT03646227|Acinetobacter baumannii (CRAb)|acinetobacter baumannii (crab)
5056414|NCT03646227|Bloodstream infection (BSI)|bloodstream infection (bsi)
5056415|NCT03646227|Microbiological characterization|microbiological characterization
5056416|NCT03646201|childhood|childhood
5056417|NCT03646201|obesity|obesity
5056418|NCT03646201|nutrition|nutrition
5056419|NCT03646201|intervention|intervention
5182164|NCT02851069|Chronic Hepatitis C|chronic hepatitis c
5182165|NCT02851069|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
5182166|NCT02851069|Sustained Virological Response|sustained virological response
5182167|NCT02851069|Observational Study|observational study
5182168|NCT02851069|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5182169|NCT02851056|Myeloma|myeloma
5182170|NCT02851056|Vaccine|vaccine
5182171|NCT02851056|Dendritic cell|dendritic cell
5182172|NCT02851056|autologous hematopoietic cell transplant|autologous hematopoietic cell transplant
5182173|NCT02851056|HCT|hct
5182174|NCT02851030|Child, Preschool|child, preschool
5182175|NCT02851030|Child Care|child care
5182176|NCT02850991|Esophageal cancer, radiation, chemotherapy|esophageal cancer, radiation, chemotherapy
5182177|NCT02850939|Breast cancer|breast cancer
5182178|NCT02850939|Endocrine hormonal therapy|endocrine hormonal therapy
5182179|NCT02850939|mHealth|mhealth
5182180|NCT02850926|Concussion|concussion
5182181|NCT02850926|Soccer|soccer
5182182|NCT02850926|Adolescent|adolescent
5182183|NCT02850874|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5182184|NCT02850874|perioperative systemic chemotherapy|perioperative systemic chemotherapy
5182185|NCT02850874|peritoneal disease|peritoneal disease
5182186|NCT02850848|Pharmacokinetic|pharmacokinetic
5182187|NCT02850835|Decision Aid|decision aid
5182188|NCT02850835|Pelvic Organ Prolapse (POP)|pelvic organ prolapse (pop)
5182189|NCT02850822|chemotherapy|chemotherapy
5182190|NCT02850809|radiofrequency ablation|radiofrequency ablation
5070955|NCT03555734|Legumes|legumes
5182191|NCT02850809|complications|complications
5182192|NCT02850796|Mindfulness|mindfulness
5182193|NCT02850796|self-compassion|self-compassion
5182194|NCT02850796|Acceptance and Commitment Therapy|acceptance and commitment therapy
5182195|NCT02850796|weight self-stigma|weight self-stigma
5182196|NCT02850796|quality-of-life|quality-of-life
5182197|NCT02850783|colon cancer|colon cancer
5182198|NCT02850757|Modified William's airway|modified william's airway
5182199|NCT02850757|fiberoptic bronchoscope|fiberoptic bronchoscope
5182200|NCT02850757|U shape Guedls airway|u shape guedls airway
5182201|NCT02850757|oral airways|oral airways
5182202|NCT02850757|efficacy and safety|efficacy and safety
5182203|NCT02850705|Neuromyelitis Optica|neuromyelitis optica
5182204|NCT02850705|Myelitis|myelitis
5182205|NCT02850705|Optic Neuritis|optic neuritis
5182206|NCT02850705|autoantibody|autoantibody
5182207|NCT02850705|demyelination|demyelination
5182208|NCT02850679|Atrial Fibrillation|atrial fibrillation
5182209|NCT02850679|Cardioversion|cardioversion
5182210|NCT02850666|social skills|social skills
5182211|NCT02850666|child|child
5182212|NCT02850666|theory of mind|theory of mind
5182213|NCT02850666|drama|drama
5182214|NCT02850666|occupational therapy|occupational therapy
5182215|NCT02850666|Speech-language pathology|speech-language pathology
5182216|NCT02850653|Acute Endophthalmitis.|acute endophthalmitis.
5182217|NCT02850653|PCR|pcr
5182218|NCT02850653|Ocular sampling|ocular sampling
5182219|NCT02850627|acute coronary syndrome|acute coronary syndrome
5182220|NCT02850627|Tongguan capsule|tongguan capsule
5182221|NCT02850627|miRNAs|mirnas
5182222|NCT02850601|Oral lichen planus|oral lichen planus
5182223|NCT02850601|Dexamethasone solution|dexamethasone solution
5182224|NCT02850562|body composition,|body composition,
5182225|NCT02850562|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5182226|NCT02850562|sarcopenia|sarcopenia
5182227|NCT02850562|peripheral quantitative computed tomography|peripheral quantitative computed tomography
5182228|NCT02850562|muscle density|muscle density
5182229|NCT02850562|elderly|elderly
5182230|NCT02850549|neck pain|neck pain
5182231|NCT02850549|cervical|cervical
5182232|NCT02850549|classification|classification
5182233|NCT02850549|outcomes|outcomes
5182234|NCT02850549|physical therapy|physical therapy
5962265|NCT04281875|Postoperative Hypocalcemia|postoperative hypocalcemia
5962266|NCT04281875|Postoperative Hypoparathyroidism|postoperative hypoparathyroidism
5962267|NCT04281836|fNIRS|fnirs
5962268|NCT04281836|Virtual Reality (VR)|virtual reality (vr)
5962269|NCT04281836|Breathing focusing based meditation|breathing focusing based meditation
5962270|NCT04281823|Cardiovascular Disease|cardiovascular disease
5962271|NCT04281823|Cardiac Magnetic Resonance|cardiac magnetic resonance
5962272|NCT04281823|Myocardial Fibrosis|myocardial fibrosis
5962273|NCT04281823|Valvular Heart Disease|valvular heart disease
5962274|NCT04281823|Ischemic Heart Disease|ischemic heart disease
5962275|NCT04281823|Cardiomyopathy|cardiomyopathy
5962276|NCT04281810|electrical stimulation|electrical stimulation
5962277|NCT04281810|diaphragmatic|diaphragmatic
5962278|NCT04281810|weaning|weaning
5962279|NCT04281810|respiratory muscle|respiratory muscle
5962280|NCT04281797|Microbiome|microbiome
5182235|NCT02850536|Colorectal Cancer|colorectal cancer
5182236|NCT02850536|Liver Metastases|liver metastases
5182237|NCT02850536|Breast Cancer|breast cancer
5182238|NCT02850536|Gastric Cancer|gastric cancer
5182239|NCT02850536|Pancreas Cancer|pancreas cancer
5182240|NCT02850536|Carcinoembryonic antigen|carcinoembryonic antigen
5182242|NCT02850536|Immunotherapy|immunotherapy
5182250|NCT02850471|Postoperative pulmonary complications|postoperative pulmonary complications
5182251|NCT02850471|Transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
5182253|NCT02850432|Magnetic resonance imaging|magnetic resonance imaging
5182254|NCT02850432|Extracellular volume matrix fraction|extracellular volume matrix fraction
5182255|NCT02850432|Peripheral artery disease|peripheral artery disease
5182256|NCT02850432|Blood-oxygen level dependent|blood-oxygen level dependent
5182257|NCT02850432|Cardiac function|cardiac function
5182258|NCT02850393|suppression mnemonic|suppression mnemonic
5182259|NCT02850393|emotional response|emotional response
5182260|NCT02850393|inhibitory control of failures|inhibitory control of failures
5182261|NCT02850393|neurological alterations|neurological alterations
5182262|NCT02850341|Physical Activity|physical activity
5182263|NCT02850341|Mental Health|mental health
5182264|NCT02850341|Health Behavior|health behavior
5182265|NCT02850341|Walking|walking
5182267|NCT02850341|Mental disorder|mental disorder
5182268|NCT02850315|optimal coherence tomography|optimal coherence tomography
5182269|NCT02850315|myocardial reperfusion|myocardial reperfusion
5182270|NCT02850276|HIV disease|hiv disease
5182271|NCT02850276|gastrointestinal problems|gastrointestinal problems
5182272|NCT02850263|Diabetic Retinopathy|diabetic retinopathy
5182273|NCT02850263|Diabetic Macular Oedema|diabetic macular oedema
5182274|NCT02850263|Diabetic Macular Edema|diabetic macular edema
5182275|NCT02850263|Aflibercept|aflibercept
5182279|NCT02850250|Cefuroxime|cefuroxime
5182280|NCT02850250|Paediatric|paediatric
5182281|NCT02850237|cerebral saturation|cerebral saturation
5182282|NCT02850237|capnography|capnography
5182283|NCT02850237|pre-hospital|pre-hospital
5182284|NCT02850198|ischemic stroke|ischemic stroke
5182285|NCT02850185|COPD|copd
5182286|NCT02850185|hydrogen|hydrogen
5182287|NCT02850172|nutrition|nutrition
5182288|NCT02850172|exercise|exercise
5182289|NCT02850172|inspiratory muscle training|inspiratory muscle training
5182291|NCT02850146|cognition|cognition
5182292|NCT02850146|longitudinal|longitudinal
5182293|NCT02850146|cognitive decline|cognitive decline
5182294|NCT02850146|observational|observational
5182295|NCT02850146|imaging|imaging
5182296|NCT02850120|surgical mesh|surgical mesh
5182297|NCT02850120|observational study|observational study
5182298|NCT02850120|intraoperative complications|intraoperative complications
5182299|NCT02850120|postoperative complications|postoperative complications
5182300|NCT02850107|Atherectomy, Drug-Coated Balloon|atherectomy, drug-coated balloon
5182301|NCT02850094|Physical activity|physical activity
5182302|NCT02850094|Exercise|exercise
5182303|NCT02850094|Financial Incentives|financial incentives
5182304|NCT02850081|Carotid endarterectomy|carotid endarterectomy
5182305|NCT02850081|CEA|cea
5182306|NCT02850081|stroke|stroke
5182307|NCT02850081|asymptomatic stenosis|asymptomatic stenosis
5182308|NCT02850055|physiotherapy, Temporomandibular Joint Disorder, tinnitus.|physiotherapy, temporomandibular joint disorder, tinnitus.
5182309|NCT02850042|motor recovery|motor recovery
5182310|NCT02850042|human|human
5182311|NCT02850042|occupation-based practice|occupation-based practice
5182312|NCT02850042|motor training|motor training
5182313|NCT02850042|transcranial magnetic stimulation|transcranial magnetic stimulation
5182314|NCT02850029|antimicrobial|antimicrobial
5182315|NCT02850029|intensive care units|intensive care units
5182319|NCT02849977|POMC|pomc
5182320|NCT02849977|PCSK1|pcsk1
5182321|NCT02849977|Pro-opiomelanocortin|pro-opiomelanocortin
5182322|NCT02849964|Incidence|incidence
5182323|NCT02849964|Renal Replacement Therapy|renal replacement therapy
5182324|NCT02849964|Socioeconomic Factors|socioeconomic factors
5182325|NCT02849964|Clinical Practice Pattern|clinical practice pattern
5182326|NCT02849951|Colitis|colitis
5182327|NCT02849951|Colitis, Ulcerative|colitis, ulcerative
5182328|NCT02849951|Ulcer|ulcer
5182329|NCT02849951|Colonic Diseases|colonic diseases
5182330|NCT02849951|Digestive System Diseases|digestive system diseases
5182331|NCT02849951|Gastroenteritis|gastroenteritis
5182332|NCT02849951|Gastrointestinal Diseases|gastrointestinal diseases
5182333|NCT02849951|Inflammatory Bowel Diseases|inflammatory bowel diseases
5182334|NCT02849951|Intestinal Diseases|intestinal diseases
5182335|NCT02849951|Pathologic Processes|pathologic processes
5182336|NCT02849951|Mesalamine|mesalamine
5182341|NCT02849925|Caries|caries
5182342|NCT02849925|Glass ionomer|glass ionomer
5182343|NCT02849925|Resin|resin
5182344|NCT02849886|GvHD|gvhd
5170163|NCT02928172|q-CON|q-con
5170164|NCT02928172|q-NOX|q-nox
5170165|NCT02928172|BIS|bis
5170166|NCT02928172|Electroencephalograms (EEG)|electroencephalograms (eeg)
5170167|NCT02928172|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
5170168|NCT02928172|Sedation|sedation
5170169|NCT02928172|General Anesthesia|general anesthesia
5170170|NCT02928159|Low Pulse Amplitude Seizure Therapy|low pulse amplitude seizure therapy
5170171|NCT02928159|Electroconvulsive Therapy|electroconvulsive therapy
5170172|NCT02928159|Low Pulse Amplitude Electroconvulsive Therapy|low pulse amplitude electroconvulsive therapy
5182345|NCT02849886|Suicide gene|suicide gene
5182346|NCT02849886|Dimerizer drug AP1903|dimerizer drug ap1903
5182347|NCT02849886|Hematological stem cell transplantation|hematological stem cell transplantation
5182348|NCT02849834|Neuropathic Pain|neuropathic pain
5182349|NCT02849834|Stimulation of the Motor Cortex (SCM)|stimulation of the motor cortex (scm)
5182350|NCT02849834|Pharmacoresistant|pharmacoresistant
5182351|NCT02849834|rTMS|rtms
5182352|NCT02849808|Corneal Transplantation|corneal transplantation
5182353|NCT02849795|Obesity, Abdominal|obesity, abdominal
5182354|NCT02849795|Adipokines|adipokines
5182355|NCT02849795|Risk of cardiovascular diseases|risk of cardiovascular diseases
5182356|NCT02849782|Gait analysis|gait analysis
5182357|NCT02849782|Fampridine|fampridine
5182358|NCT02849782|Fatigue|fatigue
5182359|NCT02849782|Daily activity|daily activity
5182360|NCT02849782|Cognition|cognition
5182361|NCT02849756|Intensive care|intensive care
5182362|NCT02849756|elderly|elderly
5182363|NCT02849756|autonomy|autonomy
5182364|NCT02849756|Future|future
5182365|NCT02849756|older patients|older patients
5182366|NCT02849756|intensive care unit|intensive care unit
5182367|NCT02849743|oxytocin|oxytocin
5182368|NCT02849743|hypothalamic obesity|hypothalamic obesity
5182369|NCT02849743|craniopharyngioma|craniopharyngioma
5182370|NCT02849743|metabolism|metabolism
5182371|NCT02849730|Epi-PCA|epi-pca
5182372|NCT02849730|Patient controlled analgesia|patient controlled analgesia
5182373|NCT02849730|Epidural patient controlled analgesia|epidural patient controlled analgesia
5182374|NCT02849730|Elderly patient|elderly patient
5182375|NCT02849730|Side effect|side effect
5182379|NCT02849704|Reduced Exocrine Pancreatic Function|reduced exocrine pancreatic function
5182380|NCT02849704|Pancreatic Insufficiency|pancreatic insufficiency
5182382|NCT02849678|Bowel Surgery|bowel surgery
5182383|NCT02849678|Regional Anesthesia|regional anesthesia
5182384|NCT02849665|Kangaroo-Mother Care Method; child development|kangaroo-mother care method; child development
5182385|NCT02849652|Smoking cessation|smoking cessation
5182386|NCT02849652|Nicotine dependence|nicotine dependence
5182387|NCT02849652|Organizational change|organizational change
5182388|NCT02849652|Mental Healthcare|mental healthcare
5182389|NCT02849639|deprescribing|deprescribing
5182390|NCT02849639|medication therapy management|medication therapy management
5182391|NCT02849626|Partial-Onset Seizures|partial-onset seizures
5182392|NCT02849626|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
5182393|NCT02849626|Adjunctive Therapy|adjunctive therapy
5182394|NCT02849626|Epilepsy|epilepsy
5182395|NCT02849613|cell therapy|cell therapy
5182396|NCT02849613|stem cell|stem cell
5182397|NCT02849613|transplantation|transplantation
5182399|NCT02849613|recovery|recovery
5182400|NCT02849613|repair|repair
5182401|NCT02849613|stroke|stroke
5182402|NCT02849613|mesenchymal stem cell|mesenchymal stem cell
5182403|NCT02849613|regenerative|regenerative
5182404|NCT02849600|Vital pulp therapy,Young permanent tooth,Treatment outcome|vital pulp therapy,young permanent tooth,treatment outcome
5182405|NCT02849587|Driving Under the Influence|driving under the influence
5182406|NCT02849587|Memory Impairment|memory impairment
5182407|NCT02849587|Reaction Time|reaction time
5182408|NCT02849587|Time Perception|time perception
5182409|NCT02849561|Pupillary light reflex|pupillary light reflex
5182410|NCT02849561|Cardio respiratory arrest|cardio respiratory arrest
5182415|NCT02849522|Lower Urinary Tract Symptoms caused by Benign Prostatic Enlargement (LUTS BPE)|lower urinary tract symptoms caused by benign prostatic enlargement (luts bpe)
5182416|NCT02849522|Prostate Artery Embolisation (PAE)|prostate artery embolisation (pae)
5182417|NCT02849522|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5182418|NCT02849522|Open prostatectomy|open prostatectomy
5182419|NCT02849522|Laser enucleation or ablation of the prostate (Green Light, KTP, HoLEP)|laser enucleation or ablation of the prostate (green light, ktp, holep)
5182420|NCT02849522|IPSS Score|ipss score
5182421|NCT02849522|IIEF Score|iief score
5182422|NCT02849522|Complications|complications
5182428|NCT02849483|nausea|nausea
5182429|NCT02849483|ramosetron|ramosetron
5182430|NCT02849470|Adipose Stem/Stromal Cells|adipose stem/stromal cells
5182432|NCT02849470|SVF|svf
5182433|NCT02849470|Cell Therapy|cell therapy
5182434|NCT02849470|Alopecia|alopecia
5182435|NCT02849470|GF|gf
5182436|NCT02849444|renal function|renal function
5182437|NCT02849444|Relapsed Multiple myeloma|relapsed multiple myeloma
5182438|NCT02849444|anti-MM therapy|anti-mm therapy
5182439|NCT02849431|mindfulness|mindfulness
5182440|NCT02849418|Botulinum toxin type A|botulinum toxin type a
5182441|NCT02849418|Urinary Incontinence|urinary incontinence
5182442|NCT02849418|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5182443|NCT02849392|Pistachio|pistachio
5182444|NCT02849392|Body composition|body composition
5182445|NCT02849392|Erythrocyte membrane incorporation of fatty acids|erythrocyte membrane incorporation of fatty acids
5056759|NCT03644511|Liver cancer|liver cancer
5182446|NCT02849392|Dietary quality/micronutrient quality|dietary quality/micronutrient quality
5182447|NCT02849392|Blood lipids|blood lipids
5182448|NCT02849392|Inflammatory markers|inflammatory markers
5962281|NCT04281797|Gut microbiome|gut microbiome
5182449|NCT02849392|Bone density|bone density
5182450|NCT02849392|Bone turnover markers|bone turnover markers
5182452|NCT02849379|tongue cancer|tongue cancer
5182453|NCT02849379|cryosurgery|cryosurgery
5182454|NCT02849379|NK immunotherapy|nk immunotherapy
5182455|NCT02849366|Sarcoma|sarcoma
5182456|NCT02849366|Cryosurgery|cryosurgery
5071273|NCT03553641|autonomy|autonomy
5182457|NCT02849366|NK Immunotherapy|nk immunotherapy
5182458|NCT02849353|Ovarian Cancer|ovarian cancer
5182459|NCT02849353|cryosurgery|cryosurgery
5182460|NCT02849353|NK immunotherapy|nk immunotherapy
5182461|NCT02849340|Cervical Cancer|cervical cancer
5182462|NCT02849340|cryosurgery|cryosurgery
5182463|NCT02849340|NK immunotherapy|nk immunotherapy
5182464|NCT02849327|Pharyngeal cancer|pharyngeal cancer
5182465|NCT02849327|Cryosurgery|cryosurgery
5182466|NCT02849327|NK immunotherapy|nk immunotherapy
5182467|NCT02849314|laryngeal cancer|laryngeal cancer
5182468|NCT02849314|cryosurgery|cryosurgery
5182473|NCT02849236|PECS block,|pecs block,
5182474|NCT02849236|pectoral block,|pectoral block,
5182475|NCT02849236|breast augmentation|breast augmentation
5182479|NCT02849197|pilonidal sinus|pilonidal sinus
5190150|NCT02802306|PAD|pad
5182480|NCT02849197|complication|complication
5182481|NCT02849197|recurrence|recurrence
5182482|NCT02849171|11C-Choline (11C-CH) PET|11c-choline (11c-ch) pet
5182484|NCT02849171|High-grade Gliomas|high-grade gliomas
5182485|NCT02849158|Rectoscopy|rectoscopy
5182486|NCT02849158|Proctectomy|proctectomy
5182487|NCT02849158|Fibroblasts|fibroblasts
5182488|NCT02849145|Circulating tumor DNA|circulating tumor dna
5182489|NCT02849119|Robot; Laparoscopic|robot; laparoscopic
5182490|NCT02849119|Partial nephrectomy|partial nephrectomy
5182491|NCT02849119|Transperitoneal|transperitoneal
5182492|NCT02849119|Retroperitoneal|retroperitoneal
5182493|NCT02849119|Laparoscopic Surgery|laparoscopic surgery
5177802|NCT02879799|Premature|premature
5182504|NCT02849067|laughter therapy|laughter therapy
5182505|NCT02849041|Circulating Tumor Cells|circulating tumor cells
5182507|NCT02849028|gut microbiota|gut microbiota
5182508|NCT02849028|sleep disorder|sleep disorder
5182509|NCT02849028|gut-brain axis|gut-brain axis
5182510|NCT02849028|circadian rhythm|circadian rhythm
5182511|NCT02849028|Traumatic Brain Injury|traumatic brain injury
5182512|NCT02849015|liver tumor|liver tumor
5182513|NCT02849015|cryosurgery|cryosurgery
5182514|NCT02849015|NK immunotherapy|nk immunotherapy
5182515|NCT02849002|Concussion|concussion
5182516|NCT02848989|Breast Cancer Surgery Pain|breast cancer surgery pain
5182517|NCT02848989|Breast Cancer|breast cancer
5182518|NCT02848950|Metformin|metformin
5182519|NCT02848950|fecundability|fecundability
5182520|NCT02848950|uterine doppler|uterine doppler
5182521|NCT02848937|calcium balance|calcium balance
5182522|NCT02848937|dialysis|dialysis
5182523|NCT02848937|concentrate with citrate|concentrate with citrate
5182524|NCT02848924|prevalence|prevalence
5182525|NCT02848924|surgery|surgery
5182526|NCT02848924|Treatments|treatments
5182527|NCT02848911|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5182528|NCT02848898|Focal Vibrations|focal vibrations
5182529|NCT02848898|Neurorehabilitation|neurorehabilitation
5182530|NCT02848898|Spasticity|spasticity
5182531|NCT02848898|Multiple Sclerosis|multiple sclerosis
5182532|NCT02848885|Magnetic resonance imaging|magnetic resonance imaging
5182533|NCT02848885|Anosognosia|anosognosia
5182630|NCT02848222|Bruder mask|bruder mask
5182534|NCT02848885|Electrical stimulation of the brain|electrical stimulation of the brain
5182535|NCT02848872|Tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
5182536|NCT02848859|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5182537|NCT02848859|randomized controlled trial|randomized controlled trial
5182538|NCT02848846|Amputees|amputees
5182539|NCT02848820|Appendicitis|appendicitis
5182540|NCT02848820|Appendectomy|appendectomy
5182541|NCT02848820|Antibiotics|antibiotics
5182542|NCT02848781|Sudden Cardiac Death|sudden cardiac death
5182543|NCT02848781|ICD Therapy|icd therapy
5182544|NCT02848781|VT Ablation|vt ablation
5182545|NCT02848729|Post-surgical pain|post-surgical pain
5182546|NCT02848729|Pharmacokinetics|pharmacokinetics
5182547|NCT02848690|Sodium restriction|sodium restriction
5182548|NCT02848690|Dietary sodium restriction questionnaire (DSRQ)|dietary sodium restriction questionnaire (dsrq)
5182549|NCT02848690|Low-sodium diet|low-sodium diet
5182550|NCT02848690|Adherence|adherence
5182551|NCT02848690|Educational intervention|educational intervention
5182552|NCT02848677|advanced glycation end-products|advanced glycation end-products
5182553|NCT02848677|Cardiovascular disease|cardiovascular disease
5182554|NCT02848677|Low Sodium Diet|low sodium diet
5182555|NCT02848677|vascular inflammation|vascular inflammation
5182556|NCT02848638|PET, Yttrium-90|pet, yttrium-90
5182557|NCT02848625|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5182558|NCT02848625|Yoga|yoga
5102769|NCT03355664|ACT|act
5182559|NCT02848625|Quality of life|quality of life
5182560|NCT02848612|anticoagulation|anticoagulation
5182561|NCT02848612|aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
5182562|NCT02848612|interventional neuroradiology|interventional neuroradiology
5182563|NCT02848612|coil embolization|coil embolization
5182564|NCT02848599|postoperative analgesia|postoperative analgesia
5182565|NCT02848599|postoperative cognitive disfunction|postoperative cognitive disfunction
5182567|NCT02848586|ECIGS|ecigs
5182568|NCT02848586|e-cigarettes|e-cigarettes
5182569|NCT02848586|lung inflammation|lung inflammation
5182570|NCT02848560|Cystic Fibrosis|cystic fibrosis
5182571|NCT02848560|orkambi|orkambi
5182572|NCT02848560|129Xe MRI|129xe mri
5182573|NCT02848560|hyperpolarized xenon|hyperpolarized xenon
5182574|NCT02848560|LCI|lci
5182575|NCT02848560|CFTR modulator therapy|cftr modulator therapy
5182576|NCT02848534|fever|fever
5182577|NCT02848534|hyperthermia|hyperthermia
5182578|NCT02848534|inflammatory syndrome|inflammatory syndrome
5182579|NCT02848521|ADPKD|adpkd
5182580|NCT02848521|CKD|ckd
5182581|NCT02848521|Rapid progressor|rapid progressor
5182584|NCT02848508|Metformin|metformin
5182585|NCT02848508|moderate renal failure|moderate renal failure
5182586|NCT02848508|severe renal failure|severe renal failure
5182587|NCT02848508|chronic kidney disease|chronic kidney disease
5182588|NCT02848508|hyperlactatemia|hyperlactatemia
5182589|NCT02848508|lactic acidosis|lactic acidosis
5182590|NCT02848495|Aneurysm|aneurysm
5182591|NCT02848495|Biocollection|biocollection
5182592|NCT02848495|Familial Form|familial form
5182593|NCT02848482|Photodynamic therapy|photodynamic therapy
5182594|NCT02848456|Manipulation, Spinal|manipulation, spinal
5182595|NCT02848456|H-Reflex|h-reflex
5182596|NCT02848456|Muscle Contraction|muscle contraction
5245904|NCT02469415|AZA-CR|aza-cr
5170455|NCT02926352|Transcranial infrared light stimulation|transcranial infrared light stimulation
5170456|NCT02926352|Near-infrared light|near-infrared light
5170457|NCT02926352|Photobiomodulation|photobiomodulation
5170458|NCT02926352|Fear Extinction|fear extinction
5170459|NCT02926352|Exposure Therapy|exposure therapy
5170460|NCT02926352|Claustrophobia|claustrophobia
5170461|NCT02926352|Fear of enclosed spaces|fear of enclosed spaces
5170462|NCT02926352|Fear of contamination|fear of contamination
5182597|NCT02848456|Muscle Strength Dynamometer|muscle strength dynamometer
5182598|NCT02848443|metastatic|metastatic
5182599|NCT02848443|colorectal|colorectal
5182600|NCT02848443|cancer|cancer
5182601|NCT02848443|oxaliplatin|oxaliplatin
5182602|NCT02848443|dose-escalation|dose-escalation
5182603|NCT02848443|Lonsurf|lonsurf
5182604|NCT02848443|nivolumab|nivolumab
5182605|NCT02848443|bevacizumab|bevacizumab
5182606|NCT02848430|Humulus lupulus|humulus lupulus
5182607|NCT02848404|Mild cognitive impairment|mild cognitive impairment
5182608|NCT02848404|Cognitive rehabilitation|cognitive rehabilitation
5182609|NCT02848404|Cognitive therapy|cognitive therapy
5182610|NCT02848404|Alzheimer's disease|alzheimer's disease
5182611|NCT02848404|Memory enhancement|memory enhancement
5182612|NCT02848404|Categorical language fluency|categorical language fluency
5182613|NCT02848378|Advanced Oxidation Protein Products|advanced oxidation protein products
5182614|NCT02848378|Gingival crevicular fluid|gingival crevicular fluid
5182615|NCT02848378|Monocyte chemoattractant protein-1|monocyte chemoattractant protein-1
5182616|NCT02848378|Periodontal Disease|periodontal disease
5182617|NCT02848365|Measurement|measurement
5182618|NCT02848248|Acute Myeloid Leukemia|acute myeloid leukemia
5182619|NCT02848248|Antibody-Drug Conjugate|antibody-drug conjugate
5182620|NCT02848248|CD123 Antigen|cd123 antigen
5182621|NCT02848248|Drug Therapy|drug therapy
5182622|NCT02848248|AML|aml
5182623|NCT02848248|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5182624|NCT02848235|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5182625|NCT02848235|Antenatal Care for HIV positive women|antenatal care for hiv positive women
5182626|NCT02848235|Kenya|kenya
5182627|NCT02848222|contact lens discomfort|contact lens discomfort
5182628|NCT02848222|dry eye disease|dry eye disease
5182629|NCT02848222|meibomian gland dysfunction|meibomian gland dysfunction
5182631|NCT02848209|Peeling|peeling
5182632|NCT02848209|Histological skin changes|histological skin changes
5182633|NCT02848209|Trichloroacetic acid peel|trichloroacetic acid peel
5182634|NCT02848209|phenol/croton oil peel|phenol/croton oil peel
5182635|NCT02848170|essential hypertension|essential hypertension
5182636|NCT02848170|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5182637|NCT02848170|Developmental Phase III|developmental phase iii
5182638|NCT02848157|dexmedetomidine|dexmedetomidine
5182639|NCT02848157|pudendal block|pudendal block
5182640|NCT02848157|hypospadias|hypospadias
5182641|NCT02848144|Immunoparalysis|immunoparalysis
5182642|NCT02848144|immune response|immune response
5182643|NCT02848144|sepsis|sepsis
5182644|NCT02848144|toxic shock syndrome|toxic shock syndrome
5182645|NCT02848118|Hypoventilation|hypoventilation
5182646|NCT02848118|capnography|capnography
5182647|NCT02848118|bronchoscopy|bronchoscopy
5182648|NCT02848105|aGVHD|agvhd
5962282|NCT04281797|Stem cell transplantation|stem cell transplantation
5182649|NCT02848105|valproic acid|valproic acid
5182650|NCT02848092|Visual Attention|visual attention
5182651|NCT02848092|Automobile Driving|automobile driving
5182652|NCT02848001|CC-90009|cc-90009
5182653|NCT02848001|Hematologic Cancers|hematologic cancers
5182654|NCT02848001|Leukemia|leukemia
5182655|NCT02848001|Acute Myeloid Leukemia|acute myeloid leukemia
5182656|NCT02848001|Myelodysplastic Syndrome|myelodysplastic syndrome
5182657|NCT02848001|AML|aml
5182658|NCT02848001|MDS|mds
5182659|NCT02847988|muscle strength|muscle strength
5182660|NCT02847988|muscle function|muscle function
5182661|NCT02847988|functional status|functional status
5182662|NCT02847975|Becker|becker
5182663|NCT02847975|dystrophy|dystrophy
5182664|NCT02847975|sympatholysis|sympatholysis
5182665|NCT02847962|Fortified-blended foods|fortified-blended foods
5182666|NCT02847962|Extrusion|extrusion
5182667|NCT02847962|Sorghum|sorghum
5182668|NCT02847962|Cowpea|cowpea
5182669|NCT02847962|Vitamin A|vitamin a
5182670|NCT02847962|Iron|iron
5182671|NCT02847962|Protein|protein
5182672|NCT02847962|Food Aid|food aid
5170561|NCT02925624|ablation index|ablation index
5182678|NCT02847962|Protein-Energy Malnutrition|protein-energy malnutrition
5182679|NCT02847962|Complementary Feeding|complementary feeding
5182680|NCT02847962|Corn|corn
5182682|NCT02847962|Fortified Foods|fortified foods
5182684|NCT02847936|triclosan|triclosan
5182685|NCT02847936|sutures|sutures
5182686|NCT02847936|infection|infection
5182687|NCT02847923|Mobile Devices|mobile devices
5182688|NCT02847923|Augmentative and Alternative Communication|augmentative and alternative communication
5182689|NCT02847923|Cerebral Palsy|cerebral palsy
5182690|NCT02847910|tissue suction tube|tissue suction tube
5182691|NCT02847910|disposable instrument|disposable instrument
5182692|NCT02847910|induced abortion|induced abortion
5182693|NCT02847884|IBD|ibd
5182694|NCT02847884|Crohn's disease|crohn's disease
5182695|NCT02847884|Remicade|remicade
5182696|NCT02847884|Infliximab|infliximab
5182697|NCT02847884|Level|level
5182698|NCT02847884|Drug Level|drug level
5182699|NCT02847884|Children|children
5182700|NCT02847871|mobility|mobility
5182701|NCT02847871|exercise|exercise
5182702|NCT02847871|nutrition|nutrition
5182703|NCT02847871|primary care|primary care
5182704|NCT02847871|prevention|prevention
5182705|NCT02847871|care pathway|care pathway
5182706|NCT02847871|elderly patient|elderly patient
5182707|NCT02847858|unsafe sex|unsafe sex
5182708|NCT02847858|unprotected sex|unprotected sex
5182709|NCT02847858|adolescents|adolescents
5182710|NCT02847858|Latinas|latinas
5182711|NCT02847858|Hispanic|hispanic
5182712|NCT02847858|mobile health applications|mobile health applications
5182713|NCT02847858|unintended pregnancy|unintended pregnancy
5182714|NCT02847858|teen pregnancy prevention|teen pregnancy prevention
5182715|NCT02847858|school-based health centers|school-based health centers
5182716|NCT02847845|chronic fatigue syndrome|chronic fatigue syndrome
5182717|NCT02847845|idiopathic chronic fatigue|idiopathic chronic fatigue
5182718|NCT02847845|red ginseng|red ginseng
5182719|NCT02847845|cortisol|cortisol
5182720|NCT02847845|anti-oxidant|anti-oxidant
5182721|NCT02847832|Adnexal Diseases|adnexal diseases
5182722|NCT02847832|Ovary|ovary
5182723|NCT02847832|Ovarian Neoplasms|ovarian neoplasms
5182724|NCT02847832|Ovarian Cysts|ovarian cysts
5182725|NCT02847832|Ovarian Diseases|ovarian diseases
5182726|NCT02847832|Ultrasonography|ultrasonography
5182727|NCT02847832|Ultrasonography, Doppler|ultrasonography, doppler
5182728|NCT02847832|Diagnosis|diagnosis
5182729|NCT02847832|Early Diagnosis|early diagnosis
5182730|NCT02847832|Early Detection of Cancer|early detection of cancer
5182731|NCT02847832|Genital Neoplasms, Female|genital neoplasms, female
5182732|NCT02847832|Genital Diseases, Female|genital diseases, female
5182733|NCT02847832|Urogenital Neoplasms|urogenital neoplasms
5182734|NCT02847832|Cysts|cysts
5182735|NCT02847832|Endocrine System Diseases|endocrine system diseases
5182736|NCT02847832|Gonadal Disorders|gonadal disorders
5182737|NCT02847832|Neoplasms|neoplasms
5182738|NCT02847832|Endocrine Gland Neoplasms|endocrine gland neoplasms
5182739|NCT02847832|International Ovarian Tumor Analysis|international ovarian tumor analysis
5182740|NCT02847832|Simple Rules|simple rules
5182741|NCT02847832|Preoperative evaluation|preoperative evaluation
5182742|NCT02847832|Prediction Models|prediction models
5182743|NCT02847832|Logistic Regression Models|logistic regression models
5182744|NCT02847832|Mathematical Models|mathematical models
5182745|NCT02847832|Adnexal Masses|adnexal masses
5182746|NCT02847832|Ovarian Tumors|ovarian tumors
5182747|NCT02847832|Risk of Malignancy|risk of malignancy
5182748|NCT02847793|Attentional Bias Modification (ABM)|attentional bias modification (abm)
5182749|NCT02847793|Cognitive Bias Modification (CBM)|cognitive bias modification (cbm)
5182750|NCT02847793|Depression|depression
5182751|NCT02847793|Dysphoria|dysphoria
5182752|NCT02847793|Gaze patterns|gaze patterns
5182753|NCT02847793|Eye-tracking|eye-tracking
5182754|NCT02847767|Liver Perfusion|liver perfusion
5170655|NCT02925117|Atopic Dermatitis|atopic dermatitis
5170657|NCT02925065|Parkinson's|parkinson's
5049777|NCT03687021|RNA|rna
5170658|NCT02925065|Non-traditional guitar instruction|non-traditional guitar instruction
5170659|NCT02925065|Guitar therapy|guitar therapy
5170660|NCT02925065|Upper extremity motor function|upper extremity motor function
5170661|NCT02925065|Hand dexterity|hand dexterity
5182762|NCT02847741|Predictive factor|predictive factor
5182763|NCT02847715|PRO|pro
5182764|NCT02847715|PROM|prom
5182765|NCT02847715|Adverse event|adverse event
5182766|NCT02847715|QTool|qtool
5182767|NCT02847715|Aftercare|aftercare
5182768|NCT02847702|Osteoarthritis|osteoarthritis
5182769|NCT02847702|Pain|pain
5182770|NCT02847702|Osteoarthritis, knee|osteoarthritis, knee
5182771|NCT02847689|Premature Birth|premature birth
5182772|NCT02847689|Obstetric Labor, Premature|obstetric labor, premature
5182773|NCT02847689|Obstetric Labor Complications|obstetric labor complications
5182774|NCT02847689|Pregnancy Complications|pregnancy complications
5182775|NCT02847676|Peritoneal adhesions|peritoneal adhesions
5182776|NCT02847676|Stem cells|stem cells
5182777|NCT02847676|MSC|msc
5182778|NCT02847663|Cold|cold
5182779|NCT02847663|recovery|recovery
5182780|NCT02847650|Early Parkinson Disease|early parkinson disease
5182781|NCT02847650|Phase 2|phase 2
5182782|NCT02847637|Hemophilia A|hemophilia a
5182783|NCT02847637|Emicizumab|emicizumab
5182785|NCT02847611|Strength of prehension|strength of prehension
5182786|NCT02847611|Comparison|comparison
5182787|NCT02847611|Device|device
5182788|NCT02847611|Diagnosis|diagnosis
5182789|NCT02847611|Healthy Volunteers|healthy volunteers
5182790|NCT02847598|CLE, SLE, Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus, Lupus|cle, sle, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus
5182791|NCT02847585|water-soluble ubiquinol supplementation|water-soluble ubiquinol supplementation
5182792|NCT02847585|pediatric cardiomyopathy|pediatric cardiomyopathy
5182793|NCT02847585|antioxidant|antioxidant
5182794|NCT02847585|inflammation|inflammation
5182795|NCT02847585|complementary therapy|complementary therapy
5182796|NCT02847533|resistant depression|resistant depression
5182797|NCT02847533|inflammation|inflammation
5182798|NCT02847520|Disorders related to gaming and gambling; poker|disorders related to gaming and gambling; poker
5182799|NCT02847507|HIV|hiv
5182800|NCT02847507|Hepatitis E|hepatitis e
5182801|NCT02847481|Fecal Microbiota Transplantation|fecal microbiota transplantation
5182802|NCT02847468|FDG PET, FCH PET|fdg pet, fch pet
5182803|NCT02847455|Ilaprazole|ilaprazole
5182804|NCT02847455|Proton pump inhibitor|proton pump inhibitor
5182805|NCT02847455|Duodenal ulcer|duodenal ulcer
5182806|NCT02847455|Acid suppression|acid suppression
5182807|NCT02847455|Randomized trial|randomized trial
5182808|NCT02847442|Ongentys|ongentys
5182809|NCT02847403|dysglycemia|dysglycemia
5182810|NCT02847403|MCI|mci
5182811|NCT02847403|exenatide LAR|exenatide lar
5182812|NCT02847403|GLP-1|glp-1
5182813|NCT02847390|diabetes mellitus|diabetes mellitus
5182814|NCT02847390|physician education|physician education
5182815|NCT02847390|nursing education|nursing education
5182816|NCT02847390|hyperglycemia|hyperglycemia
5182817|NCT02847390|hypoglycemia|hypoglycemia
5182818|NCT02847390|inpatient|inpatient
5182819|NCT02847390|hospital|hospital
5182820|NCT02847390|glycemic control|glycemic control
5182821|NCT02847364|chewing gum|chewing gum
5182822|NCT02847364|prevention|prevention
5071681|NCT03550885|bile acids and salts|bile acids and salts
5182823|NCT02847351|arabinoxylan, HOMA index, glycemic control, obesity.|arabinoxylan, homa index, glycemic control, obesity.
5182824|NCT02847338|Hypertension|hypertension
5182825|NCT02847312|Oat|oat
5182826|NCT02847312|Phenolic acid|phenolic acid
5182827|NCT02847312|Avenanthramide|avenanthramide
5182828|NCT02847312|FMD|fmd
5182829|NCT02847312|LDI|ldi
5182830|NCT02847312|Gut microbiota|gut microbiota
5182831|NCT02847312|Blood Pressure|blood pressure
5182832|NCT02847312|Renin Angiotensin|renin angiotensin
5182833|NCT02847312|Nitric Oxide|nitric oxide
5182834|NCT02847299|cough help|cough help
5182835|NCT02847299|mechanical insufflation|mechanical insufflation
5182836|NCT02847299|mechanical ventilation|mechanical ventilation
5182847|NCT02847221|scheduled extubation|scheduled extubation
5182849|NCT02847208|cystic fibrosis|cystic fibrosis
5182850|NCT02847208|contraception|contraception
5182851|NCT02847208|gynaecological follow-up|gynaecological follow-up
5182852|NCT02847208|screening|screening
5182853|NCT02847208|Pap smear|pap smear
5182854|NCT02847208|counselling|counselling
5182855|NCT02847195|pediatric intensive care|pediatric intensive care
5182856|NCT02847195|pain assessment|pain assessment
5182857|NCT02847195|tracheal aspiration|tracheal aspiration
5182858|NCT02847195|sedation|sedation
5182859|NCT02847195|pupillometer|pupillometer
5182860|NCT02847156|cystic fibrosis|cystic fibrosis
5182861|NCT02847156|viruses|viruses
5182862|NCT02847156|respiratory viral infection|respiratory viral infection
5182863|NCT02847156|children|children
5182864|NCT02847143|Attachement|attachement
5182865|NCT02847143|Oxytocin|oxytocin
5962283|NCT04281797|Kidney transplantation|kidney transplantation
5182866|NCT02847143|fMRI|fmri
5182867|NCT02847130|Clinical practice guidelines|clinical practice guidelines
5182868|NCT02847130|supportive care|supportive care
5182869|NCT02847130|pediatrics|pediatrics
5182870|NCT02847117|Natural Mastiha, Bioavailability|natural mastiha, bioavailability
5182871|NCT02847091|Ipragliflozin|ipragliflozin
5182872|NCT02847091|SGLT2 inhibitor|sglt2 inhibitor
5182873|NCT02847091|Type 2 diabetes mellitus|type 2 diabetes mellitus
5182875|NCT02847078|Coronary Disease|coronary disease
5182876|NCT02847078|percutaneous coronary intervention|percutaneous coronary intervention
5182877|NCT02847078|secondary prevention|secondary prevention
5182878|NCT02847078|smart phone app|smart phone app
5182879|NCT02847026|inactivated poliovirus vaccine|inactivated poliovirus vaccine
5182880|NCT02847026|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
5182881|NCT02847026|Rotavirus|rotavirus
5182882|NCT02847026|Rotarix|rotarix
5182884|NCT02847026|fIPV|fipv
5182886|NCT02847013|Postcesarean Section|postcesarean section
5182887|NCT02847013|Postoperative|postoperative
5182888|NCT02847000|Decitabine|decitabine
5182889|NCT02847000|Tetrahydrouridine|tetrahydrouridine
5182890|NCT02847000|Epigenetic Therapy|epigenetic therapy
5182891|NCT02846987|Abemaciclib i|abemaciclib i
5182892|NCT02846987|LY2835219|ly2835219
5182893|NCT02846987|16-376|16-376
5182894|NCT02846974|Pulse Oximetry|pulse oximetry
5182895|NCT02846974|Free and Open Source|free and open source
5182896|NCT02846961|inflammatory bowel disease|inflammatory bowel disease
5182897|NCT02846961|biosimilar|biosimilar
5182898|NCT02846961|anti-drug antibody|anti-drug antibody
5182899|NCT02846961|trough drug concentration|trough drug concentration
5182900|NCT02846948|sepsis|sepsis
5182901|NCT02846948|echocardiography|echocardiography
5182902|NCT02846948|urgent|urgent
5182903|NCT02846948|abdominal surgery|abdominal surgery
5182904|NCT02846935|p16/CDKN2A|p16/cdkn2a
5182905|NCT02846935|TP53|tp53
5182906|NCT02846935|THU|thu
5182907|NCT02846935|Decitabine|decitabine
5182908|NCT02846935|Tetrahydrouridine|tetrahydrouridine
5182909|NCT02846935|DEC|dec
5182910|NCT02846883|aneurysms|aneurysms
5182911|NCT02846857|Closed-loop system|closed-loop system
5182912|NCT02846857|Artificial pancreas|artificial pancreas
5182913|NCT02846857|Type 1 diabetes|type 1 diabetes
5182914|NCT02846857|Hypoglycemia|hypoglycemia
5182915|NCT02846857|Insulin|insulin
5182916|NCT02846857|Glucagon|glucagon
5182917|NCT02846831|Type 1 diabetes|type 1 diabetes
5182918|NCT02846831|Artificial pancreas|artificial pancreas
5182919|NCT02846831|Closed-loop system|closed-loop system
5182920|NCT02846831|Hypoglycemia|hypoglycemia
5182921|NCT02846831|Insulin|insulin
5182922|NCT02846818|Microdialysis|microdialysis
5182923|NCT02846818|Cardiac surgery|cardiac surgery
5182924|NCT02846818|Lactate to pyruvate ratio|lactate to pyruvate ratio
5182925|NCT02846818|Cardiopulmonary bypass|cardiopulmonary bypass
5182926|NCT02846818|Neurological complications|neurological complications
5182927|NCT02846779|Insulin persistence|insulin persistence
5182928|NCT02846779|Telepharmacy|telepharmacy
5182929|NCT02846766|advanced cancer|advanced cancer
5182931|NCT02846766|FGFR|fgfr
5182932|NCT02846766|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
5182933|NCT02846740|cranial electric stimulation|cranial electric stimulation
5182934|NCT02846740|suicide|suicide
5182935|NCT02846740|psychiatric inpatients|psychiatric inpatients
5182936|NCT02846727|Hypoperfusion|hypoperfusion
5182937|NCT02846727|Sepsis|sepsis
5182938|NCT02846714|Education|education
5182939|NCT02846714|Prevention and Control|prevention and control
5182940|NCT02846714|Behavioral Research|behavioral research
5182941|NCT02846701|Neuropathic pain|neuropathic pain
5182942|NCT02846701|Antidepressant|antidepressant
5182943|NCT02846701|Duloxetine|duloxetine
5182944|NCT02846701|Liquid Chromatography|liquid chromatography
5182945|NCT02846701|Mass Spectrometry|mass spectrometry
5182946|NCT02846675|SVF|svf
5182947|NCT02846675|Stromal Vascular Fraction|stromal vascular fraction
5182948|NCT02846675|osteoarthritis(OA)|osteoarthritis(oa)
5170836|NCT02924090|Major depressive disorder|major depressive disorder
5170837|NCT02924090|Etomidate|etomidate
5170838|NCT02924090|Ketamine|ketamine
5170839|NCT02924090|Hyperventilation|hyperventilation
5182949|NCT02846675|knee|knee
5182950|NCT02846675|adipose|adipose
5182951|NCT02846662|depression|depression
5182952|NCT02846662|mobile technology|mobile technology
5182953|NCT02846662|community trial|community trial
5182954|NCT02846610|anesthesia|anesthesia
5182955|NCT02846610|continuous regional anesthesia|continuous regional anesthesia
5182956|NCT02846610|complications|complications
5182957|NCT02846610|epidural analgesia|epidural analgesia
5182958|NCT02846610|antibiotics|antibiotics
5182959|NCT02846597|Respiratory distress syndrome|respiratory distress syndrome
5182960|NCT02846597|Sustained lung inflation|sustained lung inflation
5182961|NCT02846597|Delivery room|delivery room
5182962|NCT02846584|CAR T|car t
5182963|NCT02846584|HSCT|hsct
5182964|NCT02846571|Islet Transplantation|islet transplantation
5182965|NCT02846571|Type 1 Diabetes|type 1 diabetes
5182966|NCT02846571|Immune Tolerance Induction|immune tolerance induction
5962284|NCT04281758|caffeine|caffeine
5182967|NCT02846571|Diabetes Complications|diabetes complications
5111731|NCT03299140|CBT|cbt
5788071|NCT00155506|Genotyping|genotyping
5182968|NCT02846571|Intraocular Transplantation|intraocular transplantation
5182969|NCT02846571|Eye Anterior Chamber|eye anterior chamber
5182970|NCT02846571|Kidney Transplantation|kidney transplantation
5182971|NCT02846571|Immunosuppression|immunosuppression
5182972|NCT02846571|Type 2 Diabetes|type 2 diabetes
5182973|NCT02846558|calorie restriction|calorie restriction
5182974|NCT02846558|weight loss|weight loss
5182975|NCT02846532|Thromboembolism|thromboembolism
5182976|NCT02846532|Fontan Procedure|fontan procedure
5182977|NCT02846532|Children|children
5182978|NCT02846493|Ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5182979|NCT02846493|Dexamethasone|dexamethasone
5182980|NCT02846467|Informed consent|informed consent
5182981|NCT02846467|Patient Education|patient education
5182982|NCT02846467|Mobile applications|mobile applications
5182983|NCT02846441|posthepatectomy liver failure|posthepatectomy liver failure
5182984|NCT02846441|ALPPS|alpps
5182985|NCT02846441|hepatobiliary scintigraphy|hepatobiliary scintigraphy
5182987|NCT02846441|mebrofenin|mebrofenin
5182988|NCT02846415|Dementia|dementia
5182989|NCT02846415|Play and Playthings|play and playthings
5182990|NCT02846415|Cognition|cognition
5182991|NCT02846415|Memory|memory
5182992|NCT02846402|HIV testing|hiv testing
5182993|NCT02846402|Female sex workers|female sex workers
5182994|NCT02846402|HIV self-testing|hiv self-testing
5182995|NCT02846389|Radiation therapy for Breast Cancer|radiation therapy for breast cancer
5182996|NCT02846363|stroke|stroke
5182997|NCT02846363|public awareness campaign|public awareness campaign
5182998|NCT02846363|call to EMS|call to ems
5182999|NCT02846337|cardio-renal syndrome|cardio-renal syndrome
5183000|NCT02846337|hemodialysis|hemodialysis
5183001|NCT02846337|peritoneal dialysis|peritoneal dialysis
5183002|NCT02846337|hemofiltration|hemofiltration
5183003|NCT02846337|composite endpoint|composite endpoint
5183005|NCT02846311|winter|winter
5183006|NCT02846311|season|season
5183007|NCT02846298|Drug Monitoring|drug monitoring
5183008|NCT02846298|ICU|icu
5183009|NCT02846298|Pharmacokinetic|pharmacokinetic
5183010|NCT02846298|Pharmacodynamic|pharmacodynamic
5183011|NCT02846298|antibiotic|antibiotic
5183012|NCT02846298|Glycopeptides|glycopeptides
5183013|NCT02846298|β-lactam-aminoglycoside|β-lactam-aminoglycoside
5183014|NCT02846285|Bleeding|bleeding
5183015|NCT02846259|intracranial aneurysm|intracranial aneurysm
5183016|NCT02846259|cerebral ischemia|cerebral ischemia
5183017|NCT02846259|aspirin|aspirin
5183018|NCT02846246|aged care|aged care
5183019|NCT02846246|health|health
5183020|NCT02846246|home care services|home care services
5183021|NCT02846246|person-centred care|person-centred care
5183022|NCT02846220|Medication Adherence|medication adherence
5183023|NCT02846220|Middle Aged 45-64|middle aged 45-64
5183024|NCT02846220|Aged 65-79|aged 65-79
5183025|NCT02846220|Aged, 80 and over|aged, 80 and over
5183026|NCT02846207|cerebral infarction|cerebral infarction
5183027|NCT02846207|syndrome of qi deficiency and blood stasis|syndrome of qi deficiency and blood stasis
5183034|NCT02846155|capsule endoscopy|capsule endoscopy
5183035|NCT02846129|multiple gestation|multiple gestation
5183036|NCT02846129|complications|complications
5183037|NCT02846129|cesarean delivery|cesarean delivery
5183038|NCT02846116|all ceramic crown|all ceramic crown
5183039|NCT02846116|Lithium disilicate|lithium disilicate
5183040|NCT02846116|e-max|e-max
5183041|NCT02846116|vita suprinity|vita suprinity
5170932|NCT02923401|Stationary bicycle|stationary bicycle
5170933|NCT02923401|Questionnaires|questionnaires
5170934|NCT02923401|Surveys|surveys
5170935|NCT02923401|Motivational sessions|motivational sessions
5170936|NCT02923401|Phone calls|phone calls
5170937|NCT02923401|Printed materials|printed materials
5183042|NCT02846077|sleep|sleep
5183043|NCT02846077|social networks|social networks
5183044|NCT02846077|undergraduates|undergraduates
5183045|NCT02846077|mood|mood
5183046|NCT02846077|circadian rhythms|circadian rhythms
5183047|NCT02846051|varicose vein|varicose vein
5183048|NCT02846051|physical activity|physical activity
5183049|NCT02846038|Pediatric cancer|pediatric cancer
5183050|NCT02846038|Childhood cancer|childhood cancer
5183051|NCT02846038|High-risk disease|high-risk disease
5183052|NCT02846038|Prognosis|prognosis
5183053|NCT02846038|Communication|communication
5183054|NCT02846038|Bad news|bad news
5183055|NCT02846038|Pediatric oncologist|pediatric oncologist
5183056|NCT02846038|Parent|parent
5183057|NCT02846038|Relapse|relapse
5183058|NCT02846038|Progression|progression
5183059|NCT02845999|natural killer cells|natural killer cells
5183060|NCT02845999|adoptive transfer|adoptive transfer
5183061|NCT02845999|allogenic immunotherapy|allogenic immunotherapy
5183062|NCT02845999|gastrointestinal cancer EGFR+|gastrointestinal cancer egfr+
5183063|NCT02845986|Stomach Neoplasms|stomach neoplasms
5183064|NCT02845986|Laparoscopy|laparoscopy
5183065|NCT02845986|Spleen-Preserving|spleen-preserving
5183066|NCT02845986|No.10 Lymph Node Dissection|no.10 lymph node dissection
5183067|NCT02845973|gut microbiota|gut microbiota
5183068|NCT02845921|Propofol|propofol
5962285|NCT04281758|botanicals|botanicals
5183069|NCT02845921|Hypotension|hypotension
5183070|NCT02845921|Induction of anaesthesia|induction of anaesthesia
5183071|NCT02845921|Leg elevation|leg elevation
5183072|NCT02845921|Leg wrapping|leg wrapping
5183073|NCT02845895|Screening for nutritional disorder|screening for nutritional disorder
5183074|NCT02845895|Comparison of two organizations|comparison of two organizations
5183075|NCT02845895|Indicator IPAQSS|indicator ipaqss
5183076|NCT02845856|recurrent lung cancer|recurrent lung cancer
5183077|NCT02845856|EGFR mutation|egfr mutation
5183078|NCT02845856|Cetuximab|cetuximab
5183079|NCT02845856|NK immunotherapy|nk immunotherapy
5183080|NCT02845843|Middle East Respiratory Syndrome Coronavirus|middle east respiratory syndrome coronavirus
5183081|NCT02845843|MERS-CoV|mers-cov
5183082|NCT02845843|Clinical trial|clinical trial
5183083|NCT02845843|Lopinavir|lopinavir
5183084|NCT02845843|Ritonavir|ritonavir
5183085|NCT02845843|Interferon beta|interferon beta
5183086|NCT02845830|dementia|dementia
5183087|NCT02845830|elderly|elderly
5183088|NCT02845830|quality of life|quality of life
5183089|NCT02845830|assessment|assessment
5183090|NCT02845830|factor|factor
5183091|NCT02845830|trajectory|trajectory
5183092|NCT02845830|change|change
5183093|NCT02845830|early stage|early stage
5183094|NCT02845804|coronary artery disease|coronary artery disease
5183095|NCT02845804|percutaneous coronary intervention|percutaneous coronary intervention
5183096|NCT02845804|everolimus-eluting stents|everolimus-eluting stents
5183097|NCT02845778|melatonin|melatonin
5183098|NCT02845778|pharmacokinetics|pharmacokinetics
5183099|NCT02845765|Erectile Dysfunction|erectile dysfunction
5183100|NCT02845765|ED|ed
5183101|NCT02845765|Fundus Oculi|fundus oculi
5183102|NCT02845765|Retinal Vascularization|retinal vascularization
5183103|NCT02845765|International Index of Erectile Function Questionnaire|international index of erectile function questionnaire
5183104|NCT02845765|IIEF|iief
5183105|NCT02845765|Dynamic Vessel Analyzer|dynamic vessel analyzer
5183106|NCT02845765|DVA|dva
5183107|NCT02845765|Phosphodiesterase type 5 Inhibitor|phosphodiesterase type 5 inhibitor
5183108|NCT02845765|PDE5Is|pde5is
5183109|NCT02845739|kidney transplantation|kidney transplantation
5183110|NCT02845739|human papillomavirus|human papillomavirus
5183111|NCT02845687|nicotine addiction|nicotine addiction
5183112|NCT02845687|cigarette smoking|cigarette smoking
5183113|NCT02845661|Narcotrend index|narcotrend index
5183114|NCT02845661|OAA/S scale|oaa/s scale
5183115|NCT02845661|Dexmedetomidine|dexmedetomidine
5183116|NCT02845661|Sedation|sedation
5183124|NCT02845609|Congenital macrothrombocytopenia|congenital macrothrombocytopenia
5183126|NCT02845609|Bleeding|bleeding
5183127|NCT02845583|Nursing|nursing
5072047|NCT03549039|cleft lip|cleft lip
5183128|NCT02845583|Diagnosis Related Group|diagnosis related group
5183129|NCT02845583|Activity based costing|activity based costing
5183130|NCT02845557|Youth|youth
5171034|NCT02922985|Cesarean delivery|cesarean delivery
5171035|NCT02922985|Multimodal pain management|multimodal pain management
5171036|NCT02922972|Keloid scar|keloid scar
5171037|NCT02922972|Wound healing|wound healing
5171038|NCT02922972|Platelet-Rich Plasma|platelet-rich plasma
5171039|NCT02922972|RegenLab|regenlab
5171040|NCT02922959|Opioid Substitution Treatment|opioid substitution treatment
5171046|NCT02922946|HDAC|hdac
5183131|NCT02845557|Type 2 Diabetes|type 2 diabetes
5183132|NCT02845557|glucose homeostasis|glucose homeostasis
5183133|NCT02845557|incretin effect|incretin effect
5183134|NCT02845544|Postural Balance|postural balance
5183135|NCT02845531|Variant angina|variant angina
5183136|NCT02845531|Aborted sudden cardiac death|aborted sudden cardiac death
5183137|NCT02845531|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5183138|NCT02845531|Optimal Medical Therapy|optimal medical therapy
5183139|NCT02845531|ICD|icd
5183140|NCT02845505|intravascular ultrasonography|intravascular ultrasonography
5183141|NCT02845505|Computed Tomography|computed tomography
5183142|NCT02845492|Exercise|exercise
5183143|NCT02845492|Qigong|qigong
5183144|NCT02845492|Mind-Body|mind-body
5183145|NCT02845492|Fatigue|fatigue
5183146|NCT02845492|Cancer|cancer
5183147|NCT02845492|EEG|eeg
5183148|NCT02845492|HRV|hrv
5183149|NCT02845466|Venous Leg Ulcer|venous leg ulcer
5183150|NCT02845466|Diabetic Foot Ulcer|diabetic foot ulcer
5183151|NCT02845466|Wound Healing|wound healing
5183152|NCT02845466|Growth Factor|growth factor
5183153|NCT02845466|Protease Inhibitor|protease inhibitor
5183154|NCT02845453|youth|youth
5183155|NCT02845453|adolescent|adolescent
5183156|NCT02845453|young adult|young adult
5183157|NCT02845453|substance use disorder|substance use disorder
5183158|NCT02845453|bipolar disorder|bipolar disorder
5183159|NCT02845453|quetiapine|quetiapine
5183160|NCT02845453|mood dysregulation|mood dysregulation
5183161|NCT02845440|Pragmatic Trial|pragmatic trial
5183162|NCT02845440|Community Health Workers|community health workers
5183163|NCT02845440|Academic Detailing|academic detailing
5183164|NCT02845427|Closed Suction Drain|closed suction drain
5183165|NCT02845427|Wound Hematoma|wound hematoma
5183166|NCT02845401|Viral|viral
5183167|NCT02845401|Hepatitis|hepatitis
5183168|NCT02845388|IVF|ivf
5183169|NCT02845362|Neuromuscular|neuromuscular
5183170|NCT02845362|dysphagia|dysphagia
5183171|NCT02845362|Swallowing disorders|swallowing disorders
5183176|NCT02845245|Comminuted intra-articular distal tibia fractures|comminuted intra-articular distal tibia fractures
5183177|NCT02845245|3D printing|3d printing
5183178|NCT02845245|pre-operative planning|pre-operative planning
5183179|NCT02845232|Acute myeloid leukemia|acute myeloid leukemia
5183180|NCT02845232|Therapy|therapy
5183181|NCT02845232|Blood transfusion|blood transfusion
5183182|NCT02845232|Cost-effectiveness|cost-effectiveness
5183183|NCT02845232|Prognosis|prognosis
5183184|NCT02845206|Total Knee Replacement|total knee replacement
5183185|NCT02845206|Patient Specific Instrumentation|patient specific instrumentation
5183186|NCT02845180|lipectomy|lipectomy
5183187|NCT02845180|panniculectomy|panniculectomy
5183188|NCT02845154|Ischemia reperfusion|ischemia reperfusion
5183189|NCT02845154|post-reperfusion syndrome|post-reperfusion syndrome
5183190|NCT02845154|living donor liver transplantation|living donor liver transplantation
5183191|NCT02845154|patient outcome|patient outcome
5183192|NCT02845141|ACL|acl
5183193|NCT02845141|Revision surgery|revision surgery
5183194|NCT02845141|tunnel enlargement|tunnel enlargement
5183195|NCT02845141|bone substitute material|bone substitute material
5183197|NCT02845128|high-flow nasal cannula, HFNC, acute respiratory failure, intubation|high-flow nasal cannula, hfnc, acute respiratory failure, intubation
5183198|NCT02845115|Middle Ear Implant|middle ear implant
5183199|NCT02845115|laser velocimetry|laser velocimetry
5183200|NCT02845102|Chronic Illness|chronic illness
5183201|NCT02845102|Chronic Pain|chronic pain
5183202|NCT02845102|Depression|depression
5183203|NCT02845102|Comorbid Depression|comorbid depression
5183204|NCT02845102|Cognitive Behavioral Therapy|cognitive behavioral therapy
5183205|NCT02845102|Relational Agent Technology|relational agent technology
5183206|NCT02845102|CBT|cbt
5183218|NCT02845063|hypertension|hypertension
5183219|NCT02845063|molecular biology|molecular biology
5183220|NCT02845050|neo-adjuvant|neo-adjuvant
5183221|NCT02845050|vinflunine|vinflunine
5183222|NCT02845050|cisplatin|cisplatin
5183223|NCT02845050|radical cystectomy|radical cystectomy
5183224|NCT02845050|muscle-invasive bladder cancer|muscle-invasive bladder cancer
5183225|NCT02845050|JaNEO|janeo
5183226|NCT02845011|Cardio first angle|cardio first angle
5183227|NCT02845011|CPR|cpr
5183228|NCT02845011|Cardiopulmonary Arrest|cardiopulmonary arrest
5183229|NCT02845011|Clinical trial|clinical trial
5183230|NCT02844998|intravaginal ejaculatory latency time|intravaginal ejaculatory latency time
5183231|NCT02844998|international physical activity questionnaire|international physical activity questionnaire
5183232|NCT02844998|premature ejaculation diagnostic tool|premature ejaculation diagnostic tool
5183233|NCT02844985|Sexual Addiction|sexual addiction
5183234|NCT02844985|Genomics|genomics
5183235|NCT02844985|Personality|personality
5183236|NCT02844985|Polymorphism|polymorphism
5183237|NCT02844972|arrest or limitation of active treatment|arrest or limitation of active treatment
5183238|NCT02844972|emergency treatment|emergency treatment
5183239|NCT02844959|Atrial Fibrillation|atrial fibrillation
5183240|NCT02844959|Biomarkers|biomarkers
5183241|NCT02844959|Inflammatory Response|inflammatory response
5183242|NCT02844959|C-reactive protein|c-reactive protein
5183243|NCT02844959|FGF2|fgf2
5183244|NCT02844959|MMP8|mmp8
5183245|NCT02844959|troponin I|troponin i
5183246|NCT02844959|body temperature|body temperature
5183251|NCT02844907|Incretins|incretins
5183252|NCT02844907|GLP-1|glp-1
5183253|NCT02844907|Exendin-9|exendin-9
5183254|NCT02844907|Insulin Resistance|insulin resistance
5183255|NCT02844894|intubation, ischemia modified albumine, dexmedetomidine, esmolol|intubation, ischemia modified albumine, dexmedetomidine, esmolol
5183256|NCT02844868|stroke|stroke
5183257|NCT02844868|hemiplegia|hemiplegia
5183258|NCT02844868|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5183259|NCT02844868|rehabilitation|rehabilitation
5183260|NCT02844868|lower extremity|lower extremity
5183261|NCT02844868|gait training|gait training
5183262|NCT02844855|Alzheimer|alzheimer
5183263|NCT02844855|Parkinson|parkinson
5183264|NCT02844855|Action memory|action memory
5183265|NCT02844842|mild or moderate|mild or moderate
5183266|NCT02844829|Prostate Cancer|prostate cancer
5183267|NCT02844829|Magnetic Resonance Imaging|magnetic resonance imaging
5183268|NCT02844777|topical ointment|topical ointment
5183269|NCT02844777|skin|skin
5183270|NCT02844777|hexokinase|hexokinase
5183271|NCT02844777|precancerous conditions|precancerous conditions
5183272|NCT02844777|carcinoma, squamous cell|carcinoma, squamous cell
5183273|NCT02844712|Drug hypersensitivity|drug hypersensitivity
5183274|NCT02844712|Betalactam|betalactam
5183275|NCT02844712|Drug provocation test|drug provocation test
5183276|NCT02844699|prostate cancer|prostate cancer
5183277|NCT02844699|adenovirus|adenovirus
5183278|NCT02844699|TLR5|tlr5
5183279|NCT02844699|immunotherapy|immunotherapy
5183280|NCT02844699|Ad5|ad5
5183281|NCT02844686|Myocardial perfusion imaging|myocardial perfusion imaging
5183282|NCT02844686|Single-Photon Emission Computer-Assisted Tomography|single-photon emission computer-assisted tomography
5183283|NCT02844673|Sickle cell disease|sickle cell disease
5057702|NCT03638297|MSI-H|msi-h
5057703|NCT03638297|dMMR|dmmr
5057704|NCT03638297|PD-1 antibody|pd-1 antibody
5057705|NCT03638297|COX inhibitor|cox inhibitor
5057706|NCT03638297|tumor mutation burden|tumor mutation burden
5183284|NCT02844673|Hydroxyurea|hydroxyurea
5183285|NCT02844673|Adherence|adherence
5183286|NCT02844673|randomized trial|randomized trial
5183287|NCT02844673|medication possession ratio|medication possession ratio
5183288|NCT02844660|Diabetes Mellitus|diabetes mellitus
5183289|NCT02844660|Foot Diseases|foot diseases
5183290|NCT02844660|Foot Ulcer|foot ulcer
5183291|NCT02844634|pre-exposure prophylaxis|pre-exposure prophylaxis
5183292|NCT02844634|men who have sex with men|men who have sex with men
5183293|NCT02844634|HIV prevention|hiv prevention
5183294|NCT02844634|sexually transmitted infection|sexually transmitted infection
5183295|NCT02844634|syphilis|syphilis
5183296|NCT02844608|Health-related quality of life|health-related quality of life
5183298|NCT02844608|Electronic collection|electronic collection
5183299|NCT02844595|Smoking, psychological treatment, depression|smoking, psychological treatment, depression
5183300|NCT02844569|Dental Implants|dental implants
5183301|NCT02844569|Bone Grafting|bone grafting
5183302|NCT02844556|SMILE surgery|smile surgery
5183303|NCT02844556|FS-LASIK surgery|fs-lasik surgery
5183304|NCT02844556|multicenter|multicenter
5183305|NCT02844543|concussion, eye-tracking, athletes, vision|concussion, eye-tracking, athletes, vision
5183307|NCT02844517|Artificial Pancreas|artificial pancreas
5183308|NCT02844517|Closed Loop Control|closed loop control
5183309|NCT02844517|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5183310|NCT02844504|Fatigue|fatigue
5183311|NCT02844504|Breast cancer|breast cancer
5183312|NCT02844504|Force|force
5183313|NCT02844504|Motor imagery|motor imagery
5183314|NCT02844504|Cancer Treatment|cancer treatment
5171223|NCT02922075|connective tissue graft|connective tissue graft
5171224|NCT02922075|collagen matrix|collagen matrix
5171225|NCT02922062|lipids|lipids
5171226|NCT02922062|saturated fat|saturated fat
5171227|NCT02922062|palm oil|palm oil
5171232|NCT02921997|A/H5N1|a/h5n1
5171233|NCT02921997|A/H7N9|a/h7n9
5171234|NCT02921997|ASO3 Adjuvant|aso3 adjuvant
5171304|NCT02921776|App|app
5183315|NCT02844478|Caregiving|caregiving
5183316|NCT02844478|Family caregiving|family caregiving
5183317|NCT02844478|Stress|stress
5183318|NCT02844478|dementia caregiving|dementia caregiving
5183319|NCT02844478|Hispanics|hispanics
5183320|NCT02844478|Spanish|spanish
5183321|NCT02844478|Telomere|telomere
5183322|NCT02844465|epilepsy|epilepsy
5183323|NCT02844465|laser ablation|laser ablation
5183324|NCT02844465|Visualase|visualase
5183325|NCT02844465|laser interstitial thermal therapy|laser interstitial thermal therapy
5183326|NCT02844452|Atopic Dermatitis|atopic dermatitis
5183327|NCT02844452|acupuncture|acupuncture
5183328|NCT02844452|visit frequency|visit frequency
5183329|NCT02844452|adult patient with AD|adult patient with ad
5183330|NCT02844426|synbiotic|synbiotic
5183331|NCT02844426|soluble dietary fiber|soluble dietary fiber
5183332|NCT02844426|slow transit constipation|slow transit constipation
5183333|NCT02844426|microbiota|microbiota
5183334|NCT02844387|cancer|cancer
5183335|NCT02844387|brain|brain
5183336|NCT02844387|arginine|arginine
5183337|NCT02844387|radiation|radiation
5183338|NCT02844374|Epilepsy|epilepsy
5183339|NCT02844374|Surgery candidate|surgery candidate
5183340|NCT02844374|EEG's Signal|eeg's signal
5183341|NCT02844361|high-risk|high-risk
5183342|NCT02844361|ASCT|asct
5183343|NCT02844348|Pain|pain
5183344|NCT02844348|Hypnosis|hypnosis
5183345|NCT02844348|Chronic Dialysis|chronic dialysis
5183346|NCT02844348|Arterial Disease|arterial disease
5183347|NCT02844335|Breast Cancer|breast cancer
5183348|NCT02844335|Cryosurgery|cryosurgery
5183349|NCT02844335|NK Immunotherapy|nk immunotherapy
5183350|NCT02844296|short-bout exercise|short-bout exercise
5183351|NCT02844296|craving|craving
5183352|NCT02844296|handgrip|handgrip
5183353|NCT02844296|smoking cessation|smoking cessation
5183354|NCT02844296|RCT|rct
5183355|NCT02844283|HGF,myocardial infarction|hgf,myocardial infarction
5183356|NCT02844257|Acute myeloid leukaemia|acute myeloid leukaemia
5183357|NCT02844257|Transfusion dependency|transfusion dependency
5183358|NCT02844257|Transfusion intensity|transfusion intensity
5183359|NCT02844257|Prognosis|prognosis
5183360|NCT02844257|Chemotherapy|chemotherapy
5183361|NCT02844244|family well-being|family well-being
5183362|NCT02844244|positive psychology|positive psychology
5183363|NCT02844218|Acute myeloid leukemia|acute myeloid leukemia
5183364|NCT02844218|Chemotherapy|chemotherapy
5183365|NCT02844218|Low-intensity therapy|low-intensity therapy
5183366|NCT02844218|Older patients|older patients
5183367|NCT02844218|Prognosis|prognosis
5183368|NCT02844218|Supportive care|supportive care
5962286|NCT04281758|beverage|beverage
5962287|NCT04281758|mood|mood
5962288|NCT04281732|Virtual Reality|virtual reality
5962289|NCT04281732|Quality of life|quality of life
5962290|NCT04281654|Dance|dance
5183369|NCT02844205|nursing care|nursing care
5962291|NCT04281654|Music|music
5962292|NCT04281654|Social Conversation|social conversation
5057824|NCT03637426|Laser|laser
5183370|NCT02844205|observational scale|observational scale
5183371|NCT02844205|neonate|neonate
5183372|NCT02844205|premature infant|premature infant
5183373|NCT02844205|developmental care|developmental care
5183374|NCT02844192|Vancomycin|vancomycin
5183375|NCT02844192|under dosage|under dosage
5183376|NCT02844192|intensive care unit|intensive care unit
5183377|NCT02844192|pharmacokinetics|pharmacokinetics
5183378|NCT02844153|Metformin|metformin
5183379|NCT02844153|type 2 diabetes|type 2 diabetes
5183380|NCT02844153|chronic kidney disease|chronic kidney disease
5183381|NCT02844153|antidiabetic medications|antidiabetic medications
5183382|NCT02844153|lactic acidosis|lactic acidosis
5183383|NCT02844114|Ganoderma Lucidum Spore|ganoderma lucidum spore
5183384|NCT02844114|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5183385|NCT02844114|Chemotherapy|chemotherapy
5183386|NCT02844114|Gemcitabine|gemcitabine
5183387|NCT02844114|Cisplatin|cisplatin
5183388|NCT02844088|meningococcus C|meningococcus c
5183389|NCT02844075|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5183401|NCT02844023|Horton disease|horton disease
5183402|NCT02843997|Bipolar disorder|bipolar disorder
5183403|NCT02843997|Endophenotype|endophenotype
5183404|NCT02843997|Family|family
5183405|NCT02843997|Autosomal dominant expression|autosomal dominant expression
5183406|NCT02843997|Sequencing|sequencing
5183407|NCT02843997|Heritability|heritability
5183408|NCT02843984|Amniocentesis|amniocentesis
5183409|NCT02843971|Water Drinking Test|water drinking test
5183410|NCT02843971|Intraocular Pressure|intraocular pressure
5183411|NCT02843971|Sensimed Triggerfish|sensimed triggerfish
5183412|NCT02843958|Medical device|medical device
5183413|NCT02843958|Hemoptic|hemoptic
5183414|NCT02843958|Vitamin K antagonist|vitamin k antagonist
5183415|NCT02843958|Diagnostic in vitro|diagnostic in vitro
5183416|NCT02843945|brachytherapy|brachytherapy
5183417|NCT02843945|CivaSheet|civasheet
5183418|NCT02843945|CivaTech|civatech
5183419|NCT02843945|whipple|whipple
5183420|NCT02843945|radiation|radiation
5183421|NCT02843945|borderline resectable|borderline resectable
5183422|NCT02843945|locally advanced|locally advanced
5183423|NCT02843945|Pd-103|pd-103
5183424|NCT02843945|intraoperative radiation|intraoperative radiation
5183425|NCT02843932|Somatoform|somatoform
5183426|NCT02843932|Psychogenic|psychogenic
5183427|NCT02843919|Electrocardiography|electrocardiography
5183428|NCT02843919|Electroencephalography|electroencephalography
5183429|NCT02843919|Neural Correlates|neural correlates
5183430|NCT02843919|Mental Workload|mental workload
5183431|NCT02843906|alzheimer disease|alzheimer disease
5183432|NCT02843906|bipolar disorders|bipolar disorders
5183433|NCT02843906|mild cognitive impairement|mild cognitive impairement
5183434|NCT02843893|Pupillary|pupillary
5183435|NCT02843893|Reflexes|reflexes
5183436|NCT02843893|Analgesia|analgesia
5183437|NCT02843893|Sedation|sedation
5183438|NCT02843880|CMV reactivation|cmv reactivation
5183439|NCT02843880|CMV disease|cmv disease
5183440|NCT02843880|Predictive factors|predictive factors
5183441|NCT02843880|Critically ill patients|critically ill patients
5183442|NCT02843880|Septic shock|septic shock
5183443|NCT02843867|Transplantation|transplantation
5183444|NCT02843867|Immunology|immunology
5183445|NCT02843867|Atherosclerosis|atherosclerosis
5183446|NCT02843828|Exoskeleton Device|exoskeleton device
5183447|NCT02843828|elderly|elderly
5183448|NCT02843828|stroke|stroke
5183449|NCT02843828|gait rehabilitation|gait rehabilitation
5183450|NCT02843815|Non-small cell lung cancer|non-small cell lung cancer
5183451|NCT02843815|Cryosurgery|cryosurgery
5183452|NCT02843815|NK Immunotherapy|nk immunotherapy
5183453|NCT02843802|Metastatic liver cancer|metastatic liver cancer
5183454|NCT02843802|Cryosurgery|cryosurgery
5183455|NCT02843802|NK Immunotherapy|nk immunotherapy
5183456|NCT02843789|Adipokines|adipokines
5183457|NCT02843789|Tocilizumab|tocilizumab
5183458|NCT02843776|Palliative Care|palliative care
5183459|NCT02843776|Euthanasia|euthanasia
5183460|NCT02843776|Epidemiologic Studies|epidemiologic studies
5183461|NCT02843750|Rehabilitation|rehabilitation
5183462|NCT02843750|Inspiratory Muscle Training|inspiratory muscle training
5183463|NCT02843724|Uncontrolled Type 2 Diabetes|uncontrolled type 2 diabetes
5183464|NCT02843724|HbA1c >7.0%|hba1c >7.0%
5183465|NCT02843711|Lungcarta Panel|lungcarta panel
5183466|NCT02843711|lung adenocarcinoma|lung adenocarcinoma
5183467|NCT02843672|metatarsalgia|metatarsalgia
5183473|NCT02843646|gait training|gait training
5183474|NCT02843646|stepping|stepping
5183475|NCT02843633|Acute Coronary Syndrome|acute coronary syndrome
5183476|NCT02843633|Percutaneous Coronary Intervention|percutaneous coronary intervention
5183477|NCT02843633|Drug Coated Stent|drug coated stent
5183478|NCT02843633|Drug Eluting Stent|drug eluting stent
5183479|NCT02843620|Native Collagen|native collagen
5183480|NCT02843620|Joint|joint
5183481|NCT02843620|Joint Discomfort|joint discomfort
5183482|NCT02843607|Kidney Cancer|kidney cancer
5962293|NCT04281628|Ketamine|ketamine
5183483|NCT02843607|Cryosurgery|cryosurgery
5183484|NCT02843607|NK Immunotherapy|nk immunotherapy
5962294|NCT04281628|Morphine|morphine
5183485|NCT02843581|Esophageal Cancer|esophageal cancer
5183486|NCT02843581|NK immunotherapy|nk immunotherapy
5183487|NCT02843581|Safety|safety
5183488|NCT02843581|Efficacy|efficacy
5183489|NCT02843555|Leukodystrophy|leukodystrophy
5183490|NCT02843555|Myelin Gene|myelin gene
5183491|NCT02843555|Myelin Protein|myelin protein
5183492|NCT02843555|Sural Nerve Biopsy|sural nerve biopsy
5183493|NCT02843555|Undiagnosed Disease|undiagnosed disease
5183494|NCT02843555|Schwann Cell|schwann cell
5183495|NCT02843555|White Matter Pathology|white matter pathology
5183496|NCT02843555|Motor Delay|motor delay
5183497|NCT02843555|Cognitive Regression|cognitive regression
5183498|NCT02843555|Motor Deterioration|motor deterioration
5183499|NCT02843555|Unknown Disease|unknown disease
5183500|NCT02843542|Positron emission tomography-magnetic resonance imaging (PET-MR)|positron emission tomography-magnetic resonance imaging (pet-mr)
5183501|NCT02843542|Hyperthyroidism|hyperthyroidism
5423227|NCT01616589|Fragile X full mutation|fragile x full mutation
5183502|NCT02843542|Positron emission tomography-computed tomography (PET-CT)|positron emission tomography-computed tomography (pet-ct)
5183508|NCT02843490|neovascular age-related macular edema|neovascular age-related macular edema
5183510|NCT02843490|ranibizumab|ranibizumab
5183511|NCT02843490|lucentis|lucentis
5183512|NCT02843438|Toxoplasmosis|toxoplasmosis
5183513|NCT02843438|Uveitis|uveitis
5183514|NCT02843438|Chorioretinitis|chorioretinitis
5183515|NCT02843438|Infection|infection
5183516|NCT02843425|Cancer Prevention|cancer prevention
5183517|NCT02843425|Precancerous colorectal polyps|precancerous colorectal polyps
5183518|NCT02843425|Canned beans|canned beans
5183519|NCT02843425|Questionnaires|questionnaires
5183520|NCT02843425|Surveys|surveys
5183521|NCT02843425|Stool samples|stool samples
5183522|NCT02843412|Gastric cancer|gastric cancer
5183523|NCT02843412|Her2/neu|her2/neu
5183524|NCT02843412|Dual paraffin blocks|dual paraffin blocks
5183525|NCT02843412|Trastuzumab|trastuzumab
5183526|NCT02843412|Clinical Prospective Multicenter Cohort Study|clinical prospective multicenter cohort study
5183527|NCT02843399|Diabetes Mellitus Type 2|diabetes mellitus type 2
5183528|NCT02843386|Uveal melanoma|uveal melanoma
5183529|NCT02843386|High risk of metastasis|high risk of metastasis
5183530|NCT02843386|Genomic high risk signature|genomic high risk signature
5183531|NCT02843386|Adjuvant chemotherapy|adjuvant chemotherapy
5183532|NCT02843360|public health|public health
5183533|NCT02843347|Biorepository|biorepository
5183534|NCT02843347|Genetics|genetics
5183535|NCT02843334|Fabry disease|fabry disease
5183536|NCT02843334|End Stage Renal Disease|end stage renal disease
5183537|NCT02843334|chronic dialysis|chronic dialysis
5183538|NCT02843334|alpha galactosidase A|alpha galactosidase a
5183539|NCT02843334|Lyso-GB3|lyso-gb3
5183540|NCT02843334|GLA mutation|gla mutation
5183541|NCT02843334|Prevalence|prevalence
5183542|NCT02843321|infection|infection
5183543|NCT02843308|hoarding disorder|hoarding disorder
5183544|NCT02843308|hoarding|hoarding
5183545|NCT02843308|clutter|clutter
5183546|NCT02843295|renal transplantation|renal transplantation
5183547|NCT02843295|immunology|immunology
5183548|NCT02843295|rejection|rejection
5183549|NCT02843269|RCT|rct
5183550|NCT02843269|Multi-component intervention|multi-component intervention
5183551|NCT02843269|Health personnel|health personnel
5183552|NCT02843269|Physical exercise training|physical exercise training
5183553|NCT02843230|Brain Tumor|brain tumor
5183554|NCT02843204|solid tumor|solid tumor
5183555|NCT02843204|anti-PD-L1|anti-pd-l1
5183556|NCT02843204|NK immunotherapy|nk immunotherapy
5183557|NCT02843191|Rectal Cancer|rectal cancer
5183558|NCT02843191|Consolidation Chemotherapy|consolidation chemotherapy
5183559|NCT02843178|nutrition|nutrition
5183560|NCT02843178|food security|food security
5183561|NCT02843178|behavioral economics|behavioral economics
5183562|NCT02843165|stereotactic body radiation therapy|stereotactic body radiation therapy
5183563|NCT02843165|checkpoint blockade immunotherapy|checkpoint blockade immunotherapy
5183564|NCT02843139|Circulating microRNA|circulating microrna
5183565|NCT02843139|Childhood obesity|childhood obesity
5183566|NCT02843139|Adulthood diabetes|adulthood diabetes
5788173|NCT00154986|IGFBP-3|igfbp-3
5183576|NCT02843100|Diet|diet
5183577|NCT02843100|Microbiome|microbiome
5183578|NCT02843087|Breastfeeding|breastfeeding
5183579|NCT02843087|Microbiome|microbiome
5183580|NCT02843087|BEACH|beach
5183581|NCT02843087|Human milk|human milk
5183582|NCT02843087|Pediatric Obesity|pediatric obesity
5183583|NCT02843074|B-cell tumors|b-cell tumors
5183584|NCT02843074|autologous stem cell transplantation|autologous stem cell transplantation
5183585|NCT02843074|blood cancers|blood cancers
5183586|NCT02843061|B lymphoma|b lymphoma
5183587|NCT02843061|Rituximab|rituximab
5183588|NCT02843061|NK immunotherapy|nk immunotherapy
5183589|NCT02843048|Osteoporosis|osteoporosis
5183590|NCT02843048|Bariatric Surgery|bariatric surgery
5183591|NCT02843048|Physical exercise|physical exercise
5183592|NCT02843048|Obesity|obesity
5183593|NCT02843022|postpartum|postpartum
5183594|NCT02843022|nursing|nursing
5183595|NCT02843022|follow-up|follow-up
5183596|NCT02842983|Esmolol|esmolol
5183597|NCT02842983|Hypotension|hypotension
5183598|NCT02842983|Shock, Septic|shock, septic
5183599|NCT02842983|Sepsis|sepsis
5183600|NCT02842983|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5183602|NCT02842983|Adrenergic Antagonists|adrenergic antagonists
5183603|NCT02842983|Pharmacologic Actions|pharmacologic actions
5183604|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs
5183605|NCT02842931|DLBCL, R-DA-EPOCH-21, R-mNHL-BFM-90, auto-SCT|dlbcl, r-da-epoch-21, r-mnhl-bfm-90, auto-sct
5183606|NCT02842918|Thoracic Spine Manipulation|thoracic spine manipulation
5183607|NCT02842918|Neurodynamics|neurodynamics
5183608|NCT02842918|Sham|sham
5183614|NCT02842853|Meningitis|meningitis
5183615|NCT02842853|Meningococcal Meningitis|meningococcal meningitis
5183616|NCT02842853|Meningococcal Infections|meningococcal infections
5183617|NCT02842853|MenACYW conjugate vaccine|menacyw conjugate vaccine
5183619|NCT02842827|LSD1|lsd1
5183620|NCT02842814|Systemic Lupus Erythematosus|systemic lupus erythematosus
5183621|NCT02842814|Stable|stable
5183622|NCT02842814|Relapse Risk|relapse risk
5183623|NCT02842814|Glucocorticoid Withdrawal|glucocorticoid withdrawal
5183624|NCT02842788|prone position|prone position
5183625|NCT02842788|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5183626|NCT02842788|mechanical ventilation|mechanical ventilation
5183628|NCT02842788|prevalence|prevalence
5183629|NCT02842775|rehabilitation|rehabilitation
5183630|NCT02842762|Echocardiography, Three-dimensional|echocardiography, three-dimensional
5183631|NCT02842762|Cardiac Surgical Procedures|cardiac surgical procedures
5183632|NCT02842762|Cardiac Pacing, Artificial|cardiac pacing, artificial
5183633|NCT02842762|Anesthesia|anesthesia
5183634|NCT02842736|heavy menstrual bleeding|heavy menstrual bleeding
5183635|NCT02842736|endometrial ablation|endometrial ablation
5183636|NCT02842723|craniopharyngioma|craniopharyngioma
5183637|NCT02842723|protontherapy|protontherapy
5183638|NCT02842697|clinically significant portal hypertension|clinically significant portal hypertension
5183639|NCT02842697|hepatic venous pressure gradient|hepatic venous pressure gradient
5183640|NCT02842697|computed tomographic angiography|computed tomographic angiography
5183645|NCT02842645|Foetal Exposure During Pregnancy|foetal exposure during pregnancy
5183646|NCT02842645|Health|health
5183647|NCT02842645|Growth|growth
5183648|NCT02842580|colorectal|colorectal
5183649|NCT02842580|cancer|cancer
5183650|NCT02842580|metastasis|metastasis
5183651|NCT02842554|PDN|pdn
5183652|NCT02842554|Painful Diabetic Neuropathy|painful diabetic neuropathy
5183653|NCT02842554|Diabetes|diabetes
5183654|NCT02842502|Skin Substitutes|skin substitutes
5183655|NCT02842489|colonoscopy insertion|colonoscopy insertion
5183656|NCT02842489|tilt-down position|tilt-down position
5183657|NCT02842476|pulse oximetry|pulse oximetry
5183658|NCT02842437|dexmedetomidine|dexmedetomidine
5183659|NCT02842437|sepsis|sepsis
5183660|NCT02842437|respiration|respiration
5183661|NCT02842424|Ramipril|ramipril
5183662|NCT02842424|Angiotensin-converting enzyme|angiotensin-converting enzyme
5183663|NCT02842424|Claudication|claudication
5183664|NCT02842424|Myopathy|myopathy
5183665|NCT02842424|Peripheral Arterial Disease|peripheral arterial disease
5183666|NCT02842411|bowel preparation|bowel preparation
5183667|NCT02842411|chronic constipation|chronic constipation
5183668|NCT02842411|risk factor|risk factor
5183669|NCT02842398|gait|gait
5183670|NCT02842398|balance|balance
5183671|NCT02842398|street-crossing|street-crossing
5183672|NCT02842385|soft tissue thickness|soft tissue thickness
5183673|NCT02842385|dental implant|dental implant
5183674|NCT02842385|crestal bone loss|crestal bone loss
5183675|NCT02842372|Acute Graft Versus Host Disease in Skin|acute graft versus host disease in skin
5183676|NCT02842372|GvHD|gvhd
5183677|NCT02842372|Ectoin|ectoin
5183678|NCT02842372|Dermatitis|dermatitis
5183679|NCT02842372|Inflammation of the skin|inflammation of the skin
5183680|NCT02842372|Topical therapy skin GvHD|topical therapy skin gvhd
5183681|NCT02842346|Ultrasound; umbilical Doppler; resistance index; fetal growth|ultrasound; umbilical doppler; resistance index; fetal growth
5183682|NCT02842307|Acupuncture|acupuncture
5183683|NCT02842307|Expertise-based randomized controlled trial|expertise-based randomized controlled trial
5183684|NCT02842307|Nausea|nausea
5183685|NCT02842307|Vomiting|vomiting
5183686|NCT02842307|Cancer|cancer
5183687|NCT02842294|bevacizumab|bevacizumab
5183688|NCT02842294|health related quality of life|health related quality of life
5183689|NCT02842255|Sleep apnea|sleep apnea
5183690|NCT02842255|Oximeter|oximeter
5183691|NCT02842255|Calibration|calibration
5183692|NCT02842255|Oxygen partial pressure|oxygen partial pressure
5183693|NCT02842229|Myelodysplastic Syndromes|myelodysplastic syndromes
5183694|NCT02842229|Leukemia Myeloid Acute|leukemia myeloid acute
5183695|NCT02842229|Multiple Myeloma|multiple myeloma
5183696|NCT02842229|Leukemia, Lymphocytic, Chronic|leukemia, lymphocytic, chronic
5183697|NCT02842229|Elderly Patients|elderly patients
5183698|NCT02842229|Haematological malignancy|haematological malignancy
5183699|NCT02842229|Elderly|elderly
5183700|NCT02842229|Health Status|health status
5072687|NCT03544827|Atropine|atropine
5183701|NCT02842229|Scale validation|scale validation
5183702|NCT02842229|Retrospective|retrospective
5183703|NCT02842216|Pharmaceutical preparations|pharmaceutical preparations
5183704|NCT02842216|Dietary supplements|dietary supplements
5183722|NCT02842112|leukemia stem cell|leukemia stem cell
5183723|NCT02842060|Prevention & Control|prevention & control
5171615|NCT02919696|CDK4/6 Inhibitor|cdk4/6 inhibitor
5171616|NCT02919683|Head and Neck Cancer|head and neck cancer
5171617|NCT02919670|Stem Cell Transplant|stem cell transplant
5171618|NCT02919644|vaccination|vaccination
5171619|NCT02919644|autologous dendritic cells|autologous dendritic cells
5171620|NCT02919644|autologous tumour homogenate|autologous tumour homogenate
5171621|NCT02919644|curative resection|curative resection
5171622|NCT02919644|stage IV colorectal cancer|stage iv colorectal cancer
5171623|NCT02919618|Ventricular Tachycardia|ventricular tachycardia
5171624|NCT02919618|Ablation|ablation
5171625|NCT02919618|Noninvasive|noninvasive
5171626|NCT02919605|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5171627|NCT02919605|pentamidine isothionate|pentamidine isothionate
5171628|NCT02919605|treatment|treatment
5171629|NCT02919553|endoscopic ultrasound|endoscopic ultrasound
5171630|NCT02919553|wet-suction technique|wet-suction technique
5171631|NCT02919553|capillary technique|capillary technique
5171632|NCT02919553|fine needle aspiration|fine needle aspiration
5171633|NCT02919553|fine needle biopsy|fine needle biopsy
5171634|NCT02919514|fall prevention|fall prevention
5171635|NCT02919514|Aging|aging
5171636|NCT02919514|surfaces|surfaces
5171637|NCT02919475|JTE-051|jte-051
5171638|NCT02919475|Active Rheumatoid Arthritis|active rheumatoid arthritis
5171639|NCT02919475|Efficacy|efficacy
5171640|NCT02919475|Safety|safety
5171641|NCT02919475|Tolerability|tolerability
5183724|NCT02842060|Young Adult|young adult
5183725|NCT02842060|Internet|internet
5183726|NCT02842047|caregiver|caregiver
5183727|NCT02842047|end of life|end of life
5183728|NCT02842034|schizophrenia|schizophrenia
5183729|NCT02842034|rTMS|rtms
5183730|NCT02842008|Exercise Therapy|exercise therapy
5183731|NCT02842008|Shoulder pain|shoulder pain
5183732|NCT02842008|Shoulder injuries|shoulder injuries
5183733|NCT02842008|Shoulder function|shoulder function
5183734|NCT02842008|Prevention|prevention
5183735|NCT02842008|Wheelchair users|wheelchair users
5183736|NCT02841995|cGVHD|cgvhd
5183737|NCT02841995|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5183738|NCT02841995|Immune System Diseases|immune system diseases
5183739|NCT02841995|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
5183740|NCT02841995|Bone Marrow Transplantation|bone marrow transplantation
5183741|NCT02841995|Anti-Inflammatory Agents|anti-inflammatory agents
5183742|NCT02841995|Glucocorticoids|glucocorticoids
5183743|NCT02841995|Corticosteroids|corticosteroids
5183744|NCT02841969|Ulcer|ulcer
5183745|NCT02841969|Electrolysed|electrolysed
5183746|NCT02841969|Water|water
5183747|NCT02841943|Fluid responsiveness|fluid responsiveness
5183748|NCT02841943|Near-infrared spectroscopy|near-infrared spectroscopy
5183749|NCT02841943|Thoracic surgery|thoracic surgery
5183750|NCT02841943|Hypovolemia|hypovolemia
5183751|NCT02841943|veno-arterial carbon dioxide gradient|veno-arterial carbon dioxide gradient
5183752|NCT02841943|arterio-venous oxygen gradient|arterio-venous oxygen gradient
5183753|NCT02841943|hypercarbia|hypercarbia
5183754|NCT02841943|Carotid artery|carotid artery
5183755|NCT02841943|ultrasonography|ultrasonography
5183756|NCT02841943|Doppler|doppler
5183757|NCT02841930|Healthcare Access|healthcare access
5183758|NCT02841930|Undocumented Immigrants|undocumented immigrants
5788934|NCT00150904|immunologic|immunologic
5179300|NCT02869139|Ice|ice
5183783|NCT02841657|3 Dimensional Laparoscopy|3 dimensional laparoscopy
5183784|NCT02841657|Visual work load|visual work load
5183785|NCT02841657|Nasa Task Load Index|nasa task load index
5183786|NCT02841657|Simulator Sickness Questionnaire|simulator sickness questionnaire
5183787|NCT02841553|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
5183788|NCT02841540|Myelodysplastic Syndromes|myelodysplastic syndromes
5183789|NCT02841540|Acute Myeloid Leukemia|acute myeloid leukemia
5183790|NCT02841540|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5183791|NCT02841540|H3B-8800|h3b-8800
5183792|NCT02841540|Splicing Modulator|splicing modulator
5183794|NCT02841540|AML|aml
5183795|NCT02841540|MDS|mds
5183796|NCT02841501|Gene Expression Profiling|gene expression profiling
5183797|NCT02841501|Genome-Wide Association Study|genome-wide association study
5183798|NCT02841501|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5183799|NCT02841501|Drug Resistance, Fungal|drug resistance, fungal
5072785|NCT03544216|Presbyopia|presbyopia
5183800|NCT02841475|Atrial Fibrillation , Comorbidities|atrial fibrillation , comorbidities
5183801|NCT02841462|thermal ablation|thermal ablation
5183802|NCT02841462|recurrent Bursitis|recurrent bursitis
5183803|NCT02841462|chronic Bursitis|chronic bursitis
5183804|NCT02841462|olecranon|olecranon
5183805|NCT02841462|intra-bursal perfusion|intra-bursal perfusion
5183806|NCT02841449|Hydration|hydration
5183807|NCT02841449|Glycemic control|glycemic control
5183808|NCT02841449|Appetite|appetite
5183809|NCT02841449|Endocrinology|endocrinology
5183810|NCT02841436|irreversible electroporation|irreversible electroporation
5058315|NCT03634683|HCC|hcc
5183811|NCT02841436|pancreatic cancer|pancreatic cancer
5183812|NCT02841423|physical status I-III;|physical status i-iii;
5183813|NCT02841423|age > 55 yr)|age > 55 yr)
5183814|NCT02841423|undergoing surgery (duration, > 1 h)|undergoing surgery (duration, > 1 h)
5183816|NCT02841410|Emotion|emotion
5183817|NCT02841410|Health|health
5183818|NCT02841410|Nutrition|nutrition
5183819|NCT02841410|Heuristic|heuristic
5183820|NCT02841410|Reasoning|reasoning
5183821|NCT02841410|Magnetic Resonance Imaging|magnetic resonance imaging
5183822|NCT02841384|patellofemoral pain syndrome|patellofemoral pain syndrome
5183823|NCT02841384|postural balance|postural balance
5183824|NCT02841384|knee|knee
5183825|NCT02841384|physiotherapy|physiotherapy
5183826|NCT02841371|estimated glomerular filtration rate|estimated glomerular filtration rate
5183827|NCT02841371|serum creatinine|serum creatinine
5183828|NCT02841371|serum cystatin C|serum cystatin c
5183829|NCT02841371|chronic kidney disease|chronic kidney disease
5183830|NCT02841358|Niemann-Pick Disease, Type C|niemann-pick disease, type c
5183831|NCT02841358|Psychiatric|psychiatric
5183832|NCT02841358|Psychotic disorders|psychotic disorders
5183833|NCT02841345|emotional processing|emotional processing
5183835|NCT02841332|Recurrent Glioblastoma|recurrent glioblastoma
5183836|NCT02841332|Positron emission tomography|positron emission tomography
5183837|NCT02841332|Fluoro misonidazole|fluoro misonidazole
5183838|NCT02841332|MRI multimodal|mri multimodal
5183839|NCT02841319|Virtual reality|virtual reality
5183840|NCT02841319|Hemiplegic|hemiplegic
5183841|NCT02841319|Cerebral Palsy|cerebral palsy
5183842|NCT02841319|upper extremity|upper extremity
5183843|NCT02841319|hand function|hand function
5183844|NCT02841293|Anorectal cancer|anorectal cancer
5183845|NCT02841293|perineal morbidity|perineal morbidity
5183846|NCT02841293|cost-utility analysis|cost-utility analysis
5183847|NCT02841293|biological meshes|biological meshes
5183848|NCT02841241|esmolol|esmolol
5183849|NCT02841241|adrenergic storm|adrenergic storm
5183850|NCT02841241|septic shock|septic shock
5183851|NCT02841228|SIB-IMRT|sib-imrt
5183852|NCT02841228|NSCLC|nsclc
5183853|NCT02841228|Radiochemothearpy|radiochemothearpy
5183854|NCT02841215|Gale|gale
5183855|NCT02841215|Severe forms of scabies|severe forms of scabies
5183856|NCT02841215|Oral parasitic drug|oral parasitic drug
5183860|NCT02841163|Magnetic Resonance Imaging|magnetic resonance imaging
5183861|NCT02841163|Patient Satisfaction|patient satisfaction
5183862|NCT02841163|Numeric Rating Scale|numeric rating scale
5183864|NCT02841098|Carotid stenosis,stroke,endarterectomy,medical therapy|carotid stenosis,stroke,endarterectomy,medical therapy
5183865|NCT02841085|Genetic|genetic
5183866|NCT02841085|Thrombophilia|thrombophilia
5171814|NCT02918643|Elderly|elderly
5183867|NCT02841059|quality of life|quality of life
5183868|NCT02841059|urinary incontinence|urinary incontinence
5183869|NCT02841059|POP|pop
5183870|NCT02841046|stroke volume variation|stroke volume variation
5183871|NCT02841046|cardiac index|cardiac index
5183872|NCT02841046|non-severe patients|non-severe patients
5183873|NCT02841046|gastrointestinal surgery|gastrointestinal surgery
5183876|NCT02840955|Atopic dermatitis|atopic dermatitis
5183877|NCT02840955|Staphylococcus aureus|staphylococcus aureus
5183878|NCT02840955|Microbiome|microbiome
5183879|NCT02840955|Staphefekt|staphefekt
5183880|NCT02840942|intravenous line|intravenous line
5183881|NCT02840942|robot|robot
5183882|NCT02840916|Laser acupuncture|laser acupuncture
5183883|NCT02840916|Postpartum weight retention|postpartum weight retention
5183884|NCT02840916|Obesity|obesity
5183885|NCT02840903|CTA|cta
5183886|NCT02840903|Computed Tomographic Angiography|computed tomographic angiography
5183887|NCT02840877|tuberculosis culture|tuberculosis culture
5183888|NCT02840877|alcohol use|alcohol use
5183889|NCT02840851|Magnetic Resonance Imaging|magnetic resonance imaging
5183890|NCT02840851|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
5183891|NCT02840851|Hypercapnia|hypercapnia
5183895|NCT02840786|stents|stents
5183896|NCT02840786|atherectomy|atherectomy
5183897|NCT02840786|femoral artery|femoral artery
5183898|NCT02840786|popliteal artery|popliteal artery
5183899|NCT02840773|RANKL|rankl
5183900|NCT02840773|OPG|opg
5183901|NCT02840773|Peri-implant crevicular fluid|peri-implant crevicular fluid
5183902|NCT02840760|tardive dyskinesia.|tardive dyskinesia.
5183903|NCT02840760|rTMS|rtms
5183904|NCT02840747|Lymphomatoid Papulosis|lymphomatoid papulosis
5183905|NCT02840747|Sézary Syndrome|sézary syndrome
5072883|NCT03543592|ultrasound|ultrasound
5183906|NCT02840747|T-Cell Lymphoma|t-cell lymphoma
5183907|NCT02840734|Kinesio taping|kinesio taping
5183908|NCT02840734|Obese adults|obese adults
5183909|NCT02840734|Muscular function|muscular function
5183910|NCT02840734|Fatigue|fatigue
5183911|NCT02840682|resource limited setting|resource limited setting
5183912|NCT02840682|Thailand-Myanmar border|thailand-myanmar border
5183913|NCT02840669|Cardiomyopathy|cardiomyopathy
5183914|NCT02840643|hemispherectomy|hemispherectomy
5962295|NCT04281628|Laparotomy Myomectomy|laparotomy myomectomy
5183915|NCT02840643|brain|brain
5183916|NCT02840643|hand function|hand function
5183917|NCT02840630|n3 LC-PUFA|n3 lc-pufa
5962296|NCT04281615|Movement Behaviors|movement behaviors
5183918|NCT02840630|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5183919|NCT02840630|South Asian|south asian
5183920|NCT02840630|HbA1c|hba1c
5183921|NCT02840630|Omega 3 status|omega 3 status
5183922|NCT02840617|ICG|icg
5183923|NCT02840617|prostate cancer|prostate cancer
5183924|NCT02840591|Citicoline, Ramelteon, Rozerem|citicoline, ramelteon, rozerem
5183925|NCT02840539|Mantle cell lymphoma|mantle cell lymphoma
5183926|NCT02840539|Bortezomib|bortezomib
5183927|NCT02840539|Cytarabine|cytarabine
5183929|NCT02840526|PCA|pca
5183930|NCT02840526|nephrectomy|nephrectomy
5183931|NCT02840526|postoperative pain|postoperative pain
5183932|NCT02840513|Smartphone app|smartphone app
5183933|NCT02840513|CO self-monitoring|co self-monitoring
5183934|NCT02840500|Breakthrough Cancer Pain|breakthrough cancer pain
5183935|NCT02840500|Quality of life|quality of life
5183936|NCT02840500|Palliative Care Units|palliative care units
5183937|NCT02840487|Zika Infection|zika infection
5183938|NCT02840487|Flavivirus|flavivirus
5183939|NCT02840487|Vaccine-Mediated Protection|vaccine-mediated protection
5183940|NCT02840487|Immune Response|immune response
5183941|NCT02840487|Arthropod-Borne Virus|arthropod-borne virus
5183942|NCT02840474|HIV Viral Load|hiv viral load
5183943|NCT02840474|Antiviral|antiviral
5183944|NCT02840474|CD4 Count|cd4 count
5183947|NCT02840448|Williams Syndrome|williams syndrome
5183948|NCT02840448|Blood Flow|blood flow
5183949|NCT02840448|Brain|brain
5183950|NCT02840448|Arterial Stiffness|arterial stiffness
5183951|NCT02840435|Nicotine addiction|nicotine addiction
5183952|NCT02840435|Cigarette smoking|cigarette smoking
5183953|NCT02840422|Hyaluronic acid|hyaluronic acid
5183954|NCT02840422|Knee osteoarthritis|knee osteoarthritis
5183955|NCT02840422|Quality of life|quality of life
5183956|NCT02840396|language|language
5183957|NCT02840396|DLPFC|dlpfc
5183958|NCT02840396|rTMS|rtms
5183959|NCT02840396|Executive Functions|executive functions
5183960|NCT02840370|transcranial direct current stimulation|transcranial direct current stimulation
5183961|NCT02840370|aphasia|aphasia
5183962|NCT02840370|language production|language production
5183963|NCT02840370|prefrontal cortex|prefrontal cortex
5183964|NCT02840357|Chronic inflammation|chronic inflammation
5183965|NCT02840357|Adults|adults
5183966|NCT02840357|overweight|overweight
5183967|NCT02840357|obese|obese
5183968|NCT02840344|Couple Functioning|couple functioning
5171900|NCT02918084|sequential administration chemiotherapy|sequential administration chemiotherapy
5171901|NCT02918084|early breast cancer|early breast cancer
5171902|NCT02918084|breast cancer|breast cancer
5171903|NCT02918084|aromatase inhibitor|aromatase inhibitor
5171904|NCT02918084|adjuvant|adjuvant
5171905|NCT02918084|post menopausal|post menopausal
5171906|NCT02918071|Asthma,|asthma,
5171907|NCT02918071|Bronchial Diseases,|bronchial diseases,
5171908|NCT02918071|Respiratory Tract Diseases,|respiratory tract diseases,
5171909|NCT02918071|Lung Diseases,|lung diseases,
5171910|NCT02918071|Obstructive Lung Diseases,|obstructive lung diseases,
5171911|NCT02918071|Benralizumab|benralizumab
5171912|NCT02918058|Frailty|frailty
5171913|NCT02918058|Deprescription|deprescription
5183969|NCT02840344|Stress Reduction|stress reduction
5183970|NCT02840331|Gastric carcinoma|gastric carcinoma
5183971|NCT02840331|Peritoneal carcinomatosis|peritoneal carcinomatosis
5183972|NCT02840331|Photodynamic diagnosis|photodynamic diagnosis
5183973|NCT02840331|Photodynamic therapy|photodynamic therapy
5183974|NCT02840331|St. John's Wort|st. john's wort
5183975|NCT02840331|Peritoneal metastasis|peritoneal metastasis
5183976|NCT02840318|Terminal care|terminal care
5183977|NCT02840318|Residential facilities|residential facilities
5183978|NCT02840318|Integrated health care systems|integrated health care systems
5183979|NCT02840318|Interdisciplinary health team|interdisciplinary health team
5183980|NCT02840318|Palliative care|palliative care
5183981|NCT02840305|Natural scenes|natural scenes
5183982|NCT02840305|Brain bases|brain bases
5183983|NCT02840305|Visual perception|visual perception
5183984|NCT02840305|MRI|mri
5183985|NCT02840292|Late Preterms|late preterms
5183986|NCT02840292|Neurobehavioral Assessment of Preterm Infants (NAPI)|neurobehavioral assessment of preterm infants (napi)
5183987|NCT02840279|cognition|cognition
5183988|NCT02840279|dementia|dementia
5183989|NCT02840279|phosphodiesterase type 4D|phosphodiesterase type 4d
5183990|NCT02840279|PDE4D|pde4d
5183991|NCT02840227|Cancer|cancer
5183992|NCT02840227|General anesthesia|general anesthesia
5183993|NCT02840227|Epidural anesthesia|epidural anesthesia
5183994|NCT02840201|biomarkers|biomarkers
5183995|NCT02840188|goalkeeper's fracture|goalkeeper's fracture
5183996|NCT02840175|Treatment tapering|treatment tapering
5183997|NCT02840175|Oligoarticular|oligoarticular
5183998|NCT02840175|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5183999|NCT02840175|Inactive disease|inactive disease
5184000|NCT02840175|Biologic therapy|biologic therapy
5184001|NCT02840162|prostate cancer|prostate cancer
5184002|NCT02840162|NSAIDs|nsaids
5184003|NCT02840162|chemoprevention|chemoprevention
5184004|NCT02840162|celecoxib|celecoxib
5184005|NCT02840162|COX-2 inhibitors|cox-2 inhibitors
5184006|NCT02840149|68Ga-DOTA-TATE, PET/CT|68ga-dota-tate, pet/ct
5184007|NCT02840136|Respiratory infection|respiratory infection
5184008|NCT02840136|Antibiotic therapy|antibiotic therapy
5184009|NCT02840136|LC-MS/MS|lc-ms/ms
5184010|NCT02840136|Sputum antibiotic concentrations|sputum antibiotic concentrations
5184011|NCT02840097|Brain injuries|brain injuries
5184012|NCT02840097|Wounds and injuries|wounds and injuries
5184013|NCT02840097|Hemorrhage|hemorrhage
5184014|NCT02840097|Tranexamic acid|tranexamic acid
5184015|NCT02840097|Child|child
5184017|NCT02840045|electroencephalography (EEG)|electroencephalography (eeg)
5184018|NCT02840019|Fetal MRI|fetal mri
5184019|NCT02840019|Pregnancy|pregnancy
5184020|NCT02840019|Pregnant Women|pregnant women
5184021|NCT02840019|MRI Coil|mri coil
5184022|NCT02840019|MRI Sequence Development/Testing|mri sequence development/testing
5184023|NCT02840019|Abnormal Fetuses|abnormal fetuses
5184024|NCT02840019|Typically Developing Fetuses|typically developing fetuses
5184025|NCT02840019|Fetal MRI Technology Development|fetal mri technology development
5184026|NCT02840006|Vasoconstrictor Agents|vasoconstrictor agents
5184045|NCT02839824|bowel preparation|bowel preparation
5184046|NCT02839811|Betalactams|betalactams
5184047|NCT02839811|In vitro diagnosis|in vitro diagnosis
5184048|NCT02839798|sTMS|stms
5184049|NCT02839798|NEST|nest
5184050|NCT02839798|NeoSync|neosync
5184051|NCT02839798|synchronous|synchronous
5184052|NCT02839798|non-invasive neuromodulation|non-invasive neuromodulation
5673529|NCT00607906|pharmacokinetics|pharmacokinetics
5184054|NCT02839798|transcranial magnetic stimulation|transcranial magnetic stimulation
5184055|NCT02839798|EEG|eeg
5184056|NCT02839798|bipolar|bipolar
5184057|NCT02839798|depression|depression
5184058|NCT02839785|Cerebral palsy|cerebral palsy
5184059|NCT02839785|Physiotherapy|physiotherapy
5184060|NCT02839785|Children|children
5184061|NCT02839785|Ibuprofen|ibuprofen
5184062|NCT02839785|Pain|pain
5184063|NCT02839785|Anxiety|anxiety
5184064|NCT02839772|podoconiosis|podoconiosis
5184065|NCT02839772|glycerine|glycerine
5184066|NCT02839772|RCT|rct
5184067|NCT02839772|SBF|sbf
5184068|NCT02839772|TEWL|tewl
5184069|NCT02839772|SC hydration|sc hydration
5184070|NCT02839759|Hearing loss|hearing loss
5184071|NCT02839759|Presbycusis|presbycusis
5184072|NCT02839759|Aging|aging
5184073|NCT02839759|Teleaudiology|teleaudiology
5184074|NCT02839733|Brain Imaging|brain imaging
5184075|NCT02839733|Adult|adult
5184076|NCT02839733|DNA Testing|dna testing
5184077|NCT02839733|Children|children
5184078|NCT02839694|Lung Resection|lung resection
5184079|NCT02839694|Surgery|surgery
5184080|NCT02839694|Bilateral Lung Metastases|bilateral lung metastases
5184081|NCT02839681|Lung Adenocarcinoma|lung adenocarcinoma
5184082|NCT02839681|Immunotoxin|immunotoxin
5184083|NCT02839681|Immunotherapy|immunotherapy
5184084|NCT02839668|breast cancer|breast cancer
5184085|NCT02839668|angiogenesis|angiogenesis
5184086|NCT02839668|VEGF|vegf
5184087|NCT02839603|Visceral leishmaniasis|visceral leishmaniasis
5184088|NCT02839603|HIV co-infection|hiv co-infection
5184089|NCT02839603|Asymptomatic|asymptomatic
5184090|NCT02839590|Glaucoma|glaucoma
5184091|NCT02839590|Ocular hypertension|ocular hypertension
5184092|NCT02839590|Aqueous dynamics|aqueous dynamics
5184093|NCT02839564|chronic abdominal pain|chronic abdominal pain
5184094|NCT02839564|laparoscopic adhesiolysis|laparoscopic adhesiolysis
5184095|NCT02839564|placebo|placebo
5184096|NCT02839551|Betalactams|betalactams
5184097|NCT02839551|Drug hypersensitivity|drug hypersensitivity
5184098|NCT02839551|Drug provocation test|drug provocation test
5184099|NCT02839551|Reactive dose|reactive dose
5184100|NCT02839538|infiltration|infiltration
5184101|NCT02839538|hemorrhoidectomy|hemorrhoidectomy
5184102|NCT02839538|postoperative pain|postoperative pain
5184103|NCT02839525|Eccentric exercise|eccentric exercise
5184104|NCT02839525|Dietary supplement|dietary supplement
5184105|NCT02839525|Muscle damage|muscle damage
5184106|NCT02839499|seniors|seniors
5184107|NCT02839499|mixed food|mixed food
5184114|NCT02839447|oxidative stress|oxidative stress
5184115|NCT02839447|reactive oxygen species|reactive oxygen species
5184116|NCT02839447|idiopathic male infertility|idiopathic male infertility
5184117|NCT02839408|periodontitis|periodontitis
5184118|NCT02839408|azithromycin|azithromycin
5184120|NCT02839395|screen illumination|screen illumination
5184121|NCT02839395|melatonin|melatonin
5184122|NCT02839395|body temperature|body temperature
5184123|NCT02839395|cognitive functioning|cognitive functioning
5184124|NCT02839395|light pollution|light pollution
5184125|NCT02839369|walking performance|walking performance
5184126|NCT02839369|Cerebral Palsy, Typically Developed|cerebral palsy, typically developed
5184127|NCT02839330|Influenza|influenza
5184128|NCT02839330|Vaccine|vaccine
5184129|NCT02839330|Flu|flu
5184130|NCT02839330|Avian|avian
5248063|NCT02457221|Prograf|prograf
5172089|NCT02917018|Dexmedetomidine|dexmedetomidine
5172090|NCT02917018|Stress response|stress response
5172091|NCT02917018|Emergence agitation|emergence agitation
5184131|NCT02839330|Pandemic|pandemic
5184132|NCT02839330|H5N1|h5n1
5184133|NCT02839330|MF59|mf59
5184134|NCT02839317|Dysbiosis|dysbiosis
5184135|NCT02839317|Crohn's disease|crohn's disease
5184136|NCT02839317|Age|age
5184137|NCT02839278|Immunomodulation|immunomodulation
5184138|NCT02839226|ulcers|ulcers
5184139|NCT02839226|wounds|wounds
5184140|NCT02839226|diabetes|diabetes
5184141|NCT02839226|venous ulcers|venous ulcers
5184142|NCT02839226|arterial ulcers|arterial ulcers
5184143|NCT02839226|granulation tissue|granulation tissue
5184144|NCT02839226|protein kinase c|protein kinase c
5184145|NCT02839200|Insomnia|insomnia
5184146|NCT02839200|Polysomnography|polysomnography
5184147|NCT02839174|low carbohydrate diet|low carbohydrate diet
5184148|NCT02839161|Hookworm|hookworm
5184149|NCT02839161|Vaccine|vaccine
5184150|NCT02839161|Na-GST-1|na-gst-1
5184151|NCT02839161|Na-APR-1|na-apr-1
5184152|NCT02839161|Necator americanus|necator americanus
5184153|NCT02839148|Appetite, Stunting, Satiety, Children|appetite, stunting, satiety, children
5184155|NCT02839122|Tadalafil|tadalafil
5184156|NCT02839070|Sleep|sleep
5184157|NCT02839070|Learning|learning
5184158|NCT02839070|Circadian Rhythms|circadian rhythms
5184159|NCT02839057|Axis fractures|axis fractures
5184160|NCT02839057|Elderly|elderly
5184161|NCT02839057|Mortality|mortality
5184162|NCT02839057|Surgical treatment|surgical treatment
5184163|NCT02839031|diabetes mellitus|diabetes mellitus
5184164|NCT02839031|glycaemia|glycaemia
5184165|NCT02839031|cognitive-behavioral treatment|cognitive-behavioral treatment
5184166|NCT02839031|coping|coping
5184167|NCT02839031|parents|parents
5184168|NCT02839031|children|children
5184169|NCT02839005|Wound Closure Thechnical|wound closure thechnical
5184170|NCT02839005|Wound Healing|wound healing
5184171|NCT02838992|Cyclophosphamide|cyclophosphamide
5184172|NCT02838992|Umbilical Cord Blood|umbilical cord blood
5184173|NCT02838992|ATG|atg
5184174|NCT02838979|Glutamine|glutamine
5184175|NCT02838979|Chronic Kidney Disease|chronic kidney disease
5184176|NCT02838966|immunomodulation|immunomodulation
5184177|NCT02838966|immunonutrition|immunonutrition
5184178|NCT02838953|Ultrasonography|ultrasonography
5184179|NCT02838953|Respiratory Function Tests|respiratory function tests
5184180|NCT02838953|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5184181|NCT02838953|Rehabilitation|rehabilitation
5184182|NCT02838927|Hypoparathyroidism|hypoparathyroidism
5184183|NCT02838927|Epidemiology|epidemiology
5184184|NCT02838927|Medication Therapy Management|medication therapy management
5184185|NCT02838914|Right atrium|right atrium
5184186|NCT02838914|Echocardiography|echocardiography
5184187|NCT02838914|Remodeling|remodeling
5184188|NCT02838888|Adenoma|adenoma
5184189|NCT02838888|computer|computer
5184190|NCT02838888|automatic|automatic
5184191|NCT02838888|polyp|polyp
5184192|NCT02838888|detection|detection
5184193|NCT02838862|Neuroendocrine Tumors|neuroendocrine tumors
5184194|NCT02838862|MALDI-MS|maldi-ms
5184195|NCT02838862|Proteomics|proteomics
5184196|NCT02838862|Biomarkers, Tumor|biomarkers, tumor
5184197|NCT02838862|Precision Medicine|precision medicine
5184198|NCT02838836|Cancer|cancer
5184199|NCT02838836|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
5184200|NCT02838836|Disseminated tumor cells (DTCs)|disseminated tumor cells (dtcs)
5184201|NCT02838836|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
5184202|NCT02838823|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5184211|NCT02838797|5-HT4-receptor partial agonist|5-ht4-receptor partial agonist
5184212|NCT02838771|Swallowing Disorder|swallowing disorder
5184213|NCT02838771|Dysphagia|dysphagia
5184214|NCT02838758|Morton's neuroma|morton's neuroma
5184215|NCT02838758|Intermetatarsal neuroma|intermetatarsal neuroma
5184216|NCT02838758|forefoot pain|forefoot pain
5184217|NCT02838758|ultrasound guided cryoablation|ultrasound guided cryoablation
5184218|NCT02838758|ultrasound guided perineural lidocaine injection|ultrasound guided perineural lidocaine injection
5184219|NCT02838706|postoperative anemia|postoperative anemia
5184220|NCT02838706|perfusion index|perfusion index
5184221|NCT02838680|aortic stenosis|aortic stenosis
5073218|NCT03541317|Adaptive implementation|adaptive implementation
5184222|NCT02838680|transcatheter aortic valve replacement (TAVR)|transcatheter aortic valve replacement (tavr)
5184223|NCT02838654|cervical epidural space|cervical epidural space
5184224|NCT02838654|wave form analysis|wave form analysis
5184225|NCT02838615|spinal stenosis|spinal stenosis
5184226|NCT02838615|epidural steroid injection|epidural steroid injection
5184227|NCT02838602|carbon ions therapy|carbon ions therapy
5184228|NCT02838602|radiotherapy|radiotherapy
5184229|NCT02838602|radioresistant tumors|radioresistant tumors
5184231|NCT02838602|randomized trial|randomized trial
5184232|NCT02838589|Cerebrovascular Stroke|cerebrovascular stroke
5184233|NCT02838589|Ischemic Stroke|ischemic stroke
5184234|NCT02838589|Glucagon like peptide - 1|glucagon like peptide - 1
5184235|NCT02838563|Dementia|dementia
5184236|NCT02838563|Alzheimer|alzheimer
5184237|NCT02838563|Well-Being|well-being
5184238|NCT02838550|Physical Activity|physical activity
5184239|NCT02838550|Motivational Online Intervention|motivational online intervention
5184240|NCT02838550|Pedometers|pedometers
5184241|NCT02838537|Triptan|triptan
5184242|NCT02838537|Drug utilization|drug utilization
5058722|NCT03631992|Taste|taste
5184243|NCT02838537|Elderly|elderly
5184244|NCT02838537|Drug abuse|drug abuse
5184245|NCT02838537|Cardiovascular disease|cardiovascular disease
5184246|NCT02838524|Spontaneous Breathing Trial|spontaneous breathing trial
5184247|NCT02838524|Inspiratory Effort|inspiratory effort
5184248|NCT02838524|Mechanical Ventilation|mechanical ventilation
5184249|NCT02838524|Respiratory muscle load-capacity balance|respiratory muscle load-capacity balance
5184250|NCT02838498|ERCP|ercp
5184251|NCT02838498|EMS|ems
5184252|NCT02838498|Cannulation|cannulation
5184253|NCT02838498|Successful rate|successful rate
5184254|NCT02838498|Trainee|trainee
5184255|NCT02838407|Chronic lower respiratory tract infection|chronic lower respiratory tract infection
5184256|NCT02838407|Bonchoalveolar lavage|bonchoalveolar lavage
5184257|NCT02838407|Nasopharyngeal swabs|nasopharyngeal swabs
5184258|NCT02838290|Burnout|burnout
5184259|NCT02838290|Psychiatric morbidity|psychiatric morbidity
5184260|NCT02838290|Anxiety|anxiety
5184261|NCT02838290|Grief|grief
5184262|NCT02838290|Alcohol and drug use|alcohol and drug use
5184263|NCT02838277|lymphatic vessels|lymphatic vessels
5184264|NCT02838277|leaky vessels|leaky vessels
5184265|NCT02838277|hypertrophic adipocyte|hypertrophic adipocyte
5184266|NCT02838212|adverse drug reaction|adverse drug reaction
5184267|NCT02838212|hospital mortality|hospital mortality
5184268|NCT02838212|incidence|incidence
5184269|NCT02838199|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5184270|NCT02838199|TAVR|tavr
5184271|NCT02838199|TAVI|tavi
5184272|NCT02838199|SAVR|savr
5184273|NCT02838186|colonoscopy|colonoscopy
5184274|NCT02838186|right colon retroflexion|right colon retroflexion
5184275|NCT02838186|adenoma detection rate|adenoma detection rate
5184276|NCT02838186|feasibility|feasibility
5184277|NCT02838186|surveillance interval|surveillance interval
5184278|NCT02838160|educational strategies|educational strategies
5184279|NCT02838160|KAP|kap
5184280|NCT02838160|psychological and clinical outcomes|psychological and clinical outcomes
5184281|NCT02838160|intensive care unit|intensive care unit
5184282|NCT02838160|follow-up study|follow-up study
5184283|NCT02838160|RCT|rct
5184284|NCT02838134|Laparoscopic donor nephrectomy|laparoscopic donor nephrectomy
5184285|NCT02838134|Early quality of recovery|early quality of recovery
5184286|NCT02838121|bisphosphonate|bisphosphonate
5184287|NCT02838121|Total hip replacement|total hip replacement
5184288|NCT02838121|functional outcomes|functional outcomes
5184289|NCT02838121|bone mineral density|bone mineral density
5184290|NCT02838095|nap|nap
5184291|NCT02838095|sleep restriction|sleep restriction
5184292|NCT02838095|recovery sleep|recovery sleep
5179843|NCT02865707|inulin|inulin
5184293|NCT02838095|cognitive performance|cognitive performance
5184294|NCT02838095|subjective sleepiness|subjective sleepiness
5184295|NCT02838095|mood|mood
5184296|NCT02838095|neurobehavioural functions|neurobehavioural functions
5184297|NCT02838082|traumatic brain injury|traumatic brain injury
5184298|NCT02838082|sleep-wake cycle disturbance|sleep-wake cycle disturbance
5184299|NCT02838082|circadian disruption|circadian disruption
5184300|NCT02838056|anesthesia, epidural|anesthesia, epidural
5184301|NCT02838056|skin temperature|skin temperature
5184302|NCT02838030|Preeclampsia|preeclampsia
5184303|NCT02838030|L-arginine|l-arginine
5184304|NCT02838004|Refractive lens exchange (RLE) or cataract surgery|refractive lens exchange (rle) or cataract surgery
5184305|NCT02837991|Kidney Cancer|kidney cancer
5184306|NCT02837991|Celldex|celldex
5184307|NCT02837991|Dose Escalation|dose escalation
5184308|NCT02837991|Ovarian Cancer|ovarian cancer
5184309|NCT02837991|Ovarian Carcinoma|ovarian carcinoma
5184310|NCT02837991|Kidney Diseases|kidney diseases
5184311|NCT02837978|Arthritis, Rheumatoid|arthritis, rheumatoid
5184312|NCT02837978|Tacrolimus|tacrolimus
5184313|NCT02837978|Treatment outcome|treatment outcome
5184314|NCT02837978|Safety|safety
5184315|NCT02837952|Ibuprofen, acetaminophen, pain, molar extraction|ibuprofen, acetaminophen, pain, molar extraction
5184316|NCT02837913|Perioperative Warming|perioperative warming
5184317|NCT02837887|Cancer|cancer
5184318|NCT02837887|Depression|depression
5184319|NCT02837874|Gastric cancer|gastric cancer
5184320|NCT02837874|gastrojejunostomy|gastrojejunostomy
5184321|NCT02837874|isoperistaltic|isoperistaltic
5184322|NCT02837874|antiperistaltic|antiperistaltic
5184323|NCT02837861|Metabolic Support|metabolic support
5184324|NCT02837861|Nutritional Support|nutritional support
5184325|NCT02837861|Neuro-endocrine Event|neuro-endocrine event
5184326|NCT02837861|Enteral feedings|enteral feedings
5184327|NCT02837861|Parenteral feeding|parenteral feeding
5184328|NCT02837848|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
5184329|NCT02837848|Exercises|exercises
5184330|NCT02837848|Coactivation|coactivation
5184331|NCT02837848|Strengthening|strengthening
5184332|NCT02837822|Spinal Cord Stimulation|spinal cord stimulation
5184333|NCT02837822|Quantitative Sensory Testing|quantitative sensory testing
5184334|NCT02837809|low-dose computed tomography|low-dose computed tomography
5184335|NCT02837809|lung|lung
5184336|NCT02837809|randomized controlled trial|randomized controlled trial
5962297|NCT04281615|Physical Activity|physical activity
5184337|NCT02837809|neoplasms|neoplasms
5184338|NCT02837809|screening|screening
5184339|NCT02837809|smoking|smoking
5184340|NCT02837770|pain|pain
5184341|NCT02837770|intravitreal injection|intravitreal injection
5184342|NCT02837770|anti-VEGF|anti-vegf
5184343|NCT02837770|diclofenac eye drops|diclofenac eye drops
5184344|NCT02837770|oral diclofenac|oral diclofenac
5184345|NCT02837770|Short Form of McGill Pain Questionnaire|short form of mcgill pain questionnaire
5184346|NCT02837653|cardiovascular Risk|cardiovascular risk
5184347|NCT02837640|Retinitis Pigmentosa|retinitis pigmentosa
5184348|NCT02837640|Levodopa|levodopa
5184349|NCT02837627|gastroesophageal reflux|gastroesophageal reflux
5184350|NCT02837627|tube enteral feeding|tube enteral feeding
5184351|NCT02837627|preterm infants|preterm infants
5184352|NCT02837601|Laparoscopic surgical procedures|laparoscopic surgical procedures
5184353|NCT02837601|Shoulder Pain|shoulder pain
5184354|NCT02837601|Abdominal Pain|abdominal pain
5184359|NCT02837575|HSV-2|hsv-2
5184360|NCT02837575|Genital Herpes|genital herpes
5184361|NCT02837575|Herpes|herpes
5184362|NCT02837575|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
5184363|NCT02837562|Radiation exposure|radiation exposure
5184364|NCT02837562|Cardiac catheterization|cardiac catheterization
5184365|NCT02837523|Cystinosis Disease|cystinosis disease
5184366|NCT02837523|Biomarker|biomarker
5184367|NCT02837497|pediatric|pediatric
5184368|NCT02837497|heart arrest|heart arrest
5184369|NCT02837471|Pedometer usability|pedometer usability
5184370|NCT02837471|Usability and feasibility|usability and feasibility
5184371|NCT02837471|web application|web application
5184375|NCT02837432|Depression|depression
5184376|NCT02837432|Cortisol|cortisol
5184377|NCT02837432|Sadness|sadness
5184378|NCT02837432|Genetics|genetics
5184379|NCT02837432|Stress|stress
5184380|NCT02837419|extracorporeal life support|extracorporeal life support
5184381|NCT02837419|health related quality of life|health related quality of life
5184382|NCT02837380|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5184383|NCT02837380|Long-acting beta2 agonist|long-acting beta2 agonist
5184384|NCT02837380|Dry powder inhaler|dry powder inhaler
5184385|NCT02837380|Inhaled corticosteroid|inhaled corticosteroid
5184386|NCT02837367|nutrigenetics|nutrigenetics
5184387|NCT02837367|medical foods|medical foods
5184388|NCT02837367|obesity|obesity
5184389|NCT02837367|children|children
5184390|NCT02837367|adults|adults
5184391|NCT02837354|Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy|cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
5184392|NCT02837341|medical device|medical device
5184393|NCT02837328|Magnesium Supplementation|magnesium supplementation
5184394|NCT02837328|Magnesium|magnesium
5184395|NCT02837328|Dietary Supplement|dietary supplement
5184397|NCT02837302|Liver cirrhosis|liver cirrhosis
5184398|NCT02837302|Branched chain amino acid|branched chain amino acid
5184399|NCT02837302|End-Stage Liver Disease score|end-stage liver disease score
5184400|NCT02837289|patellofemoral pain syndrome|patellofemoral pain syndrome
5184401|NCT02837289|therapy taping|therapy taping
5184402|NCT02837289|knee|knee
5184403|NCT02837289|physical therapy|physical therapy
5184404|NCT02837289|runners|runners
5184405|NCT02837276|Intermittent Hypoxemia|intermittent hypoxemia
5184406|NCT02837276|Acute Kidney Injury|acute kidney injury
5184407|NCT02837276|Preterm infant|preterm infant
5184408|NCT02837250|HIV|hiv
5184409|NCT02837250|Substance Use|substance use
5073418|NCT03539965|PD-L1|pd-l1
5184410|NCT02837224|retained surgical sponge|retained surgical sponge
5184411|NCT02837224|adverse event|adverse event
5184412|NCT02837185|Cervical dystonia|cervical dystonia
5184413|NCT02837185|Transcranial magnetic stimulation|transcranial magnetic stimulation
5184414|NCT02837185|Electromyography|electromyography
5184415|NCT02837185|TMS|tms
5184416|NCT02837185|EMG|emg
5184417|NCT02837159|colorectal cancer|colorectal cancer
5184418|NCT02837159|Health Life Style Habits|health life style habits
5184419|NCT02837159|Health|health
5184420|NCT02837146|RA|ra
5184421|NCT02837120|retrospective study|retrospective study
5184422|NCT02837120|acute myocardial infarction|acute myocardial infarction
5184423|NCT02837120|acute aortic dissection|acute aortic dissection
5184424|NCT02837120|pulmonary embolism|pulmonary embolism
5184425|NCT02837120|unstable angina|unstable angina
5184426|NCT02837068|Hemiplegia|hemiplegia
5184427|NCT02837068|shoulder pain|shoulder pain
5184428|NCT02837068|wheelchair|wheelchair
5184429|NCT02837068|stroke|stroke
5184430|NCT02837068|rehabilitation|rehabilitation
5184431|NCT02837055|intubation, intratracheal|intubation, intratracheal
5184432|NCT02837055|critical care|critical care
5184433|NCT02837042|penile cancer|penile cancer
5184434|NCT02837042|Pembrolizumab|pembrolizumab
5184435|NCT02837042|penile squamous cell carcinoma|penile squamous cell carcinoma
5184436|NCT02837042|squamous cell cancer|squamous cell cancer
5184437|NCT02837016|Self-Control|self-control
5184438|NCT02837016|Biofeedback|biofeedback
5184439|NCT02837016|Respiration|respiration
5184440|NCT02837003|Drug-Eluting Stent|drug-eluting stent
5184441|NCT02836977|tegafur-uracil|tegafur-uracil
5184442|NCT02836925|hepatitis C|hepatitis c
5184443|NCT02836925|NHL|nhl
5184444|NCT02836925|Indolent B-cell lymphoma|indolent b-cell lymphoma
5184445|NCT02836912|Rehabilitation|rehabilitation
5184446|NCT02836899|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery|acute kidney injury; nitric oxide; cardiopulmonary bypass; endothelial dysfunction; cardiac surgery
5184447|NCT02836834|immunotherapy|immunotherapy
5184448|NCT02836834|check point inhibitor|check point inhibitor
5184449|NCT02836834|PD-1 antibody|pd-1 antibody
5184450|NCT02836834|solid tumor|solid tumor
5184451|NCT02836834|lymphoma|lymphoma
5184461|NCT02836782|HIV-DNA|hiv-dna
5184462|NCT02836782|Direct acting antiviral|direct acting antiviral
5184463|NCT02836769|Rehabilitation|rehabilitation
5184464|NCT02836769|Head and neck cancer|head and neck cancer
5184465|NCT02836769|Quality of life|quality of life
5184466|NCT02836769|self-efficacy|self-efficacy
5184467|NCT02836743|REM sleep behavior disorder|rem sleep behavior disorder
5184468|NCT02836743|Melatonin|melatonin
5184469|NCT02836717|sacral nerve modulation|sacral nerve modulation
5184470|NCT02836717|quality of life|quality of life
5184471|NCT02836717|stimulator maintenance|stimulator maintenance
5184472|NCT02836717|SNM|snm
5184477|NCT02836665|Emergency Room|emergency room
5184478|NCT02836665|Manchester Triage System|manchester triage system
5184479|NCT02836665|Telemedicine|telemedicine
5184480|NCT02836665|Patients|patients
5184481|NCT02836652|HeartMate II (HMII)|heartmate ii (hmii)
5184482|NCT02836652|Left Ventricular Assist Device (LVAD)|left ventricular assist device (lvad)
5184483|NCT02836600|notch inhibitor|notch inhibitor
5184484|NCT02836548|advanced melanoma|advanced melanoma
5184485|NCT02836548|BRAF V600 mutation|braf v600 mutation
5184486|NCT02836548|vorinostat|vorinostat
5184487|NCT02836548|HDAC inhibitor|hdac inhibitor
5184488|NCT02836535|complications|complications
5184489|NCT02836535|surgery|surgery
5184490|NCT02836522|Health-Related Symptom Index|health-related symptom index
5184491|NCT02836522|ANCHOR( ANal Cancer HSIL (high grade squamous intraepithelial lesions) Outcomes Research study)|anchor( anal cancer hsil (high grade squamous intraepithelial lesions) outcomes research study)
5184492|NCT02836509|Low Back Pain|low back pain
5184493|NCT02836509|Ibuprofen|ibuprofen
5184494|NCT02836509|Paracetamol|paracetamol
5184495|NCT02836509|Emergency Medicine|emergency medicine
5184501|NCT02836470|Post-operative Ileus|post-operative ileus
5184502|NCT02836470|Post-Operative Abdominal Adhesions|post-operative abdominal adhesions
5184503|NCT02836470|Return of Gastrointestinal Function|return of gastrointestinal function
5184504|NCT02836470|Anastomosis|anastomosis
5184505|NCT02836470|Enterotomy|enterotomy
5184506|NCT02836470|Enterostomy|enterostomy
5184507|NCT02836470|Colorectal Surgery|colorectal surgery
5184508|NCT02836470|Intestines Surgery|intestines surgery
5184509|NCT02836431|Pediatric|pediatric
5184510|NCT02836431|Sedation|sedation
5184511|NCT02836431|Dexmedetomidine|dexmedetomidine
5184512|NCT02836418|FSHD|fshd
5184513|NCT02836418|LGMD|lgmd
5184514|NCT02836405|Autism|autism
5184516|NCT02836405|Autistic Disorder|autistic disorder
5184517|NCT02836405|Pervasive Development Disorders|pervasive development disorders
5184518|NCT02836405|Pervasive Child Development Disorders|pervasive child development disorders
5184519|NCT02836405|Asperger's Syndrome|asperger's syndrome
5184520|NCT02836405|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5184521|NCT02836405|TMS|tms
5184522|NCT02836405|Autism Spectrum Disorder|autism spectrum disorder
5184523|NCT02836379|Breakthrough Cancer Pain|breakthrough cancer pain
5184524|NCT02836379|Quality of life|quality of life
5184525|NCT02836379|Radiotherapy|radiotherapy
5184526|NCT02836366|Proximal humerus|proximal humerus
5184527|NCT02836366|Fracture|fracture
5184528|NCT02836366|Nailing|nailing
5184529|NCT02836340|neuroprotection|neuroprotection
5184530|NCT02836327|MRI|mri
5184531|NCT02836327|Multiple Sclerosis|multiple sclerosis
5184532|NCT02836327|Neuromyelitis Optica Spectrum Disorders|neuromyelitis optica spectrum disorders
5184533|NCT02836327|Multimodel|multimodel
5184534|NCT02836314|Anorganic bovine bone mineral;|anorganic bovine bone mineral;
5184535|NCT02836314|Graft|graft
5184536|NCT02836314|Intrabony periodontal defect|intrabony periodontal defect
5184537|NCT02836314|platelet rich fibrin|platelet rich fibrin
5184538|NCT02836288|Ketamine|ketamine
5184539|NCT02836288|Treatment of Depression|treatment of depression
5184540|NCT02836275|Adnexal Diseases|adnexal diseases
5184541|NCT02836275|Ovary|ovary
5184542|NCT02836275|Ovarian Neoplasms|ovarian neoplasms
5184543|NCT02836275|Ovarian Cysts|ovarian cysts
5184544|NCT02836275|Ovarian Diseases|ovarian diseases
5184545|NCT02836275|Ultrasonography|ultrasonography
5184546|NCT02836275|Ultrasonography, Doppler|ultrasonography, doppler
5184547|NCT02836275|Magnetic Resonance Imaging|magnetic resonance imaging
5184745|NCT02835131|congenital|congenital
5184551|NCT02836275|Early Detection of Cancer|early detection of cancer
5184552|NCT02836275|Genital Neoplasms, Female|genital neoplasms, female
5184553|NCT02836275|Genital Diseases, Female|genital diseases, female
5184554|NCT02836275|Urogenital Neoplasms|urogenital neoplasms
5184555|NCT02836275|Cysts|cysts
5184556|NCT02836275|Endocrine System Diseases|endocrine system diseases
5184557|NCT02836275|Gonadal Disorders|gonadal disorders
5184558|NCT02836275|Neoplasms|neoplasms
5051644|NCT03675282|MRI|mri
5184559|NCT02836275|Endocrine Gland Neoplasms|endocrine gland neoplasms
5184560|NCT02836275|International Ovarian Tumor Analysis|international ovarian tumor analysis
5184561|NCT02836275|Simple Rules|simple rules
5184562|NCT02836275|Preoperative Evaluation|preoperative evaluation
5184563|NCT02836275|Perfusion -and Diffusion-weighted Imaging|perfusion -and diffusion-weighted imaging
5184564|NCT02836275|Adnexal Masses|adnexal masses
5184565|NCT02836275|Ovarian Tumors|ovarian tumors
5184569|NCT02836236|Hepatitis|hepatitis
5184570|NCT02836236|Tenofovir|tenofovir
5184571|NCT02836236|Viread|viread
5184572|NCT02836210|27-gauge Pars plana vitrectomy|27-gauge pars plana vitrectomy
5184573|NCT02836197|Uncertainty;hope;cancer;communication skills training;physicians|uncertainty;hope;cancer;communication skills training;physicians
5184574|NCT02836184|Hemodialysis,Hyperphosphatemia,Nicotinic Acids|hemodialysis,hyperphosphatemia,nicotinic acids
5184575|NCT02836119|Gut Microbiota|gut microbiota
5184576|NCT02836119|Gut Microbiome|gut microbiome
5184577|NCT02836119|Sleep|sleep
5184578|NCT02836119|Infancy|infancy
5184579|NCT02836119|Development|development
5184580|NCT02836106|Healthy Volunteers|healthy volunteers
5184581|NCT02836106|Obese Volunteers|obese volunteers
5184582|NCT02836093|Exercise|exercise
5184583|NCT02836093|Radiation Treatment|radiation treatment
5184584|NCT02836093|16-941|16-941
5184585|NCT02836080|Mental Health|mental health
5184586|NCT02836080|Randomized|randomized
5184587|NCT02836080|Pragmatic|pragmatic
5184588|NCT02836080|Integrated Collaborative Care|integrated collaborative care
5184589|NCT02836080|Addiction|addiction
5184590|NCT02836080|Youth|youth
5184591|NCT02836054|biomarkers|biomarkers
5184592|NCT02836054|CSF|csf
5184593|NCT02836054|MRI|mri
5184594|NCT02836054|Alzheimer's disease|alzheimer's disease
5184595|NCT02836054|bipolar disorder|bipolar disorder
5184596|NCT02836054|cognitive functions|cognitive functions
5184597|NCT02836041|assess sleep|assess sleep
5184598|NCT02836041|Sleep Deprivation|sleep deprivation
5184599|NCT02836041|16-866|16-866
5184600|NCT02836015|Shared Medical Visits|shared medical visits
5184601|NCT02836015|Spanish-speaking|spanish-speaking
5184602|NCT02835989|Community Paramedicine|community paramedicine
5184603|NCT02835989|Paramedic|paramedic
5184604|NCT02835989|Emergency Medical Services|emergency medical services
5184605|NCT02835989|High Frequency Callers|high frequency callers
5184606|NCT02835989|Lift Assists|lift assists
5184607|NCT02835963|acute heart failure|acute heart failure
5184608|NCT02835963|dyspnea|dyspnea
5184609|NCT02835963|predictive value|predictive value
5184610|NCT02835924|regorafenib|regorafenib
5184611|NCT02835924|metastatic colorectal cancer|metastatic colorectal cancer
5184612|NCT02835872|fiber|fiber
5184613|NCT02835872|cholesterol|cholesterol
5184614|NCT02835859|Obesity, sweet taste receptors|obesity, sweet taste receptors
5184615|NCT02835846|Overactive Bladder Syndrome|overactive bladder syndrome
5184616|NCT02835846|Female Urinary Microbiome|female urinary microbiome
5184617|NCT02835846|Urinary Urgency|urinary urgency
5184618|NCT02835846|Estrogen|estrogen
5184619|NCT02835846|Nocturia|nocturia
5184620|NCT02835846|Incontinence|incontinence
5184621|NCT02835833|advanced solid tumors|advanced solid tumors
5184622|NCT02835833|Nintedanib|nintedanib
5184623|NCT02835833|Bevacizumab|bevacizumab
5184624|NCT02835833|dose escalation|dose escalation
5184625|NCT02835820|HIV|hiv
5184626|NCT02835820|Neurocognitive|neurocognitive
5184627|NCT02835820|Ketogenic Diet|ketogenic diet
5184628|NCT02835807|skin cancer|skin cancer
5184629|NCT02835794|Myelodysplastic Syndromes|myelodysplastic syndromes
5184630|NCT02835781|Breast Implants|breast implants
5184631|NCT02835781|Acellular Dermal Matrix|acellular dermal matrix
5184632|NCT02835729|AML|aml
5184633|NCT02835716|Phosphodiesterase type 4 inhibitor|phosphodiesterase type 4 inhibitor
5184634|NCT02835716|ustekinumab|ustekinumab
5184635|NCT02835716|secukinumab|secukinumab
5184636|NCT02835716|P40 subunit|p40 subunit
5184637|NCT02835716|Interleukin IL-12|interleukin il-12
5184638|NCT02835716|Interleukin IL-23|interleukin il-23
5184639|NCT02835716|Apoprotein e4|apoprotein e4
5184640|NCT02835716|Interleukin IL-17A|interleukin il-17a
5184641|NCT02835703|Congenital heart disease|congenital heart disease
5184642|NCT02835703|Coarctation of aorta|coarctation of aorta
5184643|NCT02835703|Aortic arch hypoplasia|aortic arch hypoplasia
5184644|NCT02835703|Cerebral selective antegrade perfusion|cerebral selective antegrade perfusion
5789126|NCT00149773|Older men|older men
5184645|NCT02835703|Double arterial cannulation|double arterial cannulation
5184746|NCT02835079|Duchenne Tamoxifen|duchenne tamoxifen
5184646|NCT02835690|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5184647|NCT02835690|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5184648|NCT02835690|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5184649|NCT02835677|Caregivers|caregivers
5184650|NCT02835677|Activities of Daily Living|activities of daily living
5184651|NCT02835664|Nicotinamide Riboside|nicotinamide riboside
5184653|NCT02835664|Metabolic health|metabolic health
5184654|NCT02835664|Insulin resistance|insulin resistance
5962298|NCT04281615|Sedentary Behaviour|sedentary behaviour
5962299|NCT04281615|Sleep|sleep
5184655|NCT02835664|Mitochondrial function|mitochondrial function
5184656|NCT02835664|Brown adipose tissue|brown adipose tissue
5184657|NCT02835664|Energy expenditure|energy expenditure
5184658|NCT02835664|Ectopic lipid accumulation|ectopic lipid accumulation
5184659|NCT02835664|Cardiovascular risk|cardiovascular risk
5184660|NCT02835664|Acetylcarnitine|acetylcarnitine
5184661|NCT02835651|Palmitic acid|palmitic acid
5184662|NCT02835651|Stearic acid|stearic acid
5184663|NCT02835651|HDL-metabolism|hdl-metabolism
5184664|NCT02835651|Human intervention study|human intervention study
5184665|NCT02835625|Diagnostic Imaging|diagnostic imaging
5184666|NCT02835625|Mammography|mammography
5184667|NCT02835625|Randomized Controlled Trial|randomized controlled trial
5184668|NCT02835625|Tomosynthesis|tomosynthesis
5184669|NCT02835625|Early performance measures|early performance measures
5184670|NCT02835625|Recall|recall
5184671|NCT02835625|Radiation dose|radiation dose
5184672|NCT02835625|Cancer detection|cancer detection
5184673|NCT02835625|Sensitivity|sensitivity
5184674|NCT02835625|Specificity|specificity
5184675|NCT02835625|Cost|cost
5184676|NCT02835625|Economy|economy
5184677|NCT02835586|paclitaxel|paclitaxel
5184678|NCT02835586|critical ischemia|critical ischemia
5184679|NCT02835586|restenosis|restenosis
5184680|NCT02835586|femoropopliteal artery lesions TASC C and D|femoropopliteal artery lesions tasc c and d
5184681|NCT02835547|cardiovascular event|cardiovascular event
5184682|NCT02835547|risk factors|risk factors
5184683|NCT02835547|inflammatory diseases and acquired dysimmune|inflammatory diseases and acquired dysimmune
5184684|NCT02835534|acute ST elevation myocardial infarction|acute st elevation myocardial infarction
5184685|NCT02835456|CAUTI|cauti
5184686|NCT02835456|Biofilm|biofilm
5184687|NCT02835456|Urinary tract infections|urinary tract infections
5184688|NCT02835456|micropattern|micropattern
5184689|NCT02835456|Catheter|catheter
5184690|NCT02835443|Ischemic Stroke|ischemic stroke
5184691|NCT02835443|Deep Brain Stimulation|deep brain stimulation
5184692|NCT02835443|DBS|dbs
5184693|NCT02835443|Physical Therapy|physical therapy
5184694|NCT02835443|Rehab|rehab
5184695|NCT02835443|Brain Stimulation|brain stimulation
5184696|NCT02835430|Coronally advanced flap|coronally advanced flap
5184697|NCT02835430|Gingival recession|gingival recession
5184698|NCT02835430|Bone, demineralized|bone, demineralized
5184699|NCT02835430|Bone, freeze-dried|bone, freeze-dried
5184700|NCT02835430|platelet-rich fibrin|platelet-rich fibrin
5184701|NCT02835430|root coverage procedures|root coverage procedures
5184702|NCT02835417|fetal heart rate variability|fetal heart rate variability
5184703|NCT02835417|entropy|entropy
5184704|NCT02835417|multifractal analysis|multifractal analysis
5184705|NCT02835417|scattering transform|scattering transform
5184706|NCT02835417|sparse vector machine|sparse vector machine
5184707|NCT02835417|acidosis|acidosis
5184708|NCT02835378|bilateral upper limb amputation|bilateral upper limb amputation
5184709|NCT02835378|prosthetic fitting|prosthetic fitting
5184711|NCT02835378|clinical practices|clinical practices
5184712|NCT02835378|totally non-functional hand|totally non-functional hand
5184713|NCT02835365|baclofen|baclofen
5184714|NCT02835365|alcohol|alcohol
5184715|NCT02835365|withdrawal|withdrawal
5184716|NCT02835352|anxiety|anxiety
5184717|NCT02835326|Older Adults|older adults
5184718|NCT02835326|Weight Loss|weight loss
5184719|NCT02835326|Exercise|exercise
5184720|NCT02835326|Knee pain|knee pain
5184721|NCT02835300|Asthma|asthma
5184722|NCT02835300|Adolescents|adolescents
5184723|NCT02835300|e-Health|e-health
5184724|NCT02835300|Intervention|intervention
5184725|NCT02835274|parkinson disease|parkinson disease
5184726|NCT02835274|deep brain stimulation|deep brain stimulation
5184727|NCT02835274|directional stimulation|directional stimulation
5184728|NCT02835261|Obesity|obesity
5184729|NCT02835261|Metabolic Disorders|metabolic disorders
5184730|NCT02835209|spontaneous breathing test|spontaneous breathing test
5184731|NCT02835209|premature infant|premature infant
5184732|NCT02835209|work of breathing|work of breathing
5184733|NCT02835170|Immunoglobulin G|immunoglobulin g
5184734|NCT02835170|Treatment|treatment
5184735|NCT02835157|Normal saline|normal saline
5184736|NCT02835157|Balanced saline|balanced saline
5184737|NCT02835157|Septic shock|septic shock
5172676|NCT02913651|parasympathetic activity|parasympathetic activity
5172677|NCT02913651|autonomic arousal response|autonomic arousal response
5172678|NCT02913625|Brachial plexus|brachial plexus
5172679|NCT02913625|Regional anesthesia|regional anesthesia
5172680|NCT02913625|Infraclavicular|infraclavicular
5172681|NCT02913625|Retroclavicular|retroclavicular
5172682|NCT02913625|Parasagittal|parasagittal
5172683|NCT02913625|Upper limb surgery|upper limb surgery
5172684|NCT02913625|Ultrasound guided block|ultrasound guided block
5172686|NCT02913612|Hemangioma|hemangioma
5172687|NCT02913612|Infantile Hemangioma|infantile hemangioma
5172688|NCT02913612|Pharmacokinetics|pharmacokinetics
5184738|NCT02835157|Children|children
5962300|NCT04281615|Knowledge Translation|knowledge translation
5184739|NCT02835157|Hyperchloremia|hyperchloremia
5184740|NCT02835157|Acute kidney injury|acute kidney injury
5264296|NCT02364063|child|child
5059334|NCT03628092|Dysuria|dysuria
5184741|NCT02835131|hyperinsulinemia|hyperinsulinemia
5184742|NCT02835131|hypoglycemia|hypoglycemia
5184743|NCT02835131|somatostatin|somatostatin
5184744|NCT02835131|pasireotide|pasireotide
5184747|NCT02835066|Stage I|stage i
5184748|NCT02835066|Stage II|stage ii
5184749|NCT02835066|Stage IIIA|stage iiia
5184750|NCT02835066|Stage IIIB|stage iiib
5184751|NCT02835066|Stage IV|stage iv
5184752|NCT02835066|Non-Small Cell|non-small cell
5184753|NCT02835040|Corticosteroid|corticosteroid
5184754|NCT02835040|Antibiotic|antibiotic
5184755|NCT02835040|Early mobilization|early mobilization
5184756|NCT02835040|Malnutrition|malnutrition
5184757|NCT02835027|Acute limb ischaemia(ALI)|acute limb ischaemia(ali)
5184758|NCT02835027|Acute ischaemia of the lower extremity|acute ischaemia of the lower extremity
5184759|NCT02835027|Thrombosis|thrombosis
5184760|NCT02835027|Emboli|emboli
5184761|NCT02835027|Endovascular surgery|endovascular surgery
5184762|NCT02835027|Surgery|surgery
5184763|NCT02835027|Amputation free survival|amputation free survival
5184764|NCT02835027|Long time survival|long time survival
5184765|NCT02835027|Demographics|demographics
5184766|NCT02835014|Diabetes Mellitus Type I|diabetes mellitus type i
5184767|NCT02835014|Adolescents|adolescents
5184768|NCT02835014|Mental Health|mental health
5184769|NCT02835014|Self efficacy|self efficacy
5184770|NCT02835014|parenting styles|parenting styles
5184771|NCT02834988|Endometrial Cancer|endometrial cancer
5184772|NCT02834988|Sentinel Lymph Node Dissection|sentinel lymph node dissection
5184773|NCT02834988|SLND|slnd
5184774|NCT02834975|Fallopian Tube Carcinoma|fallopian tube carcinoma
5184775|NCT02834975|Peritoneal Carcinoma|peritoneal carcinoma
5184776|NCT02834975|Epithelial Ovarian Cancer|epithelial ovarian cancer
5184777|NCT02834962|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5184778|NCT02834897|EOS imagery|eos imagery
5184779|NCT02834884|rare cancer|rare cancer
5184780|NCT02834884|biomarker|biomarker
5184781|NCT02834884|molecular screening|molecular screening
5184782|NCT02834884|cancer|cancer
5184783|NCT02834884|biobanking|biobanking
5184784|NCT02834858|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5184785|NCT02834819|bronchiolitis|bronchiolitis
5184786|NCT02834819|hypoxia|hypoxia
5184787|NCT02834819|hypertonic saline|hypertonic saline
5184788|NCT02834793|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
5184789|NCT02834793|Inadequately controlled seizures|inadequately controlled seizures
5184790|NCT02834780|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5184791|NCT02834780|H3B-6527|h3b-6527
5184792|NCT02834780|Fibroblast growth factor receptor 4 (FGFR4)|fibroblast growth factor receptor 4 (fgfr4)
5184793|NCT02834780|Fibroblast growth factor 19 (FGF19)|fibroblast growth factor 19 (fgf19)
5184794|NCT02834754|post-operative|post-operative
5184795|NCT02834715|Diabetes|diabetes
5184796|NCT02834715|Stevia|stevia
5184797|NCT02834715|insulin secretion|insulin secretion
5184798|NCT02834715|insulin sensitivity|insulin sensitivity
5184818|NCT02834624|inflammation|inflammation
5184819|NCT02834624|c-reactive protein|c-reactive protein
5184820|NCT02834624|lipid peroxidation|lipid peroxidation
5184821|NCT02834546|Hepatocellular Carcinoma|hepatocellular carcinoma
5184822|NCT02834546|Sorafenib|sorafenib
5184823|NCT02834546|Toxicity|toxicity
5184824|NCT02834546|Plasmatic concentration|plasmatic concentration
5184825|NCT02834533|Lokomat;|lokomat;
5184826|NCT02834533|robotic rehabilitation.|robotic rehabilitation.
5184827|NCT02834533|Multiple Sclerosis;|multiple sclerosis;
5184828|NCT02834533|Virtual reality|virtual reality
5184829|NCT02834494|locally advanced breast cancer|locally advanced breast cancer
5184830|NCT02834494|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5184831|NCT02834481|Pain Care|pain care
5184832|NCT02834481|Pediatric and Neonatal Intensive Care Units|pediatric and neonatal intensive care units
5184833|NCT02834468|Dexamethasone|dexamethasone
5184834|NCT02834468|Rituximab|rituximab
5184835|NCT02834468|Cyclosporin|cyclosporin
5184836|NCT02834468|Intravenous Immunoglobulin|intravenous immunoglobulin
5184837|NCT02834455|Thoracoscopy|thoracoscopy
5184838|NCT02834403|breast cancer|breast cancer
5184839|NCT02834403|nitric oxide synthase|nitric oxide synthase
5184840|NCT02834403|docetaxel|docetaxel
5184841|NCT02834403|L-NMMA|l-nmma
5184842|NCT02834390|AML|aml
5184843|NCT02834390|phase 1|phase 1
5184844|NCT02834390|hematology|hematology
5184845|NCT02834390|malignancy|malignancy
5184846|NCT02834390|newly diagnosed|newly diagnosed
5184847|NCT02834377|Cardiac Output|cardiac output
5184848|NCT02834377|Hemodynamics|hemodynamics
5184849|NCT02834377|Perioperative Care|perioperative care
5184850|NCT02834338|activity tracking|activity tracking
5184851|NCT02834338|postoperative recovery|postoperative recovery
5184853|NCT02834338|fast-track surgery|fast-track surgery
5184854|NCT02834325|high flow nasal cannula|high flow nasal cannula
5184855|NCT02834325|success|success
5184856|NCT02834325|failure|failure
5184857|NCT02834325|ROX index|rox index
5962301|NCT04281589|End-Tidal Carbon Dioxide|end-tidal carbon dioxide
5184858|NCT02834312|Estetrol|estetrol
5184859|NCT02834312|Vasomotor symptoms|vasomotor symptoms
5051931|NCT03673592|PGT-A|pgt-a
5184860|NCT02834312|Menopause|menopause
5184861|NCT02834260|absorbable implant|absorbable implant
5184862|NCT02834260|subconjunctival|subconjunctival
5184863|NCT02834260|immune rejection|immune rejection
5184864|NCT02834260|safety profile|safety profile
5184865|NCT02834260|dexamethasone|dexamethasone
5184866|NCT02834234|mesothelioma|mesothelioma
5184867|NCT02834234|peritoneum|peritoneum
5184868|NCT02834234|genomic|genomic
5184869|NCT02834234|CGH arrays|cgh arrays
5184870|NCT02834221|Femoral vein puncture|femoral vein puncture
5184871|NCT02834195|Cerebral palsy|cerebral palsy
5184872|NCT02834195|reliability|reliability
5184873|NCT02834195|upper limb and hand patterns|upper limb and hand patterns
5184874|NCT02834195|classification|classification
5184875|NCT02834169|Rare peritoneal surface malignancies|rare peritoneal surface malignancies
5184876|NCT02834169|pseudomyxoma peritonei|pseudomyxoma peritonei
5184877|NCT02834169|peritoneal mesothelioma|peritoneal mesothelioma
5184878|NCT02834169|desmoplastic small round cell tumor|desmoplastic small round cell tumor
5184880|NCT02834169|primary peritoneal serous carcinoma|primary peritoneal serous carcinoma
5184881|NCT02834169|diffuse peritoneal leiomyomatosis|diffuse peritoneal leiomyomatosis
5184882|NCT02834169|appendiceal mucinous neoplasms|appendiceal mucinous neoplasms
5184883|NCT02834169|registry|registry
5184884|NCT02834169|population-based database|population-based database
5184885|NCT02834143|vascular|vascular
5184886|NCT02834143|Limb Ischemia|limb ischemia
5184887|NCT02834117|Ovulation Induction|ovulation induction
5184888|NCT02834117|quality of life|quality of life
5184889|NCT02834117|Reproductive Physiological Processes|reproductive physiological processes
5184890|NCT02834117|fertility|fertility
5184892|NCT02834078|Pre Diabetes|pre diabetes
5184893|NCT02834078|Berberine|berberine
5184894|NCT02834065|Postoperative Cognitive Decline|postoperative cognitive decline
5184895|NCT02834065|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5184896|NCT02834065|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
5184897|NCT02834065|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5184898|NCT02834065|Small Ubiquitin-Related Modifier Proteins|small ubiquitin-related modifier proteins
5184899|NCT02834052|Immunotherapy|immunotherapy
5184900|NCT02834052|Anti-programmed death 1 (PD-1) inhibitor|anti-programmed death 1 (pd-1) inhibitor
5184901|NCT02834052|Immunostimulant|immunostimulant
5184902|NCT02834052|monoclonal antibody|monoclonal antibody
5184903|NCT02834052|TLR3 agonist|tlr3 agonist
5184904|NCT02834052|Immunologic factors|immunologic factors
5184905|NCT02834039|Tidal volume|tidal volume
5184906|NCT02834039|renal transplant|renal transplant
5184907|NCT02834039|donor|donor
5184908|NCT02834039|nephrectomy|nephrectomy
5184909|NCT02834039|ventilation|ventilation
5184910|NCT02834039|Living renal transplant donor patient|living renal transplant donor patient
5184911|NCT02834026|Muscle Strength|muscle strength
5184912|NCT02834026|Muscle Strength Dynamometer|muscle strength dynamometer
5184913|NCT02834026|Chronic Renal Disease|chronic renal disease
5184914|NCT02834026|Exercise|exercise
5184915|NCT02834026|Physical therapy modalities|physical therapy modalities
5184916|NCT02833987|Direct oral anticoagulants|direct oral anticoagulants
5184917|NCT02833987|Safety|safety
5184918|NCT02833987|Major bleed|major bleed
5184919|NCT02833987|Adverse events|adverse events
5184920|NCT02833974|GSK2245035|gsk2245035
5184921|NCT02833974|TLR7 agonist|tlr7 agonist
5184922|NCT02833974|allergic asthma|allergic asthma
5184923|NCT02833974|FEV1|fev1
5184924|NCT02833948|Heart Valve Disease|heart valve disease
5184925|NCT02833948|Randomized Controlled Trial|randomized controlled trial
5184926|NCT02833948|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5184927|NCT02833948|TAVR|tavr
5184928|NCT02833948|Valve Thrombosis|valve thrombosis
5184929|NCT02833935|spinal cord injury|spinal cord injury
5184930|NCT02833935|physical activity|physical activity
5184931|NCT02833935|self-determination theory|self-determination theory
5184932|NCT02833935|life satisfaction|life satisfaction
5184933|NCT02833883|Enzalutamide|enzalutamide
5184934|NCT02833883|CC-115|cc-115
5184935|NCT02833883|16-074|16-074
5184936|NCT02833857|Secondary Hyperparathyroidism, chronic kidney disease, hemodialysis|secondary hyperparathyroidism, chronic kidney disease, hemodialysis
5184937|NCT02833844|Hyperlipidemia|hyperlipidemia
5184938|NCT02833844|Dyslipidemia|dyslipidemia
5184939|NCT02833844|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5184940|NCT02833844|Inhibition|inhibition
5184941|NCT02833844|HIV infection|hiv infection
5184942|NCT02833844|Cluster of differentiation|cluster of differentiation
5184943|NCT02833844|Viral load|viral load
5184944|NCT02833805|immunosuppression|immunosuppression
5184945|NCT02833805|nonmyeloablative|nonmyeloablative
5184946|NCT02833805|non-myeloablative|non-myeloablative
5184947|NCT02833805|allogeneic|allogeneic
5184948|NCT02833805|tacrolimus|tacrolimus
5184949|NCT02833805|bone marrow|bone marrow
5184950|NCT02833805|bone marrow transplant|bone marrow transplant
5184951|NCT02833805|cyclophosphamide|cyclophosphamide
5184952|NCT02833805|thymoglobulin|thymoglobulin
5962302|NCT04281589|P(a-ET)CO2 gradient|p(a-et)co2 gradient
5962303|NCT04281589|ETCO2|etco2
5105592|NCT03337308|LDL|ldl
5184954|NCT02833805|fludarabine|fludarabine
5184955|NCT02833766|Breast Cancer|breast cancer
5184956|NCT02833766|advanced triple Negative, EGFR positive breast cancer|advanced triple negative, egfr positive breast cancer
5184957|NCT02833766|doxorubicin|doxorubicin
5184958|NCT02833766|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5184959|NCT02833740|Mid-Upper Arm Circumference (MUAC)|mid-upper arm circumference (muac)
5184960|NCT02833740|Mother MUAC|mother muac
5184961|NCT02833740|Community screening for acute malnutrition|community screening for acute malnutrition
5184962|NCT02833727|asthma; smoking; Eosinophils; health care costs|asthma; smoking; eosinophils; health care costs
5184963|NCT02833675|angioedema|angioedema
5184964|NCT02833675|C1Inhibitor|c1inhibitor
5184965|NCT02833675|bradykinin|bradykinin
5184966|NCT02833675|Histamin|histamin
5184967|NCT02833662|Hypoxia|hypoxia
5184968|NCT02833662|Perioperative outcomes|perioperative outcomes
5184969|NCT02833649|Keratoconus|keratoconus
5184970|NCT02833649|Crosslinking|crosslinking
5184971|NCT02833649|Toric ICL|toric icl
5184972|NCT02833623|Helicobacter Pylori eradication rate|helicobacter pylori eradication rate
5184973|NCT02833623|Efficacy of Short-message-based Re-education (SMRE)|efficacy of short-message-based re-education (smre)
5184974|NCT02833610|Multiple Myeloma|multiple myeloma
5184975|NCT02833597|peripheral artery disease|peripheral artery disease
5184976|NCT02833597|transcutaneous oxygen pressure|transcutaneous oxygen pressure
5184977|NCT02833597|claudication|claudication
5184978|NCT02833597|rowing ergometer|rowing ergometer
5184979|NCT02833584|Paracetamol|paracetamol
5184980|NCT02833558|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5184981|NCT02833558|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5184982|NCT02833558|Bleeding|bleeding
5184983|NCT02833519|pregnant women|pregnant women
5184984|NCT02833519|exercise|exercise
5184985|NCT02833519|depression|depression
5184986|NCT02833519|anxiety|anxiety
5184987|NCT02833493|Magnetic Resonance Imaging|magnetic resonance imaging
5184988|NCT02833493|Iron overload|iron overload
5184989|NCT02833493|Iron chelation therapy|iron chelation therapy
5184990|NCT02833493|Follow-up|follow-up
5184991|NCT02833467|Circulating Tumor DNA|circulating tumor dna
5184992|NCT02833467|Heterogeneous|heterogeneous
5184993|NCT02833467|Multiple primary lung cancer|multiple primary lung cancer
5184994|NCT02833454|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5184995|NCT02833454|Direct Insertion of Anterior Cruciate Ligament|direct insertion of anterior cruciate ligament
5184996|NCT02833415|Visceral|visceral
5184997|NCT02833415|Obesity|obesity
5172971|NCT02911090|Chronic pelvic pain|chronic pelvic pain
5184998|NCT02833415|Adipose|adipose
5184999|NCT02833415|Diabetes|diabetes
5185000|NCT02833402|Sacral Neuromodulation|sacral neuromodulation
5185001|NCT02833402|Urinary leakage|urinary leakage
5185002|NCT02833402|Urinary incontinence|urinary incontinence
5185003|NCT02833402|Urinary microbiome|urinary microbiome
5185004|NCT02833376|microbiota|microbiota
5185005|NCT02833376|ethanol|ethanol
5185006|NCT02833376|chlorhexidine|chlorhexidine
5185007|NCT02833363|gastric microbiota|gastric microbiota
5185008|NCT02833363|Helicobacter pylori|helicobacter pylori
5185009|NCT02833363|Non-atrophic Gasrititis|non-atrophic gasrititis
5185010|NCT02833363|Atrophic gastritis|atrophic gastritis
5185011|NCT02833363|Intestinal metaplasia|intestinal metaplasia
5185012|NCT02833363|intraepithelial neoplasia|intraepithelial neoplasia
5185013|NCT02833363|Gastric cancer|gastric cancer
5185014|NCT02833337|Bone|bone
5185015|NCT02833337|Maxilla|maxilla
5185016|NCT02833337|Cone-Beam Computed Tomography|cone-beam computed tomography
5185017|NCT02833337|Regeneration|regeneration
5185018|NCT02833324|Postoperative Period|postoperative period
5185019|NCT02833324|Colorectal Surgery|colorectal surgery
5185020|NCT02833324|Surgery|surgery
5185021|NCT02833311|Neuromusculoskeletal condition|neuromusculoskeletal condition
5185022|NCT02833298|Sustained Virological Response|sustained virological response
5185024|NCT02833298|patient navigation|patient navigation
5185025|NCT02833298|screening|screening
5185026|NCT02833298|HCC|hcc
5185027|NCT02833298|HCV|hcv
5185028|NCT02833272|benzodiazepines|benzodiazepines
5185029|NCT02833272|Z-drugs|z-drugs
5185034|NCT02833259|Quality of health care|quality of health care
5185035|NCT02833259|Models, Statistical|models, statistical
5185036|NCT02833246|texting|texting
5185037|NCT02833246|Adherence to Oral Anticancer Medications|adherence to oral anticancer medications
5185038|NCT02833246|16-810|16-810
5185039|NCT02833233|Early stage|early stage
5185040|NCT02833233|Resectable|resectable
5185041|NCT02833233|Ipilimumab|ipilimumab
5185042|NCT02833233|Nivolumab|nivolumab
5185043|NCT02833233|Cryoablation|cryoablation
5185044|NCT02833233|16-495|16-495
5185045|NCT02833220|blood pressure|blood pressure
5185046|NCT02833220|heart rate variability|heart rate variability
5185047|NCT02833220|single-pulse transcranial magnetic stimulation|single-pulse transcranial magnetic stimulation
5185048|NCT02833220|non-invasive brain stimulation|non-invasive brain stimulation
5185053|NCT02833168|Neuromuscular disorders|neuromuscular disorders
5185054|NCT02833168|Sleep disordered breathing|sleep disordered breathing
5962304|NCT04281589|low tidal volüm|low tidal volüm
5185056|NCT02833155|entinostat|entinostat
5185057|NCT02833155|breast cancer|breast cancer
5185058|NCT02833142|Healthy Volunteer|healthy volunteer
5185059|NCT02833142|opicinumab|opicinumab
5185060|NCT02833116|radiculalgia|radiculalgia
5185061|NCT02833116|chronic pain|chronic pain
5185062|NCT02833116|quality of life|quality of life
5185063|NCT02833103|Pinaverium Bromide|pinaverium bromide
5185064|NCT02833103|cholecystectomy|cholecystectomy
5185065|NCT02833103|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5185066|NCT02833012|Healthy volunteers|healthy volunteers
5185067|NCT02833012|Caprylic triglyceride oil|caprylic triglyceride oil
5185068|NCT02833012|AC-1202|ac-1202
5185069|NCT02833012|AC-1204|ac-1204
5185070|NCT02833012|Pharmacokinetic|pharmacokinetic
5185071|NCT02833012|ketone body|ketone body
5185072|NCT02833012|Axona|axona
5185073|NCT02832999|Diabetes|diabetes
5185074|NCT02832999|GLP-1|glp-1
5185075|NCT02832999|Insulin secretion|insulin secretion
5185076|NCT02832999|insulin sensitivity|insulin sensitivity
5185077|NCT02832999|Africa|africa
5185078|NCT02832999|Liraglutide|liraglutide
5185081|NCT02832973|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
5185082|NCT02832973|Natriuretic Agents|natriuretic agents
5185083|NCT02832973|Renin-Angiotensin System|renin-angiotensin system
5185085|NCT02832960|Thyroid Dysfunction|thyroid dysfunction
5185086|NCT02832960|Atherosclerosis|atherosclerosis
5185087|NCT02832960|Heart Failure|heart failure
5185088|NCT02832960|Cardiovascular imaging|cardiovascular imaging
5185089|NCT02832960|Randomized Controlled Trial|randomized controlled trial
5185090|NCT02832934|Thyroid Dysfunction|thyroid dysfunction
5185091|NCT02832934|Atherosclerosis|atherosclerosis
5185092|NCT02832934|Heart Failure|heart failure
5185093|NCT02832934|Cardiovascular Imaging|cardiovascular imaging
5185094|NCT02832934|Randomized Controlled Trial|randomized controlled trial
5185095|NCT02832921|Alzheimer's disease|alzheimer's disease
5185096|NCT02832921|virtual reality|virtual reality
5185097|NCT02832921|cognitive training|cognitive training
5185098|NCT02832895|Adults|adults
5185099|NCT02832895|Frontal bone window|frontal bone window
5185100|NCT02832895|Transcranial doppler|transcranial doppler
5185101|NCT02832882|HCC|hcc
5185102|NCT02832882|RFA|rfa
5185103|NCT02832869|Polyp detection rate|polyp detection rate
5185104|NCT02832869|Adenoma detection rate|adenoma detection rate
5185105|NCT02832869|Boston Bowel Preparation Scale|boston bowel preparation scale
5185106|NCT02832830|bony metastases|bony metastases
5185107|NCT02832830|palliative radiotherapy|palliative radiotherapy
5185108|NCT02832817|Oxygen therapy|oxygen therapy
5185109|NCT02832817|Pulse oximeter|pulse oximeter
5185110|NCT02832817|Hypoxia|hypoxia
5185111|NCT02832817|Hypoxemia|hypoxemia
5185112|NCT02832817|Arterial blood gas|arterial blood gas
5185113|NCT02832791|ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION|anterior cruciate ligament reconstruction
5185114|NCT02832791|QUADRICEPS TENDON|quadriceps tendon
5185115|NCT02832791|HAMSTRING TENDON|hamstring tendon
5185116|NCT02832765|Palliative radiotherapy|palliative radiotherapy
5185117|NCT02832765|Bone metastases|bone metastases
5185118|NCT02832739|Technology acceptance|technology acceptance
5185119|NCT02832739|Usability|usability
5185120|NCT02832739|eHealth|ehealth
5185121|NCT02832739|self-management support in chronic illness|self-management support in chronic illness
5185122|NCT02832739|prevention|prevention
5185123|NCT02832739|Special Orthopaedic Co-Morbidity after hip/knee replacement|special orthopaedic co-morbidity after hip/knee replacement
5185124|NCT02832726|absorption of Vitamin B12|absorption of vitamin b12
5185125|NCT02832713|Knee osteoarthritis|knee osteoarthritis
5789322|NCT00148889|torticollis|torticollis
5185126|NCT02832713|Intra-articular botulinum toxin|intra-articular botulinum toxin
5185127|NCT02832713|Hyaluronic acid|hyaluronic acid
5185128|NCT02832713|Pain|pain
5185129|NCT02832713|Function|function
5185130|NCT02832700|glycopeptides|glycopeptides
5185131|NCT02832700|dietary proteins|dietary proteins
5185132|NCT02832700|whey protein|whey protein
5185133|NCT02832700|caseinomacropeptide|caseinomacropeptide
5185134|NCT02832700|antiinflammatories|antiinflammatories
5185135|NCT02832700|human microbiome|human microbiome
5185136|NCT02832661|renal allograft|renal allograft
5185137|NCT02832661|graft injuries|graft injuries
5185138|NCT02832661|biopsy|biopsy
5185139|NCT02832661|biomarkers|biomarkers
5185140|NCT02832661|omics approach|omics approach
5185141|NCT02832635|brain metastasis|brain metastasis
5185142|NCT02832635|whole-brain radiotherapy|whole-brain radiotherapy
5185143|NCT02832635|TMZ|tmz
5185144|NCT02832635|avoidance of hippocampus|avoidance of hippocampus
5185145|NCT02832622|MultiPoint Pacing|multipoint pacing
5185146|NCT02832622|Heart Failure|heart failure
5185147|NCT02832622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5185148|NCT02832622|SJM Quadripolar Biventricular Pacing|sjm quadripolar biventricular pacing
5185149|NCT02832609|closing volume|closing volume
5185150|NCT02832609|expiratory flow limitation|expiratory flow limitation
5185151|NCT02832609|obesity|obesity
5185152|NCT02832609|orthopnea|orthopnea
5185153|NCT02832596|Anesthesia|anesthesia
5185154|NCT02832596|Blood pressure|blood pressure
5185155|NCT02832596|Plasma Volume|plasma volume
5185156|NCT02832596|Vasopressor agents|vasopressor agents
5185157|NCT02832596|Coronary artery bypass|coronary artery bypass
5185158|NCT02832596|Glycocalyx|glycocalyx
5185159|NCT02832596|ANP|anp
5185160|NCT02832596|Coagulation|coagulation
5185161|NCT02832583|PRP, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation|prp, hyaluronic acid, mesotherapy, skin wrinkle, skin rejuvenation
5185162|NCT02832557|Autism|autism
5185163|NCT02832557|Asperger's Syndrome|asperger's syndrome
5185164|NCT02832557|microRNA|microrna
5185165|NCT02832557|epigenetic|epigenetic
5185166|NCT02832557|biomarker|biomarker
5185167|NCT02832544|atrial fibrillation|atrial fibrillation
5185168|NCT02832544|stroke|stroke
5185169|NCT02832531|atrial fibrillation|atrial fibrillation
5185170|NCT02832531|stroke|stroke
5185171|NCT02832492|disorders of consciousness|disorders of consciousness
5185172|NCT02832492|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
5185174|NCT02832492|prognosis of consciousness recovery|prognosis of consciousness recovery
5185175|NCT02832453|High intensity physical exercise|high intensity physical exercise
5185176|NCT02832453|Primary health care|primary health care
5185177|NCT02832453|Behaviour change interventions|behaviour change interventions
5185178|NCT02832427|Coronary artery bypass grafting|coronary artery bypass grafting
5185179|NCT02832427|Heart valve surgery|heart valve surgery
5185180|NCT02832427|Postoperative morbidity|postoperative morbidity
5185181|NCT02832427|Operative mortality|operative mortality
5185182|NCT02832401|event-related potentials|event-related potentials
5185183|NCT02832401|EEG|eeg
5185184|NCT02832401|caffeine|caffeine
5185185|NCT02832401|psychosis|psychosis
5185186|NCT02832401|schizophrenia|schizophrenia
5185187|NCT02832336|Caffeine|caffeine
5185188|NCT02832336|Caffeine citrate|caffeine citrate
5185189|NCT02832336|Neurological disorder|neurological disorder
5185190|NCT02832336|Excessive daytime sleepiness|excessive daytime sleepiness
5185191|NCT02832336|Orexin|orexin
5185192|NCT02832336|adenosine antagonist|adenosine antagonist
5185193|NCT02832323|hemodialysis|hemodialysis
5185194|NCT02832323|EPO|epo
5185195|NCT02832323|MIRCERA|mircera
5185196|NCT02832310|valsalva|valsalva
5185197|NCT02832258|Enterobacteria|enterobacteria
5185198|NCT02832258|Children|children
5185199|NCT02832258|Febrile urinary tract infection|febrile urinary tract infection
5185200|NCT02832258|Cystitis|cystitis
5185201|NCT02832258|Extended-spectrum beta-lactamase-producing Enterobacteriaceae|extended-spectrum beta-lactamase-producing enterobacteriaceae
5185202|NCT02832232|Physiotherapy|physiotherapy
5185203|NCT02832232|Manual Therapy|manual therapy
5185204|NCT02832232|Neck Pain|neck pain
5185205|NCT02832219|Overweight|overweight
5185206|NCT02832219|Molecular hydrogen|molecular hydrogen
5185207|NCT02832219|Insulin|insulin
5185208|NCT02832206|Atrial fibrillation|atrial fibrillation
5185209|NCT02832206|Hybrid ablation|hybrid ablation
5185210|NCT02832180|Rheumatoid|rheumatoid
5185211|NCT02832141|Skin blood flow|skin blood flow
5185212|NCT02832141|Skin redness|skin redness
5185213|NCT02832141|Sympathetic nervous system|sympathetic nervous system
5185214|NCT02832141|Regional Blood Flow|regional blood flow
5185215|NCT02832128|Cochlear Implant|cochlear implant
5185216|NCT02832115|Radial Artery Spasm|radial artery spasm
5185217|NCT02832115|Cardiac Catheterization|cardiac catheterization
5185218|NCT02832115|Vascular Access Site Complications|vascular access site complications
5185219|NCT02832115|Vasodilator|vasodilator
5185220|NCT02832115|Nitroglycerine|nitroglycerine
5185221|NCT02832115|Lidocaine|lidocaine
5185222|NCT02832102|prognostic modelling|prognostic modelling
5185223|NCT02832102|radiomics|radiomics
5185224|NCT02832102|clinical decision support system|clinical decision support system
5185225|NCT02832102|big data analysis|big data analysis
5185226|NCT02832102|multiscale prognostic signatures|multiscale prognostic signatures
5185227|NCT02832102|patient-clinician co-decision tools|patient-clinician co-decision tools
5185228|NCT02832089|atrial fibrillation|atrial fibrillation
5185229|NCT02832089|rate reduction|rate reduction
5185231|NCT02832050|therapy|therapy
5185232|NCT02832024|stents|stents
5185233|NCT02832024|atherectomy|atherectomy
5185234|NCT02832024|femoral artery|femoral artery
5185541|NCT02830126|Outcomes|outcomes
5185235|NCT02832024|popliteal artery|popliteal artery
5185236|NCT02832024|In-stent Restenosis|in-stent restenosis
5185237|NCT02831985|Child|child
5185238|NCT02831985|Middle ear ventilation|middle ear ventilation
5185239|NCT02831985|Follow-up studies|follow-up studies
5185240|NCT02831985|General practitioners|general practitioners
5185241|NCT02831972|Healthy Volunteers|healthy volunteers
5185242|NCT02831959|Non-Small Cell Lung Cancer|non-small cell lung cancer
5185243|NCT02831959|NSCLC|nsclc
5192899|NCT02787005|PD1|pd1
5185244|NCT02831959|Brain metastases|brain metastases
5185245|NCT02831959|Treatment|treatment
5185246|NCT02831959|Minimal toxicity|minimal toxicity
5185247|NCT02831959|TTFields|ttfields
5185249|NCT02831959|Tumor Treating Fields|tumor treating fields
5185250|NCT02831959|Novocure|novocure
5185251|NCT02831959|SRS|srs
5185252|NCT02831959|Stereotactic radiosurgery|stereotactic radiosurgery
5185253|NCT02831946|skin closure|skin closure
5185254|NCT02831946|intracuticular suture|intracuticular suture
5059881|NCT03624556|FontUp|fontup
5185255|NCT02831946|glue (dermabond)|glue (dermabond)
5185256|NCT02831933|lung cancer|lung cancer
5185257|NCT02831933|metastatic|metastatic
5185258|NCT02831933|gene therapy|gene therapy
5185259|NCT02831933|immunotherapy|immunotherapy
5185260|NCT02831933|melanoma|melanoma
5185261|NCT02831933|uveal|uveal
5185262|NCT02831920|Prostate Cancer|prostate cancer
5185263|NCT02831920|MRI|mri
5185264|NCT02831920|CEUS|ceus
5185265|NCT02831920|Contrast Ultrasound|contrast ultrasound
5185266|NCT02831920|Fusion|fusion
5185267|NCT02831920|targeted biopsy|targeted biopsy
5185268|NCT02831907|Ultrasonography|ultrasonography
5185269|NCT02831907|Portal vein Doppler|portal vein doppler
5185270|NCT02831907|Renal Doppler|renal doppler
5185271|NCT02831907|Cardio-Intestinal syndrome|cardio-intestinal syndrome
5185272|NCT02831907|Delirium|delirium
5185273|NCT02831907|Renal congestion|renal congestion
5185274|NCT02831907|Intra-renal hemodynamics|intra-renal hemodynamics
5185276|NCT02831894|sedative hypnotics|sedative hypnotics
5185277|NCT02831894|hypnotic tapering|hypnotic tapering
5185278|NCT02831855|Rheumatoid Arthritis|rheumatoid arthritis
5185279|NCT02831855|Tofacitinib|tofacitinib
5185280|NCT02831855|CP-690,550|cp-690,550
5185281|NCT02831855|Xeljanz|xeljanz
5185282|NCT02831855|methotrexate withdrawal|methotrexate withdrawal
5185283|NCT02831855|withdrawal study|withdrawal study
5185284|NCT02831829|cardiac rehabilitation|cardiac rehabilitation
5185285|NCT02831829|coronary artery disease|coronary artery disease
5185286|NCT02831777|non-invasive blood pressure|non-invasive blood pressure
5185287|NCT02831764|tolerability|tolerability
5185288|NCT02831764|HIV 1|hiv 1
5185289|NCT02831764|efficacy|efficacy
5185290|NCT02831764|treatment naïve|treatment naïve
5185291|NCT02831764|two-drug regimen|two-drug regimen
5185292|NCT02831764|safety|safety
5185293|NCT02831764|non inferiority|non inferiority
5185294|NCT02831751|Influenza|influenza
5185295|NCT02831751|Human|human
5185296|NCT02831751|RNA Virus Infections|rna virus infections
5185297|NCT02831751|Immulogic|immulogic
5185298|NCT02831751|Immunogenic Factors|immunogenic factors
5185299|NCT02831751|Physiological Effects of Drug|physiological effects of drug
5185300|NCT02831751|Virus Diseases|virus diseases
5185301|NCT02831751|Orthomyxoviridae Infections|orthomyxoviridae infections
5185302|NCT02831751|Infection|infection
5185303|NCT02831738|Fiber|fiber
5185304|NCT02831738|Polydextrose|polydextrose
5185305|NCT02831738|Glycemic Index|glycemic index
5185306|NCT02831712|NTBI|ntbi
5185307|NCT02831712|Iron status|iron status
5185308|NCT02831712|Iron supplement|iron supplement
5185309|NCT02831699|Zika|zika
5185310|NCT02831699|Guillain Barré|guillain barré
5185311|NCT02831686|Selinexor (KPT-330)|selinexor (kpt-330)
5185312|NCT02831686|Ixazomib|ixazomib
5185313|NCT02831686|dexamethasone|dexamethasone
5185314|NCT02831686|15-310|15-310
5185315|NCT02831673|safety|safety
5185316|NCT02831673|treatment naïve|treatment naïve
5185317|NCT02831673|HIV 1|hiv 1
5185318|NCT02831673|dolutegravir plus lamivudine|dolutegravir plus lamivudine
5185319|NCT02831673|non inferiority|non inferiority
5185320|NCT02831673|tolerability|tolerability
5185321|NCT02831673|dolutegravir plus tenofovir/emtricitabine|dolutegravir plus tenofovir/emtricitabine
5185322|NCT02831673|efficacy|efficacy
5185323|NCT02831634|Breast cancer|breast cancer
5185324|NCT02831634|cutaneous melanoma|cutaneous melanoma
5185325|NCT02831621|overweight|overweight
5185327|NCT02831621|exercise|exercise
5185328|NCT02831621|diet|diet
5185329|NCT02831582|Breast Cancer|breast cancer
5185330|NCT02831582|Postmenopausal|postmenopausal
5185331|NCT02831582|Stage IA|stage ia
5185332|NCT02831582|Stage IB|stage ib
5185333|NCT02831582|Stage IIA|stage iia
5185334|NCT02831582|Stage IIB|stage iib
5185335|NCT02831582|Stage IIIA|stage iiia
5185336|NCT02831582|Stage IIIB|stage iiib
5185337|NCT02831582|Stage IIIC|stage iiic
5185338|NCT02831556|Ultrasound|ultrasound
5185339|NCT02831556|Abdomen|abdomen
5185340|NCT02831556|Pelvis|pelvis
5185341|NCT02831556|3D|3d
5185642|NCT02829827|Radiprodil|radiprodil
5185342|NCT02831504|Myotonic Dystrophy type 1|myotonic dystrophy type 1
5185343|NCT02831504|DM1|dm1
5185344|NCT02831504|Muscular Dystrophy|muscular dystrophy
5185345|NCT02831504|Neuromuscular Diseases|neuromuscular diseases
5185346|NCT02831491|metastatic|metastatic
5962305|NCT04281589|mekanical Ventilation|mekanical ventilation
5185347|NCT02831465|Dynamic hyperinflation|dynamic hyperinflation
5185348|NCT02831465|Maximal Voluntary Ventilation|maximal voluntary ventilation
5185349|NCT02831465|Inspiratory capacity|inspiratory capacity
5185350|NCT02831465|healthy subjects|healthy subjects
5185352|NCT02831452|evaluation|evaluation
5185353|NCT02831452|dynamometer|dynamometer
5185354|NCT02831452|perineometer|perineometer
5185355|NCT02831439|Choosing Wisely|choosing wisely
5185356|NCT02831439|Breast cancer|breast cancer
5185357|NCT02831439|Controlled trial|controlled trial
5185358|NCT02831439|High-value health care|high-value health care
5185359|NCT02831439|Health services research|health services research
5185360|NCT02831348|Asthma|asthma
5059984|NCT03623841|Dual-task performance|dual-task performance
5059985|NCT03623841|Dual-task training|dual-task training
5059986|NCT03623828|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
5059988|NCT03623828|apomorphine|apomorphine
5185361|NCT02831348|Allergic rhinitis|allergic rhinitis
5185362|NCT02831348|Rhinitis|rhinitis
5185363|NCT02831348|Pneumonia|pneumonia
5185364|NCT02831348|Cystic fibrosis|cystic fibrosis
5185365|NCT02831322|Transradial|transradial
5185366|NCT02831322|ﬂow-mediated vasodilation|ﬂow-mediated vasodilation
5185367|NCT02831309|physical activity|physical activity
5185368|NCT02831296|SMA|sma
5185369|NCT02831296|Werdnig-Hoffmann disease|werdnig-hoffmann disease
5185370|NCT02831296|Kugelberg-Welander disease|kugelberg-welander disease
5185371|NCT02831283|inflammation|inflammation
5185372|NCT02831283|aging|aging
5185373|NCT02831283|mild cognitive impairment|mild cognitive impairment
5185374|NCT02831270|cardiac surgery|cardiac surgery
5185375|NCT02831270|acute normovolemic hemodilution|acute normovolemic hemodilution
5185376|NCT02831257|Neurofibromatosis 2|neurofibromatosis 2
5185377|NCT02831218|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5185378|NCT02831218|coronary artery disease|coronary artery disease
5185379|NCT02831205|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5185380|NCT02831205|coronary artery disease|coronary artery disease
5185381|NCT02831166|Vascular closure devices|vascular closure devices
5185382|NCT02831166|Transradial approach|transradial approach
5185383|NCT02831166|Transfemoral approach|transfemoral approach
5185384|NCT02831140|Fast track|fast track
5185385|NCT02831140|rehabilitation|rehabilitation
5185386|NCT02831140|post operative complications|post operative complications
5185387|NCT02831127|short message service; adherence; stent exchange; ERCP|short message service; adherence; stent exchange; ercp
5185388|NCT02831101|BIS|bis
5185389|NCT02831101|Elderly|elderly
5185390|NCT02831101|Propofol|propofol
5185391|NCT02831101|Sufentanil|sufentanil
5185392|NCT02831101|Loss of consciousness|loss of consciousness
5185393|NCT02831088|Neu2000KWL|neu2000kwl
5185394|NCT02831088|Neuroprotection|neuroprotection
5185395|NCT02831088|endovascular therapy|endovascular therapy
5185396|NCT02831088|glutamate|glutamate
5185397|NCT02831088|free radical|free radical
5185398|NCT02831075|Adipose-derived Stem Cells|adipose-derived stem cells
5185399|NCT02831062|nutrition|nutrition
5185400|NCT02831062|progression|progression
5185401|NCT02831049|Reconsolidation|reconsolidation
5185403|NCT02830971|standardized learning curve|standardized learning curve
5185405|NCT02830971|intensive care unit|intensive care unit
5185406|NCT02830971|Mastery|mastery
5185407|NCT02830971|Training|training
5185408|NCT02830971|Developing|developing
5185409|NCT02830971|Skills|skills
5185410|NCT02830919|Osteoarthritis of knee|osteoarthritis of knee
5185411|NCT02830919|Glucosamine sulfate|glucosamine sulfate
5185412|NCT02830919|Chondroitin sulfate|chondroitin sulfate
5185413|NCT02830906|Total Knee Arthroplasty|total knee arthroplasty
5185414|NCT02830906|Intrathecal Morphine|intrathecal morphine
5185415|NCT02830906|Ramosetron|ramosetron
5185416|NCT02830906|Ondansetron|ondansetron
5185417|NCT02830906|postoperative nausea and vomiting|postoperative nausea and vomiting
5185418|NCT02830880|Imaging|imaging
5185419|NCT02830880|Nuclear medicine|nuclear medicine
5185420|NCT02830880|Oncology|oncology
5185421|NCT02830880|Radiology|radiology
5185422|NCT02830880|Urogenital disorders|urogenital disorders
5185423|NCT02830867|glutathione|glutathione
5185424|NCT02830867|glutathione synthetase deficiency|glutathione synthetase deficiency
5185425|NCT02830867|autosomal inheritance|autosomal inheritance
5185429|NCT02830841|pediatric living donor liver transplantation|pediatric living donor liver transplantation
5185430|NCT02830815|Broadband click stimulus testing|broadband click stimulus testing
5185432|NCT02830815|Sevoflurane|sevoflurane
5185433|NCT02830815|Propofol|propofol
5185434|NCT02830815|Amplitude latency|amplitude latency
5185435|NCT02830815|Wave V|wave v
5185436|NCT02830776|dermatochalasis|dermatochalasis
5185437|NCT02830776|bimatoprost|bimatoprost
5185438|NCT02830776|blepharoplasty|blepharoplasty
5185439|NCT02830763|neutral lipid storage disease|neutral lipid storage disease
5185440|NCT02830763|CNT-02|cnt-02
5185441|NCT02830763|primary triglyceride deposit cardiomyovasculopathy (TGCV)|primary triglyceride deposit cardiomyovasculopathy (tgcv)
5185442|NCT02830763|neutral lipid storage disease with myopathy (NLSD-M)|neutral lipid storage disease with myopathy (nlsd-m)
5185443|NCT02830737|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
5185444|NCT02830737|No-touch RFA|no-touch rfa
5185445|NCT02830737|Traditional RFA|traditional rfa
5185446|NCT02830737|Recurrence rate|recurrence rate
5185451|NCT02830711|happiness|happiness
5185452|NCT02830711|anger|anger
5185453|NCT02830711|sadness|sadness
5185454|NCT02830711|anticipation|anticipation
5185455|NCT02830698|Nervous System|nervous system
5185456|NCT02830698|Hypnosis|hypnosis
5185457|NCT02830698|Electrocardiography, Ambulatory|electrocardiography, ambulatory
5962306|NCT04281576|TTFields|ttfields
5962307|NCT04281576|XELOX|xelox
5962308|NCT04281576|Oxaliplatin|oxaliplatin
5962309|NCT04281576|Capecitabine|capecitabine
5962310|NCT04281576|Minimal toxicity|minimal toxicity
5962311|NCT04281576|TTF|ttf
5185458|NCT02830698|Abdominal pain disorders functional|abdominal pain disorders functional
5185459|NCT02830685|pre-pectoral breast reconstruction|pre-pectoral breast reconstruction
5185460|NCT02830685|subcutaneous breast reconstruction|subcutaneous breast reconstruction
5185461|NCT02830633|laparoscopy|laparoscopy
5185462|NCT02830633|rectal cancer|rectal cancer
5185463|NCT02830633|pelvic autonomic nerve|pelvic autonomic nerve
5185464|NCT02830568|Kidney transplantation|kidney transplantation
5185465|NCT02830568|Surgical procedures|surgical procedures
5185466|NCT02830568|Kidney living donors|kidney living donors
5185467|NCT02830568|Quality of life|quality of life
5185468|NCT02830542|Clostridium difficile|clostridium difficile
5185469|NCT02830542|C Diff|c diff
5185470|NCT02830542|CDI|cdi
5185471|NCT02830529|Mindfulness|mindfulness
5185472|NCT02830529|African American|african american
5185473|NCT02830529|fMRI|fmri
5185474|NCT02830477|Previously treated patients|previously treated patients
5185475|NCT02830451|Registry|registry
5185476|NCT02830451|Spine|spine
5185477|NCT02830451|Surgery|surgery
5185478|NCT02830451|Medical Oncology|medical oncology
5185479|NCT02830451|Radiation Oncology|radiation oncology
5185480|NCT02830451|Neoplasms|neoplasms
5185481|NCT02830451|Metastasis|metastasis
5185482|NCT02830451|Chemotherapy|chemotherapy
5185483|NCT02830451|Radiation Therapy|radiation therapy
5185484|NCT02830451|Tumor Markers|tumor markers
5185485|NCT02830438|kidney disease|kidney disease
5185486|NCT02830438|fibrosis|fibrosis
5185487|NCT02830438|ultrasound|ultrasound
5185488|NCT02830438|elastography|elastography
5185489|NCT02830425|Multimorbidity|multimorbidity
5185490|NCT02830425|Polypharmacy|polypharmacy
5185491|NCT02830425|Appropriateness|appropriateness
5185493|NCT02830425|START|start
5185494|NCT02830399|treatment-resistant-depression|treatment-resistant-depression
5185495|NCT02830399|rTMS|rtms
5185496|NCT02830399|ECT|ect
5185497|NCT02830399|Augmentation strategy|augmentation strategy
5185498|NCT02830373|LVIS stents|lvis stents
5074636|NCT03532204|SBRT|sbrt
5185499|NCT02830373|Intracranial aneurysm|intracranial aneurysm
5185500|NCT02830373|Unruptured aneurysm|unruptured aneurysm
5185501|NCT02830373|Wide-necked aneurysm|wide-necked aneurysm
5185502|NCT02830360|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
5185503|NCT02830360|VT Catheter ablation|vt catheter ablation
5185504|NCT02830360|ICD Therapy|icd therapy
5185505|NCT02830360|Ischemic Heart Disease|ischemic heart disease
5185506|NCT02830347|antibiotic resistance|antibiotic resistance
5185507|NCT02830347|oral microbiome|oral microbiome
5185508|NCT02830334|Suicide|suicide
5185510|NCT02830308|Hormones|hormones
5185511|NCT02830308|Endocrine|endocrine
5185512|NCT02830308|Hypercortisolism|hypercortisolism
5185513|NCT02830308|Bone|bone
5185514|NCT02830308|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
5185515|NCT02830295|body awareness therapy|body awareness therapy
5185516|NCT02830295|physical therapy|physical therapy
5185517|NCT02830295|movement therapy|movement therapy
5185518|NCT02830269|Neuro-ICU|neuro-icu
5185519|NCT02830269|Third ventricle|third ventricle
5185520|NCT02830269|Computer Tomography|computer tomography
5185521|NCT02830269|Transcranial Doppler ultrasonography|transcranial doppler ultrasonography
5185522|NCT02830256|Intensive care unit|intensive care unit
5185523|NCT02830256|Neuro-ICU|neuro-icu
5185524|NCT02830256|Pain|pain
5185525|NCT02830256|Intubation|intubation
5185526|NCT02830256|critical care|critical care
5185527|NCT02830256|patients|patients
5185528|NCT02830217|STEMI|stemi
5185529|NCT02830217|primary PCI|primary pci
5185530|NCT02830217|sST2|sst2
5185531|NCT02830217|prognosis|prognosis
5185532|NCT02830204|mitral valve regurgitation|mitral valve regurgitation
5185533|NCT02830204|mitral valve stenosis|mitral valve stenosis
5185534|NCT02830191|Cyclosporine, Dried blood spot|cyclosporine, dried blood spot
5185535|NCT02830152|Stroke|stroke
5185536|NCT02830152|intracerebral hemorrhage|intracerebral hemorrhage
5185537|NCT02830152|left atrial appendage occlusion|left atrial appendage occlusion
5185538|NCT02830152|atrial fibrillation|atrial fibrillation
5185539|NCT02830152|oral anticoagulation|oral anticoagulation
5185540|NCT02830152|preventive therapy|preventive therapy
5185542|NCT02830126|Information technology|information technology
5185543|NCT02830113|periodontitis|periodontitis
5185544|NCT02830113|diabetes|diabetes
5185545|NCT02830113|prevention|prevention
5185546|NCT02830113|impaired glucose tolerance|impaired glucose tolerance
5185547|NCT02830113|insulin resistance|insulin resistance
5185548|NCT02830100|Intern speech|intern speech
5185549|NCT02830100|Speech and visual imaging|speech and visual imaging
5185550|NCT02830100|Mind and oral drift|mind and oral drift
5185551|NCT02830100|Cognitive performance|cognitive performance
5185552|NCT02830100|Magnetic Resonance Imaging|magnetic resonance imaging
5185553|NCT02830087|randomized controlled trial|randomized controlled trial
5185554|NCT02830087|tourniquet|tourniquet
5185555|NCT02830087|tourniquet cuff pressure|tourniquet cuff pressure
5185556|NCT02830087|total knee arthroplasty|total knee arthroplasty
5185557|NCT02830087|total knee replacement|total knee replacement
5185559|NCT02830087|range of motion, articular|range of motion, articular
5962312|NCT04281576|Tumor Treating Fields|tumor treating fields
5185560|NCT02830087|blood loss, surgical|blood loss, surgical
5185561|NCT02830087|muscle strength, quadriceps|muscle strength, quadriceps
5185563|NCT02830087|manipulation, orthopedic/therapeutic use|manipulation, orthopedic/therapeutic use
5185564|NCT02830087|wound healing/surgery|wound healing/surgery
5185565|NCT02830074|Sleep Apnea Syndromes|sleep apnea syndromes
5185566|NCT02830074|Spinal Cord Injuries|spinal cord injuries
5185567|NCT02830074|Sleep|sleep
5185568|NCT02830074|Quality of life|quality of life
5185569|NCT02830061|Cancer|cancer
5185570|NCT02830061|Teenage|teenage
5185571|NCT02830061|Young Adult|young adult
5185572|NCT02830061|Fertility|fertility
5185573|NCT02830061|Cryopreservation|cryopreservation
5185574|NCT02830061|Experience|experience
5185575|NCT02830048|diabetes|diabetes
5185576|NCT02830048|glibenclamide|glibenclamide
5185577|NCT02830048|glucagon|glucagon
5185578|NCT02830035|ultrasound guided|ultrasound guided
5185579|NCT02830035|spinal anesthesia|spinal anesthesia
5185580|NCT02830035|neuraxial block|neuraxial block
5185581|NCT02830035|paramedian|paramedian
5185582|NCT02830022|autism spectrum disorder|autism spectrum disorder
5185583|NCT02829996|glaucoma|glaucoma
5185584|NCT02829996|primary open-angle glaucoma|primary open-angle glaucoma
5185585|NCT02829996|ocular hypertension|ocular hypertension
5185586|NCT02829996|adenosine agonist|adenosine agonist
5185587|NCT02829996|eye drop|eye drop
5185588|NCT02829996|trabodenoson|trabodenoson
5185589|NCT02829996|trabecular meshwork|trabecular meshwork
5185590|NCT02829983|clarithromycin|clarithromycin
5185591|NCT02829983|periodontal debridement|periodontal debridement
5185592|NCT02829983|aggressive periodontitis|aggressive periodontitis
5185593|NCT02829970|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5185594|NCT02829970|Alcohol-Related Disorders|alcohol-related disorders
5185595|NCT02829970|Substance-Related Disorders|substance-related disorders
5185596|NCT02829970|Motivational Interviewing|motivational interviewing
5185597|NCT02829970|Behavior Therapy|behavior therapy
5185598|NCT02829944|Cesarean section|cesarean section
5185599|NCT02829931|recurrent glioma|recurrent glioma
5185600|NCT02829931|high grade glioma|high grade glioma
5185601|NCT02829931|head and neck disease|head and neck disease
5185602|NCT02829931|grade III glioma|grade iii glioma
5185603|NCT02829931|grade IV glioma|grade iv glioma
5185604|NCT02829931|radiation therapy|radiation therapy
5185605|NCT02829918|advanced biliary tract cancer|advanced biliary tract cancer
5185608|NCT02829918|immunotherapy|immunotherapy
5185609|NCT02829905|mass screening|mass screening
5185610|NCT02829905|patient satisfaction|patient satisfaction
5185612|NCT02829905|mammography|mammography
5185613|NCT02829879|Dentin Sensitivity|dentin sensitivity
5185615|NCT02829879|Potassium Nitrate|potassium nitrate
5185616|NCT02829879|Dentifrice|dentifrice
5185617|NCT02829879|RCT|rct
5185618|NCT02829853|SARCOIDOSIS|sarcoidosis
5185619|NCT02829853|GRANULOMA DISEASES|granuloma diseases
5185620|NCT02829853|GENETICS|genetics
5185621|NCT02829853|PREDISPOSITION|predisposition
5265434|NCT02357784|SNM|snm
5185622|NCT02829853|EXOME (WES-NGS)|exome (wes-ngs)
5185623|NCT02829840|Leukemia|leukemia
5185624|NCT02829840|FLT3-Mutated Acute Myeloid Leukemia|flt3-mutated acute myeloid leukemia
5185625|NCT02829840|FLT3-Mutated High-Risk Myelodysplastic Syndrome|flt3-mutated high-risk myelodysplastic syndrome
5185626|NCT02829840|Acute Myeloid Leukemia|acute myeloid leukemia
5185627|NCT02829840|AML|aml
5185628|NCT02829840|Myelodysplastic Syndrome|myelodysplastic syndrome
5185629|NCT02829840|MDS|mds
5185630|NCT02829840|Ponatinib|ponatinib
5185631|NCT02829840|Iclusig|iclusig
5185632|NCT02829840|AP24534|ap24534
5185633|NCT02829840|5-azacytidine|5-azacytidine
5185634|NCT02829840|Azacitidine|azacitidine
5185635|NCT02829840|5-aza|5-aza
5185636|NCT02829840|Vidaza|vidaza
5185637|NCT02829840|5-AZC|5-azc
5185638|NCT02829840|AZA-CR|aza-cr
5185639|NCT02829840|Ladakamycin|ladakamycin
5185640|NCT02829840|NSC-102816|nsc-102816
5185641|NCT02829840|Azacytidine|azacytidine
5185643|NCT02829827|Infantile spasms|infantile spasms
5185645|NCT02829827|Infantile|infantile
5185646|NCT02829827|Spasms|spasms
5185647|NCT02829827|Epilepsy|epilepsy
5185648|NCT02829827|Paediatrics|paediatrics
5185649|NCT02829827|Drug-resistant|drug-resistant
5185650|NCT02829827|West Syndrome|west syndrome
5185651|NCT02829827|Hypsarrhythmia|hypsarrhythmia
5185652|NCT02829814|Pain|pain
5185653|NCT02829814|Sleep|sleep
5185654|NCT02829814|Fibromyalgia|fibromyalgia
5185655|NCT02829814|FM|fm
5185656|NCT02829801|animal assisted therapy|animal assisted therapy
5185657|NCT02829801|well-being|well-being
5185658|NCT02829801|Alzheimer's Disease|alzheimer's disease
5185659|NCT02829788|Digestive peritoneal carcinomatosis|digestive peritoneal carcinomatosis
5185660|NCT02829788|laparoscopy|laparoscopy
5185661|NCT02829788|laparotomy|laparotomy
5185662|NCT02829788|peritoneal cancer index (PCI)|peritoneal cancer index (pci)
5185663|NCT02829788|staging|staging
5185664|NCT02829762|isolated|isolated
5185665|NCT02829762|at risk of isolation|at risk of isolation
5185666|NCT02829762|patients|patients
5185667|NCT02829749|Heart Valve Diseases|heart valve diseases
5185668|NCT02829749|Heart failure|heart failure
5185669|NCT02829749|Heart diseases|heart diseases
5185670|NCT02829749|Mitral valve insufficiency|mitral valve insufficiency
5185671|NCT02829736|lung neoplasm|lung neoplasm
5185672|NCT02829736|lung metastasis|lung metastasis
5185673|NCT02829736|enhanced recovery after surgery|enhanced recovery after surgery
5185674|NCT02829736|fast-track surgery|fast-track surgery
5185675|NCT02829736|intraoperative chest tube removal|intraoperative chest tube removal
5185676|NCT02829736|pain|pain
5185677|NCT02829736|lung function|lung function
5185678|NCT02829736|reasons for admission|reasons for admission
5185684|NCT02829710|Analgesia|analgesia
5185685|NCT02829710|intensive care units|intensive care units
5185686|NCT02829710|clinical protocol|clinical protocol
5185687|NCT02829710|deep sedation|deep sedation
5185688|NCT02829710|nursing assessment|nursing assessment
5185689|NCT02829697|Regional anaesthesia|regional anaesthesia
5185690|NCT02829671|Loneliness|loneliness
5185691|NCT02829671|Suicidal behavior|suicidal behavior
5185692|NCT02829671|Depression|depression
5185693|NCT02829645|eating disoders|eating disoders
5185694|NCT02829645|neuropsychology|neuropsychology
5185695|NCT02829645|pronostic|pronostic
5185696|NCT02829632|mobile technology|mobile technology
5185697|NCT02829632|feedback message|feedback message
5185698|NCT02829632|self-monitoring|self-monitoring
5185699|NCT02829619|Obesity|obesity
5185700|NCT02829619|Nutrigenetics|nutrigenetics
5185704|NCT02829606|Central Scotoma|central scotoma
5185705|NCT02829606|Head Mounted Display|head mounted display
5185706|NCT02829580|endothelial function|endothelial function
5185707|NCT02829580|flow-mediated dilation|flow-mediated dilation
5185708|NCT02829580|vascular elastic properties|vascular elastic properties
5185709|NCT02829554|Emotion|emotion
5185710|NCT02829554|Judgment|judgment
5173653|NCT02906982|Periodontal Index|periodontal index
5173654|NCT02906982|Teeth Whitening Agents|teeth whitening agents
5173655|NCT02906982|Tooth Discoloration|tooth discoloration
5173656|NCT02906982|Mean Probing Depth|mean probing depth
5173657|NCT02906982|Pocket Depth|pocket depth
5173676|NCT02906800|digoxin|digoxin
5185711|NCT02829554|Decision Making|decision making
5185712|NCT02829541|Single Ascending Dose (SAD), Healthy Volunteers|single ascending dose (sad), healthy volunteers
5185713|NCT02829502|Cerebrovascular disease|cerebrovascular disease
5185714|NCT02829502|Glucagon like peptide 1|glucagon like peptide 1
5185715|NCT02829489|nutrition|nutrition
5185716|NCT02829489|foregut tumors|foregut tumors
5185717|NCT02829489|patient related outcomes|patient related outcomes
5185718|NCT02829489|audit|audit
5185719|NCT02829476|Adolescent idiopathic Scoliosis|adolescent idiopathic scoliosis
5185720|NCT02829476|Ghrelin|ghrelin
5185721|NCT02829450|peritoneal ultrafiltration|peritoneal ultrafiltration
5185722|NCT02829450|congestive heart failure|congestive heart failure
5185723|NCT02829450|chronic kidney disease|chronic kidney disease
5185724|NCT02829398|cerebral ischemia|cerebral ischemia
5185725|NCT02829385|Apatinib|apatinib
5185726|NCT02829385|XELOX Regimen|xelox regimen
5185727|NCT02829385|metastatic colorectal cancer|metastatic colorectal cancer
5185728|NCT02829346|Tranexamic acid|tranexamic acid
5185729|NCT02829346|Peri-articular injection|peri-articular injection
5185730|NCT02829346|Total knee arthroplasty|total knee arthroplasty
5185731|NCT02829346|Blood loss|blood loss
5185732|NCT02829346|Osteoarthritis, Knee|osteoarthritis, knee
5185733|NCT02829333|analgesia|analgesia
5185734|NCT02829333|anesthesia|anesthesia
5185735|NCT02829333|leiomyomas|leiomyomas
5185736|NCT02829333|tumor|tumor
5185737|NCT02829333|vascular endothelial growth factor|vascular endothelial growth factor
5185738|NCT02829333|anesthesia technique on tumor|anesthesia technique on tumor
5185739|NCT02829320|efficacy|efficacy
5185740|NCT02829320|hemodialysis (HD)|hemodialysis (hd)
5185741|NCT02829320|hemoglobin (Hgb)|hemoglobin (hgb)
5185742|NCT02829320|erythropoiesis-stimulating agents (ESAs)|erythropoiesis-stimulating agents (esas)
5185743|NCT02829320|GSK1278863|gsk1278863
5185744|NCT02829307|89Zirconium|89zirconium
5185745|NCT02829307|Open label|open label
5185746|NCT02829307|Pharmacokinetics|pharmacokinetics
5185747|NCT02829307|Radioactive|radioactive
5185748|NCT02829307|Clearance|clearance
5185749|NCT02829307|Biodistribution|biodistribution
5185750|NCT02829281|knee osteoarthritis|knee osteoarthritis
5185751|NCT02829281|Intra-articular injection|intra-articular injection
5185752|NCT02829281|Botulinum Toxin Type A|botulinum toxin type a
5185753|NCT02829281|Corticosteroid|corticosteroid
5185754|NCT02829268|Wolfram syndrome|wolfram syndrome
5185755|NCT02829268|Diabetes Mellitus|diabetes mellitus
5185756|NCT02829268|Optic Nerve Atrophy|optic nerve atrophy
5185757|NCT02829268|Ataxia|ataxia
5185758|NCT02829268|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
5185759|NCT02829255|High altitude|high altitude
5185760|NCT02829255|Cerebral autoregulation|cerebral autoregulation
5185761|NCT02829255|Transfer function analysis|transfer function analysis
5185762|NCT02829242|Near Infrared Spectroscopy|near infrared spectroscopy
5185763|NCT02829242|Somatic Saturation|somatic saturation
5185764|NCT02829242|Well Leg Compartment Syndrome|well leg compartment syndrome
5185765|NCT02829242|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
5185766|NCT02829242|Trendelenburg Position|trendelenburg position
5185767|NCT02829216|myelosuppression|myelosuppression
5185768|NCT02829216|mesenchymal stromal cells|mesenchymal stromal cells
5185769|NCT02829203|Frailty|frailty
5185770|NCT02829203|Surgery|surgery
5185771|NCT02829190|External carotid artery|external carotid artery
5185772|NCT02829190|Facial artery|facial artery
5185773|NCT02829190|Lingual artery|lingual artery
5185774|NCT02829190|Superior thyroid artery|superior thyroid artery
5185775|NCT02829190|Internal maxillary artery|internal maxillary artery
5185776|NCT02829190|Phase-contrast MRI|phase-contrast mri
5185777|NCT02829190|Rate of flow|rate of flow
5185778|NCT02829190|Superficial temporal artery|superficial temporal artery
5185779|NCT02829177|Type 1 diabetes|type 1 diabetes
5185780|NCT02829177|Diabetic nephropathy|diabetic nephropathy
5185781|NCT02829177|Albuminuria|albuminuria
5185782|NCT02829177|Allopurinol|allopurinol
5185783|NCT02829164|Tonsillectomy|tonsillectomy
5185784|NCT02829164|primary IgA nephropathy|primary iga nephropathy
5185785|NCT02829164|primary nephropathy|primary nephropathy
5185787|NCT02829164|Berger's disease|berger's disease
5185788|NCT02829164|Purpura rheumatoid|purpura rheumatoid
5185798|NCT02829112|fasciitis|fasciitis
5185799|NCT02829112|Shulman fasciitis|shulman fasciitis
5185800|NCT02829112|eosinophilic fasciitis|eosinophilic fasciitis
5185801|NCT02829112|inflammatory disease|inflammatory disease
5185802|NCT02829112|prevalence|prevalence
5185803|NCT02829073|Tinnitus|tinnitus
5185804|NCT02829073|Double-blind|double-blind
5185805|NCT02829073|Neuromonic Tinnitus Treatment Program|neuromonic tinnitus treatment program
5185806|NCT02829073|Oasis™|oasis™
5185807|NCT02829060|nephrolithiasis|nephrolithiasis
5185808|NCT02829060|percutaneous nephrolithiasis|percutaneous nephrolithiasis
5185809|NCT02829060|urinary tract infection (UTI)|urinary tract infection (uti)
5185810|NCT02829060|Sepsis|sepsis
5185811|NCT02829034|pulmonary hypertension|pulmonary hypertension
5185812|NCT02829034|right ventricular function|right ventricular function
5185813|NCT02829034|ranolazine|ranolazine
5185814|NCT02829021|Sensitivity|sensitivity
5185815|NCT02829021|Specificity|specificity
5185816|NCT02829021|Breast cancer|breast cancer
5185817|NCT02829021|Mammography|mammography
5185818|NCT02829021|Thermography|thermography
5185819|NCT02829021|Infrared|infrared
5185820|NCT02829021|Dynamic|dynamic
5185821|NCT02829021|Diagnostic accuracy|diagnostic accuracy
5185822|NCT02829021|Diagnostic odds ratio|diagnostic odds ratio
5185823|NCT02829008|HER2 negative breast cancer|her2 negative breast cancer
5185824|NCT02829008|low-dose bevacizumab|low-dose bevacizumab
5185825|NCT02829008|pemetrexed|pemetrexed
5185826|NCT02828995|Diabetes Mellitus|diabetes mellitus
5185827|NCT02828995|Stigma|stigma
5185828|NCT02828995|Social Determinants of Health|social determinants of health
5185829|NCT02828982|powered ankle prosthesis|powered ankle prosthesis
5185830|NCT02828982|activity monitoring|activity monitoring
5185831|NCT02828982|muscle fatigue|muscle fatigue
5185832|NCT02828982|below knee amputation|below knee amputation
5185833|NCT02828969|Trajectory|trajectory
5185834|NCT02828969|Emergency room|emergency room
5185835|NCT02828969|Conduct disorder|conduct disorder
5185836|NCT02828969|Care management|care management
5185837|NCT02828956|eating disorders|eating disorders
5185838|NCT02828956|ANSOCQ|ansocq
5185839|NCT02828956|anorexia nervosa|anorexia nervosa
5185840|NCT02828878|Apoptosis|apoptosis
5185841|NCT02828878|FAS Ligand|fas ligand
5185842|NCT02828878|Bone marrow transplantation|bone marrow transplantation
5185843|NCT02828878|GvHD|gvhd
5185844|NCT02828878|Stem cells|stem cells
5185845|NCT02828865|Hepatocellular Carcinoma|hepatocellular carcinoma
5185846|NCT02828865|irreversible electroporation|irreversible electroporation
5185847|NCT02828865|liver cancer|liver cancer
5185848|NCT02828852|pregnancy|pregnancy
5185849|NCT02828852|platelets|platelets
5185850|NCT02828839|Transperineal|transperineal
5185851|NCT02828839|Transrectal|transrectal
5185852|NCT02828839|Needle Guide|needle guide
5185853|NCT02828839|Biopsy|biopsy
5185854|NCT02828761|chest pain|chest pain
5185855|NCT02828761|calcium score|calcium score
5185856|NCT02828761|coronary calcium score|coronary calcium score
5185857|NCT02828761|coronary calcium scoring|coronary calcium scoring
5185858|NCT02828761|calcium scoring|calcium scoring
5185859|NCT02828761|cacs|cacs
5185860|NCT02828761|ccs|ccs
5185862|NCT02828748|inflammatory bowel disease|inflammatory bowel disease
5185863|NCT02828722|Circadian rhythm|circadian rhythm
5185864|NCT02828722|Critical Illness|critical illness
5185865|NCT02828722|Mechanical ventilation|mechanical ventilation
5185866|NCT02828722|Environmental modulation|environmental modulation
5185867|NCT02828696|CAD-CAM composites|cad-cam composites
5185868|NCT02828696|Worn dentition|worn dentition
5185869|NCT02828696|minimally invasive treatment|minimally invasive treatment
5185870|NCT02828683|DES|des
5185871|NCT02828683|PCI|pci
5185872|NCT02828683|STEMI|stemi
5185873|NCT02828683|Interventional Cardiology|interventional cardiology
5185874|NCT02828657|ORBERA|orbera
5185875|NCT02828644|ADHD|adhd
5060554|NCT03620461|efficacy|efficacy
5185876|NCT02828592|SAA|saa
5185877|NCT02828579|obesity|obesity
5185878|NCT02828579|bariatric surgery|bariatric surgery
5185879|NCT02828579|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5185880|NCT02828553|Wearable device|wearable device
5185881|NCT02828553|Fitbit|fitbit
5185882|NCT02828553|Inpatient|inpatient
5185883|NCT02828540|HT047|ht047
5185884|NCT02828540|Pueraria lobata|pueraria lobata
5185885|NCT02828540|Scutellaria baicalensis|scutellaria baicalensis
5185886|NCT02828501|Pain Threshold|pain threshold
5185887|NCT02828436|Hypertension|hypertension
5185888|NCT02828436|High Blood Pressure|high blood pressure
5075078|NCT03529435|PTSD|ptsd
5185889|NCT02828423|periodontal regeneration|periodontal regeneration
5185890|NCT02828410|serum bovine immunoglobulin protein isolate|serum bovine immunoglobulin protein isolate
5185892|NCT02828410|quality of life|quality of life
5185893|NCT02828384|fodmap diet|fodmap diet
5185894|NCT02828332|Autism Spectrum Disorders|autism spectrum disorders
5185895|NCT02828332|Cohort|cohort
5185896|NCT02828306|stroke|stroke
5185897|NCT02828306|head trauma|head trauma
5185898|NCT02828306|Patient Specific Implant|patient specific implant
5185899|NCT02828306|skull defect|skull defect
5185900|NCT02828267|Tanzania|tanzania
5185901|NCT02828267|Alcohol Use|alcohol use
5185902|NCT02828267|Brief Intervention|brief intervention
5185903|NCT02828228|obesity|obesity
5185904|NCT02828228|weight loss|weight loss
5185905|NCT02828228|vitamin D deficiency|vitamin d deficiency
5185906|NCT02828228|body composition|body composition
5185907|NCT02828202|Melanoma|melanoma
5185908|NCT02828202|Skin|skin
5185909|NCT02828202|Biobank|biobank
5185910|NCT02828189|Physical Therapy Modalities|physical therapy modalities
5185911|NCT02828189|Breast Cancer Treatment|breast cancer treatment
5185912|NCT02828189|Exercise Therapy|exercise therapy
5185913|NCT02828189|Dyspnea|dyspnea
5185914|NCT02828176|cardiometry|cardiometry
5185915|NCT02828176|uterine displacement|uterine displacement
5185916|NCT02828111|Gorlin Syndrome|gorlin syndrome
5185917|NCT02828111|Basal Cell Nevus Syndrome BCNS|basal cell nevus syndrome bcns
5185918|NCT02828111|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5185919|NCT02828111|Basal cell carcinoma|basal cell carcinoma
5185920|NCT02828111|Hedgehog inhibitor|hedgehog inhibitor
5185921|NCT02828111|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
5185922|NCT02828111|High Frequency Basal Cell Carcinomas|high frequency basal cell carcinomas
5789838|NCT00146731|Tanzania|tanzania
5185923|NCT02828098|aggressive solid tumors|aggressive solid tumors
5185924|NCT02828059|Caesarean section|caesarean section
5185926|NCT02828007|NIV|niv
5185927|NCT02827968|PDL-1|pdl-1
5185928|NCT02827942|pylori|pylori
5185929|NCT02827903|Metformin|metformin
5185930|NCT02827903|Rosuvastatin|rosuvastatin
5185931|NCT02827903|type 2 diabetes|type 2 diabetes
5185932|NCT02827903|dyslipidemia|dyslipidemia
5185933|NCT02827864|Mirror therapy|mirror therapy
5185934|NCT02827864|transcranial direct current stimulation|transcranial direct current stimulation
5185935|NCT02827864|stroke|stroke
5185936|NCT02827864|neurorehabilitation|neurorehabilitation
5185937|NCT02827851|Damage of articular cartilage|damage of articular cartilage
5185938|NCT02827851|Cartilage degeneration|cartilage degeneration
5185939|NCT02827851|Intraarticular injection|intraarticular injection
5185940|NCT02827851|SVF|svf
5185941|NCT02827851|Stromal vascular fraction|stromal vascular fraction
5185942|NCT02827851|Adipose-derived regenerative cells (ADRC)|adipose-derived regenerative cells (adrc)
5185943|NCT02827851|Adipose tissue|adipose tissue
5185944|NCT02827851|Stem cells|stem cells
5185945|NCT02827825|Neurosurgical|neurosurgical
5186048|NCT02827058|Needles|needles
5185946|NCT02827825|Intensive Care|intensive care
5185947|NCT02827799|heart failure|heart failure
5185948|NCT02827799|insomnia|insomnia
5185949|NCT02827799|sleep disorders|sleep disorders
5185950|NCT02827799|actigraphy|actigraphy
5185951|NCT02827799|cardiomyopathy|cardiomyopathy
5185952|NCT02827799|depression|depression
5185953|NCT02827799|sleepiness|sleepiness
5185954|NCT02827799|anxiety|anxiety
5185955|NCT02827799|fatigue|fatigue
5185956|NCT02827786|hepatic tumours|hepatic tumours
5185957|NCT02827773|Literacy|literacy
5185958|NCT02827747|Keratoconus progression|keratoconus progression
5185959|NCT02827747|Vitamins and keratoconus|vitamins and keratoconus
5193542|NCT02783430|Cancer|cancer
5185960|NCT02827747|Vitamin supplementation|vitamin supplementation
5185961|NCT02827682|IoC|ioc
5185962|NCT02827682|monitor|monitor
5185963|NCT02827682|elderly|elderly
5185964|NCT02827682|postoperative effectiveness|postoperative effectiveness
5185965|NCT02827656|Fertilization in vitro|fertilization in vitro
5185966|NCT02827656|Luteal Phase|luteal phase
5185967|NCT02827656|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5185968|NCT02827617|Ibrutinib|ibrutinib
5185969|NCT02827617|TP53|tp53
5185970|NCT02827617|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5185971|NCT02827604|Caesarean section|caesarean section
5185972|NCT02827604|lower uterine segment|lower uterine segment
5185973|NCT02827604|sonography|sonography
5962313|NCT04281576|Novocure|novocure
5185974|NCT02827591|repeat cesarean section|repeat cesarean section
5185975|NCT02827591|lower uterine segment|lower uterine segment
5185976|NCT02827591|quantitative sonography|quantitative sonography
5185977|NCT02827565|colorectal cancer|colorectal cancer
5185978|NCT02827565|Kras mutation|kras mutation
5185979|NCT02827565|Nras mutation|nras mutation
5185980|NCT02827565|Braf mutation|braf mutation
5185981|NCT02827552|pediatric oncology|pediatric oncology
5185984|NCT02827513|Centanafadine|centanafadine
5185985|NCT02827513|Adult attention-deficit hyperactivity disorder|adult attention-deficit hyperactivity disorder
5185986|NCT02827513|Healthy participants|healthy participants
5185987|NCT02827448|Left Ventricular Assist Device|left ventricular assist device
5185988|NCT02827448|Heart Transplantation|heart transplantation
5185989|NCT02827448|Perioperative|perioperative
5185990|NCT02827448|Acute Kidney Injury|acute kidney injury
5185991|NCT02827448|Renal|renal
5185992|NCT02827448|Kidney|kidney
5185993|NCT02827448|Total Artificial Heart|total artificial heart
5185994|NCT02827422|therapeutic hypothermia|therapeutic hypothermia
5185995|NCT02827409|Delayed cord clamping|delayed cord clamping
5185996|NCT02827396|Disability|disability
5185997|NCT02827396|children|children
5185998|NCT02827396|parents|parents
5185999|NCT02827396|depression|depression
5186000|NCT02827396|knowledge|knowledge
5186001|NCT02827396|psychosocial intervention|psychosocial intervention
5186002|NCT02827344|PD-1/PD-L1|pd-1/pd-l1
5186003|NCT02827344|Immune checkpoints|immune checkpoints
5186004|NCT02827344|Immunotherapy|immunotherapy
5186005|NCT02827344|lung cancer|lung cancer
5186006|NCT02827344|circulating tumor cells|circulating tumor cells
5186007|NCT02827344|immunocytochemistry|immunocytochemistry
5186008|NCT02827344|ISET|iset
5186009|NCT02827344|MDSC|mdsc
5186010|NCT02827344|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5186011|NCT02827331|Benzodiazepines|benzodiazepines
5186012|NCT02827331|Fracture|fracture
5186013|NCT02827318|Blood glucose|blood glucose
5186014|NCT02827305|antiplaque|antiplaque
5186015|NCT02827305|antigingivitis|antigingivitis
5186016|NCT02827292|music|music
5186017|NCT02827292|inflammation|inflammation
5186018|NCT02827279|Autism Spectrum Disorder|autism spectrum disorder
5186019|NCT02827279|Emotion|emotion
5186020|NCT02827253|brain|brain
5186021|NCT02827253|haemodialysis|haemodialysis
5186022|NCT02827253|intradialytic hypotension|intradialytic hypotension
5186024|NCT02827240|HIV testing|hiv testing
5186025|NCT02827240|HIV self-test|hiv self-test
5186026|NCT02827227|HIV-infected patients|hiv-infected patients
5186027|NCT02827227|cART|cart
5186028|NCT02827227|immune restoration|immune restoration
5186029|NCT02827227|markers|markers
5186030|NCT02827214|Thoracolumbar spine|thoracolumbar spine
5186031|NCT02827214|Burst fractures|burst fractures
5186032|NCT02827214|Conservative treatment|conservative treatment
5186033|NCT02827214|Surgical treatment|surgical treatment
5186034|NCT02827214|Thoracic or lumbar vertebrae|thoracic or lumbar vertebrae
5186035|NCT02827201|pancreatic cancer|pancreatic cancer
5186036|NCT02827162|Dengue Fever|dengue fever
5186037|NCT02827162|Dengue Haemorrhagic Fever|dengue haemorrhagic fever
5186038|NCT02827162|Tetravalent Dengue Vaccine|tetravalent dengue vaccine
5186039|NCT02827149|HSCT|hsct
5186040|NCT02827149|high resolution HLA typing|high resolution hla typing
5186041|NCT02827149|unrelated donor|unrelated donor
5186042|NCT02827084|electromyography|electromyography
5186043|NCT02827084|torque|torque
5186044|NCT02827084|quadriceps muscle|quadriceps muscle
5186045|NCT02827058|Delivery, obstetric|delivery, obstetric
5186046|NCT02827058|Analgesia, Epidural|analgesia, epidural
5186047|NCT02827058|Injections, Epidural|injections, epidural
5186049|NCT02827058|Cesarean Section|cesarean section
5186051|NCT02827006|Bone graft|bone graft
5186052|NCT02827006|Calcium phosphate bone cement|calcium phosphate bone cement
5186053|NCT02827006|RCT|rct
5186054|NCT02827006|Xray|xray
5186055|NCT02827006|CT|ct
5186056|NCT02826993|PillCAM2|pillcam2
5186057|NCT02826967|Hydro-San Plus colonic irrigation system|hydro-san plus colonic irrigation system
5186058|NCT02826967|Screening colonoscopy|screening colonoscopy
5186059|NCT02826954|Paranasal Sinus Diseases|paranasal sinus diseases
5186060|NCT02826954|Nasal Obstruction|nasal obstruction
5186061|NCT02826941|hypothermia treatment|hypothermia treatment
5186062|NCT02826915|newborn|newborn
5186063|NCT02826915|infant|infant
5186064|NCT02826915|child|child
5186065|NCT02826915|EEG|eeg
5186066|NCT02826915|NIRS|nirs
5186067|NCT02826902|Total intravenous anesthesia|total intravenous anesthesia
5186068|NCT02826902|desflurane|desflurane
5186069|NCT02826902|QoR-40|qor-40
5186070|NCT02826902|correctional tibial osteotomy|correctional tibial osteotomy
5186071|NCT02826889|Fluid responsiveness|fluid responsiveness
5186072|NCT02826889|corrected flow time|corrected flow time
5186073|NCT02826889|pleth variability index|pleth variability index
5186074|NCT02826889|prone position|prone position
5186075|NCT02826876|Laparoscopic surgery|laparoscopic surgery
5186076|NCT02826863|seizure|seizure
5186077|NCT02826863|tonic-atonic|tonic-atonic
5186078|NCT02826863|epilepsy|epilepsy
5186079|NCT02826863|myoclonic|myoclonic
5186080|NCT02826863|encephalopathy|encephalopathy
5186081|NCT02826850|Osteoarthritis, Knee|osteoarthritis, knee
5186082|NCT02826850|Pulsed Radiofrequency Treatment|pulsed radiofrequency treatment
5186083|NCT02826850|Ultrasonography, Interventional|ultrasonography, interventional
5186084|NCT02826837|Advanced Colorectal Cancer|advanced colorectal cancer
5186085|NCT02826824|corpus callosum agenesis|corpus callosum agenesis
5186086|NCT02826824|agenesis|agenesis
5186087|NCT02826824|corpus callosum|corpus callosum
5186088|NCT02826811|Graft dysfunction|graft dysfunction
5186089|NCT02826811|Graft loss|graft loss
5186091|NCT02826811|Transplantation|transplantation
5186092|NCT02826811|BKV|bkv
5186093|NCT02826811|Anti-BKV|anti-bkv
5186094|NCT02826811|Nephropathy|nephropathy
5186095|NCT02826811|Immunosuppression|immunosuppression
5186096|NCT02826811|Prognostic markers|prognostic markers
5174047|NCT02904499|Pharmacoepidemiology|pharmacoepidemiology
5174048|NCT02904447|hemicap|hemicap
5174049|NCT02904447|hallux rigidus|hallux rigidus
5174050|NCT02904434|voriconazole|voriconazole
5174051|NCT02904434|absorption|absorption
5174057|NCT02904434|intestinal|intestinal
5186097|NCT02826798|VBI-1501A|vbi-1501a
5186098|NCT02826798|VBI-1501|vbi-1501
5186099|NCT02826798|prophylactic vaccine|prophylactic vaccine
5186100|NCT02826798|virus diseases|virus diseases
5186101|NCT02826798|cytomegalovirus|cytomegalovirus
5186102|NCT02826798|CMV|cmv
5186103|NCT02826798|cytomegalovirus infections|cytomegalovirus infections
5186104|NCT02826798|cytomegalovirus vaccines|cytomegalovirus vaccines
5186105|NCT02826798|Herpesviridae Infections|herpesviridae infections
5186106|NCT02826798|Phase 1|phase 1
5186107|NCT02826798|Human Herpesvirus 5|human herpesvirus 5
5186108|NCT02826798|HHV5|hhv5
5186109|NCT02826798|Vaccines, virus-like particle|vaccines, virus-like particle
5186110|NCT02826798|VLP|vlp
5186111|NCT02826798|enveloped virus-like particle|enveloped virus-like particle
5962314|NCT04281576|Gastric Adenocarcinoma|gastric adenocarcinoma
5186112|NCT02826798|eVLP|evlp
5186113|NCT02826759|sphingolipid|sphingolipid
5186114|NCT02826759|diabetes mellitus|diabetes mellitus
5186115|NCT02826759|biomarker|biomarker
5186116|NCT02826759|obesity|obesity
5186117|NCT02826759|insulin resistance|insulin resistance
5186118|NCT02826733|preterm infants|preterm infants
5186119|NCT02826733|term infants|term infants
5186120|NCT02826733|hemispheric dominance|hemispheric dominance
5186121|NCT02826720|HDL cholesterol|hdl cholesterol
5186122|NCT02826720|Hyperlipidemia|hyperlipidemia
5186123|NCT02826720|LDL cholesterol|ldl cholesterol
5186124|NCT02826720|Periodontal disease|periodontal disease
5186125|NCT02826720|Triglyceride|triglyceride
5186126|NCT02826655|WF-OCT|wf-oct
5186127|NCT02826655|OCT|oct
5186128|NCT02826655|diabetic retinopathy|diabetic retinopathy
5186129|NCT02826655|diabetic macular edema|diabetic macular edema
5186130|NCT02826642|newly diagnosed acute myeloid leukemia|newly diagnosed acute myeloid leukemia
5186131|NCT02826642|AML|aml
5186132|NCT02826642|myeloid dysplastic syndrome|myeloid dysplastic syndrome
5186133|NCT02826642|MDS|mds
5186134|NCT02826642|IDH305|idh305
5186135|NCT02826642|standard of care in IDH1 mutant acute myeloid leukemia|standard of care in idh1 mutant acute myeloid leukemia
5186136|NCT02826629|Sensorimotor Integration|sensorimotor integration
5186137|NCT02826629|Schizophrenia|schizophrenia
5186138|NCT02826629|TMS|tms
5186139|NCT02826629|Oculomotor|oculomotor
5186140|NCT02826629|Motor Control|motor control
5186141|NCT02826616|Trimetazidine|trimetazidine
5186142|NCT02826616|ST-segment elevation myocardial|st-segment elevation myocardial
5186143|NCT02826616|Reperfusion injury|reperfusion injury
5186144|NCT02826616|Percutaneous coronary intervention|percutaneous coronary intervention
5186145|NCT02826603|Plaque psoriasis|plaque psoriasis
5186146|NCT02826603|secukinumab|secukinumab
5186147|NCT02826603|ustekinumab|ustekinumab
5186148|NCT02826603|ain457|ain457
5186149|NCT02826603|ain457a|ain457a
5186150|NCT02826564|radiotherapy|radiotherapy
5186151|NCT02826564|immunotherapy|immunotherapy
5186152|NCT02826512|BRCA1-like|brca1-like
5186153|NCT02826512|HER2 negative|her2 negative
5186154|NCT02826499|Pediguard|pediguard
5186155|NCT02826499|Pedicular screws|pedicular screws
5186156|NCT02826499|Fluoroscopy|fluoroscopy
5186157|NCT02826473|Dementia|dementia
5186158|NCT02826473|Dementia screening|dementia screening
5186159|NCT02826473|General Hospital|general hospital
5186160|NCT02826473|Inpatients|inpatients
5186161|NCT02826460|Transplant|transplant
5186162|NCT02826460|Adherence|adherence
5186163|NCT02826434|Breast Cancer|breast cancer
5186164|NCT02826434|vaccine|vaccine
5186165|NCT02826434|immunotherapy|immunotherapy
5186166|NCT02826434|PD-L1 Inhibitor|pd-l1 inhibitor
5186167|NCT02826434|triple negative breast cancer|triple negative breast cancer
5186168|NCT02826421|Intraocular lens|intraocular lens
5186169|NCT02826395|Prostate cancer|prostate cancer
5186170|NCT02826395|diagnostic|diagnostic
5186172|NCT02826395|PET/CT|pet/ct
5186173|NCT02826395|Acetate carbon-11|acetate carbon-11
5186174|NCT02826369|Algorithms|algorithms
5186175|NCT02826369|Image Processing, Computer-Assisted/methods*|image processing, computer-assisted/methods*
5186176|NCT02826369|Magnetic Resonance Imaging/methods*|magnetic resonance imaging/methods*
5186177|NCT02826369|Data Compression|data compression
5186178|NCT02826369|Breast Neoplasms|breast neoplasms
5186179|NCT02826356|Angioedema|angioedema
5186180|NCT02826356|Emergency treatment|emergency treatment
5186181|NCT02826356|Treatment availability|treatment availability
5186182|NCT02826356|Health Equity|health equity
5186190|NCT02826304|Large uteri|large uteri
5186191|NCT02826291|OSNA|osna
5186192|NCT02826291|sentinel|sentinel
5186193|NCT02826291|lymph|lymph
5186194|NCT02826291|node|node
5186195|NCT02826291|endometrial|endometrial
5186196|NCT02826291|cancer|cancer
5186197|NCT02826278|Newborn genitalia|newborn genitalia
5186198|NCT02826278|reference charts|reference charts
5186199|NCT02826252|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5186200|NCT02826213|Renal infusion|renal infusion
5186201|NCT02826213|Renal infusion device|renal infusion device
5186202|NCT02826200|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5186203|NCT02826200|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5186204|NCT02826200|Prosthetic Cardiac Valve Thrombosis|prosthetic cardiac valve thrombosis
5186205|NCT02826200|Cerebrovascular Accident|cerebrovascular accident
5186206|NCT02826200|Prosthetic Valve Malfunction|prosthetic valve malfunction
5186207|NCT02826200|Four-dimensional volume rendered cardiac CT|four-dimensional volume rendered cardiac ct
5186208|NCT02826200|Transesophageal echocardiography|transesophageal echocardiography
5186209|NCT02826200|Transthoracic echocardiography|transthoracic echocardiography
5186210|NCT02826200|Brain MRI|brain mri
5186211|NCT02826187|Acetabular implant|acetabular implant
5186212|NCT02826161|Neoplasms|neoplasms
5186213|NCT02826161|Neoplasms by Site|neoplasms by site
5186214|NCT02826161|Lung Neoplasms|lung neoplasms
5186215|NCT02826161|Thoracic Neoplasms|thoracic neoplasms
5186216|NCT02826161|Respiratory Tract Neoplasms|respiratory tract neoplasms
5186217|NCT02826161|Bronchial Neoplasms|bronchial neoplasms
5186218|NCT02826096|Psychiatry|psychiatry
5186219|NCT02826096|psychological|psychological
5186220|NCT02826096|psychotherapy|psychotherapy
5186221|NCT02826096|randomize|randomize
5186222|NCT02826096|Biofeedback|biofeedback
5186223|NCT02826070|Chronic Hepatitis B|chronic hepatitis b
5186224|NCT02826031|Sodium Hyaluronate|sodium hyaluronate
5186225|NCT02826031|mild to moderate knee osteoarthritis|mild to moderate knee osteoarthritis
5186226|NCT02826018|RNAi therapeutic|rnai therapeutic
5186227|NCT02826018|Hepatitis B|hepatitis b
5186228|NCT02826018|Chronic Hepatitis B|chronic hepatitis b
5186229|NCT02826018|Hepatitis B, Chronic|hepatitis b, chronic
5186230|NCT02826018|Hepatitis B Infection|hepatitis b infection
5186231|NCT02826018|HBV|hbv
5186232|NCT02825927|Dysphagia|dysphagia
5186233|NCT02825927|Oral screen|oral screen
5186234|NCT02825927|Intervention|intervention
5186235|NCT02825927|Oral Health|oral health
5186236|NCT02825927|Food Intake|food intake
5186237|NCT02825927|Quality of life|quality of life
5186238|NCT02825927|Elderly|elderly
5186239|NCT02825927|Short-term care facilities|short-term care facilities
5186240|NCT02825914|glycopeptides|glycopeptides
5186241|NCT02825914|human microbiome|human microbiome
5186242|NCT02825914|caseinomacropeptide|caseinomacropeptide
5186243|NCT02825914|whey protein|whey protein
5186244|NCT02825914|dietary proteins|dietary proteins
5186245|NCT02825849|endometrium|endometrium
5186246|NCT02825849|thin uterine lining|thin uterine lining
5186247|NCT02825849|uterine scarring|uterine scarring
5186248|NCT02825836|M7583|m7583
5186249|NCT02825836|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
5186250|NCT02825836|Lymphoma|lymphoma
5186251|NCT02825836|Open|open
5186252|NCT02825836|Phase I|phase i
5186253|NCT02825810|breast cancer|breast cancer
5186254|NCT02825810|long-term survival|long-term survival
5186255|NCT02825810|motor control|motor control
5186256|NCT02825810|cervical pain|cervical pain
5186257|NCT02825797|Broadly neutralizing antibody|broadly neutralizing antibody
5186258|NCT02825797|3BNC117|3bnc117
5186259|NCT02825797|10-1074|10-1074
5186260|NCT02825784|potassium chronic kidney disease CKD children|potassium chronic kidney disease ckd children
5186261|NCT02825758|Micronutrients|micronutrients
5186262|NCT02825758|restricted|restricted
5186263|NCT02825758|ketogenic|ketogenic
5186264|NCT02825758|diet|diet
5186266|NCT02825732|Alzheimer's disease or related disorder|alzheimer's disease or related disorder
5186267|NCT02825732|Comorbidity|comorbidity
5186268|NCT02825732|Charlson comorbidity index|charlson comorbidity index
5186269|NCT02825732|Caregiver burden|caregiver burden
5186270|NCT02825732|Cohort|cohort
5186271|NCT02825732|Dementia|dementia
5186275|NCT02825719|Ulipristal|ulipristal
5186276|NCT02825719|Selective progesterone receptor modulator|selective progesterone receptor modulator
5186277|NCT02825719|Chinese|chinese
5186278|NCT02825706|Hemophilia|hemophilia
5186279|NCT02825706|Educational Physiotherapy|educational physiotherapy
5186280|NCT02825706|Pain|pain
5186281|NCT02825706|Quality of life|quality of life
5061004|NCT03617640|enteric neuropathies|enteric neuropathies
5061005|NCT03617640|Immune cells|immune cells
5061009|NCT03617627|women|women
5186282|NCT02825706|Illness Behaviour|illness behaviour
5186283|NCT02825706|Elbow|elbow
5186284|NCT02825680|Weight Loss|weight loss
5186285|NCT02825680|Body Weight Maintenance|body weight maintenance
5186286|NCT02825680|Quality Improvement|quality improvement
5186287|NCT02825667|Haemophilia|haemophilia
5186288|NCT02825667|Ankle|ankle
5186289|NCT02825667|Arthropathy|arthropathy
5186290|NCT02825667|Pain|pain
5186291|NCT02825667|Range of motion|range of motion
5186292|NCT02825667|Myofascial techniques|myofascial techniques
5186293|NCT02825654|Pulmonary|pulmonary
5186294|NCT02825654|Lung|lung
5186295|NCT02825654|Military and environmental exposures|military and environmental exposures
5186296|NCT02825654|Epidemiologic|epidemiologic
5186297|NCT02825654|Observational|observational
5186298|NCT02825654|Interview or questionnaire|interview or questionnaire
5186299|NCT02825654|Deployment related|deployment related
5186300|NCT02825654|Enduring Freedom|enduring freedom
5186301|NCT02825654|Iraqi Freedom|iraqi freedom
5186302|NCT02825615|radial artery cannulation|radial artery cannulation
5186303|NCT02825615|ultrasound guided|ultrasound guided
5186304|NCT02825615|first success rate|first success rate
5186305|NCT02825615|systolic blood pressure|systolic blood pressure
5186306|NCT02825615|shock|shock
5186307|NCT02825602|Vietnam veteran|vietnam veteran
5186308|NCT02825602|aging|aging
5186309|NCT02825602|health|health
5186310|NCT02825602|War Injury|war injury
5186311|NCT02825602|Conventional Warfare|conventional warfare
5186312|NCT02825602|Toxic Effect|toxic effect
5186313|NCT02825602|Chemical|chemical
5186314|NCT02825589|BIA|bia
5186315|NCT02825589|chronic hemodialysis|chronic hemodialysis
5186316|NCT02825589|sleep quality|sleep quality
5186317|NCT02825550|Hepatoma|hepatoma
5186318|NCT02825550|Transcatheter Arterial chemo-embolization|transcatheter arterial chemo-embolization
5186319|NCT02825550|Microsphere|microsphere
5186320|NCT02825511|basal cell carcinoma, histological diagnosis, prognostic impact|basal cell carcinoma, histological diagnosis, prognostic impact
5186321|NCT02825472|Congenital Heart Disease|congenital heart disease
5186322|NCT02825472|Sport|sport
5789839|NCT00146718|malaria|malaria
5186329|NCT02825459|harm reduction|harm reduction
5186330|NCT02825459|nicotine|nicotine
5186331|NCT02825459|nicotine dependence|nicotine dependence
5186332|NCT02825459|smoking|smoking
5186333|NCT02825459|smoking cessation|smoking cessation
5186334|NCT02825459|tobacco|tobacco
5186335|NCT02825459|vape|vape
5186336|NCT02825459|vaping|vaping
5186337|NCT02825459|withdrawal|withdrawal
5186338|NCT02825446|radio frequency denervation|radio frequency denervation
5186339|NCT02825446|tibial arteries|tibial arteries
5186340|NCT02825446|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
5186341|NCT02825381|Arthroplasty|arthroplasty
5186342|NCT02825381|Hip|hip
5186343|NCT02825355|robotic surgery procedure|robotic surgery procedure
5186344|NCT02825355|indocyanine green|indocyanine green
5186345|NCT02825355|sentinel lymph node mapping|sentinel lymph node mapping
5186346|NCT02825342|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5186347|NCT02825342|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
5186348|NCT02825316|Crohn's disease|crohn's disease
5186349|NCT02825316|inflammatory bowel diseases|inflammatory bowel diseases
5186350|NCT02825316|Mediterranean diet|mediterranean diet
5186351|NCT02825316|microbiome|microbiome
5186446|NCT02824718|Thiazides|thiazides
5186352|NCT02825303|postural changes|postural changes
5186353|NCT02825303|Height adjustable desk|height adjustable desk
5186354|NCT02825303|Prolonged sitting|prolonged sitting
5186355|NCT02825303|Cognitive performance|cognitive performance
5186356|NCT02825290|Frozen-thawed embryo transfer (FET)|frozen-thawed embryo transfer (fet)
5186357|NCT02825290|Luteal support|luteal support
5186358|NCT02825290|Progesterone|progesterone
5186359|NCT02825290|Natural cycle|natural cycle
5186360|NCT02825290|Cryopreservation|cryopreservation
5186362|NCT02825290|hCG|hcg
5186363|NCT02825290|GnRH-Agonist|gnrh-agonist
5186364|NCT02825290|Pregnancy rate|pregnancy rate
5186365|NCT02825277|3D Power Doppler|3d power doppler
5186366|NCT02825277|uteroplacental vascularization|uteroplacental vascularization
5186367|NCT02825277|preeclampsia|preeclampsia
5186368|NCT02825277|intra-uterine growth restriction|intra-uterine growth restriction
5186369|NCT02825277|placental morphology|placental morphology
5186370|NCT02825264|Glaucoma Drainage Device|glaucoma drainage device
5186372|NCT02825238|exercise|exercise
5186373|NCT02825238|osteoarthritis|osteoarthritis
5186374|NCT02825238|knee|knee
5186375|NCT02825238|patellofemoral pain|patellofemoral pain
5186376|NCT02825225|Prostatic Neoplasms|prostatic neoplasms
5186378|NCT02825225|Anesthesia|anesthesia
5962315|NCT04281576|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5962316|NCT04281511|Pancreatic cancer|pancreatic cancer
5962317|NCT04281511|Biomarker|biomarker
5186379|NCT02825225|Detection|detection
5186380|NCT02825212|Hepatitis C|hepatitis c
5186381|NCT02825212|Cryoglobulinemia|cryoglobulinemia
5962318|NCT04281511|chemotherapy|chemotherapy
5061153|NCT03616756|Stress|stress
5186388|NCT02825147|pegaspargase,methotrexate|pegaspargase,methotrexate
5186389|NCT02825134|heart valve disease|heart valve disease
5186390|NCT02825134|valvular bioprosthesis|valvular bioprosthesis
5186391|NCT02825134|aortic valve replacement|aortic valve replacement
5186392|NCT02825134|Randomized clinical trial|randomized clinical trial
5186393|NCT02825108|human chorionic gonadotropin (hCG), implantation rate intrauterine hCG clinical pregnancy rate frozen embryo transfer cycles|human chorionic gonadotropin (hcg), implantation rate intrauterine hcg clinical pregnancy rate frozen embryo transfer cycles
5186519|NCT02824289|skin cancer|skin cancer
5186394|NCT02825095|malignant pleural effusion,talc pleurodesis,quality of life|malignant pleural effusion,talc pleurodesis,quality of life
5186395|NCT02825082|Emergency general surgery|emergency general surgery
5186396|NCT02825082|Geriatric|geriatric
5186397|NCT02825082|Outcomes|outcomes
5186398|NCT02825082|Frailty|frailty
5186399|NCT02825043|COPD|copd
5186400|NCT02825004|Burnout|burnout
5186401|NCT02825004|Health Care Workers|health care workers
5186402|NCT02825004|Coping Skills|coping skills
5186403|NCT02825004|Clinical Trial|clinical trial
5186404|NCT02824952|Tagrisso|tagrisso
5186405|NCT02824952|AZD9291|azd9291
5186406|NCT02824952|EGFRm|egfrm
5186407|NCT02824952|NSCLC|nsclc
5186408|NCT02824900|Vibration Stimuli|vibration stimuli
5186409|NCT02824900|Contraversive Pusher Syndrome|contraversive pusher syndrome
5186410|NCT02824887|Electroacupuncture|electroacupuncture
5186411|NCT02824887|Deep needling|deep needling
5186412|NCT02824887|Lumbar disc herniation five points|lumbar disc herniation five points
5186413|NCT02824887|Long term effect|long term effect
5186414|NCT02824887|Prospective cohort study|prospective cohort study
5186415|NCT02824848|congenital muscular torticollis|congenital muscular torticollis
5186416|NCT02824848|infants|infants
5186417|NCT02824848|passive stretching|passive stretching
5186418|NCT02824848|perception-action approach|perception-action approach
5186419|NCT02824822|Sudden Unexpected Death in Epilepsy|sudden unexpected death in epilepsy
5186420|NCT02824822|SUDEP|sudep
5186421|NCT02824822|Sudden Cardiac Arrest|sudden cardiac arrest
5186422|NCT02824822|Sudden Cardiac Death|sudden cardiac death
5186423|NCT02824822|Sleep|sleep
5186424|NCT02824822|Ion channel disease|ion channel disease
5186425|NCT02824822|Long QT syndrome|long qt syndrome
5186426|NCT02824822|Brugada|brugada
5186427|NCT02824822|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
5186428|NCT02824809|hypogonadism|hypogonadism
5186429|NCT02824809|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5186430|NCT02824809|Severity of Illness Index|severity of illness index
5186431|NCT02824809|Testosterone|testosterone
5186432|NCT02824796|ADHD|adhd
5186433|NCT02824783|colorectal surgery|colorectal surgery
5186434|NCT02824783|enhanced recovery|enhanced recovery
5186435|NCT02824757|interstitial lung disease|interstitial lung disease
5186436|NCT02824757|glucocorticcoid|glucocorticcoid
5186437|NCT02824757|glucose|glucose
5186438|NCT02824757|continuous glucose monitor|continuous glucose monitor
5186439|NCT02824744|Bronchiolitis|bronchiolitis
5186440|NCT02824744|High flow nasal canula|high flow nasal canula
5186441|NCT02824731|brain tumors|brain tumors
5186442|NCT02824731|proton radiotherapy|proton radiotherapy
5186443|NCT02824731|photon radiotherapy|photon radiotherapy
5186444|NCT02824718|Hypoparathyroidism|hypoparathyroidism
5186445|NCT02824718|PTH(1-34)|pth(1-34)
5186447|NCT02824718|Hypercalciuria|hypercalciuria
5186448|NCT02824718|Calcium sensing receptor|calcium sensing receptor
5186449|NCT02824705|Heart|heart
5186450|NCT02824705|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5186451|NCT02824705|pediatric critical care|pediatric critical care
5186452|NCT02824705|congenital heart disease|congenital heart disease
5186453|NCT02824679|Normal labour|normal labour
5186454|NCT02824679|Augmentation of labour|augmentation of labour
5186455|NCT02824679|Hyoscine butylbromide|hyoscine butylbromide
5186456|NCT02824653|acute GVHD|acute gvhd
5186457|NCT02824653|chronic GVHD|chronic gvhd
5186458|NCT02824653|steroid-refractory|steroid-refractory
5186459|NCT02824653|Mesenchymal Stem Cells|mesenchymal stem cells
5186460|NCT02824640|Addiction|addiction
5186461|NCT02824640|Adherence|adherence
5186462|NCT02824640|Adverse Effects|adverse effects
5186463|NCT02824640|Direct Acting Antiviral Agent|direct acting antiviral agent
5186464|NCT02824640|Chronic Hepatitis C|chronic hepatitis c
5186465|NCT02824640|Resistance Development|resistance development
5186466|NCT02824640|Methadone Clinic|methadone clinic
5186467|NCT02824640|Primary Care|primary care
5186468|NCT02824640|Directly Observed Therapy|directly observed therapy
5186469|NCT02824640|Randomized Controlled Trial|randomized controlled trial
5186470|NCT02824640|Resistance|resistance
5186471|NCT02824640|Reinfection|reinfection
5186472|NCT02824640|Treatment Outcome|treatment outcome
5186473|NCT02824640|Patient Navigation|patient navigation
5186474|NCT02824640|Multi-Site|multi-site
5186477|NCT02824640|Sustained Viral Response|sustained viral response
5186479|NCT02824588|Working memory|working memory
5186480|NCT02824575|breast cancer|breast cancer
5186481|NCT02824575|chemotherapy|chemotherapy
5962319|NCT04281511|pharmacogenomic|pharmacogenomic
5186482|NCT02824575|metastasis|metastasis
5186483|NCT02824575|tumor micro-environment|tumor micro-environment
5186484|NCT02824549|Flash glucose monitoring|flash glucose monitoring
5174449|NCT02901951|adult subjects|adult subjects
5174450|NCT02901951|Hepatitis B|hepatitis b
5174456|NCT02901912|physical activity|physical activity
5174457|NCT02901912|sedentarism|sedentarism
5186485|NCT02824549|skin reactions|skin reactions
5186486|NCT02824549|usability|usability
5186487|NCT02824549|accuracy|accuracy
5186488|NCT02824536|3BNC117|3bnc117
5186489|NCT02824536|10-1074|10-1074
5186490|NCT02824536|Broadly neutralizing antibody|broadly neutralizing antibody
5186491|NCT02824536|HIV Prevention|hiv prevention
5186492|NCT02824523|asthma|asthma
5186493|NCT02824523|nasal polyps|nasal polyps
5186494|NCT02824523|aspirin sensitivity|aspirin sensitivity
5186495|NCT02824523|AERD|aerd
5186496|NCT02824484|Guided written disclosure protocol|guided written disclosure protocol
5186497|NCT02824484|Emotional disclosure|emotional disclosure
5186498|NCT02824484|Meaning|meaning
5186499|NCT02824484|Post-Traumatic Growth|post-traumatic growth
5186500|NCT02824484|Cancer|cancer
5186501|NCT02824471|Sickle Cell Disease|sickle cell disease
5186502|NCT02824471|Biofluidic Chip Technology|biofluidic chip technology
5186503|NCT02824458|EGFR tyrosine kinase inhibitors|egfr tyrosine kinase inhibitors
5186504|NCT02824458|VEGFR inhibitor|vegfr inhibitor
5186505|NCT02824458|NSCLC|nsclc
5186506|NCT02824406|Sickle Cell Anemia|sickle cell anemia
5186507|NCT02824406|Cerebrovascular Reserve|cerebrovascular reserve
5186508|NCT02824406|Perfusion|perfusion
5186509|NCT02824406|Vasculopathy|vasculopathy
5186510|NCT02824406|Magnetic Resonance Imaging|magnetic resonance imaging
5186511|NCT02824393|Mesenchymal stem cell|mesenchymal stem cell
5186512|NCT02824393|Chronic autoimmune urticaria|chronic autoimmune urticaria
5186513|NCT02824367|Parkinson|parkinson
5186514|NCT02824367|Perfectionism|perfectionism
5186515|NCT02824341|Parkinson 's disease|parkinson 's disease
5186516|NCT02824341|REM sleep behavior disorder|rem sleep behavior disorder
5186517|NCT02824341|Reward system|reward system
5186518|NCT02824341|Functional MRI|functional mri
5186520|NCT02824289|prevention|prevention
5186521|NCT02824289|worksite|worksite
5186522|NCT02824289|policy|policy
5186523|NCT02824263|obstructive sleep apnea|obstructive sleep apnea
5186524|NCT02824263|CPAP|cpap
5186525|NCT02824263|metabolism|metabolism
5186526|NCT02824250|Migraine|migraine
5186527|NCT02824250|Mindfulness|mindfulness
5186528|NCT02824250|MBSR|mbsr
5186529|NCT02824224|levonorgestrel|levonorgestrel
5186530|NCT02824224|breakthrough bleeding|breakthrough bleeding
5186531|NCT02824198|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5186532|NCT02824198|Dengue Virus|dengue virus
5186533|NCT02824198|CYD Dengue Vaccine|cyd dengue vaccine
5186534|NCT02824185|FCH-PET/MRI|fch-pet/mri
5186535|NCT02824185|primary HCC|primary hcc
5186536|NCT02824185|curative treatment|curative treatment
5186537|NCT02824185|resection|resection
5186538|NCT02824185|thermo-ablation|thermo-ablation
5186539|NCT02824185|transplantation|transplantation
5186540|NCT02824172|Cast immobilization|cast immobilization
5186541|NCT02824172|Complete rest|complete rest
5186542|NCT02824172|Osgood Schlatter|osgood schlatter
5186543|NCT02824159|ibrutinib|ibrutinib
5186544|NCT02824159|idelalisib|idelalisib
5186545|NCT02824159|side effect|side effect
5186546|NCT02824159|pharmacokinetic|pharmacokinetic
5186547|NCT02824159|plasma balance mean concentration|plasma balance mean concentration
5186548|NCT02824146|atelectasis|atelectasis
5186549|NCT02824146|children|children
5186550|NCT02824146|lung ultrasound|lung ultrasound
5186551|NCT02824146|lung recruitment|lung recruitment
5186552|NCT02824133|Glioma grade III|glioma grade iii
5186553|NCT02824133|Glioma grade IV|glioma grade iv
5186554|NCT02824133|Glioma recurrent|glioma recurrent
5186555|NCT02824133|IDHwt|idhwt
5186556|NCT02824133|FGFR-TACC fusion|fgfr-tacc fusion
5186557|NCT02824120|ischemic heart disease|ischemic heart disease
5186558|NCT02824120|laugh therapy|laugh therapy
5186559|NCT02824094|Expanded Access Protocol|expanded access protocol
5186560|NCT02824094|crizotinib|crizotinib
5186561|NCT02824094|Xalkori|xalkori
5186562|NCT02824094|ROS1|ros1
5186563|NCT02824094|Japanese|japanese
5186564|NCT02824094|A8081064|a8081064
5186565|NCT02824081|Psychiatry|psychiatry
5186566|NCT02824081|Depressive disorder|depressive disorder
5186567|NCT02824081|Suicide|suicide
5186568|NCT02824081|Inflammation|inflammation
5186569|NCT02824042|Phase 1|phase 1
5186570|NCT02824042|Solid tumors|solid tumors
5186571|NCT02824042|Mesothelin|mesothelin
5186572|NCT02824042|Itraconazole|itraconazole
5182266|NCT02850341|Physical Exercise|physical exercise
5186579|NCT02823964|cystic fibrosis|cystic fibrosis
5186580|NCT02823964|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5186581|NCT02823912|Capsaicin|capsaicin
5186582|NCT02823912|Dyslipidemia|dyslipidemia
5186583|NCT02823912|Inflammatory cytokines|inflammatory cytokines
5186584|NCT02823899|cholera vaccine|cholera vaccine
5186585|NCT02823899|hikojima serotype|hikojima serotype
5061424|NCT03615157|Home-based exercise|home-based exercise
5061425|NCT03615157|Functional capacity|functional capacity
5061426|NCT03615157|Chronic Heart Failure|chronic heart failure
5061427|NCT03615144|T-cell|t-cell
5061428|NCT03615144|B-cell|b-cell
5061429|NCT03615144|CliniMACS System|clinimacs system
5061430|NCT03615144|Melphalan|melphalan
5061431|NCT03615144|Thiotepa|thiotepa
5061448|NCT03615053|PK|pk
5186586|NCT02823899|randomized trial|randomized trial
5186587|NCT02823899|immunogenicity|immunogenicity
5186588|NCT02823886|myocardial infarction|myocardial infarction
5186590|NCT02823886|inflammatory biomarkers|inflammatory biomarkers
5186591|NCT02823873|Hypertension|hypertension
5186592|NCT02823873|Pregnant|pregnant
5186593|NCT02823873|Preeclampsia|preeclampsia
5186594|NCT02823873|Gestational Hypertension|gestational hypertension
5186595|NCT02823873|Blood Pressure|blood pressure
5186596|NCT02823873|Pregnant Women|pregnant women
5186597|NCT02823873|Postpartum Women|postpartum women
5186598|NCT02823860|Peritoneal carcinomatosis|peritoneal carcinomatosis
5186599|NCT02823860|Biobanking|biobanking
5186600|NCT02823860|Biospecimen research|biospecimen research
5186601|NCT02823860|Prospective clinical database|prospective clinical database
5186602|NCT02823860|Tissue banking|tissue banking
5186603|NCT02823860|Quality of Life|quality of life
5186604|NCT02823860|various histological subtypes|various histological subtypes
5186605|NCT02823847|Malignant neoplasms of mesothelial and soft tissue|malignant neoplasms of mesothelial and soft tissue
5186606|NCT02823847|Human immunodeficiency virus|human immunodeficiency virus
5186607|NCT02823847|HIV|hiv
5186608|NCT02823847|Carbon monoxide test|carbon monoxide test
5186609|NCT02823847|Self-help materials|self-help materials
5186610|NCT02823847|Visual Oral Screening Examination|visual oral screening examination
5186611|NCT02823847|Direct Fluorescent Oral Visualization Examination|direct fluorescent oral visualization examination
5186612|NCT02823847|Oral Biopsy|oral biopsy
5186613|NCT02823834|osteoarthritis|osteoarthritis
5186614|NCT02823834|avascular necrosis|avascular necrosis
5186615|NCT02823834|ankylosis|ankylosis
5791595|NCT00137644|Safe Sex|safe sex
5186631|NCT02823795|Self determination theory|self determination theory
5186632|NCT02823795|Motivational Interviewing|motivational interviewing
5186633|NCT02823782|Laminar HP|laminar hp
5186634|NCT02823782|Complex HP|complex hp
5186637|NCT02823743|recurrent pregnancy loss, Habitual abortion|recurrent pregnancy loss, habitual abortion
5186638|NCT02823704|Sepsis|sepsis
5186639|NCT02823704|Chest pain|chest pain
5186640|NCT02823704|Abdominal pain|abdominal pain
5186641|NCT02823704|Electrolyte disturbances|electrolyte disturbances
5186642|NCT02823704|Stroke|stroke
5186643|NCT02823704|Triage|triage
5186644|NCT02823704|Risk for death|risk for death
5186645|NCT02823691|NETs|nets
5186646|NCT02823665|gastric bypass surgery|gastric bypass surgery
5186647|NCT02823665|Hypoglycemia|hypoglycemia
5186648|NCT02823665|sleeve gastrectomy|sleeve gastrectomy
5186649|NCT02823665|glucose tolerance|glucose tolerance
5186650|NCT02823613|ENaC|enac
5186651|NCT02823613|Exosomes|exosomes
5186652|NCT02823613|Urinary biomarker|urinary biomarker
5186653|NCT02823613|Salt regulation|salt regulation
5186654|NCT02823600|retinal screening|retinal screening
5186655|NCT02823600|outpatient dialysis|outpatient dialysis
5186656|NCT02823587|Bronchiectasis|bronchiectasis
5186657|NCT02823587|Mucociliary clearance|mucociliary clearance
5186658|NCT02823587|Exercise|exercise
5186659|NCT02823587|Inflammation|inflammation
5186660|NCT02823535|military|military
5186661|NCT02823535|veteran|veteran
5186662|NCT02823535|military spouse|military spouse
5186663|NCT02823444|Magnetic Resonance Imaging|magnetic resonance imaging
5186664|NCT02823444|Magnetic Resonance Angiography|magnetic resonance angiography
5186665|NCT02823431|voiding efficiency|voiding efficiency
5186666|NCT02823431|detrusor underactivity|detrusor underactivity
5186667|NCT02823431|urodynamics|urodynamics
5186668|NCT02823418|primipara|primipara
5186669|NCT02823418|childbirth|childbirth
5186670|NCT02823418|neuraxial labor analgesia|neuraxial labor analgesia
5186671|NCT02823418|postpartum depression|postpartum depression
5186672|NCT02823405|Advance malignancy|advance malignancy
5186673|NCT02823392|unexpected difficult bag mask ventilation|unexpected difficult bag mask ventilation
5186674|NCT02823392|difficult intubation|difficult intubation
5186675|NCT02823392|predictors|predictors
5186676|NCT02823392|pediatric anesthesia|pediatric anesthesia
5186677|NCT02823379|physical activity|physical activity
5186678|NCT02823379|overweight|overweight
5186679|NCT02823379|obese|obese
5186680|NCT02823379|exercise|exercise
5186681|NCT02823379|women|women
5186682|NCT02823379|African American|african american
5186683|NCT02823379|Smartphone|smartphone
5962320|NCT04281511|clinical trials|clinical trials
5962321|NCT04281498|Phase II|phase ii
5962322|NCT04281498|Myelofibrosis|myelofibrosis
5962323|NCT04281498|Therapeutic|therapeutic
5962324|NCT04281498|Ruxolitnib|ruxolitnib
5962325|NCT04281498|Enasidenib|enasidenib
5962326|NCT04281498|IDH2|idh2
5962327|NCT04281485|Clinical trial|clinical trial
5962328|NCT04281485|Gene therapy|gene therapy
5962329|NCT04281485|Duchenne muscular dystrophy|duchenne muscular dystrophy
5962330|NCT04281459|Short-cycle therapy|short-cycle therapy
5061656|NCT03613493|HPV|hpv
5186684|NCT02823379|cardiovascular disease risk|cardiovascular disease risk
5186686|NCT02823366|UDCA|udca
5186687|NCT02823366|Fenofibrate|fenofibrate
5186688|NCT02823353|PBC|pbc
5186689|NCT02823353|UDCA|udca
5186690|NCT02823353|Fenofibrate|fenofibrate
5186691|NCT02823288|intimate partner violence|intimate partner violence
5186692|NCT02823288|masculinity|masculinity
5186693|NCT02823288|community mobilization|community mobilization
5186694|NCT02823288|social intervention|social intervention
5186696|NCT02823262|Breast Cancer|breast cancer
5174644|NCT02900534|divorce|divorce
5174645|NCT02900534|online self-help|online self-help
5174649|NCT02900469|RANK|rank
5174650|NCT02900469|RANKL|rankl
5174651|NCT02900456|Intra-aortic Balloon Pumps|intra-aortic balloon pumps
5174652|NCT02900456|Registry|registry
5174653|NCT02900417|type 2 diabetes|type 2 diabetes
5174654|NCT02900417|gut microbiota|gut microbiota
5186697|NCT02823262|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
5186698|NCT02823262|Node-negative Breast Cancer|node-negative breast cancer
5186699|NCT02823262|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
5186700|NCT02823236|Keloid|keloid
5186701|NCT02823236|Scar|scar
5186702|NCT02823223|Endobronchial Valve|endobronchial valve
5186703|NCT02823197|determinants|determinants
5186704|NCT02823197|active transport|active transport
5186705|NCT02823197|intervention|intervention
5186706|NCT02823197|adolescents|adolescents
5186707|NCT02823184|Myeloproliferative neoplasms|myeloproliferative neoplasms
5186708|NCT02823184|Endoplasmic reticulum stress|endoplasmic reticulum stress
5186709|NCT02823171|Bioequivalence Study|bioequivalence study
5186710|NCT02823171|Healthy subjects|healthy subjects
5186711|NCT02823158|Parkinson Disease|parkinson disease
5186712|NCT02823158|Morbus Parkinson|morbus parkinson
5186713|NCT02823158|Basal Ganglia|basal ganglia
5186714|NCT02823158|Pallidal Stimulation|pallidal stimulation
5186719|NCT02823145|encephalopathy|encephalopathy
5186720|NCT02823119|Mini-hysteroscopy|mini-hysteroscopy
5186721|NCT02823119|Office hysteroscopy|office hysteroscopy
5186722|NCT02823119|Pain|pain
5186723|NCT02823093|vascular calcification|vascular calcification
5186724|NCT02823093|aortic calcification|aortic calcification
5186725|NCT02823093|vitamin K antagonist|vitamin k antagonist
5186726|NCT02823093|fluindione|fluindione
5186727|NCT02823093|warfarin|warfarin
5186728|NCT02823093|matrix gla protein|matrix gla protein
5186729|NCT02823067|Pemphigoid|pemphigoid
5186730|NCT02823067|Bullous pemphigoid|bullous pemphigoid
5186731|NCT02823067|Pruritus|pruritus
5186732|NCT02823067|Senile pruritus|senile pruritus
5186733|NCT02823067|Neuropsychiatric symptoms|neuropsychiatric symptoms
5186734|NCT02823054|elective surgery|elective surgery
5186735|NCT02823054|CABG|cabg
5186736|NCT02823054|One-lung ventilation|one-lung ventilation
5186737|NCT02823054|EZ Blockers|ez blockers
5186738|NCT02823054|pleural effusion|pleural effusion
5186739|NCT02823041|cognitive training|cognitive training
5186740|NCT02823041|aerobic exercise|aerobic exercise
5186741|NCT02823041|neurotrophic factors|neurotrophic factors
5186742|NCT02823041|randomized controlled trial|randomized controlled trial
5186743|NCT02823041|functional outcome|functional outcome
5186744|NCT02823028|Smoking|smoking
5186745|NCT02823028|Social Media|social media
5186746|NCT02823028|Twitter|twitter
5186747|NCT02823028|Behavior Change|behavior change
5186748|NCT02823028|Social Support|social support
5186752|NCT02822963|Transurethral resection of the prostate|transurethral resection of the prostate
5186753|NCT02822963|Anticoagulants|anticoagulants
5186754|NCT02822963|Platelet aggregation inhibitors|platelet aggregation inhibitors
5186755|NCT02822911|elderly|elderly
5186756|NCT02822911|chronic alcoholism|chronic alcoholism
5186757|NCT02822911|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
5186758|NCT02822911|Biological Detection / Diagnosis|biological detection / diagnosis
5186759|NCT02822898|Maintenance|maintenance
5186760|NCT02822898|Intravenous solutions|intravenous solutions
5186761|NCT02822898|Intravenous fluids|intravenous fluids
5186762|NCT02822898|Tonicity|tonicity
5186763|NCT02822898|Potassium|potassium
5186764|NCT02822898|Sodium|sodium
5186765|NCT02822898|Fluid retention|fluid retention
5186766|NCT02822872|infertility|infertility
5186767|NCT02822872|stress|stress
5186768|NCT02822872|scalp hair|scalp hair
5186769|NCT02822872|cortisol|cortisol
5186770|NCT02822846|Lung ultrasound|lung ultrasound
5186771|NCT02822846|Sliding lung|sliding lung
5186772|NCT02822846|Probe position|probe position
5186773|NCT02822755|Exercise|exercise
5186774|NCT02822755|Adherence|adherence
5186775|NCT02822755|Physical Therapy|physical therapy
5186776|NCT02822703|smoking cessation|smoking cessation
5186777|NCT02822703|tobacco use disorder|tobacco use disorder
5186778|NCT02822703|delay discounting|delay discounting
5962331|NCT04281459|SCT|sct
5186779|NCT02822703|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5186780|NCT02822703|relapse prevention|relapse prevention
5186781|NCT02822690|palliative care|palliative care
5061659|NCT03613493|message design|message design
5061660|NCT03613493|health communication|health communication
5061661|NCT03613493|Jamaica|jamaica
5186782|NCT02822690|Quality of dying|quality of dying
5862721|NCT00001535|Immune Based Therapy|immune based therapy
5186794|NCT02822599|CBP, congenital heart defects, cardiopulmonary bypass|cbp, congenital heart defects, cardiopulmonary bypass
5186795|NCT02822586|CD30-positive|cd30-positive
5186796|NCT02822586|Stage IB to Stage IVA|stage ib to stage iva
5186798|NCT02822573|Cognition|cognition
5186799|NCT02822573|Breast Cancer|breast cancer
5186800|NCT02822560|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5186801|NCT02822560|percutaneous EVAR (pEVAR)|percutaneous evar (pevar)
5186802|NCT02822560|cost analysis|cost analysis
5186803|NCT02822560|procedure time|procedure time
5186804|NCT02822521|Rheumatoid Arthritis|rheumatoid arthritis
5186805|NCT02822521|Mobile Health|mobile health
5186806|NCT02822521|Pain|pain
5186807|NCT02822521|Arthritis|arthritis
5186808|NCT02822495|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5186809|NCT02822495|Solid Organ Transplant (HCT)|solid organ transplant (hct)
5186810|NCT02822495|Hematopoietic Cell Transplant (SOT)|hematopoietic cell transplant (sot)
5186813|NCT02822495|Epstein-Barr Virus-associated Lymphoma|epstein-barr virus-associated lymphoma
5186815|NCT02822495|Rheumatoid Arthritis and Lymphoma|rheumatoid arthritis and lymphoma
5186816|NCT02822495|Allogeneic, Off-The-Shelf T-cell Immunotherapy|allogeneic, off-the-shelf t-cell immunotherapy
5186817|NCT02822495|Tumor Necrosis Factor (TNF)-alpha Inhibitors and Lymphoma|tumor necrosis factor (tnf)-alpha inhibitors and lymphoma
5186818|NCT02822495|Inflammatory Bowel Disease and Lymphoma|inflammatory bowel disease and lymphoma
5186819|NCT02822495|Epstein-Barr Virus-specific Cytotoxic T lymphocyte (EBV-CTL)|epstein-barr virus-specific cytotoxic t lymphocyte (ebv-ctl)
5186820|NCT02822495|Epstein-Barr Virus+ associated Nasopharyngeal Carcinoma (EBV+ NPC)|epstein-barr virus+ associated nasopharyngeal carcinoma (ebv+ npc)
5186821|NCT02822495|Epstein-Barr Virus+ associated Leiomyosarcoma (EBV+ LMS)|epstein-barr virus+ associated leiomyosarcoma (ebv+ lms)
5186822|NCT02822469|TMD Infrared Thermography Physical Therapy Modalities|tmd infrared thermography physical therapy modalities
5186823|NCT02822456|dysphagia|dysphagia
5186824|NCT02822456|intermittent tube|intermittent tube
5186825|NCT02822456|individual 3D printed guiding tube|individual 3d printed guiding tube
5186826|NCT02822430|Pain|pain
5186827|NCT02822430|Psychiatric disorders|psychiatric disorders
5186828|NCT02822417|Recover time|recover time
5186829|NCT02822404|kidney toxicity|kidney toxicity
5186830|NCT02822378|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5186831|NCT02822378|Human|human
5186832|NCT02822378|Female|female
5186833|NCT02822378|Non-pharmacologic therapy|non-pharmacologic therapy
5186834|NCT02822326|Leukemia|leukemia
5186835|NCT02822326|CART CD19|cart cd19
5186836|NCT02822326|Chemotherapy Resistant|chemotherapy resistant
5186837|NCT02822326|Chemotherapy Refractory|chemotherapy refractory
5186838|NCT02822326|CD19 +|cd19 +
5186839|NCT02822326|Lymphoma|lymphoma
5186841|NCT02822222|essential hypertension|essential hypertension
5186842|NCT02822222|hypertension|hypertension
5186843|NCT02822222|high blood pressure|high blood pressure
5186844|NCT02822222|cardiovascular diseases|cardiovascular diseases
5186845|NCT02822222|RMJH-111b|rmjh-111b
5186846|NCT02822222|magnesium|magnesium
5186847|NCT02822222|magnesium citrate|magnesium citrate
5186848|NCT02822222|calcium channel blockers|calcium channel blockers
5186849|NCT02822222|vasodilators|vasodilators
5186850|NCT02822222|antihypertensive agents|antihypertensive agents
5186851|NCT02822209|coordinating nurse of thoracic oncology|coordinating nurse of thoracic oncology
5186852|NCT02822209|quality of care in thoracic oncology|quality of care in thoracic oncology
5186853|NCT02822209|lung cancer quality of life|lung cancer quality of life
5076209|NCT03522597|Microbiome|microbiome
5186854|NCT02822144|ischemic stroke|ischemic stroke
5186855|NCT02822144|thrombectomy|thrombectomy
5186856|NCT02822144|anesthesia|anesthesia
5186857|NCT02822144|sedation|sedation
5186858|NCT02822118|IBS-D; Chang'an I Recipe; Placebo|ibs-d; chang'an i recipe; placebo
5186859|NCT02822066|Effectivity|effectivity
5186860|NCT02822066|safety|safety
5186861|NCT02822066|irreversible electroporation|irreversible electroporation
5186862|NCT02822066|liver|liver
5186863|NCT02822066|pancreas|pancreas
5186864|NCT02822053|Ultrasonography-guided Laser Ablation|ultrasonography-guided laser ablation
5186866|NCT02822040|Panoramic Radiograph|panoramic radiograph
5186867|NCT02822001|Sugammadex|sugammadex
5186868|NCT02821975|Depression|depression
5186869|NCT02821975|Cognitive function|cognitive function
5186871|NCT02821962|Sedentary behaviour|sedentary behaviour
5186872|NCT02821949|Non Small Cells Lung Cancer|non small cells lung cancer
5186873|NCT02821949|Procalcitonin|procalcitonin
5186874|NCT02821936|positron emission tomography|positron emission tomography
5186875|NCT02821936|parametric imaging|parametric imaging
5186876|NCT02821936|lung cancer|lung cancer
5186877|NCT02821884|Stroke|stroke
5174847|NCT02898987|AIDS|aids
5174848|NCT02898948|procalcitonin|procalcitonin
5174849|NCT02898948|bacterial infection|bacterial infection
5962332|NCT04281459|rilpivirine|rilpivirine
5962333|NCT04281459|HIVTSQs|hivtsqs
5962334|NCT04281459|patients' satisfaction|patients' satisfaction
5962335|NCT04281446|Menstrual cycle|menstrual cycle
5962336|NCT04281446|Photobiomodulation therapy|photobiomodulation therapy
5061765|NCT03612934|Breast Cancer|breast cancer
5061766|NCT03612934|palliative care|palliative care
5061769|NCT03612934|esas|esas
5174851|NCT02898909|nuclear lens fragmentation|nuclear lens fragmentation
5186878|NCT02821884|Transcranial direct current stimulation|transcranial direct current stimulation
5186879|NCT02821884|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5186880|NCT02821884|upper extremity motor recovery|upper extremity motor recovery
5186881|NCT02821832|Drug-Resistance|drug-resistance
5186882|NCT02821832|Heteroresistance|heteroresistance
5186883|NCT02821832|Relapse-markers|relapse-markers
5186884|NCT02821832|Medical Imaging|medical imaging
5186885|NCT02821832|Treatment-shortening|treatment-shortening
5186886|NCT02821819|ovarian stimulation|ovarian stimulation
5186887|NCT02821819|random|random
5186888|NCT02821819|egg donation|egg donation
5186889|NCT02821819|antagonist|antagonist
5186890|NCT02821819|gnrh agonist trigger|gnrh agonist trigger
5186891|NCT02821806|Normal Volunteer|normal volunteer
5186892|NCT02821806|Donation|donation
5186893|NCT02821806|Adoptive T Cell Therapy|adoptive t cell therapy
5186894|NCT02821806|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5186904|NCT02821754|Ablative Therapy|ablative therapy
5186905|NCT02821754|Combination of Tremelimumab and Durvalumab|combination of tremelimumab and durvalumab
5186906|NCT02821741|Sensory Stimulation|sensory stimulation
5186907|NCT02821728|Prostate|prostate
5186908|NCT02821728|Sulphate|sulphate
5186910|NCT02821728|PTEN|pten
5186911|NCT02821702|placenta accreta|placenta accreta
5186912|NCT02821702|cesarean section|cesarean section
5186913|NCT02821702|artery embolization|artery embolization
5186914|NCT02821689|Dermatopolymyositis|dermatopolymyositis
5186915|NCT02821689|Interstitial lung disease|interstitial lung disease
5186916|NCT02821689|Pirfenidone|pirfenidone
5186917|NCT02821637|teens|teens
5186918|NCT02821637|effort rehabilitation|effort rehabilitation
5186919|NCT02821637|quality of life|quality of life
5186920|NCT02821637|wellbeing|wellbeing
5186921|NCT02821637|physical skills assessment|physical skills assessment
5186922|NCT02821611|Student Stress|student stress
5186923|NCT02821611|Meditation|meditation
5186924|NCT02821611|Sleep Quality|sleep quality
5186925|NCT02821611|Blood Pressure|blood pressure
5186926|NCT02821559|Colorectal cancer|colorectal cancer
5186927|NCT02821559|raltitrexed|raltitrexed
5186928|NCT02821559|oxaliplatin|oxaliplatin
5186929|NCT02821559|bevacizumab|bevacizumab
5186930|NCT02821559|biweekly|biweekly
5186931|NCT02821559|triweekly|triweekly
5186932|NCT02821520|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5186933|NCT02821520|Photodynamic Therapy|photodynamic therapy
5186934|NCT02821520|Conbercept|conbercept
5186935|NCT02821520|Efficacy|efficacy
5186936|NCT02821520|Safety|safety
5186937|NCT02821520|vascular endothelial growth factor|vascular endothelial growth factor
5186939|NCT02821494|Vaccination|vaccination
5186940|NCT02821494|Immunotherapy|immunotherapy
5186941|NCT02821481|Neuromuscular|neuromuscular
5186942|NCT02821481|Supplementation|supplementation
5186943|NCT02821481|Elderly|elderly
5186944|NCT02821455|Isoflurane|isoflurane
5186945|NCT02821455|Sevoflurane|sevoflurane
5186946|NCT02821455|Bispectral Index|bispectral index
5186947|NCT02821455|Pulmonary Surgical Procedures|pulmonary surgical procedures
5186948|NCT02821442|Electroacupuncture|electroacupuncture
5186949|NCT02821442|Neuropathic Pain|neuropathic pain
5186950|NCT02821442|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
5186951|NCT02821429|Respiratory weaning|respiratory weaning
5186952|NCT02821429|Pulmonary ventilation|pulmonary ventilation
5186953|NCT02821416|asthma|asthma
5186954|NCT02821390|intravitreal injection|intravitreal injection
5186955|NCT02821390|pain|pain
5186956|NCT02821390|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5186957|NCT02821390|anti-VEGF|anti-vegf
5186958|NCT02821390|nepafenac|nepafenac
5186959|NCT02821377|cirrhosis|cirrhosis
5186960|NCT02821377|ascites|ascites
5186961|NCT02821377|immunology|immunology
5186962|NCT02821377|inflammation|inflammation
5186963|NCT02821377|nutrition|nutrition
5186964|NCT02821351|Afib|afib
5186965|NCT02821338|Bioequivalence|bioequivalence
5186966|NCT02821338|Lamotrigine Extended Release|lamotrigine extended release
5186967|NCT02821338|Generic|generic
5186968|NCT02821338|Pharmacokinetic|pharmacokinetic
5186969|NCT02821299|Laryngeal transplantation|laryngeal transplantation
5186970|NCT02821299|Laryngeal function|laryngeal function
5186978|NCT02821208|Psychogenic nonepileptic seizure, quality of life|psychogenic nonepileptic seizure, quality of life
5174949|NCT02898116|Ensartinib|ensartinib
5174950|NCT02898116|X-396|x-396
5174951|NCT02898116|anti-PD-L1|anti-pd-l1
5186979|NCT02821169|sinus surgery|sinus surgery
5186980|NCT02821169|sphenopalatin ganglion|sphenopalatin ganglion
5186981|NCT02821169|ropivacaine|ropivacaine
5962337|NCT04281446|Fatigue|fatigue
5962338|NCT04281446|Clinical Trial|clinical trial
5962339|NCT04281407|drug metabolism|drug metabolism
5186982|NCT02821169|local anesthesia|local anesthesia
5186983|NCT02821143|Telemedicine|telemedicine
5186984|NCT02821143|Nursing Home|nursing home
5962340|NCT04281407|CYP3A|cyp3a
5186985|NCT02821143|Hospitalization|hospitalization
5186986|NCT02821130|Dyspnea|dyspnea
5186987|NCT02821130|Exercise|exercise
5186988|NCT02821130|Cystic Fibrosis|cystic fibrosis
5186989|NCT02821117|Diabetes Mellitus, Paediatric|diabetes mellitus, paediatric
5186990|NCT02821117|Sensing Technology|sensing technology
5186991|NCT02821104|Complement|complement
5186992|NCT02821104|endothelial function|endothelial function
5186993|NCT02821104|insulin sensitivity|insulin sensitivity
5186994|NCT02821104|adolescents|adolescents
5186995|NCT02821104|inflammation|inflammation
5186996|NCT02821078|phase-contrast MRI|phase-contrast mri
5186997|NCT02821078|blood flow|blood flow
5194553|NCT02777775|NF1|nf1
5186998|NCT02821078|velocity mapping|velocity mapping
5186999|NCT02821078|abdominal imaging|abdominal imaging
5187000|NCT02821078|Quantitative MRI|quantitative mri
5187001|NCT02821039|Idiopathic Pulmonary Fibrosis, Usual Interstitial Pneumonia|idiopathic pulmonary fibrosis, usual interstitial pneumonia
5187002|NCT02821000|PD1|pd1
5187003|NCT02821000|PD-1|pd-1
5187004|NCT02821000|PDL1|pdl1
5187005|NCT02821000|PD-L1|pd-l1
5187006|NCT02820987|Septic shock, Beta Lactams, Extended infusion, PK/PD|septic shock, beta lactams, extended infusion, pk/pd
5187007|NCT02820961|Breast Neoplasms|breast neoplasms
5187008|NCT02820961|Breast Diseases|breast diseases
5187009|NCT02820961|Exemestane|exemestane
5187010|NCT02820961|Protein Kinase Inhibitors|protein kinase inhibitors
5187011|NCT02820961|Aromatase Inhibitors|aromatase inhibitors
5187012|NCT02820961|entinostat|entinostat
5187013|NCT02820961|Cancer of the Breast|cancer of the breast
5187014|NCT02820961|Metastatic Breast Cancer|metastatic breast cancer
5187015|NCT02820961|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
5187016|NCT02820961|Estrogen Receptor|estrogen receptor
5187017|NCT02820961|ER+ Breast Cancer|er+ breast cancer
5187018|NCT02820961|Breast Tumor|breast tumor
5187019|NCT02820935|Cytochrome P450|cytochrome p450
5187020|NCT02820935|Pharmacokinetics|pharmacokinetics
5187021|NCT02820935|CC-220|cc-220
5187022|NCT02820935|Healthy Subjects|healthy subjects
5187023|NCT02820922|Emergency orthopedic surgery|emergency orthopedic surgery
5187024|NCT02820922|anesthesia|anesthesia
5187025|NCT02820922|general anesthesia|general anesthesia
5187026|NCT02820922|regional anesthesia|regional anesthesia
5187027|NCT02820909|ultrasound guidance|ultrasound guidance
5187028|NCT02820909|emergency wards|emergency wards
5187029|NCT02820909|arterial and venous catheters|arterial and venous catheters
5187030|NCT02820909|femoral|femoral
5187031|NCT02820909|complications|complications
5187032|NCT02820870|Cardiovascular Disease|cardiovascular disease
5187033|NCT02820870|Quality Improvement|quality improvement
5187034|NCT02820870|Decision Support Tool|decision support tool
5187035|NCT02820870|Performance Measurement|performance measurement
5187036|NCT02820870|Primary Prevention|primary prevention
5187136|NCT02820376|Living Donors|living donors
5187037|NCT02820857|Gastroentero-pancreatic neuroendocrine carcinomas|gastroentero-pancreatic neuroendocrine carcinomas
5187038|NCT02820857|Second-line treatment|second-line treatment
5187039|NCT02820857|Bevacizumab|bevacizumab
5187040|NCT02820857|Folfiri|folfiri
5187041|NCT02820844|Overactive bladder|overactive bladder
5187042|NCT02820844|Botulinum toxin type A|botulinum toxin type a
5187043|NCT02820844|Urinary incontinence|urinary incontinence
5187044|NCT02820831|Frail Elderly|frail elderly
5187045|NCT02820831|Peripheral Vascular Surgery|peripheral vascular surgery
5187046|NCT02820831|Risk Assessment|risk assessment
5187047|NCT02820831|Functional status|functional status
5187048|NCT02820818|thoracic magnetic resonance imaging|thoracic magnetic resonance imaging
5187049|NCT02820818|pulmonary function test|pulmonary function test
5187050|NCT02820805|children|children
5187051|NCT02820805|dietary carbohydrates|dietary carbohydrates
5187052|NCT02820805|solanum tuberosum|solanum tuberosum
5187053|NCT02820805|cognition|cognition
5187054|NCT02820805|memory|memory
5187055|NCT02820805|emotions|emotions
5187056|NCT02820805|blood glucose|blood glucose
5187057|NCT02820779|Willis|willis
5187062|NCT02820753|Universal Medication Schedule|universal medication schedule
5187064|NCT02820753|Medication adherence|medication adherence
5187065|NCT02820740|Epilepsy|epilepsy
5175041|NCT02897310|critically ill patients|critically ill patients
5175042|NCT02897310|acute kidney injury|acute kidney injury
5175043|NCT02897310|renal replacement therapy|renal replacement therapy
5175044|NCT02897310|long term outcome|long term outcome
5175054|NCT02897245|Chronic|chronic
5187066|NCT02820740|Medial Temporal Lobe Epilepsy|medial temporal lobe epilepsy
5187067|NCT02820740|Seizure|seizure
5187068|NCT02820740|NeuroBlate|neuroblate
5187069|NCT02820740|LITT|litt
5187070|NCT02820740|Quality of Life|quality of life
5187071|NCT02820701|Osteopathic Manipulation|osteopathic manipulation
5187072|NCT02820701|Somatic Dysfunction|somatic dysfunction
5187073|NCT02820701|Musculoskeletal Ultrasound|musculoskeletal ultrasound
5187074|NCT02820688|Local Anesthtetics|local anesthtetics
5187075|NCT02820688|Nerve Block|nerve block
5187076|NCT02820688|Bupivacaine|bupivacaine
5187077|NCT02820688|Prilocaine|prilocaine
5187078|NCT02820675|quality improvement|quality improvement
5187079|NCT02820675|routine data|routine data
5187080|NCT02820675|risk adjustment|risk adjustment
5187081|NCT02820675|sepsis, severe sepsis, septic shock|sepsis, severe sepsis, septic shock
5187082|NCT02820675|quality of coding|quality of coding
5187083|NCT02820649|Exercise training|exercise training
5187084|NCT02820649|Endothelial function|endothelial function
5187085|NCT02820636|Suicidal ideation|suicidal ideation
5187086|NCT02820636|Suicide attempt|suicide attempt
5187087|NCT02820636|Latinx teens|latinx teens
5187088|NCT02820623|implementation|implementation
5187089|NCT02820623|fidelity|fidelity
5187090|NCT02820623|cognitive behavioral therapy|cognitive behavioral therapy
5187091|NCT02820558|Neuropeptide|neuropeptide
5187092|NCT02820558|Therapy|therapy
5187093|NCT02820558|Onset|onset
5187094|NCT02820545|patient safety culture|patient safety culture
5187096|NCT02820545|patient perception|patient perception
5187097|NCT02820545|healthcare professional perception|healthcare professional perception
5187098|NCT02820545|sociological|sociological
5187099|NCT02820545|qualitative|qualitative
5187100|NCT02820545|questionnaire construct|questionnaire construct
5187101|NCT02820545|psychometrics|psychometrics
5187102|NCT02820519|Neuropathic pain|neuropathic pain
5187103|NCT02820519|Loxapine|loxapine
5187104|NCT02820519|Antipsychotics|antipsychotics
5187105|NCT02820519|Co-Analgesics|co-analgesics
5187106|NCT02820519|Tolerability|tolerability
5187107|NCT02820519|Analgesic efficacy|analgesic efficacy
5187108|NCT02820506|robotic surgery procedures|robotic surgery procedures
5187109|NCT02820506|indocyanine green|indocyanine green
5187110|NCT02820506|sentinel lymph node mapping|sentinel lymph node mapping
5187111|NCT02820480|stroke|stroke
5187112|NCT02820480|rehabilitation|rehabilitation
5187113|NCT02820480|robotics|robotics
5187114|NCT02820480|cerebral palsy|cerebral palsy
5187115|NCT02820480|therapy|therapy
5187116|NCT02820467|Indocyanine|indocyanine
5187117|NCT02820467|Angiography|angiography
5187118|NCT02820467|Ischemia|ischemia
5187119|NCT02820454|AGuIX|aguix
5187120|NCT02820454|polysiloxane gadolinium-chelates based nanoparticles|polysiloxane gadolinium-chelates based nanoparticles
5187121|NCT02820415|aneuploidy|aneuploidy
5187122|NCT02820415|next generation sequencing|next generation sequencing
5187123|NCT02820415|oocyte vitrification|oocyte vitrification
5187124|NCT02820415|preimplantation genetic diagnosis|preimplantation genetic diagnosis
5187125|NCT02820415|preimplantation genetic screening|preimplantation genetic screening
5187126|NCT02820402|Pregnancy|pregnancy
5187127|NCT02820402|Obesity|obesity
5187128|NCT02820402|Diet|diet
5187129|NCT02820402|Maternal/child health|maternal/child health
5187130|NCT02820402|Asthma/allergy|asthma/allergy
5187131|NCT02820402|Air pollution|air pollution
5187132|NCT02820402|Epigenetics|epigenetics
5187133|NCT02820402|Cognition/behavior|cognition/behavior
5187134|NCT02820376|4D computed tomography|4d computed tomography
5187135|NCT02820376|Kidney function tests|kidney function tests
5187137|NCT02820363|wound|wound
5187138|NCT02820363|open fracture|open fracture
5187139|NCT02820363|fracture|fracture
5187140|NCT02820363|tibial|tibial
5187141|NCT02820350|Acute Renal Failure|acute renal failure
5187142|NCT02820350|Acute kidney injury|acute kidney injury
5187143|NCT02820350|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5187144|NCT02820350|Selective cytopheretic device|selective cytopheretic device
5187145|NCT02820350|Pediatric|pediatric
5187146|NCT02820311|Thorough QT (TQT)|thorough qt (tqt)
5187147|NCT02820311|cardiac safety|cardiac safety
5182883|NCT02847026|RotaTeq|rotateq
5175139|NCT02896686|Incisional hernia|incisional hernia
5175140|NCT02896673|positive expiratory pressure (PEP)|positive expiratory pressure (pep)
5187156|NCT02820246|benchmarking|benchmarking
5187157|NCT02820246|risk assessment|risk assessment
5187158|NCT02820246|scoring system|scoring system
5187159|NCT02820220|Knowledge|knowledge
5187160|NCT02820220|Programs|programs
5187161|NCT02820220|Patients|patients
5187162|NCT02820220|Students|students
5187163|NCT02820220|Nurses|nurses
5187164|NCT02820207|Carotid Artery Plaque|carotid artery plaque
5187165|NCT02820207|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
5187166|NCT02820207|Plague Histopathology|plague histopathology
5187167|NCT02820181|tracheostomy ties|tracheostomy ties
5187168|NCT02820168|Designing|designing
5187169|NCT02820168|Patient-Oriented|patient-oriented
5187170|NCT02820168|Prescriptions|prescriptions
5187171|NCT02820155|Alzheimer's disease,cognitive function|alzheimer's disease,cognitive function
5187172|NCT02820142|biomarker|biomarker
5187173|NCT02820142|Renal Function|renal function
5187174|NCT02820129|polypharmacy|polypharmacy
5187175|NCT02820129|wallet card|wallet card
5187176|NCT02820129|medication|medication
5187177|NCT02820129|self-efficacy|self-efficacy
5187178|NCT02820129|patient enablement|patient enablement
5187179|NCT02820103|Patient delay|patient delay
5962341|NCT04281407|UGT|ugt
5187180|NCT02820103|Behaviour change|behaviour change
5187181|NCT02820103|Intervention Modelling Experiment|intervention modelling experiment
5187182|NCT02820090|Inflammatory Factor|inflammatory factor
5187183|NCT02820090|Mechanical Ventilation|mechanical ventilation
5962342|NCT04281407|SULT|sult
5062076|NCT03611062|virtual reality|virtual reality
5187184|NCT02820077|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5187185|NCT02820051|bronchoscopy|bronchoscopy
5187186|NCT02820051|conscious sedation|conscious sedation
5187187|NCT02820051|midazolam|midazolam
5187188|NCT02820051|patient comfort|patient comfort
5187189|NCT02820051|propofol|propofol
5187190|NCT02820012|Scoliosis|scoliosis
5187205|NCT02819960|Lactobacillus rhamnosus|lactobacillus rhamnosus
5187206|NCT02819960|Bifidobacterium animalis|bifidobacterium animalis
5187207|NCT02819960|prevention|prevention
5187208|NCT02819960|chemotherapy|chemotherapy
5187209|NCT02819947|systemic sclerosis|systemic sclerosis
5187210|NCT02819947|cohort|cohort
5187211|NCT02819947|Korean|korean
5187212|NCT02819921|Hot Flashes|hot flashes
5187213|NCT02819921|Breast Neoplasms|breast neoplasms
5187214|NCT02819921|Tamoxifen|tamoxifen
5187215|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate
5187216|NCT02819895|Phone Appointment Reminder|phone appointment reminder
5187217|NCT02819895|Immunization Rates|immunization rates
5187218|NCT02819895|mHealth|mhealth
5187219|NCT02819882|Unresectable|unresectable
5187220|NCT02819882|locally|locally
5187221|NCT02819882|advanced|advanced
5187222|NCT02819882|metastatic disease|metastatic disease
5187223|NCT02819856|Ebselen|ebselen
5187224|NCT02819856|Tinnitus|tinnitus
5187225|NCT02819856|Hearing Loss|hearing loss
5187226|NCT02819856|Vertigo|vertigo
5187227|NCT02819856|Cystic Fibrosis|cystic fibrosis
5187228|NCT02819856|Pulmonary Exacerbation|pulmonary exacerbation
5187229|NCT02819856|Tobramycin|tobramycin
5187230|NCT02819856|Safety|safety
5187231|NCT02819856|Pharmacokinetics|pharmacokinetics
5187232|NCT02819856|Pharmacodynamics|pharmacodynamics
5187233|NCT02819856|Aminoglycoside|aminoglycoside
5187234|NCT02819856|SPI-1005|spi-1005
5187235|NCT02819856|Efficacy|efficacy
5187236|NCT02819856|Pharmacogenomics|pharmacogenomics
5187237|NCT02819856|Ototoxicity|ototoxicity
5187238|NCT02819843|T-VEC (Talimogene Laherparepvec)|t-vec (talimogene laherparepvec)
5187239|NCT02819843|Radiotherapy|radiotherapy
5187240|NCT02819843|16-224|16-224
5187241|NCT02819830|Aerobic exercise|aerobic exercise
5187242|NCT02819830|Strength training|strength training
5187243|NCT02819830|Inflammation|inflammation
5187244|NCT02819830|cardiovascular disease|cardiovascular disease
5187245|NCT02819817|Aloe Vera, wound, healing|aloe vera, wound, healing
5187246|NCT02819791|Cardiovascular|cardiovascular
5187247|NCT02819791|therapeutic education|therapeutic education
5187248|NCT02819778|Diagnosis|diagnosis
5187249|NCT02819778|Craniocerebral Trauma|craniocerebral trauma
5187250|NCT02819778|Pediatrics|pediatrics
5187251|NCT02819778|S100B|s100b
5187252|NCT02819778|mild traumatic brain injury|mild traumatic brain injury
5187258|NCT02819713|instillagel|instillagel
5187259|NCT02819713|ultrasound conductive gel|ultrasound conductive gel
5187260|NCT02819700|behavioural disorders|behavioural disorders
5187261|NCT02819687|Phase I|phase i
5187262|NCT02819687|Healthy|healthy
5187263|NCT02819687|Pharmacokinetics|pharmacokinetics
5187264|NCT02819687|Pharmacodynamics|pharmacodynamics
5187265|NCT02819674|hypertension|hypertension
5187266|NCT02819674|early onset|early onset
5187272|NCT02819648|symptomatic|symptomatic
5187273|NCT02819648|irreversible|irreversible
5187274|NCT02819635|Upadacitinib (ABT-494)|upadacitinib (abt-494)
5187275|NCT02819635|Moderately to Severely Active UC|moderately to severely active uc
5187276|NCT02819570|early-onset neonatal sepsis|early-onset neonatal sepsis
5187277|NCT02819570|Prophylactic antibiotics|prophylactic antibiotics
5187278|NCT02819570|Pregnancy|pregnancy
5187279|NCT02819570|PPROM|pprom
5187281|NCT02819544|Digestive System|digestive system
5187282|NCT02819531|Coronary Atherectomy|coronary atherectomy
5187283|NCT02819531|percutaneous coronary intervention|percutaneous coronary intervention
5187284|NCT02819518|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5187285|NCT02819518|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5187286|NCT02819505|beta-alanine|beta-alanine
5187287|NCT02819505|carnosine|carnosine
5187288|NCT02819505|neuromuscular|neuromuscular
5187297|NCT02819479|Radiation adverse event|radiation adverse event
5187298|NCT02819479|Intra-arterial chemotherapy|intra-arterial chemotherapy
5187300|NCT02819479|Blood brain barrier disruption|blood brain barrier disruption
5187301|NCT02819479|Blood brain barrier breakdown|blood brain barrier breakdown
5187302|NCT02819466|intragastric volume|intragastric volume
5187303|NCT02819466|stomach|stomach
5187304|NCT02819466|fasting|fasting
5187305|NCT02819453|Corticosteroid|corticosteroid
5187306|NCT02819427|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5187307|NCT02819427|Electroencephalography|electroencephalography
5187308|NCT02819427|children|children
5187309|NCT02819388|randomized control trial; contraception; inequalities|randomized control trial; contraception; inequalities
5962343|NCT04281394|burns|burns
5187310|NCT02819375|propofol|propofol
5187311|NCT02819375|ketamine|ketamine
5187312|NCT02819375|remifentanil|remifentanil
5187317|NCT02819336|urinary incontinence|urinary incontinence
5187318|NCT02819336|electroacupuncture|electroacupuncture
5187319|NCT02819336|stroke|stroke
5187321|NCT02819336|randomized controlled trial|randomized controlled trial
5187322|NCT02819336|pilot projects|pilot projects
5187323|NCT02819284|Ocular Discomfort|ocular discomfort
5187324|NCT02819284|Pain|pain
5187325|NCT02819284|Corticosteroid|corticosteroid
5187326|NCT02819284|Hyperemia|hyperemia
5187327|NCT02819284|Dry Eye|dry eye
5187328|NCT02819219|Dietary Supplements|dietary supplements
5187329|NCT02819219|Exercise|exercise
5187330|NCT02819193|Breastfeeding|breastfeeding
5187331|NCT02819193|mother's milk|mother's milk
5187332|NCT02819193|breast milk|breast milk
5187333|NCT02819193|raw milk|raw milk
5187334|NCT02819193|neonate|neonate
5187335|NCT02819193|Neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
5187336|NCT02819180|Influenza|influenza
5187337|NCT02819167|ischemic stroke|ischemic stroke
5187338|NCT02819167|brain reserve|brain reserve
5187339|NCT02819167|cognitive reserve|cognitive reserve
5187340|NCT02819167|cognitive prognosis|cognitive prognosis
5187341|NCT02819115|Influenza|influenza
5187342|NCT02819089|anterior cervical spine surgery|anterior cervical spine surgery
5187343|NCT02819089|ACDF|acdf
5187344|NCT02819089|Dexmedetomidine|dexmedetomidine
5187345|NCT02819089|Anesthesia|anesthesia
5187346|NCT02819089|Agitation|agitation
5187347|NCT02819089|Riker sedation agitation scores|riker sedation agitation scores
5187348|NCT02819050|CPAP|cpap
5187349|NCT02819050|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
5187350|NCT02819050|Non-invasive respiratory support|non-invasive respiratory support
5187351|NCT02819050|Premature infants|premature infants
5187352|NCT02819050|Non invasive ventilation weaning|non invasive ventilation weaning
5187353|NCT02819037|Gastric bypass|gastric bypass
5187354|NCT02819037|Intestinal Bacterial Overgrowth Syndrome|intestinal bacterial overgrowth syndrome
5187355|NCT02819037|Gas chromatography|gas chromatography
5187363|NCT02818998|Diabetic macular edema|diabetic macular edema
5187364|NCT02818998|DME|dme
5187365|NCT02818959|Aortic Valve Disease|aortic valve disease
5187366|NCT02818959|Aortic Valve Replacement|aortic valve replacement
5187367|NCT02818959|Transcatheter|transcatheter
5187368|NCT02818959|Transfemoral|transfemoral
5187369|NCT02818959|Aortic Stenosis|aortic stenosis
5187370|NCT02818946|MRI|mri
5187371|NCT02818946|Spontaneous Nipple Discharge|spontaneous nipple discharge
5187372|NCT02818946|Breast Cancer|breast cancer
5187373|NCT02818933|24-hour diet recall|24-hour diet recall
5187374|NCT02818933|Adolescents|adolescents
5187375|NCT02818933|Web-based diet recall|web-based diet recall
5187379|NCT02818894|THA, Hip Replacement, Spinal Anesthesia|tha, hip replacement, spinal anesthesia
5187380|NCT02818894|Total hip arthroplasty|total hip arthroplasty
5187381|NCT02818894|anterior total hip replacement|anterior total hip replacement
5187383|NCT02818881|muscle activity|muscle activity
5187384|NCT02818881|energy expenditure|energy expenditure
5187385|NCT02818855|Root coverage|root coverage
5798975|NCT00110305|Combivir|combivir
5187392|NCT02818842|Neonatal pathologies|neonatal pathologies
5187394|NCT02818829|Endoscopic ultrasonography|endoscopic ultrasonography
5187395|NCT02818829|Fine-needle aspiration|fine-needle aspiration
5187396|NCT02818829|Biomarkers|biomarkers
5187397|NCT02818829|Epidemiology|epidemiology
5187398|NCT02818829|DNA tumors|dna tumors
5187399|NCT02818816|Brimonidine tartrate|brimonidine tartrate
5187400|NCT02818816|Intraocular pressure|intraocular pressure
5187401|NCT02818816|Prostate Cancer|prostate cancer
5187402|NCT02818816|Prostatectomy|prostatectomy
5187403|NCT02818803|propolis|propolis
5187404|NCT02818803|therapeutic|therapeutic
5187405|NCT02818803|miconazole|miconazole
5187406|NCT02818803|denture stomatitis|denture stomatitis
5187408|NCT02818790|Motivational Interviewing|motivational interviewing
5187409|NCT02818790|Obesity|obesity
5187410|NCT02818790|Prevention|prevention
5187411|NCT02818790|Diet|diet
5187412|NCT02818790|Physical Activity|physical activity
5187413|NCT02818790|Health Preventive System|health preventive system
5187414|NCT02818777|Parkinson's Disease|parkinson's disease
5187415|NCT02818777|Tremor|tremor
5187416|NCT02818777|tolerability|tolerability
5187417|NCT02818777|safety|safety
5187418|NCT02818777|cognition|cognition
5187419|NCT02818777|anxiety|anxiety
5187420|NCT02818777|psychosis|psychosis
5187421|NCT02818777|mood|mood
5187422|NCT02818777|dyskinesia|dyskinesia
5187423|NCT02818777|cannabidiol|cannabidiol
5187424|NCT02818777|cannabis|cannabis
5187425|NCT02818777|efficacy|efficacy
5187426|NCT02818777|sleep|sleep
5187427|NCT02818777|motor symptoms|motor symptoms
5187428|NCT02818777|non-motor symptoms|non-motor symptoms
5187429|NCT02818777|quality of life|quality of life
5187430|NCT02818777|marijuana|marijuana
5187436|NCT02818751|Anxiety|anxiety
5187437|NCT02818751|Adolescents with Anxiety|adolescents with anxiety
5187438|NCT02818738|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5187638|NCT02817555|Cost|cost
5187439|NCT02818738|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
5187440|NCT02818738|Levamisole|levamisole
5187441|NCT02818738|Prednisone|prednisone
5187442|NCT02818738|Children|children
5187443|NCT02818686|Ulcerative Colitis, Active Moderate and Severe|ulcerative colitis, active moderate and severe
5187444|NCT02818673|diagnostic performances|diagnostic performances
5187445|NCT02818673|ascites|ascites
5187446|NCT02818647|tonsillectomy|tonsillectomy
5187447|NCT02818647|electrocautery|electrocautery
5187448|NCT02818647|postoperative pain|postoperative pain
5187449|NCT02818647|visual analogue scale|visual analogue scale
5187450|NCT02818608|Cerebrovascular Accident|cerebrovascular accident
5187451|NCT02818608|Cerebrovascular Stroke|cerebrovascular stroke
5187452|NCT02818608|Cerebral Stroke|cerebral stroke
5187453|NCT02818595|voice recognition|voice recognition
5187454|NCT02818582|Liberia|liberia
5187455|NCT02818582|Guinea|guinea
5187456|NCT02818504|obesity|obesity
5187457|NCT02818504|dysglycemia|dysglycemia
5187458|NCT02818504|hypercholesterolemia|hypercholesterolemia
5187459|NCT02818504|lifestyle|lifestyle
5187460|NCT02818504|smoking|smoking
5187461|NCT02818504|physical activity|physical activity
5187462|NCT02818439|Old person|old person
5187463|NCT02818426|cancer immunotherapy|cancer immunotherapy
5187464|NCT02818426|CD4 T lymphocyte helper|cd4 t lymphocyte helper
5187465|NCT02818426|telomerase|telomerase
5187466|NCT02818413|Stool microbiome|stool microbiome
5187467|NCT02818413|Stool metabolome|stool metabolome
5187468|NCT02818413|Single nucleotide polymorphisms|single nucleotide polymorphisms
5187469|NCT02818400|maxillofacial surgery|maxillofacial surgery
5187470|NCT02818400|face graft|face graft
5187471|NCT02818400|composite tissue|composite tissue
5187472|NCT02818400|stem cell infusion|stem cell infusion
5187473|NCT02818400|allotransplantation|allotransplantation
5187474|NCT02818400|microsurgery|microsurgery
5187475|NCT02818387|propofol|propofol
5187476|NCT02818387|midazolam|midazolam
5187477|NCT02818387|remifentanil|remifentanil
5187478|NCT02818387|combination|combination
5187479|NCT02818387|synergic|synergic
5187480|NCT02818387|pharmacodynamics|pharmacodynamics
5187481|NCT02818387|Loss of consciousness|loss of consciousness
5187482|NCT02818361|Rheumatoid Arthritis|rheumatoid arthritis
5187483|NCT02818361|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
5187484|NCT02818361|double-blinded|double-blinded
5187485|NCT02818361|randomized controlled trial|randomized controlled trial
5187490|NCT02818348|Darunavir/cobicistat|darunavir/cobicistat
5183196|NCT02845141|bone graft|bone graft
5187491|NCT02818348|Etravirine, drug-drug interactions|etravirine, drug-drug interactions
5187492|NCT02818348|Population PK analysis|population pk analysis
5187493|NCT02818296|Intolerance of uncertainty|intolerance of uncertainty
5187495|NCT02818283|Human Immunodeficiency Virus|human immunodeficiency virus
5187496|NCT02818283|hypercholesterolemia|hypercholesterolemia
5187497|NCT02818283|pretzels|pretzels
5187498|NCT02818283|nutritional study|nutritional study
5187499|NCT02818283|dietary soy|dietary soy
5187500|NCT02818283|antiretroviral therapy|antiretroviral therapy
5187501|NCT02818244|commercial heart monitors|commercial heart monitors
5187502|NCT02818244|accuracy|accuracy
5187503|NCT02818244|EKG|ekg
5187504|NCT02818244|varying degrees of exertion|varying degrees of exertion
5187505|NCT02818166|magnetic resonance|magnetic resonance
5187506|NCT02818166|right mini-thoracotomy|right mini-thoracotomy
5187507|NCT02818153|Allergic rhinitis|allergic rhinitis
5187508|NCT02818140|Postoperative pain|postoperative pain
5187509|NCT02818140|Transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
5187510|NCT02818140|Block|block
5187511|NCT02818140|Ropivacaine|ropivacaine
5187512|NCT02818140|TQL|tql
5187513|NCT02818140|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5187514|NCT02818140|PNL|pnl
5187515|NCT02818140|Ultrasound-guided|ultrasound-guided
5187516|NCT02818114|PTSD|ptsd
5187517|NCT02818114|Prolonged Exposure|prolonged exposure
5187518|NCT02818114|Peer Support|peer support
5187519|NCT02818075|Peer support|peer support
5187520|NCT02818075|Postpartum Depression|postpartum depression
5187521|NCT02818075|Adolescent Pregnancy|adolescent pregnancy
5187522|NCT02818062|Endophthalmitis|endophthalmitis
5187523|NCT02818062|Cytokines|cytokines
5187524|NCT02818062|Chemokines|chemokines
5187525|NCT02818062|Inflammation|inflammation
5187526|NCT02818062|Regulation|regulation
5187527|NCT02818049|Bronchioalveolar Lavage|bronchioalveolar lavage
5187528|NCT02818010|physical activity|physical activity
5187529|NCT02818010|chronic kidney disease|chronic kidney disease
5187530|NCT02818010|nephrology|nephrology
5187531|NCT02818010|stage 3|stage 3
5187532|NCT02818010|stage 4|stage 4
5187533|NCT02818010|stage 5|stage 5
5187534|NCT02817997|patient registry|patient registry
5187535|NCT02817997|ACCELERATE study|accelerate study
5187536|NCT02817997|CD|cd
5187537|NCT02817997|MCD|mcd
5187538|NCT02817997|iMCD|imcd
5187539|NCT02817997|Castleman|castleman
5187540|NCT02817997|Castleman's Disease|castleman's disease
5187541|NCT02817997|Angiofollicular Lymph Hyperplasia|angiofollicular lymph hyperplasia
5187542|NCT02817997|multicentric Castleman's disease|multicentric castleman's disease
5187543|NCT02817997|multicentric Castleman disease|multicentric castleman disease
5187544|NCT02817984|Abdominoplasty|abdominoplasty
5187545|NCT02817971|feedback|feedback
5187546|NCT02817971|pneumonia|pneumonia
5187547|NCT02817971|quality of care|quality of care
5187548|NCT02817958|inguinal lymph nodes|inguinal lymph nodes
5187549|NCT02817958|penile cancer|penile cancer
5187550|NCT02817958|squamous|squamous
5187551|NCT02817958|TIP chemotherapy|tip chemotherapy
5187552|NCT02817945|TATE-RGD|tate-rgd
5187553|NCT02817945|SSTR2|sstr2
5187554|NCT02817945|integrin αvβ3|integrin αvβ3
5187555|NCT02817919|Pharmacovigilance|pharmacovigilance
5187556|NCT02817919|Africa|africa
5187557|NCT02817893|∆POP: variation of the plethysmographic waveform of pulse oximetry|∆pop: variation of the plethysmographic waveform of pulse oximetry
5187558|NCT02817893|∆PP: pulse pressure variation|∆pp: pulse pressure variation
5187559|NCT02817893|pulse oximetry plethysmographic|pulse oximetry plethysmographic
5187560|NCT02817893|abdominal surgery|abdominal surgery
5187561|NCT02817880|rTMS, tDCS, tsDCS, pain, algoneurodystrophy , neurostimulation|rtms, tdcs, tsdcs, pain, algoneurodystrophy , neurostimulation
5187562|NCT02817841|Estetrol|estetrol
5187563|NCT02817841|Drospirenone|drospirenone
5187564|NCT02817841|Prevention of pregnancy|prevention of pregnancy
5187565|NCT02817841|Oral contraception|oral contraception
5187566|NCT02817828|Estetrol|estetrol
5187567|NCT02817815|Atrial fibrillation, blood platelet|atrial fibrillation, blood platelet
5187572|NCT02817789|TAVI|tavi
5187573|NCT02817789|Antiplatelet agent|antiplatelet agent
5187574|NCT02817789|Ticagrelor|ticagrelor
5187575|NCT02817789|Cerebrovascular events|cerebrovascular events
5187576|NCT02817776|Interventional|interventional
5187577|NCT02817776|Radiofrequency Ablation|radiofrequency ablation
5187578|NCT02817776|Persistent Atrial Fibrillation|persistent atrial fibrillation
5187579|NCT02817750|volunteers|volunteers
5187580|NCT02817750|Pharmacokinetics|pharmacokinetics
5187581|NCT02817724|Breast Neoplasms|breast neoplasms
5187582|NCT02817724|survivor|survivor
5187583|NCT02817724|occupational therapy|occupational therapy
5187584|NCT02817724|mobile applications|mobile applications
5187585|NCT02817724|Quality of Life|quality of life
5187586|NCT02817711|infection|infection
5187587|NCT02817711|bone and joint infection|bone and joint infection
5187588|NCT02817711|relapse|relapse
5187589|NCT02817711|adverse event|adverse event
5187590|NCT02817698|smoking|smoking
5187591|NCT02817698|cannabis|cannabis
5187592|NCT02817698|cocaine|cocaine
5187593|NCT02817685|surveillance|surveillance
5187594|NCT02817685|hepatocellular carcinoma|hepatocellular carcinoma
5187596|NCT02817685|cirrhosis|cirrhosis
5187597|NCT02817685|chronic hepatitis B|chronic hepatitis b
5187598|NCT02817672|Human|human
5187599|NCT02817672|Mental Disorders|mental disorders
5187600|NCT02817672|intervention|intervention
5187601|NCT02817672|digital health|digital health
5187602|NCT02817659|Glucagon|glucagon
5187603|NCT02817646|Intensive Care Unit|intensive care unit
5187604|NCT02817646|Critical Illness|critical illness
5187605|NCT02817646|Body composition|body composition
5187606|NCT02817646|Protein nutrition|protein nutrition
5187607|NCT02817633|Antibodies|antibodies
5187608|NCT02817633|TSR-022|tsr-022
5187609|NCT02817633|Advanced solid tumors|advanced solid tumors
5187610|NCT02817633|Metastatic solid tumors|metastatic solid tumors
5187611|NCT02817633|Immunotherapy|immunotherapy
5187612|NCT02817633|PD-1|pd-1
5187613|NCT02817633|Anti-PD-1|anti-pd-1
5187614|NCT02817633|colorectal cancer|colorectal cancer
5187615|NCT02817633|non-small cell lung cancer|non-small cell lung cancer
5187616|NCT02817633|Melanoma|melanoma
5187617|NCT02817633|Anti-LAG-3|anti-lag-3
5187618|NCT02817633|TSR-033|tsr-033
5187619|NCT02817633|TSR-042|tsr-042
5187620|NCT02817607|Sensation|sensation
5187621|NCT02817594|Chronic Hepatitis C|chronic hepatitis c
5187622|NCT02817594|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
5187623|NCT02817594|Sustained Virological Response|sustained virological response
5187624|NCT02817594|Observational Study|observational study
5187625|NCT02817594|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5187626|NCT02817594|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5187627|NCT02817581|National Early Warning Score (NEWS)|national early warning score (news)
5187628|NCT02817581|Lactate|lactate
5187629|NCT02817581|Emergency Department|emergency department
5187630|NCT02817568|Aggressive Periodontitis|aggressive periodontitis
5187631|NCT02817568|C-C chemokine receptor 2|c-c chemokine receptor 2
5187632|NCT02817568|Gene expression|gene expression
5187633|NCT02817568|monocyte chemoattractant protein-1,|monocyte chemoattractant protein-1,
5187634|NCT02817568|restriction fragment length polymorphism|restriction fragment length polymorphism
5187635|NCT02817555|Anemia|anemia
5187636|NCT02817555|Hemodialysis|hemodialysis
5187637|NCT02817555|Erythropoiesis Stimulating Agent|erythropoiesis stimulating agent
5187639|NCT02817516|Drug Therapy|drug therapy
5187640|NCT02817503|hypertension|hypertension
5187641|NCT02817503|BP titration|bp titration
5187642|NCT02817503|intensive blood pressure control|intensive blood pressure control
5187643|NCT02817503|primary prevention|primary prevention
5187644|NCT02817503|China|china
5187645|NCT02817503|H-type Hypertension|h-type hypertension
5187646|NCT02817490|hypermobility|hypermobility
5962344|NCT04281394|rehabilitation|rehabilitation
5187647|NCT02817490|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5187648|NCT02817490|patient education program|patient education program
5187649|NCT02817477|Intranasal Ketamine, Analgesia, Trauma, Morphine, Mass Casualty|intranasal ketamine, analgesia, trauma, morphine, mass casualty
5187650|NCT02817451|Diphtheria|diphtheria
5187652|NCT02817451|Pertussis|pertussis
5187653|NCT02817451|Hepatitis B|hepatitis b
5187654|NCT02817451|DTaP IPV HB PRP-T Combined Vaccine|dtap ipv hb prp-t combined vaccine
5187655|NCT02817451|Human Immunodeficiency Virus|human immunodeficiency virus
5187657|NCT02817425|Adjuvant Chemotherapy|adjuvant chemotherapy
5187658|NCT02817425|TEGAFOX|tegafox
5187659|NCT02817412|binge eating|binge eating
5187660|NCT02817412|obesity|obesity
5187661|NCT02817412|overeating|overeating
5187662|NCT02817399|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5187663|NCT02817399|Functional Electrical stimulation|functional electrical stimulation
5187664|NCT02817399|Gait analysis|gait analysis
5187665|NCT02817399|Physical therapy|physical therapy
5187666|NCT02817386|postoperative delirium|postoperative delirium
5187667|NCT02817386|microRNA|microrna
5187669|NCT02817373|embryo transfer|embryo transfer
5187670|NCT02817373|ultrasound|ultrasound
5187671|NCT02817373|implantation|implantation
5187672|NCT02817334|Near-infrared fluorescence|near-infrared fluorescence
5187673|NCT02817334|Indocyanine green, ICG|indocyanine green, icg
5187674|NCT02817334|breast cancer|breast cancer
5187675|NCT02817308|Antigen, CA-19-9|antigen, ca-19-9
5187676|NCT02817308|Salivas|salivas
5187677|NCT02817308|body fluids|body fluids
5187678|NCT02817269|Shoulder pain|shoulder pain
5187679|NCT02817269|Trigger points|trigger points
5187680|NCT02817269|Referred pain|referred pain
5187681|NCT02817269|Visual analogue scale|visual analogue scale
5187682|NCT02817191|age-related cataract|age-related cataract
5187683|NCT02817191|Holy-Comod|holy-comod
5187684|NCT02817191|Tears Naturale Forte|tears naturale forte
5187685|NCT02817191|phacoemulsification|phacoemulsification
5187686|NCT02817191|inflammatory mediators|inflammatory mediators
5187687|NCT02817165|Probiotics, diarrhea, antibiotic, children, hospital|probiotics, diarrhea, antibiotic, children, hospital
5187688|NCT02817152|periodontal treatment|periodontal treatment
5187689|NCT02817152|low-level light therapy|low-level light therapy
5187690|NCT02817126|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5187691|NCT02817126|Robotic Surgical Procedures|robotic surgical procedures
5187692|NCT02817126|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
5187694|NCT02817126|Intraoperative Complications|intraoperative complications
5187695|NCT02817126|Postoperative Complications|postoperative complications
5187696|NCT02817126|Recovery of Function|recovery of function
5187697|NCT02817126|Recurrence|recurrence
5187698|NCT02817126|Disease Progression|disease progression
5187699|NCT02817126|Survival|survival
5187700|NCT02817087|Stroke|stroke
5187701|NCT02817087|chronic ischemic stroke|chronic ischemic stroke
5187702|NCT02817087|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
5187703|NCT02817087|ischaemic stroke|ischaemic stroke
5187704|NCT02817061|no keywords for disease type and/or category|no keywords for disease type and/or category
5187705|NCT02817035|interstitial lung disease|interstitial lung disease
5187706|NCT02817035|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5187707|NCT02817035|mechanical ventilation|mechanical ventilation
5187708|NCT02817035|expiratory delay|expiratory delay
5187709|NCT02817035|neural inspiratory time|neural inspiratory time
5187710|NCT02817022|Developmentally Supportive Care|developmentally supportive care
5187711|NCT02817009|Behavioral Health Intervention|behavioral health intervention
5187712|NCT02817009|Randomized Control Trial|randomized control trial
5187713|NCT02817009|Family Intervention|family intervention
5187714|NCT02817009|Nutrition|nutrition
5187715|NCT02817009|Weight Management|weight management
5187716|NCT02817009|Multidisciplinary Program|multidisciplinary program
5187717|NCT02816944|Endoscopic ultrasonography|endoscopic ultrasonography
5187718|NCT02816944|Laser ablation|laser ablation
5187719|NCT02816931|Treatment|treatment
5187720|NCT02816931|Drug Monitoring|drug monitoring
5187721|NCT02816931|Minimum Inhibitory Concentration|minimum inhibitory concentration
5187722|NCT02816931|Dried Blood Spot Method|dried blood spot method
5187723|NCT02816931|Pharmacokinetics|pharmacokinetics
5187724|NCT02816931|Pharmacodynamics|pharmacodynamics
5187725|NCT02816905|intraocular pressure|intraocular pressure
5187726|NCT02816905|topical steroids|topical steroids
5187727|NCT02816905|strabismus|strabismus
5187728|NCT02816892|aortic dissection|aortic dissection
5187729|NCT02816892|biomarkers|biomarkers
5187730|NCT02816892|diagnosis|diagnosis
5187731|NCT02816866|childhood cancer|childhood cancer
5187732|NCT02816866|survivorship care|survivorship care
5187733|NCT02816866|health services|health services
5187734|NCT02816866|barriers|barriers
5187735|NCT02816840|prostate cancer|prostate cancer
5187736|NCT02816840|radiotherapy|radiotherapy
5187737|NCT02816840|PET-CT/MRI|pet-ct/mri
5187738|NCT02816814|Menopause|menopause
5187740|NCT02816814|Lipidomic profile|lipidomic profile
5187741|NCT02816814|Vasomotor symptoms|vasomotor symptoms
5187742|NCT02816814|Omega-3 fatty acids|omega-3 fatty acids
5187743|NCT02816788|PTSD|ptsd
5187744|NCT02816788|Equine Assisted Therapy|equine assisted therapy
5187745|NCT02816775|hemodynamics|hemodynamics
5187746|NCT02816775|QT interval|qt interval
5187747|NCT02816762|CPAP|cpap
5187748|NCT02816762|Sleep apnea|sleep apnea
5187749|NCT02816762|Diabetes|diabetes
5187750|NCT02816762|Nephropathy|nephropathy
5187751|NCT02816762|Albuminuria|albuminuria
5187752|NCT02816749|Diabetic Foot|diabetic foot
5187753|NCT02816749|Wound Healing|wound healing
5187754|NCT02816749|Larva|larva
5187755|NCT02816749|Occlusive Dressings|occlusive dressings
5187756|NCT02816736|Heart Failure|heart failure
5187757|NCT02816736|Heart Diseases|heart diseases
5187758|NCT02816736|Cardiovascular Diseases|cardiovascular diseases
5187759|NCT02816736|Valsartan|valsartan
5187760|NCT02816736|Entresto|entresto
5187761|NCT02816723|mindfulness|mindfulness
5187762|NCT02816723|aging|aging
5187763|NCT02816723|Veterans|veterans
5187764|NCT02816710|Conbercept|conbercept
5187765|NCT02816710|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5187766|NCT02816710|Silicone oil tamponade|silicone oil tamponade
5187767|NCT02816697|Smoking Habits|smoking habits
5187768|NCT02816684|phobic disorders|phobic disorders
5187769|NCT02816684|anxiety disorders|anxiety disorders
5187770|NCT02816645|Parkinson's Disease|parkinson's disease
5187771|NCT02816645|Biomarker|biomarker
5187772|NCT02816645|Iron|iron
5187773|NCT02816645|R2*|r2*
5187774|NCT02816645|MRI|mri
5187775|NCT02816645|Patients|patients
5187776|NCT02816645|UK Parkinson's Disease Society Brain Bank|uk parkinson's disease society brain bank
5187777|NCT02816632|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5187778|NCT02816632|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
5187783|NCT02816619|Parkinson's disease|parkinson's disease
5187784|NCT02816619|Physical activity|physical activity
5187785|NCT02816619|Physical exercise|physical exercise
5187786|NCT02816606|ACL reconstruction|acl reconstruction
5187787|NCT02816593|carbamide peroxide|carbamide peroxide
5187788|NCT02816593|Hydrogen peroxide|hydrogen peroxide
5187789|NCT02816593|Quality of life|quality of life
5187790|NCT02816554|Japanese Encephalitis|japanese encephalitis
5187791|NCT02816554|JECEVAX|jecevax
5187792|NCT02816554|Vietnam|vietnam
5187793|NCT02816528|Antibiotics|antibiotics
5187794|NCT02816528|Primary care|primary care
5187796|NCT02816528|General practitioners|general practitioners
5187797|NCT02816515|Non interventional study|non interventional study
5187798|NCT02816515|Ectoin|ectoin
5187799|NCT02816515|Mouth wash|mouth wash
5187800|NCT02816515|Mucositis|mucositis
5187801|NCT02816515|Chemotherapy|chemotherapy
5187802|NCT02816515|Radiotherapy|radiotherapy
5187803|NCT02816502|childhood|childhood
5187804|NCT02816502|adversity|adversity
5187805|NCT02816450|Water|water
5187806|NCT02816450|Children|children
5187807|NCT02816450|Cognition|cognition
5187808|NCT02816450|Hydration|hydration
5187809|NCT02816424|Screening and Brief Intervention|screening and brief intervention
5187810|NCT02816424|Motivational Interviewing|motivational interviewing
5187811|NCT02816424|Teen Pregnancy Prevention|teen pregnancy prevention
5187812|NCT02816385|PV-loops (pressure-volume loops)|pv-loops (pressure-volume loops)
5187813|NCT02816385|Myocardial contractility|myocardial contractility
5187814|NCT02816385|Cardioplegia|cardioplegia
5187815|NCT02816385|Induced|induced
5187816|NCT02816359|Position patient|position patient
5187817|NCT02816359|Esophageal pressure|esophageal pressure
5187818|NCT02816346|shigella|shigella
5187819|NCT02816320|hospital mortality|hospital mortality
5187820|NCT02816320|standardized mortality ratios|standardized mortality ratios
5187821|NCT02816320|patient safety|patient safety
5187822|NCT02816320|healthcare quality|healthcare quality
5187823|NCT02816320|hospital performance|hospital performance
5187824|NCT02816320|administrative data|administrative data
5187825|NCT02816281|Surgical case cancellation|surgical case cancellation
5187826|NCT02816281|Pre-operative assessment clinic|pre-operative assessment clinic
5187827|NCT02816242|Concept Map|concept map
5187828|NCT02816242|critical thinking|critical thinking
5187829|NCT02816242|medical student teaching|medical student teaching
5187830|NCT02816229|Haemoptysis|haemoptysis
5187831|NCT02816229|Aspergillus|aspergillus
5187832|NCT02816229|Endobronchial valve|endobronchial valve
5187833|NCT02816229|Interventional pulmonology|interventional pulmonology
5187834|NCT02816229|Tuberculosis|tuberculosis
5187835|NCT02816138|Geriatrics|geriatrics
5187836|NCT02816138|Depression|depression
5187837|NCT02816138|Elderly|elderly
5187838|NCT02816138|Cognition|cognition
5187839|NCT02816138|Memory|memory
5187840|NCT02816125|breast cancer|breast cancer
5187841|NCT02816125|fatty acids|fatty acids
5187842|NCT02816125|omega-3|omega-3
5187843|NCT02816060|pain measurement|pain measurement
5187848|NCT02816034|Learning|learning
5187849|NCT02816034|Cerebellum|cerebellum
5187850|NCT02816021|Melanoma and other malignant neoplasms of skin|melanoma and other malignant neoplasms of skin
5187851|NCT02816021|Metastatic melanoma|metastatic melanoma
5187852|NCT02816021|Advanced melanoma|advanced melanoma
5187853|NCT02816021|Azacitidine|azacitidine
5187854|NCT02816021|5-azacytidine|5-azacytidine
5187855|NCT02816021|5-aza|5-aza
5187856|NCT02816021|Vidaza|vidaza
5187857|NCT02816021|5-AZC|5-azc
5187858|NCT02816021|Ladakamycin|ladakamycin
5187859|NCT02816021|NSC-102816|nsc-102816
5187860|NCT02816021|Azacytidine|azacytidine
5187861|NCT02816021|Pembrolizumab|pembrolizumab
5187862|NCT02816021|Keytruda|keytruda
5187863|NCT02816021|MK-3475|mk-3475
5187864|NCT02816021|SCH-900475|sch-900475
5187865|NCT02816008|cognitive rehabilitation|cognitive rehabilitation
5187866|NCT02816008|memory|memory
5187867|NCT02816008|attention|attention
5187868|NCT02816008|spatial neglect|spatial neglect
5187869|NCT02816008|executive dysfunctioning|executive dysfunctioning
5187870|NCT02815995|Malignant neoplasms of bone and articular cartilage|malignant neoplasms of bone and articular cartilage
5187871|NCT02815995|Multiple sarcoma subtypes|multiple sarcoma subtypes
5187872|NCT02815995|Advanced and/or metastatic sarcoma|advanced and/or metastatic sarcoma
5187873|NCT02815995|Adipocytic tumors|adipocytic tumors
5187874|NCT02815995|Vascular tumors|vascular tumors
5187875|NCT02815995|Leiomyosarcoma|leiomyosarcoma
5187876|NCT02815995|Angiosarcoma|angiosarcoma
5187877|NCT02815995|Epithelioid hemangioendothelioma|epithelioid hemangioendothelioma
5798976|NCT00110305|Truvada|truvada
5187878|NCT02815995|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
5187879|NCT02815995|Synovial sarcoma|synovial sarcoma
5187880|NCT02815995|Osteosarcoma|osteosarcoma
5187881|NCT02815995|Other sarcoma histologies|other sarcoma histologies
5187882|NCT02815995|Durvalumab|durvalumab
5187883|NCT02815995|Tremelimumab|tremelimumab
5187884|NCT02815969|neuroendocrine tumors|neuroendocrine tumors
5187885|NCT02815969|indol profile|indol profile
5077351|NCT03516032|aged|aged
5187886|NCT02815969|catecholamines|catecholamines
5187887|NCT02815969|LC-MS/MS|lc-ms/ms
5187888|NCT02815956|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
5187889|NCT02815956|randomized|randomized
5187890|NCT02815956|controlled study|controlled study
5187891|NCT02815930|High cost user (HCU)|high cost user (hcu)
5187892|NCT02815930|Healthcare utilization|healthcare utilization
5187893|NCT02815930|Healthcare expenditures|healthcare expenditures
5187894|NCT02815930|Medication use|medication use
5187895|NCT02815930|Medication expenditures|medication expenditures
5187896|NCT02815930|Multimorbidity|multimorbidity
5187897|NCT02815930|Observational study|observational study
5187898|NCT02815904|Neonates|neonates
5187899|NCT02815904|physical therapy|physical therapy
5187900|NCT02815904|neonatal intensive care units|neonatal intensive care units
5187901|NCT02815904|yakson touch|yakson touch
5187902|NCT02815904|kinesthetic stimulation|kinesthetic stimulation
5187903|NCT02815865|Primiparous|primiparous
5187904|NCT02815865|Foley catheter|foley catheter
5187905|NCT02815865|Dinoprostone|dinoprostone
5187906|NCT02815865|Induction|induction
5187907|NCT02815852|breast cancer in women under 40 years old|breast cancer in women under 40 years old
5187908|NCT02815852|biopsy|biopsy
5187909|NCT02815852|ultrasonography|ultrasonography
5187910|NCT02815852|Magnetic Resonance Imaging|magnetic resonance imaging
5187911|NCT02815839|urate transporter 1|urate transporter 1
5187912|NCT02815839|SHR4640|shr4640
5187913|NCT02815839|single ascending dose|single ascending dose
5187914|NCT02815839|pharmacokinetics|pharmacokinetics
5187915|NCT02815839|pharmacodynamics|pharmacodynamics
5187916|NCT02815813|Serious Mental Illness|serious mental illness
5187917|NCT02815813|Young Adults|young adults
5187918|NCT02815813|Obesity|obesity
5187919|NCT02815813|Cardiometabolic Risk|cardiometabolic risk
5187920|NCT02815813|Physical Activity|physical activity
5187921|NCT02815813|Weight Loss|weight loss
5187922|NCT02815813|Fitness|fitness
5187923|NCT02815813|Peer Support|peer support
5187924|NCT02815813|Smartphone|smartphone
5187925|NCT02815813|Mobile Technology|mobile technology
5187926|NCT02815813|mHealth|mhealth
5187927|NCT02815813|Social Media|social media
5187928|NCT02815813|Facebook|facebook
5187929|NCT02815813|Lifestyle Intervention|lifestyle intervention
5187930|NCT02815800|Treatment|treatment
5187931|NCT02815800|Motor signs|motor signs
5187932|NCT02815800|Non motor signs|non motor signs
5187933|NCT02815800|Fluctuations|fluctuations
5187934|NCT02815800|Open labelled|open labelled
5187935|NCT02815787|SP2086|sp2086
5187936|NCT02815787|Glyburide|glyburide
5187937|NCT02815787|drug-drug interaction|drug-drug interaction
5187938|NCT02815774|SP2086|sp2086
5187939|NCT02815774|Renal Insufficiency|renal insufficiency
5187940|NCT02815774|Pharmacokinetic|pharmacokinetic
5187941|NCT02815748|SP2086|sp2086
5187942|NCT02815748|Metabolite identification|metabolite identification
5187943|NCT02815748|Material balance|material balance
5187944|NCT02815722|SP2086|sp2086
5187945|NCT02815722|Simvastatin|simvastatin
5187946|NCT02815722|drug-drug interaction|drug-drug interaction
5187947|NCT02815696|MRI T2 weighted|mri t2 weighted
5187948|NCT02815696|intervertebral disc|intervertebral disc
5187949|NCT02815696|glycosaminoglycans|glycosaminoglycans
5187950|NCT02815683|Bronchoscopy|bronchoscopy
5187951|NCT02815683|Emphysema|emphysema
5187952|NCT02815657|SP2086|sp2086
5187953|NCT02815657|Valsartan|valsartan
5187954|NCT02815657|Drug-drug Interaction|drug-drug interaction
5187955|NCT02815631|fractional flow reserve|fractional flow reserve
5187956|NCT02815631|cardiogoniometry|cardiogoniometry
5187957|NCT02815618|Time-resolved spectroscopy|time-resolved spectroscopy
5187958|NCT02815618|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
5187959|NCT02815618|Neonatology|neonatology
5187960|NCT02815579|HIV|hiv
5187961|NCT02815579|Food insecurity|food insecurity
5187962|NCT02815579|Microcredit loan|microcredit loan
5187963|NCT02815579|Agriculture|agriculture
5187964|NCT02815579|Livelihoods|livelihoods
5187965|NCT02815566|kidney, antiretroviral agent, tenofovir, osteoporosis, women|kidney, antiretroviral agent, tenofovir, osteoporosis, women
5187966|NCT02815527|enteral nutrition|enteral nutrition
5187967|NCT02815527|intensive care unit|intensive care unit
5187968|NCT02815527|whey|whey
5187969|NCT02815527|protein|protein
5187970|NCT02815527|muscle mass|muscle mass
5187971|NCT02815527|leucin|leucin
5187972|NCT02815527|energy expenditure|energy expenditure
5187973|NCT02815514|aortic valve stenosis|aortic valve stenosis
5187974|NCT02815514|aortic valve insufficiency|aortic valve insufficiency
5187975|NCT02815514|transapical aortic valve implantation|transapical aortic valve implantation
5187976|NCT02815514|aortic valve replacement|aortic valve replacement
5187990|NCT02815410|Levetiracetam|levetiracetam
5187991|NCT02815410|Temozolomide|temozolomide
5187992|NCT02815410|Survival outcome|survival outcome
5187993|NCT02815397|Double Hit DLBCL|double hit dlbcl
5187994|NCT02815319|Dexamethasone|dexamethasone
5187995|NCT02815319|Chemotherapy|chemotherapy
5187996|NCT02815306|Congenital idiopathic clubfoot|congenital idiopathic clubfoot
5187997|NCT02815306|Pirani score|pirani score
5187998|NCT02815306|infant|infant
5187999|NCT02815306|polyaxial brace|polyaxial brace
5188001|NCT02815293|evaporative dry eye|evaporative dry eye
5188002|NCT02815280|acne|acne
5188003|NCT02815267|acne|acne
5188004|NCT02815254|Physiotherapy|physiotherapy
5188005|NCT02815254|hip fracture|hip fracture
5188006|NCT02815254|rehabilitation|rehabilitation
5188007|NCT02815254|high dose exercise|high dose exercise
5188008|NCT02815254|low dose exercise|low dose exercise
5188009|NCT02815215|congenital clubfoot|congenital clubfoot
5188010|NCT02815189|pain|pain
5188011|NCT02815176|Plasminogen activator inhibitor-1|plasminogen activator inhibitor-1
5188012|NCT02815176|Wide angle fluorescein angiography|wide angle fluorescein angiography
5188014|NCT02815137|Digital PCR|digital pcr
5188015|NCT02815137|classical|classical
5188016|NCT02815137|Hodgkin Lymphoma|hodgkin lymphoma
5188017|NCT02815137|mutation|mutation
5188018|NCT02815085|heart failure|heart failure
5188019|NCT02815085|mHealth|mhealth
5188020|NCT02815072|Fontan palliation|fontan palliation
5188021|NCT02815072|Marfan's syndrome|marfan's syndrome
5188022|NCT02815046|urgency urinary incontinence|urgency urinary incontinence
5188023|NCT02815046|stress urinary incontinence|stress urinary incontinence
5188024|NCT02815046|Botulinum toxin A|botulinum toxin a
5188025|NCT02815046|Bulkamid|bulkamid
5188033|NCT02815020|Primary care|primary care
5188034|NCT02815020|Self-management support|self-management support
5188035|NCT02815020|Care coordination|care coordination
5188036|NCT02815020|Practice-based research network|practice-based research network
5188037|NCT02814994|Mechanical Ventilation|mechanical ventilation
5188038|NCT02814994|ARDS|ards
5188039|NCT02814994|Ventilator Strategy|ventilator strategy
5188040|NCT02814994|Outcome|outcome
5188041|NCT02814981|hydroxyzine|hydroxyzine
5188042|NCT02814981|Long QT|long qt
5188050|NCT02814955|atrial fibrillation|atrial fibrillation
5188051|NCT02814955|pulmonary veins|pulmonary veins
5188052|NCT02814955|oral anticoagulant|oral anticoagulant
5188053|NCT02814955|electrophysiology|electrophysiology
5188054|NCT02814955|anticoagulant drugs|anticoagulant drugs
5188056|NCT02814929|Risk factors|risk factors
5188057|NCT02814929|Incidence|incidence
5188058|NCT02814929|Turkey|turkey
5188059|NCT02814916|Acute Bacterial Skin and Skin Structure Infection (ABSSSI)|acute bacterial skin and skin structure infection (absssi)
5188060|NCT02814903|aldosterone|aldosterone
5188061|NCT02814903|cardiac surgery|cardiac surgery
5188062|NCT02814903|atrial fibrillation|atrial fibrillation
5188063|NCT02814903|galectin-3|galectin-3
5188064|NCT02814903|mitochondria|mitochondria
5188065|NCT02814903|ngal|ngal
5188066|NCT02814903|acute kidney failure|acute kidney failure
5188067|NCT02814903|epicardial fat|epicardial fat
5188068|NCT02814903|right atrial sample|right atrial sample
5188069|NCT02814890|Thoracic paravertebral block|thoracic paravertebral block
5188070|NCT02814890|Dexmedetomidine|dexmedetomidine
5188071|NCT02814890|Video-assisted Pneumonectomy|video-assisted pneumonectomy
5188072|NCT02814890|Ropivacaine|ropivacaine
5188073|NCT02814890|Pain, Postoperative|pain, postoperative
5188074|NCT02814877|Antibiotic stewardship|antibiotic stewardship
5423228|NCT01616589|Fragile X premutation|fragile x premutation
5188075|NCT02814877|cost-effectiveness evaluation|cost-effectiveness evaluation
5188076|NCT02814877|Antibiotic use|antibiotic use
5188077|NCT02814864|Hematology|hematology
5188078|NCT02814864|Mesenchymal Stromal Cell|mesenchymal stromal cell
5188079|NCT02814864|radiotherapy|radiotherapy
5188080|NCT02814864|gastro-intestinal complications|gastro-intestinal complications
5188081|NCT02814864|lower digestive tract cancers|lower digestive tract cancers
5188082|NCT02814864|colitis|colitis
5188083|NCT02814864|bleeding|bleeding
5188084|NCT02814864|diarrhea|diarrhea
5188085|NCT02814864|pelvic radiation disease|pelvic radiation disease
5188086|NCT02814851|Left atrium appendage (LAA) occlusion|left atrium appendage (laa) occlusion
5188087|NCT02814851|Transesophageal echocardiography|transesophageal echocardiography
5188088|NCT02814851|Cardiac output hemodynamic measurement|cardiac output hemodynamic measurement
5188089|NCT02814851|Leycom Pressure/Volume Combination Catheter|leycom pressure/volume combination catheter
5188090|NCT02814838|Diabetes mellitus Type 1|diabetes mellitus type 1
5188091|NCT02814838|Beta cells function|beta cells function
5188092|NCT02814825|ViviGen|vivigen
5188093|NCT02814825|ACDF|acdf
5188094|NCT02814825|Cervical|cervical
5188095|NCT02814760|acute ischemic stroke|acute ischemic stroke
5188096|NCT02814760|stepped-wedge|stepped-wedge
5188097|NCT02814760|interactive training|interactive training
5188098|NCT02814760|implementation|implementation
5188099|NCT02814760|emergency department|emergency department
5188100|NCT02814734|Intra-Abdominal Hypertension|intra-abdominal hypertension
5077582|NCT03514433|Social Determinants|social determinants
5188101|NCT02814734|Abdominal Compartment Syndrome|abdominal compartment syndrome
5188102|NCT02814734|Round Belly Sign|round belly sign
5188103|NCT02814734|Radiology|radiology
5188104|NCT02814734|CT findings|ct findings
5188105|NCT02814734|Intensive Care|intensive care
5188106|NCT02814708|Sepsis|sepsis
5188107|NCT02814708|Vaccination|vaccination
5188108|NCT02814695|Male infertility|male infertility
5188109|NCT02814695|oxidative stress|oxidative stress
5188110|NCT02814695|antioxidants|antioxidants
5188111|NCT02814695|probiotics|probiotics
5188112|NCT02814695|Vitamin E|vitamin e
5188113|NCT02814695|Baker's Yeast|baker's yeast
5188114|NCT02814682|palliative care|palliative care
5188115|NCT02814682|quality|quality
5188116|NCT02814682|indicator|indicator
5188117|NCT02814682|multi-dimensional|multi-dimensional
5188118|NCT02814656|muscarinic receptor antagonist and β2 adrenoceptor agonist [MABA]|muscarinic receptor antagonist and β2 adrenoceptor agonist [maba]
5188119|NCT02814656|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5188120|NCT02814656|Asthma (in combination with an inhaled corticosteroid [ICS]|asthma (in combination with an inhaled corticosteroid [ics]
5188121|NCT02814656|alpha-lactose monohydrate|alpha-lactose monohydrate
5188123|NCT02814656|long-acting β2-agonist (LABA)|long-acting β2-agonist (laba)
5188124|NCT02814656|long-acting muscarinic antagonist (LAMA)|long-acting muscarinic antagonist (lama)
5188125|NCT02814656|fixed-dose combination (FDC)|fixed-dose combination (fdc)
5188126|NCT02814643|Male and female adolescent patients|male and female adolescent patients
5188127|NCT02814643|severe asthma|severe asthma
5188128|NCT02814604|Front-of-Pack Labelling|front-of-pack labelling
5188129|NCT02814604|Star rating system|star rating system
5188130|NCT02814604|Traffic light rating system|traffic light rating system
5188131|NCT02814604|Consumer Behavior|consumer behavior
5188132|NCT02814604|Health Literacy|health literacy
5188133|NCT02814604|Mobile Apps|mobile apps
5188134|NCT02814604|Nutrition Labeling|nutrition labeling
5188135|NCT02814604|Healthy food choices|healthy food choices
5188137|NCT02814578|IVUS|ivus
5188138|NCT02814578|BVS|bvs
5188139|NCT02814565|Drug therapy|drug therapy
5188140|NCT02814526|exercise|exercise
5188141|NCT02814513|Children|children
5188142|NCT02814513|Adolescents|adolescents
5188143|NCT02814487|DAM|dam
5188144|NCT02814487|multiple sclerosis|multiple sclerosis
5188145|NCT02814487|MSFC|msfc
5188146|NCT02814487|application|application
5188147|NCT02814487|smartphone|smartphone
5188148|NCT02814474|PET/CT|pet/ct
5188149|NCT02814474|Heart failure|heart failure
5188150|NCT02814474|hydroxybutyrate|hydroxybutyrate
5188151|NCT02814435|Retina|retina
5188152|NCT02814435|Retinal Degeneration|retinal degeneration
5188153|NCT02814435|Quality of Life Measures|quality of life measures
5188154|NCT02814422|Triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
5188155|NCT02814422|dementia|dementia
5188156|NCT02814422|Alzheimer's disease|alzheimer's disease
5188157|NCT02814422|mild cognition impairment|mild cognition impairment
5188158|NCT02814422|amyloid-beta|amyloid-beta
5188159|NCT02814396|Ventricular|ventricular
5188160|NCT02814396|CVD|cvd
5188161|NCT02814396|Ventricular arrhythmias|ventricular arrhythmias
5188162|NCT02814383|Prematurity|prematurity
5188163|NCT02814383|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5188164|NCT02814383|Cerebral Perfusion|cerebral perfusion
5188165|NCT02814383|Cerebral Autoregulation|cerebral autoregulation
5188166|NCT02814357|Blood glucose, serum insulin|blood glucose, serum insulin
5188167|NCT02814344|labour|labour
5188168|NCT02814331|Video-EEG|video-eeg
5188169|NCT02814331|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5423229|NCT01616589|Fragile X intermediate|fragile x intermediate
5188174|NCT02814318|Rectovaginal GBS colonization|rectovaginal gbs colonization
5188175|NCT02814318|Vaginal GBS colonization|vaginal gbs colonization
5188177|NCT02814318|Prophylaxis|prophylaxis
5188178|NCT02814227|obstructive sleep apnea screening device|obstructive sleep apnea screening device
5188179|NCT02814201|Motor slowing|motor slowing
5188180|NCT02814201|Computerized mental chronometry paradigm|computerized mental chronometry paradigm
5188181|NCT02814188|Exercise|exercise
5188182|NCT02814175|Psoriatic Arthritis|psoriatic arthritis
5188183|NCT02814162|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
5188184|NCT02814162|Predictive|predictive
5188185|NCT02814162|Adiponectin|adiponectin
5188186|NCT02814149|delayed implant|delayed implant
5188187|NCT02814149|esthetics|esthetics
5188188|NCT02814149|immediate implant|immediate implant
5188189|NCT02814149|bone augmentation|bone augmentation
5188195|NCT02814110|Granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5188196|NCT02814110|muscular dystrophy|muscular dystrophy
5188197|NCT02814110|muscle strength|muscle strength
5188198|NCT02814110|children|children
5188199|NCT02814110|adolescents|adolescents
5188200|NCT02814097|Heart Failure|heart failure
5188201|NCT02814097|HFpEF|hfpef
5188202|NCT02814097|elamipretide|elamipretide
5188203|NCT02814097|MTP-131|mtp-131
5188204|NCT02814097|Bendavia™|bendavia™
5188205|NCT02814071|Early Feeding|early feeding
5188206|NCT02814071|Acute Pancreatitis|acute pancreatitis
5188207|NCT02814071|Pediatric|pediatric
5356805|NCT01917903|walking|walking
5188208|NCT02814058|pharmacokinetics|pharmacokinetics
5188209|NCT02814058|Healthy Volunteers|healthy volunteers
5188210|NCT02814045|biomarkers, sleep fragmentation, intermittent hypoxia|biomarkers, sleep fragmentation, intermittent hypoxia
5188211|NCT02814032|proteomic|proteomic
5188212|NCT02814032|cervical lymph node metastasis|cervical lymph node metastasis
5188213|NCT02814019|respiratory function in DMD|respiratory function in dmd
5188214|NCT02814006|marital relationship|marital relationship
5188215|NCT02813993|infertility|infertility
5188216|NCT02813993|fertility awareness|fertility awareness
5188217|NCT02813993|preconceptional care|preconceptional care
5188218|NCT02813993|health interventions|health interventions
5188219|NCT02813993|couples|couples
5188220|NCT02813980|SUDEP|sudep
5188221|NCT02813980|Sudden cardiac death|sudden cardiac death
5188222|NCT02813980|Sudden unexpected death in epilepsy|sudden unexpected death in epilepsy
5176102|NCT02890836|Preeclampsia|preeclampsia
5176103|NCT02890836|Anti-hypertensiva|anti-hypertensiva
5176104|NCT02890823|Antiepileptic Drugs|antiepileptic drugs
5176105|NCT02890823|Vitamin D Deficiency|vitamin d deficiency
5188230|NCT02813941|GRADE|grade
5188231|NCT02813941|AHRQ|ahrq
5188232|NCT02813928|ColoRectal Cancer|colorectal cancer
5188233|NCT02813928|Cancerology|cancerology
5188234|NCT02813928|Translational Research|translational research
5188235|NCT02813928|ccfDNA|ccfdna
5188236|NCT02813915|cardiac monitoring, Cheetah Medical, passive leg raises|cardiac monitoring, cheetah medical, passive leg raises
5188237|NCT02813889|infant|infant
5188238|NCT02813889|baby|baby
5188239|NCT02813889|developmental delay|developmental delay
5188240|NCT02813889|robotics|robotics
5188241|NCT02813889|cerebral palsy|cerebral palsy
5188242|NCT02813850|sickle cell disease|sickle cell disease
5188243|NCT02813850|oxygen therapy|oxygen therapy
5188244|NCT02813850|pregnancy|pregnancy
5188245|NCT02813850|pregnancy in sickle cell disease|pregnancy in sickle cell disease
5188246|NCT02813837|relapsed|relapsed
5188247|NCT02813837|refractory|refractory
5188248|NCT02813837|CD19+|cd19+
5188249|NCT02813837|leukemia|leukemia
5188250|NCT02813837|lymphoma|lymphoma
5188251|NCT02813811|Temperature-controlled Laminar Airflow|temperature-controlled laminar airflow
5188252|NCT02813811|Exacerbation frequency|exacerbation frequency
5188253|NCT02813798|Renal Insufficiency|renal insufficiency
5188254|NCT02813772|infants|infants
5188255|NCT02813772|colic|colic
5188256|NCT02813759|GLYCEMIA|glycemia
5188257|NCT02813759|SATIETY|satiety
5188258|NCT02813759|C PEPTIDE|c peptide
5188259|NCT02813759|PRELOAD|preload
5188260|NCT02813759|INSULIN|insulin
5188261|NCT02813746|Obesity|obesity
5188262|NCT02813746|Tobacco|tobacco
5188263|NCT02813746|Epigenetic|epigenetic
5188264|NCT02813746|Transcriptomic|transcriptomic
5188265|NCT02813746|microRNAs|micrornas
5188266|NCT02813746|miRNAs|mirnas
5188267|NCT02813733|thyroid surgery|thyroid surgery
5188268|NCT02813733|surgical outcomes|surgical outcomes
5188269|NCT02813733|patient safety|patient safety
5188270|NCT02813733|healthcare quality|healthcare quality
5188275|NCT02813720|Psoriatic arthritis|psoriatic arthritis
5188276|NCT02813707|Vitamins|vitamins
5188277|NCT02813707|Mineral|mineral
5188278|NCT02813707|Surgery|surgery
5188279|NCT02813694|Pneumonia|pneumonia
5188280|NCT02813694|CABP|cabp
5188281|NCT02813694|CAP|cap
5188282|NCT02813694|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
5188283|NCT02813681|Acute Pain|acute pain
5188284|NCT02813681|ultrasonography|ultrasonography
5188285|NCT02813668|Nutrition|nutrition
5188286|NCT02813668|Occupational Health|occupational health
5188287|NCT02813655|tetracosactide|tetracosactide
5188288|NCT02813655|Synacthène®|synacthène®
5188289|NCT02813655|cosyntropin|cosyntropin
5188290|NCT02813655|post-dural syndrom|post-dural syndrom
5188291|NCT02813655|post-dural puncture headache|post-dural puncture headache
5188292|NCT02813642|chronic kidney disease starting dialysis|chronic kidney disease starting dialysis
5188293|NCT02813642|cardiovascular risk|cardiovascular risk
5188294|NCT02813642|bone mineral metabolism markers|bone mineral metabolism markers
5188295|NCT02813629|transcranial Direct Current Stimulation|transcranial direct current stimulation
5188296|NCT02813629|Peripheral Electrical Stimulation|peripheral electrical stimulation
5188297|NCT02813629|Sickle Cell Disease|sickle cell disease
5188298|NCT02813629|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5188299|NCT02813629|quantitative Electroencephalography|quantitative electroencephalography
5188300|NCT02813603|EBUS-TBNA|ebus-tbna
5188301|NCT02813603|staging|staging
5188302|NCT02813603|lymph node metastases|lymph node metastases
5188303|NCT02813577|Legs|legs
5188304|NCT02813577|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5188305|NCT02813577|Experimental|experimental
5188306|NCT02813577|Standard Angioplasty Balloon|standard angioplasty balloon
5188307|NCT02813564|Autism|autism
5188308|NCT02813564|Cognitive Training|cognitive training
5188309|NCT02813564|Brain|brain
5188310|NCT02813564|fMRI|fmri
5188311|NCT02813551|Preeclampsia, puerperium|preeclampsia, puerperium
5188312|NCT02813538|Thrombelastography|thrombelastography
5188313|NCT02813538|Antithrombin proteins|antithrombin proteins
5188314|NCT02813538|Liver surgery|liver surgery
5188315|NCT02813538|Liver function tests|liver function tests
5188316|NCT02813525|Aortic Isthmus|aortic isthmus
5188317|NCT02813525|Isthmic Systolic Index|isthmic systolic index
5188318|NCT02813525|feasibility|feasibility
5188319|NCT02813525|reproducibility|reproducibility
5188320|NCT02813525|mortality|mortality
5188321|NCT02813525|delivery|delivery
5188322|NCT02813499|Acute Coronary Syndrome|acute coronary syndrome
5188323|NCT02813473|SYNTAX Score II|syntax score ii
5188324|NCT02813473|Multi Slice Computed Tomography|multi slice computed tomography
5188325|NCT02813473|MSCT|msct
5188326|NCT02813473|Heart Team|heart team
5188327|NCT02813473|Fractional Flow Reserve Computed Tomography|fractional flow reserve computed tomography
5188328|NCT02813473|FFR|ffr
5188329|NCT02813473|FFR MSCT|ffr msct
5188330|NCT02813473|PCI|pci
5188331|NCT02813473|CABG|cabg
5188332|NCT02813473|Percutaneous Coronary Intervention|percutaneous coronary intervention
5188333|NCT02813473|Coronary Artery Bypass Graft|coronary artery bypass graft
5188334|NCT02813434|Cerebral amyloid imaging|cerebral amyloid imaging
5188335|NCT02813434|Florbetapir|florbetapir
5188336|NCT02813434|18F-AV-45|18f-av-45
5188337|NCT02813434|poststroke|poststroke
5188338|NCT02813421|CGM|cgm
5188339|NCT02813382|bupivacaine|bupivacaine
5188340|NCT02813382|prilocaine|prilocaine
5188341|NCT02813382|2-chloroprocaine|2-chloroprocaine
5188342|NCT02813330|Women|women
5188343|NCT02813330|severe|severe
5188344|NCT02813330|low back ache|low back ache
5188345|NCT02813330|labor|labor
5188346|NCT02813317|Surgery|surgery
5188347|NCT02813317|Breast cancer|breast cancer
5188348|NCT02813317|Quality of life|quality of life
5188349|NCT02813317|Care pathway|care pathway
5188350|NCT02813317|Economic evaluation|economic evaluation
5188351|NCT02813304|Acute|acute
5188352|NCT02813304|rotator cuff tendinopathy|rotator cuff tendinopathy
5188353|NCT02813304|exercise|exercise
5188354|NCT02813304|loading|loading
5188355|NCT02813304|ice|ice
5188356|NCT02813304|cryotherapy|cryotherapy
5188357|NCT02813304|randomised control trial|randomised control trial
5188358|NCT02813291|Motor imagery|motor imagery
5188359|NCT02813291|transcranial direct current stimulation|transcranial direct current stimulation
5188360|NCT02813291|motor learning|motor learning
5188361|NCT02813291|aging|aging
5188362|NCT02813265|Ocular Discomfort|ocular discomfort
5188363|NCT02813265|Pain|pain
5188364|NCT02813265|Corticosteroid|corticosteroid
5188365|NCT02813265|Hyperemia|hyperemia
5188366|NCT02813265|Dry Eye|dry eye
5188370|NCT02813239|IVF|ivf
5188371|NCT02813239|Dual trigger|dual trigger
5188372|NCT02813239|GnRH agonist|gnrh agonist
5188373|NCT02813239|hCG|hcg
5188374|NCT02813239|mature oocytes|mature oocytes
5188375|NCT02813226|castration-resistant|castration-resistant
5188376|NCT02813226|molecular imaging|molecular imaging
5188377|NCT02813226|abiraterone acetate|abiraterone acetate
5188378|NCT02813226|enzalutamide|enzalutamide
5188379|NCT02813226|metabolic response|metabolic response
5188380|NCT02813213|skin transplantation|skin transplantation
5188381|NCT02813213|grafting skin|grafting skin
5188382|NCT02813200|COPD, inhaler device, handling|copd, inhaler device, handling
5188383|NCT02813187|venous leg ulcer|venous leg ulcer
5188384|NCT02813187|venous|venous
5188385|NCT02813187|QCDR|qcdr
5188386|NCT02813187|quality measure|quality measure
5188387|NCT02813187|wound|wound
5188388|NCT02813187|Outcome|outcome
5188389|NCT02813187|Lymphedema|lymphedema
5188390|NCT02813161|diabetic foot ulcer|diabetic foot ulcer
5962345|NCT04281394|robot assisted gait training|robot assisted gait training
5188391|NCT02813161|diabetes|diabetes
5188392|NCT02813161|arterial disease|arterial disease
5188393|NCT02813161|neuropathy|neuropathy
5962346|NCT04281381|Desmoid-Type Fibromatosis|desmoid-type fibromatosis
5188394|NCT02813161|amputation|amputation
5188395|NCT02813161|QCDR|qcdr
5188396|NCT02813161|quality measure|quality measure
5188397|NCT02813161|wound|wound
5188398|NCT02813096|HCC|hcc
5188399|NCT02813096|PVTT|pvtt
5188400|NCT02813096|Folofox4|folofox4
5188401|NCT02813096|Early Recurrence|early recurrence
5188402|NCT02813044|anesthesia|anesthesia
5188403|NCT02813044|intravenous|intravenous
5188404|NCT02813044|neurosurgery|neurosurgery
5188405|NCT02813044|pituitary neoplasm|pituitary neoplasm
5188406|NCT02813044|postoperative period|postoperative period
5188407|NCT02813031|functional meat products|functional meat products
5188408|NCT02813031|hypocaloric fats|hypocaloric fats
5188409|NCT02813031|diglyceride|diglyceride
5188410|NCT02813031|obesity|obesity
5188411|NCT02813018|child|child
5188412|NCT02813018|analgesia|analgesia
5188413|NCT02813018|epidural|epidural
5188414|NCT02813018|pain|pain
5188415|NCT02813018|postoperative|postoperative
5188416|NCT02813018|orthopedics|orthopedics
5188417|NCT02813005|High frequency jet ventilation|high frequency jet ventilation
5077921|NCT03512743|ferritin|ferritin
5188418|NCT02812966|peripheral arterial disease|peripheral arterial disease
5188419|NCT02812966|drug coated balloon|drug coated balloon
5188425|NCT02812888|Betatrophin|betatrophin
5188426|NCT02812875|Mesothelioma|mesothelioma
5188427|NCT02812875|PD-L1|pd-l1
5188428|NCT02812875|VISTA|vista
5188429|NCT02812875|PD-1|pd-1
5188430|NCT02812836|anorectal manometry|anorectal manometry
5188431|NCT02812836|children|children
5188432|NCT02812836|constipation|constipation
5188433|NCT02812823|manometry|manometry
5188434|NCT02812823|children|children
5188435|NCT02812823|constipation|constipation
5188436|NCT02812823|functional disorders|functional disorders
5188437|NCT02812797|Adipokines|adipokines
5188438|NCT02812797|Chronic Heart Failure|chronic heart failure
5188439|NCT02812797|Prognosis|prognosis
5188440|NCT02812784|Nephrocheck™|nephrocheck™
5188441|NCT02812784|acute kidney injury|acute kidney injury
5188442|NCT02812758|sedation depth|sedation depth
5188443|NCT02812758|indices of preload dependence|indices of preload dependence
5188444|NCT02812745|anaesthesia|anaesthesia
5188445|NCT02812732|HPV vaccination|hpv vaccination
5188446|NCT02812732|provider education|provider education
5188447|NCT02812667|Metastatic|metastatic
5188448|NCT02812667|NSCLC|nsclc
5188449|NCT02812667|nivolumab|nivolumab
5188450|NCT02812667|plinabulin|plinabulin
5188451|NCT02812667|BPI-2358|bpi-2358
5188452|NCT02812667|opdivo|opdivo
5188453|NCT02812667|Non-Small Cell Lung Cancer|non-small cell lung cancer
5188454|NCT02812667|cancer|cancer
5188455|NCT02812654|Sarcoma|sarcoma
5188456|NCT02812654|soft tissue sarcoma|soft tissue sarcoma
5188457|NCT02812654|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5188458|NCT02812654|neoadjuvant radiotherapy|neoadjuvant radiotherapy
5188459|NCT02812654|hypofractionated radiotherapy|hypofractionated radiotherapy
5188460|NCT02812641|Concurrent chemoradiation|concurrent chemoradiation
5188461|NCT02812641|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5188462|NCT02812641|Vascular endothelial growth factor|vascular endothelial growth factor
5188463|NCT02812628|laparoscopic surgery|laparoscopic surgery
5188464|NCT02812628|abdominoperineal resection|abdominoperineal resection
5188465|NCT02812628|rectal cancer|rectal cancer
5188466|NCT02812628|individualized surgery|individualized surgery
5188467|NCT02812628|levator muscle|levator muscle
5188468|NCT02812615|Environmental Enteric Dysfunction|environmental enteric dysfunction
5188469|NCT02812602|Total Knee Replacement|total knee replacement
5188470|NCT02812602|Stitch|stitch
5188471|NCT02812602|Removal|removal
5188472|NCT02812602|Pain|pain
5188473|NCT02812589|MRI|mri
5188474|NCT02812576|Group B streptococcus|group b streptococcus
5188475|NCT02812576|Infants|infants
5188476|NCT02812576|China|china
5188477|NCT02812550|full-spectrum endoscopy|full-spectrum endoscopy
5188478|NCT02812550|polyp detection rate|polyp detection rate
5188479|NCT02812550|colorectal cancer|colorectal cancer
5188480|NCT02812550|colorectal screening|colorectal screening
5188481|NCT02812550|adenoma detection rate|adenoma detection rate
5188482|NCT02812550|endoscopic innovations|endoscopic innovations
5188483|NCT02812537|Trajectories|trajectories
5188484|NCT02812537|emergency room|emergency room
5188485|NCT02812537|conduct disorder|conduct disorder
5188486|NCT02812537|care management|care management
5188487|NCT02812524|Immunotherapy|immunotherapy
5188488|NCT02812524|Yervoy|yervoy
5188489|NCT02812524|Head and neck cancer|head and neck cancer
5188490|NCT02812524|Pre-operative|pre-operative
5188491|NCT02812498|teleconsultation|teleconsultation
5188492|NCT02812498|insulin therapy|insulin therapy
5188493|NCT02812498|HbA1c|hba1c
5188494|NCT02812459|Electrical Stimulation Therapy|electrical stimulation therapy
5188495|NCT02812459|Kinesio taping|kinesio taping
5188496|NCT02812459|Exercise|exercise
5962347|NCT04281381|Desmoid Fibromatosis|desmoid fibromatosis
5188498|NCT02812446|staphylokinase|staphylokinase
5188499|NCT02812446|Staphylococcus aureus|staphylococcus aureus
5188500|NCT02812446|microarrays|microarrays
5188501|NCT02812446|bone binding sialoprotein|bone binding sialoprotein
5188502|NCT02812446|bone and joint infection|bone and joint infection
5188503|NCT02812446|blood group|blood group
5188504|NCT02812433|birth asphyxia|birth asphyxia
5188505|NCT02812433|brain|brain
5188506|NCT02812433|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5188507|NCT02812433|neonate|neonate
5188508|NCT02812433|neuroprotection|neuroprotection
5188509|NCT02812433|neurorestoration|neurorestoration
5188510|NCT02812433|newborn|newborn
5188511|NCT02812433|sildenafil|sildenafil
5188512|NCT02812394|Parkinson's disease|parkinson's disease
5188513|NCT02812394|Episodic motor fluctuations (OFF periods)|episodic motor fluctuations (off periods)
5188514|NCT02812381|Trigger Points, movement|trigger points, movement
5188515|NCT02812355|off-pump|off-pump
5184230|NCT02838602|cancer|cancer
5188516|NCT02812355|coronary artery bypass|coronary artery bypass
5188517|NCT02812355|heparinization|heparinization
5188518|NCT02812342|Alopecia|alopecia
5188519|NCT02812316|Myopia|myopia
5188520|NCT02812316|Scleral lens|scleral lens
5188521|NCT02812316|Astigmatism|astigmatism
5188522|NCT02812316|Presbyopia|presbyopia
5188523|NCT02812290|antibody mediated rejection|antibody mediated rejection
5188524|NCT02812290|T cell mediated rejection|t cell mediated rejection
5188525|NCT02812277|anastrozole|anastrozole
5188526|NCT02812277|letrozole|letrozole
5188527|NCT02812277|postmenopausal patients|postmenopausal patients
5188528|NCT02812238|Inflammasome|inflammasome
5188529|NCT02812238|Sirt3|sirt3
5188530|NCT02812238|Nicotinamide Riboside|nicotinamide riboside
5188531|NCT02812238|Fasting|fasting
5188532|NCT02812212|ureteropelvic junction obstruction|ureteropelvic junction obstruction
5188533|NCT02812212|cortical transit time|cortical transit time
5188534|NCT02812186|Neuromuscular blockade|neuromuscular blockade
5188535|NCT02812173|urinary drainage|urinary drainage
5188536|NCT02812173|urethral catheter|urethral catheter
5188537|NCT02812173|suprapubic tube|suprapubic tube
5188538|NCT02812173|pain|pain
5188539|NCT02812173|discomfort|discomfort
5188540|NCT02812173|radical prostatectomy|radical prostatectomy
5188541|NCT02812173|robotic surgery|robotic surgery
5188542|NCT02812173|urinary infection|urinary infection
5188543|NCT02812160|weight loss|weight loss
5188544|NCT02812147|L-dihydoxyphenylserine|l-dihydoxyphenylserine
5188545|NCT02812147|L-DOPS|l-dops
5188546|NCT02812147|Northera|northera
5188547|NCT02812134|phosphorus supplementation|phosphorus supplementation
5188548|NCT02812134|FGF23|fgf23
5188549|NCT02812134|anorexic|anorexic
5188550|NCT02812134|adolescents|adolescents
5188551|NCT02812134|undernutrition|undernutrition
5188552|NCT02812108|intracranial aneurysm|intracranial aneurysm
5188553|NCT02812108|endovascular treatment|endovascular treatment
5188554|NCT02812108|recanalization|recanalization
5188555|NCT02812108|outcome|outcome
5188556|NCT02812108|hemodynamics|hemodynamics
5188557|NCT02812108|computational fluid dynamic|computational fluid dynamic
5188558|NCT02812108|stent|stent
5188559|NCT02812108|flow diversion|flow diversion
5188560|NCT02812082|Web-based|web-based
5188561|NCT02812082|patient education application|patient education application
5188562|NCT02812082|16-769|16-769
5188563|NCT02812056|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
5188564|NCT02812056|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5188565|NCT02812056|Malignant neoplasms of lip oral cavity and pharynx|malignant neoplasms of lip oral cavity and pharynx
5188566|NCT02812056|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5188567|NCT02812056|Human papilloma virus associated malignancies|human papilloma virus associated malignancies
5188568|NCT02812056|HPV|hpv
5188569|NCT02812056|Alisertib|alisertib
5188570|NCT02812056|MLN8237|mln8237
5188571|NCT02812056|TAK-228|tak-228
5188572|NCT02812056|MLN0128|mln0128
5798977|NCT00110305|Zidovudine|zidovudine
5188573|NCT02812043|onychomycosis|onychomycosis
5188574|NCT02812043|amorolfine|amorolfine
5188575|NCT02812043|long-pulsed Nd:YAG|long-pulsed nd:yag
5188576|NCT02812043|fungal infection|fungal infection
5188577|NCT02812030|Observational Study|observational study
5188578|NCT02812030|aflibercept|aflibercept
5188579|NCT02812030|Diabetic Retinopathy|diabetic retinopathy
5188580|NCT02812030|Visual Acuity|visual acuity
5188581|NCT02812017|educational intervention|educational intervention
5188582|NCT02812017|language development|language development
5188583|NCT02812017|postpartum|postpartum
5188584|NCT02812017|parental attachment|parental attachment
5188585|NCT02812017|achievement gap|achievement gap
5188586|NCT02812017|language gap|language gap
5188587|NCT02812017|school readiness|school readiness
5188588|NCT02812004|Vitreous Floaters|vitreous floaters
5188589|NCT02812004|Mouches Voulantes|mouches voulantes
5188590|NCT02811991|paracetamol|paracetamol
5188591|NCT02811991|post-operative analgesia|post-operative analgesia
5188592|NCT02811965|heel|heel
5188593|NCT02811965|pressure ulcer|pressure ulcer
5188594|NCT02811965|pressure mapping|pressure mapping
5196065|NCT02768779|hair|hair
5188596|NCT02811939|Cannabis|cannabis
5188597|NCT02811939|Marijuana|marijuana
5188599|NCT02811939|Dronabinol|dronabinol
5188600|NCT02811939|Pregnenolone|pregnenolone
5063599|NCT03601962|hibiscus|hibiscus
5063600|NCT03601962|oral health|oral health
5063604|NCT03601923|Pancreatic Cancer|pancreatic cancer
5063605|NCT03601897|rebastinib|rebastinib
5063606|NCT03601897|paclitaxel|paclitaxel
5063607|NCT03601897|breast cancer|breast cancer
5063608|NCT03601897|ovarian cancer|ovarian cancer
5063609|NCT03601897|endometrial cancer|endometrial cancer
5063610|NCT03601884|Well-being|well-being
5063611|NCT03601884|Self-efficacy|self-efficacy
5063612|NCT03601884|Self-management|self-management
5063613|NCT03601884|Psychosocial|psychosocial
5063614|NCT03601884|Malaysia|malaysia
5063615|NCT03601871|Thalidomide|thalidomide
5063616|NCT03601871|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5063617|NCT03601871|cisplatin|cisplatin
5063618|NCT03601858|Attention deficit|attention deficit
5188601|NCT02811939|PREG|preg
5188602|NCT02811939|Psychotic Disorders|psychotic disorders
5188603|NCT02811926|parastomal bulging|parastomal bulging
5188604|NCT02811926|peristomal bulging|peristomal bulging
5188605|NCT02811926|ileostomy|ileostomy
5188606|NCT02811926|colostomy|colostomy
5188607|NCT02811926|enterostomy|enterostomy
5188608|NCT02811926|incidence|incidence
5188609|NCT02811926|risk factor|risk factor
5188610|NCT02811913|sensory impairment|sensory impairment
5188611|NCT02811913|sensory deficit|sensory deficit
5188612|NCT02811913|upper limb|upper limb
5188616|NCT02811900|obesity surgery|obesity surgery
5188617|NCT02811900|Roux en Y gastric bypass|roux en y gastric bypass
5188618|NCT02811900|sleeve gastrectomy|sleeve gastrectomy
5188619|NCT02811900|excess weight loss|excess weight loss
5188620|NCT02811900|quality of life|quality of life
5188624|NCT02811861|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
5188625|NCT02811861|Lenvatinib|lenvatinib
5188626|NCT02811861|First-line RCC|first-line rcc
5188627|NCT02811861|Treatment-naive RCC|treatment-naive rcc
5188628|NCT02811861|Everolimus|everolimus
5188629|NCT02811861|Pembrolizumab|pembrolizumab
5188630|NCT02811861|Sunitinib|sunitinib
5188631|NCT02811861|Phase 3 RCC|phase 3 rcc
5188632|NCT02811861|Phase 3 first-line RCC|phase 3 first-line rcc
5188633|NCT02811861|Phase 3 treatment-naive RCC|phase 3 treatment-naive rcc
5188634|NCT02811822|GMI-1271|gmi-1271
5188635|NCT02811822|bortezomib|bortezomib
5188636|NCT02811822|carfilzomib|carfilzomib
5188637|NCT02811822|multiple myeloma|multiple myeloma
5188644|NCT02811796|drug eluting stents|drug eluting stents
5188740|NCT02811016|hypoxia|hypoxia
5188645|NCT02811796|flow fractional reserve|flow fractional reserve
5188646|NCT02811796|prognosis|prognosis
5188647|NCT02811796|angio-based FFR|angio-based ffr
5188648|NCT02811783|Pruritus|pruritus
5188649|NCT02811783|Mycosis Fungoides|mycosis fungoides
5188650|NCT02811783|CTCL|ctcl
5188651|NCT02811783|naloxone|naloxone
5188652|NCT02811783|opiate antagonist|opiate antagonist
5188653|NCT02811783|Sézary Syndrome|sézary syndrome
5188654|NCT02811718|Stress Management|stress management
5188655|NCT02811718|Resiliency|resiliency
5188656|NCT02811718|Skype|skype
5188657|NCT02811692|Database|database
5188658|NCT02811692|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5188659|NCT02811692|Wet Age-related Macular Degeneration (wAMD)|wet age-related macular degeneration (wamd)
5188660|NCT02811692|Retinal Diseases|retinal diseases
5188661|NCT02811692|Optic Nerve Diseases|optic nerve diseases
5188662|NCT02811692|Corneal Diseases|corneal diseases
5188663|NCT02811692|Vision Disorders|vision disorders
5188664|NCT02811679|Lymphoma|lymphoma
5188665|NCT02811653|Motor slowing|motor slowing
5188666|NCT02811640|Intra-Abdominal Pressure|intra-abdominal pressure
5188667|NCT02811640|Stryker Pressure Monitor|stryker pressure monitor
5188668|NCT02811627|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5188669|NCT02811627|Memantine|memantine
5188670|NCT02811627|Treatment prediction biomarker|treatment prediction biomarker
5188671|NCT02811614|intracerebral hemorrhage,hypertensive|intracerebral hemorrhage,hypertensive
5188673|NCT02811614|neuroendoscopic surgery|neuroendoscopic surgery
5188674|NCT02811614|stereotactic aspiration|stereotactic aspiration
5188675|NCT02811601|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5188677|NCT02811549|Cochlear Implant|cochlear implant
5188678|NCT02811549|HiRes™ 90K Advantage Implant|hires™ 90k advantage implant
5962348|NCT04281381|Desmoid|desmoid
5962349|NCT04281381|Fibromatosis|fibromatosis
5962350|NCT04281381|20-026|20-026
5962351|NCT04281381|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5962352|NCT04281368|IUFD|iufd
5962353|NCT04281329|Atrial fibrillation|atrial fibrillation
5962354|NCT04281329|Catheter ablation|catheter ablation
5962355|NCT04281329|Magnetic resonance imaging|magnetic resonance imaging
5962356|NCT04281329|Computed tomography|computed tomography
5962357|NCT04281316|non-compliance|non-compliance
5962358|NCT04281316|NIV|niv
5962359|NCT04281316|NHF|nhf
5962360|NCT04281316|COPD|copd
5962361|NCT04281316|hypercapnic respiratory failure|hypercapnic respiratory failure
5962362|NCT04281303|NASH|nash
5962363|NCT04281303|Obesity|obesity
5962364|NCT04281303|endoscopic vertical gastroplasty|endoscopic vertical gastroplasty
5962365|NCT04281303|cirrhosis|cirrhosis
5962366|NCT04281290|Pancreatic cancer|pancreatic cancer
5962367|NCT04281290|Electrochemotherapy|electrochemotherapy
5962368|NCT04281290|Bleomycin|bleomycin
5962369|NCT04281277|renal resistive index|renal resistive index
5188679|NCT02811549|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
5188680|NCT02811549|HiFocus™ 1J electrode|hifocus™ 1j electrode
5188681|NCT02811549|HiFocus Helix™ electrode|hifocus helix™ electrode
5188682|NCT02811549|Cochlear Implantation|cochlear implantation
5188683|NCT02811549|Listening Benefits|listening benefits
5188684|NCT02811549|Adults|adults
5188685|NCT02811549|Cochlear Implant Benefit|cochlear implant benefit
5188686|NCT02811549|Electrical Stimulation|electrical stimulation
5188687|NCT02811549|HiRes™ Ultra Implant with HiFocus™ Mid‐Scala electrode|hires™ ultra implant with hifocus™ mid‐scala electrode
5188688|NCT02811484|Obesity|obesity
5188689|NCT02811458|Panic Disorder|panic disorder
5188690|NCT02811458|Agoraphobia|agoraphobia
5188691|NCT02811458|Social Anxiety Disorder|social anxiety disorder
5188692|NCT02811458|Generalized Anxiety Disorder|generalized anxiety disorder
5188693|NCT02811458|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5188694|NCT02811445|microbiome, metabolome, aging, lean mass, physical function|microbiome, metabolome, aging, lean mass, physical function
5188695|NCT02811432|Kangaroo mother care|kangaroo mother care
5188697|NCT02811432|Low birth weight|low birth weight
5188698|NCT02811432|Unstable|unstable
5188699|NCT02811393|Bariatric surgery, sarcopenia|bariatric surgery, sarcopenia
5188701|NCT02811380|Healthcare associated infections (HAI)|healthcare associated infections (hai)
5188702|NCT02811380|CLABSI|clabsi
5188703|NCT02811380|Noble metal alloy coating|noble metal alloy coating
5188704|NCT02811380|CVC related thrombosis|cvc related thrombosis
5188705|NCT02811341|Scopolamine butylbromide PCLE|scopolamine butylbromide pcle
5188706|NCT02811276|High-protein diet|high-protein diet
5188707|NCT02811276|Energy metabolism|energy metabolism
5188708|NCT02811276|Substrate oxidation|substrate oxidation
5188709|NCT02811250|Renal cancer|renal cancer
5188710|NCT02811250|Stereotactic radiotherapy|stereotactic radiotherapy
5188712|NCT02811185|CT|ct
5188713|NCT02811185|PET/CT|pet/ct
5188714|NCT02811172|Biological multi-paradigm model|biological multi-paradigm model
5188715|NCT02811172|Biomarkers|biomarkers
5188716|NCT02811172|Triglycerides|triglycerides
5188717|NCT02811172|Cholesterol|cholesterol
5188718|NCT02811172|Prolactin|prolactin
5188719|NCT02811172|Glucose|glucose
5188720|NCT02811146|Heart Failure|heart failure
5188721|NCT02811146|Noninvasive Ventilation|noninvasive ventilation
5188722|NCT02811146|Positive- Pressure Respiration|positive- pressure respiration
5188724|NCT02811120|meningococcal|meningococcal
5188725|NCT02811120|conjugate|conjugate
5188726|NCT02811120|vaccine|vaccine
5188727|NCT02811120|quadrivalent|quadrivalent
5188728|NCT02811120|meningococcal quadrivalent conjugate vaccine|meningococcal quadrivalent conjugate vaccine
5188729|NCT02811107|anxiety|anxiety
5188730|NCT02811107|pain|pain
5188731|NCT02811107|preoperative area|preoperative area
5188732|NCT02811107|premedication|premedication
5188733|NCT02811068|HPV|hpv
5188734|NCT02811068|vaccine|vaccine
5188735|NCT02811068|Human Papillomavirus Virus Vaccine|human papillomavirus virus vaccine
5188736|NCT02811029|neurological|neurological
5188737|NCT02811029|difficulties|difficulties
5188738|NCT02811016|High Altitude|high altitude
5188739|NCT02811016|budesonide|budesonide
5188741|NCT02811003|Insertional Achilles|insertional achilles
5188742|NCT02810990|bosutinib|bosutinib
5188743|NCT02810990|chronic myeloid leukemia|chronic myeloid leukemia
5188744|NCT02810977|gastric volume|gastric volume
5188745|NCT02810977|gastric content|gastric content
5188746|NCT02810977|ultrasound|ultrasound
5188747|NCT02810977|perioperative fasting|perioperative fasting
5188748|NCT02810964|Schizophrenia|schizophrenia
5188749|NCT02810964|Schizoaffective Disorder|schizoaffective disorder
5188750|NCT02810964|Sulforaphane|sulforaphane
5188751|NCT02810964|Sulforaphane supplement|sulforaphane supplement
5188753|NCT02810938|Ablation|ablation
5188754|NCT02810938|Mifi technology|mifi technology
5188755|NCT02810938|maximum voltage-guided ablation|maximum voltage-guided ablation
5188756|NCT02810899|child|child
5188757|NCT02810899|craniotomy|craniotomy
5188758|NCT02810899|intelligence tests|intelligence tests
5188759|NCT02810899|dexmedetomidine|dexmedetomidine
5188760|NCT02810899|Disruption|disruption
5188761|NCT02810899|Dehiscence|dehiscence
5188762|NCT02810899|Mild Cognitive Disorder|mild cognitive disorder
5188763|NCT02810886|Prostate Cancer|prostate cancer
5188765|NCT02810847|Amblyopia|amblyopia
5188766|NCT02810847|strabismus|strabismus
5188767|NCT02810847|virtual reality|virtual reality
5188768|NCT02810847|computer games|computer games
5188769|NCT02810834|Executive Function|executive function
5188775|NCT02810821|Obesity|obesity
5188776|NCT02810821|Atherosclerosis|atherosclerosis
5188777|NCT02810821|Glucose metabolism disorders|glucose metabolism disorders
5188778|NCT02810821|Metabolic syndrome|metabolic syndrome
5188911|NCT02810106|Stress Test|stress test
5188779|NCT02810821|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5188780|NCT02810808|Neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
5188781|NCT02810808|Ranibizumab|ranibizumab
5188782|NCT02810808|Pro Re Nata|pro re nata
5188783|NCT02810795|Coronary|coronary
5188784|NCT02810795|Artery|artery
5056114|NCT03648190|GT|gt
5188785|NCT02810795|Computed tomography|computed tomography
5188786|NCT02810795|FFR|ffr
5188787|NCT02810795|CT myocardial perfusion|ct myocardial perfusion
5188788|NCT02810795|Dynamic|dynamic
5188789|NCT02810782|opiate dependence|opiate dependence
5188790|NCT02810782|withdrawal|withdrawal
5188791|NCT02810782|newborn|newborn
5188792|NCT02810730|pancreas|pancreas
5188793|NCT02810730|adenocarcinoma|adenocarcinoma
5188794|NCT02810704|Anticoagulant|anticoagulant
5188795|NCT02810704|Venous Thromboembolism|venous thromboembolism
5188796|NCT02810704|Pulmonary Embolism|pulmonary embolism
5188797|NCT02810704|Total Knee Arthroplasty|total knee arthroplasty
5188798|NCT02810704|Total Hip Arthroplasty|total hip arthroplasty
5188799|NCT02810691|Diabetes|diabetes
5188800|NCT02810691|Fiber|fiber
5188801|NCT02810691|Supplementation|supplementation
5188802|NCT02810691|Soluble fiber|soluble fiber
5188803|NCT02810691|Post-prandial blood glucose|post-prandial blood glucose
5188806|NCT02810665|Repeatability|repeatability
5188807|NCT02810665|Concordance|concordance
5188808|NCT02810665|Agreement|agreement
5188809|NCT02810665|ETDRS visual acuity chart|etdrs visual acuity chart
5188810|NCT02810665|numeric|numeric
5188811|NCT02810665|Landolt C|landolt c
5188812|NCT02810665|Roman alphabet|roman alphabet
5188813|NCT02810652|Cancer Surgery Care|cancer surgery care
5188814|NCT02810639|pain|pain
5188815|NCT02810587|Endophthalmitis|endophthalmitis
5188816|NCT02810587|Intravitreous injection|intravitreous injection
5188817|NCT02810587|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5188819|NCT02810561|Troponin|troponin
5188820|NCT02810535|Local IgE|local ige
5188821|NCT02810535|Non-allergic rhinitis|non-allergic rhinitis
5188822|NCT02810535|Allergic rhinitis to house dust mite|allergic rhinitis to house dust mite
5188823|NCT02810509|Wafarin|wafarin
5188824|NCT02810509|Cardioembolic (CE) stroke|cardioembolic (ce) stroke
5188825|NCT02810509|ischemic stroke|ischemic stroke
5188826|NCT02810483|Prader-Willi|prader-willi
5188827|NCT02810483|SPW|spw
5188828|NCT02810483|impulsivity|impulsivity
5188829|NCT02810483|eating disorders|eating disorders
5188830|NCT02810483|topiramate|topiramate
5188831|NCT02810457|Cancer|cancer
5188832|NCT02810457|Bevacizumab|bevacizumab
5188833|NCT02810457|Carboplatin|carboplatin
5188834|NCT02810457|Paclitaxel|paclitaxel
5188839|NCT02810405|Sample|sample
5188840|NCT02810405|Storage|storage
5188841|NCT02810405|Molecular Profiling|molecular profiling
5188842|NCT02810405|Biopsy|biopsy
5188843|NCT02810405|Repository|repository
5188844|NCT02810379|informed consent|informed consent
5188845|NCT02810379|ERCP|ercp
5188846|NCT02810379|video|video
5188847|NCT02810366|Verbal Autopsy|verbal autopsy
5188848|NCT02810366|Physician-coded verbal autopsy|physician-coded verbal autopsy
5188849|NCT02810366|Computer-coded verbal autopsy|computer-coded verbal autopsy
5188850|NCT02810366|InterVA|interva
5188851|NCT02810366|Naive Bayes Classifier (NBC)|naive bayes classifier (nbc)
5188852|NCT02810366|Tariff|tariff
5188853|NCT02810366|InSilicoVA|insilicova
5188854|NCT02810366|Randomised Control Trial|randomised control trial
5188855|NCT02810366|SmartVA|smartva
5188856|NCT02810366|King-Lu|king-lu
5188857|NCT02810327|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5188858|NCT02810327|AATD|aatd
5188859|NCT02810327|Alpha-1|alpha-1
5188860|NCT02810327|SERPINA1|serpina1
5188862|NCT02810327|Carrier|carrier
5188863|NCT02810327|Heterozygote|heterozygote
5188864|NCT02810327|Smoking|smoking
5188865|NCT02810327|COPD|copd
5188866|NCT02810327|Emphysema|emphysema
5188867|NCT02810327|Sequencing|sequencing
5188868|NCT02810301|gluten|gluten
5188869|NCT02810301|non-celiac|non-celiac
5188870|NCT02810301|gluten sensitivity|gluten sensitivity
5188871|NCT02810288|Airway anatomy|airway anatomy
5188872|NCT02810288|difficult intubation|difficult intubation
5188873|NCT02810288|congenital syndromes|congenital syndromes
5188874|NCT02810262|Lung cancer|lung cancer
5188875|NCT02810262|Bone metastases|bone metastases
5188876|NCT02810262|EGFR|egfr
5188877|NCT02810262|KRAS|kras
5188878|NCT02810262|Bone biomarkers|bone biomarkers
5188879|NCT02810262|Metabolic parameters|metabolic parameters
5188880|NCT02810249|African American YMSM|african american ymsm
5188881|NCT02810249|PrEP|prep
5188882|NCT02810249|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
5188883|NCT02810249|Common Sense Model|common sense model
5962370|NCT04281277|mean arterial pressure|mean arterial pressure
5962371|NCT04281264|bone mineral density|bone mineral density
5188884|NCT02810249|Healthcare|healthcare
5188885|NCT02810249|HIV Prevention|hiv prevention
5188886|NCT02810236|Focal breast pain|focal breast pain
5188887|NCT02810236|Directed Ultrasound|directed ultrasound
5188888|NCT02810236|Reassurance|reassurance
5188889|NCT02810236|Anxiety|anxiety
5188890|NCT02810210|Zika|zika
5188891|NCT02810210|microcephaly|microcephaly
5188892|NCT02810210|congenital abnormalities|congenital abnormalities
5188893|NCT02810210|new-born|new-born
5188894|NCT02810210|infant|infant
5188895|NCT02810184|bone augmentation|bone augmentation
5188896|NCT02810184|long-term bone volume changes|long-term bone volume changes
5188897|NCT02810184|immediate provisional implant|immediate provisional implant
5188898|NCT02810171|anxiety|anxiety
5188899|NCT02810171|social anxiety disorder|social anxiety disorder
5188900|NCT02810171|generalized anxiety disorder|generalized anxiety disorder
5188901|NCT02810171|phobias|phobias
5188902|NCT02810171|fears|fears
5188903|NCT02810171|worry|worry
5188904|NCT02810145|traumatic brain injury|traumatic brain injury
5188905|NCT02810145|cerebral desaturation|cerebral desaturation
5188906|NCT02810145|intensive care|intensive care
5188907|NCT02810145|hemodynamics|hemodynamics
5188908|NCT02810145|Loss|loss
5188909|NCT02810145|Consciousness|consciousness
5188910|NCT02810106|Spect|spect
5188912|NCT02810106|Myocardial Perfusion CT|myocardial perfusion ct
5188913|NCT02810106|CT angiography|ct angiography
5188914|NCT02810093|Breast cancer|breast cancer
5188915|NCT02810093|Text mining|text mining
5188917|NCT02810093|Machine Learning|machine learning
5188918|NCT02810054|regeneration|regeneration
5188919|NCT02810054|intrabony defects|intrabony defects
5188920|NCT02810054|enamel matrix derivative|enamel matrix derivative
5188921|NCT02810054|MIST|mist
5188922|NCT02810028|Limb girdle muscular dystrophy|limb girdle muscular dystrophy
5188923|NCT02810028|Becker's muscular dystrophy|becker's muscular dystrophy
5188924|NCT02810028|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
5188925|NCT02810028|Inclusion-body myositis|inclusion-body myositis
5176798|NCT02886156|cognitive function|cognitive function
5176799|NCT02886156|gut microbiota|gut microbiota
5176800|NCT02886156|metabolomics|metabolomics
5176801|NCT02886130|Alpha-GPC|alpha-gpc
5176802|NCT02886130|Volleyball|volleyball
5176803|NCT02886130|Athletes|athletes
5176804|NCT02886130|Executive functions|executive functions
5176805|NCT02886130|Vertical jump|vertical jump
5176806|NCT02886130|Peak power|peak power
5176807|NCT02886104|synchronous|synchronous
5176808|NCT02886104|metachronous|metachronous
5176809|NCT02886104|colorectal liver metastasis|colorectal liver metastasis
5176812|NCT02886091|Keloids|keloids
5188926|NCT02810028|Acceptance and Commitment Therapy|acceptance and commitment therapy
5188928|NCT02809950|postoperative nausea and vomiting, oral carbohydrate beverage|postoperative nausea and vomiting, oral carbohydrate beverage
5188929|NCT02809937|aged|aged
5188930|NCT02809937|surgical procedures, operative|surgical procedures, operative
5188931|NCT02809937|delirium|delirium
5188946|NCT02809820|Beta-Adrenergic Blockers|beta-adrenergic blockers
5188947|NCT02809807|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort; COPD|work of breathing; hypoxemia; respiratory acidosis; respiratory effort; copd
5188948|NCT02809781|ankylosing spondylitis|ankylosing spondylitis
5188949|NCT02809781|mesenchymal stem cell|mesenchymal stem cell
5188950|NCT02809781|etanercept|etanercept
5188951|NCT02809768|Healthy participants|healthy participants
5188952|NCT02809768|Pharmacokinetic Drug-Drug Interaction|pharmacokinetic drug-drug interaction
5188953|NCT02809768|Avatrombopag|avatrombopag
5188954|NCT02809755|Obesity|obesity
5188955|NCT02809755|laparoscopic gastric banding|laparoscopic gastric banding
5188956|NCT02809755|band revision|band revision
5188957|NCT02809755|laparoscopic gastric banding sleeve gastrectomy|laparoscopic gastric banding sleeve gastrectomy
5188958|NCT02809742|Pregnant|pregnant
5188959|NCT02809742|Labor|labor
5188960|NCT02809742|Epidural|epidural
5188961|NCT02809742|Analgesia|analgesia
5188962|NCT02809742|Intermittent|intermittent
5188963|NCT02809651|Infrascanner|infrascanner
5188964|NCT02809651|Intracranial hemorrhage|intracranial hemorrhage
5188965|NCT02809625|Dynamic contrast -enhanced MRI|dynamic contrast -enhanced mri
5188966|NCT02809625|brucella spondylitis|brucella spondylitis
5188967|NCT02809599|vertigo|vertigo
5188968|NCT02809599|dizziness|dizziness
5188969|NCT02809586|Alcohol|alcohol
5188970|NCT02809586|Teens|teens
5188971|NCT02809586|Young Adults|young adults
5188972|NCT02809586|Social Media|social media
5188973|NCT02809573|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5188974|NCT02809573|PTCL|ptcl
5188975|NCT02809573|chidamide|chidamide
5188976|NCT02809573|CHOP|chop
5188977|NCT02809573|phase Ib|phase ib
5188978|NCT02809560|Lymphocytes Th2|lymphocytes th2
5188979|NCT02809560|Cav1 channels|cav1 channels
5188980|NCT02809534|Anlotinib|anlotinib
5188981|NCT02809534|AL3818|al3818
5188982|NCT02809508|Omega-3|omega-3
5188983|NCT02809508|Child nutrition|child nutrition
5188984|NCT02809508|Dietary recommendations|dietary recommendations
5188985|NCT02809508|Cardiovascular risk markers|cardiovascular risk markers
5188986|NCT02809508|Cognitive function|cognitive function
5188987|NCT02809508|Mental health|mental health
5188988|NCT02809482|Volunteers|volunteers
5188989|NCT02809443|Zika|zika
5188990|NCT02809443|Vaccine|vaccine
5188992|NCT02809391|Postural Balance|postural balance
5188993|NCT02809391|Gait|gait
5188994|NCT02809391|Foot Orthotic|foot orthotic
5188995|NCT02809391|Proprioception|proprioception
5188996|NCT02809391|Somatosensory|somatosensory
5188997|NCT02809365|insulin treated|insulin treated
5188998|NCT02809339|Chemotherapy|chemotherapy
5188999|NCT02809339|ovarian cancer|ovarian cancer
5962372|NCT04281264|healthy aging|healthy aging
5110563|NCT03306589|LPS|lps
5189000|NCT02809339|Patient reported outcome|patient reported outcome
5189001|NCT02809339|Quality of Care|quality of care
5189002|NCT02809326|efficiency|efficiency
5189003|NCT02809326|exposure therapy|exposure therapy
5189004|NCT02809326|PTSD|ptsd
5189005|NCT02809326|combat|combat
5189006|NCT02809326|veterans|veterans
5189007|NCT02809313|gingivitis|gingivitis
5189008|NCT02809313|probiotic|probiotic
5189009|NCT02809313|non- surgical treatment|non- surgical treatment
5189010|NCT02809274|iron deficiency|iron deficiency
5189011|NCT02809274|polycythemia vera|polycythemia vera
5189012|NCT02809261|Carpal Tunnel Syndrome|carpal tunnel syndrome
5189013|NCT02809261|Perineural injection|perineural injection
5189014|NCT02809261|Dextrose|dextrose
5189015|NCT02809248|LTX Study|ltx study
5189016|NCT02809235|asthma|asthma
5189017|NCT02809235|smooth muscle|smooth muscle
5189018|NCT02809235|lauric acid|lauric acid
5189019|NCT02809235|dietary supplement|dietary supplement
5189020|NCT02809222|Myelodysplastic syndrome|myelodysplastic syndrome
5189021|NCT02809222|Ascorbic acid|ascorbic acid
5189022|NCT02809222|Oxidative stress|oxidative stress
5189023|NCT02809222|Preleukemia|preleukemia
5189024|NCT02809196|Food Habits|food habits
5189025|NCT02809196|Adolescents|adolescents
5189026|NCT02809196|Digital Communication|digital communication
5189027|NCT02809183|metabolic acidosis|metabolic acidosis
5189028|NCT02809183|serum bicarbonate|serum bicarbonate
5189029|NCT02809183|kidney disease|kidney disease
5189030|NCT02809131|CIED infection|cied infection
5189031|NCT02809118|Deafness|deafness
5189032|NCT02809118|Hearing Loss|hearing loss
5189033|NCT02809118|Hearing Loss, Sensorineural|hearing loss, sensorineural
5189034|NCT02809118|Ear Diseases|ear diseases
5189035|NCT02809118|Hearing Disorders|hearing disorders
5189036|NCT02809118|Nervous System Diseases|nervous system diseases
5189037|NCT02809118|Neurologic Manifestations|neurologic manifestations
5189038|NCT02809118|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5189039|NCT02809118|Sensation Disorders|sensation disorders
5189040|NCT02809118|Signs and Symptoms|signs and symptoms
5189041|NCT02809118|Hearing and Speech Impairment|hearing and speech impairment
5189042|NCT02809118|Hearing Loss, Unilateral|hearing loss, unilateral
5189043|NCT02809105|Chronic constipation|chronic constipation
5189044|NCT02809105|Linaclotide|linaclotide
5189045|NCT02809105|ASP0456|asp0456
5189046|NCT02809092|Acute Myeloid Leukemia, Natural Killer Cells|acute myeloid leukemia, natural killer cells
5189047|NCT02809066|premenstrual syndrome|premenstrual syndrome
5189049|NCT02809066|quality of life|quality of life
5189050|NCT02809053|low tumor burden follicular lymphoma (LTBFL)|low tumor burden follicular lymphoma (ltbfl)
5189051|NCT02809014|Fluoride|fluoride
5189052|NCT02809014|Dental caries|dental caries
5189053|NCT02809014|Dentifrice|dentifrice
5189054|NCT02809001|Fat grafting|fat grafting
5189055|NCT02809001|Expansion-related complications|expansion-related complications
5189056|NCT02808988|Bisphosphonate|bisphosphonate
5189057|NCT02808988|osteoporosis|osteoporosis
5189058|NCT02808988|RANKL|rankl
5189059|NCT02808988|OPG|opg
5189060|NCT02808988|periodontitis|periodontitis
5189061|NCT02808975|Hidradenitis Suppurativa|hidradenitis suppurativa
5189062|NCT02808975|axilla|axilla
5189063|NCT02808975|inguinal region|inguinal region
5189064|NCT02808975|Hurley Stage I, II, or III|hurley stage i, ii, or iii
5189065|NCT02808975|adalimumab|adalimumab
5189066|NCT02808975|secondary intention|secondary intention
5189067|NCT02808975|abcess and inflammatory nodule (AN) count|abcess and inflammatory nodule (an) count
5189068|NCT02808949|Prevention|prevention
5189069|NCT02808949|Lactating Women|lactating women
5189070|NCT02808949|Healthy|healthy
5189071|NCT02808936|remote ischemic conditioning|remote ischemic conditioning
5189072|NCT02808936|orthopedic surgery|orthopedic surgery
5189073|NCT02808936|ischemic heart disease|ischemic heart disease
5189074|NCT02808910|behavior|behavior
5189086|NCT02808871|TRAIL|trail
5189087|NCT02808871|Pirfenidone|pirfenidone
5189088|NCT02808858|MDS|mds
5189089|NCT02808858|Myelodisplastic Syndrome|myelodisplastic syndrome
5189090|NCT02808845|coronary angiography|coronary angiography
5189091|NCT02808845|contrast-induced acute kidney injury|contrast-induced acute kidney injury
5189092|NCT02808845|microalbuminuria|microalbuminuria
5189093|NCT02808832|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5189094|NCT02808832|Cervical cancer screening|cervical cancer screening
5189095|NCT02808832|Provider intervention|provider intervention
5189101|NCT02808806|stroke|stroke
5189102|NCT02808806|cerebral infarction|cerebral infarction
5189103|NCT02808806|brain infarction|brain infarction
5189104|NCT02808806|ischemic stroke|ischemic stroke
5189105|NCT02808806|treatment|treatment
5189106|NCT02808806|intravenous thrombolysis|intravenous thrombolysis
5189107|NCT02808806|intraarterial thrombectomy|intraarterial thrombectomy
5189108|NCT02808806|delay|delay
5189109|NCT02808806|total system delay|total system delay
5962373|NCT04281264|resistance training|resistance training
5189110|NCT02808806|pre-hospital delay|pre-hospital delay
5189111|NCT02808806|in-hospital delay|in-hospital delay
5189112|NCT02808806|feedback|feedback
5189113|NCT02808806|real-time feedback|real-time feedback
5189114|NCT02808806|visual feedback|visual feedback
5189115|NCT02808793|ISM|ism
5189116|NCT02808793|Mastocytosis|mastocytosis
5189117|NCT02808793|Indolent Mastocytosis|indolent mastocytosis
5189123|NCT02808767|Acute myocardial infarction|acute myocardial infarction
5189124|NCT02808767|Primary coronary intervention|primary coronary intervention
5189125|NCT02808767|Antiplatelet therapy|antiplatelet therapy
5189126|NCT02808728|Total Knee Arthroplasty|total knee arthroplasty
5189127|NCT02808728|Total Knee Replacement|total knee replacement
5189128|NCT02808728|Exparel|exparel
5189129|NCT02808728|Liposomal Bupivacaine|liposomal bupivacaine
5189130|NCT02808728|Ropivacaine|ropivacaine
5189131|NCT02808728|Postoperative Pain Management|postoperative pain management
5189132|NCT02808702|Attention|attention
5189133|NCT02808702|Cognitive behavioral therapy|cognitive behavioral therapy
5189135|NCT02808689|Moderate|moderate
5189136|NCT02808689|Severe|severe
5189137|NCT02808676|Cognitive training|cognitive training
5189138|NCT02808676|Vitamin D|vitamin d
5189139|NCT02808676|Exercise|exercise
5189140|NCT02808637|Pain management|pain management
5189142|NCT02808637|manual pressure|manual pressure
5189143|NCT02808637|needle aspiration|needle aspiration
5189144|NCT02808624|Oxaliplatin, peripheral neuropathy, L-CARNOSINE|oxaliplatin, peripheral neuropathy, l-carnosine
5189145|NCT02808598|Clinical Trials|clinical trials
5189146|NCT02808598|Education|education
5189147|NCT02808598|Hispanic Americans|hispanic americans
5189148|NCT02808598|African Americans|african americans
5189744|NCT02804841|Muscle mass|muscle mass
5189149|NCT02808598|Health Disparities|health disparities
5189150|NCT02808598|Patient Participation|patient participation
5189151|NCT02808598|Refusal to Participate|refusal to participate
5189152|NCT02808572|chronic kidney disease|chronic kidney disease
5189153|NCT02808572|vascular calcifications|vascular calcifications
5189154|NCT02808572|cardiovascular risk|cardiovascular risk
5189155|NCT02808546|Gallbladder stone|gallbladder stone
5189156|NCT02808546|Risk factor|risk factor
5189157|NCT02808546|Case-control study|case-control study
5189158|NCT02808546|Obesity|obesity
5189159|NCT02808546|Hypertension|hypertension
5189160|NCT02808546|Alcohol consumption|alcohol consumption
5189161|NCT02808520|Social participation|social participation
5189162|NCT02808520|Children and adolescents with cancer|children and adolescents with cancer
5189163|NCT02808520|Quality of life with hodgkin-lymphoma|quality of life with hodgkin-lymphoma
5189164|NCT02808520|Social inequalities and cancer|social inequalities and cancer
5189165|NCT02808494|Preeclampsia|preeclampsia
5189166|NCT02808494|Fetal Growth Restriction|fetal growth restriction
5189167|NCT02808481|systemic sclerosis|systemic sclerosis
5189168|NCT02808481|cardiac disease|cardiac disease
5189169|NCT02808481|Heart transplantation|heart transplantation
5189170|NCT02808481|primitive cardiac damage|primitive cardiac damage
5189171|NCT02808468|Sexual assault|sexual assault
5189172|NCT02808468|Posttraumatic Stress Disorder|posttraumatic stress disorder
5189173|NCT02808468|Alcohol use|alcohol use
5189174|NCT02808468|Cognitive therapy|cognitive therapy
5189175|NCT02808429|Atacicept|atacicept
5189176|NCT02808429|IgA Nephropathy|iga nephropathy
5189177|NCT02808429|Berger´s disease|berger´s disease
5189178|NCT02808429|Glomerulonephritis|glomerulonephritis
5189179|NCT02808429|Proteinuria|proteinuria
5189180|NCT02808416|Solid tumors|solid tumors
5189181|NCT02808416|Brain metastases|brain metastases
5189182|NCT02808416|DC vaccine|dc vaccine
5189183|NCT02808416|Personalized vaccine|personalized vaccine
5189184|NCT02808416|Tumor antigens|tumor antigens
5189185|NCT02808364|Recurrent glioblastoma|recurrent glioblastoma
5189186|NCT02808364|DC vaccine|dc vaccine
5189187|NCT02808364|tumor antigen|tumor antigen
5189188|NCT02808364|personalized vaccine|personalized vaccine
5189189|NCT02808299|statin|statin
5189190|NCT02808299|hepatitis B virus|hepatitis b virus
5189191|NCT02808273|Bemiparine|bemiparine
5189192|NCT02808273|Antithrombotic microsurgery protocol|antithrombotic microsurgery protocol
5189193|NCT02808273|Comparative study|comparative study
5189194|NCT02808273|Anticoagulant microsurgery protocol|anticoagulant microsurgery protocol
5189195|NCT02808260|sub-clinical atrial fibrillation|sub-clinical atrial fibrillation
5189196|NCT02808260|biomarkers|biomarkers
5189197|NCT02808260|implanted pacemaker or defibrillator|implanted pacemaker or defibrillator
5189198|NCT02808247|advanced metastatic soft tissue sarcoma|advanced metastatic soft tissue sarcoma
5189199|NCT02808221|Heart failure|heart failure
5189200|NCT02808221|heart disease|heart disease
5189201|NCT02808221|left ventricular|left ventricular
5189202|NCT02808195|Cerebral Palsy|cerebral palsy
5189203|NCT02808195|Neurological Rehabilitation|neurological rehabilitation
5189204|NCT02808195|Upper Extremity|upper extremity
5189205|NCT02808156|Cerebral Palsy,|cerebral palsy,
5189206|NCT02808156|Upper limb neurorehabilitation|upper limb neurorehabilitation
5189207|NCT02808156|Upper Extremity|upper extremity
5189208|NCT02808156|Neurological Rehabilitation|neurological rehabilitation
5189209|NCT02808130|hyperlipidemia, periodontal disease, oxidative stress,|hyperlipidemia, periodontal disease, oxidative stress,
5189210|NCT02808117|microfinance institution|microfinance institution
5189211|NCT02808117|MFI|mfi
5189217|NCT02808065|Kidney transplantation|kidney transplantation
5189218|NCT02808065|Renal transplant|renal transplant
5189219|NCT02808065|Renal transplantation|renal transplantation
5189220|NCT02808052|Bacterial infections|bacterial infections
5189221|NCT02808026|severe hypertension|severe hypertension
5189222|NCT02808026|grade III hypertension|grade iii hypertension
5189223|NCT02808026|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5189224|NCT02807987|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5189225|NCT02807987|Moderate renal impairment|moderate renal impairment
5189227|NCT02807974|Hypertension with Type 2 Diabetes and Albuminuria|hypertension with type 2 diabetes and albuminuria
5189228|NCT02807974|Diabetic nephropathy|diabetic nephropathy
5189229|NCT02807974|Diabetic renal disease|diabetic renal disease
5189231|NCT02807974|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5189232|NCT02807961|Translational read through|translational read through
5189233|NCT02807948|MRI Scan, pacemakers, ICD, CRT|mri scan, pacemakers, icd, crt
5189234|NCT02807922|Palliative Care|palliative care
5189235|NCT02807922|zopiclone|zopiclone
5189236|NCT02807896|biomarker|biomarker
5189745|NCT02804815|Aspirin|aspirin
5189240|NCT02807883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5189242|NCT02807883|B-lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
5189243|NCT02807883|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
5189244|NCT02807883|Blinatumomab|blinatumomab
5189245|NCT02807883|Blincyto|blincyto
5189246|NCT02807883|Post allogeneic stem cell transplant|post allogeneic stem cell transplant
5189247|NCT02807870|Parental training|parental training
5189248|NCT02807870|Preschool age|preschool age
5189249|NCT02807870|Attention Deficit/Hyperactivity Disorder (ADHD)|attention deficit/hyperactivity disorder (adhd)
5189250|NCT02807857|low-interventional observational study,|low-interventional observational study,
5189251|NCT02807857|CHF,|chf,
5189252|NCT02807857|heart failure,|heart failure,
5189253|NCT02807857|primary care,|primary care,
5189254|NCT02807857|ESC guidelines,|esc guidelines,
5189255|NCT02807857|Europe,|europe,
5189256|NCT02807857|NT-proBNP,|nt-probnp,
5189257|NCT02807857|reduced ventricular ejection fraction (EF),|reduced ventricular ejection fraction (ef),
5189266|NCT02807831|Executive Function|executive function
5189267|NCT02807831|Language|language
5189268|NCT02807831|Preschool child|preschool child
5189269|NCT02807831|Development|development
5189270|NCT02807818|Child development|child development
5189271|NCT02807818|Infant|infant
5189272|NCT02807818|Mother-Child Relations|mother-child relations
5189273|NCT02807805|castration resistant prostate cancer|castration resistant prostate cancer
5189274|NCT02807792|Perianal surgery|perianal surgery
5189275|NCT02807779|angioplasty|angioplasty
5189276|NCT02807779|peripheral artery disease|peripheral artery disease
5189277|NCT02807779|peripheral vascular disease|peripheral vascular disease
5189278|NCT02807779|atherosclerosis|atherosclerosis
5189279|NCT02807779|balloon angioplasty|balloon angioplasty
5189280|NCT02807779|dexamethasone|dexamethasone
5189281|NCT02807779|drug coated balloon|drug coated balloon
5189282|NCT02807779|paclitaxel|paclitaxel
5189283|NCT02807779|walking|walking
5189284|NCT02807779|claudication|claudication
5189285|NCT02807766|autism|autism
5189286|NCT02807766|Brain Plasticity|brain plasticity
5189287|NCT02807766|Behavioral Intervention|behavioral intervention
5189288|NCT02807766|Magnetic Resonance Imaging|magnetic resonance imaging
5189289|NCT02807753|Hemophilia|hemophilia
5189290|NCT02807753|Arthropathy|arthropathy
5189291|NCT02807753|Pediatric|pediatric
5189292|NCT02807740|Virtual Reality|virtual reality
5189293|NCT02807740|Rehabilitation|rehabilitation
5189294|NCT02807740|Cardiocirculatory system|cardiocirculatory system
5189295|NCT02807740|Parkinson Disease|parkinson disease
5189296|NCT02807688|health promotion|health promotion
5189297|NCT02807688|lifestyles|lifestyles
5189298|NCT02807688|physical comorbidity|physical comorbidity
5189299|NCT02807688|risk factors|risk factors
5189300|NCT02807688|behavioural change|behavioural change
5189301|NCT02807662|posttraumatic stress disorder|posttraumatic stress disorder
5189302|NCT02807662|prenatal care|prenatal care
5189303|NCT02807636|Urothelial carcinoma|urothelial carcinoma
5189304|NCT02807636|Bladder cancer|bladder cancer
5189305|NCT02807636|Anti-PD-L1|anti-pd-l1
5189306|NCT02807636|Transitional carcinoma|transitional carcinoma
5189307|NCT02807636|Tecentriq|tecentriq
5189308|NCT02807636|Atezolizumab|atezolizumab
5189309|NCT02807636|IMvigor130|imvigor130
5189310|NCT02807610|Etomidate lipuro|etomidate lipuro
5189311|NCT02807610|Induction characteristics|induction characteristics
5189312|NCT02807584|Wound|wound
5189313|NCT02807584|burns|burns
5189314|NCT02807584|acute|acute
5189315|NCT02807584|chronic|chronic
5189316|NCT02807584|foam|foam
5189317|NCT02807584|adhesive|adhesive
5189318|NCT02807584|dressing|dressing
5189319|NCT02807571|Hand|hand
5189320|NCT02807558|AML|aml
5189321|NCT02807558|MDS|mds
5189322|NCT02807545|Scoliosis-Specific Exercises|scoliosis-specific exercises
5189323|NCT02807545|Schroth|schroth
5189324|NCT02807519|Oral health|oral health
5189325|NCT02807519|Saliva|saliva
5189326|NCT02807519|Biomarker|biomarker
5189327|NCT02807519|Cytokines|cytokines
5189328|NCT02807519|Cancer|cancer
5189329|NCT02807519|children|children
5189330|NCT02807506|elders|elders
5189331|NCT02807506|robotics|robotics
5189332|NCT02807506|low income population|low income population
5189333|NCT02807506|activities of daily living|activities of daily living
5189334|NCT02807506|instrumental activities of daily living|instrumental activities of daily living
5189335|NCT02807506|social robotics|social robotics
5189336|NCT02807506|stroke|stroke
5189337|NCT02807506|aged|aged
5189338|NCT02807506|Retirement|retirement
5189339|NCT02807506|Housing for elderly|housing for elderly
5189340|NCT02807506|Homes for the aged|homes for the aged
5189341|NCT02807493|Pregnancy|pregnancy
5185055|NCT02833168|Dyspnea|dyspnea
5189342|NCT02807493|Labor and Delivery|labor and delivery
5189343|NCT02807493|Occlusal Support Device|occlusal support device
5189344|NCT02807467|reduction|reduction
5189345|NCT02807467|delirium|delirium
5189346|NCT02807467|duration|duration
5189347|NCT02807467|severity|severity
5189348|NCT02807454|Phase 2|phase 2
5189349|NCT02807454|Open-Label|open-label
5189350|NCT02807454|Durvalumab|durvalumab
5189351|NCT02807454|Daratumumab|daratumumab
5189352|NCT02807454|Multiple Myeloma|multiple myeloma
5189353|NCT02807454|Relapsed and Refractory (RRMM)|relapsed and refractory (rrmm)
5189354|NCT02807454|FUSION MM-003|fusion mm-003
5189355|NCT02807454|PD-L1|pd-l1
5189356|NCT02807441|Bleeding|bleeding
5189357|NCT02807441|Aspirin|aspirin
5189358|NCT02807441|Spine|spine
5189359|NCT02807441|Surgery|surgery
5189360|NCT02807428|post-surgical pain|post-surgical pain
5189361|NCT02807428|total knee arthroplasty|total knee arthroplasty
5189362|NCT02807428|total knee replacement|total knee replacement
5798978|NCT00110305|Lamivudine|lamivudine
5189364|NCT02807415|CFTR|cftr
5189365|NCT02807415|CFTR modulation|cftr modulation
5189366|NCT02807415|sweat test|sweat test
5189367|NCT02807415|intestinal current measurement, ICM|intestinal current measurement, icm
5189368|NCT02807415|nasal transepithelial potential difference measurement, NPD|nasal transepithelial potential difference measurement, npd
5189369|NCT02807402|Chronic Hepatitis C|chronic hepatitis c
5189370|NCT02807402|Paritaprevir|paritaprevir
5189371|NCT02807402|Ombitasvir|ombitasvir
5189372|NCT02807402|Dasabuvir|dasabuvir
5189374|NCT02807363|endometriosis|endometriosis
5189375|NCT02807363|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
5189376|NCT02807363|healthy volunteers|healthy volunteers
5189377|NCT02807363|leuprolide oral tablet|leuprolide oral tablet
5189378|NCT02807350|Intermittent Exotropia|intermittent exotropia
5189379|NCT02807350|IXT|ixt
5189380|NCT02807350|overminus|overminus
5189382|NCT02807311|Malnutrition|malnutrition
5189383|NCT02807311|Undernutrition|undernutrition
5189384|NCT02807311|lung transplantation|lung transplantation
5189385|NCT02807311|artificial nutrition|artificial nutrition
5189386|NCT02807311|nutritional supplements|nutritional supplements
5189387|NCT02807311|enteral nutrition|enteral nutrition
5189388|NCT02807298|Intarligamentary|intarligamentary
5189389|NCT02807298|Articaine|articaine
5189390|NCT02807298|Lidocaine|lidocaine
5189391|NCT02807246|Probiotic|probiotic
5189392|NCT02807246|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
5189393|NCT02807220|Imuneks|imuneks
5189394|NCT02807207|To Study pharmacokinetics and Cardiac safety pacritinib study|to study pharmacokinetics and cardiac safety pacritinib study
5189395|NCT02807155|Transitional Care|transitional care
5189396|NCT02807155|Young Adult|young adult
5189397|NCT02807155|Guided Imagery|guided imagery
5189398|NCT02807116|Drug-Interaction Study|drug-interaction study
5189399|NCT02807103|Rituximab|rituximab
5189400|NCT02807103|remission induction|remission induction
5189401|NCT02807103|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
5189402|NCT02807090|Low Back Pain|low back pain
5189403|NCT02807090|Exercise|exercise
5189404|NCT02807090|Dance Therapy|dance therapy
5177295|NCT02882763|Educational opportunities|educational opportunities
5177296|NCT02882763|Randomized controlled trial|randomized controlled trial
5177297|NCT02882763|Evaluation|evaluation
5177298|NCT02882763|Parenting|parenting
5177299|NCT02882763|Parent-child interaction|parent-child interaction
5177300|NCT02882750|Lung Cancer|lung cancer
5177301|NCT02882750|Quality of Life|quality of life
5177302|NCT02882750|VATS|vats
5177303|NCT02882750|SABR|sabr
5177304|NCT02882698|Down syndrome|down syndrome
5177305|NCT02882698|motor skills|motor skills
5177306|NCT02882698|physiotherapy|physiotherapy
5177307|NCT02882698|mobile telephone|mobile telephone
5177308|NCT02882698|exposure to virtual reality therapy|exposure to virtual reality therapy
5177309|NCT02882685|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5177310|NCT02882685|Mini-gastric bypass|mini-gastric bypass
5177311|NCT02882685|Single anastomosis gastric bypass|single anastomosis gastric bypass
5177312|NCT02882659|Clinical Trial, Phase I|clinical trial, phase i
5177313|NCT02882646|stroke|stroke
5177314|NCT02882646|cerebral palsy|cerebral palsy
5177315|NCT02882646|rehabilitation|rehabilitation
5064458|NCT03596372|CEACAM6|ceacam6
5177316|NCT02882646|robotics|robotics
5177317|NCT02882646|therapy|therapy
5177318|NCT02882646|bilateral|bilateral
5177319|NCT02882633|lumbar plexus block|lumbar plexus block
5177320|NCT02882633|fascia iliac block|fascia iliac block
5177321|NCT02882633|quality of recovery score|quality of recovery score
5177322|NCT02882633|pain score|pain score
5177323|NCT02882620|Colorectal neoplasm|colorectal neoplasm
5177324|NCT02882620|Screening|screening
5177325|NCT02882620|Patient navigation|patient navigation
5177326|NCT02882620|Randomized controlled trial|randomized controlled trial
5177327|NCT02882620|Cost-benefit analysis|cost-benefit analysis
5177328|NCT02882620|Health behavior|health behavior
5177329|NCT02882620|Health equity|health equity
5177330|NCT02882620|American Indians|american indians
5177331|NCT02882620|Community-based participatory research|community-based participatory research
5177332|NCT02882620|Fecal occult blood test|fecal occult blood test
5177333|NCT02882607|HIV|hiv
5189456|NCT02806778|hypoxic brain injury|hypoxic brain injury
5189457|NCT02806765|Dynamic Stability|dynamic stability
5189458|NCT02806765|Postural Stability|postural stability
5189460|NCT02806765|Hand Grip Strength|hand grip strength
5189461|NCT02806765|Timed Get-up and Go|timed get-up and go
5189462|NCT02806765|Older Adults|older adults
5673530|NCT00607893|Sleep-Disordered Breathing|sleep-disordered breathing
5270323|NCT02328794|NRT|nrt
5189463|NCT02806752|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5189464|NCT02806739|Soy protein|soy protein
5189465|NCT02806739|isoflavones|isoflavones
5189466|NCT02806739|gestational diabetes|gestational diabetes
5189467|NCT02806700|Diabetes|diabetes
5189468|NCT02806700|Social Media|social media
5189469|NCT02806687|Locally advanced pancreatic adenocarcinoma|locally advanced pancreatic adenocarcinoma
5189470|NCT02806687|gene therapy|gene therapy
5189471|NCT02806687|gemcitabine|gemcitabine
5189472|NCT02806687|chemosensitization|chemosensitization
5189473|NCT02806674|Helicobacter pylori|helicobacter pylori
5189474|NCT02806674|Antibiotic resistance|antibiotic resistance
5189475|NCT02806674|Sequencing|sequencing
5189476|NCT02806661|Robotic surgery|robotic surgery
5189477|NCT02806661|Vagus nerve preserving|vagus nerve preserving
5189478|NCT02806635|Relationship Distress|relationship distress
5189479|NCT02806635|Relationship Satisfaction|relationship satisfaction
5189480|NCT02806635|Marriage|marriage
5189481|NCT02806635|Web-based|web-based
5189482|NCT02806635|Internet|internet
5189483|NCT02806622|Sports|sports
5189484|NCT02806622|University|university
5189485|NCT02806622|Lower Extremity|lower extremity
5189486|NCT02806622|Hip Joint|hip joint
5189487|NCT02806609|football|football
5189488|NCT02806609|cryotherapy|cryotherapy
5189489|NCT02806609|balance|balance
5189490|NCT02806609|electromyography|electromyography
5189491|NCT02806557|Neoplasms|neoplasms
5189492|NCT02806557|Neutropenia|neutropenia
5189493|NCT02806557|drug therapy|drug therapy
5189494|NCT02806557|Hematologic tests|hematologic tests
5189495|NCT02806557|Point-of-care Systems|point-of-care systems
5189496|NCT02806557|Febrile neutropenia|febrile neutropenia
5079176|NCT03504514|speech|speech
5189497|NCT02806544|Breast neoplasms|breast neoplasms
5189498|NCT02806544|Breast cancer|breast cancer
5189499|NCT02806544|Locally advanced breast cancer|locally advanced breast cancer
5189500|NCT02806544|Neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
5189501|NCT02806544|Tamoxifen|tamoxifen
5189502|NCT02806544|Low and middle income country|low and middle income country
5189503|NCT02806531|vaccine|vaccine
5189504|NCT02806531|safety|safety
5189505|NCT02806518|DIEP|diep
5189506|NCT02806518|Computed Tomography|computed tomography
5189507|NCT02806518|Doppler|doppler
5189508|NCT02806518|Thermography|thermography
5189509|NCT02806440|Low dose naltrexone|low dose naltrexone
5189510|NCT02806440|Pain|pain
5189511|NCT02806375|Myelofibrosis|myelofibrosis
5189512|NCT02806375|Ruxolitinib|ruxolitinib
5189513|NCT02806375|Cyclophosphamide|cyclophosphamide
5189514|NCT02806375|Immunosuppressive Agents|immunosuppressive agents
5189515|NCT02806375|Immune System Diseases|immune system diseases
5189516|NCT02806375|Busulfan|busulfan
5189517|NCT02806375|Fludarabine|fludarabine
5189518|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5189519|NCT02806375|Myeloablative Agonists|myeloablative agonists
5189520|NCT02806375|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5189521|NCT02806375|Allogeneic|allogeneic
5189522|NCT02806362|Non-cirrhotic|non-cirrhotic
5189523|NCT02806362|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5177488|NCT02881827|Saliva|saliva
5177489|NCT02881827|Low-level laser therapy|low-level laser therapy
5177490|NCT02881827|Masseter muscle|masseter muscle
5189524|NCT02806362|moderate fibrosis|moderate fibrosis
5189525|NCT02806362|Chronic Hepatitis C Virus ( HCV)|chronic hepatitis c virus ( hcv)
5189526|NCT02806362|Chronic Hepatitis C Genotype 1b|chronic hepatitis c genotype 1b
5189527|NCT02806349|American ginseng|american ginseng
5189528|NCT02806349|Konjac glucomannan fiber|konjac glucomannan fiber
5189529|NCT02806336|exercise training|exercise training
5189530|NCT02806336|assistive device|assistive device
5962374|NCT04281264|normobaric hypoxia|normobaric hypoxia
5057727|NCT03638141|CTLA-4|ctla-4
5189531|NCT02806336|weight loss|weight loss
5189532|NCT02806336|function|function
5189533|NCT02806336|mobility|mobility
5189534|NCT02806310|Aortic Valve|aortic valve
5189535|NCT02806310|Bicuspid|bicuspid
5189536|NCT02806297|cholecystectomy|cholecystectomy
5189537|NCT02806284|vaccination|vaccination
5189538|NCT02806284|Streptococcus pneumoniae|streptococcus pneumoniae
5189539|NCT02806271|Worry Postponement|worry postponement
5189540|NCT02806271|Stimulus Control|stimulus control
5189541|NCT02806245|Congenital Heart Disease (CHD)|congenital heart disease (chd)
5189542|NCT02806245|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5189543|NCT02806245|Cardiac Index|cardiac index
5189544|NCT02806245|Hemodynamics|hemodynamics
5189545|NCT02806245|Pediatrics|pediatrics
5189546|NCT02806232|Praziquantel ODT formulation|praziquantel odt formulation
5189547|NCT02806232|Biltricide|biltricide
5189554|NCT02806193|CMR|cmr
5189555|NCT02806193|CT|ct
5189556|NCT02806193|ECG|ecg
5189557|NCT02806193|magnetic resonance|magnetic resonance
5189558|NCT02806193|imaging|imaging
5189559|NCT02806154|Cancer|cancer
5189560|NCT02806154|Chemotherapy toxicity|chemotherapy toxicity
5189561|NCT02806154|Elderly patients|elderly patients
5189562|NCT02806154|DEXA|dexa
5189563|NCT02806154|muscle mass|muscle mass
5189564|NCT02806141|Aerosolized colistin|aerosolized colistin
5189565|NCT02806141|Intravenous colistin|intravenous colistin
5189566|NCT02806128|cerebral infarction|cerebral infarction
5189567|NCT02806128|kallikrein|kallikrein
5189568|NCT02806128|KLK|klk
5189569|NCT02806089|chronic kidney disease|chronic kidney disease
5189570|NCT02806089|malnutrition inflammation atherogenesis syndrome|malnutrition inflammation atherogenesis syndrome
5189571|NCT02806089|muscle strength|muscle strength
5189572|NCT02806089|muscle mass|muscle mass
5189573|NCT02806089|lean body mass|lean body mass
5189574|NCT02806089|physical activity|physical activity
5189575|NCT02806076|HCC|hcc
5189576|NCT02806076|RFA|rfa
5189577|NCT02806063|Prosthesis|prosthesis
5189578|NCT02806063|joint infection|joint infection
5189579|NCT02806063|perioperative samples|perioperative samples
5189580|NCT02806050|FES PET|fes pet
5189581|NCT02806050|Palbociclib|palbociclib
5189582|NCT02805985|Degenerative Disc Disease|degenerative disc disease
5189583|NCT02805985|Spondylolisthesis|spondylolisthesis
5189584|NCT02805985|Retrolisthesis|retrolisthesis
5189585|NCT02805972|Obesity|obesity
5189586|NCT02805972|Binge eating|binge eating
5189587|NCT02805868|Severe|severe
5189588|NCT02805868|Anemia|anemia
5189589|NCT02805868|Aplastic|aplastic
5189590|NCT02805868|Post-Polycythemic|post-polycythemic
5189591|NCT02805868|Transformation|transformation
5189592|NCT02805868|Thrombocythemia|thrombocythemia
5189593|NCT02805868|Essential|essential
5189594|NCT02805842|non adherence|non adherence
5189595|NCT02805842|Tacrolimus|tacrolimus
5189596|NCT02805842|Advagraf|advagraf
5189597|NCT02805829|NK cells|nk cells
5189598|NCT02805829|Trastuzumab|trastuzumab
5189599|NCT02805816|Celiac disease|celiac disease
5189600|NCT02805816|Tissue transglutaminase|tissue transglutaminase
5189601|NCT02805816|Histology|histology
5189602|NCT02805790|Primary Mitochondrial Disease|primary mitochondrial disease
5189603|NCT02805790|Mitochondrial Myopathy|mitochondrial myopathy
5189604|NCT02805790|Elamipretide|elamipretide
5189605|NCT02805790|MTP-131|mtp-131
5189606|NCT02805790|Bendavia™|bendavia™
5189607|NCT02805764|obstructive sleep apnea|obstructive sleep apnea
5189608|NCT02805764|malocclusion|malocclusion
5189609|NCT02805764|polysomnography|polysomnography
5189610|NCT02805764|quality of life|quality of life
5189611|NCT02805751|Achilles|achilles
5189612|NCT02805751|Tendon|tendon
5189613|NCT02805751|Loading|loading
5189614|NCT02805751|Rehabilitation|rehabilitation
5189615|NCT02805738|Chronic Hepatitis B|chronic hepatitis b
5189616|NCT02805738|tenofovir|tenofovir
5189617|NCT02805738|CKD-390|ckd-390
5189618|NCT02805725|Advanced solid tumor|advanced solid tumor
5189619|NCT02805725|Advanced pretreated soft tissue sarcomas|advanced pretreated soft tissue sarcomas
5189620|NCT02805725|Phase I/II trial|phase i/ii trial
5189621|NCT02805725|Dose escalation|dose escalation
5177590|NCT02881034|Antiviral Agents|antiviral agents
5177591|NCT02881034|Glomerular Filtration Rate|glomerular filtration rate
5177592|NCT02881034|Hepatitis C|hepatitis c
5177593|NCT02881034|Ribavirin|ribavirin
5177594|NCT02881034|Telaprevir|telaprevir
5962375|NCT04281264|cardiovascular health|cardiovascular health
5177595|NCT02881021|elastic tape|elastic tape
5177596|NCT02881021|kinesiology taping|kinesiology taping
5177597|NCT02881021|physiotherapy|physiotherapy
5177598|NCT02881021|rotator cuff|rotator cuff
5177599|NCT02881021|shoulder pain|shoulder pain
5177600|NCT02881021|tendon injuries|tendon injuries
5177601|NCT02880995|dopamine receptor occupancy|dopamine receptor occupancy
5177602|NCT02880995|antipsychotics|antipsychotics
5177603|NCT02880995|positron emission tomography|positron emission tomography
5177604|NCT02880956|Early Alzheimer's Disease (AD)|early alzheimer's disease (ad)
5177605|NCT02880956|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5177606|NCT02880956|Mild Alzheimer's Disease (AD)|mild alzheimer's disease (ad)
5064729|NCT03594214|breast cancer|breast cancer
5177607|NCT02880956|Tau|tau
5189622|NCT02805725|PK study|pk study
5189623|NCT02805712|Heart Failure|heart failure
5189624|NCT02805712|Palliative Care|palliative care
5189625|NCT02805699|Clinical Efficacy|clinical efficacy
5189626|NCT02805699|Baofeikang Granules|baofeikang granules
5189627|NCT02805699|Combined Pulmonary Fibrosis and Emphysema|combined pulmonary fibrosis and emphysema
5189628|NCT02805686|Toxicity, Drug|toxicity, drug
5189629|NCT02805673|Osteopathy|osteopathy
5189630|NCT02805673|Support|support
5189631|NCT02805673|Treatment|treatment
5189632|NCT02805673|Pain|pain
5189659|NCT02805504|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5189660|NCT02805491|Hypospadias|hypospadias
5189661|NCT02805491|newborns|newborns
5189662|NCT02805491|pesticide|pesticide
5189663|NCT02805491|Picardie|picardie
5189664|NCT02805465|Heart Failure|heart failure
5189665|NCT02805465|Atrial Fibrillation|atrial fibrillation
5189667|NCT02805465|BiVP|bivp
5189668|NCT02805465|HBP|hbp
5079387|NCT03503292|Ondansetron|ondansetron
5189669|NCT02805387|labor dystocia|labor dystocia
5189670|NCT02805374|Pharmacokinetics|pharmacokinetics
5189671|NCT02805374|ASP1517|asp1517
5189672|NCT02805374|Food effect|food effect
5189673|NCT02805348|Kiklin|kiklin
5189674|NCT02805348|Bixalomer|bixalomer
5189675|NCT02805348|Chronic Kidney Disease|chronic kidney disease
5189676|NCT02805335|Central Venous Catheter|central venous catheter
5189677|NCT02805335|Catheter Bloodstream Related Infection|catheter bloodstream related infection
5189678|NCT02805335|Economic evaluation|economic evaluation
5189679|NCT02805309|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5189680|NCT02805309|Exercise|exercise
5189681|NCT02805309|Frailty|frailty
5189682|NCT02805309|Functional Outcomes|functional outcomes
5189683|NCT02805309|Cognitive Behavioral Intervention|cognitive behavioral intervention
5189684|NCT02805283|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5189685|NCT02805270|adverse drug events, preventable, potential, counselling, medication reconciliation|adverse drug events, preventable, potential, counselling, medication reconciliation
5189686|NCT02805244|JTZ-951|jtz-951
5189687|NCT02805244|Pharmacokinetics|pharmacokinetics
5189688|NCT02805244|14C-JTZ-951|14c-jtz-951
5189689|NCT02805244|Mass balance|mass balance
5189690|NCT02805244|Time course|time course
5189691|NCT02805205|PEG-rhG-CSF neutropenia|peg-rhg-csf neutropenia
5189692|NCT02805192|Emergency Department|emergency department
5189693|NCT02805192|Estimation of age and weight|estimation of age and weight
5189694|NCT02805192|Size measurement|size measurement
5189695|NCT02805166|PEG-rhG-CSF|peg-rhg-csf
5189696|NCT02805153|PEG-rhG-CSF|peg-rhg-csf
5189697|NCT02805140|mother|mother
5189698|NCT02805140|social support|social support
5189699|NCT02805140|mobile app|mobile app
5189700|NCT02805140|videoconference|videoconference
5189701|NCT02805140|sedentary|sedentary
5189702|NCT02805140|physical activity|physical activity
5189705|NCT02805127|Capnography|capnography
5189706|NCT02805114|Asthma|asthma
5189707|NCT02805114|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5189708|NCT02805114|Capnography|capnography
5189709|NCT02805062|Trapped Lung|trapped lung
5189710|NCT02805036|alveolar recruitment|alveolar recruitment
5189711|NCT02805036|stroke volume/physiology|stroke volume/physiology
5189712|NCT02805036|cardiac output/physiology|cardiac output/physiology
5189713|NCT02804997|non-invasive ventilation|non-invasive ventilation
5189714|NCT02804997|cardiac surgery|cardiac surgery
5189715|NCT02804984|idiopathic cytopenia of undetermined significance (ICUS)|idiopathic cytopenia of undetermined significance (icus)
5189716|NCT02804984|molecular defects|molecular defects
5189717|NCT02804958|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5189718|NCT02804958|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5189719|NCT02804958|Clinical outcomes|clinical outcomes
5189720|NCT02804945|Blood And Marrow Transplantation|blood and marrow transplantation
5189721|NCT02804945|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
5189722|NCT02804945|ARDS|ards
5189723|NCT02804945|Allogeneic human mesenchymal stem cells|allogeneic human mesenchymal stem cells
5189724|NCT02804945|hMSCs|hmscs
5189726|NCT02804945|Plasma-Lyte A solution|plasma-lyte a solution
5189727|NCT02804945|Standard of Care|standard of care
5189728|NCT02804945|Recent onset pulmonary toxicity|recent onset pulmonary toxicity
5189729|NCT02804893|Lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery|lung cancer, video-assisted thoracoscopic surgery, robotic-assisted thoracoscopic surgery
5189730|NCT02804880|Smoking cessation|smoking cessation
5189731|NCT02804880|Quit to Win|quit to win
5189732|NCT02804880|Brief intervention|brief intervention
5189733|NCT02804880|Personalized active referral|personalized active referral
5189734|NCT02804880|Instant messaging|instant messaging
5189735|NCT02804880|SMS|sms
5189736|NCT02804880|Smoking Cessation Intervention|smoking cessation intervention
5189737|NCT02804841|Vitamin D supplementation|vitamin d supplementation
5962376|NCT04281251|appendicitis|appendicitis
5189738|NCT02804841|Cognitive function|cognitive function
5189739|NCT02804841|Physical function|physical function
5189740|NCT02804841|Successful ageing|successful ageing
5064850|NCT03593629|AIDS|aids
5189741|NCT02804841|Prevention|prevention
5189742|NCT02804841|Cholecalciferol|cholecalciferol
5189743|NCT02804841|Dementia|dementia
5189746|NCT02804815|prostate|prostate
5189747|NCT02804815|colorectal|colorectal
5189748|NCT02804815|breast|breast
5189749|NCT02804815|gastro-oesophageal|gastro-oesophageal
5189750|NCT02804815|recurrence|recurrence
5189751|NCT02804789|Prevention|prevention
5189752|NCT02804763|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5189753|NCT02804763|Dapirolizumab Pegol (DZP)|dapirolizumab pegol (dzp)
5189754|NCT02804750|Cushing's Syndrome|cushing's syndrome
5189755|NCT02804750|Cushing's Disease|cushing's disease
5189756|NCT02804750|Cushing's|cushing's
5189757|NCT02804750|Hypercortisolemia|hypercortisolemia
5189758|NCT02804750|Cushingoid|cushingoid
5079472|NCT03502642|cesarean|cesarean
5189762|NCT02804750|Adrenal Corticotrophic Hormone (ACTH)|adrenal corticotrophic hormone (acth)
5189764|NCT02804750|Primary Pigmented Nodular Adrenal Disease (PPNAD)|primary pigmented nodular adrenal disease (ppnad)
5189765|NCT02804750|Moon Facies|moon facies
5189766|NCT02804750|Dorsocervical Fat Pad|dorsocervical fat pad
5189767|NCT02804750|Adrenal Adenoma|adrenal adenoma
5189768|NCT02804750|Adrenal Carcinoma|adrenal carcinoma
5189769|NCT02804750|Adrenal Autonomy|adrenal autonomy
5189770|NCT02804750|Cortisol|cortisol
5189772|NCT02804724|Human immunodeficiency virus|human immunodeficiency virus
5189773|NCT02804724|Late diagnosis|late diagnosis
5189774|NCT02804672|Cardiovascular health|cardiovascular health
5189775|NCT02804672|Diet|diet
5189776|NCT02804672|Functional limitations|functional limitations
5189777|NCT02804672|Frailty|frailty
5189778|NCT02804672|Older adults|older adults
5189779|NCT02804659|micro-RNA|micro-rna
5177775|NCT02879942|Uterine artery doppler|uterine artery doppler
5177776|NCT02879929|chronic nasal dysfunction|chronic nasal dysfunction
5177777|NCT02879929|Quality of life|quality of life
5177778|NCT02879929|measurement|measurement
5177779|NCT02879929|self-reporting questionnaire|self-reporting questionnaire
5177780|NCT02879929|development|development
5177781|NCT02879929|validation|validation
5177782|NCT02879903|Porphyromonas gingivalis|porphyromonas gingivalis
5177783|NCT02879903|Periodontal treatment|periodontal treatment
5177784|NCT02879903|Smokers|smokers
5177785|NCT02879877|First in human|first in human
5177786|NCT02879877|subjects|subjects
5189780|NCT02804646|Recombinant human endostatin(Endostar)|recombinant human endostatin(endostar)
5189781|NCT02804646|Durative transfusion|durative transfusion
5189782|NCT02804646|adenocarcinoma of lung|adenocarcinoma of lung
5189783|NCT02804633|IV acetaminophen|iv acetaminophen
5189784|NCT02804633|Colorectal Surgery|colorectal surgery
5189785|NCT02804633|Enhance Recovery|enhance recovery
5189786|NCT02804633|Opioid Consumption|opioid consumption
5189787|NCT02804633|Pain Management|pain management
5189788|NCT02804607|burn|burn
5189789|NCT02804607|child|child
5189808|NCT02804477|MMAS 8, morisky medication adherence scale|mmas 8, morisky medication adherence scale
5189809|NCT02804477|validation|validation
5189810|NCT02804425|Medical Education|medical education
5189811|NCT02804425|Simulation|simulation
5189812|NCT02804425|Anesthesia crisis management|anesthesia crisis management
5189813|NCT02804425|Learning outcomes|learning outcomes
5189814|NCT02804412|communication disorders|communication disorders
5189815|NCT02804412|language and speech disorder rehabilitation|language and speech disorder rehabilitation
5189816|NCT02804412|stroke|stroke
5189817|NCT02804399|rifampin|rifampin
5189818|NCT02804399|pharmacokinetics|pharmacokinetics
5189819|NCT02804399|PF-06463922|pf-06463922
5189820|NCT02804399|drug interaction|drug interaction
5189821|NCT02804386|HCV|hcv
5189822|NCT02804386|safety|safety
5189823|NCT02804386|efficacy|efficacy
5189824|NCT02804386|EVR|evr
5189825|NCT02804386|SVR|svr
5189826|NCT02804373|oxytocin|oxytocin
5189827|NCT02804373|adults|adults
5189828|NCT02804347|Olfactory Dysfunction|olfactory dysfunction
5189829|NCT02804347|Electroconvulsive Therapy|electroconvulsive therapy
5189830|NCT02804347|Theta Burst Stimulation|theta burst stimulation
5189831|NCT02804321|catheter ablation|catheter ablation
5189832|NCT02804321|galectin 3|galectin 3
5189833|NCT02804321|ngal|ngal
5189834|NCT02804321|aldosterone|aldosterone
5189835|NCT02804321|atrial fibrillation|atrial fibrillation
5189836|NCT02804308|Combined Training|combined training
5189837|NCT02804308|Breast Cancer|breast cancer
5189838|NCT02804308|Body Composition|body composition
5189839|NCT02804308|Postmenopausal Women|postmenopausal women
5189840|NCT02804308|Aromatase Inhibitors|aromatase inhibitors
5189841|NCT02804308|Quality of life|quality of life
5189842|NCT02804295|Prescription Drug|prescription drug
5189843|NCT02804295|Misuse|misuse
5189844|NCT02804269|Healthy Volunteer|healthy volunteer
5189845|NCT02804269|Dilated cardiomyopathy|dilated cardiomyopathy
5189846|NCT02804269|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5189944|NCT02803502|factor VIII|factor viii
5189847|NCT02804269|ischemic heart disease|ischemic heart disease
5189848|NCT02804269|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
5962377|NCT04281251|endoscopic drainage|endoscopic drainage
5189849|NCT02804243|nasal high flow therapy|nasal high flow therapy
5189850|NCT02804243|rehabilitation|rehabilitation
5189851|NCT02804243|exercise endurance|exercise endurance
5189856|NCT02804165|Type 1 diabetes|type 1 diabetes
5189858|NCT02804165|Genetics|genetics
5189859|NCT02804165|Gene-Virus interaction|gene-virus interaction
5255484|NCT02415556|Placebo|placebo
5177869|NCT02879370|Anastomotic Leak|anastomotic leak
5177870|NCT02879370|Rectal cancer|rectal cancer
5177871|NCT02879370|Double stapling technique|double stapling technique
5177872|NCT02879357|Care management|care management
5177873|NCT02879357|end of life|end of life
5177874|NCT02879357|advanced care planning|advanced care planning
5177906|NCT02879136|PD|pd
5189860|NCT02804152|pregnancy|pregnancy
5189861|NCT02804152|pain|pain
5189862|NCT02804152|prescription opioid|prescription opioid
5189863|NCT02804139|Cesarean Section|cesarean section
5189864|NCT02804139|Postpartum issues|postpartum issues
5189865|NCT02804126|acute pain|acute pain
5189866|NCT02804126|transversus abdominis plane block|transversus abdominis plane block
5189867|NCT02804126|quadratus lumborum block|quadratus lumborum block
5189868|NCT02804126|neuropathic pain|neuropathic pain
5189869|NCT02804100|Circulating Tumor DNA|circulating tumor dna
5189870|NCT02804100|Lung cancer|lung cancer
5189885|NCT02803944|cystic fibrosis|cystic fibrosis
5189886|NCT02803944|pulmonary function|pulmonary function
5189887|NCT02803931|Cardiogoniometry|cardiogoniometry
5189888|NCT02803931|Electrocardiography|electrocardiography
5189889|NCT02803879|cardiac resynchronisation therapy|cardiac resynchronisation therapy
5189890|NCT02803879|cardiogoniometry|cardiogoniometry
5189891|NCT02803866|Parenting Self-efficacy|parenting self-efficacy
5189892|NCT02803866|Parent training program|parent training program
5189893|NCT02803866|Perceived self-efficacy tool|perceived self-efficacy tool
5189894|NCT02803853|Native American|native american
5189895|NCT02803853|Obesity|obesity
5189896|NCT02803853|Multi level|multi level
5189897|NCT02803853|Policy|policy
5189898|NCT02803853|Schools|schools
5189899|NCT02803853|Worksite|worksite
5189900|NCT02803853|Social Media|social media
5189901|NCT02803853|Food Store|food store
5189902|NCT02803840|Large B-Cell|large b-cell
5189903|NCT02803840|Diffuse|diffuse
5189904|NCT02803827|diarrhoea|diarrhoea
5189905|NCT02803827|gastroenteritis|gastroenteritis
5189906|NCT02803827|rapid diagnostics|rapid diagnostics
5189907|NCT02803827|probiotics|probiotics
5189908|NCT02803814|Pancreatoduodenectomy|pancreatoduodenectomy
5189909|NCT02803814|Pancreatic tumors|pancreatic tumors
5189910|NCT02803814|Periampullary tumors|periampullary tumors
5189911|NCT02803801|Parents' ability to guide their child|parents' ability to guide their child
5189912|NCT02803801|Parent perception of competence|parent perception of competence
5189913|NCT02803801|Parent understanding of their child's unique learning style|parent understanding of their child's unique learning style
5189914|NCT02803788|ramosetron, ondansetron, dexamethasone,|ramosetron, ondansetron, dexamethasone,
5189915|NCT02803762|ADME|adme
5189916|NCT02803762|Pacritinib|pacritinib
5189917|NCT02803671|preterm neonates|preterm neonates
5189918|NCT02803671|EEG-NIRS|eeg-nirs
5189919|NCT02803658|smoking|smoking
5189920|NCT02803645|healthy subjects|healthy subjects
5189921|NCT02803645|cardiovascular risk factors|cardiovascular risk factors
5189922|NCT02803645|markers of arterial inflammation|markers of arterial inflammation
5189923|NCT02803645|markers of oxidative stress|markers of oxidative stress
5189924|NCT02803632|young|young
5189925|NCT02803632|disruptive mood dysregulation disorder|disruptive mood dysregulation disorder
5189926|NCT02803632|actigraphic profile|actigraphic profile
5189927|NCT02803619|Non-small cell lung cancer|non-small cell lung cancer
5189928|NCT02803619|leptomeningeal metastasis|leptomeningeal metastasis
5189929|NCT02803619|EGFR sensitive mutations|egfr sensitive mutations
5189930|NCT02803606|hypothermia|hypothermia
5189931|NCT02803606|routine care|routine care
5189932|NCT02803606|preterm neonates|preterm neonates
5189933|NCT02803593|a technology-based intervention|a technology-based intervention
5189935|NCT02803593|survivorship|survivorship
5189936|NCT02803541|chronic kidney disease|chronic kidney disease
5189937|NCT02803541|exercise|exercise
5189938|NCT02803541|pediatrics|pediatrics
5189939|NCT02803541|summer camp|summer camp
5189940|NCT02803515|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
5189941|NCT02803515|peritoneal carcinomatosis|peritoneal carcinomatosis
5189942|NCT02803515|ovarian cancer|ovarian cancer
5189948|NCT02803489|diabetes|diabetes
5189950|NCT02803476|Vitamin D|vitamin d
5189951|NCT02803476|Insulin resistance|insulin resistance
5189952|NCT02803463|peritoneal closure|peritoneal closure
5799740|NCT00108563|Depression|depression
5189953|NCT02803463|appendectomy|appendectomy
5189954|NCT02803463|postoperative pain|postoperative pain
5189955|NCT02803463|life quality|life quality
5189956|NCT02803450|Effects of; Anesthesia|effects of; anesthesia
5189957|NCT02803450|spinal and epidural|spinal and epidural
5189958|NCT02803437|Castration-resistant prostate cancer|castration-resistant prostate cancer
5189959|NCT02803424|robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
5189960|NCT02803424|Autoflow|autoflow
5189961|NCT02803424|trendelenburg position|trendelenburg position
5189962|NCT02803424|pneumoperitoneum|pneumoperitoneum
5189963|NCT02803411|Coronary Heart Disease|coronary heart disease
5189964|NCT02803411|Coronary Computed Tomography Angiography (CCTA)|coronary computed tomography angiography (ccta)
5189965|NCT02803411|Coronary Atherosclerotic Plaque|coronary atherosclerotic plaque
5189966|NCT02803411|coronary atherosclerosis|coronary atherosclerosis
5189967|NCT02803398|Compression bandages|compression bandages
5189968|NCT02803385|Patient Controlled Epidural Analgesia|patient controlled epidural analgesia
5189969|NCT02803385|Continous Epidural Infusion Analgesia|continous epidural infusion analgesia
5189970|NCT02803372|partial nephrectomy|partial nephrectomy
5189971|NCT02803372|acute kidney injury|acute kidney injury
5189972|NCT02803372|LiDCOrapid|lidcorapid
5189973|NCT02803372|circulatory management|circulatory management
5079756|NCT03500731|BMT|bmt
5189974|NCT02803359|Laryngeal evoked brainstem response (LEBR)|laryngeal evoked brainstem response (lebr)
5189975|NCT02803359|laryngopharyngeal sensory discrimination testing (LPSDT)|laryngopharyngeal sensory discrimination testing (lpsdt)
5189976|NCT02803359|brainstem activity|brainstem activity
5189978|NCT02803346|septic shock|septic shock
5189979|NCT02803346|immunosuppression|immunosuppression
5189980|NCT02803346|HLA-DR|hla-dr
5189981|NCT02803346|lymphopenia|lymphopenia
5189982|NCT02803333|NSCLC|nsclc
5189983|NCT02803333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5189984|NCT02803333|Lung Diseases|lung diseases
5189985|NCT02803333|Thoracic Neoplasms|thoracic neoplasms
5189986|NCT02803320|Sunscreen active|sunscreen active
5189987|NCT02803307|osteoarthritis of the knee|osteoarthritis of the knee
5189988|NCT02803307|TLC599|tlc599
5189989|NCT02803307|Dexamethasone|dexamethasone
5189990|NCT02803307|DSP|dsp
5189991|NCT02803255|Injuries|injuries
5189992|NCT02803255|Spinal Cord|spinal cord
5189993|NCT02803242|copd|copd
5189994|NCT02803242|emphysema|emphysema
5189995|NCT02803242|bronchitis|bronchitis
5189996|NCT02803242|bronchiectasis|bronchiectasis
5189997|NCT02803203|Osimertinib|osimertinib
5189998|NCT02803203|bevacizumab|bevacizumab
5189999|NCT02803203|metastatic|metastatic
5190000|NCT02803203|16-033|16-033
5190006|NCT02803177|large bone defect|large bone defect
5190007|NCT02803177|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
5190008|NCT02803151|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5190009|NCT02803151|Lymph node metastasis|lymph node metastasis
5190010|NCT02803151|T cell immunity|t cell immunity
5190011|NCT02803151|cell-free DNA|cell-free dna
5190012|NCT02803138|Chronic Hepatitis C|chronic hepatitis c
5190013|NCT02803138|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
5190014|NCT02803138|Sustained Virological Response|sustained virological response
5190015|NCT02803138|Observational Study|observational study
5190016|NCT02803138|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5190017|NCT02803138|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5190018|NCT02803125|PTSD|ptsd
5190019|NCT02803125|Aging|aging
5190020|NCT02803125|Veteran|veteran
5190021|NCT02803125|Intervention|intervention
5190022|NCT02803086|Prostate cancer|prostate cancer
5190023|NCT02803086|Radiotherapy|radiotherapy
5190024|NCT02803086|Hematopoietic stem cells|hematopoietic stem cells
5190025|NCT02803086|Radiotoxicity|radiotoxicity
5190026|NCT02802982|Thrombocytopenia|thrombocytopenia
5190027|NCT02802982|Neonates|neonates
5190028|NCT02802956|Life participation|life participation
5190029|NCT02802943|CLL, Peptid Vaccination|cll, peptid vaccination
5190030|NCT02802917|Eye stinging potential|eye stinging potential
5190031|NCT02802904|Healthy subjects|healthy subjects
5190032|NCT02802891|Asthma|asthma
5190033|NCT02802891|Allergy|allergy
5190034|NCT02802891|Diagnosis|diagnosis
5190035|NCT02802891|Endocrine disruptors|endocrine disruptors
5190036|NCT02802891|Children|children
5190037|NCT02802839|Virtual Reality|virtual reality
5190038|NCT02802839|venipuncture|venipuncture
5190039|NCT02802826|Exercise|exercise
5190040|NCT02802826|Chemotherapy|chemotherapy
5190041|NCT02802826|Physical Activity|physical activity
5190042|NCT02802826|Breast Cancer|breast cancer
5190043|NCT02802813|Single-blinded controlled trial|single-blinded controlled trial
5190044|NCT02802813|Primaquine|primaquine
5190045|NCT02802787|Quality of life|quality of life
5190046|NCT02802787|Occupation|occupation
5190047|NCT02802787|Pain|pain
5190048|NCT02802787|Fatigue|fatigue
5190053|NCT02802748|PAM50|pam50
5190054|NCT02802748|Luminal A|luminal a
5190055|NCT02802748|Luminal B|luminal b
5190056|NCT02802748|proliferation signature|proliferation signature
5190057|NCT02802748|metronomic vinorelbine|metronomic vinorelbine
5190058|NCT02802748|letrozole|letrozole
5190059|NCT02802735|Pharmacokinetics|pharmacokinetics
5190060|NCT02802735|Apremilast|apremilast
5190061|NCT02802735|Healthy Adult Male|healthy adult male
5190062|NCT02802735|Korean Subjects|korean subjects
5190063|NCT02802722|convalescence|convalescence
5190064|NCT02802722|inflammation|inflammation
5190065|NCT02802722|resolution|resolution
5190066|NCT02802722|vitamin D|vitamin d
5190067|NCT02802709|knee|knee
5190068|NCT02802696|Transfusion|transfusion
5065165|NCT03591822|Dementia|dementia
5190069|NCT02802696|Transfusion Medicine|transfusion medicine
5190070|NCT02802696|Diuretic|diuretic
5190071|NCT02802683|Hypotension|hypotension
5190072|NCT02802683|cesarean section|cesarean section
5190073|NCT02802657|Age-related Macular Degeneration|age-related macular degeneration
5190074|NCT02802657|Conbercept|conbercept
5190075|NCT02802657|Treat-and-Extend Regimen|treat-and-extend regimen
5190076|NCT02802657|Pro Re Nata|pro re nata
5190077|NCT02802631|Bacterial infections|bacterial infections
5190083|NCT02802579|obesity|obesity
5190084|NCT02802579|dual source CT|dual source ct
5190085|NCT02802579|coronary CT angiography|coronary ct angiography
5190086|NCT02802579|prognosis|prognosis
5190087|NCT02802579|bariatric surgery|bariatric surgery
5190088|NCT02802579|gastric bypass surgery|gastric bypass surgery
5190089|NCT02802579|coronary arterial disease|coronary arterial disease
5190090|NCT02802579|major adverse coronary event|major adverse coronary event
5190091|NCT02802566|Maternal Obesity|maternal obesity
5190092|NCT02802566|Inflammation|inflammation
5190093|NCT02802553|SmartGoggles|smartgoggles
5190094|NCT02802553|sentinel lymph nodes|sentinel lymph nodes
5190095|NCT02802553|indocyanine green|indocyanine green
5190096|NCT02802553|Cardio-Green|cardio-green
5190097|NCT02802553|Spy Elite|spy elite
5190098|NCT02802540|nabilone|nabilone
5190099|NCT02802540|anorexia|anorexia
5190100|NCT02802540|Non-Small Cell Lung Cancer|non-small cell lung cancer
5190101|NCT02802514|Gastrointestinal|gastrointestinal
5190102|NCT02802514|Glucagon like peptide|glucagon like peptide
5190103|NCT02802514|Nausea|nausea
5190104|NCT02802514|Magnetic resonance imaging|magnetic resonance imaging
5190105|NCT02802501|Safety|safety
5190106|NCT02802501|Artemisinin Combination Therapy|artemisinin combination therapy
5190107|NCT02802501|Efficacy|efficacy
5190108|NCT02802501|Tafenoquine|tafenoquine
5190109|NCT02802501|Superiority|superiority
5190110|NCT02802501|Primaquine|primaquine
5190111|NCT02802501|Radical cure|radical cure
5190112|NCT02802501|Vivax|vivax
5190114|NCT02802501|Plasmodium vivax malaria|plasmodium vivax malaria
5190115|NCT02802501|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5190116|NCT02802488|D-dimers|d-dimers
5190117|NCT02802488|Atrial fibrillation|atrial fibrillation
5190118|NCT02802475|antibodies|antibodies
5190119|NCT02802475|auto-immune encephalitis|auto-immune encephalitis
5190120|NCT02802475|epilepsy|epilepsy
5190121|NCT02802475|limbic encephalitis|limbic encephalitis
5190122|NCT02802462|endothelial progenitor cell|endothelial progenitor cell
5190123|NCT02802462|hemodynamic|hemodynamic
5190124|NCT02802462|Exercise|exercise
5190125|NCT02802462|HIIT|hiit
5190126|NCT02802449|Vitamin D|vitamin d
5190127|NCT02802449|Hypovitaminosis D|hypovitaminosis d
5190128|NCT02802449|HTN|htn
5190129|NCT02802423|TNBC|tnbc
5190130|NCT02802423|Breast cancer|breast cancer
5190131|NCT02802423|Triple negative|triple negative
5190132|NCT02802397|Early ovarian reserve decreased|early ovarian reserve decreased
5190133|NCT02802384|Paget's Disease of Bone|paget's disease of bone
5190134|NCT02802384|Healthy controls|healthy controls
5190135|NCT02802371|caregiver burden|caregiver burden
5190136|NCT02802371|Alzheimer disease and related disorders|alzheimer disease and related disorders
5190137|NCT02802371|elderly|elderly
5190138|NCT02802371|pharmaceutical care|pharmaceutical care
5190139|NCT02802371|optimization of drug prescribing|optimization of drug prescribing
5190140|NCT02802371|psychosocial intervention|psychosocial intervention
5190141|NCT02802358|Falls|falls
5190142|NCT02802358|Functionality|functionality
5190143|NCT02802332|neonatal|neonatal
5190144|NCT02802332|preterm|preterm
5190145|NCT02802332|Nepal|nepal
5190146|NCT02802332|family-initiated identification|family-initiated identification
5190147|NCT02802332|basic newborn care|basic newborn care
5190148|NCT02802306|Angioplasty|angioplasty
5190149|NCT02802306|Peripheral Artery Disease|peripheral artery disease
5190151|NCT02802306|Lesion|lesion
5178173|NCT02877199|anti-E1E2 antibodies|anti-e1e2 antibodies
5178174|NCT02877199|cirrhosis|cirrhosis
5178175|NCT02877199|triple therapy|triple therapy
5178176|NCT02877173|Arteriosclerosis Obliterans|arteriosclerosis obliterans
5178177|NCT02877173|Atherosclerotic Occlusive Disease of the Lower Extremities|atherosclerotic occlusive disease of the lower extremities
5190152|NCT02802306|Claudication|claudication
5190153|NCT02802293|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5190154|NCT02802293|Major Depressive Disorder|major depressive disorder
5190155|NCT02802280|endothelial dysfunction|endothelial dysfunction
5190156|NCT02802254|physical activity|physical activity
5190157|NCT02802254|patient feedback|patient feedback
5190158|NCT02802254|risk perception|risk perception
5190159|NCT02802254|pedometer|pedometer
5190160|NCT02802215|Diabetes Mellitus|diabetes mellitus
5190161|NCT02802215|Pregnancy|pregnancy
5190162|NCT02802202|Palpation|palpation
5190163|NCT02802202|Chronic Pain|chronic pain
5190164|NCT02802202|Muscle|muscle
5962378|NCT04281238|ankylosing spondylitis|ankylosing spondylitis
5190165|NCT02802189|Chronic Mechanical Neck Pain|chronic mechanical neck pain
5190166|NCT02802189|exercise|exercise
5057551|NCT03639311|HIV|hiv
5190167|NCT02802189|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
5190168|NCT02802163|untreated multiple myeloma|untreated multiple myeloma
5190169|NCT02802163|newly diagnosed myeloma|newly diagnosed myeloma
5190170|NCT02802163|transplant eligible|transplant eligible
5190181|NCT02802124|toxicity|toxicity
5190182|NCT02802124|efficacy|efficacy
5190183|NCT02802111|Beta Agonists|beta agonists
5190184|NCT02802111|Asthma|asthma
5190185|NCT02802111|Albuterol|albuterol
5190186|NCT02802111|Levalbuterol|levalbuterol
5190187|NCT02802098|Metastatic breast cancer|metastatic breast cancer
5190188|NCT02802098|bevacizumab maintenance|bevacizumab maintenance
5190189|NCT02802098|Durvalumab|durvalumab
5190190|NCT02802085|Total Knee Arthroplasty|total knee arthroplasty
5190191|NCT02802085|Total Knee Replacement|total knee replacement
5190192|NCT02802085|TKA|tka
5190193|NCT02802085|TKR|tkr
5190194|NCT02802085|Stiffness of Knee|stiffness of knee
5190195|NCT02802085|Deformity|deformity
5190196|NCT02802085|Knee Joint|knee joint
5190197|NCT02802085|Instability|instability
5190198|NCT02802085|Post-traumatic|post-traumatic
5190199|NCT02802085|Arthrosis|arthrosis
5190200|NCT02802046|FFRCT|ffrct
5190201|NCT02802046|Angina pectoris grade|angina pectoris grade
5190202|NCT02802046|Fractional flow reserve|fractional flow reserve
5190203|NCT02802046|CCTA|ccta
5190204|NCT02802033|Registry|registry
5190205|NCT02802033|Spine|spine
5190206|NCT02802033|Osteobiologics|osteobiologics
5190207|NCT02802033|Spinal Fusion|spinal fusion
5190208|NCT02801994|Patient-ventilator interaction|patient-ventilator interaction
5190209|NCT02801994|Inspiratory muscles|inspiratory muscles
5190210|NCT02801994|Electromyogram|electromyogram
5190211|NCT02801994|Mechanical ventilation|mechanical ventilation
5190212|NCT02801994|Proportional Assist Ventilation|proportional assist ventilation
5190213|NCT02801981|tolerability|tolerability
5190214|NCT02801981|healthy volunteers|healthy volunteers
5190215|NCT02801981|Cholestasis|cholestasis
5190216|NCT02801981|safety|safety
5190217|NCT02801955|gastric adenocarcinoma|gastric adenocarcinoma
5190218|NCT02801955|tumor markers|tumor markers
5190219|NCT02801955|peritoneal cytology|peritoneal cytology
5190220|NCT02801942|Biomarker|biomarker
5190221|NCT02801942|Immune Profile|immune profile
5190222|NCT02801942|Biopsy|biopsy
5190223|NCT02801942|Leukocyte subsets|leukocyte subsets
5190224|NCT02801942|Inguinal lymph nodes|inguinal lymph nodes
5190225|NCT02801942|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5190226|NCT02801916|Humans|humans
5190227|NCT02801916|Glycemic response|glycemic response
5190228|NCT02801916|Oat beta-glucan|oat beta-glucan
5190229|NCT02801877|Depression|depression
5190230|NCT02801877|Anxiety|anxiety
5190231|NCT02801877|Behavior Therapy|behavior therapy
5190232|NCT02801877|Technology Assisted|technology assisted
5190233|NCT02801877|Mobile Phone|mobile phone
5190234|NCT02801877|Cellular Phone|cellular phone
5190235|NCT02801877|Smartphone|smartphone
5190236|NCT02801877|App|app
5190237|NCT02801877|Coach|coach
5190238|NCT02801864|tDCS|tdcs
5190243|NCT02801864|aphasia|aphasia
5190244|NCT02801864|production|production
5190245|NCT02801864|language|language
5190246|NCT02801851|Delirium|delirium
5190247|NCT02801838|Inspiratory muscles|inspiratory muscles
5190248|NCT02801838|Patient-ventilator interaction|patient-ventilator interaction
5190250|NCT02801838|Mechanical ventilation|mechanical ventilation
5190251|NCT02801825|axillay artery|axillay artery
5190252|NCT02801825|cannulation|cannulation
5190253|NCT02801825|femoral artery|femoral artery
5190257|NCT02801799|Nerve blocks|nerve blocks
5190258|NCT02801799|Peripheral nerve blocks|peripheral nerve blocks
5190259|NCT02801799|Regional anaesthesia|regional anaesthesia
5190260|NCT02801799|therapeutic techniques|therapeutic techniques
5190261|NCT02801799|ropivacaine|ropivacaine
5190262|NCT02801799|nerve block duration|nerve block duration
5190263|NCT02801799|lower limb|lower limb
5190264|NCT02801799|Postoperative pain|postoperative pain
5190265|NCT02801786|Mammography|mammography
5190266|NCT02801786|Premedication|premedication
5190267|NCT02801786|Pain|pain
5190268|NCT02801786|Discomfort|discomfort
5190269|NCT02801786|Breast|breast
5190270|NCT02801773|gingivitis|gingivitis
5190271|NCT02801773|probiotic|probiotic
5190272|NCT02801773|non- surgical treatment|non- surgical treatment
5190273|NCT02801760|HIV|hiv
5190274|NCT02801760|Self-Consent|self-consent
5190280|NCT02801747|engagement in HIV care|engagement in hiv care
5190281|NCT02801747|Multiphase Optimization Strategy (MOST)|multiphase optimization strategy (most)
5190282|NCT02801708|Embolic stroke of undetermined source|embolic stroke of undetermined source
5190283|NCT02801708|Atrial fibrillation|atrial fibrillation
5190284|NCT02801695|pre-eclampsia|pre-eclampsia
5190285|NCT02801695|citrulline|citrulline
5190286|NCT02801695|pregnancy|pregnancy
5190287|NCT02801669|anticoagulants|anticoagulants
5962379|NCT04281238|yoga|yoga
5190288|NCT02801669|DU-176b|du-176b
5190289|NCT02801669|edoxaban|edoxaban
5190290|NCT02801669|factor Xa|factor xa
5190291|NCT02801669|oral|oral
5190292|NCT02801669|prevention|prevention
5065406|NCT03590275|FOLFIRINOX|folfirinox
5065407|NCT03590275|prognostic|prognostic
5065408|NCT03590249|osteopathic manipulative treatment|osteopathic manipulative treatment
5065409|NCT03590236|women|women
5065410|NCT03590236|chronic pelvic pain|chronic pelvic pain
5065411|NCT03590236|fear avoidance|fear avoidance
5065412|NCT03590197|Melatonin|melatonin
5065414|NCT03590197|Responder rate|responder rate
5190293|NCT02801669|atrial fibrillation|atrial fibrillation
5190294|NCT02801643|PET|pet
5190295|NCT02801643|dopamine|dopamine
5190296|NCT02801643|fMRI|fmri
5190297|NCT02801643|reward|reward
5190298|NCT02801617|Latanoprost|latanoprost
5190299|NCT02801617|Glaucoma|glaucoma
5190300|NCT02801617|Ocular hypertension|ocular hypertension
5190301|NCT02801617|Crossover study|crossover study
5190309|NCT02801552|regenerative endodontic treatment|regenerative endodontic treatment
5190310|NCT02801552|platelet-rich fibrin|platelet-rich fibrin
5190311|NCT02801552|Immature permanent tooth|immature permanent tooth
5190312|NCT02801552|apical periodontitis|apical periodontitis
5190313|NCT02801513|mindfulness|mindfulness
5190314|NCT02801513|EEG|eeg
5190315|NCT02801513|error-related negativity|error-related negativity
5190316|NCT02801513|late positive potential|late positive potential
5190317|NCT02801513|long-range temporal correlations|long-range temporal correlations
5190318|NCT02801500|bilioenteric anastomosis|bilioenteric anastomosis
5190321|NCT02801435|EGFR inhibitor|egfr inhibitor
5190322|NCT02801435|topical agent|topical agent
5190323|NCT02801435|psoriasis|psoriasis
5190324|NCT02801435|phase 1|phase 1
5190325|NCT02801422|cannabis|cannabis
5190326|NCT02801422|fMRI|fmri
5190327|NCT02801422|addiction|addiction
5190328|NCT02801422|relapse|relapse
5190329|NCT02801409|Lung Cancer|lung cancer
5190330|NCT02801409|Surgical Resection|surgical resection
5190331|NCT02801409|Epidural Anesthesia and Analgesia|epidural anesthesia and analgesia
5190332|NCT02801409|Long-Term Outcome|long-term outcome
5190333|NCT02801357|substance withdrawal syndrome|substance withdrawal syndrome
5190334|NCT02801357|opiate addiction|opiate addiction
5190335|NCT02801357|opiate dependence|opiate dependence
5190336|NCT02801357|opioid withdrawal syndrome|opioid withdrawal syndrome
5190337|NCT02801357|buprenorphine|buprenorphine
5190338|NCT02801344|exercise|exercise
5190339|NCT02801344|performance|performance
5190340|NCT02801344|recovery|recovery
5190341|NCT02801344|muscle|muscle
5190342|NCT02801344|protein|protein
5190343|NCT02801331|Stochastic Resonance|stochastic resonance
5190344|NCT02801331|Fetus/Newborn Infant|fetus/newborn infant
5190345|NCT02801331|Drug Withdrawal|drug withdrawal
5190346|NCT02801331|Substance Abuse|substance abuse
5190347|NCT02801318|Patient|patient
5190348|NCT02801305|Scleroderma|scleroderma
5190349|NCT02801305|Diltiazem|diltiazem
5190350|NCT02801305|Nitroglycerin|nitroglycerin
5190351|NCT02801305|Topical|topical
5190352|NCT02801279|Cerebral Palsy|cerebral palsy
5190353|NCT02801279|Occupational Therapy|occupational therapy
5190354|NCT02801279|Upper Limb Motor Training|upper limb motor training
5271422|NCT02322970|tcd|tcd
5190355|NCT02801266|Contraception|contraception
5190356|NCT02801266|Reproductive and Sexual Health|reproductive and sexual health
5190357|NCT02801266|Counseling|counseling
5190358|NCT02801266|Contraceptive Counseling|contraceptive counseling
5190359|NCT02801240|Inflammatory Bowel Disease|inflammatory bowel disease
5190360|NCT02801227|premature rupture of membrane|premature rupture of membrane
5190361|NCT02801227|primipara|primipara
5190362|NCT02801227|term|term
5190363|NCT02801227|bishop|bishop
5190364|NCT02801214|cannabis|cannabis
5190365|NCT02801214|fMRI|fmri
5190366|NCT02801214|emotion|emotion
5190367|NCT02801201|sedation|sedation
5190368|NCT02801201|spinal anesthesia|spinal anesthesia
5190369|NCT02801162|arterial blood gas|arterial blood gas
5190370|NCT02801123|Complimentary Cancer Therapies|complimentary cancer therapies
5190371|NCT02801123|Psychosocial Oncology|psychosocial oncology
5190372|NCT02801123|Behavioural Medicine|behavioural medicine
5190373|NCT02801123|Mindfulness Based Cancer Recovery|mindfulness based cancer recovery
5190374|NCT02801123|Tai Chi|tai chi
5190375|NCT02801123|Qigong|qigong
5190376|NCT02801123|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5190377|NCT02801123|Yoga|yoga
5190378|NCT02801123|Preference-based trial|preference-based trial
5190381|NCT02801084|Stimulation|stimulation
5190382|NCT02801071|Post-Polio Syndrome|post-polio syndrome
5190383|NCT02801071|PPS|pps
5190384|NCT02801058|Osteopathic manipulative treatment|osteopathic manipulative treatment
5962380|NCT04281225|attention to variability|attention to variability
5962381|NCT04281225|placebo|placebo
5962382|NCT04281225|hearing|hearing
5962383|NCT04281212|Chronic Coronary Occlusion|chronic coronary occlusion
5962384|NCT04281212|Peripheral Component Interconnect|peripheral component interconnect
5962385|NCT04281212|Coronary angioplasty|coronary angioplasty
5962386|NCT04281160|mobile app|mobile app
5962387|NCT04281160|TUG test|tug test
5190385|NCT02801058|Abdominal Diaphragm mobility|abdominal diaphragm mobility
5190386|NCT02801058|Thoracic Ultrasounds|thoracic ultrasounds
5190387|NCT02800980|lymphocele|lymphocele
5190388|NCT02800980|sclerotherapy|sclerotherapy
5962388|NCT04281160|25 foot walk|25 foot walk
5065583|NCT03589352|midwife|midwife
5190389|NCT02800980|drainage|drainage
5190390|NCT02800980|percutaneous|percutaneous
5190391|NCT02800967|platelet activation|platelet activation
5190392|NCT02800967|platelet aggregation|platelet aggregation
5190393|NCT02800967|Aronia|aronia
5190394|NCT02800967|flow cytometry|flow cytometry
5190395|NCT02800967|polyphenols|polyphenols
5190396|NCT02800967|cardiovascular disease risk|cardiovascular disease risk
5190397|NCT02800954|Multiple Myeloma|multiple myeloma
5190398|NCT02800954|bone lesions|bone lesions
5190399|NCT02800954|Macrophage-Colony Stimulating Factor|macrophage-colony stimulating factor
5190400|NCT02800941|Pulmonary Arterial hypertension|pulmonary arterial hypertension
5190401|NCT02800941|Oral anticoagulants|oral anticoagulants
5190402|NCT02800941|Major bleedings|major bleedings
5190403|NCT02800915|Spinal Cord Injury|spinal cord injury
5190404|NCT02800915|Pressure Ulcer|pressure ulcer
5190405|NCT02800915|Health Related Quality of Life|health related quality of life
5190406|NCT02800915|Telemedicine|telemedicine
5190407|NCT02800915|Service Innovation|service innovation
5190408|NCT02800915|Rehabilitation|rehabilitation
5190409|NCT02800915|Interdisciplinary collaboration|interdisciplinary collaboration
5190410|NCT02800915|User- participation|user- participation
5190411|NCT02800915|Activity and participation|activity and participation
5190412|NCT02800915|Health economics|health economics
5190413|NCT02800889|relapsed|relapsed
5190414|NCT02800889|refractory|refractory
5190415|NCT02800889|solid tumors|solid tumors
5190416|NCT02800850|Dementia|dementia
5190417|NCT02800850|Depression|depression
5190418|NCT02800850|Agitation|agitation
5190419|NCT02800850|Bright Light|bright light
5190420|NCT02800837|left main|left main
5190421|NCT02800837|stent|stent
5190422|NCT02800837|self-expandable|self-expandable
5190423|NCT02800837|DES|des
5190424|NCT02800837|Stentys|stentys
5190425|NCT02800811|FR104|fr104
5190426|NCT02800811|CD28|cd28
5190427|NCT02800811|immunomodulation|immunomodulation
5190428|NCT02800811|T regulatory cell|t regulatory cell
5190429|NCT02800811|Pegylated monovalent anti-CD28 Fab antibody|pegylated monovalent anti-cd28 fab antibody
5190430|NCT02800798|Obstructive sleep apnea|obstructive sleep apnea
5190431|NCT02800798|Preeclampsia|preeclampsia
5190432|NCT02800798|Pregnancy|pregnancy
5190433|NCT02800798|Stopbang|stopbang
5190434|NCT02800772|pancreatic duct|pancreatic duct
5190435|NCT02800772|ERCP|ercp
5190436|NCT02800772|acetic acid|acetic acid
5190437|NCT02800746|Prognathic surgery|prognathic surgery
5190438|NCT02800746|intravenous iron|intravenous iron
5190439|NCT02800720|Fibromyalgia Syndromey|fibromyalgia syndromey
5190440|NCT02800681|Asperger Syndrome|asperger syndrome
5190441|NCT02800681|Autism Spectrum Disorder|autism spectrum disorder
5190442|NCT02800681|Schizotypal disorder|schizotypal disorder
5190443|NCT02800681|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
5190444|NCT02800681|Psychopathology|psychopathology
5190445|NCT02800681|Examination of Anomalous Self Disorder|examination of anomalous self disorder
5190446|NCT02800681|Autism Diagnostic Observation Schedule|autism diagnostic observation schedule
5190447|NCT02800681|Phenomenology|phenomenology
5190448|NCT02800681|Differential diagnosis|differential diagnosis
5190449|NCT02800681|Young Adult|young adult
5190450|NCT02800668|Duodenal Jejunal Bypass Liner|duodenal jejunal bypass liner
5190451|NCT02800668|obesity|obesity
5190456|NCT02800655|Proteus Digital Health|proteus digital health
5190458|NCT02800642|Aflibercept|aflibercept
5190459|NCT02800642|Eylea|eylea
5190460|NCT02800642|Intravitreal|intravitreal
5190461|NCT02800616|Academic Achievement|academic achievement
5190462|NCT02800616|Accelerometry|accelerometry
5190463|NCT02800616|Children|children
5190464|NCT02800616|Primary school Intervention|primary school intervention
5190465|NCT02800616|Nutrition|nutrition
5190466|NCT02800616|Obesity|obesity
5190467|NCT02800616|Physical Activity|physical activity
5190468|NCT02800616|Prevention|prevention
5190469|NCT02800616|School Health|school health
5190470|NCT02800603|preschool mental health|preschool mental health
5092201|NCT03422653|CKD|ckd
5190471|NCT02800603|emotional and behaviour problems|emotional and behaviour problems
5190472|NCT02800590|Adult participants|adult participants
5190473|NCT02800590|Sedation|sedation
5190474|NCT02800590|elective|elective
5190475|NCT02800525|Benign pigmented lesions|benign pigmented lesions
5190476|NCT02800525|Picosecond laser|picosecond laser
5190477|NCT02800525|Q-switched laser|q-switched laser
5190478|NCT02800512|pelvic organ prolapse|pelvic organ prolapse
5190479|NCT02800512|cystocele|cystocele
5190480|NCT02800512|rectocele|rectocele
5190481|NCT02800512|enterocele|enterocele
5190482|NCT02800473|Bladder cancer|bladder cancer
5190483|NCT02800473|Hexvix|hexvix
5190484|NCT02800473|Bimodal Endoscopic Imager|bimodal endoscopic imager
5190485|NCT02800473|Cystoscopy|cystoscopy
5190486|NCT02800460|Subthalamic nucleus|subthalamic nucleus
5190487|NCT02800460|Basal ganglia|basal ganglia
5190488|NCT02800460|Parkinson disease|parkinson disease
5190489|NCT02800460|Magnetic Resonance Imaging|magnetic resonance imaging
5190490|NCT02800460|Susceptibility-Weighted Imaging|susceptibility-weighted imaging
5962389|NCT04281160|six minute walk|six minute walk
5190491|NCT02800434|allograft|allograft
5190492|NCT02800434|hands|hands
5190493|NCT02800434|immunosuppression|immunosuppression
5190494|NCT02800434|fMRI|fmri
5190495|NCT02800395|Alzheimer|alzheimer
5190496|NCT02800395|oxydative stress|oxydative stress
5190497|NCT02800395|nutrition|nutrition
5190498|NCT02800395|biomarkers|biomarkers
5190499|NCT02800382|paraoxonase|paraoxonase
5190500|NCT02800382|lung diseases|lung diseases
5190501|NCT02800369|Human papillomavirus|human papillomavirus
5190502|NCT02800369|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5190503|NCT02800369|zinc finger nuclease|zinc finger nuclease
5190509|NCT02800304|malnutrition|malnutrition
5190510|NCT02800304|food intake|food intake
5190511|NCT02800304|frailty|frailty
5190512|NCT02800291|food intake|food intake
5190513|NCT02800265|healthy volunteer|healthy volunteer
5190514|NCT02800265|healthy|healthy
5190515|NCT02800265|cancer prevention|cancer prevention
5190516|NCT02800265|prevention|prevention
5190517|NCT02800252|fatty acids|fatty acids
5190518|NCT02800252|aspirin|aspirin
5190519|NCT02800252|diabetes mellitus|diabetes mellitus
5190520|NCT02800252|chronic periodontitis|chronic periodontitis
5190521|NCT02800252|periodontal debridement|periodontal debridement
5190522|NCT02800200|platelet rich plasma|platelet rich plasma
5190523|NCT02800200|extracorporeal shock wave|extracorporeal shock wave
5190524|NCT02800122|acute dyspnea|acute dyspnea
5190525|NCT02800122|emergency|emergency
5190526|NCT02800122|acute heart failure|acute heart failure
5190527|NCT02800109|Fetal growth|fetal growth
5190528|NCT02800109|Newborn growth|newborn growth
5190529|NCT02800070|autologous stem cell transplant|autologous stem cell transplant
5190530|NCT02800070|gene therapy|gene therapy
5190531|NCT02800070|Fabry disease|fabry disease
5190532|NCT02800070|lentivirus|lentivirus
5190533|NCT02800070|haematopoietic stem cell transplant|haematopoietic stem cell transplant
5190534|NCT02800018|hypothermia therapy|hypothermia therapy
5190535|NCT02800018|perinatal asphyxia|perinatal asphyxia
5190536|NCT02800005|gastric cancer|gastric cancer
5190537|NCT02800005|gastrectomy|gastrectomy
5190538|NCT02800005|laparotomy|laparotomy
5190539|NCT02800005|surgical outcome|surgical outcome
5190540|NCT02800005|survival|survival
5190541|NCT02800005|abdominal fat area|abdominal fat area
5190542|NCT02800005|Body Mass Index|body mass index
5190543|NCT02799953|diabetes mellitus and hypertension|diabetes mellitus and hypertension
5190544|NCT02799953|consumer health information technology|consumer health information technology
5190545|NCT02799953|self-monitoring|self-monitoring
5190546|NCT02799953|randomized controlled trial|randomized controlled trial
5190547|NCT02799927|Indirect Pulp Treatment|indirect pulp treatment
5190548|NCT02799927|Primary Teeth|primary teeth
5190549|NCT02799927|Biodentine|biodentine
5190550|NCT02799927|Calcium Hydroxide|calcium hydroxide
5799380|NCT00109772|RSDS|rsds
5190551|NCT02799927|Split-Mouth design|split-mouth design
5190552|NCT02799901|advanced melanoma|advanced melanoma
5190553|NCT02799901|high dose radiotherapy|high dose radiotherapy
5190554|NCT02799901|Nivolumab|nivolumab
5190555|NCT02799888|Graft-versus-host Disease|graft-versus-host disease
5190556|NCT02799888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5190557|NCT02799888|Acute Leukemia|acute leukemia
5190558|NCT02799888|Myelodysplastic syndrome|myelodysplastic syndrome
5190559|NCT02799888|Lymphoma|lymphoma
5190560|NCT02799875|respiratory distress syndrome|respiratory distress syndrome
5190561|NCT02799875|permissive hypercapnia|permissive hypercapnia
5190562|NCT02799875|ventilator strategy|ventilator strategy
5190563|NCT02799862|metastatic|metastatic
5190564|NCT02799862|locally advanced|locally advanced
5190565|NCT02799862|unresectable|unresectable
5190567|NCT02799849|narcolepsy|narcolepsy
5190568|NCT02799849|metabolism|metabolism
5190569|NCT02799823|aortic stenosis|aortic stenosis
5190570|NCT02799823|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5190571|NCT02799810|lung transplantation|lung transplantation
5190572|NCT02799810|psychosocial functioning|psychosocial functioning
5190573|NCT02799810|longitudinal|longitudinal
5190574|NCT02799810|TERS|ters
5190575|NCT02799810|adherence|adherence
5190576|NCT02799810|Quality of life|quality of life
5190577|NCT02799797|adductor canal block|adductor canal block
5190578|NCT02799784|tiotropium|tiotropium
5190579|NCT02799784|COPD|copd
5190580|NCT02799784|olodaterol|olodaterol
5190581|NCT02799784|Umeclidinium bromide|umeclidinium bromide
5190582|NCT02799784|efficacy|efficacy
5190583|NCT02799784|vilanterol|vilanterol
5190584|NCT02799771|Pulmonary arterial hypertension|pulmonary arterial hypertension
5190585|NCT02799771|Interstitial lung disease at HRCT|interstitial lung disease at hrct
5190586|NCT02799745|Therapeutic Cancer Progression|therapeutic cancer progression
5190589|NCT02799745|Prostate Cancer|prostate cancer
5190590|NCT02799745|Active surveillance|active surveillance
5190591|NCT02799732|Feasibility Study|feasibility study
5190592|NCT02799732|HPV vaccine|hpv vaccine
5190593|NCT02799732|1Dose Trial|1dose trial
5190594|NCT02799719|Fat mass|fat mass
5190595|NCT02799719|hemodialysis patients|hemodialysis patients
5190596|NCT02799719|inflammation|inflammation
5190597|NCT02799719|adipocytokines|adipocytokines
5190598|NCT02799719|bioimpedance spectroscopy|bioimpedance spectroscopy
5190599|NCT02799706|Prostate cancer|prostate cancer
5190600|NCT02799706|GnRH antagonist|gnrh antagonist
5190601|NCT02799706|GnRH agonist|gnrh agonist
5190602|NCT02799706|radiation therapy|radiation therapy
5190603|NCT02799706|very high risk localized prostate cancer|very high risk localized prostate cancer
5190604|NCT02799706|locally advanced prostate cancer|locally advanced prostate cancer
5190605|NCT02799693|Catheter Ablation|catheter ablation
5190606|NCT02799693|Ventricular Tachycardia|ventricular tachycardia
5190607|NCT02799693|Intramural Needle Catheter|intramural needle catheter
5190608|NCT02799680|CART|cart
5190609|NCT02799680|AML|aml
5190610|NCT02799667|negative pressure wound therapy|negative pressure wound therapy
5190611|NCT02799667|cesarean delivery|cesarean delivery
5190612|NCT02799654|Total Hip Arthroplasty|total hip arthroplasty
5190613|NCT02799641|Contraception|contraception
5190614|NCT02799641|IUD|iud
5190615|NCT02799641|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
5190616|NCT02799641|lidocaine|lidocaine
5190617|NCT02799641|valium|valium
5190618|NCT02799641|diazepam|diazepam
5190619|NCT02799641|pain|pain
5190620|NCT02799641|VAS|vas
5190621|NCT02799641|visual analog scale|visual analog scale
5190622|NCT02799628|Trust|trust
5190623|NCT02799628|Low Back Pain|low back pain
5190624|NCT02799628|Treatment Outcome|treatment outcome
5190625|NCT02799602|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
5190626|NCT02799576|Ultrasound|ultrasound
5190627|NCT02799576|Regional blockade|regional blockade
5190628|NCT02799576|Infraclavicular brachial plexus|infraclavicular brachial plexus
5190629|NCT02799550|CART|cart
5190630|NCT02799550|ALL|all
5190631|NCT02799550|Relapsed|relapsed
5190632|NCT02799550|Refractory|refractory
5190633|NCT02799550|CD19+|cd19+
5190634|NCT02799511|biological markers|biological markers
5190635|NCT02799498|etanercept|etanercept
5190636|NCT02799498|healthy subject|healthy subject
5190637|NCT02799498|open-label|open-label
5190638|NCT02799498|randomized|randomized
5190639|NCT02799498|PK|pk
5190640|NCT02799498|auto-injection|auto-injection
5190641|NCT02799498|pharmacokinetic|pharmacokinetic
5190642|NCT02799472|GSK3196165|gsk3196165
5190643|NCT02799472|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5190644|NCT02799472|disease-modifying antirheumatic drugs (DMARDs)|disease-modifying antirheumatic drugs (dmards)
5190645|NCT02799472|granulocyte-macrophage colony stimulating factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
5190646|NCT02799472|Rheumatoid Arthritis|rheumatoid arthritis
5190647|NCT02799472|Methotrexate|methotrexate
5190648|NCT02799459|Hypnoanesthesia|hypnoanesthesia
5190649|NCT02799459|Hypnosis|hypnosis
5190650|NCT02799459|conization|conization
5190651|NCT02799446|sinusitis, rhinitis, rhinosinusitis, chronic|sinusitis, rhinitis, rhinosinusitis, chronic
5190652|NCT02799433|Water|water
5190653|NCT02799433|Physical activity|physical activity
5190654|NCT02799433|Child care|child care
5190655|NCT02799433|Weight change|weight change
5190656|NCT02799420|confocal laser endomicroscopy|confocal laser endomicroscopy
5190657|NCT02799420|undifferentiated gastric cancer|undifferentiated gastric cancer
5190658|NCT02799420|target biopsy|target biopsy
5190659|NCT02799381|carbidopa|carbidopa
5190660|NCT02799381|levodopa|levodopa
5190661|NCT02799381|efficacy|efficacy
5190662|NCT02799381|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5190663|NCT02799381|Advanced Parkinson's Disease|advanced parkinson's disease
5190664|NCT02799303|screening|screening
5190665|NCT02799303|biopsy|biopsy
5190666|NCT02799303|magnetic resonance imaging|magnetic resonance imaging
5190667|NCT02799303|prostate specific antigen|prostate specific antigen
5190668|NCT02799264|fasted|fasted
5190669|NCT02799264|healthy volunteers|healthy volunteers
5190670|NCT02799264|cabotegravir|cabotegravir
5190671|NCT02799264|high fat|high fat
5190672|NCT02799264|pharmacokinetics|pharmacokinetics
5190673|NCT02799264|randomized|randomized
5190674|NCT02799264|Phase I|phase i
5190675|NCT02799264|two way crossover|two way crossover
5190676|NCT02799251|lymphopenia|lymphopenia
5190677|NCT02799251|postoperative infection|postoperative infection
5190678|NCT02799251|thoracic cancer surgery|thoracic cancer surgery
5190679|NCT02799251|digestive cancer surgery|digestive cancer surgery
5186575|NCT02823977|ketamine|ketamine
5862722|NCT00001535|Ex Vivo Cell Processing|ex vivo cell processing
5862723|NCT00001535|Identical Twins|identical twins
5862724|NCT00001535|HIV/AIDS|hiv/aids
5190680|NCT02799238|glioblastoma, GBM, immunotherapy, autologous lymphoid effector cells specific against tumour cells, ALECSAT, Stupp regimen, TMZ, radiotherapy/TMZ|glioblastoma, gbm, immunotherapy, autologous lymphoid effector cells specific against tumour cells, alecsat, stupp regimen, tmz, radiotherapy/tmz
5190682|NCT02799212|Hepatocellular carcinoma|hepatocellular carcinoma
5190683|NCT02799212|Hepatectomy|hepatectomy
5190684|NCT02799212|Ascites|ascites
5190685|NCT02799212|Somatostatin|somatostatin
5190686|NCT02799186|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
5190687|NCT02799186|haematoma|haematoma
5190688|NCT02799186|Fibromuscular Dysplasia|fibromuscular dysplasia
5190689|NCT02799186|genetic analysis|genetic analysis
5190690|NCT02799186|Acute Coronary Syndrome|acute coronary syndrome
5190691|NCT02799173|cardiovascular calcification|cardiovascular calcification
5190692|NCT02799173|RANK: Receptor Activator of Nuclear Factor kappa B|rank: receptor activator of nuclear factor kappa b
5190693|NCT02799173|RANKL: Receptor Activator of Nuclear Factor kappa B Ligand|rankl: receptor activator of nuclear factor kappa b ligand
5190694|NCT02799173|OPG: Osteoprotegerin|opg: osteoprotegerin
5190695|NCT02799173|SLE: Systemic lupus erythematosus|sle: systemic lupus erythematosus
5190696|NCT02799147|Allogeneic Transplantation|allogeneic transplantation
5190697|NCT02799147|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5190698|NCT02799147|Leukemia, Acute Lymphoblastic|leukemia, acute lymphoblastic
5190699|NCT02799147|Acute Myeloid Leukemia|acute myeloid leukemia
5190700|NCT02799147|Mixed-Lineage Acute Leukemias|mixed-lineage acute leukemias
5190701|NCT02799147|Immune System Diseases|immune system diseases
5190702|NCT02799147|Immunosuppressive Agents|immunosuppressive agents
5190703|NCT02799147|Myeloablative Agonists|myeloablative agonists
5190704|NCT02799147|Busulfan|busulfan
5190705|NCT02799147|Fludarabine|fludarabine
5190706|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5190707|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride
5190708|NCT02799134|Cortisol Awakening Response suppression|cortisol awakening response suppression
5190709|NCT02799134|Dexamethasone Suppression Test|dexamethasone suppression test
5190710|NCT02799134|high-order cognition|high-order cognition
5190711|NCT02799134|social cognition|social cognition
5190712|NCT02799108|children|children
5190713|NCT02799108|language|language
5190714|NCT02799108|NIRS|nirs
5190715|NCT02799095|Immunotherapy|immunotherapy
5190716|NCT02799095|IL-2|il-2
5190717|NCT02799095|Interleukin-2|interleukin-2
5190718|NCT02799095|Solid tumors|solid tumors
5190719|NCT02799095|Melanoma|melanoma
5190720|NCT02799095|Renal cell carcinoma|renal cell carcinoma
5190721|NCT02799095|Non-small-cell lung cancer|non-small-cell lung cancer
5190722|NCT02799095|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5190723|NCT02799056|Airway Extubation|airway extubation
5190724|NCT02799056|Ultrasonography|ultrasonography
5190725|NCT02799056|Ventilator Weaning|ventilator weaning
5190726|NCT02799043|FIRMap, Rotor, FIRM-guided procedure|firmap, rotor, firm-guided procedure
5190727|NCT02799017|Aphasia|aphasia
5190728|NCT02799017|Reading|reading
5190730|NCT02799017|Naming|naming
5190731|NCT02799017|Language|language
5190732|NCT02799017|Chronic post stroke|chronic post stroke
5190733|NCT02799017|Phonology|phonology
5190734|NCT02799017|Semantic Feature Analysis|semantic feature analysis
5190735|NCT02799017|Recovery|recovery
5342974|NCT01981317|Cognitive Behavioral Therapy|cognitive behavioral therapy
5190736|NCT02798991|REarranged during Transfection Growth Factor Receptor Tyrosine Kinase Inhibitor|rearranged during transfection growth factor receptor tyrosine kinase inhibitor
5190737|NCT02798978|pharmacokinetics|pharmacokinetics
5190738|NCT02798978|TLR4 agonist|tlr4 agonist
5190739|NCT02798978|cancer|cancer
5190740|NCT02798978|tolerability|tolerability
5190741|NCT02798978|GSK1795091|gsk1795091
5190742|NCT02798978|pharmacodynamics|pharmacodynamics
5190743|NCT02798978|safety|safety
5190744|NCT02798965|parvovirus genome|parvovirus genome
5190745|NCT02798952|Hepatitis B antibodies|hepatitis b antibodies
5190746|NCT02798952|Safety|safety
5190747|NCT02798952|Challenge dose|challenge dose
5190748|NCT02798952|Persistence|persistence
5190749|NCT02798952|Engerix B Kinder|engerix b kinder
5190750|NCT02798952|Infanrix hexa|infanrix hexa
5190751|NCT02798952|Immunogenicity|immunogenicity
5190752|NCT02798952|Adolescents|adolescents
5190753|NCT02798939|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5190754|NCT02798939|lactoferrin|lactoferrin
5190755|NCT02798939|procalcitonin|procalcitonin
5190756|NCT02798939|Aution® urine dipsticks|aution® urine dipsticks
5190757|NCT02798926|hypothermia|hypothermia
5190758|NCT02798926|central venous catheter placement|central venous catheter placement
5190759|NCT02798926|Polyethylene bag|polyethylene bag
5190760|NCT02798913|dual antiplatelet therapy|dual antiplatelet therapy
5190761|NCT02798913|peripheral transluminal angioplasty|peripheral transluminal angioplasty
5190762|NCT02798900|Task-specific exercise|task-specific exercise
5190763|NCT02798900|Ultrasonic Waves|ultrasonic waves
5190764|NCT02798900|Biomechanics|biomechanics
5190765|NCT02798900|Gait|gait
5190766|NCT02798900|Rehabilitation|rehabilitation
5190767|NCT02798900|Exercise therapy|exercise therapy
5190768|NCT02798887|Regeneration|regeneration
5190769|NCT02798887|Bone regeneration|bone regeneration
5190770|NCT02798887|Grafting, Bone|grafting, bone
5190771|NCT02798887|Allograft|allograft
5190772|NCT02798887|Xenograft|xenograft
5190773|NCT02798874|Ticagrelor|ticagrelor
5190774|NCT02798874|No-reflow|no-reflow
5190775|NCT02798874|Acute ST-segment elevation myocardial|acute st-segment elevation myocardial
5190776|NCT02798874|Reperfusion injury|reperfusion injury
5190777|NCT02798874|Percutaneous coronary intervention|percutaneous coronary intervention
5190778|NCT02798796|breast cancer|breast cancer
5190779|NCT02798796|conservative surgery|conservative surgery
5190781|NCT02798783|Vestibular Aqueduct|vestibular aqueduct
5190782|NCT02798783|SLC26A4|slc26a4
5190783|NCT02798783|FOXI1|foxi1
5190784|NCT02798783|Temporal Bone|temporal bone
5190785|NCT02798731|Heart transplant|heart transplant
5190786|NCT02798731|Microvascular dysfunction|microvascular dysfunction
5190787|NCT02798731|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
5190788|NCT02798731|Fractional flow reserve|fractional flow reserve
5190789|NCT02798731|Coronary flow reserve|coronary flow reserve
5190790|NCT02798731|Index of microvascular resistance|index of microvascular resistance
5190791|NCT02798705|Cardiac amyloidosis|cardiac amyloidosis
5190792|NCT02798705|Fractional flow reserve|fractional flow reserve
5190793|NCT02798705|Microvascular dysfunction|microvascular dysfunction
5190794|NCT02798705|Coronary flow reserve|coronary flow reserve
5190795|NCT02798705|Index of microcirculatory resistance|index of microcirculatory resistance
5190796|NCT02798692|Prevention|prevention
5190797|NCT02798666|Physical fitness|physical fitness
5190798|NCT02798666|Respiratory exchange ratio|respiratory exchange ratio
5190799|NCT02798666|Insulin sensitivity|insulin sensitivity
5190800|NCT02798666|High intensity interval training|high intensity interval training
5190801|NCT02798666|Continuous exercise training|continuous exercise training
5190802|NCT02798601|Cerebral edema|cerebral edema
5190803|NCT02798601|Hypernatremia|hypernatremia
5190804|NCT02798601|Extended Glasgow Outcome Scale|extended glasgow outcome scale
5190805|NCT02798601|Intracranial pressure|intracranial pressure
5190806|NCT02798601|Mannitol|mannitol
5190807|NCT02798601|Hypertonic saline|hypertonic saline
5190808|NCT02798601|Mortality|mortality
5190809|NCT02798588|coma|coma
5190810|NCT02798588|prognosis|prognosis
5190811|NCT02798588|comparative study|comparative study
5190812|NCT02798588|functional imaging|functional imaging
5190813|NCT02798588|PET-MRI|pet-mri
5190814|NCT02798588|electrophysiology|electrophysiology
5190815|NCT02798575|COPD|copd
5190816|NCT02798575|invasive ventilation|invasive ventilation
5190817|NCT02798575|exacerbation|exacerbation
5190818|NCT02798575|home care|home care
5190819|NCT02798575|mechanical ventilation|mechanical ventilation
5190820|NCT02798575|unsuccessful weaning|unsuccessful weaning
5190821|NCT02798575|ventilatory parameters|ventilatory parameters
5190822|NCT02798562|low dose CT|low dose ct
5190823|NCT02798562|contrast-enhanced|contrast-enhanced
5190824|NCT02798562|breast cancer screening|breast cancer screening
5190825|NCT02798562|computer tomography|computer tomography
5190826|NCT02798549|HBV|hbv
5190827|NCT02798549|liver|liver
5190828|NCT02798536|Immunotoxin|immunotoxin
5190829|NCT02798536|Mesothelin|mesothelin
5190830|NCT02798536|Targeted Therapy|targeted therapy
5190831|NCT02798523|Methylprednisolone|methylprednisolone
5190834|NCT02798523|Topical|topical
5190835|NCT02798523|Intravenous|intravenous
5190836|NCT02798510|Gallbladder Carcinoma|gallbladder carcinoma
5190837|NCT02798510|Extrahepatic Cholangiocarcinoma|extrahepatic cholangiocarcinoma
5190838|NCT02798510|Chemoradiotherapy|chemoradiotherapy
5190839|NCT02798497|PVL|pvl
5190840|NCT02798497|Pneumonias|pneumonias
5190841|NCT02798497|Staphylococcus aureus|staphylococcus aureus
5190842|NCT02798484|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
5190843|NCT02798484|Breast cancer|breast cancer
5190844|NCT02798484|Neo-adjuvant therapy|neo-adjuvant therapy
5190845|NCT02798471|Pediatric|pediatric
5190846|NCT02798471|Venous thrombolism|venous thrombolism
5190847|NCT02798471|Pulmonary embolism|pulmonary embolism
5190850|NCT02798445|venous ulcer|venous ulcer
5190851|NCT02798445|vein|vein
5190852|NCT02798445|juxta cures|juxta cures
5190853|NCT02798445|foam|foam
5190854|NCT02798445|laser|laser
5190855|NCT02798432|Total Knee Arthroplasty|total knee arthroplasty
5190856|NCT02798432|Hybrid|hybrid
5190857|NCT02798432|Cemented|cemented
5190858|NCT02798432|Fixation|fixation
5190859|NCT02798406|brain|brain
5190860|NCT02798406|Central Nervous System (CNS) diseases|central nervous system (cns) diseases
5190861|NCT02798406|Central Nervous System (CNS) neoplasms|central nervous system (cns) neoplasms
5190862|NCT02798406|CNS|cns
5190863|NCT02798406|conditionally replicative adenovirus|conditionally replicative adenovirus
5190864|NCT02798406|DNX-2401|dnx-2401
5190865|NCT02798406|pembrolizumab|pembrolizumab
5190866|NCT02798406|KEYTRUDA|keytruda
5190867|NCT02798406|MK-3475|mk-3475
5190868|NCT02798406|SCH 900475|sch 900475
5190869|NCT02798406|lambrolizumab|lambrolizumab
5190870|NCT02798406|neoplasm, germ cell and embryonal|neoplasm, germ cell and embryonal
5862725|NCT00001535|Kaposi's Sarcoma|kaposi's sarcoma
5190871|NCT02798406|neoplasm, granular and epithelial|neoplasm, granular and epithelial
5190873|NCT02798406|Alcyone Lifesciences|alcyone lifesciences
5190874|NCT02798406|AMC|amc
5190875|NCT02798406|cannula|cannula
5190876|NCT02798406|MEMS cannula|mems cannula
5190877|NCT02798406|DNX-2401 + pembrolizumab|dnx-2401 + pembrolizumab
5190878|NCT02798406|Delta-24|delta-24
5190879|NCT02798406|Delta-24-RGD|delta-24-rgd
5190880|NCT02798406|Checkpoint inhibitor|checkpoint inhibitor
5190881|NCT02798406|anti-PD1/PD-L1|anti-pd1/pd-l1
5190882|NCT02798406|immunotherapy|immunotherapy
5190883|NCT02798406|monoclonal antibody|monoclonal antibody
5190884|NCT02798406|KEYNOTE-192|keynote-192
5190885|NCT02798367|insomnia|insomnia
5190886|NCT02798367|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5190887|NCT02798367|melatonin|melatonin
5190888|NCT02798354|Depression|depression
5190889|NCT02798354|Blood Pressure|blood pressure
5190890|NCT02798354|Anemias, Iron-Deficiency|anemias, iron-deficiency
5190891|NCT02798354|Streptococcal Infections|streptococcal infections
5190892|NCT02798354|Sexually Transmitted Diseases|sexually transmitted diseases
5190893|NCT02798354|Lead Poisoning, Nervous System, Childhood|lead poisoning, nervous system, childhood
5190894|NCT02798354|Thyrotropin|thyrotropin
5190895|NCT02798315|Paritaprevir/r - Ombitasvir, ± Dasabuvir|paritaprevir/r - ombitasvir, ± dasabuvir
5190896|NCT02798315|Sustained Virological Response|sustained virological response
5190897|NCT02798315|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5190898|NCT02798315|Observational Study|observational study
5190899|NCT02798315|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5190900|NCT02798315|Chronic Hepatitis C|chronic hepatitis c
5190901|NCT02798276|Myocardial infarction|myocardial infarction
5190902|NCT02798276|Cardiac regeneration|cardiac regeneration
5190903|NCT02798276|Cardiac surgery|cardiac surgery
5190904|NCT02798250|Type 1 diabetes|type 1 diabetes
5190905|NCT02798250|Artificial pancreas|artificial pancreas
5190906|NCT02798250|Closed-loop system|closed-loop system
5190907|NCT02798250|Postprandial glucose control|postprandial glucose control
5190908|NCT02798250|Hypoglycemia|hypoglycemia
5190909|NCT02798250|Insulin|insulin
5190910|NCT02798250|Glucagon|glucagon
5190911|NCT02798237|exercise|exercise
5190912|NCT02798237|walking|walking
5190913|NCT02798237|health|health
5190914|NCT02798224|Colorectal Cancer Screening|colorectal cancer screening
5190915|NCT02798224|CRC Screening|crc screening
5190916|NCT02798224|Rectum|rectum
5190917|NCT02798224|Colon|colon
5190918|NCT02798224|Screening|screening
5190919|NCT02798224|Populations at Risk|populations at risk
5190920|NCT02798224|CRC|crc
5190921|NCT02798224|colorectal cancer (CRC)|colorectal cancer (crc)
5190922|NCT02798211|PsA, ACR, CASPAR|psa, acr, caspar
5190923|NCT02798159|Sexual Dysfunction|sexual dysfunction
5190924|NCT02798159|Physiological Sexual Dysfunctions|physiological sexual dysfunctions
5190925|NCT02798159|Psychological Sexual and Gender Disorders|psychological sexual and gender disorders
5178944|NCT02871791|Her2-negative metastatic breast cancer|her2-negative metastatic breast cancer
5178952|NCT02871752|MBSR|mbsr
5190926|NCT02798159|Sildenafil|sildenafil
5190927|NCT02798146|in-vitro fertilization|in-vitro fertilization
5190928|NCT02798146|luteal phase|luteal phase
5799381|NCT00109772|Pain|pain
5190939|NCT02798003|Food reward|food reward
5190940|NCT02797990|[G08.686.785.760.769.500]|[g08.686.785.760.769.500]
5190941|NCT02797990|[G08.686.785.760.769]|[g08.686.785.760.769]
5190942|NCT02797990|[N02.360]|[n02.360]
5190943|NCT02797990|[C25.775.650]|[c25.775.650]
5190944|NCT02797990|[C25.775.793]|[c25.775.793]
5190945|NCT02797990|[C25.775.635]|[c25.775.635]
5190946|NCT02797990|[C25.775.675]|[c25.775.675]
5190947|NCT02797990|[C25.775.300]|[c25.775.300]
5190948|NCT02797990|[C25.775.467]|[c25.775.467]
5190949|NCT02797990|[C25.775.225]|[c25.775.225]
5190950|NCT02797990|[C25.775.100]|[c25.775.100]
5190951|NCT02797990|[C25.775]|[c25.775]
5190952|NCT02797977|Replication Stress|replication stress
5190953|NCT02797977|Advanced solid tumors|advanced solid tumors
5190954|NCT02797977|CCNE1|ccne1
5190955|NCT02797977|TP53|tp53
5190956|NCT02797977|BRCA1|brca1
5190957|NCT02797977|BRCA2|brca2
5190959|NCT02797977|RAD50|rad50
5190960|NCT02797977|Fanconi anemia|fanconi anemia
5190961|NCT02797977|Cell Cycle|cell cycle
5190962|NCT02797977|High grade serious ovarian cancer|high grade serious ovarian cancer
5190963|NCT02797977|Small cell lung cancer|small cell lung cancer
5190964|NCT02797977|Soft tissue sarcoma|soft tissue sarcoma
5190965|NCT02797977|Cervical/anogenital cancer|cervical/anogenital cancer
5190966|NCT02797977|Phase 1|phase 1
5190967|NCT02797977|Phase 2|phase 2
5190968|NCT02797977|Dose escalation|dose escalation
5190969|NCT02797977|Chk1 inhibitor|chk1 inhibitor
5190970|NCT02797977|Checkpoint Kinase 1|checkpoint kinase 1
5190971|NCT02797977|Synthetic lethality|synthetic lethality
5190972|NCT02797977|Next-Generation Sequencing|next-generation sequencing
5190973|NCT02797977|Genetic biomarkers|genetic biomarkers
5190974|NCT02797964|Replication stress|replication stress
5190975|NCT02797964|Advanced solid tumors|advanced solid tumors
5190976|NCT02797964|CCNE1|ccne1
5190977|NCT02797964|TP53|tp53
5190983|NCT02797964|Cell cycle|cell cycle
5190984|NCT02797964|Metastatic Colorectal Cancer|metastatic colorectal cancer
5190985|NCT02797964|Platinum-Resistant or Intolerant High Grade Serious Ovarian Cancer|platinum-resistant or intolerant high grade serious ovarian cancer
5190986|NCT02797964|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5190987|NCT02797964|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5962390|NCT04281160|working memory test|working memory test
5190988|NCT02797964|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5190989|NCT02797964|Squamous Cell Carcinoma of the Anus|squamous cell carcinoma of the anus
5190990|NCT02797964|Phase 1|phase 1
5190991|NCT02797964|Phase 2|phase 2
5190992|NCT02797964|Dose escalation|dose escalation
5190993|NCT02797964|Chk1 inhibitor|chk1 inhibitor
5190994|NCT02797964|Checkpoint kinase 1|checkpoint kinase 1
5190995|NCT02797964|Synthetic lethality|synthetic lethality
5190996|NCT02797964|Next-Generation Sequencing|next-generation sequencing
5190997|NCT02797964|Genetic biomarkers|genetic biomarkers
5191008|NCT02797925|Achilles tendon|achilles tendon
5191009|NCT02797925|Patella tendon|patella tendon
5191010|NCT02797925|Inflammation|inflammation
5191011|NCT02797925|Edema|edema
5191012|NCT02797925|Clinical|clinical
5191013|NCT02797925|Structural|structural
5191014|NCT02797912|pulmonary function|pulmonary function
5191015|NCT02797912|respiratory muscle function|respiratory muscle function
5191016|NCT02797912|body composition|body composition
5191017|NCT02797912|exercise tolerance|exercise tolerance
5191018|NCT02797886|Hemiplegia|hemiplegia
5191019|NCT02797886|Drop foot|drop foot
5191020|NCT02797886|Foot drop|foot drop
5191021|NCT02797860|Transabdominal cervicoisthmic cerclage|transabdominal cervicoisthmic cerclage
5191022|NCT02797860|Rocuronium|rocuronium
5191023|NCT02797860|Pregnant Women|pregnant women
5191024|NCT02797847|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
5191025|NCT02797847|Amyloidosis, Hereditary|amyloidosis, hereditary
5191026|NCT02797847|Amyloid Neuropathies, Familial|amyloid neuropathies, familial
5191027|NCT02797847|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
5191028|NCT02797847|Amyloid Neuropathies|amyloid neuropathies
5191029|NCT02797847|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
5191030|NCT02797847|Familial Amyloidosis|familial amyloidosis
5191031|NCT02797847|RNAi therapeutic|rnai therapeutic
5191032|NCT02797834|Extracellular vesicles|extracellular vesicles
5191033|NCT02797834|Endometrial fluid|endometrial fluid
5191034|NCT02797834|Menstrual cycle|menstrual cycle
5191035|NCT02797834|Exosomes|exosomes
5191036|NCT02797834|Microvesicles|microvesicles
5191037|NCT02797834|Apoptotic bodies|apoptotic bodies
5191039|NCT02797821|asfotase alfa|asfotase alfa
5191040|NCT02797808|OCD|ocd
5191041|NCT02797743|Healthy Volunteers|healthy volunteers
5191042|NCT02797730|Art Therapy|art therapy
5191043|NCT02797730|Caregiver's|caregiver's
5191044|NCT02797691|Cognitive Behavior Therapy|cognitive behavior therapy
5191045|NCT02797691|Depression|depression
5191046|NCT02797691|Anxiety|anxiety
5191047|NCT02797691|Pashto|pashto
5191048|NCT02797691|Pakistani|pakistani
5191049|NCT02797691|Afghan|afghan
5191050|NCT02797652|Breast cancer|breast cancer
5191051|NCT02797652|ctDNA|ctdna
5191052|NCT02797652|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5191053|NCT02797652|Adjuvant chemotherapy|adjuvant chemotherapy
5191054|NCT02797639|Intellectual Disability|intellectual disability
5191055|NCT02797639|Collaborative Consultation|collaborative consultation
5191056|NCT02797639|Participation|participation
5191057|NCT02797600|Appalachia|appalachia
5191058|NCT02797587|Alcohol Use|alcohol use
5191059|NCT02797587|Tobacco Use|tobacco use
5191060|NCT02797587|Smoking|smoking
5191061|NCT02797587|Inflammation|inflammation
5191062|NCT02797587|Coronary Heart Disease|coronary heart disease
5191063|NCT02797587|Russia|russia
5191064|NCT02797587|Varenicline|varenicline
5191065|NCT02797587|Cytisine|cytisine
5191066|NCT02797587|Nicotine Replacement Therapy|nicotine replacement therapy
5191067|NCT02797587|Partial Agonist Therapy|partial agonist therapy
5191068|NCT02797587|HIV|hiv
5191069|NCT02797587|Reynolds risk score|reynolds risk score
5191070|NCT02797587|VACS index|vacs index
5191071|NCT02797561|Fractional flow reserve|fractional flow reserve
5191073|NCT02797561|Percutaneous Coronary Intervention|percutaneous coronary intervention
5191074|NCT02797548|drug-eluting stent|drug-eluting stent
5191075|NCT02797548|antiplatelet therapy|antiplatelet therapy
5191076|NCT02797548|noncardiac surgery|noncardiac surgery
5191077|NCT02797509|Intensive Care Unit|intensive care unit
5191078|NCT02797496|Parkinson's disease|parkinson's disease
5191079|NCT02797496|Mild to moderate stage|mild to moderate stage
5191080|NCT02797496|Asymmetric Motor Strengthening|asymmetric motor strengthening
5191081|NCT02797496|Rehabilitation|rehabilitation
5191082|NCT02797457|Bilateral amputation of the forearms|bilateral amputation of the forearms
5191085|NCT02797457|Medical economic evaluation|medical economic evaluation
5191086|NCT02797418|Attentional disorders, intellectual deficiency|attentional disorders, intellectual deficiency
5191087|NCT02797405|radiation therapy|radiation therapy
5191088|NCT02797405|radiosensitivity|radiosensitivity
5191089|NCT02797405|in vitro diagnostic medical devices|in vitro diagnostic medical devices
5191090|NCT02797405|Adverse Event post radiotherapy|adverse event post radiotherapy
5191091|NCT02797392|Tailored lifestyle intervention|tailored lifestyle intervention
5191092|NCT02797392|Selective prevention|selective prevention
5191093|NCT02797392|Primary care|primary care
5191094|NCT02797392|Web based health risk assessment|web based health risk assessment
5962391|NCT04281160|Contrast Sensitivity|contrast sensitivity
5113013|NCT03290469|ICU|icu
5191095|NCT02797392|Patient-centered health information system|patient-centered health information system
5191096|NCT02797392|Lifestyle intervention|lifestyle intervention
5191097|NCT02797392|preventive treatment|preventive treatment
5191098|NCT02797379|Psychoeducation|psychoeducation
5191099|NCT02797379|Self-help|self-help
5191100|NCT02797327|Molecular signature|molecular signature
5191101|NCT02797327|Thailand-Myanmar border|thailand-myanmar border
5191102|NCT02797314|Type 2 diabetes|type 2 diabetes
5191103|NCT02797314|Bone quality|bone quality
5191104|NCT02797314|Bone biopsies|bone biopsies
5191105|NCT02797314|Vertebral fractures|vertebral fractures
5191106|NCT02797314|Osteodensitometry|osteodensitometry
5191107|NCT02797314|Trabecular Bone Score|trabecular bone score
5191108|NCT02797301|early reading skills|early reading skills
5191109|NCT02797249|preeclampsia|preeclampsia
5191110|NCT02797249|low dose aspirin|low dose aspirin
5191111|NCT02797249|prevention|prevention
5191112|NCT02797236|Phase I|phase i
5191113|NCT02797236|conjugate vaccine|conjugate vaccine
5191114|NCT02797236|Shigella flexneri 2a|shigella flexneri 2a
5191115|NCT02797236|safety|safety
5191116|NCT02797236|Immunogenicity|immunogenicity
5191117|NCT02797236|Healthy adults|healthy adults
5191118|NCT02797223|alopecia|alopecia
5191119|NCT02797223|chemotherapy|chemotherapy
5191120|NCT02797223|breast cancer|breast cancer
5191121|NCT02797158|TAVI|tavi
5799382|NCT00109772|CC-5013|cc-5013
5191122|NCT02797158|Aortic stenosis|aortic stenosis
5191123|NCT02797158|Coronary artery disease|coronary artery disease
5191124|NCT02797158|Coronary angiography|coronary angiography
5191125|NCT02797158|Percutaneous Coronary Intervention|percutaneous coronary intervention
5191126|NCT02797158|Myocardial ischemia|myocardial ischemia
5191128|NCT02797158|Coronary revascularization|coronary revascularization
5191129|NCT02797145|Digoxin|digoxin
5191130|NCT02797132|CF|cf
5191131|NCT02797119|Tranexamic acid|tranexamic acid
5191132|NCT02797119|Fibrinolysis|fibrinolysis
5191133|NCT02797119|Cesarean section|cesarean section
5191134|NCT02797119|Pharmacokinetics|pharmacokinetics
5191135|NCT02797119|D dimers|d dimers
5191136|NCT02797119|Fibrinogen|fibrinogen
5191137|NCT02797119|Plasmin|plasmin
5191138|NCT02797119|Transfusion|transfusion
5191139|NCT02797106|Drooling|drooling
5191140|NCT02797106|Cerebral palsy|cerebral palsy
5191141|NCT02797106|Botulinium toxin|botulinium toxin
5191142|NCT02797106|Practice survey of health professionals|practice survey of health professionals
5191143|NCT02797106|Children|children
5191144|NCT02797093|anti-retroviral therapy|anti-retroviral therapy
5191145|NCT02797080|ACTIMMUNE|actimmune
5191146|NCT02797080|interferon y-1b|interferon y-1b
5191147|NCT02797067|Extracorporeal Shock Wave lithotripsy(ESWL)|extracorporeal shock wave lithotripsy(eswl)
5191148|NCT02797067|Prophylaxis|prophylaxis
5191149|NCT02797067|Indomethacin|indomethacin
5191150|NCT02797067|Chronic pancreatitis|chronic pancreatitis
5191151|NCT02797054|HPV vaccination|hpv vaccination
5191152|NCT02797054|Vaccination decision-making|vaccination decision-making
5191153|NCT02797054|Tailored health messaging|tailored health messaging
5191154|NCT02797054|Barriers to vaccination|barriers to vaccination
5191155|NCT02797054|Attitudes|attitudes
5191156|NCT02797041|Multiple myeloma|multiple myeloma
5191157|NCT02797041|Bortezomib|bortezomib
5191158|NCT02797041|Relapsed multiple myeloma|relapsed multiple myeloma
5191159|NCT02797041|Rechallenge|rechallenge
5191160|NCT02797028|Hyperuricemia|hyperuricemia
5191161|NCT02797028|endothelial function|endothelial function
5191162|NCT02797028|anthocyanidins|anthocyanidins
5191164|NCT02797015|RMS|rms
5191165|NCT02797015|Multiple Sclerosis|multiple sclerosis
5191166|NCT02797015|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5191167|NCT02796976|arterial stiffness|arterial stiffness
5191168|NCT02796976|retinal vessels|retinal vessels
5191169|NCT02796976|physical activity|physical activity
5191170|NCT02796976|ageing|ageing
5191171|NCT02796963|HIV|hiv
5191172|NCT02796963|MSM|msm
5191173|NCT02796963|test uptake|test uptake
5191174|NCT02796963|crowdsourcing|crowdsourcing
5191175|NCT02796950|Acipimox|acipimox
5191176|NCT02796950|GLP-1|glp-1
5191177|NCT02796950|Insulin secretion|insulin secretion
5191178|NCT02796937|Pulmonary Emphysema|pulmonary emphysema
5191179|NCT02796937|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5191180|NCT02796937|AATD|aatd
5191181|NCT02796937|Alpha-1 PI Deficiency|alpha-1 pi deficiency
5191182|NCT02796937|Alpha-1 Proteinase Inhibitor|alpha-1 proteinase inhibitor
5191183|NCT02796924|Psychogenic Non-Epileptic Seizure|psychogenic non-epileptic seizure
5191184|NCT02796924|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5191185|NCT02796924|Brain Stimulation|brain stimulation
5191186|NCT02796898|Prostate Cancer|prostate cancer
5191187|NCT02796898|PSA|psa
5191188|NCT02796898|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
5191189|NCT02796859|Inflammation|inflammation
5191190|NCT02796859|Psychosis|psychosis
5191191|NCT02796859|Schizophrenia|schizophrenia
5962392|NCT04281160|Coded Message Cognitive Test|coded message cognitive test
5191192|NCT02796846|CPAP (continuous positive airway pressure)|cpap (continuous positive airway pressure)
5191193|NCT02796846|OSA (Obstructive sleep apnea)|osa (obstructive sleep apnea)
5191194|NCT02796833|Home parenteral nutrition|home parenteral nutrition
5191195|NCT02796833|Liver injury|liver injury
5191196|NCT02796833|Intravenous Lipid Emulsions|intravenous lipid emulsions
5191197|NCT02796833|Catheter-related infections|catheter-related infections
5191198|NCT02796833|Safety|safety
5191199|NCT02796820|Huaier Granule|huaier granule
5191200|NCT02796820|After radical surgery|after radical surgery
5191201|NCT02796820|Prevention of Recurrence and Metastasis|prevention of recurrence and metastasis
5191202|NCT02796820|Efficacy and safety|efficacy and safety
5191203|NCT02796794|Enteral nutrition|enteral nutrition
5191204|NCT02796794|Genistein|genistein
5191205|NCT02796794|Cytokine|cytokine
5191206|NCT02796755|Central Nervous System (CNS) Glutamate|central nervous system (cns) glutamate
5191207|NCT02796755|Breast Cancer Treatment|breast cancer treatment
5191208|NCT02796755|Fatigue|fatigue
5191209|NCT02796755|Cognitive Dysfunction|cognitive dysfunction
5191210|NCT02796755|Behavioral|behavioral
5191211|NCT02796755|Psychometrics|psychometrics
5191212|NCT02796755|Imaging Technology|imaging technology
5191213|NCT02796755|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5191214|NCT02796742|SSTIs|sstis
5191215|NCT02796742|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5191216|NCT02796742|Methicillin susceptible Staphylococcus aureus (MSSA)|methicillin susceptible staphylococcus aureus (mssa)
5191217|NCT02796742|the toxin Panton-Valentine Leukocidin (PVL)|the toxin panton-valentine leukocidin (pvl)
5191218|NCT02796742|Emergency Departments|emergency departments
5191219|NCT02796716|Wounded warriors|wounded warriors
5191220|NCT02796716|Battlefield infection|battlefield infection
5191221|NCT02796716|ESBL|esbl
5191222|NCT02796716|MRSA|mrsa
5191224|NCT02796690|nasal carriage|nasal carriage
5191225|NCT02796690|Staphylococcus aureus|staphylococcus aureus
5191226|NCT02796690|good hygiene practices|good hygiene practices
5191227|NCT02796677|Safety|safety
5191228|NCT02796677|Efficacy|efficacy
5191229|NCT02796677|Aclidinium bromide|aclidinium bromide
5191230|NCT02796677|Formoterol fumarate|formoterol fumarate
5191231|NCT02796677|Tiotropium|tiotropium
5179235|NCT02869815|Indocyanine green|indocyanine green
5179236|NCT02869815|Neoadjuvant Therapy|neoadjuvant therapy
5179237|NCT02869815|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5179239|NCT02869802|Cancer|cancer
5191232|NCT02796677|Bronchodilation|bronchodilation
5191233|NCT02796677|COPD|copd
5191234|NCT02796664|Ginseng|ginseng
5191235|NCT02796664|Stroke|stroke
5191236|NCT02796664|Quantitative MR flow analysis|quantitative mr flow analysis
5191237|NCT02796651|Perforomist|perforomist
5191238|NCT02796651|Pressair|pressair
5191239|NCT02796651|COPD|copd
5191240|NCT02796651|Cigarette smoking|cigarette smoking
5191241|NCT02796651|Formoterol fumarate|formoterol fumarate
5191242|NCT02796651|long-acting β2-adrenergic agonists (LABA)|long-acting β2-adrenergic agonists (laba)
5191243|NCT02796651|long-acting muscarinic antagonists (LAMA)|long-acting muscarinic antagonists (lama)
5191244|NCT02796638|Acute Heart Failure|acute heart failure
5191245|NCT02796638|Positive-Pressure Ventilation|positive-pressure ventilation
5191246|NCT02796638|Adaptive Servo-Ventilation|adaptive servo-ventilation
5191247|NCT02796625|EEG|eeg
5191248|NCT02796625|healthy subjects|healthy subjects
5191249|NCT02796612|anxiety|anxiety
5191250|NCT02796612|breast cancer, suspected|breast cancer, suspected
5191251|NCT02796612|breast biopsy|breast biopsy
5191252|NCT02796612|empathy|empathy
5191253|NCT02796612|standardized and structured information|standardized and structured information
5191254|NCT02796612|anxiety reduction|anxiety reduction
5191255|NCT02796586|Refugee Health|refugee health
5191256|NCT02796586|Resettled Refugee|resettled refugee
5191257|NCT02796586|Family Planning|family planning
5191258|NCT02796586|Contraception|contraception
5191259|NCT02796586|Group Counseling|group counseling
5191260|NCT02796586|Group contraceptive counseling|group contraceptive counseling
5191261|NCT02796573|blended care|blended care
5191262|NCT02796573|CBT|cbt
5191263|NCT02796573|B-CBT|b-cbt
5191264|NCT02796573|depression|depression
5191266|NCT02796560|Generic Equivalency|generic equivalency
5191267|NCT02796547|Episiotomy|episiotomy
5191268|NCT02796547|Levobupivacaine|levobupivacaine
5191269|NCT02796534|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5191270|NCT02796521|malnutrition|malnutrition
5191271|NCT02796521|aging|aging
5191272|NCT02796521|diet therapy|diet therapy
5862726|NCT00001534|Genetics|genetics
5191277|NCT02796508|Working memory|working memory
5191278|NCT02796508|Wellbeing|wellbeing
5191279|NCT02796495|Neuroplasticity|neuroplasticity
5191280|NCT02796495|Sensory Feedback|sensory feedback
5191281|NCT02796495|Nerve stimulation|nerve stimulation
5191282|NCT02796495|Robotic Hand|robotic hand
5191283|NCT02796456|apelin|apelin
5191284|NCT02796456|colostrum|colostrum
5191285|NCT02796456|plasma|plasma
5191286|NCT02796456|glycemic markers|glycemic markers
5191287|NCT02796456|lipidic markers|lipidic markers
5191288|NCT02796456|pregnancy|pregnancy
5191289|NCT02796456|postpartum|postpartum
5191290|NCT02796443|acute cholecystitis|acute cholecystitis
5191291|NCT02796443|early versus delayed surgery|early versus delayed surgery
5191292|NCT02796430|Indirect calorimetry|indirect calorimetry
5191293|NCT02796430|critical care|critical care
5191294|NCT02796430|mechanical ventilation|mechanical ventilation
5191295|NCT02796430|energy expenditure|energy expenditure
5191296|NCT02796430|ICALIC study|icalic study
5191297|NCT02796404|home monitoring|home monitoring
5191298|NCT02796404|cardiac monitoring|cardiac monitoring
5191299|NCT02796391|nicotine|nicotine
5191300|NCT02796391|cigarettes|cigarettes
5191301|NCT02796391|very low nicotine content (VLNC)|very low nicotine content (vlnc)
5191302|NCT02796391|smoking cessation|smoking cessation
5191303|NCT02796378|physical activity|physical activity
5191304|NCT02796378|statin therapy|statin therapy
5191305|NCT02796378|diabetes mellitus|diabetes mellitus
5191306|NCT02796378|cardiovascular disease|cardiovascular disease
5191307|NCT02796378|Q10-supplementation|q10-supplementation
5191308|NCT02796365|Exercise|exercise
5191309|NCT02796365|Cancer|cancer
5191310|NCT02796365|Cardiotoxicity|cardiotoxicity
5191311|NCT02796365|Cardiomyopathy|cardiomyopathy
5191312|NCT02796365|Cardiac Rehabilitation|cardiac rehabilitation
5191313|NCT02796339|Inflammatory Bowel Diseases|inflammatory bowel diseases
5940381|NCT00674479|Advanced Hematologic Malignancies|advanced hematologic malignancies
5191314|NCT02796339|natural Mastiha|natural mastiha
5191315|NCT02796339|supplement|supplement
5191316|NCT02796326|tracheal stenosis|tracheal stenosis
5191317|NCT02796326|tracheal dilatation|tracheal dilatation
5191319|NCT02796300|bioflo|bioflo
5191320|NCT02796300|Duramax catheter|duramax catheter
5191321|NCT02796300|dialysis|dialysis
5191322|NCT02796287|Amnesia|amnesia
5191323|NCT02796287|transient global amnesia|transient global amnesia
5191324|NCT02796261|Anaplastic Astrocytoma|anaplastic astrocytoma
5191325|NCT02796261|Grade 3 Glioma|grade 3 glioma
5191326|NCT02796261|Glioma|glioma
5940382|NCT00674479|Cancer|cancer
5191327|NCT02796261|Eflornithine|eflornithine
5191328|NCT02796261|Brain Cancer|brain cancer
5191329|NCT02796261|Brain Tumor|brain tumor
5191330|NCT02796261|Neuro-oncology|neuro-oncology
5191331|NCT02796261|Progressive Anaplastic Astrocytoma|progressive anaplastic astrocytoma
5191332|NCT02796261|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
5191333|NCT02796261|Progressive Glioma|progressive glioma
5191334|NCT02796261|Recurrent Glioma|recurrent glioma
5191335|NCT02796261|Malignant Glioma|malignant glioma
5191336|NCT02796261|Progressive Brain Tumor|progressive brain tumor
5191337|NCT02796261|Recurrent Brain Tumor|recurrent brain tumor
5191338|NCT02796248|type 1 diabetes|type 1 diabetes
5191339|NCT02796248|glucose control|glucose control
5191341|NCT02796248|youth|youth
5191342|NCT02796222|Hemophilia|hemophilia
5191343|NCT02796222|Recombinant factor VIII|recombinant factor viii
5191344|NCT02796222|Recombinant factor VIII Fc|recombinant factor viii fc
5191345|NCT02796222|Recombinant factor IX|recombinant factor ix
5191346|NCT02796222|Patient-reported outcomes|patient-reported outcomes
5191347|NCT02796222|Recombinant factor IX Fc|recombinant factor ix fc
5191348|NCT02796209|atomoxetine|atomoxetine
5191349|NCT02796209|autonomic failure|autonomic failure
5191350|NCT02796196|Hematopoietic|hematopoietic
5191351|NCT02796196|Recipient|recipient
5191352|NCT02796170|SGLT-2 inhibitor|sglt-2 inhibitor
5191353|NCT02796170|urinary angiotensinogen|urinary angiotensinogen
5191354|NCT02796157|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease|bioresorbable vascular scaffold, drug eluting stent, coronary artery disease
5191355|NCT02796144|schizophrenia|schizophrenia
5191356|NCT02796144|schizoaffective disorder|schizoaffective disorder
5191357|NCT02796144|overweight|overweight
5191358|NCT02796144|obesity|obesity
5191359|NCT02796144|weight loss|weight loss
5191360|NCT02796144|metformin|metformin
5191361|NCT02796144|lorcaserin|lorcaserin
5191362|NCT02796131|Phase I|phase i
5191363|NCT02796131|Healthy|healthy
5191364|NCT02796131|Pharmacodynamics|pharmacodynamics
5191365|NCT02796118|Pharmacokinetics|pharmacokinetics
5423230|NCT01616589|CGG repeat length|cgg repeat length
5191366|NCT02796118|Healthy non-elderly and elderly subjects|healthy non-elderly and elderly subjects
5191367|NCT02796118|ASP2151|asp2151
5191369|NCT02796092|Pelvic Congestion Syndrome|pelvic congestion syndrome
5191370|NCT02796092|Pelvic Venous Insufficiency|pelvic venous insufficiency
5191371|NCT02796092|Chronic pelvic pain|chronic pelvic pain
5191372|NCT02796066|Acne, topical, SCD-1 inhibitor, moderate, severe|acne, topical, scd-1 inhibitor, moderate, severe
5191373|NCT02796040|Parkinson's disease|parkinson's disease
5191374|NCT02796040|Impulse control disorders|impulse control disorders
5191375|NCT02796040|Diffusion tensor imaging|diffusion tensor imaging
5191376|NCT02796040|MRI|mri
5191377|NCT02796040|Mesocorticolimbic pathway|mesocorticolimbic pathway
5191378|NCT02796027|Health Services Research|health services research
5191379|NCT02795988|Secondary|secondary
5191380|NCT02795962|Endovascular Procedures|endovascular procedures
5191381|NCT02795962|Emergency Medical Services|emergency medical services
5191382|NCT02795949|Enterobacteriaceae|enterobacteriaceae
5191383|NCT02795949|Bacteremia|bacteremia
5191384|NCT02795949|Escalation|escalation
5113371|NCT03288298|PCR|pcr
5191385|NCT02795949|Bacterial resistance|bacterial resistance
5191386|NCT02795949|Bloodstream infection|bloodstream infection
5191387|NCT02795949|Recurrence|recurrence
5191388|NCT02795936|rehabilitation|rehabilitation
5191389|NCT02795936|exercise|exercise
5191390|NCT02795897|genetics|genetics
5191391|NCT02795897|genomics|genomics
5191392|NCT02795897|amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5191393|NCT02795897|primary lateral sclerosis (PLS)|primary lateral sclerosis (pls)
5191394|NCT02795897|progressive muscular atrophy (PMA)|progressive muscular atrophy (pma)
5191395|NCT02795897|motor neuron disease|motor neuron disease
5191396|NCT02795884|Lung cancer|lung cancer
5191397|NCT02795884|NSCLC|nsclc
5191398|NCT02795884|adjuvant treatment|adjuvant treatment
5191399|NCT02795871|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5191400|NCT02795871|Prenatal treatment|prenatal treatment
5191401|NCT02795871|Dexamethasone|dexamethasone
5191402|NCT02795871|Neuropsychological assessment|neuropsychological assessment
5191403|NCT02795871|Cognitive development|cognitive development
5191404|NCT02795858|Carcinoid Tumors|carcinoid tumors
5191406|NCT02795793|appendicitis|appendicitis
5081368|NCT03490448|obesity|obesity
5191407|NCT02795793|non-operative management|non-operative management
5191408|NCT02795793|children|children
5191409|NCT02795793|pediatric|pediatric
5191410|NCT02795754|GSK2838232|gsk2838232
5191411|NCT02795754|HIV|hiv
5191412|NCT02795754|repeated dose escalation|repeated dose escalation
5191413|NCT02795754|immediate release tablet|immediate release tablet
5191416|NCT02795702|tDCS|tdcs
5191417|NCT02795676|Glomerular filtration rate|glomerular filtration rate
5191418|NCT02795676|Proteinuria|proteinuria
5191419|NCT02795676|PRX-102|prx-102
5191420|NCT02795676|pegunigalsidase alfa|pegunigalsidase alfa
5191421|NCT02795676|Fabry Disease|fabry disease
5191422|NCT02795663|Near-InfraRed Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5940383|NCT00674479|Blood|blood
5940384|NCT00674479|Bone marrow|bone marrow
5191423|NCT02795663|Deep brain stimulation of SubThalamic Nucleus (DBS)|deep brain stimulation of subthalamic nucleus (dbs)
5191424|NCT02795650|Metastatic|metastatic
5191425|NCT02795650|Pancreas|pancreas
5191426|NCT02795637|Attention deficit hyperactivity disorder (ADHD),|attention deficit hyperactivity disorder (adhd),
5191427|NCT02795637|Binge-Eating Disorder (BED)|binge-eating disorder (bed)
5191428|NCT02795611|Family-centered|family-centered
5191429|NCT02795611|Autism spectrum disorder|autism spectrum disorder
5191430|NCT02795611|Occupational therapy|occupational therapy
5191431|NCT02795611|Participation|participation
5191432|NCT02795611|Play|play
5191433|NCT02795585|Fractional Flow Reserve|fractional flow reserve
5191434|NCT02795585|Coronary Artery Disease|coronary artery disease
5191435|NCT02795572|Breast Neoplasms|breast neoplasms
5191436|NCT02795572|Peripheral Neuropathies|peripheral neuropathies
5191437|NCT02795559|Nutrition|nutrition
5191438|NCT02795559|Humans|humans
5191439|NCT02795559|Obesity|obesity
5191440|NCT02795559|Blood glucose|blood glucose
5191441|NCT02795559|Dietary fiber|dietary fiber
5191442|NCT02795559|Appetite|appetite
5191443|NCT02795559|Short chain fatty acids|short chain fatty acids
5191444|NCT02795546|periodontal regeneration|periodontal regeneration
5191445|NCT02795533|Cognitive function|cognitive function
5191446|NCT02795533|Quality of Life|quality of life
5191447|NCT02795507|cross education|cross education
5191448|NCT02795507|visual feedback|visual feedback
5191449|NCT02795468|Peripheral|peripheral
5191450|NCT02795468|Arterial|arterial
5191451|NCT02795468|Catheterization|catheterization
5191452|NCT02795455|Eating Disorders|eating disorders
5191453|NCT02795455|Food Avoidance|food avoidance
5191454|NCT02795455|Reward Learning|reward learning
5191455|NCT02795455|Reward System|reward system
5191456|NCT02795455|Family-based treatment|family-based treatment
5191457|NCT02795455|interoceptive exposure|interoceptive exposure
5191458|NCT02795455|insula-amygdala-ventral striatum subcircuits|insula-amygdala-ventral striatum subcircuits
5191459|NCT02795429|Phase Ib/II|phase ib/ii
5191460|NCT02795429|INC280|inc280
5191461|NCT02795429|PDR001|pdr001
5191462|NCT02795429|checkpoint inhibitor|checkpoint inhibitor
5191463|NCT02795429|PD-1|pd-1
5423231|NCT01616576|cochlear implant|cochlear implant
5191464|NCT02795416|Moderate to severe plaque psoriasis, PASI, secukinumab, monoclonal antibody, Turkish population|moderate to severe plaque psoriasis, pasi, secukinumab, monoclonal antibody, turkish population
5191465|NCT02795403|HCV, liver|hcv, liver
5191466|NCT02795390|Chinese herbal medicine formula|chinese herbal medicine formula
5191467|NCT02795390|MaZiRenWan|mazirenwan
5191468|NCT02795390|Randomized controlled trial|randomized controlled trial
5191469|NCT02795390|Constipation|constipation
5191470|NCT02795390|Palliative care in cancer|palliative care in cancer
5191471|NCT02795377|arterial hypertension|arterial hypertension
5191472|NCT02795377|microparticle|microparticle
5191473|NCT02795377|endothelial function|endothelial function
5191474|NCT02795364|High Grade Glioma|high grade glioma
5191475|NCT02795364|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5191476|NCT02795364|Surgical resection|surgical resection
5191477|NCT02795364|Prognosis|prognosis
5962393|NCT04281160|Fine motor function|fine motor function
5066780|NCT03581565|dental implant|dental implant
5066781|NCT03581565|crown|crown
5191478|NCT02795325|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
5191480|NCT02795325|Calcium Oxalate Stones|calcium oxalate stones
5191481|NCT02795325|Kidney Stones|kidney stones
5191482|NCT02795325|Liver Enzyme Deficiency|liver enzyme deficiency
5191483|NCT02795325|Genetic Diseases|genetic diseases
5191484|NCT02795325|Inborn Kidney Diseases|inborn kidney diseases
5191485|NCT02795325|Metabolic Diseases|metabolic diseases
5191486|NCT02795325|Inborn Errors|inborn errors
5191487|NCT02795325|Urological Diseases|urological diseases
5191488|NCT02795325|Carbohydrate Metabolism|carbohydrate metabolism
5191489|NCT02795325|Hyperoxaluria|hyperoxaluria
5191490|NCT02795325|AGT|agt
5191491|NCT02795325|RNAi|rnai
5191492|NCT02795325|siRNA|sirna
5191493|NCT02795325|DCR-PH1|dcr-ph1
5191494|NCT02795312|Cigarette Smoking|cigarette smoking
5191495|NCT02795286|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5191496|NCT02795286|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5191497|NCT02795286|Chronic Hemodialysis|chronic hemodialysis
5191498|NCT02795286|In-center HD|in-center hd
5191499|NCT02795286|Sodium|sodium
5191500|NCT02795286|Isotonic Dialysis|isotonic dialysis
5191501|NCT02795273|Rhinitis|rhinitis
5191502|NCT02795273|Conjunctivitis|conjunctivitis
5191503|NCT02795273|Grass|grass
5191504|NCT02795273|Allergy|allergy
5191505|NCT02795260|ESAT6|esat6
5191506|NCT02795260|CFP10|cfp10
5191507|NCT02795260|skin test|skin test
5191508|NCT02795260|diagnostic test|diagnostic test
5191511|NCT02795182|Relapsed|relapsed
5191512|NCT02795182|Refractory|refractory
5191513|NCT02795156|regorafenib|regorafenib
5191514|NCT02795156|afatinib|afatinib
5191515|NCT02795156|targeted therapy|targeted therapy
5191516|NCT02795156|cabozantinib|cabozantinib
5191517|NCT02795143|TEN|ten
5191518|NCT02795104|RISE|rise
5191519|NCT02795091|clean supplies|clean supplies
5191520|NCT02795091|ICU floor|icu floor
5191521|NCT02795091|bacteria colony|bacteria colony
5191522|NCT02795091|catheter associated with infection|catheter associated with infection
5191523|NCT02795078|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
5191524|NCT02795078|Intracranial Aneurysms|intracranial aneurysms
5191525|NCT02795052|Neurologic Disease|neurologic disease
5191526|NCT02795052|Cerebral Vascular Accident|cerebral vascular accident
5191527|NCT02795052|Stroke|stroke
5191528|NCT02795052|Traumatic Brain Injury|traumatic brain injury
5191529|NCT02795052|Multiple Sclerosis|multiple sclerosis
5191530|NCT02795052|Parkinsons Disease|parkinsons disease
5191531|NCT02795052|Neuropathy|neuropathy
5191532|NCT02795052|Neurodegeneration|neurodegeneration
5191533|NCT02795052|Diabetic Neuropathy|diabetic neuropathy
5191534|NCT02795052|Cerebral Ischemia|cerebral ischemia
5191535|NCT02795026|dry needling|dry needling
5191536|NCT02795026|vulvodynia|vulvodynia
5191537|NCT02795026|pelvic pain chronic|pelvic pain chronic
5191538|NCT02795013|Genetic studies|genetic studies
5191539|NCT02795013|Pediatric|pediatric
5191540|NCT02795000|Primary Ovarian Insufficiency|primary ovarian insufficiency
5191541|NCT02795000|nomogram|nomogram
5191542|NCT02794987|Bile duct|bile duct
5191543|NCT02794987|indeterminate stricture|indeterminate stricture
5191544|NCT02794987|cholangioscopy|cholangioscopy
5191545|NCT02794987|Spyglass|spyglass
5191546|NCT02794948|primary ovarian insufficiency|primary ovarian insufficiency
5191547|NCT02794948|TCM intervention|tcm intervention
5191548|NCT02794935|inspiratory muscle training|inspiratory muscle training
5191549|NCT02794935|heart failure|heart failure
5191550|NCT02794935|obstructive sleep apnea|obstructive sleep apnea
5191551|NCT02794922|Vitamin B|vitamin b
5191552|NCT02794922|Temporomandibular joint disorder|temporomandibular joint disorder
5191553|NCT02794922|trpv1|trpv1
5191554|NCT02794909|Point-of-care ultrasound|point-of-care ultrasound
5191555|NCT02794909|ED|ed
5191556|NCT02794909|Low and middle-income country|low and middle-income country
5191557|NCT02794909|Echocardiography|echocardiography
5191558|NCT02794909|Lung ultrasound|lung ultrasound
5191559|NCT02794909|Resuscitation|resuscitation
5191560|NCT02794857|ALS|als
5191561|NCT02794857|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5191562|NCT02794857|Motor Neuron Disease|motor neuron disease
5191563|NCT02794857|Central Nervous System Diseases|central nervous system diseases
5191564|NCT02794857|Nervous System Diseases|nervous system diseases
5191565|NCT02794857|Neurodegenerative Diseases|neurodegenerative diseases
5191566|NCT02794857|Neuromuscular Diseases|neuromuscular diseases
5191567|NCT02794857|Inflammation|inflammation
5191568|NCT02794857|C-Reactive Protein|c-reactive protein
5191570|NCT02794831|Bacterial Infections|bacterial infections
5191571|NCT02794831|Severity|severity
5191572|NCT02794831|Self Medication|self medication
5962394|NCT04281160|Digit Modality test|digit modality test
5962395|NCT04281147|Metastatic castrate resistant prostate cancer mCRPC|metastatic castrate resistant prostate cancer mcrpc
5191573|NCT02794818|Prevention|prevention
5191574|NCT02794818|Nutrition|nutrition
5191575|NCT02794792|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5191576|NCT02794792|ASP1941|asp1941
5059036|NCT03630003|ICU|icu
5066886|NCT03580772|Total knee arthroplasty|total knee arthroplasty
5066887|NCT03580772|Gait analysis|gait analysis
5066888|NCT03580733|ICU|icu
5066889|NCT03580733|yeast intra abdominal infection|yeast intra abdominal infection
5191577|NCT02794792|Ipragliflozin|ipragliflozin
5191578|NCT02794779|cesarean section|cesarean section
5191579|NCT02794779|labor|labor
5191580|NCT02794779|oxytocin|oxytocin
5191581|NCT02794753|Trichotillomania|trichotillomania
5191582|NCT02794753|Hair-pulling Disorder|hair-pulling disorder
5191583|NCT02794753|Cognitive Training|cognitive training
5191584|NCT02794753|Neuroplasticity|neuroplasticity
5191585|NCT02794753|Working Memory|working memory
5191586|NCT02794740|Osteoarthritis|osteoarthritis
5191587|NCT02794714|Laparoscopic Gynecologic Surgeries|laparoscopic gynecologic surgeries
5191588|NCT02794688|Non-lactating|non-lactating
5191589|NCT02794688|idiopathic granulomatous mastitis|idiopathic granulomatous mastitis
5191590|NCT02794688|periductal mastitis|periductal mastitis
5191591|NCT02794688|ductal lavage|ductal lavage
5191592|NCT02794675|resectable|resectable
5191593|NCT02794675|Cesium 131|cesium 131
5191594|NCT02794675|brachytherapy|brachytherapy
5191595|NCT02794662|Oxygen Delivery System, Nasal Cannula|oxygen delivery system, nasal cannula
5191596|NCT02794662|Oxygen Delivery System, Incubator|oxygen delivery system, incubator
5191597|NCT02794623|cochlear implants|cochlear implants
5191598|NCT02794623|hearing loss|hearing loss
5191599|NCT02794610|Tacrolimus|tacrolimus
5191600|NCT02794610|Ocular penetration|ocular penetration
5191601|NCT02794610|Topical|topical
5191602|NCT02794597|Unplanned Pregnancy, LARC|unplanned pregnancy, larc
5191603|NCT02794558|Breast Cancer, MRgFus, Focused Ultrasound|breast cancer, mrgfus, focused ultrasound
5191604|NCT02794519|Asthma Control Questionnaire|asthma control questionnaire
5191605|NCT02794519|interleukin-6|interleukin-6
5191606|NCT02794519|Sirukumab|sirukumab
5342975|NCT01981317|Stepped Care CBT|stepped care cbt
5191607|NCT02794519|severe, poorly controlled asthma|severe, poorly controlled asthma
5191608|NCT02794519|asthma|asthma
5191610|NCT02794506|Diabetes mellitus|diabetes mellitus
5191611|NCT02794506|Chronic periodontitis|chronic periodontitis
5191612|NCT02794506|Propolis|propolis
5191613|NCT02794480|ELLIPTA|ellipta
5191614|NCT02794480|metered dose inhaler|metered dose inhaler
5191615|NCT02794480|Dry powder inhaler|dry powder inhaler
5191616|NCT02794467|Heavy menstrual bleeding|heavy menstrual bleeding
5191617|NCT02794467|Adenomyosis|adenomyosis
5191618|NCT02794467|Safety|safety
5179620|NCT02867098|volunteer|volunteer
5179621|NCT02867085|MDS|mds
5179623|NCT02867033|desmoid tumour|desmoid tumour
5191619|NCT02794467|Epelsiban|epelsiban
5191620|NCT02794467|Tolerability|tolerability
5191621|NCT02794467|Proof of concept|proof of concept
5191622|NCT02794428|Gastric adenocarcinoma|gastric adenocarcinoma
5191623|NCT02794428|Gastric intestinal metaplasia|gastric intestinal metaplasia
5191624|NCT02794428|Atrophic gastritis|atrophic gastritis
5191625|NCT02794428|Gastric premalignant lesion|gastric premalignant lesion
5191627|NCT02794415|disability|disability
5191628|NCT02794415|rehabilitation|rehabilitation
5191629|NCT02794415|exercise|exercise
5191630|NCT02794389|Acetylcysteine|acetylcysteine
5191632|NCT02794350|RBANS-H|rbans-h
5191633|NCT02794350|Cochlear implantation|cochlear implantation
5191634|NCT02794350|Cognition|cognition
5191635|NCT02794350|Older adults|older adults
5191636|NCT02794350|RBANS|rbans
5191637|NCT02794285|Lupus Erythematosus, Systemic Autoimmune Diseases, Connective Tissue Diseases,Immune System Diseases|lupus erythematosus, systemic autoimmune diseases, connective tissue diseases,immune system diseases
5191638|NCT02794272|GABA concentration|gaba concentration
5191639|NCT02794272|tDCS|tdcs
5191640|NCT02794259|GABA concentration|gaba concentration
5191641|NCT02794259|tDCS|tdcs
5191642|NCT02794233|Deep Brain Stimulation|deep brain stimulation
5191643|NCT02794233|Electric Impedance|electric impedance
5191644|NCT02794233|Parkinson disease|parkinson disease
5191645|NCT02794220|E-cigarette|e-cigarette
5191646|NCT02794220|healthy volunteer study|healthy volunteer study
5191647|NCT02794220|Pharmacokinetics|pharmacokinetics
5191648|NCT02794220|Nicorette|nicorette
5191649|NCT02794207|Pediatric|pediatric
5191650|NCT02794207|Cancer|cancer
5191651|NCT02794207|AML|aml
5191652|NCT02794207|Qualitative Interview|qualitative interview
5191653|NCT02794194|Chronic Ankle Instability|chronic ankle instability
5191654|NCT02794194|Whole Body Vibration|whole body vibration
5191655|NCT02794194|Proprioception|proprioception
5191656|NCT02794181|Transfusion-Transmitted Infections|transfusion-transmitted infections
5191657|NCT02794181|Dengue Virus|dengue virus
5191658|NCT02794181|Chikungunya Virus|chikungunya virus
5191659|NCT02794181|Natural History|natural history
5191660|NCT02794181|Blood Transfusion|blood transfusion
5191661|NCT02794142|hemodialysis|hemodialysis
5191662|NCT02794142|muscle dysfunction|muscle dysfunction
5191663|NCT02794142|mitochondria|mitochondria
5962396|NCT04281134|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5962397|NCT04281134|Treatment Resistant OCD|treatment resistant ocd
5962398|NCT04281134|Intractable OCD|intractable ocd
5962399|NCT04281134|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5962400|NCT04281134|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
5191664|NCT02794142|oxidative stress|oxidative stress
5191665|NCT02794142|inflammation|inflammation
5191666|NCT02794142|renal transplantation|renal transplantation
5191667|NCT02794103|Virtual reality|virtual reality
5191668|NCT02794103|Immersive distraction|immersive distraction
5191669|NCT02794103|Virtual world|virtual world
5191670|NCT02794103|Virtual environment|virtual environment
5191671|NCT02794103|Procedural pain|procedural pain
5191672|NCT02794103|Procedural anxiety|procedural anxiety
5191673|NCT02794103|Acute pain|acute pain
5191674|NCT02794103|Pain management|pain management
5191675|NCT02794103|Anxiety|anxiety
5191676|NCT02794103|Children, Child|children, child
5191677|NCT02794103|Kid, Kids|kid, kids
5191678|NCT02794103|Pediatric, Pediatrics|pediatric, pediatrics
5191679|NCT02794103|Young children|young children
5191680|NCT02794103|Burns|burns
5191681|NCT02794103|Burn injuries|burn injuries
5191682|NCT02794103|Burn unit|burn unit
5191683|NCT02794103|Hydrotherapy|hydrotherapy
5191684|NCT02794103|Burn dressing|burn dressing
5191685|NCT02794103|Non-pharmacological|non-pharmacological
5191686|NCT02794103|Clinical Research|clinical research
5191687|NCT02794103|Nursing Practice|nursing practice
5191688|NCT02794090|Behavioral treatment|behavioral treatment
5191689|NCT02794090|Telephone coaching|telephone coaching
5191690|NCT02794090|Outpatient clinic|outpatient clinic
5191691|NCT02794077|Nasopharyngeal undifferentiated carcinoma|nasopharyngeal undifferentiated carcinoma
5191692|NCT02793947|Peri-incisional injection|peri-incisional injection
5191693|NCT02793947|Multimodal analgesia|multimodal analgesia
5191694|NCT02793947|Femur fracture|femur fracture
5191695|NCT02793934|Rehabilitation|rehabilitation
5191696|NCT02793934|ICF|icf
5191697|NCT02793934|Pilot project|pilot project
5191698|NCT02793934|Stroke|stroke
5191699|NCT02793934|Acute myocardial infarction|acute myocardial infarction
5191700|NCT02793934|Total hip replacement|total hip replacement
5191701|NCT02793921|Alteration|alteration
5191702|NCT02793921|Cognitive Function|cognitive function
5191703|NCT02793921|Exercise|exercise
5191704|NCT02793908|Endometriosis|endometriosis
5191705|NCT02793908|Subcutaneous progesterone|subcutaneous progesterone
5191706|NCT02793908|luteal phase|luteal phase
5191707|NCT02793895|Atrial fibrillation/flutter|atrial fibrillation/flutter
5191708|NCT02793895|Postoperative atrial arrhythmia|postoperative atrial arrhythmia
5191709|NCT02793895|Cardiac surgery|cardiac surgery
5191710|NCT02793895|Stroke prevention|stroke prevention
5191711|NCT02793895|Oral anticoagulation|oral anticoagulation
5191712|NCT02793895|Cardiac rhythm monitoring|cardiac rhythm monitoring
5940385|NCT00674479|Lymph nodes|lymph nodes
5940386|NCT00674479|JAK kinase inhibitor INCB018424 phosphate|jak kinase inhibitor incb018424 phosphate
5940387|NCT00674479|Acute Myeloid Leukemia|acute myeloid leukemia
5940388|NCT00674479|AML|aml
5191713|NCT02793869|congenital cataract;anterior segment characteristics|congenital cataract;anterior segment characteristics
5191714|NCT02793856|lung cancer|lung cancer
5191715|NCT02793856|immune checkpoint|immune checkpoint
5191716|NCT02793856|PD-1|pd-1
5191717|NCT02793856|CRISPER|crisper
5191718|NCT02793856|autologous cell infusion|autologous cell infusion
5191719|NCT02793830|medication adherence|medication adherence
5191720|NCT02793830|mHealth|mhealth
5191721|NCT02793830|China|china
5191722|NCT02793830|heart disease|heart disease
5191723|NCT02793817|postsurgical|postsurgical
5191724|NCT02793817|postoperative|postoperative
5191725|NCT02793817|ocular|ocular
5191726|NCT02793817|cataract|cataract
5191727|NCT02793817|inflammation|inflammation
5191728|NCT02793817|pain|pain
5191729|NCT02793817|corticosteroid|corticosteroid
5191730|NCT02793804|HIV self-testing|hiv self-testing
5191731|NCT02793804|HIV|hiv
5191732|NCT02793804|Zambia|zambia
5191733|NCT02793791|high grade dysplastic nodule (HGDN)|high grade dysplastic nodule (hgdn)
5191734|NCT02793791|low grade dysplastic nodule (LGDN)|low grade dysplastic nodule (lgdn)
5191735|NCT02793778|Crohn's Disease|crohn's disease
5191736|NCT02793778|Digestive System Diseases|digestive system diseases
5191737|NCT02793778|Gastrointestinal Diseases|gastrointestinal diseases
5191738|NCT02793778|Intestinal Diseases|intestinal diseases
5191739|NCT02793778|mucosal healing|mucosal healing
5191740|NCT02793778|inflammatory bowel disease|inflammatory bowel disease
5191741|NCT02793778|Medical Food|medical food
5191742|NCT02793778|Nutritional intervention|nutritional intervention
5191743|NCT02793765|Advanced Prostate Cancer|advanced prostate cancer
5191744|NCT02793765|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5191745|NCT02793765|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5191746|NCT02793765|Metastatic disease|metastatic disease
5191747|NCT02793765|CRPC|crpc
5191748|NCT02793752|IVF|ivf
5191749|NCT02793752|In vitro fertilization|in vitro fertilization
5191750|NCT02793752|Cumulus Cells|cumulus cells
5191751|NCT02793752|Oocyte|oocyte
5191752|NCT02793752|Embryo|embryo
5191753|NCT02793752|Fertility|fertility
5191754|NCT02793739|Safety|safety
5191755|NCT02793739|Efficacy|efficacy
5191756|NCT02793739|Longevity|longevity
5191757|NCT02793726|Hip Prosthesis|hip prosthesis
5191758|NCT02793713|EBUS|ebus
5191759|NCT02793713|Prediction|prediction
5191760|NCT02793713|malignancy|malignancy
5191761|NCT02793713|lymph nodes|lymph nodes
5191762|NCT02793713|lung cancer|lung cancer
5191763|NCT02793713|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
5191764|NCT02793700|Betamethasone|betamethasone
5191765|NCT02793674|effort of breathing|effort of breathing
5191766|NCT02793674|high flow nasal cannula|high flow nasal cannula
5191767|NCT02793674|respiratory distress|respiratory distress
5191768|NCT02793648|Depression|depression
5191769|NCT02793648|Elderly|elderly
5191770|NCT02793635|Paraplegia|paraplegia
5191771|NCT02793635|Gait|gait
5191772|NCT02793635|Exoskeleton|exoskeleton
5191773|NCT02793622|Chemoprevention|chemoprevention
5191774|NCT02793622|Malaria|malaria
5191775|NCT02793622|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
5191776|NCT02793622|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
5191777|NCT02793609|induction of labor|induction of labor
5191778|NCT02793609|double balloon catheter|double balloon catheter
5191779|NCT02793609|mechanical ripening|mechanical ripening
5191780|NCT02793505|metformin|metformin
5191781|NCT02793505|pregnancy outcomes|pregnancy outcomes
5191782|NCT02793505|birth defects|birth defects
5191783|NCT02793505|spontaneous abortion|spontaneous abortion
5191784|NCT02793505|pharmacoepidemiology|pharmacoepidemiology
5191785|NCT02793466|Durvalumab|durvalumab
5191786|NCT02793466|solid tumors|solid tumors
5191787|NCT02793466|Immunotherapy|immunotherapy
5191788|NCT02793466|Check Point Inhibitor|check point inhibitor
5191789|NCT02793466|pediatrics|pediatrics
5191790|NCT02793466|children|children
5191791|NCT02793401|High Intensity Laser|high intensity laser
5191792|NCT02793401|Ultrasound|ultrasound
5191793|NCT02793401|Chronic Shoulder Pain|chronic shoulder pain
5191794|NCT02793375|Montelukast|montelukast
5191795|NCT02793375|Tonsillectomy|tonsillectomy
5191796|NCT02793349|angioplasty|angioplasty
5191797|NCT02793349|stents|stents
5191798|NCT02793349|polymers|polymers
5191799|NCT02793349|absorbable implants|absorbable implants
5191800|NCT02793271|Depression|depression
5191801|NCT02793271|Primary Health Care|primary health care
5191802|NCT02793271|Social Stigma|social stigma
5191803|NCT02793271|Stereotyping|stereotyping
5191804|NCT02793271|Health Care Quality|health care quality
5191805|NCT02793271|Access|access
5191806|NCT02793271|Evaluation|evaluation
5191807|NCT02793258|tDCS|tdcs
5799383|NCT00109772|Revlimid|revlimid
5191808|NCT02793258|neuromodulation|neuromodulation
5191809|NCT02793258|depression|depression
5191810|NCT02793258|cognition|cognition
5191811|NCT02793232|Safety|safety
5191812|NCT02793232|Tolerability|tolerability
5191813|NCT02793232|Pharmacokinetics|pharmacokinetics
5191814|NCT02793232|Alzheimer's disease|alzheimer's disease
5179816|NCT02865850|hypoxia-inducible factor|hypoxia-inducible factor
5179817|NCT02865850|HIF|hif
5191815|NCT02793219|Advanced Prostate Cancer|advanced prostate cancer
5191816|NCT02793219|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5191817|NCT02793219|CRPC|crpc
5191818|NCT02793219|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5191819|NCT02793219|Metastatic disease|metastatic disease
5191820|NCT02793206|Drusen|drusen
5191821|NCT02793206|SD-OCT|sd-oct
5191822|NCT02793167|acute kidney injury|acute kidney injury
5191823|NCT02793167|medication alert systems|medication alert systems
5191824|NCT02793154|gastric emptying|gastric emptying
5191825|NCT02793154|albiglutide|albiglutide
5191826|NCT02793154|GMA|gma
5191827|NCT02793154|exenatide|exenatide
5191828|NCT02793154|type 2 diabetes mellitus|type 2 diabetes mellitus
5191829|NCT02793141|Pneumonia|pneumonia
5191830|NCT02793141|Intensive Care Unit|intensive care unit
5191831|NCT02793141|Nosocomial pneumonia|nosocomial pneumonia
5191832|NCT02793141|Hospital-acquired pneumonia|hospital-acquired pneumonia
5191833|NCT02793141|Ventilator-associated pneumonia|ventilator-associated pneumonia
5191834|NCT02793141|ICU|icu
5191835|NCT02793141|HAP|hap
5191836|NCT02793141|VAP|vap
5191837|NCT02793141|Critical Care|critical care
5191838|NCT02793128|TC-3|tc-3
5191839|NCT02793128|Mitogel|mitogel
5191840|NCT02793128|UTUC|utuc
5191841|NCT02793128|Ureteral|ureteral
5191842|NCT02793128|Upper Tract|upper tract
5191843|NCT02793128|Carcinoma|carcinoma
5191844|NCT02793128|Kidney|kidney
5191845|NCT02793128|Renal|renal
5191846|NCT02793128|Gel|gel
5191847|NCT02793128|Local|local
5191848|NCT02793128|Mitomycin C|mitomycin c
5191849|NCT02793128|Prolonged Release|prolonged release
5191850|NCT02793128|Slow Release|slow release
5191851|NCT02793128|Kidney Sparing|kidney sparing
5191852|NCT02793128|T1|t1
5191853|NCT02793128|T0|t0
5191854|NCT02793128|Low Grade|low grade
5191855|NCT02793128|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
5191856|NCT02793128|TCC|tcc
5191857|NCT02793102|mental anorexia|mental anorexia
5191858|NCT02793102|sensory workshops|sensory workshops
5191859|NCT02793102|BMI|bmi
5191860|NCT02793076|Posture|posture
5191861|NCT02793076|Body image|body image
5191862|NCT02793076|Dancing|dancing
5191863|NCT02793076|Group|group
5191865|NCT02793063|Brittle Bone|brittle bone
5191866|NCT02793063|Osteogenesis Imperfecta|osteogenesis imperfecta
5191867|NCT02793063|BBD|bbd
5191868|NCT02793063|OI|oi
5191869|NCT02793063|Congenital Abnormalities|congenital abnormalities
5191870|NCT02793063|Congenital Bone Disorder|congenital bone disorder
5191871|NCT02793063|Lobstein Syndrome|lobstein syndrome
5191872|NCT02793050|Trabectedin|trabectedin
5191873|NCT02793050|Soft Tissue Sarcoma|soft tissue sarcoma
5191874|NCT02793050|Observational|observational
5191875|NCT02793037|zirconia|zirconia
5191876|NCT02793037|resin bonded bridge|resin bonded bridge
5191877|NCT02793024|food shopping intervention|food shopping intervention
5191878|NCT02792972|Analgesic|analgesic
5191879|NCT02792972|Medicinal plants|medicinal plants
5191880|NCT02792972|Skin|skin
5191881|NCT02792972|Antimicrobial agents|antimicrobial agents
5191882|NCT02792972|Pain Measurement|pain measurement
5191883|NCT02792907|Foot Surgery|foot surgery
5191884|NCT02792907|Compliance|compliance
5191885|NCT02792907|Compressive Stockings|compressive stockings
5191886|NCT02792894|cluster randomized trial|cluster randomized trial
5191887|NCT02792894|developmental delays|developmental delays
5191888|NCT02792894|neurodevelopmental disorders|neurodevelopmental disorders
5191889|NCT02792894|autism|autism
5191890|NCT02792894|intellectual disability|intellectual disability
5191891|NCT02792894|low resource settings|low resource settings
5191892|NCT02792894|family volunteers|family volunteers
5191893|NCT02792881|Stomach Neoplasms|stomach neoplasms
5191894|NCT02792881|Laparoscopy|laparoscopy
5191895|NCT02792881|Remnant gastric cancer|remnant gastric cancer
5191896|NCT02792855|Snifﬁng Position|snifﬁng position
5191897|NCT02792855|Simple Head Extension|simple head extension
5191898|NCT02792829|Bioavailability of Lenvatinib suspension|bioavailability of lenvatinib suspension
5191899|NCT02792829|Palatability of Lenvatinib suspension|palatability of lenvatinib suspension
5191900|NCT02792829|Lenvatinib|lenvatinib
5191901|NCT02792829|Lenvima|lenvima
5191902|NCT02792829|E7080|e7080
5191903|NCT02792829|Capsule formulation|capsule formulation
5191904|NCT02792829|Healthy volunteers|healthy volunteers
5191905|NCT02792803|POAG|poag
5191906|NCT02792803|Primary open angle glaucoma|primary open angle glaucoma
5191907|NCT02792803|Ocular Hypertension|ocular hypertension
5191908|NCT02792803|Xalatan|xalatan
5940389|NCT00674479|Acute Lymphocytic leukemia|acute lymphocytic leukemia
5940390|NCT00674479|ALL|all
5191909|NCT02792803|Latanoprost|latanoprost
5191910|NCT02792803|Ocular Hyperemia|ocular hyperemia
5191911|NCT02792803|IOP|iop
5191912|NCT02792803|Intraocular Pressure|intraocular pressure
5191913|NCT02792803|Allergan|allergan
5191914|NCT02792803|prostaglandin|prostaglandin
5191915|NCT02792790|Amyloidosis|amyloidosis
5179914|NCT02865447|PRESERVE|preserve
5191916|NCT02792790|Carpal tunnel syndrome|carpal tunnel syndrome
5191917|NCT02792777|Concept Mapping|concept mapping
5191918|NCT02792777|VOICe|voice
5191919|NCT02792777|Interviews|interviews
5191920|NCT02792777|Patient-Centered Research|patient-centered research
5191921|NCT02792764|port|port
5191922|NCT02792764|peripheral intravenous lines|peripheral intravenous lines
5191923|NCT02792764|oncology|oncology
5191924|NCT02792751|Depth of anesthesia|depth of anesthesia
5191925|NCT02792751|BIS|bis
5191926|NCT02792751|ERCP|ercp
5191927|NCT02792751|Positive Regulation|positive regulation
5191928|NCT02792712|Acute myocardial infarction|acute myocardial infarction
5191929|NCT02792712|Antiplatelet agents|antiplatelet agents
5191930|NCT02792712|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5191931|NCT02792686|Healthy Volunteers|healthy volunteers
5191932|NCT02792673|Embryo transfer media|embryo transfer media
5191933|NCT02792673|improvement of embryo transfer technique|improvement of embryo transfer technique
5192033|NCT02792075|NIRS|nirs
5191934|NCT02792673|improvement of implantation|improvement of implantation
5191935|NCT02792673|"Hyaluronan-enriched media Embryo Glue®"|"hyaluronan-enriched media embryo glue®"
5191936|NCT02792673|"30% Protein-supplemented Culture Medium Global Total®"|"30% protein-supplemented culture medium global total®"
5191937|NCT02792673|Autologous Follicular Fluid as embryo transfer medium|autologous follicular fluid as embryo transfer medium
5191938|NCT02792634|Bariatric surgery|bariatric surgery
5191939|NCT02792634|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5191940|NCT02792634|Obesity|obesity
5191941|NCT02792608|Mindfulness-based Therapy|mindfulness-based therapy
5191942|NCT02792608|Brain Tumour Survivors|brain tumour survivors
5191943|NCT02792608|Depressive Symptoms|depressive symptoms
5191944|NCT02792608|Quality of Life|quality of life
5191945|NCT02792608|Perceived Stress|perceived stress
5191946|NCT02792608|Wellbeing|wellbeing
5191947|NCT02792608|Treatment|treatment
5191948|NCT02792582|Brain tumor|brain tumor
5191949|NCT02792582|Pediatrics|pediatrics
5191950|NCT02792582|Radiation therapy|radiation therapy
5191951|NCT02792582|Proton therapy|proton therapy
5191952|NCT02792582|Surgery|surgery
5191953|NCT02792569|IVA|iva
5191954|NCT02792569|Hippo Pathway|hippo pathway
5191955|NCT02792569|Follicle activation|follicle activation
5191956|NCT02792569|Low Responder|low responder
5067310|NCT03578133|melioidosis|melioidosis
5191958|NCT02792569|Poor Ovarian Reserve|poor ovarian reserve
5191959|NCT02792569|Poor Ovarian Response|poor ovarian response
5191960|NCT02792569|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
5191961|NCT02792556|drug abortion|drug abortion
5191962|NCT02792556|urine pregnancy test|urine pregnancy test
5191963|NCT02792556|negative predictive value|negative predictive value
5191964|NCT02792556|check Top test|check top test
5191965|NCT02792556|transvaginal ultrasound|transvaginal ultrasound
5191966|NCT02792543|nutrition|nutrition
5191967|NCT02792543|double enterostomy|double enterostomy
5191968|NCT02792543|chyme reinfusion|chyme reinfusion
5191969|NCT02792543|randomized controlled trial|randomized controlled trial
5191970|NCT02792439|Fitness|fitness
5191971|NCT02792439|Health kit|health kit
5191972|NCT02792439|Researchkit|researchkit
5191973|NCT02792439|Walking|walking
5191974|NCT02792426|Smoking Cessation|smoking cessation
5191975|NCT02792426|Nicotine Dependence|nicotine dependence
5191976|NCT02792426|Tobacco Dependence|tobacco dependence
5191977|NCT02792413|osteoporosis|osteoporosis
5191978|NCT02792413|chronic kidney disease|chronic kidney disease
5191979|NCT02792413|anti-RANK ligand antibody|anti-rank ligand antibody
5191980|NCT02792413|bone mineral density|bone mineral density
5191981|NCT02792413|vascular calcifications|vascular calcifications
5191982|NCT02792387|cardio-renal syndrome|cardio-renal syndrome
5191983|NCT02792387|right heart dysfunction|right heart dysfunction
5191984|NCT02792387|central venous pressure|central venous pressure
5191985|NCT02792387|eGFR|egfr
5191986|NCT02792387|low-flow theory|low-flow theory
5191987|NCT02792374|Dental patients|dental patients
5191988|NCT02792374|Psychological Profile|psychological profile
5191989|NCT02792361|Post-Operative Pterional Craniotomy|post-operative pterional craniotomy
5191990|NCT02792361|Suction Drain|suction drain
5191991|NCT02792361|Benefits|benefits
5191992|NCT02792348|congenital urine flow impairment|congenital urine flow impairment
5191993|NCT02792348|urinary metabolomics profile|urinary metabolomics profile
5191994|NCT02792348|Nuclear Magnetic Resonance|nuclear magnetic resonance
5191995|NCT02792322|Cancer|cancer
5191996|NCT02792322|Oropharynx|oropharynx
5191997|NCT02792270|Surgery|surgery
5191998|NCT02792231|Relapsing multiple sclerosis|relapsing multiple sclerosis
5191999|NCT02792231|Ofatumumab|ofatumumab
5192000|NCT02792218|Relapsing multiple sclerosis|relapsing multiple sclerosis
5192001|NCT02792218|Ofatumumab|ofatumumab
5192002|NCT02792205|Willebrand factor deficiency|willebrand factor deficiency
5192003|NCT02792205|hematology|hematology
5192004|NCT02792205|Willebrand:Collagen-binding|willebrand:collagen-binding
5192005|NCT02792166|Morbid obesity|morbid obesity
5192006|NCT02792166|Metabolic syndrome|metabolic syndrome
5273566|NCT02311374|EEG|eeg
5940391|NCT00674479|Myelodysplastic Syndrome|myelodysplastic syndrome
5180040|NCT02864927|Meningococcal Meningitis|meningococcal meningitis
5180041|NCT02864927|Meningococcal Infections|meningococcal infections
5180042|NCT02864927|Menactra®|menactra®
5180043|NCT02864927|Meningococcal Vaccine|meningococcal vaccine
5180045|NCT02864888|QT/QTc interval|qt/qtc interval
5192007|NCT02792166|Metabolic surgery|metabolic surgery
5192008|NCT02792166|Bariatric surgery|bariatric surgery
5192009|NCT02792166|SADI|sadi
5192010|NCT02792166|BPD-DS|bpd-ds
5192011|NCT02792153|estrogen|estrogen
5192012|NCT02792153|anxiety|anxiety
5192013|NCT02792153|amenorrhea|amenorrhea
5192014|NCT02792153|eating disorders|eating disorders
5192015|NCT02792140|Psychology|psychology
5192016|NCT02792140|Dreams|dreams
5192017|NCT02792127|Social Anxiety|social anxiety
5192018|NCT02792127|Cognitive Behaviour Therapy|cognitive behaviour therapy
5192019|NCT02792127|Online Program|online program
5192028|NCT02792088|HBV|hbv
5192029|NCT02792075|Coronary Stenosis|coronary stenosis
5192030|NCT02792075|Intracoronary Imaging|intracoronary imaging
5192031|NCT02792075|VH-IVUS|vh-ivus
5192032|NCT02792075|OCT|oct
5192034|NCT02792075|gray scale IVUS|gray scale ivus
5192035|NCT02792062|Drug therapy|drug therapy
5192036|NCT02792023|Colorectal cancer|colorectal cancer
5192037|NCT02792023|Immunochemical occult blood test|immunochemical occult blood test
5192038|NCT02792010|T1rho MRI|t1rho mri
5192039|NCT02792010|hip|hip
5192040|NCT02792010|cartilage|cartilage
5192041|NCT02792010|Healthy participants|healthy participants
5192042|NCT02791997|Audition|audition
5192043|NCT02791997|Stroke|stroke
5192044|NCT02791997|Migraine|migraine
5192045|NCT02791997|Attention|attention
5192046|NCT02791997|Short-term memory,|short-term memory,
5192047|NCT02791997|Emotions|emotions
5192048|NCT02791997|EEG|eeg
5192049|NCT02791997|MEG|meg
5192050|NCT02791984|Suprasternal|suprasternal
5192051|NCT02791984|echography|echography
5192052|NCT02791984|fluid responsiveness|fluid responsiveness
5192053|NCT02791971|Contraception|contraception
5192054|NCT02791971|Birth control|birth control
5962401|NCT04281134|Exposure and Response Prevention (ERP)|exposure and response prevention (erp)
5192055|NCT02791971|Social communication|social communication
5192056|NCT02791971|Adolescent|adolescent
5192057|NCT02791971|Social network|social network
5192058|NCT02791971|Health education|health education
5192059|NCT02791971|Reproductive health|reproductive health
5192060|NCT02791945|TBI|tbi
5192061|NCT02791945|hazardous and harmful alcohol use|hazardous and harmful alcohol use
5192074|NCT02791906|Congestive Heart Failure|congestive heart failure
5940392|NCT00674479|MDS|mds
5940393|NCT00674479|Chronic myelogenous leukemia - Blast Crisis|chronic myelogenous leukemia - blast crisis
5940394|NCT00674479|CML|cml
5940395|NCT00674479|INCB018424|incb018424
5192075|NCT02791906|Heart Decompensation|heart decompensation
5192076|NCT02791906|Heart Failure, Congestive|heart failure, congestive
5192077|NCT02791906|Myocardial Failure|myocardial failure
5192078|NCT02791880|acute kidney injury|acute kidney injury
5192079|NCT02791880|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5192080|NCT02791880|genomics|genomics
5192081|NCT02791880|biomarker|biomarker
5192082|NCT02791841|Reading|reading
5192083|NCT02791841|Developmental Dyslexia,|developmental dyslexia,
5192084|NCT02791841|Music|music
5192086|NCT02791841|Action Video Games|action video games
5192087|NCT02791841|Hemisphere-Specific Stimulation|hemisphere-specific stimulation
5192088|NCT02791815|selexipag|selexipag
5192089|NCT02791815|pharmacokinetics|pharmacokinetics
5192090|NCT02791815|midazolam|midazolam
5192091|NCT02791802|Lipoprotein(a)|lipoprotein(a)
5192092|NCT02791802|lipoprotein/lipid apheresis|lipoprotein/lipid apheresis
5192093|NCT02791802|CV disease|cv disease
5192094|NCT02791789|Autism Spectrum Disorder|autism spectrum disorder
5192095|NCT02791789|SEMATIC|sematic
5192096|NCT02791789|software|software
5192097|NCT02791776|scoliosis|scoliosis
5192098|NCT02791763|Renal Anemia|renal anemia
5192099|NCT02791763|Japanese|japanese
5192100|NCT02791763|chronic kidney disease|chronic kidney disease
5192101|NCT02791763|Peritoneal dialysis|peritoneal dialysis
5192102|NCT02791763|GSK1278863|gsk1278863
5192103|NCT02791763|Non-dialysis|non-dialysis
5192104|NCT02791750|hormone replacement therapy|hormone replacement therapy
5192105|NCT02791750|breast cancer|breast cancer
5192106|NCT02791750|follow up|follow up
5192107|NCT02791737|Hematologic Malignancy|hematologic malignancy
5192108|NCT02791737|Exercise|exercise
5192122|NCT02791659|left lateral decubitus|left lateral decubitus
5192123|NCT02791607|Circulating tumor cells|circulating tumor cells
5192124|NCT02791607|Head and neck cancer|head and neck cancer
5192125|NCT02791607|Survival Prognosis|survival prognosis
5192127|NCT02791607|HPV|hpv
5192128|NCT02791581|Breast Cancer|breast cancer
5192129|NCT02791581|Fatigue|fatigue
5192130|NCT02791581|Cardiovascular Events|cardiovascular events
5192131|NCT02791555|pradaxa|pradaxa
5192132|NCT02791555|warfarin|warfarin
5192133|NCT02791542|Asthma|asthma
5192134|NCT02791516|Osteoporosis.|osteoporosis.
5192135|NCT02791516|Osteoporosis-Postmenopausal.|osteoporosis-postmenopausal.
5192136|NCT02791516|Bone Diseases-Metabolic.|bone diseases-metabolic.
5192137|NCT02791516|Bone Diseases.|bone diseases.
5192138|NCT02791516|Musculoskeletal Diseases.|musculoskeletal diseases.
5192139|NCT02791503|Irreversible electroporation (IRE|irreversible electroporation (ire
5192140|NCT02791503|Stereotactic ablative radiotherapy (SABR|stereotactic ablative radiotherapy (sabr
5192141|NCT02791503|Efficacy|efficacy
5192142|NCT02791503|Tumor ablation|tumor ablation
5192143|NCT02791503|Chemotherapy|chemotherapy
5192144|NCT02791503|Locally advanced pancreatic cancer (LAPC)|locally advanced pancreatic cancer (lapc)
5192145|NCT02791477|Attune|attune
5192146|NCT02791464|Meditation|meditation
5192147|NCT02791464|TM|tm
5192148|NCT02791464|PTSD|ptsd
5192149|NCT02791464|Trauma|trauma
5192150|NCT02791464|Female Prisoners|female prisoners
5192151|NCT02791451|COPD|copd
5192152|NCT02791451|telemonitoring|telemonitoring
5192153|NCT02791451|exacerbation|exacerbation
5192154|NCT02791425|Brain-Computer Interface|brain-computer interface
5192155|NCT02791425|Intratracheal intubation|intratracheal intubation
5192156|NCT02791425|Mechanical ventilation|mechanical ventilation
5192157|NCT02791425|Nonverbal communication|nonverbal communication
5192158|NCT02791425|Critical illness|critical illness
5192159|NCT02791425|Electroencephalography|electroencephalography
5192160|NCT02791425|Visual Evoked Potential|visual evoked potential
5192161|NCT02791412|left main|left main
5192162|NCT02791412|unprotected|unprotected
5192163|NCT02791412|percutaneous coronary intervention|percutaneous coronary intervention
5192164|NCT02791412|coronary-artery bypass graft|coronary-artery bypass graft
5192175|NCT02791360|Brain|brain
5192176|NCT02791360|Radiotherapy|radiotherapy
5192177|NCT02791360|MRI|mri
5192178|NCT02791360|Sequelae|sequelae
5192179|NCT02791334|PDL1|pdl1
5192180|NCT02791334|PD-L1|pd-l1
5192181|NCT02791295|Type 2 diabetes|type 2 diabetes
5192182|NCT02791295|lifestyle intervention|lifestyle intervention
5192183|NCT02791295|insulin pump treatment|insulin pump treatment
5192184|NCT02791295|body weight|body weight
5192185|NCT02791295|body composition|body composition
5192186|NCT02791282|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5192187|NCT02791282|MRI|mri
5192188|NCT02791282|SPECT|spect
5192194|NCT02791191|BACE inhibitor|bace inhibitor
5192195|NCT02791100|height|height
5192196|NCT02791100|weight|weight
5192197|NCT02791100|diet|diet
5192198|NCT02791100|complementary foods|complementary foods
5192199|NCT02791100|protein|protein
5192200|NCT02791100|calcium|calcium
5192201|NCT02791009|HF|hf
5192202|NCT02791009|HFrEF|hfref
5192203|NCT02791009|HFpEF|hfpef
5192204|NCT02791009|MRI|mri
5192205|NCT02791009|biomarker|biomarker
5192206|NCT02790996|sepsis|sepsis
5192207|NCT02790996|neonate|neonate
5192208|NCT02790996|vancomycin|vancomycin
5192209|NCT02790983|Registry|registry
5192210|NCT02790983|Spine|spine
5192211|NCT02790983|Surgery|surgery
5192212|NCT02790983|Medical Oncology|medical oncology
5192213|NCT02790983|Radiation Oncology|radiation oncology
5192214|NCT02790983|Neoplasms|neoplasms
5192215|NCT02790944|Germline|germline
5192216|NCT02790944|Pancreatic|pancreatic
5180215|NCT02864030|Polymorphisms|polymorphisms
5180216|NCT02864030|Tolerability|tolerability
5180220|NCT02863978|Sepsis|sepsis
5192217|NCT02790944|Genetic Testing|genetic testing
5192218|NCT02790931|diabetic foot|diabetic foot
5192219|NCT02790931|therapeutic exercises|therapeutic exercises
5192220|NCT02790931|foot|foot
5192221|NCT02790931|preventive care|preventive care
5192222|NCT02790931|rehabilitation|rehabilitation
5192223|NCT02790931|Diabetic Neuropathy|diabetic neuropathy
5192224|NCT02790918|Pulmonary Hypertension|pulmonary hypertension
5192225|NCT02790918|MRI|mri
5192226|NCT02790905|pregnant and post-partum women|pregnant and post-partum women
5192227|NCT02790905|Validation questionnaires|validation questionnaires
5192228|NCT02790905|Thai-Myanmar border|thai-myanmar border
5192229|NCT02790892|type 1 diabetes|type 1 diabetes
5192230|NCT02790892|type 2 diabetes|type 2 diabetes
5192231|NCT02790892|children|children
5192232|NCT02790892|adolescents|adolescents
5192233|NCT02790892|young adults|young adults
5192234|NCT02790892|youth|youth
5192235|NCT02790892|transition|transition
5192236|NCT02790892|art therapy|art therapy
5192237|NCT02790892|behavioral therapy|behavioral therapy
5192238|NCT02790879|Transitional care|transitional care
5192239|NCT02790879|teenagers|teenagers
5192240|NCT02790879|cystic fibrosis|cystic fibrosis
5192241|NCT02790879|pulmonary function|pulmonary function
5192242|NCT02790879|nutritional function|nutritional function
5192243|NCT02790879|Patients who experiment a transition pediatric - adult care|patients who experiment a transition pediatric - adult care
5192244|NCT02790866|Decision Aid|decision aid
5192245|NCT02790866|Informed Decision Making|informed decision making
5192246|NCT02790866|Shared Decision making|shared decision making
5192247|NCT02790866|Screening|screening
5192248|NCT02790840|Volunteers|volunteers
5192249|NCT02790801|chronic heart failure|chronic heart failure
5192250|NCT02790801|atrial fibrillation|atrial fibrillation
5192251|NCT02790801|anticoagulant|anticoagulant
5192252|NCT02790762|stem cells|stem cells
5192253|NCT02790762|Mesenchymal Stem Cells|mesenchymal stem cells
5192254|NCT02790762|Umbilical Cord-Mesenchymal Stem Cells|umbilical cord-mesenchymal stem cells
5192255|NCT02790762|Pneumoconiosis|pneumoconiosis
5192256|NCT02790749|Developmental hip dysplasia|developmental hip dysplasia
5192257|NCT02790749|Intra-articular pathology|intra-articular pathology
5192258|NCT02790749|Adult hip dysplasia|adult hip dysplasia
5192259|NCT02790749|Labral tear, hip|labral tear, hip
5192260|NCT02790749|Chondromalacia, hip|chondromalacia, hip
5192261|NCT02790736|propranolol|propranolol
5192262|NCT02790736|public speaking anxiety|public speaking anxiety
5192263|NCT02790710|propanolol|propanolol
5192264|NCT02790710|obsessive-compulsive disorder|obsessive-compulsive disorder
5192265|NCT02790697|Indirect calorimetry|indirect calorimetry
5192266|NCT02790697|ICALIC Study|icalic study
5192267|NCT02790697|Energy expenditure|energy expenditure
5192268|NCT02790697|VO2|vo2
5192269|NCT02790697|VCO2|vco2
5192270|NCT02790697|Respiratory quotient|respiratory quotient
5192271|NCT02790658|Grumixama|grumixama
5192272|NCT02790658|Urolithins|urolithins
5192273|NCT02790658|Anthocyanins|anthocyanins
5192274|NCT02790658|Metabolomic Approach|metabolomic approach
5192275|NCT02790658|Ellagitannins|ellagitannins
5082404|NCT03483623|WELP mattress|welp mattress
5192278|NCT02790645|Health technologies|health technologies
5192279|NCT02790645|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5192280|NCT02790645|Telemedicine|telemedicine
5192281|NCT02790645|Glycemic variability|glycemic variability
5192282|NCT02790645|Inflammatory markers,|inflammatory markers,
5192283|NCT02790645|Oxidative stress|oxidative stress
5192285|NCT02790645|Quality of life|quality of life
5192286|NCT02790645|Cost-effectiveness|cost-effectiveness
5192287|NCT02790632|Aneurysm, Ruptured|aneurysm, ruptured
5192288|NCT02790632|Nimodipine|nimodipine
5192289|NCT02790632|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5192290|NCT02790606|ESRD|esrd
5192291|NCT02790606|Stenosis|stenosis
5192292|NCT02790606|Restenosis|restenosis
5192293|NCT02790606|Hemodialysis|hemodialysis
5192294|NCT02790606|AV Graft|av graft
5192295|NCT02790567|diagnostic performance|diagnostic performance
5192296|NCT02790567|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5962402|NCT04281108|APT-1011|apt-1011
5192297|NCT02790567|rapid immunological diagnostic method|rapid immunological diagnostic method
5192298|NCT02790567|immunoassay|immunoassay
5192299|NCT02790567|pretest scoring systems|pretest scoring systems
5192300|NCT02790567|4Ts score|4ts score
5192301|NCT02790567|HEP score|hep score
5192303|NCT02790541|HBOT|hbot
5192304|NCT02790541|reverse|reverse
5192305|NCT02790541|angiogenesis|angiogenesis
5192306|NCT02790541|elderly|elderly
5192307|NCT02790541|mitochohndria|mitochohndria
5192308|NCT02790528|statin|statin
5192309|NCT02790528|vasospastic angina|vasospastic angina
5192310|NCT02790476|Safe|safe
5192311|NCT02790476|Prescribing|prescribing
5192312|NCT02790476|Opioids|opioids
5192314|NCT02790398|Transdiagnostic treatment protocol|transdiagnostic treatment protocol
5192317|NCT02790372|Norway|norway
5192318|NCT02790359|Carbon dioxide|carbon dioxide
5192319|NCT02790359|Air|air
5192320|NCT02790359|Colonoscopy|colonoscopy
5192321|NCT02790346|hemiparesis|hemiparesis
5192322|NCT02790346|deformity of the foot and ankle|deformity of the foot and ankle
5192323|NCT02790320|Eribulin mesylate|eribulin mesylate
5192324|NCT02790320|Halaven|halaven
5192325|NCT02790320|Breast cancer|breast cancer
5192326|NCT02790307|multiple sclerosis|multiple sclerosis
5192327|NCT02790307|overactive bladder|overactive bladder
5192328|NCT02790307|urinary incontinence|urinary incontinence
5192329|NCT02790307|tibial nerve stimulation|tibial nerve stimulation
5192330|NCT02790294|magnetic resonance imaging|magnetic resonance imaging
5192331|NCT02790268|Cionni Ring|cionni ring
5192332|NCT02790268|Ultrasound Biomicroscopy|ultrasound biomicroscopy
5192333|NCT02790242|Mechanical Circulatory Support Device (MCSD)|mechanical circulatory support device (mcsd)
5192334|NCT02790242|ventricular Assist Device (VAD)|ventricular assist device (vad)
5192335|NCT02790229|rehabilitation, anti-gravity treadmill|rehabilitation, anti-gravity treadmill
5192336|NCT02790216|Image guided brachytherapy|image guided brachytherapy
5192337|NCT02790151|working memory, recollection training, transfer|working memory, recollection training, transfer
5192338|NCT02790138|Drug Therapy|drug therapy
5192339|NCT02790112|Body Mass Index|body mass index
5192340|NCT02790112|Body Composition|body composition
5192341|NCT02790112|Glucose Metabolism Disorders|glucose metabolism disorders
5192342|NCT02790112|Bone Development|bone development
5192343|NCT02790112|Gonadal Disorders|gonadal disorders
5192344|NCT02790112|Fertility|fertility
5192345|NCT02790112|Overweight|overweight
5192346|NCT02790112|Obesity|obesity
5192347|NCT02790112|Menarche|menarche
5192348|NCT02790099|Pain|pain
5192349|NCT02790099|Postoperative pain control|postoperative pain control
5192350|NCT02790099|Rectus sheath block|rectus sheath block
5192351|NCT02790099|Intrathecal morphine|intrathecal morphine
5192352|NCT02790099|Caesarean section|caesarean section
5192353|NCT02790086|hypothermia|hypothermia
5192354|NCT02790086|prevalence|prevalence
5192355|NCT02790086|perioperative|perioperative
5192356|NCT02790086|anemia|anemia
5192357|NCT02790086|myocardial injury|myocardial injury
5192358|NCT02790086|troponin T|troponin t
5192359|NCT02790086|noncardiac surgery|noncardiac surgery
5192360|NCT02790073|Calciphylaxis|calciphylaxis
5192361|NCT02790073|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
5192362|NCT02790073|Dialysis|dialysis
5192363|NCT02790073|End Stage Renal Disease|end stage renal disease
5192364|NCT02790073|Rare disease (ORPHA280062)|rare disease (orpha280062)
5192365|NCT02790073|Calcification|calcification
5192366|NCT02790073|Calcium Metabolism Disorders|calcium metabolism disorders
5192367|NCT02790073|Calcinosis|calcinosis
5192368|NCT02790073|Metabolic Diseases|metabolic diseases
5192369|NCT02790060|diabetes|diabetes
5192370|NCT02790047|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5192371|NCT02790047|Exercise Therapy|exercise therapy
5192372|NCT02790047|Positive Expiratory Pressure|positive expiratory pressure
5192373|NCT02790047|Physical Fitness|physical fitness
5192374|NCT02790047|Quality of Life|quality of life
5192375|NCT02790008|echocardiography|echocardiography
5192376|NCT02790008|magnetic resonance imaging|magnetic resonance imaging
5192377|NCT02790008|cardiopulmonary exercise test|cardiopulmonary exercise test
5192378|NCT02789995|Intensive Care Unit - Acquired Weakness (ICU-AW)|intensive care unit - acquired weakness (icu-aw)
5192380|NCT02789982|Trauma related disorders|trauma related disorders
5192381|NCT02789982|Reconsolidation blockade|reconsolidation blockade
5192382|NCT02789982|Paris attacks|paris attacks
5192383|NCT02789956|Internal connection|internal connection
5192384|NCT02789956|Cobalt/Chrome|cobalt/chrome
5192385|NCT02789956|Cad-cam Framework|cad-cam framework
5192386|NCT02789956|marginal bone level|marginal bone level
5192387|NCT02789943|IHD Normal EF|ihd normal ef
5192388|NCT02789930|Weight estimation|weight estimation
5192389|NCT02789930|Patient safety|patient safety
5192390|NCT02789917|ACS|acs
5192391|NCT02789917|Triple-Therapy|triple-therapy
5192392|NCT02789917|AF|af
5192393|NCT02789917|oral anticoagulation (OAC)|oral anticoagulation (oac)
5192394|NCT02789917|non-vitamin-K oral anticoagulant (NOAC)|non-vitamin-k oral anticoagulant (noac)
5192397|NCT02789865|Acute appendicitis|acute appendicitis
5192398|NCT02789865|Endoscopic retrograde appendicitis therapy|endoscopic retrograde appendicitis therapy
5192399|NCT02789865|Endoscopic retrograde appendicography|endoscopic retrograde appendicography
5192400|NCT02789865|Endoscopic therapy|endoscopic therapy
5192401|NCT02789865|Appendectomy|appendectomy
5192402|NCT02789865|Antibiotic Therapy|antibiotic therapy
5192403|NCT02789787|Cleft Lip|cleft lip
5192405|NCT02789787|Class III|class iii
5192406|NCT02789787|Malocclusion|malocclusion
5192407|NCT02789787|Protraction|protraction
5274077|NCT02308384|FIT|fit
5192408|NCT02789761|Flow-mediated dilatation (FMD)|flow-mediated dilatation (fmd)
5192409|NCT02789761|Vascular function|vascular function
5192410|NCT02789761|cognitive function|cognitive function
5192411|NCT02789735|Pregnancy|pregnancy
5192412|NCT02789735|laser therapy|laser therapy
5192413|NCT02789735|persistent pain|persistent pain
5192414|NCT02789735|pelvic pain|pelvic pain
5192416|NCT02789722|Vascular protection|vascular protection
5192417|NCT02789722|Endothelial function|endothelial function
5192418|NCT02789722|Ilex paraguariensis|ilex paraguariensis
5192419|NCT02789657|neoadjuvant breast cancer|neoadjuvant breast cancer
5192420|NCT02789657|stage I-III breast cancer|stage i-iii breast cancer
5192421|NCT02789657|HER 2 positive breast cancer|her 2 positive breast cancer
5192422|NCT02789644|Ursodeoxycholic acid|ursodeoxycholic acid
5192423|NCT02789644|Metabolomics/biomarker|metabolomics/biomarker
5192424|NCT02789644|Pharmacokinetics|pharmacokinetics
5192425|NCT02789605|Aphthous Stomatitis [C07.465.864.750]|aphthous stomatitis [c07.465.864.750]
5192426|NCT02789592|REM Sleep Behavior Disorder|rem sleep behavior disorder
5192427|NCT02789592|Parkinson Disease|parkinson disease
5192428|NCT02789592|Randomized Controlled Trial|randomized controlled trial
5192429|NCT02789592|Clinical Trial|clinical trial
5192430|NCT02789592|Melatonin|melatonin
5192431|NCT02789592|Clonazepam|clonazepam
5192432|NCT02789579|prophylactic|prophylactic
5192433|NCT02789579|Urinary Tract Infections|urinary tract infections
5192434|NCT02789579|Minimally invasive upper tract lithotomy|minimally invasive upper tract lithotomy
5192435|NCT02789566|Primaquine|primaquine
5192436|NCT02789566|Pharmacokinetic|pharmacokinetic
5192437|NCT02789553|Glucose digestion|glucose digestion
5192438|NCT02789553|Bypass surgery|bypass surgery
5192439|NCT02789553|C13-glucose tracer|c13-glucose tracer
5192440|NCT02789553|Insulin secretion|insulin secretion
5192441|NCT02789540|COPD symptoms|copd symptoms
5192442|NCT02789527|healthy volunteers|healthy volunteers
5192443|NCT02789514|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5192444|NCT02789514|paediatric|paediatric
5192445|NCT02789501|Catheter|catheter
5192446|NCT02789501|Dysfunctions|dysfunctions
5192447|NCT02789501|Blood Stream Infections|blood stream infections
5192448|NCT02789501|Haemodialysis|haemodialysis
5192449|NCT02789501|Taurolidine|taurolidine
5192450|NCT02789501|Tunneled|tunneled
5192451|NCT02789436|halitosis|halitosis
5192452|NCT02789436|chronic periodontitis|chronic periodontitis
5192453|NCT02789436|probiotic|probiotic
5192454|NCT02789410|Cesarean delivery|cesarean delivery
5192455|NCT02789410|Analgesia|analgesia
5192456|NCT02789410|Intrathecal opioids|intrathecal opioids
5192457|NCT02789397|Granulomatous and lymphocytic interstitial lung disease|granulomatous and lymphocytic interstitial lung disease
5192458|NCT02789397|common variable immunodeficiency|common variable immunodeficiency
5192459|NCT02789397|Rituximab|rituximab
5192460|NCT02789397|Azathioprine|azathioprine
5192461|NCT02789397|primary immunodeficiency|primary immunodeficiency
5192462|NCT02789397|GLIILD|gliild
5192463|NCT02789397|CVID|cvid
5192464|NCT02789384|soft-tissue sarcomas|soft-tissue sarcomas
5192465|NCT02789384|CINSARC|cinsarc
5192466|NCT02789384|biomarker|biomarker
5192467|NCT02789384|efficacy|efficacy
5192468|NCT02789384|pronostic|pronostic
5192469|NCT02789371|EUS-FNA|eus-fna
5192470|NCT02789371|modified wet suction technique|modified wet suction technique
5192471|NCT02789371|dry suction technique|dry suction technique
5192472|NCT02789358|cryotherapy|cryotherapy
5192473|NCT02789345|T790M|t790m
5188497|NCT02812446|biofilm|biofilm
5192475|NCT02789332|carboplatin|carboplatin
5192476|NCT02789332|olaparib|olaparib
5192478|NCT02789332|neoadjuvant|neoadjuvant
5192479|NCT02789332|triple-negative|triple-negative
5192480|NCT02789332|hormonreceptor-positive|hormonreceptor-positive
5192482|NCT02789332|HRD, homologous recominant deficient|hrd, homologous recominant deficient
5192483|NCT02789332|breast cancer|breast cancer
5192484|NCT02789332|genetic testing (somatic and germline mutations)|genetic testing (somatic and germline mutations)
5192485|NCT02789319|Blood Glucose Monitoring System|blood glucose monitoring system
5192486|NCT02789319|BGMS|bgms
5192487|NCT02789319|Diabetes|diabetes
5192488|NCT02789319|Patient Use|patient use
5192489|NCT02789306|Preventive therapy|preventive therapy
5192490|NCT02789306|Dental implants|dental implants
5192491|NCT02789293|Glaucoma|glaucoma
5192492|NCT02789293|Ultrasound|ultrasound
5192493|NCT02789293|Ciliary body|ciliary body
5192494|NCT02789267|Head and Neck Cancer|head and neck cancer
5192495|NCT02789267|Quality of Life|quality of life
5192496|NCT02789267|Dietary support|dietary support
5192497|NCT02789254|acute myeloid leukemia|acute myeloid leukemia
5192498|NCT02789254|Fms-like receptor tyrosine kinase (FLT3)|fms-like receptor tyrosine kinase (flt3)
5192499|NCT02789254|stem cell transplantation|stem cell transplantation
5192500|NCT02789254|complete remission|complete remission
5192501|NCT02789254|CD135|cd135
5192502|NCT02789254|antibodies|antibodies
5192503|NCT02789254|Leukemia|leukemia
5192505|NCT02789254|Fc-optimized|fc-optimized
5192506|NCT02789241|Endotoxin|endotoxin
5192507|NCT02789241|healthy|healthy
5180504|NCT02862054|unknown etiology|unknown etiology
5180505|NCT02862028|PD-1 antibody|pd-1 antibody
5180506|NCT02862028|CAR-T cells|car-t cells
5180507|NCT02862028|EGFR family|egfr family
5180508|NCT02862028|advanced solid tumor|advanced solid tumor
5180509|NCT02862002|opioid therapy|opioid therapy
5180510|NCT02862002|medical oncology.|medical oncology.
5180511|NCT02861989|osteoporosis|osteoporosis
5180512|NCT02861989|prevention|prevention
5180513|NCT02861989|care management|care management
5180514|NCT02861989|focus groups|focus groups
5192508|NCT02789241|volunteers|volunteers
5192509|NCT02789241|males|males
5192510|NCT02789241|females|females
5192511|NCT02789215|Child care food costs|child care food costs
5192512|NCT02789215|Meal participation rates|meal participation rates
5192513|NCT02789215|Child and Adult Care Food Program|child and adult care food program
5192514|NCT02789202|dental caries|dental caries
5192515|NCT02789202|deciduous tooth|deciduous tooth
5192516|NCT02789176|Phenobarbital|phenobarbital
5192517|NCT02789176|EEG|eeg
5192518|NCT02789176|family impact|family impact
5192519|NCT02789176|neurodevelopment|neurodevelopment
5192520|NCT02789163|breast|breast
5192521|NCT02789163|ultrasound|ultrasound
5192522|NCT02789163|diagnostic exam|diagnostic exam
5192523|NCT02789163|automated volume breast scanner|automated volume breast scanner
5192524|NCT02789137|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5192525|NCT02789124|fluid responsiveness|fluid responsiveness
5192526|NCT02789124|carotid artery flow time|carotid artery flow time
5192527|NCT02789124|passive leg raise|passive leg raise
5192528|NCT02789098|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5192529|NCT02789098|Ventricular remodeling|ventricular remodeling
5192530|NCT02789098|Biomarkers|biomarkers
5192531|NCT02789098|Coronary endothelial function|coronary endothelial function
5192532|NCT02789098|Positron Emission Tomography|positron emission tomography
5192533|NCT02789085|TENS|tens
5192534|NCT02789085|ULF-TENS|ulf-tens
5192535|NCT02789085|ANS|ans
5192536|NCT02789085|Dentistry|dentistry
5192537|NCT02789085|TMD|tmd
5192538|NCT02789059|Becker muscular dystrophy|becker muscular dystrophy
5192730|NCT02787759|stroke|stroke
5192539|NCT02789059|Facioscapulohumeral dystrophy|facioscapulohumeral dystrophy
5192540|NCT02789059|congenital myopathy|congenital myopathy
5192541|NCT02789059|motor neurone diseases|motor neurone diseases
5192542|NCT02789046|adult|adult
5192543|NCT02789046|vascular access|vascular access
5192544|NCT02789046|preoperative period|preoperative period
5192545|NCT02789046|peripheral venous catheterization|peripheral venous catheterization
5192546|NCT02789033|diabetic foot ulcers|diabetic foot ulcers
5192547|NCT02789033|chitosan|chitosan
5192548|NCT02789033|isosorbide dinitrate spray|isosorbide dinitrate spray
5192549|NCT02789020|Rasagiline|rasagiline
5192550|NCT02788981|triple-negative breast cancer|triple-negative breast cancer
5192551|NCT02788981|advanced breast cancer|advanced breast cancer
5192552|NCT02788981|nab-paclitaxel|nab-paclitaxel
5192553|NCT02788981|mifepristone|mifepristone
5192554|NCT02788981|glucocorticoid receptor-positive breast cancer|glucocorticoid receptor-positive breast cancer
5192555|NCT02788968|Psychology and Cognitive Neuroscience of development|psychology and cognitive neuroscience of development
5192556|NCT02788968|Adolescent and young adult healthy volunteers|adolescent and young adult healthy volunteers
5192557|NCT02788968|Anatomical and functionally Magnetic Resonance Imaging (MRI)|anatomical and functionally magnetic resonance imaging (mri)
5192567|NCT02788929|Percutaneous Transluminal Coronary Intervention|percutaneous transluminal coronary intervention
5192568|NCT02788929|Cardiac Rehabilitation|cardiac rehabilitation
5192569|NCT02788929|Fitbit Charge HR|fitbit charge hr
5192571|NCT02788903|Obesity Counseling|obesity counseling
5192572|NCT02788864|Forest ranger|forest ranger
5192573|NCT02788864|P.falciparum|p.falciparum
5192574|NCT02788864|P.vivax|p.vivax
5192575|NCT02788864|Dihydroartemisinine-piperaquine (DP)|dihydroartemisinine-piperaquine (dp)
5192576|NCT02788864|Primaquine|primaquine
5192577|NCT02788851|Stimulant Medication|stimulant medication
5192578|NCT02788851|Exercise|exercise
5192579|NCT02788851|Functional Outcome|functional outcome
5192580|NCT02788851|Effectiveness|effectiveness
5940419|NCT00667368|bacterial vaginosis|bacterial vaginosis
5940420|NCT00667368|children|children
5940421|NCT00667368|chlamydia|chlamydia
5940422|NCT00667368|gonorrhea|gonorrhea
5940423|NCT00667368|mentronidazole|mentronidazole
5940424|NCT00667368|vaginal|vaginal
5180603|NCT02861456|Adolescent|adolescent
5180605|NCT02861456|Athlete|athlete
5192581|NCT02788851|Symptoms|symptoms
5192582|NCT02788838|Magnetic Resonance Imaging|magnetic resonance imaging
5192583|NCT02788838|Energy Intake|energy intake
5192584|NCT02788838|Commercials|commercials
5962403|NCT04281108|Esophagitis|esophagitis
5962404|NCT04281108|Eosinophilic Esophagitis|eosinophilic esophagitis
5068036|NCT03573817|COPD|copd
5192585|NCT02788838|Children|children
5192586|NCT02788799|ST Elevation|st elevation
5192587|NCT02788799|LCX Artery|lcx artery
5192588|NCT02788786|chlorhexidine|chlorhexidine
5192589|NCT02788786|cetylpyridinium chloride|cetylpyridinium chloride
5192590|NCT02788786|gingival crevicular fluid|gingival crevicular fluid
5192591|NCT02788734|carpal tunnel syndrome|carpal tunnel syndrome
5192592|NCT02788734|CTS|cts
5192593|NCT02788734|inherited peripheral neuropathy|inherited peripheral neuropathy
5192594|NCT02788734|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
5192595|NCT02788734|Hereditary Neuropathy|hereditary neuropathy
5192596|NCT02788734|Pressure Palsies|pressure palsies
5192615|NCT02788539|Chronic Pain|chronic pain
5192616|NCT02788539|mhealth|mhealth
5192617|NCT02788539|Integrative Medicine|integrative medicine
5192618|NCT02788539|MBSR|mbsr
5192619|NCT02788539|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5192620|NCT02788539|Web based|web based
5192621|NCT02788539|Internet Based|internet based
5192622|NCT02788526|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5192623|NCT02788526|Chemoembolization|chemoembolization
5192624|NCT02788526|Adjuvant therapy|adjuvant therapy
5192625|NCT02788526|Hepatocellular|hepatocellular
5192626|NCT02788526|Microvessels invasion|microvessels invasion
5192627|NCT02788500|Epidemiology|epidemiology
5192628|NCT02788500|Sports medicine|sports medicine
5192629|NCT02788500|Research protocol|research protocol
5192630|NCT02788500|Athletic injuries|athletic injuries
5192631|NCT02788500|Sports for persons with disabilities|sports for persons with disabilities
5192632|NCT02788448|Percutaneous vascular closure device|percutaneous vascular closure device
5192633|NCT02788448|Large hole closure device|large hole closure device
5192634|NCT02788396|STEMI|stemi
5192635|NCT02788396|PPCI|ppci
5192636|NCT02788396|post-dilatation|post-dilatation
5192637|NCT02788396|coronary microcirculation|coronary microcirculation
5192638|NCT02788370|Positive expiratory pressure|positive expiratory pressure
5192639|NCT02788370|Cardiopulmonary responses|cardiopulmonary responses
5192640|NCT02788370|Exercise|exercise
5192641|NCT02788370|Older people|older people
5192642|NCT02788357|motor training|motor training
5192643|NCT02788357|motor recovery|motor recovery
5192644|NCT02788357|human|human
5192645|NCT02788357|neuroplasticity|neuroplasticity
5192646|NCT02788357|transcranial magnetic stimulation|transcranial magnetic stimulation
5192647|NCT02788344|Observational study|observational study
5192648|NCT02788344|Myocardial revascularization|myocardial revascularization
5192649|NCT02788344|Thrombolytic therapy|thrombolytic therapy
5192650|NCT02788344|Hospital mortality|hospital mortality
5192651|NCT02788344|Hemorrhage|hemorrhage
5192652|NCT02788344|Quality of health care|quality of health care
5192653|NCT02788344|Angioplasty|angioplasty
5192654|NCT02788318|Epilepsy|epilepsy
5192655|NCT02788318|SUDEP|sudep
5192656|NCT02788318|Serotonin|serotonin
5192657|NCT02788292|acetylcysteine|acetylcysteine
5192658|NCT02788292|three-dimensional reconstruction|three-dimensional reconstruction
5192661|NCT02788266|Cervical lesion|cervical lesion
5192662|NCT02788266|gingival recession|gingival recession
5192663|NCT02788266|restorative materials|restorative materials
5192664|NCT02788253|Mallampati|mallampati
5192665|NCT02788253|Intubation difficult|intubation difficult
5192666|NCT02788253|Mask ventilation difficult|mask ventilation difficult
5192668|NCT02788214|Gastric Cancer|gastric cancer
5192669|NCT02788214|Bacterial Risk Factors|bacterial risk factors
5192670|NCT02788214|DNA Methylation|dna methylation
5192671|NCT02788214|DNA Sequencing|dna sequencing
5192672|NCT02788214|Biobank|biobank
5192676|NCT02788188|First in Human|first in human
5192677|NCT02788188|Middle East Respiratory Syndrome (MERS)|middle east respiratory syndrome (mers)
5192678|NCT02788188|Tc Bovine-Derived|tc bovine-derived
5192679|NCT02788188|Transchromosomic Cattle|transchromosomic cattle
5192683|NCT02788149|Ultrasonography|ultrasonography
5192684|NCT02788149|Submental|submental
5192685|NCT02788149|Lateral Parapharyngeal wall|lateral parapharyngeal wall
5192686|NCT02788149|Tongue base thickness|tongue base thickness
5192687|NCT02788149|Polysomnography|polysomnography
5192688|NCT02788123|De-Nol|de-nol
5192689|NCT02788123|NSAID-induced gastropathy|nsaid-induced gastropathy
5192690|NCT02788123|Pantoprazole|pantoprazole
5192691|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate
5192692|NCT02788123|Russia|russia
5192694|NCT02788097|progesterone|progesterone
5192695|NCT02788097|implantation|implantation
5192696|NCT02788097|artificial frozen embryo transfer|artificial frozen embryo transfer
5192697|NCT02788084|Next Generation Sequencing|next generation sequencing
5940425|NCT00667368|women|women
5180704|NCT02860637|Spinal cord injuries|spinal cord injuries
5180705|NCT02860637|Penile erection|penile erection
5180706|NCT02860637|erectile dysfunction|erectile dysfunction
5192698|NCT02788084|Cell free DNA|cell free dna
5192699|NCT02788071|Irritable Bowel Syndrome|irritable bowel syndrome
5192700|NCT02788071|Fecal Microbiota Transplantation|fecal microbiota transplantation
5192701|NCT02788071|Microbiota|microbiota
5962405|NCT04281108|Esophageal Diseases|esophageal diseases
5962406|NCT04281108|Gastrointestinal Diseases|gastrointestinal diseases
5060192|NCT03622684|Stress|stress
5068107|NCT03573531|omega-6 fatty acids|omega-6 fatty acids
5068108|NCT03573531|preterm infants|preterm infants
5068109|NCT03573531|malondialdehyde|malondialdehyde
5068110|NCT03573518|Synthetic CBD|synthetic cbd
5068111|NCT03573518|Cannabidiol|cannabidiol
5068112|NCT03573479|rehabilitation|rehabilitation
5068116|NCT03573466|ALS|als
5192702|NCT02788058|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5192703|NCT02788058|EGFR Positive|egfr positive
5192704|NCT02788058|Lung Adenocarcinoma|lung adenocarcinoma
5192705|NCT02788058|Limited Metastases|limited metastases
5192706|NCT02788019|Adductor canal block, nerve block|adductor canal block, nerve block
5192707|NCT02787941|acute coronary syndrome|acute coronary syndrome
5192708|NCT02787941|medication adherence|medication adherence
5192709|NCT02787941|pharmacist-led interventions|pharmacist-led interventions
5192710|NCT02787941|Vietnam|vietnam
5192711|NCT02787915|dendritic cells|dendritic cells
5192712|NCT02787915|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5192713|NCT02787915|DC vaccine|dc vaccine
5192715|NCT02787837|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5192716|NCT02787837|Abiraterone Acetate|abiraterone acetate
5192717|NCT02787837|Biomarkers|biomarkers
5192718|NCT02787824|iron deficiency|iron deficiency
5192719|NCT02787824|hemodialysis|hemodialysis
5192721|NCT02787811|Pregnancy rate|pregnancy rate
5192722|NCT02787811|predictors|predictors
5192723|NCT02787798|Nervous System|nervous system
5192724|NCT02787798|Cardiac disease|cardiac disease
5192725|NCT02787785|Subcutaneous|subcutaneous
5192726|NCT02787785|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5192727|NCT02787785|MADIT|madit
5192728|NCT02787785|Diabetes|diabetes
5192729|NCT02787785|Myocardial Infarction|myocardial infarction
5192731|NCT02787759|walking|walking
5192732|NCT02787759|balance|balance
5192733|NCT02787759|exercise|exercise
5192734|NCT02787746|AD|ad
5192735|NCT02787746|Donepezil|donepezil
5192736|NCT02787746|Safety|safety
5192737|NCT02787733|performance|performance
5192738|NCT02787733|recovery|recovery
5192739|NCT02787720|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5192740|NCT02787720|Pulmonary Rehabilitation|pulmonary rehabilitation
5192741|NCT02787720|Rehabilitation Plan|rehabilitation plan
5192742|NCT02787720|Rehabilitation Techniques|rehabilitation techniques
5192743|NCT02787720|Survivor|survivor
5192744|NCT02787720|Randomized Controlled Trial|randomized controlled trial
5192745|NCT02787707|Breast cancer|breast cancer
5192746|NCT02787707|Traditional medicine|traditional medicine
5192747|NCT02787707|Chemotherapy Induced Nausea and Vomiting|chemotherapy induced nausea and vomiting
5192748|NCT02787707|Bunium Persicum|bunium persicum
5192749|NCT02787707|Rhus Coriaria|rhus coriaria
5192750|NCT02787694|stroke|stroke
5192751|NCT02787694|walking|walking
5192752|NCT02787694|balance|balance
5192753|NCT02787694|exercise|exercise
5192754|NCT02787668|childhood obesity|childhood obesity
5192755|NCT02787668|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5192756|NCT02787668|insulin resistance|insulin resistance
5192757|NCT02787668|carbohydrate-restriction|carbohydrate-restriction
5192758|NCT02787655|Aging|aging
5192766|NCT02787577|Energy Intake|energy intake
5192767|NCT02787577|Energy Expenditure|energy expenditure
5192768|NCT02787577|Energy Balance|energy balance
5192769|NCT02787577|Cardiovascular Risk|cardiovascular risk
5192770|NCT02787564|fruit, vegetables|fruit, vegetables
5192771|NCT02787538|Rheumatoid Arthritis|rheumatoid arthritis
5192772|NCT02787538|Decision Aids|decision aids
5192773|NCT02787538|Biologics|biologics
5192774|NCT02787512|ERCP|ercp
5192775|NCT02787512|stent|stent
5192776|NCT02787512|preoperative biliary drainage|preoperative biliary drainage
5192777|NCT02787499|Drug resistance|drug resistance
5192778|NCT02787499|Standard of care|standard of care
5192779|NCT02787499|sub-saharan africa|sub-saharan africa
5192780|NCT02787499|antiretroviral therapy|antiretroviral therapy
5192781|NCT02787499|diagnostics|diagnostics
5192782|NCT02787499|implementation|implementation
5192783|NCT02787486|Down syndrome|down syndrome
5192784|NCT02787486|Edwards syndrome|edwards syndrome
5192785|NCT02787486|Patau syndrome|patau syndrome
5192786|NCT02787486|Klinefelter syndrome|klinefelter syndrome
5192787|NCT02787486|DiGeorge syndrome|digeorge syndrome
5962407|NCT04281108|Digestive System Diseases|digestive system diseases
5192788|NCT02787486|Chromosome Deletion|chromosome deletion
5192789|NCT02787486|Aneuploidy|aneuploidy
5192790|NCT02787473|Squamous cell lung cancer|squamous cell lung cancer
5192791|NCT02787473|Pemetrexed|pemetrexed
5180801|NCT02859987|US|us
5180802|NCT02859987|Nursing Services|nursing services
5962408|NCT04281108|Gastroenteritis|gastroenteritis
5962409|NCT04281108|Eosinophilia|eosinophilia
5962410|NCT04281108|Leukocyte Disorders|leukocyte disorders
5962411|NCT04281108|Hematologic Diseases|hematologic diseases
5962412|NCT04281108|Hypersensitivity, Immediate|hypersensitivity, immediate
5962413|NCT04281108|Hypersensitivity|hypersensitivity
5962414|NCT04281108|Immune System Diseases|immune system diseases
5180803|NCT02859974|Paradoxical vocal fold motion disorder (PVFMD)|paradoxical vocal fold motion disorder (pvfmd)
5180804|NCT02859974|vocal cord dysfunction (VCD)|vocal cord dysfunction (vcd)
5962415|NCT04281108|Fluticasone|fluticasone
5180805|NCT02859974|Respiratory retraining|respiratory retraining
5180806|NCT02859974|Respiratory disorders|respiratory disorders
5180807|NCT02859948|AML|aml
5192792|NCT02787473|Radiosensitivity|radiosensitivity
5192793|NCT02787460|Parenting|parenting
5192794|NCT02787460|Family Relations|family relations
5192795|NCT02787460|Marriage|marriage
5192796|NCT02787460|Relationships|relationships
5192797|NCT02787447|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5192798|NCT02787447|Thymosin Alpha 1|thymosin alpha 1
5192799|NCT02787447|Lung Adenocarcinoma|lung adenocarcinoma
5192800|NCT02787447|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5192801|NCT02787434|African american men|african american men
5192802|NCT02787434|prostate cancer screening|prostate cancer screening
5192803|NCT02787434|web-based decision aid|web-based decision aid
5192804|NCT02787434|informed decision making|informed decision making
5192805|NCT02787434|shared decision-making|shared decision-making
5192806|NCT02787421|Reconstructive Surgery|reconstructive surgery
5192807|NCT02787421|Rhinoplasty|rhinoplasty
5192808|NCT02787382|cytomegalovirus|cytomegalovirus
5192810|NCT02787382|prenatal diagnosis|prenatal diagnosis
5192811|NCT02787382|congenital infections|congenital infections
5192812|NCT02787382|fetal abnormalities|fetal abnormalities
5192813|NCT02787382|echocardiography|echocardiography
5192814|NCT02787382|myocardial deformation|myocardial deformation
5192815|NCT02787369|Refractory Leukemia|refractory leukemia
5192816|NCT02787369|Leukemia|leukemia
5192817|NCT02787356|Skin Diseases, Erythema|skin diseases, erythema
5192818|NCT02787330|pediatric cancer|pediatric cancer
5192819|NCT02787330|psychosocial|psychosocial
5192820|NCT02787330|siblings|siblings
5192821|NCT02787317|bivalirudin|bivalirudin
5192822|NCT02787317|myocardial injure|myocardial injure
5192823|NCT02787304|NAFLD activity score|nafld activity score
5192824|NCT02787304|ASBTi|asbti
5192825|NCT02787304|MRI PDFF|mri pdff
5192826|NCT02787304|NAS|nas
5192827|NCT02787304|NAFLD|nafld
5192828|NCT02787304|liver disease|liver disease
5192829|NCT02787304|ASBT|asbt
5192830|NCT02787304|MRI proton density fat fraction|mri proton density fat fraction
5192831|NCT02787304|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5192832|NCT02787304|apical sodium dependent bile acid transporter inhibitor|apical sodium dependent bile acid transporter inhibitor
5192833|NCT02787304|fatty liver|fatty liver
5192834|NCT02787304|NASH|nash
5192835|NCT02787278|rtPA|rtpa
5192836|NCT02787278|Intracranial hemorrhage|intracranial hemorrhage
5192837|NCT02787265|High density spinal cord stimulation|high density spinal cord stimulation
5192838|NCT02787265|Virtual expert registry|virtual expert registry
5192839|NCT02787226|liposomal bupivacaine|liposomal bupivacaine
5192840|NCT02787226|analgesia for total shoulder arthroplasty|analgesia for total shoulder arthroplasty
5192841|NCT02787226|peripheral nerve blocks for total shoulder arthroplasty|peripheral nerve blocks for total shoulder arthroplasty
5192851|NCT02787174|Medication adherence|medication adherence
5192852|NCT02787174|Intervention study|intervention study
5192853|NCT02787161|Chronic Kidney Disease|chronic kidney disease
5192854|NCT02787161|Hemodialysis|hemodialysis
5192855|NCT02787161|Hemodiafiltration|hemodiafiltration
5192856|NCT02787161|Renal Replacement Therapy|renal replacement therapy
5192857|NCT02787161|Physical Activity|physical activity
5192858|NCT02787161|Accelerometer|accelerometer
5192859|NCT02787148|cognitive behavioral therapy|cognitive behavioral therapy
5192860|NCT02787148|psychotherapy|psychotherapy
5192861|NCT02787148|cardiovascular health|cardiovascular health
5192862|NCT02787148|psychoneuroimmunology|psychoneuroimmunology
5192863|NCT02787135|Delusions|delusions
5192864|NCT02787135|Schizophrenia|schizophrenia
5192865|NCT02787135|Cognitive Behavior Therapy|cognitive behavior therapy
5192866|NCT02787135|Emotion|emotion
5192867|NCT02787135|Emotion regulation|emotion regulation
5192868|NCT02787135|self-esteem|self-esteem
5192869|NCT02787135|sleep quality|sleep quality
5192870|NCT02787135|Efficacy of change|efficacy of change
5192871|NCT02787122|Schizophrenia|schizophrenia
5180891|NCT02859337|body weight|body weight
5180893|NCT02859337|emergency contraception|emergency contraception
5180894|NCT02859337|levonorgestrel|levonorgestrel
5180895|NCT02859337|ulipristal acetate|ulipristal acetate
5180896|NCT02859324|CC-122|cc-122
5180897|NCT02859324|Nivolumab|nivolumab
5180898|NCT02859324|Hepatocellular Carcinoma|hepatocellular carcinoma
5180899|NCT02859324|Phase 1/2|phase 1/2
5180900|NCT02859324|Safety|safety
5180901|NCT02859311|Recovery|recovery
5180902|NCT02859298|Premature Delivery|premature delivery
5180903|NCT02859298|Polarimetric Imaging|polarimetric imaging
5180904|NCT02859298|Polarimetric colposcope|polarimetric colposcope
5180906|NCT02859285|Arousal|arousal
5192872|NCT02787122|psychotic disorders|psychotic disorders
5192873|NCT02787122|Cognitive Behavior Therapy|cognitive behavior therapy
5192874|NCT02787122|emotion regulation|emotion regulation
5192875|NCT02787122|self-esteem|self-esteem
5192876|NCT02787122|randomized-controlled trial|randomized-controlled trial
5192877|NCT02787109|Safety|safety
5192878|NCT02787109|Immunogenicity|immunogenicity
5192879|NCT02787109|Phase I|phase i
5192880|NCT02787096|dynamic knee laxity measurement|dynamic knee laxity measurement
5192881|NCT02787096|laxi-MRI|laxi-mri
5192882|NCT02787096|partial anterior cruciate ligament tear|partial anterior cruciate ligament tear
5192883|NCT02787083|Interstitial Cystitis|interstitial cystitis
5192884|NCT02787044|influenza vaccine|influenza vaccine
5192885|NCT02787044|cardiopulmonary hospitalization|cardiopulmonary hospitalization
5192886|NCT02787044|heart failure|heart failure
5192887|NCT02787044|myocardial infarction|myocardial infarction
5192888|NCT02787044|clinical trial|clinical trial
5192889|NCT02787031|hip fracture|hip fracture
5192890|NCT02787031|geriatric|geriatric
5192891|NCT02787031|epidemiology|epidemiology
5192892|NCT02787031|practice variation|practice variation
5192893|NCT02787031|anesthesia|anesthesia
5192894|NCT02787018|Brachial plexus block|brachial plexus block
5192895|NCT02787018|Ropivacaine|ropivacaine
5192896|NCT02787018|Dexmedetomidine|dexmedetomidine
5192897|NCT02787018|Dexamethasone|dexamethasone
5192898|NCT02787018|Adjuvants, anesthesia|adjuvants, anesthesia
5192900|NCT02787005|PD-1|pd-1
5192901|NCT02787005|PDL1|pdl1
5192902|NCT02787005|PD-L1|pd-l1
5192903|NCT02786992|Misoprostol|misoprostol
5192904|NCT02786992|Oxytocin|oxytocin
5192905|NCT02786992|Carbetocin|carbetocin
5192906|NCT02786992|Prevention|prevention
5192907|NCT02786992|Post-partum hemorrhage|post-partum hemorrhage
5192908|NCT02786979|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5192909|NCT02786979|Arteriosclerosis|arteriosclerosis
5192910|NCT02786979|beraprost|beraprost
5192911|NCT02786979|Aspirin|aspirin
5192912|NCT02786966|Cervical spine injuries|cervical spine injuries
5192913|NCT02786966|Canadian C-spine Rule|canadian c-spine rule
5192914|NCT02786966|Emergency Medical Services|emergency medical services
5192915|NCT02786966|Paramedic|paramedic
5192916|NCT02786966|Cervical spine fracture|cervical spine fracture
5192917|NCT02786953|Sleep|sleep
5192918|NCT02786953|Adherence|adherence
5192937|NCT02786862|ventilation/perfusion mismatch|ventilation/perfusion mismatch
5192938|NCT02786862|thoracic anesthesia|thoracic anesthesia
5192939|NCT02786849|Electric Stimulation|electric stimulation
5192940|NCT02786849|Electric Stimulation Therapy|electric stimulation therapy
5192941|NCT02786836|acute liver failure|acute liver failure
5192942|NCT02786836|methacetin|methacetin
5192943|NCT02786836|breath test|breath test
5192944|NCT02786836|severe acute liver injury|severe acute liver injury
5192945|NCT02786836|hepatic encephalopathy|hepatic encephalopathy
5259494|NCT02391480|Cancer|cancer
5180994|NCT02858804|EDOCH|edoch
5180995|NCT02858804|DHAP|dhap
5180996|NCT02858804|maintenance therapy|maintenance therapy
5180997|NCT02858778|Palliative Care|palliative care
5180998|NCT02858778|Emergency Department|emergency department
5180999|NCT02858752|Attention|attention
5192946|NCT02786836|ALFSG Registry|alfsg registry
5192947|NCT02786836|acetaminophen toxicity|acetaminophen toxicity
5192948|NCT02786797|breast cancer|breast cancer
5192949|NCT02786797|mindfulness-based stress reduction|mindfulness-based stress reduction
5192950|NCT02786797|cognitive impairment|cognitive impairment
5192951|NCT02786771|Stress Management|stress management
5192952|NCT02786771|Mindfulness|mindfulness
5192953|NCT02786771|Meditation|meditation
5192954|NCT02786771|Stress Resilience|stress resilience
5192955|NCT02786732|Psoriasis|psoriasis
5192956|NCT02786719|Sargramostim|sargramostim
5192957|NCT02786719|Cyclophosphamide|cyclophosphamide
5192958|NCT02786719|Topotecan|topotecan
5192959|NCT02786719|Cisplatin|cisplatin
5192960|NCT02786719|Dexrazoxane|dexrazoxane
5192961|NCT02786719|Doxorubicin|doxorubicin
5192962|NCT02786719|Etoposide|etoposide
5192963|NCT02786719|Filgrastim|filgrastim
5192964|NCT02786719|Vincristine|vincristine
5192965|NCT02786719|Mesna|mesna
5192966|NCT02786706|Traumatic Brain Injury|traumatic brain injury
5192967|NCT02786706|Intracranial Pressure|intracranial pressure
5192968|NCT02786706|Ultrasonography|ultrasonography
5192969|NCT02786706|Computer-Assisted Image Analysis|computer-assisted image analysis
5192970|NCT02786706|Intracranial Hypertension|intracranial hypertension
5192971|NCT02786706|Acute brain injuries|acute brain injuries
5192972|NCT02786693|TEP-scan|tep-scan
5192973|NCT02786654|Acute myocardial infarction|acute myocardial infarction
5192974|NCT02786654|mortality|mortality
5192975|NCT02786654|evidence-based care|evidence-based care
5192976|NCT02786654|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5192977|NCT02786654|β blockers|β blockers
5192978|NCT02786641|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5192979|NCT02786641|induction chemotherapy|induction chemotherapy
5192980|NCT02786641|concurrent chemotherapy|concurrent chemotherapy
5192981|NCT02786641|docetaxel|docetaxel
5192982|NCT02786641|cisplatin|cisplatin
5192983|NCT02786641|xeloda|xeloda
5192984|NCT02786641|nomogram|nomogram
5192985|NCT02786615|men who have sex with men (MSM)|men who have sex with men (msm)
5192997|NCT02786537|Hepatitis C|hepatitis c
5192998|NCT02786524|Palliative Care|palliative care
5192999|NCT02786524|Triage|triage
5193000|NCT02786524|Symptom Evaluation|symptom evaluation
5193001|NCT02786524|Chemotherapy|chemotherapy
5193002|NCT02786524|Patient Distress|patient distress
5193003|NCT02786498|Tibial Shaft|tibial shaft
5193004|NCT02786498|Tibia|tibia
5193005|NCT02786498|Femoral Shaft|femoral shaft
5193006|NCT02786498|Femur|femur
5193023|NCT02786459|Prostate|prostate
5193024|NCT02786459|Local Recurrence|local recurrence
5193025|NCT02786459|Radical Prostatectomy|radical prostatectomy
5193026|NCT02786446|Lidocaine gel|lidocaine gel
5193027|NCT02786446|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
5193028|NCT02786446|Naproxen sodium|naproxen sodium
5193029|NCT02786446|Pain score|pain score
5193030|NCT02786420|pregnancy|pregnancy
5193031|NCT02786420|magnetic resonance imaging|magnetic resonance imaging
5193032|NCT02786420|environmental air pollutants|environmental air pollutants
5193033|NCT02786407|overactive bladder|overactive bladder
5423232|NCT01616576|adults|adults
5193034|NCT02786407|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
5193035|NCT02786368|Food Production|food production
5193036|NCT02786368|Inadequacy|inadequacy
5193037|NCT02786368|Dietary zinc|dietary zinc
5193038|NCT02786368|Iron|iron
5193039|NCT02786368|vitamin A|vitamin a
5193040|NCT02786342|Hepatocellular Carcinoma|hepatocellular carcinoma
5193041|NCT02786342|Sorafenib|sorafenib
5193043|NCT02786342|Angiogenesis|angiogenesis
5193044|NCT02786342|Polymorphisms|polymorphisms
5193045|NCT02786329|colorectal cancer|colorectal cancer
5193046|NCT02786329|TIVA|tiva
5193047|NCT02786329|sevoflurane|sevoflurane
5193048|NCT02786329|lidocaine|lidocaine
5193175|NCT02785419|Upper Extremity|upper extremity
5193049|NCT02786264|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5193050|NCT02786264|anesthesia|anesthesia
5193051|NCT02786264|conscious sedation|conscious sedation
5193052|NCT02786264|managed anesthesia care|managed anesthesia care
5193053|NCT02786199|Hepatocellular Carcinoma(HCC)|hepatocellular carcinoma(hcc)
5193054|NCT02786199|Ultrasound|ultrasound
5193055|NCT02786199|Backscatter|backscatter
5193056|NCT02786199|Differentiation grade|differentiation grade
5193057|NCT02786199|Survival|survival
5193066|NCT02786173|PRIME|prime
5193068|NCT02786173|PVD|pvd
5193069|NCT02786173|Observational|observational
5193070|NCT02786173|CLI|cli
5193071|NCT02786173|PRIME Registry|prime registry
5193072|NCT02786147|Breast Cancer|breast cancer
5193073|NCT02786147|Ovarian Cancer|ovarian cancer
5193074|NCT02786147|B-RST|b-rst
5193075|NCT02786121|hip replacement,|hip replacement,
5193076|NCT02786121|rehabilitation,|rehabilitation,
5193077|NCT02786121|early ambulation,|early ambulation,
5193078|NCT02786108|left gastric artery|left gastric artery
5193079|NCT02786108|embolization|embolization
5193080|NCT02786108|obesity|obesity
5193081|NCT02786095|Atrial fibrillation|atrial fibrillation
5193082|NCT02786095|anti arrhythmic drug|anti arrhythmic drug
5193083|NCT02786095|NOAC|noac
5193084|NCT02786095|warfarin|warfarin
5193085|NCT02786095|coumadin|coumadin
5193086|NCT02786056|Respiratory Function Tests|respiratory function tests
5193087|NCT02786056|Lung|lung
5193088|NCT02785965|electroacupuncture|electroacupuncture
5193089|NCT02785965|lifestyle modification|lifestyle modification
5193090|NCT02785965|diet|diet
5193091|NCT02785965|exercise|exercise
5193092|NCT02785965|Dai Meridian|dai meridian
5193093|NCT02785926|pesticide exposure|pesticide exposure
5193094|NCT02785926|respiratory control|respiratory control
5193095|NCT02785926|sleep|sleep
5193096|NCT02785900|Antibodies, monoclonal|antibodies, monoclonal
5193097|NCT02785900|Antibody drug conjugate|antibody drug conjugate
5193098|NCT02785900|Antigens, cluster of differentiation 33 (CD33)|antigens, cluster of differentiation 33 (cd33)
5193099|NCT02785900|Drug therapy|drug therapy
5193100|NCT02785900|Immunotherapy|immunotherapy
5193101|NCT02785887|Breast cancer|breast cancer
5193102|NCT02785887|lung cancer|lung cancer
5193103|NCT02785887|Gastrointestinal Cancer|gastrointestinal cancer
5193104|NCT02785887|Ovarian cancer|ovarian cancer
5193105|NCT02785887|Prostate cancer|prostate cancer
5193106|NCT02785887|bladder cancer|bladder cancer
5193107|NCT02785861|hormonal therapy|hormonal therapy
5193108|NCT02785861|walking|walking
5193109|NCT02785861|fatigue|fatigue
5193110|NCT02785822|Reproductive Techniques, Assisted|reproductive techniques, assisted
5193111|NCT02785809|Oral contraceptives|oral contraceptives
5193112|NCT02785809|long-term use|long-term use
5193114|NCT02785809|Ovarian reserve parameters|ovarian reserve parameters
5193115|NCT02785783|EndoRings™|endorings™
5193116|NCT02785757|adenocarcinoma|adenocarcinoma
5193117|NCT02785757|venous thromboembolism|venous thromboembolism
5193118|NCT02785757|thrombin generation assay|thrombin generation assay
5193119|NCT02785731|pelvic mass|pelvic mass
5193120|NCT02785731|ovarian cancer|ovarian cancer
5193121|NCT02785731|gynecological cancer|gynecological cancer
5193122|NCT02785731|risk prediction|risk prediction
5193123|NCT02785718|Contact system|contact system
5193124|NCT02785718|Factor XI deficiency|factor xi deficiency
5193125|NCT02785718|Factor XII deficiency|factor xii deficiency
5193126|NCT02785718|Global haemostasis assays|global haemostasis assays
5193127|NCT02785705|immunization|immunization
5068557|NCT03570450|stem cell|stem cell
5068558|NCT03570450|transplantation|transplantation
5068559|NCT03570450|graft|graft
5068570|NCT03570424|Organelle Biogenesis|organelle biogenesis
5068572|NCT03570424|Whey Proteins|whey proteins
5193128|NCT02785705|vaccine schedule|vaccine schedule
5193129|NCT02785705|poliomyelitis|poliomyelitis
5193130|NCT02785705|polio|polio
5193131|NCT02785705|oral polio vaccine|oral polio vaccine
5193132|NCT02785705|inactivated polio vaccine|inactivated polio vaccine
5193133|NCT02785692|soft tissue sarcoma|soft tissue sarcoma
5193134|NCT02785692|IMRT and sarcoma|imrt and sarcoma
5193135|NCT02785692|preoperative highly conformal radiation therapy|preoperative highly conformal radiation therapy
5193136|NCT02785692|soft tissue sarcoma and wound healing|soft tissue sarcoma and wound healing
5193137|NCT02785692|postoperative complications|postoperative complications
5193138|NCT02785692|treatment tolerance of soft tissue IMRT|treatment tolerance of soft tissue imrt
5193139|NCT02785679|Allergy|allergy
5193140|NCT02785679|Cow's milk|cow's milk
5193141|NCT02785679|breast feeding|breast feeding
5193142|NCT02785679|Cow's milk formula|cow's milk formula
5193143|NCT02785679|prevention|prevention
5193144|NCT02785666|Men who have sex with men|men who have sex with men
5193145|NCT02785666|Elimination|elimination
5193146|NCT02785653|sevoflurane|sevoflurane
5193147|NCT02785653|rocuronium|rocuronium
5193148|NCT02785653|intubation|intubation
5193149|NCT02785627|Bone health|bone health
5193150|NCT02785627|Bone microarchitecture|bone microarchitecture
5193151|NCT02785627|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
5193152|NCT02785588|MRI Scanner|mri scanner
5193153|NCT02785588|NICU|nicu
5193154|NCT02785562|PDL1 expression : Protein Death Ligand 1 expression .|pdl1 expression : protein death ligand 1 expression .
5193155|NCT02785549|Acute diverticulitis|acute diverticulitis
5181187|NCT02857504|double lumen tube|double lumen tube
5181188|NCT02857504|hook|hook
5181190|NCT02857413|Xerostomia|xerostomia
5193156|NCT02785549|Antibiotic|antibiotic
5193157|NCT02785549|Outpatient treatment|outpatient treatment
5193158|NCT02785536|minority health|minority health
5193159|NCT02785536|social class|social class
5193160|NCT02785536|healthcare disparities|healthcare disparities
5193161|NCT02785536|tobacco use disorder|tobacco use disorder
5193162|NCT02785497|Electrical stimulation|electrical stimulation
5193163|NCT02785497|wound healing|wound healing
5193164|NCT02785497|Polarity current|polarity current
5193165|NCT02785497|Burn|burn
5193166|NCT02785497|Chronic ulcer|chronic ulcer
5193167|NCT02785484|Cigarette smoking|cigarette smoking
5193168|NCT02785484|Smoking|smoking
5193169|NCT02785484|Tobacco use|tobacco use
5193170|NCT02785471|Suicide prevention|suicide prevention
5193171|NCT02785471|men's mental health|men's mental health
5193172|NCT02785471|depression|depression
5193173|NCT02785471|suicide ideation and behaviors|suicide ideation and behaviors
5193174|NCT02785419|Rehabilitation|rehabilitation
5193176|NCT02785419|Physical Therapy|physical therapy
5193177|NCT02785406|cocaine|cocaine
5193178|NCT02785406|sleep|sleep
5193179|NCT02785406|anxiety|anxiety
5193180|NCT02785406|craving|craving
5193181|NCT02785406|addiction|addiction
5193182|NCT02785406|orexin|orexin
5193183|NCT02785406|cue reactivity|cue reactivity
5193184|NCT02785406|suvorexant|suvorexant
5193185|NCT02785406|Belsomra|belsomra
5193186|NCT02785393|Methamphetamine|methamphetamine
5193187|NCT02785393|Dependence|dependence
5193188|NCT02785341|adapted physical activity|adapted physical activity
5193189|NCT02785328|Memory|memory
5193190|NCT02785328|sleep|sleep
5193191|NCT02785328|narcolepsy|narcolepsy
5193192|NCT02785328|apnea|apnea
5193193|NCT02785328|epilepsy|epilepsy
5193194|NCT02785302|Pediatric|pediatric
5193196|NCT02785302|Transition|transition
5193197|NCT02785302|Adult Care|adult care
5193198|NCT02785263|Anal cancer|anal cancer
5193199|NCT02785263|Shared decision making|shared decision making
5193200|NCT02785250|T cell activation|t cell activation
5193201|NCT02785250|immunotherapy|immunotherapy
5193202|NCT02785250|ovarian|ovarian
5193203|NCT02785250|fallopian tube|fallopian tube
5193204|NCT02785250|peritoneal|peritoneal
5193205|NCT02785250|cancer|cancer
5193206|NCT02785250|recurrent|recurrent
5193207|NCT02785250|tumor|tumor
5193208|NCT02785250|measurable|measurable
5193209|NCT02785237|Drug-eluting stent|drug-eluting stent
5193211|NCT02785237|Re-endothelialization|re-endothelialization
5193212|NCT02785146|Huaier Granule|huaier granule
5193213|NCT02785146|After radical surgery|after radical surgery
5189373|NCT02807402|HCV|hcv
5193217|NCT02785120|Efficacy|efficacy
5193219|NCT02785120|Ischemic Stroke|ischemic stroke
5193220|NCT02785107|Exercise|exercise
5193221|NCT02785107|Habit|habit
5962416|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents
5962417|NCT04281108|Bronchodilator Agents|bronchodilator agents
5962418|NCT04281108|Autonomic Agents|autonomic agents
5962419|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents
5962420|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents
5193222|NCT02785107|MVPA|mvpa
5193223|NCT02785107|M-PAC|m-pac
5193224|NCT02785107|Automaticity|automaticity
5193225|NCT02785107|Physical Activity|physical activity
5193226|NCT02785094|Caesarean Section Rate|caesarean section rate
5193227|NCT02785094|Primigravida|primigravida
5193228|NCT02785081|Thoracic epidural|thoracic epidural
5193229|NCT02785081|Magnetic Resonance Imaging|magnetic resonance imaging
5193230|NCT02785081|Children|children
5193231|NCT02785068|Phase I|phase i
5193232|NCT02785068|Cancer|cancer
5193233|NCT02785068|EGFR|egfr
5193234|NCT02785068|Metastatic Colorectal Cancer|metastatic colorectal cancer
5193235|NCT02785068|Oncology|oncology
5193236|NCT02785068|RAS/RAF Wild-Type|ras/raf wild-type
5193238|NCT02785068|EGFR Inhibitor|egfr inhibitor
5193239|NCT02785068|Oligoclonal Antibody|oligoclonal antibody
5193240|NCT02785068|Nanoliposome|nanoliposome
5193241|NCT02785068|Nanoliposomal Irinotecan|nanoliposomal irinotecan
5193242|NCT02785016|Stress Urinary Incontinence|stress urinary incontinence
5193243|NCT02785016|Suburethral Sling|suburethral sling
5193244|NCT02785003|Colorectal Surgery|colorectal surgery
5193245|NCT02785003|Acute Pain|acute pain
5193246|NCT02785003|Pain|pain
5193247|NCT02785003|post-operative pain|post-operative pain
5193248|NCT02785003|ketamine|ketamine
5193249|NCT02784938|Employment|employment
5193250|NCT02784938|Mental Illness|mental illness
5193251|NCT02784938|Photovoice|photovoice
5193252|NCT02784912|Biomarkers|biomarkers
5193253|NCT02784912|Ventricular Dysfunction|ventricular dysfunction
5193254|NCT02784912|Ventricular Tachycardia|ventricular tachycardia
5193255|NCT02784912|Electrical Storm|electrical storm
5193257|NCT02784912|Galectin-3|galectin-3
5193258|NCT02784912|NT-proBNP|nt-probnp
5193259|NCT02784912|Iron Deficiency|iron deficiency
5193260|NCT02784912|hs-CRP|hs-crp
5193261|NCT02784912|hs-TnT|hs-tnt
5181288|NCT02856373|Renal Artery|renal artery
5181292|NCT02856347|Medullary Thyroid Cancer|medullary thyroid cancer
5193262|NCT02784886|Placenta accreta|placenta accreta
5193263|NCT02784886|previous caesarean|previous caesarean
5193264|NCT02784886|placenta praevia|placenta praevia
5193265|NCT02784886|Cell-free fetal DNA|cell-free fetal dna
5193266|NCT02784886|Biological markers|biological markers
5193267|NCT02784873|High intensity interval training|high intensity interval training
5193268|NCT02784873|Coronary heart disease|coronary heart disease
5193269|NCT02784873|Exercise training|exercise training
5193270|NCT02784873|Cardiac rehabilitation|cardiac rehabilitation
5193271|NCT02784873|Interval training|interval training
5193272|NCT02784860|colonoscopy|colonoscopy
5193273|NCT02784860|lidocaine|lidocaine
5193274|NCT02784860|propofol|propofol
5193275|NCT02784860|sedation|sedation
5193277|NCT02784834|cancer|cancer
5193278|NCT02784834|DMF|dmf
5193279|NCT02784834|SLL|sll
5193280|NCT02784834|dimethylfumarate|dimethylfumarate
5193281|NCT02784834|relapsed|relapsed
5193282|NCT02784834|refractory|refractory
5193283|NCT02784795|Notch Inhibitor|notch inhibitor
5193284|NCT02784782|Spinal|spinal
5193285|NCT02784782|Vertebral|vertebral
5193286|NCT02784782|Burstfracture|burstfracture
5193287|NCT02784782|Orthesis|orthesis
5193288|NCT02784782|Brace|brace
5193289|NCT02784782|Thoracolumbar|thoracolumbar
5193290|NCT02784756|Quantiferon-CMV|quantiferon-cmv
5193291|NCT02784756|solid organ transplant|solid organ transplant
5193292|NCT02784756|CMV Disease|cmv disease
5193293|NCT02784743|Wuchereria bancrofti|wuchereria bancrofti
5193294|NCT02784743|Anopheles|anopheles
5193301|NCT02784730|implantable device|implantable device
5193302|NCT02784730|randomized controlled trial|randomized controlled trial
5193303|NCT02784730|iterative placement|iterative placement
5193304|NCT02784730|Catheterization, Central Venous|catheterization, central venous
5193305|NCT02784717|rivaroxaban,|rivaroxaban,
5193306|NCT02784717|non-interventional,|non-interventional,
5193307|NCT02784717|atrial fibrillation,|atrial fibrillation,
5193308|NCT02784717|stroke prevention,|stroke prevention,
5193309|NCT02784665|CSC|csc
5193310|NCT02784665|Micropulse Laser|micropulse laser
5193311|NCT02784665|Traditional Laser|traditional laser
5193312|NCT02784639|KRAS/BRAF mutational status|kras/braf mutational status
5193313|NCT02784626|Dexmedetomidine|dexmedetomidine
5193314|NCT02784626|Propofol|propofol
5193315|NCT02784626|Pain, Postoperative|pain, postoperative
5193318|NCT02784587|stellate ganglion block|stellate ganglion block
5193319|NCT02784587|cardiac surgery|cardiac surgery
5193320|NCT02784574|Rehabilitation|rehabilitation
5193321|NCT02784574|Aftercare|aftercare
5862727|NCT00001534|Myocardial Ischemia|myocardial ischemia
5193324|NCT02784561|acute leukemia|acute leukemia
5193325|NCT02784561|relapsed/refractory|relapsed/refractory
5193326|NCT02784535|norepinephrine transporter inhibitors|norepinephrine transporter inhibitors
5193327|NCT02784509|Physical Activity|physical activity
5193328|NCT02784509|Sedentary Behavior|sedentary behavior
5193329|NCT02784509|Cardiometabolic Risk Factors|cardiometabolic risk factors
5193330|NCT02784509|Childhood and Adolescence|childhood and adolescence
5193331|NCT02784444|NASH|nash
5193332|NCT02784405|percutaneous coronary intervention|percutaneous coronary intervention
5193333|NCT02784405|stent implantation|stent implantation
5193334|NCT02784379|Mastalgia|mastalgia
5068788|NCT03569319|Lifestyle|lifestyle
5193335|NCT02784379|electromyography|electromyography
5193336|NCT02784379|Pectoral|pectoral
5193337|NCT02784366|Cancer immunotherapy|cancer immunotherapy
5193338|NCT02784366|Ipilimumab|ipilimumab
5193339|NCT02784353|Rehabilitation|rehabilitation
5193340|NCT02784353|Quality of life|quality of life
5193341|NCT02784353|Surgery|surgery
5193342|NCT02784353|Hepatic neoplasms|hepatic neoplasms
5193343|NCT02784353|Biliary tract neoplasms|biliary tract neoplasms
5193344|NCT02784353|Pancreatic neoplasms|pancreatic neoplasms
5193345|NCT02784340|Postoperative pain|postoperative pain
5193346|NCT02784340|dexamethasone|dexamethasone
5193347|NCT02784340|cesarean section|cesarean section
5193348|NCT02784314|Clinically localized prostate cancer|clinically localized prostate cancer
5193349|NCT02784314|Robotic-assisted prostatectomy|robotic-assisted prostatectomy
5083631|NCT03475576|elderly|elderly
5193350|NCT02784314|Laparoscopic prostatectomy|laparoscopic prostatectomy
5193351|NCT02784314|Erectile function ;|erectile function ;
5193352|NCT02784314|Cost efficacy study|cost efficacy study
5193353|NCT02784288|head and neck neoplasms|head and neck neoplasms
5193355|NCT02784288|human papilloma virus|human papilloma virus
5193356|NCT02784288|de-escalation|de-escalation
5193357|NCT02784288|low-risk|low-risk
5193358|NCT02784288|oropharyngeal cancer|oropharyngeal cancer
5193359|NCT02784262|Botulinum Toxin Type A|botulinum toxin type a
5193360|NCT02784262|Block|block
5193361|NCT02784262|Sphenopalatine Ganglion|sphenopalatine ganglion
5193363|NCT02784249|glaucoma surgery|glaucoma surgery
5193364|NCT02784249|ab interno|ab interno
5260001|NCT02388256|colon|colon
5181387|NCT02855944|Rubraca|rubraca
5193365|NCT02784223|F18-choline|f18-choline
5193366|NCT02784223|Surgery|surgery
5193367|NCT02784223|Indeterminate|indeterminate
5193368|NCT02784223|Thyroid node|thyroid node
5193374|NCT02784197|coronary angiography|coronary angiography
5193375|NCT02784197|ventricular ejection fraction|ventricular ejection fraction
5193376|NCT02784197|coronary artery disease|coronary artery disease
5193377|NCT02784184|Hypothalamic-pituitary-gonadal axis|hypothalamic-pituitary-gonadal axis
5193378|NCT02784158|Non-small cell lung cancer|non-small cell lung cancer
5193379|NCT02784158|Non-small cell lung carcinoma|non-small cell lung carcinoma
5193380|NCT02784158|Epithelial lung cancer|epithelial lung cancer
5193381|NCT02784158|Squamous cell carcinoma|squamous cell carcinoma
5193382|NCT02784158|Large cell carcinoma|large cell carcinoma
5193383|NCT02784158|Adenocarcinoma|adenocarcinoma
5193384|NCT02784158|Anaplastic lymphoma kinase (ALK)|anaplastic lymphoma kinase (alk)
5193385|NCT02784158|Carcinoma|carcinoma
5193386|NCT02784158|Advanced Cancers|advanced cancers
5193387|NCT02784158|Brigatinib|brigatinib
5193388|NCT02784158|AP26113|ap26113
5193389|NCT02784119|temporary porto-caval shunt|temporary porto-caval shunt
5193390|NCT02784119|liver graft|liver graft
5193422|NCT02783989|Genes related to vascular risk|genes related to vascular risk
5193423|NCT02783963|Coronary Artery Disease|coronary artery disease
5193424|NCT02783963|Coronary Thrombosis|coronary thrombosis
5193425|NCT02783963|Coronary Stenosis|coronary stenosis
5193426|NCT02783963|Tomography, Optical Coherence|tomography, optical coherence
5193427|NCT02783963|Magnetic Resonance Imaging|magnetic resonance imaging
5193428|NCT02783950|Genomics|genomics
5193429|NCT02783950|Adjuvant Treatment|adjuvant treatment
5193430|NCT02783937|Premature|premature
5193431|NCT02783937|Ovarian|ovarian
5193432|NCT02783937|Failure|failure
5193433|NCT02783937|Filgrastim|filgrastim
5193434|NCT02783924|vitamin D|vitamin d
5193435|NCT02783924|genomics|genomics
5193436|NCT02783924|proteomics|proteomics
5193437|NCT02783924|metabolomics|metabolomics
5193438|NCT02783924|adipose tissue|adipose tissue
5193439|NCT02783911|Clinical and Radiograph|clinical and radiograph
5193440|NCT02783898|pre syncope, palpitations|pre syncope, palpitations
5193441|NCT02783859|Children|children
5193442|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents
5193443|NCT02783859|Indigenous Population|indigenous population
5193444|NCT02783859|Hospitals|hospitals
5193445|NCT02783846|Propofol|propofol
5193446|NCT02783846|Dexmedetomidine|dexmedetomidine
5193447|NCT02783846|Dose|dose
5193448|NCT02783846|Bispectral index monitor|bispectral index monitor
5193449|NCT02783833|malaria, induced blood stage model challenge|malaria, induced blood stage model challenge
5193452|NCT02783794|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
5193453|NCT02783794|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
5193454|NCT02783794|Metastatic Breast Cancer|metastatic breast cancer
5193455|NCT02783794|Platinum analogue|platinum analogue
5193456|NCT02783794|Metronomic chemotherapy|metronomic chemotherapy
5193457|NCT02783794|Breast cancer|breast cancer
5193458|NCT02783794|Cisplatin|cisplatin
5193459|NCT02783794|Cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
5962421|NCT04281108|Respiratory System Agents|respiratory system agents
5962422|NCT04281108|Anti-Allergic Agents|anti-allergic agents
5193460|NCT02783781|Cardiac surgery (extracorporeal circulation; beating heart)|cardiac surgery (extracorporeal circulation; beating heart)
5193461|NCT02783781|Biological data|biological data
5193462|NCT02783781|Preoperative biological variables|preoperative biological variables
5193463|NCT02783781|EuroSCORE II|euroscore ii
5193464|NCT02783781|Risk prediction|risk prediction
5193465|NCT02783768|E-cigarettes|e-cigarettes
5193466|NCT02783768|COPD|copd
5193467|NCT02783755|pain|pain
5193468|NCT02783755|coping|coping
5193469|NCT02783755|mhealth|mhealth
5193470|NCT02783755|Breast cancer|breast cancer
5193471|NCT02783742|provider-patient communication|provider-patient communication
5193472|NCT02783742|coaching|coaching
5193473|NCT02783742|feedback|feedback
5193474|NCT02783742|burnout|burnout
5193475|NCT02783729|E2006|e2006
5193476|NCT02783729|Lemborexant|lemborexant
5193477|NCT02783729|zolpidem tartrate|zolpidem tartrate
5193478|NCT02783729|Ambien CR|ambien cr
5193479|NCT02783729|Insomnia|insomnia
5193480|NCT02783703|Hyperinsulinemia|hyperinsulinemia
5193481|NCT02783664|Breast Cancer|breast cancer
5193482|NCT02783664|BRCA1|brca1
5193483|NCT02783664|BRCA2|brca2
5193484|NCT02783664|stress|stress
5193485|NCT02783664|gene testing|gene testing
5193486|NCT02783664|genetic screening|genetic screening
5193487|NCT02783664|psychological support|psychological support
5193488|NCT02783664|State-Trait Anxiety Inventory|state-trait anxiety inventory
5193489|NCT02783664|Cancer Worry Scale|cancer worry scale
5181485|NCT02855359|Hematologic Diseases|hematologic diseases
5181486|NCT02855359|Immune System Diseases|immune system diseases
5181487|NCT02855359|Immunoproliferative Disorders|immunoproliferative disorders
5181488|NCT02855359|Immunotherapy|immunotherapy
5181489|NCT02855359|Lymphatic Diseases|lymphatic diseases
5181490|NCT02855359|Lymphoma|lymphoma
5181491|NCT02855359|Lymphoma, B-Cell|lymphoma, b-cell
5181492|NCT02855359|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5193490|NCT02783664|Health Anxiety Inventory|health anxiety inventory
5193491|NCT02783664|gene mutations|gene mutations
5193492|NCT02783625|Duvelisib|duvelisib
5193493|NCT02783625|Romidepsin|romidepsin
5193494|NCT02783625|Bortezomib|bortezomib
5193496|NCT02783573|dementia|dementia
5193497|NCT02783573|brain diseases|brain diseases
5193498|NCT02783573|neurodegenerative diseases|neurodegenerative diseases
5193499|NCT02783573|central nervous system diseases|central nervous system diseases
5193500|NCT02783573|nervous system diseases|nervous system diseases
5193501|NCT02783573|mental disorders|mental disorders
5193502|NCT02783573|delirium, dementia, amnestic, cognitive|delirium, dementia, amnestic, cognitive
5193503|NCT02783573|tauopathies|tauopathies
5193504|NCT02783573|memory|memory
5193505|NCT02783573|amyloid|amyloid
5193506|NCT02783560|Sleep|sleep
5193507|NCT02783560|Electrodermal Activity|electrodermal activity
5193508|NCT02783560|Mealtimes|mealtimes
5193509|NCT02783534|Acupuncture|acupuncture
5193510|NCT02783534|Primary Dysmenorrhea|primary dysmenorrhea
5193511|NCT02783534|Randomized Controlled Trial|randomized controlled trial
5193512|NCT02783534|Placebo Effect|placebo effect
5193513|NCT02783521|Hispanic men|hispanic men
5193514|NCT02783521|Weight loss|weight loss
5193515|NCT02783521|Diet|diet
5193516|NCT02783521|Physical activity|physical activity
5193517|NCT02783521|Intervention|intervention
5193518|NCT02783508|Labor analgesia|labor analgesia
5193519|NCT02783508|Nitrous Oxide|nitrous oxide
5193520|NCT02783508|Meperidine|meperidine
5193521|NCT02783508|Multiparous|multiparous
5193522|NCT02783508|Visual analogue scale|visual analogue scale
5193523|NCT02783495|glioma|glioma
5193524|NCT02783495|neurocognitive|neurocognitive
5193525|NCT02783495|quality of life|quality of life
5193526|NCT02783456|renal hemodynamic|renal hemodynamic
5193527|NCT02783456|central hemodynamic|central hemodynamic
5193528|NCT02783456|pilot study|pilot study
5193529|NCT02783456|flight noise|flight noise
5193530|NCT02783456|healthy participant|healthy participant
5193531|NCT02783456|renal plasma flow|renal plasma flow
5193532|NCT02783456|filtration fraction|filtration fraction
5194545|NCT02777827|Safety|safety
5193533|NCT02783456|renal vascular resistance|renal vascular resistance
5189666|NCT02805465|CRT|crt
5193545|NCT02783430|serotonin norepinephrine reuptake inhibitors|serotonin norepinephrine reuptake inhibitors
5193547|NCT02783404|bacteraemia|bacteraemia
5193548|NCT02783404|endocarditis|endocarditis
5193549|NCT02783404|antibiotic prophylaxis|antibiotic prophylaxis
5193550|NCT02783404|dentistry|dentistry
5193551|NCT02783378|impedance metry|impedance metry
5193552|NCT02783378|gaviscon|gaviscon
5193553|NCT02783339|Next Generation Neuroform Stent System|next generation neuroform stent system
5193554|NCT02783339|Intracranial|intracranial
5193555|NCT02783339|Stent system|stent system
5193556|NCT02783339|Saccular aneurysm|saccular aneurysm
5193557|NCT02783339|Stent assisted coiling|stent assisted coiling
5193558|NCT02783326|Chronic Disease Obstructive Pulmonary|chronic disease obstructive pulmonary
5193559|NCT02783326|Rehabilitation|rehabilitation
5193560|NCT02783326|Physical Therapy|physical therapy
5193561|NCT02783313|pathogen inactivation|pathogen inactivation
5193562|NCT02783313|platelets|platelets
5193563|NCT02783300|GSK3326595|gsk3326595
5193564|NCT02783300|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5193565|NCT02783300|Solid tumor|solid tumor
5193566|NCT02783300|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5193567|NCT02783300|Breast cancer|breast cancer
5193568|NCT02783300|Urinary tract cancer|urinary tract cancer
5193569|NCT02783300|Dose escalation|dose escalation
5193570|NCT02783287|Exercise adherence|exercise adherence
5193571|NCT02783287|Medication adherence|medication adherence
5193572|NCT02783287|Mobile health|mobile health
5193573|NCT02783287|Cardiac rehabilitation|cardiac rehabilitation
5193574|NCT02783261|radioembolization|radioembolization
5193575|NCT02783261|hypertrophy|hypertrophy
5193577|NCT02783248|Percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
5193578|NCT02783248|Mitral Stenosis|mitral stenosis
5193588|NCT02783170|Whooping Cough|whooping cough
5193589|NCT02783170|Pertussis|pertussis
5193590|NCT02783170|Influenza|influenza
5193591|NCT02783157|Autonomic|autonomic
5193592|NCT02783157|Vagal nerve stimulation|vagal nerve stimulation
5193593|NCT02783157|Postoperative atrial fibrillation|postoperative atrial fibrillation
5193594|NCT02783144|Analgesia|analgesia
5193595|NCT02783144|Dexamethasone|dexamethasone
5193596|NCT02783144|Levobupivacaine|levobupivacaine
5193597|NCT02783144|Ultrasound-guided|ultrasound-guided
5193598|NCT02783144|Tranversus Abdominis|tranversus abdominis
5193599|NCT02783131|inventions|inventions
5193600|NCT02783131|Simulation Training|simulation training
5193601|NCT02783131|Postpartum Haemorrhage|postpartum haemorrhage
5193602|NCT02783131|Non Technical Skills|non technical skills
5193603|NCT02783131|teamwork|teamwork
5193604|NCT02783131|Crew Resource Management, Healthcare|crew resource management, healthcare
5193605|NCT02783118|Depression|depression
5193606|NCT02783118|Prevention|prevention
5193607|NCT02783118|CBT|cbt
5193608|NCT02783118|Smartphone app|smartphone app
5193609|NCT02783105|Music therapy|music therapy
5193610|NCT02783105|Paroxysmal sympathetic hyperactivity|paroxysmal sympathetic hyperactivity
5193611|NCT02783105|Traumatic brain injury|traumatic brain injury
5193612|NCT02783079|Breast Cancer|breast cancer
5193613|NCT02783079|Prostate Cancer|prostate cancer
5193614|NCT02783079|Colon Cancer|colon cancer
5193615|NCT02783079|Lung Cancer|lung cancer
5193616|NCT02783079|Gynecologic Cancer|gynecologic cancer
5193617|NCT02783014|overactive bladder|overactive bladder
5193618|NCT02782988|Olfaction|olfaction
5193619|NCT02782988|CMV|cmv
5193620|NCT02782962|nystagmus|nystagmus
5193621|NCT02782962|vertigo|vertigo
5193622|NCT02782962|unsteadiness|unsteadiness
5193623|NCT02782962|emergency duplex ultrasonography|emergency duplex ultrasonography
5193624|NCT02782936|Work of Breathing; Hypoxemia; Respiratory Acidosis; Respiratory effort|work of breathing; hypoxemia; respiratory acidosis; respiratory effort
5193625|NCT02782923|Cervical Spine Surgery|cervical spine surgery
5193626|NCT02782923|Simulation|simulation
5193627|NCT02782897|intravenous immunoglobulin|intravenous immunoglobulin
5193628|NCT02782897|intracerebral hemorrhage|intracerebral hemorrhage
5193629|NCT02782897|perihematomal edema|perihematomal edema
5193630|NCT02782884|post-operative pain|post-operative pain
5193631|NCT02782871|Transfer|transfer
5193632|NCT02782871|Intra-hospital|intra-hospital
5193633|NCT02782871|Ventilator|ventilator
5193634|NCT02782871|Manual ventilation|manual ventilation
5193635|NCT02782871|Head and neck surgery|head and neck surgery
5193636|NCT02782858|Multiple Sclerosis|multiple sclerosis
5193637|NCT02782858|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
5193638|NCT02782858|GNbAC1|gnbac1
5193639|NCT02782858|MRI|mri
5193640|NCT02782858|Monoclonal antibody|monoclonal antibody
5193641|NCT02782858|Multiple Sclerosis associated retrovirus MSRV|multiple sclerosis associated retrovirus msrv
5193642|NCT02782858|MS|ms
5193643|NCT02782858|RRMS|rrms
5193644|NCT02782858|HERV-W|herv-w
5193645|NCT02782832|Neuromuscular|neuromuscular
5193646|NCT02782832|Blockade|blockade
5193647|NCT02782832|Surgery|surgery
5193648|NCT02782819|Shock resuscitation|shock resuscitation
5193649|NCT02782819|colloid|colloid
5193650|NCT02782819|crystalloid|crystalloid
5193651|NCT02782806|Noninvasive|noninvasive
5193652|NCT02782806|Pulse|pulse
5193653|NCT02782806|CO-Oximeter|co-oximeter
5193654|NCT02782806|Validation|validation
5193655|NCT02782793|Endoscopic|endoscopic
5193656|NCT02782793|Mucosal|mucosal
5193657|NCT02782793|Resection|resection
5084013|NCT03473496|CD56-CART|cd56-cart
5193662|NCT02782728|intimate partner violence|intimate partner violence
5193663|NCT02782728|reproductive coercion|reproductive coercion
5193664|NCT02782728|women's health|women's health
5193665|NCT02782728|relationship abuse|relationship abuse
5193666|NCT02782702|Botulism Toxin|botulism toxin
5193672|NCT02782650|Limits|limits
5193673|NCT02782650|Prenatal Counseling|prenatal counseling
5193674|NCT02782650|Decision-making|decision-making
5193675|NCT02782650|Foetal Complications|foetal complications
5193676|NCT02782650|Counseling|counseling
5193677|NCT02782650|Viability|viability
5193678|NCT02782637|limits of viability|limits of viability
5193679|NCT02782637|Prenatal Counseling|prenatal counseling
5193680|NCT02782637|Decision-making|decision-making
5193681|NCT02782637|Viability|viability
5193683|NCT02782611|Happiness|happiness
5193684|NCT02782611|Subjective Well-Being|subjective well-being
5193685|NCT02782611|Psychological Flourishing|psychological flourishing
5193686|NCT02782611|Well-Being|well-being
5193687|NCT02782611|Health|health
5193688|NCT02782611|Behavioral Change|behavioral change
5193689|NCT02782611|Life Satisfaction|life satisfaction
5193690|NCT02782611|Affect|affect
5193691|NCT02782611|Emotion|emotion
5193692|NCT02782611|Goals|goals
5193693|NCT02782611|Meaning in Life|meaning in life
5193694|NCT02782598|Negative|negative
5193695|NCT02782598|Atrioventricular|atrioventricular
5193696|NCT02782598|Hysteresis|hysteresis
5193697|NCT02782598|Cardiac Resynchronization|cardiac resynchronization
5193698|NCT02782598|MultiPoint|multipoint
5193699|NCT02782585|neck pain|neck pain
5193700|NCT02782585|Manual therapy|manual therapy
5193701|NCT02782585|psychological interaction|psychological interaction
5193702|NCT02782572|Exercise|exercise
5193703|NCT02782572|Cardiac Rehabilitation|cardiac rehabilitation
5193704|NCT02782572|Non-invasive ventilation|non-invasive ventilation
5193705|NCT02782520|Cardiopulmonary bypass|cardiopulmonary bypass
5193706|NCT02782520|Swan Ganz|swan ganz
5193707|NCT02782520|Fluid expansion|fluid expansion
5193708|NCT02782520|hypertonic saline solution|hypertonic saline solution
5193709|NCT02782507|pilot study|pilot study
5193710|NCT02782507|CBT trial|cbt trial
5193711|NCT02782494|Latent tuberculosis infection, dialysis|latent tuberculosis infection, dialysis
5193712|NCT02782468|Drug Therapy|drug therapy
5193713|NCT02782442|cognitive training|cognitive training
5193714|NCT02782429|ketamine|ketamine
5193715|NCT02782429|Cardiac Surgery|cardiac surgery
5193716|NCT02782429|Neurocognitive Disorders|neurocognitive disorders
5193717|NCT02782416|Renal|renal
5193718|NCT02782416|Latent|latent
5193719|NCT02782416|Tuberculosis|tuberculosis
5193720|NCT02782390|Stainless dental crown|stainless dental crown
5193721|NCT02782390|Composite Resin|composite resin
5193722|NCT02782390|Primary teeth|primary teeth
5193723|NCT02782377|Faecal Incontinence|faecal incontinence
5193724|NCT02782377|Obstructive Defaecation|obstructive defaecation
5193725|NCT02782377|Rectal Prolapse|rectal prolapse
5193726|NCT02782364|Faecal Incontinence|faecal incontinence
5193727|NCT02782338|warfarin|warfarin
5193728|NCT02782338|Voltaren eye drops|voltaren eye drops
5193730|NCT02782312|Bronchiectasis|bronchiectasis
5193731|NCT02782312|ICS+LABA|ics+laba
5193732|NCT02782299|Decision aid|decision aid
5193733|NCT02782299|Shared decision making|shared decision making
5195555|NCT02771951|Obesity|obesity
5193734|NCT02782299|Older adult patients|older adult patients
5193735|NCT02782299|Distal radius fracture|distal radius fracture
5193736|NCT02782286|ketorolac|ketorolac
5193737|NCT02782286|pain relieve|pain relieve
5193738|NCT02782286|morphine|morphine
5193739|NCT02782273|ketorolac|ketorolac
5193740|NCT02782273|pain relieve|pain relieve
5193743|NCT02782221|ATGL|atgl
5193744|NCT02782182|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5193745|NCT02782182|FOLFIRINOX|folfirinox
5193746|NCT02782182|resectable pancreatic cancer|resectable pancreatic cancer
5193747|NCT02782156|Process Evaluation|process evaluation
5193748|NCT02782156|alcohol withdrawal syndrome|alcohol withdrawal syndrome
5193749|NCT02782143|delirium detection|delirium detection
5193750|NCT02782130|HIV|hiv
5193751|NCT02782130|YMSM|ymsm
5193752|NCT02782130|Trans women|trans women
5193753|NCT02782130|ART Adherence|art adherence
5193754|NCT02782130|Intervention|intervention
5193755|NCT02782104|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
5193756|NCT02782104|Esketamine|esketamine
5193757|NCT02782104|JNJ-54135419|jnj-54135419
5193758|NCT02782091|MET|met
5193759|NCT02782091|Prognosis|prognosis
5193760|NCT02782091|Cognition|cognition
5193761|NCT02782091|Ecological|ecological
5193762|NCT02782091|Executive function|executive function
5193763|NCT02782078|osteoarticular infection|osteoarticular infection
5193764|NCT02782078|rifampicin|rifampicin
5193765|NCT02782078|clindamycin|clindamycin
5193766|NCT02782078|enzymatic induction|enzymatic induction
5193767|NCT02782078|antibiotherapy resistance|antibiotherapy resistance
5193768|NCT02782065|validation|validation
5193769|NCT02782065|pediatrics|pediatrics
5193770|NCT02782065|asthma severity|asthma severity
5193771|NCT02782052|pulmonary arterial hypertension|pulmonary arterial hypertension
5193772|NCT02782052|spirometry|spirometry
5193773|NCT02782052|dynamic lung hyperinflation|dynamic lung hyperinflation
5193774|NCT02782052|bronchodilator|bronchodilator
5193775|NCT02782052|dyspnoea|dyspnoea
5193776|NCT02782052|Idiopathic|idiopathic
5193777|NCT02782052|heritable|heritable
5193778|NCT02782052|PAH|pah
5193779|NCT02782026|pulmonary hypertension|pulmonary hypertension
5193780|NCT02782026|early detection|early detection
5193781|NCT02782013|community acquired pneumonia|community acquired pneumonia
5193782|NCT02782013|CAP|cap
5193783|NCT02782013|disease progression|disease progression
5193784|NCT02782000|dementia|dementia
5193792|NCT02781922|autologous cell therapy|autologous cell therapy
5193793|NCT02781922|functional single ventricle|functional single ventricle
5193794|NCT02781922|congenital heart disease|congenital heart disease
5193795|NCT02781909|NSAIDS|nsaids
5193796|NCT02781909|tuberculosis treatment|tuberculosis treatment
5193797|NCT02781909|anti-inflammatories|anti-inflammatories
5193798|NCT02781909|Host-directed therapies|host-directed therapies
5193799|NCT02781909|TB|tb
5193800|NCT02781896|TAVI|tavi
5193801|NCT02781896|aortic valve bioprothesis|aortic valve bioprothesis
5193802|NCT02781896|TAVI simplification|tavi simplification
5193803|NCT02781896|aortic stenosis|aortic stenosis
5193804|NCT02781896|rapid left ventricular pacing|rapid left ventricular pacing
5193805|NCT02781896|TAVR|tavr
5193806|NCT02781883|Liposomal Grb-2 treatment of AML or High Risk MDS|liposomal grb-2 treatment of aml or high risk mds
5193807|NCT02781883|Liposomal Grb-2 with decitabine for AML or High Risk MDS|liposomal grb-2 with decitabine for aml or high risk mds
5193808|NCT02781857|Exhaled Breath|exhaled breath
5193809|NCT02781857|Mass Spectrometry|mass spectrometry
5193810|NCT02781857|Fingerprinting|fingerprinting
5193811|NCT02781818|hidradenitis|hidradenitis
5193812|NCT02781818|intralesional|intralesional
5193813|NCT02781818|triamcinolone|triamcinolone
5193814|NCT02781779|Cardiac Implantable Electronic Device|cardiac implantable electronic device
5193815|NCT02781779|Implant|implant
5193816|NCT02781766|Haemophilia A|haemophilia a
5193817|NCT02781766|prophylaxis|prophylaxis
5193818|NCT02781766|thrombin generation assay|thrombin generation assay
5193819|NCT02781766|factor VIII|factor viii
5193820|NCT02781766|prophylactic therapy|prophylactic therapy
5193821|NCT02781740|Continous Positive Airway Pressure|continous positive airway pressure
5193822|NCT02781740|CPAP|cpap
5193823|NCT02781740|Sham CPAP|sham cpap
5193824|NCT02781740|CPAP withdrawal|cpap withdrawal
5193825|NCT02781740|suboptimal CPAP|suboptimal cpap
5193826|NCT02781727|Human Growth Hormone|human growth hormone
5193827|NCT02781727|hGH|hgh
5193828|NCT02781727|GHD|ghd
5193829|NCT02781727|rHGH|rhgh
5193830|NCT02781727|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
5193831|NCT02781727|Long Acting Growth Hormone|long acting growth hormone
5193832|NCT02781727|Somatropin|somatropin
5193833|NCT02781727|Prodrug|prodrug
5193834|NCT02781727|Growth Failure|growth failure
5193835|NCT02781727|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5193836|NCT02781727|Sustained Release|sustained release
5193837|NCT02781727|Sustained Release Growth Hormone|sustained release growth hormone
5193838|NCT02781727|Growth Hormone Deficiency|growth hormone deficiency
5193839|NCT02781714|contraception|contraception
5193840|NCT02781714|postpartum period|postpartum period
5193841|NCT02781714|mobile health|mobile health
5193842|NCT02781714|mHealth|mhealth
5193843|NCT02781714|Kenya|kenya
5193844|NCT02781714|couples|couples
5193845|NCT02781675|Diet|diet
5193846|NCT02781675|Mediterranean|mediterranean
5193847|NCT02781675|Cholesterol|cholesterol
5193848|NCT02781675|Inflammation|inflammation
5193849|NCT02781662|Safety|safety
5193850|NCT02781662|Hospitalization|hospitalization
5193851|NCT02781662|Older Persons|older persons
5193852|NCT02781662|High-Risk|high-risk
5193853|NCT02781649|Renal|renal
5193854|NCT02781649|Transplants|transplants
5193855|NCT02781649|Hepatitis C|hepatitis c
5193856|NCT02781649|HCV-negative|hcv-negative
5193857|NCT02781649|Infected|infected
5193858|NCT02781649|Donors|donors
5193859|NCT02781636|Efficacy|efficacy
5193860|NCT02781636|Implantable|implantable
5193861|NCT02781636|Wireless|wireless
5193862|NCT02781636|Neuromodulation|neuromodulation
5193863|NCT02781636|Device|device
5193864|NCT02781636|Tibial|tibial
5193865|NCT02781623|Quadriceps|quadriceps
5193866|NCT02781623|Tibial Plateau|tibial plateau
5193867|NCT02781623|Fracture|fracture
5193875|NCT02781597|Hemoptysis|hemoptysis
5193876|NCT02781597|Tranexamic acid|tranexamic acid
5193877|NCT02781597|VAS score|vas score
5193878|NCT02781545|Child Development|child development
5193879|NCT02781545|Psychomotor Performance|psychomotor performance
5193880|NCT02781545|Newborns|newborns
5193881|NCT02781545|Surgery|surgery
5193882|NCT02781493|Prucalopride|prucalopride
5193883|NCT02781493|Polyethylene Glycol|polyethylene glycol
5193884|NCT02781493|bowel preparation|bowel preparation
5193885|NCT02781467|Acute Myeloid|acute myeloid
5193886|NCT02781467|Leukemia|leukemia
5193887|NCT02781467|PNK-007|pnk-007
5193888|NCT02781467|Human IL-2|human il-2
5193889|NCT02781467|RHIL-2|rhil-2
5193890|NCT02781467|Fludarabine|fludarabine
5193891|NCT02781467|Cyclophosphamide|cyclophosphamide
5193892|NCT02781454|SALS|sals
5193893|NCT02781454|Mexiletine|mexiletine
5193894|NCT02781454|TMS|tms
5193895|NCT02781454|NCS|ncs
5193896|NCT02781402|Overweight BMI Individuals|overweight bmi individuals
5193897|NCT02781402|Normal BMI Individuals|normal bmi individuals
5193898|NCT02781402|Recovery Heart Rate|recovery heart rate
5193899|NCT02781389|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
5193900|NCT02781389|advanced BCC (aBCC)|advanced bcc (abcc)
5193901|NCT02781376|Primary Care|primary care
5193902|NCT02781376|Computer Decision Support System|computer decision support system
5193903|NCT02781376|Guidelines|guidelines
5193904|NCT02781376|Snoring|snoring
5193905|NCT02781363|thoracic ultrasound|thoracic ultrasound
5193906|NCT02781363|children|children
5193909|NCT02781350|high fat diet|high fat diet
5193910|NCT02781350|insulinogenesis|insulinogenesis
5193911|NCT02781350|Fiber|fiber
5193912|NCT02781350|inflammation|inflammation
5193913|NCT02781324|Ultrasonic Bone Scalpel|ultrasonic bone scalpel
5193914|NCT02781324|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5193915|NCT02781324|Posterior Spinal Fusion|posterior spinal fusion
5193916|NCT02781324|Estimated Blood Loss|estimated blood loss
5193917|NCT02781272|pelvic mass|pelvic mass
5193918|NCT02781272|ovarian cancer|ovarian cancer
5193919|NCT02781272|gynecological cancer|gynecological cancer
5193920|NCT02781272|risk prediction|risk prediction
5193921|NCT02781259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5193922|NCT02781259|Fluorescence|fluorescence
5193923|NCT02781259|Breast Neoplasms|breast neoplasms
5193924|NCT02781259|Indocyanine Green|indocyanine green
5193925|NCT02781220|MCI|mci
5193926|NCT02781220|Dementia|dementia
5193927|NCT02781220|amyloid PET|amyloid pet
5193928|NCT02781220|physician diagnosis|physician diagnosis
5193929|NCT02781220|Alzheimer's disease|alzheimer's disease
5193930|NCT02781220|AD|ad
5193931|NCT02781220|PET imaging|pet imaging
5193932|NCT02781220|Appropriate Use Criteria|appropriate use criteria
5193933|NCT02781220|patient-reported outcomes|patient-reported outcomes
5193934|NCT02781220|patient adherence|patient adherence
5193935|NCT02781207|syncope|syncope
5193936|NCT02781207|point-of-care ultrasound|point-of-care ultrasound
5193937|NCT02781181|Stenting|stenting
5193938|NCT02781181|Protection device|protection device
5193939|NCT02781181|EPD usage|epd usage
5193940|NCT02781168|Premature newborn|premature newborn
5193941|NCT02781168|Cortisol|cortisol
5193942|NCT02781168|Stress|stress
5193943|NCT02781155|Health related quality of life|health related quality of life
5193944|NCT02781155|Moxibustion|moxibustion
5193945|NCT02781155|Cancer|cancer
5193946|NCT02781155|Chemotherapy|chemotherapy
5193947|NCT02781155|Neutropenia|neutropenia
5193948|NCT02781155|Anaemia|anaemia
5193949|NCT02781155|Thrombocytopenia|thrombocytopenia
5193950|NCT02781155|Self management|self management
5193951|NCT02781155|Wellbeing|wellbeing
5193954|NCT02781090|HIV|hiv
5193955|NCT02781090|Tobacco|tobacco
5193956|NCT02781090|Cigarette|cigarette
5193957|NCT02781090|Smoking|smoking
5193958|NCT02781090|Social Network|social network
5193959|NCT02781090|Internet|internet
5193960|NCT02781090|Cessation|cessation
5193961|NCT02781077|Stroke|stroke
5193962|NCT02781077|walking competency|walking competency
5193963|NCT02781077|Task-oriented exercise program|task-oriented exercise program
5193964|NCT02781077|Exercise intensity|exercise intensity
5193965|NCT02781012|Pancreatic Disease|pancreatic disease
5193966|NCT02781012|Pancreas|pancreas
5193967|NCT02781012|Borderline Resectable|borderline resectable
5193968|NCT02781012|Pancreatic Cancer|pancreatic cancer
5193969|NCT02781012|Pancreatitis|pancreatitis
5193970|NCT02781012|Family history of pancreatic cancer|family history of pancreatic cancer
5193972|NCT02781012|Healthy at risk|healthy at risk
5193973|NCT02780999|Osteoarthritis|osteoarthritis
5193974|NCT02780999|hand|hand
5193975|NCT02780999|orthotic|orthotic
5193976|NCT02780999|rehabilitation|rehabilitation
5193977|NCT02780986|female entertainment worker|female entertainment worker
5193978|NCT02780986|heterosexual men|heterosexual men
5193979|NCT02780986|entertainment establishment|entertainment establishment
5193980|NCT02780986|condom use|condom use
5084356|NCT03471689|Multimodal|multimodal
5193981|NCT02780986|sexually transmitted infection|sexually transmitted infection
5193982|NCT02780986|Singapore|singapore
5193983|NCT02780947|Ventricular tachycardia|ventricular tachycardia
5193984|NCT02780947|Ablation|ablation
5193985|NCT02780947|Myocardial Infarction|myocardial infarction
5193986|NCT02780947|Heart Failure|heart failure
5193987|NCT02780934|Pressure Dressing|pressure dressing
5193988|NCT02780934|Post-operative Care|post-operative care
5193989|NCT02780934|Simple Adhesive Dressing|simple adhesive dressing
5193990|NCT02780934|Mohs|mohs
5193991|NCT02780921|Prehabilitation|prehabilitation
5193992|NCT02780921|Oesophageal cancer|oesophageal cancer
5193993|NCT02780921|Gastric cancer|gastric cancer
5193994|NCT02780921|Fitness|fitness
5193995|NCT02780921|Preconditionning|preconditionning
5193996|NCT02780921|two parallel arms|two parallel arms
5193997|NCT02780895|Parkinson Disease|parkinson disease
5193998|NCT02780895|stereotactic surgery|stereotactic surgery
5193999|NCT02780895|human allogeneic fetal derived stem cells|human allogeneic fetal derived stem cells
5194000|NCT02780882|Pasireotide|pasireotide
5194001|NCT02780882|Ectopic ACTH|ectopic acth
5194002|NCT02780882|SOM230|som230
5194003|NCT02780882|ectopic ACTH-dependent Cushing's syndrome|ectopic acth-dependent cushing's syndrome
5194004|NCT02780856|Caries Activity Demineralisation|caries activity demineralisation
5194005|NCT02780856|Demineralisation|demineralisation
5194006|NCT02780843|Stroke|stroke
5194007|NCT02780843|Tomography, X-Ray Computed|tomography, x-ray computed
5194008|NCT02780843|Magnetic Resonance Imaging|magnetic resonance imaging
5194009|NCT02780843|Thrombolytic Therapy|thrombolytic therapy
5194010|NCT02780830|Lymphoma|lymphoma
5194011|NCT02780830|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5194012|NCT02780830|non-GCB Diffuse Large B-Cell Lymphoma|non-gcb diffuse large b-cell lymphoma
5194013|NCT02780830|Relapsed or Refractory non-GCB Diffuse Large B-Cell Lymphoma|relapsed or refractory non-gcb diffuse large b-cell lymphoma
5194014|NCT02780830|Vistusertib|vistusertib
5194015|NCT02780830|AZD2014|azd2014
5194016|NCT02780830|Ibrutinib|ibrutinib
5194017|NCT02780830|Imbruvica|imbruvica
5194018|NCT02780791|Infertility|infertility
5194019|NCT02780791|Ovarian Failure, Premature|ovarian failure, premature
5194020|NCT02780791|Ovarian Follicle|ovarian follicle
5194021|NCT02780791|Ovary|ovary
5194022|NCT02780791|Tissue Transplantation|tissue transplantation
5194023|NCT02780791|Cryopreservation|cryopreservation
5194024|NCT02780791|Pelvis|pelvis
5194025|NCT02780791|Chemotherapy|chemotherapy
5194026|NCT02780791|Pregnancy Rate|pregnancy rate
5194027|NCT02780791|Folliculogenesis|folliculogenesis
5194028|NCT02780791|Endometrium|endometrium
5194029|NCT02780791|Estrogens|estrogens
5194030|NCT02780791|Progestins|progestins
5194031|NCT02780791|Follicle Stimulating Hormone|follicle stimulating hormone
5194033|NCT02780791|Progesterone|progesterone
5194034|NCT02780791|Hormones|hormones
5194035|NCT02780791|Maturation of Follicles|maturation of follicles
5194036|NCT02780791|Pregnant Women|pregnant women
5194037|NCT02780791|Premature Menopause|premature menopause
5194038|NCT02780791|Ovarian Insufficiency|ovarian insufficiency
5194039|NCT02780791|Ovarian Insufficiency, Premature|ovarian insufficiency, premature
5194040|NCT02780791|Cytotoxic therapy|cytotoxic therapy
5194041|NCT02780791|Fertility Protection|fertility protection
5194042|NCT02780791|Reproductive Medicine|reproductive medicine
5194043|NCT02780791|Reproductive Techniques|reproductive techniques
5194044|NCT02780791|Reproductive Technology|reproductive technology
5194045|NCT02780791|Cryotherapy|cryotherapy
5194046|NCT02780791|Pregnancy|pregnancy
5194047|NCT02780739|Psychological Tests|psychological tests
5194048|NCT02780739|Neuropsychological Tests|neuropsychological tests
5194049|NCT02780739|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5194050|NCT02780739|Exercise|exercise
5194051|NCT02780739|Circuit-Based Exercise|circuit-based exercise
5194052|NCT02780739|Video Games|video games
5194053|NCT02780739|Magnetic Resonance Imaging|magnetic resonance imaging
5194054|NCT02780739|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5194055|NCT02780739|Cognition|cognition
5194056|NCT02780739|Executive Function|executive function
5194057|NCT02780739|Learning|learning
5194058|NCT02780739|Problem Solving|problem solving
5194059|NCT02780739|Transfer (Psychology)|transfer (psychology)
5194060|NCT02780739|Decision Making|decision making
5194061|NCT02780739|Brain|brain
5194062|NCT02780739|Gray Matter|gray matter
5194063|NCT02780739|White Matter|white matter
5194065|NCT02780726|Roxadustat|roxadustat
5194066|NCT02780726|Renal anemia|renal anemia
5194067|NCT02780726|ASP1517|asp1517
5194068|NCT02780713|Breast cancer|breast cancer
5194069|NCT02780713|Healthy volunteers|healthy volunteers
5194070|NCT02780713|Pharmacokinetics|pharmacokinetics
5194071|NCT02780713|AZD9496|azd9496
5194072|NCT02780713|Safety|safety
5194073|NCT02780713|Tolerability|tolerability
5194074|NCT02780674|Polymyositis, dermatomyositis, Sjogren's syndrome, SLE, SSc|polymyositis, dermatomyositis, sjogren's syndrome, sle, ssc
5194075|NCT02780648|stereotactic radiotherapy|stereotactic radiotherapy
5194076|NCT02780648|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5194077|NCT02780635|family, caregiving, ptsd, couples|family, caregiving, ptsd, couples
5194078|NCT02780609|autologous hematopoietic cell transplantation (HCT)|autologous hematopoietic cell transplantation (hct)
5194079|NCT02780609|high-dose melphalan|high-dose melphalan
5194080|NCT02780609|selinexor|selinexor
5194081|NCT02780596|Infant|infant
5194082|NCT02780596|Toddler|toddler
5194083|NCT02780596|Primary Care|primary care
5194084|NCT02780570|SVPE|svpe
5194085|NCT02780570|intravenous immunoglobulin|intravenous immunoglobulin
5194086|NCT02780570|plasmapheresis|plasmapheresis
5194087|NCT02780557|Vocabulary|vocabulary
5194088|NCT02780557|Book reading|book reading
5194089|NCT02780557|Infancy|infancy
5194090|NCT02780557|Parenting|parenting
5194091|NCT02780544|Infant, premature|infant, premature
5194092|NCT02780544|Pain|pain
5194093|NCT02780544|Stress, physiological|stress, physiological
5194094|NCT02780544|Stress, psychological|stress, psychological
5194095|NCT02780544|skin-to-skin contact|skin-to-skin contact
5194096|NCT02780518|oxygen|oxygen
5194097|NCT02780518|carbon dioxide|carbon dioxide
5194098|NCT02780492|Duchenne muscular dystrophy|duchenne muscular dystrophy
5194099|NCT02780492|Natural history|natural history
5194100|NCT02780492|Outcome measures|outcome measures
5194101|NCT02780492|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
5194102|NCT02780492|6 minute walk distance (6MWD)|6 minute walk distance (6mwd)
5194103|NCT02780492|Myoset|myoset
5194104|NCT02780492|Exon skipping|exon skipping
5194105|NCT02780479|Prednisone|prednisone
5069577|NCT03564275|Radiation Therapy|radiation therapy
5194106|NCT02780479|Dexamethasone|dexamethasone
5194107|NCT02780479|Asthma exacerbation|asthma exacerbation
5194108|NCT02780479|Hospitalized|hospitalized
5194109|NCT02780466|Septic shock|septic shock
5194110|NCT02780466|Endotracheal intubation|endotracheal intubation
5194111|NCT02780466|Outcome|outcome
5194112|NCT02780440|Post Stroke Recovery|post stroke recovery
5194113|NCT02780440|Mirror Therapy|mirror therapy
5194114|NCT02780440|Unimanual mirror therapy|unimanual mirror therapy
5194115|NCT02780440|Bimanual mirror therapy|bimanual mirror therapy
5194116|NCT02780440|Stroke|stroke
5194117|NCT02780427|Dose-Response Relationship, Drug|dose-response relationship, drug
5194118|NCT02780414|Hypertension|hypertension
5194119|NCT02780414|Proteinuria|proteinuria
5194120|NCT02780414|Thrombocytopenia|thrombocytopenia
5194121|NCT02780414|Renal Insufficiency|renal insufficiency
5194122|NCT02780414|Impaired Liver Function|impaired liver function
5194123|NCT02780414|Pulmonary Edema|pulmonary edema
5194124|NCT02780401|Stage I|stage i
5194125|NCT02780401|Stage II|stage ii
5194126|NCT02780401|Stage III|stage iii
5194127|NCT02780388|MEDI4920, VIB4920, CD40L, RA, rheumatoid arthritis|medi4920, vib4920, cd40l, ra, rheumatoid arthritis
5194128|NCT02780375|Transcriptional Responses|transcriptional responses
5194129|NCT02780375|Radiation|radiation
5194130|NCT02780323|Celecoxib|celecoxib
5194131|NCT02780323|CELBESTA|celbesta
5194132|NCT02780310|Lenvatinib|lenvatinib
5194134|NCT02780297|primary hyperoxaluria|primary hyperoxaluria
5194135|NCT02780297|Dent Disease|dent disease
5194136|NCT02780297|enteric hyperoxaluria|enteric hyperoxaluria
5194137|NCT02780297|cystinuria|cystinuria
5194138|NCT02780297|Lowe Syndrome|lowe syndrome
5194139|NCT02780297|Adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency
5194141|NCT02780297|APRTd|aprtd
5194142|NCT02780297|APRT|aprt
5194143|NCT02780297|hyperoxaluria|hyperoxaluria
5194144|NCT02780297|oxalate|oxalate
5194145|NCT02780297|oxalosis|oxalosis
5194146|NCT02780297|PH type 1|ph type 1
5194147|NCT02780297|PH type 2|ph type 2
5194148|NCT02780297|PH type 3|ph type 3
5194149|NCT02780297|Dents|dents
5194150|NCT02780297|Dent|dent
5194151|NCT02780297|Dent 1|dent 1
5194152|NCT02780297|Dent 2|dent 2
5194153|NCT02780297|APRT deficiency|aprt deficiency
5194154|NCT02780284|Gut Microbiota|gut microbiota
5194155|NCT02780284|Butyrate|butyrate
5194156|NCT02780284|Physical activity|physical activity
5194157|NCT02780271|Breast Cancer|breast cancer
5194158|NCT02780271|Cancer survivor|cancer survivor
5194159|NCT02780271|e-communication|e-communication
5194160|NCT02780271|diet and physical activity|diet and physical activity
5194161|NCT02780271|fruits/vegetables daily servings|fruits/vegetables daily servings
5194162|NCT02780271|energy density|energy density
5194163|NCT02780245|Caesarean Section|caesarean section
5194164|NCT02780245|Tranexamic Acid|tranexamic acid
5194165|NCT02780245|Postpartum Hemorrhage|postpartum hemorrhage
5194167|NCT02780232|Depression|depression
5194168|NCT02780232|Adolescence|adolescence
5194169|NCT02780232|Prevention|prevention
5194170|NCT02780232|Early intervention|early intervention
5194171|NCT02780232|E-Mental Health|e-mental health
5194172|NCT02780180|Aminopeptidase A inhibitor|aminopeptidase a inhibitor
5194173|NCT02780180|Heart Failure|heart failure
5194174|NCT02780180|Up-titration|up-titration
5194175|NCT02780180|Dose-Response Relationship, Drug|dose-response relationship, drug
5194176|NCT02780180|Pharmacokinetics|pharmacokinetics
5194177|NCT02780180|Patient Safety|patient safety
5194178|NCT02780180|Treatment Efficacy|treatment efficacy
5194179|NCT02780167|Phase 2|phase 2
5194180|NCT02780167|randomized|randomized
5194181|NCT02780167|double-blind|double-blind
5194182|NCT02780167|placebo|placebo
5194183|NCT02780167|atopic dermatitis|atopic dermatitis
5194184|NCT02780167|safety|safety
5194185|NCT02780167|efficacy|efficacy
5194186|NCT02780167|JAK|jak
5194187|NCT02780167|janus kinase|janus kinase
5194188|NCT02780167|moderate|moderate
5194189|NCT02780167|severe|severe
5194190|NCT02780154|7G8 clone|7g8 clone
5194191|NCT02780154|NF54 strain|nf54 strain
5194192|NCT02780154|Non-immune|non-immune
5194193|NCT02780154|PCR|pcr
5194194|NCT02780154|PfSPZ Challenge|pfspz challenge
5194195|NCT02780154|Plasmodium falciparum|plasmodium falciparum
5194196|NCT02780154|qPCR|qpcr
5194197|NCT02780154|Sporozoites|sporozoites
5194198|NCT02780141|Renal anemia|renal anemia
5194199|NCT02780141|Roxadustat|roxadustat
5194200|NCT02780141|ASP1517|asp1517
5962423|NCT04281069|diabetes mellitus type 2|diabetes mellitus type 2
5194201|NCT02780141|Hemodialysis|hemodialysis
5194202|NCT02780128|neuroblastoma|neuroblastoma
5194203|NCT02780128|cancer|cancer
5194204|NCT02780128|genetic profiling|genetic profiling
5194205|NCT02780128|ceritinib|ceritinib
5194206|NCT02780128|ribociclib|ribociclib
5194207|NCT02780128|trametinib|trametinib
5194208|NCT02780128|HDM201|hdm201
5194210|NCT02780102|Cognitive-motor rehabilitation|cognitive-motor rehabilitation
5194211|NCT02780102|Active Control Group|active control group
5962424|NCT04281069|quality of life|quality of life
5069672|NCT03563586|mechanical bowel preparation|mechanical bowel preparation
5069673|NCT03563586|colorectal cancer|colorectal cancer
5069674|NCT03563586|surgical site infection|surgical site infection
5194212|NCT02780102|Stimulant Medication|stimulant medication
5194213|NCT02780089|Metastatic|metastatic
5194214|NCT02780089|Unresectable|unresectable
5194215|NCT02780063|Dilation|dilation
5194216|NCT02780063|Intraocular|intraocular
5194217|NCT02780063|Ophthalmology|ophthalmology
5194218|NCT02780050|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5194219|NCT02780050|manikins|manikins
5194220|NCT02780050|physical fitness|physical fitness
5194221|NCT02780024|Neo-Adjuvant Metformin|neo-adjuvant metformin
5194222|NCT02780024|Neo-Adjuvant Temozolomide|neo-adjuvant temozolomide
5194223|NCT02780024|Temozolomide and accelerated hypofractionation|temozolomide and accelerated hypofractionation
5194224|NCT02780024|Metformin and accelerated hypofractionation|metformin and accelerated hypofractionation
5194225|NCT02780024|Adjuvant Temozolomide|adjuvant temozolomide
5194226|NCT02780024|Adjuvant Metformin|adjuvant metformin
5194227|NCT02780011|CD30+|cd30+
5194228|NCT02780011|Relapsed|relapsed
5194229|NCT02780011|Refractory|refractory
5194230|NCT02780011|ALCL|alcl
5194231|NCT02779985|Lycium Barbarum|lycium barbarum
5194232|NCT02779985|Energy expenditure|energy expenditure
5194233|NCT02779985|Postprandial metabolism|postprandial metabolism
5194234|NCT02779972|Cardiac Physiology|cardiac physiology
5194236|NCT02779933|Hospital-acquired Pneumonia|hospital-acquired pneumonia
5194237|NCT02779933|Epidemiology|epidemiology
5194238|NCT02779933|Risk Factors|risk factors
5194239|NCT02779920|refractory gastroparesis|refractory gastroparesis
5194240|NCT02779920|per oral pyloromyotomy|per oral pyloromyotomy
5194241|NCT02779907|Paediatric|paediatric
5194242|NCT02779907|Malawi|malawi
5194243|NCT02779894|Sleep Apnea|sleep apnea
5194244|NCT02779894|Communication Based Technology|communication based technology
5194246|NCT02779868|body composition|body composition
5194247|NCT02779868|functional capacity|functional capacity
5194248|NCT02779868|quality of life|quality of life
5194249|NCT02779855|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5194250|NCT02779855|estrogen receptor|estrogen receptor
5194251|NCT02779855|progesterone receptor|progesterone receptor
5194252|NCT02779855|invasive ductal carcinoma|invasive ductal carcinoma
5194253|NCT02779855|breast cancer tumors|breast cancer tumors
5194254|NCT02779816|Diabetes Mellitus|diabetes mellitus
5194255|NCT02779816|Arthritis|arthritis
5194256|NCT02779790|Systematic Review and Meta-Analysis|systematic review and meta-analysis
5194257|NCT02779790|Evidence-Based Medicine|evidence-based medicine
5194258|NCT02779790|Evidence-Based Nutrition|evidence-based nutrition
5194259|NCT02779790|Clinical Practice Guidelines|clinical practice guidelines
5194260|NCT02779790|Liquid Meal Replacements|liquid meal replacements
5194261|NCT02779790|Body Weight|body weight
5194262|NCT02779790|Systolic Blood Pressure|systolic blood pressure
5194263|NCT02779790|Diastolic Blood Pressure|diastolic blood pressure
5194264|NCT02779790|Fasting Blood Glucose|fasting blood glucose
5194265|NCT02779790|Fasting Blood Insulin|fasting blood insulin
5194266|NCT02779790|HbA1c|hba1c
5194267|NCT02779790|Total Cholesterol|total cholesterol
5194268|NCT02779790|Triglycerides|triglycerides
5194269|NCT02779790|LDL-C|ldl-c
5194270|NCT02779790|HDL-C|hdl-c
5194271|NCT02779790|Controlled Feeding Trials|controlled feeding trials
5194272|NCT02779764|Hemodialysis|hemodialysis
5194273|NCT02779764|ASP1517|asp1517
5194274|NCT02779764|Roxadustat|roxadustat
5194275|NCT02779764|Renal anemia|renal anemia
5194276|NCT02779725|Symptom Management|symptom management
5194277|NCT02779712|Remote ischaemic conditioning|remote ischaemic conditioning
5194278|NCT02779686|Macular Degeneration|macular degeneration
5194279|NCT02779686|Genetic testing|genetic testing
5194280|NCT02779686|Age-Related Macular degeneration|age-related macular degeneration
5194281|NCT02779686|Age-Related Maculopathies|age-related maculopathies
5194282|NCT02779660|Atrial Fibrillation|atrial fibrillation
5194283|NCT02779647|Overweight, obesity, play, physical activity, accelerometry.|overweight, obesity, play, physical activity, accelerometry.
5194284|NCT02779608|malignant ascites|malignant ascites
5194285|NCT02779582|Progesterone|progesterone
5194286|NCT02779582|Menstrual Flow|menstrual flow
5194287|NCT02779556|Health Literacy|health literacy
5194288|NCT02779556|Diabetes|diabetes
5194289|NCT02779543|In lab sleep studies|in lab sleep studies
5194290|NCT02779517|upper extremity|upper extremity
5194291|NCT02779517|stroke|stroke
5194292|NCT02779517|rehabilitation|rehabilitation
5194293|NCT02779517|robotics|robotics
5194294|NCT02779517|telepresence|telepresence
5194295|NCT02779517|elderly|elderly
5194296|NCT02779517|aged|aged
5962425|NCT04281069|interdisciplinary care|interdisciplinary care
5962426|NCT04281056|Teeth loss|teeth loss
5962427|NCT04281056|edentulousness|edentulousness
5194297|NCT02779517|Housing for the elderly|housing for the elderly
5194298|NCT02779517|retirement|retirement
5194299|NCT02779517|homes for the aged|homes for the aged
5194300|NCT02779491|fruit and vegetables|fruit and vegetables
5194301|NCT02779491|food intake|food intake
5962428|NCT04281056|denture|denture
5962429|NCT04281056|tast|tast
5194302|NCT02779491|knowledge|knowledge
5194303|NCT02779478|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5194304|NCT02779478|cavitary|cavitary
5182277|NCT02850250|pharmacokinetic|pharmacokinetic
5182278|NCT02850250|cardiac|cardiac
5194305|NCT02779478|nodular bronchiectatic disease|nodular bronchiectatic disease
5194306|NCT02779478|NTM|ntm
5194307|NCT02779465|vitamin D treatment|vitamin d treatment
5194308|NCT02779465|chronic hepatitis B|chronic hepatitis b
5194309|NCT02779452|neurodevelopment|neurodevelopment
5194310|NCT02779452|electroencephalography|electroencephalography
5194311|NCT02779452|gestational diabetes mellitus|gestational diabetes mellitus
5194312|NCT02779452|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
5194313|NCT02779426|Atopic dermatitis|atopic dermatitis
5194314|NCT02779426|Text Messages|text messages
5194315|NCT02779426|Health literacy|health literacy
5194316|NCT02779400|INR|inr
5194317|NCT02779400|coagulation|coagulation
5194318|NCT02779400|vitamin K antagonist|vitamin k antagonist
5194319|NCT02779387|GnRH-a|gnrh-a
5194320|NCT02779387|endometriosis|endometriosis
5194321|NCT02779387|efficiency|efficiency
5194322|NCT02779374|ovarian insufficiency Bone Marrow|ovarian insufficiency bone marrow
5194323|NCT02779361|green tea|green tea
5194324|NCT02779361|steroid profile|steroid profile
5194325|NCT02779348|Nebicapone|nebicapone
5194326|NCT02779348|Warfarin|warfarin
5194327|NCT02779335|tube-fed|tube-fed
5194328|NCT02779335|Formula Tolerance|formula tolerance
5194329|NCT02779335|Pediatric Patients|pediatric patients
5194330|NCT02779322|gastric bypass|gastric bypass
5194331|NCT02779322|hospital charges|hospital charges
5194332|NCT02779322|mini gastric bypass|mini gastric bypass
5194333|NCT02779309|Frail Older Adults|frail older adults
5194334|NCT02779309|Mortality|mortality
5194335|NCT02779309|Home Care|home care
5194336|NCT02779309|Survival Analysis|survival analysis
5194337|NCT02779309|Clinical Prediction Rule|clinical prediction rule
5194338|NCT02779296|Cyanoacrylates|cyanoacrylates
5194339|NCT02779296|Mammaplasty|mammaplasty
5194340|NCT02779296|Mastectomy|mastectomy
5194341|NCT02779257|hypoglycemia|hypoglycemia
5194342|NCT02779244|Orthopedic|orthopedic
5194343|NCT02779244|Post-operative|post-operative
5194344|NCT02779244|Weight bearing|weight bearing
5194345|NCT02779244|Range of motion|range of motion
5194346|NCT02779218|Hemiplegia|hemiplegia
5194347|NCT02779205|Cell therapy|cell therapy
5194348|NCT02779205|Stromal Cells|stromal cells
5194349|NCT02779205|Stem cells|stem cells
5194350|NCT02779205|Adipose tissue|adipose tissue
5194351|NCT02779205|Children|children
5194352|NCT02779192|Acute Noise Induced Hearing Loss|acute noise induced hearing loss
5194353|NCT02779192|Prevent Acute Noise Induced Hearing Loss|prevent acute noise induced hearing loss
5194354|NCT02779166|hip arthroscopy|hip arthroscopy
5194356|NCT02779153|H.P. Acthar Gel|h.p. acthar gel
5194357|NCT02779140|BoNT|bont
5194358|NCT02779140|botulinum|botulinum
5194359|NCT02779140|Botulism|botulism
5194360|NCT02779140|Clostridium|clostridium
5194361|NCT02779140|Neurotoxin|neurotoxin
5194362|NCT02779140|NTM-1632|ntm-1632
5194363|NCT02779127|Smoking|smoking
5194364|NCT02779127|Endothelium|endothelium
5194365|NCT02779127|Passive smoking|passive smoking
5194366|NCT02779114|Rheumatoid Arthritis|rheumatoid arthritis
5194367|NCT02779114|Remission|remission
5194368|NCT02779114|Dose reduction|dose reduction
5194369|NCT02779101|Central nervous system lymphoma|central nervous system lymphoma
5194373|NCT02779075|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5194374|NCT02779036|Stroke|stroke
5194375|NCT02779036|task-oriented home exercise|task-oriented home exercise
5194376|NCT02779036|walking competency|walking competency
5194377|NCT02779036|Usual Physiotherapy care|usual physiotherapy care
5194378|NCT02778997|Shunt|shunt
5194379|NCT02778997|CSF|csf
5194380|NCT02778997|Dysfunction|dysfunction
5194381|NCT02778997|Complication|complication
5194382|NCT02778984|Anesthesia|anesthesia
5194383|NCT02778984|facial mask|facial mask
5194384|NCT02778971|MCI|mci
5194385|NCT02778971|Dementia|dementia
5276568|NCT02294409|CBT|cbt
5194386|NCT02778971|amyloid PET|amyloid pet
5194387|NCT02778971|physician diagnosis|physician diagnosis
5194388|NCT02778971|Alzheimer's disease|alzheimer's disease
5194389|NCT02778971|AD|ad
5194390|NCT02778971|PET imaging|pet imaging
5194391|NCT02778971|Appropriate Use Criteria|appropriate use criteria
5194392|NCT02778971|patient-reported outcomes|patient-reported outcomes
5194393|NCT02778958|bariatric surgery|bariatric surgery
5194394|NCT02778958|morbid obesity|morbid obesity
5194395|NCT02778958|nonopioid analgesics|nonopioid analgesics
5194396|NCT02778945|spinal surgery|spinal surgery
5194397|NCT02778945|sugammadex|sugammadex
5194398|NCT02778945|deep neuromuscular block|deep neuromuscular block
5194399|NCT02778945|shear wave elastography|shear wave elastography
5194400|NCT02778945|neuromuscular monitoring|neuromuscular monitoring
5182376|NCT02849730|Postoperative pain|postoperative pain
5182377|NCT02849704|Chronic Pancreatitis|chronic pancreatitis
5182378|NCT02849704|Pancreatic Function|pancreatic function
5182381|NCT02849678|Postoperative Pain|postoperative pain
5194401|NCT02778919|Endometriosis|endometriosis
5194402|NCT02778906|Abatacept|abatacept
5194403|NCT02778893|Conmana|conmana
5194404|NCT02778893|Thalidomide|thalidomide
5194405|NCT02778893|NSCLC|nsclc
5194406|NCT02778893|EGFR mutation|egfr mutation
5194407|NCT02778854|NSCLC|nsclc
5194408|NCT02778854|liquid biopsy|liquid biopsy
5194409|NCT02778854|driver mutation|driver mutation
5194410|NCT02778828|linezolide|linezolide
5194411|NCT02778828|tuberculosis|tuberculosis
5194412|NCT02778828|MDR-TB|mdr-tb
5194413|NCT02778802|Pulmonary Hypertension|pulmonary hypertension
5194414|NCT02778802|Emphysema|emphysema
5194415|NCT02778802|COPD|copd
5194416|NCT02778776|Metformin|metformin
5194417|NCT02778776|Agave Inulin|agave inulin
5194418|NCT02778776|METS|mets
5194419|NCT02778776|Inflammation parameters|inflammation parameters
5194420|NCT02778776|Urodynamic parameters|urodynamic parameters
5194421|NCT02778776|Prostate hyperplasia|prostate hyperplasia
5194422|NCT02778763|Breast cancer|breast cancer
5194423|NCT02778763|TLR2|tlr2
5194424|NCT02778763|Neutropenia|neutropenia
5194425|NCT02778750|Cystic Fibrosis (CF)|cystic fibrosis (cf)
5194426|NCT02778737|ACT, CBT, Randomized controlled trial, Chronic Pain|act, cbt, randomized controlled trial, chronic pain
5194427|NCT02778711|anti-IL-17|anti-il-17
5194428|NCT02778711|secukinumab|secukinumab
5194429|NCT02778672|bacterial pneumonia|bacterial pneumonia
5194430|NCT02778672|children|children
5194431|NCT02778672|diagnosing pneumonia|diagnosing pneumonia
5194432|NCT02778672|thermal imaging|thermal imaging
5194433|NCT02778633|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
5423233|NCT01616576|HiResolution™|hiresolution™
5194434|NCT02778620|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
5194435|NCT02778607|Atypical Parkinsonism Syndrome (APS)|atypical parkinsonism syndrome (aps)
5194436|NCT02778581|Cognitive Impairment, Alzheimer's Disease, Vegetal Oil|cognitive impairment, alzheimer's disease, vegetal oil
5194437|NCT02778542|Automated Hovering|automated hovering
5194438|NCT02778542|Remote Monitoring|remote monitoring
5194439|NCT02778542|Bidirectional Text Messaging|bidirectional text messaging
5194440|NCT02778529|stroke|stroke
5194441|NCT02778529|amputees|amputees
5194442|NCT02778529|spinal cord injuries|spinal cord injuries
5194443|NCT02778529|cerebral palsy|cerebral palsy
5194444|NCT02778529|robotics|robotics
5194445|NCT02778529|rehabilitation|rehabilitation
5194446|NCT02778503|Tooth, Deciduous|tooth, deciduous
5194447|NCT02778503|Dentition, Permanent|dentition, permanent
5194448|NCT02778503|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5194449|NCT02778503|Glass Ionomer Cements|glass ionomer cements
5194450|NCT02778503|Dental Caries|dental caries
5194451|NCT02778490|sleeve gastrectomy, bariatric surgery|sleeve gastrectomy, bariatric surgery
5194452|NCT02778464|Inflammatory Bowel Disease|inflammatory bowel disease
5194453|NCT02778464|Pregnancy|pregnancy
5194454|NCT02778464|Stool markers|stool markers
5194455|NCT02778464|Calprotectin|calprotectin
5194456|NCT02778464|Faecal S100A12 (f-SA12)|faecal s100a12 (f-sa12)
5194457|NCT02778464|Faecal calprotectin (f-Cp)|faecal calprotectin (f-cp)
5194464|NCT02778399|Endometriosis|endometriosis
5194465|NCT02778399|Dysmenorrhea|dysmenorrhea
5194466|NCT02778399|Dyspareunia|dyspareunia
5194467|NCT02778360|Attention deficit|attention deficit
5194468|NCT02778360|Neurofeedback|neurofeedback
5194469|NCT02778360|ADHD|adhd
5194470|NCT02778360|Methylphenidate|methylphenidate
5194471|NCT02778347|Palliative care|palliative care
5194472|NCT02778347|Need assessment|need assessment
5194473|NCT02778347|Tools|tools
5194474|NCT02778347|Validity|validity
5194475|NCT02778347|Quality of care|quality of care
5194476|NCT02778308|Gallbladder cancer, adjuvant chemotherapy, gemcitabine|gallbladder cancer, adjuvant chemotherapy, gemcitabine
5194477|NCT02778295|Fabry Disease|fabry disease
5194478|NCT02778295|Biomarker|biomarker
5194479|NCT02778269|ECG|ecg
5194480|NCT02778269|CGM|cgm
5194481|NCT02778269|Hypoglycaemia|hypoglycaemia
5903627|NCT00341835|Association|association
5194482|NCT02778269|Sudden Cardiac Death|sudden cardiac death
5194483|NCT02778256|depression, bipolar disorder|depression, bipolar disorder
5194484|NCT02778230|fiber|fiber
5194485|NCT02778230|gastrointestinal|gastrointestinal
5194486|NCT02778230|microbiota|microbiota
5194487|NCT02778191|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5182469|NCT02849314|NK immunotherapy|nk immunotherapy
5182470|NCT02849249|allergy|allergy
5182471|NCT02849249|Immunotherapy|immunotherapy
5182472|NCT02849249|SCIT|scit
5182483|NCT02849171|16-676|16-676
5194488|NCT02778191|cisplatin|cisplatin
5194489|NCT02778191|carboplatin|carboplatin
5194490|NCT02778191|5-fluorouracil|5-fluorouracil
5194491|NCT02778087|motor recovery|motor recovery
5194492|NCT02778087|mirror therapy|mirror therapy
5194493|NCT02778087|upper extremity|upper extremity
5194494|NCT02778074|Internet Cognitive Behavioural Therapy|internet cognitive behavioural therapy
5194495|NCT02778061|Intra Uterine Ball|intra uterine ball
5194496|NCT02778061|IUD|iud
5194497|NCT02778061|copper|copper
5194498|NCT02778061|contraception|contraception
5070013|NCT03561402|biomarker|biomarker
5194499|NCT02778022|Child behavior disorders|child behavior disorders
5194500|NCT02778022|Parent child relationship|parent child relationship
5194501|NCT02778022|Primary care|primary care
5194502|NCT02778009|Medical student|medical student
5194503|NCT02778009|Activity Monitor|activity monitor
5194504|NCT02778009|Medical school|medical school
5194505|NCT02778009|Fitness|fitness
5194506|NCT02777996|screening|screening
5194507|NCT02777983|patient education|patient education
5194508|NCT02777983|low back pain|low back pain
5194509|NCT02777983|technology|technology
5194510|NCT02777970|Acute pain|acute pain
5194511|NCT02777970|Acute moderate to severe pain|acute moderate to severe pain
5194512|NCT02777970|Postoperative pain|postoperative pain
5194513|NCT02777970|Dexketoprofen Tramadol|dexketoprofen tramadol
5194514|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol
5194515|NCT02777970|Tramadol hydrochloride|tramadol hydrochloride
5194516|NCT02777970|Multimodal analgesia|multimodal analgesia
5194517|NCT02777970|Third molar extraction|third molar extraction
5194518|NCT02777970|Fixed drug combination|fixed drug combination
5194519|NCT02777970|Paracetamol|paracetamol
5194520|NCT02777970|Analgesics|analgesics
5194521|NCT02777957|Echocardiography|echocardiography
5194522|NCT02777957|Lung Transplantation|lung transplantation
5194523|NCT02777944|motivation|motivation
5194524|NCT02777944|attendance|attendance
5194525|NCT02777918|food intake|food intake
5194526|NCT02777905|late life|late life
5194527|NCT02777905|mindfulness meditation|mindfulness meditation
5194528|NCT02777879|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5194530|NCT02777853|cardiovascular|cardiovascular
5194531|NCT02777853|vascular|vascular
5194532|NCT02777853|metabolism|metabolism
5194533|NCT02777853|microcirculation|microcirculation
5194534|NCT02777853|physical inactivity|physical inactivity
5194535|NCT02777853|polyphenols|polyphenols
5194536|NCT02777853|conduit artery|conduit artery
5194537|NCT02777853|endothelial function|endothelial function
5194538|NCT02777853|cerebrovascular|cerebrovascular
5194539|NCT02777853|insulin sensitivity|insulin sensitivity
5194540|NCT02777827|Abediterol|abediterol
5194541|NCT02777827|Dry powder inhaler|dry powder inhaler
5194542|NCT02777827|Pressured metered-dose inhaler|pressured metered-dose inhaler
5194543|NCT02777827|Pharmacokinetic|pharmacokinetic
5194544|NCT02777827|Pharmacodynamic|pharmacodynamic
5194546|NCT02777814|colorectal cancer|colorectal cancer
5194547|NCT02777814|Entecavir|entecavir
5194548|NCT02777814|Hepatitis B Carrier|hepatitis b carrier
5194549|NCT02777801|gastric cancer|gastric cancer
5194557|NCT02777736|Lymphoma, B cell|lymphoma, b cell
5194558|NCT02777736|Central nervous system relapse|central nervous system relapse
5194559|NCT02777736|Methotrexate|methotrexate
5194560|NCT02777736|Intrathecal chemotherapy|intrathecal chemotherapy
5194561|NCT02777723|Dry Eye Syndrome|dry eye syndrome
5194562|NCT02777723|Sodium Hyaluronate|sodium hyaluronate
5194563|NCT02777723|CKD-350|ckd-350
5194564|NCT02777697|cancer treatment protocols|cancer treatment protocols
5194565|NCT02777697|chronic cancer pain|chronic cancer pain
5194566|NCT02777697|cognitive function|cognitive function
5194567|NCT02777697|quality of life|quality of life
5194568|NCT02777697|anxiety|anxiety
5194569|NCT02777697|depression|depression
5194570|NCT02777684|Physical activity|physical activity
5194571|NCT02777684|Knee osteoarthritis|knee osteoarthritis
5194572|NCT02777684|Non pharmacological treatment|non pharmacological treatment
5194573|NCT02777684|Qualitative study|qualitative study
5194574|NCT02777658|Epidermal Growth Factor Receptor (EGFR), non-small cell lung cancer (NSCLC), EGFR T790M, EGFR Mutation-Positive Locally Advanced or Advanced NSCLC|epidermal growth factor receptor (egfr), non-small cell lung cancer (nsclc), egfr t790m, egfr mutation-positive locally advanced or advanced nsclc
5194575|NCT02777619|Pharmacodynamic|pharmacodynamic
5194576|NCT02777619|Dexmedetomidine|dexmedetomidine
5194577|NCT02777619|Propofol|propofol
5194578|NCT02777619|Target-controlled Infusion Intravenous Anesthesia|target-controlled infusion intravenous anesthesia
5194579|NCT02777606|Severe Sepsis|severe sepsis
5194580|NCT02777606|Sini Decoction|sini decoction
5194581|NCT02777606|Immune Function|immune function
5194582|NCT02777606|Mortality|mortality
5194583|NCT02777580|Thrombolytic Therapy|thrombolytic therapy
5194584|NCT02777580|Primary PCI|primary pci
5194585|NCT02777554|Healthy Subjects|healthy subjects
5194586|NCT02777554|Apremilast|apremilast
5194587|NCT02777554|Pharmacokinetic|pharmacokinetic
5194588|NCT02777541|early enteral nutrition|early enteral nutrition
5194589|NCT02777541|children|children
5194590|NCT02777541|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5194591|NCT02777515|electronic cigarette|electronic cigarette
5194592|NCT02777489|obesity|obesity
5194593|NCT02777489|perindopril|perindopril
5194594|NCT02777489|carboxypeptidase D|carboxypeptidase d
5194595|NCT02777489|genotyping|genotyping
5194596|NCT02777489|theranostic|theranostic
5194597|NCT02777450|low back pain|low back pain
5194598|NCT02777450|physical examination|physical examination
5194599|NCT02777450|local anesthesia|local anesthesia
5962430|NCT04281056|trigeminal senses|trigeminal senses
5194600|NCT02777437|Colonic Neoplasms|colonic neoplasms
5194601|NCT02777437|Laparoscopic Surgery|laparoscopic surgery
5194602|NCT02777437|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5194604|NCT02777411|Vaccines|vaccines
5194605|NCT02777411|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5194606|NCT02777411|EV71 enteroviruses vaccine|ev71 enteroviruses vaccine
5194607|NCT02777398|Intra-spinal Canal|intra-spinal canal
5194608|NCT02777398|Tumor|tumor
5194609|NCT02777398|Minimal Invasive Surgery|minimal invasive surgery
5194610|NCT02777398|Clinical Trial|clinical trial
5194611|NCT02777398|Quadrant Channel|quadrant channel
5194612|NCT02777385|Head and Neck|head and neck
5194613|NCT02777385|Locally Advanced|locally advanced
5194614|NCT02777385|Squamous Cell Carcinoma|squamous cell carcinoma
5194615|NCT02777385|SCCHN|scchn
5194616|NCT02777385|Untreated|untreated
5194617|NCT02777385|High Risk|high risk
5194618|NCT02777385|Intermediate Risk|intermediate risk
5194619|NCT02777385|Radiation Therapy|radiation therapy
5194620|NCT02777385|Cisplatin|cisplatin
5194621|NCT02777372|Zoloft|zoloft
5194622|NCT02777372|PMS|pms
5194623|NCT02777372|Menses|menses
5194624|NCT02777359|patent foramen ovale|patent foramen ovale
5194625|NCT02777359|migraine|migraine
5194626|NCT02777359|treatment|treatment
5194627|NCT02777346|WOUNDS, PENETRATING|wounds, penetrating
5194628|NCT02777346|CHILD, PRESCHOOL|child, preschool
5194629|NCT02777346|CHILD|child
5194630|NCT02777346|INFANT|infant
5194631|NCT02777346|ADOLESCENT|adolescent
5194632|NCT02777346|SUTURES|sutures
5194633|NCT02777346|POLYGLACTIN 910|polyglactin 910
5194634|NCT02777346|POLYPROPYLENES|polypropylenes
5194636|NCT02777333|Arthroscopy|arthroscopy
5194637|NCT02777333|Motion analysis|motion analysis
5194638|NCT02777320|Sciatica|sciatica
5194639|NCT02777320|Ibuprofen|ibuprofen
5194640|NCT02777320|Paracetamol|paracetamol
5194641|NCT02777320|Emergency Medicine|emergency medicine
5194642|NCT02777307|Laparoscopic|laparoscopic
5194643|NCT02777307|Cholecistectomy|cholecistectomy
5194644|NCT02777307|Collection|collection
5194645|NCT02777307|Bleeding|bleeding
5194647|NCT02777281|Shoulder Pain|shoulder pain
5194649|NCT02777281|Spinal Cord injury|spinal cord injury
5194650|NCT02777242|Hypogonadism|hypogonadism
5194651|NCT02777242|Testosterone enanthate|testosterone enanthate
5194652|NCT02777216|RDN|rdn
5194653|NCT02777203|morcellation|morcellation
5194654|NCT02777203|myomectomy|myomectomy
5194655|NCT02777203|hysterectomy|hysterectomy
5194656|NCT02777190|misoprostol|misoprostol
5194657|NCT02777190|cytotec|cytotec
5194658|NCT02777190|cervical ripening|cervical ripening
5194659|NCT02777190|labor, induced|labor, induced
5194660|NCT02777190|active labor|active labor
5194661|NCT02777138|Adipose tissue|adipose tissue
5194662|NCT02777138|Inflammation|inflammation
5194663|NCT02777138|Age Comparison|age comparison
5194664|NCT02777138|Macrophages|macrophages
5194665|NCT02777138|T-lymphocytes|t-lymphocytes
5194666|NCT02777138|Adipose Progenitors|adipose progenitors
5194667|NCT02777125|pediatrics|pediatrics
5194668|NCT02777125|metered dose inhalers|metered dose inhalers
5194669|NCT02777125|breath actuated nebulizers|breath actuated nebulizers
5194670|NCT02777112|high-risk|high-risk
5194671|NCT02777112|early prevention|early prevention
5194672|NCT02777112|productivity|productivity
5194673|NCT02777112|return on investment|return on investment
5194674|NCT02777112|workplace|workplace
5194675|NCT02777112|e-mental health program|e-mental health program
5194676|NCT02777112|job coach|job coach
5194677|NCT02777099|remote ischemic postconditioning|remote ischemic postconditioning
5194678|NCT02777099|autonomic function|autonomic function
5194679|NCT02777099|heart rate variability|heart rate variability
5194680|NCT02777099|acute ischemic stroke|acute ischemic stroke
5182681|NCT02847962|Soy|soy
5194681|NCT02777099|prognosis|prognosis
5194682|NCT02777086|HIV|hiv
5194683|NCT02777086|Risk Behaviors|risk behaviors
5194688|NCT02777073|glucose (sugar) control|glucose (sugar) control
5194689|NCT02777073|SGLT-2 inhibitors|sglt-2 inhibitors
5194690|NCT02777060|virtual reality|virtual reality
5194691|NCT02777060|sensor-based balance training|sensor-based balance training
5194692|NCT02777060|gait|gait
5194693|NCT02777060|balance|balance
5194694|NCT02777047|Thromboembolism|thromboembolism
5194695|NCT02777047|Medication Safety|medication safety
5194696|NCT02777047|Hospital-community collaboration|hospital-community collaboration
5194697|NCT02777047|Pilot RCT|pilot rct
5194698|NCT02777047|Telehealth|telehealth
5194699|NCT02777034|Laparoscopy|laparoscopy
5194700|NCT02777034|Enhanced Recovery|enhanced recovery
5194701|NCT02777034|Fast-track|fast-track
5194702|NCT02777021|Pediatric|pediatric
5194703|NCT02777021|Acute Myeloid Leukemia|acute myeloid leukemia
5194704|NCT02777021|Quality of Life|quality of life
5194705|NCT02777021|Neutropenia Management|neutropenia management
5194706|NCT02777021|Patient Centered Outcomes|patient centered outcomes
5194707|NCT02777021|Chemotherapy|chemotherapy
5194708|NCT02776982|Gastroesophageal reflux disease|gastroesophageal reflux disease
5194709|NCT02776982|GERD|gerd
5194710|NCT02776982|Barrett's Esophagus|barrett's esophagus
5194711|NCT02776982|Esophageal adenocarcinoma|esophageal adenocarcinoma
5194712|NCT02776969|Papillary Carcinoma|papillary carcinoma
5194713|NCT02776969|Gene Hunting|gene hunting
5194714|NCT02776969|Familial|familial
5194715|NCT02776956|atrial fibrillation;left atrial function|atrial fibrillation;left atrial function
5194716|NCT02776930|Injury Prediction|injury prediction
5194717|NCT02776930|Return to Work|return to work
5194718|NCT02776930|Injury Prevention|injury prevention
5194719|NCT02776917|metastatic breast cancer|metastatic breast cancer
5194720|NCT02776917|locally advanced, unresectable breast cancer|locally advanced, unresectable breast cancer
5194721|NCT02776917|HER2/NEU negative|her2/neu negative
5194726|NCT02776891|lymphoma|lymphoma
5194727|NCT02776891|gallium citrate|gallium citrate
5194728|NCT02776891|PET|pet
5194729|NCT02776865|suprascapular nerve block|suprascapular nerve block
5194730|NCT02776813|CD20+|cd20+
5194731|NCT02776813|B-cell|b-cell
5194732|NCT02776813|ACTR087|actr087
5194733|NCT02776813|Relapsed|relapsed
5194734|NCT02776813|Refractory|refractory
5194735|NCT02776800|Wound|wound
5194736|NCT02776800|Surgical Wound|surgical wound
5194737|NCT02776800|Trauma Wound|trauma wound
5194738|NCT02776800|Home Health Care|home health care
5194739|NCT02776800|Home Health Nurse|home health nurse
5194740|NCT02776800|Pressure Ulcer|pressure ulcer
5194741|NCT02776800|Diabetic Foot Ulcer|diabetic foot ulcer
5194742|NCT02776800|Venous Leg Ulcer|venous leg ulcer
5194743|NCT02776800|Arterial Ulcer|arterial ulcer
5194744|NCT02776800|Wound Dehiscence|wound dehiscence
5194746|NCT02776774|spine|spine
5194747|NCT02776748|Tenofovir disoproxil|tenofovir disoproxil
5194748|NCT02776748|Pre-exposure prophylaxis|pre-exposure prophylaxis
5195859|NCT02770105|RVRT|rvrt
5194749|NCT02776748|Breastfeeding|breastfeeding
5194750|NCT02776748|Emtricitabine|emtricitabine
5194751|NCT02776748|Tenofovir|tenofovir
5194752|NCT02776748|Post-partum|post-partum
5194753|NCT02776748|HIV prevention|hiv prevention
5194754|NCT02776748|Women|women
5194756|NCT02776722|Systematic Review and Meta-analysis|systematic review and meta-analysis
5194757|NCT02776722|randomized controlled trial|randomized controlled trial
5194758|NCT02776722|Evidence-Based Medicine|evidence-based medicine
5194759|NCT02776722|carbohydrate metabolism|carbohydrate metabolism
5194760|NCT02776722|postprandial|postprandial
5194761|NCT02776722|glycemic response|glycemic response
5194762|NCT02776722|glycemic control|glycemic control
5194763|NCT02776722|insulin sensitivity|insulin sensitivity
5194764|NCT02776722|beta-cell function|beta-cell function
5194765|NCT02776722|sugars|sugars
5194766|NCT02776722|fructose|fructose
5194767|NCT02776722|allulose|allulose
5194768|NCT02776722|tagatose|tagatose
5194769|NCT02776722|sorbose|sorbose
5194770|NCT02776696|Closed Loop|closed loop
5194771|NCT02776696|Artificial Pancreas|artificial pancreas
5194772|NCT02776644|renal cell carcinoma|renal cell carcinoma
5194773|NCT02776644|sunitinib, pazopanib|sunitinib, pazopanib
5194774|NCT02776644|temsirolimus|temsirolimus
5194775|NCT02776644|sorafenib|sorafenib
5194776|NCT02776644|everolimus|everolimus
5194777|NCT02776644|interferon alpha|interferon alpha
5194778|NCT02776644|interleukin 2|interleukin 2
5194779|NCT02776592|Healthy Children|healthy children
5194780|NCT02776579|Resistance Training; Muscle Strength|resistance training; muscle strength
5194781|NCT02776566|Anticoagulation|anticoagulation
5194782|NCT02776566|Anticoagulation Management|anticoagulation management
5194783|NCT02776566|Self-Testing|self-testing
5194784|NCT02776566|Self-Management|self-management
5194785|NCT02776566|Warfarin|warfarin
5194786|NCT02776566|Thromboembolism|thromboembolism
5194787|NCT02776566|Blood Coagulation Disorders|blood coagulation disorders
5194788|NCT02776566|Health Disparities|health disparities
5194789|NCT02776566|Minorities|minorities
5194790|NCT02776566|African American|african american
5194791|NCT02776566|Hispanic|hispanic
5194792|NCT02776566|Cardiovascular Disease|cardiovascular disease
5194793|NCT02776566|Models of Anticoagulation Care|models of anticoagulation care
5194794|NCT02776566|Tele-Health|tele-health
5194795|NCT02776566|Home Self-Testing|home self-testing
5194796|NCT02776527|Gastric cancer|gastric cancer
5194797|NCT02776527|D2 Lymphadenectomy|d2 lymphadenectomy
5194798|NCT02776527|postoprative adjuvant chemotherapy|postoprative adjuvant chemotherapy
5194799|NCT02776527|Apatinib|apatinib
5194800|NCT02776527|disease free survival|disease free survival
5194801|NCT02776488|brain trauma, metabolic therapy|brain trauma, metabolic therapy
5194802|NCT02776462|Eye Tracking|eye tracking
5194803|NCT02776462|Concussion|concussion
5194804|NCT02776462|Outcome Measures|outcome measures
5194805|NCT02776410|sustainable healthy eating|sustainable healthy eating
5194806|NCT02776410|consumer behaviour|consumer behaviour
5194807|NCT02776410|consumer attitudes|consumer attitudes
5194808|NCT02776384|Heart Failure|heart failure
5194809|NCT02776384|Biomarkers|biomarkers
5194810|NCT02776384|Echocardiography|echocardiography
5194811|NCT02776384|Cardiopulmonary Function Tests|cardiopulmonary function tests
5194812|NCT02776371|Helicobacter pylori|helicobacter pylori
5962431|NCT04281056|oral sensory ability|oral sensory ability
5070359|NCT03559335|C-reactive protein (CRP)|c-reactive protein (crp)
5070361|NCT03559296|imaging|imaging
5194813|NCT02776371|Sequential therapy|sequential therapy
5194814|NCT02776371|Modified non-clarithromycin triple therapy|modified non-clarithromycin triple therapy
5194815|NCT02776345|calcific tendonitis|calcific tendonitis
5194816|NCT02776345|rotator cuff calcific tendonitis|rotator cuff calcific tendonitis
5194817|NCT02776332|breastfeeding|breastfeeding
5194818|NCT02776332|premature infants|premature infants
5194819|NCT02776332|manual expression|manual expression
5194820|NCT02776319|Non-invasive brain stimulation|non-invasive brain stimulation
5194821|NCT02776319|tobacco use disorder|tobacco use disorder
5194822|NCT02776319|craving|craving
5194823|NCT02776280|water|water
5194824|NCT02776280|salt|salt
5194825|NCT02776280|oral fluids|oral fluids
5194826|NCT02776280|plaque|plaque
5194827|NCT02776280|dental caries|dental caries
5194828|NCT02776254|anti-retroviral therapy|anti-retroviral therapy
5194829|NCT02776254|differentiated care|differentiated care
5194830|NCT02776241|ADPKD|adpkd
5194831|NCT02776241|total kidney volume|total kidney volume
5194832|NCT02776241|kidney disease|kidney disease
5194833|NCT02776189|Anaesthesia|anaesthesia
5194835|NCT02776189|Brain|brain
5194836|NCT02776176|enhanced recovery after surgery|enhanced recovery after surgery
5194837|NCT02776176|hirschsprung disease|hirschsprung disease
5194838|NCT02776163|Salivary Gland Tumors|salivary gland tumors
5194839|NCT02776163|Head-an-Neck cancer|head-an-neck cancer
5194840|NCT02776163|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5194841|NCT02776163|High-Risk|high-risk
5194842|NCT02776163|Cisplatin|cisplatin
5194843|NCT02776163|Docetaxel|docetaxel
5194844|NCT02776150|probe melting curve|probe melting curve
5194845|NCT02776150|Drug resistance|drug resistance
5194846|NCT02776150|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5194847|NCT02776137|Docetaxel|docetaxel
5195960|NCT02769390|Analgesia|analgesia
5194848|NCT02776137|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5194849|NCT02776137|High-Risk|high-risk
5194850|NCT02776137|Squamous Cell Carcinoma|squamous cell carcinoma
5194851|NCT02776137|Head-and-Neck Cancer|head-and-neck cancer
5194852|NCT02776124|Nutritional status|nutritional status
5194853|NCT02776124|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5194854|NCT02776124|Nutritional Counseling|nutritional counseling
5085355|NCT03465293|Bowel preparation|bowel preparation
5194855|NCT02776124|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5194856|NCT02776124|oral nutritional supplements|oral nutritional supplements
5194857|NCT02776111|Kidney Transplant|kidney transplant
5194858|NCT02776098|Cystic Fibrosis|cystic fibrosis
5194859|NCT02776098|Glucose Intolerance|glucose intolerance
5194860|NCT02776098|Muscle Accrual|muscle accrual
5194861|NCT02776098|Cystic Fibrosis-related Diabetes|cystic fibrosis-related diabetes
5194862|NCT02776098|Healthy Controls|healthy controls
5194863|NCT02776098|Healthy Participants|healthy participants
5194864|NCT02776085|optic nerve sheath diameter|optic nerve sheath diameter
5194866|NCT02776085|shunt failure|shunt failure
5194867|NCT02776072|Tecfidera, DMF, dimethyl fumarate, Fingolimod, Glatiramer acetate, Teriflunomide, Gilenya, Copaxone, Aubagio|tecfidera, dmf, dimethyl fumarate, fingolimod, glatiramer acetate, teriflunomide, gilenya, copaxone, aubagio
5194868|NCT02776059|survival|survival
5194869|NCT02776059|pegfilgrastim|pegfilgrastim
5194870|NCT02776059|cirrhosis, alcoholic|cirrhosis, alcoholic
5194871|NCT02776046|Oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy|oxygen, surgical site infection, postoperative complication, recruitment maneuvers, open lung strategy
5194872|NCT02776033|tolerability|tolerability
5194873|NCT02776033|safety|safety
5194874|NCT02776033|GSK2982772|gsk2982772
5194875|NCT02776033|RIP1 kinase inhibitor|rip1 kinase inhibitor
5194876|NCT02776033|psoriasis|psoriasis
5194877|NCT02776007|Continuous Glucose Monitoring System|continuous glucose monitoring system
5194878|NCT02775955|Pharmacokinetics|pharmacokinetics
5194879|NCT02775929|Tenofovir disoproxil|tenofovir disoproxil
5194880|NCT02775929|Emtricitabine|emtricitabine
5194881|NCT02775929|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5194882|NCT02775929|Antiretroviral Therapy|antiretroviral therapy
5194883|NCT02775929|HIV Prevention|hiv prevention
5194884|NCT02775929|FTC TDF|ftc tdf
5194885|NCT02775929|PrEP|prep
5194886|NCT02775929|HIV Infected Partners|hiv infected partners
5194887|NCT02775929|HIV Uninfected Partners|hiv uninfected partners
5194888|NCT02775903|MEDI4736|medi4736
5194889|NCT02775903|Durvalumab|durvalumab
5194890|NCT02775903|Myelodysplastic Syndromes|myelodysplastic syndromes
5194891|NCT02775903|Acute Myeloid Leukemia|acute myeloid leukemia
5194892|NCT02775903|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5194893|NCT02775903|Azacitidine|azacitidine
5194894|NCT02775903|Safety|safety
5194895|NCT02775903|Efficacy|efficacy
5194896|NCT02775903|PD-L1|pd-l1
5194897|NCT02775877|PCOS|pcos
5194898|NCT02775877|letrozole|letrozole
5194899|NCT02775877|clomiphene|clomiphene
5194900|NCT02775786|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5194901|NCT02775786|Pancreatic Cancer|pancreatic cancer
5194902|NCT02775773|TXA|txa
5962432|NCT04281017|robotic gynecologic surgery|robotic gynecologic surgery
5962433|NCT04280991|Metabolism|metabolism
5962434|NCT04280991|Hypoxia|hypoxia
5194903|NCT02775773|PPH|pph
5194904|NCT02775760|brain|brain
5194905|NCT02775760|brain mapping|brain mapping
5194906|NCT02775760|cognition|cognition
5194907|NCT02775760|exercise|exercise
5194908|NCT02775760|physical activity|physical activity
5194909|NCT02775760|hippocampus|hippocampus
5194910|NCT02775760|entorhinal cortex|entorhinal cortex
5194911|NCT02775760|spatial navigation|spatial navigation
5194912|NCT02775760|learning|learning
5194913|NCT02775760|memory|memory
5194914|NCT02775760|magnetic resonance imaging|magnetic resonance imaging
5194915|NCT02775760|functional neuroimaging|functional neuroimaging
5194916|NCT02775760|physical endurance|physical endurance
5194917|NCT02775760|physical fitness|physical fitness
5194918|NCT02775760|resistance training|resistance training
5194919|NCT02775760|walking|walking
5194920|NCT02775760|muscle stretching exercises|muscle stretching exercises
5194921|NCT02775760|exercise test|exercise test
5194922|NCT02775760|neuropsychological tests|neuropsychological tests
5194923|NCT02775760|executive function|executive function
5194924|NCT02775760|attention|attention
5194925|NCT02775760|body composition|body composition
5194926|NCT02775734|Polycystic Ovary Syndrome|polycystic ovary syndrome
5194927|NCT02775734|N-acetyl-cysteine|n-acetyl-cysteine
5194928|NCT02775734|Clomiphene citrate|clomiphene citrate
5194929|NCT02775734|Clomiphene citrate resistant|clomiphene citrate resistant
5194930|NCT02775734|Laparoscopic ovarian drilling|laparoscopic ovarian drilling
5194931|NCT02775734|therapy|therapy
5194932|NCT02775721|Nursing Education|nursing education
5194933|NCT02775721|Weight Loss|weight loss
5194934|NCT02775721|Gastrostomy Tube Care|gastrostomy tube care
5194935|NCT02775695|pancreatic cancer|pancreatic cancer
5194936|NCT02775695|Resectable Pancreatic Cancer|resectable pancreatic cancer
5194937|NCT02775695|Doxycycline|doxycycline
5194938|NCT02775695|Metakaryote cells|metakaryote cells
5194939|NCT02775695|Eukaryotic cells|eukaryotic cells
5194940|NCT02775695|Cancer Stem Cells|cancer stem cells
5194941|NCT02775695|Targeted Cancer Stem Cell Therapy|targeted cancer stem cell therapy
5194942|NCT02775695|Multi-metakaryocide therapy|multi-metakaryocide therapy
5194943|NCT02775695|Doxycycline Hyclate|doxycycline hyclate
5194944|NCT02775695|Tetracycline|tetracycline
5191072|NCT02797561|Tandem|tandem
5194945|NCT02775682|epilepsy, dynamic cerebral autoregulation|epilepsy, dynamic cerebral autoregulation
5194946|NCT02775669|noninvasive ICP monitoring|noninvasive icp monitoring
5194947|NCT02775656|Cimzia®|cimzia®
5194949|NCT02775656|Pregnancy Follow up study|pregnancy follow up study
5194950|NCT02775656|Autoimmune diseases|autoimmune diseases
5194951|NCT02775656|Pregnancy outcomes|pregnancy outcomes
5194952|NCT02775656|major congenital malformations|major congenital malformations
5194953|NCT02775656|birth outcomes|birth outcomes
5194954|NCT02775656|malformation|malformation
5194955|NCT02775656|birth defect|birth defect
5194956|NCT02775643|Melanoma|melanoma
5194957|NCT02775643|Spitzoid Melanoma|spitzoid melanoma
5194958|NCT02775643|Congenital Melanoma|congenital melanoma
5194959|NCT02775643|Melanoma Arising in Giant Nevi|melanoma arising in giant nevi
5194960|NCT02775643|Melanocytic lesions with indeterminate biological behavior|melanocytic lesions with indeterminate biological behavior
5194961|NCT02775643|Pigment synthesizing melanomas|pigment synthesizing melanomas
5194962|NCT02775604|fall risks at home|fall risks at home
5194963|NCT02775604|video technology|video technology
5194964|NCT02775604|home assessment|home assessment
5194965|NCT02775578|heart failure|heart failure
5194966|NCT02775578|coronary artery disease|coronary artery disease
5194967|NCT02775578|biomarkers|biomarkers
5194968|NCT02775578|Percutaneous Coronary Intervention, PCI|percutaneous coronary intervention, pci
5800999|NCT00104156|Meditation|meditation
5194982|NCT02775526|Tension-Free Vaginal Tape (TVT)|tension-free vaginal tape (tvt)
5194983|NCT02775526|Burch colposuspension|burch colposuspension
5194984|NCT02775526|Urinary incontinence|urinary incontinence
5194985|NCT02775500|pregnancy|pregnancy
5194986|NCT02775500|apremilast|apremilast
5194988|NCT02775500|autoimmune disease|autoimmune disease
5194989|NCT02775500|psoriatic arthritis|psoriatic arthritis
5194990|NCT02775500|psoriasis|psoriasis
5194991|NCT02775500|TNF|tnf
5194992|NCT02775500|tumor necrosis factor|tumor necrosis factor
5194993|NCT02775500|birth outcome|birth outcome
5194994|NCT02775500|birth defect|birth defect
5194995|NCT02775487|COPD|copd
5194996|NCT02775487|Air quality|air quality
5194997|NCT02775474|Methadone|methadone
5194998|NCT02775474|Pain, Postoperative|pain, postoperative
5194999|NCT02775474|Chronic Pain|chronic pain
5195000|NCT02775474|Bariatric Surgery|bariatric surgery
5195013|NCT02775448|Homeopathy|homeopathy
5195014|NCT02775448|Carduus marianus|carduus marianus
5195015|NCT02775448|Dyslipidemia|dyslipidemia
5195016|NCT02775448|Climacteric|climacteric
5195017|NCT02775448|Obesity|obesity
5195018|NCT02775448|Triglycerides|triglycerides
5195019|NCT02775448|Cholesterol|cholesterol
5195020|NCT02775448|Insulin resistance|insulin resistance
5195021|NCT02775448|LDL-cholesterol|ldl-cholesterol
5195022|NCT02775448|HDL-cholesterol|hdl-cholesterol
5195027|NCT02775383|National MDS Study|national mds study
5195028|NCT02775383|MDS|mds
5195029|NCT02775383|Idiopathic|idiopathic
5195030|NCT02775383|cytopenia|cytopenia
5195031|NCT02775383|cytopenias|cytopenias
5195032|NCT02775383|ICUS|icus
5195033|NCT02775383|MDS/MPN|mds/mpn
5195034|NCT02775383|Myeloproliferative Neoplasm|myeloproliferative neoplasm
5195035|NCT02775383|Biorepository|biorepository
5195036|NCT02775344|Laparoscopy|laparoscopy
5195037|NCT02775344|ovarian cystectomy|ovarian cystectomy
5195038|NCT02775344|three dimension laparoscopy|three dimension laparoscopy
5195039|NCT02775331|shift scheduling|shift scheduling
5195040|NCT02775331|work-life interaction|work-life interaction
5195961|NCT02769390|Bupivacaine|bupivacaine
5195041|NCT02775331|working time control|working time control
5195042|NCT02775331|public sector|public sector
5195043|NCT02775318|Stellate Ganglion|stellate ganglion
5195044|NCT02775318|Digital Subtraction Angiography|digital subtraction angiography
5195045|NCT02775318|Transcranial Doppler Ultrasonography|transcranial doppler ultrasonography
5195046|NCT02775279|acute coronary syndrome, telomere length, predictive factor|acute coronary syndrome, telomere length, predictive factor
5195047|NCT02775253|Brown adipose tissue|brown adipose tissue
5195048|NCT02775253|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
5195049|NCT02775253|White adipose tissue|white adipose tissue
5195050|NCT02775240|Maribavir|maribavir
5195051|NCT02775214|Storz C-MAC|storz c-mac
5195052|NCT02775214|direct laryngoscopy|direct laryngoscopy
5195053|NCT02775214|pyloromyotomy|pyloromyotomy
5195054|NCT02775214|rapid sequence|rapid sequence
5195055|NCT02775201|plantaris|plantaris
5195056|NCT02775201|Tendinopathy|tendinopathy
5195057|NCT02775201|Achilles|achilles
5195058|NCT02775201|Release|release
5195059|NCT02775175|Ramadan|ramadan
5195060|NCT02775175|Fasting|fasting
5195061|NCT02775175|Nutrition|nutrition
5195062|NCT02775175|Quality of Life|quality of life
5195063|NCT02775136|brain injuries|brain injuries
5195064|NCT02775136|neurological monitoring|neurological monitoring
5195065|NCT02775084|n-3|n-3
5195066|NCT02775084|Polyunsaturated|polyunsaturated
5195067|NCT02775084|Fatty acids|fatty acids
5195068|NCT02775084|Antigens|antigens
5195069|NCT02775084|Cognition|cognition
5277437|NCT02289820|RSV|rsv
5195070|NCT02775084|CD4|cd4
5195071|NCT02775045|EoE|eoe
5195072|NCT02775032|advance care planning|advance care planning
5195074|NCT02775032|family practice|family practice
5195075|NCT02775032|palliative care|palliative care
5195076|NCT02775032|end-of-life care|end-of-life care
5195077|NCT02774967|root coverage|root coverage
5195078|NCT02774967|gingival recession|gingival recession
5195079|NCT02774967|periodontal surgery|periodontal surgery
5195080|NCT02774954|Change the cycle|change the cycle
5195081|NCT02774954|social learning theory|social learning theory
5195082|NCT02774954|people who inject drugs|people who inject drugs
5195083|NCT02774954|injection drug use|injection drug use
5195084|NCT02774954|Information, Motivation, Behavior Skills Model|information, motivation, behavior skills model
5195085|NCT02774954|Longitudinal cohort study|longitudinal cohort study
5195086|NCT02774928|Pulmonary Hypertension|pulmonary hypertension
5195087|NCT02774928|COPD|copd
5195088|NCT02774928|ILD|ild
5195089|NCT02774928|OSA|osa
5195090|NCT02774902|Drug Therapy|drug therapy
5195091|NCT02774889|Falls Prevention|falls prevention
5195092|NCT02774889|Stepping On|stepping on
5195093|NCT02774889|Health Promotion|health promotion
5195094|NCT02774889|Implementation|implementation
5195095|NCT02774889|Health Maintenance|health maintenance
5195096|NCT02774876|Closed-loop system|closed-loop system
5195097|NCT02774876|Artificial pancreas|artificial pancreas
5195098|NCT02774876|Glucose control|glucose control
5195099|NCT02774876|Meal|meal
5195100|NCT02774850|Pediatric|pediatric
5195101|NCT02774850|Neutropenia Management|neutropenia management
5195102|NCT02774850|Acute Myeloid Leukemia|acute myeloid leukemia
5195103|NCT02774850|Chart Abstraction|chart abstraction
5195104|NCT02774850|Chemotherapy|chemotherapy
5195105|NCT02774837|nucleoside analogues|nucleoside analogues
5195106|NCT02774837|tenofovir|tenofovir
5195107|NCT02774837|telbivudine|telbivudine
5195108|NCT02774837|quantitative HBsAg|quantitative hbsag
5195109|NCT02774837|combination therapy|combination therapy
5195110|NCT02774798|Rectal Prolapse|rectal prolapse
5195111|NCT02774798|Rectal Intussuception|rectal intussuception
5195112|NCT02774759|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5195113|NCT02774759|Endometrial cancer survivors|endometrial cancer survivors
5195114|NCT02774759|Obese|obese
5195115|NCT02774759|Weight loss intervention|weight loss intervention
5195116|NCT02774759|Resistance training|resistance training
5195117|NCT02774759|Aerobic exercise|aerobic exercise
5195118|NCT02774759|Questionnaires|questionnaires
5195119|NCT02774759|Surveys|surveys
5195120|NCT02774759|Accelerometer|accelerometer
5195121|NCT02774759|Fitness Test|fitness test
5195122|NCT02774759|Telephone Coaching|telephone coaching
5195123|NCT02774759|Video Chat Sessions|video chat sessions
5195124|NCT02774707|Dry eye|dry eye
5195125|NCT02774694|nociceptive flexion reflex|nociceptive flexion reflex
5195126|NCT02774694|interventional pain management|interventional pain management
5195127|NCT02774668|gender|gender
5195128|NCT02774668|arterial stiffness|arterial stiffness
5195129|NCT02774668|blood pressure|blood pressure
5195130|NCT02774668|weight loss|weight loss
5195131|NCT02774668|uric acid|uric acid
5195132|NCT02774655|healthy volunteers|healthy volunteers
5195133|NCT02774655|patient compliance|patient compliance
5195134|NCT02774655|exercise|exercise
5195135|NCT02774655|motivation|motivation
5195136|NCT02774642|PTSD|ptsd
5195137|NCT02774642|insomnia|insomnia
5195138|NCT02774642|CBT-I|cbt-i
5195139|NCT02774642|Prolonged Exposure|prolonged exposure
5195140|NCT02774642|Veteran|veteran
5195141|NCT02774629|food allergy|food allergy
5195142|NCT02774629|skin prick test|skin prick test
5195143|NCT02774629|atopy patch test|atopy patch test
5195144|NCT02774590|Acne vulgaris|acne vulgaris
5195145|NCT02774590|Rosacea|rosacea
5195146|NCT02774577|Oxygen Consumption|oxygen consumption
5195147|NCT02774577|Aged|aged
5195148|NCT02774577|Whole Body Vibration|whole body vibration
5195149|NCT02774551|Body composition|body composition
5195150|NCT02774551|Muscle strength|muscle strength
5195151|NCT02774551|Health related quality of life|health related quality of life
5195152|NCT02774538|Cervical HPV infection|cervical hpv infection
5195153|NCT02774538|Oral HPV infection|oral hpv infection
5195154|NCT02774538|Sexually transmitted infection|sexually transmitted infection
5195155|NCT02774525|child welfare system|child welfare system
5195156|NCT02774525|parental substance use problem|parental substance use problem
5195157|NCT02774525|child maltreatment|child maltreatment
5195158|NCT02774525|parenting|parenting
5195159|NCT02774408|backup ventilation|backup ventilation
5195160|NCT02774408|preterm infants|preterm infants
5195161|NCT02774408|functional residual capacity|functional residual capacity
5195162|NCT02774408|chronic lung disease|chronic lung disease
5195163|NCT02774382|Recurrence|recurrence
5195164|NCT02774382|Infection|infection
5195165|NCT02774369|cancer|cancer
5195166|NCT02774369|insomnia|insomnia
5195167|NCT02774369|sleep|sleep
5195168|NCT02774369|physical exercise|physical exercise
5903628|NCT00341835|Genetics|genetics
5195169|NCT02774369|aerobic|aerobic
5195170|NCT02774369|cognitive-behavioral therapy|cognitive-behavioral therapy
5195171|NCT02774369|self-help|self-help
5195173|NCT02774356|Brainstem|brainstem
5195174|NCT02774356|Encoding|encoding
5195175|NCT02774356|Pitch|pitch
5195176|NCT02774304|elastance|elastance
5195177|NCT02774304|fluid responsiveness|fluid responsiveness
5195178|NCT02774265|Fracture|fracture
5195179|NCT02774265|Prophylaxis|prophylaxis
5195180|NCT02774226|Flow-Mediated Dilation|flow-mediated dilation
5195181|NCT02774226|Kuvan|kuvan
5195182|NCT02774226|Antioxidant|antioxidant
5195183|NCT02774226|FEV1|fev1
5195184|NCT02774187|Hepatocellular Carcinoma|hepatocellular carcinoma
5195185|NCT02774187|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5195186|NCT02774187|Sorafenib|sorafenib
5195187|NCT02774174|Proximal Humerus|proximal humerus
5195188|NCT02774109|low back pain|low back pain
5195189|NCT02774109|fish oil|fish oil
5195190|NCT02774109|omega 3|omega 3
5195191|NCT02774096|Aortic dissection|aortic dissection
5195192|NCT02774096|Cerebral and Spinal Protection|cerebral and spinal protection
5195193|NCT02774096|Post-conditioning|post-conditioning
5195194|NCT02774083|older people|older people
5195195|NCT02774083|cognitive training|cognitive training
5195196|NCT02774070|AAJ RA MRI synovitis|aaj ra mri synovitis
5195197|NCT02774057|Captafer®|captafer®
5195198|NCT02774057|Iron Sulfate|iron sulfate
5195199|NCT02774057|Iron deficiency anemia|iron deficiency anemia
5195200|NCT02774057|inflammatory bowel disease|inflammatory bowel disease
5195201|NCT02774044|preterm neonates, surfactant|preterm neonates, surfactant
5195202|NCT02774031|Anesthesia, Inhalation|anesthesia, inhalation
5262293|NCT02376049|AD|ad
5183172|NCT02845362|Questionnaire|questionnaire
5183173|NCT02845362|Assessment|assessment
5183174|NCT02845284|adolescent|adolescent
5183175|NCT02845284|reproductive health|reproductive health
5195203|NCT02774031|Laparoscopy|laparoscopy
5195204|NCT02774031|Prostatectomy|prostatectomy
5195205|NCT02774031|Cystectomy|cystectomy
5195206|NCT02774031|Gynecologic Surgical Procedures|gynecologic surgical procedures
5195207|NCT02774018|Mindfulness|mindfulness
5195208|NCT02774018|Elderly|elderly
5195209|NCT02774018|Psychopathology|psychopathology
5195210|NCT02773992|Solitary Pulmonary Nodule|solitary pulmonary nodule
5195211|NCT02773992|Itos|itos
5195212|NCT02773992|lung cancer|lung cancer
5195213|NCT02773979|challenge|challenge
5195214|NCT02773979|malaria|malaria
5195215|NCT02773979|P. falciparum|p. falciparum
5195216|NCT02773979|PfSPZ|pfspz
5195217|NCT02773979|sporozoites|sporozoites
5195218|NCT02773979|vaccine|vaccine
5195219|NCT02773953|CPAP|cpap
5195220|NCT02773953|Telemonitoring|telemonitoring
5195221|NCT02773927|Agave inulin|agave inulin
5195222|NCT02773927|Adiponectin|adiponectin
5195223|NCT02773927|Metabolic syndrome|metabolic syndrome
5195224|NCT02773927|Metformin|metformin
5195225|NCT02773927|Insulin resistance|insulin resistance
5195226|NCT02773914|Activity of Daily Living (ADL)|activity of daily living (adl)
5195227|NCT02773914|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5070832|NCT03556449|Musculoskeletal Diseases/diagnosis*|musculoskeletal diseases/diagnosis*
5070833|NCT03556436|YH25448|yh25448
5195228|NCT02773914|Elderly|elderly
5195229|NCT02773914|Frailty|frailty
5195230|NCT02773914|Randomized controlled study|randomized controlled study
5195231|NCT02773901|intracranial pressure|intracranial pressure
5195232|NCT02773901|noninvasive monitoring|noninvasive monitoring
5195233|NCT02773901|lumbar puncture|lumbar puncture
5195234|NCT02773888|intracranial pressure|intracranial pressure
5195235|NCT02773888|noninvasive monitoring|noninvasive monitoring
5195236|NCT02773875|artificial pancreas|artificial pancreas
5195237|NCT02773862|brain injuries|brain injuries
5195238|NCT02773862|noninvasive monitoring|noninvasive monitoring
5195239|NCT02773862|intracranial pressure|intracranial pressure
5195240|NCT02773849|IFN|ifn
5195241|NCT02773849|BCG-unresponsive|bcg-unresponsive
5195242|NCT02773849|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5195243|NCT02773836|tobacco use|tobacco use
5195244|NCT02773836|e-cigarettes|e-cigarettes
5195245|NCT02773836|public policy|public policy
5195246|NCT02773836|ITC|itc
5195247|NCT02773823|obesity|obesity
5195248|NCT02773823|children|children
5195249|NCT02773823|cardiovascular health|cardiovascular health
5195250|NCT02773823|intervention study|intervention study
5195251|NCT02773797|Sedation|sedation
5195252|NCT02773797|Dexmedetomidine|dexmedetomidine
5195253|NCT02773771|Muscle Atrophy|muscle atrophy
5195254|NCT02773771|Critical Illness|critical illness
5195255|NCT02773771|Ultrasound|ultrasound
5195256|NCT02773771|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
5195257|NCT02773771|ICU|icu
5195258|NCT02773680|respiration|respiration
5195259|NCT02773680|monitoring, physiologic|monitoring, physiologic
5195260|NCT02773680|diagnostic techniques, respiratory system|diagnostic techniques, respiratory system
5195261|NCT02773654|shoulder|shoulder
5195262|NCT02773654|motion|motion
5195263|NCT02773654|measurement|measurement
5195264|NCT02773654|healthy shoulder|healthy shoulder
5195265|NCT02773654|shoulder motion|shoulder motion
5195266|NCT02773602|Analgesia|analgesia
5195267|NCT02773602|caudal analgesia|caudal analgesia
5195268|NCT02773602|ropivacaine|ropivacaine
5195269|NCT02773602|clonidine|clonidine
5195270|NCT02773602|dexamethasone|dexamethasone
5195275|NCT02773524|Stomach|stomach
5195276|NCT02773524|Adenocarcinoma|adenocarcinoma
5195277|NCT02773524|Undifferentiated Carcinoma|undifferentiated carcinoma
5195278|NCT02773472|colorectal|colorectal
5195279|NCT02773472|electroacupuncture|electroacupuncture
5195280|NCT02773472|laparoscopic surgery|laparoscopic surgery
5195281|NCT02773446|ETEC|etec
5195282|NCT02773446|Escherichia coli|escherichia coli
5195283|NCT02773446|enteritis|enteritis
5195284|NCT02773446|Challenge|challenge
5195285|NCT02773446|CS6|cs6
5195286|NCT02773446|Enterotoxigenic|enterotoxigenic
5195287|NCT02773407|Undifferentiated febrile illness|undifferentiated febrile illness
5195288|NCT02773407|Azithromycin|azithromycin
5940506|NCT00539656|Cord blood stem cell transplantation|cord blood stem cell transplantation
5940507|NCT00539656|Ex vivo expansion|ex vivo expansion
5195289|NCT02773407|Cotrimoxazole|cotrimoxazole
5195290|NCT02773407|Efficacy|efficacy
5195291|NCT02773407|Enteric fever|enteric fever
5195292|NCT02773407|Fever clearance time|fever clearance time
5195293|NCT02773394|Hepatitis C Virus|hepatitis c virus
5195294|NCT02773394|Observational|observational
5195295|NCT02773394|Brazil|brazil
5195296|NCT02773342|Invasive Pulmonal Aspergillosis|invasive pulmonal aspergillosis
5195297|NCT02773342|Neutropenic Patients|neutropenic patients
5195298|NCT02773342|Haematological Malignancies|haematological malignancies
5195299|NCT02773342|Chest Computed Tomography|chest computed tomography
5195300|NCT02773329|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5195301|NCT02773329|Cancer|cancer
5195302|NCT02773329|game-based exercise|game-based exercise
5195303|NCT02773329|exercise|exercise
5195304|NCT02773329|wearable sensors|wearable sensors
5195305|NCT02773329|balance|balance
5195306|NCT02773329|falls|falls
5195307|NCT02773329|virtual reality|virtual reality
5195308|NCT02773303|Neurofeedback|neurofeedback
5195309|NCT02773303|balance, postural|balance, postural
5195310|NCT02773303|postural equilibrium|postural equilibrium
5195311|NCT02773303|EEG|eeg
5195312|NCT02773290|Aplastic Anemia|aplastic anemia
5195313|NCT02773251|Postoperative adhesion|postoperative adhesion
5195314|NCT02773251|Laparoscopy|laparoscopy
5195315|NCT02773251|Adhesion barrier|adhesion barrier
5195316|NCT02773225|non severe Aplastic Anemia,|non severe aplastic anemia,
5195317|NCT02773186|postoperative|postoperative
5195318|NCT02773186|behavioral changes|behavioral changes
5195319|NCT02773173|Colorectal Laparoscopic Surgery|colorectal laparoscopic surgery
5195320|NCT02773134|Post-operative Bracing|post-operative bracing
5195321|NCT02773134|Rigid Lumbosacral Orthosis|rigid lumbosacral orthosis
5962435|NCT04280991|Glucose metabolism|glucose metabolism
5962436|NCT04280939|knee replacement|knee replacement
5962437|NCT04280939|hip replacement|hip replacement
5195322|NCT02773134|Posterior Spine Fusion|posterior spine fusion
5195323|NCT02773134|Quality of Life|quality of life
5195324|NCT02773134|Lumbar Degenerative Conditions|lumbar degenerative conditions
5195325|NCT02773121|Cognition|cognition
5195326|NCT02773121|Learning|learning
5195327|NCT02773121|Memory|memory
5195328|NCT02773121|Executive Function|executive function
5195329|NCT02773121|Attention|attention
5195330|NCT02773121|Neuropsychological Tests|neuropsychological tests
5195331|NCT02773121|Physical Activity|physical activity
5195332|NCT02773121|Physical Fitness|physical fitness
5195333|NCT02773121|Exercise|exercise
5195334|NCT02773121|Resistance Training|resistance training
5195335|NCT02773121|Walking|walking
5195336|NCT02773121|Muscle Stretching Exercises|muscle stretching exercises
5195337|NCT02773121|Exercise Test|exercise test
5195338|NCT02773121|Balance|balance
5195339|NCT02773121|Flexibility|flexibility
5195340|NCT02773121|Body Composition|body composition
5195341|NCT02773095|Novartis Access|novartis access
5195342|NCT02773095|noncommunicable disease burden|noncommunicable disease burden
5195343|NCT02773095|medicine availability and price|medicine availability and price
5195344|NCT02773095|Kenya|kenya
5195345|NCT02773082|Treatment-Resistant|treatment-resistant
5195346|NCT02773082|Anxiety|anxiety
5195347|NCT02773056|transfemoral|transfemoral
5195348|NCT02773056|amputation|amputation
5195349|NCT02773056|perspiration|perspiration
5195350|NCT02773056|socket|socket
5195351|NCT02773056|socket comfort|socket comfort
5195352|NCT02773030|Multiple Myeloma|multiple myeloma
5195353|NCT02773030|Relapsed|relapsed
5195354|NCT02773030|Refractory|refractory
5195355|NCT02773030|Pharmacokinetics|pharmacokinetics
5195356|NCT02773030|Safety|safety
5195357|NCT02773030|Efficacy|efficacy
5195358|NCT02773030|CC-220|cc-220
5195359|NCT02773030|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
5195360|NCT02773030|Dexamethasone|dexamethasone
5195361|NCT02773030|Daratumumab|daratumumab
5195362|NCT02773030|Bortezomib|bortezomib
5195363|NCT02773017|sedation|sedation
5195364|NCT02773017|age|age
5195365|NCT02773017|dexmedetomidine|dexmedetomidine
5195366|NCT02773004|Genomic test|genomic test
5195367|NCT02773004|Chemotherapy decision|chemotherapy decision
5195368|NCT02772978|decision making|decision making
5195369|NCT02772978|impulsivity|impulsivity
5195370|NCT02772926|Benfotiamine|benfotiamine
5195371|NCT02772926|Advanced glycation end products|advanced glycation end products
5195372|NCT02772926|Soluble receptor for AGEs|soluble receptor for ages
5195373|NCT02772926|Endogenous secretory receptor for AGEs|endogenous secretory receptor for ages
5195374|NCT02772900|Aging|aging
5195375|NCT02772900|Beetroot|beetroot
5195376|NCT02772900|Dietary Nitrate|dietary nitrate
5195377|NCT02772900|Functional Food|functional food
5195378|NCT02772900|Vascular Function|vascular function
5195379|NCT02772887|pregnancy|pregnancy
5195380|NCT02772887|type 2 diabetes|type 2 diabetes
5195381|NCT02772887|asymmetric dimethylarginine|asymmetric dimethylarginine
5195382|NCT02772887|L-arginine|l-arginine
5195383|NCT02772887|L-citrulline|l-citrulline
5195384|NCT02772887|placental growth factor (PlGF)|placental growth factor (plgf)
5195385|NCT02772887|blood pressure|blood pressure
5195386|NCT02772874|fecal incontinence|fecal incontinence
5195387|NCT02772874|severity|severity
5195388|NCT02772874|ultrasound|ultrasound
5195389|NCT02772874|anorectal manometry|anorectal manometry
5195390|NCT02772874|classification|classification
5195391|NCT02772835|nCPAP|ncpap
5195392|NCT02772835|nHFOV|nhfov
5195393|NCT02772835|Preterm|preterm
5195395|NCT02772835|CO2 Elimination|co2 elimination
5195396|NCT02772809|stroke|stroke
5195397|NCT02772809|hemiplegia|hemiplegia
5195398|NCT02772809|rehabilitation|rehabilitation
5195399|NCT02772809|robotics|robotics
5195400|NCT02772809|neuroplasticity|neuroplasticity
5195401|NCT02772796|Pharmacokinetics|pharmacokinetics
5195402|NCT02772796|Healthy Volunteer Study|healthy volunteer study
5195403|NCT02772783|brain|brain
5195404|NCT02772783|fMRI|fmri
5195405|NCT02772783|carbohydrate|carbohydrate
5195406|NCT02772783|insulin clamp|insulin clamp
5195407|NCT02772783|intake regulation|intake regulation
5195408|NCT02772783|overweight|overweight
5195409|NCT02772783|glycemic index|glycemic index
5195410|NCT02772757|hearing loss|hearing loss
5195411|NCT02772757|hearing aids|hearing aids
5195412|NCT02772757|outcome assessment|outcome assessment
5195413|NCT02772744|Hepatitis C virus genotype 4|hepatitis c virus genotype 4
5195414|NCT02772744|Antiviral|antiviral
5195415|NCT02772744|Virologic Response|virologic response
5195416|NCT02772731|mastectomy|mastectomy
5195417|NCT02772718|Hypoglycemia|hypoglycemia
5195418|NCT02772705|Standardized Uptake Value|standardized uptake value
5195419|NCT02772705|Diagnosis|diagnosis
5195420|NCT02772679|Diabetes|diabetes
5195421|NCT02772679|Treg|treg
5195422|NCT02772679|Proluekin|proluekin
5195423|NCT02772666|Relative afferent pupillary defect (RAPD)|relative afferent pupillary defect (rapd)
5195424|NCT02772666|Multiple sclerosis|multiple sclerosis
5195425|NCT02772666|Glaucoma|glaucoma
5195426|NCT02772653|Microcirculation|microcirculation
5195427|NCT02772653|Videomicroscopy|videomicroscopy
5962438|NCT04280939|spinal anesthesia|spinal anesthesia
5195428|NCT02772653|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5195429|NCT02772653|B-Type Natriuretic Peptide|b-type natriuretic peptide
5195430|NCT02772653|Thromboelastometry|thromboelastometry
5195431|NCT02772653|Trauma|trauma
5195432|NCT02772653|Resuscitation|resuscitation
5195433|NCT02772653|Hypovolemic shock|hypovolemic shock
5195434|NCT02772640|Hypercholesterolemia|hypercholesterolemia
5195435|NCT02772640|Rosuvastatin|rosuvastatin
5195436|NCT02772640|Statin|statin
5195437|NCT02772640|Ezetimibe|ezetimibe
5195438|NCT02772640|Compliance|compliance
5195439|NCT02772640|Cholesterol|cholesterol
5195440|NCT02772640|Secondary prevention|secondary prevention
5195441|NCT02772640|Coronary artery disease|coronary artery disease
5195442|NCT02772640|Cholesterol absorption inhibitor|cholesterol absorption inhibitor
5195443|NCT02772627|Parkinson's disease, Nebicapone|parkinson's disease, nebicapone
5195444|NCT02772614|Nebicapone, Parkinson's disease|nebicapone, parkinson's disease
5195445|NCT02772601|ABBV-066|abbv-066
5195446|NCT02772601|BI 655066|bi 655066
5195447|NCT02772601|risankizumab|risankizumab
5195448|NCT02772588|ARN-509|arn-509
5195449|NCT02772588|Abiraterone|abiraterone
5195450|NCT02772588|Leuprolide|leuprolide
5195660|NCT02771366|cognitive function|cognitive function
5195451|NCT02772588|Intensity-Modulated and Image-Guided Radiation Therapy|intensity-modulated and image-guided radiation therapy
5195452|NCT02772588|15-334|15-334
5195453|NCT02772588|apalutamide,|apalutamide,
5195454|NCT02772588|JNJ-56021927|jnj-56021927
5195455|NCT02772575|MOLECULAR PREDICTORS|molecular predictors
5195456|NCT02772575|Hepatic trans-arterial embolization (TAE)|hepatic trans-arterial embolization (tae)
5195457|NCT02772575|16-385|16-385
5195458|NCT02772562|prostate cancer|prostate cancer
5195459|NCT02772549|Diagnosis|diagnosis
5195460|NCT02772536|Chronic Tinnitus Tinted Light Change in Perception|chronic tinnitus tinted light change in perception
5195461|NCT02772523|Primary Prevention|primary prevention
5195462|NCT02772510|Stroke|stroke
5195463|NCT02772510|Rehabilitation|rehabilitation
5195464|NCT02772510|Hand|hand
5195465|NCT02772510|Game|game
5195466|NCT02772510|Functional electrical stimulation|functional electrical stimulation
5195467|NCT02772510|Virtual reality|virtual reality
5195469|NCT02772497|Anti VEGF|anti vegf
5195470|NCT02772497|VEGF trap|vegf trap
5195471|NCT02772497|Diabetes|diabetes
5195472|NCT02772497|Diabetic retinopathy|diabetic retinopathy
5195473|NCT02772497|ZALTRAP|zaltrap
5195477|NCT02772471|noninvasive monitoring|noninvasive monitoring
5195478|NCT02772458|Crohn's Disease|crohn's disease
5195479|NCT02772458|gut brain axis|gut brain axis
5195480|NCT02772458|reduced appetite|reduced appetite
5195481|NCT02772445|Empowerment|empowerment
5195482|NCT02772445|Caregiver|caregiver
5195483|NCT02772432|resiliency training|resiliency training
5195484|NCT02772432|parenting|parenting
5195485|NCT02772432|special learning disability|special learning disability
5195486|NCT02772406|ulcerative colitis|ulcerative colitis
5195487|NCT02772406|colonoscopy|colonoscopy
5195488|NCT02772406|Dysplasia|dysplasia
5195489|NCT02772406|Diagnosis|diagnosis
5195490|NCT02772367|cardiotoxicity|cardiotoxicity
5195491|NCT02772367|16-025|16-025
5195492|NCT02772354|Pediatric population, ablation|pediatric population, ablation
5195493|NCT02772341|Asthma|asthma
5195494|NCT02772341|Halotherapy|halotherapy
5195495|NCT02772341|Airway hyper-reactivity|airway hyper-reactivity
5195496|NCT02772341|Metacholine|metacholine
5195497|NCT02772328|Testing|testing
5195498|NCT02772328|Access|access
5195499|NCT02772315|genomics|genomics
5195500|NCT02772315|proteomics|proteomics
5195501|NCT02772315|metabolomics|metabolomics
5195502|NCT02772315|endocrine hypertension|endocrine hypertension
5940508|NCT00539656|Alternative donor|alternative donor
5183468|NCT02843672|surgery|surgery
5183469|NCT02843672|weil|weil
5183470|NCT02843672|MIS|mis
5183471|NCT02843672|percutaneous|percutaneous
5183472|NCT02843672|DMMO|dmmo
5195503|NCT02772315|primary aldosteronism|primary aldosteronism
5195504|NCT02772315|Cushing syndrom|cushing syndrom
5195505|NCT02772315|pheochromocytoma|pheochromocytoma
5195506|NCT02772289|Mesenchyme Stem Cells|mesenchyme stem cells
5195507|NCT02772289|Cesarean Section|cesarean section
5195508|NCT02772289|Scars|scars
5195509|NCT02772276|Glomerular Filtration Rate|glomerular filtration rate
5195510|NCT02772263|Paramedicine|paramedicine
5195511|NCT02772263|Community Paramedic|community paramedic
5195512|NCT02772263|Elderly|elderly
5195513|NCT02772250|bowel preparation|bowel preparation
5195514|NCT02772250|polyethylene glycol|polyethylene glycol
5195515|NCT02772250|face-to-face re-education|face-to-face re-education
5195516|NCT02772250|telephone re-education|telephone re-education
5195517|NCT02772250|Boston Bowel Preparation Scale|boston bowel preparation scale
5195518|NCT02772237|concussion|concussion
5195519|NCT02772237|sports-related concussion|sports-related concussion
5195520|NCT02772237|mTBI|mtbi
5195521|NCT02772237|Riboflavin|riboflavin
5195522|NCT02772237|Vitamin B2|vitamin b2
5195523|NCT02772159|COPD|copd
5195524|NCT02772159|ADME|adme
5195525|NCT02772159|Healthy Normal Males|healthy normal males
5195526|NCT02772159|Phase 1|phase 1
5195527|NCT02772120|Infertility|infertility
5195528|NCT02772120|In vitro fertilization|in vitro fertilization
5195529|NCT02772120|Embryo transfer|embryo transfer
5195530|NCT02772120|Blastocyst|blastocyst
5195531|NCT02772120|Progesterone|progesterone
5195532|NCT02772120|Crinone|crinone
5195533|NCT02772107|Small Cell Lung Carcinoma|small cell lung carcinoma
5195534|NCT02772094|glioblastoma multiforme|glioblastoma multiforme
5195535|NCT02772094|glioblastoma|glioblastoma
5195536|NCT02772094|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5195537|NCT02772094|immunotherapy|immunotherapy
5195538|NCT02772094|dendritic cells|dendritic cells
5195539|NCT02772094|grade IV astrocytoma|grade iv astrocytoma
5195540|NCT02772094|oncology|oncology
5195541|NCT02772094|neurology|neurology
5195542|NCT02772094|glioma|glioma
5195543|NCT02772094|brain tumor|brain tumor
5195544|NCT02772094|ADCTA-G|adcta-g
5195548|NCT02772042|Manual Therapy|manual therapy
5195549|NCT02772042|Physiotherapy|physiotherapy
5195550|NCT02772042|Manipulation|manipulation
5195551|NCT02771990|Back Pain|back pain
5195552|NCT02771964|outcome assessment|outcome assessment
5195553|NCT02771964|postoperative period|postoperative period
5195554|NCT02771951|Childhood|childhood
5195556|NCT02771938|radiotherapy, breast cancer, DIEP flap|radiotherapy, breast cancer, diep flap
5195557|NCT02771925|Gabapentin|gabapentin
5195558|NCT02771925|Alcohol Dependence|alcohol dependence
5195559|NCT02771899|Imaging, Three-Dimensional|imaging, three-dimensional
5195560|NCT02771899|Spine|spine
5195561|NCT02771899|Scoliosis|scoliosis
5195562|NCT02771886|mindfulness|mindfulness
5195563|NCT02771886|urges|urges
5195564|NCT02771886|adolescents|adolescents
5195565|NCT02771886|risk behaviors|risk behaviors
5195566|NCT02771886|therapy intervention|therapy intervention
5195567|NCT02771860|denosumab|denosumab
5195568|NCT02771860|RANKL-blockade|rankl-blockade
5195569|NCT02771834|Postural balance|postural balance
5195570|NCT02771834|Osteoporosis|osteoporosis
5195571|NCT02771834|Postmenopause|postmenopause
5195572|NCT02771834|Vitamin D|vitamin d
5195573|NCT02771834|Kyfhosis|kyfhosis
5195574|NCT02771834|Muscle strength|muscle strength
5195575|NCT02771808|CABG|cabg
5195587|NCT02771769|liquid biopsy|liquid biopsy
5195589|NCT02771756|Breast cancer|breast cancer
5195590|NCT02771756|Lung cancer|lung cancer
5195591|NCT02771756|Nutritional support|nutritional support
5195593|NCT02771756|Effectiveness|effectiveness
5195594|NCT02771743|Neuroblastoma|neuroblastoma
5195595|NCT02771743|High risk|high risk
5195596|NCT02771743|Tandem high dose chemotherapy|tandem high dose chemotherapy
5195597|NCT02771691|Adolescent|adolescent
5195598|NCT02771652|Multiple Sclerosis|multiple sclerosis
5195599|NCT02771652|Quality of Life|quality of life
5195600|NCT02771652|exercise|exercise
5195601|NCT02771652|internet|internet
5195602|NCT02771639|Hip arthroplasty|hip arthroplasty
5195603|NCT02771639|periprosthetic joint infection|periprosthetic joint infection
5195604|NCT02771639|outcome|outcome
5195607|NCT02771626|NSCLC|nsclc
5195608|NCT02771626|Immuno-Oncology|immuno-oncology
5195609|NCT02771626|Tumor Metabolism|tumor metabolism
5195610|NCT02771626|Glutaminase|glutaminase
5195611|NCT02771626|Glutaminase Inhibitor|glutaminase inhibitor
5183567|NCT02843126|recurrent breast cancer|recurrent breast cancer
5183568|NCT02843126|Her-2 positive|her-2 positive
5183569|NCT02843126|Trastuzumab|trastuzumab
5183570|NCT02843126|NK immunotherapy|nk immunotherapy
5183571|NCT02843113|single father|single father
5183572|NCT02843113|parenting behavior|parenting behavior
5183573|NCT02843100|Crohn's Disease|crohn's disease
5183574|NCT02843100|Pediatric|pediatric
5183575|NCT02843100|Exclusive Enteral Nutrition|exclusive enteral nutrition
5195612|NCT02771613|Morbidity Mortality Review|morbidity mortality review
5195613|NCT02771613|medical simulation|medical simulation
5195614|NCT02771613|in situ simulation|in situ simulation
5195615|NCT02771613|multi professional simulation|multi professional simulation
5195616|NCT02771613|hospital adverse event|hospital adverse event
5195617|NCT02771600|Procedural pain|procedural pain
5195618|NCT02771600|Procedural anxiety|procedural anxiety
5195619|NCT02771600|Pediatrics|pediatrics
5195620|NCT02771600|Needle-related procedures|needle-related procedures
5195621|NCT02771587|alcohol|alcohol
5195622|NCT02771587|energy drink|energy drink
5195623|NCT02771587|coagulability|coagulability
5195624|NCT02771587|caffeine|caffeine
5195625|NCT02771587|taurine|taurine
5195626|NCT02771587|driving performance|driving performance
5195627|NCT02771574|Bariatric surgery complications|bariatric surgery complications
5195628|NCT02771574|Glucose Metabolism Disorders|glucose metabolism disorders
5195629|NCT02771574|Exendin (9-39)|exendin (9-39)
5195630|NCT02771574|GLP-1|glp-1
5195631|NCT02771561|Patent Foramen Ovale|patent foramen ovale
5195632|NCT02771561|Obstructive Sleep Apnea|obstructive sleep apnea
5195633|NCT02771561|Apnea-Hypopnea Index|apnea-hypopnea index
5195634|NCT02771561|Oxygen Desaturation Index|oxygen desaturation index
5195635|NCT02771561|Epworth Sleepiness Scale|epworth sleepiness scale
5195636|NCT02771561|Quality of life|quality of life
5195637|NCT02771561|Continuous Positive Airway Pressure|continuous positive airway pressure
5071312|NCT03553498|acetaminophen|acetaminophen
5195638|NCT02771561|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
5195639|NCT02771561|Gore™ septal occluder device|gore™ septal occluder device
5195640|NCT02771548|Knee injuries|knee injuries
5195641|NCT02771548|Rehabilitation|rehabilitation
5195642|NCT02771548|Return to sport|return to sport
5195643|NCT02771548|Biomechanics|biomechanics
5195644|NCT02771522|Caries, Acitivity, Demineralsiation|caries, acitivity, demineralsiation
5195645|NCT02771509|CPB|cpb
5195646|NCT02771509|Cardiac Surgery|cardiac surgery
5195647|NCT02771509|Acute Kidney Injury|acute kidney injury
5195648|NCT02771470|Gut microflora|gut microflora
5195649|NCT02771470|Lung cancer|lung cancer
5195650|NCT02771470|Chemotherapy|chemotherapy
5195651|NCT02771470|Immunity|immunity
5195652|NCT02771470|Nutrition|nutrition
5195653|NCT02771457|Influximab|influximab
5195654|NCT02771457|IFX|ifx
5195655|NCT02771457|Remicade|remicade
5195656|NCT02771418|Carotid endarterectomy|carotid endarterectomy
5195657|NCT02771418|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5195658|NCT02771405|HCV-HCC-DAAs|hcv-hcc-daas
5195659|NCT02771366|neuroinflammation|neuroinflammation
5195661|NCT02771366|aging adults|aging adults
5195662|NCT02771314|NSCLC|nsclc
5195663|NCT02771314|AZD9291|azd9291
5195664|NCT02771314|>= 2nd line|>= 2nd line
5195665|NCT02771314|liquid biopsy|liquid biopsy
5195666|NCT02771314|EGFR TKIs|egfr tkis
5195667|NCT02771314|EGFR mutant|egfr mutant
5195668|NCT02771301|IDH1R132H Dendritic cell glioma|idh1r132h dendritic cell glioma
5195669|NCT02771288|Kawasaki disease|kawasaki disease
5195670|NCT02771288|optical coherence tomography|optical coherence tomography
5195671|NCT02771288|multislice computed tomography|multislice computed tomography
5195685|NCT02771210|Enthesitis|enthesitis
5195686|NCT02771210|Achilles tendon|achilles tendon
5195687|NCT02771197|AML|aml
5195688|NCT02771171|Pediatric Airway, Three-dimensional Imaging, CT Scan|pediatric airway, three-dimensional imaging, ct scan
5195689|NCT02771158|critical care|critical care
5195690|NCT02771158|shock, septic|shock, septic
5195691|NCT02771158|sepsis|sepsis
5195692|NCT02771158|hypotension|hypotension
5195693|NCT02771158|midodrine|midodrine
5195694|NCT02771093|Type 2, Diabetes, Diabetes Mellitus|type 2, diabetes, diabetes mellitus
5195695|NCT02771041|Hip prothesis|hip prothesis
5262978|NCT02371824|Hip|hip
5195696|NCT02771002|critically ill patients|critically ill patients
5195697|NCT02771002|septic shock|septic shock
5195698|NCT02771002|peripheral perfusion index|peripheral perfusion index
5195699|NCT02771002|capillary refill time|capillary refill time
5195700|NCT02771002|mottling score|mottling score
5195701|NCT02771002|microcirculation|microcirculation
5195702|NCT02770989|Cardiac Ablation|cardiac ablation
5195703|NCT02770989|Safety|safety
5195704|NCT02770989|Performance|performance
5195705|NCT02770989|Laser|laser
5195706|NCT02770963|discogenic|discogenic
5195707|NCT02770963|Acupuncture Therapy|acupuncture therapy
5195708|NCT02770963|randomized controlled trial|randomized controlled trial
5195709|NCT02770950|Knee Osteoarthritis|knee osteoarthritis
5195710|NCT02770937|laparoscopy, simulator|laparoscopy, simulator
5195711|NCT02770924|cataract|cataract
5195712|NCT02770924|phacoemulsification|phacoemulsification
5195713|NCT02770924|AT LISA TRI TORIC|at lisa tri toric
5195714|NCT02770924|IOL|iol
5195715|NCT02770911|Rectal Carcinoma|rectal carcinoma
5195716|NCT02770911|Laparoscopy|laparoscopy
5195717|NCT02770911|Anastomotic Leak|anastomotic leak
5195718|NCT02770911|Double-stapling technique|double-stapling technique
5195719|NCT02770898|probation|probation
5195720|NCT02770898|evidence-based|evidence-based
5195721|NCT02770898|well-being|well-being
5195722|NCT02770898|physical exercise|physical exercise
5195723|NCT02770898|family well-being|family well-being
5195724|NCT02770872|serum amyloid a|serum amyloid a
5195725|NCT02770872|lipoprotein|lipoprotein
5195726|NCT02770872|insulin resistance|insulin resistance
5195727|NCT02770872|dyslipidemia|dyslipidemia
5195728|NCT02770859|Achalasia|achalasia
5195729|NCT02770833|Proteins (seafood and meat)|proteins (seafood and meat)
5195730|NCT02770833|GI|gi
5195731|NCT02770833|Energy expenditure|energy expenditure
5195732|NCT02770833|Energy balance|energy balance
5195733|NCT02770833|Thermogenesis (DIT)|thermogenesis (dit)
5195734|NCT02770833|Appetite regulating hormones|appetite regulating hormones
5195735|NCT02770833|Appetite sensations|appetite sensations
5195736|NCT02770833|Glucose allostatis|glucose allostatis
5195737|NCT02770833|Amino acid metabolism|amino acid metabolism
5195738|NCT02770833|Satiety|satiety
5195739|NCT02770833|Food preferences|food preferences
5195740|NCT02770807|Ataxia Teleangiectasia|ataxia teleangiectasia
5195741|NCT02770807|AT|at
5195742|NCT02770807|EryDex system|erydex system
5195743|NCT02770807|Dexamethasone|dexamethasone
5962439|NCT04280926|Troponin|troponin
5195744|NCT02770807|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
5195745|NCT02770781|survivors|survivors
5195746|NCT02770781|physical fitness|physical fitness
5195747|NCT02770768|HSDD (Hypoactive Sexual Desire Disorder)|hsdd (hypoactive sexual desire disorder)
5962440|NCT04280926|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
5063379|NCT03603028|Walking|walking
5071444|NCT03552627|surgery|surgery
5195748|NCT02770768|EEG (Electroencephalogram)|eeg (electroencephalogram)
5195749|NCT02770742|patient satisfaction|patient satisfaction
5195750|NCT02770742|unsedated colonoscopy|unsedated colonoscopy
5195751|NCT02770742|intestinal diseases|intestinal diseases
5195752|NCT02770729|intracameral moxifloxacin|intracameral moxifloxacin
5195753|NCT02770729|endophthalmitis|endophthalmitis
5195754|NCT02770729|Vigamox|vigamox
5195755|NCT02770729|endothelial cell density|endothelial cell density
5195756|NCT02770716|Type 1|type 1
5195757|NCT02770677|Yoga|yoga
5195758|NCT02770677|COPD|copd
5195759|NCT02770677|rehabilitation|rehabilitation
5195858|NCT02770105|fMRI|fmri
5195760|NCT02770651|optical coherence tomography|optical coherence tomography
5195761|NCT02770651|everolimus-eluting stent|everolimus-eluting stent
5195762|NCT02770651|zotarolimus-eluting stent|zotarolimus-eluting stent
5195763|NCT02770638|Healthy|healthy
5195767|NCT02770638|University|university
5195768|NCT02770638|Adults|adults
5195769|NCT02770638|Rugby Football Union|rugby football union
5195770|NCT02770638|Professional|professional
5195771|NCT02770638|Competitive sport|competitive sport
5195772|NCT02770638|Scoop Stretcher|scoop stretcher
5195773|NCT02770638|Ferno Scoop Stretcher|ferno scoop stretcher
5195774|NCT02770638|Long back spinal board|long back spinal board
5195775|NCT02770638|Emergency Medical Services|emergency medical services
5195776|NCT02770638|Long backboard|long backboard
5195777|NCT02770638|Patient Extrication|patient extrication
5195778|NCT02770638|Triple Immobilisation|triple immobilisation
5195779|NCT02770638|Pre hospital Medicine|pre hospital medicine
5195780|NCT02770638|Rigid Cervical Collar|rigid cervical collar
5195781|NCT02770638|Pressure Testing|pressure testing
5195782|NCT02770638|Tissue Pressure Testing|tissue pressure testing
5195783|NCT02770638|Visual Analogue Scale|visual analogue scale
5195784|NCT02770638|Pressure Sores|pressure sores
5195785|NCT02770638|Pressure area damage|pressure area damage
5195786|NCT02770638|Tissue Viability|tissue viability
5195787|NCT02770638|Tissue Interface Pressure|tissue interface pressure
5195788|NCT02770638|Comfort|comfort
5195789|NCT02770638|Pain|pain
5195790|NCT02770625|Type I Gaucher|type i gaucher
5195791|NCT02770625|ISU302|isu302
5195792|NCT02770625|Imiglucerase|imiglucerase
5195793|NCT02770599|IBD|ibd
5195794|NCT02770599|HRQoL|hrqol
5195795|NCT02770599|QoC|qoc
5195796|NCT02770599|Adherence|adherence
5195798|NCT02770599|MDT|mdt
5195799|NCT02770573|nano-hydroxyapatite|nano-hydroxyapatite
5195800|NCT02770508|antiretroviral naive|antiretroviral naive
5195801|NCT02770508|dual therapy|dual therapy
5195802|NCT02770482|dementia|dementia
5195803|NCT02770482|biomarkers|biomarkers
5195804|NCT02770482|cerebrospinal fluid|cerebrospinal fluid
5195805|NCT02770469|Breast Cancer|breast cancer
5195806|NCT02770469|Korean Americans|korean americans
5195807|NCT02770469|Survivorship|survivorship
5195808|NCT02770469|Quality of Life|quality of life
5195809|NCT02770469|Coping Skills|coping skills
5195810|NCT02770469|Perceived Stress|perceived stress
5195811|NCT02770456|fish oil, preterm birth, pregnancy, China, prevention|fish oil, preterm birth, pregnancy, china, prevention
5195812|NCT02770443|Recovered LVEF|recovered lvef
5195813|NCT02770443|DCM|dcm
5195814|NCT02770391|HSD3B1 Genotype|hsd3b1 genotype
5195815|NCT02770391|Steroid Metabolism|steroid metabolism
5195816|NCT02770391|High-risk Prostate Cancer|high-risk prostate cancer
5195817|NCT02770391|ARN-509|arn-509
5195818|NCT02770378|Temozolomide|temozolomide
5086414|NCT03458234|SBRT|sbrt
5195819|NCT02770378|Recurrent Glioblastoma|recurrent glioblastoma
5195820|NCT02770352|retrospective chart review|retrospective chart review
5195821|NCT02770352|prospective chart review|prospective chart review
5195822|NCT02770352|fistula formation and repair|fistula formation and repair
5195823|NCT02770352|database|database
5195824|NCT02770352|demographics of women with fistulas|demographics of women with fistulas
5195825|NCT02770352|internationally accepted risks factors for fistula formation|internationally accepted risks factors for fistula formation
5195826|NCT02770339|Pharmacogenomics|pharmacogenomics
5195827|NCT02770339|Psychiatric crisis|psychiatric crisis
5195828|NCT02770339|Drug overdose|drug overdose
5195829|NCT02770339|Psychotropic medications|psychotropic medications
5195830|NCT02770326|Safety of Stool Transplant|safety of stool transplant
5195831|NCT02770326|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
5195832|NCT02770326|15-337|15-337
5195833|NCT02770300|automatic|automatic
5195834|NCT02770300|personalized|personalized
5195835|NCT02770300|robotic therapy|robotic therapy
5195836|NCT02770261|DP-R208|dp-r208
5195837|NCT02770222|Pharmacokinetics|pharmacokinetics
5195838|NCT02770196|Community-Supported Agriculture|community-supported agriculture
5195839|NCT02770196|Local Food System|local food system
5195840|NCT02770196|Vegetable|vegetable
5195841|NCT02770196|Fruit|fruit
5195842|NCT02770196|Childhood Obesity|childhood obesity
5195843|NCT02770183|Myocardial stunning|myocardial stunning
5195844|NCT02770183|Echocardiography, Transesophageal|echocardiography, transesophageal
5962441|NCT04280926|acute myocardial infarction|acute myocardial infarction
5962442|NCT04280926|Siemens Atellica|siemens atellica
5195845|NCT02770183|Extracorporeal Circulation|extracorporeal circulation
5195846|NCT02770144|Child Quality of Life|child quality of life
5195847|NCT02770144|Financial Coaching|financial coaching
5195848|NCT02770144|Socioeconomic Status|socioeconomic status
5195849|NCT02770144|Social Determinants of Health|social determinants of health
5195850|NCT02770131|hypercholesterolaemia|hypercholesterolaemia
5195851|NCT02770131|lipid-lowering therapies|lipid-lowering therapies
5195852|NCT02770118|sleep restriction|sleep restriction
5195854|NCT02770118|brown adipose tissue|brown adipose tissue
5195855|NCT02770105|L-theanine|l-theanine
5195856|NCT02770105|caffeine|caffeine
5195857|NCT02770105|selective attention|selective attention
5195860|NCT02770079|Insulin sensitivity|insulin sensitivity
5195861|NCT02770053|Foraminal enlargement|foraminal enlargement
5195862|NCT02770053|Root canal treatment|root canal treatment
5195863|NCT02770040|Acute Severe Ulcerative Colitis|acute severe ulcerative colitis
5195864|NCT02770040|Steroid Refractory Ulcerative Colitis|steroid refractory ulcerative colitis
5195866|NCT02770027|blood viscosity|blood viscosity
5195867|NCT02770014|Non-Small Cell Lung Cancer|non-small cell lung cancer
5195868|NCT02770014|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5195869|NCT02770001|Admixture|admixture
5195870|NCT02770001|African American|african american
5195871|NCT02770001|African American Genetics|african american genetics
5195872|NCT02769988|Adolescents|adolescents
5195873|NCT02769988|Health Information Literacy|health information literacy
5195874|NCT02769988|Health Education|health education
5195875|NCT02769975|Endocrinology|endocrinology
5195901|NCT02769832|Abraxane|abraxane
5195902|NCT02769832|Albumin-bound Paclitaxel|albumin-bound paclitaxel
5195903|NCT02769832|SCLC|sclc
5195904|NCT02769832|Gemzar|gemzar
5195905|NCT02769819|Flexible fiberscope|flexible fiberscope
5195906|NCT02769754|LIVER|liver
5195907|NCT02769754|RESECTION|resection
5195908|NCT02769754|SURGERY|surgery
5195909|NCT02769741|Cashew|cashew
5195910|NCT02769741|Lipoprotein|lipoprotein
5195911|NCT02769715|Removable partial dentures|removable partial dentures
5195912|NCT02769715|partial edentulism|partial edentulism
5195913|NCT02769702|Uveitis|uveitis
5195914|NCT02769689|Multiple sclerosis|multiple sclerosis
5195915|NCT02769689|Natalizumab|natalizumab
5195916|NCT02769689|Fingolimod|fingolimod
5195917|NCT02769689|Methylprednisolone|methylprednisolone
5183857|NCT02841215|Ivermectin|ivermectin
5183858|NCT02841202|optical coherence tomography|optical coherence tomography
5183859|NCT02841202|oral contraceptive pills|oral contraceptive pills
5183863|NCT02841124|Decision making|decision making
5195918|NCT02769650|Coronary stenosis|coronary stenosis
5195919|NCT02769650|Drug-eluting stent|drug-eluting stent
5195920|NCT02769650|Coronary angioplasty with stenting|coronary angioplasty with stenting
5195921|NCT02769650|Ischemic Heart Disease|ischemic heart disease
5195922|NCT02769650|Chronic total occlusion|chronic total occlusion
5195923|NCT02769650|Right coronary artery|right coronary artery
5195924|NCT02769650|Stress-MRI|stress-mri
5195925|NCT02769637|upper gastrointestinal tract|upper gastrointestinal tract
5195926|NCT02769637|lung microbiota and inflammation|lung microbiota and inflammation
5195927|NCT02769624|Congenital heart disease|congenital heart disease
5195928|NCT02769598|Pain|pain
5195929|NCT02769598|Nociception|nociception
5195930|NCT02769598|Pediatric intensive care|pediatric intensive care
5195931|NCT02769598|Pain assessment scale|pain assessment scale
5195932|NCT02769598|ANI index|ani index
5195933|NCT02769585|Obesity|obesity
5195934|NCT02769585|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5195935|NCT02769585|weight reduction|weight reduction
5195939|NCT02769520|squamous cell carcinoma head and neck|squamous cell carcinoma head and neck
5195940|NCT02769520|pembrolizumab|pembrolizumab
5195941|NCT02769520|cancer|cancer
5195942|NCT02769520|SCCHN|scchn
5195943|NCT02769494|Oral ulcer|oral ulcer
5195944|NCT02769494|Crohn's disease|crohn's disease
5195945|NCT02769468|Temperature-Probe Placement-preterm infant-case room|temperature-probe placement-preterm infant-case room
5195946|NCT02769455|Food Labelling|food labelling
5195947|NCT02769442|Intravenous|intravenous
5195948|NCT02769442|Catheter|catheter
5195949|NCT02769442|Puncture|puncture
5195950|NCT02769442|Peripheral Catheterization|peripheral catheterization
5195951|NCT02769442|First Stick Success|first stick success
5195952|NCT02769442|Contamination|contamination
5195953|NCT02769442|Terumo|terumo
5195954|NCT02769442|SurFlash|surflash
5195955|NCT02769416|spinal cord injury|spinal cord injury
5195956|NCT02769416|traumatic brain injury|traumatic brain injury
5195957|NCT02769403|Job Satisfaction|job satisfaction
5195958|NCT02769403|Job Performance|job performance
5195959|NCT02769403|Primary Care|primary care
5195962|NCT02769390|Clonidine|clonidine
5195963|NCT02769377|diabetes, glucometer, mobile-phone|diabetes, glucometer, mobile-phone
5195964|NCT02769364|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
5195965|NCT02769364|Eribulin|eribulin
5195966|NCT02769351|volume overload|volume overload
5195967|NCT02769351|heart failure|heart failure
5195968|NCT02769351|cardiac decompensation|cardiac decompensation
5071671|NCT03551002|HIV|hiv
5195969|NCT02769351|ultrafiltration|ultrafiltration
5195970|NCT02769338|Implementation|implementation
5195971|NCT02769338|Quality Improvement|quality improvement
5195972|NCT02769338|Stroke|stroke
5195973|NCT02769338|Transient Ischemic Attack|transient ischemic attack
5195975|NCT02769338|Systems Redesign|systems redesign
5195976|NCT02769338|QI Intervention|qi intervention
5195977|NCT02769325|atropine|atropine
5195981|NCT02769312|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5195982|NCT02769312|Feasibility studies|feasibility studies
5195983|NCT02769260|pyrosequencing|pyrosequencing
5195984|NCT02769260|16S DNA gene|16s dna gene
5195985|NCT02769260|Confocal Laser Scanning Microscope|confocal laser scanning microscope
5195986|NCT02769260|bacterial viability|bacterial viability
5195987|NCT02769260|bacterial diversity|bacterial diversity
5195988|NCT02769247|naproxen|naproxen
5195989|NCT02769247|lidocaine|lidocaine
5196001|NCT02769208|HEPA Filter|hepa filter
5196002|NCT02769208|Electrostatic Precipitator|electrostatic precipitator
5196003|NCT02769208|Cardiovascular Disease Biomarkers|cardiovascular disease biomarkers
5196004|NCT02769208|Respiratory Disease Biomarkers|respiratory disease biomarkers
5196005|NCT02769182|Older adults|older adults
5196007|NCT02769182|cognition|cognition
5196008|NCT02769182|smart phone|smart phone
5196009|NCT02769169|Ranibizumab, regression of the polyps|ranibizumab, regression of the polyps
5196010|NCT02769143|Postmenopausal|postmenopausal
5196011|NCT02769143|Bone Density|bone density
5196012|NCT02769143|Exercise|exercise
5196013|NCT02769104|aromatase inhibitors|aromatase inhibitors
5196014|NCT02769104|chemotherapy|chemotherapy
5196015|NCT02769104|neoadjuvant|neoadjuvant
5196016|NCT02769104|postmenopausal|postmenopausal
5196017|NCT02769104|breast cancer|breast cancer
5196018|NCT02769078|Anticoagulation|anticoagulation
5196019|NCT02769065|Drug Therapy|drug therapy
5196020|NCT02769052|endometriosis|endometriosis
5196021|NCT02769052|dyspareunia|dyspareunia
5196022|NCT02769052|physical therapy|physical therapy
5196023|NCT02769052|sexuality|sexuality
5196024|NCT02769052|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5196025|NCT02769013|Schistosoma haematobium plasmodium falciparum transmission|schistosoma haematobium plasmodium falciparum transmission
5196026|NCT02768987|exercise|exercise
5196027|NCT02768987|physical activity|physical activity
5196028|NCT02768987|behavior modification|behavior modification
5196029|NCT02768987|coping skills|coping skills
5196030|NCT02768987|self management|self management
5196031|NCT02768987|glycemic control|glycemic control
5196033|NCT02768987|obesity|obesity
5196034|NCT02768987|body composition|body composition
5196035|NCT02768987|adherence|adherence
5196036|NCT02768961|sofosbuvir|sofosbuvir
5196037|NCT02768961|ledipasvir|ledipasvir
5196038|NCT02768961|ribavirin|ribavirin
5196039|NCT02768961|prisoner|prisoner
5196040|NCT02768961|hepatitis c|hepatitis c
5196041|NCT02768961|prevalence|prevalence
5196042|NCT02768961|hepatitis b|hepatitis b
5196043|NCT02768922|Telemedicine|telemedicine
5196044|NCT02768922|Telerehabilitation|telerehabilitation
5196045|NCT02768922|Speech and language therapy|speech and language therapy
5196046|NCT02768883|Childhood asthma|childhood asthma
5196047|NCT02768883|Latino|latino
5196048|NCT02768870|Mitral Valve Repair|mitral valve repair
5196049|NCT02768870|Transapical|transapical
5196050|NCT02768870|Artificial Chordae|artificial chordae
5196051|NCT02768844|Stochastic Resonance|stochastic resonance
5196052|NCT02768844|Fetus/Newborn Infant|fetus/newborn infant
5196053|NCT02768844|Drug Withdrawal|drug withdrawal
5196054|NCT02768844|Substance Abuse|substance abuse
5196055|NCT02768818|Maternal Obesity Complicating Pregnancy|maternal obesity complicating pregnancy
5196056|NCT02768805|Influenza|influenza
5196057|NCT02768805|Human|human
5196058|NCT02768805|RNA Virus Infections|rna virus infections
5196059|NCT02768805|Immunologic|immunologic
5196060|NCT02768805|Immunogenic Factors|immunogenic factors
5196061|NCT02768805|Physiological Effects of Drug|physiological effects of drug
5196062|NCT02768805|Virus Diseases|virus diseases
5196063|NCT02768805|Orthomyxoviridae Infections|orthomyxoviridae infections
5196064|NCT02768805|Infection|infection
5196066|NCT02768766|MEK inhibitor|mek inhibitor
5196067|NCT02768766|Selumetinib|selumetinib
5196068|NCT02768766|hyd-sulfate AZD6244|hyd-sulfate azd6244
5196069|NCT02768766|Uveal melanoma|uveal melanoma
5196070|NCT02768766|Melanoma|melanoma
5196071|NCT02768753|Robotic thyroidectomy|robotic thyroidectomy
5196072|NCT02768753|Robotic central neck dissection|robotic central neck dissection
5196073|NCT02768753|Axillary bilateral-breast approach|axillary bilateral-breast approach
5196074|NCT02768753|Bilateral axillo-breast approach|bilateral axillo-breast approach
5196075|NCT02768727|neurocognitive function|neurocognitive function
5962443|NCT04280900|Cocaine-Related Disorders|cocaine-related disorders
5962444|NCT04280900|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5903629|NCT00341835|Linkage|linkage
5196078|NCT02768714|Breast Cancer High risk Stage II or Stage III / IV|breast cancer high risk stage ii or stage iii / iv
5196079|NCT02768701|Pembrolizumab|pembrolizumab
5196080|NCT02768701|cyclophosphamide|cyclophosphamide
5196082|NCT02768688|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5196083|NCT02768688|Dexmedetomidine|dexmedetomidine
5196084|NCT02768688|Cerebral blood flow|cerebral blood flow
5196085|NCT02768675|Kyphotic|kyphotic
5196086|NCT02768675|Corrective Surgery|corrective surgery
5196087|NCT02768675|Spinal fractures|spinal fractures
5196088|NCT02768636|Omega-3, ANS, HRV, SDNN|omega-3, ans, hrv, sdnn
5196089|NCT02768610|dexmedetomidine|dexmedetomidine
5196090|NCT02768584|severe mental illness|severe mental illness
5196091|NCT02768584|nursing|nursing
5196092|NCT02768584|therapeutic alliance|therapeutic alliance
5196093|NCT02768584|psychiatric diseases|psychiatric diseases
5196094|NCT02768571|cerebrolysin, stroke, motor function|cerebrolysin, stroke, motor function
5196099|NCT02768545|Ezetimibe|ezetimibe
5196100|NCT02768545|Cholesterol|cholesterol
5196101|NCT02768545|Enterohepatic Circulation|enterohepatic circulation
5196102|NCT02768545|Bile|bile
5196103|NCT02768545|Feces|feces
5196104|NCT02768532|Crohn's disease|crohn's disease
5196105|NCT02768532|Vedolizumab|vedolizumab
5196106|NCT02768532|TNF (Tumor Necrosis Factor)|tnf (tumor necrosis factor)
5196107|NCT02768532|Clinical response|clinical response
5196108|NCT02768532|Clinical remission|clinical remission
5196109|NCT02768519|Participants|participants
5196110|NCT02768506|obesity, malabsorption, gastric bypass, SADI-S|obesity, malabsorption, gastric bypass, sadi-s
5196111|NCT02768480|Diabetes|diabetes
5196112|NCT02768480|phone calls|phone calls
5196113|NCT02768480|glycemic control|glycemic control
5196114|NCT02768467|Alloderm graft|alloderm graft
5196115|NCT02768467|Allograft|allograft
5196116|NCT02768467|Buccal Mucosa|buccal mucosa
5196117|NCT02768454|broad-spectrum antimicrobial|broad-spectrum antimicrobial
5196118|NCT02768454|antibiotics pharmacist|antibiotics pharmacist
5196119|NCT02768428|Knowledge [K01.468]|knowledge [k01.468]
5196120|NCT02768428|Video-Audio Media [V01.255.500]|video-audio media [v01.255.500]
5196121|NCT02768428|Handbooks [V02.520]|handbooks [v02.520]
5196122|NCT02768402|Mitral Valve Regurgitation|mitral valve regurgitation
5196123|NCT02768402|Primary MR|primary mr
5196124|NCT02768402|Secondary MR|secondary mr
5196125|NCT02768402|MR|mr
5196126|NCT02768402|Heart Failure|heart failure
5196127|NCT02768402|Structural Heart|structural heart
5196128|NCT02768402|Secondary Mitral Valve Regurgitation|secondary mitral valve regurgitation
5196129|NCT02768402|Primary Mitral Valve Regurgitation|primary mitral valve regurgitation
5196130|NCT02768402|Transseptal|transseptal
5196131|NCT02768402|Transcatheter|transcatheter
5196132|NCT02768389|Modified Atkins Diet|modified atkins diet
5196133|NCT02768389|MAD|mad
5196134|NCT02768389|Brain Tumor|brain tumor
5196135|NCT02768389|Glioblastoma|glioblastoma
5196136|NCT02768363|Immunotherapy|immunotherapy
5196137|NCT02768363|Tumor vaccine|tumor vaccine
5196138|NCT02768363|Immuno-oncology|immuno-oncology
5196139|NCT02768363|Cytotoxicity|cytotoxicity
5196140|NCT02768363|Prostate cancer|prostate cancer
5196141|NCT02768363|Active Surveillance|active surveillance
5196142|NCT02768350|lung collapse|lung collapse
5196143|NCT02768350|ventilator hyper inflation|ventilator hyper inflation
5196144|NCT02768350|hemodynamic responses|hemodynamic responses
5196145|NCT02768350|ventilatory responses|ventilatory responses
5196146|NCT02768350|trauma patients|trauma patients
5196147|NCT02768337|brain metastasis|brain metastasis
5196148|NCT02768337|operable brain metastasis|operable brain metastasis
5196150|NCT02768324|Gastrointestinal Microbiome|gastrointestinal microbiome
5196151|NCT02768324|Gut microbiota|gut microbiota
5196152|NCT02768324|Gut Flora|gut flora
5196153|NCT02768324|Intestinal Flora|intestinal flora
5196154|NCT02768311|Instrumentation Post-operative pain Root canal preparation|instrumentation post-operative pain root canal preparation
5196155|NCT02768298|heart failure|heart failure
5196156|NCT02768298|systolic heart failure|systolic heart failure
5196157|NCT02768298|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5196158|NCT02768298|exercise capacity|exercise capacity
5196159|NCT02768285|apical patency|apical patency
5196160|NCT02768285|root canal treatment|root canal treatment
5196161|NCT02768233|Medication-overuse Headache|medication-overuse headache
5196162|NCT02768233|Educational Programme|educational programme
5196163|NCT02768233|Personality Profiles|personality profiles
5196164|NCT02768181|nutrition-specific behaviour change communication|nutrition-specific behaviour change communication
5196165|NCT02768181|dietary supplements|dietary supplements
5196166|NCT02768168|Dezocine|dezocine
5196167|NCT02768168|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
5196168|NCT02768168|Pain|pain
5196169|NCT02768168|Pruritus|pruritus
5802767|NCT00097409|Recurrent|recurrent
5196176|NCT02768103|rehabilitation|rehabilitation
5196178|NCT02768077|sleep disturbances|sleep disturbances
5196179|NCT02768025|smoking cessation|smoking cessation
5196180|NCT02768025|tobacco control|tobacco control
5196181|NCT02768025|acupuncture|acupuncture
5196182|NCT02768025|Korean Medicine|korean medicine
5196183|NCT02768025|Traditional & Complementary Medicine|traditional & complementary medicine
5196184|NCT02767999|Acute ischemic stroke|acute ischemic stroke
5196185|NCT02767986|Health Disparities|health disparities
5196186|NCT02767986|Mental Models|mental models
5196187|NCT02767986|Hispanic|hispanic
5196188|NCT02767986|Health Belief Model|health belief model
5196189|NCT02767986|Cultural Consensus Theory|cultural consensus theory
5196190|NCT02767986|Cancer Genetics|cancer genetics
5196191|NCT02767986|Qualitative|qualitative
5196192|NCT02767960|Tenascin-C|tenascin-c
5196193|NCT02767908|Tobacco|tobacco
5196194|NCT02767908|Smoking Cessation|smoking cessation
5196195|NCT02767869|Metabolic syndrome|metabolic syndrome
5196196|NCT02767869|central obesity|central obesity
5196197|NCT02767869|Banaba|banaba
5196198|NCT02767869|insulin secretion|insulin secretion
5196201|NCT02767778|Acute ischemic stroke|acute ischemic stroke
5196202|NCT02767778|Neuroprotection|neuroprotection
5196203|NCT02767778|Extremely low frequency magnetic fields|extremely low frequency magnetic fields
5196204|NCT02767752|Resectable pancreatic cancer|resectable pancreatic cancer
5196205|NCT02767752|Adjuvant|adjuvant
5196206|NCT02767713|Cognition Disorders|cognition disorders
5196207|NCT02767713|Cardiac Surgical Procedures|cardiac surgical procedures
5196208|NCT02767713|dexamethasone|dexamethasone
5196209|NCT02767687|Postoperative Care|postoperative care
5196210|NCT02767687|Postoperative Period|postoperative period
5196211|NCT02767687|Heart Surgery|heart surgery
5196212|NCT02767674|R-Gemox|r-gemox
5196213|NCT02767674|R-miniCHOP|r-minichop
5196214|NCT02767674|elderly patients with diffuse large B cell lymphoma|elderly patients with diffuse large b cell lymphoma
5196215|NCT02767661|metronomic capecitabine|metronomic capecitabine
5196216|NCT02767661|aromatase inhibitor|aromatase inhibitor
5196217|NCT02767661|first line treatment|first line treatment
5196218|NCT02767661|metastatic breast cancer|metastatic breast cancer
5196219|NCT02767648|cholestasis|cholestasis
5196220|NCT02767648|neonatal|neonatal
5196221|NCT02767648|infant|infant
5196222|NCT02767596|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5196223|NCT02767596|treatment|treatment
5196224|NCT02767596|GLP-1|glp-1
5196225|NCT02767583|Neuropathology|neuropathology
5196226|NCT02767570|Osteoarthritis, Knee|osteoarthritis, knee
5196227|NCT02767570|Arthritis|arthritis
5196228|NCT02767570|Joint Diseases|joint diseases
5196229|NCT02767570|Musculoskeletal Diseases|musculoskeletal diseases
5196230|NCT02767570|Rheumatic Diseases|rheumatic diseases
5196231|NCT02767544|laparoscopic hysterectomy|laparoscopic hysterectomy
5196232|NCT02767544|postoperative pain|postoperative pain
5196233|NCT02767544|local analgesia|local analgesia
5196234|NCT02767544|vaginal wound|vaginal wound
5196235|NCT02767479|eradication rates|eradication rates
5196236|NCT02767479|rabeprazole|rabeprazole
5196237|NCT02767479|esomeprazole|esomeprazole
5196238|NCT02767453|Shoulder arthroplasty|shoulder arthroplasty
5196239|NCT02767453|Closed suction drainage|closed suction drainage
5196240|NCT02767453|Glenohumeral|glenohumeral
5196241|NCT02767453|Drainage tube|drainage tube
5196249|NCT02767401|PET-CT|pet-ct
5196250|NCT02767401|Cardiac magnetic resonance (CMR) imaging|cardiac magnetic resonance (cmr) imaging
5196251|NCT02767401|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
5196252|NCT02767401|coronary artery disease|coronary artery disease
5196253|NCT02767375|Hepatocellular Carcinoma|hepatocellular carcinoma
5196353|NCT02766699|Molecular Targeted Therapy|molecular targeted therapy
5196254|NCT02767375|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5196255|NCT02767362|atorvastatin|atorvastatin
5196256|NCT02767362|endometrium|endometrium
5196257|NCT02767362|endometrial cancer|endometrial cancer
5196258|NCT02767310|Bioequivalence|bioequivalence
5196259|NCT02767310|two rosuvastatin-containing products|two rosuvastatin-containing products
5196260|NCT02767284|Contrast Sensitivity|contrast sensitivity
5673919|NCT00606125|Solid Tumors|solid tumors
5196263|NCT02767258|Diseases of the eye and adnexa|diseases of the eye and adnexa
5196265|NCT02767245|Congestive heart failure|congestive heart failure
5196266|NCT02767245|Atrial fibrillation|atrial fibrillation
5196267|NCT02767245|Graves' disease|graves' disease
5196268|NCT02767232|PHLO|phlo
5196269|NCT02767232|deep vein thrombosis|deep vein thrombosis
5196270|NCT02767232|deep venous thrombosis|deep venous thrombosis
5196271|NCT02767232|blood clot|blood clot
5196272|NCT02767232|catheter-directed thrombolysis|catheter-directed thrombolysis
5196273|NCT02767232|thrombolysis|thrombolysis
5196274|NCT02767232|post-thrombotic syndrome|post-thrombotic syndrome
5196275|NCT02767232|PTS|pts
5196276|NCT02767232|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5196277|NCT02767232|rt-PA|rt-pa
5196278|NCT02767232|Activase|activase
5196279|NCT02767232|Alteplase|alteplase
5196280|NCT02767219|Ophthalmology|ophthalmology
5196281|NCT02767206|Transnasal endoscopy|transnasal endoscopy
5196282|NCT02767206|ultrathin endoscopes|ultrathin endoscopes
5196283|NCT02767206|esophageal varices|esophageal varices
5196284|NCT02767206|gastric varices|gastric varices
5196285|NCT02767167|Cow's milk|cow's milk
5196286|NCT02767167|Iodine|iodine
5196287|NCT02767167|Selenium|selenium
5196288|NCT02767167|Women|women
5196289|NCT02767167|Child-bearing age|child-bearing age
5196290|NCT02767154|extracorporeal circulation|extracorporeal circulation
5196291|NCT02767141|Hunger|hunger
5196292|NCT02767141|food insecurity|food insecurity
5196293|NCT02767141|behaviors|behaviors
5196294|NCT02767128|pharmacokinetics|pharmacokinetics
5196295|NCT02767128|healthy adult volunteer|healthy adult volunteer
5196296|NCT02767102|Mediterranean diet|mediterranean diet
5196297|NCT02767102|indoleamine|indoleamine
5196298|NCT02767102|nutraceuticals|nutraceuticals
5196299|NCT02767102|nutrition|nutrition
5196300|NCT02767102|oxidative stress|oxidative stress
5192404|NCT02789787|Palate|palate
5196301|NCT02767089|Glucocorticoids, Biomarkers, Dissociated Agonist of the Glucocorticoid Receptor|glucocorticoids, biomarkers, dissociated agonist of the glucocorticoid receptor
5196302|NCT02767076|paramedian spinal anesthesia|paramedian spinal anesthesia
5196303|NCT02767076|real time|real time
5196304|NCT02767076|ultrasound|ultrasound
5196305|NCT02767076|knee surgeries|knee surgeries
5196306|NCT02767076|conventional|conventional
5196307|NCT02767050|DENTAL CARIES|dental caries
5196308|NCT02767050|TOBACCO USERS|tobacco users
5196309|NCT02767050|SMOKERS|smokers
5196310|NCT02767050|SMOKELESS TOBACCO CHEWERS|smokeless tobacco chewers
5196311|NCT02767011|surgical site infection|surgical site infection
5196312|NCT02766985|FSHD|fshd
5196313|NCT02766985|muscular dystrophy|muscular dystrophy
5196314|NCT02766972|Intracranial Aneurysm|intracranial aneurysm
5196315|NCT02766972|Surgical Clipping|surgical clipping
5196316|NCT02766972|Rapid Ventricular Pacing|rapid ventricular pacing
5196317|NCT02766959|chronic rhinosinusitis|chronic rhinosinusitis
5196318|NCT02766959|airway physiology|airway physiology
5196319|NCT02766959|taste receptors|taste receptors
5196320|NCT02766959|tas2r|tas2r
5196321|NCT02766959|epithelial biology|epithelial biology
5196322|NCT02766959|upper respiratory disease|upper respiratory disease
5196323|NCT02766946|Mechanical Ventilation|mechanical ventilation
5196324|NCT02766933|tenofovir|tenofovir
5196325|NCT02766933|hepatocellular carcinoma|hepatocellular carcinoma
5196326|NCT02766933|cirrhosis|cirrhosis
5196330|NCT02766855|cysteamine|cysteamine
5196331|NCT02766855|nephropathic cystinosis|nephropathic cystinosis
5196332|NCT02766855|cystine crystals|cystine crystals
5196333|NCT02766842|SharkCore|sharkcore
5196334|NCT02766842|ProCore|procore
5196335|NCT02766829|spinal|spinal
5196336|NCT02766829|anesthesia|anesthesia
5196337|NCT02766829|sitting|sitting
5196338|NCT02766829|cross leg|cross leg
5196339|NCT02766829|spinal-bone contact|spinal-bone contact
5196340|NCT02766738|residential aged care|residential aged care
5196341|NCT02766738|mobility|mobility
5196342|NCT02766738|social participation|social participation
5196343|NCT02766738|functional capability|functional capability
5196344|NCT02766712|catheter ablation|catheter ablation
5196345|NCT02766712|atrial fibrillation|atrial fibrillation
5196346|NCT02766699|Astrocytoma, Grade IV|astrocytoma, grade iv
5196347|NCT02766699|Doxorubicin|doxorubicin
5196348|NCT02766699|Glioblastoma|glioblastoma
5196349|NCT02766699|Neoplasms|neoplasms
5196350|NCT02766699|Neoplasms by Site|neoplasms by site
5196351|NCT02766699|Antineoplastic Agents|antineoplastic agents
5196352|NCT02766699|Drug Delivery Systems|drug delivery systems
5196354|NCT02766699|Nanoparticles|nanoparticles
5196355|NCT02766699|Disease Progression|disease progression
5196356|NCT02766699|Recurrence|recurrence
5196357|NCT02766699|Brain Neoplasms|brain neoplasms
5196358|NCT02766699|Immunotherapy|immunotherapy
5196359|NCT02766699|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
5196360|NCT02766699|Antibodies, Bispecific|antibodies, bispecific
5196361|NCT02766686|Prostate cancer|prostate cancer
5196362|NCT02766686|proton radiotherapy|proton radiotherapy
5196363|NCT02766686|photon radiotherapy|photon radiotherapy
5196364|NCT02766660|Thyroid ophthalmopathy|thyroid ophthalmopathy
5196365|NCT02766660|optical coherence tomography|optical coherence tomography
5196366|NCT02766647|Filgrastim|filgrastim
5196367|NCT02766634|filgrastim|filgrastim
5196368|NCT02766621|First in human, Phase 1, Healthy volunteers|first in human, phase 1, healthy volunteers
5196370|NCT02766582|Ovarian|ovarian
5196371|NCT02766582|platinum|platinum
5196372|NCT02766582|pembrolizumab|pembrolizumab
5196373|NCT02766582|taxane|taxane
5196374|NCT02766569|IRFACODE II, ASD closure, ASD device, erosion, arrhythmia|irfacode ii, asd closure, asd device, erosion, arrhythmia
5196375|NCT02766543|prostate cancer|prostate cancer
5196376|NCT02766543|high intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
5196377|NCT02766543|MRI-guided|mri-guided
5196378|NCT02766543|minimally invasive|minimally invasive
5196379|NCT02766543|real-time temperature feedback control|real-time temperature feedback control
5196380|NCT02766491|Stretching|stretching
5196381|NCT02766465|Sickle Cell Disease|sickle cell disease
5196382|NCT02766465|Young Adults|young adults
5196383|NCT02766465|Phase II Trial|phase ii trial
5196384|NCT02766465|Hematopoietic Cell Transplantation (HCT)|hematopoietic cell transplantation (hct)
5196385|NCT02766465|Human Leukocyte Antigen (HLA)|human leukocyte antigen (hla)
5196386|NCT02766400|Stroke|stroke
5196387|NCT02766400|Rehabilitation|rehabilitation
5196388|NCT02766400|Cognition|cognition
5196389|NCT02766400|Disability|disability
5196390|NCT02766400|Intervention|intervention
5196391|NCT02766374|Asthma|asthma
5196392|NCT02766374|Biofeedback|biofeedback
5962445|NCT04280900|Behavior Therapy|behavior therapy
5196393|NCT02766374|Heart rate variability biofeedback|heart rate variability biofeedback
5196394|NCT02766374|Inhaled corticosteroids|inhaled corticosteroids
5196395|NCT02766361|Bipolar disorder|bipolar disorder
5196396|NCT02766361|Psychotherapy|psychotherapy
5196397|NCT02766361|Cognitive rehabilitation|cognitive rehabilitation
5196398|NCT02766348|DC-CTL, NSCLC|dc-ctl, nsclc
5196399|NCT02766322|Alcohol metabolism|alcohol metabolism
5196400|NCT02766322|Bariatric surgery|bariatric surgery
5196401|NCT02766309|Self-assessment of health, Sf12-v2|self-assessment of health, sf12-v2
5196404|NCT02766296|working memory|working memory
5196405|NCT02766296|working memory training|working memory training
5196406|NCT02766283|Children|children
5196407|NCT02766283|Iodinated contrast agents|iodinated contrast agents
5196408|NCT02766270|Grade II/III Glioma|grade ii/iii glioma
5196409|NCT02766270|IDH|idh
5196410|NCT02766270|TERT|tert
5196411|NCT02766270|Chemoradiotherapy|chemoradiotherapy
5196412|NCT02766270|Temozolomide|temozolomide
5196413|NCT02766218|toddler obesity|toddler obesity
5196414|NCT02766218|responsive feeding|responsive feeding
5196415|NCT02766218|behavioral weight control|behavioral weight control
5196416|NCT02766218|pregnancy weight gain|pregnancy weight gain
5196417|NCT02766218|early life risk factors|early life risk factors
5196418|NCT02766205|Embolic Stroke of Undetermined Source|embolic stroke of undetermined source
5196419|NCT02766205|Atrial fibrillation|atrial fibrillation
5196420|NCT02766205|prognostic score|prognostic score
5196421|NCT02766192|ketamine|ketamine
5196422|NCT02766192|mindfulness based cognitive therapy|mindfulness based cognitive therapy
5196423|NCT02766192|PTSD|ptsd
5196424|NCT02766192|trauma memory|trauma memory
5196425|NCT02766192|memory extinction|memory extinction
5196426|NCT02766192|memory re-consolidation|memory re-consolidation
5196427|NCT02766192|metabolomics|metabolomics
5184355|NCT02837601|Pediatrics|pediatrics
5184356|NCT02837588|chronic pelvic pain|chronic pelvic pain
5184357|NCT02837588|trigger points|trigger points
5184358|NCT02837588|hiperthermy|hiperthermy
5196428|NCT02766192|TIMBER (Trauma Intervention using Mindfulness Based Extinction and Re-consolidation of trauma memories)|timber (trauma intervention using mindfulness based extinction and re-consolidation of trauma memories)
5196429|NCT02766127|radiotherapy|radiotherapy
5196430|NCT02766114|CTS|cts
5196431|NCT02766114|Carpal tunnel syndrome|carpal tunnel syndrome
5196432|NCT02766114|Carpal tunnel release|carpal tunnel release
5196433|NCT02766114|Mini incision of carpal tunnel release|mini incision of carpal tunnel release
5196434|NCT02766114|Cosmetic surgery of carpal tunnel syndrome|cosmetic surgery of carpal tunnel syndrome
5196435|NCT02766114|endoscopic carpal tunnel surgery|endoscopic carpal tunnel surgery
5196436|NCT02766114|Carpal Tunnel Release Through Mini Transverse Approach|carpal tunnel release through mini transverse approach
5196437|NCT02766114|Dr. Sayed Issa's Approach|dr. sayed issa's approach
5196438|NCT02766114|CTRMTA|ctrmta
5196439|NCT02766114|OCTR|octr
5196440|NCT02766114|ECTR|ectr
5196441|NCT02766114|Open Carpal Tunnel Release|open carpal tunnel release
5196442|NCT02766114|Endoscopic Carpal Tunnel Release|endoscopic carpal tunnel release
5196443|NCT02766114|Syria|syria
5196444|NCT02766114|Cosmetic|cosmetic
5196445|NCT02766114|Safety|safety
5196446|NCT02766114|Rehabilitation,|rehabilitation,
5196447|NCT02766114|Complications|complications
5196449|NCT02766114|Satisfaction|satisfaction
5196450|NCT02766088|Dengue|dengue
5196451|NCT02766088|Household|household
5196452|NCT02766088|Southeast Asia|southeast asia
5196453|NCT02766088|Latin America|latin america
5279168|NCT02279823|topical|topical
5196454|NCT02766088|Surveillance|surveillance
5196455|NCT02766075|Transcatheter Aortic Valve Disease|transcatheter aortic valve disease
5196584|NCT02765451|health institution|health institution
5196456|NCT02766075|Supervised TAVR Exercise Program|supervised tavr exercise program
5196457|NCT02766062|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5196458|NCT02766062|metabolic syndrome|metabolic syndrome
5196459|NCT02766062|propofol|propofol
5196460|NCT02766062|sevoflurane|sevoflurane
5196462|NCT02766049|immunotherapy|immunotherapy
5196463|NCT02766049|clinical trial|clinical trial
5196464|NCT02766049|dendritic cell|dendritic cell
5196465|NCT02766036|Proteinuria|proteinuria
5196466|NCT02766036|Propolis|propolis
5196467|NCT02766036|Chronic Kidney Disease|chronic kidney disease
5196468|NCT02766023|CTV-05|ctv-05
5196469|NCT02766023|LACTIN-V|lactin-v
5196470|NCT02766023|Lactobacillus|lactobacillus
5196471|NCT02766023|MetroGel®|metrogel®
5196472|NCT02766023|Vaginitis|vaginitis
5196473|NCT02765997|AML|aml
5196474|NCT02765997|ALL|all
5196475|NCT02765997|MDS|mds
5196476|NCT02765984|implantation site|implantation site
5196477|NCT02765984|placental site|placental site
5196478|NCT02765984|Doppler|doppler
5196479|NCT02765971|chewing gums|chewing gums
5196480|NCT02765971|laxatives|laxatives
5196481|NCT02765971|bowel function|bowel function
5196482|NCT02765945|Exercise|exercise
5196483|NCT02765945|Osteoporosis|osteoporosis
5196484|NCT02765945|Cytokines|cytokines
5196485|NCT02765932|Hip|hip
5196486|NCT02765932|Knee|knee
5196487|NCT02765932|replacement|replacement
5196488|NCT02765932|surgery|surgery
5196489|NCT02765919|Carcinoma cervix|carcinoma cervix
5196490|NCT02765919|RCT(randomised controlled trial)|rct(randomised controlled trial)
5196491|NCT02765919|9 Gray|9 gray
5196492|NCT02765919|Brachytherapy|brachytherapy
5196493|NCT02765906|video|video
5196494|NCT02765906|educational tool|educational tool
5196495|NCT02765906|preeclampsia|preeclampsia
5196496|NCT02765906|hypertension|hypertension
5192597|NCT02788734|CMT|cmt
5196500|NCT02765906|eclampsia|eclampsia
5196502|NCT02765906|anxiety|anxiety
5196503|NCT02765906|anxiety assessment|anxiety assessment
5196504|NCT02765906|STAI 6|stai 6
5196505|NCT02765841|HoFH|hofh
5196506|NCT02765815|TKA|tka
5196507|NCT02765815|Knee replacement|knee replacement
5196508|NCT02765815|Arthritis|arthritis
5196509|NCT02765815|Knee|knee
5196510|NCT02765776|Anti-HIV Drugs|anti-hiv drugs
5196511|NCT02765776|Raltegravir Potassium|raltegravir potassium
5196512|NCT02765776|Aged|aged
5196513|NCT02765776|Retrospective Study|retrospective study
5196514|NCT02765776|Medical Records|medical records
5196515|NCT02765750|Emergence agitation|emergence agitation
5196516|NCT02765711|ticagrelor|ticagrelor
5940536|NCT00514098|Microbicide|microbicide
5940537|NCT00514098|Seroconversion|seroconversion
5196517|NCT02765711|acute coronary syndrome|acute coronary syndrome
5196518|NCT02765698|Magnetic Resonance Imaging|magnetic resonance imaging
5196519|NCT02765672|Combat Veterans|combat veterans
5196520|NCT02765672|Automobile Driving|automobile driving
5196521|NCT02765672|Fitness to Drive|fitness to drive
5196522|NCT02765659|HIV|hiv
5940538|NCT00514098|Treatment Experienced|treatment experienced
5184452|NCT02836834|phase 1 trial|phase 1 trial
5184453|NCT02836808|Multidisciplinary interventions|multidisciplinary interventions
5184454|NCT02836808|Long term control|long term control
5184455|NCT02836808|Empowerment|empowerment
5184456|NCT02836795|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5184457|NCT02836795|advanced solid tumors|advanced solid tumors
5184458|NCT02836795|safety|safety
5184459|NCT02836782|HIV/HCV|hiv/hcv
5184460|NCT02836782|Antiretroviral therapy|antiretroviral therapy
5196523|NCT02765659|Prevention|prevention
5196524|NCT02765659|Implementation|implementation
5196525|NCT02765659|Community based participatory research|community based participatory research
5196526|NCT02765620|Positron-Emission Tomography|positron-emission tomography
5196527|NCT02765620|Response Criteria|response criteria
5196528|NCT02765620|solid tumor|solid tumor
5196529|NCT02765607|Blood circulation|blood circulation
5196530|NCT02765607|Cardiac surgical procedures|cardiac surgical procedures
5196531|NCT02765607|Homeostasis|homeostasis
5196532|NCT02765594|Glomerulonephritis, IGA|glomerulonephritis, iga
5196533|NCT02765594|Kidney Diseases|kidney diseases
5196534|NCT02765594|Autoimmune Diseases|autoimmune diseases
5196535|NCT02765594|Glomerulonephritis|glomerulonephritis
5196536|NCT02765594|Nephritis|nephritis
5196537|NCT02765594|Immune System Diseases|immune system diseases
5196538|NCT02765594|Urologic Diseases|urologic diseases
5196539|NCT02765594|Hydroxychloroquine|hydroxychloroquine
5196540|NCT02765594|Anti-Infective Agents|anti-infective agents
5196541|NCT02765594|Antimalarials|antimalarials
5196542|NCT02765594|Antiparasitic Agents|antiparasitic agents
5196543|NCT02765594|Antiprotozoal Agents|antiprotozoal agents
5196544|NCT02765594|Antirheumatic Agents|antirheumatic agents
5196545|NCT02765594|Enzyme Inhibitors|enzyme inhibitors
5196546|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5196547|NCT02765594|Pharmacologic Actions|pharmacologic actions
5196548|NCT02765594|Therapeutic Uses|therapeutic uses
5196549|NCT02765594|interleukin-6|interleukin-6
5196550|NCT02765594|interferon-alpha|interferon-alpha
5196551|NCT02765594|tumor necrosis factor-alpha|tumor necrosis factor-alpha
5196552|NCT02765581|Acupuncture|acupuncture
5196553|NCT02765581|Migraine without aura|migraine without aura
5196554|NCT02765581|Efficacy|efficacy
5196555|NCT02765581|Randomized controlled trial|randomized controlled trial
5196556|NCT02765581|Non-penetrating sham acupuncture|non-penetrating sham acupuncture
5196557|NCT02765568|Coronary Artery Disease|coronary artery disease
5196558|NCT02765568|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5196559|NCT02765542|Depression|depression
5196560|NCT02765542|mHealth|mhealth
5196561|NCT02765542|Interactive Voice Response|interactive voice response
5196562|NCT02765542|Bolivia|bolivia
5196563|NCT02765542|Mental health|mental health
5196564|NCT02765529|Environmental Pollution|environmental pollution
5196565|NCT02765529|Fine particles|fine particles
5196566|NCT02765529|Biomarkers|biomarkers
5196567|NCT02765529|Elderly|elderly
5196568|NCT02765490|Hepatitis C, Chronic|hepatitis c, chronic
5196569|NCT02765490|AL-335|al-335
5196570|NCT02765490|Odalasvir|odalasvir
5196571|NCT02765490|Simeprevir|simeprevir
5196572|NCT02765490|ODV|odv
5196573|NCT02765490|SMV|smv
5196574|NCT02765490|ACH-3102|ach-3102
5196575|NCT02765490|ACH-0143102|ach-0143102
5196576|NCT02765490|TMC435|tmc435
5196577|NCT02765477|Acute myocardial infarction|acute myocardial infarction
5196578|NCT02765477|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5962446|NCT04280874|dinoprostone|dinoprostone
5064246|NCT03597750|Elderly|elderly
5072417|NCT03546660|EoE|eoe
5196579|NCT02765477|Acute Coronary Occlusion|acute coronary occlusion
5196580|NCT02765477|Electrocardiogram|electrocardiogram
5196581|NCT02765477|Ventricular Paced Rhythm|ventricular paced rhythm
5196594|NCT02765412|patient preferences|patient preferences
5196595|NCT02765412|risk adjustment|risk adjustment
5196596|NCT02765386|Cochlear implants|cochlear implants
5196597|NCT02765386|Hybrid fittings|hybrid fittings
5196598|NCT02765386|Cross-over frequency|cross-over frequency
5196599|NCT02765373|aromatase inhibitors|aromatase inhibitors
5196600|NCT02765373|lipid levels|lipid levels
5940539|NCT00514098|Treatment Naive|treatment naive
5184548|NCT02836275|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5184549|NCT02836275|Diagnosis|diagnosis
5196602|NCT02765360|NIV|niv
5196603|NCT02765308|Uveitis|uveitis
5196604|NCT02765308|Glaucoma|glaucoma
5196605|NCT02765308|Aqueous humor dynamics|aqueous humor dynamics
5196606|NCT02765295|Hydrogen|hydrogen
5196607|NCT02765295|Inhalation|inhalation
5196608|NCT02765295|bronchiectasis|bronchiectasis
5196609|NCT02765282|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5196610|NCT02765282|Kinesia|kinesia
5196611|NCT02765269|cancer pain|cancer pain
5196612|NCT02765269|mobile applications|mobile applications
5196613|NCT02765243|neuroblastoma|neuroblastoma
5196614|NCT02765243|GD2|gd2
5196615|NCT02765243|Chimeric antigen receptor|chimeric antigen receptor
5196616|NCT02765243|Immunotherapy|immunotherapy
5196617|NCT02765243|Cyclophosphamide|cyclophosphamide
5196618|NCT02765243|Fludarabine|fludarabine
5196619|NCT02765217|Antibiotic associated diarrhea|antibiotic associated diarrhea
5196620|NCT02765217|Children|children
5196621|NCT02765217|Prevention|prevention
5196622|NCT02765217|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
5196623|NCT02765217|Probiotic|probiotic
5196624|NCT02765191|Magnetic Resonance Imaging|magnetic resonance imaging
5196625|NCT02765191|Norepinephrine|norepinephrine
5196626|NCT02765191|Fluid Therapy|fluid therapy
5196627|NCT02765191|Renal Circulation|renal circulation
5196628|NCT02765165|Phase 1|phase 1
5196629|NCT02765165|Phase 2|phase 2
5196630|NCT02765165|Glioblastoma Multiforme|glioblastoma multiforme
5196631|NCT02765165|Glioblastoma|glioblastoma
5196632|NCT02765165|GBM|gbm
5196633|NCT02765165|Brain Tumor|brain tumor
5196634|NCT02765165|Brain Cancer|brain cancer
5196635|NCT02765165|Tumor|tumor
5196636|NCT02765165|Solid Tumor|solid tumor
5196637|NCT02765165|Tumour|tumour
5196638|NCT02765165|Lomustine|lomustine
5196639|NCT02765165|CCNU|ccnu
5196640|NCT02765165|CXCR4|cxcr4
5196641|NCT02765165|Phase 1 Clinical Trial|phase 1 clinical trial
5196642|NCT02765165|Phase 2 Clinical Trial|phase 2 clinical trial
5196643|NCT02765152|exercise|exercise
5196644|NCT02765152|rhythmic movement|rhythmic movement
5196645|NCT02765152|discrete movement|discrete movement
5196646|NCT02765100|Bipolar Disorder|bipolar disorder
5196647|NCT02765100|Obesity|obesity
5196648|NCT02765100|Depression|depression
5196649|NCT02765074|subcutaneous tocilizumab|subcutaneous tocilizumab
5196650|NCT02765074|High Resolution peripheral QCT (HR-pQCT)|high resolution peripheral qct (hr-pqct)
5196651|NCT02765074|bone erosion|bone erosion
5196652|NCT02765074|bone microarchitecture|bone microarchitecture
5196653|NCT02765074|rheumatoid arthritis|rheumatoid arthritis
5196654|NCT02765048|Adolescent girls|adolescent girls
5196655|NCT02765048|Child welfare|child welfare
5196656|NCT02765048|Trauma treatment|trauma treatment
5196658|NCT02765048|Depression|depression
5196660|NCT02765009|Fluid overload|fluid overload
5196661|NCT02765009|Multiple organ failure|multiple organ failure
5196662|NCT02765009|Diuretics|diuretics
5196663|NCT02765009|Fluid restriction|fluid restriction
5196664|NCT02765009|Body weight|body weight
5196665|NCT02764983|Combat Veterans|combat veterans
5196666|NCT02764983|Automobile Driving|automobile driving
5196667|NCT02764983|Fitness to Drive|fitness to drive
5196668|NCT02764905|Diabetes|diabetes
5196669|NCT02764905|Cognitive-physical rehabilitation|cognitive-physical rehabilitation
5196670|NCT02764905|Self care management|self care management
5196671|NCT02764879|Omega 3 fatty acids|omega 3 fatty acids
5196672|NCT02764879|Root planning|root planning
5196673|NCT02764879|chronic periodontitis|chronic periodontitis
5196677|NCT02764853|HIV|hiv
5196678|NCT02764853|Black|black
5196679|NCT02764853|African American|african american
5196680|NCT02764853|Women|women
5196681|NCT02764853|Cognitive Behavioral Therapy|cognitive behavioral therapy
5196682|NCT02764853|Racism|racism
5196683|NCT02764853|Stigma|stigma
5196684|NCT02764853|Discrimination|discrimination
5962447|NCT04280874|Bishop score|bishop score
5196685|NCT02764853|Gender related stressors|gender related stressors
5196686|NCT02764853|Resilience|resilience
5196687|NCT02764853|Behavioral Medicine|behavioral medicine
5196688|NCT02764827|skin prick test|skin prick test
5196689|NCT02764827|grass and weed pollens|grass and weed pollens
5196690|NCT02764788|Auriculotherapy|auriculotherapy
5962448|NCT04280874|labor induction|labor induction
5196692|NCT02764749|vascular function|vascular function
5196693|NCT02764749|endothelial function|endothelial function
5072480|NCT03546257|Early gastric cancer|early gastric cancer
5072481|NCT03546257|Invasion depth|invasion depth
5196694|NCT02764749|polyphenols|polyphenols
5196695|NCT02764697|Glaucoma associated with uveitis|glaucoma associated with uveitis
5196696|NCT02764671|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5196697|NCT02764671|safety|safety
5196698|NCT02764671|immunogenicity|immunogenicity
5196699|NCT02764645|Cardiopulmonary Bypass|cardiopulmonary bypass
5196700|NCT02764619|Upstream therapy, spironolactone|upstream therapy, spironolactone
5196701|NCT02764619|Atrial remodelling|atrial remodelling
5196702|NCT02764619|Modified look-locker inversion recover (MOLLI) sequences|modified look-locker inversion recover (molli) sequences
5196703|NCT02764619|T1 mapping|t1 mapping
5196704|NCT02764619|Diffuse myocardial fibrosis|diffuse myocardial fibrosis
5196705|NCT02764606|Lung Cancer|lung cancer
5196706|NCT02764606|Biomarkers|biomarkers
5196707|NCT02764606|Bone|bone
5196708|NCT02764606|Metastases|metastases
5196709|NCT02764593|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5196710|NCT02764593|HNSCC|hnscc
5196711|NCT02764593|Nivolumab|nivolumab
5196712|NCT02764554|Post-Marketing Surveillance|post-marketing surveillance
5196713|NCT02764554|Lenvima|lenvima
5196714|NCT02764554|Lenvatinib|lenvatinib
5196715|NCT02764554|E7080|e7080
5196716|NCT02764554|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5196717|NCT02764554|Refractory to radioactive iodine|refractory to radioactive iodine
5196718|NCT02764554|Progressive|progressive
5196719|NCT02764554|locally recurrent|locally recurrent
5196720|NCT02764554|metastatic|metastatic
5196721|NCT02764541|Breast Cancer|breast cancer
5196722|NCT02764541|Invasive Lobular Carcinoma|invasive lobular carcinoma
5196723|NCT02764528|Hygiene|hygiene
5196724|NCT02764515|Kunxian Capsule|kunxian capsule
5196725|NCT02764515|efficacy|efficacy
5196726|NCT02764515|rheumatoid arthritis|rheumatoid arthritis
5196727|NCT02764515|Methotrexate|methotrexate
5196728|NCT02764502|Epidural Identification pressure gauge|epidural identification pressure gauge
5196729|NCT02764476|psychogenic|psychogenic
5196730|NCT02764476|non-epileptic seizures|non-epileptic seizures
5196731|NCT02764476|functional neurological symptom disorder|functional neurological symptom disorder
5196732|NCT02764476|PNES|pnes
5196733|NCT02764476|PMD|pmd
5196734|NCT02764476|virtual reality|virtual reality
5196735|NCT02764476|3D augmented reality|3d augmented reality
5196736|NCT02764476|mirror therapy|mirror therapy
5196737|NCT02764463|Fiber Reinforced Composites|fiber reinforced composites
5196738|NCT02764463|Resin cements|resin cements
5196739|NCT02764463|Survival|survival
5196740|NCT02764450|composite|composite
5196741|NCT02764450|restoration|restoration
5196742|NCT02764450|polymerization|polymerization
5196743|NCT02764424|Newborn|newborn
5196744|NCT02764424|Heart Rate Variability (HRV)|heart rate variability (hrv)
5196745|NCT02764424|Analgesic Nociception Index (ANI)|analgesic nociception index (ani)
5196746|NCT02764424|Autonomous Nervous System (ANS)|autonomous nervous system (ans)
5203855|NCT02720380|Asthma|asthma
5196747|NCT02764411|Capillary malformations|capillary malformations
5196748|NCT02764411|Onrealtea|onrealtea
5196749|NCT02764411|port-wine stain|port-wine stain
5196750|NCT02764411|treatment|treatment
5196751|NCT02764411|topical|topical
5196752|NCT02764372|Arm rehabilitation|arm rehabilitation
5196753|NCT02764372|Serious games|serious games
5196754|NCT02764372|stroke|stroke
5196755|NCT02764372|Multiple sclerosis|multiple sclerosis
5196756|NCT02764346|Arthritis|arthritis
5196757|NCT02764346|Self-management|self-management
5196758|NCT02764346|Pain|pain
5196759|NCT02764333|TPIV200/huFR-1|tpiv200/hufr-1
5196760|NCT02764333|Anti-PD-L1|anti-pd-l1
5196761|NCT02764333|vaccine|vaccine
5196762|NCT02764333|16-011|16-011
5196763|NCT02764294|anxiety|anxiety
5196764|NCT02764294|pain|pain
5196765|NCT02764294|satisfaction|satisfaction
5196766|NCT02764294|cystoscopy|cystoscopy
5196767|NCT02764294|music|music
5196768|NCT02764294|video|video
5196769|NCT02764294|stress ball|stress ball
5196770|NCT02764294|nursing|nursing
5196771|NCT02764268|Gastric Cancer|gastric cancer
5196772|NCT02764268|Pharmacokinetics|pharmacokinetics
5196773|NCT02764268|Dose titration|dose titration
5196774|NCT02764242|insect sting allergy|insect sting allergy
5196775|NCT02764242|recombinant venom allergen|recombinant venom allergen
5196776|NCT02764203|Dark Chocolate|dark chocolate
5196777|NCT02764203|Blood Pressure|blood pressure
5196778|NCT02764203|Wearable Devices|wearable devices
5196779|NCT02764203|Digital Health|digital health
5196781|NCT02764151|GBM|gbm
5962449|NCT04280874|term pregnancy|term pregnancy
5962450|NCT04280835|schizophrenia|schizophrenia
5196782|NCT02764151|malignant glioma|malignant glioma
5196783|NCT02764151|glioma|glioma
5196784|NCT02764151|anaplastic glioma|anaplastic glioma
5196785|NCT02764151|astrocytoma|astrocytoma
5196786|NCT02764151|IDO|ido
5196787|NCT02764151|IDO1|ido1
5196788|NCT02764151|PF-06840003|pf-06840003
5196789|NCT02764138|poverty|poverty
5196790|NCT02764138|discrimination|discrimination
5196791|NCT02764125|Parkinson's Disease|parkinson's disease
5196792|NCT02764125|Wearing-off|wearing-off
5962451|NCT04280835|psychoeducation|psychoeducation
5196793|NCT02764112|warfarin|warfarin
5196794|NCT02764073|Heart failure|heart failure
5196795|NCT02764073|Bioimpedance|bioimpedance
5196796|NCT02764073|Lung ultrasonography|lung ultrasonography
5196797|NCT02764060|Periodontitis|periodontitis
5196798|NCT02764060|Tongue coating|tongue coating
5196799|NCT02764060|Tongue cleaning|tongue cleaning
5196800|NCT02764060|Bacterial load|bacterial load
5196801|NCT02764047|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5196802|NCT02764047|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5196803|NCT02764047|NAFLD|nafld
5196804|NCT02764047|NASH|nash
5196805|NCT02764034|Low level Laser|low level laser
5196806|NCT02764034|Tissue culture|tissue culture
5196807|NCT02764034|Endometrial receptivity|endometrial receptivity
5196808|NCT02764021|HbA1c|hba1c
5196809|NCT02764021|Diabetes-Releated Complications|diabetes-releated complications
5196810|NCT02764021|Diet, Low Carbohydrate|diet, low carbohydrate
5196811|NCT02764021|Carbohydrate-Restricted Diet|carbohydrate-restricted diet
5196812|NCT02764021|Diabetes Mellitus|diabetes mellitus
5196813|NCT02764021|Metabolic Disorder|metabolic disorder
5196814|NCT02764021|Glucose Metabolism Disorders|glucose metabolism disorders
5196815|NCT02764021|Endocrine System Diseases|endocrine system diseases
5196816|NCT02764008|Postoperative Analgesia|postoperative analgesia
5196817|NCT02764008|Peritubal infiltration|peritubal infiltration
5196818|NCT02764008|Ultrasound guided low thoracic paravertebral block|ultrasound guided low thoracic paravertebral block
5196819|NCT02764008|Percutaneous Nephrolithotomy pain|percutaneous nephrolithotomy pain
5196821|NCT02763995|pharmaceutical care|pharmaceutical care
5196822|NCT02763995|older patients|older patients
5196823|NCT02763995|cardiovascular risk|cardiovascular risk
5196824|NCT02763995|pharmacotherapy follow up|pharmacotherapy follow up
5196825|NCT02763982|left ventricular ejection fraction|left ventricular ejection fraction
5196826|NCT02763982|peak oxygen uptake|peak oxygen uptake
5196827|NCT02763982|respiratory muscles|respiratory muscles
5196828|NCT02763982|quality of life|quality of life
5196829|NCT02763956|Gelstix, Hydrogel|gelstix, hydrogel
5196830|NCT02763930|Cardiovascular disease|cardiovascular disease
5196831|NCT02763930|Blood pressure|blood pressure
5196832|NCT02763930|Hypertension|hypertension
5196833|NCT02763930|Dairy products|dairy products
5196834|NCT02763930|Milk|milk
5196835|NCT02763930|Cheese|cheese
5196836|NCT02763891|Balance|balance
5196837|NCT02763891|Mobility|mobility
5196838|NCT02763891|Trunk control|trunk control
5196839|NCT02763878|Uncut Roux-en-Y|uncut roux-en-y
5196840|NCT02763878|Billroth II anastomosis|billroth ii anastomosis
5196841|NCT02763878|Distal gastric cancer|distal gastric cancer
5196842|NCT02763878|Nutrition status|nutrition status
5196843|NCT02763878|Postoperative complications|postoperative complications
5196844|NCT02763852|Parkinson's Disease|parkinson's disease
5196845|NCT02763852|Nebicapone|nebicapone
5196846|NCT02763839|Parkinson's disease|parkinson's disease
5196847|NCT02763839|Nebicapone|nebicapone
5196848|NCT02763826|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5196849|NCT02763826|tDCS|tdcs
5196850|NCT02763800|Parkinson's disease|parkinson's disease
5196851|NCT02763800|Nebicapone|nebicapone
5196852|NCT02763774|coronary artery bypass|coronary artery bypass
5196853|NCT02763774|sistemic inflammatory response syndrome|sistemic inflammatory response syndrome
5196854|NCT02763774|left ventricular dysfunction|left ventricular dysfunction
5196855|NCT02763774|postoperative complications|postoperative complications
5196856|NCT02763774|physical fitness|physical fitness
5196957|NCT02763228|Breast Cancer|breast cancer
5196868|NCT02763696|Vaginal microflora|vaginal microflora
5196869|NCT02763696|High-throughput sequencing|high-throughput sequencing
5196870|NCT02763683|Parkinsons Disease|parkinsons disease
5196871|NCT02763683|PET Imaging|pet imaging
5196873|NCT02763683|VAT|vat
5196874|NCT02763683|Dementia|dementia
5196875|NCT02763670|Heart failure|heart failure
5196876|NCT02763670|patient education as topic|patient education as topic
5196877|NCT02763670|patient care management|patient care management
5196878|NCT02763657|fMRI|fmri
5196879|NCT02763657|reasoning|reasoning
5196880|NCT02763657|development|development
5196881|NCT02763644|transplant associated microangiopathy|transplant associated microangiopathy
5196882|NCT02763618|Neurofeedback|neurofeedback
5196883|NCT02763618|theta/beta ratio|theta/beta ratio
5196884|NCT02763618|multiple baseline|multiple baseline
5196885|NCT02763605|Acanthamoeba Keratitis|acanthamoeba keratitis
5196886|NCT02763605|in vivo confocal microscopic|in vivo confocal microscopic
5196887|NCT02763592|Localized Neuropathic pain|localized neuropathic pain
5196888|NCT02763592|5% lidocaine medicated plaster|5% lidocaine medicated plaster
5196889|NCT02763592|Knee surgery|knee surgery
5196894|NCT02763553|Ketone Bodies|ketone bodies
5196895|NCT02763553|Enteral Nutrition|enteral nutrition
5196896|NCT02763553|Ketogenic Diet|ketogenic diet
5196897|NCT02763540|ILD|ild
5196898|NCT02763540|Pathology|pathology
5196899|NCT02763540|diagnosis|diagnosis
5196900|NCT02763540|lung biopsy|lung biopsy
5196901|NCT02763527|smoking cessation|smoking cessation
5196902|NCT02763501|bariatric surgery|bariatric surgery
5196903|NCT02763501|gastric bypass|gastric bypass
5072722|NCT03544580|crestal bone loss|crestal bone loss
5196904|NCT02763501|intestinal obstruction|intestinal obstruction
5196905|NCT02763501|postoperative complication|postoperative complication
5196906|NCT02763501|methods|methods
5196907|NCT02763501|laparoscopy|laparoscopy
5196908|NCT02763488|blood flow restriction training|blood flow restriction training
5196909|NCT02763488|occlusion training|occlusion training
5196910|NCT02763488|total knee arthroplasty|total knee arthroplasty
5196911|NCT02763488|post-operative rehabilitation|post-operative rehabilitation
5196912|NCT02763475|Killer Cells, Natural|killer cells, natural
5196913|NCT02763475|Consolidation treatment|consolidation treatment
5196914|NCT02763475|cytologic remission|cytologic remission
5196915|NCT02763475|Haploidentical NK Cells|haploidentical nk cells
5196916|NCT02763475|allogeneic|allogeneic
5196917|NCT02763475|IL-2 Expanded NK Cells|il-2 expanded nk cells
5196918|NCT02763462|Acute Febrile Illness|acute febrile illness
5196926|NCT02763423|umbilical cord stem cell|umbilical cord stem cell
5196927|NCT02763423|diabetic ketoacidosis|diabetic ketoacidosis
5196928|NCT02763371|high GI lunch|high gi lunch
5196929|NCT02763371|low GI lunch|low gi lunch
5196930|NCT02763358|obesity|obesity
5196931|NCT02763358|weight loss|weight loss
5196932|NCT02763332|Fibromyalgia|fibromyalgia
5196933|NCT02763332|Efficacy|efficacy
5196934|NCT02763332|Taping|taping
5196935|NCT02763319|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5196936|NCT02763319|bendamustine|bendamustine
5196937|NCT02763319|rituximab|rituximab
5196938|NCT02763319|combination therapy|combination therapy
5196939|NCT02763319|CD19 monoclonal antibody|cd19 monoclonal antibody
5196940|NCT02763319|transplant ineligible|transplant ineligible
5196941|NCT02763293|pain|pain
5196942|NCT02763293|effectiveness|effectiveness
5196943|NCT02763293|manual therapy|manual therapy
5196944|NCT02763267|Insulin sensitivity|insulin sensitivity
5196945|NCT02763267|Insulin secretion|insulin secretion
5196946|NCT02763267|Pregnancy|pregnancy
5196947|NCT02763267|Placental proteins|placental proteins
5196948|NCT02763254|Epstein-Barr Virus|epstein-barr virus
5196949|NCT02763254|DLBCL|dlbcl
5196950|NCT02763254|PTLD|ptld
5196951|NCT02763254|EBV|ebv
5196952|NCT02763254|CIVIC|civic
5196953|NCT02763254|HL|hl
5196954|NCT02763254|T cell|t cell
5196955|NCT02763241|rhinitis|rhinitis
5196956|NCT02763228|Physical Activity|physical activity
5196958|NCT02763228|minority|minority
5196959|NCT02763228|African American|african american
5196960|NCT02763202|transition of care|transition of care
5196961|NCT02763202|pragmatic clinical trial|pragmatic clinical trial
5196962|NCT02763202|telemedicine|telemedicine
5196963|NCT02763202|emergency medical technician|emergency medical technician
5196964|NCT02763189|Mentoring|mentoring
5196965|NCT02763189|Endotracheal Tube Exchange|endotracheal tube exchange
5196966|NCT02763189|Training|training
5196967|NCT02763176|hCG testing, multi-level pregnancy test|hcg testing, multi-level pregnancy test
5196968|NCT02763150|Gestational Diabetes Prevention|gestational diabetes prevention
5196969|NCT02763124|Pseudophakic|pseudophakic
5196970|NCT02763111|ankylosing spondylitis|ankylosing spondylitis
5196971|NCT02763111|interleukin 17|interleukin 17
5196972|NCT02763111|monoclonal antibody|monoclonal antibody
5196973|NCT02763098|cardiovascular responses|cardiovascular responses
5196974|NCT02763098|analgesics opioid|analgesics opioid
5196975|NCT02763098|remifentanil|remifentanil
5196976|NCT02763046|Ankylosing Spondylitis|ankylosing spondylitis
5196978|NCT02763046|ASAS|asas
5196979|NCT02763046|Secukinumab|secukinumab
5196980|NCT02763046|Subcutaneous|subcutaneous
5196981|NCT02763020|high glycemic index, polyphenols, blood glucose, satiety|high glycemic index, polyphenols, blood glucose, satiety
5196982|NCT02762994|interleukin 17|interleukin 17
5196983|NCT02762994|monoclonal antibody|monoclonal antibody
5196984|NCT02762994|psoriasis|psoriasis
5196985|NCT02762981|CORT125134|cort125134
5196986|NCT02762981|nabpaclitaxel|nabpaclitaxel
5196987|NCT02762981|Triple-Negative Breast Cancer|triple-negative breast cancer
5196988|NCT02762981|Ovarian Epithelial Cancer|ovarian epithelial cancer
5196989|NCT02762981|GR Antagonist|gr antagonist
5196990|NCT02762981|Glucocorticoid Receptor Antagonist|glucocorticoid receptor antagonist
5196991|NCT02762981|Pancreatic Cancer|pancreatic cancer
5196992|NCT02762981|Solid Tumors|solid tumors
5196993|NCT02762955|adalimumab|adalimumab
5196994|NCT02762955|biosimilar|biosimilar
5196995|NCT02762955|BCD-057|bcd-057
5196996|NCT02762955|psoriasis|psoriasis
5196997|NCT02762955|tumor necrosis factor|tumor necrosis factor
5196998|NCT02762955|monoclonal antibody|monoclonal antibody
5196999|NCT02762942|cervical ripening|cervical ripening
5197000|NCT02762942|misoprostol|misoprostol
5197001|NCT02762942|supracervical balloon|supracervical balloon
5197002|NCT02762942|Foley catheter|foley catheter
5197003|NCT02762929|Analgesia|analgesia
5197004|NCT02762929|Bunionectomy|bunionectomy
5197005|NCT02762903|Shoulder arthroplasty|shoulder arthroplasty
5197006|NCT02762903|Lesser Tuberosity Osteotomy|lesser tuberosity osteotomy
5197007|NCT02762903|Subscapularis tenotomy|subscapularis tenotomy
5962452|NCT04280835|compliance to treatment|compliance to treatment
5197008|NCT02762864|aspirin|aspirin
5962453|NCT04280835|quality of life|quality of life
5072838|NCT03543826|sugammadex|sugammadex
5197009|NCT02762864|ticagrelor|ticagrelor
5197010|NCT02762864|clopidogrel|clopidogrel
5197011|NCT02762851|Influenza|influenza
5197012|NCT02762851|Vaccine|vaccine
5197013|NCT02762851|Heart failure|heart failure
5197014|NCT02762851|Vascular|vascular
5197015|NCT02762799|neutrophil count|neutrophil count
5197016|NCT02762799|filgrastim|filgrastim
5197017|NCT02762799|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5197018|NCT02762747|Hernia, Inguinal|hernia, inguinal
5197019|NCT02762747|Extraperitoneal Hernioplasty|extraperitoneal hernioplasty
5197020|NCT02762747|Drain|drain
5197021|NCT02762747|Mesh Repair|mesh repair
5197022|NCT02762747|Laparoscopic|laparoscopic
5197023|NCT02762734|adolescent|adolescent
5197024|NCT02762734|suicide|suicide
5197025|NCT02762721|FGFR2 fusion|fgfr2 fusion
5197026|NCT02762721|iCCA|icca
5197027|NCT02762721|mixed HCC-CCA|mixed hcc-cca
5197028|NCT02762721|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5087747|NCT03449524|6 Minute Walk Distance|6 minute walk distance
5197029|NCT02762721|Mixed Hepatocellular Cholangiocarcinoma|mixed hepatocellular cholangiocarcinoma
5197030|NCT02762721|Cholangiocarcinoma|cholangiocarcinoma
5197031|NCT02762721|ArQule|arqule
5197032|NCT02762708|Bariatric Surgery|bariatric surgery
5197033|NCT02762708|Weight loss|weight loss
5197034|NCT02762695|Hypertension|hypertension
5197035|NCT02762695|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5197036|NCT02762695|Case Management|case management
5197037|NCT02762669|Uterine contraction|uterine contraction
5197038|NCT02762669|Oxytocin desensitization|oxytocin desensitization
5197039|NCT02762643|DP-R213|dp-r213
5197040|NCT02762617|Healthy Volunteers|healthy volunteers
5197041|NCT02762617|Women's Health|women's health
5197042|NCT02762552|Stroke|stroke
5197043|NCT02762552|Etiology|etiology
5197044|NCT02762552|Recurrence|recurrence
5197045|NCT02762552|Transcranial holter|transcranial holter
5197046|NCT02762552|Microembolic signals|microembolic signals
5197047|NCT02762526|lipectomy|lipectomy
5197048|NCT02762526|abdominoplasty|abdominoplasty
5197049|NCT02762526|plethysmography optoelectronics|plethysmography optoelectronics
5197050|NCT02762526|diaphragmatic mobility|diaphragmatic mobility
5197051|NCT02762526|lung function|lung function
5197052|NCT02762526|respiratory muscles|respiratory muscles
5197053|NCT02762474|nab-paclitaxel|nab-paclitaxel
5197054|NCT02762474|IMRT|imrt
5197055|NCT02762474|esophageal cancer|esophageal cancer
5197056|NCT02762461|Fertilization in Vitro|fertilization in vitro
5197057|NCT02762461|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
5197058|NCT02762461|Endometriosis|endometriosis
5197059|NCT02762422|endothelial function|endothelial function
5197060|NCT02762422|iron stores|iron stores
5197061|NCT02762422|red blood cell|red blood cell
5197062|NCT02762422|blood donation|blood donation
5197063|NCT02762409|critical care|critical care
5197064|NCT02762409|reduction of depression syndrome|reduction of depression syndrome
5197065|NCT02762409|anxiety|anxiety
5197066|NCT02762409|quality of life|quality of life
5197067|NCT02762409|post traumatic stress|post traumatic stress
5197068|NCT02762409|discomforts|discomforts
5197069|NCT02762396|Young ischemic stroke|young ischemic stroke
5197070|NCT02762396|Risk factors|risk factors
5197071|NCT02762396|Causes|causes
5197072|NCT02762396|Consequences|consequences
5197073|NCT02762370|osteoarthritis|osteoarthritis
5197074|NCT02762370|knee|knee
5197076|NCT02762370|diabetes|diabetes
5197077|NCT02762370|intra-articular|intra-articular
5197078|NCT02762370|injection|injection
5197079|NCT02762370|corticosteroid|corticosteroid
5197080|NCT02762357|Novosyn Quick|novosyn quick
5197081|NCT02762357|Episiotomy|episiotomy
5197082|NCT02762331|Vitamin C|vitamin c
5197083|NCT02762331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5197084|NCT02762331|Atrial Fibrillation|atrial fibrillation
5197085|NCT02762331|Cardiac Valve Repair|cardiac valve repair
5197086|NCT02762305|fall risk|fall risk
5197087|NCT02762305|RSVP bone builders|rsvp bone builders
5197088|NCT02762305|group exercise|group exercise
5197089|NCT02762305|older adults|older adults
5197090|NCT02762305|balance confidence|balance confidence
5197091|NCT02762305|life satisfaction|life satisfaction
5197092|NCT02762305|balance|balance
5197093|NCT02762305|walking speed|walking speed
5197094|NCT02762292|Mechanical ventilation|mechanical ventilation
5197095|NCT02762292|Children|children
5197096|NCT02762292|Work of breathing|work of breathing
5197097|NCT02762279|Mechanical ventilation|mechanical ventilation
5193256|NCT02784912|ST2|st2
5197100|NCT02762279|Pleural Pressure|pleural pressure
5197101|NCT02762240|Accreditation|accreditation
5197102|NCT02762240|Certification|certification
5197103|NCT02762240|General Practice|general practice
5962454|NCT04280835|well-being|well-being
5197104|NCT02762240|Family Medicine|family medicine
5197105|NCT02762240|Randomized Controlled Trial|randomized controlled trial
5197106|NCT02762227|CEUS|ceus
5197108|NCT02762227|gallbladder cholesterol polyps|gallbladder cholesterol polyps
5197109|NCT02762227|adenoma|adenoma
5197110|NCT02762227|gallbladder cancer|gallbladder cancer
5197111|NCT02762214|Uterin manipulator|uterin manipulator
5064763|NCT03594058|urgency|urgency
5072937|NCT03543280|MRI|mri
5197112|NCT02762214|Endometrial Cancer|endometrial cancer
5197113|NCT02762214|Laparoscopy|laparoscopy
5197114|NCT02762214|Robotic|robotic
5197115|NCT02762188|wet ARMD|wet armd
5197116|NCT02762188|VEGF|vegf
5197117|NCT02762188|intra vitreal injections|intra vitreal injections
5197118|NCT02762175|maxillomandibular advancement|maxillomandibular advancement
5197119|NCT02762175|obstructive sleep apnea|obstructive sleep apnea
5197120|NCT02762175|apnea-hypopnea index|apnea-hypopnea index
5197121|NCT02762175|quality of life|quality of life
5197122|NCT02762162|antiplatelet|antiplatelet
5197123|NCT02762162|stent thrombosis|stent thrombosis
5197124|NCT02762149|Tsui Test|tsui test
5185033|NCT02833259|Observational study|observational study
5197126|NCT02762149|Epidural catheter|epidural catheter
5197127|NCT02762097|polyps|polyps
5197128|NCT02762097|saline sonography|saline sonography
5197129|NCT02762097|infertility|infertility
5197130|NCT02762084|Gorlin Syndrome|gorlin syndrome
5197131|NCT02762084|Basal Cell|basal cell
5197132|NCT02762084|Nevus Syndrome|nevus syndrome
5197133|NCT02762084|BCNS|bcns
5197134|NCT02762084|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5197135|NCT02762084|Basal cell carcinoma|basal cell carcinoma
5197136|NCT02762084|Hedgehog|hedgehog
5197137|NCT02762084|Surgically Eligible Basal Cell Carcinomas|surgically eligible basal cell carcinomas
5197138|NCT02762058|Acquired Brain Injury|acquired brain injury
5197139|NCT02762058|Stroke Rehabilitation|stroke rehabilitation
5197140|NCT02762045|Therapeutic Vaccine HIV Adenovirus type 5 vector|therapeutic vaccine hiv adenovirus type 5 vector
5197141|NCT02762032|Skin Biopsy|skin biopsy
5197142|NCT02762032|PrimaVie|primavie
5197143|NCT02762032|Herbal Supplement|herbal supplement
5197144|NCT02762019|Stomatitis|stomatitis
5197145|NCT02762019|Laser|laser
5197146|NCT02762019|Children|children
5197147|NCT02762019|Chemotherapy|chemotherapy
5197148|NCT02762019|Treatment|treatment
5197153|NCT02761980|ibuprofen; acetaminophen; induced fever; fever|ibuprofen; acetaminophen; induced fever; fever
5197154|NCT02761967|Physical activity|physical activity
5197155|NCT02761967|Pregnancy|pregnancy
5197156|NCT02761967|Childbirth|childbirth
5197157|NCT02761967|Postpartum period|postpartum period
5197158|NCT02761967|Exercise|exercise
5197159|NCT02761954|regional anesthesia|regional anesthesia
5197160|NCT02761954|caudal block|caudal block
5197161|NCT02761928|Facet Joint|facet joint
5197162|NCT02761928|Sacroiliac Joint|sacroiliac joint
5197163|NCT02761928|Myofascial Trigger Point Pain|myofascial trigger point pain
5197164|NCT02761928|Injectables|injectables
5197165|NCT02761915|Neuroblastoma|neuroblastoma
5197166|NCT02761915|Immunotherapy|immunotherapy
5197167|NCT02761915|1RG-CART|1rg-cart
5197168|NCT02761915|Cyclophosphamide|cyclophosphamide
5197169|NCT02761915|Fludarabine|fludarabine
5197170|NCT02761915|CAR T-cells|car t-cells
5197171|NCT02761915|Anti-GD2|anti-gd2
5197172|NCT02761915|GD2|gd2
5197173|NCT02761915|CAR|car
5197174|NCT02761915|Chimeric Antigen Receptor|chimeric antigen receptor
5197175|NCT02761902|Children|children
5197176|NCT02761902|Polysomnography|polysomnography
5197177|NCT02761902|sleep|sleep
5197178|NCT02761902|obstructive sleep apnea;|obstructive sleep apnea;
5197179|NCT02761902|Chinese|chinese
5197180|NCT02761863|Mesothelioma|mesothelioma
5197181|NCT02761863|CD 74|cd 74
5197182|NCT02761863|VEGF|vegf
5197183|NCT02761824|Quality of Life|quality of life
5197184|NCT02761824|Occupation|occupation
5197185|NCT02761772|Preimplantation Factor|preimplantation factor
5197186|NCT02761746|HIV|hiv
5197187|NCT02761746|Adherence|adherence
5197188|NCT02761746|Health Outcomes|health outcomes
5197189|NCT02761733|Shared Decision Making|shared decision making
5197190|NCT02761733|Case Management|case management
5197191|NCT02761733|Decision Aid|decision aid
5197192|NCT02761694|AKT1|akt1
5197193|NCT02761694|AKT2|akt2
5197194|NCT02761694|AKT3|akt3
5197195|NCT02761694|PI3K|pi3k
5197196|NCT02761694|solid tumors|solid tumors
5197197|NCT02761694|cancer|cancer
5197198|NCT02761694|ARQ 751|arq 751
5197199|NCT02761694|ArQule|arqule
5197200|NCT02761694|PTEN|pten
5197201|NCT02761681|Acceptance and Commitment Therapy|acceptance and commitment therapy
5962455|NCT04280822|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5197202|NCT02761681|Mindfulness|mindfulness
5197203|NCT02761681|Guided self-help|guided self-help
5197204|NCT02761681|College students|college students
5197211|NCT02761668|xenogeneic bone graft|xenogeneic bone graft
5197212|NCT02761668|orthodontic therapy|orthodontic therapy
5197213|NCT02761655|Dementia|dementia
5197214|NCT02761655|Medication Adherence|medication adherence
5197215|NCT02761655|Perspective Memory|perspective memory
5197216|NCT02761590|intermuscular fat|intermuscular fat
5197217|NCT02761590|circuit training|circuit training
5197218|NCT02761590|adipokines|adipokines
5197219|NCT02761590|inflammation|inflammation
5197220|NCT02761590|computed tomography scan|computed tomography scan
5197221|NCT02761577|Acetylcysteine|acetylcysteine
5197222|NCT02761577|Sodium Bicarbonate|sodium bicarbonate
5073050|NCT03542383|Gulf War Illness|gulf war illness
5073051|NCT03542383|Memory|memory
5073052|NCT03542383|Word Finding|word finding
5197223|NCT02761577|Lipocalins|lipocalins
5197224|NCT02761577|Creatinine|creatinine
5197225|NCT02761577|Blood Urea Nitrogen|blood urea nitrogen
5197226|NCT02761564|Cardiac surgery|cardiac surgery
5197227|NCT02761564|Blood transfusion|blood transfusion
5197228|NCT02761564|ScvO2|scvo2
5197229|NCT02761538|obesity|obesity
5197230|NCT02761538|Overweight|overweight
5197231|NCT02761538|ICTs|icts
5197232|NCT02761538|Cost-effectiveness|cost-effectiveness
5087992|NCT03447912|Smoking behavior|smoking behavior
5197233|NCT02761525|silver nanoparticles antimicrobial activity|silver nanoparticles antimicrobial activity
5197234|NCT02761486|aspirin|aspirin
5197235|NCT02761486|gut microbiome|gut microbiome
5197236|NCT02761486|inflammation|inflammation
5197237|NCT02761486|placebo|placebo
5197238|NCT02761486|circulating biomarker|circulating biomarker
5197239|NCT02761447|Motor control Laterality|motor control laterality
5197240|NCT02761447|Pain Perception|pain perception
5197241|NCT02761447|Lower Extremity|lower extremity
5197242|NCT02761447|Complementary Therapies|complementary therapies
5197243|NCT02761447|Physical Therapy Modalities|physical therapy modalities
5197244|NCT02761434|copeptin|copeptin
5197245|NCT02761434|vasopressin|vasopressin
5197246|NCT02761434|dehydration|dehydration
5197247|NCT02761434|insulin resistance|insulin resistance
5197248|NCT02761434|Diabetes|diabetes
5197249|NCT02761434|Glucose regulation|glucose regulation
5197250|NCT02761421|IOPD|iopd
5197251|NCT02761408|Head and neck cancer|head and neck cancer
5197252|NCT02761408|Asian|asian
5197253|NCT02761408|ALDH2|aldh2
5197254|NCT02761369|food addiction|food addiction
5197255|NCT02761369|obesity|obesity
5197256|NCT02761369|deep TMS|deep tms
5197258|NCT02761369|Food Stroop|food stroop
5197259|NCT02761369|brain laterality|brain laterality
5197260|NCT02761369|EEG|eeg
5197261|NCT02761369|INP|inp
5197262|NCT02761343|cardiac arrhythmia|cardiac arrhythmia
5197263|NCT02761343|cardiac ablation|cardiac ablation
5197264|NCT02761343|congenital cardiac disease|congenital cardiac disease
5197265|NCT02761343|cardiac ablation lesions under Magnetic Resonance imaging|cardiac ablation lesions under magnetic resonance imaging
5197266|NCT02761330|Anesthesia|anesthesia
5197267|NCT02761330|Electroconvulsive therapy|electroconvulsive therapy
5197268|NCT02761330|Delirium|delirium
5197269|NCT02761330|Electroencephalography|electroencephalography
5197270|NCT02761330|Seizures|seizures
5197271|NCT02761330|Depression|depression
5197272|NCT02761330|Ketamine|ketamine
5197273|NCT02761330|Etomidate|etomidate
5197274|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs
5197275|NCT02761330|Pharmacologic Actions|pharmacologic actions
5197276|NCT02761330|Confusion|confusion
5197277|NCT02761330|Mental Disorders|mental disorders
5197278|NCT02761330|Neurobehavioral Manifestations|neurobehavioral manifestations
5197279|NCT02761330|Signs and Symptoms|signs and symptoms
5197280|NCT02761330|Neurologic Manifestations|neurologic manifestations
5197281|NCT02761330|Cognitive Disorders|cognitive disorders
5197282|NCT02761317|bowel preparation|bowel preparation
5197284|NCT02761317|polyethyleneglycol|polyethyleneglycol
5197285|NCT02761317|colorectal surgery|colorectal surgery
5197286|NCT02761291|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5197287|NCT02761291|EB virus|eb virus
5197288|NCT02761291|metastasis|metastasis
5197289|NCT02761291|recurrence|recurrence
5197290|NCT02761291|cytolytic viral activation therapy|cytolytic viral activation therapy
5197291|NCT02761291|gemcitabine|gemcitabine
5197292|NCT02761291|valproic acid|valproic acid
5197293|NCT02761291|ganciclovir|ganciclovir
5197294|NCT02761291|valganciclovir|valganciclovir
5197295|NCT02761265|Degenerative Adult Scoliosis|degenerative adult scoliosis
5197296|NCT02761265|Gait Analysis|gait analysis
5197297|NCT02761265|Balance Analysis|balance analysis
5197298|NCT02761265|Biomechanics|biomechanics
5197299|NCT02761265|Neuromuscular Control|neuromuscular control
5197300|NCT02761265|Thoracolumbar Deformity|thoracolumbar deformity
5197301|NCT02761252|Bilastine|bilastine
5197302|NCT02761252|Montelukast|montelukast
5197303|NCT02761252|total symptom score|total symptom score
5197304|NCT02761252|AQLQ|aqlq
5197305|NCT02761239|cricopharyngeal muscle|cricopharyngeal muscle
5197306|NCT02761239|innervation by EBSLN|innervation by ebsln
5197307|NCT02761239|A prospective case-controlled study|a prospective case-controlled study
5197308|NCT02761226|platform switching|platform switching
5197309|NCT02761226|dental implant|dental implant
5962456|NCT04280822|Neoadjuvant immunochemotherapy|neoadjuvant immunochemotherapy
5962457|NCT04280796|acute pain|acute pain
5962458|NCT04280796|chronic pain|chronic pain
5197310|NCT02761226|crestal bone level|crestal bone level
5197311|NCT02761226|implant stability|implant stability
5197312|NCT02761226|postoperative complication|postoperative complication
5197313|NCT02761187|Drug Therapy|drug therapy
5197314|NCT02761174|Vascular lesions|vascular lesions
5197315|NCT02761174|inflammation|inflammation
5197317|NCT02761161|PTSD|ptsd
5197318|NCT02761161|Sleep|sleep
5197319|NCT02761161|Refugee|refugee
5185230|NCT02832050|play|play
5197320|NCT02761161|IRT|irt
5197321|NCT02761161|Mianserin|mianserin
5197322|NCT02761148|white matter hyperintensity|white matter hyperintensity
5197323|NCT02761148|brain network|brain network
5197324|NCT02761148|MRI|mri
5197325|NCT02761148|cognition|cognition
5197326|NCT02761148|emotion|emotion
5197327|NCT02761135|Biopsy technique|biopsy technique
5197328|NCT02761135|Transrectal ultrasonography probe|transrectal ultrasonography probe
5197329|NCT02761135|Side-fire|side-fire
5197330|NCT02761135|Prostate cancer|prostate cancer
5197331|NCT02761135|End-fire|end-fire
5197332|NCT02761083|Eye surgery|eye surgery
5197333|NCT02761083|Suture material|suture material
5197334|NCT02761083|Novosyn Quick|novosyn quick
5197335|NCT02761083|Vicryl Rapid|vicryl rapid
5197336|NCT02761070|glioblastoma|glioblastoma
5197337|NCT02761070|recurrent|recurrent
5197338|NCT02761070|dose-dense temozolomide|dose-dense temozolomide
5197339|NCT02761070|bevacizumab|bevacizumab
5197340|NCT02761031|Heart rate variability|heart rate variability
5197341|NCT02761031|Electrocardiography|electrocardiography
5197342|NCT02761031|Observational study|observational study
5197343|NCT02761031|Non-interventional study|non-interventional study
5197344|NCT02761031|Risk assessment|risk assessment
5197345|NCT02761031|Perioperative|perioperative
5197346|NCT02761005|Eradication therapy|eradication therapy
5197347|NCT02761005|Mutation of 23S rRNA of H. pylori|mutation of 23s rrna of h. pylori
5197348|NCT02761005|Personalized therapy|personalized therapy
5197349|NCT02760979|knee arthroplasty|knee arthroplasty
5197350|NCT02760953|Bladder Cancer|bladder cancer
5197351|NCT02760953|Cryoablation|cryoablation
5197352|NCT02760940|Inflammatory bowel diseases|inflammatory bowel diseases
5197353|NCT02760940|Anemia|anemia
5197354|NCT02760940|Crohn's disease|crohn's disease
5197355|NCT02760940|Ulcerative colitis|ulcerative colitis
5197356|NCT02760940|Oral iron|oral iron
5197357|NCT02760940|Quality of life|quality of life
5197358|NCT02760914|adipose tissue|adipose tissue
5197359|NCT02760914|inflammatory mediators|inflammatory mediators
5197360|NCT02760914|gene expression|gene expression
5197361|NCT02760875|Achilles Tendon Rupture|achilles tendon rupture
5673920|NCT00606125|Sorafenib|sorafenib
5197362|NCT02760875|Conservative treatment|conservative treatment
5197363|NCT02760875|early weight bearing|early weight bearing
5197364|NCT02760875|Achilles Tendon Length|achilles tendon length
5197365|NCT02760875|Ultrasound|ultrasound
5197366|NCT02760875|Foot Pressure Mapping|foot pressure mapping
5197367|NCT02760875|ATRA|atra
5197368|NCT02760875|Heel Raise Work|heel raise work
5197369|NCT02760836|Crohn's disease|crohn's disease
5197370|NCT02760836|disease outcomes|disease outcomes
5197371|NCT02760784|Achilles Tendon Rupture|achilles tendon rupture
5197372|NCT02760784|Conservative treatment|conservative treatment
5197373|NCT02760784|early weight bearing|early weight bearing
5197374|NCT02760784|Dynamic|dynamic
5197375|NCT02760784|ATRS|atrs
5197376|NCT02760784|ATRA|atra
5197377|NCT02760784|Heel Raise Work|heel raise work
5197378|NCT02760771|THV (trans-catheter heart valve)|thv (trans-catheter heart valve)
5197379|NCT02760771|severe aortic stenosis|severe aortic stenosis
5197380|NCT02760771|pre-dilation|pre-dilation
5197381|NCT02760771|rapid pacing|rapid pacing
5197382|NCT02760771|BAV (balloon artery valvuloplasty|bav (balloon artery valvuloplasty
5197383|NCT02760758|non-nucleoside inhibitor|non-nucleoside inhibitor
5197385|NCT02760758|HCV|hcv
5197386|NCT02760758|DAA|daa
5197387|NCT02760745|fever|fever
5197388|NCT02760745|shivering|shivering
5197389|NCT02760745|chills|chills
5197390|NCT02760745|rigors|rigors
5197391|NCT02760745|severe bacterial infection|severe bacterial infection
5197392|NCT02760719|3% hypertonic solution|3% hypertonic solution
5197393|NCT02760719|duration of hospitalisation|duration of hospitalisation
5197394|NCT02760693|bipolar disorder, naturalistic cohort study,|bipolar disorder, naturalistic cohort study,
5197395|NCT02760693|defined catchment area,long term treatment|defined catchment area,long term treatment
5197396|NCT02760680|Chronic Heart Failure|chronic heart failure
5197397|NCT02760680|Sleep-Disordered Breathing|sleep-disordered breathing
5197398|NCT02760680|Peripheral Arterial Tone|peripheral arterial tone
5197400|NCT02760667|Laryngeal cancer|laryngeal cancer
5197402|NCT02760641|low carbohydrate diet|low carbohydrate diet
5197403|NCT02760641|metabolism|metabolism
5197404|NCT02760641|body composition|body composition
5197405|NCT02760641|visceral fat|visceral fat
5197406|NCT02760641|older adults|older adults
5197407|NCT02760641|insulin sensitivity|insulin sensitivity
5197408|NCT02760615|Drug therapy|drug therapy
5197409|NCT02760602|anti-amyloid|anti-amyloid
5197410|NCT02760602|monoclonal antibody|monoclonal antibody
5197411|NCT02760589|ACL tear|acl tear
5197412|NCT02760589|ACL lesion|acl lesion
5197413|NCT02760589|ACL reconstruction|acl reconstruction
5197414|NCT02760589|InternalBrace|internalbrace
5197415|NCT02760589|functional performance test|functional performance test
5197416|NCT02760589|anterior cruciate ligament|anterior cruciate ligament
5185326|NCT02831621|ectopic fat|ectopic fat
5197417|NCT02760537|Liver Neoplasms|liver neoplasms
5197418|NCT02760537|Hepatitis B|hepatitis b
5197419|NCT02760537|Hepatitis B vaccination|hepatitis b vaccination
5197420|NCT02760537|Asian Americans|asian americans
5197421|NCT02760537|Lay health workers|lay health workers
5197422|NCT02760537|Community health workers|community health workers
5197423|NCT02760511|Randomized Controlled Trial|randomized controlled trial
5197424|NCT02760511|Anthocyanin|anthocyanin
5197425|NCT02760511|Antioxidants|antioxidants
5197426|NCT02760485|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5197427|NCT02760485|Relapsed Diffuse large B-cell lymphoma|relapsed diffuse large b-cell lymphoma
5197428|NCT02760485|Refractory Diffuse large B-cell lymphoma|refractory diffuse large b-cell lymphoma
5197429|NCT02760485|activated B cell|activated b cell
5197430|NCT02760485|germinal center B-cell|germinal center b-cell
5197431|NCT02760485|non-Hodgkin lymphoma|non-hodgkin lymphoma
5197432|NCT02760485|JAK1 inhibitor|jak1 inhibitor
5197433|NCT02760485|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
5197434|NCT02760472|Retinopathy of Prematurity|retinopathy of prematurity
5197435|NCT02760472|Preterm|preterm
5197436|NCT02760472|Fatty acids|fatty acids
5197437|NCT02760433|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5197438|NCT02760433|severe Rheumatoid Arthritis|severe rheumatoid arthritis
5197439|NCT02760433|Olokizumab|olokizumab
5197440|NCT02760407|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5197441|NCT02760407|severe Rheumatoid Arthritis|severe rheumatoid arthritis
5197442|NCT02760407|subcutaneous|subcutaneous
5197443|NCT02760407|Olokizumab|olokizumab
5197444|NCT02760394|chronic ischemic heart disease|chronic ischemic heart disease
5197445|NCT02760394|coronary bypass|coronary bypass
5197446|NCT02760394|refractory stable angina|refractory stable angina
5197447|NCT02760394|HBOT|hbot
5197448|NCT02760394|reperfusion|reperfusion
5197449|NCT02760394|neoangiogenesis|neoangiogenesis
5197450|NCT02760394|microvascular|microvascular
5197451|NCT02760394|myocardial perfusion|myocardial perfusion
5197452|NCT02760368|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5197453|NCT02760368|severe Rheumatoid Arthritis|severe rheumatoid arthritis
5197454|NCT02760368|subcutaneous|subcutaneous
5197455|NCT02760368|Olokizumab|olokizumab
5197462|NCT02760329|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5197464|NCT02760329|chronic airways disease|chronic airways disease
5197465|NCT02760329|obstructive lung disease|obstructive lung disease
5197466|NCT02760316|Healthy Volunteers|healthy volunteers
5197467|NCT02760316|Obese|obese
5197468|NCT02760316|Insulin Resistant Subjects|insulin resistant subjects
5197469|NCT02760316|Rheumatoid Arthritis|rheumatoid arthritis
5197470|NCT02760303|insulin dependent diabetes mellitus|insulin dependent diabetes mellitus
5197471|NCT02760303|adolescents and young adults|adolescents and young adults
5197472|NCT02760303|stress reduction|stress reduction
5197473|NCT02760303|metabolic control|metabolic control
5197474|NCT02760290|Forced Expiratory Volume in 1 second|forced expiratory volume in 1 second
5197475|NCT02760290|Forced expiratory vital capacity|forced expiratory vital capacity
5197476|NCT02760290|Peak expiratory flow|peak expiratory flow
5197477|NCT02760277|Duchenne muscular dystrophy|duchenne muscular dystrophy
5197478|NCT02760277|vamorolone|vamorolone
5197479|NCT02760264|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5197480|NCT02760264|vamorolone|vamorolone
5197481|NCT02760251|immunomodulation|immunomodulation
5197482|NCT02760238|myeloproliferative neoplasm|myeloproliferative neoplasm
5197483|NCT02760238|myelodysplastic syndrome|myelodysplastic syndrome
5197485|NCT02760238|leukemia|leukemia
5197486|NCT02760238|Bone Marrow Diseases|bone marrow diseases
5197487|NCT02760238|Hematologic Diseases|hematologic diseases
5197488|NCT02760238|Neoplasms|neoplasms
5197489|NCT02760225|Pembrolizumab|pembrolizumab
5197490|NCT02760225|PET imaging|pet imaging
5197491|NCT02760225|Melanoma|melanoma
5197492|NCT02760225|Non-small cell lung cancer|non-small cell lung cancer
5197493|NCT02760212|Shockwave therapy|shockwave therapy
5197494|NCT02760212|fMRI|fmri
5197495|NCT02760212|blood biomarkers|blood biomarkers
5197496|NCT02760173|verticality perception|verticality perception
5193729|NCT02782338|INR|inr
5197498|NCT02760134|Super-Mini Percutaneous Nephrolithotomy(SMP)|super-mini percutaneous nephrolithotomy(smp)
5197499|NCT02760134|Renal Pelvic Pressure|renal pelvic pressure
5197500|NCT02760121|Acetazolamide|acetazolamide
5197501|NCT02760121|Methazolamide|methazolamide
5197502|NCT02760121|Control of breathing|control of breathing
5197503|NCT02760121|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5197504|NCT02760108|Early onset Parkinson's disease|early onset parkinson's disease
5197505|NCT02760108|Familial Parkinson's disease|familial parkinson's disease
5197506|NCT02760108|Parkinson's disease|parkinson's disease
5197507|NCT02760108|Genetics|genetics
5197508|NCT02760095|environmental enteric dysfunction|environmental enteric dysfunction
5197509|NCT02760095|environmental enteropathy|environmental enteropathy
5197510|NCT02760095|zinc|zinc
5197511|NCT02760095|vitamin A|vitamin a
5197512|NCT02760095|Bangladesh|bangladesh
5197514|NCT02760082|Qualitative study|qualitative study
5197515|NCT02760082|Motivation|motivation
5197516|NCT02760056|Thyroid hormone|thyroid hormone
5197517|NCT02760056|Remyelination|remyelination
5197518|NCT02760004|Depression|depression
5073356|NCT03540407|Oncoxin-Viusid|oncoxin-viusid
5197519|NCT02759991|Hepatitis E virus|hepatitis e virus
5197520|NCT02759991|Viral Hepatitis Vaccines|viral hepatitis vaccines
5197521|NCT02759978|Imaging|imaging
5197522|NCT02759978|Computed Tomography|computed tomography
5197523|NCT02759978|Magnetic Resonance Imaging|magnetic resonance imaging
5197524|NCT02759978|Positron Emission Tomography|positron emission tomography
5197525|NCT02759978|Leukocyte Scintigraphy|leukocyte scintigraphy
5197526|NCT02759978|Microbiological diagnostics|microbiological diagnostics
5197527|NCT02759978|Sonication|sonication
5197528|NCT02759978|Drug Monitoring|drug monitoring
5197529|NCT02759978|Cardiac Surgery|cardiac surgery
5197530|NCT02759952|retinitis pigmentosa|retinitis pigmentosa
5197531|NCT02759952|PDE6A|pde6a
5197532|NCT02759952|gene therapy trial|gene therapy trial
5197533|NCT02759939|Shared Decision-Making|shared decision-making
5197534|NCT02759939|Patient-Provider Communication|patient-provider communication
5197535|NCT02759926|Healthy volunteers|healthy volunteers
5197536|NCT02759926|Obesity|obesity
5197537|NCT02759926|Bitter|bitter
5197538|NCT02759913|neuromuscular diseases|neuromuscular diseases
5197539|NCT02759848|COPD, tuberculosis, mortality|copd, tuberculosis, mortality
5197545|NCT02759822|Haploidentical Hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
5342976|NCT01981317|Exposure and Response Prevention|exposure and response prevention
5197546|NCT02759822|Partially Matched Hematopoietic Stem Cell Transplantation|partially matched hematopoietic stem cell transplantation
5197547|NCT02759822|Post-transplant Cyclophosphamide|post-transplant cyclophosphamide
5197548|NCT02759822|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5197549|NCT02759783|Radiotherapy|radiotherapy
5197550|NCT02759783|oligometastases|oligometastases
5197552|NCT02759757|Kinesio Taping|kinesio taping
5197553|NCT02759757|Low back Pain|low back pain
5197554|NCT02759757|Electromyographic|electromyographic
5197555|NCT02759757|EMG|emg
5197561|NCT02759731|Murine Models|murine models
5197562|NCT02759731|Rheumatoid Arthritis|rheumatoid arthritis
5197563|NCT02759731|Corticosteroids|corticosteroids
5197564|NCT02759731|Systemic Therapy|systemic therapy
5197565|NCT02759731|Inflammatory Cytokines|inflammatory cytokines
5197566|NCT02759718|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5197567|NCT02759718|chromogranin A|chromogranin a
5197568|NCT02759705|fertility|fertility
5197569|NCT02759705|sexuality|sexuality
5197570|NCT02759705|male|male
5197571|NCT02759705|exstrophy-epispadias complex|exstrophy-epispadias complex
5197572|NCT02759705|bladder exstrophy|bladder exstrophy
5197573|NCT02759705|epispadias|epispadias
5197574|NCT02759666|PARP|parp
5197575|NCT02759666|advanced solid tumor|advanced solid tumor
5197576|NCT02759640|c-Met kinase inhibitor|c-met kinase inhibitor
5197577|NCT02759640|Advanced solid tumors|advanced solid tumors
5197578|NCT02759627|Rehabilitation|rehabilitation
5197579|NCT02759627|Gait|gait
5197580|NCT02759627|Ambulation|ambulation
5197581|NCT02759627|Exercise Therapy|exercise therapy
5197582|NCT02759627|Physical Exertion|physical exertion
5197583|NCT02759627|Motor Skills|motor skills
5197584|NCT02759601|HDAC Inhibitor|hdac inhibitor
5197586|NCT02759601|Inflammation|inflammation
5197587|NCT02759601|Hepatocellular Carcinoma|hepatocellular carcinoma
5197588|NCT02759601|Cancer associated Inflammation in Hepatocellular Carcinoma|cancer associated inflammation in hepatocellular carcinoma
5197589|NCT02759588|GL-ONC1|gl-onc1
5197590|NCT02759588|oncolytic virus|oncolytic virus
5197591|NCT02759588|virotherapy|virotherapy
5197592|NCT02759588|Viral therapy|viral therapy
5197593|NCT02759588|immunotherapy|immunotherapy
5197594|NCT02759588|immune therapy|immune therapy
5197595|NCT02759588|vaccinia|vaccinia
5197596|NCT02759588|vaccinia virus|vaccinia virus
5197597|NCT02759588|Genelux|genelux
5197598|NCT02759588|ovarian cancer|ovarian cancer
5197599|NCT02759588|platinum resistant|platinum resistant
5197600|NCT02759588|platinum refractory|platinum refractory
5197601|NCT02759588|peritoneal carcinomatosis|peritoneal carcinomatosis
5197608|NCT02759588|neoplasms|neoplasms
5197609|NCT02759588|neoplasms by histological type|neoplasms by histological type
5197610|NCT02759588|neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5197611|NCT02759588|Poxviridae infections|poxviridae infections
5197612|NCT02759588|Virus diseases|virus diseases
5197613|NCT02759588|recurrent ovarian cancer|recurrent ovarian cancer
5197614|NCT02759588|intermediate platinum-sensitive|intermediate platinum-sensitive
5197615|NCT02759549|Radiation Therapy|radiation therapy
5197616|NCT02759523|Magnetic Resonance Imaging|magnetic resonance imaging
5197617|NCT02759523|Portion Size|portion size
5197618|NCT02759523|Energy Intake|energy intake
5197619|NCT02759510|cardiac output|cardiac output
5197620|NCT02759510|norepinephrin|norepinephrin
5197621|NCT02759510|cesarean section|cesarean section
5197622|NCT02759484|CHWs|chws
5197623|NCT02759484|Health Education|health education
5197624|NCT02759484|Disease Self Management|disease self management
5197625|NCT02759445|alcohol induced cardiomyopathy|alcohol induced cardiomyopathy
5197626|NCT02759445|myocardial deformation imaging|myocardial deformation imaging
5962459|NCT04280796|low back pain|low back pain
5962460|NCT04280796|hedonic shift|hedonic shift
5073456|NCT03539783|Pediatric Acute Respiratory Distress Syndrome|pediatric acute respiratory distress syndrome
5085558|NCT03463967|diet|diet
5073457|NCT03539783|Gene Expression|gene expression
5197627|NCT02759432|high-intensity interval training|high-intensity interval training
5197628|NCT02759432|adolescents|adolescents
5197629|NCT02759432|physical fitness|physical fitness
5197630|NCT02759432|quality of life|quality of life
5197631|NCT02759432|school-based intervention|school-based intervention
5197632|NCT02759367|Nutrition|nutrition
5197633|NCT02759367|Potassium|potassium
5197634|NCT02759354|Immune response|immune response
5197635|NCT02759328|Stroke|stroke
5197636|NCT02759328|Rehabilitation|rehabilitation
5197637|NCT02759328|Serious games|serious games
5197638|NCT02759328|Virtual reality|virtual reality
5197639|NCT02759328|Xbox Kinect™|xbox kinect™
5197640|NCT02759302|MRI|mri
5197641|NCT02759302|LGMD|lgmd
5197642|NCT02759302|POMT2|pomt2
5197643|NCT02759289|Arsenic|arsenic
5197644|NCT02759276|Nailfold Videocapillaroscopy|nailfold videocapillaroscopy
5197645|NCT02759276|Venous Occlusion Plethysmography|venous occlusion plethysmography
5197646|NCT02759276|Endothelial Function|endothelial function
5197647|NCT02759276|Microcirculation|microcirculation
5197648|NCT02759276|Inflammatory Biomarkers|inflammatory biomarkers
5197649|NCT02759185|PTSD|ptsd
5197650|NCT02759185|marijuana|marijuana
5197651|NCT02759185|cannabis|cannabis
5197652|NCT02759185|sleep|sleep
5197653|NCT02759185|THC|thc
5197654|NCT02759185|CBD|cbd
5197655|NCT02759172|Suicide prevention|suicide prevention
5197656|NCT02759172|Jail|jail
5197657|NCT02759120|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5197658|NCT02759120|IPF|ipf
5197659|NCT02759120|pulmonary fibrosis|pulmonary fibrosis
5197660|NCT02759120|antimicrobial therapy|antimicrobial therapy
5197661|NCT02759120|doxycycline|doxycycline
5197662|NCT02759120|co-trimoxazole|co-trimoxazole
5197663|NCT02759094|GERD|gerd
5197664|NCT02759094|Implantable medical device|implantable medical device
5197665|NCT02759094|RefluxStop|refluxstop
5197666|NCT02759094|Reflux|reflux
5197667|NCT02759094|Gastroesophageal Reflux|gastroesophageal reflux
5197668|NCT02759094|Laparoscopy|laparoscopy
5197669|NCT02759094|pH-Monitoring|ph-monitoring
5197670|NCT02759094|PPI proton pump inhibitors|ppi proton pump inhibitors
5197671|NCT02759068|vegetative state|vegetative state
5197672|NCT02759068|minimally conscious state|minimally conscious state
5197673|NCT02759068|music|music
5197674|NCT02759068|preference|preference
5197675|NCT02758990|Food|food
5197676|NCT02758990|Nutrigenomics|nutrigenomics
5197677|NCT02758990|Precision Medicine|precision medicine
5197678|NCT02758990|Pharmacogenetics|pharmacogenetics
5197679|NCT02758990|Lifestyle|lifestyle
5197680|NCT02758977|Colorectal liver metastases|colorectal liver metastases
5197681|NCT02758977|Liver Surgery|liver surgery
5197682|NCT02758977|ALPPS|alpps
5197683|NCT02758977|Two Stage Hepatectomy|two stage hepatectomy
5197684|NCT02758977|Surgical Oncology|surgical oncology
5197685|NCT02758977|Hepatectomy|hepatectomy
5197687|NCT02758964|TAVI|tavi
5197688|NCT02758964|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5197689|NCT02758964|Intracranial Embolism|intracranial embolism
5197690|NCT02758951|Colorectal Neoplasms|colorectal neoplasms
5197691|NCT02758951|Peritoneal Neoplasms|peritoneal neoplasms
5197692|NCT02758951|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
5197693|NCT02758951|Hyperthermia, Induced|hyperthermia, induced
5197694|NCT02758951|Neoadjuvant Therapy|neoadjuvant therapy
5197695|NCT02758951|Adjuvant Chemotherapy|adjuvant chemotherapy
5197696|NCT02758951|Bevacizumab|bevacizumab
5197697|NCT02758951|Randomized Controlled Trial|randomized controlled trial
5197698|NCT02758951|Mortality|mortality
5197699|NCT02758951|Progression-Free Survival|progression-free survival
5197700|NCT02758899|Anterior cervical discectomy|anterior cervical discectomy
5197701|NCT02758899|Anterior cervical fusion|anterior cervical fusion
5197703|NCT02758860|Diverticular disease of the colon|diverticular disease of the colon
5197704|NCT02758860|Classification|classification
5197705|NCT02758847|critical lower limb ischemia with tissue loss|critical lower limb ischemia with tissue loss
5197706|NCT02758834|Preterm Infants|preterm infants
5197707|NCT02758834|Phytosterols|phytosterols
5197708|NCT02758834|Parenteral Nutrition|parenteral nutrition
5197709|NCT02758821|C-reactive protein|c-reactive protein
5197710|NCT02758821|antibiotic|antibiotic
5197711|NCT02758795|protein|protein
5197712|NCT02758795|inflammation|inflammation
5088550|NCT03444454|Virtual reality|virtual reality
5197713|NCT02758795|anti-inflammatory agents|anti-inflammatory agents
5197714|NCT02758743|smoking|smoking
5197715|NCT02758743|tobacco|tobacco
5197716|NCT02758743|smoking cessation|smoking cessation
5197717|NCT02758730|GBA mutation|gba mutation
5197718|NCT02758704|Intubation|intubation
5197719|NCT02758704|Neonatal|neonatal
5197720|NCT02758704|Teaching|teaching
5197721|NCT02758704|Stress|stress
5197722|NCT02758704|Simulation|simulation
5962461|NCT04280796|emotional-motivation components of pain|emotional-motivation components of pain
5962462|NCT04280796|sensory-discriminative components of pain|sensory-discriminative components of pain
5962463|NCT04280796|operant conditioning|operant conditioning
5962464|NCT04280770|retina|retina
5197723|NCT02758691|memory|memory
5197724|NCT02758691|insulin|insulin
5197725|NCT02758678|P-selectin|p-selectin
5197726|NCT02758678|Lung Cancer|lung cancer
5197727|NCT02758678|Raman Spectroscopy|raman spectroscopy
5197728|NCT02758665|CLL|cll
5197729|NCT02758665|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5197730|NCT02758665|ibrutinib|ibrutinib
5197731|NCT02758665|venetoclax|venetoclax
5197732|NCT02758665|obinutuzumab|obinutuzumab
5197733|NCT02758665|TP53 Deletion|tp53 deletion
5197734|NCT02758652|chemoresistance|chemoresistance
5197735|NCT02758652|miRNA|mirna
5197736|NCT02758652|microRNA|microrna
5197737|NCT02758639|parental cancer|parental cancer
5197738|NCT02758639|children psychosocial adjustment|children psychosocial adjustment
5197739|NCT02758639|psychosocial intervention|psychosocial intervention
5197740|NCT02758574|acute pulmonary embolism|acute pulmonary embolism
5197741|NCT02758574|submassive pulmonary embolism|submassive pulmonary embolism
5197742|NCT02758574|thrombolysis|thrombolysis
5197743|NCT02758574|catheter directed thrombolysis|catheter directed thrombolysis
5197744|NCT02758574|ultrasound assisted thrombolysis|ultrasound assisted thrombolysis
5197745|NCT02758561|decisional aid|decisional aid
5197746|NCT02758561|workshops|workshops
5197747|NCT02758561|urinary incontinence|urinary incontinence
5197748|NCT02758561|pelvic organ prolapse|pelvic organ prolapse
5197749|NCT02758561|pelvic floor dysfunction|pelvic floor dysfunction
5197750|NCT02758561|decisional conflict|decisional conflict
5197751|NCT02758548|Total IgE measurement|total ige measurement
5197752|NCT02758548|Novel Point-of-care test device|novel point-of-care test device
5197753|NCT02758548|atopic conditions|atopic conditions
5197754|NCT02758548|in vitro diagnostic test|in vitro diagnostic test
5197755|NCT02758522|Diabetes Mellitus|diabetes mellitus
5197756|NCT02758522|Hospital Hyperglycemia|hospital hyperglycemia
5197952|NCT02757378|Straight Leg Raise|straight leg raise
5197757|NCT02758496|Autism, chart review, transcranial magnetic stimulation (TMS)|autism, chart review, transcranial magnetic stimulation (tms)
5197758|NCT02758470|Muscle Fatigue|muscle fatigue
5197759|NCT02758470|Acetazolamide|acetazolamide
5197760|NCT02758470|Methazolamide|methazolamide
5197761|NCT02758457|cad/cam|cad/cam
5197762|NCT02758457|dental porcelain|dental porcelain
5197763|NCT02758457|zirconia|zirconia
5197764|NCT02758457|press on metal|press on metal
5197765|NCT02758444|environmental enteric dysfunction|environmental enteric dysfunction
5197766|NCT02758444|environmental enteropathy|environmental enteropathy
5197767|NCT02758444|zinc absorption|zinc absorption
5197768|NCT02758444|Bangladesh|bangladesh
5197769|NCT02758444|toddlers|toddlers
5197770|NCT02758444|zinc isotope|zinc isotope
5197771|NCT02758431|testosterone|testosterone
5197772|NCT02758418|Adjustment disorders online|adjustment disorders online
5197773|NCT02758418|Psychological Treatments|psychological treatments
5197774|NCT02758418|Information and Communication Technologies|information and communication technologies
5197775|NCT02758418|Internet|internet
5197776|NCT02758405|Epidural|epidural
5197777|NCT02758405|Labor analgesia|labor analgesia
5197778|NCT02758405|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5197779|NCT02758392|Healthy|healthy
5197780|NCT02758392|JNJ-61178104|jnj-61178104
5197781|NCT02758392|Placebo|placebo
5197782|NCT02758392|Safety|safety
5197783|NCT02758379|coronary artery disease|coronary artery disease
5197784|NCT02758379|calcified lesions|calcified lesions
5197785|NCT02758379|lithotripsy|lithotripsy
5197786|NCT02758366|glioblastoma multiforme|glioblastoma multiforme
5197787|NCT02758366|high grade glioma|high grade glioma
5197788|NCT02758366|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5197789|NCT02758366|DIPG|dipg
5197790|NCT02758366|doxorubicin|doxorubicin
5197791|NCT02758366|temozolomide|temozolomide
5197792|NCT02758366|malignant glioma|malignant glioma
5197793|NCT02758366|Brainstem Glioma|brainstem glioma
5197794|NCT02758366|diffuse spinal glioma|diffuse spinal glioma
5197795|NCT02758366|bilateral thalamic glioma|bilateral thalamic glioma
5197796|NCT02758366|Anaplastic Astrocytoma|anaplastic astrocytoma
5197797|NCT02758366|Gliomatosis Cerebri|gliomatosis cerebri
5197798|NCT02758366|Midline Diffuse Glioma|midline diffuse glioma
5197799|NCT02758353|Malaria in Pregnancy|malaria in pregnancy
5197801|NCT02758353|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
5197806|NCT02758340|foley's balloon catheter|foley's balloon catheter
5197807|NCT02758327|Tear Osmolarity|tear osmolarity
5197808|NCT02758327|Keratitis Sicca|keratitis sicca
5197809|NCT02758327|Ocular Surface Disease|ocular surface disease
5197810|NCT02758327|TheraTears|theratears
5197811|NCT02758314|PD-1|pd-1
5197812|NCT02758314|PD-L1|pd-l1
5197813|NCT02758314|NSCLC|nsclc
5197814|NCT02758288|Kidney transplant|kidney transplant
5197815|NCT02758288|BK Viremia|bk viremia
5197816|NCT02758288|BK Nephropathy|bk nephropathy
5197817|NCT02758275|Medication adherence|medication adherence
5197818|NCT02758275|Patient compliance|patient compliance
5197819|NCT02758275|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5197820|NCT02758275|Hypertension|hypertension
5197821|NCT02758275|Nursing|nursing
5065559|NCT03589547|NSCLC|nsclc
5197822|NCT02758275|Nursing process|nursing process
5197823|NCT02758275|Teaching|teaching
5197824|NCT02758275|Randomized controlled trial|randomized controlled trial
5197825|NCT02758210|Bradycardia|bradycardia
5197826|NCT02758210|Atrial Tachyarrhythmia|atrial tachyarrhythmia
5197827|NCT02758210|Smart Phone|smart phone
5197828|NCT02758210|Tablet|tablet
5197829|NCT02758197|Mindfulness|mindfulness
5197830|NCT02758197|Chronic Pain|chronic pain
5197831|NCT02758197|Quality of Life|quality of life
5197832|NCT02758197|Immune Function|immune function
5197833|NCT02758197|Cancer survivors|cancer survivors
5197834|NCT02758197|Disability|disability
5197835|NCT02758132|Castrate-resistant prostate cancer with bone metastases|castrate-resistant prostate cancer with bone metastases
5197836|NCT02758106|chest wall oscillation|chest wall oscillation
5197837|NCT02758106|acute respiratory failure|acute respiratory failure
5197838|NCT02758106|airway secretion|airway secretion
5197843|NCT02758028|Adventure-based training|adventure-based training
5197844|NCT02758028|WhatsApp messages|whatsapp messages
5197846|NCT02758015|betaine hydrochloride|betaine hydrochloride
5197847|NCT02758015|healthy volunteer|healthy volunteer
5197848|NCT02758015|gastric pH|gastric ph
5197852|NCT02757989|Low risk MDS|low risk mds
5197853|NCT02757989|Transplantation|transplantation
5197854|NCT02757963|Screening tool|screening tool
5197953|NCT02757378|Remapping|remapping
5197855|NCT02757963|International Prostate Symptom Score|international prostate symptom score
5197856|NCT02757963|Lower urinary tract symptoms|lower urinary tract symptoms
5197857|NCT02757963|BPO|bpo
5197858|NCT02757963|BPE|bpe
5197859|NCT02757963|Benign prostatic enlargement|benign prostatic enlargement
5197860|NCT02757963|Benign prostatic obstruction|benign prostatic obstruction
5197861|NCT02757963|LUTS|luts
5197862|NCT02757963|Benign prostatic hyperplasia|benign prostatic hyperplasia
5197863|NCT02757963|IPSS|ipss
5197864|NCT02757963|BPH|bph
5197865|NCT02757950|exposed and unexposed cohorts|exposed and unexposed cohorts
5197866|NCT02757950|post-marketing, maternal immunization|post-marketing, maternal immunization
5197867|NCT02757950|neonate related Adverse Events|neonate related adverse events
5197868|NCT02757950|Congenital anomaly|congenital anomaly
5197869|NCT02757950|RefortrixTM|refortrixtm
5197870|NCT02757950|Pregnancy related Adverse Events|pregnancy related adverse events
5197871|NCT02757937|Medication Adherence|medication adherence
5197872|NCT02757937|Self-efficacy|self-efficacy
5197873|NCT02757937|Behavior|behavior
5197874|NCT02757937|Diabetes|diabetes
5197875|NCT02757937|Diabetes Mellitus|diabetes mellitus
5197876|NCT02757911|XCGD|xcgd
5197877|NCT02757898|Red Blood Cell (RBC) transfusion|red blood cell (rbc) transfusion
5197878|NCT02757898|Biotin labeled red blood cells|biotin labeled red blood cells
5197879|NCT02757885|bone marrow transplant|bone marrow transplant
5197880|NCT02757872|Hypertension|hypertension
5197881|NCT02757872|Kidney Diseases|kidney diseases
5197883|NCT02757872|Omega 3 fatty acids|omega 3 fatty acids
5197884|NCT02757846|Radiomics|radiomics
5197885|NCT02757846|prognosis|prognosis
5197886|NCT02757846|medical images|medical images
5197887|NCT02757846|Hepatocellular carcinoma|hepatocellular carcinoma
5197888|NCT02757820|anesthesia; airway; laryngeal mask airway; I-gel; Air-Q|anesthesia; airway; laryngeal mask airway; i-gel; air-q
5197889|NCT02757807|Erectile Dysfunction|erectile dysfunction
5197890|NCT02757781|Patient empowerment|patient empowerment
5197891|NCT02757781|Patient involvement|patient involvement
5197892|NCT02757781|Patient participation|patient participation
5197893|NCT02757781|Healthcare professional attitudes|healthcare professional attitudes
5197894|NCT02757781|Chronic diseases|chronic diseases
5197895|NCT02757768|Myrbetriq|myrbetriq
5197896|NCT02757768|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5197897|NCT02757768|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5197898|NCT02757768|Overactive Bladder|overactive bladder
5197899|NCT02757768|Betmiga|betmiga
5197900|NCT02757768|Mirabegron|mirabegron
5197901|NCT02757768|Tamsulosin Hydrochloride|tamsulosin hydrochloride
5197902|NCT02757742|sudden cardiac death|sudden cardiac death
5197903|NCT02757742|ventricular arrhythmias|ventricular arrhythmias
5197905|NCT02757742|late gadolinium enhancement|late gadolinium enhancement
5197906|NCT02757716|addiction remission|addiction remission
5197907|NCT02757716|addiction transfer|addiction transfer
5197908|NCT02757703|somatostatin|somatostatin
5197909|NCT02757703|variceal bleeding|variceal bleeding
5197910|NCT02757703|terlipressin|terlipressin
5197915|NCT02757612|laser diode, pain|laser diode, pain
5197916|NCT02757586|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5197917|NCT02757586|XPO1|xpo1
5197918|NCT02757586|in vitro|in vitro
5197919|NCT02757586|in vivo|in vivo
5197920|NCT02757560|saturated fat|saturated fat
5197921|NCT02757560|acute insulin resistance|acute insulin resistance
5197922|NCT02757560|insulin suppression test|insulin suppression test
5197923|NCT02757560|dietary fatty acids|dietary fatty acids
5197924|NCT02757521|Bipolar Depressive Disorder|bipolar depressive disorder
5197925|NCT02757521|Treatment- Resistant Bipolar Disorder|treatment- resistant bipolar disorder
5962465|NCT04280770|silicone|silicone
5197926|NCT02757521|Nitrous Oxide|nitrous oxide
5197927|NCT02757495|sevoflurane emergence agitation|sevoflurane emergence agitation
5197928|NCT02757495|caudal dexmedetomidine|caudal dexmedetomidine
5197929|NCT02757482|Patient training|patient training
5197930|NCT02757482|Warfarin|warfarin
5197931|NCT02757482|International Normalized Ratio|international normalized ratio
5197932|NCT02757482|Nursing|nursing
5197933|NCT02757456|exercise|exercise
5197934|NCT02757456|hemodialysis|hemodialysis
5197935|NCT02757456|pulse wave velocity|pulse wave velocity
5197936|NCT02757456|micro RNAs|micro rnas
5197937|NCT02757443|Phosphocreatine|phosphocreatine
5197938|NCT02757443|Creatine Phosphate|creatine phosphate
5197939|NCT02757443|Neoton|neoton
5197940|NCT02757443|Phosphate, Creatine|phosphate, creatine
5197941|NCT02757443|Phosphorylcreatine|phosphorylcreatine
5197942|NCT02757404|botulinum toxin|botulinum toxin
5197943|NCT02757404|spasticity|spasticity
5197944|NCT02757404|injection technique|injection technique
5197945|NCT02757404|neuronox|neuronox
5197946|NCT02757404|meditoxin|meditoxin
5197947|NCT02757378|Pain|pain
5197948|NCT02757378|Brain|brain
5197949|NCT02757378|Plasticity|plasticity
5197950|NCT02757378|Education|education
5197951|NCT02757378|Manual Therapy|manual therapy
5197954|NCT02757365|aspirin|aspirin
5197955|NCT02757352|ankylosing|ankylosing
5197956|NCT02757352|nonradiographic spondyloarthritis|nonradiographic spondyloarthritis
5197957|NCT02757339|neurobiology|neurobiology
5197958|NCT02757339|PTSD|ptsd
5197959|NCT02757339|DID|did
5197960|NCT02757326|sphingosine kinase 2 inhibitor|sphingosine kinase 2 inhibitor
5197961|NCT02757326|sphingosine kinase 2|sphingosine kinase 2
5197962|NCT02757326|SK2 inhibitor|sk2 inhibitor
5197963|NCT02757326|SK2|sk2
5197964|NCT02757313|marijuana|marijuana
5197965|NCT02757313|driving|driving
5197966|NCT02757313|THC|thc
5197967|NCT02757313|cannabis|cannabis
5197968|NCT02757313|intoxication|intoxication
5197969|NCT02757313|MRI|mri
5197970|NCT02757287|Ovarian stimulation|ovarian stimulation
5197971|NCT02757287|LH inhibition|lh inhibition
5197972|NCT02757274|Urologic Surgical Procedure|urologic surgical procedure
5197973|NCT02757274|Male|male
5197974|NCT02757261|Bruxism|bruxism
5197975|NCT02757261|Child|child
5197976|NCT02757261|Occlusal splint|occlusal splint
5197977|NCT02757261|Bite force|bite force
5197978|NCT02757261|Acunpuncture|acunpuncture
5197979|NCT02757261|Laser|laser
5197980|NCT02757261|Muscle actvity|muscle actvity
5197981|NCT02757261|Salivary Cortisol|salivary cortisol
5197982|NCT02757235|chronic subdural hematoma|chronic subdural hematoma
5197983|NCT02757235|irrigation|irrigation
5197984|NCT02757235|recurrence|recurrence
5197985|NCT02757235|burr hole evacuation|burr hole evacuation
5197986|NCT02757235|temperature|temperature
5197987|NCT02757209|ASTHMA|asthma
5197988|NCT02757209|COPD|copd
5197989|NCT02757209|budesonide|budesonide
5197990|NCT02757209|formoterol|formoterol
5197991|NCT02757209|Salmeterol|salmeterol
5197992|NCT02757209|Fluticasone|fluticasone
5197993|NCT02757209|Spiromax|spiromax
5197994|NCT02757209|DPI|dpi
5197995|NCT02757209|Diskus|diskus
5197996|NCT02757196|Immune Thrombocytopenia|immune thrombocytopenia
5197997|NCT02757196|Rituximab|rituximab
5197998|NCT02757196|methylprednisolone|methylprednisolone
5197999|NCT02757157|Hydrotherapy|hydrotherapy
5198000|NCT02757157|Walking|walking
5198001|NCT02757131|Mobility|mobility
5198002|NCT02757131|Elderly|elderly
5198003|NCT02757131|Hospitalized patient|hospitalized patient
5198004|NCT02757118|Cardiac Surgery, blood viscosity|cardiac surgery, blood viscosity
5198005|NCT02757092|Pulmonary rehabilitation|pulmonary rehabilitation
5198006|NCT02757092|lung cancer|lung cancer
5198007|NCT02757092|Thoracoscopy|thoracoscopy
5198008|NCT02757079|Melatonin|melatonin
5198009|NCT02757079|NPC-15|npc-15
5198010|NCT02757079|Sleep disorders|sleep disorders
5198011|NCT02757079|Neurodevelopmental disorder|neurodevelopmental disorder
5198012|NCT02757079|Sleep latency|sleep latency
5198013|NCT02757079|DSM-5|dsm-5
5198014|NCT02757066|Melatonin|melatonin
5198016|NCT02757066|Sleep disorders|sleep disorders
5198017|NCT02757066|Autism spectrum disorders|autism spectrum disorders
5198018|NCT02757066|DSM-5|dsm-5
5198019|NCT02757053|Brain Concussion|brain concussion
5198020|NCT02757053|Brain Injuries|brain injuries
5198021|NCT02757053|Diffuse Axonal Injury|diffuse axonal injury
5198022|NCT02757053|Football|football
5198023|NCT02757053|Head Protective Devices|head protective devices
5198024|NCT02757053|Magnetic Resonance Imaging|magnetic resonance imaging
5198025|NCT02757053|Helmet|helmet
5198026|NCT02757053|Third party add-on|third party add-on
5198027|NCT02757040|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5198028|NCT02757040|ibrutinib|ibrutinib
5198029|NCT02757040|arsenic trioxide|arsenic trioxide
5198030|NCT02757040|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5198031|NCT02757027|CABG surgery|cabg surgery
5198032|NCT02757027|blood viscosity|blood viscosity
5198033|NCT02757001|Retrievable Inferior Vena Cava Filters|retrievable inferior vena cava filters
5198034|NCT02757001|Pulmonary Embolism|pulmonary embolism
5198035|NCT02756949|HIV|hiv
5198036|NCT02756949|Viral load|viral load
5065760|NCT03588273|Obesity|obesity
5073893|NCT03537365|Neonatology|neonatology
5073894|NCT03537365|Colostrum|colostrum
5198037|NCT02756949|CD4 count|cd4 count
5198038|NCT02756949|mHealth|mhealth
5198039|NCT02756949|Smartphone|smartphone
5198040|NCT02756949|Linkage to care|linkage to care
5198041|NCT02756949|Retention in care|retention in care
5198042|NCT02756949|Antiretroviral treatment|antiretroviral treatment
5198043|NCT02756949|Randomized controlled trial|randomized controlled trial
5198044|NCT02756949|Johannesburg|johannesburg
5198045|NCT02756949|Mobile app|mobile app
5198046|NCT02756949|Treatment adherence|treatment adherence
5198047|NCT02756923|Male Infertility|male infertility
5198048|NCT02756923|Spermatogonial stem cell|spermatogonial stem cell
5198049|NCT02756910|open abdominal surgery|open abdominal surgery
5198050|NCT02756910|anesthesia, general|anesthesia, general
5198051|NCT02756845|Non CNS Tumor|non cns tumor
5198052|NCT02756832|Drug Therapy|drug therapy
5198053|NCT02756819|Drug Therapy|drug therapy
5198054|NCT02756806|Tattoo removal, Picosecond Laser, Q-switched Laser|tattoo removal, picosecond laser, q-switched laser
5198055|NCT02756780|Remission|remission
5198056|NCT02756780|Carer|carer
5198057|NCT02756780|Psychological|psychological
5198058|NCT02756780|Bereaved|bereaved
5198059|NCT02756780|Cancer|cancer
5198060|NCT02756780|Breast|breast
5198061|NCT02756780|Prostate|prostate
5198062|NCT02756780|Colorectal|colorectal
5198063|NCT02756780|Music|music
5198064|NCT02756741|Cirrhosis|cirrhosis
5198065|NCT02756741|hepatitis B virus|hepatitis b virus
5198066|NCT02756741|Alcohol|alcohol
5198067|NCT02756741|varices|varices
5198068|NCT02756702|TKA|tka
5198069|NCT02756702|TKR|tkr
5198070|NCT02756702|All-Poly|all-poly
5198071|NCT02756702|posterior stabilized|posterior stabilized
5198072|NCT02756689|Mechanical cervical ripening|mechanical cervical ripening
5198073|NCT02756689|Transcervical catheter|transcervical catheter
5198074|NCT02756689|Foley catheter for labor induction|foley catheter for labor induction
5198075|NCT02756689|Cervical ripening|cervical ripening
5198076|NCT02756689|Induction of labor|induction of labor
5198077|NCT02756676|Parkinson Disease|parkinson disease
5198078|NCT02756676|Quality of Life|quality of life
5198079|NCT02756676|Rehabilitation|rehabilitation
5198080|NCT02756663|multiple myeloma|multiple myeloma
5198081|NCT02756663|MM|mm
5198082|NCT02756663|relapsed|relapsed
5198083|NCT02756663|relapsed and refractory|relapsed and refractory
5198084|NCT02756663|panobinostat|panobinostat
5198085|NCT02756663|LBH589|lbh589
5198086|NCT02756663|histone deacetylase inhibitor|histone deacetylase inhibitor
5198087|NCT02756663|carfilzomib|carfilzomib
5198088|NCT02756663|proteasome inhibitor|proteasome inhibitor
5198089|NCT02756650|Behcet Disease|behcet disease
5198090|NCT02756650|Inflammation|inflammation
5198091|NCT02756650|Immune system|immune system
5198092|NCT02756650|Arthritis|arthritis
5198093|NCT02756611|Oncology|oncology
5198094|NCT02756611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5198095|NCT02756611|17p Deletion|17p deletion
5198096|NCT02756611|TP53 Mutation|tp53 mutation
5198097|NCT02756611|Relapsed|relapsed
5198098|NCT02756611|Refractory|refractory
5198099|NCT02756611|B-Cell receptor inhibitor|b-cell receptor inhibitor
5198100|NCT02756598|sufentanil|sufentanil
5198101|NCT02756598|propofol|propofol
5198102|NCT02756598|personality/stress test|personality/stress test
5198103|NCT02756598|fast-track|fast-track
5198104|NCT02756585|computed tomography|computed tomography
5198105|NCT02756585|perfusion imaging|perfusion imaging
5198106|NCT02756585|brain death|brain death
5198107|NCT02756585|traumatic brain injury|traumatic brain injury
5198109|NCT02756559|microRNAs|micrornas
5198110|NCT02756520|chronic kidney disease, pre-dialytic|chronic kidney disease, pre-dialytic
5198111|NCT02756520|Ketosteril, keto-acids|ketosteril, keto-acids
5198112|NCT02756520|diet, protein-restricted|diet, protein-restricted
5198113|NCT02756520|renal function|renal function
5198114|NCT02756507|anxiety symptoms|anxiety symptoms
5198115|NCT02756507|depression symptoms|depression symptoms
5194355|NCT02779153|SLE|sle
5198116|NCT02756507|internalizing symptoms|internalizing symptoms
5198117|NCT02756468|pancreatic cancer|pancreatic cancer
5198118|NCT02756468|procalcitonin|procalcitonin
5198119|NCT02756455|gastric cancer|gastric cancer
5198120|NCT02756455|procalcitonin|procalcitonin
5198121|NCT02756429|atrial fibrillation|atrial fibrillation
5198122|NCT02756429|stroke|stroke
5198123|NCT02756429|thromboembolism|thromboembolism
5198124|NCT02756429|inflammation|inflammation
5198125|NCT02756416|Reversible Cerebral Vasoconstriction Syndrome (RCVS)|reversible cerebral vasoconstriction syndrome (rcvs)
5198126|NCT02756416|Arterial spin labeling (ASL) MRI|arterial spin labeling (asl) mri
5198127|NCT02756390|Insomnia cancer Survivor|insomnia cancer survivor
5198128|NCT02756364|Drug Therapy|drug therapy
5198129|NCT02756325|Azoospermia, IVF, MRI|azoospermia, ivf, mri
5198130|NCT02756299|Sleep Apnea|sleep apnea
5198131|NCT02756299|Positive Airway Pressure|positive airway pressure
5962466|NCT04280770|laser|laser
5962467|NCT04280770|break|break
5962468|NCT04280770|vitrectomy|vitrectomy
5962469|NCT04280757|fetal growth|fetal growth
5074043|NCT03536416|Schools|schools
5198132|NCT02756299|Patient Education|patient education
5198133|NCT02756286|Electroencephalography|electroencephalography
5198134|NCT02756286|Attention|attention
5198135|NCT02756273|ileostomy|ileostomy
5198136|NCT02756273|morbidity|morbidity
5198137|NCT02756273|colorectal surgery|colorectal surgery
5198138|NCT02756247|Buparlisib|buparlisib
5198139|NCT02756247|BKM120|bkm120
5198140|NCT02756247|Ibrutinib|ibrutinib
5198141|NCT02756247|16-009|16-009
5198148|NCT02756195|quality improvement|quality improvement
5198149|NCT02756195|health systems|health systems
5198150|NCT02756195|observational study|observational study
5198151|NCT02756195|non-routine event|non-routine event
5198152|NCT02756195|National Surgical Improvement Program|national surgical improvement program
5198153|NCT02756169|Obesity|obesity
5198154|NCT02756169|Breastfeeding|breastfeeding
5198155|NCT02756169|Grow up|grow up
5198156|NCT02756169|Milk composition|milk composition
5198157|NCT02756169|Mexico|mexico
5198158|NCT02756156|interscalene|interscalene
5198159|NCT02756156|infraclavicular|infraclavicular
5198160|NCT02756156|humerus surgery|humerus surgery
5198161|NCT02756143|fetal heart|fetal heart
5198162|NCT02756143|cesarean section|cesarean section
5198163|NCT02756143|exercise|exercise
5198164|NCT02756143|pregnancy|pregnancy
5198165|NCT02756091|Intracranial Artery Dissection|intracranial artery dissection
5198167|NCT02756091|Stroke|stroke
5198168|NCT02756091|Observational Study|observational study
5198169|NCT02756065|Bipolar|bipolar
5198170|NCT02756065|schizophrenia|schizophrenia
5198171|NCT02756065|schizoaffective|schizoaffective
5198172|NCT02756026|Breast milk|breast milk
5198173|NCT02756026|mineral|mineral
5198174|NCT02756026|vitamin|vitamin
5198175|NCT02756013|chemotherapy dosing|chemotherapy dosing
5198176|NCT02756013|Body surface area|body surface area
5198178|NCT02756013|paclitaxel|paclitaxel
5198179|NCT02756013|carboplatin|carboplatin
5198180|NCT02756013|dose dense|dose dense
5198181|NCT02756000|myocardial infarction|myocardial infarction
5198182|NCT02756000|percutaneous coronary intervention|percutaneous coronary intervention
5198183|NCT02756000|multivessel coronary artery disease|multivessel coronary artery disease
5198184|NCT02756000|dobutamine stress echocardiography|dobutamine stress echocardiography
5198185|NCT02755974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5198186|NCT02755961|End-stage renal disease|end-stage renal disease
5198187|NCT02755961|Phosphate binders|phosphate binders
5198188|NCT02755961|Hyperphosphatemia|hyperphosphatemia
5198189|NCT02755961|Dietary education|dietary education
5198190|NCT02755948|Influenza|influenza
5198191|NCT02755948|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5198192|NCT02755948|RSV A Memphis 37|rsv a memphis 37
5198193|NCT02755922|Mesenchymal Stem Cells|mesenchymal stem cells
5198194|NCT02755922|Treatment|treatment
5198195|NCT02755909|Cardiac surgery, anxiety, education|cardiac surgery, anxiety, education
5198196|NCT02755883|Physical activity|physical activity
5198197|NCT02755883|non-small lung cancer|non-small lung cancer
5198198|NCT02755883|positive affect|positive affect
5198199|NCT02755857|Prophylaxis|prophylaxis
5198200|NCT02755857|Bioavailability|bioavailability
5198201|NCT02755857|Pharmacokinetics|pharmacokinetics
5198202|NCT02755844|endometrial carcinomas|endometrial carcinomas
5198203|NCT02755844|metronomic cyclophosphamide|metronomic cyclophosphamide
5198204|NCT02755844|metformin|metformin
5198205|NCT02755844|olaparib|olaparib
5198206|NCT02755844|dose-escalation study|dose-escalation study
5198208|NCT02755831|pregnancy|pregnancy
5198209|NCT02755831|adverse pregnancy outcomes|adverse pregnancy outcomes
5198210|NCT02755831|continuous positive airway pressure|continuous positive airway pressure
5198211|NCT02755831|preeclampsia|preeclampsia
5198212|NCT02755831|gestational diabetes|gestational diabetes
5198218|NCT02755805|Stroke|stroke
5198219|NCT02755805|Rehabilitation|rehabilitation
5198220|NCT02755805|Cognition|cognition
5198221|NCT02755805|Intervention|intervention
5198222|NCT02755805|Strategy training|strategy training
5198223|NCT02755792|Mild Cognitive Impairment|mild cognitive impairment
5198224|NCT02755792|Cognitive training|cognitive training
5198225|NCT02755792|Calligraphy|calligraphy
5198226|NCT02755792|Emotional calmness|emotional calmness
5198227|NCT02755792|Working memory|working memory
5198228|NCT02755753|Rebamipide|rebamipide
5198230|NCT02755688|atrial fibrillation|atrial fibrillation
5198231|NCT02755688|catheter ablation|catheter ablation
5198232|NCT02755688|thoracoscopic surgical ablation|thoracoscopic surgical ablation
5198233|NCT02755688|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
5198234|NCT02755662|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5198235|NCT02755662|mandibular repositioning device|mandibular repositioning device
5198236|NCT02755636|Health Behavior Change|health behavior change
5198237|NCT02755636|Primary Health Care|primary health care
5198238|NCT02755636|Patient Participation|patient participation
5198239|NCT02755636|Provider-Patient Communication|provider-patient communication
5198249|NCT02755584|Senescent Cells|senescent cells
5198250|NCT02755532|Pharmacokinetics|pharmacokinetics
5962470|NCT04280757|biochemical parameters|biochemical parameters
5074132|NCT03535649|Drug therapy|drug therapy
5198251|NCT02755532|Bupivacaine|bupivacaine
5198252|NCT02755532|Axillary brachial plexus block|axillary brachial plexus block
5198253|NCT02755519|primary aldosteronism|primary aldosteronism
5198254|NCT02755519|confirmatory test|confirmatory test
5198255|NCT02755519|hypertension|hypertension
5198256|NCT02755506|Ultrasound elastography|ultrasound elastography
5198257|NCT02755506|Thoracic lesions|thoracic lesions
5198258|NCT02755506|EBUS-TBNA|ebus-tbna
5198259|NCT02755480|bone marrow transplant|bone marrow transplant
5198260|NCT02755480|infection|infection
5198261|NCT02755480|computed tomography|computed tomography
5198262|NCT02755480|radiation dose|radiation dose
5198263|NCT02755441|Diagnosis|diagnosis
5198264|NCT02755441|Prognosis|prognosis
5198265|NCT02755441|Biomarker|biomarker
5198266|NCT02755415|Rehabilitation|rehabilitation
5198268|NCT02755415|Gait|gait
5198269|NCT02755415|Quality of Life|quality of life
5198270|NCT02755389|Tracheal intubation|tracheal intubation
5198271|NCT02755389|High flow nasal oxygen|high flow nasal oxygen
5198272|NCT02755389|Airway management|airway management
5198273|NCT02755389|Apneic oxygenation|apneic oxygenation
5198274|NCT02755363|COPD|copd
5198275|NCT02755363|residual volume|residual volume
5198276|NCT02755363|osteopathy|osteopathy
5198277|NCT02755363|hyperinflation|hyperinflation
5198278|NCT02755350|PrEP|prep
5198279|NCT02755350|HIV Prevention|hiv prevention
5198280|NCT02755350|combination prevention|combination prevention
5198281|NCT02755350|demonstration project|demonstration project
5198282|NCT02755337|adenocarcinoma|adenocarcinoma
5198283|NCT02755337|non-adenocarcinoma|non-adenocarcinoma
5198284|NCT02755298|Treatment Outcome|treatment outcome
5198285|NCT02755298|Acetazolamide|acetazolamide
5198286|NCT02755272|Triple Negative Breast Cancer|triple negative breast cancer
5198287|NCT02755259|Acetazolamide|acetazolamide
5198288|NCT02755259|Hemodynamics|hemodynamics
5198289|NCT02755246|subjective cognitive decline|subjective cognitive decline
5198290|NCT02755246|dementia|dementia
5198291|NCT02755246|lifestyle|lifestyle
5198292|NCT02755246|polyamine|polyamine
5198293|NCT02755246|memory|memory
5198294|NCT02755246|elderly|elderly
5198295|NCT02755246|prevention|prevention
5198296|NCT02755246|treatment|treatment
5198297|NCT02755246|dietary supplement|dietary supplement
5198298|NCT02755246|Polyamine-enriched diet|polyamine-enriched diet
5198299|NCT02755194|pharmacokinetics|pharmacokinetics
5198300|NCT02755194|Drug-in-milk|drug-in-milk
5198301|NCT02755194|breastfeeding|breastfeeding
5198302|NCT02755194|drug safety|drug safety
5198303|NCT02755194|population pharmacokinetics|population pharmacokinetics
5198304|NCT02755155|acute circulatory failure requiring norepinephrine|acute circulatory failure requiring norepinephrine
5198305|NCT02755155|SIRS|sirs
5198306|NCT02755155|Albumin, therapeutic|albumin, therapeutic
5198307|NCT02755116|Nausea|nausea
5198308|NCT02755116|Vomiting|vomiting
5198309|NCT02755103|Mindfulness|mindfulness
5198310|NCT02755103|Comorbid PTSD and SUD|comorbid ptsd and sud
5198311|NCT02755103|Meditation|meditation
5198312|NCT02755090|nitrous|nitrous
5198313|NCT02755090|pain|pain
5198314|NCT02755077|Anesthesia induction|anesthesia induction
5198315|NCT02755077|Airway|airway
5198316|NCT02755077|Mask ventilation|mask ventilation
5198317|NCT02755038|postmenopausal women|postmenopausal women
5198318|NCT02755038|scalp hair|scalp hair
5198319|NCT02755038|estrogen|estrogen
5198320|NCT02755038|progesterone|progesterone
5198321|NCT02755025|Sepsis|sepsis
5198322|NCT02755025|SOFA score|sofa score
5198323|NCT02755025|Automated calculation|automated calculation
5198324|NCT02755012|Maternal Health|maternal health
5198325|NCT02755012|Guatemala|guatemala
5198326|NCT02755012|Indigenous Population|indigenous population
5198327|NCT02755012|Stunting|stunting
5198328|NCT02755012|Food Insecurity|food insecurity
5198329|NCT02755012|Poverty|poverty
5089219|NCT03440437|FS118|fs118
5198330|NCT02755012|Social Support|social support
5198331|NCT02755012|Maternal Autonomy|maternal autonomy
5198332|NCT02755012|Paternal Support|paternal support
5198333|NCT02755012|Cortisol Rhythm|cortisol rhythm
5198334|NCT02754986|heart rate variability|heart rate variability
5198336|NCT02754960|Vascular malformation|vascular malformation
5198337|NCT02754960|Angiodysplasia|angiodysplasia
5198339|NCT02754947|Assessment and Consultation Team (ACT)|assessment and consultation team (act)
5198340|NCT02754947|Rapid Response Team (RRT)|rapid response team (rrt)
5198341|NCT02754947|Perioperative complications|perioperative complications
5198342|NCT02754947|Respiratory insufficiency|respiratory insufficiency
5198343|NCT02754947|ASA status|asa status
5198344|NCT02754934|chronic|chronic
5198345|NCT02754895|acute coronary syndrome|acute coronary syndrome
5198346|NCT02754895|health behavior|health behavior
5198347|NCT02754895|factorial design|factorial design
5198348|NCT02754895|positive psychology|positive psychology
5962471|NCT04280705|Adaptive|adaptive
5198349|NCT02754882|NSCLC|nsclc
5198350|NCT02754882|bevacizumab|bevacizumab
5198351|NCT02754882|avastin|avastin
5198352|NCT02754778|arterial stiffness|arterial stiffness
5198353|NCT02754778|preeclampsia|preeclampsia
5962472|NCT04280705|COVID-19|covid-19
5074243|NCT03534921|Schizoaffective disorder|schizoaffective disorder
5074244|NCT03534921|Bipolar disorder|bipolar disorder
5074245|NCT03534921|Severe mental illness|severe mental illness
5074246|NCT03534895|midazolam|midazolam
5198354|NCT02754778|HELLP-syndrome|hellp-syndrome
5198355|NCT02754778|pulse wave velocity|pulse wave velocity
5198356|NCT02754778|advanced glycation endproducts|advanced glycation endproducts
5198357|NCT02754778|skin autofluorescence|skin autofluorescence
5198358|NCT02754778|conditional workout|conditional workout
5198359|NCT02754778|postpartum|postpartum
5198360|NCT02754778|cardiovascular risk|cardiovascular risk
5198361|NCT02754778|pregnancy|pregnancy
5198362|NCT02754778|vicorder|vicorder
5198363|NCT02754778|age reader|age reader
5198364|NCT02754739|Pravastatin|pravastatin
5198365|NCT02754739|Insulin Resistance|insulin resistance
5198366|NCT02754700|Anterior Cruciate Ligament|anterior cruciate ligament
5198367|NCT02754687|male contraception|male contraception
5198368|NCT02754687|healthy men|healthy men
5198369|NCT02754687|androgen|androgen
5198370|NCT02754687|Nortestosterone|nortestosterone
5198371|NCT02754687|Dodecylcarbonate|dodecylcarbonate
5198372|NCT02754687|11-Beta|11-beta
5198373|NCT02754687|11β|11β
5198374|NCT02754687|contraception|contraception
5198375|NCT02754661|Polyps; Capsule endoscopy; CT Colonography; Colonoscopy; Average risk patients for colorectal cancer screening|polyps; capsule endoscopy; ct colonography; colonoscopy; average risk patients for colorectal cancer screening
5198376|NCT02754635|Abnormal first or second trimester biochemical markers|abnormal first or second trimester biochemical markers
5198377|NCT02754635|maternal and perinatal morbidity/mortality|maternal and perinatal morbidity/mortality
5198378|NCT02754622|Rehabilitation|rehabilitation
5198379|NCT02754609|Celiac Disease|celiac disease
5198380|NCT02754609|Necator americanus|necator americanus
5198381|NCT02754609|Helminths|helminths
5198382|NCT02754609|Autoimmunity|autoimmunity
5198383|NCT02754609|Clinical Trials, Phase I|clinical trials, phase i
5198384|NCT02754609|Randomized Controlled Trial|randomized controlled trial
5198385|NCT02754583|trachoma|trachoma
5198386|NCT02754583|soil transmitted helminths|soil transmitted helminths
5198387|NCT02754583|sanitation|sanitation
5198388|NCT02754583|face washing|face washing
5198389|NCT02754583|antibiotics|antibiotics
5198390|NCT02754570|Open-angle glaucoma|open-angle glaucoma
5198391|NCT02754570|Ocular hypertension|ocular hypertension
5198392|NCT02754570|Latanoprost|latanoprost
5198393|NCT02754570|Pilocarpine|pilocarpine
5198394|NCT02754531|Cole formula|cole formula
5198395|NCT02754531|Pediatric patients|pediatric patients
5198396|NCT02754531|intubation|intubation
5198397|NCT02754531|Ultrasonography|ultrasonography
5198398|NCT02754531|Endotracheal tube|endotracheal tube
5198399|NCT02754531|uncuffed|uncuffed
5198400|NCT02754531|pediatric|pediatric
5198401|NCT02754505|Keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization|keywords: intensive care, muscle wasting, discharge, neuromuscular weakness, mobilization
5198402|NCT02754453|Weight Regain|weight regain
5198403|NCT02754453|Group Treatment|group treatment
5198404|NCT02754453|Weight Loss|weight loss
5198405|NCT02754427|Surveillance|surveillance
5198406|NCT02754427|Physiotherapy|physiotherapy
5198407|NCT02754427|Arm morbidity|arm morbidity
5198408|NCT02754414|platelets|platelets
5198409|NCT02754414|transfusion|transfusion
5198410|NCT02754414|cold storage|cold storage
5198411|NCT02754414|apheresis|apheresis
5198412|NCT02754401|public health|public health
5198413|NCT02754401|periodontitis|periodontitis
5198414|NCT02754401|self-reported questionnaire|self-reported questionnaire
5198416|NCT02754375|biological markers|biological markers
5198417|NCT02754375|rTMS|rtms
5198418|NCT02754362|Poly-ICLC and bevacizumab|poly-iclc and bevacizumab
5198419|NCT02754362|humanized monoclonal antibody|humanized monoclonal antibody
5198420|NCT02754349|pulse wave velocity|pulse wave velocity
5198421|NCT02754349|augmentation index|augmentation index
5198422|NCT02754349|central pulse pressure|central pulse pressure
5198423|NCT02754310|Education, medical|education, medical
5198424|NCT02754310|Simulation Training|simulation training
5198425|NCT02754297|Neuroendocrine tumors|neuroendocrine tumors
5198426|NCT02754297|Personalized|personalized
5198427|NCT02754297|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
5186323|NCT02825472|Exercise training|exercise training
5186324|NCT02825459|abstinence|abstinence
5186325|NCT02825459|abuse liability|abuse liability
5186326|NCT02825459|electronic cigarette|electronic cigarette
5186327|NCT02825459|e-cigarette|e-cigarette
5186328|NCT02825459|electronic nicotine delivery device|electronic nicotine delivery device
5198428|NCT02754297|PRRT|prrt
5198429|NCT02754297|177Lu-DOTATATE|177lu-dotatate
5198440|NCT02754219|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5198441|NCT02754193|Venous-Arterial ExtraCorporeal Membrane Oxygenation|venous-arterial extracorporeal membrane oxygenation
5198442|NCT02754180|adjuvant|adjuvant
5198443|NCT02754180|pancreatic cancer|pancreatic cancer
5198444|NCT02754180|R1 resection|r1 resection
5962473|NCT04280705|Efficacy|efficacy
5962474|NCT04280705|Multicenter|multicenter
5962475|NCT04280705|novel coronavirus|novel coronavirus
5962476|NCT04280705|Safety|safety
5962477|NCT04280692|PfSPZ|pfspz
5962478|NCT04280692|Kenya|kenya
5121919|NCT03233594|PET|pet
5198445|NCT02754180|positive lymph nodes|positive lymph nodes
5198446|NCT02754167|Hepcidin|hepcidin
5198447|NCT02754167|hemoglobin|hemoglobin
5198448|NCT02754167|iron|iron
5198449|NCT02754167|anemia of chronic disease|anemia of chronic disease
5198450|NCT02754089|Body weight changes|body weight changes
5198451|NCT02754089|Medicine, Traditional|medicine, traditional
5198452|NCT02754089|Herbal medicine|herbal medicine
5198453|NCT02754089|Rhus|rhus
5198454|NCT02754089|Waist Circumference|waist circumference
5198455|NCT02754089|Waist-Hip Ratio|waist-hip ratio
5198456|NCT02754089|Body mass index|body mass index
5198457|NCT02754076|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
5198458|NCT02754024|Stemless shoulder prosthesis|stemless shoulder prosthesis
5198459|NCT02754011|HER2 negative|her2 negative
5198856|NCT02751528|Phase 1|phase 1
5198460|NCT02754011|Locally advanced or metastatic|locally advanced or metastatic
5198461|NCT02753998|Stenosis of arteriovenous fistula|stenosis of arteriovenous fistula
5198462|NCT02753998|Angioplasty|angioplasty
5198463|NCT02753998|Paclitaxel-Coated Balloon Angioplasty|paclitaxel-coated balloon angioplasty
5198464|NCT02753920|voiding trial|voiding trial
5198465|NCT02753920|prolapse|prolapse
5198466|NCT02753894|Dose-finding|dose-finding
5198467|NCT02753894|Hemodialysis|hemodialysis
5198468|NCT02753894|ASP1585|asp1585
5198469|NCT02753894|Chronic kidney disease|chronic kidney disease
5198470|NCT02753868|Intradialytic exercise|intradialytic exercise
5198471|NCT02753868|Cardiac and arterial function|cardiac and arterial function
5198472|NCT02753842|Sexually Transmitted Infections|sexually transmitted infections
5198473|NCT02753842|Condoms|condoms
5198474|NCT02753842|Contraceptive Devices|contraceptive devices
5198476|NCT02753816|Tranexamic Acid|tranexamic acid
5198477|NCT02753816|Burn|burn
5198478|NCT02753816|Surgery|surgery
5198479|NCT02753816|Tangential|tangential
5198480|NCT02753816|Excision|excision
5198481|NCT02753790|Brain|brain
5198482|NCT02753790|Metastasis|metastasis
5198483|NCT02753790|IMRT|imrt
5198484|NCT02753790|Radiation|radiation
5198485|NCT02753790|Cancer|cancer
5198486|NCT02753790|Hippocampus|hippocampus
5198487|NCT02753790|Intensity modulated radiotherapy|intensity modulated radiotherapy
5198488|NCT02753790|Quality of life|quality of life
5198490|NCT02753712|Small airway disease|small airway disease
5198491|NCT02753712|asthma|asthma
5198492|NCT02753699|Chronic hepatitis C|chronic hepatitis c
5198493|NCT02753686|HR+ HER2|hr+ her2
5198494|NCT02753686|pre/postmenopausal|pre/postmenopausal
5198495|NCT02753686|men|men
5198496|NCT02753686|advanced breast cancer|advanced breast cancer
5198497|NCT02753686|non steroidal aromatase inhibitor (NSAI) exposure|non steroidal aromatase inhibitor (nsai) exposure
5198498|NCT02753686|metastatic|metastatic
5198499|NCT02753686|endocrine therapy|endocrine therapy
5198500|NCT02753686|targeted therapy|targeted therapy
5198501|NCT02753686|prospective|prospective
5198502|NCT02753686|observational|observational
5198503|NCT02753686|registry|registry
5198504|NCT02753686|real world setting|real world setting
5198505|NCT02753686|non-interventional|non-interventional
5198506|NCT02753686|Canadian|canadian
5198507|NCT02753673|Breast Conserving Therapy|breast conserving therapy
5089470|NCT03439046|CDK|cdk
5198508|NCT02753673|Reported Outcomes Instrument|reported outcomes instrument
5198509|NCT02753673|16-325|16-325
5423234|NCT01616576|Fidelity 120™|fidelity 120™
5198510|NCT02753660|spinal, anesthesia, pendant, spinal-bone contact, puncture|spinal, anesthesia, pendant, spinal-bone contact, puncture
5198511|NCT02753608|exhaled breath condensate|exhaled breath condensate
5198512|NCT02753608|volatile organic compounds|volatile organic compounds
5198513|NCT02753595|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
5198514|NCT02753595|Eribulin Mesylate|eribulin mesylate
5198515|NCT02753595|E7389|e7389
5198516|NCT02753595|PEGPH20|pegph20
5194745|NCT02776800|Open Wound|open wound
5198517|NCT02753595|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
5198518|NCT02753595|High-Hyaluronan|high-hyaluronan
5198519|NCT02753582|Elderly, pre-frail, SOD|elderly, pre-frail, sod
5198520|NCT02753569|Magnetic Resonance Imaging|magnetic resonance imaging
5198522|NCT02753569|non-small cell lung cancer|non-small cell lung cancer
5198523|NCT02753556|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5198524|NCT02753556|COPD|copd
5198525|NCT02753556|ScreenFlow|screenflow
5198526|NCT02753556|Screening|screening
5198527|NCT02753556|Lung Disease|lung disease
5198528|NCT02753556|Mobile Health|mobile health
5198529|NCT02753556|Peak Flow Meter|peak flow meter
5198530|NCT02753556|Usability|usability
5198531|NCT02753517|hepatobiliary scintigraphy|hepatobiliary scintigraphy
5198532|NCT02753517|extended hepatectomy|extended hepatectomy
5198533|NCT02753517|volumetry|volumetry
5198534|NCT02753504|Dyslipidemia|dyslipidemia
5198535|NCT02753491|short interview, diabetes, lifestyle changes, primary care|short interview, diabetes, lifestyle changes, primary care
5198536|NCT02753478|hypothermia|hypothermia
5198537|NCT02753465|Rectal Neoplasms|rectal neoplasms
5198538|NCT02753465|anastomosis|anastomosis
5962479|NCT04280692|Gametocytes|gametocytes
5198539|NCT02753465|OS|os
5198540|NCT02753465|DFS|dfs
5198541|NCT02753465|LCA|lca
5198542|NCT02753465|laparoscopic surgery|laparoscopic surgery
5198543|NCT02753452|youth|youth
5198544|NCT02753452|disability|disability
5198545|NCT02753452|transition|transition
5198546|NCT02753452|life skills|life skills
5198547|NCT02753452|adolescence|adolescence
5198548|NCT02753413|Vaccine|vaccine
5198549|NCT02753413|Safety|safety
5198550|NCT02753413|Reactogenicity|reactogenicity
5198551|NCT02753413|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5198552|NCT02753387|mouthwash|mouthwash
5198553|NCT02753387|head and neck cancer|head and neck cancer
5198554|NCT02753387|chlorhexidine|chlorhexidine
5198555|NCT02753387|pathogens germs|pathogens germs
5198556|NCT02753374|cystic fibrosis, Chinese, children|cystic fibrosis, chinese, children
5198557|NCT02753361|Ultrasound|ultrasound
5198558|NCT02753361|regional blockade|regional blockade
5198559|NCT02753361|lipoma|lipoma
5198658|NCT02752854|pressure algometer|pressure algometer
5198560|NCT02753335|CRPS, graded motor imagery, desensitization, fMRI, DMN|crps, graded motor imagery, desensitization, fmri, dmn
5198561|NCT02753322|Dual task training|dual task training
5198562|NCT02753322|Dual task interference|dual task interference
5198563|NCT02753322|Sub-acute stroke|sub-acute stroke
5198564|NCT02753322|Physiotherapy training|physiotherapy training
5198565|NCT02753322|Community ambulation|community ambulation
5198566|NCT02753322|Balance|balance
5198567|NCT02753309|BCG|bcg
5198568|NCT02753309|Rapamycin|rapamycin
5198569|NCT02753296|Cancer|cancer
5198570|NCT02753296|Fertility Preservation|fertility preservation
5198571|NCT02753296|Patient Decision Aid|patient decision aid
5198572|NCT02753283|Bone loss|bone loss
5198573|NCT02753283|Frail Geriatric Patients|frail geriatric patients
5198574|NCT02753283|Nursing Home Patients|nursing home patients
5198575|NCT02753283|Long-term Care Patients|long-term care patients
5198576|NCT02753283|Osteoporosis|osteoporosis
5198577|NCT02753283|Osteoporotic Fractures|osteoporotic fractures
5198578|NCT02753257|stroke|stroke
5198579|NCT02753257|stroke mimic|stroke mimic
5198580|NCT02753244|Cognitive VideoGames|cognitive videogames
5198581|NCT02753179|Bilateral vestibular hypofunction|bilateral vestibular hypofunction
5198582|NCT02753179|Video Head Impulse Test|video head impulse test
5198583|NCT02753179|Covert-saccades|covert-saccades
5198584|NCT02753179|Quality of life|quality of life
5198585|NCT02753179|Dynamic visual acuity|dynamic visual acuity
5089550|NCT03438617|Integrated Care|integrated care
5198586|NCT02753166|PTSD (Post Traumatic Stress Disorder)|ptsd (post traumatic stress disorder)
5198587|NCT02753166|Emergency Department|emergency department
5198588|NCT02753127|Colorectal Neoplasms|colorectal neoplasms
5198589|NCT02753127|Colonic Diseases|colonic diseases
5198590|NCT02753127|Digestive System Diseases|digestive system diseases
5198591|NCT02753127|Digestive System Neoplasms|digestive system neoplasms
5198592|NCT02753127|Gastrointestinal Diseases|gastrointestinal diseases
5198593|NCT02753127|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5198594|NCT02753127|Intestinal Diseases|intestinal diseases
5198595|NCT02753127|Intestinal Neoplasms|intestinal neoplasms
5198596|NCT02753127|Neoplasms|neoplasms
5198597|NCT02753127|Neoplasms by Histologic Type|neoplasms by histologic type
5198598|NCT02753127|Neoplasms by Site|neoplasms by site
5198599|NCT02753127|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5198600|NCT02753127|Rectal Diseases|rectal diseases
5198601|NCT02753114|Ketamine|ketamine
5198602|NCT02753114|Intranasal|intranasal
5198603|NCT02753114|Emergency Medical Services|emergency medical services
5198604|NCT02753114|Pain|pain
5198605|NCT02753114|Analgesia|analgesia
5198606|NCT02753101|Positron Emission Tomography|positron emission tomography
5198607|NCT02753101|Magnetic Resonance Imaging|magnetic resonance imaging
5198608|NCT02753101|PET/MRI|pet/mri
5198609|NCT02753101|sigma-1 receptor|sigma-1 receptor
5198610|NCT02753101|radiopharmaceutical|radiopharmaceutical
5198611|NCT02753101|complex regional pain syndrome|complex regional pain syndrome
5198612|NCT02753101|sciatica|sciatica
5198613|NCT02753101|chronic pain|chronic pain
5198614|NCT02753088|Equivalence|equivalence
5198615|NCT02753088|BCD-063|bcd-063
5198616|NCT02753088|Copaxone-Teva|copaxone-teva
5198617|NCT02753049|HIV|hiv
5198618|NCT02753049|AIDS|aids
5198619|NCT02753049|Adolescent|adolescent
5198620|NCT02753049|Adherence|adherence
5198621|NCT02753049|Retention|retention
5198622|NCT02753049|mHealth|mhealth
5198623|NCT02753036|cognition|cognition
5198624|NCT02753036|chemotherapy|chemotherapy
5198625|NCT02753036|polyneuropathy|polyneuropathy
5198626|NCT02753036|paclitaxel|paclitaxel
5198627|NCT02753036|cancer|cancer
5198628|NCT02753036|chemobrain|chemobrain
5198629|NCT02752984|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
5198630|NCT02752932|Head and neck cancer|head and neck cancer
5198631|NCT02752932|Patient derived Xenograft|patient derived xenograft
5198632|NCT02752932|Chemotherapy|chemotherapy
5198633|NCT02752932|Metastases|metastases
5198634|NCT02752906|Meningitis|meningitis
5198635|NCT02752906|Meningococcal Meningitis|meningococcal meningitis
5198636|NCT02752906|Meningococcal Infections|meningococcal infections
5198637|NCT02752906|MenACYW conjugate vaccine|menacyw conjugate vaccine
5198638|NCT02752906|Licensed Meningococcal Conjugate Vaccine (MCV4)|licensed meningococcal conjugate vaccine (mcv4)
5198639|NCT02752893|estrogen|estrogen
5198640|NCT02752893|estrogen receptor|estrogen receptor
5198641|NCT02752893|ER+|er+
5198642|NCT02752893|HER2|her2
5198643|NCT02752893|HER2-|her2-
5198644|NCT02752893|HER2-negative|her2-negative
5198645|NCT02752893|xenograft|xenograft
5198646|NCT02752893|co-clinical|co-clinical
5198647|NCT02752893|mice|mice
5198648|NCT02752893|patient-derived xenograft|patient-derived xenograft
5198649|NCT02752893|patient-derived|patient-derived
5198650|NCT02752893|breast cancer|breast cancer
5198651|NCT02752893|precision medicine|precision medicine
5198652|NCT02752893|personalized medicine|personalized medicine
5198653|NCT02752867|traditional Chinese medicine granules|traditional chinese medicine granules
5198654|NCT02752867|Cognitive Impairment|cognitive impairment
5198655|NCT02752867|Acute cerebral infraction|acute cerebral infraction
5198656|NCT02752867|treatment|treatment
5198657|NCT02752854|pain scores|pain scores
5198659|NCT02752854|healthy volunteer adults|healthy volunteer adults
5198660|NCT02752802|Contrast Media|contrast media
5198661|NCT02752802|Angiography|angiography
5198662|NCT02752789|alloantibodies|alloantibodies
5198663|NCT02752789|donor specific antibodies (DSA)-preformed, de novo|donor specific antibodies (dsa)-preformed, de novo
5198664|NCT02752789|self-antigens|self-antigens
5198665|NCT02752789|chronic allograft function|chronic allograft function
5198666|NCT02752776|secukinumab|secukinumab
5198667|NCT02752776|AIN457|ain457
5198668|NCT02752776|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5198669|NCT02752776|immune-mediated systemic disease|immune-mediated systemic disease
5198670|NCT02752776|scaly patches|scaly patches
5198671|NCT02752776|papules|papules
5198672|NCT02752776|plaques|plaques
5198673|NCT02752776|itching|itching
5198674|NCT02752763|Dry eye|dry eye
5198675|NCT02752763|isotretinoin, AS|isotretinoin, as
5198676|NCT02752763|Autologous serum|autologous serum
5198677|NCT02752724|major depressive disorder|major depressive disorder
5198678|NCT02752724|electroconvulsive therapy|electroconvulsive therapy
5198679|NCT02752724|metabolomics|metabolomics
5198680|NCT02752724|treatment resistant depression|treatment resistant depression
5198681|NCT02752724|anesthesiology|anesthesiology
5198682|NCT02752724|ketamine|ketamine
5198683|NCT02752724|prospective randomized clinical trial|prospective randomized clinical trial
5198684|NCT02752711|Minor head trauma|minor head trauma
5198685|NCT02752711|Children|children
5198686|NCT02752711|Clinical decision rule|clinical decision rule
5198687|NCT02752685|Nab-Paclitaxel|nab-paclitaxel
5198688|NCT02752685|Abraxane|abraxane
5198689|NCT02752685|MK-3475|mk-3475
5198690|NCT02752672|dithranol|dithranol
5198691|NCT02752672|therapeutic mechanisms|therapeutic mechanisms
5198692|NCT02752659|Monitoring|monitoring
5198693|NCT02752646|cataract|cataract
5198694|NCT02752633|Xanthine dehydrogenase inhibitor treatment, pharmacotherapy|xanthine dehydrogenase inhibitor treatment, pharmacotherapy
5198695|NCT02752620|osteopathic manipulative treatment|osteopathic manipulative treatment
5198696|NCT02752620|Chronic nonspecific low back pain|chronic nonspecific low back pain
5198697|NCT02752620|low back pain|low back pain
5198698|NCT02752594|probiotic|probiotic
5198699|NCT02752594|mutans streptococci|mutans streptococci
5198700|NCT02752594|bacillus coagulans|bacillus coagulans
5198701|NCT02752594|caries|caries
5198702|NCT02752581|suction drain|suction drain
5198703|NCT02752581|knee arthroscopy|knee arthroscopy
5186616|NCT02823834|protrusio acetabuli|protrusio acetabuli
5186617|NCT02823834|painful hip dysplasia|painful hip dysplasia
5186618|NCT02823834|rheumatoid arthritis|rheumatoid arthritis
5186619|NCT02823834|correction of functional deformity|correction of functional deformity
5186627|NCT02823795|Patient participation|patient participation
5186628|NCT02823795|Empowerment|empowerment
5186629|NCT02823795|Medication management|medication management
5186630|NCT02823795|Symptom management|symptom management
5198714|NCT02752438|high frequency oscillatory ventilation|high frequency oscillatory ventilation
5198715|NCT02752438|rescue|rescue
5198716|NCT02752438|newborn|newborn
5198717|NCT02752425|Speech disorders|speech disorders
5198718|NCT02752425|Speech therapy|speech therapy
5198719|NCT02752425|Visual feedback|visual feedback
5198720|NCT02752425|Buccopharyngeal surgery|buccopharyngeal surgery
5198721|NCT02752425|Central nervous system damage|central nervous system damage
5198722|NCT02752373|GTC Seizures|gtc seizures
5198723|NCT02752360|intestinal reconstruction|intestinal reconstruction
5198724|NCT02752360|end to end anastomosis|end to end anastomosis
5198725|NCT02752321|patient discharge|patient discharge
5198726|NCT02752321|patient engagement|patient engagement
5198727|NCT02752321|patient satisfaction|patient satisfaction
5198728|NCT02752321|continuity of patient care|continuity of patient care
5198729|NCT02752321|hospital discharge|hospital discharge
5198730|NCT02752321|health technology|health technology
5198731|NCT02752321|eDischarge|edischarge
5198732|NCT02752321|multimedia|multimedia
5198733|NCT02752321|mobile applications|mobile applications
5198734|NCT02752321|software applications|software applications
5962480|NCT04280692|Transmission|transmission
5198735|NCT02752321|portable electronic applications|portable electronic applications
5198736|NCT02752282|Family Planning|family planning
5198737|NCT02752282|LNG-IUS|lng-ius
5198738|NCT02752282|Health Education|health education
5198739|NCT02752256|tissue plasminogen activator|tissue plasminogen activator
5198740|NCT02752243|acute leukemia|acute leukemia
5198741|NCT02752243|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5198742|NCT02752243|Stem Cell Transplantation|stem cell transplantation
5198743|NCT02752230|Post operative pain|post operative pain
5198744|NCT02752230|Bariatric Surgery|bariatric surgery
5198745|NCT02752204|Relapsed|relapsed
5198746|NCT02752204|Refractory|refractory
5198747|NCT02752204|Lymphoma|lymphoma
5198748|NCT02752191|ferumoxytol|ferumoxytol
5198749|NCT02752178|Depression|depression
5198750|NCT02752178|Major depressive disorder|major depressive disorder
5198752|NCT02752152|Counseling|counseling
5198753|NCT02752152|Reminder|reminder
5198754|NCT02752152|Early diagnosis|early diagnosis
5198755|NCT02752139|Sleep Disorders|sleep disorders
5198756|NCT02752139|Cerebral Hemodynamics|cerebral hemodynamics
5198757|NCT02752139|Dynamic Cerebral Auto-Regulation|dynamic cerebral auto-regulation
5198758|NCT02752139|Stroke|stroke
5198759|NCT02752126|Esophageal sparing|esophageal sparing
5198760|NCT02752126|Conventional radiotherapy|conventional radiotherapy
5198761|NCT02752126|Palliative radiation|palliative radiation
5198762|NCT02752126|Central lung tumors|central lung tumors
5198763|NCT02752113|diabetes mellitus type 2|diabetes mellitus type 2
5198764|NCT02752113|Metformin|metformin
5198765|NCT02752113|Micro- and macrocirculation|micro- and macrocirculation
5198766|NCT02752113|HbA1c >= 7%|hba1c >= 7%
5198767|NCT02752100|Lower Extremity Arterial Occlusive Disease|lower extremity arterial occlusive disease
5198768|NCT02752100|Interventional Therapy|interventional therapy
5198769|NCT02752074|Melanoma|melanoma
5198770|NCT02752074|Metastatic Melanoma|metastatic melanoma
5198772|NCT02752035|ASP2215|asp2215
5198773|NCT02752035|Newly Diagnosed AML|newly diagnosed aml
5198774|NCT02752035|gilteritinib|gilteritinib
5198775|NCT02752035|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5198776|NCT02752035|FLT3|flt3
5198777|NCT02752022|e-cigarettes|e-cigarettes
5198778|NCT02752022|nitrosamines|nitrosamines
5198779|NCT02752022|smoking cessation|smoking cessation
5198780|NCT02752009|Breast Cancer|breast cancer
5198781|NCT02752009|Armpit lymph nodes Cancer|armpit lymph nodes cancer
5198782|NCT02751996|Chronic Hepatitis|chronic hepatitis
5198783|NCT02751996|HBV|hbv
5186715|NCT02823145|seizure|seizure
5186716|NCT02823145|tonic clonic|tonic clonic
5186717|NCT02823145|epilepsy|epilepsy
5186718|NCT02823145|myoclonic|myoclonic
5198784|NCT02751996|Double blind|double blind
5198785|NCT02751983|Suicide|suicide
5198786|NCT02751983|Psychiatric Rehabilitation|psychiatric rehabilitation
5198787|NCT02751983|Acceptance and Commitment Therapy|acceptance and commitment therapy
5198788|NCT02751983|Brief Psychotherapy|brief psychotherapy
5198789|NCT02751983|Inpatients|inpatients
5198794|NCT02751944|joint pain|joint pain
5198795|NCT02751944|joint stiffness|joint stiffness
5198796|NCT02751944|post-menopausal|post-menopausal
5198797|NCT02751944|women|women
5198798|NCT02751944|cartilage turnover|cartilage turnover
5198799|NCT02751944|CTX-II|ctx-ii
5198800|NCT02751931|Pediatrics|pediatrics
5198801|NCT02751931|Urodynamics|urodynamics
5198802|NCT02751931|Mirabegron|mirabegron
5198803|NCT02751931|Phase 3|phase 3
5198804|NCT02751931|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5198805|NCT02751918|Mesothelin-expressing platinum-resistant cancer|mesothelin-expressing platinum-resistant cancer
5198806|NCT02751814|Childcare Center Regulations|childcare center regulations
5198807|NCT02751814|Physical Activity|physical activity
5198808|NCT02751814|Sedentary Behavior|sedentary behavior
5198809|NCT02751814|Screen-time Behavior|screen-time behavior
5198810|NCT02751788|childcare center regulations|childcare center regulations
5198811|NCT02751788|physical activity|physical activity
5198812|NCT02751788|sedentary behavior|sedentary behavior
5198813|NCT02751788|screen-time behavior|screen-time behavior
5198814|NCT02751775|Childcare center regulations|childcare center regulations
5198815|NCT02751775|Physical Activity|physical activity
5198816|NCT02751775|Sedentary Behavior|sedentary behavior
5198817|NCT02751775|Screen-Time Behavior|screen-time behavior
5198818|NCT02751775|Focus groups|focus groups
5198819|NCT02751723|cancer disease|cancer disease
5198820|NCT02751723|palliative care|palliative care
5198821|NCT02751723|palliative therapy|palliative therapy
5198822|NCT02751723|cancer|cancer
5198823|NCT02751723|patient´s needs|patient´s needs
5198824|NCT02751723|patient care|patient care
5198825|NCT02751723|disease burden|disease burden
5198826|NCT02751684|Rapid Sequence Induction|rapid sequence induction
5198827|NCT02751684|European|european
5198828|NCT02751684|Evaluation|evaluation
5198829|NCT02751684|EUROpE RSI|europe rsi
5198830|NCT02751684|Standards|standards
5198831|NCT02751684|RSI|rsi
5198832|NCT02751645|Pediatric|pediatric
5198833|NCT02751645|Cardiac|cardiac
5198834|NCT02751645|Surgery|surgery
5198835|NCT02751632|Ultra High Risk of Psychosis|ultra high risk of psychosis
5198836|NCT02751632|Prodrome|prodrome
5198837|NCT02751632|Clinical High Risk of Psychosis|clinical high risk of psychosis
5198838|NCT02751619|Pre-emptive analgesia|pre-emptive analgesia
5198839|NCT02751619|Post-thoracotomy pain|post-thoracotomy pain
5198840|NCT02751619|Lidocaine patch|lidocaine patch
5198841|NCT02751606|Ferumoxtran|ferumoxtran
5198842|NCT02751606|MRI Scans|mri scans
5198843|NCT02751593|pregnancy|pregnancy
5198844|NCT02751593|Immune Thrombocytopenia|immune thrombocytopenia
5198845|NCT02751593|dexamethasone|dexamethasone
5198846|NCT02751528|Breast Cancer|breast cancer
5198847|NCT02751528|Breast Cancer male|breast cancer male
5198848|NCT02751528|Breast Neoplasms|breast neoplasms
5198849|NCT02751528|Breast Neoplasms male|breast neoplasms male
5198851|NCT02751528|HER2|her2
5198852|NCT02751528|Metastatic|metastatic
5198853|NCT02751528|Locally Advanced|locally advanced
5198854|NCT02751528|Unresectable|unresectable
5198855|NCT02751528|Solid Tumor|solid tumor
5198857|NCT02751528|Cancer Vaccine|cancer vaccine
5198858|NCT02751502|Children|children
5198859|NCT02751502|Pediatrics|pediatrics
5198860|NCT02751502|Arm|arm
5198861|NCT02751502|Upper limb|upper limb
5198862|NCT02751502|bimanual training|bimanual training
5198863|NCT02751502|physical training|physical training
5198864|NCT02751437|preterm|preterm
5198865|NCT02751437|arginine|arginine
5198866|NCT02751437|immune function|immune function
5198867|NCT02751437|nutrition|nutrition
5198868|NCT02751424|Multidrug-resistant|multidrug-resistant
5198869|NCT02751424|Gram negative bacterial infection|gram negative bacterial infection
5198870|NCT02751424|Safety|safety
5198871|NCT02751424|Pharmacokinetic|pharmacokinetic
5198872|NCT02751333|Esophageal stricture|esophageal stricture
5198873|NCT02751333|Esophageal leak|esophageal leak
5101086|NCT03366337|IgAN|igan
5198874|NCT02751333|Esophageal perforation|esophageal perforation
5198875|NCT02751333|Esophageal fistula|esophageal fistula
5198876|NCT02751333|Endostitch|endostitch
5198877|NCT02751333|Esophageal stent|esophageal stent
5186811|NCT02822495|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
5186812|NCT02822495|Acquired Immunodeficiency (AID)|acquired immunodeficiency (aid)
5186814|NCT02822495|HIV/AIDS Lymphoma|hiv/aids lymphoma
5198878|NCT02751307|metformin|metformin
5198879|NCT02751307|clozapine|clozapine
5198880|NCT02751307|schizophrenia|schizophrenia
5198881|NCT02751307|metabolic traits|metabolic traits
5198882|NCT02751294|Healthy Volunteer|healthy volunteer
5198883|NCT02751294|Malaria|malaria
5198884|NCT02751294|Pharmacokinetics|pharmacokinetics
5198885|NCT02751294|Tafenoquine|tafenoquine
5198891|NCT02751268|septorhinoplasty|septorhinoplasty
5198892|NCT02751268|general anesthesia|general anesthesia
5198893|NCT02751268|postoperative analgesia|postoperative analgesia
5198894|NCT02751242|Diuretic Resistance|diuretic resistance
5198895|NCT02751242|Emergency Medicine|emergency medicine
5198896|NCT02751229|Mental illness|mental illness
5198897|NCT02751229|adolescents|adolescents
5198898|NCT02751229|intervention|intervention
5198899|NCT02751229|stigma|stigma
5198900|NCT02751229|disclosure|disclosure
5198901|NCT02751229|secrecy|secrecy
5198902|NCT02751216|high frequency / high density spinal cord stimulation|high frequency / high density spinal cord stimulation
5198904|NCT02751216|conditioned pain modulation|conditioned pain modulation
5198905|NCT02751177|KRAS gene mutation|kras gene mutation
5198906|NCT02751177|NRAS gene mutation|nras gene mutation
5198907|NCT02751177|BRAF gene mutation|braf gene mutation
5198908|NCT02751138|Immune phenotype|immune phenotype
5198909|NCT02751138|Cytokines|cytokines
5198910|NCT02751138|Genetic aberration|genetic aberration
5198911|NCT02751138|Overall survival|overall survival
5198912|NCT02751138|Progression free survival|progression free survival
5198913|NCT02751125|Mesenchymal stem cells|mesenchymal stem cells
5198914|NCT02751125|bone augmentation|bone augmentation
5198915|NCT02751125|bone regeneration|bone regeneration
5198916|NCT02751086|minimally invasive surgery|minimally invasive surgery
5198917|NCT02751086|gastrectomy|gastrectomy
5198918|NCT02751086|robotic surgery|robotic surgery
5198919|NCT02751086|laparoscopic surgery|laparoscopic surgery
5198920|NCT02751086|laparoscopy|laparoscopy
5198921|NCT02751086|robot-assisted|robot-assisted
5198922|NCT02751086|robotic|robotic
5198923|NCT02751086|robotic gastrectomy|robotic gastrectomy
5673921|NCT00606125|Carboplatin|carboplatin
5198924|NCT02751086|laparoscopic gastrectomy|laparoscopic gastrectomy
5198925|NCT02751086|minimally invasive gastrectomy|minimally invasive gastrectomy
5198926|NCT02751073|Microbiota|microbiota
5198927|NCT02751073|Proteome|proteome
5198928|NCT02751034|Wrinkle Severity Rating Scale|wrinkle severity rating scale
5198929|NCT02751034|Global Aesthetic Improvement Scale|global aesthetic improvement scale
5198930|NCT02751034|Hyaluronic acid filler|hyaluronic acid filler
5198931|NCT02751034|filler|filler
5198932|NCT02751034|Nasolabial Fold|nasolabial fold
5198933|NCT02750995|myelodysplastic syndrome|myelodysplastic syndrome
5198934|NCT02750995|acute myeloid leukemia|acute myeloid leukemia
5198935|NCT02750995|azacitidine|azacitidine
5198936|NCT02750995|peptide vaccine|peptide vaccine
5198937|NCT02750995|cancer testis antigen|cancer testis antigen
5198938|NCT02750995|cancer vaccine|cancer vaccine
5198939|NCT02750995|immunotherapy|immunotherapy
5198940|NCT02750995|combination therapy|combination therapy
5198941|NCT02750995|NY-ESO-1|ny-eso-1
5198942|NCT02750995|PRAME|prame
5198943|NCT02750995|MAGE-A3|mage-a3
5198944|NCT02750995|WT-1|wt-1
5198945|NCT02750995|vaccine|vaccine
5198946|NCT02750969|tinnitus|tinnitus
5198947|NCT02750969|lidocain patch|lidocain patch
5198948|NCT02750956|endocan protein|endocan protein
5198949|NCT02750956|VEGF A|vegf a
5198950|NCT02750956|TNF-alpha|tnf-alpha
5198951|NCT02750956|after treatment|after treatment
5198952|NCT02750930|Extension|extension
5198953|NCT02750930|Long-term Safety|long-term safety
5198954|NCT02750930|Pharmacodynamics|pharmacodynamics
5198955|NCT02750930|Albiglutide|albiglutide
5198956|NCT02750930|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5198957|NCT02750917|postoperative pain|postoperative pain
5198958|NCT02750917|lornoxicam|lornoxicam
5198959|NCT02750917|etoricoxib|etoricoxib
5198960|NCT02750917|total knee arthroplasty|total knee arthroplasty
5198961|NCT02750904|Smoking Cessation|smoking cessation
5198962|NCT02750904|Acceptance & Commitment Therapy|acceptance & commitment therapy
5198963|NCT02750904|Cognitive Behavioral Therapy|cognitive behavioral therapy
5198964|NCT02750904|Bipolar Disorder|bipolar disorder
5198965|NCT02750891|high grade glioma|high grade glioma
5198967|NCT02750891|DIPG|dipg
5186900|NCT02821767|Eye Diseases|eye diseases
5186901|NCT02821754|PDL1-Mediated Adaptive Resistance|pdl1-mediated adaptive resistance
5186902|NCT02821754|Monoclonal Antibody|monoclonal antibody
5186903|NCT02821754|CTLA-4|ctla-4
5198968|NCT02750878|Urinary Incontinence, Stress [C13.351.968.934.814.500]|urinary incontinence, stress [c13.351.968.934.814.500]
5198969|NCT02750865|biomedical technology|biomedical technology
5198970|NCT02750865|palliative care|palliative care
5090040|NCT03435731|OSA|osa
5198971|NCT02750800|Rheumatoid arthritis|rheumatoid arthritis
5198972|NCT02750800|Ankylosing spondylitis|ankylosing spondylitis
5198973|NCT02750800|Psoriatic arthritis|psoriatic arthritis
5198974|NCT02750800|Psoriasis|psoriasis
5198982|NCT02750800|Humira|humira
5198983|NCT02750800|Adherence|adherence
5198984|NCT02750800|Health-related quality of life|health-related quality of life
5198985|NCT02750800|Healthcare resource utilization|healthcare resource utilization
5198986|NCT02750800|Disease activity|disease activity
5198987|NCT02750800|Treatment satisfaction|treatment satisfaction
5198988|NCT02750800|Workability|workability
5198989|NCT02750722|Exercise|exercise
5198990|NCT02750722|Lung diffusion capacity|lung diffusion capacity
5198991|NCT02750722|Sputum viscoelasticity|sputum viscoelasticity
5198992|NCT02750722|Lung disease|lung disease
5198993|NCT02750709|HT-1|ht-1
5198994|NCT02750709|Tyrosinemia|tyrosinemia
5198995|NCT02750709|Nitisinone|nitisinone
5198996|NCT02750709|Bioequivalence|bioequivalence
5198997|NCT02750709|Healthy Volunteer|healthy volunteer
5198998|NCT02750709|Orfadin|orfadin
5198999|NCT02750696|Acetaminophen|acetaminophen
5199000|NCT02750696|Analgesia|analgesia
5199001|NCT02750696|Codeine|codeine
5199002|NCT02750696|Drug Combinations|drug combinations
5199003|NCT02750696|Endodontics|endodontics
5199004|NCT02750696|Periapical abscess|periapical abscess
5199005|NCT02750696|Randomized Controlled Trial|randomized controlled trial
5199006|NCT02750696|Tramadol|tramadol
5199007|NCT02750696|Visual analog scale|visual analog scale
5199008|NCT02750683|inotropic effect, norepinephrine, septic shock,|inotropic effect, norepinephrine, septic shock,
5199009|NCT02750670|Lymphoma|lymphoma
5199010|NCT02750670|Non-Hodgkin's|non-hodgkin's
5199011|NCT02750670|CD20+|cd20+
5199012|NCT02750670|Obinutuzumab|obinutuzumab
5199013|NCT02750670|GDP Chemotherapy|gdp chemotherapy
5199014|NCT02750670|Refractory and aggressive non-Hodgkin lymphoma|refractory and aggressive non-hodgkin lymphoma
5199015|NCT02750631|depression|depression
5199016|NCT02750631|melatonin|melatonin
5199017|NCT02750631|light therapy|light therapy
5199018|NCT02750631|Wake Therapy|wake therapy
5199019|NCT02750631|chronobiology|chronobiology
5199020|NCT02750592|Ankylosing Spondylitis|ankylosing spondylitis
5199021|NCT02750592|secukinumab|secukinumab
5199022|NCT02750592|AIN457H|ain457h
5199023|NCT02750592|SpondyloArthritis|spondyloarthritis
5199032|NCT02750371|Cavernous sinus meningioma|cavernous sinus meningioma
5199033|NCT02750371|Pituitary adenoma|pituitary adenoma
5199035|NCT02750371|Irradiation|irradiation
5199036|NCT02750371|Autobiographical memory|autobiographical memory
5199037|NCT02750358|Enzalutamide|enzalutamide
5199038|NCT02750358|15-307|15-307
5199039|NCT02750345|HT-1|ht-1
5199040|NCT02750345|Tyrosinemia|tyrosinemia
5199041|NCT02750345|Nitisinone|nitisinone
5199042|NCT02750345|Bioavailability|bioavailability
5199043|NCT02750345|Healthy Volunteer|healthy volunteer
5199044|NCT02750345|Food-Effect|food-effect
5199045|NCT02750332|HT-1|ht-1
5199046|NCT02750332|Tyrosinemia|tyrosinemia
5199047|NCT02750332|Nitisinone|nitisinone
5199048|NCT02750332|Bioavailability|bioavailability
5199049|NCT02750332|Healthy Volunteer|healthy volunteer
5199050|NCT02750332|Food-Effect|food-effect
5199054|NCT02750293|vitamin D|vitamin d
5199055|NCT02750293|blood pressure|blood pressure
5199056|NCT02750293|serum lipids|serum lipids
5199057|NCT02750293|glucose metabolism|glucose metabolism
5199058|NCT02750293|muscle function|muscle function
5199059|NCT02750293|arterial stiffness|arterial stiffness
5199060|NCT02750293|depression|depression
5199061|NCT02750293|psoriasis|psoriasis
5199062|NCT02750293|sleep|sleep
5199063|NCT02750293|bone density|bone density
5199064|NCT02750267|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5199065|NCT02750267|Artificial Pancreas Project (APP)|artificial pancreas project (app)
5199066|NCT02750267|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5199067|NCT02750267|Closed-Loop Control (CLC)|closed-loop control (clc)
5199068|NCT02750267|Continuous Glucose Monitor|continuous glucose monitor
5199069|NCT02750267|Pediatric|pediatric
5199070|NCT02750267|Insulin Pump|insulin pump
5199071|NCT02750241|active video game|active video game
5199072|NCT02750241|mHealth|mhealth
5199073|NCT02750241|cancer survivor|cancer survivor
5199074|NCT02750241|women's health|women's health
5199075|NCT02750241|breast cancer|breast cancer
5199076|NCT02750241|physical activity|physical activity
5199077|NCT02750241|support group|support group
5199078|NCT02750241|survivorship|survivorship
5199079|NCT02750215|MET exon 14 skipping|met exon 14 skipping
5199080|NCT02750215|Stage IV non-small cell lung cancer NSCLC|stage iv non-small cell lung cancer nsclc
5199087|NCT02750176|Rehabilitation|rehabilitation
5199088|NCT02750176|Closed chain exercises|closed chain exercises
5199089|NCT02750137|Tetracaine|tetracaine
5199090|NCT02750124|participation|participation
5199091|NCT02750124|self sampling|self sampling
5199092|NCT02750124|Screening|screening
5199093|NCT02750098|Diabetes Mellitus, Cataract, Aqueous humor|diabetes mellitus, cataract, aqueous humor
5199094|NCT02750085|Hemophilia A|hemophilia a
5199095|NCT02750085|pharmacokinetics|pharmacokinetics
5199096|NCT02750085|myPKFiT|mypkfit
5199097|NCT02750020|Telephone survey|telephone survey
5199098|NCT02749955|HIV prevention|hiv prevention
5199099|NCT02749955|Pre exposure prophylaxis|pre exposure prophylaxis
5199100|NCT02749955|Men who have sex with men|men who have sex with men
5199101|NCT02749955|Partner services|partner services
5199102|NCT02749955|Linkage to care|linkage to care
5199103|NCT02749955|Seronegative|seronegative
5199104|NCT02749955|Sexually transmitted diseases|sexually transmitted diseases
5199105|NCT02749942|Diabetes|diabetes
5199106|NCT02749942|Remote Ischemic Conditioning|remote ischemic conditioning
5199107|NCT02749942|Neuropathy|neuropathy
5199108|NCT02749942|Angiopathy|angiopathy
5199109|NCT02749929|Distal radius fracture, Low Level Laser Therapy|distal radius fracture, low level laser therapy
5199110|NCT02749916|SWI|swi
5199111|NCT02749916|MP-RAGE|mp-rage
5199112|NCT02749916|DANTE T1-SPACE|dante t1-space
5199113|NCT02749877|Pediatric Cancer|pediatric cancer
5199114|NCT02749877|Training|training
5199115|NCT02749877|Working Memory|working memory
5199116|NCT02749877|Physical Activity|physical activity
5199117|NCT02749877|Brain Tumor|brain tumor
5199118|NCT02749877|Physical Exercise|physical exercise
5199119|NCT02749864|Hepatitis|hepatitis
5199120|NCT02749864|Prevalence|prevalence
5199121|NCT02749864|Epidemiology|epidemiology
5199122|NCT02749864|Infectious diseases|infectious diseases
5199123|NCT02749851|pregnancy|pregnancy
5199124|NCT02749851|growth restriction|growth restriction
5282537|NCT02259569|I-gel|i-gel
5199125|NCT02749838|Cancer|cancer
5199126|NCT02749838|Genomic testing|genomic testing
5199127|NCT02749838|Genetic testing|genetic testing
5199128|NCT02749838|Molecular screening|molecular screening
5199129|NCT02749838|Molecular Profiling|molecular profiling
5199130|NCT02749838|Biomarker|biomarker
5199131|NCT02749838|Biopsy|biopsy
5199132|NCT02749838|Tumor sampling|tumor sampling
5199133|NCT02749838|Registry|registry
5199134|NCT02749825|Prostate|prostate
5199135|NCT02749825|Cancer|cancer
5199136|NCT02749825|Trelstar|trelstar
5199137|NCT02749760|Ulnar collateral ligament|ulnar collateral ligament
5199138|NCT02749760|elbow injuries|elbow injuries
5199139|NCT02749760|dynamic elbow stabilizers|dynamic elbow stabilizers
5199140|NCT02749760|Tommy John's procedure|tommy john's procedure
5199141|NCT02749760|elbow injuries in pitchers|elbow injuries in pitchers
5199142|NCT02749747|Menopause|menopause
5199143|NCT02749747|nonhormonal treatment|nonhormonal treatment
5199144|NCT02749747|sulpiride|sulpiride
5199145|NCT02749734|Human embryo stem cell derived retinal pigment epitheliums|human embryo stem cell derived retinal pigment epitheliums
5199146|NCT02749734|Subretinal transplantation|subretinal transplantation
5199147|NCT02749734|Wet Age related Macular degeneration|wet age related macular degeneration
5199148|NCT02749734|Stargardt's macular dystrophy|stargardt's macular dystrophy
5199149|NCT02749721|depression|depression
5199150|NCT02749721|brain network activation|brain network activation
5199151|NCT02749721|vortioxetine|vortioxetine
5199152|NCT02749708|IRX5183|irx5183
5199153|NCT02749708|relapsed/refractory AML|relapsed/refractory aml
5199154|NCT02749708|high-risk MDS|high-risk mds
5199155|NCT02749695|menopause, climacteric syndrome, insomnia, placental extract|menopause, climacteric syndrome, insomnia, placental extract
5962481|NCT04280692|CHMI|chmi
5199156|NCT02749682|Nyhus classification|nyhus classification
5199157|NCT02749682|constipation severity scale|constipation severity scale
5199158|NCT02749682|groin hernia|groin hernia
5199159|NCT02749669|Inappropriate hospitalization|inappropriate hospitalization
5199160|NCT02749669|elderly|elderly
5199161|NCT02749669|mild or moderate cognitive impairment|mild or moderate cognitive impairment
5199162|NCT02749669|qualitative research|qualitative research
5199163|NCT02749669|economic evaluation|economic evaluation
5199164|NCT02749656|Scalp psoriasis|scalp psoriasis
5199165|NCT02749656|0.25% Desoximetasone cream|0.25% desoximetasone cream
5199166|NCT02749591|stroke rehabilitation|stroke rehabilitation
5199167|NCT02749591|spasticity|spasticity
5199168|NCT02749591|Botulinum toxin type A injection|botulinum toxin type a injection
5199169|NCT02749591|robot-assisted therapy|robot-assisted therapy
5199170|NCT02749591|mirror therapy|mirror therapy
5199174|NCT02749565|airway remodeling|airway remodeling
5199176|NCT02749565|hypoxia|hypoxia
5199177|NCT02749539|Mastectomy|mastectomy
5199178|NCT02749539|Shoulder Pain|shoulder pain
5199179|NCT02749539|ROM|rom
5199180|NCT02749539|Kinesio Tape|kinesio tape
5199181|NCT02749526|Recombinant human endostatin，Endo|recombinant human endostatin，endo
5199182|NCT02749500|Motor control|motor control
5199183|NCT02749487|Critical Care|critical care
5199184|NCT02749487|Neutrophils|neutrophils
5199185|NCT02749487|Lymphocytes|lymphocytes
5199186|NCT02749461|preterm infants|preterm infants
5199187|NCT02749461|pain|pain
5199190|NCT02749461|diagnostic accuracy|diagnostic accuracy
5199191|NCT02749435|Digital disease management tool|digital disease management tool
5199192|NCT02749435|Type 2 diabetes mellitus/ T2DM|type 2 diabetes mellitus/ t2dm
5199193|NCT02749435|HbA1c|hba1c
5199194|NCT02749435|Standard care|standard care
5199195|NCT02749435|PRO questionnaires|pro questionnaires
5199196|NCT02749435|Smart phone/ personal computer with internet access|smart phone/ personal computer with internet access
5199197|NCT02749422|cognitive dysfunction|cognitive dysfunction
5199198|NCT02749422|memory loss|memory loss
5199199|NCT02749422|non-invasive transcranial magnetic stimulation (TMS)|non-invasive transcranial magnetic stimulation (tms)
5199200|NCT02749422|rTMS|rtms
5199201|NCT02749422|Magstim Rapid2|magstim rapid2
5199202|NCT02749357|gait|gait
5199203|NCT02749357|robotic orthosis|robotic orthosis
5199204|NCT02749344|Frozen Embryo Transfer, Progesterone, Endometrium|frozen embryo transfer, progesterone, endometrium
5199205|NCT02749318|Behavior Modification|behavior modification
5199206|NCT02749318|Genetic Testing|genetic testing
5199207|NCT02749318|Risk Management|risk management
5199208|NCT02749318|Oral Health Care|oral health care
5199212|NCT02749266|chiropractic, cognition|chiropractic, cognition
5199213|NCT02749253|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5199214|NCT02749253|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
5199215|NCT02749227|Clinically non-functioning pituitary adenomas (CNFAs)|clinically non-functioning pituitary adenomas (cnfas)
5199221|NCT02749188|Newborn|newborn
5199222|NCT02749188|Feasibility Studies|feasibility studies
5199223|NCT02749188|Bladder stimulation|bladder stimulation
5199224|NCT02749175|cricoid pressure|cricoid pressure
5199227|NCT02749149|Frailty|frailty
5199228|NCT02749149|Frail|frail
5199229|NCT02749149|Patients|patients
5199230|NCT02749149|Recovery|recovery
5199231|NCT02749149|Morbidity|morbidity
5199232|NCT02749149|Outcomes|outcomes
5199233|NCT02749149|Mortality|mortality
5199234|NCT02749149|Heart|heart
5199235|NCT02749149|Perioperative|perioperative
5199236|NCT02749149|Disability|disability
5199237|NCT02749149|WHODAS|whodas
5199238|NCT02749136|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5199239|NCT02749136|Borderline resectable|borderline resectable
5199240|NCT02749136|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5199241|NCT02749136|FOLFIRINOX|folfirinox
5199242|NCT02749110|Mass screening|mass screening
5199243|NCT02749110|Family medicine|family medicine
5199244|NCT02749110|Human Papillomavirus DNA tests|human papillomavirus dna tests
5199245|NCT02749110|Papanicolaou test|papanicolaou test
5199246|NCT02749110|Early detection of cancer/methods*|early detection of cancer/methods*
5199247|NCT02749110|Specimen Handling/methods*|specimen handling/methods*
5199248|NCT02749110|Patient compliance|patient compliance
5199249|NCT02749110|Adult|adult
5199250|NCT02749110|Female|female
5199251|NCT02749110|Humans|humans
5199252|NCT02749110|Randomized controlled trial|randomized controlled trial
5199253|NCT02749084|chronic graft versus host disease|chronic graft versus host disease
5199254|NCT02749084|T regulatory cell|t regulatory cell
5199255|NCT02749058|capsulectomy|capsulectomy
5199256|NCT02749058|capsulotomy|capsulotomy
5199257|NCT02749019|BBN-RGD|bbn-rgd
5199258|NCT02749019|GRPR|grpr
5199259|NCT02749019|integrin αvβ3|integrin αvβ3
5199264|NCT02748967|Healthy|healthy
5199265|NCT02748967|ExPEC4V|expec4v
5199266|NCT02748967|JNJ-63871860|jnj-63871860
5199267|NCT02748967|Safety|safety
5199268|NCT02748941|unstable/stable atherosclerotic plaque|unstable/stable atherosclerotic plaque
5199269|NCT02748941|HITS|hits
5199271|NCT02748941|CEUS|ceus
5199272|NCT02748941|HR MRI|hr mri
5067010|NCT03580044|BSI|bsi
5199273|NCT02748941|mi-RNA|mi-rna
5199274|NCT02748915|Cochlear Implant|cochlear implant
5199275|NCT02748915|ECAP|ecap
5199276|NCT02748915|EABR|eabr
5199277|NCT02748915|perceptual levels|perceptual levels
5199278|NCT02748915|hearing performances|hearing performances
5199279|NCT02748902|Verruca vulgaris|verruca vulgaris
5199280|NCT02748902|Common warts|common warts
5199281|NCT02748902|Verruca|verruca
5267415|NCT02346097|QRS|qrs
5187191|NCT02820012|ST2R|st2r
5187192|NCT02819986|occupational functioning|occupational functioning
5187193|NCT02819986|Worries|worries
5187194|NCT02819986|Pain|pain
5187195|NCT02819986|Disability|disability
5187202|NCT02819960|probiotics|probiotics
5187203|NCT02819960|irinotecan|irinotecan
5187204|NCT02819960|diarrhea|diarrhea
5199282|NCT02748902|Warts|warts
5199283|NCT02748902|Papilloma virus|papilloma virus
5199284|NCT02748902|ingenol mebutate 0.05% gel|ingenol mebutate 0.05% gel
5199285|NCT02748902|hands|hands
5199286|NCT02748889|SCLC|sclc
5199287|NCT02748889|Small Cell|small cell
5199288|NCT02748889|Lung Cancer|lung cancer
5199289|NCT02748889|MPDL3280A|mpdl3280a
5199290|NCT02748889|atezolizumab|atezolizumab
5199291|NCT02748863|psoriasis|psoriasis
5199292|NCT02748863|secukinumab|secukinumab
5199293|NCT02748863|pre-filled syringes|pre-filled syringes
5199302|NCT02748772|Endostar|endostar
5199303|NCT02748772|Thalidomide|thalidomide
5199304|NCT02748772|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5199305|NCT02748759|Continous Passive Motion|continous passive motion
5199306|NCT02748759|Manual Physical Therapy|manual physical therapy
5199307|NCT02748759|Range of Motion, Articular|range of motion, articular
5199308|NCT02748759|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5199309|NCT02748759|Rehabilitation|rehabilitation
5199310|NCT02748759|Kaltenborn Manual Therapy|kaltenborn manual therapy
5199311|NCT02748746|Lymphedema|lymphedema
5199312|NCT02748746|Electric Impedance|electric impedance
5199313|NCT02748746|Breast Cancer|breast cancer
5199314|NCT02748733|Adapted APD|adapted apd
5199315|NCT02748733|Dialytic Sodium Removal|dialytic sodium removal
5199316|NCT02748733|Ultrafiltration|ultrafiltration
5199317|NCT02748733|Clearance rate|clearance rate
5199318|NCT02748733|Intraperitoneal pressure|intraperitoneal pressure
5199319|NCT02748720|Premature|premature
5199320|NCT02748720|Respiratory Function Monitor|respiratory function monitor
5199321|NCT02748694|Drug Therapy|drug therapy
5199322|NCT02748681|obstructive sleep apnea|obstructive sleep apnea
5199323|NCT02748681|CPAP|cpap
5199324|NCT02748681|stroke|stroke
5199325|NCT02748681|telemedicine|telemedicine
5199326|NCT02748681|neurorehabilitation|neurorehabilitation
5199327|NCT02748681|systolic blood pressure|systolic blood pressure
5199328|NCT02748629|inguinal hernia|inguinal hernia
5199329|NCT02748629|mesh|mesh
5199330|NCT02748629|lichtenstein|lichtenstein
5199331|NCT02748629|hernia repair|hernia repair
5199332|NCT02748629|selfgripping mesh|selfgripping mesh
5199333|NCT02748616|Colitis|colitis
5199334|NCT02748616|Bile|bile
5199335|NCT02748577|Migraines|migraines
5199336|NCT02748577|Pain responses|pain responses
5199337|NCT02748551|Gastric cancer|gastric cancer
5199338|NCT02748551|locally advanced gastric cancer|locally advanced gastric cancer
5199339|NCT02748551|laparoscopic surgery|laparoscopic surgery
5199340|NCT02748551|laparoscopic procedure|laparoscopic procedure
5199341|NCT02748551|comparison laparoscopic with open procedure|comparison laparoscopic with open procedure
5199342|NCT02748551|multicenter trials|multicenter trials
5199343|NCT02748486|schizophrenia|schizophrenia
5199344|NCT02748486|randomized controlled trial|randomized controlled trial
5199345|NCT02748486|metacognitive training|metacognitive training
5199346|NCT02748486|single sessions|single sessions
5199347|NCT02748473|Pilates exercises|pilates exercises
5199348|NCT02748473|pelvic floor muscle contraction|pelvic floor muscle contraction
5199349|NCT02748434|iPro2 Continuous Blood Glucose Recorder|ipro2 continuous blood glucose recorder
5199350|NCT02748434|Subclinical|subclinical
5199351|NCT02748421|retina surgery|retina surgery
5199352|NCT02748421|image guided surgery|image guided surgery
5199353|NCT02748421|optical coherence tomography assisted|optical coherence tomography assisted
5199354|NCT02748369|TCA cycle flux|tca cycle flux
5199355|NCT02748369|in vivo measurements|in vivo measurements
5199356|NCT02748369|Stable isotopes|stable isotopes
5199357|NCT02748369|Arteriovenous balance|arteriovenous balance
5199358|NCT02748369|Metabolome|metabolome
5199359|NCT02748369|Proteome|proteome
5199360|NCT02748369|Exosomes|exosomes
5199361|NCT02748356|Spina Bifida|spina bifida
5199362|NCT02748356|Spinal Cord Injury|spinal cord injury
5199363|NCT02748317|Spina Bifida|spina bifida
5962482|NCT04280692|Challenge|challenge
5187289|NCT02819505|stimulation|stimulation
5187290|NCT02819505|skeletal muscle|skeletal muscle
5187291|NCT02819492|Adenoma|adenoma
5187292|NCT02819492|Colonoscopy|colonoscopy
5187293|NCT02819492|Withdrawal|withdrawal
5187294|NCT02819492|Proximal|proximal
5187295|NCT02819492|Observation Time|observation time
5187296|NCT02819479|Radiation necrosis|radiation necrosis
5075376|NCT03527693|Knee Chondropathy, Osteoarthritis, Micro-fragmented fat.|knee chondropathy, osteoarthritis, micro-fragmented fat.
5075377|NCT03527628|Stage II B Classical Hodgkin Lymphoma|stage ii b classical hodgkin lymphoma
5075378|NCT03527628|Stage III Classical Hodgkin Lymphoma|stage iii classical hodgkin lymphoma
5075379|NCT03527628|Stage IV Classical Hodgkin Lymphoma|stage iv classical hodgkin lymphoma
5075385|NCT03527589|PAE|pae
5187299|NCT02819479|Bevacizumab|bevacizumab
5199364|NCT02748317|Spinal Cord Injury|spinal cord injury
5199365|NCT02748317|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5199366|NCT02748317|Probiotics|probiotics
5199367|NCT02748317|Intermittent Catheterization|intermittent catheterization
5199368|NCT02748291|Sedentary|sedentary
5199369|NCT02748291|Knee osteoarthritis|knee osteoarthritis
5199370|NCT02748291|Knee pain|knee pain
5199371|NCT02748291|Gonarthritis|gonarthritis
5199372|NCT02748291|Arthritis|arthritis
5199381|NCT02748291|Increase function|increase function
5199382|NCT02748291|Activity Monitoring|activity monitoring
5199383|NCT02748291|Monitoring, Ambulatory/instrumentation|monitoring, ambulatory/instrumentation
5199384|NCT02748278|subfertility|subfertility
5199385|NCT02748278|In-vitro fertilization|in-vitro fertilization
5199386|NCT02748239|diabetes self-management education|diabetes self-management education
5199387|NCT02748239|insulin therapy|insulin therapy
5199389|NCT02748174|Curelator|curelator
5199390|NCT02748161|Hepatocellular carcinoma|hepatocellular carcinoma
5199391|NCT02748161|DEB-TACE|deb-tace
5199393|NCT02748148|Medication Therapy Management|medication therapy management
5199394|NCT02748148|Pharmacogenomics|pharmacogenomics
5199395|NCT02748122|Adolescents|adolescents
5199396|NCT02748122|Insulin|insulin
5199397|NCT02748122|T2DM|t2dm
5199398|NCT02748109|Physical Therapy|physical therapy
5199399|NCT02748109|Balance Disorder|balance disorder
5199400|NCT02748109|Concussion|concussion
5199401|NCT02748109|Mild Traumatic Brain Injury|mild traumatic brain injury
5199402|NCT02748096|Unicompartmental Knee Replacement|unicompartmental knee replacement
5199403|NCT02748096|Patient Specific Instrumentation|patient specific instrumentation
5199404|NCT02748083|tDCS|tdcs
5199405|NCT02748083|schizophrenia|schizophrenia
5199406|NCT02748083|cognition|cognition
5199407|NCT02748083|fMRI|fmri
5199408|NCT02748031|Congenital cataracts|congenital cataracts
5199409|NCT02748031|Opacity location|opacity location
5199410|NCT02748031|Opacity shape|opacity shape
5199411|NCT02748031|Classification|classification
5199412|NCT02748031|Clinical applicability|clinical applicability
5199413|NCT02748005|Fenugreek seed extract|fenugreek seed extract
5199414|NCT02748005|testosterone|testosterone
5199415|NCT02748005|protodioscin|protodioscin
5199416|NCT02748005|hypogonadism|hypogonadism
5199417|NCT02747979|hemodialysis|hemodialysis
5199418|NCT02747979|hyperparathyroidism|hyperparathyroidism
5199419|NCT02747979|refractory pruritus|refractory pruritus
5199420|NCT02747979|ostalgia|ostalgia
5199421|NCT02747979|insomnia|insomnia
5199422|NCT02747979|CVD incidence|cvd incidence
5199423|NCT02747979|life quality|life quality
5199424|NCT02747966|access flow|access flow
5199425|NCT02747966|access recirculation|access recirculation
5199426|NCT02747966|cardiac output|cardiac output
5199427|NCT02747966|cardiac index|cardiac index
5199428|NCT02747966|hemodialysis|hemodialysis
5199429|NCT02747927|Drug therapy|drug therapy
5199430|NCT02747901|KINESIOTAPING|kinesiotaping
5199431|NCT02747901|COLD THERAPY|cold therapy
5199432|NCT02747901|FUNCTIONAL PERFORMANCE|functional performance
5199433|NCT02747888|Thyroid|thyroid
5199434|NCT02747875|pediatric|pediatric
5199435|NCT02747875|cardiac bypass surgery|cardiac bypass surgery
5199436|NCT02747875|methadone|methadone
5199437|NCT02747875|fentanyl|fentanyl
5199438|NCT02747875|morphine|morphine
5199439|NCT02747862|Attenuated Familial Adenomatous Polyposis|attenuated familial adenomatous polyposis
5199440|NCT02747862|AFAP|afap
5199441|NCT02747862|Deleterious Familial Adenomatous Polyposis|deleterious familial adenomatous polyposis
5199443|NCT02747862|Chart review|chart review
5199444|NCT02747797|Advanced Cancer|advanced cancer
5199445|NCT02747797|Lucitanib (E3810)|lucitanib (e3810)
5199446|NCT02747797|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
5199447|NCT02747797|FGFR|fgfr
5187386|NCT02818855|Gingival recession|gingival recession
5187387|NCT02818855|Plastic surgery|plastic surgery
5187388|NCT02818855|Connective tissue graft|connective tissue graft
5187389|NCT02818855|Mucograft|mucograft
5187390|NCT02818842|Database|database
5187391|NCT02818842|Birth defects|birth defects
5187393|NCT02818829|Adenocarcinoma|adenocarcinoma
5199448|NCT02747797|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
5962483|NCT04280692|semi-immune adults|semi-immune adults
5962484|NCT04280679|HIFU|hifu
5962485|NCT04280679|High Intensity Focused Ultrasound|high intensity focused ultrasound
5962486|NCT04280666|Colorectal Cancer|colorectal cancer
5962487|NCT04280666|Next-generation sequencing|next-generation sequencing
5962488|NCT04280666|Genetic Susceptibility|genetic susceptibility
5962489|NCT04280627|microbiome|microbiome
5962490|NCT04280601|Vitamin D|vitamin d
5962491|NCT04280601|ANCA|anca
5962492|NCT04280601|Vasculitis|vasculitis
5075503|NCT03527121|Ankle|ankle
5075504|NCT03527121|Exercise|exercise
5075505|NCT03527121|Activities of daily living|activities of daily living
5075506|NCT03527121|Treatment outcome|treatment outcome
5199449|NCT02747797|VEGFR|vegfr
5199450|NCT02747797|Platelet Derived Growth Factor Receptor|platelet derived growth factor receptor
5199451|NCT02747797|PDGFR|pdgfr
5090568|NCT03432793|DDI|ddi
5199452|NCT02747797|metastatic malignancy|metastatic malignancy
5199453|NCT02747784|cognitive dysfunction|cognitive dysfunction
5199454|NCT02747784|cognitive training|cognitive training
5199455|NCT02747771|effectiveness|effectiveness
5199456|NCT02747771|trichotillomania|trichotillomania
5199464|NCT02747758|transcranial direct current stimulation|transcranial direct current stimulation
5199466|NCT02747745|Case Management|case management
5199467|NCT02747745|Community Dwelling|community dwelling
5199468|NCT02747706|peer mentor|peer mentor
5199469|NCT02747706|health coach|health coach
5199470|NCT02747706|parent support|parent support
5199471|NCT02747706|parent mentor|parent mentor
5199472|NCT02747680|type 1 diabetes|type 1 diabetes
5199473|NCT02747680|hypoglycemia unawareness|hypoglycemia unawareness
5199474|NCT02747680|healthy control|healthy control
5199475|NCT02747667|iol dislocation|iol dislocation
5199476|NCT02747667|iol complication|iol complication
5199477|NCT02747667|intraocular lens|intraocular lens
5199478|NCT02747667|Implant or Graft|implant or graft
5199480|NCT02747654|NAT2 genotype guided dosing|nat2 genotype guided dosing
5199481|NCT02747628|Transdermal nicotine|transdermal nicotine
5199482|NCT02747628|Transdermal melatonin|transdermal melatonin
5199483|NCT02747628|Postoperative pain|postoperative pain
5199484|NCT02747628|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5199485|NCT02747615|Preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit|preoperative autologous blood donation, allogeneic blood transfusion, parenteral iron, tranexamic acid, revision total hip arthroplasty, hemoglobin, hematocrit
5199486|NCT02747602|Healthy volunteers|healthy volunteers
5199487|NCT02747602|Caprylic triglyceride oil|caprylic triglyceride oil
5199488|NCT02747602|AC-1204|ac-1204
5199489|NCT02747602|Pharmacokinetic|pharmacokinetic
5199490|NCT02747602|Ketone body|ketone body
5199491|NCT02747576|Childhood Cancer Survivor|childhood cancer survivor
5199492|NCT02747576|Social-cognition|social-cognition
5199493|NCT02747576|Healthy Volunteers|healthy volunteers
5199494|NCT02747563|prostate cancer|prostate cancer
5199495|NCT02747563|PSA|psa
5199496|NCT02747563|digital rectal examination|digital rectal examination
5199497|NCT02747472|GIP|gip
5199498|NCT02747472|GIP receptor antagonist|gip receptor antagonist
5199499|NCT02747446|fructose, triglyceride, oral glucose tolerance|fructose, triglyceride, oral glucose tolerance
5199500|NCT02747433|robot-assisted therapy|robot-assisted therapy
5199501|NCT02747433|task-oriented training|task-oriented training
5199502|NCT02747433|motor learning|motor learning
5199503|NCT02747433|cognitive strategy training|cognitive strategy training
5199504|NCT02747420|Posterior Tibial Nerve Stimulation, Bladder|posterior tibial nerve stimulation, bladder
5199505|NCT02747368|Wet age-related macular degeneration|wet age-related macular degeneration
5199506|NCT02747368|Age-related macular degeneration|age-related macular degeneration
5199507|NCT02747368|Ocusweep|ocusweep
5199508|NCT02747368|Driving health|driving health
5199509|NCT02747368|Visual field|visual field
5199510|NCT02747368|Contrast sensitivity|contrast sensitivity
5199511|NCT02747342|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5199512|NCT02747329|BuMA Supreme|buma supreme
5199513|NCT02747329|Xience V/Prime|xience v/prime
5199514|NCT02747329|OCT|oct
5199515|NCT02747329|neointima formation|neointima formation
5199516|NCT02747316|Iron bioavailability|iron bioavailability
5199517|NCT02747316|Hepcidin|hepcidin
5199518|NCT02747316|Iron absorption|iron absorption
5199519|NCT02747303|brain metastases|brain metastases
5199520|NCT02747303|Stereotactic Radiosurgery|stereotactic radiosurgery
5199521|NCT02747290|BBN-RGD|bbn-rgd
5199522|NCT02747290|PET|pet
5199523|NCT02747290|integrin αvβ3|integrin αvβ3
5199524|NCT02747290|GRPR|grpr
5199525|NCT02747264|eRAPID|erapid
5187486|NCT02818361|Tripterygium|tripterygium
5187487|NCT02818361|Administration|administration
5187488|NCT02818361|Topical|topical
5187489|NCT02818348|HIV infection|hiv infection
5199527|NCT02747264|PROM|prom
5199528|NCT02747264|Adverse event|adverse event
5199529|NCT02747264|QTool|qtool
5199530|NCT02747264|CTCAE|ctcae
5199531|NCT02747251|"Shoulder Impingement Syndrome[Mesh]"|"shoulder impingement syndrome[mesh]"
5199532|NCT02747251|"Rehabilitation[Mesh]"|"rehabilitation[mesh]"
5199533|NCT02747251|"Exercise[Mesh]"|"exercise[mesh]"
5199534|NCT02747251|"Rotator Cuff[Mesh]"|"rotator cuff[mesh]"
5199535|NCT02747238|Pregnancy|pregnancy
5199536|NCT02747238|Epidural|epidural
5199537|NCT02747238|Labor|labor
5199538|NCT02747225|electrical properties|electrical properties
5199539|NCT02747225|malignant tissues|malignant tissues
5199546|NCT02747199|OCT|oct
5962493|NCT04280562|Neuropathic pain|neuropathic pain
5962494|NCT04280562|Pain|pain
5962495|NCT04280562|Wearable devices|wearable devices
5962496|NCT04280562|Pain management|pain management
5962497|NCT04280562|Neuromodulation|neuromodulation
5199547|NCT02747199|coronary angioscopy|coronary angioscopy
5199548|NCT02747199|coronary artery disease|coronary artery disease
5199549|NCT02747186|lidocaine, jaw|lidocaine, jaw
5090680|NCT03431987|Marijuana|marijuana
5199550|NCT02747173|metastatic, bone metastases|metastatic, bone metastases
5199551|NCT02747160|Cancer|cancer
5199552|NCT02747160|Anxiety|anxiety
5199553|NCT02747160|Cognitive behavior therapy|cognitive behavior therapy
5199554|NCT02747160|Elderly|elderly
5199555|NCT02747160|Caregivers|caregivers
5199556|NCT02747121|External inspections|external inspections
5199557|NCT02747108|Veterans|veterans
5199558|NCT02747108|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5199559|NCT02747108|Prediabetes|prediabetes
5199560|NCT02747108|Decision-making|decision-making
5199561|NCT02747108|Motivation|motivation
5199562|NCT02747108|Health Promotion|health promotion
5199563|NCT02747108|Prevention and Control|prevention and control
5199564|NCT02747095|CT|ct
5199565|NCT02747095|Spectral Images|spectral images
5199566|NCT02747082|endodontic retreatment|endodontic retreatment
5199567|NCT02747082|sodium hypochlorite|sodium hypochlorite
5199568|NCT02747082|chlorhexidine|chlorhexidine
5199569|NCT02747082|calcium hydroxide|calcium hydroxide
5199570|NCT02747082|Retreatment|retreatment
5199571|NCT02747069|Heart rate|heart rate
5199572|NCT02747069|Electronic Stethoscope|electronic stethoscope
5199573|NCT02747069|Electrocardiogram|electrocardiogram
5199574|NCT02747069|Resuscitation|resuscitation
5199575|NCT02747030|Central retinal vein occlusion|central retinal vein occlusion
5199576|NCT02747030|Retinal endovascular surgery|retinal endovascular surgery
5199577|NCT02747030|Retinal vein cannulation|retinal vein cannulation
5199578|NCT02747030|Ocriplasmin|ocriplasmin
5199579|NCT02747017|transplant|transplant
5199580|NCT02746965|magnetic seizure therapy|magnetic seizure therapy
5199581|NCT02746965|randomized controlled trials|randomized controlled trials
5199582|NCT02746965|schizophrenia|schizophrenia
5199583|NCT02746965|cognition|cognition
5199584|NCT02746939|program evaluation|program evaluation
5199585|NCT02746939|health literacy|health literacy
5199586|NCT02746939|fitness|fitness
5199587|NCT02746939|nutrition|nutrition
5199588|NCT02746939|education|education
5199589|NCT02746913|Pelvic, Urodynamic, Vaginal Wall|pelvic, urodynamic, vaginal wall
5199590|NCT02746874|Total Knee Replacement, Replacement of the knee joint,|total knee replacement, replacement of the knee joint,
5199591|NCT02746861|peer mentor|peer mentor
5199592|NCT02746861|peer supporter|peer supporter
5199593|NCT02746861|peer coach|peer coach
5199594|NCT02746861|peer-to-peer mentoring|peer-to-peer mentoring
5199595|NCT02746848|cornea epithelium healing Amniotic Membrane Eye Drop|cornea epithelium healing amniotic membrane eye drop
5199596|NCT02746835|physical condition|physical condition
5199597|NCT02746835|self-efficacy|self-efficacy
5199598|NCT02746835|fall risk|fall risk
5199599|NCT02746835|exercise program|exercise program
5199600|NCT02746822|acute myocardial infarction,|acute myocardial infarction,
5199601|NCT02746822|thrombus aspiration|thrombus aspiration
5199602|NCT02746679|Asherman syndrome|asherman syndrome
5199603|NCT02746679|Mindfulness|mindfulness
5199604|NCT02746679|Anxiety|anxiety
5199605|NCT02746679|Depression|depression
5199614|NCT02746588|Chronic infection|chronic infection
5199615|NCT02746562|Assisted reproduction|assisted reproduction
5199616|NCT02746562|In vitro fertilisation|in vitro fertilisation
5199617|NCT02746562|Frozen embryo transfer (FET)|frozen embryo transfer (fet)
5199618|NCT02746536|COPD|copd
5199619|NCT02746536|Inspiratory capacity|inspiratory capacity
5199620|NCT02746536|Exercise|exercise
5199621|NCT02746523|NHL|nhl
5199622|NCT02746523|Concussion|concussion
5199623|NCT02746523|Biomarkers|biomarkers
5199624|NCT02746497|Menopause|menopause
5199625|NCT02746497|Hot flushes|hot flushes
5199626|NCT02746497|Acupuncture|acupuncture
5199627|NCT02746497|Randomized controlled trial|randomized controlled trial
5199628|NCT02746458|Blood Flow Restriction|blood flow restriction
5199629|NCT02746458|Muscle Weakness|muscle weakness
5199630|NCT02746458|Physical therapy techniques|physical therapy techniques
5199631|NCT02746458|closed femoral fracture injuries|closed femoral fracture injuries
5199634|NCT02746445|Autism Spectrum Disorder|autism spectrum disorder
5199635|NCT02746432|CRC-Insulin|crc-insulin
5199636|NCT02746354|Chronic Pain|chronic pain
5199637|NCT02746354|Analgesics, Opioid|analgesics, opioid
5199638|NCT02746354|Primary Health Care|primary health care
5199639|NCT02746276|malnutrition|malnutrition
5199640|NCT02746276|antibiotics|antibiotics
5199641|NCT02746276|antimicrobial resistance|antimicrobial resistance
5199642|NCT02746276|pharmacokinetics|pharmacokinetics
5196032|NCT02768987|overweight|overweight
5199643|NCT02746263|Elective total knee arthroplasty|elective total knee arthroplasty
5199645|NCT02746237|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5199646|NCT02746237|Pharmacokinetics|pharmacokinetics
5199647|NCT02746237|Phase 1|phase 1
5199648|NCT02746237|Healthy Volunteers|healthy volunteers
5199649|NCT02746224|Colorectal cancer|colorectal cancer
5199650|NCT02746224|Colorectal surgery|colorectal surgery
5199651|NCT02746211|immunology|immunology
5199652|NCT02746211|pathogenicity|pathogenicity
5962498|NCT04280536|FTD/TPI|ftd/tpi
5962499|NCT04280536|TAS-102|tas-102
5199653|NCT02746198|Probiotics, Antibiotics, AAD, Helicobacter p.|probiotics, antibiotics, aad, helicobacter p.
5199654|NCT02746185|cancer|cancer
5199655|NCT02746185|venous thromboembolism|venous thromboembolism
5199656|NCT02746185|low-molecular weight heparin|low-molecular weight heparin
5199657|NCT02746185|rivaroxaban|rivaroxaban
5199658|NCT02746172|cochlear implants|cochlear implants
5199659|NCT02746172|Mapping|mapping
5199660|NCT02746172|in-situ audiometry|in-situ audiometry
5199661|NCT02746107|shared decision making|shared decision making
5199662|NCT02746107|oral anticoagulant|oral anticoagulant
5199663|NCT02746107|atrial fibrillation|atrial fibrillation
5199664|NCT02746107|stroke|stroke
5199665|NCT02746107|decision to treat|decision to treat
5199676|NCT02746068|Bone Marrow Lesions|bone marrow lesions
5199677|NCT02746068|AXS02|axs02
5199678|NCT02746068|Axsome|axsome
5199679|NCT02746068|Knee OA|knee oa
5199680|NCT02746068|Osteoarthritis|osteoarthritis
5199681|NCT02746042|chronic rhinosinusitis|chronic rhinosinusitis
5199682|NCT02746042|Sinupret extract|sinupret extract
5199683|NCT02746042|herbal medicinal product|herbal medicinal product
5199684|NCT02746003|drinking water|drinking water
5199685|NCT02746003|salinity|salinity
5199686|NCT02745990|erythropoietin|erythropoietin
5199687|NCT02745990|preterm|preterm
5199688|NCT02745990|brain injury|brain injury
5199689|NCT02745990|cerebral palsy|cerebral palsy
5199690|NCT02745990|PVL|pvl
5199691|NCT02745951|cardiopulmonary bypass|cardiopulmonary bypass
5199692|NCT02745951|cardioplegia|cardioplegia
5199693|NCT02745951|cardioprotection|cardioprotection
5199694|NCT02745951|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5199695|NCT02745951|heliox|heliox
5199696|NCT02745938|Exercise test|exercise test
5199697|NCT02745938|GDF-15|gdf-15
5199698|NCT02745938|Growth and Differentiation Factor 15|growth and differentiation factor 15
5199699|NCT02745925|Iron bioavailability|iron bioavailability
5199700|NCT02745925|Inflammation|inflammation
5199701|NCT02745925|Hepcidin|hepcidin
5199702|NCT02745925|Iron absorption|iron absorption
5199703|NCT02745912|Drug Therapy|drug therapy
5199704|NCT02745899|asthma|asthma
5199705|NCT02745899|cow milk|cow milk
5199706|NCT02745899|pulmonary function testing|pulmonary function testing
5283322|NCT02255331|Hip|hip
5199707|NCT02745899|children|children
5199708|NCT02745899|mucus|mucus
5199709|NCT02745860|selexipag|selexipag
5199710|NCT02745860|pharmacokinetics|pharmacokinetics
5199711|NCT02745821|coronary flow reserve|coronary flow reserve
5199712|NCT02745821|fractional flow reserve|fractional flow reserve
5199713|NCT02745821|diabetes mellitus|diabetes mellitus
5199714|NCT02745821|coronary artery disease|coronary artery disease
5199715|NCT02745821|percutaneous coronary intervention|percutaneous coronary intervention
5199716|NCT02745821|coronary physiology|coronary physiology
5199717|NCT02745821|index of microcirculatory resistance|index of microcirculatory resistance
5199718|NCT02745795|Motivational interview|motivational interview
5199719|NCT02745795|adolescents|adolescents
5199720|NCT02745795|obesity|obesity
5199721|NCT02745795|overweight|overweight
5199722|NCT02745795|physical activity|physical activity
5199723|NCT02745795|diet|diet
5199724|NCT02745782|Pulpitis|pulpitis
5199725|NCT02745782|Syncope|syncope
5199726|NCT02745782|Trigeminal Cardio-Reflex|trigeminal cardio-reflex
5199727|NCT02745756|Children|children
5199728|NCT02745756|Cancer|cancer
5199729|NCT02745756|High-risk neuroblastoma|high-risk neuroblastoma
5199730|NCT02745743|Phase 1|phase 1
5199731|NCT02745743|Dose escalation|dose escalation
5199732|NCT02745743|Dose expansion|dose expansion
5199733|NCT02745743|Positive transcription elongation factor b inhibitor|positive transcription elongation factor b inhibitor
5199734|NCT02745743|Cyclin-dependent kinase 9 inhibitor|cyclin-dependent kinase 9 inhibitor
5199735|NCT02745717|Severe aplastic anemia|severe aplastic anemia
5199736|NCT02745717|immunosuppressive therapy|immunosuppressive therapy
5199737|NCT02745717|cord blood transfusion|cord blood transfusion
5199738|NCT02745704|chronic hepatitis B|chronic hepatitis b
5199739|NCT02745704|peginterferon alfa|peginterferon alfa
5199740|NCT02745691|quality of life|quality of life
5199741|NCT02745691|psychometric validation|psychometric validation
5199742|NCT02745691|international field study|international field study
5199743|NCT02745691|patient-reported outcome (PRO)|patient-reported outcome (pro)
5199745|NCT02745678|Ulcerative Colitis|ulcerative colitis
5199746|NCT02745652|median nerve|median nerve
5199747|NCT02745652|wrist joint|wrist joint
5199748|NCT02745652|carpal tunnel|carpal tunnel
5199749|NCT02745639|rectal cancer|rectal cancer
5199750|NCT02745639|radiotherapy|radiotherapy
5199751|NCT02745639|chemotherapy|chemotherapy
5199752|NCT02745639|VMAT|vmat
5199753|NCT02745639|toxicity|toxicity
5199755|NCT02745600|Liver|liver
5199756|NCT02745600|Ablation Techniques|ablation techniques
5199757|NCT02745600|Treatment Simulation|treatment simulation
5199758|NCT02745600|Computer assisted therapy|computer assisted therapy
5199759|NCT02745574|should and upper abdominal pain, post-laparoscopy|should and upper abdominal pain, post-laparoscopy
5090907|NCT03430206|oxygen|oxygen
5199760|NCT02745561|Endostatin|endostatin
5199761|NCT02745561|Oxaliplatin|oxaliplatin
5962500|NCT04280510|Celiac Disease|celiac disease
5199762|NCT02745561|Esophageal Cancer|esophageal cancer
5199763|NCT02745561|chemoradiotherapy|chemoradiotherapy
5199764|NCT02745548|Lung Cancer|lung cancer
5199765|NCT02745548|NSCLC (Non Small Cell Lung Cancer)|nsclc (non small cell lung cancer)
5199766|NCT02745548|SABR (Stereotactic ablative radiotherapy)|sabr (stereotactic ablative radiotherapy)
5199767|NCT02745535|Hepatitis C relapse|hepatitis c relapse
5199768|NCT02745522|Placebo effect|placebo effect
5199769|NCT02745522|Working memory|working memory
5199770|NCT02745509|Extensive Intraoperative Peritoneal Lavage|extensive intraoperative peritoneal lavage
5199771|NCT02745509|EIPL|eipl
5199772|NCT02745509|Gastric Cancer|gastric cancer
5199773|NCT02745496|Image-guided biopsy|image-guided biopsy
5199774|NCT02745496|Tumour detection|tumour detection
5199775|NCT02745496|Diagnostic|diagnostic
5199776|NCT02745496|Biomarkers|biomarkers
5199778|NCT02745470|lean/obese diabetes mellitus|lean/obese diabetes mellitus
5199779|NCT02745470|functional MRI|functional mri
5199780|NCT02745470|GLP-1|glp-1
5199781|NCT02745470|appetite|appetite
5199782|NCT02745470|activation of brain|activation of brain
5199783|NCT02745470|connectivity|connectivity
5199784|NCT02745444|Living kidney transplantation|living kidney transplantation
5199785|NCT02745444|Chronic kidney disease|chronic kidney disease
5199786|NCT02745444|Acute kidney injury|acute kidney injury
5199787|NCT02745431|Likeability|likeability
5199788|NCT02745431|Being liked|being liked
5199789|NCT02745405|Weight Stigma|weight stigma
5199790|NCT02745405|Cortisol Reactivity|cortisol reactivity
5199791|NCT02745405|Eating Behavior|eating behavior
5199792|NCT02745392|migraine|migraine
5199793|NCT02745392|migraine headache|migraine headache
5199794|NCT02745392|acute migraine|acute migraine
5199795|NCT02745392|acute migraine headache|acute migraine headache
5199796|NCT02745353|Cancer|cancer
5199797|NCT02745353|Constipation|constipation
5199798|NCT02745353|Opioid|opioid
5199799|NCT02745327|oral vaccination|oral vaccination
5199800|NCT02745327|nutrition|nutrition
5199801|NCT02745314|Aortic Stenosis, Frailty, Elderly, moertality|aortic stenosis, frailty, elderly, moertality
5199802|NCT02745275|Peer Education|peer education
5199803|NCT02745275|Health Coaches|health coaches
5283406|NCT02255032|CME|cme
5199804|NCT02745275|Community Dwelling Seniors|community dwelling seniors
5199805|NCT02745275|Health Literacy|health literacy
5199806|NCT02745275|Health Education|health education
5199807|NCT02745275|Healthy Ageing|healthy ageing
5199808|NCT02745236|Atrial Fibrillation|atrial fibrillation
5199809|NCT02745236|Health Related Quality of Life|health related quality of life
5199810|NCT02745236|Nurse Practitioner|nurse practitioner
5199811|NCT02745236|Sustainable Models of Healthcare|sustainable models of healthcare
5199812|NCT02745236|Patient Satisfaction|patient satisfaction
5199813|NCT02745171|Parkinson's disease|parkinson's disease
5199814|NCT02745171|Quality of life|quality of life
5199815|NCT02745171|Functional mobility|functional mobility
5199816|NCT02745171|Follow up|follow up
5199817|NCT02745158|Fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva
5199818|NCT02745158|FOP|fop
5199819|NCT02745158|International FOP Association|international fop association
5199820|NCT02745158|Patient Advocacy Group|patient advocacy group
5199821|NCT02745158|Patient Registry|patient registry
5199822|NCT02745158|Natural History|natural history
5199823|NCT02745158|Patient-Reported Outcomes|patient-reported outcomes
5199824|NCT02745158|Observational Database|observational database
5199825|NCT02745158|Bone Morphogenetic Protein|bone morphogenetic protein
5199826|NCT02745158|BMP|bmp
5199827|NCT02745158|Bone Growth|bone growth
5199828|NCT02745158|Joint|joint
5199829|NCT02745158|Mobility|mobility
5199830|NCT02745158|Flare-Up|flare-up
5199831|NCT02745158|Heterotopic Ossification|heterotopic ossification
5187779|NCT02816632|Feedback Processing|feedback processing
5187780|NCT02816632|Reward, Social, Vestibular System|reward, social, vestibular system
5187781|NCT02816632|Cingulate Cortex|cingulate cortex
5187782|NCT02816632|Decision-making|decision-making
5199832|NCT02745158|Ectopic Bone|ectopic bone
5199833|NCT02745158|Osteochondroma|osteochondroma
5199834|NCT02745158|Hallux Valgus|hallux valgus
5199835|NCT02745158|ALK2|alk2
5199836|NCT02745158|ACVR1|acvr1
5199837|NCT02745158|Activin A|activin a
5199838|NCT02745158|IFOPA|ifopa
5199839|NCT02745158|Activin A Receptor Type I|activin a receptor type i
5199840|NCT02745158|Activin Receptor-like Kinase-2|activin receptor-like kinase-2
5199841|NCT02745145|Double-Blind Method|double-blind method
5199842|NCT02745145|Interstitial Lung Diseases|interstitial lung diseases
5199843|NCT02745145|Systemic Scleroderma|systemic scleroderma
5199845|NCT02745145|Mycophenolate|mycophenolate
5199846|NCT02745145|Efficacy, Safety|efficacy, safety
5199853|NCT02745106|Chronic thromboembolic pulmonary hypertension, Navigation system, Ablation|chronic thromboembolic pulmonary hypertension, navigation system, ablation
5199854|NCT02745093|Abortion induced|abortion induced
5199855|NCT02745093|Patient Acceptance of Healthcare|patient acceptance of healthcare
5199856|NCT02745093|safety|safety
5199857|NCT02745093|effectiveness|effectiveness
5199858|NCT02745093|misoprostol|misoprostol
5199859|NCT02745093|mifepristone|mifepristone
5962501|NCT04280510|Autoimmune enteropathy|autoimmune enteropathy
5075953|NCT03524326|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5075954|NCT03524326|17-635|17-635
5075955|NCT03524313|cardiac output|cardiac output
5075956|NCT03524313|end tidal carbon monoxide|end tidal carbon monoxide
5075957|NCT03524313|echocardiography|echocardiography
5199860|NCT02745080|Psoriatic Arthritis|psoriatic arthritis
5199861|NCT02745080|secukinumab|secukinumab
5199862|NCT02745080|adalimumab|adalimumab
5199863|NCT02745080|monoclonal antibody|monoclonal antibody
5199864|NCT02745080|CASPAR|caspar
5199865|NCT02745054|oral anticoagulants|oral anticoagulants
5199866|NCT02745054|bleeding|bleeding
5199867|NCT02745054|anticoagulation reversal|anticoagulation reversal
5199868|NCT02745041|Fibrinogen|fibrinogen
5199869|NCT02745041|Cryoprecipitate|cryoprecipitate
5199870|NCT02745028|delayed gastric emptying|delayed gastric emptying
5199871|NCT02745028|children|children
5199872|NCT02745028|monosodium glutamate|monosodium glutamate
5199873|NCT02745015|periodontitis|periodontitis
5199874|NCT02745015|diabetes|diabetes
5199875|NCT02745015|HbA1c|hba1c
5199876|NCT02745015|inflammation|inflammation
5199877|NCT02745002|Bronchoscopy|bronchoscopy
5199878|NCT02745002|Bronchoscopes|bronchoscopes
5199879|NCT02744989|Schizophrenia|schizophrenia
5199880|NCT02744989|Transcranial direct-current stimulation (tDCS)|transcranial direct-current stimulation (tdcs)
5199881|NCT02744989|Sham|sham
5199882|NCT02744989|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
5199883|NCT02744989|Functional Magnetic Resonance Imaging (fRMI)|functional magnetic resonance imaging (frmi)
5199884|NCT02744989|Brain-Derived-Neurotrophic Factor (BDNF)|brain-derived-neurotrophic factor (bdnf)
5199885|NCT02744976|Coronary artery disease|coronary artery disease
5199886|NCT02744976|Atherosclerosis|atherosclerosis
5199887|NCT02744976|Prediabetes|prediabetes
5199888|NCT02744976|Intravascular ultrasound|intravascular ultrasound
5199889|NCT02744976|Insulin resistance|insulin resistance
5199890|NCT02744976|Percutaneous coronary intervention|percutaneous coronary intervention
5199891|NCT02744976|Metformin|metformin
5199892|NCT02744950|pulley|pulley
5199893|NCT02744950|scalp defects|scalp defects
5199894|NCT02744911|speech problems|speech problems
5199895|NCT02744898|uterus|uterus
5199896|NCT02744898|gynecological|gynecological
5199897|NCT02744898|corpus uteri|corpus uteri
5199898|NCT02744872|lung transplantation|lung transplantation
5199899|NCT02744872|chronic renal insufficiency|chronic renal insufficiency
5199900|NCT02744859|Decision Making|decision making
5199901|NCT02744859|Consumption|consumption
5199902|NCT02744859|Economics|economics
5199903|NCT02744846|antibiotics|antibiotics
5199904|NCT02744846|children|children
5199905|NCT02744846|pediatric|pediatric
5199906|NCT02744846|body mass index|body mass index
5199907|NCT02744846|Observational Study|observational study
5199908|NCT02744846|Comparative Effectiveness Research|comparative effectiveness research
5199909|NCT02744846|Obesity|obesity
5199910|NCT02744846|Growth Trajectory|growth trajectory
5199911|NCT02744846|Cohort Study|cohort study
5199912|NCT02744846|Electronic Medical Record|electronic medical record
5199913|NCT02744846|Qualitative Research|qualitative research
5199914|NCT02744833|DVT|dvt
5199915|NCT02744807|intrauterine adhesions|intrauterine adhesions
5199916|NCT02744807|Chronic endometritis|chronic endometritis
5199917|NCT02744807|infections|infections
5199918|NCT02744807|Hysteroscopy|hysteroscopy
5199919|NCT02744781|Muscular Atrophy|muscular atrophy
5199920|NCT02744781|Asymmetry|asymmetry
5199921|NCT02744781|Athletes|athletes
5199922|NCT02744768|Acute Lymphoblastic Leukemia, adult, dasatinib, blinatumomab|acute lymphoblastic leukemia, adult, dasatinib, blinatumomab
5199923|NCT02744716|intrauterine balloon|intrauterine balloon
5199924|NCT02744716|uterine endometrial repair|uterine endometrial repair
5199925|NCT02744716|intrauterine adhesion|intrauterine adhesion
5199926|NCT02744716|aspirin|aspirin
5199927|NCT02744690|Eye Disease|eye disease
5199928|NCT02744690|Intraocular Pressure|intraocular pressure
5199929|NCT02744690|Visual Acuity|visual acuity
5199930|NCT02744690|Trabeculectomy|trabeculectomy
5199931|NCT02744677|Tetralogy of Fallot|tetralogy of fallot
5199932|NCT02744677|Aortic Valve Defect/Disease Resulting in Ross Procedure|aortic valve defect/disease resulting in ross procedure
5199933|NCT02744677|Pulmonary Atresia|pulmonary atresia
5199934|NCT02744677|Pulmonary Stenosis|pulmonary stenosis
5199935|NCT02744677|Truncus Arteriosus|truncus arteriosus
5199936|NCT02744677|Transposition of the Great Arteries|transposition of the great arteries
5199937|NCT02744677|Transcatheter pulmonary valve implantation|transcatheter pulmonary valve implantation
5199938|NCT02744677|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
5199940|NCT02744677|TPVR|tpvr
5199941|NCT02744677|TPVI|tpvi
5199942|NCT02744664|Lung Neoplasms|lung neoplasms
5199943|NCT02744664|EGFR mutation|egfr mutation
5199944|NCT02744664|Cryotherapy|cryotherapy
5199945|NCT02744664|Icotinib|icotinib
5962502|NCT04280510|Primary immunodeficiency|primary immunodeficiency
5962503|NCT04280510|Intestinal lymphoma|intestinal lymphoma
5962504|NCT04280510|Liver autoimmune diseases|liver autoimmune diseases
5962505|NCT04280497|Sepsis|sepsis
5962506|NCT04280497|Corticosteroid|corticosteroid
5962507|NCT04280497|intensive care unit|intensive care unit
5962508|NCT04280497|CS-resistant Sepsis|cs-resistant sepsis
5067722|NCT03575871|JAK|jak
5199946|NCT02744638|bacterial vaginosis|bacterial vaginosis
5199947|NCT02744638|probiotics|probiotics
5199948|NCT02744638|Amsel Score|amsel score
5199949|NCT02744638|Nugent Score|nugent score
5199950|NCT02744599|Feasibility trial|feasibility trial
5199951|NCT02744586|Sexually transmitted infections|sexually transmitted infections
5199952|NCT02744586|Neglected tropical diseases|neglected tropical diseases
5199953|NCT02744586|Non-communicable diseases|non-communicable diseases
5199954|NCT02744534|Prostate Cancer|prostate cancer
5199955|NCT02744534|Imaging Technology|imaging technology
5199956|NCT02744534|Oncology|oncology
5199957|NCT02744534|Prostate Biopsy|prostate biopsy
5199958|NCT02744508|palonosetron, dexamethasone, PONV (postoperative nausea and vomiting)|palonosetron, dexamethasone, ponv (postoperative nausea and vomiting)
5199959|NCT02744495|cardiac surgery|cardiac surgery
5199960|NCT02744495|corticoids|corticoids
5199961|NCT02744495|droperidol|droperidol
5199962|NCT02744495|antiemetics|antiemetics
5199963|NCT02744495|Postoperative Vomiting|postoperative vomiting
5199964|NCT02744495|Postoperative Nausea|postoperative nausea
5199965|NCT02744495|Postoperative Emesis|postoperative emesis
5199966|NCT02744495|prophylaxis|prophylaxis
5199967|NCT02744469|Tuberculosis|tuberculosis
5199968|NCT02744469|population structure|population structure
5199969|NCT02744469|implications|implications
5199970|NCT02744469|lineages|lineages
5199971|NCT02744469|spoligotyping|spoligotyping
5199972|NCT02744469|sputum|sputum
5199973|NCT02744469|resistance|resistance
5199974|NCT02744469|culture|culture
5199975|NCT02744469|diagnostics|diagnostics
5199976|NCT02744469|outcome|outcome
5199977|NCT02744469|new/retreatment patient|new/retreatment patient
5199978|NCT02744456|Hydrochlorothiazide tablet|hydrochlorothiazide tablet
5199979|NCT02744456|Norvasc|norvasc
5199980|NCT02744456|Cozaar|cozaar
5199981|NCT02744456|amlodipine besylate tablets|amlodipine besylate tablets
5199982|NCT02744456|losartan potassium tablets|losartan potassium tablets
5199983|NCT02744456|Hypertension|hypertension
5199984|NCT02744456|High Blood Pressure|high blood pressure
5199985|NCT02744430|Medical expulsive therapy|medical expulsive therapy
5199986|NCT02744430|ureteral stone|ureteral stone
5199987|NCT02744430|stent pain|stent pain
5199988|NCT02744417|smoking cessation|smoking cessation
5199989|NCT02744417|tobacco|tobacco
5199990|NCT02744417|periodontal|periodontal
5199991|NCT02744417|subgingival microorganisms|subgingival microorganisms
5199992|NCT02744352|infraclavicular brachial plexus block|infraclavicular brachial plexus block
5673922|NCT00606125|Paclitaxel|paclitaxel
5199993|NCT02744352|quality of recovery score|quality of recovery score
5199995|NCT02744352|disability assessment of shoulder and hand questionnaire|disability assessment of shoulder and hand questionnaire
5199996|NCT02744339|PH-HFpEF|ph-hfpef
5199997|NCT02744300|Gestational diabetes mellitus (GDM) in most recent pregnancy|gestational diabetes mellitus (gdm) in most recent pregnancy
5199998|NCT02744287|prostate stem cell antigen|prostate stem cell antigen
5199999|NCT02744287|BPX-601|bpx-601
5200000|NCT02744287|AP1903|ap1903
5200001|NCT02744287|CAR T|car t
5200002|NCT02744287|PSCA-CAR|psca-car
5200003|NCT02744287|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5200004|NCT02744287|rimiducid|rimiducid
5200005|NCT02744287|gastric cancer|gastric cancer
5200006|NCT02744287|gastroesophageal junction cancer|gastroesophageal junction cancer
5200007|NCT02744287|pancreatic cancer|pancreatic cancer
5200008|NCT02744274|acupuncture|acupuncture
5200009|NCT02744274|chemotherapy|chemotherapy
5200010|NCT02744274|peripheral neuropathy|peripheral neuropathy
5200011|NCT02744274|randomized clinical trial|randomized clinical trial
5200012|NCT02744274|numbness|numbness
5187977|NCT02815514|percutaneous aortic valve replacement|percutaneous aortic valve replacement
5187978|NCT02815514|aortic valve valvuloplasty|aortic valve valvuloplasty
5187979|NCT02815501|Thyroid dysfunction|thyroid dysfunction
5187980|NCT02815501|obstetric complications|obstetric complications
5187981|NCT02815462|Frequent hospital admissions|frequent hospital admissions
5187982|NCT02815462|Risk stratification|risk stratification
5187983|NCT02815462|Readmissions|readmissions
5187984|NCT02815449|Iron fortification|iron fortification
5187985|NCT02815449|Bioavailability|bioavailability
5187986|NCT02815449|Nigeria|nigeria
5187987|NCT02815449|Women|women
5187988|NCT02815449|Bouillon cubes|bouillon cubes
5187989|NCT02815410|Glioblastoma Multiforme|glioblastoma multiforme
5188000|NCT02815293|EDE|ede
5200013|NCT02744261|HIV|hiv
5200014|NCT02744261|STI|sti
5200015|NCT02744261|Primary Prevention|primary prevention
5200016|NCT02744261|Topical Microbicides|topical microbicides
5196461|NCT02766049|HIV|hiv
5200035|NCT02744131|PCOS|pcos
5200036|NCT02744131|Metformin|metformin
5200037|NCT02744131|OCP|ocp
5200038|NCT02744131|metabolic parameters|metabolic parameters
5200039|NCT02744118|Media Use|media use
5200040|NCT02744092|Rivaroxaban (Xarelto)|rivaroxaban (xarelto)
5200041|NCT02744092|Apixaban (Eliquis)|apixaban (eliquis)
5200042|NCT02744092|Edoxaban (Savaysa)|edoxaban (savaysa)
5200043|NCT02744092|Dabigatran (Pradaxa)|dabigatran (pradaxa)
5200044|NCT02744092|Warfarin (Coumadin)|warfarin (coumadin)
5962509|NCT04280497|CS-sensitive Sepsis|cs-sensitive sepsis
5200045|NCT02744092|Low molecular weight heparin (LMWH)|low molecular weight heparin (lmwh)
5200046|NCT02744079|diet|diet
5200047|NCT02744079|dietary intervention|dietary intervention
5200048|NCT02744079|carbohydrate restriction|carbohydrate restriction
5200049|NCT02744079|low carbohydrate|low carbohydrate
5200050|NCT02744079|fat restriction|fat restriction
5200051|NCT02744079|low fat|low fat
5200052|NCT02744079|cancer|cancer
5200053|NCT02744079|breast cancer|breast cancer
5200054|NCT02744079|pre-surgical window|pre-surgical window
5200055|NCT02744079|biomarker|biomarker
5200056|NCT02744040|HIV reservoir|hiv reservoir
5200057|NCT02744040|alcohol|alcohol
5200058|NCT02744040|ART|art
5200059|NCT02744027|Generalized Lymphatic Anomaly|generalized lymphatic anomaly
5200060|NCT02744027|Kaposiform Lymphangiomatosis|kaposiform lymphangiomatosis
5200061|NCT02744027|Dynamic Contrast Enhanced Magnetic Resonance Lymphangiogram|dynamic contrast enhanced magnetic resonance lymphangiogram
5200062|NCT02744027|Magnetic Resonance Imaging|magnetic resonance imaging
5200063|NCT02743988|cerebral oxygenation|cerebral oxygenation
5200064|NCT02743988|NIRS|nirs
5200065|NCT02743988|near-infrared spectroscopy|near-infrared spectroscopy
5200066|NCT02743988|bradycardia|bradycardia
5200067|NCT02743988|hypoxemia|hypoxemia
5200068|NCT02743988|cerebral perfusion|cerebral perfusion
5200069|NCT02743988|cardiac output|cardiac output
5200070|NCT02743988|apnea|apnea
5200071|NCT02743988|desaturation|desaturation
5200072|NCT02743988|oxygen saturation target range|oxygen saturation target range
5200074|NCT02743910|preoperative|preoperative
5200075|NCT02743910|neoadjuvant|neoadjuvant
5200076|NCT02743910|plasma tumor DNA|plasma tumor dna
5200077|NCT02743910|ptDNA|ptdna
5200078|NCT02743897|end-stage renal disease|end-stage renal disease
5200079|NCT02743871|FIH, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, Atopic Dermatitis, Chronic Rhinosinusitis, Nasal Polyps|fih, pharmacokinetics, pharmacodynamics, safety, tolerability, atopic dermatitis, chronic rhinosinusitis, nasal polyps
5200080|NCT02743858|Lymphedema|lymphedema
5200081|NCT02743858|Surveillance Program|surveillance program
5200082|NCT02743858|Axillary Lymph Node Dissection|axillary lymph node dissection
5200083|NCT02743858|16-220|16-220
5200084|NCT02743845|Rare|rare
5200085|NCT02743845|Undiagnosed|undiagnosed
5200086|NCT02743845|Orphan Disease|orphan disease
5200087|NCT02743845|Genomic Sequencing|genomic sequencing
5200088|NCT02743832|Surgery, Oral|surgery, oral
5200097|NCT02743780|Ocular Hypertension|ocular hypertension
5200098|NCT02743780|Open-Angle Glaucoma|open-angle glaucoma
5200099|NCT02743780|POAG|poag
5200100|NCT02743780|Glaucoma|glaucoma
5200101|NCT02743767|Airway management|airway management
5200102|NCT02743767|General anaesthesia|general anaesthesia
5200103|NCT02743767|Critical incidents|critical incidents
5200104|NCT02743767|Complications|complications
5862728|NCT00001534|Diastolic Dysfunction|diastolic dysfunction
5200106|NCT02743728|perinatal stroke|perinatal stroke
5200107|NCT02743728|transcranial magnetic stimulation|transcranial magnetic stimulation
5200108|NCT02743728|magnetic resonance imaging|magnetic resonance imaging
5200109|NCT02743728|diffusion tensor imaging|diffusion tensor imaging
5200110|NCT02743728|non-invasive brain stimulation|non-invasive brain stimulation
5200111|NCT02743728|infant|infant
5200112|NCT02743715|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5200113|NCT02743715|Transcranial direct current stimulation|transcranial direct current stimulation
5200114|NCT02743715|Neuromodulation|neuromodulation
5200115|NCT02743702|Effectiveness|effectiveness
5200116|NCT02743702|Physical therapy modalities|physical therapy modalities
5200117|NCT02743702|neuromuscular diseases|neuromuscular diseases
5200118|NCT02743689|Postoperative|postoperative
5200119|NCT02743689|Cardiac surgery|cardiac surgery
5200120|NCT02743676|Avian Influenza|avian influenza
5200121|NCT02743663|pediatric|pediatric
5200122|NCT02743663|lung ventilation inhomogeneity|lung ventilation inhomogeneity
5200123|NCT02743663|preschool|preschool
5200124|NCT02743663|asthma|asthma
5200125|NCT02743663|wheeze|wheeze
5200126|NCT02743650|Low Serum Bicarbonate Level|low serum bicarbonate level
5200127|NCT02743650|Sodium Bicarbonate|sodium bicarbonate
5200128|NCT02743637|Cancer|cancer
5200129|NCT02743637|Oncology|oncology
5200130|NCT02743637|Solid Tumors|solid tumors
5200131|NCT02743637|Phase 1|phase 1
5200132|NCT02743637|SDX-7320|sdx-7320
5200133|NCT02743637|SynDevRx|syndevrx
5200134|NCT02743637|MetAP2|metap2
5200135|NCT02743637|Breast|breast
5200136|NCT02743637|Post menopausal|post menopausal
5200137|NCT02743637|Colorectal|colorectal
5200138|NCT02743637|Pancreatic|pancreatic
5200139|NCT02743637|Ovarian|ovarian
5200140|NCT02743637|Endometrial|endometrial
5200141|NCT02743637|Esophageal|esophageal
5200142|NCT02743637|Lung|lung
5200143|NCT02743637|Renal|renal
5200144|NCT02743637|Prostate|prostate
5200145|NCT02743637|Liver|liver
5200146|NCT02743611|BPX-701|bpx-701
5200147|NCT02743611|AP1903|ap1903
5200148|NCT02743611|rimiducid|rimiducid
5200149|NCT02743611|AML|aml
5200150|NCT02743611|MDS|mds
5200151|NCT02743611|relapsed AML|relapsed aml
5200152|NCT02743611|uveal melanoma|uveal melanoma
5200153|NCT02743611|PRAME|prame
5200158|NCT02743572|premature infant|premature infant
5200159|NCT02743572|anemia|anemia
5200160|NCT02743572|iron-fortification|iron-fortification
5200161|NCT02743572|parenteral nutrition|parenteral nutrition
5200162|NCT02743572|randomized controlled trial|randomized controlled trial
5200163|NCT02743546|B-Cell, Malignancy|b-cell, malignancy
5200164|NCT02743546|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5200165|NCT02743546|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5200166|NCT02743546|Lymphoma, Follicular|lymphoma, follicular
5200167|NCT02743546|Lymphocytic, Chronic, B-Cell|lymphocytic, chronic, b-cell
5200168|NCT02743546|JNJ-64052781|jnj-64052781
5200169|NCT02743546|Ibrutinib|ibrutinib
5200170|NCT02743533|cardiovascular diseases, prognosis|cardiovascular diseases, prognosis
5200171|NCT02743520|sleep apnea|sleep apnea
5200172|NCT02743481|Pesticide|pesticide
5200173|NCT02743481|Agriculture|agriculture
5200174|NCT02743481|Cancer|cancer
5200175|NCT02743481|Childhood|childhood
5200176|NCT02743481|Leukemia|leukemia
5200182|NCT02743455|Fever|fever
5200183|NCT02743455|Immunogenicity|immunogenicity
5200184|NCT02743455|MVA-BN|mva-bn
5200185|NCT02743455|Reactogenicity|reactogenicity
5200186|NCT02743455|Vaccine|vaccine
5200187|NCT02743455|Yellow|yellow
5200188|NCT02743429|ch14.18/CHO|ch14.18/cho
5200189|NCT02743429|neuroblastoma|neuroblastoma
5200190|NCT02743429|long term infusion|long term infusion
5200191|NCT02743416|Screening|screening
5200192|NCT02743416|Stroke prevention|stroke prevention
5200193|NCT02743416|Cost effectiveness|cost effectiveness
5200194|NCT02743390|blood pressure|blood pressure
5200195|NCT02743390|inflammation|inflammation
5200196|NCT02743390|tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5200197|NCT02743377|GsI+/-|gsi+/-
5200198|NCT02743377|Camp|camp
5200199|NCT02743377|GNAS|gnas
5200200|NCT02743351|Cell Transplants|cell transplants
5188170|NCT02814318|Vancomycin|vancomycin
5188171|NCT02814318|Penicillin|penicillin
5188172|NCT02814318|Clindamycin|clindamycin
5188173|NCT02814318|Group B streptococcal infection|group b streptococcal infection
5188176|NCT02814318|Intrapartum|intrapartum
5200201|NCT02743351|Hematopoietic Cell Transplant|hematopoietic cell transplant
5200202|NCT02743351|HSCT|hsct
5200203|NCT02743351|Hematologic Malignancies|hematologic malignancies
5200204|NCT02743351|Hematologic Malignancy|hematologic malignancy
5200205|NCT02743351|Acute Myeloid Leukemia|acute myeloid leukemia
5200206|NCT02743351|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5200207|NCT02743351|ALL|all
5200208|NCT02743351|AML|aml
5200209|NCT02743351|Myelodysplastic Syndrome|myelodysplastic syndrome
5200210|NCT02743351|MDS|mds
5200211|NCT02743351|Allogeneic|allogeneic
5200216|NCT02743351|Acute graft-versus-host Disease|acute graft-versus-host disease
5200217|NCT02743338|Sleep Restriction|sleep restriction
5200218|NCT02743338|Sleep Compression|sleep compression
5200219|NCT02743338|Cognitive Behavioral Therapy|cognitive behavioral therapy
5200220|NCT02743312|Balance-Based Torso-Weighting|balance-based torso-weighting
5200221|NCT02743312|Physical Activity|physical activity
5200222|NCT02743312|Neurorehabilitation|neurorehabilitation
5200223|NCT02743286|sedentary behavior|sedentary behavior
5200224|NCT02743286|sitting|sitting
5200225|NCT02743286|feasibility|feasibility
5200226|NCT02743286|endothelial function|endothelial function
5200227|NCT02743286|metabolism|metabolism
5200228|NCT02743260|phenotype|phenotype
5200229|NCT02743260|transporter|transporter
5200230|NCT02743260|cocktail|cocktail
5200231|NCT02743247|Healthy volunteer|healthy volunteer
5200232|NCT02743221|metastatic|metastatic
5200233|NCT02743221|colorectal|colorectal
5200234|NCT02743221|cancer|cancer
5200235|NCT02743221|untreated|untreated
5200236|NCT02743221|first-line|first-line
5200237|NCT02743221|S95005 (Trifluridine/tipiracil)|s95005 (trifluridine/tipiracil)
5200238|NCT02743221|bevacizumab|bevacizumab
5200239|NCT02743221|capecitabine|capecitabine
5091447|NCT03427086|Biotin|biotin
5200240|NCT02743208|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5200241|NCT02743208|Surgical Procedures, Operative|surgical procedures, operative
5200242|NCT02743208|Hip Prosthesis|hip prosthesis
5200243|NCT02743169|Geographic Information Systems|geographic information systems
5200244|NCT02743169|Spatial Analysis|spatial analysis
5200245|NCT02743169|Emergency Medical Services|emergency medical services
5200246|NCT02743156|IVUS|ivus
5200247|NCT02743156|Acute Renal Failure|acute renal failure
5200248|NCT02743156|Angioplasty|angioplasty
5200249|NCT02743156|stent|stent
5200250|NCT02743156|contrast|contrast
5200251|NCT02743156|percutaneous coronary intervention|percutaneous coronary intervention
5200252|NCT02743156|intravascular ultrasound|intravascular ultrasound
5200253|NCT02743143|Exercise therapy|exercise therapy
5200254|NCT02743143|Cardiovascular disease|cardiovascular disease
5200256|NCT02743130|Berries|berries
5200257|NCT02743130|Blackcurrant (Ribes nigrum)|blackcurrant (ribes nigrum)
5200258|NCT02743130|Lingonberry (Vaccinium vitis-idaea)|lingonberry (vaccinium vitis-idaea)
5200259|NCT02743130|Sucrose|sucrose
5200260|NCT02743130|Inverted sugar|inverted sugar
5200261|NCT02743130|Postprandial glucose response|postprandial glucose response
5200262|NCT02743130|Postprandial insulin response|postprandial insulin response
5076403|NCT03521531|Quality of Life|quality of life
5200263|NCT02743117|Trivalent|trivalent
5200264|NCT02743117|Influenza|influenza
5200265|NCT02743117|FluMist Quadrivalent|flumist quadrivalent
5200266|NCT02743117|Vaccine|vaccine
5200267|NCT02743117|Prevention|prevention
5200268|NCT02743117|Healthy|healthy
5200269|NCT02743117|Monovalent|monovalent
5200270|NCT02743091|heart failure|heart failure
5200271|NCT02743091|survival|survival
5200272|NCT02743091|end-stage kidney disease|end-stage kidney disease
5200273|NCT02743078|Glioblastoma|glioblastoma
5200274|NCT02743078|Glioma|glioma
5200275|NCT02743078|Gliosarcoma|gliosarcoma
5200276|NCT02743078|Optune|optune
5200277|NCT02743078|TTFields|ttfields
5200278|NCT02743065|HepaSphere|hepasphere
5200279|NCT02743039|Low income|low income
5200280|NCT02743039|Education|education
5200281|NCT02743039|Poverty|poverty
5200282|NCT02743039|Children|children
5200283|NCT02743039|Parents|parents
5200284|NCT02743039|Head Start|head start
5200285|NCT02743000|fMRI|fmri
5200286|NCT02743000|emotion conflict task|emotion conflict task
5200287|NCT02743000|monetary incentive delay|monetary incentive delay
5200288|NCT02742974|Trauma|trauma
5200289|NCT02742974|Minimally Invasive Hemodynamic Monitoring|minimally invasive hemodynamic monitoring
5200290|NCT02742974|Perioperative|perioperative
5200291|NCT02742974|Complications|complications
5200303|NCT02742922|culturally adapted therapy|culturally adapted therapy
5940670|NCT00443599|Congenital Heart Defects|congenital heart defects
5200304|NCT02742922|problem solving therapy|problem solving therapy
5940671|NCT00443599|Insulin|insulin
5188271|NCT02813733|surgeons performance|surgeons performance
5188272|NCT02813720|Erosions|erosions
5188273|NCT02813720|Onycholysis|onycholysis
5200305|NCT02742922|low and middle income countries|low and middle income countries
5200306|NCT02742896|Erectile dysfunction|erectile dysfunction
5200307|NCT02742896|cognitive function|cognitive function
5200308|NCT02742870|Diffusion MRI|diffusion mri
5200309|NCT02742870|ADC histograms|adc histograms
5200310|NCT02742870|Adnexal tumor|adnexal tumor
5200322|NCT02742818|forced-air warming|forced-air warming
5200323|NCT02742818|hypothermia|hypothermia
5200324|NCT02742818|endovascular surgery|endovascular surgery
5200326|NCT02742805|hives|hives
5200327|NCT02742792|sleep apnea|sleep apnea
5200328|NCT02742792|elderly|elderly
5200329|NCT02742792|exercise|exercise
5200333|NCT02742766|Pharmacokinetics|pharmacokinetics
5200334|NCT02742766|GSK3008356|gsk3008356
5200335|NCT02742766|Tolerability|tolerability
5200336|NCT02742753|Otitis|otitis
5200337|NCT02742753|Vaccine|vaccine
5200338|NCT02742753|Sweden|sweden
5200339|NCT02742753|Database|database
5200340|NCT02742675|prostate cancer|prostate cancer
5200341|NCT02742675|androgen deprivation therapy|androgen deprivation therapy
5200342|NCT02742675|local treatment|local treatment
5200343|NCT02742662|Obesity|obesity
5200344|NCT02742662|Overweight|overweight
5200345|NCT02742662|Prediabetes|prediabetes
5200346|NCT02742662|Smartphone application|smartphone application
5200347|NCT02742662|Technology|technology
5200348|NCT02742662|Weight Loss|weight loss
5200349|NCT02742662|Lifestyle Intervention|lifestyle intervention
5200350|NCT02742623|Cancer|cancer
5200351|NCT02742623|Deep Venous Thrombosis|deep venous thrombosis
5200352|NCT02742623|Pulmonary Embolism|pulmonary embolism
5200353|NCT02742584|cough stress test|cough stress test
5200354|NCT02742584|urodynamics|urodynamics
5200355|NCT02742584|pad test|pad test
5200356|NCT02742571|Biological evaluation of denutrition|biological evaluation of denutrition
5200357|NCT02742571|Denutrition|denutrition
5200358|NCT02742571|PINI score|pini score
5200359|NCT02742558|cholera vaccine|cholera vaccine
5200360|NCT02742558|randomized trial|randomized trial
5200361|NCT02742558|immunogenicity|immunogenicity
5200362|NCT02742506|Brain-damaged|brain-damaged
5200363|NCT02742506|Disorders of consciousness|disorders of consciousness
5200364|NCT02742506|Post-coma|post-coma
5200365|NCT02742506|consciousness|consciousness
5200366|NCT02742506|coma|coma
5200367|NCT02742506|vegetative state|vegetative state
5200368|NCT02742506|minimally conscious state|minimally conscious state
5200369|NCT02742506|music|music
5200370|NCT02742506|P300|p300
5200371|NCT02742493|relapse|relapse
5200372|NCT02742493|irregularity|irregularity
5200373|NCT02742493|recession|recession
5200374|NCT02742493|retention|retention
5200375|NCT02742480|stroke|stroke
5200376|NCT02742480|oral anticoagulants|oral anticoagulants
5200377|NCT02742480|cardioembolic|cardioembolic
5200378|NCT02742454|Umbilical Cord Clamping|umbilical cord clamping
5200379|NCT02742454|Intraventricular Hemorrhage|intraventricular hemorrhage
5200380|NCT02742454|Extremely Preterm Infants|extremely preterm infants
5200382|NCT02742324|efficacy|efficacy
5962510|NCT04280471|Gut GvHD|gut gvhd
5200383|NCT02742324|safety|safety
5200384|NCT02742298|Neuromuscular Ultrasound|neuromuscular ultrasound
5200385|NCT02742298|Electrical Impedance Myography|electrical impedance myography
5200386|NCT02742285|antimalarials|antimalarials
5200387|NCT02742285|blood samples|blood samples
5962511|NCT04280471|FMT|fmt
5076514|NCT03520985|OptiPOM|optipom
5200388|NCT02742285|drug concentrations|drug concentrations
5200389|NCT02742285|pharmacokinetics|pharmacokinetics
5200390|NCT02742285|lumefantrine|lumefantrine
5200391|NCT02742285|healthy volunteers|healthy volunteers
5200392|NCT02742233|Diabetes|diabetes
5200393|NCT02742233|Wound Healing|wound healing
5200394|NCT02742233|Dipeptidyl Peptidase 4 Inhibition|dipeptidyl peptidase 4 inhibition
5200395|NCT02742220|intermittent claudication|intermittent claudication
5200396|NCT02742220|exercise|exercise
5200397|NCT02742220|blood pressure|blood pressure
5200398|NCT02742220|cardiovascular system|cardiovascular system
5200399|NCT02742194|ginger obesity|ginger obesity
5200400|NCT02742194|ginger inflammation|ginger inflammation
5200401|NCT02742194|treatment of obesity|treatment of obesity
5200402|NCT02742155|Family Research|family research
5200403|NCT02742116|Expanded carrier screening|expanded carrier screening
5200404|NCT02742090|CLL|cll
5200405|NCT02742025|Coronary Angiography|coronary angiography
5200406|NCT02742012|electroencephalogram|electroencephalogram
5200407|NCT02742012|hemodynamic monitoring|hemodynamic monitoring
5200408|NCT02742012|respiratory monitoring|respiratory monitoring
5200409|NCT02741986|risk assessment|risk assessment
5200410|NCT02741986|sepsis|sepsis
5200411|NCT02741986|acute kidney injury (AKI)|acute kidney injury (aki)
5940672|NCT00443599|Euglycemia|euglycemia
5940673|NCT00443599|Normoglycemia|normoglycemia
5200412|NCT02741973|Yoga|yoga
5200413|NCT02741973|Stress|stress
5200414|NCT02741973|Adolescents|adolescents
5200415|NCT02741973|School|school
5200416|NCT02741973|Children|children
5200417|NCT02741960|metformin|metformin
5200418|NCT02741960|systemic lupus erythematosus|systemic lupus erythematosus
5200419|NCT02741947|Parkinson|parkinson
5200420|NCT02741947|Therapeutic Equivalence|therapeutic equivalence
5200421|NCT02741947|Levodopa|levodopa
5200422|NCT02741895|Biosensing Techniques|biosensing techniques
5200423|NCT02741895|Patient Readmission|patient readmission
5200424|NCT02741882|Microcephaly|microcephaly
5200425|NCT02741882|zika Virus|zika virus
5200426|NCT02741882|Case-control study|case-control study
5200427|NCT02741869|Staphylococcus aureus; nare carriage|staphylococcus aureus; nare carriage
5200428|NCT02741804|Memory|memory
5200429|NCT02741791|AXS-05|axs-05
5200430|NCT02741791|Major Depressive Disorder|major depressive disorder
5200431|NCT02741791|Treatment Resistant Depression|treatment resistant depression
5200432|NCT02741791|TRD|trd
5200433|NCT02741791|MDD|mdd
5200434|NCT02741791|Axsome|axsome
5200435|NCT02741791|NMDA receptor|nmda receptor
5200436|NCT02741791|Refractory depression|refractory depression
5200437|NCT02741791|Resistant depression|resistant depression
5200438|NCT02741791|Depression|depression
5200439|NCT02741778|Esophagogastric Junction|esophagogastric junction
5200440|NCT02741778|Adenocarcinoma|adenocarcinoma
5200441|NCT02741778|Cardia|cardia
5200442|NCT02741765|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5200443|NCT02741765|Exercise|exercise
5200444|NCT02741765|Brain Plasticity|brain plasticity
5200445|NCT02741752|histomorphometry|histomorphometry
5200446|NCT02741739|Drug concentration|drug concentration
5200447|NCT02741739|REGN1033|regn1033
5200448|NCT02741739|blood|blood
5200449|NCT02741700|Adherence|adherence
5200450|NCT02741700|Disparities|disparities
5200451|NCT02741700|Patient Outcomes|patient outcomes
5200452|NCT02741687|stress hyperglycemia|stress hyperglycemia
5200453|NCT02741687|blood glucose|blood glucose
5200454|NCT02741674|Observational Study|observational study
5200455|NCT02741674|Comparative Effectiveness Research|comparative effectiveness research
5200456|NCT02741648|Red Blood Cell Transfusion|red blood cell transfusion
5200457|NCT02741648|Digestive tract problems|digestive tract problems
5200458|NCT02741648|Extremely Low Birth Weight|extremely low birth weight
5200459|NCT02741622|Exercise therapy|exercise therapy
5200460|NCT02741609|Borrelia|borrelia
5200461|NCT02741609|spirochetes|spirochetes
5200462|NCT02741609|culture|culture
5200463|NCT02741609|immunostaining|immunostaining
5200464|NCT02741596|DX-2930(SHP643)|dx-2930(shp643)
5200465|NCT02741596|Dyax|dyax
5200466|NCT02741596|Hereditary Angioedema|hereditary angioedema
5200467|NCT02741557|Fixed-dose Combination (FDC)|fixed-dose combination (fdc)
5200468|NCT02741557|Bioequivalence|bioequivalence
5200469|NCT02741557|Dolutegravir|dolutegravir
5200470|NCT02741557|Rilpivirine|rilpivirine
5200471|NCT02741544|Second primary cancers|second primary cancers
5200472|NCT02741544|Cataracts|cataracts
5200473|NCT02741544|Newly-diagnosed multiple myeloma|newly-diagnosed multiple myeloma
5200474|NCT02741544|Revlimid capsules|revlimid capsules
5200475|NCT02741518|obesity|obesity
5200476|NCT02741518|FMT|fmt
5200477|NCT02741505|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5200478|NCT02741505|sleep|sleep
5200479|NCT02741505|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5200480|NCT02741505|Sleep Disordered Breathing (SDB)|sleep disordered breathing (sdb)
5200481|NCT02741505|Period Limb Movement during Sleep (PLMS)|period limb movement during sleep (plms)
5200482|NCT02741479|dancers|dancers
5962512|NCT04280458|children polyhandicap|children polyhandicap
5962513|NCT04280458|rehabilitation|rehabilitation
5200483|NCT02741440|Spinocerebellar Ataxia|spinocerebellar ataxia
5200484|NCT02741427|Tooth discoloration|tooth discoloration
5200485|NCT02741427|Toothpaste|toothpaste
5200486|NCT02741427|Tooth bleaching|tooth bleaching
5200487|NCT02741427|Clinical trial|clinical trial
5200488|NCT02741414|Helicobacter pylori|helicobacter pylori
5200489|NCT02741414|Antibiotic resistance|antibiotic resistance
5200490|NCT02741414|Sequencing|sequencing
5200491|NCT02741414|Mechanism|mechanism
5200492|NCT02741401|Complementary therapies|complementary therapies
5200493|NCT02741401|Massage|massage
5673923|NCT00606099|Adults|adults
5200494|NCT02741401|Gastrointestinal cancer|gastrointestinal cancer
5200495|NCT02741388|selinexor|selinexor
5200496|NCT02741388|lymphoma|lymphoma
5200497|NCT02741388|inhibitor of nuclear export|inhibitor of nuclear export
5200498|NCT02741362|Type III hypersensitivity autoimmune disease|type iii hypersensitivity autoimmune disease
5200499|NCT02741349|Atrial fibrillation|atrial fibrillation
5200500|NCT02741349|Risk score|risk score
5200501|NCT02741323|HIV-infected with end-stage kidney disease|hiv-infected with end-stage kidney disease
5200502|NCT02741297|Spinal Cord Stimulation|spinal cord stimulation
5200503|NCT02741297|Chronic Pain|chronic pain
5200504|NCT02741232|analgesics, opioids|analgesics, opioids
5200505|NCT02741232|pectoral block|pectoral block
5200506|NCT02741206|psycho-education|psycho-education
5200507|NCT02741206|maternal depression|maternal depression
5200508|NCT02741206|Reach Out Stay Strong Essentials|reach out stay strong essentials
5200513|NCT02741167|peritoneal surface malignancies|peritoneal surface malignancies
5200514|NCT02741167|cytoreductive surgery|cytoreductive surgery
5200515|NCT02741167|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5200516|NCT02741154|aromataze inhibitor, poor responder ,induction|aromataze inhibitor, poor responder ,induction
5200521|NCT02741115|Fontan|fontan
5200522|NCT02741115|Maximal Oxygen Consumption|maximal oxygen consumption
5200523|NCT02741115|Vascular Function|vascular function
5200524|NCT02741115|EndoPAT|endopat
5200525|NCT02741115|Myocardial Performance|myocardial performance
5200526|NCT02741102|Infertility|infertility
5200527|NCT02741102|AUFI|aufi
5200528|NCT02741089|Analgosedation|analgosedation
5200529|NCT02741089|Internal Quality Assurance|internal quality assurance
5200530|NCT02741063|oxytocin|oxytocin
5200531|NCT02741063|attentional bias|attentional bias
5200532|NCT02741063|Autism|autism
5200533|NCT02741011|Cone-Beam Computed Tomography|cone-beam computed tomography
5200535|NCT02740998|Microbiome|microbiome
5200536|NCT02740998|Progestin|progestin
5200537|NCT02740998|Long-acting contraception|long-acting contraception
5200538|NCT02740985|AZD4635|azd4635
5200539|NCT02740985|durvalumab|durvalumab
5200540|NCT02740985|oleclumab|oleclumab
5200541|NCT02740985|docetaxel|docetaxel
5200542|NCT02740985|non-small cell lung cancer|non-small cell lung cancer
5200543|NCT02740985|advanced solid malignancies|advanced solid malignancies
5200544|NCT02740985|prostate cancer|prostate cancer
5200545|NCT02740985|colorectal cancer|colorectal cancer
5200546|NCT02740985|abiraterone acetate|abiraterone acetate
5200547|NCT02740985|enzalutamide|enzalutamide
5200548|NCT02740933|Brain Tumor Surgery|brain tumor surgery
5200549|NCT02740868|Magnetic Resonance Imaging,cystic fibrosis,asthma,healthy|magnetic resonance imaging,cystic fibrosis,asthma,healthy
5200550|NCT02740855|sclerotherapy|sclerotherapy
5200551|NCT02740855|ethanol|ethanol
5200552|NCT02740855|pulmonal hypertension|pulmonal hypertension
5200553|NCT02740790|Human papillomavirus|human papillomavirus
5200554|NCT02740790|vaccine|vaccine
5200555|NCT02740790|cervical infection|cervical infection
5200556|NCT02740790|cervical cancer|cervical cancer
5200557|NCT02740764|Functional autonomy level|functional autonomy level
5200558|NCT02740764|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
5200559|NCT02740764|Cognitive disorders|cognitive disorders
5200560|NCT02740764|Potentially inappropriate medication|potentially inappropriate medication
5200561|NCT02740764|elderly|elderly
5200562|NCT02740764|Optimization of drug prescribing|optimization of drug prescribing
5200563|NCT02740738|Knee Arthroplasty|knee arthroplasty
5200564|NCT02740738|Hip Arthroplasty|hip arthroplasty
5200565|NCT02740725|Amblyopia|amblyopia
5200566|NCT02740725|Interaction Binocular Treatment (I-BiTTM)|interaction binocular treatment (i-bittm)
5200567|NCT02740725|Patch Therapy|patch therapy
5200568|NCT02740712|rucaparib|rucaparib
5200569|NCT02740712|CO-338|co-338
5200570|NCT02740712|Clovis|clovis
5200571|NCT02740712|Clovis Oncology|clovis oncology
5200572|NCT02740712|PARP Inhibitor|parp inhibitor
5200573|NCT02740712|Drug-Drug Interaction|drug-drug interaction
5200574|NCT02740699|Cholesterol|cholesterol
5200575|NCT02740699|Heart Disease|heart disease
5200576|NCT02740699|CT Scan|ct scan
5200577|NCT02740699|Crestor|crestor
5200578|NCT02740699|Lipitor|lipitor
5200579|NCT02740686|COPD|copd
5200580|NCT02740686|Exercise|exercise
5200581|NCT02740686|Immunity|immunity
5200582|NCT02740686|Inflammation|inflammation
5200583|NCT02740686|Biomarkers|biomarkers
5200584|NCT02740660|Albuterol|albuterol
5200585|NCT02740660|Caffeine|caffeine
5200586|NCT02740660|Lean Body Mass|lean body mass
5200587|NCT02740660|Fat Mass|fat mass
5200591|NCT02740595|endothelial function|endothelial function
5200592|NCT02740595|oxidative stress|oxidative stress
5200593|NCT02740569|scleroderma|scleroderma
5200594|NCT02740569|sleep apnea|sleep apnea
5200595|NCT02740569|pulmonary disease|pulmonary disease
5200596|NCT02740556|Hepatitis C|hepatitis c
5200597|NCT02740556|Adherence|adherence
5200598|NCT02740556|Adheretech|adheretech
5200599|NCT02740556|HepCure|hepcure
5200600|NCT02740556|Telehealth|telehealth
5200601|NCT02740556|Health apps|health apps
5200602|NCT02740543|World Trade Center|world trade center
5200603|NCT02740543|WTC|wtc
5200604|NCT02740543|Induced Sputum|induced sputum
5200605|NCT02740543|Exhaled Breath Condensate|exhaled breath condensate
5200606|NCT02740504|Respiration rate|respiration rate
5200607|NCT02740465|ACE|ace
5188598|NCT02811939|THC|thc
5200608|NCT02740465|Anxiety|anxiety
5200609|NCT02740465|COPD|copd
5200610|NCT02740452|Rupture|rupture
5200611|NCT02740452|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
5200612|NCT02740452|Laxity knee|laxity knee
5200613|NCT02740452|Instability knee|instability knee
5200614|NCT02740400|Endobronchial ultrasonography|endobronchial ultrasonography
5200615|NCT02740400|guided sheath|guided sheath
5200616|NCT02740400|diagnosis|diagnosis
5200617|NCT02740400|accuracy|accuracy
5200618|NCT02740400|complication|complication
5200619|NCT02740374|ROTEM|rotem
5200620|NCT02740374|Thromboelastometry|thromboelastometry
5200621|NCT02740374|spine surgery|spine surgery
5200622|NCT02740374|allogenic blood transfusion|allogenic blood transfusion
5200623|NCT02740374|blood loss|blood loss
5200624|NCT02740374|red blood cell transfusion|red blood cell transfusion
5200625|NCT02740335|anticoagulant reversal|anticoagulant reversal
5200626|NCT02740335|urgent surgery|urgent surgery
5200627|NCT02740335|invasive procedures|invasive procedures
5200628|NCT02740335|vitamin K|vitamin k
5200629|NCT02740335|prothrombin complex concentrate|prothrombin complex concentrate
5200630|NCT02740335|four-factor prothrombin complex concentrate (4F-PCC)|four-factor prothrombin complex concentrate (4f-pcc)
5200631|NCT02740322|Hum Test, Weber test, audiogram|hum test, weber test, audiogram
5200632|NCT02740309|inflammatory bowel disease|inflammatory bowel disease
5200633|NCT02740309|childhood chronic disease|childhood chronic disease
5200634|NCT02740309|adolescent depression|adolescent depression
5200636|NCT02740309|integrated brief behavioral therapy|integrated brief behavioral therapy
5200637|NCT02740309|adolescent psychosocial risks|adolescent psychosocial risks
5200638|NCT02740309|adolescent chronic disease|adolescent chronic disease
5200639|NCT02740309|childhood depression|childhood depression
5200640|NCT02740309|childhood anxiety|childhood anxiety
5091908|NCT03424356|LMA|lma
5200641|NCT02740309|childhood psychosocial risks|childhood psychosocial risks
5200642|NCT02740283|Gestational Diabetes Mellitus|gestational diabetes mellitus
5200643|NCT02740283|Oral Glucose Tolerance Test|oral glucose tolerance test
5200644|NCT02740270|advanced solid tumors|advanced solid tumors
5200646|NCT02740270|GWN323|gwn323
5200647|NCT02740270|PDR001|pdr001
5200648|NCT02740270|advanced malignancies|advanced malignancies
5200649|NCT02740270|anti-GITR|anti-gitr
5200650|NCT02740270|anti-PD-1|anti-pd-1
5200651|NCT02740270|adults|adults
5200652|NCT02740231|viscosupplement|viscosupplement
5200653|NCT02740231|osteoarthritis|osteoarthritis
5200654|NCT02740231|knee|knee
5200655|NCT02740231|intra-articular injection|intra-articular injection
5200656|NCT02740231|arthritis|arthritis
5200657|NCT02740231|degenerative|degenerative
5200658|NCT02740218|Psoriasis|psoriasis
5200659|NCT02740218|Apremilast|apremilast
5200660|NCT02740218|APPRECIATE|appreciate
5200661|NCT02740218|Dermatology|dermatology
5200662|NCT02740218|Retrospective|retrospective
5200663|NCT02740218|Observational|observational
5200665|NCT02740179|Eplerenone|eplerenone
5200666|NCT02740179|Cardiovascular Disease|cardiovascular disease
5200667|NCT02740179|Mineralocorticoid Receptor Antagonist|mineralocorticoid receptor antagonist
5200668|NCT02740179|Coronary Vasculature|coronary vasculature
5200669|NCT02740179|Myocardial Inflammation|myocardial inflammation
5200670|NCT02740179|Myocardial Fibrosis|myocardial fibrosis
5200671|NCT02740179|Atherosclerosis|atherosclerosis
5200672|NCT02740179|Aldosterone|aldosterone
5200673|NCT02740166|Esophageal Varices; propranolol; banding ligation|esophageal varices; propranolol; banding ligation
5200674|NCT02740140|chronic coinfection|chronic coinfection
5200675|NCT02740127|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5200676|NCT02740127|Adult Penile Prosthesis Surgery|adult penile prosthesis surgery
5200677|NCT02740127|Caudal nerve block|caudal nerve block
5200678|NCT02740127|CNB|cnb
5200679|NCT02740127|General anesthesia|general anesthesia
5200680|NCT02740127|GA|ga
5200681|NCT02740127|Ropivacaine|ropivacaine
5200682|NCT02740127|Naropin|naropin
5200683|NCT02740127|Epinephrine|epinephrine
5200684|NCT02740127|Decadron|decadron
5200685|NCT02740127|Dexamethasone|dexamethasone
5200686|NCT02740127|Clonidine|clonidine
5200687|NCT02740127|Propofol|propofol
5200688|NCT02740127|Diprivan|diprivan
5200689|NCT02740114|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5200690|NCT02740114|Open gynecologic surgery|open gynecologic surgery
5200691|NCT02740114|Local wound infiltration|local wound infiltration
5200692|NCT02740114|Gynecologic cancer|gynecologic cancer
5200693|NCT02740114|Bupivacaine|bupivacaine
5200694|NCT02740114|Liposomal Bupivacaine|liposomal bupivacaine
5200695|NCT02740114|Oxycodone|oxycodone
5200696|NCT02740114|ETH-Oxydose [DSC]|eth-oxydose [dsc]
5200697|NCT02740114|OxyContin|oxycontin
5200698|NCT02740114|OxyIR|oxyir
5200699|NCT02740114|Roxicodone|roxicodone
5200700|NCT02740114|Questionnaires|questionnaires
5200701|NCT02740114|Surveys|surveys
5200702|NCT02740114|MD Anderson Symptom Inventory|md anderson symptom inventory
5200703|NCT02740114|MDASI|mdasi
5188672|NCT02811614|minimally invasive surgery|minimally invasive surgery
5188676|NCT02811575|Coloscopy|coloscopy
5200704|NCT02740114|Pill diary|pill diary
5200705|NCT02740114|Medication log|medication log
5200706|NCT02740101|oxytocin|oxytocin
5200707|NCT02740101|social reward|social reward
5200708|NCT02740101|social punishment|social punishment
5200709|NCT02740075|Mechanical versus hand ventilation|mechanical versus hand ventilation
5200710|NCT02740075|Transport ventilation|transport ventilation
5200711|NCT02740049|Epithelial Cells|epithelial cells
5200713|NCT02740010|extended depth of focus|extended depth of focus
5200714|NCT02740010|cataract|cataract
5200715|NCT02740010|visual acuity|visual acuity
5200716|NCT02740010|halos|halos
5200717|NCT02739984|diabetes|diabetes
5200718|NCT02739984|type 2 diabetes|type 2 diabetes
5200719|NCT02739984|high blood cholesterol|high blood cholesterol
5200720|NCT02739984|hypercholesterolemia|hypercholesterolemia
5200721|NCT02739984|mixed dyslipidemia|mixed dyslipidemia
5200722|NCT02739984|high cholesterol|high cholesterol
5200723|NCT02739984|statin intolerant|statin intolerant
5200724|NCT02739945|Ulnar Nerve Compression, Cubital Tunnel|ulnar nerve compression, cubital tunnel
5200725|NCT02739932|Attenuated Psychotic Symptoms|attenuated psychotic symptoms
5200726|NCT02739919|Kidney stones|kidney stones
5200727|NCT02739919|Renal Calculi|renal calculi
5200728|NCT02739880|Vaginal discomfort|vaginal discomfort
5200729|NCT02739880|Vaginal dryness|vaginal dryness
5200730|NCT02739867|occult cancer|occult cancer
5200731|NCT02739867|venous thromboembolism|venous thromboembolism
5200734|NCT02739867|early diagnosis|early diagnosis
5200735|NCT02739867|screening|screening
5200736|NCT02739854|trauma|trauma
5200737|NCT02739854|atelectasis|atelectasis
5200738|NCT02739841|hemodynamic response|hemodynamic response
5200739|NCT02739828|Quality of life|quality of life
5200740|NCT02739815|Caesarean Section|caesarean section
5200741|NCT02739815|Tranexamic Acid|tranexamic acid
5200742|NCT02739815|Postpartum Hemorrhage|postpartum hemorrhage
5200743|NCT02739815|Ecbolics|ecbolics
5200744|NCT02739789|tDCS rejection affect mood fMRI|tdcs rejection affect mood fmri
5200745|NCT02739763|PfSPZ|pfspz
5200746|NCT02739763|Semi-immune adults|semi-immune adults
5200747|NCT02739763|Kenya|kenya
5200748|NCT02739763|challenge|challenge
5200749|NCT02739763|CHMI|chmi
5200750|NCT02739763|malaria|malaria
5200751|NCT02739737|Bias|bias
5200752|NCT02739737|Orthopedics|orthopedics
5200753|NCT02739737|Peer Review|peer review
5200754|NCT02739698|ovarian cancer|ovarian cancer
5200755|NCT02739659|prostate carcinoma|prostate carcinoma
5200756|NCT02739659|carbon-ion radiotherapy|carbon-ion radiotherapy
5200757|NCT02739659|efficacy|efficacy
5200758|NCT02739659|toxicity|toxicity
5200759|NCT02739633|Chemotherapy|chemotherapy
5200760|NCT02739633|Gemcitabine|gemcitabine
5200761|NCT02739633|Recurrent and metastatic adenocarcinoma of the pancreas|recurrent and metastatic adenocarcinoma of the pancreas
5200762|NCT02739633|Genexol-PM|genexol-pm
5200763|NCT02739633|Paclitaxel|paclitaxel
5200764|NCT02739607|emotional disorders|emotional disorders
5200765|NCT02739607|internet-delivered intervention|internet-delivered intervention
5200766|NCT02739607|anxiety|anxiety
5200767|NCT02739607|depression|depression
5200768|NCT02739607|transdiagnostic|transdiagnostic
5200770|NCT02739568|OSA|osa
5200771|NCT02739555|Osteoid osteoma|osteoid osteoma
5200772|NCT02739555|Bisphophonates|bisphophonates
5200773|NCT02739542|Radiologically Isolated Syndrome (RIS)|radiologically isolated syndrome (ris)
5200774|NCT02739490|physiotherapeutic techniques|physiotherapeutic techniques
5200775|NCT02739490|pelvis|pelvis
5200776|NCT02739490|Muscle strength|muscle strength
5200777|NCT02739477|Favipiravir|favipiravir
5200778|NCT02739477|Tolerance|tolerance
5200779|NCT02739477|Survivor|survivor
5200780|NCT02739477|Ebola Virus|ebola virus
5200781|NCT02739477|Genital reservoir|genital reservoir
5200782|NCT02739477|Guinea|guinea
5200783|NCT02739464|Burn|burn
5200784|NCT02739464|Exercise|exercise
5200785|NCT02739464|Ergometer|ergometer
5200786|NCT02739464|MP-10|mp-10
5200787|NCT02739451|immunocompromized patients|immunocompromized patients
5200788|NCT02739451|critically ill patients|critically ill patients
5200789|NCT02739438|Pulmonary inflammation|pulmonary inflammation
5200790|NCT02739438|Endothelial dysfunction|endothelial dysfunction
5200791|NCT02739438|Electronic Cigarettes|electronic cigarettes
5200792|NCT02739425|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5200793|NCT02739425|Superparamagnetic iron oxide (SPIO) tracer|superparamagnetic iron oxide (spio) tracer
5200794|NCT02739399|phenylephrine|phenylephrine
5200795|NCT02739399|alpha mimetics|alpha mimetics
5200796|NCT02739399|pulse pressure variation|pulse pressure variation
5200797|NCT02739399|venous return|venous return
5200798|NCT02739347|tDCS|tdcs
5200799|NCT02739347|cognitive control|cognitive control
5200800|NCT02739347|working memory|working memory
5188770|NCT02810834|Academic Performance|academic performance
5188771|NCT02810821|Gonadal hormones|gonadal hormones
5188772|NCT02810821|Gonadotropins|gonadotropins
5188773|NCT02810821|Cardiovascular diseases|cardiovascular diseases
5188774|NCT02810821|Lipids|lipids
5200802|NCT02739347|gamma oscillations|gamma oscillations
5200803|NCT02739321|Autism|autism
5200804|NCT02739321|ASD|asd
5200805|NCT02739321|Sleep|sleep
5200806|NCT02739321|Mattress|mattress
5200807|NCT02739308|proprioception|proprioception
5200808|NCT02739308|ankle sprain|ankle sprain
5200809|NCT02739308|fencing|fencing
5200810|NCT02739269|ovarian response|ovarian response
5200811|NCT02739269|anti-Mullerian hormone|anti-mullerian hormone
5200812|NCT02739269|antral follicle count|antral follicle count
5200813|NCT02739256|voiding trial|voiding trial
5200814|NCT02739256|pelvic organ prolapse|pelvic organ prolapse
5200815|NCT02739256|post-operative catheterization|post-operative catheterization
5200816|NCT02739204|Celecoxib|celecoxib
5200817|NCT02739204|Relapse-free OSCC patient|relapse-free oscc patient
5200818|NCT02739204|Recurrence|recurrence
5200819|NCT02739204|Survival|survival
5200820|NCT02739204|Prognosis|prognosis
5200821|NCT02739191|NPWT|npwt
5200822|NCT02739165|Acute exacerbations|acute exacerbations
5200823|NCT02739165|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5200824|NCT02739165|Recombinant human soluble thrombomodulin|recombinant human soluble thrombomodulin
5200825|NCT02739165|ART-123|art-123
5200826|NCT02739152|Sepsis|sepsis
5200827|NCT02739152|Severe sepsis|severe sepsis
5200835|NCT02739061|cognitive behavioral group therapy|cognitive behavioral group therapy
5200836|NCT02738996|Diabetes|diabetes
5200837|NCT02738996|Sedentary Lifestyle|sedentary lifestyle
5200838|NCT02738983|Non-small cell lung cancer|non-small cell lung cancer
5200839|NCT02738983|epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)|epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki)
5200840|NCT02738983|Radiotherapy|radiotherapy
5200841|NCT02738983|wild type|wild type
5200842|NCT02738931|dolutegravir|dolutegravir
5200843|NCT02738931|lamivudine|lamivudine
5200844|NCT02738931|Bioavailability|bioavailability
5200845|NCT02738931|fixed dose combinations|fixed dose combinations
5200846|NCT02738918|Renal Transplant|renal transplant
5200847|NCT02738918|Anti HLA antibodies|anti hla antibodies
5200848|NCT02738918|Humoral rejection|humoral rejection
5200849|NCT02738892|Pregnancy|pregnancy
5200850|NCT02738892|Stillbirth|stillbirth
5200851|NCT02738892|Preterm birth|preterm birth
5200852|NCT02738866|breast cancer|breast cancer
5200853|NCT02738866|Metastatic Breast Cancer|metastatic breast cancer
5200854|NCT02738866|palbociclib|palbociclib
5200855|NCT02738866|fulvestrant|fulvestrant
5200856|NCT02738814|emergence agitation|emergence agitation
5200857|NCT02738814|emergence delirium|emergence delirium
5200858|NCT02738814|PAED scale|paed scale
5200859|NCT02738814|The Modified Aldrete Scoring System|the modified aldrete scoring system
5200860|NCT02738814|treatment|treatment
5200861|NCT02738814|pediatric|pediatric
5200862|NCT02738814|sevoflurane|sevoflurane
5200863|NCT02738801|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5200864|NCT02738801|GLPG1690|glpg1690
5200865|NCT02738801|Autotaxin|autotaxin
5200867|NCT02738788|airway changes|airway changes
5200868|NCT02738788|MMS|mms
5200869|NCT02738788|prone position|prone position
5200870|NCT02738788|Trendelenburg position|trendelenburg position
5200871|NCT02738775|multiple sclerosis|multiple sclerosis
5200872|NCT02738762|intensive care|intensive care
5200873|NCT02738762|glutamine|glutamine
5200874|NCT02738762|length of stay|length of stay
5200875|NCT02738749|sudden cardiac death, sodium channel splicing variant|sudden cardiac death, sodium channel splicing variant
5200876|NCT02738723|Limited-stage small cell lung cancer|limited-stage small cell lung cancer
5200877|NCT02738723|Stereotactic body radiation therapy|stereotactic body radiation therapy
5200878|NCT02738723|Intensity modulated radiation therapy|intensity modulated radiation therapy
5200879|NCT02738723|Radiation|radiation
5200881|NCT02738697|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5200882|NCT02738697|Adjuvant chemotherapy|adjuvant chemotherapy
5200883|NCT02738697|Microvessels invasion|microvessels invasion
5200884|NCT02738697|Survival|survival
5200885|NCT02738697|Recurrence|recurrence
5200886|NCT02738684|lung cancer|lung cancer
5200887|NCT02738684|adenocarcinoma|adenocarcinoma
5200891|NCT02738671|olfactory function|olfactory function
5200892|NCT02738671|bariatric surgery|bariatric surgery
5200893|NCT02738658|Coronary microcirculatory dysfunction|coronary microcirculatory dysfunction
5200894|NCT02738658|Coronary endothelium dysfunction|coronary endothelium dysfunction
5200896|NCT02738619|immunotherapy|immunotherapy
5077146|NCT03517228|18-173|18-173
5200897|NCT02738619|vitamin D|vitamin d
5200898|NCT02738554|HBV|hbv
5200899|NCT02738554|treatment cessation|treatment cessation
5200900|NCT02738554|HBsAg|hbsag
5200901|NCT02738554|HBcrAg|hbcrag
5200902|NCT02738554|nucleoside analogue|nucleoside analogue
5200903|NCT02738554|entecavir|entecavir
5200904|NCT02738554|tenofovir|tenofovir
5200905|NCT02738502|HIV|hiv
5200906|NCT02738502|prevention of mother-to-child transmission|prevention of mother-to-child transmission
5200907|NCT02738502|Ritonavir boosted darunavir monotherapy|ritonavir boosted darunavir monotherapy
5200908|NCT02738489|PD-1/PD-L1 advanced Melanoma immunotherapy|pd-1/pd-l1 advanced melanoma immunotherapy
5200909|NCT02738463|ferritin LBW|ferritin lbw
5200910|NCT02738450|cognitive decline|cognitive decline
5200911|NCT02738437|osteogenesis|osteogenesis
5200912|NCT02738437|Positron-Emission Tomography|positron-emission tomography
5200913|NCT02738437|Radiostereometric analysis|radiostereometric analysis
5200914|NCT02738424|Low Back Pain|low back pain
5200915|NCT02738424|MRI|mri
5200916|NCT02738372|Chronic Pain|chronic pain
5200917|NCT02738372|Biopsychosocial Factors|biopsychosocial factors
5200918|NCT02738372|Shoulder pain|shoulder pain
5200919|NCT02738372|Prognosis|prognosis
5200920|NCT02738372|Central Nervous System Sensitization|central nervous system sensitization
5200921|NCT02738359|colon cancer|colon cancer
5200922|NCT02738359|rectum cancer|rectum cancer
5200924|NCT02738359|fecal immunological test|fecal immunological test
5200925|NCT02738359|colon capsule|colon capsule
5200926|NCT02738346|Small Cell Lung Cancer|small cell lung cancer
5200927|NCT02738346|Topotecan|topotecan
5200928|NCT02738346|Etoposide|etoposide
5200929|NCT02738307|High Altitude|high altitude
5200930|NCT02738307|Attention|attention
5200931|NCT02738307|Cognitive Function|cognitive function
5200932|NCT02738307|Acclimatization|acclimatization
5200933|NCT02738307|Sleep|sleep
5200934|NCT02738255|Obstructive sleep apnea|obstructive sleep apnea
5200935|NCT02738255|Mouth breathing|mouth breathing
5200936|NCT02738255|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
5200937|NCT02738242|Functional Electrical Stimulation|functional electrical stimulation
5200938|NCT02738242|Upper motor neuron injury or disease|upper motor neuron injury or disease
5200939|NCT02738242|Drop foot|drop foot
5200940|NCT02738242|Thigh muscle weakness|thigh muscle weakness
5200941|NCT02738203|Pain Management|pain management
5200942|NCT02738203|IUD insertion|iud insertion
5200943|NCT02738190|albumin|albumin
5200944|NCT02738190|fresh frozen plasma|fresh frozen plasma
5200945|NCT02738190|extracorporeal circulation|extracorporeal circulation
5200946|NCT02738190|cardiovascular surgery|cardiovascular surgery
5200947|NCT02738190|pediatric population|pediatric population
5200948|NCT02738177|misopristol|misopristol
5200949|NCT02738177|effox|effox
5200950|NCT02738177|cervical ripening|cervical ripening
5200951|NCT02738138|HCV Genotype 3|hcv genotype 3
5200952|NCT02738138|Non-cirrhotic|non-cirrhotic
5200953|NCT02738138|HCV Genotype 1|hcv genotype 1
5200954|NCT02738138|HCV Genotype 6|hcv genotype 6
5200955|NCT02738138|Human Immunodeficiency Virus (HIV) Infection|human immunodeficiency virus (hiv) infection
5200956|NCT02738138|HCV Genotype 5|hcv genotype 5
5200957|NCT02738138|HCV Treatment Naive|hcv treatment naive
5200958|NCT02738138|HCV Genotype 4|hcv genotype 4
5200959|NCT02738138|HCV Treatment Experienced|hcv treatment experienced
5200960|NCT02738138|HCV Genotype 2|hcv genotype 2
5200961|NCT02738138|Hepatitis C Virus (HCV) Infection|hepatitis c virus (hcv) infection
5200962|NCT02738138|Compensated Cirrhosis|compensated cirrhosis
5200963|NCT02738125|Adalimumab|adalimumab
5200964|NCT02738125|Ulcerative Colitis|ulcerative colitis
5200965|NCT02738125|SOTHIS|sothis
5200966|NCT02738125|Effectiveness|effectiveness
5200970|NCT02738034|Hypertension|hypertension
5200971|NCT02738034|Cognition|cognition
5200972|NCT02738034|Computerized Training|computerized training
5200973|NCT02738034|Cogmed|cogmed
5200974|NCT02738021|Psychosocial|psychosocial
5200975|NCT02738021|Psychotherapy|psychotherapy
5200976|NCT02738021|Maternal|maternal
5200977|NCT02737995|Iron deficiency|iron deficiency
5200978|NCT02737982|coronary heart disease|coronary heart disease
5200979|NCT02737982|gender|gender
5200980|NCT02737982|platelet|platelet
5200981|NCT02737982|microvascular dysfunction|microvascular dysfunction
5200982|NCT02737982|sexual hormones|sexual hormones
5200983|NCT02737982|cardiac magnetic resonance|cardiac magnetic resonance
5200984|NCT02737982|percutaneous coronary interventions|percutaneous coronary interventions
5200985|NCT02737969|Transesophageal Echocardiography/angiography (TEE/Angio)|transesophageal echocardiography/angiography (tee/angio)
5200986|NCT02737943|Skin graft|skin graft
5200987|NCT02737943|Burn|burn
5200988|NCT02737943|MEBO|mebo
5200989|NCT02737943|Wound dressing|wound dressing
5200990|NCT02737943|Wound care|wound care
5200991|NCT02737943|Raw Area|raw area
5962514|NCT04280458|psychomotor|psychomotor
5200992|NCT02737930|Acute ischemic stroke|acute ischemic stroke
5200993|NCT02737930|Homonymous hemianopia|homonymous hemianopia
5200994|NCT02737930|Homonymous quadrantanopia|homonymous quadrantanopia
5200995|NCT02737930|Visual field loss|visual field loss
5200996|NCT02737930|Post-stroke recovery|post-stroke recovery
5200998|NCT02737930|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5200999|NCT02737904|Muscle spasticity|muscle spasticity
5201000|NCT02737865|Focal nodular hyperplasia|focal nodular hyperplasia
5201001|NCT02737865|Ultrasonography|ultrasonography
5201002|NCT02737865|Superb-Microvascular imaging|superb-microvascular imaging
5201003|NCT02737865|Contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
5201004|NCT02737813|isobaric marcaine|isobaric marcaine
5201005|NCT02737813|hyperbaric marcaine|hyperbaric marcaine
5201006|NCT02737787|Second or Greater Remission|second or greater remission
5201007|NCT02737787|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
5201008|NCT02737787|Montanide|montanide
5201009|NCT02737787|GM-CSF|gm-csf
5201010|NCT02737787|Nivolumab|nivolumab
5201011|NCT02737787|15-247|15-247
5201012|NCT02737774|Icotinib|icotinib
5201013|NCT02737774|chemotherapy|chemotherapy
5201014|NCT02737774|EGFR|egfr
5201015|NCT02737761|Heart Failure|heart failure
5201016|NCT02737761|Positive Psychology|positive psychology
5201017|NCT02737761|Adherence to Health Behaviors|adherence to health behaviors
5201018|NCT02737748|Donor Site Wounds|donor site wounds
5201019|NCT02737696|prescription opioid|prescription opioid
5201020|NCT02737696|prevention|prevention
5201021|NCT02737696|computer-based|computer-based
5201022|NCT02737696|adolescent|adolescent
5201023|NCT02737683|Disease|disease
5201024|NCT02737683|anxiety|anxiety
5201027|NCT02737683|negative emotional states|negative emotional states
5201028|NCT02737683|functional dyspepsia|functional dyspepsia
5201029|NCT02737657|Canagliflozin|canagliflozin
5201030|NCT02737657|Metformin|metformin
5201031|NCT02737657|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5201032|NCT02737657|INVOKANA|invokana
5201033|NCT02737657|Sulfonylurea|sulfonylurea
5201034|NCT02737644|Congenital Heart Disease|congenital heart disease
5201035|NCT02737644|Key Nutritional Factors|key nutritional factors
5201036|NCT02737644|conception|conception
5201037|NCT02737644|pregnant|pregnant
5201038|NCT02737605|Esketamine|esketamine
5201039|NCT02737605|Healthy|healthy
5201040|NCT02737605|Pharmacokinetics|pharmacokinetics
5201041|NCT02737605|Electrocardiogram|electrocardiogram
5201042|NCT02737605|Repolarization|repolarization
5201043|NCT02737579|cardiac catheterization|cardiac catheterization
5201044|NCT02737579|cardiac MRI|cardiac mri
5201045|NCT02737566|Smoking Cessation|smoking cessation
5201046|NCT02737566|Financial Incentives|financial incentives
5201047|NCT02737566|Contingency Management|contingency management
5201048|NCT02737566|Vulnerable Populations|vulnerable populations
5201049|NCT02737566|Medically Uninsured|medically uninsured
5201050|NCT02737566|Medicaid|medicaid
5201051|NCT02737527|ultrasound|ultrasound
5201052|NCT02737527|lumbar sympathetic block|lumbar sympathetic block
5201053|NCT02737514|adenoma detection rate|adenoma detection rate
5201054|NCT02737514|colonoscopy|colonoscopy
5201055|NCT02737514|water exchange|water exchange
5201056|NCT02737501|Non-small cell lung cancer|non-small cell lung cancer
5201057|NCT02737501|Non-small cell lung carcinoma|non-small cell lung carcinoma
5201058|NCT02737501|Epithelial lung cancer|epithelial lung cancer
5201059|NCT02737501|Squamous cell carcinoma|squamous cell carcinoma
5201060|NCT02737501|Large cell carcinoma|large cell carcinoma
5201061|NCT02737501|Adenocarcinoma|adenocarcinoma
5201062|NCT02737501|Carcinoma|carcinoma
5201063|NCT02737501|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
5201064|NCT02737501|Advanced Cancers|advanced cancers
5201065|NCT02737501|Brigatinib|brigatinib
5201066|NCT02737501|AP26113|ap26113
5201067|NCT02737488|Therapy|therapy
5201068|NCT02737488|Trauma Systems Therapy|trauma systems therapy
5201069|NCT02737410|Resilience|resilience
5201070|NCT02737410|Coping|coping
5201071|NCT02737410|Psychosomatic|psychosomatic
5201072|NCT02737410|Hypnosis|hypnosis
5201073|NCT02737410|Construct Validation|construct validation
5201074|NCT02737384|Combined immunodeficiencies|combined immunodeficiencies
5201075|NCT02737384|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5201076|NCT02737384|CD45RA|cd45ra
5201077|NCT02737384|primitive immunodeficiencies|primitive immunodeficiencies
5201078|NCT02737384|pediatric transplantation|pediatric transplantation
5201079|NCT02737384|CD45RA depletion|cd45ra depletion
5201080|NCT02737358|nicotine|nicotine
5201082|NCT02737358|smoking|smoking
5201083|NCT02737358|cessation|cessation
5201084|NCT02737358|N-acetylcysteine|n-acetylcysteine
5201085|NCT02737358|NAC|nac
5201086|NCT02737358|pharmacotherapy|pharmacotherapy
5201087|NCT02737358|relapse|relapse
5201088|NCT02737358|tobacco use disorder|tobacco use disorder
5189076|NCT02808910|salt|salt
5189077|NCT02808910|vegetables|vegetables
5189078|NCT02808910|portion size|portion size
5189079|NCT02808910|weight loss|weight loss
5189080|NCT02808910|habits|habits
5189081|NCT02808897|Chest tubes|chest tubes
5189082|NCT02808897|Atrial fibrillation|atrial fibrillation
5189083|NCT02808897|Thoracic surgery|thoracic surgery
5189084|NCT02808897|Critical care|critical care
5189085|NCT02808871|TRAIL1|trail1
5201089|NCT02737345|fibrinolysis|fibrinolysis
5201090|NCT02737345|liver transplant|liver transplant
5201091|NCT02737345|thromboelastometry|thromboelastometry
5201092|NCT02737319|Contrast,nephropathy, angioplasty, stable coronary|contrast,nephropathy, angioplasty, stable coronary
5201093|NCT02737306|RIC Allogeneic Stem-Cell Transplantation|ric allogeneic stem-cell transplantation
5201094|NCT02737280|infant|infant
5201095|NCT02737280|high flow nasal cannulae|high flow nasal cannulae
5201096|NCT02737280|oxygen therapy|oxygen therapy
5201097|NCT02737280|bronchiolitis|bronchiolitis
5201098|NCT02737267|Genetics|genetics
5201099|NCT02737267|Polymorphism|polymorphism
5201100|NCT02737267|Epigenetics|epigenetics
5201101|NCT02737267|Metagenomics|metagenomics
5201102|NCT02737267|Metabolomics|metabolomics
5201103|NCT02737267|Metabolic syndrome conditions|metabolic syndrome conditions
5201104|NCT02737267|Precision nutrition|precision nutrition
5201105|NCT02737254|Attachment|attachment
5201106|NCT02737254|Oxytocin|oxytocin
5201107|NCT02737254|Cognitive bias modification|cognitive bias modification
5201108|NCT02737254|Middle childhood|middle childhood
5201109|NCT02737241|Prostate|prostate
5201110|NCT02737241|Laser|laser
5201111|NCT02737241|Enucleation|enucleation
5201112|NCT02737202|LAM|lam
5201113|NCT02737189|Basilar Artery Occlusion|basilar artery occlusion
5201114|NCT02737189|Ischemic Stroke|ischemic stroke
5197585|NCT02759601|Tefinostat|tefinostat
5201129|NCT02737098|virtual care|virtual care
5201130|NCT02737098|implementation|implementation
5201131|NCT02737098|telepsychiatry|telepsychiatry
5201132|NCT02737098|telepsychology|telepsychology
5201133|NCT02737085|CD19-targeted CAR-T Cell|cd19-targeted car-t cell
5201134|NCT02737085|CD20-targeted CAR-T Cell|cd20-targeted car-t cell
5201135|NCT02737085|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5201136|NCT02737072|immuno-oncology|immuno-oncology
5201137|NCT02737046|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
5201139|NCT02737033|ADHD|adhd
5201140|NCT02737033|Adults|adults
5201141|NCT02737033|Treatment|treatment
5201142|NCT02737033|Rhodiola|rhodiola
5201143|NCT02737020|ADHD|adhd
5201144|NCT02737020|Adults|adults
5201145|NCT02737020|Treatment|treatment
5201146|NCT02737020|Rhodiola rosea|rhodiola rosea
5201147|NCT02737007|Malaria|malaria
5201148|NCT02737007|Microdose|microdose
5201149|NCT02737007|GSK3191607|gsk3191607
5201150|NCT02736994|edentulous|edentulous
5201151|NCT02736994|patients|patients
5201152|NCT02736994|with full|with full
5201153|NCT02736981|Obesity|obesity
5201154|NCT02736981|Weight Loss|weight loss
5201155|NCT02736981|Young Adults|young adults
5201161|NCT02736890|Botulinum Toxin A|botulinum toxin a
5201162|NCT02736890|Neuropathic pain|neuropathic pain
5201163|NCT02736890|Spinal cord injury|spinal cord injury
5201164|NCT02736890|Pain management|pain management
5201165|NCT02736890|Rehabilitation|rehabilitation
5201166|NCT02736877|keratoconus|keratoconus
5201167|NCT02736877|bullous keratopathy|bullous keratopathy
5201168|NCT02736877|corneal dystrophy|corneal dystrophy
5201169|NCT02736851|disability|disability
5201170|NCT02736851|home|home
5201171|NCT02736851|stretching exercises|stretching exercises
5201172|NCT02736838|Pressure|pressure
5201173|NCT02736838|Pressure Ulcer|pressure ulcer
5201174|NCT02736838|Skin perfusion|skin perfusion
5201175|NCT02736838|Skin oxygenation|skin oxygenation
5201176|NCT02736812|Randomized controlled trial|randomized controlled trial
5201177|NCT02736812|Lyophilized Plasma|lyophilized plasma
5201178|NCT02736812|Advanced Trauma Life Support Care|advanced trauma life support care
5201179|NCT02736786|proton|proton
5201180|NCT02736773|Guided Bone|guided bone
5201181|NCT02736773|Pre-implant referred|pre-implant referred
5201182|NCT02736773|Regeneration|regeneration
5201183|NCT02736747|Stroke|stroke
5201184|NCT02736747|Muscle Spasticity|muscle spasticity
5201185|NCT02736747|Cryotherapy|cryotherapy
5201186|NCT02736747|Gait|gait
5201187|NCT02736747|Muscle Weakness|muscle weakness
5201188|NCT02736747|Proprioception|proprioception
5201189|NCT02736708|Primary sclerosing cholangitis|primary sclerosing cholangitis
5201190|NCT02736695|PPA|ppa
5201191|NCT02736669|weight loss|weight loss
5201192|NCT02736669|body weight|body weight
5201193|NCT02736669|behavioral|behavioral
5201194|NCT02736643|LDCT, screening|ldct, screening
5201195|NCT02736630|general anaesthesia|general anaesthesia
5201196|NCT02736630|elective surgery|elective surgery
5201197|NCT02736630|national epidemiology|national epidemiology
5201198|NCT02736630|turkey|turkey
5201199|NCT02736565|metastatic|metastatic
5201200|NCT02736565|askin tumor|askin tumor
5201201|NCT02736565|neuroectodermal tumor|neuroectodermal tumor
5201202|NCT02736565|pNET|pnet
5201203|NCT02736565|sarcoma|sarcoma
5201204|NCT02736565|soft tissue|soft tissue
5201205|NCT02736565|ESFT|esft
5201206|NCT02736565|Immunotherapy|immunotherapy
5201207|NCT02736552|Gastric cancer|gastric cancer
5201208|NCT02736552|Adjuvant chemotherapy|adjuvant chemotherapy
5201209|NCT02736552|S-1|s-1
5201210|NCT02736552|D2 resection|d2 resection
5201211|NCT02736526|moderate intermittent exotropia|moderate intermittent exotropia
5197686|NCT02758964|TAVR|tavr
5201212|NCT02736526|surgical treatment|surgical treatment
5201213|NCT02736526|observation|observation
5069046|NCT03567720|TNBC|tnbc
5201214|NCT02736513|Tagrisso|tagrisso
5201215|NCT02736513|AZD9291|azd9291
5201216|NCT02736513|EGFRm|egfrm
5201217|NCT02736513|brain metastases|brain metastases
5201218|NCT02736513|NSCLC|nsclc
5201219|NCT02736500|neuroendocrine tumors|neuroendocrine tumors
5201220|NCT02736500|gastro entero pancreatic neuroendocrine tumors|gastro entero pancreatic neuroendocrine tumors
5201221|NCT02736500|Radioisotope therapy|radioisotope therapy
5201222|NCT02736500|177Lu-DOTATATE|177lu-dotatate
5201223|NCT02736500|METRONOMIC CAPECITABINE|metronomic capecitabine
5201224|NCT02736487|Air Pollution|air pollution
5201225|NCT02736487|Exposure Assessment|exposure assessment
5201226|NCT02736487|Filtration|filtration
5201227|NCT02736487|Cardiovascular Outcomes|cardiovascular outcomes
5201228|NCT02736487|Respiratory Outcomes|respiratory outcomes
5201229|NCT02736487|Short-term Intervention|short-term intervention
5201230|NCT02736461|Orbital fractures|orbital fractures
5201231|NCT02736461|Strabismus|strabismus
5201232|NCT02736461|Predicting factors|predicting factors
5201233|NCT02736461|orbital floor fractures|orbital floor fractures
5201234|NCT02736448|GEP-NET tumors|gep-net tumors
5201235|NCT02736448|Lu-PRRT|lu-prrt
5201236|NCT02736448|177Lutethium - Peptide Receptor Radionuclide Therapy|177lutethium - peptide receptor radionuclide therapy
5201237|NCT02736448|gastro-entero-pancreatic neuroendocrine tumors|gastro-entero-pancreatic neuroendocrine tumors
5201238|NCT02736448|18-FDG Positron Emission Tomography (PET) positive|18-fdg positron emission tomography (pet) positive
5201239|NCT02736448|low dose of capecitabine|low dose of capecitabine
5201240|NCT02736435|Magnetic Resonance Guided High Intensity Focused Ultrasound|magnetic resonance guided high intensity focused ultrasound
5201241|NCT02736435|MR-HIFU|mr-hifu
5201242|NCT02736435|Fibroids|fibroids
5201243|NCT02736435|Leuprolide Acetate|leuprolide acetate
5201244|NCT02736357|Lymphoma|lymphoma
5201245|NCT02736357|Cohort|cohort
5201246|NCT02736357|non-Hodgkin|non-hodgkin
5092596|NCT03420053|HIV+|hiv+
5201247|NCT02736344|coronary luminal diameter|coronary luminal diameter
5201248|NCT02736344|lesions|lesions
5201249|NCT02736344|vessels|vessels
5201250|NCT02736331|Cognitive performance|cognitive performance
5201251|NCT02736331|Metabolic control|metabolic control
5201252|NCT02736331|Pharmacokinetic profile|pharmacokinetic profile
5201253|NCT02736331|Anthocyanins|anthocyanins
5201254|NCT02736305|ovarian|ovarian
5201255|NCT02736305|regorafenib|regorafenib
5201256|NCT02736305|platinum resistant|platinum resistant
5201257|NCT02736305|clear cell|clear cell
5201258|NCT02736305|endometrioid|endometrioid
5201259|NCT02736266|Muscle-invasive|muscle-invasive
5201260|NCT02736266|Urothelial bladder carcinoma|urothelial bladder carcinoma
5201261|NCT02736266|Neoadjuvant therapy|neoadjuvant therapy
5201262|NCT02736266|Radical cystectomy|radical cystectomy
5201263|NCT02736253|foot amputation|foot amputation
5201264|NCT02736253|Osteomyelitis|osteomyelitis
5201265|NCT02736253|Diabetic Foot|diabetic foot
5201266|NCT02736227|liver transplantation|liver transplantation
5201267|NCT02736227|immunosuppression|immunosuppression
5201268|NCT02736227|everolimus|everolimus
5201269|NCT02736227|tacrolimus|tacrolimus
5201270|NCT02736227|kidney function|kidney function
5201271|NCT02736227|liver function|liver function
5201272|NCT02736227|biomarkers|biomarkers
5201273|NCT02736188|GNE Myopathy|gne myopathy
5201274|NCT02736188|GNEM|gnem
5201275|NCT02736188|Nonaka|nonaka
5201276|NCT02736188|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5201277|NCT02736188|HIBM|hibm
5201278|NCT02736188|DMRV|dmrv
5201279|NCT02736188|QSM|qsm
5201280|NCT02736162|Perampanel|perampanel
5201281|NCT02736162|E2007|e2007
5201282|NCT02736162|Phase 4|phase 4
5201283|NCT02736162|Fycompa|fycompa
5201284|NCT02736136|maternal parenting self-efficacy|maternal parenting self-efficacy
5201285|NCT02736136|parental stress|parental stress
5201286|NCT02736136|maternal sensitivity|maternal sensitivity
5201287|NCT02736136|mother-infant bond|mother-infant bond
5201288|NCT02736110|Osteoarthritis, knee|osteoarthritis, knee
5201289|NCT02736084|optimism|optimism
5201290|NCT02736084|positive affect|positive affect
5201291|NCT02736084|adherence|adherence
5201292|NCT02736084|health behavior|health behavior
5201293|NCT02736084|diabetes|diabetes
5201294|NCT02736006|Alveolo-capillar membrane|alveolo-capillar membrane
5201295|NCT02736006|decompression illness|decompression illness
5201296|NCT02736006|diving|diving
5201297|NCT02736006|occupational|occupational
5201298|NCT02735993|Celution|celution
5201299|NCT02735993|ADRC|adrc
5201300|NCT02735993|Heart Failure|heart failure
5201301|NCT02735993|Device|device
5201302|NCT02735980|SCLC|sclc
5201303|NCT02735980|LY2606368|ly2606368
5201304|NCT02735980|CHK1|chk1
5201305|NCT02735915|Immunogenicity|immunogenicity
5962515|NCT04280458|cognitive-motor|cognitive-motor
5201306|NCT02735915|Safety|safety
5201307|NCT02735915|Long term follow-up|long term follow-up
5201308|NCT02735915|Adults|adults
5201309|NCT02735915|Herpes zoster|herpes zoster
5201310|NCT02735902|antivitamins K|antivitamins k
5201311|NCT02735902|direct oral anti-coagulant|direct oral anti-coagulant
5201312|NCT02735876|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5201313|NCT02735876|Btk|btk
5201315|NCT02735876|Mantle Cell Lymphoma|mantle cell lymphoma
5201316|NCT02735876|MCL|mcl
5201317|NCT02735811|Implantable defibrillator|implantable defibrillator
5201318|NCT02735811|Cardiomyopathies|cardiomyopathies
5201319|NCT02735720|thoracic endovascular aortic repair|thoracic endovascular aortic repair
5201320|NCT02735720|endograft|endograft
5201321|NCT02735720|cardiac remodelling|cardiac remodelling
5201322|NCT02735720|thoracic aortic aneurysm|thoracic aortic aneurysm
5201323|NCT02735720|penetrating aortic ulcer|penetrating aortic ulcer
5201324|NCT02735720|MRI|mri
5201325|NCT02735707|Pneumonia|pneumonia
5201326|NCT02735707|Lung Diseases|lung diseases
5201327|NCT02735707|Respiratory Tract Diseases|respiratory tract diseases
5201328|NCT02735707|Respiratory Tract Infections|respiratory tract infections
5201329|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents
5201330|NCT02735707|Moxifloxacin|moxifloxacin
5201331|NCT02735707|Levofloxacin|levofloxacin
5201332|NCT02735707|Cephalosporins|cephalosporins
5201333|NCT02735707|Antibiotics|antibiotics
5201334|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate
5201335|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate
5201336|NCT02735707|Cortisol succinate|cortisol succinate
5201337|NCT02735707|Hydrocortisone|hydrocortisone
5201338|NCT02735707|Anti-Infective Agents|anti-infective agents
5201339|NCT02735694|Sleep apnea|sleep apnea
5201340|NCT02735694|Hypoglossal Nerve|hypoglossal nerve
5201341|NCT02735694|N-methyl-D-aspartate receptors|n-methyl-d-aspartate receptors
5201342|NCT02735694|Cycloserine|cycloserine
5201343|NCT02735694|Short-term potentiation|short-term potentiation
5201344|NCT02735668|Shoulder Pain|shoulder pain
5201345|NCT02735668|Pattern Motor|pattern motor
5201346|NCT02735668|Physical Therapy Modalities|physical therapy modalities
5201347|NCT02735668|Breast Cancer Treatment|breast cancer treatment
5201348|NCT02735655|endoscopy|endoscopy
5201349|NCT02735655|Education|education
5201350|NCT02735655|capsule endoscopy|capsule endoscopy
5201351|NCT02735655|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5201352|NCT02735655|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5201353|NCT02735655|colonoscopy|colonoscopy
5201354|NCT02735655|Double-Balloon Enteroscopy|double-balloon enteroscopy
5201355|NCT02735655|Global status|global status
5201356|NCT02735655|unmet need|unmet need
5201357|NCT02735616|heart rate variability|heart rate variability
5201358|NCT02735616|stroke|stroke
5201359|NCT02735577|Alcohol|alcohol
5201360|NCT02735577|Craving|craving
5201361|NCT02735577|Functional MRI|functional mri
5201362|NCT02735577|Cognitive control|cognitive control
5201363|NCT02735577|Risky decision-making|risky decision-making
5201364|NCT02735577|Disulfiram|disulfiram
5201365|NCT02735564|Weight Loss|weight loss
5201366|NCT02735564|Magnetic Resonance Imaging|magnetic resonance imaging
5201367|NCT02735564|gut microbiota|gut microbiota
5201369|NCT02735551|IUD|iud
5201370|NCT02735551|Contraceptive Implant|contraceptive implant
5201371|NCT02735551|Contraception|contraception
5201372|NCT02735551|Community college|community college
5201373|NCT02735525|telemedicine|telemedicine
5201374|NCT02735525|smartphone|smartphone
5201375|NCT02735499|onabotulinum toxin A|onabotulinum toxin a
5201376|NCT02735499|Urinary bladder|urinary bladder
5201377|NCT02735499|EMDA|emda
5189363|NCT02807415|cystic fibrosis|cystic fibrosis
5201378|NCT02735499|iontophoresis|iontophoresis
5201379|NCT02735499|electrophoresis|electrophoresis
5201380|NCT02735499|Urinary incontinence|urinary incontinence
5201381|NCT02735486|Ginger|ginger
5201382|NCT02735486|blood pressure|blood pressure
5201383|NCT02735486|flow mediated dilatation|flow mediated dilatation
5201384|NCT02735434|Health anxiety|health anxiety
5201385|NCT02735434|illness anxiety disorder|illness anxiety disorder
5201386|NCT02735434|ACT|act
5201387|NCT02735434|internet|internet
5201388|NCT02735421|acne|acne
5201389|NCT02735421|scars|scars
5201390|NCT02735395|Periodontal Diseases|periodontal diseases
5201391|NCT02735395|Metronidazole|metronidazole
5201392|NCT02735395|Amoxicillin|amoxicillin
5201393|NCT02735395|Chronic periodontitis|chronic periodontitis
5201394|NCT02735395|Root Planing|root planing
5201395|NCT02735382|Translational Medical Research|translational medical research
5201396|NCT02735382|Clinical Practice Guidelines|clinical practice guidelines
5201397|NCT02735382|Electronic Health Records|electronic health records
5201398|NCT02735382|Smoking|smoking
5201399|NCT02735382|Tobacco|tobacco
5201400|NCT02735382|Quitline|quitline
5201401|NCT02735330|CCP|ccp
5201402|NCT02735317|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5201403|NCT02735317|radiotherapy|radiotherapy
5201404|NCT02735317|oral mucositis (OM)|oral mucositis (om)
5201405|NCT02735291|Leukemia CAR-T|leukemia car-t
5201406|NCT02735265|Rehabilitation|rehabilitation
5201407|NCT02735265|Virtual reality|virtual reality
5201408|NCT02735252|Castration Resistant|castration resistant
5201409|NCT02735252|Metastatic|metastatic
5201410|NCT02735239|Oesophageal Cancer|oesophageal cancer
5201411|NCT02735239|Oesophageal adenocarcinoma|oesophageal adenocarcinoma
5201412|NCT02735239|Oesophageal squamous cell carcinoma|oesophageal squamous cell carcinoma
5077705|NCT03513809|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5201415|NCT02735239|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
5201416|NCT02735239|Programmed death ligand 1 (PD-L1)|programmed death ligand 1 (pd-l1)
5201417|NCT02735226|stroke|stroke
5201418|NCT02735226|Shanghai Healthcare|shanghai healthcare
5201419|NCT02735226|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
5201420|NCT02735213|Central Serous Choroidopathy|central serous choroidopathy
5201421|NCT02735213|Micropulse Laser Treatment|micropulse laser treatment
5201422|NCT02735213|Traditional laser Treatment|traditional laser treatment
5201423|NCT02735213|optical coherence tomography|optical coherence tomography
5201424|NCT02735174|Telehealth|telehealth
5201425|NCT02735174|Sensor cap|sensor cap
5201426|NCT02735174|School based care|school based care
5201427|NCT02735174|Community health|community health
5201428|NCT02735174|AsthmaTreatSmart Application|asthmatreatsmart application
5201429|NCT02735161|Sarcoidosis|sarcoidosis
5201430|NCT02735161|Fatigue|fatigue
5201431|NCT02735161|Exercise|exercise
5201432|NCT02735148|Postural balance|postural balance
5201433|NCT02735148|Accidental falls|accidental falls
5201434|NCT02735148|Rehabilitation|rehabilitation
5201435|NCT02735148|Cerebrovascular Accident|cerebrovascular accident
5201436|NCT02735148|Walking|walking
5201437|NCT02735148|Mobility limitation|mobility limitation
5201438|NCT02735135|bedridden|bedridden
5201439|NCT02735109|VIN|vin
5201440|NCT02735096|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
5201441|NCT02735096|Unilateral Vestibular Hypofunction|unilateral vestibular hypofunction
5201442|NCT02735096|Imbalance|imbalance
5201443|NCT02735070|Common cold treatment|common cold treatment
5201444|NCT02735057|oesophagus cancer|oesophagus cancer
5201445|NCT02735031|Glucagon-Like Peptide 1|glucagon-like peptide 1
5201446|NCT02735031|Impaired hypoglycemic awareness|impaired hypoglycemic awareness
5201447|NCT02734992|Migraines|migraines
5201448|NCT02734992|Tension-type Headache|tension-type headache
5201449|NCT02734992|Acceptance|acceptance
5201450|NCT02734979|lymphedema|lymphedema
5201451|NCT02734979|edema|edema
5201452|NCT02734966|Drug-Induced|drug-induced
5201453|NCT02734966|Acute Liver Injury|acute liver injury
5201454|NCT02734953|Inhaled nitric oxide|inhaled nitric oxide
5201455|NCT02734953|Exercise|exercise
5201456|NCT02734953|6 minute walk test|6 minute walk test
5201457|NCT02734953|CardioMems|cardiomems
5201458|NCT02734927|schizophrenia|schizophrenia
5201459|NCT02734927|motivation|motivation
5201460|NCT02734927|executive control|executive control
5201461|NCT02734901|polyphenols|polyphenols
5201462|NCT02734901|vascular function|vascular function
5201463|NCT02734901|endothelial function|endothelial function
5201464|NCT02734901|raspberry|raspberry
5201465|NCT02734888|arterial inflammation|arterial inflammation
5201466|NCT02734888|electronic cigarettes|electronic cigarettes
5201467|NCT02734888|PET scan|pet scan
5201468|NCT02734875|anticoagulants|anticoagulants
5201470|NCT02734875|warfarin|warfarin
5201471|NCT02734875|randomized designed delay|randomized designed delay
5201472|NCT02734875|intervention|intervention
5201513|NCT02734602|depression|depression
5201514|NCT02734602|post-traumatic stress disorder|post-traumatic stress disorder
5201515|NCT02734602|sv2a|sv2a
5201516|NCT02734602|ketamine|ketamine
5201518|NCT02734589|Ulcerative Colitis|ulcerative colitis
5201519|NCT02734589|Nutrition|nutrition
5201520|NCT02734589|microbiome|microbiome
5201523|NCT02734550|Sepsis|sepsis
5201524|NCT02734550|Invasive Candida Infection|invasive candida infection
5201525|NCT02734550|Biomarker|biomarker
5201526|NCT02734550|(1,3)-β-D-glucan|(1,3)-β-d-glucan
5201527|NCT02734550|Antifungal therapy|antifungal therapy
5201528|NCT02734550|Intensive care medicine|intensive care medicine
5201529|NCT02734550|Critically ill|critically ill
5201530|NCT02734524|Natural killer cells|natural killer cells
5201531|NCT02734524|NSCLC|nsclc
5201533|NCT02734524|Combined therapy|combined therapy
5201534|NCT02734485|Progressive supranuclear palsy|progressive supranuclear palsy
5201535|NCT02734485|Deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
5201536|NCT02734472|blood pressure|blood pressure
5201537|NCT02734472|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5201538|NCT02734472|Vascular Stiffness|vascular stiffness
5201539|NCT02734472|Proteinuria|proteinuria
5201540|NCT02734472|Carotid Artery Diseases|carotid artery diseases
5201541|NCT02734446|Bronchial Inflammation|bronchial inflammation
5201542|NCT02734446|Asthma|asthma
5201543|NCT02734446|Childhood Asthma Control Test (C-ACT)|childhood asthma control test (c-act)
5201544|NCT02734446|Asthma Exacerbations|asthma exacerbations
5201545|NCT02734433|Advanced solid tumors|advanced solid tumors
5201546|NCT02734433|Asian subjects|asian subjects
5201547|NCT02734433|Developmental Phase I|developmental phase i
5201548|NCT02734420|Dental caries|dental caries
5201549|NCT02734420|PDT|pdt
5201550|NCT02734420|LLLT|lllt
5201551|NCT02734420|pediatric dentistry|pediatric dentistry
5201552|NCT02734394|exercise|exercise
5201553|NCT02734394|body composition|body composition
5962516|NCT04280458|adaptative skill|adaptative skill
5962517|NCT04280445|Aging|aging
5125585|NCT03209531|ACL|acl
5201554|NCT02734394|metabolism|metabolism
5201555|NCT02734394|nutrition|nutrition
5201556|NCT02734381|elderly patients|elderly patients
5201557|NCT02734381|prevalence|prevalence
5201558|NCT02734381|emergency department use|emergency department use
5201559|NCT02734381|main presenting disease|main presenting disease
5201560|NCT02734355|atrial fibrillation|atrial fibrillation
5201561|NCT02734355|catheter ablation|catheter ablation
5201562|NCT02734355|left atrium|left atrium
5201563|NCT02734355|mechanical function|mechanical function
5201564|NCT02734355|contractility|contractility
5201565|NCT02734329|Nephron sparing surgery|nephron sparing surgery
5201566|NCT02734329|Zero ischemia|zero ischemia
5201567|NCT02734329|Warm ischemia|warm ischemia
5201568|NCT02734329|Laparoscopic|laparoscopic
5201569|NCT02734329|Radiofrequency ablation|radiofrequency ablation
5201570|NCT02734329|Microwave ablation|microwave ablation
5201575|NCT02734290|metastatic|metastatic
5201576|NCT02734290|Human epidermal growth factor receptor 2 (HER2) negative breast cancer|human epidermal growth factor receptor 2 (her2) negative breast cancer
5092888|NCT03418220|Inflammation|inflammation
5201577|NCT02734290|Estrogen Receptor (ER) negative breast cancer|estrogen receptor (er) negative breast cancer
5201578|NCT02734290|Progesterone Receptor (PR) negative breast cancer|progesterone receptor (pr) negative breast cancer
5201579|NCT02734290|Immunotherapy|immunotherapy
5201580|NCT02734290|Breast Cancer|breast cancer
5201581|NCT02734277|Insulin|insulin
5201582|NCT02734277|Glucose Intolerance|glucose intolerance
5201583|NCT02734277|Prior ITN027AI Study Participants-NCT00129259|prior itn027ai study participants-nct00129259
5342977|NCT01981317|Psychotherapy|psychotherapy
5201584|NCT02734277|Prior ITN045AI Study Participants-NCT00965458|prior itn045ai study participants-nct00965458
5201585|NCT02734251|Healthy mood|healthy mood
5201586|NCT02734251|Stress management|stress management
5201588|NCT02734251|Healthy subjects|healthy subjects
5201589|NCT02734225|total knee replacement|total knee replacement
5201590|NCT02734225|total knee arthroplasty|total knee arthroplasty
5201591|NCT02734225|rehabilitation|rehabilitation
5201592|NCT02734225|physical therapy|physical therapy
5201593|NCT02734225|balance|balance
5201594|NCT02734212|Stigmatization|stigmatization
5201595|NCT02734199|Birth Control|birth control
5201596|NCT02734199|Contraception|contraception
5201597|NCT02734199|IUD|iud
5201598|NCT02734186|Filariasis|filariasis
5201599|NCT02734186|Schistosoma Mansoni|schistosoma mansoni
5201600|NCT02734186|Coinfection|coinfection
5201601|NCT02734160|immunotherapy|immunotherapy
5201602|NCT02734160|check point inhibitors|check point inhibitors
5201603|NCT02734160|transforming growth factor (TGF)-beta R1 kinase inhibitor|transforming growth factor (tgf)-beta r1 kinase inhibitor
5201604|NCT02734134|Periprosthetic joint infection|periprosthetic joint infection
5201605|NCT02734121|breast cancer|breast cancer
5201606|NCT02734121|breast reconstruction|breast reconstruction
5201607|NCT02734121|shared decision making|shared decision making
5201608|NCT02734121|decision support intervention|decision support intervention
5201609|NCT02734108|Sever anorexia nervosa|sever anorexia nervosa
5201610|NCT02734082|stroke|stroke
5201611|NCT02734082|ischemia|ischemia
5201612|NCT02734082|Berne|berne
5201613|NCT02734069|carboplatin|carboplatin
5201614|NCT02734043|bundled payment|bundled payment
5201615|NCT02734030|Anterior Knee Pain Syndrome|anterior knee pain syndrome
5201616|NCT02734030|Quadriceps Femoris|quadriceps femoris
5201617|NCT02734030|Muscle Inhibition|muscle inhibition
5201618|NCT02734030|Interpolated Twitch Technique|interpolated twitch technique
5201619|NCT02734030|Muscle Architecture|muscle architecture
5201620|NCT02734030|Single Leg Squat|single leg squat
5201621|NCT02734030|Women Knee Pain|women knee pain
5201622|NCT02734004|MEDIOLA|mediola
5201623|NCT02734004|Olaparib|olaparib
5201624|NCT02734004|MEDI4736|medi4736
5201625|NCT02734004|Bevacizumab|bevacizumab
5201626|NCT02734004|Ovarian cancer|ovarian cancer
5201627|NCT02734004|Breast cancer|breast cancer
5201628|NCT02734004|Small Cell Lung Cancer|small cell lung cancer
5201629|NCT02734004|Gastric Cancer|gastric cancer
5201630|NCT02734004|Phase I/II, Adults|phase i/ii, adults
5201631|NCT02734004|PDL-1|pdl-1
5201632|NCT02733978|Ozone oxygen|ozone oxygen
5201633|NCT02733978|ulcer healing|ulcer healing
5201634|NCT02733965|clinical pharmacy consultations|clinical pharmacy consultations
5201635|NCT02733965|oral anti-cancer therapy|oral anti-cancer therapy
5201636|NCT02733965|serious adverse events|serious adverse events
5201637|NCT02733965|medication reconciliation|medication reconciliation
5201638|NCT02733939|technology|technology
5201639|NCT02733939|informal care|informal care
5201640|NCT02733939|caregiver burden|caregiver burden
5201641|NCT02733913|atrial fibrillation|atrial fibrillation
5201642|NCT02733913|pulmonary vein isolation|pulmonary vein isolation
5201643|NCT02733913|heart rate turbulence|heart rate turbulence
5201644|NCT02733913|baroreflex sensitivity|baroreflex sensitivity
5201645|NCT02733900|aseptic osteonecrosis|aseptic osteonecrosis
5201646|NCT02733900|femoral head|femoral head
5201647|NCT02733900|micro scanner|micro scanner
5201648|NCT02733900|Raman spectrometry|raman spectrometry
5201649|NCT02733900|MRI|mri
5201650|NCT02733861|dental implant|dental implant
5962518|NCT04280445|Acceptance and Commitment Therapy|acceptance and commitment therapy
5125723|NCT03208686|Men|men
5201651|NCT02733861|stability|stability
5201652|NCT02733861|implant stability quotient|implant stability quotient
5201653|NCT02733848|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5201654|NCT02733848|Hypoglycemia|hypoglycemia
5201656|NCT02733822|opiate|opiate
5201657|NCT02733822|heroin|heroin
5201658|NCT02733822|opioid|opioid
5201659|NCT02733822|overdose|overdose
5201660|NCT02733822|naloxone|naloxone
5201661|NCT02733809|Hepatocellular Carcinoma|hepatocellular carcinoma
5201662|NCT02733809|Sorafenib|sorafenib
5201663|NCT02733796|zika virus|zika virus
5092998|NCT03417362|education|education
5201664|NCT02733796|semen analysis|semen analysis
5201665|NCT02733796|sexual transmission|sexual transmission
5201666|NCT02733757|Clonidine|clonidine
5201667|NCT02733757|Sub-Tenon's and Peribulbar block|sub-tenon's and peribulbar block
5201668|NCT02733757|IOP|iop
5201669|NCT02733757|OPP|opp
5201670|NCT02733757|OPA|opa
5201671|NCT02733744|Stem cell transplant|stem cell transplant
5201672|NCT02733744|fecal microbiota transplantation|fecal microbiota transplantation
5201673|NCT02733718|Necrotizing enterocolitis|necrotizing enterocolitis
5201674|NCT02733718|Transfusion|transfusion
5201675|NCT02733718|Mesenteric Oxygenisation|mesenteric oxygenisation
5201676|NCT02733705|Pain|pain
5201677|NCT02733705|TRUS biopsy|trus biopsy
5201678|NCT02733692|HIV|hiv
5201679|NCT02733692|STDs|stds
5201680|NCT02733692|web-based app|web-based app
5201681|NCT02733692|women|women
5201682|NCT02733666|Absorbable screw|absorbable screw
5201683|NCT02733666|Internal fixation|internal fixation
5201684|NCT02733666|Children|children
5201685|NCT02733653|Superficial Femoral Artery|superficial femoral artery
5201686|NCT02733653|Proximal Popliteal Artery|proximal popliteal artery
5201687|NCT02733653|Endovascular therapy|endovascular therapy
5201688|NCT02733653|Atherectomy|atherectomy
5201689|NCT02733601|breast cancer epidemiology algeria registry|breast cancer epidemiology algeria registry
5201690|NCT02733588|hypoglycemia|hypoglycemia
5201691|NCT02733588|glucagon|glucagon
5201692|NCT02733588|glucose metabolism disorders|glucose metabolism disorders
5201693|NCT02733588|hormones|hormones
5201694|NCT02733588|gastrointestinal agents|gastrointestinal agents
5201695|NCT02733588|bariatric surgery|bariatric surgery
5201696|NCT02733588|incretins|incretins
5201697|NCT02733536|endotracheal intubation|endotracheal intubation
5201698|NCT02733536|trauma|trauma
5201699|NCT02733536|paramedic|paramedic
5201700|NCT02733510|kidney transplantation|kidney transplantation
5201701|NCT02733510|subclinical rejection|subclinical rejection
5201702|NCT02733510|steroid pulse therapy|steroid pulse therapy
5201703|NCT02733497|sympathectomy, sympathicotomy, heart rate variability,|sympathectomy, sympathicotomy, heart rate variability,
5201704|NCT02733484|Obesity,Probiotics,Treatment|obesity,probiotics,treatment
5201706|NCT02733471|Endoscopy|endoscopy
5201707|NCT02733471|Tolerance|tolerance
5201708|NCT02733393|Thoracotomy|thoracotomy
5201709|NCT02733393|Postoperative|postoperative
5201710|NCT02733393|Lidocaine|lidocaine
5201711|NCT02733393|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5201712|NCT02733380|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5201713|NCT02733380|Relapsed and refractory|relapsed and refractory
5201714|NCT02733380|Histone deacetylase inhibitor|histone deacetylase inhibitor
5201715|NCT02733380|Chidamide|chidamide
5201716|NCT02733341|Adenosine Diphosphate|adenosine diphosphate
5201717|NCT02733341|Cardiovascular Magnetic Resonance (CMR)|cardiovascular magnetic resonance (cmr)
5201718|NCT02733341|Index of microvascular resistance (IMR)|index of microvascular resistance (imr)
5201719|NCT02733341|Vasodilator stimulated phosphoprotein phosphorylation (VASP)|vasodilator stimulated phosphoprotein phosphorylation (vasp)
5201720|NCT02733341|Pharmacodynamic|pharmacodynamic
5201721|NCT02733341|Antiplatelet|antiplatelet
5201722|NCT02733341|Myocardial Infarction (MI)|myocardial infarction (mi)
5201723|NCT02733341|Cangrelor|cangrelor
5201724|NCT02733341|Ticagrelor|ticagrelor
5201725|NCT02733341|Coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
5201726|NCT02733341|Primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
5201727|NCT02733328|Cardio-pulmonary bypass (CPB)|cardio-pulmonary bypass (cpb)
5201728|NCT02733328|renal replacement therapy (RRT)|renal replacement therapy (rrt)
5201729|NCT02733328|enzyme-linked immunosorbent assay (ELISA)|enzyme-linked immunosorbent assay (elisa)
5201730|NCT02733263|gut microbiota|gut microbiota
5201731|NCT02733263|fiber|fiber
5201732|NCT02733263|diet quality|diet quality
5201733|NCT02733263|immunity|immunity
5201734|NCT02733250|NSCLC|nsclc
5201735|NCT02733250|Pembrolizumab|pembrolizumab
5201736|NCT02733250|Nab-paclitaxel|nab-paclitaxel
5201737|NCT02733237|oxytocin|oxytocin
5201738|NCT02733237|infidelity|infidelity
5201739|NCT02733224|lenalidomide adherence MEMS|lenalidomide adherence mems
5201740|NCT02733211|Closed Loop|closed loop
5201741|NCT02733185|chelation|chelation
5201742|NCT02733172|Vulvodynia|vulvodynia
5201743|NCT02733172|Endophenotypes|endophenotypes
5201744|NCT02733172|functional MRI|functional mri
5201745|NCT02733159|Performance Status 2|performance status 2
5962519|NCT04280445|Psychological distress|psychological distress
5201746|NCT02733159|Pembrolizumab|pembrolizumab
5201748|NCT02733133|Testosterone|testosterone
5201749|NCT02733133|AndroGel|androgel
5198207|NCT02755831|OSA|osa
5201750|NCT02733133|Transference|transference
5201751|NCT02733133|Women|women
5201752|NCT02733133|Children|children
5201753|NCT02733107|Non-small Cell Lung Cancer|non-small cell lung cancer
5201754|NCT02733107|Apatinib|apatinib
5201755|NCT02733107|Etoposide|etoposide
5201756|NCT02733081|Long Acting Reversible Contraception|long acting reversible contraception
5201757|NCT02733081|Intrauterine Device (IUD)|intrauterine device (iud)
5201758|NCT02733081|Intrauterine Device (IUD) Insertion|intrauterine device (iud) insertion
5201759|NCT02733081|Family Planning|family planning
5201760|NCT02733081|International Family Planning|international family planning
5201761|NCT02733055|Postural Equilibrium|postural equilibrium
5201762|NCT02733055|Musculoskeletal Equilibrium|musculoskeletal equilibrium
5201763|NCT02733055|Eye Movements|eye movements
5201764|NCT02733055|Saccades|saccades
5201765|NCT02733055|Pursuit, Smooth|pursuit, smooth
5201766|NCT02733042|Lymphoma|lymphoma
5201767|NCT02733042|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5201768|NCT02733042|Durvalumab|durvalumab
5201769|NCT02733042|Anti-PD-L1 Antibody|anti-pd-l1 antibody
5201770|NCT02733042|MEDI4736|medi4736
5201771|NCT02733042|Immune Checkpoint|immune checkpoint
5201772|NCT02733042|Lymphatic Disease|lymphatic disease
5201773|NCT02733042|B-Cell Malignancies|b-cell malignancies
5201774|NCT02733042|Abscopal Effect|abscopal effect
5201775|NCT02733042|Lenalidomide|lenalidomide
5201776|NCT02733042|Bendamustine|bendamustine
5201777|NCT02733042|Rituximab|rituximab
5201780|NCT02733042|Lymphoma, Non Hodgkin,|lymphoma, non hodgkin,
5189759|NCT02804750|Type 2 Diabetes|type 2 diabetes
5189760|NCT02804750|Impaired Glucose Intolerance|impaired glucose intolerance
5189761|NCT02804750|Hypertension|hypertension
5189763|NCT02804750|Adrenocortical Carcinoma|adrenocortical carcinoma
5201781|NCT02733042|Hodgkin Disease|hodgkin disease
5201782|NCT02733042|Leukemia, Lymphocytic, Chronic, B-Cell,|leukemia, lymphocytic, chronic, b-cell,
5201783|NCT02733042|Lymphoma, Follicular|lymphoma, follicular
5201784|NCT02733042|Lymphoma, Diffuse Large B-Cell|lymphoma, diffuse large b-cell
5201785|NCT02733042|Lymphoma, Mantle Cell|lymphoma, mantle cell
5201786|NCT02733042|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
5201787|NCT02733042|Immune System Diseases|immune system diseases
5201788|NCT02733042|Immunoproliferative Disorders|immunoproliferative disorders
5201789|NCT02733042|Lymphoproliferative Disorders|lymphoproliferative disorders
5201790|NCT02733003|Implementation Science|implementation science
5201791|NCT02733003|HIV|hiv
5201792|NCT02733003|Sexual Risk|sexual risk
5201793|NCT02733003|Sexually Transmitted Diseases|sexually transmitted diseases
5201794|NCT02733003|Substance Abuse|substance abuse
5201795|NCT02733003|Violence and Victimization|violence and victimization
5201796|NCT02733003|Linkage to care|linkage to care
5201797|NCT02733003|Gender-based Violence|gender-based violence
5201798|NCT02733003|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
5201799|NCT02732990|Training|training
5201800|NCT02732990|One-legged exercise|one-legged exercise
5201801|NCT02732990|Peripheral blood flow|peripheral blood flow
5201802|NCT02732990|Cardiac function|cardiac function
5201803|NCT02732990|Muscle metaboreflex|muscle metaboreflex
5201804|NCT02732964|satisfaction|satisfaction
5201805|NCT02732938|CCR2i, nab-paclitaxel, Abraxane, gemcitabine, pancreas|ccr2i, nab-paclitaxel, abraxane, gemcitabine, pancreas
5201806|NCT02732925|Vertebral Compression Fracture|vertebral compression fracture
5201807|NCT02732925|Balloon Kyphoplasty|balloon kyphoplasty
5201808|NCT02732925|Conservative treatment|conservative treatment
5201809|NCT02732925|Sham procedure|sham procedure
5201810|NCT02732925|VCFs|vcfs
5201811|NCT02732925|Multiple Myeloma|multiple myeloma
5201812|NCT02732912|falls|falls
5201813|NCT02732912|sleep|sleep
5201814|NCT02732899|AMD|amd
5201815|NCT02732886|foam dressing|foam dressing
5201816|NCT02732860|personalized patient-derived xenografts (pPDX)|personalized patient-derived xenografts (ppdx)
5201817|NCT02732860|molecular profiling|molecular profiling
5201818|NCT02732860|epigenetic analysis|epigenetic analysis
5201819|NCT02732860|drug sensitivity testing|drug sensitivity testing
5201820|NCT02732860|triple negative|triple negative
5201821|NCT02732860|metastatic|metastatic
5201822|NCT02732860|serous|serous
5201823|NCT02732847|Respiratory infections|respiratory infections
5201824|NCT02732847|Primary care|primary care
5201825|NCT02732847|Antibiotics|antibiotics
5201826|NCT02732847|Delayed prescriptions|delayed prescriptions
5201829|NCT02732821|Gastroparesis|gastroparesis
5201830|NCT02732821|G-POEM|g-poem
5201831|NCT02732821|Gastric Per Oral Endoscopic Myotomy|gastric per oral endoscopic myotomy
5201832|NCT02732808|Double stimulations|double stimulations
5201833|NCT02732808|luteal-phase ovarian stimulation|luteal-phase ovarian stimulation
5201834|NCT02732808|poor ovarian response|poor ovarian response
5201835|NCT02732782|Achilles tendon|achilles tendon
5201836|NCT02732782|isometric muscle training|isometric muscle training
5201837|NCT02732782|competitive sports|competitive sports
5201838|NCT02732782|strength training|strength training
5201839|NCT02732782|eccentric exercise|eccentric exercise
5201840|NCT02732782|isometric exercise|isometric exercise
5078159|NCT03511365|Probiotic|probiotic
5078160|NCT03511365|Microbiome|microbiome
5078161|NCT03511365|Inflammation|inflammation
5078162|NCT03511365|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5078163|NCT03511339|Concussion|concussion
5078164|NCT03511326|field-treatment|field-treatment
5078167|NCT03511300|Cognition|cognition
5201841|NCT02732782|chronic condition|chronic condition
5201842|NCT02732782|regeneration|regeneration
5201843|NCT02732782|tendon|tendon
5201844|NCT02732782|tendon properties|tendon properties
5201851|NCT02732756|Sleep|sleep
5201852|NCT02732756|Attention|attention
5201853|NCT02732756|Adolescence|adolescence
5201854|NCT02732743|childhod constipation|childhod constipation
5201855|NCT02732730|ART (Antir-retroviral therapy)|art (antir-retroviral therapy)
5201955|NCT02732119|PR-positive|pr-positive
5201856|NCT02732730|PrEP (Pre-Exposure Prophylaxis)|prep (pre-exposure prophylaxis)
5201857|NCT02732730|DAIDS (Division of AIDS)|daids (division of aids)
5201858|NCT02732730|HPTN (HIV Prevention Trials Network)|hptn (hiv prevention trials network)
5201859|NCT02732704|Aortic Valve Disease|aortic valve disease
5201860|NCT02732704|Aortic Regurgitation|aortic regurgitation
5201861|NCT02732704|Aortic Insufficiency|aortic insufficiency
5201862|NCT02732691|Aortic Valve Disease|aortic valve disease
5201863|NCT02732691|Aortic Valve Stenosis|aortic valve stenosis
5201864|NCT02732613|Laryngeal Mask Airway|laryngeal mask airway
5201865|NCT02732613|Body weight|body weight
5201866|NCT02732613|Complication|complication
5270826|NCT02326051|APS|aps
5189857|NCT02804165|Enterovirus|enterovirus
5201867|NCT02732600|Veterans|veterans
5201868|NCT02732600|Veterans Health|veterans health
5201869|NCT02732600|Patient Compliance|patient compliance
5201870|NCT02732600|Primary Health Care|primary health care
5201871|NCT02732600|Health Care Providers|health care providers
5201872|NCT02732600|Health Promotion|health promotion
5201873|NCT02732522|misoprostol|misoprostol
5201874|NCT02732522|induction of labor|induction of labor
5201875|NCT02732522|sublingual|sublingual
5201876|NCT02732496|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5201877|NCT02732496|Tourette Syndrome|tourette syndrome
5201878|NCT02732496|Working Memory Training|working memory training
5201879|NCT02732483|gastric cancer|gastric cancer
5201880|NCT02732483|bleeding|bleeding
5201881|NCT02732483|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5201882|NCT02732470|Systemic Lupus Erythematous|systemic lupus erythematous
5201884|NCT02732470|Quality of life|quality of life
5201885|NCT02732457|HIV|hiv
5201886|NCT02732457|Persistence|persistence
5201887|NCT02732457|Reservoirs|reservoirs
5201888|NCT02732457|Stem Cell Transplant|stem cell transplant
5201889|NCT02732457|Functional Cure|functional cure
5201890|NCT02732444|Erythrocytes Membranes Stability|erythrocytes membranes stability
5201891|NCT02732444|Oxidative Stress|oxidative stress
5201892|NCT02732444|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5201893|NCT02732444|Advanced Pulmonary Disease (APD)|advanced pulmonary disease (apd)
5201894|NCT02732444|Long-Term Home Oxygen Therapy (LTOT)|long-term home oxygen therapy (ltot)
5201895|NCT02732418|CI-contraceptive injection|ci-contraceptive injection
5201896|NCT02732418|DMPA-Depot medroxyprogesterone acetate|dmpa-depot medroxyprogesterone acetate
5201897|NCT02732418|MPA-Medroxyprogesterone Acetate|mpa-medroxyprogesterone acetate
5201898|NCT02732418|subQ-subcutaneous|subq-subcutaneous
5201899|NCT02732379|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5201900|NCT02732379|Aromatherapy|aromatherapy
5201901|NCT02732379|Quality of Health Care|quality of health care
5201902|NCT02732366|aged [MeSH term]|aged [mesh term]
5201903|NCT02732366|exercise [MeSH term]|exercise [mesh term]
5201904|NCT02732340|triple-branched stent graft|triple-branched stent graft
5201905|NCT02732340|the occluded rate of false lumen|the occluded rate of false lumen
5201906|NCT02732275|Adult T-cell leukemia-lymphoma (ATL)|adult t-cell leukemia-lymphoma (atl)
5201907|NCT02732275|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
5201908|NCT02732262|acute pain|acute pain
5201909|NCT02732262|postoperative|postoperative
5201910|NCT02732262|surgery|surgery
5201911|NCT02732249|Helicobacter pylori|helicobacter pylori
5201912|NCT02732249|Clarithromycin|clarithromycin
5201913|NCT02732249|Amoxicillin|amoxicillin
5201914|NCT02732249|Metronidazole|metronidazole
5201915|NCT02732249|Eradication|eradication
5201916|NCT02732236|marginal zone lymphoma|marginal zone lymphoma
5201917|NCT02732236|Cohort|cohort
5201918|NCT02732236|Rituximab|rituximab
5201919|NCT02732236|HBV|hbv
5201920|NCT02732223|Atherosclerosis|atherosclerosis
5201921|NCT02732223|omega 3|omega 3
5201922|NCT02732223|plant sterols|plant sterols
5201923|NCT02732223|polyphenols|polyphenols
5201924|NCT02732184|AML|aml
5201925|NCT02732184|MDS|mds
5201926|NCT02732158|Novel laboratory methods|novel laboratory methods
5962520|NCT04280445|Anxiety|anxiety
5962521|NCT04280445|Depression|depression
5962522|NCT04280445|Hermeneutics|hermeneutics
5962523|NCT04280419|Motivational Music|motivational music
5962524|NCT04280419|respiratory muscle endurance|respiratory muscle endurance
5962525|NCT04280419|perceived exertion|perceived exertion
5962526|NCT04280406|dental implants|dental implants
5962527|NCT04280406|antibiotics|antibiotics
5962528|NCT04280406|bone|bone
5201927|NCT02732145|Three-Vulvar-Rings|three-vulvar-rings
5201928|NCT02732145|Three-Rings-Vulvoscopy|three-rings-vulvoscopy
5201929|NCT02732145|N-S-P scheme|n-s-p scheme
5201930|NCT02732145|Vulvoscopy Index|vulvoscopy index
5201931|NCT02732145|Vulvar Dermatosis|vulvar dermatosis
5201932|NCT02732145|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
5201933|NCT02732145|Lichen Planus|lichen planus
5201935|NCT02732145|Vulvodynia|vulvodynia
5201936|NCT02732145|Provoked Vestibulodynia|provoked vestibulodynia
5201937|NCT02732145|Vulvar Vestibulitis|vulvar vestibulitis
5201938|NCT02732145|Vulvar Diseases|vulvar diseases
5201939|NCT02732119|HR-positive|hr-positive
5201940|NCT02732119|HER2-negative|her2-negative
5201941|NCT02732119|Advanced breast cancer|advanced breast cancer
5201942|NCT02732119|LEE011|lee011
5201943|NCT02732119|ribociclib|ribociclib
5201944|NCT02732119|everolimus|everolimus
5201945|NCT02732119|Afinitor|afinitor
5201946|NCT02732119|exemestane|exemestane
5201947|NCT02732119|Aromasin|aromasin
5201949|NCT02732119|CDK4|cdk4
5201950|NCT02732119|CDK6|cdk6
5201951|NCT02732119|CDK4/6|cdk4/6
5201952|NCT02732119|CDK4/6 inhibitor|cdk4/6 inhibitor
5201953|NCT02732119|Phase III|phase iii
5201954|NCT02732119|ER-positive|er-positive
5201956|NCT02732119|Postmenopausal|postmenopausal
5201957|NCT02732106|ADRCs, cell characterization|adrcs, cell characterization
5201958|NCT02732080|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5201959|NCT02732080|microvascular obstruction|microvascular obstruction
5201960|NCT02732080|myocardial edema|myocardial edema
5201961|NCT02732080|microvascular resistance|microvascular resistance
5940711|NCT00419562|oral insulin|oral insulin
5940712|NCT00419562|autoantigen|autoantigen
5189977|NCT02803346|sepsis|sepsis
5201962|NCT02732080|acute myocardial infarction|acute myocardial infarction
5201963|NCT02732067|Anesthesia|anesthesia
5201964|NCT02732054|HBV vaccination, immunity|hbv vaccination, immunity
5201965|NCT02732002|shoulder|shoulder
5201966|NCT02732002|rotator cuff- injury|rotator cuff- injury
5201967|NCT02732002|management|management
5201968|NCT02732002|rehabilitation model|rehabilitation model
5201976|NCT02731924|Emergency Department|emergency department
5201978|NCT02731872|oxygen treatment|oxygen treatment
5201979|NCT02731872|quality of life|quality of life
5201980|NCT02731846|Efficacy|efficacy
5201981|NCT02731846|Triple therapy|triple therapy
5201982|NCT02731846|Parallel|parallel
5201983|NCT02731846|Respiratory|respiratory
5201984|NCT02731820|potassium citrate|potassium citrate
5201985|NCT02731807|TA-65|ta-65
5201986|NCT02731807|Telemorase|telemorase
5201987|NCT02731807|Dietary Supplement|dietary supplement
5201988|NCT02731794|cardiopulmonary bypass|cardiopulmonary bypass
5201989|NCT02731794|coronary artery bypass grafting|coronary artery bypass grafting
5201990|NCT02731794|inflammatory response|inflammatory response
5201991|NCT02731794|cardiac dysfunction|cardiac dysfunction
5201992|NCT02731781|OUTCOME|outcome
5201993|NCT02731781|PROGNOSIS|prognosis
5201994|NCT02731781|PEDIATRIC HEAd injury|pediatric head injury
5201995|NCT02731781|CT SCAN|ct scan
5201996|NCT02731755|Oats|oats
5201997|NCT02731755|Phenolic acid|phenolic acid
5201999|NCT02731755|LDI|ldi
5202000|NCT02731755|Avenanthramide|avenanthramide
5202001|NCT02731729|Ipilimumab|ipilimumab
5202002|NCT02731729|Nivolumab|nivolumab
5202003|NCT02731729|Stage III-IV Melanoma|stage iii-iv melanoma
5202004|NCT02731729|Progressed or Relapsed on PD-1 Inhibitor Therapy|progressed or relapsed on pd-1 inhibitor therapy
5202006|NCT02731703|overdenture|overdenture
5202007|NCT02731703|overlay|overlay
5202008|NCT02731703|implant supported|implant supported
5202009|NCT02731703|denture|denture
5202010|NCT02731703|dental prosthesis|dental prosthesis
5202011|NCT02731703|maxillary|maxillary
5202012|NCT02731690|GNE Myopathy|gne myopathy
5202013|NCT02731690|Nonaka|nonaka
5202014|NCT02731690|GNEM|gnem
5202015|NCT02731690|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5202016|NCT02731690|HIBM|hibm
5202017|NCT02731690|DMRV|dmrv
5202018|NCT02731690|QSM|qsm
5202019|NCT02731664|Irritable bowel syndrome|irritable bowel syndrome
5202020|NCT02731664|Functional dyspepsia|functional dyspepsia
5202021|NCT02731664|Gastric emptying|gastric emptying
5202022|NCT02731664|Gastrointestinal peptide hormones|gastrointestinal peptide hormones
5202023|NCT02731638|cornea|cornea
5202024|NCT02731638|ulcer|ulcer
5202025|NCT02731638|fungal|fungal
5202026|NCT02731638|keratitis|keratitis
5202027|NCT02731625|Kettlebell training|kettlebell training
5202028|NCT02731625|High-intensity interval training|high-intensity interval training
5202033|NCT02731599|Parkinson Disease|parkinson disease
5202034|NCT02731599|treadmill|treadmill
5202035|NCT02731599|Rehabilitation|rehabilitation
5202036|NCT02731586|Dental Implants|dental implants
5202037|NCT02731586|Allogenic mesenchymal stem cells|allogenic mesenchymal stem cells
5202038|NCT02731586|osseointegration|osseointegration
5202039|NCT02731586|primary stability|primary stability
5202040|NCT02731586|resonance frequency analysis|resonance frequency analysis
5202041|NCT02731586|RFA|rfa
5202042|NCT02731586|implants and stem cells|implants and stem cells
5202043|NCT02731586|use of stem cells|use of stem cells
5202044|NCT02731586|stem cells|stem cells
5202045|NCT02731573|Mediastenitis|mediastenitis
5202046|NCT02731560|Pakistan, Rituximab|pakistan, rituximab
5202047|NCT02731560|RA|ra
5202048|NCT02731521|MRS Biomarkers|mrs biomarkers
5202049|NCT02731508|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5202050|NCT02731508|Neuroplasticity|neuroplasticity
5202051|NCT02731482|Bronchiectasis|bronchiectasis
5202052|NCT02731482|Rehabilitation|rehabilitation
5202053|NCT02731482|Quality of Life|quality of life
5202054|NCT02731482|Physiotherapy Specialty|physiotherapy specialty
5202055|NCT02731456|high altitude|high altitude
5202056|NCT02731456|cognition|cognition
5202057|NCT02731456|sleep|sleep
5202062|NCT02731378|erythropoietin|erythropoietin
5202063|NCT02731378|iron supplementation|iron supplementation
5202064|NCT02731378|inadequately responsive|inadequately responsive
5202065|NCT02731378|chemotherapy-induced anaemia|chemotherapy-induced anaemia
5202066|NCT02731365|Parkinson's Disease|parkinson's disease
5202067|NCT02731300|Transcranial direct current stimulation|transcranial direct current stimulation
5202068|NCT02731300|Cathodal stimulation|cathodal stimulation
5202069|NCT02731300|Childhood Pharmacoresistant epilepsy|childhood pharmacoresistant epilepsy
5202070|NCT02731300|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5202071|NCT02731235|Stroke|stroke
5202072|NCT02731235|stroke, acute|stroke, acute
5940713|NCT00419562|self tolerance|self tolerance
5202073|NCT02731235|Cerebral small vessel disease|cerebral small vessel disease
5202074|NCT02731222|CEAP classification|ceap classification
5202075|NCT02731222|CVD: Chronic Venous Disease|cvd: chronic venous disease
5202076|NCT02731222|Onychodystrophy|onychodystrophy
5190049|NCT02802774|Post-operative treatment|post-operative treatment
5190050|NCT02802748|Early Breast Cancer|early breast cancer
5190051|NCT02802748|Hormone Receptor-positive|hormone receptor-positive
5190052|NCT02802748|Window-of-opportunity|window-of-opportunity
5202077|NCT02731222|Body Mass Index|body mass index
5202078|NCT02731196|exercise|exercise
5202079|NCT02731196|lumbar microdiscectomy|lumbar microdiscectomy
5202080|NCT02731183|Fecal Microbiota Transplantation|fecal microbiota transplantation
5202081|NCT02731183|Chronic intestinal pseudo obstruction|chronic intestinal pseudo obstruction
5202082|NCT02731183|Efficacy and safety|efficacy and safety
5202083|NCT02731170|Parkinson Disease|parkinson disease
5202084|NCT02731170|Advanced Stages|advanced stages
5202085|NCT02731170|Rehabilitation|rehabilitation
5202086|NCT02731144|Loss of Physical Function|loss of physical function
5202087|NCT02731118|glaucoma|glaucoma
5202088|NCT02731118|intraocular pressure lowering treatment|intraocular pressure lowering treatment
5202089|NCT02731118|antisectory factor (AF)|antisectory factor (af)
5202090|NCT02731118|Salovum|salovum
5202091|NCT02731105|acne|acne
5202092|NCT02731105|vulgaris|vulgaris
5202093|NCT02731105|Clindamycin|clindamycin
5202094|NCT02731105|Tretinoin|tretinoin
5202095|NCT02731105|Adapalen|adapalen
5202096|NCT02731105|Benzoylperoxid|benzoylperoxid
5202097|NCT02731105|Epiduo|epiduo
5202098|NCT02731105|Acnatac|acnatac
5202099|NCT02731092|lactoferrin|lactoferrin
5202100|NCT02731092|very low birth weight infants|very low birth weight infants
5202101|NCT02731092|preterm infants|preterm infants
5202102|NCT02731079|Sleeve gastrectomy stapler Covidien Ethicon bleeding leak|sleeve gastrectomy stapler covidien ethicon bleeding leak
5202103|NCT02731053|Depression|depression
5202104|NCT02731053|Prevention|prevention
5202105|NCT02731053|Adolescents|adolescents
5202106|NCT02731053|School|school
5202107|NCT02731053|Effectiveness|effectiveness
5202108|NCT02731014|Dry Needling|dry needling
5202109|NCT02730975|pharmacokinetics|pharmacokinetics
5202110|NCT02730975|food-effect|food-effect
5202111|NCT02730975|fat diet|fat diet
5209038|NCT02689284|Pembro|pembro
5202112|NCT02730975|abiraterone acetate|abiraterone acetate
5202113|NCT02730949|D-Chiro-Inositol, type 1 diabetes|d-chiro-inositol, type 1 diabetes
5202114|NCT02730923|Clinical Trials, Randomized|clinical trials, randomized
5202115|NCT02730923|Clinical Trial, Phase I|clinical trial, phase i
5202116|NCT02730923|Clinical Trial, Phase II|clinical trial, phase ii
5202117|NCT02730923|Multicenter Trials|multicenter trials
5202118|NCT02730923|Aromatase Inhibitors|aromatase inhibitors
5202119|NCT02730923|mTOR kinase inhibitor|mtor kinase inhibitor
5202120|NCT02730910|Bioavailability|bioavailability
5202121|NCT02730910|adults|adults
5202122|NCT02730897|Surgery|surgery
5202123|NCT02730897|Thoracotomy|thoracotomy
5202124|NCT02730897|VATS|vats
5202125|NCT02730884|Leukemia|leukemia
5202126|NCT02730884|Myelofibrosis|myelofibrosis
5202128|NCT02730884|Anemia|anemia
5202129|NCT02730884|Splenomegaly|splenomegaly
5202130|NCT02730884|Post-polycythemia vera MF|post-polycythemia vera mf
5202131|NCT02730884|post-PV|post-pv
5202132|NCT02730884|post-essential thrombocythemia MF|post-essential thrombocythemia mf
5202133|NCT02730884|post-ET|post-et
5202134|NCT02730884|Rigosertib|rigosertib
5202135|NCT02730884|ON 01910.Na|on 01910.na
5202136|NCT02730884|Questionnaire|questionnaire
5202137|NCT02730884|Survey|survey
5202138|NCT02730858|Metastatic Breast Cancer|metastatic breast cancer
5202139|NCT02730858|Palliative Care|palliative care
5202140|NCT02730858|Breast Cancer|breast cancer
5202141|NCT02730858|End of life|end of life
5202142|NCT02730858|Health service research|health service research
5202143|NCT02730845|Elective|elective
5202144|NCT02730845|local anesthesia|local anesthesia
5202145|NCT02730845|knee arthroscopy|knee arthroscopy
5202146|NCT02730845|Dexmedetomidine|dexmedetomidine
5202149|NCT02730754|Mood Disorders|mood disorders
5202150|NCT02730754|Illness Perception|illness perception
5202151|NCT02730754|Primary Care|primary care
5202152|NCT02730754|Medication Adherence|medication adherence
5202154|NCT02730741|metfomin|metfomin
5202155|NCT02730741|type 2 diabetes|type 2 diabetes
5202156|NCT02730741|microbiota|microbiota
5202157|NCT02730728|adductor canal block|adductor canal block
5202158|NCT02730728|tinetti score|tinetti score
5202159|NCT02730728|time to up and go test|time to up and go test
5202160|NCT02730728|Ambulation distance|ambulation distance
5202161|NCT02730728|pain score|pain score
5202162|NCT02730728|quality of recovery score|quality of recovery score
5202163|NCT02730689|DP-R207|dp-r207
5202164|NCT02730689|Rosuvastatin|rosuvastatin
5202165|NCT02730689|Ezetimibe|ezetimibe
5202166|NCT02730676|electronic cigarettes|electronic cigarettes
5202167|NCT02730676|e-cigarette|e-cigarette
5202168|NCT02730676|combustible cigarette|combustible cigarette
5940714|NCT00419562|oral tolerance|oral tolerance
5940715|NCT00419562|Diabetes Prevention Trial - 1 (DPT-1)|diabetes prevention trial - 1 (dpt-1)
5940716|NCT00419562|prevention|prevention
5940717|NCT00419562|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5940718|NCT00419562|juvenile diabetes|juvenile diabetes
5202169|NCT02730676|cigarette|cigarette
5202170|NCT02730676|menthol|menthol
5202171|NCT02730676|cig-alike|cig-alike
5202172|NCT02730676|subjective measures|subjective measures
5202173|NCT02730676|pharmacokinetics|pharmacokinetics
5202175|NCT02730663|Endoscopic ultrasound guided transluminal drainage|endoscopic ultrasound guided transluminal drainage
5202176|NCT02730650|FACE-Q|face-q
5202177|NCT02730650|Platelet Rich Therapy|platelet rich therapy
5202178|NCT02730650|PRT|prt
5202179|NCT02730624|piperacillin/tazobactam|piperacillin/tazobactam
5202180|NCT02730624|critically ill|critically ill
5202181|NCT02730624|severe sepsis|severe sepsis
5202182|NCT02730624|septic shock|septic shock
5202183|NCT02730611|Vertical sleeve gastrectomy|vertical sleeve gastrectomy
5202184|NCT02730611|Metabolic syndrome|metabolic syndrome
5202185|NCT02730611|Disorder of Bile Acid and Cholesterol Metabolism|disorder of bile acid and cholesterol metabolism
5202186|NCT02730611|Cholangiocarcinoma|cholangiocarcinoma
5202187|NCT02730611|Hepatocellular carcinoma|hepatocellular carcinoma
5202188|NCT02730585|C-reactive protein|c-reactive protein
5202189|NCT02730572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5202190|NCT02730572|Methylphenidate|methylphenidate
5202191|NCT02730559|Motivational Interviewing|motivational interviewing
5202192|NCT02730533|endoscopic submucosal dissection|endoscopic submucosal dissection
5202193|NCT02730533|proton pump inhibitor|proton pump inhibitor
5202194|NCT02730533|bleeding|bleeding
5202195|NCT02730520|respiratory disease|respiratory disease
5202196|NCT02730520|allergen sensitization|allergen sensitization
5202197|NCT02730520|aging|aging
5202198|NCT02730520|skin tests|skin tests
5202199|NCT02730520|air allergens|air allergens
5202200|NCT02730494|mycosis|mycosis
5202201|NCT02730494|Candidiasis|candidiasis
5202202|NCT02730494|Lcr35®|lcr35®
5202203|NCT02730494|Lcr Regenerans®|lcr regenerans®
5202204|NCT02730455|Stroke|stroke
5202205|NCT02730351|Fluticasone furoate|fluticasone furoate
5202206|NCT02730351|activity monitoring|activity monitoring
5202207|NCT02730351|Vilanterol|vilanterol
5202208|NCT02730351|Cross-over|cross-over
5202209|NCT02730351|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5202210|NCT02730351|exercise challenge|exercise challenge
5202211|NCT02730351|double-dummy|double-dummy
5202212|NCT02730351|asthma|asthma
5202213|NCT02730351|spirometry|spirometry
5202214|NCT02730351|fluticasone propionate|fluticasone propionate
5202215|NCT02730338|Castrate resistant|castrate resistant
5202216|NCT02730338|Exercise|exercise
5202217|NCT02730338|Metastatic|metastatic
5202218|NCT02730338|Prostate cancer|prostate cancer
5202219|NCT02730325|CDI|cdi
5202220|NCT02730325|C. diff|c. diff
5202221|NCT02730325|Ulcerative Colitis|ulcerative colitis
5202222|NCT02730325|UC|uc
5202223|NCT02730325|IBD|ibd
5202224|NCT02730325|Inflammatory Bowel Disease|inflammatory bowel disease
5202225|NCT02730312|AML|aml
5202226|NCT02730312|B-ALL|b-all
5202227|NCT02730312|BPDCN|bpdcn
5202228|NCT02730312|CML|cml
5202229|NCT02730312|Blast Crisis|blast crisis
5202230|NCT02730286|human activity|human activity
5202231|NCT02730286|International Classification of Functioning|international classification of functioning
5202232|NCT02730260|Directive coaching|directive coaching
5202233|NCT02730260|Nondirective coaching|nondirective coaching
5202234|NCT02730260|smoking cessation quitline|smoking cessation quitline
5202235|NCT02730260|social support|social support
5202236|NCT02730247|ramucirumab|ramucirumab
5202237|NCT02730247|docetaxel|docetaxel
5202238|NCT02730221|Administrative workload|administrative workload
5202239|NCT02730221|Patient data management system|patient data management system
5202240|NCT02730221|Intensive Care Unit|intensive care unit
5202241|NCT02730221|Work sampling method|work sampling method
5202242|NCT02730221|Nursing Activity Score|nursing activity score
5202243|NCT02730182|postural control|postural control
5202244|NCT02730182|high altitude|high altitude
5202245|NCT02730169|Hypogonadotropic|hypogonadotropic
5202246|NCT02730169|hypogonadism|hypogonadism
5202247|NCT02730169|testosterone|testosterone
5202249|NCT02730143|Nocturnal breathing pattern|nocturnal breathing pattern
5202250|NCT02730130|Pembrolizumab|pembrolizumab
5202251|NCT02730130|Radiotherapy|radiotherapy
5202252|NCT02730130|16-032|16-032
5202253|NCT02730117|Acute kidney injury|acute kidney injury
5202254|NCT02730117|Furosemide stress test|furosemide stress test
5202255|NCT02730117|critical care|critical care
5202256|NCT02730078|Mood Disorders|mood disorders
5202257|NCT02730078|Self Care|self care
5202258|NCT02730078|Primary Care|primary care
5202842|NCT02726334|Metastatic|metastatic
5202259|NCT02730065|Cerebral small vessel disease|cerebral small vessel disease
5202260|NCT02730065|Lifestyle modification|lifestyle modification
5202261|NCT02730065|Physical activity|physical activity
5202262|NCT02730065|Primary prevention|primary prevention
5202263|NCT02730065|Aerobic dance|aerobic dance
5202264|NCT02730065|Cognition|cognition
5202265|NCT02730065|Depression|depression
5202266|NCT02730065|Activities of daily living|activities of daily living
5940719|NCT00419562|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
5190254|NCT02801812|Nailfold Capillaroscopy|nailfold capillaroscopy
5190255|NCT02801799|Anaesthesia|anaesthesia
5190256|NCT02801799|Analgesia|analgesia
5202267|NCT02730065|Cerebral autoregulation|cerebral autoregulation
5202268|NCT02730052|Blood pressure control|blood pressure control
5202269|NCT02730052|Hypertension|hypertension
5202270|NCT02730052|Office blood pressure|office blood pressure
5202271|NCT02730052|Self-measured blood pressure,|self-measured blood pressure,
5202272|NCT02730052|Telemonitoring|telemonitoring
5202273|NCT02730039|Cancer Care Providers|cancer care providers
5202274|NCT02730039|Psychotherapy|psychotherapy
5202275|NCT02730039|15-321|15-321
5202276|NCT02730026|Ketofrofen|ketofrofen
5202277|NCT02730026|Omeprazole|omeprazole
5202278|NCT02730026|Lower Third Molar|lower third molar
5202279|NCT02730026|Oral Surgery|oral surgery
5202280|NCT02730013|Older adults|older adults
5202281|NCT02730013|Square stepping exercise|square stepping exercise
5202282|NCT02730013|Mind-motor exercise|mind-motor exercise
5202283|NCT02730013|Long-term care|long-term care
5202284|NCT02730013|Global cognitive functioning|global cognitive functioning
5202285|NCT02730000|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5202286|NCT02730000|Primary Teeth|primary teeth
5202287|NCT02730000|Clinical Efficacy|clinical efficacy
5202288|NCT02730000|Cost Analysis|cost analysis
5202289|NCT02730000|Glass Ionomer Cement|glass ionomer cement
5202290|NCT02729987|online|online
5202291|NCT02729987|internet|internet
5202293|NCT02729987|Stress|stress
5202294|NCT02729987|Work|work
5202295|NCT02729987|Internet based treatment|internet based treatment
5202296|NCT02729974|thromboelastography|thromboelastography
5202297|NCT02729935|Parecoxib|parecoxib
5202298|NCT02729935|Bladder Discomfort|bladder discomfort
5202299|NCT02729909|Drug therapy|drug therapy
5202300|NCT02729870|Ketones|ketones
5202301|NCT02729870|Gastroenteritis|gastroenteritis
5202302|NCT02729844|Incidence|incidence
5202303|NCT02729844|Risk factors|risk factors
5202304|NCT02729844|Outcome|outcome
5202305|NCT02729831|decision making|decision making
5202306|NCT02729831|decision aids|decision aids
5202307|NCT02729831|decision quality instruments|decision quality instruments
5202308|NCT02729831|osteoarthritis|osteoarthritis
5202309|NCT02729831|shared decision making|shared decision making
5202310|NCT02729818|Retina|retina
5202311|NCT02729818|Microperimetry|microperimetry
5202312|NCT02729818|Visual Fields|visual fields
5202313|NCT02729805|ketamine|ketamine
5202314|NCT02729805|chronic pain|chronic pain
5202315|NCT02729805|mastectomy|mastectomy
5202316|NCT02729805|acute pain|acute pain
5202317|NCT02729792|depression|depression
5202318|NCT02729792|treatment resistance|treatment resistance
5202319|NCT02729792|biomarkers|biomarkers
5202320|NCT02729792|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5202321|NCT02729766|Hyponatremia|hyponatremia
5202322|NCT02729766|SGLT2 inhibitor|sglt2 inhibitor
5202323|NCT02729740|Penumbra Smart coils|penumbra smart coils
5202324|NCT02729740|PC 400|pc 400
5202325|NCT02729740|AV malformations|av malformations
5202326|NCT02729740|AV fistulae|av fistulae
5202327|NCT02729740|POD|pod
5202328|NCT02729688|Venous insufficiency|venous insufficiency
5202329|NCT02729688|Compression|compression
5202330|NCT02729688|Bandaging|bandaging
5202331|NCT02729675|fruit & vegetable, market, education, worksite, food access|fruit & vegetable, market, education, worksite, food access
5202332|NCT02729597|neuromuscular disorders|neuromuscular disorders
5202333|NCT02729597|MRI|mri
5078752|NCT03507283|Pterygium|pterygium
5078753|NCT03507283|double-headed|double-headed
5078754|NCT03507283|vertical|vertical
5078755|NCT03507270|FABP|fabp
5078756|NCT03507270|non ST Segment Elevation Myocardial Infarction|non st segment elevation myocardial infarction
5078768|NCT03507244|Leptomeningeal metastasis|leptomeningeal metastasis
5078769|NCT03507244|Malignant solid tumors|malignant solid tumors
5078770|NCT03507244|Pemetrexed|pemetrexed
5078771|NCT03507244|Intrathecal chemotherapy|intrathecal chemotherapy
5078772|NCT03507244|Radiotherapy|radiotherapy
5078799|NCT03507062|pH|ph
5202334|NCT02729597|white matter|white matter
5202335|NCT02729597|brain|brain
5202336|NCT02729597|myotonic dystrophy|myotonic dystrophy
5202337|NCT02729558|brain metastases|brain metastases
5202339|NCT02729558|resection|resection
5202340|NCT02729545|acupuncture|acupuncture
5202342|NCT02729545|total testosterone (TT)|total testosterone (tt)
5202343|NCT02729545|polycystic ovarian syndrome(PCOS)|polycystic ovarian syndrome(pcos)
5202344|NCT02729532|Extra-pulmonary tuberculosis|extra-pulmonary tuberculosis
5202345|NCT02729532|multiple drug resistant tuberculosis|multiple drug resistant tuberculosis
5202346|NCT02729532|mycobacterium tuberculosis|mycobacterium tuberculosis
5202347|NCT02729532|human immunodeficiency virus|human immunodeficiency virus
5202348|NCT02729506|hepatocellular carcinoma|hepatocellular carcinoma
5202349|NCT02729506|transarterial radioembolization|transarterial radioembolization
5202350|NCT02729506|chemoembolization chemoembolization|chemoembolization chemoembolization
5202351|NCT02729506|clinical trial|clinical trial
5202352|NCT02729493|Liver Cancer CAR-T|liver cancer car-t
5202353|NCT02729467|Healthy|healthy
5202354|NCT02729467|JNJ-53718678|jnj-53718678
5202355|NCT02729467|Itraconazole|itraconazole
5202356|NCT02729467|Rifampicin|rifampicin
5202357|NCT02729467|Pharmacokinetics|pharmacokinetics
5202358|NCT02729428|Aging|aging
5202359|NCT02729428|White Matter Hyperintensity Volume|white matter hyperintensity volume
5940720|NCT00419562|diabetes mellitus|diabetes mellitus
5940721|NCT00419562|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5940722|NCT00419562|TrialNet|trialnet
5202360|NCT02729428|Default Mode Network Connectivity|default mode network connectivity
5202361|NCT02729428|Cognitive Function|cognitive function
5202362|NCT02729428|Cardiorespiratory Fitness|cardiorespiratory fitness
5202363|NCT02729428|Magnetic Resonance Imaging|magnetic resonance imaging
5202365|NCT02729415|Alopecia|alopecia
5202366|NCT02729402|Adults|adults
5202367|NCT02729389|Social Status|social status
5202391|NCT02729298|EGFR+ NSCLC with progression on ≤2 lines of oral TKIs|egfr+ nsclc with progression on ≤2 lines of oral tkis
5202393|NCT02729298|KRAS-Mutated CRC|kras-mutated crc
5202394|NCT02729298|NRAS-Mutated CRC|nras-mutated crc
5202395|NCT02729298|Persistent/Recurrent Ovarian Cancer|persistent/recurrent ovarian cancer
5202396|NCT02729298|BRAF-Mutated Melanoma with immunotherapy progression|braf-mutated melanoma with immunotherapy progression
5202398|NCT02729233|mucosal barrier function|mucosal barrier function
5202399|NCT02729220|Aging|aging
5202400|NCT02729220|Oxidative stress|oxidative stress
5202401|NCT02729220|Proteases|proteases
5202402|NCT02729220|Bronchoscopy|bronchoscopy
5202403|NCT02729207|NSAID Patch|nsaid patch
5202404|NCT02729168|Rabies|rabies
5202405|NCT02729168|Vaccine|vaccine
5202406|NCT02729168|Safety|safety
5202407|NCT02729168|INDIRAB|indirab
5202408|NCT02729168|Vietnam|vietnam
5202409|NCT02729155|Ischemic Preconditioning|ischemic preconditioning
5202410|NCT02729155|Postconditioning|postconditioning
5202411|NCT02729155|Angioplasty|angioplasty
5202412|NCT02729155|Angiography|angiography
5202413|NCT02729155|Contrast-Induced Nephropathy|contrast-induced nephropathy
5202414|NCT02729142|HRpQCT|hrpqct
5202415|NCT02729142|transplant|transplant
5202416|NCT02729142|bone microarchitecture|bone microarchitecture
5202417|NCT02729129|Diesel exhaust|diesel exhaust
5202418|NCT02729129|Air pollution|air pollution
5202419|NCT02729129|Intervention|intervention
5202420|NCT02729129|Plethysmography|plethysmography
5202425|NCT02729090|Peripheral Arterial Disease, exercise|peripheral arterial disease, exercise
5202433|NCT02729051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5202434|NCT02729051|fluticasone furoate/umeclidinium bromide/vilanterol (FF/UMEC/VI)|fluticasone furoate/umeclidinium bromide/vilanterol (ff/umec/vi)
5202435|NCT02729051|Umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
5202436|NCT02729051|Closed triple therapy|closed triple therapy
5202437|NCT02729051|Placebo|placebo
5202438|NCT02729051|Open triple therapy|open triple therapy
5202439|NCT02729051|fluticasone furoate/vilanterol (FF/VI)|fluticasone furoate/vilanterol (ff/vi)
5962529|NCT04280406|pain|pain
5962530|NCT04280393|adenoma|adenoma
5962531|NCT04280393|colonoscopy|colonoscopy
5962532|NCT04280393|endocuff|endocuff
5962533|NCT04280393|screening|screening
5962534|NCT04280380|CMV|cmv
5962535|NCT04280380|intensive care|intensive care
5962536|NCT04280380|prevalence|prevalence
5962537|NCT04280367|learning disorders|learning disorders
5962538|NCT04280367|executive function disorders|executive function disorders
5962539|NCT04280367|psychosis|psychosis
5962540|NCT04280367|children|children
5962541|NCT04280367|adult-age|adult-age
5962542|NCT04280354|Community-acquired Pneumonia|community-acquired pneumonia
5962543|NCT04280354|biomarker|biomarker
5962544|NCT04280354|clinical data warehouse (CDWH)|clinical data warehouse (cdwh)
5126709|NCT03202524|Albumin|albumin
5202440|NCT02729038|Normal Renal Function|normal renal function
5202441|NCT02729038|end stage renal disease (ESRD)|end stage renal disease (esrd)
5202442|NCT02729038|Pharmacokinetics|pharmacokinetics
5202443|NCT02729038|Gepotidacin|gepotidacin
5202444|NCT02729038|Renal Impairment|renal impairment
5202445|NCT02729025|Hyperlipidemia|hyperlipidemia
5202447|NCT02729025|Proprotein convertase subtilisin/kexin type 9 (PCSK9) Inhibition|proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibition
5202448|NCT02729025|Arterial Wall Inflamation|arterial wall inflamation
5202449|NCT02729025|Elevated lipoprotein a|elevated lipoprotein a
5202450|NCT02729012|Children|children
5202451|NCT02728999|Trendelenburg position|trendelenburg position
5202452|NCT02728999|Robotic assisted gynecologic procedures|robotic assisted gynecologic procedures
5202453|NCT02728999|benign gynecologic conditions|benign gynecologic conditions
5202454|NCT02728986|Costs and Cost Analysis|costs and cost analysis
5202455|NCT02728986|Humans|humans
5202456|NCT02728986|Health Care Costs|health care costs
5202457|NCT02728986|varicose ulcer|varicose ulcer
5202458|NCT02728986|Compression Bandages|compression bandages
5202459|NCT02728973|colorectal resection|colorectal resection
5202460|NCT02728973|enhanced recovery after surgery|enhanced recovery after surgery
5202461|NCT02728973|Postoperative Complications|postoperative complications
5202462|NCT02728973|length of hospital stay|length of hospital stay
5202463|NCT02728947|Parkinson's Disease|parkinson's disease
5202464|NCT02728934|Rheumatoid Arthritis|rheumatoid arthritis
5202465|NCT02728934|Golimumab|golimumab
5202466|NCT02728934|Infliximab|infliximab
5202467|NCT02728895|Drug Therapy|drug therapy
5202468|NCT02728882|Lymphoma CAR-T|lymphoma car-t
5202469|NCT02728843|Parkinson's disease|parkinson's disease
5202470|NCT02728843|Deferiprone|deferiprone
5202471|NCT02728830|gynecologic cancers|gynecologic cancers
5202472|NCT02728830|mullerian cancers|mullerian cancers
5202473|NCT02728830|tumoral immunoprofile|tumoral immunoprofile
5202474|NCT02728817|Vascular access|vascular access
5202475|NCT02728817|Hemodialysis|hemodialysis
5202476|NCT02728817|Arteriovenous fistula|arteriovenous fistula
5202477|NCT02728817|Stenosis|stenosis
5202478|NCT02728817|Failure|failure
5202480|NCT02728726|Postoperative respiratory depression|postoperative respiratory depression
5202481|NCT02728726|Neuromuscular Agents|neuromuscular agents
5202482|NCT02728713|Cranial manipulation|cranial manipulation
5202483|NCT02728713|Visual function|visual function
5202484|NCT02728687|peripheral neuropathy|peripheral neuropathy
5202485|NCT02728687|Diabetes|diabetes
5202486|NCT02728687|Pain|pain
5202487|NCT02728674|COPD|copd
5202488|NCT02728674|Breathlessness|breathlessness
5190452|NCT02800668|weight loss therapy|weight loss therapy
5190453|NCT02800655|ARV treatment|arv treatment
5190454|NCT02800655|Medication Adherence|medication adherence
5190455|NCT02800655|Digital Health Feedback System|digital health feedback system
5190457|NCT02800642|Bayer|bayer
5202489|NCT02728674|Symptom|symptom
5202490|NCT02728674|Opioids|opioids
5202491|NCT02728674|Gender bias|gender bias
5202492|NCT02728648|Pain Management|pain management
5202493|NCT02728648|Pharmacokinetics|pharmacokinetics
5202494|NCT02728648|Pharmacodynamics|pharmacodynamics
5202495|NCT02728635|Adipose tissue, epigenetic, abdominal gluteal fat|adipose tissue, epigenetic, abdominal gluteal fat
5202496|NCT02728622|ovarian cancer|ovarian cancer
5202497|NCT02728622|platinum-resistant|platinum-resistant
5202498|NCT02728622|endocrine treatment|endocrine treatment
5202499|NCT02728622|chemotherapy|chemotherapy
5202500|NCT02728622|tamoxifen|tamoxifen
5202501|NCT02728583|Plant sterols|plant sterols
5202502|NCT02728583|Fish oil|fish oil
5202503|NCT02728583|Blood lipids|blood lipids
5202504|NCT02728570|flavonoids|flavonoids
5202505|NCT02728570|insulin resistance|insulin resistance
5202506|NCT02728570|plasma lipids|plasma lipids
5202507|NCT02728570|intestinal microbiome|intestinal microbiome
5202508|NCT02728570|intestinal inflammation|intestinal inflammation
5202509|NCT02728570|subclinical inflammation|subclinical inflammation
5202510|NCT02728557|Therapeutic alliance|therapeutic alliance
5202511|NCT02728557|Psychotherapy|psychotherapy
5202512|NCT02728557|Psychodynamic psychotherapy|psychodynamic psychotherapy
5202513|NCT02728557|supportive-expressive treatment|supportive-expressive treatment
5202514|NCT02728557|Process research|process research
5202515|NCT02728557|Attachment theory|attachment theory
5202516|NCT02728557|Attachment orientation|attachment orientation
5202517|NCT02728557|Mechanism of change in psychotherapy|mechanism of change in psychotherapy
5202518|NCT02728466|flavanols|flavanols
5202519|NCT02728466|cocoa procyanidins|cocoa procyanidins
5202520|NCT02728466|vascular function|vascular function
5202521|NCT02728466|endothelial function|endothelial function
5202522|NCT02728427|Suprapubic Catheterization|suprapubic catheterization
5202523|NCT02728427|Transurethral Catheterization|transurethral catheterization
5202524|NCT02728427|Rectal Cancer|rectal cancer
5202525|NCT02728427|Laparoscopic Surgery|laparoscopic surgery
5202526|NCT02728414|Diabetes Mellitus, Type 2, Probiotics, Treatment|diabetes mellitus, type 2, probiotics, treatment
5202527|NCT02728401|inflammation|inflammation
5962545|NCT04280354|machine learning|machine learning
5202529|NCT02728401|pediatric|pediatric
5202530|NCT02728401|transcripts|transcripts
5202531|NCT02728401|serum proteins|serum proteins
5202532|NCT02728401|cardiopulmonary bypass|cardiopulmonary bypass
5202533|NCT02728388|NF1|nf1
5202534|NCT02728388|Neurofibroma|neurofibroma
5202535|NCT02728388|Neurofibromatosis Type 1|neurofibromatosis type 1
5202536|NCT02728362|tibial shaft fractures|tibial shaft fractures
5202537|NCT02728284|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5202538|NCT02728219|Recurrent Hepatocellular Carcinoma|recurrent hepatocellular carcinoma
5423235|NCT01616576|listening benefits|listening benefits
5202539|NCT02728219|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5202540|NCT02728219|AFP conversion|afp conversion
5202541|NCT02728193|treatments|treatments
5202542|NCT02728193|hepatocellular carcinoma|hepatocellular carcinoma
5202543|NCT02728180|Acute Ischemic Stroke|acute ischemic stroke
5202544|NCT02728180|Xingnaojing injection|xingnaojing injection
5202545|NCT02728180|Randomized Controlled Trial|randomized controlled trial
5202546|NCT02728180|Traditional Chinese Medicine|traditional chinese medicine
5202547|NCT02728167|Hepatectomy|hepatectomy
5202548|NCT02728167|Liver metastasis|liver metastasis
5202549|NCT02728167|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
5342978|NCT01981317|Counseling|counseling
5202550|NCT02728167|Liver metastases (LM) requiring surgery|liver metastases (lm) requiring surgery
5202556|NCT02728102|Multiple Myeloma|multiple myeloma
5202557|NCT02728102|Lenalidomide|lenalidomide
5202558|NCT02728102|Maintenance Therapy|maintenance therapy
5202559|NCT02728102|Hematologic Disorders|hematologic disorders
5202561|NCT02728102|GM-CSF|gm-csf
5202562|NCT02728102|Transplant|transplant
5202563|NCT02728102|Anti-Myeloma Agents|anti-myeloma agents
5202564|NCT02728076|Breast Cancer|breast cancer
5202565|NCT02728076|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
5202566|NCT02728037|Myofascial Trigger Points|myofascial trigger points
5202567|NCT02728037|Myofascial Pain|myofascial pain
5202568|NCT02728037|Intramuscular Anesthetic Injection|intramuscular anesthetic injection
5202569|NCT02727998|PTSD|ptsd
5202570|NCT02727972|depression|depression
5202571|NCT02727972|bipolar|bipolar
5202572|NCT02727972|post-traumatic stress disorder|post-traumatic stress disorder
5202573|NCT02727972|mood disorders|mood disorders
5202575|NCT02727972|mGluRr|mglurr
5202576|NCT02727972|glutamate system|glutamate system
5202577|NCT02727972|MRI|mri
5202578|NCT02727959|UC|uc
5202579|NCT02727959|CD|cd
5202580|NCT02727959|IBD|ibd
5202581|NCT02727894|Screening|screening
5202582|NCT02727894|pTNM|ptnm
5202583|NCT02727894|Metastasis|metastasis
5202584|NCT02727894|Chemotherapy|chemotherapy
5202585|NCT02727894|Resection Margins|resection margins
5202586|NCT02727894|Colorectal Cancer|colorectal cancer
5202587|NCT02727881|AMD, CNV, choroidal neovascularization, retinal eye disease|amd, cnv, choroidal neovascularization, retinal eye disease
5202588|NCT02727855|Cholera|cholera
5202589|NCT02727855|Vaccine|vaccine
5202590|NCT02727855|Strategy|strategy
5202591|NCT02727842|cochlear implant|cochlear implant
5202592|NCT02727842|Sound Processor|sound processor
5202593|NCT02727777|Lymphoma|lymphoma
5202594|NCT02727777|Relapsed Lymphoma|relapsed lymphoma
5202595|NCT02727777|MLN0128|mln0128
5202596|NCT02727777|Blood sugar|blood sugar
5202597|NCT02727777|Glucometer|glucometer
5202598|NCT02727777|TK228|tk228
5202599|NCT02727764|Arthritis|arthritis
5202600|NCT02727764|Gene therapy|gene therapy
5202601|NCT02727764|Phase Ib|phase ib
5202602|NCT02727764|Intra-articular|intra-articular
5202603|NCT02727738|Hyperthyroidism|hyperthyroidism
5202604|NCT02727738|Methimazole|methimazole
5202605|NCT02727738|Selenium|selenium
5202606|NCT02727712|coronary artery bypass graft|coronary artery bypass graft
5202607|NCT02727712|thoracic paravertebral block|thoracic paravertebral block
5202608|NCT02727699|Dementia|dementia
5202609|NCT02727699|Alzheimer's Disease|alzheimer's disease
5202610|NCT02727699|Xanamem|xanamem
5202611|NCT02727699|UE2343|ue2343
5202612|NCT02727699|Cortisol|cortisol
5202613|NCT02727699|XanADu|xanadu
5202614|NCT02727699|Actinogen|actinogen
5202615|NCT02727699|11β-HSD1|11β-hsd1
5202616|NCT02727699|11-beta-Hydroxysteroid Dehydrogenase Type 1|11-beta-hydroxysteroid dehydrogenase type 1
5202617|NCT02727699|Mild Alzheimer's Disease|mild alzheimer's disease
5202618|NCT02727699|Cognitive Impairments|cognitive impairments
5202619|NCT02727686|transsphenoidal pituitary surgery|transsphenoidal pituitary surgery
5202620|NCT02727673|cancer stem cells|cancer stem cells
5202621|NCT02727660|COPD|copd
5202622|NCT02727647|Moderate hemophilia A|moderate hemophilia a
5202623|NCT02727647|Severe hemophilia A|severe hemophilia a
5202624|NCT02727647|Intermediate dose prophylaxis|intermediate dose prophylaxis
5202625|NCT02727647|Low dose prophylaxis|low dose prophylaxis
5202626|NCT02727634|Hemodynamics|hemodynamics
5202627|NCT02727634|Echocardiography, Doppler, Pulsed|echocardiography, doppler, pulsed
5202628|NCT02727621|Dexmedetomidine|dexmedetomidine
5202629|NCT02727621|Cardiac|cardiac
5202630|NCT02727621|Coronary Artery Bypass Grapht|coronary artery bypass grapht
5202631|NCT02727621|Sedation|sedation
5202632|NCT02727621|Propofol|propofol
5202633|NCT02727621|Intravenous Anesthetics|intravenous anesthetics
5202635|NCT02727556|skin conductance response|skin conductance response
5202636|NCT02727556|facial muscle activity|facial muscle activity
5202637|NCT02727556|heart rate variability|heart rate variability
5202638|NCT02727556|eyetracking|eyetracking
5202639|NCT02727543|Hypertension|hypertension
5202640|NCT02727543|mHealth|mhealth
5202641|NCT02727543|Medication Non-adherence|medication non-adherence
5202642|NCT02727530|Infant Colic|infant colic
5202643|NCT02727530|Manual Therapy|manual therapy
5202644|NCT02727530|Effectiveness|effectiveness
5202645|NCT02727517|Resuscitation|resuscitation
5202646|NCT02727517|Cord clamping|cord clamping
5202941|NCT02725814|Neonates|neonates
5202647|NCT02727504|Aortic valve stenosis|aortic valve stenosis
5202649|NCT02727504|dobutamine stress echocardiography|dobutamine stress echocardiography
5202650|NCT02727491|opioid analgesics,|opioid analgesics,
5202651|NCT02727491|opioid consumption|opioid consumption
5202652|NCT02727491|adverse effects|adverse effects
5202653|NCT02727491|postoperative pain|postoperative pain
5202654|NCT02727491|tonsillectomy|tonsillectomy
5202655|NCT02727478|Balance|balance
5202656|NCT02727478|Rehabilitation|rehabilitation
5202657|NCT02727478|Exercise|exercise
5202658|NCT02727478|basal ganglia|basal ganglia
5202659|NCT02727478|Gait|gait
5202660|NCT02727478|Training|training
5202661|NCT02727478|physical activity|physical activity
5202662|NCT02727439|microvascular function|microvascular function
5202663|NCT02727439|laser Doppler flowmetry|laser doppler flowmetry
5202664|NCT02727439|exercise|exercise
5202665|NCT02727426|microvascular function|microvascular function
5202666|NCT02727426|laser Doppler flowmetry|laser doppler flowmetry
5202667|NCT02727426|high salt diet|high salt diet
5202668|NCT02727374|Fear to Fall|fear to fall
5202669|NCT02727374|Geriatric|geriatric
5202670|NCT02727374|Rehabilitation|rehabilitation
5202671|NCT02727374|Psychology|psychology
5202672|NCT02727361|Dystonia|dystonia
5202673|NCT02727361|Binding potential|binding potential
5202674|NCT02727361|FEOBV|feobv
5202675|NCT02727348|femoral sciatic block spinal diabetic foot haemodynamic pain|femoral sciatic block spinal diabetic foot haemodynamic pain
5202676|NCT02727335|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
5202677|NCT02727335|crizotinib|crizotinib
5202678|NCT02727309|Apatinib|apatinib
5202679|NCT02727309|Second-line Treatment|second-line treatment
5202680|NCT02727309|Hepatocellular Cancer|hepatocellular cancer
5202681|NCT02727309|TACE|tace
5202682|NCT02727283|Healthy volunteer|healthy volunteer
5202683|NCT02727283|Safety|safety
5202684|NCT02727283|Pharmacokinetics|pharmacokinetics
5202685|NCT02727283|Dose escalation|dose escalation
5202686|NCT02727283|GSK3179106|gsk3179106
5202687|NCT02727283|Rearranged during Transfection|rearranged during transfection
5202688|NCT02727283|Irritable Bowel Syndrome|irritable bowel syndrome
5202689|NCT02727283|Adults|adults
5202690|NCT02727270|Movement disorders|movement disorders
5202691|NCT02727270|Metabolic Stress|metabolic stress
5202692|NCT02727270|Basal Ganglia Disorders|basal ganglia disorders
5202693|NCT02727257|Parkinson's disease|parkinson's disease
5202694|NCT02727257|rehabilitation|rehabilitation
5202695|NCT02727257|attention|attention
5202696|NCT02727257|executive functions|executive functions
5202697|NCT02727244|Pain Catastrophizing Scale|pain catastrophizing scale
5202698|NCT02727231|closed loop glucose control|closed loop glucose control
5202699|NCT02727231|hypoglycemia|hypoglycemia
5202700|NCT02727231|type 1 diabetes|type 1 diabetes
5202701|NCT02727231|HbA1C<7.5%|hba1c<7.5%
5202702|NCT02727192|Atrial fibrillation|atrial fibrillation
5202703|NCT02727192|CPAP|cpap
5202704|NCT02727192|Sleep apnea|sleep apnea
5202705|NCT02727192|Sleep disordered breathing|sleep disordered breathing
5202706|NCT02727166|intestinal gas|intestinal gas
5202707|NCT02727166|functional gut symptoms|functional gut symptoms
5202708|NCT02727166|intestinal sensitivity|intestinal sensitivity
5202709|NCT02727166|intestinal motility|intestinal motility
5202710|NCT02727153|Colonic cancer|colonic cancer
5202711|NCT02727153|E.R.A.S. programs|e.r.a.s. programs
5202712|NCT02727153|Safety|safety
5202713|NCT02727114|skin thickness|skin thickness
5202714|NCT02727114|high-frequency ultrasound|high-frequency ultrasound
5202715|NCT02727101|Focal epilepsy, Perampanel|focal epilepsy, perampanel
5202716|NCT02727088|Dental Pulp Disease|dental pulp disease
5202717|NCT02727088|Endodontics|endodontics
5202718|NCT02727088|Pulp Capping|pulp capping
5202719|NCT02727088|Pulpotomy|pulpotomy
5202720|NCT02727088|Pulpectomy|pulpectomy
5094247|NCT03409627|non-stem cell|non-stem cell
5202721|NCT02727075|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
5202722|NCT02727075|Iron Deficiency Anemia|iron deficiency anemia
5202723|NCT02727075|Aged 75 Years and Older|aged 75 years and older
5202724|NCT02727062|pain|pain
5202725|NCT02727062|radiation|radiation
5202726|NCT02727062|head and neck cancer|head and neck cancer
5202727|NCT02727062|smartphone application|smartphone application
5202728|NCT02727062|OM Pain App|om pain app
5202729|NCT02727023|Healthy|healthy
5079222|NCT03504215|young adults|young adults
5202730|NCT02727010|Motor disability|motor disability
5202731|NCT02727010|Motor impairment|motor impairment
5202732|NCT02727010|Pregnancy|pregnancy
5202733|NCT02727010|Parenthood|parenthood
5202734|NCT02727010|Child psychology|child psychology
5202735|NCT02726984|stroke|stroke
5202736|NCT02726984|carotid plaque|carotid plaque
5202737|NCT02726984|18F-sodium fluoride PET/MR|18f-sodium fluoride pet/mr
5202738|NCT02726971|Intrauterine Adhesion|intrauterine adhesion
5202739|NCT02726971|Oestrogen Artificial Periodic Therapy|oestrogen artificial periodic therapy
5202740|NCT02726958|aortic valve replacement|aortic valve replacement
5202741|NCT02726958|percutaneous valve|percutaneous valve
5202742|NCT02726958|blood glucose variability|blood glucose variability
5202743|NCT02726958|TAVI|tavi
5202744|NCT02726932|Peritonitis|peritonitis
5199226|NCT02749149|Surgery|surgery
5202745|NCT02726932|Inflammatory Markers|inflammatory markers
5202942|NCT02725814|Nursing|nursing
5202746|NCT02726932|Patient Outcome Assessment|patient outcome assessment
5802975|NCT00096759|Arthritis|arthritis
5202747|NCT02726932|Classification|classification
5202748|NCT02726932|Multiple Organ Failure|multiple organ failure
5202749|NCT02726932|Intraabdominal Infections|intraabdominal infections
5202750|NCT02726919|focal epilepsy|focal epilepsy
5202751|NCT02726919|clobazam|clobazam
5202752|NCT02726906|Alzheimer's disease|alzheimer's disease
5202753|NCT02726906|Mild Cognitive Impairment|mild cognitive impairment
5202754|NCT02726906|Brain Imaging|brain imaging
5202755|NCT02726867|refractory status epilepticus|refractory status epilepticus
5202756|NCT02726867|levetiracetam|levetiracetam
5202757|NCT02726867|lacosamide|lacosamide
5202758|NCT02726867|ketamine|ketamine
5202759|NCT02726841|Thoracic aorta|thoracic aorta
5202760|NCT02726841|Abdominal aorta|abdominal aorta
5202761|NCT02726841|Stents|stents
5202762|NCT02726789|nucleic acid polymer REP 2139 HBsAg hepatitis B|nucleic acid polymer rep 2139 hbsag hepatitis b
5202763|NCT02726763|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5202764|NCT02726763|Cognitive Training|cognitive training
5202765|NCT02726763|16-034|16-034
5202766|NCT02726750|Monoclonal gammopathy of unknown significance|monoclonal gammopathy of unknown significance
5202768|NCT02726750|Smoldering multiple myeloma|smoldering multiple myeloma
5202769|NCT02726750|SMM|smm
5202770|NCT02726750|Asymptomatic monoclonal gammopathies|asymptomatic monoclonal gammopathies
5202771|NCT02726750|Biomarker testing|biomarker testing
5202772|NCT02726750|Blood collection|blood collection
5202773|NCT02726750|Blood draw|blood draw
5202774|NCT02726737|inferior alveolar nerve block|inferior alveolar nerve block
5202775|NCT02726737|irreversible pulpitis|irreversible pulpitis
5202776|NCT02726737|local anesthesia|local anesthesia
5202777|NCT02726737|sodium bicarbonate|sodium bicarbonate
5202778|NCT02726724|Stress-Resident performance-Observers|stress-resident performance-observers
5202779|NCT02726685|respiratory training|respiratory training
5202780|NCT02726685|functional performance|functional performance
5202781|NCT02726672|inspiratory muscles|inspiratory muscles
5202782|NCT02726672|multiple sclerosis|multiple sclerosis
5202783|NCT02726672|rehabilitation|rehabilitation
5202784|NCT02726646|Local Drug Delivery|local drug delivery
5202785|NCT02726646|Antibiotics|antibiotics
5202786|NCT02726646|Doxycycline|doxycycline
5202787|NCT02726646|Smokers|smokers
5202788|NCT02726646|Chronic Periodontitis|chronic periodontitis
5202789|NCT02726620|Decision support|decision support
5202790|NCT02726620|Decision Support Systems, Clinical|decision support systems, clinical
5202791|NCT02726620|Decision Support Techniques|decision support techniques
5202792|NCT02726620|Hypotension|hypotension
5202793|NCT02726620|Intraoperative Hypotension|intraoperative hypotension
5202794|NCT02726620|Acute Kidney Injury|acute kidney injury
5202795|NCT02726620|Postoperative Mortality|postoperative mortality
5202796|NCT02726620|Blood Pressure|blood pressure
5202797|NCT02726607|Prevention of mother-to-child transmission (PMTCT)|prevention of mother-to-child transmission (pmtct)
5202798|NCT02726607|Kenya|kenya
5202799|NCT02726607|HITSystem 2.0|hitsystem 2.0
5202800|NCT02726607|retention through PMTCT cascade of care|retention through pmtct cascade of care
5202801|NCT02726607|Early Infant Diagnosis|early infant diagnosis
5202802|NCT02726607|eHealth system-level intervention|ehealth system-level intervention
5202803|NCT02726594|Magnetic Resonance Imaging, Patient Satisfaction|magnetic resonance imaging, patient satisfaction
5202804|NCT02726568|EGFR-TKI|egfr-tki
5202805|NCT02726568|NSCLC|nsclc
5202806|NCT02726568|Icotinib|icotinib
5202807|NCT02726568|SRS|srs
5202808|NCT02726568|radiotherapy|radiotherapy
5202809|NCT02726555|Red yeast rice|red yeast rice
5202810|NCT02726555|Atorvastatin|atorvastatin
5202811|NCT02726555|Mild cardiovascular disease|mild cardiovascular disease
5202812|NCT02726542|obesity|obesity
5202813|NCT02726542|adolescence|adolescence
5202814|NCT02726542|fatty liver|fatty liver
5202815|NCT02726542|growth hormone|growth hormone
5202816|NCT02726516|Performance|performance
5202817|NCT02726503|anaplastic thyroid cancer, lenvatinib|anaplastic thyroid cancer, lenvatinib
5202818|NCT02726490|gestational diabetes, pregnancy, diabetes|gestational diabetes, pregnancy, diabetes
5962546|NCT04280354|data-driven algorithms|data-driven algorithms
5202819|NCT02726464|Platelet-rich Plasma|platelet-rich plasma
5202820|NCT02726464|Cell-Derived Microparticles|cell-derived microparticles
5202821|NCT02726464|Pain Management|pain management
5202822|NCT02726464|Blood Platelets|blood platelets
5202823|NCT02726464|Therapeutics|therapeutics
5202824|NCT02726464|Inflammation|inflammation
5202825|NCT02726464|ThromboLUX|thrombolux
5202826|NCT02726464|Dynamic Light Scattering|dynamic light scattering
5202827|NCT02726425|Diabetes self management|diabetes self management
5202828|NCT02726425|Second Life platform|second life platform
5202830|NCT02726399|Ramucirumab|ramucirumab
5202831|NCT02726399|Trastuzumab|trastuzumab
5202832|NCT02726399|Capecitabine|capecitabine
5202833|NCT02726399|Cisplatin|cisplatin
5202834|NCT02726399|HER2-Positive|her2-positive
5202835|NCT02726399|15-301|15-301
5202836|NCT02726360|Communication|communication
5202837|NCT02726360|15-316|15-316
5202838|NCT02726360|Physician|physician
5202840|NCT02726360|Non-English|non-english
5202841|NCT02726360|Language Skills|language skills
5202843|NCT02726308|Dexamethasone|dexamethasone
5202844|NCT02726308|Super-hydration|super-hydration
5202845|NCT02726308|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5202846|NCT02726308|Nausea|nausea
5202847|NCT02726308|Vomiting|vomiting
5202848|NCT02726308|Postoperative|postoperative
5202849|NCT02726269|Helicobacter Pylory infections|helicobacter pylory infections
5202850|NCT02726269|Levofloxacin|levofloxacin
5202851|NCT02726269|Antibiotic resistance|antibiotic resistance
5202852|NCT02726269|Clarithromycin|clarithromycin
5202853|NCT02726269|Mutations|mutations
5202854|NCT02726269|Fluorescence|fluorescence
5202855|NCT02726269|Hybridization|hybridization
5202856|NCT02726256|Diabetes|diabetes
5202857|NCT02726256|DM complication|dm complication
5202858|NCT02726243|Inflammatory bowel disease|inflammatory bowel disease
5202859|NCT02726243|Crohn's Disease|crohn's disease
5202860|NCT02726243|Ulcerative Colitis|ulcerative colitis
5202861|NCT02726243|colorectal cancer|colorectal cancer
5202862|NCT02726243|primary sclerosing cholangitis|primary sclerosing cholangitis
5190832|NCT02798523|Immunologic|immunologic
5190833|NCT02798523|Infusion|infusion
5202863|NCT02726217|CareSmarts|caresmarts
5202864|NCT02726217|SMS-based mobile|sms-based mobile
5202865|NCT02726178|Apnea|apnea
5202866|NCT02726178|bradycardia|bradycardia
5202867|NCT02726178|immunization|immunization
5202868|NCT02726178|inflammation|inflammation
5202869|NCT02726178|preterms|preterms
5202870|NCT02726152|Diagnostic laparoscopy|diagnostic laparoscopy
5202871|NCT02726152|Acute appendicitis|acute appendicitis
5202872|NCT02726152|Appendiceal stump|appendiceal stump
5202873|NCT02726139|Factor VIII|factor viii
5202874|NCT02726139|inhibitor|inhibitor
5202875|NCT02726139|assay|assay
5202876|NCT02726126|Transdermal fentanyl|transdermal fentanyl
5202877|NCT02726126|Transdermal melatonin|transdermal melatonin
5202878|NCT02726126|Postoperative pain|postoperative pain
5202879|NCT02726126|lumber laminectomy|lumber laminectomy
5202880|NCT02726126|Relief|relief
5202881|NCT02726113|prostate cancer|prostate cancer
5202882|NCT02726113|vitamin D|vitamin d
5202883|NCT02726100|Telemedicine|telemedicine
5202884|NCT02726100|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5202885|NCT02726100|Decision Support Systems, Clinical|decision support systems, clinical
5202886|NCT02726100|Family Health Promoter|family health promoter
5202887|NCT02726100|Primary Health Care|primary health care
5202888|NCT02726087|Ministernotomy|ministernotomy
5202889|NCT02726087|aortic valve stenosis|aortic valve stenosis
5202890|NCT02726087|quality of life|quality of life
5202891|NCT02726087|satisfaction|satisfaction
5202892|NCT02726087|cardiac surgery|cardiac surgery
5202893|NCT02726074|epilepsy|epilepsy
5202894|NCT02726074|partial-onset seizures|partial-onset seizures
5202895|NCT02726074|secondarily generalized seizures|secondarily generalized seizures
5202896|NCT02726035|Self-injurious behavior|self-injurious behavior
5202897|NCT02726035|Self mutilation|self mutilation
5202898|NCT02726035|naltrexone|naltrexone
5202899|NCT02725996|Hepatocellular Carcinoma|hepatocellular carcinoma
5202900|NCT02725996|Natural Killer cells|natural killer cells
5202901|NCT02725983|Gingivitis|gingivitis
5202902|NCT02725983|Oral Hygiene|oral hygiene
5202903|NCT02725983|Intra oral camera|intra oral camera
5202904|NCT02725983|Self regulation|self regulation
5202905|NCT02725983|bleeding|bleeding
5202906|NCT02725970|HEALTH|health
5202907|NCT02725970|barriers|barriers
5202908|NCT02725970|facilitators|facilitators
5202911|NCT02725970|Public Schools|public schools
5202912|NCT02725957|Bioblast|bioblast
5202913|NCT02725944|Cryptogenic stroke|cryptogenic stroke
5202914|NCT02725944|Occult paroxysmal atrial fibrillation|occult paroxysmal atrial fibrillation
5202915|NCT02725931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5202916|NCT02725931|COPD|copd
5202917|NCT02725931|Pulmonary rehabilitation|pulmonary rehabilitation
5202918|NCT02725931|Physical activity|physical activity
5202919|NCT02725931|Exercise|exercise
5202920|NCT02725918|NSCLC|nsclc
5202921|NCT02725918|EGFR-TKI failure|egfr-tki failure
5202922|NCT02725918|chemotherapy|chemotherapy
5202923|NCT02725905|Weight Management Counseling|weight management counseling
5202924|NCT02725905|Medical School Education|medical school education
5202925|NCT02725892|lung cancer epidemiology algeria registry|lung cancer epidemiology algeria registry
5202926|NCT02725866|Observational Study|observational study
5202927|NCT02725866|Sustained Virological Response|sustained virological response
5202928|NCT02725866|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5202929|NCT02725866|Chronic Hepatitis C|chronic hepatitis c
5202930|NCT02725866|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
5202931|NCT02725866|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5202932|NCT02725853|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5202933|NCT02725853|Arm Training|arm training
5202934|NCT02725853|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5202935|NCT02725840|pulmonary vasculature|pulmonary vasculature
5202936|NCT02725840|radiation late effects|radiation late effects
5202937|NCT02725840|proton therapy|proton therapy
5202956|NCT02725645|children|children
5202957|NCT02725645|backpack|backpack
5202958|NCT02725632|Sodium channel|sodium channel
5202960|NCT02725632|sleep apnea syndrome|sleep apnea syndrome
5202961|NCT02725606|Neutropenia|neutropenia
5202962|NCT02725606|Breast Cancer|breast cancer
5202963|NCT02725606|GW003|gw003
5202964|NCT02725593|Diabetes Mellitus|diabetes mellitus
5202965|NCT02725593|Dapagliflozin|dapagliflozin
5202966|NCT02725593|Placebo|placebo
5202967|NCT02725593|Insulin resistance|insulin resistance
5202968|NCT02725593|Metabolic Diseases|metabolic diseases
5202969|NCT02725580|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
5202971|NCT02725580|Gene Transfer|gene transfer
5202972|NCT02725541|HER2 equivocal|her2 equivocal
5202973|NCT02725541|Trastuzumab emtansine|trastuzumab emtansine
5202974|NCT02725541|Breast cancer|breast cancer
5202975|NCT02725502|T1DM|t1dm
5202976|NCT02725502|Linagliptin|linagliptin
5202977|NCT02725502|mix meal test|mix meal test
5202992|NCT02725463|vestibular|vestibular
5202993|NCT02725463|implant|implant
5202994|NCT02725463|prosthesis|prosthesis
5202995|NCT02725463|labyrinth|labyrinth
5202996|NCT02725463|ototoxicity|ototoxicity
5202997|NCT02725463|gentamicin|gentamicin
5202998|NCT02725463|oscillopsia|oscillopsia
5202999|NCT02725463|disequilibrium|disequilibrium
5203000|NCT02725463|dizziness|dizziness
5203001|NCT02725463|vestibulopathy|vestibulopathy
5203002|NCT02725463|inner ear|inner ear
5203003|NCT02725450|Motor Imagery|motor imagery
5203004|NCT02725450|Fine motor skills|fine motor skills
5203005|NCT02725450|Disabled|disabled
5203006|NCT02725411|Chronic low back pain|chronic low back pain
5203007|NCT02725411|Chronic pain|chronic pain
5203008|NCT02725398|Buscopan|buscopan
5203009|NCT02725398|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5203010|NCT02725398|Imaging Quality|imaging quality
5203011|NCT02725385|No Evidence of Disease|no evidence of disease
5203012|NCT02725372|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5203013|NCT02725372|PAH|pah
5203014|NCT02725372|Inhaled Nitric Oxide|inhaled nitric oxide
5203015|NCT02725372|iNO|ino
5203016|NCT02725372|long term oxygen therapy|long term oxygen therapy
5203017|NCT02725372|oxygen therapy|oxygen therapy
5203018|NCT02725359|Thyroidectomy pain|thyroidectomy pain
5203019|NCT02725359|Tizanidine|tizanidine
5203020|NCT02725359|Postoperative analgesia|postoperative analgesia
5203021|NCT02725359|Ultrasound guided Superficial cervical plexus block|ultrasound guided superficial cervical plexus block
5203022|NCT02725346|Surgical Planning Solution|surgical planning solution
5203023|NCT02725346|Acromioplasty|acromioplasty
5203024|NCT02725346|Shoulder Surgery|shoulder surgery
5203025|NCT02725346|Critical Shoulder Angle|critical shoulder angle
5203026|NCT02725333|Glenohumeral stabilization|glenohumeral stabilization
5203027|NCT02725333|Computer tomography|computer tomography
5203028|NCT02725333|Subtle or minor instability|subtle or minor instability
5203029|NCT02725333|Unstable painful shoulder|unstable painful shoulder
5203030|NCT02725333|Apprehension|apprehension
5203031|NCT02725333|Dislocation|dislocation
5203032|NCT02725333|Subluxation|subluxation
5203033|NCT02725333|Kinematics modeling|kinematics modeling
5203034|NCT02725333|Biomechanics|biomechanics
5203035|NCT02725333|Motion capture|motion capture
5203036|NCT02725333|3D simulation|3d simulation
5203037|NCT02725320|rotator cuff|rotator cuff
5203038|NCT02725320|shoulder reconstruction|shoulder reconstruction
5203039|NCT02725294|exacerbation|exacerbation
5203041|NCT02725294|telemedicine|telemedicine
5203045|NCT02725229|Sternotomy|sternotomy
5203047|NCT02725203|Cardiovascular risk management|cardiovascular risk management
5203048|NCT02725203|behaviour change techniques|behaviour change techniques
5203049|NCT02725203|self-management|self-management
5203050|NCT02725203|physical activity|physical activity
5203051|NCT02725203|nurse-led|nurse-led
5203052|NCT02725203|behaviour change wheel|behaviour change wheel
5203053|NCT02725203|primary care|primary care
5203054|NCT02725203|clustered RCT|clustered rct
5203055|NCT02725177|Ocular Sarcoidosis|ocular sarcoidosis
5079560|NCT03501966|visual loss|visual loss
5203056|NCT02725164|oxygen|oxygen
5203057|NCT02725164|nitrous oxide|nitrous oxide
5203058|NCT02725164|sevoflurane|sevoflurane
5203059|NCT02725164|carbon dioxide|carbon dioxide
5203060|NCT02725164|endotracheal tube|endotracheal tube
5203061|NCT02725164|respiration|respiration
5203062|NCT02725151|inferior vena cava ultrasound|inferior vena cava ultrasound
5203063|NCT02725151|acute|acute
5203064|NCT02725151|heart failure|heart failure
5203065|NCT02725151|management|management
5203066|NCT02725151|decompensation|decompensation
5203067|NCT02725138|Helicobacter pylori|helicobacter pylori
5203068|NCT02725138|probiotic|probiotic
5203069|NCT02725138|bacterial density|bacterial density
5203070|NCT02725125|Stomach Cancer CAR-T|stomach cancer car-t
5203071|NCT02725099|STEMI|stemi
5203072|NCT02725060|POTS|pots
5203073|NCT02725060|Orthostatic Intolerance|orthostatic intolerance
5203074|NCT02725060|Orthostatic Tachycardia|orthostatic tachycardia
5203075|NCT02725047|Osteoarthritis, Knee|osteoarthritis, knee
5203076|NCT02725047|Cryotherapy|cryotherapy
5203077|NCT02725047|Thermotherapy|thermotherapy
5203078|NCT02725047|Hypothermia|hypothermia
5203079|NCT02725047|Knee|knee
5203080|NCT02725047|Physiotherapy|physiotherapy
5203081|NCT02725021|tobacco prevention|tobacco prevention
5203082|NCT02725008|Asthma|asthma
5203083|NCT02725008|Pediatric|pediatric
5203084|NCT02725008|Emergency Department|emergency department
5203085|NCT02725008|Dexamethasone|dexamethasone
5203086|NCT02725008|Steroid|steroid
5203087|NCT02724982|Self esteem|self esteem
5203088|NCT02724982|Body mass index|body mass index
5203089|NCT02724969|text messaging|text messaging
5203090|NCT02724969|short message service|short message service
5203091|NCT02724956|supraglottic airway device (SGAD) insertion|supraglottic airway device (sgad) insertion
5203092|NCT02724956|SGAD|sgad
5203093|NCT02724956|ventilation and intubation|ventilation and intubation
5203094|NCT02724956|gastric drainage channel|gastric drainage channel
5203095|NCT02724956|fiberoptic assessment|fiberoptic assessment
5203096|NCT02724943|child obesity|child obesity
5203097|NCT02724943|primary prevention|primary prevention
5203098|NCT02724943|primary care|primary care
5203099|NCT02724943|weight management|weight management
5203100|NCT02724943|child overweight|child overweight
5203101|NCT02724943|BMI|bmi
5203102|NCT02724930|low back pain, chronic pain, cognitive behavior therapy|low back pain, chronic pain, cognitive behavior therapy
5203103|NCT02724904|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5203104|NCT02724904|CNS Non-Hodgkin lymphoma|cns non-hodgkin lymphoma
5203105|NCT02724891|Pelvic Floor Dysfunction|pelvic floor dysfunction
5203106|NCT02724878|Kidney Cancer|kidney cancer
5203107|NCT02724865|Oral Appliance Therapy|oral appliance therapy
5203108|NCT02724852|MMR|mmr
5203109|NCT02724852|vaccination|vaccination
5203110|NCT02724852|HIV|hiv
5203111|NCT02724852|Serologic response|serologic response
5203112|NCT02724826|Expectations|expectations
5203113|NCT02724826|Outcomes|outcomes
5203114|NCT02724826|Qigong|qigong
5203115|NCT02724826|Exercise therapy|exercise therapy
5203116|NCT02724826|Disability|disability
5203117|NCT02724826|Neck movements,|neck movements,
5203118|NCT02724800|Insomnia|insomnia
5203119|NCT02724800|Veterans|veterans
5203120|NCT02724800|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
5203121|NCT02724800|Brief Behavioral Treatment for Insomnia|brief behavioral treatment for insomnia
5203122|NCT02724800|Comparative Effectiveness Research|comparative effectiveness research
5203123|NCT02724787|Post-traumatic stress disorder|post-traumatic stress disorder
5203124|NCT02724787|Veterans|veterans
5203125|NCT02724787|Aggression|aggression
5203126|NCT02724787|Emotion regulation|emotion regulation
5203127|NCT02724774|infants|infants
5203128|NCT02724774|mental health|mental health
5203129|NCT02724774|postpartum period|postpartum period
5203133|NCT02724735|Depression|depression
5203134|NCT02724735|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5203135|NCT02724735|Major Depressive Disorder|major depressive disorder
5203136|NCT02724735|Neurogenesis|neurogenesis
5203137|NCT02724735|Synaptogenesis|synaptogenesis
5203138|NCT02724735|NSI-189|nsi-189
5203139|NCT02724735|Neuralstem|neuralstem
5203140|NCT02724722|melamine|melamine
5203141|NCT02724722|phthalate|phthalate
5203142|NCT02724709|Automatic Data Processing|automatic data processing
5191127|NCT02797158|SPECT|spect
5203143|NCT02724709|Three-Dimensional Echocardiography|three-dimensional echocardiography
5203145|NCT02724683|ascites|ascites
5203146|NCT02724683|drainage|drainage
5203148|NCT02724683|symptoms|symptoms
5203149|NCT02724683|management|management
5203150|NCT02724683|quality of life|quality of life
5203151|NCT02724683|malignant|malignant
5203152|NCT02724683|cancer|cancer
5203153|NCT02724657|Child|child
5203154|NCT02724657|Breathing exercises|breathing exercises
5203155|NCT02724631|Clogged enteral access devices|clogged enteral access devices
5203156|NCT02724631|Occluded enteral access device|occluded enteral access device
5203157|NCT02724631|Enteral nutrition|enteral nutrition
5962547|NCT04280354|multi-dimensional modelling|multi-dimensional modelling
5203158|NCT02724631|Enteral access device|enteral access device
5203159|NCT02724631|Tube Feeding|tube feeding
5203160|NCT02724631|Gastric Feeding Tubes|gastric feeding tubes
5203161|NCT02724618|Curcumin|curcumin
5203162|NCT02724618|Protection, Radiation|protection, radiation
5203163|NCT02724618|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5203164|NCT02724618|Radiation Therapy|radiation therapy
5203165|NCT02724618|Prostate Cancer|prostate cancer
5203166|NCT02724605|RBCS,|rbcs,
5203167|NCT02724605|Transfusion,|transfusion,
5203168|NCT02724605|Pediatric|pediatric
5203169|NCT02724605|Changes|changes
5203170|NCT02724566|Type 2 diabetic volunteers|type 2 diabetic volunteers
5203171|NCT02724527|Cystic Fibrosis|cystic fibrosis
5203172|NCT02724527|N91115|n91115
5203173|NCT02724527|Cavosonstat|cavosonstat
5203174|NCT02724488|Advanced cancer|advanced cancer
5203175|NCT02724488|Advanced solid tumors|advanced solid tumors
5203176|NCT02724488|Phase I clinical trial candidates|phase i clinical trial candidates
5203177|NCT02724488|Phase II clinical trial candidates|phase ii clinical trial candidates
5203178|NCT02724488|Phase III clinical trial candidates|phase iii clinical trial candidates
5203179|NCT02724488|Head and Neck|head and neck
5203180|NCT02724488|Melanoma|melanoma
5203181|NCT02724488|Upper Aerodigestive cancer|upper aerodigestive cancer
5203182|NCT02724488|Oral Cavity|oral cavity
5203183|NCT02724488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
5203184|NCT02724488|ICIs|icis
5203185|NCT02724488|ctDNA|ctdna
5203186|NCT02724488|Whole Exome Sequencing|whole exome sequencing
5203187|NCT02724488|Molecular Profiling|molecular profiling
5203188|NCT02724475|Laser Ablation|laser ablation
5203189|NCT02724475|Portal Vein Tumor|portal vein tumor
5203190|NCT02724475|Thrombus|thrombus
5203191|NCT02724462|smoking cessation|smoking cessation
5203192|NCT02724462|app for quitting smoking|app for quitting smoking
5203194|NCT02724449|Fecal incontinence|fecal incontinence
5203195|NCT02724436|Yittrium-90|yittrium-90
5203196|NCT02724436|Hepatocellular Carcinoma|hepatocellular carcinoma
5203197|NCT02724423|epilepsy|epilepsy
5203198|NCT02724423|seizure|seizure
5203199|NCT02724410|appendectomy|appendectomy
5203200|NCT02724397|Colon cancer|colon cancer
5203201|NCT02724397|Diagnosis|diagnosis
5203202|NCT02724397|Adenoma|adenoma
5203203|NCT02724397|Serrated lesions|serrated lesions
5203204|NCT02724358|Carcinoma|carcinoma
5203205|NCT02724358|Hepatocellular|hepatocellular
5203206|NCT02724358|Notch1|notch1
5203207|NCT02724345|Cell keratin 18|cell keratin 18
5203208|NCT02724332|Aspartate beta hydroxylase|aspartate beta hydroxylase
5203209|NCT02724332|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5203210|NCT02724319|percutaneous coronary intervention|percutaneous coronary intervention
5203211|NCT02724319|clopidogrel|clopidogrel
5203212|NCT02724319|loss-of-function allele|loss-of-function allele
5203213|NCT02724267|131I-chTNT-1/B treatment|131i-chtnt-1/b treatment
5203214|NCT02724254|Genital warts|genital warts
5203215|NCT02724254|HPV types|hpv types
5203216|NCT02724254|Sexually Transmitted Disease|sexually transmitted disease
5203217|NCT02724254|Papillomavirus Infections|papillomavirus infections
5203218|NCT02724254|Viral Disease|viral disease
5203219|NCT02724254|Anogenital warts|anogenital warts
5203221|NCT02724254|HPV6|hpv6
5203222|NCT02724254|HPV11|hpv11
5203223|NCT02724254|Human papillomavirus infection|human papillomavirus infection
5203224|NCT02724254|HPV|hpv
5203225|NCT02724254|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5203226|NCT02724254|Aviragen Therapeutics|aviragen therapeutics
5203227|NCT02724254|Aviragen|aviragen
5203228|NCT02724241|nicotine|nicotine
5203229|NCT02724241|autonomic tone|autonomic tone
5203230|NCT02724241|oxidative stress|oxidative stress
5203231|NCT02724228|Achondroplasia|achondroplasia
5203232|NCT02724228|Dwarfism|dwarfism
5203233|NCT02724228|Bone Diseases, Developmental|bone diseases, developmental
5203234|NCT02724228|Bone Diseases|bone diseases
5203235|NCT02724215|Subarachnoid hemorrhage|subarachnoid hemorrhage
5203236|NCT02724215|Sleep Apnea|sleep apnea
5203237|NCT02724202|Curcumin|curcumin
5203238|NCT02724202|5FU|5fu
5203239|NCT02724202|5-fluorouracil|5-fluorouracil
5203240|NCT02724202|Adracil|adracil
5203241|NCT02724202|5FU Resistant|5fu resistant
5423236|NCT01616576|noise|noise
5203242|NCT02724202|Metastatic Colon Cancer|metastatic colon cancer
5203244|NCT02724189|electronic pre-assessment|electronic pre-assessment
5203245|NCT02724189|preoperative assessment|preoperative assessment
5203246|NCT02724163|Acute Myeloid Leukaemia|acute myeloid leukaemia
5203249|NCT02724163|Liposomal daunorubicin|liposomal daunorubicin
5203250|NCT02724163|Mitoxantrone|mitoxantrone
5203251|NCT02724163|Randomised controlled trial|randomised controlled trial
5203252|NCT02724163|Risk stratification|risk stratification
5203253|NCT02724163|Minimal residual disease|minimal residual disease
5203254|NCT02724163|Stem cell transplant|stem cell transplant
5203255|NCT02724150|Gastroduodenal Ulcer|gastroduodenal ulcer
5203256|NCT02724150|Marginal Ulcer|marginal ulcer
5203257|NCT02724150|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
5203258|NCT02724150|Peptic Ulcer|peptic ulcer
5203259|NCT02724137|Total Knee Replacement|total knee replacement
5203260|NCT02724137|Physical Therapy|physical therapy
5203261|NCT02724137|Fitbit®|fitbit®
5203262|NCT02724124|exercise muscle stretching|exercise muscle stretching
5203263|NCT02724124|electromyography|electromyography
5203264|NCT02724111|Neuromuscular blockade|neuromuscular blockade
5203265|NCT02724111|Surgical rating scale|surgical rating scale
5203266|NCT02724111|Rocuronium|rocuronium
5203267|NCT02724111|Sugammadex|sugammadex
5203268|NCT02724111|Spinal surgery|spinal surgery
5203269|NCT02724111|General anesthesia|general anesthesia
5203270|NCT02724098|Palliative Therapy|palliative therapy
5203271|NCT02724072|Thoracic Surgery|thoracic surgery
5203272|NCT02724072|Aortic Arch|aortic arch
5203273|NCT02724072|Frozen Elephant Trunk|frozen elephant trunk
5203274|NCT02724072|Performance Goal|performance goal
5203275|NCT02724046|Neisseria meningitidis|neisseria meningitidis
5203276|NCT02724046|Ciprofloxacin|ciprofloxacin
5203277|NCT02724046|Chemoprevention|chemoprevention
5203278|NCT02724033|post operative nausea vomiting|post operative nausea vomiting
5203279|NCT02724033|Inner ear surgery|inner ear surgery
5203280|NCT02724020|Drug therapy|drug therapy
5203282|NCT02724007|India|india
5203283|NCT02724007|ICISS|iciss
5203284|NCT02723994|B-cell acute lymphoblastic leukemia (ALL)|b-cell acute lymphoblastic leukemia (all)
5203285|NCT02723994|pediatric|pediatric
5203286|NCT02723994|multi-agent chemotherapy|multi-agent chemotherapy
5203287|NCT02723994|JAK inhibitor|jak inhibitor
5203288|NCT02723981|Stent , COMBO Stent, anticoagulation|stent , combo stent, anticoagulation
5203289|NCT02723955|ICOS receptor agonist antibody|icos receptor agonist antibody
5203290|NCT02723955|Pembrolizumab|pembrolizumab
5203291|NCT02723955|KEYNOTE-478|keynote-478
5203292|NCT02723955|GSK3359609|gsk3359609
5203293|NCT02723955|Cohort expansion|cohort expansion
5203294|NCT02723955|Dose escalation|dose escalation
5203295|NCT02723942|glypican-3(GPC3)|glypican-3(gpc3)
5203296|NCT02723942|chimeric antigen receptor-modified T cell(CAR-T)|chimeric antigen receptor-modified t cell(car-t)
5203297|NCT02723942|hepatocellular carcinoma(HCC)|hepatocellular carcinoma(hcc)
5203298|NCT02723929|transcranial direct current stimulation|transcranial direct current stimulation
5203299|NCT02723929|transcranial ultrasound|transcranial ultrasound
5203300|NCT02723929|non-invasive brain stimulation|non-invasive brain stimulation
5203301|NCT02723916|Parents|parents
5203302|NCT02723916|Child|child
5203303|NCT02723916|Preschool|preschool
5203304|NCT02723916|eHealth|ehealth
5203305|NCT02723903|somatization symptom score|somatization symptom score
5203306|NCT02723903|SSS checklist|sss checklist
5203307|NCT02723903|coronary angiography|coronary angiography
5203308|NCT02723903|Patient Health Questionnaire|patient health questionnaire
5203309|NCT02723903|Generalized Anxiety Disorder 7-items|generalized anxiety disorder 7-items
5203310|NCT02723877|TNBC|tnbc
5203311|NCT02723864|Pharmacodynamic|pharmacodynamic
5203312|NCT02723864|DNA Damage Repair|dna damage repair
5203313|NCT02723864|BRCA Null|brca null
5203314|NCT02723864|Apoptosis|apoptosis
5203315|NCT02723864|Combination Therapy|combination therapy
5203316|NCT02723838|Bladder|bladder
5203317|NCT02723838|Cancer|cancer
5203318|NCT02723838|REOLYSIN®|reolysin®
5203319|NCT02723838|Gemcitabine|gemcitabine
5203320|NCT02723838|Cisplatin|cisplatin
5203321|NCT02723838|Reovirus|reovirus
5203322|NCT02723838|Oncolytic virus|oncolytic virus
5203323|NCT02723825|Distal tibia|distal tibia
5203324|NCT02723825|fractures|fractures
5203325|NCT02723825|epiphyses|epiphyses
5203326|NCT02723825|children|children
5203327|NCT02723812|Influenza|influenza
5203328|NCT02723812|GCFLU|gcflu
5203329|NCT02723812|vaccine|vaccine
5203330|NCT02723812|Vietnam|vietnam
5203331|NCT02723799|Hope|hope
5203332|NCT02723786|Delayed Graft Function|delayed graft function
5203333|NCT02723786|Renal Transplantation|renal transplantation
5203334|NCT02723786|Prevention|prevention
5203335|NCT02723786|GSK1070806|gsk1070806
5203336|NCT02723773|Efficacy|efficacy
5203337|NCT02723773|Immunogenicity|immunogenicity
5203338|NCT02723773|Safety|safety
5203339|NCT02723773|Adults|adults
5203340|NCT02723773|Herpes zoster|herpes zoster
5203341|NCT02723747|myocardial ischemia|myocardial ischemia
5191318|NCT02796326|ventilation|ventilation
5203342|NCT02723747|magnetic resonance imaging|magnetic resonance imaging
5203343|NCT02723747|perfusion|perfusion
5203344|NCT02723747|software|software
5203345|NCT02723734|Decipher®|decipher®
5203347|NCT02723734|prostate|prostate
5203348|NCT02723734|low risk PCa|low risk pca
5203349|NCT02723734|intermediate risk PCa|intermediate risk pca
5203350|NCT02723734|genomic classifier (GC)|genomic classifier (gc)
5203351|NCT02723721|Lentigo maligna|lentigo maligna
5203352|NCT02723695|Cochlear implant|cochlear implant
5203353|NCT02723695|Perception|perception
5203354|NCT02723695|Posture|posture
5203355|NCT02723695|Quality of life|quality of life
5203356|NCT02723669|Relative Bioavailability|relative bioavailability
5203357|NCT02723656|smoking|smoking
5203358|NCT02723656|cancer|cancer
5203359|NCT02723656|cancer registry|cancer registry
5203360|NCT02723656|smoking cessation|smoking cessation
5079892|NCT03499899|LAG525|lag525
5203361|NCT02723643|Hypertension|hypertension
5203362|NCT02723643|Essential hypertension|essential hypertension
5203363|NCT02723643|Blood pressure|blood pressure
5203364|NCT02723643|Cardiovascular diseases|cardiovascular diseases
5203365|NCT02723630|Bioequivalence|bioequivalence
5203366|NCT02723630|Lenvatinib|lenvatinib
5203367|NCT02723630|Healthy Volunteers|healthy volunteers
5203368|NCT02723630|Lenvima|lenvima
5203369|NCT02723630|E7080|e7080
5203370|NCT02723591|FK506|fk506
5203371|NCT02723591|Kidney Transplantation|kidney transplantation
5203372|NCT02723591|Tacrolimus|tacrolimus
5203373|NCT02723591|Astagraf XL|astagraf xl
5203374|NCT02723552|preeclampsia|preeclampsia
5203375|NCT02723552|young adult hypertension|young adult hypertension
5203376|NCT02723552|preterm birth|preterm birth
5203377|NCT02723526|Metastatic Hormone-Sensitive Prostate Cancer；circulating tumor cells；Prognosis；Liquid biopsy|metastatic hormone-sensitive prostate cancer；circulating tumor cells；prognosis；liquid biopsy
5203378|NCT02723513|Proton MRI|proton mri
5203379|NCT02723513|Noble Gas MRI|noble gas mri
5203380|NCT02723513|Pulmonary Function|pulmonary function
5203381|NCT02723500|Magnetic Resonance Imaging|magnetic resonance imaging
5203382|NCT02723500|Pulmonary Function|pulmonary function
5203383|NCT02723487|TAP block|tap block
5203384|NCT02723487|pediatric|pediatric
5203385|NCT02723487|Laparoscopic|laparoscopic
5203386|NCT02723487|postoperative pain|postoperative pain
5203387|NCT02723474|Magnetic Resonance Imaging|magnetic resonance imaging
5203388|NCT02723474|Pulmonary Function|pulmonary function
5203389|NCT02723396|Parkinson's disease|parkinson's disease
5203390|NCT02723396|Sleep Benefit|sleep benefit
5203391|NCT02723383|alcoholism|alcoholism
5203392|NCT02723383|intensive care|intensive care
5203393|NCT02723383|Baclofen|baclofen
5203394|NCT02723383|restlessness|restlessness
5203395|NCT02723383|Delirium tremens|delirium tremens
5203396|NCT02723383|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
5203397|NCT02723370|Quality of Healthcare|quality of healthcare
5203398|NCT02723370|Colorectal neoplasms|colorectal neoplasms
5203399|NCT02723370|Health Literacy|health literacy
5203400|NCT02723370|Teach-Back Communication|teach-back communication
5203401|NCT02723370|Evidence Based Practice|evidence based practice
5203402|NCT02723370|Colonoscopy|colonoscopy
5203403|NCT02723357|Financial Coaching|financial coaching
5203404|NCT02723357|Mental Health|mental health
5203405|NCT02723357|Social Determinants|social determinants
5203406|NCT02723357|Medical-Financial Partnership|medical-financial partnership
5203407|NCT02723357|Toxic Stress|toxic stress
5203408|NCT02723344|PTSD|ptsd
5203409|NCT02723344|Mild TBI|mild tbi
5203410|NCT02723344|Probiotic|probiotic
5203411|NCT02723344|Inflammation|inflammation
5203412|NCT02723331|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5203413|NCT02723331|Perioperative Therapy|perioperative therapy
5203414|NCT02723331|Resectable Pancreas Ductal Adenocarcinoma|resectable pancreas ductal adenocarcinoma
5203415|NCT02723331|Borderline Resectable Pancreas Ductal Adenocarcinoma|borderline resectable pancreas ductal adenocarcinoma
5203416|NCT02723331|Nab-paclitaxel|nab-paclitaxel
5203417|NCT02723331|Abraxane|abraxane
5203418|NCT02723331|Gemcitabine|gemcitabine
5203419|NCT02723331|Neoadjuvant Therapy|neoadjuvant therapy
5203420|NCT02723331|Adjuvant Therapy|adjuvant therapy
5203421|NCT02723318|Cognition|cognition
5203422|NCT02723318|Financial Coaching|financial coaching
5203423|NCT02723318|Social Determinants of Health|social determinants of health
5203424|NCT02723318|Socioeconomic Status|socioeconomic status
5203425|NCT02723305|Klinefelter syndrome|klinefelter syndrome
5203426|NCT02723305|XXY|xxy
5203427|NCT02723305|Sex chromosome aneuploidy|sex chromosome aneuploidy
5203428|NCT02723305|sex chromosome variation|sex chromosome variation
5203429|NCT02723305|hypogonadism|hypogonadism
5203430|NCT02723305|cardiometabolic|cardiometabolic
5203431|NCT02723305|body composition|body composition
5203432|NCT02723305|exercise capacity|exercise capacity
5203433|NCT02723279|Urgency-frequency Syndrome|urgency-frequency syndrome
5203434|NCT02723279|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
5203435|NCT02723279|Tolterodine Tartrate|tolterodine tartrate
5191414|NCT02795754|single dose escalation|single dose escalation
5191415|NCT02795715|tDCS|tdcs
5203436|NCT02723266|American Indian, Alaska Native Adolescents|american indian, alaska native adolescents
5203438|NCT02723266|Reproductive Health|reproductive health
5203439|NCT02723266|Gestational Diabetes Mellitus|gestational diabetes mellitus
5203444|NCT02723253|Oxaliplatin|oxaliplatin
5203445|NCT02723240|NUC-3373|nuc-3373
5203446|NCT02723240|Dose escalation|dose escalation
5203447|NCT02723240|Nucleotide Analogue|nucleotide analogue
5203448|NCT02723227|Parenting Stress|parenting stress
5203449|NCT02723227|Stress|stress
5203450|NCT02723227|Social Determinants|social determinants
5203451|NCT02723227|Socioeconomic status|socioeconomic status
5203452|NCT02723227|Financial Coaching|financial coaching
5203453|NCT02723175|Fibromyalgia|fibromyalgia
5203454|NCT02723175|Pain|pain
5203455|NCT02723136|Smartphone|smartphone
5203456|NCT02723136|Internship|internship
5962548|NCT04280354|sepsis-related mortality|sepsis-related mortality
5203457|NCT02723136|Internal Medicine|internal medicine
5203458|NCT02723123|CPAP|cpap
5203459|NCT02723123|NIPPV|nippv
5203460|NCT02723123|Extubation failure|extubation failure
5203461|NCT02723123|Cardiorespiratory behaviour|cardiorespiratory behaviour
5203462|NCT02723123|NIV-NAVA|niv-nava
5203463|NCT02723110|Type 2 Diabetes Risk|type 2 diabetes risk
5203464|NCT02723084|Hepatitis C Virus|hepatitis c virus
5203465|NCT02723084|Non-cirrhotic|non-cirrhotic
5203466|NCT02723084|Hepatitis C Genotype 2|hepatitis c genotype 2
5203467|NCT02723084|Chronic Hepatitis C Virus|chronic hepatitis c virus
5203468|NCT02723084|Hepatitis C|hepatitis c
5203469|NCT02723058|Depression|depression
5203470|NCT02723058|Homelessness|homelessness
5203471|NCT02723058|Primary care|primary care
5203472|NCT02723006|Drug Therapy|drug therapy
5203473|NCT02722954|malignancy|malignancy
5203474|NCT02722954|metastatic|metastatic
5203475|NCT02722954|Demcizumab|demcizumab
5203476|NCT02722954|Pembrolizumab|pembrolizumab
5203477|NCT02722954|Phase 1b|phase 1b
5203478|NCT02722941|autologous hematopoietic cell transplant (HCT)|autologous hematopoietic cell transplant (hct)
5203479|NCT02722941|autologous|autologous
5203480|NCT02722928|Postoperative pneumocephalus|postoperative pneumocephalus
5203481|NCT02722928|Fraction of inspired oxygen|fraction of inspired oxygen
5203482|NCT02722928|Intracranial surgery|intracranial surgery
5203483|NCT02722915|fMRI|fmri
5203484|NCT02722915|neurofeedback|neurofeedback
5203485|NCT02722915|hallucination|hallucination
5203486|NCT02722915|schizophrenia|schizophrenia
5203487|NCT02722902|Metabolic flexibility|metabolic flexibility
5203488|NCT02722902|Insulin sensitivity|insulin sensitivity
5203489|NCT02722889|Ascending aorta|ascending aorta
5203490|NCT02722889|Elongation of the aorta|elongation of the aorta
5203491|NCT02722889|Type A dissection|type a dissection
5203492|NCT02722889|Aortic rupture|aortic rupture
5203493|NCT02722889|Aortic length|aortic length
5203494|NCT02722876|Rehabilitation|rehabilitation
5203495|NCT02722876|Cross-education|cross-education
5203496|NCT02722850|breast cancer|breast cancer
5203497|NCT02722850|cancer survivorship|cancer survivorship
5203498|NCT02722850|dietary intake|dietary intake
5203499|NCT02722850|physical activity|physical activity
5203500|NCT02722850|quality of life|quality of life
5203501|NCT02722824|motor symptoms|motor symptoms
5203502|NCT02722811|Etanercept|etanercept
5203503|NCT02722811|Osteoarthritis Of Knee|osteoarthritis of knee
5203505|NCT02722811|IL-1α|il-1α
5203506|NCT02722811|Subcutaneous Injection|subcutaneous injection
5203507|NCT02722785|Exercise training|exercise training
5203508|NCT02722785|Surgical complications|surgical complications
5203509|NCT02722785|Cancer prognosis|cancer prognosis
5203510|NCT02722785|Muscle function|muscle function
5203511|NCT02722785|Body composition|body composition
5203512|NCT02722785|Pulmonary function|pulmonary function
5203513|NCT02722785|Quality of life|quality of life
5203514|NCT02722772|Intra-Articular Injection|intra-articular injection
5203515|NCT02722772|Etanercept|etanercept
5203516|NCT02722772|TNF-α|tnf-α
5203517|NCT02722772|IL-1|il-1
5203518|NCT02722772|Osteoarthritis of Knee|osteoarthritis of knee
5203520|NCT02722733|Hodgkin's lymphoma|hodgkin's lymphoma
5203521|NCT02722733|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5203522|NCT02722733|mobilization|mobilization
5203523|NCT02722733|G-CSF|g-csf
5203524|NCT02722733|filgrastim|filgrastim
5203525|NCT02722733|cytosine arabinoside|cytosine arabinoside
5203526|NCT02722733|autologous stem cell transplantation|autologous stem cell transplantation
5203527|NCT02722720|Carotid atherosclerosis|carotid atherosclerosis
5203528|NCT02722720|Carotid stenosis|carotid stenosis
5203529|NCT02722720|Ischemic attack|ischemic attack
5203530|NCT02722720|Stroke|stroke
5203531|NCT02722720|Carotid stenting|carotid stenting
5203532|NCT02722720|Transradial approach|transradial approach
5203533|NCT02722720|Transfemoral approach|transfemoral approach
5203534|NCT02722720|Bleeding|bleeding
5203535|NCT02722720|Thromboembolism|thromboembolism
5203536|NCT02722720|Embolism|embolism
5203537|NCT02722720|Neurocognitive disorders|neurocognitive disorders
5203538|NCT02722668|AML|aml
5203539|NCT02722668|ALL|all
5203540|NCT02722668|CML|cml
5203541|NCT02722668|CLL|cll
5203542|NCT02722668|SLL|sll
5203543|NCT02722655|Pediatrics|pediatrics
5203544|NCT02722629|COPD|copd
5203545|NCT02722629|Respiratory Aspiration|respiratory aspiration
5203546|NCT02722629|COPD acute exacerbation|copd acute exacerbation
5203547|NCT02722616|Ultrasound|ultrasound
5203548|NCT02722590|Epilepsy|epilepsy
5203549|NCT02722590|Partial-onset seizures|partial-onset seizures
5203550|NCT02722590|secondarily generalized seizures|secondarily generalized seizures
5203551|NCT02722551|Mitral|mitral
5203552|NCT02722551|Regurgitation|regurgitation
5203553|NCT02722551|Insufficiency|insufficiency
5203554|NCT02722551|Degenerative|degenerative
5203555|NCT02722551|Functional|functional
5203556|NCT02722551|Primary|primary
5203557|NCT02722551|Secondary|secondary
5203558|NCT02722551|Organic|organic
5203559|NCT02722551|Transcatheter|transcatheter
5203560|NCT02722551|TMVR|tmvr
5203561|NCT02722551|TMVI|tmvi
5203562|NCT02722551|Heart valve|heart valve
5203563|NCT02722551|Mitral valve|mitral valve
5203564|NCT02722551|Transapical|transapical
5203565|NCT02722551|Transfemoral|transfemoral
5203566|NCT02722551|Transeptal|transeptal
5203567|NCT02722551|Severe|severe
5203569|NCT02722525|Prostate cancer|prostate cancer
5203570|NCT02722499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5203571|NCT02722499|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5203572|NCT02722499|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5203573|NCT02722499|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
5203574|NCT02722499|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5203575|NCT02722499|African American|african american
5203576|NCT02722499|Blacks|blacks
5203577|NCT02722499|non-Hispanic Blacks|non-hispanic blacks
5203578|NCT02722499|Randomized Control Trial|randomized control trial
5203579|NCT02722499|Controlled Clinical Trial|controlled clinical trial
5203580|NCT02722499|Behavioral Research|behavioral research
5203581|NCT02722499|Behavioral Medicine|behavioral medicine
5203582|NCT02722421|efavirenz|efavirenz
5203583|NCT02722421|levonorgestrel|levonorgestrel
5203584|NCT02722421|contraceptive implant|contraceptive implant
5203585|NCT02722408|LDL-C|ldl-c
5203586|NCT02722408|Lipid Regulator|lipid regulator
5203587|NCT02722382|Chronic Kidney Disease|chronic kidney disease
5203588|NCT02722291|presbyopia|presbyopia
5203589|NCT02722265|Essential hypertension|essential hypertension
5203590|NCT02722265|Long-term treatment|long-term treatment
5203591|NCT02722265|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5203592|NCT02722252|In Vitro Fertilization with ICSI|in vitro fertilization with icsi
5203593|NCT02722239|Xigduo;|xigduo;
5203594|NCT02722239|bioequivalence;|bioequivalence;
5203595|NCT02722239|crossover;|crossover;
5203596|NCT02722239|Russia|russia
5203597|NCT02722226|High fidelity simulation|high fidelity simulation
5203598|NCT02722226|Sedation|sedation
5203599|NCT02722226|Medical education|medical education
5203600|NCT02722200|fMRI obesity|fmri obesity
5203601|NCT02722148|Eosinophilic Esophagitis|eosinophilic esophagitis
5203602|NCT02722148|Diet Elimination Therapy|diet elimination therapy
5203603|NCT02722122|Cystic Fibrosis|cystic fibrosis
5203604|NCT02722122|CF|cf
5203605|NCT02722122|AIR DNase™|air dnase™
5203606|NCT02722122|Digestive System Diseases|digestive system diseases
5203607|NCT02722122|Genetic Diseases, Inborn|genetic diseases, inborn
5203608|NCT02722122|Infant, New born, Diseases|infant, new born, diseases
5203609|NCT02722122|Lung diseases|lung diseases
5203610|NCT02722122|Pancreatic Diseases|pancreatic diseases
5203611|NCT02722122|Respiratory Tract Diseases|respiratory tract diseases
5203612|NCT02722096|arteriovenous fistula|arteriovenous fistula
5203613|NCT02722096|regional anesthesia|regional anesthesia
5203614|NCT02722096|local anesthesia|local anesthesia
5203615|NCT02722096|early complication|early complication
5203616|NCT02722031|intensive care|intensive care
5203617|NCT02722031|prevalence|prevalence
5203618|NCT02722031|hypoxemia|hypoxemia
5203619|NCT02722031|ARDS|ards
5203620|NCT02722005|Health related quality of life|health related quality of life
5203621|NCT02722005|Financial Coaching|financial coaching
5203622|NCT02722005|Medical Financial Partnership|medical financial partnership
5203623|NCT02722005|Social Determinants of Health|social determinants of health
5203624|NCT02722005|Socioeconomic status|socioeconomic status
5203625|NCT02721966|Assessment of spondyloarthritis international society (ASAS)|assessment of spondyloarthritis international society (asas)
5203626|NCT02721966|ASAS|asas
5203627|NCT02721966|axial|axial
5203628|NCT02721966|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
5203629|NCT02721966|PsA|psa
5203630|NCT02721966|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5203631|NCT02721966|MRI|mri
5203632|NCT02721927|refugees|refugees
5203633|NCT02721927|Syrian|syrian
5203634|NCT02721927|cost|cost
5203635|NCT02721927|visit|visit
5203638|NCT02721914|Gymnastics|gymnastics
5203639|NCT02721914|disability|disability
5203640|NCT02721901|Gastrointestinal Disorders|gastrointestinal disorders
5203641|NCT02721901|Nutrition|nutrition
5203642|NCT02721901|Behavioral|behavioral
5203643|NCT02721862|gallstones|gallstones
5203644|NCT02721862|cholelithiasis|cholelithiasis
5203645|NCT02721862|sleeve gastrectomy|sleeve gastrectomy
5203646|NCT02721797|hypermobility|hypermobility
5203650|NCT02721784|MRI|mri
5203651|NCT02721784|Radiotherapy|radiotherapy
5203652|NCT02721758|Motivational Interviewing|motivational interviewing
5203653|NCT02721758|Health Behavior|health behavior
5203654|NCT02721758|Cardiac Rehabilitation|cardiac rehabilitation
5203655|NCT02721719|Ulcerative Colitis|ulcerative colitis
5203656|NCT02721719|UC|uc
5203657|NCT02721719|Vedolizumab|vedolizumab
5203658|NCT02721719|Entyvio|entyvio
5203659|NCT02721719|Inflammatory Bowl Disease|inflammatory bowl disease
5203660|NCT02721719|IBD|ibd
5203661|NCT02721719|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5203662|NCT02721706|Nutrition assessment|nutrition assessment
5203663|NCT02721706|inpatients|inpatients
5203664|NCT02721706|cost-benefit analysis|cost-benefit analysis
5203665|NCT02721706|quality of life|quality of life
5203666|NCT02721706|body composition|body composition
5203667|NCT02721706|mass screening|mass screening
5203668|NCT02721693|Troponin|troponin
5203669|NCT02721693|Exercise|exercise
5203670|NCT02721667|Blood pressure|blood pressure
5203671|NCT02721667|Telemonitoring|telemonitoring
5203672|NCT02721667|Case management|case management
5203673|NCT02721667|Seniors|seniors
5203674|NCT02721654|Plasma-Lyte|plasma-lyte
5203675|NCT02721654|Sodium chloride|sodium chloride
5203676|NCT02721654|Saline|saline
5203677|NCT02721654|Fluid resuscitation|fluid resuscitation
5203678|NCT02721654|Intravenous fluid therapy|intravenous fluid therapy
5203679|NCT02721654|Critically ill|critically ill
5203680|NCT02721654|Critical care|critical care
5203681|NCT02721628|Keratoconus|keratoconus
5203682|NCT02721615|intra spinal pressure|intra spinal pressure
5203683|NCT02721615|spinal cord perfusion pressure|spinal cord perfusion pressure
5203684|NCT02721615|microdialysis|microdialysis
5203685|NCT02721615|duroplasty|duroplasty
5203686|NCT02721537|Brain Nicotinamide Adenine Dinucleotide (NAD+)|brain nicotinamide adenine dinucleotide (nad+)
5203687|NCT02721537|Adenosine Triphosphate (ATP) Depletion|adenosine triphosphate (atp) depletion
5203688|NCT02721537|Polyadenosine Diphosphate-Ribosepolymerase (PARP) Activation|polyadenosine diphosphate-ribosepolymerase (parp) activation
5203689|NCT02721524|Ring Annuloplasty|ring annuloplasty
5203690|NCT02721524|Suture Annuloplasty|suture annuloplasty
5203691|NCT02721524|Functional Tricuspid Regurgitation|functional tricuspid regurgitation
5203692|NCT02721498|Respiratory Physiotherapy|respiratory physiotherapy
5203693|NCT02721498|Airway clearance techniques|airway clearance techniques
5203694|NCT02721498|Outcome measures|outcome measures
5203695|NCT02721485|Ringer's Lactate|ringer's lactate
5203696|NCT02721485|Normal Saline|normal saline
5203697|NCT02721485|resuscitation fluids|resuscitation fluids
5203698|NCT02721485|hypovolemia|hypovolemia
5203699|NCT02721459|unresectable melanoma|unresectable melanoma
5203700|NCT02721459|stage III melanoma|stage iii melanoma
5203701|NCT02721459|stage IV melanoma|stage iv melanoma
5203702|NCT02721459|AJCC melanoma staging|ajcc melanoma staging
5203703|NCT02721459|American Joint Committee on Cancer (AJCC)|american joint committee on cancer (ajcc)
5203704|NCT02721459|BRAF V600 E mutation|braf v600 e mutation
5203705|NCT02721459|BRAF V600 K mutation|braf v600 k mutation
5203706|NCT02721394|Challenging Behaviour|challenging behaviour
5203707|NCT02721394|Functional Communication Training|functional communication training
5203708|NCT02721394|Positive Behavioural Support|positive behavioural support
5203709|NCT02721394|Family carer training|family carer training
5203710|NCT02721381|Autism Spectrum Disorder|autism spectrum disorder
5203711|NCT02721381|Parent training|parent training
5203712|NCT02721381|Telehealth|telehealth
5203713|NCT02721381|RCT|rct
5203714|NCT02721355|Chronic gastritis|chronic gastritis
5203715|NCT02721355|Gastric ulcer|gastric ulcer
5203716|NCT02721355|Helicobacter pylori|helicobacter pylori
5203717|NCT02721355|IgY|igy
5203718|NCT02721342|Chronic proteinuric nephropathies|chronic proteinuric nephropathies
5203719|NCT02721329|Obstructive Sleep Apnea|obstructive sleep apnea
5203720|NCT02721329|OSA|osa
5203721|NCT02721329|Insomnia|insomnia
5203722|NCT02721329|CPAP|cpap
5203723|NCT02721329|SensAwake|sensawake
5203724|NCT02721290|Knee surgery|knee surgery
5203725|NCT02721277|Parenteral nutrition, Total|parenteral nutrition, total
5203726|NCT02721277|Infant, newborn|infant, newborn
5203727|NCT02721277|Cholestasis|cholestasis
5203728|NCT02721277|Enterocolitis, Necrotizing|enterocolitis, necrotizing
5203732|NCT02721212|Robotic|robotic
5203733|NCT02721212|Stroke|stroke
5802976|NCT00096759|Tai Chi|tai chi
5203734|NCT02721212|Upper Limb Rehabilitation|upper limb rehabilitation
5203735|NCT02721186|Malaria|malaria
5203736|NCT02721186|Plasmodium|plasmodium
5203737|NCT02721186|Mass drug administration|mass drug administration
5203738|NCT02721186|Malaria elimination|malaria elimination
5203739|NCT02721186|Zanzibar|zanzibar
5203740|NCT02721186|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
5203741|NCT02721186|Single low dose Primaquine|single low dose primaquine
5203742|NCT02721173|Tazarotene|tazarotene
5203743|NCT02721173|Adapalene|adapalene
5203744|NCT02721173|Clindamycin|clindamycin
5203745|NCT02721160|performance-based financing|performance-based financing
5203747|NCT02721160|impact evaluation|impact evaluation
5203748|NCT02721108|Mindfulness|mindfulness
5203749|NCT02721108|Headspace|headspace
5203750|NCT02721108|Psychological approaches|psychological approaches
5203751|NCT02721108|Progressive muscle relaxation|progressive muscle relaxation
5203752|NCT02721082|tobacco treatment|tobacco treatment
5203753|NCT02721069|Seizures|seizures
5203754|NCT02721069|Epilepsy|epilepsy
5203755|NCT02721043|Personalized vaccine|personalized vaccine
5203756|NCT02721043|Poly-ICLC|poly-iclc
5203757|NCT02721043|Immunotherapy|immunotherapy
5203759|NCT02721030|Heartfailure|heartfailure
5203760|NCT02721030|1-year mortality|1-year mortality
5203761|NCT02721030|heartfailure quality of life|heartfailure quality of life
5203762|NCT02721030|sub-Saharan Africa|sub-saharan africa
5203763|NCT02721017|Nuss|nuss
5203764|NCT02721017|Nuss Procedure|nuss procedure
5203765|NCT02721017|pectus excavatum|pectus excavatum
5203766|NCT02721017|cryoanalgesia|cryoanalgesia
5203767|NCT02721004|Rheumatoid arthritis|rheumatoid arthritis
5203768|NCT02721004|RoActemra|roactemra
5203769|NCT02721004|Tocilizumab|tocilizumab
5203770|NCT02720965|Pain Acute|pain acute
5203771|NCT02720965|Orthopedic Surgery|orthopedic surgery
5203772|NCT02720965|Satisfaction Nerve Blocks|satisfaction nerve blocks
5203773|NCT02720913|Time|time
5203774|NCT02720913|COR-KNOT|cor-knot
5203775|NCT02720913|Standard|standard
5203776|NCT02720913|Cost|cost
5203777|NCT02720887|pregnant women|pregnant women
5203778|NCT02720887|nanoparticles|nanoparticles
5203779|NCT02720887|amniotic fluid|amniotic fluid
5203780|NCT02720861|RNF213 rs112735431 Gene|rnf213 rs112735431 gene
5203781|NCT02720861|Acute Non-embolic ischemic stroke|acute non-embolic ischemic stroke
5203782|NCT02720848|double-balloon enteroscopy|double-balloon enteroscopy
5203783|NCT02720809|micronutrients|micronutrients
5203784|NCT02720809|blood pressure|blood pressure
5203785|NCT02720809|allergy|allergy
5203786|NCT02720809|lung function|lung function
5203787|NCT02720796|PDX|pdx
5203788|NCT02720796|TumorGraft|tumorgraft
5203789|NCT02720796|Patient derived xenograft|patient derived xenograft
5203790|NCT02720796|sarcoma|sarcoma
5203791|NCT02720783|Pharmacokinetics|pharmacokinetics
5203792|NCT02720783|Econazole nitrate 150mg|econazole nitrate 150mg
5203793|NCT02720783|Benzydamine HCl 6mg|benzydamine hcl 6mg
5203794|NCT02720783|Vaginal pessary|vaginal pessary
5203795|NCT02720783|Tolerability|tolerability
5203796|NCT02720770|growth hormone|growth hormone
5203797|NCT02720718|Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth and the Puerperium|gastric bypass status for obesity complicating pregnancy, childbirth and the puerperium
5203798|NCT02720718|Laparoscopy|laparoscopy
5203799|NCT02720718|Suture Techniques|suture techniques
5203800|NCT02720718|Sutures|sutures
5203801|NCT02720705|sevoflurane emergence agitation|sevoflurane emergence agitation
5203802|NCT02720692|Pain|pain
5203803|NCT02720692|Analgesia|analgesia
5203804|NCT02720692|N1539|n1539
5203805|NCT02720692|Phase 3|phase 3
5203806|NCT02720679|Genetics|genetics
5203807|NCT02720679|Whole genome sequencing|whole genome sequencing
5203808|NCT02720679|Pediatrics and hematology|pediatrics and hematology
5203809|NCT02720627|acne|acne
5203810|NCT02720627|cortexolone|cortexolone
5203811|NCT02720627|anti-androgen|anti-androgen
5203812|NCT02720614|accelerated hypofractionated radiotherapy|accelerated hypofractionated radiotherapy
5203813|NCT02720614|three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
5203814|NCT02720614|concurrent radiochemotherapy|concurrent radiochemotherapy
5203815|NCT02720601|irinotecan|irinotecan
5203816|NCT02720601|capecitabine|capecitabine
5203817|NCT02720601|gemcitabine|gemcitabine
5203818|NCT02720601|biliary tract cancer|biliary tract cancer
5203819|NCT02720601|gallbladder cancer|gallbladder cancer
5203820|NCT02720601|second-line|second-line
5203821|NCT02720575|Vitamin D|vitamin d
5203822|NCT02720575|Bioavailability|bioavailability
5203823|NCT02720575|Fortified Bread|fortified bread
5203824|NCT02720536|Anemia.|anemia.
5203825|NCT02720536|Myelodysplastic Syndrome|myelodysplastic syndrome
5203826|NCT02720536|Thalassemia|thalassemia
5203827|NCT02720536|Film coated tablet|film coated tablet
5203828|NCT02720523|rheumatoid arthritis|rheumatoid arthritis
5203829|NCT02720523|ABT-494|abt-494
5203830|NCT02720523|Japanese|japanese
5203831|NCT02720523|Antirheumatic agents|antirheumatic agents
5203832|NCT02720510|multiple myeloma|multiple myeloma
5203834|NCT02720510|panobinostat|panobinostat
5203835|NCT02720510|LBH589|lbh589
5203836|NCT02720510|ASCT|asct
5203837|NCT02720510|transplant|transplant
5203838|NCT02720471|local analgesia|local analgesia
5203839|NCT02720471|total hip replacement|total hip replacement
5203840|NCT02720471|local infiltrations|local infiltrations
5203841|NCT02720458|Hypnotics withdrawal in insomniac patients|hypnotics withdrawal in insomniac patients
5203842|NCT02720458|Cognitive-Behavioural Therapy (CBT)|cognitive-behavioural therapy (cbt)
5203843|NCT02720458|Internet-delivered self-help program|internet-delivered self-help program
5203844|NCT02720458|Sleep restriction|sleep restriction
5203845|NCT02720458|Stimulus control|stimulus control
5200381|NCT02742337|Epigenetic|epigenetic
5203846|NCT02720458|Half-life benzodiazepine|half-life benzodiazepine
5203847|NCT02720458|Z-drug|z-drug
5203848|NCT02720445|Alzheimer's Disease|alzheimer's disease
5203849|NCT02720445|Nicotine|nicotine
5203850|NCT02720445|Transdermal Patch|transdermal patch
5203851|NCT02720432|early intervention, infant|early intervention, infant
5203852|NCT02720419|drug eluting stent|drug eluting stent
5203853|NCT02720419|percutaneous coronary intervention|percutaneous coronary intervention
5203854|NCT02720419|real world|real world
5203856|NCT02720380|Physical Therapy Specialty|physical therapy specialty
5203857|NCT02720380|Breathing Exercises|breathing exercises
5203859|NCT02720380|Clinical Trail|clinical trail
5203860|NCT02720302|Overweight|overweight
5203861|NCT02720302|Children|children
5203862|NCT02720302|Treatment|treatment
5203863|NCT02720302|Prevention|prevention
5203864|NCT02720302|Lifestyle intervention|lifestyle intervention
5203865|NCT02720289|injury prevention|injury prevention
5203866|NCT02720276|stroke|stroke
5203867|NCT02720276|exercise|exercise
5203868|NCT02720276|walking|walking
5203869|NCT02720276|mobility|mobility
5203870|NCT02720263|Schizophrenia|schizophrenia
5203871|NCT02720263|ASP4345|asp4345
5203872|NCT02720250|omega-3 fatty acids, microcirculation, laser Doppler flowmetry, lipid profile|omega-3 fatty acids, microcirculation, laser doppler flowmetry, lipid profile
5203873|NCT02720237|Alcohol use|alcohol use
5203875|NCT02720237|Viral Load|viral load
5203876|NCT02720237|ART|art
5203877|NCT02720211|headache|headache
5203878|NCT02720211|photophobia|photophobia
5203879|NCT02720211|migraine|migraine
5203880|NCT02720211|light sensitivity|light sensitivity
5203881|NCT02720211|tints|tints
5203882|NCT02720211|thin films|thin films
5203883|NCT02720146|Dry eye|dry eye
5203884|NCT02720133|ramadan fasting|ramadan fasting
5203885|NCT02720133|variation of biochemical parameters|variation of biochemical parameters
5203886|NCT02720133|variation of hematological parameters|variation of hematological parameters
5203887|NCT02720133|verify now assay|verify now assay
5203888|NCT02720107|fingolimod|fingolimod
5203889|NCT02720107|Biomarker|biomarker
5203890|NCT02720107|Multiple sclerosis|multiple sclerosis
5203891|NCT02720107|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5203892|NCT02720094|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5203893|NCT02720094|PrEP|prep
5203894|NCT02720068|PD1|pd1
5203895|NCT02720068|PD-1|pd-1
5203896|NCT02720068|PDL1|pdl1
5203897|NCT02720068|PD-L1|pd-l1
5203898|NCT02720055|Distal Radius Fracture|distal radius fracture
5203899|NCT02720055|Outcomes|outcomes
5203900|NCT02720055|Psychological Intervention|psychological intervention
5203901|NCT02720029|aspiration|aspiration
5203902|NCT02720029|reflux|reflux
5203903|NCT02720016|Post Traumatic Stress Disorder|post traumatic stress disorder
5203904|NCT02720016|Marital Therapy|marital therapy
5203905|NCT02720016|Veterans|veterans
5203906|NCT02720016|Telemedicine|telemedicine
5203907|NCT02720016|Couples|couples
5203908|NCT02720003|Atherosclerosis|atherosclerosis
5203909|NCT02720003|Superficial Femoral Artery|superficial femoral artery
5203910|NCT02720003|Proximal Popliteal Artery|proximal popliteal artery
5203911|NCT02719990|VRS-317|vrs-317
5203912|NCT02719990|Long Acting Growth Hormone|long acting growth hormone
5203913|NCT02719990|Versartis|versartis
5203914|NCT02719990|somavaratan|somavaratan
5203915|NCT02719990|Growth Hormone Deficiency|growth hormone deficiency
5203916|NCT02719990|Adult Growth Hormone Deficiency|adult growth hormone deficiency
5203917|NCT02719990|AGHD|aghd
5203918|NCT02719990|Growth Hormone Replacement|growth hormone replacement
5203919|NCT02719990|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5203920|NCT02719990|XTEN|xten
5203921|NCT02719964|Cognitive Training|cognitive training
5203922|NCT02719964|Traumatic Brain Injury|traumatic brain injury
5203923|NCT02719964|Video Games|video games
5203924|NCT02719951|autism|autism
5203925|NCT02719951|fragile X syndrome (FXS)|fragile x syndrome (fxs)
5203926|NCT02719951|PET (Positron Emission Tomography)|pet (positron emission tomography)
5203927|NCT02719951|glutamate|glutamate
5203928|NCT02719925|magnesium deficiency|magnesium deficiency
5203929|NCT02719925|stress psycological|stress psycological
5203930|NCT02719925|sleep duration and quality|sleep duration and quality
5203931|NCT02719925|mineral water rich in magnesium|mineral water rich in magnesium
5203938|NCT02719847|Non-Small Cell Lung|non-small cell lung
5203939|NCT02719847|NSCLC|nsclc
5095624|NCT03400748|Metastatic|metastatic
5203940|NCT02719847|Suspected non small cell lung cancer|suspected non small cell lung cancer
5203941|NCT02719847|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
5203942|NCT02719847|EBUS-TBNA|ebus-tbna
5203943|NCT02719821|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5203944|NCT02719821|Fatigue|fatigue
5203945|NCT02719821|Insomnia|insomnia
5203946|NCT02719821|Depression|depression
5203947|NCT02719821|Behavioral Intervention|behavioral intervention
5203948|NCT02719808|Vertical infection transmission|vertical infection transmission
5203949|NCT02719808|Tenofovir|tenofovir
5203950|NCT02719795|Breast Neoplasms|breast neoplasms
5203951|NCT02719795|Nerve block|nerve block
5203952|NCT02719795|Anesthesia|anesthesia
5203953|NCT02719769|Positive Blood Culture|positive blood culture
5203954|NCT02719743|children|children
5203955|NCT02719743|H5N1|h5n1
5203956|NCT02719743|observer-blind|observer-blind
5203957|NCT02719743|Influenza|influenza
5203958|NCT02719743|dose-ranging|dose-ranging
5203959|NCT02719717|VATS lobectomy|vats lobectomy
5203960|NCT02719717|vascular sealing|vascular sealing
5203961|NCT02719717|energy|energy
5203962|NCT02719717|pulmonary artery|pulmonary artery
5203963|NCT02719691|MLN0128|mln0128
5203964|NCT02719691|Dual TORC1/2 Inhibitor|dual torc1/2 inhibitor
5203965|NCT02719691|MLN8237|mln8237
5203966|NCT02719691|Aurora A inhibitor|aurora a inhibitor
5203967|NCT02719691|Alisertib|alisertib
5203968|NCT02719691|Triple-Negative Breast Cancer|triple-negative breast cancer
5203969|NCT02719665|peripheral arterial disease|peripheral arterial disease
5203970|NCT02719665|claudication|claudication
5203971|NCT02719665|PAD|pad
5203972|NCT02719665|Vascular Disease|vascular disease
5203973|NCT02719665|Vascular Occlusion|vascular occlusion
5203974|NCT02719665|Vacular Calcification|vacular calcification
5203975|NCT02719665|intermittent claudication|intermittent claudication
5203976|NCT02719665|Osteoarthritis|osteoarthritis
5203977|NCT02719652|intracranial atherosclerotic disease（ICAD）|intracranial atherosclerotic disease（icad）
5203978|NCT02719652|vulnerable plaque|vulnerable plaque
5203979|NCT02719652|high-resolution magnetic resonance imaging （HR-MRI）|high-resolution magnetic resonance imaging （hr-mri）
5203980|NCT02719626|senior|senior
5203981|NCT02719626|nutrition|nutrition
5203982|NCT02719626|home delivered meals|home delivered meals
5203983|NCT02719626|food safety|food safety
5203984|NCT02719626|emergency prep|emergency prep
5203985|NCT02719600|Virtual Reality|virtual reality
5203986|NCT02719587|saliva|saliva
5203987|NCT02719587|omega-3|omega-3
5203988|NCT02719574|AML|aml
5203989|NCT02719574|MDS|mds
5203990|NCT02719574|IDH1|idh1
5203991|NCT02719574|IDH|idh
5203992|NCT02719535|corneal reshaping therapy|corneal reshaping therapy
5203993|NCT02719535|corneal biomechanics|corneal biomechanics
5203994|NCT02719483|Children|children
5203995|NCT02719483|Spasticity|spasticity
5203996|NCT02719483|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5203997|NCT02719483|Cerebral palsy|cerebral palsy
5203998|NCT02719483|Gross motor function|gross motor function
5203999|NCT02719470|Cognition Impairment|cognition impairment
5204000|NCT02719470|Rehabilitation|rehabilitation
5204001|NCT02719470|Parkinson's Disease|parkinson's disease
5204002|NCT02719457|Exercise testing|exercise testing
5204003|NCT02719457|COPD|copd
5204004|NCT02719457|Upper and Lower limb exercise|upper and lower limb exercise
5204005|NCT02719418|Thromboembolism|thromboembolism
5204006|NCT02719418|Venous Thrombosis|venous thrombosis
5204007|NCT02719418|Embolism and Thrombosis|embolism and thrombosis
5204008|NCT02719418|Chronic Renal Diseases|chronic renal diseases
5204009|NCT02719418|Kidney Failure, Chronic|kidney failure, chronic
5204010|NCT02719418|Renal Failure, Chronic|renal failure, chronic
5204011|NCT02719418|Venous Thromboembolism|venous thromboembolism
5204012|NCT02719418|Tinzaparin|tinzaparin
5204013|NCT02719418|Innohep|innohep
5204014|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5204015|NCT02719405|milk|milk
5204016|NCT02719405|allergy|allergy
5204017|NCT02719405|tolerance|tolerance
5204018|NCT02719327|Alzheimer's disease|alzheimer's disease
5204019|NCT02719327|Cerebrospinal fluid|cerebrospinal fluid
5204020|NCT02719327|brain blood flow|brain blood flow
5204021|NCT02719327|cognition|cognition
5204022|NCT02719327|icosapent ethyl|icosapent ethyl
5204023|NCT02719327|Vascepa|vascepa
5204024|NCT02719327|omega-3 fatty acids|omega-3 fatty acids
5204025|NCT02719327|eicosapentaenoic acid|eicosapentaenoic acid
5204026|NCT02719262|Melamine|melamine
5204027|NCT02719262|Renal damage|renal damage
5204028|NCT02719262|Workplace intervention|workplace intervention
5204029|NCT02719249|ESRD|esrd
5204030|NCT02719249|Fabry disease|fabry disease
5204031|NCT02719236|Coxarthrosis|coxarthrosis
5204033|NCT02719236|Direct Anterior Approach|direct anterior approach
5204034|NCT02719236|Direct Lateral Approach|direct lateral approach
5204035|NCT02719223|Intradialytic hypotension|intradialytic hypotension
5204036|NCT02719223|hemodynamic parameters|hemodynamic parameters
5204037|NCT02719223|Hemodiafiltration|hemodiafiltration
5204038|NCT02719223|NICAS device (non-invasive cardiac system)|nicas device (non-invasive cardiac system)
5204039|NCT02719158|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
5204040|NCT02719158|OTIPRIO|otiprio
5204041|NCT02719145|micro RNA|micro rna
5204042|NCT02719145|asthma|asthma
5204043|NCT02719145|COPD|copd
5204044|NCT02719132|Diabetes Mellitus type 2, dapagliflozin, quality of life|diabetes mellitus type 2, dapagliflozin, quality of life
5204045|NCT02719106|real world data|real world data
5204046|NCT02719106|percutaneous coronary intervention|percutaneous coronary intervention
5204047|NCT02719106|drug eluting stent|drug eluting stent
5204048|NCT02719093|Infertility Male|infertility male
5204049|NCT02719093|Receptors FSH|receptors fsh
5204050|NCT02719093|Varicocele|varicocele
5204051|NCT02719093|FSH therapy|fsh therapy
5204052|NCT02719080|anaesthetists, surgeons, stress, burnout|anaesthetists, surgeons, stress, burnout
5204053|NCT02719067|neuropsychological function|neuropsychological function
5204054|NCT02719067|neuroimage|neuroimage
5204055|NCT02719067|developmental changes|developmental changes
5204056|NCT02719054|Depression|depression
5204057|NCT02719054|Child Development|child development
5204058|NCT02719054|Stimulation|stimulation
5204060|NCT02719054|Bangladesh|bangladesh
5204061|NCT02719015|Melanoma|melanoma
5204062|NCT02719015|Refractory Metastatic Melanoma|refractory metastatic melanoma
5204063|NCT02719015|rAd.CD40L|rad.cd40l
5204064|NCT02719015|ISF35|isf35
5204065|NCT02719015|Intratumoral|intratumoral
5204066|NCT02719015|IT|it
5204067|NCT02719015|Pembrolizumab|pembrolizumab
5204068|NCT02719015|Keytruda|keytruda
5204069|NCT02719015|MK-3475|mk-3475
5204070|NCT02719015|SCH-900475|sch-900475
5204071|NCT02719015|MM|mm
5204072|NCT02718989|H-reflex|h-reflex
5204073|NCT02718989|TENS|tens
5204074|NCT02718989|Tone|tone
5204075|NCT02718976|Hip surgery anesthesia|hip surgery anesthesia
5204076|NCT02718976|Perioperative analgesia|perioperative analgesia
5204077|NCT02718950|Brown Adipose Tissue|brown adipose tissue
5204078|NCT02718950|Hypothalamic Activation|hypothalamic activation
5204079|NCT02718950|Non-shivering Thermogenesis|non-shivering thermogenesis
5204080|NCT02718950|Basal Metabolic Rate|basal metabolic rate
5204081|NCT02718950|Liraglutide|liraglutide
5204082|NCT02718950|Victoza|victoza
5204083|NCT02718950|Body Composition|body composition
5204084|NCT02718950|Body weight|body weight
5204085|NCT02718950|Adipose Tissue Biopsy|adipose tissue biopsy
5204086|NCT02718937|Viral diseases|viral diseases
5204087|NCT02718937|Antiviral|antiviral
5204088|NCT02718937|Paramyxoviridae infections|paramyxoviridae infections
5204089|NCT02718937|RSV|rsv
5204090|NCT02718937|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5204091|NCT02718937|Aviragen Therapeutics|aviragen therapeutics
5204092|NCT02718937|Aviragen|aviragen
5204093|NCT02718924|Thromboelastometry|thromboelastometry
5204094|NCT02718924|pregnancy|pregnancy
5204095|NCT02718924|obesity|obesity
5204096|NCT02718898|genital|genital
5204097|NCT02718885|inulin-type fructans|inulin-type fructans
5204098|NCT02718885|hemodialysis|hemodialysis
5204099|NCT02718885|gut microbiome|gut microbiome
5204100|NCT02718885|mineral and bone disorder|mineral and bone disorder
5204101|NCT02718859|advanced pancreatic cancer|advanced pancreatic cancer
5204102|NCT02718859|nature killer cell|nature killer cell
5204103|NCT02718859|irreversible electroporation|irreversible electroporation
5204104|NCT02718833|Multiple Myeloma|multiple myeloma
5204105|NCT02718833|Relapse|relapse
5204106|NCT02718807|Patient Care|patient care
5204107|NCT02718807|Education|education
5204108|NCT02718794|Simulation Training [I02.903.847]|simulation training [i02.903.847]
5204109|NCT02718794|Problem-Based Learning [F02.463.425.720]|problem-based learning [f02.463.425.720]
5204110|NCT02718794|Airway Management [E02.041]|airway management [e02.041]
5204111|NCT02718755|Hematologic malignancy|hematologic malignancy
5204112|NCT02718755|Relapsed and refractory hematologic malignancies|relapsed and refractory hematologic malignancies
5204113|NCT02718755|Acute myeloid leukemia|acute myeloid leukemia
5204114|NCT02718755|AML|aml
5204115|NCT02718755|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5204116|NCT02718755|ALL|all
5204117|NCT02718755|Burkitt's leukemia/lymphoma|burkitt's leukemia/lymphoma
5204118|NCT02718755|Prolymphocytic leukemia|prolymphocytic leukemia
5204119|NCT02718755|Biphenotypic acute leukemia|biphenotypic acute leukemia
5204120|NCT02718755|Blast-phase of chronic myeloid leukemia|blast-phase of chronic myeloid leukemia
5204121|NCT02718755|CML|cml
5204122|NCT02718755|B-cell lymphoma|b-cell lymphoma
5204250|NCT02718001|Severe|severe
5204123|NCT02718755|Richter's transformation of chronic lymphocytic leukemia|richter's transformation of chronic lymphocytic leukemia
5204124|NCT02718755|CLL|cll
5204125|NCT02718755|Fludarabine|fludarabine
5204132|NCT02718755|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5204133|NCT02718729|Anastomotic leakage|anastomotic leakage
5204134|NCT02718729|Rectal cancer|rectal cancer
5204135|NCT02718729|Laparoscopic|laparoscopic
5204136|NCT02718729|Rectal resection|rectal resection
5204137|NCT02718716|ITP|itp
5204138|NCT02718690|H-Reflex|h-reflex
5204139|NCT02718690|Current Density|current density
5204140|NCT02718690|TENS|tens
5204657|NCT02715661|exercise|exercise
5204146|NCT02718625|Pressure Ulcers|pressure ulcers
5204147|NCT02718625|Bed sores|bed sores
5204148|NCT02718625|Long-term care|long-term care
5204149|NCT02718625|Nursing home|nursing home
5204150|NCT02718612|Uraemic Sarcopenia|uraemic sarcopenia
5204151|NCT02718612|Sarcopenic Obesity|sarcopenic obesity
5192109|NCT02791737|Decreased Physical Activity|decreased physical activity
5192110|NCT02791711|Bronchiolitis|bronchiolitis
5192111|NCT02791711|Continuous Positive Airway Pressure|continuous positive airway pressure
5192112|NCT02791711|HFNC|hfnc
5192113|NCT02791698|cortisol|cortisol
5192114|NCT02791698|hair|hair
5192115|NCT02791698|urinary|urinary
5192116|NCT02791685|Cardiac Rehabilitation|cardiac rehabilitation
5192117|NCT02791672|Perioperative Care|perioperative care
5192118|NCT02791672|Breast Reconstruction|breast reconstruction
5192119|NCT02791659|radiation exposure|radiation exposure
5192120|NCT02791659|ERCP|ercp
5204165|NCT02718521|percutaneous coronary intervention|percutaneous coronary intervention
5204167|NCT02718469|VSV|vsv
5204168|NCT02718469|Vesicular Stomatitis Virus|vesicular stomatitis virus
5204169|NCT02718469|Vaccine|vaccine
5204170|NCT02718469|Zaire|zaire
5204171|NCT02718417|untreated epithelial ovarian|untreated epithelial ovarian
5204172|NCT02718417|fallopian tube|fallopian tube
5204173|NCT02718417|primary peritoneal cancer|primary peritoneal cancer
5204174|NCT02718404|MR-HIFU|mr-hifu
5204175|NCT02718404|bone metastases|bone metastases
5204176|NCT02718404|pain treatment|pain treatment
5204177|NCT02718391|Intradermal Autologous Dendritic Cell Vaccine|intradermal autologous dendritic cell vaccine
5204178|NCT02718391|Malignant Melanoma|malignant melanoma
5080786|NCT03494257|brimonidinde|brimonidinde
5080787|NCT03494257|fixed combination|fixed combination
5080788|NCT03494244|acellular dermal matrix|acellular dermal matrix
5080797|NCT03494218|vegetative state|vegetative state
5080865|NCT03493646|MDS|mds
5204179|NCT02718391|Adjuvant|adjuvant
5204180|NCT02718391|vaccin|vaccin
5204181|NCT02718391|therapy|therapy
5204182|NCT02718391|randomized trial|randomized trial
5204183|NCT02718391|observation|observation
5204184|NCT02718378|safety|safety
5204185|NCT02718378|pharmacokinetics|pharmacokinetics
5204186|NCT02718378|pharmacodynamics|pharmacodynamics
5204187|NCT02718378|randomized|randomized
5204188|NCT02718365|Lung Neoplasms|lung neoplasms
5204189|NCT02718365|Surgery|surgery
5204190|NCT02718365|VATS|vats
5204191|NCT02718365|GGO|ggo
5204192|NCT02718365|GGN|ggn
5204193|NCT02718365|Segmentectomy|segmentectomy
5204194|NCT02718365|Wedge Resection|wedge resection
5204195|NCT02718365|Prognosis|prognosis
5204196|NCT02718313|intraventricular conduction delay|intraventricular conduction delay
5204197|NCT02718300|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
5204198|NCT02718300|post-polycythemia vera myelofibrosis (PPV-MF)|post-polycythemia vera myelofibrosis (ppv-mf)
5204199|NCT02718300|post-essential thrombocythemia myelofibrosis (PET-MF)|post-essential thrombocythemia myelofibrosis (pet-mf)
5204200|NCT02718300|myeloproliferative neoplasms (MPNs)|myeloproliferative neoplasms (mpns)
5204201|NCT02718300|phosphoinositide 3-kinase (PI3K) inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
5204202|NCT02718300|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5204203|NCT02718287|language development|language development
5204204|NCT02718287|socio-emotional development|socio-emotional development
5204205|NCT02718287|cognitive development|cognitive development
5204206|NCT02718287|motor skills|motor skills
5204207|NCT02718274|HIV self-testing|hiv self-testing
5204208|NCT02718274|Malawi|malawi
5204209|NCT02718274|HIV|hiv
5204210|NCT02718248|self-harm|self-harm
5204211|NCT02718248|problem-solving therapy|problem-solving therapy
5204212|NCT02718248|emergency department|emergency department
5204213|NCT02718248|e-therapy|e-therapy
5204214|NCT02718248|suicide prevention|suicide prevention
5204215|NCT02718222|Post-partum intrauterine device (PPIUD)|post-partum intrauterine device (ppiud)
5204216|NCT02718157|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5204217|NCT02718157|GBS|gbs
5204218|NCT02718157|Streptococcus agalactiae|streptococcus agalactiae
5204219|NCT02718157|Antepartum women|antepartum women
5204220|NCT02718144|dose-escalation|dose-escalation
5204222|NCT02718144|dose-limiting toxicity|dose-limiting toxicity
5204223|NCT02718131|Tibial Pseudarthrosis|tibial pseudarthrosis
5204224|NCT02718105|KIR HLA-C|kir hla-c
5204225|NCT02718105|ART|art
5204226|NCT02718066|HBI-8000|hbi-8000
5204227|NCT02718066|Nivolumab|nivolumab
5204228|NCT02718066|Melanoma|melanoma
5204229|NCT02718066|Renal Cell Carcinoma|renal cell carcinoma
5204230|NCT02718066|Non-Small Cell Lung Cancer|non-small cell lung cancer
5204232|NCT02718027|Biomarker|biomarker
5204233|NCT02718014|Non Surgical Therapy|non surgical therapy
5204234|NCT02718001|Mitral|mitral
5204235|NCT02718001|Regurgitation|regurgitation
5204236|NCT02718001|Insufficiency|insufficiency
5204237|NCT02718001|Degenerative|degenerative
5204238|NCT02718001|Functional|functional
5204239|NCT02718001|Primary|primary
5204240|NCT02718001|Secondary|secondary
5204241|NCT02718001|Organic|organic
5204242|NCT02718001|Transcatheter|transcatheter
5204243|NCT02718001|TMVR|tmvr
5204244|NCT02718001|TMVI|tmvi
5204245|NCT02718001|Heart Valve|heart valve
5204246|NCT02718001|Mitral Valve|mitral valve
5204247|NCT02718001|Transseptal|transseptal
5204248|NCT02718001|Trans-Septal|trans-septal
5204249|NCT02718001|Transeptal|transeptal
5204251|NCT02717988|rheumatoid arthritis|rheumatoid arthritis
5204252|NCT02717988|healthy volunteers|healthy volunteers
5204253|NCT02717988|moderately to severely active|moderately to severely active
5204254|NCT02717975|Urinary retention|urinary retention
5204255|NCT02717975|trial removal of catheter|trial removal of catheter
5204256|NCT02717975|valve|valve
5204257|NCT02717962|Glioma|glioma
5204258|NCT02717962|Glioblastoma|glioblastoma
5204259|NCT02717962|Glioblastoma multiforme|glioblastoma multiforme
5204260|NCT02717962|GBM|gbm
5204261|NCT02717962|brain tumor|brain tumor
5204262|NCT02717962|brain cancer|brain cancer
5204263|NCT02717962|recurrent brain tumor|recurrent brain tumor
5204264|NCT02717962|recurrent brain cancer|recurrent brain cancer
5204265|NCT02717962|refractory brain tumor|refractory brain tumor
5962549|NCT04280354|Streptococcus pneumoniae|streptococcus pneumoniae
5204266|NCT02717962|refractory brain cancer|refractory brain cancer
5204267|NCT02717962|recurrent GBM|recurrent gbm
5204268|NCT02717962|refractory GBM|refractory gbm
5204269|NCT02717962|recurrent glioma|recurrent glioma
5962550|NCT04280341|RC48-ADC|rc48-adc
5962551|NCT04280341|JS001|js001
5962552|NCT04280341|HER2 positive solid Tumor|her2 positive solid tumor
5962553|NCT04280315|Dermatology|dermatology
5962554|NCT04280315|Skin Barrier Function|skin barrier function
5204270|NCT02717962|refractory glioma|refractory glioma
5962555|NCT04280302|vestibular|vestibular
5204271|NCT02717962|recurrent glioblastoma|recurrent glioblastoma
5204272|NCT02717962|refractory glioblastoma|refractory glioblastoma
5204273|NCT02717962|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5204274|NCT02717962|refractory glioblastoma multiforme|refractory glioblastoma multiforme
5204275|NCT02717962|failed bevacizumab|failed bevacizumab
5204276|NCT02717962|temodar failure|temodar failure
5204277|NCT02717962|temozolomide failure|temozolomide failure
5204278|NCT02717962|adjuvant therapy|adjuvant therapy
5204279|NCT02717949|hepatitis C|hepatitis c
5204280|NCT02717949|low-grade lymphoma|low-grade lymphoma
5204281|NCT02717936|squamous cell carcinoma|squamous cell carcinoma
5204282|NCT02717936|dermatosurgery|dermatosurgery
5204283|NCT02717936|immunohistochemistry|immunohistochemistry
5204284|NCT02717923|metastatic colorectal cancer|metastatic colorectal cancer
5204285|NCT02717923|maintenance treatment|maintenance treatment
5204286|NCT02717923|cetuximab|cetuximab
5204287|NCT02717910|Games|games
5204288|NCT02717910|Adolescent|adolescent
5204289|NCT02717910|Health education|health education
5204290|NCT02717910|Smoking|smoking
5204291|NCT02717910|Health literacy|health literacy
5204293|NCT02717884|MDS|mds
5204294|NCT02717884|relapsed|relapsed
5204295|NCT02717884|trans-retinoic acid ATRA|trans-retinoic acid atra
5204296|NCT02717884|epigenetic treatment|epigenetic treatment
5204297|NCT02717884|non-M3 AML blasts|non-m3 aml blasts
5204298|NCT02717884|tranylcypromine TCP|tranylcypromine tcp
5204299|NCT02717884|LSD1|lsd1
5204300|NCT02717884|refractory|refractory
5204301|NCT02717871|Collagen cross-linking, PACK-CXL, infectious keratitis, CXL.|collagen cross-linking, pack-cxl, infectious keratitis, cxl.
5204302|NCT02717845|varus malignment|varus malignment
5204303|NCT02717845|osteoarthritis|osteoarthritis
5204304|NCT02717845|knee|knee
5204305|NCT02717819|Sarcopenia|sarcopenia
5204306|NCT02717819|Muscular atrophy|muscular atrophy
5204307|NCT02717819|Frailty|frailty
5204308|NCT02717819|Acute illness|acute illness
5204309|NCT02717819|Ageing|ageing
5204310|NCT02717819|Protein supplementation|protein supplementation
5204311|NCT02717819|Whey protein|whey protein
5204312|NCT02717819|Resistance training|resistance training
5204313|NCT02717819|Strength training|strength training
5204314|NCT02717767|pneumonia|pneumonia
5204315|NCT02717767|diagnosis|diagnosis
5204316|NCT02717767|prognosis|prognosis
5204317|NCT02717767|tracheal aspirate|tracheal aspirate
5204318|NCT02717767|bronchoalveolar lavage|bronchoalveolar lavage
5204319|NCT02717663|Reinforcement|reinforcement
5204320|NCT02717663|Walking|walking
5204321|NCT02717663|Exercise|exercise
5204322|NCT02717663|Built Environment|built environment
5204323|NCT02717663|Adaptive|adaptive
5204326|NCT02717650|Exercise Testing|exercise testing
5204327|NCT02717650|Maximal Exercise Testing|maximal exercise testing
5204328|NCT02717650|Maximal Exercise Capacity|maximal exercise capacity
5204329|NCT02717650|Peak Exercise Capacity|peak exercise capacity
5204330|NCT02717650|Adults|adults
5204331|NCT02717650|Step Tests|step tests
5204332|NCT02717637|oxycodone, caesarean, spinal anesthesia|oxycodone, caesarean, spinal anesthesia
5204333|NCT02717624|Bruton Tyrosine Kinase Inhibitor|bruton tyrosine kinase inhibitor
5204334|NCT02717624|BTK|btk
5204339|NCT02717611|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5204340|NCT02717611|Ibrutinib Intolerant|ibrutinib intolerant
5204341|NCT02717598|cold snare polypectomy|cold snare polypectomy
5204342|NCT02717598|hot snare polypectomy|hot snare polypectomy
5204343|NCT02717585|Continuous Positive Airway Pressure therapy|continuous positive airway pressure therapy
5204344|NCT02717585|Chronic Pain|chronic pain
5204345|NCT02717585|Sleep Disturbance|sleep disturbance
5205140|NCT02712840|Fresh|fresh
5204346|NCT02717559|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
5204347|NCT02717559|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
5204348|NCT02717559|knee injuries / surgery|knee injuries / surgery
5204349|NCT02717559|outcomes research|outcomes research
5204350|NCT02717559|prospective studies|prospective studies
5204351|NCT02717559|osteoarthritis|osteoarthritis
5204352|NCT02717546|Distal Tibia Fracture Screw|distal tibia fracture screw
5204353|NCT02717520|glass hybrid|glass hybrid
5204354|NCT02717520|composite|composite
5204355|NCT02717494|PPV-23|ppv-23
5204356|NCT02717494|PCV-10|pcv-10
5204357|NCT02717494|HIV|hiv
5204358|NCT02717494|Immunization|immunization
5204359|NCT02717494|Pregnancy|pregnancy
5204360|NCT02717455|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5204361|NCT02717442|Meniere's Disease|meniere's disease
5204362|NCT02717442|Vertigo|vertigo
5204363|NCT02717416|upper gastrointestinal bleeding|upper gastrointestinal bleeding
5204364|NCT02717416|endoscopic hemostasis|endoscopic hemostasis
5204365|NCT02717416|hemostatic powder|hemostatic powder
5204366|NCT02717403|Chronic Disease Management|chronic disease management
5204367|NCT02717403|Rheumatoid Arthritis|rheumatoid arthritis
5204368|NCT02717403|Facebook|facebook
5204369|NCT02717403|Social networking|social networking
5204370|NCT02717403|Internet|internet
5204371|NCT02717403|Questionnaires|questionnaires
5204372|NCT02717403|Surveys|surveys
5204373|NCT02717403|Phone interview|phone interview
5072369|NCT03547050|RE|re
5204374|NCT02717390|Reading|reading
5204375|NCT02717390|Early Childhood development|early childhood development
5204376|NCT02717390|Talking|talking
5204377|NCT02717390|Playing|playing
5204378|NCT02717390|Praising|praising
5204379|NCT02717390|Safety|safety
5204380|NCT02717390|Injury prevention|injury prevention
5204381|NCT02717377|Micro bouts|micro bouts
5204382|NCT02717377|Physical Activity|physical activity
5204383|NCT02717338|blood donor|blood donor
5204384|NCT02717338|retention|retention
5204385|NCT02717338|motivation|motivation
5204386|NCT02717338|self-determination theory|self-determination theory
5204387|NCT02717247|tRNS|trns
5204388|NCT02717247|Food addiction,|food addiction,
5204389|NCT02717247|Obesity|obesity
5204390|NCT02717247|Craving|craving
5204391|NCT02717247|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5204392|NCT02717182|self management program|self management program
5204393|NCT02717182|patient education|patient education
5204394|NCT02717182|self care program|self care program
5204395|NCT02717169|health promotion|health promotion
5204396|NCT02717169|health action process|health action process
5204397|NCT02717169|activity tracker|activity tracker
5204398|NCT02717169|sleep regulation|sleep regulation
5096148|NCT03397030|Biomarkers|biomarkers
5204399|NCT02717143|Acute myocarditis|acute myocarditis
5204400|NCT02717143|Dilated cardiomyopathy|dilated cardiomyopathy
5204401|NCT02717143|Magnetic resonance imaging|magnetic resonance imaging
5204402|NCT02717117|Motility|motility
5204403|NCT02717117|MRI|mri
5204404|NCT02717117|Gut peptides|gut peptides
5204405|NCT02717117|Feeding|feeding
5204406|NCT02717104|femoropopliteal|femoropopliteal
5204412|NCT02717065|Neuromodulation|neuromodulation
5204413|NCT02717065|Noninvasive|noninvasive
5204414|NCT02717065|Plasticity|plasticity
5204415|NCT02717065|Hearing|hearing
5204416|NCT02717065|Hyperacusis|hyperacusis
5204417|NCT02717013|Muscle|muscle
5204420|NCT02716974|Lupron|lupron
5204421|NCT02716974|Bicalutamide|bicalutamide
5204422|NCT02716974|Docetaxel|docetaxel
5204423|NCT02716896|cystectomy|cystectomy
5204424|NCT02716896|radiation|radiation
5204425|NCT02716896|chemotherapy|chemotherapy
5204426|NCT02716883|keratitis|keratitis
5204427|NCT02716883|AMT|amt
5204428|NCT02716883|bacterial keratitis|bacterial keratitis
5204429|NCT02716883|medication|medication
5204430|NCT02716870|Systematic review and meta-analysis|systematic review and meta-analysis
5204431|NCT02716870|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5204432|NCT02716870|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5204433|NCT02716870|Clinical practice guidelines|clinical practice guidelines
5204434|NCT02716870|Clinical trials|clinical trials
5204435|NCT02716870|Dietary sugars|dietary sugars
5204436|NCT02716870|Fructose|fructose
5204437|NCT02716870|High fructose corn syrup|high fructose corn syrup
5204438|NCT02716870|Fruit|fruit
5204439|NCT02716870|Isocaloric|isocaloric
5204440|NCT02716870|Hypercaloric|hypercaloric
5204441|NCT02716870|Cardiometabolic risk factors|cardiometabolic risk factors
5204442|NCT02716870|Triglycerides|triglycerides
5204444|NCT02716870|Glycemic control|glycemic control
5204445|NCT02716870|Insulin resistance|insulin resistance
5204446|NCT02716870|Body weight|body weight
5204447|NCT02716870|Uric acid|uric acid
5204448|NCT02716870|Blood pressure|blood pressure
5204449|NCT02716870|Fatty liver|fatty liver
5204450|NCT02716870|Fasting|fasting
5204451|NCT02716870|Postprandial|postprandial
5204452|NCT02716844|Osteoporosis|osteoporosis
5204453|NCT02716844|Clinic Pilates Exercise|clinic pilates exercise
5204454|NCT02716844|Kinesiophobia|kinesiophobia
5204455|NCT02716844|Pain|pain
5204456|NCT02716831|Bulimia Nervosa|bulimia nervosa
5204457|NCT02716831|Eating Disorders|eating disorders
5204458|NCT02716831|Binge Eating|binge eating
5204459|NCT02716831|Bulimia|bulimia
5204460|NCT02716831|Purging|purging
5204461|NCT02716818|Glucocorticoid therapy|glucocorticoid therapy
5204462|NCT02716805|autologous stem cell transplant|autologous stem cell transplant
5204463|NCT02716805|HDT/ASCT|hdt/asct
5204464|NCT02716805|CTLA-4|ctla-4
5204465|NCT02716805|PD-L1|pd-l1
5204466|NCT02716805|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5204467|NCT02716805|PBMC|pbmc
5204468|NCT02716805|ASCT|asct
5204469|NCT02716766|Sorafenib|sorafenib
5204470|NCT02716766|Drug Therapy|drug therapy
5204471|NCT02716740|Post-obesity surgery|post-obesity surgery
5204472|NCT02716740|Leucine-enriched amino acid supplementation|leucine-enriched amino acid supplementation
5204473|NCT02716740|Anabolic substance|anabolic substance
5204474|NCT02716740|Physical training|physical training
5204475|NCT02716740|Muscular mass|muscular mass
5204476|NCT02716740|Loss of weight|loss of weight
5204477|NCT02716714|Korean|korean
5204478|NCT02716701|Exercise|exercise
5204479|NCT02716688|Esophageal cancer|esophageal cancer
5962556|NCT04280302|unilateral vestibular|unilateral vestibular
5204480|NCT02716688|Radiotherapy|radiotherapy
5204481|NCT02716688|elder|elder
5204482|NCT02716688|S-1|s-1
5204484|NCT02716649|Trauma|trauma
5204485|NCT02716649|ICISS|iciss
5204486|NCT02716649|India|india
5081181|NCT03491579|AML|aml
5204487|NCT02716649|ICD-10|icd-10
5204488|NCT02716597|albumin, septic shock|albumin, septic shock
5204489|NCT02716571|Healthy Subjects|healthy subjects
5204490|NCT02716571|Healthy Participants|healthy participants
5204491|NCT02716545|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
5204492|NCT02716545|Endoscopic Therapy|endoscopic therapy
5204493|NCT02716519|Diabetes|diabetes
5204494|NCT02716519|diabetic foot ulcer|diabetic foot ulcer
5204495|NCT02716519|foot sore|foot sore
5204496|NCT02716519|type 2 diabetes|type 2 diabetes
5204497|NCT02716519|type 1 diabetes|type 1 diabetes
5204498|NCT02716519|DFU|dfu
5204499|NCT02716519|pressure ulcers|pressure ulcers
5204500|NCT02716519|bed sores|bed sores
5204501|NCT02716506|POP surgery|pop surgery
5204502|NCT02716493|Telerehabilitation|telerehabilitation
5096273|NCT03396536|implant|implant
5204503|NCT02716480|Nutrition|nutrition
5204504|NCT02716480|Physical activity|physical activity
5204505|NCT02716480|Bariatric surgery|bariatric surgery
5204506|NCT02716480|Obesity|obesity
5204507|NCT02716480|Health technology|health technology
5204508|NCT02716480|Health-connected devices|health-connected devices
5204510|NCT02716467|intercessory prayer|intercessory prayer
5204511|NCT02716467|spirituality|spirituality
5204512|NCT02716467|clinical trials|clinical trials
5204513|NCT02716454|Early surgery|early surgery
5204514|NCT02716454|Crohn's disease|crohn's disease
5204515|NCT02716454|Step-up therapy|step-up therapy
5204516|NCT02716415|neonates|neonates
5204517|NCT02716415|infants|infants
5204518|NCT02716402|Cyanotic congenital heart disease|cyanotic congenital heart disease
5204519|NCT02716402|pulmonary thrombosis|pulmonary thrombosis
5204520|NCT02716402|cerebral thrombosis|cerebral thrombosis
5204521|NCT02716376|Head and neck neoplasms|head and neck neoplasms
5204522|NCT02716376|Radiotherapy|radiotherapy
5204523|NCT02716376|Otitis media|otitis media
5204524|NCT02716337|human milk target fortification|human milk target fortification
5204525|NCT02716324|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5204526|NCT02716324|Shared-Decision Making|shared-decision making
5204527|NCT02716324|Care Manager|care manager
5204528|NCT02716324|Children|children
5204529|NCT02716324|Parents|parents
5204530|NCT02716324|Teachers|teachers
5204531|NCT02716311|EGFR|egfr
5204542|NCT02716259|Cardiovascular diseases|cardiovascular diseases
5204543|NCT02716259|Bacteremia|bacteremia
5204544|NCT02716259|Scaling and root planing|scaling and root planing
5204545|NCT02716259|Flow-mediated dilation|flow-mediated dilation
5204546|NCT02716259|carotid intima-media thickness|carotid intima-media thickness
5204547|NCT02716259|Porphyromonas gingivalis|porphyromonas gingivalis
5204548|NCT02716259|Aggregatibacter actinomycetemcomitans|aggregatibacter actinomycetemcomitans
5204549|NCT02716246|MPS IIIA|mps iiia
5204550|NCT02716246|Sanfilippo|sanfilippo
5204551|NCT02716246|Gene Therapy|gene therapy
5204552|NCT02716220|DREAMS 2G|dreams 2g
5204553|NCT02716220|Scaffold|scaffold
5201081|NCT02737358|tobacco|tobacco
5204554|NCT02716220|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
5204555|NCT02716220|Coronary Artery Disease|coronary artery disease
5204556|NCT02716207|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5204557|NCT02716207|CyberKnife|cyberknife
5204558|NCT02716207|Dose Escalation|dose escalation
5204559|NCT02716181|Atopic Dermatitis|atopic dermatitis
5204560|NCT02716181|Topical therapy|topical therapy
5204562|NCT02716168|tele-health|tele-health
5204563|NCT02716168|Shared care|shared care
5204564|NCT02716168|Continuity|continuity
5204575|NCT02716103|AL amyloidosis, systemic primary amyloidosis|al amyloidosis, systemic primary amyloidosis
5204576|NCT02716064|chronic conditions, self-management, PHR|chronic conditions, self-management, phr
5204577|NCT02716038|Non-Small Cell Lung Cancer|non-small cell lung cancer
5204578|NCT02716038|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5204579|NCT02716038|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
5204580|NCT02716038|NSCLC|nsclc
5204581|NCT02716012|Oligonucleotide|oligonucleotide
5204583|NCT02716012|saRNA|sarna
5204584|NCT02716012|Fibrosis|fibrosis
5204585|NCT02716012|Cirrhosis|cirrhosis
5204586|NCT02715986|ECT|ect
5204587|NCT02715986|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
5204588|NCT02715986|fMRI|fmri
5204589|NCT02715947|Psoriasis Vulgaris|psoriasis vulgaris
5204590|NCT02715947|Methotrexate|methotrexate
5204591|NCT02715934|Diabetes Education|diabetes education
5204592|NCT02715934|Chronic Disease Management|chronic disease management
5204593|NCT02715934|Health Care Delivery|health care delivery
5204594|NCT02715934|Patient-Centered Medical Home|patient-centered medical home
5204595|NCT02715934|Primary Care|primary care
5204597|NCT02715895|Growth|growth
5204598|NCT02715895|Body Weight Changes|body weight changes
5204599|NCT02715895|Infant Formula|infant formula
5204600|NCT02715895|Randomized Controlled Trial|randomized controlled trial
5204601|NCT02715882|Colorectal cancer|colorectal cancer
5204602|NCT02715882|TLR5|tlr5
5204603|NCT02715882|Immunotherapy|immunotherapy
5204604|NCT02715869|Myocardial Preconditioning, inotropic score|myocardial preconditioning, inotropic score
5962557|NCT04280302|virtual reality|virtual reality
5962558|NCT04280302|rehabilitation|rehabilitation
5204605|NCT02715856|Bone metastases|bone metastases
5204606|NCT02715856|Intramedullary nailing surgery|intramedullary nailing surgery
5204607|NCT02715856|IM|im
5204608|NCT02715856|Physical tasks|physical tasks
5204609|NCT02715856|Surveys|surveys
5204610|NCT02715856|Questionnaires|questionnaires
5204611|NCT02715856|Smartphone|smartphone
5204612|NCT02715856|Tablet|tablet
5204613|NCT02715856|Telemedicine|telemedicine
5204614|NCT02715856|Telemonitoring|telemonitoring
5204615|NCT02715843|CD20|cd20
5204616|NCT02715843|immunotoxin|immunotoxin
5204617|NCT02715843|NHL|nhl
5204618|NCT02715843|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5204619|NCT02715843|lymphoma|lymphoma
5204620|NCT02715843|cancer|cancer
5204621|NCT02715843|antibodies|antibodies
5204622|NCT02715843|immunotherapy|immunotherapy
5204623|NCT02715843|safety|safety
5204624|NCT02715843|pharmacokinetics|pharmacokinetics
5204625|NCT02715843|MT-3724|mt-3724
5204626|NCT02715843|relapsed|relapsed
5204627|NCT02715843|refractory|refractory
5204628|NCT02715830|angioplasty|angioplasty
5204629|NCT02715830|infrapopliteal arteries|infrapopliteal arteries
5204630|NCT02715817|Stroke|stroke
5204631|NCT02715817|Hemiparesis|hemiparesis
5204632|NCT02715817|Physical Therapy|physical therapy
5204633|NCT02715817|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5204635|NCT02715804|Pancreatic ductal adenocarcinoma (PDA)|pancreatic ductal adenocarcinoma (pda)
5204636|NCT02715804|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
5204637|NCT02715804|PEGylated Recombinant Human Hyaluronidase (PEGPH20)|pegylated recombinant human hyaluronidase (pegph20)
5204638|NCT02715804|Nab-paclitaxel|nab-paclitaxel
5204639|NCT02715804|Gemcitabine|gemcitabine
5204640|NCT02715804|Metastatic|metastatic
5204641|NCT02715804|Stage IV|stage iv
5204642|NCT02715791|Self-Management|self-management
5192598|NCT02788734|HNPP|hnpp
5192599|NCT02788708|paclitaxel|paclitaxel
5192600|NCT02788708|lenvatinib|lenvatinib
5192601|NCT02788695|Visual Nonspecific|visual nonspecific
5192602|NCT02788682|VDBP|vdbp
5192603|NCT02788682|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
5192604|NCT02788682|interferon based therapy|interferon based therapy
5192605|NCT02788682|Egypt|egypt
5192611|NCT02788604|psychosocial screening, quality of life|psychosocial screening, quality of life
5192612|NCT02788552|Neurological|neurological
5192613|NCT02788552|Diet and Nutrition|diet and nutrition
5192614|NCT02788552|Mental Health|mental health
5204643|NCT02715791|Health Connectors|health connectors
5204644|NCT02715791|Volunteers|volunteers
5204645|NCT02715791|Technology|technology
5204646|NCT02715791|Interprofessional team|interprofessional team
5204647|NCT02715791|Chronic disease|chronic disease
5204648|NCT02715791|Self-efficacy|self-efficacy
5204649|NCT02715791|Patient-centredness|patient-centredness
5204650|NCT02715791|Community Engagement|community engagement
5204651|NCT02715739|Trauma|trauma
5204652|NCT02715739|India|india
5204653|NCT02715739|ICISS|iciss
5204654|NCT02715713|Autonomic neuropathy, Testosterone Deficiency|autonomic neuropathy, testosterone deficiency
5204669|NCT02715570|Allergic Bronchopulmonary|allergic bronchopulmonary
5204671|NCT02715544|Intervention|intervention
5204672|NCT02715544|Physical activity|physical activity
5204673|NCT02715544|Eating habit|eating habit
5204674|NCT02715544|Connectedness to nature|connectedness to nature
5204675|NCT02715518|Acute ST-segment elevation myocardial infarction|acute st-segment elevation myocardial infarction
5204676|NCT02715518|Acute myocardial infarction|acute myocardial infarction
5204677|NCT02715518|Fractional flow reserve|fractional flow reserve
5204678|NCT02715518|Percutaneous coronary intervention|percutaneous coronary intervention
5204679|NCT02715518|Multivessel disease|multivessel disease
5204680|NCT02715518|STEMI|stemi
5204681|NCT02715518|NSTEMI|nstemi
5204682|NCT02715505|Hurler syndrome, MLD, Krabbe, cALD, Hematopoietic Stem Cell Transplantation (HSCT)|hurler syndrome, mld, krabbe, cald, hematopoietic stem cell transplantation (hsct)
5204683|NCT02715453|Frailty|frailty
5204684|NCT02715453|Acute myocardial infarction|acute myocardial infarction
5204685|NCT02715440|Benzodiazepines|benzodiazepines
5204686|NCT02715440|drugs|drugs
5204687|NCT02715440|withdrawal|withdrawal
5204688|NCT02715440|nursing home|nursing home
5204689|NCT02715440|elderly|elderly
5204690|NCT02715440|therapy elderly|therapy elderly
5204691|NCT02715440|Adverse Effect|adverse effect
5204692|NCT02715440|pharmacokinetics|pharmacokinetics
5204693|NCT02715440|Decreased Drug Tolerance|decreased drug tolerance
5204695|NCT02715362|immunotherapy GPC3 CAR-T HCC|immunotherapy gpc3 car-t hcc
5204696|NCT02715349|schizophrenia|schizophrenia
5204697|NCT02715349|psychoeducation|psychoeducation
5204698|NCT02715349|Vietnam|vietnam
5204699|NCT02715336|In vitro fertilization|in vitro fertilization
5204701|NCT02715336|Assisted Reproductive Technologies|assisted reproductive technologies
5204703|NCT02715336|OHSS|ohss
5204704|NCT02715336|Ovarian hyperstimulation|ovarian hyperstimulation
5204705|NCT02715336|dual triggering|dual triggering
5204706|NCT02715336|GnRH|gnrh
5204707|NCT02715323|dry eye|dry eye
5096502|NCT03395093|Bispectral Index|bispectral index
5204708|NCT02715323|immunological profile|immunological profile
5204709|NCT02715323|autoimmune|autoimmune
5204710|NCT02715297|glioblastoma|glioblastoma
5204711|NCT02715297|GBM|gbm
5204712|NCT02715297|radiotherapy|radiotherapy
5204713|NCT02715297|Re-irradiation|re-irradiation
5204714|NCT02715297|progression|progression
5204715|NCT02715284|Metastatic solid tumors|metastatic solid tumors
5204716|NCT02715284|Advanced solid tumors|advanced solid tumors
5204717|NCT02715284|anti-PD-1|anti-pd-1
5204718|NCT02715284|TSR-042|tsr-042
5204719|NCT02715284|Immunotherapy|immunotherapy
5192720|NCT02787811|IUI|iui
5204720|NCT02715284|PD-1|pd-1
5204721|NCT02715284|Endometrial|endometrial
5204722|NCT02715284|Non-small cell lung cancer, NSCLC|non-small cell lung cancer, nsclc
5204723|NCT02715284|MSI-High|msi-high
5204724|NCT02715284|Dostarlimab|dostarlimab
5204725|NCT02715284|dMMR|dmmr
5204726|NCT02715245|home rehabilitation|home rehabilitation
5204727|NCT02715245|Primary Health Care|primary health care
5204728|NCT02715245|Physiotherapy|physiotherapy
5204729|NCT02715245|chronic disease|chronic disease
5204730|NCT02715206|rural adolescents, substance use, prevention, adaptation|rural adolescents, substance use, prevention, adaptation
5204731|NCT02715154|Epidural Anaesthesia|epidural anaesthesia
5204732|NCT02715154|Cesarean Section|cesarean section
5204733|NCT02715154|Dexmedetomidine|dexmedetomidine
5204734|NCT02715141|surveillance, molecular stool testing|surveillance, molecular stool testing
5204735|NCT02715115|Autism|autism
5204736|NCT02715115|Rett's syndrome|rett's syndrome
5204737|NCT02715115|Rett disorder|rett disorder
5204738|NCT02715115|Rett's disorder|rett's disorder
5204739|NCT02715115|Ataxia|ataxia
5204740|NCT02715102|lung cancer|lung cancer
5204741|NCT02715102|lung neoplasms|lung neoplasms
5204743|NCT02715102|screening tests for cancer|screening tests for cancer
5204744|NCT02715089|NGS|ngs
5204745|NCT02715089|Liver Neoplasms|liver neoplasms
5204746|NCT02715089|Biliary Tract Neoplasms|biliary tract neoplasms
5204747|NCT02715089|Hepatobiliary Neoplasms|hepatobiliary neoplasms
5204748|NCT02715076|Thoracic Surgery|thoracic surgery
5204749|NCT02715076|Thoracic surgery, Video assisted|thoracic surgery, video assisted
5204750|NCT02715076|Open Abdominal Surgery|open abdominal surgery
5204751|NCT02715076|Anesthesia, General|anesthesia, general
5204752|NCT02715050|phototherapy|phototherapy
5204753|NCT02715050|photobiostimulation|photobiostimulation
5204754|NCT02715050|muscle training|muscle training
5204755|NCT02715050|muscular adaptation|muscular adaptation
5205442|NCT02710903|IL29|il29
5204756|NCT02715037|fusobacterium necrophorum|fusobacterium necrophorum
5204757|NCT02715037|acute tonsillitis|acute tonsillitis
5204758|NCT02715037|peritonsillar cellulitis|peritonsillar cellulitis
5204759|NCT02715037|infectious mononucleosis|infectious mononucleosis
5204760|NCT02715037|microbiology|microbiology
5204761|NCT02715037|antibody development|antibody development
5204762|NCT02715024|Tamsulosin|tamsulosin
5204763|NCT02715024|Solifenacin|solifenacin
5204764|NCT02715024|Lower urinary tract symptoms|lower urinary tract symptoms
5204765|NCT02715024|Overactive bladder|overactive bladder
5204766|NCT02715011|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5204767|NCT02715011|JNJ-63709178|jnj-63709178
5204768|NCT02714998|ectopic pregnancy|ectopic pregnancy
5204769|NCT02714998|ovarian reserve|ovarian reserve
5204770|NCT02714998|salpingectomy|salpingectomy
5204771|NCT02714998|methotrexate|methotrexate
5204772|NCT02714985|chikungunya virus|chikungunya virus
5204773|NCT02714985|RT-PCR|rt-pcr
5204774|NCT02714985|urine|urine
5204775|NCT02714985|diagnosis|diagnosis
5204776|NCT02714946|Thyroid Nodule|thyroid nodule
5204777|NCT02714946|Percutaneous radiofrequency ablation (RFA)|percutaneous radiofrequency ablation (rfa)
5204778|NCT02714946|Percutaneous laser ablation (LA)|percutaneous laser ablation (la)
5204779|NCT02714933|pulmonary|pulmonary
5204780|NCT02714933|parenchyma|parenchyma
5204781|NCT02714933|MRI sequence Advanced ZTE|mri sequence advanced zte
5204782|NCT02714933|chest computed tomography|chest computed tomography
5204783|NCT02714920|DNA Repair Enzyme Signature|dna repair enzyme signature
5204784|NCT02714920|instrinsic radio- or chemo-resistance|instrinsic radio- or chemo-resistance
5204785|NCT02714920|treatment-induced radio- or chemo-resistance|treatment-induced radio- or chemo-resistance
5204786|NCT02714894|magnetic resonance imaging|magnetic resonance imaging
5204787|NCT02714894|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5204788|NCT02714868|repeated measures|repeated measures
5204789|NCT02714868|matched comparison|matched comparison
5204790|NCT02714868|manualized intervention|manualized intervention
5204791|NCT02714868|self-determination|self-determination
5204792|NCT02714868|participation|participation
5204793|NCT02714868|advocacy|advocacy
5204794|NCT02714868|problem-solving|problem-solving
5204795|NCT02714868|commuinity participation|commuinity participation
5204796|NCT02714868|occupational therapy|occupational therapy
5204797|NCT02714868|environment|environment
5204798|NCT02714829|Injectable Ceramics Bone Graft Substitute Containing rhBMP-2|injectable ceramics bone graft substitute containing rhbmp-2
5204799|NCT02714790|Acute Myeloid Leukemia|acute myeloid leukemia
5204800|NCT02714790|Minimal Residual Disease|minimal residual disease
5204801|NCT02714790|Wilms Tumor|wilms tumor
5204802|NCT02714777|General anesthesia|general anesthesia
5204803|NCT02714777|Autonomic nervous system|autonomic nervous system
5204804|NCT02714777|Children|children
5204805|NCT02714764|Alexander Disease|alexander disease
5204806|NCT02714738|Brachial plexus block|brachial plexus block
5204807|NCT02714738|Regional anesthesia|regional anesthesia
5204808|NCT02714738|Ultrasound|ultrasound
5192809|NCT02787382|TORCH|torch
5204809|NCT02714725|Dexmedetomidine|dexmedetomidine
5204810|NCT02714725|Microcirculation|microcirculation
5204812|NCT02714725|CABG|cabg
5204813|NCT02714686|Fertility|fertility
5204814|NCT02714686|Total Contraception Prevalence Rate|total contraception prevalence rate
5204815|NCT02714686|Family planning methods|family planning methods
5204816|NCT02714686|Birth Control|birth control
5204817|NCT02714686|Mass Media Campaign|mass media campaign
5204818|NCT02714686|Demand for contraception|demand for contraception
5204819|NCT02714686|Modern Contraception Prevalence Rate|modern contraception prevalence rate
5204820|NCT02714686|Birth intervals|birth intervals
5204821|NCT02714647|motor learning|motor learning
5204822|NCT02714647|attention|attention
5204823|NCT02714647|priming|priming
5204824|NCT02714647|rehabilitation|rehabilitation
5204825|NCT02714621|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5204826|NCT02714621|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
5204827|NCT02714621|Focused Ultrasound Surgery|focused ultrasound surgery
5204828|NCT02714595|cefiderocol|cefiderocol
5204829|NCT02714595|Bloodstream infections (BSI)|bloodstream infections (bsi)
5204830|NCT02714595|Complicated urinary tract infection (cUTI)|complicated urinary tract infection (cuti)
5204831|NCT02714595|Ventilator associated pneumonia (VAP)|ventilator associated pneumonia (vap)
5204834|NCT02714595|multi-drug resistant pathogens|multi-drug resistant pathogens
5204836|NCT02714595|Gram-negative pathogens|gram-negative pathogens
5204837|NCT02714595|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
5204838|NCT02714595|carbapenem resistant pathogens|carbapenem resistant pathogens
5204839|NCT02714582|Shift report|shift report
5204840|NCT02714582|Bedside|bedside
5204841|NCT02714582|Nursing|nursing
5204842|NCT02714582|Matched controlled trial|matched controlled trial
5204843|NCT02714582|Mixed method|mixed method
5204844|NCT02714582|Patient participation|patient participation
5204845|NCT02714556|Lung volume|lung volume
5204846|NCT02714556|Lung Clearance Index|lung clearance index
5205443|NCT02710903|IL28B|il28b
5204847|NCT02714556|Functional Residual Capacity|functional residual capacity
5204848|NCT02714556|Respiratory function|respiratory function
5204849|NCT02714543|OSMF|osmf
5204850|NCT02714543|Aloevera|aloevera
5204851|NCT02714543|Hydrocortisone|hydrocortisone
5204852|NCT02714543|Hyaluronidase|hyaluronidase
5204853|NCT02714504|Prophylaxis|prophylaxis
5204854|NCT02714465|Hyperbaric Oxygen Therapy; Gamma Knife Radiosurgery|hyperbaric oxygen therapy; gamma knife radiosurgery
5204855|NCT02714452|Person-centred care|person-centred care
5204856|NCT02714452|Thriving|thriving
5204857|NCT02714452|Satisfaction with care|satisfaction with care
5204858|NCT02714452|Residential aged care|residential aged care
5204859|NCT02714452|Caring environment|caring environment
5204860|NCT02714439|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5204861|NCT02714439|Cervical Cancer Prevention|cervical cancer prevention
5204862|NCT02714439|Abnormal Pap test|abnormal pap test
5204863|NCT02714439|Positive HPV test|positive hpv test
5204864|NCT02714439|History of cervical dysplasia|history of cervical dysplasia
5204865|NCT02714439|Colposcopy|colposcopy
5204866|NCT02714439|Proflavine|proflavine
5204867|NCT02714439|Proflavine hemisulfate|proflavine hemisulfate
5204868|NCT02714439|High-Resolution Microendoscopy|high-resolution microendoscopy
5204869|NCT02714439|HRME|hrme
5204870|NCT02714439|Human papillomavirus|human papillomavirus
5204871|NCT02714426|Cognitive Aging|cognitive aging
5204872|NCT02714426|Attention|attention
5204873|NCT02714426|Mindfulness|mindfulness
5204874|NCT02714413|D-allulose|d-allulose
5204875|NCT02714413|Caucasian|caucasian
5204876|NCT02714413|African American|african american
5204877|NCT02714400|Obstructive Sleep Apnea|obstructive sleep apnea
5204878|NCT02714400|Arousal threshold|arousal threshold
5204879|NCT02714400|Venlafaxine|venlafaxine
5204880|NCT02714387|Non traumatic acute brain injury|non traumatic acute brain injury
5204881|NCT02714374|GL-ONC1|gl-onc1
5204882|NCT02714374|Solid Organ Cancer|solid organ cancer
5204883|NCT02714374|Cancer|cancer
5204884|NCT02714374|Surgery|surgery
5204885|NCT02714374|Oncolytic Virus|oncolytic virus
5204886|NCT02714374|Soliris|soliris
5204887|NCT02714374|Metastatic melanoma|metastatic melanoma
5204888|NCT02714374|Esophageal and gastric adenocarcinoma (Stage III/IV)|esophageal and gastric adenocarcinoma (stage iii/iv)
5204889|NCT02714374|Cholangiocarcinoma|cholangiocarcinoma
5204890|NCT02714374|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5204891|NCT02714374|Gallbladder cancer|gallbladder cancer
5204892|NCT02714374|Colorectal cancer (Stage IV)|colorectal cancer (stage iv)
5204893|NCT02714374|High-grade mucinous appendix cancer|high-grade mucinous appendix cancer
5204894|NCT02714374|High-grade gastrointestinal neuroendocrine cancer|high-grade gastrointestinal neuroendocrine cancer
5204895|NCT02714374|Mesothelioma|mesothelioma
5204896|NCT02714374|High-grade soft tissue sarcoma|high-grade soft tissue sarcoma
5962559|NCT04280289|CBD|cbd
5204897|NCT02714374|Stage III or IV|stage iii or iv
5204898|NCT02714361|Iron deficiency|iron deficiency
5204899|NCT02714361|Vitamin D|vitamin d
5204900|NCT02714361|Iron absorption|iron absorption
5204901|NCT02714361|Hepcidin|hepcidin
5204902|NCT02714348|Helminth infection|helminth infection
5204903|NCT02714348|Vaccination|vaccination
5204904|NCT02714322|Adalimumab|adalimumab
5204905|NCT02714322|Biologics|biologics
5204906|NCT02714322|Biosimilar|biosimilar
5204907|NCT02714309|Postprandial glycemia|postprandial glycemia
5204908|NCT02714309|Metabolic health measures|metabolic health measures
5204909|NCT02714296|colon preparation for endoscopy|colon preparation for endoscopy
5204910|NCT02714296|enteral feeding|enteral feeding
5204911|NCT02714296|sip feeding|sip feeding
5204912|NCT02714296|nutridrink|nutridrink
5204913|NCT02714296|nutridrink compact protein|nutridrink compact protein
5204914|NCT02714283|nontuberculous mycobacteria|nontuberculous mycobacteria
5204915|NCT02714283|corticosteroids|corticosteroids
5204916|NCT02714283|macrolides|macrolides
5204917|NCT02714283|antibiotics|antibiotics
5204918|NCT02714205|Hot flash|hot flash
5204919|NCT02714153|Lead extraction|lead extraction
5204920|NCT02714153|Superior Vena Cava Tear|superior vena cava tear
5204921|NCT02714153|Pacemaker/Defibrillator lead extraction|pacemaker/defibrillator lead extraction
5204922|NCT02714127|Human Papillomavirus|human papillomavirus
5204923|NCT02714127|Biomarker|biomarker
5204925|NCT02714127|First-void urine|first-void urine
5204926|NCT02714127|Cervicovaginal fluid|cervicovaginal fluid
5204927|NCT02714127|Colposcopy|colposcopy
5204928|NCT02714114|Antibodies|antibodies
5204929|NCT02714114|Vaccination|vaccination
5204930|NCT02714114|Self-sampling|self-sampling
5204931|NCT02714114|First-void urine|first-void urine
5204932|NCT02714114|Serum|serum
5204933|NCT02714088|High-intensity interval training|high-intensity interval training
5204934|NCT02714088|Functional fitness|functional fitness
5204935|NCT02714088|Quality of life|quality of life
5204936|NCT02714088|Older adults|older adults
5204937|NCT02714062|Adolescent Obesity|adolescent obesity
5204938|NCT02714062|Childhood Obesity|childhood obesity
5204939|NCT02714062|Qsymia|qsymia
5204940|NCT02714062|Pharmacokinetics|pharmacokinetics
5204941|NCT02714062|VI-0521|vi-0521
5204942|NCT02714062|Phentermine|phentermine
5204943|NCT02714062|Topiramate|topiramate
5205444|NCT02710890|Epilepsy|epilepsy
5204944|NCT02714049|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5204945|NCT02714049|Addyi|addyi
5204946|NCT02714049|flibanserin|flibanserin
5204947|NCT02714049|low sexual desire|low sexual desire
5204948|NCT02714049|HSDD|hsdd
5204950|NCT02714010|EGFR-TKI|egfr-tki
5204951|NCT02714010|whole brain radiotherapy|whole brain radiotherapy
5204952|NCT02714010|brain metastasis|brain metastasis
5204953|NCT02714010|non-small cell lung cancer|non-small cell lung cancer
5204954|NCT02713984|HER2 CAR-T|her2 car-t
5204955|NCT02713984|safety|safety
5204956|NCT02713984|efficiency|efficiency
5204957|NCT02713984|refractory and relapsed cancer|refractory and relapsed cancer
5204958|NCT02713971|Rehabilitation|rehabilitation
5204959|NCT02713971|Balance|balance
5204960|NCT02713971|Gait|gait
5204961|NCT02713971|Biofeedback|biofeedback
5204962|NCT02713958|Telerehabilitation|telerehabilitation
5204963|NCT02713958|Elbow fractures|elbow fractures
5204964|NCT02713958|Arthrolysis|arthrolysis
5204965|NCT02713958|MediTouch|meditouch
5204966|NCT02713958|Occupational Therapy|occupational therapy
5204967|NCT02713958|Active exercises|active exercises
5204968|NCT02713945|Simvastatin|simvastatin
5204969|NCT02713945|Ras|ras
5204970|NCT02713945|MAPK|mapk
5204971|NCT02713932|Aortic valve stenosis|aortic valve stenosis
5204972|NCT02713932|Aortic valve regurgitation|aortic valve regurgitation
5204973|NCT02713932|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5204974|NCT02713919|Cancer|cancer
5096793|NCT03393520|AVP-786|avp-786
5204975|NCT02713919|Outpatients|outpatients
5204976|NCT02713919|Family Caregivers|family caregivers
5204977|NCT02713893|Pharmacokinetics|pharmacokinetics
5204978|NCT02713893|Econazole nitrate 1%|econazole nitrate 1%
5204979|NCT02713893|Benzydamine HCl 0.12%|benzydamine hcl 0.12%
5204980|NCT02713893|Intravaginal cream|intravaginal cream
5204982|NCT02713893|Tolerability|tolerability
5204983|NCT02713880|Amyloid Neuropathies|amyloid neuropathies
5204984|NCT02713880|Biomarker|biomarker
5204985|NCT02713854|Subfertility|subfertility
5204986|NCT02713854|In-vitro fertilization|in-vitro fertilization
5204987|NCT02713854|BAP-EB|bap-eb
5204988|NCT02713854|Endometrial epithelial cells|endometrial epithelial cells
5204989|NCT02713854|Repeated implantation failure|repeated implantation failure
5204990|NCT02713828|gpNMB-Expressing Squamous Cell Carcinoma of the Lung|gpnmb-expressing squamous cell carcinoma of the lung
5204991|NCT02713828|Stage IIIb|stage iiib
5204992|NCT02713828|Stage IV|stage iv
5204993|NCT02713828|Advanced Squamous Cell Cancer of the Lung|advanced squamous cell cancer of the lung
5204994|NCT02713828|Metastatic Squamous Cell Cancer of the Lung|metastatic squamous cell cancer of the lung
5204995|NCT02713828|gpNMB-Expressing|gpnmb-expressing
5204996|NCT02713828|Glembatumumab Vedotin|glembatumumab vedotin
5192986|NCT02786589|Lung cancer Immunotherapy|lung cancer immunotherapy
5081755|NCT03488134|Exosome|exosome
5192987|NCT02786589|Plasmodium vivax|plasmodium vivax
5192988|NCT02786589|Immunotherapy|immunotherapy
5192989|NCT02786576|Moderate to Severe Hidradenitis Suppurativa|moderate to severe hidradenitis suppurativa
5192990|NCT02786576|Adalimumab|adalimumab
5192991|NCT02786563|power doppler (PD)|power doppler (pd)
5192992|NCT02786563|ultrasonographic (US)|ultrasonographic (us)
5192993|NCT02786563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5192994|NCT02786563|disease activity scale (DAS)|disease activity scale (das)
5192995|NCT02786563|C-reactive protein (CRP)|c-reactive protein (crp)
5192996|NCT02786550|Lower blepharoplasty, Botulinum toxin, Scar|lower blepharoplasty, botulinum toxin, scar
5193042|NCT02786342|HCC|hcc
5204997|NCT02713815|Amphetamine-type stimulants|amphetamine-type stimulants
5204998|NCT02713815|prefrontal-striatal circuits|prefrontal-striatal circuits
5204999|NCT02713815|rTMS|rtms
5205000|NCT02713815|Glutamate/GABA|glutamate/gaba
5205001|NCT02713815|motivational and cognitive intervention|motivational and cognitive intervention
5205002|NCT02713789|ED|ed
5205003|NCT02713776|High-Output Enterostomy|high-output enterostomy
5205004|NCT02713776|Pasireotide|pasireotide
5205005|NCT02713776|Somatostatin Analogues|somatostatin analogues
5205006|NCT02713763|Sunitinib|sunitinib
5205007|NCT02713750|Combined Oral Contraceptives|combined oral contraceptives
5862729|NCT00001534|Renin-Angiotensin System|renin-angiotensin system
5205026|NCT02713698|Pharmacokinetics|pharmacokinetics
5205027|NCT02713698|Pharmacodynamics|pharmacodynamics
5205028|NCT02713698|Propofol pharmacokinetic-pharmacodynamic model|propofol pharmacokinetic-pharmacodynamic model
5205029|NCT02713685|regional anesthesia|regional anesthesia
5205030|NCT02713685|lower limb surgery|lower limb surgery
5205031|NCT02713685|Bupivacaine|bupivacaine
5205032|NCT02713659|Literacy|literacy
5205033|NCT02713659|Child Development|child development
5205034|NCT02713659|Reading|reading
5205035|NCT02713646|MRI|mri
5205036|NCT02713646|Virtual Endoscopy|virtual endoscopy
5205037|NCT02713646|Pain Measurement|pain measurement
5205038|NCT02713620|HBV vaccination, immunity|hbv vaccination, immunity
5205039|NCT02713581|Proximal venous thromboembolism|proximal venous thromboembolism
5205040|NCT02713568|Macrosomia|macrosomia
5205141|NCT02712840|Vitrification|vitrification
5205041|NCT02713568|Magnetic Resonance- Estimated Fetal Weight|magnetic resonance- estimated fetal weight
5205042|NCT02713568|Ultrasound-Estimated Fetal Weight|ultrasound-estimated fetal weight
5205043|NCT02713568|Large-for-date fetus|large-for-date fetus
5205044|NCT02713529|Solid Tumor|solid tumor
5205045|NCT02713529|Pancreatic Cancer|pancreatic cancer
5205046|NCT02713529|Colorectal Cancer|colorectal cancer
5205047|NCT02713529|Non-Small Cell Lung Cancer|non-small cell lung cancer
5205048|NCT02713516|Anxiety|anxiety
5205050|NCT02713516|Obsessive Compulsive Disorder|obsessive compulsive disorder
5205051|NCT02713516|Generalized Anxiety|generalized anxiety
5205052|NCT02713516|Social Phobia|social phobia
5205053|NCT02713516|Separation Anxiety|separation anxiety
5205054|NCT02713516|GAD|gad
5205055|NCT02713516|Youth|youth
5205056|NCT02713516|Teen|teen
5205057|NCT02713516|Therapy|therapy
5205058|NCT02713451|Oxygen|oxygen
5205059|NCT02713438|Physical activity|physical activity
5205060|NCT02713438|Planning|planning
5205061|NCT02713438|Implementation intention|implementation intention
5205062|NCT02713438|Quality of life|quality of life
5205063|NCT02713438|Body weight|body weight
5205064|NCT02713425|Anxiety|anxiety
5205065|NCT02713425|Social Phobia|social phobia
5205069|NCT02713425|Phobia|phobia
5205070|NCT02713425|video game|video game
5205071|NCT02713425|teen|teen
5205072|NCT02713425|youth|youth
5205073|NCT02713425|child|child
5205074|NCT02713425|adolescent|adolescent
5205075|NCT02713347|Quality of Life|quality of life
5205076|NCT02713347|Symptom Assessment|symptom assessment
5205077|NCT02713347|Palliative Care|palliative care
5205078|NCT02713347|Disease Management|disease management
5205079|NCT02713347|Delivery of Health Care|delivery of health care
5205080|NCT02713347|Advance Care Planning|advance care planning
5205081|NCT02713334|Decision Making|decision making
5205082|NCT02713334|Communication|communication
5205083|NCT02713334|16-080|16-080
5205084|NCT02713321|diabetes|diabetes
5205085|NCT02713321|vulnerable populations|vulnerable populations
5205086|NCT02713321|comorbidity|comorbidity
5205087|NCT02713321|patient-centered outcomes research|patient-centered outcomes research
5205088|NCT02713321|Medicaid reform|medicaid reform
5205089|NCT02713321|health disparities|health disparities
5205090|NCT02713295|Moderate Plaque Psoriasis|moderate plaque psoriasis
5205091|NCT02713295|Severe Plaque Psoriasis|severe plaque psoriasis
5205092|NCT02713295|Plaque Psoriasis|plaque psoriasis
5205093|NCT02713282|Schizophrenia|schizophrenia
5205095|NCT02713282|Paliperidone Palmitate|paliperidone palmitate
5205096|NCT02713256|Graves' disease|graves' disease
5205097|NCT02713256|Hyperthyroidism|hyperthyroidism
5205098|NCT02713256|CFZ533|cfz533
5205099|NCT02713256|TSH|tsh
5205100|NCT02713243|Primary bile acid diarrhea,|primary bile acid diarrhea,
5205101|NCT02713243|FXR agonist,|fxr agonist,
5205102|NCT02713243|bile acid malabsorption.|bile acid malabsorption.
5962560|NCT04280289|cannabidiol extract|cannabidiol extract
5073153|NCT03541707|TMS|tms
5205103|NCT02713217|depressive disorder|depressive disorder
5205104|NCT02713217|alcohol-related disorders|alcohol-related disorders
5205105|NCT02713217|telemedicine|telemedicine
5205106|NCT02713217|rural health|rural health
5205107|NCT02713217|collaborative care|collaborative care
5802977|NCT00096759|Meditation|meditation
5205108|NCT02713217|post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5205109|NCT02713191|Bronchoscopy|bronchoscopy
5205110|NCT02713191|Sedation|sedation
5205111|NCT02713191|Dexmedetomidine|dexmedetomidine
5205112|NCT02713165|Gut Microbiota|gut microbiota
5205113|NCT02713139|vaginal|vaginal
5205114|NCT02713139|discharge|discharge
5205115|NCT02713139|women|women
5205116|NCT02713048|Cardiac arrest|cardiac arrest
5205117|NCT02713048|Troponin I|troponin i
5205118|NCT02713048|coronary anatomy|coronary anatomy
5205119|NCT02713022|DEXA Scan|dexa scan
5205120|NCT02713022|15-235|15-235
5205121|NCT02713009|Maternal body weight|maternal body weight
5205122|NCT02713009|Vitamin D|vitamin d
5205123|NCT02713009|Pregnancy|pregnancy
5205124|NCT02712996|Traumatic Brain Injury|traumatic brain injury
5205125|NCT02712996|Attention Deficit|attention deficit
5205126|NCT02712996|TBI|tbi
5205127|NCT02712996|Vyvanse|vyvanse
5205128|NCT02712983|Inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary Pseudomonas aeruginosa infection; dose-finding study|inhaled tobramycin; tobramycin inhalation powder; bronchiectasis; pulmonary pseudomonas aeruginosa infection; dose-finding study
5205129|NCT02712918|Depression|depression
5205130|NCT02712918|Inpatient|inpatient
5205131|NCT02712918|Acute|acute
5205132|NCT02712918|Brief Behavioral Activation Treatment for Depression|brief behavioral activation treatment for depression
5205133|NCT02712905|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5205134|NCT02712905|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5205135|NCT02712905|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5205136|NCT02712905|myelofibrosis (MF)|myelofibrosis (mf)
5205137|NCT02712905|solid tumor, lysine-specific demethylase 1 (LSD1) inhibitor|solid tumor, lysine-specific demethylase 1 (lsd1) inhibitor
5205138|NCT02712840|Single embryo transfer|single embryo transfer
5205139|NCT02712840|Freeze-all|freeze-all
5205142|NCT02712840|Clinical Pregnancy|clinical pregnancy
5205143|NCT02712840|Blastocyst|blastocyst
5205144|NCT02712827|self-gripping mesh, fibrin glue, total extraperitoneal|self-gripping mesh, fibrin glue, total extraperitoneal
5205149|NCT02712788|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5205150|NCT02712788|Cerebral Vasospasm|cerebral vasospasm
5205151|NCT02712788|Milrinone|milrinone
5205152|NCT02712788|Hyperdynamic Therapy|hyperdynamic therapy
5205153|NCT02712762|immunological profiles|immunological profiles
5205154|NCT02712749|Binaural Beat|binaural beat
5205155|NCT02712749|Elderly|elderly
5205156|NCT02712749|preoperative medication|preoperative medication
5205157|NCT02712749|postoperative merphine consumption|postoperative merphine consumption
5205158|NCT02712749|postoperative pain|postoperative pain
5205159|NCT02712736|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5205160|NCT02712723|ER+, HER2-negative breast cancer|er+, her2-negative breast cancer
5205161|NCT02712723|Stage II or III|stage ii or iii
5205162|NCT02712723|Letrozole|letrozole
5205163|NCT02712723|Femara|femara
5205164|NCT02712723|Ribociclib|ribociclib
5205165|NCT02712723|LEE011|lee011
5205166|NCT02712723|Neo-adjuvant|neo-adjuvant
5205167|NCT02712710|knee, osteoarthritis, brace|knee, osteoarthritis, brace
5205168|NCT02712697|liver-kidney yin deficiency syndrome|liver-kidney yin deficiency syndrome
5205169|NCT02712697|primary severe IgA nephropathy|primary severe iga nephropathy
5205170|NCT02712697|Lee's grade Ⅲ|lee's grade ⅲ
5205171|NCT02712671|Cost-Benefit Analysis|cost-benefit analysis
5205172|NCT02712671|Quality of Life|quality of life
5205173|NCT02712593|Healthy participants|healthy participants
5205174|NCT02712593|Dietary supplement|dietary supplement
5205175|NCT02712593|Bioavailability|bioavailability
5205176|NCT02712593|Niagen™|niagen™
5205177|NCT02712593|Nicotinamide riboside|nicotinamide riboside
5205178|NCT02712593|N-methylnicotinamide|n-methylnicotinamide
5205179|NCT02712580|pediatric burns|pediatric burns
5205180|NCT02712580|deep dermal wounds|deep dermal wounds
5205181|NCT02712580|wound healing|wound healing
5205182|NCT02712580|ChildPain Measurement|childpain measurement
5205183|NCT02712580|Treatment Outcome Wound Healing/physiology|treatment outcome wound healing/physiology
5205184|NCT02712580|wireless electric stimulation|wireless electric stimulation
5205185|NCT02712580|wireless current stimulation|wireless current stimulation
5205186|NCT02712580|wireless technology|wireless technology
5205187|NCT02712580|children|children
5205188|NCT02712580|conservative treatment|conservative treatment
5205189|NCT02712580|deep dermal scalds|deep dermal scalds
5205190|NCT02712580|humans|humans
5205191|NCT02712580|deep dermal burns|deep dermal burns
5205192|NCT02712580|burns|burns
5205193|NCT02712580|wound healing process|wound healing process
5205194|NCT02712554|Pain|pain
5205195|NCT02712554|Nausea|nausea
5205196|NCT02712554|Vomiting|vomiting
5205197|NCT02712541|Caregiver burden Index|caregiver burden index
5205198|NCT02712528|bispectral index|bispectral index
5962561|NCT04280289|cannabidiol|cannabidiol
5739417|NCT00360009|PD|pd
5205199|NCT02712528|extubation|extubation
5205200|NCT02712528|recovery|recovery
5205201|NCT02712528|remifentanil|remifentanil
5205202|NCT02712489|HAART-treated participants|haart-treated participants
5205203|NCT02712489|Tat|tat
5205204|NCT02712489|Therapeutic immunization|therapeutic immunization
5205205|NCT02712476|Mannitol|mannitol
5205206|NCT02712476|Furosemid|furosemid
5205207|NCT02712476|Brain Relaxation|brain relaxation
5205208|NCT02712463|Schizophrenia|schizophrenia
5205209|NCT02712463|Oral antipsychotics|oral antipsychotics
5205210|NCT02712463|Long acting Injectable antipsychotics|long acting injectable antipsychotics
5205211|NCT02712450|geriatric|geriatric
5205212|NCT02712450|emergency|emergency
5205213|NCT02712450|clinical pathway|clinical pathway
5205214|NCT02712450|regulation|regulation
5205215|NCT02712450|SAMU|samu
5205216|NCT02712450|training|training
5205217|NCT02712437|Insomnia|insomnia
5205218|NCT02712437|Quality of Life|quality of life
5205219|NCT02712437|Cognitive behavioral therapy|cognitive behavioral therapy
5205220|NCT02712424|Vaccine|vaccine
5205221|NCT02712372|AZD4831 oral suspension|azd4831 oral suspension
5205222|NCT02712372|Healthy male subjects|healthy male subjects
5205223|NCT02712372|Safety|safety
5205224|NCT02712372|Tolerability|tolerability
5205225|NCT02712372|Pharmacokinetics|pharmacokinetics
5205226|NCT02712372|Pharmacodynamics|pharmacodynamics
5205227|NCT02712359|Havrix|havrix
5205228|NCT02712359|Cross-sectional seroprevalence survey|cross-sectional seroprevalence survey
5205229|NCT02712359|Panama|panama
5205230|NCT02712359|Long-term persistence|long-term persistence
5205231|NCT02712359|Hepatitis|hepatitis
5205232|NCT02712346|Sickle Cell Anemia|sickle cell anemia
5205233|NCT02712346|Sickle Cell Thalassemia|sickle cell thalassemia
5205234|NCT02712346|Sickle Beta Thalassemia|sickle beta thalassemia
5205235|NCT02712346|Proteinuria|proteinuria
5205236|NCT02712346|Sickle nephropathy|sickle nephropathy
5205237|NCT02712333|PM2.5|pm2.5
5205238|NCT02712333|air purification|air purification
5205239|NCT02712333|randomized controlled trial|randomized controlled trial
5205240|NCT02712333|metabolomics|metabolomics
5205241|NCT02712333|Metabolites|metabolites
5205242|NCT02712333|exhaled nitric oxide|exhaled nitric oxide
5205243|NCT02712320|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
5205244|NCT02712320|Safety Extension|safety extension
5205245|NCT02712294|pulmonary hypertension|pulmonary hypertension
5205246|NCT02712294|peripheral muscle electrostimulation|peripheral muscle electrostimulation
5205247|NCT02712294|capacity of the exercises|capacity of the exercises
5205248|NCT02712294|quality of life|quality of life
5205249|NCT02712281|Food Selectivity|food selectivity
5205250|NCT02712281|Autism MEAL Plan|autism meal plan
5205251|NCT02712281|Parent Education|parent education
5205252|NCT02712268|Polypharmacy|polypharmacy
5205253|NCT02712268|Clinical decision-making|clinical decision-making
5205254|NCT02712255|Physical activity|physical activity
5205255|NCT02712255|Quality of life|quality of life
5205256|NCT02712255|Planning|planning
5205257|NCT02712255|Implementation intentions|implementation intentions
5205258|NCT02712255|Cardiovascular disease|cardiovascular disease
5205259|NCT02712255|Diabetes|diabetes
5193295|NCT02784743|Albendazole|albendazole
5193296|NCT02784743|Ivermectin|ivermectin
5193297|NCT02784743|MDA|mda
5193298|NCT02784730|breast cancer|breast cancer
5193299|NCT02784730|chemotherapy|chemotherapy
5193300|NCT02784730|peripherally inserted central catheter|peripherally inserted central catheter
5205260|NCT02712203|Measles vaccine|measles vaccine
5205261|NCT02712203|Priorix|priorix
5205262|NCT02712203|Priorix-Tetra|priorix-tetra
5097133|NCT03391583|Pain|pain
5205263|NCT02712203|Age at vaccination|age at vaccination
5205264|NCT02712177|vaccine safety|vaccine safety
5205265|NCT02712177|interaction|interaction
5205266|NCT02712164|Split-thickness skin graft|split-thickness skin graft
5205267|NCT02712164|STSG|stsg
5205268|NCT02712164|donor site|donor site
5205269|NCT02712164|negative-pressure wound therapy|negative-pressure wound therapy
5205270|NCT02712164|NPWT|npwt
5205271|NCT02712164|dressing|dressing
5423237|NCT01616576|cochlear implant benefit|cochlear implant benefit
5205272|NCT02712151|transversus abdominal plane block|transversus abdominal plane block
5205273|NCT02712138|Gilbert Syndrome|gilbert syndrome
5205274|NCT02712138|Biomarker|biomarker
5205275|NCT02712060|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5205276|NCT02712060|Obstructive Sleep Apnea|obstructive sleep apnea
5205277|NCT02712060|Prevalence|prevalence
5205278|NCT02712060|Children|children
5205279|NCT02712060|Pediatric|pediatric
5205280|NCT02712060|Adolescents|adolescents
5205281|NCT02712047|Fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
5205282|NCT02712047|Asthma|asthma
5205283|NCT02712047|fraction of exhaled nitric oxide|fraction of exhaled nitric oxide
5962562|NCT04280289|CBDE|cbde
5205284|NCT02712047|cross-over|cross-over
5205292|NCT02712021|Static Balance|static balance
5205293|NCT02711995|botulinum toxin|botulinum toxin
5205294|NCT02711995|injection augmentation|injection augmentation
5205295|NCT02711995|essential voice tremor|essential voice tremor
5962563|NCT04280289|pharmacokinetics|pharmacokinetics
5205296|NCT02711956|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5205298|NCT02711956|Prostate Cancer|prostate cancer
5205299|NCT02711956|Pharmacokinetics (PK)|pharmacokinetics (pk)
5205300|NCT02711956|ZEN003694|zen003694
5205301|NCT02711956|ZEN-3694|zen-3694
5205321|NCT02711891|fingerstick|fingerstick
5205322|NCT02711891|opioid|opioid
5205323|NCT02711891|heelstick|heelstick
5205324|NCT02711891|loperamide|loperamide
5205325|NCT02711891|topical opioid|topical opioid
5205326|NCT02711826|graft inflammation|graft inflammation
5205327|NCT02711826|Treg|treg
5205328|NCT02711826|polyclonally expanded Tregs (polyTregs)|polyclonally expanded tregs (polytregs)
5205329|NCT02711826|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
5205330|NCT02711826|mTOR inhibitors|mtor inhibitors
5205331|NCT02711787|Hand|hand
5205332|NCT02711787|Paralysis|paralysis
5205333|NCT02711787|Stroke|stroke
5205334|NCT02711722|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5205335|NCT02711709|Intra-abdominal sepsis|intra-abdominal sepsis
5205336|NCT02711709|Surgical ICU|surgical icu
5205337|NCT02711696|Celiac Disease,|celiac disease,
5205338|NCT02711696|Gluten Free Diet|gluten free diet
5205339|NCT02711696|Gluten contamination|gluten contamination
5205340|NCT02711670|nephrolithiasis|nephrolithiasis
5205341|NCT02711670|calcium stones|calcium stones
5205342|NCT02711670|kidney stones|kidney stones
5205343|NCT02711670|hypercalciuria|hypercalciuria
5205344|NCT02711670|thiazide|thiazide
5205345|NCT02711657|Fibrocytes|fibrocytes
5205346|NCT02711657|Interstitial Lung Diseases|interstitial lung diseases
5205347|NCT02711657|Rheumatoid Arthritis|rheumatoid arthritis
5205348|NCT02711657|Asthma|asthma
5205349|NCT02711644|Pregnancy|pregnancy
5205350|NCT02711644|Prenatal|prenatal
5205351|NCT02711644|Nutrition|nutrition
5205352|NCT02711631|coronary angioplasty|coronary angioplasty
5205353|NCT02711631|cardiac rehabilitation|cardiac rehabilitation
5205354|NCT02711631|coronary artery bypass graft|coronary artery bypass graft
5205355|NCT02711605|ultrasound|ultrasound
5205357|NCT02711592|Orthopaedic Pain Management|orthopaedic pain management
5205358|NCT02711566|Rehabilitation|rehabilitation
5205359|NCT02711566|Robot-assisted therapy|robot-assisted therapy
5205360|NCT02711501|post-operative pain|post-operative pain
5205361|NCT02711501|diode laser|diode laser
5205362|NCT02711488|school-based intervention|school-based intervention
5205363|NCT02711488|sedentary behavior|sedentary behavior
5205364|NCT02711488|physical activity|physical activity
5205365|NCT02711488|sugar sweetened beverages|sugar sweetened beverages
5205366|NCT02711462|Healthy Subjects|healthy subjects
5193391|NCT02784119|extended criteria donor|extended criteria donor
5193392|NCT02784106|Rheumatoid Arthritis|rheumatoid arthritis
5193393|NCT02784106|M2951|m2951
5193394|NCT02784106|Bruton's Tyrosine Kinase (BTK)|bruton's tyrosine kinase (btk)
5193395|NCT02784093|Chronic Constipation|chronic constipation
5193396|NCT02784093|Fecal impaction|fecal impaction
5193397|NCT02784093|Gastrografin|gastrografin
5193398|NCT02784093|Randomized Controlled Trial|randomized controlled trial
5193415|NCT02784041|knee arthroplasty|knee arthroplasty
5193416|NCT02784041|adductor canal block|adductor canal block
5193417|NCT02784041|periarticular infiltration|periarticular infiltration
5193418|NCT02784028|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5193419|NCT02784028|SGM-101|sgm-101
5193420|NCT02783989|Endothelial function|endothelial function
5193421|NCT02783989|Inflammation|inflammation
5194245|NCT02779894|ICT|ict
5097222|NCT03390920|cartilage|cartilage
5205367|NCT02711449|acute surgery|acute surgery
5205368|NCT02711449|laparoscopy|laparoscopy
5205369|NCT02711371|addiction|addiction
5205370|NCT02711371|cannabis|cannabis
5205371|NCT02711371|fMRI|fmri
5205372|NCT02711345|LTT462|ltt462
5205373|NCT02711345|ERK|erk
5205374|NCT02711345|MAPK|mapk
5205375|NCT02711345|solid tumor|solid tumor
5205376|NCT02711267|Open Flow Microperfusion|open flow microperfusion
5205377|NCT02711241|Gastroenteritis|gastroenteritis
5205378|NCT02711241|Analgesia|analgesia
5205379|NCT02711241|Emergency department|emergency department
5205380|NCT02711189|Addiction|addiction
5205381|NCT02711189|Oxytocin|oxytocin
5202005|NCT02731729|16-043|16-043
5205433|NCT02710968|FETO|feto
5205434|NCT02710916|Optical Coherence Tomography|optical coherence tomography
5205435|NCT02710916|Intraocular pressure|intraocular pressure
5205436|NCT02710916|Optic Nerve Head|optic nerve head
5205437|NCT02710916|Nerve fiber layer|nerve fiber layer
5205438|NCT02710916|Bruch Membrane Opening -Minimum Rim Width|bruch membrane opening -minimum rim width
5205439|NCT02710903|Periodontitis|periodontitis
5205440|NCT02710903|SNP|snp
5205441|NCT02710903|Pathogenesis|pathogenesis
5205445|NCT02710890|pediatric|pediatric
5205446|NCT02710890|intravenous|intravenous
5205447|NCT02710890|children|children
5205448|NCT02710890|Lacosamide|lacosamide
5205449|NCT02710890|VIMPAT®|vimpat®
5205450|NCT02710890|seizure|seizure
5205451|NCT02710877|epidural analgesia|epidural analgesia
5205452|NCT02710877|patient controlled analgesia|patient controlled analgesia
5205453|NCT02710877|obstetric outcome|obstetric outcome
5205455|NCT02710851|human papillomavirus vaccine|human papillomavirus vaccine
5205456|NCT02710851|condylomata acuminata|condylomata acuminata
5205457|NCT02710838|Early gastric cancer|early gastric cancer
5205458|NCT02710838|Infrared endoscope|infrared endoscope
5205459|NCT02710799|Endocrinology|endocrinology
5205460|NCT02710799|Referral list|referral list
5205461|NCT02710799|Teleconsultation|teleconsultation
5205462|NCT02710799|Telemedicine|telemedicine
5205463|NCT02710799|Cluster randomized clinical trial|cluster randomized clinical trial
5205464|NCT02710773|Gait|gait
5205465|NCT02710773|Randomized controlled trial|randomized controlled trial
5205466|NCT02710773|Chronic Stroke|chronic stroke
5205467|NCT02710773|Treadmill training|treadmill training
5205468|NCT02710760|Biomarkers|biomarkers
5205469|NCT02710760|Child Nutrition Sciences|child nutrition sciences
5205470|NCT02710760|Economics, Behavioral|economics, behavioral
5205471|NCT02710747|warfarin|warfarin
5205472|NCT02710747|Chinese patients|chinese patients
5205473|NCT02710747|heart valve replacement|heart valve replacement
5205474|NCT02710734|Urothelial|urothelial
5205479|NCT02710708|birth control,|birth control,
5205480|NCT02710708|contraceptives safety,|contraceptives safety,
5205481|NCT02710708|contraceptives efficacy,|contraceptives efficacy,
5205482|NCT02710708|moderate acne vulgaris|moderate acne vulgaris
5205483|NCT02710682|Lateral Epicondylitis of the elbow|lateral epicondylitis of the elbow
5205484|NCT02710682|Tendon Fenestration|tendon fenestration
5205485|NCT02710682|Minimally invasive Surgery|minimally invasive surgery
5205486|NCT02710682|Ultrasound-guided procedure|ultrasound-guided procedure
5205487|NCT02710682|Ultrasonography|ultrasonography
5205488|NCT02710682|Elastography|elastography
5205489|NCT02710669|ablation|ablation
5205490|NCT02710656|Atherosclerosis|atherosclerosis
5205491|NCT02710656|SFA|sfa
5205492|NCT02710656|Poplitea|poplitea
5205493|NCT02710656|Drug coated balloon|drug coated balloon
5205494|NCT02710656|Angioplasty|angioplasty
5205495|NCT02710656|Restenosis|restenosis
5205496|NCT02710656|Peripheral artery disease (PAD)|peripheral artery disease (pad)
5205498|NCT02710643|Lymphoma|lymphoma
5205499|NCT02710643|Grade 1|grade 1
5205500|NCT02710643|Grade 2|grade 2
5205501|NCT02710643|Grade 3A|grade 3a
5205502|NCT02710604|chronic hepatitis B(CHB)|chronic hepatitis b(chb)
5205503|NCT02710591|Rimeporide|rimeporide
5205504|NCT02710578|Alcohol impaired driving|alcohol impaired driving
5205505|NCT02710578|Driving simulation|driving simulation
5205506|NCT02710578|Residual effects of alcohol|residual effects of alcohol
5205507|NCT02710578|Acute psychomotor effects of alcohol|acute psychomotor effects of alcohol
5205508|NCT02710578|Young drivers|young drivers
5205509|NCT02710565|Endo bronchial ultrasound|endo bronchial ultrasound
5205510|NCT02710565|Trans bronchial needle aspiration|trans bronchial needle aspiration
5205511|NCT02710565|Cell line|cell line
5205512|NCT02710565|Lung cancer|lung cancer
5205513|NCT02710552|arterial hypertension|arterial hypertension
5205514|NCT02710552|antihypertensive drugs|antihypertensive drugs
5205515|NCT02710539|arterial hypertension|arterial hypertension
5205516|NCT02710539|antihypertensive drugs|antihypertensive drugs
5205517|NCT02710513|beta-glucans|beta-glucans
5205518|NCT02710513|gut microbiota|gut microbiota
5205519|NCT02710513|p-cresyl sulphate (pCS)|p-cresyl sulphate (pcs)
5205520|NCT02710513|indoxyl sulphate (IS)|indoxyl sulphate (is)
5205521|NCT02710513|short-chain fatty acid (SCFA)|short-chain fatty acid (scfa)
5205522|NCT02710500|LGMD2B|lgmd2b
5205523|NCT02710500|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
5205524|NCT02710500|Miyoshi|miyoshi
5205525|NCT02710500|Gene Transfer|gene transfer
5205526|NCT02710500|Dysferlin|dysferlin
5205527|NCT02710487|Parkinson's disease, Sleep Benefit|parkinson's disease, sleep benefit
5205528|NCT02710474|preterm birth|preterm birth
5205530|NCT02710474|neonatal|neonatal
5205531|NCT02710474|kangaroo care|kangaroo care
5205532|NCT02710474|separation stress|separation stress
5205533|NCT02710474|family nurture|family nurture
5205534|NCT02710474|maternal confidence|maternal confidence
5205535|NCT02710474|maternal competence|maternal competence
5205536|NCT02710474|calming cycle|calming cycle
5205537|NCT02710474|infant neurodevelopment|infant neurodevelopment
5205538|NCT02710474|infant psychological development|infant psychological development
5205539|NCT02710474|mother-infant co-regulation|mother-infant co-regulation
5205540|NCT02710474|post-partum depression|post-partum depression
5205541|NCT02710461|Polyphenols|polyphenols
5205542|NCT02710461|Grape|grape
5205543|NCT02710461|Pomegranate|pomegranate
5205544|NCT02710461|Metabolic syndrome|metabolic syndrome
5205545|NCT02710461|Abdominal obesity|abdominal obesity
5205546|NCT02710461|Postprandial glucose|postprandial glucose
5205547|NCT02710461|Insulin resistance|insulin resistance
5205548|NCT02710435|Coronary Sinus|coronary sinus
5205549|NCT02710435|Reducer|reducer
5205550|NCT02710435|Refractory Angina|refractory angina
5205551|NCT02710435|Angina Pectoris|angina pectoris
5205552|NCT02710435|Angina Pectoris, Stable|angina pectoris, stable
5205553|NCT02710435|Chronic Stable Angina|chronic stable angina
5205554|NCT02710435|Persistent Angina|persistent angina
5082363|NCT03483805|permeability|permeability
5082364|NCT03483805|gluten free diet|gluten free diet
5205555|NCT02710435|Neovasc Reducer System|neovasc reducer system
5205556|NCT02710435|Refractory Angina Pectoris|refractory angina pectoris
5205557|NCT02710435|Coronary Sinus Narrowing|coronary sinus narrowing
5205558|NCT02710435|Reversible Ischemic Heart Disease|reversible ischemic heart disease
5205559|NCT02710435|Chronic Angina|chronic angina
5205560|NCT02710435|End Stage Angina|end stage angina
5205561|NCT02710435|Coronary Sinus Reduction|coronary sinus reduction
5205562|NCT02710435|Coronary Sinus Reducer|coronary sinus reducer
5205563|NCT02710435|Chronic Refractory Angina|chronic refractory angina
5205564|NCT02710435|Chronic Refractory Angina Pectoris|chronic refractory angina pectoris
5205565|NCT02710422|Prostate Cancer|prostate cancer
5193580|NCT02783235|Cervical Cancer|cervical cancer
5193581|NCT02783235|Training|training
5193582|NCT02783222|breast cancer|breast cancer
5193583|NCT02783222|elderly patients|elderly patients
5193584|NCT02783170|Tdap vaccine|tdap vaccine
5193585|NCT02783170|Flu vaccine|flu vaccine
5193586|NCT02783170|vaccines in pregnancy|vaccines in pregnancy
5193587|NCT02783170|immunizations in pregnancy|immunizations in pregnancy
5205566|NCT02710422|Amniotic Membrane Placement|amniotic membrane placement
5205567|NCT02710422|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
5205568|NCT02710422|RARP|rarp
5205569|NCT02710422|Human Amniotic Membrane Allograft|human amniotic membrane allograft
5205570|NCT02710409|safety, immunogenicity , quadrivalent influenza vaccine|safety, immunogenicity , quadrivalent influenza vaccine
5205571|NCT02710396|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5205572|NCT02710396|Non-Small Cell Lung Cancer|non-small cell lung cancer
5205573|NCT02710396|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5205574|NCT02710396|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
5205575|NCT02710396|NSCLC|nsclc
5205576|NCT02710383|Cystic Fibrosis|cystic fibrosis
5205577|NCT02710383|Biomarker|biomarker
5205578|NCT02710370|Bariatric Surgery|bariatric surgery
5205579|NCT02710370|Gastric Bypass|gastric bypass
5205580|NCT02710370|Obesity/surgery|obesity/surgery
5205581|NCT02710370|Endoscopy, Digestive System|endoscopy, digestive system
5205582|NCT02710370|Blood Glucose/metabolism|blood glucose/metabolism
5205591|NCT02710357|Denture, Complete, Lower|denture, complete, lower
5205592|NCT02710318|Immunizations|immunizations
5205593|NCT02710318|Immunization Information System (IIS)|immunization information system (iis)
5205594|NCT02710318|Immunization notifications|immunization notifications
5205595|NCT02710279|Psychiatry|psychiatry
5205596|NCT02710279|Depressive disorder|depressive disorder
5205597|NCT02710279|Suicide|suicide
5205598|NCT02710266|Synthetic Protease Inhibitor|synthetic protease inhibitor
5205599|NCT02710266|Hepatectomy|hepatectomy
5205600|NCT02710266|Postoperative Complications|postoperative complications
5205601|NCT02710214|Hot flash|hot flash
5205602|NCT02710214|Estrogen|estrogen
5205603|NCT02710214|Women|women
5205604|NCT02710149|CAR-T|car-t
5205605|NCT02710149|Leukemia|leukemia
5205606|NCT02710149|Lymphoma|lymphoma
5205607|NCT02710136|Asthma|asthma
5205608|NCT02710136|Glycerinated German cockroach allergenic extract|glycerinated german cockroach allergenic extract
5205609|NCT02710136|Cockroach Nasal Allergen Challenge|cockroach nasal allergen challenge
5205610|NCT02710058|support group|support group
5205611|NCT02710058|15-246|15-246
5205612|NCT02710058|The Arab American Breast Cancer Education and Referral Program (AMBER)|the arab american breast cancer education and referral program (amber)
5205613|NCT02710045|Immunity, Innate|immunity, innate
5205614|NCT02710045|Immunity, Non-Specific|immunity, non-specific
5205615|NCT02710045|Antibodies|antibodies
5205616|NCT02710045|Cytokines|cytokines
5205617|NCT02710045|Immunity, Cellular|immunity, cellular
5205618|NCT02710032|Transgender women|transgender women
5205619|NCT02710032|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
5205620|NCT02710032|Adherence|adherence
5205621|NCT02710032|Peru|peru
5205622|NCT02710032|Social Networks|social networks
5205623|NCT02710019|substance use|substance use
5205624|NCT02710019|psychosis|psychosis
5205625|NCT02710019|youth|youth
5205626|NCT02710019|video game|video game
5205627|NCT02710006|Uterus|uterus
5205628|NCT02710006|Ultrasound|ultrasound
5205629|NCT02709980|Brain Injury|brain injury
5205630|NCT02709980|Insomnia|insomnia
5205631|NCT02709980|Sleep|sleep
5205632|NCT02709941|Obstructive Sleep Apnea|obstructive sleep apnea
5205633|NCT02709941|Inspiratory Muscle Strength Training|inspiratory muscle strength training
5205634|NCT02709941|Baroreceptor Sensitivity|baroreceptor sensitivity
5205635|NCT02709941|Blood Pressure|blood pressure
5205636|NCT02709928|Multiple ascending dose|multiple ascending dose
5205637|NCT02709850|ANGPTL-3|angptl-3
5205638|NCT02709837|bioavailability|bioavailability
5205639|NCT02709837|amino acid|amino acid
5205640|NCT02709837|carnosine|carnosine
5205641|NCT02709837|lycopene|lycopene
5205642|NCT02709837|mastication|mastication
5962564|NCT04280250|Implementation Intention|implementation intention
5962565|NCT04280250|If-Then plan|if-then plan
5962566|NCT04280250|Tertiary mental health services|tertiary mental health services
5205643|NCT02709837|meat|meat
5205644|NCT02709798|Shenfu Injection|shenfu injection
5205645|NCT02709798|Reperfusion Injury|reperfusion injury
5205646|NCT02709798|Myocardial Protection|myocardial protection
5205647|NCT02709798|Percutaneous Coronary Intervention|percutaneous coronary intervention
5205648|NCT02709746|paediatric patients|paediatric patients
5205649|NCT02709733|Virtual Reality|virtual reality
5205650|NCT02709733|Negative Symptoms|negative symptoms
5205652|NCT02709720|Cancer Lung Disease|cancer lung disease
5205653|NCT02709720|NORA|nora
5205654|NCT02709720|GECP 15/02|gecp 15/02
5205655|NCT02709720|Metronomic administration|metronomic administration
5205656|NCT02709707|Diabetes, Blood Sugar|diabetes, blood sugar
5205657|NCT02709681|Sickle Cell Disease|sickle cell disease
5205658|NCT02709681|Hydroxyurea|hydroxyurea
5205659|NCT02709668|MTHFR depression vitamins Homocysteine|mthfr depression vitamins homocysteine
5205661|NCT02709616|Glioblastoma|glioblastoma
5205662|NCT02709616|DC vaccine|dc vaccine
5205663|NCT02709616|tumor antigen|tumor antigen
5205664|NCT02709616|personalized vaccine|personalized vaccine
5205665|NCT02709551|corporate health management|corporate health management
5205667|NCT02709551|mindfulness|mindfulness
5205668|NCT02709525|hyaluronic acid|hyaluronic acid
5205669|NCT02709525|bone repair|bone repair
5205670|NCT02709525|dental socket|dental socket
5205671|NCT02709525|cone beam computed tomography|cone beam computed tomography
5205672|NCT02709512|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5205673|NCT02709486|Osteoarthritis, pain, tanezumab.|osteoarthritis, pain, tanezumab.
5205675|NCT02709473|remifentanil|remifentanil
5205676|NCT02709473|rocuronium|rocuronium
5205677|NCT02709460|hematoma|hematoma
5205678|NCT02709460|complication|complication
5205679|NCT02709460|hysterectomy|hysterectomy
5205680|NCT02709447|Intimate Partner Violence|intimate partner violence
5205681|NCT02709447|Juvenile Delinquency|juvenile delinquency
5205682|NCT02709447|Sexual Behavior|sexual behavior
5205683|NCT02709421|post-Endoscopic Retrograde cholangiopancreatography pancreatitis|post-endoscopic retrograde cholangiopancreatography pancreatitis
5205684|NCT02709421|Risk factors|risk factors
5205685|NCT02709421|Indomethacin|indomethacin
5205686|NCT02709408|Carbapenem resistance|carbapenem resistance
5205687|NCT02709408|Enterobacteriaceae|enterobacteriaceae
5205688|NCT02709408|Acinetobacter baumannii|acinetobacter baumannii
5205689|NCT02709408|Bloodstream infections|bloodstream infections
5205697|NCT02709408|Clinical response|clinical response
5205698|NCT02709408|Length of hospital stay|length of hospital stay
5205699|NCT02709369|HIRREM|hirrem
5205700|NCT02709369|Neuro-technology|neuro-technology
5205701|NCT02709369|Closed-loop|closed-loop
5205702|NCT02709369|Acoustic stimulation|acoustic stimulation
5205703|NCT02709369|Allostatic|allostatic
5205704|NCT02709369|heart rate variability|heart rate variability
5205705|NCT02709369|baroreflex sensitivity|baroreflex sensitivity
5205706|NCT02709369|traumatic brain injury|traumatic brain injury
5205707|NCT02709369|sports concussion|sports concussion
5205708|NCT02709369|PTSD|ptsd
5205709|NCT02709369|hot flashes|hot flashes
5205710|NCT02709369|headache|headache
5205711|NCT02709369|insomnia|insomnia
5205712|NCT02709304|urinary catheter discomfort|urinary catheter discomfort
5205713|NCT02709278|BCG|bcg
5205714|NCT02709278|Aerosol|aerosol
5205715|NCT02709278|Tuberculosis|tuberculosis
5205716|NCT02709278|Challenge|challenge
5205721|NCT02709213|Inflammatory chronic bowel disease|inflammatory chronic bowel disease
5205722|NCT02709213|ICBD|icbd
5205723|NCT02709213|Colorectal cancer|colorectal cancer
5205724|NCT02709213|Infectious colitis|infectious colitis
5205725|NCT02709187|DP-R208|dp-r208
5205726|NCT02709174|Pulmonary Embolism|pulmonary embolism
5205727|NCT02709174|Pregnancy|pregnancy
5205728|NCT02709174|D-Dimer|d-dimer
5205729|NCT02709161|neurofeedback|neurofeedback
5205730|NCT02709161|major depressive disorder|major depressive disorder
5205731|NCT02709161|amygdala|amygdala
5205732|NCT02709148|Parkinson's Disease|parkinson's disease
5205733|NCT02709070|highly-purified CTL|highly-purified ctl
5205734|NCT02709044|Acute pancreatitis|acute pancreatitis
5205735|NCT02709044|Fluid resuscitation|fluid resuscitation
5205736|NCT02709044|Crystalloids|crystalloids
5205737|NCT02709031|Cicletanine|cicletanine
5205738|NCT02709031|Magnesium|magnesium
5205739|NCT02709031|Metabolic disease|metabolic disease
5205740|NCT02709018|posttraumatic stress disorder|posttraumatic stress disorder
5205741|NCT02709018|losartan|losartan
5205742|NCT02709018|angiotensin receptor blocker|angiotensin receptor blocker
5205743|NCT02709005|Bacterial Vaginosis|bacterial vaginosis
5205744|NCT02709005|Monolaurin Vaginal Gel|monolaurin vaginal gel
5205745|NCT02708992|Azithromycin|azithromycin
5205746|NCT02708992|Cefixime|cefixime
5205747|NCT02708992|Duration|duration
5205748|NCT02708992|High-Dose|high-dose
5205749|NCT02708992|Neisseria gonorrhoeae|neisseria gonorrhoeae
5205750|NCT02708992|Pharmacokinetics|pharmacokinetics
5205751|NCT02708992|Susceptibility|susceptibility
5205752|NCT02708979|Stress|stress
5205753|NCT02708979|Eating|eating
5205754|NCT02708966|Gymnema Sylvestre|gymnema sylvestre
5073764|NCT03538028|LAG-3|lag-3
5082608|NCT03482167|blood pressure|blood pressure
5082609|NCT03482167|arterial stiffness|arterial stiffness
5082610|NCT03482167|cerebrovascular function|cerebrovascular function
5082611|NCT03482167|cognitive function|cognitive function
5193785|NCT02782000|early recognition|early recognition
5193786|NCT02782000|general practitioner|general practitioner
5193787|NCT02782000|training|training
5193788|NCT02781935|unresectable colorectal liver metastasis|unresectable colorectal liver metastasis
5193789|NCT02781935|diffusion weighted MRI|diffusion weighted mri
5193790|NCT02781935|disappearing liver metastasis|disappearing liver metastasis
5193791|NCT02781922|cardiac stem/progenitor cells|cardiac stem/progenitor cells
5205755|NCT02708966|Glycemic control|glycemic control
5205756|NCT02708927|social integration|social integration
5205757|NCT02708927|cognitive impairment|cognitive impairment
5205758|NCT02708927|emotional processing|emotional processing
5205759|NCT02708927|quality of life|quality of life
5205760|NCT02708901|Autism Spectrum Disorder|autism spectrum disorder
5205761|NCT02708901|Probiotic Vivomixx®|probiotic vivomixx®
5205762|NCT02708901|Gastrointestinal Symptoms|gastrointestinal symptoms
5205763|NCT02708901|Gut-Brain Axis|gut-brain axis
5205764|NCT02708901|Endophenotypes|endophenotypes
5205765|NCT02708888|Trunk|trunk
5205766|NCT02708888|Biomechanical Phenomena|biomechanical phenomena
5205767|NCT02708888|Gait|gait
5205768|NCT02708888|Electromyography|electromyography
5205769|NCT02708888|Rehabilitation|rehabilitation
5205770|NCT02708888|Balance|balance
5205775|NCT02708823|Postoperative delirium|postoperative delirium
5205776|NCT02708823|Risk assessment|risk assessment
5205777|NCT02708823|Clinical screening tool|clinical screening tool
5205778|NCT02708823|Tablet computer|tablet computer
5205791|NCT02708745|communication|communication
5205792|NCT02708745|immunization|immunization
5205793|NCT02708719|COPD|copd
5205794|NCT02708719|MID|mid
5205795|NCT02708719|1-minute sit-to-stand-test|1-minute sit-to-stand-test
5205796|NCT02708706|adhesive capsulitis|adhesive capsulitis
5205797|NCT02708706|hyaluronic acid|hyaluronic acid
5205798|NCT02708667|non-small cell lung cancer|non-small cell lung cancer
5205799|NCT02708667|crizotinib|crizotinib
5205800|NCT02708667|hepatic toxicity|hepatic toxicity
5205801|NCT02708654|Remote monitoring|remote monitoring
5205802|NCT02708654|Incentives|incentives
5205803|NCT02708628|scar prevention|scar prevention
5205804|NCT02708628|sectio|sectio
5205805|NCT02708628|extract of allium cepae|extract of allium cepae
5205806|NCT02708628|allantoin|allantoin
5205807|NCT02708628|heparin|heparin
5205808|NCT02708602|β2-adrenergic receptor|β2-adrenergic receptor
5205809|NCT02708602|genetic polymorphisms|genetic polymorphisms
5205810|NCT02708602|labor progress|labor progress
5205811|NCT02708563|meconium|meconium
5205812|NCT02708563|neonatal resuscitation|neonatal resuscitation
5205813|NCT02708498|Palliative care|palliative care
5205814|NCT02708498|Frail elderly|frail elderly
5205815|NCT02708498|Comorbidity|comorbidity
5205816|NCT02708498|Staff Development|staff development
5205817|NCT02708498|Nursing Homes|nursing homes
5205818|NCT02708472|Generalized Anxiety Disorder|generalized anxiety disorder
5205819|NCT02708472|synchronized Transcranial Magnetic Stimulation|synchronized transcranial magnetic stimulation
5205820|NCT02708472|Anxiety|anxiety
5205821|NCT02708472|Neurostimulation|neurostimulation
5205822|NCT02708472|TMS|tms
5205823|NCT02708446|Second Trimester|second trimester
5205824|NCT02708446|Abortion|abortion
5205825|NCT02708446|Misoprostol|misoprostol
5205826|NCT02708446|Sublingual|sublingual
5205827|NCT02708446|Buccal|buccal
5205828|NCT02708433|lidocaine, jaw|lidocaine, jaw
5205829|NCT02708420|Glidescope|glidescope
5205830|NCT02708420|Cardiovascular surgery|cardiovascular surgery
5205831|NCT02708420|Macintosh Laryngoscope|macintosh laryngoscope
5205832|NCT02708420|Hemodynamic response|hemodynamic response
5205833|NCT02708420|Anesthesia|anesthesia
5205834|NCT02708381|Population 70 years and older|population 70 years and older
5205835|NCT02708381|Geriatric|geriatric
5205836|NCT02708381|Oncogeriatric|oncogeriatric
5205837|NCT02708381|Senior adult|senior adult
5205838|NCT02708368|Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)|chronic kidney disease - mineral bone disorder (ckd-mbd)
5205839|NCT02708329|Coronary stenosis|coronary stenosis
5205840|NCT02708329|Drug-eluting stent|drug-eluting stent
5205841|NCT02708329|Coronary angioplasty with stenting|coronary angioplasty with stenting
5205842|NCT02708329|Ischemic Heart Disease|ischemic heart disease
5962567|NCT04280250|Secondary mental health services|secondary mental health services
5205843|NCT02708329|Chronic total occlusion|chronic total occlusion
5205844|NCT02708329|Bifurcational lesion|bifurcational lesion
5205845|NCT02708329|Bifurcational stenting|bifurcational stenting
5205846|NCT02708303|Esophageal Reflux|esophageal reflux
5205847|NCT02708303|Gastric Acid Reflux|gastric acid reflux
5205848|NCT02708303|Gastric Acid Reflux Disease|gastric acid reflux disease
5205849|NCT02708303|Gastro-Esophageal Reflux|gastro-esophageal reflux
5962568|NCT04280237|antibiotic prophylaxis|antibiotic prophylaxis
5962569|NCT04280237|liver transplant|liver transplant
5962570|NCT04280237|surgical site infection|surgical site infection
5962571|NCT04280237|Cefazolin|cefazolin
5962572|NCT04280211|vestibular dysfunction|vestibular dysfunction
5962573|NCT04280211|COPD|copd
5205850|NCT02708303|Gastro-oesophageal Reflux|gastro-oesophageal reflux
5205851|NCT02708303|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5205852|NCT02708303|Reflux, Gastroesophageal|reflux, gastroesophageal
5205853|NCT02708303|Esophageal Hernia|esophageal hernia
5205854|NCT02708303|Hernia, Esophageal|hernia, esophageal
5205855|NCT02708303|Hernia, Paraesophageal|hernia, paraesophageal
5205856|NCT02708303|Hiatal Hernia|hiatal hernia
5205857|NCT02708303|Sliding Hiatal Hernia|sliding hiatal hernia
5205858|NCT02708303|Sliding Esophageal Hernia|sliding esophageal hernia
5205859|NCT02708303|Hernia, Hiatus|hernia, hiatus
5205860|NCT02708303|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
5205861|NCT02708303|Questionnaires|questionnaires
5205862|NCT02708277|intrauterine contraceptive device|intrauterine contraceptive device
5205863|NCT02708277|intrauterine balloon|intrauterine balloon
5205864|NCT02708238|Infantile colics|infantile colics
5205865|NCT02708199|Drug resistance malaria|drug resistance malaria
5205866|NCT02708199|Myanmar Artemisinin Resistance Containment Zone|myanmar artemisinin resistance containment zone
5205867|NCT02708199|Asymptomatic malaria|asymptomatic malaria
5205869|NCT02708186|Dementia with Lewy bodies|dementia with lewy bodies
5205870|NCT02708186|Lewy bodies|lewy bodies
5205871|NCT02708186|REM sleep behavior disorder|rem sleep behavior disorder
5205872|NCT02708186|Parkinson's disease dementia|parkinson's disease dementia
5205874|NCT02708173|safety|safety
5205875|NCT02708134|Chest compressions|chest compressions
5205876|NCT02708134|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5205877|NCT02708069|Autism Spectrum Disorder|autism spectrum disorder
5205878|NCT02708056|Sugammadex|sugammadex
5205879|NCT02708056|Rocuronium|rocuronium
5205880|NCT02708056|Infant patients|infant patients
5205881|NCT02708017|Subcostal TAP block|subcostal tap block
5205882|NCT02708017|Posterior TAP block|posterior tap block
5205883|NCT02708017|Ultrasound|ultrasound
5205884|NCT02708017|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5205885|NCT02707991|Continuity of Patient Care|continuity of patient care
5291187|NCT02218983|trauma|trauma
5205886|NCT02707991|Treatment Cascade|treatment cascade
5205887|NCT02707978|Dementia|dementia
5205888|NCT02707978|Brain Diseases|brain diseases
5205889|NCT02707978|Central Nervous System Diseases|central nervous system diseases
5205890|NCT02707978|Mild Cognitive Impairment|mild cognitive impairment
5205891|NCT02707978|tauopathies|tauopathies
5205892|NCT02707978|Neurodegenerative Disease|neurodegenerative disease
5205893|NCT02707965|Generic brittle|generic brittle
5205894|NCT02707965|Anti-epileptic drug|anti-epileptic drug
5205895|NCT02707965|Bioequivalence|bioequivalence
5205896|NCT02707952|Compensated cirrhosis|compensated cirrhosis
5205897|NCT02707952|Non-cirrhotic|non-cirrhotic
5205898|NCT02707952|Renal impairment|renal impairment
5205899|NCT02707952|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5205900|NCT02707952|Hepatitis C|hepatitis c
5205901|NCT02707952|Chronic Hepatitis C|chronic hepatitis c
5205902|NCT02707952|Hepatitis C Genotype 1|hepatitis c genotype 1
5205903|NCT02707952|Hepatitis C Genotype 2|hepatitis c genotype 2
5205904|NCT02707952|Hepatitis C Genotype 3|hepatitis c genotype 3
5205905|NCT02707952|Hepatitis C Genotype 4|hepatitis c genotype 4
5205906|NCT02707952|Hepatitis C Genotype 5|hepatitis c genotype 5
5205907|NCT02707952|Hepatitis C Genotype 6|hepatitis c genotype 6
5205908|NCT02707952|DAA-experienced|daa-experienced
5205909|NCT02707900|Vorinostat|vorinostat
5205910|NCT02707900|AGS-004|ags-004
5205911|NCT02707900|HIV virus|hiv virus
5205912|NCT02707900|AIDS|aids
5205913|NCT02707887|Mental Disorders|mental disorders
5205914|NCT02707887|Mood Disorders|mood disorders
5205915|NCT02707887|Behavioral Activation|behavioral activation
5205917|NCT02707861|Resistant|resistant
5205918|NCT02707861|Salvage|salvage
5205919|NCT02707861|ibalizumab|ibalizumab
5205920|NCT02707861|antibody|antibody
5205921|NCT02707861|AIDS|aids
5205922|NCT02707835|Edema,taping,ultrasound|edema,taping,ultrasound
5205923|NCT02707822|tacrolimus|tacrolimus
5205924|NCT02707822|pharmacokinetics|pharmacokinetics
5205925|NCT02707822|gene polymorphism|gene polymorphism
5205926|NCT02707822|clinical factors|clinical factors
5205927|NCT02707796|oxygen reserve index, partial oxygen pressure, hemicolectomy|oxygen reserve index, partial oxygen pressure, hemicolectomy
5205928|NCT02707783|stable and unstable angina|stable and unstable angina
5205929|NCT02707783|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5205930|NCT02707783|BVS|bvs
5205931|NCT02707783|PCI|pci
5205932|NCT02707770|COPD, pulmonary rehabilitation, ambulatory oxygen therapy|copd, pulmonary rehabilitation, ambulatory oxygen therapy
5205933|NCT02707757|Haemodialysis|haemodialysis
5205934|NCT02707757|Anaemia|anaemia
5205935|NCT02707757|Iron|iron
5205936|NCT02707757|Erythropoeitin stimulating agents|erythropoeitin stimulating agents
5205937|NCT02707744|Heart Failure|heart failure
5205938|NCT02707744|Atrial Fibrillation|atrial fibrillation
5205939|NCT02707744|Ambulatory ECG monitor|ambulatory ecg monitor
5205940|NCT02707718|sepsis|sepsis
5205941|NCT02707718|biomarker|biomarker
5205942|NCT02707718|prognostic|prognostic
5205943|NCT02707718|emergency department|emergency department
5205944|NCT02707718|diagnosis|diagnosis
5205945|NCT02707692|HIV|hiv
5205946|NCT02707692|AIDS|aids
5205947|NCT02707692|Immune Stimulation|immune stimulation
5205948|NCT02707692|HIV Reservoir|hiv reservoir
5205949|NCT02707679|Knee|knee
5205950|NCT02707679|Mobilization|mobilization
5205951|NCT02707679|Taping|taping
5205952|NCT02707679|Function|function
5205953|NCT02707679|Balance|balance
5205954|NCT02707666|resectable malignant pleural mesothelioma|resectable malignant pleural mesothelioma
5205955|NCT02707666|Pembrolizumab|pembrolizumab
5205956|NCT02707627|Pediatric|pediatric
5205957|NCT02707627|Laser|laser
5205958|NCT02707627|Burn|burn
5205959|NCT02707627|Scar|scar
5205960|NCT02707627|Photothermolysis|photothermolysis
5205961|NCT02707601|HIV|hiv
5205962|NCT02707601|HCV|hcv
5205963|NCT02707601|Antiretroviral therapy|antiretroviral therapy
5205964|NCT02707601|HCV direct acting antiviral(s) (DAA)|hcv direct acting antiviral(s) (daa)
5205965|NCT02707588|Determine the tolerance and efficacy of Pembrolizumab|determine the tolerance and efficacy of pembrolizumab
5205968|NCT02707562|Cystic fibrosis G551D mutation|cystic fibrosis g551d mutation
5205969|NCT02707562|GLPG1837|glpg1837
5205970|NCT02707549|crystalloid solutions|crystalloid solutions
5205971|NCT02707549|acid-base imbalance|acid-base imbalance
5205972|NCT02707549|water-electrolyte Imbalance|water-electrolyte imbalance
5205973|NCT02707523|RSV|rsv
5205974|NCT02707523|respiratory support|respiratory support
5205975|NCT02707523|RSV induced respiratory failure|rsv induced respiratory failure
5205976|NCT02707510|logotherapy|logotherapy
5205977|NCT02707510|cognitive behavior therapy|cognitive behavior therapy
5205978|NCT02707510|metastatic breast cancer|metastatic breast cancer
5205979|NCT02707497|sepsis|sepsis
5205980|NCT02707497|severe thrombocytopenia|severe thrombocytopenia
5205981|NCT02707497|recombinant human thrombopoietin|recombinant human thrombopoietin
5205982|NCT02707497|platelets|platelets
5857582|NCT00022867|Diet|diet
5205994|NCT02707432|Community-Based Participatory Research|community-based participatory research
5205995|NCT02707432|African Americans|african americans
5205996|NCT02707419|Total knee replacement|total knee replacement
5205997|NCT02707419|Action observation treatment|action observation treatment
5205998|NCT02707419|Rehabilitation|rehabilitation
5205999|NCT02707393|stem cell transplantation|stem cell transplantation
5206000|NCT02707393|pediatrics|pediatrics
5206001|NCT02707354|GVHD|gvhd
5206002|NCT02707354|confocal endomicroscopy|confocal endomicroscopy
5206003|NCT02707341|psoriasis|psoriasis
5206004|NCT02707341|disease registry|disease registry
5206005|NCT02707328|Gemcitabine|gemcitabine
5206006|NCT02707328|Gemzar|gemzar
5206007|NCT02707328|CyberKnife|cyberknife
5206008|NCT02707328|Cyber knife|cyber knife
5206010|NCT02707328|abraxane|abraxane
5206011|NCT02707328|nab-paclitaxel|nab-paclitaxel
5206012|NCT02707315|Cyber Knife|cyber knife
5206013|NCT02707315|CyberKnife|cyberknife
5206014|NCT02707315|Stereotactic Radiosurgery|stereotactic radiosurgery
5206015|NCT02707315|CK|ck
5206019|NCT02707263|heparin|heparin
5206020|NCT02707250|pethidine|pethidine
5206021|NCT02707250|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5206022|NCT02707250|bupivacaine|bupivacaine
5206023|NCT02707224|DP-R208|dp-r208
5206024|NCT02707172|Diethylhexyl Phthalate|diethylhexyl phthalate
5206025|NCT02707172|Hand hygiene|hand hygiene
5206026|NCT02707172|Soaps|soaps
5206027|NCT02707172|N-of-1 design|n-of-1 design
5206028|NCT02707172|Cross-Over Studies|cross-over studies
5206029|NCT02707159|Circulating tumor cells|circulating tumor cells
5206030|NCT02707159|Nab-paclitaxel|nab-paclitaxel
5206031|NCT02707159|Metastatic pancreatic cancer|metastatic pancreatic cancer
5206032|NCT02707159|Gemcitabine|gemcitabine
5206033|NCT02707120|PRGF, Neurotrophic Keratitis, platelet rich plasma, PRP|prgf, neurotrophic keratitis, platelet rich plasma, prp
5206034|NCT02707094|back|back
5206035|NCT02707094|pain|pain
5206036|NCT02707094|chronic|chronic
5206037|NCT02707068|Quality of Life|quality of life
5206038|NCT02707068|Self-help intervention|self-help intervention
5206039|NCT02707055|Alcohol Consumption|alcohol consumption
5206040|NCT02707055|Alcohol Treatment|alcohol treatment
5206041|NCT02707055|Alcoholism|alcoholism
5206042|NCT02707055|Ghrelin|ghrelin
5206043|NCT02707055|Ghrelin Antagonism|ghrelin antagonism
5206044|NCT02707042|Microbiome|microbiome
5206045|NCT02707042|Amoxicillin|amoxicillin
5206046|NCT02707042|Azithromycin|azithromycin
5206047|NCT02707042|Stool|stool
5206048|NCT02707042|Healthy|healthy
5194140|NCT02780297|PH|ph
5206049|NCT02707029|Screening Protocol|screening protocol
5206050|NCT02707029|Pain|pain
5206051|NCT02707029|Phenotypes|phenotypes
5206052|NCT02707016|Emergence delirium|emergence delirium
5206053|NCT02707016|Sevoflurane|sevoflurane
5206054|NCT02707016|Pediatric anesthesia|pediatric anesthesia
5206055|NCT02707003|Post-operative respiratory distress|post-operative respiratory distress
5206056|NCT02706977|Ophthalmology|ophthalmology
5206057|NCT02706964|metastasis|metastasis
5206058|NCT02706964|3D imaging|3d imaging
5206059|NCT02706964|early detection|early detection
5206065|NCT02706938|Gastroesophageal reflux disease|gastroesophageal reflux disease
5206066|NCT02706938|Head of bed elevation|head of bed elevation
5206067|NCT02706938|Quality of life|quality of life
5206068|NCT02706938|Nocturnal symptoms|nocturnal symptoms
5206069|NCT02706938|Lifestyle measures|lifestyle measures
5206070|NCT02706912|Stroke|stroke
5206071|NCT02706912|Hemiparesis|hemiparesis
5206072|NCT02706912|Activities of Daily Living|activities of daily living
5206073|NCT02706912|Virtual World|virtual world
5206074|NCT02706912|Occupational Therapy|occupational therapy
5206075|NCT02706899|Antibody-Drug Conjugate CD33 Antigen|antibody-drug conjugate cd33 antigen
5206076|NCT02706886|PH1|ph1
5206077|NCT02706886|Primary Hyperoxaluria|primary hyperoxaluria
5206078|NCT02706886|RNAi therapeutic|rnai therapeutic
5206079|NCT02706886|siRNA|sirna
5206080|NCT02706886|AGT|agt
5206105|NCT02706704|Intravitreal Adalimumab|intravitreal adalimumab
5206106|NCT02706704|Subcutaneous Adalimumab|subcutaneous adalimumab
5206110|NCT02706665|Anesthetics|anesthetics
5206111|NCT02706665|Propofol|propofol
5206112|NCT02706665|Electroencephalography|electroencephalography
5206113|NCT02706665|SEDline monitor|sedline monitor
5206114|NCT02706652|Screening|screening
5206115|NCT02706652|Genotype|genotype
5206116|NCT02706652|Drug Dosing|drug dosing
5206117|NCT02706652|Trial Selection|trial selection
5206118|NCT02706639|Biospecimen Procurement|biospecimen procurement
5206119|NCT02706639|Laboratory Research Specimens|laboratory research specimens
5206120|NCT02706639|Sample Collection|sample collection
5206121|NCT02706639|Rare Diseases|rare diseases
5206122|NCT02706587|Critical illness polyneuropathy|critical illness polyneuropathy
5206123|NCT02706587|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5206124|NCT02706574|Eye Tracking|eye tracking
5206125|NCT02706574|Blood-based Biomarkers|blood-based biomarkers
5206126|NCT02706574|CSF-based Biomarkers|csf-based biomarkers
5206127|NCT02706574|Magnetic Resonance Imaging|magnetic resonance imaging
5206128|NCT02706574|Computed Tomography Scan|computed tomography scan
5206129|NCT02706574|Outcome Measures|outcome measures
5206130|NCT02706561|15-317|15-317
5206131|NCT02706548|occupational therapy|occupational therapy
5206132|NCT02706548|medication adherence|medication adherence
5206133|NCT02706548|intervention studies|intervention studies
5206134|NCT02706535|Itraconazole|itraconazole
5206135|NCT02706535|Rifampicin|rifampicin
5206233|NCT02705755|PD|pd
5206136|NCT02706535|Pharmacokinetics|pharmacokinetics
5206137|NCT02706535|Cross-over|cross-over
5206138|NCT02706496|aging of elderly|aging of elderly
5206139|NCT02706496|falling prevention|falling prevention
5206140|NCT02706496|electroencephalography|electroencephalography
5206141|NCT02706496|postural control|postural control
5206142|NCT02706496|biomechanics|biomechanics
5206143|NCT02706470|recurrent miscarriage; immunology|recurrent miscarriage; immunology
5206144|NCT02706457|intensive care|intensive care
5206145|NCT02706457|functionality|functionality
5206146|NCT02706405|PD-L1|pd-l1
5206147|NCT02706405|immunotherapy|immunotherapy
5206148|NCT02706405|non-Hodgkin lymphoma|non-hodgkin lymphoma
5206149|NCT02706353|Melanoma|melanoma
5206150|NCT02706353|Metastatic Melanoma|metastatic melanoma
5206151|NCT02706353|Intratumoral APX005M|intratumoral apx005m
5206152|NCT02706353|Pembrolizumab|pembrolizumab
5206153|NCT02706353|Keytruda|keytruda
5206154|NCT02706353|MK-3475|mk-3475
5206155|NCT02706353|SCH-900475|sch-900475
5206156|NCT02706327|orthotic insoles|orthotic insoles
5206157|NCT02706327|pain|pain
5206158|NCT02706327|quality of life|quality of life
5206159|NCT02706327|athletic performance|athletic performance
5206160|NCT02706301|colorectal cancer survivor|colorectal cancer survivor
5206161|NCT02706301|cancer pain|cancer pain
5206162|NCT02706301|psychological distress|psychological distress
5206163|NCT02706301|coping skills training|coping skills training
5206164|NCT02706301|symptom management|symptom management
5206165|NCT02706301|cancer survivorship|cancer survivorship
5206166|NCT02706210|Mild Cognitive Impairment|mild cognitive impairment
5206167|NCT02706210|Diffusion Tensor Imaging|diffusion tensor imaging
5206168|NCT02706197|Electron Paramagnetic Resonance|electron paramagnetic resonance
5206169|NCT02706197|Hypoxia|hypoxia
5206170|NCT02706197|OxyChip|oxychip
5206171|NCT02706184|gastric cancer|gastric cancer
5206172|NCT02706184|colorectal cancer|colorectal cancer
5206173|NCT02706184|chemotherapy induced diarrhea|chemotherapy induced diarrhea
5206174|NCT02706184|5-Fluoruracil|5-fluoruracil
5206175|NCT02706184|chemotherapeutic remedy|chemotherapeutic remedy
5206176|NCT02706145|social norms|social norms
5206177|NCT02706145|youth violence|youth violence
5206178|NCT02706145|media|media
5206179|NCT02706132|Mesenchymal stromal cells|mesenchymal stromal cells
5206180|NCT02706132|Liver Transplantation|liver transplantation
5206183|NCT02706119|glargine insulin|glargine insulin
5206184|NCT02706119|insulin|insulin
5206185|NCT02706080|Antithrombotic agents|antithrombotic agents
5206187|NCT02706080|Direct Oral Anticoagulant|direct oral anticoagulant
5206188|NCT02706080|Antiplatelet|antiplatelet
5206189|NCT02706080|Bleeding|bleeding
5206190|NCT02706080|Emergency|emergency
5206191|NCT02706041|Exploratory Lap (Ex Lap)|exploratory lap (ex lap)
5206192|NCT02706041|Damage Control Laparotomy (DCL)|damage control laparotomy (dcl)
5206193|NCT02706041|Definitive|definitive
5206194|NCT02706028|underwater ultrasound|underwater ultrasound
5206195|NCT02706028|rheumatoid arthritis|rheumatoid arthritis
5206196|NCT02706015|Headache|headache
5206197|NCT02706015|Aura|aura
5206198|NCT02706015|Migraine|migraine
5206199|NCT02705937|xerostomia, Saliva, iatrogenic oral dryness, dairy product|xerostomia, saliva, iatrogenic oral dryness, dairy product
5206200|NCT02705898|alcohol use disorders|alcohol use disorders
5206201|NCT02705898|physical activity|physical activity
5206202|NCT02705898|women's health|women's health
5206203|NCT02705885|IgY|igy
5206204|NCT02705885|Periodontitis|periodontitis
5206205|NCT02705885|Porphyromonas gingivalis|porphyromonas gingivalis
5206206|NCT02705885|gingipains|gingipains
5206207|NCT02705885|Efficacy|efficacy
5206208|NCT02705872|Epidural|epidural
5206209|NCT02705872|Programmed intermittent boluses|programmed intermittent boluses
5206210|NCT02705872|Cesarian section|cesarian section
5206211|NCT02705872|Instrumented delivery|instrumented delivery
5206215|NCT02705820|Metastatic, Lung Cancer, Switch, Maintenance, Pembrolizumab.|metastatic, lung cancer, switch, maintenance, pembrolizumab.
5206216|NCT02705807|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5206218|NCT02705807|FLOLAN|flolan
5206219|NCT02705807|New Thermostable Formulation|new thermostable formulation
5206220|NCT02705807|dose adjustment|dose adjustment
5206221|NCT02705807|reformulated diluents|reformulated diluents
5206222|NCT02705807|currently marketed diluent|currently marketed diluent
5206223|NCT02705794|intubation, laryngoscopy|intubation, laryngoscopy
5206224|NCT02705768|Neuron-specific enolase (NSE)|neuron-specific enolase (nse)
5206225|NCT02705768|Carbamazepine|carbamazepine
5206226|NCT02705768|Oxcarbazepine|oxcarbazepine
5206227|NCT02705755|Neurogenic Orthostatic Hypotension (nOH)|neurogenic orthostatic hypotension (noh)
5206228|NCT02705755|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
5206229|NCT02705755|Pure Autonomic Failure|pure autonomic failure
5206230|NCT02705755|Parkinson Disease(PD)|parkinson disease(pd)
5206231|NCT02705755|nOH|noh
5206232|NCT02705755|MSA|msa
5206234|NCT02705755|PAF|paf
5206235|NCT02705755|Orthostatic Hypotension|orthostatic hypotension
5206236|NCT02705755|ampreloxetine|ampreloxetine
5206237|NCT02705755|TD-9855|td-9855
5206238|NCT02705742|Mesenchymal stem cells|mesenchymal stem cells
5206239|NCT02705742|Liver cirrhosis|liver cirrhosis
5206240|NCT02705742|Hepatitis C|hepatitis c
5206241|NCT02705729|dental caries|dental caries
5206242|NCT02705729|proximal surfaces|proximal surfaces
5206243|NCT02705729|posterior teeth|posterior teeth
5206244|NCT02705729|carious lesions|carious lesions
5206245|NCT02705729|tooth diseases|tooth diseases
5206246|NCT02705729|dental restorations|dental restorations
5206247|NCT02705729|glass-ionomer|glass-ionomer
5206248|NCT02705664|Onychomycosis|onychomycosis
5206249|NCT02705612|Cervical cancer|cervical cancer
5206250|NCT02705612|cisplatin|cisplatin
5206251|NCT02705612|nimotuzumab|nimotuzumab
5206252|NCT02705599|Ischemic stroke|ischemic stroke
5206253|NCT02705599|High resolution MRI|high resolution mri
5206254|NCT02705599|Perfusion|perfusion
5206255|NCT02705599|Mechanism|mechanism
5206256|NCT02705586|Movement disorders|movement disorders
5206257|NCT02705586|Metabolic Stress|metabolic stress
5206258|NCT02705547|Friedreich Ataxia|friedreich ataxia
5206259|NCT02705534|Hepatitis C|hepatitis c
5206260|NCT02705534|Cirrhosis|cirrhosis
5206261|NCT02705534|Sofosbuvir|sofosbuvir
5206262|NCT02705534|Ledipasvir|ledipasvir
5206263|NCT02705534|Ribavirin|ribavirin
5206264|NCT02705521|shoulder|shoulder
5206265|NCT02705521|impingement|impingement
5206266|NCT02705521|rehabilitation|rehabilitation
5206267|NCT02705521|physiotherapy|physiotherapy
5206268|NCT02705521|gamification|gamification
5206269|NCT02705521|activation|activation
5206270|NCT02705521|engagement|engagement
5206271|NCT02705508|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
5206272|NCT02705508|nasal type|nasal type
5206273|NCT02705508|chemotherapy|chemotherapy
5206274|NCT02705508|radiotherapy|radiotherapy
5206275|NCT02705482|Advanced solid tumors|advanced solid tumors
5206276|NCT02705482|MEDI0562|medi0562
5206277|NCT02705482|durvalumab|durvalumab
5206278|NCT02705482|tremelimumab|tremelimumab
5206279|NCT02705482|OX40|ox40
5206280|NCT02705482|PD-L1|pd-l1
5276426|NCT02294942|RNTA06|rnta06
5206281|NCT02705482|CTLA-4|ctla-4
5206284|NCT02705469|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5206286|NCT02705469|Prostate Cancer|prostate cancer
5206287|NCT02705469|Pharmacokinetics (PK)|pharmacokinetics (pk)
5206289|NCT02705469|ZEN-3694|zen-3694
5206290|NCT02705469|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
5206291|NCT02705469|BET inhibitor (BETi)|bet inhibitor (beti)
5206292|NCT02705469|Bromodomain|bromodomain
5206293|NCT02705469|Pharmacodynamics (PD)|pharmacodynamics (pd)
5206294|NCT02705469|Epigenetics|epigenetics
5206295|NCT02705456|Dental Caries|dental caries
5206296|NCT02705456|Tooth Paste|tooth paste
5206297|NCT02705456|Orthodontics|orthodontics
5206298|NCT02705456|Fluorides|fluorides
5206299|NCT02705417|arteriovenous fistula|arteriovenous fistula
5206300|NCT02705417|colour Doppler|colour doppler
5962574|NCT04280211|balance|balance
5206301|NCT02705417|physical examination|physical examination
5206302|NCT02705417|renal dialysis|renal dialysis
5206303|NCT02705417|retrospective studies|retrospective studies
5206304|NCT02705404|multifocal|multifocal
5206305|NCT02705404|genetic|genetic
5206306|NCT02705404|bronchoalveolar carcinoma|bronchoalveolar carcinoma
5206307|NCT02705404|adenocarcinoma in situ|adenocarcinoma in situ
5206308|NCT02705404|ground glass opacity|ground glass opacity
5206309|NCT02705404|next generation sequencing|next generation sequencing
5206310|NCT02705378|Intensive care unit|intensive care unit
5206311|NCT02705378|ICU|icu
5206312|NCT02705378|Critical Illness|critical illness
5206315|NCT02705365|Low-Dose Computer Tomography|low-dose computer tomography
5206316|NCT02705365|Patient Navigation|patient navigation
5206320|NCT02705313|neuroendocrine tumors|neuroendocrine tumors
5206321|NCT02705313|177Lu-DOTA0-Tyr3-Octreotate|177lu-dota0-tyr3-octreotate
5206322|NCT02705313|PRRT|prrt
5206323|NCT02705287|vitamin D|vitamin d
5206324|NCT02705287|half life|half life
5206325|NCT02705287|kinetics|kinetics
5206326|NCT02705261|child|child
5206327|NCT02705261|behavior therapy|behavior therapy
5206328|NCT02705261|cognitive therapy|cognitive therapy
5206329|NCT02705261|parent|parent
5206330|NCT02705261|anxiety|anxiety
5206331|NCT02705222|Abnormal uterine bleeding|abnormal uterine bleeding
5206332|NCT02705222|Dilatation and curettage|dilatation and curettage
5206333|NCT02705222|Hysteroscopy|hysteroscopy
5206334|NCT02705196|oncolytic|oncolytic
5206335|NCT02705196|adenovirus|adenovirus
5206336|NCT02705196|pancreatic|pancreatic
5206337|NCT02705196|cancer|cancer
5206338|NCT02705196|LOKON|lokon
5206339|NCT02705196|LOAd703|load703
5206340|NCT02705183|surgical treatment|surgical treatment
5206341|NCT02705183|post-operative radiotherapy|post-operative radiotherapy
5206342|NCT02705183|quality of life|quality of life
5206343|NCT02705183|complications|complications
5206344|NCT02705183|survival|survival
5206345|NCT02705183|long bones|long bones
5206346|NCT02705170|index of microvascular resistance|index of microvascular resistance
5206347|NCT02705157|long bones|long bones
5206348|NCT02705157|survival|survival
5206349|NCT02705157|prognosis|prognosis
5206350|NCT02705157|treatment|treatment
5206351|NCT02705157|quality of life|quality of life
5206352|NCT02705131|Cervical radiculopathy|cervical radiculopathy
5206353|NCT02705131|Balance chiropractic therapy|balance chiropractic therapy
5206354|NCT02705118|radiofrequency ablation|radiofrequency ablation
5206355|NCT02705118|image fusion|image fusion
5206356|NCT02705105|Metastatic Solid Tumors|metastatic solid tumors
5206357|NCT02705105|Advanced Solid Tumors|advanced solid tumors
5206358|NCT02705105|KW-0761|kw-0761
5206359|NCT02705105|ONO-4538/BMS-936558|ono-4538/bms-936558
5206360|NCT02705105|Anti-tumor|anti-tumor
5206361|NCT02705105|Mogamulizumab|mogamulizumab
5206362|NCT02705105|Nivolumab|nivolumab
5206363|NCT02705105|Oncology|oncology
5206365|NCT02705105|Hepatocellular carcinoma|hepatocellular carcinoma
5206366|NCT02705053|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5206367|NCT02705053|Artificial Pancreas|artificial pancreas
5206368|NCT02705053|Autoimmune Diseases|autoimmune diseases
5206369|NCT02705053|Diabetes Mellitus|diabetes mellitus
5206370|NCT02705053|Hyperglycemia|hyperglycemia
5206371|NCT02705053|Hypoglycemia|hypoglycemia
5206372|NCT02705040|male osteoporosis|male osteoporosis
5206373|NCT02705040|miRNA|mirna
5206374|NCT02705040|biomarker|biomarker
5206375|NCT02705014|pituitary stalk interruption syndrome|pituitary stalk interruption syndrome
5206376|NCT02705014|pulsatile GnRH therapy|pulsatile gnrh therapy
5206377|NCT02705014|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5206378|NCT02705014|hypopituitarism|hypopituitarism
5206379|NCT02704975|Dry Needling, Shoulder Stabilization|dry needling, shoulder stabilization
5206380|NCT02704962|schizophrenia|schizophrenia
5206381|NCT02704962|olanzapine|olanzapine
5206382|NCT02704962|trifluoperazine|trifluoperazine
5206383|NCT02704962|antipsychotic polypharmacy|antipsychotic polypharmacy
5206384|NCT02704949|Urolithiasis|urolithiasis
5206385|NCT02704949|Fluoroscopy|fluoroscopy
5206386|NCT02704949|Radiation|radiation
5206388|NCT02704923|Atropine|atropine
5206389|NCT02704923|Pneumonia|pneumonia
5206390|NCT02704923|Ventilator|ventilator
5206391|NCT02704923|Adults|adults
5206392|NCT02704923|Intensive care unit.|intensive care unit.
5206393|NCT02704871|SeptiCyte|septicyte
5206394|NCT02704858|recurrent glioblastoma|recurrent glioblastoma
5206395|NCT02704858|recurrent GBM|recurrent gbm
5206396|NCT02704845|Inflammatory back pain|inflammatory back pain
5206397|NCT02704845|Ankylosing spondylitis|ankylosing spondylitis
5206398|NCT02704845|Non-specific low back pain|non-specific low back pain
5206399|NCT02704845|Pain experience|pain experience
5206400|NCT02704845|Disability|disability
5206401|NCT02704845|Behavioural|behavioural
5206402|NCT02704845|Psychological|psychological
5206403|NCT02704845|Biopsychosocial|biopsychosocial
5206404|NCT02704845|Pain profiles|pain profiles
5206405|NCT02704832|Geriatric oncology|geriatric oncology
5206406|NCT02704832|Intervention|intervention
5206407|NCT02704832|Case management|case management
5206408|NCT02704819|Decision Support System|decision support system
5206409|NCT02704819|Dizziness|dizziness
5206410|NCT02704819|Vertigo|vertigo
5206411|NCT02704819|Balance|balance
5206412|NCT02704780|Retained placenta|retained placenta
5206413|NCT02704780|Misoprostol|misoprostol
5206414|NCT02704780|double blind|double blind
5206415|NCT02704780|Randomization|randomization
5206416|NCT02704780|Haemorrhage|haemorrhage
5206417|NCT02704715|postoperative pain|postoperative pain
5206418|NCT02704715|general anesthesia|general anesthesia
5206420|NCT02704676|CA-125|ca-125
5206421|NCT02704676|Pre-Eclampsia|pre-eclampsia
5206422|NCT02704663|adnexal mass|adnexal mass
5206423|NCT02704663|laparoscopy|laparoscopy
5206424|NCT02704663|removal route|removal route
5206425|NCT02704663|postoperative pain|postoperative pain
5206426|NCT02704637|vasospasm|vasospasm
5206427|NCT02704624|Crohn Disease|crohn disease
5206428|NCT02704624|Fatigue|fatigue
5206429|NCT02704624|Osteopenia|osteopenia
5206430|NCT02704624|Exercise Tolerance|exercise tolerance
5206431|NCT02704624|Vitamin d|vitamin d
5206432|NCT02704585|Neonatal resuscitation|neonatal resuscitation
5206433|NCT02704585|Pulse oximetry|pulse oximetry
5206434|NCT02704572|Herpes zoster vaccine|herpes zoster vaccine
5206435|NCT02704572|cell-mediated immunity|cell-mediated immunity
5206436|NCT02704533|Plasmodium falciparum|plasmodium falciparum
5206437|NCT02704533|PfSPZ Vaccine|pfspz vaccine
5206438|NCT02704533|PfSPZ Challenge (NF54)|pfspz challenge (nf54)
5206439|NCT02704533|PfSPZ Challenge (7G8)|pfspz challenge (7g8)
5206440|NCT02704533|CHMI|chmi
5206441|NCT02704520|Rectal Cancer|rectal cancer
5206442|NCT02704520|Magnetic Resonance Imaging|magnetic resonance imaging
5206443|NCT02704520|Chemoradiotherapy|chemoradiotherapy
5206444|NCT02704520|Chemotherapy|chemotherapy
5206445|NCT02704520|Diagnostic Imaging|diagnostic imaging
5206446|NCT02704507|tretinoin|tretinoin
5206447|NCT02704507|topical steroid|topical steroid
5206448|NCT02704507|irritation|irritation
5206449|NCT02704507|retinoid induced irritation|retinoid induced irritation
5206450|NCT02704494|Resveratrol|resveratrol
5206451|NCT02704494|Diabetes mellitus|diabetes mellitus
5206452|NCT02704494|Diabetes complications|diabetes complications
5206453|NCT02704494|Diabetic nephropathies|diabetic nephropathies
5206454|NCT02704494|Proteinuria|proteinuria
5206455|NCT02704494|Albuminuria|albuminuria
5206456|NCT02704494|renal insufficiency|renal insufficiency
5206457|NCT02704481|mifepristone|mifepristone
5206458|NCT02704481|misoprostol|misoprostol
5206459|NCT02704481|medical abortion|medical abortion
5206460|NCT02704468|CAVI|cavi
5206461|NCT02704468|FGF-21|fgf-21
5206462|NCT02704468|arterial stiffness|arterial stiffness
5206463|NCT02704468|renal transplant|renal transplant
5206464|NCT02704455|children|children
5206465|NCT02704442|anesthesiology|anesthesiology
5206466|NCT02704442|ophthalmology|ophthalmology
5206467|NCT02704416|Ventricular arrhythmias|ventricular arrhythmias
5206468|NCT02704416|aborted cardiac arrest|aborted cardiac arrest
5206469|NCT02704416|cardiac death|cardiac death
5206470|NCT02704403|Elafibranor|elafibranor
5206471|NCT02704403|NASH|nash
5206472|NCT02704403|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5206473|NCT02704403|Fatty liver disease|fatty liver disease
5206474|NCT02704403|Fibrosis|fibrosis
5206475|NCT02704390|ORADUR®-Methylphenidate|oradur®-methylphenidate
5206476|NCT02704377|Prostate Cancer Survivor|prostate cancer survivor
5206477|NCT02704338|Autoimmune Diseases, Treg|autoimmune diseases, treg
5206478|NCT02704325|DMD|dmd
5206479|NCT02704325|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5206480|NCT02704273|MTM|mtm
5206481|NCT02704273|XLMTM|xlmtm
5206482|NCT02704208|Antiretroviral Therapy|antiretroviral therapy
5857583|NCT00022867|Puberty|puberty
5206489|NCT02704169|head and neck cancer|head and neck cancer
5206490|NCT02704169|H&N cancer|h&n cancer
5206491|NCT02704156|Stereotactic body radiation therapy|stereotactic body radiation therapy
5206492|NCT02704156|CyberKnife|cyberknife
5206493|NCT02704156|Initial treatment|initial treatment
5206494|NCT02704130|Therapeutic Embolization|therapeutic embolization
5206495|NCT02704130|Ablation Techniques|ablation techniques
5206496|NCT02704130|Transarterial Embolization|transarterial embolization
5206498|NCT02704130|Microwave Ablation|microwave ablation
5206500|NCT02704104|topical hemostat|topical hemostat
5206501|NCT02704104|self-assembling peptide barrier|self-assembling peptide barrier
5206502|NCT02704065|amyloidosis|amyloidosis
5206503|NCT02704065|renal transplantation|renal transplantation
5206504|NCT02704026|Body composition|body composition
5206505|NCT02704026|Nutritional status|nutritional status
5206506|NCT02704013|Neurotrophins|neurotrophins
5206507|NCT02704013|Nerve Growth Factor|nerve growth factor
5206508|NCT02704013|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5206509|NCT02704013|Urinary Biomarkers|urinary biomarkers
5206510|NCT02704013|Urodynamics|urodynamics
5206511|NCT02704013|Anticholinergics|anticholinergics
5206512|NCT02704013|Children|children
5206513|NCT02703961|CCRT|ccrt
5206514|NCT02703961|adjuvant chemotherapy|adjuvant chemotherapy
5206515|NCT02703961|cisplatin and docetaxel|cisplatin and docetaxel
5206516|NCT02703909|morbid obesity|morbid obesity
5206517|NCT02703909|laparoscopic surgery|laparoscopic surgery
5206518|NCT02703909|neuromuscular blockade|neuromuscular blockade
5206519|NCT02703896|g a, bile reflux. PPIs, H2RAs, prokinetic agents|g a, bile reflux. ppis, h2ras, prokinetic agents
5206520|NCT02703831|adult spine deformity|adult spine deformity
5206521|NCT02703831|time-driven activity-based costing|time-driven activity-based costing
5206522|NCT02703831|three-column posterior osteotomy|three-column posterior osteotomy
5206523|NCT02703805|Community program|community program
5206525|NCT02703805|Exercise|exercise
5206526|NCT02703805|Physical Activity|physical activity
5206527|NCT02703805|Education|education
5206528|NCT02703805|Stroke|stroke
5206529|NCT02703805|Self-management|self-management
5206530|NCT02703779|Multiple Myeloma|multiple myeloma
5206531|NCT02703779|Bortezomib|bortezomib
5206532|NCT02703779|Autologous|autologous
5206533|NCT02703779|Stem Cell|stem cell
5206534|NCT02703779|Purging|purging
5206535|NCT02703779|In-vivo purging|in-vivo purging
5206536|NCT02703779|Ex-vivo purging|ex-vivo purging
5206537|NCT02703779|Leukapheresis|leukapheresis
5206538|NCT02703779|Contaminated|contaminated
5206539|NCT02703779|Stem Cell Harvest|stem cell harvest
5206540|NCT02703779|Stem Cell Transplant|stem cell transplant
5206541|NCT02703779|Transplantation|transplantation
5206542|NCT02703727|polypharmacy|polypharmacy
5206543|NCT02703727|polymedication check|polymedication check
5206544|NCT02703727|anticoagulation treatment|anticoagulation treatment
5206545|NCT02703714|Advanced|advanced
5206546|NCT02703714|Locally-advanced|locally-advanced
5206547|NCT02703714|Not eligible for resection|not eligible for resection
5206548|NCT02703714|Prior chemotherapy treatment|prior chemotherapy treatment
5206549|NCT02703701|Patient Satisfaction|patient satisfaction
5206550|NCT02703701|Emergency Department efficiency|emergency department efficiency
5206551|NCT02703662|Biologic mesh|biologic mesh
5206552|NCT02703662|abdominal wall reconstruction|abdominal wall reconstruction
5206553|NCT02703649|Aromatase inhibitor|aromatase inhibitor
5206554|NCT02703649|induction of ovulation|induction of ovulation
5206555|NCT02703636|Alzheimer's disease|alzheimer's disease
5206556|NCT02703610|Pain|pain
5206557|NCT02703610|Elderly|elderly
5206558|NCT02703597|Cigarette Smoking Behavior|cigarette smoking behavior
5206559|NCT02703597|Smoking curiosity|smoking curiosity
5206560|NCT02703597|Smoking Cessation|smoking cessation
5206561|NCT02703597|Smoking Prevention|smoking prevention
5206562|NCT02703597|Health improvement|health improvement
5206563|NCT02703597|Smoking prevention interactive experience|smoking prevention interactive experience
5206564|NCT02703597|ASPIRE|aspire
5206565|NCT02703597|Game-based social activities|game-based social activities
5206566|NCT02703597|GSA's|gsa's
5206567|NCT02703597|Surveys|surveys
5206568|NCT02703597|Questionnaires|questionnaires
5206569|NCT02703597|Interviews|interviews
5206570|NCT02703584|Double trigger|double trigger
5206583|NCT02703532|Therapy|therapy
5206584|NCT02703532|Rehabilitation|rehabilitation
5206585|NCT02703532|Caregiver|caregiver
5206586|NCT02703519|cesarean section, repeat|cesarean section, repeat
5206587|NCT02703519|uterine scar tissue|uterine scar tissue
5206588|NCT02703519|transvaginal ultrasound|transvaginal ultrasound
5206589|NCT02703519|uterine rupture|uterine rupture
5206590|NCT02703519|placenta accreta|placenta accreta
5206591|NCT02703519|placenta percreta|placenta percreta
5206592|NCT02703519|placenta increta|placenta increta
5206593|NCT02703467|Exhaled hydrogen sulphide|exhaled hydrogen sulphide
5206594|NCT02703428|Abdominal|abdominal
5206595|NCT02703428|Aortic|aortic
5206596|NCT02703428|Aneurysm|aneurysm
5206597|NCT02703415|immune|immune
5206598|NCT02703415|interleukin|interleukin
5206599|NCT02703415|tramadol|tramadol
5206600|NCT02703415|postoperartive analgesia|postoperartive analgesia
5206601|NCT02703415|pediatric|pediatric
5206602|NCT02703415|caudal bupivacaine|caudal bupivacaine
5206603|NCT02703402|low back pain|low back pain
5206604|NCT02703402|physical exercise and quality of life|physical exercise and quality of life
5206605|NCT02703389|knowledge translation|knowledge translation
5206606|NCT02703389|antimicrobial stewardship|antimicrobial stewardship
5206607|NCT02703311|Valtech Cardio|valtech cardio
5206608|NCT02703311|Cardioband|cardioband
5206609|NCT02703311|Mitral Valve|mitral valve
5206610|NCT02703298|Advanced Solid Malignancy|advanced solid malignancy
5206611|NCT02703298|Safety and Tolerability|safety and tolerability
5206612|NCT02703298|Tumor Response|tumor response
5206613|NCT02703298|Oncology|oncology
5206614|NCT02703272|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5206615|NCT02703272|Ibrutinib|ibrutinib
5206616|NCT02703272|JNJ-54179060|jnj-54179060
5206617|NCT02703246|Hysterectomy, Vaginal|hysterectomy, vaginal
5206618|NCT02703246|Hysterectomy, Abdominal|hysterectomy, abdominal
5206619|NCT02703220|sleep apnea|sleep apnea
5206620|NCT02703220|chemoresponsiveness|chemoresponsiveness
5206621|NCT02703220|cerebrovascular response|cerebrovascular response
5206622|NCT02703220|hyperoxia|hyperoxia
5206623|NCT02703220|acetazolamide|acetazolamide
5206624|NCT02703220|finasteride|finasteride
5206625|NCT02703220|apneic threshold|apneic threshold
5206626|NCT02703220|carbon-dioxide reserve|carbon-dioxide reserve
5206627|NCT02703207|obstructive sleep apnea|obstructive sleep apnea
5206628|NCT02703207|COPD|copd
5206629|NCT02703207|Overlap syndrome|overlap syndrome
5206630|NCT02703207|quality of life|quality of life
5206631|NCT02703207|neurocognitive function|neurocognitive function
5206632|NCT02703207|sleepiness|sleepiness
5206633|NCT02703207|elderly|elderly
5206634|NCT02703194|IgG4-related disease|igg4-related disease
5203243|NCT02724202|Colon Cancer|colon cancer
5206635|NCT02703194|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
5206636|NCT02703194|Mikulicz disease|mikulicz disease
5206637|NCT02703194|Pancreatitis|pancreatitis
5206638|NCT02703194|Retroperitoneal fibrosis|retroperitoneal fibrosis
5206639|NCT02703194|Lymphadenopathy|lymphadenopathy
5206640|NCT02703181|Safety|safety
5206641|NCT02703181|Dose Escalation|dose escalation
5206642|NCT02703181|Repeat Dosing|repeat dosing
5206643|NCT02703181|Epelsiban|epelsiban
5206644|NCT02703181|Pharmacokinetics|pharmacokinetics
5206645|NCT02703181|Healthy Women Volunteers|healthy women volunteers
5206646|NCT02703181|Tolerability|tolerability
5206647|NCT02703181|Oxytocin|oxytocin
5206648|NCT02703168|Dental implants|dental implants
5206649|NCT02703142|esophagogastrostomy|esophagogastrostomy
5206650|NCT02703142|gastric conduit ischemia|gastric conduit ischemia
5206651|NCT02703142|endoscopy|endoscopy
5206652|NCT02703129|Migraine|migraine
5206653|NCT02703129|Diet quality|diet quality
5206654|NCT02703129|Nutritional intervention|nutritional intervention
5206655|NCT02703129|Severity of disease|severity of disease
5206656|NCT02703129|Depressive symptoms|depressive symptoms
5206657|NCT02703116|HIV|hiv
5206658|NCT02703116|Substance Use|substance use
5206659|NCT02703103|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5206660|NCT02703103|chest compression|chest compression
5206661|NCT02703103|adult|adult
5206662|NCT02703103|simulation|simulation
5206663|NCT02703064|Furocyst|furocyst
5206664|NCT02703064|PCOS|pcos
5206665|NCT02703038|cardiogenic shock|cardiogenic shock
5206666|NCT02703038|observatory|observatory
5206667|NCT02703025|Obesity, green coffee bean extract, weight management|obesity, green coffee bean extract, weight management
5206668|NCT02702973|Characteristic analysis|characteristic analysis
5206669|NCT02702960|FL-HCC|fl-hcc
5206670|NCT02702960|living donor liver transplant|living donor liver transplant
5206671|NCT02702960|HLA matched first degree relative|hla matched first degree relative
5206672|NCT02702960|Milan Criteria|milan criteria
5206673|NCT02702960|Ephraim Fuchs|ephraim fuchs
5206674|NCT02702960|Fibrolamellar Cancer Foundation|fibrolamellar cancer foundation
5206675|NCT02702960|fibrolamellar|fibrolamellar
5206676|NCT02702960|non-fibrolamellar|non-fibrolamellar
5206677|NCT02702947|BPH|bph
5206678|NCT02702947|Prunus Domestica extract|prunus domestica extract
5206679|NCT02702882|Fenugreek seed extract, hypogonadism, protodioscin, testosterone|fenugreek seed extract, hypogonadism, protodioscin, testosterone
5206680|NCT02702869|cleft lip|cleft lip
5206681|NCT02702869|cleft palate|cleft palate
5206682|NCT02702869|cleft lip and palate|cleft lip and palate
5206683|NCT02702869|cleft alveolus|cleft alveolus
5206684|NCT02702869|multidisciplinary team|multidisciplinary team
5206685|NCT02702869|interdisciplinary team|interdisciplinary team
5206686|NCT02702856|Prostate Cancer|prostate cancer
5206687|NCT02702856|Gleason Grade|gleason grade
5206688|NCT02702856|Prostatic Neoplasms|prostatic neoplasms
5206689|NCT02702817|Alzheimer's disease, biomarkers, cognitive decline, pre-clinical|alzheimer's disease, biomarkers, cognitive decline, pre-clinical
5206690|NCT02702791|Physical activity|physical activity
5206691|NCT02702791|Pulmonary rehabilitation|pulmonary rehabilitation
5206692|NCT02702791|COPD|copd
5206693|NCT02702778|Polymyalgia Rheumatica (PMR)|polymyalgia rheumatica (pmr)
5206694|NCT02702765|sCD163|scd163
5206695|NCT02702765|liver cirrhosis|liver cirrhosis
5206696|NCT02702765|disease severity|disease severity
5206697|NCT02702752|Heart diseases stromal differentiation factor alpha 1|heart diseases stromal differentiation factor alpha 1
5194684|NCT02777086|Decision-making|decision-making
5194685|NCT02777073|Diabetic ketoacidosis|diabetic ketoacidosis
5194686|NCT02777073|Insulin|insulin
5194687|NCT02777073|Type 1 Diabetes|type 1 diabetes
5206698|NCT02702713|bioactive|bioactive
5206699|NCT02702713|enriched foods|enriched foods
5206700|NCT02702713|anthocyanins (AC)|anthocyanins (ac)
5206701|NCT02702713|beta-glucans (BG)|beta-glucans (bg)
5206702|NCT02702713|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5206704|NCT02702687|Childhood Asthma|childhood asthma
5206705|NCT02702687|Bronchial Diseases|bronchial diseases
5206706|NCT02702687|Immune System Diseases|immune system diseases
5206707|NCT02702687|Lung Diseases|lung diseases
5206708|NCT02702687|Lung Diseases, Obstructive|lung diseases, obstructive
5206709|NCT02702687|Respiratory Tract Diseases|respiratory tract diseases
5206710|NCT02702687|Peak Flow Meter|peak flow meter
5206711|NCT02702687|Symptom Perception|symptom perception
5206712|NCT02702687|Illness Representation|illness representation
5206713|NCT02702661|Fascia Iliaca Block|fascia iliaca block
5206714|NCT02702661|Local Anaesthetic Infiltration|local anaesthetic infiltration
5206715|NCT02702661|Hip Arthroscopy|hip arthroscopy
5206716|NCT02702648|healthy subjects|healthy subjects
5206717|NCT02702648|first-in-man|first-in-man
5206718|NCT02702648|safety|safety
5206719|NCT02702622|bananas|bananas
5206720|NCT02702622|biofortified|biofortified
5206721|NCT02702622|carotenoids|carotenoids
5206722|NCT02702622|vitamin A|vitamin a
5206723|NCT02702583|Myelosuppressive Chemotherapy|myelosuppressive chemotherapy
5206724|NCT02702583|Febrile Neutropenia|febrile neutropenia
5206725|NCT02702583|Solid Tumors|solid tumors
5206726|NCT02702583|Dental Infection|dental infection
5206727|NCT02702583|Oral Infection|oral infection
5206733|NCT02702557|Adherence|adherence
5206734|NCT02702557|Feasibility|feasibility
5206937|NCT02701673|GlutaSolve|glutasolve
5206735|NCT02702531|Laparoscopic Surgery|laparoscopic surgery
5206736|NCT02702531|FloShield Defogging and Cleaning System|floshield defogging and cleaning system
5206737|NCT02702531|Clearify Defogging and Cleaning System|clearify defogging and cleaning system
5206738|NCT02702531|gynecologic|gynecologic
5206739|NCT02702518|rhDNase I, Pulmozyme, oGVHD, Dry Eye|rhdnase i, pulmozyme, ogvhd, dry eye
5206740|NCT02702505|Pulp|pulp
5206741|NCT02702505|pulpotomies|pulpotomies
5206742|NCT02702505|mineral trioxide aggregate|mineral trioxide aggregate
5206743|NCT02702492|PAK4|pak4
5206744|NCT02702492|KPT-9274|kpt-9274
5206745|NCT02702492|Karyopharm|karyopharm
5206747|NCT02702492|solid tumors|solid tumors
5206748|NCT02702492|NAMPT|nampt
5206749|NCT02702479|Systematic review and meta-analysis|systematic review and meta-analysis
5206750|NCT02702479|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5206751|NCT02702479|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5206752|NCT02702479|Clinical practice guidelines|clinical practice guidelines
5206753|NCT02702479|Clinical trials|clinical trials
5206754|NCT02702479|Dietary sugars|dietary sugars
5206755|NCT02702479|Fructose|fructose
5206756|NCT02702479|High fructose corn syrup|high fructose corn syrup
5206757|NCT02702479|Isocaloric|isocaloric
5206758|NCT02702479|Hypercaloric|hypercaloric
5206759|NCT02702479|Cardiometabolic Risk Factors|cardiometabolic risk factors
5206760|NCT02702479|Triglycerides|triglycerides
5206761|NCT02702479|Cholesterol|cholesterol
5206762|NCT02702479|Glycemic control|glycemic control
5206763|NCT02702479|Body weight|body weight
5206764|NCT02702479|Uric acid|uric acid
5206765|NCT02702479|Blood pressure|blood pressure
5206766|NCT02702479|Fatty liver|fatty liver
5206767|NCT02702479|Fasting|fasting
5206768|NCT02702479|Postprandial|postprandial
5206769|NCT02702466|Upper limb musculoskeletal disorders|upper limb musculoskeletal disorders
5206770|NCT02702466|Spa treatment|spa treatment
5206773|NCT02702466|Self- management|self- management
5206775|NCT02702466|Exercise|exercise
5206776|NCT02702466|Non pharmacological treatment|non pharmacological treatment
5206777|NCT02702440|Systematic review and meta-analysis|systematic review and meta-analysis
5206778|NCT02702440|Sugars|sugars
5206779|NCT02702440|Liquid calories|liquid calories
5206780|NCT02702440|Solid calories|solid calories
5206781|NCT02702440|Clinical trials|clinical trials
5206782|NCT02702440|Body weight|body weight
5206783|NCT02702440|Body Mass Index|body mass index
5206784|NCT02702440|Evidence-base nutrition (EBN)|evidence-base nutrition (ebn)
5206785|NCT02702440|Evidence-base medicine (EBM)|evidence-base medicine (ebm)
5206786|NCT02702440|Clinical practice guidelines|clinical practice guidelines
5206787|NCT02702427|viral infections post HSCT, virus-specific T-cells|viral infections post hsct, virus-specific t-cells
5206788|NCT02702414|PD1|pd1
5206789|NCT02702414|PD-1|pd-1
5206790|NCT02702414|PDL1|pdl1
5206791|NCT02702414|PD-L1|pd-l1
5206796|NCT02702388|Lenvatinib|lenvatinib
5206797|NCT02702388|E7080|e7080
5206798|NCT02702388|Iodine-131 Refractory Differentiated Thyroid Cancer|iodine-131 refractory differentiated thyroid cancer
5206799|NCT02702388|Lenvima|lenvima
5206800|NCT02702388|Phase 2|phase 2
5206801|NCT02702388|RR-DTC|rr-dtc
5206802|NCT02702375|Systematic review and meta-analysis|systematic review and meta-analysis
5206803|NCT02702375|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5206804|NCT02702375|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5206805|NCT02702375|Clinical practice guidelines|clinical practice guidelines
5206806|NCT02702375|Prospective cohort studies|prospective cohort studies
5206807|NCT02702375|Dietary sugars|dietary sugars
5206808|NCT02702375|Fructose|fructose
5206809|NCT02702375|Sucrose|sucrose
5206810|NCT02702375|High fructose corn syrup|high fructose corn syrup
5206811|NCT02702375|HFCS|hfcs
5206812|NCT02702375|Cohort studies|cohort studies
5206813|NCT02702375|Prospective studies|prospective studies
5206814|NCT02702375|Diabetes Mellitus|diabetes mellitus
5206815|NCT02702375|Metabolic syndrome|metabolic syndrome
5206816|NCT02702375|Coronary heart disease|coronary heart disease
5206817|NCT02702375|Stroke|stroke
5206818|NCT02702375|Hypertension|hypertension
5206819|NCT02702375|Gout|gout
5206820|NCT02702362|disorders of consciousness|disorders of consciousness
5206821|NCT02702362|minimally conscious state|minimally conscious state
5206822|NCT02702362|traumatic brain injury|traumatic brain injury
5206823|NCT02702362|stroke|stroke
5206824|NCT02702362|transcranial direct current stimulation|transcranial direct current stimulation
5203440|NCT02723253|rectal cancer|rectal cancer
5083831|NCT03474536|affinity|affinity
5206825|NCT02702323|hepatocellular carcinoma|hepatocellular carcinoma
5206826|NCT02702323|pulmonary metastasis|pulmonary metastasis
5206827|NCT02702323|Apatinib|apatinib
5206828|NCT02702323|efficacy|efficacy
5206829|NCT02702323|safety|safety
5206830|NCT02702297|Preterm premature rupture of the membranes|preterm premature rupture of the membranes
5206831|NCT02702297|PPROM|pprom
5206832|NCT02702297|PROM|prom
5206833|NCT02702297|fetal membranes|fetal membranes
5206834|NCT02702297|premature rupture|premature rupture
5206835|NCT02702297|neonatal early onset sepsis|neonatal early onset sepsis
5206836|NCT02702297|amniotic fluid|amniotic fluid
5206837|NCT02702297|amniotic infection|amniotic infection
5206838|NCT02702297|fetal inflammatory response syndrome|fetal inflammatory response syndrome
5206839|NCT02702297|adverse neonatal outcome|adverse neonatal outcome
5206840|NCT02702297|FIRS|firs
5206841|NCT02702284|Advance Directives|advance directives
5206842|NCT02702284|Healthcare power of attorney|healthcare power of attorney
5206843|NCT02702258|mindfulness|mindfulness
5206844|NCT02702258|blood pressure|blood pressure
5206845|NCT02702258|hypertension|hypertension
5206846|NCT02702258|prehypertension|prehypertension
5206847|NCT02702206|Shoulder pain|shoulder pain
5206848|NCT02702206|subdeltoid bursitis|subdeltoid bursitis
5206849|NCT02702206|subacromial bursitis|subacromial bursitis
5206850|NCT02702206|intra-bursa injection|intra-bursa injection
5206851|NCT02702167|brain stimulation|brain stimulation
5206852|NCT02702167|rTMS|rtms
5206853|NCT02702154|brain stimulation|brain stimulation
5206854|NCT02702154|rTMS|rtms
5206855|NCT02702141|Non-hodgkin lymphoma|non-hodgkin lymphoma
5206856|NCT02702141|Antibody-drug conjugate|antibody-drug conjugate
5206857|NCT02702141|CD19|cd19
5206858|NCT02702141|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5206859|NCT02702141|DLBCL|dlbcl
5206860|NCT02702141|Grade 3 follicular lymphoma|grade 3 follicular lymphoma
5206861|NCT02702128|Bleeding perioperative|bleeding perioperative
5206862|NCT02702128|EXACYL|exacyl
5206863|NCT02702128|Oorthognathism surgery|oorthognathism surgery
5206864|NCT02702128|Hematoma|hematoma
5206865|NCT02702115|Mucopolysaccharidosis I|mucopolysaccharidosis i
5206866|NCT02702115|MPS I|mps i
5206867|NCT02702115|Hurler-Scheie syndrome|hurler-scheie syndrome
5206868|NCT02702115|Gene Therapy|gene therapy
5206869|NCT02702115|Gene Editing|gene editing
5206870|NCT02702115|Zinc Finger|zinc finger
5206871|NCT02702115|SB-318|sb-318
5206872|NCT02702115|Rare|rare
5206873|NCT02702115|Genetic|genetic
5206874|NCT02702115|DNA|dna
5206875|NCT02702115|Sangamo|sangamo
5206876|NCT02702115|Genome editing|genome editing
5206877|NCT02702115|Empowers|empowers
5206878|NCT02702115|ZFN|zfn
5206879|NCT02702115|Hurler|hurler
5206880|NCT02702115|Gene Specific Targeted Insertion|gene specific targeted insertion
5206881|NCT02702076|Apomorphine|apomorphine
5206882|NCT02702050|Physiotherapy|physiotherapy
5206883|NCT02702050|Mechanical Stimulation|mechanical stimulation
5206884|NCT02702050|Mastectomy Scar|mastectomy scar
5206885|NCT02702024|efficacy|efficacy
5206886|NCT02702024|double incision technique|double incision technique
5206887|NCT02702024|uterus preserving surgery|uterus preserving surgery
5206888|NCT02701998|Ischemic Stroke|ischemic stroke
5206889|NCT02701998|Transient Ischemic Attack|transient ischemic attack
5206890|NCT02701998|Physical Activity|physical activity
5206891|NCT02701998|Sedentary Behavior|sedentary behavior
5206892|NCT02701998|Lifestyle|lifestyle
5206893|NCT02701998|Behavior|behavior
5206897|NCT02701946|Total knee arthroplasty|total knee arthroplasty
5206898|NCT02701946|Bandage|bandage
5206899|NCT02701946|Dressing|dressing
5206900|NCT02701920|Premature Birth|premature birth
5206901|NCT02701920|Infant|infant
5206902|NCT02701920|Heart rate|heart rate
5206903|NCT02701881|Femoropopliteal Artery|femoropopliteal artery
5206904|NCT02701881|Drug-eluting Stent|drug-eluting stent
5206905|NCT02701881|Endovascular Therapy|endovascular therapy
5206906|NCT02701868|Infant Formula|infant formula
5206910|NCT02701816|Peripheral Artery Disease|peripheral artery disease
5206911|NCT02701816|Femoropopliteal Artery|femoropopliteal artery
5206912|NCT02701816|Nitinol Stent|nitinol stent
5206913|NCT02701816|Restenosis|restenosis
5206914|NCT02701777|spike timing dependant plasticity|spike timing dependant plasticity
5206915|NCT02701764|laser-assisted in situ keratomileusis|laser-assisted in situ keratomileusis
5206916|NCT02701764|dry eye symptoms|dry eye symptoms
5206917|NCT02701764|LASIK|lasik
5206918|NCT02701764|prevention|prevention
5206919|NCT02701712|magnetic resonance|magnetic resonance
5206920|NCT02701712|external beam radiotherapy|external beam radiotherapy
5206921|NCT02701712|brachytherapy|brachytherapy
5206922|NCT02701712|radiotherapy|radiotherapy
5206923|NCT02701699|Lung Cancer|lung cancer
5206924|NCT02701699|FAZA PET Imaging|faza pet imaging
5206925|NCT02701699|Lung Radiotherapy|lung radiotherapy
5206926|NCT02701686|smoking cessation|smoking cessation
5962575|NCT04280198|relative reinforcing value of food|relative reinforcing value of food
5206927|NCT02701673|Refractory or Relapsed Lymphoma|refractory or relapsed lymphoma
5206928|NCT02701673|Busulfan|busulfan
5206929|NCT02701673|Busulfex|busulfex
5206930|NCT02701673|Myleran|myleran
5206931|NCT02701673|Caphosol|caphosol
5203568|NCT02722525|ADT|adt
5206932|NCT02701673|Glutamine|glutamine
5206933|NCT02701673|Enterex|enterex
5206934|NCT02701673|Glutapak-10|glutapak-10
5206935|NCT02701673|NutreStore|nutrestore
5206936|NCT02701673|Resource|resource
5206938|NCT02701673|Sympt-X-G.I.|sympt-x-g.i.
5206939|NCT02701673|Sympt-X|sympt-x
5206940|NCT02701673|Pyridoxine|pyridoxine
5206941|NCT02701673|Belinostat|belinostat
5206942|NCT02701673|Azacitidine|azacitidine
5206943|NCT02701673|5-azacytidine|5-azacytidine
5206944|NCT02701673|5-aza|5-aza
5206945|NCT02701673|Azacytidine|azacytidine
5206946|NCT02701673|Vidaza|vidaza
5206947|NCT02701673|5-AZC|5-azc
5206948|NCT02701673|AZA-CR|aza-cr
5206949|NCT02701673|Ladakamycin|ladakamycin
5206950|NCT02701673|Gemcitabine|gemcitabine
5206951|NCT02701673|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5206952|NCT02701673|Gemzar|gemzar
5206953|NCT02701673|Stem cell transplant|stem cell transplant
5206954|NCT02701673|SCT|sct
5206955|NCT02701673|Melphalan|melphalan
5206956|NCT02701673|Alkeran|alkeran
5206957|NCT02701660|Pharmaceutical Care|pharmaceutical care
5206958|NCT02701660|Adherence|adherence
5206959|NCT02701660|Polypharmacy|polypharmacy
5206960|NCT02701660|e-Health|e-health
5206961|NCT02701660|opioid substitution therapy|opioid substitution therapy
5206962|NCT02701647|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5206963|NCT02701647|metaplasticity|metaplasticity
5206964|NCT02701647|gait training|gait training
5206965|NCT02701634|Chronic Graft Versus Host Disease (cGVHD)|chronic graft versus host disease (cgvhd)
5206966|NCT02701634|newly diagnosed cGVHD|newly diagnosed cgvhd
5206967|NCT02701634|immune reconstitution|immune reconstitution
5206968|NCT02701634|Immune System Diseases|immune system diseases
5206969|NCT02701634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5206970|NCT02701634|SYK inhibitor|syk inhibitor
5206971|NCT02701621|Parkinson's disease, aquatic therapy, balance, MIRT|parkinson's disease, aquatic therapy, balance, mirt
5206972|NCT02701517|conditioning treatment|conditioning treatment
5206975|NCT02701517|chronic lymphoproliferative disorders|chronic lymphoproliferative disorders
5206976|NCT02701504|sleep apnea|sleep apnea
5206977|NCT02701504|coronary artery bypass grafting|coronary artery bypass grafting
5206978|NCT02701504|outcomes|outcomes
5206979|NCT02701465|Shoulder|shoulder
5206980|NCT02701465|Exercise therapy|exercise therapy
5206981|NCT02701452|GnRH agonist triggering|gnrh agonist triggering
5206982|NCT02701426|Macrosomia|macrosomia
5206983|NCT02701426|Weight gain|weight gain
5206984|NCT02701426|Participation|participation
5206985|NCT02701426|Adhesion|adhesion
5206986|NCT02701426|Physical activity|physical activity
5206987|NCT02701426|Nutrition|nutrition
5206991|NCT02701387|bone implant interaction|bone implant interaction
5206992|NCT02701387|implant stability|implant stability
5206993|NCT02701387|resonance frequency analysis (RFA)|resonance frequency analysis (rfa)
5206994|NCT02701387|implant stability quotient (ISQ)|implant stability quotient (isq)
5206995|NCT02701374|TRK-700|trk-700
5206996|NCT02701374|Post-Herpetic Neuralgia|post-herpetic neuralgia
5206997|NCT02701361|mindfulness|mindfulness
5206998|NCT02701361|critical illness|critical illness
5206999|NCT02701361|intensive care unit|intensive care unit
5194969|NCT02775578|Coronary Artery Bypass Grafting, CABG|coronary artery bypass grafting, cabg
5194970|NCT02775552|Child Nutrition|child nutrition
5194971|NCT02775552|Breastfeeding|breastfeeding
5194972|NCT02775552|Complementary Feeding|complementary feeding
5194973|NCT02775552|Infant and Young Child Feeding|infant and young child feeding
5194974|NCT02775552|Social and Behavior Change Communication|social and behavior change communication
5194975|NCT02775552|Ethiopia|ethiopia
5194976|NCT02775539|Pulmonary hypertension|pulmonary hypertension
5194977|NCT02775539|Mirabegron|mirabegron
5194978|NCT02775539|Heart failure|heart failure
5194979|NCT02775539|B3 adrenergic|b3 adrenergic
5194980|NCT02775526|Mixed urinary incontinence|mixed urinary incontinence
5194981|NCT02775526|Transobturator tape (TOT)|transobturator tape (tot)
5207000|NCT02701361|mindfulness-based stress reduction|mindfulness-based stress reduction
5207001|NCT02701348|neoadjuvant endocrine|neoadjuvant endocrine
5207002|NCT02701335|Osteoarthritis|osteoarthritis
5207003|NCT02701335|Hand|hand
5207004|NCT02701335|Rehabilitation|rehabilitation
5207005|NCT02701322|Velopharyngeal Insufficiency|velopharyngeal insufficiency
5207006|NCT02701322|Fluoroscopy|fluoroscopy
5207007|NCT02701309|Iron deficiency|iron deficiency
5207008|NCT02701309|Child|child
5207009|NCT02701309|Infancy|infancy
5207010|NCT02701309|Preschool children|preschool children
5207011|NCT02701309|iron deficiency anemia|iron deficiency anemia
5423238|NCT01616563|central obesity|central obesity
5423239|NCT01616563|abdominal obesity|abdominal obesity
5207012|NCT02701296|Infiltration between popliteal artery and capsule of knee (iPACK)|infiltration between popliteal artery and capsule of knee (ipack)
5207013|NCT02701270|Glycemic Index|glycemic index
5207014|NCT02701270|Dietary Fiber|dietary fiber
5207015|NCT02701257|Bionic Pancreas|bionic pancreas
5207016|NCT02701257|Insulin|insulin
5207017|NCT02701257|Glucagon|glucagon
5207018|NCT02701257|Continuous Glucose Monitor|continuous glucose monitor
5207019|NCT02701244|Infiltrating Ductal Carcinoma|infiltrating ductal carcinoma
5207020|NCT02701244|Ductal Carcinoma In Situ|ductal carcinoma in situ
5207039|NCT02701166|cholestasis|cholestasis
5207040|NCT02701075|peripheral neuropathy|peripheral neuropathy
5207041|NCT02701075|traumatic tissue injury|traumatic tissue injury
5207042|NCT02701075|radiculopathy|radiculopathy
5207043|NCT02701036|sporadic ataxia|sporadic ataxia
5207044|NCT02701036|MSAc|msac
5207045|NCT02701036|SAOA|saoa
5207046|NCT02701036|multiple system atrophy of cerebellar type|multiple system atrophy of cerebellar type
5207047|NCT02701036|natural history|natural history
5207048|NCT02701010|behavioral therapy|behavioral therapy
5207049|NCT02701010|overactive bladder|overactive bladder
5207050|NCT02701010|urinary incontinence|urinary incontinence
5207051|NCT02700958|Remote ischemic preconditioning|remote ischemic preconditioning
5207052|NCT02700958|Contrast-induced Nephropathy|contrast-induced nephropathy
5207053|NCT02700958|Stable coronary artery disease|stable coronary artery disease
5207054|NCT02700958|Lower extremity arterial disease|lower extremity arterial disease
5207055|NCT02700958|Low molecular weight metabolites|low molecular weight metabolites
5207056|NCT02700958|Functional properties of arteries|functional properties of arteries
5207057|NCT02700932|non-invasive|non-invasive
5207058|NCT02700906|Lateral epicondylitis|lateral epicondylitis
5207059|NCT02700906|tennis elbow|tennis elbow
5207060|NCT02700906|Lidocaine|lidocaine
5207061|NCT02700906|corticosteroid|corticosteroid
5207062|NCT02700880|wearable cardioverter defibrillator|wearable cardioverter defibrillator
5207063|NCT02700880|ischemic cardiomyopathy|ischemic cardiomyopathy
5207064|NCT02700880|new onset heart failure|new onset heart failure
5207065|NCT02700880|sudden cardiac death|sudden cardiac death
5207066|NCT02700867|intraosseous access|intraosseous access
5207067|NCT02700867|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5207068|NCT02700867|paramedic|paramedic
5207069|NCT02700867|simulation|simulation
5207071|NCT02700854|Hypothermia treatment|hypothermia treatment
5207072|NCT02700854|Hypocapnia|hypocapnia
5207073|NCT02700854|Inhaled CO2|inhaled co2
5207074|NCT02700854|Neuroprotection|neuroprotection
5207075|NCT02700828|Hypothermia treatment|hypothermia treatment
5207076|NCT02700828|Circulatory failure|circulatory failure
5207077|NCT02700828|Neonatal hypotension|neonatal hypotension
5207078|NCT02700828|Relative adrenal insufficiency|relative adrenal insufficiency
5207079|NCT02700828|Hydrocortisone supplementation|hydrocortisone supplementation
5207080|NCT02700802|food insecurity|food insecurity
5207081|NCT02700802|informal caregiver health|informal caregiver health
5207082|NCT02700802|clinic-to-community linkages|clinic-to-community linkages
5207083|NCT02700802|community resources|community resources
5207084|NCT02700789|diagnostic accuracy|diagnostic accuracy
5207085|NCT02700789|double decidual sac sign|double decidual sac sign
5207086|NCT02700789|intrauterine pregnancy|intrauterine pregnancy
5207087|NCT02700776|screening mammogram|screening mammogram
5207088|NCT02700776|GP88|gp88
5207089|NCT02700776|breast cancer|breast cancer
5207090|NCT02700763|Brain metastasis|brain metastasis
5207091|NCT02700737|cardiovascular modeling|cardiovascular modeling
5207092|NCT02700737|aortic coarctation|aortic coarctation
5207093|NCT02700737|virtual stenting|virtual stenting
5207094|NCT02700698|Mitochondria|mitochondria
5207095|NCT02700698|women|women
5207096|NCT02700698|muscle|muscle
5207097|NCT02700698|PBMC|pbmc
5207098|NCT02700672|Ageing|ageing
5207099|NCT02700672|Cognition|cognition
5207101|NCT02700672|Gait|gait
5207102|NCT02700620|emotional eating|emotional eating
5207103|NCT02700620|restrictive eating|restrictive eating
5207104|NCT02700620|body dissatisfaction|body dissatisfaction
5207105|NCT02700607|cerebral aneurysm, coiling embolization, blood viscosity|cerebral aneurysm, coiling embolization, blood viscosity
5207106|NCT02700555|colorectal cancer|colorectal cancer
5207107|NCT02700555|diabetes|diabetes
5207108|NCT02700555|metabolic parameters|metabolic parameters
5207109|NCT02700555|Surveillance|surveillance
5207110|NCT02700542|asthma|asthma
5207111|NCT02700542|pest management|pest management
5207112|NCT02700503|Diabetes prevention|diabetes prevention
5207113|NCT02700503|type 2 diabetes|type 2 diabetes
5207114|NCT02700503|prediabetes|prediabetes
5207115|NCT02700503|family|family
5207116|NCT02700477|Type-2 Diabetic|type-2 diabetic
5207117|NCT02700477|HbA1c|hba1c
5207119|NCT02700477|PPBS|ppbs
5207120|NCT02700477|C-peptide|c-peptide
5207121|NCT02700451|IV acetaminophen|iv acetaminophen
5207122|NCT02700451|IV Ketorolac|iv ketorolac
5207123|NCT02700451|Post-operative analgesia|post-operative analgesia
5207124|NCT02700451|Opioid use|opioid use
5207125|NCT02700425|Wide QRS|wide qrs
5207126|NCT02700425|Ventricular Dyssynchrony|ventricular dyssynchrony
5207127|NCT02700399|Rehabilitation|rehabilitation
5207128|NCT02700386|Breast|breast
5207129|NCT02700386|Cancer|cancer
5207130|NCT02700386|Hypofractionated|hypofractionated
5207131|NCT02700386|Node-Positive Breast Cancer|node-positive breast cancer
5207132|NCT02700386|Radiation Therapy|radiation therapy
5962576|NCT04280198|food reinforcement|food reinforcement
5084203|NCT03472482|Retina|retina
5207133|NCT02700386|Comprehensive Radiation Therapy|comprehensive radiation therapy
5207134|NCT02700360|EC-18|ec-18
5207135|NCT02700360|Hematology|hematology
5207136|NCT02700360|Cancer|cancer
5207137|NCT02700360|Neutropenia|neutropenia
5207138|NCT02700334|Prediabetes|prediabetes
5207139|NCT02700334|Impaired fasting glucose|impaired fasting glucose
5207140|NCT02700334|Hyperglycemia|hyperglycemia
5207141|NCT02700334|Impaired glucose tolerance|impaired glucose tolerance
5207142|NCT02700334|Glucose intolerance|glucose intolerance
5207143|NCT02700334|Dapagliflozin|dapagliflozin
5207144|NCT02700334|Sodium glucose cotransporter 2 inhibitor|sodium glucose cotransporter 2 inhibitor
5207145|NCT02700334|SGLT2|sglt2
5207146|NCT02700321|non severely hypoxemic respiratory failure|non severely hypoxemic respiratory failure
5207147|NCT02700321|preoxygenation|preoxygenation
5207148|NCT02700321|crash induction|crash induction
5207149|NCT02700308|Solid tumors|solid tumors
5207150|NCT02700308|Spine metastasis|spine metastasis
5207151|NCT02700308|Vertebroplasty|vertebroplasty
5207152|NCT02700308|kyphoplasty|kyphoplasty
5207153|NCT02700308|randomization|randomization
5207154|NCT02700295|Orthokeratology|orthokeratology
5207155|NCT02700282|Cystic fibrosis|cystic fibrosis
5207156|NCT02700282|Backpack carrying|backpack carrying
5207157|NCT02700282|Respiratory function|respiratory function
5207158|NCT02700282|Children|children
5207159|NCT02700256|surgery|surgery
5207160|NCT02700256|15-315|15-315
5207161|NCT02700243|Cystic Fibrosis|cystic fibrosis
5207162|NCT02700243|Exercise|exercise
5207163|NCT02700243|Fitbit|fitbit
5207172|NCT02700061|Robotic Occupational Therapy|robotic occupational therapy
5207173|NCT02700061|Neuroplasticity|neuroplasticity
5207174|NCT02700048|type 1 diabetes|type 1 diabetes
5207175|NCT02700048|hypoglycemia|hypoglycemia
5207176|NCT02700048|hypoglycemia unawareness|hypoglycemia unawareness
5207177|NCT02700035|Intervention|intervention
5207178|NCT02700035|Prevention|prevention
5207179|NCT02700035|Randomized Controlled Trial|randomized controlled trial
5207180|NCT02700035|Bii-Zin-Da-De-Dah|bii-zin-da-de-dah
5207181|NCT02700022|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5207182|NCT02700022|Alisertib|alisertib
5207183|NCT02699905|Sepsis|sepsis
5207184|NCT02699905|Septic Shock|septic shock
5207185|NCT02699905|Multiple Organ Dysfunction|multiple organ dysfunction
5207186|NCT02699905|FFA2|ffa2
5207187|NCT02699905|GPR43|gpr43
5207188|NCT02699866|Small diameter implant|small diameter implant
5207189|NCT02699840|Meningitis|meningitis
5207190|NCT02699840|Meningococcal Meningitis|meningococcal meningitis
5207191|NCT02699840|Meningococcal Infections|meningococcal infections
5207192|NCT02699840|Menactra®|menactra®
5207193|NCT02699840|Meningococcal Vaccine|meningococcal vaccine
5207194|NCT02699827|Levobupivacaine|levobupivacaine
5207195|NCT02699827|Magnesium|magnesium
5207196|NCT02699827|Preeclampsia|preeclampsia
5207197|NCT02699827|Epidural|epidural
5207198|NCT02699814|Depression|depression
5207199|NCT02699814|Children|children
5207200|NCT02699814|Anxiety|anxiety
5207201|NCT02699775|Botulinum toxin injections|botulinum toxin injections
5207202|NCT02699775|Stroke|stroke
5207203|NCT02699775|3D motion analysis|3d motion analysis
5207204|NCT02699775|Gait pattern|gait pattern
5207205|NCT02699762|self rehabilitation|self rehabilitation
5207206|NCT02699762|stroke|stroke
5207207|NCT02699762|botulinum toxin injection|botulinum toxin injection
5207208|NCT02699762|arm functions|arm functions
5207209|NCT02699749|Drug Therapy|drug therapy
5207211|NCT02699736|HIV-1|hiv-1
5207212|NCT02699736|Hepatitis C|hepatitis c
5207214|NCT02699736|prospective|prospective
5207215|NCT02699736|cohort|cohort
5207216|NCT02699736|coinfection|coinfection
5207217|NCT02699671|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5207218|NCT02699671|Routine Clinical Practice|routine clinical practice
5207219|NCT02699671|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5207220|NCT02699671|Coronary Artery Disease|coronary artery disease
5207221|NCT02699671|drug eluting stent|drug eluting stent
5207222|NCT02699671|acute myocardial infarction|acute myocardial infarction
5207223|NCT02699658|levofloxacin|levofloxacin
5207224|NCT02699658|population pharmacokinetics|population pharmacokinetics
5207225|NCT02699658|pharmacodynamics|pharmacodynamics
5207228|NCT02699632|Survey|survey
5207229|NCT02699619|Undisplaced|undisplaced
5207237|NCT02699580|Biodegradable collagen implant|biodegradable collagen implant
5207238|NCT02699580|scleral thinning|scleral thinning
5207239|NCT02699580|strabismus surgery|strabismus surgery
5207240|NCT02699567|taste perception|taste perception
5207241|NCT02699567|individual differences|individual differences
5207242|NCT02699567|fat|fat
5207243|NCT02699567|genetics|genetics
5207244|NCT02699541|Diabetes Self-Management Education|diabetes self-management education
5207245|NCT02699541|Behavioural change theory|behavioural change theory
5207246|NCT02699541|IMB model|imb model
5962577|NCT04280198|positive parenting|positive parenting
5207247|NCT02699541|Diabetes Type 2|diabetes type 2
5207248|NCT02699515|MSB0011359C|msb0011359c
5207249|NCT02699476|NFL|nfl
5207250|NCT02699476|veterans|veterans
5207251|NCT02699476|cognitive training|cognitive training
5207253|NCT02699476|concussion|concussion
5207254|NCT02699437|Preeclampsia|preeclampsia
5207255|NCT02699437|Antiphospholipid Antibodies|antiphospholipid antibodies
5445360|NCT01522170|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5445361|NCT01522170|aHUS|ahus
5445362|NCT01522170|Eculizumab|eculizumab
5207256|NCT02699411|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.|ligament anterior cruciate , dry needling, physioterapy, propioception, knee arthroplasty, vastus medialis.
5207257|NCT02699385|Gastroenteritis|gastroenteritis
5207258|NCT02699385|Domperidone|domperidone
5207259|NCT02699385|Pediatric participants|pediatric participants
5207260|NCT02699372|Healthy Volunteers|healthy volunteers
5207261|NCT02699359|concussion|concussion
5207262|NCT02699359|mild traumatic brain injuries|mild traumatic brain injuries
5207263|NCT02699346|concussion|concussion
5207264|NCT02699346|mild traumatic brain injuries|mild traumatic brain injuries
5207265|NCT02699320|Short bowel syndrome|short bowel syndrome
5207266|NCT02699320|Intestinal microbiota|intestinal microbiota
5207267|NCT02699320|immune|immune
5207268|NCT02699307|physical activity|physical activity
5207269|NCT02699294|Pain Threshold|pain threshold
5207270|NCT02699294|Pectoralis Minor|pectoralis minor
5207271|NCT02699294|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
5207272|NCT02699294|Physiotherapy|physiotherapy
5207273|NCT02699294|Rehabilitation|rehabilitation
5207274|NCT02699242|Fiberoptic intubation Training Simulation Performance|fiberoptic intubation training simulation performance
5207275|NCT02699216|Macular Degeneration|macular degeneration
5207276|NCT02699216|Eye Diseases|eye diseases
5207277|NCT02699216|Retinal Degeneration|retinal degeneration
5207278|NCT02699216|Retinal Diseases|retinal diseases
5207279|NCT02699190|Leukodystrophy|leukodystrophy
5207280|NCT02699190|White Matter Disease|white matter disease
5207281|NCT02699190|Whole Genome Sequencing|whole genome sequencing
5207282|NCT02699190|WGS|wgs
5207283|NCT02699177|ciliary beat frequency,|ciliary beat frequency,
5207284|NCT02699164|non surgical spinal decompression therapy|non surgical spinal decompression therapy
5207285|NCT02699164|deep friction massage|deep friction massage
5207286|NCT02699164|exercise|exercise
5207287|NCT02699099|Children|children
5207288|NCT02699099|Infants|infants
5207289|NCT02699099|SB257049|sb257049
5207290|NCT02699099|Malaria|malaria
5207291|NCT02699099|Immunogenicity|immunogenicity
5207292|NCT02699099|Surveillance|surveillance
5207293|NCT02699099|Efficacy|efficacy
5207294|NCT02699099|Safety|safety
5207295|NCT02699099|Africa|africa
5207296|NCT02699099|Plasmodium falciparum|plasmodium falciparum
5207297|NCT02699086|ADHD|adhd
5207298|NCT02699073|colorectal cancer|colorectal cancer
5207299|NCT02699073|metastatic|metastatic
5207300|NCT02699073|regorafenib|regorafenib
5207301|NCT02699073|CHOI criteria|choi criteria
5207302|NCT02699073|RECIST criteria|recist criteria
5207303|NCT02699060|GERD|gerd
5207304|NCT02699060|Barrett`s esophagus|barrett`s esophagus
5207305|NCT02699060|macrophage|macrophage
5207306|NCT02699060|FSSG questionnaire|fssg questionnaire
5207307|NCT02699047|Gastrointestinal cancer|gastrointestinal cancer
5207308|NCT02699047|Fish oil|fish oil
5207309|NCT02699047|Oxidative stress|oxidative stress
5207311|NCT02699047|Quality of life|quality of life
5207312|NCT02699047|Nutritional status|nutritional status
5207313|NCT02699047|Colorectal cancer|colorectal cancer
5207314|NCT02699047|Stomach cancer|stomach cancer
5207315|NCT02699047|Chemotherapy|chemotherapy
5207316|NCT02699047|polyunsaturated fatty acids n-3|polyunsaturated fatty acids n-3
5207317|NCT02699034|real-time MRI|real-time mri
5207318|NCT02699034|electrophysiology study|electrophysiology study
5207319|NCT02699034|atrial flutter ablation|atrial flutter ablation
5207320|NCT02699034|active tracking|active tracking
5207321|NCT02699008|clopidogrel；antiplatelet therapy|clopidogrel；antiplatelet therapy
5207323|NCT02698982|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5207324|NCT02698982|postoperative delirium|postoperative delirium
5207325|NCT02698982|depth of anesthesia|depth of anesthesia
5207326|NCT02698982|intraoperative blood pressure monitoring|intraoperative blood pressure monitoring
5207327|NCT02698969|Sugammadex|sugammadex
5207328|NCT02698969|Post-operative residual curarization|post-operative residual curarization
5207329|NCT02698969|Diaphragm Ultrasonography|diaphragm ultrasonography
5207330|NCT02698956|SAPIEN 3 THV|sapien 3 thv
5207332|NCT02698956|Transfemoral|transfemoral
5207333|NCT02698956|Transaortic|transaortic
5207334|NCT02698956|Transapical|transapical
5207335|NCT02698956|Aortic valve|aortic valve
5207336|NCT02698943|cataract; intraocular lens; posterior capsule opacification; glistening; ENVISTA|cataract; intraocular lens; posterior capsule opacification; glistening; envista
5207337|NCT02698930|Infective endocarditis|infective endocarditis
5207338|NCT02698930|acute kidney injury|acute kidney injury
5207339|NCT02698930|dexmedetomidine|dexmedetomidine
5207340|NCT02698917|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5207341|NCT02698917|Resuscitation|resuscitation
5207342|NCT02698917|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
5207343|NCT02698904|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5207344|NCT02698904|Relaxation Technique|relaxation technique
5084495|NCT03470766|SCS|scs
5207345|NCT02698904|Anxiety|anxiety
5207346|NCT02698891|Early Stage Breast Cancer|early stage breast cancer
5207347|NCT02698878|Lupin Protein|lupin protein
5207348|NCT02698878|Glucose Metabolism|glucose metabolism
5207349|NCT02698878|GLUT4|glut4
5207350|NCT02698878|Muscle Unloading|muscle unloading
5207351|NCT02698878|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5207352|NCT02698852|Drug eluting stents|drug eluting stents
5207353|NCT02698852|Interventional Cardiology|interventional cardiology
5207354|NCT02698839|Drug eluting stents|drug eluting stents
5207355|NCT02698839|Interventional Cardiology|interventional cardiology
5342979|NCT01981304|Coronary artery disease|coronary artery disease
5356862|NCT01917695|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
5207356|NCT02698826|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
5207357|NCT02698761|Vaso-Occlusive Crises|vaso-occlusive crises
5207358|NCT02698761|Sickle Cell Disease|sickle cell disease
5207359|NCT02698761|Decreasing Length of Stay|decreasing length of stay
5207360|NCT02698761|Comprehensive Care Plan|comprehensive care plan
5207361|NCT02698748|Chloroquine|chloroquine
5207362|NCT02698748|Malaria Elimination|malaria elimination
5207363|NCT02698748|P.falciparum|p.falciparum
5207364|NCT02698748|Clinical Trial|clinical trial
5207365|NCT02698748|Mozambique|mozambique
5207366|NCT02698748|Adults|adults
5207367|NCT02698709|Keratoconus|keratoconus
5207368|NCT02698709|Corneal Topography|corneal topography
5207369|NCT02698709|Diagnosis|diagnosis
5207370|NCT02698709|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
5207371|NCT02698696|Cognitive Remediation|cognitive remediation
5207372|NCT02698696|Mood disorders|mood disorders
5207373|NCT02698696|Neuropsychology|neuropsychology
5207374|NCT02698683|Nutrition|nutrition
5207375|NCT02698683|Lymphocyte Count|lymphocyte count
5207376|NCT02698683|Immunoparalysis|immunoparalysis
5207377|NCT02698683|nutritional status of septic patients|nutritional status of septic patients
5207378|NCT02698670|Cardiac Arrhythmias|cardiac arrhythmias
5207379|NCT02698670|Cardiovascular Disease|cardiovascular disease
5207380|NCT02698670|Radiofrequency Ablation|radiofrequency ablation
5207381|NCT02698670|Cardiac Mapping|cardiac mapping
5207382|NCT02698657|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5207383|NCT02698657|Methotrexate|methotrexate
5207384|NCT02698657|ASP5094|asp5094
5207385|NCT02698631|Catheter Ablation|catheter ablation
5207386|NCT02698631|Radiofrequency|radiofrequency
5207387|NCT02698631|Fibrosis|fibrosis
5207388|NCT02698631|Late-gadolinium enhanced MRI|late-gadolinium enhanced mri
5207389|NCT02698618|Diabetes|diabetes
5207390|NCT02698618|IMR|imr
5207391|NCT02698618|Microcirculation|microcirculation
5207392|NCT02698618|Ticagrelor|ticagrelor
5207393|NCT02698618|CFR|cfr
5207394|NCT02698618|FFR|ffr
5207395|NCT02698618|Coronary microcirculation|coronary microcirculation
5207396|NCT02698592|atrial flutter|atrial flutter
5207397|NCT02698592|ablation|ablation
5207398|NCT02698592|Thermocool SF catheter|thermocool sf catheter
5207399|NCT02698579|Adrenoleukodystrophy|adrenoleukodystrophy
5207400|NCT02698579|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
5207401|NCT02698579|Hematopoietic Stem Cells|hematopoietic stem cells
5207402|NCT02698553|Major depressive disorder|major depressive disorder
5207403|NCT02698553|Extended release Bupropion|extended release bupropion
5207404|NCT02698527|lidocaine|lidocaine
5207406|NCT02698501|Airway hyperresponsiveness|airway hyperresponsiveness
5207407|NCT02698501|TSLP|tslp
5207408|NCT02698501|Mast cell|mast cell
5204059|NCT02719054|CBT|cbt
5207409|NCT02698501|Eosinophil|eosinophil
5207410|NCT02698475|Psoriasis|psoriasis
5207411|NCT02698475|Ustekinumab|ustekinumab
5207412|NCT02698475|STELARA|stelara
5207413|NCT02698462|Advanced neoplasia|advanced neoplasia
5207414|NCT02698462|Colorectal cancer|colorectal cancer
5207415|NCT02698462|Population screening|population screening
5207416|NCT02698462|Family history|family history
5207417|NCT02698436|Acne|acne
5207418|NCT02698371|composite resins|composite resins
5207419|NCT02698371|dental restoration|dental restoration
5207420|NCT02698371|adhesives|adhesives
5207421|NCT02698371|non-carious cervical lesions|non-carious cervical lesions
5207422|NCT02698371|clinical effectiveness|clinical effectiveness
5207423|NCT02698371|Adhese universal|adhese universal
5207424|NCT02698371|Futurabond U|futurabond u
5207425|NCT02698371|Futurabond DC|futurabond dc
5207426|NCT02698371|self-etch|self-etch
5207427|NCT02698371|multimode/universal|multimode/universal
5207428|NCT02698371|clinical trial|clinical trial
5207429|NCT02698358|Peripheral artery disease, Iliac artery, nitinol stent, restenosis|peripheral artery disease, iliac artery, nitinol stent, restenosis
5207430|NCT02698345|Popliteal artery disease, drug-eluting balloon, angioplasty|popliteal artery disease, drug-eluting balloon, angioplasty
5207431|NCT02698319|Triage|triage
5207432|NCT02698319|Systematic Triage|systematic triage
5207433|NCT02698280|Bevacizumab|bevacizumab
5207434|NCT02698280|Nimustine|nimustine
5207435|NCT02698280|Pathology, Molecular|pathology, molecular
5962578|NCT04280198|parenting intervention|parenting intervention
5075489|NCT03527160|AKI|aki
5207436|NCT02698241|Cardiac Resynchronization Therapy Defibrillator (CRT-D)|cardiac resynchronization therapy defibrillator (crt-d)
5207437|NCT02698241|heart failure|heart failure
5207438|NCT02698241|integrated diagnostics|integrated diagnostics
5207439|NCT02698241|chronic medication management|chronic medication management
5207440|NCT02698228|anesthesia|anesthesia
5207441|NCT02698202|Tomosynthesis,sensitivity,specificity,screening,mammography|tomosynthesis,sensitivity,specificity,screening,mammography
5207442|NCT02698176|OTX015|otx015
5207443|NCT02698176|MK-8628|mk-8628
5207444|NCT02698163|Root Canal Therapy|root canal therapy
5207445|NCT02698150|Mitral regurgitation|mitral regurgitation
5207446|NCT02698150|Mitraclip|mitraclip
5207447|NCT02698150|Remote monitoring|remote monitoring
5207448|NCT02698150|Wearables|wearables
5857584|NCT00022854|ACL|acl
5207455|NCT02698098|Methadone|methadone
5195474|NCT02772497|Ziv aflibercept|ziv aflibercept
5195475|NCT02772484|noninvasive monitoring|noninvasive monitoring
5195476|NCT02772471|intracranial pressure|intracranial pressure
5207456|NCT02698098|Drug Relapse|drug relapse
5207457|NCT02698098|Drug and Narcotic Control|drug and narcotic control
5207458|NCT02698098|Opiate Substitution Treatment|opiate substitution treatment
5207459|NCT02698098|Prisons|prisons
5207460|NCT02698085|carpal tunnel syndrome|carpal tunnel syndrome
5207461|NCT02698085|physiotherapy|physiotherapy
5207462|NCT02698085|manual therapy|manual therapy
5207463|NCT02698072|Stiffness|stiffness
5207464|NCT02698072|Pain|pain
5207465|NCT02698072|Disfunction|disfunction
5207466|NCT02698046|Heart failure|heart failure
5207467|NCT02698046|Iron|iron
5207468|NCT02698046|Anemia|anemia
5207469|NCT02698046|Chronic disease|chronic disease
5207470|NCT02698033|food allergy|food allergy
5207471|NCT02698033|peanut|peanut
5207472|NCT02698033|food challenge|food challenge
5207473|NCT02698020|Newborn|newborn
5207474|NCT02698020|Anesthesia|anesthesia
5207475|NCT02698020|Oxygen|oxygen
5207476|NCT02698020|Hyperoxia|hyperoxia
5207477|NCT02697994|Sterile Water Injection|sterile water injection
5207478|NCT02697994|Midwifery|midwifery
5207479|NCT02697981|sleeve gastrectomy|sleeve gastrectomy
5207480|NCT02697929|Rocuronium|rocuronium
5207481|NCT02697916|aspirin|aspirin
5207482|NCT02697916|ACSD|acsd
5207483|NCT02697916|PCORI|pcori
5207484|NCT02697903|Creatine kinase supplementation|creatine kinase supplementation
5207485|NCT02697903|C-reactive protein|c-reactive protein
5207486|NCT02697903|resistance training|resistance training
5207487|NCT02697903|Pomegranate supplementation|pomegranate supplementation
5207488|NCT02697903|pomegranate juice|pomegranate juice
5207489|NCT02697903|muscle damage response|muscle damage response
5207490|NCT02697786|Aortic valve surgery|aortic valve surgery
5207491|NCT02697773|osteoarthritis of the knee|osteoarthritis of the knee
5207492|NCT02697773|osteoarthritis of the hip|osteoarthritis of the hip
5207493|NCT02697773|nerve growth factor inhibitor|nerve growth factor inhibitor
5207494|NCT02697773|tanezumab|tanezumab
5207495|NCT02697760|cadmium-zinc-telluride，CZT cameras|cadmium-zinc-telluride，czt cameras
5207496|NCT02697760|myocardial blood flow，MBF|myocardial blood flow，mbf
5207497|NCT02697760|myocardial flow reserve，MFR|myocardial flow reserve，mfr
5207498|NCT02697747|Ultrasound|ultrasound
5207499|NCT02697747|Palpation|palpation
5207500|NCT02697747|Analgesia|analgesia
5207501|NCT02697747|Epidural|epidural
5207510|NCT02697721|Caregivers|caregivers
5207511|NCT02697721|Behavioral symptoms|behavioral symptoms
5207512|NCT02697721|Dementia|dementia
5207513|NCT02697721|Alzheimer disease|alzheimer disease
5207514|NCT02697721|Physical activity|physical activity
5207515|NCT02697721|Depressive symptoms|depressive symptoms
5207516|NCT02697721|Powerful Tools for Caregivers|powerful tools for caregivers
5862730|NCT00001534|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5207521|NCT02697669|myocardial perfusion|myocardial perfusion
5207522|NCT02697669|single-photon emission tomography|single-photon emission tomography
5207727|NCT02696629|Loop gain|loop gain
5207523|NCT02697643|clinical decision support|clinical decision support
5207524|NCT02697643|substance use|substance use
5207526|NCT02697630|Uveal melanoma|uveal melanoma
5207527|NCT02697591|Solid tumor|solid tumor
5207528|NCT02697591|adenocarcinoma of the endometrium|adenocarcinoma of the endometrium
5207529|NCT02697591|melanoma, non-small cell lung cancer (NSCLC)|melanoma, non-small cell lung cancer (nsclc)
5207530|NCT02697591|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5207531|NCT02697591|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
5207532|NCT02697565|childhood obesity|childhood obesity
5207533|NCT02697565|obesity|obesity
5207534|NCT02697565|prevention|prevention
5207535|NCT02697565|nutrition|nutrition
5207536|NCT02697565|health|health
5207537|NCT02697565|preschool|preschool
5207538|NCT02697565|childcare|childcare
5207539|NCT02697565|role model|role model
5207540|NCT02697565|pediatric obesity|pediatric obesity
5207541|NCT02697565|weight|weight
5207542|NCT02697565|overweight|overweight
5207543|NCT02697565|early childhood|early childhood
5962579|NCT04280159|Head and Neck|head and neck
5207544|NCT02697565|train the trainer|train the trainer
5207545|NCT02697526|radial artery|radial artery
5207546|NCT02697526|occlusion|occlusion
5293433|NCT02208466|TMS|tms
5207547|NCT02697526|functional|functional
5207548|NCT02697526|complications|complications
5207549|NCT02697526|consequences|consequences
5207550|NCT02697487|Depression|depression
5207551|NCT02697487|Cohort|cohort
5207552|NCT02697474|Hepatitis B|hepatitis b
5207553|NCT02697474|DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine|dtap-ipv-hep b-prp-t hexavalent vaccine
5207554|NCT02697474|Euvax-B®|euvax-b®
5207555|NCT02697474|Hexaxim®|hexaxim®
5195580|NCT02771795|Breast|breast
5195581|NCT02771795|Positive|positive
5195583|NCT02771782|TDaP-IPV|tdap-ipv
5195584|NCT02771782|DPT Vaccine|dpt vaccine
5195585|NCT02771769|cell-free DNA|cell-free dna
5195605|NCT02771626|RCC|rcc
5207556|NCT02697474|Infanrix® hexa|infanrix® hexa
5207557|NCT02697435|Chronic Low Back Pain|chronic low back pain
5207558|NCT02697435|Aged|aged
5207559|NCT02697435|Elderly|elderly
5207560|NCT02697435|Primary Care|primary care
5207561|NCT02697435|Assessment|assessment
5207562|NCT02697435|Lumbar|lumbar
5207563|NCT02697435|Spinal Stenosis|spinal stenosis
5207564|NCT02697435|Hip Osteoarthritis|hip osteoarthritis
5207565|NCT02697435|Myofascial Pain Syndrome|myofascial pain syndrome
5207566|NCT02697435|Fibromyalgia|fibromyalgia
5207567|NCT02697435|Depression|depression
5207568|NCT02697435|Maladaptive Coping|maladaptive coping
5207569|NCT02697435|Lumbar Spinal Stenosis|lumbar spinal stenosis
5207570|NCT02697435|Insomnia|insomnia
5207571|NCT02697435|Sacroiliac Joint Pain|sacroiliac joint pain
5207572|NCT02697435|Lateral Hip and Thigh Pain|lateral hip and thigh pain
5207573|NCT02697435|Anxiety|anxiety
5207574|NCT02697435|Dementia|dementia
5207575|NCT02697435|Recent Leg Length Discrepancy|recent leg length discrepancy
5207576|NCT02697422|Smoking (tobacco use)|smoking (tobacco use)
5207577|NCT02697422|Peer health coach|peer health coach
5207578|NCT02697422|Systolic blood pressure|systolic blood pressure
5207579|NCT02697422|Framingham Cardiovascular risk score|framingham cardiovascular risk score
5207580|NCT02697422|Lipid|lipid
5207581|NCT02697422|Health related quality of life|health related quality of life
5207582|NCT02697422|Health care utilization|health care utilization
5207583|NCT02697422|Medication adherence|medication adherence
5207584|NCT02697422|Physical activity|physical activity
5207585|NCT02697422|Nutrition|nutrition
5207586|NCT02697422|Alcohol use|alcohol use
5207587|NCT02697422|Stress management|stress management
5207588|NCT02697396|Social Marketing Campaign|social marketing campaign
5207589|NCT02697396|Mexican American Children|mexican american children
5207590|NCT02697396|16-069|16-069
5207591|NCT02697383|Ixazomib (MLN9708)|ixazomib (mln9708)
5207592|NCT02697383|Dexamethasone|dexamethasone
5207593|NCT02697383|15-294|15-294
5207594|NCT02697370|Haemophilia A prophylaxis pharmacokinetic dosing|haemophilia a prophylaxis pharmacokinetic dosing
5207595|NCT02697357|Emotion Regulation Therapy|emotion regulation therapy
5207596|NCT02697357|Distress Among Caregivers|distress among caregivers
5207597|NCT02697357|15-219|15-219
5207598|NCT02697331|Short cervix, twins, progesterone|short cervix, twins, progesterone
5207599|NCT02697305|Insulin response|insulin response
5207600|NCT02697305|Incretin effect|incretin effect
5207601|NCT02697305|GLP-1|glp-1
5207602|NCT02697305|GIP|gip
5207603|NCT02697305|Valine|valine
5207604|NCT02697305|Leucine|leucine
5204292|NCT02717884|AML|aml
5207612|NCT02697279|Loop|loop
5207613|NCT02697279|Drainage|drainage
5207614|NCT02697253|Roux-en-Y Bariatric Surgery|roux-en-y bariatric surgery
5207615|NCT02697253|Psychosocial Variables|psychosocial variables
5207616|NCT02697253|Behavioral Variables|behavioral variables
5207617|NCT02697253|Weight Loss|weight loss
5207618|NCT02697253|Food Intake|food intake
5207619|NCT02697253|GLP-1|glp-1
5207620|NCT02697253|Reinforcing Value of Food|reinforcing value of food
5207621|NCT02697253|Exendin 9-39|exendin 9-39
5207622|NCT02697240|sickle cell disease|sickle cell disease
5207623|NCT02697240|citrulline|citrulline
5207624|NCT02697214|commercial heart rate monitors|commercial heart rate monitors
5207625|NCT02697214|accuracy|accuracy
5207627|NCT02697214|varying degrees of exertion|varying degrees of exertion
5207628|NCT02697201|Mitochondrial Dynamics|mitochondrial dynamics
5207629|NCT02697201|Insulin Resistance|insulin resistance
5207630|NCT02697188|testosterone|testosterone
5207631|NCT02697188|male hypogonadism|male hypogonadism
5207632|NCT02697188|low testosterone|low testosterone
5207633|NCT02697175|live video-colposcopy|live video-colposcopy
5207634|NCT02697175|cervical dysplasia|cervical dysplasia
5207635|NCT02697175|anxiety|anxiety
5207636|NCT02697175|randomized controlled trial|randomized controlled trial
5207637|NCT02697175|colposcopy|colposcopy
5207638|NCT02697162|Intermittent catheterisation|intermittent catheterisation
5207639|NCT02697162|Antiseptic|antiseptic
5207640|NCT02697162|Octenidine chloride|octenidine chloride
5207641|NCT02697162|Children|children
5207642|NCT02697149|ERCP|ercp
5207643|NCT02697149|nonradiation-to-endoscopist|nonradiation-to-endoscopist
5207644|NCT02697149|gallstones|gallstones
5207645|NCT02697136|Low HDL|low hdl
5293470|NCT02208206|HIV|hiv
5084798|NCT03468842|caries|caries
5207646|NCT02697136|Low apoA-I|low apoa-i
5207647|NCT02697136|ABCA-1 mutations|abca-1 mutations
5207648|NCT02697136|ApoA-I mutations|apoa-i mutations
5207649|NCT02697123|Venous Thrombosis|venous thrombosis
5207650|NCT02697123|Pregnancy|pregnancy
5207651|NCT02697123|postpartum|postpartum
5207652|NCT02697123|antepartum|antepartum
5207653|NCT02697110|Cognition|cognition
5207654|NCT02697110|Brain Stimulation|brain stimulation
5207655|NCT02697110|Early Child Development|early child development
5207656|NCT02697097|Hip Muscle Strength|hip muscle strength
5207658|NCT02697071|Ketamine|ketamine
5207659|NCT02697071|Migraine|migraine
5207660|NCT02697071|Headache|headache
5207661|NCT02697071|Emergency Department|emergency department
5207662|NCT02697045|Schizophrenia|schizophrenia
5207663|NCT02697045|Quality of Life|quality of life
5207664|NCT02697045|Functionality|functionality
5207665|NCT02697045|Long Acting Injectable|long acting injectable
5207666|NCT02697045|Aripiprazole|aripiprazole
5207667|NCT02697045|Naturalistic|naturalistic
5207668|NCT02697045|Open-label|open-label
5207669|NCT02697045|Single Arm|single arm
5207670|NCT02697045|Uncontrolled Study|uncontrolled study
5207671|NCT02697032|FDHT|fdht
5207672|NCT02697032|PET|pet
5207673|NCT02697032|Breast cancer|breast cancer
5207674|NCT02697032|Bicalutamide|bicalutamide
5207675|NCT02697019|Nonsuicidal Self-Injury (NSSI), Deliberate Self-Harm (DSH), Self-harm, Self-injury|nonsuicidal self-injury (nssi), deliberate self-harm (dsh), self-harm, self-injury
5207676|NCT02696980|obesity|obesity
5207677|NCT02696980|asthma|asthma
5207678|NCT02696967|Apelin|apelin
5207679|NCT02696967|CLR325|clr325
5207680|NCT02696967|Chronic heart failure|chronic heart failure
5207681|NCT02696954|Artemether-lumefantrine|artemether-lumefantrine
5207682|NCT02696954|Amodiaquine|amodiaquine
5207683|NCT02696954|Primaquine|primaquine
5207684|NCT02696902|Pseudomonas aeruginosa, Pneumonia|pseudomonas aeruginosa, pneumonia
5207685|NCT02696889|Infertility|infertility
5207686|NCT02696889|Premature Ovarian Failure|premature ovarian failure
5207687|NCT02696889|Stem Cells|stem cells
5207688|NCT02696889|Amenorrhea|amenorrhea
5207689|NCT02696889|Low Ovarian Reserve|low ovarian reserve
5207690|NCT02696889|Ovarian Insufficiency|ovarian insufficiency
5207691|NCT02696889|Premature menopause|premature menopause
5207692|NCT02696889|Premature Ovarian Insufficiency|premature ovarian insufficiency
5207693|NCT02696876|Cartilage|cartilage
5207694|NCT02696876|Mesenchymal stromal cell|mesenchymal stromal cell
5207695|NCT02696876|Microfracture|microfracture
5207696|NCT02696876|Knee|knee
5207697|NCT02696876|Defect|defect
5207698|NCT02696876|Injury|injury
5207699|NCT02696876|Stem cell|stem cell
5207700|NCT02696876|Autologous|autologous
5207701|NCT02696876|Minimally manipulated|minimally manipulated
5207703|NCT02696850|rhinosinusitis|rhinosinusitis
5207704|NCT02696850|rhinitis|rhinitis
5207705|NCT02696850|nasal lavage|nasal lavage
5207706|NCT02696811|cancer|cancer
5207707|NCT02696811|inflammation|inflammation
5207708|NCT02696811|dietary intervention trial|dietary intervention trial
5207709|NCT02696798|Ankylosing Spondylitis|ankylosing spondylitis
5207710|NCT02696785|Ankylosing Spondylitis|ankylosing spondylitis
5207711|NCT02696759|Breast|breast
5207713|NCT02696733|TURBT|turbt
5207714|NCT02696733|ultrasound guided|ultrasound guided
5207715|NCT02696733|ONB|onb
5207716|NCT02696733|interadductor approach|interadductor approach
5207717|NCT02696720|lidocaine|lidocaine
5207718|NCT02696720|phantom limb pain (PLP)|phantom limb pain (plp)
5207719|NCT02696720|Primary/secondary scar hyperalgesia|primary/secondary scar hyperalgesia
5207720|NCT02696707|cardiac toxicities|cardiac toxicities
5207721|NCT02696668|multisensory exercises|multisensory exercises
5207722|NCT02696668|group-based balance exercise programme|group-based balance exercise programme
5207723|NCT02696655|transplantation|transplantation
5207724|NCT02696642|mesothelin-expressing advanced solid cancers|mesothelin-expressing advanced solid cancers
5207725|NCT02696629|Ventilatory control|ventilatory control
5207726|NCT02696629|Obstructive sleep apnea|obstructive sleep apnea
5207728|NCT02696629|Upper airway|upper airway
5207729|NCT02696629|Surgery|surgery
5207730|NCT02696603|Health app research|health app research
5207731|NCT02696603|mHealth research|mhealth research
5207732|NCT02696603|Mobile health research|mobile health research
5207733|NCT02696603|Mobile application health research|mobile application health research
5207734|NCT02696564|COPD|copd
5207735|NCT02696564|emphysema|emphysema
5207736|NCT02696564|HRCT|hrct
5207737|NCT02696564|losartan|losartan
5207738|NCT02696551|Medical education|medical education
5207739|NCT02696551|Spondyloarthritis|spondyloarthritis
5207740|NCT02696551|Physician action|physician action
5207741|NCT02696538|Fall risk|fall risk
5207742|NCT02696538|Rehabiliation|rehabiliation
5207743|NCT02696538|Physical Therapy|physical therapy
5962580|NCT04280159|SCC|scc
5207744|NCT02696538|Functional Gait Assessment|functional gait assessment
5207745|NCT02696538|mini-Balance Evaluation Systems Test|mini-balance evaluation systems test
5207746|NCT02696538|Berg Balance Scale|berg balance scale
5207748|NCT02696538|Validity|validity
5962581|NCT04280159|PET/CT|pet/ct
5207749|NCT02696538|Inter-rater reliability|inter-rater reliability
5207750|NCT02696538|Montreal Cognitive Assessment|montreal cognitive assessment
5207751|NCT02696525|Circulating Tumor DNA|circulating tumor dna
5207752|NCT02696525|Lung cancer|lung cancer
5207753|NCT02696525|lead time|lead time
5207754|NCT02696512|Severe Disorders of Consciousness (SDOC)|severe disorders of consciousness (sdoc)
5207755|NCT02696512|Coma|coma
5207756|NCT02696512|Vegetative State|vegetative state
5207757|NCT02696512|Minimally Conscious State|minimally conscious state
5207758|NCT02696499|Uremic pruritus|uremic pruritus
5207759|NCT02696499|Pruritus|pruritus
5207760|NCT02696499|Chronic itch|chronic itch
5207762|NCT02696499|Hemodialysis|hemodialysis
5207763|NCT02696499|End-stage renal disease|end-stage renal disease
5207764|NCT02696473|Bioavailability|bioavailability
5207765|NCT02696473|Polyacetylenes|polyacetylenes
5207766|NCT02696473|Falcarinol|falcarinol
5207767|NCT02696473|Falcarindiol|falcarindiol
5207768|NCT02696473|Falcarindiol-3-acetate|falcarindiol-3-acetate
5207769|NCT02696473|Carrot|carrot
5207770|NCT02696473|Biological Availability|biological availability
5207771|NCT02696460|debridement|debridement
5207772|NCT02696460|analgesia|analgesia
5207773|NCT02696447|Radiation therapy|radiation therapy
5207774|NCT02696447|Thrombosis|thrombosis
5207775|NCT02696434|naltrexone|naltrexone
5207776|NCT02696434|VIVITROL|vivitrol
5207777|NCT02696434|buprenorphine|buprenorphine
5207778|NCT02696434|opioid|opioid
5207779|NCT02696434|addiction|addiction
5207780|NCT02696408|Mucositis|mucositis
5207781|NCT02696408|Low level laser therapy|low level laser therapy
5207782|NCT02696408|Autograft|autograft
5207783|NCT02696408|Allograft|allograft
5207784|NCT02696382|Veterans|veterans
5207785|NCT02696382|Progressive High Intensity Physical Therapy|progressive high intensity physical therapy
5207786|NCT02696382|Gait Speed|gait speed
5207787|NCT02696382|Acute Hospitalization|acute hospitalization
5207788|NCT02696382|Hospital Associated Deconditioning|hospital associated deconditioning
5207789|NCT02696356|HLA-A*02|hla-a*02
5207790|NCT02696343|somatosensory stimulation|somatosensory stimulation
5207791|NCT02696343|orocutaneous|orocutaneous
5207792|NCT02696343|gene expression|gene expression
5207793|NCT02696291|Dengue|dengue
5207794|NCT02696291|Arbovirus Infections|arbovirus infections
5207795|NCT02696291|Flaviviridae Infections|flaviviridae infections
5207796|NCT02696291|Flavivirus Infections|flavivirus infections
5207797|NCT02696291|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
5207798|NCT02696291|RNA Virus Infections|rna virus infections
5207799|NCT02696291|Virus Diseases|virus diseases
5207800|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions
5207801|NCT02696291|Pharmacologic Actions|pharmacologic actions
5207802|NCT02696291|Therapeutic Uses|therapeutic uses
5207804|NCT02696278|obesity|obesity
5207805|NCT02696278|toddlers|toddlers
5207806|NCT02696278|fiber|fiber
5207807|NCT02696278|unsaturated fats|unsaturated fats
5207808|NCT02696265|Atrial Fibrillation|atrial fibrillation
5207809|NCT02696265|Complex Fractionated Atrial Electrocardiograms|complex fractionated atrial electrocardiograms
5207810|NCT02696265|Pulmonary Vein Isolation|pulmonary vein isolation
5207811|NCT02696265|Ablation|ablation
5207812|NCT02696265|CFAE/spatiotemporal dispersion guided ablation|cfae/spatiotemporal dispersion guided ablation
5207813|NCT02696252|Endocrine System Diseases|endocrine system diseases
5207814|NCT02696252|Glucose Metabolism Disorders|glucose metabolism disorders
5207815|NCT02696252|Metabolic Diseases|metabolic diseases
5207816|NCT02696239|vaginal cuff closure|vaginal cuff closure
5207817|NCT02696239|Robotic Hysterectomy|robotic hysterectomy
5207818|NCT02696200|Concussion|concussion
5207819|NCT02696187|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5207820|NCT02696187|Feasibility|feasibility
5207821|NCT02696187|Health promotion tool|health promotion tool
5207822|NCT02696187|Self management|self management
5207823|NCT02696187|Evidence based care|evidence based care
5207824|NCT02696187|Knowledge transfer|knowledge transfer
5207825|NCT02696187|Implementation|implementation
5207826|NCT02696161|platelet rich plasma|platelet rich plasma
5207827|NCT02696161|Perineural injection therapy|perineural injection therapy
5207828|NCT02696135|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5207829|NCT02696135|clinical outcomes|clinical outcomes
5207830|NCT02696135|multi-omics|multi-omics
5207831|NCT02696135|risk stratification|risk stratification
5207832|NCT02696122|Pain, postoperative|pain, postoperative
5207833|NCT02696122|Hernia, abdominal|hernia, abdominal
5207834|NCT02696122|Anesthesia, spinal|anesthesia, spinal
5207835|NCT02696122|Anesthesia, local|anesthesia, local
5207836|NCT02696122|Anesthesia, general|anesthesia, general
5207837|NCT02696122|Quality of life|quality of life
5207838|NCT02696122|Anesthesia recovery period|anesthesia recovery period
5207839|NCT02696122|Personal satisfaction|personal satisfaction
5207840|NCT02696122|Postoperative complications|postoperative complications
5207841|NCT02696122|Quality of recovery|quality of recovery
5195876|NCT02769975|Obesity|obesity
5195877|NCT02769975|Pediatric|pediatric
5195878|NCT02769975|Growth Disorder|growth disorder
5962582|NCT04280159|Staging|staging
5195879|NCT02769975|Pubertal Development|pubertal development
5195890|NCT02769936|Receptors|receptors
5195891|NCT02769936|N-Methyl-D-Aspartate|n-methyl-d-aspartate
5195892|NCT02769923|WestPharma ID-adapter|westpharma id-adapter
5195893|NCT02769923|Star ID syringe|star id syringe
5195894|NCT02769923|BCG needle syringe|bcg needle syringe
5195895|NCT02769923|fractional dose IPV|fractional dose ipv
5195896|NCT02769923|fIPV|fipv
5195897|NCT02769923|polio|polio
5195898|NCT02769923|Polio Endgame|polio endgame
5195899|NCT02769923|IPV|ipv
5195900|NCT02769884|artificial pancreas|artificial pancreas
5207848|NCT02696070|Pulsed Electromagnetic Energy Field|pulsed electromagnetic energy field
5207850|NCT02696070|PPDN|ppdn
5207851|NCT02696044|Gastrointestinal Disorders|gastrointestinal disorders
5207852|NCT02696031|non-radiographic spondyloarthritis|non-radiographic spondyloarthritis
5207853|NCT02696031|axial spondyloarthritis|axial spondyloarthritis
5207854|NCT02696031|Ankylosing Spondylitis|ankylosing spondylitis
5207855|NCT02696018|Diaphragm|diaphragm
5207856|NCT02696018|Ultrasound|ultrasound
5207857|NCT02696018|Critically ill patients|critically ill patients
5207858|NCT02695992|Rate control in atrial fibrillation|rate control in atrial fibrillation
5207859|NCT02695992|Beta blockers|beta blockers
5207860|NCT02695992|Calcium channel blockers|calcium channel blockers
5207861|NCT02695992|Permanent atrial fibrillation|permanent atrial fibrillation
5207862|NCT02695992|Management of atrial fibrillation|management of atrial fibrillation
5207863|NCT02695992|Atrial fibrillation and biomarkers|atrial fibrillation and biomarkers
5207864|NCT02695992|Arrhythmias, cardiac|arrhythmias, cardiac
5207865|NCT02695992|Heart Diseases|heart diseases
5207866|NCT02695992|Pathological processes|pathological processes
5207867|NCT02695992|Diltiazem|diltiazem
5207868|NCT02695992|Metoprolol|metoprolol
5207869|NCT02695992|Adrenergic Agents|adrenergic agents
5207870|NCT02695992|Adrenergic Antagonists|adrenergic antagonists
5207871|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
5207872|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5207873|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents
5207874|NCT02695992|Antihypertensive Agents|antihypertensive agents
5207875|NCT02695992|Autonomic Agents|autonomic agents
5207876|NCT02695992|Cardiovascular Agents|cardiovascular agents
5207877|NCT02695992|Membrane Transport Modulators|membrane transport modulators
5207878|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5207879|NCT02695992|Neurotransmitter Agents|neurotransmitter agents
5207880|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents
5207881|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs
5207882|NCT02695992|Sympatholytics|sympatholytics
5207883|NCT02695992|Therapeutic Uses|therapeutic uses
5207884|NCT02695992|Vasodilator Agents|vasodilator agents
5207885|NCT02695992|Troponins|troponins
5207903|NCT02695836|Organizational Context|organizational context
5207904|NCT02695836|Quality Improvement|quality improvement
5207905|NCT02695836|Care Aides|care aides
5207906|NCT02695836|Leadership|leadership
5207907|NCT02695836|Resident Assessment Instrument (RAI)|resident assessment instrument (rai)
5207908|NCT02695836|Alberta Context Tool (ACT)|alberta context tool (act)
5207909|NCT02695823|intracranial hypertension|intracranial hypertension
5207910|NCT02695823|liver transplantation|liver transplantation
5207911|NCT02695823|transcranial Doppler|transcranial doppler
5207912|NCT02695823|optic nerve sheath diameter|optic nerve sheath diameter
5278541|NCT02283060|HIV|hiv
5195978|NCT02769325|pain, postoperative|pain, postoperative
5195979|NCT02769312|Quality of Life|quality of life
5195980|NCT02769312|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5195991|NCT02769247|IUD|iud
5207913|NCT02695797|Intractable cryptogenic epilepsy with autoimmune antibody|intractable cryptogenic epilepsy with autoimmune antibody
5207915|NCT02695771|bladder tumors|bladder tumors
5207916|NCT02695771|urinary tumors|urinary tumors
5207917|NCT02695771|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
5207918|NCT02695771|NMIBC|nmibc
5207919|NCT02695732|Esophageal and Gastric Varices|esophageal and gastric varices
5207920|NCT02695732|Primary Prophylaxis|primary prophylaxis
5207921|NCT02695732|Carvedilol|carvedilol
5207922|NCT02695732|Endoscopy|endoscopy
5207923|NCT02695719|Drug therapy|drug therapy
5207924|NCT02695706|Diabetes|diabetes
5207925|NCT02695706|Skin acceptability|skin acceptability
5207926|NCT02695706|Clinical Research|clinical research
5207927|NCT02695680|Lung Cancer|lung cancer
5207928|NCT02695680|SBRT|sbrt
5207929|NCT02695680|Motion Management|motion management
5207930|NCT02695641|Arteriovenous Fistula|arteriovenous fistula
5207931|NCT02695641|Arteriovenous Graft|arteriovenous graft
5207932|NCT02695641|Bevacizumab|bevacizumab
5207933|NCT02695641|Hemodialysis|hemodialysis
5207934|NCT02695641|VEGF|vegf
5207937|NCT02695615|Spielberger State Trait Anxiety Inventory|spielberger state trait anxiety inventory
5207939|NCT02695563|Amniocentesis|amniocentesis
5207940|NCT02695524|Rehabilitation|rehabilitation
5207941|NCT02695524|Shoulder|shoulder
5207942|NCT02695498|migraine with aura|migraine with aura
5207943|NCT02695498|migraine without aura|migraine without aura
5207945|NCT02695498|controls|controls
5740473|NCT00356317|Therapy|therapy
5207946|NCT02695498|mind-body|mind-body
5207947|NCT02695485|dorsal digital island flap|dorsal digital island flap
5207948|NCT02695485|sensory reconstruction|sensory reconstruction
5207949|NCT02695472|Depression|depression
5207950|NCT02695472|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5207951|NCT02695472|Major Depressive Disorder|major depressive disorder
5207952|NCT02695472|Neurogenesis|neurogenesis
5207953|NCT02695472|Synaptogenesis|synaptogenesis
5207954|NCT02695472|NSI-189|nsi-189
5207955|NCT02695472|Neuralstem|neuralstem
5207956|NCT02695433|Pre-diabetes|pre-diabetes
5207957|NCT02695433|Metabolic syndrome|metabolic syndrome
5207958|NCT02695433|Matsuda composite index of insulin sensitivity (MISI)|matsuda composite index of insulin sensitivity (misi)
5207959|NCT02695433|Blood glucose|blood glucose
5207960|NCT02695433|Insulin response|insulin response
5207961|NCT02695433|HbA1c|hba1c
5207962|NCT02695433|Lipid|lipid
5207963|NCT02695433|Inflammation|inflammation
5207964|NCT02695420|Heart Failure|heart failure
5207965|NCT02695407|artery cannulation|artery cannulation
5204700|NCT02715336|IVF|ivf
5207976|NCT02695316|Maternal Health Services|maternal health services
5207977|NCT02695316|Health Services Needs and Demand|health services needs and demand
5207978|NCT02695316|Access to Health Care|access to health care
5207979|NCT02695316|Professional-Patient Relations|professional-patient relations
5207980|NCT02695316|Eritrea|eritrea
5207981|NCT02695316|Kosovo|kosovo
5207982|NCT02695316|Switzerland|switzerland
5207983|NCT02695277|Atrial Fibrillation|atrial fibrillation
5207984|NCT02695277|Persistent and Longstanding Persistent AF|persistent and longstanding persistent af
5207985|NCT02695277|Hybrid Procedure|hybrid procedure
5207986|NCT02695277|Catheter Ablation|catheter ablation
5207987|NCT02695264|intracranial pressure|intracranial pressure
5207988|NCT02695264|intracranial hypertension|intracranial hypertension
5207989|NCT02695264|severe traumatic brain injury|severe traumatic brain injury
5207990|NCT02695199|Doppler Ultrasound|doppler ultrasound
5207991|NCT02695199|Laparoscopic|laparoscopic
5207992|NCT02695199|Microscopic Subinguinal Varicocelectomy|microscopic subinguinal varicocelectomy
5207993|NCT02695186|Intestinal metaplasia|intestinal metaplasia
5207994|NCT02695186|Metabolic syndrome|metabolic syndrome
5207995|NCT02695186|Oxidative stress|oxidative stress
5207996|NCT02695108|Scapula|scapula
5207997|NCT02695108|Neck|neck
5207998|NCT02695108|Pain|pain
5207999|NCT02695108|Therapy|therapy
5208000|NCT02695108|Kinematic|kinematic
5208001|NCT02695069|Complete Placenta Previa|complete placenta previa
5208002|NCT02695069|Random Placenta Margin Incision|random placenta margin incision
5208003|NCT02695069|Cesarean Section|cesarean section
5208004|NCT02695069|Hemorrhage|hemorrhage
5208005|NCT02694991|surgery|surgery
5208006|NCT02694991|outcome|outcome
5208007|NCT02694991|pain|pain
5208008|NCT02694991|osteopathic manipulative treatment|osteopathic manipulative treatment
5196076|NCT02768727|neural inertia|neural inertia
5196077|NCT02768727|xenon gas|xenon gas
5196081|NCT02768688|Human Brain|human brain
5208009|NCT02694978|iron deficiency anemia|iron deficiency anemia
5208010|NCT02694978|IDA|ida
5208011|NCT02694978|ferumoxytol|ferumoxytol
5208012|NCT02694978|ferric carboxymaltose|ferric carboxymaltose
5208013|NCT02694978|FCM|fcm
5208014|NCT02694978|Injectafer|injectafer
5208015|NCT02694978|Feraheme|feraheme
5208016|NCT02694978|Ferinject|ferinject
5208017|NCT02694926|adrenal crisis|adrenal crisis
5208018|NCT02694926|education programme|education programme
5208019|NCT02694887|Capillary blood|capillary blood
5208020|NCT02694887|Venous blood|venous blood
5208021|NCT02694887|Lactate|lactate
5208022|NCT02694887|Emergency Department|emergency department
5208023|NCT02694874|Adjunctive treatment|adjunctive treatment
5208024|NCT02694874|Severe malaria|severe malaria
5208025|NCT02694861|Angina Pectoris|angina pectoris
5208026|NCT02694861|Angina, Stable|angina, stable
5208027|NCT02694861|Chest Pain|chest pain
5208028|NCT02694796|Web and smartphone-based physical activity program|web and smartphone-based physical activity program
5208029|NCT02694796|Connected devices|connected devices
5208030|NCT02694796|Balneotherapy|balneotherapy
5208031|NCT02694783|HLA Matched|hla matched
5208032|NCT02694783|JCV|jcv
5208033|NCT02694783|Donor|donor
5208034|NCT02694783|PyVST|pyvst
5208035|NCT02694783|PML|pml
5208036|NCT02694770|aGvHD|agvhd
5208037|NCT02694770|GvHD|gvhd
5208038|NCT02694770|sr-aGvHD|sr-agvhd
5962583|NCT04280133|Hematologic Malignancy|hematologic malignancy
5208039|NCT02694770|biologics|biologics
5208040|NCT02694770|monoclonal antibody|monoclonal antibody
5208041|NCT02694757|Ostom-i|ostom-i
5208042|NCT02694757|OIA device|oia device
5208043|NCT02694744|Treatment of Hyperkalemia|treatment of hyperkalemia
5208044|NCT02694744|Hyperkalemia|hyperkalemia
5208045|NCT02694744|Potassium|potassium
5208046|NCT02694744|Chronic Kidney Disease|chronic kidney disease
5208047|NCT02694731|Craving|craving
5208048|NCT02694731|Mobile Apps|mobile apps
5208049|NCT02694705|Oxygen Inhalation Therapy|oxygen inhalation therapy
5208050|NCT02694705|Intubation|intubation
5208051|NCT02694705|Emergency Medicine|emergency medicine
5208052|NCT02694679|social networks, maternal and child health, global health|social networks, maternal and child health, global health
5208053|NCT02694653|C/section, Acetaminophen|c/section, acetaminophen
5208054|NCT02694640|Breast cancer|breast cancer
5208055|NCT02694640|Exercise|exercise
5208056|NCT02694640|Physical activity|physical activity
5208057|NCT02694640|Community volunteers|community volunteers
5208058|NCT02694640|Peer mentors|peer mentors
5208059|NCT02694640|Peer coaches|peer coaches
5208060|NCT02694640|Social support|social support
5208061|NCT02694640|Exercise maintenance|exercise maintenance
5208064|NCT02694614|individualised dietary coaching|individualised dietary coaching
5208065|NCT02694614|smartphone-assisted dietary coaching|smartphone-assisted dietary coaching
5208066|NCT02694614|health behavior change|health behavior change
5208067|NCT02694601|Ketones|ketones
5208068|NCT02694601|Glucose|glucose
5208069|NCT02694601|Caffeine|caffeine
5208070|NCT02694588|Vedolizumab|vedolizumab
5208071|NCT02694588|Infliximab|infliximab
5208072|NCT02694562|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
5208073|NCT02694549|Vascular Closure Devices|vascular closure devices
5208074|NCT02694549|Catheterization Closure Devices|catheterization closure devices
5208075|NCT02694549|Vascular Access Devices|vascular access devices
5208076|NCT02694523|Psoriasis|psoriasis
5208077|NCT02694523|Skin Diseases|skin diseases
5208078|NCT02694523|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
5208079|NCT02694523|Adalimumab|adalimumab
5208080|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents
5208081|NCT02694523|ABBV-066|abbv-066
5208082|NCT02694523|BI 655066|bi 655066
5208083|NCT02694523|Risankizumab|risankizumab
5208084|NCT02694510|Preterm infants|preterm infants
5208085|NCT02694510|Oxidative stress|oxidative stress
5208086|NCT02694510|Parenteral nutrition|parenteral nutrition
5208087|NCT02694497|transmission|transmission
5208088|NCT02694497|women|women
5208089|NCT02694497|genital|genital
5208090|NCT02694497|anorectal|anorectal
5208091|NCT02694484|Cytomegalovirus|cytomegalovirus
5208092|NCT02694484|Stool sample|stool sample
5208093|NCT02694484|Healthy Volunteers|healthy volunteers
5208094|NCT02694484|Fecal microbiota transplant|fecal microbiota transplant
5208095|NCT02694471|Ageing|ageing
5208096|NCT02694471|Physical inactivity|physical inactivity
5208097|NCT02694471|Functional decline|functional decline
5208098|NCT02694471|Reconditioning|reconditioning
5208099|NCT02694458|Vancomycin|vancomycin
5208100|NCT02694458|Children|children
5208101|NCT02694458|Infection|infection
5208102|NCT02694458|Antibiotic|antibiotic
5208103|NCT02694458|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5278818|NCT02281630|CC|cc
5196170|NCT02768155|OA, Osteoarthritis, Knee|oa, osteoarthritis, knee
5196171|NCT02768116|Active Transfer of Plaque|active transfer of plaque
5196172|NCT02768103|upper extremity|upper extremity
5196173|NCT02768103|spinal cord injury|spinal cord injury
5196174|NCT02768103|surgical reconstruction|surgical reconstruction
5196175|NCT02768103|MRI, functional|mri, functional
5196177|NCT02768077|melatonin|melatonin
5208104|NCT02694458|Population-based pharmacokinetic modeling|population-based pharmacokinetic modeling
5208105|NCT02694458|Pharmacokinetics|pharmacokinetics
5208106|NCT02694458|Pharmacodynamics|pharmacodynamics
5208107|NCT02694458|Bayesian approach|bayesian approach
5208108|NCT02694458|Therapeutic drug monitoring|therapeutic drug monitoring
5208109|NCT02694432|high blood pressure, systolic, diastolic|high blood pressure, systolic, diastolic
5208110|NCT02694432|complementary therapies, meditation|complementary therapies, meditation
5208111|NCT02694419|endometrium|endometrium
5208112|NCT02694406|Diagnosis|diagnosis
5208113|NCT02694367|genetic basis|genetic basis
5208114|NCT02694341|Management|management
5208115|NCT02694328|Alkermes|alkermes
5208116|NCT02694328|ALKS 3831|alks 3831
5208117|NCT02694328|Samidorphan|samidorphan
5208118|NCT02694328|Schizophrenia|schizophrenia
5208119|NCT02694328|Olanzapine|olanzapine
5208120|NCT02694328|Weight|weight
5208121|NCT02694302|Stroke|stroke
5208122|NCT02694250|cervical|cervical
5208123|NCT02694250|fusion|fusion
5208124|NCT02694250|radiculopathy|radiculopathy
5208125|NCT02694250|DTRAX|dtrax
5208126|NCT02694224|breast cancer|breast cancer
5208127|NCT02694224|triple negative|triple negative
5208128|NCT02694224|neoadjuvant|neoadjuvant
5208129|NCT02694211|work related stress|work related stress
5208130|NCT02694185|Medication Adherence|medication adherence
5208131|NCT02694185|Randomized Controlled Trial|randomized controlled trial
5208132|NCT02694185|Veterans|veterans
5208133|NCT02694172|diabetes mellitus type 2|diabetes mellitus type 2
5208140|NCT02694146|WOMAC|womac
5208141|NCT02694133|telerehabilitation|telerehabilitation
5208142|NCT02694133|aphasia|aphasia
5208143|NCT02694133|speech therapy|speech therapy
5208144|NCT02694133|rehabilitation device|rehabilitation device
5208145|NCT02694133|visual action therapy|visual action therapy
5208146|NCT02694133|naming drills|naming drills
5208147|NCT02694094|cholesterol|cholesterol
5208148|NCT02694094|seizure|seizure
5208149|NCT02694094|epilepsy|epilepsy
5208150|NCT02694094|ketogenic|ketogenic
5076233|NCT03522454|Frailty|frailty
5208151|NCT02694094|diet|diet
5208152|NCT02694081|reflux|reflux
5208153|NCT02694081|residue|residue
5208154|NCT02694081|Gastric stasis|gastric stasis
5208155|NCT02694081|Emptying time|emptying time
5208156|NCT02694068|Peritoneal Dialysis|peritoneal dialysis
5289923|NCT02224560|CBD|cbd
5208166|NCT02694055|Access to Health Care|access to health care
5208167|NCT02694042|Pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
5208168|NCT02694042|Crohn's disease|crohn's disease
5208169|NCT02694042|Ulcerative colitis|ulcerative colitis
5208170|NCT02694042|Web-based teaching and support|web-based teaching and support
5208171|NCT02694042|disease self-management|disease self-management
5208172|NCT02694042|peer support|peer support
5208173|NCT02694016|Remote ischemic preconditioning|remote ischemic preconditioning
5208174|NCT02694016|Neuroprotection|neuroprotection
5208175|NCT02694003|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5208176|NCT02694003|Fetal Alcohol Spectrum Disorder (FASD)|fetal alcohol spectrum disorder (fasd)
5208177|NCT02694003|Cerebral Palsy (CP)|cerebral palsy (cp)
5208178|NCT02694003|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
5208179|NCT02694003|Behavioural Insomnia|behavioural insomnia
5208180|NCT02694003|Neurodevelopmental Disorders|neurodevelopmental disorders
5208181|NCT02693990|Tumor lining the brain|tumor lining the brain
5208182|NCT02693990|Meningioma|meningioma
5208183|NCT02693990|Brain Tumor|brain tumor
5208185|NCT02693977|sleep apnea|sleep apnea
5208187|NCT02693977|adenotonsillectomy|adenotonsillectomy
5208188|NCT02693977|pediatric|pediatric
5208189|NCT02693964|Type 1 Diabetes|type 1 diabetes
5208190|NCT02693964|Menopause|menopause
5208191|NCT02693964|Cardiovascular Risk|cardiovascular risk
5208193|NCT02693951|gastric varices|gastric varices
5208194|NCT02693951|endoscopic injection of tissue adhesive|endoscopic injection of tissue adhesive
5208195|NCT02693938|diabetes|diabetes
5208196|NCT02693938|menstrual cycle|menstrual cycle
5208197|NCT02693938|insulin|insulin
5208198|NCT02693912|efferocytosis|efferocytosis
5208199|NCT02693912|macrophage|macrophage
5208200|NCT02693873|Osteoarthritis, Hip|osteoarthritis, hip
5208201|NCT02693873|Osteoarthritis, Knee|osteoarthritis, knee
5208202|NCT02693873|Patient Education|patient education
5208203|NCT02693873|Exercise, Neuromuscular|exercise, neuromuscular
5208204|NCT02693873|Disease Management|disease management
5208205|NCT02693873|Evidence-Based Health Care|evidence-based health care
5208206|NCT02693873|Pilot Study|pilot study
5208219|NCT02693821|Gabapentin|gabapentin
5208220|NCT02693821|prevention|prevention
5208221|NCT02693821|incidence|incidence
5208222|NCT02693808|Temporal hollowing|temporal hollowing
5208223|NCT02693808|Lateral orbital wall decompression|lateral orbital wall decompression
5208224|NCT02693808|Thyroid eye disease|thyroid eye disease
5208225|NCT02693795|myocardial infarction|myocardial infarction
5208226|NCT02693795|left ventricular remodeling|left ventricular remodeling
5208227|NCT02693782|Fibre|fibre
5208228|NCT02693782|Wheat Bran Extract|wheat bran extract
5208229|NCT02693782|Microbiota|microbiota
5208230|NCT02693782|Microbiota metabolites|microbiota metabolites
5857585|NCT00022854|Nerve block|nerve block
5208231|NCT02693782|Gastrointestinal tolerance|gastrointestinal tolerance
5208232|NCT02693743|suicidality|suicidality
5208233|NCT02693743|rTMS|rtms
5208234|NCT02693743|suicide ideation|suicide ideation
5208235|NCT02693730|Irritable Bowel Syndrome|irritable bowel syndrome
5208236|NCT02693730|IBS|ibs
5208237|NCT02693730|Ulcerative Colitis|ulcerative colitis
5208238|NCT02693730|UC|uc
5208239|NCT02693730|Inflammatory Bowel Disease|inflammatory bowel disease
5208240|NCT02693730|IBD|ibd
5208241|NCT02693730|Healthy Control|healthy control
5208242|NCT02693730|HC|hc
5208243|NCT02693730|Visceral Pain|visceral pain
5208244|NCT02693730|Gut|gut
5208245|NCT02693730|Neuroimaging|neuroimaging
5208246|NCT02693730|fMRI|fmri
5208247|NCT02693730|resting state|resting state
5208248|NCT02693730|structural MRI|structural mri
5208249|NCT02693730|functional MRI|functional mri
5208250|NCT02693730|diffusion tensor imaging|diffusion tensor imaging
5208251|NCT02693730|MR Spectroscopy|mr spectroscopy
5208252|NCT02693678|Proprioception|proprioception
5208253|NCT02693678|Doms|doms
5208254|NCT02693678|Pain|pain
5208255|NCT02693678|Massage|massage
5208256|NCT02693678|Diathermy|diathermy
5204981|NCT02713893|Antimycotic|antimycotic
5208262|NCT02693665|communication|communication
5208263|NCT02693665|decision making|decision making
5208264|NCT02693665|surrogate decision maker|surrogate decision maker
5208265|NCT02693665|health care proxy|health care proxy
5208266|NCT02693665|intervention|intervention
5208267|NCT02693665|randomized clinical trial|randomized clinical trial
5208268|NCT02693665|cancer|cancer
5208269|NCT02693665|quality of life|quality of life
5208270|NCT02693665|spiritual|spiritual
5208271|NCT02693665|religion|religion
5208272|NCT02693665|treatment congruence|treatment congruence
5208273|NCT02693665|treatment preferences|treatment preferences
5962584|NCT04280133|CAR-T cell therapy|car-t cell therapy
5208274|NCT02693665|FAmily CEntered (FACE) Advance Care Planning|family centered (face) advance care planning
5208275|NCT02693639|PANX1|panx1
5208276|NCT02693639|Infection|infection
5208277|NCT02693639|Liver transplantation|liver transplantation
5208278|NCT02693626|mobile phone-based text message interventions|mobile phone-based text message interventions
5208279|NCT02693626|'Happy Quit'|'happy quit'
5208280|NCT02693626|smoking cessation|smoking cessation
5208281|NCT02693613|Drug-drug interaction|drug-drug interaction
5208282|NCT02693613|Kremezin|kremezin
5208283|NCT02693613|Pharmacokinetics|pharmacokinetics
5208284|NCT02693613|ASP1517|asp1517
5208285|NCT02693600|Total Trapeziectomy|total trapeziectomy
5208286|NCT02693600|Partial Trapeziectomy|partial trapeziectomy
5208287|NCT02693600|Ligamentoplasty|ligamentoplasty
5208288|NCT02693574|Helicobacter pylori|helicobacter pylori
5208289|NCT02693574|Helicobacter Infections|helicobacter infections
5208290|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors
5208291|NCT02693561|Self-help book|self-help book
5208292|NCT02693561|Deep breathing|deep breathing
5208306|NCT02693392|Blood glucose|blood glucose
5208307|NCT02693379|cervical cancer|cervical cancer
5208309|NCT02693379|VIA|via
5208310|NCT02693379|screening|screening
5208311|NCT02693379|smartphone|smartphone
5208312|NCT02693379|telemedicine|telemedicine
5208313|NCT02693366|bone marrow cells|bone marrow cells
5208314|NCT02693366|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5208315|NCT02693366|Chronic Kidney Diseases|chronic kidney diseases
5208316|NCT02693366|stem cell|stem cell
5208317|NCT02693366|cell therapy|cell therapy
5208318|NCT02693327|Gut Microbiome|gut microbiome
5208319|NCT02693327|Mental Disorder|mental disorder
5208320|NCT02693327|Dysbiosis|dysbiosis
5208321|NCT02693314|Jarro-Dophilus|jarro-dophilus
5208322|NCT02693314|probiotic|probiotic
5208323|NCT02693314|microbiota|microbiota
5208324|NCT02693314|gastrointestinal|gastrointestinal
5208330|NCT02693288|Wrist fracture|wrist fracture
5208331|NCT02693288|postoperative pain|postoperative pain
5208332|NCT02693288|local anesthesia|local anesthesia
5208333|NCT02693275|Community Sampling|community sampling
5208337|NCT02693262|CRT-D|crt-d
5208338|NCT02693262|cardiac resynchronization therapy|cardiac resynchronization therapy
5208339|NCT02693262|rate response|rate response
5208341|NCT02693262|closed-loop stimulation|closed-loop stimulation
5208342|NCT02693262|accelerometer|accelerometer
5208343|NCT02693262|chronotropic incompetence|chronotropic incompetence
5208344|NCT02693249|accidents|accidents
5208345|NCT02693249|adolescents|adolescents
5208346|NCT02693249|children|children
5208347|NCT02693249|posttraumatic cognitions|posttraumatic cognitions
5208348|NCT02693223|stroke|stroke
5208349|NCT02693197|Hepatic Impairment|hepatic impairment
5208350|NCT02693145|HIV/AIDS|hiv/aids
5208351|NCT02693145|re-engagement in care|re-engagement in care
5208352|NCT02693145|data to care|data to care
5208353|NCT02693132|Obesity|obesity
5208354|NCT02693132|Exercise|exercise
5208355|NCT02693119|LHON|lhon
5208356|NCT02693119|Ocuvia™|ocuvia™
5208357|NCT02693119|elamipretide|elamipretide
5208358|NCT02693119|MTP-131|mtp-131
5208359|NCT02693041|Probiotics|probiotics
5208360|NCT02693041|inflammation|inflammation
5208361|NCT02693041|immunological response|immunological response
5208362|NCT02693041|preterm birth|preterm birth
5208363|NCT02693041|preeclampsia|preeclampsia
5208364|NCT02693028|Microbiome|microbiome
5208365|NCT02693028|probiotic|probiotic
5208366|NCT02692976|Castration-resistant prostate cancer|castration-resistant prostate cancer
5208367|NCT02692976|Dendritic Cells|dendritic cells
5208368|NCT02692976|Immunotherapy|immunotherapy
5208369|NCT02692976|Vaccines|vaccines
5208370|NCT02692937|Neurosurgical Procedures|neurosurgical procedures
5208371|NCT02692937|Nerve Block|nerve block
5208372|NCT02692937|Exercise therapy|exercise therapy
5208373|NCT02692937|Physical Therapy Specialty|physical therapy specialty
5208376|NCT02692911|Gallbaldder|gallbaldder
5208377|NCT02692911|Cancer|cancer
5208378|NCT02692911|Gallstones|gallstones
5208379|NCT02692911|Cholecystectomy|cholecystectomy
5208381|NCT02692898|Brain Tumor|brain tumor
5208382|NCT02692898|Molecular Pathology|molecular pathology
5208383|NCT02692898|Clinical Data|clinical data
5208384|NCT02692898|Imaging Data|imaging data
5208385|NCT02692885|Phenotype|phenotype
5208386|NCT02692885|Adipose Tissue|adipose tissue
5208387|NCT02692885|Brown Adipose Tissue|brown adipose tissue
5208388|NCT02692872|Alpha Thalassemia|alpha thalassemia
5208389|NCT02692872|Double Deletion|double deletion
5208390|NCT02692846|CONNECTIVE TISSUE DISEASES|connective tissue diseases
5208391|NCT02692846|Cardiovascular Disease|cardiovascular disease
5208392|NCT02692846|Elastin Gene Mutation|elastin gene mutation
5208393|NCT02692846|Multisystem Developmental Disorder|multisystem developmental disorder
5208394|NCT02692833|Telomere|telomere
5208395|NCT02692833|Telomerase|telomerase
5208396|NCT02692833|DNA methylation|dna methylation
5208397|NCT02692833|Cell aging|cell aging
5208398|NCT02692833|Thoracic Surgery|thoracic surgery
5208400|NCT02692820|Probiotic|probiotic
5208401|NCT02692807|hip arthroscopy|hip arthroscopy
5076450|NCT03521310|SSC|ssc
5085569|NCT03463915|Women|women
5085570|NCT03463915|Pelvic pain|pelvic pain
5085571|NCT03463915|Urologic pain|urologic pain
5085572|NCT03463915|Bladder instillation|bladder instillation
5085573|NCT03463915|Kenalog|kenalog
5085574|NCT03463915|Steroid|steroid
5085579|NCT03463798|structured light plethysmography|structured light plethysmography
5085580|NCT03463798|sonar|sonar
5085583|NCT03463785|race|race
5208402|NCT02692807|femoroacetabular impingement|femoroacetabular impingement
5208403|NCT02692807|exercise therapy after hip arthroscopy|exercise therapy after hip arthroscopy
5208404|NCT02692807|rehabilitation after hip arthroscopy|rehabilitation after hip arthroscopy
5208405|NCT02692794|sinusitis|sinusitis
5208406|NCT02692794|oximetry|oximetry
5208407|NCT02692794|paranasal sinus diseases|paranasal sinus diseases
5208408|NCT02692781|Obesity|obesity
5208409|NCT02692768|total shoulder arthroplasty|total shoulder arthroplasty
5208410|NCT02692768|total shoulder replacement|total shoulder replacement
5208411|NCT02692768|adult|adult
5208412|NCT02692768|reverse shoulder arthroplasty|reverse shoulder arthroplasty
5208414|NCT02692742|Chemotherapy|chemotherapy
5208415|NCT02692742|Chemotherapy-induced Neutropenia|chemotherapy-induced neutropenia
5208416|NCT02692742|Supportive Care|supportive care
5208417|NCT02692742|Myelosuppression|myelosuppression
5208418|NCT02692742|CIN|cin
5208419|NCT02692703|HCV Treatment Experienced|hcv treatment experienced
5208420|NCT02692703|Hepatitis C|hepatitis c
5208421|NCT02692703|HCV Genotype 3|hcv genotype 3
5208422|NCT02692703|Without cirrhosis|without cirrhosis
5208423|NCT02692703|Non-cirrhotic|non-cirrhotic
5208424|NCT02692703|HCV Genotype 2|hcv genotype 2
5208425|NCT02692703|Renal Transplant|renal transplant
5208426|NCT02692703|HCV Treatment Naive|hcv treatment naive
5208427|NCT02692703|Post transplant|post transplant
5208428|NCT02692703|HCV Genotype 6|hcv genotype 6
5208429|NCT02692703|Liver Transplant|liver transplant
5208430|NCT02692703|HCV Genotype 5|hcv genotype 5
5208431|NCT02692703|HCV Genotype 4|hcv genotype 4
5208432|NCT02692703|Kidney Transplant|kidney transplant
5208433|NCT02692703|HCV Genotype 1|hcv genotype 1
5208434|NCT02692677|Healthy|healthy
5857586|NCT00022854|Knee|knee
5208435|NCT02692677|JNJ-42756493|jnj-42756493
5208436|NCT02692664|iliac side branch|iliac side branch
5208437|NCT02692651|vancomycin|vancomycin
5208438|NCT02692651|fidaxomicin|fidaxomicin
5208439|NCT02692651|CDI|cdi
5208440|NCT02692651|diarrhea|diarrhea
5208441|NCT02692599|live attenuated mumps vaccine|live attenuated mumps vaccine
5208442|NCT02692599|safety|safety
5208443|NCT02692599|immunogenicity|immunogenicity
5208444|NCT02692599|infant|infant
5208445|NCT02692586|Thromboembolism|thromboembolism
5208446|NCT02692586|Thrombectomy|thrombectomy
5208447|NCT02692586|Right Heart Strain|right heart strain
5208448|NCT02692586|Submassive PE|submassive pe
5208449|NCT02692586|Right Ventricle Dysfunction|right ventricle dysfunction
5208450|NCT02692586|Massive PE|massive pe
5208451|NCT02692560|Sedentary time|sedentary time
5208452|NCT02692560|Sit-to-stand transitions|sit-to-stand transitions
5208453|NCT02692534|Anesthesia|anesthesia
5208454|NCT02692534|Cocaine Use|cocaine use
5208455|NCT02692508|cardiovascular MRI|cardiovascular mri
5208456|NCT02692508|apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
5208457|NCT02692508|giant negative T-wave|giant negative t-wave
5208458|NCT02692508|wall thickness|wall thickness
5208459|NCT02692508|Nuclear Magnetic Resonance|nuclear magnetic resonance
5208460|NCT02692508|Early Diagnosis|early diagnosis
5208461|NCT02692508|Prognosis|prognosis
5208462|NCT02692495|body odor|body odor
5208463|NCT02692495|halitosis|halitosis
5208464|NCT02692495|dysbiosis|dysbiosis
5208465|NCT02692495|leaky gut|leaky gut
5208466|NCT02692495|microbiome|microbiome
5208467|NCT02692495|PATM|patm
5208468|NCT02692495|breath odor|breath odor
5208469|NCT02692469|Bariatric Surgery, Obesity, Laparoscopy|bariatric surgery, obesity, laparoscopy
5208470|NCT02692443|Congenital Heart Disease|congenital heart disease
5208471|NCT02692443|Magnetic Brain Resonance|magnetic brain resonance
5208472|NCT02692443|CHD|chd
5208473|NCT02692443|MRI|mri
5208474|NCT02692443|Neurodevelopmental|neurodevelopmental
5208475|NCT02692430|Portosystemic Shunt|portosystemic shunt
5208476|NCT02692430|Hepatic encephalopathy|hepatic encephalopathy
5208477|NCT02692430|Portal hypertension|portal hypertension
5208478|NCT02692430|Liver cirrhosis|liver cirrhosis
5208479|NCT02692417|hypoactive desire disorder|hypoactive desire disorder
5208480|NCT02692417|female sexual dysfunction|female sexual dysfunction
5962585|NCT04280107|magnetic resonance imaging|magnetic resonance imaging
5962586|NCT04280107|cone beam computed tomography|cone beam computed tomography
5962587|NCT04280107|temporomandibular dysfunction|temporomandibular dysfunction
5962588|NCT04280107|Styloid-Stylohoid Syndrome|styloid-stylohoid syndrome
5962589|NCT04280081|Non-Small Cell Lung Cancer|non-small cell lung cancer
5962590|NCT04280081|NSCLC|nsclc
5962591|NCT04280081|Targeted Therapy|targeted therapy
5962592|NCT04280081|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
5962593|NCT04280081|Thyroid Cancer|thyroid cancer
5962594|NCT04280081|RET Alteration|ret alteration
5208481|NCT02692417|genital arousal disorder|genital arousal disorder
5208483|NCT02692417|dysfunction|dysfunction
5208484|NCT02692417|female|female
5208485|NCT02692417|arousal|arousal
5208486|NCT02692417|electrical stimulation|electrical stimulation
5208487|NCT02692417|transcutaneous electrical stimulation|transcutaneous electrical stimulation
5208488|NCT02692417|women|women
5208489|NCT02692404|Postpartum Depression|postpartum depression
5208490|NCT02692404|Perinatal Depression|perinatal depression
5208491|NCT02692404|Pregnancy|pregnancy
5208492|NCT02692404|Anesthesia|anesthesia
5208493|NCT02692404|Obstetric|obstetric
5208494|NCT02692404|Pain|pain
5208495|NCT02692404|Analgesia|analgesia
5208496|NCT02692404|Epidural|epidural
5208497|NCT02692404|Midwife|midwife
5208498|NCT02692404|Infant Development|infant development
5208499|NCT02692404|Pain Management|pain management
5208500|NCT02692391|Acute pancreatitis|acute pancreatitis
5208501|NCT02692391|Indomethacin|indomethacin
5208502|NCT02692391|Organ failure|organ failure
5208503|NCT02692391|Prevention|prevention
5208504|NCT02692378|Haemodialysis|haemodialysis
5208505|NCT02692378|sodium bicarbonate|sodium bicarbonate
5208506|NCT02692378|potassium|potassium
5208507|NCT02692378|arrhythmia|arrhythmia
5208508|NCT02692378|muscle|muscle
5208509|NCT02692378|symptoms|symptoms
5208510|NCT02692339|Relapsed Multiple Myeloma|relapsed multiple myeloma
5208511|NCT02692339|Refractory Multiple Myeloma|refractory multiple myeloma
5208512|NCT02692339|Lenalidomide|lenalidomide
5208513|NCT02692339|Dexamethasone|dexamethasone
5208514|NCT02692339|Observational Study|observational study
5208515|NCT02692339|Safety of Len/Dex|safety of len/dex
5208516|NCT02692326|intrahepatic cholestasis|intrahepatic cholestasis
5208517|NCT02692326|infant newborn|infant newborn
5208518|NCT02692326|cyclic parenteral nutrition|cyclic parenteral nutrition
5208519|NCT02692313|epinephrine|epinephrine
5208520|NCT02692313|counterregulation|counterregulation
5208521|NCT02692313|dose responses|dose responses
5208522|NCT02692300|anesthesia|anesthesia
5208523|NCT02692300|delirium|delirium
5208524|NCT02692300|surgery|surgery
5208525|NCT02692300|electroencephalography|electroencephalography
5208526|NCT02692300|burst suppression|burst suppression
5208527|NCT02692300|PTSD|ptsd
5208528|NCT02692300|anxiety|anxiety
5208529|NCT02692300|depression|depression
5208530|NCT02692300|falls|falls
5208531|NCT02692274|Point-of-care diagnostics|point-of-care diagnostics
5208532|NCT02692274|Rural primary health care|rural primary health care
5208533|NCT02692274|Access|access
5208534|NCT02692274|Need|need
5208535|NCT02692274|Usage|usage
5208536|NCT02692274|Maternal Health|maternal health
5208537|NCT02692235|carnitine|carnitine
5208538|NCT02692222|pulse pressure variation monitoring|pulse pressure variation monitoring
5208539|NCT02692222|Captesia|captesia
5208540|NCT02692222|cardiac output monitoring|cardiac output monitoring
5208541|NCT02692209|Mammography|mammography
5208542|NCT02692196|Neurofeedback|neurofeedback
5208543|NCT02692196|Emotion processing|emotion processing
5208544|NCT02692196|Real-time|real-time
5208545|NCT02692196|fMRI|fmri
5208546|NCT02692183|Parkinson's disease|parkinson's disease
5208549|NCT02692183|FUS|fus
5208550|NCT02692183|BNA|bna
5208551|NCT02692183|Essential tremor|essential tremor
5208552|NCT02692131|Left Ventricle strain, speckle strain|left ventricle strain, speckle strain
5208553|NCT02692105|prostate adenocarcinoma|prostate adenocarcinoma
5208554|NCT02692105|intermediate risk group|intermediate risk group
5208555|NCT02692105|brachytherapy|brachytherapy
5208556|NCT02692105|High Dose Rate vs Low Dose Rate|high dose rate vs low dose rate
5208557|NCT02692105|Quality of Life|quality of life
5208558|NCT02692092|Complications|complications
5445363|NCT01522157|Diet|diet
5208559|NCT02692092|Arthroplasty, Hip Replacement|arthroplasty, hip replacement
5208560|NCT02692092|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
5208561|NCT02692079|Angiogenesis|angiogenesis
5208562|NCT02692079|Bilateral infrabony defect|bilateral infrabony defect
5208563|NCT02692079|Flap surgery|flap surgery
5208564|NCT02692079|Titanium-prepared, platelet-rich ﬁbrin|titanium-prepared, platelet-rich ﬁbrin
5208565|NCT02692040|obesity|obesity
5208566|NCT02692040|diabetes mellitus|diabetes mellitus
5208567|NCT02692040|glucagon-like peptide-1|glucagon-like peptide-1
5208568|NCT02692027|Community-based initiation of antiretroviral therapy|community-based initiation of antiretroviral therapy
5208569|NCT02692027|Home-based HIV testing and counseling|home-based hiv testing and counseling
5208570|NCT02692027|Lesotho|lesotho
5208571|NCT02692027|Sub-sahara Africa|sub-sahara africa
5208572|NCT02692027|antiretroviral therapy|antiretroviral therapy
5208573|NCT02692027|AIDS|aids
5208574|NCT02692027|Test and treat|test and treat
5208575|NCT02691988|Inhaled corticosteroids|inhaled corticosteroids
5208576|NCT02691988|General practice|general practice
5208577|NCT02691988|Primary care|primary care
5208578|NCT02691988|Pharmacotherapy|pharmacotherapy
5208579|NCT02691936|Genitourinary symptoms of menopause|genitourinary symptoms of menopause
5208580|NCT02691936|Menopause|menopause
5208581|NCT02691936|Atrophic vaginitis|atrophic vaginitis
5208582|NCT02691923|High Grade Glioma|high grade glioma
5208583|NCT02691923|Low Grade Glioma|low grade glioma
5208584|NCT02691923|Brain Tumor|brain tumor
5208585|NCT02691910|malaria|malaria
5208586|NCT02691910|Plasmodium vivax|plasmodium vivax
5208587|NCT02691910|treatment|treatment
5085839|NCT03461874|ACT|act
5208588|NCT02691910|Chloroquine|chloroquine
5208589|NCT02691910|Primaquine|primaquine
5208590|NCT02691897|Diabetes mellitus|diabetes mellitus
5208591|NCT02691897|Melatonin|melatonin
5208592|NCT02691897|Blood Glucose|blood glucose
5208593|NCT02691897|Therapeutics|therapeutics
5208594|NCT02691897|Pineal gland|pineal gland
5208595|NCT02691884|Heart Rate, Fetal|heart rate, fetal
5208596|NCT02691884|Electronic Fetal Monitoring|electronic fetal monitoring
5208597|NCT02691884|Transducers, Pressure|transducers, pressure
5208598|NCT02691858|Intussusception|intussusception
5208599|NCT02691819|jailed-balloon technique|jailed-balloon technique
5208600|NCT02691754|Paracetamol|paracetamol
5208601|NCT02691754|PPI|ppi
5208602|NCT02691754|Opioids|opioids
5208603|NCT02691754|NSAID|nsaid
5196659|NCT02765048|Social problem-solving|social problem-solving
5208604|NCT02691754|Drug Prescription|drug prescription
5208605|NCT02691702|Multiple Ascending Dose Study|multiple ascending dose study
5208606|NCT02691702|Safety and Tolerability|safety and tolerability
5208607|NCT02691702|Pharmacokinetics|pharmacokinetics
5208608|NCT02691702|Pharmacodynamics|pharmacodynamics
5208609|NCT02691702|Melatonin|melatonin
5208610|NCT02691702|Plasma|plasma
5208611|NCT02691702|Dim Light Melatonin Onset|dim light melatonin onset
5208612|NCT02691676|crystalloids, fluid therapy, Plasmalyte, Ringerfundin|crystalloids, fluid therapy, plasmalyte, ringerfundin
5208613|NCT02691663|Geriatric|geriatric
5208614|NCT02691663|bicarbonate|bicarbonate
5208615|NCT02691650|serum cholinesterase|serum cholinesterase
5208616|NCT02691650|plasma cholinesterase|plasma cholinesterase
5208617|NCT02691650|pseudocholinesterase|pseudocholinesterase
5208618|NCT02691650|systemic inflammation|systemic inflammation
5208619|NCT02691650|SIRS|sirs
5208620|NCT02691650|polytrauma|polytrauma
5208621|NCT02691637|Helicobacter pylori infection|helicobacter pylori infection
5208622|NCT02691637|Eradication treatment|eradication treatment
5208623|NCT02691637|Reversibility|reversibility
5208624|NCT02691637|atrophic gastritis|atrophic gastritis
5208625|NCT02691637|intestinal metaplasia|intestinal metaplasia
5208626|NCT02691624|Lymphedema of Upper Arm|lymphedema of upper arm
5208627|NCT02691624|Breast cancer|breast cancer
5208628|NCT02691624|Breast cancer-related Lymphedema|breast cancer-related lymphedema
5208629|NCT02691624|Lymphoscintigraphy|lymphoscintigraphy
5208630|NCT02691546|Chronic Kidney Diseases|chronic kidney diseases
5208631|NCT02691546|Older|older
5208632|NCT02691546|Geriatric assessment|geriatric assessment
5208633|NCT02691546|Biomarkers|biomarkers
5208634|NCT02691533|Acute|acute
5208635|NCT02691520|Treatment Resistant Depression|treatment resistant depression
5208636|NCT02691507|Eczema, Itchy Skin|eczema, itchy skin
5208637|NCT02691494|Elagolix|elagolix
5208638|NCT02691494|Elagolix Sodium|elagolix sodium
5208639|NCT02691494|Heavy uterine bleeding|heavy uterine bleeding
5208640|NCT02691494|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
5208641|NCT02691494|Leiomyomata|leiomyomata
5208642|NCT02691494|Menorrhagia|menorrhagia
5208644|NCT02691494|Elagolix + E2/NETA (Elagolix + Norethindrone acetate)|elagolix + e2/neta (elagolix + norethindrone acetate)
5208645|NCT02691468|one lung ventilation|one lung ventilation
5208646|NCT02691468|double lumen endobronchial tube|double lumen endobronchial tube
5208647|NCT02691468|displacement|displacement
5208648|NCT02691468|Fiberoptic bronchoscope|fiberoptic bronchoscope
5208649|NCT02691442|Peripheral nerve block|peripheral nerve block
5208650|NCT02691429|Vitreoretinal surgery|vitreoretinal surgery
5100622|NCT03369236|MPGN|mpgn
5208651|NCT02691429|euterpe oleracea|euterpe oleracea
5208652|NCT02691429|chromovitrectomy|chromovitrectomy
5208653|NCT02691325|ELLIPTA|ellipta
5208654|NCT02691325|GSK2269557|gsk2269557
5208655|NCT02691325|Tolerability|tolerability
5208656|NCT02691325|Safety|safety
5208657|NCT02691325|Dry powder Inhaler (DPI)|dry powder inhaler (dpi)
5208658|NCT02691325|Pharmacokinetics|pharmacokinetics
5208659|NCT02691312|type 1 diabetes|type 1 diabetes
5208660|NCT02691312|retinopathy|retinopathy
5208661|NCT02691299|NSCLC|nsclc
5208662|NCT02691260|obesity|obesity
5208663|NCT02691260|behavioral intervention|behavioral intervention
5208664|NCT02691260|diet|diet
5208665|NCT02691247|T1DM|t1dm
5208666|NCT02691247|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5208667|NCT02691247|T regulatory cell|t regulatory cell
5208668|NCT02691247|Immunotherapy|immunotherapy
5208669|NCT02691247|Cell therapy|cell therapy
5208670|NCT02691247|T-Reg|t-reg
5208671|NCT02691221|Suicidal behavior, Mobile Application, Mobile Health Tool|suicidal behavior, mobile application, mobile health tool
5208672|NCT02691208|acupuncture|acupuncture
5208673|NCT02691208|breast cancer|breast cancer
5208674|NCT02691208|rehabilitation|rehabilitation
5208675|NCT02691208|pain|pain
5208676|NCT02691195|Ultrasound|ultrasound
5208677|NCT02691195|Serratus Plane Block|serratus plane block
5208678|NCT02691195|Quality of recovery|quality of recovery
5208679|NCT02691156|Hematofluorometer|hematofluorometer
5208680|NCT02691130|influenza|influenza
5208684|NCT02691130|prime|prime
5208685|NCT02691130|boost|boost
5208686|NCT02691130|HAI|hai
5208687|NCT02691130|CMI|cmi
5208688|NCT02691130|UNISEC|unisec
5962595|NCT04280081|MTC|mtc
5208689|NCT02691117|Alopecia Areata|alopecia areata
5208690|NCT02691117|Garlic concentrate|garlic concentrate
5208691|NCT02691052|pancreatic cancer|pancreatic cancer
5208692|NCT02691052|metastatic|metastatic
5208693|NCT02691026|MPNST|mpnst
5208694|NCT02691026|Pembrolizumab|pembrolizumab
5208695|NCT02691000|depression|depression
5208696|NCT02691000|depressive symptoms|depressive symptoms
5208697|NCT02691000|stage b heart failure|stage b heart failure
5208698|NCT02691000|bright white light|bright white light
5208699|NCT02691000|light therapy|light therapy
5208700|NCT02690987|tobacco|tobacco
5208701|NCT02690987|GLP1|glp1
5208702|NCT02690987|ghrelin|ghrelin
5208703|NCT02690987|alcohol|alcohol
5208704|NCT02690987|appetite|appetite
5208705|NCT02690987|reward|reward
5208706|NCT02690987|addiction|addiction
5208707|NCT02690987|hormone|hormone
5208708|NCT02690987|cigarette|cigarette
5208709|NCT02690987|functional MRI|functional mri
5208710|NCT02690974|HFrEF,|hfref,
5208711|NCT02690974|ACEi,|acei,
5208712|NCT02690974|ACE inhibitor,|ace inhibitor,
5208713|NCT02690974|ARBs,|arbs,
5208714|NCT02690974|systolic heart failure,|systolic heart failure,
5208715|NCT02690974|chronic heart failure,|chronic heart failure,
5208716|NCT02690974|CHF,|chf,
5208717|NCT02690974|reduced EF,|reduced ef,
5208718|NCT02690974|Ejection Fraction|ejection fraction
5208719|NCT02690961|Healthy|healthy
5208720|NCT02690935|grass pollen|grass pollen
5208721|NCT02690935|homeopathy|homeopathy
5208722|NCT02690935|placebo|placebo
5208723|NCT02690935|quality of life|quality of life
5208724|NCT02690909|Uncontrolled Hypertension|uncontrolled hypertension
5208725|NCT02690909|Resistant Hypertension|resistant hypertension
5208726|NCT02690909|Renal Denervation|renal denervation
5208727|NCT02690896|caregiver burden|caregiver burden
5208728|NCT02690896|caregiver support groups|caregiver support groups
5208729|NCT02690870|tamoxifen|tamoxifen
5208730|NCT02690870|clomiphene|clomiphene
5208731|NCT02690870|mild stimulation|mild stimulation
5208732|NCT02690870|poor ovarian response|poor ovarian response
5208733|NCT02690870|clinical pregnancy rate|clinical pregnancy rate
5208734|NCT02690831|Asthma|asthma
5208735|NCT02690831|Inspiratory Muscle Training|inspiratory muscle training
5208736|NCT02690831|Manual Therapies|manual therapies
5208737|NCT02690818|Tuberculosis|tuberculosis
5208738|NCT02690818|Latent Tuberculosis|latent tuberculosis
5208739|NCT02690818|Texting|texting
5208740|NCT02690818|Adherence|adherence
5294840|NCT02201953|HCV|hcv
5208741|NCT02690818|Medication|medication
5208742|NCT02690792|Healthy|healthy
5208743|NCT02690792|NAFLD|nafld
5208744|NCT02690792|NASH|nash
5208745|NCT02690792|Liver Metabolism|liver metabolism
5208746|NCT02690792|Vitamin E|vitamin e
5208747|NCT02690766|Cancer|cancer
5208748|NCT02690766|Breast Cancer|breast cancer
5208749|NCT02690766|Endometrial cancer,|endometrial cancer,
5208751|NCT02690753|Repositioning|repositioning
5208752|NCT02690753|Incontinence care|incontinence care
5208753|NCT02690753|Prevention|prevention
5208754|NCT02690740|titrated quantitative conjunctival provocation test|titrated quantitative conjunctival provocation test
5208755|NCT02690727|Fasting|fasting
5208756|NCT02690727|Fed condition|fed condition
5208757|NCT02690727|Pharmacokinetics|pharmacokinetics
5100726|NCT03368573|ADHD|adhd
5208758|NCT02690701|psoriasis|psoriasis
5208759|NCT02690701|plaque psoriasis|plaque psoriasis
5208760|NCT02690701|secukinumab|secukinumab
5208761|NCT02690701|AIN457|ain457
5208762|NCT02690701|biologic|biologic
5208763|NCT02690701|monoclonal antibody|monoclonal antibody
5208764|NCT02690701|aortic vascular inflammation|aortic vascular inflammation
5208765|NCT02690688|Pulse Pressure Variation|pulse pressure variation
5208766|NCT02690688|NIRS|nirs
5208767|NCT02690688|Pneumoperitoneum|pneumoperitoneum
5208768|NCT02690688|Abdominal surgery|abdominal surgery
5208769|NCT02690675|Neurodevelopment|neurodevelopment
5208770|NCT02690675|Bayley Scale|bayley scale
5208771|NCT02690675|Growth|growth
5208772|NCT02690675|Iron fortification|iron fortification
5208773|NCT02690662|Obesity|obesity
5208774|NCT02690662|Kidney stones|kidney stones
5208775|NCT02690662|Diet|diet
5208776|NCT02690649|anticoagulants|anticoagulants
5208777|NCT02690649|Personal Health Records|personal health records
5208778|NCT02690623|hospitalist|hospitalist
5208779|NCT02690623|pediatric inpatient care|pediatric inpatient care
5208780|NCT02690610|EBUS, Mediastinal lesions, Mediastinal lymph node|ebus, mediastinal lesions, mediastinal lymph node
5208781|NCT02690597|Anxiety analogic visual scale|anxiety analogic visual scale
5208782|NCT02690597|Pain|pain
5208783|NCT02690597|State Trait Inventory anxiety scale|state trait inventory anxiety scale
5208784|NCT02690597|Anxiety|anxiety
5208785|NCT02690584|Psychotherapy|psychotherapy
5205529|NCT02710474|NICU|nicu
5208787|NCT02690571|Biodiesel exhaust|biodiesel exhaust
5208788|NCT02690571|Bronchoscopy|bronchoscopy
5208789|NCT02690571|Metabolomics|metabolomics
5208790|NCT02690558|muscle-invasive|muscle-invasive
5208791|NCT02690545|CAR T cells|car t cells
5208792|NCT02690545|CD30|cd30
5208793|NCT02690545|Lymphoma|lymphoma
5208794|NCT02690545|T Lymphocytes|t lymphocytes
5208795|NCT02690532|Celiac|celiac
5208796|NCT02690532|Gluten|gluten
5208797|NCT02690532|Sensitivity|sensitivity
5208798|NCT02690532|Permeability|permeability
5208799|NCT02690532|Non-celiac gluten intolerance|non-celiac gluten intolerance
5208800|NCT02690532|Gastrointestinal Diseases|gastrointestinal diseases
5208801|NCT02690532|Digestive System Diseases|digestive system diseases
5208802|NCT02690519|Cystic fibrosis S1251N mutation|cystic fibrosis s1251n mutation
5208803|NCT02690519|GLPG1837|glpg1837
5208804|NCT02690506|pregabalin|pregabalin
5208805|NCT02690506|spinal anesthesia|spinal anesthesia
5208806|NCT02690480|fulvestrant|fulvestrant
5196857|NCT02763735|Pulmonary arterial hypertension|pulmonary arterial hypertension
5196858|NCT02763735|Right ventricle|right ventricle
5196859|NCT02763735|Right ventricular function|right ventricular function
5196860|NCT02763735|Metabolism|metabolism
5196861|NCT02763735|Non-invasive imaging|non-invasive imaging
5196862|NCT02763735|Healthy Subjects|healthy subjects
5196863|NCT02763722|atopic dermatitis|atopic dermatitis
5196864|NCT02763722|allergic contact dermatitis|allergic contact dermatitis
5196865|NCT02763722|cosmetics|cosmetics
5196866|NCT02763722|transepidermal water loos|transepidermal water loos
5196867|NCT02763696|Metagenomics|metagenomics
5208807|NCT02690480|palbociclib|palbociclib
5208808|NCT02690480|metastases|metastases
5208809|NCT02690480|postmenopausal|postmenopausal
5208810|NCT02690480|breast cancer|breast cancer
5208811|NCT02690480|hormone receptor positive|hormone receptor positive
5208812|NCT02690467|Insulin therapy|insulin therapy
5208813|NCT02690467|Needle|needle
5208814|NCT02690454|ticagrelor|ticagrelor
5208815|NCT02690454|ticagrelor active metabolite (AR-C124910XX)|ticagrelor active metabolite (ar-c124910xx)
5208816|NCT02690454|platelet function tests|platelet function tests
5208817|NCT02690454|the flow cytometric VASP assay|the flow cytometric vasp assay
5208818|NCT02690454|the VerifyNow® device|the verifynow® device
5208819|NCT02690454|the Multiplate® analyzer|the multiplate® analyzer
5208820|NCT02690454|pharmacokinetics|pharmacokinetics
5208821|NCT02690454|pharmacodynamics|pharmacodynamics
5208822|NCT02690454|Multiplate® ADPtest|multiplate® adptest
5208823|NCT02690454|VerifyNow® PRUTest™|verifynow® prutest™
5208824|NCT02690454|Platelet VASP/P2Y12 assay|platelet vasp/p2y12 assay
5208826|NCT02690441|CBT|cbt
5208827|NCT02690441|Physical exercise|physical exercise
5208828|NCT02690441|Older adults|older adults
5208829|NCT02690428|Hyperthermia, Induced|hyperthermia, induced
5208830|NCT02690428|Laser Coagulation|laser coagulation
5208831|NCT02690428|Laser Therapy|laser therapy
5208832|NCT02690389|Acupuncture|acupuncture
5208833|NCT02690389|Flumazenil|flumazenil
5208834|NCT02690389|Narcotrend|narcotrend
5208835|NCT02690389|General Anaesthesia|general anaesthesia
5208836|NCT02690389|Sedation|sedation
5208837|NCT02690337|Advanced solid malignant tumors|advanced solid malignant tumors
5208838|NCT02690337|phase 1|phase 1
5208839|NCT02690337|oncology|oncology
5208840|NCT02690337|refractory|refractory
5857693|NCT00021723|AIP-001|aip-001
5208841|NCT02690337|no standard treatment|no standard treatment
5208842|NCT02690272|kidney transplant|kidney transplant
5208843|NCT02690272|psychic process|psychic process
5208844|NCT02690259|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5208845|NCT02690233|endothelial dysfunction|endothelial dysfunction
5208847|NCT02690233|cardiovascular complications|cardiovascular complications
5208848|NCT02690233|EndoPat|endopat
5208849|NCT02690233|myocardial injury|myocardial injury
5208850|NCT02690233|myocardial infarction|myocardial infarction
5208851|NCT02690220|polypropylene mesh|polypropylene mesh
5208853|NCT02690220|cystocele|cystocele
5208854|NCT02690220|surgical mesh|surgical mesh
5208855|NCT02690207|Herpes Zoster|herpes zoster
5208856|NCT02690207|Safety|safety
5208857|NCT02690207|Adults|adults
5208858|NCT02690207|Cross-vaccination|cross-vaccination
5208859|NCT02690194|Buddhify|buddhify
5208860|NCT02690194|Stress|stress
5208861|NCT02690194|Anxiety|anxiety
5208862|NCT02690194|Relaxation Technique|relaxation technique
5208863|NCT02690168|Fasting|fasting
5208864|NCT02690168|Carbon-13 Magnetic Resonance Spectroscopy|carbon-13 magnetic resonance spectroscopy
5208865|NCT02690168|Neuroimaging|neuroimaging
5208866|NCT02690155|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5208867|NCT02690155|Prevention|prevention
5208868|NCT02690155|Stroke|stroke
5208869|NCT02690129|progesterone|progesterone
5208870|NCT02690129|threatened abortion|threatened abortion
5208871|NCT02690116|Meditative movement|meditative movement
5208872|NCT02690116|Breast cancer survivors|breast cancer survivors
5208873|NCT02690116|Qigong|qigong
5208874|NCT02690116|Tai Chi Easy|tai chi easy
5208875|NCT02690116|Fatigue|fatigue
5208876|NCT02690103|Arabinoxylan|arabinoxylan
5208892|NCT02690038|AECOPD|aecopd
5208893|NCT02690038|COPD|copd
5208894|NCT02689999|Gastroesophageal Reflux Disease (GERD), GERD, impedence|gastroesophageal reflux disease (gerd), gerd, impedence
5208895|NCT02689986|Cold agglutinin|cold agglutinin
5208896|NCT02689986|Cold agglutinin disease|cold agglutinin disease
5208897|NCT02689986|Anemia|anemia
5208898|NCT02689986|Hemolytic|hemolytic
5208899|NCT02689986|Autoimmune|autoimmune
5086116|NCT03459963|cesarean section|cesarean section
5208900|NCT02689986|Bendamustine|bendamustine
5208901|NCT02689986|Rituximab|rituximab
5208902|NCT02689973|adolescence|adolescence
5208903|NCT02689973|body fat|body fat
5208904|NCT02689973|physical activity|physical activity
5208905|NCT02689973|psychosocial intervention|psychosocial intervention
5208906|NCT02689973|self-efficacy|self-efficacy
5208907|NCT02689973|planning|planning
5208908|NCT02689960|addison disease|addison disease
5208909|NCT02689960|adrenal crisis|adrenal crisis
5208910|NCT02689960|prednisone|prednisone
5208911|NCT02689934|hypercholesterolemia|hypercholesterolemia
5208912|NCT02689934|bifidobacterium longum BB536|bifidobacterium longum bb536
5208913|NCT02689934|red yeast rice|red yeast rice
5208914|NCT02689934|monacolin K|monacolin k
5208915|NCT02689934|lactoflorene colesterolo|lactoflorene colesterolo
5208916|NCT02689908|Thorax CT|thorax ct
5208917|NCT02689908|Low Dose|low dose
5208918|NCT02689908|Body Mass Index|body mass index
5208919|NCT02689908|Neck Circumference|neck circumference
5208920|NCT02689895|adolescents|adolescents
5208921|NCT02689895|second line treatment failure|second line treatment failure
5208922|NCT02689895|adherence|adherence
5208923|NCT02689895|drug resistance|drug resistance
5208924|NCT02689882|nicotinamide riboside|nicotinamide riboside
5208925|NCT02689882|nicotinamide ribonucleoside|nicotinamide ribonucleoside
5208926|NCT02689882|Nicotinamide-Adenine Dinucleotide|nicotinamide-adenine dinucleotide
5208927|NCT02689869|indolent lymphoma|indolent lymphoma
5208928|NCT02689869|novel agents|novel agents
5208929|NCT02689869|chemotherapy free treatment|chemotherapy free treatment
5208930|NCT02689869|ibrutinib|ibrutinib
5208931|NCT02689869|obinutuzumab|obinutuzumab
5208932|NCT02689869|GA101|ga101
5208933|NCT02689843|Inflammation|inflammation
5208934|NCT02689843|Complement system proteins|complement system proteins
5208935|NCT02689843|Homocysteine|homocysteine
5208936|NCT02689843|C-Reactive Protein|c-reactive protein
5208937|NCT02689843|Cyproterone|cyproterone
5208938|NCT02689843|Ethinyl Estradiol|ethinyl estradiol
5208939|NCT02689843|Androgen Antagonists|androgen antagonists
5208940|NCT02689843|Metformin|metformin
5208941|NCT02689843|Thiazolidinediones|thiazolidinediones
5208942|NCT02689843|Pioglitazone|pioglitazone
5208943|NCT02689817|Pressure ulcer|pressure ulcer
5208944|NCT02689817|Monitoring|monitoring
5208945|NCT02689817|Pressure|pressure
5208946|NCT02689817|Physiologic feedback|physiologic feedback
5208947|NCT02689804|Emergency contraception|emergency contraception
5208948|NCT02689791|Appetite|appetite
5208949|NCT02689791|Food Intake|food intake
5208950|NCT02689791|Satiety Hormones|satiety hormones
5208951|NCT02689778|Pirfenidone|pirfenidone
5208952|NCT02689778|Diabetic nephropathy|diabetic nephropathy
5208953|NCT02689752|mass balance|mass balance
5208955|NCT02689713|Burn Pain|burn pain
5208956|NCT02689713|Hyperalgesia|hyperalgesia
5208957|NCT02689713|TRPV1|trpv1
5208958|NCT02689713|OLAMs|olams
5208959|NCT02689700|Human Cytomegalovirus|human cytomegalovirus
5208960|NCT02689700|Varicella Zoster Virus|varicella zoster virus
5208961|NCT02689700|Materno-fetal antibody transfer|materno-fetal antibody transfer
5208962|NCT02689700|Pregnancy|pregnancy
5208963|NCT02689700|Gestational age|gestational age
5208966|NCT02689622|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
5208967|NCT02689609|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5208968|NCT02689609|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5208969|NCT02689609|Hypothyroidism|hypothyroidism
5208970|NCT02689609|Predictors|predictors
5208971|NCT02689583|Helicobacter pylori|helicobacter pylori
5208972|NCT02689583|Antibiotic resistance|antibiotic resistance
5208973|NCT02689583|Sequencing|sequencing
5208974|NCT02689583|Mechanism|mechanism
5208975|NCT02689583|Cause|cause
5208976|NCT02689570|type 1 diabetes|type 1 diabetes
5208977|NCT02689570|coronary artery calcifications|coronary artery calcifications
5208978|NCT02689570|diastolic dysfunction|diastolic dysfunction
5208979|NCT02689570|adipokines|adipokines
5208980|NCT02689570|visceral adipose tissue|visceral adipose tissue
5208981|NCT02689544|exercise muscle stretching|exercise muscle stretching
5208982|NCT02689544|range of motion|range of motion
5208983|NCT02689544|dynamometer of muscle strength|dynamometer of muscle strength
5208984|NCT02689544|electromyography|electromyography
5208986|NCT02689518|Wet AMD|wet amd
5208987|NCT02689518|Macular degeneration|macular degeneration
5208988|NCT02689518|Wet macular degeneration|wet macular degeneration
5208989|NCT02689518|Neovascularization|neovascularization
5208990|NCT02689518|Retina|retina
5208991|NCT02689518|Retinal degeneration|retinal degeneration
5208992|NCT02689479|Clinical Islet Transplantation|clinical islet transplantation
5208993|NCT02689479|Positron Emission Tomography (PET) Computed Tomography (CT) imaging|positron emission tomography (pet) computed tomography (ct) imaging
5208994|NCT02689466|Adult|adult
5208995|NCT02689466|Acetylcholine|acetylcholine
5208996|NCT02689466|Movement Disorder|movement disorder
5208997|NCT02689466|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5208998|NCT02689466|PET Imaging|pet imaging
5962596|NCT04280068|Human Immunodeficiency Virus|human immunodeficiency virus
5208999|NCT02689453|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
5209000|NCT02689453|CD4/CD25 Expressing T-cells in Blood and Lymphoid Tissues|cd4/cd25 expressing t-cells in blood and lymphoid tissues
5209001|NCT02689453|Anti-CD52 Monoclonal Antibody|anti-cd52 monoclonal antibody
5209002|NCT02689453|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
5209003|NCT02689427|Androgen Receptor positive TNBC|androgen receptor positive tnbc
5209004|NCT02689414|Atherosclerosis|atherosclerosis
5209005|NCT02689401|Esophageal Cancer|esophageal cancer
5209006|NCT02689401|lymph nodes tumor|lymph nodes tumor
5209007|NCT02689388|analgesia|analgesia
5209008|NCT02689388|regional analgesia|regional analgesia
5209009|NCT02689388|femoral nerve block|femoral nerve block
5209010|NCT02689388|older persons|older persons
5209011|NCT02689388|frail|frail
5209012|NCT02689362|Diabetes Mellitus Type 2|diabetes mellitus type 2
5209013|NCT02689349|hearing|hearing
5209014|NCT02689349|implant|implant
5209015|NCT02689349|moderate degree|moderate degree
5209016|NCT02689349|severe degree|severe degree
5209017|NCT02689310|Wound Care|wound care
5209018|NCT02689310|Medical Grade Honey|medical grade honey
5209019|NCT02689310|Pressure Ulcers|pressure ulcers
5209020|NCT02689284|Stomach Cancer|stomach cancer
5209021|NCT02689284|Gastroesophageal Junction|gastroesophageal junction
5209022|NCT02689284|Gastric Cancer|gastric cancer
5209023|NCT02689284|Cancer of the Stomach|cancer of the stomach
5209024|NCT02689284|Cancer of Stomach|cancer of stomach
5209025|NCT02689284|Stomach|stomach
5209026|NCT02689284|Pembrolizumab|pembrolizumab
5209027|NCT02689284|Keytruda|keytruda
5209028|NCT02689284|HER2+|her2+
5209029|NCT02689284|GEJ|gej
5209030|NCT02689284|HER2 positive|her2 positive
5209031|NCT02689284|Metastatic|metastatic
5209032|NCT02689284|Margetuximab|margetuximab
5209033|NCT02689284|Immunotherapy|immunotherapy
5209034|NCT02689284|Trastuzumab|trastuzumab
5209035|NCT02689284|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5209036|NCT02689284|Human epidermal growth factor receptor 2-positive|human epidermal growth factor receptor 2-positive
5674151|NCT00604786|IgE receptors|ige receptors
5209063|NCT02689167|renal cell carcinoma|renal cell carcinoma
5209064|NCT02689167|sunitinib|sunitinib
5209065|NCT02689167|metastatic|metastatic
5209066|NCT02689167|schedule|schedule
5209067|NCT02689167|toxicity|toxicity
5209068|NCT02689167|safety|safety
5209069|NCT02689154|Pediatric Obesity|pediatric obesity
5209070|NCT02689154|Food Addiction|food addiction
5209071|NCT02689154|Mobile Health (mHealth)|mobile health (mhealth)
5209072|NCT02689154|Weight Management|weight management
5209073|NCT02689141|chronic lymphocytic leukemia CLL|chronic lymphocytic leukemia cll
5209074|NCT02689141|untreated chronic lymphocytic leukemia|untreated chronic lymphocytic leukemia
5209075|NCT02689141|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5209076|NCT02689141|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5209077|NCT02689128|Anesthesia|anesthesia
5209078|NCT02689128|postoperative|postoperative
5209080|NCT02689128|vomiting|vomiting
5209081|NCT02689115|Nuclear factor Kappa B|nuclear factor kappa b
5209082|NCT02689115|IKK epsilon|ikk epsilon
5209083|NCT02689102|Optical coherence tomography|optical coherence tomography
5209084|NCT02689102|Confocal laser endomicroscopy|confocal laser endomicroscopy
5209088|NCT02689063|Analgesic|analgesic
5209089|NCT02689024|Nerve block|nerve block
5209090|NCT02689024|Analgesia|analgesia
5209091|NCT02689011|Total Knee Arthroplasty|total knee arthroplasty
5209092|NCT02689011|Femoral Nerve Block|femoral nerve block
5209093|NCT02689011|Epidural Analgesia|epidural analgesia
5209094|NCT02689011|Urinary Retention|urinary retention
5209095|NCT02689011|Lumbar Epidural|lumbar epidural
5209096|NCT02688998|HER2 negative|her2 negative
5209097|NCT02688959|motor attention training|motor attention training
5209098|NCT02688959|exercise|exercise
5209099|NCT02688959|tai chi|tai chi
5209100|NCT02688959|ADHD|adhd
5209101|NCT02688855|Bone Growth Stimulator|bone growth stimulator
5209102|NCT02688855|Ankle Fracture|ankle fracture
5209103|NCT02688829|Sirolimus eluting stents|sirolimus eluting stents
5209104|NCT02688829|percutaneous coronary intervention|percutaneous coronary intervention
5209105|NCT02688829|First in man|first in man
5356863|NCT01917682|robotic-assisted PCI|robotic-assisted pci
5209106|NCT02688816|visual inspection with acetic acid|visual inspection with acetic acid
5209107|NCT02688816|Xpert HPV|xpert hpv
5209108|NCT02688816|OncoE6|oncoe6
5209109|NCT02688816|screening|screening
5209110|NCT02688803|HER2 Negative|her2 negative
5209111|NCT02688790|Dalbavancin|dalbavancin
5209112|NCT02688790|DALVANCE®|dalvance®
5209113|NCT02688790|Suspected or Confirmed Bacterial Infection|suspected or confirmed bacterial infection
5209114|NCT02688777|Rehabilitation|rehabilitation
5209115|NCT02688777|Gait|gait
5209116|NCT02688777|Postural Balance|postural balance
5209117|NCT02688777|Exercise|exercise
5209118|NCT02688777|Accidental Falls|accidental falls
5209119|NCT02688777|Kinesiology, Applied|kinesiology, applied
5209120|NCT02688764|PA21|pa21
5962597|NCT04280068|Unsafe Drinking|unsafe drinking
5209121|NCT02688764|phosphate binder|phosphate binder
5209123|NCT02688712|Xeloda|xeloda
5209124|NCT02688712|radiation therapy|radiation therapy
5209125|NCT02688712|LY2157299|ly2157299
5209126|NCT02688712|tumor resection|tumor resection
5209127|NCT02688712|capecitabine|capecitabine
5209128|NCT02688712|5FU|5fu
5209129|NCT02688712|Fluorouracil|fluorouracil
5209130|NCT02688712|IIB|iib
5209131|NCT02688712|IIC|iic
5209132|NCT02688712|IV|iv
5209133|NCT02688712|neoadjuvant|neoadjuvant
5209134|NCT02688712|Rectal cancer|rectal cancer
5209135|NCT02688712|Immunotherapy|immunotherapy
5209136|NCT02688660|Pediatrics|pediatrics
5209137|NCT02688660|Neuroimaging|neuroimaging
5209138|NCT02688647|Pulmonary Fibrosis|pulmonary fibrosis
5209139|NCT02688647|Fibrosis|fibrosis
5209142|NCT02688634|Cleft Palate Surgery|cleft palate surgery
5209143|NCT02688634|Antibiotic treatment|antibiotic treatment
5209144|NCT02688621|weight loss|weight loss
5209145|NCT02688621|financial incentives|financial incentives
5209146|NCT02688621|internet weight loss|internet weight loss
5209147|NCT02688595|Infant, Newborn|infant, newborn
5209148|NCT02688595|Ultrasonography|ultrasonography
5209149|NCT02688582|Target Controlled Infusion|target controlled infusion
5209150|NCT02688582|Pharmacokinetics|pharmacokinetics
5209151|NCT02688582|Cefepime|cefepime
5209152|NCT02688582|critically ill patients|critically ill patients
5209154|NCT02688556|dry eye|dry eye
5209155|NCT02688556|cyclosporine|cyclosporine
5209156|NCT02688543|radio frequency treatment|radio frequency treatment
5209157|NCT02688543|genicular nerves|genicular nerves
5209158|NCT02688543|osteoarthritis of the knee|osteoarthritis of the knee
5209159|NCT02688504|labelled medicines|labelled medicines
5209160|NCT02688504|drivers involved in serious and non-serious road accidents|drivers involved in serious and non-serious road accidents
5209161|NCT02688504|relevance and effectiveness of pictograms on medicines packaging|relevance and effectiveness of pictograms on medicines packaging
5209162|NCT02688478|Phthalate|phthalate
5209163|NCT02688478|Dibutylphthalate (DBP)|dibutylphthalate (dbp)
5209164|NCT02688478|Airway responsiveness|airway responsiveness
5209165|NCT02688478|Allergies|allergies
5209166|NCT02688452|strenuous exercise|strenuous exercise
5209167|NCT02688452|muscle soreness|muscle soreness
5209168|NCT02688413|Virtual reality|virtual reality
5209169|NCT02688413|Stroke|stroke
5209170|NCT02688413|Neurorehabilitation|neurorehabilitation
5209171|NCT02688413|Upper-limb rehabilitation|upper-limb rehabilitation
5209172|NCT02688413|Training games|training games
5209173|NCT02688400|Osteoarthritis|osteoarthritis
5209174|NCT02688400|Knee|knee
5209175|NCT02688400|Osteoarthritis, Knee|osteoarthritis, knee
5209176|NCT02688400|Diacerein|diacerein
5209177|NCT02688400|Celecoxib|celecoxib
5209178|NCT02688400|Phase III|phase iii
5209179|NCT02688400|Phase IV|phase iv
5209180|NCT02688400|Phase III-IV|phase iii-iv
5209182|NCT02688400|Spain|spain
5209183|NCT02688400|Austria|austria
5209184|NCT02688400|Czech Republic|czech republic
5209185|NCT02688400|WOMAC|womac
5209186|NCT02688387|Ambrisentan|ambrisentan
5209187|NCT02688387|Bioavailability|bioavailability
5209188|NCT02688387|Tadalafil|tadalafil
5209189|NCT02688387|Fixed Dose combination|fixed dose combination
5209190|NCT02688322|sulbactam|sulbactam
5209191|NCT02688322|pharmacokinetics|pharmacokinetics
5209192|NCT02688322|pharmacodynamics|pharmacodynamics
5209194|NCT02688257|Magnetic Resonance Imaging|magnetic resonance imaging
5209195|NCT02688257|Ultrasound|ultrasound
5209196|NCT02688257|Breast Cancer|breast cancer
5209197|NCT02688244|complicated appendicitis|complicated appendicitis
5209198|NCT02688244|laparoscopic appendectomy|laparoscopic appendectomy
5209199|NCT02688244|irrigation|irrigation
5209200|NCT02688244|suction|suction
5209201|NCT02688244|abdominal abscess|abdominal abscess
5209202|NCT02688231|Multiple Sclerosis|multiple sclerosis
5209203|NCT02688231|Upper limb rehabilitation|upper limb rehabilitation
5209204|NCT02688218|exercise|exercise
5209205|NCT02688218|artificial pancreas|artificial pancreas
5209206|NCT02688218|hypoglycemia|hypoglycemia
5209207|NCT02688218|type 1 diabetes|type 1 diabetes
5209208|NCT02688205|Cyriax's functional examination|cyriax's functional examination
5209209|NCT02688205|Ultrasound|ultrasound
5209210|NCT02688205|Correlation|correlation
5209224|NCT02688075|Observational Study|observational study
5209225|NCT02688036|Limited Disease Small Cell Lung Cancer|limited disease small cell lung cancer
5209226|NCT02688036|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5209227|NCT02688036|dose fractionation|dose fractionation
5209228|NCT02688023|5-fluorouracil|5-fluorouracil
5209229|NCT02688023|Irinotecan|irinotecan
5209230|NCT02688023|Oxaliplatin|oxaliplatin
5209231|NCT02688023|Colorectal cancer|colorectal cancer
5209232|NCT02688023|neoadjuvant|neoadjuvant
5209233|NCT02688023|chemotherapy|chemotherapy
5209249|NCT02687919|quality of life|quality of life
5209250|NCT02687893|Sleep|sleep
5209251|NCT02687893|Exercise|exercise
5209252|NCT02687867|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5209253|NCT02687867|Prevention|prevention
5209254|NCT02687867|Stroke|stroke
5209255|NCT02687854|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5209256|NCT02687854|Prevention|prevention
5209257|NCT02687854|Stroke|stroke
5209258|NCT02687841|acute kidney injury|acute kidney injury
5209259|NCT02687841|indoxylsulfate|indoxylsulfate
5209260|NCT02687841|p-cresol|p-cresol
5209261|NCT02687841|AST-120|ast-120
5209262|NCT02687828|Intestinal Behcet's disease (BD)|intestinal behcet's disease (bd)
5209263|NCT02687828|Adalimumab|adalimumab
5209264|NCT02687828|Safety|safety
5209265|NCT02687828|Effectiveness|effectiveness
5209266|NCT02687828|AMORE study|amore study
5209267|NCT02687815|Vitamin D, severe asthma exacerbations, children|vitamin d, severe asthma exacerbations, children
5209268|NCT02687802|respiratory mechanics|respiratory mechanics
5209269|NCT02687802|Respiratory Insufficiency|respiratory insufficiency
5209270|NCT02687802|artificial, ventilation|artificial, ventilation
5209271|NCT02687789|Bacterial Vaginosis|bacterial vaginosis
5209272|NCT02687789|BV|bv
5209273|NCT02687776|Copeptin, human|copeptin, human
5209274|NCT02687763|vaccines|vaccines
5209275|NCT02687763|ProQuad|proquad
5209276|NCT02687763|immunosuppressed|immunosuppressed
5209277|NCT02687763|solid organ transplant|solid organ transplant
5209278|NCT02687763|MMRV|mmrv
5209279|NCT02687737|Tongue|tongue
5209280|NCT02687737|Genioglossus|genioglossus
5209281|NCT02687737|genioglossus recruitment|genioglossus recruitment
5209282|NCT02687711|Non-interventional (NIS)|non-interventional (nis)
5209283|NCT02687711|Epilepsy|epilepsy
5209284|NCT02687711|Partial Onset Seizures (POS)|partial onset seizures (pos)
5209285|NCT02687711|add-on therapy|add-on therapy
5209286|NCT02687685|Skin to Skin Contact|skin to skin contact
5209287|NCT02687685|Infant, Newborn|infant, newborn
5209288|NCT02687607|Endovascular|endovascular
5209289|NCT02687607|Brain aneurysm|brain aneurysm
5209290|NCT02687607|Ruptured aneurysm|ruptured aneurysm
5209291|NCT02687542|Parkinson Disease|parkinson disease
5209292|NCT02687542|Motor Fluctuation|motor fluctuation
5209293|NCT02687529|Tuberculosis|tuberculosis
5209296|NCT02687516|Child|child
5209297|NCT02687516|Obesity|obesity
5209298|NCT02687516|Behavioral treatment|behavioral treatment
5209299|NCT02687503|Immune system|immune system
5209300|NCT02687503|Probiotics|probiotics
5209301|NCT02687464|Pediatric Surgery|pediatric surgery
5209302|NCT02687464|Pediatrics|pediatrics
5209303|NCT02687464|Randomized controlled trial,|randomized controlled trial,
5209304|NCT02687464|Antibiotics|antibiotics
5209305|NCT02687464|Cost effectiveness|cost effectiveness
5209306|NCT02687451|Surgical Pain|surgical pain
5209307|NCT02687451|Acute Post-Surgical Pain|acute post-surgical pain
5209308|NCT02687438|Steroid-eluting implant Mometasone Furoate|steroid-eluting implant mometasone furoate
5209309|NCT02687425|Pioglitazone|pioglitazone
5209310|NCT02687425|Chronic Myeloid Leukemia|chronic myeloid leukemia
5209311|NCT02687412|Fast-track surgery|fast-track surgery
5209312|NCT02687412|Gynecological oncology|gynecological oncology
5209313|NCT02687412|Hospitalization post-operation|hospitalization post-operation
5209314|NCT02687412|Complication|complication
5209315|NCT02687399|knee arthroplasty|knee arthroplasty
5101279|NCT03365115|pain|pain
5209316|NCT02687386|Recurrent|recurrent
5209317|NCT02687386|Refractory|refractory
5209318|NCT02687373|Plasmodium falciparum|plasmodium falciparum
5209319|NCT02687373|PfSPZ Vaccine|pfspz vaccine
5209320|NCT02687360|Methadone|methadone
5356864|NCT01917682|coronary intervention|coronary intervention
5280305|NCT02273102|AML|aml
5209323|NCT02687308|Minimally invasive prostate cancer surgery|minimally invasive prostate cancer surgery
5209324|NCT02687282|Modified Mallampati score|modified mallampati score
5209325|NCT02687282|Cesarean delivery|cesarean delivery
5209326|NCT02687269|myocardial protection|myocardial protection
5209327|NCT02687269|coronary artery bypass grafting|coronary artery bypass grafting
5209332|NCT02687217|PerioperativeHyperoxygenation|perioperativehyperoxygenation
5209333|NCT02687217|Wound Site Infection|wound site infection
5209335|NCT02687191|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma|safety, maximum tolerated dose, modified continual reassessment method, intracerebral, hemorrhage, hematoma
5209337|NCT02687113|fusion|fusion
5209338|NCT02687100|intubation|intubation
5209339|NCT02687100|intensive care|intensive care
5209340|NCT02687100|cardiac surgery|cardiac surgery
5209341|NCT02687100|sore throat|sore throat
5209342|NCT02687087|Radiotherapy Induced Xerostomia (RIX)|radiotherapy induced xerostomia (rix)
5209343|NCT02687074|HFNC|hfnc
5209344|NCT02687074|Respiratory Failure|respiratory failure
5209345|NCT02687074|Intubation|intubation
5209346|NCT02687074|Mortality|mortality
5209347|NCT02687061|Recall study|recall study
5209348|NCT02687061|Lost to follow-up|lost to follow-up
5209349|NCT02687048|mindful meditation|mindful meditation
5209350|NCT02687035|S3iCAP|s3icap
5209351|NCT02687035|SAPIEN 3|sapien 3
5209352|NCT02687035|Transfemoral|transfemoral
5209353|NCT02687035|Commander|commander
5209354|NCT02687035|Certitude|certitude
5209355|NCT02687035|TAVR|tavr
5209356|NCT02687035|TAVI|tavi
5209357|NCT02687035|Aortic stenosis|aortic stenosis
5209358|NCT02687035|THV|thv
5209359|NCT02687035|Transcatheter Heart Valve|transcatheter heart valve
5209360|NCT02687035|TVT|tvt
5209361|NCT02687035|TVTR|tvtr
5209365|NCT02686996|carnosine|carnosine
5209366|NCT02686996|Insulin sensitivity|insulin sensitivity
5209367|NCT02686996|low grade inflammation|low grade inflammation
5209368|NCT02686996|Oxidative stress|oxidative stress
5209369|NCT02686996|Advanced glycation|advanced glycation
5209370|NCT02686996|Type 2 diabetes|type 2 diabetes
5209371|NCT02686996|Cardiovascular disease|cardiovascular disease
5209372|NCT02686970|Family|family
5209373|NCT02686970|Quality|quality
5209374|NCT02686970|Validate|validate
5209375|NCT02686970|ICU|icu
5209376|NCT02686944|GIST|gist
5209377|NCT02686931|Developmental delayed|developmental delayed
5209378|NCT02686931|Orthopedic disease|orthopedic disease
5209379|NCT02686931|Longitudinal study|longitudinal study
5209380|NCT02686892|Inflamatory bowel disease|inflamatory bowel disease
5209381|NCT02686892|Crohns disease|crohns disease
5209382|NCT02686892|ulcerative colitis|ulcerative colitis
5209383|NCT02686892|incidence|incidence
5209384|NCT02686892|epidemiology|epidemiology
5209385|NCT02686879|hyperopes|hyperopes
5209386|NCT02686879|axial length|axial length
5209387|NCT02686879|peripheral defocus|peripheral defocus
5209388|NCT02686853|Intrathecal administration|intrathecal administration
5209389|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b
5209390|NCT02686853|Without Acquired Immune Deficiency Syndrome|without acquired immune deficiency syndrome
5209391|NCT02686814|Valvular heart disease|valvular heart disease
5209392|NCT02686814|Severe aortic stenosis|severe aortic stenosis
5209393|NCT02686814|Aortic valve replacement|aortic valve replacement
5209394|NCT02686801|nutrition|nutrition
5209395|NCT02686801|prematurity|prematurity
5209396|NCT02686801|body composition|body composition
5209397|NCT02686788|multiple sclerosis|multiple sclerosis
5209398|NCT02686788|relapsing remitting|relapsing remitting
5209399|NCT02686788|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
5209401|NCT02686762|NASH|nash
5209402|NCT02686736|internet-based educational intervention|internet-based educational intervention
5209403|NCT02686736|risky sexual behaviors|risky sexual behaviors
5209404|NCT02686736|prevention|prevention
5209405|NCT02686723|ACL injury|acl injury
5209406|NCT02686723|Return to sport|return to sport
5209407|NCT02686723|Motion analysis|motion analysis
5209408|NCT02686723|Isokinetic evaluation|isokinetic evaluation
5209409|NCT02686723|Risk factor|risk factor
5209410|NCT02686697|L-Carnosine|l-carnosine
5209411|NCT02686697|Schizophrenia|schizophrenia
5209412|NCT02686697|Psychosis|psychosis
5209413|NCT02686697|Cognition|cognition
5209414|NCT02686671|Bursitis|bursitis
5209415|NCT02686671|Injections|injections
5209416|NCT02686671|Shoulder Pain|shoulder pain
5101398|NCT03364504|PXE|pxe
5209417|NCT02686658|Geographic Atrophy (GA)|geographic atrophy (ga)
5209418|NCT02686658|Dry age-related macular degeneration|dry age-related macular degeneration
5209419|NCT02686658|AMD|amd
5209420|NCT02686658|Zimura|zimura
5209421|NCT02686658|Anti-inflammatory|anti-inflammatory
5209422|NCT02686658|complement factor C5 inhibitor|complement factor c5 inhibitor
5209423|NCT02686658|ARC1905|arc1905
5209424|NCT02686658|avacincaptad pegol|avacincaptad pegol
5209425|NCT02686645|Fecal Microbiota Transplantation|fecal microbiota transplantation
5209428|NCT02686632|Prosthesis Stomatitis|prosthesis stomatitis
5209429|NCT02686632|Oral Candidiasis|oral candidiasis
5209430|NCT02686632|Palatal inflammation|palatal inflammation
5209431|NCT02686593|Clofarabine|clofarabine
5209432|NCT02686593|Acute Myeloid Leukemia|acute myeloid leukemia
5209433|NCT02686567|transanal drainage tube|transanal drainage tube
5209434|NCT02686567|anastomotic leakage|anastomotic leakage
5209435|NCT02686567|laparoscopic anterior resection|laparoscopic anterior resection
5209436|NCT02686567|rectal cancer|rectal cancer
5209437|NCT02686554|Biomarker|biomarker
5209438|NCT02686528|total hip arthroplasty|total hip arthroplasty
5209439|NCT02686528|hip precautions|hip precautions
5209440|NCT02686528|posterior approach|posterior approach
5209441|NCT02686515|balance|balance
5209442|NCT02686476|Empagliflozin, Fatty Liver Disease|empagliflozin, fatty liver disease
5209443|NCT02686463|malignant ovarian cancer|malignant ovarian cancer
5209444|NCT02686463|laparoscopy|laparoscopy
5209445|NCT02686463|laparotomy|laparotomy
5209446|NCT02686437|shoulder dysfunction|shoulder dysfunction
5209447|NCT02686437|kinesiology tape|kinesiology tape
5209448|NCT02686437|rehabilitation|rehabilitation
5209449|NCT02686424|MAGE-A3 protein|mage-a3 protein
5209450|NCT02686424|NY-ESO-1 protein|ny-eso-1 protein
5209451|NCT02686424|WT1 Proteins|wt1 proteins
5209452|NCT02686424|PRAME protein|prame protein
5209453|NCT02686411|Benign neoplasms|benign neoplasms
5209454|NCT02686411|In situ neoplasms|in situ neoplasms
5209455|NCT02686411|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5209456|NCT02686411|Consult with palliative care doctor|consult with palliative care doctor
5209457|NCT02686411|Palliative care unit|palliative care unit
5209459|NCT02686411|Questionnaires|questionnaires
5209460|NCT02686411|Surveys|surveys
5209461|NCT02686398|Influenza Vaccines|influenza vaccines
5209462|NCT02686398|MF59 oil emulsion|mf59 oil emulsion
5209463|NCT02686398|End Stage Renal Failure on Dialysis|end stage renal failure on dialysis
5209464|NCT02686372|hepatocellular carcinoma|hepatocellular carcinoma
5209465|NCT02686359|physiology|physiology
5209466|NCT02686359|pain|pain
5209467|NCT02686359|analgesia|analgesia
5209468|NCT02686359|saliva|saliva
5209469|NCT02686359|opiorphin|opiorphin
5209470|NCT02686346|Relapsed|relapsed
5209471|NCT02686346|Refractory|refractory
5209472|NCT02686333|Meditation|meditation
5209473|NCT02686333|Dialysis|dialysis
5209474|NCT02686320|Rheumatoid arthritis|rheumatoid arthritis
5209475|NCT02686320|Elderly|elderly
5209476|NCT02686320|infections|infections
5209477|NCT02686320|cardio-vascular disease|cardio-vascular disease
5209478|NCT02686320|osteoporosis|osteoporosis
5209479|NCT02686320|cancer|cancer
5209480|NCT02686268|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5209481|NCT02686268|ALS|als
5209482|NCT02686268|C9ORF72 gene mutation|c9orf72 gene mutation
5209483|NCT02686268|Chromosome 9 open reading frame 72 protein|chromosome 9 open reading frame 72 protein
5209484|NCT02686268|Natural history|natural history
5209485|NCT02686268|Biomarkers|biomarkers
5209486|NCT02686268|Amyotrophic Lateral Sclerosis, Familial|amyotrophic lateral sclerosis, familial
5209487|NCT02686268|Amyotrophic Lateral Sclerosis, Sporadic|amyotrophic lateral sclerosis, sporadic
5209488|NCT02686268|Frontotemporal Dementia-Amyotrophic Lateral Sclerosis|frontotemporal dementia-amyotrophic lateral sclerosis
5209489|NCT02686242|cesarean section|cesarean section
5209490|NCT02686242|spinal anesthesia|spinal anesthesia
5209491|NCT02686242|general anesthesia|general anesthesia
5209492|NCT02686229|Low grade glioma, registry, neurosurgery, brain tumor|low grade glioma, registry, neurosurgery, brain tumor
5209493|NCT02686216|F-18 THK-5351 PET|f-18 thk-5351 pet
5423240|NCT01616563|hypertension|hypertension
5209494|NCT02686190|Alzheimer; luxtherapy, sleep disturbance, behaviour disturbance|alzheimer; luxtherapy, sleep disturbance, behaviour disturbance
5209495|NCT02686177|Type 2 diabetes|type 2 diabetes
5209496|NCT02686177|Angiogenesis|angiogenesis
5209497|NCT02686177|Liraglutide|liraglutide
5209498|NCT02686177|Glucagon like peptide 1 receptor agonist|glucagon like peptide 1 receptor agonist
5209499|NCT02686164|Lenvatinib|lenvatinib
5209500|NCT02686164|Lenvima|lenvima
5209501|NCT02686164|E7080|e7080
5209502|NCT02686164|Phase 1|phase 1
5209503|NCT02686164|Solid tumors|solid tumors
5209504|NCT02686164|Midazolam|midazolam
5209505|NCT02686164|CYP3A4|cyp3a4
5209506|NCT02686151|Letrozole|letrozole
5209509|NCT02686099|Sternal Plating|sternal plating
5209510|NCT02686099|Sternal Closure|sternal closure
5209511|NCT02686099|Sternalock|sternalock
5209512|NCT02686073|BMI|bmi
5209513|NCT02686073|progress of labor|progress of labor
5209514|NCT02686073|nulliparous women|nulliparous women
5209515|NCT02686047|Knee osteoarthritis|knee osteoarthritis
5209516|NCT02686047|Hyaluronic acid|hyaluronic acid
5209517|NCT02686047|Viscosupplementation|viscosupplementation
5209518|NCT02686034|Migraine|migraine
5209519|NCT02686034|Non-invasive vagus nerve stimulation|non-invasive vagus nerve stimulation
5209520|NCT02686034|Vagus nerve stimulation|vagus nerve stimulation
5209521|NCT02686034|Vagal nerve stimulation|vagal nerve stimulation
5209522|NCT02686034|gammaCore|gammacore
5209523|NCT02686034|episodic migraine|episodic migraine
5209524|NCT02685982|Unipolar|unipolar
5209525|NCT02685982|Depression|depression
5209526|NCT02685982|Depressive Disorder|depressive disorder
5209527|NCT02685982|Behavioural Symptoms|behavioural symptoms
5674152|NCT00604786|omalizumab|omalizumab
5209528|NCT02685982|Mood Disorder|mood disorder
5209529|NCT02685982|Adjunctive Therapy|adjunctive therapy
5209530|NCT02685982|Music Therapy|music therapy
5209531|NCT02685982|Brain Stimulation|brain stimulation
5209532|NCT02685969|Prevention|prevention
5209533|NCT02685969|Positron Emission Tomography|positron emission tomography
5209534|NCT02685930|invasive mechanical ventilation|invasive mechanical ventilation
5209535|NCT02685878|urinary continence|urinary continence
5209536|NCT02685878|prevalence of depression|prevalence of depression
5209537|NCT02685878|reproductive outcomes|reproductive outcomes
5209538|NCT02685878|quality of life|quality of life
5209539|NCT02685878|HIV status|hiv status
5209540|NCT02685878|obstetric fistula|obstetric fistula
5209541|NCT02685865|pancreatic fluid collection; pancreatic necrosis; stent;|pancreatic fluid collection; pancreatic necrosis; stent;
5209542|NCT02685839|frailty syndrome, Intelligent POWER Rehabilitation Cluster Machine, Internet of Things, wearable|frailty syndrome, intelligent power rehabilitation cluster machine, internet of things, wearable
5209543|NCT02685826|Open-label|open-label
5209544|NCT02685826|Phase 1/2|phase 1/2
5209545|NCT02685826|Durvalumab|durvalumab
5209546|NCT02685826|MEDI4736|medi4736
5209547|NCT02685826|Lenalidomide (Len)|lenalidomide (len)
5209548|NCT02685826|Dexamethasone (dex)|dexamethasone (dex)
5209549|NCT02685826|Multiple Myeloma|multiple myeloma
5209550|NCT02685826|Newly-Diagnosed (NDMM)|newly-diagnosed (ndmm)
5209551|NCT02685826|Transplant Non-eligible (TNE)|transplant non-eligible (tne)
5209552|NCT02685826|PD-L1|pd-l1
5209553|NCT02685826|Durvalumab (DURVA)|durvalumab (durva)
5209554|NCT02685813|Ultra sound|ultra sound
5209555|NCT02685813|birth defects|birth defects
5209556|NCT02685787|Care-giver burden|care-giver burden
5209558|NCT02685787|Alzheimer's disease|alzheimer's disease
5209559|NCT02685787|Care-giver depression|care-giver depression
5209560|NCT02685787|Care-giver anxiety|care-giver anxiety
5209561|NCT02685709|Octreotide Capsules|octreotide capsules
5209562|NCT02685709|Acromegaly|acromegaly
5209563|NCT02685709|Somatostatin|somatostatin
5209564|NCT02685709|Mpowered|mpowered
5209565|NCT02685709|OOC-ACM-302|ooc-acm-302
5209566|NCT02685683|Crohn's Disease|crohn's disease
5209567|NCT02685683|GED-0301|ged-0301
5209568|NCT02685683|Open-label|open-label
5209569|NCT02685683|Pharmacodynamic|pharmacodynamic
5209570|NCT02685683|Mongersen|mongersen
5209571|NCT02685644|endometrioma|endometrioma
5209572|NCT02685644|laparoscopy|laparoscopy
5209573|NCT02685644|anti-mullerian hormone|anti-mullerian hormone
5209574|NCT02685644|ovarian reserve|ovarian reserve
5209575|NCT02685631|Hepatocellular carcinoma|hepatocellular carcinoma
5209576|NCT02685631|Colorectal cancer|colorectal cancer
5209577|NCT02685631|Neuroendocrine tumor|neuroendocrine tumor
5209578|NCT02685631|Cholangiocarcinoma|cholangiocarcinoma
5209579|NCT02685631|Breast cancer|breast cancer
5209580|NCT02685631|Tumor of unknown primary|tumor of unknown primary
5209581|NCT02685631|Pancreatic cancer|pancreatic cancer
5209582|NCT02685605|Glioblastoma|glioblastoma
5209583|NCT02685605|Intraoperative Radiotherapy|intraoperative radiotherapy
5209584|NCT02685605|Radiotherapy Dose Escalation|radiotherapy dose escalation
5209585|NCT02685592|Lentigo Maligna|lentigo maligna
5209586|NCT02685592|Photodynamic Therapy|photodynamic therapy
5209587|NCT02685592|Hyperspectral Imaging|hyperspectral imaging
5209588|NCT02685566|Mammography|mammography
5209589|NCT02685540|Anesthesia|anesthesia
5209590|NCT02685540|mortality|mortality
5209591|NCT02685514|HIFU|hifu
5209592|NCT02685514|Graves' disease|graves' disease
5209593|NCT02685514|treatment|treatment
5209594|NCT02685475|Diabetes mellitus|diabetes mellitus
5209595|NCT02685475|Axillary brachial plexus block|axillary brachial plexus block
5209596|NCT02685475|Block duration|block duration
5209597|NCT02685475|Time-to-first pain|time-to-first pain
5209598|NCT02685475|Postoperative analgesia|postoperative analgesia
5209599|NCT02685449|diabetes type 1|diabetes type 1
5209600|NCT02685449|insulin pump|insulin pump
5209603|NCT02685449|high protein meal|high protein meal
5209604|NCT02685449|square bolus|square bolus
5209605|NCT02685449|square-wave bolus|square-wave bolus
5209606|NCT02685449|insulin bolus|insulin bolus
5209607|NCT02685449|dietary protein|dietary protein
5209608|NCT02685423|Amblyopia|amblyopia
5209609|NCT02685423|Lazy Eye|lazy eye
5209610|NCT02685423|Anisometropia|anisometropia
5209611|NCT02685384|healthcare access|healthcare access
5209612|NCT02685384|healthcare utilization|healthcare utilization
5209613|NCT02685384|health expenditures|health expenditures
5209614|NCT02685384|preventive services|preventive services
5209615|NCT02685384|biomarkers|biomarkers
5209616|NCT02685358|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5209617|NCT02685358|Primary Health Care|primary health care
5209618|NCT02685358|Mobile Applications|mobile applications
5209619|NCT02685358|Veterans|veterans
5209620|NCT02685345|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5209621|NCT02685345|sitagliptin|sitagliptin
5209622|NCT02685345|adult|adult
5209623|NCT02685345|Phase 2|phase 2
5674153|NCT00604773|delirium|delirium
5209624|NCT02685280|rechargeable neurostimulators|rechargeable neurostimulators
5209625|NCT02685254|Group Therapy|group therapy
5209626|NCT02685254|Structured Skills Training|structured skills training
5209627|NCT02685254|Dialectic Behavioural Therapy|dialectic behavioural therapy
5209628|NCT02685241|Exhaled breath|exhaled breath
5209629|NCT02685241|Biomarker|biomarker
5209630|NCT02685215|intensive care unit|intensive care unit
5209631|NCT02685215|muscular dystrophy|muscular dystrophy
5209632|NCT02685215|mortality|mortality
5209633|NCT02685215|prognosis|prognosis
5209634|NCT02685215|tracheostomy|tracheostomy
5209635|NCT02685202|orofacial pain|orofacial pain
5209636|NCT02685202|sleep-disordered breathing|sleep-disordered breathing
5209637|NCT02685202|temporomandibular disorder|temporomandibular disorder
5209638|NCT02685202|oral appliance|oral appliance
5209639|NCT02685202|upper airway collapse|upper airway collapse
5209640|NCT02685176|hypothermia|hypothermia
5209641|NCT02685176|rewarming|rewarming
5209642|NCT02685176|non-shivering|non-shivering
5209643|NCT02685150|Endoscopic Tri-Modal Imaging|endoscopic tri-modal imaging
5209644|NCT02685150|Gastric juice|gastric juice
5209645|NCT02685150|Functional dyspepsia|functional dyspepsia
5209646|NCT02685150|Acid reflux disease|acid reflux disease
5209647|NCT02685150|Bile reflux|bile reflux
5209648|NCT02685137|Kernicterus|kernicterus
5209649|NCT02685137|Neonatal Jaundice|neonatal jaundice
5209650|NCT02685137|Newborn Jaundice|newborn jaundice
5209651|NCT02685137|Hyperbilirubinemia|hyperbilirubinemia
5209652|NCT02685137|Stannsoporfin|stannsoporfin
5209653|NCT02685111|Breast cancer|breast cancer
5209654|NCT02685111|Adjuvant|adjuvant
5209655|NCT02685111|Docetaxel|docetaxel
5209656|NCT02685111|Adriamycin|adriamycin
5209657|NCT02685111|Cyclophosphamide|cyclophosphamide
5209658|NCT02685111|Neutropenia|neutropenia
5209659|NCT02685111|Filgrastim|filgrastim
5209660|NCT02685111|Pegfilgrastim|pegfilgrastim
5209661|NCT02685098|Stem cells|stem cells
5209662|NCT02685098|MSCs|mscs
5209663|NCT02685098|Mesenchymal|mesenchymal
5209664|NCT02685098|Amputation|amputation
5209666|NCT02685098|below knee amputation|below knee amputation
5209667|NCT02685098|CHAMP|champ
5209668|NCT02685098|AKA|aka
5209669|NCT02685098|Above Knee Amputation|above knee amputation
5209670|NCT02685098|Stromal cells|stromal cells
5209671|NCT02685098|bone marrow stem cell injection|bone marrow stem cell injection
5209672|NCT02685098|Allogeneic|allogeneic
5209673|NCT02685072|Smoking Cessation|smoking cessation
5209674|NCT02685072|Nicotine Cessation|nicotine cessation
5209675|NCT02685059|breast cancer|breast cancer
5209676|NCT02685059|Medi4736|medi4736
5209677|NCT02685059|Anti PD-L1|anti pd-l1
5209678|NCT02685059|Nab-Paclitaxel|nab-paclitaxel
5209679|NCT02685059|Placebo|placebo
5209680|NCT02685059|triple negative|triple negative
5209681|NCT02685033|Osteomyelitis|osteomyelitis
5209682|NCT02685033|dalbavancin|dalbavancin
5209683|NCT02685033|antibiotic|antibiotic
5209684|NCT02685020|Healthy|healthy
5209685|NCT02685020|Human Immunodeficiency Virus|human immunodeficiency virus
5209686|NCT02685020|adenovirus serotype 26|adenovirus serotype 26
5209687|NCT02685020|Ad26.Mos.HIV|ad26.mos.hiv
5209688|NCT02685020|Vaccine|vaccine
5209689|NCT02685020|Placebo|placebo
5209690|NCT02685020|Glycoprotein|glycoprotein
5209691|NCT02685020|IPCAVD010|ipcavd010
5209692|NCT02685007|minimal invasive surgery|minimal invasive surgery
5209693|NCT02684994|Trauma|trauma
5209694|NCT02684994|Sexual assault|sexual assault
5209695|NCT02684994|Sexual abuse|sexual abuse
5209696|NCT02684994|Physical assault|physical assault
5209697|NCT02684994|Physical abuse|physical abuse
5209698|NCT02684994|PTSD|ptsd
5209699|NCT02684994|Interpersonal Violence|interpersonal violence
5209700|NCT02684994|Women|women
5209701|NCT02684955|cardiac arrest|cardiac arrest
5209702|NCT02684955|near-infrared spectroscopy|near-infrared spectroscopy
5209703|NCT02684955|automated infrared pupillometry|automated infrared pupillometry
5209704|NCT02684955|prognostication|prognostication
5209705|NCT02684942|Meperidine|meperidine
5209706|NCT02684942|Fentanyl|fentanyl
5209707|NCT02684942|Pain management|pain management
5209708|NCT02684942|brachytherapy|brachytherapy
5209709|NCT02684929|insulin resistance|insulin resistance
5209710|NCT02684929|bcaa|bcaa
5209711|NCT02684929|mitochondrial biogenesis|mitochondrial biogenesis
5209712|NCT02684916|Chiropractic spinal manipulation|chiropractic spinal manipulation
5209713|NCT02684916|Children|children
5209714|NCT02684916|Pediatric|pediatric
5209715|NCT02684916|Headache|headache
5209716|NCT02684903|Child Abuse|child abuse
5209717|NCT02684903|Parent Child Interaction Therapy (PCIT)|parent child interaction therapy (pcit)
5209718|NCT02684903|Evidenced Based Intervention|evidenced based intervention
5209719|NCT02684903|Self-control|self-control
5209720|NCT02684877|Fatigue|fatigue
5209721|NCT02684877|Quality of life|quality of life
5209722|NCT02684877|Critically ill patients|critically ill patients
5209723|NCT02684864|biomarker|biomarker
5209724|NCT02684864|inflammation|inflammation
5209725|NCT02684864|knee|knee
5209726|NCT02684864|prognosis|prognosis
5857694|NCT00021710|Stroke|stroke
5209727|NCT02684838|Gliadel, Carmustine wafer implant|gliadel, carmustine wafer implant
5209728|NCT02684825|Stroke|stroke
5209729|NCT02684825|ischemic stroke|ischemic stroke
5209730|NCT02684825|atrial fibrillation|atrial fibrillation
5209731|NCT02684825|continuous cardiac monitoring|continuous cardiac monitoring
5209732|NCT02684825|insertable cardiac monitoring|insertable cardiac monitoring
5209733|NCT02684825|implantable loop recorder|implantable loop recorder
5209734|NCT02684825|antithrombotics|antithrombotics
5209735|NCT02684825|anticoagulants|anticoagulants
5209736|NCT02684825|stroke subtype|stroke subtype
5209737|NCT02684825|atherothrombotic stroke|atherothrombotic stroke
5209738|NCT02684825|lacunar stroke|lacunar stroke
5209739|NCT02684812|antifibrinolytic therapy|antifibrinolytic therapy
5209740|NCT02684812|recurrent bleeding|recurrent bleeding
5209741|NCT02684812|tranexamic acid|tranexamic acid
5209742|NCT02684773|Hemodialysis|hemodialysis
5209743|NCT02684773|Left Ventricular Mass|left ventricular mass
5209744|NCT02684773|Cardiac Magnetic resonance Imaging|cardiac magnetic resonance imaging
5209745|NCT02684760|Inflammatory Bowel Disease|inflammatory bowel disease
5209746|NCT02684747|Healthy Volunteers|healthy volunteers
5209747|NCT02684747|Sports Medicine|sports medicine
5209748|NCT02684747|Athletes|athletes
5209749|NCT02684747|Anti-doping|anti-doping
5209750|NCT02684734|Ulcerative Colitis|ulcerative colitis
5209752|NCT02684734|Cytomegalovirus|cytomegalovirus
5209753|NCT02684734|CMV|cmv
5209754|NCT02684721|rehabilitation|rehabilitation
5209755|NCT02684721|physical capacity|physical capacity
5209756|NCT02684721|quality of life|quality of life
5209757|NCT02684695|Magnetic resonance imaging|magnetic resonance imaging
5209758|NCT02684695|Imaging biomarker|imaging biomarker
5209759|NCT02684695|Diffusion-weighted imaging|diffusion-weighted imaging
5209760|NCT02684682|Toothbrushing|toothbrushing
5209761|NCT02684682|Gingivitis|gingivitis
5209762|NCT02684682|Dental Plaque|dental plaque
5209763|NCT02684682|Periodontal Diseases|periodontal diseases
5209764|NCT02684682|Clinical Trial|clinical trial
5209765|NCT02684669|burn injury|burn injury
5209766|NCT02684669|controlled trial|controlled trial
5209767|NCT02684669|latent sensitization|latent sensitization
5209768|NCT02684669|naloxone|naloxone
5209769|NCT02684669|secondary hyperalgesia|secondary hyperalgesia
5209770|NCT02684669|volunteers|volunteers
5209771|NCT02684656|Oxalate|oxalate
5209772|NCT02684656|Inflammation|inflammation
5209773|NCT02684656|Hemodiafiltration|hemodiafiltration
5209774|NCT02684656|Hemodialysis|hemodialysis
5209775|NCT02684656|Oxalate Blood Sample|oxalate blood sample
5209776|NCT02684643|individualised therapy|individualised therapy
5209777|NCT02684643|hyperphosphatemia|hyperphosphatemia
5209778|NCT02684643|hemodialysis|hemodialysis
5209779|NCT02684643|clinical trials|clinical trials
5209780|NCT02684643|restricted phosphate diet|restricted phosphate diet
5209781|NCT02684643|phosphate binders|phosphate binders
5209782|NCT02684565|pre-diabetes|pre-diabetes
5209783|NCT02684565|blood glucose regulation|blood glucose regulation
5209784|NCT02684565|branching chain amino acids|branching chain amino acids
5209785|NCT02684565|diabetes|diabetes
5209786|NCT02684565|lower blood sugar|lower blood sugar
5209787|NCT02684513|Well-being|well-being
5209788|NCT02684513|Quality of Recovery|quality of recovery
5209789|NCT02684513|Maternal complications|maternal complications
5209790|NCT02684500|aSAH|asah
5209791|NCT02684487|vitamin D|vitamin d
5209792|NCT02684487|vitamin D3|vitamin d3
5209793|NCT02684487|sepsis|sepsis
5209794|NCT02684487|severe sepsis|severe sepsis
5209795|NCT02684487|critical illness|critical illness
5209797|NCT02684396|Drug therapy|drug therapy
5209798|NCT02684383|Dengue Vaccine|dengue vaccine
5209799|NCT02684370|Psoriasis|psoriasis
5209800|NCT02684370|Skin Diseases|skin diseases
5209801|NCT02684370|Skin Diseases, Papulosquamous|skin diseases, papulosquamous
5209802|NCT02684370|ustekinumab|ustekinumab
5209803|NCT02684370|Dermatologic Agents|dermatologic agents
5197842|NCT02758028|Youth|youth
5197845|NCT02758015|betaine|betaine
5209806|NCT02684370|risankizumab|risankizumab
5209807|NCT02684357|ABBV-066|abbv-066
5209808|NCT02684357|BI 655066|bi 655066
5209809|NCT02684357|risankizumab|risankizumab
5209810|NCT02684344|Post-Operative Urinary Retention|post-operative urinary retention
5209811|NCT02684292|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5209812|NCT02684292|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5209813|NCT02684266|neoplasm, Cycline-Dependent Kinase|neoplasm, cycline-dependent kinase
5209814|NCT02684253|Nivolumab|nivolumab
5209815|NCT02684253|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5209816|NCT02684253|15-253|15-253
5209817|NCT02684214|food security|food security
5209818|NCT02684201|Phantom Limb|phantom limb
5209819|NCT02684201|Upper Amputee|upper amputee
5209820|NCT02684201|Electrodes|electrodes
5209821|NCT02684201|Implant|implant
5209822|NCT02684201|Pain|pain
5209823|NCT02684175|Audiometry|audiometry
5209824|NCT02684175|Cochlear Implants|cochlear implants
5209825|NCT02684175|Adult|adult
5209829|NCT02684175|Technology Assessment, Biomedical|technology assessment, biomedical
5209831|NCT02684149|Arterial puncture|arterial puncture
5209832|NCT02684149|Cross-over|cross-over
5209833|NCT02684149|Relational touch|relational touch
5209834|NCT02684149|Pain|pain
5209835|NCT02684136|insomnia|insomnia
5209836|NCT02684136|fibromyalgia|fibromyalgia
5209837|NCT02684136|polysomnography|polysomnography
5209838|NCT02684136|pain management|pain management
5209839|NCT02684123|Alopecia areata|alopecia areata
5209840|NCT02684097|Alopecia, Alopecia Totalis, Alopecia Universalis|alopecia, alopecia totalis, alopecia universalis
5209841|NCT02684084|Diabetic Macular Edema|diabetic macular edema
5209843|NCT02684084|Lucentis|lucentis
5209844|NCT02684071|medulloblastoma, ependymoma, AT/RT, embryonal|medulloblastoma, ependymoma, at/rt, embryonal
5209845|NCT02684058|Malignant glioma|malignant glioma
5209846|NCT02684058|BRAF mutant positive|braf mutant positive
5209847|NCT02684058|High grade glioma|high grade glioma
5209848|NCT02684058|Low grade glioma|low grade glioma
5209849|NCT02684058|Dabrafenib|dabrafenib
5209850|NCT02684058|Trametinib|trametinib
5209851|NCT02684058|Pediatrics|pediatrics
5209852|NCT02684058|Brain neoplasma|brain neoplasma
5209853|NCT02684032|PI3K (phosphoinositide 3-kinase)|pi3k (phosphoinositide 3-kinase)
5209854|NCT02684032|mTOR (mechanistic target of rapamycin)|mtor (mechanistic target of rapamycin)
5209855|NCT02684032|PI3K/mTOR|pi3k/mtor
5209856|NCT02684032|metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
5209857|NCT02684032|ER+ (estrogen receptor positive)|er+ (estrogen receptor positive)
5209858|NCT02684032|HER2- (human epidermal growth factor receptor 2 negative)|her2- (human epidermal growth factor receptor 2 negative)
5209859|NCT02684019|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5209860|NCT02684019|sedation|sedation
5209861|NCT02684019|dexmedetomidine|dexmedetomidine
5209863|NCT02684019|Magnesium sulphate|magnesium sulphate
5209864|NCT02684019|Bispectral index monitoring|bispectral index monitoring
5209870|NCT02683915|Acute kidney injury|acute kidney injury
5209871|NCT02683915|Perinatal asphyxia|perinatal asphyxia
5209872|NCT02683915|Therapeutic hypothermia|therapeutic hypothermia
5209873|NCT02683915|Serum NGAL|serum ngal
5209874|NCT02683915|Serum cystatin-C|serum cystatin-c
5209875|NCT02683902|prediabetes|prediabetes
5209876|NCT02683902|tDCS|tdcs
5209877|NCT02683902|transcranial direct current stimulation|transcranial direct current stimulation
5209878|NCT02683902|obesity|obesity
5209879|NCT02683902|diabetes|diabetes
5209880|NCT02683876|body odor, malodor, halitosis|body odor, malodor, halitosis
5209881|NCT02683837|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
5209882|NCT02683837|Reflex, Pupillary|reflex, pupillary
5209883|NCT02683837|remifentanil|remifentanil
5209884|NCT02683811|adolescence|adolescence
5209885|NCT02683811|prevention|prevention
5209886|NCT02683811|wellbeing|wellbeing
5209887|NCT02683811|evaluation|evaluation
5209888|NCT02683811|effectiveness|effectiveness
5209889|NCT02683811|school-based program|school-based program
5209890|NCT02683798|Weight loss maintenance|weight loss maintenance
5209891|NCT02683785|Pain intensity|pain intensity
5209892|NCT02683785|Hand Osteoarthritis|hand osteoarthritis
5209893|NCT02683785|GSK3196165|gsk3196165
5209894|NCT02683785|AUSCAN|auscan
5209895|NCT02683785|GM-CSF|gm-csf
5209896|NCT02683785|Numerical Rating Scale|numerical rating scale
5209897|NCT02683772|NIV, NIPPV, ventilation|niv, nippv, ventilation
5209898|NCT02683746|Pharmacodynamics|pharmacodynamics
5209899|NCT02683746|Safety|safety
5206703|NCT02702687|Asthma|asthma
5209902|NCT02683746|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5209903|NCT02683746|Efficacy|efficacy
5209904|NCT02683707|Percutaneous Coronary Intervention|percutaneous coronary intervention
5209905|NCT02683707|Blood Platelets|blood platelets
5209906|NCT02683707|Fentanyl|fentanyl
5209907|NCT02683694|Epiretinal membrane|epiretinal membrane
5209908|NCT02683694|lamellar holes of the macula|lamellar holes of the macula
5209909|NCT02683694|macular holes|macular holes
5209910|NCT02683694|vitreomacular traction syndrome|vitreomacular traction syndrome
5209911|NCT02683668|Inhalers|inhalers
5209912|NCT02683668|Tiotropium|tiotropium
5209913|NCT02683629|Parkinson's Disease|parkinson's disease
5101915|NCT03361111|anti-IgE|anti-ige
5209914|NCT02683629|Xenotransplantation|xenotransplantation
5209915|NCT02683629|choroid plexus|choroid plexus
5209916|NCT02683603|colistin|colistin
5209917|NCT02683603|aerosol|aerosol
5209918|NCT02683603|ventilator associated pneumonia|ventilator associated pneumonia
5209919|NCT02683603|nephrotoxicity|nephrotoxicity
5209920|NCT02683603|intravenous|intravenous
5209921|NCT02683590|Sternectomie|sternectomie
5209922|NCT02683590|Ceramic Implant|ceramic implant
5209923|NCT02683590|Bones Tumors|bones tumors
5209925|NCT02683525|Allogeneic|allogeneic
5209926|NCT02683525|Sitagliptin|sitagliptin
5209927|NCT02683499|Tooth preparation|tooth preparation
5209928|NCT02683499|Prosthodontics|prosthodontics
5209929|NCT02683447|Continuing Medical Education|continuing medical education
5209930|NCT02683447|Simulation|simulation
5209931|NCT02683447|Non-technical Skills|non-technical skills
5209932|NCT02683447|Crisis Resource Management|crisis resource management
5209933|NCT02683434|soccer|soccer
5209934|NCT02683421|Rheumatoid arthritis|rheumatoid arthritis
5209935|NCT02683421|Tilmanocept|tilmanocept
5209936|NCT02683421|Imaging|imaging
5209937|NCT02683395|PLX51107|plx51107
5209938|NCT02683395|Acute Myeloid Leukemia|acute myeloid leukemia
5209939|NCT02683395|Myelodysplastic Syndrome|myelodysplastic syndrome
5209940|NCT02683395|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5209941|NCT02683369|Non-anemic Iron Deficiency, Iron Supplementation|non-anemic iron deficiency, iron supplementation
5209942|NCT02683356|Percutaneous Coronary Intervention|percutaneous coronary intervention
5209943|NCT02683356|Stents|stents
5209944|NCT02683330|PD|pd
5209945|NCT02683330|Parkinson's|parkinson's
5209946|NCT02683317|DHA|dha
5209947|NCT02683317|Retinopathy of Prematurity|retinopathy of prematurity
5209948|NCT02683291|Kidney transplantation|kidney transplantation
5209949|NCT02683291|sirolimus|sirolimus
5209950|NCT02683291|cytomegalovirus|cytomegalovirus
5209951|NCT02683291|aged|aged
5209952|NCT02683252|Magnetic resonance imaging|magnetic resonance imaging
5209953|NCT02683252|perfusion|perfusion
5209954|NCT02683252|quantitative|quantitative
5209955|NCT02683213|fluoxetine|fluoxetine
5209956|NCT02683213|outcome|outcome
5209957|NCT02683213|depression|depression
5209958|NCT02683213|plasticity|plasticity
5209959|NCT02683187|insulin secretion|insulin secretion
5209960|NCT02683187|GLP-1|glp-1
5209961|NCT02683187|alpha cell|alpha cell
5209962|NCT02683187|paracrine effect|paracrine effect
5209963|NCT02683187|Glucagon-Like Peptide 1|glucagon-like peptide 1
5209964|NCT02683174|syncope|syncope
5209965|NCT02683122|Organ dysfunction scores|organ dysfunction scores
5209966|NCT02683122|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5209967|NCT02683122|Intensive care units|intensive care units
5209968|NCT02683070|Catheter-related bladder discomfort|catheter-related bladder discomfort
5209969|NCT02683070|Pudendal nerve block|pudendal nerve block
5209970|NCT02683070|Tramadol|tramadol
5209971|NCT02683070|Randomized controlled trial|randomized controlled trial
5209972|NCT02683070|catheter-related bladder discomfort prevention|catheter-related bladder discomfort prevention
5209973|NCT02683044|Erectile dysfunction|erectile dysfunction
5209974|NCT02683044|Low-Density Shock Waves|low-density shock waves
5209975|NCT02683044|Randomized Clinical Trial|randomized clinical trial
5209976|NCT02683031|fertilization arrest|fertilization arrest
5209977|NCT02683031|Cleavage failure|cleavage failure
5209978|NCT02683031|Embryonic development|embryonic development
5209979|NCT02683031|Calcium ionophore|calcium ionophore
5209980|NCT02683005|treatment|treatment
5209981|NCT02683005|pharmacokinetics|pharmacokinetics
5209982|NCT02682979|therapeutic limitation code|therapeutic limitation code
5209983|NCT02682979|emergency unit admittance|emergency unit admittance
5209984|NCT02682966|troponin|troponin
5209985|NCT02682966|coronary artery disease|coronary artery disease
5209986|NCT02682966|pulmonary embolism|pulmonary embolism
5209987|NCT02682966|Computed Tomography Angiography|computed tomography angiography
5209988|NCT02682966|postoperative myocardial injury|postoperative myocardial injury
5209989|NCT02682927|seizure|seizure
5209990|NCT02682927|tonic-atonic|tonic-atonic
5209991|NCT02682927|clonic|clonic
5209992|NCT02682927|epilepsy|epilepsy
5209993|NCT02682927|myoclonic|myoclonic
5209994|NCT02682927|encephalopathy|encephalopathy
5209995|NCT02682914|Psychological distress|psychological distress
5209996|NCT02682914|Stroke etiology|stroke etiology
5209997|NCT02682914|Young patients|young patients
5209998|NCT02682888|brain functional connectivity changes|brain functional connectivity changes
5209999|NCT02682862|tiotropium|tiotropium
5210000|NCT02682862|olodaterol|olodaterol
5210001|NCT02682862|smoker|smoker
5210002|NCT02682862|cigarette|cigarette
5210003|NCT02682862|bronchodilator|bronchodilator
5210004|NCT02682836|physical activity|physical activity
5210005|NCT02682836|chemotherapy|chemotherapy
5210006|NCT02682836|fatigue|fatigue
5210007|NCT02682810|HIV|hiv
5210008|NCT02682810|point-of-care HIV diagnosis|point-of-care hiv diagnosis
5210009|NCT02682810|Alere Q|alere q
5210010|NCT02682810|diagnostic|diagnostic
5210011|NCT02682810|children|children
5210012|NCT02682771|gastroplasty, breathing exercices, positive pressure|gastroplasty, breathing exercices, positive pressure
5210013|NCT02682758|xenon|xenon
5210014|NCT02682758|transpulmonary pressure|transpulmonary pressure
5210015|NCT02682758|electrical impedance tomography|electrical impedance tomography
5210016|NCT02682758|tidal volume|tidal volume
5210017|NCT02682758|esophageal pressure measurement|esophageal pressure measurement
5210018|NCT02682732|Acute Myeloid Leukemia|acute myeloid leukemia
5296436|NCT02194439|BMT|bmt
5210019|NCT02682732|PET/CT Scan|pet/ct scan
5210020|NCT02682719|Natriuretic peptide, brain|natriuretic peptide, brain
5210021|NCT02682719|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5210022|NCT02682719|Hypertension|hypertension
5210023|NCT02682719|Cardiovascular prevention|cardiovascular prevention
5210024|NCT02682719|Left atrial volume index|left atrial volume index
5210025|NCT02682719|Angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
5210026|NCT02682719|LCZ696|lcz696
5210027|NCT02682719|Valsartan|valsartan
5210028|NCT02682719|Sacubitril|sacubitril
5210029|NCT02682706|brown adipose tissue|brown adipose tissue
5210030|NCT02682706|magnetic resonance imaging|magnetic resonance imaging
5210031|NCT02682706|energy expenditure|energy expenditure
5210032|NCT02682706|non-shivering thermogenesis|non-shivering thermogenesis
5210033|NCT02682680|diabetes|diabetes
5210333|NCT02680821|Laxity|laxity
5210034|NCT02682680|hyperlipidaemia|hyperlipidaemia
5210035|NCT02682680|colesevelam|colesevelam
5210036|NCT02682680|ezetimibe|ezetimibe
5210037|NCT02682680|LDL cholesterol|ldl cholesterol
5210038|NCT02682680|glycated hemoglobin|glycated hemoglobin
5210039|NCT02682667|Apheresis Products|apheresis products
5210040|NCT02682667|Immunological|immunological
5210041|NCT02682667|Diverse Malignan|diverse malignan
5210042|NCT02682667|Premalignant|premalignant
5210043|NCT02682667|Protein|protein
5210044|NCT02682654|Pain|pain
5210045|NCT02682654|Ankle|ankle
5210046|NCT02682654|Knee|knee
5210047|NCT02682654|Brace|brace
5210048|NCT02682615|Cardiac Index|cardiac index
5210049|NCT02682615|Noninvasive|noninvasive
5210050|NCT02682615|esCCO|escco
5210051|NCT02682615|PiCCO|picco
5210052|NCT02682615|Thermodilution|thermodilution
5210053|NCT02682602|total hip arthroplasty|total hip arthroplasty
5210054|NCT02682589|Complete Mesocolic Excision|complete mesocolic excision
5210055|NCT02682589|locally advanced Colon Cancer|locally advanced colon cancer
5210056|NCT02682589|Laparoscopic|laparoscopic
5210057|NCT02682576|brachial artery ultrasound imaging|brachial artery ultrasound imaging
5210058|NCT02682576|flow-mediated dilation|flow-mediated dilation
5210059|NCT02682576|endothelium|endothelium
5210060|NCT02682563|SGLT-2 inhibition, Renal, Cardiovascular, Type 2 diabetes, forxiga, dapagliflozin|sglt-2 inhibition, renal, cardiovascular, type 2 diabetes, forxiga, dapagliflozin
5210061|NCT02682550|polytrauma|polytrauma
5210062|NCT02682550|hemorrhagic shock|hemorrhagic shock
5210063|NCT02682550|sepsis|sepsis
5210064|NCT02682550|MODS|mods
5210065|NCT02682537|Resting energy expenditure|resting energy expenditure
5210066|NCT02682537|Calorie requirements|calorie requirements
5210067|NCT02682537|Indirect Calorimetry|indirect calorimetry
5210068|NCT02682511|Ifetroban|ifetroban
5210069|NCT02682511|Scleroderma|scleroderma
5210070|NCT02682511|Systemic Sclerosis|systemic sclerosis
5210071|NCT02682498|Knee Arthroplasty, Total|knee arthroplasty, total
5210072|NCT02682498|Liposomal Bupivicaine|liposomal bupivicaine
5210073|NCT02682485|Rectal Cancer|rectal cancer
5210074|NCT02682485|low anterior resection|low anterior resection
5210075|NCT02682485|SES|ses
5210076|NCT02682485|SES-DTA|ses-dta
5210077|NCT02682485|anastomotic leak|anastomotic leak
5210078|NCT02682485|anastomotic healing|anastomotic healing
5210079|NCT02682485|intestinal healing|intestinal healing
5210080|NCT02682485|anastomosis|anastomosis
5210081|NCT02682459|Extracapillary glomerulonephritis|extracapillary glomerulonephritis
5210082|NCT02682459|crescentic glomerulonephritis|crescentic glomerulonephritis
5210083|NCT02682459|rapidly progressive renal failure|rapidly progressive renal failure
5210084|NCT02682459|chronic kidney disease|chronic kidney disease
5210085|NCT02682459|ACE-inhibitors|ace-inhibitors
5210086|NCT02682459|fibrosis|fibrosis
5210087|NCT02682446|Early gastric cancer|early gastric cancer
5210088|NCT02682446|endoscopic submucosal dissection|endoscopic submucosal dissection
5210089|NCT02682446|serum pepsinogen|serum pepsinogen
5210090|NCT02682446|Helicobacter pylori|helicobacter pylori
5210091|NCT02682407|IgAN|igan
5210092|NCT02682407|MN|mn
5210093|NCT02682407|C3 Glomerulopathy|c3 glomerulopathy
5210094|NCT02682407|Lupus Nephritis|lupus nephritis
5210097|NCT02682394|MRI|mri
5210098|NCT02682381|Teduglutide|teduglutide
5210099|NCT02682381|pediatric|pediatric
5210100|NCT02682381|GLP-2|glp-2
5210101|NCT02682381|parenteral support|parenteral support
5210102|NCT02682381|Short Bowel Syndrome|short bowel syndrome
5210103|NCT02682381|short gut syndrome|short gut syndrome
5210104|NCT02682381|short gut|short gut
5210105|NCT02682381|SBS|sbs
5210106|NCT02682381|parenteral nutrition|parenteral nutrition
5210107|NCT02682368|Surgeon performed ultrasound|surgeon performed ultrasound
5210108|NCT02682368|Point of care ultrasound|point of care ultrasound
5210109|NCT02682329|Peroxide|peroxide
5210110|NCT02682316|undergoing laparotomy|undergoing laparotomy
5210111|NCT02682316|15-309|15-309
5210112|NCT02682303|Adhesive elastic bandaging|adhesive elastic bandaging
5210113|NCT02682303|balance|balance
5210114|NCT02682303|posturography|posturography
5210121|NCT02682277|polyglucosamine|polyglucosamine
5210122|NCT02682277|L112|l112
5210123|NCT02682277|caloric restriction|caloric restriction
5210124|NCT02682277|physical activity|physical activity
5210125|NCT02682264|acne|acne
5210126|NCT02682251|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
5210127|NCT02682251|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5210128|NCT02682225|Esketamine|esketamine
5210129|NCT02682225|Placebo|placebo
5210130|NCT02682225|Racemic ketamine|racemic ketamine
5210131|NCT02682225|Pharmacokinetics|pharmacokinetics
5210132|NCT02682212|Pelvic floor|pelvic floor
5210133|NCT02682212|obstetrics|obstetrics
5210134|NCT02682212|perineal tear|perineal tear
5210135|NCT02682212|physiotherapy|physiotherapy
5210136|NCT02682186|Prosthetic breast surgery|prosthetic breast surgery
5210137|NCT02682186|Locoregional anesthesia|locoregional anesthesia
5210138|NCT02682186|Pectoral nerve block|pectoral nerve block
5210140|NCT02682186|Postoperative analgesia|postoperative analgesia
5210141|NCT02682160|bariatric surgery|bariatric surgery
5210142|NCT02682134|Sore Throat|sore throat
5210143|NCT02682134|Intubation|intubation
5210144|NCT02682134|Xylocaine|xylocaine
5210145|NCT02682134|Dexamethasone|dexamethasone
5210146|NCT02682108|Hepatitis B|hepatitis b
5210147|NCT02682108|Hepatitis C|hepatitis c
5210148|NCT02682108|Fibrosis, Liver|fibrosis, liver
5210149|NCT02682108|Magnetic Resonance Imaging|magnetic resonance imaging
5210150|NCT02682095|Hypertension|hypertension
5210151|NCT02682095|Blood Pressure Control|blood pressure control
5210152|NCT02682095|Adherence|adherence
5210153|NCT02682095|Mixed Methods|mixed methods
5210154|NCT02682082|Pancreatic cancer|pancreatic cancer
5210155|NCT02682082|Pain Management|pain management
5210156|NCT02682082|Celiac plexus neurolysis|celiac plexus neurolysis
5210157|NCT02682082|Bupivacaine|bupivacaine
5210158|NCT02682082|Palliative treatment|palliative treatment
5210163|NCT02682056|Pediatrics|pediatrics
5210164|NCT02682056|Endocrinology|endocrinology
5210165|NCT02682056|Adolescent|adolescent
5210166|NCT02682056|Microneedle|microneedle
5210167|NCT02682030|Airway Clearance Devices|airway clearance devices
5210168|NCT02682030|High Frequency Chest Compression Devices|high frequency chest compression devices
5210169|NCT02682030|Cough Assist|cough assist
5210170|NCT02682017|Seaweed|seaweed
5210171|NCT02682017|Pork|pork
5210172|NCT02682017|Fucoidan|fucoidan
5210173|NCT02682017|Laminarin|laminarin
5210174|NCT02682017|Functional Food|functional food
5210175|NCT02682017|Antioxidant activity|antioxidant activity
5210176|NCT02681913|Cardioplegia|cardioplegia
5210177|NCT02681913|Cardiac Surgery|cardiac surgery
5210178|NCT02681913|Adenosine|adenosine
5210179|NCT02681913|Therapeutic Uses|therapeutic uses
5210180|NCT02681913|Intermittent warm blood cardioplegia|intermittent warm blood cardioplegia
5210181|NCT02681913|Minimally Invasive Surgery|minimally invasive surgery
5210182|NCT02681913|minimally invasive mitral valve plasty (mini-MPL)|minimally invasive mitral valve plasty (mini-mpl)
5210183|NCT02681913|minimally invasive mitral valve replacement (mini-MVR)|minimally invasive mitral valve replacement (mini-mvr)
5210184|NCT02681874|dietary pattern|dietary pattern
5210185|NCT02681874|stress|stress
5210186|NCT02681874|nutrition|nutrition
5210187|NCT02681874|health|health
5210188|NCT02681874|obesity|obesity
5210189|NCT02681874|children|children
5210190|NCT02681874|minority|minority
5210191|NCT02681874|pre-schoolers|pre-schoolers
5210192|NCT02681861|Pharmacodynamics|pharmacodynamics
5210193|NCT02681861|Pharmacokinetics|pharmacokinetics
5210195|NCT02681861|Maximum tolerated dose|maximum tolerated dose
5210196|NCT02681861|Healthy subjects|healthy subjects
5210197|NCT02681848|Primary care attendance|primary care attendance
5210198|NCT02681848|All-cause|all-cause
5210199|NCT02681848|Cause specific|cause specific
5210200|NCT02681848|Hospital attendance|hospital attendance
5210201|NCT02681822|Genome-wide association studies|genome-wide association studies
5210202|NCT02681822|Environmental factors|environmental factors
5210203|NCT02681822|Behavioral Assessment|behavioral assessment
5210204|NCT02681822|Pathway analysis|pathway analysis
5210205|NCT02681783|aflibercept|aflibercept
5210206|NCT02681770|kidney transplantation|kidney transplantation
5210207|NCT02681770|adherence|adherence
5210208|NCT02681770|quality of life|quality of life
5210209|NCT02681770|couples|couples
5210210|NCT02681770|fundamental frequency|fundamental frequency
5210211|NCT02681770|communication|communication
5210212|NCT02681770|social support|social support
5210213|NCT02681757|pediatric hand burn|pediatric hand burn
5210214|NCT02681757|pediatric foot burn|pediatric foot burn
5210215|NCT02681757|mepitel Ag|mepitel ag
5210216|NCT02681757|soft cast technique for burn wound heaing|soft cast technique for burn wound heaing
5210217|NCT02681718|A1C≥9%|a1c≥9%
5210218|NCT02681718|minorities|minorities
5210219|NCT02681718|economically disadvantaged|economically disadvantaged
5210220|NCT02681692|colonoscopy|colonoscopy
5210221|NCT02681692|colonoscopy education|colonoscopy education
5210222|NCT02681692|magnetic endoscope imaging|magnetic endoscope imaging
5210223|NCT02681692|Colonic Diseases|colonic diseases
5210224|NCT02681666|FODMAP Diet|fodmap diet
5210225|NCT02681666|Bowel Habit|bowel habit
5210226|NCT02681666|Rome IV Criteria|rome iv criteria
5210227|NCT02681666|Mindfulness|mindfulness
5210228|NCT02681666|Abdominal pain|abdominal pain
5210229|NCT02681666|Irritable Bowel Syndrome|irritable bowel syndrome
5210231|NCT02681653|Septic Shock|septic shock
5210232|NCT02681614|Imaging|imaging
5210233|NCT02681614|Prostate|prostate
5210234|NCT02681614|Multiparametric MRI|multiparametric mri
5210235|NCT02681614|brachytherapy|brachytherapy
5210236|NCT02681601|Diet, Food, and Nutrition|diet, food, and nutrition
5210237|NCT02681588|diabetes, obesity, skinfold, newborn|diabetes, obesity, skinfold, newborn
5210238|NCT02681562|olaparib|olaparib
5210239|NCT02681510|medication tolerability|medication tolerability
5210240|NCT02681497|canagliflozin|canagliflozin
5210241|NCT02681497|diabetes|diabetes
5210242|NCT02681497|SGLT2|sglt2
5210243|NCT02681497|real-world data|real-world data
5210244|NCT02681471|Monopolar|monopolar
5210245|NCT02681471|Bipolar|bipolar
5210246|NCT02681471|TURP syndrome|turp syndrome
5210247|NCT02681471|hyponatremia|hyponatremia
5210248|NCT02681432|HIPEC|hipec
5210249|NCT02681432|ovarian cancer|ovarian cancer
5210250|NCT02681432|peritoneal carcinomatosis|peritoneal carcinomatosis
5210251|NCT02681393|Physical activity, brochures, telephone support, stroke|physical activity, brochures, telephone support, stroke
5210252|NCT02681380|simulated patient|simulated patient
5210253|NCT02681380|Balint|balint
5210254|NCT02681380|empathy|empathy
5210255|NCT02681380|medical student|medical student
5210256|NCT02681367|Recurrent implantation failure|recurrent implantation failure
5210257|NCT02681367|Freeze all policy|freeze all policy
5210258|NCT02681367|endometrial receptivity|endometrial receptivity
5210259|NCT02681367|implantation|implantation
5210260|NCT02681367|clinical outcome|clinical outcome
5210261|NCT02681354|elderly|elderly
5210262|NCT02681289|infant|infant
5210263|NCT02681289|risk|risk
5210264|NCT02681289|rehabilitation|rehabilitation
5210265|NCT02681276|Irrigation during root canal treatment|irrigation during root canal treatment
5210266|NCT02681276|Sodium Hypochlorite|sodium hypochlorite
5210267|NCT02681250|Zirconium|zirconium
5210268|NCT02681250|Randomized Controlled Trial|randomized controlled trial
5210269|NCT02681250|Dental Implants|dental implants
5210270|NCT02681250|Dental Material|dental material
5210271|NCT02681250|Titanium|titanium
5210272|NCT02681211|migraine headache|migraine headache
5210273|NCT02681211|acupuncture|acupuncture
5210274|NCT02681198|Healthy|healthy
5210275|NCT02681198|Lofexidine|lofexidine
5210276|NCT02681198|Paroxetine|paroxetine
5210277|NCT02681198|Volunteer|volunteer
5210279|NCT02681172|Alzheimer's Disease (AD) and related dementia|alzheimer's disease (ad) and related dementia
5210280|NCT02681172|HAS recommendations|has recommendations
5210281|NCT02681159|Anesthesia|anesthesia
5210282|NCT02681146|education|education
5210283|NCT02681146|physiotherapy|physiotherapy
5210284|NCT02681133|Physical activity level|physical activity level
5210286|NCT02681133|Non pharmacological treatment|non pharmacological treatment
5210288|NCT02681133|Socio-demographic, clinical variables|socio-demographic, clinical variables
5210289|NCT02681133|Barriers, facilitators Fears and beliefs|barriers, facilitators fears and beliefs
5210290|NCT02681133|Function|function
5210291|NCT02681120|Biomarkers|biomarkers
5210292|NCT02681120|Breast imaging|breast imaging
5210293|NCT02681107|Radiation therapy|radiation therapy
5210294|NCT02681107|Accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
5210295|NCT02681107|Breast conserving surgery|breast conserving surgery
5210296|NCT02681107|Stage 1|stage 1
5210297|NCT02681094|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
5210298|NCT02681094|saxagliptin,|saxagliptin,
5210299|NCT02681094|dapagliflozin,|dapagliflozin,
5210300|NCT02681094|metformin|metformin
5210301|NCT02681081|Neuroplasticity|neuroplasticity
5210302|NCT02681068|Fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
5210303|NCT02681068|Clostridium difficile associated diarrhea (CDAD)|clostridium difficile associated diarrhea (cdad)
5210304|NCT02681055|NASH|nash
5210305|NCT02681055|NAFLD|nafld
5210306|NCT02681029|Cleavage stage blastocyst transfer cryopreservation|cleavage stage blastocyst transfer cryopreservation
5210307|NCT02681016|Calypso|calypso
5210308|NCT02681016|Xience|xience
5210309|NCT02681016|Coronary stenosis|coronary stenosis
5210310|NCT02681016|Drug-eluting stent|drug-eluting stent
5210311|NCT02681016|Coronary angioplasty with stenting|coronary angioplasty with stenting
5210312|NCT02681016|Ischemic Heart Disease|ischemic heart disease
5210322|NCT02680899|behavioral intervention|behavioral intervention
5210323|NCT02680886|Rapid Absorbable Suture Material|rapid absorbable suture material
5210324|NCT02680886|Children / Adults|children / adults
5210325|NCT02680886|Novosyn Quick|novosyn quick
5210326|NCT02680873|type 2 diabetes , obesity , SASI|type 2 diabetes , obesity , sasi
5210327|NCT02680847|Pediatric|pediatric
5210328|NCT02680847|pain indication|pain indication
5210329|NCT02680847|controlled release oxycodone|controlled release oxycodone
5210334|NCT02680821|Knee|knee
5210335|NCT02680821|Rupture|rupture
5210337|NCT02680795|UGT1A1*28|ugt1a1*28
5210338|NCT02680795|Belinostat|belinostat
5210339|NCT02680795|beleodaq|beleodaq
5210340|NCT02680795|wild type genotypes|wild type genotypes
5210341|NCT02680795|heterozygous genotypes|heterozygous genotypes
5210342|NCT02680795|homozygous genotypes|homozygous genotypes
5210343|NCT02680782|Healthy Volunteers|healthy volunteers
5210344|NCT02680782|Comparison|comparison
5210345|NCT02680782|Once-Daily|once-daily
5210346|NCT02680782|Twice-Daily|twice-daily
5210347|NCT02680782|X4P-001|x4p-001
5210354|NCT02680730|Autonomic nervous system|autonomic nervous system
5210355|NCT02680730|Auditory processing disorder|auditory processing disorder
5210356|NCT02680730|Social behavior|social behavior
5210357|NCT02680691|infratentorial stroke|infratentorial stroke
5210358|NCT02680691|robot|robot
5210359|NCT02680691|postural balance|postural balance
5210360|NCT02680691|Rehabilitation|rehabilitation
5210361|NCT02680652|CVID|cvid
5210362|NCT02680652|Common Variable Immune Deficiency|common variable immune deficiency
5210363|NCT02680639|High-Frequency Ventilation|high-frequency ventilation
5210364|NCT02680639|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
5210365|NCT02680613|Behaviour Change|behaviour change
5210366|NCT02680613|Secondary Prevention|secondary prevention
5210367|NCT02680613|mHealth|mhealth
5210368|NCT02680587|Prostate Cancer|prostate cancer
5210369|NCT02680587|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5210370|NCT02680587|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
5210371|NCT02680587|Oligometastasis|oligometastasis
5210372|NCT02680574|vadadustat|vadadustat
5210373|NCT02680574|AKB-6548|akb-6548
5210374|NCT02680574|Chronic kidney disease|chronic kidney disease
5210375|NCT02680574|anemia|anemia
5210376|NCT02680574|CKD|ckd
5210377|NCT02680574|chronic renal insufficiency|chronic renal insufficiency
5210378|NCT02680574|renal impairment|renal impairment
5210379|NCT02680574|erythropoietin|erythropoietin
5210380|NCT02680574|kidney|kidney
5210381|NCT02680574|renal|renal
5210382|NCT02680574|oral anemia treatment|oral anemia treatment
5210383|NCT02680574|hemoglobin|hemoglobin
5210384|NCT02680574|hypoxia-inducible factor|hypoxia-inducible factor
5210385|NCT02680574|HIF|hif
5210386|NCT02680574|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5210387|NCT02680574|HIF-PHI|hif-phi
5210388|NCT02680574|efficacy|efficacy
5210389|NCT02680574|safety|safety
5210390|NCT02680574|Phase 3|phase 3
5210391|NCT02680574|cardiovascular|cardiovascular
5210392|NCT02680574|NDD-CKD|ndd-ckd
5210393|NCT02680548|ankle pain|ankle pain
5210394|NCT02680548|foot pain|foot pain
5210395|NCT02680548|methylprednisolone|methylprednisolone
5210396|NCT02680548|neuropathic pain|neuropathic pain
5210397|NCT02680522|Parkinson's disease|parkinson's disease
5210398|NCT02680522|Heart Rate Variability|heart rate variability
5210399|NCT02680522|Physiotherapy|physiotherapy
5210402|NCT02680496|Energy Consumption|energy consumption
5210403|NCT02680496|Cardiorespiratory Load|cardiorespiratory load
5210404|NCT02680496|Stroke [MeSH]|stroke [mesh]
5210405|NCT02680483|Atrial fibrillation|atrial fibrillation
5210406|NCT02680483|Registry|registry
5210407|NCT02680483|Middle East|middle east
5210409|NCT02680483|risk factors|risk factors
5210410|NCT02680483|in hospital management|in hospital management
5210411|NCT02680483|long term management|long term management
5210412|NCT02680470|Tuberculosis|tuberculosis
5210413|NCT02680470|Management|management
5210414|NCT02680470|Observed therapy|observed therapy
5210415|NCT02680444|Mindfulness|mindfulness
5210416|NCT02680444|Primary Promotion|primary promotion
5210417|NCT02680444|Mental Health|mental health
5210418|NCT02680444|Well-being|well-being
5210419|NCT02680444|Positive Reappraisal|positive reappraisal
5210420|NCT02680392|Pulsed and Continuous Radiofrequency Treatment|pulsed and continuous radiofrequency treatment
5210421|NCT02680392|Continuous adductor canal block|continuous adductor canal block
5210422|NCT02680392|Postoperative pain|postoperative pain
5210423|NCT02680392|Functional recovery|functional recovery
5210424|NCT02680392|Total Knee Joint Replacement|total knee joint replacement
5210425|NCT02680379|Fragile X Syndrome|fragile x syndrome
5210426|NCT02680379|Autism|autism
5210427|NCT02680379|FMR1|fmr1
5210428|NCT02680379|FRAXA|fraxa
5210429|NCT02680340|Total Hip Arthroplasty THA|total hip arthroplasty tha
5210430|NCT02680314|unripe cervix|unripe cervix
5210431|NCT02680301|Wet Wraps|wet wraps
5210432|NCT02680301|Topical Steroid|topical steroid
5210433|NCT02680288|Psychostimulant, Craving, Cocaine.|psychostimulant, craving, cocaine.
5210434|NCT02680275|Chronic endometritis|chronic endometritis
5210435|NCT02680275|Miscarriage|miscarriage
5210436|NCT02680275|Infertility|infertility
5210437|NCT02680262|HPV self-sampling, cervical cancer screening|hpv self-sampling, cervical cancer screening
5210438|NCT02680249|Safety, Bioavailability and Pharmacokinetics|safety, bioavailability and pharmacokinetics
5210439|NCT02680236|Pain|pain
5210440|NCT02680236|Cancer|cancer
5210441|NCT02680236|Chemotherapy|chemotherapy
5210442|NCT02680236|Anxiety|anxiety
5210443|NCT02680236|Depression|depression
5210444|NCT02680236|Isolation|isolation
5210445|NCT02680197|COPD|copd
5210446|NCT02680184|Malignant Melanoma|malignant melanoma
5210447|NCT02680184|Stage IV Skin Melanoma|stage iv skin melanoma
5210448|NCT02680171|Cognitive Rehabilitation|cognitive rehabilitation
5210449|NCT02680171|Prism Adaptation|prism adaptation
5210450|NCT02680171|Stroke|stroke
5210451|NCT02680171|Spatial Neglect|spatial neglect
5210452|NCT02680145|Pessary|pessary
5210453|NCT02680145|Prolapse|prolapse
5210454|NCT02680145|Cystocele|cystocele
5210455|NCT02680106|Nanofibers|nanofibers
5210456|NCT02680106|Dressing|dressing
5210457|NCT02680106|Donor site|donor site
5210458|NCT02680106|Polycaprolactone|polycaprolactone
5210459|NCT02680067|Healthy Individual|healthy individual
5210460|NCT02680067|Lymphatic Transport|lymphatic transport
5210461|NCT02680067|Near InfraRed|near infrared
5210462|NCT02680067|Imaging|imaging
5210463|NCT02680067|Indocyanine Green|indocyanine green
5210465|NCT02680067|NIR|nir
5210466|NCT02680067|NIR-ICG|nir-icg
5210467|NCT02680067|MSImager|msimager
5210468|NCT02680067|rheumatoid arthritis|rheumatoid arthritis
5210469|NCT02680015|PEERS|peers
5210470|NCT02680015|friendships|friendships
5210471|NCT02680015|brain|brain
5210472|NCT02679989|Insulin sensitivity|insulin sensitivity
5210473|NCT02679989|Weight loss|weight loss
5210474|NCT02679989|Intermittent fasting|intermittent fasting
5210475|NCT02679989|Sympathetic nervous system|sympathetic nervous system
5210476|NCT02679950|Next generation genome sequencing|next generation genome sequencing
5210477|NCT02679950|Late relapse|late relapse
5210478|NCT02679950|Genetic profiles|genetic profiles
5210479|NCT02679937|U.S. Military|u.s. military
5210480|NCT02679937|Overweight|overweight
5210481|NCT02679937|Obesity|obesity
5210482|NCT02679937|Service Members|service members
5210483|NCT02679937|Prevention|prevention
5210484|NCT02679911|Onychomycosis|onychomycosis
5210485|NCT02679898|Arterial function|arterial function
5210486|NCT02679898|Whole-body vibration training|whole-body vibration training
5210487|NCT02679898|Aortic blood pressures|aortic blood pressures
5210488|NCT02679898|Wave reflection|wave reflection
5210489|NCT02679898|Muscle strength|muscle strength
5210490|NCT02679898|Endothelial function|endothelial function
5210491|NCT02679898|Blood flow|blood flow
5210492|NCT02679872|Non-technical skills|non-technical skills
5210493|NCT02679872|Patient safety|patient safety
5087848|NCT03448835|capecitabine|capecitabine
5087849|NCT03448835|oxaliplatin|oxaliplatin
5087850|NCT03448835|docetaxel|docetaxel
5087851|NCT03448809|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
5087852|NCT03448809|Children and Adolescents|children and adolescents
5210494|NCT02679872|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5210495|NCT02679872|Operating theatre team|operating theatre team
5210496|NCT02679872|Operating room|operating room
5210497|NCT02679859|Natriuretic Peptide, Brain|natriuretic peptide, brain
5210498|NCT02679859|Surgery|surgery
5210499|NCT02679846|withdrawal of antiepileptic drugs|withdrawal of antiepileptic drugs
5210503|NCT02679846|standardized protocol|standardized protocol
5210504|NCT02679833|Cobalamin biomarkers|cobalamin biomarkers
5210505|NCT02679833|Anemia|anemia
5210506|NCT02679833|Vegan diet|vegan diet
5210507|NCT02679833|Subclinical|subclinical
5210508|NCT02679833|Metabolic functional markers|metabolic functional markers
5210509|NCT02679833|Holotranscobalamin|holotranscobalamin
5210510|NCT02679833|Methylmalonic acid|methylmalonic acid
5210511|NCT02679755|Hormone receptor positive advanced breast cancer|hormone receptor positive advanced breast cancer
5210512|NCT02679742|beta hydroxy beta methylbutyrate|beta hydroxy beta methylbutyrate
5210513|NCT02679742|older people|older people
5210514|NCT02679742|muscle mass|muscle mass
5210515|NCT02679742|muscle strength|muscle strength
5210516|NCT02679742|post-acute|post-acute
5210517|NCT02679729|inhaled dose|inhaled dose
5210518|NCT02679729|intravenous dose|intravenous dose
5210519|NCT02679729|healthy subjects|healthy subjects
5210520|NCT02679729|safety|safety
5210521|NCT02679729|tolerability|tolerability
5210522|NCT02679729|pharmacokinetics|pharmacokinetics
5210523|NCT02679729|AZD5634|azd5634
5210524|NCT02679729|jet nebulizer|jet nebulizer
5210525|NCT02679677|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5210526|NCT02679677|Randomized controlled trial|randomized controlled trial
5210527|NCT02679677|Physical activity|physical activity
5210528|NCT02679638|breast cancer|breast cancer
5210529|NCT02679638|treatment choice|treatment choice
5210530|NCT02679638|factor|factor
5210531|NCT02679638|perception|perception
5210533|NCT02679560|femur fracture, hip fracture, exparel, liposomal bupivacaine|femur fracture, hip fracture, exparel, liposomal bupivacaine
5210534|NCT02679547|Appendix|appendix
5210535|NCT02679547|Breastfeeding|breastfeeding
5210536|NCT02679547|Adult|adult
5210537|NCT02679534|pain|pain
5210538|NCT02679534|thoracic surgery|thoracic surgery
5210539|NCT02679534|massage|massage
5210540|NCT02679521|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5210541|NCT02679521|Painful Heel|painful heel
5210542|NCT02679521|Plantar fasciitis|plantar fasciitis
5210543|NCT02679508|Esophagitis|esophagitis
5210544|NCT02679495|early gastric cancer|early gastric cancer
5210545|NCT02679495|lifestyle|lifestyle
5210546|NCT02679482|Primary Open Angle Glaucoma|primary open angle glaucoma
5210547|NCT02679482|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5210548|NCT02679482|Pattern Scan Laser Trabeculoplasty|pattern scan laser trabeculoplasty
5210549|NCT02679443|Lung Adenocarcinoma|lung adenocarcinoma
5210550|NCT02679443|Non-squamous NSCLC|non-squamous nsclc
5210551|NCT02679443|Chemotherapy|chemotherapy
5210552|NCT02679443|Pemetrexed|pemetrexed
5210553|NCT02679443|Vitamin B12|vitamin b12
5210554|NCT02679443|Folate|folate
5210555|NCT02679443|Supplementation|supplementation
5210556|NCT02679443|Cytopenia|cytopenia
5210557|NCT02679417|Aminotransferase|aminotransferase
5210558|NCT02679417|Fibrosis, liver|fibrosis, liver
5210559|NCT02679417|Anthropometry|anthropometry
5210560|NCT02679417|Exercise|exercise
5210561|NCT02679404|Biological aortic valves|biological aortic valves
5210562|NCT02679404|Mechanical aortic valves|mechanical aortic valves
5210563|NCT02679404|Aortic conduits|aortic conduits
5210564|NCT02679404|Sutureless Aortic Valve|sutureless aortic valve
5210565|NCT02679391|Abdominoplasty|abdominoplasty
5210566|NCT02679391|Early complications|early complications
5210567|NCT02679391|Guidelines|guidelines
5210568|NCT02679391|Sequelae|sequelae
5210569|NCT02679391|bariatric patients|bariatric patients
5210570|NCT02679326|Therapeutic ultrasound, Treatment, Plantar fasciitis|therapeutic ultrasound, treatment, plantar fasciitis
5210571|NCT02679300|Chronic Low Back Pain|chronic low back pain
5210572|NCT02679300|Virtual Reality|virtual reality
5210573|NCT02679300|Serious Gaming|serious gaming
5210574|NCT02679300|Exercise Therapy|exercise therapy
5210575|NCT02679300|Distraction|distraction
5210576|NCT02679287|Closed-Loop Control (CLC)|closed-loop control (clc)
5210577|NCT02679287|Sensor-Augmented Therapy (SAP)|sensor-augmented therapy (sap)
5210578|NCT02679287|USS Virginia|uss virginia
5210579|NCT02679287|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5210580|NCT02679287|Insulin Pump|insulin pump
5210581|NCT02679287|Artificial Pancreas (AP)|artificial pancreas (ap)
5962598|NCT04280068|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
5962599|NCT04280068|Clinician Guide (CG)|clinician guide (cg)
5962600|NCT04280055|Cluster Headache|cluster headache
5962601|NCT04280055|Psilocybin|psilocybin
5962602|NCT04280055|Prophylactic|prophylactic
5962603|NCT04280055|Treatment|treatment
5962604|NCT04280055|Hallucinogens|hallucinogens
5087970|NCT03448029|Vascular Diseases|vascular diseases
5210582|NCT02679274|Aging, Frailty, Hypogonadism|aging, frailty, hypogonadism
5210583|NCT02679261|Aortic dilation|aortic dilation
5210584|NCT02679261|Statins|statins
5210585|NCT02679261|Aortic degeneration|aortic degeneration
5210586|NCT02679248|Pre-hypertension|pre-hypertension
5210587|NCT02679248|Mild hypertension|mild hypertension
5210588|NCT02679248|Dietary supplement|dietary supplement
5210589|NCT02679248|Efficacy|efficacy
5210590|NCT02679248|Nitric oxide|nitric oxide
5210591|NCT02679248|Neo40 Daily|neo40 daily
5210592|NCT02679170|ALK+|alk+
5210593|NCT02679157|Posttraumatic stress disorder|posttraumatic stress disorder
5210594|NCT02679157|Depression|depression
5210595|NCT02679157|Anxiety|anxiety
5210597|NCT02679157|Health-related quality of life|health-related quality of life
5210598|NCT02679157|ICU survivorship|icu survivorship
5210599|NCT02679131|relapsed/refractory solid tumors|relapsed/refractory solid tumors
5210601|NCT02679131|renal impairment|renal impairment
5210602|NCT02679131|belinostat|belinostat
5210603|NCT02679131|hematological malignancies|hematological malignancies
5210604|NCT02679118|intestinal perforation|intestinal perforation
5210605|NCT02679118|bariatric surgery|bariatric surgery
5210606|NCT02679118|gastric bypass|gastric bypass
5210607|NCT02679118|gastric perforation|gastric perforation
5210608|NCT02679118|colonic perforation|colonic perforation
5210609|NCT02679092|Induced Abortion|induced abortion
5210610|NCT02679092|Mifepristone|mifepristone
5210611|NCT02679092|Dilation and Evacuation|dilation and evacuation
5210612|NCT02679092|Cervical Preparation|cervical preparation
5210613|NCT02679092|Osmotic Dilators|osmotic dilators
5210614|NCT02679092|Misoprostol|misoprostol
5210615|NCT02678962|Multifocal Intraocular Lenses|multifocal intraocular lenses
5210616|NCT02678962|bilateral implantation|bilateral implantation
5210617|NCT02678897|Abortion, Drug-Induced|abortion, drug-induced
5210618|NCT02678897|Pain Management|pain management
5210619|NCT02678884|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5210620|NCT02678884|Radiation therapy|radiation therapy
5210621|NCT02678884|Head and Neck Cancers|head and neck cancers
5210622|NCT02678871|Aortic Valve Stenosis|aortic valve stenosis
5210623|NCT02678871|Left atrial appendage|left atrial appendage
5210624|NCT02678858|social cognition|social cognition
5210625|NCT02678858|social skills|social skills
5210626|NCT02678858|cognitive remediation|cognitive remediation
5210627|NCT02678858|functional outcome|functional outcome
5210628|NCT02678858|treatment adherence|treatment adherence
5210629|NCT02678767|HIV|hiv
5210630|NCT02678767|Dementia|dementia
5210631|NCT02678767|Neuroimaging|neuroimaging
5210632|NCT02678702|Sleep|sleep
5210633|NCT02678702|Depression|depression
5210634|NCT02678702|Comorbid Insomnia|comorbid insomnia
5210635|NCT02678702|Cognitive Behavioral Therapy|cognitive behavioral therapy
5210636|NCT02678702|Sleep Restriction|sleep restriction
5210637|NCT02678702|Stimulus Control therapy|stimulus control therapy
5210638|NCT02678702|Relaxation|relaxation
5210639|NCT02678676|Drug Therapy|drug therapy
5210640|NCT02678663|Colon polyp|colon polyp
5210641|NCT02678663|Polypectomy|polypectomy
5210642|NCT02678663|Cold snare|cold snare
5210643|NCT02678663|Endoscopic mucosal resection|endoscopic mucosal resection
5210644|NCT02678650|Volatile Anesthetics|volatile anesthetics
5210645|NCT02678650|MicroRNA|microrna
5210646|NCT02678650|Off-pump Coronary Artery Bypass Surgery|off-pump coronary artery bypass surgery
5210647|NCT02678650|Internal Mammary Artery|internal mammary artery
5210648|NCT02678650|Ascending Aorta|ascending aorta
5210649|NCT02678637|MRI|mri
5210650|NCT02678637|CCSA|ccsa
5210651|NCT02678637|Contractile Cross Sectional Area|contractile cross sectional area
5210652|NCT02678637|Strength|strength
5210653|NCT02678637|Calf muscle|calf muscle
5210654|NCT02678611|Healthy participants|healthy participants
5210655|NCT02678611|Dietary supplement|dietary supplement
5210656|NCT02678611|Safety|safety
5210657|NCT02678611|Tolerability|tolerability
5210658|NCT02678611|Older Adults|older adults
5210659|NCT02678611|Basis|basis
5210660|NCT02678611|Nicotinamide riboside|nicotinamide riboside
5210661|NCT02678611|Pterostilbene|pterostilbene
5210662|NCT02678598|Micafungin|micafungin
5210663|NCT02678598|Candida|candida
5210664|NCT02678598|Aspergillosis|aspergillosis
5210665|NCT02678598|Antifungal|antifungal
5210666|NCT02678572|uveal liver PHP hepatic perfusion chemosaturation Delcath|uveal liver php hepatic perfusion chemosaturation delcath
5210667|NCT02678559|Alveolar recruitment manoeuvre|alveolar recruitment manoeuvre
5210668|NCT02678559|Lung recruitment|lung recruitment
5210669|NCT02678559|Preload dependency|preload dependency
5210670|NCT02678559|Cardiac surgery|cardiac surgery
5210671|NCT02678559|Transoesophageal echocardiography|transoesophageal echocardiography
5210672|NCT02678546|Traditional Chinese Medicine|traditional chinese medicine
5962605|NCT04280042|atrial fibrillation|atrial fibrillation
5210673|NCT02678533|Fanconi Anemia|fanconi anemia
5210674|NCT02678533|CD34+ cells mobilization|cd34+ cells mobilization
5210675|NCT02678533|G-CSF|g-csf
5210676|NCT02678533|Plerixafor|plerixafor
5210677|NCT02678533|gene therapy|gene therapy
5962606|NCT04280042|thoracoscopic surgical AF ablation|thoracoscopic surgical af ablation
5210678|NCT02678520|Prostate Cancer|prostate cancer
5210679|NCT02678520|Post Operative|post operative
5210680|NCT02678520|Radiation|radiation
5210681|NCT02678520|Prostatectomy|prostatectomy
5210682|NCT02678520|3-D CRT|3-d crt
5210683|NCT02678520|IMRT|imrt
5210685|NCT02678520|CRT|crt
5210686|NCT02678520|Conformal Radiation Therapy|conformal radiation therapy
5210687|NCT02678520|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5210688|NCT02678520|Hormone|hormone
5210689|NCT02678520|Surgery|surgery
5210690|NCT02678520|Hormonal Therapy|hormonal therapy
5210691|NCT02678494|Spinal Cord Injury|spinal cord injury
5210692|NCT02678481|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
5210693|NCT02678481|MR-targeted prostate biopsy|mr-targeted prostate biopsy
5210694|NCT02678481|saturation TRUS-guided prostate biopsy|saturation trus-guided prostate biopsy
5207525|NCT02697643|opioid|opioid
5210698|NCT02678403|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5210699|NCT02678403|walking ability|walking ability
5210700|NCT02678403|endothelial function|endothelial function
5210701|NCT02678364|Vitamin D-biofortified eggs|vitamin d-biofortified eggs
5210702|NCT02678364|Vitamin D status|vitamin d status
5857695|NCT00021710|Learning|learning
5210711|NCT02678286|Phase 3|phase 3
5210712|NCT02678273|population|population
5210713|NCT02678273|Singapore|singapore
5210714|NCT02678260|Advanced malignancies|advanced malignancies
5210715|NCT02678260|PDR001|pdr001
5210716|NCT02678260|Japanese patients|japanese patients
5210717|NCT02678260|adults|adults
5210718|NCT02678247|prosthesis|prosthesis
5210719|NCT02678247|prosthetic socket|prosthetic socket
5210720|NCT02678247|transfemoral amputation|transfemoral amputation
5210721|NCT02678247|socket comfort|socket comfort
5210722|NCT02678247|gait biomechanics|gait biomechanics
5210723|NCT02678156|Dura mater substitute|dura mater substitute
5210724|NCT02678156|Graft|graft
5210725|NCT02678156|Lyoplant|lyoplant
5210726|NCT02678156|Lyostypt|lyostypt
5210727|NCT02678156|Lyoplant onlay|lyoplant onlay
5210728|NCT02678156|Xenograft|xenograft
5210729|NCT02678130|Intervertebral disc degeneration|intervertebral disc degeneration
5210730|NCT02678130|Bone Disease|bone disease
5210731|NCT02678130|Musculoskeletal disease|musculoskeletal disease
5210732|NCT02678130|Spinal disease|spinal disease
5210733|NCT02678104|Dry Socket|dry socket
5210734|NCT02678104|Honey|honey
5210735|NCT02678104|Tooth Extraction|tooth extraction
5210736|NCT02678078|cancer|cancer
5210737|NCT02678078|diagnosis|diagnosis
5210738|NCT02678078|biopsy|biopsy
5210739|NCT02678078|chemotherapy drugs|chemotherapy drugs
5210740|NCT02678078|tumor|tumor
5210741|NCT02678052|Drug therapy|drug therapy
5210742|NCT02677961|sarcoma|sarcoma
5210743|NCT02677961|registry|registry
5210744|NCT02677922|Acute Myeloid Leukemia|acute myeloid leukemia
5210745|NCT02677922|Leukemia|leukemia
5210746|NCT02677922|Azacitidine|azacitidine
5210747|NCT02677922|AG-120|ag-120
5210748|NCT02677922|AG-221|ag-221
5210749|NCT02677909|Parenteral Nutrition|parenteral nutrition
5210750|NCT02677909|Critical Care|critical care
5210755|NCT02677870|Saproterin dihydrochloride|saproterin dihydrochloride
5210756|NCT02677870|Kuvan|kuvan
5210757|NCT02677870|Amish|amish
5210758|NCT02677831|Physical functioning|physical functioning
5210759|NCT02677831|Neuropsychiatric Disorders|neuropsychiatric disorders
5210760|NCT02677831|Frailty|frailty
5210761|NCT02677818|Plasma Factor VIII Levels|plasma factor viii levels
5210762|NCT02677818|Ischemic stroke|ischemic stroke
5210763|NCT02677818|Antithrombotic therapy|antithrombotic therapy
5210764|NCT02677818|Bleeding|bleeding
5210765|NCT02677766|Occupational Therapy|occupational therapy
5210766|NCT02677766|Complex patients|complex patients
5210767|NCT02677766|Randomized controlled trial|randomized controlled trial
5210768|NCT02677766|Occupational performance problem|occupational performance problem
5210769|NCT02677766|Rehabilitation Complexity Scale|rehabilitation complexity scale
5210770|NCT02677740|MRI|mri
5210771|NCT02677740|MRS|mrs
5210772|NCT02677740|rTMS|rtms
5210773|NCT02677727|Cisplatin-based chemotherapy|cisplatin-based chemotherapy
5210774|NCT02677727|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5210775|NCT02677688|systemic lupus erythematosus|systemic lupus erythematosus
5210776|NCT02677688|autologous anti-EBV CTL|autologous anti-ebv ctl
5210777|NCT02677688|adoptive therapy|adoptive therapy
5210778|NCT02677688|phase 1 -2|phase 1 -2
5210779|NCT02677662|Diesel exhaust|diesel exhaust
5210780|NCT02677662|Oxidative stress|oxidative stress
5210781|NCT02677662|Systemic inflammation|systemic inflammation
5210782|NCT02677662|Air pollution|air pollution
5210783|NCT02677649|cranberry, microbiome, polyphenols, healthy|cranberry, microbiome, polyphenols, healthy
5210784|NCT02677636|Dermatitis, Atopic|dermatitis, atopic
5210785|NCT02677636|Eczema|eczema
5210786|NCT02677636|Dermatitis|dermatitis
5210787|NCT02677636|Pruritus|pruritus
5210788|NCT02677636|Genetic Diseases, Inborn|genetic diseases, inborn
5210789|NCT02677636|Hypersensitivity|hypersensitivity
5962607|NCT04280042|catheter ablation|catheter ablation
5210790|NCT02677636|Hypersensitivity, Immediate|hypersensitivity, immediate
5210791|NCT02677636|Immune System Diseases|immune system diseases
5210792|NCT02677636|Skin Diseases, Eczematous|skin diseases, eczematous
5210793|NCT02677636|Skin Diseases, Genetic|skin diseases, genetic
5210794|NCT02677636|Skin Diseases|skin diseases
5210795|NCT02677636|Itching|itching
5210796|NCT02677636|Rash|rash
5210797|NCT02677636|Steroid|steroid
5210798|NCT02677610|Dermatitis, Atopic|dermatitis, atopic
5210799|NCT02677610|Eczema|eczema
5210800|NCT02677610|Dermatitis|dermatitis
5210801|NCT02677610|Pruritus|pruritus
5210802|NCT02677610|Genetic Diseases, Inborn|genetic diseases, inborn
5210803|NCT02677610|Hypersensitivity|hypersensitivity
5210804|NCT02677610|Hypersensitivity, Immediate|hypersensitivity, immediate
5210805|NCT02677610|Immune System Diseases|immune system diseases
5857696|NCT00021710|Plasticity|plasticity
5210808|NCT02677610|Skin Diseases|skin diseases
5210809|NCT02677610|Itching|itching
5210810|NCT02677610|Rash|rash
5210812|NCT02677584|caffeine|caffeine
5210813|NCT02677584|apnea|apnea
5210814|NCT02677584|preterm infant|preterm infant
5210815|NCT02677558|Pregnancy|pregnancy
5210816|NCT02677558|Obesity|obesity
5210817|NCT02677558|Echocardiography|echocardiography
5210818|NCT02677519|ADHD|adhd
5210819|NCT02677519|children|children
5210820|NCT02677519|methylphenidate|methylphenidate
5210821|NCT02677506|elbow|elbow
5210822|NCT02677480|Microflora|microflora
5210823|NCT02677480|Probiotics|probiotics
5210824|NCT02677480|Hyposalivation|hyposalivation
5210825|NCT02677480|Lactobacilli|lactobacilli
5210826|NCT02677480|Mutans streptococci|mutans streptococci
5210827|NCT02677480|pH-rising components|ph-rising components
5210828|NCT02677454|Blood Glucose|blood glucose
5210829|NCT02677454|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5210830|NCT02677428|Veterans|veterans
5210831|NCT02677428|world wide web|world wide web
5210832|NCT02677428|Counseling|counseling
5210833|NCT02677428|Workman's Compensation|workman's compensation
5210834|NCT02677415|Ischemic Stroke|ischemic stroke
5210835|NCT02677415|Anesthesia|anesthesia
5210836|NCT02677415|Endovascular Procedures|endovascular procedures
5210837|NCT02677402|femoral vein|femoral vein
5210838|NCT02677402|saphenous vein|saphenous vein
5210839|NCT02677402|hydrostatic pressure|hydrostatic pressure
5210841|NCT02677402|recovery|recovery
5210842|NCT02677363|Elderly|elderly
5210843|NCT02677363|Older|older
5210844|NCT02677363|Adults|adults
5210845|NCT02677363|Resistant Exercise|resistant exercise
5210846|NCT02677363|Strength Training|strength training
5210847|NCT02677363|Cognitive function|cognitive function
5210848|NCT02677324|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5210850|NCT02677272|Nursing home|nursing home
5210851|NCT02677272|emergency department|emergency department
5210852|NCT02677272|inappropriate transfer|inappropriate transfer
5210853|NCT02677272|elderly|elderly
5210854|NCT02677259|luteal phase|luteal phase
5210855|NCT02677259|estradiol|estradiol
5210856|NCT02677259|pregnancy rate|pregnancy rate
5210857|NCT02677246|Bone marrow transplantation|bone marrow transplantation
5210858|NCT02677246|Children|children
5210859|NCT02677246|Bone complications|bone complications
5210860|NCT02677246|Denosumab.|denosumab.
5210862|NCT02677181|Matched sibling donor|matched sibling donor
5210863|NCT02677181|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5210864|NCT02677168|obstructive sleep apnea|obstructive sleep apnea
5210865|NCT02677168|sleep apnea|sleep apnea
5210867|NCT02677168|cNEP|cnep
5210868|NCT02677168|continuous negative external pressure|continuous negative external pressure
5210869|NCT02677155|Follicular lymphoma|follicular lymphoma
5210870|NCT02677155|Intranodal therapy|intranodal therapy
5210871|NCT02677155|Autologous dendritic cells|autologous dendritic cells
5210872|NCT02677155|Rituximab|rituximab
5210873|NCT02677155|Immunotherapy|immunotherapy
5210874|NCT02677155|Cancer vaccine|cancer vaccine
5210875|NCT02677155|Anti-PD1|anti-pd1
5210876|NCT02677155|Pembrolizumab|pembrolizumab
5210877|NCT02677155|Radiotherapy|radiotherapy
5210878|NCT02677142|pediatric|pediatric
5210879|NCT02677142|Childhood Brain Tumour Survivors|childhood brain tumour survivors
5210880|NCT02677142|Social Skills Rating System|social skills rating system
5210881|NCT02677142|social skills intervention program (SSIP)|social skills intervention program (ssip)
5210882|NCT02677103|Radial shock wave therapy,calcific tendinitis, ultrasound guidance|radial shock wave therapy,calcific tendinitis, ultrasound guidance
5210883|NCT02677090|Fiber tolerability|fiber tolerability
5210884|NCT02677090|Children|children
5210885|NCT02677077|RRMS|rrms
5210886|NCT02677077|MRI|mri
5210887|NCT02677064|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5210888|NCT02677064|Identify Barriers|identify barriers
5210889|NCT02677064|16-024|16-024
5210890|NCT02677025|HIV|hiv
5210891|NCT02677025|Sexual Risk|sexual risk
5210892|NCT02677025|Sexually Transmitted Diseases|sexually transmitted diseases
5210893|NCT02677025|Substance Abuse|substance abuse
5210894|NCT02677025|Violence and Victimization|violence and victimization
5210899|NCT02676973|pelvic organ prolapse|pelvic organ prolapse
5210900|NCT02676973|POP|pop
5210901|NCT02676973|vault prolapse|vault prolapse
5210902|NCT02676973|cystocele|cystocele
5210903|NCT02676973|vaginal prolapse|vaginal prolapse
5210904|NCT02676973|post-hysterectomy vaginal prolapse|post-hysterectomy vaginal prolapse
5210905|NCT02676921|sinus membrane|sinus membrane
5210906|NCT02676921|osteogenic|osteogenic
5210907|NCT02676908|endovenous ablation|endovenous ablation
5210908|NCT02676908|laser|laser
5210909|NCT02676908|radiofrequency|radiofrequency
5210910|NCT02676908|stockings|stockings
5210911|NCT02676882|Depressive Disorder|depressive disorder
5210912|NCT02676882|Depression|depression
5210913|NCT02676882|Antidepressants|antidepressants
5210914|NCT02676882|Pregnancy|pregnancy
5210915|NCT02676882|Folate|folate
5210916|NCT02676882|Dietary Supplements|dietary supplements
5210917|NCT02676882|Omega-3 Fatty Acids|omega-3 fatty acids
5210918|NCT02676882|Women's Health|women's health
5210920|NCT02676856|acute myeloid leukemia|acute myeloid leukemia
5210921|NCT02676856|hematopoietic stem cell microtransplantation|hematopoietic stem cell microtransplantation
5210922|NCT02676843|FTLD|ftld
5210924|NCT02676817|colitis|colitis
5210925|NCT02676817|endoscopy|endoscopy
5210926|NCT02676804|Exercise|exercise
5210927|NCT02676778|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
5210928|NCT02676778|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5210929|NCT02676778|E7777|e7777
5210930|NCT02676778|Phase 2|phase 2
5210931|NCT02676765|Allergic rhinitis|allergic rhinitis
5210932|NCT02676765|Immunotherapy, Allergen|immunotherapy, allergen
5210933|NCT02676765|Sublingual Immunotherapy|sublingual immunotherapy
5210934|NCT02676752|head and neck cancer|head and neck cancer
5210935|NCT02676752|lymphedema and fibrosis|lymphedema and fibrosis
5210936|NCT02676726|extraperitoneal|extraperitoneal
5210937|NCT02676726|transperitoneal|transperitoneal
5210938|NCT02676726|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
5210939|NCT02676726|endometrial cancer|endometrial cancer
5210940|NCT02676726|ovarian cancer|ovarian cancer
5210941|NCT02676726|surgical staging|surgical staging
5210942|NCT02676713|Traditional Chinese Medicine|traditional chinese medicine
5210943|NCT02676713|Chinese Herbal|chinese herbal
5210944|NCT02676700|Urinary stress incontinence|urinary stress incontinence
5210945|NCT02676700|pelvic floor muscle|pelvic floor muscle
5210946|NCT02676700|Kaatsu training|kaatsu training
5210947|NCT02676687|surgery, noneloquent area|surgery, noneloquent area
5210948|NCT02676661|peri-implant disease|peri-implant disease
5210949|NCT02676661|risk factors|risk factors
5210950|NCT02676661|prevalence|prevalence
5210951|NCT02676622|Crohn's Disease|crohn's disease
5210952|NCT02676622|Autologous Hematopoietic Stem cell Transplant|autologous hematopoietic stem cell transplant
5210953|NCT02676622|Cyclophosphamide|cyclophosphamide
5210954|NCT02676622|IL-2|il-2
5210955|NCT02676622|Aldesleukin|aldesleukin
5210956|NCT02676622|Proleukin|proleukin
5210957|NCT02676622|PCDAI|pcdai
5210958|NCT02676609|Type 1 diabetes|type 1 diabetes
5210959|NCT02676609|Smart phone application|smart phone application
5210960|NCT02676609|carbohydrate counting|carbohydrate counting
5210961|NCT02676609|meal insulin dose|meal insulin dose
5210962|NCT02676583|pain|pain
5210963|NCT02676583|tonsillectomy|tonsillectomy
5210964|NCT02676583|tonsillar fossa|tonsillar fossa
5210965|NCT02676583|suture|suture
5210966|NCT02676583|tonsil fossa closure|tonsil fossa closure
5210967|NCT02676544|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
5210968|NCT02676544|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5210969|NCT02676544|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5210971|NCT02676544|BPH|bph
5210972|NCT02676544|LUTS|luts
5210973|NCT02676544|Prostate Artery Embolization|prostate artery embolization
5210974|NCT02676544|Embospheres|embospheres
5210975|NCT02676531|Walking Meditation|walking meditation
5210976|NCT02676531|Vascular Function|vascular function
5210977|NCT02676531|Flow-mediated dilatation|flow-mediated dilatation
5210978|NCT02676531|Breast Cancer Patients|breast cancer patients
5210979|NCT02676531|Anthracyclines Chemotherapy|anthracyclines chemotherapy
5210980|NCT02676518|polycystic ovary syndrome|polycystic ovary syndrome
5210981|NCT02676518|Serum anti-Mullerian hormone|serum anti-mullerian hormone
5210982|NCT02676518|glucose intolerance|glucose intolerance
5210983|NCT02676518|metabolic syndrome|metabolic syndrome
5210984|NCT02676466|Mobility|mobility
5210985|NCT02676440|Oral Health|oral health
5210986|NCT02676401|Diabetic Nephropathy|diabetic nephropathy
5210987|NCT02676388|Slow Transit Constipation|slow transit constipation
5210988|NCT02676388|Freeze-dried, Capsulized FMT|freeze-dried, capsulized fmt
5210989|NCT02676388|Fresh FMT|fresh fmt
5210990|NCT02676349|mFolfirinox|mfolfirinox
5210991|NCT02676349|Chemoradiotherapy|chemoradiotherapy
5210992|NCT02676349|Neoadjuvant treatment|neoadjuvant treatment
5210993|NCT02676349|Borderline|borderline
5210994|NCT02676336|FBC|fbc
5210995|NCT02676336|cyclic mastalgia|cyclic mastalgia
5210996|NCT02676336|breast discomfort|breast discomfort
5962608|NCT04280042|implanted loop recorder|implanted loop recorder
5210997|NCT02676323|Maximum tolerated dose|maximum tolerated dose
5088425|NCT03445221|Cardiac Patient|cardiac patient
5088426|NCT03445221|Mitral Valve Replacement|mitral valve replacement
5088427|NCT03445182|pain control|pain control
5088431|NCT03445156|First-person shooter (FPS)|first-person shooter (fps)
5210998|NCT02676323|Childhood leukemia|childhood leukemia
5103058|NCT03353428|Lung cancer|lung cancer
5210999|NCT02676323|Hematological malignancies|hematological malignancies
5211000|NCT02676297|inhalation|inhalation
5211001|NCT02676297|anticholinergic|anticholinergic
5211002|NCT02676258|silicone hydrogel daily disposable soft contact lens|silicone hydrogel daily disposable soft contact lens
5857697|NCT00021710|Motor|motor
5297708|NCT02189161|AIN|ain
5211003|NCT02676245|Prenatal Education|prenatal education
5211004|NCT02676245|Residual Specimens|residual specimens
5211005|NCT02676232|Online Intervention|online intervention
5199024|NCT02750540|Tenofovir enema|tenofovir enema
5199025|NCT02750501|CF, EPI, diabetes, PERT, LCPUFA, DHA, EPA, Omega-3 index|cf, epi, diabetes, pert, lcpufa, dha, epa, omega-3 index
5199026|NCT02750423|Cardiology|cardiology
5199027|NCT02750423|Surgery|surgery
5199028|NCT02750397|HIV|hiv
5199029|NCT02750397|Kidney Transplant|kidney transplant
5199030|NCT02750397|Liver Transplant|liver transplant
5199031|NCT02750397|Transplant|transplant
5199034|NCT02750371|Hippocampus|hippocampus
5211019|NCT02676167|people who inject drugs|people who inject drugs
5211020|NCT02676154|Episodic Hypertension|episodic hypertension
5211021|NCT02676154|Spinal Cord Injury|spinal cord injury
5211022|NCT02676154|Traumatic Spinal Cord Injury|traumatic spinal cord injury
5211023|NCT02676154|Blood Pressure|blood pressure
5211024|NCT02676154|Fesoterodine|fesoterodine
5211025|NCT02676154|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5211026|NCT02676154|Autonomic Dysreflexia|autonomic dysreflexia
5211027|NCT02676154|Urodynamic Studies|urodynamic studies
5211028|NCT02676154|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
5211029|NCT02676154|Cerebral Blood Flow|cerebral blood flow
5211030|NCT02676128|HIV|hiv
5211031|NCT02676128|Medication Adherence|medication adherence
5211032|NCT02676128|Mobile Health|mobile health
5211033|NCT02676115|Cosmetic Wound Healing|cosmetic wound healing
5211034|NCT02676115|anterior cruciate ligament (ACL)|anterior cruciate ligament (acl)
5211035|NCT02676102|barber shops|barber shops
5211036|NCT02676102|organ transplant|organ transplant
5211037|NCT02676102|transplants|transplants
5211038|NCT02676102|organ donor registration|organ donor registration
5211039|NCT02676089|Asthma, Anticholinergics, Triple combination|asthma, anticholinergics, triple combination
5211040|NCT02676076|asthma, anticholinergics, triple combination|asthma, anticholinergics, triple combination
5211041|NCT02676063|predictive factors|predictive factors
5211042|NCT02676063|neurodevelopmental disabilities|neurodevelopmental disabilities
5211043|NCT02676011|Atropine|atropine
5211044|NCT02676011|Succinycholine|succinycholine
5211045|NCT02676011|Laparoscopy|laparoscopy
5211046|NCT02676011|Gynecology|gynecology
5211047|NCT02675985|Physical Therapy, early intervention|physical therapy, early intervention
5211048|NCT02675972|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
5211049|NCT02675959|stem cell transplantation|stem cell transplantation
5211050|NCT02675959|sickle cell disease|sickle cell disease
5211051|NCT02675959|haploidentical|haploidentical
5211052|NCT02675959|defibrotide|defibrotide
5211053|NCT02675946|WNT inhibitor|wnt inhibitor
5211054|NCT02675920|surveillance|surveillance
5211055|NCT02675920|ultrasonography|ultrasonography
5211056|NCT02675920|computed tomography|computed tomography
5211058|NCT02675907|Bunionectomy|bunionectomy
5211059|NCT02675907|Pain|pain
5211060|NCT02675907|Analgesia|analgesia
5211061|NCT02675907|N1539|n1539
5211062|NCT02675907|Phase 3|phase 3
5211064|NCT02675881|RFA|rfa
5211065|NCT02675868|noradrenaline|noradrenaline
5211066|NCT02675868|vasopressin|vasopressin
5211067|NCT02675868|phenylephrine|phenylephrine
5211068|NCT02675868|endotoxemia|endotoxemia
5211069|NCT02675868|Lipopolysaccharide|lipopolysaccharide
5211070|NCT02675868|vasopressor|vasopressor
5211071|NCT02675855|Grafix|grafix
5211072|NCT02675829|HER2 mutant|her2 mutant
5211073|NCT02675829|HER2 amplified|her2 amplified
5211074|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine
5211075|NCT02675829|15-335|15-335
5211076|NCT02675816|Obstructive Sleep Apnea|obstructive sleep apnea
5211077|NCT02675816|OSA|osa
5211078|NCT02675816|neurostimulation|neurostimulation
5211079|NCT02675816|hypoglossal nerve|hypoglossal nerve
5211080|NCT02675816|tongue|tongue
5211081|NCT02675816|upper airway stimulation|upper airway stimulation
5211082|NCT02675816|surgery|surgery
5211083|NCT02675803|Rheumatoid arthritis|rheumatoid arthritis
5211084|NCT02675790|hydroxyurea|hydroxyurea
5211085|NCT02675790|sub-Saharan Africa|sub-saharan africa
5211086|NCT02675790|secondary stroke prevention|secondary stroke prevention
5211087|NCT02675777|Alcohol misuse|alcohol misuse
5211088|NCT02675777|Unhealthy alcohol use|unhealthy alcohol use
5211089|NCT02675777|Alcoholism|alcoholism
5962609|NCT04280029|In-stent restenosis|in-stent restenosis
5962610|NCT04280029|Drug Eluting Balloon|drug eluting balloon
5962611|NCT04280029|Coronary|coronary
5962612|NCT04280016|Diabetes; off-loading; exercise|diabetes; off-loading; exercise
5962613|NCT04279977|rehabilitation|rehabilitation
5962614|NCT04279977|discharge|discharge
5211090|NCT02675777|Alcohol dependence|alcohol dependence
5211091|NCT02675777|Alcohol abuse|alcohol abuse
5211092|NCT02675777|Risky drinking|risky drinking
5211093|NCT02675764|hand function|hand function
5211096|NCT02675673|G-Tube|g-tube
5211097|NCT02675673|GJ Tube|gj tube
5211098|NCT02675660|kinetic data|kinetic data
5211099|NCT02675660|volunteers|volunteers
5211100|NCT02675608|vaccine efficacy|vaccine efficacy
5211101|NCT02675608|inflammation|inflammation
5211108|NCT02675569|Catheter|catheter
5211110|NCT02675556|Depression|depression
5211111|NCT02675530|NMDA|nmda
5211112|NCT02675530|glutamate|glutamate
5211113|NCT02675530|schizophrenia|schizophrenia
5211114|NCT02675504|scary scale|scary scale
5211115|NCT02675491|Advanced solid tumor|advanced solid tumor
5211116|NCT02675491|DS-6051b|ds-6051b
5211117|NCT02675491|ROS1|ros1
5211118|NCT02675491|NTRK|ntrk
5211119|NCT02675491|refractory to standard therapy|refractory to standard therapy
5211120|NCT02675491|no standard therapy|no standard therapy
5211121|NCT02675478|AML|aml
5211122|NCT02675478|phase 1|phase 1
5211123|NCT02675478|oncology|oncology
5211124|NCT02675465|Pompe, rhGAA|pompe, rhgaa
5211131|NCT02675413|Cerebral Spinal Fluid|cerebral spinal fluid
5211132|NCT02675413|Dimethyl Fumarate|dimethyl fumarate
5211133|NCT02675413|Tecfidera|tecfidera
5211134|NCT02675413|Multiple Sclerosis|multiple sclerosis
5211135|NCT02675413|Relapsing MS|relapsing ms
5211136|NCT02675413|RRMS|rrms
5211137|NCT02675413|Mechanism of Action|mechanism of action
5211138|NCT02675400|ADHD|adhd
5211139|NCT02675400|ADD|add
5211140|NCT02675400|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5211141|NCT02675400|Attention|attention
5211142|NCT02675400|Hyperactivity|hyperactivity
5211143|NCT02675374|Cardiac surgery|cardiac surgery
5211144|NCT02675374|cardiopulmonary bypass|cardiopulmonary bypass
5211145|NCT02675374|dexchlorpheniramine|dexchlorpheniramine
5211146|NCT02675374|H1 blockers|h1 blockers
5211147|NCT02675374|norepinephrine|norepinephrine
5211148|NCT02675374|histamine release|histamine release
5211149|NCT02675361|Transfer to adult care|transfer to adult care
5211150|NCT02675361|Continuity of patient care|continuity of patient care
5211151|NCT02675361|Transition program|transition program
5211152|NCT02675335|Diabetic foot ulcer, Sitagliptin|diabetic foot ulcer, sitagliptin
5211153|NCT02675296|outcome|outcome
5211154|NCT02675283|Point of care test|point of care test
5211155|NCT02675283|Diagnosis|diagnosis
5211156|NCT02675283|Case finding|case finding
5211157|NCT02675257|Diabetes mellitus|diabetes mellitus
5211158|NCT02675257|Affective disorders|affective disorders
5211159|NCT02675257|Depressive symptoms|depressive symptoms
5211160|NCT02675257|Diabetes distress|diabetes distress
5211161|NCT02675257|Hyperglycaemia|hyperglycaemia
5211162|NCT02675257|Dysglycaemia|dysglycaemia
5211163|NCT02675257|Glycaemic control|glycaemic control
5211164|NCT02675257|Self-care behaviour|self-care behaviour
5211165|NCT02675257|Quality of Life|quality of life
5211166|NCT02675257|Diabetes acceptance|diabetes acceptance
5211167|NCT02675257|Diabetes complications|diabetes complications
5211168|NCT02675257|Low-grade inflammation|low-grade inflammation
5211169|NCT02675257|Inflammatory markers|inflammatory markers
5211170|NCT02675257|Stress reactivity|stress reactivity
5211171|NCT02675257|Health-care costs|health-care costs
5211172|NCT02675244|Tricuspid Valve Regurgitation|tricuspid valve regurgitation
5211173|NCT02675192|sarcopenia|sarcopenia
5211174|NCT02675192|elderly|elderly
5211175|NCT02675192|muscle biopsy|muscle biopsy
5211176|NCT02675166|Childhood cancer|childhood cancer
5211177|NCT02675166|Sequels|sequels
5211178|NCT02675166|Complications|complications
5211179|NCT02675166|Surgery|surgery
5211180|NCT02675166|Radiotherapy|radiotherapy
5211181|NCT02675166|Chemotherapy|chemotherapy
5211182|NCT02675166|Cancer|cancer
5211183|NCT02675153|Inflammatory Bowel Disease|inflammatory bowel disease
5211184|NCT02675153|stenosis|stenosis
5211185|NCT02675153|sirolimus|sirolimus
5211186|NCT02675153|rapamycin|rapamycin
5211187|NCT02675153|stricture|stricture
5211188|NCT02675114|Sapien 3|sapien 3
5211189|NCT02675114|cardiovascular disease|cardiovascular disease
5211190|NCT02675114|heart disease|heart disease
5211191|NCT02675114|aortic stenosis|aortic stenosis
5211192|NCT02675114|SAVR|savr
5211193|NCT02675114|TAVR|tavr
5211194|NCT02675088|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
5211195|NCT02675088|thoracic radiotherapy|thoracic radiotherapy
5211196|NCT02675088|radiotherapy regimen|radiotherapy regimen
5211197|NCT02675075|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5211198|NCT02675075|Voice|voice
5211199|NCT02675075|Voice Quality|voice quality
5211200|NCT02675075|Total Lung Capacity|total lung capacity
5211201|NCT02675062|Accelerometry|accelerometry
5211202|NCT02675062|Osteoarthritis|osteoarthritis
5103262|NCT03352024|Alzheimer's disease|alzheimer's disease
5199216|NCT02749227|silent corticotroph adenomas|silent corticotroph adenomas
5199217|NCT02749201|Obesity|obesity
5199218|NCT02749201|sleeve gastrectomy|sleeve gastrectomy
5199219|NCT02749188|Urine Specimen Collection/methods|urine specimen collection/methods
5199220|NCT02749188|Infant|infant
5211203|NCT02675062|Habitual physical activity|habitual physical activity
5211210|NCT02675036|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics|ectopiccanine teeth, impacted teeth, tooth eruption, orthodontics
5211211|NCT02674997|Goal setting|goal setting
5211212|NCT02674997|Feasibility|feasibility
5211213|NCT02674997|Standardized Goal Attainment Scaling menu for Hemophilia (GAS-Hem)|standardized goal attainment scaling menu for hemophilia (gas-hem)
5211214|NCT02674997|Patient reported outcome (PRO)|patient reported outcome (pro)
5211215|NCT02674997|Goal attainment scaling (GAS)|goal attainment scaling (gas)
5211216|NCT02674958|endothelial progenitor cells|endothelial progenitor cells
5211218|NCT02674958|acetylsalicylic acid|acetylsalicylic acid
5211219|NCT02674958|alcohol septal ablation|alcohol septal ablation
5211220|NCT02674945|fitbit|fitbit
5211221|NCT02674945|activity tracker|activity tracker
5211222|NCT02674945|sleep|sleep
5211223|NCT02674945|quality of life|quality of life
5211224|NCT02674919|Repeated-sprint ability|repeated-sprint ability
5211225|NCT02674919|Nordic Hamstring exercise|nordic hamstring exercise
5211226|NCT02674919|Eccentric hamstring muscle strength|eccentric hamstring muscle strength
5211227|NCT02674893|BMI>27|bmi>27
5211228|NCT02674893|Treatment with Liraglutide|treatment with liraglutide
5211229|NCT02674841|Adolescent|adolescent
5211230|NCT02674841|Physical therapy modalities|physical therapy modalities
5211231|NCT02674841|Exercise intervention|exercise intervention
5211232|NCT02674841|Auditive feedback|auditive feedback
5211233|NCT02674841|Visual feedback|visual feedback
5211234|NCT02674815|Exercise|exercise
5211235|NCT02674815|Preoperative|preoperative
5211236|NCT02674815|High Intensity Interval Training|high intensity interval training
5211237|NCT02674815|Colorectal|colorectal
5211238|NCT02674815|Thoracic|thoracic
5211239|NCT02674815|Postoperative|postoperative
5211240|NCT02674802|Reinfection|reinfection
5211241|NCT02674802|Eradication therapy|eradication therapy
5211242|NCT02674802|C-urea breath test|c-urea breath test
5211243|NCT02674802|Helicobacter Pylori|helicobacter pylori
5211244|NCT02674789|Exercise|exercise
5211245|NCT02674789|Athletes|athletes
5211246|NCT02674789|Ionized Magnesium|ionized magnesium
5211247|NCT02674789|Variation|variation
5211248|NCT02674789|Blood|blood
5211249|NCT02674763|Acute Myeloid Leukemia|acute myeloid leukemia
5211250|NCT02674763|AML|aml
5211251|NCT02674763|IMGN779|imgn779
5211252|NCT02674763|ImmunoGen|immunogen
5211253|NCT02674763|Phase 1|phase 1
5211254|NCT02674763|Relapsed|relapsed
5211255|NCT02674763|Refractory|refractory
5211257|NCT02674763|Dose Escalation|dose escalation
5211258|NCT02674763|Dose Expansion|dose expansion
5211259|NCT02674750|DLBCL|dlbcl
5211260|NCT02674750|MYC|myc
5211261|NCT02674724|Resistance Training|resistance training
5211262|NCT02674724|Postural Balance|postural balance
5211263|NCT02674724|Exercise|exercise
5211264|NCT02674711|patient education|patient education
5211265|NCT02674711|low back pain|low back pain
5211266|NCT02674711|post-surgical pain|post-surgical pain
5211267|NCT02674711|chronic opioid use|chronic opioid use
5211268|NCT02674711|Neck Pain|neck pain
5211269|NCT02674672|VenaTech® Retrievable Vena Cava Filter|venatech® retrievable vena cava filter
5211270|NCT02674672|safety|safety
5211271|NCT02674672|efficacy|efficacy
5211272|NCT02674659|resistance training, PCSK9, coronary artery bypass grafting|resistance training, pcsk9, coronary artery bypass grafting
5211273|NCT02674633|ADHD|adhd
5211274|NCT02674594|Anticoagulation|anticoagulation
5211275|NCT02674568|SCLC|sclc
5211276|NCT02674568|Small Cell Lung Cancer|small cell lung cancer
5211277|NCT02674568|DLL#|dll#
5211278|NCT02674568|Relapsed|relapsed
5211279|NCT02674568|Refractory|refractory
5211280|NCT02674555|Phase 1|phase 1
5211281|NCT02674555|Metabolism|metabolism
5211282|NCT02674555|Excretion|excretion
5211283|NCT02674555|Absorption|absorption
5211284|NCT02674555|[14C]-radioactivity|[14c]-radioactivity
5211285|NCT02674555|Pharmacokinetics|pharmacokinetics
5211286|NCT02674555|naquotinib|naquotinib
5211287|NCT02674555|Oncology|oncology
5211288|NCT02674542|Family planning|family planning
5211289|NCT02674542|Birth spacing|birth spacing
5211290|NCT02674529|Depression|depression
5211291|NCT02674529|Neuroimaging biomarkers|neuroimaging biomarkers
5211292|NCT02674529|MDD|mdd
5199392|NCT02748161|QED|qed
5211293|NCT02674529|Neurofeedback|neurofeedback
5211294|NCT02674516|antisocial behavior|antisocial behavior
5211295|NCT02674516|aggression|aggression
5211296|NCT02674516|transcranial direct current stimulation|transcranial direct current stimulation
5211297|NCT02674516|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5211301|NCT02674503|Randomized controlled trial|randomized controlled trial
5211302|NCT02674490|aphasia, language|aphasia, language
5211303|NCT02674373|gastric cancer|gastric cancer
5211304|NCT02674373|biomarker|biomarker
5211305|NCT02674373|Circulating tumor DNA|circulating tumor dna
5211306|NCT02674373|Chemotherapy|chemotherapy
5211307|NCT02674373|Prognosis|prognosis
5211308|NCT02674373|Predictive|predictive
5211309|NCT02674334|orthopedic procedures|orthopedic procedures
5211310|NCT02674321|Tourette Syndrome|tourette syndrome
5211311|NCT02674321|adolescents|adolescents
5211312|NCT02674308|Drug therapy|drug therapy
5211313|NCT02674295|Healthy|healthy
5211314|NCT02674295|JNJ-54135419|jnj-54135419
5211315|NCT02674295|Esketamine|esketamine
5211316|NCT02674282|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5211317|NCT02674282|anterior cruciate ligament|anterior cruciate ligament
5211318|NCT02674282|sports medicine|sports medicine
5211319|NCT02674282|soccer|soccer
5211320|NCT02674282|maximum oxygen uptake|maximum oxygen uptake
5211321|NCT02674282|return to play|return to play
5211322|NCT02674269|Overactive bladder|overactive bladder
5211323|NCT02674269|Botox|botox
5211324|NCT02674269|TC-3 Gel|tc-3 gel
5211325|NCT02674269|Intravesical|intravesical
5211326|NCT02674269|UroGen Pharma|urogen pharma
5211327|NCT02674269|Botulinum Toxin|botulinum toxin
5211328|NCT02674269|Urgency|urgency
5211329|NCT02674269|OAB|oab
5211330|NCT02674269|Incontinence|incontinence
5211331|NCT02674269|I-QOL|i-qol
5211332|NCT02674269|KHQ|khq
5211333|NCT02674269|TBS|tbs
5211334|NCT02674269|RTG|rtg
5211335|NCT02674256|health|health
5211336|NCT02674256|age between 18 to 60 years old|age between 18 to 60 years old
5211337|NCT02674256|no history of gastrointestinal symptoms or complaints|no history of gastrointestinal symptoms or complaints
5211338|NCT02674243|Malignant pleural effusion|malignant pleural effusion
5211339|NCT02674243|Pleurodesis|pleurodesis
5211340|NCT02674243|Talc|talc
5211341|NCT02674243|Iodopovidone solution|iodopovidone solution
5211342|NCT02674243|Povidone-iodine|povidone-iodine
5211343|NCT02674204|Statin therapy|statin therapy
5211344|NCT02674204|trastuzumab|trastuzumab
5211541|NCT02672878|Stent|stent
5211345|NCT02674191|miniplates ,molar intrusion, hyperdivergent|miniplates ,molar intrusion, hyperdivergent
5211346|NCT02674139|post placental-caesarean-IUD|post placental-caesarean-iud
5211347|NCT02674126|Cardiac Surgery|cardiac surgery
5211348|NCT02674126|Maternal sound|maternal sound
5211349|NCT02674126|Cortisol|cortisol
5211350|NCT02674126|Blood sugar|blood sugar
5211351|NCT02674126|Stress|stress
5211352|NCT02674061|PD1|pd1
5211353|NCT02674061|PD-1|pd-1
5211354|NCT02674061|PDL1|pdl1
5211355|NCT02674061|PD-L1|pd-l1
5217919|NCT02634918|Doppler|doppler
5211356|NCT02674035|Abdominoplasty|abdominoplasty
5211357|NCT02674035|Sutures|sutures
5211358|NCT02674035|Abdominal deformities|abdominal deformities
5211359|NCT02674035|Plication|plication
5211360|NCT02674035|Monofilament nylon suture|monofilament nylon suture
5211361|NCT02674035|Barbed suture|barbed suture
5211362|NCT02674022|Maternal Health|maternal health
5211363|NCT02674022|Autistic Disorder|autistic disorder
5211364|NCT02674022|Metabolism|metabolism
5211365|NCT02674022|Folic Acid|folic acid
5211366|NCT02673996|antibody|antibody
5211367|NCT02673996|autoimmune|autoimmune
5211368|NCT02673996|adrenergic|adrenergic
5211369|NCT02673996|autonomic|autonomic
5211370|NCT02673983|Intestinal|intestinal
5211371|NCT02673983|Biopsy|biopsy
5211372|NCT02673983|full thickness|full thickness
5211373|NCT02673983|endoscopic|endoscopic
5211374|NCT02673970|Melanoma|melanoma
5211375|NCT02673931|Open Heart Surgery|open heart surgery
5211376|NCT02673931|Organ protection|organ protection
5211377|NCT02673918|Rehabilitation|rehabilitation
5211378|NCT02673918|Home-Based Intervention|home-based intervention
5211379|NCT02673905|nasal chondrocytes|nasal chondrocytes
5211380|NCT02673905|articular chondral lesions|articular chondral lesions
5211381|NCT02673905|tissue engineering|tissue engineering
5211382|NCT02673905|femoral condyle|femoral condyle
5211383|NCT02673905|trochlea|trochlea
5211384|NCT02673892|discharge|discharge
5211385|NCT02673892|transitions|transitions
5211386|NCT02673892|patient experience|patient experience
5211387|NCT02673866|Diabetic Peripheral Neuropathic Pain (DPNP)|diabetic peripheral neuropathic pain (dpnp)
5211388|NCT02673866|Diabetes|diabetes
5211389|NCT02673866|Pregabalin|pregabalin
5211390|NCT02673866|Spontaneous Pain|spontaneous pain
5211391|NCT02673866|Hyperalgesia|hyperalgesia
5211392|NCT02673866|Allodynia|allodynia
5211393|NCT02673866|Average Daily Pain Score (ADPS)|average daily pain score (adps)
5211394|NCT02673866|Pain Associated Sleep Interference|pain associated sleep interference
5211395|NCT02673853|Supraglottic airway|supraglottic airway
5211396|NCT02673853|Mini-dose atracurium|mini-dose atracurium
5211397|NCT02673853|Postoperative residual paralysis|postoperative residual paralysis
5211398|NCT02673840|dengue fever|dengue fever
5211399|NCT02673840|dengue hemorrhagic fever|dengue hemorrhagic fever
5211400|NCT02673840|ketotifen|ketotifen
5211401|NCT02673840|vascular leakage|vascular leakage
5211402|NCT02673840|pleural effusion|pleural effusion
5211403|NCT02673840|plasma leakage|plasma leakage
5211404|NCT02673801|Referral and Consultation|referral and consultation
5211405|NCT02673801|Orthopedics|orthopedics
5211406|NCT02673775|Macrophage|macrophage
5211407|NCT02673749|Lactose maldigestion|lactose maldigestion
5211408|NCT02673749|Dairy intolerance|dairy intolerance
5211409|NCT02673749|Intolerance to milk|intolerance to milk
5211410|NCT02673749|Intolerance to dairy|intolerance to dairy
5211411|NCT02673749|Milk intolerance|milk intolerance
5211412|NCT02673749|GI disorder|gi disorder
5211413|NCT02673749|Lactose metabolism|lactose metabolism
5211414|NCT02673749|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
5211415|NCT02673736|PLX73086|plx73086
5211416|NCT02673736|Synovitis, Pigmented Villonodular|synovitis, pigmented villonodular
5211417|NCT02673736|Tenosynovial Giant Cell Tumor|tenosynovial giant cell tumor
5211418|NCT02673736|Joint Diseases|joint diseases
5211419|NCT02673736|Neoplasms|neoplasms
5211420|NCT02673736|Synovitis|synovitis
5211421|NCT02673723|docozine|docozine
5211422|NCT02673697|Sutureless valve|sutureless valve
5211423|NCT02673658|infant development, early intervention|infant development, early intervention
5211424|NCT02673645|Educational Achievement|educational achievement
5211425|NCT02673632|Anti-Müllerian hormone|anti-müllerian hormone
5211426|NCT02673632|Ovarian stimulation|ovarian stimulation
5211427|NCT02673632|Polycystic ovary syndrome|polycystic ovary syndrome
5211428|NCT02673632|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5211430|NCT02673619|Palmar Hyperhidrosis|palmar hyperhidrosis
5211431|NCT02673619|Umeclidinium|umeclidinium
5211433|NCT02673593|Pharmacokinetics|pharmacokinetics
5211434|NCT02673593|Food Effect|food effect
5211435|NCT02673554|Glucose-dependent Insulinotropic Polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
5211436|NCT02673554|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
5211437|NCT02673554|Incretin|incretin
5211438|NCT02673554|Insulin secretion|insulin secretion
5211439|NCT02673554|Tachyphylaxis|tachyphylaxis
5211440|NCT02673528|appendectomy|appendectomy
5211441|NCT02673528|laparoscopy|laparoscopy
5211442|NCT02673528|laparoscopic assisted appendectomy|laparoscopic assisted appendectomy
5211443|NCT02673528|cost utility|cost utility
5211444|NCT02673515|Alternate Day Fasting|alternate day fasting
5211445|NCT02673502|Carbohydrate drink|carbohydrate drink
5211446|NCT02673502|Post operative complication|post operative complication
5211447|NCT02673502|insulin resistance|insulin resistance
5211448|NCT02673502|Fasting blood glucose|fasting blood glucose
5211449|NCT02673437|Acute coronary syndrome|acute coronary syndrome
5211450|NCT02673411|elastography|elastography
5211451|NCT02673411|ultrasonography|ultrasonography
5211452|NCT02673372|Geriatric, Pain, Ketamine, Emergency Medicine|geriatric, pain, ketamine, emergency medicine
5211453|NCT02673359|Preterm labor|preterm labor
5211454|NCT02673359|Short cervix|short cervix
5211455|NCT02673359|Progesterone|progesterone
5211456|NCT02673359|Cervical cerclage|cervical cerclage
5211457|NCT02673333|Pembrolizumab|pembrolizumab
5211458|NCT02673333|15-286|15-286
5211459|NCT02673320|Acute Traumatic Cervical Central Cord Syndrom Injury|acute traumatic cervical central cord syndrom injury
5211460|NCT02673320|Delay of Surgery|delay of surgery
5211461|NCT02673320|Decompressive Surgery|decompressive surgery
5211462|NCT02673320|Canal Stenosis|canal stenosis
5211463|NCT02673320|Schneider Syndrom|schneider syndrom
5211464|NCT02673320|Quality of life|quality of life
5211465|NCT02673320|Functional Outcome|functional outcome
5211466|NCT02673281|walnuts|walnuts
5211467|NCT02673281|brain|brain
5211468|NCT02673281|appetite|appetite
5211469|NCT02673281|energy intake|energy intake
5211470|NCT02673281|obesity|obesity
5211471|NCT02673255|Plasma|plasma
5211472|NCT02673255|Plasma Donor|plasma donor
5211473|NCT02673255|Plasma Donation|plasma donation
5211474|NCT02673255|Tetanus|tetanus
5211476|NCT02673255|Immunoglobulin|immunoglobulin
5211477|NCT02673255|Hyper-immunization|hyper-immunization
5211478|NCT02673229|Santyl|santyl
5211479|NCT02673229|Burn|burn
5211480|NCT02673229|Partial Thickness Burn|partial thickness burn
5211481|NCT02673229|Second Degree Burn|second degree burn
5211482|NCT02673229|Minor Burn Bacitracin|minor burn bacitracin
5211483|NCT02673229|Scar Appearance|scar appearance
5211484|NCT02673203|glucose monitoring|glucose monitoring
5211485|NCT02673203|hunger levels|hunger levels
5211486|NCT02673203|food intake|food intake
5211487|NCT02673177|robot-assisted total mesorectal excision(RTME)|robot-assisted total mesorectal excision(rtme)
5211488|NCT02673177|laparoscopic total mesorectal excision(LTME)|laparoscopic total mesorectal excision(ltme)
5211489|NCT02673177|urinary function|urinary function
5211490|NCT02673177|sexual function|sexual function
5211491|NCT02673177|sphincter- preservation|sphincter- preservation
5211492|NCT02673177|low rectal cancer|low rectal cancer
5211493|NCT02673164|Heart failure|heart failure
5211494|NCT02673164|stem cell|stem cell
5211495|NCT02673164|adipose derived stem cell|adipose derived stem cell
5211496|NCT02673164|Stem cell therapy|stem cell therapy
5211497|NCT02673164|ischemic heart disease|ischemic heart disease
5211498|NCT02673125|Preimplantation Genetic Screening|preimplantation genetic screening
5211500|NCT02673112|mild traumatic brain injury|mild traumatic brain injury
5211501|NCT02673112|post concussion syndrome|post concussion syndrome
5211502|NCT02673112|child|child
5211503|NCT02673099|HDF online|hdf online
5211504|NCT02673099|ESRD|esrd
5211505|NCT02673099|Hemodialysis|hemodialysis
5211506|NCT02673099|oxidative stress|oxidative stress
5211507|NCT02673099|quality of life|quality of life
5211508|NCT02673099|Hemodialysis treatment|hemodialysis treatment
5088968|NCT03442192|PrEP|prep
5211509|NCT02673086|retroclavicular approach|retroclavicular approach
5211510|NCT02673086|coracoid approach|coracoid approach
5211511|NCT02673086|ultrasound|ultrasound
5211512|NCT02673086|upper limb surgery|upper limb surgery
5211513|NCT02673086|needle visibility|needle visibility
5211514|NCT02673086|infraclavicular brachial plexus block|infraclavicular brachial plexus block
5211515|NCT02673073|Heart failure|heart failure
5211516|NCT02673073|patient's diary|patient's diary
5211517|NCT02673073|self awareness|self awareness
5211518|NCT02672995|stereotactic radiosurgery,Bevacizumab|stereotactic radiosurgery,bevacizumab
5211519|NCT02672969|smoke evacuation system|smoke evacuation system
5211520|NCT02672969|surgical smoke|surgical smoke
5211521|NCT02672943|Parkinson disease|parkinson disease
5211522|NCT02672943|Autonomic nervous system|autonomic nervous system
5211523|NCT02672943|MicroRNA|microrna
5211524|NCT02672943|Inflammation|inflammation
5211525|NCT02672943|Oxidative stress|oxidative stress
5211526|NCT02672943|noradrenergic network|noradrenergic network
5211527|NCT02672943|Rehabilitation treatment|rehabilitation treatment
5211528|NCT02672930|calcium gluconate|calcium gluconate
5211529|NCT02672930|hyperpotassemia treatment|hyperpotassemia treatment
5211530|NCT02672917|CA19-9 Positive Malignancies|ca19-9 positive malignancies
5211531|NCT02672904|vocal cord|vocal cord
5211532|NCT02672904|carcinoma|carcinoma
5211533|NCT02672904|ktp laser|ktp laser
5211534|NCT02672904|co2 laser|co2 laser
5211535|NCT02672904|endoscopic surgery|endoscopic surgery
5211536|NCT02672891|Postpartum Hemorrhage|postpartum hemorrhage
5211537|NCT02672891|Uterine Tamponade|uterine tamponade
5211538|NCT02672891|Condom Catheter|condom catheter
5211539|NCT02672878|In-stent restenosis|in-stent restenosis
5211540|NCT02672878|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
5211542|NCT02672878|Drug-eluting stent|drug-eluting stent
5211543|NCT02672878|Coronary angiography|coronary angiography
5211544|NCT02672852|ABBV-066|abbv-066
5211545|NCT02672852|BI 655066|bi 655066
5211546|NCT02672852|risankizumab|risankizumab
5211547|NCT02672813|Pectoral nerve I and II blocks|pectoral nerve i and ii blocks
5211548|NCT02672813|Breast surgery|breast surgery
5211549|NCT02672813|Ropivacaine|ropivacaine
5211550|NCT02672813|Postoperative opioid consumption|postoperative opioid consumption
5211551|NCT02672787|Antihypertensive adherence|antihypertensive adherence
5211552|NCT02672787|Emergency medicine|emergency medicine
5211553|NCT02672787|Antihypertensives|antihypertensives
5211555|NCT02672748|Native American|native american
5211557|NCT02672748|Emotional health|emotional health
5211558|NCT02672748|Physical health|physical health
5211559|NCT02672735|corrective exercise program|corrective exercise program
5211560|NCT02672735|movement efficiency|movement efficiency
5211561|NCT02672722|This term was found doing the MeSH search and is the only thing that fits since we will be working with healthy subjects with no conditions.|this term was found doing the mesh search and is the only thing that fits since we will be working with healthy subjects with no conditions.
5211562|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors
5211563|NCT02672709|Renal Dialysis|renal dialysis
5211564|NCT02672696|Navigation|navigation
5211565|NCT02672696|Gamma Nail|gamma nail
5211566|NCT02672657|Health-Related Quality of life|health-related quality of life
5211567|NCT02672657|Cancer|cancer
5211568|NCT02672657|Elderly|elderly
5211569|NCT02672657|Caregivers|caregivers
5211570|NCT02672618|heart failure|heart failure
5211571|NCT02672618|infrared thermal imaging|infrared thermal imaging
5211572|NCT02672592|Metabolic syndrome X|metabolic syndrome x
5211573|NCT02672592|Hypogonadism|hypogonadism
5211574|NCT02672592|Testosterone|testosterone
5211575|NCT02672592|Inflammation|inflammation
5211576|NCT02672592|Obesity|obesity
5211577|NCT02672566|Fetal Growth Retardation|fetal growth retardation
5211578|NCT02672566|enoxaparin|enoxaparin
5211579|NCT02672553|Aortic Valve Replacement|aortic valve replacement
5211580|NCT02672553|Minimal Invasive Sternotomy|minimal invasive sternotomy
5199606|NCT02746679|Quality of Life|quality of life
5199607|NCT02746653|Fascia Closure Device, hernia,|fascia closure device, hernia,
5199608|NCT02746614|adaptive behavior|adaptive behavior
5199609|NCT02746614|motor proficiency|motor proficiency
5199610|NCT02746614|psychomotor therapy|psychomotor therapy
5199611|NCT02746614|intellectual disability|intellectual disability
5199612|NCT02746588|miscarriage|miscarriage
5199613|NCT02746588|uterine abnormalities|uterine abnormalities
5211581|NCT02672540|Sickle Cell|sickle cell
5211582|NCT02672540|Anemia|anemia
5211596|NCT02672397|Ethnicity|ethnicity
5211597|NCT02672397|Education|education
5211598|NCT02672397|Labor|labor
5211599|NCT02672397|obstetrical analgesia|obstetrical analgesia
5211600|NCT02672384|Intensive care unit|intensive care unit
5211601|NCT02672384|Invasive mechanical ventilation|invasive mechanical ventilation
5211602|NCT02672384|Chronic periodontitis|chronic periodontitis
5211603|NCT02672384|Point of Care P. gingivalis test|point of care p. gingivalis test
5211604|NCT02672358|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5211605|NCT02672358|NSCLC|nsclc
5211606|NCT02672358|dabrafenib|dabrafenib
5211607|NCT02672358|trametinib|trametinib
5962615|NCT04279977|inpatient rehabilitation|inpatient rehabilitation
5089085|NCT03441295|ACL|acl
5211608|NCT02672358|Japanese patients|japanese patients
5211609|NCT02672358|BRAF V600E mutation positive metastatic|braf v600e mutation positive metastatic
5211610|NCT02672358|stage IV|stage iv
5211611|NCT02672345|Sevoflurane|sevoflurane
5211612|NCT02672345|MicroRNAs|micrornas
5211613|NCT02672345|Inflammatory Response|inflammatory response
5211614|NCT02672345|Cytokines|cytokines
5211615|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation
5211616|NCT02672345|Macrophage Inflammatory Proteins|macrophage inflammatory proteins
5211617|NCT02672267|AMI, hBMMSCs, stem cells,|ami, hbmmscs, stem cells,
5211618|NCT02672241|Radiation Therapy|radiation therapy
5211619|NCT02672241|Brainstem Tumor in Children|brainstem tumor in children
5211620|NCT02672202|Chronic Pain|chronic pain
5211621|NCT02672202|Pain Modulation Profile|pain modulation profile
5211622|NCT02672202|CPM|cpm
5211623|NCT02672202|acute post operative pain|acute post operative pain
5211624|NCT02672189|Climacteric symptoms|climacteric symptoms
5211625|NCT02672189|Menopause|menopause
5211626|NCT02672189|Breast Cancer Survivors|breast cancer survivors
5211627|NCT02672189|Internet-based|internet-based
5211628|NCT02672189|Cognitive behavioral therapy|cognitive behavioral therapy
5211629|NCT02672189|Psychosocial intervention|psychosocial intervention
5211630|NCT02672176|Diabetes mellitus|diabetes mellitus
5211631|NCT02672176|Motivational Interviewing|motivational interviewing
5211632|NCT02672176|Mobile Health Technology|mobile health technology
5211633|NCT02672176|Patient-generated Health Data (PGHD)|patient-generated health data (pghd)
5211634|NCT02672163|autologous micrografts|autologous micrografts
5211635|NCT02672163|heart failure|heart failure
5211636|NCT02672163|coronary artery bypass surgery|coronary artery bypass surgery
5211637|NCT02672163|cell therapy|cell therapy
5211638|NCT02672163|atrial appendage|atrial appendage
5211639|NCT02672163|epicardial cell delivery|epicardial cell delivery
5211640|NCT02672150|evidence-based practice implementation|evidence-based practice implementation
5211641|NCT02672150|system change|system change
5211642|NCT02672150|interagency collaboration|interagency collaboration
5211643|NCT02672150|substance use|substance use
5211644|NCT02672150|treatment services|treatment services
5211645|NCT02672150|data-driven decision making|data-driven decision making
5211646|NCT02672150|juvenile justice|juvenile justice
5211647|NCT02672150|adolescents|adolescents
5211648|NCT02672150|justice-involved youth|justice-involved youth
5211649|NCT02672150|cluster randomized trial|cluster randomized trial
5211650|NCT02672137|myocardial infarction|myocardial infarction
5211651|NCT02672137|knowledge transfer|knowledge transfer
5211652|NCT02672137|acute coronary syndromes|acute coronary syndromes
5211653|NCT02672020|pheochromocytoma|pheochromocytoma
5211654|NCT02672020|paraganglioma|paraganglioma
5211655|NCT02672020|adrenocortical carcinoma|adrenocortical carcinoma
5211656|NCT02672007|Respiratory rate measurement methods.|respiratory rate measurement methods.
5211657|NCT02671994|Geriatric Assessment|geriatric assessment
5211658|NCT02671994|G8 screening|g8 screening
5211659|NCT02671994|Oncologic treatment|oncologic treatment
5211661|NCT02671968|hypoglycemic events|hypoglycemic events
5211662|NCT02671955|Advanced Cancer|advanced cancer
5211663|NCT02671955|JNJ-61610588|jnj-61610588
5211664|NCT02671942|roflumilast|roflumilast
5211665|NCT02671916|QoL and Survival one year after ICU stay|qol and survival one year after icu stay
5211666|NCT02671864|Incretin-based therapy|incretin-based therapy
5211669|NCT02671864|Hypoglycaemic treatment|hypoglycaemic treatment
5211670|NCT02671851|Thoracic Paravertebral Blocks|thoracic paravertebral blocks
5211671|NCT02671851|Ultrasound Guidance|ultrasound guidance
5211672|NCT02671851|Reduction Mammoplasty|reduction mammoplasty
5211673|NCT02671851|Time to First Pain|time to first pain
5211674|NCT02671851|Postoperative Analgesia|postoperative analgesia
5211675|NCT02671825|Pharmacokinetics|pharmacokinetics
5211676|NCT02671812|dental implant|dental implant
5211677|NCT02671812|patient satisfaction|patient satisfaction
5211678|NCT02671812|treatment outcome|treatment outcome
5211679|NCT02671812|cytokine profile|cytokine profile
5211680|NCT02671812|risk factor|risk factor
5211681|NCT02671812|risk predictor|risk predictor
5211682|NCT02671786|Severe Acute Malnutrition|severe acute malnutrition
5211683|NCT02671786|Severe Underweight|severe underweight
5211684|NCT02671786|IAP Grade III-IV|iap grade iii-iv
5211685|NCT02671786|Severe Stunting|severe stunting
5211686|NCT02671786|Village Health Workers|village health workers
5674154|NCT00604773|critical care|critical care
5211691|NCT02671760|sedative|sedative
5211692|NCT02671760|hypnotic|hypnotic
5211693|NCT02671734|endoscopy|endoscopy
5103778|NCT03348683|Propranolol|propranolol
5211694|NCT02671682|Immunoadsorption|immunoadsorption
5211695|NCT02671682|Plasmapheresis|plasmapheresis
5211696|NCT02671656|Uricemia|uricemia
5211697|NCT02671630|Cognitive function|cognitive function
5211698|NCT02671630|Depression|depression
5211699|NCT02671630|Quality of life|quality of life
5211700|NCT02671630|Community-based computerized cognitive training program|community-based computerized cognitive training program
5211701|NCT02671630|Randomized controlled trial|randomized controlled trial
5211702|NCT02671617|Abdominal Cavity|abdominal cavity
5211703|NCT02671617|Aged|aged
5962616|NCT04279977|skilled nursing|skilled nursing
5211704|NCT02671604|acute renal failure|acute renal failure
5211705|NCT02671604|prostatectomy|prostatectomy
5211706|NCT02671604|minimal invasive surgery|minimal invasive surgery
5211707|NCT02671578|nitrous oxide|nitrous oxide
5211708|NCT02671578|conscious sedation|conscious sedation
5211709|NCT02671578|pain|pain
5211710|NCT02671578|anxiety|anxiety
5211711|NCT02671565|Intraarticular hyaluronic acid injections|intraarticular hyaluronic acid injections
5211712|NCT02671565|Total knee replacement|total knee replacement
5211713|NCT02671565|Observational study|observational study
5211714|NCT02671565|Intraarticular corticosteroid injections|intraarticular corticosteroid injections
5211715|NCT02671565|Comparative effectiveness|comparative effectiveness
5211716|NCT02671539|gene therapy|gene therapy
5211717|NCT02671539|hereditary retinal degeneration|hereditary retinal degeneration
5211718|NCT02671539|rAAV2.REP1|raav2.rep1
5211719|NCT02671513|Melanoma|melanoma
5211720|NCT02671513|Cycline-Dependent Kinase|cycline-dependent kinase
5211721|NCT02671487|Problem Behavior|problem behavior
5211722|NCT02671487|Aggression|aggression
5211723|NCT02671487|Posttraumatic Stress Disorder|posttraumatic stress disorder
5211724|NCT02671487|Adolescents|adolescents
5211725|NCT02671448|Homebound|homebound
5211726|NCT02671448|Homecare|homecare
5211727|NCT02671448|15-022|15-022
5211729|NCT02671396|Virtual Reality|virtual reality
5211730|NCT02671396|Postural Stability|postural stability
5212130|NCT02668653|Quizartinib|quizartinib
5211731|NCT02671396|Balance Training|balance training
5211732|NCT02671396|Parkinson's Disease|parkinson's disease
5211733|NCT02671383|Antiretroviral Agents|antiretroviral agents
5211734|NCT02671383|Treatment|treatment
5211735|NCT02671383|Viral Load|viral load
5211736|NCT02671357|pancreatic surgery; neoplasms|pancreatic surgery; neoplasms
5211737|NCT02671318|cytomegalovirus|cytomegalovirus
5211738|NCT02671318|sirolimus|sirolimus
5211739|NCT02671318|cytomegalovirus recurrence|cytomegalovirus recurrence
5211740|NCT02671318|kidney transplant|kidney transplant
5211741|NCT02671318|conversion|conversion
5211742|NCT02671305|delayed cord clamping|delayed cord clamping
5211743|NCT02671305|cord milking|cord milking
5211744|NCT02671305|bedside neonatal resuscitation|bedside neonatal resuscitation
5211745|NCT02671292|Loss of Control Eating|loss of control eating
5211746|NCT02671292|Binge Eating|binge eating
5211748|NCT02671292|Prevention|prevention
5211749|NCT02671292|Interpersonal Psychotherapy|interpersonal psychotherapy
5211750|NCT02671292|Adolescent|adolescent
5211751|NCT02671266|Oxytocin|oxytocin
5211752|NCT02671266|Body dysmorphic disorder|body dysmorphic disorder
5211753|NCT02671266|Obsessive-compulsive disorder|obsessive-compulsive disorder
5211754|NCT02671240|Parkinson disease|parkinson disease
5211755|NCT02671240|behavioral addiction|behavioral addiction
5211756|NCT02671240|akinéto-rigid syndrome|akinéto-rigid syndrome
5211757|NCT02671240|dopamine agonist|dopamine agonist
5211758|NCT02671214|guar gum|guar gum
5211759|NCT02671214|konjac mannan|konjac mannan
5211760|NCT02671214|blood glucose|blood glucose
5211761|NCT02671214|legume flour|legume flour
5211762|NCT02671188|C-C chemokine receptor|c-c chemokine receptor
5211763|NCT02671188|Psoriatic arthritis|psoriatic arthritis
5211764|NCT02671188|Chemokine (C-C motif) ligand 20|chemokine (c-c motif) ligand 20
5211765|NCT02671188|Monoclonal antibody|monoclonal antibody
5211766|NCT02671188|psoriasis|psoriasis
5211768|NCT02671162|Pruritus|pruritus
5211769|NCT02671162|End-Stage Renal Disease|end-stage renal disease
5211770|NCT02671110|weight loss treatment|weight loss treatment
5211771|NCT02671110|Obesity|obesity
5211772|NCT02671084|Sevoflurane|sevoflurane
5211773|NCT02671084|Ck-MB|ck-mb
5211775|NCT02671058|bioavailability|bioavailability
5211776|NCT02671045|lung cancer|lung cancer
5211777|NCT02671045|genomic profile|genomic profile
5211778|NCT02671045|targeted therapy|targeted therapy
5211779|NCT02671045|FoundationOne|foundationone
5211780|NCT02671032|Cochlear Prosthesis Implantation|cochlear prosthesis implantation
5211785|NCT02670941|ginger|ginger
5211786|NCT02670941|lavender|lavender
5211787|NCT02670941|orange|orange
5211788|NCT02670941|jojoba|jojoba
5211789|NCT02670941|essential oils|essential oils
5211790|NCT02670941|cancer|cancer
5211791|NCT02670928|Diabetes|diabetes
5211792|NCT02670928|lifestyle change|lifestyle change
5211793|NCT02670928|weight management|weight management
5211794|NCT02670928|control of glycemic in HbA1C and FPG|control of glycemic in hba1c and fpg
5211795|NCT02670850|Mild Cognitive Impairment|mild cognitive impairment
5211796|NCT02670850|Family caregiver|family caregiver
5211797|NCT02670850|Intervention program|intervention program
5211798|NCT02670850|Elders|elders
5211799|NCT02670811|Hypertension|hypertension
5211800|NCT02670811|Fermented Milk|fermented milk
5211801|NCT02670811|Clinical Study|clinical study
5211802|NCT02670811|Randomized|randomized
5211803|NCT02670811|Double-blind|double-blind
5211804|NCT02670798|neuromuscular|neuromuscular
5211805|NCT02670798|scoliosis|scoliosis
5211806|NCT02670772|Antiretroviral Agents|antiretroviral agents
5211807|NCT02670746|Pancreatic Cancer|pancreatic cancer
5211808|NCT02670746|Observational|observational
5211809|NCT02670746|Nab-Paclitaxel|nab-paclitaxel
5211810|NCT02670746|Abraxane|abraxane
5211811|NCT02670746|ABI-007|abi-007
5211812|NCT02670746|Gemcitabine|gemcitabine
5211813|NCT02670746|Non-interventional|non-interventional
5211814|NCT02670746|Netherlands|netherlands
5211815|NCT02670746|Quality of Life|quality of life
5211816|NCT02670733|mechanical ventilation|mechanical ventilation
5211817|NCT02670733|positive end-expiratory pressure|positive end-expiratory pressure
5211818|NCT02670720|BCX4161|bcx4161
5211819|NCT02670720|avoralstat|avoralstat
5211820|NCT02670720|HAE|hae
5211821|NCT02670720|hereditary angioedema|hereditary angioedema
5211822|NCT02670720|prophylaxis|prophylaxis
5211827|NCT02670694|Rett Syndrome|rett syndrome
5211828|NCT02670694|Prader-Willi Syndrome|prader-willi syndrome
5211829|NCT02670694|Angelman Syndrome|angelman syndrome
5211830|NCT02670694|Sleep Problems|sleep problems
5211831|NCT02670681|Exercise|exercise
5211832|NCT02670681|Aerobic Exercise|aerobic exercise
5211833|NCT02670668|BRCA1/2;Mutations;Neoadjuvant chemotherapy;TNBC|brca1/2;mutations;neoadjuvant chemotherapy;tnbc
5211834|NCT02670655|Ablative fractional laser|ablative fractional laser
5211835|NCT02670655|Iontophoresis|iontophoresis
5211836|NCT02670655|Actinic keratosis|actinic keratosis
5211837|NCT02670655|Photodynamic therapy|photodynamic therapy
5211838|NCT02670629|Pediatric orthopedics|pediatric orthopedics
5211839|NCT02670577|stage I|stage i
5211840|NCT02670577|stage II|stage ii
5211841|NCT02670577|HER2 positive|her2 positive
5211842|NCT02670577|Triple Negative|triple negative
5211843|NCT02670564|pharmacogenetics|pharmacogenetics
5211844|NCT02670564|busulfan|busulfan
5211845|NCT02670564|treosulfan|treosulfan
5211846|NCT02670564|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5211847|NCT02670564|fludarabine|fludarabine
5211848|NCT02670564|pediatric patients|pediatric patients
5211849|NCT02670564|TBI|tbi
5211850|NCT02670564|leukemia|leukemia
5211851|NCT02670564|leukemia, lymphoid|leukemia, lymphoid
5211852|NCT02670564|precursor cell lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5211853|NCT02670564|Immune System disease|immune system disease
5218409|NCT02632422|walk|walk
5211854|NCT02670564|Immunoproliferative Disorders|immunoproliferative disorders
5211855|NCT02670564|stem cell transplantation|stem cell transplantation
5211856|NCT02670564|children and adolescent|children and adolescent
5211857|NCT02670564|high risk acute lymphoblastic leukemia|high risk acute lymphoblastic leukemia
5211858|NCT02670564|NCT01949129 add-on|nct01949129 add-on
5211859|NCT02670564|ALL SCTped FORUM|all sctped forum
5211860|NCT02670525|Recurrent, Refractory, or High Risk Leukemias|recurrent, refractory, or high risk leukemias
5211861|NCT02670525|Matched targeted therapy|matched targeted therapy
5211862|NCT02670512|End-Stage Renal Disease|end-stage renal disease
5211863|NCT02670512|Peritoneal Dialysis|peritoneal dialysis
5211864|NCT02670512|Telehomecare|telehomecare
5211865|NCT02670512|Telehome Monitoring|telehome monitoring
5211866|NCT02670486|Overactive bladder|overactive bladder
5211867|NCT02670486|Urge urinary incontinence|urge urinary incontinence
5211868|NCT02670486|Urodynamics|urodynamics
5211869|NCT02670408|Heart transplant|heart transplant
5211870|NCT02670408|global gene expression|global gene expression
5211871|NCT02670408|molecular diagnostics|molecular diagnostics
5211872|NCT02670395|Healthy|healthy
5211874|NCT02670395|Ascending Dose|ascending dose
5211875|NCT02670369|Sedentary time|sedentary time
5211876|NCT02670369|Sit-to-stand transitions|sit-to-stand transitions
5211877|NCT02670356|fish oil|fish oil
5211881|NCT02670356|Metabolic Syndrome|metabolic syndrome
5211882|NCT02670330|Amicus Therapeutics|amicus therapeutics
5211883|NCT02670330|Scioderm, Inc.|scioderm, inc.
5211884|NCT02670330|Simplex|simplex
5211885|NCT02670330|Recessive Dystrophic|recessive dystrophic
5211886|NCT02670330|Junctional non-Herlitz|junctional non-herlitz
5211887|NCT02670330|Epidermolysis Bullosa|epidermolysis bullosa
5211888|NCT02670330|SD-101 6%|sd-101 6%
5211889|NCT02670330|SD-101-6.0|sd-101-6.0
5211890|NCT02670330|Allantoin 6%|allantoin 6%
5211891|NCT02670330|Zorblisa|zorblisa
5211892|NCT02670317|DLBCL|dlbcl
5211893|NCT02670317|large B cell lymphoma|large b cell lymphoma
5211894|NCT02670317|NHL|nhl
5211895|NCT02670304|letrozole|letrozole
5211896|NCT02670304|ovarian hyperstimulating syndrome|ovarian hyperstimulating syndrome
5211897|NCT02670291|auditory hallucinations|auditory hallucinations
5211898|NCT02670291|schizophrenia|schizophrenia
5211899|NCT02670291|cTBS|ctbs
5211900|NCT02670291|noninvasive brain stimulation|noninvasive brain stimulation
5211901|NCT02670265|malnutrition|malnutrition
5211902|NCT02670265|parenteral nutrition|parenteral nutrition
5211903|NCT02670265|weight loss|weight loss
5211904|NCT02670265|pancreatic cancer|pancreatic cancer
5211905|NCT02670265|biliary tract cancer|biliary tract cancer
5211906|NCT02670265|quality of life|quality of life
5211907|NCT02670226|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5211908|NCT02670226|Muscle metabolism|muscle metabolism
5211909|NCT02670226|Metabolomics|metabolomics
5211910|NCT02670226|Transcriptomics|transcriptomics
5211911|NCT02670200|psychooncology|psychooncology
5211912|NCT02670200|mental health support|mental health support
5211913|NCT02670200|ICBT|icbt
5211914|NCT02670200|supportive treatment for cancer patients|supportive treatment for cancer patients
5211915|NCT02670200|depression|depression
5211916|NCT02670200|online-therapy|online-therapy
5211917|NCT02670200|Psycho-oncological support via internet|psycho-oncological support via internet
5211918|NCT02670200|internet-delivered cognitive behavior medicine|internet-delivered cognitive behavior medicine
5211919|NCT02670187|MERS CoV|mers cov
5211920|NCT02670187|MERS-CoV|mers-cov
5211921|NCT02670187|Middle East Respiratory Syndrome|middle east respiratory syndrome
5211922|NCT02670187|MERS|mers
5211923|NCT02670187|DNA Vaccine|dna vaccine
5211924|NCT02670174|Shoulder impingement syndrome|shoulder impingement syndrome
5211925|NCT02670174|Overhead athletes|overhead athletes
5211926|NCT02670174|Kinetic chain|kinetic chain
5211927|NCT02670174|Exercise treatment|exercise treatment
5211928|NCT02670148|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
5211929|NCT02670148|Low back pain|low back pain
5211930|NCT02670148|Trunk muscle strength|trunk muscle strength
5211931|NCT02670148|Balance|balance
5211932|NCT02670148|Active military personnel|active military personnel
5211933|NCT02670122|Hepatocellular Carcinoma|hepatocellular carcinoma
5211934|NCT02670122|TACE|tace
5211935|NCT02670096|acetazolamide|acetazolamide
5211936|NCT02670096|Treatment Emergent Sleep Disordered Breathing|treatment emergent sleep disordered breathing
5211937|NCT02670096|Sleep Apnea|sleep apnea
5211938|NCT02670031|Hypertensive Heart Disease|hypertensive heart disease
5211939|NCT02670031|Hypertension|hypertension
5211940|NCT02670031|Left Ventricular Hypertrophy|left ventricular hypertrophy
5211941|NCT02670031|Myocardial Fibrosis|myocardial fibrosis
5211942|NCT02670031|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
5211943|NCT02669992|Ileostomy|ileostomy
5211944|NCT02669979|elderly|elderly
5211945|NCT02669979|oral care|oral care
5211947|NCT02669940|Ombitasvir|ombitasvir
5211948|NCT02669940|Dasabuvir|dasabuvir
5211949|NCT02669940|Paritaprevir|paritaprevir
5211950|NCT02669927|hip surgery|hip surgery
5211951|NCT02669927|frail older people|frail older people
5211952|NCT02669901|Opioid-Related Disorders|opioid-related disorders
5211953|NCT02669901|Naloxone|naloxone
5211954|NCT02669901|Harm Reduction|harm reduction
5211955|NCT02669901|Drug Overdose Deaths|drug overdose deaths
5211956|NCT02669901|Opioid Misuse|opioid misuse
5211957|NCT02669901|Naloxone Coprescribing|naloxone coprescribing
5211958|NCT02669901|Universal Precautions|universal precautions
5211959|NCT02669901|Opioid Substance Use Disorder|opioid substance use disorder
5211960|NCT02669888|Indigo Naturalis|indigo naturalis
5211961|NCT02669888|Atopic Dermatitis|atopic dermatitis
5199994|NCT02744352|pain score|pain score
5211963|NCT02669823|Diagnosis|diagnosis
5211964|NCT02669797|Childhood Obesity|childhood obesity
5211965|NCT02669797|Ecological Momentary Intervention|ecological momentary intervention
5211966|NCT02669797|Video Feedback|video feedback
5211967|NCT02669771|Xtandi|xtandi
5211968|NCT02669771|MDV3100|mdv3100
5211969|NCT02669771|long term use|long term use
5211970|NCT02669771|enzalutamide|enzalutamide
5211971|NCT02669758|Alkermes|alkermes
5211972|NCT02669758|ALKS 3831|alks 3831
5211973|NCT02669758|Samidorphan|samidorphan
5211976|NCT02669745|Chinese women|chinese women
5858960|NCT00009035|CNS Tumor|cns tumor
5211985|NCT02669667|MEDI9314|medi9314
5211987|NCT02669667|Tolerability|tolerability
5211988|NCT02669667|Pharmacokinetics|pharmacokinetics
5211989|NCT02669667|Immunogenicity|immunogenicity
5211990|NCT02669641|Steatosis, Fatty liver, Steatohepatitis|steatosis, fatty liver, steatohepatitis
5211991|NCT02669615|multiple myeloma|multiple myeloma
5211992|NCT02669615|Melphalan HCl|melphalan hcl
5211993|NCT02669615|Autologous Transplantation|autologous transplantation
5211994|NCT02669602|Nutritional epidemiology|nutritional epidemiology
5211995|NCT02669602|Prospective|prospective
5212005|NCT02669550|Fiberoptic bronchoscope|fiberoptic bronchoscope
5212006|NCT02669550|Disposcope endoscope|disposcope endoscope
5212007|NCT02669550|Awake orotracheal intubation|awake orotracheal intubation
5212008|NCT02669511|DLBCL|dlbcl
5212010|NCT02669485|colectomy|colectomy
5212011|NCT02669485|anastomotic leak|anastomotic leak
5212012|NCT02669485|anastomotic leakage rate|anastomotic leakage rate
5212013|NCT02669485|surgical decision|surgical decision
5212014|NCT02669459|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5212015|NCT02669459|Imiquimod|imiquimod
5212016|NCT02669459|Human papillomavirus|human papillomavirus
5212017|NCT02669459|quality of life|quality of life
5212018|NCT02669459|biological markers|biological markers
5212019|NCT02669446|Non interventional study|non interventional study
5212020|NCT02669446|Ectoin|ectoin
5212021|NCT02669446|Lozenges|lozenges
5212022|NCT02669446|pharyngitis|pharyngitis
5212023|NCT02669433|Dementia with Lewy bodies|dementia with lewy bodies
5212024|NCT02669433|Lewy bodies|lewy bodies
5212025|NCT02669433|intepirdine|intepirdine
5212026|NCT02669433|RVT-101|rvt-101
5212027|NCT02669433|dementia|dementia
5212028|NCT02669381|Phenylalanine|phenylalanine
5212029|NCT02669381|Direct Amino Acid Oxidation|direct amino acid oxidation
5212030|NCT02669381|Stable isotopes|stable isotopes
5212031|NCT02669355|White coat physician attire|white coat physician attire
5212033|NCT02669342|Urinary Catheter|urinary catheter
5212034|NCT02669342|Sharklet|sharklet
5212035|NCT02669316|diet|diet
5212036|NCT02669303|Subacromial injection|subacromial injection
5212037|NCT02669303|methylprednisolone|methylprednisolone
5212038|NCT02669303|treatment|treatment
5212039|NCT02669303|Platelet-rich plasma|platelet-rich plasma
5212040|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine
5212041|NCT02669251|Optimal Biologic Dose|optimal biologic dose
5212042|NCT02669251|Safety|safety
5212043|NCT02669251|Chronic Graft-Versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
5212044|NCT02669251|Inflammatory Lung Disease|inflammatory lung disease
5212045|NCT02669251|FEV1|fev1
5212046|NCT02669225|18 F florbetaben|18 f florbetaben
5212047|NCT02669225|Sleep Deprivation|sleep deprivation
5212048|NCT02669225|rested wakefulness|rested wakefulness
5212049|NCT02669225|glymphatic system|glymphatic system
5212050|NCT02669212|Chronic Fatigue Syndrome|chronic fatigue syndrome
5212051|NCT02669212|Lyme Disease|lyme disease
5212052|NCT02669212|Healthy Volunteers|healthy volunteers
5212053|NCT02669212|Movement Disorder|movement disorder
5212054|NCT02669186|analgesia|analgesia
5212055|NCT02669186|cancer|cancer
5212056|NCT02669186|natural killer cell|natural killer cell
5212057|NCT02669186|opioid|opioid
5212058|NCT02669173|Myeloid derived suppressor cells|myeloid derived suppressor cells
5212059|NCT02669173|brain tumor|brain tumor
5212060|NCT02669173|MDSC|mdsc
5212061|NCT02669173|GBM|gbm
5212062|NCT02669173|recurrent|recurrent
5212063|NCT02669160|Motorized Orthotic Devices|motorized orthotic devices
5212064|NCT02669160|Minors|minors
5212065|NCT02669160|CP (Cerebral Palsy)|cp (cerebral palsy)
5212066|NCT02669160|Exoskeleton Device|exoskeleton device
5212067|NCT02669134|cardiac resynchronization therapy|cardiac resynchronization therapy
5212068|NCT02669134|optimization|optimization
5212069|NCT02669134|heart failure|heart failure
5212070|NCT02669134|reverse left ventricular remodeling|reverse left ventricular remodeling
5212071|NCT02669121|Drug therapy|drug therapy
5212072|NCT02669108|testis|testis
5212073|NCT02669108|spermatogenesis|spermatogenesis
5212074|NCT02669082|Drug Therapy|drug therapy
5212075|NCT02669069|Bi-modal neuromodulation|bi-modal neuromodulation
5212076|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine
5283776|NCT02252900|MRI|mri
5200089|NCT02743832|Tumor budding|tumor budding
5200090|NCT02743819|Melanoma|melanoma
5200091|NCT02743819|Pembrolizumab|pembrolizumab
5200092|NCT02743819|Ipilimumab|ipilimumab
5200093|NCT02743806|Drug Therapy|drug therapy
5200094|NCT02743793|single organ liver or kidney allograft|single organ liver or kidney allograft
5200095|NCT02743793|operationally tolerant allograft recipients|operationally tolerant allograft recipients
5200096|NCT02743793|longitudinal follow-up|longitudinal follow-up
5212087|NCT02668900|Feasibility trial|feasibility trial
5208985|NCT02689518|AMD|amd
5212098|NCT02668874|Dental caries|dental caries
5212100|NCT02668848|Dehydration|dehydration
5212101|NCT02668848|Fluid therapy|fluid therapy
5212113|NCT02668718|radiotherapy, adjuvant|radiotherapy, adjuvant
5212114|NCT02668718|prostatectomy|prostatectomy
5212115|NCT02668692|LEO 80185 gel, calcipotriol, betamethasone|leo 80185 gel, calcipotriol, betamethasone
5212116|NCT02668679|Dream Doctors|dream doctors
5212117|NCT02668679|Medical Clown|medical clown
5212118|NCT02668679|Pediatrics|pediatrics
5212119|NCT02668679|Sedation|sedation
5212120|NCT02668679|Endoscopy|endoscopy
5212121|NCT02668666|Palbociclib|palbociclib
5212122|NCT02668666|Tamoxifen|tamoxifen
5212123|NCT02668666|CDK4/6 Inhibitor|cdk4/6 inhibitor
5212124|NCT02668653|Newly diagnosed Acute Myeloid Leukemia|newly diagnosed acute myeloid leukemia
5212125|NCT02668653|FLT3-ITD positive|flt3-itd positive
5212126|NCT02668653|Chemotherapy|chemotherapy
5212127|NCT02668653|Induction chemotherapy|induction chemotherapy
5212128|NCT02668653|Consolidation chemotherapy|consolidation chemotherapy
5212129|NCT02668653|Maintenance chemotherapy|maintenance chemotherapy
5212131|NCT02668653|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5212132|NCT02668653|Feline McDonough sarcoma (FMS)-like tyrosine kinase 3|feline mcdonough sarcoma (fms)-like tyrosine kinase 3
5212133|NCT02668653|AC220|ac220
5212134|NCT02668653|FLT3-ITD|flt3-itd
5212136|NCT02668640|Quality of life (QOL)|quality of life (qol)
5212137|NCT02668640|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5212138|NCT02668640|Work productivity|work productivity
5212139|NCT02668640|Adalimumab|adalimumab
5212140|NCT02668627|Stroke|stroke
5212141|NCT02668627|Collateral status|collateral status
5212142|NCT02668627|Endovascular treatment|endovascular treatment
5212143|NCT02668614|Detection|detection
5212144|NCT02668601|Gestational Diabetes Mellitus|gestational diabetes mellitus
5212145|NCT02668601|Childhood Obesity|childhood obesity
5212146|NCT02668601|Offspring|offspring
5212148|NCT02668562|acute coronary syndrome|acute coronary syndrome
5212149|NCT02668562|coronary artery bypass surgery|coronary artery bypass surgery
5212150|NCT02668562|ticagrelor|ticagrelor
5212151|NCT02668562|antiplatelet therapy|antiplatelet therapy
5212152|NCT02668562|platelet function testing|platelet function testing
5212153|NCT02668536|sunscreen|sunscreen
5212154|NCT02668536|melanoma|melanoma
5212155|NCT02668536|improved protection from uv rays|improved protection from uv rays
5212156|NCT02668523|Presbyopia|presbyopia
5212157|NCT02668523|Corneal Inlay|corneal inlay
5212158|NCT02668523|Pseudophakic|pseudophakic
5212159|NCT02668523|Pseudophakia|pseudophakia
5212160|NCT02668510|Heel Pain|heel pain
5212161|NCT02668510|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5212162|NCT02668510|ESWT|eswt
5212163|NCT02668510|shock wave|shock wave
5212164|NCT02668510|Soldiers|soldiers
5212165|NCT02668510|Platelet rich plasma|platelet rich plasma
5212166|NCT02668510|PRP|prp
5212167|NCT02668510|Autologous conditioned plasma|autologous conditioned plasma
5212168|NCT02668510|Military|military
5212169|NCT02668497|Movement disorders|movement disorders
5212170|NCT02668497|Botulinum toxin type A|botulinum toxin type a
5212171|NCT02668497|Tremor|tremor
5212172|NCT02668497|Kinematics|kinematics
5212173|NCT02668484|TAVI|tavi
5212174|NCT02668484|trans-femoral|trans-femoral
5212175|NCT02668484|Sapien|sapien
5212176|NCT02668484|Lotus|lotus
5212177|NCT02668445|Concurrent|concurrent
5212178|NCT02668445|muscle|muscle
5212179|NCT02668445|glycogen|glycogen
5212180|NCT02668445|molecular|molecular
5212181|NCT02668406|Blood infection, melioidosis, rapid diagnostic test|blood infection, melioidosis, rapid diagnostic test
5212182|NCT02668380|Apatinib|apatinib
5212183|NCT02668380|metastatic gastric cancer|metastatic gastric cancer
5212184|NCT02668380|Non-interventionalStudy|non-interventionalstudy
5212185|NCT02668367|Viral Diseases|viral diseases
5212186|NCT02668367|Antiviral|antiviral
5212187|NCT02668367|Paramyxoviridae Infections|paramyxoviridae infections
5212189|NCT02668367|Respiratory Syncytial Virus|respiratory syncytial virus
5212190|NCT02668367|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5212191|NCT02668367|Aviragen Therapeutics|aviragen therapeutics
5212193|NCT02668354|Childhood Cancer|childhood cancer
5212194|NCT02668354|Pediatric Oncology|pediatric oncology
5212195|NCT02668354|Infant tumors|infant tumors
5212196|NCT02668302|Steroid-eluting sinus implant|steroid-eluting sinus implant
5212197|NCT02668302|Mometasone furoate|mometasone furoate
5212198|NCT02668302|Endoscopic sinus surgery|endoscopic sinus surgery
5212199|NCT02668276|Prostatic neoplasms|prostatic neoplasms
5212200|NCT02668276|Oncotype DX|oncotype dx
5212201|NCT02668276|Treatment Decisions|treatment decisions
5212202|NCT02668263|Breast cancer|breast cancer
5212203|NCT02668263|mastectomy|mastectomy
5212204|NCT02668263|seromas|seromas
5212205|NCT02668211|osteoarthritis|osteoarthritis
5212206|NCT02668211|radiostereometric analysis|radiostereometric analysis
5212207|NCT02668211|correction of functional deformity|correction of functional deformity
5212208|NCT02668211|procedures|procedures
5212209|NCT02668211|total hip arthroplasty|total hip arthroplasty
5212210|NCT02668211|musculoskeletal diseases|musculoskeletal diseases
5212211|NCT02668198|Endoscopic mucosal resection, residual polyp, near focus imaging|endoscopic mucosal resection, residual polyp, near focus imaging
5212212|NCT02668172|pegvisomant|pegvisomant
5212213|NCT02668172|pasireotide LAR|pasireotide lar
5212214|NCT02668172|long acting somatostatin analogues|long acting somatostatin analogues
5212215|NCT02668146|essential tremor|essential tremor
5212216|NCT02668146|Perampanel|perampanel
5212217|NCT02668146|clinical trial|clinical trial
5212218|NCT02668133|zinc deficiency|zinc deficiency
5212219|NCT02668133|zinc absorption|zinc absorption
5212220|NCT02668120|chronic histiocytic intervillositis|chronic histiocytic intervillositis
5212221|NCT02668120|serum alkaline phosphatase|serum alkaline phosphatase
5212222|NCT02668120|placenta|placenta
5104320|NCT03345225|HCC|hcc
5212223|NCT02668120|case-control study|case-control study
5212224|NCT02668094|propofol|propofol
5212225|NCT02668094|lidocaine|lidocaine
5212226|NCT02668094|pregabalin|pregabalin
5212227|NCT02668081|Endoscopic sphincterotomy|endoscopic sphincterotomy
5212329|NCT02667418|Fidaxomicin|fidaxomicin
5212228|NCT02668081|Endoscopic papillary balloon dilation|endoscopic papillary balloon dilation
5212229|NCT02668081|Metagenomics|metagenomics
5212230|NCT02668068|Pneumoconiosis|pneumoconiosis
5212231|NCT02668068|Mesenchymal Stem Cells|mesenchymal stem cells
5212232|NCT02668068|whole-lung lavage (WLL)|whole-lung lavage (wll)
5212234|NCT02668055|Difficult to heal|difficult to heal
5212235|NCT02668029|Oxygen therapy|oxygen therapy
5212236|NCT02668016|cardiovascular diseases|cardiovascular diseases
5212237|NCT02668016|hyperlipidemias|hyperlipidemias
5212238|NCT02668003|Prevention trial|prevention trial
5212239|NCT02668003|Cognitive Behaviour Therapy|cognitive behaviour therapy
5212240|NCT02668003|CWP|cwp
5212241|NCT02668003|Chronic widespread pain|chronic widespread pain
5212242|NCT02668003|RCT|rct
5212243|NCT02668003|Fibromyalgia|fibromyalgia
5212244|NCT02668003|Prevention|prevention
5212245|NCT02667990|metatarsalgia|metatarsalgia
5212246|NCT02667990|pedobar|pedobar
5212247|NCT02667990|foot|foot
5212248|NCT02667990|stiletto|stiletto
5212249|NCT02667990|insoles|insoles
5089773|NCT03437343|HOOS|hoos
5212250|NCT02667977|fluids, pediatric, gastroenteritis|fluids, pediatric, gastroenteritis
5212251|NCT02667951|Elderly|elderly
5212252|NCT02667951|Dementia|dementia
5212253|NCT02667951|Intervention program|intervention program
5212254|NCT02667925|ovarian cancer|ovarian cancer
5212255|NCT02667925|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5212256|NCT02667912|Hypertension, Endovascular Procedures, Catheter Ablation, Renal Artery|hypertension, endovascular procedures, catheter ablation, renal artery
5212257|NCT02667899|disorders of consciousness|disorders of consciousness
5212258|NCT02667899|deep brain stimulation|deep brain stimulation
5212259|NCT02667899|transcranial magnetic stimulation|transcranial magnetic stimulation
5212260|NCT02667860|intracorporeal anastomosis|intracorporeal anastomosis
5212261|NCT02667860|laparoscopic colectomy|laparoscopic colectomy
5212262|NCT02667860|outcomes|outcomes
5212263|NCT02667860|length of stay|length of stay
5212264|NCT02667860|analgesia|analgesia
5212265|NCT02667860|aesthetic|aesthetic
5212266|NCT02667860|extracorporeal anastomosis|extracorporeal anastomosis
5212267|NCT02667860|laparoscopic|laparoscopic
5212268|NCT02667847|preoperative anxiety assessment|preoperative anxiety assessment
5858961|NCT00009035|Glioma|glioma
5212273|NCT02667782|Dementia|dementia
5212274|NCT02667782|Caregiving|caregiving
5212275|NCT02667782|Burden|burden
5212276|NCT02667782|Stress|stress
5212277|NCT02667782|Anxiety|anxiety
5212278|NCT02667782|Depression|depression
5200292|NCT02742974|Hemodynamics|hemodynamics
5200293|NCT02742974|Operative procedures|operative procedures
5200294|NCT02742961|orthopedics|orthopedics
5200295|NCT02742961|anesthesiology|anesthesiology
5200296|NCT02742961|nerve block|nerve block
5200297|NCT02742961|length of stay|length of stay
5200298|NCT02742961|Patient readmission|patient readmission
5200299|NCT02742948|elective caesarean section|elective caesarean section
5200300|NCT02742948|antibiotics|antibiotics
5200301|NCT02742948|endometritis|endometritis
5212294|NCT02667639|safety|safety
5212295|NCT02667639|tolerability|tolerability
5212296|NCT02667639|RPH-104|rph-104
5212297|NCT02667639|RPH104|rph104
5212298|NCT02667639|Anti-IL1 beta|anti-il1 beta
5212299|NCT02667639|Anti-IL1|anti-il1
5212300|NCT02667626|Breast cancer survivor|breast cancer survivor
5212301|NCT02667626|Cancer survivorship|cancer survivorship
5212302|NCT02667626|Survivorship care plan|survivorship care plan
5212303|NCT02667626|Vaginal dryness|vaginal dryness
5212304|NCT02667626|Vulvovaginal atrophy|vulvovaginal atrophy
5212305|NCT02667626|Vasomotor symptom|vasomotor symptom
5212306|NCT02667626|Infertility|infertility
5212307|NCT02667626|Family planning|family planning
5212308|NCT02667613|motor skill learning|motor skill learning
5212309|NCT02667613|functional changes|functional changes
5212310|NCT02667613|neuroplastic changes|neuroplastic changes
5212311|NCT02667600|Cesarean|cesarean
5212312|NCT02667600|Blood Loss|blood loss
5212313|NCT02667600|Triton|triton
5212314|NCT02667574|basal cell carcinoma|basal cell carcinoma
5212315|NCT02667574|surgery|surgery
5212316|NCT02667574|stage|stage
5212317|NCT02667574|vismodegib|vismodegib
5212318|NCT02667548|percutaneous coronary intervention|percutaneous coronary intervention
5212319|NCT02667509|Evolutionary Model|evolutionary model
5212320|NCT02667483|Duchenne muscular dystrophy|duchenne muscular dystrophy
5212322|NCT02667483|Oligonucleotides, Antisense|oligonucleotides, antisense
5212323|NCT02667483|Exon skipping|exon skipping
5212324|NCT02667470|Solifenacin|solifenacin
5104403|NCT03344809|next|next
5212325|NCT02667470|Overactive bladder|overactive bladder
5212326|NCT02667431|SUI|sui
5212327|NCT02667418|Clostridium|clostridium
5212328|NCT02667418|Difficile|difficile
5212330|NCT02667418|Vancomycin|vancomycin
5212331|NCT02667418|Recurrent|recurrent
5212332|NCT02667418|Pulse|pulse
5212333|NCT02667418|Taper|taper
5212334|NCT02667392|Stroke|stroke
5212335|NCT02667392|Gait|gait
5212336|NCT02667392|Walking|walking
5212337|NCT02667392|Rehabilitation|rehabilitation
5212338|NCT02667392|Exercise|exercise
5212339|NCT02667392|Exercise Therapy|exercise therapy
5212340|NCT02667392|Physical Therapy Modalities|physical therapy modalities
5212341|NCT02667392|Exercise Movement Techniques|exercise movement techniques
5212342|NCT02667379|Cat|cat
5212343|NCT02667379|allergy|allergy
5212344|NCT02667379|dander|dander
5212345|NCT02667379|Fel d 1|fel d 1
5212346|NCT02667379|Felis domesticus|felis domesticus
5212347|NCT02667366|mild and moderate depression|mild and moderate depression
5212348|NCT02667353|electroconvulsive|electroconvulsive
5212349|NCT02667353|hippocampus|hippocampus
5212350|NCT02667353|elderly|elderly
5212351|NCT02667353|working mechanism|working mechanism
5962617|NCT04279977|activity measure for post-acute care|activity measure for post-acute care
5212352|NCT02667340|exercise|exercise
5212353|NCT02667340|carbohydrate|carbohydrate
5212354|NCT02667340|Superstarch|superstarch
5212361|NCT02667314|Cognition|cognition
5212362|NCT02667314|Cognitive Aging|cognitive aging
5212363|NCT02667314|Dementia|dementia
5212364|NCT02667314|Neurocognitive Disorders|neurocognitive disorders
5212365|NCT02667314|Cognitive Therapy|cognitive therapy
5089897|NCT03436563|Immunotherapy|immunotherapy
5212366|NCT02667314|Cognitive Reserve|cognitive reserve
5212367|NCT02667314|Cognitive Enrichment|cognitive enrichment
5212368|NCT02667314|Jigsaw Puzzles|jigsaw puzzles
5212369|NCT02667275|seborrheic keratosis|seborrheic keratosis
5212370|NCT02667249|cholecystectomy, check list|cholecystectomy, check list
5212371|NCT02667236|seborrheic keratosis|seborrheic keratosis
5212372|NCT02667223|pharmacokinetics|pharmacokinetics
5212373|NCT02667223|pharmacodynamics|pharmacodynamics
5212374|NCT02667223|RN316|rn316
5212375|NCT02667223|recombinant human hyaluronidase|recombinant human hyaluronidase
5212377|NCT02667145|self care program|self care program
5212378|NCT02667145|assistive tecnology|assistive tecnology
5212379|NCT02667132|Granulomatous, Mastitis|granulomatous, mastitis
5212380|NCT02667132|C17.800.090.968.400|c17.800.090.968.400
5212381|NCT02667132|C13.703.844.603.400|c13.703.844.603.400
5212382|NCT02667093|Acute Leukemia|acute leukemia
5212383|NCT02667093|Acute Myeloid Leukemia|acute myeloid leukemia
5212385|NCT02667080|Semen quality|semen quality
5212386|NCT02667080|Sexual Abstinence|sexual abstinence
5212387|NCT02667080|sperm motility|sperm motility
5212388|NCT02667080|DNA fragmentation|dna fragmentation
5212389|NCT02667015|Substance Use Disorders|substance use disorders
5212390|NCT02667015|Anxiety|anxiety
5212391|NCT02667015|Anxiety Sensitivity|anxiety sensitivity
5212392|NCT02667015|Brief Intervention|brief intervention
5212393|NCT02667015|Treatment|treatment
5212394|NCT02666989|Depression|depression
5212395|NCT02666989|Placebo|placebo
5212396|NCT02666989|Open-label|open-label
5212397|NCT02666989|Clinical practice|clinical practice
5212398|NCT02666976|Gastroesophageal reflux, proton pump inhibitors, ilaprazole|gastroesophageal reflux, proton pump inhibitors, ilaprazole
5212399|NCT02666963|RTA 901|rta 901
5212400|NCT02666963|RTA 901 capsules|rta 901 capsules
5212401|NCT02666898|Residual disease|residual disease
5212402|NCT02666885|Personalized Medicine|personalized medicine
5212403|NCT02666885|Radiation Oncology|radiation oncology
5212404|NCT02666885|Functional Imaging|functional imaging
5212405|NCT02666885|Biomarker|biomarker
5212406|NCT02666885|Decision Support System|decision support system
5212407|NCT02666885|Radiomics|radiomics
5212408|NCT02666872|Vaccination|vaccination
5212409|NCT02666872|Infant|infant
5212410|NCT02666872|Parents|parents
5212411|NCT02666872|Intention|intention
5212412|NCT02666846|UVB Pain Model|uvb pain model
5212414|NCT02666846|Topical|topical
5212415|NCT02666846|NSAIDs|nsaids
5212416|NCT02666833|Skin Cancer|skin cancer
5212417|NCT02666833|Basal Cell Carcinoma|basal cell carcinoma
5212418|NCT02666833|Squamous Cell Carcinoma|squamous cell carcinoma
5212419|NCT02666833|Mohs Surgery|mohs surgery
5212420|NCT02666833|Imaging|imaging
5212421|NCT02666807|NF-κB|nf-κb
5212422|NCT02666807|Ginger|ginger
5212423|NCT02666794|analgesia|analgesia
5212424|NCT02666794|fetal bradycardia|fetal bradycardia
5212425|NCT02666794|hypertonic uterine|hypertonic uterine
5212426|NCT02666781|OSA, Surgery, Postoperative, Rostral Fluid Shift|osa, surgery, postoperative, rostral fluid shift
5212427|NCT02666755|Lung Neoplasms digital polymerase chain reaction|lung neoplasms digital polymerase chain reaction
5212428|NCT02666716|pharmacokinetics|pharmacokinetics
5212429|NCT02666716|fluconazole|fluconazole
5212430|NCT02666716|invasive fungal infection|invasive fungal infection
5212431|NCT02666716|candidiasis|candidiasis
5212432|NCT02666716|intensive care unit|intensive care unit
5212433|NCT02666703|cardiac surgery|cardiac surgery
5212434|NCT02666703|systemic inflammatory response|systemic inflammatory response
5212435|NCT02666703|immunoadsorption|immunoadsorption
5212436|NCT02666677|polytrauma, emergency medicine|polytrauma, emergency medicine
5212437|NCT02666664|hyperlipidemia|hyperlipidemia
5212438|NCT02666664|cholesterol|cholesterol
5212439|NCT02666664|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5212440|NCT02666664|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5212441|NCT02666664|ASCVD|ascvd
5212442|NCT02666664|HeFH|hefh
5212444|NCT02666638|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5212445|NCT02666612|Patients|patients
5212446|NCT02666599|F-18-FDG|f-18-fdg
5212447|NCT02666599|neoplasm|neoplasm
5212448|NCT02666599|probe|probe
5212449|NCT02666599|positron|positron
5212450|NCT02666599|diagnosis|diagnosis
5212451|NCT02666599|surgery|surgery
5212452|NCT02666599|radioguided surgery|radioguided surgery
5212453|NCT02666573|drug therapy|drug therapy
5212454|NCT02666573|Photosensitizing Agents|photosensitizing agents
5212455|NCT02666573|therapeutic use|therapeutic use
5212456|NCT02666560|Auditory Cueing|auditory cueing
5212457|NCT02666560|Gait|gait
5212458|NCT02666547|68Ga-NODAGA-RGD|68ga-nodaga-rgd
5212459|NCT02666547|18F-FDG|18f-fdg
5212460|NCT02666547|18F-FET|18f-fet
5212461|NCT02666547|PET/CT|pet/ct
5212462|NCT02666547|neoangiogenesis|neoangiogenesis
5212463|NCT02666534|Ablative fractional laser|ablative fractional laser
5212464|NCT02666534|microinvasive squamous cell carcinoma|microinvasive squamous cell carcinoma
5212465|NCT02666534|photodynamic therapy|photodynamic therapy
5212466|NCT02666521|Primary Health Care|primary health care
5962618|NCT04279964|Immunization|immunization
5090025|NCT03435887|Kenya|kenya
5212467|NCT02666508|plaque identifying toothpaste|plaque identifying toothpaste
5212468|NCT02666508|plaque score|plaque score
5212469|NCT02666508|C-reactive protein|c-reactive protein
5212470|NCT02666495|Schema Therapy|schema therapy
5212471|NCT02666482|smoking|smoking
5212472|NCT02666482|stop smoking|stop smoking
5212473|NCT02666482|tobacco use cessation|tobacco use cessation
5859742|NCT00006158|hormones|hormones
5212474|NCT02666469|Hyperbaric oxygen treatment, rehabilitation|hyperbaric oxygen treatment, rehabilitation
5212476|NCT02666443|supraclavicular|supraclavicular
5212477|NCT02666443|duration|duration
5212478|NCT02666443|dexamethasone|dexamethasone
5212479|NCT02666443|block|block
5212480|NCT02666417|Iron fortification|iron fortification
5212481|NCT02666417|Anemia|anemia
5212482|NCT02666417|Iron Deficiency|iron deficiency
5212483|NCT02666417|Iron Absorption|iron absorption
5212484|NCT02666417|Prebiotics|prebiotics
5212485|NCT02666417|Stable isotopes|stable isotopes
5212486|NCT02666404|Volume Resuscitation|volume resuscitation
5212487|NCT02666404|Shock|shock
5212488|NCT02666404|Body Impedance Measurement|body impedance measurement
5212489|NCT02666404|Renal Resistive Index|renal resistive index
5212490|NCT02666404|Acute Kidney Injury|acute kidney injury
5212491|NCT02666404|Renal Replacement Therapy|renal replacement therapy
5212492|NCT02666365|anesthesia|anesthesia
5212493|NCT02666365|surgical antimicrobial prophylaxis|surgical antimicrobial prophylaxis
5212494|NCT02666365|surgical site infections|surgical site infections
5212495|NCT02666339|Hortitherapy|hortitherapy
5212496|NCT02666339|Care-garden|care-garden
5212497|NCT02666339|Anxiety|anxiety
5212498|NCT02666339|Therapeutic alliance|therapeutic alliance
5212499|NCT02666326|Acute Coronary Syndrome|acute coronary syndrome
5212500|NCT02666326|Prehospital emergency care|prehospital emergency care
5212501|NCT02666326|Biological markers|biological markers
5212502|NCT02666326|Copeptin|copeptin
5212503|NCT02666326|Troponin|troponin
5212504|NCT02666326|Rule-out|rule-out
5212505|NCT02666326|Point-of-Care systems|point-of-care systems
5212506|NCT02666326|Infarction|infarction
5212507|NCT02666326|Cardiovascular Diseases|cardiovascular diseases
5212508|NCT02666326|Heart Diseases|heart diseases
5212509|NCT02666326|Ischemia|ischemia
5212510|NCT02666326|Myocardial Ischemia|myocardial ischemia
5212511|NCT02666326|copeptins|copeptins
5212512|NCT02666326|Troponin T|troponin t
5212513|NCT02666326|Diagnostic Techniques (Cardiovascular)|diagnostic techniques (cardiovascular)
5212514|NCT02666326|High sensitivity troponin|high sensitivity troponin
5212515|NCT02666300|Postoperative sore throat,Anesthesia|postoperative sore throat,anesthesia
5212516|NCT02666287|Fluticasone furoate|fluticasone furoate
5212517|NCT02666287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5212518|NCT02666287|Batefenterol|batefenterol
5212519|NCT02666287|Dry Powder Inhaler|dry powder inhaler
5212520|NCT02666287|Respiratory|respiratory
5212521|NCT02666287|Pharmacokinetics|pharmacokinetics
5212522|NCT02666287|Ellipta|ellipta
5212523|NCT02666287|Healthy Subjects|healthy subjects
5212524|NCT02666274|carbapenem resistance|carbapenem resistance
5212525|NCT02666274|bacterial carriage|bacterial carriage
5212526|NCT02666274|multi-drug resistant gram negative bacteria|multi-drug resistant gram negative bacteria
5212527|NCT02666222|hearing loss|hearing loss
5212528|NCT02666222|sensorineural|sensorineural
5212529|NCT02666222|hearing implant|hearing implant
5212530|NCT02666209|Multiple Myeloma|multiple myeloma
5212531|NCT02666209|Relapsed Multiple Myeloma|relapsed multiple myeloma
5212630|NCT02665507|Aviation|aviation
5212532|NCT02666209|Refractory Multiple Myeloma|refractory multiple myeloma
5212533|NCT02666183|cancer|cancer
5212534|NCT02666183|caregiver|caregiver
5212535|NCT02666183|videoconferencing|videoconferencing
5212536|NCT02666157|atrial fibrillation|atrial fibrillation
5212537|NCT02666157|stroke|stroke
5212538|NCT02666157|systemic embolism|systemic embolism
5212539|NCT02666157|bleeding|bleeding
5212540|NCT02666157|oral anticoagulant|oral anticoagulant
5212541|NCT02666118|pain|pain
5212542|NCT02666118|pain management|pain management
5212543|NCT02666118|shoulder repair|shoulder repair
5212544|NCT02666118|nerve blockade|nerve blockade
5212545|NCT02666118|regional anesthesia|regional anesthesia
5212546|NCT02666118|pediatrics|pediatrics
5212547|NCT02666105|NSCLC|nsclc
5212549|NCT02666092|Immunoelectrophoresis|immunoelectrophoresis
5212550|NCT02666092|Western Blot|western blot
5212551|NCT02666092|ImmunoCAP|immunocap
5212552|NCT02666079|Wide local excision (WLE) for breast cancer|wide local excision (wle) for breast cancer
5212553|NCT02666027|Fluid monitoring|fluid monitoring
5212554|NCT02666014|PONV|ponv
5212555|NCT02666014|nausea|nausea
5212556|NCT02666014|vomiting|vomiting
5212557|NCT02666014|sugammadex|sugammadex
5212558|NCT02666014|neostigmine|neostigmine
5212559|NCT02665988|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5212560|NCT02665975|Tinnitus treatment|tinnitus treatment
5962619|NCT04279964|Boot Camp Translation|boot camp translation
5212561|NCT02665975|Internet-intervention|internet-intervention
5212564|NCT02665936|epidural analgesia|epidural analgesia
5212565|NCT02665871|vaccine|vaccine
5212566|NCT02665871|safety|safety
5212567|NCT02665871|intranasal administration|intranasal administration
5212568|NCT02665806|Ciclesonide|ciclesonide
5212569|NCT02665806|Fluticasone propionate|fluticasone propionate
5212570|NCT02665806|Nasal Polyposis|nasal polyposis
5200590|NCT02740595|nicotine|nicotine
5212571|NCT02665806|Chronic Sinuitis|chronic sinuitis
5212572|NCT02665806|Chronic rhinosinusitis|chronic rhinosinusitis
5212573|NCT02665793|Peanut allergy|peanut allergy
5212574|NCT02665793|Food allergy|food allergy
5212575|NCT02665793|Thresholds|thresholds
5212576|NCT02665793|Anaphylaxis|anaphylaxis
5862846|NCT00001483|Bipolar Illness|bipolar illness
5212577|NCT02665780|halitosis, periodontal debridement, chemotherapeutics|halitosis, periodontal debridement, chemotherapeutics
5212579|NCT02665754|Allergic rhinitis|allergic rhinitis
5212580|NCT02665754|Injection, intralymphatic|injection, intralymphatic
5212581|NCT02665754|Immunotherapy|immunotherapy
5212582|NCT02665754|Dermatophagoides farinae|dermatophagoides farinae
5212583|NCT02665754|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
5212584|NCT02665754|Dogs|dogs
5212585|NCT02665754|Cats|cats
5212586|NCT02665741|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection|distal colonoscope attachments, colon cancer screening, screening colonoscopy, adenoma detection
5212587|NCT02665715|Reactive hypoglycemia|reactive hypoglycemia
5212588|NCT02665715|Hyperinsulinaemia|hyperinsulinaemia
5212589|NCT02665715|Diet|diet
5212590|NCT02665715|Glucagon-like Peptide-1|glucagon-like peptide-1
5212591|NCT02665715|Glucagon|glucagon
5212592|NCT02665715|Peptide YY|peptide yy
5212593|NCT02665715|Ghrelin|ghrelin
5212594|NCT02665689|Diabetic Macular Edema, Ranibizumab, Visual Acuity, Diabetic Control|diabetic macular edema, ranibizumab, visual acuity, diabetic control
5212595|NCT02665676|Childhood Cancer|childhood cancer
5212596|NCT02665676|Pediatric Oncology|pediatric oncology
5212597|NCT02665676|Embryonal Neoplasms|embryonal neoplasms
5212598|NCT02665676|Embryonic Neoplasms|embryonic neoplasms
5212599|NCT02665676|Embryonic Tumors|embryonic tumors
5212600|NCT02665676|Embryonal Tumors|embryonal tumors
5212601|NCT02665624|Bowel cleansing|bowel cleansing
5212602|NCT02665624|Colonoscopy|colonoscopy
5212603|NCT02665624|Stewed apricot juice|stewed apricot juice
5212604|NCT02665624|Senna|senna
5212605|NCT02665598|Posterior Reversible Encephalopathy Syndrome,Prognosis|posterior reversible encephalopathy syndrome,prognosis
5212606|NCT02665585|carotid disease|carotid disease
5212607|NCT02665585|stroke|stroke
5212608|NCT02665585|stent|stent
5212609|NCT02665585|carotid stenting|carotid stenting
5212610|NCT02665572|renal transplantation|renal transplantation
5212611|NCT02665572|defunctionalized bladder|defunctionalized bladder
5212612|NCT02665572|bladder recycling|bladder recycling
5212613|NCT02665559|HIV|hiv
5212614|NCT02665559|Hypogonadism|hypogonadism
5212615|NCT02665559|Metabolic Syndrom|metabolic syndrom
5212616|NCT02665559|Reservoirs|reservoirs
5212617|NCT02665559|Osteodensitometry|osteodensitometry
5212618|NCT02665559|Erectil dysfonction|erectil dysfonction
5212619|NCT02665559|Depression|depression
5212620|NCT02665546|Dyspnea|dyspnea
5212621|NCT02665546|pulmonary hypertension|pulmonary hypertension
5212622|NCT02665546|Histiocytosis Langerhans cells|histiocytosis langerhans cells
5212623|NCT02665546|exercise test|exercise test
5212624|NCT02665533|pain measurement|pain measurement
5212625|NCT02665533|edema|edema
5212626|NCT02665533|trismus|trismus
5212627|NCT02665520|stem cells injections|stem cells injections
5212628|NCT02665520|erectile dysfunction|erectile dysfunction
5212629|NCT02665507|Photobiomodulation|photobiomodulation
5212631|NCT02665481|Exercise|exercise
5212632|NCT02665481|Mindfulness|mindfulness
5212633|NCT02665481|Education|education
5212634|NCT02665481|Elderly|elderly
5212635|NCT02665468|Supported adoption|supported adoption
5212636|NCT02665468|Secure messaging|secure messaging
5212637|NCT02665468|Patient aligned care team (PACT)|patient aligned care team (pact)
5212638|NCT02665468|My HealtheVet Coordinator|my healthevet coordinator
5212639|NCT02665455|Diabetes Mellitus|diabetes mellitus
5212640|NCT02665455|Sensing Technology|sensing technology
5212641|NCT02665442|Esophageal Stylet|esophageal stylet
5212642|NCT02665442|EsoSure|esosure
5212643|NCT02665442|Atrial Fibrillation|atrial fibrillation
5212644|NCT02665442|Catheter Ablation|catheter ablation
5212645|NCT02665442|Mechanical esophageal displacement|mechanical esophageal displacement
5212646|NCT02665429|Emergency Medicine|emergency medicine
5212647|NCT02665390|lung cancer|lung cancer
5212648|NCT02665390|Percutaneous cryoablation|percutaneous cryoablation
5212649|NCT02665390|treatment of medically inoperable|treatment of medically inoperable
5212650|NCT02665338|transcranial magnetic stimulation|transcranial magnetic stimulation
5212651|NCT02665338|fMRI|fmri
5212652|NCT02665338|cue craving|cue craving
5212653|NCT02665325|TSH-suppressive therapy|tsh-suppressive therapy
5212654|NCT02665325|cognitive function|cognitive function
5212655|NCT02665312|cardiotoxicity|cardiotoxicity
5212656|NCT02665312|fluoropyrimidine|fluoropyrimidine
5212657|NCT02665312|colorectal cancer|colorectal cancer
5212658|NCT02665299|colon cancer|colon cancer
5212659|NCT02665299|colon polyps|colon polyps
5962620|NCT04279964|Adolescent|adolescent
5212660|NCT02665299|colon adenomas|colon adenomas
5212661|NCT02665299|colonoscopy|colonoscopy
5212662|NCT02665299|circulating tumor DNA|circulating tumor dna
5212664|NCT02665221|Multiple Sclerosis|multiple sclerosis
5212665|NCT02665221|erythema|erythema
5212666|NCT02665208|cigarettes|cigarettes
5212667|NCT02665208|smoking|smoking
5212668|NCT02665208|opiate-dependence|opiate-dependence
5212669|NCT02665208|alcohol|alcohol
5212670|NCT02665208|detoxification|detoxification
5212671|NCT02665182|orchitis|orchitis
5862847|NCT00001483|Depression|depression
5212672|NCT02665182|testicular diseases|testicular diseases
5212673|NCT02665169|Postural Balance|postural balance
5212674|NCT02665169|Cost-Benefit Analysis|cost-benefit analysis
5212675|NCT02665169|Morbidity|morbidity
5212676|NCT02665169|Exercise|exercise
5212677|NCT02665143|acute myeloid leukemia|acute myeloid leukemia
5212678|NCT02665130|COPD|copd
5212679|NCT02665130|Pulmonary rehabilitation|pulmonary rehabilitation
5212680|NCT02665117|Hypokalemia|hypokalemia
5212681|NCT02665117|Isoprostanes|isoprostanes
5212682|NCT02665117|Insulin resistance|insulin resistance
5212683|NCT02665117|Aldosterone|aldosterone
5212684|NCT02665117|Hepatic fat|hepatic fat
5212685|NCT02665117|Muscle Magnesium|muscle magnesium
5212686|NCT02665117|Liver fat|liver fat
5212687|NCT02665104|Cerebral oxygen saturation|cerebral oxygen saturation
5212689|NCT02665104|NIRS|nirs
5212690|NCT02665104|Carotid endarterectomy|carotid endarterectomy
5212691|NCT02665078|Lung Cancer|lung cancer
5212692|NCT02665065|Acute Myeloid Leukemia|acute myeloid leukemia
5212693|NCT02665065|Leukemia, Acute Myeloid|leukemia, acute myeloid
5212694|NCT02665065|Myeloid Leukemia, Acute|myeloid leukemia, acute
5212695|NCT02665065|Bone Marrow Cell Transplant|bone marrow cell transplant
5212696|NCT02665065|Transplant, Bone Marrow|transplant, bone marrow
5212697|NCT02665065|HCT|hct
5212698|NCT02665065|HSCT|hsct
5212699|NCT02665065|Refractory AML|refractory aml
5212700|NCT02665065|Relapsed AML|relapsed aml
5212701|NCT02665065|BC8|bc8
5212702|NCT02665065|I-131|i-131
5212703|NCT02665065|Iomab|iomab
5212704|NCT02665065|Iomab-B|iomab-b
5212705|NCT02665065|CD45|cd45
5212706|NCT02665065|Iodine|iodine
5212707|NCT02665065|Iodine-131|iodine-131
5212708|NCT02665065|131-I|131-i
5212710|NCT02665065|BMT|bmt
5212711|NCT02665065|Radioimmunotherapy|radioimmunotherapy
5212712|NCT02665052|Rehabilitation|rehabilitation
5212713|NCT02665052|Motor Recovery|motor recovery
5212714|NCT02665052|upper extremity|upper extremity
5212715|NCT02664987|pain management, pain control, cancer|pain management, pain control, cancer
5212716|NCT02664961|TRC105|trc105
5212717|NCT02664961|CD105|cd105
5212718|NCT02664961|Endoglin|endoglin
5212719|NCT02664961|Angiogenesis inhibitor|angiogenesis inhibitor
5212720|NCT02664961|GTN|gtn
5212721|NCT02664961|Bevacizumab|bevacizumab
5212722|NCT02664961|Avastin|avastin
5212723|NCT02664948|early follow-up|early follow-up
5212724|NCT02664948|geriatrics|geriatrics
5212725|NCT02664935|NSCLC|nsclc
5212726|NCT02664935|Lung Cancer|lung cancer
5212727|NCT02664935|Adenocarcinoma|adenocarcinoma
5212728|NCT02664935|Matrix|matrix
5212729|NCT02664935|SMP2|smp2
5212730|NCT02664935|Umbrella Trial Design|umbrella trial design
5212731|NCT02664935|Multi-arm|multi-arm
5212732|NCT02664922|Electrophysiology|electrophysiology
5212733|NCT02664922|Anesthetics|anesthetics
5212734|NCT02664909|Hip Hemiarthroplasty|hip hemiarthroplasty
5212735|NCT02664909|Tranexamic Acid|tranexamic acid
5212736|NCT02664909|Topical|topical
5212737|NCT02664909|Blood Transfusion|blood transfusion
5212738|NCT02664896|Knee pain|knee pain
5212739|NCT02664896|Knee Osteoarthritis|knee osteoarthritis
5212740|NCT02664870|synovial fluid|synovial fluid
5212741|NCT02664870|biomarkers|biomarkers
5212742|NCT02664857|Vitamin D|vitamin d
5212743|NCT02664857|Postoperative Pain|postoperative pain
5212744|NCT02664857|Mental Motor Retardation|mental motor retardation
5212745|NCT02664844|Obesity|obesity
5212746|NCT02664844|Appetite regulation|appetite regulation
5212747|NCT02664844|Insulin sensitivity|insulin sensitivity
5212748|NCT02664844|Adolescents|adolescents
5212749|NCT02664844|Exercise|exercise
5212750|NCT02664831|cardiac arrest|cardiac arrest
5212751|NCT02664831|inflammation|inflammation
5212752|NCT02664831|immune|immune
5212753|NCT02664831|neuregulin|neuregulin
5212754|NCT02664831|lipids|lipids
5212755|NCT02664831|lymphocyte|lymphocyte
5212756|NCT02664818|Heart failure|heart failure
5212757|NCT02664818|China|china
5212758|NCT02664818|Registry|registry
5212759|NCT02664818|Characteristic|characteristic
5212760|NCT02664818|Outcome|outcome
5212761|NCT02664792|Non-small cell lung carcinoma|non-small cell lung carcinoma
5212762|NCT02664792|PET/CT|pet/ct
5212763|NCT02664792|18F-FDG|18f-fdg
5212764|NCT02664766|Heavy drinking|heavy drinking
5212765|NCT02664766|Heavy drinking cessation|heavy drinking cessation
5212766|NCT02664766|Alcohol abuse|alcohol abuse
5212767|NCT02664766|alcohol use disorder|alcohol use disorder
5212768|NCT02664740|Phage Therapy|phage therapy
5212769|NCT02664727|alcohol|alcohol
5212770|NCT02664727|alcohol abuse|alcohol abuse
5212771|NCT02664727|alcohol dependence|alcohol dependence
5212772|NCT02664727|alcohol use disorder|alcohol use disorder
5212773|NCT02664727|heavy drinking|heavy drinking
5212774|NCT02664727|alcohol abuse cessation|alcohol abuse cessation
5212775|NCT02664714|physiotherapy, perineometer, adherence|physiotherapy, perineometer, adherence
5212776|NCT02664688|spondylolisthesis|spondylolisthesis
5212777|NCT02664688|low back pain|low back pain
5212778|NCT02664688|stabilization exercise|stabilization exercise
5212779|NCT02664662|Breast cancer|breast cancer
5212780|NCT02664662|Health literacy|health literacy
5212781|NCT02664662|Tailored education|tailored education
5212783|NCT02664662|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
5212785|NCT02664649|Apixaban|apixaban
5212786|NCT02664649|Anticoagulant|anticoagulant
5212787|NCT02664649|VKA|vka
5212788|NCT02664649|Antiplatelet therapy|antiplatelet therapy
5212789|NCT02664649|Aortic stenosis|aortic stenosis
5212790|NCT02664610|hypertension treatment|hypertension treatment
5212791|NCT02664610|stroke prevention|stroke prevention
5212792|NCT02664597|ADNEXMR SCORING system|adnexmr scoring system
5212793|NCT02664597|MRI|mri
5212794|NCT02664597|adnexal masses|adnexal masses
5212795|NCT02664519|Chronic Kidney Disease|chronic kidney disease
5212796|NCT02664519|Functional sympatholysis|functional sympatholysis
5212797|NCT02664519|Exercise training|exercise training
5212798|NCT02664519|Exercise intolerance|exercise intolerance
5212799|NCT02664519|Handgrip exercise|handgrip exercise
5212800|NCT02664519|Near infrared spectroscopy|near infrared spectroscopy
5212801|NCT02664519|Lower body negative pressure|lower body negative pressure
5212802|NCT02664493|kidney transplantation|kidney transplantation
5212803|NCT02664493|subclinical borderline rejection|subclinical borderline rejection
5212804|NCT02664493|steroid pulse therapy|steroid pulse therapy
5212805|NCT02664480|Salivary Alpha-amylase|salivary alpha-amylase
5212806|NCT02664480|ovulation|ovulation
5212807|NCT02664454|Elderly|elderly
5212808|NCT02664454|Health care organization|health care organization
5212809|NCT02664454|Primary care|primary care
5212810|NCT02664441|Obesity|obesity
5212811|NCT02664441|Drug intervention|drug intervention
5212812|NCT02664441|Children|children
5212813|NCT02664441|Adolescents|adolescents
5212814|NCT02664441|Young adults|young adults
5212815|NCT02664441|Hypothalamic lesion|hypothalamic lesion
5212816|NCT02664441|Change of weight status|change of weight status
5212817|NCT02664441|Food intake|food intake
5212818|NCT02664441|Energy expenditure|energy expenditure
5104904|NCT03341416|dentate nucleus|dentate nucleus
5212819|NCT02664441|Hormonal changes|hormonal changes
5212820|NCT02664441|Glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
5212821|NCT02664441|Bydureon|bydureon
5212822|NCT02664441|Weight Loss|weight loss
5212823|NCT02664441|Energy balance|energy balance
5212824|NCT02664415|Human Monoclonal Antibody|human monoclonal antibody
5212825|NCT02664402|Palliative Care|palliative care
5212826|NCT02664402|Pain|pain
5212827|NCT02664402|Community Health|community health
5212828|NCT02664376|sarcopenia|sarcopenia
5212829|NCT02664376|geriatry|geriatry
5212830|NCT02664311|Pulmonary Vein Isolation|pulmonary vein isolation
5212831|NCT02664311|Jet Ventilation|jet ventilation
5212832|NCT02664311|Atrial Fibrillation|atrial fibrillation
5212833|NCT02664298|severely atrophic jaw|severely atrophic jaw
5212834|NCT02664298|cranial bone-graft|cranial bone-graft
5212835|NCT02664298|dental implants|dental implants
5212836|NCT02664298|immediate loading|immediate loading
5212837|NCT02664298|augmentation maxilla/mandible|augmentation maxilla/mandible
5212838|NCT02664298|sinus-floor elevation/sinuslift|sinus-floor elevation/sinuslift
5212839|NCT02664298|dental prosthesis|dental prosthesis
5212840|NCT02664298|implant supported|implant supported
5212841|NCT02664298|provisional implants|provisional implants
5212842|NCT02664298|temporary implants|temporary implants
5212843|NCT02664298|one-stage surgery|one-stage surgery
5212844|NCT02664298|alveolar ridge augmentation|alveolar ridge augmentation
5212845|NCT02664298|maxilla|maxilla
5212846|NCT02664259|Endobronchial ultrasonography|endobronchial ultrasonography
5212847|NCT02664259|Peripheral pulmonary lesions|peripheral pulmonary lesions
5212848|NCT02664259|Ultrathin bronchoscopy|ultrathin bronchoscopy
5212849|NCT02664246|contrast-induced nephropathy|contrast-induced nephropathy
5212850|NCT02664246|Percutaneous coronary intervention|percutaneous coronary intervention
5212851|NCT02664246|risk factors|risk factors
5212852|NCT02664246|incidence|incidence
5212853|NCT02664233|Diabetes|diabetes
5212854|NCT02664233|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5212855|NCT02664233|obesity|obesity
5212856|NCT02664233|self-monitoring|self-monitoring
5212857|NCT02664233|goal setting|goal setting
5212858|NCT02664233|mobile health|mobile health
5212859|NCT02664233|connected health|connected health
5212860|NCT02664220|Povidone-iodine irrigation|povidone-iodine irrigation
5212861|NCT02664207|Myelomeningocele repair|myelomeningocele repair
5212862|NCT02664207|Open Neural Tube Defect|open neural tube defect
5212863|NCT02664207|BMI of 35-40 kg/m2,|bmi of 35-40 kg/m2,
5212864|NCT02664207|Open Fetal Surgery|open fetal surgery
5212865|NCT02664207|Elevated body mass index|elevated body mass index
5212866|NCT02664194|Hypothermia|hypothermia
5212867|NCT02664194|Rewarming|rewarming
5212868|NCT02664194|Myocardial Infarction|myocardial infarction
5200888|NCT02738684|EGFR|egfr
5200889|NCT02738684|plasma free nucleic acids|plasma free nucleic acids
5200890|NCT02738671|functional MRI|functional mri
5212869|NCT02664194|Percutaneous Cornonary Intervention|percutaneous cornonary intervention
5212870|NCT02664181|Cancer|cancer
5212871|NCT02664181|Nivolumab|nivolumab
5212872|NCT02664181|Decitabine|decitabine
5212873|NCT02664181|Tetrahydrouridine|tetrahydrouridine
5212877|NCT02664155|Pulmonary Embolism (PE)|pulmonary embolism (pe)
5212878|NCT02664155|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
5212879|NCT02664155|Heparins|heparins
5212880|NCT02664142|General Surgery|general surgery
5212881|NCT02664142|Child|child
5212882|NCT02664142|Anaesthesia|anaesthesia
5212883|NCT02664142|Depth of anaesthesia|depth of anaesthesia
5212884|NCT02664142|BIS monitoring|bis monitoring
5212885|NCT02664129|schizophrenia|schizophrenia
5212886|NCT02664129|awareness|awareness
5212887|NCT02664129|insight|insight
5212888|NCT02664129|video|video
5212889|NCT02664129|self-observation|self-observation
5212890|NCT02664116|Severe Migraine Headache|severe migraine headache
5212891|NCT02664090|acute respiratory distress syndrome|acute respiratory distress syndrome
5212892|NCT02664090|prone ventilation|prone ventilation
5212893|NCT02664090|trans-esophageal doppler|trans-esophageal doppler
5212894|NCT02664077|NSABP|nsabp
5212895|NCT02664077|Colon cancer|colon cancer
5212896|NCT02664077|Regorafenib|regorafenib
5212897|NCT02664077|Stage III|stage iii
5212898|NCT02664077|Adjuvant therapy|adjuvant therapy
5212899|NCT02664064|prediabetes, weight loss, behavior modification|prediabetes, weight loss, behavior modification
5212901|NCT02664038|Neuropsychology|neuropsychology
5212902|NCT02664038|Cognitive Remediation|cognitive remediation
5212903|NCT02664025|teaching vaginal examination|teaching vaginal examination
5212904|NCT02664012|adoption|adoption
5212905|NCT02664012|electronic cigarettes|electronic cigarettes
5212906|NCT02664012|e-cigarettes|e-cigarettes
5212907|NCT02664012|menthol|menthol
5212908|NCT02664012|combustible cigarettes|combustible cigarettes
5212909|NCT02664012|nicotine polacrilex|nicotine polacrilex
5212910|NCT02664012|own brand cigarette|own brand cigarette
5212911|NCT02664012|subjective measures|subjective measures
5212912|NCT02664012|pharmacokinetics|pharmacokinetics
5212913|NCT02664012|pharmacodynamics|pharmacodynamics
5212914|NCT02664012|cigarette|cigarette
5212915|NCT02663999|dose proportionality|dose proportionality
5212916|NCT02663999|diazepam nasal spray|diazepam nasal spray
5212917|NCT02663986|Organization, Time Management, and Planning (OTMP)|organization, time management, and planning (otmp)
5212918|NCT02663973|Breast cancer|breast cancer
5212919|NCT02663960|Regional citrate anticoagulation|regional citrate anticoagulation
5212920|NCT02663960|Protocol|protocol
5212921|NCT02663960|Filter lifespan|filter lifespan
5212922|NCT02663947|ventriculoperitoneal shunt|ventriculoperitoneal shunt
5212923|NCT02663947|optic nerve sheath diameter|optic nerve sheath diameter
5212924|NCT02663947|intracranial pressure|intracranial pressure
5212925|NCT02663934|HIV, AIDS, Cognition, Memory, Exercise, Stretching|hiv, aids, cognition, memory, exercise, stretching
5212926|NCT02663921|Fitzpatrick Skin-Type|fitzpatrick skin-type
5212927|NCT02663921|Melanin|melanin
5212928|NCT02663921|Ultraviolet Light (UV)|ultraviolet light (uv)
5212929|NCT02663882|smoking|smoking
5212930|NCT02663882|self control|self control
5212931|NCT02663804|Total Knee Arthroplasty|total knee arthroplasty
5212932|NCT02663804|Patient Satisfaction|patient satisfaction
5212933|NCT02663804|PROMs|proms
5213035|NCT02663427|gastrin|gastrin
5212934|NCT02663804|Implant Design|implant design
5212935|NCT02663791|Alcohol|alcohol
5212936|NCT02663791|Aortic stiffness|aortic stiffness
5212937|NCT02663791|Arterial stiffness|arterial stiffness
5212938|NCT02663791|Pulse wave velocity|pulse wave velocity
5212939|NCT02663791|Longitudinal|longitudinal
5212940|NCT02663752|deferasirox|deferasirox
5212942|NCT02663752|RNA expression|rna expression
5212943|NCT02663752|predictive biomarker|predictive biomarker
5212944|NCT02663739|Stanford type B aortic dissection|stanford type b aortic dissection
5212945|NCT02663739|Malperfusion|malperfusion
5212946|NCT02663739|Rupture|rupture
5212947|NCT02663739|Acute disease|acute disease
5212948|NCT02663739|Endovascular procedures|endovascular procedures
5212949|NCT02663726|Physically inactive|physically inactive
5212950|NCT02663726|Older adults|older adults
5212951|NCT02663713|Pharmacodynamics|pharmacodynamics
5212952|NCT02663713|Ticagrelor|ticagrelor
5212953|NCT02663713|Clopidogrel|clopidogrel
5212954|NCT02663713|MI|mi
5212955|NCT02663700|Adults|adults
5212956|NCT02663700|Burkina Faso|burkina faso
5212957|NCT02663700|malaria|malaria
5212958|NCT02663700|PfSPZ Vaccine|pfspz vaccine
5212959|NCT02663700|Placebo|placebo
5212960|NCT02663700|Randomized|randomized
5212961|NCT02663674|CAP|cap
5212962|NCT02663674|Coccidioidomycosis|coccidioidomycosis
5212963|NCT02663674|Community Acquired Pneumonia|community acquired pneumonia
5212964|NCT02663674|FLEET|fleet
5212965|NCT02663674|Fluconazole|fluconazole
5090622|NCT03432455|prevalence|prevalence
5090623|NCT03432455|epidemiology|epidemiology
5090624|NCT03432455|juvenile dermatomyositis|juvenile dermatomyositis
5212966|NCT02663674|Parent Study of 16-0008|parent study of 16-0008
5212967|NCT02663674|Pneumonia|pneumonia
5212968|NCT02663674|Valley Fever|valley fever
5212969|NCT02663661|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
5212970|NCT02663661|TrialNet|trialnet
5212971|NCT02663661|Pathway to Prevention (PTP)|pathway to prevention (ptp)
5212972|NCT02663661|First and second degree relatives of persons with T1DM|first and second degree relatives of persons with t1dm
5212973|NCT02663661|Insulin-glucagon-glucose (IGG)|insulin-glucagon-glucose (igg)
5212974|NCT02663661|Immunological risk to develop T1DM|immunological risk to develop t1dm
5212975|NCT02663648|myeloproliferative disorders|myeloproliferative disorders
5212976|NCT02663648|cell cycle regulatory protein|cell cycle regulatory protein
5212977|NCT02663609|Cushing's Syndrome|cushing's syndrome
5212978|NCT02663609|Mifepristone|mifepristone
5212979|NCT02663609|Adrenal|adrenal
5212980|NCT02663609|Retrospective|retrospective
5212981|NCT02663609|Chart Review|chart review
5212982|NCT02663596|Pediatric|pediatric
5212983|NCT02663596|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5212984|NCT02663596|Dialysis|dialysis
5212985|NCT02663596|Therapeutic drug monitoring|therapeutic drug monitoring
5212986|NCT02663596|Pharmacokinetics|pharmacokinetics
5212987|NCT02663596|Pharmacodynamics|pharmacodynamics
5212988|NCT02663583|Oropharynx squamous cell carcinoma|oropharynx squamous cell carcinoma
5212989|NCT02663583|OPSCC|opscc
5212990|NCT02663583|Actigraph accelerometer|actigraph accelerometer
5212991|NCT02663583|MD Anderson Symptom Inventory - Head and Neck module|md anderson symptom inventory - head and neck module
5212992|NCT02663583|MDASI-HN|mdasi-hn
5212993|NCT02663583|Intensity-Modulated Proton Therapy|intensity-modulated proton therapy
5212994|NCT02663583|IMPT|impt
5212995|NCT02663583|TransOral Robotic Surgery|transoral robotic surgery
5212996|NCT02663583|TORS|tors
5212997|NCT02663583|Surveys|surveys
5212998|NCT02663583|Questionnaires|questionnaires
5212999|NCT02663557|stroke, blood pressure, prognosis|stroke, blood pressure, prognosis
5213000|NCT02663544|Diabetes|diabetes
5213001|NCT02663544|Metabolic syndrome|metabolic syndrome
5213002|NCT02663544|Obesity|obesity
5213003|NCT02663544|NAFLD|nafld
5213004|NCT02663518|T-Cell|t-cell
5213005|NCT02663518|CTCL|ctcl
5213006|NCT02663518|PTCL|ptcl
5213007|NCT02663518|ALL|all
5213008|NCT02663518|Rituximab|rituximab
5213009|NCT02663518|Nivolumab|nivolumab
5213010|NCT02663518|TTI-621|tti-621
5213011|NCT02663518|Solid Tumor|solid tumor
5213012|NCT02663518|Hematologic Malignancies|hematologic malignancies
5213013|NCT02663518|Lymphoma|lymphoma
5213014|NCT02663518|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5213015|NCT02663518|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5213016|NCT02663518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5213017|NCT02663518|CD47|cd47
5213018|NCT02663492|Acupuncture|acupuncture
5213019|NCT02663492|electrical stimulation of acupoints|electrical stimulation of acupoints
5213020|NCT02663492|chemotherapy|chemotherapy
5213021|NCT02663492|Diyu Shengbai Pian|diyu shengbai pian
5213022|NCT02663492|nursing care|nursing care
5213023|NCT02663466|pilonidal sinus|pilonidal sinus
5213024|NCT02663466|Limberg flap|limberg flap
5213025|NCT02663466|off-midline closure concept|off-midline closure concept
5213026|NCT02663466|recurrence|recurrence
5213027|NCT02663453|preterm|preterm
5213028|NCT02663453|parenteral nutrition|parenteral nutrition
5213029|NCT02663453|cholestasis|cholestasis
5213030|NCT02663453|fish oil|fish oil
5213031|NCT02663427|pepsinogen Ⅰ|pepsinogen ⅰ
5213032|NCT02663427|pepsinogen Ⅱ|pepsinogen ⅱ
5213033|NCT02663427|gastric cancer screening|gastric cancer screening
5213034|NCT02663427|helicobacter pylori|helicobacter pylori
5213036|NCT02663375|TAVI|tavi
5213037|NCT02663375|Aortic Stenosis|aortic stenosis
5213038|NCT02663375|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5213039|NCT02663375|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5213040|NCT02663375|Transapical Access|transapical access
5213041|NCT02663362|magnetic resonance imaging|magnetic resonance imaging
5213042|NCT02663362|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5213043|NCT02663336|masked hypertension, chronic kidney disease|masked hypertension, chronic kidney disease
5213044|NCT02663323|Coronary Artery Disease|coronary artery disease
5213045|NCT02663323|MeRes-1 Extend|meres-1 extend
5213046|NCT02663323|MeRes100|meres100
5213047|NCT02663323|Sirolimus Eluting Bioresorbable Vascular Scaffold System|sirolimus eluting bioresorbable vascular scaffold system
5213048|NCT02663310|spinal cord injury|spinal cord injury
5213049|NCT02663310|Kunming Locomotor Scale|kunming locomotor scale
5213050|NCT02663310|surgical decompression|surgical decompression
5213051|NCT02663310|untethering|untethering
5213052|NCT02663310|weight bearing rehabilitation|weight bearing rehabilitation
5213053|NCT02663297|CAR T cells|car t cells
5213054|NCT02663297|CD30|cd30
5962621|NCT04279964|Human Papillomavirus|human papillomavirus
5962622|NCT04279964|Vaccine|vaccine
5962623|NCT04279951|Resistance exercise|resistance exercise
5962624|NCT04279951|Omega 3|omega 3
5081365|NCT03490474|massage|massage
5213055|NCT02663297|Lymphoma|lymphoma
5213056|NCT02663297|T Lymphocytes|t lymphocytes
5285024|NCT02246816|SBS|sbs
5213057|NCT02663245|Type 2 diabetes mellitus|type 2 diabetes mellitus
5213058|NCT02663245|glycemic control|glycemic control
5213059|NCT02663232|V600 BRAF mutation|v600 braf mutation
5213060|NCT02663232|Metastatic melanoma|metastatic melanoma
5213061|NCT02663219|MSM|msm
5213062|NCT02663219|ART|art
5213063|NCT02663219|CCM|ccm
5213064|NCT02663219|DAIDS|daids
5213065|NCT02663219|HPTN|hptn
5213066|NCT02663219|ACA|aca
5213068|NCT02663219|PEP|pep
5213071|NCT02663206|achalasia|achalasia
5213072|NCT02663206|diffuse esophageal spasm|diffuse esophageal spasm
5213073|NCT02663206|hypercontractile (jackhammer) esophagus|hypercontractile (jackhammer) esophagus
5213074|NCT02663206|Botulinum toxin injection|botulinum toxin injection
5213075|NCT02663206|peroral endoscopic myotomy|peroral endoscopic myotomy
5213076|NCT02663193|Prostate Cancer|prostate cancer
5213077|NCT02663193|Observational study|observational study
5213078|NCT02663193|Enzalutamide|enzalutamide
5213079|NCT02663193|Abiraterone Acetate|abiraterone acetate
5213080|NCT02663193|Prednisone|prednisone
5213081|NCT02663193|Tolerability|tolerability
5213082|NCT02663154|Aromatherapy|aromatherapy
5213083|NCT02663102|Safety|safety
5213084|NCT02663102|Post-marketing|post-marketing
5213085|NCT02663102|Korea|korea
5213086|NCT02663102|Drug utilization study|drug utilization study
5213087|NCT02663102|Fluarix Tetra|fluarix tetra
5213088|NCT02663089|total radioactivity|total radioactivity
5213089|NCT02663089|[14C]-GSK961081|[14c]-gsk961081
5213090|NCT02663089|Pharmacokinetics|pharmacokinetics
5213091|NCT02663089|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5213092|NCT02663089|Microtracer|microtracer
5213093|NCT02663063|Complementary and alternative medicine|complementary and alternative medicine
5213094|NCT02663063|Hospice Palliative Care|hospice palliative care
5213095|NCT02663050|Dysmenorrhea|dysmenorrhea
5213096|NCT02663050|kinesio tape|kinesio tape
5213097|NCT02663037|Segmentation|segmentation
5213098|NCT02663037|Health needs|health needs
5213099|NCT02662985|Power Doppler Ultrasonography, Psoriatic Arthritis, Enthesitis, Synovitis, Outcome Measures in Rheumatology, Spondyloarthritis Research Consortium of Canada|power doppler ultrasonography, psoriatic arthritis, enthesitis, synovitis, outcome measures in rheumatology, spondyloarthritis research consortium of canada
5213100|NCT02662972|Nerve block|nerve block
5213101|NCT02662972|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5213102|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a
5213103|NCT02662959|Chemotherapy, metastatic gastric cancer, irinotecan|chemotherapy, metastatic gastric cancer, irinotecan
5213104|NCT02662907|Head and Neck Cancer|head and neck cancer
5213105|NCT02662907|Post-radiotherapy H&N cancer survivors|post-radiotherapy h&n cancer survivors
5213106|NCT02662907|Aspiration|aspiration
5213107|NCT02662907|Expiratory muscle strength training|expiratory muscle strength training
5213108|NCT02662907|EMST|emst
5213109|NCT02662907|Dysphagia therapy|dysphagia therapy
5213110|NCT02662907|Modified barium swallow|modified barium swallow
5213111|NCT02662907|Neurocognitive exams|neurocognitive exams
5213112|NCT02662907|Questionnaires|questionnaires
5213113|NCT02662907|Surveys|surveys
5213114|NCT02662907|Digital Manometer|digital manometer
5213115|NCT02662868|Breast cancer|breast cancer
5213116|NCT02662868|Metastasis|metastasis
5213117|NCT02662842|infusion set|infusion set
5213118|NCT02662842|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5213119|NCT02662829|Lesotho|lesotho
5213120|NCT02662829|tuberculosis|tuberculosis
5213121|NCT02662829|TB|tb
5213122|NCT02662829|HIV|hiv
5213123|NCT02662829|adherence|adherence
5213124|NCT02662829|community-based intervention|community-based intervention
5213125|NCT02662829|retention|retention
5213126|NCT02662816|Glutathione|glutathione
5213127|NCT02662816|Liver|liver
5213128|NCT02662816|Muscle|muscle
5213129|NCT02662816|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
5213130|NCT02662816|Healthy human|healthy human
5213131|NCT02662803|Generalized Anxiety Disorder|generalized anxiety disorder
5213133|NCT02662803|physical exercise|physical exercise
5213134|NCT02662803|aerobe exercise|aerobe exercise
5213135|NCT02662803|mental disorder|mental disorder
5213136|NCT02662803|high-intensive aerobe exercise|high-intensive aerobe exercise
5213137|NCT02662777|esophageal anastomosis leakage|esophageal anastomosis leakage
5213138|NCT02662777|endoscopic vacuum therapy|endoscopic vacuum therapy
5213139|NCT02662777|esophageal perforation|esophageal perforation
5213140|NCT02662777|upper gastrointestinal tract|upper gastrointestinal tract
5213141|NCT02662777|esophageal leak|esophageal leak
5213142|NCT02662777|endoscopy|endoscopy
5213143|NCT02662738|Blood glucose|blood glucose
5213144|NCT02662725|melanoma|melanoma
5213145|NCT02662725|brain metastasis|brain metastasis
5213146|NCT02662725|stereotactic radiosurgery|stereotactic radiosurgery
5213147|NCT02662725|Ipilimumab|ipilimumab
5213148|NCT02662725|survival|survival
5213149|NCT02662725|safety|safety
5213150|NCT02662725|efficacy|efficacy
5213151|NCT02662712|Healthy|healthy
5962625|NCT04279912|Tremor|tremor
5213152|NCT02662712|Hepatitis, Chronic|hepatitis, chronic
5213153|NCT02662712|JNJ-56136379|jnj-56136379
5213154|NCT02662712|Placebo|placebo
5213155|NCT02662699|Anemia|anemia
5213156|NCT02662699|Hematologic Diseases|hematologic diseases
5213157|NCT02662699|Erythrocytes|erythrocytes
5213158|NCT02662699|Hemoglobin|hemoglobin
5213159|NCT02662699|Hemolytic|hemolytic
5213160|NCT02662686|Embryo Implantation|embryo implantation
5213161|NCT02662686|Mitochondrial genes|mitochondrial genes
5213164|NCT02662686|Embryo selection|embryo selection
5213165|NCT02662686|Embryo viability|embryo viability
5213166|NCT02662686|Embryo biomarker|embryo biomarker
5105397|NCT03338530|School intervention|school intervention
5213167|NCT02662686|Diagnosis of embryo viability in euploids embryos|diagnosis of embryo viability in euploids embryos
5213169|NCT02662673|Prostate Cancer|prostate cancer
5213170|NCT02662673|Focal|focal
5213171|NCT02662673|Quality of life|quality of life
5213172|NCT02662673|Index study|index study
5213173|NCT02662647|demethylating agent|demethylating agent
5213174|NCT02662647|lymphocyte infusion|lymphocyte infusion
5213175|NCT02662634|NSCLC|nsclc
5213176|NCT02662634|resectable|resectable
5213177|NCT02662634|non-small cell lung cancer|non-small cell lung cancer
5213178|NCT02662634|immunotherapy|immunotherapy
5213179|NCT02662634|autologous|autologous
5213180|NCT02662634|dendritic cell|dendritic cell
5213181|NCT02662621|personalized care|personalized care
5213182|NCT02662621|early diagnosis|early diagnosis
5213183|NCT02662621|ovarian cancer|ovarian cancer
5213184|NCT02662621|breast cancer|breast cancer
5213185|NCT02662621|lung cancer|lung cancer
5213186|NCT02662621|Early Detection|early detection
5213187|NCT02662621|Cancer [E01.390.500]|cancer [e01.390.500]
5213188|NCT02662608|Brontictuzumab|brontictuzumab
5213189|NCT02662595|mHealth|mhealth
5213190|NCT02662595|mobile phones|mobile phones
5213191|NCT02662595|measles vaccination|measles vaccination
5213192|NCT02662582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5213193|NCT02662582|CK-2127107|ck-2127107
5213194|NCT02662582|COPD|copd
5213195|NCT02662543|rotavirus,|rotavirus,
5213196|NCT02662543|acute gastroenteritis|acute gastroenteritis
5213197|NCT02662543|vaccination|vaccination
5213198|NCT02662543|Estonia|estonia
5213199|NCT02662543|impact|impact
5213200|NCT02662543|severity scales|severity scales
5213201|NCT02662517|Neurotrophins|neurotrophins
5213202|NCT02662517|Stem Cells|stem cells
5213203|NCT02662517|Prematurity|prematurity
5213204|NCT02662504|mesothelioma|mesothelioma
5213205|NCT02662504|multimodal treatment|multimodal treatment
5213207|NCT02662504|pleura|pleura
5213208|NCT02662478|Laparoscopic gastric resection|laparoscopic gastric resection
5213209|NCT02662478|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5213210|NCT02662478|laparoscopic surgery|laparoscopic surgery
5213211|NCT02662465|Interventional|interventional
5213213|NCT02662465|Laser|laser
5213214|NCT02662439|Heart Failure|heart failure
5213215|NCT02662439|Bioimpedance analysis|bioimpedance analysis
5213216|NCT02662439|Fluid overload|fluid overload
5213217|NCT02662426|Seasonal Influenza|seasonal influenza
5213218|NCT02662426|Lingdancao|lingdancao
5213219|NCT02662426|RCT|rct
5213220|NCT02662361|peri-implant disease; risk factors; prevalence|peri-implant disease; risk factors; prevalence
5213221|NCT02662322|Communication|communication
5213222|NCT02662322|Confusion|confusion
5213223|NCT02662322|Intravenous Catheterization|intravenous catheterization
5213224|NCT02662322|Comfort|comfort
5213227|NCT02662283|IGA Nephropathy|iga nephropathy
5213228|NCT02662283|proteinurien|proteinurien
5213229|NCT02662283|Reh-acteoside|reh-acteoside
5213230|NCT02662283|Prednisolone|prednisolone
5213231|NCT02662270|Fibromyalgia|fibromyalgia
5213232|NCT02662270|QEEG|qeeg
5213233|NCT02662270|Brain activity|brain activity
5213235|NCT02662270|Diagnosis|diagnosis
5213236|NCT02662257|Sevoflurane|sevoflurane
5213237|NCT02662257|Propofol|propofol
5213238|NCT02662257|Aged|aged
5213239|NCT02662257|Neoplasm|neoplasm
5213240|NCT02662257|Surgical Procedure, Operative|surgical procedure, operative
5213241|NCT02662257|Delirium|delirium
5213242|NCT02662257|Postoperative Complications|postoperative complications
5213243|NCT02662257|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5213244|NCT02662231|Surgical Site Infection|surgical site infection
5213245|NCT02662231|General Surgery|general surgery
5213246|NCT02662231|Laparotomy|laparotomy
5213247|NCT02662231|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5213248|NCT02662231|Developing Countries|developing countries
5213249|NCT02662231|International Cooperation|international cooperation
5213250|NCT02662231|Specialties, Surgical|specialties, surgical
5213251|NCT02662231|Developed Countries|developed countries
5213252|NCT02662231|Quality of Health Care|quality of health care
5213253|NCT02662179|Elderly patients|elderly patients
5213254|NCT02662179|Onco-geriatrics|onco-geriatrics
5213255|NCT02662179|Fried criteria|fried criteria
5213256|NCT02662166|bladder cancer|bladder cancer
5213257|NCT02662166|MRI|mri
5213258|NCT02662166|TUR-BT|tur-bt
5213259|NCT02662166|cystectomy|cystectomy
5213260|NCT02662166|chemotherapy|chemotherapy
5962626|NCT04279912|Multiple Sclerosis|multiple sclerosis
5213261|NCT02662075|alternative tobacco products (ATPs)|alternative tobacco products (atps)
5213262|NCT02662075|electronic cigarettes|electronic cigarettes
5859846|NCT00005935|T Cells|t cells
5213263|NCT02662062|Non-metastatic muscle invasive bladder cancer|non-metastatic muscle invasive bladder cancer
5213264|NCT02662023|Healthy Human Volunteers|healthy human volunteers
5213265|NCT02662010|AGEs|ages
5213266|NCT02662010|glycemic control|glycemic control
5213267|NCT02662010|T2DM|t2dm
5213268|NCT02661997|Tai Chi|tai chi
5213269|NCT02661997|Wellness|wellness
5213270|NCT02661997|Mind-body|mind-body
5213271|NCT02661997|Gulf War Illness|gulf war illness
5213272|NCT02661997|Gulf War Veteran's Illness|gulf war veteran's illness
5213273|NCT02661997|GWVI|gwvi
5213274|NCT02661984|FeNO, exhaled nitric oxide|feno, exhaled nitric oxide
5213275|NCT02661958|acne vulgaris|acne vulgaris
5213276|NCT02661958|acne|acne
5213277|NCT02661945|near focus with narrow band imaging|near focus with narrow band imaging
5213278|NCT02661945|tumor margin|tumor margin
5213279|NCT02661945|indigocarmine chromoendoscopy|indigocarmine chromoendoscopy
5213280|NCT02661932|Fertility preservation|fertility preservation
5213281|NCT02661932|letrozole|letrozole
5213282|NCT02661932|Ovarian stimulation|ovarian stimulation
5213283|NCT02661919|Epilepsy|epilepsy
5213284|NCT02661919|Seizure|seizure
5213285|NCT02661919|Seizures|seizures
5213286|NCT02661919|Mattress monitor|mattress monitor
5213287|NCT02661919|Bed monitor|bed monitor
5213288|NCT02661919|Bed alarm|bed alarm
5213289|NCT02661919|Generalized tonic-clonic seizure|generalized tonic-clonic seizure
5213291|NCT02661893|Healthy|healthy
5213292|NCT02661893|JNJ-42847922|jnj-42847922
5213293|NCT02661893|Rifampin|rifampin
5213294|NCT02661893|Pharmacokinetics|pharmacokinetics
5213295|NCT02661867|Childbirth|childbirth
5213296|NCT02661867|Pelvic organ prolapse|pelvic organ prolapse
5213297|NCT02661867|Urinary incontinence|urinary incontinence
5213298|NCT02661867|Fecal incontinence|fecal incontinence
5213299|NCT02661854|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
5213300|NCT02661854|Vaccine|vaccine
5213301|NCT02661854|Immunotherapy|immunotherapy
5213302|NCT02661854|Mite|mite
5213303|NCT02661854|Allergy|allergy
5213304|NCT02661828|Tapering Antidepressant Regimen|tapering antidepressant regimen
5213305|NCT02661828|Antidepressant Discontinuation Syndrome|antidepressant discontinuation syndrome
5213306|NCT02661789|Mental health|mental health
5213307|NCT02661789|Brain Imaging|brain imaging
5213308|NCT02661789|Steroid hormones|steroid hormones
5213309|NCT02661789|Serotonin|serotonin
5213310|NCT02661789|PET|pet
5213311|NCT02661789|MRI|mri
5213312|NCT02661789|fMRI|fmri
5213313|NCT02661789|human|human
5213314|NCT02661789|gender|gender
5213315|NCT02661789|risk model|risk model
5213316|NCT02661776|natural killer cell|natural killer cell
5213317|NCT02661776|head and neck cancer|head and neck cancer
5213318|NCT02661776|opioid|opioid
5213319|NCT02661763|Rheumatic heart disease|rheumatic heart disease
5213320|NCT02661750|Cleansing the colon|cleansing the colon
5213321|NCT02661711|Macular Oedema Retinitis Pigmentosa|macular oedema retinitis pigmentosa
5213322|NCT02661685|Cancer immunotherapy|cancer immunotherapy
5213323|NCT02661685|IFN-γ-producing killer dendritic cell-like cells|ifn-γ-producing killer dendritic cell-like cells
5213324|NCT02661685|Natural killer cells|natural killer cells
5213325|NCT02661672|Intracranial hemorrhage|intracranial hemorrhage
5213326|NCT02661672|Neurosurgery|neurosurgery
5213327|NCT02661659|mesothelioma|mesothelioma
5213328|NCT02661659|multipeptide vaccine|multipeptide vaccine
5213329|NCT02661659|S-588210|s-588210
5213330|NCT02661646|Chronic Swelling|chronic swelling
5213331|NCT02661646|Leg Lymphedema|leg lymphedema
5213332|NCT02661646|Primary Lymphedema|primary lymphedema
5213333|NCT02661646|Secondary Lymphedema|secondary lymphedema
5213334|NCT02661633|Concussion|concussion
5213335|NCT02661633|Mild Traumatic Brain Injury|mild traumatic brain injury
5213336|NCT02661633|Sport Related Concussion|sport related concussion
5213337|NCT02661620|REDAPT Femoral System modular stem implant|redapt femoral system modular stem implant
5213338|NCT02661620|Total Hip arthroplasty revision|total hip arthroplasty revision
5213339|NCT02661594|TQT|tqt
5213340|NCT02661594|amisulpride|amisulpride
5213341|NCT02661594|volunteer|volunteer
5213342|NCT02661594|ECG|ecg
5213343|NCT02661581|Diabetes|diabetes
5213344|NCT02661581|Peer Leader Support|peer leader support
5213345|NCT02661529|Shunt|shunt
5213346|NCT02661529|Echocardiogram|echocardiogram
5213347|NCT02661490|Norovirus|norovirus
5213348|NCT02661464|Healthy|healthy
5213349|NCT02661464|Ebola viruses|ebola viruses
5213350|NCT02661464|Ebola virus disease (EVD)|ebola virus disease (evd)
5213351|NCT02661464|Filoviruses|filoviruses
5213352|NCT02661464|Safety|safety
5213353|NCT02661464|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5213354|NCT02661464|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
5213355|NCT02661464|Hemorrhagic fever|hemorrhagic fever
5213356|NCT02661451|Valve|valve
5213357|NCT02661438|Usability Test|usability test
5213359|NCT02661425|IBS|ibs
5862296|NCT00001650|BrDU|brdu
5300717|NCT02173561|CPT|cpt
5213360|NCT02661412|immediate loading|immediate loading
5213361|NCT02661412|biological stability|biological stability
5213362|NCT02661412|mechanical stability|mechanical stability
5213363|NCT02661412|long-term|long-term
5213364|NCT02661412|marginal bone level|marginal bone level
5213365|NCT02661412|maxilla|maxilla
5213366|NCT02661412|immediate placement|immediate placement
5213367|NCT02661412|dental implant|dental implant
5862848|NCT00001483|Bupropion|bupropion
5105623|NCT03337022|Psoriasis|psoriasis
5213368|NCT02661412|fibre-reinforced provisional fixed prosthesis|fibre-reinforced provisional fixed prosthesis
5213370|NCT02661373|Antimalarial|antimalarial
5213371|NCT02661373|First-in-Human|first-in-human
5213372|NCT02661373|Pharmacokinetic|pharmacokinetic
5213373|NCT02661360|swaddling|swaddling
5213374|NCT02661347|First Episode|first episode
5213375|NCT02661347|Schizophreniform|schizophreniform
5213376|NCT02661347|Schizoaffective Disorder|schizoaffective disorder
5213377|NCT02661347|Psychosis|psychosis
5213378|NCT02661347|Schizophrenia|schizophrenia
5213379|NCT02661347|tDCS|tdcs
5213380|NCT02661347|Risperidone|risperidone
5213381|NCT02661347|Anti-psychotic medication|anti-psychotic medication
5213382|NCT02661334|creatine|creatine
5213383|NCT02661334|creatine monohydrate|creatine monohydrate
5213384|NCT02661334|supplement|supplement
5213385|NCT02661334|exercise|exercise
5213386|NCT02661334|fitness|fitness
5213387|NCT02661256|pharyngeal swallow|pharyngeal swallow
5213388|NCT02661256|airway compromise|airway compromise
5213389|NCT02661256|NICU|nicu
5213390|NCT02661243|Sjogren's Syndrome|sjogren's syndrome
5213391|NCT02661243|Dental Implants|dental implants
5213392|NCT02661230|exergaming|exergaming
5213393|NCT02661230|intensive care unit|intensive care unit
5213394|NCT02661230|feasibility acceptability|feasibility acceptability
5213395|NCT02661230|heart|heart
5213396|NCT02661230|brain function|brain function
5213397|NCT02661217|Acute decompensated heart failure|acute decompensated heart failure
5213398|NCT02661217|Reduced ejection fraction|reduced ejection fraction
5213399|NCT02661217|Pre-discharge treatment|pre-discharge treatment
5213400|NCT02661217|Post-discharge treatment|post-discharge treatment
5213401|NCT02661217|Angiotensin receptor neprilysine inhibitor|angiotensin receptor neprilysine inhibitor
5213402|NCT02661217|HFrEF|hfref
5213403|NCT02661191|asthma|asthma
5213404|NCT02661191|vitamin D|vitamin d
5213405|NCT02661191|exacerbations|exacerbations
5213406|NCT02661191|airway obstruction|airway obstruction
5213407|NCT02661178|Parasitic Diseases|parasitic diseases
5213408|NCT02661178|Helminthiasis|helminthiasis
5213409|NCT02661178|Nematode Infections|nematode infections
5213410|NCT02661178|Secernentea Infections|secernentea infections
5213411|NCT02661178|Spirurida Infections|spirurida infections
5213412|NCT02661178|Filariasis|filariasis
5213413|NCT02661178|Skin Diseases, Parasitic|skin diseases, parasitic
5213414|NCT02661178|Skin and Connective Tissue Diseases|skin and connective tissue diseases
5213415|NCT02661178|Skin Diseases|skin diseases
5213416|NCT02661178|Skin Diseases, Infectious|skin diseases, infectious
5213417|NCT02661178|Depsipeptides|depsipeptides
5213418|NCT02661178|Emodepside|emodepside
5213419|NCT02661178|Neglected disease|neglected disease
5213420|NCT02661178|Africa|africa
5213421|NCT02661178|New drug|new drug
5213422|NCT02661178|Oral drug|oral drug
5213423|NCT02661178|Parasite|parasite
5213424|NCT02661178|Anthelmintic drug|anthelmintic drug
5213425|NCT02661178|Cyclooctadepsipeptide|cyclooctadepsipeptide
5213426|NCT02661178|Single ascending dose|single ascending dose
5213427|NCT02661178|Volunteers|volunteers
5213428|NCT02661178|Phase 1|phase 1
5213429|NCT02661178|Safety|safety
5213430|NCT02661178|Tolerability|tolerability
5213431|NCT02661178|Pharmacokinetics|pharmacokinetics
5213432|NCT02661178|Relative bioavailability|relative bioavailability
5213433|NCT02661178|Onchocerciasis|onchocerciasis
5213434|NCT02661139|bisphosphonates and/or targeted therapy by monoclonal antibodies|bisphosphonates and/or targeted therapy by monoclonal antibodies
5213435|NCT02661139|jaw reconstruction|jaw reconstruction
5213436|NCT02661139|prosthetic rehabilitation|prosthetic rehabilitation
5213437|NCT02661139|quality of life|quality of life
5213438|NCT02661100|Vaccine|vaccine
5213439|NCT02661100|NY-ESO-1|ny-eso-1
5213440|NCT02661100|DEC-205|dec-205
5213441|NCT02661100|Poly-ICLC|poly-iclc
5213442|NCT02661100|Pembrolizumab|pembrolizumab
5213443|NCT02661100|Cancer|cancer
5213444|NCT02661087|submucosal myoma|submucosal myoma
5213445|NCT02661087|hysteroscopic resection|hysteroscopic resection
5213446|NCT02661087|bipolar energy|bipolar energy
5213447|NCT02661087|monopolar energy|monopolar energy
5213448|NCT02661074|Fisherman|fisherman
5213449|NCT02661074|Fish industry|fish industry
5213450|NCT02661061|ketamine|ketamine
5213451|NCT02661061|glutamate|glutamate
5213452|NCT02661061|relapse prevention|relapse prevention
5213454|NCT02661035|ALL|all
5213455|NCT02661035|CML|cml
5213456|NCT02661035|MDS|mds
5213457|NCT02661035|CLL|cll
5201488|NCT02734693|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
5201489|NCT02734680|Pancreatic cancer|pancreatic cancer
5201490|NCT02734680|Intraoperative radiotherapy(IORT)|intraoperative radiotherapy(iort)
5201491|NCT02734680|Postoperative radiochemotherapy|postoperative radiochemotherapy
5201492|NCT02734654|oxidative stress|oxidative stress
5213459|NCT02661035|NHL|nhl
5213460|NCT02661009|NSCLC|nsclc
5213461|NCT02661009|EGFR|egfr
5213462|NCT02661009|EGFR-TKI|egfr-tki
5213463|NCT02661009|PCR|pcr
5213464|NCT02660970|Iberogast|iberogast
5213465|NCT02660970|Acupressure|acupressure
5213466|NCT02660970|gut-brain-axis|gut-brain-axis
5213476|NCT02660892|Threonine|threonine
5213477|NCT02660892|Children|children
5213478|NCT02660879|Education|education
5213479|NCT02660879|Inhaler|inhaler
5213480|NCT02660866|intermittent claudication|intermittent claudication
5213481|NCT02660866|randomized controlled trial|randomized controlled trial
5213482|NCT02660853|Exacerbations|exacerbations
5213483|NCT02660814|Chemerin|chemerin
5213484|NCT02660814|Interleukin-6|interleukin-6
5213485|NCT02660814|Gingival crevicular fluid|gingival crevicular fluid
5213486|NCT02660801|spinal manipulation|spinal manipulation
5213487|NCT02660801|spinal mobilization|spinal mobilization
5213488|NCT02660801|spinal stiffness|spinal stiffness
5213489|NCT02660788|6-24 months overdue|6-24 months overdue
5213490|NCT02660788|screening mammography|screening mammography
5213491|NCT02660775|schizophrenia|schizophrenia
5213492|NCT02660736|Albiglutide|albiglutide
5213493|NCT02660736|Randomized|randomized
5213494|NCT02660736|Pharmacokinetics|pharmacokinetics
5213495|NCT02660736|GSK716155|gsk716155
5213496|NCT02660736|Bioequivalence study|bioequivalence study
5213497|NCT02660723|M01.774.500|m01.774.500
5213498|NCT02660723|Volunteers|volunteers
5213499|NCT02660710|single arm phase 2|single arm phase 2
5213500|NCT02660710|safety and efficacy|safety and efficacy
5213501|NCT02660710|R-CHOP|r-chop
5213502|NCT02660697|socket preservation, implant site development|socket preservation, implant site development
5213503|NCT02660684|Prograf|prograf
5213504|NCT02660684|Graft versus host disease|graft versus host disease
5213505|NCT02660684|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5213506|NCT02660684|Prophylaxis|prophylaxis
5213507|NCT02660684|Peripheral hematopoietic stem cell transplantation|peripheral hematopoietic stem cell transplantation
5213508|NCT02660645|Cysview|cysview
5213509|NCT02660645|Hexaminolevulinate|hexaminolevulinate
5213510|NCT02660645|Hexvix|hexvix
5213511|NCT02660645|NMIBC|nmibc
5213512|NCT02660645|BLCC|blcc
5213513|NCT02660645|Blue Light Cystoscopy with Cysview|blue light cystoscopy with cysview
5213514|NCT02660645|Cystoscopy|cystoscopy
5213515|NCT02660645|TURBT|turbt
5213516|NCT02660645|TUR|tur
5213517|NCT02660645|Fluorescent cystoscopy|fluorescent cystoscopy
5213518|NCT02660645|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5213519|NCT02660645|Transurethral resection (TUR)|transurethral resection (tur)
5213520|NCT02660593|Diabetes Mellitus|diabetes mellitus
5213521|NCT02660593|Chinese medicine|chinese medicine
5213522|NCT02660593|exercise|exercise
5213523|NCT02660593|diet|diet
5213524|NCT02660580|Adalimumab|adalimumab
5213525|NCT02660580|MSB11022|msb11022
5213526|NCT02660580|Psoriasis|psoriasis
5213527|NCT02660580|Phase III|phase iii
5213528|NCT02660567|postpartum hemorrhage|postpartum hemorrhage
5213529|NCT02660567|PPH|pph
5213530|NCT02660567|atonic|atonic
5213531|NCT02660567|new maneuver|new maneuver
5213532|NCT02660554|Pneumonia|pneumonia
5213533|NCT02660554|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5213534|NCT02660554|Polymerase Chain Reaction|polymerase chain reaction
5213535|NCT02660554|Intensive care units|intensive care units
5213536|NCT02660554|Drug Resistance|drug resistance
5213537|NCT02660541|Dressing for burn wounds|dressing for burn wounds
5213538|NCT02660515|complete articular distal radius fracture|complete articular distal radius fracture
5213539|NCT02660515|wrist arthroscopy|wrist arthroscopy
5213540|NCT02660489|CRTH2 antagonist|crth2 antagonist
5213541|NCT02660489|Prostaglandin D2 receptor|prostaglandin d2 receptor
5213542|NCT02660489|Anti-Asthmatic Agents|anti-asthmatic agents
5213543|NCT02660489|OC459|oc459
5213544|NCT02660489|Allergic asthma|allergic asthma
5213545|NCT02660489|Eosinophilia|eosinophilia
5213549|NCT02660476|Complication|complication
5213550|NCT02660476|Cardiovascular disease|cardiovascular disease
5213551|NCT02660476|Obesity|obesity
5213552|NCT02660476|Stress|stress
5213553|NCT02660476|Obstructive Sleep Apnoea (OSA)|obstructive sleep apnoea (osa)
5213554|NCT02660463|incidence|incidence
5213555|NCT02660463|risk factors|risk factors
5213556|NCT02660437|COPD|copd
5213557|NCT02660437|Carbon dioxide partial pressure (pCO2)|carbon dioxide partial pressure (pco2)
5213558|NCT02660437|Cerebral blood flow (CBF)|cerebral blood flow (cbf)
5213559|NCT02660437|Cognitive dysfunction|cognitive dysfunction
5213560|NCT02660437|Mild/Moderate Cognitive Impairment (MCI)|mild/moderate cognitive impairment (mci)
5213561|NCT02660437|Pulmonary Rehabilitation (PR)|pulmonary rehabilitation (pr)
5962627|NCT04279912|MR-guided Focused Ultrasound|mr-guided focused ultrasound
5213562|NCT02660437|Standardized Mini Mental State Examination (SMMSE)|standardized mini mental state examination (smmse)
5213563|NCT02660437|Addenbrooke's Cognitive Examination (ACE-R)|addenbrooke's cognitive examination (ace-r)
5213564|NCT02660437|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
5213565|NCT02660437|Telephone Interview for Cognitive Status (TICS)|telephone interview for cognitive status (tics)
5213566|NCT02660437|Stroop test (Reaction Time)|stroop test (reaction time)
5213567|NCT02660411|Sevoflurane|sevoflurane
5213568|NCT02660411|Propofol|propofol
5213569|NCT02660411|Aged|aged
5213570|NCT02660411|Neoplasm|neoplasm
5213571|NCT02660411|Surgical Procedure, Operative|surgical procedure, operative
5213572|NCT02660411|Long-term survival|long-term survival
5213573|NCT02660385|pain|pain
5213574|NCT02660385|insomnia|insomnia
5213575|NCT02660385|cardiac failure|cardiac failure
5213576|NCT02660385|sleep|sleep
5213577|NCT02660385|fatigue|fatigue
5213578|NCT02660385|heart disease|heart disease
5213579|NCT02660385|anxiety|anxiety
5213580|NCT02660385|actigraphy|actigraphy
5213581|NCT02660385|psychomotor vigilance|psychomotor vigilance
5213582|NCT02660385|six minute walk|six minute walk
5213583|NCT02660385|depression|depression
5213584|NCT02660385|cognitive behavioral therapy|cognitive behavioral therapy
5213585|NCT02660385|self-management|self-management
5213586|NCT02660385|self-care|self-care
5213587|NCT02660346|IL-10|il-10
5213588|NCT02660346|MRSA|mrsa
5213589|NCT02660346|Bacteremia|bacteremia
5213590|NCT02660333|Obesity|obesity
5213591|NCT02660333|Inflammation|inflammation
5213592|NCT02660333|Nutritional status|nutritional status
5213593|NCT02660333|Prebiotic|prebiotic
5213594|NCT02660333|Synbiotic|synbiotic
5213595|NCT02660307|stress|stress
5213596|NCT02660307|work|work
5213597|NCT02660307|employees|employees
5213598|NCT02660307|mindfulness|mindfulness
5213599|NCT02660307|depression|depression
5213600|NCT02660307|anxiety|anxiety
5213601|NCT02660268|Clinical pathway|clinical pathway
5213602|NCT02660268|Infection|infection
5213604|NCT02660268|Prosthesis|prosthesis
5213605|NCT02660255|CBD|cbd
5213606|NCT02660255|Epidiolex|epidiolex
5213607|NCT02660255|Myoclonic|myoclonic
5213608|NCT02660255|Brain Disease|brain disease
5213609|NCT02660255|Central Nervous System Disease|central nervous system disease
5213610|NCT02660255|GWP42003|gwp42003
5213611|NCT02660242|T1D|t1d
5213612|NCT02660242|Type 1 Diabetes|type 1 diabetes
5213613|NCT02660242|Mini-dose Glucagon|mini-dose glucagon
5213614|NCT02660242|Adults|adults
5213615|NCT02660242|Exercise|exercise
5213616|NCT02660242|Hypoglycemia|hypoglycemia
5213617|NCT02660229|Intravenous injection in cancer pain|intravenous injection in cancer pain
5213618|NCT02660216|minimally invasive|minimally invasive
5213619|NCT02660216|le fort I osteotomy|le fort i osteotomy
5213620|NCT02660216|3D virtual treatment planning|3d virtual treatment planning
5213621|NCT02660216|accuracy|accuracy
5213622|NCT02660203|chest physiotherapy|chest physiotherapy
5213623|NCT02660203|post operative period|post operative period
5213624|NCT02660203|forced expiration|forced expiration
5213625|NCT02660203|pleural drainage duration|pleural drainage duration
5213626|NCT02660164|Concussion|concussion
5213627|NCT02660125|ICSI|icsi
5213628|NCT02660125|endometrial injury|endometrial injury
5213629|NCT02660125|implantation rate|implantation rate
5213630|NCT02660086|Weight|weight
5213631|NCT02660086|Prevention|prevention
5213632|NCT02660086|Food choice|food choice
5213633|NCT02660086|Nutrition|nutrition
5213634|NCT02660086|Behavior change|behavior change
5213635|NCT02660086|Behavioral economics|behavioral economics
5213636|NCT02660086|Feedback|feedback
5213637|NCT02660086|Incentives|incentives
5213638|NCT02660060|Pramipexole|pramipexole
5213639|NCT02660060|Bioequivalence|bioequivalence
5213640|NCT02660060|Pharmacokinetics|pharmacokinetics
5213641|NCT02660047|South Asian descent|south asian descent
5213646|NCT02660021|three-dimensional virtual treatment planning|three-dimensional virtual treatment planning
5213647|NCT02660021|orthognathic surgery|orthognathic surgery
5213648|NCT02659995|glycemic variability|glycemic variability
5213649|NCT02659995|infection|infection
5213650|NCT02659956|Multiple Sclerosis|multiple sclerosis
5213651|NCT02659956|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
5213652|NCT02659943|Gene Therapy|gene therapy
5213653|NCT02659943|Adoptive T Cell Therapy|adoptive t cell therapy
5213654|NCT02659943|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5213655|NCT02659943|T-cell infusion|t-cell infusion
5213656|NCT02659943|Residual Malignancy|residual malignancy
5213658|NCT02659930|AIDS|aids
5213659|NCT02659930|Multicentric Castleman Disease|multicentric castleman disease
5213660|NCT02659917|glass-ionomer cement|glass-ionomer cement
5213661|NCT02659917|atraumatic restorative treatment|atraumatic restorative treatment
5213662|NCT02659917|pit and fissure sealants|pit and fissure sealants
5213663|NCT02659904|Free gingival graft|free gingival graft
5213666|NCT02659852|Hilar malignant biliary obstruction|hilar malignant biliary obstruction
5213667|NCT02659852|bilateral metal stent|bilateral metal stent
5213669|NCT02659852|side by side|side by side
5213670|NCT02659839|Cancer|cancer
5213671|NCT02659839|Intensive care unit|intensive care unit
5213672|NCT02659839|Mortality|mortality
5213673|NCT02659826|Transcutaneous spinal direct current stimulation|transcutaneous spinal direct current stimulation
5213674|NCT02659826|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5213675|NCT02659826|Gait Training|gait training
5213676|NCT02659826|Central Nervous System Excitability|central nervous system excitability
5213677|NCT02659826|Healthy|healthy
5213678|NCT02659813|Orthodontic wires|orthodontic wires
5213679|NCT02659774|Smoking cessation interventions|smoking cessation interventions
5213680|NCT02659761|Human Immunodeficiency Virus|human immunodeficiency virus
5213681|NCT02659761|Injection drug use|injection drug use
5213682|NCT02659761|Single-tablet antiretroviral treatment|single-tablet antiretroviral treatment
5213683|NCT02659761|Dolutegravir|dolutegravir
5213684|NCT02659761|Tolerability|tolerability
5213685|NCT02659761|Adherence|adherence
5213686|NCT02659761|Efficacy|efficacy
5213687|NCT02659748|Bioactive fatty acids|bioactive fatty acids
5213688|NCT02659748|Insulin sensitivity|insulin sensitivity
5213689|NCT02659748|Diet|diet
5213690|NCT02659748|Milk fat|milk fat
5213691|NCT02659748|Lipid metabolism|lipid metabolism
5213692|NCT02659748|Inflammation markers|inflammation markers
5213693|NCT02659748|Fecal microbiota composition|fecal microbiota composition
5213694|NCT02659735|Influenza A virus|influenza a virus
5213695|NCT02659735|JNJ-63623872|jnj-63623872
5213696|NCT02659735|Healthy|healthy
5213697|NCT02659722|INTERVERTEBRAL DISC DEGENERATION|intervertebral disc degeneration
5213698|NCT02659722|Bone Disease|bone disease
5213699|NCT02659722|Musculoskeletal disease|musculoskeletal disease
5213700|NCT02659722|Spinal disease|spinal disease
5213701|NCT02659709|Glaucoma|glaucoma
5213702|NCT02659709|Smartphone|smartphone
5213703|NCT02659709|Tablet|tablet
5213704|NCT02659709|Application|application
5213705|NCT02659709|Eye Drops|eye drops
5213706|NCT02659631|P-cadherin|p-cadherin
5213707|NCT02659631|PF-06671008|pf-06671008
5213708|NCT02659631|solid tumors|solid tumors
5213709|NCT02659631|lung cancer|lung cancer
5213710|NCT02659631|breast cancer|breast cancer
5213711|NCT02659631|colorectal cancer|colorectal cancer
5213712|NCT02659631|NSCLC|nsclc
5213713|NCT02659631|TNBC|tnbc
5213715|NCT02659631|neoplasms|neoplasms
5213716|NCT02659631|Triple negative breast cancer|triple negative breast cancer
5213717|NCT02659631|Non-small cell lung cancer|non-small cell lung cancer
5213718|NCT02659618|Asthma|asthma
5213719|NCT02659605|pre-term birth|pre-term birth
5213720|NCT02659605|delayed cord clamping|delayed cord clamping
5213721|NCT02659605|skin to skin|skin to skin
5213722|NCT02659592|fertility preservation|fertility preservation
5213723|NCT02659592|ovarian tissue transplantation|ovarian tissue transplantation
5213724|NCT02659592|ovarian endocrine function|ovarian endocrine function
5213725|NCT02659592|assisted reproductive technology|assisted reproductive technology
5213726|NCT02659592|pregnancy and live birth|pregnancy and live birth
5213727|NCT02659579|Shared Book Reading|shared book reading
5213728|NCT02659579|Vocabulary|vocabulary
5213729|NCT02659579|Language Development|language development
5213730|NCT02659579|Young Children|young children
5213731|NCT02659579|Randomised Control Trial|randomised control trial
5213732|NCT02659566|Markers|markers
5213733|NCT02659566|Parasitemia|parasitemia
5213734|NCT02659566|Coartem|coartem
5213735|NCT02659566|Plasmodium|plasmodium
5213736|NCT02659566|Infection|infection
5213737|NCT02659553|Liver Transplantation - Steatosis - Fatty Liver|liver transplantation - steatosis - fatty liver
5213738|NCT02659540|Ipilimumab|ipilimumab
5213739|NCT02659540|Nivolumab|nivolumab
5213740|NCT02659540|Radiotherapy|radiotherapy
5213745|NCT02659501|Breast reconstruction|breast reconstruction
5213746|NCT02659501|Bupivacaine|bupivacaine
5213747|NCT02659501|Liposomal bupivacaine|liposomal bupivacaine
5213748|NCT02659501|Postoperative analgesia|postoperative analgesia
5201778|NCT02733042|Ibrutinib|ibrutinib
5201779|NCT02733042|Lymphoma, B-Cell|lymphoma, b-cell
5213749|NCT02659462|Repaired Congenital Heart Disease|repaired congenital heart disease
5213750|NCT02659462|Cardio Pulmonary Exercise Testing|cardio pulmonary exercise testing
5213751|NCT02659462|Fontan|fontan
5213752|NCT02659462|Fontan Palliation|fontan palliation
5213753|NCT02659462|functional capacity|functional capacity
5213754|NCT02659449|hands|hands
5213755|NCT02659436|Cognitive Behavioural Therapy|cognitive behavioural therapy
5213756|NCT02659423|Bystanding behaviors|bystanding behaviors
5213757|NCT02659423|Campus|campus
5213758|NCT02659423|Prevention|prevention
5213759|NCT02659423|Sexual Assault|sexual assault
5213760|NCT02659423|CampusSave|campussave
5213761|NCT02659410|Physiologically based pharmacokinetic modeling|physiologically based pharmacokinetic modeling
5213762|NCT02659410|Organic solvents|organic solvents
5213763|NCT02659397|LDL-cholesterol|ldl-cholesterol
5213764|NCT02659397|Hypercholesterolemia|hypercholesterolemia
5213765|NCT02659397|ETC-1002|etc-1002
5213766|NCT02659397|Adenosine triphosphate citrate lyase|adenosine triphosphate citrate lyase
5213767|NCT02659397|Atorvastatin|atorvastatin
5213768|NCT02659358|Advanced solid malignancy|advanced solid malignancy
5213769|NCT02659358|Activity monitor|activity monitor
5213770|NCT02659358|Biosensor|biosensor
5213774|NCT02659358|Performance Status|performance status
5213775|NCT02659358|Eastern Cooperative Oncology Group Performance Status (ECOG-PS)|eastern cooperative oncology group performance status (ecog-ps)
5213777|NCT02659345|Chemotherapy|chemotherapy
5213778|NCT02659319|Child overweight|child overweight
5213779|NCT02659319|Child obesity|child obesity
5213780|NCT02659319|Family dynamics|family dynamics
5213781|NCT02659319|Peer relationships|peer relationships
5213782|NCT02659319|Family intervention|family intervention
5213783|NCT02659319|School intervention|school intervention
5213784|NCT02659319|Parenting|parenting
5213785|NCT02659293|Multiple myeloma|multiple myeloma
5213786|NCT02659293|stem-cell transplant|stem-cell transplant
5213787|NCT02659293|Symptomatic myeloma|symptomatic myeloma
5213788|NCT02659293|lenalidomide|lenalidomide
5213789|NCT02659293|carfilzomib|carfilzomib
5213790|NCT02659293|dexamethasone|dexamethasone
5213791|NCT02659280|telerehabilitation|telerehabilitation
5213792|NCT02659267|Health Promotion|health promotion
5213793|NCT02659267|Physical Activity|physical activity
5213794|NCT02659267|Eating habits|eating habits
5213795|NCT02659267|Health System|health system
5213796|NCT02659267|Users from Health Academy Program|users from health academy program
5213797|NCT02659254|Drug-Eluting Stents,Absorbable Implants,Stents|drug-eluting stents,absorbable implants,stents
5213798|NCT02659215|Hyaluronic Acid|hyaluronic acid
5213799|NCT02659215|Cartilage Repair|cartilage repair
5213800|NCT02659215|Knee|knee
5213801|NCT02659202|Exercise|exercise
5213802|NCT02659202|Heart Failure|heart failure
5213803|NCT02659202|Blood Pressure|blood pressure
5213804|NCT02659163|cardiometabolic risk|cardiometabolic risk
5213805|NCT02659163|obesity|obesity
5213806|NCT02659163|mHealth|mhealth
5213807|NCT02659163|health behaviors|health behaviors
5213808|NCT02659150|tocilizumab|tocilizumab
5213809|NCT02659150|subcutaneous injection|subcutaneous injection
5213810|NCT02659150|rheumatoid arthritis|rheumatoid arthritis
5213811|NCT02659150|plaque inflammation|plaque inflammation
5213812|NCT02659150|atherosclerotic plaque|atherosclerotic plaque
5213813|NCT02659150|joint inflammation|joint inflammation
5213814|NCT02659150|FDG-PET|fdg-pet
5213815|NCT02659150|PET-MR|pet-mr
5213816|NCT02659150|ACTEMRA|actemra
5213817|NCT02659137|LBBB|lbbb
5213818|NCT02659137|TAVI|tavi
5213819|NCT02659124|facial laser|facial laser
5213820|NCT02659124|fraction ablative resurfacing|fraction ablative resurfacing
5213821|NCT02659124|total ablative resurfacing|total ablative resurfacing
5213822|NCT02659124|EpiFix|epifix
5213823|NCT02659124|rhytides|rhytides
5213824|NCT02659124|wrinkles|wrinkles
5213825|NCT02659124|AmnioFix|amniofix
5213826|NCT02659111|Exercise Therapy|exercise therapy
5213827|NCT02659098|Best Corrected Visual Acuity|best corrected visual acuity
5213828|NCT02659098|Geographic Atrophy|geographic atrophy
5213829|NCT02659098|Macular Degeneration|macular degeneration
5213830|NCT02659098|CNTO 2476|cnto 2476
5213831|NCT02659085|Depressive Disorder, Major|depressive disorder, major
5213832|NCT02659085|Antidepressive Agents/adverse effects|antidepressive agents/adverse effects
5214134|NCT02657486|15-090|15-090
5213833|NCT02659085|Depressive Disorder, Major/drug therapy|depressive disorder, major/drug therapy
5213834|NCT02659085|Infusions, Intravenous|infusions, intravenous
5213835|NCT02659085|Ketamine/administration & dosage*|ketamine/administration & dosage*
5213836|NCT02659085|Ketamine/adverse effects|ketamine/adverse effects
5213837|NCT02659085|Treatment Outcome|treatment outcome
5213838|NCT02659085|Electroconvulsive therapy|electroconvulsive therapy
5213839|NCT02659046|Traumatic Brain Injury|traumatic brain injury
5213840|NCT02659033|microbiota|microbiota
5213841|NCT02659033|resistant bacteria|resistant bacteria
5213842|NCT02659007|yoga|yoga
5213843|NCT02659007|balance|balance
5213844|NCT02658968|Radioimmunotherapy|radioimmunotherapy
5213845|NCT02658968|Lu-177|lu-177
5213846|NCT02658968|Phase I study|phase i study
5213847|NCT02658968|Betalutin|betalutin
5213848|NCT02658968|ARC|arc
5213849|NCT02658968|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
5213850|NCT02658968|HH1|hh1
5213851|NCT02658968|Rituximab|rituximab
5213852|NCT02658968|177Lu-DOTA-HH1|177lu-dota-hh1
5213853|NCT02658968|Lilotomab|lilotomab
5213854|NCT02658968|Lutetium (177Lu)-lilotomab satetraxetan|lutetium (177lu)-lilotomab satetraxetan
5674155|NCT00604773|risk factors|risk factors
5213855|NCT02658968|Additional relevant MeSH terms:|additional relevant mesh terms:
5213856|NCT02658968|Lymphoma|lymphoma
5213857|NCT02658968|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5213858|NCT02658968|Immune System Diseases|immune system diseases
5213859|NCT02658968|Immunoproliferative Disorders|immunoproliferative disorders
5213860|NCT02658968|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5213861|NCT02658968|Lymphatic Diseases|lymphatic diseases
5213862|NCT02658968|Lymphoproliferative Disorders|lymphoproliferative disorders
5213863|NCT02658968|Neoplasms|neoplasms
5213864|NCT02658968|Neoplasms by Histologic Type|neoplasms by histologic type
5213866|NCT02658968|Refractory DLBCL|refractory dlbcl
5213867|NCT02658968|Relapsed DLBCL|relapsed dlbcl
5213868|NCT02658955|Abdominal wall closure|abdominal wall closure
5213869|NCT02658942|renal stones|renal stones
5213870|NCT02658942|lower calyx|lower calyx
5213871|NCT02658942|Ureteroscopy|ureteroscopy
5213872|NCT02658942|Shockwave lithotripsy|shockwave lithotripsy
5213873|NCT02658942|Holmium laser|holmium laser
5213874|NCT02658942|Adult|adult
5213875|NCT02658942|Kidney|kidney
5213876|NCT02658929|Multiple Myeloma|multiple myeloma
5213877|NCT02658929|Efficacy and Safety|efficacy and safety
5213878|NCT02658929|bb2121|bb2121
5213879|NCT02658929|CAR T Cell|car t cell
5213880|NCT02658929|BCMA|bcma
5213881|NCT02658903|Foley|foley
5213882|NCT02658903|Infection|infection
5213883|NCT02658903|Hospital acquired|hospital acquired
5213884|NCT02658903|catheter associated|catheter associated
5213885|NCT02658903|urinary|urinary
5213886|NCT02658877|Xolair|xolair
5213887|NCT02658877|corticosteroids|corticosteroids
5213888|NCT02658877|asthma|asthma
5213889|NCT02658877|long-acting beta-agonists|long-acting beta-agonists
5213890|NCT02658864|lafutidine tablet|lafutidine tablet
5213891|NCT02658864|pharmacokinetics|pharmacokinetics
5213892|NCT02658864|food|food
5213893|NCT02658864|safety|safety
5213894|NCT02658864|healthy subjects|healthy subjects
5213895|NCT02658851|lymphocele|lymphocele
5213896|NCT02658851|pelvic lymph node dissection|pelvic lymph node dissection
5213897|NCT02658851|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
5213898|NCT02658851|PLND|plnd
5213899|NCT02658851|RARP|rarp
5213900|NCT02658851|prostatectomy|prostatectomy
5213901|NCT02658851|Patel|patel
5213902|NCT02658825|Healthy|healthy
5213903|NCT02658825|JNJ-63623872|jnj-63623872
5213904|NCT02658825|Moxifloxacin|moxifloxacin
5213905|NCT02658799|periodontitis|periodontitis
5213906|NCT02658799|anti-inflammatory agents|anti-inflammatory agents
5213907|NCT02658760|Femoral Fractures|femoral fractures
5213908|NCT02658721|Systemic Tramadol|systemic tramadol
5213909|NCT02658721|Adjunct Tramadol|adjunct tramadol
5213910|NCT02658721|Lidocain|lidocain
5213911|NCT02658695|ICSI|icsi
5213912|NCT02658695|embryo transfer|embryo transfer
5213913|NCT02658695|air bubbles depth|air bubbles depth
5213914|NCT02658669|Insomnia|insomnia
5213915|NCT02658669|Injury, Brain, Traumatic Mild|injury, brain, traumatic mild
5213916|NCT02658656|Exoskeleton|exoskeleton
5213917|NCT02658643|biliodigestive anastomosis techniques|biliodigestive anastomosis techniques
5213918|NCT02658630|arm rehabilitation|arm rehabilitation
5213919|NCT02658630|recovery of function|recovery of function
5213920|NCT02658617|Empathy|empathy
5213921|NCT02658617|Interoceptive Awareness|interoceptive awareness
5213922|NCT02658617|fMRI|fmri
5213923|NCT02658617|MRS|mrs
5213924|NCT02658591|Food intake|food intake
5213925|NCT02658591|Satiety|satiety
5213926|NCT02658591|Appetite|appetite
5213927|NCT02658591|Glycemia|glycemia
5213928|NCT02658591|Faba bean|faba bean
5213929|NCT02658591|Protein|protein
5213930|NCT02658591|Snack|snack
5213931|NCT02658565|Intraoperative Consultation|intraoperative consultation
5213932|NCT02658552|HIFU|hifu
5213933|NCT02658552|Benign thyroid nodule|benign thyroid nodule
5213934|NCT02658552|Low risk|low risk
5213935|NCT02658552|New treatment|new treatment
5214536|NCT02655016|HRD|hrd
5213936|NCT02658539|Body fat distribution|body fat distribution
5213937|NCT02658539|Bone mineral density|bone mineral density
5213938|NCT02658539|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5213939|NCT02658526|cognition|cognition
5213940|NCT02658526|anesthesia|anesthesia
5201969|NCT02731976|Gluten-Free diet|gluten-free diet
5201970|NCT02731976|Healthy individuals|healthy individuals
5201971|NCT02731963|Outcomes|outcomes
5201972|NCT02731963|Bowel preparation|bowel preparation
5201973|NCT02731950|Sternotomy , cardiac surgery , pain|sternotomy , cardiac surgery , pain
5201974|NCT02731924|Appendicitis|appendicitis
5201975|NCT02731924|Ultrasound|ultrasound
5213941|NCT02658526|surgery|surgery
5213942|NCT02658526|stress|stress
5213943|NCT02658526|child|child
5213944|NCT02658500|early infant feeding|early infant feeding
5213945|NCT02658500|infant intestinal flora|infant intestinal flora
5213946|NCT02658500|infant health|infant health
5213947|NCT02658474|Chronic pain|chronic pain
5213948|NCT02658474|Acceptance and Commitment Therapy|acceptance and commitment therapy
5213949|NCT02658474|Multidisciplinary treatment|multidisciplinary treatment
5213950|NCT02658474|Group treatment|group treatment
5213951|NCT02658435|Malaria|malaria
5213952|NCT02658435|Retinal|retinal
5213953|NCT02658435|Ophthalmic|ophthalmic
5213954|NCT02658435|Plasmodium. vivax|plasmodium. vivax
5213955|NCT02658435|Tafenoquine|tafenoquine
5213956|NCT02658435|Pharmacodynamic|pharmacodynamic
5213957|NCT02658409|CCIV|cciv
5213958|NCT02658409|quadrivalent cell-culture based influenza vaccine|quadrivalent cell-culture based influenza vaccine
5213959|NCT02658409|Influenza vaccine|influenza vaccine
5213969|NCT02658344|adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
5213970|NCT02658344|osteoarthritis|osteoarthritis
5962628|NCT04279873|Nosocomial, Pneumonia|nosocomial, pneumonia
5091769|NCT03425058|CTC|ctc
5213971|NCT02658344|degenerative arthritis|degenerative arthritis
5213972|NCT02658344|biostar|biostar
5213973|NCT02658344|Rbio|rbio
5213974|NCT02658331|Ebola Virus Disease|ebola virus disease
5213975|NCT02658331|Rapid Diagnosis|rapid diagnosis
5213976|NCT02658331|Point of care|point of care
5213977|NCT02658331|Molecular platform|molecular platform
5213978|NCT02658318|peri- and postoperative complications|peri- and postoperative complications
5213979|NCT02658318|airway obstruction|airway obstruction
5213980|NCT02658318|adapted Furlow palatoplasty|adapted furlow palatoplasty
5213981|NCT02658305|transoral approach|transoral approach
5213982|NCT02658305|transbuccal approach|transbuccal approach
5213983|NCT02658305|postoperative complications|postoperative complications
5213984|NCT02658292|fungus|fungus
5213985|NCT02658292|antifungal|antifungal
5213986|NCT02658292|skin infection|skin infection
5213987|NCT02658292|hair infection|hair infection
5213988|NCT02658292|dermatophyte|dermatophyte
5213989|NCT02658292|scalp|scalp
5213990|NCT02658292|skin|skin
5213991|NCT02658292|eyebrows|eyebrows
5213992|NCT02658292|eyelashes|eyelashes
5213993|NCT02658292|hair|hair
5213994|NCT02658292|Trichophyton|trichophyton
5213995|NCT02658292|Microsporum|microsporum
5213996|NCT02658292|Endothrix|endothrix
5213997|NCT02658292|spores|spores
5213998|NCT02658279|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
5213999|NCT02658279|15-227|15-227
5214000|NCT02658279|Hypermutator Phenotype|hypermutator phenotype
5214001|NCT02658266|resistance training|resistance training
5214002|NCT02658266|adult|adult
5214003|NCT02658266|muscle strength|muscle strength
5214004|NCT02658266|muscle endurance|muscle endurance
5214005|NCT02658266|muscle metabolism|muscle metabolism
5214006|NCT02658253|Placental malaria vaccine|placental malaria vaccine
5214007|NCT02658253|Plasmodium|plasmodium
5214008|NCT02658253|PRIMALVAC|primalvac
5214009|NCT02658240|Nerve block|nerve block
5214010|NCT02658240|Periarticular infiltration|periarticular infiltration
5214011|NCT02658240|Ropivacaine|ropivacaine
5214012|NCT02658240|Pain|pain
5214013|NCT02658214|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic|durvalumab, tremelimumab, metastatic, solid tumors, immuno-oncology, first-line chemotherapy, esophageal, pancreatic
5214014|NCT02658188|Restless legs syndrome patients|restless legs syndrome patients
5214015|NCT02658188|ASP8825|asp8825
5214017|NCT02658110|Postprandial glycemia|postprandial glycemia
5214018|NCT02658110|Metabolic health measures|metabolic health measures
5214019|NCT02658097|Lung Cancer|lung cancer
5214020|NCT02658097|pembrolizumab|pembrolizumab
5214021|NCT02658097|focal radiation|focal radiation
5214023|NCT02658084|HER2-Positive|her2-positive
5214024|NCT02658084|Metastatic Breast Cancer|metastatic breast cancer
5214025|NCT02658071|exfoliative glaucoma|exfoliative glaucoma
5214026|NCT02658071|cataract|cataract
5214027|NCT02658071|ocular pressure|ocular pressure
5214028|NCT02658058|Ultrasound|ultrasound
5214029|NCT02658058|Spinal anesthesia|spinal anesthesia
5214030|NCT02658058|Elderly|elderly
5214031|NCT02658058|Landmark|landmark
5214032|NCT02658045|oxygen saturation|oxygen saturation
5214033|NCT02658045|monitoring|monitoring
5214034|NCT02658045|oximeter|oximeter
5214035|NCT02658019|Hepatocellular Carcinoma|hepatocellular carcinoma
5214036|NCT02658019|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5214037|NCT02658019|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5214038|NCT02658006|Near Infrared Spectroscopy|near infrared spectroscopy
5214039|NCT02658006|Ultrasonography|ultrasonography
5214040|NCT02658006|Hepatic vein Doppler|hepatic vein doppler
5214041|NCT02658006|Portal vein Doppler|portal vein doppler
5214042|NCT02658006|Lung ultrasound|lung ultrasound
5214043|NCT02658006|Positive fluid balance|positive fluid balance
5214044|NCT02658006|Mixed venous saturation|mixed venous saturation
5214045|NCT02657993|Breast Neoplasms|breast neoplasms
5214046|NCT02657993|Aromatase Inhibitors|aromatase inhibitors
5214047|NCT02657993|Musculoskeletal Pain|musculoskeletal pain
5214048|NCT02657993|Hypnosis|hypnosis
5211063|NCT02675894|RFA|rfa
5214049|NCT02657993|Medication Adherence|medication adherence
5214050|NCT02657993|Cost-Benefit Analysis|cost-benefit analysis
5214051|NCT02657993|Treatment Outcomes|treatment outcomes
5214052|NCT02657980|Major Depressive Disorder|major depressive disorder
5214053|NCT02657980|tDCS|tdcs
5214055|NCT02657980|transcranial Direct Current Stimulation|transcranial direct current stimulation
5214056|NCT02657954|Homeless persons|homeless persons
5214057|NCT02657954|Veterans|veterans
5214058|NCT02657954|Mental disorders|mental disorders
5214059|NCT02657954|Cognition|cognition
5214060|NCT02657954|Rehabilitation|rehabilitation
5214061|NCT02657941|Schizophrenia|schizophrenia
5214062|NCT02657941|Obesity|obesity
5214063|NCT02657941|Metabolic Syndrome|metabolic syndrome
5962629|NCT04279873|Diagnostics|diagnostics
5214064|NCT02657915|FF-VEP|ff-vep
5214065|NCT02657915|mfVEP|mfvep
5214066|NCT02657915|Human anti-LINGO-1|human anti-lingo-1
5214067|NCT02657915|BIIB033|biib033
5214068|NCT02657915|AON|aon
5214069|NCT02657889|PARP inhibitor|parp inhibitor
5214070|NCT02657889|PD-1|pd-1
5091900|NCT03424395|metabolism|metabolism
5214071|NCT02657889|Niraparib|niraparib
5214072|NCT02657889|Pembrolizumab|pembrolizumab
5214073|NCT02657889|Keynote|keynote
5214074|NCT02657889|TOPACIO|topacio
5214075|NCT02657837|CF|cf
5214076|NCT02657837|Multiple Breath Washout|multiple breath washout
5214077|NCT02657837|Lung Clearance Index|lung clearance index
5214078|NCT02657837|Pediatrics|pediatrics
5214079|NCT02657824|Ejection fraction|ejection fraction
5214080|NCT02657824|mitral valve|mitral valve
5214081|NCT02657824|e-point septal separation|e-point septal separation
5214082|NCT02657811|Time-Lapse Imaging|time-lapse imaging
5214083|NCT02657811|Embryo Culture Techniques|embryo culture techniques
5214084|NCT02657811|Fertilization in Vitro|fertilization in vitro
5214085|NCT02657811|Embryology|embryology
5214086|NCT02657811|Assisted Reproductive Techniques|assisted reproductive techniques
5214087|NCT02657811|Infertility|infertility
5214088|NCT02657811|Preimplantation diagnosis|preimplantation diagnosis
5214089|NCT02657772|Target Ultra coils|target ultra coils
5214090|NCT02657772|small aneurysms|small aneurysms
5214091|NCT02657746|blood pressure monitoring|blood pressure monitoring
5214092|NCT02657746|high blood pressure|high blood pressure
5214093|NCT02657746|cardiovascular disease|cardiovascular disease
5214094|NCT02657746|Antihypertensive agents|antihypertensive agents
5214095|NCT02657746|Non-pharmacological treatment|non-pharmacological treatment
5214096|NCT02657746|community health care workers|community health care workers
5214097|NCT02657746|cost-effectiveness|cost-effectiveness
5214098|NCT02657733|Respiratory Conditions for Adults|respiratory conditions for adults
5214099|NCT02657720|Respiratory Conditions for Adults|respiratory conditions for adults
5214100|NCT02657707|stent|stent
5214101|NCT02657707|stenosis|stenosis
5214102|NCT02657707|artery|artery
5214103|NCT02657707|carotid|carotid
5214104|NCT02657668|Irritable Bowel Syndrome|irritable bowel syndrome
5214105|NCT02657668|Emotion Focused Therapy|emotion focused therapy
5214106|NCT02657668|Stress|stress
5214107|NCT02657668|Resilience|resilience
5214108|NCT02657668|Coping Strategies|coping strategies
5214109|NCT02657655|Parkinson's Disease|parkinson's disease
5214110|NCT02657655|Dyskinesia|dyskinesia
5214111|NCT02657655|Tremor|tremor
5214112|NCT02657655|Symptom Management|symptom management
5214113|NCT02657655|Technology|technology
5214114|NCT02657655|Wearable Sensors|wearable sensors
5214115|NCT02657655|Continuous Monitoring|continuous monitoring
5214116|NCT02657655|Mobility|mobility
5214117|NCT02657642|drug related problems, elderly|drug related problems, elderly
5214118|NCT02657603|Peripheral Nerve Blocks|peripheral nerve blocks
5214119|NCT02657577|Women|women
5214120|NCT02657577|Infants and Children|infants and children
5214121|NCT02657551|Thyroid Cancer|thyroid cancer
5214122|NCT02657538|Interproximal caries|interproximal caries
5214123|NCT02657538|Enamel caries|enamel caries
5202174|NCT02730676|craving|craving
5214124|NCT02657538|Caries detection|caries detection
5214125|NCT02657538|Caries diagnostics|caries diagnostics
5214126|NCT02657538|Near-infrared light transillumination|near-infrared light transillumination
5214127|NCT02657538|DIAGNOcam|diagnocam
5214128|NCT02657512|Rivaroxaban, pharmacokinetics, activated charcoal, poisoning|rivaroxaban, pharmacokinetics, activated charcoal, poisoning
5214129|NCT02657499|healthcare access|healthcare access
5214130|NCT02657499|utilization|utilization
5214131|NCT02657499|expenditures|expenditures
5214132|NCT02657499|preventive services|preventive services
5214133|NCT02657486|BGJ398|bgj398
5214135|NCT02657460|chemotherapy|chemotherapy
5214136|NCT02657460|microparticle|microparticle
5214137|NCT02657460|malignant pleural effusion|malignant pleural effusion
5214138|NCT02657447|Radioimmunotherapy|radioimmunotherapy
5214139|NCT02657447|Lu-177|lu-177
5214140|NCT02657447|Phase I study|phase i study
5214141|NCT02657447|Betalutin|betalutin
5214142|NCT02657447|ARC|arc
5214143|NCT02657447|Antibody Radionuclide Conjugate|antibody radionuclide conjugate
5214144|NCT02657447|HH1|hh1
5214145|NCT02657447|Rituximab|rituximab
5214146|NCT02657447|177Lu-DOTA-HH1|177lu-dota-hh1
5214147|NCT02657447|Lymphoma|lymphoma
5214148|NCT02657447|Lymphoma Non-Hodgkin|lymphoma non-hodgkin
5214149|NCT02657447|Immune System Diseases|immune system diseases
5106517|NCT03332069|cervix|cervix
5862849|NCT00001483|Sertraline|sertraline
5214152|NCT02657447|Lymphoplasmacytoid|lymphoplasmacytoid
5214153|NCT02657447|Lymphatic Diseases|lymphatic diseases
5214154|NCT02657447|Lymphoproliferative Disorders|lymphoproliferative disorders
5214155|NCT02657447|Neoplasms|neoplasms
5214156|NCT02657447|Neoplasms by Histological Type|neoplasms by histological type
5214157|NCT02657447|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5214158|NCT02657447|Classical Mantle Cell Lymphoma|classical mantle cell lymphoma
5214159|NCT02657447|Lilotomab|lilotomab
5214160|NCT02657447|Lutetium (177Lu) lilotomab satetraxetan|lutetium (177lu) lilotomab satetraxetan
5214161|NCT02657382|Biofeedback|biofeedback
5214162|NCT02657382|Myocardial Imaging|myocardial imaging
5214163|NCT02657369|Lenvatinib|lenvatinib
5214164|NCT02657369|Thyroid Cancer, Anaplastic|thyroid cancer, anaplastic
5962630|NCT04279873|16s|16s
5214165|NCT02657369|Lenvima|lenvima
5214166|NCT02657369|E7080|e7080
5962631|NCT04279873|18s|18s
5214167|NCT02657356|Pulmonary Hypertension|pulmonary hypertension
5214168|NCT02657356|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5214169|NCT02657356|Connective Tissue Disease-Associated Pulmonary Arterial Hypertension|connective tissue disease-associated pulmonary arterial hypertension
5214170|NCT02657356|Bardoxolone methyl|bardoxolone methyl
5214171|NCT02657356|PAH|pah
5214172|NCT02657356|RTA 402|rta 402
5214173|NCT02657356|6-minute walk distance|6-minute walk distance
5214174|NCT02657343|Breast Cancer With Positive HER2|breast cancer with positive her2
5214175|NCT02657330|Locally Advanced|locally advanced
5214176|NCT02657330|Metastatic|metastatic
5214177|NCT02657317|chronic pain|chronic pain
5214178|NCT02657317|pain management|pain management
5214179|NCT02657317|trauma|trauma
5214180|NCT02657317|ptsd|ptsd
5214181|NCT02657317|tbi|tbi
5214182|NCT02657317|opioid medication|opioid medication
5214183|NCT02657304|Sleep Apnea|sleep apnea
5214184|NCT02657304|CPAP|cpap
5214185|NCT02657278|Peripheral arterial disease,|peripheral arterial disease,
5214186|NCT02657278|Cardipulmonary Exercise Test|cardipulmonary exercise test
5214187|NCT02657252|telangiectasis|telangiectasis
5214188|NCT02657252|varicose veins|varicose veins
5214189|NCT02657252|veins|veins
5214190|NCT02657252|glucose|glucose
5214191|NCT02657252|sclerotherapy|sclerotherapy
5214192|NCT02657239|Physical Function|physical function
5214193|NCT02657213|Diabetes, Type 1|diabetes, type 1
5214194|NCT02657213|Hypoglycemia|hypoglycemia
5214195|NCT02657213|Insulin Infusion Systems|insulin infusion systems
5214196|NCT02657200|miscarriage|miscarriage
5214197|NCT02657200|Flanders|flanders
5214198|NCT02657200|spontaneous abortion|spontaneous abortion
5214199|NCT02657200|KAP|kap
5214200|NCT02657200|midwives|midwives
5214201|NCT02657174|third molar|third molar
5214202|NCT02657174|auriculotherapy|auriculotherapy
5214203|NCT02657174|inflammation|inflammation
5214204|NCT02657174|pain|pain
5214205|NCT02657122|Single ascending dose|single ascending dose
5214206|NCT02657122|SAD|sad
5214207|NCT02657122|multiple ascending dose|multiple ascending dose
5214208|NCT02657122|MAD|mad
5214209|NCT02657122|Phase 1|phase 1
5214210|NCT02657122|first-in-human|first-in-human
5214211|NCT02657122|volunteers|volunteers
5214212|NCT02657122|TD-1473|td-1473
5214213|NCT02657109|valve replacement|valve replacement
5214214|NCT02657109|physical therapy|physical therapy
5214215|NCT02657109|early mobilization|early mobilization
5214216|NCT02657096|Chronic Periodontitis|chronic periodontitis
5214217|NCT02657096|Hybenx|hybenx
5214218|NCT02657096|Desiccant agent|desiccant agent
5214219|NCT02657096|Healing|healing
5214220|NCT02657096|Microbiology|microbiology
5214221|NCT02657096|Periodontal Diseases|periodontal diseases
5214222|NCT02657096|Periodontitis|periodontitis
5202292|NCT02729987|CBT|cbt
5214223|NCT02657096|Split-mouth clinical Study|split-mouth clinical study
5214224|NCT02657070|Stroke|stroke
5214225|NCT02657070|learned non-use|learned non-use
5214226|NCT02657070|Virtual Reality|virtual reality
5214227|NCT02657070|Hemiparesis|hemiparesis
5214228|NCT02657057|neuromodulation|neuromodulation
5214229|NCT02657057|electrical estimulation|electrical estimulation
5214230|NCT02657057|percutaneous|percutaneous
5214231|NCT02657057|transcutaneous|transcutaneous
5214232|NCT02657057|OAB|oab
5214233|NCT02657044|EMR|emr
5214234|NCT02657044|ESD|esd
5214235|NCT02657044|endoscopic mucosal resection|endoscopic mucosal resection
5214236|NCT02657044|endoscopic submucosal resection|endoscopic submucosal resection
5214237|NCT02657044|colorectal adenomas|colorectal adenomas
5214238|NCT02657031|Headache, Migraine|headache, migraine
5214239|NCT02656992|Bronchiectasis|bronchiectasis
5214240|NCT02656992|High-intensity inspiratory muscle training|high-intensity inspiratory muscle training
5214241|NCT02656979|Glaucoma|glaucoma
5214242|NCT02656979|Blood flow|blood flow
5214243|NCT02656979|Pseudoexfoliation|pseudoexfoliation
5214244|NCT02656979|Intraocular pressure|intraocular pressure
5214245|NCT02656979|Brain perfusion|brain perfusion
5214246|NCT02656979|Magnetic Resonance Imaging|magnetic resonance imaging
5214247|NCT02656953|VDU workers|vdu workers
5211256|NCT02674763|CD33|cd33
5214249|NCT02656953|Neck complaints|neck complaints
5214250|NCT02656953|Visual complaints|visual complaints
5214252|NCT02656940|lipids|lipids
5214253|NCT02656940|energy expenditure|energy expenditure
5214254|NCT02656940|gene expression|gene expression
5214255|NCT02656927|Spinal Cord Injury|spinal cord injury
5214256|NCT02656927|Yoga|yoga
5214259|NCT02656927|Pain|pain
5214260|NCT02656849|Solid Tumor|solid tumor
5214261|NCT02656823|ANKYLOS|ankylos
5214262|NCT02656823|Simplant|simplant
5214263|NCT02656823|maxilla|maxilla
5214264|NCT02656823|edentulous|edentulous
5214265|NCT02656823|short implants|short implants
5214266|NCT02656797|Leishmania major|leishmania major
5214267|NCT02656797|Leishmania tropica|leishmania tropica
5214268|NCT02656797|Amphotericin B|amphotericin b
5214272|NCT02656745|Smoking|smoking
5214273|NCT02656745|Cigarette Smoking|cigarette smoking
5214274|NCT02656745|Tobacco Smoking|tobacco smoking
5214275|NCT02656745|Nicotine|nicotine
5214276|NCT02656745|Drug|drug
5214277|NCT02656745|Addiction|addiction
5214278|NCT02656745|Tobacco|tobacco
5214279|NCT02656719|tracheostomy|tracheostomy
5214280|NCT02656719|complications|complications
5214281|NCT02656719|ultrasound|ultrasound
5214282|NCT02656719|bronchoscopy|bronchoscopy
5214283|NCT02656706|Adjuvant melanoma|adjuvant melanoma
5214284|NCT02656706|Advanced melanoma|advanced melanoma
5214285|NCT02656693|Weight Reduction Programs|weight reduction programs
5214286|NCT02656693|Weight Loss Programs|weight loss programs
5214287|NCT02656693|Obesity|obesity
5214288|NCT02656667|COPD pulmonary rehabilitation|copd pulmonary rehabilitation
5214289|NCT02656667|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5214290|NCT02656667|sit to stand test COPD|sit to stand test copd
5214291|NCT02656667|quadriceps strengthening|quadriceps strengthening
5214292|NCT02656602|Computer Assisted Instruction|computer assisted instruction
5214293|NCT02656602|Patient Counselling|patient counselling
5214294|NCT02656602|Endoscopy|endoscopy
5214295|NCT02656589|breast cancer|breast cancer
5214296|NCT02656589|herceptin|herceptin
5214297|NCT02656589|microRNA|microrna
5214298|NCT02656576|Human Papillomavirus|human papillomavirus
5214299|NCT02656576|oropharynx biopsy|oropharynx biopsy
5214300|NCT02656576|tonsillar lesion|tonsillar lesion
5214301|NCT02656550|Uterine Transplant|uterine transplant
5214302|NCT02656550|AUI|aui
5214303|NCT02656550|Rokitansky Syndrome|rokitansky syndrome
5214304|NCT02656524|Metastatic colorectal cancer|metastatic colorectal cancer
5214305|NCT02656511|immediate antiretroviral therapy|immediate antiretroviral therapy
5214306|NCT02656511|hyperacute infection|hyperacute infection
5214307|NCT02656498|Tau, neurodegeneration, positron emission computed tomography|tau, neurodegeneration, positron emission computed tomography
5214308|NCT02656472|Pediatric Cardiac surgery|pediatric cardiac surgery
5214309|NCT02656472|Inflammatory response|inflammatory response
5214310|NCT02656472|Tranexamic acid|tranexamic acid
5214311|NCT02656472|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
5214312|NCT02656459|gene expression|gene expression
5214313|NCT02656446|Neuraxial|neuraxial
5214314|NCT02656446|Ultrasound|ultrasound
5214315|NCT02656433|QEEG|qeeg
5214316|NCT02656433|ERP|erp
5214317|NCT02656433|tRNS|trns
5214318|NCT02656433|Brain injury|brain injury
5214319|NCT02656433|Motor Impairment|motor impairment
5214320|NCT02656433|Transcranial Brain non-invasive stimulation|transcranial brain non-invasive stimulation
5214321|NCT02656433|electroencephalogram|electroencephalogram
5214322|NCT02656407|Functional Ultrasound|functional ultrasound
5214323|NCT02656407|Intraoperative|intraoperative
5214324|NCT02656407|Brain|brain
5214325|NCT02656407|Doppler|doppler
5214326|NCT02656407|Ultrasound|ultrasound
5214327|NCT02656394|ocular surface disease|ocular surface disease
5286657|NCT02238925|MDS|mds
5202368|NCT02729389|Hispanics|hispanics
5202369|NCT02729389|Energy Balance|energy balance
5202370|NCT02729389|Stress|stress
5202371|NCT02729376|Healthy Volunteers|healthy volunteers
5202377|NCT02729324|nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5202378|NCT02729324|radiation dermatitis|radiation dermatitis
5202379|NCT02729324|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5202380|NCT02729311|exercise|exercise
5202381|NCT02729311|function|function
5202382|NCT02729311|quality of life|quality of life
5202383|NCT02729311|caregiver|caregiver
5202384|NCT02729298|Tolero|tolero
5202385|NCT02729298|Phase 1a / 1b|phase 1a / 1b
5202386|NCT02729298|First in human|first in human
5202387|NCT02729298|Solid Tumors with immunotherapy progression|solid tumors with immunotherapy progression
5202388|NCT02729298|AXL inhibitor|axl inhibitor
5202389|NCT02729298|Advanced Malignancy|advanced malignancy
5202390|NCT02729298|Cancer|cancer
5202392|NCT02729298|BRAF-Mutated CRC|braf-mutated crc
5214328|NCT02656394|glaucoma medications|glaucoma medications
5214329|NCT02656381|Sarcoidosis|sarcoidosis
5214330|NCT02656381|Behcet's Disease|behcet's disease
5214331|NCT02656381|Natural History Study|natural history study
5214332|NCT02656381|Biological Specimens|biological specimens
5214333|NCT02656381|Immune System|immune system
5214353|NCT02656238|CTEPH|cteph
5214354|NCT02656238|Balloon pulmonary angioplasty|balloon pulmonary angioplasty
5214355|NCT02656238|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5214356|NCT02656238|Pulmonary endarterectomy|pulmonary endarterectomy
5214358|NCT02656238|PEA|pea
5214359|NCT02656225|postpartum anemia|postpartum anemia
5214360|NCT02656225|hemoglobin|hemoglobin
5214361|NCT02656225|iron metabolism|iron metabolism
5214362|NCT02656225|Traditional Chinese Medicine|traditional chinese medicine
5214363|NCT02656225|Ejiao|ejiao
5214364|NCT02656212|epicatechin|epicatechin
5214365|NCT02656212|pre-diabetes|pre-diabetes
5214366|NCT02656199|Diaphragm|diaphragm
5214367|NCT02656199|Ventilators, Mechanical|ventilators, mechanical
5214368|NCT02656173|Tamsulosin|tamsulosin
5214369|NCT02656173|Overactive bladder|overactive bladder
5214370|NCT02656173|Benign prostatic hypertrophy|benign prostatic hypertrophy
5214371|NCT02656173|Mirabegron|mirabegron
5214372|NCT02656147|Leukemia|leukemia
5214373|NCT02656147|Lymphoma|lymphoma
5214374|NCT02656147|CAR γδT|car γδt
5214375|NCT02656134|Familial Adenomatous Polyposis|familial adenomatous polyposis
5214376|NCT02656121|PCOS, vitamin D|pcos, vitamin d
5214377|NCT02656082|Discoid lupus erythematosus|discoid lupus erythematosus
5214378|NCT02656082|Intradermal injection of etanercept|intradermal injection of etanercept
5214379|NCT02656017|kidney disease|kidney disease
5214380|NCT02656017|polycystic kidney disease|polycystic kidney disease
5214381|NCT02656017|autosomal dominant kidney disease|autosomal dominant kidney disease
5214382|NCT02656017|kidney cysts|kidney cysts
5214383|NCT02656017|PKD|pkd
5214384|NCT02656004|Eucalyptus|eucalyptus
5214385|NCT02656004|Autonomic nervous system|autonomic nervous system
5214386|NCT02656004|Isometric resistance exercise|isometric resistance exercise
5214387|NCT02655991|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5214388|NCT02655991|Ambulatory Care|ambulatory care
5214389|NCT02655991|Telemedicine|telemedicine
5214390|NCT02655991|Remote Consultation|remote consultation
5214391|NCT02655991|Health Services Accessibility|health services accessibility
5214392|NCT02655965|Breast cancer|breast cancer
5214393|NCT02655965|lumpectomy|lumpectomy
5214394|NCT02655965|mastectomy|mastectomy
5214395|NCT02655965|PECS bloc|pecs bloc
5214396|NCT02655939|Gonarthrosis|gonarthrosis
5214397|NCT02655926|OCD|ocd
5214398|NCT02655926|DBS|dbs
5214399|NCT02655926|Deep Brain Stimulation|deep brain stimulation
5214400|NCT02655913|Sodium ascorbate|sodium ascorbate
5214401|NCT02655913|Non-Small-Cell Lung cancer|non-small-cell lung cancer
5214402|NCT02655913|Oncothermia|oncothermia
5214404|NCT02655913|Life quality|life quality
5214405|NCT02655913|Tumor marker|tumor marker
5214406|NCT02655913|Survival time|survival time
5214407|NCT02655900|Obstetric anal sphincter injury,|obstetric anal sphincter injury,
5214408|NCT02655900|Ultrasound diagnosis|ultrasound diagnosis
5214409|NCT02655887|Vernacular|vernacular
5214410|NCT02655887|Iliofemoral Occlusive Disease|iliofemoral occlusive disease
5214411|NCT02655874|Seasonal Influenza|seasonal influenza
5214412|NCT02655874|Antibody response|antibody response
5214413|NCT02655874|Influenza Vaccines|influenza vaccines
5214414|NCT02655874|Hemagglutination Inhibition|hemagglutination inhibition
5214415|NCT02655874|Elderly|elderly
5214416|NCT02655874|immunosenescence|immunosenescence
5214417|NCT02655874|Tropics|tropics
5214418|NCT02655848|Popeye|popeye
5214419|NCT02655848|Long Head Biceps Tendon|long head biceps tendon
5214420|NCT02655848|Arthroscopy|arthroscopy
5214421|NCT02655848|Functional result|functional result
5214422|NCT02655835|mindfulness|mindfulness
5214423|NCT02655835|meditation|meditation
5214424|NCT02655835|internet|internet
5214425|NCT02655822|RCC|rcc
5214426|NCT02655822|Kidney Cancer|kidney cancer
5214427|NCT02655822|mCRPC|mcrpc
5214428|NCT02655822|Prostate Cancer|prostate cancer
5214429|NCT02655796|Accidental Falls|accidental falls
5214430|NCT02655796|Risk Assessment|risk assessment
5214431|NCT02655796|Frail Elderly|frail elderly
5214432|NCT02655783|induction of labor|induction of labor
5214433|NCT02655744|Neurobehavioral Assessment|neurobehavioral assessment
5214434|NCT02655744|Radiotherapy (RT)|radiotherapy (rt)
5214435|NCT02655744|Chemotherapy|chemotherapy
5214436|NCT02655744|Neurotoxicity|neurotoxicity
5214437|NCT02655718|ACS|acs
5214438|NCT02655718|Non obstructive coronary atherosclerosis|non obstructive coronary atherosclerosis
5214439|NCT02655705|Cyclosporine|cyclosporine
5214440|NCT02655705|Methotrexate|methotrexate
5214441|NCT02655692|PTSD|ptsd
5214442|NCT02655692|Ketamine|ketamine
5214443|NCT02655692|Veteran|veteran
5214444|NCT02655692|Military|military
5214445|NCT02655692|Clinical Trial|clinical trial
5214446|NCT02655679|Eczema|eczema
5214447|NCT02655640|illness perceptions|illness perceptions
5214448|NCT02655627|Type 2 DM|type 2 dm
5214449|NCT02655627|internet based exercise training|internet based exercise training
5214450|NCT02655627|group exercise training|group exercise training
5214451|NCT02655627|glycemic control|glycemic control
5214458|NCT02655484|noninvasive ventilation|noninvasive ventilation
5214459|NCT02655484|exercise|exercise
5214460|NCT02655484|CO2 rebreathing|co2 rebreathing
5214461|NCT02655458|Multiple Myeloma|multiple myeloma
5214462|NCT02655458|Induction Therapy|induction therapy
5214463|NCT02655458|Autologous Stem Cell Transplant|autologous stem cell transplant
5214464|NCT02655458|ASCT|asct
5214465|NCT02655458|Auto-SCT|auto-sct
5214466|NCT02655419|cIAIs in hospitalized adults|ciais in hospitalized adults
5214467|NCT02655406|Foam sclerotherapy|foam sclerotherapy
5214468|NCT02655406|Compression|compression
5214469|NCT02655367|MRI|mri
5214470|NCT02655367|oats|oats
5214471|NCT02655367|porridge|porridge
5214472|NCT02655367|satiety|satiety
5214473|NCT02655367|GI hormones|gi hormones
5214474|NCT02655367|processing|processing
5214475|NCT02655341|Dehydration|dehydration
5214476|NCT02655341|Primary PCI|primary pci
5214477|NCT02655341|Acute Myocardial Infarction|acute myocardial infarction
5214478|NCT02655341|Bioimpedance|bioimpedance
5214479|NCT02655341|Renal Angiography|renal angiography
5214480|NCT02655328|asthma|asthma
5214481|NCT02655328|athlete|athlete
5214482|NCT02655315|Parkinson|parkinson
5092366|NCT03421522|PPSP|ppsp
5092367|NCT03421522|ICBN|icbn
5092368|NCT03421509|cutaneous silent period|cutaneous silent period
5092369|NCT03421509|spasticity|spasticity
5092370|NCT03421509|stroke|stroke
5092371|NCT03421483|Folate|folate
5092372|NCT03421483|Absorption|absorption
5092373|NCT03421483|Metabolism|metabolism
5214483|NCT02655315|Deferiprone|deferiprone
5214484|NCT02655315|Chelation|chelation
5214485|NCT02655302|Interleukin-17|interleukin-17
5214486|NCT02655302|Interleukin-22|interleukin-22
5214487|NCT02655302|Microbiota|microbiota
5214488|NCT02655302|Exacerbations|exacerbations
5214489|NCT02655302|Immunity|immunity
5214490|NCT02655302|Mucosal|mucosal
5214491|NCT02655276|microencapsulated glycine|microencapsulated glycine
5214492|NCT02655276|attentional performance|attentional performance
5214493|NCT02655276|motoric activity|motoric activity
5214494|NCT02655276|hyperactivity|hyperactivity
5214495|NCT02655237|Drug Therapy|drug therapy
5214496|NCT02655224|Drug Therapy|drug therapy
5214497|NCT02655198|refractory childhood epilepsy|refractory childhood epilepsy
5214498|NCT02655198|Lennox Gastaut syndrome|lennox gastaut syndrome
5214499|NCT02655198|fenfluramine|fenfluramine
5214500|NCT02655198|anti-epileptic treatment|anti-epileptic treatment
5214501|NCT02655185|Lipids|lipids
5214502|NCT02655185|Atrial Fibrillation|atrial fibrillation
5214503|NCT02655185|Heart Failure|heart failure
5214504|NCT02655172|Schizophrenia, affordance,|schizophrenia, affordance,
5214505|NCT02655172|perception-action binding,|perception-action binding,
5214506|NCT02655172|stimulus-response-compatibility|stimulus-response-compatibility
5214507|NCT02655159|Breast Cancer|breast cancer
5214508|NCT02655159|Metastatic breast cancer|metastatic breast cancer
5214509|NCT02655159|nab-paclitaxel|nab-paclitaxel
5214510|NCT02655159|Abraxane|abraxane
5214511|NCT02655159|Observational|observational
5214513|NCT02655159|AMBER|amber
5214514|NCT02655146|Frozen embryo transfer,luteal support, GnRHa|frozen embryo transfer,luteal support, gnrha
5214515|NCT02655120|Femoral head necrosis|femoral head necrosis
5214516|NCT02655120|Autologous Bone Marrow|autologous bone marrow
5214517|NCT02655120|BMP7|bmp7
5214518|NCT02655107|blood gas monitoring|blood gas monitoring
5214519|NCT02655107|non-invasive|non-invasive
5214520|NCT02655107|hemoglobin|hemoglobin
5214521|NCT02655094|minimal-invasive surgery, mitral valve|minimal-invasive surgery, mitral valve
5214522|NCT02655081|Urinary diversion|urinary diversion
5214523|NCT02655081|Bladder Neoplasm|bladder neoplasm
5214524|NCT02655081|Nutritional Supplement|nutritional supplement
5214525|NCT02655081|Cystectomy|cystectomy
5214526|NCT02655068|Head and Neck Cancer|head and neck cancer
5214527|NCT02655068|Definitive Therapy|definitive therapy
5214528|NCT02655068|Positron Emission Tomography - Computed Tomography (PET/CT)|positron emission tomography - computed tomography (pet/ct)
5214529|NCT02655068|Computed Tomography (CT)|computed tomography (ct)
5214530|NCT02655055|apheresis|apheresis
5214531|NCT02655055|citrate anticoagulation|citrate anticoagulation
5214532|NCT02655055|blood donor|blood donor
5214533|NCT02655055|bone|bone
5214534|NCT02655016|Ovarian Cancer|ovarian cancer
5214535|NCT02655016|PARP Inhibitor|parp inhibitor
5214537|NCT02655016|HRD positive|hrd positive
5214538|NCT02655016|PRIMA|prima
5214539|NCT02655016|PRIMA Clinical Trial|prima clinical trial
5214540|NCT02655016|PRIMA Study|prima study
5214541|NCT02655003|behavioral symptoms|behavioral symptoms
5214542|NCT02655003|psychological symptoms|psychological symptoms
5214543|NCT02655003|dementia|dementia
5214544|NCT02655003|neuropsychiatric symptoms|neuropsychiatric symptoms
5214551|NCT02654951|Stroke|stroke
5214552|NCT02654951|Rehabilitation Robotics|rehabilitation robotics
5214553|NCT02654951|Bimanual|bimanual
5214554|NCT02654951|Compensatory movements|compensatory movements
5214555|NCT02654951|Hemiplegia|hemiplegia
5214556|NCT02654951|Kinematics|kinematics
5214557|NCT02654951|Reaching|reaching
5214558|NCT02654951|Trunk|trunk
5214559|NCT02654938|prostate cancer|prostate cancer
5214560|NCT02654938|adenovirus|adenovirus
5214561|NCT02654938|TLR5|tlr5
5214562|NCT02654938|immunotherapy|immunotherapy
5214563|NCT02654912|malaria|malaria
5214564|NCT02654912|elimination|elimination
5214565|NCT02654912|surveillance and response|surveillance and response
5214566|NCT02654912|dihydroartemisinin+piperaquine|dihydroartemisinin+piperaquine
5214567|NCT02654899|Healthy subjects|healthy subjects
5214568|NCT02654899|Single Ascending Dose|single ascending dose
5214569|NCT02654899|Hyperlipidemia|hyperlipidemia
5214570|NCT02654899|Dyslipidemia|dyslipidemia
5214571|NCT02654886|exercise|exercise
5214572|NCT02654886|Pompe disease|pompe disease
5214573|NCT02654886|Pompe|pompe
5214574|NCT02654873|histopathology|histopathology
5214575|NCT02654873|gallbladder|gallbladder
5214576|NCT02654873|specimen|specimen
5962632|NCT04279873|PCR|pcr
5962633|NCT04279873|Next Generation Sequencing|next generation sequencing
5962634|NCT04279847|Myelofibrosis|myelofibrosis
5962635|NCT04279847|BET protein inhibitor|bet protein inhibitor
5962636|NCT04279847|relapsed primary myelofibrosis|relapsed primary myelofibrosis
5962637|NCT04279847|refractory primary myelofibrosis|refractory primary myelofibrosis
5962638|NCT04279847|secondary myelofibrosis|secondary myelofibrosis
5962639|NCT04279847|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
5214577|NCT02654847|vasopressor|vasopressor
5214578|NCT02654847|blood pressure|blood pressure
5214579|NCT02654847|Cesarean section|cesarean section
5214580|NCT02654847|spinal anesthesia|spinal anesthesia
5214581|NCT02654821|Melanoma|melanoma
5214582|NCT02654821|TCR|tcr
5214583|NCT02654808|Gynecology|gynecology
5214584|NCT02654808|Laparoscopy|laparoscopy
5214585|NCT02654808|Pneumoperitoneum|pneumoperitoneum
5214586|NCT02654808|CO2 absorption|co2 absorption
5214587|NCT02654782|Lactated Ringer's|lactated ringer's
5214588|NCT02654782|Human Albumin|human albumin
5214589|NCT02654756|Risk Assessment|risk assessment
5214590|NCT02654704|Personalized Medicine|personalized medicine
5214591|NCT02654704|Precision Medicine|precision medicine
5214592|NCT02654691|Chemotherapy|chemotherapy
5214593|NCT02654639|Metastatic Colorectal Cancer|metastatic colorectal cancer
5214594|NCT02654639|Advanced Colorectal Cancer|advanced colorectal cancer
5214595|NCT02654600|cardiac surgery|cardiac surgery
5214596|NCT02654600|thoracopulmonary compliance|thoracopulmonary compliance
5214597|NCT02654587|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5214598|NCT02654587|NSCLC|nsclc
5214599|NCT02654587|Immunotherapy|immunotherapy
5214600|NCT02654587|Cancer vaccine|cancer vaccine
5214601|NCT02654587|Metastasis|metastasis
5214602|NCT02654574|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
5214603|NCT02654574|Functional autonomy level|functional autonomy level
5214604|NCT02654574|Lawton Instrumental Activities of Daily Living|lawton instrumental activities of daily living
5214605|NCT02654574|The Functional autonomy level|the functional autonomy level
5214606|NCT02654561|Severe sepsis|severe sepsis
5214607|NCT02654561|Disseminated intravascular coagulation|disseminated intravascular coagulation
5214608|NCT02654561|Unfractionated heparin|unfractionated heparin
5214609|NCT02654535|Systematic review and meta-analysis|systematic review and meta-analysis
5214610|NCT02654535|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5214611|NCT02654535|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5214612|NCT02654535|Clinical practice guidelines|clinical practice guidelines
5214613|NCT02654535|Clinical trials|clinical trials
5214614|NCT02654535|Tree Nuts|tree nuts
5214615|NCT02654535|Peanuts|peanuts
5214617|NCT02654535|Prospective cohort studies|prospective cohort studies
5214618|NCT02654496|Gut Microbiota|gut microbiota
5214619|NCT02654496|Weight Regain|weight regain
5214620|NCT02654496|Gastric Bypass|gastric bypass
5214621|NCT02654457|Immunohistochemical|immunohistochemical
5214622|NCT02654457|Ki-67|ki-67
5214623|NCT02654457|Breast cancer|breast cancer
5214624|NCT02654457|IHC|ihc
5214625|NCT02654444|Immunohistochemical (IHC)|immunohistochemical (ihc)
5214626|NCT02654444|Her2/Neu|her2/neu
5214627|NCT02654444|Breast cancer|breast cancer
5214628|NCT02654431|Immunohistochemical (IHC)|immunohistochemical (ihc)
5214629|NCT02654431|ER/PR|er/pr
5214630|NCT02654431|Breast cancer|breast cancer
5214631|NCT02654418|colonic polyps ≥20 mm,|colonic polyps ≥20 mm,
5214632|NCT02654418|adenomas|adenomas
5214633|NCT02654418|polyps|polyps
5214634|NCT02654405|HDAC inhibitors|hdac inhibitors
5214635|NCT02654405|Inflammation|inflammation
5214636|NCT02654392|Omega-3|omega-3
5214637|NCT02654392|Omega-6|omega-6
5214738|NCT02653872|Diltiazem|diltiazem
5214638|NCT02654392|Exercise Performance|exercise performance
5214639|NCT02654366|Syringe exchange|syringe exchange
5214640|NCT02654366|HIV risk reduction|hiv risk reduction
5214641|NCT02654366|Drug-free community support|drug-free community support
5445364|NCT01522157|Low-carbohydrate|low-carbohydrate
5214642|NCT02654353|Persistent atrial fibrillation, catheter ablation, outcome|persistent atrial fibrillation, catheter ablation, outcome
5214643|NCT02654340|Tuberous sclerosis complex|tuberous sclerosis complex
5214644|NCT02654340|Biomarker|biomarker
5214645|NCT02654327|Extracorporeal|extracorporeal
5214646|NCT02654327|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5214647|NCT02654327|Protective Lung Ventilation|protective lung ventilation
5674156|NCT00604773|prediction|prediction
5214648|NCT02654327|Ventilator Induced Lung Injury|ventilator induced lung injury
5214649|NCT02654327|Carbon Dioxide Removal|carbon dioxide removal
5214650|NCT02654327|Lung|lung
5214651|NCT02654327|Lung Injury|lung injury
5214652|NCT02654314|prevention; delirium; in-patients; melatonin,|prevention; delirium; in-patients; melatonin,
5214653|NCT02654301|Xylose|xylose
5214654|NCT02654301|prediabetes|prediabetes
5214655|NCT02654301|postprandial hyperglycemia|postprandial hyperglycemia
5214656|NCT02654301|glucose|glucose
5214657|NCT02654288|pancreatic cancer|pancreatic cancer
5214658|NCT02654288|gemcitabine|gemcitabine
5214659|NCT02654288|chemotherapy|chemotherapy
5214660|NCT02654288|immunoglobulin G 4|immunoglobulin g 4
5214661|NCT02654249|Hemorrhoids grade III and IV|hemorrhoids grade iii and iv
5214662|NCT02654249|transanal hemorrhoidal dearterialization|transanal hemorrhoidal dearterialization
5214663|NCT02654249|hemorroidectomy|hemorroidectomy
5214665|NCT02654249|LigaSure|ligasure
5214666|NCT02654223|Rhinitis / Rhinoconjunctivitis|rhinitis / rhinoconjunctivitis
5214667|NCT02654223|Vaccine|vaccine
5214668|NCT02654223|Immunotherapy|immunotherapy
5214669|NCT02654223|Grass pollen|grass pollen
5214670|NCT02654223|Allergy|allergy
5214671|NCT02654210|birth cohort|birth cohort
5214672|NCT02654210|infectious diseases|infectious diseases
5214673|NCT02654210|microbiome|microbiome
5214674|NCT02654210|immune system|immune system
5214675|NCT02654210|immune response|immune response
5214676|NCT02654184|Right lateral|right lateral
5214677|NCT02654184|Induction|induction
5214678|NCT02654184|Children|children
5214679|NCT02654184|Anesthesia|anesthesia
5214680|NCT02654171|RSV|rsv
5214681|NCT02654171|AK0529|ak0529
5214682|NCT02654158|acute upper respiratory infection|acute upper respiratory infection
5214683|NCT02654145|mepolizumab|mepolizumab
5214684|NCT02654145|Omalizumab|omalizumab
5214685|NCT02654145|SGRQ|sgrq
5214686|NCT02654145|severe eosinophilic asthma|severe eosinophilic asthma
5214687|NCT02654145|ACQ|acq
5214688|NCT02654145|exacerbations|exacerbations
5214689|NCT02654106|multiple brain metastases|multiple brain metastases
5214690|NCT02654106|large brain metastases|large brain metastases
5287146|NCT02236650|Parents|parents
5214691|NCT02654106|meningeal metastases|meningeal metastases
5214692|NCT02654106|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
5214693|NCT02654106|temozolomide|temozolomide
5214694|NCT02654054|Elagolix|elagolix
5214695|NCT02654054|Elagolix Sodium|elagolix sodium
5214696|NCT02654054|Heavy Uterine Bleeding|heavy uterine bleeding
5214697|NCT02654054|Heavy Menstrual Bleeding|heavy menstrual bleeding
5214698|NCT02654054|Leiomyomata|leiomyomata
5214699|NCT02654054|Menorrhagia|menorrhagia
5214700|NCT02654054|ABT-620|abt-620
5214701|NCT02654054|Elagolix + E2/NETA|elagolix + e2/neta
5214702|NCT02654054|Elagolix + Norethindrone Acetate|elagolix + norethindrone acetate
5214703|NCT02654054|HMB|hmb
5214704|NCT02654015|intracranial hemorrhage|intracranial hemorrhage
5214705|NCT02654015|neurosurgery|neurosurgery
5214706|NCT02653963|Steroid, Triamcinolone, Ahmed Glaucoma valve|steroid, triamcinolone, ahmed glaucoma valve
5214707|NCT02653937|IBS|ibs
5214708|NCT02653937|MUPS|mups
5214709|NCT02653937|FSS|fss
5214710|NCT02653937|shigyakusan|shigyakusan
5214711|NCT02653937|Katsumi's points|katsumi's points
5214712|NCT02653937|Nakatani's N line|nakatani's n line
5214713|NCT02653924|Suture|suture
5214714|NCT02653924|bacteria|bacteria
5214717|NCT02653898|Antimalarials|antimalarials
5214718|NCT02653898|Malaria Elimination|malaria elimination
5214719|NCT02653898|Mass Drug Administration|mass drug administration
5214720|NCT02653898|Malaria Prophylaxis|malaria prophylaxis
5214721|NCT02653898|Mobile population|mobile population
5214722|NCT02653898|Drug resistance|drug resistance
5214723|NCT02653898|Focused screening and treatment|focused screening and treatment
5214724|NCT02653898|Monthly Malaria Prophylaxis|monthly malaria prophylaxis
5214725|NCT02653898|Mass screening and treatment|mass screening and treatment
5214726|NCT02653898|Primaquine|primaquine
5214727|NCT02653898|Malaria transmission|malaria transmission
5214728|NCT02653898|Permethrin insecticide|permethrin insecticide
5214729|NCT02653898|Thai-Cambodian border|thai-cambodian border
5214730|NCT02653898|Cambodia|cambodia
5214731|NCT02653898|AFRIMS|afrims
5214732|NCT02653885|cardiac surgery|cardiac surgery
5214733|NCT02653885|open heart surgery|open heart surgery
5214734|NCT02653885|hemogram|hemogram
5214735|NCT02653872|Non-randomized|non-randomized
5214736|NCT02653872|Verapamil|verapamil
5214737|NCT02653872|Itraconazole|itraconazole
5214740|NCT02653872|Tolerability|tolerability
5214741|NCT02653872|Pharmacokinetics|pharmacokinetics
5214742|NCT02653859|CTC|ctc
5214743|NCT02653859|PCR|pcr
5214744|NCT02653833|Becker|becker
5214745|NCT02653833|Muscular Dystrophy|muscular dystrophy
5214746|NCT02653833|Skeletal Muscle|skeletal muscle
5214747|NCT02653833|blood flow|blood flow
5214748|NCT02653833|Ultrasound|ultrasound
5214749|NCT02653807|manual therapy|manual therapy
5214750|NCT02653807|osteopathy|osteopathy
5214751|NCT02653807|mobilization with movement|mobilization with movement
5214753|NCT02653807|stiffness|stiffness
5214754|NCT02653794|Juvenile Subjects'characteristics|juvenile subjects'characteristics
5214755|NCT02653768|Osteoarthritis, Knee|osteoarthritis, knee
5214756|NCT02653768|Exercise|exercise
5214757|NCT02653755|Breast Cancer Radiation|breast cancer radiation
5214758|NCT02653755|Radiotherapy for Favorable-Risk Breast cancer|radiotherapy for favorable-risk breast cancer
5214759|NCT02653755|Radiotherapy Omission|radiotherapy omission
5214760|NCT02653729|cognitive behaviour therapy|cognitive behaviour therapy
5214761|NCT02653729|first episode|first episode
5214762|NCT02653716|New Orleans Intervention Model|new orleans intervention model
5214763|NCT02653716|Case Management|case management
5214764|NCT02653716|Maltreatment|maltreatment
5214765|NCT02653716|Child|child
5214766|NCT02653664|Chronic Pain|chronic pain
5214767|NCT02653664|Sleep|sleep
5214768|NCT02653651|Ketamine|ketamine
5214769|NCT02653651|Lidocaine|lidocaine
5214770|NCT02653651|Nephrectomy|nephrectomy
5214771|NCT02653651|Chronic pain|chronic pain
5214772|NCT02653638|Cerebral Vasodilator Function|cerebral vasodilator function
5214773|NCT02653638|White Matter Hyperintensity Volume|white matter hyperintensity volume
5214774|NCT02653638|Default Mode Network Connectivity|default mode network connectivity
5214775|NCT02653638|Cognitive Function|cognitive function
5214776|NCT02653638|Cardiorespiratory Fitness|cardiorespiratory fitness
5214777|NCT02653638|Aging|aging
5214778|NCT02653625|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5214779|NCT02653612|surgery|surgery
5214780|NCT02653612|folate receptor|folate receptor
5214781|NCT02653586|resilience|resilience
5214782|NCT02653586|prevention program|prevention program
5214783|NCT02653586|body image|body image
5214784|NCT02653586|self esteem|self esteem
5214785|NCT02653573|young adult|young adult
5214786|NCT02653560|Potassium|potassium
5214787|NCT02653560|Magnesium|magnesium
5214788|NCT02653560|Citrate|citrate
5214789|NCT02653560|DASH|dash
5214790|NCT02653547|tinnitus|tinnitus
5214791|NCT02653547|transcranial random noise stimulation|transcranial random noise stimulation
5214792|NCT02653547|rTMS|rtms
5214793|NCT02653547|multisite stimulation|multisite stimulation
5214794|NCT02653547|non-invasive brain stimulation|non-invasive brain stimulation
5214795|NCT02653534|Kangaroo Mother Care in community|kangaroo mother care in community
5214796|NCT02653534|mortality|mortality
5214797|NCT02653521|Esophageal Cancer|esophageal cancer
5214798|NCT02653521|Adaptive Radiation Therapy|adaptive radiation therapy
5214799|NCT02653508|BMI: Body Mass Index|bmi: body mass index
5214800|NCT02653508|obesity|obesity
5214801|NCT02653508|adolescents|adolescents
5214802|NCT02653508|overweight|overweight
5214803|NCT02653508|CI:confidence interval|ci:confidence interval
5214804|NCT02653508|CDC: Center Disease Control|cdc: center disease control
5214805|NCT02653482|heart failure|heart failure
5214806|NCT02653482|dapagliflozin|dapagliflozin
5214807|NCT02653482|SGLT-2 inhibitors|sglt-2 inhibitors
5214808|NCT02653456|excimer laser|excimer laser
5214809|NCT02653456|percutaneous catheter|percutaneous catheter
5214810|NCT02653456|photoablation|photoablation
5214811|NCT02653456|chronic total occlusion|chronic total occlusion
5214812|NCT02653456|symptomatic infrainguinal lower extremity vascular disease|symptomatic infrainguinal lower extremity vascular disease
5214813|NCT02653443|INTERCEPT|intercept
5214814|NCT02653443|Platelet|platelet
5214815|NCT02653443|Pathogen Inactivation|pathogen inactivation
5214816|NCT02653443|Platelets Components Stored|platelets components stored
5214817|NCT02653443|Therapeutic Efficacy|therapeutic efficacy
5214819|NCT02653430|BMI|bmi
5214820|NCT02653430|efficacy|efficacy
5214821|NCT02653430|bariatric surgery|bariatric surgery
5214822|NCT02653430|gut flora|gut flora
5214823|NCT02653430|fMRI|fmri
5214824|NCT02653391|Fuchs' Corneal Endothelial Dystrophy|fuchs' corneal endothelial dystrophy
5214825|NCT02653391|FCED|fced
5214826|NCT02653391|Ocuvia™|ocuvia™
5214827|NCT02653391|MTP-131|mtp-131
5214828|NCT02653352|randomized controlled trials|randomized controlled trials
5214829|NCT02653352|soft drinks|soft drinks
5214830|NCT02653352|hypercholesterolemia|hypercholesterolemia
5214831|NCT02653352|serum cholesterol|serum cholesterol
5214832|NCT02653352|blood glucose|blood glucose
5214833|NCT02653352|overweight|overweight
5214834|NCT02653352|carbonated beverages|carbonated beverages
5214835|NCT02653339|traditional Chinese medicine|traditional chinese medicine
5214836|NCT02653339|Loratadine|loratadine
5214837|NCT02653339|questionnaire survey|questionnaire survey
5214838|NCT02653326|Tertiary Prevention|tertiary prevention
5214840|NCT02653287|Fatigue, Physical Activity, Lupus|fatigue, physical activity, lupus
5214841|NCT02653274|MRI|mri
5214842|NCT02653274|blood glucose|blood glucose
5214843|NCT02653274|satiety|satiety
5214844|NCT02653274|breakfast|breakfast
5214845|NCT02653274|porridge|porridge
5214846|NCT02653274|grains|grains
5214847|NCT02653261|tranexamic acid|tranexamic acid
5214848|NCT02653261|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5214849|NCT02653261|Transurethral Resection of a Bladder Tumor (TURBT)|transurethral resection of a bladder tumor (turbt)
5214851|NCT02653261|Blood Transfusion|blood transfusion
5214852|NCT02653222|Ethanol Sympathicolysis|ethanol sympathicolysis
5214853|NCT02653222|Computer Tomography guidance|computer tomography guidance
5214854|NCT02653222|Denervation|denervation
5214855|NCT02653222|Kidney Transplantation|kidney transplantation
5214856|NCT02653222|Dialysis|dialysis
5214857|NCT02653209|Type 2 diabetes|type 2 diabetes
5214858|NCT02653209|Stratification|stratification
5214859|NCT02653209|Biomarkers|biomarkers
5214860|NCT02653209|Pharmacogenetics|pharmacogenetics
5214861|NCT02653209|SGLT2 inhibitors|sglt2 inhibitors
5214862|NCT02653209|Thiazolidinediones|thiazolidinediones
5214863|NCT02653209|DPP4 inhibitors|dpp4 inhibitors
5214864|NCT02653170|acute stroke|acute stroke
5214865|NCT02653170|care transitions|care transitions
5214866|NCT02653170|patient engagement|patient engagement
5214867|NCT02653170|patient education|patient education
5214868|NCT02653170|caregivers|caregivers
5214869|NCT02653170|social workers|social workers
5214870|NCT02653157|multidrug resistance|multidrug resistance
5214871|NCT02653157|burns|burns
5214872|NCT02653157|infections, gram-negative bacilli|infections, gram-negative bacilli
5214873|NCT02653157|ventilator-associated pneumonia|ventilator-associated pneumonia
5214874|NCT02653157|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
5214875|NCT02653157|gram-negative bacilli colonization|gram-negative bacilli colonization
5214876|NCT02653144|post operative pain, Dexmedetomidine, Regional anesthesia|post operative pain, dexmedetomidine, regional anesthesia
5214877|NCT02653131|Short bowel syndrome|short bowel syndrome
5214878|NCT02653105|High risk of cancer, BRCA1 or 2 mutation, Olfactomedine 4|high risk of cancer, brca1 or 2 mutation, olfactomedine 4
5214879|NCT02653066|recruitment|recruitment
5214880|NCT02653040|Lighting|lighting
5214881|NCT02653040|Inpatients|inpatients
5214882|NCT02653040|Recovery|recovery
5214883|NCT02653040|Sleep|sleep
5214884|NCT02653027|Genetics|genetics
5214885|NCT02652988|tDCS|tdcs
5214886|NCT02652988|chronic pain|chronic pain
5214887|NCT02652988|fibromyalgia|fibromyalgia
5214888|NCT02652923|ultrasound contrast agent|ultrasound contrast agent
5214889|NCT02652923|lymphosonography|lymphosonography
5214890|NCT02652923|breast cancer|breast cancer
5214891|NCT02652897|bleeding|bleeding
5214892|NCT02652897|clotting tests|clotting tests
5214893|NCT02652897|neurosurgery|neurosurgery
5214894|NCT02652897|clotting time|clotting time
5214895|NCT02652897|maximum clot firmness|maximum clot firmness
5214896|NCT02652897|kinetics|kinetics
5214897|NCT02652897|lysis|lysis
5214898|NCT02652897|primary hemostasis|primary hemostasis
5214899|NCT02652897|platelet dysfunction|platelet dysfunction
5214900|NCT02652897|coagulation|coagulation
5214901|NCT02652884|transient hypoparathyroidism|transient hypoparathyroidism
5214902|NCT02652884|steroids|steroids
5214903|NCT02652884|total thyroidectomy|total thyroidectomy
5214904|NCT02652871|Leukemia|leukemia
5214905|NCT02652871|Acute Myeloid Leukemia|acute myeloid leukemia
5214906|NCT02652871|AML|aml
5214907|NCT02652871|Relapsed or Refractory|relapsed or refractory
5214908|NCT02652871|Acute myelogenous leukemia|acute myelogenous leukemia
5214909|NCT02652871|LY2510924|ly2510924
5214910|NCT02652871|Idarubicin|idarubicin
5214911|NCT02652871|Idamycin|idamycin
5214912|NCT02652871|Cytarabine|cytarabine
5214913|NCT02652871|Ara-C|ara-c
5214914|NCT02652871|Cytosar|cytosar
5214915|NCT02652871|DepoCyt|depocyt
5211962|NCT02669888|TCM|tcm
5214916|NCT02652871|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5214918|NCT02652806|Chronic Kidney Disease|chronic kidney disease
5214919|NCT02652780|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5214920|NCT02652780|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5214921|NCT02652780|Heredity Optic Atrophy|heredity optic atrophy
5214922|NCT02652780|Eye Diseases|eye diseases
5214923|NCT02652780|Hereditary Eye Diseases|hereditary eye diseases
5214924|NCT02652780|Inborn Genetic Disease|inborn genetic disease
5214925|NCT02652780|Genetic Therapy|genetic therapy
5214926|NCT02652780|Intravitreal Injections|intravitreal injections
5214927|NCT02652780|Mitochondrial Disease|mitochondrial disease
5214928|NCT02652780|AAV2 Vectors|aav2 vectors
5214929|NCT02652780|Nervous System Diseases|nervous system diseases
5214930|NCT02652780|Neurodegenerative Disease|neurodegenerative disease
5214931|NCT02652780|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
5214932|NCT02652767|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5215029|NCT02652208|shared decision making|shared decision making
5214933|NCT02652767|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5214934|NCT02652767|Heredity Optic Atrophy|heredity optic atrophy
5214935|NCT02652767|Eye Diseases|eye diseases
5214936|NCT02652767|Hereditary Eye Diseases|hereditary eye diseases
5214937|NCT02652767|Inborn Genetic Disease|inborn genetic disease
5214938|NCT02652767|Genetic Therapy|genetic therapy
5214939|NCT02652767|Intravitreal Injections|intravitreal injections
5214940|NCT02652767|Mitochondrial Disease|mitochondrial disease
5214941|NCT02652767|AAV2 Vectors|aav2 vectors
5214942|NCT02652767|Nervous System Diseases|nervous system diseases
5214943|NCT02652767|Neurodegenerative Disease|neurodegenerative disease
5214944|NCT02652767|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
5214945|NCT02652754|Granexin|granexin
5214946|NCT02652754|diabetic foot ulcers|diabetic foot ulcers
5214947|NCT02652754|pharmacokinetic study|pharmacokinetic study
5214948|NCT02652754|FirstString Research|firststring research
5214949|NCT02652702|circular stapler-assisted colostomy|circular stapler-assisted colostomy
5214950|NCT02652689|pulmonary embolism|pulmonary embolism
5214951|NCT02652689|pulmonary disease|pulmonary disease
5214952|NCT02652689|Lung Doppler signals|lung doppler signals
5214953|NCT02652676|Infant Cardiac Transplantation|infant cardiac transplantation
5214954|NCT02652676|End-stage Idiopathic Dilated Cardiomyopathy|end-stage idiopathic dilated cardiomyopathy
5214955|NCT02652676|Mechanical Circulatory Device|mechanical circulatory device
5214956|NCT02652676|End Stage Dilated Left Ventriculopathy|end stage dilated left ventriculopathy
5214957|NCT02652676|Acute-on-Chronic Left Ventricular Failure|acute-on-chronic left ventricular failure
5214958|NCT02652663|colorectal cancer|colorectal cancer
5214959|NCT02652663|liver|liver
5214960|NCT02652663|MRI|mri
5214961|NCT02652663|contrast|contrast
5214962|NCT02652663|gadoxetic acid|gadoxetic acid
5214963|NCT02652650|Healthy|healthy
5092883|NCT03418246|gingiva|gingiva
5214964|NCT02652650|JNJ-63623872|jnj-63623872
5214965|NCT02652650|Ethinylestradiol|ethinylestradiol
5214966|NCT02652650|Norethindrone|norethindrone
5214967|NCT02652611|Screw Removal vs. Non-screw removal|screw removal vs. non-screw removal
5214968|NCT02652611|Complications|complications
5214969|NCT02652611|SI Screw Stabilization|si screw stabilization
5214970|NCT02652585|Alcoholism|alcoholism
5214971|NCT02652585|alcohol self-administration|alcohol self-administration
5214972|NCT02652572|Granexin|granexin
5214973|NCT02652572|venous leg ulcer|venous leg ulcer
5214974|NCT02652572|pharmacokinetic study|pharmacokinetic study
5214975|NCT02652572|FirstString Research|firststring research
5214976|NCT02652559|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5214977|NCT02652559|Non-invasive ventilation|non-invasive ventilation
5214978|NCT02652559|Home initiation|home initiation
5203042|NCT02725268|Drug Therapy|drug therapy
5203043|NCT02725229|Postoperative pain|postoperative pain
5203044|NCT02725229|Parasternal block|parasternal block
5214979|NCT02652546|HIV/AIDS|hiv/aids
5214980|NCT02652546|Immune Activation|immune activation
5214981|NCT02652546|Anti-Inflammatory|anti-inflammatory
5214982|NCT02652546|TNF|tnf
5214983|NCT02652546|Phosphodieterase Inhibitor|phosphodieterase inhibitor
5214984|NCT02652520|Kidney transplantation|kidney transplantation
5214985|NCT02652520|Organ preservation|organ preservation
5214986|NCT02652507|Sedation|sedation
5214987|NCT02652507|MRI|mri
5214988|NCT02652507|Dexmedetomidine|dexmedetomidine
5214989|NCT02652507|Ketamine|ketamine
5214990|NCT02652507|General anesthesia|general anesthesia
5214991|NCT02652507|MRI of Brain|mri of brain
5214992|NCT02652507|MRI of Brain/Spine|mri of brain/spine
5214993|NCT02652494|Psoriasis|psoriasis
5214994|NCT02652494|Observational|observational
5214995|NCT02652494|Apremilast|apremilast
5214996|NCT02652494|APRIL|april
5214997|NCT02652494|Non-Interventional|non-interventional
5214998|NCT02652494|The Netherlands|the netherlands
5214999|NCT02652455|cutaneous|cutaneous
5215000|NCT02652455|unresectable|unresectable
5215001|NCT02652455|mucosal metastatic stage III/IV melanoma|mucosal metastatic stage iii/iv melanoma
5215002|NCT02652442|dizziness|dizziness
5215007|NCT02652429|Inhaled Nitric Oxide|inhaled nitric oxide
5215009|NCT02652403|Denture, Complete|denture, complete
5215010|NCT02652403|Mouth, Edentulous|mouth, edentulous
5215011|NCT02652351|Stem cell|stem cell
5215012|NCT02652351|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
5215013|NCT02652351|Mesenchymal Stem Cell|mesenchymal stem cell
5215014|NCT02652351|Hepatic Cirrhosis|hepatic cirrhosis
5215015|NCT02652338|heart rhythm disturbances and symptoms|heart rhythm disturbances and symptoms
5215016|NCT02652338|dietary supplement|dietary supplement
5215017|NCT02652312|Dexmedetomidine|dexmedetomidine
5215018|NCT02652312|Desflurane|desflurane
5215019|NCT02652312|Bispectral Index BIS|bispectral index bis
5215020|NCT02652299|Fibrocytes|fibrocytes
5215021|NCT02652299|Synovial biopsy|synovial biopsy
5215022|NCT02652286|VATS|vats
5215023|NCT02652286|Energy sealing|energy sealing
5215024|NCT02652247|trauma|trauma
5215025|NCT02652247|ventilator|ventilator
5215026|NCT02652247|surgical ICU|surgical icu
5215027|NCT02652208|decision making|decision making
5215028|NCT02652208|decision aids|decision aids
5215031|NCT02652208|cardiology|cardiology
5215032|NCT02652195|Neural correlates|neural correlates
5215033|NCT02652195|oxytocin administration|oxytocin administration
5215034|NCT02652156|transversus abdominis plane|transversus abdominis plane
5215035|NCT02652156|postoperative|postoperative
5215043|NCT02652091|Patient satisfaction|patient satisfaction
5215044|NCT02652065|Psoriasis|psoriasis
5215045|NCT02652065|Microcirculation|microcirculation
5215046|NCT02652065|TRPV1|trpv1
5215047|NCT02652026|dental root planing and scaling|dental root planing and scaling
5215048|NCT02652026|periodontal disease|periodontal disease
5215049|NCT02652026|type 2 diabetes mellitus|type 2 diabetes mellitus
5215050|NCT02652026|glycosylated hemoglobin A|glycosylated hemoglobin a
5215057|NCT02651961|Total hip prosthesis|total hip prosthesis
5215058|NCT02651961|Total knee prosthesis|total knee prosthesis
5215059|NCT02651961|Chronic infection|chronic infection
5215060|NCT02651961|One stage exchange|one stage exchange
5215061|NCT02651961|Two stage exchange|two stage exchange
5215062|NCT02651961|Cost-effectiveness|cost-effectiveness
5215063|NCT02651935|Respiration, Artificial|respiration, artificial
5215064|NCT02651935|weaning|weaning
5215065|NCT02651935|critical care|critical care
5215066|NCT02651922|Nervous restlessness|nervous restlessness
5215067|NCT02651922|Pascoflair|pascoflair
5215068|NCT02651922|Passiflora incarnata|passiflora incarnata
5215069|NCT02651922|Benzodiazepine|benzodiazepine
5215073|NCT02651870|Hypertension|hypertension
5215074|NCT02651844|Progesterone receptor isoforms|progesterone receptor isoforms
5215075|NCT02651844|Antiprogestins|antiprogestins
5962640|NCT04279847|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5215076|NCT02651844|Mifepristone|mifepristone
5215077|NCT02651844|Neoadjuvant|neoadjuvant
5215078|NCT02651844|Breast cancer|breast cancer
5215079|NCT02651831|ICMs|icms
5215080|NCT02651831|Immune checkpoint modulators|immune checkpoint modulators
5215081|NCT02651818|Goiter|goiter
5215082|NCT02651818|Thyroid disease|thyroid disease
5215083|NCT02651818|Struma|struma
5215084|NCT02651805|Palliative Care|palliative care
5215085|NCT02651805|Respiratory Secretion|respiratory secretion
5215086|NCT02651792|ketamine|ketamine
5215087|NCT02651792|propofol|propofol
5215088|NCT02651792|pethidine|pethidine
5215089|NCT02651792|ERCP|ercp
5215090|NCT02651792|endoscopist|endoscopist
5215091|NCT02651740|Rifaximin|rifaximin
5215092|NCT02651740|Fecal microbiota transplantation|fecal microbiota transplantation
5215093|NCT02651740|Gut microbiota|gut microbiota
5215094|NCT02651675|LDL Receptors|ldl receptors
5215095|NCT02651675|Gene therapy|gene therapy
5215096|NCT02651675|Metabolic Diseases|metabolic diseases
5215097|NCT02651675|Rare diseases|rare diseases
5215098|NCT02651675|Genetic Diseases|genetic diseases
5215099|NCT02651675|Atherosclerosis|atherosclerosis
5215100|NCT02651675|cardiovascular disease|cardiovascular disease
5215101|NCT02651610|PPHM 1401|pphm 1401
5215102|NCT02651610|bavituximab|bavituximab
5215103|NCT02651610|Peregrine|peregrine
5215104|NCT02651610|Breast Cancer|breast cancer
5215105|NCT02651610|HER-2 Negative|her-2 negative
5215106|NCT02651610|HER2 Negative|her2 negative
5215107|NCT02651597|Oatmeal|oatmeal
5215108|NCT02651597|Beta glucan|beta glucan
5215109|NCT02651597|Postprandial Glycemic Response|postprandial glycemic response
5215110|NCT02651597|Blood Glucose|blood glucose
5215111|NCT02651571|Knee|knee
5215112|NCT02651571|Replacement|replacement
5215113|NCT02651571|Prosthesis|prosthesis
5215114|NCT02651571|Mobile-bearing|mobile-bearing
5215115|NCT02651532|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5215116|NCT02651532|inflammation|inflammation
5215117|NCT02651532|Irritable Bowel Syndrome|irritable bowel syndrome
5215119|NCT02651519|regional cerebral oxygen saturation|regional cerebral oxygen saturation
5215120|NCT02651519|Stellate-ganglion block|stellate-ganglion block
5215121|NCT02651506|Lung cancer biopsy|lung cancer biopsy
5215122|NCT02651506|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
5215123|NCT02651506|Transthoracic Needle Biopsy|transthoracic needle biopsy
5215124|NCT02651480|Diet, Vegetarian|diet, vegetarian
5215125|NCT02651480|Diet, Fat-Restricted|diet, fat-restricted
5215126|NCT02651480|Quality of Life|quality of life
5215127|NCT02651480|Glycemic Index|glycemic index
5215128|NCT02651454|metabolic syndrome|metabolic syndrome
5215129|NCT02651454|Daesiho-tang|daesiho-tang
5215130|NCT02651454|Taeeumjowi-tang|taeeumjowi-tang
5215131|NCT02651454|Korean medicine|korean medicine
5215132|NCT02651441|D-CIK|d-cik
5215133|NCT02651441|lung cancer|lung cancer
5215134|NCT02651428|Kidney Failure, Chronic|kidney failure, chronic
5215135|NCT02651428|Catheter-Related Infections|catheter-related infections
5215136|NCT02651428|Central Venous Catheter|central venous catheter
5862297|NCT00001650|HIV|hiv
5215139|NCT02651415|mCRC|mcrc
5215140|NCT02651415|Regorafenib|regorafenib
5215141|NCT02651415|Stivarga|stivarga
5215142|NCT02651415|Perindopril|perindopril
5215143|NCT02651415|Perindopril erbumine|perindopril erbumine
5215144|NCT02651415|Coversyl|coversyl
5215145|NCT02651402|Anxiety Disorders|anxiety disorders
5215146|NCT02651402|Internalizing|internalizing
5215147|NCT02651402|Anxiety|anxiety
5215148|NCT02651389|Digital Orthoptic Platform|digital orthoptic platform
5215149|NCT02651389|Vision test|vision test
5215150|NCT02651376|Immunodeficiency|immunodeficiency
5215151|NCT02651376|Allogenic Mononuclear Cell Transplantation|allogenic mononuclear cell transplantation
5215152|NCT02651350|Drug-induced Liver Injury|drug-induced liver injury
5215153|NCT02651350|Recurrence|recurrence
5215154|NCT02651350|Methylprednisolone|methylprednisolone
5215155|NCT02651285|G-CSF|g-csf
5215156|NCT02651285|BLASTOCYST|blastocyst
5215157|NCT02651285|IVF|ivf
5215158|NCT02651272|Pulmonary Hypertension|pulmonary hypertension
5215159|NCT02651272|Sickle Cell Disease|sickle cell disease
5215160|NCT02651272|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5215161|NCT02651272|Macitentan|macitentan
5215162|NCT02651194|Treatment-naïve|treatment-naïve
5215163|NCT02651194|HCV Gentoype 2|hcv gentoype 2
5215164|NCT02651194|Non-cirrhotic|non-cirrhotic
5215165|NCT02651194|Chronic Hepatitis C|chronic hepatitis c
5215166|NCT02651194|HCV Gentoype 5|hcv gentoype 5
5215167|NCT02651194|HCV Gentoype 4|hcv gentoype 4
5215168|NCT02651194|HCV Gentoype 6|hcv gentoype 6
5215169|NCT02651194|HCV Gentoype 1|hcv gentoype 1
5215170|NCT02651194|Compensated cirrhotic|compensated cirrhotic
5215171|NCT02651194|Treatment-experienced|treatment-experienced
5215172|NCT02651194|HCV Gentoype 3|hcv gentoype 3
5215173|NCT02651168|Diabetic Macular Edema|diabetic macular edema
5215174|NCT02651168|Ocular Cytokines|ocular cytokines
5215175|NCT02651168|aflibercept|aflibercept
5215176|NCT02651168|ranibizumab|ranibizumab
5215177|NCT02651155|Drug therapy|drug therapy
5215178|NCT02651129|noise|noise
5215179|NCT02651129|obstetric|obstetric
5215180|NCT02651129|operating rooms|operating rooms
5215305|NCT02650401|Infantile fibrosarcoma|infantile fibrosarcoma
5215182|NCT02651090|contraindication for CECT|contraindication for cect
5215183|NCT02651090|contraindication for CEMRI|contraindication for cemri
5215184|NCT02651090|liver pathology|liver pathology
5215185|NCT02651090|renal failure|renal failure
5215186|NCT02651090|contrast enhanced ultrasound|contrast enhanced ultrasound
5215187|NCT02651090|sonazoid|sonazoid
5215188|NCT02651077|Endometriosis, chemical contaminants, BFRs|endometriosis, chemical contaminants, bfrs
5215189|NCT02651064|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
5215190|NCT02651064|fruits and vegetables|fruits and vegetables
5215194|NCT02650973|Bioequivalence|bioequivalence
5215195|NCT02650947|Sucralose|sucralose
5215196|NCT02650947|Insulin Secretion|insulin secretion
5215197|NCT02650947|Insulin Sensitivity|insulin sensitivity
5215198|NCT02650947|Incretin|incretin
5215199|NCT02650947|Gut Microbiota|gut microbiota
5215200|NCT02650947|Food and Eating Behaviour|food and eating behaviour
5215201|NCT02650947|Healthy Volunteers|healthy volunteers
5215202|NCT02650934|STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI|stemi, heart failure, inflammation, haptoglobin polymorphisms, adverse remodeling, genetics, gwas, mri
5215204|NCT02650908|Meniscus|meniscus
5215205|NCT02650908|Avivement|avivement
5215206|NCT02650908|Suturing area|suturing area
5215207|NCT02650882|Respiratory muscles|respiratory muscles
5215208|NCT02650882|athletic performance|athletic performance
5215209|NCT02650882|handball|handball
5215210|NCT02650869|Necrotizing Enterocolitis|necrotizing enterocolitis
5215211|NCT02650869|probiotics|probiotics
5215212|NCT02650869|very low birth weight|very low birth weight
5215217|NCT02650843|Parkinsonism|parkinsonism
5215218|NCT02650843|DAT Dopamine transporter|dat dopamine transporter
5215219|NCT02650843|SPECT|spect
5215220|NCT02650830|type 2 diabetes|type 2 diabetes
5215221|NCT02650830|prediabetes|prediabetes
5215225|NCT02650804|Cancer|cancer
5215226|NCT02650804|Advanced Pancreatic Cancer|advanced pancreatic cancer
5215227|NCT02650778|Breast Cancer|breast cancer
5862298|NCT00001650|Labeling|labeling
5215228|NCT02650778|Automated whole breast ultrasound|automated whole breast ultrasound
5215229|NCT02650778|BI-RADS category 3 lesions|bi-rads category 3 lesions
5215230|NCT02650765|Brain injury|brain injury
5215231|NCT02650765|Head injury|head injury
5215232|NCT02650765|Computed tomography|computed tomography
5215233|NCT02650765|Emergency department|emergency department
5215234|NCT02650752|Lapatinib|lapatinib
5215235|NCT02650752|Capecitabine|capecitabine
5215236|NCT02650752|HER2|her2
5215237|NCT02650752|15-278|15-278
5215238|NCT02650687|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5215239|NCT02650687|Elderly, geriatric|elderly, geriatric
5215240|NCT02650687|Anesthesia|anesthesia
5215241|NCT02650687|Anesthetic depth|anesthetic depth
5215242|NCT02650687|Bispectral index monitor|bispectral index monitor
5215243|NCT02650687|Function|function
5215244|NCT02650687|Recovery after surgery|recovery after surgery
5215245|NCT02650687|Surgery|surgery
5215246|NCT02650674|glycemic & insulin response|glycemic & insulin response
5215248|NCT02650674|cereal product|cereal product
5215249|NCT02650674|Nutrition|nutrition
5215250|NCT02650674|Carbohydrate|carbohydrate
5215251|NCT02650674|Absorption|absorption
5215252|NCT02650674|Intestine|intestine
5215253|NCT02650661|Cancer survivors|cancer survivors
5215254|NCT02650648|Humanized Anti-GD2 Antibody Hu3F8|humanized anti-gd2 antibody hu3f8
5215255|NCT02650648|Allogeneic Natural Killer Cells|allogeneic natural killer cells
5215256|NCT02650648|rIL-2|ril-2
5215257|NCT02650648|15-272|15-272
5215258|NCT02650622|Metabolism|metabolism
5215259|NCT02650622|Genetics|genetics
5215260|NCT02650622|Metabolomics|metabolomics
5215261|NCT02650622|Genomics|genomics
5215262|NCT02650609|chronic subdural hematomas|chronic subdural hematomas
5215263|NCT02650609|surgical treatment|surgical treatment
5215264|NCT02650609|corticosteroids|corticosteroids
5215265|NCT02650570|Cancer|cancer
5215266|NCT02650570|Cachexia|cachexia
5215267|NCT02650557|coronary slow flow|coronary slow flow
5215268|NCT02650557|P-wave dispersion|p-wave dispersion
5215269|NCT02650544|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5215270|NCT02650544|Depression|depression
5215271|NCT02650544|mirtazapine|mirtazapine
5215272|NCT02650544|patients health questionnaire (PHQ-9)|patients health questionnaire (phq-9)
5215273|NCT02650531|Follow up studies|follow up studies
5215274|NCT02650531|Risk factors|risk factors
5215275|NCT02650518|Catheter-Associated Urinary Tract Infections|catheter-associated urinary tract infections
5215276|NCT02650518|Antimicrobial Stewardship|antimicrobial stewardship
5215277|NCT02650518|Short-Course Antimicrobials|short-course antimicrobials
5215278|NCT02650492|Hyperthermia, Induced|hyperthermia, induced
5215279|NCT02650492|Laser Coagulation|laser coagulation
5215280|NCT02650492|Laser Therapy|laser therapy
5215281|NCT02650453|Stent|stent
5215282|NCT02650453|Angioplasty|angioplasty
5215283|NCT02650453|Endophlebectomy|endophlebectomy
5215284|NCT02650440|robotics|robotics
5215285|NCT02650440|locomotion|locomotion
5215286|NCT02650440|gait|gait
5215287|NCT02650440|walking|walking
5215288|NCT02650440|rehabilitation|rehabilitation
5093284|NCT03415841|Post MI|post mi
5215289|NCT02650414|Biological: CART 22|biological: cart 22
5215291|NCT02650401|Tyrosine kinase|tyrosine kinase
5215292|NCT02650401|NTRK|ntrk
5215293|NCT02650401|NTRK1|ntrk1
5215294|NCT02650401|NTRK2|ntrk2
5215295|NCT02650401|NTRK3|ntrk3
5215296|NCT02650401|ROS1|ros1
5215298|NCT02650401|Pediatric|pediatric
5215299|NCT02650401|Relapsed|relapsed
5215300|NCT02650401|Refractory|refractory
5215301|NCT02650401|Solid Tumor|solid tumor
5215302|NCT02650401|Metastatic Cancer|metastatic cancer
5215303|NCT02650401|Gene rearrangement|gene rearrangement
5215304|NCT02650401|Neuroblastoma|neuroblastoma
5215306|NCT02650401|Secretory breast cancer|secretory breast cancer
5215307|NCT02650401|Congenital mesoblastic nephroma|congenital mesoblastic nephroma
5215308|NCT02650401|Pontine glioma|pontine glioma
5215309|NCT02650401|Brain tumors|brain tumors
5215310|NCT02650401|CNS tumors|cns tumors
5215312|NCT02650401|Ewing sarcoma|ewing sarcoma
5215313|NCT02650401|Glial tumors|glial tumors
5215314|NCT02650401|Salivary Gland Cancer (MASC)|salivary gland cancer (masc)
5215315|NCT02650401|Papillary thyroid cancer|papillary thyroid cancer
5215316|NCT02650401|Medulloblastoma|medulloblastoma
5215317|NCT02650401|Wilms tumor (anaplastic)|wilms tumor (anaplastic)
5215318|NCT02650362|spinal cord stimulation|spinal cord stimulation
5215319|NCT02650362|resting state functional magnetic resonance|resting state functional magnetic resonance
5215320|NCT02650362|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
5215321|NCT02650349|spinal cord stimulation|spinal cord stimulation
5212443|NCT02666664|LDL|ldl
5862855|NCT00001480|Dementia|dementia
5215322|NCT02650349|resting state functional magnetic resonance|resting state functional magnetic resonance
5215323|NCT02650349|voxel-based magnetic resonance morphometry|voxel-based magnetic resonance morphometry
5215325|NCT02650297|Breast cancer|breast cancer
5215326|NCT02650297|Body image|body image
5215327|NCT02650271|adjuvant|adjuvant
5215328|NCT02650271|entecavir|entecavir
5215837|NCT02647411|Myopia|myopia
5215333|NCT02650245|ammonia|ammonia
5215334|NCT02650245|blood|blood
5215335|NCT02650245|protein|protein
5215336|NCT02650245|cirrhosis|cirrhosis
5215337|NCT02650245|encephalopathy|encephalopathy
5215338|NCT02650232|Volunteers|volunteers
5215339|NCT02650206|diabetes|diabetes
5215340|NCT02650206|macrophage|macrophage
5215341|NCT02650206|inflammation|inflammation
5215342|NCT02650206|adipose tissue|adipose tissue
5215343|NCT02650206|weight loss|weight loss
5215344|NCT02650206|liraglutide|liraglutide
5215345|NCT02650193|HSP-130 Phase 1-2 Study in patients with Breast cancer|hsp-130 phase 1-2 study in patients with breast cancer
5215346|NCT02650180|Rehabilitation|rehabilitation
5215347|NCT02650154|sedation|sedation
5215348|NCT02650154|children|children
5215349|NCT02650154|infants|infants
5221860|NCT02612051|PET|pet
5215350|NCT02650154|ketamine|ketamine
5215351|NCT02650154|neurotoxicity|neurotoxicity
5215352|NCT02650128|Coronary Artery Disease|coronary artery disease
5215353|NCT02650128|Calcified Coronary Lesions|calcified coronary lesions
5215354|NCT02650128|Coronary Arterial Stenosis|coronary arterial stenosis
5215355|NCT02650089|Resistance Exercise|resistance exercise
5215356|NCT02650089|Postexercise Hypotension|postexercise hypotension
5215357|NCT02650089|Sympathovagal balance|sympathovagal balance
5215358|NCT02650089|Professor|professor
5215359|NCT02650011|Chronic liver disease|chronic liver disease
5215360|NCT02650011|Liver cirrhosis|liver cirrhosis
5215361|NCT02649998|Fursemide|fursemide
5215362|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate
5215363|NCT02649998|Heart Decompensation|heart decompensation
5215364|NCT02649998|Clinical Trials, Randomized|clinical trials, randomized
5215365|NCT02649998|Clinical Efficacy|clinical efficacy
5215366|NCT02649972|Cobimetinib|cobimetinib
5215368|NCT02649959|Autism|autism
5215369|NCT02649946|ESRD|esrd
5215370|NCT02649946|Stenosis|stenosis
5215371|NCT02649946|Restenosis|restenosis
5215372|NCT02649946|Hemodialysis|hemodialysis
5215373|NCT02649946|AV Fistula|av fistula
5215374|NCT02649946|Arteriovenous (AV)|arteriovenous (av)
5215375|NCT02649933|pregnancy|pregnancy
5215376|NCT02649933|obstructive sleep apnea|obstructive sleep apnea
5215377|NCT02649920|unfavorable cervix|unfavorable cervix
5215378|NCT02649920|obese pregnant women|obese pregnant women
5215379|NCT02649894|malignant pleural effusion|malignant pleural effusion
5215380|NCT02649881|macrophage|macrophage
5962641|NCT04279834|Sleepiness|sleepiness
5215381|NCT02649881|vulnerable coronary plaque|vulnerable coronary plaque
5215382|NCT02649868|Radio-Opaque Bland Beads|radio-opaque bland beads
5215383|NCT02649868|Thermal Ablation|thermal ablation
5215384|NCT02649868|Transarterial Embolization|transarterial embolization
5215390|NCT02649829|dendritic cell vaccination|dendritic cell vaccination
5215391|NCT02649829|chemo-immunotherapy|chemo-immunotherapy
5215392|NCT02649829|Wilms' tumor 1 (WT1)|wilms' tumor 1 (wt1)
5215393|NCT02649816|Pit and fissure sealants|pit and fissure sealants
5215394|NCT02649816|Dental Caries|dental caries
5215395|NCT02649816|Prevention|prevention
5203437|NCT02723266|Preconception Counseling|preconception counseling
5215396|NCT02649816|Dental undergraduate students|dental undergraduate students
5215397|NCT02649816|patient's caries risk|patient's caries risk
5215398|NCT02649803|pediatric|pediatric
5215399|NCT02649803|asthma control|asthma control
5215400|NCT02649803|community|community
5215401|NCT02649790|Multiple Myeloma|multiple myeloma
5215402|NCT02649790|Karyopharm|karyopharm
5215403|NCT02649790|KPT-8602|kpt-8602
5215404|NCT02649790|MM|mm
5215405|NCT02649790|Phase 1|phase 1
5215406|NCT02649790|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
5215407|NCT02649790|Myelodysplastic Syndrome|myelodysplastic syndrome
5215408|NCT02649790|MDS|mds
5215409|NCT02649790|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5215410|NCT02649790|mCRPC|mcrpc
5215411|NCT02649790|CRC|crc
5215412|NCT02649790|Metastatic Colorectal Cancer|metastatic colorectal cancer
5215413|NCT02649777|oxidative stress|oxidative stress
5215414|NCT02649751|Cystic Fibrosis|cystic fibrosis
5215415|NCT02649751|Roscovitine|roscovitine
5215416|NCT02649751|Seliciclib|seliciclib
5215417|NCT02649751|CYC202|cyc202
5215418|NCT02649738|keratoconus|keratoconus
5215419|NCT02649738|corneal tissue inlay|corneal tissue inlay
5215420|NCT02649699|Primary Brain Cancer|primary brain cancer
5215421|NCT02649673|lung carcinoma|lung carcinoma
5215422|NCT02649673|topotecan|topotecan
5215423|NCT02649673|Hycamtin|hycamtin
5215424|NCT02649673|ovarian neoplasms|ovarian neoplasms
5215425|NCT02649673|LCL161|lcl161
5215426|NCT02649673|IAP inhibitors|iap inhibitors
5215427|NCT02649660|Fabry Disease|fabry disease
5215428|NCT02649660|Platelets|platelets
5215431|NCT02649660|α-Galactosidase A|α-galactosidase a
5215432|NCT02649660|Globotriaosylceramide|globotriaosylceramide
5215434|NCT02649660|GL-3|gl-3
5215435|NCT02649660|CD77|cd77
5215436|NCT02649660|Alpha-galactosidase|alpha-galactosidase
5215437|NCT02649660|Platelet activation|platelet activation
5215438|NCT02649660|Lysosomal storage disease|lysosomal storage disease
5215439|NCT02649660|LysoGb3|lysogb3
5215440|NCT02649660|Spingosine-1-Phosphate|spingosine-1-phosphate
5215441|NCT02649660|Platelet function|platelet function
5215442|NCT02649660|CD62P|cd62p
5215443|NCT02649660|P-selectin|p-selectin
5215444|NCT02649647|Rectal cancer|rectal cancer
5215445|NCT02649647|Neoadjuvant therapy|neoadjuvant therapy
5215446|NCT02649647|Chemoradiotherapy|chemoradiotherapy
5215447|NCT02649647|Resection margin|resection margin
5215448|NCT02649647|Bowel function|bowel function
5215449|NCT02649647|Anastomosis|anastomosis
5215450|NCT02649634|Motivational Interviewing|motivational interviewing
5215451|NCT02649634|Obesity|obesity
5215452|NCT02649634|Weight Loss|weight loss
5215453|NCT02649634|Behavioral Medicine|behavioral medicine
5423244|NCT01616563|insulin resistance|insulin resistance
5221918|NCT02611635|VKA|vka
5215454|NCT02649621|Limbal Stem Cell Deficiency Amniotic Membrane Extract Eye Drop in vivo cultivation|limbal stem cell deficiency amniotic membrane extract eye drop in vivo cultivation
5215455|NCT02649595|Homeless|homeless
5215456|NCT02649595|Homelessness|homelessness
5215457|NCT02649595|Respite care|respite care
5215458|NCT02649595|EQ-5D|eq-5d
5215459|NCT02649595|Quality of life questionnaire|quality of life questionnaire
5215460|NCT02649595|Economic evaluation|economic evaluation
5215461|NCT02649595|Cost-utility analysis|cost-utility analysis
5215462|NCT02649582|Dendritic cells|dendritic cells
5215463|NCT02649582|Chemoimmunotherapy|chemoimmunotherapy
5215464|NCT02649582|Adjuvant therapy|adjuvant therapy
5215465|NCT02649556|Candidate modified risk tobacco product|candidate modified risk tobacco product
5215466|NCT02649556|Conventional cigarette|conventional cigarette
5215467|NCT02649556|Exposure response|exposure response
5215468|NCT02649556|Smoking|smoking
5215469|NCT02649556|Tobacco Heating System|tobacco heating system
5215470|NCT02649543|Surgical Wound Infection|surgical wound infection
5215471|NCT02649543|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5215472|NCT02649543|Wound Closure Techniques|wound closure techniques
5215473|NCT02649543|Laparotomy.|laparotomy.
5215474|NCT02649543|Abdominal Wound Closure Techniques|abdominal wound closure techniques
5215475|NCT02649517|decompensated heart failure|decompensated heart failure
5215476|NCT02649517|ischemic heart disease|ischemic heart disease
5215477|NCT02649517|inflammatory cardiomyopathy|inflammatory cardiomyopathy
5215478|NCT02649491|Radiotherapy|radiotherapy
5215479|NCT02649491|Chemotherapy|chemotherapy
5215480|NCT02649491|Metabonomics|metabonomics
5215481|NCT02649491|Electronic Sensing|electronic sensing
5215482|NCT02649491|GI Toxicity|gi toxicity
5215483|NCT02649452|Whole body Vibration|whole body vibration
5215484|NCT02649439|Vaccine|vaccine
5215485|NCT02649439|PSA|psa
5215486|NCT02649439|Surveillance|surveillance
5215487|NCT02649439|Immunotherapy|immunotherapy
5215488|NCT02649426|denervation|denervation
5215489|NCT02649426|resistant hypertension|resistant hypertension
5288182|NCT02231853|EBV|ebv
5215490|NCT02649426|essential hypertension|essential hypertension
5215491|NCT02649361|Anlotinib|anlotinib
5215492|NCT02649348|gastric neoplasm|gastric neoplasm
5215493|NCT02649348|metabolic syndrome|metabolic syndrome
5215494|NCT02649348|prehabilitation|prehabilitation
5093483|NCT03414372|disclosure|disclosure
5215495|NCT02649348|pre-operative exercise|pre-operative exercise
5215496|NCT02649348|laparoscopic radical gastrectomy|laparoscopic radical gastrectomy
5215497|NCT02649335|Non selective beta blockers|non selective beta blockers
5215498|NCT02649335|Ascites|ascites
5215499|NCT02649309|Ischemic Preconditioning|ischemic preconditioning
5215500|NCT02649309|Postconditioning|postconditioning
5215501|NCT02649309|Angioplasty|angioplasty
5215502|NCT02649270|Tolerability|tolerability
5215503|NCT02649270|Safety|safety
5215504|NCT02649270|Pharmacokinetic Study|pharmacokinetic study
5215505|NCT02649270|preliminary pharmacodynamic study|preliminary pharmacodynamic study
5215506|NCT02649270|Humanized Anti-CD6 Monoclonal Antibody(T1h)|humanized anti-cd6 monoclonal antibody(t1h)
5215507|NCT02649257|IOL rotation|iol rotation
5215508|NCT02649257|capsular tension ring|capsular tension ring
5215509|NCT02649257|IOL rotational stability|iol rotational stability
5215510|NCT02649218|QGE031|qge031
5215511|NCT02649218|chronic|chronic
5215512|NCT02649218|spontaneous|spontaneous
5215513|NCT02649218|Urticaria|urticaria
5215514|NCT02649218|CSU|csu
5215515|NCT02649218|adults|adults
5215516|NCT02649218|Safety|safety
5215517|NCT02649192|Children|children
5215518|NCT02649192|Vitamin Supplements|vitamin supplements
5215519|NCT02649192|Influenza virus vaccine|influenza virus vaccine
5215520|NCT02649166|Essential tremor|essential tremor
5215521|NCT02649166|Kinetic tremor|kinetic tremor
5215522|NCT02649166|Intention tremor|intention tremor
5215525|NCT02649140|Vinegar|vinegar
5215526|NCT02649127|exercise|exercise
5215533|NCT02649075|Crohn's|crohn's
5215534|NCT02649075|Crohns|crohns
5215535|NCT02649075|SBI|sbi
5215536|NCT02649075|Serum-derived bovine immunoglobulin / protein isolate|serum-derived bovine immunoglobulin / protein isolate
5215537|NCT02649075|EnteraGam|enteragam
5215538|NCT02649010|Type 1 Diabetes|type 1 diabetes
5215539|NCT02649010|Type 2 Diabetes|type 2 diabetes
5215540|NCT02649010|Enlite 3 Sensor|enlite 3 sensor
5215541|NCT02649010|Continuous Glucose Monitoring|continuous glucose monitoring
5215542|NCT02648997|Atypical Meningioma|atypical meningioma
5215543|NCT02648997|Anaplastic Meningioma|anaplastic meningioma
5215544|NCT02648984|Pulmonary vascular disease|pulmonary vascular disease
5215545|NCT02648971|knee|knee
5215546|NCT02648971|arthroscopy|arthroscopy
5215547|NCT02648971|portal|portal
5215548|NCT02648971|meniscus|meniscus
5215549|NCT02648971|cartilage injury|cartilage injury
5215550|NCT02648932|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5215551|NCT02648932|High-Risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
5215552|NCT02648932|hematopoietic cell transplantation|hematopoietic cell transplantation
5215553|NCT02648932|haplo-cord search|haplo-cord search
5215554|NCT02648932|matched unrelated donor search|matched unrelated donor search
5215555|NCT02648893|iron|iron
5215556|NCT02648893|zinc|zinc
5215557|NCT02648893|vitamin A|vitamin a
5215558|NCT02648893|biofortified|biofortified
5215559|NCT02648893|efficacy|efficacy
5215560|NCT02648893|India|india
5215561|NCT02648893|infant|infant
5215562|NCT02648893|trial|trial
5215563|NCT02648880|Exercise|exercise
5215564|NCT02648880|Physical Activity|physical activity
5215565|NCT02648841|gastric cancer|gastric cancer
5215566|NCT02648841|adjuvant chemo-radiotherapy|adjuvant chemo-radiotherapy
5215567|NCT02648828|Judgment|judgment
5215568|NCT02648828|risk assessment|risk assessment
5215569|NCT02648828|clinical deterioration|clinical deterioration
5215570|NCT02648828|cardiac arrest|cardiac arrest
5215571|NCT02648828|Rothman Index|rothman index
5215572|NCT02648815|Necrotizing pancreatitis|necrotizing pancreatitis
5215573|NCT02648815|Sepsis|sepsis
5215574|NCT02648815|Infection|infection
5215575|NCT02648815|Drainage|drainage
5215576|NCT02648802|breast-conserving surgery(BCS)|breast-conserving surgery(bcs)
5215577|NCT02648802|Cavity shave margin|cavity shave margin
5215578|NCT02648802|Proportion of positive margins|proportion of positive margins
5215579|NCT02648789|Primary oral cancer|primary oral cancer
5215580|NCT02648789|DNA methylation|dna methylation
5215581|NCT02648789|Recurrence oral cancer|recurrence oral cancer
5215582|NCT02648776|hypnotic agents|hypnotic agents
5215583|NCT02648776|sleep disorders|sleep disorders
5215584|NCT02648776|elderly|elderly
5215585|NCT02648750|self-management|self-management
5215586|NCT02648750|rehabilitation|rehabilitation
5215592|NCT02648724|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
5215593|NCT02648724|MET Gene Amplification|met gene amplification
5215594|NCT02648724|MET Amplification|met amplification
5215595|NCT02648724|Wild-type|wild-type
5215596|NCT02648724|NSCLC|nsclc
5215597|NCT02648724|METex14del|metex14del
5215598|NCT02648724|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5203636|NCT02721914|low-back pain|low-back pain
5203637|NCT02721914|massage therapy|massage therapy
5203648|NCT02721797|joint|joint
5215599|NCT02648711|solid tumors|solid tumors
5215600|NCT02648698|chronic endometritis|chronic endometritis
5215601|NCT02648698|CD138|cd138
5215602|NCT02648685|post prandial glucose (PPG)|post prandial glucose (ppg)
5962642|NCT04279834|Hypertension|hypertension
5962643|NCT04279834|Sleep|sleep
5084190|NCT03472560|Inlyta|inlyta
5215603|NCT02648685|basal blood glucose (BBG)|basal blood glucose (bbg)
5215604|NCT02648685|overall glycaemia|overall glycaemia
5215605|NCT02648633|Brain Cancer|brain cancer
5215606|NCT02648633|Immunotherapy|immunotherapy
5215607|NCT02648633|Nivolumab|nivolumab
5215608|NCT02648633|Radiosurgery|radiosurgery
5215609|NCT02648633|Gamma Knife|gamma knife
5215610|NCT02648620|Paclitaxel|paclitaxel
5215611|NCT02648620|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5215612|NCT02648620|PAD|pad
5215613|NCT02648620|Peripheral Artery Disease|peripheral artery disease
5215614|NCT02648620|Pharmacokinetics|pharmacokinetics
5215615|NCT02648607|Pelvic Girdle Pain|pelvic girdle pain
5215616|NCT02648607|Chronic Pelvic Girdle Pain|chronic pelvic girdle pain
5215617|NCT02648607|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
5215618|NCT02648607|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
5215619|NCT02648607|Physiotherapy|physiotherapy
5215620|NCT02648607|Physical Therapy|physical therapy
5215621|NCT02648607|Orthoses|orthoses
5215622|NCT02648607|Orthosis|orthosis
5215623|NCT02648607|Orthotic Devices|orthotic devices
5215624|NCT02648594|lung|lung
5215625|NCT02648594|thoracoscopy|thoracoscopy
5215626|NCT02648594|hook wire localization|hook wire localization
5215628|NCT02648581|ulcers|ulcers
5215629|NCT02648581|uveitis|uveitis
5215630|NCT02648581|ustekinumab|ustekinumab
5215631|NCT02648581|biologics|biologics
5215637|NCT02648529|Benign childhood epilepsy with centro-temporal spikes|benign childhood epilepsy with centro-temporal spikes
5215638|NCT02648529|rolandic epilepsy|rolandic epilepsy
5215639|NCT02648529|brain development|brain development
5215641|NCT02648529|functional MRI|functional mri
5215642|NCT02648529|structural MRI|structural mri
5215643|NCT02648529|idiopathic focal epilepsy|idiopathic focal epilepsy
5215644|NCT02648529|cryptogenic epilepsy of childhood|cryptogenic epilepsy of childhood
5215645|NCT02648516|Immune Reconstitution|immune reconstitution
5215646|NCT02648516|Allogenic HLA-Mismatched Mononuclear Cells Transplantation|allogenic hla-mismatched mononuclear cells transplantation
5215647|NCT02648503|Sugammadex|sugammadex
5215648|NCT02648503|Post-operative Quality Recovery Scale (PQRS)|post-operative quality recovery scale (pqrs)
5215649|NCT02648490|metastatic or recurrent epithelial cancer|metastatic or recurrent epithelial cancer
5215650|NCT02648464|Hydroxychloroquine|hydroxychloroquine
5215651|NCT02648464|anti-inflammatory|anti-inflammatory
5215652|NCT02648464|Myocardial infarction|myocardial infarction
5215653|NCT02648464|cardiovascular diseases|cardiovascular diseases
5215654|NCT02648438|AZD7594|azd7594
5215655|NCT02648438|Bioavailability|bioavailability
5215656|NCT02648438|Healthy male subjects|healthy male subjects
5215657|NCT02648438|Safety|safety
5215658|NCT02648438|Tolerability|tolerability
5215659|NCT02648438|Pharmacokinetics|pharmacokinetics
5215660|NCT02648438|Monodose inhaler|monodose inhaler
5215661|NCT02648438|Multiple-dose dry powder inhaler|multiple-dose dry powder inhaler
5215663|NCT02648425|Varlitinib|varlitinib
5215664|NCT02648399|thyroid carcinoma|thyroid carcinoma
5215665|NCT02648399|center lymph node dissection|center lymph node dissection
5215666|NCT02648360|exercise|exercise
5215667|NCT02648360|diet|diet
5215668|NCT02648360|patients, underserved|patients, underserved
5215669|NCT02648360|text messaging|text messaging
5215670|NCT02648347|vadadustat|vadadustat
5215671|NCT02648347|AKB-6548|akb-6548
5215672|NCT02648347|Chronic kidney disease|chronic kidney disease
5215673|NCT02648347|anemia|anemia
5215674|NCT02648347|CKD|ckd
5215675|NCT02648347|chronic renal insufficiency|chronic renal insufficiency
5215676|NCT02648347|renal impairment|renal impairment
5215677|NCT02648347|erythropoietin|erythropoietin
5215678|NCT02648347|kidney|kidney
5215679|NCT02648347|renal|renal
5215680|NCT02648347|oral anemia treatment|oral anemia treatment
5215681|NCT02648347|hemoglobin|hemoglobin
5215682|NCT02648347|hypoxia-inducible factor|hypoxia-inducible factor
5215683|NCT02648347|HIF|hif
5215684|NCT02648347|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5215685|NCT02648347|HIF-PHI|hif-phi
5215686|NCT02648347|efficacy|efficacy
5215687|NCT02648347|safety|safety
5215688|NCT02648347|Phase 3|phase 3
5215689|NCT02648347|cardiovascular|cardiovascular
5215690|NCT02648347|NDD-CKD|ndd-ckd
5215691|NCT02648334|Drug-Coated Balloon|drug-coated balloon
5215692|NCT02648334|Superficial Femoral artery|superficial femoral artery
5215693|NCT02648334|popliteal peripheral Artery|popliteal peripheral artery
5215694|NCT02648321|Motivational Interviewing|motivational interviewing
5215695|NCT02648321|Exercise|exercise
5215696|NCT02648308|Education, Medical|education, medical
5215697|NCT02648282|vaccine|vaccine
5215698|NCT02648282|immunotherapy|immunotherapy
5215699|NCT02648282|antibody|antibody
5215700|NCT02648282|PD-1|pd-1
5215701|NCT02648282|radiation|radiation
5215702|NCT02648256|Pneumocystis jirovecii|pneumocystis jirovecii
5215703|NCT02648256|Polymerase Chain Reaction|polymerase chain reaction
5215704|NCT02648256|Oropharyngeal Rinse|oropharyngeal rinse
5215705|NCT02648243|Qatar|qatar
5962644|NCT04279834|Sleep Apnea|sleep apnea
5962645|NCT04279834|Endothelial Function|endothelial function
5093699|NCT03413111|ERCP|ercp
5215706|NCT02648243|Acute Coronary Syndrome|acute coronary syndrome
5215707|NCT02648243|Pharmacist|pharmacist
5215708|NCT02648243|Medication burden|medication burden
5215709|NCT02648243|Mortality|mortality
5215710|NCT02648243|Readmission|readmission
5215711|NCT02648243|Adherence|adherence
5215712|NCT02648243|Impact|impact
5215713|NCT02648230|Ischemia|ischemia
5215714|NCT02648230|Fractional Flow Reserve|fractional flow reserve
5215715|NCT02648230|Stent|stent
5215716|NCT02648191|Obesity|obesity
5215717|NCT02648191|Bariatric Surgery|bariatric surgery
5215718|NCT02648191|No invasive intra-auricular vagus nerve stimulation|no invasive intra-auricular vagus nerve stimulation
5215719|NCT02648191|Weight loss|weight loss
5215720|NCT02648191|Autonomic nervous system|autonomic nervous system
5215721|NCT02648113|Myocardial Infarction|myocardial infarction
5215722|NCT02648113|Anemia|anemia
5215723|NCT02648113|Blood Transfusion|blood transfusion
5215724|NCT02648100|Muscle invasive bladder cancer|muscle invasive bladder cancer
5215736|NCT02648061|Biological markers|biological markers
5862856|NCT00001480|Alzheimer's Disease|alzheimer's disease
5215738|NCT02648048|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5215740|NCT02648048|Pirfenidone|pirfenidone
5215741|NCT02648022|Care Integration|care integration
5215742|NCT02648022|Hepatitis C|hepatitis c
5215743|NCT02648022|Substance Use Disorder|substance use disorder
5215744|NCT02648022|PTSD|ptsd
5215745|NCT02647970|Energy metabolism|energy metabolism
5215746|NCT02647957|acute ischemic stroke|acute ischemic stroke
5215747|NCT02647957|quality|quality
5215748|NCT02647905|type 1 diabetes|type 1 diabetes
5215749|NCT02647905|type 2 diabetes|type 2 diabetes
5215751|NCT02647905|implantable|implantable
5215752|NCT02647905|accuracy|accuracy
5215753|NCT02647905|longevity|longevity
5215754|NCT02647866|4083-002|4083-002
5215755|NCT02647866|Intestinal Diseases|intestinal diseases
5215756|NCT02647866|Ulcerative Colitis|ulcerative colitis
5215758|NCT02647866|Mayo Clinic Scoring|mayo clinic scoring
5215759|NCT02647866|Gastrointestinal Tract|gastrointestinal tract
5215760|NCT02647840|dysphonia|dysphonia
5215761|NCT02647840|voice therapy|voice therapy
5215762|NCT02647827|Acupuncture|acupuncture
5215763|NCT02647827|Metformin|metformin
5215764|NCT02647827|Glucose metabolism|glucose metabolism
5215765|NCT02647827|Hba1c|hba1c
5215766|NCT02647814|Parent activation|parent activation
5215767|NCT02647814|Text-messages|text-messages
5215768|NCT02647814|LEP|lep
5215769|NCT02647814|Latino populations|latino populations
5215770|NCT02647814|pediatrics|pediatrics
5215771|NCT02647801|Network approach|network approach
5215772|NCT02647801|mindfulness|mindfulness
5215773|NCT02647801|self-control|self-control
5215774|NCT02647801|ambulatory assessment|ambulatory assessment
5215775|NCT02647788|Pain, Postoperative|pain, postoperative
5215776|NCT02647775|Thoracoscopic surgery|thoracoscopic surgery
5215777|NCT02647723|Omega-3|omega-3
5215778|NCT02647723|Fatty acid|fatty acid
5222219|NCT02609698|Stent|stent
5215780|NCT02647723|Pregnant|pregnant
5215781|NCT02647723|neurodevelopment|neurodevelopment
5215782|NCT02647723|stress|stress
5215783|NCT02647723|urban|urban
5215784|NCT02647723|african-american|african-american
5215785|NCT02647723|supplement|supplement
5215786|NCT02647723|nutrition|nutrition
5215787|NCT02647723|mental health|mental health
5215788|NCT02647710|HIV Prevention|hiv prevention
5215789|NCT02647710|Juvenile Justice|juvenile justice
5215790|NCT02647710|Sexual Health|sexual health
5215791|NCT02647710|Evidence Based Intervention|evidence based intervention
5215792|NCT02647697|UCB3491|ucb3491
5215793|NCT02647697|Phase 1|phase 1
5215794|NCT02647697|Pharmacokinetics|pharmacokinetics
5215795|NCT02647697|Radiprodil|radiprodil
5215796|NCT02647697|Healthy volunteers|healthy volunteers
5215797|NCT02647684|Cancer|cancer
5215798|NCT02647684|Parenting|parenting
5215799|NCT02647684|Self-directed Triple P|self-directed triple p
5215800|NCT02647671|Colon polyp|colon polyp
5215801|NCT02647671|Colorectal cancer|colorectal cancer
5215802|NCT02647671|Chemoprevention|chemoprevention
5215803|NCT02647671|Natural product|natural product
5215804|NCT02647658|acute low back pain|acute low back pain
5215805|NCT02647658|primary care|primary care
5215806|NCT02647658|psychologically informed physical therapy|psychologically informed physical therapy
5215807|NCT02647658|cluster randomized pragmatic trial|cluster randomized pragmatic trial
5215808|NCT02647658|comparative effectiveness|comparative effectiveness
5215809|NCT02647658|secondary prevention|secondary prevention
5215810|NCT02647632|HCV genotype 1 or 4|hcv genotype 1 or 4
5215811|NCT02647632|failure to DAA|failure to daa
5962646|NCT04279834|Alertness|alertness
5215812|NCT02647619|Primary Dd disase|primary dd disase
5215814|NCT02647580|Growth|growth
5215815|NCT02647580|Children|children
5215816|NCT02647580|Appetite-regulating hormones|appetite-regulating hormones
5215817|NCT02647580|Gut Microbiota|gut microbiota
5215818|NCT02647567|Cognitive|cognitive
5215819|NCT02647567|Aerobic Exercise|aerobic exercise
5215820|NCT02647567|Performance|performance
5215821|NCT02647554|sepsis|sepsis
5962647|NCT04279834|Behavioral Intervention|behavioral intervention
5215822|NCT02647554|septic shock|septic shock
5215823|NCT02647554|Ulinastatin|ulinastatin
5215824|NCT02647554|adult|adult
5215825|NCT02647554|China|china
5215826|NCT02647541|Children|children
5215827|NCT02647541|Congenital heart disease|congenital heart disease
5215828|NCT02647541|Nutritional status|nutritional status
5215829|NCT02647541|Bioelectrical impedance|bioelectrical impedance
5215830|NCT02647476|immunonutrition|immunonutrition
5215831|NCT02647476|gastric cancer|gastric cancer
5215832|NCT02647476|enteral nutrition|enteral nutrition
5215833|NCT02647463|Attachment|attachment
5215834|NCT02647463|Cortisol|cortisol
5215835|NCT02647463|Parent sensitivity|parent sensitivity
5215836|NCT02647411|Prevalence|prevalence
5215838|NCT02647398|Cancer survivors|cancer survivors
5215839|NCT02647398|training|training
5215840|NCT02647398|exercise|exercise
5215841|NCT02647398|cancer-related fatigue|cancer-related fatigue
5215842|NCT02647385|serratus anterior plane block|serratus anterior plane block
5215843|NCT02647385|pectoral nerve block|pectoral nerve block
5215844|NCT02647385|breast surgery|breast surgery
5215845|NCT02647385|cancer|cancer
5215846|NCT02647385|analgesia|analgesia
5215849|NCT02647372|deep brain stimulation|deep brain stimulation
5215851|NCT02647372|subthalamic nucleus|subthalamic nucleus
5215852|NCT02647320|type 2 diabetes mellitus|type 2 diabetes mellitus
5215853|NCT02647320|interventional|interventional
5215854|NCT02647320|double blind|double blind
5215855|NCT02647320|phase 2|phase 2
5215856|NCT02647281|Single dose|single dose
5215857|NCT02647281|Multiple ascending doses (MAD)|multiple ascending doses (mad)
5215858|NCT02647281|Pharmacokinetics|pharmacokinetics
5215859|NCT02647281|Safety|safety
5215860|NCT02647281|GSK3389404|gsk3389404
5215861|NCT02647281|Tolerability|tolerability
5215862|NCT02647268|Uterine contraction|uterine contraction
5215863|NCT02647268|Oxytocin|oxytocin
5215864|NCT02647268|Magnesium sulphate|magnesium sulphate
5215865|NCT02647255|crescentic IgA nephropathy|crescentic iga nephropathy
5215866|NCT02647255|plasma exchange treatment or plasmapheresis|plasma exchange treatment or plasmapheresis
5108360|NCT03320642|Acute leukemia|acute leukemia
5215867|NCT02647255|randomized controlled trial|randomized controlled trial
5215868|NCT02647255|intensive immunosuppressive treatment|intensive immunosuppressive treatment
5215869|NCT02647255|methylprednisolone pulse|methylprednisolone pulse
5215870|NCT02647216|Mindfulness Based Cognitive Therapy (MBCT)|mindfulness based cognitive therapy (mbct)
5215871|NCT02647216|anxiety|anxiety
5215872|NCT02647216|depression|depression
5215873|NCT02647203|Fluoride toothpaste|fluoride toothpaste
5215874|NCT02647203|Root caries|root caries
5215875|NCT02647203|Randomized clinical trial|randomized clinical trial
5215876|NCT02647190|Erwinia Chrysanthemi Asparaginase|erwinia chrysanthemi asparaginase
5215877|NCT02647190|15-107|15-107
5215878|NCT02647164|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
5215879|NCT02647164|Circulating tumor cells|circulating tumor cells
5215880|NCT02647151|Acid Methyl Aminolevulinate (MAL)|acid methyl aminolevulinate (mal)
5215881|NCT02647151|Aminolevulinic Gel (ALA) and Actinic Keratosis|aminolevulinic gel (ala) and actinic keratosis
5215885|NCT02647099|Aspirin|aspirin
5215886|NCT02647099|PI3K signaling pathway|pi3k signaling pathway
5215887|NCT02647086|Eczema|eczema
5215888|NCT02647073|Mobile Monitoring|mobile monitoring
5215889|NCT02647073|Post-Opioid Consumption|post-opioid consumption
5215890|NCT02647073|Vital Signs|vital signs
5215891|NCT02647060|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5215892|NCT02647060|right ventricle function|right ventricle function
5215893|NCT02647060|cardio output|cardio output
5215894|NCT02647060|pulmonary hypertension|pulmonary hypertension
5215895|NCT02647060|quality of life|quality of life
5215896|NCT02647047|spinal analgesia|spinal analgesia
5215897|NCT02647047|epidural analgesia|epidural analgesia
5215898|NCT02647047|laparotomic liver resection|laparotomic liver resection
5215899|NCT02647047|ERAS|eras
5215900|NCT02647047|length of stay|length of stay
5215901|NCT02647021|physical therapy|physical therapy
5215902|NCT02647021|cancer rehabilitation|cancer rehabilitation
5215903|NCT02647021|exercise|exercise
5215904|NCT02647008|outpatient hysteroscopy, TENS|outpatient hysteroscopy, tens
5215905|NCT02646982|Alzheimer's disease|alzheimer's disease
5203936|NCT02719873|obesity , pregnancy , maternal and fetal outcome|obesity , pregnancy , maternal and fetal outcome
5203937|NCT02719847|Lung cancer|lung cancer
5215906|NCT02646982|Vascular function|vascular function
5215907|NCT02646982|Neuroinflammation|neuroinflammation
5215908|NCT02646956|Sweet Taste|sweet taste
5215909|NCT02646956|Psychophysics|psychophysics
5215910|NCT02646956|Genetics|genetics
5215911|NCT02646956|Diet|diet
5215912|NCT02646956|Age|age
5215913|NCT02646956|Nonnutritive Sweetener|nonnutritive sweetener
5215914|NCT02646943|Cohort|cohort
5215915|NCT02646943|Biomarkers|biomarkers
5215916|NCT02646943|Cardiomyopathy|cardiomyopathy
5215917|NCT02646930|chronic endometritis|chronic endometritis
5215918|NCT02646930|invitro fertilization|invitro fertilization
5215919|NCT02646930|spontaneous abortion|spontaneous abortion
5215920|NCT02646891|Rotavirus Vaccine|rotavirus vaccine
5215921|NCT02646878|Type 1 Diabetes|type 1 diabetes
5215923|NCT02646878|Harmony Sensor|harmony sensor
5215924|NCT02646878|Continuous Glucose Monitoring|continuous glucose monitoring
5215925|NCT02646878|CGM|cgm
5215926|NCT02646865|social phobia|social phobia
5215927|NCT02646865|compassion|compassion
5215928|NCT02646865|shame|shame
5862299|NCT00001650|CD4 Cells|cd4 cells
5215929|NCT02646839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5215930|NCT02646839|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5215931|NCT02646839|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5215932|NCT02646839|KIR-Favorable|kir-favorable
5215933|NCT02646839|Haploidentical Transplantation|haploidentical transplantation
5216125|NCT02645383|Pattern scan laser|pattern scan laser
5215934|NCT02646839|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5215935|NCT02646800|Micafungin|micafungin
5215936|NCT02646800|Antifungal|antifungal
5215937|NCT02646800|Candidiasis|candidiasis
5215938|NCT02646800|Aspergillosis|aspergillosis
5215943|NCT02646670|diabetic macular edema|diabetic macular edema
5215944|NCT02646670|aflibercept|aflibercept
5215945|NCT02646670|ranibizumab|ranibizumab
5215946|NCT02646605|Depression|depression
5215947|NCT02646605|AIDS|aids
5215948|NCT02646605|HIV|hiv
5215949|NCT02646579|Orthopedics|orthopedics
5215950|NCT02646527|dignity, end of life, existential, treatment|dignity, end of life, existential, treatment
5215951|NCT02646514|Cholangiocarcinoma, radiofrequency ablation, metal stent|cholangiocarcinoma, radiofrequency ablation, metal stent
5215952|NCT02646488|cholesterol|cholesterol
5215953|NCT02646488|smoking|smoking
5215954|NCT02646488|aspirin|aspirin
5215955|NCT02646488|chronic care model|chronic care model
5215956|NCT02646475|renin-angiotensin system|renin-angiotensin system
5215957|NCT02646475|angiotensin|angiotensin
5215958|NCT02646475|insulin resistance|insulin resistance
5215959|NCT02646475|blood pressure|blood pressure
5215960|NCT02646462|pancreas adenocarcinoma, lymph node metastases|pancreas adenocarcinoma, lymph node metastases
5215961|NCT02646449|Major Depressive Disorder|major depressive disorder
5215962|NCT02646449|Alcohol Use Disorder|alcohol use disorder
5215963|NCT02646436|unplanned peritoneal dialysis|unplanned peritoneal dialysis
5215964|NCT02646436|unplanned heamodialysis|unplanned heamodialysis
5215965|NCT02646423|Trial of labor after cesarean|trial of labor after cesarean
5215966|NCT02646423|Elective repeat cesarean delivery|elective repeat cesarean delivery
5215967|NCT02646423|Decision tool|decision tool
5215968|NCT02646423|Shared decision making|shared decision making
5215969|NCT02646410|malaria|malaria
5215970|NCT02646410|seasonal malaria chemoprevention|seasonal malaria chemoprevention
5215971|NCT02646410|immunity|immunity
5215972|NCT02646410|resistance|resistance
5215973|NCT02646410|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5215974|NCT02646410|amodiaquine|amodiaquine
5215975|NCT02646410|delivery method|delivery method
5215976|NCT02646397|glomerular filtration rate|glomerular filtration rate
5215977|NCT02646397|hypertension|hypertension
5215978|NCT02646345|Checklist|checklist
5215979|NCT02646345|Mortality|mortality
5215980|NCT02646345|Latin America|latin america
5215981|NCT02646345|Surgery|surgery
5215982|NCT02646345|Morbidity|morbidity
5215983|NCT02646332|Helicobacter pylori|helicobacter pylori
5215984|NCT02646332|Eradication rate|eradication rate
5215985|NCT02646306|shoulder|shoulder
5215986|NCT02646306|proprioception|proprioception
5215987|NCT02646306|movement|movement
5215988|NCT02646306|reaching|reaching
5215989|NCT02646280|Low back pain|low back pain
5215990|NCT02646280|interoceptive awareness|interoceptive awareness
5215991|NCT02646280|motor imagery|motor imagery
5215992|NCT02646280|massage|massage
5215993|NCT02646267|Atrial fibrillation|atrial fibrillation
5215994|NCT02646267|Dabigatran|dabigatran
5215995|NCT02646267|Warfarin|warfarin
5215996|NCT02646267|Anticoagulation|anticoagulation
5215997|NCT02646267|Elderly|elderly
5204032|NCT02719236|Hip arthroplasty|hip arthroplasty
5215998|NCT02646254|tetralogy of fallot, cardioplegia|tetralogy of fallot, cardioplegia
5215999|NCT02646241|stomach neoplasm|stomach neoplasm
5216000|NCT02646241|biopsy|biopsy
5216001|NCT02646150|Magnetic Resonance perfusion imaging|magnetic resonance perfusion imaging
5216002|NCT02646150|distal perfusion|distal perfusion
5216003|NCT02646150|Critical Limb Ischemia|critical limb ischemia
5216004|NCT02646150|endovascular revascularization|endovascular revascularization
5216005|NCT02646124|benzodiazepine|benzodiazepine
5216006|NCT02646111|"Hepatitis C Virus"|"hepatitis c virus"
5216007|NCT02646111|"Triple Therapy"|"triple therapy"
5216008|NCT02646111|"PI Failure"|"pi failure"
5216009|NCT02646111|"Genotype 1"|"genotype 1"
5216011|NCT02646098|mantle cell lymphoma|mantle cell lymphoma
5216012|NCT02646098|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5216013|NCT02646072|diabetes mellitus|diabetes mellitus
5216014|NCT02646072|aqueous humor|aqueous humor
5216015|NCT02646072|inflammatory cytokines|inflammatory cytokines
5216016|NCT02646072|cystoid macular edema, postoperative|cystoid macular edema, postoperative
5216017|NCT02646072|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5216018|NCT02646046|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5216019|NCT02646046|Emergency Medical Services|emergency medical services
5216020|NCT02646046|Cell phones|cell phones
5216021|NCT02646046|Simulation Training|simulation training
5862760|NCT00001524|Cytokines|cytokines
5216022|NCT02646033|Intraocular Pressure, Trendelenburg position|intraocular pressure, trendelenburg position
5216023|NCT02646020|pruritus|pruritus
5216024|NCT02646020|Non-small Cell Lung Cancer|non-small cell lung cancer
5216025|NCT02646020|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
5216026|NCT02646020|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5216027|NCT02646007|Autologous Cell therapy Kienböck's disease|autologous cell therapy kienböck's disease
5216028|NCT02646007|bone marrow derived mesenchymal stromal/stem cell|bone marrow derived mesenchymal stromal/stem cell
5216030|NCT02645994|Target Controlled Infusion|target controlled infusion
5216031|NCT02645981|Donafeinb|donafeinb
5216032|NCT02645981|Sorafenib|sorafenib
5216034|NCT02645981|Overall Survival|overall survival
5216035|NCT02645968|Pneumology|pneumology
5216036|NCT02645968|Registry|registry
5216037|NCT02645968|EXCITING|exciting
5216038|NCT02645968|Interstitial lung disease|interstitial lung disease
5216040|NCT02645942|Carnitine|carnitine
5216041|NCT02645942|placebo|placebo
5216042|NCT02645942|risk factors|risk factors
5216043|NCT02645916|Cold Hypersensitivity in the Hands|cold hypersensitivity in the hands
5216044|NCT02645916|Korean medicine|korean medicine
5216045|NCT02645916|DSGOST|dsgost
5216046|NCT02645903|transversus abdominis plane block|transversus abdominis plane block
5216047|NCT02645903|living liver transplantation|living liver transplantation
5216048|NCT02645903|postoperative analgesia|postoperative analgesia
5216049|NCT02645890|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5216050|NCT02645890|Healthy Male Volunteer|healthy male volunteer
5216051|NCT02645890|Tamsulosin|tamsulosin
5216052|NCT02645890|Tadalafil|tadalafil
5216053|NCT02645877|Pre-hospital Care|pre-hospital care
5216054|NCT02645877|Diseases Spectrum|diseases spectrum
5216055|NCT02645877|Call Demands|call demands
5216056|NCT02645877|Emergency Response Time|emergency response time
5216057|NCT02645864|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5216058|NCT02645864|Apatinib|apatinib
5216059|NCT02645864|Irinotecan|irinotecan
5216060|NCT02645851|Fluid Therapy|fluid therapy
5216061|NCT02645851|Plasma Substitutes|plasma substitutes
5216062|NCT02645851|Fluid Balance|fluid balance
5216063|NCT02645838|Motivational Interviewing|motivational interviewing
5216064|NCT02645838|Smoking Cessation|smoking cessation
5216065|NCT02645825|superficial adenopathy - echography|superficial adenopathy - echography
5216066|NCT02645812|Fatigue|fatigue
5216067|NCT02645812|Brief Fatigue Inventory (BFI)|brief fatigue inventory (bfi)
5216068|NCT02645812|Primary care|primary care
5216069|NCT02645812|General Practitioners|general practitioners
5216070|NCT02645786|thyroid neoplasms|thyroid neoplasms
5216071|NCT02645786|heart|heart
5216072|NCT02645786|thyroxine|thyroxine
5216073|NCT02645786|thyrotoxicosis|thyrotoxicosis
5216074|NCT02645708|RIRS|rirs
5216075|NCT02645708|EPVL|epvl
5216076|NCT02645708|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
5216077|NCT02645708|Randomized Controlled Trial|randomized controlled trial
5216078|NCT02645695|Pulmonary Rehabilitation|pulmonary rehabilitation
5216079|NCT02645695|Chest Physiotherapy|chest physiotherapy
5216080|NCT02645695|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5216081|NCT02645682|central venous catheter (CVC)|central venous catheter (cvc)
5216082|NCT02645682|catheter-related bloodstream infection (CRBSI)|catheter-related bloodstream infection (crbsi)
5216083|NCT02645682|catheter-related thrombosis (CRT)|catheter-related thrombosis (crt)
5216084|NCT02645656|Oral Submucous Fibrosis|oral submucous fibrosis
5216085|NCT02645656|Curcumin|curcumin
5204126|NCT02718755|Fludarabine phosphate|fludarabine phosphate
5204127|NCT02718755|Fludara|fludara
5204128|NCT02718755|Cytarabine|cytarabine
5204129|NCT02718755|Ara-C|ara-c
5204130|NCT02718755|Cytosar|cytosar
5204131|NCT02718755|DepoCyt|depocyt
5216086|NCT02645643|medical students|medical students
5216087|NCT02645643|professionalism|professionalism
5216088|NCT02645643|medical education|medical education
5216089|NCT02645643|study emotion|study emotion
5216090|NCT02645630|Cervical spine|cervical spine
5216091|NCT02645630|Spinal manipulation|spinal manipulation
5216092|NCT02645604|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
5216093|NCT02645591|Prostate cancer|prostate cancer
5216094|NCT02645591|Dehydrated human amnion/chorion membrane|dehydrated human amnion/chorion membrane
5216095|NCT02645591|dHACM|dhacm
5216096|NCT02645591|Robotic assisted laparoscopic radical prostatectomy|robotic assisted laparoscopic radical prostatectomy
5216097|NCT02645591|RARP|rarp
5216098|NCT02645591|AmnioFix®|amniofix®
5216099|NCT02645591|Sexual function score|sexual function score
5216100|NCT02645591|Neurovascular bundle inflammation|neurovascular bundle inflammation
5216101|NCT02645591|Questionnaire|questionnaire
5216102|NCT02645591|Survey|survey
5216103|NCT02645578|Coma|coma
5216104|NCT02645578|traumatic brain injury|traumatic brain injury
5216105|NCT02645578|median nerve stimulation|median nerve stimulation
5094143|NCT03410485|NoL index|nol index
5216106|NCT02645552|Traumatic brain injury|traumatic brain injury
5216107|NCT02645539|Heart failure|heart failure
5216108|NCT02645539|Bridge-to-transplant|bridge-to-transplant
5216109|NCT02645539|circulatory support|circulatory support
5216110|NCT02645539|VAD|vad
5216111|NCT02645539|IABP|iabp
5216112|NCT02645513|mHealth|mhealth
5216113|NCT02645513|text message|text message
5863321|NCT00001325|Glucose|glucose
5216117|NCT02645448|Resistance Exercise|resistance exercise
5216118|NCT02645448|Diabetes Mellitus|diabetes mellitus
5216119|NCT02645448|Heart Rate Variability|heart rate variability
5216124|NCT02645396|Cytomegalovirus|cytomegalovirus
5216134|NCT02645357|evidence-based|evidence-based
5216135|NCT02645357|computerized|computerized
5216136|NCT02645357|decision|decision
5216137|NCT02645357|support system|support system
5216138|NCT02645357|linked|linked
5216139|NCT02645357|electronic health records|electronic health records
5216140|NCT02645344|Unilateral neglect|unilateral neglect
5216141|NCT02645344|Right hemiplegia|right hemiplegia
5216142|NCT02645318|Circulating Tumor DNA|circulating tumor dna
5216143|NCT02645318|Lung cancer|lung cancer
5216144|NCT02645318|Targeted sequencing|targeted sequencing
5216145|NCT02645305|Safety and Efficacy|safety and efficacy
5216146|NCT02645305|Adipose stem cells|adipose stem cells
5216147|NCT02645305|Stem Cell therapy|stem cell therapy
5216148|NCT02645279|newborn|newborn
5216149|NCT02645279|MRI|mri
5216150|NCT02645279|oral 30% glucose|oral 30% glucose
5216151|NCT02645253|Safety|safety
5216152|NCT02645253|Pharmacokinetics|pharmacokinetics
5216153|NCT02645253|Pharmacodynamics|pharmacodynamics
5216154|NCT02645253|Glucocorticoid receptor modulator|glucocorticoid receptor modulator
5216155|NCT02645253|Healthy male subjects|healthy male subjects
5216156|NCT02645201|probiotic|probiotic
5216157|NCT02645188|Electromyography|electromyography
5216158|NCT02645188|Exercise|exercise
5216159|NCT02645175|Paclitaxel|paclitaxel
5216160|NCT02645175|docetaxel|docetaxel
5216161|NCT02645175|vinorelbine|vinorelbine
5216162|NCT02645175|eribulin|eribulin
5216163|NCT02645162|Pakistan|pakistan
5216164|NCT02645162|Early Child Development, Care and Education|early child development, care and education
5216165|NCT02645162|Youth Leaders|youth leaders
5216166|NCT02645149|Metastatic Melanoma|metastatic melanoma
5216167|NCT02645149|Molecular Testing|molecular testing
5216168|NCT02645149|Targeted Therapy|targeted therapy
5216169|NCT02645123|spinal mobilization|spinal mobilization
5216170|NCT02645123|manual therapy|manual therapy
5216171|NCT02645123|gait analysis|gait analysis
5216172|NCT02645123|low back pain|low back pain
5216173|NCT02645123|chronic|chronic
5216174|NCT02645097|Adult|adult
5216175|NCT02645097|nerve blocks in foot and ankle surgery|nerve blocks in foot and ankle surgery
5216176|NCT02645097|saphenous|saphenous
5216177|NCT02645071|physical activity|physical activity
5216178|NCT02645071|family well being,|family well being,
5216180|NCT02645058|Ureterorenoscopy|ureterorenoscopy
5216181|NCT02645058|extracorporeal shock waves lithotripsy|extracorporeal shock waves lithotripsy
5216182|NCT02645045|Dry eye|dry eye
5216183|NCT02645045|Lipiview|lipiview
5216184|NCT02645045|Tear Lipid Layer|tear lipid layer
5216185|NCT02645045|meibomian gland dysfunction|meibomian gland dysfunction
5216186|NCT02645032|Typhoid conjugate vaccine|typhoid conjugate vaccine
5216187|NCT02645032|Vi-DT|vi-dt
5216188|NCT02645032|Safety|safety
5216189|NCT02645032|Immunogenicuty|immunogenicuty
5216190|NCT02645006|falls|falls
5216191|NCT02645006|elderly|elderly
5216192|NCT02645006|Exercise,Physical|exercise,physical
5216193|NCT02645006|vitamin d|vitamin d
5216194|NCT02645006|home hazards|home hazards
5216195|NCT02645006|mediterranean diet|mediterranean diet
5216196|NCT02645006|body mass index|body mass index
5216197|NCT02645006|lower extremity exercise movement technics|lower extremity exercise movement technics
5216198|NCT02645006|vitamin D intake|vitamin d intake
5216199|NCT02645006|Short Physical Performance Battery (SPPB o Test de Guralnik)|short physical performance battery (sppb o test de guralnik)
5216200|NCT02644980|Target Controlled Infusion|target controlled infusion
5216201|NCT02644967|ILLUMINATE- 204|illuminate- 204
5216202|NCT02644954|psoriasis|psoriasis
5216203|NCT02644954|Metformin|metformin
5216204|NCT02644928|Chronic kidney disease|chronic kidney disease
5216205|NCT02644928|Bariatric Surgery Candidate|bariatric surgery candidate
5216206|NCT02644928|Caloric restriction|caloric restriction
5216207|NCT02644915|ischemia-reperfusion(I/R) injury|ischemia-reperfusion(i/r) injury
5216208|NCT02644915|Edaravone|edaravone
5216209|NCT02644902|Avatar assisted cascade training and supervision|avatar assisted cascade training and supervision
5216210|NCT02644902|maternal depression|maternal depression
5216211|NCT02644902|postconflict|postconflict
5216212|NCT02644902|THP|thp
5216213|NCT02644889|Epidermal growth factor receptor(EGFR)|epidermal growth factor receptor(egfr)
5216220|NCT02644824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
5216221|NCT02644824|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5216222|NCT02644824|Cardiac Index|cardiac index
5216223|NCT02644824|Hemodynamics|hemodynamics
5962648|NCT04279821|Segmental colitis associated with colic diverticulosis|segmental colitis associated with colic diverticulosis
5094274|NCT03409471|Self-Sampling|self-sampling
5216224|NCT02644824|Pediatrics|pediatrics
5216225|NCT02644811|Miniscrew|miniscrew
5862857|NCT00001480|Cerebrospinal Fluid|cerebrospinal fluid
5216226|NCT02644811|Temporary anchorage device (TAD)|temporary anchorage device (tad)
5216228|NCT02644811|Miniscrew implant (MSI)|miniscrew implant (msi)
5216229|NCT02644798|ARDS|ards
5216230|NCT02644798|Gene polymorphism|gene polymorphism
5216231|NCT02644785|cardiac by-pass|cardiac by-pass
5216232|NCT02644785|protamine|protamine
5216233|NCT02644785|tryptase|tryptase
5216234|NCT02644785|hypotension|hypotension
5216235|NCT02644785|anaphylaxis|anaphylaxis
5216236|NCT02644772|Acute Exacerbation of COPD|acute exacerbation of copd
5216237|NCT02644772|Clinical problems in COPD|clinical problems in copd
5216238|NCT02644759|Stem Cells|stem cells
5216239|NCT02644759|Transplantation|transplantation
5216240|NCT02644759|Immunomodulation|immunomodulation
5216241|NCT02644759|CD34|cd34
5216242|NCT02644759|CD133|cd133
5216243|NCT02644759|ClinicMACS|clinicmacs
5216244|NCT02644746|degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
5216245|NCT02644746|acupuncture|acupuncture
5216246|NCT02644746|randomized controlled trial|randomized controlled trial
5216247|NCT02644668|Reldesemtiv|reldesemtiv
5216248|NCT02644655|Recurrent B-Cell Tumor|recurrent b-cell tumor
5216249|NCT02644655|Refractory B-Cell Tumor|refractory b-cell tumor
5216250|NCT02644655|New Cluster of Differentiation Antigen 19-chimeric Antigen Receptor T Cells|new cluster of differentiation antigen 19-chimeric antigen receptor t cells
5216251|NCT02644655|safety|safety
5216252|NCT02644655|prognosis|prognosis
5216253|NCT02644616|tolvaptan|tolvaptan
5216254|NCT02644616|safety and efficacy|safety and efficacy
5216255|NCT02644616|left heart valves replacement|left heart valves replacement
5216256|NCT02644603|Enhanced Recovery After Surgery|enhanced recovery after surgery
5216257|NCT02644603|hepatocellular carcinoma|hepatocellular carcinoma
5216258|NCT02644590|Melatonin|melatonin
5216259|NCT02644590|Nocturnal Hypertension|nocturnal hypertension
5216260|NCT02644590|Type 1 Diabetes Melitus|type 1 diabetes melitus
5216261|NCT02644577|Metformin|metformin
5216262|NCT02644577|antipsychotic-induced metabolic syndrome|antipsychotic-induced metabolic syndrome
5216263|NCT02644577|bipolar disorder|bipolar disorder
5216264|NCT02644564|Soft tissue shoulder injury|soft tissue shoulder injury
5216265|NCT02644564|Rotator cuff tear|rotator cuff tear
5216266|NCT02644564|Ultrasonography|ultrasonography
5216267|NCT02644538|HBsAg clearance|hbsag clearance
5216273|NCT02644434|Percutaneous Coronary Intervention|percutaneous coronary intervention
5216274|NCT02644434|Coronary Bifurcation Intervention|coronary bifurcation intervention
5216275|NCT02644434|Randomized Clinical Trial|randomized clinical trial
5216276|NCT02644421|Neuropathic Pain|neuropathic pain
5216277|NCT02644421|Sciatica|sciatica
5216278|NCT02644408|Chemoradiotherapy|chemoradiotherapy
5216279|NCT02644408|Esophageal Squamous Cancer|esophageal squamous cancer
5216280|NCT02644408|Megestrol|megestrol
5216285|NCT02644317|Motor development delay|motor development delay
5216286|NCT02644317|balance|balance
5216287|NCT02644317|flatfoot|flatfoot
5216288|NCT02644317|shoe insert|shoe insert
5216289|NCT02644291|medulloblastoma|medulloblastoma
5216290|NCT02644291|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
5216291|NCT02644291|high grade glioma|high grade glioma
5216292|NCT02644291|glioblastoma|glioblastoma
5216293|NCT02644291|brain stem malignant glioma|brain stem malignant glioma
5216294|NCT02644278|VX15-984-001|vx15-984-001
5216295|NCT02644278|VX-984|vx-984
5216296|NCT02644278|M9831|m9831
5216297|NCT02644278|Advanced Solid Tumor|advanced solid tumor
5216298|NCT02644278|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5216299|NCT02644265|Acute acquired brain injury|acute acquired brain injury
5216300|NCT02644265|Disorders of consciousness|disorders of consciousness
5216301|NCT02644265|Traumatic brain injury|traumatic brain injury
5216302|NCT02644265|Non-traumatic brain injury|non-traumatic brain injury
5216303|NCT02644265|Anoxic-ischemic encephalopathy|anoxic-ischemic encephalopathy
5216304|NCT02644265|Stroke|stroke
5216305|NCT02644265|Vegetative state|vegetative state
5216306|NCT02644265|Minimal conscious state|minimal conscious state
5216307|NCT02644265|Locked-in syndrome|locked-in syndrome
5216311|NCT02644174|Lung function test|lung function test
5216312|NCT02644174|Bariatric surgery|bariatric surgery
5216314|NCT02644161|depression|depression
5216315|NCT02644161|stroke sequelae|stroke sequelae
5216316|NCT02644161|acupuncture|acupuncture
5216317|NCT02644161|DCEAS|dceas
5216319|NCT02644161|LAS|las
5216320|NCT02644135|Healthy volunteer|healthy volunteer
5216515|NCT02643017|desflurane|desflurane
5216321|NCT02644122|advanced cancer|advanced cancer
5216322|NCT02644122|metastatic cancer|metastatic cancer
5216323|NCT02644122|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5216324|NCT02644122|SCCHN|scchn
5216325|NCT02644122|gene mutation|gene mutation
5216326|NCT02644122|PIK3R1, PIK3R5 and PIK3AP1|pik3r1, pik3r5 and pik3ap1
5216327|NCT02644122|PIK3CG|pik3cg
5216328|NCT02644122|AKT and mTOR|akt and mtor
5216329|NCT02644122|PIK3CA gene|pik3ca gene
5962649|NCT04279795|2019 Novel Coronavirus|2019 novel coronavirus
5216330|NCT02644122|PI-3 kinase inhibitor|pi-3 kinase inhibitor
5216331|NCT02644122|PI-3 kinase pathway genes|pi-3 kinase pathway genes
5216332|NCT02644096|Rehabilitation|rehabilitation
5216333|NCT02644096|RCT|rct
5216335|NCT02644096|Self-Rated Health|self-rated health
5216336|NCT02644070|Alveolar bone loss|alveolar bone loss
5216337|NCT02644070|Alveoloplasty|alveoloplasty
5216338|NCT02644070|Bone remodeling|bone remodeling
5216339|NCT02644070|Xenograft|xenograft
5216340|NCT02644070|Tooth socket|tooth socket
5216341|NCT02644070|Dental implant|dental implant
5216342|NCT02644044|Progressive multiple sclerosis|progressive multiple sclerosis
5216343|NCT02644044|methotrexate|methotrexate
5216344|NCT02644031|Instrumentation|instrumentation
5216345|NCT02644031|Post-operative pain|post-operative pain
5216346|NCT02644031|Root canal preparation|root canal preparation
5216347|NCT02644018|Ingavirin|ingavirin
5216348|NCT02644018|Common Cold|common cold
5216349|NCT02644018|Influenza|influenza
5216350|NCT02644018|Acute Respiratory Viral Infections|acute respiratory viral infections
5216351|NCT02644018|pediatric clinical trial|pediatric clinical trial
5216352|NCT02644018|Imidazolyl ethanamide pentandioic acid|imidazolyl ethanamide pentandioic acid
5216353|NCT02643979|Ketamine|ketamine
5216354|NCT02643979|Propofol|propofol
5216355|NCT02643979|Ketofol|ketofol
5216356|NCT02643979|Obese|obese
5216357|NCT02643979|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5216358|NCT02643979|Sedation|sedation
5216359|NCT02643979|Bariatric|bariatric
5216360|NCT02643966|whole breast ultrasound|whole breast ultrasound
5216361|NCT02643966|digital breast tomosynthesis|digital breast tomosynthesis
5216362|NCT02643966|breast density|breast density
5216363|NCT02643966|breast cancer screening|breast cancer screening
5216364|NCT02643953|Maternal Health|maternal health
5216365|NCT02643953|Maternal Mortality|maternal mortality
5216366|NCT02643953|Global Health|global health
5216367|NCT02643953|RCT|rct
5216368|NCT02643940|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5216369|NCT02643940|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5216370|NCT02643940|Cardiac MRI|cardiac mri
5216371|NCT02643940|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
5216372|NCT02643875|myopia control|myopia control
5216373|NCT02643875|orthokeratology|orthokeratology
5216374|NCT02643823|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
5216375|NCT02643823|Mesenchymal Stem Cell|mesenchymal stem cell
5216376|NCT02643823|Rheumatoid Arthritis|rheumatoid arthritis
5216377|NCT02643810|exercise training|exercise training
5216383|NCT02643784|acute ischemic stroke|acute ischemic stroke
5216384|NCT02643771|Dental Scaling|dental scaling
5216385|NCT02643771|Blood Glucose|blood glucose
5216386|NCT02643771|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5216387|NCT02643758|Myopia control, bifocal soft contact lenses, children|myopia control, bifocal soft contact lenses, children
5216388|NCT02643745|acute kidney injury|acute kidney injury
5216389|NCT02643745|cardiac surgery|cardiac surgery
5216390|NCT02643732|Activity|activity
5216391|NCT02643719|migraine|migraine
5216392|NCT02643719|topiramate|topiramate
5216393|NCT02643706|Aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
5216394|NCT02643706|contrast induced nephropathy|contrast induced nephropathy
5216395|NCT02643706|Gene polymorphism|gene polymorphism
5216396|NCT02643693|Conventional cigarette|conventional cigarette
5216397|NCT02643693|Nicotine lactate delivery system|nicotine lactate delivery system
5216398|NCT02643693|e-cigarette|e-cigarette
5216399|NCT02643693|VUSE|vuse
5216400|NCT02643693|Combustible cigarette|combustible cigarette
5216401|NCT02643680|Biocellulose|biocellulose
5216402|NCT02643680|Silk sericin|silk sericin
5216403|NCT02643680|Polyhexamethylene biguanide|polyhexamethylene biguanide
5216404|NCT02643680|Split thickness skin graft donor site|split thickness skin graft donor site
5216405|NCT02643667|Radical prostatectomy (RP)|radical prostatectomy (rp)
5216406|NCT02643654|interleukin-1alpha|interleukin-1alpha
5216407|NCT02643641|Grass pollen allergy|grass pollen allergy
5216408|NCT02643641|subcutaneous immunotherapy|subcutaneous immunotherapy
5216409|NCT02643641|allergy vaccine|allergy vaccine
5216410|NCT02643641|dose regimen|dose regimen
5216411|NCT02643615|Visual Evoked Potentials|visual evoked potentials
5216412|NCT02643589|haploidentical hematopoietic Stem Cell Transplantation Antithymocyte globulin|haploidentical hematopoietic stem cell transplantation antithymocyte globulin
5216413|NCT02643589|acute graft-versus-host disease|acute graft-versus-host disease
5216920|NCT02640547|Fibrosis|fibrosis
5216414|NCT02643589|antithymocyte globulin|antithymocyte globulin
5216415|NCT02643563|Brachial Plexus Block|brachial plexus block
5216416|NCT02643563|Anesthetics, Local|anesthetics, local
5216417|NCT02643524|Adult|adult
5216418|NCT02643524|CAM boot|cam boot
5216419|NCT02643524|controlled ankle movement|controlled ankle movement
5216420|NCT02643498|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5216421|NCT02643498|15-109|15-109
5216422|NCT02643472|neonate|neonate
5216423|NCT02643472|newborn|newborn
5216424|NCT02643472|neonatal intensive care unit|neonatal intensive care unit
5216425|NCT02643472|NICU|nicu
5216426|NCT02643472|NICU discharge|nicu discharge
5216427|NCT02643472|parent navigator|parent navigator
5216428|NCT02643472|peer to peer|peer to peer
5216429|NCT02643472|peer coaching|peer coaching
5216430|NCT02643459|Triage|triage
5216431|NCT02643459|Risk stratification|risk stratification
5216433|NCT02643459|suPAR|supar
5216434|NCT02643446|Poliovirus Vaccine, Inactivated|poliovirus vaccine, inactivated
5216435|NCT02643446|Poliovirus Vaccine, Oral|poliovirus vaccine, oral
5216436|NCT02643446|Immunity|immunity
5216437|NCT02643446|Seroconversion|seroconversion
5216438|NCT02643433|Immunogenicity|immunogenicity
5216439|NCT02643433|Coadministration|coadministration
5216440|NCT02643433|Measles|measles
5216441|NCT02643433|Rubella|rubella
5216442|NCT02643433|Japanese encephalitis|japanese encephalitis
5216443|NCT02643433|Vaccine|vaccine
5216444|NCT02643420|Neutropenia|neutropenia
5216445|NCT02643420|Breast Cancer|breast cancer
5216446|NCT02643420|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
5216447|NCT02643420|Early Stage Breast Cancer|early stage breast cancer
5216448|NCT02643420|Docetaxel + Cyclophosphamide (TC) chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
5216449|NCT02643407|squamous cell carcinoma|squamous cell carcinoma
5216450|NCT02643407|nedaplatin|nedaplatin
5216451|NCT02643407|cisplatin|cisplatin
5216452|NCT02643407|docetaxel|docetaxel
5216453|NCT02643394|Acetaminophen|acetaminophen
5216454|NCT02643394|Postoperative pain|postoperative pain
5216455|NCT02643394|Sinus Surgery|sinus surgery
5216456|NCT02643381|etomidate|etomidate
5216457|NCT02643381|ketamine|ketamine
5216458|NCT02643381|endotracheal intubation|endotracheal intubation
5216459|NCT02643381|anesthesia induction medications|anesthesia induction medications
5216460|NCT02643368|Polio|polio
5216461|NCT02643368|Inactivated polio vaccine|inactivated polio vaccine
5216462|NCT02643368|oral polio vaccine|oral polio vaccine
5216463|NCT02643368|monovalent type 2 oral polio vaccine|monovalent type 2 oral polio vaccine
5216464|NCT02643355|Narcotic Withdrawal|narcotic withdrawal
5216465|NCT02643355|Opiate Withdrawal|opiate withdrawal
5216466|NCT02643355|Emergency Department|emergency department
5216467|NCT02643342|myopia control|myopia control
5216468|NCT02643342|orthokeratology|orthokeratology
5216469|NCT02643303|Durvalumab|durvalumab
5216470|NCT02643303|MEDI4736|medi4736
5216471|NCT02643303|Tremelimumab|tremelimumab
5216472|NCT02643303|PolyICLC|polyiclc
5216473|NCT02643303|Hiltonol|hiltonol
5216474|NCT02643303|Locally Recurrent Breast Cancer|locally recurrent breast cancer
5216475|NCT02643303|Metastatic Melanoma|metastatic melanoma
5216476|NCT02643303|In Situ|in situ
5216477|NCT02643303|CTLA-4 Antibody|ctla-4 antibody
5216478|NCT02643303|PD-L1 Antibody|pd-l1 antibody
5216479|NCT02643303|TLR3 Agonist|tlr3 agonist
5216480|NCT02643303|CTCL|ctcl
5216481|NCT02643290|Adult Scoliosis|adult scoliosis
5216482|NCT02643290|Pain Management|pain management
5216483|NCT02643290|Orthosis|orthosis
5216484|NCT02643264|insula|insula
5216485|NCT02643264|alcohol addiction|alcohol addiction
5216486|NCT02643264|transcranial magnetic stimulation|transcranial magnetic stimulation
5216487|NCT02643251|Diabetes Mellitus|diabetes mellitus
5216488|NCT02643251|Pain|pain
5216489|NCT02643251|Foot Pain|foot pain
5216490|NCT02643251|Neuropathy|neuropathy
5216491|NCT02643160|Trunk Training|trunk training
5204532|NCT02716311|Lung Cancer|lung cancer
5204533|NCT02716285|Irritable Bowel Syndrome|irritable bowel syndrome
5204534|NCT02716285|Abdominal pain|abdominal pain
5204535|NCT02716285|Targeted Delivery|targeted delivery
5204536|NCT02716285|Peppermint oil|peppermint oil
5204537|NCT02716272|mesothelioma|mesothelioma
5204538|NCT02716272|immunotherapy|immunotherapy
5204539|NCT02716272|nivolumab|nivolumab
5204540|NCT02716272|ipilimumab|ipilimumab
5204541|NCT02716259|Periodontitis|periodontitis
5204561|NCT02716168|Cancer|cancer
5216492|NCT02643160|Motor Function|motor function
5216493|NCT02643147|Heart Failure|heart failure
5216494|NCT02643147|Renal Failure|renal failure
5216495|NCT02643147|Biomarker guided-therapy|biomarker guided-therapy
5216496|NCT02643147|Loop diuretics|loop diuretics
5216497|NCT02643147|Carbohydrate antigen 125|carbohydrate antigen 125
5216503|NCT02643108|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
5216505|NCT02643108|Anal incontinence|anal incontinence
5216506|NCT02643069|Frailty|frailty
5216507|NCT02643069|Frailty tools|frailty tools
5216508|NCT02643069|Clinical settings|clinical settings
5216509|NCT02643069|Disability|disability
5216510|NCT02643069|Quality of life|quality of life
5216511|NCT02643069|Functional Autonomy|functional autonomy
5216512|NCT02643043|Next Generation Sequencing|next generation sequencing
5216513|NCT02643043|Genomic Analysis|genomic analysis
5216514|NCT02643017|cognitive function|cognitive function
5216516|NCT02643017|dexmedetomidine|dexmedetomidine
5216517|NCT02642978|minimally invasive surgery|minimally invasive surgery
5216518|NCT02642978|colorectal liver metastasis|colorectal liver metastasis
5216519|NCT02642978|robotic surgery|robotic surgery
5216520|NCT02642978|Patients with resectable colorectal liver metastasis|patients with resectable colorectal liver metastasis
5216521|NCT02642952|arterial stiffness, central hemodynamics|arterial stiffness, central hemodynamics
5216522|NCT02642926|menorrhagia|menorrhagia
5085157|NCT03466294|AML|aml
5094649|NCT03407196|Endocrinology|endocrinology
5094650|NCT03407196|Internal diseases|internal diseases
5094651|NCT03407196|Type II diabetes mellitus|type ii diabetes mellitus
5094654|NCT03407196|BP|bp
5094656|NCT03407170|PD1|pd1
5216523|NCT02642926|higham PBAC score|higham pbac score
5216524|NCT02642926|endometrial ablation|endometrial ablation
5216525|NCT02642926|bipolar energy|bipolar energy
5216544|NCT02642783|laxatives|laxatives
5216545|NCT02642783|sensory evaluation|sensory evaluation
5216546|NCT02642783|acceptability|acceptability
5216547|NCT02642783|colonoscopy|colonoscopy
5216548|NCT02642770|Transesophageal echocardiography, Speckle tracking strain|transesophageal echocardiography, speckle tracking strain
5216549|NCT02642757|alcohol drinking|alcohol drinking
5216550|NCT02642757|hazardous alcohol use|hazardous alcohol use
5216551|NCT02642757|risky alcohol consumption|risky alcohol consumption
5216552|NCT02642757|heavy alcohol consumption|heavy alcohol consumption
5216553|NCT02642731|total knee arthroplasty|total knee arthroplasty
5216554|NCT02642731|Kidney function|kidney function
5216555|NCT02642731|Renal markers|renal markers
5216556|NCT02642718|preemptive analgesia|preemptive analgesia
5216557|NCT02642718|postoperative pain|postoperative pain
5216558|NCT02642718|NSAIDs|nsaids
5216559|NCT02642718|ketorolac|ketorolac
5216560|NCT02642718|abdominal hysterectomy|abdominal hysterectomy
5216561|NCT02642692|ACL reconstruction|acl reconstruction
5216562|NCT02642692|Single bundle|single bundle
5216563|NCT02642692|Clinical results|clinical results
5216564|NCT02642692|Soccer players|soccer players
5216565|NCT02642679|Split-thickness skin graft, donor site, chitosan, dressing|split-thickness skin graft, donor site, chitosan, dressing
5216566|NCT02642666|Attention|attention
5216567|NCT02642666|Hyperactivity|hyperactivity
5216568|NCT02642666|Impulsivity|impulsivity
5216569|NCT02642666|Yoga|yoga
5216570|NCT02642666|Preschool|preschool
5216571|NCT02642653|Fra(X) Syndrome|fra(x) syndrome
5216572|NCT02642653|Trinucleotide Repeat Expansion|trinucleotide repeat expansion
5216573|NCT02642653|Fragile X Syndrome|fragile x syndrome
5216574|NCT02642653|Fragile X Mental Retardation Syndrome|fragile x mental retardation syndrome
5216575|NCT02642653|Intellectual Disability|intellectual disability
5216576|NCT02642653|Parent Implemented Language Intervention (PILI)|parent implemented language intervention (pili)
5216577|NCT02642653|FXS|fxs
5289538|NCT02226081|BI-RADS|bi-rads
5204634|NCT02715817|Video Games|video games
5216578|NCT02642653|Mental Retardation, X-linked|mental retardation, x-linked
5216579|NCT02642653|Genetic Diseases, X-linked|genetic diseases, x-linked
5216580|NCT02642653|Neurobehavioral Manifestations|neurobehavioral manifestations
5216581|NCT02642653|Chromosome Disorders|chromosome disorders
5216582|NCT02642601|indomethacin, ICSI, difficult embryo transfer|indomethacin, icsi, difficult embryo transfer
5216583|NCT02642562|Intravenous iron|intravenous iron
5216584|NCT02642562|PROBE design|probe design
5216585|NCT02642536|Veteran|veteran
5216586|NCT02642523|natriuretic peptide|natriuretic peptide
5216587|NCT02642523|insulin|insulin
5216588|NCT02642523|lipolysis|lipolysis
5216589|NCT02642523|hormones|hormones
5216590|NCT02642523|metabolism|metabolism
5216591|NCT02642497|postoperative analgesia|postoperative analgesia
5216592|NCT02642497|ketamine|ketamine
5216593|NCT02642497|total thyroidectomy|total thyroidectomy
5216594|NCT02642471|sentinel lymph node|sentinel lymph node
5216595|NCT02642471|pelvic lymphadenectomy|pelvic lymphadenectomy
5216596|NCT02642471|cervical carcinoma|cervical carcinoma
5216598|NCT02642471|radiotherapy|radiotherapy
5216599|NCT02642445|Renal sympathetic denervation;hypertension|renal sympathetic denervation;hypertension
5216600|NCT02642432|HCV Genotype 1|hcv genotype 1
5216601|NCT02642432|HCV Genotype 4|hcv genotype 4
5216602|NCT02642432|HCV Genotype 2|hcv genotype 2
5216603|NCT02642432|Cirrhotic|cirrhotic
5216604|NCT02642432|Interferon-Free|interferon-free
5216605|NCT02642432|Compensated Cirrhosis|compensated cirrhosis
5216606|NCT02642432|HCV Genotype 5|hcv genotype 5
5216607|NCT02642432|Hepatitis C|hepatitis c
5216608|NCT02642432|HCV Genotype 6|hcv genotype 6
5216609|NCT02642393|SURE-PD3|sure-pd3
5216921|NCT02640547|Cirrhosis|cirrhosis
5216610|NCT02642393|Parkinson's disease|parkinson's disease
5216612|NCT02642393|Inosine|inosine
5216613|NCT02642393|Urate|urate
5216614|NCT02642393|Parkinson Study Group (PSG)|parkinson study group (psg)
5216618|NCT02642328|Aerobic Exercise|aerobic exercise
5216619|NCT02642328|Physical Conditioning|physical conditioning
5216621|NCT02642302|Aerobic Exercise|aerobic exercise
5216622|NCT02642302|Physical Conditioning|physical conditioning
5216623|NCT02642289|Probiotics|probiotics
5216624|NCT02642276|exercise training|exercise training
5216625|NCT02642250|safety|safety
5216626|NCT02642250|efficacy|efficacy
5216627|NCT02642237|Fluenz|fluenz
5216628|NCT02642237|innate immune response|innate immune response
5216629|NCT02642237|endotoxin tolerance|endotoxin tolerance
5962650|NCT04279782|2019 Novel Coronavirus|2019 novel coronavirus
5962651|NCT04279769|Arginase inhibitor|arginase inhibitor
5962652|NCT04279769|CB-280|cb-280
5962653|NCT04279756|Hip mobilization on hip internal rotation|hip mobilization on hip internal rotation
5962654|NCT04279704|Metastable epialleles|metastable epialleles
5962655|NCT04279704|Monozygotic|monozygotic
5216630|NCT02642237|priming|priming
5216631|NCT02642224|Violence|violence
5216632|NCT02642224|firearm|firearm
5216633|NCT02642224|guns|guns
5216634|NCT02642224|homicide|homicide
5216635|NCT02642224|trauma|trauma
5216636|NCT02642224|injury|injury
5216637|NCT02642198|NiBP|nibp
5216638|NCT02642185|microwave|microwave
5216639|NCT02642185|ablation|ablation
5216640|NCT02642185|resection|resection
5216641|NCT02642185|liver|liver
5216642|NCT02642185|colorectal|colorectal
5216643|NCT02642185|survival|survival
5216644|NCT02642185|metastasis|metastasis
5216646|NCT02642107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5216647|NCT02642107|elective neck irradiation|elective neck irradiation
5216648|NCT02642081|NSAIDs|nsaids
5216649|NCT02642081|Heart failure|heart failure
5216650|NCT02642081|Acute kidney injury|acute kidney injury
5216651|NCT02642068|Drug-naïve Adult ADHD|drug-naïve adult adhd
5216652|NCT02642068|Neuropsychology|neuropsychology
5216653|NCT02642068|Neurophysiology|neurophysiology
5216654|NCT02642068|Neuroimaging|neuroimaging
5216655|NCT02642068|Follow-up|follow-up
5216656|NCT02642055|ADHD|adhd
5216657|NCT02642055|Neurofeedback|neurofeedback
5216658|NCT02642055|Biofeedback|biofeedback
5216659|NCT02642055|Neuro+|neuro+
5216660|NCT02642055|Go/no-go|go/no-go
5216661|NCT02642055|Attention training|attention training
5216662|NCT02642029|time perception|time perception
5216663|NCT02642029|executive function|executive function
5216664|NCT02642029|psychosis|psychosis
5216665|NCT02642029|mood symptoms|mood symptoms
5216666|NCT02642016|KTN0158|ktn0158
5216667|NCT02642016|Advanced Cancer|advanced cancer
5216668|NCT02642016|Phase 1|phase 1
5216669|NCT02642016|Monoclonal Antibody|monoclonal antibody
5216670|NCT02642016|Safety and Pharmacokinetics|safety and pharmacokinetics
5216671|NCT02641925|Metabolic syndrome|metabolic syndrome
5216672|NCT02641925|gastric cancer|gastric cancer
5216673|NCT02641925|omentectomy|omentectomy
5216674|NCT02641899|Adult|adult
5216675|NCT02641899|Male|male
5216676|NCT02641899|Female|female
5216677|NCT02641899|Volunteers|volunteers
5216678|NCT02641886|traditional Chinese medicine granules|traditional chinese medicine granules
5216679|NCT02641886|Cognitive Impairment|cognitive impairment
5216680|NCT02641886|Acute cerebral infraction|acute cerebral infraction
5216681|NCT02641886|prevention|prevention
5216682|NCT02641873|metastatic Colorectal Cancer|metastatic colorectal cancer
5216684|NCT02641847|triple negative breast cancer|triple negative breast cancer
5216685|NCT02641847|mRNA-lncRNA signature|mrna-lncrna signature
5216686|NCT02641847|chemotherapy|chemotherapy
5216687|NCT02641847|high risk|high risk
5216688|NCT02641834|diet|diet
5216689|NCT02641834|vegetarian|vegetarian
5216690|NCT02641834|cardiovascular risk|cardiovascular risk
5216691|NCT02641795|cochlear implantation|cochlear implantation
5216692|NCT02641795|robotics|robotics
5216693|NCT02641795|image guidance|image guidance
5216694|NCT02641782|High Risk Neuroblastoma|high risk neuroblastoma
5216695|NCT02641756|HIV reservoir|hiv reservoir
5216701|NCT02641730|Palmoplantar Pustulosis|palmoplantar pustulosis
5216702|NCT02641717|patient-collected|patient-collected
5216703|NCT02641717|self-collected|self-collected
5216704|NCT02641717|vaginitis|vaginitis
5216705|NCT02641717|vaginosis, bacterial|vaginosis, bacterial
5216706|NCT02641717|candidiasis|candidiasis
5216707|NCT02641717|trichomonas|trichomonas
5216708|NCT02641717|vaginal discharge|vaginal discharge
5216709|NCT02641678|Atrial Fibrillation|atrial fibrillation
5216710|NCT02641678|stroke|stroke
5216711|NCT02641678|implantable cardiac monitor|implantable cardiac monitor
5216712|NCT02641678|automated ECG analysis|automated ecg analysis
5216713|NCT02641652|paroxysmal hypertension|paroxysmal hypertension
5216714|NCT02641652|pseudopheochromocytoma|pseudopheochromocytoma
5216720|NCT02641587|Smoking|smoking
5216721|NCT02641587|Cigarettes|cigarettes
5216722|NCT02641587|Reduced exposure|reduced exposure
5216723|NCT02641587|Confinement|confinement
5216724|NCT02641587|Ambulatory|ambulatory
5216725|NCT02641587|Carbon Heated Tobacco Product|carbon heated tobacco product
5216726|NCT02641561|Pancreatitis|pancreatitis
5216727|NCT02641561|ERCP|ercp
5216728|NCT02641561|Indomethacin|indomethacin
5216729|NCT02641561|Lactated ringer's|lactated ringer's
5216730|NCT02641522|T1D|t1d
5216732|NCT02641496|Obstructive Sleep Apnea|obstructive sleep apnea
5216734|NCT02641496|Posttraumatic Stress Disorder|posttraumatic stress disorder
5216735|NCT02641496|Cognitive Behavioral Therapy|cognitive behavioral therapy
5216736|NCT02641496|Continuous Positive Airway Pressure|continuous positive airway pressure
5216737|NCT02641496|CPAP|cpap
5216738|NCT02641496|Cognition|cognition
5216739|NCT02641496|Memory|memory
5216740|NCT02641496|Quality of Life|quality of life
5216741|NCT02641496|Self Efficacy|self efficacy
5216742|NCT02641496|CBT|cbt
5216743|NCT02641496|OSA|osa
5216744|NCT02641496|Sleep Apnea|sleep apnea
5216745|NCT02641496|Education|education
5216746|NCT02641496|Psychotherapy|psychotherapy
5216747|NCT02641496|Post Traumatic Stress Disorder|post traumatic stress disorder
5216748|NCT02641496|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5085344|NCT03465332|COPD|copd
5094883|NCT03405857|cognitive training program|cognitive training program
5094884|NCT03405844|Shoulder|shoulder
5094885|NCT03405844|glenohumeral|glenohumeral
5094886|NCT03405844|stretching|stretching
5094949|NCT03405480|PPS|pps
5216749|NCT02641496|Therapy|therapy
5216750|NCT02641457|rubeosis iridis|rubeosis iridis
5216751|NCT02641457|glaucoma|glaucoma
5216752|NCT02641457|ranibizumab|ranibizumab
5216753|NCT02641457|aflibercept|aflibercept
5216754|NCT02641431|radiofrequency ablation|radiofrequency ablation
5216755|NCT02641431|mapping|mapping
5216756|NCT02641431|sudden death|sudden death
5216757|NCT02641431|syncope|syncope
5216758|NCT02641418|Exercise|exercise
5216759|NCT02641405|Gait analysis|gait analysis
5216760|NCT02641405|Proprioceptive focal stimulation|proprioceptive focal stimulation
5216761|NCT02641405|Parkinson|parkinson
5216762|NCT02641392|Crohn's Disease|crohn's disease
5216763|NCT02641392|GED 0301|ged 0301
5216764|NCT02641392|Mongersen|mongersen
5216765|NCT02641392|Safety|safety
5216766|NCT02641392|Irritable Bowel Disease|irritable bowel disease
5216767|NCT02641353|Apremilast|apremilast
5216768|NCT02641353|Healthy volunteers|healthy volunteers
5216769|NCT02641353|Bioavailability|bioavailability
5216770|NCT02641353|Food effect|food effect
5216771|NCT02641353|Pharmacokinetic|pharmacokinetic
5216772|NCT02641327|Inhospital patients|inhospital patients
5216773|NCT02641314|Recurrent Neuroblastoma|recurrent neuroblastoma
5216774|NCT02641301|obesity|obesity
5216775|NCT02641301|Roux-en-Y-gastric bypass|roux-en-y-gastric bypass
5216776|NCT02641301|pharmacokinetics|pharmacokinetics
5216777|NCT02641301|Pain|pain
5216778|NCT02641301|morphine|morphine
5216779|NCT02641275|Parental stress|parental stress
5216780|NCT02641275|Muscular Dystrophies|muscular dystrophies
5216781|NCT02641275|Coping|coping
5216782|NCT02641275|Parental support|parental support
5216783|NCT02641262|Myocardial Infarction|myocardial infarction
5216784|NCT02641262|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
5216785|NCT02641262|Drug Therapy|drug therapy
5216786|NCT02641236|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5216787|NCT02641236|Acute GVH Disease|acute gvh disease
5216788|NCT02641210|Chronic periodontitis|chronic periodontitis
5216789|NCT02641210|Hepcidin|hepcidin
5216790|NCT02641210|Hemoglobin|hemoglobin
5216791|NCT02641210|Inflammation|inflammation
5216792|NCT02641197|flow-mediated dilation|flow-mediated dilation
5216793|NCT02641197|AngioDefender|angiodefender
5216794|NCT02641197|device precision|device precision
5216795|NCT02641197|repeatability|repeatability
5216796|NCT02641197|reproducibility|reproducibility
5216802|NCT02641184|Diabetes|diabetes
5216803|NCT02641158|HIV|hiv
5216804|NCT02641158|Hepatitis C|hepatitis c
5216805|NCT02641158|Substance users|substance users
5216806|NCT02641158|Drug users|drug users
5216807|NCT02641145|amyloidosis|amyloidosis
5216808|NCT02641145|F-18 florbetapir|f-18 florbetapir
5216809|NCT02641145|Positron emission tomography|positron emission tomography
5216810|NCT02641145|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5216811|NCT02641119|Albumin|albumin
5216812|NCT02641119|Resuscitation|resuscitation
5216813|NCT02641106|Telemedicine|telemedicine
5216814|NCT02641106|Mobile Phone|mobile phone
5216815|NCT02641106|Adherence|adherence
5216816|NCT02641106|Latent Tuberculosis Infection|latent tuberculosis infection
5216817|NCT02641106|Directly Observed Therapy|directly observed therapy
5216818|NCT02641106|Video DOT|video dot
5216820|NCT02641041|Single Ascending Dose (SAD)|single ascending dose (sad)
5216919|NCT02640547|Quality of Life|quality of life
5216821|NCT02641041|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5216822|NCT02641015|UTI|uti
5216823|NCT02641002|CC-90002|cc-90002
5216824|NCT02641002|Monoclonal|monoclonal
5216825|NCT02641002|Antibody|antibody
5216826|NCT02641002|CD47|cd47
5216827|NCT02641002|Hematologic Cancers|hematologic cancers
5216828|NCT02641002|Acute Myeloid Leukemia|acute myeloid leukemia
5216829|NCT02641002|AML|aml
5216830|NCT02641002|Myelodysplastic syndrome|myelodysplastic syndrome
5216831|NCT02641002|MDS|mds
5216832|NCT02641002|Blood disorder|blood disorder
5216833|NCT02640989|Influenza Vaccine|influenza vaccine
5216834|NCT02640989|Safety|safety
5216835|NCT02640989|Immunogenicity|immunogenicity
5216836|NCT02640976|in vitro fertilization|in vitro fertilization
5962656|NCT04279704|Epigenetic|epigenetic
5962657|NCT04279704|Twins|twins
5962658|NCT04279704|DNA methylation|dna methylation
5962659|NCT04279704|Genetic|genetic
5962660|NCT04279652|ADHD|adhd
5962661|NCT04279652|Exercise|exercise
5216837|NCT02640976|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5216839|NCT02640976|estrogen receptor 2 gene polymorphism|estrogen receptor 2 gene polymorphism
5216840|NCT02640976|follicle stimulating hormone receptor gene polymorphism|follicle stimulating hormone receptor gene polymorphism
5216841|NCT02640976|anti-mullerian hormone|anti-mullerian hormone
5216842|NCT02640963|exercise|exercise
5216843|NCT02640963|older adults|older adults
5216844|NCT02640963|physical performance|physical performance
5962662|NCT04279652|motor proficiency|motor proficiency
5962663|NCT04279626|Laparoscopy|laparoscopy
5216845|NCT02640937|Staphylococcus epidermidis|staphylococcus epidermidis
5216846|NCT02640937|biofilm formation|biofilm formation
5216847|NCT02640937|antibiotic resistance|antibiotic resistance
5216848|NCT02640937|Orthopaedic device related infections|orthopaedic device related infections
5216849|NCT02640937|risk factor|risk factor
5216850|NCT02640924|Hepatocellular carcinoma|hepatocellular carcinoma
5216851|NCT02640924|Proton therapy|proton therapy
5216852|NCT02640924|Radiation therapy|radiation therapy
5216853|NCT02640924|Switching control radiofrequency ablation|switching control radiofrequency ablation
5216854|NCT02640872|sarcopenia|sarcopenia
5216855|NCT02640872|sarcopenic obesity|sarcopenic obesity
5216856|NCT02640872|osteoporosis|osteoporosis
5216857|NCT02640872|fracture|fracture
5216858|NCT02640872|cardiovascular disease|cardiovascular disease
5216859|NCT02640872|mortality|mortality
5216860|NCT02640846|Levosimendan|levosimendan
5216861|NCT02640846|Milrinone|milrinone
5216862|NCT02640846|Myocardial strain|myocardial strain
5216863|NCT02640846|Septic cardiomyopathy|septic cardiomyopathy
5216864|NCT02640846|Norepinephrine|norepinephrine
5216865|NCT02640833|Refractory Lymphoma|refractory lymphoma
5216866|NCT02640833|Relapsed Leukemia|relapsed leukemia
5216867|NCT02640820|HPV|hpv
5216868|NCT02640820|Verruca Vulgaris|verruca vulgaris
5216869|NCT02640807|sepsis lymphocytopenia IL-7|sepsis lymphocytopenia il-7
5216870|NCT02640807|immune reconstitution|immune reconstitution
5216871|NCT02640794|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5216872|NCT02640794|Antithrombotic treatment|antithrombotic treatment
5216873|NCT02640794|Clopidogrel|clopidogrel
5216874|NCT02640794|Aspirin/acetylsalicylic acid|aspirin/acetylsalicylic acid
5216875|NCT02640794|Myocardial Infarction|myocardial infarction
5216876|NCT02640794|Ischemic stroke|ischemic stroke
5216877|NCT02640794|Major bleeding|major bleeding
5216878|NCT02640768|in-hospital diabetes|in-hospital diabetes
5216879|NCT02640768|clinical and management model|clinical and management model
5216880|NCT02640755|Radiolabelled|radiolabelled
5216881|NCT02640729|Lewy body dementia|lewy body dementia
5216882|NCT02640729|Dementia with Lewy bodies|dementia with lewy bodies
5216883|NCT02640729|Parkinson's disease dementia|parkinson's disease dementia
5216884|NCT02640729|Lewy bodies|lewy bodies
5216885|NCT02640729|Visual hallucinations|visual hallucinations
5216894|NCT02640664|intravitreal ranibizumab|intravitreal ranibizumab
5216895|NCT02640664|laser ablation therapy|laser ablation therapy
5216896|NCT02640664|retinopathy of prematurity|retinopathy of prematurity
5216898|NCT02640664|RAINBOW|rainbow
5216899|NCT02640638|Racial disparities|racial disparities
5216900|NCT02640625|HIV|hiv
5216901|NCT02640625|Probiotics|probiotics
5216902|NCT02640625|Microbiota|microbiota
5216903|NCT02640625|Mucosal immunology|mucosal immunology
5216904|NCT02640625|Gut biopsy|gut biopsy
5216905|NCT02640599|Vestibular|vestibular
5216906|NCT02640599|Rehabilitation|rehabilitation
5216907|NCT02640560|Children|children
5216908|NCT02640560|Allergy|allergy
5216909|NCT02640560|Peanuts|peanuts
5216910|NCT02640560|Hazelnuts|hazelnuts
5216911|NCT02640560|Walnuts|walnuts
5216912|NCT02640560|Mollusks|mollusks
5216913|NCT02640560|Shellfish|shellfish
5216914|NCT02640560|Food|food
5216915|NCT02640547|Chronic Hepatitis C|chronic hepatitis c
5216916|NCT02640547|Dasabuvir|dasabuvir
5216917|NCT02640547|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
5216918|NCT02640547|Observational Study|observational study
5216922|NCT02640547|Work Ability|work ability
5216923|NCT02640534|Prostate cancer|prostate cancer
5216924|NCT02640534|Cancer of the prostate|cancer of the prostate
5216925|NCT02640534|Metformin|metformin
5216926|NCT02640534|Enzalutamide|enzalutamide
5216927|NCT02640534|Xtandi|xtandi
5216928|NCT02640534|castration resistant prostate cancer|castration resistant prostate cancer
5216929|NCT02640534|phase II|phase ii
5216930|NCT02640534|Androgen deprivation therapy|androgen deprivation therapy
5216931|NCT02640495|Treatment Efficacy|treatment efficacy
5216932|NCT02640495|drug resistance|drug resistance
5216933|NCT02640495|Artemisinin|artemisinin
5216934|NCT02640482|Treatment-Naive|treatment-naive
5216935|NCT02640482|Hepatitis C Virus Genotype 2|hepatitis c virus genotype 2
5216936|NCT02640482|Sofosbuvir (SOF)-Experienced|sofosbuvir (sof)-experienced
5216937|NCT02640482|Treatment-Experienced|treatment-experienced
5216938|NCT02640482|Non-cirrhotic|non-cirrhotic
5216939|NCT02640469|chlorhexidine|chlorhexidine
5216940|NCT02640469|sterility|sterility
5216941|NCT02640469|sterile hands|sterile hands
5216942|NCT02640456|retropharyngeal abscess|retropharyngeal abscess
5216943|NCT02640456|parapharyngeal abscess|parapharyngeal abscess
5216944|NCT02640456|peritonsillar abscess|peritonsillar abscess
5216945|NCT02640456|bacteriology|bacteriology
5216946|NCT02640456|Fusobacterium necrophorum|fusobacterium necrophorum
5216947|NCT02640417|Nucleotides (uridine, cytidine)|nucleotides (uridine, cytidine)
5216948|NCT02640417|Vitamin B1|vitamin b1
5216949|NCT02640417|Vitamin B6|vitamin b6
5216950|NCT02640417|Vitamin B12|vitamin b12
5216951|NCT02640404|Meningitis|meningitis
5216952|NCT02640404|Meningococcal Meningitis|meningococcal meningitis
5216953|NCT02640404|Meningococcal Infections|meningococcal infections
5216954|NCT02640404|Menactra®|menactra®
5216955|NCT02640404|Meningococcal Vaccine|meningococcal vaccine
5216956|NCT02640391|Ulcerative colitis|ulcerative colitis
5216957|NCT02640391|fecal calprotectin|fecal calprotectin
5216958|NCT02640391|mucosal healing|mucosal healing
5216960|NCT02640365|GERCOR|gercor
5216961|NCT02640365|unresectable|unresectable
5216962|NCT02640365|MM-398|mm-398
5216963|NCT02640365|CPT-11|cpt-11
5216964|NCT02640365|colorectal|colorectal
5216965|NCT02640365|non colorectal|non colorectal
5216966|NCT02640326|Urinary Catheterization|urinary catheterization
5216967|NCT02640326|Randomized Controlled Trial|randomized controlled trial
5216968|NCT02640326|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5216969|NCT02640326|Quality Improvement|quality improvement
5216970|NCT02640326|Evidence-Based Practice|evidence-based practice
5216971|NCT02640326|Post-operative complications|post-operative complications
5216972|NCT02640313|18F-fluormethylcholine|18f-fluormethylcholine
5216973|NCT02640313|[F18] choline|[f18] choline
5216974|NCT02640313|[F18] fluormethylcholine|[f18] fluormethylcholine
5216975|NCT02640300|antipsychotics, clozapine, schizophrenia, switching strategy|antipsychotics, clozapine, schizophrenia, switching strategy
5216976|NCT02640274|Practise Patterns, Nurses'|practise patterns, nurses'
5216977|NCT02640274|Directive Counseling|directive counseling
5216978|NCT02640274|Self Care|self care
5216979|NCT02640261|r-hLH|r-hlh
5216980|NCT02640261|Cytokines|cytokines
5216981|NCT02640261|Follicular Fluid|follicular fluid
5216982|NCT02640235|Hemostasis|hemostasis
5216983|NCT02640235|Oxidized Cellulose Strip|oxidized cellulose strip
5216984|NCT02640235|Traumacel|traumacel
5216985|NCT02640235|Traumastem|traumastem
5216986|NCT02640235|Cardiothoracic Surgery|cardiothoracic surgery
5216987|NCT02640235|General Surgery|general surgery
5216988|NCT02640235|Vascular Surgery|vascular surgery
5216989|NCT02640196|Laryngoscope|laryngoscope
5216990|NCT02640196|Macintosh|macintosh
5216991|NCT02640196|Glidescope|glidescope
5216992|NCT02640196|King Vision|king vision
5216993|NCT02640196|Airtraq|airtraq
5217002|NCT02640157|Hep C|hep c
5217003|NCT02640157|sofosbuvir|sofosbuvir
5217004|NCT02640157|Chronic Hepatitis C|chronic hepatitis c
5217005|NCT02640157|Daklinza|daklinza
5217006|NCT02640144|Hyaluronic acid|hyaluronic acid
5217007|NCT02640144|Knee arthroscopy|knee arthroscopy
5217008|NCT02640144|pain reduction|pain reduction
5217009|NCT02640144|swelling|swelling
5109544|NCT03313297|skin|skin
5217010|NCT02640144|osteoarthritis|osteoarthritis
5217011|NCT02640144|cartilage lesion|cartilage lesion
5217012|NCT02640144|rehabilitation following knee arthroscopy|rehabilitation following knee arthroscopy
5217013|NCT02640144|Hyaluronic acid injection|hyaluronic acid injection
5217014|NCT02640131|prostate cancer|prostate cancer
5217015|NCT02640131|radical prostatectomy|radical prostatectomy
5217016|NCT02640131|survivorship|survivorship
5217017|NCT02640131|quality of life|quality of life
5217018|NCT02640131|erectile dysfunction|erectile dysfunction
5217019|NCT02640131|sexual dysfunction|sexual dysfunction
5217020|NCT02640131|feasibility study|feasibility study
5217021|NCT02640079|Cognitive behavioral therapy|cognitive behavioral therapy
5217022|NCT02640079|Laboratory pain responsivity|laboratory pain responsivity
5217029|NCT02639988|type 2 diabetes mellitus|type 2 diabetes mellitus
5217030|NCT02639988|Rheumatoid arthritis|rheumatoid arthritis
5217031|NCT02639975|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
5217032|NCT02639962|culprit lesion|culprit lesion
5217033|NCT02639962|arteriosclerosis|arteriosclerosis
5217034|NCT02639962|cardiac CT|cardiac ct
5217036|NCT02639923|microRNA|microrna
5217037|NCT02639923|S-100B|s-100b
5217038|NCT02639910|CD19|cd19
5217039|NCT02639910|MOR208|mor208
5217040|NCT02639910|MOR00208|mor00208
5217041|NCT02639910|CLL|cll
5217042|NCT02639910|SLL|sll
5217043|NCT02639910|COSMOS|cosmos
5217044|NCT02639910|tafasitamab|tafasitamab
5217045|NCT02639871|Huntington disease|huntington disease
5217046|NCT02639871|Neuroimaging metabolic biomarker|neuroimaging metabolic biomarker
5217047|NCT02639832|Triple Negative Breast Cancer|triple negative breast cancer
5217048|NCT02639832|Breast Cancer|breast cancer
5217049|NCT02639832|Natural Killer Cells|natural killer cells
5217050|NCT02639832|BRCA Mutation|brca mutation
5217051|NCT02639819|Intracerebral Hemorrhage|intracerebral hemorrhage
5217052|NCT02639819|Stroke|stroke
5217053|NCT02639819|Cerebrovascular|cerebrovascular
5217054|NCT02639806|stroke|stroke
5217055|NCT02639806|endovascular|endovascular
5217056|NCT02639806|thrombectomy|thrombectomy
5217057|NCT02639806|ischemic stroke|ischemic stroke
5217058|NCT02639806|general anesthetic|general anesthetic
5217059|NCT02639806|local anesthetic|local anesthetic
5217060|NCT02639806|recanalization|recanalization
5862858|NCT00001480|Diagnostic Test|diagnostic test
5217061|NCT02639793|arrhythmias, quality of life|arrhythmias, quality of life
5217062|NCT02639767|Pemetrexed|pemetrexed
5217063|NCT02639767|Cisplatin|cisplatin
5217064|NCT02639767|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5217065|NCT02639767|15-304|15-304
5217066|NCT02639741|Melatonin|melatonin
5095176|NCT03403972|gut microbiome|gut microbiome
5217067|NCT02639741|Vitamin C|vitamin c
5217068|NCT02639741|Morphine consumption|morphine consumption
5217069|NCT02639728|Bowel surgery|bowel surgery
5217070|NCT02639728|Postoperative bowel recovery|postoperative bowel recovery
5217071|NCT02639702|Clozapine|clozapine
5217073|NCT02639702|Once daily|once daily
5217074|NCT02639702|Regimen|regimen
5217075|NCT02639702|Schizophrenia|schizophrenia
5217076|NCT02639689|Deficits of foot relievers of central origin|deficits of foot relievers of central origin
5217077|NCT02639689|Walkaide|walkaide
5217078|NCT02639676|Infant|infant
5217079|NCT02639676|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5217080|NCT02639676|Premature|premature
5217081|NCT02639650|gestational trophoblastic tumor|gestational trophoblastic tumor
5217082|NCT02639650|paclitaxel|paclitaxel
5217083|NCT02639650|cisplatin|cisplatin
5217084|NCT02639650|carboplatin|carboplatin
5217085|NCT02639650|chemotherapy|chemotherapy
5217086|NCT02639637|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5217087|NCT02639637|Sitagliptin|sitagliptin
5217088|NCT02639637|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
5217089|NCT02639637|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
5217090|NCT02639637|Enalaprilat|enalaprilat
5217091|NCT02639637|Neuropeptide Y|neuropeptide y
5863322|NCT00001325|Cerebral|cerebral
5217101|NCT02639585|asunaprevir|asunaprevir
5217102|NCT02639533|fibromyalgia|fibromyalgia
5217103|NCT02639533|pregabalin|pregabalin
5217104|NCT02639533|cortical excitability|cortical excitability
5217105|NCT02639533|functional near infrared spectroscopy|functional near infrared spectroscopy
5217106|NCT02639520|Uncomplicated urinary tract infection|uncomplicated urinary tract infection
5217107|NCT02639481|traumatic brain injury|traumatic brain injury
5217108|NCT02639481|stroke|stroke
5217109|NCT02639481|disorders of consciousness|disorders of consciousness
5217110|NCT02639481|rehabilitation|rehabilitation
5217111|NCT02639481|robotic rehabilitation device|robotic rehabilitation device
5217112|NCT02639416|severe acute malnutrition|severe acute malnutrition
5217113|NCT02639416|polymeric therapeutic formula|polymeric therapeutic formula
5217114|NCT02639416|elemental therapeutic formula|elemental therapeutic formula
5217115|NCT02639403|Rectal cancer|rectal cancer
5217116|NCT02639403|Radiotherapy|radiotherapy
5217117|NCT02639403|Occlusion|occlusion
5217118|NCT02639390|Robotics|robotics
5217119|NCT02639390|upper extremity|upper extremity
5217120|NCT02639390|neurorehabilitation|neurorehabilitation
5217121|NCT02639390|movement therapy|movement therapy
5217122|NCT02639377|Dental Implantation|dental implantation
5217123|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate
5217124|NCT02639338|Chronic|chronic
5217129|NCT02639312|Cranofacial|cranofacial
5217140|NCT02639286|Hypertriglyceridemia|hypertriglyceridemia
5217146|NCT02639260|Nephrotic Syndrome|nephrotic syndrome
5217147|NCT02639260|Glomerular Filtration Rate|glomerular filtration rate
5217148|NCT02639260|Sialic Acid|sialic acid
5217149|NCT02639260|Proteinuria|proteinuria
5217150|NCT02639247|Chronic|chronic
5217151|NCT02639208|Breast Cancer I|breast cancer i
5217152|NCT02639208|Breast Cancer Stage II|breast cancer stage ii
5217153|NCT02639208|Breast Cancer Stage III|breast cancer stage iii
5217154|NCT02639182|Axitinib|axitinib
5217155|NCT02639182|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5217156|NCT02639182|AGS-16C3F|ags-16c3f
5217157|NCT02639169|music therapy|music therapy
5217158|NCT02639169|Distress|distress
5217159|NCT02639169|Mood|mood
5217160|NCT02639169|HSCT|hsct
5217161|NCT02639130|Gastric Inhibitory Polypeptide (GIP)|gastric inhibitory polypeptide (gip)
5217162|NCT02639130|Glucagon-Like Peptide 1 (GLP-1)|glucagon-like peptide 1 (glp-1)
5217163|NCT02639130|DPP-4 inhibition; Exendin [9-39]|dpp-4 inhibition; exendin [9-39]
5217164|NCT02639130|Gastric emptying|gastric emptying
5217165|NCT02639130|Glucagon|glucagon
5217166|NCT02639130|Incretin|incretin
5217167|NCT02639130|Insulin Secretion|insulin secretion
5217168|NCT02639130|Normal glucose-tolerant|normal glucose-tolerant
5217169|NCT02639117|basal cell carcinoma, photodynamic therapy, vismodegib|basal cell carcinoma, photodynamic therapy, vismodegib
5217170|NCT02639104|neck pain|neck pain
5217171|NCT02639104|cervical lordosis|cervical lordosis
5217172|NCT02639104|long thoracic nerve|long thoracic nerve
5217173|NCT02639091|Phase 1|phase 1
5217174|NCT02639091|Solid tumors|solid tumors
5217175|NCT02639091|Mesothelioma|mesothelioma
5217176|NCT02639091|Lung cancer|lung cancer
5217177|NCT02639091|Pemetrexed|pemetrexed
5217178|NCT02639091|Cisplatin|cisplatin
5217179|NCT02639078|Single ascending dose|single ascending dose
5217180|NCT02639078|volunteers|volunteers
5217181|NCT02639078|Phase 1|phase 1
5217182|NCT02639078|first-in-human|first-in-human
5217183|NCT02639078|TD-0714|td-0714
5217184|NCT02639065|Durvalumab|durvalumab
5217185|NCT02639065|MEDI4736|medi4736
5217186|NCT02639065|PD-L1 inhibitor|pd-l1 inhibitor
5217189|NCT02639052|Healthy Volunteers|healthy volunteers
5217190|NCT02638987|Dry needling|dry needling
5217191|NCT02638987|office workers|office workers
5962664|NCT04279626|Two-port|two-port
5217192|NCT02638987|myofascial pain|myofascial pain
5217193|NCT02638987|electromyography|electromyography
5863467|NCT00001275|Infertility|infertility
5217194|NCT02638961|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5217195|NCT02638961|physical therapy|physical therapy
5217196|NCT02638961|exercise capacity|exercise capacity
5217197|NCT02638961|quality of life|quality of life
5217198|NCT02638935|Virtual Touch Tissue Imaging|virtual touch tissue imaging
5217199|NCT02638935|VTIQ|vtiq
5217200|NCT02638935|Elastography|elastography
5217201|NCT02638935|Breast Cancer|breast cancer
5217202|NCT02638935|BI-RADS|bi-rads
5217203|NCT02638935|Differentiation of breast lesions|differentiation of breast lesions
5217204|NCT02638935|Breast Lesion|breast lesion
5217205|NCT02638909|Gastrointestinal malignancies|gastrointestinal malignancies
5217206|NCT02638896|Ankylosing Spondylitis|ankylosing spondylitis
5217207|NCT02638896|Etanercept|etanercept
5217208|NCT02638896|Sulfasalazine|sulfasalazine
5217209|NCT02638896|Efficacy|efficacy
5217210|NCT02638896|Safety|safety
5217211|NCT02638896|dose|dose
5217212|NCT02638896|reduction|reduction
5217213|NCT02638857|Recurrence Hepatocellular Carcinoma|recurrence hepatocellular carcinoma
5217214|NCT02638857|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5217215|NCT02638857|Dendritic Cell -Precision Multiple Antigen T Cells|dendritic cell -precision multiple antigen t cells
5217216|NCT02638857|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5217217|NCT02638844|echocardiography|echocardiography
5217218|NCT02638831|Pain|pain
5217219|NCT02638831|Gonarthrosis|gonarthrosis
5217220|NCT02638831|Low Back Pain|low back pain
5217221|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine
5217222|NCT02638831|Ketoprofen|ketoprofen
5217223|NCT02638818|pancreaticoduodenectomy|pancreaticoduodenectomy
5217224|NCT02638818|Whipple|whipple
5217225|NCT02638779|Septic shock|septic shock
5217226|NCT02638779|severe trauma|severe trauma
5217227|NCT02638779|severe burn|severe burn
5217228|NCT02638779|major surgery|major surgery
5217229|NCT02638779|immunosuppression|immunosuppression
5217230|NCT02638779|Healthcare-Associated Infections|healthcare-associated infections
5217231|NCT02638766|metastatic|metastatic
5217232|NCT02638766|unresectable|unresectable
5217233|NCT02638766|KIT/PDGFR wild type GIST|kit/pdgfr wild type gist
5217234|NCT02638753|non specific chronic low back pain|non specific chronic low back pain
5217235|NCT02638753|education on pain neurophysiology|education on pain neurophysiology
5217236|NCT02638753|education on pain biology|education on pain biology
5217237|NCT02638753|education on pain neuroscience|education on pain neuroscience
5217238|NCT02638753|hypnosis|hypnosis
5217239|NCT02638727|vascular disease|vascular disease
5217240|NCT02638727|endothelial function|endothelial function
5217241|NCT02638727|L-Citrulline|l-citrulline
5217242|NCT02638714|Optic Neuropathies|optic neuropathies
5217243|NCT02638714|Stem Cell Therapy|stem cell therapy
5217244|NCT02638675|financial health incentives|financial health incentives
5217245|NCT02638675|physical activity|physical activity
5217246|NCT02638675|behavioral economics|behavioral economics
5217247|NCT02638675|randomized control trial|randomized control trial
5217248|NCT02638675|workplace health|workplace health
5217249|NCT02638649|lung ultrasound|lung ultrasound
5217250|NCT02638636|Cognitive behavior therapy|cognitive behavior therapy
5217251|NCT02638636|Randomized controlled trial|randomized controlled trial
5217252|NCT02638636|Exposure therapy|exposure therapy
5217253|NCT02638636|Fibromyalgia|fibromyalgia
5217254|NCT02638623|Knee Arthroplasty|knee arthroplasty
5217255|NCT02638623|Hip Arthroplasty|hip arthroplasty
5217256|NCT02638584|Ilaprazole|ilaprazole
5217257|NCT02638584|Gastric Adenoma|gastric adenoma
5217258|NCT02638584|Early Gastric Cancer|early gastric cancer
5217259|NCT02638584|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5217260|NCT02638532|Fat Pad|fat pad
5217261|NCT02638532|Fat Pad Atrophy|fat pad atrophy
5217262|NCT02638532|Foot|foot
5217263|NCT02638532|Feet|feet
5217264|NCT02638532|Heel|heel
5217265|NCT02638532|Forefoot|forefoot
5217266|NCT02638506|Headaches, Migraines, Fentanyl|headaches, migraines, fentanyl
5217267|NCT02638493|HIV|hiv
5217268|NCT02638493|tenofovir-emtricitabine|tenofovir-emtricitabine
5217269|NCT02638493|antiretroviral therapy|antiretroviral therapy
5217270|NCT02638493|Prevention|prevention
5217271|NCT02638493|tenofovir alafenamide|tenofovir alafenamide
5217272|NCT02638454|Exercise|exercise
5217273|NCT02638454|Anabolic Resistance|anabolic resistance
5217274|NCT02638454|Skeletal Muscle|skeletal muscle
5217275|NCT02638454|microRNA|microrna
5217276|NCT02638441|psychological health|psychological health
5217277|NCT02638441|women|women
5217278|NCT02638441|anxiety|anxiety
5217279|NCT02638441|depression|depression
5217280|NCT02638415|HVPG|hvpg
5217281|NCT02638402|glycosylation|glycosylation
5217282|NCT02638402|mucin|mucin
5217284|NCT02638402|ovarian cancer|ovarian cancer
5217285|NCT02638402|endometrial cancer|endometrial cancer
5217286|NCT02638376|Keraroconus|keraroconus
5217287|NCT02638376|keratectasia|keratectasia
5217288|NCT02638376|treatment|treatment
5217289|NCT02638350|lung ultrasound|lung ultrasound
5217290|NCT02638350|Pulmonary Edema|pulmonary edema
5217291|NCT02638350|Respiratory Distress Syndrome|respiratory distress syndrome
5217292|NCT02638337|Vulvo-vaginal Atrophy|vulvo-vaginal atrophy
5217293|NCT02638337|menopause|menopause
5217294|NCT02638259|Biosimilars|biosimilars
5217295|NCT02638259|Rheumatoid Arthritis|rheumatoid arthritis
5217296|NCT02638259|Etanercept|etanercept
5217297|NCT02638233|CHC|chc
5217298|NCT02638233|IVDA (intravenous drug abuse)|ivda (intravenous drug abuse)
5217299|NCT02638233|Hepatitis C|hepatitis c
5217300|NCT02638233|Sofosbuvir|sofosbuvir
5217301|NCT02638233|Ledipasvir|ledipasvir
5217302|NCT02638233|Opiate Substitution Therapy|opiate substitution therapy
5217303|NCT02638220|Cerebrotendinous Xanthomatosis|cerebrotendinous xanthomatosis
5217304|NCT02638220|CTX Prevalence Study|ctx prevalence study
5217305|NCT02638220|CTX|ctx
5217306|NCT02638220|Idiopathic Bilateral Cataracts|idiopathic bilateral cataracts
5217307|NCT02638220|Cataracts|cataracts
5217308|NCT02638220|Bilateral Cataracts|bilateral cataracts
5217309|NCT02638220|Early-Onset Idiopathic Bilateral Cataracts|early-onset idiopathic bilateral cataracts
5217310|NCT02638220|Observational Study|observational study
5217311|NCT02638220|Ophthalmology|ophthalmology
5217312|NCT02638207|Chronic Inflammatory Demyelinating Poly Neuropathy (CIDP)|chronic inflammatory demyelinating poly neuropathy (cidp)
5217313|NCT02638194|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5217314|NCT02638194|smoking|smoking
5217315|NCT02638194|secondhand smoke|secondhand smoke
5217316|NCT02638181|matrix metalloproteinase 13|matrix metalloproteinase 13
5217317|NCT02638181|tissue inhibitor of metalloproteinases 3|tissue inhibitor of metalloproteinases 3
5217318|NCT02638181|calcium-sensing receptor|calcium-sensing receptor
5217319|NCT02638181|trabecular meshwork|trabecular meshwork
5217320|NCT02638181|open-angle glaucoma|open-angle glaucoma
5217321|NCT02638142|loop diuretic|loop diuretic
5217322|NCT02638142|heart failure|heart failure
5217323|NCT02638142|renal dysfunction|renal dysfunction
5217324|NCT02638142|congestion signs|congestion signs
5217325|NCT02638142|BNP|bnp
5217326|NCT02638129|Drug therapy|drug therapy
5217327|NCT02638116|Ibrutinib|ibrutinib
5205302|NCT02711956|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
5205303|NCT02711956|BET inhibitor (BETi)|bet inhibitor (beti)
5205304|NCT02711956|Bromodomain|bromodomain
5205305|NCT02711956|Pharmacodynamics (PD)|pharmacodynamics (pd)
5205306|NCT02711956|Enzalutamide|enzalutamide
5205307|NCT02711956|XTANDI|xtandi
5205308|NCT02711956|MDV3100|mdv3100
5205309|NCT02711956|Epigenetics|epigenetics
5205310|NCT02711930|intra-ocular pressure|intra-ocular pressure
5205311|NCT02711930|prone ventilation|prone ventilation
5205312|NCT02711917|Propofol|propofol
5205313|NCT02711917|Sevoflurane|sevoflurane
5205314|NCT02711917|Etomidate|etomidate
5205315|NCT02711917|Rocuronium|rocuronium
5205316|NCT02711917|BIS|bis
5205317|NCT02711917|Closed loop infusion system|closed loop infusion system
5205318|NCT02711904|Extubation|extubation
5205319|NCT02711904|Cough|cough
5205320|NCT02711904|Target Controlled Anesthesia (TACAN)|target controlled anesthesia (tacan)
5217328|NCT02638116|Proton pump inhibitors|proton pump inhibitors
5217329|NCT02638116|Pharmacokinetics|pharmacokinetics
5217330|NCT02638116|Drug Interaction|drug interaction
5217331|NCT02638090|advanced lung cancer|advanced lung cancer
5217332|NCT02638090|immune therapy naive|immune therapy naive
5217333|NCT02638090|immune therapy pre-treated|immune therapy pre-treated
5217334|NCT02638090|NSCLC|nsclc
5217335|NCT02638090|Stage IV lung cancer|stage iv lung cancer
5217336|NCT02638090|pembrolizumab|pembrolizumab
5217337|NCT02638090|vorinostat|vorinostat
5217338|NCT02638090|immunogenicity|immunogenicity
5217339|NCT02638077|Differentiated Thyroid Cancer|differentiated thyroid cancer
5217340|NCT02638077|the initial management|the initial management
5217341|NCT02638051|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5217342|NCT02638051|Malignant Ascites|malignant ascites
5217343|NCT02638051|Modulated Electro-Hyperthermia|modulated electro-hyperthermia
5217344|NCT02638051|Traditional Chinese Medicine|traditional chinese medicine
5217345|NCT02637960|VA106483, fedovapagon, BPH, nocturia, EQUINOC|va106483, fedovapagon, bph, nocturia, equinoc
5217346|NCT02637921|bed rest|bed rest
5217347|NCT02637921|bone metabolism|bone metabolism
5217348|NCT02637908|Mindfulness|mindfulness
5217349|NCT02637908|Parents|parents
5217350|NCT02637908|Families|families
5217351|NCT02637895|PTSD,|ptsd,
5217352|NCT02637895|trauma|trauma
5217353|NCT02637895|stress disorder|stress disorder
5217354|NCT02637895|post-traumatic stress disorder|post-traumatic stress disorder
5217355|NCT02637895|anxiety disorder|anxiety disorder
5217356|NCT02637869|Health Expenditures|health expenditures
5217357|NCT02637869|Prospective Payment System|prospective payment system
5217358|NCT02637869|Health Care Utilization|health care utilization
5217383|NCT02637726|Total intravenous anesthesia|total intravenous anesthesia
5217384|NCT02637726|Target Controlled Infusion|target controlled infusion
5217385|NCT02637726|Propofol|propofol
5217386|NCT02637726|Bispectral index|bispectral index
5217387|NCT02637726|Children|children
5217388|NCT02637713|GERD|gerd
5086019|NCT03460561|TEA|tea
5217389|NCT02637713|sleeve gastrectomy|sleeve gastrectomy
5217390|NCT02637713|reflux|reflux
5205408|NCT02711124|hemoglobin A1c|hemoglobin a1c
5205409|NCT02711124|coronary artery bypass grafting|coronary artery bypass grafting
5205410|NCT02711124|impedance aggregometry|impedance aggregometry
5205411|NCT02711124|platelet reactivity|platelet reactivity
5205412|NCT02711124|clinical outcomes|clinical outcomes
5205413|NCT02711098|cardiac arrest|cardiac arrest
5205414|NCT02711098|hypothermia|hypothermia
5205415|NCT02711098|critical care|critical care
5205416|NCT02711059|hyperparathyroidism|hyperparathyroidism
5217391|NCT02637713|morbidly obese|morbidly obese
5217392|NCT02637700|Small Fiber Neuropathy|small fiber neuropathy
5217393|NCT02637700|Painful Neuropathy|painful neuropathy
5217394|NCT02637700|Intravenous Immunoglobulin Therapy|intravenous immunoglobulin therapy
5217395|NCT02637687|Advanced solid tumors|advanced solid tumors
5217396|NCT02637687|Central nervous system (CNS) tumor|central nervous system (cns) tumor
5217397|NCT02637687|Extra-cranial tumor|extra-cranial tumor
5217398|NCT02637687|Infantile fibrosarcoma (IFS)|infantile fibrosarcoma (ifs)
5217399|NCT02637687|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5217401|NCT02637687|NTRK2|ntrk2
5217402|NCT02637687|NTRK3|ntrk3
5217403|NCT02637687|Fusion Positive|fusion positive
5217404|NCT02637687|TRK fusion|trk fusion
5217405|NCT02637687|TRKA|trka
5217406|NCT02637687|TRKB|trkb
5217407|NCT02637687|TRKC|trkc
5217408|NCT02637687|ETV6|etv6
5217409|NCT02637674|allotransplantation|allotransplantation
5217410|NCT02637661|earlobe crease|earlobe crease
5217411|NCT02637661|acute myocardial infarction|acute myocardial infarction
5217412|NCT02637661|risk factor|risk factor
5217413|NCT02637635|Mammaplasty|mammaplasty
5217414|NCT02637635|Transplantation, Autologous|transplantation, autologous
5217415|NCT02637635|Mastectomy|mastectomy
5217416|NCT02637635|Breast Implants|breast implants
5217417|NCT02637635|Radiotherapy, Adjuvant|radiotherapy, adjuvant
5217418|NCT02637622|conjoint analysis|conjoint analysis
5217419|NCT02637622|stated-preference methods|stated-preference methods
5217420|NCT02637622|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
5217421|NCT02637622|community-based participatory research (CBPR)|community-based participatory research (cbpr)
5217422|NCT02637622|patient preference|patient preference
5217423|NCT02637622|diabetes|diabetes
5217424|NCT02637609|conjoint analysis|conjoint analysis
5217425|NCT02637609|stated-preference methods|stated-preference methods
5217426|NCT02637609|patient centered outcome research (PCOR)|patient centered outcome research (pcor)
5862859|NCT00001480|Cognitive Testing|cognitive testing
5217438|NCT02637531|Melanoma|melanoma
5217439|NCT02637531|PI3K|pi3k
5217440|NCT02637531|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
5217441|NCT02637531|Triple Negative Breast Cancer|triple negative breast cancer
5217442|NCT02637531|Adrenocortical Carcinoma|adrenocortical carcinoma
5217443|NCT02637531|Mesothelioma|mesothelioma
5217444|NCT02637531|High-circulating myeloid-derived suppressor cells (MDSCs)|high-circulating myeloid-derived suppressor cells (mdscs)
5217445|NCT02637518|Frailty|frailty
5217446|NCT02637518|Frailty screening tools|frailty screening tools
5217447|NCT02637518|Clinical settings|clinical settings
5217448|NCT02637518|Social settings|social settings
5217449|NCT02637518|Geriatrics|geriatrics
5217450|NCT02637518|Functional autonomy|functional autonomy
5217451|NCT02637518|Disability|disability
5217452|NCT02637505|Articular cartilage|articular cartilage
5217453|NCT02637505|Focal cartilage injury|focal cartilage injury
5217454|NCT02637505|Focal cartilage injury in the knee|focal cartilage injury in the knee
5217455|NCT02637505|Knee cartilage|knee cartilage
5217456|NCT02637505|Microfracture|microfracture
5217458|NCT02637492|Critical limb ischaemia|critical limb ischaemia
5217459|NCT02637492|Peripheral occlusive arterial disease|peripheral occlusive arterial disease
5217460|NCT02637492|Clinical prediction|clinical prediction
5217461|NCT02637492|Ankle pressure|ankle pressure
5217462|NCT02637492|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
5217463|NCT02637492|Toe pressure|toe pressure
5217464|NCT02637492|Microcirculation|microcirculation
5356865|NCT01917682|CorPath PRECISION Registry|corpath precision registry
5217465|NCT02637453|Paroxysmal Atrial Fibrillation;Additional Linear Ablation|paroxysmal atrial fibrillation;additional linear ablation
5217466|NCT02637427|Fresh frozen plasma|fresh frozen plasma
5217467|NCT02637427|Bleeding|bleeding
5217468|NCT02637414|Stress|stress
5217469|NCT02637414|Well-being|well-being
5217470|NCT02637414|Positive psychology|positive psychology
5217471|NCT02637388|Appetite|appetite
5217472|NCT02637388|Beta-glucans|beta-glucans
5217473|NCT02637388|Energy Intake|energy intake
5217474|NCT02637388|Glucagon-Like Peptide 1|glucagon-like peptide 1
5217475|NCT02637388|Glucose|glucose
5217476|NCT02637388|Insulin|insulin
5217477|NCT02637388|Incretins|incretins
5217478|NCT02637375|triple-negative breast cancer|triple-negative breast cancer
5342980|NCT01981304|Percutaneous coronary intervention|percutaneous coronary intervention
5217479|NCT02637336|Therapies. Autonomic nervous system. Cardiovascular stress|therapies. autonomic nervous system. cardiovascular stress
5962665|NCT04279548|Deep Brain Stimulation|deep brain stimulation
5217480|NCT02637323|osteoarthritis|osteoarthritis
5217481|NCT02637323|knee|knee
5217482|NCT02637323|pain|pain
5217483|NCT02637323|corticosteroid|corticosteroid
5217484|NCT02637323|intra-articular|intra-articular
5217485|NCT02637323|injection|injection
5217486|NCT02637284|Healthy volunteers|healthy volunteers
5217487|NCT02637271|Calorie restriction|calorie restriction
5217488|NCT02637271|Meal replacement|meal replacement
5217489|NCT02637271|fMRI|fmri
5217490|NCT02637271|Food-cue reactivity|food-cue reactivity
5217491|NCT02637271|Obesity|obesity
5217492|NCT02637258|optic nerve sheath diameter|optic nerve sheath diameter
5217493|NCT02637258|neurological outcome|neurological outcome
5217494|NCT02637258|OHCA|ohca
5217495|NCT02637245|diabetic macular edema|diabetic macular edema
5217496|NCT02637245|diabetic retinopathy|diabetic retinopathy
5217497|NCT02637206|Healthy Japanese|healthy japanese
5217498|NCT02637206|GSK2894512|gsk2894512
5217499|NCT02637206|skin safety|skin safety
5217500|NCT02637180|osteoporosis|osteoporosis
5217501|NCT02637180|fracture|fracture
5217502|NCT02637180|liaison service|liaison service
5217503|NCT02637167|Heart failure|heart failure
5217504|NCT02637167|inflammation|inflammation
5217505|NCT02637167|rifaximin|rifaximin
5217506|NCT02637167|Saccharomyces boulardii|saccharomyces boulardii
5217507|NCT02637167|gut microbiota|gut microbiota
5217508|NCT02637154|Adolescent|adolescent
5217509|NCT02637154|Type 1 diabetes|type 1 diabetes
5217510|NCT02637154|Metabolic control|metabolic control
5217511|NCT02637154|Motivational interviewing|motivational interviewing
5217513|NCT02637141|gluten|gluten
5217514|NCT02637141|Interleukin 15 (IL-15)|interleukin 15 (il-15)
5217515|NCT02637141|AMG 714|amg 714
5217516|NCT02637141|gluten challenge|gluten challenge
5217517|NCT02637128|MALARIA, FALCIPARUM|malaria, falciparum
5217518|NCT02637128|MALAWI|malawi
5217519|NCT02637128|ARTEMETHER-LUMEFANTRINE|artemether-lumefantrine
5217520|NCT02637128|ARTESUNATE-AMODIAQUINE|artesunate-amodiaquine
5217521|NCT02637115|Gut microbiota|gut microbiota
5217522|NCT02637115|Akkermansia muciniphila|akkermansia muciniphila
5217523|NCT02637076|Xyrem|xyrem
5217524|NCT02637076|narcolepsy with cataplexy|narcolepsy with cataplexy
5217525|NCT02637076|positron emission tomography|positron emission tomography
5217526|NCT02637076|dopamine|dopamine
5217527|NCT02637063|Lifestyle behavior change|lifestyle behavior change
5217528|NCT02637050|Type IV Pulmonary Hypertension|type iv pulmonary hypertension
5217529|NCT02637050|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5217530|NCT02637050|CTEPH|cteph
5217531|NCT02637037|dapagliflozin/metformin XR 5/500 mg|dapagliflozin/metformin xr 5/500 mg
5217532|NCT02637037|dapagliflozin/metformin XR10/1000 mg|dapagliflozin/metformin xr10/1000 mg
5217533|NCT02637037|bioequivalence|bioequivalence
5217534|NCT02637037|fixed dose combination tablets|fixed dose combination tablets
5217535|NCT02637037|pharmacokinetic|pharmacokinetic
5217536|NCT02637037|type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5217537|NCT02637037|safety|safety
5217538|NCT02637024|Breast Cancer|breast cancer
5217539|NCT02637024|DCIS|dcis
5217540|NCT02637024|Radiotherapy|radiotherapy
5217541|NCT02637024|Partial breast irradiation|partial breast irradiation
5217542|NCT02637024|Radiation fractions|radiation fractions
5217543|NCT02637011|acute respiratory distress syndrome|acute respiratory distress syndrome
5217544|NCT02637011|intensive care medicine|intensive care medicine
5217545|NCT02637011|critical illness|critical illness
5217546|NCT02637011|long-term outcomes|long-term outcomes
5217547|NCT02637011|quality of life|quality of life
5217548|NCT02637011|return to work|return to work
5217549|NCT02637011|quality of care|quality of care
5217550|NCT02636972|TLR2|tlr2
5217551|NCT02636972|TLR4|tlr4
5217552|NCT02636972|Biomarker|biomarker
5217553|NCT02636972|TLR responsiveness|tlr responsiveness
5217554|NCT02636972|Peripheral blood responsiveness|peripheral blood responsiveness
5217555|NCT02636972|Inflammatory pain|inflammatory pain
5217556|NCT02636933|Asthma|asthma
5217557|NCT02636933|Allergic Rhinitis|allergic rhinitis
5217558|NCT02636933|Children|children
5217559|NCT02636933|Atopy|atopy
5217560|NCT02636920|Asthma|asthma
5217561|NCT02636920|Children|children
5217562|NCT02636855|Solid and Hematological Malignancies|solid and hematological malignancies
5217563|NCT02636855|Screening|screening
5217564|NCT02636855|Metastatic|metastatic
5217565|NCT02636855|Previously Treated|previously treated
5217566|NCT02636855|NY-ESO-1|ny-eso-1
5217567|NCT02636855|MAGE A10|mage a10
5217568|NCT02636855|MAGE-A4|mage-a4
5217569|NCT02636842|Schizophrenia|schizophrenia
5217570|NCT02636842|Schizoaffective Disorder|schizoaffective disorder
5217571|NCT02636842|Aripiprazole Lauroxil|aripiprazole lauroxil
5217572|NCT02636842|Aripiprazole|aripiprazole
5217573|NCT02636842|ALKS 9072|alks 9072
5217574|NCT02636842|Alkermes|alkermes
5217575|NCT02636803|trichuris|trichuris
5217576|NCT02636803|hookworms|hookworms
5217577|NCT02636803|Ascaris|ascaris
5217578|NCT02636777|low back pain|low back pain
5306070|NCT02147665|Hookah|hookah
5217579|NCT02636777|chronic pain|chronic pain
5144995|NCT03085511|Glucose|glucose
5217580|NCT02636777|self-management|self-management
5217581|NCT02636777|longitudinal study|longitudinal study
5217582|NCT02636777|predictive modelling|predictive modelling
5217583|NCT02636751|Prehabilitation|prehabilitation
5217584|NCT02636751|Telemedicine|telemedicine
5217585|NCT02636751|Osteoarthritis|osteoarthritis
5217586|NCT02636751|Arthroplasty|arthroplasty
5217587|NCT02636751|Hip|hip
5217588|NCT02636751|Knee|knee
5217589|NCT02636725|Advanced Alveolar Soft Part Sarcoma|advanced alveolar soft part sarcoma
5217590|NCT02636725|ASPS|asps
5217591|NCT02636725|Soft Tissue Sarcomas|soft tissue sarcomas
5217592|NCT02636725|STS|sts
5217593|NCT02636725|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5217594|NCT02636686|DMD|dmd
5217595|NCT02636686|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5217596|NCT02636686|Drisapersen|drisapersen
5217597|NCT02636686|Kyndrisa|kyndrisa
5217598|NCT02636686|exon-skipping|exon-skipping
5217599|NCT02636686|exon-51|exon-51
5217600|NCT02636686|BMN-051-302|bmn-051-302
5217601|NCT02636686|051-302|051-302
5217602|NCT02636660|Critical care|critical care
5217603|NCT02636660|Mechanical Ventilation|mechanical ventilation
5217604|NCT02636660|Quality of Life|quality of life
5217605|NCT02636660|Stressors|stressors
5217606|NCT02636660|Nursing Sensitive Outcomes|nursing sensitive outcomes
5217607|NCT02636660|Nursing|nursing
5217608|NCT02636647|hepatic encephalopathy|hepatic encephalopathy
5217609|NCT02636647|fecal transplant|fecal transplant
5217610|NCT02636647|cirrhosis|cirrhosis
5217611|NCT02636634|diagnostic strategy|diagnostic strategy
5217614|NCT02636634|relapse|relapse
5217615|NCT02636634|PET-FET and MSR|pet-fet and msr
5217616|NCT02636634|radiosurgery|radiosurgery
5217617|NCT02636621|Fatigue|fatigue
5217618|NCT02636621|excessive daytime sleepiness|excessive daytime sleepiness
5217619|NCT02636621|flow limitation|flow limitation
5217620|NCT02636608|Chronic Hepatitis C|chronic hepatitis c
5217621|NCT02636608|Dasabuvir|dasabuvir
5217622|NCT02636608|Paritaprevir/r/Ombitasvir|paritaprevir/r/ombitasvir
5217623|NCT02636608|Observational Study|observational study
5217624|NCT02636608|Quality of Life|quality of life
5217625|NCT02636608|Fibrosis|fibrosis
5217626|NCT02636608|Cirrhosis|cirrhosis
5217627|NCT02636608|Work Ability|work ability
5217628|NCT02636595|Hepatitis C Genotype 4|hepatitis c genotype 4
5217629|NCT02636595|Hepatitis C|hepatitis c
5217630|NCT02636595|Chronic Hepatitis C|chronic hepatitis c
5217631|NCT02636595|Hepatitis C Genotype 6|hepatitis c genotype 6
5217632|NCT02636595|Hepatitis C Genotype 5|hepatitis c genotype 5
5217633|NCT02636556|thymoma|thymoma
5217634|NCT02636556|thymic carcinoma|thymic carcinoma
5217635|NCT02636556|chemoradiotherapy|chemoradiotherapy
5217636|NCT02636556|inoperable|inoperable
5217637|NCT02636543|genetic diagnosis|genetic diagnosis
5217638|NCT02636543|information|information
5217639|NCT02636543|letter model|letter model
5217640|NCT02636517|Fecal Microbiota transplant|fecal microbiota transplant
5217641|NCT02636504|Pulp vitality|pulp vitality
5217642|NCT02636504|Pulp testing|pulp testing
5217643|NCT02636439|Diastolic heart failure|diastolic heart failure
5217644|NCT02636439|Heart Failure|heart failure
5217645|NCT02636439|Elderly|elderly
5217646|NCT02636439|Obesity|obesity
5217647|NCT02636426|phase I study|phase i study
5217648|NCT02636426|sorafenib|sorafenib
5217649|NCT02636426|high-dose schedule|high-dose schedule
5217650|NCT02636426|pharmacokinetics|pharmacokinetics
5217651|NCT02636426|drug monitoring|drug monitoring
5217652|NCT02636400|Infertility|infertility
5217653|NCT02636400|endometriosis|endometriosis
5217655|NCT02636348|Vitamin D|vitamin d
5217656|NCT02636309|ergonomics|ergonomics
5217657|NCT02636309|multifaceted intervention|multifaceted intervention
5217658|NCT02636309|industry|industry
5217659|NCT02636309|physiotherapy|physiotherapy
5217660|NCT02636309|physical exercises|physical exercises
5217661|NCT02636309|workplace|workplace
5217662|NCT02636309|acupuncture|acupuncture
5217663|NCT02636309|work|work
5217664|NCT02636309|quality of life|quality of life
5217665|NCT02636309|absenteeism|absenteeism
5217666|NCT02636309|efficiency|efficiency
5356866|NCT01917682|PCI|pci
5205690|NCT02709408|Intrabdominal infections|intrabdominal infections
5962666|NCT04279509|Organoid|organoid
5205691|NCT02709408|Urinary tract infections|urinary tract infections
5205692|NCT02709408|Pneumonia|pneumonia
5205693|NCT02709408|Risk factors|risk factors
5205694|NCT02709408|Outcome|outcome
5205695|NCT02709408|Hospitalised patients|hospitalised patients
5205696|NCT02709408|Mortality|mortality
5217667|NCT02636309|musculoskeletal pain|musculoskeletal pain
5217668|NCT02636309|WMSD|wmsd
5217669|NCT02636296|Pilates method|pilates method
5217670|NCT02636296|elderly|elderly
5217671|NCT02636296|postural balance|postural balance
5217672|NCT02636257|Silicone Nasolacrimal Intubation|silicone nasolacrimal intubation
5217673|NCT02636257|Dacryocystorhinostomy|dacryocystorhinostomy
5217674|NCT02636231|Endostar|endostar
5217675|NCT02636231|IMRT|imrt
5217676|NCT02636231|recurrent|recurrent
5217677|NCT02636231|NPC|npc
5217678|NCT02636218|Ketamine|ketamine
5217679|NCT02636192|Sodium-glucose co-transporter 2 inhibitors|sodium-glucose co-transporter 2 inhibitors
5217680|NCT02636192|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5342981|NCT01981291|Lower Extremity|lower extremity
5306252|NCT02146846|cml|cml
5217681|NCT02636179|In Vitro Fertilization, follow-up of children|in vitro fertilization, follow-up of children
5217682|NCT02636166|Pregnancy|pregnancy
5217683|NCT02636153|phosphorus,dietary|phosphorus,dietary
5217684|NCT02636153|circadian rhythm|circadian rhythm
5217685|NCT02636153|phosphorus|phosphorus
5217686|NCT02636088|Phase II study, clinical trial|phase ii study, clinical trial
5217687|NCT02636062|Coronary disease|coronary disease
5217688|NCT02636062|Coronary artery disease (CAD)|coronary artery disease (cad)
5217689|NCT02636062|Endothelial dysfunction|endothelial dysfunction
5217690|NCT02636062|Coronary artery calcium (CAC)|coronary artery calcium (cac)
5217691|NCT02636049|pharmacokinetics|pharmacokinetics
5217692|NCT02636049|healthy adult volunteer|healthy adult volunteer
5217693|NCT02635997|osteoporosis|osteoporosis
5217694|NCT02635997|ibandronate|ibandronate
5217695|NCT02635997|vitamine D|vitamine d
5217696|NCT02635997|calcium|calcium
5217697|NCT02635997|bone mineral density|bone mineral density
5217698|NCT02635997|health-related quality of life|health-related quality of life
5217699|NCT02635971|transcatheter arterial infusion|transcatheter arterial infusion
5217700|NCT02635971|randomized controlled trial|randomized controlled trial
5217701|NCT02635971|chemotherapy|chemotherapy
5217702|NCT02635958|Body Mass Index|body mass index
5217713|NCT02635919|Smoking cessation|smoking cessation
5217714|NCT02635919|Quit smoking|quit smoking
5217716|NCT02635906|CORONARY ANGIOPLASTY|coronary angioplasty
5217717|NCT02635893|SCI|sci
5217718|NCT02635867|vital pulp|vital pulp
5217719|NCT02635867|reversible pulpitis|reversible pulpitis
5217720|NCT02635867|pulp capping|pulp capping
5217721|NCT02635867|deep cavity|deep cavity
5218803|NCT02630342|Child|child
5217722|NCT02635867|Management of Deep Dental Caries|management of deep dental caries
5217723|NCT02635854|leukocyte and platelet aggregates|leukocyte and platelet aggregates
5217724|NCT02635854|platelet activation|platelet activation
5217725|NCT02635841|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
5217726|NCT02635841|PKAN|pkan
5217727|NCT02635841|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
5217728|NCT02635841|NBIA|nbia
5217729|NCT02635841|Deferiprone|deferiprone
5217730|NCT02635841|Ferriprox|ferriprox
5217731|NCT02635828|Palonosetron|palonosetron
5217732|NCT02635828|Craniotomy|craniotomy
5217733|NCT02635828|Nausea|nausea
5217734|NCT02635828|Vomiting|vomiting
5217735|NCT02635802|remifentanil|remifentanil
5217736|NCT02635802|analgesia|analgesia
5217737|NCT02635802|intensive care units|intensive care units
5217738|NCT02635789|Sirolimus|sirolimus
5217739|NCT02635789|Skin lesions|skin lesions
5217740|NCT02635789|TSC|tsc
5217741|NCT02635789|Tuberous Sclerosis Complex|tuberous sclerosis complex
5217742|NCT02635789|NPC-12G|npc-12g
5217743|NCT02635789|Angiofibroma|angiofibroma
5217744|NCT02635789|Hypomelanotic macule|hypomelanotic macule
5217745|NCT02635789|Plaque|plaque
5217746|NCT02635776|AR101 (Characterized Peanut Allergen)|ar101 (characterized peanut allergen)
5356867|NCT01917682|angioplasty|angioplasty
5217747|NCT02635776|Characterized Peanut Allergen|characterized peanut allergen
5217748|NCT02635776|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5217749|NCT02635776|OIT (oral immunotherapy)|oit (oral immunotherapy)
5217750|NCT02635776|Oral Immunotherapy|oral immunotherapy
5217751|NCT02635776|Peanut Allergy|peanut allergy
5217752|NCT02635776|Allergy|allergy
5217753|NCT02635776|Peanut-Allergic Children|peanut-allergic children
5217754|NCT02635776|Peanut-Allergic Adults|peanut-allergic adults
5217755|NCT02635776|Desensitization|desensitization
5217756|NCT02635763|nerve block|nerve block
5217757|NCT02635763|general anesthesia|general anesthesia
5217758|NCT02635763|hip fracture|hip fracture
5217759|NCT02635763|recovery|recovery
5217760|NCT02635724|Acute uncomplicated|acute uncomplicated
5217761|NCT02635724|Elderly|elderly
5217762|NCT02635685|Atrial fibrillation|atrial fibrillation
5217763|NCT02635685|Stroke|stroke
5217764|NCT02635685|Clinical Decision Support|clinical decision support
5217765|NCT02635685|Anticoagulants|anticoagulants
5217766|NCT02635672|Solid tumors|solid tumors
5217767|NCT02635672|Aggressive non-hodgkin's lymphoma (NHL)|aggressive non-hodgkin's lymphoma (nhl)
5217768|NCT02635659|food intake, satiety, satiation, nutrients, ileal brake|food intake, satiety, satiation, nutrients, ileal brake
5217769|NCT02635633|partial epilepsy|partial epilepsy
5217770|NCT02635633|unifocal neocortical|unifocal neocortical
5217771|NCT02635633|treatment resistant|treatment resistant
5217772|NCT02635633|transcranial magnetic stimulation|transcranial magnetic stimulation
5217773|NCT02635633|thetaburst stimulation|thetaburst stimulation
5217778|NCT02635542|Postoperative Pulmonary Complications|postoperative pulmonary complications
5217779|NCT02635542|Residual Neuromuscular Blockade|residual neuromuscular blockade
5217780|NCT02635542|Cardiac Surgical Procedures|cardiac surgical procedures
5217781|NCT02635503|colorectal cancer|colorectal cancer
5217782|NCT02635503|laparoscopic surgery|laparoscopic surgery
5217783|NCT02635503|natural orifice specimen extraction|natural orifice specimen extraction
5217784|NCT02635503|Inflammatory response|inflammatory response
5217785|NCT02635490|prophylactic antibiotics, urinary tract infection.|prophylactic antibiotics, urinary tract infection.
5217786|NCT02635451|vitamin c|vitamin c
5217787|NCT02635451|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
5217788|NCT02635438|Oropharyngeal Candidiasis|oropharyngeal candidiasis
5217789|NCT02635412|Placenta|placenta
5217790|NCT02635412|Accreta|accreta
5217793|NCT02635399|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy|pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
5217794|NCT02635386|PCOS|pcos
5217795|NCT02635386|GLP1 agonists|glp1 agonists
5217796|NCT02635386|SGLT2 inhibitors|sglt2 inhibitors
5217797|NCT02635373|Calciphylaxis|calciphylaxis
5217798|NCT02635373|Rare disease (ORPHA280062)|rare disease (orpha280062)
5217799|NCT02635373|Renal insufficiency|renal insufficiency
5217800|NCT02635373|ESRD|esrd
5217801|NCT02635373|Calcification|calcification
5217802|NCT02635373|Chronic kidney disease|chronic kidney disease
5217803|NCT02635373|Dialysis|dialysis
5217804|NCT02635373|Vascular disease|vascular disease
5217810|NCT02635347|Remote ischemic preconditioning|remote ischemic preconditioning
5217811|NCT02635347|Remote ischemic perconditioning|remote ischemic perconditioning
5217812|NCT02635347|Remote ischemic postconditioning|remote ischemic postconditioning
5217813|NCT02635347|Remote ischemic conditioning|remote ischemic conditioning
5217814|NCT02635347|Orthotopic liver transplant|orthotopic liver transplant
5217815|NCT02635347|Brain Death Organ Donor|brain death organ donor
5217817|NCT02635321|LGMD|lgmd
5217818|NCT02635321|GMPPB|gmppb
5217819|NCT02635308|hip fracture|hip fracture
5217820|NCT02635308|physical function|physical function
5217821|NCT02635308|muscle function|muscle function
5217822|NCT02635308|symmetry|symmetry
5217823|NCT02635295|Clinical practicum|clinical practicum
5217824|NCT02635295|Nursing student|nursing student
5217825|NCT02635295|Nurse teacher|nurse teacher
5217826|NCT02635295|Mobile technology|mobile technology
5217827|NCT02635295|Cooperation|cooperation
5217828|NCT02635295|Nurse competence|nurse competence
5217829|NCT02635269|Ergometry|ergometry
5217830|NCT02635269|Stable isotope tracers|stable isotope tracers
5217831|NCT02635256|hypofractionation|hypofractionation
5217832|NCT02635256|prostate cancer|prostate cancer
5217833|NCT02635256|radiotherapy|radiotherapy
5217834|NCT02635230|Atrial Fibrillations|atrial fibrillations
5217835|NCT02635230|Heart Valve Prostheses|heart valve prostheses
5217836|NCT02635230|Acute Coronary Syndromes|acute coronary syndromes
5217837|NCT02635230|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
5217838|NCT02635230|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5217839|NCT02635230|Coronary Artery Diseases|coronary artery diseases
5217840|NCT02635230|Myocardial Infarction|myocardial infarction
5217841|NCT02635230|Ischemic stroke|ischemic stroke
5217842|NCT02635230|Bleeding|bleeding
5217843|NCT02635230|Thrombosis|thrombosis
5217844|NCT02635230|Myocardial Ischemia|myocardial ischemia
5217845|NCT02635230|Heart Diseases|heart diseases
5217850|NCT02635230|Clopidogrel|clopidogrel
5217851|NCT02635230|Ticagrelor|ticagrelor
5217852|NCT02635230|Prasugrel|prasugrel
5217853|NCT02635230|Antithrombotic treatment|antithrombotic treatment
5217854|NCT02635230|Oral anticoagulation|oral anticoagulation
5217855|NCT02635230|Warfarin|warfarin
5217856|NCT02635230|Dabigatran etexilate mesylate|dabigatran etexilate mesylate
5217857|NCT02635230|Apixaban|apixaban
5217858|NCT02635230|Rivaroxaban|rivaroxaban
5217859|NCT02635230|Direct Factor Xa Inhibitors|direct factor xa inhibitors
5217860|NCT02635230|Direct Thrombin Inhibitors|direct thrombin inhibitors
5217861|NCT02635217|Colonoscopy|colonoscopy
5217862|NCT02635217|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5217863|NCT02635217|Patient satisfaction|patient satisfaction
5217864|NCT02635217|Bidirectional endoscopies|bidirectional endoscopies
5217865|NCT02635191|Helicobacter pylori|helicobacter pylori
5217866|NCT02635191|Therapy|therapy
5306441|NCT02145897|CLI|cli
5217867|NCT02635191|Children|children
5217868|NCT02635139|meal skipping|meal skipping
5217869|NCT02635139|isocaloric diet|isocaloric diet
5217870|NCT02635139|macronutrient oxidation|macronutrient oxidation
5217871|NCT02635139|glucose homeostasis|glucose homeostasis
5217872|NCT02635139|arterial stiffness|arterial stiffness
5217873|NCT02635113|balance|balance
5217874|NCT02635113|gait|gait
5217875|NCT02635113|falls|falls
5217876|NCT02635113|sensory deficits|sensory deficits
5217877|NCT02635113|vibration|vibration
5217878|NCT02635113|visual acuity|visual acuity
5217879|NCT02635113|dizziness|dizziness
5217880|NCT02635113|postural control|postural control
5217881|NCT02635113|proprioceptive function|proprioceptive function
5217882|NCT02635113|stereoacuity|stereoacuity
5217883|NCT02635113|depth perception|depth perception
5217884|NCT02635113|vestibular dysfunction|vestibular dysfunction
5217885|NCT02635100|Sleep Disordered Breathing|sleep disordered breathing
5217886|NCT02635100|Sleep Apnea|sleep apnea
5217887|NCT02635048|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5217888|NCT02635048|Kidney stones|kidney stones
5217889|NCT02635048|Efficacy|efficacy
5217896|NCT02634983|COPD|copd
5217897|NCT02634983|Smokers|smokers
5217898|NCT02634983|Ex-smokers|ex-smokers
5217899|NCT02634970|wet AMD, ranibizumab, aflibercept, neovascularization|wet amd, ranibizumab, aflibercept, neovascularization
5217900|NCT02634957|phonomicrosurgery|phonomicrosurgery
5217902|NCT02634957|voice rest|voice rest
5217903|NCT02634957|vhi-10|vhi-10
5217904|NCT02634957|CPP|cpp
5217905|NCT02634944|Concussion|concussion
5217906|NCT02634944|Vestibular|vestibular
5217907|NCT02634944|Ocular-Motor|ocular-motor
5217908|NCT02634931|Sirolimus|sirolimus
5217909|NCT02634931|Skin lesions|skin lesions
5217910|NCT02634931|TSC|tsc
5217911|NCT02634931|Tuberous Sclerosis Complex|tuberous sclerosis complex
5217912|NCT02634931|NPC-12G|npc-12g
5217913|NCT02634931|Angiofibroma|angiofibroma
5217914|NCT02634931|Hypomelanotic Macule|hypomelanotic macule
5217915|NCT02634931|Plaque|plaque
5217916|NCT02634918|ultrasound,|ultrasound,
5217917|NCT02634918|ultrasonography|ultrasonography
5217918|NCT02634918|hemophilic joint|hemophilic joint
5217920|NCT02634905|atopic dermatitis|atopic dermatitis
5217921|NCT02634905|Therapeutic patient education|therapeutic patient education
5217922|NCT02634905|pediatric dermatology|pediatric dermatology
5217923|NCT02634892|Sacral|sacral
5217924|NCT02634892|Overlay Mattress|overlay mattress
5217925|NCT02634892|Cooling|cooling
5217926|NCT02634866|hypertension|hypertension
5217927|NCT02634866|exercise|exercise
5217928|NCT02634866|diastolic heart failure|diastolic heart failure
5217929|NCT02634853|Dry Eye|dry eye
5217930|NCT02634840|inferior alveolar nerve|inferior alveolar nerve
5217931|NCT02634840|neurosensory disturbance|neurosensory disturbance
5217932|NCT02634840|bilateral sagittal spilt osteotomy|bilateral sagittal spilt osteotomy
5217933|NCT02634840|mandibular surgery|mandibular surgery
5217934|NCT02634840|neurosensory function|neurosensory function
5217935|NCT02634801|Fumaderm|fumaderm
5217936|NCT02634788|Post-Surgical Pain|post-surgical pain
5217937|NCT02634788|Bunionectomy|bunionectomy
5217938|NCT02634775|Pediatrics|pediatrics
5217939|NCT02634775|Nephrology|nephrology
5217940|NCT02634775|Dialysis|dialysis
5217941|NCT02634749|Nordic countries|nordic countries
5217942|NCT02634749|Eating behavior|eating behavior
5217943|NCT02634749|Human microbiome|human microbiome
5217944|NCT02634749|Child nutrition|child nutrition
5217945|NCT02634749|Metabolic profile|metabolic profile
5217946|NCT02634749|Body composition|body composition
5217947|NCT02634710|soft tissue sarcoma|soft tissue sarcoma
5205992|NCT02707458|prevention|prevention
5205993|NCT02707432|Cardiovascular Diseases|cardiovascular diseases
5206009|NCT02707328|CK|ck
5217956|NCT02634684|Schizophrenia|schizophrenia
5217957|NCT02634684|Schizoaffective Disorder|schizoaffective disorder
5217958|NCT02634684|Mental Disorders|mental disorders
5217959|NCT02634684|Anti-Dyskinesia Agents|anti-dyskinesia agents
5217960|NCT02634684|Antiparkinson Agents|antiparkinson agents
5217961|NCT02634684|Central Nervous System Agents|central nervous system agents
5217962|NCT02634684|Dopamine Agents|dopamine agents
5217963|NCT02634684|Excitatory Amino Acid Agents|excitatory amino acid agents
5217964|NCT02634684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists
5217965|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5306560|NCT02145403|Relapse|relapse
5217966|NCT02634684|Neurotransmitter Agents|neurotransmitter agents
5217967|NCT02634684|Pharmacologic Actions|pharmacologic actions
5217968|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs
5217969|NCT02634684|Therapeutic Uses|therapeutic uses
5217970|NCT02634684|Prepulse inhibition|prepulse inhibition
5217971|NCT02634684|Neurocognition|neurocognition
5217972|NCT02634684|Working memory|working memory
5217973|NCT02634684|Dextroamphetamine|dextroamphetamine
5217974|NCT02634684|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
5217975|NCT02634684|Pharmacologic Augmentation of Cognitive Therapies|pharmacologic augmentation of cognitive therapies
5217976|NCT02634684|Sensory discrimination learning|sensory discrimination learning
5217977|NCT02634684|Targeted Cognitive Training|targeted cognitive training
5217978|NCT02634684|rs4680 polymorphism of catechol-O-methyltransferase (COMT)|rs4680 polymorphism of catechol-o-methyltransferase (comt)
5217979|NCT02634671|schizophrenia|schizophrenia
5217980|NCT02634671|Facial emotions|facial emotions
5217981|NCT02634619|urethral stricture|urethral stricture
5217982|NCT02634606|Cholesterol|cholesterol
5217983|NCT02634593|nutrition|nutrition
5217984|NCT02634580|Japanese|japanese
5217985|NCT02634580|High cholesterol|high cholesterol
5217986|NCT02634580|Treatment of high cholesterol|treatment of high cholesterol
5217987|NCT02634580|Lowering cholesterol|lowering cholesterol
5217988|NCT02634580|Lowering high cholesterol|lowering high cholesterol
5217989|NCT02634580|Hypercholesterolemia|hypercholesterolemia
5217990|NCT02634580|Statin intolerant|statin intolerant
5217991|NCT02634528|intermediate-acting human isophane insulin, biosimilar|intermediate-acting human isophane insulin, biosimilar
5217992|NCT02634515|soluble human insulin, biosimilar|soluble human insulin, biosimilar
5217993|NCT02634502|radiofrequency|radiofrequency
5217994|NCT02634502|chemotherapy|chemotherapy
5217995|NCT02634502|microRNA|microrna
5217996|NCT02634489|Bladder outlet obstruction|bladder outlet obstruction
5217997|NCT02634489|Overactive bladder|overactive bladder
5217998|NCT02634489|Urinary incontinence|urinary incontinence
5217999|NCT02634489|Omnic OCAS®|omnic ocas®
5206098|NCT02706821|clinical trial|clinical trial
5206099|NCT02706808|chronic kidney disease|chronic kidney disease
5206100|NCT02706808|hemodialysis|hemodialysis
5206101|NCT02706808|conservative treatment|conservative treatment
5206102|NCT02706808|resistance starch|resistance starch
5206103|NCT02706795|Cervical dystonia|cervical dystonia
5206104|NCT02706795|Spasmodic torticollis|spasmodic torticollis
5206107|NCT02706678|FK506|fk506
5218013|NCT02634463|Risperidone|risperidone
5218014|NCT02634450|HIV|hiv
5218015|NCT02634450|Diagnostic|diagnostic
5218016|NCT02634450|children|children
5218017|NCT02634424|Hemophilia A|hemophilia a
5218018|NCT02634424|Prophylaxy|prophylaxy
5218019|NCT02634424|Pharmacokinetic|pharmacokinetic
5218020|NCT02634424|Bayesian|bayesian
5218021|NCT02634411|Ventilator Associated|ventilator associated
5218022|NCT02634411|Pneumonia|pneumonia
5218023|NCT02634411|Antibiotic treatment|antibiotic treatment
5218024|NCT02634411|Pseudomonas aeruginosa|pseudomonas aeruginosa
5218025|NCT02634372|Bipolar Disorder|bipolar disorder
5218026|NCT02634372|Traumatic event|traumatic event
5445365|NCT01522157|Postprandial|postprandial
5218027|NCT02634372|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
5218028|NCT02634372|Supportive therapy|supportive therapy
5218029|NCT02634372|Relapse prevention|relapse prevention
5218030|NCT02634346|Alkermes|alkermes
5218031|NCT02634346|ALKS 3831|alks 3831
5218032|NCT02634346|Samidorphan|samidorphan
5218033|NCT02634346|Schizophrenia|schizophrenia
5218034|NCT02634346|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
5218035|NCT02634333|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5218036|NCT02634333|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
5218037|NCT02634320|Alkermes|alkermes
5218038|NCT02634320|ARISTADA|aristada
5218039|NCT02634320|Aripiprazole Lauroxil|aripiprazole lauroxil
5218040|NCT02634320|Schizophrenia|schizophrenia
5218041|NCT02634307|Multiple Sclerosis|multiple sclerosis
5218042|NCT02634307|MS|ms
5218043|NCT02634307|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5218044|NCT02634307|RRMS|rrms
5218045|NCT02634307|dimethyl fumarate|dimethyl fumarate
5218046|NCT02634307|DMF|dmf
5218047|NCT02634294|Hematological Neoplasms|hematological neoplasms
5218048|NCT02634294|recurrence|recurrence
5218049|NCT02634294|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5218050|NCT02634294|peginterferon alfa-2b|peginterferon alfa-2b
5218051|NCT02634294|Graft vs Host Disease|graft vs host disease
5218052|NCT02634268|randomized controlled trial|randomized controlled trial
5218053|NCT02634268|diet|diet
5218054|NCT02634268|exercise|exercise
5218055|NCT02634268|obesity|obesity
5218056|NCT02634268|overweight|overweight
5218057|NCT02634268|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5218058|NCT02634268|lifestyle|lifestyle
5218059|NCT02634255|rocuronium|rocuronium
5218060|NCT02634255|onset time|onset time
5218061|NCT02634255|anxiety|anxiety
5218062|NCT02634242|Si Wu Tang|si wu tang
5218063|NCT02634242|antioxidation|antioxidation
5218064|NCT02634242|anthropometric measurements|anthropometric measurements
5218065|NCT02634242|liver|liver
5218066|NCT02634242|skin|skin
5218067|NCT02634229|monogenic diabetes|monogenic diabetes
5218068|NCT02634229|MODY|mody
5218069|NCT02634229|beta-cell|beta-cell
5218070|NCT02634229|insulin secretion|insulin secretion
5218071|NCT02634216|Hyperglycemia|hyperglycemia
5218072|NCT02634216|Capros|capros
5218073|NCT02634216|Type 1 Diabetes|type 1 diabetes
5215290|NCT02650401|TRK|trk
5218087|NCT02634138|Critical Limb Ischaemia|critical limb ischaemia
5218088|NCT02634112|anastomotic leakage|anastomotic leakage
5218089|NCT02634112|rectal cancer surgery|rectal cancer surgery
5206181|NCT02706132|ABO blood group|abo blood group
5206182|NCT02706119|total parenteral nutrition|total parenteral nutrition
5206186|NCT02706080|VKA|vka
5218090|NCT02634112|anastomotic leakage predictive score|anastomotic leakage predictive score
5218091|NCT02634099|major pediatric surgery|major pediatric surgery
5218092|NCT02634099|hemoglobin measurement|hemoglobin measurement
5218093|NCT02634086|Coronary artery disease|coronary artery disease
5218094|NCT02634086|Percutaneous coronary intervention|percutaneous coronary intervention
5218095|NCT02634086|Coronary artery bypass graft|coronary artery bypass graft
5218096|NCT02634086|Medication therapy|medication therapy
5218097|NCT02634073|Lamivudine|lamivudine
5218098|NCT02634073|Safety|safety
5218099|NCT02634073|Sorbitol|sorbitol
5218100|NCT02634073|Pharmacokinetics|pharmacokinetics
5218101|NCT02634060|adalimumab|adalimumab
5218102|NCT02634060|fecal calprotectin|fecal calprotectin
5218103|NCT02634060|home based|home based
5218104|NCT02634047|transesophageal echocardiography|transesophageal echocardiography
5218105|NCT02634047|videolaryngoscope|videolaryngoscope
5096333|NCT03396133|Snap|snap
5096334|NCT03396133|symptomatic arrhythmia|symptomatic arrhythmia
5096335|NCT03396133|diagnosis|diagnosis
5096336|NCT03396133|follow-up|follow-up
5218106|NCT02634047|oropharyngeal injury|oropharyngeal injury
5218107|NCT02634008|Pangenotypic|pangenotypic
5218108|NCT02634008|Treatment|treatment
5218109|NCT02633956|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5218110|NCT02633956|NAFLD|nafld
5218111|NCT02633956|Fatty Liver Disease|fatty liver disease
5218112|NCT02633956|NASH|nash
5218113|NCT02633930|helicobacter pylori|helicobacter pylori
5218114|NCT02633930|berberine-containing quadruple therapy|berberine-containing quadruple therapy
5218115|NCT02633930|clarithromycin-containing quadruple therapy|clarithromycin-containing quadruple therapy
5218116|NCT02633917|Low back pain|low back pain
5218117|NCT02633917|Motor control|motor control
5218118|NCT02633917|Joint mobilization|joint mobilization
5218119|NCT02633904|Hip Dislocation|hip dislocation
5218120|NCT02633904|Congenital|congenital
5218121|NCT02633904|osteotomy|osteotomy
5218122|NCT02633904|Femur Head Necrosis|femur head necrosis
5218123|NCT02633891|neuropathies|neuropathies
5218124|NCT02633891|metabolic diseases|metabolic diseases
5218125|NCT02633891|nervous system diseases|nervous system diseases
5218126|NCT02633891|peripheral nervous system diseases|peripheral nervous system diseases
5218127|NCT02633878|Threatened Miscarriage|threatened miscarriage
5218128|NCT02633878|The First Trimester|the first trimester
5218129|NCT02633878|Micronized Progesterone|micronized progesterone
5218130|NCT02633878|Chinese Herbal Medicine|chinese herbal medicine
5218131|NCT02633878|Live Birth|live birth
5218132|NCT02633865|patient characteristics|patient characteristics
5218133|NCT02633852|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5218134|NCT02633852|Aflibercept (EYLEA)|aflibercept (eylea)
5218135|NCT02633839|Adults|adults
5218136|NCT02633826|alloreactive T cell|alloreactive t cell
5218137|NCT02633826|donor-specific antibody|donor-specific antibody
5218138|NCT02633813|Bioequivalence|bioequivalence
5218139|NCT02633813|Tinea pedis|tinea pedis
5218140|NCT02633813|Naftin|naftin
5218141|NCT02633800|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
5218142|NCT02633800|Squamous cell carcinoma|squamous cell carcinoma
5218143|NCT02633800|Head and neck cancer|head and neck cancer
5218144|NCT02633800|Neoplasms by site|neoplasms by site
5218145|NCT02633787|Meningitis|meningitis
5218146|NCT02633787|Meningococcal Meningitis|meningococcal meningitis
5218147|NCT02633787|Meningococcal Infections|meningococcal infections
5218148|NCT02633787|Menactra®|menactra®
5218149|NCT02633761|Fetal death|fetal death
5218150|NCT02633761|mifepristone|mifepristone
5218151|NCT02633761|misoprostol|misoprostol
5215367|NCT02649972|15-216|15-216
5218156|NCT02633696|Clinical Pharmacology|clinical pharmacology
5218157|NCT02633696|Bioavailability|bioavailability
5218158|NCT02633696|Silybin|silybin
5218159|NCT02633696|Liver Trasplantation|liver trasplantation
5218160|NCT02633683|Restless Legs Syndrome|restless legs syndrome
5218162|NCT02633657|Restless Legs Syndrome|restless legs syndrome
5218163|NCT02633657|RLS|rls
5218164|NCT02633644|Heart Failure|heart failure
5218165|NCT02633644|Cardiovascular Diseases|cardiovascular diseases
5218166|NCT02633644|Heart Diseases|heart diseases
5218167|NCT02633592|High Resolution Anorectal Manometry|high resolution anorectal manometry
5218168|NCT02633592|Magnetic Resonance Imaging|magnetic resonance imaging
5218169|NCT02633592|Balloon Expulsion|balloon expulsion
5218170|NCT02633592|Position|position
5218171|NCT02633579|Healthy volunteers|healthy volunteers
5218172|NCT02633566|Flatfoot|flatfoot
5218173|NCT02633566|orthoses|orthoses
5218174|NCT02633566|children|children
5218175|NCT02633553|thymoma|thymoma
5218176|NCT02633553|adjuvant radiotherapy|adjuvant radiotherapy
5218177|NCT02633553|complete resection|complete resection
5218178|NCT02633540|T1a Larynx Cancer|t1a larynx cancer
5218179|NCT02633540|T2a Larynx Cancer|t2a larynx cancer
5218180|NCT02633514|thymoma|thymoma
5218181|NCT02633514|thymic carcinoma|thymic carcinoma
5218182|NCT02633514|adjuvant radiotherapy|adjuvant radiotherapy
5218183|NCT02633514|adjuvant radiochemotherapy|adjuvant radiochemotherapy
5218184|NCT02633514|incomplete resection|incomplete resection
5218186|NCT02633475|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5218187|NCT02633449|tDCS|tdcs
5218188|NCT02633449|cognitive behavioral therapy|cognitive behavioral therapy
5218189|NCT02633436|esophageal cancer|esophageal cancer
5218190|NCT02633436|SLC1A5|slc1a5
5218191|NCT02633423|Cardiopulmonary bypass|cardiopulmonary bypass
5218192|NCT02633423|Mechanical ventilation|mechanical ventilation
5218193|NCT02633423|Expiratory Flow Limitation|expiratory flow limitation
5218194|NCT02633423|Best PEEP|best peep
5218195|NCT02633397|SCD|scd
5218196|NCT02633397|Sickle Cell Disease|sickle cell disease
5218197|NCT02633397|Riociguat|riociguat
5218198|NCT02633397|Adempas|adempas
5218199|NCT02633384|Parenteral nutrition associated cholestasis|parenteral nutrition associated cholestasis
5962667|NCT04279483|smoking|smoking
5962668|NCT04279483|smoker|smoker
5962669|NCT04279483|tobacco|tobacco
5962670|NCT04279483|cigarette|cigarette
5962671|NCT04279483|cigarettes|cigarettes
5962672|NCT04279483|Philadelphia|philadelphia
5218200|NCT02633384|Intravenous lipid emulsions|intravenous lipid emulsions
5218201|NCT02633384|Surgical neonates|surgical neonates
5218202|NCT02633384|Congenital gastrointestinal abnormalities|congenital gastrointestinal abnormalities
5218203|NCT02633358|Acute myocardial infarction, cardiogenic shock|acute myocardial infarction, cardiogenic shock
5218204|NCT02633319|Parenting|parenting
5218205|NCT02633319|Child maltreatment|child maltreatment
5218206|NCT02633319|Economic strengthening|economic strengthening
5218207|NCT02633319|Early childhood development|early childhood development
5218208|NCT02633319|Cluster randomized controlled trial|cluster randomized controlled trial
5218209|NCT02633319|Pilot evaluation|pilot evaluation
5218210|NCT02633306|trigeminal region pain|trigeminal region pain
5218216|NCT02633267|social anxiety|social anxiety
5218217|NCT02633267|unemployment|unemployment
5218218|NCT02633267|cognitive behavioral therapy|cognitive behavioral therapy
5218219|NCT02633267|group therapy|group therapy
5218220|NCT02633267|work|work
5218221|NCT02633267|vocation|vocation
5218222|NCT02633241|pediatrics|pediatrics
5218223|NCT02633241|sedation|sedation
5218224|NCT02633241|dexmedetomidine|dexmedetomidine
5218225|NCT02633241|propofol|propofol
5218226|NCT02633241|MRI|mri
5218227|NCT02633228|Multifocal Intraocular Lens|multifocal intraocular lens
5218228|NCT02633228|Binocular Trifocality|binocular trifocality
5218229|NCT02633228|Cataract Surgery|cataract surgery
5218230|NCT02633228|Spectacle Independence|spectacle independence
5218231|NCT02633228|Intermediate Vision|intermediate vision
5218232|NCT02633228|Photopic Vision|photopic vision
5218233|NCT02633228|Mesopic Vision|mesopic vision
5218234|NCT02633228|Scotopic Vision|scotopic vision
5218235|NCT02633228|Binocular Vision|binocular vision
5218236|NCT02633215|motor recovery|motor recovery
5218237|NCT02633215|neuroplasticity|neuroplasticity
5218238|NCT02633215|chronic|chronic
5218239|NCT02633215|human|human
5218240|NCT02633215|sensory|sensory
5218241|NCT02633202|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5218242|NCT02633202|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5218243|NCT02633202|intermediate risk|intermediate risk
5218244|NCT02633202|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5218245|NCT02633189|stage IV|stage iv
5218246|NCT02633189|stage IIIB|stage iiib
5218247|NCT02633189|EGFR mutation|egfr mutation
5218248|NCT02633189|non-squamous|non-squamous
5218249|NCT02633189|liquid biopsy|liquid biopsy
5218250|NCT02633189|erlotinib|erlotinib
5218251|NCT02633189|bevacizumab|bevacizumab
5218252|NCT02633163|Systemic Lupus Erythematosus|systemic lupus erythematosus
5218253|NCT02633163|Stem Cell|stem cell
5218255|NCT02633150|Obesity|obesity
5218261|NCT02633124|Premature infants|premature infants
5218262|NCT02633124|Catheter-related bacteremia|catheter-related bacteremia
5218263|NCT02633124|Infusion device|infusion device
5218264|NCT02633124|Neonatal intensive care|neonatal intensive care
5218265|NCT02633124|Central Venous Catheter|central venous catheter
5218266|NCT02633124|Drug Infusion Systems|drug infusion systems
5218267|NCT02633111|DNA Sequencing|dna sequencing
5218269|NCT02633098|Artesunate|artesunate
5218270|NCT02633098|Artemisinins|artemisinins
5218271|NCT02633098|Antimalarial|antimalarial
5218272|NCT02633098|Neoadjuvant|neoadjuvant
5218273|NCT02633098|Pre-operative|pre-operative
5218274|NCT02633085|Unicompartment Knee Replacement|unicompartment knee replacement
5218275|NCT02633072|Multifocal Intraocular Lens|multifocal intraocular lens
5218276|NCT02633072|Binocular Trifocality|binocular trifocality
5218277|NCT02633072|Cataract Surgery|cataract surgery
5218278|NCT02633072|Spectacle Independence|spectacle independence
5218279|NCT02633072|Intermediate Vision|intermediate vision
5218280|NCT02633072|Photopic Vision|photopic vision
5218281|NCT02633072|Mesopic Vision|mesopic vision
5218282|NCT02633072|Scotopic Vision|scotopic vision
5218283|NCT02633072|Binocular Vision|binocular vision
5218284|NCT02633046|FSGS|fsgs
5218285|NCT02633046|primary FSGS|primary fsgs
5218286|NCT02633046|idiopathic FSGS|idiopathic fsgs
5218287|NCT02633033|Multiple Sclerosis|multiple sclerosis
5218288|NCT02633033|Relapsing-Remitting|relapsing-remitting
5218289|NCT02633033|Acthar|acthar
5218290|NCT02633033|Corticotropin|corticotropin
5218292|NCT02632981|Interleukin-32|interleukin-32
5218293|NCT02632981|periodontitis|periodontitis
5218294|NCT02632955|arteriovenous fistula|arteriovenous fistula
5218295|NCT02632955|hemodialysis|hemodialysis
5218296|NCT02632955|drug coated balloon|drug coated balloon
5218297|NCT02632942|arteriovenous fistula|arteriovenous fistula
5218298|NCT02632942|hemodialysis|hemodialysis
5218299|NCT02632942|maturation|maturation
5218300|NCT02632929|foot ulcer, diabetic|foot ulcer, diabetic
5218301|NCT02632929|wound healing|wound healing
5218302|NCT02632929|diabetic foot ulcer|diabetic foot ulcer
5218303|NCT02632877|pirfenidone|pirfenidone
5218304|NCT02632877|Modified oxide diallyl disulfide (MODD)|modified oxide diallyl disulfide (modd)
5218305|NCT02632877|ketanserin|ketanserin
5218306|NCT02632877|diabetic foot ulcer|diabetic foot ulcer
5218307|NCT02632851|inhalation|inhalation
5218308|NCT02632851|isotonic saline|isotonic saline
5218309|NCT02632851|NaCl solution 0.9 %|nacl solution 0.9 %
5218310|NCT02632851|Ectoin|ectoin
5096571|NCT03394703|Lung cancer|lung cancer
5218311|NCT02632851|bronchitis|bronchitis
5218312|NCT02632851|respiratory tract infection|respiratory tract infection
5218313|NCT02632838|Hypertension|hypertension
5218314|NCT02632838|mHealth|mhealth
5218315|NCT02632838|underserved community|underserved community
5218316|NCT02632825|Nasal High Flow|nasal high flow
5218317|NCT02632825|gas exchange|gas exchange
5218318|NCT02632825|newborn|newborn
5218319|NCT02632799|Nasal High Flow|nasal high flow
5218320|NCT02632799|CPAP|cpap
5218321|NCT02632799|airway pressure|airway pressure
5218322|NCT02632799|newborn|newborn
5218323|NCT02632786|amyloidosis|amyloidosis
5218324|NCT02632786|ntprobnp|ntprobnp
5218325|NCT02632786|NEOD001|neod001
5218326|NCT02632786|Prothena|prothena
5218327|NCT02632786|PRONTO|pronto
5218328|NCT02632786|amyloid|amyloid
5218329|NCT02632786|plasma cell dyscrasia|plasma cell dyscrasia
5218330|NCT02632786|immunotherapy|immunotherapy
5218331|NCT02632773|Language Intervention|language intervention
5218332|NCT02632773|Parent-Mediated Intervention|parent-mediated intervention
5218333|NCT02632734|alveolar bone preservation|alveolar bone preservation
5218334|NCT02632734|coral grafting device|coral grafting device
5218335|NCT02632708|Acute Myeloid Leukemia|acute myeloid leukemia
5218336|NCT02632708|AML|aml
5218337|NCT02632708|Untreated AML|untreated aml
5218338|NCT02632708|De novo AML|de novo aml
5218339|NCT02632708|Secondary AML|secondary aml
5218340|NCT02632708|Newly diagnosed AML|newly diagnosed aml
5218341|NCT02632708|IDH1|idh1
5218342|NCT02632708|IDH2|idh2
5218343|NCT02632708|Induction therapy|induction therapy
5218344|NCT02632708|Consolidation therapy|consolidation therapy
5218345|NCT02632708|IDH|idh
5224755|NCT02594488|ECG|ecg
5218346|NCT02632682|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5218347|NCT02632669|Focal brachytherapy|focal brachytherapy
5218348|NCT02632669|Seed implant|seed implant
5218349|NCT02632669|Quality of life|quality of life
5218350|NCT02632669|Toxicity|toxicity
5218351|NCT02632643|TMD|tmd
5218352|NCT02632643|HYPERTONIA|hypertonia
5218353|NCT02632643|PARAFUNCTIONS|parafunctions
5218354|NCT02632643|SENSORIMOTOR APPROACH|sensorimotor approach
5218355|NCT02632630|Peripheral Parenteral Nutrition|peripheral parenteral nutrition
5218356|NCT02632630|Oral nutritional supplementation|oral nutritional supplementation
5218357|NCT02632630|Acute Care hospitals|acute care hospitals
5218358|NCT02632617|Heart Valve Diseases|heart valve diseases
5218359|NCT02632617|Coronary Artery Disease|coronary artery disease
5218360|NCT02632617|Computed Tomographic Angiography|computed tomographic angiography
5218361|NCT02632617|Preoperative Procedure|preoperative procedure
5218363|NCT02632565|lidocaine|lidocaine
5218364|NCT02632565|pain|pain
5218365|NCT02632565|ultrasound|ultrasound
5218366|NCT02632552|care transition|care transition
5218367|NCT02632552|technology|technology
5218368|NCT02632552|chronic heart failure|chronic heart failure
5218369|NCT02632552|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5218370|NCT02632552|virtual nurse|virtual nurse
5218371|NCT02632552|texting|texting
5218372|NCT02632552|informatics|informatics
5218373|NCT02632552|Veterans|veterans
5218374|NCT02632539|ventilator associated pneumonia|ventilator associated pneumonia
5218375|NCT02632539|Subglottic Secretion Drainage|subglottic secretion drainage
5206483|NCT02704208|Medication Adherence|medication adherence
5206484|NCT02704208|Technology-based Intervention|technology-based intervention
5206485|NCT02704195|Parkinson disease|parkinson disease
5206486|NCT02704195|Deep brain stimulation|deep brain stimulation
5206487|NCT02704195|Freezing of Gait|freezing of gait
5206488|NCT02704182|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
5206497|NCT02704130|TAE|tae
5218376|NCT02632539|manual air-impingement operation|manual air-impingement operation
5218377|NCT02632526|AZD5718 oral suspension crystalline|azd5718 oral suspension crystalline
5218378|NCT02632526|AZD5718 oral suspension amorphous|azd5718 oral suspension amorphous
5218379|NCT02632526|Single ascending dose/multiple ascending dose (SAD/MAD)|single ascending dose/multiple ascending dose (sad/mad)
5218380|NCT02632526|Placebo-controlled|placebo-controlled
5218381|NCT02632526|Safety|safety
5218382|NCT02632526|Tolerability|tolerability
5218383|NCT02632526|Pharmacokinetics|pharmacokinetics
5218384|NCT02632526|Pharmacodynamics|pharmacodynamics
5218385|NCT02632513|continuous ultrasonic irrigation, syringe irrigation|continuous ultrasonic irrigation, syringe irrigation
5218386|NCT02632500|Cardio-Pulmonary Resuscitation|cardio-pulmonary resuscitation
5218387|NCT02632500|Cardiac Arrest|cardiac arrest
5218388|NCT02632500|Training|training
5218389|NCT02632474|HIV Infections|hiv infections
5218390|NCT02632474|Tenofovir|tenofovir
5218391|NCT02632474|Efavirenz|efavirenz
5218392|NCT02632461|Diet|diet
5218393|NCT02632461|Weight Loss|weight loss
5218394|NCT02632461|Tracking|tracking
5962673|NCT04279483|healthy|healthy
5218395|NCT02632461|Calories|calories
5218396|NCT02632448|Metastatic cancer|metastatic cancer
5218397|NCT02632448|Advanced cancer|advanced cancer
5218398|NCT02632448|Recurrent cancer|recurrent cancer
5218399|NCT02632448|Colorectal neoplasms|colorectal neoplasms
5218400|NCT02632448|Triple negative breast cancer|triple negative breast cancer
5218401|NCT02632448|Ovarian neoplasms|ovarian neoplasms
5218402|NCT02632448|Colon neoplasms|colon neoplasms
5218403|NCT02632448|Rectal neoplasms|rectal neoplasms
5218404|NCT02632448|Triple negative breast neoplasms|triple negative breast neoplasms
5218405|NCT02632448|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5218406|NCT02632448|Pancreatic Neoplasms|pancreatic neoplasms
5218804|NCT02630342|Anxiety|anxiety
5218407|NCT02632448|Pancreatic Cancer|pancreatic cancer
5218408|NCT02632435|HER2 positive|her2 positive
5218410|NCT02632422|rehabilitation|rehabilitation
5218411|NCT02632422|strength|strength
5218412|NCT02632422|movement|movement
5218413|NCT02632422|spinal cord trauma|spinal cord trauma
5218414|NCT02632422|spinal cord injury|spinal cord injury
5218415|NCT02632383|Diabetes type 1|diabetes type 1
5218416|NCT02632383|Transition|transition
5218417|NCT02632383|Telemedicine|telemedicine
5218418|NCT02632383|mHealth app|mhealth app
5218419|NCT02632383|Youth|youth
5218420|NCT02632383|Self-management|self-management
5218421|NCT02632370|Malignant Gliomas|malignant gliomas
5218422|NCT02632370|5-ALA|5-ala
5218423|NCT02632370|tumor resection|tumor resection
5218424|NCT02632370|malignant tumor|malignant tumor
5218425|NCT02632357|Neurodynamics|neurodynamics
5218426|NCT02632344|Laryngeal papilloma, recurrent|laryngeal papilloma, recurrent
5218427|NCT02632344|Respiratory papillomatosis|respiratory papillomatosis
5218428|NCT02632344|Juvenile-onset recurrent respiratory papillomatosis|juvenile-onset recurrent respiratory papillomatosis
5218429|NCT02632344|Human papillomavirus|human papillomavirus
5218430|NCT02632344|Virally-related diseases|virally-related diseases
5218431|NCT02632331|Food effect|food effect
5218432|NCT02632331|Pharmacokinetics|pharmacokinetics
5218433|NCT02632331|ASP8825|asp8825
5218434|NCT02632331|XP13512|xp13512
5218435|NCT02632305|unresectable biliary tract cancer|unresectable biliary tract cancer
5218436|NCT02632305|nab-paclitaxel|nab-paclitaxel
5218437|NCT02632305|cisplatin|cisplatin
5218438|NCT02632305|gemcitabine|gemcitabine
5218439|NCT02632279|Parkinson's disease|parkinson's disease
5218440|NCT02632279|Deep Brain Stimulation|deep brain stimulation
5218441|NCT02632279|Subthalamic nucleus|subthalamic nucleus
5218454|NCT02632240|mucogingival surgery|mucogingival surgery
5218455|NCT02632240|collagen matrix|collagen matrix
5218456|NCT02632240|connective tissue graft|connective tissue graft
5206581|NCT02703545|familial pancreas cancer|familial pancreas cancer
5206582|NCT02703545|pancreatic cyst|pancreatic cyst
5218457|NCT02632240|tunnel technique|tunnel technique
5218458|NCT02632214|Face processing|face processing
5218459|NCT02632214|asymmetry|asymmetry
5218460|NCT02632214|deaf|deaf
5218461|NCT02632214|fMRI|fmri
5218462|NCT02632201|gastric cancer|gastric cancer
5218463|NCT02632201|liver metastasis|liver metastasis
5218464|NCT02632201|PIK-HER2 cells|pik-her2 cells
5218465|NCT02632201|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
5218466|NCT02632188|Recurrence|recurrence
5218467|NCT02632188|Metastasis|metastasis
5218468|NCT02632188|liver cancer|liver cancer
5218469|NCT02632175|Ulcerative Colitis|ulcerative colitis
5218470|NCT02632149|PINS Vagus Nerve Stimulator|pins vagus nerve stimulator
5218471|NCT02632136|Laparoscopic|laparoscopic
5218472|NCT02632136|TAP Block|tap block
5218473|NCT02632136|Total extra peritoneal Inguinal hernia repair|total extra peritoneal inguinal hernia repair
5218474|NCT02632123|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5218475|NCT02632123|outcome|outcome
5218476|NCT02632123|prognosis|prognosis
5218477|NCT02632123|survival|survival
5218478|NCT02632110|Actinic Keratosis|actinic keratosis
5218479|NCT02632097|inguinal hernia|inguinal hernia
5218480|NCT02632097|mesh fixation|mesh fixation
5218481|NCT02632097|glue|glue
5218482|NCT02632097|cyanoacrylate|cyanoacrylate
5218483|NCT02632097|Lichtenstein|lichtenstein
5218484|NCT02632097|ambulatory surgery|ambulatory surgery
5218485|NCT02632071|Breast Cancer|breast cancer
5218486|NCT02632071|Breast Carcinoma|breast carcinoma
5218487|NCT02632071|Breast tumors|breast tumors
5218488|NCT02632071|Cancer of the Breast|cancer of the breast
5218489|NCT02632071|Malignant tumor of the breast|malignant tumor of the breast
5218490|NCT02632071|Metastatic Breast Cancer|metastatic breast cancer
5218491|NCT02632071|Unresectable breast cancer|unresectable breast cancer
5218492|NCT02632045|Breast Neoplasms|breast neoplasms
5218493|NCT02632045|Breast Cancer|breast cancer
5218494|NCT02632045|Breast Carcinoma|breast carcinoma
5218495|NCT02632045|Breast tumors|breast tumors
5218496|NCT02632045|Cancer of the Breast|cancer of the breast
5218497|NCT02632032|Type 1 diabetes|type 1 diabetes
5218498|NCT02632032|children|children
5218499|NCT02632032|diabetes camps|diabetes camps
5218500|NCT02632032|glycemic control|glycemic control
5218501|NCT02632019|advanced biliary tract malignant tumor|advanced biliary tract malignant tumor
5218502|NCT02632019|dendritic cell|dendritic cell
5218503|NCT02632019|precision T cell for neo-antigen|precision t cell for neo-antigen
5218504|NCT02632006|PIK-PD-1 Cells|pik-pd-1 cells
5218505|NCT02632006|dendritic cell-precision multiple antigen T cells|dendritic cell-precision multiple antigen t cells
5218506|NCT02632006|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5218507|NCT02631993|Psoralen|psoralen
5218509|NCT02631993|Time-to-treatment|time-to-treatment
5218510|NCT02631993|GVL|gvl
5218511|NCT02631980|Hepcidin|hepcidin
5218512|NCT02631967|Crohn disease|crohn disease
5218513|NCT02631967|ileocecal resection|ileocecal resection
5218514|NCT02631967|anastomosis|anastomosis
5218515|NCT02631967|Kono|kono
5218516|NCT02631928|biphasic human insulin|biphasic human insulin
5218517|NCT02631928|biosimilar|biosimilar
5218518|NCT02631902|Community-based intervention|community-based intervention
5218519|NCT02631902|Exercise program|exercise program
5218520|NCT02631902|Dietary intervention program|dietary intervention program
5218521|NCT02631902|Health promotion|health promotion
5218522|NCT02631902|Subjective well-being|subjective well-being
5218523|NCT02631902|Cardiovascular risk|cardiovascular risk
5218524|NCT02631876|Epithelial ovarian cancer|epithelial ovarian cancer
5218525|NCT02631876|Fallopian tube cancer|fallopian tube cancer
5218526|NCT02631876|Primary peritoneal cancer|primary peritoneal cancer
5218531|NCT02631876|Antibody|antibody
5218532|NCT02631876|Folate receptor alpha|folate receptor alpha
5218533|NCT02631876|mirvetuximab soravtansine|mirvetuximab soravtansine
5218535|NCT02631876|platinum-resistant|platinum-resistant
5218536|NCT02631850|Constraint-induced movement therapy|constraint-induced movement therapy
5218537|NCT02631850|gaming|gaming
5218538|NCT02631850|virtual reality|virtual reality
5218539|NCT02631850|upper extremity|upper extremity
5218540|NCT02631850|CI therapy|ci therapy
5218541|NCT02631850|rehabilitation|rehabilitation
5218542|NCT02631850|stroke|stroke
5218543|NCT02631850|hemiparesis|hemiparesis
5218544|NCT02631850|therapy|therapy
5218545|NCT02631837|NOTES|notes
5218546|NCT02631837|Laparoscopic surgery|laparoscopic surgery
5218547|NCT02631824|fragility fractures|fragility fractures
5218548|NCT02631824|hip fractures|hip fractures
5863468|NCT00001275|Ovulation|ovulation
5218556|NCT02631785|Fear conditioning|fear conditioning
5218557|NCT02631785|Fear extinction|fear extinction
5218558|NCT02631759|Acute intraCerebral Haemorrhage, Epileptic seizures, Lévétiracetam|acute intracerebral haemorrhage, epileptic seizures, lévétiracetam
5218808|NCT02630329|Benign adnexal disease|benign adnexal disease
5218559|NCT02631720|Chronic Lung Allograft Dysfunction (CLAD)|chronic lung allograft dysfunction (clad)
5218560|NCT02631720|Restrictive chronic lung allograft dysfunction (RCLAD)|restrictive chronic lung allograft dysfunction (rclad)
5218561|NCT02631720|Bronchiolitis Obliterans Syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
5218562|NCT02631720|CLAD risk factors|clad risk factors
5218563|NCT02631720|observational study|observational study
5218564|NCT02631668|iron deficiency anemia, vitamin C, ferrous succinate|iron deficiency anemia, vitamin c, ferrous succinate
5218565|NCT02631629|Vitamin D|vitamin d
5218566|NCT02631629|Fortification|fortification
5218567|NCT02631616|Prostatic Neoplasma, Castration-Resistant|prostatic neoplasma, castration-resistant
5218568|NCT02631616|neuroendocrine differentiation|neuroendocrine differentiation
5218569|NCT02631616|68Ga-DOTATET|68ga-dotatet
5218571|NCT02631590|intra-hepatic biliary system|intra-hepatic biliary system
5218572|NCT02631590|extra-hepatic biliary system|extra-hepatic biliary system
5218573|NCT02631590|gall bladder|gall bladder
5218574|NCT02631590|advanced biliary cancer|advanced biliary cancer
5218575|NCT02631590|unresectable|unresectable
5218576|NCT02631590|locally advanced|locally advanced
5218577|NCT02631590|metastatic disease|metastatic disease
5218578|NCT02631564|mCRC;TACE;hepatic infusion;raltitrexed|mcrc;tace;hepatic infusion;raltitrexed
5218579|NCT02631551|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5218587|NCT02631525|Airway extubation|airway extubation
5218588|NCT02631525|Anesthesia Recovery Period|anesthesia recovery period
5218589|NCT02631525|Desflurane|desflurane
5218590|NCT02631525|Propofol|propofol
5218591|NCT02631525|Intravenous anesthesia|intravenous anesthesia
5218592|NCT02631525|Balanced Anesthesia|balanced anesthesia
5218593|NCT02631499|Circulating Tumor Cells|circulating tumor cells
5218594|NCT02631499|Hepatoectomy|hepatoectomy
5218595|NCT02631499|TACE|tace
5218596|NCT02631499|prognosis|prognosis
5218597|NCT02631499|relapse|relapse
5218598|NCT02631499|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5218599|NCT02631486|Rotator Cuff Tears|rotator cuff tears
5218600|NCT02631447|Metastatic Melanoma|metastatic melanoma
5218601|NCT02631447|BRAF mutation|braf mutation
5218602|NCT02631408|spinal fusion|spinal fusion
5218603|NCT02631408|topical antibiotics|topical antibiotics
5218604|NCT02631408|vancomycin|vancomycin
5218605|NCT02631408|surgical site infection|surgical site infection
5218606|NCT02631395|Exercise movement techniques|exercise movement techniques
5218607|NCT02631382|wet cupping Saudi Arabia|wet cupping saudi arabia
5218608|NCT02631343|Kangaroo mother care in the community|kangaroo mother care in the community
5218609|NCT02631330|Geriatric Assessment|geriatric assessment
5218610|NCT02631330|Physical Education and Training|physical education and training
5218611|NCT02631317|acute ischemic stroke|acute ischemic stroke
5218612|NCT02631317|intravenous rt-PA thrombolysis|intravenous rt-pa thrombolysis
5218613|NCT02631317|process reengineering|process reengineering
5218614|NCT02631317|door-to-needle time|door-to-needle time
5218615|NCT02631304|Postoperative delirium|postoperative delirium
5218616|NCT02631304|Cholinesterase activity|cholinesterase activity
5218617|NCT02631304|Buturylcholinesterase activity|buturylcholinesterase activity
5218618|NCT02631304|Acetylcholinesterase activity|acetylcholinesterase activity
5218619|NCT02631304|Elderly patients|elderly patients
5218620|NCT02631304|Cardiac surgery|cardiac surgery
5218621|NCT02631265|Type 1 diabetes|type 1 diabetes
5218622|NCT02631265|Exercise|exercise
5218623|NCT02631265|Hypoglycemia|hypoglycemia
5218624|NCT02631265|Insulin pump|insulin pump
5218625|NCT02631252|Leukemia|leukemia
5218626|NCT02631252|Acute Myelogenous|acute myelogenous
5218627|NCT02631252|Phase I|phase i
5218628|NCT02631252|Mitoxantrone|mitoxantrone
5218629|NCT02631252|Etoposide|etoposide
5218630|NCT02631252|Hydroxychloroquine|hydroxychloroquine
5218631|NCT02631252|Relapsed|relapsed
5218632|NCT02631252|Autophagy inhibitor|autophagy inhibitor
5218634|NCT02631252|Relapsed AML|relapsed aml
5218635|NCT02631200|Advance Care Planning|advance care planning
5218636|NCT02631200|Palliative care|palliative care
5218637|NCT02631200|Frail Elderly|frail elderly
5218638|NCT02631200|Renal Dialysis|renal dialysis
5218639|NCT02631187|Grade 2 retraction of the pars tensa of the tympanic membrane|grade 2 retraction of the pars tensa of the tympanic membrane
5218640|NCT02631187|Grade 3 retraction of the pars tensa of the tympanic membrane|grade 3 retraction of the pars tensa of the tympanic membrane
5218641|NCT02631135|Dexmedetomidine|dexmedetomidine
5218642|NCT02631135|cognitive functions|cognitive functions
5218643|NCT02631135|MMSE|mmse
5218644|NCT02631122|Retroclavicular|retroclavicular
5218645|NCT02631122|Supraclavicular|supraclavicular
5218646|NCT02631122|Diagphram|diagphram
5218647|NCT02631122|hemiparesis|hemiparesis
5218648|NCT02631122|nerve block|nerve block
5218649|NCT02631122|regional anesthesia|regional anesthesia
5218650|NCT02631122|anesthesiology|anesthesiology
5218651|NCT02631109|Pegaspargase|pegaspargase
5218652|NCT02631109|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5206771|NCT02702466|Randomized controlled trials|randomized controlled trials
5206772|NCT02702466|Education|education
5206774|NCT02702466|Self-care|self-care
5218653|NCT02631109|Epstein Barr virus|epstein barr virus
5218654|NCT02631070|Luspatercept|luspatercept
5218655|NCT02631070|Transfusion dependent|transfusion dependent
5218656|NCT02631070|Lower risk|lower risk
5218657|NCT02631070|Low risk|low risk
5218658|NCT02631070|Myelodysplastic Syndromes|myelodysplastic syndromes
5218659|NCT02631070|ESA refractory|esa refractory
5218660|NCT02631070|ESA intolerant|esa intolerant
5218661|NCT02631070|ESA ineligible|esa ineligible
5218662|NCT02631070|ACE-536|ace-536
5218663|NCT02631070|Anemia|anemia
5218664|NCT02631070|Ring Sideroblasts|ring sideroblasts
5218665|NCT02631070|Require Red Blood Cell Transfusions|require red blood cell transfusions
5218666|NCT02631070|MEDALIST|medalist
5218667|NCT02631070|MDS|mds
5218668|NCT02631070|IPSS-R very low/IPSS-R low/IPSS-R intermediate|ipss-r very low/ipss-r low/ipss-r intermediate
5218669|NCT02631044|JCAR017|jcar017
5218670|NCT02631044|chimeric antigen receptor|chimeric antigen receptor
5218671|NCT02631044|non-Hodgkin lymphoma|non-hodgkin lymphoma
5218672|NCT02631044|CAR|car
5218673|NCT02631044|CAR T cells|car t cells
5218674|NCT02631044|autologous T cell therapy|autologous t cell therapy
5218675|NCT02631044|cell therapy|cell therapy
5218676|NCT02631044|NHL|nhl
5218677|NCT02631031|Chronokinetics|chronokinetics
5218678|NCT02631031|chronodynamics|chronodynamics
5218679|NCT02631031|chronopharmacology|chronopharmacology
5218680|NCT02631031|valsartan|valsartan
5218681|NCT02631005|systemic lupus erythematosus|systemic lupus erythematosus
5218682|NCT02631005|exercise|exercise
5218683|NCT02630992|ear infections|ear infections
5218684|NCT02630992|antibiotics|antibiotics
5218685|NCT02630992|antibiotic resistance|antibiotic resistance
5218686|NCT02630992|pediatrics|pediatrics
5218688|NCT02630992|children|children
5218689|NCT02630992|amoxicillin-clavulanate|amoxicillin-clavulanate
5218690|NCT02630966|Drug therapy|drug therapy
5218691|NCT02630966|Fistulizing Crohn´s disease|fistulizing crohn´s disease
5218692|NCT02630966|Perianal Fistula|perianal fistula
5218693|NCT02630953|Physical Activity|physical activity
5218694|NCT02630953|Latinas|latinas
5218695|NCT02630953|Spanish-language|spanish-language
5218696|NCT02630953|Text-Message|text-message
5218697|NCT02630953|English-language|english-language
5218698|NCT02630953|Exercise|exercise
5218699|NCT02630927|Safety and Tolerability|safety and tolerability
5218700|NCT02630927|Pharmacokinetic Study|pharmacokinetic study
5218701|NCT02630927|Healthy Volunteer|healthy volunteer
5218702|NCT02630927|Pyruvate Kinase|pyruvate kinase
5218703|NCT02630927|Rare Genetic|rare genetic
5218704|NCT02630914|Epicardial surgical removal|epicardial surgical removal
5218705|NCT02630914|Closure of the left atrial|closure of the left atrial
5218706|NCT02630914|Left atrial appendage (LAA)|left atrial appendage (laa)
5218707|NCT02630888|Bipolar Disorder|bipolar disorder
5218708|NCT02630888|Memantine|memantine
5218709|NCT02630888|Lithium|lithium
5218710|NCT02630888|Aripiprazole|aripiprazole
5087417|NCT03452306|AUC|auc
5218711|NCT02630888|Quetiapine|quetiapine
5218712|NCT02630888|Central Nervous System Agents|central nervous system agents
5218713|NCT02630888|Therapeutic Uses|therapeutic uses
5218714|NCT02630888|Pharmacologic Actions|pharmacologic actions
5218715|NCT02630888|Psychotropic Drugs|psychotropic drugs
5218716|NCT02630888|Cognitive effect of drugs|cognitive effect of drugs
5218717|NCT02630862|oxidative stress|oxidative stress
5218718|NCT02630862|atherosclerosis|atherosclerosis
5218719|NCT02630862|carotid stenosis|carotid stenosis
5218720|NCT02630862|oxysterols|oxysterols
5218721|NCT02630862|vitamin E|vitamin e
5218722|NCT02630862|lipid peroxidation|lipid peroxidation
5218723|NCT02630862|antioxidants|antioxidants
5218724|NCT02630862|aspirin|aspirin
5218725|NCT02630862|dipyridamole|dipyridamole
5216010|NCT02646098|NHL|nhl
5218729|NCT02630836|allogeneic|allogeneic
5218730|NCT02630836|bone marrow|bone marrow
5218731|NCT02630836|bone regeneration|bone regeneration
5218732|NCT02630836|fracture|fracture
5218733|NCT02630797|Bone Health|bone health
5218735|NCT02630797|Osteoporosis|osteoporosis
5218736|NCT02630797|Polyphenolics|polyphenolics
5218737|NCT02630784|Non-invasive ventilation|non-invasive ventilation
5218738|NCT02630784|NIV ventilator|niv ventilator
5218739|NCT02630784|Exhalation by a calibrated leak|exhalation by a calibrated leak
5218740|NCT02630784|ICU ventilator|icu ventilator
5307591|NCT02140684|UK|uk
5218741|NCT02630784|Respiratory acidosis|respiratory acidosis
5218742|NCT02630784|ICU|icu
5218743|NCT02630758|depression|depression
5218744|NCT02630758|yoga|yoga
5218745|NCT02630758|mindfulness|mindfulness
5218746|NCT02630745|endodontic treatment|endodontic treatment
5218747|NCT02630745|open flap debridement|open flap debridement
5218748|NCT02630732|Back School|back school
5218753|NCT02630628|Lupus Nephritis|lupus nephritis
5218754|NCT02630628|mycophenolate mofetil|mycophenolate mofetil
5218755|NCT02630628|tacrolimus|tacrolimus
5218756|NCT02630615|Circulating tumor cells|circulating tumor cells
5218757|NCT02630589|tinnitus|tinnitus
5218758|NCT02630589|auditory brainstem implant|auditory brainstem implant
5218759|NCT02630589|electrical stimulation|electrical stimulation
5218760|NCT02630576|electromyography|electromyography
5218761|NCT02630576|neuromuscular blockade|neuromuscular blockade
5218762|NCT02630550|Cardiac output|cardiac output
5218763|NCT02630550|Intraoperative Monitoring|intraoperative monitoring
5218764|NCT02630550|Echocardiography, Transesophageal|echocardiography, transesophageal
5218765|NCT02630550|Vascular cross-clamping|vascular cross-clamping
5218766|NCT02630550|Endarterectomy|endarterectomy
5218767|NCT02630550|Monitoring, Physiologic/instrumentation|monitoring, physiologic/instrumentation
5218768|NCT02630550|Cardiography, Impedance|cardiography, impedance
5218769|NCT02630537|Cytomegalovirus|cytomegalovirus
5218770|NCT02630537|Epstein- Barr virus|epstein- barr virus
5218771|NCT02630537|Cell-mediated immunity|cell-mediated immunity
5218772|NCT02630537|T-Track® CMV|t-track® cmv
5218773|NCT02630537|T-Track® EBV|t-track® ebv
5218774|NCT02630537|hemodialysis|hemodialysis
5218775|NCT02630537|ELISpot|elispot
5218776|NCT02630498|pain|pain
5218777|NCT02630498|surgical|surgical
5218778|NCT02630498|brachial plexus|brachial plexus
5218779|NCT02630485|Randomized Controlled Trial|randomized controlled trial
5218780|NCT02630459|Migraine Prevention|migraine prevention
5218781|NCT02630459|Headache|headache
5218782|NCT02630459|Prophylaxis|prophylaxis
5218783|NCT02630446|respite care|respite care
5218784|NCT02630446|effectiveness|effectiveness
5218785|NCT02630446|cost-effectiveness|cost-effectiveness
5218786|NCT02630446|support|support
5218787|NCT02630446|caregiver|caregiver
5218788|NCT02630446|dementia|dementia
5218789|NCT02630446|community-based|community-based
5218790|NCT02630433|Biliary pancreatitis|biliary pancreatitis
5218791|NCT02630433|Cholecystectomy|cholecystectomy
5218792|NCT02630394|sickle cell disease|sickle cell disease
5218793|NCT02630394|acute chest syndrome|acute chest syndrome
5218794|NCT02630381|high-energy shock waves|high-energy shock waves
5218795|NCT02630368|Advanced Soft-tissue Sarcoma|advanced soft-tissue sarcoma
5218796|NCT02630368|Advanced Breast Cancer|advanced breast cancer
5218797|NCT02630368|Maximum Tolerated Dose|maximum tolerated dose
5218798|NCT02630368|Efficacy and safety|efficacy and safety
5218799|NCT02630342|Mock Scanner|mock scanner
5218800|NCT02630342|Child Life Specialist|child life specialist
5218801|NCT02630342|Patient Preparation|patient preparation
5218802|NCT02630342|Child, Preschool|child, preschool
5218805|NCT02630342|Human|human
5218806|NCT02630342|Anesthesia, General|anesthesia, general
5962674|NCT04279470|CAR-T cell|car-t cell
5218807|NCT02630329|NOTES|notes
5218809|NCT02630329|Laparoscopy|laparoscopy
5218815|NCT02630303|light emitting diode-red light|light emitting diode-red light
5218816|NCT02630303|LED-RL|led-rl
5218817|NCT02630303|high fluence|high fluence
5218818|NCT02630303|skin fibrosis|skin fibrosis
5218819|NCT02630303|wound healing|wound healing
5218820|NCT02630303|scar|scar
5218821|NCT02630303|keloid|keloid
5218822|NCT02630303|RCT|rct
5218823|NCT02630290|Brachial plexus block|brachial plexus block
5218824|NCT02630290|Dexmedetomidine|dexmedetomidine
5218825|NCT02630290|Ropivacaine|ropivacaine
5218826|NCT02630290|ultrasound-guided nerve block|ultrasound-guided nerve block
5218827|NCT02630290|supraclavicular brachial plexus block|supraclavicular brachial plexus block
5218828|NCT02630277|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5218829|NCT02630277|High Risk PDR|high risk pdr
5218830|NCT02630277|aflibercept|aflibercept
5218831|NCT02630277|regression of retinal neovascularization|regression of retinal neovascularization
5218832|NCT02630264|clinical trial|clinical trial
5218833|NCT02630264|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
5218836|NCT02630251|Safety|safety
5218837|NCT02630251|GSK2820151|gsk2820151
5218838|NCT02630251|Dose escalation|dose escalation
5218839|NCT02630251|Tolerability|tolerability
5218840|NCT02630251|Pharmacodynamics|pharmacodynamics
5218841|NCT02630251|Pharmacokinetics|pharmacokinetics
5218842|NCT02630238|Exercise|exercise
5218843|NCT02630238|Amino Acids, Branched-Chain|amino acids, branched-chain
5218844|NCT02630225|case management|case management
5218845|NCT02630225|motivational interviewing|motivational interviewing
5218846|NCT02630212|Aortic dissection|aortic dissection
5218847|NCT02630212|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
5218848|NCT02630212|Risk factor|risk factor
5218849|NCT02630212|aldehyde dehydrogenase 2|aldehyde dehydrogenase 2
5206973|NCT02701517|alemtuzumab|alemtuzumab
5206974|NCT02701517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5218850|NCT02630173|endodontic treatment|endodontic treatment
5218851|NCT02630173|scaling|scaling
5218852|NCT02630173|root planning|root planning
5218853|NCT02630147|Late preterm|late preterm
5218854|NCT02630147|Vanilla|vanilla
5218855|NCT02630147|Hypoxic intermittent events|hypoxic intermittent events
5218857|NCT02630108|TACE|tace
5218858|NCT02630108|Thermal Ablation|thermal ablation
5218859|NCT02630108|Safety/Efficacy|safety/efficacy
5218860|NCT02630095|anticoagulation|anticoagulation
5218861|NCT02630082|HIV Preventive Vaccine|hiv preventive vaccine
5218862|NCT02630082|HIV Seronegativity|hiv seronegativity
5218863|NCT02630082|Immune Response, Mucosal|immune response, mucosal
5218864|NCT02630069|amphetamine type stimulant|amphetamine type stimulant
5218865|NCT02630069|adolescents|adolescents
5218866|NCT02630056|radiotherapy hematologic toxicity pelvic bone marrow|radiotherapy hematologic toxicity pelvic bone marrow
5218867|NCT02630004|Mucositis|mucositis
5218868|NCT02630004|Head and Neck cancer|head and neck cancer
5218869|NCT02630004|Chemoradiation|chemoradiation
5218870|NCT02629991|Prader-Willi Syndrome (PWS)|prader-willi syndrome (pws)
5218871|NCT02629991|Hyperphagia|hyperphagia
5218872|NCT02629978|pulmonary|pulmonary
5218873|NCT02629978|lung|lung
5218874|NCT02629978|cancer|cancer
5218875|NCT02629978|carcinoma|carcinoma
5218876|NCT02629978|nodule|nodule
5218877|NCT02629978|malignant|malignant
5218878|NCT02629978|radiofrequency ablation|radiofrequency ablation
5218880|NCT02629952|glucose tolerance|glucose tolerance
5218881|NCT02629952|type 2 diabetes|type 2 diabetes
5218882|NCT02629952|blueberry tea|blueberry tea
5218883|NCT02629900|Weight Loss|weight loss
5218884|NCT02629900|Intermittent fasting|intermittent fasting
5218885|NCT02629887|supraglottic airway|supraglottic airway
5218886|NCT02629887|neonatal resuscitation|neonatal resuscitation
5218887|NCT02629887|ventilation|ventilation
5218888|NCT02629887|term infant|term infant
5218889|NCT02629874|EA-230|ea-230
5218890|NCT02629874|Inflammatory response|inflammatory response
5218891|NCT02629874|Kidney Injury|kidney injury
5218892|NCT02629874|Endotoxemia|endotoxemia
5218893|NCT02629848|Drug therapy|drug therapy
5218894|NCT02629796|Biomarker|biomarker
5218895|NCT02629796|CIDP|cidp
5218896|NCT02629796|IVIG|ivig
5218897|NCT02629796|treatment response|treatment response
5218898|NCT02629757|High-grade glioma|high-grade glioma
5218899|NCT02629757|chemotherapy|chemotherapy
5218900|NCT02629757|β-elemene|β-elemene
5218901|NCT02629731|foot|foot
5218902|NCT02629731|ankle|ankle
5218903|NCT02629731|osteoarthritis|osteoarthritis
5218904|NCT02629731|flat foot|flat foot
5218905|NCT02629718|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5218906|NCT02629718|radical surgery|radical surgery
5218907|NCT02629718|cervical carcinoma|cervical carcinoma
5218908|NCT02629653|carotid endarterectomy|carotid endarterectomy
5218909|NCT02629653|stroke|stroke
5218910|NCT02629653|hypothermia|hypothermia
5218911|NCT02629653|endovascular cooling|endovascular cooling
5218912|NCT02629640|vCJD|vcjd
5218913|NCT02629640|prion disease|prion disease
5218914|NCT02629640|dementia|dementia
5218915|NCT02629640|old-age|old-age
5218916|NCT02629640|surveillance|surveillance
5218917|NCT02629640|brain banking|brain banking
5218918|NCT02629640|public health|public health
5218919|NCT02629627|Conjugated Linoleic Acid|conjugated linoleic acid
5218920|NCT02629627|Leucine|leucine
5218921|NCT02629627|visceral fat area|visceral fat area
5218922|NCT02629627|Epicardial Fat|epicardial fat
5218923|NCT02629627|Hemodinamic Parameters|hemodinamic parameters
5218924|NCT02629601|physical activity|physical activity
5218925|NCT02629601|financial incentives|financial incentives
5218926|NCT02629601|behavioral economics|behavioral economics
5218927|NCT02629588|Coma|coma
5218928|NCT02629588|Persistent Vegetative State|persistent vegetative state
5218929|NCT02629588|Sensory Stimulation|sensory stimulation
5218930|NCT02629497|platelets|platelets
5218931|NCT02629497|12-lipoxygenase|12-lipoxygenase
5218932|NCT02629497|fatty acids|fatty acids
5218933|NCT02629497|DGLA|dgla
5218935|NCT02629497|EPA|epa
5218936|NCT02629497|12-LOX|12-lox
5218940|NCT02629484|outcomes|outcomes
5218941|NCT02629432|MRI|mri
5218942|NCT02629432|COPD|copd
5218943|NCT02629419|STAT3 deficient Hyper IgE syndrome|stat3 deficient hyper ige syndrome
5218944|NCT02629419|Gain of function STAT1 defects|gain of function stat1 defects
5218945|NCT02629419|Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)|autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (apeced)
5218949|NCT02629406|hypoxia|hypoxia
5218950|NCT02629406|chemoreflex|chemoreflex
5218951|NCT02629406|baroreflex|baroreflex
5218952|NCT02629406|MIR210|mir210
5207118|NCT02700477|FBS|fbs
5218953|NCT02629393|Molybdenum Cofactor Deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
5218954|NCT02629393|Molybdenum Cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
5218955|NCT02629393|sulfite oxidase (SO)|sulfite oxidase (so)
5218956|NCT02629393|S sulfocysteine (SSC)|s sulfocysteine (ssc)
5218957|NCT02629393|xanthine oxidoreductase|xanthine oxidoreductase
5218958|NCT02629393|aldehyde oxidase|aldehyde oxidase
5218959|NCT02629380|meniscectomy|meniscectomy
5218960|NCT02629380|hyaluronic acid|hyaluronic acid
5218961|NCT02629380|intra-op injection|intra-op injection
5218962|NCT02629380|randomized controlled trial|randomized controlled trial
5218963|NCT02629380|placebo|placebo
5218964|NCT02629341|woman osteopenia osteoporosis enriched calcium vit D yogurt|woman osteopenia osteoporosis enriched calcium vit d yogurt
5218965|NCT02629328|CardioCel|cardiocel
5218966|NCT02629328|FDA cleared|fda cleared
5218967|NCT02629328|Tri-leaflet repair|tri-leaflet repair
5218968|NCT02629328|Aortic valves|aortic valves
5218969|NCT02629289|HSP-130|hsp-130
5218970|NCT02629289|Pharmacodynamic and Pharmacokinetic equivalence|pharmacodynamic and pharmacokinetic equivalence
5218971|NCT02629289|Pegfilgrastim|pegfilgrastim
5218972|NCT02629276|neck pain|neck pain
5218973|NCT02629276|arm pain|arm pain
5218974|NCT02629276|neurodynamic tests|neurodynamic tests
5218975|NCT02629276|quantitative sensory testing|quantitative sensory testing
5218976|NCT02629276|somatosensory profile|somatosensory profile
5218977|NCT02629250|proximal femoral fracture|proximal femoral fracture
5218978|NCT02629250|goal-directed therapy|goal-directed therapy
5218979|NCT02629250|myocardial injury|myocardial injury
5218980|NCT02629250|supernormal oxygen delivery|supernormal oxygen delivery
5218981|NCT02629250|elders|elders
5218982|NCT02629250|stroke volume maximization|stroke volume maximization
5218983|NCT02629237|glaucoma surgery|glaucoma surgery
5218984|NCT02629237|educational intervention|educational intervention
5218985|NCT02629237|satisfaction|satisfaction
5218986|NCT02629237|rural|rural
5218987|NCT02629224|Impaired renal function|impaired renal function
5218988|NCT02629224|Haemodialysis|haemodialysis
5218989|NCT02629224|ASP8825|asp8825
5218990|NCT02629224|XP13512|xp13512
5218991|NCT02629211|Inflammatory Bowel Diseases|inflammatory bowel diseases
5218992|NCT02629211|Colitis, Ulcerative|colitis, ulcerative
5218993|NCT02629211|Crohn Disease|crohn disease
5218994|NCT02629211|Single-Balloon Enteroscopy|single-balloon enteroscopy
5218995|NCT02629211|NaviAid AB™ Device|naviaid ab™ device
5218996|NCT02629211|NaviAid AB™ Procedure|naviaid ab™ procedure
5218997|NCT02629211|AB Device|ab device
5218998|NCT02629211|Pediatric IBD|pediatric ibd
5218999|NCT02629211|Pediatric Enteroscopy|pediatric enteroscopy
5219000|NCT02629198|Vitamin D|vitamin d
5219001|NCT02629185|Bone|bone
5219002|NCT02629185|Vitamin D|vitamin d
5219003|NCT02629185|Cardiovascular|cardiovascular
5219009|NCT02629159|Musculoskeletal disease|musculoskeletal disease
5219010|NCT02629159|Arthritis|arthritis
5219011|NCT02629159|Joint disease|joint disease
5219012|NCT02629159|Anti-inflammatory agents|anti-inflammatory agents
5219013|NCT02629159|Antirheumatic agents|antirheumatic agents
5219014|NCT02629146|Midazolam|midazolam
5219015|NCT02629146|Fentanyl|fentanyl
5219016|NCT02629133|Intimate Partner Violence|intimate partner violence
5219017|NCT02629133|Sheltered Battered Women|sheltered battered women
5219018|NCT02629133|Substance Use|substance use
5219019|NCT02629120|The National Marrow Donor Program (NMDP)|the national marrow donor program (nmdp)
5219020|NCT02629120|Matched Unrelated Donor (MUD)|matched unrelated donor (mud)
5219021|NCT02629120|HLA Matched Related Donor|hla matched related donor
5219022|NCT02629107|Sleep|sleep
5219023|NCT02629107|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5219024|NCT02629107|Electroencephalogram (EEG)|electroencephalogram (eeg)
5219025|NCT02629094|Hepatic Steatosis|hepatic steatosis
5219026|NCT02629094|Cardiac Steatosis|cardiac steatosis
5219027|NCT02629094|Aldosterone|aldosterone
5219028|NCT02629094|Eplerenone|eplerenone
5219029|NCT02629094|Mineralcorticoid Receptor|mineralcorticoid receptor
5219030|NCT02629081|heartburn|heartburn
5219031|NCT02629081|GERD|gerd
5219032|NCT02629081|NERD|nerd
5219033|NCT02629081|non-erosive reflux disease|non-erosive reflux disease
5219034|NCT02629068|Adolescent|adolescent
5219035|NCT02629068|Social Support|social support
5219036|NCT02629068|Social Media|social media
5219037|NCT02629068|Parents|parents
5219040|NCT02629055|Non-invasive ventilation|non-invasive ventilation
5219046|NCT02629042|Mandibulae|mandibulae
5219047|NCT02629042|Pain Management|pain management
5219048|NCT02629042|Partial Endodontic Treatment|partial endodontic treatment
5219049|NCT02629003|Positron Emission Tomography|positron emission tomography
5219050|NCT02629003|Serotonin|serotonin
5219051|NCT02629003|5-HT2A|5-ht2a
5219052|NCT02629003|Radioligand|radioligand
5219053|NCT02629003|Radiation dosimetry|radiation dosimetry
5219054|NCT02629003|Radiation dosage|radiation dosage
5219057|NCT02628938|Halitosis|halitosis
5219058|NCT02628938|Oral Malodor|oral malodor
5207166|NCT02700126|propofol|propofol
5207170|NCT02700087|Laryngomalacia|laryngomalacia
5219059|NCT02628938|Miswak|miswak
5219060|NCT02628938|Salvadora Persica|salvadora persica
5219061|NCT02628925|mass screening|mass screening
5219062|NCT02628925|Nursing diagnosis|nursing diagnosis
5219063|NCT02628925|Psychiatric Status Rating Scale|psychiatric status rating scale
5219064|NCT02628912|Cardiopulmonary Fitness|cardiopulmonary fitness
5219065|NCT02628912|Long-Term Survivors|long-term survivors
5219066|NCT02628912|15-277|15-277
5219067|NCT02628912|HPV|hpv
5219068|NCT02628912|Survivors|survivors
5219071|NCT02628873|HSG|hsg
5219072|NCT02628873|HyCoSy|hycosy
5219073|NCT02628873|Contraception|contraception
5219074|NCT02628873|Essure|essure
5219075|NCT02628873|Saline Infused sonography|saline infused sonography
5219076|NCT02628873|SIS|sis
5219077|NCT02628873|Air bubbles|air bubbles
5219078|NCT02628860|ferric carboxymaltose|ferric carboxymaltose
5219079|NCT02628860|Ferinject®|ferinject®
5219080|NCT02628860|pancreatoduodenectomy|pancreatoduodenectomy
5219081|NCT02628847|stroke|stroke
5219082|NCT02628847|rehabilitation|rehabilitation
5219083|NCT02628847|motor skills|motor skills
5219084|NCT02628847|sildenafil citrate|sildenafil citrate
5219085|NCT02628847|White matter|white matter
5219086|NCT02628834|Loading|loading
5219087|NCT02628834|Gait|gait
5219088|NCT02628834|Multiple Sclerosis|multiple sclerosis
5219089|NCT02628834|Manual Therapy|manual therapy
5219090|NCT02628808|autism|autism
5219091|NCT02628808|asperger|asperger
5219092|NCT02628808|Pervasive Developmental Disorder No Otherwise Specify|pervasive developmental disorder no otherwise specify
5219093|NCT02628808|gene|gene
5219094|NCT02628808|polymorphism|polymorphism
5219095|NCT02628808|mutation|mutation
5219096|NCT02628795|total hip arthroplasty|total hip arthroplasty
5219097|NCT02628795|total knee arthroplasty|total knee arthroplasty
5219098|NCT02628782|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
5219099|NCT02628782|Vascular Closure Device|vascular closure device
5219100|NCT02628769|Solithromycin|solithromycin
5219101|NCT02628769|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5219102|NCT02628769|Inflammation|inflammation
5219103|NCT02628769|Macrolide|macrolide
5219104|NCT02628730|Atrial Fibrillation|atrial fibrillation
5219105|NCT02628730|Ablation|ablation
5219106|NCT02628730|Pulmonary vein isolation|pulmonary vein isolation
5219107|NCT02628730|Ablation Index|ablation index
5219108|NCT02628717|Hepatitis C|hepatitis c
5219109|NCT02628717|sofosbuvir|sofosbuvir
5219110|NCT02628717|ledipasvir|ledipasvir
5219111|NCT02628717|daclatasvir|daclatasvir
5219112|NCT02628717|simeprevir|simeprevir
5219113|NCT02628704|Karyopharm|karyopharm
5219114|NCT02628704|selinexor|selinexor
5219115|NCT02628704|KPT-330|kpt-330
5219116|NCT02628704|multiple myeloma|multiple myeloma
5219117|NCT02628704|SCORE|score
5219118|NCT02628678|Prebiotic|prebiotic
5219119|NCT02628678|FOS|fos
5219120|NCT02628678|fructooligosaccharide|fructooligosaccharide
5219121|NCT02628678|polyglycan|polyglycan
5219122|NCT02628678|microbiome|microbiome
5219123|NCT02628678|microbiota|microbiota
5219124|NCT02628678|Healthy Volunteers|healthy volunteers
5219125|NCT02628652|Microbiome|microbiome
5219126|NCT02628652|FOS|fos
5219127|NCT02628652|polyglycan|polyglycan
5219128|NCT02628652|prebiotic|prebiotic
5219129|NCT02628652|Healthy Volunteers|healthy volunteers
5219130|NCT02628626|Incontinence|incontinence
5219131|NCT02628626|Diarrhea|diarrhea
5219132|NCT02628626|Bile acid|bile acid
5219133|NCT02628626|Microbiome|microbiome
5219134|NCT02628613|Breast cancer|breast cancer
5219135|NCT02628613|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5219136|NCT02628613|TEKT4|tekt4
5219137|NCT02628600|ALIS|alis
5219138|NCT02628600|ARIKAYCE|arikayce
5219139|NCT02628587|Acute Coronary Syndrome|acute coronary syndrome
5219140|NCT02628587|Clopidogrel|clopidogrel
5219141|NCT02628587|Platelet reactivity|platelet reactivity
5219142|NCT02628574|Metastatic|metastatic
5219143|NCT02628574|Stage III or IV|stage iii or iv
5219144|NCT02628574|recurrent|recurrent
5219159|NCT02628444|CYD Dengue Vaccine|cyd dengue vaccine
5219160|NCT02628418|Rehabilitation|rehabilitation
5219161|NCT02628418|Robotics|robotics
5219162|NCT02628392|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5219164|NCT02628392|Developmental Phase II|developmental phase ii
5219167|NCT02628379|CUP|cup
5219168|NCT02628366|Cluster randomized Controlled Trial|cluster randomized controlled trial
5219169|NCT02628366|Personalized Dialysate Temperature|personalized dialysate temperature
5219170|NCT02628366|Cooler Dialysate Temperature|cooler dialysate temperature
5219171|NCT02628366|Mortality|mortality
5219172|NCT02628366|Cardiovascular Events|cardiovascular events
5219173|NCT02628366|Myocardial Infarction|myocardial infarction
5219174|NCT02628366|Ischemic Stroke|ischemic stroke
5219175|NCT02628366|Congestive Heart Failure|congestive heart failure
5219176|NCT02628366|Dialysis Solutions|dialysis solutions
5219177|NCT02628353|Cardiovascular diseases|cardiovascular diseases
5219178|NCT02628353|endothelial function|endothelial function
5219179|NCT02628353|systolic blood pressure|systolic blood pressure
5219180|NCT02628353|metabolomics|metabolomics
5219181|NCT02628353|cardiovascular risk factor|cardiovascular risk factor
5219182|NCT02628353|bioavailability|bioavailability
5219183|NCT02628353|phenolic compounds|phenolic compounds
5219184|NCT02628353|hypertension|hypertension
5219185|NCT02628327|glaucoma care|glaucoma care
5219186|NCT02628327|quality of life|quality of life
5219187|NCT02628327|patient satisfaction|patient satisfaction
5219188|NCT02628301|Obesity|obesity
5219189|NCT02628301|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5219190|NCT02628301|Hypercaloric diet|hypercaloric diet
5219191|NCT02628301|Microcirculation|microcirculation
5219192|NCT02628301|Microvascular dysfunction|microvascular dysfunction
5219193|NCT02628301|Insulin Resistance|insulin resistance
5219194|NCT02628301|Insulin Sensitivity|insulin sensitivity
5219195|NCT02628301|Insulin signaling|insulin signaling
5219196|NCT02628262|Macular hole|macular hole
5219197|NCT02628236|Actinic keratosis|actinic keratosis
5219198|NCT02628223|glaucoma|glaucoma
5219199|NCT02628223|Elevated IOP|elevated iop
5219200|NCT02628223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5219202|NCT02628223|open angle glaucoma|open angle glaucoma
5219203|NCT02628223|ocular hypertension|ocular hypertension
5219204|NCT02628223|Glaucoma, Open Angle, Pseudo-exfoliative|glaucoma, open angle, pseudo-exfoliative
5219205|NCT02628223|pigment dispersion syndrome|pigment dispersion syndrome
5219206|NCT02628223|Pseudoexfoliation|pseudoexfoliation
5219207|NCT02628223|IOP ≥ 21 mmHg|iop ≥ 21 mmhg
5219208|NCT02628158|Epiretinal membrane|epiretinal membrane
5219209|NCT02628145|Sarcopenia|sarcopenia
5219210|NCT02628145|aging|aging
5219512|NCT02626793|LAPIS-Pso|lapis-pso
5219211|NCT02628145|resistance training|resistance training
5219212|NCT02628145|physical functioning|physical functioning
5219213|NCT02628132|triple negative|triple negative
5219214|NCT02628132|breast cancer|breast cancer
5219215|NCT02628132|durvalumab|durvalumab
5219216|NCT02628132|paclitaxel|paclitaxel
5219217|NCT02628132|safety|safety
5219218|NCT02628132|efficacy|efficacy
5219219|NCT02628132|PD-L1|pd-l1
5219220|NCT02628132|PD-1|pd-1
5219221|NCT02628132|Metastatic|metastatic
5219222|NCT02628132|AstraZeneca|astrazeneca
5219223|NCT02628132|MEDI4736|medi4736
5219224|NCT02628119|Hemodialysis|hemodialysis
5219225|NCT02628119|vascular access|vascular access
5219226|NCT02628119|access flow|access flow
5219227|NCT02628080|Hypoxia|hypoxia
5219274|NCT02628002|[E01.370.370.380.140]|[e01.370.370.380.140]
5219275|NCT02627937|Pediatric obstructive sleep apnea/hypopnea syndrome|pediatric obstructive sleep apnea/hypopnea syndrome
5219276|NCT02627937|Polysomnography|polysomnography
5219277|NCT02627924|Rheumatoid Arthritis|rheumatoid arthritis
5219278|NCT02627924|Work productivity|work productivity
5219279|NCT02627924|patient-reported QoL(Quality of Life)|patient-reported qol(quality of life)
5219280|NCT02627898|Green tea extract|green tea extract
5219281|NCT02627898|Arterial stiffness|arterial stiffness
5219282|NCT02627898|PWVao|pwvao
5219283|NCT02627885|internet treatment|internet treatment
5219284|NCT02627885|cognitive behavioral therapy|cognitive behavioral therapy
5219285|NCT02627885|level of functioning|level of functioning
5219286|NCT02627885|quality of life|quality of life
5219287|NCT02627833|induced Sputum|induced sputum
5219288|NCT02627833|lung clearance index|lung clearance index
5219289|NCT02627833|miRNA|mirna
5219290|NCT02627833|inflammation|inflammation
5219291|NCT02627833|chronic lung disease|chronic lung disease
5219292|NCT02627820|Senile|senile
5219293|NCT02627820|ATTRwt|attrwt
5219294|NCT02627820|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
5219295|NCT02627807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5219296|NCT02627807|Intensity modulated radiotherapy|intensity modulated radiotherapy
5219297|NCT02627807|Clinical target volume|clinical target volume
5219298|NCT02627807|Clinical trial|clinical trial
5219299|NCT02627794|Middle Meatus|middle meatus
5219300|NCT02627794|Synechiae|synechiae
5219301|NCT02627794|Endoscopic Sinus Surgery|endoscopic sinus surgery
5219302|NCT02627794|Silastic spacer|silastic spacer
5219303|NCT02627794|Restora™ steroid eluting MM spacer|restora™ steroid eluting mm spacer
5219304|NCT02627781|acute appendicitis|acute appendicitis
5087933|NCT03448341|VFS|vfs
5219305|NCT02627781|Alvarado Score|alvarado score
5219307|NCT02627781|right abdominal pain|right abdominal pain
5219308|NCT02627768|STELARA|stelara
5219309|NCT02627768|Psoriatic Arthritis|psoriatic arthritis
5219310|NCT02627768|Ustekinumab|ustekinumab
5219311|NCT02627755|videolaryngoscopy|videolaryngoscopy
5219312|NCT02627755|difficult airway management|difficult airway management
5219313|NCT02627716|Psychiatric advanced directives|psychiatric advanced directives
5219314|NCT02627716|Joint crisis plan|joint crisis plan
5219315|NCT02627716|Schizophrenia|schizophrenia
5219316|NCT02627716|Primary care|primary care
5219318|NCT02627677|CP-CML|cp-cml
5219319|NCT02627677|Leukemia|leukemia
5219320|NCT02627677|Leukemia, Myeloid|leukemia, myeloid
5219321|NCT02627677|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5219322|NCT02627677|Neoplasms by Histologic Type|neoplasms by histologic type
5219323|NCT02627677|Neoplasms|neoplasms
5219324|NCT02627677|Myeloproliferative Disorders|myeloproliferative disorders
5219325|NCT02627677|Bone Marrow Diseases|bone marrow diseases
5219326|NCT02627677|Hematologic Diseases|hematologic diseases
5219327|NCT02627664|Idiopathic early|idiopathic early
5219328|NCT02627664|Parkinson's Disease|parkinson's disease
5219329|NCT02627638|osteopathy|osteopathy
5219330|NCT02627638|complementary therapy|complementary therapy
5219331|NCT02627638|symptoms in cancer patients|symptoms in cancer patients
5219336|NCT02627612|Iraq/Afghanistan|iraq/afghanistan
5219338|NCT02627612|PTSD|ptsd
5219339|NCT02627612|Suicide|suicide
5219340|NCT02627612|Criminal Activity|criminal activity
5219341|NCT02627599|COPD|copd
5219342|NCT02627599|LTOT|ltot
5219343|NCT02627599|Long-Term Oxygen Therapy|long-term oxygen therapy
5219344|NCT02627599|Oxygen Conserving Device|oxygen conserving device
5219345|NCT02627599|Quality of Life|quality of life
5219346|NCT02627599|Six Minute Walk Distance|six minute walk distance
5219347|NCT02627599|Portable Oxygen Source|portable oxygen source
5219348|NCT02627599|Oxygen Saturation|oxygen saturation
5219349|NCT02627599|Breath Responsive Variable Bolus Oxygen Conserving Device|breath responsive variable bolus oxygen conserving device
5219350|NCT02627599|BRVB-OCD|brvb-ocd
5219351|NCT02627599|Pulse Oximetry|pulse oximetry
5219352|NCT02627586|exercise therapy|exercise therapy
5219353|NCT02627586|left ventricular remodeling|left ventricular remodeling
5219354|NCT02627586|ventricular ejection fraction|ventricular ejection fraction
5219355|NCT02627586|high-intensity interval training|high-intensity interval training
5219356|NCT02627573|Cyclophosphamide|cyclophosphamide
5219357|NCT02627573|Thymoglobulin|thymoglobulin
5219358|NCT02627573|Myelodysplastic Syndromes|myelodysplastic syndromes
5219359|NCT02627573|Immunosuppressive Agents|immunosuppressive agents
5219360|NCT02627573|Immune System Diseases|immune system diseases
5219361|NCT02627573|Busulfan|busulfan
5219362|NCT02627573|Fludarabine|fludarabine
5219363|NCT02627573|Tacrolimus|tacrolimus
5219364|NCT02627573|Mycophenolate mofetil|mycophenolate mofetil
5219365|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5219366|NCT02627573|Myeloablative Agonists|myeloablative agonists
5219367|NCT02627573|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5219368|NCT02627573|Allogeneic Transplantation|allogeneic transplantation
5219369|NCT02627573|Leukemia, Chronic Myeloid|leukemia, chronic myeloid
5219370|NCT02627573|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative|leukemia, myeloid, chronic, atypical, bcr-abl negative
5219371|NCT02627560|Administration, topical|administration, topical
5219372|NCT02627560|Tranexamic acid|tranexamic acid
5219373|NCT02627560|Postoperative care|postoperative care
5219374|NCT02627560|Mastectomy|mastectomy
5219375|NCT02627547|Flavanones|flavanones
5219376|NCT02627547|Endurance-trained athletes|endurance-trained athletes
5219377|NCT02627547|Biological availability|biological availability
5219378|NCT02627534|Photodynamic therapy|photodynamic therapy
5219379|NCT02627534|Ultrasonic debridement|ultrasonic debridement
5219380|NCT02627534|Chronic periodontitis|chronic periodontitis
5219381|NCT02627534|Type 2 diabetes|type 2 diabetes
5219382|NCT02627508|Autism Spectrum Disorder|autism spectrum disorder
5219383|NCT02627508|Autism|autism
5219384|NCT02627508|Pregnenolone|pregnenolone
5219385|NCT02627495|maladaptive plasticity|maladaptive plasticity
5219386|NCT02627495|Limb amputation|limb amputation
5219387|NCT02627495|phantom limb pain|phantom limb pain
5219388|NCT02627495|tDCS|tdcs
5219389|NCT02627495|non-invasive brain stimulation|non-invasive brain stimulation
5219390|NCT02627469|Microbiota|microbiota
5219391|NCT02627469|aged|aged
5219392|NCT02627469|oral health|oral health
5219398|NCT02627417|ITP|itp
5219399|NCT02627417|Dapsone|dapsone
5219400|NCT02627404|Bipolar disorders|bipolar disorders
5219401|NCT02627404|Genetic|genetic
5219402|NCT02627404|Biomarkers|biomarkers
5219403|NCT02627404|Circadian rhythm|circadian rhythm
5219404|NCT02627391|Aortic valve|aortic valve
5219405|NCT02627391|Stenosis|stenosis
5219406|NCT02627391|Surgery|surgery
5962675|NCT04279470|Cellular Therapies|cellular therapies
5219407|NCT02627365|ART|art
5219408|NCT02627365|mobile messaging|mobile messaging
5219409|NCT02627365|behaviour|behaviour
5088042|NCT03447535|Family|family
5097623|NCT03388255|PDRN|pdrn
5219410|NCT02627365|motivation|motivation
5219411|NCT02627352|Glaucoma|glaucoma
5219412|NCT02627352|Micropulse Transscleral Cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
5219414|NCT02627339|Contrast Sensitivity|contrast sensitivity
5219415|NCT02627326|chlorhexidine|chlorhexidine
5219416|NCT02627326|endodontic treatment|endodontic treatment
5219417|NCT02627313|Feasibility Studies|feasibility studies
5219418|NCT02627300|PID|pid
5219419|NCT02627261|residual disease|residual disease
5219420|NCT02627235|Physical Activity|physical activity
5219421|NCT02627235|Cancer Prevention|cancer prevention
5219422|NCT02627222|Pro-vitamin A|pro-vitamin a
5207449|NCT02698111|nasopharyngeal carcinoma,donafeinib|nasopharyngeal carcinoma,donafeinib
5207450|NCT02698098|Malaysia|malaysia
5207451|NCT02698098|Asia|asia
5207452|NCT02698098|Southeast Asia|southeast asia
5207453|NCT02698098|Compulsory Drug Detention Centers|compulsory drug detention centers
5207454|NCT02698098|Compulsory Centers for Drug Users|compulsory centers for drug users
5219423|NCT02627222|Cassava|cassava
5219424|NCT02627222|Vitamin A deficiency|vitamin a deficiency
5219425|NCT02627222|Retinol Isotope Dilution|retinol isotope dilution
5219426|NCT02627222|Preschool children|preschool children
5219427|NCT02627222|Nigeria|nigeria
5219428|NCT02627209|Angiotensin converting enzyme|angiotensin converting enzyme
5219429|NCT02627209|Lysozyme|lysozyme
5219430|NCT02627209|Ankylosing spondylitis|ankylosing spondylitis
5219431|NCT02627209|Behcet's disease|behcet's disease
5219432|NCT02627209|Sarcoidosis|sarcoidosis
5219433|NCT02627209|Syphilis|syphilis
5219434|NCT02627209|Tuberculosis|tuberculosis
5219435|NCT02627209|Ocular inflammation|ocular inflammation
5219436|NCT02627183|Atrial Fibrillation|atrial fibrillation
5219437|NCT02627170|Adults|adults
5219438|NCT02627144|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5219440|NCT02627144|Bevacizumab|bevacizumab
5219441|NCT02627131|Autism|autism
5219442|NCT02627131|Stem Cells|stem cells
5219443|NCT02627105|weight loss|weight loss
5219444|NCT02627105|red meats|red meats
5219445|NCT02627105|obesity|obesity
5219446|NCT02627105|lean body mass|lean body mass
5219447|NCT02627105|body composition|body composition
5219448|NCT02627105|dietary protein|dietary protein
5219449|NCT02627066|Exercise|exercise
5219450|NCT02627066|Nutrition|nutrition
5219451|NCT02627066|Hemodialysis|hemodialysis
5219452|NCT02627014|Chronic Migraine|chronic migraine
5219453|NCT02627014|Temporomandibular Disorders|temporomandibular disorders
5219454|NCT02627014|Physical Therapy|physical therapy
5219455|NCT02627014|Manual Therapy|manual therapy
5219456|NCT02627014|Home physical Therapy|home physical therapy
5219457|NCT02626988|Diet Diversity|diet diversity
5219458|NCT02626988|Biodiversity|biodiversity
5219459|NCT02626988|Agrobiodiversity|agrobiodiversity
5219460|NCT02626988|Nutrition|nutrition
5219461|NCT02626988|Vietnam|vietnam
5219462|NCT02626975|knee|knee
5219463|NCT02626975|short hamstring autograft|short hamstring autograft
5219464|NCT02626975|ligament|ligament
5219466|NCT02626962|melanoma|melanoma
5219467|NCT02626949|HIV|hiv
5219468|NCT02626949|AIDS|aids
5219469|NCT02626949|Mindfulness|mindfulness
5219470|NCT02626949|Mindfulness-based stress reduction|mindfulness-based stress reduction
5219471|NCT02626949|Stress|stress
5219472|NCT02626949|Intervention|intervention
5219473|NCT02626949|Inflammation|inflammation
5219474|NCT02626936|Type 1 diabetes|type 1 diabetes
5219475|NCT02626936|Artificial pancreas|artificial pancreas
5219476|NCT02626936|Closed-loop system|closed-loop system
5219477|NCT02626936|Postprandial glucose control|postprandial glucose control
5219478|NCT02626936|Hypoglycemia|hypoglycemia
5219479|NCT02626936|Insulin|insulin
5219480|NCT02626936|Glucagon|glucagon
5219481|NCT02626910|Disability|disability
5219482|NCT02626910|Activity of Daily Living|activity of daily living
5219483|NCT02626910|Patient Satisfaction|patient satisfaction
5219484|NCT02626897|Sarcoidosis|sarcoidosis
5219485|NCT02626897|Daily activity|daily activity
5219486|NCT02626897|Exercise|exercise
5219487|NCT02626897|Accelerometer|accelerometer
5219488|NCT02626845|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
5219489|NCT02626845|Wegener's Granulomatosis|wegener's granulomatosis
5219490|NCT02626845|GPA|gpa
5219491|NCT02626845|Rituximab|rituximab
5219492|NCT02626845|Rituxan|rituxan
5219493|NCT02626845|ENT GPA|ent gpa
5219494|NCT02626832|vasopressin|vasopressin
5219495|NCT02626832|AVP|avp
5219496|NCT02626832|NMDA|nmda
5219497|NCT02626832|osmolality|osmolality
5219498|NCT02626819|Obesity|obesity
5219499|NCT02626819|Weight Management|weight management
5219500|NCT02626819|Primary Care|primary care
5219501|NCT02626819|Health Coach|health coach
5962676|NCT04279431|BrainScope|brainscope
5962677|NCT04279431|Closed Head Injury|closed head injury
5219502|NCT02626819|iPad|ipad
5219503|NCT02626819|Goal Setting|goal setting
5219504|NCT02626819|5As|5as
5219505|NCT02626819|technology|technology
5219506|NCT02626806|exercise test|exercise test
5219507|NCT02626806|HS -troponin|hs -troponin
5219508|NCT02626806|Coronary artery disease|coronary artery disease
5219509|NCT02626793|Plaque psoriasis|plaque psoriasis
5219510|NCT02626793|Apremilast|apremilast
5219511|NCT02626793|Otezla®|otezla®
5219521|NCT02626754|Sunitinib, 2/1 schedule, Renal cell carcinoma|sunitinib, 2/1 schedule, renal cell carcinoma
5219522|NCT02626702|immune modulators|immune modulators
5219523|NCT02626702|IVF outcomes|ivf outcomes
5219524|NCT02626702|relationship|relationship
5219525|NCT02626689|Beta-Thalassemia|beta-thalassemia
5219526|NCT02626689|Quality of Life|quality of life
5219527|NCT02626689|Healthcare Utilization|healthcare utilization
5219528|NCT02626689|Transfusion dependent (TD) β-thalassemia|transfusion dependent (td) β-thalassemia
5219529|NCT02626689|Non-transfusion dependent β-thalassemia|non-transfusion dependent β-thalassemia
5219530|NCT02626689|Standard of care|standard of care
5219531|NCT02626689|TransQoL|transqol
5219533|NCT02626689|Fact-An|fact-an
5219534|NCT02626689|NTD beta-thalassemia PRO|ntd beta-thalassemia pro
5219535|NCT02626676|renal dialysis, hyperphosphatemia, educational programme|renal dialysis, hyperphosphatemia, educational programme
5219537|NCT02626637|fatigue|fatigue
5219538|NCT02626637|physical activity|physical activity
5219539|NCT02626598|facial wrinkles|facial wrinkles
5219540|NCT02626598|photoaging|photoaging
5219541|NCT02626585|rhinoplasty|rhinoplasty
5219542|NCT02626585|postrhinoplasty taping|postrhinoplasty taping
5219543|NCT02626585|edema|edema
5219544|NCT02626585|draping|draping
5219546|NCT02626585|nasal skin thickness|nasal skin thickness
5219547|NCT02626585|supratip fullness|supratip fullness
5219548|NCT02626585|postoperative swelling|postoperative swelling
5219549|NCT02626533|Cytokines|cytokines
5219550|NCT02626507|ER+/HER2|er+/her2
5219551|NCT02626481|Multiple Myeloma|multiple myeloma
5219552|NCT02626481|Cancer|cancer
5219553|NCT02626481|refractory|refractory
5219554|NCT02626481|daratumumab|daratumumab
5219555|NCT02626455|Clinical trial, Phase III|clinical trial, phase iii
5219556|NCT02626455|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
5219557|NCT02626455|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5219558|NCT02626455|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
5219559|NCT02626442|Cognition|cognition
5219560|NCT02626442|Exercise|exercise
5219561|NCT02626416|Telemedicine|telemedicine
5219562|NCT02626403|vegetative state|vegetative state
5219563|NCT02626403|minimally conscious state|minimally conscious state
5219564|NCT02626403|disorder of consciousness|disorder of consciousness
5219565|NCT02626403|transcranial current direct stimulation|transcranial current direct stimulation
5219566|NCT02626403|non invasive brain stimulation|non invasive brain stimulation
5219567|NCT02626403|neuromodulation|neuromodulation
5219568|NCT02626377|Informal caregivers|informal caregivers
5219569|NCT02626377|Elderly|elderly
5219570|NCT02626377|Quality of life|quality of life
5219571|NCT02626377|Cost effectiveness|cost effectiveness
5219572|NCT02626377|Cohort study|cohort study
5219573|NCT02626377|Randomized study|randomized study
5219574|NCT02626351|postnatal|postnatal
5219575|NCT02626299|Preterm birth, very low birth weight|preterm birth, very low birth weight
5219576|NCT02626286|HIV|hiv
5219577|NCT02626286|Men who have sex with men|men who have sex with men
5219578|NCT02626273|obesity|obesity
5219579|NCT02626273|adolescents|adolescents
5219580|NCT02626273|physical activity|physical activity
5219581|NCT02626273|adipocytes|adipocytes
5219582|NCT02626273|osteocytes|osteocytes
5219583|NCT02626273|weight loss|weight loss
5219584|NCT02626273|bone|bone
5219585|NCT02626273|fat|fat
5219586|NCT02626247|elderly|elderly
5219587|NCT02626234|cMET, INC280, rosuvastatin, digoxin|cmet, inc280, rosuvastatin, digoxin
5219588|NCT02626208|Contraceptive vaginal ring|contraceptive vaginal ring
5219589|NCT02626195|malnutrition|malnutrition
5219590|NCT02626195|nutrition|nutrition
5219591|NCT02626195|nutritional support|nutritional support
5219592|NCT02626195|hepatobiliary pancreatic cancer|hepatobiliary pancreatic cancer
5219593|NCT02626195|hepatobiliary pancreatic surgery|hepatobiliary pancreatic surgery
5219594|NCT02626169|15-epi-lipoxin A4|15-epi-lipoxin a4
5219595|NCT02626169|inflammation|inflammation
5219596|NCT02626169|atherosclerosis|atherosclerosis
5219597|NCT02626156|post healed venous leg ulcer|post healed venous leg ulcer
5219598|NCT02626156|posted healed diabetic foot ulcer|posted healed diabetic foot ulcer
5219599|NCT02626104|lactoferrin|lactoferrin
5219600|NCT02626104|clostridium difficile|clostridium difficile
5219601|NCT02626104|antibiotic associated diarrhoea|antibiotic associated diarrhoea
5219602|NCT02626104|children|children
5219603|NCT02626104|antibiotic therapy|antibiotic therapy
5219604|NCT02626104|diarrhoea|diarrhoea
5219605|NCT02626091|Anastomotic perfusion|anastomotic perfusion
5219606|NCT02626091|ICG Fluorescence|icg fluorescence
5219607|NCT02626091|Enhanced reality|enhanced reality
5219608|NCT02626091|Left-sided colonic resection|left-sided colonic resection
5219609|NCT02626078|Malnutrition|malnutrition
5219610|NCT02626078|Food practices|food practices
5962678|NCT04279431|Concussion|concussion
5219611|NCT02626078|Elderly|elderly
5219612|NCT02626078|Nursing Home|nursing home
5219613|NCT02626078|Aging|aging
5219614|NCT02626078|Nutritional status|nutritional status
5219615|NCT02626078|Quality of life|quality of life
5219616|NCT02626065|Melanoma|melanoma
5219617|NCT02626065|Anti-PD1 monoclonal antibodies|anti-pd1 monoclonal antibodies
5219618|NCT02626065|Immune modulation|immune modulation
5219619|NCT02626065|BRAF|braf
5219620|NCT02626052|Skull vibration induced nystagmus test|skull vibration induced nystagmus test
5219621|NCT02626052|mastoid vibration test|mastoid vibration test
5219622|NCT02626039|Metastatic Breast Cancer|metastatic breast cancer
5219623|NCT02626039|CTCs|ctcs
5219624|NCT02626039|cfDNA|cfdna
5219625|NCT02626039|genomics|genomics
5219626|NCT02626039|somatic mutations|somatic mutations
5219627|NCT02626000|Recurrent Metastatic Squamous Cell Carcinoma Head and Neck|recurrent metastatic squamous cell carcinoma head and neck
5219628|NCT02625987|Appendicectomy, wound complications, skin closure|appendicectomy, wound complications, skin closure
5219637|NCT02625935|estrogen receptor positive|estrogen receptor positive
5219638|NCT02625935|node negative|node negative
5219639|NCT02625935|HER2 negative|her2 negative
5219640|NCT02625922|Serelaxin,|serelaxin,
5219641|NCT02625922|Chronic heart failure,|chronic heart failure,
5219642|NCT02625922|Spiroergometry,|spiroergometry,
5219643|NCT02625922|Troponin,|troponin,
5219644|NCT02625922|New York Heart Association (NYHA) functional Class II/III,|new york heart association (nyha) functional class ii/iii,
5219645|NCT02625922|Left ventricular ejection fraction,|left ventricular ejection fraction,
5219646|NCT02625896|Aviation|aviation
5219647|NCT02625896|Parachuting|parachuting
5219649|NCT02625857|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
5219650|NCT02625857|JNJ-64041809|jnj-64041809
5219651|NCT02625857|Listeria monocytogenes|listeria monocytogenes
5219652|NCT02625831|ficolin-3|ficolin-3
5219653|NCT02625831|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
5219654|NCT02625831|lupus nephritis|lupus nephritis
5219655|NCT02625831|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5219656|NCT02625831|biomarker|biomarker
5219657|NCT02625818|Emergency Services, Psychiatric|emergency services, psychiatric
5219658|NCT02625818|Prognosis|prognosis
5219659|NCT02625818|Biological markers|biological markers
5219660|NCT02625818|Anxiety|anxiety
5219661|NCT02625818|Panic|panic
5219662|NCT02625818|Psychomotor Agitation|psychomotor agitation
5219663|NCT02625818|Self-injurious Behavior|self-injurious behavior
5219664|NCT02625792|Post ESD ulcer|post esd ulcer
5219665|NCT02625792|Bleeding|bleeding
5219666|NCT02625792|Prophylaxis|prophylaxis
5219667|NCT02625779|Bipolar depression|bipolar depression
5219668|NCT02625779|Cytidine|cytidine
5219669|NCT02625779|Creatine|creatine
5219670|NCT02625779|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5219671|NCT02625766|Operative vs. Non-operative|operative vs. non-operative
5219672|NCT02625766|LC pelvic fracture|lc pelvic fracture
5219673|NCT02625766|Complications|complications
5219674|NCT02625753|photorefractive keratectomy|photorefractive keratectomy
5219675|NCT02625753|pain|pain
5219676|NCT02625753|analgesia|analgesia
5219677|NCT02625753|opioid|opioid
5219678|NCT02625727|knee osteoarthritis|knee osteoarthritis
5219679|NCT02625727|hyaluronic acid|hyaluronic acid
5219680|NCT02625727|corticosteroid|corticosteroid
5219681|NCT02625727|intra-articular injection|intra-articular injection
5219682|NCT02625727|therapeutic effect|therapeutic effect
5219683|NCT02625701|operative mortality|operative mortality
5219684|NCT02625701|myocardial infarct, arrhythmia, heart failure, stroke|myocardial infarct, arrhythmia, heart failure, stroke
5219685|NCT02625701|pneumonia, atelectasis, acute lung injury|pneumonia, atelectasis, acute lung injury
5219686|NCT02625701|surgical site infection|surgical site infection
5219687|NCT02625701|acute kidney injury|acute kidney injury
5219688|NCT02625701|body weight|body weight
5219689|NCT02625662|muscular dystrophy|muscular dystrophy
5219690|NCT02625662|natural history|natural history
5219691|NCT02625662|genetic profilling|genetic profilling
5219692|NCT02625649|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5219693|NCT02625649|obesity|obesity
5219694|NCT02625649|type 2 diabetes mellitus|type 2 diabetes mellitus
5219695|NCT02625649|diabetic nephropathy|diabetic nephropathy
5219696|NCT02625649|diabetic retinopathy|diabetic retinopathy
5219697|NCT02625623|Avelumab|avelumab
5219698|NCT02625623|Gastric cancer|gastric cancer
5219699|NCT02625623|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
5219700|NCT02625610|Avelumab|avelumab
5219701|NCT02625610|Cancer|cancer
5219702|NCT02625610|Unresectable|unresectable
5219703|NCT02625610|Locally advanced|locally advanced
5219704|NCT02625610|Metastatic|metastatic
5219900|NCT02624466|Dialysis|dialysis
5219705|NCT02625610|Adenocarcinoma of the stomach|adenocarcinoma of the stomach
5219706|NCT02625610|Gastro-esophageal junction|gastro-esophageal junction
5219707|NCT02625584|Shared Book Reading|shared book reading
5219708|NCT02625584|Dialogic Reading|dialogic reading
5219709|NCT02625584|Language Development|language development
5219710|NCT02625584|Syntax|syntax
5219711|NCT02625584|Vocabulary|vocabulary
5219712|NCT02625584|Young Children|young children
5219713|NCT02625584|Randomised Control Trial|randomised control trial
5219714|NCT02625584|Language Intervention|language intervention
5219715|NCT02625558|riociguat|riociguat
5219716|NCT02625558|saph|saph
5219717|NCT02625558|sarcoidosis|sarcoidosis
5207747|NCT02696538|Psychometric properties|psychometric properties
5219718|NCT02625558|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
5219719|NCT02625532|Controlled Ovarian stimulation|controlled ovarian stimulation
5219720|NCT02625532|Follicular phase|follicular phase
5219721|NCT02625532|Luteal phase|luteal phase
5219722|NCT02625532|Reproductive Techniques, Assisted|reproductive techniques, assisted
5342982|NCT01981291|Sciatic Nerve|sciatic nerve
5219727|NCT02625519|Oocyte donors|oocyte donors
5219728|NCT02625493|Percutaneous coronary intervention|percutaneous coronary intervention
5219729|NCT02625493|Patient Preference|patient preference
5219730|NCT02625493|Radial access|radial access
5219731|NCT02625493|Femoral access|femoral access
5219732|NCT02625493|Coronary angiography|coronary angiography
5219733|NCT02625493|Shared decision making|shared decision making
5219734|NCT02625467|Keratoconus|keratoconus
5219735|NCT02625454|Acetaminophen|acetaminophen
5219736|NCT02625454|Labor|labor
5219737|NCT02625454|Intrapartum Fever|intrapartum fever
5219738|NCT02625454|Maternal Fever|maternal fever
5219739|NCT02625454|Fetal Tachycardia|fetal tachycardia
5219740|NCT02625454|Intravenous Acetaminophen|intravenous acetaminophen
5219746|NCT02625402|decision making|decision making
5219747|NCT02625402|decision aids|decision aids
5219748|NCT02625402|decision quality instruments|decision quality instruments
5219749|NCT02625402|osteoarthritis|osteoarthritis
5219750|NCT02625402|shared decision making|shared decision making
5219752|NCT02625363|Glycemic Index|glycemic index
5219753|NCT02625363|Water Intake|water intake
5219754|NCT02625363|Glycemic Response|glycemic response
5219755|NCT02625350|instant noodle|instant noodle
5219756|NCT02625350|water content|water content
5219757|NCT02625350|glycemic index|glycemic index
5219758|NCT02625350|serving method|serving method
5219759|NCT02625298|periapical diseases|periapical diseases
5219760|NCT02625298|dental injuries|dental injuries
5219762|NCT02625272|hand-assisted laparoscopic surgery|hand-assisted laparoscopic surgery
5219763|NCT02625272|right colon cancer|right colon cancer
5219764|NCT02625272|complete mesocolic excision|complete mesocolic excision
5219765|NCT02625272|no touch isolation|no touch isolation
5219766|NCT02625272|recurrence|recurrence
5219767|NCT02625272|overall survival|overall survival
5219768|NCT02625259|Drug therapy|drug therapy
5219769|NCT02625246|bronchiectasis|bronchiectasis
5219770|NCT02625246|mesenchymal stem cell|mesenchymal stem cell
5219771|NCT02625246|lung|lung
5219772|NCT02625246|pulmonary|pulmonary
5219773|NCT02625246|interstitial lung disease|interstitial lung disease
5219774|NCT02625207|Maraviroc, CYP3A5, pharmacokinetics, pharmacogenomics|maraviroc, cyp3a5, pharmacokinetics, pharmacogenomics
5219775|NCT02625181|Decision support|decision support
5219776|NCT02625181|Prediction models|prediction models
5219777|NCT02625181|PONV|ponv
5219778|NCT02625181|prophylaxis|prophylaxis
5219779|NCT02625181|Decision Support Systems, Clinical|decision support systems, clinical
5219780|NCT02625181|Decision Support Techniques|decision support techniques
5219781|NCT02625168|Afatinib|afatinib
5219782|NCT02625168|Erlotinib|erlotinib
5219783|NCT02625168|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
5219784|NCT02625168|Efficacy|efficacy
5219785|NCT02625168|Safety|safety
5219786|NCT02625155|Pharmacogenomics|pharmacogenomics
5219787|NCT02625155|Urine Drug Testing|urine drug testing
5219788|NCT02625155|antidepressants|antidepressants
5219789|NCT02625155|benzodiazepines|benzodiazepines
5219790|NCT02625155|opioids|opioids
5219791|NCT02625155|muscle relaxants|muscle relaxants
5219792|NCT02625155|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
5219793|NCT02625155|TDRAE|tdrae
5219794|NCT02625142|Morning Rounds|morning rounds
5219795|NCT02625142|Patient-centered Care|patient-centered care
5219796|NCT02625142|Hospital Medicine|hospital medicine
5219797|NCT02625142|Pediatrics|pediatrics
5219798|NCT02625142|Hospitals, Pediatric|hospitals, pediatric
5219799|NCT02625116|Cohort|cohort
5219901|NCT02624453|cryptococcus|cryptococcus
5219800|NCT02625103|Schizophrenia, Clozapine, TDM, Serum Concentration|schizophrenia, clozapine, tdm, serum concentration
5219801|NCT02625090|Drug-resistance|drug-resistance
5219802|NCT02625090|focal epilepsy|focal epilepsy
5219803|NCT02625090|partial-onset seizures|partial-onset seizures
5219804|NCT02625077|Valvuloplasty|valvuloplasty
5219805|NCT02625077|Fundoplication|fundoplication
5219806|NCT02625077|Acid reflux|acid reflux
5219808|NCT02625077|Reflux disease|reflux disease
5219809|NCT02625077|Hiatal hernia|hiatal hernia
5219810|NCT02625064|ARDS|ards
5219811|NCT02625064|biomarkers|biomarkers
5219813|NCT02625012|Ultraviolet Therapy|ultraviolet therapy
5219815|NCT02625012|Melanocytes|melanocytes
5219816|NCT02625012|Pigmentation|pigmentation
5219817|NCT02624999|Head and Neck Cancer|head and neck cancer
5219818|NCT02624999|SCCHN|scchn
5219819|NCT02624999|R/M SCCHN|r/m scchn
5219820|NCT02624999|Carcinoma|carcinoma
5219821|NCT02624973|neoadjuvant treatment|neoadjuvant treatment
5098099|NCT03385161|Prostate|prostate
5207846|NCT02696070|Pain|pain
5207847|NCT02696070|Diabetic Neuropathy|diabetic neuropathy
5207849|NCT02696070|PEMF|pemf
5219822|NCT02624973|personalized medicine|personalized medicine
5219824|NCT02624895|"metastatic colorectal cancer gene RAS not mutated WILD TYPE"|"metastatic colorectal cancer gene ras not mutated wild type"
5219825|NCT02624882|blistering distal dactylitis|blistering distal dactylitis
5219826|NCT02624882|Streptococcus pyogenes|streptococcus pyogenes
5219827|NCT02624882|antibiotics|antibiotics
5219828|NCT02624869|Hypercholesterolemia|hypercholesterolemia
5219829|NCT02624869|Elevated Cholesterol|elevated cholesterol
5219830|NCT02624869|High Cholesterol|high cholesterol
5219831|NCT02624869|PCSK9 mutations|pcsk9 mutations
5219832|NCT02624869|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
5219833|NCT02624869|evolocumab|evolocumab
5219834|NCT02624869|Repatha|repatha
5219835|NCT02624869|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5219836|NCT02624869|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5219837|NCT02624869|Pediatric|pediatric
5219838|NCT02624869|Paediatric|paediatric
5219839|NCT02624856|primary total knee arthroplasty|primary total knee arthroplasty
5219840|NCT02624856|liposomal bupivacaine|liposomal bupivacaine
5219841|NCT02624804|Diabetes|diabetes
5219842|NCT02624791|astigmatism, contact lens, driving|astigmatism, contact lens, driving
5219843|NCT02624765|RCT A: Fetal Atrial Flutter without Hydrops|rct a: fetal atrial flutter without hydrops
5219844|NCT02624765|RCT B: Fetal Supraventricular Tachycardia without Hydrops|rct b: fetal supraventricular tachycardia without hydrops
5219845|NCT02624765|RCT C: Fetal Supraventricular Tachycardia with Hydrops|rct c: fetal supraventricular tachycardia with hydrops
5219846|NCT02624752|Oral Nutrition Supplementation|oral nutrition supplementation
5219847|NCT02624726|1st line|1st line
5219849|NCT02624726|Aflibercept|aflibercept
5219850|NCT02624726|mCRC|mcrc
5219851|NCT02624713|eating disorder|eating disorder
5219852|NCT02624713|childhood obesity|childhood obesity
5219853|NCT02624713|family based treatment|family based treatment
5219854|NCT02624700|ER-negative|er-negative
5219855|NCT02624700|PgR-negative|pgr-negative
5219856|NCT02624700|Human epidermal growth factor receptor 2 (HER2-negative)|human epidermal growth factor receptor 2 (her2-negative)
5219857|NCT02624700|Triple Negative Breast Cancer|triple negative breast cancer
5219858|NCT02624700|HER2-negative|her2-negative
5219859|NCT02624661|Trigeminal ganglion|trigeminal ganglion
5219860|NCT02624661|Glycerol|glycerol
5219861|NCT02624661|Nerve block|nerve block
5219862|NCT02624648|Sexual Dysfunction|sexual dysfunction
5219863|NCT02624648|Postmenopausal women|postmenopausal women
5219864|NCT02624648|Sexual desire|sexual desire
5219865|NCT02624635|Manual Therapy|manual therapy
5219866|NCT02624635|Pain|pain
5219867|NCT02624635|Hip|hip
5219868|NCT02624635|Muscle Strength|muscle strength
5219869|NCT02624622|omphalitis|omphalitis
5219870|NCT02624622|neonate|neonate
5219871|NCT02624622|developing countries|developing countries
5219872|NCT02624596|OCD|ocd
5219873|NCT02624583|Fasting|fasting
5219874|NCT02624583|Clopidogrel|clopidogrel
5219875|NCT02624570|AML|aml
5219876|NCT02624570|FLT3|flt3
5219877|NCT02624570|ITD|itd
5219878|NCT02624570|TKD|tkd
5219879|NCT02624570|acute myeloid leukemia|acute myeloid leukemia
5219880|NCT02624570|induction|induction
5219881|NCT02624570|consolidation|consolidation
5219882|NCT02624570|continuation|continuation
5219883|NCT02624570|EAP|eap
5219884|NCT02624570|ETP|etp
5219885|NCT02624570|midostaurin|midostaurin
5219886|NCT02624570|PKC412|pkc412
5219887|NCT02624557|Hepatic impairment|hepatic impairment
5219888|NCT02624557|Healthy volunteers|healthy volunteers
5219889|NCT02624557|Clinical pharmacology study|clinical pharmacology study
5219890|NCT02624557|BYL719|byl719
5219891|NCT02624557|alpelisib|alpelisib
5219892|NCT02624531|NACT|nact
5219893|NCT02624531|Cervical cancer|cervical cancer
5219894|NCT02624531|Fertility sparing|fertility sparing
5219895|NCT02624531|Pregnancy|pregnancy
5219896|NCT02624531|Treatment Strategy|treatment strategy
5219897|NCT02624479|Pharmacokinetics|pharmacokinetics
5219898|NCT02624466|Pediatrics|pediatrics
5219899|NCT02624466|Nephrology|nephrology
5219902|NCT02624453|IMMY LFA|immy lfa
5219903|NCT02624453|meningitis|meningitis
5219904|NCT02624453|antigen|antigen
5219905|NCT02624440|Multiple Myeloma|multiple myeloma
5219906|NCT02624440|Infection|infection
5219907|NCT02624440|Clarithromycin|clarithromycin
5219908|NCT02624440|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5219909|NCT02624427|Glaucoma|glaucoma
5219910|NCT02624427|Intraocular Pressure|intraocular pressure
5219914|NCT02624388|Pediatric Cancer|pediatric cancer
5219915|NCT02624388|Isoflavone|isoflavone
5219916|NCT02624362|Odor|odor
5219917|NCT02624362|trigger|trigger
5219918|NCT02624362|inflammation|inflammation
5962679|NCT04279431|EEG Evaluation|eeg evaluation
5207936|NCT02695615|cesarean operation|cesarean operation
5207938|NCT02695615|pain|pain
5207944|NCT02695498|pain|pain
5219919|NCT02624362|nocebo|nocebo
5219920|NCT02624336|periodontal disease|periodontal disease
5219921|NCT02624336|caries|caries
5219930|NCT02624297|Coronary artery disease|coronary artery disease
5219931|NCT02624297|Chemoreceptors|chemoreceptors
5219932|NCT02624297|Sympathetic nerve activity|sympathetic nerve activity
5219933|NCT02624297|Exercise|exercise
5219934|NCT02624271|gastric cancer|gastric cancer
5219935|NCT02624271|gastric precancerous lesions|gastric precancerous lesions
5219936|NCT02624271|blood test|blood test
5219937|NCT02624232|Anorectal malformation|anorectal malformation
5219938|NCT02624232|Anorectal atresia|anorectal atresia
5219939|NCT02624232|anorectal stenosis|anorectal stenosis
5219940|NCT02624232|Follow-Up Studies|follow-up studies
5219941|NCT02624219|A/H5N8|a/h5n8
5219942|NCT02624219|AS03|as03
5219943|NCT02624219|Controlled|controlled
5219944|NCT02624219|Double-Blind|double-blind
5219945|NCT02624219|Immunogenicity|immunogenicity
5219946|NCT02624219|Inactivated|inactivated
5219947|NCT02624219|Influenza|influenza
5219948|NCT02624219|MF59|mf59
5219949|NCT02624219|Monovalent|monovalent
5219950|NCT02624219|Randomized|randomized
5219951|NCT02624219|Reactogenicity|reactogenicity
5219952|NCT02624219|Safety|safety
5219953|NCT02624219|Trial|trial
5219954|NCT02624219|Vaccine|vaccine
5219955|NCT02624193|Treatment Adherence|treatment adherence
5219956|NCT02624193|Mental Health|mental health
5219957|NCT02624193|Well-being|well-being
5219958|NCT02624193|Emerging Adults|emerging adults
5219959|NCT02624193|Youth|youth
5219960|NCT02624128|head and neck cancer|head and neck cancer
5219961|NCT02624128|valproic acid|valproic acid
5219962|NCT02624128|recurrent|recurrent
5219963|NCT02624128|metastatic|metastatic
5219964|NCT02624102|Major depressive disorder|major depressive disorder
5219965|NCT02624102|Cognitive behavioral therapy|cognitive behavioral therapy
5219966|NCT02624102|Trial based cognitive therapy|trial based cognitive therapy
5219967|NCT02624102|Behavioral activation|behavioral activation
5219968|NCT02624076|unexplained infertility|unexplained infertility
5219969|NCT02624076|Acupuncture|acupuncture
5219970|NCT02624050|ACEI|acei
5219972|NCT02624050|Hypotension|hypotension
5219973|NCT02624050|General Anesthesia|general anesthesia
5219974|NCT02624050|Methohexital|methohexital
5219975|NCT02624050|Propofol|propofol
5219976|NCT02624037|Inflammatory Bowel Disease, Ulcerative Colitis|inflammatory bowel disease, ulcerative colitis
5219977|NCT02624037|Crohn's Disease|crohn's disease
5219978|NCT02624037|Pharmacokinetics, Individualized Dosage, Dashboard System|pharmacokinetics, individualized dosage, dashboard system
5219979|NCT02624037|Remicade, Infliximab|remicade, infliximab
5219980|NCT02623998|Diabetes|diabetes
5219981|NCT02623998|Insulin|insulin
5219982|NCT02623998|Glargine|glargine
5219983|NCT02623998|Metformin|metformin
5219984|NCT02623998|Sitagliptin|sitagliptin
5219985|NCT02623998|Diet|diet
5219986|NCT02623998|Excercise|excercise
5219987|NCT02623998|Lifestyle|lifestyle
5219988|NCT02623972|inflammatory breast cancer|inflammatory breast cancer
5445366|NCT01522157|Type 2 diabetes mellitus|type 2 diabetes mellitus
5219989|NCT02623972|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
5219990|NCT02623959|Advanced Cancers|advanced cancers
5219991|NCT02623959|Malignant pleural effusions|malignant pleural effusions
5219993|NCT02623959|Indwelling pleural catheter|indwelling pleural catheter
5219994|NCT02623959|IPC|ipc
5219995|NCT02623959|Questionnaires|questionnaires
5219996|NCT02623959|Surveys|surveys
5219997|NCT02623959|Fentanyl patch|fentanyl patch
5219998|NCT02623959|Fentanyl by vein|fentanyl by vein
5219999|NCT02623959|Sublimaze|sublimaze
5220000|NCT02623959|Doxycycline|doxycycline
5220001|NCT02623959|Vibramycin|vibramycin
5220002|NCT02623959|Periostat|periostat
5220003|NCT02623959|Doryx|doryx
5220004|NCT02623959|:Phone calls|:phone calls
5220005|NCT02623946|motor evoked potentials|motor evoked potentials
5220006|NCT02623933|HDR monotherapy|hdr monotherapy
5221908|NCT02611713|tremor|tremor
5220007|NCT02623933|MRI guidance|mri guidance
5220008|NCT02623933|Intraprostatic lesion|intraprostatic lesion
5220009|NCT02623933|dose paining|dose paining
5220018|NCT02623881|Cervical pessary|cervical pessary
5220019|NCT02623881|Vaginal progesterone|vaginal progesterone
5220020|NCT02623881|Twins|twins
5220021|NCT02623881|Premature birth|premature birth
5220022|NCT02623855|Parks|parks
5220023|NCT02623855|Well-being|well-being
5220024|NCT02623855|Stress|stress
5220025|NCT02623855|Physical Activity|physical activity
5220026|NCT02623855|Nature|nature
5220027|NCT02623855|Greenspace|greenspace
5220031|NCT02623829|scar prophylaxis|scar prophylaxis
5220032|NCT02623829|Botulinum Toxin|botulinum toxin
5220037|NCT02623764|Cholinergic index|cholinergic index
5220038|NCT02623725|Dengue Fever|dengue fever
5220039|NCT02623725|Dengue virus|dengue virus
5220040|NCT02623725|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5220041|NCT02623725|CYD Dengue Vaccine|cyd dengue vaccine
5220045|NCT02623686|Sleep|sleep
5220046|NCT02623686|ICU|icu
5220047|NCT02623686|Massage Therapy|massage therapy
5220048|NCT02623686|Inhalation Patch|inhalation patch
5220049|NCT02623660|Inflammation|inflammation
5220050|NCT02623660|Edema|edema
5220051|NCT02623660|Arthroplasty|arthroplasty
5220052|NCT02623660|Rehabilitation|rehabilitation
5220053|NCT02623660|Replacement|replacement
5220054|NCT02623660|Knee|knee
5220055|NCT02623660|Total Knee Replacement|total knee replacement
5220056|NCT02623660|Pain, Postoperative|pain, postoperative
5220057|NCT02623660|Exercise Therapy|exercise therapy
5220058|NCT02623660|Therapeutics|therapeutics
5220059|NCT02623660|Early Ambulation|early ambulation
5220060|NCT02623660|Myofunctional Therapy|myofunctional therapy
5220061|NCT02623660|Electric Stimulation Therapy|electric stimulation therapy
5220062|NCT02623660|Orthopedic Procedures|orthopedic procedures
5220063|NCT02623660|Wound Healing|wound healing
5220064|NCT02623660|Total Knee Arthroplasty|total knee arthroplasty
5220065|NCT02623634|Cuff leak test, relative factors|cuff leak test, relative factors
5220066|NCT02623608|type 2 diabetes risk|type 2 diabetes risk
5220067|NCT02623608|cardiovascular disease risk|cardiovascular disease risk
5220068|NCT02623595|non-small cell lung cancer|non-small cell lung cancer
5220069|NCT02623595|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5220070|NCT02623595|Stereotactic body radiotherapy|stereotactic body radiotherapy
5220071|NCT02623595|abscopal effect|abscopal effect
5220073|NCT02623595|immunotherapy|immunotherapy
5220074|NCT02623556|diagnosis of tuberculosis|diagnosis of tuberculosis
5220075|NCT02623556|ESAT6-CFP10|esat6-cfp10
5220076|NCT02623556|skin test|skin test
5220077|NCT02623556|diagnostic test|diagnostic test
5220078|NCT02623530|Nursing|nursing
5220079|NCT02623530|Nursing education research|nursing education research
5220080|NCT02623530|Critical thinking|critical thinking
5220081|NCT02623530|Decision Making|decision making
5220082|NCT02623517|CIED|cied
5220084|NCT02623517|arrhythmia|arrhythmia
5220085|NCT02623517|atrial fibrillation|atrial fibrillation
5220086|NCT02623517|cardiac device|cardiac device
5220087|NCT02623517|pacemaker|pacemaker
5220088|NCT02623517|defibrillator|defibrillator
5220089|NCT02623504|Carbamazepine|carbamazepine
5220090|NCT02623504|Equetro|equetro
5220091|NCT02623504|Bipolar I Disorder|bipolar i disorder
5220092|NCT02623504|Bipolar I Disorder in Children|bipolar i disorder in children
5220093|NCT02623491|JNJ-55375515|jnj-55375515
5220094|NCT02623491|Healthy|healthy
5220095|NCT02623491|Placebo|placebo
5220096|NCT02623439|hematologic malignancies|hematologic malignancies
5220099|NCT02623400|preterm birth|preterm birth
5220100|NCT02623400|perinatal stress|perinatal stress
5220101|NCT02623400|growth and development|growth and development
5220102|NCT02623387|paravertebral block|paravertebral block
5220103|NCT02623348|dialysis|dialysis
5220104|NCT02623348|end-stage renal disease|end-stage renal disease
5220105|NCT02623335|patient decision making|patient decision making
5220106|NCT02623335|surgical decision making|surgical decision making
5220107|NCT02623335|question prompt list|question prompt list
5220108|NCT02623335|shared decision making|shared decision making
5222111|NCT02610270|Sport|sport
5220109|NCT02623335|decision support techniques|decision support techniques
5220110|NCT02623257|Non-small Cell Lung Cancer|non-small cell lung cancer
5220111|NCT02623257|circulating tumor DNA|circulating tumor dna
5220112|NCT02623257|amplification refractory mutation system|amplification refractory mutation system
5220113|NCT02623244|ovarian endometrioma|ovarian endometrioma
5220114|NCT02623244|lower urinary tract symptoms|lower urinary tract symptoms
5220115|NCT02623244|sexual dysfunction|sexual dysfunction
5220116|NCT02623244|gastrointestinal symptoms|gastrointestinal symptoms
5220117|NCT02623218|traumatic brain injury|traumatic brain injury
5220118|NCT02623218|acupuncture|acupuncture
5220119|NCT02623218|transcranial doppler ultrasound|transcranial doppler ultrasound
5220120|NCT02623166|Pneumonia|pneumonia
5220121|NCT02623166|Fever|fever
5220122|NCT02623166|Diarrhoea|diarrhoea
5220123|NCT02623140|Coronary drug eluting stents|coronary drug eluting stents
5220124|NCT02623140|Outcomes|outcomes
5220125|NCT02623127|Thymic carcinoma|thymic carcinoma
5220126|NCT02623127|Sunitinib|sunitinib
5220127|NCT02623127|Metastatic|metastatic
5220128|NCT02623127|Recurrent|recurrent
5220129|NCT02623101|Reflectance confocal microscopy|reflectance confocal microscopy
5220130|NCT02623101|Basal cell carcinoma|basal cell carcinoma
5208134|NCT02694172|healthy subjects|healthy subjects
5208135|NCT02694172|human microbiome|human microbiome
5208184|NCT02693977|OSA|osa
5220131|NCT02623101|Biopsy|biopsy
5220132|NCT02623101|Diagnostics|diagnostics
5220133|NCT02623088|Obstructive Sleep Apnea|obstructive sleep apnea
5220134|NCT02623088|Endothelial dysfunction|endothelial dysfunction
5220135|NCT02623088|Arterial stiffness|arterial stiffness
5220136|NCT02623088|PAP therapies|pap therapies
5220137|NCT02623049|New oral anticoagulants|new oral anticoagulants
5220138|NCT02623049|Blood levels|blood levels
5220139|NCT02623049|Octogenarians|octogenarians
5220140|NCT02623036|chronotherapy|chronotherapy
5220141|NCT02623036|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5220142|NCT02623036|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5220143|NCT02623010|Primary CNS lymphoma|primary cns lymphoma
5220144|NCT02623010|Ibrutinib|ibrutinib
5220145|NCT02623010|Elderly|elderly
5220146|NCT02623010|Maintenance|maintenance
5220147|NCT02622997|HPV self-sampling|hpv self-sampling
5220148|NCT02622971|phototherapy|phototherapy
5220149|NCT02622971|cryotherapy|cryotherapy
5220150|NCT02622971|exercise|exercise
5220151|NCT02622971|fatigue|fatigue
5220152|NCT02622971|recovery|recovery
5220153|NCT02622958|Social Anxiety Disorder|social anxiety disorder
5220154|NCT02622958|Social Phobia|social phobia
5220155|NCT02622958|Performance Anxiety|performance anxiety
5220156|NCT02622958|Social Anxiety|social anxiety
5220157|NCT02622958|Anxiety|anxiety
5220158|NCT02622906|Gastrointestinal angiodysplasia|gastrointestinal angiodysplasia
5220159|NCT02622906|Pasireotide|pasireotide
5220160|NCT02622906|Gastrointestinal bleeding|gastrointestinal bleeding
5220161|NCT02622867|Lactobacillus plantarum|lactobacillus plantarum
5220162|NCT02622867|Maltodextrin|maltodextrin
5220163|NCT02622867|Probiotics|probiotics
5220164|NCT02622867|Randomized Controlled Trial|randomized controlled trial
5220165|NCT02622854|plasma exchange|plasma exchange
5220166|NCT02622854|hypertriglyceridemia|hypertriglyceridemia
5220167|NCT02622841|First in man|first in man
5220168|NCT02622841|Spinal metastases|spinal metastases
5220169|NCT02622841|Stereotactic bodyradiotherapy|stereotactic bodyradiotherapy
5220170|NCT02622841|Palliative care|palliative care
5220171|NCT02622841|Safety|safety
5220172|NCT02622841|Surgical stabilisation|surgical stabilisation
5220173|NCT02622828|wheelchairs|wheelchairs
5220174|NCT02622828|social participation|social participation
5220175|NCT02622815|Hypercoagulation|hypercoagulation
5220177|NCT02622815|Cancer Risk Assessment|cancer risk assessment
5220178|NCT02622815|Cancer Prognosis|cancer prognosis
5220179|NCT02622802|ex-vivo placenta perfusion|ex-vivo placenta perfusion
5220180|NCT02622802|transplacental transfer|transplacental transfer
5220181|NCT02622802|paracetamol|paracetamol
5220182|NCT02622802|erythromycin|erythromycin
5220183|NCT02622802|azithromycin|azithromycin
5220184|NCT02622789|Spinal alignment|spinal alignment
5220185|NCT02622789|Kinematics|kinematics
5220186|NCT02622789|Pilates|pilates
5220187|NCT02622789|Physical Therapy|physical therapy
5220189|NCT02622750|triple-branched stent graft|triple-branched stent graft
5220190|NCT02622750|total arch replace|total arch replace
5220191|NCT02622750|the occluded rate of false lumen|the occluded rate of false lumen
5220192|NCT02622737|Parkinson disease|parkinson disease
5220193|NCT02622737|Accidental Falls|accidental falls
5220194|NCT02622737|Exercise therapy|exercise therapy
5220195|NCT02622737|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5220196|NCT02622724|ARDS, human|ards, human
5220197|NCT02622724|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5220198|NCT02622724|Respiratory Insufficiency|respiratory insufficiency
5220199|NCT02622711|breast cancer|breast cancer
5220200|NCT02622711|obesity|obesity
5220201|NCT02622711|weight control|weight control
5220202|NCT02622711|exercise and physical fitness|exercise and physical fitness
5220203|NCT02622672|Antioxidation|antioxidation
5220204|NCT02622672|Anti-inflammation|anti-inflammation
5220205|NCT02622672|Blood glucose|blood glucose
5220206|NCT02622672|Blood lipids|blood lipids
5220207|NCT02622659|acute upper respiratory infection|acute upper respiratory infection
5220208|NCT02622620|dynamic contrast-enhanced MR imaging|dynamic contrast-enhanced mr imaging
5220209|NCT02622620|three-dimensional arterial spin labeling|three-dimensional arterial spin labeling
5220210|NCT02622620|diffusion-weighted imaging|diffusion-weighted imaging
5220211|NCT02622607|ZOL|zol
5220212|NCT02622607|Prevention|prevention
5220213|NCT02622607|lung cancer|lung cancer
5220214|NCT02622529|Awake craniotomy|awake craniotomy
5220215|NCT02622529|Psychological consequences|psychological consequences
5220216|NCT02622529|Fear and Anxiety|fear and anxiety
5220217|NCT02622516|Rehabilitation|rehabilitation
5863469|NCT00001275|Amenorrhea|amenorrhea
5220219|NCT02622516|Postural Balance|postural balance
5220221|NCT02622516|Dizziness|dizziness
5220222|NCT02622438|FSHD|fshd
5220223|NCT02622438|Usual care performed at Montpellier hospital|usual care performed at montpellier hospital
5220224|NCT02622438|Muscle function|muscle function
5220225|NCT02622438|Antioxidants|antioxidants
5220226|NCT02622438|Oxidative stress|oxidative stress
5220227|NCT02622438|Quality of life|quality of life
5220228|NCT02622438|Physical activities, development of food-based dietary guidelines|physical activities, development of food-based dietary guidelines
5220229|NCT02622438|Co-morbidity|co-morbidity
5220230|NCT02622425|Carotenoid|carotenoid
5220231|NCT02622425|Bacillus|bacillus
5220232|NCT02622425|Microbiota|microbiota
5220233|NCT02622425|Cardiovascular health|cardiovascular health
5220234|NCT02622412|Quality of Life|quality of life
5220235|NCT02622412|Palliative Therapy|palliative therapy
5220236|NCT02622412|Outpatient Services|outpatient services
5220238|NCT02622373|Pea Pod|pea pod
5220239|NCT02622373|Body composition|body composition
5220240|NCT02622308|Arterial leg ulcers|arterial leg ulcers
5220241|NCT02622308|Intermittent Negative Pressure|intermittent negative pressure
5220242|NCT02622308|Peripheral Circulation|peripheral circulation
5220243|NCT02622308|Wound healing|wound healing
5220244|NCT02622308|Peripheral blood flow|peripheral blood flow
5220245|NCT02622295|metabolism|metabolism
5220246|NCT02622295|glucose|glucose
5220247|NCT02622295|osteoporosis|osteoporosis
5220248|NCT02622295|secondary health conditions|secondary health conditions
5220249|NCT02622295|quality of life|quality of life
5220250|NCT02622295|standing|standing
5220251|NCT02622295|electrical stimulation|electrical stimulation
5220252|NCT02622295|diabetes|diabetes
5220253|NCT02622295|insulin|insulin
5220254|NCT02622295|skeletal muscle|skeletal muscle
5220255|NCT02622282|physical activity|physical activity
5220256|NCT02622282|physical inactivity|physical inactivity
5220257|NCT02622282|PAD|pad
5220258|NCT02622282|Diabetes|diabetes
5220259|NCT02622282|High blood pressure|high blood pressure
5220260|NCT02622282|High cholesterol|high cholesterol
5220261|NCT02622282|Smoking|smoking
5220262|NCT02622269|Urography|urography
5220263|NCT02622269|Radiation dosage|radiation dosage
5220264|NCT02622269|image enhancement|image enhancement
5220265|NCT02622256|Social Media|social media
5220266|NCT02622256|Twitter|twitter
5220267|NCT02622256|Hypertension|hypertension
5220268|NCT02622256|Cardiovascular|cardiovascular
5220269|NCT02622256|CVD|cvd
5220270|NCT02622256|HTN|htn
5220271|NCT02622230|Uygur Medicine|uygur medicine
5220272|NCT02622217|anesthesiology|anesthesiology
5220273|NCT02622217|non technical kills|non technical kills
5220274|NCT02622191|Glaucoma|glaucoma
5226497|NCT02583880|ICU|icu
5220275|NCT02622191|Optical Coherence Tomography|optical coherence tomography
5220276|NCT02622191|Primary Open Angle Glaucoma|primary open angle glaucoma
5220277|NCT02622191|Visual Field|visual field
5220278|NCT02622165|health promotion|health promotion
5220279|NCT02622165|nutrition|nutrition
5220280|NCT02622165|intervention|intervention
5220281|NCT02622165|adolescents|adolescents
5220282|NCT02622165|serious game|serious game
5220283|NCT02622152|Right lateral|right lateral
5220284|NCT02622152|Oxygenation|oxygenation
5220285|NCT02622152|Cardiac|cardiac
5220286|NCT02622152|Congenital|congenital
5220287|NCT02622152|Pediatric|pediatric
5220288|NCT02622152|Postoperative|postoperative
5220289|NCT02622139|Photoacoustics|photoacoustics
5220290|NCT02622139|Optoacoustics|optoacoustics
5220291|NCT02622139|Ultrasound|ultrasound
5220292|NCT02622126|Preloading|preloading
5220293|NCT02622126|Colloid|colloid
5220294|NCT02622126|Cesarean section|cesarean section
5220295|NCT02622126|D-dimer|d-dimer
5220296|NCT02622126|Hypotension|hypotension
5220297|NCT02622113|insulin resistance|insulin resistance
5220298|NCT02622100|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5113008|NCT03290495|isoflurane|isoflurane
5220299|NCT02622100|Routine Clinical Practice|routine clinical practice
5220300|NCT02622100|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5220301|NCT02622100|Coronary Artery Disease|coronary artery disease
5220302|NCT02622100|drug eluting stent|drug eluting stent
5220303|NCT02622074|PD1|pd1
5220304|NCT02622074|PD-1|pd-1
5220305|NCT02622074|PDL1|pdl1
5220306|NCT02622074|PD-L1|pd-l1
5220307|NCT02622074|Triple Negative Breast Cancer|triple negative breast cancer
5220308|NCT02622048|Mental Health|mental health
5220309|NCT02622048|Psychosis|psychosis
5220310|NCT02622048|Parent|parent
5220312|NCT02622022|randomised|randomised
5220313|NCT02622022|placebo controlled|placebo controlled
5220314|NCT02622022|clinical trial|clinical trial
5220315|NCT02622009|stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV|stable copd; bronchoalveolar lavage; biopsy; hrv; rsv
5220316|NCT02621996|Surface Electromyography|surface electromyography
5220317|NCT02621996|Hypotonia|hypotonia
5208334|NCT02693262|defibrillator|defibrillator
5208335|NCT02693262|heart failure|heart failure
5208336|NCT02693262|ICD|icd
5208340|NCT02693262|CLS|cls
5220318|NCT02621996|Patient Positioning|patient positioning
5220319|NCT02621983|Schizophrenia|schizophrenia
5220320|NCT02621983|Exercise|exercise
5220321|NCT02621983|Cognition|cognition
5220322|NCT02621905|Prophylaxis|prophylaxis
5220323|NCT02621905|Steady-State|steady-state
5220325|NCT02621866|hypertension|hypertension
5220326|NCT02621866|ultraviolet|ultraviolet
5220327|NCT02621853|Steatosis|steatosis
5220328|NCT02621827|vitamin D|vitamin d
5220330|NCT02621814|Infant|infant
5220331|NCT02621814|Growth|growth
5220332|NCT02621814|Body Weight Changes|body weight changes
5220333|NCT02621814|Infant Formula|infant formula
5220334|NCT02621814|Randomized Controlled Trial|randomized controlled trial
5220335|NCT02621788|mind/body medicine|mind/body medicine
5220336|NCT02621788|3RP|3rp
5220337|NCT02621788|stress management|stress management
5220338|NCT02621788|resident burnout|resident burnout
5220339|NCT02621775|Stress management|stress management
5220340|NCT02621775|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
5220341|NCT02621775|Self-help|self-help
5220342|NCT02621775|e-health|e-health
5220343|NCT02621775|Adjustment disorder with anxiety|adjustment disorder with anxiety
5220344|NCT02621736|children|children
5220345|NCT02621736|desmopressin|desmopressin
5220346|NCT02621736|copeptin|copeptin
5220347|NCT02621723|Preventability|preventability
5220348|NCT02621697|dual task|dual task
5220349|NCT02621697|aging|aging
5220350|NCT02621671|Healthy Volunteers|healthy volunteers
5220351|NCT02621658|Colorectal Cancer|colorectal cancer
5220352|NCT02621658|Colonoscopy|colonoscopy
5220353|NCT02621658|Adenoma Detection Rate|adenoma detection rate
5220354|NCT02621658|Bowel Preparation|bowel preparation
5220355|NCT02621658|Time to Cecal Intubation|time to cecal intubation
5220356|NCT02621645|monochorionic|monochorionic
5220357|NCT02621645|TRAP|trap
5220358|NCT02621645|acardiac twin|acardiac twin
5220359|NCT02621632|Compression therapy|compression therapy
5220360|NCT02621619|Older adults|older adults
5220361|NCT02621619|Elderly|elderly
5220362|NCT02621619|Acute pain|acute pain
5220363|NCT02621619|IV acetaminophen|iv acetaminophen
5220364|NCT02621619|IV hydromorphone|iv hydromorphone
5220365|NCT02621619|Analgesia|analgesia
5220366|NCT02621619|Adjunctive analgesia|adjunctive analgesia
5220367|NCT02621593|Meibomian Gland Dysfunction|meibomian gland dysfunction
5220368|NCT02621593|Dry eye symptoms|dry eye symptoms
5220369|NCT02621593|Intense Pulsed Light|intense pulsed light
5220370|NCT02621580|Panretinal Photocoagulation|panretinal photocoagulation
5220371|NCT02621554|Memory|memory
5220372|NCT02621554|Resveratrol|resveratrol
5220373|NCT02621554|elderly|elderly
5220374|NCT02621554|cognition|cognition
5220375|NCT02621541|neuroendocrine tumor|neuroendocrine tumor
5220376|NCT02621541|pancreas|pancreas
5220377|NCT02621541|diagnosis|diagnosis
5220378|NCT02621541|positron emission tomography|positron emission tomography
5220379|NCT02621528|CeraFlex occluder|ceraflex occluder
5220380|NCT02621515|Nivolumab|nivolumab
5220381|NCT02621515|Brain metastasis|brain metastasis
5220382|NCT02621515|Melanoma|melanoma
5220383|NCT02621502|Quinoa|quinoa
5220384|NCT02621502|Satiety|satiety
5220385|NCT02621502|Visual analogue scale|visual analogue scale
5220386|NCT02621502|Cross-over studies|cross-over studies
5220387|NCT02621489|Glucagon-like peptide-1|glucagon-like peptide-1
5220388|NCT02621489|Endothelialization|endothelialization
5220389|NCT02621489|Cardiac Function|cardiac function
5220390|NCT02621489|Exenatide|exenatide
5220391|NCT02621489|Optical Coherence Tomography|optical coherence tomography
5220392|NCT02621450|chronic renal failure|chronic renal failure
5220393|NCT02621450|hypertension|hypertension
5220394|NCT02621450|ampulatory blood pressure|ampulatory blood pressure
5220395|NCT02621437|pain|pain
5220396|NCT02621437|quality of life|quality of life
5220397|NCT02621437|osteopathy|osteopathy
5220398|NCT02621437|oncology|oncology
5220399|NCT02621437|surgery|surgery
5220400|NCT02621437|breast|breast
5220401|NCT02621424|dementia|dementia
5220402|NCT02621424|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5220403|NCT02621424|RTMS|rtms
5220404|NCT02621424|CVLT|cvlt
5220405|NCT02621411|Substance abuse|substance abuse
5220406|NCT02621411|Emergency operation|emergency operation
5220407|NCT02621411|Preoperative screen|preoperative screen
5220408|NCT02621320|Vitamin D|vitamin d
5220409|NCT02621320|Exercise Performance|exercise performance
5220410|NCT02621320|Wheelchair Athletes|wheelchair athletes
5220411|NCT02621320|Indoor sports|indoor sports
5220412|NCT02621320|Wingate|wingate
5220413|NCT02621320|Isokinetic Dynamometer|isokinetic dynamometer
5220414|NCT02621307|postprandial glycemia|postprandial glycemia
5220415|NCT02621307|subjective appetite|subjective appetite
5220416|NCT02621307|Salba|salba
5220417|NCT02621307|Flax|flax
5220418|NCT02621294|Protein|protein
5220419|NCT02621294|indicator amino acid oxidation method|indicator amino acid oxidation method
5220420|NCT02621294|athletes|athletes
5220421|NCT02621281|hypothermic machine perfusion|hypothermic machine perfusion
5220422|NCT02621281|Kidney Transplantation|kidney transplantation
5220423|NCT02621281|Delayed graft function|delayed graft function
5220424|NCT02621281|perfusion pressure|perfusion pressure
5220425|NCT02621216|percutaneous coronary intervention|percutaneous coronary intervention
5220426|NCT02621190|circulating tumor cells|circulating tumor cells
5220427|NCT02621190|predictive factor|predictive factor
5220428|NCT02621151|combination therapy|combination therapy
5220429|NCT02621151|immunotherapy|immunotherapy
5220430|NCT02621151|immune checkpoint inhibition|immune checkpoint inhibition
5220431|NCT02621099|handheld gamma camera|handheld gamma camera
5220432|NCT02621086|Oligosaccharide, Tolerability,|oligosaccharide, tolerability,
5220433|NCT02621073|lower extremity|lower extremity
5220434|NCT02621073|status-post ORIF|status-post orif
5220435|NCT02621060|Chlorogenic acid|chlorogenic acid
5220436|NCT02621060|Control glucose|control glucose
5220437|NCT02621060|Insulin Secretion|insulin secretion
5220438|NCT02621060|Insulin Sensitivity|insulin sensitivity
5220439|NCT02621047|Healthy volunteer|healthy volunteer
5220440|NCT02621047|Alectinib|alectinib
5220441|NCT02621047|Hepatic impairment|hepatic impairment
5220442|NCT02621034|Root canal treatment|root canal treatment
5220443|NCT02621034|pain|pain
5220444|NCT02621034|endodontic instruments|endodontic instruments
5220445|NCT02621021|Melanoma|melanoma
5220446|NCT02621021|Skin Cancer|skin cancer
5220447|NCT02621021|Immunotherapy|immunotherapy
5220448|NCT02621021|Cell Therapy|cell therapy
5220449|NCT02621008|diabetes|diabetes
5220450|NCT02621008|hypertension|hypertension
5220451|NCT02621008|obesity|obesity
5220452|NCT02621008|mobile phone|mobile phone
5220453|NCT02621008|stress|stress
5220454|NCT02621008|healthy living|healthy living
5220455|NCT02621008|pre-diabetes|pre-diabetes
5220456|NCT02620995|hypertension|hypertension
5220457|NCT02620995|endothelial dysfunction|endothelial dysfunction
5220458|NCT02620995|erectile dysfunction|erectile dysfunction
5220459|NCT02620995|sildenafil|sildenafil
5220460|NCT02620982|Shockwave|shockwave
5220461|NCT02620982|vascular ED|vascular ed
5220462|NCT02620982|Organic ED|organic ed
5220463|NCT02620969|Paediatrics|paediatrics
5220464|NCT02620969|Haemodialysis|haemodialysis
5220465|NCT02620969|Kinetics|kinetics
5220466|NCT02620943|Anemia|anemia
5220467|NCT02620943|Pregnancy Outcome|pregnancy outcome
5220468|NCT02620943|Pregnancy|pregnancy
5220469|NCT02620943|Dietary Diversity|dietary diversity
5220470|NCT02620943|Birth Weight|birth weight
5220471|NCT02620930|Sleep Disorders|sleep disorders
5220472|NCT02620930|Sleep Apnea|sleep apnea
5220473|NCT02620930|Apnea-Hypopnea Index (AHI)|apnea-hypopnea index (ahi)
5220474|NCT02620930|Respiratory Disturbance Index (RDI)|respiratory disturbance index (rdi)
5220475|NCT02620917|type 1 diabetes|type 1 diabetes
5220476|NCT02620917|CSII|csii
5220477|NCT02620904|mifepristone|mifepristone
5220478|NCT02620904|randomized controlled trial|randomized controlled trial
5220479|NCT02620904|vaginal delivery|vaginal delivery
5220480|NCT02620904|progesterone receptor modulator|progesterone receptor modulator
5220481|NCT02620904|induction of labor|induction of labor
5220482|NCT02620891|helium oxygen mixture|helium oxygen mixture
5220483|NCT02620891|Meconium aspiration syndrome|meconium aspiration syndrome
5220484|NCT02620878|Artificial pancreas|artificial pancreas
5220486|NCT02620878|children|children
5220487|NCT02620878|adolescents|adolescents
5220488|NCT02620878|type 1 diabetes|type 1 diabetes
5220489|NCT02620852|Breast screening|breast screening
5220490|NCT02620852|mammography|mammography
5220491|NCT02620852|prevention|prevention
5220492|NCT02620852|risk assessment|risk assessment
5220493|NCT02620852|DCIS|dcis
5220494|NCT02620852|Breast cancer|breast cancer
5220495|NCT02620852|Wisdom|wisdom
5220496|NCT02620839|CDKN2A-p16 Positive|cdkn2a-p16 positive
5220497|NCT02620839|Locally Advanced Solid Neoplasm|locally advanced solid neoplasm
5220498|NCT02620839|Metastatic Malignant Solid Neoplasm|metastatic malignant solid neoplasm
5220499|NCT02620813|acne|acne
5220500|NCT02620813|sebaceous gland|sebaceous gland
5220501|NCT02620813|lipid|lipid
5220502|NCT02620813|sebum|sebum
5220503|NCT02620800|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5220504|NCT02620800|Adenocarcinoma|adenocarcinoma
5220505|NCT02620800|Open-label|open-label
5220506|NCT02620800|Phase 1/2|phase 1/2
5220507|NCT02620800|Metronomic|metronomic
5220508|NCT02620800|Chemotherapy|chemotherapy
5220509|NCT02620800|ABI-007|abi-007
5220510|NCT02620800|nab-paclitaxel|nab-paclitaxel
5220511|NCT02620800|Abraxane|abraxane
5220512|NCT02620800|gemcitabine|gemcitabine
5220513|NCT02620800|Gemzar|gemzar
5220514|NCT02620800|bevacizumab|bevacizumab
5220515|NCT02620800|Avastin|avastin
5220516|NCT02620800|5-Fluorouracil (5-FU)|5-fluorouracil (5-fu)
5220517|NCT02620800|leucovorin|leucovorin
5220518|NCT02620800|oxaliplatin|oxaliplatin
5220519|NCT02620800|Eloxatin|eloxatin
5220520|NCT02620735|Exercise, health coaching, RCT, telehealth,|exercise, health coaching, rct, telehealth,
5220521|NCT02620722|tourniquet|tourniquet
5220522|NCT02620722|safety|safety
5220523|NCT02620722|personalized|personalized
5220524|NCT02620722|surgery|surgery
5220525|NCT02620709|Native Hawaiians|native hawaiians
5220526|NCT02620709|Community-based participatory research|community-based participatory research
5220527|NCT02620709|Health disparities|health disparities
5220528|NCT02620709|Minority populations|minority populations
5220529|NCT02620709|Chronic disease|chronic disease
5220530|NCT02620683|lidocaine, jaw|lidocaine, jaw
5220531|NCT02620670|Physical Activity|physical activity
5220532|NCT02620670|Glycemic Variability|glycemic variability
5220533|NCT02620644|no retinopathy|no retinopathy
5220534|NCT02620631|Morphine|morphine
5220536|NCT02620631|Pain|pain
5220537|NCT02620631|TKR|tkr
5220538|NCT02620631|Arthroplasty|arthroplasty
5220539|NCT02620618|Safety|safety
5220540|NCT02620618|Efficacy|efficacy
5220541|NCT02620618|intravitreal infliximab|intravitreal infliximab
5220542|NCT02620618|ocular behcets|ocular behcets
5220543|NCT02620618|refractory posterior uveitis|refractory posterior uveitis
5220544|NCT02620605|Cabergoline|cabergoline
5220545|NCT02620605|Ovarian Hyper Stimulation Syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
5220546|NCT02620592|Healthy Subject|healthy subject
5220547|NCT02620592|ZYDPLA1|zydpla1
5220548|NCT02620592|DPPIV inhibitor|dppiv inhibitor
5220549|NCT02620592|Pharmacokinetics|pharmacokinetics
5220550|NCT02620592|Safety|safety
5220551|NCT02620579|Personalized Pharmaceutical|personalized pharmaceutical
5220552|NCT02620579|Personalized Education|personalized education
5220553|NCT02620566|caudal block|caudal block
5962680|NCT04279431|Cognitive Evaluation|cognitive evaluation
5220554|NCT02620566|local wound infiltration|local wound infiltration
5220555|NCT02620566|hernia repair|hernia repair
5220556|NCT02620553|Type 1 Diabetes|type 1 diabetes
5220557|NCT02620553|Diabetes|diabetes
5220558|NCT02620553|Autoimmune Diabetes|autoimmune diabetes
5220559|NCT02620540|Broselow Tape|broselow tape
5220560|NCT02620540|Weight estimation|weight estimation
5220561|NCT02620540|Patient safety|patient safety
5220562|NCT02620527|Circulating Tumor DNA|circulating tumor dna
5220563|NCT02620527|Cancer|cancer
5220564|NCT02620527|Neoplasms|neoplasms
5220565|NCT02620527|Genomic Testing|genomic testing
5220566|NCT02620527|FoundationOne|foundationone
5220567|NCT02620527|Cell Free DNA|cell free dna
5220568|NCT02620527|ctDNA|ctdna
5220569|NCT02620527|cfDNA|cfdna
5220570|NCT02620514|Digestive Disease and Disorders|digestive disease and disorders
5220571|NCT02620514|Inflammation|inflammation
5220573|NCT02620501|topical lidocaine|topical lidocaine
5220574|NCT02620501|recovery time|recovery time
5220575|NCT02620501|intravenous sedation|intravenous sedation
5220576|NCT02620488|Pain Perception|pain perception
5220577|NCT02620488|Autonomic Nervous System|autonomic nervous system
5220578|NCT02620488|Sickle Cell Disease|sickle cell disease
5220579|NCT02620488|Hypnosis|hypnosis
5220580|NCT02620488|Guided Imagery|guided imagery
5220581|NCT02620462|Postural Balance|postural balance
5220582|NCT02620462|Pain|pain
5220583|NCT02620462|Gait|gait
5220584|NCT02620462|Physical Activity Level|physical activity level
5220585|NCT02620449|phosphorus|phosphorus
5220586|NCT02620449|fibroblast growth factor 23|fibroblast growth factor 23
5220587|NCT02620449|diet|diet
5226817|NCT02581839|CNS|cns
5220588|NCT02620436|Maternal & Child Health|maternal & child health
5220589|NCT02620436|Mother Shelters|mother shelters
5220590|NCT02620436|Maternity Waiting Homes|maternity waiting homes
5220591|NCT02620423|Pancreatic|pancreatic
5220592|NCT02620423|Cancer|cancer
5220593|NCT02620423|REOLYSIN®|reolysin®
5220594|NCT02620423|Chemotherapy|chemotherapy
5220595|NCT02620423|Pembrolizumab|pembrolizumab
5220596|NCT02620423|KEYTRUDA®|keytruda®
5220597|NCT02620423|Pelareorep|pelareorep
5220598|NCT02620423|Reovirus|reovirus
5220599|NCT02620423|Oncolytic virus|oncolytic virus
5220600|NCT02620410|OAB|oab
5220601|NCT02620384|Metolazone|metolazone
5220602|NCT02620384|Heart Failure|heart failure
5220603|NCT02620358|Mechanical Ventilation|mechanical ventilation
5220604|NCT02620358|Weaning|weaning
5220605|NCT02620345|Fibroids|fibroids
5220606|NCT02620319|bronchoscopy|bronchoscopy
5220607|NCT02620319|polydioxanone|polydioxanone
5220608|NCT02620319|absorbable implants|absorbable implants
5220609|NCT02620319|stents|stents
5220610|NCT02620280|Triple Negative Breast Cancer|triple negative breast cancer
5220611|NCT02620267|Mismatch Negativity|mismatch negativity
5220612|NCT02620267|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5220613|NCT02620267|MMN|mmn
5220614|NCT02620267|tDCS|tdcs
5220615|NCT02620254|mastocytosis|mastocytosis
5220616|NCT02620254|cutaneous mastocytosis|cutaneous mastocytosis
5220617|NCT02620254|urticaria pigmentosa|urticaria pigmentosa
5220618|NCT02620254|telangiectasia macularis eruptiva perstans (TMEP)|telangiectasia macularis eruptiva perstans (tmep)
5222112|NCT02610270|fatty acid|fatty acid
5220619|NCT02620254|diffuse cutaneous mastocytosis|diffuse cutaneous mastocytosis
5220620|NCT02620254|solitary cutaneous mastocytosis|solitary cutaneous mastocytosis
5220621|NCT02620254|systemic mastocytosis|systemic mastocytosis
5220622|NCT02620254|indolent systemic mastocytosis|indolent systemic mastocytosis
5220623|NCT02620254|smoldering systemic mastocytosis|smoldering systemic mastocytosis
5220624|NCT02620254|aggressive systemic mastocytosis|aggressive systemic mastocytosis
5220625|NCT02620254|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease|systemic mastocytosis with associated clonal hematologic non-mast cell lineage disease
5220626|NCT02620254|mast cell leukemia|mast cell leukemia
5220627|NCT02620241|gastro-oesophageal reflux|gastro-oesophageal reflux
5220628|NCT02620241|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
5220629|NCT02620241|positioning|positioning
5220630|NCT02620228|Bioimpedance|bioimpedance
5220631|NCT02620228|Biopsy|biopsy
5220632|NCT02620228|Liver tumour|liver tumour
5220633|NCT02620228|Biopsy needle guidance|biopsy needle guidance
5220634|NCT02620202|Troponin|troponin
5220635|NCT02620202|Myocardial infarction|myocardial infarction
5220636|NCT02620150|HIV|hiv
5220637|NCT02620150|AIDS|aids
5220638|NCT02620150|Depression|depression
5220639|NCT02620150|SSRI|ssri
5220640|NCT02620150|Escitalopram|escitalopram
5220641|NCT02620150|Immunity|immunity
5220642|NCT02620085|Graves' disease|graves' disease
5220643|NCT02620085|Hyperthyroidism|hyperthyroidism
5220644|NCT02620085|Personality traits|personality traits
5220645|NCT02620072|Type 1 diabetes|type 1 diabetes
5220646|NCT02620072|T1D|t1d
5220647|NCT02620072|diabetes mellitus|diabetes mellitus
5220648|NCT02620072|oral insulin|oral insulin
5220649|NCT02620072|oral tolerance|oral tolerance
5220650|NCT02620072|autoantigen|autoantigen
5220651|NCT02620072|self tolerance|self tolerance
5220652|NCT02620072|prevention|prevention
5220653|NCT02620072|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
5220654|NCT02620072|juvenile diabetes|juvenile diabetes
5220655|NCT02620072|dysglycemia|dysglycemia
5220656|NCT02620059|Postpartum Period|postpartum period
5220657|NCT02620046|Drug therapy|drug therapy
5220658|NCT02620033|Prostatectomy|prostatectomy
5220659|NCT02620033|Yoga therapy|yoga therapy
5220660|NCT02620033|Health related quality of life|health related quality of life
5220661|NCT02620007|Adult|adult
5220662|NCT02620007|AIEC|aiec
5220663|NCT02619994|Multidrug-resistant tuberculosis|multidrug-resistant tuberculosis
5220664|NCT02619994|Linezolid|linezolid
5220665|NCT02619994|Delamanid|delamanid
5220666|NCT02619994|Multicenter randomized trial|multicenter randomized trial
5220667|NCT02619994|Non-inferiority|non-inferiority
5220668|NCT02619994|Shorter regimen|shorter regimen
5220669|NCT02619968|Chronic renal failure|chronic renal failure
5220670|NCT02619968|Arteriovenous fistula|arteriovenous fistula
5220671|NCT02619968|Isometric exercises|isometric exercises
5220672|NCT02619968|Vascular endothelium|vascular endothelium
5220673|NCT02619955|hepcidin deficiency|hepcidin deficiency
5220674|NCT02619955|genetic|genetic
5220675|NCT02619955|except C282Y Homozygosity|except c282y homozygosity
5220676|NCT02619942|Right colon cancer, Survival, Laparoscopic surgery|right colon cancer, survival, laparoscopic surgery
5220677|NCT02619929|Oral Vinorelbine|oral vinorelbine
5220678|NCT02619929|Advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
5113512|NCT03287466|oxygen saturation|oxygen saturation
5220679|NCT02619929|Metastatic Breast Cancer|metastatic breast cancer
5220680|NCT02619916|Cancer|cancer
5220681|NCT02619916|Depression|depression
5220682|NCT02619916|MBCT|mbct
5220683|NCT02619916|CBT|cbt
5220684|NCT02619890|Adult Glioma|adult glioma
5220685|NCT02619890|MRI|mri
5220686|NCT02619838|Double Arthrodesis|double arthrodesis
5220687|NCT02619838|Triple Arthrodesis|triple arthrodesis
5220688|NCT02619838|Subtalar Arthrodesis|subtalar arthrodesis
5220689|NCT02619825|Child|child
5220690|NCT02619799|magnesium sulphate|magnesium sulphate
5220691|NCT02619799|intrathecal route|intrathecal route
5220692|NCT02619799|midazolam|midazolam
5220693|NCT02619773|Colorectal Surgery|colorectal surgery
5220694|NCT02619760|Percutaneous Coronary Intervention|percutaneous coronary intervention
5220695|NCT02619760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5220696|NCT02619747|pH monitoring|ph monitoring
5220697|NCT02619734|Cell Therapy|cell therapy
5220698|NCT02619734|Sickle cell disease|sickle cell disease
5220699|NCT02619734|Autologous implantation|autologous implantation
5220700|NCT02619734|Mesenchymal stromal cell|mesenchymal stromal cell
5220701|NCT02619734|Edothelial Progenitor cell|edothelial progenitor cell
5220702|NCT02619721|PINS SNS OAB|pins sns oab
5220703|NCT02619708|immersive preoperative experience|immersive preoperative experience
5220704|NCT02619695|ketoprofen|ketoprofen
5220705|NCT02619695|gel|gel
5220706|NCT02619695|low back pain|low back pain
5220707|NCT02619695|emergency department|emergency department
5220708|NCT02619669|Neoadjuvant|neoadjuvant
5220709|NCT02619669|TAK-228 (MLN0128)|tak-228 (mln0128)
5220710|NCT02619669|Letrozole|letrozole
5220711|NCT02619669|ER+|er+
5220712|NCT02619669|HER2-|her2-
5220713|NCT02619656|PEG|peg
5220714|NCT02619656|CO2 insufflation|co2 insufflation
5220715|NCT02619656|Room Air insufflation|room air insufflation
5220716|NCT02619656|pneumoperitoneum|pneumoperitoneum
5220717|NCT02619617|Cluster Headache|cluster headache
5220718|NCT02619617|Patient Diary collection of headache pain|patient diary collection of headache pain
5220719|NCT02619578|Transcutaneous electric acupoint stimulation (TEAS)|transcutaneous electric acupoint stimulation (teas)
5220720|NCT02619578|gynecological laparoscopic surgery|gynecological laparoscopic surgery
5220721|NCT02619578|QoQ-40|qoq-40
5220722|NCT02619578|MMSE|mmse
5220723|NCT02619578|VAS|vas
5220724|NCT02619565|Myelodysplastic syndromes|myelodysplastic syndromes
5220725|NCT02619565|mutations|mutations
5220726|NCT02619565|overall survival|overall survival
5220727|NCT02619565|prognosis|prognosis
5220728|NCT02619513|Paravertebral Blocks|paravertebral blocks
5220729|NCT02619513|Dexmedetomidine|dexmedetomidine
5220730|NCT02619513|Analgesia|analgesia
5220731|NCT02619513|Inflammatory response|inflammatory response
5220732|NCT02619513|Thoracotomy|thoracotomy
5220733|NCT02619474|Parent Satisfaction|parent satisfaction
5220734|NCT02619474|Patient Satisfaction|patient satisfaction
5220735|NCT02619474|Whiteboard|whiteboard
5220736|NCT02619474|Communication|communication
5220737|NCT02619448|inoperable|inoperable
5220738|NCT02619448|Solitary [T1bN0, T2aN0, T2bN0] lesion measuring 2-7 cm|solitary [t1bn0, t2an0, t2bn0] lesion measuring 2-7 cm
5220739|NCT02619435|RAS-mutant|ras-mutant
5220740|NCT02619422|Cardiac rehabilitation programs|cardiac rehabilitation programs
5220741|NCT02619422|Adherence to secondary preventive measures|adherence to secondary preventive measures
5220742|NCT02619422|Acute coronary syndrome|acute coronary syndrome
5220743|NCT02619422|More intensive cardiac rehabilitation program in less time|more intensive cardiac rehabilitation program in less time
5220744|NCT02619396|radiofrequency power|radiofrequency power
5099035|NCT03379194|resistance|resistance
5220745|NCT02619396|lesion size index|lesion size index
5220746|NCT02619396|esophageal temperature alerts|esophageal temperature alerts
5220747|NCT02619383|HBOT|hbot
5220748|NCT02619383|hyperbaric oxygen|hyperbaric oxygen
5220749|NCT02619383|DCE|dce
5220750|NCT02619383|ED|ed
5220751|NCT02619383|erectile dysfunction|erectile dysfunction
5220752|NCT02619370|advance care planning|advance care planning
5220753|NCT02619370|advance directive|advance directive
5220754|NCT02619370|caregiving|caregiving
5220755|NCT02619357|Asthma|asthma
5220756|NCT02619357|wearable physical activity monitor|wearable physical activity monitor
5220757|NCT02619357|step counts|step counts
5220758|NCT02619357|Exercise|exercise
5220759|NCT02619357|energy expenditure|energy expenditure
5220760|NCT02619357|COPD|copd
5113613|NCT03286933|JIA|jia
5220761|NCT02619357|indirect calorimetry|indirect calorimetry
5220762|NCT02619318|Balancing Everyday Life (BEL)|balancing everyday life (bel)
5220763|NCT02619318|activity-based lifestyle intervention|activity-based lifestyle intervention
5220764|NCT02619318|standard occupational therapy|standard occupational therapy
5220765|NCT02619292|cancer survivor|cancer survivor
5220766|NCT02619292|immune function|immune function
5220767|NCT02619266|Cancer Anorexia Cachexia Syndrome|cancer anorexia cachexia syndrome
5220768|NCT02619266|Acupuncture|acupuncture
5220769|NCT02619266|Megestrol acetate|megestrol acetate
5220770|NCT02619266|Poor Appetite|poor appetite
5220771|NCT02619266|Anorexia|anorexia
5220772|NCT02619266|Randomized Controlled Trial|randomized controlled trial
5220773|NCT02619253|Immunotherapy|immunotherapy
5220774|NCT02619253|Safety|safety
5220775|NCT02619253|Pharmacodynamics|pharmacodynamics
5220776|NCT02619253|Efficacy|efficacy
5220777|NCT02619214|Oxidative Stress|oxidative stress
5220778|NCT02619214|Oxygen|oxygen
5220779|NCT02619214|General Anesthesia|general anesthesia
5220780|NCT02619201|vomiting in children|vomiting in children
5220781|NCT02619201|ondansetron|ondansetron
5220782|NCT02619201|metoclopramide|metoclopramide
5220783|NCT02619201|antiemetics|antiemetics
5220784|NCT02619188|Nutrition|nutrition
5220785|NCT02619188|Hyperemesis gravidarum|hyperemesis gravidarum
5220786|NCT02619188|Prealbumin|prealbumin
5220787|NCT02619188|Questionnaire|questionnaire
5220788|NCT02619162|breast cancer non metastatic|breast cancer non metastatic
5220789|NCT02619162|adjuvant letrozole|adjuvant letrozole
5220790|NCT02619162|Nintedanib BIFF1120|nintedanib biff1120
5220791|NCT02619136|Blood Transfusion|blood transfusion
5220792|NCT02619123|breast density|breast density
5220793|NCT02619123|breast cancer|breast cancer
5220794|NCT02619123|risk-based screening|risk-based screening
5220795|NCT02619123|Tailored breast cancer screening|tailored breast cancer screening
5220796|NCT02619123|premenopausal women|premenopausal women
5220797|NCT02619110|Chronic Stroke|chronic stroke
5220798|NCT02619110|cardiopulmonary|cardiopulmonary
5220799|NCT02619110|Berg Balance Scale (BBS)|berg balance scale (bbs)
5220800|NCT02619084|Tourette Syndrome|tourette syndrome
5220801|NCT02619084|Subthalamic Nucleus|subthalamic nucleus
5220802|NCT02619084|STN|stn
5220803|NCT02619084|Deep Brain Stimulation|deep brain stimulation
5220804|NCT02619084|DBS|dbs
5220805|NCT02619084|Tic|tic
5220806|NCT02619084|Obsessive-compulsive disorders|obsessive-compulsive disorders
5220807|NCT02619071|acute myeloid leukemia- refractory AML- relapsed AML- precision medecine-|acute myeloid leukemia- refractory aml- relapsed aml- precision medecine-
5220808|NCT02619058|NKT|nkt
5220809|NCT02619058|metastatic melanoma|metastatic melanoma
5220810|NCT02619032|remifentanil|remifentanil
5220811|NCT02619032|fentanyl|fentanyl
5220812|NCT02619032|dental surgery|dental surgery
5220813|NCT02619006|Anemia, Iron-Deficiency|anemia, iron-deficiency
5220814|NCT02619006|Myelination|myelination
5220815|NCT02619006|Ferritin|ferritin
5220816|NCT02619006|Umbilical cord clamping|umbilical cord clamping
5220817|NCT02619006|Umbilical Cord Milking|umbilical cord milking
5220818|NCT02619006|Placental Transfusion|placental transfusion
5220819|NCT02619006|Brain Development|brain development
5220820|NCT02618993|mandibular nerve block|mandibular nerve block
5220821|NCT02618993|mandibular osteotomy|mandibular osteotomy
5220822|NCT02618980|acute coronary syndrome|acute coronary syndrome
5220823|NCT02618980|gastrointestinal bleeding|gastrointestinal bleeding
5220824|NCT02618980|endoscopy|endoscopy
5220825|NCT02618967|Lupus|lupus
5220826|NCT02618967|Healthy Volunteer|healthy volunteer
5220827|NCT02618967|Safety Study|safety study
5220828|NCT02618967|Placebo Control|placebo control
5220829|NCT02618967|Phase 1|phase 1
5220830|NCT02618954|Rheumatoid arthritis|rheumatoid arthritis
5220831|NCT02618954|Articular ultrasound|articular ultrasound
5220832|NCT02618954|Synovitis|synovitis
5220833|NCT02618954|Relapse risk|relapse risk
5220835|NCT02618928|Chronic Hepatitis C|chronic hepatitis c
5220836|NCT02618915|gene therapy|gene therapy
5220837|NCT02618915|Hemophilia B|hemophilia b
5220838|NCT02618902|patient safety|patient safety
5220839|NCT02618902|tolerogenic dendritic cells|tolerogenic dendritic cells
5220840|NCT02618902|tolDC|toldc
5962681|NCT04279431|Concussion Symptom Inventory|concussion symptom inventory
5220841|NCT02618850|metabolic response|metabolic response
5962682|NCT04279431|mTBI|mtbi
5220842|NCT02618850|chemotherapy|chemotherapy
5220843|NCT02618850|PET|pet
5220844|NCT02618837|NSTEMI|nstemi
5220845|NCT02618837|NSTEACS|nsteacs
5220846|NCT02618837|prasugrel|prasugrel
5220847|NCT02618837|ticagrelor|ticagrelor
5220848|NCT02618837|Downstream versus Upstream strategy|downstream versus upstream strategy
5220849|NCT02618811|sarcopenia|sarcopenia
5220850|NCT02618811|myosteatosis|myosteatosis
5220851|NCT02618811|enhanced recovery after surgery|enhanced recovery after surgery
5220852|NCT02618811|colorectal cancer|colorectal cancer
5220853|NCT02618811|minimally invasive surgery|minimally invasive surgery
5220854|NCT02618811|complications|complications
5220855|NCT02618798|chronic liver disease|chronic liver disease
5220856|NCT02618798|CLD|cld
5220857|NCT02618798|platelet function|platelet function
5220858|NCT02618785|Hysterosalpingography|hysterosalpingography
5220859|NCT02618785|antispasmodic drug|antispasmodic drug
5220860|NCT02618785|infertile women|infertile women
5220861|NCT02618772|Pediatrics|pediatrics
5220862|NCT02618772|Laceration|laceration
5220863|NCT02618772|Anxiety|anxiety
5220864|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents
5220865|NCT02618746|Telemonitoring|telemonitoring
5220866|NCT02618746|Home Rehabilitation|home rehabilitation
5220867|NCT02618746|Exacerbations|exacerbations
5220868|NCT02618746|Physical Activity|physical activity
5220869|NCT02618746|COPD|copd
5220870|NCT02618720|Antimicrobial prophylaxis|antimicrobial prophylaxis
5220871|NCT02618720|Colorectal surgery|colorectal surgery
5220872|NCT02618720|Surgical Site Infection|surgical site infection
5220873|NCT02618720|Postoperative morbidity|postoperative morbidity
5220874|NCT02618707|Lactate|lactate
5220875|NCT02618707|Congenital cardiac defect|congenital cardiac defect
5220876|NCT02618707|CPB|cpb
5220877|NCT02618707|Pediatric|pediatric
5220878|NCT02618694|adrenal|adrenal
5220879|NCT02618694|supra-renal|supra-renal
5220880|NCT02618694|adrenalectomy|adrenalectomy
5220881|NCT02618694|retroperitoneoscopy|retroperitoneoscopy
5220882|NCT02618694|posterior retroperitoneoscopy|posterior retroperitoneoscopy
5220883|NCT02618694|Laparoscopic adrenalectomy|laparoscopic adrenalectomy
5220884|NCT02618681|earlobe crease|earlobe crease
5220885|NCT02618681|acute myocardial infarction|acute myocardial infarction
5220886|NCT02618655|TBDs；diagnosis|tbds；diagnosis
5220887|NCT02618642|electrodiagnostics|electrodiagnostics
5220888|NCT02618642|i/t curve|i/t curve
5220889|NCT02618642|neuromuscular excitation|neuromuscular excitation
5220890|NCT02618642|PILER (Polychromatic Incoherent Low-Energy Radiation)|piler (polychromatic incoherent low-energy radiation)
5220891|NCT02618642|algometry|algometry
5220892|NCT02618603|Stroke|stroke
5220893|NCT02618603|Should pain|should pain
5220894|NCT02618603|Botulinum Toxin|botulinum toxin
5220895|NCT02618590|non-small cell lung cancer|non-small cell lung cancer
5220896|NCT02618590|EGFR mutant type|egfr mutant type
5220897|NCT02618590|first/second line EGFR-TKI|first/second line egfr-tki
5220898|NCT02618577|Anticoagulation|anticoagulation
5220899|NCT02618577|atrial high rate episodes|atrial high rate episodes
5220900|NCT02618577|Atrial Fibrillation|atrial fibrillation
5220901|NCT02618577|VKA|vka
5220902|NCT02618577|NOAC|noac
5220903|NCT02618551|Thermoplasty|thermoplasty
5220904|NCT02618551|Severe asthma|severe asthma
5220905|NCT02618551|Dynamic hyperinflation|dynamic hyperinflation
5220906|NCT02618499|birth|birth
5220907|NCT02618499|oxytocin|oxytocin
5220908|NCT02618499|placental transfusion|placental transfusion
5220913|NCT02618473|diagnostic utility|diagnostic utility
5220914|NCT02618460|Non-contrast enhanced MRI|non-contrast enhanced mri
5220920|NCT02618304|Meibomian gland dysfunction|meibomian gland dysfunction
5220921|NCT02618304|Lipiview|lipiview
5220922|NCT02618304|Tear Lipid Layer|tear lipid layer
5220923|NCT02618291|primary health care|primary health care
5220924|NCT02618265|stroke|stroke
5220925|NCT02618265|secondary prevention|secondary prevention
5220926|NCT02618265|platelet response polymorphism|platelet response polymorphism
5220927|NCT02618265|mobile terminal|mobile terminal
5220928|NCT02618252|difficult IV access|difficult iv access
5220929|NCT02618252|ultrasound|ultrasound
5220930|NCT02618252|veinviewer|veinviewer
5220931|NCT02618252|near infrared device|near infrared device
5220932|NCT02618239|intestinal gas|intestinal gas
5220933|NCT02618239|Healthy subjects|healthy subjects
5220934|NCT02618239|microbiota|microbiota
5220935|NCT02618239|prebiotics|prebiotics
5220936|NCT02618226|Traumatic Brain Injury|traumatic brain injury
5220937|NCT02618226|TBI|tbi
5220938|NCT02618226|Optic nerve ultrasound|optic nerve ultrasound
5220939|NCT02618226|ONUS|onus
5220941|NCT02618226|ICP|icp
5220942|NCT02618226|Intracranial hypertension|intracranial hypertension
5220943|NCT02618213|Continuous Positive Airway Pressure|continuous positive airway pressure
5220944|NCT02618213|High Flow Oxygenation therapy|high flow oxygenation therapy
5220945|NCT02618213|Bronchiolitis|bronchiolitis
5220946|NCT02618213|Children|children
5220947|NCT02618200|Prostate cancer|prostate cancer
5220948|NCT02618200|Computer-Aided Diagnosis|computer-aided diagnosis
5220949|NCT02618161|EBRT and HDR Brachytherapy|ebrt and hdr brachytherapy
5220950|NCT02618109|B acute lymphoblastic leukemia|b acute lymphoblastic leukemia
5220951|NCT02618109|leukemia relapse|leukemia relapse
5220952|NCT02618109|pediatric onco-hematology|pediatric onco-hematology
5220953|NCT02618096|membrane sweeping|membrane sweeping
5220954|NCT02618096|dinoprostone|dinoprostone
5220955|NCT02618096|multiparas|multiparas
5220956|NCT02618096|labor induction|labor induction
5220957|NCT02618096|cesarean delivery|cesarean delivery
5220958|NCT02618044|Gastroesophageal reflux|gastroesophageal reflux
5220959|NCT02618044|Obesity|obesity
5220960|NCT02618044|Esophageal manometry|esophageal manometry
5220961|NCT02618044|24 H impedance pH-monitoring|24 h impedance ph-monitoring
5220962|NCT02618044|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
5220963|NCT02618031|capillary index score|capillary index score
5220964|NCT02618031|acute ischemic stroke|acute ischemic stroke
5220965|NCT02618031|collateral circulation|collateral circulation
5220966|NCT02618031|cerebral ischemia|cerebral ischemia
5220967|NCT02618031|diagnostic imaging|diagnostic imaging
5220968|NCT02618018|astigmatism|astigmatism
5220969|NCT02618018|toric intraocular lens|toric intraocular lens
5220970|NCT02618005|Astronauts|astronauts
5220971|NCT02618005|Probiotics|probiotics
5220972|NCT02618005|Immune function|immune function
5220973|NCT02618005|Intestinal microbiota|intestinal microbiota
5220979|NCT02617953|Tinnitus|tinnitus
5220980|NCT02617953|EEG|eeg
5220981|NCT02617953|ERP|erp
5220982|NCT02617940|dental caries|dental caries
5220983|NCT02617940|primary tooth|primary tooth
5220984|NCT02617940|resin-based sealants|resin-based sealants
5220985|NCT02617914|ARDS|ards
5220987|NCT02617914|ECMO|ecmo
5220988|NCT02617901|Bone age|bone age
5220989|NCT02617901|Greulich & Pyle|greulich & pyle
5220990|NCT02617901|TW3|tw3
5220991|NCT02617901|Radiography|radiography
5220992|NCT02617901|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5220993|NCT02617888|radiation|radiation
5220994|NCT02617888|cardiac computed tomography|cardiac computed tomography
5220995|NCT02617888|CCTA|ccta
5220996|NCT02617888|breast shielding|breast shielding
5220997|NCT02617888|Myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
5220998|NCT02617888|MPS|mps
5220999|NCT02617888|Invasive coronary angiography|invasive coronary angiography
5221000|NCT02617888|ICA|ica
5221006|NCT02617862|Diagnostic imaging|diagnostic imaging
5221007|NCT02617862|Retina|retina
5221008|NCT02617862|Pediatrics|pediatrics
5221009|NCT02617810|Healthy|healthy
5221010|NCT02617810|JNJ-42847922|jnj-42847922
5221011|NCT02617810|Midazolam|midazolam
5221012|NCT02617810|Warfarin|warfarin
5221013|NCT02617810|Pharmacokinetics|pharmacokinetics
5221014|NCT02617797|Urinary Stress Incontinence|urinary stress incontinence
5221015|NCT02617797|Radiofrequency|radiofrequency
5221016|NCT02617797|Women|women
5221017|NCT02617758|Healthy|healthy
5209037|NCT02689284|gastroesophageal junction cancer|gastroesophageal junction cancer
5209039|NCT02689284|PD-L1|pd-l1
5209040|NCT02689284|PD-1|pd-1
5209041|NCT02689284|PD|pd
5209042|NCT02689284|Tumor|tumor
5209043|NCT02689284|Cancer|cancer
5209044|NCT02689271|MRI|mri
5209045|NCT02689271|Magnetic resonance imaging|magnetic resonance imaging
5209046|NCT02689271|Biomarkers|biomarkers
5209047|NCT02689271|Fluidics|fluidics
5209048|NCT02689271|Diffusion MRI|diffusion mri
5209049|NCT02689219|Antigens, CD30, Embryonal Germ Cell Tumors|antigens, cd30, embryonal germ cell tumors
5209060|NCT02689180|heart failure|heart failure
5209061|NCT02689180|diuretics|diuretics
5209062|NCT02689180|furosemide|furosemide
5221018|NCT02617758|Bioequivalence Study|bioequivalence study
5221019|NCT02617758|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
5221020|NCT02617758|DURAGESIC|duragesic
5221021|NCT02617745|Stupp protocol, glioblastoma, thrombocytopenia|stupp protocol, glioblastoma, thrombocytopenia
5221022|NCT02617732|glucose variability|glucose variability
5221023|NCT02617732|continuous glucose mornitoring system|continuous glucose mornitoring system
5221024|NCT02617732|traditional Chinese medicine|traditional chinese medicine
5221025|NCT02617706|Anorectal surgeries|anorectal surgeries
5221026|NCT02617706|infection|infection
5221027|NCT02617706|topical oxygen|topical oxygen
5221028|NCT02617680|Desflurane|desflurane
5221029|NCT02617680|end tidal concentration|end tidal concentration
5221030|NCT02617680|age|age
5221031|NCT02617680|anesthesia|anesthesia
5221032|NCT02617641|Secondary Prevention|secondary prevention
5221033|NCT02617641|Walking|walking
5221034|NCT02617641|Health Behavior|health behavior
5221035|NCT02617641|Internet|internet
5221036|NCT02617641|eHealth|ehealth
5221037|NCT02617641|Computer-Assisted Instruction|computer-assisted instruction
5221038|NCT02617641|Multicenter Study|multicenter study
5221039|NCT02617641|Randomized Controlled Trial|randomized controlled trial
5221040|NCT02617641|Intervention Studies|intervention studies
5221041|NCT02617641|Motivation|motivation
5221042|NCT02617641|Self Efficacy|self efficacy
5221043|NCT02617641|Theory, Nursing|theory, nursing
5221044|NCT02617641|Theory, Psychological|theory, psychological
5221045|NCT02617641|Nursing Research|nursing research
5221046|NCT02617628|opioid addiction|opioid addiction
5221047|NCT02617615|MB-110|mb-110
5221048|NCT02617602|Congenital heart defect|congenital heart defect
5099390|NCT03376971|Biopsy|biopsy
5221049|NCT02617602|Cardiopulmonary bypass|cardiopulmonary bypass
5221050|NCT02617602|Goal directed therapy|goal directed therapy
5221051|NCT02617602|Acute heart failure|acute heart failure
5221052|NCT02617563|spondylolisthesis|spondylolisthesis
5221053|NCT02617563|CD Horizon® Spinal Systems|cd horizon® spinal systems
5221054|NCT02617563|minimal invasive|minimal invasive
5221055|NCT02617563|Spinal Fusion|spinal fusion
5221056|NCT02617563|MAST procedure|mast procedure
5221057|NCT02617563|Lumbar fusion|lumbar fusion
5221058|NCT02617524|dedicated sheath|dedicated sheath
5221059|NCT02617498|living donor liver transplantation|living donor liver transplantation
5221060|NCT02617459|Safety|safety
5221061|NCT02617459|efficacy|efficacy
5221062|NCT02617459|Levobetaxolol eye drops|levobetaxolol eye drops
5221063|NCT02617459|Chinese patients|chinese patients
5221064|NCT02617446|safety|safety
5221065|NCT02617446|efficacy|efficacy
5221066|NCT02617446|istaroxime|istaroxime
5221067|NCT02617407|Dental Plaque|dental plaque
5221068|NCT02617407|Gingivitis|gingivitis
5221069|NCT02617407|Bacterial Infection|bacterial infection
5221070|NCT02617407|Oral Hygiene|oral hygiene
5221071|NCT02617407|HSCT|hsct
5221072|NCT02617407|Oral Microbiome|oral microbiome
5221073|NCT02617407|Gut Microbiome|gut microbiome
5221074|NCT02617407|Blood Microbiome|blood microbiome
5221075|NCT02617368|Keratoconus, Corneal crosslinking, Fourier Analysis of Topographic Data|keratoconus, corneal crosslinking, fourier analysis of topographic data
5221076|NCT02617342|Intervention|intervention
5221324|NCT02615470|Pneumococcal Vaccines|pneumococcal vaccines
5221077|NCT02617342|Autism Spectrum Disorder|autism spectrum disorder
5221078|NCT02617342|Social Skills|social skills
5221079|NCT02617329|Extracorporeal shock wave therapy (ESWT), Neck Pain|extracorporeal shock wave therapy (eswt), neck pain
5221080|NCT02617316|running speeds, strike patterns|running speeds, strike patterns
5221081|NCT02617303|elderly|elderly
5221082|NCT02617303|accidental falls|accidental falls
5221083|NCT02617303|osteoporosis|osteoporosis
5221084|NCT02617303|fractures|fractures
5221085|NCT02617303|Primary Care|primary care
5209140|NCT02688647|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
5209141|NCT02688647|Lung Diseases|lung diseases
5221086|NCT02617303|Randomized clinical trial|randomized clinical trial
5221087|NCT02617303|Otago exercise programme|otago exercise programme
5227293|NCT02579408|CAP|cap
5221088|NCT02617290|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5221089|NCT02617290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5221090|NCT02617277|AZD1775|azd1775
5221091|NCT02617277|MEDI4736|medi4736
5221092|NCT02617277|AZD1775 + MEDI4736|azd1775 + medi4736
5221093|NCT02617277|Advanced Solid Tumours|advanced solid tumours
5221094|NCT02617277|Adavosertib|adavosertib
5221095|NCT02617277|Durvalumab|durvalumab
5221096|NCT02617238|arterial stiffness|arterial stiffness
5221097|NCT02617238|cardiovascular risk|cardiovascular risk
5221098|NCT02617238|cardiovascular events|cardiovascular events
5221099|NCT02617238|renal events|renal events
5221100|NCT02617212|dental implant|dental implant
5221101|NCT02617212|bone preservation|bone preservation
5221102|NCT02617212|definitive abutment|definitive abutment
5221103|NCT02617212|one abutment one time|one abutment one time
5221104|NCT02617199|epidural anesthesia|epidural anesthesia
5221105|NCT02617199|pain management|pain management
5221106|NCT02617199|microcirculation|microcirculation
5221107|NCT02617160|Insulin Pump Treatment|insulin pump treatment
5221108|NCT02617160|Type 1 Diabetes|type 1 diabetes
5221109|NCT02617160|Insulin Pump Setting|insulin pump setting
5221113|NCT02617108|Foley balloon|foley balloon
5221114|NCT02617082|breast cancer|breast cancer
5221115|NCT02617082|partial breast irradiation|partial breast irradiation
5221116|NCT02617082|DCIS|dcis
5221117|NCT02617069|Atrial fibrillation|atrial fibrillation
5221118|NCT02617069|botulinum toxin|botulinum toxin
5221119|NCT02617056|electrodermal response|electrodermal response
5221120|NCT02617043|breast cancer|breast cancer
5221121|NCT02617043|hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
5221122|NCT02617017|Parkinson disease|parkinson disease
5221123|NCT02617017|Levodopa induce dyskinesia|levodopa induce dyskinesia
5221124|NCT02616952|Stress urinary incontinence|stress urinary incontinence
5221125|NCT02616952|Chinese Herb|chinese herb
5221126|NCT02616952|Traditional Chinese medicine|traditional chinese medicine
5221127|NCT02616952|Pelvic floor muscle training|pelvic floor muscle training
5221128|NCT02616939|Multidetector computed tomography|multidetector computed tomography
5221129|NCT02616926|hepatocellular carcinoma|hepatocellular carcinoma
5221130|NCT02616926|hepatectomy|hepatectomy
5221131|NCT02616926|transarterial chemoembolization|transarterial chemoembolization
5221132|NCT02616926|radiofrequency ablation|radiofrequency ablation
5221133|NCT02616874|HIV infection|hiv infection
5221134|NCT02616874|Early treatment|early treatment
5221135|NCT02616874|Romidepsin|romidepsin
5221136|NCT02616874|HDACi|hdaci
5221137|NCT02616874|Therapeutic Vaccines|therapeutic vaccines
5221138|NCT02616874|HIVconsv|hivconsv
5221139|NCT02616874|HIV reservoir|hiv reservoir
5962683|NCT04279418|Subjective cognitive decline|subjective cognitive decline
5221140|NCT02616874|Population PK/PD analysis|population pk/pd analysis
5221141|NCT02616848|Everolimus|everolimus
5221142|NCT02616848|eribulin|eribulin
5221143|NCT02616822|hypertension|hypertension
5221144|NCT02616822|endothelium|endothelium
5221145|NCT02616822|resveratrol|resveratrol
5221146|NCT02616822|clinical trials|clinical trials
5221147|NCT02616783|HIV 1 Infection|hiv 1 infection
5221148|NCT02616783|HIV|hiv
5221149|NCT02616783|Virologically-Suppressed|virologically-suppressed
5221150|NCT02616744|aromatase inhibitors|aromatase inhibitors
5221151|NCT02616744|breast cancer|breast cancer
5221152|NCT02616744|bone mineral density|bone mineral density
5221153|NCT02616692|HCC|hcc
5221154|NCT02616692|Patient preferences|patient preferences
5221155|NCT02616666|Type 2 diabetes mellitus|type 2 diabetes mellitus
5221156|NCT02616666|Randomised|randomised
5221157|NCT02616666|Pragmatic|pragmatic
5221158|NCT02616666|Standard of Care|standard of care
5221159|NCT02616666|Dapagliflozin|dapagliflozin
5221160|NCT02616666|FORXIGA|forxiga
5221161|NCT02616640|Multiple Myeloma|multiple myeloma
5221162|NCT02616640|Relapsed|relapsed
5221163|NCT02616640|Refractory|refractory
5221164|NCT02616640|MEDI4736|medi4736
5221165|NCT02616640|Durvalumab|durvalumab
5221166|NCT02616640|Pomalidomide (POM)|pomalidomide (pom)
5221167|NCT02616640|Dexamethasone (DEX)|dexamethasone (dex)
5221168|NCT02616640|PD-L1|pd-l1
5221169|NCT02616627|bone mineral density|bone mineral density
5221170|NCT02616627|chronic dialysis|chronic dialysis
5221171|NCT02616627|end-stage renal disease|end-stage renal disease
5221172|NCT02616627|body composition analysis|body composition analysis
5221173|NCT02616627|sarcopenia|sarcopenia
5221174|NCT02616588|advanced stage cancer,|advanced stage cancer,
5221175|NCT02616588|patient navigator,|patient navigator,
5221176|NCT02616588|social work|social work
5221177|NCT02616575|home care|home care
5221178|NCT02616575|monitoring system|monitoring system
5221179|NCT02616575|risk assessment|risk assessment
5221180|NCT02616575|telehealth|telehealth
5295465|NCT02199054|Soy|soy
5209241|NCT02687984|Schizophrenia|schizophrenia
5209242|NCT02687984|Long-acting Risperidone|long-acting risperidone
5209243|NCT02687984|Atrigel|atrigel
5209245|NCT02687932|Functional Mitral Regurgitation|functional mitral regurgitation
5209246|NCT02687932|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5209247|NCT02687919|diet (gluten-free)|diet (gluten-free)
5209248|NCT02687919|diet therapy|diet therapy
5221181|NCT02616536|Flipped classroom|flipped classroom
5221182|NCT02616536|Teaching methods|teaching methods
5221183|NCT02616536|Knowledge gain|knowledge gain
5221184|NCT02616523|dexmedetomidine|dexmedetomidine
5221185|NCT02616523|lidocaine|lidocaine
5221186|NCT02616523|neuropathic pain|neuropathic pain
5221187|NCT02616523|laparoscopic intestine resection|laparoscopic intestine resection
5221188|NCT02616523|cognitive function|cognitive function
5221189|NCT02616497|aspirin|aspirin
5221190|NCT02616497|triflusal|triflusal
5221191|NCT02616497|antiplatelet drugs|antiplatelet drugs
5221192|NCT02616497|atherothrombosis|atherothrombosis
5221193|NCT02616497|secondary prevention|secondary prevention
5221194|NCT02616497|bleeding|bleeding
5221197|NCT02616471|Cheese|cheese
5221198|NCT02616471|Dairy|dairy
5221199|NCT02616471|Saturated fat|saturated fat
5221200|NCT02616471|Blood lipid concentrations|blood lipid concentrations
5221201|NCT02616471|Lipoprotein particle size|lipoprotein particle size
5221202|NCT02616471|Metabolic Syndrome|metabolic syndrome
5221203|NCT02616471|Insulin sensitivity|insulin sensitivity
5221204|NCT02616471|Blood glucose concentrations|blood glucose concentrations
5221205|NCT02616445|Xanamem|xanamem
5221206|NCT02616432|Tomosynthesis|tomosynthesis
5221207|NCT02616432|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
5221208|NCT02616432|Breast Imaging|breast imaging
5222214|NCT02609737|15-161|15-161
5221209|NCT02616432|Full-field digital mammography|full-field digital mammography
5221210|NCT02616432|Breast screening|breast screening
5221211|NCT02616419|Emergency Department|emergency department
5221212|NCT02616419|Procedural pain|procedural pain
5221213|NCT02616419|Procedural anxiety|procedural anxiety
5221214|NCT02616419|Needle-related procedures|needle-related procedures
5221215|NCT02616419|Clinical Nursing Research|clinical nursing research
5221216|NCT02616419|Nursing practice|nursing practice
5221217|NCT02616419|Non-pharmacological method|non-pharmacological method
5221218|NCT02616406|recovery of function|recovery of function
5221219|NCT02616380|Quality of life (QOL)|quality of life (qol)
5221220|NCT02616380|Work productivity|work productivity
5221221|NCT02616380|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5221222|NCT02616354|Pharmacokinetics; pharmacodynamic; imipenem; sepsis|pharmacokinetics; pharmacodynamic; imipenem; sepsis
5221224|NCT02616302|Drug therapy|drug therapy
5221225|NCT02616276|Glycemic Index|glycemic index
5221226|NCT02616276|Postprandial Period|postprandial period
5221227|NCT02616276|Vascular Stiffness|vascular stiffness
5221228|NCT02616276|Blood glucose|blood glucose
5221229|NCT02616276|Cognition|cognition
5221230|NCT02616237|Chinese population|chinese population
5221231|NCT02616237|acupressure|acupressure
5090021|NCT03435887|HIV|hiv
5221232|NCT02616237|physical activity|physical activity
5221233|NCT02616237|nutrition|nutrition
5221234|NCT02616237|Facebook|facebook
5221235|NCT02616198|glass ionomers|glass ionomers
5221236|NCT02616198|surface coating|surface coating
5221237|NCT02616198|clinical trial|clinical trial
5221238|NCT02616120|Herbal therapy|herbal therapy
5221239|NCT02616120|Parkinson's Disease|parkinson's disease
5221240|NCT02616120|Non-motor Symptoms|non-motor symptoms
5221241|NCT02616120|Randomized controlled trial|randomized controlled trial
5221242|NCT02616107|Caregiver|caregiver
5221243|NCT02616107|Self-management|self-management
5221244|NCT02616107|Care options|care options
5221245|NCT02616107|Goals of care|goals of care
5221246|NCT02616107|Breast cancer|breast cancer
5221247|NCT02616107|Palliative care|palliative care
5221248|NCT02616081|Urinary Bladder|urinary bladder
5221249|NCT02616081|Neurogenic|neurogenic
5221250|NCT02616081|Quality of Life|quality of life
5221251|NCT02616081|Spinal cord injury|spinal cord injury
5221252|NCT02616081|incontinence|incontinence
5221253|NCT02616081|Bladder|bladder
5221254|NCT02616042|Centella asiatica|centella asiatica
5221255|NCT02616042|bamboo salt|bamboo salt
5221256|NCT02616042|dentifrice|dentifrice
5221257|NCT02616003|Morbid Obesity|morbid obesity
5221258|NCT02616003|Giant Obese|giant obese
5221259|NCT02616003|Preoperative Procedure|preoperative procedure
5221260|NCT02616003|Liraglutide|liraglutide
5221261|NCT02616003|Leucine|leucine
5221262|NCT02615977|Pavlovian conditioning, Operant conditioning|pavlovian conditioning, operant conditioning
5295579|NCT02198573|K13|k13
5209334|NCT02687217|Appendicitis|appendicitis
5209336|NCT02687113|ablation|ablation
5221263|NCT02615977|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
5221264|NCT02615977|Functional imaging|functional imaging
5221265|NCT02615977|Relapse risk|relapse risk
5221266|NCT02615977|Behavioural Intervention|behavioural intervention
5221267|NCT02615951|Regulatory B cells (Breg)|regulatory b cells (breg)
5221268|NCT02615951|Genes|genes
5221269|NCT02615951|Cell surface proteins|cell surface proteins
5221270|NCT02615951|Nutrient transporters|nutrient transporters
5221271|NCT02615951|Chemokine receptors|chemokine receptors
5221272|NCT02615899|Older Adults, Falls|older adults, falls
5221273|NCT02615886|rice bran|rice bran
5221274|NCT02615886|infants|infants
5221275|NCT02615886|stool metabolome|stool metabolome
5221276|NCT02615886|stool microbiome|stool microbiome
5221277|NCT02615886|dietary intervention|dietary intervention
5221278|NCT02615873|Parkinson's Disease|parkinson's disease
5221279|NCT02615873|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
5221280|NCT02615873|Carbidopa|carbidopa
5221281|NCT02615873|Levodopa|levodopa
5221282|NCT02615873|Accordion|accordion
5221283|NCT02615860|HIV-infection|hiv-infection
5221284|NCT02615860|anal cancer (AC)|anal cancer (ac)
5221285|NCT02615860|anal cancer prevention|anal cancer prevention
5221286|NCT02615860|anal dysplasia|anal dysplasia
5221287|NCT02615860|anal intraepithelial neoplasia (AIN)|anal intraepithelial neoplasia (ain)
5221288|NCT02615860|human papillomavirus (HPV)|human papillomavirus (hpv)
5423245|NCT01616563|diabetes mellitus|diabetes mellitus
5221289|NCT02615860|HPV-induced anal cancer precursor lesions|hpv-induced anal cancer precursor lesions
5221290|NCT02615860|electrocautery (ECA)|electrocautery (eca)
5221291|NCT02615860|topical trichloroacetic acid (TCA) treatment.|topical trichloroacetic acid (tca) treatment.
5221292|NCT02615704|Brilique treatment adherence via electronic device application (APP)|brilique treatment adherence via electronic device application (app)
5221293|NCT02615678|neuropathy|neuropathy
5221294|NCT02615678|peripheral|peripheral
5221295|NCT02615678|chemotherapy|chemotherapy
5221296|NCT02615678|breast cancer|breast cancer
5221297|NCT02615665|NK-cells|nk-cells
5221298|NCT02615665|T-cells|t-cells
5221299|NCT02615639|HPDC-T cells|hpdc-t cells
5221300|NCT02615639|CHB|chb
5221301|NCT02615639|immuno therapy|immuno therapy
5221302|NCT02615626|Visfatin|visfatin
5221303|NCT02615626|GCF|gcf
5221304|NCT02615626|serum|serum
5221305|NCT02615626|Non-surgical Periodontal Treatment.|non-surgical periodontal treatment.
5221306|NCT02615613|Hedonics, Ghrelin, Hunger|hedonics, ghrelin, hunger
5221307|NCT02615600|tinnitus|tinnitus
5221308|NCT02615600|transcranial random noise stimulation|transcranial random noise stimulation
5221309|NCT02615600|tRNS|trns
5221310|NCT02615600|auditory cortex|auditory cortex
5221311|NCT02615600|non-invasive brain stimulation|non-invasive brain stimulation
5221312|NCT02615587|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5221313|NCT02615561|Safety|safety
5221314|NCT02615561|Efficacy|efficacy
5221315|NCT02615561|Atopic dermatitis|atopic dermatitis
5221316|NCT02615561|Cosmetic products|cosmetic products
5962684|NCT04279418|Mixed functional foods|mixed functional foods
5221317|NCT02615548|exercises|exercises
5221318|NCT02615535|traumatic brain injury|traumatic brain injury
5221319|NCT02615522|primary TKR|primary tkr
5221320|NCT02615509|Mammography|mammography
5221321|NCT02615509|Tomosynthesis|tomosynthesis
5221322|NCT02615496|Health Care Surveys|health care surveys
5221323|NCT02615496|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5221325|NCT02615470|Shingles|shingles
5221326|NCT02615470|Pharmacy|pharmacy
5221327|NCT02615470|Vaccine|vaccine
5221328|NCT02615470|Immunization|immunization
5221329|NCT02615444|Metabolic Syndrome X|metabolic syndrome x
5221330|NCT02615444|Overweight|overweight
5221331|NCT02615444|Waist Circumference|waist circumference
5221332|NCT02615444|Blood Pressure|blood pressure
5221333|NCT02615444|Cholesterol|cholesterol
5221334|NCT02615444|Oat beta glucan|oat beta glucan
5221335|NCT02615392|RCT|rct
5221336|NCT02615392|Park Prescription|park prescription
5221337|NCT02615392|Park Use|park use
5221338|NCT02615392|Physical Activity|physical activity
5221339|NCT02615392|Health Promotion|health promotion
5221340|NCT02615392|Health Behavior|health behavior
5221341|NCT02615392|Mental Well-Being|mental well-being
5221342|NCT02615392|Body composition|body composition
5221343|NCT02615392|Blood levels|blood levels
5221344|NCT02615392|Accelerometry|accelerometry
5221345|NCT02615392|Improving general physical and mental health|improving general physical and mental health
5221346|NCT02615379|instrumented spinal fusion|instrumented spinal fusion
5221347|NCT02615379|infection|infection
5221348|NCT02615379|topical oxygen|topical oxygen
5221349|NCT02615340|delirium|delirium
5221350|NCT02615340|melatonin|melatonin
5221351|NCT02615340|pharmacokinetics|pharmacokinetics
5221352|NCT02615340|feasibility|feasibility
5221353|NCT02615340|prevention|prevention
5221354|NCT02615327|Fiber|fiber
5221355|NCT02615327|Polydextrose|polydextrose
5221356|NCT02615327|Glycemic Index|glycemic index
5221357|NCT02615314|migraine|migraine
5221358|NCT02615314|benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5221359|NCT02615288|Vitamin D|vitamin d
5221360|NCT02615262|Pediatric cardiac surgery|pediatric cardiac surgery
5221361|NCT02615262|Dexamethasone|dexamethasone
5221362|NCT02615262|Steroids|steroids
5221363|NCT02615262|Cardiopulmonary bypass|cardiopulmonary bypass
5221364|NCT02615262|Congenital heart defects|congenital heart defects
5221365|NCT02615262|Infants|infants
5221366|NCT02615197|PTSD|ptsd
5221367|NCT02615197|Multi-diagnostic|multi-diagnostic
5221368|NCT02615197|Dialectical Behavior Therapy|dialectical behavior therapy
5221369|NCT02615197|Prolonged Exposure Therapy|prolonged exposure therapy
5221370|NCT02615184|Drug therapy|drug therapy
5221371|NCT02615158|Feeding practices|feeding practices
5221372|NCT02615158|Diet|diet
5221373|NCT02615158|Physical activity|physical activity
5221374|NCT02615158|Prevention|prevention
5221375|NCT02615145|Chronic Hepatitis C|chronic hepatitis c
5221376|NCT02615145|Dasabuvir|dasabuvir
5221377|NCT02615145|Ombitasvir+Paritaprevir+Ritonavir|ombitasvir+paritaprevir+ritonavir
5221378|NCT02615145|Observational Study|observational study
5221379|NCT02615145|Quality of life|quality of life
5221380|NCT02615145|Work-ability|work-ability
5221381|NCT02615145|Fibrosis|fibrosis
5221382|NCT02615145|Cirrhosis|cirrhosis
5221383|NCT02615119|heartbeat|heartbeat
5221384|NCT02615119|respiration|respiration
5221385|NCT02615119|interoception|interoception
5221386|NCT02615119|anxiety|anxiety
5221387|NCT02615119|eating|eating
5221388|NCT02615106|Radiation Therapy|radiation therapy
5221389|NCT02615106|Neuroblastoma|neuroblastoma
5221390|NCT02615067|Diagnostic|diagnostic
5221391|NCT02615067|Active surveillance|active surveillance
5221392|NCT02615067|Very low risk|very low risk
5221393|NCT02615067|Imaging|imaging
5221394|NCT02615067|PSMA|psma
5221395|NCT02615067|SPECT/CT|spect/ct
5221396|NCT02615067|99mTc|99mtc
5221397|NCT02615067|Newly Diagnosed|newly diagnosed
5221398|NCT02615067|Prostatectomy|prostatectomy
5221399|NCT02615067|Biopsy|biopsy
5221400|NCT02615054|Cardiovascular Impairment|cardiovascular impairment
5221401|NCT02615054|15-258|15-258
5221402|NCT02615041|Meropenem|meropenem
5221403|NCT02615041|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5221404|NCT02615041|population pharmacokinetics|population pharmacokinetics
5221456|NCT02614703|Barrett's Esophagus|barrett's esophagus
5221457|NCT02614703|Acetic Acid Chromoendoscopy|acetic acid chromoendoscopy
5221458|NCT02614690|Fracture of the upper limb|fracture of the upper limb
5221459|NCT02614677|Disability Evaluation System|disability evaluation system
5221460|NCT02614677|SF-12|sf-12
5221461|NCT02614677|ICF model|icf model
5221462|NCT02614612|Acute Graft Versus Host Disease|acute graft versus host disease
5221464|NCT02614599|ADHD|adhd
5221465|NCT02614599|Proteins|proteins
5221466|NCT02614599|Dietary|dietary
5221467|NCT02614599|Nutrition|nutrition
5221468|NCT02614599|QEEG|qeeg
5221469|NCT02614599|ERP|erp
5221470|NCT02614599|ICA|ica
5221471|NCT02614586|Drug Therapy|drug therapy
5221472|NCT02614573|Dependent|dependent
5221473|NCT02614573|Aged, 80 and over|aged, 80 and over
5221474|NCT02614573|Aged|aged
5221475|NCT02614560|acute myeloid leukemia|acute myeloid leukemia
5221477|NCT02614560|antibody-drug conjugate|antibody-drug conjugate
5221479|NCT02614521|Pulmonary veins ablation|pulmonary veins ablation
5221480|NCT02614521|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5221481|NCT02614482|Children|children
5221482|NCT02614482|Antimuscarinics|antimuscarinics
5221483|NCT02614482|Antocholinergics|antocholinergics
5221484|NCT02614482|Overactive bladder|overactive bladder
5221485|NCT02614443|Depression|depression
5221486|NCT02614443|Anxiety|anxiety
5221487|NCT02614443|Stress|stress
5221488|NCT02614443|Online interventions|online interventions
5221489|NCT02614443|University students|university students
5221490|NCT02614443|CBT|cbt
5221491|NCT02614430|Rehabilitation|rehabilitation
5221492|NCT02614430|Prediction|prediction
5221493|NCT02614430|Inflammation|inflammation
5221494|NCT02614404|Plasmodium falciparum|plasmodium falciparum
5221495|NCT02614404|Uncomplicated malarial|uncomplicated malarial
5221496|NCT02614404|imatinib mesylate|imatinib mesylate
5221497|NCT02614404|antimalarials|antimalarials
5221498|NCT02614391|Procedural pain|procedural pain
5221499|NCT02614391|Phlebotomy|phlebotomy
5221500|NCT02614391|Distraction|distraction
5221501|NCT02614391|Videogame|videogame
5221502|NCT02614391|Computer tablet|computer tablet
5221503|NCT02614391|Child|child
5221504|NCT02614378|abortive effect|abortive effect
5221505|NCT02614326|Depression|depression
5221506|NCT02614326|Cognitive risk factors|cognitive risk factors
5221507|NCT02614326|Autobiographical memory|autobiographical memory
5221508|NCT02614326|Cognitive bias|cognitive bias
5221509|NCT02614326|Relapse prevention|relapse prevention
5221510|NCT02614313|Fructose|fructose
5221511|NCT02614313|Irritable Bowel Syndrome|irritable bowel syndrome
5221512|NCT02614313|Breath test|breath test
5221513|NCT02614313|Placebo|placebo
5221514|NCT02614300|pulmonary rehabilitation|pulmonary rehabilitation
5221515|NCT02614300|chest physiotherapy|chest physiotherapy
5221516|NCT02614300|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
5221517|NCT02614300|exercise tolerance|exercise tolerance
5221518|NCT02614300|bronchiectasis|bronchiectasis
5221519|NCT02614300|respiratory therapy|respiratory therapy
5221520|NCT02614287|prevention|prevention
5221521|NCT02614287|prophylaxis|prophylaxis
5221522|NCT02614287|headache|headache
5221523|NCT02614274|knee|knee
5221524|NCT02614274|pain|pain
5221525|NCT02614274|osteoarthritis|osteoarthritis
5221526|NCT02614274|nutraceutical|nutraceutical
5221527|NCT02614274|nutrition|nutrition
5221528|NCT02614274|supplement|supplement
5221529|NCT02614274|non-surgical|non-surgical
5221530|NCT02614274|biomarker|biomarker
5221531|NCT02614274|joint health|joint health
5221532|NCT02614261|prevention|prevention
5221533|NCT02614261|prophylaxis|prophylaxis
5221534|NCT02614261|headache|headache
5221535|NCT02614235|Cardiac Arrhythmia|cardiac arrhythmia
5221536|NCT02614235|Syncope|syncope
5221537|NCT02614235|Ambulatory Electrocardiography Monitoring|ambulatory electrocardiography monitoring
5221538|NCT02614222|Computer Assisted Instrument Guidance (CAIG)|computer assisted instrument guidance (caig)
5221539|NCT02614222|Peripheral Nerve Block|peripheral nerve block
5221540|NCT02614222|Clear Guide ONE|clear guide one
5221541|NCT02614222|Needle path|needle path
5221542|NCT02614222|Needle Guidance|needle guidance
5221543|NCT02614222|Ultrasound|ultrasound
5221544|NCT02614209|ED|ed
5221545|NCT02614209|BNP|bnp
5221546|NCT02614196|prevention|prevention
5221547|NCT02614196|prophylaxis|prophylaxis
5227720|NCT02577107|PK|pk
5221548|NCT02614196|headache|headache
5221549|NCT02614183|prevention|prevention
5221550|NCT02614183|prophylaxis|prophylaxis
5221551|NCT02614183|headache|headache
5221552|NCT02614157|rectal cancer|rectal cancer
5221553|NCT02614157|lateral lymph node dissection|lateral lymph node dissection
5221554|NCT02614157|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5221555|NCT02614157|total mesorectal excision|total mesorectal excision
5221556|NCT02614157|surgery|surgery
5221557|NCT02614157|recurrence|recurrence
5221558|NCT02614157|metastasis|metastasis
5221559|NCT02614157|overall survival|overall survival
5221560|NCT02614144|Hospital Acquired Pneumonia|hospital acquired pneumonia
5221561|NCT02614144|Mortality|mortality
5221562|NCT02614118|Endodontic treatment|endodontic treatment
5221563|NCT02614118|non steroid|non steroid
5221564|NCT02614118|pain|pain
5221565|NCT02614118|pre medication|pre medication
5221566|NCT02614092|Mild Cognitive Impairment|mild cognitive impairment
5221567|NCT02614092|memory impairment|memory impairment
5221568|NCT02614092|Physical Activity|physical activity
5221569|NCT02614092|Exercise|exercise
5221570|NCT02614092|Cognitive Training|cognitive training
5221571|NCT02614092|Veterans|veterans
5221572|NCT02614092|Older Adults|older adults
5221573|NCT02614079|lumbago|lumbago
5221574|NCT02614079|low back pain|low back pain
5221575|NCT02614079|leg pain|leg pain
5221576|NCT02614040|crystalloid|crystalloid
5221577|NCT02614040|acute kidney injury|acute kidney injury
5221578|NCT02614001|breathing training, congestive heart failure, stroke|breathing training, congestive heart failure, stroke
5221579|NCT02613988|Glioblastoma|glioblastoma
5221581|NCT02613988|standard treatment|standard treatment
5221582|NCT02613949|fibromyalgia|fibromyalgia
5221583|NCT02613949|pain|pain
5221584|NCT02613949|stimulation|stimulation
5221585|NCT02613936|traumatic brain injury|traumatic brain injury
5221586|NCT02613936|post concussive symptoms|post concussive symptoms
5099966|NCT03373214|CpG|cpg
5221587|NCT02613936|depression|depression
5221588|NCT02613936|executive dysfunction|executive dysfunction
5221589|NCT02613936|brain stimulation|brain stimulation
5221590|NCT02613923|Breast Cancer|breast cancer
5221591|NCT02613923|GO! to sleep|go! to sleep
5221592|NCT02613923|sleep|sleep
5221593|NCT02613910|Ofatumumab|ofatumumab
5221594|NCT02613910|Pemphigus Vulgaris|pemphigus vulgaris
5221595|NCT02613910|Long-Term Extension Study|long-term extension study
5221596|NCT02613845|Postoperative delirium|postoperative delirium
5221597|NCT02613845|Cardiac surgery|cardiac surgery
5221598|NCT02613845|Cardiopulmonary bypass|cardiopulmonary bypass
5221599|NCT02613845|Risk factor|risk factor
5221600|NCT02613832|Noncooperative patients|noncooperative patients
5221601|NCT02613806|Dexmedetomidine|dexmedetomidine
5221602|NCT02613806|Coughing Response|coughing response
5221603|NCT02613806|Postoperative Recovery Quality|postoperative recovery quality
5221604|NCT02613806|Thyroid Surgery|thyroid surgery
5863734|NCT00001202|LHRH|lhrh
5221608|NCT02613728|Colorectal cancer|colorectal cancer
5221609|NCT02613728|Colorectal cancer surgery|colorectal cancer surgery
5221610|NCT02613728|Polyp(s)|polyp(s)
5222320|NCT02609217|elective|elective
5221611|NCT02613728|Accelerated Enhanced Recovery|accelerated enhanced recovery
5221612|NCT02613728|RecoverMI|recovermi
5221613|NCT02613728|Fluid diary|fluid diary
5221614|NCT02613728|Questionnaires|questionnaires
5221616|NCT02613728|RecoverMI device|recovermi device
5221617|NCT02613715|Flavonoids|flavonoids
5221618|NCT02613715|Anthocyanins|anthocyanins
5221619|NCT02613715|Blackberry Juice|blackberry juice
5221620|NCT02613715|Bioavailability|bioavailability
5221621|NCT02613715|Obesity|obesity
5221622|NCT02613702|Free gingival graft|free gingival graft
5221623|NCT02613702|keratinized gingival tissue|keratinized gingival tissue
5221624|NCT02613689|smokeless tobacco, text message, tobacco cessation, tobacco|smokeless tobacco, text message, tobacco cessation, tobacco
5221625|NCT02613637|lung cancer|lung cancer
5221626|NCT02613637|registry study|registry study
5221627|NCT02613637|Biological Disease Profile|biological disease profile
5221628|NCT02613624|KMC in community|kmc in community
5221629|NCT02613559|Neovascular Age-Related Macular Degeneration, Subfoveal CNV, TK001|neovascular age-related macular degeneration, subfoveal cnv, tk001
5221630|NCT02613546|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
5221631|NCT02613546|Sexual Dysfunctions|sexual dysfunctions
5221632|NCT02613546|Women|women
5221633|NCT02613520|PfSPZ Vaccine|pfspz vaccine
5221634|NCT02613520|Plasmodium falciparum|plasmodium falciparum
5221635|NCT02613494|clozapine|clozapine
5221636|NCT02613494|hypersalivation|hypersalivation
5221637|NCT02613494|refractory schizophrenia|refractory schizophrenia
5221638|NCT02613468|Pregnancy|pregnancy
5221639|NCT02613468|Low birth weight|low birth weight
5221640|NCT02613468|Gingivitis|gingivitis
5221641|NCT02613468|Inflammation|inflammation
5221642|NCT02613468|Periodontitis|periodontitis
5221643|NCT02613390|Epidural metastasis|epidural metastasis
5221644|NCT02613390|Magnetic resonance imaging|magnetic resonance imaging
5221646|NCT02613390|Guidance system|guidance system
5221647|NCT02613390|Spinal surgery|spinal surgery
5221648|NCT02613390|Questionnaires|questionnaires
5221649|NCT02613390|Surveys|surveys
5221650|NCT02613377|Transfusion-related acute lung injury, Red Blood Cell|transfusion-related acute lung injury, red blood cell
5221651|NCT02613351|Exercise Tolerance|exercise tolerance
5221652|NCT02613351|Lung Diseases, Obstructive|lung diseases, obstructive
5221653|NCT02613325|Melanoma|melanoma
5221654|NCT02613325|Imaging|imaging
5221655|NCT02613325|Pigmented Lesions|pigmented lesions
5221656|NCT02613325|Melanoma Management|melanoma management
5221657|NCT02613247|Viscosupplementation|viscosupplementation
5221658|NCT02613247|Hyaluronic acid|hyaluronic acid
5221659|NCT02613247|Synvisc|synvisc
5221660|NCT02613247|Synvisc-One|synvisc-one
5221661|NCT02613247|Patellofemoral pain syndrome|patellofemoral pain syndrome
5221662|NCT02613247|PFPS|pfps
5221663|NCT02613247|Anterior knee pain|anterior knee pain
5221664|NCT02613247|Runner's knee|runner's knee
5221669|NCT02613221|Metastatic colorectal cancer, Panitumumab, TAS-102|metastatic colorectal cancer, panitumumab, tas-102
5221670|NCT02613195|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
5221671|NCT02613195|oxidative stress|oxidative stress
5221672|NCT02613195|organ preservation|organ preservation
5221673|NCT02613195|Hydrogen|hydrogen
5221674|NCT02613195|Kidney Transplantation|kidney transplantation
5221675|NCT02613169|M. tuberculosis infection|m. tuberculosis infection
5221676|NCT02613169|isoniazid|isoniazid
5221677|NCT02613169|HIV-exposed infants|hiv-exposed infants
5221678|NCT02613156|laparoscopic|laparoscopic
5221679|NCT02613156|hepatocellular carcinoma|hepatocellular carcinoma
5221680|NCT02613156|recurrence|recurrence
5221681|NCT02613143|malignant glaucoma|malignant glaucoma
5962685|NCT04279418|Non-pharmacologic intervention|non-pharmacologic intervention
5218856|NCT02630108|HCC|hcc
5221683|NCT02613091|volunteers|volunteers
5221684|NCT02613078|Children|children
5221685|NCT02613078|Functional Abdominal Pain Syndrome|functional abdominal pain syndrome
5221686|NCT02613078|Irritable Bowel Syndrome|irritable bowel syndrome
5221687|NCT02613078|Gut-Directed Hypnotherapy|gut-directed hypnotherapy
5221688|NCT02613078|Probiotic|probiotic
5221689|NCT02613065|Ad libitum|ad libitum
5221690|NCT02613065|Energy balance|energy balance
5221691|NCT02613065|Protein|protein
5221692|NCT02613039|oral contraceptives|oral contraceptives
5221693|NCT02613039|female sexuality|female sexuality
5221694|NCT02613026|Breast tumor|breast tumor
5221695|NCT02613026|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5221696|NCT02613026|Pathological complete remission|pathological complete remission
5221697|NCT02612987|CBT|cbt
5221702|NCT02612961|Mechanically ventilated patients|mechanically ventilated patients
5221703|NCT02612961|Normal Saline|normal saline
5221704|NCT02612961|Tracheostomy Tube Suctioning|tracheostomy tube suctioning
5221705|NCT02612922|Influenza|influenza
5221706|NCT02612909|Avian Influenza|avian influenza
5221707|NCT02612909|A/H5N1 vaccine|a/h5n1 vaccine
5221708|NCT02612909|IVAC|ivac
5221709|NCT02612896|Taenia solium|taenia solium
5221710|NCT02612896|control|control
5221711|NCT02612896|elimination|elimination
5221712|NCT02612896|One Health|one health
5221713|NCT02612883|Flux measurement|flux measurement
5221714|NCT02612870|Breast Cancer|breast cancer
5221715|NCT02612870|Sentinel Node|sentinel node
5221716|NCT02612870|Sentinel Node Biopsy|sentinel node biopsy
5221717|NCT02612870|Breast Surgery|breast surgery
5221718|NCT02612857|dermatomyositis|dermatomyositis
5221719|NCT02612857|IMO-8400|imo-8400
5221720|NCT02612857|Pioneer|pioneer
5221721|NCT02612818|coelioscopy|coelioscopy
5221722|NCT02612766|celiac disease|celiac disease
5221723|NCT02612766|oat|oat
5221724|NCT02612766|gluten free diet|gluten free diet
5221725|NCT02612753|Aphasia|aphasia
5221726|NCT02612753|Speaking therapy|speaking therapy
5221727|NCT02612753|Language therapy|language therapy
5221728|NCT02612753|transcranial Direct current stimulation|transcranial direct current stimulation
5221729|NCT02612740|Bio Oss|bio oss
5221730|NCT02612740|critical-size defect|critical-size defect
5221731|NCT02612740|bone grafting|bone grafting
5221732|NCT02612740|cyst|cyst
5221733|NCT02612740|CT bone analysis|ct bone analysis
5221734|NCT02612740|alveolar bone|alveolar bone
5221735|NCT02612727|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
5221736|NCT02612714|diabetes|diabetes
5221737|NCT02612714|hypercholesterolemia|hypercholesterolemia
5221738|NCT02612714|sexual dysfunction|sexual dysfunction
5221739|NCT02612714|statin|statin
5221740|NCT02612714|testosterone|testosterone
5221741|NCT02612701|Myocardial perfusion|myocardial perfusion
5221742|NCT02612701|Electronic cigarettes|electronic cigarettes
5221743|NCT02612701|Cigarettes|cigarettes
5221744|NCT02612701|Cigarette smoking|cigarette smoking
5221745|NCT02612688|Advance Care Planning|advance care planning
5221746|NCT02612688|Advance Directives|advance directives
5221747|NCT02612688|Alzheimer Disease|alzheimer disease
5221748|NCT02612688|Dementia|dementia
5221749|NCT02612688|Do-Not-Resuscitate Orders|do-not-resuscitate orders
5221750|NCT02612688|Enteral Nutrition|enteral nutrition
5221751|NCT02612688|Heart Failure|heart failure
5221752|NCT02612688|Hospices|hospices
5221753|NCT02612688|Hospitalization|hospitalization
5221754|NCT02612688|Instructional Films and Videos|instructional films and videos
5221755|NCT02612688|Intubation|intubation
5221756|NCT02612688|Nursing Homes|nursing homes
5221757|NCT02612688|Parenteral Nutrition|parenteral nutrition
5221758|NCT02612688|Pragmatic Clinical Trials|pragmatic clinical trials
5221759|NCT02612688|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5221760|NCT02612688|Randomized Controlled Trials|randomized controlled trials
5221761|NCT02612688|Resuscitation Orders|resuscitation orders
5221762|NCT02612688|Skilled Nursing Facilities|skilled nursing facilities
5221768|NCT02612649|Irritable bowel syndrome|irritable bowel syndrome
5221769|NCT02612649|YM060|ym060
5221770|NCT02612649|Ramosetron|ramosetron
5221771|NCT02612649|Survey|survey
5221772|NCT02612636|Delirium|delirium
5221773|NCT02612636|Ear Plug|ear plug
5221774|NCT02612636|Eye Mask|eye mask
5221775|NCT02612636|Mechanical ventilation|mechanical ventilation
5221776|NCT02612636|Sleep|sleep
5221777|NCT02612597|before and after bedrest|before and after bedrest
5221778|NCT02612597|healthy untrained|healthy untrained
5221779|NCT02612597|before and after exercise training|before and after exercise training
5221780|NCT02612558|Warm antibody autoimmune hemolytic anemia (AIHA)|warm antibody autoimmune hemolytic anemia (aiha)
5221781|NCT02612545|Plasmodium Falciparum|plasmodium falciparum
5221782|NCT02612545|Artemisinin Combination Therapy|artemisinin combination therapy
5221783|NCT02612545|Triple Artemisinin Combination Therapy|triple artemisinin combination therapy
5221784|NCT02612545|Piperaquine|piperaquine
5221785|NCT02612545|Mefloquine|mefloquine
5221786|NCT02612493|obesity surgery|obesity surgery
5221787|NCT02612493|type I diabetes|type i diabetes
5221788|NCT02612493|weight loss|weight loss
5221789|NCT02612493|insulin dosage|insulin dosage
5221790|NCT02612493|postsurgery metabolic changes|postsurgery metabolic changes
5221791|NCT02612480|endotoxin|endotoxin
5221792|NCT02612480|LPS|lps
5221793|NCT02612480|ticagrelor|ticagrelor
5221794|NCT02612480|clopidogrel|clopidogrel
5221795|NCT02612480|acetylsalicyclic acid|acetylsalicyclic acid
5221805|NCT02612389|Meditative Movement|meditative movement
5221806|NCT02612389|Flight Attendants|flight attendants
5221807|NCT02612389|Secondhand Smoke|secondhand smoke
5222321|NCT02609217|cesarean|cesarean
5221809|NCT02612389|Blood Pressure|blood pressure
5221810|NCT02612389|6 minute walk test|6 minute walk test
5114767|NCT03279458|Capnography|capnography
5221811|NCT02612363|septic shock|septic shock
5221812|NCT02612363|sedation|sedation
5221813|NCT02612363|microcirculation|microcirculation
5221815|NCT02612350|high risk for developing cancer|high risk for developing cancer
5221816|NCT02612350|Plasma|plasma
5221817|NCT02612350|Relative Risk|relative risk
5221818|NCT02612350|Early Detection of Cancer|early detection of cancer
5221819|NCT02612350|Cancer Screening Tests|cancer screening tests
5221820|NCT02612350|Cancer Screening|cancer screening
5221821|NCT02612337|Meniere's Disease|meniere's disease
5221822|NCT02612337|Vertigo|vertigo
5221823|NCT02612324|adolescents|adolescents
5221824|NCT02612324|teen pregnancy prevention|teen pregnancy prevention
5221825|NCT02612324|sexually transmitted infections prevention|sexually transmitted infections prevention
5221826|NCT02612324|place-based programs|place-based programs
5221827|NCT02612324|health education|health education
5296250|NCT02195284|MDI|mdi
5209826|NCT02684175|Telemedicine|telemedicine
5209827|NCT02684175|Health Services Accessibility|health services accessibility
5209828|NCT02684175|Rural Population|rural population
5209830|NCT02684149|Intensive care|intensive care
5221828|NCT02612298|Essential Hypertension|essential hypertension
5221829|NCT02612298|Arotinolol|arotinolol
5221830|NCT02612298|Morning Blood Pressure|morning blood pressure
5221831|NCT02612233|Pain|pain
5221832|NCT02612220|liver resection|liver resection
5221833|NCT02612181|dexmedetomidine|dexmedetomidine
5221834|NCT02612181|microcirculation|microcirculation
5221835|NCT02612181|septic shock|septic shock
5221836|NCT02612168|Diagnosis|diagnosis
5221837|NCT02612168|skin imaging|skin imaging
5221838|NCT02612155|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5221839|NCT02612155|autologous cord blood cells|autologous cord blood cells
5221840|NCT02612155|newborn infants|newborn infants
5221849|NCT02612103|Biochemical markers|biochemical markers
5221850|NCT02612090|Nutrition|nutrition
5221851|NCT02612090|Polyphenols|polyphenols
5221852|NCT02612090|Berries|berries
5221853|NCT02612090|Lipid Panels|lipid panels
5221854|NCT02612051|patients|patients
5221855|NCT02612051|FTIH|ftih
5221856|NCT02612051|healthy volunteers|healthy volunteers
5221857|NCT02612051|GSK3008348|gsk3008348
5221858|NCT02612051|[18F]-FBA-A20FMDV2|[18f]-fba-a20fmdv2
5221859|NCT02612051|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5221861|NCT02612038|Obstructive sleep apnea|obstructive sleep apnea
5221862|NCT02612038|Expiratory flow limitation|expiratory flow limitation
5221863|NCT02612012|breast cancer|breast cancer
5221864|NCT02612012|positive sentinel lymph nodes|positive sentinel lymph nodes
5221865|NCT02612012|axillary radiotherapy|axillary radiotherapy
5221866|NCT02611999|Physicians' ordering behavior with price information|physicians' ordering behavior with price information
5221867|NCT02611986|Airway management|airway management
5221868|NCT02611986|video laryngoscope|video laryngoscope
5221869|NCT02611973|Essential Thrombocythemia|essential thrombocythemia
5221870|NCT02611973|Aspirin|aspirin
5221875|NCT02611947|emphysema|emphysema
5221876|NCT02611947|airway remodelling|airway remodelling
5221877|NCT02611947|multidetector computed tomography|multidetector computed tomography
5221878|NCT02611921|Ketamine|ketamine
5221879|NCT02611921|Social Impairment|social impairment
5221881|NCT02611921|Autistic Disorder|autistic disorder
5221882|NCT02611908|CLL|cll
5221883|NCT02611908|cancer|cancer
5221884|NCT02611908|obinutuzumab|obinutuzumab
5221885|NCT02611908|ibrutinib|ibrutinib
5221886|NCT02611908|SLL|sll
5221887|NCT02611895|Aviremic HIV-1 infected patients|aviremic hiv-1 infected patients
5221888|NCT02611895|HAART|haart
5221889|NCT02611895|Integrase inhibitor Raltegravir|integrase inhibitor raltegravir
5221890|NCT02611895|Ongoing HIV infection|ongoing hiv infection
5221891|NCT02611856|twin to twin,|twin to twin,
5221892|NCT02611856|transfusion syndrome|transfusion syndrome
5221893|NCT02611843|peer support|peer support
5221894|NCT02611843|web-based treatment|web-based treatment
5221895|NCT02611843|veterans|veterans
5221896|NCT02611843|PTSD|ptsd
5221897|NCT02611843|Substance Use Disorders|substance use disorders
5221898|NCT02611830|Drug therapy|drug therapy
5221899|NCT02611817|Drug therapy|drug therapy
5221900|NCT02611791|Treatment by Pulsed Radio Frequency, Collagen, Female|treatment by pulsed radio frequency, collagen, female
5221901|NCT02611713|Advanced Parkinson's Disease|advanced parkinson's disease
5221902|NCT02611713|Duodopa/Duopa|duodopa/duopa
5221903|NCT02611713|carbidopa levodopa enteral suspension (CLES)|carbidopa levodopa enteral suspension (cles)
5862860|NCT00001480|Memory Disorder|memory disorder
5221904|NCT02611713|levodopa-carbidopa intestinal gel (LCIG)|levodopa-carbidopa intestinal gel (lcig)
5221906|NCT02611713|motor and non-motor symptoms|motor and non-motor symptoms
5221907|NCT02611713|dyskinesia|dyskinesia
5221909|NCT02611713|Quality of Life|quality of life
5221910|NCT02611713|Observational|observational
5221911|NCT02611713|Long-term|long-term
5221912|NCT02611713|Caregiver Burden|caregiver burden
5221913|NCT02611713|effectiveness|effectiveness
5221914|NCT02611713|fluctuations|fluctuations
5221915|NCT02611635|non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5221916|NCT02611635|Patient treatment preference|patient treatment preference
5221917|NCT02611635|NOAC|noac
5221919|NCT02611583|TENS|tens
5221920|NCT02611570|Lung cancer|lung cancer
5221921|NCT02611570|Low dose computed tomography|low dose computed tomography
5221922|NCT02611570|Screening|screening
5221923|NCT02611570|Non-smoker|non-smoker
5221924|NCT02611570|Gender issue|gender issue
5221925|NCT02611557|MRI|mri
5221926|NCT02611557|lymphedema|lymphedema
5221927|NCT02611557|manual lymphatic drainage|manual lymphatic drainage
5221928|NCT02611544|Fear of Cancer Recurrence|fear of cancer recurrence
5221929|NCT02611544|Fear of Cancer Return|fear of cancer return
5221930|NCT02611544|Breast Cancer Survivor|breast cancer survivor
5221931|NCT02611544|Breast Cancer Remission|breast cancer remission
5221933|NCT02611518|JNJ-54861911|jnj-54861911
5221934|NCT02611518|Rosuvastatin|rosuvastatin
5221935|NCT02611518|Metformin|metformin
5221936|NCT02611505|Healthy|healthy
5221937|NCT02611505|Esketamine|esketamine
5221938|NCT02611505|Hepatic Impairment|hepatic impairment
5221939|NCT02611505|Pharmacokinetics|pharmacokinetics
5221940|NCT02611479|patient reported outcomes|patient reported outcomes
5221941|NCT02611466|Osteoarthritis|osteoarthritis
5221942|NCT02611466|ASP7962|asp7962
5221943|NCT02611453|choledocholithiasis|choledocholithiasis
5221944|NCT02611453|ERCP|ercp
5221945|NCT02611453|cholangiography|cholangiography
5221946|NCT02611453|biliary stricture|biliary stricture
5221947|NCT02611453|bile ducts|bile ducts
5221948|NCT02611453|carbon dioxide|carbon dioxide
5221949|NCT02611440|ischemic stroke|ischemic stroke
5221950|NCT02611440|medication adherence|medication adherence
5221951|NCT02611440|cardiovascular disease prevention|cardiovascular disease prevention
5221952|NCT02611427|spine|spine
5221953|NCT02611427|lumbar|lumbar
5221954|NCT02611427|postoperative|postoperative
5221955|NCT02611427|physical activity|physical activity
5221956|NCT02611414|functional dyspepsia|functional dyspepsia
5221957|NCT02611414|tDCS|tdcs
5221958|NCT02611401|multiple sclerosis|multiple sclerosis
5221959|NCT02611401|depression|depression
5221960|NCT02611401|mindfulness|mindfulness
5221961|NCT02611336|Left Ventricular Hypertrophy|left ventricular hypertrophy
5221962|NCT02611336|Diastolic Dysfunction|diastolic dysfunction
5221963|NCT02611336|Myocardial Fibrosis|myocardial fibrosis
5221964|NCT02611336|Acromegaly|acromegaly
5221965|NCT02611297|Cryoprobes|cryoprobes
5221966|NCT02611297|Cryobiopsy|cryobiopsy
5221967|NCT02611297|Transbronchial lung biopsy|transbronchial lung biopsy
5221968|NCT02611284|Beractant|beractant
5221969|NCT02611284|Feasibility Studies|feasibility studies
5221970|NCT02611284|Infant, Premature|infant, premature
5221971|NCT02611284|Noninvasive Ventilation|noninvasive ventilation
5221972|NCT02611258|Left Ventricular Hypertrophy|left ventricular hypertrophy
5221973|NCT02611258|Diastolic Dysfunction|diastolic dysfunction
5221974|NCT02611258|Myocardial Fibrosis|myocardial fibrosis
5221975|NCT02611258|Cushing's Syndrome|cushing's syndrome
5221976|NCT02611245|Thoracic Duct|thoracic duct
5221977|NCT02611245|Sentinel lymph node biopsy|sentinel lymph node biopsy
5221978|NCT02611232|Diabetes Type 1|diabetes type 1
5221979|NCT02611232|Diabetes, Insulin-Dependent|diabetes, insulin-dependent
5221980|NCT02611232|Liraglutide|liraglutide
5221981|NCT02611232|Preclinical Type 1 Diabetes|preclinical type 1 diabetes
5221982|NCT02611232|GLP-1 Analogue|glp-1 analogue
5221983|NCT02611206|rTMS|rtms
5221984|NCT02611167|mesenchymal stem cells|mesenchymal stem cells
5221985|NCT02611154|Healthy Volunteers|healthy volunteers
5221986|NCT02611154|Sports Medicine|sports medicine
5221987|NCT02611154|Men's Health|men's health
5221988|NCT02611154|Athletes|athletes
5221989|NCT02611154|Anti-Doping|anti-doping
5221990|NCT02611141|Retromolar Intubation|retromolar intubation
5221991|NCT02611115|Pulmonary Embolism|pulmonary embolism
5221992|NCT02611115|Multidetector Computed Tomography|multidetector computed tomography
5221993|NCT02611115|Radiation Dosage|radiation dosage
5221994|NCT02611115|Contrast Media|contrast media
5221995|NCT02611115|Individualized Medicine|individualized medicine
5221996|NCT02611089|Muscle connective tissue|muscle connective tissue
5222000|NCT02611076|self-help|self-help
5222001|NCT02611076|Spanish language|spanish language
5222002|NCT02611063|allogeneic stem cell transplant|allogeneic stem cell transplant
5222003|NCT02611050|patient decision aid|patient decision aid
5222004|NCT02611050|multi-vessel coronary artery disease|multi-vessel coronary artery disease
5222005|NCT02611037|MPM|mpm
5222006|NCT02611037|Unresectable|unresectable
5222007|NCT02611037|Respiratory|respiratory
5222008|NCT02611037|Intrathoracic|intrathoracic
5222010|NCT02611037|Chemoperfusion|chemoperfusion
5222011|NCT02611024|lurbinectedin|lurbinectedin
5222013|NCT02611024|tumors|tumors
5222014|NCT02611024|cancer|cancer
5222015|NCT02611024|Pharma Mar|pharma mar
5222016|NCT02611011|Congo Red Dot Test|congo red dot test
5222017|NCT02610985|Imaging, Three-Dimensional|imaging, three-dimensional
5222018|NCT02610985|Hysterectomy|hysterectomy
5222019|NCT02610985|laparoscopic hysterectomy|laparoscopic hysterectomy
5222020|NCT02610972|Congo Red test GV-005|congo red test gv-005
5222021|NCT02610946|pediatric|pediatric
5222022|NCT02610946|adolescent|adolescent
5222023|NCT02610946|compliance|compliance
5222024|NCT02610933|vascular calcification|vascular calcification
5222025|NCT02610933|hemodialysis|hemodialysis
5222026|NCT02610933|rivaroxaban|rivaroxaban
5222027|NCT02610933|vitamin K2|vitamin k2
5222028|NCT02610894|postoperative symptom management|postoperative symptom management
5222029|NCT02610894|symptom management|symptom management
5222030|NCT02610894|mHealth application|mhealth application
5222031|NCT02610868|Cerebral Palsy|cerebral palsy
5222033|NCT02610868|Stroke|stroke
5222034|NCT02610868|Neuroleptics|neuroleptics
5222035|NCT02610803|stroke|stroke
5222036|NCT02610803|ischemic stroke|ischemic stroke
5222037|NCT02610803|recurrent stroke|recurrent stroke
5222038|NCT02610803|atrial fibrillation|atrial fibrillation
5222039|NCT02610803|premature atrial complexes|premature atrial complexes
5222040|NCT02610803|heart rhythm monitoring|heart rhythm monitoring
5222041|NCT02610803|cardiac telemetry|cardiac telemetry
5222042|NCT02610790|connected bracelets, footsteps|connected bracelets, footsteps
5222043|NCT02610777|Drug Therapy|drug therapy
5222044|NCT02610764|Circulating Tumor Cells|circulating tumor cells
5222045|NCT02610764|Response evaluation|response evaluation
5222046|NCT02610751|Maternal Smoking|maternal smoking
5222047|NCT02610751|Female Fetal Testosterone|female fetal testosterone
5222048|NCT02610751|Anogenital Distance|anogenital distance
5222049|NCT02610751|Maternal Testosterone|maternal testosterone
5222050|NCT02610751|Maternal Cotinine|maternal cotinine
5222051|NCT02610712|ketamine|ketamine
5222052|NCT02610712|treatment-resistant|treatment-resistant
5222053|NCT02610712|depression|depression
5222054|NCT02610712|spectroscopy|spectroscopy
5222055|NCT02610712|neuroinflammation|neuroinflammation
5222056|NCT02610686|Plasmodium vivax|plasmodium vivax
5222057|NCT02610686|recurrence|recurrence
5222058|NCT02610686|drug resistance|drug resistance
5222059|NCT02610634|Parkinson's disease|parkinson's disease
5222060|NCT02610634|Older adults|older adults
5222061|NCT02610634|Vision|vision
5222062|NCT02610634|Cognition|cognition
5222063|NCT02610634|Visual cues|visual cues
5222064|NCT02610634|Eye-tracking|eye-tracking
5222065|NCT02610634|Gait|gait
5222066|NCT02610634|Saccades|saccades
5222067|NCT02610634|Dual task|dual task
5222068|NCT02610634|Visual sampling|visual sampling
5222069|NCT02610621|Clinically node negative|clinically node negative
5222070|NCT02610621|T1 and T2 invasive breast cancer|t1 and t2 invasive breast cancer
5222071|NCT02610595|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5222072|NCT02610595|Jianpiyiqi Recipe|jianpiyiqi recipe
5222073|NCT02610595|Huoxuejiedu Recipe|huoxuejiedu recipe
5222074|NCT02610595|Effectiveness|effectiveness
5222075|NCT02610595|Safety|safety
5222076|NCT02610582|CNGA3-linked|cnga3-linked
5222077|NCT02610569|Colonic capsule|colonic capsule
5222078|NCT02610569|ulcerative colitis|ulcerative colitis
5222079|NCT02610569|mucosal healing|mucosal healing
5222080|NCT02610569|endoscopic score|endoscopic score
5222081|NCT02610556|NPC|npc
5423246|NCT01616550|analgesia|analgesia
5222082|NCT02610556|concurrent chemotherapy|concurrent chemotherapy
5222083|NCT02610556|docetaxel|docetaxel
5222084|NCT02610556|cisplatin|cisplatin
5222085|NCT02610543|Primary Sjögren's Syndrome|primary sjögren's syndrome
5222086|NCT02610530|type 2 diabetes|type 2 diabetes
5222087|NCT02610530|metabolic surgery|metabolic surgery
5222088|NCT02610530|medical treatment|medical treatment
5222089|NCT02610517|Hazardous alcohol use|hazardous alcohol use
5222090|NCT02610517|Computer based intervention (CBI)|computer based intervention (cbi)
5222091|NCT02610517|Pharmacotherapy|pharmacotherapy
5222092|NCT02610504|degenerative arthritis|degenerative arthritis
5222099|NCT02610387|Spasticity|spasticity
5222100|NCT02610374|Gut microbiota composition|gut microbiota composition
5222101|NCT02610348|Hepatitis B|hepatitis b
5222102|NCT02610348|Hexaxim®|hexaxim®
5222103|NCT02610348|Hexyon®|hexyon®
5222104|NCT02610348|Hexacima®|hexacima®
5222105|NCT02610348|Prevnar®|prevnar®
5222106|NCT02610348|DTaP-IPV-HB-Hib hexavalent vaccine|dtap-ipv-hb-hib hexavalent vaccine
5222107|NCT02610335|lumbar spinal stenosis|lumbar spinal stenosis
5222108|NCT02610309|family-based crisis intervention|family-based crisis intervention
5222109|NCT02610309|adolescent suicide|adolescent suicide
5222110|NCT02610283|AKI|aki
5222114|NCT02610257|Parkinson's disease|parkinson's disease
5222115|NCT02610257|Freezing of gait|freezing of gait
5222116|NCT02610257|Motor blocks|motor blocks
5222117|NCT02610257|Somatosensory|somatosensory
5222118|NCT02610257|Proprioception|proprioception
5222119|NCT02610257|Muscle vibration|muscle vibration
5222121|NCT02610231|Parkinson's disease|parkinson's disease
5222122|NCT02610231|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
5100504|NCT03369886|OCTA|octa
5222123|NCT02610218|Cell free DNA|cell free dna
5222124|NCT02610218|Circulating tumor cell|circulating tumor cell
5222125|NCT02610218|Therapeutic efficacy|therapeutic efficacy
5222126|NCT02610205|Caring touch|caring touch
5222127|NCT02610205|Tactile massage|tactile massage
5222128|NCT02610205|Healing touch|healing touch
5222129|NCT02610192|Autologous Protein Solution|autologous protein solution
5222130|NCT02610192|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
5222131|NCT02610192|Female|female
5222132|NCT02610114|Assisted reproductive technology (ART)|assisted reproductive technology (art)
5222133|NCT02610114|zygotes|zygotes
5222134|NCT02610114|Z-score (Zygote Score)|z-score (zygote score)
5222135|NCT02610114|Infertility|infertility
5210115|NCT02682290|SPUTUM|sputum
5210116|NCT02682290|RHEOLOGY|rheology
5210117|NCT02682277|obesity|obesity
5210118|NCT02682277|body weight|body weight
5210119|NCT02682277|overweight|overweight
5210120|NCT02682277|weight loss|weight loss
5222136|NCT02610101|Specific Carbohydrate Diet|specific carbohydrate diet
5222137|NCT02610101|Diet|diet
5222138|NCT02610101|Nutrition|nutrition
5222139|NCT02610088|Diabetes|diabetes
5222140|NCT02610088|Atherosclerosis|atherosclerosis
5222141|NCT02610088|Cardiovascular disease|cardiovascular disease
5222142|NCT02610088|Endothelial dysfunction|endothelial dysfunction
5222143|NCT02610088|Vascular function|vascular function
5222144|NCT02610088|Dapagliflozin|dapagliflozin
5222145|NCT02610088|Gliclazide|gliclazide
5222146|NCT02610075|AZD1775|azd1775
5222147|NCT02610075|Metastatic solid tumors|metastatic solid tumors
5222148|NCT02610075|Ovarian cancer|ovarian cancer
5222149|NCT02610062|AML|aml
5222150|NCT02610062|Acute Myeloid Leukemia|acute myeloid leukemia
5222151|NCT02610049|PTSD|ptsd
5222152|NCT02610036|diabetes|diabetes
5222153|NCT02610036|foot ulcer|foot ulcer
5222154|NCT02610010|NPC|npc
5222155|NCT02610010|concurrent chemotherapy|concurrent chemotherapy
5222156|NCT02610010|IMRT|imrt
5222157|NCT02610010|stage II|stage ii
5222158|NCT02609997|Intraocular lens|intraocular lens
5222159|NCT02609984|immunotherapy|immunotherapy
5222160|NCT02609984|CMB305|cmb305
5222161|NCT02609984|LV305|lv305
5222162|NCT02609984|GLA-SE|gla-se
5222163|NCT02609984|Atezolizumab|atezolizumab
5222164|NCT02609984|NY-ESO-1|ny-eso-1
5222165|NCT02609971|Anterior cruciate ligament|anterior cruciate ligament
5222166|NCT02609971|Neuromuscular Performance and balance|neuromuscular performance and balance
5222167|NCT02609945|Migraine attacks|migraine attacks
5222168|NCT02609932|Interferon-gamma|interferon-gamma
5222169|NCT02609932|innate immunity|innate immunity
5222170|NCT02609919|study of contrast reaction in children under 2 years of age|study of contrast reaction in children under 2 years of age
5222171|NCT02609919|safety|safety
5222172|NCT02609906|proximal humerus|proximal humerus
5222173|NCT02609906|AO 11-A3 fracture|ao 11-a3 fracture
5222174|NCT02609906|MultiLoc|multiloc
5222175|NCT02609906|Philos augmented|philos augmented
5222176|NCT02609893|HCV|hcv
5222177|NCT02609880|Psycho-Oncology|psycho-oncology
5222178|NCT02609880|Psychoneuroimmunology|psychoneuroimmunology
5222179|NCT02609880|Cognitive Behavioral Therapy|cognitive behavioral therapy
5222180|NCT02609880|Gynecologic Cancer|gynecologic cancer
5222181|NCT02609880|Insomnia|insomnia
5222182|NCT02609880|Pain|pain
5222183|NCT02609880|Distress|distress
5222184|NCT02609880|Cortisol|cortisol
5222185|NCT02609880|Cytokines|cytokines
5222186|NCT02609854|herniated disc|herniated disc
5222187|NCT02609854|sustained acoustic medicine|sustained acoustic medicine
5222188|NCT02609854|ultrasound|ultrasound
5222189|NCT02609854|CLBP|clbp
5222192|NCT02609789|Systemic Lupus Erythematosus|systemic lupus erythematosus
5222193|NCT02609789|JNJ-55920839|jnj-55920839
5222194|NCT02609789|Healthy Volunteers|healthy volunteers
5222195|NCT02609789|CNTO 6358|cnto 6358
5342983|NCT01981291|Anesthesia, Regional|anesthesia, regional
5222209|NCT02609737|Radiolabeled Somatostatin Antagonists|radiolabeled somatostatin antagonists
5222210|NCT02609737|68Ga-DOTA-JR11|68ga-dota-jr11
5222211|NCT02609737|177Lu-DOTA-JR11|177lu-dota-jr11
5222212|NCT02609737|Pet scan|pet scan
5222213|NCT02609737|CT scan|ct scan
5222215|NCT02609724|breast cancer|breast cancer
5222216|NCT02609724|lymphedema|lymphedema
5222217|NCT02609724|manual lymph drainage|manual lymph drainage
5222218|NCT02609724|near infrared fluorescence imaging|near infrared fluorescence imaging
5222220|NCT02609698|Polymer-free|polymer-free
5222221|NCT02609698|Antiplatelet therapy|antiplatelet therapy
5222222|NCT02609698|Clopidogrel|clopidogrel
5222223|NCT02609698|DES|des
5222224|NCT02609698|DAPT|dapt
5222225|NCT02609685|Thyroid cancer|thyroid cancer
5962686|NCT04279379|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
5222226|NCT02609685|Active surveillance|active surveillance
5222227|NCT02609685|PTMC|ptmc
5222228|NCT02609672|Exercise|exercise
5222229|NCT02609672|Resilience|resilience
5222230|NCT02609659|Chronic Hepatitis C Infection|chronic hepatitis c infection
5222232|NCT02609646|Pharmacokinetics|pharmacokinetics
5222233|NCT02609646|Critically ill patients|critically ill patients
5100617|NCT03369236|fD|fd
5222234|NCT02609594|human amniotic membrane|human amniotic membrane
5222235|NCT02609594|compression therapy|compression therapy
5222236|NCT02609594|venous leg ulcer|venous leg ulcer
5222237|NCT02609581|Non Interventional Study|non interventional study
5222238|NCT02609581|NIS|nis
5222239|NCT02609581|sublingual immunotherapy|sublingual immunotherapy
5222240|NCT02609581|allergen|allergen
5222241|NCT02609581|Mites|mites
5222242|NCT02609568|Children|children
5222243|NCT02609568|Head injury|head injury
5222244|NCT02609568|Salivary biomarker|salivary biomarker
5222245|NCT02609568|Trauma Brain Injury|trauma brain injury
5222246|NCT02609555|TEM|tem
5222247|NCT02609555|Rectopexy|rectopexy
5222248|NCT02609555|rectal prolapse|rectal prolapse
5222249|NCT02609542|oral language|oral language
5222250|NCT02609542|STOL|stol
5222251|NCT02609542|memory|memory
5222252|NCT02609542|eye tracking|eye tracking
5222253|NCT02609529|Irritable Bowel Syndrome|irritable bowel syndrome
5222254|NCT02609529|Pediatrics|pediatrics
5222255|NCT02609529|Nutrition|nutrition
5222256|NCT02609516|Multimorbidity|multimorbidity
5222257|NCT02609516|Health inequalities|health inequalities
5222258|NCT02609516|Ageing|ageing
5222259|NCT02609516|Mortality|mortality
5222260|NCT02609477|Recreational stimulant users|recreational stimulant users
5222261|NCT02609477|Recreational Drug Users|recreational drug users
5222262|NCT02609451|quality of life|quality of life
5222263|NCT02609451|feasibility|feasibility
5222264|NCT02609451|safety|safety
5222265|NCT02609451|protective ileostomy closure|protective ileostomy closure
5222266|NCT02609438|worksite|worksite
5222267|NCT02609438|intervention|intervention
5222268|NCT02609438|sitting|sitting
5222269|NCT02609399|Influenza|influenza
5222270|NCT02609399|Antiviral treatment|antiviral treatment
5222271|NCT02609399|Emergency department|emergency department
5222272|NCT02609399|Influenza therapeutics|influenza therapeutics
5222273|NCT02609399|Rapid influenza testing|rapid influenza testing
5222274|NCT02609386|Head and Neck Neoplasms|head and neck neoplasms
5222275|NCT02609386|Immunotherapy|immunotherapy
5222276|NCT02609386|Cancer|cancer
5222277|NCT02609386|Oral Cavity|oral cavity
5222278|NCT02609373|shiftwork|shiftwork
5222279|NCT02609373|sleep hygiene|sleep hygiene
5222280|NCT02609373|prevention|prevention
5222281|NCT02609373|intervention|intervention
5222282|NCT02609373|occupational|occupational
5222283|NCT02609373|biological|biological
5222284|NCT02609373|breast cancer|breast cancer
5222285|NCT02609373|lifestyle|lifestyle
5222286|NCT02609360|Acute Respiratory Failure|acute respiratory failure
5222287|NCT02609360|ARDS|ards
5222288|NCT02609360|ECMO|ecmo
5222289|NCT02609360|Lung transplantation|lung transplantation
5222290|NCT02609360|Acid-Base Equilibrium|acid-base equilibrium
5222291|NCT02609347|Manual Therapy|manual therapy
5222292|NCT02609347|Ankle Fracture|ankle fracture
5222293|NCT02609347|Hindfoot Fracture|hindfoot fracture
5222294|NCT02609321|Paravertebral|paravertebral
5222295|NCT02609321|Single injection|single injection
5222296|NCT02609321|Breast surgery|breast surgery
5222297|NCT02609321|Analgesia|analgesia
5222298|NCT02609308|ankle sprain|ankle sprain
5222299|NCT02609308|platelet-rich plasma|platelet-rich plasma
5222300|NCT02609308|ankle injuries|ankle injuries
5222301|NCT02609295|α-linolenic acid|α-linolenic acid
5222302|NCT02609295|perilla oil|perilla oil
5222303|NCT02609295|aPTT|aptt
5222304|NCT02609295|Collagen-epinephrine closure time|collagen-epinephrine closure time
5222305|NCT02609295|Lp-PLA2|lp-pla2
5222306|NCT02609282|Sedentary behaviour|sedentary behaviour
5222307|NCT02609282|sitting|sitting
5222308|NCT02609282|workplace|workplace
5222309|NCT02609282|prompts|prompts
5222310|NCT02609256|Intracranial hypertension|intracranial hypertension
5222311|NCT02609256|cerebral herniation|cerebral herniation
5222312|NCT02609256|Stereotactic infarct tissue aspiration|stereotactic infarct tissue aspiration
5222313|NCT02609256|fatality|fatality
5222314|NCT02609256|disability|disability
5222315|NCT02609243|prediabetes|prediabetes
5222316|NCT02609243|diabetes mellitus type 2|diabetes mellitus type 2
5222317|NCT02609243|obesity|obesity
5222318|NCT02609243|NAFLD|nafld
5222319|NCT02609243|dyslipoproteinemia|dyslipoproteinemia
5222322|NCT02609204|Pattern Electroretinogram (PERG)|pattern electroretinogram (perg)
5222323|NCT02609204|Flash Electroretinogram (FERG)|flash electroretinogram (ferg)
5222324|NCT02609178|artificial crown|artificial crown
5222325|NCT02609178|biomorphic|biomorphic
5222326|NCT02609178|functional generated path|functional generated path
5962687|NCT04279379|PD-1 blockade|pd-1 blockade
5222327|NCT02609178|muscle-action theory|muscle-action theory
5222328|NCT02609178|anatomic theory|anatomic theory
5222329|NCT02609126|osteoarthritis|osteoarthritis
5222330|NCT02609126|knee|knee
5222331|NCT02609113|Carpal Tunnel Syndrome|carpal tunnel syndrome
5222332|NCT02609074|bone substitute|bone substitute
5296800|NCT02192944|ECG|ecg
5210313|NCT02680977|Mucuna pruriens|mucuna pruriens
5210314|NCT02680977|Levodopa|levodopa
5210315|NCT02680951|Pediatric|pediatric
5210316|NCT02680951|Adolescent|adolescent
5210317|NCT02680912|Bi syndrome|bi syndrome
5210318|NCT02680899|science education|science education
5210319|NCT02680899|health promotion|health promotion
5210320|NCT02680899|mental health promotion|mental health promotion
5210321|NCT02680899|stigmatization|stigmatization
5222333|NCT02609074|CPC|cpc
5222334|NCT02609074|rhBMP-2|rhbmp-2
5222335|NCT02609048|PBC|pbc
5222336|NCT02609022|Myasthenia Gravis|myasthenia gravis
5222337|NCT02609022|CV-MG01 therapeutic vaccine|cv-mg01 therapeutic vaccine
5222338|NCT02609022|Acetylcholine receptor mimetic peptides|acetylcholine receptor mimetic peptides
5222339|NCT02609022|Safety|safety
5222340|NCT02609022|Immunogenic response|immunogenic response
5222341|NCT02609022|First-in-Human|first-in-human
5222342|NCT02609022|Proof-of-Concept|proof-of-concept
5222343|NCT02609022|Myasterix|myasterix
5222344|NCT02609009|Back Pain|back pain
5222345|NCT02609009|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5222346|NCT02609009|Spinal Manipulation|spinal manipulation
5222347|NCT02608983|Seaweed|seaweed
5222348|NCT02608983|Hydrocolloid|hydrocolloid
5222349|NCT02608983|Functional Food|functional food
5222350|NCT02608983|Dietary Fibre|dietary fibre
5222351|NCT02608983|Prebiotic|prebiotic
5222352|NCT02608983|Low molecular weight polysaccharides|low molecular weight polysaccharides
5222353|NCT02608983|Alginate|alginate
5222354|NCT02608983|Agar|agar
5222355|NCT02608983|HYFFI|hyffi
5222356|NCT02608983|Low molecular weight seaweed derived hydrocolloids as functional food ingredients|low molecular weight seaweed derived hydrocolloids as functional food ingredients
5222357|NCT02608983|subjects|subjects
5222358|NCT02608931|delta-9-tetrahydrocannabinol (THC)|delta-9-tetrahydrocannabinol (thc)
5222359|NCT02608892|Breastfeeding|breastfeeding
5222360|NCT02608892|Skin to skin care|skin to skin care
5222361|NCT02608892|Sucrose|sucrose
5222362|NCT02608892|Newborn screening|newborn screening
5222363|NCT02608892|Blood test|blood test
5222364|NCT02608892|Neonate|neonate
5222365|NCT02608892|Infant|infant
5222366|NCT02608892|Knowledge translation|knowledge translation
5222367|NCT02608879|proinflammatory cytokines|proinflammatory cytokines
5222368|NCT02608879|microbiome|microbiome
5222369|NCT02608879|radiation therapy|radiation therapy
5222370|NCT02608866|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5222371|NCT02608866|spine metastasis|spine metastasis
5222372|NCT02608840|slow-wave sleep|slow-wave sleep
5222373|NCT02608840|cognition|cognition
5222374|NCT02608840|auditory stimulation|auditory stimulation
5222375|NCT02608827|Hypertension; slow breathing; sympathetic nerve activity|hypertension; slow breathing; sympathetic nerve activity
5222376|NCT02608788|postoperative sore throat|postoperative sore throat
5222377|NCT02608788|American Society of Anesthesiologists status|american society of anesthesiologists status
5222378|NCT02608788|general anesthesia|general anesthesia
5222379|NCT02608788|post-anesthesia care unit(PACU)|post-anesthesia care unit(pacu)
5222380|NCT02608775|ANI|ani
5222381|NCT02608775|SPI|spi
5222382|NCT02608775|Autonomic balance|autonomic balance
5222383|NCT02608775|Nociception measurement|nociception measurement
5222384|NCT02608762|Pediatric brain tumors|pediatric brain tumors
5222385|NCT02608762|Radiation therapy|radiation therapy
5222386|NCT02608762|Neurobehavioral functions|neurobehavioral functions
5222387|NCT02608762|Proton radiotherapy|proton radiotherapy
5222388|NCT02608749|Osteoporosis|osteoporosis
5222389|NCT02608749|Fall|fall
5222390|NCT02608749|Fracture|fracture
5222391|NCT02608749|Sacopenia|sacopenia
5222392|NCT02608749|Body Composition|body composition
5222393|NCT02608736|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5222394|NCT02608736|histone deacetylases|histone deacetylases
5222395|NCT02608736|valproic acid|valproic acid
5222396|NCT02608736|acetylation|acetylation
5222397|NCT02608736|chemoprevention|chemoprevention
5222398|NCT02608736|DNA methyltransferase|dna methyltransferase
5222399|NCT02608736|methylation|methylation
5222400|NCT02608723|shock wave|shock wave
5222401|NCT02608723|plantar fasciitis|plantar fasciitis
5222402|NCT02608723|placebo effect|placebo effect
5222403|NCT02608723|nocebo effect|nocebo effect
5222404|NCT02608684|immunotherapy|immunotherapy
5222405|NCT02608684|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
5222406|NCT02608684|immune checkpoint inhibitors|immune checkpoint inhibitors
5222407|NCT02608671|Episiotomy|episiotomy
5222408|NCT02608671|continuous suture|continuous suture
5222409|NCT02608671|Skin adhesive tape|skin adhesive tape
5222410|NCT02608658|Cirrhosis|cirrhosis
5222411|NCT02608658|Ascites|ascites
5222413|NCT02608632|Renal denervation|renal denervation
5222414|NCT02608632|Ablation|ablation
5222415|NCT02608619|18F-fluorocholine|18f-fluorocholine
5222416|NCT02608619|Pet imaging|pet imaging
5222417|NCT02608619|Biopsy|biopsy
5222418|NCT02608619|15-268|15-268
5222419|NCT02608580|pediatric hospital care|pediatric hospital care
5222420|NCT02608580|adult hospital care|adult hospital care
5222421|NCT02608580|sickle cell disease|sickle cell disease
5115363|NCT03275363|Dementia|dementia
5222422|NCT02608554|Polycystic ovary sybdrome|polycystic ovary sybdrome
5222423|NCT02608554|Taichi|taichi
5222424|NCT02608541|Multiple Rib Fractures, Frail Chest|multiple rib fractures, frail chest
5222425|NCT02608476|acne|acne
5222426|NCT02608463|neuropathic pain|neuropathic pain
5222427|NCT02608463|pregnancy|pregnancy
5222428|NCT02608450|acne|acne
5222429|NCT02608437|melanoma|melanoma
5222430|NCT02608437|ipilimumab|ipilimumab
5222431|NCT02608437|SGI-110|sgi-110
5222432|NCT02608424|Foot mechanical stimulation|foot mechanical stimulation
5222433|NCT02608424|Autonomic nervous system|autonomic nervous system
5222434|NCT02608424|Inflammation|inflammation
5222435|NCT02608424|Parkinson's disease|parkinson's disease
5222436|NCT02608424|Spectral analysis|spectral analysis
5222437|NCT02608424|Heart rate variability|heart rate variability
5222438|NCT02608424|Blood pressure variability|blood pressure variability
5222439|NCT02608398|obesity|obesity
5222440|NCT02608398|weight-loss|weight-loss
5222441|NCT02608398|metabonomics|metabonomics
5222442|NCT02608398|gut microbiome|gut microbiome
5222443|NCT02608372|Seaweed|seaweed
5222444|NCT02608372|Insulin|insulin
5222445|NCT02608372|Glucose tolerance|glucose tolerance
5222446|NCT02608372|C-peptide|c-peptide
5222447|NCT02608372|Appetide|appetide
5222448|NCT02608372|Metabolomics|metabolomics
5222449|NCT02608359|Post-Marketing Surveillance|post-marketing surveillance
5222450|NCT02608359|Abiraterone Acetate|abiraterone acetate
5222451|NCT02608359|Zytiga|zytiga
5222452|NCT02608346|Circulating tumor DNA|circulating tumor dna
5222453|NCT02608346|BRCA1 mutation|brca1 mutation
5222454|NCT02608346|Circulating tumor cells|circulating tumor cells
5222455|NCT02608333|Early intervention|early intervention
5222456|NCT02608333|ESDM|esdm
5222457|NCT02608333|behavioral and developmental intervention|behavioral and developmental intervention
5222458|NCT02608320|Healthy|healthy
5222459|NCT02608320|JNJ-35685-AAA-G016|jnj-35685-aaa-g016
5222460|NCT02608320|JNJ-35685-AAA-G021|jnj-35685-aaa-g021
5222461|NCT02608320|DURAGESIC|duragesic
5222462|NCT02608320|Fentanyl|fentanyl
5222463|NCT02608307|Treatment Decision-Making|treatment decision-making
5222464|NCT02608307|Adolescents and Young Adult Oncology|adolescents and young adult oncology
5222465|NCT02608294|stroke|stroke
5222466|NCT02608294|gait|gait
5222467|NCT02608294|balance|balance
5222468|NCT02608281|Spectral Mammography|spectral mammography
5222469|NCT02608281|Dual energy|dual energy
5222470|NCT02608281|Contrast enhanced|contrast enhanced
5222471|NCT02608268|Solid tumors|solid tumors
5222472|NCT02608268|Melanoma|melanoma
5222473|NCT02608268|Non small cell lung cancer|non small cell lung cancer
5222474|NCT02608268|NSCLC|nsclc
5222475|NCT02608268|Renal cell carcinoma|renal cell carcinoma
5222477|NCT02608268|Phase I-Ib/II|phase i-ib/ii
5222478|NCT02608268|MBG453|mbg453
5222479|NCT02608268|PDR001|pdr001
5222480|NCT02608268|Checkpoint inhibitor|checkpoint inhibitor
5222481|NCT02608268|PD-1|pd-1
5222482|NCT02608268|TIM-3|tim-3
5222483|NCT02608164|Healthy adults|healthy adults
5222484|NCT02608151|neurodevelopement|neurodevelopement
5222485|NCT02608151|Very preterm infant|very preterm infant
5222486|NCT02608138|iodine|iodine
5222487|NCT02608138|urine|urine
5222488|NCT02608138|children|children
5222489|NCT02608138|schools|schools
5222490|NCT02608138|cognitive performance|cognitive performance
5222491|NCT02608138|salt fortification|salt fortification
5222492|NCT02608125|FGFR|fgfr
5222493|NCT02608099|Atrial fibrillation|atrial fibrillation
5222494|NCT02608099|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5222495|NCT02608099|Catheter ablation|catheter ablation
5222496|NCT02608099|Apixaban|apixaban
5222497|NCT02608099|Warfarin|warfarin
5222498|NCT02608099|Harvard Clinical Research Institute|harvard clinical research institute
5222499|NCT02608086|PTSD|ptsd
5222500|NCT02608086|Trauma|trauma
5222501|NCT02608086|Emergency|emergency
5222503|NCT02608086|Psychological First Aid|psychological first aid
5222504|NCT02608021|Alzheimer's Disease|alzheimer's disease
5222505|NCT02608021|MRI|mri
5222506|NCT02608008|3D-Ultrasound|3d-ultrasound
5222507|NCT02608008|Live X-rays|live x-rays
5222508|NCT02608008|EchoNavigator System|echonavigator system
5222509|NCT02607982|Esophageal cancer|esophageal cancer
5222510|NCT02607982|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5222511|NCT02607982|Oxaliplatin|oxaliplatin
5222512|NCT02607982|Paclitaxel|paclitaxel
5222513|NCT02607982|Survival|survival
5222514|NCT02607982|Toxicity|toxicity
5222515|NCT02607969|Deformational Plagiocephaly,Treatment,Compliance|deformational plagiocephaly,treatment,compliance
5222517|NCT02607943|acute stroke|acute stroke
5222518|NCT02607943|hyperglycemia|hyperglycemia
5222519|NCT02607943|regular insulin|regular insulin
5222520|NCT02607943|long-acting insulin|long-acting insulin
5222522|NCT02607917|Cardiovascular Disease|cardiovascular disease
5222523|NCT02607904|Cannabidiol|cannabidiol
5222524|NCT02607904|GWP42003-P|gwp42003-p
5222525|NCT02607904|Epidiolex|epidiolex
5222526|NCT02607904|Stiripentol|stiripentol
5222527|NCT02607904|Valproate|valproate
5222528|NCT02607891|Cannabidiol|cannabidiol
5222529|NCT02607891|GWP42003-P|gwp42003-p
5222530|NCT02607891|Epidiolex|epidiolex
5222531|NCT02607891|Stiripentol|stiripentol
5222532|NCT02607891|Valproate|valproate
5222533|NCT02607878|Cardiac arrest|cardiac arrest
5222534|NCT02607878|Coma|coma
5222536|NCT02607878|Automated pupillometry|automated pupillometry
5222537|NCT02607878|EEG|eeg
5222538|NCT02607878|Evoked potentials|evoked potentials
5222539|NCT02607878|Targeted Temperature Management (TTM)|targeted temperature management (ttm)
5222540|NCT02607852|Patient Reported Outcomes Measure|patient reported outcomes measure
5222541|NCT02607852|Burns|burns
5222542|NCT02607839|lipid handling by the gut and liver|lipid handling by the gut and liver
5222543|NCT02607813|LXH254, CRAF, MAPK, solid tumor, PDR001|lxh254, craf, mapk, solid tumor, pdr001
5222544|NCT02607800|Chronic Hepatitis C Infection|chronic hepatitis c infection
5222545|NCT02607787|Exercise Rehabilitation|exercise rehabilitation
5222546|NCT02607774|Plaque psoriasis|plaque psoriasis
5222547|NCT02607774|disease-drug-drug-interaction|disease-drug-drug-interaction
5222548|NCT02607774|midazolam|midazolam
5222549|NCT02607774|secukinumab|secukinumab
5222550|NCT02607761|infertility|infertility
5222551|NCT02607761|fertility awareness|fertility awareness
5222552|NCT02607761|health interventions|health interventions
5222553|NCT02607761|young adults|young adults
5222554|NCT02607748|18F-NaF PET|18f-naf pet
5222555|NCT02607748|18F-sodium fluoride PET|18f-sodium fluoride pet
5222556|NCT02607748|Coronary CTA|coronary cta
5222557|NCT02607735|Chronic Hepatitis C Infection|chronic hepatitis c infection
5222558|NCT02607644|Intubation|intubation
5222559|NCT02607644|Ventilation|ventilation
5222560|NCT02607644|Cardiac arrest|cardiac arrest
5222561|NCT02607644|prehospital|prehospital
5222562|NCT02607644|Laryngeal Masks|laryngeal masks
5222563|NCT02607644|Laryngeal Tube|laryngeal tube
5222564|NCT02607644|airway management|airway management
5222565|NCT02607631|Thymic epithelial tumors|thymic epithelial tumors
5222566|NCT02607631|Pembrolizumab|pembrolizumab
5222567|NCT02607605|lung cancer|lung cancer
5222568|NCT02607605|leptomeningeal metastases|leptomeningeal metastases
5222569|NCT02607605|cell-free DNA|cell-free dna
5222570|NCT02607592|Non-Small-Cell Lung cancer|non-small-cell lung cancer
5222571|NCT02607592|overall toxicity value|overall toxicity value
5222572|NCT02607566|Diabetes|diabetes
5222573|NCT02607566|Yoga|yoga
5222574|NCT02607566|Walking|walking
5222575|NCT02607566|Stress|stress
5222576|NCT02607566|exercise|exercise
5222577|NCT02607566|glycemic control|glycemic control
5222578|NCT02607540|Chemoradiotherapy|chemoradiotherapy
5222579|NCT02607540|Esophageal Squamous Cancer|esophageal squamous cancer
5222580|NCT02607540|Cisplatin-5-fluorouracil|cisplatin-5-fluorouracil
5222581|NCT02607501|coil embolization|coil embolization
5222582|NCT02607501|bifurcation|bifurcation
5222583|NCT02607488|Obese patients|obese patients
5222584|NCT02607488|Undergoing bariatric surgery|undergoing bariatric surgery
5222585|NCT02607475|telesonography|telesonography
5222586|NCT02607475|ultrasound|ultrasound
5222587|NCT02607475|robotic telesonography|robotic telesonography
5222588|NCT02607449|Tuberculosis|tuberculosis
5222589|NCT02607449|Multi-drug resistant TB|multi-drug resistant tb
5222590|NCT02607449|TB treatment|tb treatment
5222591|NCT02607410|Type 2 diabetes|type 2 diabetes
5222592|NCT02607410|sitagliptin|sitagliptin
5222593|NCT02607410|NPH insulin|nph insulin
5222594|NCT02607410|GLP-1|glp-1
5222595|NCT02607371|Patient treatment preference|patient treatment preference
5222596|NCT02607371|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5222597|NCT02607371|NOAC|noac
5222598|NCT02607371|VKA|vka
5222599|NCT02607358|Clopidogrel|clopidogrel
5222600|NCT02607358|acetacylic acid|acetacylic acid
5222601|NCT02607358|antiplatelet therapy|antiplatelet therapy
5222602|NCT02607358|HOTPR|hotpr
5222603|NCT02607358|VerifyNow|verifynow
5222604|NCT02607332|single-center|single-center
5222605|NCT02607332|prospective|prospective
5222606|NCT02607332|single-arm|single-arm
5222610|NCT02607319|Implantation|implantation
5222611|NCT02607319|low molecular weight heparin|low molecular weight heparin
5222612|NCT02607319|In vitro Fertilization|in vitro fertilization
5222613|NCT02607319|Assisted Reproductive Technology|assisted reproductive technology
5222614|NCT02607319|Pregnancy|pregnancy
5222615|NCT02607293|Polycystic Ovary Syndrome|polycystic ovary syndrome
5222616|NCT02607293|Gonadotropin releasing hormone agonist (GnRH-a)|gonadotropin releasing hormone agonist (gnrh-a)
5222617|NCT02607293|Gonal-f|gonal-f
5222618|NCT02607293|Assisted Reproductive Technology|assisted reproductive technology
5222619|NCT02607280|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
5222620|NCT02607280|post-herpetic neuralgia|post-herpetic neuralgia
5222621|NCT02607280|renal impairment|renal impairment
5222622|NCT02607267|EOSS|eoss
5222623|NCT02607267|Metabolic Surgery|metabolic surgery
5224024|NCT02598830|Muscle|muscle
5222624|NCT02607267|postoperative outcome|postoperative outcome
5222625|NCT02607267|30 - day mortality|30 - day mortality
5222626|NCT02607241|drug-coated balloon|drug-coated balloon
5222627|NCT02607241|bioresorbable scaffold|bioresorbable scaffold
5222628|NCT02607241|fractional flow reserve|fractional flow reserve
5222629|NCT02607241|optical coherence tomography|optical coherence tomography
5222630|NCT02607150|Spinal Fusion|spinal fusion
5222631|NCT02607150|Cerebral Oxygenation|cerebral oxygenation
5222632|NCT02607150|Blood Transfusion|blood transfusion
5222633|NCT02607124|DIPG|dipg
5151032|NCT03048448|adults,|adults,
5222637|NCT02607072|APREMEC, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival|apremec, aspirin, colorectal cancer, adjuvant therapy, recurrence, metastasis, survival
5222638|NCT02607046|rehabilitation|rehabilitation
5222639|NCT02607046|exercise training|exercise training
5222640|NCT02607033|Exercise|exercise
5222641|NCT02607033|Weight Loss|weight loss
5222642|NCT02607033|Mobility Limitation|mobility limitation
5222643|NCT02607007|Dairy|dairy
5222644|NCT02607007|Post-prandial Glycemia|post-prandial glycemia
5222645|NCT02607007|Satiety|satiety
5222646|NCT02607007|Food Intake|food intake
5222647|NCT02607007|Insulin|insulin
5222648|NCT02607007|Milk|milk
5222649|NCT02607007|Greek yogurt|greek yogurt
5222650|NCT02607007|Cheese|cheese
5222651|NCT02607007|Soy beverage|soy beverage
5222652|NCT02606994|oral mucositis|oral mucositis
5222653|NCT02606994|chemotherapy|chemotherapy
5222654|NCT02606994|toothpaste|toothpaste
5222655|NCT02606981|Water treatment|water treatment
5222656|NCT02606981|Child growth|child growth
5222657|NCT02606981|Enteric infection|enteric infection
5222658|NCT02606955|Bioimpedance|bioimpedance
5222659|NCT02606955|Dry weight|dry weight
5222660|NCT02606955|Hemodialysis|hemodialysis
5222661|NCT02606955|Resistance|resistance
5222662|NCT02606942|chondromalacia patellae (CMP)|chondromalacia patellae (cmp)
5222663|NCT02606942|patella|patella
5222664|NCT02606916|Once-daily Simultaneous Modulated Accelerated Radiotherapy|once-daily simultaneous modulated accelerated radiotherapy
5222665|NCT02606916|S-1|s-1
5222666|NCT02606916|DDP|ddp
5222667|NCT02606916|elderly patients|elderly patients
5222668|NCT02606890|Magnetic Resonance Imaging|magnetic resonance imaging
5222669|NCT02606890|Stroke Lesion Pattern|stroke lesion pattern
5222670|NCT02606890|Atrial Fibrillation|atrial fibrillation
5222671|NCT02606890|Stroke|stroke
5222672|NCT02606851|Proton Pump Inhibitor, GERD, GERD Q|proton pump inhibitor, gerd, gerd q
5222673|NCT02606799|Esophagectomy Inflammation Hemoperfusion Cytokines|esophagectomy inflammation hemoperfusion cytokines
5222674|NCT02606786|stabilization exercises|stabilization exercises
5222675|NCT02606773|vitamin C supplementation|vitamin c supplementation
5222676|NCT02606760|Nail psoriasis|nail psoriasis
5222677|NCT02606747|DPN|dpn
5222678|NCT02606747|fall|fall
5222679|NCT02606747|fMRI|fmri
5222680|NCT02606747|balance|balance
5222681|NCT02606721|Food Hypersensitivity|food hypersensitivity
5222682|NCT02606721|Oral Food Challenge|oral food challenge
5222683|NCT02606721|Skin Prick Test|skin prick test
5222684|NCT02606721|Food Biomarkers|food biomarkers
5222685|NCT02606695|Spine Surgery Patients|spine surgery patients
5222686|NCT02606682|Phase 1|phase 1
5222687|NCT02606682|Safety|safety
5222688|NCT02606682|Tolerability|tolerability
5222689|NCT02606682|Pharmacokinetics|pharmacokinetics
5222690|NCT02606682|Parkinson's Disease|parkinson's disease
5222691|NCT02606630|Relapsing multiple sclerosis|relapsing multiple sclerosis
5222692|NCT02606617|Mosapride|mosapride
5222693|NCT02606617|blood glucose|blood glucose
5222694|NCT02606617|serum lipid|serum lipid
5222695|NCT02606604|Functional Electrical Stimulation|functional electrical stimulation
5222696|NCT02606604|Cycling|cycling
5222697|NCT02606591|Electroencephalograph|electroencephalograph
5222698|NCT02606591|EEG|eeg
5222699|NCT02606591|Hair sample|hair sample
5222700|NCT02606591|Cognitive tests|cognitive tests
5222701|NCT02606591|Cortisol analysis|cortisol analysis
5222702|NCT02606591|Brain activity|brain activity
5222703|NCT02606591|Stress hormones|stress hormones
5222704|NCT02606552|drug eluting stent|drug eluting stent
5222705|NCT02606552|atrial appendage closure|atrial appendage closure
5222706|NCT02606539|gestaional trophoblastic neoplasm|gestaional trophoblastic neoplasm
5222707|NCT02606539|hystrectomy|hystrectomy
5222708|NCT02606539|chemotherapy|chemotherapy
5222710|NCT02606513|Computed Tomography Urography|computed tomography urography
5222711|NCT02606513|Magnetic Resonance Urography|magnetic resonance urography
5222713|NCT02606487|Exacerbation|exacerbation
5222714|NCT02606487|Hyerpolarized xenon MRI|hyerpolarized xenon mri
5222715|NCT02606487|Pediatrics|pediatrics
5222716|NCT02606487|Lung Clearance Index|lung clearance index
5222717|NCT02606461|Advanced unresectable dedifferentiated liposarcoma|advanced unresectable dedifferentiated liposarcoma
5222718|NCT02606461|selinexor|selinexor
5222719|NCT02606461|KCP-330|kcp-330
5210708|NCT02678286|Pain|pain
5210709|NCT02678286|Analgesia|analgesia
5210710|NCT02678286|N1539|n1539
5222720|NCT02606461|Karyopharm|karyopharm
5222721|NCT02606461|Phase 2 / 3|phase 2 / 3
5222722|NCT02606461|dedifferentiated liposarcoma|dedifferentiated liposarcoma
5222723|NCT02606461|Liposarcoma|liposarcoma
5222724|NCT02606448|pain control|pain control
5222725|NCT02606448|patient satisfaction|patient satisfaction
5222726|NCT02606448|liposomal bupivacaine|liposomal bupivacaine
5222727|NCT02606448|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5222728|NCT02606422|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5222729|NCT02606422|neurodegeneration|neurodegeneration
5222730|NCT02606422|language therapy|language therapy
5962688|NCT04279379|decitabine|decitabine
5962689|NCT04279379|sintilimab|sintilimab
5222731|NCT02606422|Primary Progressive Aphasia (PPA)|primary progressive aphasia (ppa)
5862731|NCT00001534|Left Ventricular (LV) Hypertrophy|left ventricular (lv) hypertrophy
5222732|NCT02606370|Unstable Shoes;Trunk muscles;Lumbar lordosis;Low Back Pain|unstable shoes;trunk muscles;lumbar lordosis;low back pain
5222733|NCT02606318|Occupational Therapy|occupational therapy
5222734|NCT02606318|Quality of Life|quality of life
5222735|NCT02606305|Epithelial ovarian cancer|epithelial ovarian cancer
5222736|NCT02606305|Fallopian tube cancer|fallopian tube cancer
5222737|NCT02606305|Primary peritoneal cancer|primary peritoneal cancer
5222740|NCT02606305|Antibody drug conjugate|antibody drug conjugate
5222741|NCT02606305|ImmunoGen|immunogen
5222742|NCT02606305|Antibody|antibody
5222743|NCT02606305|Phase 1|phase 1
5222744|NCT02606305|Folate receptor alpha|folate receptor alpha
5222745|NCT02606253|loop diuretics|loop diuretics
5222746|NCT02606253|thiazide diuretics|thiazide diuretics
5222747|NCT02606253|vasopressin antagonists|vasopressin antagonists
5222748|NCT02606253|diuretic resistance|diuretic resistance
5222749|NCT02606253|heart failure|heart failure
5222750|NCT02606227|Pregnant smokers|pregnant smokers
5222751|NCT02606227|smoking cessation|smoking cessation
5222752|NCT02606227|financial incentives|financial incentives
5222753|NCT02606227|control group|control group
5222754|NCT02606227|randomized study|randomized study
5222755|NCT02606214|Tuberculosis|tuberculosis
5222756|NCT02606214|TBA-354|tba-354
5222757|NCT02606214|Pulmonary Tuberculosis|pulmonary tuberculosis
5222758|NCT02606214|TB|tb
5222759|NCT02606201|stress urinary incontinence|stress urinary incontinence
5222760|NCT02606201|intrinsic sphincter deficiency|intrinsic sphincter deficiency
5222761|NCT02606201|myofiber|myofiber
5222762|NCT02606201|autologous|autologous
5222763|NCT02606201|skeletal muscle precursor cells|skeletal muscle precursor cells
5222764|NCT02606201|autologous serum|autologous serum
5222765|NCT02606188|Modified High-flow nasal cannula|modified high-flow nasal cannula
5222766|NCT02606188|Bronchoscopy|bronchoscopy
5222767|NCT02606188|Oxygen therapy|oxygen therapy
5222768|NCT02606175|health literacy|health literacy
5222769|NCT02606175|patient medication knowledge|patient medication knowledge
5222770|NCT02606175|kidney transplantation|kidney transplantation
5222771|NCT02606175|medication adherence|medication adherence
5222772|NCT02606175|kidney transplant|kidney transplant
5222773|NCT02606175|renal transplantation|renal transplantation
5222774|NCT02606149|Lung cancer|lung cancer
5222775|NCT02606149|chemotherapy outcome|chemotherapy outcome
5222776|NCT02606149|ethics|ethics
5222777|NCT02606149|information|information
5222778|NCT02606136|Duchenne|duchenne
5222779|NCT02606136|muscular|muscular
5222780|NCT02606136|dystrophy|dystrophy
5222781|NCT02606136|DMD|dmd
5222782|NCT02606136|non-ambulatory|non-ambulatory
5222783|NCT02606123|Prostate Cancer|prostate cancer
5222784|NCT02606123|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5222785|NCT02606110|ReBuilder|rebuilder
5222786|NCT02606110|breast cancer|breast cancer
5222787|NCT02606110|chemotherapy induced|chemotherapy induced
5222788|NCT02606084|Renal Impairment|renal impairment
5222789|NCT02606084|Healthy|healthy
5222790|NCT02606084|Esketamine|esketamine
5222791|NCT02606071|cardiac resynchronization therapy|cardiac resynchronization therapy
5222792|NCT02606071|multipoint left ventricular pacing|multipoint left ventricular pacing
5222793|NCT02606045|menorrhagia|menorrhagia
5222794|NCT02606045|VWD|vwd
5222795|NCT02606032|Fecal Microbiota Transplant|fecal microbiota transplant
5222796|NCT02606032|Antibiotics|antibiotics
5222797|NCT02606019|Pentraxin 3|pentraxin 3
5222798|NCT02606019|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5222799|NCT02606019|dengue|dengue
5222800|NCT02606006|Physical Therapy Modalities|physical therapy modalities
5222801|NCT02606006|Motivation|motivation
5222802|NCT02606006|Patient Participation|patient participation
5222803|NCT02606006|Animal Assisted Therapy|animal assisted therapy
5222804|NCT02605993|complement inhibitor|complement inhibitor
5297508|NCT02189889|EPO|epo
5210806|NCT02677610|Skin Diseases, Eczematous|skin diseases, eczematous
5210807|NCT02677610|Skin Diseases, Genetic|skin diseases, genetic
5210861|NCT02677181|ATG|atg
5222811|NCT02605954|HIV 1 Infection|hiv 1 infection
5222812|NCT02605954|HIV|hiv
5222813|NCT02605954|Virologically-Suppressed|virologically-suppressed
5222814|NCT02605954|Antiretroviral agents|antiretroviral agents
5222815|NCT02605941|DNA methylation|dna methylation
5222816|NCT02605941|Cervical cancer|cervical cancer
5222817|NCT02605928|Arthritis|arthritis
5222818|NCT02605928|Bioimpedance|bioimpedance
5222819|NCT02605928|Glucocorticoid|glucocorticoid
5222820|NCT02605928|Intra-articular injection|intra-articular injection
5222821|NCT02605928|Needle Guidance|needle guidance
5222822|NCT02605902|Chronic tic disorders|chronic tic disorders
5222823|NCT02605902|Tourette syndrome|tourette syndrome
5222824|NCT02605876|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5222825|NCT02605863|Enzalutamide|enzalutamide
5222826|NCT02605863|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5222827|NCT02605863|Androgen Deprivation Therapy|androgen deprivation therapy
5222828|NCT02605850|heart health|heart health
5222829|NCT02605811|limited small cell lung cancer|limited small cell lung cancer
5222830|NCT02605811|brain metastases|brain metastases
5220083|NCT02623517|AF|af
5222831|NCT02605811|prophylactic cranial radiotherapy|prophylactic cranial radiotherapy
5222833|NCT02605785|PSP|psp
5222834|NCT02605733|Premature infant|premature infant
5222835|NCT02605733|Amplitude integrated EEG|amplitude integrated eeg
5222836|NCT02605733|Near-infrared spectroscopy|near-infrared spectroscopy
5222837|NCT02605707|Endothelial Progenitor Cells|endothelial progenitor cells
5222838|NCT02605707|Transplantation|transplantation
5222839|NCT02605707|Stroke|stroke
5222840|NCT02605681|midkine|midkine
5222841|NCT02605681|endothelial injury|endothelial injury
5222842|NCT02605681|sepsis|sepsis
5222843|NCT02605681|angiotensin-converting enzyme|angiotensin-converting enzyme
5222844|NCT02605681|angiotensin II|angiotensin ii
5222845|NCT02605668|Anxiety Disorders|anxiety disorders
5222846|NCT02605668|Extinction Learning|extinction learning
5222847|NCT02605668|Optimized Extinction|optimized extinction
5222848|NCT02605668|Behavioral Therapy|behavioral therapy
5222849|NCT02605668|Massed Confrontation|massed confrontation
5222850|NCT02605668|Social Anxiety Disorder|social anxiety disorder
5222851|NCT02605668|Specific Phobia|specific phobia
5222852|NCT02605668|Panic Disorder|panic disorder
5222853|NCT02605668|Agoraphobia|agoraphobia
5222854|NCT02605655|obesity|obesity
5222855|NCT02605655|hyperlipidemia|hyperlipidemia
5222856|NCT02605655|hyperglycemia|hyperglycemia
5222857|NCT02605642|CT-P13|ct-p13
5222858|NCT02605642|Inflectra|inflectra
5222859|NCT02605642|Remsima|remsima
5222860|NCT02605642|Remicade|remicade
5222861|NCT02605642|Infliximab|infliximab
5222862|NCT02605642|Observational|observational
5222863|NCT02605642|Follow-up|follow-up
5222864|NCT02605642|Safety|safety
5222865|NCT02605603|Gaucher Type 1, Gaucher Type 2, Gaucher Type 3|gaucher type 1, gaucher type 2, gaucher type 3
5222866|NCT02605577|late preterm infants|late preterm infants
5222867|NCT02605577|nutrition|nutrition
5222868|NCT02605577|systemic management|systemic management
5222869|NCT02605525|IgAN|igan
5222870|NCT02605512|Radiotherapy|radiotherapy
5222871|NCT02605512|Echocardiography|echocardiography
5222872|NCT02605512|Strain strain rate|strain strain rate
5222873|NCT02605512|Coronary computed tomography angiography|coronary computed tomography angiography
5222874|NCT02605512|Segments of coronary arteries|segments of coronary arteries
5222875|NCT02605512|Subclinical functional and anatomical cardiac lesions|subclinical functional and anatomical cardiac lesions
5222876|NCT02605512|Biomarkers|biomarkers
5222877|NCT02605512|Heart dosimetry|heart dosimetry
5222878|NCT02605486|palbociclib|palbociclib
5222879|NCT02605486|bicalutamide|bicalutamide
5222880|NCT02605486|AR(+)|ar(+)
5222881|NCT02605486|15-207|15-207
5222882|NCT02605460|Bone Marrow Transplantation|bone marrow transplantation
5222883|NCT02605460|Conditioning Regimen|conditioning regimen
5222884|NCT02605434|Parkinson's Disease|parkinson's disease
5222885|NCT02605434|Fluctuating Parkinson's Disease|fluctuating parkinson's disease
5222886|NCT02605434|Advanced Parkinson's Disease|advanced parkinson's disease
5222887|NCT02605434|Carbidopa|carbidopa
5222888|NCT02605434|Levodopa|levodopa
5222889|NCT02605434|Accordion|accordion
5222890|NCT02605434|Accordance|accordance
5222891|NCT02605421|High-risk neuroblastoma|high-risk neuroblastoma
5222892|NCT02605421|Neuroblastoma|neuroblastoma
5312813|NCT02116985|NI|ni
5222893|NCT02605421|Myeloablative chemotherapy|myeloablative chemotherapy
5222894|NCT02605421|Myeloablative consolidation chemotherapy|myeloablative consolidation chemotherapy
5222895|NCT02605421|Autologous peripheral blood stem cell rescue|autologous peripheral blood stem cell rescue
5222897|NCT02605421|Autologous stem cell rescue|autologous stem cell rescue
5222898|NCT02605395|Bioequivalence|bioequivalence
5222899|NCT02605395|Fed condition|fed condition
5222900|NCT02605395|PARIET 20 mg|pariet 20 mg
5115982|NCT03271138|microbiota|microbiota
5222901|NCT02605395|IDIAZOLE 20mg|idiazole 20mg
5222902|NCT02605395|Rabeprazole|rabeprazole
5222903|NCT02605382|Dental Implantation|dental implantation
5222904|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate
5222905|NCT02605356|Radium-223 dichloride|radium-223 dichloride
5222906|NCT02605356|bortezomib|bortezomib
5222907|NCT02605356|dexamethasone|dexamethasone
5222908|NCT02605356|early relapsed multiple myeloma|early relapsed multiple myeloma
5222909|NCT02605356|combination therapy multiple myeloma|combination therapy multiple myeloma
5222910|NCT02605343|PGx|pgx
5222911|NCT02605343|pharmacogenetic testing|pharmacogenetic testing
5222912|NCT02605343|Pain Management|pain management
5222913|NCT02605343|AltheaDx|altheadx
5222914|NCT02605343|Post-Operative Pain Management|post-operative pain management
5222915|NCT02605317|Emergency Physicians|emergency physicians
5222916|NCT02605317|Consulting Physicians|consulting physicians
5222917|NCT02605317|WhatsApp|whatsapp
5222918|NCT02605278|Primary Health Care, Patient Education, Care Managament|primary health care, patient education, care managament
5222919|NCT02605265|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
5222920|NCT02605265|Irinotecan|irinotecan
5222921|NCT02605265|UGT1A1|ugt1a1
5222922|NCT02605252|Chronic hepatitis B|chronic hepatitis b
5222923|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b
5222924|NCT02605252|Nucleotide analogue|nucleotide analogue
5222925|NCT02605200|Diabetes|diabetes
5222926|NCT02605200|Endocrinology|endocrinology
5222928|NCT02605187|cesarean|cesarean
5222929|NCT02605187|postoperative pain|postoperative pain
5222930|NCT02605187|patient choice|patient choice
5222931|NCT02605161|Blood brain barrier|blood brain barrier
5222932|NCT02605161|movement disorder|movement disorder
5222933|NCT02605161|deep brain stimulation|deep brain stimulation
5222934|NCT02605161|essential tremor|essential tremor
5222935|NCT02605161|cervical dystonia|cervical dystonia
5222936|NCT02605161|magnetic resonance imaging|magnetic resonance imaging
5222937|NCT02605161|neostriatum|neostriatum
5222938|NCT02605148|Islet autoimmunity|islet autoimmunity
5222939|NCT02605148|gluten free diet|gluten free diet
5222940|NCT02605148|prediabetes|prediabetes
5222941|NCT02605148|prevention|prevention
5222942|NCT02605148|type 1 diabetes|type 1 diabetes
5222943|NCT02605148|glucose tolerance test|glucose tolerance test
5222944|NCT02605122|pneumonia|pneumonia
5222945|NCT02605122|macrolide|macrolide
5222946|NCT02605122|pediatric|pediatric
5222947|NCT02605109|MERS-CoV|mers-cov
5222948|NCT02605109|Infection control|infection control
5222949|NCT02605109|Case-control studies|case-control studies
5222950|NCT02605096|suspected scaphoid fracture|suspected scaphoid fracture
5222951|NCT02605083|Cancer|cancer
5222952|NCT02605083|Neoplasm|neoplasm
5222953|NCT02605083|Solid Tumor|solid tumor
5222954|NCT02605083|Breast|breast
5222955|NCT02605083|Head and Neck|head and neck
5222956|NCT02605083|Lung|lung
5222957|NCT02605083|Pancreatic|pancreatic
5222958|NCT02605083|Hepatic|hepatic
5222959|NCT02605083|Melanoma|melanoma
5222960|NCT02605083|Colon|colon
5222961|NCT02605083|Renal|renal
5222962|NCT02605083|Thyroid|thyroid
5222963|NCT02605083|Prostate|prostate
5222964|NCT02605083|Ovarian|ovarian
5222965|NCT02605083|MNK1|mnk1
5222966|NCT02605083|MNK2|mnk2
5222967|NCT02605083|eIF4E|eif4e
5222968|NCT02605005|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position|interscalene block, general anesthesia, shoulder arthroscopy, cerebral oxygen saturation, beach chair position
5222969|NCT02604992|Comparative Bioavailability|comparative bioavailability
5222970|NCT02604966|P. falciparum|p. falciparum
5222971|NCT02604966|resistance to artemisinin|resistance to artemisinin
5222972|NCT02604966|Central Vietnam|central vietnam
5222973|NCT02604953|glaucoma|glaucoma
5222974|NCT02604953|VEP|vep
5222975|NCT02604953|PERG|perg
5222976|NCT02604953|SD-tVEP|sd-tvep
5222977|NCT02604953|ss-PERG|ss-perg
5222978|NCT02604940|Postoperative narcotic requirements|postoperative narcotic requirements
5222979|NCT02604940|Dexmedetomidine|dexmedetomidine
5222980|NCT02604940|Bariatric Surgery|bariatric surgery
5222981|NCT02604901|medication adherence|medication adherence
5222982|NCT02604901|community pharmacies|community pharmacies
5222983|NCT02604901|screening and brief intervention|screening and brief intervention
5222984|NCT02604888|Baldness|baldness
5222985|NCT02604888|Alopecia Areata|alopecia areata
5222986|NCT02604888|Alopecia|alopecia
5222987|NCT02604888|Hair loss|hair loss
5222988|NCT02604784|Pressurized Intra Peritoneal Air-flow Chemotherapy (PIPAC)|pressurized intra peritoneal air-flow chemotherapy (pipac)
5222989|NCT02604784|Chemotherapy|chemotherapy
5222990|NCT02604784|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5222991|NCT02604758|Alcoholics [M01.066]|alcoholics [m01.066]
5222992|NCT02604745|degenerative mitral regurgitation|degenerative mitral regurgitation
5222993|NCT02604667|Biomarkers|biomarkers
5222994|NCT02604667|Mechanisms|mechanisms
5222995|NCT02604667|Transcranial Doppler|transcranial doppler
5222996|NCT02604641|skin rejuvenation|skin rejuvenation
5222997|NCT02604641|anti-ageing effects|anti-ageing effects
5222998|NCT02604641|minimal erythema dose|minimal erythema dose
5222999|NCT02604641|dermis structure|dermis structure
5115997|NCT03271073|S1|s1
5223000|NCT02604641|physiological skin condition|physiological skin condition
5223001|NCT02604641|wrinkling|wrinkling
5223002|NCT02604641|dry skin|dry skin
5223003|NCT02604628|Pneumonia|pneumonia
5223004|NCT02604628|Antibiotic Stewardship|antibiotic stewardship
5223005|NCT02604628|Stepped wedge|stepped wedge
5223006|NCT02604628|Antibiotic|antibiotic
5223007|NCT02604615|Chemoradiotherapy|chemoradiotherapy
5223008|NCT02604615|Esophageal Squamous Cancer|esophageal squamous cancer
5223009|NCT02604615|Capecitabine and oxaliplatin|capecitabine and oxaliplatin
5223010|NCT02604615|Chinese|chinese
5223011|NCT02604615|Randomized Controlled Trials|randomized controlled trials
5223012|NCT02604602|PPH|pph
5223013|NCT02604589|Catheters, Indwelling|catheters, indwelling
5223014|NCT02604589|Infusion Pumps|infusion pumps
5223015|NCT02604589|Anesthesia, Local|anesthesia, local
5223016|NCT02604589|Analgesia, Patient-Controlled|analgesia, patient-controlled
5223017|NCT02604589|Bupivacaine|bupivacaine
5223018|NCT02604576|functional dyspepsia|functional dyspepsia
5223019|NCT02604524|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5223020|NCT02604524|Artificial Pancreas (AP)|artificial pancreas (ap)
5223021|NCT02604524|Sensor-Augmented Pump (SAP) Therapy|sensor-augmented pump (sap) therapy
5101481|NCT03363997|estriol|estriol
5223022|NCT02604524|Closed Loop Control|closed loop control
5223023|NCT02604524|Insulin Pump|insulin pump
5223024|NCT02604524|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5223025|NCT02604511|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5223026|NCT02604485|Hypoglycemia|hypoglycemia
5223027|NCT02604485|Congenital Hyperinsulinism|congenital hyperinsulinism
5223028|NCT02604472|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5223029|NCT02604472|induction chemotherapy|induction chemotherapy
5223030|NCT02604472|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5223031|NCT02604446|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5223032|NCT02604446|Analgesics|analgesics
5223033|NCT02604446|Administration and dosage|administration and dosage
5223034|NCT02604446|Knee|knee
5223035|NCT02604446|Postoperational care|postoperational care
5223036|NCT02604446|Pain management|pain management
5223037|NCT02604433|ACE-536|ace-536
5223038|NCT02604433|Safety|safety
5223039|NCT02604433|Efficacy|efficacy
5223040|NCT02604433|Placebo|placebo
5223041|NCT02604433|Red Blood Cell Transfusions|red blood cell transfusions
5223042|NCT02604433|Beta -Thalassemia|beta -thalassemia
5223043|NCT02604394|Rheolytic Thrombectomy|rheolytic thrombectomy
5223044|NCT02604394|Percutaneous Coronary Intervention|percutaneous coronary intervention
5223045|NCT02604394|Angioplasty|angioplasty
5223046|NCT02604394|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5223047|NCT02604394|Myocardial Salvage Index|myocardial salvage index
5223048|NCT02604394|STEMI, ST elevation Myocardial Infarction|stemi, st elevation myocardial infarction
5223049|NCT02604394|Corrected TIMI Frame Count, cTFC|corrected timi frame count, ctfc
5223050|NCT02604394|Index of microcirculatory resistance, thermodilution, IMR|index of microcirculatory resistance, thermodilution, imr
5223051|NCT02604381|Osteoarthritis|osteoarthritis
5223052|NCT02604381|Knee|knee
5223053|NCT02604381|Glucosamine Sulfate|glucosamine sulfate
5223054|NCT02604381|Ginkgo Biloba|ginkgo biloba
5223055|NCT02604381|WOMAC|womac
5223056|NCT02604381|Joint Health Wellness|joint health wellness
5223057|NCT02604381|Interleukin-1-beta|interleukin-1-beta
5223058|NCT02604368|hemoglobin SS|hemoglobin ss
5223059|NCT02604368|hemoglobin SC|hemoglobin sc
5223060|NCT02604368|hemoglobin S/β°-thalassemia|hemoglobin s/β°-thalassemia
5223061|NCT02604329|low level laser therapy|low level laser therapy
5223062|NCT02604329|oral mucositis|oral mucositis
5223063|NCT02604329|child|child
5223064|NCT02604316|Overweight and Obesity|overweight and obesity
5223065|NCT02604316|Appetite|appetite
5223066|NCT02604316|Gut hormones and obesity|gut hormones and obesity
5223067|NCT02604316|Arabinoxylan, Beta-Glucan|arabinoxylan, beta-glucan
5223068|NCT02604316|SmartPill|smartpill
5223069|NCT02604303|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5223070|NCT02604303|RhoA|rhoa
5223071|NCT02604303|Biomarker|biomarker
5223072|NCT02604290|Kinesio taping|kinesio taping
5223073|NCT02604290|Neuromuscular taping|neuromuscular taping
5223074|NCT02604290|Targeted treatment|targeted treatment
5223075|NCT02604290|Chronic low back pain|chronic low back pain
5223076|NCT02604290|Randomised controlled trial|randomised controlled trial
5223077|NCT02604277|Psychology|psychology
5223078|NCT02604238|Pulmonary Embolism at intermediate risk|pulmonary embolism at intermediate risk
5223079|NCT02604225|Anaethesiology|anaethesiology
5223080|NCT02604186|Spasticity|spasticity
5223081|NCT02604186|Botulinum Toxin|botulinum toxin
5211103|NCT02675608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5211104|NCT02675608|flu vaccine|flu vaccine
5211105|NCT02675569|Vascular access|vascular access
5211106|NCT02675569|Hemodialysis|hemodialysis
5211107|NCT02675569|Kidney failure|kidney failure
5211109|NCT02675569|Fistula|fistula
5223082|NCT02604186|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5223083|NCT02604134|silver nitrate|silver nitrate
5223084|NCT02604134|children|children
5223085|NCT02604134|dental caries|dental caries
5223086|NCT02604134|medical management|medical management
5223087|NCT02604134|quality of life|quality of life
5223088|NCT02604121|oral cavity|oral cavity
5223089|NCT02604121|cancerous and precancerous lesions|cancerous and precancerous lesions
5223090|NCT02604108|physical activity|physical activity
5223091|NCT02604108|healthy diet|healthy diet
5223092|NCT02604095|Acanthosis nigricans|acanthosis nigricans
5223093|NCT02604095|Obesity|obesity
5223094|NCT02604069|Breast reconstruction|breast reconstruction
5223095|NCT02604069|Breast cancer|breast cancer
5223096|NCT02604069|Microsurgery|microsurgery
5223097|NCT02604069|Continuous flap monitor|continuous flap monitor
5223098|NCT02604043|supraglottic pH|supraglottic ph
5223099|NCT02604017|HCV GT1|hcv gt1
5223100|NCT02604017|Non-cirrhotic|non-cirrhotic
5223101|NCT02604017|RBV Free|rbv free
5223102|NCT02604017|Without cirrhosis|without cirrhosis
5223103|NCT02604017|Chronic Hepatitis C|chronic hepatitis c
5223104|NCT02604017|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
5223105|NCT02604017|IFN free|ifn free
5223106|NCT02604017|Hepatitis C|hepatitis c
5223107|NCT02604017|Ribavirin Free|ribavirin free
5223108|NCT02604017|Interferon (IFN) Free|interferon (ifn) free
5223109|NCT02604017|HCV|hcv
5962690|NCT04279379|hypomethylation|hypomethylation
5092024|NCT03423576|BMI|bmi
5223110|NCT02604017|Hepatitis C virus|hepatitis c virus
5223111|NCT02604017|DAA|daa
5223112|NCT02604004|lamivudine|lamivudine
5223113|NCT02604004|bioequivalence test|bioequivalence test
5223114|NCT02604004|pharmacokinetics|pharmacokinetics
5223115|NCT02604004|high-performance liquid chromatography|high-performance liquid chromatography
5223118|NCT02604004|mass spectrometry|mass spectrometry
5223119|NCT02603991|children and adolescents|children and adolescents
5223120|NCT02603991|Prospective cohort study|prospective cohort study
5223121|NCT02603991|vagus nerve stimulation|vagus nerve stimulation
5223122|NCT02603991|PINS|pins
5223123|NCT02603952|Influenza|influenza
5223124|NCT02603952|Influenza A|influenza a
5223125|NCT02603952|Flu|flu
5223126|NCT02603952|Flu A|flu a
5223127|NCT02603939|Pain|pain
5223128|NCT02603939|Magnetic resonance imaging|magnetic resonance imaging
5223129|NCT02603913|Pre-eclampsia|pre-eclampsia
5223130|NCT02603913|Pregnancy induced hypertension|pregnancy induced hypertension
5223131|NCT02603913|Preterm birth|preterm birth
5223132|NCT02603913|Intra-uterine growth restriction|intra-uterine growth restriction
5223133|NCT02603913|Oxidative stress|oxidative stress
5223134|NCT02603900|Adductor Canal Catheter|adductor canal catheter
5223135|NCT02603900|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5223136|NCT02603900|Local infiltration of analgesia|local infiltration of analgesia
5223137|NCT02603874|Fluoroscopy|fluoroscopy
5223138|NCT02603874|Spinal Fusion|spinal fusion
5223139|NCT02603874|Wrong Level Surgery|wrong level surgery
5223140|NCT02603848|Inguinal surgery|inguinal surgery
5223141|NCT02603848|Hernia Repair|hernia repair
5223142|NCT02603848|Orchidopexy|orchidopexy
5223143|NCT02603848|Hydrocele|hydrocele
5223144|NCT02603848|Pediatric|pediatric
5223145|NCT02603848|Post-operative pain|post-operative pain
5223146|NCT02603848|Morphine sulfate|morphine sulfate
5223147|NCT02603848|Ibuprofen|ibuprofen
5223148|NCT02603835|SSO2 Therapy|sso2 therapy
5223149|NCT02603835|Acute myocardial infarction|acute myocardial infarction
5223150|NCT02603835|Anterior myocardial infarction|anterior myocardial infarction
5223151|NCT02603835|SuperSaturated oxygen delivery|supersaturated oxygen delivery
5223152|NCT02603835|Left main coronary artery|left main coronary artery
5223153|NCT02603835|Myocardial infarction|myocardial infarction
5223154|NCT02603835|Heart attack|heart attack
5223155|NCT02603835|Percutaneous coronary intervention|percutaneous coronary intervention
5223156|NCT02603835|Cardiac catheterization laboratory|cardiac catheterization laboratory
5223157|NCT02603835|PCI|pci
5223158|NCT02603835|Stent|stent
5223159|NCT02603835|Stenting|stenting
5223160|NCT02603835|Stents|stents
5223161|NCT02603835|Angioplasty|angioplasty
5223162|NCT02603835|LMCA|lmca
5223163|NCT02603835|Delivery of supersaturated oxygen (SSO2) therapy for the treatment of anterior acute myocardial infarction|delivery of supersaturated oxygen (sso2) therapy for the treatment of anterior acute myocardial infarction
5223164|NCT02603796|3-Dimensional|3-dimensional
5223165|NCT02603796|continuous positive airway pressure|continuous positive airway pressure
5223166|NCT02603796|nasal changes|nasal changes
5223167|NCT02603757|Vitamin D|vitamin d
5223168|NCT02603744|Premature ovarian failure adipose derived stromal cells intraovarian injection|premature ovarian failure adipose derived stromal cells intraovarian injection
5223169|NCT02603718|Stroke|stroke
5223170|NCT02603718|On-line EEG|on-line eeg
5223171|NCT02603718|BEI index|bei index
5223172|NCT02603718|Attention|attention
5223173|NCT02603718|Rehabilitation|rehabilitation
5223174|NCT02603705|chronic pain|chronic pain
5223175|NCT02603705|opioid|opioid
5223176|NCT02603705|oxycodone|oxycodone
5223177|NCT02603705|non cancer pain|non cancer pain
5223183|NCT02603679|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
5223184|NCT02603666|cystic fibrosis|cystic fibrosis
5223185|NCT02603666|elastography|elastography
5223186|NCT02603666|liver biopsy|liver biopsy
5223187|NCT02603614|Chronic Heart Failure|chronic heart failure
5223188|NCT02603614|Renal Insufficiency|renal insufficiency
5223189|NCT02603614|Natriuretic Peptides|natriuretic peptides
5223190|NCT02603614|Cenderitide|cenderitide
5223191|NCT02603601|Randomized controlled trial|randomized controlled trial
5223192|NCT02603601|Mindfulness|mindfulness
5223193|NCT02603601|Obesity|obesity
5223194|NCT02603588|Acupuncture|acupuncture
5223195|NCT02603588|Sphenopalatine ganglion|sphenopalatine ganglion
5223196|NCT02603588|Nasal ventilation|nasal ventilation
5223197|NCT02603588|Neuropeptides|neuropeptides
5223198|NCT02603575|Caspofungin|caspofungin
5223199|NCT02603575|corticosteroids|corticosteroids
5223200|NCT02603575|Pneumocystis Pneumonia|pneumocystis pneumonia
5223201|NCT02603575|Immunocompromised|immunocompromised
5223202|NCT02603575|Non-HIV|non-hiv
5223203|NCT02603575|respiratory failure|respiratory failure
5223204|NCT02603562|FSHD|fshd
5223205|NCT02603536|Text Messaging|text messaging
5223206|NCT02603536|Harm Reduction|harm reduction
5223207|NCT02603523|accidental falls|accidental falls
5223208|NCT02603523|older people|older people
5223209|NCT02603523|dance|dance
5223210|NCT02603523|randomized controlled trial|randomized controlled trial
5962691|NCT04279379|epigenetics|epigenetics
5223211|NCT02603497|ASP015K|asp015k
5223212|NCT02603497|impaired renal function|impaired renal function
5223213|NCT02603497|Pharmacokinetics|pharmacokinetics
5223214|NCT02603471|HIV+|hiv+
5223215|NCT02603471|Alcohol dependence|alcohol dependence
5223216|NCT02603471|Mobile Technology|mobile technology
5223217|NCT02603458|Schizophrenia|schizophrenia
5223218|NCT02603458|Naurex|naurex
5223219|NCT02603458|Intravenous Treatment|intravenous treatment
5223220|NCT02603458|NRX-1074|nrx-1074
5223227|NCT02603432|Bladder cancer|bladder cancer
5223228|NCT02603432|Urologic neoplasms|urologic neoplasms
5223229|NCT02603432|urothelial carcinoma|urothelial carcinoma
5223230|NCT02603432|PD-L1|pd-l1
5223231|NCT02603432|programmed cell death protein|programmed cell death protein
5223232|NCT02603432|maintenance treatment|maintenance treatment
5223233|NCT02603419|classical Hodgkins Lymphoma (relapsed/refractory)|classical hodgkins lymphoma (relapsed/refractory)
5223234|NCT02603419|post-allogeneic HSCT|post-allogeneic hsct
5223235|NCT02603419|anti PD-L1|anti pd-l1
5223236|NCT02603419|Phase 1|phase 1
5223238|NCT02603419|Receptor occupancy|receptor occupancy
5223239|NCT02603419|Immunophenotypic biomarkers|immunophenotypic biomarkers
5223240|NCT02603393|COPD, QVA149|copd, qva149
5223241|NCT02603380|Delirium|delirium
5223242|NCT02603380|Feasibility study|feasibility study
5223243|NCT02603380|software application|software application
5223244|NCT02603380|qualitative|qualitative
5223245|NCT02603328|Cerebral cavernous malformation|cerebral cavernous malformation
5223246|NCT02603328|Statins|statins
5223248|NCT02603328|Permeability|permeability
5223249|NCT02603328|Quantitative susceptibility mapping|quantitative susceptibility mapping
5223250|NCT02603302|rectal cancer|rectal cancer
5223251|NCT02603302|radiotherapy|radiotherapy
5223252|NCT02603302|escalated dose|escalated dose
5223253|NCT02603302|interval|interval
5223254|NCT02603276|hypercholesterolemia|hypercholesterolemia
5223255|NCT02603276|dietary supplements|dietary supplements
5223256|NCT02603276|red yeast rice|red yeast rice
5223257|NCT02603276|plant sterols|plant sterols
5223258|NCT02603263|social norms|social norms
5223259|NCT02603263|healthy eating|healthy eating
5223260|NCT02603263|vegetables|vegetables
5223261|NCT02603263|field study|field study
5223262|NCT02603250|Anemia|anemia
5223263|NCT02603250|Iron deficiency|iron deficiency
5223264|NCT02603250|noninvasive anemia screening|noninvasive anemia screening
5223265|NCT02603211|breast cancer|breast cancer
5223266|NCT02603198|third molar|third molar
5223267|NCT02603198|tooth extraction|tooth extraction
5223268|NCT02603198|impacted tooth|impacted tooth
5223269|NCT02603185|Phase 1, Healthy subjects|phase 1, healthy subjects
5223270|NCT02603172|GSK3039294|gsk3039294
5223271|NCT02603172|GSK2315698|gsk2315698
5223272|NCT02603172|systemic amyloidosis|systemic amyloidosis
5223273|NCT02603172|CPHPC|cphpc
5223274|NCT02603172|dose-escalation|dose-escalation
5223275|NCT02603159|Chemoradiotherapy|chemoradiotherapy
5223276|NCT02603159|Esophageal Squamous Cancer|esophageal squamous cancer
5223277|NCT02603159|Capecitabine|capecitabine
5223284|NCT02603133|fatigue|fatigue
5223285|NCT02603133|NICU|nicu
5223286|NCT02603133|safety culture|safety culture
5223287|NCT02603133|quality of care|quality of care
5223288|NCT02603081|Meniere's|meniere's
5223289|NCT02603081|hearing loss|hearing loss
5223290|NCT02603081|vertigo|vertigo
5223291|NCT02603081|tinnitus|tinnitus
5223292|NCT02603081|ebselen|ebselen
5223293|NCT02603055|Safety|safety
5223294|NCT02603055|immunogenicity|immunogenicity
5223295|NCT02603055|Hepatitis E|hepatitis e
5223296|NCT02603042|Hypophosphatasia Disease|hypophosphatasia disease
5223297|NCT02603042|Biomarker|biomarker
5223298|NCT02603029|skin rejuvenation|skin rejuvenation
5223299|NCT02603029|anti-ageing effects|anti-ageing effects
5223300|NCT02603029|minimal erythema dose|minimal erythema dose
5223301|NCT02603029|dermis structure|dermis structure
5223302|NCT02603029|physiological skin condition|physiological skin condition
5223303|NCT02603029|wrinkling|wrinkling
5223304|NCT02603016|Clinical Nutrition|clinical nutrition
5223305|NCT02603003|Circulating tumor cells(CTCs)|circulating tumor cells(ctcs)
5223306|NCT02603003|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
5223307|NCT02603003|Myeloid-derived suppressor cells(MDSCs)|myeloid-derived suppressor cells(mdscs)
5223309|NCT02602990|Arteriovenous|arteriovenous
5223310|NCT02602990|Malformation|malformation
5223311|NCT02602990|Embolization|embolization
5223312|NCT02602990|Endovascular|endovascular
5223313|NCT02602977|inflammation|inflammation
5223314|NCT02602977|remote ischemic preconditioning|remote ischemic preconditioning
5223316|NCT02602938|circulating tumor cells|circulating tumor cells
5223317|NCT02602938|metastatic breast cancer|metastatic breast cancer
5223318|NCT02602938|metastatic colorectal cancer|metastatic colorectal cancer
5223319|NCT02602899|PINS|pins
5223320|NCT02602899|Deep Brain Stimulator|deep brain stimulator
5223321|NCT02602899|Refractory Epilepsy|refractory epilepsy
5962692|NCT04279366|Individualised Health|individualised health
5223322|NCT02602899|Anterior Thalamic Nucleus|anterior thalamic nucleus
5223323|NCT02602860|SV2A|sv2a
5223324|NCT02602860|Levetiracetam|levetiracetam
5092231|NCT03422510|FIRSTx|firstx
5223325|NCT02602860|Brivaracetam|brivaracetam
5223326|NCT02602860|PET|pet
5223327|NCT02602847|Liver transplantation|liver transplantation
5223328|NCT02602847|HBV|hbv
5223329|NCT02602847|cccDNA|cccdna
5223330|NCT02602834|exercise test|exercise test
5223331|NCT02602834|biological markers|biological markers
5223332|NCT02602808|acute pancreatitis|acute pancreatitis
5223333|NCT02602808|non-coding RNA|non-coding rna
5223334|NCT02602808|biological markers|biological markers
5223335|NCT02602808|receiver operating characteristic curve|receiver operating characteristic curve
5223336|NCT02602808|post-ERCP pancreatitis|post-ercp pancreatitis
5223337|NCT02602795|Opiate Dependence|opiate dependence
5223338|NCT02602795|Sexually Transmitted Diseases|sexually transmitted diseases
5223340|NCT02602795|Extended release naltrexone|extended release naltrexone
5223341|NCT02602756|Choroid Melanoma|choroid melanoma
5223342|NCT02602743|sedation|sedation
5223343|NCT02602743|remifentanyl|remifentanyl
5223344|NCT02602743|pediatric patient|pediatric patient
5223345|NCT02602743|colonoscopy|colonoscopy
5223346|NCT02602730|Cigarette smoking|cigarette smoking
5223347|NCT02602730|Smoking, Tobacco|smoking, tobacco
5223348|NCT02602730|postpartum|postpartum
5223349|NCT02602730|internet|internet
5223350|NCT02602730|interactive|interactive
5223351|NCT02602730|coach|coach
5223352|NCT02602717|follicular origin|follicular origin
5223353|NCT02602691|Heart transplantation|heart transplantation
5223354|NCT02602691|AlloMap® gene expression profiling test|allomap® gene expression profiling test
5223355|NCT02602691|Medico-economic study|medico-economic study
5223356|NCT02602678|Children.|children.
5223357|NCT02602678|prone position|prone position
5223358|NCT02602678|acute viral bronchiolitis|acute viral bronchiolitis
5223359|NCT02602678|syncytial virus|syncytial virus
5223360|NCT02602678|work of breathing|work of breathing
5223361|NCT02602678|intrinsic PEEP|intrinsic peep
5223362|NCT02602665|catheter placement|catheter placement
5223363|NCT02602652|geometric mean titer|geometric mean titer
5223364|NCT02602652|seroprotection|seroprotection
5223365|NCT02602652|live attenuated chimeric JE vaccine|live attenuated chimeric je vaccine
5223366|NCT02602652|JE-CV|je-cv
5223367|NCT02602652|SA14-14-2 vaccine|sa14-14-2 vaccine
5223368|NCT02602626|Human Papillomavirus|human papillomavirus
5223369|NCT02602626|HPV|hpv
5223370|NCT02602626|Postpartum|postpartum
5223371|NCT02602587|acute myeloid leukemia|acute myeloid leukemia
5223372|NCT02602587|Dendrogenin A|dendrogenin a
5223373|NCT02602587|5,6-cholesterol epoxide|5,6-cholesterol epoxide
5223374|NCT02602587|6-oxo-cholestane-3beta|6-oxo-cholestane-3beta
5223375|NCT02602587|5alpha-diol|5alpha-diol
5223376|NCT02602587|cholesterol epoxide hydrolase|cholesterol epoxide hydrolase
5223377|NCT02602587|oxysterols|oxysterols
5342984|NCT01981291|Anesthetics, Local|anesthetics, local
5223378|NCT02602574|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5223379|NCT02602574|Pancreatitis|pancreatitis
5223380|NCT02602574|Heat-Shock Proteins|heat-shock proteins
5223381|NCT02602574|Pentraxin 3 protein|pentraxin 3 protein
5223382|NCT02602574|C-Reactive Protein|c-reactive protein
5223383|NCT02602574|procalcitonin|procalcitonin
5223384|NCT02602574|Interleukin-1 beta|interleukin-1 beta
5223385|NCT02602574|Leukocytes, Mononuclear|leukocytes, mononuclear
5223386|NCT02602574|Killer Cells, Natural|killer cells, natural
5223387|NCT02602574|natural-killer group 2, member D receptor|natural-killer group 2, member d receptor
5223389|NCT02602561|beta-hydroxy-beta-methylbutyrate|beta-hydroxy-beta-methylbutyrate
5223390|NCT02602561|ACL|acl
5223391|NCT02602561|surgery|surgery
5223392|NCT02602561|muscle mass|muscle mass
5223393|NCT02602548|Propionibacterium acnes|propionibacterium acnes
5223394|NCT02602548|shoulder surgery|shoulder surgery
5223395|NCT02602548|infection|infection
5223396|NCT02602496|Diet|diet
5223397|NCT02602496|Whole grain|whole grain
5223398|NCT02602496|Fruits|fruits
5223399|NCT02602496|Vegetables|vegetables
5223400|NCT02602496|Gut health|gut health
5223401|NCT02602496|Anti-inflammatory|anti-inflammatory
5223402|NCT02602483|temporomandibular|temporomandibular
5223403|NCT02602483|joint|joint
5223404|NCT02602483|pain|pain
5223405|NCT02602483|ibuprofen|ibuprofen
5223406|NCT02602483|magnesium|magnesium
5223407|NCT02602483|vitamin C|vitamin c
5223408|NCT02602457|Atrial Fibrillation|atrial fibrillation
5223409|NCT02602444|ticagrelor|ticagrelor
5223410|NCT02602444|STEMI|stemi
5223411|NCT02602444|NSTEMI|nstemi
5223412|NCT02602444|pharmacokinetics|pharmacokinetics
5223413|NCT02602444|pharmacodynamics|pharmacodynamics
5223414|NCT02602431|laser|laser
5223415|NCT02602431|third molar|third molar
5223416|NCT02602431|low laser|low laser
5223417|NCT02602431|inflammatory response|inflammatory response
5223418|NCT02602418|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5223419|NCT02602418|working memory training|working memory training
5962693|NCT04279366|Prediction|prediction
5223420|NCT02602418|brain function|brain function
5223421|NCT02602418|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5223422|NCT02602405|Outcome Assessment (Health Care)|outcome assessment (health care)
5223423|NCT02602405|Return to work|return to work
5223424|NCT02602405|Registries|registries
5223425|NCT02602405|Norway|norway
5223426|NCT02602392|Self management|self management
5223427|NCT02602392|Education|education
5223428|NCT02602392|Children|children
5223429|NCT02602392|Caregivers|caregivers
5223430|NCT02602392|Health Care Providers|health care providers
5223431|NCT02602379|Pain|pain
5223432|NCT02602379|Monitoring|monitoring
5223433|NCT02602379|Analgesia Nociception Index|analgesia nociception index
5223434|NCT02602379|NoL|nol
5223436|NCT02602379|Remifentanil|remifentanil
5223437|NCT02602366|HIV|hiv
5223438|NCT02602366|DCE|dce
5223439|NCT02602366|MPT|mpt
5223440|NCT02602366|Microbicide|microbicide
5223441|NCT02602327|radioembolization|radioembolization
5223442|NCT02602327|Yttrium-90|yttrium-90
5223443|NCT02602327|90Y|90y
5223444|NCT02602327|Resin microspheres|resin microspheres
5223445|NCT02602327|Tas-102|tas-102
5223446|NCT02602327|Lonsurf|lonsurf
5223447|NCT02602327|SIR-Sphere|sir-sphere
5223448|NCT02602314|Chronic myeloid leukemia|chronic myeloid leukemia
5223449|NCT02602314|Nilotinib|nilotinib
5223450|NCT02602314|Imatinib|imatinib
5223451|NCT02602301|oxytocin|oxytocin
5223452|NCT02602223|Alveolar Ridge Augmentation|alveolar ridge augmentation
5223453|NCT02602223|Tooth Socket|tooth socket
5223454|NCT02602223|Guided Tissue Regeneration|guided tissue regeneration
5223455|NCT02602223|Membranes|membranes
5223456|NCT02602210|cirrhosis|cirrhosis
5223457|NCT02602210|liver|liver
5223458|NCT02602210|corticosteroids|corticosteroids
5223459|NCT02602210|hypotension|hypotension
5223460|NCT02602210|sepsis|sepsis
5223461|NCT02602210|cortisol|cortisol
5223462|NCT02602197|Paracetamol|paracetamol
5223463|NCT02602197|Dexketoprofen|dexketoprofen
5223464|NCT02602197|postoperative pain|postoperative pain
5223465|NCT02602197|septoplasty|septoplasty
5223466|NCT02602184|skin regeneration|skin regeneration
5223467|NCT02602184|re-epithelialization|re-epithelialization
5223468|NCT02602184|split thickness wounds|split thickness wounds
5223469|NCT02602184|Abdominoplasty|abdominoplasty
5223470|NCT02602158|breath test|breath test
5223471|NCT02602158|lipid emulsions|lipid emulsions
5223472|NCT02602158|MRI|mri
5223473|NCT02602158|gastric emptying|gastric emptying
5223474|NCT02602145|femoral|femoral
5223475|NCT02602145|popliteal|popliteal
5223476|NCT02602145|stent|stent
5223477|NCT02602145|modeling|modeling
5223478|NCT02602145|flexion|flexion
5223479|NCT02602132|INDWELLING URINARY CATHETER|indwelling urinary catheter
5223480|NCT02602132|CLAMPING|clamping
5223481|NCT02602132|REMOVAL|removal
5223482|NCT02602106|Aquatic activities|aquatic activities
5223483|NCT02602106|Aerobic exercise|aerobic exercise
5223484|NCT02602106|Resistance exercise|resistance exercise
5223486|NCT02602106|Maternal weight gain|maternal weight gain
5223487|NCT02602106|birthweight|birthweight
5223488|NCT02602093|Lumbar Disk Herniation|lumbar disk herniation
5223489|NCT02602093|Percutaneous Transforaminal Endoscopic Discectomy|percutaneous transforaminal endoscopic discectomy
5223490|NCT02602093|Micro Discectomy|micro discectomy
5223491|NCT02602093|Minimal Invasive Spine Surgery|minimal invasive spine surgery
5223492|NCT02602054|persistent ductus arteriosus|persistent ductus arteriosus
5223493|NCT02602054|preterm infants|preterm infants
5223494|NCT02602054|surgical treatment|surgical treatment
5223495|NCT02602054|pharmacological treatment|pharmacological treatment
5223496|NCT02602028|Familial Mediterranean Fever|familial mediterranean fever
5223497|NCT02602028|Colchicine|colchicine
5223498|NCT02602002|Remifentanil, Pharmacodynamic Pain assessments, Intravenous, South Korea|remifentanil, pharmacodynamic pain assessments, intravenous, south korea
5223499|NCT02601976|PegInterferon alpha-2a|peginterferon alpha-2a
5223500|NCT02601976|Ribavirin|ribavirin
5223501|NCT02601976|Hepatitis C Virus|hepatitis c virus
5223502|NCT02601976|Sustained Virological Response|sustained virological response
5223503|NCT02601976|End of Treatment Response|end of treatment response
5223504|NCT02601976|Unipeg|unipeg
5223505|NCT02601976|Ribazole|ribazole
5223507|NCT02601924|injection|injection
5223508|NCT02601924|pain|pain
5223509|NCT02601924|pressure massage|pressure massage
5223510|NCT02601924|topical gel|topical gel
5223511|NCT02601911|Failure|failure
5223512|NCT02601911|Injection|injection
5223513|NCT02601911|Ketorolac|ketorolac
5223514|NCT02601911|Premedication|premedication
5223515|NCT02601885|Relapsing-remitting|relapsing-remitting
5223516|NCT02601885|Secondary progressive|secondary progressive
5223517|NCT02601885|Relapsing forms|relapsing forms
5223518|NCT02601833|Caries|caries
5223519|NCT02601833|Cavity|cavity
5223520|NCT02601820|patient-reported outcomes|patient-reported outcomes
5223521|NCT02601820|observational|observational
5223522|NCT02601820|HCV|hcv
5223523|NCT02601820|Hepatitis C|hepatitis c
5223524|NCT02601820|Liver Disease|liver disease
5223525|NCT02601820|Liver|liver
5223526|NCT02601820|Infectious Disease|infectious disease
5223527|NCT02601820|PROs|pros
5223528|NCT02601807|Back|back
5223529|NCT02601807|Pain|pain
5223530|NCT02601807|PSWT|pswt
5223531|NCT02601807|ActiPatch|actipatch
5152158|NCT03041324|MPS ll|mps ll
5223532|NCT02601807|Pulsed shortwave therapy|pulsed shortwave therapy
5223533|NCT02601794|Breast Cancer|breast cancer
5223534|NCT02601794|mHealth|mhealth
5223535|NCT02601794|Mindfulness|mindfulness
5223536|NCT02601794|Complementary Therapies|complementary therapies
5223537|NCT02601781|Bioresorbable Vascular Scaffold (BVS)|bioresorbable vascular scaffold (bvs)
5223538|NCT02601781|STEMI|stemi
5223539|NCT02601781|Primary PCI|primary pci
5223540|NCT02601768|ASD II|asd ii
5223541|NCT02601768|transcatheter closure|transcatheter closure
5223542|NCT02601768|percutaneous closure|percutaneous closure
5223543|NCT02601768|3D TEE|3d tee
5223544|NCT02601768|balloon-sizing|balloon-sizing
5223545|NCT02601742|zinc|zinc
5223546|NCT02601742|Duration|duration
5223547|NCT02601729|Type 1 diabetes|type 1 diabetes
5223548|NCT02601729|real-time continuous glucose monitoring|real-time continuous glucose monitoring
5223549|NCT02601729|observational study|observational study
5223550|NCT02601729|insulin pump|insulin pump
5223551|NCT02601729|Belgium|belgium
5223552|NCT02601716|Plasmodium falciparum|plasmodium falciparum
5223553|NCT02601716|PfSPZ Vaccine|pfspz vaccine
5223554|NCT02601716|Sporozoites|sporozoites
5223555|NCT02601716|Controlled Human Malaria Infection|controlled human malaria infection
5223556|NCT02601690|Rye Grass|rye grass
5223557|NCT02601690|Ragweed|ragweed
5223558|NCT02601690|Cat|cat
5223559|NCT02601690|House Dust Mite|house dust mite
5223560|NCT02601677|Obsessive Compulsive Disorder|obsessive compulsive disorder
5223561|NCT02601677|Deep Brain Stimulation|deep brain stimulation
5116629|NCT03266848|Ferumoxytol|ferumoxytol
5223562|NCT02601677|Nucleus accumbens|nucleus accumbens
5223563|NCT02601651|Totally Extraperitoneal Inguinal Hernioplasty|totally extraperitoneal inguinal hernioplasty
5223564|NCT02601651|Lidocaine infusion|lidocaine infusion
5223565|NCT02601651|Postoperative opioid consumption|postoperative opioid consumption
5223566|NCT02601625|Tolerability|tolerability
5223567|NCT02601625|Anifrolumab|anifrolumab
5223568|NCT02601625|Subcutaneous injection|subcutaneous injection
5223569|NCT02601625|Intravenous infusion|intravenous infusion
5223570|NCT02601599|Smoking Cessation|smoking cessation
5223571|NCT02601599|Tobacco Use Cessation|tobacco use cessation
5223572|NCT02601599|Motivational Interviewing|motivational interviewing
5223573|NCT02601599|Students, Medical|students, medical
5223574|NCT02601599|Randomized Controlled Trial|randomized controlled trial
5223575|NCT02601560|Coronary Artery Disease|coronary artery disease
5223576|NCT02601560|CAD|cad
5223577|NCT02601547|Positron-Emission Tomography|positron-emission tomography
5223578|NCT02601547|chemotherapy-induced brain damage|chemotherapy-induced brain damage
5223579|NCT02601547|neuro-cognitive function alteration|neuro-cognitive function alteration
5223587|NCT02601482|Interval Training|interval training
5223588|NCT02601456|Amputation, Traumatic|amputation, traumatic
5223589|NCT02601456|Biomechanics|biomechanics
5223590|NCT02601456|Asymmetry|asymmetry
5223591|NCT02601456|Amputee Running|amputee running
5223592|NCT02601456|Prolonged Effort|prolonged effort
5223593|NCT02601417|Cholangitis|cholangitis
5223594|NCT02601417|Bile culture|bile culture
5223595|NCT02601391|STEPPS-HI|stepps-hi
5223596|NCT02601391|personality disorder|personality disorder
5223597|NCT02601391|evaluation|evaluation
5223598|NCT02601391|forensic|forensic
5223607|NCT02601339|spectroscopy, Near-Infrared|spectroscopy, near-infrared
5223608|NCT02601300|Ulcerative Colitis|ulcerative colitis
5223609|NCT02601300|GED-0301|ged-0301
5223610|NCT02601300|Mongersen|mongersen
5223611|NCT02601300|Efficacy|efficacy
5223613|NCT02601261|pregnant|pregnant
5223614|NCT02601261|gestational ages|gestational ages
5223615|NCT02601261|hospitalized|hospitalized
5223616|NCT02601261|problem of pregnancy|problem of pregnancy
5223617|NCT02601248|safety, PK|safety, pk
5223618|NCT02601235|nasal congestion|nasal congestion
5223619|NCT02601222|chronic eczema|chronic eczema
5223620|NCT02601222|efficacy and safety|efficacy and safety
5223621|NCT02601222|Runzao zhiyang capsule|runzao zhiyang capsule
5223622|NCT02601196|Leiomyoma|leiomyoma
5223623|NCT02601196|Infertility|infertility
5223624|NCT02601196|IVF|ivf
5223625|NCT02601196|Ulipristal acetate|ulipristal acetate
5223626|NCT02601183|brain temperture，thrombolysis，early diagnosis|brain temperture，thrombolysis，early diagnosis
5223627|NCT02601170|Platelet Rich Plasma|platelet rich plasma
5223628|NCT02601170|Hemophilia|hemophilia
5223629|NCT02601170|Hemophilic arthropathy|hemophilic arthropathy
5223630|NCT02601157|stent|stent
5223631|NCT02601157|polymer|polymer
5223632|NCT02601157|antiplatelet therapy|antiplatelet therapy
5223633|NCT02601157|clopidogrel|clopidogrel
5223634|NCT02601144|DBS|dbs
5223635|NCT02601144|VFS|vfs
5223636|NCT02601144|FOG|fog
5223637|NCT02601131|platelet count|platelet count
5223638|NCT02601131|platelet transfusion|platelet transfusion
5223639|NCT02601131|complement factors|complement factors
5223640|NCT02601131|endothelial markers|endothelial markers
5962694|NCT04279366|Risk Assessment|risk assessment
5223641|NCT02601131|stem cell transplantation|stem cell transplantation
5223642|NCT02601105|gotu kola|gotu kola
5223643|NCT02601105|centella asiatica|centella asiatica
5223644|NCT02601092|Mini Gastric Bypass|mini gastric bypass
5223645|NCT02601092|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5223646|NCT02601092|RCT|rct
5223647|NCT02601079|Biopsy|biopsy
5223648|NCT02601079|Diagnostics|diagnostics
5223649|NCT02601079|Genetic analysis|genetic analysis
5223650|NCT02601066|LMNA|lmna
5223651|NCT02601066|Sudden Death|sudden death
5223652|NCT02601066|Neuromuscular|neuromuscular
5223653|NCT02601040|Safety|safety
5223654|NCT02601040|Immunogenicity|immunogenicity
5223655|NCT02601040|Vaccine|vaccine
5223656|NCT02601040|Hepatitis A|hepatitis a
5223657|NCT02601014|Hormone-Resistant Prostate Cancer|hormone-resistant prostate cancer
5862732|NCT00001532|Genetic Polymorphism|genetic polymorphism
5223658|NCT02601014|Prostate Carcinoma Metastatic in the Bone|prostate carcinoma metastatic in the bone
5223659|NCT02600988|Graft-Versus-Host-Disease|graft-versus-host-disease
5223660|NCT02600988|post-allogeneic transplant|post-allogeneic transplant
5223661|NCT02600988|haematopoietic progenitors|haematopoietic progenitors
5116721|NCT03266393|Grafting, Kidney|grafting, kidney
5223662|NCT02600936|venous outflow obstruction|venous outflow obstruction
5223663|NCT02600936|peripheral venous disease|peripheral venous disease
5223664|NCT02600936|vein stent|vein stent
5223665|NCT02600936|Wallstent|wallstent
5223666|NCT02600936|registry|registry
5223667|NCT02600936|May Thurner|may thurner
5223668|NCT02600923|palbociclib, ibrance, breast cancer|palbociclib, ibrance, breast cancer
5223669|NCT02600910|Manual Wheelchair|manual wheelchair
5223670|NCT02600910|Shoulder injury|shoulder injury
5223671|NCT02600910|Shoulder function|shoulder function
5223672|NCT02600910|rotator cuff|rotator cuff
5223673|NCT02600910|Tendinopathy|tendinopathy
5223674|NCT02600910|Spinal cord injury|spinal cord injury
5223675|NCT02600910|Shoulder pain|shoulder pain
5223676|NCT02600910|Shoulder impingement|shoulder impingement
5223678|NCT02600871|Antiseptic|antiseptic
5223679|NCT02600871|Provodine|provodine
5223680|NCT02600871|Povidone-Iodine|povidone-iodine
5223681|NCT02600819|End stage renal disease|end stage renal disease
5223682|NCT02600819|Hemodialysis|hemodialysis
5223683|NCT02600819|Open-label|open-label
5211687|NCT02671786|MAHAN RUTF & MAHAN Vit-Mim mix|mahan rutf & mahan vit-mim mix
5211688|NCT02671773|Microbiota|microbiota
5211689|NCT02671760|Short-term insomnia|short-term insomnia
5211690|NCT02671760|difficulty sleeping|difficulty sleeping
5223684|NCT02600819|HIV-1 Infection|hiv-1 infection
5223685|NCT02600806|Community-acquired pneumonia|community-acquired pneumonia
5223686|NCT02600806|Procalcitonin|procalcitonin
5223687|NCT02600806|Outpatients|outpatients
5223688|NCT02600806|Outcomes|outcomes
5223689|NCT02600806|Azithromycin|azithromycin
5223690|NCT02600806|Fluoroquinolones|fluoroquinolones
5223691|NCT02600780|Febuxostat|febuxostat
5223692|NCT02600780|Efficacy|efficacy
5223693|NCT02600780|Safety|safety
5223694|NCT02600780|Allopurinol|allopurinol
5223695|NCT02600780|Hyperuricemia|hyperuricemia
5223696|NCT02600780|Zurig|zurig
5223697|NCT02600780|Getz Pharma|getz pharma
5223698|NCT02600754|older adults, depressive symptoms, psychosocial treatment|older adults, depressive symptoms, psychosocial treatment
5223699|NCT02600741|Schizophrenia|schizophrenia
5223700|NCT02600741|Caregiver|caregiver
5223701|NCT02600741|Psycho-education and skills training|psycho-education and skills training
5223702|NCT02600741|Paliperidone Palmitate|paliperidone palmitate
5223703|NCT02600741|Oral Antipsychotic|oral antipsychotic
5223704|NCT02600728|Parkinson Disease|parkinson disease
5223705|NCT02600728|Gait|gait
5223706|NCT02600728|cues|cues
5223707|NCT02600728|memory|memory
5223708|NCT02600728|training|training
5223709|NCT02600702|Home base exercise|home base exercise
5223710|NCT02600689|Pulmonary rehab|pulmonary rehab
5223711|NCT02600689|Exergame|exergame
5223712|NCT02600689|Home-based|home-based
5223713|NCT02600637|stroke|stroke
5223714|NCT02600637|depression|depression
5223715|NCT02600637|anxiety|anxiety
5223716|NCT02600637|mindfulness|mindfulness
5223717|NCT02600637|meditation|meditation
5223718|NCT02600572|balance, postural|balance, postural
5223719|NCT02600572|postural equilibrium|postural equilibrium
5223720|NCT02600572|mental speed|mental speed
5223721|NCT02600572|isometric exercise|isometric exercise
5223722|NCT02600572|eccentric exercise|eccentric exercise
5223723|NCT02600559|Otitis media|otitis media
5223724|NCT02600559|Ear infection|ear infection
5223725|NCT02600559|Tympanostomy tubes|tympanostomy tubes
5223726|NCT02600533|minority group recruitment|minority group recruitment
5223727|NCT02600533|stages of implementation|stages of implementation
5223728|NCT02600533|clinical trials education|clinical trials education
5223729|NCT02600481|standard-pressure pneumoperitoneum|standard-pressure pneumoperitoneum
5223730|NCT02600481|prolonged pneumoperitoneum|prolonged pneumoperitoneum
5223731|NCT02600481|myocardial injuries|myocardial injuries
5223732|NCT02600481|troponin T(TnT)|troponin t(tnt)
5223733|NCT02600481|Trendelenburg position|trendelenburg position
5223734|NCT02600481|chest CT scan|chest ct scan
5223735|NCT02600481|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
5223736|NCT02600481|robot-assisted surgery|robot-assisted surgery
5223737|NCT02600442|Neoadjuvant Therapy|neoadjuvant therapy
5223738|NCT02600442|Chemotherapy|chemotherapy
5223739|NCT02600442|Positron-Emission Tomography|positron-emission tomography
5223740|NCT02600442|PET-CT|pet-ct
5223742|NCT02600442|Fluorodeoxyglucose|fluorodeoxyglucose
5223743|NCT02600442|Diagnosis|diagnosis
5223744|NCT02600442|Prognosis|prognosis
5223745|NCT02600442|Pathological complete response|pathological complete response
5223746|NCT02600442|molecular biology|molecular biology
5223747|NCT02600442|proliferation genes|proliferation genes
5223748|NCT02600429|Neurotrophic Keratopathy|neurotrophic keratopathy
5223750|NCT02600403|Visual Evoked Potentials|visual evoked potentials
5223751|NCT02600403|Optical Coherence Tomography|optical coherence tomography
5223752|NCT02600403|Visual Fields|visual fields
5220986|NCT02617914|PEEP|peep
5223754|NCT02600390|LU|lu
5223755|NCT02600390|SANGUINATE|sanguinate
5223756|NCT02600390|QOL|qol
5223757|NCT02600390|SCD|scd
5223758|NCT02600390|Sickle Cell Disease|sickle cell disease
5223759|NCT02600390|Sickle Cell|sickle cell
5223760|NCT02600390|Anemia|anemia
5223761|NCT02600390|Leg Wound|leg wound
5223762|NCT02600390|Leg|leg
5223763|NCT02600390|Skin Lesion|skin lesion
5223764|NCT02600364|Aneurysm|aneurysm
5223765|NCT02600364|intracerebral|intracerebral
5223766|NCT02600364|stroke|stroke
5223767|NCT02600364|p64|p64
5223768|NCT02600351|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5223769|NCT02600351|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
5223770|NCT02600351|Ribavirin|ribavirin
5223771|NCT02600338|Systematic review and meta-analysis|systematic review and meta-analysis
5223772|NCT02600338|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5223773|NCT02600338|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5223774|NCT02600338|Clinical practice guidelines|clinical practice guidelines
5223775|NCT02600338|Clinical trials|clinical trials
5223776|NCT02600338|Legumes|legumes
5211781|NCT02670980|Retina Implant|retina implant
5211782|NCT02670980|Visual Prosthesis|visual prosthesis
5211783|NCT02670941|aromatherapy|aromatherapy
5211784|NCT02670941|chemotherapy|chemotherapy
5223777|NCT02600338|Beans, peas, chickpeas, lentils, soy, peanuts, lupins|beans, peas, chickpeas, lentils, soy, peanuts, lupins
5223778|NCT02600338|Cardiometabolic risk factors|cardiometabolic risk factors
5223779|NCT02600338|Blood pressure|blood pressure
5223780|NCT02600325|Acute Hepatitis C|acute hepatitis c
5223781|NCT02600325|Human Immunodeficiency virus|human immunodeficiency virus
5223782|NCT02600325|Grazoprevir|grazoprevir
5223783|NCT02600325|Elbasvir|elbasvir
5342985|NCT01981291|Mepivacaine|mepivacaine
5223784|NCT02600286|Physical medicine and rehabilitation|physical medicine and rehabilitation
5223785|NCT02600286|Neurology|neurology
5223786|NCT02600260|thrombophilia|thrombophilia
5223787|NCT02600260|thrombosis|thrombosis
5223788|NCT02600260|Pregnancy, High-Risk|pregnancy, high-risk
5223789|NCT02600260|venous thrombosis|venous thrombosis
5223790|NCT02600260|enoxaparin|enoxaparin
5223791|NCT02600260|risk assessment|risk assessment
5223792|NCT02600260|deep vein thrombosis|deep vein thrombosis
5223793|NCT02600260|pulmonary embolism|pulmonary embolism
5223794|NCT02600260|hospitalization|hospitalization
5223795|NCT02600247|Total knee arthroplasty|total knee arthroplasty
5223796|NCT02600247|Duloxetine|duloxetine
5223797|NCT02600221|ACOS|acos
5223798|NCT02600195|Intensive Care, Neonatal|intensive care, neonatal
5223799|NCT02600195|Nosocomial Infections|nosocomial infections
5223800|NCT02600195|Quality Improvement|quality improvement
5223801|NCT02600182|Thoracic surgery|thoracic surgery
5223802|NCT02600182|Non-invasive ventilation|non-invasive ventilation
5223803|NCT02600182|Physiotherapy|physiotherapy
5223804|NCT02600143|Melanoma|melanoma
5223805|NCT02600143|Colitis|colitis
5223806|NCT02600143|Ipilimumab|ipilimumab
5223807|NCT02600143|Nivolumab|nivolumab
5223808|NCT02600143|Pembrolizumab|pembrolizumab
5223809|NCT02600091|Anxiety|anxiety
5223810|NCT02600091|Depression|depression
5223811|NCT02600091|Type 1 Diabetes|type 1 diabetes
5223812|NCT02600091|Mindfulness-based Cognitive Therapy|mindfulness-based cognitive therapy
5223813|NCT02600091|Glycaemic control|glycaemic control
5223814|NCT02600078|hypoxia|hypoxia
5223815|NCT02600078|ataxia|ataxia
5223816|NCT02600013|incomplete motor SCI|incomplete motor sci
5223817|NCT02600013|robotic gait training|robotic gait training
5223818|NCT02600013|exoskeleton|exoskeleton
5223819|NCT02600013|rehabilitation tool|rehabilitation tool
5223820|NCT02600013|EKSO-GT|ekso-gt
5223821|NCT02599961|Glut 1 DS|glut 1 ds
5223822|NCT02599935|Nutritional status|nutritional status
5223824|NCT02599935|GSA|gsa
5223825|NCT02599909|Tumor Microenvironment|tumor microenvironment
5223826|NCT02599909|100 Trillion Microbial Cells|100 trillion microbial cells
5223827|NCT02599909|Liver Tumors|liver tumors
5223828|NCT02599909|Intestinal Microbiota|intestinal microbiota
5223829|NCT02599909|Immune Regulation|immune regulation
5223830|NCT02599896|Dose Escalation|dose escalation
5223831|NCT02599896|HIV Prevention|hiv prevention
5223832|NCT02599896|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
5223833|NCT02599896|Open-Label|open-label
5223834|NCT02599896|Half-Life|half-life
5223835|NCT02599883|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5223836|NCT02599883|Diagnostic Imaging|diagnostic imaging
5223837|NCT02599883|Disease Management|disease management
5223838|NCT02599883|Clinical Decision Support Systems|clinical decision support systems
5116960|NCT03264638|Dingkundan|dingkundan
5223839|NCT02599883|Cost-Utility Analysis|cost-utility analysis
5223840|NCT02599870|PGx|pgx
5223841|NCT02599870|pharmacogenetic testing|pharmacogenetic testing
5223842|NCT02599870|IDgenetix|idgenetix
5223843|NCT02599870|Pain Management|pain management
5223844|NCT02599870|AltheaDx|altheadx
5223845|NCT02599870|Post-Operative Pain Management|post-operative pain management
5223846|NCT02599844|acute kidney injury|acute kidney injury
5223847|NCT02599831|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
5223848|NCT02599831|Pelvic floor muscle training|pelvic floor muscle training
5223849|NCT02599831|Transanal electrical stimulation|transanal electrical stimulation
5223850|NCT02599831|Post radical prostatectomy incontinence|post radical prostatectomy incontinence
5223851|NCT02599831|Comparative study|comparative study
5223852|NCT02599792|Safety and Pharmacokinetics|safety and pharmacokinetics
5223853|NCT02599779|Renal cell cancer|renal cell cancer
5223855|NCT02599779|Pembrolizumab|pembrolizumab
5223856|NCT02599766|animal assisted intervention, brain injury, rehabilitation|animal assisted intervention, brain injury, rehabilitation
5223857|NCT02599740|Blood glucose|blood glucose
5223858|NCT02599727|balance, postural|balance, postural
5223859|NCT02599727|postural equilibrium|postural equilibrium
5223860|NCT02599727|heart rate|heart rate
5223861|NCT02599727|blood pressure|blood pressure
5223862|NCT02599727|pulse oxygenation|pulse oxygenation
5223863|NCT02599727|mental speed|mental speed
5223864|NCT02599714|AZD2014|azd2014
5211880|NCT02670356|krill oil|krill oil
5223865|NCT02599714|Palbociclib|palbociclib
5223866|NCT02599714|Fulvestrant|fulvestrant
5223867|NCT02599714|Hormonal Therapy|hormonal therapy
5223868|NCT02599714|Estrogen Receptor Positive|estrogen receptor positive
5223869|NCT02599714|Breast Cancer|breast cancer
5223870|NCT02599701|Delta Sleep|delta sleep
5223871|NCT02599701|Growth Hormone|growth hormone
5223872|NCT02599701|IGF-1|igf-1
5223873|NCT02599675|Muscle|muscle
5223874|NCT02599675|Vitamin D|vitamin d
5223875|NCT02599675|Strength|strength
5223876|NCT02599675|Endurance|endurance
5223877|NCT02599675|Muscle fiber|muscle fiber
5223878|NCT02599662|Cancer|cancer
5223879|NCT02599662|Intraoperative Radiation Therapy - IORT|intraoperative radiation therapy - iort
5223880|NCT02599649|Myelodysplastic syndrome|myelodysplastic syndrome
5223881|NCT02599649|MDS|mds
5223882|NCT02599649|Low or intermediate-1 MDS|low or intermediate-1 mds
5223883|NCT02599649|High Risk MDS|high risk mds
5223884|NCT02599649|Lirilumab|lirilumab
5223885|NCT02599649|Nivolumab|nivolumab
5223886|NCT02599649|BMS-936558|bms-936558
5223888|NCT02599649|Azacitidine|azacitidine
5223889|NCT02599649|5-azacytidine|5-azacytidine
5223890|NCT02599649|5-aza|5-aza
5223891|NCT02599649|Vidaza|vidaza
5223892|NCT02599649|5-AZC|5-azc
5223893|NCT02599649|AZA-CR|aza-cr
5223894|NCT02599649|Ladakamycin|ladakamycin
5223895|NCT02599649|NSC-102816|nsc-102816
5223896|NCT02599649|Azacytidine|azacytidine
5223897|NCT02599623|Incarcerated|incarcerated
5223898|NCT02599623|Anesthesia|anesthesia
5223899|NCT02599623|Hernia|hernia
5223900|NCT02599610|labor, vaginal examination, transperineal ultrasound, pain, anxiety|labor, vaginal examination, transperineal ultrasound, pain, anxiety
5223901|NCT02599584|behaviour|behaviour
5223902|NCT02599558|EOE|eoe
5223903|NCT02599532|Apixaban|apixaban
5223904|NCT02599532|Pharmacokinetics|pharmacokinetics
5223905|NCT02599532|Pharmacodynamics|pharmacodynamics
5223906|NCT02599506|breast cancer|breast cancer
5223907|NCT02599506|fear of recurrence|fear of recurrence
5223908|NCT02599506|longitudinal study|longitudinal study
5223909|NCT02599506|radiation therapy|radiation therapy
5223910|NCT02599506|emotional concerns|emotional concerns
5223911|NCT02599506|trajectory|trajectory
5223912|NCT02599506|psychological constructs|psychological constructs
5223913|NCT02599506|diary keeping|diary keeping
5223915|NCT02599480|left ventricular hypertrophy|left ventricular hypertrophy
5223916|NCT02599480|cardiac remodeling,|cardiac remodeling,
5223917|NCT02599467|Nerve Pain|nerve pain
5223918|NCT02599467|Electromyography|electromyography
5223919|NCT02599467|Median Nerve|median nerve
5223920|NCT02599467|Breast Neoplasms|breast neoplasms
5223921|NCT02599415|psoriasis patients referred to receive TL01 NB-UVB therapy|psoriasis patients referred to receive tl01 nb-uvb therapy
5224025|NCT02598830|Strength training|strength training
5224026|NCT02598804|Physical activity level|physical activity level
5223922|NCT02599389|in-stent restenosis; drug-coated balloons; Excimer Laser, cost effectiveness study, quality of life|in-stent restenosis; drug-coated balloons; excimer laser, cost effectiveness study, quality of life
5223923|NCT02599350|Ventilation|ventilation
5223924|NCT02599350|Gas exchange|gas exchange
5117058|NCT03263962|CHF|chf
5223925|NCT02599350|V/Q ratio|v/q ratio
5223926|NCT02599350|Requirement for mechanical ventilation|requirement for mechanical ventilation
5223927|NCT02599337|bioequivalence|bioequivalence
5223928|NCT02599311|pelvic organ prolapse|pelvic organ prolapse
5223929|NCT02599298|sleep|sleep
5223930|NCT02599298|treatment|treatment
5223931|NCT02599259|Stroke|stroke
5223932|NCT02599259|Oral anticoagulants|oral anticoagulants
5223933|NCT02599259|NOAC|noac
5223934|NCT02599259|wireless monitoring|wireless monitoring
5223935|NCT02599259|Warfarin|warfarin
5223936|NCT02599259|Xarelto|xarelto
5223937|NCT02599259|compliance|compliance
5223938|NCT02599259|adherence|adherence
5223939|NCT02599259|monitoring|monitoring
5223940|NCT02599259|directly observed therapy|directly observed therapy
5223941|NCT02599259|DOT|dot
5223942|NCT02599259|mobile device|mobile device
5223943|NCT02599259|electronic monitoring|electronic monitoring
5223944|NCT02599259|artificial intelligence|artificial intelligence
5223945|NCT02599259|oral anticoagulation therapy|oral anticoagulation therapy
5223946|NCT02599259|adherence monitoring methods|adherence monitoring methods
5223947|NCT02599259|nonadherence|nonadherence
5223948|NCT02599259|non-adherence|non-adherence
5223949|NCT02599246|Home ventilator|home ventilator
5223950|NCT02599246|FiO2|fio2
5223952|NCT02599246|NIV|niv
5223953|NCT02599246|COPD|copd
5223954|NCT02599233|pain trajectory|pain trajectory
5223955|NCT02599181|Perineural cathether|perineural cathether
5223956|NCT02599181|Catheter infection|catheter infection
5223957|NCT02599168|dexmedetomidine|dexmedetomidine
5223958|NCT02599168|propofol|propofol
5223959|NCT02599168|BIS|bis
5223960|NCT02599168|CLADS|clads
5223961|NCT02599155|crystalloid|crystalloid
5223962|NCT02599155|colloid|colloid
5223963|NCT02599155|children|children
5223964|NCT02599155|infant|infant
5223965|NCT02599155|cardiac surgery|cardiac surgery
5211977|NCT02669745|Breast cancer|breast cancer
5211978|NCT02669732|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5211979|NCT02669732|Adult|adult
5211980|NCT02669732|Developmental Phase II|developmental phase ii
5211981|NCT02669719|Lung Cancer|lung cancer
5211982|NCT02669719|Chemotherapy|chemotherapy
5211983|NCT02669719|Immunotherapy|immunotherapy
5211984|NCT02669693|Olives, oleuropein|olives, oleuropein
5223966|NCT02599142|radiotherapy immobilisation|radiotherapy immobilisation
5223967|NCT02599142|open-face shells|open-face shells
5223968|NCT02599129|Alopecia areata|alopecia areata
5223969|NCT02599116|cytoreductive surgery|cytoreductive surgery
5223970|NCT02599116|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5223971|NCT02599116|microbiome|microbiome
5223972|NCT02599090|Glioblastoma|glioblastoma
5223973|NCT02599090|Gliosarcoma|gliosarcoma
5223974|NCT02599090|Brain Cancer|brain cancer
5223975|NCT02599090|Sorafenib|sorafenib
5223976|NCT02599090|Temozolomide|temozolomide
5223977|NCT02599090|Radiation|radiation
5223978|NCT02599090|Radiotherapy|radiotherapy
5223980|NCT02599077|oral contraceptives|oral contraceptives
5223981|NCT02599077|endometrioma|endometrioma
5223994|NCT02599038|Glutathione|glutathione
5223995|NCT02599025|Cerebral palsy|cerebral palsy
5223996|NCT02599025|passive cycling|passive cycling
5223997|NCT02599025|autonomic control system|autonomic control system
5223998|NCT02598986|glycemic index, pita bread, phosphorus, potassium, magnesium|glycemic index, pita bread, phosphorus, potassium, magnesium
5224001|NCT02598947|posterior shoulder tightness|posterior shoulder tightness
5224002|NCT02598947|shoulder impingement syndrome|shoulder impingement syndrome
5224003|NCT02598947|Glenohumeral joint|glenohumeral joint
5224004|NCT02598947|exercise|exercise
5224005|NCT02598921|Assisted reproductive technology|assisted reproductive technology
5224006|NCT02598882|Elderly|elderly
5224007|NCT02598882|Videogame|videogame
5224008|NCT02598882|energy expenditure|energy expenditure
5224009|NCT02598882|electromyography|electromyography
5224010|NCT02598882|rehabilitation|rehabilitation
5224011|NCT02598869|Triamcinolone acetonide|triamcinolone acetonide
5224012|NCT02598856|Emergency Treatment|emergency treatment
5224013|NCT02598856|Morphine Derivates|morphine derivates
5224014|NCT02598856|Heroin|heroin
5224015|NCT02598856|Antidotes|antidotes
5224016|NCT02598856|Administration, Intravenous|administration, intravenous
5224017|NCT02598856|Pharmacology|pharmacology
5224018|NCT02598856|Naloxone|naloxone
5224019|NCT02598856|Healthy volunteers|healthy volunteers
5224020|NCT02598856|Administration, intramuscular|administration, intramuscular
5224021|NCT02598856|Administration, intranasal|administration, intranasal
5224022|NCT02598830|Cachexia|cachexia
5224023|NCT02598830|Vitamin D|vitamin d
5224027|NCT02598804|Knee osteoarthritis|knee osteoarthritis
5224028|NCT02598804|Randomized controlled trials|randomized controlled trials
5224029|NCT02598804|Alternate month design study|alternate month design study
5224030|NCT02598804|Self-management|self-management
5224032|NCT02598804|Education and exercise in knee osteoarthritis|education and exercise in knee osteoarthritis
5224033|NCT02598804|Education|education
5224034|NCT02598804|Non pharmacological treatment|non pharmacological treatment
5224035|NCT02598791|incretin hormones|incretin hormones
5224036|NCT02598791|GIP|gip
5224037|NCT02598791|GLP-1|glp-1
5224038|NCT02598765|Glaucoma|glaucoma
5224039|NCT02598765|Trabeculectomy|trabeculectomy
5224040|NCT02598765|Eye Disease|eye disease
5224041|NCT02598765|Intraocular Pressure|intraocular pressure
5224042|NCT02598765|Visual Acuity|visual acuity
5224046|NCT02598739|Physical exercise|physical exercise
5224047|NCT02598739|Psoriatic arthritis|psoriatic arthritis
5224048|NCT02598739|Quality of life|quality of life
5224049|NCT02598700|total hip arthroplasty|total hip arthroplasty
5224050|NCT02598700|imaging|imaging
5224051|NCT02598700|arthritis|arthritis
5224052|NCT02598700|surgical technique|surgical technique
5224053|NCT02598674|acute kidney injury|acute kidney injury
5224060|NCT02598648|FXR|fxr
5224061|NCT02598648|RIPK3|ripk3
5224062|NCT02598648|Neonates|neonates
5224063|NCT02598648|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5224064|NCT02598648|Acute Lung Injury|acute lung injury
5224065|NCT02598635|Cholecalciferol|cholecalciferol
5224066|NCT02598635|peritoneal dialysis|peritoneal dialysis
5224067|NCT02598635|FGF23|fgf23
5224068|NCT02598635|Calcium|calcium
5224070|NCT02598609|Adverse event|adverse event
5224071|NCT02598609|Neonatal Intensive Care Unit|neonatal intensive care unit
5224072|NCT02598609|Catheter-related Bloodstream Infection (CRBSI) nos|catheter-related bloodstream infection (crbsi) nos
5224073|NCT02598609|Extravasation injury|extravasation injury
5212077|NCT02669004|Analgesia, Epidural,Pain, Postoperative|analgesia, epidural,pain, postoperative
5212078|NCT02668991|Autism Spectrum Disorder|autism spectrum disorder
5212079|NCT02668991|Janssen Autism Knowledge Engine|janssen autism knowledge engine
5212080|NCT02668991|Autism Behavior Inventory|autism behavior inventory
5212081|NCT02668978|lung surgery|lung surgery
5212082|NCT02668978|air leak|air leak
5212083|NCT02668978|prevention|prevention
5212084|NCT02668965|Clinical pregnancy rate|clinical pregnancy rate
5212085|NCT02668913|gynaecology|gynaecology
5212086|NCT02668913|Oncology|oncology
5224074|NCT02598609|Medication error|medication error
5224075|NCT02598609|Central venous catheter complication|central venous catheter complication
5224076|NCT02598609|Unprogrammed extubation|unprogrammed extubation
5224077|NCT02598596|Refractory gout|refractory gout
5224078|NCT02598596|Chronic gout|chronic gout
5224079|NCT02598583|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5224081|NCT02598583|complement inhibitor|complement inhibitor
5224083|NCT02598570|Phosphoinositide 3-kinase (PI3K) Inhibitor|phosphoinositide 3-kinase (pi3k) inhibitor
5224085|NCT02598570|Japanese|japanese
5224086|NCT02598570|Refractory Lymphoma|refractory lymphoma
5224087|NCT02598518|Integrating Combined Therapies|integrating combined therapies
5224088|NCT02598518|Alcohol Use Disorder|alcohol use disorder
5224089|NCT02598518|Mental Health Disorder|mental health disorder
5224090|NCT02598492|Mechanical Ventilator|mechanical ventilator
5224091|NCT02598479|Cancer|cancer
5224092|NCT02598479|Insulin Potentiation Low Dose Chemotherapy|insulin potentiation low dose chemotherapy
5224093|NCT02598479|IPT|ipt
5224094|NCT02598479|IPTLD|iptld
5224095|NCT02598479|Nutrition therapy|nutrition therapy
5224096|NCT02598427|Breast Cancer|breast cancer
5224097|NCT02598427|HER2 Positive|her2 positive
5224098|NCT02598427|HER2+|her2+
5224099|NCT02598427|Brain Metastases|brain metastases
5224100|NCT02598427|Metastatic Breast Cancer|metastatic breast cancer
5224101|NCT02598427|Intrathecal Treatment|intrathecal treatment
5224102|NCT02598427|Lumbar Puncture|lumbar puncture
5224103|NCT02598427|Pertuzumab|pertuzumab
5224104|NCT02598427|Trastuzumab|trastuzumab
5224105|NCT02598427|Advanced Breast Cancer|advanced breast cancer
5224106|NCT02598427|Duke University|duke university
5224107|NCT02598414|Colorectal Disease|colorectal disease
5224108|NCT02598414|Robotic Surgery|robotic surgery
5224109|NCT02598414|Indocyanine Green Fluorescence Imaging|indocyanine green fluorescence imaging
5224110|NCT02598414|Anastomotic Leak|anastomotic leak
5224111|NCT02598414|Short-term Outcomes|short-term outcomes
5224112|NCT02598388|Healthy|healthy
5224113|NCT02598388|Vaccine|vaccine
5224114|NCT02598388|Ebola viruses|ebola viruses
5224115|NCT02598388|Ebola virus disease (EVD)|ebola virus disease (evd)
5224116|NCT02598388|Filoviruses|filoviruses
5224117|NCT02598388|Hemorrhagic fever|hemorrhagic fever
5224118|NCT02598388|Monovalent vaccine|monovalent vaccine
5224119|NCT02598388|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
5224120|NCT02598388|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
5224121|NCT02598388|Safety|safety
5224122|NCT02598388|Immunogenicity|immunogenicity
5224123|NCT02598375|Early reached target enteral nutrition in PICU feeding intolerance IFABP|early reached target enteral nutrition in picu feeding intolerance ifabp
5224124|NCT02598362|ciprofloxacin|ciprofloxacin
5117296|NCT03262441|Latency|latency
5224125|NCT02598362|pharmacokinetics|pharmacokinetics
5224126|NCT02598362|excretion|excretion
5224127|NCT02598362|clearance|clearance
5224128|NCT02598362|infant|infant
5224129|NCT02598362|children|children
5224130|NCT02598362|adolescent|adolescent
5224131|NCT02598349|Unresectable|unresectable
5224132|NCT02598349|Borderline resectable|borderline resectable
5224133|NCT02598336|Structured Light Plethysmography|structured light plethysmography
5224134|NCT02598336|Spirometry|spirometry
5224135|NCT02598336|Pneumotachograph|pneumotachograph
5224136|NCT02598297|Early Myelofibrosis|early myelofibrosis
5224137|NCT02598297|high molecular risk mutations.|high molecular risk mutations.
5224138|NCT02598297|Ruxolitinib|ruxolitinib
5224139|NCT02598297|INC424|inc424
5224140|NCT02598297|High molecular risk mutations|high molecular risk mutations
5224141|NCT02598297|HMR|hmr
5224142|NCT02598284|Preventive measures|preventive measures
5224143|NCT02598284|Quality Improvement|quality improvement
5224146|NCT02598258|Sauna|sauna
5224147|NCT02598258|Cold water bath|cold water bath
5224148|NCT02598245|urinary incontinence, CESA, VASA, TOT, TVT|urinary incontinence, cesa, vasa, tot, tvt
5224151|NCT02598206|healthy volunteers|healthy volunteers
5224152|NCT02598206|pharmacokinetics|pharmacokinetics
5224153|NCT02598206|CCR2i|ccr2i
5224154|NCT02598141|Protheses, nails, screws or plates|protheses, nails, screws or plates
5224156|NCT02598089|Seasonal Influenza|seasonal influenza
5221463|NCT02614599|ADD|add
5224158|NCT02598089|Inactivated Vaccine|inactivated vaccine
5224159|NCT02598050|postoperative health outcomes|postoperative health outcomes
5224160|NCT02598050|older surgical patients|older surgical patients
5224161|NCT02598037|Obesity|obesity
5224162|NCT02598037|Polymorphism|polymorphism
5224163|NCT02598037|Hormones|hormones
5224164|NCT02597985|Frailty|frailty
5224165|NCT02597959|ergonomic risk factors|ergonomic risk factors
5224166|NCT02597959|allied health professionals|allied health professionals
5224167|NCT02597959|surgical care|surgical care
5224168|NCT02597881|natural history|natural history
5224169|NCT02597868|therapy|therapy
5224170|NCT02597868|Capecitabine|capecitabine
5224171|NCT02597868|breast cancer|breast cancer
5224172|NCT02597842|Postoperative nausea and vomiting|postoperative nausea and vomiting
5224173|NCT02597842|TEAS|teas
5224174|NCT02597829|Inflammatory Bowel Disease|inflammatory bowel disease
5224175|NCT02597829|Mucosal Healing|mucosal healing
5224176|NCT02597829|Certolizumab pegol|certolizumab pegol
5224177|NCT02597803|Dry Eye Syndrome|dry eye syndrome
5224178|NCT02597803|Dry Eye|dry eye
5224179|NCT02597803|DES|des
5224180|NCT02597790|endothelial function|endothelial function
5224181|NCT02597790|cardiovascular risk|cardiovascular risk
5224182|NCT02597790|HIV|hiv
5224183|NCT02597790|Hepatitis C|hepatitis c
5224184|NCT02597790|metabolic disease|metabolic disease
5224185|NCT02597790|inflammation|inflammation
5224186|NCT02597764|Diaphragmatic breathing (DB)|diaphragmatic breathing (db)
5224187|NCT02597764|Bladder and bowel disorders (BBD)|bladder and bowel disorders (bbd)
5224188|NCT02597764|Autonomic nervous system (ANS)|autonomic nervous system (ans)
5224189|NCT02597764|Heart rate variability (HRV)|heart rate variability (hrv)
5224190|NCT02597764|Deep breathing|deep breathing
5224191|NCT02597764|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5224192|NCT02597751|DCD|dcd
5224193|NCT02597751|Neuroimaging|neuroimaging
5224194|NCT02597751|Rehabilitation|rehabilitation
5224195|NCT02597725|Urodynamics|urodynamics
5224196|NCT02597725|Late effects|late effects
5224197|NCT02597725|Urinary Incontinence|urinary incontinence
5224198|NCT02597712|acid reflux|acid reflux
5224199|NCT02597712|intragastric pH|intragastric ph
5224200|NCT02597712|gastrin|gastrin
5224201|NCT02597712|hypergastrinemia|hypergastrinemia
5224202|NCT02597699|Termination of pregnancy|termination of pregnancy
5224203|NCT02597699|Feticide|feticide
5224204|NCT02597699|Fetal pain|fetal pain
5224205|NCT02597699|Remifentanil Ultiva®|remifentanil ultiva®
5224206|NCT02597699|Fetal asystole|fetal asystole
5224207|NCT02597699|Fetopathologic analysis|fetopathologic analysis
5224208|NCT02597660|patellar tendinopathy|patellar tendinopathy
5224209|NCT02597660|somatropin|somatropin
5224210|NCT02597660|jumper's knee|jumper's knee
5224211|NCT02597647|immunology|immunology
5224212|NCT02597647|Microbiota|microbiota
5224213|NCT02597582|LigaSure|ligasure
5224214|NCT02597582|Neck dissection|neck dissection
5224215|NCT02597582|Operative duration|operative duration
5224216|NCT02597582|Postoperative drainage|postoperative drainage
5224217|NCT02597582|Postoperative pain|postoperative pain
5224218|NCT02597569|stroke|stroke
5224219|NCT02597569|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
5224317|NCT02596984|Shock|shock
5224220|NCT02597569|health services accessibility|health services accessibility
5224221|NCT02597569|cognitive impairment|cognitive impairment
5224222|NCT02597569|rehabilitation|rehabilitation
5224223|NCT02597569|integrated knowledge translation|integrated knowledge translation
5224224|NCT02597569|interrupted time series|interrupted time series
5224225|NCT02597569|The CO-OP Approach|the co-op approach
5224226|NCT02597556|Albendazole|albendazole
5224227|NCT02597556|Ancylostoma duodenale|ancylostoma duodenale
5224228|NCT02597556|Ascariasis lumbricoides|ascariasis lumbricoides
5224229|NCT02597556|Coinfection|coinfection
5224230|NCT02597556|Diarrhea|diarrhea
5224231|NCT02597556|Helminths|helminths
5224232|NCT02597556|Necator americanus|necator americanus
5224233|NCT02597556|Microbiota|microbiota
5224234|NCT02597556|Trichuris trichiura|trichuris trichiura
5224235|NCT02597543|heart transplantation|heart transplantation
5224236|NCT02597543|cardiac MRI|cardiac mri
5224237|NCT02597543|graft rejection|graft rejection
5224238|NCT02597543|nonspecific allograft dysfunction|nonspecific allograft dysfunction
5224239|NCT02597543|allograft vasculopathy|allograft vasculopathy
5224241|NCT02597530|anesthesia|anesthesia
5224242|NCT02597517|gastritis|gastritis
5224243|NCT02597517|chromoendoscopy|chromoendoscopy
5224244|NCT02597517|magnification|magnification
5224245|NCT02597517|Helicobacter pylori|helicobacter pylori
5212269|NCT02667847|levels of preoperative anxiety using two different scales|levels of preoperative anxiety using two different scales
5212270|NCT02667834|social cognition|social cognition
5212271|NCT02667834|cognitive remediation|cognitive remediation
5212272|NCT02667782|Mindfulness-based interventions|mindfulness-based interventions
5212293|NCT02667652|RCT|rct
5224246|NCT02597517|Atrophic gastritis|atrophic gastritis
5224247|NCT02597491|Smoking,|smoking,
5224248|NCT02597491|Smoking cessation|smoking cessation
5224249|NCT02597491|Sequential, multiple assignment, randomized trials (SMART)|sequential, multiple assignment, randomized trials (smart)
5224250|NCT02597491|Lung cancer screening|lung cancer screening
5224251|NCT02597478|Advanced Cancers|advanced cancers
5224252|NCT02597478|Fentanyl Sublingual Spray|fentanyl sublingual spray
5224253|NCT02597478|Fentanyl SL Spray|fentanyl sl spray
5224254|NCT02597478|FSS|fss
5224255|NCT02597478|Questionnaires|questionnaires
5224256|NCT02597478|Surveys|surveys
5224257|NCT02597478|Mental Abilities Test|mental abilities test
5224258|NCT02597478|Phone Call|phone call
5224259|NCT02597478|Shuttle Walk Test|shuttle walk test
5224260|NCT02597452|breast lump|breast lump
5224261|NCT02597452|breast exam|breast exam
5224262|NCT02597452|breast cancer screening|breast cancer screening
5224263|NCT02597452|breast lump detection|breast lump detection
5224264|NCT02597439|Ultra-high risk|ultra-high risk
5224265|NCT02597439|UHR|uhr
5224266|NCT02597439|psychosis|psychosis
5224267|NCT02597426|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5224268|NCT02597426|Intensity-Modulated Radiotherapy|intensity-modulated radiotherapy
5224269|NCT02597426|Post treatment|post treatment
5224270|NCT02597374|Electroencephalography|electroencephalography
5224271|NCT02597374|mu rhythm|mu rhythm
5224275|NCT02597361|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
5224276|NCT02597361|Type 2 Angiotensin Receptor Blockers|type 2 angiotensin receptor blockers
5224278|NCT02597348|Metastasis|metastasis
5224279|NCT02597348|Colorectal cancer|colorectal cancer
5224280|NCT02597348|Liver transplantation|liver transplantation
5224281|NCT02597335|Glioma|glioma
5224282|NCT02597335|IDH1/IDH2 mutation|idh1/idh2 mutation
5224283|NCT02597335|Spectroscopy MRI|spectroscopy mri
5224284|NCT02597335|D-2-hydroxyglutarate|d-2-hydroxyglutarate
5224285|NCT02597335|Free circulating DNA|free circulating dna
5224286|NCT02597322|Axitinib|axitinib
5224287|NCT02597322|T2a Renal tumor|t2a renal tumor
5224288|NCT02597322|organ confined tumors|organ confined tumors
5224289|NCT02597322|nephron sparing surgery|nephron sparing surgery
5224290|NCT02597322|nephron sparing procedure|nephron sparing procedure
5224291|NCT02597322|radical nephrectomy|radical nephrectomy
5224292|NCT02597283|Bifurcation lesions|bifurcation lesions
5224293|NCT02597283|Percutaneous coronary intervention|percutaneous coronary intervention
5224294|NCT02597283|Randomized controlled trial|randomized controlled trial
5224295|NCT02597270|Hepatitis C virus|hepatitis c virus
5224296|NCT02597257|Lidocaine infusion therapy|lidocaine infusion therapy
5224297|NCT02597244|Lumbar foraminal stenosis|lumbar foraminal stenosis
5224298|NCT02597231|Delirium|delirium
5224299|NCT02597231|Melatonin|melatonin
5224300|NCT02597218|Hepatectomy|hepatectomy
5224301|NCT02597218|Prophylaxis|prophylaxis
5224302|NCT02597205|Medical adherence|medical adherence
5224303|NCT02597205|Lifestyle modification|lifestyle modification
5224304|NCT02597205|Mobile Health|mobile health
5224305|NCT02597205|Secondary Prevention|secondary prevention
5224306|NCT02597192|gingivitis|gingivitis
5224307|NCT02597192|gingival inflammation|gingival inflammation
5224308|NCT02597192|probiotics|probiotics
5224309|NCT02597192|Bacillus|bacillus
5224314|NCT02597036|Advanced, Angiopoietin|advanced, angiopoietin
5224315|NCT02596997|Adenovirus Brincidofovir|adenovirus brincidofovir
5224316|NCT02596984|Intensive Care Unit|intensive care unit
5224318|NCT02596984|Antifungal agent|antifungal agent
5224319|NCT02596984|Pharmacokinetics|pharmacokinetics
5224320|NCT02596984|Sepsis|sepsis
5224321|NCT02596932|Intrapartum|intrapartum
5224322|NCT02596893|Crohn's Disease|crohn's disease
5224323|NCT02596893|GED-0301|ged-0301
5224324|NCT02596893|Mongersen|mongersen
5224326|NCT02596893|Safety|safety
5224327|NCT02596893|Efficacy|efficacy
5224328|NCT02596880|Hepatitis C|hepatitis c
5224329|NCT02596880|Cirrhosis|cirrhosis
5224330|NCT02596880|Sofosbuvir|sofosbuvir
5224331|NCT02596880|Daclatasvir|daclatasvir
5224332|NCT02596880|Ribavirin|ribavirin
5224333|NCT02596867|B adrenergic pathway|b adrenergic pathway
5224334|NCT02596867|B Blocker|b blocker
5224335|NCT02596841|Lung diffusing capacity|lung diffusing capacity
5224336|NCT02596841|Idiopathic Interstitial Pneumonias|idiopathic interstitial pneumonias
5224337|NCT02596828|molecular targeted therapy|molecular targeted therapy
5224338|NCT02596828|protein kinase inhibitor|protein kinase inhibitor
5224339|NCT02596828|mTOR Inhibitor|mtor inhibitor
5224340|NCT02596828|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
5224341|NCT02596828|temozolomide|temozolomide
5224342|NCT02596828|irinotecan|irinotecan
5224343|NCT02596828|dasatinib|dasatinib
5224344|NCT02596828|rapamycin|rapamycin
5224345|NCT02596802|Fetoscopic Endoluminal Tracheal Occlusion|fetoscopic endoluminal tracheal occlusion
5224346|NCT02596802|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5224347|NCT02596763|Off-label prescription|off-label prescription
5224348|NCT02596763|Alcoholism|alcoholism
5224349|NCT02596763|Pharmacovigilance|pharmacovigilance
5224350|NCT02596763|Pharmacoepidemiology|pharmacoepidemiology
5224351|NCT02596763|Baclofen|baclofen
5224352|NCT02596737|health|health
5224353|NCT02596737|work|work
5224354|NCT02596737|lifestyle|lifestyle
5224355|NCT02596737|behavior|behavior
5224356|NCT02596737|management|management
5224357|NCT02596737|stress|stress
5224358|NCT02596737|physical activity|physical activity
5224359|NCT02596737|nutrition|nutrition
5224360|NCT02596737|mortality|mortality
5224361|NCT02596737|morbidity|morbidity
5224362|NCT02596737|public health|public health
5224363|NCT02596724|Breast Cancer|breast cancer
5224364|NCT02596724|Neoadjuvant therapy for breast cancer|neoadjuvant therapy for breast cancer
5224365|NCT02596711|Cancer Prevention|cancer prevention
5224366|NCT02596711|Tobacco Use Cessation|tobacco use cessation
5224367|NCT02596711|Nicotine Patch|nicotine patch
5224369|NCT02596711|Questionnaires|questionnaires
5224370|NCT02596711|Surveys|surveys
5224371|NCT02596711|Carbon Monoxide Test|carbon monoxide test
5224372|NCT02596711|CO|co
5224373|NCT02596711|Health Education|health education
5224374|NCT02596711|Handouts|handouts
5224375|NCT02596711|Pamphlets|pamphlets
5224376|NCT02596711|Counseling sessions|counseling sessions
5224377|NCT02596698|Mood Disorder|mood disorder
5224378|NCT02596672|physical activity|physical activity
5224379|NCT02596672|older adults|older adults
5224380|NCT02596672|retirement homes|retirement homes
5224381|NCT02596672|walking|walking
5224382|NCT02596672|feasibility study|feasibility study
5224383|NCT02596659|lateral epicondylosis|lateral epicondylosis
5224384|NCT02596659|lateral epicondylitis|lateral epicondylitis
5224385|NCT02596659|shockwave|shockwave
5224386|NCT02596659|sonoelastography|sonoelastography
5224387|NCT02596659|tennis elbow|tennis elbow
5224388|NCT02596659|pain intensity|pain intensity
5224389|NCT02596659|grip strength|grip strength
5224390|NCT02596659|upper limb function|upper limb function
5224391|NCT02596659|stiffness of common extensor tendon|stiffness of common extensor tendon
5224392|NCT02596620|Helicobacter pylori|helicobacter pylori
5224393|NCT02596620|Proton pump inhibitor|proton pump inhibitor
5224394|NCT02596620|Eradication|eradication
5224395|NCT02596607|ischemic stroke, acute phase, thrombolysis, management times|ischemic stroke, acute phase, thrombolysis, management times
5224396|NCT02596594|IUGR|iugr
5224397|NCT02596594|severe IUGR|severe iugr
5224398|NCT02596594|brain sparing|brain sparing
5224399|NCT02596594|fetal nutrition|fetal nutrition
5224400|NCT02596594|Prolongation|prolongation
5224401|NCT02596594|pregnancy|pregnancy
5224402|NCT02596594|neonatal outcome|neonatal outcome
5224403|NCT02596581|periodontitis|periodontitis
5224404|NCT02596581|diabetes mellitus|diabetes mellitus
5224405|NCT02596581|chemerin|chemerin
5224406|NCT02596581|interleukin-6|interleukin-6
5224407|NCT02596503|young adults|young adults
5224408|NCT02596503|adolescents|adolescents
5224409|NCT02596490|Non-Small Cell Lung Cancer|non-small cell lung cancer
5224410|NCT02596490|NSCLC|nsclc
5224411|NCT02596490|Couples-based meditation program|couples-based meditation program
5224412|NCT02596490|Couples-based cancer-related discussion program|couples-based cancer-related discussion program
5224413|NCT02596490|Questionnaires|questionnaires
5224414|NCT02596490|Surveys|surveys
5224415|NCT02596490|Metastatic lung cancer|metastatic lung cancer
5224416|NCT02596490|Quality of life|quality of life
5224417|NCT02596490|QOL|qol
5224418|NCT02596477|Heart failure|heart failure
5224419|NCT02596412|children|children
5224420|NCT02596412|botulinum toxin|botulinum toxin
5224421|NCT02596412|augmented reality|augmented reality
5224422|NCT02596412|Pain|pain
5224423|NCT02596399|Healthy volunteers|healthy volunteers
5224424|NCT02596399|DSTA4637S|dsta4637s
5224425|NCT02596360|Antinociception|antinociception
5224426|NCT02596360|Freeze-induced hyperalgesia model|freeze-induced hyperalgesia model
5224427|NCT02596360|Dextromethorphan|dextromethorphan
5224428|NCT02596360|NMDA-receptors|nmda-receptors
5224429|NCT02596360|Pharmacogenetic|pharmacogenetic
5224430|NCT02596360|CYP3A4 gene|cyp3a4 gene
5224431|NCT02596360|MDR1 gene|mdr1 gene
5224432|NCT02596334|HIV-1 infected patient|hiv-1 infected patient
5224433|NCT02596334|monotherapy|monotherapy
5224434|NCT02596334|dolutegravir|dolutegravir
5224435|NCT02596321|House Dust Mite|house dust mite
5224436|NCT02596308|Plague vaccine|plague vaccine
5224437|NCT02596308|Immunogenicity|immunogenicity
5224438|NCT02596308|Safety|safety
5224439|NCT02596282|neonatal male circumcision|neonatal male circumcision
5224440|NCT02596282|Clinical officers vs Nurse midwives|clinical officers vs nurse midwives
5212475|NCT02666443|brachial plexus|brachial plexus
5224441|NCT02596282|Rakai, Uganda|rakai, uganda
5423247|NCT01616550|thoracic surgery|thoracic surgery
5224442|NCT02596282|acceptability and safety of neonatal male circumcision|acceptability and safety of neonatal male circumcision
5224443|NCT02596243|CIN2, CIN2/3, CIN3|cin2, cin2/3, cin3
5224444|NCT02596243|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5224445|NCT02596243|High-Risk HPV|high-risk hpv
5224446|NCT02596243|HPV infection|hpv infection
5224447|NCT02596243|precancer Diseases|precancer diseases
5224448|NCT02596243|Double Blind|double blind
5224449|NCT02596243|Safety/Efficacy|safety/efficacy
5224450|NCT02596217|ABBV-066|abbv-066
5224451|NCT02596217|BI 655066|bi 655066
5224452|NCT02596217|risankizumab|risankizumab
5224453|NCT02596165|validation|validation
5224454|NCT02596165|pulse wave analysis|pulse wave analysis
5224455|NCT02596165|blood pressure monitoring|blood pressure monitoring
5224456|NCT02596152|balance|balance
5224458|NCT02596152|barriers towards exercise|barriers towards exercise
5224459|NCT02596152|quality of life|quality of life
5224460|NCT02596152|body dissatisfaction|body dissatisfaction
5224461|NCT02596152|executive functions|executive functions
5224462|NCT02596152|eating behavior|eating behavior
5224463|NCT02596152|fitness|fitness
5224464|NCT02596126|Polypill|polypill
5224465|NCT02596126|Prevention of Secondary Cardiovascular Disease|prevention of secondary cardiovascular disease
5224466|NCT02596126|Cardiovascular Disease|cardiovascular disease
5224467|NCT02596126|Myocardial Infarction|myocardial infarction
5224468|NCT02596126|Cardiovascular Combination Polypill AAR|cardiovascular combination polypill aar
5342986|NCT01981291|Ultrasonography|ultrasonography
5224597|NCT02595398|Intermediate Uveitis|intermediate uveitis
5224473|NCT02596126|Secondary Cardiovascular Disease|secondary cardiovascular disease
5224474|NCT02596126|Secondary Cardiovascular Prevention|secondary cardiovascular prevention
5224475|NCT02596126|Randomized Cardiovascular Trial|randomized cardiovascular trial
5224476|NCT02596126|Randomized Trial|randomized trial
5224477|NCT02596126|Cardiovascular Polypill|cardiovascular polypill
5224478|NCT02596113|colorectal cancer|colorectal cancer
5224479|NCT02596113|genes involved in carcinogenesis of the colon|genes involved in carcinogenesis of the colon
5224480|NCT02596113|screening colorectal cancer|screening colorectal cancer
5224481|NCT02596100|Bioequivalence|bioequivalence
5224482|NCT02596009|COPD|copd
5224483|NCT02596009|Cachexia due to chronic obstructive pulmonary disease|cachexia due to chronic obstructive pulmonary disease
5224484|NCT02596009|wasting syndrome|wasting syndrome
5224485|NCT02596009|Loss of weight|loss of weight
5224486|NCT02596009|muscle atrophy|muscle atrophy
5224487|NCT02596009|loss of body mass|loss of body mass
5224488|NCT02596009|signficant loss of appetite|signficant loss of appetite
5224489|NCT02596009|cachectic syndrome|cachectic syndrome
5224491|NCT02595983|Familial Amyloidotic Polyneuropathy|familial amyloidotic polyneuropathy
5224492|NCT02595983|ATTR Amyloidosis|attr amyloidosis
5224493|NCT02595983|Orthotopic Liver Transplant|orthotopic liver transplant
5224494|NCT02595983|RNAi therapeutic|rnai therapeutic
5224495|NCT02595970|Psoriasis|psoriasis
5224496|NCT02595970|Secukinumab|secukinumab
5224497|NCT02595970|Simplified Psoriasis Index|simplified psoriasis index
5224498|NCT02595970|CAIN457A|cain457a
5224499|NCT02595970|AIN457AFR01|ain457afr01
5224500|NCT02595970|AIN457A|ain457a
5224501|NCT02595970|Skin condition|skin condition
5224502|NCT02595970|skin disease|skin disease
5224503|NCT02595970|itching condition|itching condition
5224504|NCT02595970|psoriasis vulgaris|psoriasis vulgaris
5224505|NCT02595970|relapsing/remitting psoriasis|relapsing/remitting psoriasis
5224506|NCT02595970|immune-mediated systemic disease|immune-mediated systemic disease
5224507|NCT02595970|skin lesions|skin lesions
5224508|NCT02595970|red skin lesions|red skin lesions
5224509|NCT02595970|scaly patches|scaly patches
5224510|NCT02595970|papules|papules
5224511|NCT02595970|plaques|plaques
5224512|NCT02595970|itching|itching
5224619|NCT02595281|neoadjuvant|neoadjuvant
5224516|NCT02595853|Upper GastroIntestinal bleeding, endoscopy, Hemospray|upper gastrointestinal bleeding, endoscopy, hemospray
5224517|NCT02595827|Pediatrics|pediatrics
5224518|NCT02595827|Epidemiology|epidemiology
5224519|NCT02595827|Fever|fever
5224520|NCT02595827|Democratic Republic of the Congo|democratic republic of the congo
5224521|NCT02595827|Randomized Controlled Trial|randomized controlled trial
5224522|NCT02595814|Registry|registry
5224523|NCT02595814|Heart failure|heart failure
5224524|NCT02595814|Hospitalized|hospitalized
5224525|NCT02595814|Global|global
5224526|NCT02595814|Morbidity|morbidity
5224527|NCT02595814|Mortality|mortality
5224528|NCT02595814|Quality of life|quality of life
5224529|NCT02595814|AHF|ahf
5224530|NCT02595775|endoscopy measures|endoscopy measures
5224531|NCT02595775|audit and feedback|audit and feedback
5224532|NCT02595775|quality improvement|quality improvement
5224533|NCT02595775|randomized controlled trial|randomized controlled trial
5224534|NCT02595775|Colonoscopy|colonoscopy
5224535|NCT02595710|Cryptogenic Chronic Hepatitis|cryptogenic chronic hepatitis
5224536|NCT02595710|Bartonellosis|bartonellosis
5224538|NCT02595684|Tadalfil|tadalfil
5224539|NCT02595684|Insulin secretion|insulin secretion
5224540|NCT02595684|Insulin sensitivity|insulin sensitivity
5224541|NCT02595671|Digital coaching|digital coaching
5224543|NCT02595671|Self-determination theory|self-determination theory
5224544|NCT02595671|Obesity|obesity
5224545|NCT02595671|Overweight|overweight
5224546|NCT02595671|Diet|diet
5224547|NCT02595671|Physical activity|physical activity
5224548|NCT02595645|colorectal adenoma|colorectal adenoma
5224549|NCT02595645|colorectal cancer|colorectal cancer
5224550|NCT02595645|next generation sequencing|next generation sequencing
5224551|NCT02595645|liquid biopsy|liquid biopsy
5224552|NCT02595645|screening colonoscopy|screening colonoscopy
5224553|NCT02595645|surveillance strategies|surveillance strategies
5224555|NCT02595619|Extracorporeal Carbon Dioxide Removal|extracorporeal carbon dioxide removal
5224556|NCT02595619|Renal Replacement Therapy|renal replacement therapy
5221880|NCT02611921|Autism|autism
5224557|NCT02595619|Mechanical Ventilation|mechanical ventilation
5224558|NCT02595606|dry eye syndromes|dry eye syndromes
5224559|NCT02595606|diabetes mellitus|diabetes mellitus
5224560|NCT02595593|Trauma|trauma
5224561|NCT02595593|Rib Plate|rib plate
5224562|NCT02595593|Rib Fixation|rib fixation
5224563|NCT02595580|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5224564|NCT02595567|Liver disease|liver disease
5224565|NCT02595567|Pleural effusion|pleural effusion
5224566|NCT02595554|Cervical cancer, Stage IIB, Neoadjuvant chemotherapy|cervical cancer, stage iib, neoadjuvant chemotherapy
5224567|NCT02595541|pediatric|pediatric
5224568|NCT02595541|cardiac|cardiac
5224569|NCT02595541|sildenfil|sildenfil
5224570|NCT02595541|milrinone|milrinone
5224571|NCT02595541|pulmonary hypertension|pulmonary hypertension
5224572|NCT02595489|Leukodystrophy|leukodystrophy
5224573|NCT02595489|ABCD1|abcd1
5224574|NCT02595489|Demyelination|demyelination
5224575|NCT02595489|Inflammation|inflammation
5224576|NCT02595489|ALD|ald
5224577|NCT02595489|Vitamin D|vitamin d
5224578|NCT02595489|Oxidative Stress|oxidative stress
5224579|NCT02595489|X- linked|x- linked
5224580|NCT02595489|Adrenoleukodystrophy|adrenoleukodystrophy
5224581|NCT02595476|analgesia|analgesia
5224582|NCT02595476|pupillometry|pupillometry
5224583|NCT02595476|general anesthesia|general anesthesia
5224584|NCT02595450|Non-small cell lung cancer|non-small cell lung cancer
5224585|NCT02595437|dialysis|dialysis
5224586|NCT02595437|pediatric|pediatric
5224587|NCT02595437|chronic kidney disease|chronic kidney disease
5224588|NCT02595411|Children|children
5224589|NCT02595411|Rehabilitation|rehabilitation
5224590|NCT02595411|Upper Limb|upper limb
5224591|NCT02595411|Assessments|assessments
5224592|NCT02595411|Outcome Measures|outcome measures
5224593|NCT02595398|Uveitis|uveitis
5224594|NCT02595398|UME|ume
5224595|NCT02595398|Posterior Uveitis|posterior uveitis
5224596|NCT02595398|Anterior Uveitis|anterior uveitis
5224598|NCT02595398|Panuveitis|panuveitis
5224599|NCT02595398|Non-infectious Uveitis|non-infectious uveitis
5224600|NCT02595398|Triamcinolone|triamcinolone
5224601|NCT02595398|Choroid|choroid
5224602|NCT02595398|Choroidal Injection|choroidal injection
5224603|NCT02595398|Suprachoroidal|suprachoroidal
5224604|NCT02595398|Microneedle|microneedle
5224605|NCT02595398|Microinjection|microinjection
5224606|NCT02595359|endophthalmitis|endophthalmitis
5224607|NCT02595359|antibiotic therapy|antibiotic therapy
5224608|NCT02595359|cataract surgery|cataract surgery
5224609|NCT02595359|prevention|prevention
5224610|NCT02595333|repeat cesarean section|repeat cesarean section
5224611|NCT02595333|pain|pain
5224612|NCT02595320|breast, gastrointestinal,capecitabine, cancer, metastatic|breast, gastrointestinal,capecitabine, cancer, metastatic
5224613|NCT02595307|Risk Recall|risk recall
5224614|NCT02595307|Pamphlet|pamphlet
5224615|NCT02595307|Brochure|brochure
5224616|NCT02595307|Patient satisfaction|patient satisfaction
5224617|NCT02595307|Informed Consent|informed consent
5224618|NCT02595281|Ovarian Carcinoma|ovarian carcinoma
5224620|NCT02595281|ROMA|roma
5224621|NCT02595281|Ca125|ca125
5224622|NCT02595281|HE4|he4
5224623|NCT02595281|biomarker|biomarker
5224624|NCT02595268|Healthy|healthy
5224625|NCT02595268|Pitavastatin|pitavastatin
5224626|NCT02595268|JNJ-63623872|jnj-63623872
5224627|NCT02595255|chemotherapy/GnRH analogues/lymphoma/children/fertility|chemotherapy/gnrh analogues/lymphoma/children/fertility
5224628|NCT02595203|Bioavailability|bioavailability
5224629|NCT02595190|Sacral perineurial cysts(Tarlov Cysts)|sacral perineurial cysts(tarlov cysts)
5224630|NCT02595190|Resting state functional magnetic resonance imaging (rfMRI)|resting state functional magnetic resonance imaging (rfmri)
5224631|NCT02595190|VAS|vas
5224632|NCT02595190|Medicine conservative treatment|medicine conservative treatment
5224633|NCT02595190|Surgical treatment|surgical treatment
5224634|NCT02595177|multifocal IOL|multifocal iol
5224635|NCT02595177|monovision|monovision
5224636|NCT02595177|hybrid monovision|hybrid monovision
5224637|NCT02595177|spectacles independence|spectacles independence
5224638|NCT02595151|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5224639|NCT02595151|chronic atrophic antral gastritis|chronic atrophic antral gastritis
5224640|NCT02595151|microcirculatory dynamics|microcirculatory dynamics
5224641|NCT02595138|zoledronic acid|zoledronic acid
5224642|NCT02595138|triple-negative breast cancer|triple-negative breast cancer
5224643|NCT02595138|adjuvant treatment|adjuvant treatment
5224644|NCT02595125|intrauterine device|intrauterine device
5224645|NCT02595125|contraceptive method|contraceptive method
5224646|NCT02595125|direct technique|direct technique
5224647|NCT02595125|torpedo technique|torpedo technique
5224648|NCT02595125|verbal numeric scale|verbal numeric scale
5224649|NCT02595112|staphylococcal infections|staphylococcal infections
5224650|NCT02595112|nasal carriage|nasal carriage
5224651|NCT02595112|nasal cavity|nasal cavity
5224652|NCT02595112|Staphylococcus aureus|staphylococcus aureus
5224653|NCT02595060|acute lung injury, molgramostim, GM-CSF, pneumonia, barrier restoration|acute lung injury, molgramostim, gm-csf, pneumonia, barrier restoration
5224654|NCT02595047|Self-regeneration, in vivo tissue prefabrication,|self-regeneration, in vivo tissue prefabrication,
5224655|NCT02595021|Total or subtotal colectomy|total or subtotal colectomy
5224656|NCT02595021|Ovarian cancer|ovarian cancer
5224657|NCT02595021|Complications|complications
5224658|NCT02595021|One-year disease-free survival|one-year disease-free survival
5224659|NCT02595021|Stage IIIc|stage iiic
5224660|NCT02595021|Stage IV|stage iv
5224661|NCT02594982|Delirium|delirium
5224662|NCT02594982|intensive care nursing|intensive care nursing
5224663|NCT02594982|Acute acquired brain injury|acute acquired brain injury
5224664|NCT02594982|neurointensive care|neurointensive care
5224665|NCT02594982|Intensive care delirium screening checklist|intensive care delirium screening checklist
5224666|NCT02594982|Confusion Assessment Method for the ICU|confusion assessment method for the icu
5224667|NCT02594969|atopic dermatitis|atopic dermatitis
5224668|NCT02594956|nasogastric decompression|nasogastric decompression
5224669|NCT02594943|Diagnostics|diagnostics
5224671|NCT02594943|Diffuse gastric cancer|diffuse gastric cancer
5224672|NCT02594930|synovial biopsy|synovial biopsy
5224673|NCT02594930|knee arthroplasty|knee arthroplasty
5224674|NCT02594930|infection|infection
5224675|NCT02594904|G6PD Deficiency|g6pd deficiency
5224676|NCT02594904|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
5224677|NCT02594904|Yinzhihuang Oral Liquid|yinzhihuang oral liquid
5224678|NCT02594904|Indirect Bilirubin|indirect bilirubin
5224679|NCT02594891|cholangitis|cholangitis
5224680|NCT02594891|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5224681|NCT02594891|complication|complication
5224682|NCT02594878|Chronic non-bacterial osteomyelitis|chronic non-bacterial osteomyelitis
5224683|NCT02594878|Chronic recurrent multifocal osteomyelitis|chronic recurrent multifocal osteomyelitis
5224684|NCT02594878|Non- bacterial osteomyelitis|non- bacterial osteomyelitis
5224685|NCT02594878|SAPHO syndrome|sapho syndrome
5224686|NCT02594878|Whole body MRI|whole body mri
5224687|NCT02594878|Pamidronate|pamidronate
5224688|NCT02594878|Inflammatory bone disease|inflammatory bone disease
5224689|NCT02594878|Autoinflammatory disease|autoinflammatory disease
5224690|NCT02594865|Enteral Nutrition|enteral nutrition
5224691|NCT02594865|Continuous Glucose Monitoring|continuous glucose monitoring
5224692|NCT02594839|interstitial lung disease|interstitial lung disease
5224693|NCT02594839|idiopathic interstitial pneumonia|idiopathic interstitial pneumonia
5224694|NCT02594839|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5224695|NCT02594839|stem cells|stem cells
5224696|NCT02594800|Atherosclerotic Intracranial Arterial Stenosis|atherosclerotic intracranial arterial stenosis
5224697|NCT02594800|Intensive Rosuvastatin Therapy|intensive rosuvastatin therapy
5224698|NCT02594800|Computed Tomography Perfusion (CTP)|computed tomography perfusion (ctp)
5224699|NCT02594735|Juvenile dermatomyositis|juvenile dermatomyositis
5224700|NCT02594735|inflammatory myopathies|inflammatory myopathies
5224701|NCT02594735|Orencia|orencia
5224702|NCT02594735|Abatacept|abatacept
5224703|NCT02594722|COPD|copd
5224704|NCT02594722|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
5224705|NCT02594722|Pulmonary Rehabilitation|pulmonary rehabilitation
5224706|NCT02594696|Major depression and Cancer|major depression and cancer
5224707|NCT02594696|Schizophrenia and Cancer|schizophrenia and cancer
5224708|NCT02594696|Bipolar disorder and Cancer|bipolar disorder and cancer
5224709|NCT02594696|Lung Cancer|lung cancer
5224710|NCT02594696|Breast Cancer|breast cancer
5224711|NCT02594696|Head and Neck cancer|head and neck cancer
5224712|NCT02594696|GI cancer|gi cancer
5224713|NCT02594696|Schizophrenia|schizophrenia
5224714|NCT02594696|Bipolar disorder|bipolar disorder
5224715|NCT02594670|acupoints|acupoints
5224716|NCT02594670|insomnia|insomnia
5224717|NCT02594670|acupuncture|acupuncture
5224718|NCT02594670|randomized controlled trial|randomized controlled trial
5224719|NCT02594657|Eccentric|eccentric
5224720|NCT02594657|Ergometer|ergometer
5224721|NCT02594657|Pedal rate|pedal rate
5224722|NCT02594657|Oxygen consumption|oxygen consumption
5224723|NCT02594657|Only health volunteers|only health volunteers
5224724|NCT02594631|Urethral stones|urethral stones
5224725|NCT02594631|Acute Cacular urinary retention|acute cacular urinary retention
5224726|NCT02594631|Extracorporeal Shock Wave Lithotripsy (ESWL)|extracorporeal shock wave lithotripsy (eswl)
5224727|NCT02594631|Visual lithotripsy|visual lithotripsy
5224728|NCT02594631|bladder stone|bladder stone
5224729|NCT02594592|Osteoporosis|osteoporosis
5224730|NCT02594592|Osteoporosis Self-Assessment Tool|osteoporosis self-assessment tool
5224731|NCT02594592|One-Minute Osteoporosis Risk Test|one-minute osteoporosis risk test
5224733|NCT02594566|Cytomegalovirus|cytomegalovirus
5224735|NCT02594566|Congenital Infection|congenital infection
5224736|NCT02594553|Antibiotics|antibiotics
5224737|NCT02594553|Children|children
5224738|NCT02594553|General Practitioner|general practitioner
5224740|NCT02594553|After-hours care|after-hours care
5224741|NCT02594553|Out-of-hours care|out-of-hours care
5224742|NCT02594553|Booklet|booklet
5224743|NCT02594553|Primary Health Care|primary health care
5224744|NCT02594553|Child|child
5224745|NCT02594527|Older people|older people
5224746|NCT02594527|Physical activity|physical activity
5224747|NCT02594527|Hospital|hospital
5224748|NCT02594514|cardiovascular risk|cardiovascular risk
5224749|NCT02594514|metabolic profile|metabolic profile
5224750|NCT02594488|Myocardial infarction|myocardial infarction
5224751|NCT02594488|Autonomic nervous system|autonomic nervous system
5224752|NCT02594488|Risk stratification|risk stratification
5224753|NCT02594488|Implantable cardiac monitor|implantable cardiac monitor
5224754|NCT02594488|Sudden cardiac death|sudden cardiac death
5224756|NCT02594475|endoscopic retrograde cholangiopancreatography, position|endoscopic retrograde cholangiopancreatography, position
5224757|NCT02594462|contraception|contraception
5224758|NCT02594462|Anemia, Sickle Cell|anemia, sickle cell
5224759|NCT02594449|Pharmacodynamic Study of BCS|pharmacodynamic study of bcs
5224760|NCT02594436|Actinic Keratosis|actinic keratosis
5224762|NCT02594436|ingenol mebutate|ingenol mebutate
5224763|NCT02594436|Picato®|picato®
5224764|NCT02594384|Phase 1|phase 1
5224765|NCT02594384|Safety|safety
5224766|NCT02594384|Apilimod dimesylate|apilimod dimesylate
5224767|NCT02594384|Pharmacokinetics|pharmacokinetics
5224768|NCT02594384|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5224769|NCT02594384|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5224770|NCT02594358|Caffeine|caffeine
5224771|NCT02594332|eosinophilic asthma|eosinophilic asthma
5224772|NCT02594332|mepolizumab|mepolizumab
5224773|NCT02594332|treatment|treatment
5224774|NCT02594306|drug addiction|drug addiction
5224775|NCT02594306|Heroin|heroin
5224776|NCT02594306|craving|craving
5224777|NCT02594306|event related potential|event related potential
5224778|NCT02594306|crystal methamphetamine|crystal methamphetamine
5224779|NCT02594267|PTCL|ptcl
5224780|NCT02594267|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5224781|NCT02594267|Folotyn|folotyn
5224782|NCT02594267|Pralatrexate|pralatrexate
5224783|NCT02594267|CHOP|chop
5224784|NCT02594241|Ventral hernia|ventral hernia
5224785|NCT02594241|Abdominal wall reconstruction|abdominal wall reconstruction
5224786|NCT02594241|Enhanced recovery after surgery|enhanced recovery after surgery
5224787|NCT02594241|Steroid|steroid
5224788|NCT02594215|AKT1|akt1
5224789|NCT02594215|Overgrowth|overgrowth
5224790|NCT02594202|Specimen Collection|specimen collection
5224791|NCT02594202|Carcinogenesis|carcinogenesis
5224792|NCT02594202|Prognostic Biomarkers|prognostic biomarkers
5224793|NCT02594202|Molecular Mechanims|molecular mechanims
5224794|NCT02594202|Cell Lines|cell lines
5224795|NCT02594189|Influenza A|influenza a
5224796|NCT02594189|H3N2|h3n2
5224797|NCT02594189|Challenge Model|challenge model
5224798|NCT02594189|Influenza|influenza
5224799|NCT02594189|Human Challenge|human challenge
5224800|NCT02594137|Decompressive craniectomy|decompressive craniectomy
5224801|NCT02594137|Brain Edema|brain edema
5224802|NCT02593890|Breast Cancer|breast cancer
5224803|NCT02593890|Breast Surgery|breast surgery
5224804|NCT02593890|Mastectomy|mastectomy
5224805|NCT02593890|Lumpectomy|lumpectomy
5224806|NCT02593890|Post-operative|post-operative
5224807|NCT02593890|Bra|bra
5224808|NCT02593890|Lingerie|lingerie
5224809|NCT02593890|Body Image|body image
5224810|NCT02593890|Psycho-social|psycho-social
5224811|NCT02593890|Impact|impact
5224812|NCT02593656|protein ingestion|protein ingestion
5224813|NCT02593656|resistance exercise|resistance exercise
5224814|NCT02593656|interval exercise|interval exercise
5224815|NCT02593656|stretching exercise|stretching exercise
5224816|NCT02593656|endurance exercise|endurance exercise
5224817|NCT02593617|Energy Drinks|energy drinks
5224818|NCT02593617|Alcohol Drinking|alcohol drinking
5224819|NCT02593617|Substance Use|substance use
5224820|NCT02593500|Bioequivalence, budesonide,|bioequivalence, budesonide,
5224821|NCT02593448|Cardiopulmonary Bypass|cardiopulmonary bypass
5224822|NCT02593448|Anoxia|anoxia
5224823|NCT02594176|Osteoarthritis|osteoarthritis
5224824|NCT02594176|Pain|pain
5224825|NCT02594176|NSAID|nsaid
5224826|NCT02594176|Sequessome|sequessome
5224827|NCT02594124|SMA|sma
5224828|NCT02594124|SMN|smn
5224829|NCT02594124|SMNRx|smnrx
5224835|NCT02594124|Spinraza|spinraza
5224836|NCT02594124|nusinersen|nusinersen
5224837|NCT02594111|inflammation|inflammation
5224838|NCT02594111|percutaneous coronary intervention|percutaneous coronary intervention
5224839|NCT02594111|coronary artery disease|coronary artery disease
5224840|NCT02594111|colchicine|colchicine
5224841|NCT02594098|Atopic dermatitis|atopic dermatitis
5224842|NCT02594098|extrinsic atopic dermatitis|extrinsic atopic dermatitis
5224843|NCT02594098|intrinsic atopic dermatitis|intrinsic atopic dermatitis
5224844|NCT02594059|endothelial function, idiopathic pulmonary fibrosis|endothelial function, idiopathic pulmonary fibrosis
5224845|NCT02594020|suspected caries|suspected caries
5224846|NCT02594020|initial enamel lesions|initial enamel lesions
5224847|NCT02594007|telehealth|telehealth
5224848|NCT02594007|heart failure|heart failure
5224849|NCT02593994|Onyx|onyx
5224850|NCT02593994|drug eluting stent|drug eluting stent
5224851|NCT02593994|Routine Clinical Practice|routine clinical practice
5224852|NCT02593994|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5224853|NCT02593994|Coronary Artery Disease|coronary artery disease
5224854|NCT02593981|sleep|sleep
5224855|NCT02593981|fruit|fruit
5224856|NCT02593981|honey|honey
5224857|NCT02593981|geriatric|geriatric
5224858|NCT02593929|squamous cell carcinoma|squamous cell carcinoma
5224859|NCT02593929|head and neck cancer|head and neck cancer
5224861|NCT02593903|Antibiotic Prophylaxis|antibiotic prophylaxis
5224862|NCT02593877|Trauma|trauma
5224863|NCT02593877|Hemostasis|hemostasis
5224864|NCT02593877|Resuscitation|resuscitation
5224865|NCT02593877|Coagulopathy|coagulopathy
5224866|NCT02593877|Transfusion|transfusion
5224867|NCT02593851|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5224868|NCT02593851|JNJ-53718678|jnj-53718678
5224869|NCT02593851|Placebo|placebo
5224870|NCT02593851|Infants|infants
5224871|NCT02593812|Learning|learning
5224872|NCT02593812|Practice|practice
5224873|NCT02593799|Liver cirrhosis|liver cirrhosis
5224874|NCT02593799|Esophageal and Gastric Varices|esophageal and gastric varices
5224875|NCT02593799|Endoscopy|endoscopy
5224876|NCT02593773|Interferon gamma|interferon gamma
5224877|NCT02593747|Allergy|allergy
5224878|NCT02593708|HER2+|her2+
5224879|NCT02593695|Anorexia Nervosa|anorexia nervosa
5224880|NCT02593695|Deep Brain Stimulation|deep brain stimulation
5224881|NCT02593695|Nucleus accumbens|nucleus accumbens
5224882|NCT02593643|Major Depressive Disorder|major depressive disorder
5224883|NCT02593643|Bipolar Disorder|bipolar disorder
5224884|NCT02593643|Depression|depression
5224885|NCT02593643|Suicide|suicide
5224886|NCT02593643|Suicidal Ideation|suicidal ideation
5224887|NCT02593643|Ketamine|ketamine
5224888|NCT02593643|Midazolam|midazolam
5224889|NCT02593643|Inpatients|inpatients
5224890|NCT02593604|Hidradenitis suppurativa|hidradenitis suppurativa
5224891|NCT02593604|Wide excision|wide excision
5224892|NCT02593604|Quality of Life|quality of life
5224893|NCT02593604|Sexual Function|sexual function
5224899|NCT02593513|Embryo Transfer|embryo transfer
5224900|NCT02593513|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
5224901|NCT02593513|Assisted Reproductive Technology|assisted reproductive technology
5224902|NCT02593487|Coronary Artery Disease|coronary artery disease
5224903|NCT02593487|Hyperlipidemia|hyperlipidemia
5224904|NCT02593487|Rosuvastatin|rosuvastatin
5224905|NCT02593487|Lipoproteins|lipoproteins
5224906|NCT02593487|high-density lipoprotein|high-density lipoprotein
5224907|NCT02593487|HDL2|hdl2
5224908|NCT02593474|Adolescent|adolescent
5224909|NCT02593474|Youth|youth
5224910|NCT02593461|Embryo Transfer|embryo transfer
5224911|NCT02593461|Embryo Selection Criteria for Implantation|embryo selection criteria for implantation
5224912|NCT02593461|Assisted Reproductive Technology|assisted reproductive technology
5225305|NCT02591446|Plasticity|plasticity
5224913|NCT02593435|BRCA1/2 gene mutation|brca1/2 gene mutation
5224914|NCT02593435|Breast Cancer|breast cancer
5224915|NCT02593435|Chinese high risk group|chinese high risk group
5224916|NCT02593422|ovarian cancer|ovarian cancer
5224917|NCT02593422|expressive writing|expressive writing
5224918|NCT02593422|writing interventions|writing interventions
5224919|NCT02593422|psychosocial support|psychosocial support
5224920|NCT02593409|HIV-1|hiv-1
5224921|NCT02593409|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5224922|NCT02593409|immune response|immune response
5224923|NCT02593396|sexual dysfunctions|sexual dysfunctions
5224924|NCT02593396|erectile dysfunctions|erectile dysfunctions
5224925|NCT02593396|hypoactive sexual desire dysfunctions|hypoactive sexual desire dysfunctions
5224927|NCT02593383|efficacy|efficacy
5224928|NCT02593370|Hip surgery anesthesia|hip surgery anesthesia
5224929|NCT02593370|Perioperative analgesia|perioperative analgesia
5224930|NCT02593357|endothelial function|endothelial function
5224931|NCT02593357|COPD|copd
5224932|NCT02593357|pulmonary function|pulmonary function
5224933|NCT02593344|asthma, endothelial function|asthma, endothelial function
5224934|NCT02593318|energy metabolism|energy metabolism
5224935|NCT02593318|oxaloacetate|oxaloacetate
5224936|NCT02593305|nitrate|nitrate
5224937|NCT02593305|blood flow|blood flow
5224938|NCT02593305|blood pressure|blood pressure
5224939|NCT02593305|vascular function|vascular function
5224941|NCT02593292|Clinical pathway|clinical pathway
5224942|NCT02593292|Electronic Health Records|electronic health records
5224943|NCT02593292|Maternal Health Services & administration|maternal health services & administration
5224944|NCT02593292|Patient Access to Records|patient access to records
5224945|NCT02593292|Patient Satisfaction|patient satisfaction
5224946|NCT02593292|Prenatal Care/methods|prenatal care/methods
5224947|NCT02593279|Asthma|asthma
5224948|NCT02593279|phenotype|phenotype
5224949|NCT02593279|small|small
5224950|NCT02593279|airway|airway
5224951|NCT02593279|proximal|proximal
5224952|NCT02593279|dysfunction|dysfunction
5224953|NCT02593266|Prevention|prevention
5224954|NCT02593266|Family|family
5224956|NCT02593266|Depression|depression
5224957|NCT02593266|Children|children
5224958|NCT02593253|Quality Improvement|quality improvement
5224959|NCT02593253|Quality Indicators, Health Care|quality indicators, health care
5224960|NCT02593253|Hospital Medicine|hospital medicine
5224961|NCT02593240|Energy|energy
5224962|NCT02593240|Presenteeism|presenteeism
5224963|NCT02593240|Absenteeism|absenteeism
5224964|NCT02593240|Cardiometabolic health|cardiometabolic health
5224966|NCT02593240|Overweight|overweight
5224967|NCT02593240|Weight Loss|weight loss
5224968|NCT02593240|Quality of Life|quality of life
5224969|NCT02593240|Weight Control|weight control
5224970|NCT02593240|Eating Behavior|eating behavior
5224971|NCT02593240|Food Cravings|food cravings
5224972|NCT02593240|Hunger|hunger
5224973|NCT02593240|Worksite Wellness|worksite wellness
5224975|NCT02593214|Condoms, Female|condoms, female
5224976|NCT02593214|Contraception, Barrier|contraception, barrier
5224977|NCT02593136|Vitamins|vitamins
5224978|NCT02593136|Public Health|public health
5224979|NCT02593136|Nutrition|nutrition
5224980|NCT02593123|Donor Type (Matched Related Donor or Matched Unrelated Donor)|donor type (matched related donor or matched unrelated donor)
5224981|NCT02593084|Resistance Training|resistance training
5224982|NCT02593084|Exercise|exercise
5224983|NCT02593084|Walking|walking
5224984|NCT02593084|Safety|safety
5224985|NCT02593084|Feasibility Studies|feasibility studies
5224986|NCT02593058|Anhedonia|anhedonia
5224987|NCT02593058|Apathy|apathy
5224988|NCT02593058|Negative symptoms|negative symptoms
5224989|NCT02593058|Anticipatory pleasure|anticipatory pleasure
5224990|NCT02593058|Savoring|savoring
5224991|NCT02593032|hemoglobin A1c protein, human > 7.5|hemoglobin a1c protein, human > 7.5
5224992|NCT02593006|Joint Diseases|joint diseases
5224993|NCT02593006|Juvenile Arthritis|juvenile arthritis
5224994|NCT02593006|treatment|treatment
5224995|NCT02593006|biologic therapy|biologic therapy
5224996|NCT02593006|comparative effectiveness|comparative effectiveness
5224997|NCT02592967|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5224998|NCT02592967|JNJ-64041757|jnj-64041757
5224999|NCT02592967|Listeria monocytogenes|listeria monocytogenes
5225000|NCT02592928|eHealth|ehealth
5225001|NCT02592928|Spirometry|spirometry
5225002|NCT02592928|Lung Function|lung function
5225003|NCT02592928|Primary Care|primary care
5225004|NCT02592928|Telehealth|telehealth
5225005|NCT02592928|Integrated Care|integrated care
5225006|NCT02592902|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5225007|NCT02592902|extra oesophageal reflux|extra oesophageal reflux
5225008|NCT02592902|laryngeal cyst|laryngeal cyst
5225009|NCT02592902|phonosurgery|phonosurgery
5225010|NCT02592902|oesophageal impedance|oesophageal impedance
5225011|NCT02592889|MITRAL REGURGITATION|mitral regurgitation
5225012|NCT02592876|Antibodies, Monoclonal|antibodies, monoclonal
5225013|NCT02592876|Antibody-Drug Conjugate|antibody-drug conjugate
5225014|NCT02592876|Antigens, CD19|antigens, cd19
5225015|NCT02592876|Autologous Stem Cell Transplant|autologous stem cell transplant
5225016|NCT02592876|Drug Therapy|drug therapy
5225017|NCT02592876|Follicular Lymphoma Grade 3b|follicular lymphoma grade 3b
5225018|NCT02592876|Hematologic Diseases|hematologic diseases
5225019|NCT02592876|Immune System Diseases|immune system diseases
5225020|NCT02592876|Immunoproliferative Disorders|immunoproliferative disorders
5225021|NCT02592876|Immunotherapy|immunotherapy
5225022|NCT02592876|Lymphatic Diseases|lymphatic diseases
5225023|NCT02592876|Lymphoma|lymphoma
5225024|NCT02592876|Lymphoma, B-Cell|lymphoma, b-cell
5225025|NCT02592876|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5225026|NCT02592876|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5225027|NCT02592876|Monomethylauristatin F|monomethylauristatin f
5225028|NCT02592876|Neoplasms|neoplasms
5225029|NCT02592876|Neoplasms by Histologic Type|neoplasms by histologic type
5225030|NCT02592876|Transformed Lymphoma / DLBCL|transformed lymphoma / dlbcl
5225031|NCT02592876|Rituximab|rituximab
5225032|NCT02592876|Ifosfamide|ifosfamide
5225033|NCT02592876|Carboplatin|carboplatin
5225034|NCT02592876|Etoposide|etoposide
5231053|NCT02558257|Survey|survey
5225035|NCT02592850|Osteopathic manipulative treatment|osteopathic manipulative treatment
5225036|NCT02592850|Frequent Episodic Tension-Type Headache|frequent episodic tension-type headache
5094058|NCT03410927|MTD|mtd
5165452|NCT02957981|Men|men
5225037|NCT02592850|Randomized Controlled Trial|randomized controlled trial
5225038|NCT02592837|Endobronchial ultrasound|endobronchial ultrasound
5225040|NCT02592837|TBNA|tbna
5225041|NCT02592837|Mediastinal ymphadenopathy|mediastinal ymphadenopathy
5225042|NCT02592837|Hilar lymphadenopathy|hilar lymphadenopathy
5225043|NCT02592837|Lung cancer|lung cancer
5225044|NCT02592824|glutamate, heart failure, coronary artery bypass surgery|glutamate, heart failure, coronary artery bypass surgery
5225045|NCT02592811|Cholangiopancreatography|cholangiopancreatography
5225046|NCT02592811|therapeutic strategy|therapeutic strategy
5225047|NCT02592811|Endoscopic Retrograde|endoscopic retrograde
5225048|NCT02592772|menthol|menthol
5225049|NCT02592772|nicotine|nicotine
5225050|NCT02592772|reduced nicotine|reduced nicotine
5225058|NCT02592720|Fractional Flow Reserve|fractional flow reserve
5225059|NCT02592720|Percutaneous Coronary Intervention|percutaneous coronary intervention
5225060|NCT02592681|menstrual migraine|menstrual migraine
5225061|NCT02592681|acupuncture|acupuncture
5225062|NCT02592681|acupressure|acupressure
5225063|NCT02592655|tourniquet|tourniquet
5225064|NCT02592655|arterial|arterial
5225065|NCT02592655|pre-hospital|pre-hospital
5225066|NCT02592655|SOFTT-W|softt-w
5225067|NCT02592655|Battle Wrap|battle wrap
5225068|NCT02592655|windlass|windlass
5225069|NCT02592655|exsanguination|exsanguination
5225070|NCT02592655|hemorrhage|hemorrhage
5225071|NCT02592655|amputation|amputation
5225072|NCT02592642|lumbar spinal stenosis|lumbar spinal stenosis
5225073|NCT02592642|neurogenic claudication|neurogenic claudication
5225074|NCT02592642|non-operative|non-operative
5225075|NCT02592642|treatment|treatment
5225076|NCT02592642|outcomes|outcomes
5225077|NCT02592642|clinical trial|clinical trial
5225078|NCT02592629|subacromial injection|subacromial injection
5225079|NCT02592629|rotator cuff disease|rotator cuff disease
5225080|NCT02592629|steroid injection|steroid injection
5225081|NCT02592616|Exercise|exercise
5225082|NCT02592616|Appetite|appetite
5225083|NCT02592616|Energy intake|energy intake
5225084|NCT02592603|Serrated lesions|serrated lesions
5225085|NCT02592603|Surveillance|surveillance
5225086|NCT02592603|Colorectal cancer|colorectal cancer
5225087|NCT02592603|Endocuff|endocuff
5225088|NCT02592603|Sessile serrated adenoma|sessile serrated adenoma
5225089|NCT02592603|Colonoscopy|colonoscopy
5225090|NCT02592590|Exercise|exercise
5225091|NCT02592590|Physical Activity|physical activity
5225092|NCT02592590|Smartphone|smartphone
5225093|NCT02592590|Technology|technology
5225094|NCT02592577|Previously Treated|previously treated
5225095|NCT02592577|Cell Therapy|cell therapy
5225096|NCT02592577|T Cell Therapy|t cell therapy
5225097|NCT02592577|MAGE-A10|mage-a10
5225098|NCT02592577|Immuno-oncology|immuno-oncology
5225099|NCT02592577|T Cell Receptor|t cell receptor
5225100|NCT02592577|Metastatic|metastatic
5225101|NCT02592564|Magnetic Resonance Imaging|magnetic resonance imaging
5225102|NCT02592564|Cognitive Behavior Therapy|cognitive behavior therapy
5225103|NCT02592564|Telomerase|telomerase
5225104|NCT02592564|Telomere Length, Mean Leukocyte|telomere length, mean leukocyte
5225105|NCT02592538|Biliary duct carcinoma;|biliary duct carcinoma;
5225106|NCT02592538|radiofrequency ablation|radiofrequency ablation
5225107|NCT02592538|S-1|s-1
5225108|NCT02592512|Hypoxia|hypoxia
5225109|NCT02592512|hypercapnia|hypercapnia
5225110|NCT02592499|HM III|hm iii
5225111|NCT02592499|survival|survival
5225112|NCT02592499|LVAD|lvad
5225113|NCT02592486|quadrivalent influenza vaccine|quadrivalent influenza vaccine
5225114|NCT02592486|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
5225115|NCT02592486|immunogenicity|immunogenicity
5225116|NCT02592473|Prostate Artery Embolization (PAE)|prostate artery embolization (pae)
5225117|NCT02592473|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5225118|NCT02592473|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5225119|NCT02592473|BPH|bph
5225120|NCT02592473|PAE|pae
5225121|NCT02592473|LUTS|luts
5225122|NCT02592473|Prostatic Artery Embolization|prostatic artery embolization
5225123|NCT02592447|CML|cml
5225124|NCT02592447|chronic phase CML|chronic phase cml
5225125|NCT02592447|leukemia|leukemia
5225134|NCT02592395|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5225135|NCT02592395|electrochemotherapy|electrochemotherapy
5225136|NCT02592395|electroporation|electroporation
5225137|NCT02592395|radiogenomics|radiogenomics
5225138|NCT02592395|imaging|imaging
5213162|NCT02662686|Mitochondrial DNA|mitochondrial dna
5213163|NCT02662686|MitoScore|mitoscore
5225139|NCT02592395|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5225140|NCT02592343|fecal microbiota transplantation|fecal microbiota transplantation
5225141|NCT02592343|lyophilized|lyophilized
5225142|NCT02592330|LSCD treatment|lscd treatment
5225143|NCT02592330|Limbal Stem Cell Deficiency|limbal stem cell deficiency
5962695|NCT04279353|Stress, Resident, Anesthesiologist, Mindfulness, Medical, Education|stress, resident, anesthesiologist, mindfulness, medical, education
5225144|NCT02592330|CALEC|calec
5225145|NCT02592330|Cultivated Autologous Limbal Epithelial Cell Transplantation|cultivated autologous limbal epithelial cell transplantation
5962696|NCT04279327|immunohistochemistry|immunohistochemistry
5094147|NCT03410420|Hypoxia|hypoxia
5103760|NCT03348800|RCT|rct
5225146|NCT02592330|Corneal epithelial stem cells|corneal epithelial stem cells
5225147|NCT02592330|Corneal scarring|corneal scarring
5225149|NCT02592330|Chemical injury eye|chemical injury eye
5225150|NCT02592330|Thermal injury eye|thermal injury eye
5225151|NCT02592330|Autologous stem cell|autologous stem cell
5225152|NCT02592330|Epithelial defect|epithelial defect
5225153|NCT02592330|Corneal cloudiness|corneal cloudiness
5225154|NCT02592330|Occular burn|occular burn
5225155|NCT02592330|Occular injury|occular injury
5225156|NCT02592330|Autograft|autograft
5225157|NCT02592330|CLAU|clau
5225158|NCT02592330|Conjunctival Limbal Autograft|conjunctival limbal autograft
5225159|NCT02592330|LSCD research|lscd research
5225160|NCT02592330|Chronic contact lens wear|chronic contact lens wear
5225161|NCT02592330|Chronic keratoconjunctivitis|chronic keratoconjunctivitis
5225162|NCT02592330|Corneal conjunctivalization|corneal conjunctivalization
5225163|NCT02592330|Corneal fibrovascular pannus|corneal fibrovascular pannus
5225164|NCT02592330|Corneal neovascularization|corneal neovascularization
5225165|NCT02592330|Corneal regeneration|corneal regeneration
5225166|NCT02592330|Infectious keratitus|infectious keratitus
5225167|NCT02592330|Limbal epithelial stem cell deficiency LESC|limbal epithelial stem cell deficiency lesc
5225168|NCT02592330|Ocular injury drug toxicity|ocular injury drug toxicity
5225169|NCT02592330|Ocular surface disorder|ocular surface disorder
5225170|NCT02592330|Neovascularization pannus|neovascularization pannus
5225171|NCT02592330|Neurotrophic keratitis|neurotrophic keratitis
5225172|NCT02592330|Occular surface Inflammation|occular surface inflammation
5225173|NCT02592330|Eye injury ionizing radiation|eye injury ionizing radiation
5225174|NCT02592330|Eye injury ultraviolet radiation|eye injury ultraviolet radiation
5225175|NCT02592330|Corneal pannus|corneal pannus
5225176|NCT02592330|Corneal wound healing|corneal wound healing
5225177|NCT02592330|Neurotrophic keratopathy|neurotrophic keratopathy
5225178|NCT02592330|LSCD trial|lscd trial
5225179|NCT02592330|Stem cell therapy|stem cell therapy
5225180|NCT02592330|Epithelial surface integrity|epithelial surface integrity
5225181|NCT02592330|Regrowing corneas|regrowing corneas
5225182|NCT02592317|JNJ-56021927|jnj-56021927
5225183|NCT02592317|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
5225184|NCT02592291|Mobile health|mobile health
5225185|NCT02592291|Apps|apps
5225186|NCT02592291|Applications|applications
5225187|NCT02592291|Smart phone|smart phone
5225188|NCT02592291|mHealth|mhealth
5225189|NCT02592291|Chronic and Complex Conditions|chronic and complex conditions
5225190|NCT02592291|Self-Management|self-management
5225191|NCT02592291|Self-Care|self-care
5225192|NCT02592278|Dental Caries|dental caries
5225193|NCT02592278|Fluoride Varnish|fluoride varnish
5225194|NCT02592278|Preschool child|preschool child
5225195|NCT02592278|Prevention|prevention
5225196|NCT02592239|Functional brain MRI|functional brain mri
5225197|NCT02592239|functional dyspepsia|functional dyspepsia
5225198|NCT02592239|hedonic response|hedonic response
5225199|NCT02592200|Female|female
5225200|NCT02592200|Constipation|constipation
5225201|NCT02592200|Lactobacillus gasseri DSM 27123|lactobacillus gasseri dsm 27123
5225202|NCT02592200|Probiotics|probiotics
5225203|NCT02592187|Life-logging|life-logging
5225204|NCT02592187|Cognitive Training|cognitive training
5225205|NCT02592187|Mild Cognitive Impairment|mild cognitive impairment
5225206|NCT02592187|Memory|memory
5225207|NCT02592187|Information and communications technology (ICT) in healthcare|information and communications technology (ict) in healthcare
5225208|NCT02592187|Portable camera|portable camera
5225209|NCT02592135|Acute Cardiac Insufficiency|acute cardiac insufficiency
5225210|NCT02592135|Acute Heart Failure|acute heart failure
5225211|NCT02592122|Mechanical ventilation|mechanical ventilation
5225212|NCT02592122|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5225213|NCT02592122|Airway resistance|airway resistance
5225214|NCT02592122|Bronchial dilation test|bronchial dilation test
5225215|NCT02592109|Complementary Feeding Recommendation|complementary feeding recommendation
5225216|NCT02592109|Linear Programming|linear programming
5225217|NCT02592109|Nutritional Status|nutritional status
5225218|NCT02592109|Omega-3 Fatty Acids|omega-3 fatty acids
5225219|NCT02592109|Malondialdehyde|malondialdehyde
5225220|NCT02592109|alpha-Tocopherol|alpha-tocopherol
5225221|NCT02592096|safety and bioavailability|safety and bioavailability
5225222|NCT02592083|Neoadjuvant Therapy|neoadjuvant therapy
5225223|NCT02592083|Cyclin-Dependent Kinase Inhibitor p16|cyclin-dependent kinase inhibitor p16
5225224|NCT02592044|pain|pain
5225225|NCT02592044|anxiety|anxiety
5225226|NCT02592044|Catheterization, Peripheral|catheterization, peripheral
5225227|NCT02592005|pollution|pollution
5225228|NCT02591979|Sleep Apnea Syndrome|sleep apnea syndrome
5225229|NCT02591979|Primary Health Care|primary health care
5225230|NCT02591940|cardiovascular modeling|cardiovascular modeling
5225231|NCT02591940|aortic coarctation|aortic coarctation
5225232|NCT02591940|aortic valve disease|aortic valve disease
5225233|NCT02591927|myocardial infarction|myocardial infarction
5962697|NCT04279327|cytology|cytology
5962698|NCT04279327|moc 31 monoclonal antibody, human|moc 31 monoclonal antibody, human
5225234|NCT02591927|glucose-insulin-potassium|glucose-insulin-potassium
5225235|NCT02591901|Spinal Cord Injuries|spinal cord injuries
5225236|NCT02591901|Multiple Sclerosis|multiple sclerosis
5225237|NCT02591901|Transverse Myelitis|transverse myelitis
5423248|NCT01616537|solid tumors|solid tumors
5225238|NCT02591901|Neurogenic Bladder Dysfunction|neurogenic bladder dysfunction
5225239|NCT02591901|Feasibility Study|feasibility study
5225240|NCT02591901|Urinary Tract Infection|urinary tract infection
5342987|NCT01981278|Healthy|healthy
5225241|NCT02591875|Cardiac Catheter Ablation|cardiac catheter ablation
5225242|NCT02591875|Cardiac Arrhythmias|cardiac arrhythmias
5225243|NCT02591875|Atrial Flutter|atrial flutter
5225244|NCT02591836|LDL‐C|ldl‐c
5225245|NCT02591836|Lipid Regulator|lipid regulator
5225246|NCT02591797|pain|pain
5225247|NCT02591797|Infant Behavior|infant behavior
5225248|NCT02591797|Heart rate|heart rate
5225249|NCT02591797|Dental Anxiety|dental anxiety
5225250|NCT02591784|nimotuzumab esophageal radiotherapy|nimotuzumab esophageal radiotherapy
5225251|NCT02591771|Adrenaline|adrenaline
5225252|NCT02591771|Extra Corporeal Life Support|extra corporeal life support
5225253|NCT02591771|Inotropes|inotropes
5225254|NCT02591758|Hexo-Skin|hexo-skin
5225255|NCT02591758|Hexoskin|hexoskin
5225256|NCT02591758|NOVA-SKIN|nova-skin
5225257|NCT02591758|angina|angina
5225258|NCT02591758|biometric vest|biometric vest
5225259|NCT02591706|Single missing tooth|single missing tooth
5225260|NCT02591706|Implants|implants
5225261|NCT02591706|Peri-implant bone remodeling|peri-implant bone remodeling
5225262|NCT02591706|Bone thickness|bone thickness
5225263|NCT02591706|Thickness of soft tissue|thickness of soft tissue
5225264|NCT02591693|Family Caregivers|family caregivers
5225265|NCT02591693|Occupational Therapy|occupational therapy
5225266|NCT02591693|Activities of Daily Living|activities of daily living
5225267|NCT02591667|Colorectal cancer|colorectal cancer
5225268|NCT02591667|Peritoneal metastasis|peritoneal metastasis
5225269|NCT02591667|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5225271|NCT02591667|Oxaliplatin|oxaliplatin
5225272|NCT02591667|Irinotecan|irinotecan
5225273|NCT02591667|Bevacizumab|bevacizumab
5225274|NCT02591667|Histopathological response|histopathological response
5225276|NCT02591654|Pembrolizumab|pembrolizumab
5225277|NCT02591654|Metastatic Melanoma|metastatic melanoma
5225278|NCT02591654|MK-3475|mk-3475
5225279|NCT02591641|pre-hospital transport|pre-hospital transport
5225280|NCT02591641|shear force|shear force
5225281|NCT02591641|tissue interface pressure|tissue interface pressure
5225282|NCT02591628|Hypertension|hypertension
5225283|NCT02591628|Thiazide diuretics|thiazide diuretics
5225284|NCT02591589|Hyperoxia|hyperoxia
5225285|NCT02591589|Delirium|delirium
5225286|NCT02591589|Normoxic|normoxic
5225287|NCT02591589|t-MoCA|t-moca
5225288|NCT02591576|Diabetes|diabetes
5225289|NCT02591576|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
5225290|NCT02591576|non-STEMI|non-stemi
5225291|NCT02591576|Excess mortality|excess mortality
5225292|NCT02591576|Relative survival|relative survival
5225293|NCT02591550|chronic cough|chronic cough
5225294|NCT02591550|cough reflex sensitivity|cough reflex sensitivity
5225295|NCT02591550|transient receptor potential vanilloid 1|transient receptor potential vanilloid 1
5225296|NCT02591550|transient receptor potential ankyrin 1|transient receptor potential ankyrin 1
5225297|NCT02591498|cognitive training|cognitive training
5225298|NCT02591485|PTSD prevention|ptsd prevention
5225299|NCT02591485|Acute stress disorder|acute stress disorder
5225300|NCT02591485|Attention training|attention training
5225301|NCT02591485|Cognitive bias modification|cognitive bias modification
5225302|NCT02591459|Autism|autism
5225303|NCT02591446|TMS|tms
5225304|NCT02591446|Autism Spectrum Disorders|autism spectrum disorders
5225306|NCT02591407|Continuous Epidural Analgesia|continuous epidural analgesia
5225307|NCT02591407|Transversus Abdominis Plane block|transversus abdominis plane block
5225308|NCT02591381|urinary stress incontinence|urinary stress incontinence
5225309|NCT02591355|Platelet Rich Plasma|platelet rich plasma
5225310|NCT02591355|Hair Loss|hair loss
5225311|NCT02591342|femoral neck fracture|femoral neck fracture
5225312|NCT02591342|hip arthroplasty|hip arthroplasty
5225313|NCT02591342|complication|complication
5225314|NCT02591342|periprosthetic femoral fracture|periprosthetic femoral fracture
5225315|NCT02591316|nutrition|nutrition
5225316|NCT02591316|physical activity|physical activity
5225317|NCT02591316|breast cancer survivor|breast cancer survivor
5225318|NCT02591316|cognition|cognition
5225319|NCT02591303|Insomnia|insomnia
5225320|NCT02591303|Stress|stress
5225321|NCT02591303|Real-life stressful events|real-life stressful events
5225322|NCT02591290|Meningitis|meningitis
5225323|NCT02591290|Meningococcal Meningitis|meningococcal meningitis
5225324|NCT02591290|Meningococcal Infections|meningococcal infections
5225325|NCT02591290|Menactra®|menactra®
5225326|NCT02591290|Meningococcal Vaccine|meningococcal vaccine
5225327|NCT02591277|Hepatitis C virus|hepatitis c virus
5225328|NCT02591277|observational|observational
5225329|NCT02591277|post-marketing|post-marketing
5225330|NCT02591277|ledipasvir/sofosbuvir|ledipasvir/sofosbuvir
5225331|NCT02591277|Japan|japan
5225332|NCT02591238|smoking|smoking
5225333|NCT02591238|melatonin|melatonin
5225334|NCT02591238|vascular injury|vascular injury
5225335|NCT02591225|left atrial thrombus size|left atrial thrombus size
5225336|NCT02591225|transesophageale echocardiography|transesophageale echocardiography
5225337|NCT02591225|silent cerebral embolism|silent cerebral embolism
5225338|NCT02591212|Bystanding behaviors|bystanding behaviors
5225339|NCT02591212|Campus|campus
5225341|NCT02591212|Sexual Assault|sexual assault
5225342|NCT02591212|CampusSave|campussave
5225343|NCT02591173|Autonomic|autonomic
5225344|NCT02591173|Hypertension|hypertension
5225345|NCT02591173|Renin-Angiotensin System|renin-angiotensin system
5225346|NCT02591134|weight loss|weight loss
5225347|NCT02591134|NNS|nns
5225348|NCT02591134|beverages|beverages
5225349|NCT02591134|diet|diet
5225350|NCT02591134|appetite|appetite
5225351|NCT02591134|satiety|satiety
5225352|NCT02591134|weight control|weight control
5225353|NCT02591108|train of four|train of four
5225354|NCT02591108|neuromuscular blockade|neuromuscular blockade
5225355|NCT02591108|surgery|surgery
5225356|NCT02591069|Vagus nerve stimulation|vagus nerve stimulation
5225357|NCT02591069|vegetative state|vegetative state
5225358|NCT02591069|minimally conscious state|minimally conscious state
5225359|NCT02591069|akinetic mutism|akinetic mutism
5225360|NCT02591069|consciousness|consciousness
5225361|NCT02591069|connectivity|connectivity
5225362|NCT02591043|Pelvic|pelvic
5225363|NCT02591043|Treatment Outcome|treatment outcome
5225364|NCT02591030|Bile Duct Cancer|bile duct cancer
5225365|NCT02591030|phase II/III|phase ii/iii
5222709|NCT02606539|methotrxate|methotrxate
5225368|NCT02591004|Neuroprotection|neuroprotection
5225369|NCT02591004|calcium channel blockers|calcium channel blockers
5225370|NCT02591004|magnesium sulhate|magnesium sulhate
5225371|NCT02591004|Middle cerebral artery doppler|middle cerebral artery doppler
5225372|NCT02590978|gallstone pancreatitis|gallstone pancreatitis
5225373|NCT02590978|mild acute pancreatitis|mild acute pancreatitis
5225374|NCT02590978|adult|adult
5225376|NCT02590926|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5225377|NCT02590913|fructose|fructose
5225378|NCT02590913|metabolism|metabolism
5225379|NCT02590913|acute|acute
5225380|NCT02590900|pharmacokinetics|pharmacokinetics
5225381|NCT02590900|pregnancy|pregnancy
5225382|NCT02590900|oral contraceptives|oral contraceptives
5225383|NCT02590900|oestradiol|oestradiol
5225384|NCT02590874|Mild Cognitive Impairment|mild cognitive impairment
5225385|NCT02590874|Cognition|cognition
5225386|NCT02590874|Memory|memory
5225387|NCT02590874|Depression|depression
5225388|NCT02590874|Depressive disorder|depressive disorder
5225389|NCT02590874|Antidepressive agents|antidepressive agents
5225390|NCT02590874|Duloxetine|duloxetine
5225391|NCT02590874|Cymbalta|cymbalta
5225392|NCT02590874|Selective serotonin and norepinephrine uptake inhibitors|selective serotonin and norepinephrine uptake inhibitors
5225393|NCT02590861|Partial Dentures|partial dentures
5225394|NCT02590861|Dental Implants|dental implants
5225395|NCT02590861|Quality of Life|quality of life
5225396|NCT02590861|Partial Edentulism|partial edentulism
5225397|NCT02590848|Walnut intake|walnut intake
5225398|NCT02590848|Brain development|brain development
5225399|NCT02590848|Nutritional intervention|nutritional intervention
5225400|NCT02590848|Healthy adolescents|healthy adolescents
5225401|NCT02590835|Adult patients|adult patients
5225402|NCT02590835|Patient demand for orthodontic treatment|patient demand for orthodontic treatment
5225403|NCT02590822|Diabetes|diabetes
5225404|NCT02590822|T2DM|t2dm
5225405|NCT02590822|young adults|young adults
5225406|NCT02590822|heart|heart
5225407|NCT02590822|weight loss|weight loss
5225408|NCT02590822|MRI|mri
5225409|NCT02590822|exercise|exercise
5225410|NCT02590822|diastolic function|diastolic function
5225411|NCT02590809|Left ventricular obstruction|left ventricular obstruction
5225412|NCT02590796|Delirium|delirium
5225413|NCT02590796|Inattention|inattention
5225414|NCT02590796|Medical device|medical device
5225415|NCT02590796|Software application|software application
5225416|NCT02590796|Validation study|validation study
5225417|NCT02590796|Diagnosis|diagnosis
5225418|NCT02590796|Dementia|dementia
5225419|NCT02590783|treatment|treatment
5225420|NCT02590757|non-invasive ventilation|non-invasive ventilation
5225421|NCT02590757|non-invasive neurally adjusted ventilatory assist|non-invasive neurally adjusted ventilatory assist
5225422|NCT02590757|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5225423|NCT02590744|Emergence Agitation|emergence agitation
5225425|NCT02590744|preschool children|preschool children
5225426|NCT02590653|STEMI|stemi
5225427|NCT02590653|myocardial strain|myocardial strain
5225428|NCT02590653|atorvastatin|atorvastatin
5225429|NCT02590627|Parasite clearance, Treatment failure|parasite clearance, treatment failure
5225430|NCT02590601|PPCM|ppcm
5225431|NCT02590601|Bromocriptine|bromocriptine
5225432|NCT02590601|Peripartum cardiomyopathy|peripartum cardiomyopathy
5225433|NCT02590588|IgM-associated AL amyloidosis|igm-associated al amyloidosis
5225434|NCT02590575|extracorporeal CO2 removal|extracorporeal co2 removal
5225435|NCT02590575|renal replacement therapy|renal replacement therapy
5225436|NCT02590575|Prismalung|prismalung
5225437|NCT02590575|ARDS|ards
5225438|NCT02590575|hypercapnia|hypercapnia
5342988|NCT01981278|Tapentadol|tapentadol
5225439|NCT02590575|Changes in the arterial pCO2 value|changes in the arterial pco2 value
5225440|NCT02590575|ventilated|ventilated
5225441|NCT02590575|Hypercapnic|hypercapnic
5225442|NCT02590549|Keratoconus|keratoconus
5225443|NCT02590549|riboflavin|riboflavin
5225444|NCT02590549|corneal collagen crosslinking|corneal collagen crosslinking
5225445|NCT02590549|intrasromal ring|intrasromal ring
5225446|NCT02590536|Sildenafil|sildenafil
5225447|NCT02590536|Fetal growth Restriction|fetal growth restriction
5225448|NCT02590536|Umbilical Artery Doppler|umbilical artery doppler
5225449|NCT02590510|Intrathecal chemotherapy|intrathecal chemotherapy
5225450|NCT02590471|Angioplasty with stenting of the superficial femoral artery|angioplasty with stenting of the superficial femoral artery
5225451|NCT02590471|Fasciotomy in Hunter's channel|fasciotomy in hunter's channel
5225452|NCT02590471|Breakage of stent|breakage of stent
5225453|NCT02590458|Breast Cancer|breast cancer
5225454|NCT02590458|Short Breast MRI Scan|short breast mri scan
5225456|NCT02590458|Routine MRI|routine mri
5225457|NCT02590458|High risk for breast cancer|high risk for breast cancer
5225458|NCT02590458|Screening|screening
5225459|NCT02590432|Immunogenicity|immunogenicity
5225460|NCT02590432|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
5225461|NCT02590432|Chronic Idiopathic Constipation|chronic idiopathic constipation
5225462|NCT02590432|Linaclotide|linaclotide
5225463|NCT02590432|Linzess|linzess
5225464|NCT02590406|Morbid Obesity|morbid obesity
5225465|NCT02590406|Bariatric Surgery|bariatric surgery
5225466|NCT02590406|Pre-Oxygenation|pre-oxygenation
5225467|NCT02590406|Anesthesia Induction|anesthesia induction
5225468|NCT02590406|Positive pressure ventilation|positive pressure ventilation
5225469|NCT02590406|Non hypoxic apnea time|non hypoxic apnea time
5225470|NCT02590406|Positive-Pressure Respiration|positive-pressure respiration
5225471|NCT02590406|Anesthesia, General|anesthesia, general
5225472|NCT02590393|Nicotine addiction|nicotine addiction
5225473|NCT02590393|Cigarette smoking|cigarette smoking
5225474|NCT02590393|E-cigarettes|e-cigarettes
5225475|NCT02590380|Adolescent|adolescent
5225476|NCT02590380|paediatric|paediatric
5225477|NCT02590380|pediatric|pediatric
5225478|NCT02590380|scoliosis|scoliosis
5225479|NCT02590380|spine deformity|spine deformity
5225480|NCT02590367|oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
5225481|NCT02590367|HD6610 granule|hd6610 granule
5225482|NCT02590367|colorectal cancer|colorectal cancer
5225483|NCT02590354|Treatment interruption|treatment interruption
5225484|NCT02590354|functional cure|functional cure
5225485|NCT02590341|myocarditis|myocarditis
5225486|NCT02590341|children|children
5225487|NCT02590341|adolescents|adolescents
5225488|NCT02590341|registry|registry
5225489|NCT02590341|multi-center|multi-center
5225490|NCT02590341|pediatric|pediatric
5225491|NCT02590341|heart failure|heart failure
5225492|NCT02590341|inflammatory heart disease|inflammatory heart disease
5225493|NCT02590341|inflammatory cardiomyopathy|inflammatory cardiomyopathy
5225494|NCT02590328|Neonatal Screening|neonatal screening
5225495|NCT02590328|Severe Combined Immunodeficiency|severe combined immunodeficiency
5225496|NCT02590328|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5225497|NCT02590328|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
5225498|NCT02590328|T-cell Receptor Excision Circle|t-cell receptor excision circle
5225500|NCT02590302|Clinical pathway|clinical pathway
5225501|NCT02590302|Mental Health|mental health
5225502|NCT02590302|Emergency Department|emergency department
5225503|NCT02590302|Paediatric|paediatric
5225504|NCT02590302|Risk assessment|risk assessment
5225505|NCT02590302|Service integration|service integration
5225506|NCT02590302|Transitions in care|transitions in care
5225507|NCT02590302|Implementation|implementation
5225508|NCT02590302|Scoring tools|scoring tools
5225509|NCT02590302|Clinical Pathway Evaluation|clinical pathway evaluation
5225510|NCT02590276|frontotemporal Dementia|frontotemporal dementia
5225511|NCT02590276|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5225512|NCT02590276|Biomarkers|biomarkers
5225513|NCT02590276|brain Imaging PET|brain imaging pet
5225514|NCT02590263|WHO grade III|who grade iii
5225515|NCT02590263|WHO grade IV|who grade iv
5225517|NCT02590237|Laryngoscopy|laryngoscopy
5225518|NCT02590237|Video Laryngoscopy|video laryngoscopy
5225519|NCT02590211|experimental study|experimental study
5225520|NCT02590211|cognitive mechanisms|cognitive mechanisms
5225521|NCT02590211|poker|poker
5225522|NCT02590211|cognitive remediation therapy|cognitive remediation therapy
5225523|NCT02590133|Refractory Nasopharyngeal Carcinoma, Endostar, 5-Fu|refractory nasopharyngeal carcinoma, endostar, 5-fu
5225524|NCT02590081|Normal saline|normal saline
5225525|NCT02590081|Destrose 5%|destrose 5%
5225526|NCT02590081|Blood pressure|blood pressure
5225527|NCT02590081|Interdialytic weight gain|interdialytic weight gain
5225528|NCT02590081|thirst level|thirst level
5154668|NCT03025698|CsA|csa
5104159|NCT03346304|Fotolon|fotolon
5225529|NCT02590081|End Stage Renal Failure|end stage renal failure
5225530|NCT02589990|health|health
5225531|NCT02589990|muscle strength|muscle strength
5225532|NCT02589990|exercise genomics|exercise genomics
5316188|NCT02102867|HIV|hiv
5225533|NCT02589977|magnetic resonance imaging|magnetic resonance imaging
5423249|NCT01616537|hematological malignancy|hematological malignancy
5225534|NCT02589977|positron-emission tomography|positron-emission tomography
5225535|NCT02589977|echocardiography|echocardiography
5225536|NCT02589977|myocardial blood flow|myocardial blood flow
5225537|NCT02589977|energy metabolism|energy metabolism
5225538|NCT02589964|probiotics|probiotics
5225539|NCT02589964|antibiotic associated diarrhea|antibiotic associated diarrhea
5225540|NCT02589964|clostridium difficile|clostridium difficile
5225541|NCT02589938|hypopharyngeal cancer|hypopharyngeal cancer
5225542|NCT02589938|laryngeal cancer|laryngeal cancer
5225543|NCT02589938|lip and oral cavity cancer|lip and oral cavity cancer
5225544|NCT02589938|nasopharyngeal cancer|nasopharyngeal cancer
5225545|NCT02589938|oropharyngeal cancer|oropharyngeal cancer
5225546|NCT02589938|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5225547|NCT02589938|salivary gland cancer|salivary gland cancer
5225548|NCT02589938|radiation toxicity|radiation toxicity
5225549|NCT02589938|xerostomia|xerostomia
5225550|NCT02589938|long-term effects of cancer treatment|long-term effects of cancer treatment
5225551|NCT02589938|oral complications of radiation therapy|oral complications of radiation therapy
5225552|NCT02589925|deep brain stimulation|deep brain stimulation
5225553|NCT02589925|subthalamic nucleus|subthalamic nucleus
5225554|NCT02589925|Nucleus basalis Meynert|nucleus basalis meynert
5225555|NCT02589886|Self-help|self-help
5225558|NCT02589873|Lifestyle Intervention|lifestyle intervention
5225559|NCT02589873|Workplace|workplace
5225560|NCT02589873|Diabetes Prevention|diabetes prevention
5225561|NCT02589860|Stem Cell Transplantation|stem cell transplantation
5225562|NCT02589847|Clostridium difficile|clostridium difficile
5225564|NCT02589847|CDI|cdi
5225565|NCT02589847|CDAD|cdad
5225566|NCT02589847|Fecal transplant|fecal transplant
5225567|NCT02589847|Fecal Microbiota transplant|fecal microbiota transplant
5225568|NCT02589847|diarrhea|diarrhea
5225569|NCT02589847|FMT|fmt
5225570|NCT02589847|microbiota restoration therapy|microbiota restoration therapy
5225571|NCT02589847|microbiota suspension|microbiota suspension
5225572|NCT02589847|fecal bacteriotherapy|fecal bacteriotherapy
5225573|NCT02589847|C diff diarrhea|c diff diarrhea
5225574|NCT02589808|pre-operative|pre-operative
5225575|NCT02589808|transthoracic echocardiography|transthoracic echocardiography
5225576|NCT02589808|handheld|handheld
5225577|NCT02589795|safety|safety
5225578|NCT02589795|immunogenicity|immunogenicity
5225579|NCT02589795|HIV vaccine|hiv vaccine
5225580|NCT02589782|bedaquiline|bedaquiline
5225581|NCT02589782|Nitroimidazoles|nitroimidazoles
5225582|NCT02589782|diarylquinolines|diarylquinolines
5225583|NCT02589782|linezolid|linezolid
5225584|NCT02589782|clofazimine|clofazimine
5225585|NCT02589782|pretomanid|pretomanid
5225586|NCT02589782|moxifloxacin|moxifloxacin
5225587|NCT02589756|obesity|obesity
5225588|NCT02589756|persistent organic pollutants|persistent organic pollutants
5225589|NCT02589756|metabolic syndrome|metabolic syndrome
5225590|NCT02589743|clinical trial|clinical trial
5225591|NCT02589743|pit and fissure sealants|pit and fissure sealants
5225592|NCT02589743|tooth eruption|tooth eruption
5225593|NCT02589743|retention|retention
5225594|NCT02589743|adhesive system|adhesive system
5225595|NCT02589743|intermediary layer|intermediary layer
5225596|NCT02589730|Smartphone app|smartphone app
5225597|NCT02589730|diabetic management|diabetic management
5225598|NCT02589730|lifestyle behaviors|lifestyle behaviors
5225599|NCT02589730|medication management|medication management
5225600|NCT02589678|AIDS|aids
5225601|NCT02589678|Immunology|immunology
5225602|NCT02589678|Public Health|public health
5225603|NCT02589678|Female sex workers|female sex workers
5225604|NCT02589678|Single mothers|single mothers
5225605|NCT02589665|IL-23 antibody|il-23 antibody
5225606|NCT02589652|Pegylated interferon|pegylated interferon
5225607|NCT02589652|Entecavir|entecavir
5225608|NCT02589600|Bone loss|bone loss
5225609|NCT02589600|Frail Geriatric Women|frail geriatric women
5225610|NCT02589600|Nursing Home Patients|nursing home patients
5213664|NCT02659904|Palatal donor site healing|palatal donor site healing
5213665|NCT02659878|Takotsubo cardiomyopathy;NT-proBNP;urine metanephrine|takotsubo cardiomyopathy;nt-probnp;urine metanephrine
5225611|NCT02589600|Long-term Care Patients|long-term care patients
5225612|NCT02589600|Osteoporosis|osteoporosis
5225613|NCT02589600|Osteoporotic Fractures|osteoporotic fractures
5225614|NCT02589561|hearing loss|hearing loss
5962699|NCT04279301|Neonatal morbidity|neonatal morbidity
5225615|NCT02589561|hearing aids|hearing aids
5225616|NCT02589548|Hodgkin Lymphoma|hodgkin lymphoma
5225617|NCT02589548|Hodgkin Disease|hodgkin disease
5225618|NCT02589509|Event-related potentials|event-related potentials
5225619|NCT02589509|Attention|attention
5225620|NCT02589509|Cognitive rehabilitation|cognitive rehabilitation
5225621|NCT02589509|Independent activities of daily living|independent activities of daily living
5225622|NCT02589470|cognitive rehabilitation|cognitive rehabilitation
5225624|NCT02589470|epilepsy|epilepsy
5225625|NCT02589457|Chronic Hepatitis B virus, HIV-1 infection|chronic hepatitis b virus, hiv-1 infection
5225626|NCT02589457|Healthy Male Volunteer|healthy male volunteer
5864108|NCT00000415|Children|children
5225627|NCT02589457|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5225628|NCT02589444|Clinical Endocrinology|clinical endocrinology
5225629|NCT02589444|Immunology|immunology
5225630|NCT02589444|Inflammation|inflammation
5225631|NCT02589444|Microbiology|microbiology
5225632|NCT02589444|Respiratory Disorders|respiratory disorders
5225633|NCT02589444|Vitamins|vitamins
5225634|NCT02589431|hypothalamo pituitary adrenal axis|hypothalamo pituitary adrenal axis
5225635|NCT02589418|Manual acupuncture|manual acupuncture
5225636|NCT02589418|Experimental dental pain|experimental dental pain
5225637|NCT02589418|Psychophysics|psychophysics
5225638|NCT02589418|Autonomic nervous system|autonomic nervous system
5225639|NCT02589418|Subjective pain ratings|subjective pain ratings
5225640|NCT02589379|postoperative pancreatic fistula|postoperative pancreatic fistula
5225641|NCT02589379|soft and hard pancreas|soft and hard pancreas
5225642|NCT02589366|Lymphoseek|lymphoseek
5225643|NCT02589366|endometrial cancer|endometrial cancer
5225644|NCT02589366|sentinel lymph node|sentinel lymph node
5225645|NCT02589366|lymph node dissection|lymph node dissection
5225646|NCT02589275|TNX-102 SL|tnx-102 sl
5225648|NCT02589275|sublingual|sublingual
5225649|NCT02589275|3-month|3-month
5225650|NCT02589275|long term safety|long term safety
5225651|NCT02589275|long term efficacy|long term efficacy
5225652|NCT02589275|Fibromyalgia|fibromyalgia
5225653|NCT02589236|Cystic Fibrosis|cystic fibrosis
5225655|NCT02589236|Cavosonstat|cavosonstat
5225656|NCT02589223|multisensory stimulation|multisensory stimulation
5225657|NCT02589210|Diabetes Mellitus|diabetes mellitus
5225658|NCT02589210|Foot Disease|foot disease
5225659|NCT02589210|Foot Ulcer|foot ulcer
5225660|NCT02589197|osteoarthritis|osteoarthritis
5225661|NCT02589197|correction of functional deformity|correction of functional deformity
5225662|NCT02589197|procedures|procedures
5225663|NCT02589197|traumatic osteoarthritis|traumatic osteoarthritis
5225664|NCT02589197|degenerative osteoarthritis|degenerative osteoarthritis
5225665|NCT02589197|total knee arthroplasty|total knee arthroplasty
5225666|NCT02589197|Healthy Volunteers|healthy volunteers
5225667|NCT02589197|electromyography|electromyography
5225668|NCT02589197|Musculoskeletal Diseases|musculoskeletal diseases
5225669|NCT02589184|balance, postural|balance, postural
5225670|NCT02589184|postural equilibrium|postural equilibrium
5225671|NCT02589184|pain scale|pain scale
5225672|NCT02589184|range of motion|range of motion
5225673|NCT02589145|Blood And Marrow Transplantation|blood and marrow transplantation
5225674|NCT02589145|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5225675|NCT02589145|DLBCL|dlbcl
5755749|NCT00298883|PRA|pra
5225676|NCT02589145|Busulfan|busulfan
5225677|NCT02589145|Busulfex|busulfex
5225678|NCT02589145|Myleran|myleran
5225679|NCT02589145|Lenalidomide|lenalidomide
5225680|NCT02589145|CC-5013|cc-5013
5225681|NCT02589145|Revlimid|revlimid
5225682|NCT02589145|Vorinostat|vorinostat
5225683|NCT02589145|SAHA|saha
5225684|NCT02589145|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5225685|NCT02589145|MSK-390|msk-390
5225686|NCT02589145|Zolinza|zolinza
5225687|NCT02589145|Gemcitabine|gemcitabine
5225688|NCT02589145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5225689|NCT02589145|Gemzar|gemzar
5225690|NCT02589145|Melphalan|melphalan
5225691|NCT02589145|Alkeran|alkeran
5225692|NCT02589145|Rituximab|rituximab
5225693|NCT02589145|Rituxan|rituxan
5225694|NCT02589145|Dexamethasone|dexamethasone
5225695|NCT02589145|Decadron|decadron
5225696|NCT02589145|Glutamine|glutamine
5225697|NCT02589145|Enterex|enterex
5225698|NCT02589145|Glutapack-10|glutapack-10
5225699|NCT02589145|NutreStore|nutrestore
5225700|NCT02589145|Resource|resource
5225701|NCT02589145|GlutaSolve|glutasolve
5225702|NCT02589145|Sympt-X G.I.|sympt-x g.i.
5225703|NCT02589145|Symptx-X|symptx-x
5225704|NCT02589145|Pyridoxine|pyridoxine
5225705|NCT02589145|Enoxaparin|enoxaparin
5225706|NCT02589145|Lovenox Injection|lovenox injection
5225707|NCT02589145|Palifermin|palifermin
5225708|NCT02589145|Kepivance|kepivance
5225709|NCT02589119|cryptoglandular|cryptoglandular
5225710|NCT02589119|perianal fistula|perianal fistula
5225711|NCT02589119|cryptoglandular perianal fistulas|cryptoglandular perianal fistulas
5225712|NCT02589106|Anisotropic Textile Braces|anisotropic textile braces
5225713|NCT02589093|Analgesia|analgesia
5225714|NCT02589093|Monitoring|monitoring
5225715|NCT02589093|Analgesia Nociception Index|analgesia nociception index
5225716|NCT02589093|ANI|ani
5225717|NCT02589093|PhysioDoloris|physiodoloris
5225718|NCT02589093|Pain|pain
5225719|NCT02589041|intraneural sciatic block|intraneural sciatic block
5225720|NCT02589028|diabetes mellitus|diabetes mellitus
5225721|NCT02589028|incretin hormone|incretin hormone
5225723|NCT02589028|GLP-1|glp-1
5225724|NCT02589028|GIP|gip
5225725|NCT02589028|premeal protein|premeal protein
5225726|NCT02589015|morbid obesity|morbid obesity
5225727|NCT02589015|neck circumference|neck circumference
5225728|NCT02589015|difficult mask ventilation|difficult mask ventilation
5225731|NCT02589002|insulin sensitivity|insulin sensitivity
5225732|NCT02589002|beta-cell response|beta-cell response
5225733|NCT02589002|appetite regulating hormone|appetite regulating hormone
5225734|NCT02588976|Activated clotting time|activated clotting time
5225735|NCT02588976|Sonoclot|sonoclot
5225736|NCT02588963|upper respiratory tract infections|upper respiratory tract infections
5225737|NCT02588963|lower respiratory tract infections|lower respiratory tract infections
5225738|NCT02588963|health promotion|health promotion
5225739|NCT02588963|respiratory physiotherapy|respiratory physiotherapy
5225741|NCT02588937|Entecavir, EntecaBell ODT., Hepatitis B|entecavir, entecabell odt., hepatitis b
5225742|NCT02588924|Parkinson Disease|parkinson disease
5225743|NCT02588924|ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO METALS|environmental and occupational exposure to metals
5225744|NCT02588911|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5225745|NCT02588911|Operative Surgical Procedure|operative surgical procedure
5225746|NCT02588911|Saphenous Vein|saphenous vein
5225747|NCT02588885|physical therapy|physical therapy
5225748|NCT02588885|psychotherapy|psychotherapy
5225749|NCT02588885|dysfunctional sexual behavior|dysfunctional sexual behavior
5225750|NCT02588885|pelvic pain|pelvic pain
5225751|NCT02588885|posttraumatic stress|posttraumatic stress
5225752|NCT02588885|PTSD|ptsd
5225753|NCT02588885|chronic pain|chronic pain
5225754|NCT02588872|platelet-rich plasma|platelet-rich plasma
5225757|NCT02588846|Prostate|prostate
5225758|NCT02588846|Radiotherapy|radiotherapy
5225759|NCT02588846|IGRT|igrt
5225760|NCT02588846|VMAT|vmat
5225761|NCT02588846|Image-guided radiation therapy|image-guided radiation therapy
5225762|NCT02588846|Volumetric modulated arc therapy|volumetric modulated arc therapy
5225763|NCT02588846|Adaptive radiotherapy|adaptive radiotherapy
5225764|NCT02588820|HIV|hiv
5225765|NCT02588794|sepsis, acute kidney injury , CytoSorb|sepsis, acute kidney injury , cytosorb
5225766|NCT02588768|Low-level laser therapy|low-level laser therapy
5225767|NCT02588768|Light emitting diodes|light emitting diodes
5225768|NCT02588768|Rugby|rugby
5225769|NCT02588768|Field test|field test
5225770|NCT02588768|Photobiomodulation|photobiomodulation
5225771|NCT02588755|Chemoembolization|chemoembolization
5225772|NCT02588755|Therapeutic|therapeutic
5225773|NCT02588755|Tegafur|tegafur
5225774|NCT02588742|elderly ICU patients|elderly icu patients
5225775|NCT02588729|Gestational diabetes|gestational diabetes
5225776|NCT02588729|app|app
5225777|NCT02588729|RCT|rct
5225778|NCT02588729|diet|diet
5225779|NCT02588729|physical activity|physical activity
5225780|NCT02588716|Hepatectomy, Surgical Blood Loss, terlipressin|hepatectomy, surgical blood loss, terlipressin
5225781|NCT02588677|Amyotrophic Lateral Sclerosis (ALS) - masitinib|amyotrophic lateral sclerosis (als) - masitinib
5225782|NCT02588664|Early Supported Discharge|early supported discharge
5225786|NCT02588638|NGS|ngs
5225787|NCT02588638|Quality of life|quality of life
5225788|NCT02588638|Diagnosis|diagnosis
5225789|NCT02588638|Rare disease|rare disease
5225790|NCT02588638|Next-generation sequencing|next-generation sequencing
5225791|NCT02588612|Immuno-oncology|immuno-oncology
5225792|NCT02588612|Cell Therapy|cell therapy
5225793|NCT02588612|NY-ESO-1|ny-eso-1
5225794|NCT02588612|T Cell Therapy|t cell therapy
5225795|NCT02588612|Previously Treated|previously treated
5225796|NCT02588612|T Cell Receptor|t cell receptor
5225797|NCT02588586|HIV|hiv
5225798|NCT02588586|3BNC117|3bnc117
5225799|NCT02588586|Broadly neutralizing antibody|broadly neutralizing antibody
5225891|NCT02587897|Cumulative Trauma Disorders|cumulative trauma disorders
5225800|NCT02588560|lymphoma, hepatitis C virus, chemotherapy|lymphoma, hepatitis c virus, chemotherapy
5225801|NCT02588547|Shivering|shivering
5225802|NCT02588547|Granisetron|granisetron
5225803|NCT02588547|Spinal|spinal
5225804|NCT02588547|Cesarean section|cesarean section
5225805|NCT02588534|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic|etanercept, healthy subject,open-label, randomized, auto-injection, bioequivalence, pharmacokinetic
5225806|NCT02588508|perineal tear|perineal tear
5225807|NCT02588508|pain|pain
5225808|NCT02588508|pelvic floor|pelvic floor
5225809|NCT02588508|Labour|labour
5225810|NCT02588495|Ultrasound|ultrasound
5225811|NCT02588495|Gastric area|gastric area
5225812|NCT02588495|Accuracy|accuracy
5225813|NCT02588495|Aspirate|aspirate
5225814|NCT02588482|electroencephalography (EEG)|electroencephalography (eeg)
5225815|NCT02588482|mismatch negativity (MMN)|mismatch negativity (mmn)
5225816|NCT02588469|pediatric obesity|pediatric obesity
5225817|NCT02588469|obstructive sleep apnea|obstructive sleep apnea
5225818|NCT02588469|physical exercise|physical exercise
5225819|NCT02588469|compression socks|compression socks
5864201|NCT00000404|Knee|knee
5225821|NCT02588391|premature birth; executive function; preschool|premature birth; executive function; preschool
5225822|NCT02588365|Attention Deficit Hyperactivity Disorder; executive function; preschool|attention deficit hyperactivity disorder; executive function; preschool
5225823|NCT02588339|Hematologic disorder|hematologic disorder
5225824|NCT02588339|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5225825|NCT02588326|Bioequivalence|bioequivalence
5225826|NCT02588326|Suspension nasal spray|suspension nasal spray
5225827|NCT02588326|Mometasone furoate|mometasone furoate
5225829|NCT02588326|Particle size distribution|particle size distribution
5225830|NCT02588274|Chronic prostatitis|chronic prostatitis
5225831|NCT02588274|chronic pelvic pain syndrome|chronic pelvic pain syndrome
5225832|NCT02588274|acupuncture|acupuncture
5225833|NCT02588274|placebo needle|placebo needle
5225834|NCT02588274|randomized controlled trial|randomized controlled trial
5225835|NCT02588261|erlotinib|erlotinib
5225836|NCT02588261|EGFR mutation|egfr mutation
5225837|NCT02588261|naquotinib|naquotinib
5225838|NCT02588261|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5225839|NCT02588261|ASP8273|asp8273
5225840|NCT02588261|gefitinib|gefitinib
5225841|NCT02588248|Colon Cancer|colon cancer
5225842|NCT02588248|Colonic Polyps|colonic polyps
5225843|NCT02588248|L-Menthol|l-menthol
5225844|NCT02588248|C-Mint|c-mint
5225845|NCT02588183|atrial fibrillation|atrial fibrillation
5225846|NCT02588183|catheter ablation|catheter ablation
5225847|NCT02588183|pulmonary vein|pulmonary vein
5225848|NCT02588183|cryoenergy|cryoenergy
5225849|NCT02588183|cryoablation|cryoablation
5225850|NCT02588183|ArcticFront|arcticfront
5225851|NCT02588157|Rapid sequence induction intubation|rapid sequence induction intubation
5225852|NCT02588157|McGrath X-Blade|mcgrath x-blade
5225854|NCT02588157|Macintosh|macintosh
5225855|NCT02588144|Parkinson's disease|parkinson's disease
5225856|NCT02588144|freezing of gait|freezing of gait
5225857|NCT02588144|deep brain stimulation|deep brain stimulation
5225858|NCT02588144|substantia nigra pars reticulata|substantia nigra pars reticulata
5225859|NCT02588144|subthalamic nucleus|subthalamic nucleus
5225860|NCT02588131|tremelimumab|tremelimumab
5225861|NCT02588131|anti-PD-L1 MEDI4736 (Durvalumab)|anti-pd-l1 medi4736 (durvalumab)
5225862|NCT02588131|malignant mesothelioma|malignant mesothelioma
5225863|NCT02588105|Phase I, open label study; safety and efficacy of AZD0156; ATM inhibitor|phase i, open label study; safety and efficacy of azd0156; atm inhibitor
5225865|NCT02588079|Dental Fear|dental fear
5225866|NCT02588079|Dental Phobia|dental phobia
5225867|NCT02588079|Internet based cognitive behavioral therapy|internet based cognitive behavioral therapy
5225868|NCT02588079|specific phobia|specific phobia
5225869|NCT02588079|children and adolescents anxiety|children and adolescents anxiety
5225870|NCT02588079|Self Efficacy|self efficacy
5225871|NCT02588040|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
5225872|NCT02588040|Leukocyte- and Platelet-Rich Plasma|leukocyte- and platelet-rich plasma
5225873|NCT02588040|Recover-L-PRP|recover-l-prp
5225874|NCT02587988|Erectile dysfunction & Hypertension|erectile dysfunction & hypertension
5225875|NCT02587949|acute cerebrovascular stroke|acute cerebrovascular stroke
5225876|NCT02587936|Chronic|chronic
5225877|NCT02587936|Risk prediction model|risk prediction model
5225878|NCT02587936|Quality Improvement (QI)|quality improvement (qi)
5225879|NCT02587936|Pragmatic trial|pragmatic trial
5225880|NCT02587936|Cluster randomization|cluster randomization
5225881|NCT02587936|Collaborative care|collaborative care
5225882|NCT02587936|clinical informatics|clinical informatics
5225883|NCT02587936|Chronic kidney disease|chronic kidney disease
5225884|NCT02587936|hypertension|hypertension
5225885|NCT02587936|high BP|high bp
5225886|NCT02587936|diabetes|diabetes
5225887|NCT02587897|Ultrasonography|ultrasonography
5225888|NCT02587897|Nerve Conduction Velocity|nerve conduction velocity
5225889|NCT02587897|Ergonomics|ergonomics
5225890|NCT02587897|Work Related Injury|work related injury
5225892|NCT02587884|Recurrence|recurrence
5225893|NCT02587884|Microvascular Invasion|microvascular invasion
5225894|NCT02587884|Aspartate beta-hydroxylase|aspartate beta-hydroxylase
5225896|NCT02587858|PKAN|pkan
5225897|NCT02587858|brain iron|brain iron
5225898|NCT02587858|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
5225899|NCT02587858|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
5225900|NCT02587858|Pantothenate Kinase Associated Neurodegeneration|pantothenate kinase associated neurodegeneration
5225901|NCT02587858|PLAN|plan
5225902|NCT02587858|INAD|inad
5225903|NCT02587858|PLA2G6-associated neurodegeneration|pla2g6-associated neurodegeneration
5225904|NCT02587858|BPAN|bpan
5225905|NCT02587858|Beta-propeller Protein-associated neurodegenration|beta-propeller protein-associated neurodegenration
5225906|NCT02587858|WDR45|wdr45
5225907|NCT02587858|PLA2G6|pla2g6
5225908|NCT02587845|total hip arthroplasty|total hip arthroplasty
5225909|NCT02587845|transexamic acid|transexamic acid
5225910|NCT02587832|cpap|cpap
5225911|NCT02587832|HHHFNC|hhhfnc
5225913|NCT02587832|ELBW|elbw
5225914|NCT02587806|RRMS|rrms
5225915|NCT02587793|Hepatocellular Carcinoma|hepatocellular carcinoma
5225916|NCT02587793|primary culture|primary culture
5225917|NCT02587793|fine-needle aspiration|fine-needle aspiration
5225918|NCT02587793|cancer-associated fibroblast|cancer-associated fibroblast
5225919|NCT02587741|type 2 diabetes mellitus|type 2 diabetes mellitus
5225920|NCT02587741|Diabetic Retinopathy|diabetic retinopathy
5225921|NCT02587741|glucose fluctuation|glucose fluctuation
5225922|NCT02587741|oxidative stress|oxidative stress
5225923|NCT02587741|Insulin|insulin
5225924|NCT02587741|Oral drugs|oral drugs
5225925|NCT02587728|Carpal Tunnel Syndrome|carpal tunnel syndrome
5225927|NCT02587715|RRMS|rrms
5225928|NCT02587702|Term Infants|term infants
5225929|NCT02587624|atrial fibrillation|atrial fibrillation
5225930|NCT02587624|catheter ablation|catheter ablation
5225931|NCT02587624|remote magnetic navigation|remote magnetic navigation
5225932|NCT02587598|leukemia|leukemia
5225933|NCT02587598|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5225934|NCT02587598|myelodysplastic/myeloproliferative neoplasms (MDS/MPN)|myelodysplastic/myeloproliferative neoplasms (mds/mpn)
5225935|NCT02587598|myelofibrosis (MF)|myelofibrosis (mf)
5225936|NCT02587598|lymphoproliferative disorders|lymphoproliferative disorders
5225937|NCT02587598|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5225938|NCT02587598|lymphomas|lymphomas
5225939|NCT02587598|multiple myeloma (MM)|multiple myeloma (mm)
5225940|NCT02587598|PIM kinases|pim kinases
5225941|NCT02587559|physical therapy|physical therapy
5225942|NCT02587546|laryngeal carcinoma|laryngeal carcinoma
5225943|NCT02587546|bilateral vocal cord paralysis|bilateral vocal cord paralysis
5225944|NCT02587546|laryngotracheal stenosis|laryngotracheal stenosis
5225945|NCT02587546|laser treatment|laser treatment
5225946|NCT02587546|decannulation|decannulation
5225947|NCT02587546|voice|voice
5225948|NCT02587546|swallowing|swallowing
5225949|NCT02587533|Baroreflex|baroreflex
5225950|NCT02587533|Chemoreflex|chemoreflex
5225951|NCT02587533|Autonomic nervous system|autonomic nervous system
5225952|NCT02587533|Sympathetic activity|sympathetic activity
5225953|NCT02587533|Muscle sympathetic nerve activity (MSNA)|muscle sympathetic nerve activity (msna)
5225954|NCT02587533|Microneurography|microneurography
5225955|NCT02587533|Electrical baroreflex stimulation|electrical baroreflex stimulation
5225956|NCT02587533|Resistant hypertension|resistant hypertension
5225957|NCT02587533|Device-based therapy|device-based therapy
5225959|NCT02587520|Diphtheria|diphtheria
5225960|NCT02587520|Pertussis|pertussis
5225961|NCT02587520|SP0173|sp0173
5225962|NCT02587520|Tdap vaccine|tdap vaccine
5225963|NCT02587481|Acute coronary syndrom|acute coronary syndrom
5119321|NCT03249935|Youth|youth
5225964|NCT02587481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5225965|NCT02587481|Myocardial infarction|myocardial infarction
5225966|NCT02587481|Blood based biomarkers|blood based biomarkers
5225967|NCT02587468|phenolics|phenolics
5225968|NCT02587468|absorption|absorption
5225969|NCT02587468|fruit & vegetable concentrate|fruit & vegetable concentrate
5225970|NCT02587468|Bioavailability of phenolic compounds|bioavailability of phenolic compounds
5225971|NCT02587455|Non-small cell carcinoma|non-small cell carcinoma
5225972|NCT02587442|Acute Radiation Syndrome|acute radiation syndrome
5225974|NCT02587442|Amifostine|amifostine
5225975|NCT02587442|Radio-protectants|radio-protectants
5225976|NCT02587416|Pharmacokinetics|pharmacokinetics
5225977|NCT02587416|Lipid Regulator|lipid regulator
5225978|NCT02587390|Pharmacokinetics|pharmacokinetics
5225979|NCT02587390|Lipid Regulator|lipid regulator
5225980|NCT02587364|Pharmacokinetics|pharmacokinetics
5225981|NCT02587364|Lipid Regulator|lipid regulator
5225982|NCT02587351|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5225983|NCT02587351|COPD|copd
5225984|NCT02587351|Exacerbation|exacerbation
5225985|NCT02587351|Lung function|lung function
5225986|NCT02587351|Cardiac|cardiac
5225987|NCT02587351|Cardiovascular|cardiovascular
5225988|NCT02587351|Beta blockers|beta blockers
5225989|NCT02587351|Metoprolol succinate|metoprolol succinate
5225990|NCT02587351|Smoking|smoking
5214054|NCT02657980|MDD|mdd
5225991|NCT02587338|Subjective Memory Impairment|subjective memory impairment
5225992|NCT02587338|tDCS|tdcs
5225993|NCT02587338|NIRS|nirs
5225994|NCT02587338|Cognitive Training|cognitive training
5225995|NCT02587338|Working Memory|working memory
5225996|NCT02587286|mHealth|mhealth
5225997|NCT02587286|Telemedicine|telemedicine
5225998|NCT02587286|Randomized Controlled Trial|randomized controlled trial
5225999|NCT02587286|Glucose control|glucose control
5226000|NCT02587273|Critical care|critical care
5226001|NCT02587273|Intensive Care|intensive care
5226002|NCT02587273|Fentanyl|fentanyl
5226003|NCT02587273|Pharmacokinetics|pharmacokinetics
5226004|NCT02587273|Multiple Organ Failure|multiple organ failure
5226005|NCT02587260|P2Y12 inhibitors|p2y12 inhibitors
5226006|NCT02587260|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5226007|NCT02587260|Endothelial function|endothelial function
5226008|NCT02587260|Adenosine measurement in human subject|adenosine measurement in human subject
5226009|NCT02587260|Endopath|endopath
5226010|NCT02587234|motor recovery|motor recovery
5226011|NCT02587234|chronic|chronic
5226012|NCT02587234|human|human
5226013|NCT02587234|sensory|sensory
5226014|NCT02587234|afferent input|afferent input
5226015|NCT02587234|motor training|motor training
5095117|NCT03404310|HPV|hpv
5226016|NCT02587208|circumcision|circumcision
5226017|NCT02587208|plastibell|plastibell
5226018|NCT02587208|infants|infants
5226019|NCT02587208|open sleeve|open sleeve
5226020|NCT02587195|Multiple Sclerosis|multiple sclerosis
5226021|NCT02587169|liposarcoma|liposarcoma
5226022|NCT02587169|leiomyosarcoma|leiomyosarcoma
5226023|NCT02587169|retroperitoneum|retroperitoneum
5226024|NCT02587169|chondrosarcoma|chondrosarcoma
5226025|NCT02587156|Required dietary protein|required dietary protein
5226026|NCT02587156|Amino acid|amino acid
5226027|NCT02587156|Splanchnic extraction|splanchnic extraction
5226028|NCT02587130|intractable pain|intractable pain
5226029|NCT02587130|pressure ulcer|pressure ulcer
5226030|NCT02587130|bed sore|bed sore
5226031|NCT02587130|palliative medicine|palliative medicine
5226032|NCT02587130|ketamine|ketamine
5226033|NCT02587130|pain management|pain management
5226034|NCT02587117|Antioxidant|antioxidant
5226035|NCT02587117|Lycopene|lycopene
5226036|NCT02587117|Prednisolone|prednisolone
5226037|NCT02587104|Diabetes Mellitus|diabetes mellitus
5226038|NCT02587104|Foot Diseases|foot diseases
5226039|NCT02587104|Foot Ulcer|foot ulcer
5226040|NCT02587078|Haemodynamic stabilization|haemodynamic stabilization
5226041|NCT02587052|biopsy-proven acute rejection|biopsy-proven acute rejection
5226042|NCT02587052|graft loss|graft loss
5226043|NCT02587052|graft survival|graft survival
5226044|NCT02587039|delirium|delirium
5226045|NCT02587039|heart|heart
5226046|NCT02587039|valve|valve
5226047|NCT02587039|graft|graft
5226048|NCT02587039|surgery|surgery
5226049|NCT02587039|coronary|coronary
5226050|NCT02587026|Biorepository|biorepository
5226051|NCT02587026|Precision Genomics|precision genomics
5226053|NCT02587000|ulipristal acetate|ulipristal acetate
5226054|NCT02587000|sonography|sonography
5226055|NCT02587000|Magnetic resonance imaging [MRI]|magnetic resonance imaging [mri]
5226056|NCT02587000|Pictorial Blood-loss Assessment Chart [PBAC]|pictorial blood-loss assessment chart [pbac]
5226057|NCT02586987|Selumetinib|selumetinib
5226058|NCT02586987|Tremelimumab|tremelimumab
5226059|NCT02586987|MEDI4736|medi4736
5226060|NCT02586987|Safety|safety
5226061|NCT02586987|Tolerability|tolerability
5226062|NCT02586987|Pharmacokinetics|pharmacokinetics
5119418|NCT03249350|Adolescents|adolescents
5226063|NCT02586987|Patients with advanced solid tumours|patients with advanced solid tumours
5226064|NCT02586987|Disease progression|disease progression
5226065|NCT02586974|CO2 insufflation|co2 insufflation
5226066|NCT02586974|robot assisted radical prostatectomy|robot assisted radical prostatectomy
5226067|NCT02586974|laparoscopy|laparoscopy
5226068|NCT02586974|hypothermia|hypothermia
5226069|NCT02586974|cytokine response|cytokine response
5226070|NCT02586961|randomized prospective study|randomized prospective study
5226071|NCT02586961|complication rate|complication rate
5226072|NCT02586961|bronchiolitis|bronchiolitis
5226073|NCT02586961|children|children
5226074|NCT02586948|extracorporeal CO2 removal|extracorporeal co2 removal
5226075|NCT02586935|ASD|asd
5226076|NCT02586935|Autism|autism
5226077|NCT02586909|Alzheimer's disease|alzheimer's disease
5226078|NCT02586909|RVT-101|rvt-101
5226079|NCT02586909|donepezil|donepezil
5226080|NCT02586883|Dilation of the Bronchi|dilation of the bronchi
5226081|NCT02586883|Bronchial potential difference|bronchial potential difference
5226082|NCT02586883|Dilation of the Bronchi (DDB)|dilation of the bronchi (ddb)
5226083|NCT02586857|Glioblastoma Multiforme|glioblastoma multiforme
5226084|NCT02586857|GBM|gbm
5226085|NCT02586844|NET|net
5226086|NCT02586844|PanNET|pannet
5226087|NCT02586844|Molecular profiling|molecular profiling
5226088|NCT02586844|Transcriptome sequencing|transcriptome sequencing
5226089|NCT02586831|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5226090|NCT02586831|Hypoglycemia|hypoglycemia
5226091|NCT02586831|Autoimmune Diseases|autoimmune diseases
5226092|NCT02586831|Diabetes Mellitus|diabetes mellitus
5226093|NCT02586805|DX-2930|dx-2930
5226094|NCT02586805|Hereditary Angioedema|hereditary angioedema
5226095|NCT02586805|Dyax|dyax
5226096|NCT02586792|Influenza,Open-Label, Vaccine, Intramusclar, H7N7, H7N9, Non-adjuvanted, sub-study|influenza,open-label, vaccine, intramusclar, h7n7, h7n9, non-adjuvanted, sub-study
5226097|NCT02586779|Referral and consultation|referral and consultation
5226098|NCT02586779|emergency department|emergency department
5226099|NCT02586779|WhatsApp|whatsapp
5226100|NCT02586766|Youth Violence|youth violence
5226101|NCT02586727|Radiation Retinopathy|radiation retinopathy
5226102|NCT02586727|aflibercept|aflibercept
5226103|NCT02586688|child depression|child depression
5226104|NCT02586688|depression|depression
5226105|NCT02586688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5226106|NCT02586688|Adolescent Major Depressive Disorder|adolescent major depressive disorder
5226107|NCT02586688|TMS|tms
5226108|NCT02586688|adolescent depression|adolescent depression
5226109|NCT02586675|ER+ breast cancer|er+ breast cancer
5226110|NCT02586675|PR+ breast cancer|pr+ breast cancer
5226111|NCT02586675|hormone receptor positive|hormone receptor positive
5226112|NCT02586675|HER2- breast cancer|her2- breast cancer
5226113|NCT02586675|HER2 negative|her2 negative
5962700|NCT04279275|Field of Anaesthesiology|field of anaesthesiology
5226114|NCT02586675|locally advanced|locally advanced
5226115|NCT02586675|metastatic|metastatic
5226116|NCT02586662|scapular dyskinesis|scapular dyskinesis
5226117|NCT02586662|kinematics|kinematics
5226118|NCT02586649|tiotropium bromide|tiotropium bromide
5226119|NCT02586636|Metformin|metformin
5226120|NCT02586636|OCT1|oct1
5226121|NCT02586623|Parkinson's Disease|parkinson's disease
5226122|NCT02586623|Multiple System Atrophy|multiple system atrophy
5226123|NCT02586623|Pure Autonomic Failure|pure autonomic failure
5226124|NCT02586623|Primary Autonomic Failure|primary autonomic failure
5226125|NCT02586623|Dopamine Beta Hydroxylase Deficiency|dopamine beta hydroxylase deficiency
5226126|NCT02586610|Pembrolizumab|pembrolizumab
5226127|NCT02586610|Chemoradiation|chemoradiation
5226128|NCT02586610|Anti-PD-1 Antibody|anti-pd-1 antibody
5226129|NCT02586610|MK-3475|mk-3475
5226130|NCT02586597|Stroke|stroke
5226132|NCT02586597|TMS|tms
5226133|NCT02586597|cortical excitability|cortical excitability
5226134|NCT02586597|plasticity|plasticity
5226135|NCT02586584|Patient-Reported Outcome, Antiretroviral Therapy|patient-reported outcome, antiretroviral therapy
5226136|NCT02586571|Body Composition|body composition
5226137|NCT02586571|Breast Feeding|breast feeding
5226138|NCT02586571|Growth|growth
5226139|NCT02586571|Infant|infant
5226140|NCT02586571|Milk, Human|milk, human
5226141|NCT02586571|Nutritional Sciences|nutritional sciences
5226142|NCT02586571|Weaning|weaning
5226143|NCT02586532|Detection|detection
5226144|NCT02586532|Cancer|cancer
5226145|NCT02586532|Antibody|antibody
5226146|NCT02586532|Biopsy|biopsy
5226147|NCT02586532|Registry|registry
5226148|NCT02586519|wearable technology|wearable technology
5226150|NCT02586519|SurroSense Rx|surrosense rx
5226151|NCT02586519|smart insole|smart insole
5226152|NCT02586519|TCC|tcc
5226153|NCT02586519|total contact cast|total contact cast
5226154|NCT02586519|insole|insole
5226155|NCT02586519|removable cast walker|removable cast walker
5226156|NCT02586519|RCW|rcw
5226157|NCT02586506|correct use of inhaler|correct use of inhaler
5226158|NCT02586506|dose left|dose left
5226159|NCT02586506|ease of use|ease of use
5226160|NCT02586506|ELLIPTA|ellipta
5226161|NCT02586506|Asthma|asthma
5226162|NCT02586493|Placebo|placebo
5226163|NCT02586493|ELLIPTA inhaler|ellipta inhaler
5226164|NCT02586493|Correct use|correct use
5226165|NCT02586493|COPD|copd
5226166|NCT02586493|Ease of use|ease of use
5226167|NCT02586480|bradycardia|bradycardia
5226168|NCT02586454|Transmuscular quadratus lumborum block, total abdominal hysterectomy|transmuscular quadratus lumborum block, total abdominal hysterectomy
5226169|NCT02586441|Bispectral index (BIS)|bispectral index (bis)
5226170|NCT02586441|EEG|eeg
5226171|NCT02586441|Depth of anesthesia|depth of anesthesia
5226172|NCT02586415|endovascular|endovascular
5226173|NCT02586415|endovascular procedure|endovascular procedure
5226174|NCT02586415|Mechanical Thrombectomy|mechanical thrombectomy
5226175|NCT02586402|ESAs CKD|esas ckd
5226176|NCT02586363|Entecavir|entecavir
5226177|NCT02586363|Food effect|food effect
5226178|NCT02586363|Cavir Tab 0.5mg|cavir tab 0.5mg
5226179|NCT02586363|Baraclude Tab. 0.5mg|baraclude tab. 0.5mg
5226180|NCT02586285|S-Adenosyl Methionine|s-adenosyl methionine
5226181|NCT02586285|Recurrence|recurrence
5226182|NCT02586272|Embryo Transfer|embryo transfer
5226183|NCT02586272|assisted reproductive technology|assisted reproductive technology
5226184|NCT02586246|CDP870|cdp870
5226185|NCT02586246|Rheumatoid arthritis|rheumatoid arthritis
5226186|NCT02586246|Long-term|long-term
5226187|NCT02586207|Larynx|larynx
5226188|NCT02586207|Squamous Cell|squamous cell
5226189|NCT02586207|Oral cavity|oral cavity
5226190|NCT02586207|Oropharynx|oropharynx
5226191|NCT02586207|Hypopharynx|hypopharynx
5226192|NCT02586194|Impaired hepatic function|impaired hepatic function
5214257|NCT02656927|Psychological Flexibility|psychological flexibility
5214258|NCT02656927|Mindfulness|mindfulness
5226291|NCT02585323|Exercise|exercise
5226193|NCT02586194|Pharmacokinetics|pharmacokinetics
5226194|NCT02586194|ASP015K|asp015k
5226195|NCT02586168|Insulin Resistance|insulin resistance
5226196|NCT02586168|Lipid Regulator|lipid regulator
5226197|NCT02586142|spasticity|spasticity
5226198|NCT02586142|claw toe|claw toe
5226199|NCT02586142|ultrasounds guidance|ultrasounds guidance
5226200|NCT02586142|botulinum toxin|botulinum toxin
5226201|NCT02586142|stretching exercise|stretching exercise
5226202|NCT02586090|Pediatric Obesity|pediatric obesity
5226203|NCT02586090|Lifestyle Intervention|lifestyle intervention
5226204|NCT02586090|Family-based Intervention|family-based intervention
5226205|NCT02586090|Motivational Interviewing|motivational interviewing
5226206|NCT02586064|posttraumatic stress disorder|posttraumatic stress disorder
5226207|NCT02586064|Veterans|veterans
5226208|NCT02586064|Psychotherapy|psychotherapy
5226209|NCT02586064|Randomized Controlled Trial|randomized controlled trial
5226210|NCT02586064|Treatment|treatment
5226335|NCT02585011|Hemiarthroplasty|hemiarthroplasty
5226211|NCT02585999|Hormonal contraception, hormone pharmacokinetics|hormonal contraception, hormone pharmacokinetics
5226213|NCT02585973|Cisplatin|cisplatin
5962701|NCT04279275|Knowledge|knowledge
5962702|NCT04279275|Survey|survey
5226214|NCT02585973|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5226216|NCT02585973|Chemoradiotherapy|chemoradiotherapy
5226217|NCT02585973|Radiotherapy|radiotherapy
5226218|NCT02585973|CRT|crt
5226219|NCT02585947|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5226220|NCT02585947|Tenofovir|tenofovir
5226221|NCT02585934|Alzheimer's disease|alzheimer's disease
5226222|NCT02585934|RVT-101|rvt-101
5226223|NCT02585934|donepezil|donepezil
5226224|NCT02585934|intepirdine|intepirdine
5226225|NCT02585934|dementia|dementia
5226226|NCT02585921|Urban Health|urban health
5226227|NCT02585895|LDL-C Apheresis|ldl-c apheresis
5226228|NCT02585895|Hypercholesterolemia|hypercholesterolemia
5226229|NCT02585895|Elevated Cholesterol|elevated cholesterol
5226230|NCT02585895|High Cholesterol|high cholesterol
5226231|NCT02585895|PCSK9 mutations|pcsk9 mutations
5226232|NCT02585895|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
5226233|NCT02585895|evolocumab|evolocumab
5226234|NCT02585895|Repatha|repatha
5226235|NCT02585869|Lipid Regulator|lipid regulator
5226236|NCT02585869|TG|tg
5226237|NCT02585856|Biliary duct carcinoma|biliary duct carcinoma
5226238|NCT02585856|Photodynamic therapy|photodynamic therapy
5226239|NCT02585843|Heart Failure|heart failure
5226240|NCT02585843|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
5226241|NCT02585843|Loop diuretic resistance|loop diuretic resistance
5226242|NCT02585817|Cardiac Implantable Electronic Devices|cardiac implantable electronic devices
5226243|NCT02585804|FSGS, SGLT2, chronic kidney disease, GFR, proteinuria|fsgs, sglt2, chronic kidney disease, gfr, proteinuria
5226244|NCT02585791|electronic cigarette|electronic cigarette
5223612|NCT02601300|Safety|safety
5226245|NCT02585791|airway inflammation|airway inflammation
5226246|NCT02585791|nasal potential difference|nasal potential difference
5226247|NCT02585726|Varicose Veins|varicose veins
5226248|NCT02585726|Great Saphenous Vein|great saphenous vein
5226249|NCT02585726|Venous Insufficiency|venous insufficiency
5226250|NCT02585700|Grippe|grippe
5226251|NCT02585700|Human Flu|human flu
5226252|NCT02585700|Human influenza|human influenza
5226253|NCT02585687|Liver Perfusion MRI, Hepatocellular carcinoma|liver perfusion mri, hepatocellular carcinoma
5226254|NCT02585622|Diabetic Kidney Disease|diabetic kidney disease
5226255|NCT02585622|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
5226256|NCT02585622|immune response|immune response
5226257|NCT02585622|allogeneic|allogeneic
5226258|NCT02585622|disease progression|disease progression
5226259|NCT02585609|Sleep|sleep
5226260|NCT02585583|Deep Brain|deep brain
5226261|NCT02585583|Essential tremor|essential tremor
5226262|NCT02585583|Parkinson Disease|parkinson disease
5226263|NCT02585583|Tremor|tremor
5226264|NCT02585583|Radiosurgery|radiosurgery
5226265|NCT02585583|Thalamotomy|thalamotomy
5226266|NCT02585583|deep brain stimulation|deep brain stimulation
5226268|NCT02585583|intractable, drug resistant, invalidating tremor|intractable, drug resistant, invalidating tremor
5226269|NCT02585570|shoulder|shoulder
5226270|NCT02585570|phenylephrine|phenylephrine
5226271|NCT02585570|hypotension|hypotension
5226272|NCT02585544|genital prolapse|genital prolapse
5226273|NCT02585544|day-care management|day-care management
5226274|NCT02585544|vaginal route|vaginal route
5226275|NCT02585544|prosthetic reinforcement|prosthetic reinforcement
5226276|NCT02585531|Bronchiolitis|bronchiolitis
5226277|NCT02585531|Dexamethasone|dexamethasone
5226278|NCT02585531|Epinephrine|epinephrine
5226279|NCT02585531|Hypertonic saline|hypertonic saline
5226280|NCT02585427|Diabetes|diabetes
5226281|NCT02585427|Obesity|obesity
5226282|NCT02585427|metabolic disorders|metabolic disorders
5226283|NCT02585388|pretreated metastatic breast cancer|pretreated metastatic breast cancer
5226285|NCT02585336|Sugar-Sweetened beverages|sugar-sweetened beverages
5226286|NCT02585336|Metabolic health|metabolic health
5226287|NCT02585336|Soft drinks|soft drinks
5226288|NCT02585323|Physical activity|physical activity
5226289|NCT02585323|Osteoarthritis|osteoarthritis
5226290|NCT02585323|Knee|knee
5226292|NCT02585323|Arthritis|arthritis
5226293|NCT02585310|PRBC transfusion|prbc transfusion
5226294|NCT02585310|CABGs|cabgs
5226295|NCT02585245|Hospital Nutrition screens|hospital nutrition screens
5226296|NCT02585232|Behavioral sciences|behavioral sciences
5226297|NCT02585232|Counseling|counseling
5226298|NCT02585232|Intervention Studies|intervention studies
5226299|NCT02585232|Cognitive Behavioral Therapy|cognitive behavioral therapy
5226300|NCT02585232|Telemedicine|telemedicine
5226301|NCT02585232|Mindfulness|mindfulness
5226302|NCT02585206|Mobile Phone|mobile phone
5226303|NCT02585206|Text Messaging|text messaging
5226304|NCT02585206|Internet|internet
5226305|NCT02585206|Tobacco Use|tobacco use
5226306|NCT02585180|Ventilator-associated pneumonia|ventilator-associated pneumonia
5226307|NCT02585180|Surveillance|surveillance
5226308|NCT02585180|Subglottic-secretions|subglottic-secretions
5226309|NCT02585180|Critically ill patients|critically ill patients
5226310|NCT02585180|Prevention|prevention
5226311|NCT02585167|VAAFT|vaaft
5226312|NCT02585167|anal fistula|anal fistula
5095490|NCT03401411|ICU|icu
5104997|NCT03340805|Sepsis|sepsis
5226313|NCT02585167|sphincter reconstruction|sphincter reconstruction
5226314|NCT02585154|Deep Brain Stimulation|deep brain stimulation
5226315|NCT02585128|Delirium|delirium
5226316|NCT02585128|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5226317|NCT02585128|Elderly|elderly
5226318|NCT02585102|Vegetables|vegetables
5226319|NCT02585089|Hypertension|hypertension
5226320|NCT02585089|active biopeptide|active biopeptide
5226321|NCT02585089|cardiovascular pathophysiology|cardiovascular pathophysiology
5226322|NCT02585089|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
5226323|NCT02585089|cured-pork ham|cured-pork ham
5226324|NCT02585076|Stroke prevention|stroke prevention
5226325|NCT02585076|Risk assessment|risk assessment
5226326|NCT02585063|independent prescribing,|independent prescribing,
5226327|NCT02585063|optometrist|optometrist
5226328|NCT02585063|acute care|acute care
5226329|NCT02585050|do not attempt resuscitation|do not attempt resuscitation
5226330|NCT02585050|neurological outcome|neurological outcome
5226331|NCT02585050|live discharged ratio|live discharged ratio
5226332|NCT02585024|smoking|smoking
5226333|NCT02585024|cytisine|cytisine
5226334|NCT02585024|Pharmacokinetics|pharmacokinetics
5226336|NCT02585011|Anesthesia, Local|anesthesia, local
5226337|NCT02585011|Pain, Postoperative|pain, postoperative
5226338|NCT02584972|Postural control|postural control
5226339|NCT02584972|Gait|gait
5226340|NCT02584972|Children|children
5226341|NCT02584972|Autism Spectrum Disorder|autism spectrum disorder
5226343|NCT02584933|Malignancies|malignancies
5226344|NCT02584907|Critically ill|critically ill
5226345|NCT02584907|Diet|diet
5226346|NCT02584907|Blood glucose|blood glucose
5226347|NCT02584894|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5226348|NCT02584894|trauma exposure|trauma exposure
5226349|NCT02584894|Repeated transcranial magnetic stimulation|repeated transcranial magnetic stimulation
5226350|NCT02584855|Spondyloarthritis|spondyloarthritis
5226351|NCT02584855|Spondylarthropathy|spondylarthropathy
5226352|NCT02584816|BRV-PV|brv-pv
5226353|NCT02584816|Rotavirus vaccine|rotavirus vaccine
5226354|NCT02584816|lot-to-lot consistency|lot-to-lot consistency
5226355|NCT02584816|interference with routine immunization|interference with routine immunization
5226356|NCT02584790|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5226357|NCT02584790|Narrow band imaging|narrow band imaging
5226358|NCT02584777|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5226359|NCT02584777|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5226360|NCT02584738|Asthma|asthma
5226361|NCT02584738|Exacerbation|exacerbation
5226362|NCT02584738|Nebulization|nebulization
5226363|NCT02584738|Magnesium|magnesium
5226364|NCT02584738|Pediatric|pediatric
5226365|NCT02584725|Tranexamic Acid|tranexamic acid
5226366|NCT02584725|Total Joint Arthroplasty|total joint arthroplasty
5226367|NCT02584725|Intraoperative Blood Loss|intraoperative blood loss
5226368|NCT02584660|Rivaroxaban|rivaroxaban
5226369|NCT02584660|JNJ39039039|jnj39039039
5226370|NCT02584660|Pulmonary embolism|pulmonary embolism
5226371|NCT02584647|Unresectable|unresectable
5226372|NCT02584634|Non-Small Cell Lung Cancer|non-small cell lung cancer
5226373|NCT02584634|NSCLC|nsclc
5226374|NCT02584634|ALK|alk
5226375|NCT02584634|avelumab|avelumab
5226376|NCT02584634|crizotinib|crizotinib
5226377|NCT02584634|PF-06463922|pf-06463922
5226378|NCT02584595|Tachycardia|tachycardia
5226379|NCT02584595|Ventricular Tachycardia|ventricular tachycardia
5226380|NCT02584595|Cardiac Arrhythmias|cardiac arrhythmias
5226381|NCT02584595|Cardiovascular Diseases|cardiovascular diseases
5226382|NCT02584595|Heart Diseases|heart diseases
5226383|NCT02584582|Glucagon|glucagon
5214452|NCT02655575|dizziness|dizziness
5214453|NCT02655575|cognitive therapy|cognitive therapy
5214454|NCT02655575|primary care|primary care
5214455|NCT02655575|vestibular rehabilitation|vestibular rehabilitation
5214456|NCT02655575|chronic|chronic
5214457|NCT02655484|COPD|copd
5226384|NCT02584582|Glukagon-like peptide-1 (GLP-1)|glukagon-like peptide-1 (glp-1)
5226385|NCT02584582|GLP-1 receptor agonist (GLP-1RA)|glp-1 receptor agonist (glp-1ra)
5226386|NCT02584582|Incretins|incretins
5226387|NCT02584569|Drug therapy|drug therapy
5226388|NCT02584530|ultrasound|ultrasound
5226389|NCT02584530|PICC line|picc line
5226390|NCT02584530|neonate|neonate
5226391|NCT02584517|Vasculitis|vasculitis
5226392|NCT02584517|Autoimmune disease|autoimmune disease
5226393|NCT02584517|Connective tissue disease|connective tissue disease
5226394|NCT02584517|Polymyalgia rheumatica|polymyalgia rheumatica
5226395|NCT02584517|Musculoskeletal Diseases|musculoskeletal diseases
5226396|NCT02584517|Immune disorder|immune disorder
5226397|NCT02584517|Rheumatic disease|rheumatic disease
5226398|NCT02584504|Non-statin LMT|non-statin lmt
5226399|NCT02584504|Low dose statin|low dose statin
5226400|NCT02584478|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
5962703|NCT04279262|Community first responder|community first responder
5226401|NCT02584478|Anti-angiogenic therapy|anti-angiogenic therapy
5226402|NCT02584478|Combination Therapy|combination therapy
5155792|NCT03018184|MRI|mri
5105210|NCT03339531|2D|2d
5226403|NCT02584439|ivabradine|ivabradine
5226404|NCT02584439|heart rate|heart rate
5226406|NCT02584439|visco-elasticity|visco-elasticity
5226407|NCT02584426|Cefazolin|cefazolin
5226408|NCT02584400|prostatic tumors|prostatic tumors
5226409|NCT02584400|[18F]HX4 Pet imaging|[18f]hx4 pet imaging
5226410|NCT02584400|hypoxia|hypoxia
5226411|NCT02584400|phase II trial|phase ii trial
5226412|NCT02584400|esophageal tumors|esophageal tumors
5226413|NCT02584400|rectal tumors|rectal tumors
5226414|NCT02584400|brain metastases|brain metastases
5226415|NCT02584400|primary brain tumors|primary brain tumors
5226416|NCT02584374|iliac vein compression|iliac vein compression
5226417|NCT02584361|Hearing loss|hearing loss
5226418|NCT02584361|Cochlear implant|cochlear implant
5226419|NCT02584348|ultrasound, antrum, pulmonary aspiration, emergency surgery|ultrasound, antrum, pulmonary aspiration, emergency surgery
5226420|NCT02584335|wound treatment|wound treatment
5226421|NCT02584335|lidocaine|lidocaine
5226422|NCT02584335|pain reduction|pain reduction
5226423|NCT02584335|local anesthetic|local anesthetic
5226424|NCT02584283|Liver Transplantation|liver transplantation
5226425|NCT02584283|Donation after Circulatory Death|donation after circulatory death
5226426|NCT02584283|Machine Perfusion|machine perfusion
5226427|NCT02584270|palatal drop prosthesis|palatal drop prosthesis
5226428|NCT02584231|Desmopressin|desmopressin
5226429|NCT02584231|Paediatrics|paediatrics
5226430|NCT02584231|urinary concentration test|urinary concentration test
5226431|NCT02584205|inspiratory muscle training|inspiratory muscle training
5226432|NCT02584205|obstructive sleep apnea|obstructive sleep apnea
5226433|NCT02584205|functional capacity|functional capacity
5226434|NCT02584179|mpMRI, significant cancer|mpmri, significant cancer
5226435|NCT02584166|Morbidity|morbidity
5226436|NCT02584166|Mortality|mortality
5226437|NCT02584166|conferences|conferences
5226438|NCT02584166|human science|human science
5226439|NCT02584153|Hernia|hernia
5226440|NCT02584153|Ventral|ventral
5226442|NCT02584153|Abdominal|abdominal
5226443|NCT02584153|Herniorrhaphy|herniorrhaphy
5226444|NCT02584153|Recurrence|recurrence
5226445|NCT02584153|laparotomy|laparotomy
5226446|NCT02584153|prevention|prevention
5226447|NCT02584140|PrEP|prep
5226448|NCT02584140|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5226449|NCT02584140|HIV Prevention|hiv prevention
5226450|NCT02584127|Smoking|smoking
5226451|NCT02584127|cessation|cessation
5226452|NCT02584127|Internet program|internet program
5226453|NCT02584101|Acceptance and Commitment Therapy|acceptance and commitment therapy
5226454|NCT02584088|NovaSure|novasure
5226455|NCT02584088|Ablation|ablation
5226456|NCT02584088|Menorrhagia|menorrhagia
5226457|NCT02584088|Endometrium|endometrium
5226458|NCT02584049|Osteopathic treatment|osteopathic treatment
5226459|NCT02584049|Care-induced Pain|care-induced pain
5226460|NCT02584049|Pain|pain
5226461|NCT02584049|Elderly|elderly
5226462|NCT02584036|influenza|influenza
5226463|NCT02584036|vaccine|vaccine
5226464|NCT02584036|public health|public health
5226465|NCT02584036|preventable disease|preventable disease
5226466|NCT02584036|vaccine history|vaccine history
5226467|NCT02584036|point-of-care|point-of-care
5226468|NCT02584023|ultrasonography|ultrasonography
5226469|NCT02584023|infant|infant
5226470|NCT02584023|perioperative period|perioperative period
5226471|NCT02584023|general anesthesia|general anesthesia
5226472|NCT02584010|Postoperative scars|postoperative scars
5226473|NCT02584010|Cicatrix|cicatrix
5226474|NCT02584010|Cicatrization|cicatrization
5226475|NCT02583997|To suture or not to suture....|to suture or not to suture....
5226476|NCT02583997|Tooth extraction|tooth extraction
5226477|NCT02583997|Third molar|third molar
5226478|NCT02583971|Direct current cardioversion|direct current cardioversion
5226479|NCT02583971|Medical management|medical management
5226480|NCT02583971|Atrial fibrillation ablation|atrial fibrillation ablation
5226481|NCT02583945|acute kidney injury|acute kidney injury
5226482|NCT02583945|hemodynamic stabilisation|hemodynamic stabilisation
5226483|NCT02583945|nephrotoxic medication|nephrotoxic medication
5226484|NCT02583932|Randomized controlled trial|randomized controlled trial
5226485|NCT02583932|Psychological|psychological
5226486|NCT02583932|Meaning|meaning
5226487|NCT02583932|Existential|existential
5226488|NCT02583932|Quality of life|quality of life
5226489|NCT02583932|Intervention|intervention
5226490|NCT02583932|Cancer|cancer
5226491|NCT02583932|Advanced disease|advanced disease
5226492|NCT02583932|New diagnosis|new diagnosis
5226493|NCT02583880|nutritional status|nutritional status
5226494|NCT02583880|malnutrition|malnutrition
5226495|NCT02583880|energy intake|energy intake
5226496|NCT02583880|caloric deficit|caloric deficit
5962704|NCT04279262|Rural health|rural health
5962705|NCT04279262|Ambulance service|ambulance service
5226498|NCT02583880|hospital|hospital
5226499|NCT02583880|enteral nutrition|enteral nutrition
5226500|NCT02583880|parenteral nutrition|parenteral nutrition
5226501|NCT02583880|nutrition|nutrition
5226502|NCT02583854|Coronary angiography|coronary angiography
5226503|NCT02583854|Transradial|transradial
5155970|NCT03016923|fes|fes
5105280|NCT03339063|MAC|mac
5226504|NCT02583854|Patient experience|patient experience
5226505|NCT02583854|VAS|vas
5226515|NCT02583763|pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
5226516|NCT02583763|Insulin-Like Growth Factor Binding Proteins|insulin-like growth factor binding proteins
5226517|NCT02583763|Insulin-Like Growth Factor I|insulin-like growth factor i
5226518|NCT02583763|Echocardiography|echocardiography
5226519|NCT02583763|Velocity Vector Imaging|velocity vector imaging
5226520|NCT02583763|Heart Function Tests|heart function tests
5226521|NCT02583750|glucose metabolism|glucose metabolism
5226522|NCT02583750|sleep deprivation|sleep deprivation
5226524|NCT02583737|maxillary sinus|maxillary sinus
5226525|NCT02583672|Gaucher Disease|gaucher disease
5226526|NCT02583672|GD1|gd1
5226527|NCT02583672|N-acetylcysteine|n-acetylcysteine
5226528|NCT02583672|glutathione|glutathione
5226529|NCT02583672|GSH|gsh
5226530|NCT02583659|Gastric cancer|gastric cancer
5226531|NCT02583659|First-line chemotherapy|first-line chemotherapy
5226532|NCT02583659|Biomarker|biomarker
5226537|NCT02583620|high myopia|high myopia
5226538|NCT02583568|breast cancer|breast cancer
5226539|NCT02583568|image-guided surgery|image-guided surgery
5226540|NCT02583555|Quality of Life|quality of life
5226541|NCT02583555|Health Care Utilization|health care utilization
5226548|NCT02583529|Parkinson Disease|parkinson disease
5226549|NCT02583529|Neurogenic Overactive Bladder|neurogenic overactive bladder
5226550|NCT02583529|Posterior Tibial Nerve Electrostimulation|posterior tibial nerve electrostimulation
5226551|NCT02583503|Total knee arthroplasty|total knee arthroplasty
5226552|NCT02583503|Total knee replacement|total knee replacement
5226553|NCT02583503|TKA|tka
5226554|NCT02583503|TKR|tkr
5226555|NCT02583490|Electroconvulsive Therapy|electroconvulsive therapy
5226556|NCT02583490|Low Pulse Amplitude Focal Electroconvulsive Therapy|low pulse amplitude focal electroconvulsive therapy
5226557|NCT02583490|ECT|ect
5226558|NCT02583490|Depression|depression
5226559|NCT02583490|Suicidal Ideation|suicidal ideation
5226560|NCT02583477|Pancreatic Ductal Adenocarcinoma, PDAC, immunotherapy, PDL1, AZD5069, MEDI4736|pancreatic ductal adenocarcinoma, pdac, immunotherapy, pdl1, azd5069, medi4736
5226561|NCT02583438|Gut Microbiota|gut microbiota
5226562|NCT02583438|inflammatory marker|inflammatory marker
5226563|NCT02583438|Glucose and lipid metabolism|glucose and lipid metabolism
5226564|NCT02583399|Pediatric (Birth to less than 6 months of age)|pediatric (birth to less than 6 months of age)
5226566|NCT02583399|Fever|fever
5226567|NCT02583386|mobility|mobility
5226568|NCT02583386|falls|falls
5226569|NCT02583386|fall prevention|fall prevention
5226570|NCT02583386|gait and balance|gait and balance
5226571|NCT02583386|automatic fall detector|automatic fall detector
5226572|NCT02583373|Pneumonia|pneumonia
5226573|NCT02583373|Streptococcus pneumoniae|streptococcus pneumoniae
5226574|NCT02583373|Pneumolysin|pneumolysin
5226578|NCT02583334|acupuncture|acupuncture
5226579|NCT02583334|fibromyalgia|fibromyalgia
5226580|NCT02583334|rheumatism|rheumatism
5226581|NCT02583334|clinical trial|clinical trial
5226582|NCT02583321|chlorhexidine gluconate|chlorhexidine gluconate
5226583|NCT02583321|oral care|oral care
5226584|NCT02583321|mechanical ventilation|mechanical ventilation
5226585|NCT02583321|critically ill patients|critically ill patients
5226586|NCT02583321|tracheal secretions|tracheal secretions
5226587|NCT02583321|subglottic secretions|subglottic secretions
5226588|NCT02583308|Ventilator-associated pneumonia|ventilator-associated pneumonia
5226589|NCT02583308|Surveillance|surveillance
5226590|NCT02583308|Subglottic-secretions|subglottic-secretions
5226591|NCT02583308|Critically ill patients|critically ill patients
5226592|NCT02583308|Prevention|prevention
5226593|NCT02583295|Awareness|awareness
5226594|NCT02583295|Cardiac Surgery|cardiac surgery
5226595|NCT02583295|Maternal|maternal
5226596|NCT02583295|Pediatric|pediatric
5226597|NCT02583295|Sound|sound
5226598|NCT02583295|Music|music
5226599|NCT02583256|Influenza Vaccine|influenza vaccine
5226600|NCT02583256|MF59 adjuvant|mf59 adjuvant
5226601|NCT02583243|Opioid dependence|opioid dependence
5226602|NCT02583243|HIV/AIDS|hiv/aids
5226603|NCT02583243|Hepatitis C|hepatitis c
5864202|NCT00000404|HMO|hmo
5226609|NCT02583230|Telemedicine|telemedicine
5226610|NCT02583230|Primary Care|primary care
5226611|NCT02583217|Laryngeal mask|laryngeal mask
5226613|NCT02583217|Remifentanyl|remifentanyl
5226614|NCT02583165|advanced solid tumors|advanced solid tumors
5226615|NCT02583165|immunotherapy|immunotherapy
5226616|NCT02583165|immuno-oncology|immuno-oncology
5226617|NCT02583139|Children, Moderate and/or highly emetogenic chemotherapy|children, moderate and/or highly emetogenic chemotherapy
5226618|NCT02583126|Teenager|teenager
5226619|NCT02583126|moderate and/or highly emetogenic chemotherapy|moderate and/or highly emetogenic chemotherapy
5226620|NCT02583113|Total Knee Replacement|total knee replacement
5226621|NCT02583113|Unicompartment Knee Replacement|unicompartment knee replacement
5226622|NCT02583087|Barrett esophagus|barrett esophagus
5226623|NCT02583087|Esophageal adenocarcinoma|esophageal adenocarcinoma
5226624|NCT02583087|Endoscopic submucosal dissection|endoscopic submucosal dissection
5962706|NCT04279249|Ultrafine Particles (UFP)|ultrafine particles (ufp)
5226625|NCT02583074|deep brain stimulation|deep brain stimulation
5226626|NCT02583074|Subthalamic Nucleus|subthalamic nucleus
5226627|NCT02583074|dystonia|dystonia
5226628|NCT02583035|cancer|cancer
5226629|NCT02583035|geriatric|geriatric
5226630|NCT02582996|Headache|headache
5226631|NCT02582996|Aura|aura
5226632|NCT02582996|Migraine|migraine
5226633|NCT02582996|Moderate to Severe|moderate to severe
5226640|NCT02582918|Randomized Controlled Trial|randomized controlled trial
5226641|NCT02582918|Mass Screening|mass screening
5226642|NCT02582905|Alcohol Use Disorder|alcohol use disorder
5226643|NCT02582905|Bipolar Disorder|bipolar disorder
5226644|NCT02582905|Mood|mood
5226645|NCT02582905|Alcohol craving|alcohol craving
5226646|NCT02582905|Pregnenolone|pregnenolone
5226647|NCT02582905|Citicoline|citicoline
5226648|NCT02582879|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5226649|NCT02582879|CLL|cll
5226650|NCT02582879|Small Lymphocytic Leukemia|small lymphocytic leukemia
5226651|NCT02582879|SLL|sll
5226652|NCT02582866|Lacosamide|lacosamide
5226653|NCT02582866|Vimpat|vimpat
5226654|NCT02582866|Epilepsy|epilepsy
5226655|NCT02582866|Partial onset seizures|partial onset seizures
5226656|NCT02582866|Tonic-clonic seizures|tonic-clonic seizures
5226657|NCT02582866|Monotherapy|monotherapy
5226658|NCT02582866|AED|aed
5226659|NCT02582853|GBS|gbs
5226661|NCT02582853|Spinal fluid|spinal fluid
5226662|NCT02582853|sCD163|scd163
5226663|NCT02582840|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
5226664|NCT02582827|Advanced Solid Tumors|advanced solid tumors
5226665|NCT02582827|solid tumor|solid tumor
5226666|NCT02582827|lymphoma|lymphoma
5226667|NCT02582814|Japanese patients with type 1 diabetes with inadequate glycemic control on insulin|japanese patients with type 1 diabetes with inadequate glycemic control on insulin
5226668|NCT02582801|PET/CT|pet/ct
5226669|NCT02582801|Alfatide Ⅱ|alfatide ⅱ
5226670|NCT02582801|breast cancer|breast cancer
5226671|NCT02582762|Nail gel|nail gel
5226672|NCT02582762|Nail surface abnormality|nail surface abnormality
5226673|NCT02582762|Efficacy|efficacy
5224031|NCT02598804|Self-care|self-care
5226674|NCT02582749|Androgen Deprivation Therapy|androgen deprivation therapy
5226675|NCT02582749|Androgen Receptor Antagonist|androgen receptor antagonist
5226676|NCT02582749|Radium-223 Dichloride|radium-223 dichloride
5226677|NCT02582749|Placebo|placebo
5226678|NCT02582736|Antipsychotics|antipsychotics
5226679|NCT02582736|Drug side effects|drug side effects
5226680|NCT02582736|Psychosis|psychosis
5226681|NCT02582736|Hyperglycemic emergencies|hyperglycemic emergencies
5226682|NCT02582736|Diabetes|diabetes
5226683|NCT02582736|Epidemiology|epidemiology
5226684|NCT02582736|Database research|database research
5226685|NCT02582736|CNODES|cnodes
5226686|NCT02582697|Germ Cell|germ cell
5226687|NCT02582697|Intermediate and poor-risk metastatic germ cell tumours|intermediate and poor-risk metastatic germ cell tumours
5226688|NCT02582671|Real World Effectiveness|real world effectiveness
5226689|NCT02582671|Observational Study|observational study
5226690|NCT02582671|Sustained Virologic Response|sustained virologic response
5226691|NCT02582671|Chronic Hepatitis C|chronic hepatitis c
5226692|NCT02582671|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5226693|NCT02582671|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
5226694|NCT02582658|Paritaprevir|paritaprevir
5226695|NCT02582658|Dasabuvir|dasabuvir
5226696|NCT02582658|Ombitasvir|ombitasvir
5226697|NCT02582658|Chronic Hepatitis C|chronic hepatitis c
5317698|NCT02096042|SGN-35|sgn-35
5226698|NCT02582658|HCV|hcv
5214752|NCT02653807|ankle|ankle
5226699|NCT02582645|impaction|impaction
5226700|NCT02582645|impacted canine|impacted canine
5226701|NCT02582645|palatally|palatally
5226702|NCT02582645|open window|open window
5226703|NCT02582645|closed window|closed window
5226704|NCT02582645|management|management
5226705|NCT02582632|Hepatitis C Virus|hepatitis c virus
5226706|NCT02582632|Interferon-Free|interferon-free
5226707|NCT02582632|Ribavirin-Free|ribavirin-free
5226708|NCT02582632|Hepatitis C|hepatitis c
5226709|NCT02582632|Hepatitis C Genotype 1b|hepatitis c genotype 1b
5226710|NCT02582619|Spinal Cord Injury and Employment|spinal cord injury and employment
5226711|NCT02582606|Insulin Resistance|insulin resistance
5226712|NCT02582606|Meal pattern|meal pattern
5226713|NCT02582606|Obese|obese
5226714|NCT02582593|Cognitive Aging|cognitive aging
5226715|NCT02582593|Neuromodulation|neuromodulation
5226716|NCT02582593|Low Level Light Therapy|low level light therapy
5226717|NCT02582593|Near Infrared Light|near infrared light
5226718|NCT02582593|Neurostimulation|neurostimulation
5226719|NCT02582580|pelvic floor|pelvic floor
5226720|NCT02582580|perineal trauma|perineal trauma
5226721|NCT02582580|physiotherapy|physiotherapy
5226722|NCT02582580|perineal integrity|perineal integrity
5226723|NCT02582567|Pregnant Women|pregnant women
5226724|NCT02582567|Quality of Life|quality of life
5226725|NCT02582567|Exercise|exercise
5226726|NCT02582567|Sleep|sleep
5226727|NCT02582567|Fetal Research|fetal research
5962707|NCT04279249|HEPA|hepa
5226728|NCT02582567|Diet, Mediterranean|diet, mediterranean
5226729|NCT02582567|Physical Fitness|physical fitness
5226730|NCT02582567|Oxidative stress|oxidative stress
5120202|NCT03243838|OS|os
5226731|NCT02582567|Inflammation|inflammation
5226732|NCT02582528|cognitive remediation|cognitive remediation
5226733|NCT02582528|cognition|cognition
5226734|NCT02582528|youth|youth
5226735|NCT02582528|mental health|mental health
5226736|NCT02582528|functional outcome|functional outcome
5226737|NCT02582515|d-cycloserine|d-cycloserine
5226738|NCT02582515|comprehensive behavioral intervention for tics|comprehensive behavioral intervention for tics
5226739|NCT02582515|habit reversal training|habit reversal training
5226740|NCT02582502|Hyperbaric Oxygen|hyperbaric oxygen
5226741|NCT02582502|HBOT|hbot
5226742|NCT02582502|Hyperbaric Chamber|hyperbaric chamber
5226743|NCT02582502|Pressurized Oxygen|pressurized oxygen
5226744|NCT02582489|Mesenchymal stem cells|mesenchymal stem cells
5226745|NCT02582489|Bone marrow aspirate concentrate|bone marrow aspirate concentrate
5226746|NCT02582476|Hypokalemic Periodic Paralysis|hypokalemic periodic paralysis
5226747|NCT02582476|Bumetanide|bumetanide
5226748|NCT02582476|Periodic Paralysis|periodic paralysis
5226749|NCT02582463|Risk Assessment|risk assessment
5226750|NCT02582463|Hospitals|hospitals
5226751|NCT02582463|Pharmacists|pharmacists
5226752|NCT02582463|Medication Systems|medication systems
5226753|NCT02582463|Patient Selection|patient selection
5226754|NCT02582463|Prognosis research|prognosis research
5226755|NCT02582450|Haemophilia|haemophilia
5226756|NCT02582450|Adherence of Treatment|adherence of treatment
5226757|NCT02582450|Knowledge of Illness|knowledge of illness
5226758|NCT02582450|Medical-patient Relationship|medical-patient relationship
5226759|NCT02582450|Illness Behavior|illness behavior
5226760|NCT02582450|Treatment Difficulties|treatment difficulties
5226761|NCT02582450|Veritas|veritas
5226762|NCT02582437|Minimum Alveolar Concentration|minimum alveolar concentration
5226763|NCT02582411|Healthy Subjects|healthy subjects
5226764|NCT02582385|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5226765|NCT02582385|Cytokines|cytokines
5226766|NCT02582385|Neuropathology|neuropathology
5226767|NCT02582359|Acute Myeloid Leukemia|acute myeloid leukemia
5226769|NCT02582346|Neurography|neurography
5226770|NCT02582346|Tractography|tractography
5226771|NCT02582346|Pelvic nerves|pelvic nerves
5226773|NCT02582203|Vancomycin|vancomycin
5226774|NCT02582203|Acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
5226775|NCT02582203|Methicillin-resistant S. aureus|methicillin-resistant s. aureus
5226776|NCT02582190|electrical cardioversion|electrical cardioversion
5226777|NCT02582190|persistent atrial fibrillation|persistent atrial fibrillation
5226778|NCT02582177|Fungal infection|fungal infection
5226779|NCT02582177|Skin infection|skin infection
5226780|NCT02582177|Dermatophytoses|dermatophytoses
5226781|NCT02582164|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
5226782|NCT02582164|Swept Source OCT|swept source oct
5226783|NCT02582138|physical frailty|physical frailty
5226784|NCT02582138|sarcopenia|sarcopenia
5226785|NCT02582138|exercise|exercise
5226786|NCT02582138|nutrition|nutrition
5226787|NCT02582138|information and communications technology|information and communications technology
5226788|NCT02582125|ONO-4538|ono-4538
5226789|NCT02582125|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5226790|NCT02582047|influenza vaccine|influenza vaccine
5226791|NCT02582047|pneumococcal vaccine|pneumococcal vaccine
5226792|NCT02582047|simultaneous vaccination|simultaneous vaccination
5214850|NCT02653261|Hemorrhage|hemorrhage
5226793|NCT02582034|Optimized Dosimetry versus standard Dosimetry|optimized dosimetry versus standard dosimetry
5226794|NCT02582034|Internal Radiation Therapy|internal radiation therapy
5226795|NCT02582021|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
5226796|NCT02582021|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5226797|NCT02582021|Coronary angiography|coronary angiography
5226798|NCT02582021|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
5226799|NCT02581995|Diabetic macular edema|diabetic macular edema
5226800|NCT02581995|Intravitreal injection|intravitreal injection
5226801|NCT02581982|Urothelial cancer|urothelial cancer
5226802|NCT02581982|Bladder cancer|bladder cancer
5226803|NCT02581982|Immunotherapy|immunotherapy
5226804|NCT02581982|Paclitaxel|paclitaxel
5226805|NCT02581969|Hemophilia A, Congenital|hemophilia a, congenital
5226806|NCT02581956|Immunology|immunology
5226807|NCT02581891|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5226808|NCT02581891|nAMD)|namd)
5226809|NCT02581878|Thorium-227|thorium-227
5226810|NCT02581878|BAY1862864 Injection|bay1862864 injection
5226811|NCT02581878|Safety|safety
5226812|NCT02581878|Pharmacokinetics|pharmacokinetics
5226813|NCT02581878|CD22|cd22
5226814|NCT02581878|Radioimmunotherapy|radioimmunotherapy
5226815|NCT02581839|eribulin|eribulin
5226816|NCT02581839|central nervous system|central nervous system
5226818|NCT02581839|Eribulin Mesylate|eribulin mesylate
5226819|NCT02581839|Halaven|halaven
5226820|NCT02581813|Bone health|bone health
5226821|NCT02581813|Body composition|body composition
5095974|NCT03398317|SDF|sdf
5226822|NCT02581813|Dairy foods|dairy foods
5226823|NCT02581813|Exercise|exercise
5226824|NCT02581813|inflammation|inflammation
5226825|NCT02581813|nutrition intervention|nutrition intervention
5226826|NCT02581813|weight management|weight management
5226827|NCT02581774|induction|induction
5226828|NCT02581774|cesarean delivery|cesarean delivery
5226829|NCT02581761|Hemodynamically stable women >18 years old|hemodynamically stable women >18 years old
5226830|NCT02581761|with abnormal plateauing serum βHCG|with abnormal plateauing serum βhcg
5226831|NCT02581735|Haemophilia|haemophilia
5226832|NCT02581735|Adherence|adherence
5226833|NCT02581735|Prophylaxis treatment|prophylaxis treatment
5226834|NCT02581735|Quality of Life|quality of life
5226835|NCT02581735|Illness Behavior|illness behavior
5226836|NCT02581735|Veritas-Pro questionnaire|veritas-pro questionnaire
5226837|NCT02581735|uPatient|upatient
5226838|NCT02581722|PrePex, Male Circumcision, HIV Prevention, Adolescents|prepex, male circumcision, hiv prevention, adolescents
5226839|NCT02581709|Feasibility study|feasibility study
5226840|NCT02581709|Cognition|cognition
5226841|NCT02581709|Chemotherapy|chemotherapy
5226842|NCT02581709|Neoplasms|neoplasms
5226843|NCT02581670|oligometastatic breast cancer|oligometastatic breast cancer
5226844|NCT02581618|ischemic preconditioning|ischemic preconditioning
5226845|NCT02581618|myocardial injury|myocardial injury
5226846|NCT02581618|percutaneous coronary intervention|percutaneous coronary intervention
5226847|NCT02581592|Hepatic Impairment|hepatic impairment
5226849|NCT02581592|Liver Cirrhosis|liver cirrhosis
5226850|NCT02581579|Tuberculosis|tuberculosis
5226851|NCT02581579|Tregs|tregs
5226852|NCT02581579|Tolerance|tolerance
5226853|NCT02581579|Probiotic|probiotic
5226854|NCT02581579|Mycobacteria|mycobacteria
5226855|NCT02581540|Troponin|troponin
5226856|NCT02581540|High Sensitivity Troponin T|high sensitivity troponin t
5226857|NCT02581540|MACE|mace
5226858|NCT02581540|risk stratification|risk stratification
5226859|NCT02581540|suspected cardiac chest pain|suspected cardiac chest pain
5226860|NCT02581540|Acute Coronary Syndrome|acute coronary syndrome
5226861|NCT02581540|GRACE|grace
5226862|NCT02581540|TIMI|timi
5226863|NCT02581540|HEART|heart
5226864|NCT02581514|decision algorithm|decision algorithm
5226865|NCT02581501|Xeloda|xeloda
5226866|NCT02581501|Gemcitabine|gemcitabine
5226867|NCT02581501|Abraxane|abraxane
5226868|NCT02581501|Pancreatic Cancer|pancreatic cancer
5226869|NCT02581501|Metastatic Cancer|metastatic cancer
5226871|NCT02581501|5-FU|5-fu
5226872|NCT02581501|Capecitabine|capecitabine
5226873|NCT02581501|Gemzar|gemzar
5226874|NCT02581501|NAB-Paclitaxel|nab-paclitaxel
5226875|NCT02581501|Chemotherapy|chemotherapy
5226876|NCT02581488|Diabetes|diabetes
5226877|NCT02581488|diabetic foot ulcer|diabetic foot ulcer
5226878|NCT02581488|foot sore|foot sore
5226879|NCT02581488|type 2 diabetes|type 2 diabetes
5226880|NCT02581488|type 1 diabetes|type 1 diabetes
5226881|NCT02581488|neuropathy|neuropathy
5226882|NCT02581488|DFU|dfu
5226883|NCT02581475|Adenoma detection rate|adenoma detection rate
5226884|NCT02581475|Colonoscopy|colonoscopy
5226885|NCT02581475|Withdrawal time|withdrawal time
5226886|NCT02581449|omega-3 fatty acids|omega-3 fatty acids
5226887|NCT02581449|hemodialysis|hemodialysis
5226888|NCT02581449|oxidative stress|oxidative stress
5226889|NCT02581449|dyslipidemia|dyslipidemia
5226900|NCT02581410|Safety|safety
5226901|NCT02581397|cough|cough
5226902|NCT02581397|expectorant|expectorant
5226903|NCT02581397|upper respiratory tract infections|upper respiratory tract infections
5226904|NCT02581397|respiratory tract infections|respiratory tract infections
5226905|NCT02581397|antitussive agents|antitussive agents
5226906|NCT02581384|Ewing Sarcoma|ewing sarcoma
5226907|NCT02581384|Rhabdomyosarcoma|rhabdomyosarcoma
5226908|NCT02581384|Wilms Tumor|wilms tumor
5226909|NCT02581384|Rhabdomyosarcoma of Mediastinum|rhabdomyosarcoma of mediastinum
5226910|NCT02581384|Ewing's Sarcoma Metastatic|ewing's sarcoma metastatic
5226911|NCT02581384|Ewing Family of Tumors|ewing family of tumors
5226912|NCT02581384|Ewing's Tumor Metastatic|ewing's tumor metastatic
5226913|NCT02581384|Osteosarcoma, Metastatic|osteosarcoma, metastatic
5226914|NCT02581384|Osteosarcoma in Children|osteosarcoma in children
5226915|NCT02581384|Rhabdoid Tumor|rhabdoid tumor
5226916|NCT02581384|Lung Metastasis|lung metastasis
5226917|NCT02581384|Radiation for Children|radiation for children
5226918|NCT02581384|SBRT for children|sbrt for children
5226919|NCT02581384|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5226920|NCT02581384|Pulmonary Metastasis|pulmonary metastasis
5962708|NCT04279249|Traffic-Related Air Pollution|traffic-related air pollution
5226921|NCT02581384|Lung Metastasis in Children|lung metastasis in children
5226922|NCT02581384|Pulmonary Metastasis in Children|pulmonary metastasis in children
5226923|NCT02581384|Comfort Care|comfort care
5226924|NCT02581384|Palliative Care|palliative care
5226925|NCT02581371|Cerebrolysin|cerebrolysin
5226926|NCT02581371|neuroplasticity|neuroplasticity
5226927|NCT02581371|upper limb|upper limb
5226928|NCT02581371|middle cerebral artery|middle cerebral artery
5226929|NCT02581371|NBS|nbs
5962709|NCT04279249|Air Filtration|air filtration
5226930|NCT02581371|navigation brain stimulation|navigation brain stimulation
5226931|NCT02581371|paretic limb|paretic limb
5226933|NCT02581371|ischemic stroke|ischemic stroke
5226934|NCT02581371|rehabilitation|rehabilitation
5226935|NCT02581371|Frenchay Arm Test|frenchay arm test
5226936|NCT02581371|NBS eXimia Nexstim|nbs eximia nexstim
5226937|NCT02581371|Barthel index|barthel index
5226943|NCT02581345|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5226944|NCT02581345|Psoriasis|psoriasis
5226945|NCT02581332|behavioral intervention|behavioral intervention
5226946|NCT02581254|Snare|snare
5226947|NCT02581254|Polypectomy|polypectomy
5226948|NCT02581241|QT interval prolongation|qt interval prolongation
5226949|NCT02581215|mFOLFIRINOX|mfolfirinox
5226950|NCT02581215|Ramucirumab|ramucirumab
5226951|NCT02581202|antiretroviral therapy|antiretroviral therapy
5226952|NCT02581189|Chronic Hepatitis C|chronic hepatitis c
5226953|NCT02581189|Effectiveness|effectiveness
5226954|NCT02581189|Influence of adherence|influence of adherence
5226955|NCT02581189|Patient reported outcomes|patient reported outcomes
5226956|NCT02581189|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
5226957|NCT02581189|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5226958|NCT02581189|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5226959|NCT02581163|Effectiveness|effectiveness
5226960|NCT02581163|Influence of adherence|influence of adherence
5226961|NCT02581163|Patient reported outcomes|patient reported outcomes
5226962|NCT02581163|Ombitasvir/paritaprevir/ritonavir ± dasabuvir|ombitasvir/paritaprevir/ritonavir ± dasabuvir
5226963|NCT02581163|Chronic Hepatitis C genotype 1|chronic hepatitis c genotype 1
5226964|NCT02581163|Chronic Hepatitis C genotype 4|chronic hepatitis c genotype 4
5226965|NCT02581150|Outpatient hospitalization|outpatient hospitalization
5226966|NCT02581150|Randomized trial|randomized trial
5226967|NCT02581150|Peripheral arterial disease|peripheral arterial disease
5226968|NCT02581150|Endovascular treatment|endovascular treatment
5226969|NCT02581150|Health Economics|health economics
5226970|NCT02581124|JTZ-951|jtz-951
5226971|NCT02581124|Lapatinib|lapatinib
5226972|NCT02581124|Pharmacokinetics|pharmacokinetics
5226973|NCT02581085|Tocotrienol|tocotrienol
5226974|NCT02581085|Vitamin E|vitamin e
5226975|NCT02581059|Regorafenib|regorafenib
5226976|NCT02581059|American Ginseng|american ginseng
5226977|NCT02581059|Fatigue|fatigue
5226979|NCT02581020|Follow-up|follow-up
5226980|NCT02581020|Observation|observation
5226981|NCT02581020|Japanese|japanese
5227002|NCT02580981|Oncology|oncology
5227003|NCT02580981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5227005|NCT02580981|Genomics|genomics
5227006|NCT02580981|Genetics|genetics
5227007|NCT02580981|Sequencing|sequencing
5227010|NCT02580981|Ph-like|ph-like
5227011|NCT02580968|Electroacupuncture therapy|electroacupuncture therapy
5227012|NCT02580968|Migraine|migraine
5227013|NCT02580968|Acupuncture Therapy|acupuncture therapy
5215036|NCT02652156|pain|pain
5215037|NCT02652143|in vivo culture|in vivo culture
5215038|NCT02652130|GVHD, Graft versus Host Disease|gvhd, graft versus host disease
5215039|NCT02652104|Advanced|advanced
5215040|NCT02652104|Deep brain stimulation|deep brain stimulation
5215041|NCT02652091|Adherence|adherence
5215042|NCT02652091|Persistence|persistence
5227014|NCT02580929|Radiotherapy|radiotherapy
5227015|NCT02580929|General Surgery|general surgery
5227016|NCT02580916|non-melanoma skin cancer|non-melanoma skin cancer
5227017|NCT02580916|outcome assessment|outcome assessment
5227018|NCT02580916|quality of life|quality of life
5227019|NCT02580877|oral insulin|oral insulin
5227020|NCT02580838|Stroke|stroke
5227021|NCT02580838|Spasticity|spasticity
5227022|NCT02580838|OnabotulinumtoxinA|onabotulinumtoxina
5227023|NCT02580825|Childhood obesity|childhood obesity
5227024|NCT02580825|Ground reaction force|ground reaction force
5227025|NCT02580825|Knee pain|knee pain
5227026|NCT02580812|Perinatal listeriosis|perinatal listeriosis
5227027|NCT02580812|Neurological impairment|neurological impairment
5227028|NCT02580812|Sepsis|sepsis
5227029|NCT02580812|Prematurity|prematurity
5227030|NCT02580812|Neurotropism|neurotropism
5227031|NCT02580812|Listeria monocytogenes|listeria monocytogenes
5227032|NCT02580812|Intellectual Quotient|intellectual quotient
5227033|NCT02580773|Sickle cell disease|sickle cell disease
5227034|NCT02580773|Anemia|anemia
5227035|NCT02580773|Rare disease|rare disease
5227036|NCT02580773|Reanimation|reanimation
5227037|NCT02580773|Prophylactic anticoagulation|prophylactic anticoagulation
5227038|NCT02580760|Silicone|silicone
5227039|NCT02580760|Transgender|transgender
5227040|NCT02580760|Dermatology|dermatology
5227041|NCT02580760|Blood contamination|blood contamination
5227042|NCT02580760|Adverse event after injection|adverse event after injection
5227043|NCT02580734|burning mouth syndrome|burning mouth syndrome
5227044|NCT02580734|treatment|treatment
5227045|NCT02580734|oral chronic pain|oral chronic pain
5227046|NCT02580721|mucosal tissue thickness|mucosal tissue thickness
5227047|NCT02580721|dental implant|dental implant
5227048|NCT02580721|marginal bone loss|marginal bone loss
5096151|NCT03397004|HHT|hht
5227049|NCT02580721|soft tissue|soft tissue
5227050|NCT02580643|Autologous Protein Solution|autologous protein solution
5227051|NCT02580643|Osteoarthritis|osteoarthritis
5227052|NCT02580643|Intra-articular Injection|intra-articular injection
5227053|NCT02580630|Strength training, injection, glucocorticoid|strength training, injection, glucocorticoid
5227054|NCT02580565|sickle cell disease|sickle cell disease
5227064|NCT02580539|Allogeneic Transplantation|allogeneic transplantation
5227065|NCT02580539|T cell|t cell
5227066|NCT02580539|Epstein-Barr Virus|epstein-barr virus
5227067|NCT02580513|Circadian Rhythm|circadian rhythm
5227068|NCT02580513|Circadian Misalignment|circadian misalignment
5227069|NCT02580513|Insulin Sensitivity|insulin sensitivity
5227070|NCT02580500|Epidural anesthesia|epidural anesthesia
5227071|NCT02580500|Spinal anesthesia|spinal anesthesia
5227072|NCT02580500|pilonidal dermoid sinus|pilonidal dermoid sinus
5227073|NCT02580487|acute appendicitis|acute appendicitis
5227074|NCT02580487|pain management|pain management
5227075|NCT02580487|analgesics|analgesics
5227076|NCT02580487|pediatric patients|pediatric patients
5227077|NCT02580487|laparoscopy|laparoscopy
5227078|NCT02580487|open surgery|open surgery
5227079|NCT02580461|family caregivers|family caregivers
5227080|NCT02580461|cancer|cancer
5227081|NCT02580461|exercise intervention|exercise intervention
5227082|NCT02580461|center based|center based
5227083|NCT02580448|Breast Cancer|breast cancer
5227084|NCT02580448|Breast|breast
5227085|NCT02580448|Advanced Breast Cancer|advanced breast cancer
5227086|NCT02580448|Metastatic Breast Cancer|metastatic breast cancer
5227087|NCT02580448|CYP17|cyp17
5227088|NCT02580448|Male Breast Cancer|male breast cancer
5227186|NCT02579967|Congenital|congenital
5227089|NCT02580448|Triple Negative Cancer|triple negative cancer
5227090|NCT02580448|ER+ Breast Cancer|er+ breast cancer
5227091|NCT02580435|multiple sclerosis|multiple sclerosis
5227092|NCT02580435|microbiome|microbiome
5227093|NCT02580435|prediction|prediction
5227094|NCT02580435|outcome|outcome
5227095|NCT02580422|Echocardiography|echocardiography
5227096|NCT02580409|health care utilization|health care utilization
5227097|NCT02580409|health care costs|health care costs
5227098|NCT02580383|Radiofrequency ablation|radiofrequency ablation
5227099|NCT02580383|RF-MB|rf-mb
5227100|NCT02580383|Lumbar RF|lumbar rf
5227101|NCT02580383|Facet joint syndrome|facet joint syndrome
5227103|NCT02580383|Sensory stimulation|sensory stimulation
5227104|NCT02580370|REALISE 1|realise 1
5227105|NCT02580357|Connective tissue graft|connective tissue graft
5227106|NCT02580357|Gingival recession|gingival recession
5215137|NCT02651415|Metastatic colorectal cancer|metastatic colorectal cancer
5215138|NCT02651415|Metastatic colorectal carcinoma|metastatic colorectal carcinoma
5227107|NCT02580357|Low level laser therapy|low level laser therapy
5227108|NCT02580305|SUVN-502|suvn-502
5227109|NCT02580305|5-HT6|5-ht6
5227110|NCT02580305|Phase 2|phase 2
5227111|NCT02580305|Cognition|cognition
5227112|NCT02580305|Donepezil|donepezil
5227113|NCT02580305|Memantine|memantine
5227114|NCT02580305|Alzheimer's Disease|alzheimer's disease
5227115|NCT02580305|Triple Combination|triple combination
5227116|NCT02580305|Proof of Concept (POC)|proof of concept (poc)
5227117|NCT02580279|Breast Neoplasms|breast neoplasms
5227118|NCT02580279|prevention & control|prevention & control
5227119|NCT02580279|Epigallocatechin gallate|epigallocatechin gallate
5227120|NCT02580279|Dermatitis|dermatitis
5227121|NCT02580266|Kidney|kidney
5227122|NCT02580266|Diabetes|diabetes
5227123|NCT02580240|septic shock|septic shock
5227124|NCT02580240|hydrocortisone|hydrocortisone
5227125|NCT02580240|mortality|mortality
5227126|NCT02580227|Tranexamic Acid|tranexamic acid
5227127|NCT02580227|Blood Transfusions|blood transfusions
5227128|NCT02580188|Neuromuscular blockade|neuromuscular blockade
5227129|NCT02580188|Sugammadex|sugammadex
5227130|NCT02580188|Laparoscopic surgery|laparoscopic surgery
5227131|NCT02580188|Intra abdominal pressure alarm|intra abdominal pressure alarm
5227132|NCT02580136|Esthesioneuroblastoma|esthesioneuroblastoma
5227133|NCT02580136|Tumor|tumor
5227134|NCT02580136|Skull Base Surgery|skull base surgery
5227135|NCT02580136|Sinonasal Cancer|sinonasal cancer
5227136|NCT02580110|no specific condition|no specific condition
5227137|NCT02580097|Arterial Spin Labeling|arterial spin labeling
5227138|NCT02580097|Ischemic stroke|ischemic stroke
5227139|NCT02580097|Collateral Circulation|collateral circulation
5227140|NCT02580097|Perfusion imaging|perfusion imaging
5227141|NCT02580084|atherosclerosis of the peripheral arteries|atherosclerosis of the peripheral arteries
5227142|NCT02580084|Aorta-femoral Bypass|aorta-femoral bypass
5227143|NCT02580084|Hybrid Intervention|hybrid intervention
5227144|NCT02580084|Iliac Arteries With Stenting and Plasty of the Common Femoral Artery|iliac arteries with stenting and plasty of the common femoral artery
5227145|NCT02580084|plastic arteries with lesions of the common femoral artery and deep femoral artery|plastic arteries with lesions of the common femoral artery and deep femoral artery
5227146|NCT02580071|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5227147|NCT02580071|Chinese Herbal Medicine|chinese herbal medicine
5962710|NCT04279249|In-home|in-home
5962711|NCT04279210|Stress urinary incontinence|stress urinary incontinence
5105964|NCT03335098|Bortezomib|bortezomib
5227148|NCT02580071|immune reconstitution|immune reconstitution
5227149|NCT02580071|clinical trial|clinical trial
5227151|NCT02580071|AML|aml
5227152|NCT02580058|platinum resistant|platinum resistant
5227153|NCT02580058|platinum refractory|platinum refractory
5227154|NCT02580045|metastatic cancer|metastatic cancer
5227155|NCT02580045|lumbar puncture|lumbar puncture
5227156|NCT02580045|advanced cancer|advanced cancer
5227157|NCT02580045|brain metastases|brain metastases
5227158|NCT02580045|chemotherapy|chemotherapy
5227159|NCT02580045|endocrine therapy|endocrine therapy
5227160|NCT02580045|HER2 targeted therapy|her2 targeted therapy
5227161|NCT02580045|immune therapy|immune therapy
5227162|NCT02580045|anti-cancer therapy|anti-cancer therapy
5227163|NCT02580045|blood brain barrier|blood brain barrier
5227164|NCT02580045|pharmacokinetics|pharmacokinetics
5227165|NCT02580045|Duke University|duke university
5227166|NCT02580045|brain metastasis|brain metastasis
5227167|NCT02580019|Cellular therapy|cellular therapy
5227168|NCT02580019|Stroke|stroke
5227169|NCT02580019|Neuronal Plasticity|neuronal plasticity
5227170|NCT02580019|Recovery|recovery
5227171|NCT02580019|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5227172|NCT02580019|Transplantation|transplantation
5227173|NCT02580019|Cardiovascular Diseases|cardiovascular diseases
5227174|NCT02580019|Ischemia|ischemia
5227175|NCT02580019|Brain Infarction|brain infarction
5227176|NCT02580019|Brain Ischemia|brain ischemia
5227177|NCT02580019|Cerebrovascular Disorders|cerebrovascular disorders
5227178|NCT02579993|Cornea|cornea
5227179|NCT02579993|Limbal stem cell|limbal stem cell
5227180|NCT02579980|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
5227181|NCT02579980|Diffusion Weighted MRI|diffusion weighted mri
5227182|NCT02579980|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5227183|NCT02579967|Haploidentical|haploidentical
5227184|NCT02579967|Autoimmunity|autoimmunity
5227185|NCT02579967|Immune Dysregulation|immune dysregulation
5227187|NCT02579967|Opportunistic Infection|opportunistic infection
5227188|NCT02579941|Hyperfibrinolysis|hyperfibrinolysis
5227189|NCT02579941|Pregnant women at term|pregnant women at term
5227190|NCT02579941|Tranexamic acid|tranexamic acid
5227191|NCT02579928|Ketamine|ketamine
5227192|NCT02579928|Depression|depression
5227193|NCT02579928|Major Depressive Disorder|major depressive disorder
5227194|NCT02579928|Anxiety|anxiety
5227195|NCT02579928|School refusal|school refusal
5227197|NCT02579928|Generalized Anxiety|generalized anxiety
5227198|NCT02579928|Suicidal Ideation|suicidal ideation
5227199|NCT02579902|Irritable Bowel Syndrome|irritable bowel syndrome
5227200|NCT02579902|inflammation|inflammation
5227201|NCT02579902|oxidative stress|oxidative stress
5227202|NCT02579902|clinical signs|clinical signs
5227203|NCT02579902|vitamin D3|vitamin d3
5227204|NCT02579889|Closed Loop Stimulation|closed loop stimulation
5227205|NCT02579889|Atrial Fibrillation|atrial fibrillation
5227207|NCT02579889|Heart Failure|heart failure
5227208|NCT02579889|Pacemaker|pacemaker
5227209|NCT02579889|ICD|icd
5227210|NCT02579876|Milk Allergy|milk allergy
5227211|NCT02579876|Viaskin Milk|viaskin milk
5227212|NCT02579876|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
5227213|NCT02579876|Eosinophilic Esophagitis|eosinophilic esophagitis
5227214|NCT02579876|Milk-Induced Eosinophilic Esophagitis|milk-induced eosinophilic esophagitis
5227215|NCT02579863|PD1|pd1
5227216|NCT02579863|PD-1|pd-1
5227217|NCT02579863|PD-L1|pd-l1
5227218|NCT02579863|PDL1|pdl1
5227219|NCT02579850|COPD|copd
5227220|NCT02579850|COPD Exacerbation|copd exacerbation
5227221|NCT02579850|EXACT-PRO|exact-pro
5227222|NCT02579837|screening|screening
5227223|NCT02579824|Myeloma|myeloma
5227224|NCT02579824|Relapsed and/or Refractory|relapsed and/or refractory
5227225|NCT02579824|Multiple Myeloma|multiple myeloma
5227226|NCT02579824|MM|mm
5227227|NCT02579824|DS-3032b|ds-3032b
5227228|NCT02579811|Kidney|kidney
5227229|NCT02579811|Cancer|cancer
5227230|NCT02579811|Axitinib|axitinib
5227231|NCT02579811|Pd-1 inhibitor|pd-1 inhibitor
5227232|NCT02579811|Pd-L1 inhibitor|pd-l1 inhibitor
5227233|NCT02579798|Bariatric surgery|bariatric surgery
5227234|NCT02579798|Post-surgery hypoxemia|post-surgery hypoxemia
5227235|NCT02579798|Obesity|obesity
5227236|NCT02579785|Family Planning|family planning
5227237|NCT02579785|Abortion|abortion
5227238|NCT02579785|mHealth|mhealth
5227239|NCT02579785|Behaviour Change Communication|behaviour change communication
5227240|NCT02579785|Menstrual Regulation|menstrual regulation
5227241|NCT02579785|Postabortion|postabortion
5227242|NCT02579785|Bangladesh|bangladesh
5227244|NCT02579746|hypertension|hypertension
5227245|NCT02579746|immigrant|immigrant
5227246|NCT02579746|dietary intervention|dietary intervention
5227247|NCT02579746|lifestyle modification|lifestyle modification
5962712|NCT04279210|Platelet-rich plasma|platelet-rich plasma
5227248|NCT02579720|Recurrent Grass Pollen Allergy|recurrent grass pollen allergy
5227249|NCT02579720|Pollinex® Quattro|pollinex® quattro
5227250|NCT02579707|Healthy Volunteers|healthy volunteers
5227251|NCT02579681|Cognition|cognition
5096443|NCT03395535|SLT|slt
5106109|NCT03334422|eczema|eczema
5227252|NCT02579681|Tecfidera|tecfidera
5227253|NCT02579681|RRMS|rrms
5227254|NCT02579681|BG00012|bg00012
5227255|NCT02579642|Moderate to severe depression|moderate to severe depression
5227256|NCT02579642|Monopolar|monopolar
5227257|NCT02579642|Bipolar|bipolar
5227258|NCT02579642|Ketamine|ketamine
5227259|NCT02579642|ECT|ect
5227260|NCT02579642|Electroconvulsive therapy|electroconvulsive therapy
5227261|NCT02579642|NMDA|nmda
5227262|NCT02579629|Analgesia|analgesia
5227263|NCT02579629|Cesarean section|cesarean section
5227264|NCT02579629|Opiates|opiates
5227265|NCT02579616|Lenvatinib|lenvatinib
5227266|NCT02579616|E7080|e7080
5227267|NCT02579616|Unresectable biliary tract cancer|unresectable biliary tract cancer
5227268|NCT02579616|BTC|btc
5227269|NCT02579616|Gemcitabine-based combination chemotherapy|gemcitabine-based combination chemotherapy
5227270|NCT02579616|Lenvima|lenvima
5227271|NCT02579538|Total Knee Arthroplasty|total knee arthroplasty
5227272|NCT02579538|Thoracotomy|thoracotomy
5227273|NCT02579538|Mastectomy|mastectomy
5227274|NCT02579538|Video-Assisted Thoracoscopic Surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5227275|NCT02579538|Persistent Pain|persistent pain
5227276|NCT02579538|Cognitive Flexibility|cognitive flexibility
5227277|NCT02579525|septic shock|septic shock
5227278|NCT02579525|tissue perfusion|tissue perfusion
5227279|NCT02579525|macrocirculatory|macrocirculatory
5227280|NCT02579525|mean arterial pressure|mean arterial pressure
5227281|NCT02579525|vasopressor use|vasopressor use
5227282|NCT02579525|days alive free of organ support|days alive free of organ support
5227283|NCT02579499|Coronary artery disease|coronary artery disease
5227284|NCT02579499|LDL choelsterol|ldl choelsterol
5227285|NCT02579499|Statin|statin
5227286|NCT02579473|Continuous dopaminergic stimulation|continuous dopaminergic stimulation
5227288|NCT02579460|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5227289|NCT02579434|CYP3A|cyp3a
5227296|NCT02579382|Hepatitis|hepatitis
5227297|NCT02579382|Liver Disease|liver disease
5227298|NCT02579369|Epidermolysis Bullosa|epidermolysis bullosa
5227299|NCT02579369|stem cell|stem cell
5227300|NCT02579317|Baroreflex mechanism|baroreflex mechanism
5227301|NCT02579317|Alcohol Use Disorder|alcohol use disorder
5227302|NCT02579317|Substance Use Disorder|substance use disorder
5227303|NCT02579317|Heart Rate Variability|heart rate variability
5227304|NCT02579317|Breathing|breathing
5227305|NCT02579291|Stroke|stroke
5227306|NCT02579291|Dry needling|dry needling
5303246|NCT02160938|CNV|cnv
5215329|NCT02650271|hepatocellular carcinoma|hepatocellular carcinoma
5215330|NCT02650271|hepatic resection|hepatic resection
5215332|NCT02650245|gastroenterology|gastroenterology
5227307|NCT02579291|Spasticity|spasticity
5227308|NCT02579291|Motor function|motor function
5227309|NCT02579291|Stabilometry|stabilometry
5227310|NCT02579278|EMVI|emvi
5227311|NCT02579278|Extramural Venous Invasion|extramural venous invasion
5227312|NCT02579278|mrEMVI|mremvi
5227313|NCT02579278|Rectal Cancer|rectal cancer
5227314|NCT02579278|ctDNA|ctdna
5227315|NCT02579278|Neoplasm DNA|neoplasm dna
5227316|NCT02579278|MRI|mri
5227317|NCT02579265|Parenteral nutrition|parenteral nutrition
5227318|NCT02579265|Neonates|neonates
5227319|NCT02579265|Infants|infants
5227320|NCT02579265|Lipid emulsions|lipid emulsions
5227321|NCT02579265|Intravenous|intravenous
5227322|NCT02579252|vaccine|vaccine
5227323|NCT02579252|tau protein|tau protein
5227324|NCT02579252|active|active
5227325|NCT02579252|immunization|immunization
5227326|NCT02579252|KLH|klh
5227327|NCT02579252|immunotherapy|immunotherapy
5227328|NCT02579252|tau|tau
5227329|NCT02579239|LGMD2B|lgmd2b
5227330|NCT02579239|FSHD|fshd
5227331|NCT02579226|AZD2811|azd2811
5227332|NCT02579226|Advanced solid tumours|advanced solid tumours
5227333|NCT02579226|Small-cell lung cancer|small-cell lung cancer
5227334|NCT02579213|electronic nose|electronic nose
5227335|NCT02579213|abnormal fetal karyotype|abnormal fetal karyotype
5227336|NCT02579161|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
5227337|NCT02579161|Kidney Stones|kidney stones
5227338|NCT02579161|Antibiotics|antibiotics
5227339|NCT02579148|erectile dysfunction|erectile dysfunction
5227340|NCT02579148|stem cell|stem cell
5227341|NCT02579148|collagen scaffold|collagen scaffold
5227342|NCT02579135|Condoms|condoms
5227343|NCT02579135|Sexual Abstinence|sexual abstinence
5227344|NCT02579135|Sexual Communication|sexual communication
5227345|NCT02579122|Reviparin|reviparin
5227346|NCT02579122|Bridging|bridging
5227347|NCT02579122|Phenprocoumon|phenprocoumon
5227348|NCT02579096|Gout|gout
5962713|NCT04279158|attention-deficit hyperactivity disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
5227349|NCT02579096|Allopurinol|allopurinol
5227350|NCT02579096|Febuxostat|febuxostat
5227352|NCT02579070|Diabetic Foot|diabetic foot
5227353|NCT02579070|foot temperature|foot temperature
5227354|NCT02579070|diabetic foot ulcer|diabetic foot ulcer
5227355|NCT02579057|Congestive heart failure|congestive heart failure
5962714|NCT04279158|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5227356|NCT02579057|Furosemide|furosemide
5227357|NCT02579031|Percutaneous Coronary Intervention|percutaneous coronary intervention
5227358|NCT02579031|Stents|stents
5227359|NCT02579031|Drug-Eluting Stents|drug-eluting stents
5227360|NCT02579031|Coronary Artery Disease|coronary artery disease
5227361|NCT02579031|Acute Coronary Syndrome|acute coronary syndrome
5227362|NCT02579018|Anorexia Nervosa|anorexia nervosa
5227363|NCT02579018|Exercise|exercise
5227364|NCT02579018|Healthy Adults|healthy adults
5227365|NCT02579018|Physical Activity|physical activity
5227366|NCT02579005|Radiation|radiation
5227367|NCT02579005|Immune response|immune response
5227368|NCT02579005|Anti-tumor|anti-tumor
5227369|NCT02579005|Lung Cancer|lung cancer
5227370|NCT02578992|intubating stylet|intubating stylet
5227371|NCT02578992|head and neck position|head and neck position
5227372|NCT02578979|atrial fibrillation|atrial fibrillation
5227373|NCT02578979|ischemic stroke|ischemic stroke
5227374|NCT02578979|electrocardiogram|electrocardiogram
5227375|NCT02578979|holter|holter
5227376|NCT02578966|Early Childhood Caries|early childhood caries
5227377|NCT02578966|Randomized clinical trial|randomized clinical trial
5227378|NCT02578966|Motivational Interviewing|motivational interviewing
5227379|NCT02578953|Bioequivalence|bioequivalence
5227380|NCT02578953|Fasted state|fasted state
5227381|NCT02578953|Japanese male healthy subjects|japanese male healthy subjects
5227382|NCT02578953|Dutasteride|dutasteride
5227383|NCT02578914|allergic conjunctivitis|allergic conjunctivitis
5227384|NCT02578914|seasonal allergies|seasonal allergies
5227385|NCT02578914|ragweed allergy|ragweed allergy
5227386|NCT02578914|grass allergy|grass allergy
5227387|NCT02578914|tree allergy|tree allergy
5227388|NCT02578914|NS2|ns2
5227389|NCT02578914|Aldeyra|aldeyra
5227394|NCT02578875|Sequence Technique|sequence technique
5227395|NCT02578875|Infectious Disease|infectious disease
5227396|NCT02578875|Pathogen Detection|pathogen detection
5227397|NCT02578875|Diagnostic|diagnostic
5227398|NCT02578836|Weight Loss|weight loss
5227399|NCT02578836|Overweight|overweight
5227400|NCT02578836|Endoscopic treatment for obesity|endoscopic treatment for obesity
5227401|NCT02578823|Targeted Temperature Management(TTM)|targeted temperature management(ttm)
5227402|NCT02578823|in-hospital cardiac arrest(IHCA)|in-hospital cardiac arrest(ihca)
5227403|NCT02578823|restoration of spontaneous circulation(ROSC)|restoration of spontaneous circulation(rosc)
5227404|NCT02578823|unconsciousness|unconsciousness
5227405|NCT02578823|brain injury|brain injury
5227406|NCT02578797|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
5227407|NCT02578797|Prostatic Neoplasms|prostatic neoplasms
5227408|NCT02578797|Genital Diseases, Male|genital diseases, male
5227409|NCT02578797|Genital Neoplasms, Male|genital neoplasms, male
5227411|NCT02578797|Neoplasms by Site|neoplasms by site
5227412|NCT02578797|Prostatic Diseases|prostatic diseases
5227413|NCT02578797|Urogenital Neoplasms|urogenital neoplasms
5227414|NCT02578784|Dialysis|dialysis
5227415|NCT02578758|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
5227416|NCT02578758|Positive affect regulation|positive affect regulation
5227419|NCT02578706|Clopidogrel|clopidogrel
5227420|NCT02578706|Platelet|platelet
5227421|NCT02578706|Inflammation|inflammation
5227422|NCT02578706|Cardiovascular disease|cardiovascular disease
5227423|NCT02578706|Arachidonic acid|arachidonic acid
5227424|NCT02578706|Cyclooxygenase inhibitor|cyclooxygenase inhibitor
5227425|NCT02578706|ADP inhibitor|adp inhibitor
5227426|NCT02578706|Immune activation|immune activation
5227427|NCT02578706|Monocyte|monocyte
5227428|NCT02578706|Coagulation|coagulation
5227429|NCT02578706|Thrombogenicity|thrombogenicity
5227430|NCT02578680|PD1|pd1
5227431|NCT02578680|PD-1|pd-1
5227432|NCT02578680|PDL1|pdl1
5227433|NCT02578680|PD-L1|pd-l1
5227434|NCT02578680|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5227435|NCT02578641|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5227436|NCT02578641|NPC|npc
5227437|NCT02578641|immunotherapy|immunotherapy
5227438|NCT02578641|Nasopharyngeal Cancer|nasopharyngeal cancer
5227439|NCT02578641|Nose Cancer|nose cancer
5227440|NCT02578641|Cell therapy|cell therapy
5227441|NCT02578641|Head and Neck Cancer|head and neck cancer
5227442|NCT02578641|Cytotoxic T cells|cytotoxic t cells
5227443|NCT02578641|chemotherapy|chemotherapy
5227444|NCT02578641|Epstein-Barr Virus|epstein-barr virus
5227445|NCT02578576|Diagnostic Techniques|diagnostic techniques
5227446|NCT02578576|Digestive System|digestive system
5227447|NCT02578550|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
5227448|NCT02578550|Darunavir|darunavir
5227449|NCT02578550|Cobicistat|cobicistat
5227450|NCT02578550|Emtricitabine|emtricitabine
5227451|NCT02578550|Tenofovir alafenamide|tenofovir alafenamide
5227452|NCT02578550|Healthy participants|healthy participants
5227453|NCT02578537|Ticagrelor|ticagrelor
5227454|NCT02578537|Pharmacokinetics|pharmacokinetics
5227455|NCT02578537|NSTE-ACS|nste-acs
5227456|NCT02578537|CKD|ckd
5227457|NCT02578524|cataract satisfaction|cataract satisfaction
5227458|NCT02578511|Acute Lymphoblastic Leukemia in Complete Remission|acute lymphoblastic leukemia in complete remission
5227459|NCT02578511|Lymphoblastic Lymphoma in Complete Remission|lymphoblastic lymphoma in complete remission
5227460|NCT02578511|Mixed Phenotype Acute Leukemia in Complete Remission|mixed phenotype acute leukemia in complete remission
5227461|NCT02578511|IXAZOMIB|ixazomib
5227462|NCT02578511|POMP/D|pomp/d
5227463|NCT02578511|Phase I|phase i
5227464|NCT02578511|Early Phase|early phase
5227465|NCT02578511|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5227466|NCT02578511|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5227467|NCT02578511|Mixed Phenotype Acute Leukemia|mixed phenotype acute leukemia
5227469|NCT02578498|glucagon|glucagon
5227470|NCT02578498|Carbohydrate diet|carbohydrate diet
5227471|NCT02578472|Healthy|healthy
5227472|NCT02578472|JNJ-42847922|jnj-42847922
5227473|NCT02578472|zolpidem|zolpidem
5227474|NCT02578472|Placebo|placebo
5227475|NCT02578459|Cancer pain|cancer pain
5227476|NCT02578459|Intrathecal therapy|intrathecal therapy
5227477|NCT02578459|Pain|pain
5227478|NCT02578459|Pancreatic cancer|pancreatic cancer
5227479|NCT02578433|Mindful Self Compassion short form|mindful self compassion short form
5227480|NCT02578433|Progressive Muscle Relaxation|progressive muscle relaxation
5227481|NCT02578394|Gout|gout
5227482|NCT02578394|Kidney|kidney
5227483|NCT02578394|Depo-Medrone|depo-medrone
5227484|NCT02578394|Anakinra|anakinra
5227485|NCT02578381|pressure wire|pressure wire
5227486|NCT02578381|coronary angiogram|coronary angiogram
5227487|NCT02578381|validation|validation
5227488|NCT02578368|gastric cancer|gastric cancer
5227489|NCT02578368|perioperative|perioperative
5227490|NCT02578368|FLOT|flot
5227491|NCT02578368|limited metastatic|limited metastatic
5227492|NCT02578368|GEJ cancer|gej cancer
5227493|NCT02578355|Atherosclerosis|atherosclerosis
5227496|NCT02578355|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
5227497|NCT02578355|CCTA|ccta
5227498|NCT02578355|Myocardial Infarction|myocardial infarction
5227499|NCT02578355|MI|mi
5227500|NCT02578355|OPeRA|opera
5227502|NCT02578329|blood fatty acid|blood fatty acid
5227503|NCT02578329|Coronary Artery Disease|coronary artery disease
5227504|NCT02578316|Advanced Solid Tumors|advanced solid tumors
5227505|NCT02578316|Lymphomas|lymphomas
5227506|NCT02578303|sleep apnea|sleep apnea
5215527|NCT02649127|biomarker|biomarker
5215528|NCT02649088|microcirculation|microcirculation
5215529|NCT02649088|tissue oxygenation|tissue oxygenation
5215530|NCT02649088|outcome|outcome
5215532|NCT02649075|Inflammatory Bowel Disease|inflammatory bowel disease
5227507|NCT02578303|phase-contrast MRI|phase-contrast mri
5227508|NCT02578303|cerebral blood flow|cerebral blood flow
5227509|NCT02578303|vascular risk factor|vascular risk factor
5227510|NCT02578303|dementia|dementia
5227511|NCT02578290|decision support systems|decision support systems
5227512|NCT02578290|clinical|clinical
5227513|NCT02578238|Korea|korea
5227514|NCT02578238|Humira|humira
5227515|NCT02578238|Pediatric Crohn's Disease|pediatric crohn's disease
5227516|NCT02578225|Heart|heart
5227517|NCT02578225|Chronic|chronic
5227518|NCT02578225|Failure|failure
5227520|NCT02578225|real life|real life
5227521|NCT02578225|Turkey|turkey
5227522|NCT02578160|pain|pain
5227523|NCT02578160|infant behaviour|infant behaviour
5227524|NCT02578160|heart rate|heart rate
5227525|NCT02578160|dental anxiety|dental anxiety
5227526|NCT02578147|risky sexual behavior|risky sexual behavior
5227527|NCT02578147|early intervention|early intervention
5227528|NCT02578147|adolescent pregnancy|adolescent pregnancy
5227529|NCT02578121|Relapsed|relapsed
5227530|NCT02578121|Response Rate|response rate
5227531|NCT02578121|Progression free|progression free
5227532|NCT02578082|Renal Impairment|renal impairment
5227533|NCT02578082|Renal Insufficiency|renal insufficiency
5227534|NCT02578069|Ischemic Stroke|ischemic stroke
5227535|NCT02578069|Intracranial Stenting|intracranial stenting
5227536|NCT02578056|pelvic organ prolapse|pelvic organ prolapse
5227537|NCT02578056|urinary incontinence|urinary incontinence
5227538|NCT02578017|Sickle Cell Disease|sickle cell disease
5227539|NCT02578017|Hydroxyurea|hydroxyurea
5227540|NCT02578017|Adherence|adherence
5227541|NCT02578004|Difficult|difficult
5227542|NCT02578004|environmental, microbial, immunological and genetic factors|environmental, microbial, immunological and genetic factors
5227543|NCT02578004|significantly different|significantly different
5227544|NCT02577965|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
5227545|NCT02577965|Optical Coherence Tomography|optical coherence tomography
5227546|NCT02577965|Percutaneous Coronary Intervention|percutaneous coronary intervention
5227547|NCT02577965|Thrombus histopathology|thrombus histopathology
5227548|NCT02577965|Gender differences|gender differences
5227549|NCT02577952|lipodystrophy|lipodystrophy
5227550|NCT02577952|lipodystrophy, congenital generalized|lipodystrophy, congenital generalized
5227551|NCT02577952|Berardinelli-Seip Congenital Lipodystrophy|berardinelli-seip congenital lipodystrophy
5227552|NCT02577952|Congenital generalized lipodystrophy|congenital generalized lipodystrophy
5227553|NCT02577952|generalized lipodystrophy|generalized lipodystrophy
5227554|NCT02577952|lipodystrophy, familial partial|lipodystrophy, familial partial
5227555|NCT02577952|partial lipodystrophy|partial lipodystrophy
5227556|NCT02577952|lipodystrophy, partial, acquired|lipodystrophy, partial, acquired
5227557|NCT02577952|acquired lipodystrophy|acquired lipodystrophy
5227558|NCT02577913|contraception|contraception
5227559|NCT02577913|contraceptive patch|contraceptive patch
5227560|NCT02577913|Levonorgestrel|levonorgestrel
5227561|NCT02577913|gestodene|gestodene
5227563|NCT02577900|foot ulcer and honey and silver|foot ulcer and honey and silver
5227564|NCT02577861|limbal stem cells deficinecy, LSCD, ocular burn|limbal stem cells deficinecy, lscd, ocular burn
5227565|NCT02577848|Glucagon-like peptide-1|glucagon-like peptide-1
5227566|NCT02577848|Non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
5227567|NCT02577848|Left ventricular ejection fraction|left ventricular ejection fraction
5227568|NCT02577835|Hypertension|hypertension
5227569|NCT02577835|Arterial Stiffness|arterial stiffness
5227570|NCT02577835|Ambulatory blood pressure|ambulatory blood pressure
5227571|NCT02577796|radial artery spasm|radial artery spasm
5227572|NCT02577796|radial artery occlusion|radial artery occlusion
5227573|NCT02577796|radial access|radial access
5227574|NCT02577783|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5227578|NCT02577757|Languages network|languages network
5227579|NCT02577757|Functional MRI|functional mri
5227580|NCT02577744|Electrical Impedance Tomography|electrical impedance tomography
5227581|NCT02577731|Trauma|trauma
5227582|NCT02577705|food insecurity|food insecurity
5227583|NCT02577705|adverse childhood experiences|adverse childhood experiences
5227584|NCT02577705|violence exposure|violence exposure
5227585|NCT02577705|trauma|trauma
5227586|NCT02577705|poverty|poverty
5227595|NCT02577614|Aortic Valve Repair|aortic valve repair
5227596|NCT02577614|Coronary Re-Implantation|coronary re-implantation
5227597|NCT02577614|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5227598|NCT02577614|Factor VIII Inhibitor Bypass Activity|factor viii inhibitor bypass activity
5215627|NCT02648581|Behçet|behçet
5227599|NCT02577614|Transfusion|transfusion
5227600|NCT02577601|Emergency contraception|emergency contraception
5227601|NCT02577601|Birth Control Pills|birth control pills
5227602|NCT02577588|p53 Antigen|p53 antigen
5227603|NCT02577588|T cell therapy|t cell therapy
5227604|NCT02577588|autologous|autologous
5227605|NCT02577588|Adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
5227607|NCT02577575|Syntocinon|syntocinon
5227608|NCT02577575|Social Cognition|social cognition
5227609|NCT02577575|Schizophrenia|schizophrenia
5227610|NCT02577549|Knee Pain|knee pain
5227611|NCT02577549|Exercise|exercise
5227612|NCT02577549|Diet|diet
5227613|NCT02577549|Weight Loss|weight loss
5227615|NCT02577536|Neonatal outcome|neonatal outcome
5227616|NCT02577536|Birth weight|birth weight
5227617|NCT02577536|Weight gain|weight gain
5227618|NCT02577536|Physical disability|physical disability
5227619|NCT02577510|Lateral Femoral Cutaneous Nerve Block|lateral femoral cutaneous nerve block
5227620|NCT02577510|Meralgia Parasthetica|meralgia parasthetica
5227621|NCT02577510|nerve stimulator|nerve stimulator
5227622|NCT02577510|ultrasound|ultrasound
5227623|NCT02577484|Fractional Flow Reserve|fractional flow reserve
5227624|NCT02577484|Rapid Exchange|rapid exchange
5227625|NCT02577484|Catheter|catheter
5227626|NCT02577471|Constipation|constipation
5227627|NCT02577471|pregnancy|pregnancy
5227628|NCT02577471|delivery|delivery
5227629|NCT02577432|spinal anesthesia|spinal anesthesia
5227630|NCT02577419|breast milk|breast milk
5227631|NCT02577419|chylothorax|chylothorax
5227632|NCT02577419|infants|infants
5227633|NCT02577419|cardiac surgery|cardiac surgery
5227634|NCT02577419|modified fat breast milk|modified fat breast milk
5227643|NCT02577393|Lung Neoplasms|lung neoplasms
5227644|NCT02577393|esophagitis|esophagitis
5227645|NCT02577393|Prevention & Control|prevention & control
5227646|NCT02577393|Epigallocatechin Gallate|epigallocatechin gallate
5227647|NCT02577367|Hypothyroidism|hypothyroidism
5227648|NCT02577367|Tube Feeding|tube feeding
5227649|NCT02577341|Nimotuzumab, Chemoradiotherapy,Squamous Cell Lung Cancer|nimotuzumab, chemoradiotherapy,squamous cell lung cancer
5227650|NCT02577302|Chronic Tibial nerve stimulation|chronic tibial nerve stimulation
5227651|NCT02577302|Wireless PNS|wireless pns
5227652|NCT02577302|neuromodulation|neuromodulation
5227653|NCT02577289|simultaneous implantation|simultaneous implantation
5227654|NCT02577289|Dental implant|dental implant
5227655|NCT02577289|Open sinus Lifting|open sinus lifting
5227657|NCT02577289|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
5227658|NCT02577276|stroke|stroke
5227659|NCT02577276|remote monitoring|remote monitoring
5227660|NCT02577276|hemiparesis|hemiparesis
5227661|NCT02577250|ketamine|ketamine
5227662|NCT02577250|stress disorders, post-traumatic|stress disorders, post-traumatic
5227663|NCT02577250|stress disorders, traumatic|stress disorders, traumatic
5227664|NCT02577250|anxiety disorders|anxiety disorders
5227665|NCT02577250|mental disorders|mental disorders
5227666|NCT02577250|adjuvants, anesthesia|adjuvants, anesthesia
5227667|NCT02577250|analgesics|analgesics
5227668|NCT02577250|anesthetics|anesthetics
5227669|NCT02577250|anesthetics, dissociative|anesthetics, dissociative
5227670|NCT02577250|anesthetics, general|anesthetics, general
5106576|NCT03331770|BUT|but
5227671|NCT02577250|anesthetics, intravenous|anesthetics, intravenous
5227672|NCT02577250|excitatory amino acid agents|excitatory amino acid agents
5227673|NCT02577250|excitatory amino acid antagonists|excitatory amino acid antagonists
5227674|NCT02577250|hypnotics and sedatives|hypnotics and sedatives
5227675|NCT02577250|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
5227676|NCT02577250|neurotransmitter agents|neurotransmitter agents
5227677|NCT02577250|peripheral nervous system agents|peripheral nervous system agents
5227678|NCT02577250|pharmacologic actions|pharmacologic actions
5227679|NCT02577250|physiological effects of drugs|physiological effects of drugs
5227680|NCT02577250|psychotropic drugs|psychotropic drugs
5227681|NCT02577250|sensory system agents|sensory system agents
5227684|NCT02577250|depression|depression
5227685|NCT02577250|depressive disorder|depressive disorder
5227686|NCT02577250|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
5227687|NCT02577250|behavioral symptoms|behavioral symptoms
5227688|NCT02577250|mood disorders|mood disorders
5227689|NCT02577250|therapeutic uses|therapeutic uses
5227690|NCT02577237|caregiver|caregiver
5227691|NCT02577237|simulation|simulation
5227692|NCT02577224|Patient-led care|patient-led care
5227693|NCT02577224|Botulinum toxin|botulinum toxin
5227694|NCT02577224|Dystonia|dystonia
5227695|NCT02577224|Randomised controlled trial|randomised controlled trial
5227696|NCT02577224|Acceptability|acceptability
5227697|NCT02577211|Critically ill|critically ill
5227698|NCT02577211|Enteral nutrition|enteral nutrition
5227699|NCT02577172|Testicular cancer|testicular cancer
5227700|NCT02577172|Physical Exercise|physical exercise
5227701|NCT02577172|Chemotherapy|chemotherapy
5227702|NCT02577159|sodium-glucose cotransporter 2 inhibitor|sodium-glucose cotransporter 2 inhibitor
5215725|NCT02648100|Basal subtype|basal subtype
5215726|NCT02648100|Anti-EGFR treatment|anti-egfr treatment
5215727|NCT02648100|Nanostring|nanostring
5215734|NCT02648061|Blood circulation|blood circulation
5215735|NCT02648061|Follow-up studies|follow-up studies
5215737|NCT02648061|Hemodynamics|hemodynamics
5227703|NCT02577159|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5227704|NCT02577159|dyslipidemia|dyslipidemia
5227705|NCT02577159|remnants|remnants
5227706|NCT02577159|apolipoprotein B-48|apolipoprotein b-48
5227707|NCT02577146|stone|stone
5227708|NCT02577146|ureter|ureter
5227709|NCT02577146|ultrasound|ultrasound
5227710|NCT02577133|colic|colic
5227711|NCT02577133|probiotic|probiotic
5227712|NCT02577133|Lactobacillus reuteri|lactobacillus reuteri
5227713|NCT02577133|prevention|prevention
5227715|NCT02577120|Ceramiseal|ceramiseal
5227716|NCT02577107|Age-related macular degeneration,|age-related macular degeneration,
5227717|NCT02577107|ranibizumab,|ranibizumab,
5227718|NCT02577107|conbercept,|conbercept,
5227719|NCT02577107|plasma VEGF|plasma vegf
5227721|NCT02577094|CD22 positive- lymphoblastic leukemia-RIT-Yttrium|cd22 positive- lymphoblastic leukemia-rit-yttrium
5227722|NCT02577055|Leiomyoma|leiomyoma
5227723|NCT02577055|Uterine Artery Embolization|uterine artery embolization
5227724|NCT02577055|Surgery|surgery
5121192|NCT03237754|MRI|mri
5227725|NCT02577055|childbearing age|childbearing age
5227726|NCT02577055|Fertility|fertility
5227727|NCT02577055|Noninferiority trial|noninferiority trial
5227728|NCT02577042|Raltegravir|raltegravir
5227729|NCT02577042|protease inhibitors|protease inhibitors
5227730|NCT02577042|darunavir|darunavir
5227731|NCT02577042|inflammation|inflammation
5227732|NCT02577042|statins|statins
5227733|NCT02577042|comorbidities|comorbidities
5227738|NCT02576977|PDL1|pdl1
5227739|NCT02576977|PD1|pd1
5227740|NCT02576977|Multiple Myeloma|multiple myeloma
5227741|NCT02576938|Atopic Eczema|atopic eczema
5227742|NCT02576912|Cannabis|cannabis
5227743|NCT02576912|Marijuana|marijuana
5227744|NCT02576912|THC|thc
5227745|NCT02576912|Pregnenolone|pregnenolone
5227746|NCT02576912|Psychotic Disorders|psychotic disorders
5227747|NCT02576912|PREG|preg
5227748|NCT02576899|smoking cessation|smoking cessation
5227749|NCT02576899|posttraumatic stress disorder|posttraumatic stress disorder
5227750|NCT02576899|tobacco|tobacco
5227751|NCT02576899|treatment|treatment
5227752|NCT02576899|smoking|smoking
5227753|NCT02576899|mindfulness|mindfulness
5227754|NCT02576899|acceptance|acceptance
5227755|NCT02576899|functioning|functioning
5227756|NCT02576886|supine|supine
5227757|NCT02576886|prone|prone
5227758|NCT02576886|myocardial perfusion imaging|myocardial perfusion imaging
5227759|NCT02576886|radiation exposure|radiation exposure
5227760|NCT02576886|pre-screening tool|pre-screening tool
5227761|NCT02576873|Survival|survival
5227762|NCT02576873|Hemodiafiltration|hemodiafiltration
5227763|NCT02576873|End-stage renal disease|end-stage renal disease
5227764|NCT02576873|Hemodialysis|hemodialysis
5962715|NCT04279158|attention|attention
5227765|NCT02576821|Amnesia, Alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration|amnesia, alzheimer, hippocampal sclerosis, fronto-temporal lobar degeneration
5227766|NCT02576795|Haemophilia A|haemophilia a
5227767|NCT02576795|Gene Therapy|gene therapy
5227768|NCT02576795|Clotting Disorders|clotting disorders
5962716|NCT04279158|inhibition|inhibition
5227769|NCT02576795|Blood Disorder|blood disorder
5227770|NCT02576795|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5227771|NCT02576795|Blood Coagulation Disorders|blood coagulation disorders
5227772|NCT02576795|Hematologic Diseases|hematologic diseases
5227773|NCT02576795|Coagulation Protein Disorders|coagulation protein disorders
5227774|NCT02576795|Hemorrhagic Disorders|hemorrhagic disorders
5227775|NCT02576795|Genetic Diseases, Inborn|genetic diseases, inborn
5227776|NCT02576795|Factor VIII|factor viii
5227777|NCT02576795|Coagulants|coagulants
5227778|NCT02576795|AAV5 vector|aav5 vector
5227779|NCT02576782|regional anesthesia|regional anesthesia
5227780|NCT02576782|dexamethasone|dexamethasone
5227781|NCT02576782|bupivacaine|bupivacaine
5227783|NCT02576782|sciatic|sciatic
5227784|NCT02576769|Basal cell carcinoma|basal cell carcinoma
5227785|NCT02576769|Pigmentation|pigmentation
5227786|NCT02576769|Melanocyte|melanocyte
5227787|NCT02576769|Melanin|melanin
5227788|NCT02576769|Skin cancer|skin cancer
5227789|NCT02576756|Risk on aspiration|risk on aspiration
5227790|NCT02576756|Postoperative|postoperative
5227791|NCT02576756|Difficult Intubation|difficult intubation
5227792|NCT02576743|Stroke|stroke
5227793|NCT02576743|AVM|avm
5227794|NCT02576743|Aneurysm|aneurysm
5227795|NCT02576717|MS|ms
5227796|NCT02576717|RMS|rms
5227797|NCT02576717|Multiple Sclerosis|multiple sclerosis
5227798|NCT02576717|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5227826|NCT02576626|glycopyrronium|glycopyrronium
5227827|NCT02576626|salbutamol|salbutamol
5227828|NCT02576626|Breezhaler|breezhaler
5227829|NCT02576626|Nebuliser|nebuliser
5227830|NCT02576626|Hyperinflation|hyperinflation
5227831|NCT02576626|Dyspnea|dyspnea
5227832|NCT02576626|SABA|saba
5227833|NCT02576626|short-acting muscarinic antagonists (SAMA)|short-acting muscarinic antagonists (sama)
5227834|NCT02576626|long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
5227835|NCT02576626|LAMA|lama
5227836|NCT02576626|FEV1|fev1
5227837|NCT02576574|Avelumab|avelumab
5227838|NCT02576574|MSB0010718C|msb0010718c
5227839|NCT02576574|Non-Small Cell Lung Cancer|non-small cell lung cancer
5227840|NCT02576561|human papillomavirus|human papillomavirus
5227841|NCT02576561|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5227842|NCT02576561|Cold Knife Conization|cold knife conization
5227843|NCT02576561|hysterectomy|hysterectomy
5227844|NCT02576561|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
5227845|NCT02576561|LEEP|leep
5227846|NCT02576561|HSIL|hsil
5225148|NCT02592330|Corneal opacity|corneal opacity
5227847|NCT02576561|High-Grade Squamous Intraepithelial Lesion|high-grade squamous intraepithelial lesion
5227855|NCT02576470|swallowing|swallowing
5227857|NCT02576470|dysphagia|dysphagia
5227858|NCT02576470|deglutition|deglutition
5227859|NCT02576431|Non-small cell lung cancer|non-small cell lung cancer
5227860|NCT02576431|Thyroid cancer|thyroid cancer
5227861|NCT02576431|Sarcoma|sarcoma
5227862|NCT02576431|Colorectal cancer|colorectal cancer
5227863|NCT02576431|Salivary gland cancer|salivary gland cancer
5227864|NCT02576431|Biliary cancer|biliary cancer
5227865|NCT02576431|Central nervous system (CNS) Tumor|central nervous system (cns) tumor
5227866|NCT02576431|Breast cancer|breast cancer
5227867|NCT02576431|Melanoma|melanoma
5227868|NCT02576431|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5227869|NCT02576431|NTRK1|ntrk1
5227870|NCT02576431|NTRK2|ntrk2
5227871|NCT02576431|NTRK3|ntrk3
5227872|NCT02576431|Fusion Positive|fusion positive
5227873|NCT02576431|TRK fusion|trk fusion
5227874|NCT02576431|TRKA|trka
5227875|NCT02576431|TRKB|trkb
5227876|NCT02576431|TRKC|trkc
5227877|NCT02576431|ETV6|etv6
5227878|NCT02576418|Partosure TTD test|partosure ttd test
5227879|NCT02576418|CL|cl
5227880|NCT02576418|ART|art
5227881|NCT02576418|SN|sn
5227882|NCT02576418|SP|sp
5227883|NCT02576418|PPV|ppv
5227884|NCT02576418|NPV|npv
5227885|NCT02576379|Helicopter Emergency Medical System|helicopter emergency medical system
5227886|NCT02576379|Mortality|mortality
5227887|NCT02576379|Labour market affiliation|labour market affiliation
5227888|NCT02576379|Modified Rankin Scale|modified rankin scale
5227889|NCT02576327|Lymphoma|lymphoma
5227890|NCT02576327|Aprepitant|aprepitant
5227891|NCT02576327|Chemotherapy-induced nausea and vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
5227892|NCT02576327|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5227893|NCT02576327|Hematological Malignancies|hematological malignancies
5227895|NCT02576301|MDS|mds
5227896|NCT02576288|Sitagliptin|sitagliptin
5227897|NCT02576288|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
5227898|NCT02576288|Carotid stiffness|carotid stiffness
5227899|NCT02576288|Pro-inflammatory|pro-inflammatory
5227900|NCT02576288|Pro-atherogenic|pro-atherogenic
5227901|NCT02576288|M1 macrophages|m1 macrophages
5227903|NCT02576275|iNHL|inhl
5227904|NCT02576275|Follicular Lymphoma|follicular lymphoma
5227905|NCT02576275|FL|fl
5227906|NCT02576275|PI3K|pi3k
5227907|NCT02576275|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5227909|NCT02576275|Marginal Zone Lymphoma|marginal zone lymphoma
5227910|NCT02576275|MZL|mzl
5227911|NCT02576249|osteoarthritis|osteoarthritis
5227912|NCT02576249|injection|injection
5227913|NCT02576249|steroid|steroid
5227914|NCT02576249|anesthetic|anesthetic
5227915|NCT02576236|Naïve patient|naïve patient
5227916|NCT02576236|Suspicion of H pylori infection|suspicion of h pylori infection
5227917|NCT02576236|Endoscopy|endoscopy
5227918|NCT02576236|Antibiotics therapeutic strategies|antibiotics therapeutic strategies
5227919|NCT02576236|Urea breath test|urea breath test
5227920|NCT02576223|Peripheral Nerve Blocks|peripheral nerve blocks
5227921|NCT02576197|mild to moderate|mild to moderate
5227922|NCT02576197|probiotic|probiotic
5227924|NCT02576184|Stoma|stoma
5227925|NCT02576184|rectal cancer|rectal cancer
5227926|NCT02576184|synthetic mesh|synthetic mesh
5227927|NCT02576184|biologic mesh|biologic mesh
5227928|NCT02576171|cognitive behavioral therapy;|cognitive behavioral therapy;
5227929|NCT02576171|guided self-help|guided self-help
5227930|NCT02576171|adolescent|adolescent
5227931|NCT02576067|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5227932|NCT02576067|Inflammation reduction|inflammation reduction
5227933|NCT02576041|driving simulator|driving simulator
5227934|NCT02576028|Total Hip Replacement|total hip replacement
5227935|NCT02576028|Manipulation Therapy|manipulation therapy
5227936|NCT02576002|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5227937|NCT02575989|Trauma|trauma
5227938|NCT02575989|Prehospital|prehospital
5227939|NCT02575989|Hypothermia|hypothermia
5227940|NCT02575976|Rehabilitation|rehabilitation
5227941|NCT02575976|Coronary artery disease|coronary artery disease
5227942|NCT02575976|Patient Education|patient education
5227943|NCT02575976|Randomized Controlled Trial|randomized controlled trial
5227944|NCT02575976|Protocol|protocol
5227945|NCT02575937|low glycemic diet|low glycemic diet
5227946|NCT02575937|diabetes|diabetes
5227947|NCT02575924|media|media
5227948|NCT02575924|blastocyst|blastocyst
5227949|NCT02575924|male infertility|male infertility
5227950|NCT02575924|poor responders|poor responders
5227951|NCT02575924|pgs|pgs
5227952|NCT02575859|HIPEC|hipec
5227953|NCT02575859|peritoneal lavage|peritoneal lavage
5227954|NCT02575833|Angina|angina
5227955|NCT02575833|Stable Angina|stable angina
5227956|NCT02575833|Cardiovascular Disease|cardiovascular disease
5227957|NCT02575833|Exercise-induced Angina|exercise-induced angina
5227958|NCT02575807|Ovarian cancer|ovarian cancer
5227959|NCT02575807|Fallopian cancer|fallopian cancer
5227960|NCT02575807|Primary peritoneal cancer|primary peritoneal cancer
5227961|NCT02575755|Azithromycin|azithromycin
5227963|NCT02575755|IPTp|iptp
5227964|NCT02575755|Pharmacokinetics|pharmacokinetics
5227965|NCT02575755|Efficacy|efficacy
5227966|NCT02575729|carpal tunnel syndrome|carpal tunnel syndrome
5227967|NCT02575729|local steroid injection|local steroid injection
5227968|NCT02575729|sonography|sonography
5227969|NCT02575729|sonography-guided|sonography-guided
5227970|NCT02575716|McGrath®|mcgrath®
5227971|NCT02575716|Videolaryngoscope|videolaryngoscope
5227972|NCT02575716|intubating condition|intubating condition
5227973|NCT02575716|muscle relaxant|muscle relaxant
5227974|NCT02575716|intubation|intubation
5227975|NCT02575690|spirulina, placebo, obesity,antihypertensive treatment|spirulina, placebo, obesity,antihypertensive treatment
5227976|NCT02575677|labor pain|labor pain
5227977|NCT02575677|oxycodone|oxycodone
5227978|NCT02575664|Pain|pain
5227979|NCT02575664|Arthroplasty|arthroplasty
5227980|NCT02575664|Buprenorphine|buprenorphine
5227981|NCT02575651|PARP|parp
5227982|NCT02575651|Advanced Solid Malignancies|advanced solid malignancies
5227983|NCT02575651|Fluzoparib|fluzoparib
5227984|NCT02575651|Ovarian Cancer|ovarian cancer
5227985|NCT02575651|BRCA|brca
5227986|NCT02575625|Liver steatosis|liver steatosis
5227987|NCT02575625|Steatohepatitis|steatohepatitis
5227988|NCT02575625|Fibroscan|fibroscan
5227989|NCT02575599|Self-management|self-management
5227990|NCT02575599|web-based|web-based
5227991|NCT02575599|quantitative approach|quantitative approach
5227992|NCT02575586|Trigger Points|trigger points
5227993|NCT02575586|Dry needling|dry needling
5227994|NCT02575586|Torque|torque
5227995|NCT02575586|H-Reflex|h-reflex
5227996|NCT02575573|resuscitation decision|resuscitation decision
5227997|NCT02575560|Progression-Free Survival|progression-free survival
5227998|NCT02575547|Nutritional Status|nutritional status
5227999|NCT02575547|Locoregionally Advanced Nasopharyngeal Carcinoma|locoregionally advanced nasopharyngeal carcinoma
5228000|NCT02575534|anti-arrhythmic therapy|anti-arrhythmic therapy
5228001|NCT02575482|SUVN-D4010|suvn-d4010
5228002|NCT02575482|serotonin 4 (5-HT4) receptor|serotonin 4 (5-ht4) receptor
5228003|NCT02575482|first in human|first in human
5228005|NCT02575482|pharmacokinetics|pharmacokinetics
5228006|NCT02575482|tolerability|tolerability
5228007|NCT02575482|single dose|single dose
5228008|NCT02575482|repeat dose|repeat dose
5228009|NCT02575417|advance care planning|advance care planning
5106899|NCT03329703|PNES|pnes
5228010|NCT02575417|end-of-life care|end-of-life care
5228011|NCT02575417|health games|health games
5228012|NCT02575417|Family caregivers|family caregivers
5228013|NCT02575417|Advance directives|advance directives
5228014|NCT02575404|Metastatic|metastatic
5228015|NCT02575404|Keytruda|keytruda
5228016|NCT02575404|pembrolizumab|pembrolizumab
5228017|NCT02575404|GR-MD-02|gr-md-02
5228018|NCT02575404|Galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
5228019|NCT02575404|Immunotherapy|immunotherapy
5228020|NCT02575391|L-Glutamine|l-glutamine
5228021|NCT02575391|chemotherapy|chemotherapy
5228022|NCT02575391|radiotherapy|radiotherapy
5228023|NCT02575391|therapeutic toxicity|therapeutic toxicity
5228024|NCT02575378|Metastatic Colorectal Cancer|metastatic colorectal cancer
5228025|NCT02575378|Maintenance Treatment|maintenance treatment
5228026|NCT02575378|Chinese Traditional Medicine|chinese traditional medicine
5228027|NCT02575378|Clinical Trial|clinical trial
5228028|NCT02575378|efficacy|efficacy
5228029|NCT02575378|safety|safety
5228030|NCT02575365|RRMS,|rrms,
5228031|NCT02575365|Cognition,|cognition,
5228032|NCT02575365|brain,|brain,
5228033|NCT02575365|Fingolimod,|fingolimod,
5228034|NCT02575365|Multiple Sclerosis,|multiple sclerosis,
5228035|NCT02575365|neurodegeneration,|neurodegeneration,
5228036|NCT02575365|Brain atrophy,|brain atrophy,
5228037|NCT02575365|gray matter atrophy,|gray matter atrophy,
5228038|NCT02575365|thalamic atrophy,|thalamic atrophy,
5228039|NCT02575365|biomarkers,|biomarkers,
5228040|NCT02575365|BICAMS Battery,|bicams battery,
5228041|NCT02575352|Bone Substitute|bone substitute
5228042|NCT02575352|Calcium Phosphate Cement|calcium phosphate cement
5228043|NCT02575352|GRAFTYS|graftys
5228044|NCT02575352|GRAFTYS®HBS|graftys®hbs
5228045|NCT02575352|GRAFTYS®QUICKSET|graftys®quickset
5228046|NCT02575352|Bone void filler|bone void filler
5228047|NCT02575352|Bone growth|bone growth
5228048|NCT02575352|Registry|registry
5228049|NCT02575352|Bone defect|bone defect
5228050|NCT02575352|Revision arthroplasty|revision arthroplasty
5228051|NCT02575352|Arthrodesis|arthrodesis
5228052|NCT02575339|MLN0128|mln0128
5228053|NCT02575339|Sapanisertib|sapanisertib
5228054|NCT02575339|TORC1/2 inhibitor|torc1/2 inhibitor
5228055|NCT02575339|INK128|ink128
5228056|NCT02575339|Nexavar|nexavar
5228057|NCT02575339|Sorafenib|sorafenib
5228058|NCT02575326|Asthma, Body Mass Idex, BMI, Overweight, Obesity|asthma, body mass idex, bmi, overweight, obesity
5228059|NCT02575313|L-Glutamine|l-glutamine
5228060|NCT02575313|chemotherapy|chemotherapy
5228061|NCT02575313|radiotherapy|radiotherapy
5228062|NCT02575313|therapeutic toxicity|therapeutic toxicity
5228063|NCT02575300|neuroendocrine tumors (NETs)|neuroendocrine tumors (nets)
5228065|NCT02575300|pancreatic NETs|pancreatic nets
5228066|NCT02575300|gastrointestinal (GI) tract NET|gastrointestinal (gi) tract net
5228067|NCT02575300|advanced carcinoid tumors|advanced carcinoid tumors
5228068|NCT02575274|Peri-implantitis|peri-implantitis
5228069|NCT02575274|Peri-implant disease|peri-implant disease
5228070|NCT02575274|Dental implants|dental implants
5228071|NCT02575274|Guided bone regeneration|guided bone regeneration
5228072|NCT02575261|CAR-T cell immunotherapy|car-t cell immunotherapy
5228073|NCT02575261|EphA2|epha2
5228074|NCT02575261|malignant glioma|malignant glioma
5228075|NCT02575248|dienogest|dienogest
5228076|NCT02575248|infertility|infertility
5228077|NCT02575248|endometriosis|endometriosis
5228078|NCT02575235|Sarcopenia|sarcopenia
5228079|NCT02575235|Cetylpyridinium chloride|cetylpyridinium chloride
5228080|NCT02575222|Immunotherapy|immunotherapy
5228081|NCT02575222|PD-1|pd-1
5228082|NCT02575222|anti-PD-1|anti-pd-1
5228083|NCT02575222|antibody|antibody
5228084|NCT02575222|Kidney Cancer|kidney cancer
5228085|NCT02575222|RCC|rcc
5228086|NCT02575222|non-metastatic|non-metastatic
5228087|NCT02575196|Cardiac arrest|cardiac arrest
5228088|NCT02575196|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5228089|NCT02575196|CPR|cpr
5319476|NCT02087501|AAA|aaa
5228090|NCT02575196|cerebral blood flow|cerebral blood flow
5228091|NCT02575196|cerebral perfusion|cerebral perfusion
5228092|NCT02575183|Waterpipe smoking|waterpipe smoking
5228093|NCT02575183|Nicotine dependence|nicotine dependence
5228094|NCT02575183|Smoking cessation|smoking cessation
5228095|NCT02575183|Varinecline, Chantix therapy|varinecline, chantix therapy
5228096|NCT02575183|Behavioral therapy|behavioral therapy
5228097|NCT02575170|amino acid|amino acid
5228098|NCT02575170|cesarean delivery|cesarean delivery
5228099|NCT02575170|hypothermia|hypothermia
5228100|NCT02575131|satiety|satiety
5228101|NCT02575131|overweight|overweight
5228102|NCT02575131|breakfast|breakfast
5962717|NCT04279158|Healthy Volunteers|healthy volunteers
5216114|NCT02645513|case management|case management
5216115|NCT02645500|Physical Activity|physical activity
5216116|NCT02645500|Family well-being|family well-being
5216128|NCT02645370|Migraine|migraine
5228103|NCT02575131|ecological validity|ecological validity
5228104|NCT02575105|Bispectral Index Hydrocephalus|bispectral index hydrocephalus
5228105|NCT02575092|Hyperhomocysteinemia|hyperhomocysteinemia
5228106|NCT02575092|Coronary angiography|coronary angiography
5228107|NCT02575092|Percutaneous coronary intervention|percutaneous coronary intervention
5228108|NCT02575092|Hypertension|hypertension
5228109|NCT02575092|Contrast-induced nephropathy|contrast-induced nephropathy
5228110|NCT02575066|pazopanib|pazopanib
5228111|NCT02575066|radiotherapy|radiotherapy
5228112|NCT02575053|latex allergy|latex allergy
5228113|NCT02575053|latex hypersensitivity|latex hypersensitivity
5228114|NCT02575053|powder free latex surgical gloves|powder free latex surgical gloves
5228115|NCT02575053|latex safe protocol|latex safe protocol
5228116|NCT02575001|Type 1 diabetes|type 1 diabetes
5228117|NCT02575001|Children and adolescents|children and adolescents
5228118|NCT02575001|Stress|stress
5228119|NCT02575001|Genetic factors|genetic factors
5228120|NCT02575001|Psychological background|psychological background
5228121|NCT02574988|drug allergy|drug allergy
5228122|NCT02574988|drug hypersensitivity|drug hypersensitivity
5228123|NCT02574988|adverse drug reactions|adverse drug reactions
5228124|NCT02574988|severe cutaneous adverse reactions|severe cutaneous adverse reactions
5228125|NCT02574949|radiation|radiation
5228126|NCT02574949|fluoroscopy|fluoroscopy
5228127|NCT02574949|diagnostic|diagnostic
5228128|NCT02574936|karydakis modification|karydakis modification
5228129|NCT02574936|pilonidal sinus|pilonidal sinus
5228130|NCT02574936|complication|complication
5228131|NCT02574923|Cerebral Palsy|cerebral palsy
5228132|NCT02574923|Stem Cells|stem cells
5228133|NCT02574871|Stress|stress
5228134|NCT02574871|Chronic stress|chronic stress
5228135|NCT02574871|Perceived stress|perceived stress
5228136|NCT02574871|Psychological distress|psychological distress
5228137|NCT02574832|Pain|pain
5228138|NCT02574832|Surgery|surgery
5228139|NCT02574832|Pregnancy|pregnancy
5228140|NCT02574832|Anesthesia|anesthesia
5228141|NCT02574819|opioid-induced constipation|opioid-induced constipation
5228143|NCT02574806|Reference values|reference values
5228144|NCT02574806|Newborn|newborn
5228145|NCT02574806|Ventricular function|ventricular function
5228146|NCT02574806|Stress|stress
5228147|NCT02574806|Pediatrics|pediatrics
5228148|NCT02574806|Biomarkers|biomarkers
5228149|NCT02574793|Glucose Fluctuation|glucose fluctuation
5228150|NCT02574793|GH-Secreting Adenoma|gh-secreting adenoma
5228151|NCT02574793|Cushing Syndrome|cushing syndrome
5228152|NCT02574780|lymphedema|lymphedema
5228153|NCT02574780|complex physical therapy|complex physical therapy
5228154|NCT02574780|muscle strength|muscle strength
5228155|NCT02574767|Weight gain, Fatty Acids, Omega-3|weight gain, fatty acids, omega-3
5228156|NCT02574754|warfarin|warfarin
5228157|NCT02574754|pharmacokinetics|pharmacokinetics
5228159|NCT02574754|healthy volunteer|healthy volunteer
5228160|NCT02574728|Pediatrics|pediatrics
5228161|NCT02574728|Brain Tumors|brain tumors
5228162|NCT02574728|Neuroblastoma|neuroblastoma
5228163|NCT02574728|Osteosarcoma|osteosarcoma
5228164|NCT02574728|Ewing's Sarcoma|ewing's sarcoma
5228165|NCT02574728|Rhabdomyosarcoma|rhabdomyosarcoma
5228166|NCT02574728|Wilms Tumors|wilms tumors
5228167|NCT02574728|Soft Tissue Sarcomas|soft tissue sarcomas
5228168|NCT02574702|superficial surgical site infection|superficial surgical site infection
5228169|NCT02574702|loop ileostomy|loop ileostomy
5228170|NCT02574702|Ileostomy closure|ileostomy closure
5228171|NCT02574689|Physical Activity|physical activity
5228172|NCT02574689|Cancer Prevention|cancer prevention
5228173|NCT02574637|MEDI2070|medi2070
5228174|NCT02574637|inflammatory bowel disease|inflammatory bowel disease
5228175|NCT02574637|moderate to severe Crohn's Disease|moderate to severe crohn's disease
5228176|NCT02574637|IL-23|il-23
5228177|NCT02574598|PDL1|pdl1
5228178|NCT02574598|monoclonal antibody|monoclonal antibody
5228179|NCT02574585|Spinal cord injury|spinal cord injury
5228180|NCT02574585|Paraplegia|paraplegia
5228181|NCT02574585|Stem cells|stem cells
5228182|NCT02574585|Mesenchymal cells|mesenchymal cells
5228183|NCT02574572|Spinal cord injury|spinal cord injury
5228184|NCT02574572|Mesenchymal cells|mesenchymal cells
5228185|NCT02574572|Stem cells|stem cells
5228186|NCT02574559|Caregiver|caregiver
5228187|NCT02574559|Stress|stress
5228188|NCT02574559|Depression|depression
5228189|NCT02574559|Autism Spectrum Disorder|autism spectrum disorder
5228190|NCT02574559|Compassion Meditation|compassion meditation
5228191|NCT02574546|Mastectomy|mastectomy
5228192|NCT02574533|Immunotherapy|immunotherapy
5228193|NCT02574533|PD-1 inhibitor|pd-1 inhibitor
5216214|NCT02644889|NSCLC|nsclc
5216215|NCT02644876|Postoperative pulmonary complications|postoperative pulmonary complications
5216216|NCT02644876|Selective anticholinergic bronchodilator|selective anticholinergic bronchodilator
5216217|NCT02644876|High risk patients|high risk patients
5216218|NCT02644876|Postoperative period|postoperative period
5216219|NCT02644876|Postoperative complications|postoperative complications
5228194|NCT02574533|Keytruda|keytruda
5228195|NCT02574533|checkpoint inhibitor|checkpoint inhibitor
5228196|NCT02574533|vaccine|vaccine
5228197|NCT02574533|FANG|fang
5228198|NCT02574533|Vigil|vigil
5228199|NCT02574520|Post-operative pain|post-operative pain
5228200|NCT02574520|opioid|opioid
5228201|NCT02574520|opioid reduction|opioid reduction
5228202|NCT02574520|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5228203|NCT02574520|laparoscopic surgery|laparoscopic surgery
5228204|NCT02574520|bupivacaine|bupivacaine
5228205|NCT02574520|extended release|extended release
5228206|NCT02574520|locally acting analgesic|locally acting analgesic
5228207|NCT02574507|breast cancer|breast cancer
5228208|NCT02574507|weight management|weight management
5228209|NCT02574507|couples|couples
5228210|NCT02574507|symptom management|symptom management
5228211|NCT02574481|atherosclerosis|atherosclerosis
5228212|NCT02574481|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
5228213|NCT02574481|Proximal Popliteal Artery (PPA)|proximal popliteal artery (ppa)
5228214|NCT02574481|lower extremities|lower extremities
5228215|NCT02574481|stenting|stenting
5228216|NCT02574481|paclitaxel|paclitaxel
5228217|NCT02574468|Dexamethasone|dexamethasone
5228218|NCT02574468|Direct pulp capping|direct pulp capping
5228220|NCT02574468|pulpotomy|pulpotomy
5228221|NCT02574442|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5228222|NCT02574442|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5228223|NCT02574442|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5228224|NCT02574442|adenocarcinoma in situ|adenocarcinoma in situ
5228225|NCT02574429|Borderline Personality Disorder|borderline personality disorder
5228226|NCT02574429|Posttraumatic Stress Disorder|posttraumatic stress disorder
5228227|NCT02574429|Cognitive Processing Therapy|cognitive processing therapy
5228228|NCT02574429|Group Therapy|group therapy
5228229|NCT02574429|Comorbidity|comorbidity
5228230|NCT02574429|Dialectical Behavior Therapy|dialectical behavior therapy
5228231|NCT02574416|Health behaviour|health behaviour
5228232|NCT02574416|Health outcomes|health outcomes
5228233|NCT02574416|Diet quality|diet quality
5228234|NCT02574416|Physical function|physical function
5228235|NCT02574416|Lifestyle|lifestyle
5228236|NCT02574416|Older adults|older adults
5228237|NCT02574403|atypical hemolytic uremic syndrome (aHUS)|atypical hemolytic uremic syndrome (ahus)
5228238|NCT02574403|eculizumab discontinuation|eculizumab discontinuation
5228240|NCT02574390|stem cell|stem cell
5228241|NCT02574390|biomarker|biomarker
5228242|NCT02574390|disease progression|disease progression
5228243|NCT02574364|abdomen CT|abdomen ct
5228244|NCT02574364|open appendicectomy|open appendicectomy
5228245|NCT02574312|Mechanical Axis Alignment|mechanical axis alignment
5228246|NCT02574312|Knee Arthroplasty, Total|knee arthroplasty, total
5228247|NCT02574299|dyslexia|dyslexia
5225563|NCT02589847|C diff|c diff
5228248|NCT02574299|training|training
5228249|NCT02574299|auditory rehabilitation|auditory rehabilitation
5228250|NCT02574299|hearing loss|hearing loss
5228251|NCT02574299|evoked potentials|evoked potentials
5228252|NCT02574299|dichotic|dichotic
5228253|NCT02574299|plasticity|plasticity
5228254|NCT02574299|noise|noise
5228255|NCT02574247|Audiology|audiology
5228256|NCT02574247|Auditory Pathways|auditory pathways
5228257|NCT02574247|Auditory Perception|auditory perception
5228258|NCT02574247|Brain Stem|brain stem
5228259|NCT02574247|Cochlea|cochlea
5228260|NCT02574247|Ear, Inner|ear, inner
5228261|NCT02574247|Efferent Pathways|efferent pathways
5228262|NCT02574247|Hair Cells, Auditory, Outer|hair cells, auditory, outer
5228263|NCT02574247|Learning|learning
5228264|NCT02574247|Neurons, Efferent|neurons, efferent
5228265|NCT02574247|Speech Perception|speech perception
5228266|NCT02574234|Postoperative cognitive disorders POCD|postoperative cognitive disorders pocd
5228267|NCT02574234|inflammation|inflammation
5228268|NCT02574234|Surgery|surgery
5228269|NCT02574208|Adult outpatients|adult outpatients
5228270|NCT02574208|Paris, France|paris, france
5228271|NCT02574195|Diabetes Mellitus|diabetes mellitus
5228272|NCT02574195|microvascular complications|microvascular complications
5228273|NCT02574195|macrovascular complications|macrovascular complications
5228274|NCT02574195|epidemiology|epidemiology
5228275|NCT02574195|Russia|russia
5228276|NCT02574182|Mild Cognitive Impairment|mild cognitive impairment
5216308|NCT02644265|Functional magnetic resonance imaging|functional magnetic resonance imaging
5216309|NCT02644265|Electroencephalography|electroencephalography
5216310|NCT02644174|Obesity|obesity
5216313|NCT02644161|stroke|stroke
5228277|NCT02574182|Magnetic Resonance Imaging|magnetic resonance imaging
5228278|NCT02574169|Alveolar Recruitment Maneuvers (ARM)|alveolar recruitment maneuvers (arm)
5228279|NCT02574169|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5228280|NCT02574169|Extended Sigh (eSigh)|extended sigh (esigh)
5228281|NCT02574143|Prognosis|prognosis
5228282|NCT02574143|Prospective Study|prospective study
5228283|NCT02574143|Quality of Life|quality of life
5228284|NCT02574143|Radiology|radiology
5228285|NCT02574143|Rehabilitation|rehabilitation
5228286|NCT02574143|Registry;|registry;
5228287|NCT02574143|Signs and Symptoms|signs and symptoms
5228288|NCT02574143|Therapy|therapy
5228289|NCT02574143|Bronchiectiasis|bronchiectiasis
5228290|NCT02574143|Diagnosis|diagnosis
5107274|NCT03327363|eCRF|ecrf
5228291|NCT02574143|Epidemiology|epidemiology
5228292|NCT02574143|Etiology|etiology
5228293|NCT02574143|Longitudinal Study|longitudinal study
5228294|NCT02574143|Microbiology|microbiology
5228295|NCT02574104|Intensive Care Units, Neonatal|intensive care units, neonatal
5228296|NCT02574104|Patient simulation|patient simulation
5228297|NCT02574104|Interdisciplinary Communication|interdisciplinary communication
5228298|NCT02574104|Human factors|human factors
5228402|NCT02573662|Metabolic complications|metabolic complications
5228299|NCT02574104|Hazard Analysis and Critical Control Points|hazard analysis and critical control points
5228300|NCT02574091|EGFR inhibitor|egfr inhibitor
5228301|NCT02574091|topical agent|topical agent
5228302|NCT02574091|psoriasis|psoriasis
5228303|NCT02574091|phase 1|phase 1
5228304|NCT02574065|crying|crying
5228305|NCT02574065|colicky|colicky
5228306|NCT02574065|infants|infants
5228307|NCT02574065|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
5228308|NCT02574052|Menu Labelling;|menu labelling;
5228309|NCT02574052|Nutrition Education;|nutrition education;
5228310|NCT02574052|dietary assessment tools;|dietary assessment tools;
5228311|NCT02574039|volunteers|volunteers
5228312|NCT02574039|oat|oat
5228313|NCT02574039|phenolic acid|phenolic acid
5228314|NCT02574039|bioavailability|bioavailability
5228315|NCT02574026|MEG|meg
5228316|NCT02574026|EEG|eeg
5228317|NCT02574026|MRI|mri
5228318|NCT02574026|Brain mapping|brain mapping
5228319|NCT02574026|functional imaging|functional imaging
5228320|NCT02574026|brain computer interface|brain computer interface
5228321|NCT02573974|undernutrition|undernutrition
5234217|NCT02538978|CLI|cli
5228322|NCT02573974|gastrointestinal cancer|gastrointestinal cancer
5228324|NCT02573974|energy metabolism|energy metabolism
5228325|NCT02573948|People who inject drugs|people who inject drugs
5228326|NCT02573948|Vietnam|vietnam
5228327|NCT02573948|Community support groups|community support groups
5228328|NCT02573935|Multiple Myeloma|multiple myeloma
5228329|NCT02573935|Clarithromycin|clarithromycin
5228330|NCT02573935|Induction Chemotherapy|induction chemotherapy
5228331|NCT02573935|Transplantation, Autologous|transplantation, autologous
5228332|NCT02573922|constipation|constipation
5228333|NCT02573922|opioid|opioid
5228334|NCT02573922|Oxycodone|oxycodone
5228335|NCT02573922|Oxycodone-naloxone|oxycodone-naloxone
5228336|NCT02573922|spine surgery|spine surgery
5228337|NCT02573896|relapsed refractory neuroblastoma|relapsed refractory neuroblastoma
5228338|NCT02573883|Vulva|vulva
5228339|NCT02573883|Lichen Sclerosus|lichen sclerosus
5228340|NCT02573883|Fractionated Carbon Dioxide Laser|fractionated carbon dioxide laser
5228341|NCT02573883|Mona Lisa Laser|mona lisa laser
5228342|NCT02573883|Clobetasol Proprionate|clobetasol proprionate
5228343|NCT02573883|Vulvodynia|vulvodynia
5228345|NCT02573870|DPI|dpi
5228346|NCT02573870|Batefenterol|batefenterol
5228347|NCT02573870|Fluticasone Furoate|fluticasone furoate
5228348|NCT02573857|Induced blood stage malaria|induced blood stage malaria
5228349|NCT02573857|Transmission|transmission
5228350|NCT02573857|Gametocytemia|gametocytemia
5228351|NCT02573844|irritable bowel syndrome|irritable bowel syndrome
5228352|NCT02573844|abdominal pain|abdominal pain
5228353|NCT02573844|rome III criteria|rome iii criteria
5228354|NCT02573844|abdominal distension|abdominal distension
5228355|NCT02573844|consistency of stools|consistency of stools
5228356|NCT02573844|stool frequency|stool frequency
5228357|NCT02573844|meteorism|meteorism
5228358|NCT02573844|flatulence|flatulence
5228359|NCT02573844|abdominal discomfort|abdominal discomfort
5228360|NCT02573844|proklama|proklama
5228361|NCT02573844|probiotics|probiotics
5228362|NCT02573844|alga klamath|alga klamath
5228363|NCT02573844|aphanizomenon flos-aquae|aphanizomenon flos-aquae
5228364|NCT02573844|prebiotics|prebiotics
5228365|NCT02573844|colitis ulcerosa|colitis ulcerosa
5228367|NCT02573831|pain|pain
5228368|NCT02573831|oxycodone|oxycodone
5228369|NCT02573831|placenta|placenta
5228370|NCT02573818|sedation for EGD and colonoscopy procedures|sedation for egd and colonoscopy procedures
5228371|NCT02573805|nocturnal penile tumescence and rigidity|nocturnal penile tumescence and rigidity
5228372|NCT02573805|erectile dysfunction|erectile dysfunction
5228373|NCT02573805|Chinese males|chinese males
5228374|NCT02573792|First onset of optical neuritis|first onset of optical neuritis
5228375|NCT02573779|human milk|human milk
5228376|NCT02573779|enteral nutrition|enteral nutrition
5228377|NCT02573779|microbiome|microbiome
5228378|NCT02573779|Microbiota|microbiota
5228379|NCT02573766|Neurofeedback training|neurofeedback training
5228380|NCT02573766|EEG|eeg
5228381|NCT02573766|electroencephalograph|electroencephalograph
5962718|NCT04279158|Perceptual Disorders|perceptual disorders
5228382|NCT02573766|Questionnaires|questionnaires
5228383|NCT02573766|Surveys|surveys
5228384|NCT02573766|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
5228388|NCT02573714|Ketamine|ketamine
5228389|NCT02573714|Intranasal|intranasal
5228390|NCT02573714|Pain crisis|pain crisis
5228391|NCT02573714|Vasoocclusive Pain|vasoocclusive pain
5228392|NCT02573714|Sickle cell disease|sickle cell disease
5228393|NCT02573701|Schizophrenia|schizophrenia
5228394|NCT02573701|Adolescents|adolescents
5228395|NCT02573701|Treatment|treatment
5228396|NCT02573701|Guidelines|guidelines
5228400|NCT02573675|hemodialysis|hemodialysis
5228401|NCT02573675|peritoneal dialysis|peritoneal dialysis
5228403|NCT02573662|Type 2 diabetes|type 2 diabetes
5228404|NCT02573662|Sedentary lifestyle|sedentary lifestyle
5228405|NCT02573662|Low grade inflammation|low grade inflammation
5228406|NCT02573662|Lipid metabolism|lipid metabolism
5228407|NCT02573662|Glucose metabolism|glucose metabolism
5228408|NCT02573662|Bone metabolism|bone metabolism
5228409|NCT02573662|Physical inactivity|physical inactivity
5228410|NCT02573623|Immunology diagnosis test|immunology diagnosis test
5228411|NCT02573623|Children|children
5228412|NCT02573623|Zambia|zambia
5228413|NCT02573571|single nucleotide polymorphisms|single nucleotide polymorphisms
5228414|NCT02573571|cytokines|cytokines
5228415|NCT02573571|microbiome|microbiome
5228416|NCT02573545|liver|liver
5228417|NCT02573532|myocardial ischemia/diagnosis|myocardial ischemia/diagnosis
5228418|NCT02573532|myocardial ischemia/epidemiology|myocardial ischemia/epidemiology
5228419|NCT02573532|perioperative|perioperative
5228420|NCT02573532|perioperative complications/diagnosis|perioperative complications/diagnosis
5228421|NCT02573532|prognosis|prognosis
5228422|NCT02573519|11C Donepezil PET/CT scan|11c donepezil pet/ct scan
5228423|NCT02573519|3D-Transit|3d-transit
5228424|NCT02573519|Diabetes Mellitus|diabetes mellitus
5228425|NCT02573519|Gastrointestinal motility disorder|gastrointestinal motility disorder
5228426|NCT02573519|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
5228427|NCT02573506|Non-small cell lung cancer|non-small cell lung cancer
5228428|NCT02573506|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5228429|NCT02573480|youth violence, intervention, emergency medicine|youth violence, intervention, emergency medicine
5228430|NCT02573467|sporadic inclusion body myositis,|sporadic inclusion body myositis,
5228432|NCT02573467|extension study,|extension study,
5228433|NCT02573467|BYM338,|bym338,
5228434|NCT02573467|bimagrumab,|bimagrumab,
5228435|NCT02573428|Autism Spectrum Disorder|autism spectrum disorder
5228436|NCT02573428|Eye Gaze|eye gaze
5228437|NCT02573428|Remote Eye Gaze Tracking|remote eye gaze tracking
5228438|NCT02573428|Autism|autism
5121898|NCT03233672|IMRT|imrt
5228439|NCT02573402|electric stimulation|electric stimulation
5228440|NCT02573402|urodynamic study|urodynamic study
5228441|NCT02573389|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy|pancreatic fistula, pancreatectomy, endoscopic stenting, pancreatic stenting, distal pancreatectomy
5228442|NCT02573376|HIV|hiv
5228443|NCT02573376|Hepatitis C|hepatitis c
5228444|NCT02573376|Drug Abuse|drug abuse
5228445|NCT02573376|Hepatitis C Virus|hepatitis c virus
5228446|NCT02573376|sofosbuvir|sofosbuvir
5228447|NCT02573376|ledipasvir|ledipasvir
5228448|NCT02573376|pharmacology|pharmacology
5228450|NCT02573324|Newly Diagnosed Glioblastoma|newly diagnosed glioblastoma
5228451|NCT02573324|Epithelial Growth Factor Receptor (EGFR)|epithelial growth factor receptor (egfr)
5228453|NCT02573324|ABT-414|abt-414
5228454|NCT02573324|Radiology Therapy Oncology Group|radiology therapy oncology group
5228455|NCT02573324|Antibody Drug Conjugate|antibody drug conjugate
5228456|NCT02573324|Brain Tumor|brain tumor
5228457|NCT02573324|Brain Tumor Group|brain tumor group
5228458|NCT02573324|EGFRvIII|egfrviii
5228459|NCT02573324|EGFR Amplified|egfr amplified
5228460|NCT02573324|First Line Therapy|first line therapy
5228461|NCT02573324|Brain Cancer|brain cancer
5228462|NCT02573298|cryotherapy|cryotherapy
5228463|NCT02573298|power Doppler score|power doppler score
5228464|NCT02573298|synovial fluid cytokines|synovial fluid cytokines
5228465|NCT02573298|pain VAS|pain vas
5228466|NCT02573259|efficacy|efficacy
5228467|NCT02573259|safety|safety
5228468|NCT02573259|pharmacokinetics|pharmacokinetics
5216499|NCT02643134|EPVL|epvl
5216500|NCT02643134|PDI(Percussion,Diuresis,Inversion)|pdi(percussion,diuresis,inversion)
5216501|NCT02643134|Randomized Controlled Trial(RCT)|randomized controlled trial(rct)
5216502|NCT02643108|Lateral episiotomy|lateral episiotomy
5216504|NCT02643108|Vacuum extraction|vacuum extraction
5228469|NCT02573259|pharmacodynamics|pharmacodynamics
5228470|NCT02573259|open label|open label
5228471|NCT02573259|dose response|dose response
5228472|NCT02573259|multiple ascending dose|multiple ascending dose
5228473|NCT02573259|immunogenicity|immunogenicity
5228474|NCT02573259|recommended phase 2 dose|recommended phase 2 dose
5228475|NCT02573259|subcutaneous|subcutaneous
5228476|NCT02573246|neurostimulation|neurostimulation
5228477|NCT02573246|cognitive restructuring|cognitive restructuring
5228478|NCT02573246|TMS|tms
5228479|NCT02573246|emotion regulation|emotion regulation
5228480|NCT02573246|MRI|mri
5228488|NCT02573168|Pharmacogenomic Testing|pharmacogenomic testing
5228489|NCT02573168|Pharmacogenomics|pharmacogenomics
5228490|NCT02573168|Genetic Testing|genetic testing
5228491|NCT02573168|Genetics|genetics
5228492|NCT02573168|GeneSight|genesight
5228493|NCT02573168|Enhanced GeneSight|enhanced genesight
5228494|NCT02573168|Psychotropic|psychotropic
5228495|NCT02573155|Pharmacokinetics|pharmacokinetics
5962719|NCT04279106|Morning bad breath|morning bad breath
5228496|NCT02573155|Pharmacodynamics|pharmacodynamics
5228498|NCT02573155|Safety|safety
5228499|NCT02573155|Tolerability|tolerability
5229193|NCT02569138|Balance|balance
5228500|NCT02573155|mild persistent asthma|mild persistent asthma
5228501|NCT02573155|moderate to severe COPD|moderate to severe copd
5228502|NCT02573142|obesity|obesity
5228503|NCT02573142|treatment|treatment
5228504|NCT02573142|community|community
5228505|NCT02573142|integrated|integrated
5228506|NCT02573129|cardiovascular disease risk|cardiovascular disease risk
5228507|NCT02573129|Mediterranean diet|mediterranean diet
5228508|NCT02573129|red meat|red meat
5228509|NCT02573116|obstructive sleep apnea|obstructive sleep apnea
5228510|NCT02573116|endothelial dysfunction|endothelial dysfunction
5228511|NCT02573116|periodontitis|periodontitis
5228512|NCT02573090|Occlusal caries|occlusal caries
5228513|NCT02573090|Resin based fissure sealant|resin based fissure sealant
5228514|NCT02573090|Composite resin restoration|composite resin restoration
5228515|NCT02573090|Effectiveness|effectiveness
5228516|NCT02573090|Longevity|longevity
5228517|NCT02573077|Hyponatremia due to SIADH|hyponatremia due to siadh
5228518|NCT02573077|Cancer|cancer
5228519|NCT02573038|Aflibercept|aflibercept
5228520|NCT02573038|choroidal neovascularization|choroidal neovascularization
5228521|NCT02573038|angioid streaks|angioid streaks
5228522|NCT02573038|young patient|young patient
5228523|NCT02572999|Aged|aged
5228524|NCT02572999|Frail|frail
5228525|NCT02572999|Functional decline|functional decline
5228526|NCT02572999|Impairment|impairment
5228527|NCT02572999|valvular heart disease|valvular heart disease
5228528|NCT02572999|Cohort|cohort
5228529|NCT02572999|risk factors|risk factors
5228530|NCT02572947|Dolutegravir|dolutegravir
5228531|NCT02572947|HIV infection|hiv infection
5228532|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents
5228533|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors
5228534|NCT02572947|Integrase Inhibitors|integrase inhibitors
5228535|NCT02572947|Pharmacologic Actions|pharmacologic actions
5228536|NCT02572947|Therapeutic Uses|therapeutic uses
5228537|NCT02572934|Testicular cancer|testicular cancer
5228538|NCT02572934|Survivorship|survivorship
5228539|NCT02572934|late adverse treatment effects|late adverse treatment effects
5228540|NCT02572921|Positive Psychotherapy|positive psychotherapy
5228541|NCT02572921|Depression|depression
5228542|NCT02572921|Happiness|happiness
5228543|NCT02572908|wheat, IBS, gluten, ATI|wheat, ibs, gluten, ati
5228544|NCT02572895|Cranberry|cranberry
5228545|NCT02572895|Proanthocyanidins|proanthocyanidins
5228546|NCT02572895|Urinary catabolites|urinary catabolites
5228547|NCT02572882|hemodialysis|hemodialysis
5228548|NCT02572882|p-inulin|p-inulin
5228549|NCT02572882|gut microbiome|gut microbiome
5228550|NCT02572869|Mandible Reconstruction|mandible reconstruction
5228551|NCT02572869|Fibula Osteomyocutaneous Free Flaps|fibula osteomyocutaneous free flaps
5228554|NCT02572856|Feasibility|feasibility
5228555|NCT02572856|continuous glucose monitor|continuous glucose monitor
5228556|NCT02572856|surgery|surgery
5228557|NCT02572843|NSCLC|nsclc
5228558|NCT02572843|lung cancer|lung cancer
5228559|NCT02572843|MEDI4736|medi4736
5228560|NCT02572843|non-small cell lung cancer|non-small cell lung cancer
5228561|NCT02572843|immunotherapy|immunotherapy
5228562|NCT02572843|anti-PD-L1|anti-pd-l1
5228563|NCT02572830|Reconsolidation|reconsolidation
5216597|NCT02642471|surgery|surgery
5228564|NCT02572830|EMDR|emdr
5228565|NCT02572830|PTSD|ptsd
5228566|NCT02572817|Anti-Influenza Immune Plasma|anti-influenza immune plasma
5228567|NCT02572804|bladder cancer-cystectomy|bladder cancer-cystectomy
5228568|NCT02572804|rectus sheath catheter|rectus sheath catheter
5228569|NCT02572804|epidural|epidural
5228570|NCT02572713|Parkinson's Disease|parkinson's disease
5228571|NCT02572713|alpha-synuclein|alpha-synuclein
5228572|NCT02572713|biomarker|biomarker
5228580|NCT02572674|Bipolar disorder|bipolar disorder
5228581|NCT02572674|relapse risk factors|relapse risk factors
5320054|NCT02084563|MDS|mds
5228582|NCT02572674|prospective follow up|prospective follow up
5228583|NCT02572661|Radiotherapy, Sentinel Node Mapping, Spect|radiotherapy, sentinel node mapping, spect
5228584|NCT02572648|Cardiomyopathy|cardiomyopathy
5228585|NCT02572648|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5228586|NCT02572635|Pneumococcal Infection|pneumococcal infection
5228587|NCT02572635|Phase I|phase i
5228588|NCT02572635|Immunogenicity|immunogenicity
5228589|NCT02572635|Safety|safety
5228590|NCT02572635|Vaccination|vaccination
5228591|NCT02572622|exercise|exercise
5228592|NCT02572622|deep friction massage|deep friction massage
5228593|NCT02572622|spinal decompression|spinal decompression
5228594|NCT02572622|non-surgical spinal decompression|non-surgical spinal decompression
5228595|NCT02572596|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5228596|NCT02572596|Thrombopoietin|thrombopoietin
5228597|NCT02572583|Reconciling Exterior and Interior Therapy|reconciling exterior and interior therapy
5228598|NCT02572583|Influenza|influenza
5228599|NCT02572570|Adult dental care|adult dental care
5228600|NCT02572557|Spray Cryotherapy|spray cryotherapy
5962720|NCT04279106|Halitosis|halitosis
5228601|NCT02572544|young healthy adults|young healthy adults
5228602|NCT02572544|single pinhole glasses|single pinhole glasses
5228603|NCT02572544|multiple pinhole glasses|multiple pinhole glasses
5228604|NCT02572531|Lactobacillus reuteri|lactobacillus reuteri
5228605|NCT02572531|Wound Healing|wound healing
5228606|NCT02572531|Third Molar|third molar
5228607|NCT02572531|Postoperative Complications|postoperative complications
5228608|NCT02572518|immunity yellow fever vaccine|immunity yellow fever vaccine
5228609|NCT02572505|HIV-Discordant|hiv-discordant
5228610|NCT02572505|Preexposure Prophylaxis|preexposure prophylaxis
5228611|NCT02572492|Multiple Myeloma|multiple myeloma
5228612|NCT02572492|Recurrence|recurrence
5228613|NCT02572492|Carfilzomib|carfilzomib
5228614|NCT02572492|Salvage Therapy|salvage therapy
5228615|NCT02572492|Transplantation, Autologous|transplantation, autologous
5228616|NCT02572479|fatty acids, amyotrophic lateral sclerosis, nutrient status|fatty acids, amyotrophic lateral sclerosis, nutrient status
5228617|NCT02572466|high-sensitive troponin-I|high-sensitive troponin-i
5228618|NCT02572466|End-stage renal disease|end-stage renal disease
5228619|NCT02572466|hemodialysis|hemodialysis
5228620|NCT02572440|Aortic arch surgery; Blood conservation; aPRP|aortic arch surgery; blood conservation; aprp
5228621|NCT02572401|Human immunodeficiency virus|human immunodeficiency virus
5228622|NCT02572401|Sexually transmitted disease|sexually transmitted disease
5228623|NCT02572401|Behavioral intervention|behavioral intervention
5228624|NCT02572401|Randomized controlled trial|randomized controlled trial
5228625|NCT02572401|Text messages|text messages
5228626|NCT02572401|Social cognitive theory|social cognitive theory
5228627|NCT02572401|Theory of planned behavior|theory of planned behavior
5228628|NCT02572401|Sexual behavior|sexual behavior
5228629|NCT02572401|African Americans|african americans
5228630|NCT02572401|Men|men
5228631|NCT02572349|Healthy Subjects|healthy subjects
5228632|NCT02572310|total knee arthroplasty|total knee arthroplasty
5228633|NCT02572297|epilepsy|epilepsy
5228634|NCT02572297|SUDEP|sudep
5228635|NCT02572297|SpO2|spo2
5228636|NCT02572284|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5228637|NCT02572284|High Risk Prostate Cancer|high risk prostate cancer
5228638|NCT02572284|Preoperative SBRT|preoperative sbrt
5228639|NCT02572284|Prostate Adenocarcinoma|prostate adenocarcinoma
5228640|NCT02572284|Prostatectomy|prostatectomy
5228641|NCT02572284|Quality of Life|quality of life
5228642|NCT02572271|Autologous augmentation|autologous augmentation
5228643|NCT02572271|Mastopexy|mastopexy
5228644|NCT02572271|Massive weight loss|massive weight loss
5228645|NCT02572245|Healthy Subjects|healthy subjects
5228646|NCT02572245|Device|device
5228647|NCT02572245|PK|pk
5228648|NCT02572245|Phase 1|phase 1
5228649|NCT02572245|Bioequivalence|bioequivalence
5228650|NCT02572245|Adalimumab|adalimumab
5228652|NCT02572193|achalasia|achalasia
5228653|NCT02572193|surgery|surgery
5228654|NCT02572167|Monomethyl auristatin E|monomethyl auristatin e
5228655|NCT02572167|Antigens, CD30|antigens, cd30
5228656|NCT02572167|Antibody-Drug Conjugate|antibody-drug conjugate
5228657|NCT02572167|Antibodies, Monoclonal|antibodies, monoclonal
5228658|NCT02572167|Immunotherapy|immunotherapy
5228659|NCT02572167|Autologous stem cell transplant|autologous stem cell transplant
5228660|NCT02572115|After-Hours Care|after-hours care
5216696|NCT02641756|phylogenetic analysis|phylogenetic analysis
5216697|NCT02641756|sequencing|sequencing
5216698|NCT02641730|Guselkumab|guselkumab
5216699|NCT02641730|CNTO 1959|cnto 1959
5216700|NCT02641730|Placebo|placebo
5228661|NCT02572115|Primary Care|primary care
5228662|NCT02572115|Emergency Medical Services/utilization|emergency medical services/utilization
5228663|NCT02572115|Denmark|denmark
5228664|NCT02572115|Questionnaires|questionnaires
5228665|NCT02572115|Patient Satisfaction|patient satisfaction
5228666|NCT02572115|Patient feeling of safety|patient feeling of safety
5228667|NCT02572115|Triage/standards|triage/standards
5228668|NCT02572115|Referral and Consultation/statistics & numerical data|referral and consultation/statistics & numerical data
5228669|NCT02572115|Humans|humans
5228670|NCT02572115|Male|male
5228671|NCT02572115|Female|female
5228672|NCT02572115|Hotlines|hotlines
5228673|NCT02572115|telenursing|telenursing
5228674|NCT02572115|Night Care/utilization|night care/utilization
5228675|NCT02572115|postal service|postal service
5228676|NCT02572102|ECG|ecg
5228677|NCT02572102|Blood Pressure|blood pressure
5228678|NCT02572102|Energy Drinks|energy drinks
5228679|NCT02572102|Panax Ginseng|panax ginseng
5228680|NCT02572037|Premature ejaculation|premature ejaculation
5228681|NCT02572037|Dapoxetine|dapoxetine
5228682|NCT02572037|local anaesthetics|local anaesthetics
5228683|NCT02572037|nerve electrophysiology|nerve electrophysiology
5228684|NCT02572011|Lower limb amputation|lower limb amputation
5228685|NCT02572011|Transtibial|transtibial
5228686|NCT02572011|Balance|balance
5228687|NCT02572011|Postural Control|postural control
5228688|NCT02572011|Limits of Stability|limits of stability
5228689|NCT02572011|Rehabilitation|rehabilitation
5228690|NCT02572011|Home-based intervention|home-based intervention
5228691|NCT02572011|Nintendo Wii|nintendo wii
5228692|NCT02572011|Balance Board|balance board
5107692|NCT03324984|Pain|pain
5228693|NCT02571985|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
5228694|NCT02571985|iliac aneurysm|iliac aneurysm
5228695|NCT02571985|branch|branch
5228696|NCT02571985|connections|connections
5229194|NCT02569138|Footwear|footwear
5228697|NCT02571985|endovascular graft|endovascular graft
5228698|NCT02571985|graft-iliac bifurcation|graft-iliac bifurcation
5228699|NCT02571985|Aneurysm|aneurysm
5228700|NCT02571985|Vascular Diseases|vascular diseases
5228701|NCT02571985|Cardiovascular Diseases|cardiovascular diseases
5228702|NCT02571972|dorzolamide-timolol|dorzolamide-timolol
5228703|NCT02571972|topical aqueous suppression|topical aqueous suppression
5228704|NCT02571972|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5228705|NCT02571972|macular edema|macular edema
5228706|NCT02571972|intravitreal injection|intravitreal injection
5228707|NCT02571972|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5228708|NCT02571959|Obesity|obesity
5228709|NCT02571959|Pharmacology|pharmacology
5228710|NCT02571959|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
5228711|NCT02571933|Pediatrics|pediatrics
5228712|NCT02571933|Pain Scale|pain scale
5228713|NCT02571933|Faces Pain Scale - Revised|faces pain scale - revised
5228714|NCT02571933|Cameroon|cameroon
5228715|NCT02571920|cardiac surgery|cardiac surgery
5228716|NCT02571920|cardiac output|cardiac output
5228717|NCT02571907|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
5228718|NCT02571907|Iliac aneurysm|iliac aneurysm
5228719|NCT02571907|Branch|branch
5228720|NCT02571907|Connections|connections
5228721|NCT02571907|Endovascular graft|endovascular graft
5228722|NCT02571907|Graft-iliac bifurcation|graft-iliac bifurcation
5228723|NCT02571907|Aneurysm|aneurysm
5228724|NCT02571907|Vascular Diseases|vascular diseases
5228725|NCT02571907|Cardiovascular Diseases|cardiovascular diseases
5228726|NCT02571881|constipation|constipation
5228727|NCT02571881|oxycodone|oxycodone
5228728|NCT02571881|caesarean section|caesarean section
5228729|NCT02571855|insomnia|insomnia
5228730|NCT02571855|Pharmacokinetics|pharmacokinetics
5228731|NCT02571855|Safety|safety
5228732|NCT02571855|Pharmacodynamics|pharmacodynamics
5228733|NCT02571855|Healthy|healthy
5228734|NCT02571842|Recurrent IgA nephropathy|recurrent iga nephropathy
5228735|NCT02571842|Rituximab|rituximab
5228736|NCT02571829|Liposarcoma|liposarcoma
5228737|NCT02571829|Soft tissue sarcoma|soft tissue sarcoma
5228738|NCT02571829|CDK4|cdk4
5228739|NCT02571829|CDK6|cdk6
5228740|NCT02571829|LEE011|lee011
5228741|NCT02571829|ribociclib|ribociclib
5228742|NCT02571816|Hepatic Impairment|hepatic impairment
5228743|NCT02571816|Mild Hepatic Impairment|mild hepatic impairment
5228744|NCT02571816|Healthy|healthy
5228745|NCT02571816|ASP2215|asp2215
5228746|NCT02571816|Moderate Hepatic Impairment|moderate hepatic impairment
5228747|NCT02571803|coronary artery disease|coronary artery disease
5216797|NCT02641197|cardiovascular diseases|cardiovascular diseases
5216798|NCT02641184|Myocardial Infarction|myocardial infarction
5216799|NCT02641184|Cardiovascular Diseases|cardiovascular diseases
5216801|NCT02641184|Infarction|infarction
5228748|NCT02571803|atherosclerosis|atherosclerosis
5228749|NCT02571803|DASH diet|dash diet
5228750|NCT02571790|Patient with Generalized Anxiety Disorders|patient with generalized anxiety disorders
5228751|NCT02571777|Asthma|asthma
5228752|NCT02571725|Ovarian cancer|ovarian cancer
5228753|NCT02571725|Fallopian tube cancer|fallopian tube cancer
5228754|NCT02571725|Peritoneal cancer|peritoneal cancer
5228755|NCT02571725|PARP|parp
5228756|NCT02571725|BRCA|brca
5228757|NCT02571725|Immunotherapy|immunotherapy
5228758|NCT02571725|Olaparib|olaparib
5228759|NCT02571725|Tremelimumab|tremelimumab
5228760|NCT02571725|CTLA4|ctla4
5228761|NCT02571673|Survivorship|survivorship
5228762|NCT02571673|Quality of Life|quality of life
5228763|NCT02571673|HN-STAR web-based|hn-star web-based
5228764|NCT02571673|15-245|15-245
5228765|NCT02571660|vitamin d levels|vitamin d levels
5228766|NCT02571660|exacerbation of asthma|exacerbation of asthma
5228767|NCT02571660|asthma control|asthma control
5228768|NCT02571634|intranasal fentanyl|intranasal fentanyl
5228769|NCT02571634|conscious sedation|conscious sedation
5228770|NCT02571608|Type 2 diabetes mellitus, Metformin, peri-operative|type 2 diabetes mellitus, metformin, peri-operative
5228771|NCT02571595|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
5342989|NCT01981278|Bioequivalence|bioequivalence
5228772|NCT02571595|digital cognitive behavioural therapy for insomnia (dCBT-I)|digital cognitive behavioural therapy for insomnia (dcbt-i)
5228773|NCT02571595|insomnia|insomnia
5228774|NCT02571595|cognitive Impairment|cognitive impairment
5228775|NCT02571595|concentration|concentration
5228776|NCT02571595|productivity|productivity
5228777|NCT02571582|Predictors of mortality|predictors of mortality
5228778|NCT02571543|Ibuprofen|ibuprofen
5228780|NCT02571543|minimal stimulation|minimal stimulation
5228781|NCT02571543|modified natural-cycle|modified natural-cycle
5228782|NCT02571543|nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
5962721|NCT04279106|OralChroma|oralchroma
5962722|NCT04279106|mouthwash|mouthwash
5107861|NCT03323879|LDR|ldr
5228783|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal/therapeutic use|anti-inflammatory agents, non-steroidal/therapeutic use
5228784|NCT02571543|Oocyte Retrieval|oocyte retrieval
5228785|NCT02571543|Ovarian Follicle/drug effects|ovarian follicle/drug effects
5228786|NCT02571517|Respiratory viral infection.|respiratory viral infection.
5228787|NCT02571517|Respiratory syncytial virus bronchiolitis|respiratory syncytial virus bronchiolitis
5228788|NCT02571517|METHYLPREDNISOLONE SODIUM SUCCINATE|methylprednisolone sodium succinate
5228789|NCT02571504|HIV - Human Immunodeficiency Virus|hiv - human immunodeficiency virus
5228790|NCT02571504|Memory|memory
5228791|NCT02571504|Concentration|concentration
5228792|NCT02571478|Military Couples|military couples
5228793|NCT02571478|Marriage|marriage
5228794|NCT02571478|Primary Care|primary care
5228795|NCT02571478|Marriage Intervention|marriage intervention
5228796|NCT02571478|Air Force|air force
5228797|NCT02571465|functional hemodynamic parameter|functional hemodynamic parameter
5228798|NCT02571465|passive leg raising|passive leg raising
5228799|NCT02571465|stroke volume variation|stroke volume variation
5228800|NCT02571465|pulse pressure variation|pulse pressure variation
5228801|NCT02571452|Veteran|veteran
5228802|NCT02571452|Insomnia|insomnia
5228803|NCT02571452|Primary Healthcare|primary healthcare
5228804|NCT02571439|TAP block, post-cesarean analgesia|tap block, post-cesarean analgesia
5228805|NCT02571413|animated cartoon-aided teaching|animated cartoon-aided teaching
5228806|NCT02571413|oral presentation|oral presentation
5228807|NCT02571413|allergic rhinitis|allergic rhinitis
5228808|NCT02571413|intranasal corticosteroid|intranasal corticosteroid
5228809|NCT02571413|how to use intranasal corticosteroid|how to use intranasal corticosteroid
5228810|NCT02571400|Risk|risk
5228811|NCT02571400|Opioid analgesics|opioid analgesics
5228812|NCT02571400|Opioid-related disorders|opioid-related disorders
5228813|NCT02571400|Surgery|surgery
5228814|NCT02571400|Post-operative care|post-operative care
5228815|NCT02571400|Post-operative period|post-operative period
5228816|NCT02571400|Post-operative complications|post-operative complications
5228817|NCT02571400|Opioid Use disorders|opioid use disorders
5228818|NCT02571400|Pain, post-operative|pain, post-operative
5228819|NCT02571400|Opiate Addiction|opiate addiction
5228820|NCT02571387|Motivation|motivation
5228821|NCT02571387|Impulsive eating|impulsive eating
5228822|NCT02571387|Mindfulness|mindfulness
5228823|NCT02571387|Self-help|self-help
5228824|NCT02571387|Physical activity|physical activity
5228825|NCT02571387|Weight-loss|weight-loss
5228826|NCT02571374|symbiotic|symbiotic
5228827|NCT02571374|colorectal cancer|colorectal cancer
5228828|NCT02571361|Acetaminophen|acetaminophen
5228829|NCT02571361|Ibuprofen|ibuprofen
5216893|NCT02640664|open-label, long-term, extension study|open-label, long-term, extension study
5216897|NCT02640664|preterm infants|preterm infants
5228830|NCT02571361|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5228831|NCT02571309|Self-management|self-management
5228833|NCT02571309|Patient education|patient education
5228834|NCT02571309|Health literacy|health literacy
5228835|NCT02571309|Health-related quality of life|health-related quality of life
5228836|NCT02571309|Asthma control|asthma control
5228837|NCT02571309|Adherence|adherence
5228838|NCT02571296|Preterm Birth|preterm birth
5228839|NCT02571296|Oral Micronized Progesterone|oral micronized progesterone
5228840|NCT02571283|Total Knee Arthroplasty|total knee arthroplasty
5228841|NCT02571283|Total Knee Replacement|total knee replacement
5228842|NCT02571283|Exparel|exparel
5228843|NCT02571283|Cocktail Injection|cocktail injection
5228844|NCT02571283|Pain Management|pain management
5228845|NCT02571270|Exercise|exercise
5228846|NCT02571270|quality of life|quality of life
5228847|NCT02571270|healthy|healthy
5228848|NCT02571270|cardiac remodeling|cardiac remodeling
5228849|NCT02571257|LDL-C|ldl-c
5228850|NCT02571257|Lipid Regulator|lipid regulator
5228851|NCT02571244|Tobacco Use Disorder|tobacco use disorder
5228852|NCT02571244|Hospitalized patients|hospitalized patients
5228853|NCT02571244|Text message|text message
5228854|NCT02571244|Motivational Interview|motivational interview
5228855|NCT02571244|Substance-Related Disorders|substance-related disorders
5228856|NCT02571244|Behaviors and Mental Disorders|behaviors and mental disorders
5228857|NCT02571218|atrial fibrillation|atrial fibrillation
5228858|NCT02571218|mapping|mapping
5228859|NCT02571218|substrate|substrate
5228860|NCT02571218|ablation|ablation
5228861|NCT02571205|testosterone|testosterone
5228862|NCT02571205|pubertal delay|pubertal delay
5228863|NCT02571192|ADME|adme
5228864|NCT02571179|Labor pain|labor pain
5228865|NCT02571179|Fentanyl|fentanyl
5228866|NCT02571179|Transmucosal|transmucosal
5228867|NCT02571153|Intravenous anesthesia|intravenous anesthesia
5228868|NCT02571153|Postoperative nausea vomiting|postoperative nausea vomiting
5228870|NCT02571153|Patient satisfaction|patient satisfaction
5228871|NCT02571153|Quality of health care|quality of health care
5228872|NCT02571153|Ketamine|ketamine
5228873|NCT02571114|Glycemic Responses|glycemic responses
5228874|NCT02571114|Metabolic Responses|metabolic responses
5228875|NCT02571114|Males|males
5962723|NCT04279093|digital screening|digital screening
5107908|NCT03323619|Delirium|delirium
5228876|NCT02571114|Females|females
5228877|NCT02571101|Clomipramine|clomipramine
5228878|NCT02571101|Premature ejaculation|premature ejaculation
5228879|NCT02571101|CDFR0812|cdfr0812
5228880|NCT02571101|Sildenafil|sildenafil
5228881|NCT02571088|Sickle Cell Hemoglobin C Disease|sickle cell hemoglobin c disease
5228882|NCT02571088|Sports Training|sports training
5228883|NCT02571088|Hemoglobin S Disease|hemoglobin s disease
5228884|NCT02571088|Lactate|lactate
5228885|NCT02571075|auricular|auricular
5228886|NCT02571075|acupuncture|acupuncture
5228887|NCT02571075|pain|pain
5228888|NCT02571062|bioequivalence|bioequivalence
5228889|NCT02571036|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
5228890|NCT02571036|systemic mastocytosis (SM)|systemic mastocytosis (sm)
5228891|NCT02571036|PDGFR-alpha|pdgfr-alpha
5228893|NCT02571036|mast cell leukemia (MCL)|mast cell leukemia (mcl)
5228894|NCT02571036|mast cell disease (MCD)|mast cell disease (mcd)
5228895|NCT02571036|DCC-2618|dcc-2618
5228896|NCT02571036|melanoma|melanoma
5228897|NCT02571036|aggressive systemic mastocytosis (ASM)|aggressive systemic mastocytosis (asm)
5228898|NCT02571036|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
5228899|NCT02571036|germ cell tumors|germ cell tumors
5228900|NCT02571036|penile cancer|penile cancer
5228901|NCT02571036|non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5228902|NCT02571036|renal impairment|renal impairment
5228903|NCT02571036|malignant gliomas|malignant gliomas
5228904|NCT02571023|Skull Base Trauma|skull base trauma
5228905|NCT02571023|microscope surgery|microscope surgery
5228906|NCT02571023|neuroendoscope surgery|neuroendoscope surgery
5228907|NCT02571010|static mechanical allodynia|static mechanical allodynia
5228908|NCT02571010|somatosensory rehabilitation|somatosensory rehabilitation
5228909|NCT02571010|vibrotactile stimulation|vibrotactile stimulation
5228910|NCT02570997|Alzheimer's Disease|alzheimer's disease
5228911|NCT02570997|Mild Cognitive Impairment|mild cognitive impairment
5228912|NCT02570971|mannitol|mannitol
5228913|NCT02570971|treatment|treatment
5228914|NCT02570958|robotic surgery|robotic surgery
5228915|NCT02570958|indocyanine green|indocyanine green
5228916|NCT02570958|electromagnetic navigational bronchoscopy|electromagnetic navigational bronchoscopy
5228917|NCT02570932|Adult Autologous Bone Marrow Mesenchymal Cells Expanded|adult autologous bone marrow mesenchymal cells expanded
5228918|NCT02570932|chronic spinal cord injury (SCI)|chronic spinal cord injury (sci)
5228919|NCT02570919|Prostate cancer|prostate cancer
5228920|NCT02570919|IGRT|igrt
5228921|NCT02570919|Hypofractionation|hypofractionation
5216994|NCT02640196|Double Lumen Tube|double lumen tube
5216995|NCT02640157|interferon free|interferon free
5216996|NCT02640157|Hepatitis C|hepatitis c
5216997|NCT02640157|daclatasvir|daclatasvir
5216998|NCT02640157|Sovaldi|sovaldi
5216999|NCT02640157|HCV|hcv
5217000|NCT02640157|Hepatitis C Virus|hepatitis c virus
5217001|NCT02640157|Hepatitis C Genotype 3|hepatitis c genotype 3
5217035|NCT02639923|TBI|tbi
5228922|NCT02570919|Extreme|extreme
5228923|NCT02570919|Single Fraction|single fraction
5228924|NCT02570919|Urethral Sparing|urethral sparing
5228926|NCT02570893|Esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy|esophageal cancer;adjuvant therapy;chemotherapy;radiotherapy
5228928|NCT02570867|brain function|brain function
5228929|NCT02570867|fMRI|fmri
5228931|NCT02570841|Heat pain threshold|heat pain threshold
5228932|NCT02570841|Cold pain threshold|cold pain threshold
5228933|NCT02570841|Mechanical pain threshold|mechanical pain threshold
5228934|NCT02570841|High dose Capsaicin|high dose capsaicin
5228935|NCT02570828|healthy neonate, tachypnea, thermal imaging, pneumonia|healthy neonate, tachypnea, thermal imaging, pneumonia
5228936|NCT02570815|lung cancer|lung cancer
5228937|NCT02570815|segmentectomy|segmentectomy
5228938|NCT02570815|robotic surgery|robotic surgery
5228939|NCT02570815|near-infrared fluorescent|near-infrared fluorescent
5228940|NCT02570815|IC-GREEN|ic-green
5228941|NCT02570815|indocyanine green|indocyanine green
5228942|NCT02570815|early-stage lung cancer|early-stage lung cancer
5228943|NCT02570776|Helicobacter pylori|helicobacter pylori
5228944|NCT02570776|UBT|ubt
5228945|NCT02570776|Sensitivity|sensitivity
5228946|NCT02570776|specificity|specificity
5228947|NCT02570776|prevalence|prevalence
5228948|NCT02570763|neurostimulation|neurostimulation
5228949|NCT02570763|comorbidity|comorbidity
5228950|NCT02570763|tDCS|tdcs
5228951|NCT02570763|CBT|cbt
5228952|NCT02570763|anxiety|anxiety
5228953|NCT02570763|alcohol|alcohol
5228954|NCT02570711|Acalabrutinib|acalabrutinib
5228955|NCT02570685|Gratitude Intervention|gratitude intervention
5228956|NCT02570685|positive emotion|positive emotion
5962724|NCT04279093|mental health|mental health
5228957|NCT02570685|friendships|friendships
5228958|NCT02570685|positive psychology|positive psychology
5228959|NCT02570685|life satisfaction|life satisfaction
5228960|NCT02570659|WAD|wad
5228961|NCT02570659|Whiplash|whiplash
5228962|NCT02570659|Information Video|information video
5228963|NCT02570633|Migraine|migraine
5228964|NCT02570633|Ginger|ginger
5228965|NCT02570633|Prophylactic treatment|prophylactic treatment
5108049|NCT03322917|PRP|prp
5228966|NCT02570594|Cognition|cognition
5228967|NCT02570594|Autobiographical|autobiographical
5228968|NCT02570594|memoryCognitive|memorycognitive
5228969|NCT02570594|remediation|remediation
5228970|NCT02570581|volonteeres|volonteeres
5228971|NCT02570568|Venepuncture|venepuncture
5228972|NCT02570568|Transillumination|transillumination
5228973|NCT02570555|driving|driving
5228974|NCT02570542|CD34+ Cell Dose|cd34+ cell dose
5228975|NCT02570542|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5228976|NCT02570542|15-193|15-193
5228977|NCT02570529|Pancreatic cancer|pancreatic cancer
5228978|NCT02570529|Chemoradiotherapy|chemoradiotherapy
5228979|NCT02570529|Gastrointestinal toxicity|gastrointestinal toxicity
5228980|NCT02570529|Albis|albis
5228981|NCT02570516|Indigo carmine chromoendoscopy|indigo carmine chromoendoscopy
5228982|NCT02570516|Narrow band imaging|narrow band imaging
5228983|NCT02570516|Colonoscopy|colonoscopy
5228984|NCT02570490|fusidic acid|fusidic acid
5228985|NCT02570490|skin infection|skin infection
5228986|NCT02570451|cognitive impairment|cognitive impairment
5228987|NCT02570451|post surgical outcomes|post surgical outcomes
5228988|NCT02570451|elective joint replacement surgery|elective joint replacement surgery
5228989|NCT02570438|postoperative outcomes|postoperative outcomes
5228990|NCT02570438|older surgical patients|older surgical patients
5228991|NCT02570386|In-vitro fertilization|in-vitro fertilization
5228992|NCT02570386|frozen thawed embryo transfer|frozen thawed embryo transfer
5228993|NCT02570386|fresh embryo transfer|fresh embryo transfer
5228995|NCT02570373|Guselkumab|guselkumab
5228996|NCT02570347|Snake Envenomation|snake envenomation
5228997|NCT02570347|Antibiotic Prophylaxis|antibiotic prophylaxis
5228998|NCT02570347|Viperidae|viperidae
5228999|NCT02570334|early ART|early art
5229000|NCT02570334|neurocognitive evaluation|neurocognitive evaluation
5229001|NCT02570321|Cornea|cornea
5229002|NCT02570321|Ulcer|ulcer
5229003|NCT02570321|Infectious keratitis|infectious keratitis
5229004|NCT02570321|Bacterial|bacterial
5229005|NCT02570321|Fungal|fungal
5229006|NCT02570295|Army|army
5229007|NCT02570295|Sport|sport
5229008|NCT02570295|Physical Fitness|physical fitness
5229009|NCT02570295|Injuries|injuries
5217093|NCT02639624|kidney|kidney
5217094|NCT02639624|dialysis|dialysis
5217095|NCT02639611|Breast Expanders|breast expanders
5217096|NCT02639598|chronic migraine|chronic migraine
5217097|NCT02639598|prophylaxis|prophylaxis
5217098|NCT02639598|flunarizine|flunarizine
5217099|NCT02639598|topiramate|topiramate
5217100|NCT02639585|daclatasvir|daclatasvir
5229010|NCT02570295|Psychological Tests|psychological tests
5229011|NCT02570295|Attrition|attrition
5229012|NCT02570282|Female|female
5229013|NCT02570256|stroke|stroke
5229014|NCT02570256|upper extremity|upper extremity
5229015|NCT02570256|motor exploration|motor exploration
5229016|NCT02570256|error augmentation|error augmentation
5229017|NCT02570256|robotic rehabilitation|robotic rehabilitation
5229018|NCT02570243|heparin|heparin
5229019|NCT02570243|radial artery|radial artery
5229020|NCT02570230|Thoracotomy|thoracotomy
5229021|NCT02570230|Postoperative pain|postoperative pain
5229022|NCT02570230|Ketamine|ketamine
5229023|NCT02570217|NCPAP, High Flow Nasal Cannula, pretem infants, NICU|ncpap, high flow nasal cannula, pretem infants, nicu
5229024|NCT02570178|clinical trial|clinical trial
5229025|NCT02570178|accidental falls|accidental falls
5229026|NCT02570178|postural balance|postural balance
5229027|NCT02570178|elderly|elderly
5229028|NCT02570178|primary Health Care|primary health care
5229030|NCT02570165|dry powder inhaler|dry powder inhaler
5229031|NCT02570165|vilanterol|vilanterol
5229032|NCT02570165|batefenterol|batefenterol
5229033|NCT02570152|Dengue|dengue
5229034|NCT02570152|Non-laboratory confirmed dengue (non-LCD)|non-laboratory confirmed dengue (non-lcd)
5229035|NCT02570152|Acute febrile illness (AFI)|acute febrile illness (afi)
5229036|NCT02570152|Laboratory confirmed dengue (LCD)|laboratory confirmed dengue (lcd)
5229037|NCT02570126|Immunogenicity|immunogenicity
5229038|NCT02570126|Varicella|varicella
5229039|NCT02570126|Safety|safety
5229040|NCT02570126|Human serum albumin|human serum albumin
5229041|NCT02570126|Healthy children|healthy children
5229042|NCT02570126|12 to 23 months|12 to 23 months
5229043|NCT02570100|Cancer Stem Cells|cancer stem cells
5229044|NCT02570087|Coronary ChronicTotal Occlusion|coronary chronictotal occlusion
5229045|NCT02570087|Coronary Angioplasty|coronary angioplasty
5229046|NCT02570087|Reduced Ejection Fraction|reduced ejection fraction
5229047|NCT02570061|recruitment|recruitment
5229048|NCT02570061|comprehension|comprehension
5229049|NCT02570061|satisfaction|satisfaction
5229050|NCT02570061|informed consent|informed consent
5229051|NCT02570061|telephone|telephone
5229052|NCT02570035|Mirabegron|mirabegron
5229053|NCT02570035|Overactive Bladder|overactive bladder
5229054|NCT02570035|Cardiovascular Disease|cardiovascular disease
5229055|NCT02570022|Pain control|pain control
5229056|NCT02570022|liposomal bupivacaine|liposomal bupivacaine
5962725|NCT04279093|smartphone app|smartphone app
5229057|NCT02570022|exparel|exparel
5229058|NCT02570022|shoulder arthroplasty|shoulder arthroplasty
5229059|NCT02570009|couples|couples
5229060|NCT02570009|weight loss treatment|weight loss treatment
5229061|NCT02570009|home environment|home environment
5229062|NCT02569970|Epilepsy|epilepsy
5229063|NCT02569970|SUDEP|sudep
5229064|NCT02569970|fluoxetine|fluoxetine
5229067|NCT02569918|Neuroplasticity|neuroplasticity
5229068|NCT02569918|Sensory Feedback|sensory feedback
5229069|NCT02569918|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
5229070|NCT02569918|Robotic hand|robotic hand
5229071|NCT02569905|flurbiprofen|flurbiprofen
5229072|NCT02569905|Parecoxib sodium|parecoxib sodium
5229073|NCT02569905|Postoperative Shivering|postoperative shivering
5229074|NCT02569879|Boostrix™|boostrix™
5229076|NCT02569879|maternal vaccination|maternal vaccination
5229077|NCT02569879|Pertussis|pertussis
5229078|NCT02569879|Mortality|mortality
5229079|NCT02569879|Morbidity|morbidity
5229080|NCT02569866|plastic surgery|plastic surgery
5229081|NCT02569866|mammaplasty|mammaplasty
5229082|NCT02569866|wound infection|wound infection
5229083|NCT02569866|prophylaxis|prophylaxis
5229084|NCT02569827|Uncomplicated Dengue Fever|uncomplicated dengue fever
5229085|NCT02569827|Treatment|treatment
5229086|NCT02569827|Phase Ib/IIa|phase ib/iia
5229087|NCT02569827|single centre|single centre
5229088|NCT02569827|double-blind|double-blind
5229089|NCT02569827|placebo-controlled|placebo-controlled
5229090|NCT02569827|parallel-group dose ranging trial|parallel-group dose ranging trial
5229091|NCT02569827|Modipafant|modipafant
5229092|NCT02569827|Celgosivir|celgosivir
5229095|NCT02569775|Cerebral Palsy|cerebral palsy
5229096|NCT02569775|Stem Cells|stem cells
5229097|NCT02569762|Non-Nutritive Sweeteners|non-nutritive sweeteners
5229098|NCT02569762|Artificial Sweeteners|artificial sweeteners
5229099|NCT02569762|Glucose Metabolism|glucose metabolism
5229104|NCT02569645|Rosuvastatin|rosuvastatin
5229105|NCT02569632|Meningococcal Vaccines|meningococcal vaccines
5229106|NCT02569632|Neisseria Meningitidis|neisseria meningitidis
5229107|NCT02569632|Factor H-binding Protein|factor h-binding protein
5229108|NCT02569619|Physical Activity|physical activity
5229109|NCT02569619|Mental Health|mental health
5229110|NCT02569619|Physical Exercise|physical exercise
5229111|NCT02569619|Mental disorder|mental disorder
5229113|NCT02569606|consumption of blood|consumption of blood
5229114|NCT02569606|consumption of coagulation products|consumption of coagulation products
5229115|NCT02569606|coagulation algorithm|coagulation algorithm
5229116|NCT02569606|trauma related transfusion|trauma related transfusion
5229117|NCT02569580|anti-lice treatment|anti-lice treatment
5229118|NCT02569567|Smart-Shear Wave(SSW)|smart-shear wave(ssw)
5229119|NCT02569567|Transient Elastography(TE)|transient elastography(te)
5229120|NCT02569567|Liver cirrhosis|liver cirrhosis
5229121|NCT02569554|PF-06463922|pf-06463922
5229122|NCT02569554|rabeprazole|rabeprazole
5229123|NCT02569554|proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
5229124|NCT02569554|pharmacokinetics(PK)|pharmacokinetics(pk)
5229125|NCT02569554|food effect|food effect
5229126|NCT02569541|fusidic acid|fusidic acid
5229127|NCT02569541|prosthetic joint infections|prosthetic joint infections
5229128|NCT02569541|bone infections|bone infections
5229129|NCT02569541|osteomyelitis|osteomyelitis
5229130|NCT02569528|atrial fibrillation|atrial fibrillation
5229132|NCT02569476|BGB-3111|bgb-3111
5229133|NCT02569476|Obinutuzumab|obinutuzumab
5229134|NCT02569476|B-cell|b-cell
5229135|NCT02569476|Lymphoma|lymphoma
5229136|NCT02569476|Leukemia|leukemia
5229137|NCT02569476|Therapeutic uses|therapeutic uses
5229138|NCT02569450|Surgery|surgery
5229139|NCT02569450|Performance|performance
5229140|NCT02569450|Outcome|outcome
5229141|NCT02569450|Control chart|control chart
5229142|NCT02569437|doxycycline|doxycycline
5229143|NCT02569437|oral methylprednisone|oral methylprednisone
5229144|NCT02569437|sinusitis with nasal polyps|sinusitis with nasal polyps
5229145|NCT02569424|PEEP level|peep level
5229146|NCT02569424|Trendelenburg position|trendelenburg position
5229147|NCT02569424|cross-sectional area of the jugular and subclavian veins|cross-sectional area of the jugular and subclavian veins
5229148|NCT02569424|central venous catheter|central venous catheter
5229149|NCT02569398|Alzheimer disease|alzheimer disease
5229150|NCT02569398|Atabecestat|atabecestat
5229151|NCT02569398|Dementia|dementia
5229152|NCT02569385|Weaning TTE|weaning tte
5229153|NCT02569385|patients in prolonged weaning|patients in prolonged weaning
5229154|NCT02569346|Triumeq|triumeq
5229155|NCT02569346|Pharmacokinetics|pharmacokinetics
5229156|NCT02569346|Crushing|crushing
5229157|NCT02569346|Drip feed|drip feed
5229162|NCT02569307|At Risk of Mental State|at risk of mental state
5229169|NCT02569294|hypnosis|hypnosis
5229170|NCT02569294|cognitive-behavioral therapy|cognitive-behavioral therapy
5229171|NCT02569281|Subacromial pain syndrome|subacromial pain syndrome
5229172|NCT02569281|Eccentric exercise|eccentric exercise
5229173|NCT02569281|Pressure pain|pressure pain
5229174|NCT02569281|US-guided percutaneous electrolysis|us-guided percutaneous electrolysis
5229175|NCT02569268|Arteriosclerosis|arteriosclerosis
5229176|NCT02569268|Vascular function|vascular function
5229177|NCT02569268|Vascular disease early detection system|vascular disease early detection system
5229178|NCT02569229|children|children
5229179|NCT02569229|cystic fibrosis|cystic fibrosis
5229180|NCT02569229|glucose intolerance|glucose intolerance
5229181|NCT02569229|continuous glucose measurement|continuous glucose measurement
5229182|NCT02569216|Electrical Inhibition|electrical inhibition
5229183|NCT02569216|Preterm Birth|preterm birth
5229184|NCT02569216|Premature Birth|premature birth
5229185|NCT02569216|Preterm Labor|preterm labor
5229186|NCT02569216|Premature Labor|premature labor
5229187|NCT02569216|tocolytic|tocolytic
5229189|NCT02569177|myocardial infarction|myocardial infarction
5229190|NCT02569177|cardiac surgery|cardiac surgery
5229191|NCT02569177|troponin|troponin
5445367|NCT01522131|bioresorbable membrane|bioresorbable membrane
5229192|NCT02569177|heart-type fatty acid binding protein|heart-type fatty acid binding protein
5229195|NCT02569138|Shoes|shoes
5229196|NCT02569138|Falls|falls
5229197|NCT02569125|segmental overgrowth syndrome|segmental overgrowth syndrome
5229198|NCT02569099|stroke survivors|stroke survivors
5229199|NCT02569099|caregivers|caregivers
5229200|NCT02569099|burden of care|burden of care
5229201|NCT02569099|quality of life|quality of life
5229202|NCT02569099|function|function
5229203|NCT02569099|community reintegration|community reintegration
5229204|NCT02569099|caregiver training|caregiver training
5229205|NCT02569086|Sepsis|sepsis
5229206|NCT02569086|Therapeutic Drug Monitoring|therapeutic drug monitoring
5229207|NCT02569086|Beta-lactams|beta-lactams
5229208|NCT02569086|Pharmacokinetics|pharmacokinetics
5229209|NCT02569073|Functional Chest Pain|functional chest pain
5229210|NCT02569073|Non-Cardiac Chest Pain|non-cardiac chest pain
5229211|NCT02569073|Esophageal Hypersensitivity|esophageal hypersensitivity
5229212|NCT02569060|diabetes mellitus|diabetes mellitus
5229213|NCT02569060|community intervention|community intervention
5229214|NCT02569060|intervention|intervention
5229215|NCT02569060|randomized|randomized
5229216|NCT02569060|dietary intervention|dietary intervention
5229217|NCT02569060|self-management support|self-management support
5229218|NCT02569060|food bank|food bank
5229219|NCT02569047|Atraumatic Restorative Treatment|atraumatic restorative treatment
5229220|NCT02569047|Occlusoproximal|occlusoproximal
5229221|NCT02569047|Primary Teeth|primary teeth
5229222|NCT02569047|Glass Ionomer Cements|glass ionomer cements
5229223|NCT02569047|Hall Technique|hall technique
5229224|NCT02569021|Parkinsons Disease|parkinsons disease
5229225|NCT02569021|Essential Tremor|essential tremor
5229226|NCT02569021|DBS|dbs
5229227|NCT02569021|Depp Brain Stimulation|depp brain stimulation
5229228|NCT02569008|Fluid Challenge|fluid challenge
5229229|NCT02569008|Mean systemic filling pressure|mean systemic filling pressure
5229230|NCT02569008|Fluid therapy|fluid therapy
5229231|NCT02568995|postoperative pain|postoperative pain
5229232|NCT02568995|morphine|morphine
5229233|NCT02568995|total hip arthroplasty|total hip arthroplasty
5229234|NCT02568995|femoral nerve block|femoral nerve block
5229235|NCT02568982|Cushing's disease|cushing's disease
5229236|NCT02568982|Quality of life|quality of life
5229237|NCT02568982|Metabolic|metabolic
5229238|NCT02568982|patients with Cushing's disease|patients with cushing's disease
5229239|NCT02568982|cardiovascular|cardiovascular
5229240|NCT02568982|thromboembolic|thromboembolic
5229241|NCT02568982|bone complications|bone complications
5229242|NCT02568969|Cardiosurgery, lactate|cardiosurgery, lactate
5229245|NCT02568917|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5229247|NCT02568917|Primary Teeth|primary teeth
5229248|NCT02568917|Permanent Teeth|permanent teeth
5229249|NCT02568917|Clinical Effectiveness|clinical effectiveness
5229250|NCT02568917|Cost Analysis|cost analysis
5229251|NCT02568878|Depression|depression
5229252|NCT02568878|Anxiety|anxiety
5229253|NCT02568878|Methamphetamine dependence|methamphetamine dependence
5229254|NCT02568852|D-dimer|d-dimer
5229255|NCT02568852|Fibrinogen|fibrinogen
5229256|NCT02568852|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5229257|NCT02568839|Neoadjuvant therapy|neoadjuvant therapy
5229258|NCT02568826|Low Back Pain|low back pain
5229259|NCT02568826|Muscle relaxant|muscle relaxant
5229260|NCT02568813|epilepsy|epilepsy
5229261|NCT02568813|depression|depression
5229262|NCT02568813|mood disorder|mood disorder
5229263|NCT02568813|anxiety|anxiety
5229264|NCT02568813|cyclothymia|cyclothymia
5229265|NCT02568813|Behavioral neuropsychiatric features|behavioral neuropsychiatric features
5229266|NCT02568787|NAFLD|nafld
5229267|NCT02568787|cytokines|cytokines
5229268|NCT02568787|interleukin (IL)|interleukin (il)
5229269|NCT02568787|interferon (IFN)|interferon (ifn)
5229270|NCT02568787|liver function test (LFTS)|liver function test (lfts)
5229271|NCT02568787|nutrition|nutrition
5229272|NCT02568787|bran arabinoxylan compound (RBAC)|bran arabinoxylan compound (rbac)
5229273|NCT02568787|tumor necrosis factor -- type I receptor (TNF-RI)|tumor necrosis factor -- type i receptor (tnf-ri)
5229274|NCT02568787|TNF-RII (tumor necrosis factor -- type II receptor (TNF-RII)|tnf-rii (tumor necrosis factor -- type ii receptor (tnf-rii)
5229275|NCT02568774|Post-stroke|post-stroke
5229276|NCT02568761|Snoring|snoring
5229277|NCT02568761|Sleep apnea|sleep apnea
5229278|NCT02568761|Obstructive sleep apnea|obstructive sleep apnea
5229279|NCT02568761|Speech therapy|speech therapy
5229280|NCT02568761|Injection snoreplasty|injection snoreplasty
5229281|NCT02568761|Ethanol|ethanol
5229282|NCT02568761|Oropharyngeal exercises|oropharyngeal exercises
5229283|NCT02568735|Dexketoprofen|dexketoprofen
5229284|NCT02568735|Etoricoxib|etoricoxib
5229285|NCT02568735|hip arthroplasty|hip arthroplasty
5229286|NCT02568735|pain|pain
5229287|NCT02568722|Renal replacement therapy|renal replacement therapy
5229288|NCT02568722|Acute kidney injury|acute kidney injury
5229289|NCT02568722|Dialysis|dialysis
5229290|NCT02568722|Hemodialysis|hemodialysis
5229291|NCT02568722|Critical illness|critical illness
5229292|NCT02568709|Oxytocin|oxytocin
5229293|NCT02568709|Syntocinon|syntocinon
5229294|NCT02568709|Social Cognition|social cognition
5229295|NCT02568709|Schizophrenia|schizophrenia
5229296|NCT02568709|Magnetoencephalography (MEG)|magnetoencephalography (meg)
5229297|NCT02568696|kidney transplantation|kidney transplantation
5229298|NCT02568696|renal transplantation|renal transplantation
5229299|NCT02568696|fibrinolysis|fibrinolysis
5229300|NCT02568696|cell mediated rejection|cell mediated rejection
5229301|NCT02568696|coagulation|coagulation
5229302|NCT02568696|delayed graft function|delayed graft function
5229303|NCT02568696|Halloran criteria|halloran criteria
5229305|NCT02568696|thrombin generation|thrombin generation
5229306|NCT02568696|fibrin generation|fibrin generation
5229307|NCT02568683|DLBCL|dlbcl
5229308|NCT02568683|Relapsed|relapsed
5229309|NCT02568683|Refractory|refractory
5229310|NCT02568644|Migraine|migraine
5229311|NCT02568644|Ginger|ginger
5229312|NCT02568644|Acute treatment|acute treatment
5229313|NCT02568631|Autistic Disorder|autistic disorder
5229314|NCT02568618|Military|military
5229315|NCT02568618|Genomics|genomics
5229316|NCT02568618|Pain|pain
5229317|NCT02568605|Dietary intervention|dietary intervention
5229318|NCT02568605|Prebiotic fibre|prebiotic fibre
5229319|NCT02568605|Weight loss|weight loss
5229320|NCT02568605|Gut microbiota|gut microbiota
5229321|NCT02568605|Obesity|obesity
5229322|NCT02568605|Liver fat|liver fat
5229323|NCT02568605|Hepatic fibrosis|hepatic fibrosis
5229324|NCT02568540|Hepatitis C|hepatitis c
5229325|NCT02568540|Smartphone|smartphone
5229326|NCT02568540|app|app
5229327|NCT02568540|Tracker|tracker
5229328|NCT02568540|C Tracker|c tracker
5229329|NCT02568527|LSCD|lscd
5229330|NCT02568527|SLET|slet
5229331|NCT02568527|Donor Human Amniotic Membrane (hAM)|donor human amniotic membrane (ham)
5229332|NCT02568527|PLGA|plga
5229333|NCT02568514|mhealth|mhealth
5229334|NCT02568514|text messaging|text messaging
5229335|NCT02568514|secure text messaging|secure text messaging
5229336|NCT02568514|communication|communication
5229337|NCT02568501|diabetes|diabetes
5229338|NCT02568501|adolescent|adolescent
5229339|NCT02568501|young adult|young adult
5229340|NCT02568501|behavioral economics|behavioral economics
5229341|NCT02568501|financial incentives|financial incentives
5229342|NCT02568501|social incentives|social incentives
5423250|NCT01616472|hypertension|hypertension
5423251|NCT01616472|avascular necrosis|avascular necrosis
5229343|NCT02568475|nursing home residents, decision aid, acute care transfers|nursing home residents, decision aid, acute care transfers
5229344|NCT02568462|Stents|stents
5229345|NCT02568462|Angioplasty|angioplasty
5229346|NCT02568462|Coronary Vessels|coronary vessels
5229347|NCT02568462|Coronary Artery Disease|coronary artery disease
5229348|NCT02568462|Angina Pectoris|angina pectoris
5229349|NCT02568462|Myocardial Ischemia|myocardial ischemia
5229350|NCT02568462|Myocardial Infarction|myocardial infarction
5229351|NCT02568462|Myocardial Revascularization|myocardial revascularization
5229352|NCT02568410|Mast Cells|mast cells
5229353|NCT02568410|Blood Platelets|blood platelets
5229354|NCT02568410|cardiac surgical procedures|cardiac surgical procedures
5229355|NCT02568371|biobank|biobank
5229356|NCT02568371|DNA|dna
5229357|NCT02568371|genetic|genetic
5229358|NCT02568371|young adults|young adults
5229359|NCT02568371|cohort study|cohort study
5229360|NCT02568345|Dose-Response Relationship|dose-response relationship
5229361|NCT02568345|Drug|drug
5229362|NCT02568345|Obesity|obesity
5229363|NCT02568345|Cyclodextrins|cyclodextrins
5229364|NCT02568267|Entrectinib|entrectinib
5229365|NCT02568267|RXDX-101|rxdx-101
5229366|NCT02568267|TrkA|trka
5229367|NCT02568267|TrkB|trkb
5229368|NCT02568267|TrkC|trkc
5229369|NCT02568267|NTRK1|ntrk1
5229370|NCT02568267|NTRK2|ntrk2
5229371|NCT02568267|NTRK3|ntrk3
5229372|NCT02568267|ROS1|ros1
5229373|NCT02568267|ALK|alk
5229374|NCT02568267|Trk Fusions|trk fusions
5229375|NCT02568267|NTRK Gene Rearrangements|ntrk gene rearrangements
5229376|NCT02568267|ROS1 Fusions|ros1 fusions
5229377|NCT02568267|ROS1 Gene Rearrangements|ros1 gene rearrangements
5229378|NCT02568267|ALK Fusions|alk fusions
5229379|NCT02568267|ALK Gene Rearrangements|alk gene rearrangements
5229380|NCT02568267|Basket study|basket study
5229381|NCT02568267|Non-small cell lung cancer|non-small cell lung cancer
5229382|NCT02568267|Colorectal cancer|colorectal cancer
5962726|NCT04279093|postnatal depression|postnatal depression
5229383|NCT02568267|Salivary gland cancers|salivary gland cancers
5229384|NCT02568267|Primary brain tumors|primary brain tumors
5229385|NCT02568267|Melanoma|melanoma
5229386|NCT02568267|Sarcomas|sarcomas
5229387|NCT02568267|Papillary thyroid cancer|papillary thyroid cancer
5229388|NCT02568267|Renal cell cancer|renal cell cancer
5229389|NCT02568267|Pancreatic cancer|pancreatic cancer
5229390|NCT02568267|Breast cancer|breast cancer
5229391|NCT02568267|Cholangiocarcinoma|cholangiocarcinoma
5229392|NCT02568267|Head & Neck cancers|head & neck cancers
5229393|NCT02568267|Ovarian cancer|ovarian cancer
5229394|NCT02568267|Neuroendocrine tumors|neuroendocrine tumors
5229395|NCT02568267|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5123002|NCT03226535|CT|ct
5229396|NCT02568241|Interferon Alfa-2b|interferon alfa-2b
5229397|NCT02568241|Relapse|relapse
5229398|NCT02568241|Donor lymphocyte infusion|donor lymphocyte infusion
5229399|NCT02568228|Triacylglycerols|triacylglycerols
5229400|NCT02568228|Omega-3 fatty acids|omega-3 fatty acids
5229401|NCT02568228|Krill oil|krill oil
5229402|NCT02568228|Fish|fish
5229403|NCT02568228|Healthy Volunteers|healthy volunteers
5229405|NCT02568189|Sepsis|sepsis
5229406|NCT02568189|Gastroenteritis|gastroenteritis
5229407|NCT02568189|Dehydration|dehydration
5229408|NCT02568189|Ultrasound|ultrasound
5229409|NCT02568189|Ultrasonography|ultrasonography
5229410|NCT02568189|Inferior Vena Cava|inferior vena cava
5229411|NCT02568176|Healthy|healthy
5229412|NCT02568176|Pharmacokinetics|pharmacokinetics
5229413|NCT02568176|Esketamine|esketamine
5229414|NCT02568176|JNJ-54135419|jnj-54135419
5229415|NCT02568176|Midazolam|midazolam
5229416|NCT02568176|Bupropion|bupropion
5229417|NCT02568137|mobile health|mobile health
5229418|NCT02568137|Behavior change|behavior change
5229419|NCT02568137|Africa|africa
5229420|NCT02568124|Tranexamic acid|tranexamic acid
5229421|NCT02568124|Cyklokapron|cyklokapron
5229422|NCT02568124|Conservative management|conservative management
5229423|NCT02568124|Medical management|medical management
5229424|NCT02568111|erythema|erythema
5229425|NCT02568111|PLEGRIDY|plegridy
5229426|NCT02568111|injection site reaction (ISR)|injection site reaction (isr)
5229428|NCT02568111|RRMS|rrms
5229429|NCT02568098|Drug combination|drug combination
5229430|NCT02568098|Ivermectin|ivermectin
5229431|NCT02568098|Primaquine|primaquine
5229432|NCT02568098|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
5229433|NCT02568098|Albendazole|albendazole
5229434|NCT02568098|Pharmacokinetics|pharmacokinetics
5229435|NCT02568098|Mosquito-Lethal Effect|mosquito-lethal effect
5229436|NCT02568098|Healthy adult subject|healthy adult subject
5229437|NCT02568072|exercise|exercise
5229438|NCT02568072|cardiac remodelling|cardiac remodelling
5229439|NCT02568072|left ventricular non-compaction cardiomyopathy|left ventricular non-compaction cardiomyopathy
5229440|NCT02568046|Metastatic Colorectal Cancer|metastatic colorectal cancer
5229441|NCT02567981|chronic undernutrition|chronic undernutrition
5229442|NCT02567981|anemia|anemia
5229443|NCT02567981|micronutrient supplement|micronutrient supplement
5229444|NCT02567955|HPV vaccines, interchangeable use|hpv vaccines, interchangeable use
5229445|NCT02567877|hypothyroidism|hypothyroidism
5229446|NCT02567877|deiodinase polymorphism|deiodinase polymorphism
5229448|NCT02567877|thyroidectomy|thyroidectomy
5229449|NCT02567877|levothyroxine|levothyroxine
5229450|NCT02567851|Brentuximab Vedotin|brentuximab vedotin
5229453|NCT02567825|ear infection|ear infection
5229454|NCT02567825|antibiotics|antibiotics
5229455|NCT02567825|infants|infants
5229456|NCT02567825|children|children
5229457|NCT02567825|pediatrics|pediatrics
5229458|NCT02567825|tympanostomy tubes|tympanostomy tubes
5229459|NCT02567799|Lung Neoplasms|lung neoplasms
5229460|NCT02567773|Itraconazole|itraconazole
5229461|NCT02567773|GSK2881078|gsk2881078
5229462|NCT02567773|CYP3A4|cyp3a4
5342990|NCT01981278|Fasted|fasted
5229470|NCT02567747|Colombia|colombia
5229472|NCT02567747|Database|database
5229473|NCT02567747|pneumonia|pneumonia
5229474|NCT02567734|irreversible electroporation|irreversible electroporation
5229475|NCT02567734|ablation|ablation
5229476|NCT02567734|neoplasms|neoplasms
5229477|NCT02567734|cancer|cancer
5229478|NCT02567734|carcinoma|carcinoma
5229479|NCT02567734|NanoKnife|nanoknife
5229480|NCT02567734|Ablation Techniques|ablation techniques
5229481|NCT02567721|Post-authorisation safety study (PASS)|post-authorisation safety study (pass)
5229482|NCT02567721|Adverse Drug Reaction Reporting Systems|adverse drug reaction reporting systems
5229483|NCT02567721|Post marketing product surveillance|post marketing product surveillance
5229484|NCT02567721|European Medicines Agency (EMA)|european medicines agency (ema)
5229485|NCT02567721|Influenza Vaccine|influenza vaccine
5229486|NCT02567721|Computerized Medical Record System|computerized medical record system
5229487|NCT02567721|United Kingdom|united kingdom
5229488|NCT02567721|Primary Health Care|primary health care
5229489|NCT02567708|GSK2269557|gsk2269557
5229490|NCT02567708|Asthma|asthma
5229491|NCT02567708|Pharmacokinetics|pharmacokinetics
5229492|NCT02567708|Safety|safety
5229493|NCT02567708|Adults|adults
5229494|NCT02567708|DISKUS Dry Powder Inhaler|diskus dry powder inhaler
5108523|NCT03319576|Feeding|feeding
5229495|NCT02567708|Efficacy|efficacy
5229496|NCT02567682|anemia, sickle cell|anemia, sickle cell
5229497|NCT02567669|radiotherapy|radiotherapy
5229498|NCT02567656|CTCL|ctcl
5229499|NCT02567656|PTCL|ptcl
5229500|NCT02567656|RP6530|rp6530
5229501|NCT02567643|Brain|brain
5229502|NCT02567643|CNS|cns
5229503|NCT02567643|Metastases|metastases
5229504|NCT02567617|Polyphenols, Prostaglandin E2, hormonal contraceptives|polyphenols, prostaglandin e2, hormonal contraceptives
5229505|NCT02567591|pre liver transplantation patients|pre liver transplantation patients
5229506|NCT02567552|endometrial receptivity|endometrial receptivity
5229507|NCT02567552|endometrial predecidualization|endometrial predecidualization
5229508|NCT02567552|endometrial genomics|endometrial genomics
5229509|NCT02567552|endometrial receptivity array|endometrial receptivity array
5229510|NCT02567526|food and fluid intake|food and fluid intake
5229511|NCT02567526|nursing home residents|nursing home residents
5229512|NCT02567526|staffing|staffing
5229513|NCT02567513|food and fluid intake|food and fluid intake
5229514|NCT02567513|nursing homes|nursing homes
5229515|NCT02567500|emotional|emotional
5229516|NCT02567500|auditory hallucinations|auditory hallucinations
5229517|NCT02567500|non-psychotic children|non-psychotic children
5229518|NCT02567474|chronic lung disease|chronic lung disease
5229519|NCT02567461|dual antiplatelet therapy|dual antiplatelet therapy
5229520|NCT02567461|clopidogrel|clopidogrel
5229521|NCT02567461|aspirin|aspirin
5229522|NCT02567461|edoxaban|edoxaban
5229523|NCT02567448|Obstructive Sleep Apnea|obstructive sleep apnea
5229524|NCT02567448|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5229525|NCT02567448|Overlap syndrome|overlap syndrome
5229526|NCT02567448|Pcrit|pcrit
5229527|NCT02567448|Critical closing pressure|critical closing pressure
5229528|NCT02567383|head and neck cancer|head and neck cancer
5229529|NCT02567383|hyperthermia, Thermotron RF-8|hyperthermia, thermotron rf-8
5229530|NCT02567383|radiotherapy|radiotherapy
5229531|NCT02567370|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
5229540|NCT02567344|Cannabis|cannabis
5229541|NCT02567344|rTMS|rtms
5229542|NCT02567344|Craving|craving
5229543|NCT02567344|Decision making|decision making
5229544|NCT02567318|Pain|pain
5229545|NCT02567318|Secondary hyperalgesia|secondary hyperalgesia
5229546|NCT02567318|Healthy volunteers|healthy volunteers
5229547|NCT02567318|Magnetic Resonance Imaging|magnetic resonance imaging
5229548|NCT02567292|Digestive Disease and Disorders|digestive disease and disorders
5229549|NCT02567292|Neonatal|neonatal
5229550|NCT02567292|Pediatric Disorders|pediatric disorders
5229551|NCT02567253|Cytoreductive surgery|cytoreductive surgery
5229552|NCT02567253|(H)ipec|(h)ipec
5229553|NCT02567253|Ovarian cancer|ovarian cancer
5229554|NCT02567253|Cisplatin|cisplatin
5229555|NCT02567253|Peritoneal carcinomatosis|peritoneal carcinomatosis
5229556|NCT02567253|Pharmacokinetics|pharmacokinetics
5229557|NCT02567253|Pharmacodynamics|pharmacodynamics
5229566|NCT02567201|Voluntary attention|voluntary attention
5229567|NCT02567201|Electroencephalogram|electroencephalogram
5229568|NCT02567201|Brain-computer interface|brain-computer interface
5229569|NCT02567201|Disorders of consciousness|disorders of consciousness
5229570|NCT02567162|Intracerebral hemorrhage|intracerebral hemorrhage
5229571|NCT02567162|Hemorrhagic stroke|hemorrhagic stroke
5229572|NCT02567162|Intraparenchymal hemorrhage|intraparenchymal hemorrhage
5229573|NCT02567162|Cerebrovascular disease|cerebrovascular disease
5229575|NCT02567149|Wart|wart
5229576|NCT02567110|Mid-life Depression|mid-life depression
5229577|NCT02567110|Bipolar Disorder|bipolar disorder
5229578|NCT02567110|DSM-5 MDE|dsm-5 mde
5229579|NCT02567110|Inflammation|inflammation
5229580|NCT02567110|CNS Glutamate|cns glutamate
5229581|NCT02567084|Bone substitute|bone substitute
5229582|NCT02567084|benign bone cyst|benign bone cyst
5229583|NCT02567084|ceramic|ceramic
5229584|NCT02567084|remodelling|remodelling
5229585|NCT02567071|C-section|c-section
5229586|NCT02567071|Microbiota|microbiota
5229587|NCT02567058|Achilles tendon|achilles tendon
5229588|NCT02567045|Immunochemical fecal occult blood test|immunochemical fecal occult blood test
5229589|NCT02567045|Colonoscopy|colonoscopy
5229590|NCT02567045|Screening uptake|screening uptake
5229591|NCT02567045|Screening participation|screening participation
5229592|NCT02567045|Familiar risk|familiar risk
5229593|NCT02567045|Colorectal Cancer|colorectal cancer
5229602|NCT02567006|vaccines|vaccines
5229603|NCT02567006|reminders|reminders
5229604|NCT02567006|immunization timeliness|immunization timeliness
5229605|NCT02567006|vaccine coverage|vaccine coverage
5229606|NCT02566980|depression|depression
5229607|NCT02566980|mood disorder|mood disorder
5229608|NCT02566980|post-partum depression|post-partum depression
5229609|NCT02566980|suicidality|suicidality
5229610|NCT02566980|post-partum suicidality|post-partum suicidality
5229611|NCT02566980|perinatal depression|perinatal depression
5229612|NCT02566980|perinatal mood disorder|perinatal mood disorder
5229613|NCT02566980|inflammation|inflammation
5229614|NCT02566980|kynurenine pathway|kynurenine pathway
5962727|NCT04279093|maternal mental health|maternal mental health
5108625|NCT03319017|Hyperoxia|hyperoxia
5229615|NCT02566980|glutamate|glutamate
5229616|NCT02566954|radiology|radiology
5229617|NCT02566954|3D measurement|3d measurement
5229618|NCT02566954|lower limb|lower limb
5229619|NCT02566941|critical illness polyneuropathy|critical illness polyneuropathy
5229620|NCT02566941|critical illness myopathy|critical illness myopathy
5229621|NCT02566941|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5229622|NCT02566941|intensive care unit acquired weakness|intensive care unit acquired weakness
5229623|NCT02566941|prevention of critical illness polyneuropathy|prevention of critical illness polyneuropathy
5229624|NCT02566928|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5229625|NCT02566928|Recurrence|recurrence
5229626|NCT02566928|Practice Based Research Network|practice based research network
5229627|NCT02566928|Community Health Workers/Promotoras|community health workers/promotoras
5229628|NCT02566928|Decolonization and Decontamination|decolonization and decontamination
5229629|NCT02566928|Staphylococcal Skin Infections|staphylococcal skin infections
5229630|NCT02566928|Household Transmission|household transmission
5229631|NCT02566889|Pediatric Inflammatory Bowel Disease|pediatric inflammatory bowel disease
5229632|NCT02566889|Infliximab|infliximab
5229633|NCT02566889|Pediatric Participants|pediatric participants
5229634|NCT02566889|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
5229635|NCT02566889|Pediatric Crohn's Disease|pediatric crohn's disease
5229636|NCT02566889|Dose Escalation|dose escalation
5229637|NCT02566876|Children|children
5229638|NCT02566876|Abdominal Pain|abdominal pain
5229639|NCT02566876|Functional Dyspepsia|functional dyspepsia
5229640|NCT02566876|Irritable Bowel Syndrome|irritable bowel syndrome
5229641|NCT02566876|Quality of Life|quality of life
5229642|NCT02566863|dexmedetomidine|dexmedetomidine
5229643|NCT02566863|heart rate|heart rate
5229644|NCT02566863|heart rate variability|heart rate variability
5229645|NCT02566837|ultrasound|ultrasound
5229646|NCT02566837|Electrical stimulation guidance|electrical stimulation guidance
5229647|NCT02566837|botulinum toxin|botulinum toxin
5229648|NCT02566772|Prostate Cancer|prostate cancer
5229649|NCT02566759|Drug therapy|drug therapy
5229650|NCT02566733|remifentanil|remifentanil
5229651|NCT02566720|amantadine|amantadine
5229657|NCT02566720|traumatic brain injury|traumatic brain injury
5229658|NCT02566720|acquired brain injury|acquired brain injury
5229660|NCT02566668|Severe Asthma|severe asthma
5229661|NCT02566668|IL-10|il-10
5229662|NCT02566668|IL-27|il-27
5229663|NCT02566668|IL-13|il-13
5229664|NCT02566668|Epithelial Cells|epithelial cells
5229665|NCT02566668|T lymphocytes|t lymphocytes
5229666|NCT02566668|Interferon-g|interferon-g
5229667|NCT02566629|microbiota community|microbiota community
5229668|NCT02566629|IBS|ibs
5229669|NCT02566603|ITP|itp
5229670|NCT02566603|Thrombocytopenia|thrombocytopenia
5229671|NCT02566577|Chronic anemia|chronic anemia
5229672|NCT02566577|Cardiopulmonary testing|cardiopulmonary testing
5229673|NCT02566577|Transfusion-dependent anemia|transfusion-dependent anemia
5229674|NCT02566551|Prostatic artery embolization|prostatic artery embolization
5229675|NCT02566551|Transurethral resection of the prostate|transurethral resection of the prostate
5229676|NCT02566538|Cohort study|cohort study
5229677|NCT02566538|psychometric tests|psychometric tests
5229678|NCT02566538|cognitive function|cognitive function
5229679|NCT02566538|cardiovascular risk|cardiovascular risk
5227008|NCT02580981|DNA|dna
5229681|NCT02566525|CytoSorb device|cytosorb device
5229682|NCT02566525|Plasma free hemoglobin|plasma free hemoglobin
5229683|NCT02566525|inflammation|inflammation
5229684|NCT02566525|extracorporeal bypass|extracorporeal bypass
5229685|NCT02566512|Tracheostomy|tracheostomy
5229687|NCT02566512|respiratory failure|respiratory failure
5229688|NCT02566512|cough strength|cough strength
5229689|NCT02566499|Medical imaging|medical imaging
5229690|NCT02566499|Microwaves|microwaves
5229691|NCT02566473|Patient reported outcomes|patient reported outcomes
5229692|NCT02566473|Osteoarthritis|osteoarthritis
5229693|NCT02566473|Total joint replacement|total joint replacement
5229694|NCT02566460|Lactate clearance|lactate clearance
5229695|NCT02566460|systemic central venous oxygen saturation|systemic central venous oxygen saturation
5229696|NCT02566460|septic shock|septic shock
5229697|NCT02566460|haemodynamic therapy|haemodynamic therapy
5229698|NCT02566434|Dietary Supplements|dietary supplements
5229701|NCT02566369|Efficacy|efficacy
5229703|NCT02566369|Acne vulgaris|acne vulgaris
5229704|NCT02566356|Oxytocin|oxytocin
5229705|NCT02566356|Syntocinon|syntocinon
5229706|NCT02566356|Social Cognition|social cognition
5229707|NCT02566356|Schizophrenia|schizophrenia
5229708|NCT02566356|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5229709|NCT02566343|Spirometry|spirometry
5229710|NCT02566343|Exercise Test|exercise test
5229711|NCT02566343|Blood Gas Analysis|blood gas analysis
5229712|NCT02566343|Respiratory Function Tests|respiratory function tests
5229713|NCT02566343|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
5229714|NCT02566343|Surgical Procedures, Operative|surgical procedures, operative
5229715|NCT02566330|EndoBarrier|endobarrier
5962728|NCT04279093|paternal mental health|paternal mental health
5229716|NCT02566330|Duodenojejunal Bypass Liner|duodenojejunal bypass liner
5229717|NCT02566291|laryngeal mask|laryngeal mask
5229718|NCT02566291|airway leakage|airway leakage
5229719|NCT02566291|airway morbidity|airway morbidity
5229720|NCT02566278|Obstructive Sleep Apnea|obstructive sleep apnea
5229721|NCT02566278|Pcrit|pcrit
5229722|NCT02566278|Upper airway collapsibility|upper airway collapsibility
5229723|NCT02566265|influenza|influenza
5229724|NCT02566265|multiple myeloma|multiple myeloma
5229725|NCT02566265|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5229726|NCT02566252|Safety|safety
5229727|NCT02566252|tolerability|tolerability
5229728|NCT02566239|aging|aging
5229729|NCT02566239|ORCATECH|orcatech
5229730|NCT02566239|Oregon Center for Aging & Technology|oregon center for aging & technology
5229731|NCT02566239|Life Lab|life lab
5229732|NCT02566239|Living Lab|living lab
5229733|NCT02566239|in-home assessment|in-home assessment
5229734|NCT02566239|technology and aging|technology and aging
5229735|NCT02566213|volunteers|volunteers
5229736|NCT02566200|Acute coronary syndrome|acute coronary syndrome
5229737|NCT02566200|Cardiology|cardiology
5229738|NCT02566174|Cancer Caregivers|cancer caregivers
5217774|NCT02635620|e-cigarette, electronic cigarette, lung function|e-cigarette, electronic cigarette, lung function
5217775|NCT02635607|GnRH antagonist|gnrh antagonist
5217776|NCT02635607|fixed protocol|fixed protocol
5217777|NCT02635607|flexible protocol|flexible protocol
5229739|NCT02566174|Cancer Patients|cancer patients
5229740|NCT02566174|Role Adjustment|role adjustment
5229741|NCT02566174|Mutuality|mutuality
5229742|NCT02566174|Well-Being|well-being
5229745|NCT02566148|Life-event survey|life-event survey
5229746|NCT02566148|observational survey among migrants in France|observational survey among migrants in france
5229747|NCT02566135|C-LMA|c-lma
5229748|NCT02566135|I-gel|i-gel
5229749|NCT02566135|ventilating bougie|ventilating bougie
5229750|NCT02566135|intubation|intubation
5229751|NCT02566096|major abdominal cancer|major abdominal cancer
5229756|NCT02566031|COPD|copd
5229757|NCT02566031|open-label|open-label
5229758|NCT02566031|QVA149|qva149
5229759|NCT02566031|symptomatic|symptomatic
5229760|NCT02566031|tiotropium|tiotropium
5229761|NCT02566018|elderly|elderly
5229762|NCT02566005|Misoprostol|misoprostol
5229763|NCT02566005|Induction|induction
5229764|NCT02566005|Foley|foley
5229765|NCT02565992|Pembrolizumab|pembrolizumab
5229766|NCT02565992|Coxsackievirus A21|coxsackievirus a21
5229767|NCT02565992|melanoma|melanoma
5229768|NCT02565992|CAVATAK|cavatak
5229769|NCT02565992|CVA21|cva21
5229770|NCT02565992|checkpoint inhibitor|checkpoint inhibitor
5229771|NCT02565979|Resveratrol|resveratrol
5229772|NCT02565979|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5229773|NCT02565979|Insulin Resistance|insulin resistance
5229774|NCT02565979|Metabolic Diseases|metabolic diseases
5229775|NCT02565979|Glucose Metabolism Disorders|glucose metabolism disorders
5229776|NCT02565953|Vascular access devices obstruction|vascular access devices obstruction
5229777|NCT02565927|Trachea|trachea
5229778|NCT02565927|Stent|stent
5229779|NCT02565927|Intraluminal brachytherapy|intraluminal brachytherapy
5229780|NCT02565888|Hepatitis C|hepatitis c
5229782|NCT02565888|atazanavir|atazanavir
5229783|NCT02565888|ritonavir|ritonavir
5229784|NCT02565888|daclatasvir|daclatasvir
5229785|NCT02565888|cobicistat|cobicistat
5229786|NCT02565875|Efficiency, Organizational|efficiency, organizational
5229788|NCT02565875|Communication|communication
5229789|NCT02565875|Laparoscopy|laparoscopy
5229790|NCT02565875|Medical Education|medical education
5229791|NCT02565862|HCV|hcv
5229792|NCT02565862|Diabetes Mellitus|diabetes mellitus
5229793|NCT02565862|Daclatasvir|daclatasvir
5229794|NCT02565862|Metformin|metformin
5229795|NCT02565862|drug-drug interaction|drug-drug interaction
5229796|NCT02565862|pharmacokinetics|pharmacokinetics
5229797|NCT02565836|Vitamin K 1|vitamin k 1
5229798|NCT02565836|prothrombin complex concentrates|prothrombin complex concentrates
5229799|NCT02565836|warfarin|warfarin
5229800|NCT02565823|Exercise|exercise
5229801|NCT02565797|Decubitus Ulcer, Peri-operative, support surface, alternating pressure, neurosurgery|decubitus ulcer, peri-operative, support surface, alternating pressure, neurosurgery
5229802|NCT02565771|Childhood cancer|childhood cancer
5229803|NCT02565771|Cancer|cancer
5229804|NCT02565771|Sequels|sequels
5229805|NCT02565771|Surgery|surgery
5229806|NCT02565771|Complications|complications
5229807|NCT02565771|Chemotherapy|chemotherapy
5229808|NCT02565771|Radiotherapy|radiotherapy
5229809|NCT02565758|Cancer|cancer
5229810|NCT02565758|Advanced Solid Tumors|advanced solid tumors
5229811|NCT02565758|Neoplasm|neoplasm
5229812|NCT02565758|Undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
5229813|NCT02565758|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5229814|NCT02565758|carcinoma of the breast|carcinoma of the breast
5229815|NCT02565758|antibody drug conjugate|antibody drug conjugate
5229816|NCT02565745|Prevention|prevention
5229817|NCT02565745|Pressure ulcers|pressure ulcers
5229818|NCT02565745|Clinical trial|clinical trial
5229819|NCT02565745|Nursing|nursing
5229820|NCT02565706|Fruit, vegetables, income, WIC program, farmers' market|fruit, vegetables, income, wic program, farmers' market
5229821|NCT02565680|acute urticaria|acute urticaria
5229822|NCT02565680|glucocorticoids|glucocorticoids
5229823|NCT02565680|antihistamines|antihistamines
5229824|NCT02565680|prurit|prurit
5229825|NCT02565680|itch score|itch score
5229826|NCT02565680|rash|rash
5229827|NCT02565667|low rectal carcinoma|low rectal carcinoma
5229828|NCT02565667|anastomosis|anastomosis
5229829|NCT02565667|anterior rectal resection|anterior rectal resection
5229830|NCT02565654|Irritable bowel syndrome(IBS)|irritable bowel syndrome(ibs)
5229831|NCT02565654|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
5229832|NCT02565654|Rifaximin|rifaximin
5229833|NCT02565602|Calcium metabolism|calcium metabolism
5229834|NCT02565602|Osteoporosis|osteoporosis
5229835|NCT02565602|Postmenopausal women|postmenopausal women
5229836|NCT02565576|CFZ533, Myasthenia Gravis|cfz533, myasthenia gravis
5229838|NCT02565563|Mechanisms|mechanisms
5229839|NCT02565563|Eye Movement Desensitisation Reprocessing|eye movement desensitisation reprocessing
5229840|NCT02565550|Microbiota Community|microbiota community
5229841|NCT02565550|FODMAPs|fodmaps
5229842|NCT02565550|IBS|ibs
5229843|NCT02565524|schizophrenia|schizophrenia
5229844|NCT02565524|early dissociative disorder|early dissociative disorder
5229845|NCT02565524|genetic|genetic
5229847|NCT02565498|Soft tissue sarcoma|soft tissue sarcoma
5229848|NCT02565498|Extremity|extremity
5229853|NCT02565485|epidural analgesia|epidural analgesia
5229854|NCT02565485|hypotension|hypotension
5229856|NCT02565485|fluid bolus|fluid bolus
5229857|NCT02565485|central hypovolemia|central hypovolemia
5229858|NCT02565459|Mesenchymal stromal cells|mesenchymal stromal cells
5229859|NCT02565459|kidney transplantation|kidney transplantation
5229860|NCT02565459|tolerance|tolerance
5229861|NCT02565433|brain metastases|brain metastases
5229862|NCT02565433|Gamma Knife|gamma knife
5229863|NCT02565433|Radiosurgery|radiosurgery
5229864|NCT02565433|Quality of Life|quality of life
5229865|NCT02565355|Pediatric Gastroenterology|pediatric gastroenterology
5229866|NCT02565342|Clavicle|clavicle
5229867|NCT02565303|cesarean delivery|cesarean delivery
5229868|NCT02565303|ropivacaine|ropivacaine
5229869|NCT02565303|minimum effective dose|minimum effective dose
5229870|NCT02565303|dose-response relationship|dose-response relationship
5229871|NCT02565303|intrathecal|intrathecal
5229872|NCT02565303|intervertebral space|intervertebral space
5229873|NCT02565290|polyunsaturated fatty acid|polyunsaturated fatty acid
5229874|NCT02565290|fetal ductus arteriosus|fetal ductus arteriosus
5229875|NCT02565290|inflammation|inflammation
5229876|NCT02565251|sepsis|sepsis
5229877|NCT02565251|hemodynamic monitoring|hemodynamic monitoring
5229878|NCT02565251|septic shock|septic shock
5229879|NCT02565251|volemic resuscitation|volemic resuscitation
5229880|NCT02565251|fluid resuscitation|fluid resuscitation
5229881|NCT02565212|Montelukast|montelukast
5229882|NCT02565212|Sniffin' Sticks test|sniffin' sticks test
5229883|NCT02565212|allergic rhinitis|allergic rhinitis
5229884|NCT02565212|mometasone furoate|mometasone furoate
5229885|NCT02565199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5229886|NCT02565173|glaucoma|glaucoma
5229887|NCT02565173|primary open-angle glaucoma|primary open-angle glaucoma
5229888|NCT02565173|ocular hypertension|ocular hypertension
5229890|NCT02565173|eye drop|eye drop
5229891|NCT02565173|trabodenoson|trabodenoson
5229893|NCT02565160|Osteoarthritis|osteoarthritis
5229894|NCT02565160|Septic Arthritis|septic arthritis
5229895|NCT02565147|STEMI, infarct size, CMR, bivalirudin|stemi, infarct size, cmr, bivalirudin
5229896|NCT02565121|Olfactory perception|olfactory perception
5229897|NCT02565121|Adrenal cortex hormones|adrenal cortex hormones
5229898|NCT02565121|Steroids|steroids
5229899|NCT02565121|Education|education
5229900|NCT02565108|Cannabidiol|cannabidiol
5229901|NCT02565108|GWP42003-P|gwp42003-p
5229902|NCT02565108|Clobazam|clobazam
5229903|NCT02565108|Epidiolex|epidiolex
5229905|NCT02565082|Hemostatic potential|hemostatic potential
5229906|NCT02565082|Sickle cell disease|sickle cell disease
5229907|NCT02565082|Thrombin generation test|thrombin generation test
5229908|NCT02565056|Acceptance and Commitment Therapy|acceptance and commitment therapy
5229909|NCT02565043|Negative Pressure Wound Therapy|negative pressure wound therapy
5229910|NCT02565030|Chronic thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5229911|NCT02565030|Distal Chronic thromboembolic Pulmonary Hypertension|distal chronic thromboembolic pulmonary hypertension
5229912|NCT02565030|Proximal Chronic thromboembolic Pulmonary Hypertension|proximal chronic thromboembolic pulmonary hypertension
5229913|NCT02565030|Operable disease|operable disease
5229914|NCT02565030|In-operable disease|in-operable disease
5229915|NCT02565030|Pulmonary Endarterectomy|pulmonary endarterectomy
5229916|NCT02565030|PH specific targeted therapy|ph specific targeted therapy
5229917|NCT02565030|Phosphodiesterase type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5229918|NCT02565030|Endothelin Receptor Antagonist|endothelin receptor antagonist
5229919|NCT02565030|Prostacyclin analogues|prostacyclin analogues
5962729|NCT04279067|stroke|stroke
5962730|NCT04279054|cesarean delivery|cesarean delivery
5123536|NCT03223285|Diaphragm;|diaphragm;
5229920|NCT02565030|Soluble Guanylate cyclase stimulator|soluble guanylate cyclase stimulator
5229921|NCT02565030|Sildenafil|sildenafil
5229922|NCT02565030|Tadalafil|tadalafil
5229923|NCT02565030|Bosentan|bosentan
5229924|NCT02565030|Ambrisentan|ambrisentan
5229925|NCT02565030|Macitentan|macitentan
5229926|NCT02565030|Iloprost|iloprost
5229927|NCT02565030|Riociguat|riociguat
5229928|NCT02565030|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5229929|NCT02565017|IBM Watson|ibm watson
5229930|NCT02565017|Clinical Decision Support System|clinical decision support system
5229931|NCT02565017|Patient Preferences|patient preferences
5229932|NCT02565017|15-226|15-226
5229939|NCT02564978|Eye Disease|eye disease
5229940|NCT02564978|Degenerative|degenerative
5229941|NCT02564965|Acute Necrotizing Pancreatitis|acute necrotizing pancreatitis
5342991|NCT01981252|Ulthera® System|ulthera® system
5229961|NCT02564861|pharmacokinetics|pharmacokinetics
5229962|NCT02564848|Clinical T1-2N0 ER+|clinical t1-2n0 er+
5229963|NCT02564848|Invasive breast cancer|invasive breast cancer
5229964|NCT02564848|estrogen-positive|estrogen-positive
5229965|NCT02564822|migraine disorders|migraine disorders
5229966|NCT02564822|cortical excitability|cortical excitability
5229967|NCT02564822|transcranial magnetic stimulation|transcranial magnetic stimulation
5229968|NCT02564822|electroencephalography|electroencephalography
5229969|NCT02564796|Erythropoetin|erythropoetin
5229970|NCT02564796|Cyanotic Heart Disease|cyanotic heart disease
5229971|NCT02564796|Transfusion|transfusion
5229972|NCT02564796|Congenital Heart Disease|congenital heart disease
5229973|NCT02564731|children|children
5229974|NCT02564731|prognosis|prognosis
5229975|NCT02564718|Pediatric|pediatric
5229976|NCT02564679|bariatric surgery|bariatric surgery
5229977|NCT02564679|sleeve gastrectomy|sleeve gastrectomy
5229978|NCT02564666|hepatocellular carcinoma|hepatocellular carcinoma
5229979|NCT02564666|sorafenib|sorafenib
5229980|NCT02564666|telephone counseling|telephone counseling
5229981|NCT02564640|videolaryngoscope|videolaryngoscope
5229982|NCT02564640|direct laryngoscope|direct laryngoscope
5229983|NCT02564640|hemodynamic changes|hemodynamic changes
5229984|NCT02564640|elderly patients|elderly patients
5229985|NCT02564601|intervention|intervention
5229986|NCT02564601|cognition|cognition
5229988|NCT02564601|piano training|piano training
5229989|NCT02564601|computer brain training|computer brain training
5229990|NCT02564575|Ebolavirus|ebolavirus
5229991|NCT02564562|PF-06463922|pf-06463922
5229992|NCT02564562|[14C]PF-06463922|[14c]pf-06463922
5229993|NCT02564562|Human ADME|human adme
5229994|NCT02564562|Radiolabel|radiolabel
5229995|NCT02564562|Mass Balance|mass balance
5229996|NCT02564562|Pharmacokinetics|pharmacokinetics
5229997|NCT02564549|low risk prostate cancer|low risk prostate cancer
5230010|NCT02564484|Cancer Therapy|cancer therapy
5230011|NCT02564484|Pharmacogenomics|pharmacogenomics
5230012|NCT02564484|Drug Response|drug response
5230013|NCT02564484|Genetic Variants|genetic variants
5230014|NCT02564484|Vincristine-Induced Neuropathy|vincristine-induced neuropathy
5230015|NCT02564484|Cancer Survivor|cancer survivor
5230017|NCT02564354|Cystic Fibrosis|cystic fibrosis
5230018|NCT02564354|CF|cf
5230019|NCT02564354|ΔF508|δf508
5230020|NCT02564354|CFTR|cftr
5230021|NCT02564354|QR-010|qr-010
5230022|NCT02564354|antisense oligonucleotide|antisense oligonucleotide
5230023|NCT02564354|RNA therapy|rna therapy
5230025|NCT02564354|NPD|npd
5230026|NCT02564354|nasal potential difference|nasal potential difference
5230027|NCT02564341|HIV Infection|hiv infection
5230028|NCT02564341|Pain|pain
5230029|NCT02564341|Collaborative Care|collaborative care
5230030|NCT02564341|Chronic Opioid Therapy|chronic opioid therapy
5230031|NCT02564341|Addiction|addiction
5230032|NCT02564341|Analgesics, Opioid|analgesics, opioid
5230033|NCT02564328|Stroke|stroke
5230034|NCT02564328|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
5230035|NCT02564328|Transplantation|transplantation
5230040|NCT02564302|PVI|pvi
5230045|NCT02564289|Plethysmography|plethysmography
5230046|NCT02564289|Snus|snus
5230047|NCT02564289|Arterial Stiffness|arterial stiffness
5230048|NCT02564289|EPC|epc
5230049|NCT02564276|Indocyanine Green|indocyanine green
5230050|NCT02564276|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5230051|NCT02564263|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5230052|NCT02564263|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5230053|NCT02564263|Programmed Death-Ligand 2 (PDL2, PD-L2)|programmed death-ligand 2 (pdl2, pd-l2)
5230054|NCT02564263|Gene expression profiling (GEP)|gene expression profiling (gep)
5230055|NCT02564237|Group A streptococcal|group a streptococcal
5230059|NCT02564159|malnutrition|malnutrition
5230060|NCT02564159|muscle ultrasound|muscle ultrasound
5230061|NCT02564159|intensive care unit|intensive care unit
5230062|NCT02564159|mechanical ventilation|mechanical ventilation
5230063|NCT02564159|albumin|albumin
5230064|NCT02564159|prealbumin|prealbumin
5230065|NCT02564159|nutrition|nutrition
5230066|NCT02564055|Vehicle-Controlled|vehicle-controlled
5230067|NCT02564055|GSK2894512|gsk2894512
5230068|NCT02564055|Double blind|double blind
5230069|NCT02564055|Dose-finding|dose-finding
5230070|NCT02564055|Atopic Dermatitis|atopic dermatitis
5230071|NCT02564042|Double blind|double blind
5230072|NCT02564042|Dose-finding|dose-finding
5230073|NCT02564042|Vehicle-Controlled|vehicle-controlled
5230074|NCT02564042|GSK2894512|gsk2894512
5230075|NCT02564042|Plaque Psoriasis|plaque psoriasis
5230076|NCT02563977|Breast reconstruction|breast reconstruction
5230077|NCT02563977|Deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
5230078|NCT02563977|Abdominal wall morbidity|abdominal wall morbidity
5230079|NCT02563977|Plastic and reconstructive surgery|plastic and reconstructive surgery
5230080|NCT02563964|Myocardial infarction|myocardial infarction
5230081|NCT02563964|vulnerable plaque|vulnerable plaque
5230082|NCT02563964|Positron emission tomography (PET)|positron emission tomography (pet)
5230083|NCT02563964|Cardiac magnetic resonance imaging (CMR)|cardiac magnetic resonance imaging (cmr)
5230084|NCT02563964|Biomarkers|biomarkers
5230086|NCT02563951|Vomiting|vomiting
5230087|NCT02563951|Chemotherapy|chemotherapy
5230088|NCT02563951|Radiation therapy|radiation therapy
5230089|NCT02563925|Brain Irradiation|brain irradiation
5230090|NCT02563925|Tremelimumab|tremelimumab
5230091|NCT02563925|15-038|15-038
5230092|NCT02563912|Children|children
5230093|NCT02563912|resuscitation|resuscitation
5230094|NCT02563912|simulation|simulation
5230095|NCT02563912|medication error|medication error
5230096|NCT02563899|Primary Axillary Hyperhidrosis|primary axillary hyperhidrosis
5230097|NCT02563899|GSK573719|gsk573719
5230098|NCT02563899|Hyperhidrosis Disease Severity Scale (HDSS)|hyperhidrosis disease severity scale (hdss)
5230099|NCT02563899|Topical|topical
5230101|NCT02563899|Hyperhidrosis Symptom Severity Measure (HSSM)|hyperhidrosis symptom severity measure (hssm)
5230102|NCT02563899|Umeclidinium|umeclidinium
5230103|NCT02563860|Treatment trial|treatment trial
5230104|NCT02563860|Lovastatin|lovastatin
5230105|NCT02563821|Termination of pregancy|termination of pregancy
5230106|NCT02563821|Third trimester|third trimester
5230107|NCT02563821|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5230108|NCT02563821|Continuous epidural infusion|continuous epidural infusion
5230109|NCT02563821|Epidural analgesia|epidural analgesia
5230110|NCT02563821|Legally induced abortion|legally induced abortion
5230111|NCT02563795|Spinal anesthesia|spinal anesthesia
5230112|NCT02563795|Cesarean|cesarean
5230113|NCT02563795|Maternal hypotension|maternal hypotension
5230114|NCT02563769|Cocaine|cocaine
5230115|NCT02563769|Clavulanic Acid|clavulanic acid
5230116|NCT02563756|Medial gonarthritis, knee osteoarthritis,|medial gonarthritis, knee osteoarthritis,
5230117|NCT02563756|Muscle function, muscle mass, muscle atrophy|muscle function, muscle mass, muscle atrophy
5230118|NCT02563756|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
5230119|NCT02563756|Unicondylar knee arthroplasty (UKA)|unicondylar knee arthroplasty (uka)
5230120|NCT02563756|Total knee replacement (TKR)|total knee replacement (tkr)
5230121|NCT02563756|Unicondylar knee replacement (UKR)|unicondylar knee replacement (ukr)
5230122|NCT02563756|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
5230123|NCT02563756|Patient related outcome measurements (PROMs)|patient related outcome measurements (proms)
5230124|NCT02563743|Sick-leave|sick-leave
5230125|NCT02563743|Return to work|return to work
5230126|NCT02563743|Occupational health|occupational health
5230127|NCT02563743|Common mental disorder|common mental disorder
5230128|NCT02563743|Depression|depression
5230130|NCT02563743|Adjustment disorders|adjustment disorders
5230136|NCT02563730|Cryobiopsy|cryobiopsy
5230137|NCT02563730|lung biopsy|lung biopsy
5230138|NCT02563730|interstitial lung disease|interstitial lung disease
5230144|NCT02563704|Artesunate|artesunate
5230146|NCT02563704|Efficacy|efficacy
5230147|NCT02563704|Malaria|malaria
5230148|NCT02563704|Children|children
5230149|NCT02563704|Cameroon|cameroon
5230150|NCT02563652|Abdomen/surgery|abdomen/surgery
5230151|NCT02563652|Biological markers|biological markers
5230152|NCT02563652|Length of stay|length of stay
5230153|NCT02563652|Postoperative care|postoperative care
5230154|NCT02563652|Anesthesia recovery period|anesthesia recovery period
5230155|NCT02563652|Prognosis|prognosis
5230156|NCT02563639|newly diagnosed|newly diagnosed
5230157|NCT02563639|paroxysmal|paroxysmal
5230158|NCT02563639|persistent|persistent
5230159|NCT02563626|coronary artery aneurysm|coronary artery aneurysm
5230160|NCT02563626|prognosis|prognosis
5230161|NCT02563626|outcomes|outcomes
5230162|NCT02563626|management|management
5230163|NCT02563626|incidence|incidence
5230164|NCT02563626|heart failure|heart failure
5123780|NCT03221868|women|women
5230165|NCT02563626|acute coronary syndrome|acute coronary syndrome
5230166|NCT02563626|death|death
5230167|NCT02563613|community-based intervention|community-based intervention
5230168|NCT02563613|family holistic health|family holistic health
5230169|NCT02563613|positive psychology|positive psychology
5230170|NCT02563613|physical exercise|physical exercise
5230171|NCT02563613|healthy diet|healthy diet
5230172|NCT02563587|Laughter|laughter
5230173|NCT02563587|children|children
5230174|NCT02563587|postoperative|postoperative
5230175|NCT02563587|pain|pain
5230176|NCT02563587|anxiety|anxiety
5109157|NCT03315585|IRE|ire
5230177|NCT02563587|cortisol|cortisol
5230178|NCT02563574|Alcohol and brain function|alcohol and brain function
5230179|NCT02563574|HIV and brain function|hiv and brain function
5230180|NCT02563574|Motivational Interviewing|motivational interviewing
5230181|NCT02563561|Bladder Cancer|bladder cancer
5230182|NCT02563561|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5230183|NCT02563561|Apaziquone|apaziquone
5230184|NCT02563561|TURBT|turbt
5230185|NCT02563561|Stage Ta, G1-G2|stage ta, g1-g2
5230186|NCT02563522|non healing ulcers|non healing ulcers
5230187|NCT02563522|VM202|vm202
5230188|NCT02563522|Diabetic ulcers|diabetic ulcers
5230189|NCT02563522|foot ulcers|foot ulcers
5230190|NCT02563509|HIV|hiv
5230191|NCT02563509|cellular immunity therapy|cellular immunity therapy
5230192|NCT02563509|functional cure|functional cure
5230193|NCT02563496|pharmacokinetic|pharmacokinetic
5230194|NCT02563496|pediatric|pediatric
5230195|NCT02563496|Tafenoquine|tafenoquine
5230196|NCT02563496|Plasmodium vivax Malaria|plasmodium vivax malaria
5230197|NCT02563496|G6PD deficiency|g6pd deficiency
5230198|NCT02563483|caregivers|caregivers
5230199|NCT02563483|anxiety|anxiety
5230200|NCT02563483|depression|depression
5230201|NCT02563483|yoga|yoga
5230202|NCT02563483|meditation|meditation
5230203|NCT02563483|stress|stress
5230204|NCT02563457|diabetic patients|diabetic patients
5230205|NCT02563457|periodontal treatment|periodontal treatment
5230206|NCT02563457|glycaemic control|glycaemic control
5230207|NCT02563444|Diagnostic (Biopsy) or Therapeutic Procedure (Infiltration, Ablation)|diagnostic (biopsy) or therapeutic procedure (infiltration, ablation)
5230208|NCT02563431|shoulder pain|shoulder pain
5230209|NCT02563431|prevention program|prevention program
5230210|NCT02563418|video oculography|video oculography
5230211|NCT02563405|alpha receptor blocker|alpha receptor blocker
5230212|NCT02563405|uric acid|uric acid
5230213|NCT02563405|CCB|ccb
5230214|NCT02563405|blood pressure variability|blood pressure variability
5230215|NCT02563366|kidney transplantation|kidney transplantation
5230216|NCT02563366|mesenchymal stem cell therapy|mesenchymal stem cell therapy
5230217|NCT02563366|poor early graft function|poor early graft function
5230218|NCT02563366|delayed graft function|delayed graft function
5230219|NCT02563366|ischemia reperfusion injury|ischemia reperfusion injury
5230220|NCT02563366|donation after cardiac death|donation after cardiac death
5230221|NCT02563353|whole body vibration|whole body vibration
5230222|NCT02563353|PTH|pth
5230223|NCT02563340|kidney transplantation|kidney transplantation
5230224|NCT02563340|antibody-mediated rejection|antibody-mediated rejection
5230225|NCT02563340|mesenchymal stem cell therapy|mesenchymal stem cell therapy
5230226|NCT02563340|donor specific antibody|donor specific antibody
5230227|NCT02563340|acute rejection|acute rejection
5230228|NCT02563314|Noninvasive Ventilation|noninvasive ventilation
5230229|NCT02563314|Pulmonary Disease|pulmonary disease
5230230|NCT02563314|Chronic Obstructive|chronic obstructive
5230231|NCT02563314|Renal Doppler|renal doppler
5230232|NCT02563314|Oxygen|oxygen
5230233|NCT02563314|Hypercapnia|hypercapnia
5230234|NCT02563288|esmolol|esmolol
5230235|NCT02563288|dexmedetomidine|dexmedetomidine
5230236|NCT02563288|opioids|opioids
5230237|NCT02563197|Device study|device study
5230238|NCT02563197|Peak inspiratory flow rate|peak inspiratory flow rate
5230239|NCT02563197|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
5230240|NCT02563197|T-326 Inhaler|t-326 inhaler
5230241|NCT02563171|visceral adipose-specific serpin|visceral adipose-specific serpin
5230242|NCT02563171|intelectin 1 (omentin)|intelectin 1 (omentin)
5230243|NCT02563171|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5230244|NCT02563158|liver resection|liver resection
5230245|NCT02563158|blood inflow control|blood inflow control
5230246|NCT02563158|ischemia-reperfusion injury|ischemia-reperfusion injury
5230247|NCT02563158|inflammatory response|inflammatory response
5230248|NCT02563158|randomized controlled trial|randomized controlled trial
5230249|NCT02563145|Real-time fMRI feedback|real-time fmri feedback
5230251|NCT02563132|carbon dioxide|carbon dioxide
5230252|NCT02563132|inflammatory bowel disease|inflammatory bowel disease
5230253|NCT02563093|Influenza|influenza
5230254|NCT02563093|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
5230255|NCT02563093|Fluzone® Intradermal Quadrivalent, Influenza Vaccine|fluzone® intradermal quadrivalent, influenza vaccine
5230256|NCT02563093|Fluzone® High Dose, Influenza Vaccine|fluzone® high dose, influenza vaccine
5230257|NCT02563080|exocrine insufficiency|exocrine insufficiency
5230258|NCT02563080|acute pancreatitis|acute pancreatitis
5230259|NCT02563080|severe|severe
5230260|NCT02563080|moderately severe|moderately severe
5230261|NCT02563067|Asthma|asthma
5230262|NCT02563067|QAW039|qaw039
5230263|NCT02563028|Visual Evoked Potentials|visual evoked potentials
5230264|NCT02563028|Microdiscectomy|microdiscectomy
5230265|NCT02563028|SightSaver|sightsaver
5230266|NCT02563015|Infant|infant
5230267|NCT02563015|Vitamin D|vitamin d
5230268|NCT02563015|Deficiency|deficiency
5230269|NCT02563015|Lean Mass|lean mass
5230270|NCT02563002|PD1|pd1
5230271|NCT02563002|PDL1|pdl1
5230272|NCT02563002|PD-L1|pd-l1
5962731|NCT04279054|epidural|epidural
5160445|NCT02988531|PET|pet
5230273|NCT02562924|MEDIHONEY|medihoney
5230274|NCT02562924|Chronic Rhinosinusitis With Nasal Polyposis|chronic rhinosinusitis with nasal polyposis
5230275|NCT02562924|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5230276|NCT02562911|cystic fibrosis|cystic fibrosis
5230277|NCT02562911|menstrual cycle|menstrual cycle
5230278|NCT02562911|puberty|puberty
5230279|NCT02562885|Benign epilepsy with centro-temporal spikes|benign epilepsy with centro-temporal spikes
5230280|NCT02562885|Continuous spike waves in slow wave sleep|continuous spike waves in slow wave sleep
5230281|NCT02562885|Electroencephalography|electroencephalography
5218291|NCT02633033|MS|ms
5230282|NCT02562885|Sleep, slow wave|sleep, slow wave
5230283|NCT02562872|Controlled|controlled
5230284|NCT02562872|Human|human
5230285|NCT02562872|Malaria|malaria
5230286|NCT02562872|Infection|infection
5230287|NCT02562872|Healthy|healthy
5230288|NCT02562872|Volunteer|volunteer
5230289|NCT02562846|electroconvulsive therapy|electroconvulsive therapy
5230290|NCT02562846|response prediction|response prediction
5230291|NCT02562846|cognitive side effects|cognitive side effects
5230292|NCT02562833|Osteoarthritis|osteoarthritis
5230293|NCT02562833|Self-management|self-management
5230294|NCT02562833|Multi-Component Exercise|multi-component exercise
5230295|NCT02562807|Urinary Incontinence|urinary incontinence
5230296|NCT02562807|Urinary Incontinence, Stress|urinary incontinence, stress
5230297|NCT02562807|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5230298|NCT02562794|refugee|refugee
5230299|NCT02562781|postoperative complications|postoperative complications
5230300|NCT02562781|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5230301|NCT02562781|oxygen|oxygen
5230302|NCT02562755|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5230303|NCT02562755|Pexastimogene Devacirepvec (Pexa-Vec)|pexastimogene devacirepvec (pexa-vec)
5230304|NCT02562755|Sorafenib|sorafenib
5230305|NCT02562755|GM-CSF therapy|gm-csf therapy
5230306|NCT02562755|Thymidine Kinase-Deactivated Vaccinia Virus|thymidine kinase-deactivated vaccinia virus
5230307|NCT02562755|Oncology|oncology
5230308|NCT02562755|Recombinant Vaccinia Virus|recombinant vaccinia virus
5230309|NCT02562755|Oncolytic Virus Therapy|oncolytic virus therapy
5230310|NCT02562755|Oncolytic virotherapy|oncolytic virotherapy
5230311|NCT02562742|Hepatitis C virus|hepatitis c virus
5230312|NCT02562742|observational|observational
5230313|NCT02562742|post-marketing|post-marketing
5230314|NCT02562742|sofosbuvir|sofosbuvir
5230315|NCT02562742|Infection|infection
5230316|NCT02562729|Cervical cancer; Nerve-sparing hysterectomy; simplified|cervical cancer; nerve-sparing hysterectomy; simplified
5230317|NCT02562690|Coronary Artery Disease|coronary artery disease
5230318|NCT02562690|Myocardial Ischemia|myocardial ischemia
5230319|NCT02562690|Arterial Occlusive Diseases|arterial occlusive diseases
5230320|NCT02562690|Coronary Thrombosis|coronary thrombosis
5230334|NCT02562534|rythm troubles|rythm troubles
5230335|NCT02562534|conductive troubles|conductive troubles
5230336|NCT02562534|ECG artifacts|ecg artifacts
5230337|NCT02562534|Database|database
5230338|NCT02562508|Human Papilloma Virus 16|human papilloma virus 16
5230339|NCT02562508|Human Papilloma Virus 18|human papilloma virus 18
5230340|NCT02562508|vaccine|vaccine
5230341|NCT02562508|adolescent girl|adolescent girl
5230342|NCT02562508|bridging trial|bridging trial
5230343|NCT02562508|non-inferiority|non-inferiority
5230344|NCT02562495|severe cerebral pathology|severe cerebral pathology
5230345|NCT02562495|Ultrasound|ultrasound
5230353|NCT02562456|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5230355|NCT02562456|Primary Teeth|primary teeth
5230356|NCT02562456|Clinical Efficacy|clinical efficacy
5230357|NCT02562456|Cost Analysis|cost analysis
5230358|NCT02562443|Myelodysplastic Syndrome|myelodysplastic syndrome
5230360|NCT02562430|Placebo response|placebo response
5230361|NCT02562391|atrial fibrillation|atrial fibrillation
5230362|NCT02562391|ablation|ablation
5230363|NCT02562391|thoracoscopy|thoracoscopy
5230364|NCT02562391|left atrial appendage|left atrial appendage
5230365|NCT02562365|adjuvent chemotherapy|adjuvent chemotherapy
5230366|NCT02562365|ovarian cancer|ovarian cancer
5230367|NCT02562352|polypharmacy|polypharmacy
5230368|NCT02562352|multimorbidity|multimorbidity
5230369|NCT02562352|randomized controlled trial|randomized controlled trial
5230370|NCT02562352|drug discontinuation|drug discontinuation
5230371|NCT02562352|patient preference|patient preference
5230372|NCT02562352|eHealth|ehealth
5230373|NCT02562274|Menopause|menopause
5230374|NCT02562274|Cognitive impairment|cognitive impairment
5230375|NCT02562274|Working memory|working memory
5230376|NCT02562274|Bone formation markers|bone formation markers
5230377|NCT02562274|Osteoporosis|osteoporosis
5230378|NCT02562261|sepsis|sepsis
5230379|NCT02562261|platelet|platelet
5230380|NCT02562261|platelet reactivity|platelet reactivity
5230381|NCT02562261|P2Y12|p2y12
5230383|NCT02562222|migraine disorders|migraine disorders
5230384|NCT02562222|transcranial direct current stimulation|transcranial direct current stimulation
5230385|NCT02562222|electric stimulation therapy|electric stimulation therapy
5230386|NCT02562222|pain|pain
5230387|NCT02562222|rehabilitation|rehabilitation
5962732|NCT04279054|Neuraxial block|neuraxial block
5230388|NCT02562209|Obesity|obesity
5230389|NCT02562209|Abdominal adiposity|abdominal adiposity
5230390|NCT02562209|High protein diet|high protein diet
5230391|NCT02562196|migraine disorders|migraine disorders
5230392|NCT02562196|transcranial direct current stimulation|transcranial direct current stimulation
5230393|NCT02562196|electric stimulation therapy|electric stimulation therapy
5230394|NCT02562196|pain|pain
5230395|NCT02562170|breast|breast
5230396|NCT02562170|reconstruction|reconstruction
5230397|NCT02562170|mesh|mesh
5230398|NCT02562170|acellular dermal matrix|acellular dermal matrix
5230405|NCT02562105|Intensive care unit|intensive care unit
5230406|NCT02562105|Hematological malignancy|hematological malignancy
5230407|NCT02562105|Acute respiratory failure|acute respiratory failure
5230408|NCT02562105|Prognosis|prognosis
5230409|NCT02562105|Mechanical ventilation|mechanical ventilation
5230410|NCT02562092|AIDS|aids
5230411|NCT02562092|Health Promotion|health promotion
5230412|NCT02562079|T lymphocyte|t lymphocyte
5230413|NCT02562079|OX40/OX40L|ox40/ox40l
5230414|NCT02562040|Pediatrics|pediatrics
5230415|NCT02562040|Primary Snoring|primary snoring
5230416|NCT02562040|Adenotonsillectomy|adenotonsillectomy
5230417|NCT02562001|Spinal Cord Injuries|spinal cord injuries
5230418|NCT02562001|gait training|gait training
5230419|NCT02562001|robotic|robotic
5230420|NCT02562001|Lokomat|lokomat
5230421|NCT02562001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5230422|NCT02562001|transcranial direct-current stimulation|transcranial direct-current stimulation
5230423|NCT02562001|Electroencephalography|electroencephalography
5230424|NCT02562001|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
5230425|NCT02561975|Double pulmonary diffusing capacity to carbon monoxyd (CO) associated to nitric oxide (NO)|double pulmonary diffusing capacity to carbon monoxyd (co) associated to nitric oxide (no)
5230426|NCT02561975|Evolution of membrane and capillar damages|evolution of membrane and capillar damages
5230427|NCT02561975|Early pronostic value of congenital heart disease|early pronostic value of congenital heart disease
5230428|NCT02561962|Multiple Myeloma|multiple myeloma
5230429|NCT02561962|Relapsed Multiple Myeloma|relapsed multiple myeloma
5230430|NCT02561962|Refractory Multiple Myeloma|refractory multiple myeloma
5230431|NCT02561949|Depression/therapy|depression/therapy
5230432|NCT02561949|Developing Countries|developing countries
5230433|NCT02561949|Interpersonal Relations|interpersonal relations
5230434|NCT02561949|Life Change Events|life change events
5230435|NCT02561949|Psychotherapy, group|psychotherapy, group
5230436|NCT02561949|Resilience, Psychological|resilience, psychological
5230437|NCT02561949|Sierra Leone|sierra leone
5230438|NCT02561949|Survivors/psychology|survivors/psychology
5230439|NCT02561949|Social Adjustment|social adjustment
5230440|NCT02561949|Social Behavior|social behavior
5230442|NCT02561936|Healthy|healthy
5230443|NCT02561936|EUDRANT|eudrant
5230444|NCT02561936|Rilpivirine|rilpivirine
5230445|NCT02561923|Healthy|healthy
5230446|NCT02561923|Rivaroxaban|rivaroxaban
5230447|NCT02561923|XARELTO|xarelto
5230448|NCT02561910|Inguinal hernia repair|inguinal hernia repair
5230449|NCT02561910|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5230450|NCT02561910|TAPP|tapp
5230451|NCT02561871|Ad26.RSV.FA2 (JNJ-61187165-AAA)|ad26.rsv.fa2 (jnj-61187165-aaa)
5236220|NCT02526095|Surgery|surgery
5230452|NCT02561871|Ad35.RSV.FA2 (JNJ-61187191-AAA)|ad35.rsv.fa2 (jnj-61187191-aaa)
5230453|NCT02561871|Healthy participants|healthy participants
5230454|NCT02561858|Renal Ammonium ;uric acid|renal ammonium ;uric acid
5230455|NCT02561845|Effectiveness of statins, on lipid goal attainment and lipid parameters in Percutaneous Coronary Intervention patients|effectiveness of statins, on lipid goal attainment and lipid parameters in percutaneous coronary intervention patients
5230456|NCT02561832|breast cancer|breast cancer
5230457|NCT02561819|Short Bowel Syndrome|short bowel syndrome
5230458|NCT02561819|Congenital Short Bowel Syndrome|congenital short bowel syndrome
5230459|NCT02561819|Body Composition|body composition
5230460|NCT02561819|Parenteral Nutrition|parenteral nutrition
5230461|NCT02561819|Intestinal Failure|intestinal failure
5230462|NCT02561780|Mental Health Knowledge|mental health knowledge
5230464|NCT02561780|Mental Health Literacy|mental health literacy
5230465|NCT02561767|kidney transplantation|kidney transplantation
5230466|NCT02561767|mesenchymal stem cell|mesenchymal stem cell
5230467|NCT02561767|donation after citizen's death|donation after citizen's death
5230468|NCT02561767|ischemia reperfusion injury|ischemia reperfusion injury
5230469|NCT02561767|renal function recovery|renal function recovery
5230470|NCT02561754|Diet|diet
5230471|NCT02561754|Obesity|obesity
5230472|NCT02561754|Adolescents|adolescents
5445368|NCT01522118|Prostate Cancer|prostate cancer
5230473|NCT02561754|Intellectual and Developmental Disability|intellectual and developmental disability
5230474|NCT02561728|Helmet|helmet
5230475|NCT02561728|Hangar|hangar
5230476|NCT02561728|P-Pod|p-pod
5230477|NCT02561728|Plagiocephaly|plagiocephaly
5230478|NCT02561728|Surgery|surgery
5230479|NCT02561715|Parkinson's|parkinson's
5230480|NCT02561715|Anosognosia|anosognosia
5230482|NCT02561715|Deep Brain Surgery|deep brain surgery
5230483|NCT02561689|Occlusal caries|occlusal caries
5230484|NCT02561689|Resin fissure sealant|resin fissure sealant
5230485|NCT02561689|Longevity|longevity
5962733|NCT04279054|anesthesia side effects|anesthesia side effects
5109458|NCT03314090|Scar|scar
5230486|NCT02561689|Effectiveness|effectiveness
5230487|NCT02561676|Mindfulness|mindfulness
5230488|NCT02561676|Spinal Cord Injury|spinal cord injury
5230489|NCT02561663|microcirculation|microcirculation
5230490|NCT02561663|blood pressure|blood pressure
5230491|NCT02561663|pulse wave analysis|pulse wave analysis
5230492|NCT02561663|pulse wave velocity|pulse wave velocity
5230493|NCT02561637|Case management|case management
5230494|NCT02561624|mHealth|mhealth
5230495|NCT02561624|Text message|text message
5230496|NCT02561611|Pedal Desk|pedal desk
5230497|NCT02561611|Workplace Intervention|workplace intervention
5230498|NCT02561611|Physical Activity|physical activity
5230499|NCT02561611|Energy Expenditure|energy expenditure
5230500|NCT02561546|concurrent|concurrent
5230501|NCT02561520|platelet rich plasma|platelet rich plasma
5230502|NCT02561520|platelet poor plasma|platelet poor plasma
5230503|NCT02561520|ocular GVHD|ocular gvhd
5230504|NCT02561455|Advanced solid tumors|advanced solid tumors
5230505|NCT02561455|Acute myeloid leukemia|acute myeloid leukemia
5230506|NCT02561455|gilteritinib|gilteritinib
5230507|NCT02561455|ASP2215|asp2215
5230508|NCT02561416|Fibromyalgia syndrome|fibromyalgia syndrome
5230509|NCT02561416|Mindfulness (MBSR)|mindfulness (mbsr)
5230510|NCT02561416|Neuroimaging|neuroimaging
5230511|NCT02561416|Cytokines|cytokines
5230512|NCT02561416|Randomized Controlled Trial|randomized controlled trial
5230513|NCT02561416|Cost-effectiveness|cost-effectiveness
5230514|NCT02561416|Psychoeducation (FibroQol)|psychoeducation (fibroqol)
5230515|NCT02561403|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5230516|NCT02561403|aging|aging
5230517|NCT02561403|cognitive training|cognitive training
5230518|NCT02561403|Cognitive Aging|cognitive aging
5230519|NCT02561377|resistance training|resistance training
5230520|NCT02561377|Prediabetic state|prediabetic state
5230521|NCT02561377|Metabolomics|metabolomics
5230522|NCT02561364|Fetal Biophysical Profile|fetal biophysical profile
5230523|NCT02561351|bronchial asthma|bronchial asthma
5230524|NCT02561351|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
5230525|NCT02561351|asthma exacerbation|asthma exacerbation
5230526|NCT02561338|GKA,T2DM,HMS5552|gka,t2dm,hms5552
5230527|NCT02561325|Blood pressure|blood pressure
5230528|NCT02561325|Sodium Chloride|sodium chloride
5230529|NCT02561325|Sodium Bicarbonate|sodium bicarbonate
5230530|NCT02561299|Drug-coated Balloons|drug-coated balloons
5230531|NCT02561299|Calcified Lesions|calcified lesions
5230532|NCT02561299|Orbital Atherectomy|orbital atherectomy
5230533|NCT02561299|Below the Knee|below the knee
5230534|NCT02561299|Paclitaxel|paclitaxel
5230535|NCT02561299|Lutonix 014 Drug-coated Balloon|lutonix 014 drug-coated balloon
5230536|NCT02561286|Human immunodeficiency virus|human immunodeficiency virus
5230537|NCT02561286|Sexually transmitted disease|sexually transmitted disease
5230538|NCT02561286|Men who have sex with men|men who have sex with men
5230539|NCT02561286|African Americans|african americans
5230540|NCT02561286|Behavioral intervention|behavioral intervention
5230541|NCT02561286|Randomized controlled trial|randomized controlled trial
5230542|NCT02561286|Sexual behavior|sexual behavior
5230543|NCT02561286|Mediation analysis|mediation analysis
5230544|NCT02561286|Social cognitive theory|social cognitive theory
5230545|NCT02561286|Theory of planned behavior|theory of planned behavior
5230547|NCT02561247|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5230548|NCT02561247|Blood Urea Nitrogen (BUN)|blood urea nitrogen (bun)
5230549|NCT02561247|Prismaflex|prismaflex
5230550|NCT02561247|Pediatric|pediatric
5230552|NCT02561221|pragmatic trial|pragmatic trial
5230553|NCT02561221|weight loss|weight loss
5230554|NCT02561221|overweight|overweight
5230555|NCT02561221|diet|diet
5230556|NCT02561221|physical activity|physical activity
5230557|NCT02561221|PCORI|pcori
5230558|NCT02561208|Patient adherence|patient adherence
5230559|NCT02561208|Mobile Health|mobile health
5230560|NCT02561208|HPV DNA Tests|hpv dna tests
5230561|NCT02561208|Self-collected|self-collected
5230562|NCT02561195|Clostridium difficile, Vaccine.|clostridium difficile, vaccine.
5230563|NCT02561169|antiviral|antiviral
5230564|NCT02561169|oseltamivir|oseltamivir
5230565|NCT02561156|Drug therapy|drug therapy
5230566|NCT02561143|cachexia|cachexia
5230567|NCT02561143|nutrition supplementation|nutrition supplementation
5230568|NCT02561143|IAtta|iatta
5230569|NCT02561143|palliative care|palliative care
5230570|NCT02561143|quality of life|quality of life
5230571|NCT02561130|Diabetes|diabetes
5230572|NCT02561130|Insulin|insulin
5230573|NCT02561130|Glargine|glargine
5230574|NCT02561130|Metformin|metformin
5230575|NCT02561130|Forxiga|forxiga
5230576|NCT02561130|Diet|diet
5230577|NCT02561130|Exercise|exercise
5230578|NCT02561130|Lifestyle|lifestyle
5230579|NCT02561104|cataract|cataract
5230580|NCT02561104|phacoemulsification|phacoemulsification
5230581|NCT02561104|laser-assisted surgery|laser-assisted surgery
5230582|NCT02561104|femtosecond laser|femtosecond laser
5962734|NCT04279015|Neck Pain|neck pain
5230583|NCT02561091|Deafness|deafness
5230584|NCT02561091|Hearing Loss, Sensorineural|hearing loss, sensorineural
5962735|NCT04279015|Kinesio tape|kinesio tape
5230585|NCT02561091|Ear Diseases|ear diseases
5230586|NCT02561091|Hearing Disorders|hearing disorders
5230587|NCT02561091|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5230588|NCT02561091|Sensation Disorders|sensation disorders
5230589|NCT02561091|Signs and Symptoms|signs and symptoms
5230590|NCT02561091|Hearing and Speech impairment|hearing and speech impairment
5230591|NCT02561091|Hearing Loss, Unilateral|hearing loss, unilateral
5230592|NCT02561078|insulin pumps|insulin pumps
5230593|NCT02561078|concentrated insulin|concentrated insulin
5218549|NCT02631824|augmentation|augmentation
5218550|NCT02631824|tip-apex distance|tip-apex distance
5218551|NCT02631811|acute leukaemia|acute leukaemia
5218552|NCT02631811|supportive / palliative care|supportive / palliative care
5218553|NCT02631785|ANXIETY|anxiety
5218554|NCT02631785|CBT|cbt
5218555|NCT02631785|fMRI|fmri
5230594|NCT02561078|OmniPod|omnipod
5230595|NCT02561065|Health Lifestyle|health lifestyle
5230596|NCT02561065|Lifestyle Risk Reduction|lifestyle risk reduction
5230597|NCT02561065|Health Behavior|health behavior
5230598|NCT02561065|Sedentary Lifestyle|sedentary lifestyle
5230599|NCT02561065|Intervention Studies|intervention studies
5230600|NCT02561065|Cardiovascular risk in office workers|cardiovascular risk in office workers
5230601|NCT02561065|Motivational Interview|motivational interview
5230602|NCT02561065|Preventive health services|preventive health services
5230603|NCT02561065|Health education|health education
5230604|NCT02561065|Physical activity|physical activity
5230605|NCT02561065|Dietary behaviour intervention|dietary behaviour intervention
5230606|NCT02561065|Workplace|workplace
5230607|NCT02561026|Frozen plasma|frozen plasma
5230608|NCT02561026|INR|inr
5230609|NCT02561026|procedures|procedures
5230610|NCT02561000|Platelets|platelets
5230611|NCT02561000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5230612|NCT02561000|Protease-Activated Receptor 1|protease-activated receptor 1
5230613|NCT02561000|Hemorrhage|hemorrhage
5230614|NCT02560961|Kinesio Taping|kinesio taping
5230615|NCT02560961|Soccer|soccer
5230616|NCT02560961|Hop Test|hop test
5230617|NCT02560961|Vertical Jump|vertical jump
5230618|NCT02560935|primary stroke prevention|primary stroke prevention
5230619|NCT02560935|hydroxyurea|hydroxyurea
5230620|NCT02560935|low income country|low income country
5230621|NCT02560935|sub-Saharan Africa|sub-saharan africa
5230622|NCT02560922|Osteoarthritis|osteoarthritis
5230623|NCT02560922|Knee Osteoarthritis|knee osteoarthritis
5230624|NCT02560922|Hip Osteoarthritis|hip osteoarthritis
5230625|NCT02560896|Family|family
5230626|NCT02560896|History|history
5230627|NCT02560896|Pancreas|pancreas
5230628|NCT02560896|Cancer|cancer
5230629|NCT02560896|Genetic|genetic
5230630|NCT02560883|Hairy Cell|hairy cell
5230631|NCT02560857|Quantiferon-Monitor|quantiferon-monitor
5230632|NCT02560857|organ rejection|organ rejection
5230633|NCT02560857|global immunity|global immunity
5230634|NCT02560831|Osteoarthritis|osteoarthritis
5230635|NCT02560831|Therapeutic exercises|therapeutic exercises
5230636|NCT02560831|Pain|pain
5230637|NCT02560831|Muscle strength|muscle strength
5230638|NCT02560831|Postural balance|postural balance
5230639|NCT02560818|splice profiles of messenger RNA|splice profiles of messenger rna
5230640|NCT02560779|TRC105|trc105
5230641|NCT02560779|CD105|cd105
5230642|NCT02560779|Endoglin|endoglin
5230643|NCT02560779|Angiogenesis inhibitor|angiogenesis inhibitor
5230644|NCT02560779|HCC|hcc
5230645|NCT02560779|TKI|tki
5230646|NCT02560779|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5230647|NCT02560779|Sorafenib|sorafenib
5230648|NCT02560779|Nexavar|nexavar
5230649|NCT02560766|Restless Leg Syndrome|restless leg syndrome
5230650|NCT02560766|RLS|rls
5230651|NCT02560727|Inflammatory Bowel Diseases|inflammatory bowel diseases
5230652|NCT02560727|Fecal Microbiota Transplantation|fecal microbiota transplantation
5230653|NCT02560727|transendoscopic enteral tubing|transendoscopic enteral tubing
5230654|NCT02560714|sacroiliac joint fusion|sacroiliac joint fusion
5230655|NCT02560714|SIJ Fusion|sij fusion
5230656|NCT02560714|SI Joint|si joint
5230657|NCT02560714|SIJ|sij
5230658|NCT02560701|high-deductible health plans|high-deductible health plans
5230659|NCT02560701|medication adherence|medication adherence
5230660|NCT02560688|drug interaction|drug interaction
5230661|NCT02560688|clopidogrel|clopidogrel
5230662|NCT02560688|healthy subjects|healthy subjects
5230663|NCT02560675|Whiplash Injury Pain|whiplash injury pain
5230664|NCT02560675|Chronic Pain|chronic pain
5230665|NCT02560675|TBI|tbi
5230761|NCT02560155|Staphylococcus aureus|staphylococcus aureus
5230666|NCT02560662|Breast cancer, physical exercise, recovery|breast cancer, physical exercise, recovery
5230667|NCT02560636|Muscle Invasive|muscle invasive
5230668|NCT02560636|Metastatic|metastatic
5230669|NCT02560636|Advanced|advanced
5230670|NCT02560623|Barrett's|barrett's
5230671|NCT02560623|esophagus|esophagus
5230672|NCT02560623|reflux|reflux
5230673|NCT02560623|esophageal adenocarcinoma|esophageal adenocarcinoma
5230674|NCT02560597|epilepsy|epilepsy
5230675|NCT02560597|epilepsia partialis continua|epilepsia partialis continua
5230676|NCT02560597|status epilepticus|status epilepticus
5230677|NCT02560597|treatment resistant|treatment resistant
5230678|NCT02560597|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5230679|NCT02560584|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5230680|NCT02560584|NMIBC|nmibc
5230681|NCT02560584|Cysview|cysview
5230682|NCT02560558|Immunosuppression|immunosuppression
5230683|NCT02560558|Transplantation Immunology|transplantation immunology
5230684|NCT02560532|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5230685|NCT02560532|cerebral vasospasm|cerebral vasospasm
5230686|NCT02560532|clazosentan|clazosentan
5230687|NCT02560519|human serum albumin solution|human serum albumin solution
5230688|NCT02560519|Cardiopulmonary Bypass|cardiopulmonary bypass
5230689|NCT02560493|BMIz|bmiz
5230690|NCT02560493|Exergaming|exergaming
5230691|NCT02560493|Cardiovascular Disease|cardiovascular disease
5230692|NCT02560480|groin pain, groin injury, magnetic resonance imaging|groin pain, groin injury, magnetic resonance imaging
5230693|NCT02560454|Cognitive Remediation|cognitive remediation
5230694|NCT02560454|Working Memory Training|working memory training
5230695|NCT02560454|Cognitive training|cognitive training
5230696|NCT02560428|Mixed Methods|mixed methods
5230697|NCT02560428|Cardiovascular Health|cardiovascular health
5230698|NCT02560428|Implementation Evaluation|implementation evaluation
5230699|NCT02560428|Cardiovascular Prevention Screening|cardiovascular prevention screening
5230700|NCT02560415|Autism Spectrum Disorder|autism spectrum disorder
5230701|NCT02560415|Serious Game|serious game
5230702|NCT02560415|Controlled trial|controlled trial
5230703|NCT02560415|Denver model|denver model
5230704|NCT02560402|Glomerular hyperfiltration|glomerular hyperfiltration
5230712|NCT02560376|glucagon-like peptide-1 receptor (GLP-1R) imaging|glucagon-like peptide-1 receptor (glp-1r) imaging
5230713|NCT02560363|AZD9977|azd9977
5230714|NCT02560363|Safety|safety
5230715|NCT02560363|Tolerability|tolerability
5230716|NCT02560363|Pharmacokinetics|pharmacokinetics
5230717|NCT02560363|Food effect|food effect
5230718|NCT02560363|AZD9977 capsules|azd9977 capsules
5230719|NCT02560363|AZD9977 suspension|azd9977 suspension
5230720|NCT02560350|adipose-derived stem cells|adipose-derived stem cells
5230721|NCT02560350|small intestinal submucosa|small intestinal submucosa
5230722|NCT02560350|adipocyte-containing hypodermis|adipocyte-containing hypodermis
5230723|NCT02560337|Ovarian cancer|ovarian cancer
5230724|NCT02560337|Relapse|relapse
5230725|NCT02560337|Recurrence|recurrence
5230726|NCT02560337|Chemotherapy resistance|chemotherapy resistance
5230727|NCT02560324|Ramelteon|ramelteon
5230728|NCT02560324|Nicotine|nicotine
5230729|NCT02560324|Nicotine dependence|nicotine dependence
5230730|NCT02560324|Insomnia|insomnia
5230731|NCT02560324|Tobacco Dependence|tobacco dependence
5230732|NCT02560285|Risk assessment|risk assessment
5230733|NCT02560285|Mortality|mortality
5230734|NCT02560285|Morbidity|morbidity
5230735|NCT02560285|Risk factor|risk factor
5230736|NCT02560272|vaccine|vaccine
5230737|NCT02560272|haemophilus influenzae type b|haemophilus influenzae type b
5230738|NCT02560259|knee pain|knee pain
5230739|NCT02560246|Microbiome|microbiome
5230740|NCT02560233|Neurofeedback|neurofeedback
5230741|NCT02560233|Stress|stress
5230742|NCT02560233|fMRI|fmri
5230743|NCT02560233|Real-time fMRI Neurofeedback|real-time fmri neurofeedback
5230744|NCT02560233|Anterior cingulate cortex|anterior cingulate cortex
5230745|NCT02560233|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
5230746|NCT02560233|Cortisol|cortisol
5230748|NCT02560233|Heart rate variability|heart rate variability
5230749|NCT02560233|Blood pressure|blood pressure
5230750|NCT02560233|Simultaneous EEG/fMRI|simultaneous eeg/fmri
5848823|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil
5230751|NCT02560181|recurrent prostate cancer, HDR whole gland salvage|recurrent prostate cancer, hdr whole gland salvage
5230752|NCT02560168|Coronary artery disease|coronary artery disease
5230754|NCT02560168|MyoVista|myovista
5230755|NCT02560168|Heart Test Labs|heart test labs
5230756|NCT02560168|Wavelet analysis|wavelet analysis
5230757|NCT02560168|Surface electrocardiogram|surface electrocardiogram
5124503|NCT03216759|laparotomy|laparotomy
5230758|NCT02560155|Orthopedic surgery|orthopedic surgery
5230759|NCT02560155|Surgical site infection|surgical site infection
5230760|NCT02560155|Decolonization|decolonization
5230762|NCT02560129|recovery|recovery
5230764|NCT02560129|clinic|clinic
5230765|NCT02560129|survivor|survivor
5230766|NCT02560129|physical function|physical function
5230767|NCT02560116|Pulmonary artery systolic pressure|pulmonary artery systolic pressure
5230768|NCT02560116|Optison|optison
5230769|NCT02560090|Diabetes|diabetes
5230770|NCT02560077|cognitive|cognitive
5230771|NCT02560077|memory|memory
5230772|NCT02560077|physical fitness|physical fitness
5230773|NCT02560077|psychological fitness|psychological fitness
5230774|NCT02560077|elderly|elderly
5230775|NCT02560077|middle aged|middle aged
5230776|NCT02560051|Prostate Cancer|prostate cancer
5230777|NCT02560051|Advanced|advanced
5230778|NCT02560051|Local Failures|local failures
5230779|NCT02560038|Urothelial Cancer|urothelial cancer
5230780|NCT02560038|Bladder Cancer|bladder cancer
5230781|NCT02560038|Metastatic|metastatic
5230782|NCT02560025|Acute Myeloid Leukemia|acute myeloid leukemia
5230783|NCT02560012|Renal Cell Carcinoma|renal cell carcinoma
5230785|NCT02560012|Personalized therapy|personalized therapy
5230786|NCT02560012|targeted inhibitors|targeted inhibitors
5230787|NCT02559999|Healthy Volunteers|healthy volunteers
5230789|NCT02559999|EEG|eeg
5230790|NCT02559973|Buprenorphine|buprenorphine
5230791|NCT02559973|opioid use disorder|opioid use disorder
5230792|NCT02559921|Recombinant Human Rabies Immunoglobin (rhRIG)|recombinant human rabies immunoglobin (rhrig)
5230802|NCT02559843|pomegranate|pomegranate
5230803|NCT02559843|diabetes|diabetes
5230804|NCT02559843|oxidative stress|oxidative stress
5230805|NCT02559817|Irritable Bowel Syndrome with Constipation in children|irritable bowel syndrome with constipation in children
5230806|NCT02559817|Linzess|linzess
5230807|NCT02559791|Reslizumab|reslizumab
5230828|NCT02559713|Colitis Ulcerative|colitis ulcerative
5230829|NCT02559713|Crohn Disease|crohn disease
5230831|NCT02559700|Healthy Ageing|healthy ageing
5230835|NCT02559674|Pancreas|pancreas
5230836|NCT02559674|Pancreatic|pancreatic
5230837|NCT02559674|Cancer|cancer
5230838|NCT02559674|Advanced Pancreatic Cancer|advanced pancreatic cancer
5230839|NCT02559674|Immunotherapy|immunotherapy
5230840|NCT02559674|Immunotherapeutic|immunotherapeutic
5230841|NCT02559674|Interleukin-15|interleukin-15
5230842|NCT02559674|Gemcitabine|gemcitabine
5230843|NCT02559674|Nab-paclitaxel|nab-paclitaxel
5230844|NCT02559674|Solid Tumor|solid tumor
5230845|NCT02559674|Metastatic Disease|metastatic disease
5230846|NCT02559674|Combination Immunotherapy|combination immunotherapy
5230847|NCT02559583|Multiple Myeloma|multiple myeloma
5230848|NCT02559583|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5230849|NCT02559583|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5230850|NCT02559570|Functional constipation in children|functional constipation in children
5230851|NCT02559570|LINZESS|linzess
5230852|NCT02559518|Cerebellum|cerebellum
5230853|NCT02559518|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5230854|NCT02559518|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5230855|NCT02559518|Motor Learning|motor learning
5230856|NCT02559518|Serial Reaction Time Task|serial reaction time task
5230857|NCT02559518|HandwritingTask|handwritingtask
5230858|NCT02559505|natural influenza infection|natural influenza infection
5230954|NCT02558920|Body weight|body weight
5230859|NCT02559505|live attenuated influenza vaccination (LAIV)|live attenuated influenza vaccination (laiv)
5230860|NCT02559505|inactivated influenza vaccination (IIV)|inactivated influenza vaccination (iiv)
5230862|NCT02559505|children|children
5230863|NCT02559466|pharmaco-resistant depressed patients|pharmaco-resistant depressed patients
5230864|NCT02559427|sleep apnea|sleep apnea
5230865|NCT02559427|Venous Insufficiency|venous insufficiency
5230866|NCT02559427|SPA treatment|spa treatment
5230867|NCT02559401|Eloquent cortex|eloquent cortex
5230868|NCT02559349|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5230869|NCT02559349|SBRT|sbrt
5230870|NCT02559336|Palliative Care|palliative care
5230871|NCT02559336|Cancer|cancer
5230872|NCT02559336|Health Services Research|health services research
5230873|NCT02559310|Pneumonia|pneumonia
5230874|NCT02559310|CABP|cabp
5230875|NCT02559310|CAP|cap
5230876|NCT02559310|Community acquired bacterial pneumonia|community acquired bacterial pneumonia
5230877|NCT02559297|Regulatory T cells|regulatory t cells
5230878|NCT02559297|Sevoflurane|sevoflurane
5230879|NCT02559297|Desflurane|desflurane
5230880|NCT02559297|Cytokines|cytokines
5230881|NCT02559297|Flow cytometry|flow cytometry
5230882|NCT02559297|Living Donor Kidney Transplant|living donor kidney transplant
5236627|NCT02523443|15-148|15-148
5862733|NCT00001532|Nitric Oxide Synthesis|nitric oxide synthesis
5230883|NCT02559284|Saline Solution, Isotonic / Administration & dosage|saline solution, isotonic / administration & dosage
5230884|NCT02559284|Therapeutic Irrigation / methods|therapeutic irrigation / methods
5230885|NCT02559284|Postoperative Care / methods|postoperative care / methods
5230886|NCT02559284|Quality of life|quality of life
5230887|NCT02559180|Diabetes|diabetes
5230888|NCT02559180|Macular Edema|macular edema
5230889|NCT02559180|Diabetic Retinopathy|diabetic retinopathy
5230890|NCT02559141|haemodynamic optimization|haemodynamic optimization
5230891|NCT02559141|cardiac index|cardiac index
5230892|NCT02559141|non-invasive|non-invasive
5230893|NCT02559141|pulse pressure variation|pulse pressure variation
5230894|NCT02559128|Insulin Resistance|insulin resistance
5230895|NCT02559128|Chronic Heart Failure|chronic heart failure
5230896|NCT02559128|Type 2 Diabetes|type 2 diabetes
5230897|NCT02559128|Endothelial Dysfunction|endothelial dysfunction
5230903|NCT02559102|General anaesthesia|general anaesthesia
5230904|NCT02559102|Neurodevelopment|neurodevelopment
5230906|NCT02559102|Neonates|neonates
5230907|NCT02559076|Overweight|overweight
5230908|NCT02559076|Obesity|obesity
5230909|NCT02559076|Preschool children|preschool children
5230910|NCT02559076|United Arab Emirates|united arab emirates
5230911|NCT02559076|Dietary patterns|dietary patterns
5230912|NCT02559076|BMI z-scores|bmi z-scores
5230913|NCT02559063|cognitive training|cognitive training
5230914|NCT02559063|speed of processing|speed of processing
5109943|NCT03310788|self-tonometry|self-tonometry
5230915|NCT02559063|neuroplasticity|neuroplasticity
5230916|NCT02559063|cognitive aging|cognitive aging
5230922|NCT02559024|Metastatic colorectal cancer|metastatic colorectal cancer
5230923|NCT02559024|liver lesion|liver lesion
5230924|NCT02559024|anti-OX40 antibody|anti-ox40 antibody
5230925|NCT02559024|MEDI6469|medi6469
5230926|NCT02559024|Immunotherapy|immunotherapy
5230927|NCT02559011|Arrhythmias, Cardiac|arrhythmias, cardiac
5230928|NCT02559011|Transcatheter Aortic Valve implantation|transcatheter aortic valve implantation
5230929|NCT02559011|Aortic Valve Stenosis|aortic valve stenosis
5230930|NCT02558985|Pulmonary Compliance|pulmonary compliance
5230932|NCT02558972|Postural Tachycardia Syndrome (POTS)|postural tachycardia syndrome (pots)
5230933|NCT02558972|Vasovagal Syncope (VVS)|vasovagal syncope (vvs)
5230934|NCT02558972|Fainting|fainting
5230935|NCT02558972|Orthostatic Intolerance|orthostatic intolerance
5230936|NCT02558972|Droxidopa|droxidopa
5230937|NCT02558972|Northera|northera
5230938|NCT02558933|Fetal Alcohol Syndrome|fetal alcohol syndrome
5230939|NCT02558933|Prenatal exposure|prenatal exposure
5230940|NCT02558933|Biomarkers|biomarkers
5230941|NCT02558933|Oxidative stress|oxidative stress
5230942|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate
5230943|NCT02558920|Systematic review and meta-analysis|systematic review and meta-analysis
5230944|NCT02558920|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5230945|NCT02558920|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5230946|NCT02558920|Clinical practice guidelines|clinical practice guidelines
5230947|NCT02558920|Clinical trials|clinical trials
5230948|NCT02558920|Dietary sugars|dietary sugars
5230949|NCT02558920|Fructose|fructose
5230950|NCT02558920|Sucrose|sucrose
5230951|NCT02558920|High fructose corn syrup|high fructose corn syrup
5230952|NCT02558920|Isocaloric|isocaloric
5230953|NCT02558920|Hypercaloric|hypercaloric
5230955|NCT02558920|Prospective cohort studies|prospective cohort studies
5230956|NCT02558907|geriatrics|geriatrics
5230957|NCT02558907|cancer|cancer
5230958|NCT02558907|MMS test|mms test
5230959|NCT02558907|MoCA test|moca test
5230960|NCT02558907|cognitive evaluation|cognitive evaluation
5230961|NCT02558894|Pancreatic Ductal Adenocarcinoma, PDAC|pancreatic ductal adenocarcinoma, pdac
5230962|NCT02558881|screening|screening
5230963|NCT02558881|colorectal cancer|colorectal cancer
5230964|NCT02558881|colon capsule|colon capsule
5230965|NCT02558881|virtual colonoscopy|virtual colonoscopy
5230966|NCT02558855|Thrust Joint Manipulation|thrust joint manipulation
5230967|NCT02558855|Non-thrust Joint Manipulation|non-thrust joint manipulation
5230968|NCT02558855|Transversus Abdominis|transversus abdominis
5230969|NCT02558829|Adult Growth Hormone Deficiency|adult growth hormone deficiency
5230970|NCT02558803|HPV Vaccinations|hpv vaccinations
5230971|NCT02558803|Quadrivalent Vaccine|quadrivalent vaccine
5230972|NCT02558790|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5230973|NCT02558790|ADHD|adhd
5230974|NCT02558790|Attention Deficit Disorder|attention deficit disorder
5230976|NCT02558790|Magnesium|magnesium
5230977|NCT02558777|Delirium|delirium
5230978|NCT02558777|Pilot Study|pilot study
5230979|NCT02558777|Nurse intervention|nurse intervention
5230980|NCT02558777|Hospitalization|hospitalization
5230981|NCT02558751|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5230982|NCT02558751|aging HIV|aging hiv
5230983|NCT02558738|dermatitis and irritations at the outer ear canal|dermatitis and irritations at the outer ear canal
5230984|NCT02558738|prevention of subacute otitis externa|prevention of subacute otitis externa
5230985|NCT02558712|screening|screening
5230986|NCT02558712|tele-ophthalmology|tele-ophthalmology
5230987|NCT02558686|trigger points|trigger points
5230989|NCT02558686|post-dry needling soreness|post-dry needling soreness
5230991|NCT02558673|Trimethylamine-N-oxide|trimethylamine-n-oxide
5230994|NCT02558673|Metabolism|metabolism
5230995|NCT02558673|Gut microbiome|gut microbiome
5230997|NCT02558660|Supplemental Nutrition Incentive Program (SNAP)|supplemental nutrition incentive program (snap)
5230998|NCT02558660|economic incentive|economic incentive
5230999|NCT02558647|therapy|therapy
5231000|NCT02558647|CBT-I|cbt-i
5231001|NCT02558647|internet-based|internet-based
5231002|NCT02558647|online|online
5231003|NCT02558647|short-term benefits|short-term benefits
5231004|NCT02558647|medium-term outcomes|medium-term outcomes
5231005|NCT02558647|health resource use|health resource use
5231006|NCT02558647|sick leave|sick leave
5231007|NCT02558621|Robotic Spinal Fusion Surgery|robotic spinal fusion surgery
5231008|NCT02558608|Prime Spontaneous Pneumothorax|prime spontaneous pneumothorax
5231009|NCT02558608|recurrence|recurrence
5231010|NCT02558595|PKD|pkd
5231011|NCT02558595|Kidney disease|kidney disease
5231012|NCT02558595|Vitamin B3|vitamin b3
5231013|NCT02558582|Pulmonary arterial hypertension|pulmonary arterial hypertension
5231014|NCT02558582|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5231015|NCT02558582|Rehabilitation|rehabilitation
5231016|NCT02558582|Oxygen|oxygen
5231017|NCT02558569|fentanyl, scalp block|fentanyl, scalp block
5962736|NCT04279015|Pain|pain
5962737|NCT04279015|Quality of Life|quality of life
5962738|NCT04279002|Personality traits|personality traits
5110058|NCT03310086|corticision|corticision
5231018|NCT02558556|Laparoscopic cholecystectomy (LC)|laparoscopic cholecystectomy (lc)
5231019|NCT02558556|Indocyanine green (ICG)|indocyanine green (icg)
5231020|NCT02558556|Near-Infrared Fluorescence Imaging (NIRF)|near-infrared fluorescence imaging (nirf)
5218946|NCT02629419|IL-17/IL-22 autoantibodies from thymoma|il-17/il-22 autoantibodies from thymoma
5218947|NCT02629419|Job's Syndrome (Hyperimmunoglobulin E Syndrome, Buckley Syndrome)|job's syndrome (hyperimmunoglobulin e syndrome, buckley syndrome)
5231021|NCT02558556|Critical View of Safety (CVS)|critical view of safety (cvs)
5231022|NCT02558517|Systemic Lupus Erythematosus|systemic lupus erythematosus
5231023|NCT02558517|Corticosteroids|corticosteroids
5231024|NCT02558517|Chronic disease|chronic disease
5231025|NCT02558491|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5231026|NCT02558491|Artificial Pancreas Project (APP)|artificial pancreas project (app)
5231027|NCT02558491|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5231028|NCT02558491|Insulin Pump|insulin pump
5231029|NCT02558491|Continuous Glucose Monitor|continuous glucose monitor
5231030|NCT02558491|Exercise|exercise
5231031|NCT02558491|Glucose Variability|glucose variability
5231032|NCT02558491|Decision Support System|decision support system
5231033|NCT02558491|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
5231034|NCT02558478|Whole exome sequencing|whole exome sequencing
5231036|NCT02558452|elderly kidney transplant recipient|elderly kidney transplant recipient
5231037|NCT02558452|registry|registry
5231038|NCT02558452|tacrolimus once daily|tacrolimus once daily
5231039|NCT02558426|Chronic Venous Disease|chronic venous disease
5231040|NCT02558426|Estrogen receptors|estrogen receptors
5231041|NCT02558426|GPER|gper
5231042|NCT02558413|Viral Diseases|viral diseases
5231043|NCT02558413|Antiviral|antiviral
5231044|NCT02558413|Paramyxoviridae Infections|paramyxoviridae infections
5231045|NCT02558413|RSV|rsv
5231046|NCT02558413|Respiratory Syncytial Virus|respiratory syncytial virus
5231047|NCT02558413|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5231048|NCT02558413|Aviragen Therapeutics|aviragen therapeutics
5231049|NCT02558413|Aviragen|aviragen
5231050|NCT02558348|Dual receptor Tyrosine Kinase Inhibitor|dual receptor tyrosine kinase inhibitor
5231051|NCT02558348|Anti-angiogenic therapy|anti-angiogenic therapy
5231052|NCT02558257|Advanced Cancers|advanced cancers
5231054|NCT02558257|Questionnaire|questionnaire
5231055|NCT02558244|Childhood Cancer|childhood cancer
5231056|NCT02558244|Image-defined Risk Factors|image-defined risk factors
5231057|NCT02558244|Pediatric Oncology|pediatric oncology
5231058|NCT02558192|LGG|lgg
5231059|NCT02558192|Probiotics|probiotics
5231060|NCT02558192|nosocomial infection prevention|nosocomial infection prevention
5231061|NCT02558192|pediatrics|pediatrics
5231062|NCT02558166|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5231063|NCT02558166|Renal Resistive Index (RRI)|renal resistive index (rri)
5231064|NCT02558153|drug eluting balloon|drug eluting balloon
5231065|NCT02558153|percutaneous balloon angioplasty|percutaneous balloon angioplasty
5231066|NCT02558127|asthma|asthma
5231067|NCT02558127|cystic fibrosis|cystic fibrosis
5231068|NCT02558101|Screening|screening
5231069|NCT02558101|Early detection|early detection
5231070|NCT02558101|Health inequality|health inequality
5231071|NCT02558101|Uptake|uptake
5231072|NCT02558088|salmeterol|salmeterol
5231073|NCT02558088|pharmacokinetics|pharmacokinetics
5231074|NCT02558088|doping|doping
5231075|NCT02558088|beta2-agonists|beta2-agonists
5231076|NCT02558088|long-acting beta2-agonists|long-acting beta2-agonists
5231077|NCT02558062|Ventilator Associated Pneumonia|ventilator associated pneumonia
5231078|NCT02558062|Distal lung|distal lung
5231079|NCT02558049|Patient decision aid|patient decision aid
5231080|NCT02558036|Head Neck Position Videolaryngoscopy|head neck position videolaryngoscopy
5231081|NCT02558023|PRE-ECLAMPSIA|pre-eclampsia
5231082|NCT02558023|URAPIDIL|urapidil
5231083|NCT02558023|NICARDIPINE|nicardipine
5231084|NCT02558010|Methadone|methadone
5231086|NCT02558010|Postoperative Pain|postoperative pain
5231087|NCT02558010|Posterior Spinal Fusion|posterior spinal fusion
5231088|NCT02558010|Pediatric|pediatric
5231089|NCT02557997|HIV reservoir|hiv reservoir
5231090|NCT02557997|HIV-1 DNA|hiv-1 dna
5231091|NCT02557997|Immune activation|immune activation
5231092|NCT02557997|Monocyte function|monocyte function
5231093|NCT02557997|Activation biomarkers|activation biomarkers
5231094|NCT02557984|Dopamine|dopamine
5231095|NCT02557984|Opioid|opioid
5231096|NCT02557984|Reward|reward
5231097|NCT02557958|COPD, pulmonary disease|copd, pulmonary disease
5231098|NCT02557932|PPI standard triple therapy|ppi standard triple therapy
5231099|NCT02557932|Bismuth quadruple therapy|bismuth quadruple therapy
5231100|NCT02557932|Helicobacter|helicobacter
5231101|NCT02557906|Acellular dermal matrix|acellular dermal matrix
5231102|NCT02557906|ADM|adm
5231103|NCT02557906|SurgiMend|surgimend
5231104|NCT02557906|Breast reconstruction|breast reconstruction
5231105|NCT02557906|Immediate breast reconstruction|immediate breast reconstruction
5231106|NCT02557906|Autologous reconstruction|autologous reconstruction
5231107|NCT02557906|Biological mesh|biological mesh
5231108|NCT02557867|dexmedetomidine|dexmedetomidine
5962739|NCT04279002|Anxiety|anxiety
5962740|NCT04279002|Depression|depression
5231109|NCT02557867|pharmacokinetic|pharmacokinetic
5219041|NCT02629055|Respiratory electromyography|respiratory electromyography
5219042|NCT02629042|Anesthesia|anesthesia
5219043|NCT02629042|Corticosteroids|corticosteroids
5219044|NCT02629042|Dental Emergency|dental emergency
5219045|NCT02629042|Irreversible Pulpitis|irreversible pulpitis
5231111|NCT02557841|Cerebellum|cerebellum
5231112|NCT02557841|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5231113|NCT02557841|Motor Learning|motor learning
5231114|NCT02557841|Serial Reaction Time Task|serial reaction time task
5231115|NCT02557841|Handwriting|handwriting
5231116|NCT02557815|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5231117|NCT02557815|Emotion Regulation|emotion regulation
5231118|NCT02557815|Craving|craving
5231119|NCT02557789|Absolute bioavailability|absolute bioavailability
5231120|NCT02557789|Pharmacokinetics|pharmacokinetics
5231121|NCT02557776|BRCA1|brca1
5231122|NCT02557776|BRCA2|brca2
5231123|NCT02557776|hereditary breast cancer|hereditary breast cancer
5231124|NCT02557776|genetic counseling|genetic counseling
5231125|NCT02557763|Oxford UKA|oxford uka
5231126|NCT02557763|anterior knee pain|anterior knee pain
5231127|NCT02557763|lateral facet of patella|lateral facet of patella
5231128|NCT02557750|Childhood Cancer|childhood cancer
5231129|NCT02557750|Pediatric Oncology|pediatric oncology
5231130|NCT02557737|stroke|stroke
5231131|NCT02557737|upper extremity|upper extremity
5231132|NCT02557737|spasticity|spasticity
5231133|NCT02557737|botulinum toxin|botulinum toxin
5231134|NCT02557737|ultrasonography|ultrasonography
5231135|NCT02557737|electric stimulation|electric stimulation
5231136|NCT02557711|spasticity|spasticity
5231137|NCT02557711|stroke|stroke
5231138|NCT02557711|ultrasound elastography|ultrasound elastography
5231139|NCT02557711|acoustic radiation force impulse|acoustic radiation force impulse
5231140|NCT02557659|Low Profile|low profile
5231141|NCT02557659|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5231142|NCT02557659|Endovascular|endovascular
5231143|NCT02557594|Hepatitis B|hepatitis b
5231144|NCT02557568|nasal carriage|nasal carriage
5231145|NCT02557568|Staphylococcus aureus|staphylococcus aureus
5231146|NCT02557568|hemodialysis patients|hemodialysis patients
5231147|NCT02557542|Varicose Veins; One Stop Clinic|varicose veins; one stop clinic
5231148|NCT02557529|Head and Neck Cancer|head and neck cancer
5231149|NCT02557529|Concomitant chemoradiotherapy|concomitant chemoradiotherapy
5231150|NCT02557529|Exercise Training|exercise training
5231151|NCT02557529|Progressive Resistance Training|progressive resistance training
5231152|NCT02557529|Weight loss|weight loss
5231153|NCT02557529|Lean Body Mass|lean body mass
5231154|NCT02557529|Body Composition|body composition
5231155|NCT02557503|TACE; oxaliplatin; fluorouracil; liver cancer|tace; oxaliplatin; fluorouracil; liver cancer
5231156|NCT02557490|TACE; hepatic artery infusion; oxaliplatin; raltitrexed|tace; hepatic artery infusion; oxaliplatin; raltitrexed
5231157|NCT02557464|semantic memory|semantic memory
5231158|NCT02557464|eye movements|eye movements
5231159|NCT02557464|reading|reading
5231160|NCT02557438|Bone|bone
5231161|NCT02557438|Child Health|child health
5231162|NCT02557438|Nutrition|nutrition
5231163|NCT02557425|malaria|malaria
5231164|NCT02557425|infant|infant
5124928|NCT03213886|elderly|elderly
5231165|NCT02557425|pregnancy|pregnancy
5231166|NCT02557425|prophylaxis|prophylaxis
5231167|NCT02557425|dihyroartemisinin-piperaquine|dihyroartemisinin-piperaquine
5231168|NCT02557425|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5231169|NCT02557425|behavior|behavior
5231170|NCT02557425|neurodevelopment|neurodevelopment
5231171|NCT02557425|cognitive|cognitive
5231172|NCT02557399|Clindamycin|clindamycin
5231173|NCT02557399|Gel|gel
5231174|NCT02557399|Benzoyl Peroxide|benzoyl peroxide
5231175|NCT02557399|Acne Vulgaris|acne vulgaris
5231176|NCT02557386|Cruciate ligament surgery|cruciate ligament surgery
5231177|NCT02557386|Adductor canal|adductor canal
5231178|NCT02557386|Nerve block|nerve block
5231179|NCT02557373|rice bran|rice bran
5231181|NCT02557373|stool metabolome and microbiome|stool metabolome and microbiome
5231182|NCT02557373|dietary intervention|dietary intervention
5231191|NCT02557269|Mucoadhesive Treatment|mucoadhesive treatment
5231192|NCT02557269|Nasal Decongestant|nasal decongestant
5231193|NCT02557269|Nasal Antihistamine|nasal antihistamine
5231194|NCT02557269|Nasal Corticosteroid|nasal corticosteroid
5231195|NCT02557256|Childhood Cancer|childhood cancer
5231196|NCT02557256|Abdominal Tumors|abdominal tumors
5231197|NCT02557256|Pelvic Tumors|pelvic tumors
5231198|NCT02557256|Pediatric Oncology|pediatric oncology
5231199|NCT02557243|Childhood Cancer|childhood cancer
5231200|NCT02557243|Soft Tissue Tumors|soft tissue tumors
5231201|NCT02557243|Bone Tumors|bone tumors
5231202|NCT02557243|Extremity Tumor|extremity tumor
5231203|NCT02557243|Pediatric Oncology|pediatric oncology
5231204|NCT02557230|Childhood Cancer|childhood cancer
5219145|NCT02628574|refractory|refractory
5219146|NCT02628574|solid tumors|solid tumors
5219147|NCT02628535|B7-H3-expressing neoplasms|b7-h3-expressing neoplasms
5219148|NCT02628522|ADRC|adrc
5219149|NCT02628522|Celution|celution
5219150|NCT02628509|Acquired Von Willebrand|acquired von willebrand
5219151|NCT02628509|Trans aortic valve replacement|trans aortic valve replacement
5219152|NCT02628509|mechanical circulatory support|mechanical circulatory support
5219153|NCT02628470|Cervical pain, cervicalgia|cervical pain, cervicalgia
5219154|NCT02628457|occupation ratio|occupation ratio
5219155|NCT02628457|pseudoatrophy|pseudoatrophy
5219156|NCT02628444|Dengue Fever|dengue fever
5219157|NCT02628444|Dengue virus|dengue virus
5219158|NCT02628444|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5219163|NCT02628392|Adult|adult
5231205|NCT02557230|Genitourinary tumors|genitourinary tumors
5231206|NCT02557230|urogenital tumors|urogenital tumors
5231207|NCT02557230|Pediatric Oncology|pediatric oncology
5231208|NCT02557204|nasogastric tube insertion|nasogastric tube insertion
5231209|NCT02557204|Video laryngoscope|video laryngoscope
5231210|NCT02557204|success rate|success rate
5231211|NCT02557165|Muscle regeneration|muscle regeneration
5231212|NCT02557113|cement leakage|cement leakage
5231213|NCT02557113|cement augmentation|cement augmentation
5231214|NCT02557113|vertebral body fracture|vertebral body fracture
5231215|NCT02557113|vertebral cavity|vertebral cavity
5231216|NCT02557113|vertebroplasty|vertebroplasty
5231217|NCT02557048|Childhood Cancer|childhood cancer
5231218|NCT02557048|Head and Neck Tumors|head and neck tumors
5231219|NCT02557048|Pediatric Oncology|pediatric oncology
5231220|NCT02557022|Systematic review and meta-analysis|systematic review and meta-analysis
5231221|NCT02557022|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5231222|NCT02557022|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5231223|NCT02557022|Clinical practice guidelines|clinical practice guidelines
5231224|NCT02557022|Glycemic index|glycemic index
5231225|NCT02557022|Glycemic load|glycemic load
5231226|NCT02557022|Body weight|body weight
5231227|NCT02557022|Cardiovascular risk factors|cardiovascular risk factors
5231228|NCT02557022|Cardiovascular disease|cardiovascular disease
5231229|NCT02557009|Hemodynamics|hemodynamics
5231230|NCT02557009|Central Venous Pressure|central venous pressure
5231231|NCT02557009|Pulmonary Artery Pressure|pulmonary artery pressure
5231232|NCT02557009|Cardiac Output|cardiac output
5231233|NCT02556983|Appendicitis|appendicitis
5231234|NCT02556983|Tomography, X-Ray Computed|tomography, x-ray computed
5231235|NCT02556983|Receiver operating characteristic (ROC) Curve|receiver operating characteristic (roc) curve
5231236|NCT02556983|Computer Simulation|computer simulation
5231237|NCT02556944|Depth of focus|depth of focus
5231246|NCT02556918|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
5231247|NCT02556918|Type 2 Diabetes|type 2 diabetes
5231248|NCT02556905|Multiple Myeloma|multiple myeloma
5231249|NCT02556905|Revlimid|revlimid
5231250|NCT02556905|Lenalidomide|lenalidomide
5231251|NCT02556905|Observational|observational
5231252|NCT02556905|Korea|korea
5231253|NCT02556905|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
5231254|NCT02556892|Lymphocytic Leukemia|lymphocytic leukemia
5231255|NCT02556892|Ibrutinib|ibrutinib
5231256|NCT02556892|PCI-32765|pci-32765
5231257|NCT02556892|JNJ-54179060|jnj-54179060
5231258|NCT02556879|Liver transplantation|liver transplantation
5231259|NCT02556879|Graft failure|graft failure
5231260|NCT02556879|Donor specific antibodies|donor specific antibodies
5231261|NCT02556853|Ultrasound|ultrasound
5231262|NCT02556853|Double lumen tube|double lumen tube
5231263|NCT02556840|Monogenic diabetes|monogenic diabetes
5231264|NCT02556840|maturity-onset diabetes of the young|maturity-onset diabetes of the young
5231265|NCT02556840|MODY|mody
5231266|NCT02556840|Pregnancy|pregnancy
5231267|NCT02556840|Gestational diabetes|gestational diabetes
5231268|NCT02556840|Glucokinase|glucokinase
5231269|NCT02556840|Insulin therapy during pregnancy|insulin therapy during pregnancy
5231270|NCT02556840|Evaluation of fetal growth by ultrasonography measurements|evaluation of fetal growth by ultrasonography measurements
5231271|NCT02556827|demodex|demodex
5231272|NCT02556827|oxidative stress|oxidative stress
5228553|NCT02572869|15-244|15-244
5231273|NCT02556827|reflectance confocal microscopy|reflectance confocal microscopy
5231275|NCT02556814|Caffeic Acid|caffeic acid
5231276|NCT02556814|dexamethasone|dexamethasone
5308191|NCT02137915|AMD|amd
5219258|NCT02628054|PSG|psg
5219259|NCT02628054|Typhoid Vaccine|typhoid vaccine
5219260|NCT02628054|Depression|depression
5219261|NCT02628054|Inflammation|inflammation
5219262|NCT02628041|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
5219263|NCT02628041|HDR Monotherapy|hdr monotherapy
5219264|NCT02628041|LDR monotherapy|ldr monotherapy
5219265|NCT02628015|Theory of Mind|theory of mind
5219266|NCT02628015|Very Low Birthweight Infants|very low birthweight infants
5219267|NCT02628002|antigravity treadmill|antigravity treadmill
5219268|NCT02628002|bruce protocol|bruce protocol
5219269|NCT02628002|stress myocardial perfusion imaging|stress myocardial perfusion imaging
5219270|NCT02628002|single photon emission computed tomography|single photon emission computed tomography
5219271|NCT02628002|cardiac catheterization|cardiac catheterization
5219272|NCT02628002|[E01.370.370.380.500]|[e01.370.370.380.500]
5219273|NCT02628002|[E01.370.370.380.250]|[e01.370.370.380.250]
5231277|NCT02556801|Sublingual immunotherapy|sublingual immunotherapy
5100559|NCT03369639|THC|thc
5231278|NCT02556801|Dose range finding|dose range finding
5231279|NCT02556801|Grass pollen|grass pollen
5231280|NCT02556801|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
5231281|NCT02556801|Immunogenicity|immunogenicity
5231282|NCT02556788|Efficacy|efficacy
5231283|NCT02556788|Safety|safety
5231284|NCT02556788|Acne vulgaris|acne vulgaris
5231285|NCT02556762|Esophageal cancer|esophageal cancer
5231286|NCT02556762|Simultaneous modulated accelerated boost|simultaneous modulated accelerated boost
5231287|NCT02556762|Standard dose radiotherapy|standard dose radiotherapy
5231288|NCT02556762|Chemotherapy|chemotherapy
5231289|NCT02556762|Survival|survival
5231290|NCT02556749|Cranberries|cranberries
5231291|NCT02556749|blood pressure|blood pressure
5231292|NCT02556749|cholesterol|cholesterol
5231293|NCT02556749|SphygmoCor|sphygmocor
5231294|NCT02556736|gene therapy|gene therapy
5231295|NCT02556736|optogenetics|optogenetics
5231296|NCT02556736|channelrhodopsin|channelrhodopsin
5231297|NCT02556736|retina|retina
5231298|NCT02556736|retinitis pigmentosa|retinitis pigmentosa
5231299|NCT02556710|Osteoarthritis|osteoarthritis
5231300|NCT02556710|Osteoarthritis of the Knee|osteoarthritis of the knee
5231301|NCT02556684|Breast-Specific Gamma Imaging|breast-specific gamma imaging
5231302|NCT02556684|Locally Advanced Breast Cancer|locally advanced breast cancer
5231303|NCT02556684|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5231305|NCT02556658|Smartpilot View|smartpilot view
5231306|NCT02556658|Hip fracture surgery|hip fracture surgery
5231307|NCT02556658|Depth of anaesthesia|depth of anaesthesia
5231308|NCT02556658|Intraoperative hypotension|intraoperative hypotension
5231309|NCT02556658|Quality of anaesthesia|quality of anaesthesia
5231310|NCT02556645|Combat|combat
5231311|NCT02556645|Psychological Treatment|psychological treatment
5231312|NCT02556645|Military|military
5231313|NCT02556645|Psychotherapy|psychotherapy
5231314|NCT02556645|Trauma|trauma
5231315|NCT02556645|Posttraumatic Stress|posttraumatic stress
5231316|NCT02556645|Posttraumatic Stress Disorder|posttraumatic stress disorder
5231317|NCT02556619|Liver Cancer|liver cancer
5231318|NCT02556619|Randomized Control Trial|randomized control trial
5231319|NCT02556619|Palliative Care|palliative care
5231320|NCT02556619|Liver Cell Carcinoma|liver cell carcinoma
5231321|NCT02556619|Palliative Therapy|palliative therapy
5231322|NCT02556606|ketamine|ketamine
5231323|NCT02556606|depression|depression
5231324|NCT02556606|treatment resistant|treatment resistant
5231325|NCT02556606|treatment resistant depression|treatment resistant depression
5231326|NCT02556606|late life depression|late life depression
5231327|NCT02556606|depression in the elderly|depression in the elderly
5231328|NCT02556606|geriatric depression|geriatric depression
5231329|NCT02556593|Non-Small Cell Lung Cancer|non-small cell lung cancer
5231330|NCT02556593|IMRT|imrt
5231331|NCT02556593|erlotinib|erlotinib
5231332|NCT02556593|whole-brain radiotherapy|whole-brain radiotherapy
5231333|NCT02556580|albumin|albumin
5231334|NCT02556580|surgery|surgery
5231335|NCT02556580|inflammation|inflammation
5231336|NCT02556580|volume kinetics|volume kinetics
5231337|NCT02556567|Sleep patterns|sleep patterns
5231338|NCT02556567|Physical activity|physical activity
5219332|NCT02627625|inhalation|inhalation
5219333|NCT02627625|anticholinergic|anticholinergic
5219334|NCT02627612|veteran|veteran
5219335|NCT02627612|mentorship|mentorship
5219337|NCT02627612|treatment|treatment
5231339|NCT02556567|Fitbit|fitbit
5231340|NCT02556515|CMC1|cmc1
5231341|NCT02556515|arthritis|arthritis
5231342|NCT02556515|degenerative arthritis|degenerative arthritis
5231343|NCT02556515|thumb|thumb
5231344|NCT02556515|interpositional arthroplasty|interpositional arthroplasty
5231345|NCT02556515|total joint replacement|total joint replacement
5231346|NCT02556489|immunological memory|immunological memory
5231347|NCT02556476|critical care|critical care
5231348|NCT02556476|intensive care|intensive care
5231349|NCT02556476|health related quality of life|health related quality of life
5231350|NCT02556476|cost benefit analysis|cost benefit analysis
5231351|NCT02556463|MEDI9197|medi9197
5231352|NCT02556463|TLR 7/8 Agonist|tlr 7/8 agonist
5231353|NCT02556463|Durvalumab|durvalumab
5231354|NCT02556463|MEDI4736|medi4736
5231355|NCT02556463|Imfinzi|imfinzi
5231356|NCT02556437|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
5231357|NCT02556437|MMN|mmn
5231358|NCT02556424|Ophthalmology|ophthalmology
5231359|NCT02556424|Uveitic macular edema|uveitic macular edema
5231360|NCT02556424|Triamcinolone subconjunctival injection|triamcinolone subconjunctival injection
5231361|NCT02556424|Dexamethasone intraocular implant|dexamethasone intraocular implant
5231362|NCT02556372|AIH|aih
5231363|NCT02556372|JKB-122|jkb-122
5231364|NCT02556372|autoimmune|autoimmune
5231365|NCT02556372|hepatitis|hepatitis
5231366|NCT02556346|CD20|cd20
5231367|NCT02556346|immunotoxin|immunotoxin
5962741|NCT04279002|Social support|social support
5231368|NCT02556346|CLL|cll
5231369|NCT02556346|SLL|sll
5231370|NCT02556346|leukemia|leukemia
5231371|NCT02556346|lymphocytic lymphoma|lymphocytic lymphoma
5231372|NCT02556346|lymphocytic leukemia|lymphocytic leukemia
5231374|NCT02556346|relapsed|relapsed
5231375|NCT02556346|refractory|refractory
5231376|NCT02556346|immunotherapy|immunotherapy
5231377|NCT02556346|cancer|cancer
5231378|NCT02556346|antibodies|antibodies
5231379|NCT02556346|safety|safety
5231380|NCT02556346|pharmacokinetics|pharmacokinetics
5231381|NCT02556333|TAF|taf
5231382|NCT02556333|F/TAF|f/taf
5231383|NCT02556333|antiretroviral therapy|antiretroviral therapy
5231384|NCT02556333|TDF|tdf
5231385|NCT02556333|directly observed therapy|directly observed therapy
5231386|NCT02556294|HIV risk behavior|hiv risk behavior
5231387|NCT02556268|Single-Dose, Open-Label, Non-Blinded, Non-Placebo-|single-dose, open-label, non-blinded, non-placebo-
5231388|NCT02556268|Controlled, Stratified Design|controlled, stratified design
5231389|NCT02556255|Peripheral Arterial Disease|peripheral arterial disease
5231390|NCT02556255|Peripheral Artery Disease|peripheral artery disease
5231391|NCT02556255|PAD|pad
5231392|NCT02556255|Atherosclerosis|atherosclerosis
5231393|NCT02556255|Arterial Occlusive Diseases|arterial occlusive diseases
5231394|NCT02556255|Peripheral Vascular Diseases|peripheral vascular diseases
5231395|NCT02556255|PVD|pvd
5231396|NCT02556242|vector control|vector control
5231397|NCT02556242|insecticide|insecticide
5231398|NCT02556229|Aflibercept|aflibercept
5231401|NCT02556216|bone biopsy; bone density|bone biopsy; bone density
5231402|NCT02556203|TAVR|tavr
5231403|NCT02556203|TAVI|tavi
5231404|NCT02556203|Transfemoral aortic valve implantation|transfemoral aortic valve implantation
5231405|NCT02556177|TBI|tbi
5231406|NCT02556177|MR|mr
5231407|NCT02556177|mTBI|mtbi
5231408|NCT02556177|NFL|nfl
5231409|NCT02556177|MRI|mri
5231410|NCT02556164|Electroacupuncture|electroacupuncture
5231411|NCT02556164|Body Worn Sensor|body worn sensor
5231412|NCT02556164|Gait|gait
5231413|NCT02556164|Balance|balance
5231414|NCT02556138|Intragastric Balloon|intragastric balloon
5231415|NCT02556138|ORBERA Intragastric Balloon|orbera intragastric balloon
5231416|NCT02556138|Weight Loss|weight loss
5231417|NCT02556138|BMI >35|bmi >35
5231418|NCT02556125|SCI|sci
5231419|NCT02556125|Respiratory impairment|respiratory impairment
5231420|NCT02556125|Diaphragm pacing|diaphragm pacing
5231421|NCT02556125|Diaphragm stimulation|diaphragm stimulation
5231422|NCT02556073|asthma control|asthma control
5231423|NCT02556073|adherence|adherence
5231424|NCT02556073|asthma self management plan|asthma self management plan
5231425|NCT02556073|airway inflammation|airway inflammation
5231426|NCT02556060|ketamine use disorder|ketamine use disorder
5231427|NCT02556060|lamotrigine|lamotrigine
5231428|NCT02556060|craving|craving
5231429|NCT02556008|Children|children
5231430|NCT02556008|Epilepsy|epilepsy
5231431|NCT02556008|Cannabidiol|cannabidiol
5231432|NCT02555995|AMD|amd
5231433|NCT02555995|OCT|oct
5231434|NCT02555982|Essential Head tremor|essential head tremor
5231435|NCT02555982|Botulinum toxin injections|botulinum toxin injections
5231436|NCT02555982|Quality of life|quality of life
5231437|NCT02555982|Embarrassment assessment|embarrassment assessment
5308531|NCT02136225|gun|gun
5231438|NCT02555956|Macular grid|macular grid
5231439|NCT02555956|Subthreshold|subthreshold
5231440|NCT02555956|diabetic macular edema|diabetic macular edema
5125224|NCT03212118|Absenteeism|absenteeism
5231441|NCT02555956|decrease in visual acuity|decrease in visual acuity
5231442|NCT02555930|HIV|hiv
5231443|NCT02555930|Sensory Neuropathy|sensory neuropathy
5231444|NCT02555891|Prescriptions|prescriptions
5231445|NCT02555891|Epidemiology|epidemiology
5231446|NCT02555891|Health Administration Databases|health administration databases
5231447|NCT02555891|Elderly|elderly
5231448|NCT02555891|STOPP/START criteria|stopp/start criteria
5231449|NCT02555878|Cancer|cancer
5231450|NCT02555878|Rivaroxaban|rivaroxaban
5231451|NCT02555878|Venous thromboembolism|venous thromboembolism
5231452|NCT02555865|etiology|etiology
5231453|NCT02555865|children|children
5231454|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors
5231455|NCT02555852|Pneumonia|pneumonia
5231456|NCT02555852|NSAIDs|nsaids
5231457|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists
5231458|NCT02555852|Drug safety|drug safety
5231459|NCT02555839|Relapsed Multiple Myeloma|relapsed multiple myeloma
5231460|NCT02555839|Refractory Multiple Myeloma|refractory multiple myeloma
5231461|NCT02555839|Pomalidomide|pomalidomide
5231463|NCT02555839|Non-interventional|non-interventional
5231464|NCT02555813|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5231465|NCT02555813|nab-Paclitaxel|nab-paclitaxel
5231466|NCT02555813|Gemcitabine|gemcitabine
5231467|NCT02555813|Non-interventional|non-interventional
5231468|NCT02555800|Laryngeal papillomatosis|laryngeal papillomatosis
5231469|NCT02555800|Cidofovir|cidofovir
5231470|NCT02555800|Bevacizumab|bevacizumab
5231471|NCT02555800|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5231472|NCT02555787|FK506E|fk506e
5231473|NCT02555787|Tacrolimus|tacrolimus
5231474|NCT02555787|Observational|observational
5231475|NCT02555787|Kidney transplantation|kidney transplantation
5231476|NCT02555787|Advagraf|advagraf
5231477|NCT02555774|subjective memory impairment|subjective memory impairment
5231478|NCT02555774|cognitive training|cognitive training
5231479|NCT02555735|pancreatic cancer|pancreatic cancer
5231480|NCT02555696|Metastatic Breast Cancer|metastatic breast cancer
5231481|NCT02555696|nab-paclitaxel|nab-paclitaxel
5231482|NCT02555696|Abraxane|abraxane
5231484|NCT02555683|QAW039|qaw039
5231485|NCT02555670|Muscles|muscles
5231486|NCT02555670|Intensive Care|intensive care
5231487|NCT02555670|Tomography, X-Ray Computed|tomography, x-ray computed
5231488|NCT02555670|Electric Impedance|electric impedance
5231493|NCT02555644|cancer|cancer
5231494|NCT02555631|type 2 diabetes|type 2 diabetes
5231495|NCT02555631|prevention|prevention
5231496|NCT02555631|men|men
5231497|NCT02555618|Vaccine|vaccine
5231498|NCT02555605|children|children
5231499|NCT02555605|dexmedetomidine|dexmedetomidine
5231500|NCT02555605|magnetic resonance imaging scans|magnetic resonance imaging scans
5231501|NCT02555605|deep sedation|deep sedation
5231502|NCT02555605|adverse respiratory events|adverse respiratory events
5231503|NCT02555553|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
5231504|NCT02555553|Mobile Mental Health|mobile mental health
5231506|NCT02555553|Cognitive Behavioral Therapy|cognitive behavioral therapy
5231507|NCT02555553|Eating Disorder Treatment|eating disorder treatment
5231508|NCT02555553|Self-monitoring|self-monitoring
5231509|NCT02555553|Eating Disorders|eating disorders
5231510|NCT02555553|Ecological Momentary Intervention|ecological momentary intervention
5231511|NCT02555501|children|children
5231512|NCT02555501|cancer|cancer
5231513|NCT02555501|stomatitis|stomatitis
5231514|NCT02555501|clinical trial|clinical trial
5231515|NCT02555501|laser therapy, low-level|laser therapy, low-level
5231516|NCT02555501|methylene blue|methylene blue
5231517|NCT02555501|photochemotherapy|photochemotherapy
5231518|NCT02555475|Hepatitis C|hepatitis c
5231519|NCT02555475|primary care|primary care
5231520|NCT02555397|Prostate Cancer|prostate cancer
5231521|NCT02555397|Locally Recurrent|locally recurrent
5231522|NCT02555397|Gene Therapy|gene therapy
5231523|NCT02555397|IL-12|il-12
5231524|NCT02555397|Adenovirus|adenovirus
5231525|NCT02555371|Severe eosinophilic asthma|severe eosinophilic asthma
5231526|NCT02555371|mepolizumab|mepolizumab
5231527|NCT02555371|asthma exacerbation|asthma exacerbation
5231528|NCT02555358|Resectable advanced gastric cancer|resectable advanced gastric cancer
5231529|NCT02555345|classic asthma, cough variant asthma,eosinophilic bronchitis|classic asthma, cough variant asthma,eosinophilic bronchitis
5231530|NCT02555319|Pulmonary Valve|pulmonary valve
5231531|NCT02555319|Transcatheter Pulmonary Valve|transcatheter pulmonary valve
5231532|NCT02555319|Congenital Heart Disease|congenital heart disease
5231533|NCT02555306|Macular Degeneration|macular degeneration
5231534|NCT02555293|Liver resection|liver resection
5231535|NCT02555293|fibrosis|fibrosis
5231536|NCT02555293|inflammation|inflammation
5231537|NCT02555293|Rifaximin|rifaximin
5125322|NCT03211533|MRI|mri
5231538|NCT02555267|geriatric assessment|geriatric assessment
5231539|NCT02555267|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5219536|NCT02626637|children with cancer|children with cancer
5231540|NCT02555267|activity of daily living|activity of daily living
5231541|NCT02555267|instrumental activity of daily living|instrumental activity of daily living
5231542|NCT02555267|Charlson's comorbidity index|charlson's comorbidity index
5231543|NCT02555254|cardiac arrest|cardiac arrest
5231640|NCT02554578|adherence|adherence
5231544|NCT02555254|targeted temperature management|targeted temperature management
5231545|NCT02555254|hypothermia induced|hypothermia induced
5231546|NCT02555254|shockable rhythm|shockable rhythm
5231547|NCT02555241|ASD, Children|asd, children
5231548|NCT02555228|simethicone|simethicone
5231549|NCT02555228|gastroscopy|gastroscopy
5231550|NCT02555228|McNalley score|mcnalley score
5231551|NCT02555215|Pediatrics|pediatrics
5231552|NCT02555202|dyspnea|dyspnea
5231553|NCT02555163|bladder cancer, laser|bladder cancer, laser
5231554|NCT02555137|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5231555|NCT02555137|pulmonary embolism|pulmonary embolism
5231556|NCT02555137|pulmonary hypertension|pulmonary hypertension
5231557|NCT02555137|screening|screening
5231558|NCT02555137|echocardiography|echocardiography
5231559|NCT02555124|Healthy|healthy
5231560|NCT02555124|JNJ-42847922|jnj-42847922
5231561|NCT02555111|thrombosis|thrombosis
5231562|NCT02555072|Yellow Fever Vaccine, immunity evolution|yellow fever vaccine, immunity evolution
5231566|NCT02555046|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5231567|NCT02555046|Endovascular Procedures|endovascular procedures
5231568|NCT02555046|Local Anesthesia|local anesthesia
5231569|NCT02555046|General Anesthesia|general anesthesia
5231570|NCT02555033|Instability resistance training|instability resistance training
5231571|NCT02555033|unstable surface|unstable surface
5231572|NCT02555033|elderly people|elderly people
5231573|NCT02554994|ASPRA cohort|aspra cohort
5231578|NCT02554929|Social Anxiety Disorder|social anxiety disorder
5231579|NCT02554929|Selective Mutism|selective mutism
5231581|NCT02554929|preschool anxiety disorders|preschool anxiety disorders
5231582|NCT02554916|Mobility decline|mobility decline
5231583|NCT02554903|LVAD|lvad
5231584|NCT02554890|Acute|acute
5231585|NCT02554890|Heart Failure|heart failure
5231586|NCT02554890|reduced ejection fraction|reduced ejection fraction
5231587|NCT02554890|NTproBNP|ntprobnp
5231588|NCT02554890|Heart failure with reduced ejection fraction (HFREF)|heart failure with reduced ejection fraction (hfref)
5231589|NCT02554838|Specific phobia|specific phobia
5231590|NCT02554838|Fear of Falling|fear of falling
5231591|NCT02554838|Life-space area|life-space area
5231592|NCT02554812|anti PD-L1|anti pd-l1
5231593|NCT02554812|anti 4-1BB|anti 4-1bb
5231594|NCT02554812|OX40 agonist|ox40 agonist
5231595|NCT02554812|anti M-CSF|anti m-csf
5231596|NCT02554812|TLR9 agonist|tlr9 agonist
5231597|NCT02554812|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5231598|NCT02554812|melanoma|melanoma
5231599|NCT02554812|squamous cell carcinoma of head and neck (SCCHN)|squamous cell carcinoma of head and neck (scchn)
5231600|NCT02554812|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5231601|NCT02554812|gastric cancer|gastric cancer
5231602|NCT02554812|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5231603|NCT02554812|bladder cancer|bladder cancer
5231604|NCT02554812|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5231605|NCT02554812|TGCT/PVNS|tgct/pvns
5231606|NCT02554786|QMF149, Mometasone furoate (MF), asthma|qmf149, mometasone furoate (mf), asthma
5231607|NCT02554773|Hemophilia|hemophilia
5231608|NCT02554773|RNAi therapeutic|rnai therapeutic
5231609|NCT02554721|Healthy Volunteers|healthy volunteers
5231610|NCT02554708|Aneurysm|aneurysm
5231611|NCT02554708|bifurcation|bifurcation
5231612|NCT02554708|wide neck|wide neck
5231614|NCT02554708|intracerebral|intracerebral
5231615|NCT02554708|stroke|stroke
5231616|NCT02554695|adrenergic|adrenergic
5231617|NCT02554682|Adolescent Health|adolescent health
5231618|NCT02554682|Sexual Health|sexual health
5231619|NCT02554682|Parent-Teen Communication|parent-teen communication
5231620|NCT02554682|Teen Driving|teen driving
5231621|NCT02554682|Alcohol Prevention|alcohol prevention
5231622|NCT02554669|Blood glucose (indicated by interstitial glucose)|blood glucose (indicated by interstitial glucose)
5231623|NCT02554669|Markers of systemic inflammation|markers of systemic inflammation
5231624|NCT02554643|intermittent exercise|intermittent exercise
5231625|NCT02554643|continuous exercise|continuous exercise
5231626|NCT02554643|blood glucose|blood glucose
5231627|NCT02554643|intramyocellular lipids|intramyocellular lipids
5231628|NCT02554643|diabetes|diabetes
5231629|NCT02554643|gene expression|gene expression
5231630|NCT02554617|healthy people|healthy people
5231631|NCT02554617|fractional exhaled nitric oxide (FeNo)|fractional exhaled nitric oxide (feno)
5231632|NCT02554617|factors|factors
5231633|NCT02554604|HDL|hdl
5231634|NCT02554604|Preeclampsia|preeclampsia
5231635|NCT02554604|saliva|saliva
5219633|NCT02625948|Intracerebral Hemorrhage|intracerebral hemorrhage
5219634|NCT02625948|tranexamic acid|tranexamic acid
5219635|NCT02625948|spot sign|spot sign
5219636|NCT02625935|Prosigna|prosigna
5231636|NCT02554578|mHealth|mhealth
5231637|NCT02554578|multidisciplinary team|multidisciplinary team
5231638|NCT02554578|immunosuppressive medication|immunosuppressive medication
5231639|NCT02554578|pharmaceutical care|pharmaceutical care
5231641|NCT02554578|heart transplant|heart transplant
5231642|NCT02554578|recipients|recipients
5231643|NCT02554565|Patients with cervical cancer|patients with cervical cancer
5231644|NCT02554552|Osteoarthritis|osteoarthritis
5231645|NCT02554526|hemophilia A|hemophilia a
5231646|NCT02554526|inhibitor|inhibitor
5231647|NCT02554526|bypassing therapy|bypassing therapy
5231648|NCT02554526|factor VIII|factor viii
5231649|NCT02554513|Apraxia of Speech|apraxia of speech
5231650|NCT02554513|Treatment|treatment
5231656|NCT02554474|Physical activity|physical activity
5231657|NCT02554474|Exercise|exercise
5231658|NCT02554474|Rheumatoid|rheumatoid
5231659|NCT02554474|Arthritis|arthritis
5231660|NCT02554474|Lupus|lupus
5231662|NCT02554448|Circulating Tumor Cells|circulating tumor cells
5231663|NCT02554448|rectal Neoplasms|rectal neoplasms
5231664|NCT02554448|neoadjuvant otherapy|neoadjuvant otherapy
5231665|NCT02554435|physical activity|physical activity
5231666|NCT02554435|activity monitor|activity monitor
5231667|NCT02554435|older adults|older adults
5231668|NCT02554435|5 A's counseling|5 a's counseling
5231669|NCT02554409|Fluzone Quadrivalent Intradermal Influenza Vaccine|fluzone quadrivalent intradermal influenza vaccine
5231670|NCT02554409|Pregnancy Registry|pregnancy registry
5231672|NCT02554396|ophthalmology|ophthalmology
5231673|NCT02554396|vision|vision
5231674|NCT02554396|ocular|ocular
5231675|NCT02554383|pediatrics|pediatrics
5231676|NCT02554383|antibiotics|antibiotics
5231677|NCT02554383|placebo|placebo
5231678|NCT02554344|CIN3|cin3
5231679|NCT02554344|Squamous CIN3|squamous cin3
5231680|NCT02554331|Gait|gait
5231681|NCT02554331|REM sleep behavior disorder|rem sleep behavior disorder
5231682|NCT02554331|Parkinson's disease|parkinson's disease
5231683|NCT02554331|Follow-up|follow-up
5231684|NCT02554318|Tempeh|tempeh
5231685|NCT02554318|Body weight|body weight
5231686|NCT02554318|Handgrip strength|handgrip strength
5231687|NCT02554318|6MWT|6mwt
5110884|NCT03304600|OCD|ocd
5231688|NCT02554318|Supplementation|supplementation
5231689|NCT02554318|Wasting|wasting
5231690|NCT02554305|efficacy and safety of fusion Oxygenation System|efficacy and safety of fusion oxygenation system
5231691|NCT02554305|isolated Coronary Artery Bypass Grafting|isolated coronary artery bypass grafting
5231692|NCT02554305|Bypass Grafting|bypass grafting
5231693|NCT02554227|Spondylodiscitis|spondylodiscitis
5231694|NCT02554227|erosive osteochondrosis|erosive osteochondrosis
5231695|NCT02554227|infection|infection
5231696|NCT02554227|cytokine profiles|cytokine profiles
5231697|NCT02554227|lumbar, thoracic spine|lumbar, thoracic spine
5231698|NCT02554227|suPAR|supar
5231699|NCT02554201|pudendal nerve modulation|pudendal nerve modulation
5231700|NCT02554201|transanal/transvaginal electrical stimulation|transanal/transvaginal electrical stimulation
5231701|NCT02554188|Dietary Intervention|dietary intervention
5231702|NCT02554188|Fasting-mimicking|fasting-mimicking
5231703|NCT02554188|Influenza Vaccines|influenza vaccines
5231704|NCT02554175|Propofol|propofol
5231705|NCT02554175|Schnider model|schnider model
5231706|NCT02554162|Satiety, appetite, wholegrain rye|satiety, appetite, wholegrain rye
5231707|NCT02554149|total hip|total hip
5231708|NCT02554149|stem version|stem version
5231709|NCT02554149|replacement|replacement
5231710|NCT02554149|hip|hip
5231711|NCT02554097|laparoscopic transcystic common bile duct exploration|laparoscopic transcystic common bile duct exploration
5231712|NCT02554097|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
5231713|NCT02554097|endoscopic sphincterotomy,|endoscopic sphincterotomy,
5231714|NCT02554097|cost-effective analysis|cost-effective analysis
5231715|NCT02554058|Spinal cord injury|spinal cord injury
5231716|NCT02554058|rehabilitation|rehabilitation
5231717|NCT02554058|cycling|cycling
5231718|NCT02554032|antegrade cerebral perfusion|antegrade cerebral perfusion
5231719|NCT02554032|innominate artery cannulation|innominate artery cannulation
5231720|NCT02554032|axillary artery cannulation|axillary artery cannulation
5231721|NCT02554032|aortic surgery|aortic surgery
5231722|NCT02554032|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
5231723|NCT02554019|SLE, Lupus|sle, lupus
5231724|NCT02554019|IL10, IL-10, BT063, BT-063|il10, il-10, bt063, bt-063
5231725|NCT02553993|Stroke|stroke
5231726|NCT02553993|Cognition|cognition
5231727|NCT02553993|Exergames|exergames
5231728|NCT02553993|Weight shifting|weight shifting
5231729|NCT02553993|Balance|balance
5231730|NCT02553993|Rehabilitation|rehabilitation
5231731|NCT02553980|Physical activity|physical activity
5231732|NCT02553980|Information technology|information technology
5219723|NCT02625519|Controlled ovarian stimulation|controlled ovarian stimulation
5219724|NCT02625519|Follicle-stimulating hormone|follicle-stimulating hormone
5219725|NCT02625519|Receptor N680S follicle-stimulating hormone receptor (FSHR)|receptor n680s follicle-stimulating hormone receptor (fshr)
5219726|NCT02625519|Gene polymorphism|gene polymorphism
5231733|NCT02553980|Middle-aged|middle-aged
5231734|NCT02553980|Health promotion|health promotion
5231735|NCT02553967|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5231736|NCT02553967|Breast reconstructive surgery|breast reconstructive surgery
5231737|NCT02553967|Breast Q questionnaire|breast q questionnaire
5231738|NCT02553954|Mechanisms of Senescence|mechanisms of senescence
5231739|NCT02553954|Senescence markers|senescence markers
5231740|NCT02553915|Omega-3|omega-3
5231742|NCT02553915|Depression|depression
5231743|NCT02553915|Overweight|overweight
5231744|NCT02553915|Inflammation|inflammation
5231745|NCT02553915|Eicosapentaenoic acid|eicosapentaenoic acid
5231746|NCT02553902|Positional therapy|positional therapy
5231747|NCT02553902|MAD|mad
5231748|NCT02553902|Oral appliance|oral appliance
5231749|NCT02553902|Sleep position trainer|sleep position trainer
5231750|NCT02553902|POSA|posa
5231751|NCT02553876|neurostimulation|neurostimulation
5231752|NCT02553876|dorsal root ganglion|dorsal root ganglion
5231753|NCT02553876|hand pain|hand pain
5231754|NCT02553876|upper limb pain|upper limb pain
5231755|NCT02553863|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5231756|NCT02553863|acupuncture|acupuncture
5231757|NCT02553863|pain|pain
5231758|NCT02553863|cost-effectiveness|cost-effectiveness
5231759|NCT02553837|Healthy Volunteers|healthy volunteers
5231760|NCT02553824|binge eating|binge eating
5231761|NCT02553824|bulimia nervosa|bulimia nervosa
5231762|NCT02553824|binge eating disorder|binge eating disorder
5231763|NCT02553824|eating disorder treatment|eating disorder treatment
5231764|NCT02553811|carpal tunnel syndrome|carpal tunnel syndrome
5231765|NCT02553811|clinical examination|clinical examination
5231766|NCT02553811|diagnosis|diagnosis
5231767|NCT02553811|clinical trial|clinical trial
5231768|NCT02553811|median nerve compression|median nerve compression
5231774|NCT02553785|Revivent|revivent
5231775|NCT02553785|Revivent TC|revivent tc
5231776|NCT02553759|observed action|observed action
5231777|NCT02553759|range of motion|range of motion
5231778|NCT02553759|mirror neuron|mirror neuron
5231779|NCT02553746|Ultrasound|ultrasound
5231780|NCT02553746|Spinal anesthesia|spinal anesthesia
5962742|NCT04278976|Competency-Based Education|competency-based education
5111001|NCT03304015|Intervention|intervention
5231781|NCT02553746|Epidural anesthesia|epidural anesthesia
5231782|NCT02553733|Dietary nitrate supplementation|dietary nitrate supplementation
5231783|NCT02553733|Beetroot juice|beetroot juice
5231784|NCT02553720|Post thrombotic syndrome|post thrombotic syndrome
5231785|NCT02553720|Chronic venous insufficiency|chronic venous insufficiency
5231786|NCT02553694|OSA, Apnea|osa, apnea
5231787|NCT02553668|Proteomics|proteomics
5231788|NCT02553668|Oxygen|oxygen
5231789|NCT02553668|Pathways|pathways
5231795|NCT02553590|Non Interventional Study|non interventional study
5231796|NCT02553590|NIS|nis
5231797|NCT02553590|sublingual immunotherapy|sublingual immunotherapy
5231798|NCT02553590|allergen|allergen
5231799|NCT02553590|tree|tree
5231800|NCT02553590|birch|birch
5231801|NCT02553590|alder|alder
5231802|NCT02553577|prenatal|prenatal
5231803|NCT02553577|cytokines|cytokines
5231804|NCT02553538|cancer screening|cancer screening
5231805|NCT02553538|patient navigation|patient navigation
5231806|NCT02553525|Deep Brain Stimulation|deep brain stimulation
5231807|NCT02553525|Movement Disorders|movement disorders
5231808|NCT02553525|Parkinson Disease|parkinson disease
5231809|NCT02553525|Essential Tremor|essential tremor
5231810|NCT02553525|Subthalamic Nucleus|subthalamic nucleus
5231811|NCT02553525|Globus Pallidus|globus pallidus
5231812|NCT02553525|Thalamus|thalamus
5231813|NCT02553525|Tremor|tremor
5231814|NCT02553525|Bradykinesia|bradykinesia
5231815|NCT02553525|Temporal Pattern|temporal pattern
5231816|NCT02553525|Electrical Stimulation|electrical stimulation
5231817|NCT02553525|Neuromodulation|neuromodulation
5231818|NCT02553525|PD|pd
5231819|NCT02553525|ET|et
5231820|NCT02553525|MS|ms
5231821|NCT02553525|STN|stn
5231822|NCT02553525|GPi|gpi
5231823|NCT02553525|DBS|dbs
5231824|NCT02553525|Nervous System Diseases|nervous system diseases
5231825|NCT02553525|Neurodegenerative Diseases|neurodegenerative diseases
5231826|NCT02553499|Solid tumor|solid tumor
5231827|NCT02553499|PD1|pd1
5231828|NCT02553499|PD-L1|pd-l1
5231829|NCT02553499|PDL1|pdl1
5231830|NCT02553486|adoption|adoption
5231831|NCT02553486|children|children
5231832|NCT02553486|quality of life|quality of life
5231833|NCT02553460|Infants|infants
5231834|NCT02553434|pigtail catheter|pigtail catheter
5231835|NCT02553434|small-bore catheter|small-bore catheter
5231836|NCT02553434|trauma|trauma
5231837|NCT02553434|hemothorax|hemothorax
5231838|NCT02553421|infiltration|infiltration
5231839|NCT02553421|extravasation|extravasation
5231840|NCT02553421|peripheral intravenous therapy|peripheral intravenous therapy
5231841|NCT02553356|Female Subjects|female subjects
5231842|NCT02553343|Influenza|influenza
5231843|NCT02553343|High-Dose Quadrivalent Influenza Vaccine|high-dose quadrivalent influenza vaccine
5231949|NCT02552797|CAMHS|camhs
5231844|NCT02553343|High-Dose Trivalent Influenza Vaccine|high-dose trivalent influenza vaccine
5231845|NCT02553330|Hair loss|hair loss
5231846|NCT02553330|alopecia areata|alopecia areata
5231847|NCT02553330|alopecia totalis|alopecia totalis
5231848|NCT02553330|alopecia universalis|alopecia universalis
5231849|NCT02553330|JAK inhibitors|jak inhibitors
5231850|NCT02553330|topical hair growth|topical hair growth
5231851|NCT02553278|abdominoplasty|abdominoplasty
5231852|NCT02553265|Familial dysautonomia (HSAN III)|familial dysautonomia (hsan iii)
5231853|NCT02553265|Norepinephrine|norepinephrine
5231854|NCT02553265|Sympathetic nervous system|sympathetic nervous system
5231855|NCT02553265|Autonomic nervous system|autonomic nervous system
5231856|NCT02553265|Blood pressure variability|blood pressure variability
5231857|NCT02553265|Hypertension|hypertension
5231858|NCT02553265|Carbidopa/Lodosyn|carbidopa/lodosyn
5231859|NCT02553265|Afferent baroreflex failure|afferent baroreflex failure
5231860|NCT02553265|Clinical trial|clinical trial
5231861|NCT02553252|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
5231862|NCT02553252|Sudarshan Kriya Yoga (SKY)|sudarshan kriya yoga (sky)
5231863|NCT02553239|Atrial Fibrillation|atrial fibrillation
5231864|NCT02553239|Paroxysmal|paroxysmal
5231865|NCT02553239|Cryoablation|cryoablation
5231866|NCT02553226|Active phase of labour|active phase of labour
5231867|NCT02553226|Discontinuation|discontinuation
5231868|NCT02553226|Caesarean section|caesarean section
5231869|NCT02553200|intubated patients|intubated patients
5231870|NCT02553200|secretion clearance|secretion clearance
5231871|NCT02553200|lung function|lung function
5231872|NCT02553200|breathing exercise|breathing exercise
5231873|NCT02553161|Depression|depression
5231874|NCT02553148|prevalence|prevalence
5231875|NCT02553148|epidemiology|epidemiology
5231876|NCT02553148|palliative care|palliative care
5231877|NCT02553148|pediatric|pediatric
5231878|NCT02553135|choroideremia, gene therapy|choroideremia, gene therapy
5962743|NCT04278976|Assessment, educational|assessment, educational
5231879|NCT02553122|Blood Loss|blood loss
5231880|NCT02553122|Tranexamic Acid|tranexamic acid
5231881|NCT02553122|Evicel|evicel
5231882|NCT02553109|small paraclinoid|small paraclinoid
5231883|NCT02553096|exacerbations|exacerbations
5231884|NCT02553096|self-management support|self-management support
5962744|NCT04278976|Simulation training|simulation training
5111102|NCT03303313|Renal insufficiency|renal insufficiency
5231885|NCT02553096|software application|software application
5231886|NCT02553031|Application of MR-PET|application of mr-pet
5231887|NCT02553005|Acupuncture|acupuncture
5231888|NCT02553005|Rheumatoid Arthritis|rheumatoid arthritis
5231889|NCT02553005|Quality of life|quality of life
5231890|NCT02553005|Hand Strength|hand strength
5231891|NCT02552979|atopic dermatitis|atopic dermatitis
5231892|NCT02552979|atopic patch test|atopic patch test
5231894|NCT02552927|Jaundice|jaundice
5231895|NCT02552927|Phototherapy|phototherapy
5231896|NCT02552914|Colli-Pee|colli-pee
5231897|NCT02552914|STI|sti
5231898|NCT02552914|first-void urine|first-void urine
5231899|NCT02552901|hepatic|hepatic
5231900|NCT02552901|liver|liver
5231901|NCT02552901|LFT|lft
5231902|NCT02552901|hepatic assessment|hepatic assessment
5231903|NCT02552901|ICG dye|icg dye
5231904|NCT02552901|indocyanine green dye|indocyanine green dye
5231905|NCT02552901|Diagnostic Green|diagnostic green
5231906|NCT02552901|Pulsion|pulsion
5231907|NCT02552901|Akorn|akorn
5231908|NCT02552901|Cardiox|cardiox
5231909|NCT02552901|anazen|anazen
5231910|NCT02552901|essence|essence
5231911|NCT02552901|dye detection monitor|dye detection monitor
5231912|NCT02552901|Earpads|earpads
5231913|NCT02552901|flow sensor|flow sensor
5231914|NCT02552901|scaphoid fossa|scaphoid fossa
5231915|NCT02552901|liver disease|liver disease
5231916|NCT02552901|acute hepatic failure|acute hepatic failure
5231917|NCT02552901|AHF|ahf
5231918|NCT02552901|NASH|nash
5231919|NCT02552901|hepatitis C|hepatitis c
5231920|NCT02552901|cirrhosis|cirrhosis
5231921|NCT02552901|MELD|meld
5231922|NCT02552901|pulse dye densitometry|pulse dye densitometry
5231923|NCT02552901|liver transplant|liver transplant
5231925|NCT02552901|near infra-red|near infra-red
5231926|NCT02552901|serial blood draws|serial blood draws
5231927|NCT02552901|PDR|pdr
5231928|NCT02552901|plasma disappearance rate|plasma disappearance rate
5231929|NCT02552901|R15|r15
5231930|NCT02552901|k coefficient|k coefficient
5231931|NCT02552901|transcutaneously|transcutaneously
5231932|NCT02552901|liver donor|liver donor
5231933|NCT02552901|liver dysfunction|liver dysfunction
5231934|NCT02552901|Child-Pugh|child-pugh
5231935|NCT02552901|AST|ast
5231936|NCT02552901|ALT|alt
5231937|NCT02552901|GGT|ggt
5231938|NCT02552901|alk phos|alk phos
5219922|NCT02624323|ultrasonography|ultrasonography
5219923|NCT02624323|catheterization|catheterization
5219924|NCT02624323|central line|central line
5219925|NCT02624323|mechanical ventilation|mechanical ventilation
5219926|NCT02624323|intensive care|intensive care
5219927|NCT02624323|axillary vein|axillary vein
5219928|NCT02624323|jugular vein|jugular vein
5219929|NCT02624323|randomization|randomization
5219992|NCT02623959|MPE|mpe
5231939|NCT02552901|prothrombin time|prothrombin time
5231940|NCT02552901|albumin|albumin
5231941|NCT02552901|serum ICG|serum icg
5231942|NCT02552901|liver function tests|liver function tests
5231943|NCT02552888|Endothelial Dysfunction|endothelial dysfunction
5231944|NCT02552888|Inflammation|inflammation
5231945|NCT02552875|Acceleromyography|acceleromyography
5231946|NCT02552875|staircase phenomenon|staircase phenomenon
5231947|NCT02552875|tetanic stimulation|tetanic stimulation
5231948|NCT02552797|Shared Decision Making|shared decision making
5231950|NCT02552758|violence|violence
5231952|NCT02552758|omega-3 fatty acid|omega-3 fatty acid
5231953|NCT02552758|schizophrenia|schizophrenia
5231954|NCT02552758|patient|patient
5231955|NCT02552719|Injustice Experience|injustice experience
5231956|NCT02552719|Questionnaire|questionnaire
5231957|NCT02552719|Validation|validation
5231958|NCT02552719|German translation|german translation
5231959|NCT02552706|probiotics|probiotics
5231960|NCT02552706|preterm very low birth weight infants|preterm very low birth weight infants
5231961|NCT02552706|necrotizing enterocolitis|necrotizing enterocolitis
5231962|NCT02552706|gut microflora|gut microflora
5231963|NCT02552706|TLR|tlr
5231964|NCT02552706|NF-KB|nf-kb
5231965|NCT02552706|inflammatory factors|inflammatory factors
5231966|NCT02552693|Enhancing retention|enhancing retention
5231967|NCT02552680|Work-Related Musculoskeletal Disorders|work-related musculoskeletal disorders
5231968|NCT02552680|Quality of life|quality of life
5231969|NCT02552680|Health Education|health education
5231970|NCT02552667|Asthma|asthma
5231971|NCT02552667|Allergic rhinitis|allergic rhinitis
5962745|NCT04278976|Patient simulation|patient simulation
5231972|NCT02552628|Wilson's Disease|wilson's disease
5231973|NCT02552628|Deep Brain Stimulation|deep brain stimulation
5231974|NCT02552628|dystonia|dystonia
5231975|NCT02552615|scoliosis, verticality perception, body symmetry|scoliosis, verticality perception, body symmetry
5231977|NCT02552602|Multivitamins|multivitamins
5231978|NCT02552589|clinical trial, phase III|clinical trial, phase iii
5231979|NCT02552589|plaque index|plaque index
5231980|NCT02552589|gingivitis index|gingivitis index
5231981|NCT02552589|fluoride|fluoride
5231982|NCT02552589|toothpaste|toothpaste
5231983|NCT02552550|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5231984|NCT02552550|swallowing, speech|swallowing, speech
5231985|NCT02552550|quality of life|quality of life
5231986|NCT02552524|pathological gambling|pathological gambling
5231987|NCT02552524|rTMS|rtms
5231988|NCT02552524|cognitive tests|cognitive tests
5231989|NCT02552524|autonomic nervous system|autonomic nervous system
5231990|NCT02552524|craving|craving
5231991|NCT02552472|Asthma|asthma
5231992|NCT02552472|Inhaler Use|inhaler use
5231993|NCT02552472|Adherence|adherence
5231994|NCT02552472|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5231995|NCT02552459|dexmedetomidine|dexmedetomidine
5231996|NCT02552459|patient controlled analgesia|patient controlled analgesia
5231997|NCT02552433|nutritional deficiencies|nutritional deficiencies
5231998|NCT02552433|plastic surgery|plastic surgery
5231999|NCT02552433|post-bariatric|post-bariatric
5232000|NCT02552433|protein|protein
5232001|NCT02552433|skin surplus|skin surplus
5232002|NCT02552420|infrared thermal imaging|infrared thermal imaging
5232003|NCT02552420|deep venous thrombosis|deep venous thrombosis
5232004|NCT02552407|thrombectomy|thrombectomy
5232005|NCT02552407|acute coronary syndromes|acute coronary syndromes
5232006|NCT02552407|percutaneous coronary intervention|percutaneous coronary intervention
5232007|NCT02552407|STEMI|stemi
5232008|NCT02552381|Cancer|cancer
5232009|NCT02552381|Thromboembolic event|thromboembolic event
5125790|NCT03208127|ESLD|esld
5232010|NCT02552381|Fibrin Structure|fibrin structure
5232011|NCT02552381|LMWH|lmwh
5232012|NCT02552368|Stroke Rehabilitation|stroke rehabilitation
5232013|NCT02552368|BCI|bci
5232014|NCT02552368|Stroke|stroke
5232015|NCT02552368|Upper Extremity Rehabilitation|upper extremity rehabilitation
5232016|NCT02552368|paresis|paresis
5232017|NCT02552368|hemiparesis|hemiparesis
5232018|NCT02552329|mild cognitive impairment|mild cognitive impairment
5232019|NCT02552329|Tai Chi|tai chi
5232020|NCT02552329|cognitive functions|cognitive functions
5232021|NCT02552316|microbiome|microbiome
5232022|NCT02552316|bacteria|bacteria
5232023|NCT02552316|NB-UVB Phototherapy|nb-uvb phototherapy
5232024|NCT02552316|light therapy|light therapy
5232025|NCT02552277|Diabetic|diabetic
5232026|NCT02552277|PDA-002|pda-002
5232027|NCT02552277|Placenta-Derived Cells|placenta-derived cells
5232028|NCT02552277|Peripheral neuropathy|peripheral neuropathy
5232029|NCT02552277|Neuropathy|neuropathy
5232030|NCT02552277|Double-Blind|double-blind
5232031|NCT02552277|Safety|safety
5232032|NCT02552277|Efficacy|efficacy
5232033|NCT02552277|Human Placenta-derived Cells|human placenta-derived cells
5232034|NCT02552238|Lumason|lumason
5232035|NCT02552238|Dobutamine stress echo|dobutamine stress echo
5232036|NCT02552238|stress echo|stress echo
5232037|NCT02552238|coronary artery disease|coronary artery disease
5232038|NCT02552225|laryngeal sensory neuropathy, chronic laryngeal neuropathy|laryngeal sensory neuropathy, chronic laryngeal neuropathy
5232039|NCT02552212|Axial Spondyloarthritis|axial spondyloarthritis
5232040|NCT02552212|axSpA|axspa
5232041|NCT02552212|Ankylosing Spondylitis|ankylosing spondylitis
5232042|NCT02552212|Anti TNF-alpha|anti tnf-alpha
5232043|NCT02552212|Certolizumab Pegol|certolizumab pegol
5232044|NCT02552212|Nr-axSpA|nr-axspa
5232045|NCT02552212|Non-radiographic|non-radiographic
5232046|NCT02552212|Spondylarthropathies|spondylarthropathies
5232047|NCT02552212|Arthritis|arthritis
5232048|NCT02552212|Spinal Diseases|spinal diseases
5232049|NCT02552212|Immunosuppressive Agents|immunosuppressive agents
5232050|NCT02552160|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5232051|NCT02552160|Fixed-dose Combination|fixed-dose combination
5232052|NCT02552160|LAMA/LABA (Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists)|lama/laba (long acting beta2-agonists / long acting muscarinic antagonists)
5232054|NCT02552160|Aclidinium/Formoterol|aclidinium/formoterol
5232055|NCT02552160|Glycopyrronium/Indacaterol|glycopyrronium/indacaterol
5232056|NCT02552160|Umeclidinium/Vilanterol|umeclidinium/vilanterol
5232057|NCT02552147|Autism spectrum disorder|autism spectrum disorder
5232058|NCT02552147|Aggression|aggression
5232059|NCT02552147|Irritability|irritability
5232060|NCT02552147|Nicotine|nicotine
5232061|NCT02552147|Nicotinic acetylcholine receptor|nicotinic acetylcholine receptor
5232062|NCT02552147|Nicotinic agonist|nicotinic agonist
5232063|NCT02552147|Adult autism|adult autism
5232064|NCT02552134|Access to physical activity resources, community based exercise programme, sports-clubs, health resort,|access to physical activity resources, community based exercise programme, sports-clubs, health resort,
5232065|NCT02552121|ovary cancer|ovary cancer
5232066|NCT02552121|cervix cancer|cervix cancer
5232067|NCT02552121|endometrium cancer|endometrium cancer
5232068|NCT02552121|bladder cancer|bladder cancer
5232069|NCT02552121|prostate cancer (CRPC)|prostate cancer (crpc)
5232071|NCT02552121|lung cancer (NSCLC)|lung cancer (nsclc)
5232072|NCT02552108|Cognitive-behavioural therapy|cognitive-behavioural therapy
5232073|NCT02552056|Child Adolescent Mental Integration PHC Traditional Healers|child adolescent mental integration phc traditional healers
5232074|NCT02552043|Cystic fibrosis|cystic fibrosis
5232075|NCT02552043|Exercise capacity|exercise capacity
5232076|NCT02552043|Interactive gaming console|interactive gaming console
5232077|NCT02552043|Pulmonary rehabilitation|pulmonary rehabilitation
5232078|NCT02552017|adenoma detection rate|adenoma detection rate
5232080|NCT02552017|Endocuff Vision|endocuff vision
5232081|NCT02552017|colonoscopy|colonoscopy
5232082|NCT02552017|bowel cancer screening|bowel cancer screening
5232083|NCT02552017|bowel cancer|bowel cancer
5232084|NCT02552004|pCLE|pcle
5232085|NCT02552004|Digestive surgery|digestive surgery
5232086|NCT02552004|Endocrine surgery|endocrine surgery
5232087|NCT02551991|Pancreatic cancer|pancreatic cancer
5232088|NCT02551991|MM-398|mm-398
5232089|NCT02551991|Metastatic pancreatic cancer|metastatic pancreatic cancer
5232090|NCT02551991|First line pancreatic cancer treatment|first line pancreatic cancer treatment
5232091|NCT02551978|obesity|obesity
5232092|NCT02551978|child|child
5232093|NCT02551978|primary prevention|primary prevention
5232094|NCT02551978|serious game|serious game
5232095|NCT02551978|nutrition|nutrition
5232096|NCT02551978|physical activity|physical activity
5232097|NCT02551978|psychosocial|psychosocial
5232098|NCT02551978|stress|stress
5232099|NCT02551978|knowledge|knowledge
5232100|NCT02551978|diet|diet
5232101|NCT02551965|Cancer|cancer
5232102|NCT02551965|Patient|patient
5232103|NCT02551965|Oncology|oncology
5232104|NCT02551965|Caregiver|caregiver
5232105|NCT02551952|Games|games
5232106|NCT02551952|Cognitive Tests|cognitive tests
5232107|NCT02551952|General Anesthesia|general anesthesia
5232108|NCT02551952|Surgery|surgery
5232109|NCT02551913|Psychological Theory|psychological theory
5232110|NCT02551913|adolescents|adolescents
5232111|NCT02551900|Type 2 Diabetes|type 2 diabetes
5232112|NCT02551900|Vascular Function|vascular function
5232113|NCT02551900|Water Exercise|water exercise
5232114|NCT02551900|Warm Water|warm water
5232115|NCT02551900|Cold Water|cold water
5232116|NCT02551887|HPV Vaccinations|hpv vaccinations
5232117|NCT02551887|Quadrivalent Vaccine|quadrivalent vaccine
5232118|NCT02551848|Movement disorders|movement disorders
5232119|NCT02551848|Botulinum toxin type A|botulinum toxin type a
5232120|NCT02551848|Kinematics|kinematics
5232121|NCT02551835|ODIN|odin
5232122|NCT02551835|Meta-analysis|meta-analysis
5232123|NCT02551835|Cholecalciferol|cholecalciferol
5232124|NCT02551835|25(OH)D|25(oh)d
5232125|NCT02551835|Subgroup effects|subgroup effects
5232126|NCT02551822|Urge Urinary Incontinence, sacral neuromodulation|urge urinary incontinence, sacral neuromodulation
5232127|NCT02551796|lenticule extraction|lenticule extraction
5232128|NCT02551796|laser in situ keratomileusis|laser in situ keratomileusis
5232129|NCT02551796|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
5232130|NCT02551796|tear|tear
5232131|NCT02551796|inflammatory mediators|inflammatory mediators
5232132|NCT02551783|urethral stricture|urethral stricture
5232133|NCT02551783|urethroplasty|urethroplasty
5232134|NCT02551783|buccal mucosa|buccal mucosa
5232135|NCT02551783|graft|graft
5232136|NCT02551757|Rehabilitation|rehabilitation
5232137|NCT02551757|Continuous Positive Airway Pressure|continuous positive airway pressure
5232138|NCT02551744|histamine-2 receptor antagonist|histamine-2 receptor antagonist
5232139|NCT02551744|proton pump inhibitor|proton pump inhibitor
5232140|NCT02551744|thienopyridine|thienopyridine
5232141|NCT02551744|clopidogrel|clopidogrel
5232142|NCT02551744|prevention|prevention
5232143|NCT02551679|Stem cells|stem cells
5232144|NCT02551679|Autologous|autologous
5232145|NCT02551679|Vascular disease|vascular disease
5232146|NCT02551679|Peripheral arterial disease|peripheral arterial disease
5232147|NCT02551679|Regenerative medicine|regenerative medicine
5232148|NCT02551679|Amputation|amputation
5232149|NCT02551653|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5232150|NCT02551653|Biodistribution|biodistribution
5232151|NCT02551653|Positron Emission Tomography|positron emission tomography
5232152|NCT02551653|[11C]-GSK2256098|[11c]-gsk2256098
5232153|NCT02551653|Healthy subjects|healthy subjects
5232154|NCT02551614|lipopolysaccharide|lipopolysaccharide
5232155|NCT02551614|COPD|copd
5232156|NCT02551614|neutrophil|neutrophil
5232157|NCT02551601|subfoveal choroidal thickness|subfoveal choroidal thickness
5232158|NCT02551601|optical coherence tomography|optical coherence tomography
5232159|NCT02551601|enhanced depth imaging|enhanced depth imaging
5232160|NCT02551588|fibrosis|fibrosis
5232161|NCT02551588|Magnetic resonance imaging|magnetic resonance imaging
5232162|NCT02551549|Subjects|subjects
5232163|NCT02551536|Allergic rhinitis|allergic rhinitis
5232164|NCT02551536|montelukast|montelukast
5232165|NCT02551536|fexofenadine|fexofenadine
5232166|NCT02551536|levocetrizine|levocetrizine
5232167|NCT02551510|Skin Adhesive|skin adhesive
5232168|NCT02551510|Suture|suture
5232170|NCT02551497|volunteer drug interaction study|volunteer drug interaction study
5232171|NCT02551471|Locally advanced rectal cancer|locally advanced rectal cancer
5232172|NCT02551471|Fixed primary rectal cancer|fixed primary rectal cancer
5232173|NCT02551471|Pelvic recurrence|pelvic recurrence
5232174|NCT02551471|Benchmarking France Australia|benchmarking france australia
5232175|NCT02551432|pembrolizumab|pembrolizumab
5232176|NCT02551432|paclitaxel|paclitaxel
5111482|NCT03300804|IBS|ibs
5232177|NCT02551419|mild cognitive impairment|mild cognitive impairment
5232178|NCT02551419|ketones|ketones
5125990|NCT03206931|NTRK2|ntrk2
5232179|NCT02551419|medium chain triglycerides|medium chain triglycerides
5232180|NCT02551419|Positron emission tomography|positron emission tomography
5232181|NCT02551419|magnetic resonance imaging|magnetic resonance imaging
5232182|NCT02551419|cognition|cognition
5232183|NCT02551419|brain|brain
5232184|NCT02551419|neuroimaging|neuroimaging
5232185|NCT02551406|nocturnal hypoventilation|nocturnal hypoventilation
5232186|NCT02551406|capno-oxymetry|capno-oxymetry
5232187|NCT02551393|Older adults|older adults
5232188|NCT02551393|Home Blood Pressure Monitoring|home blood pressure monitoring
5232189|NCT02551367|letrozole|letrozole
5232190|NCT02551354|Labor, Obstetric|labor, obstetric
5232191|NCT02551354|pain|pain
5232192|NCT02551354|pupil diameter|pupil diameter
5232193|NCT02551354|Visual Analogic Scale (VAS)|visual analogic scale (vas)
5232194|NCT02551341|prostatectomy|prostatectomy
5232195|NCT02551341|robotic|robotic
5232196|NCT02551315|Intra-cortical pore volume|intra-cortical pore volume
5232197|NCT02551315|HR-pQCT|hr-pqct
5232198|NCT02551315|DXA|dxa
5232199|NCT02551315|bone mineral density|bone mineral density
5232200|NCT02551315|bone turnover markers|bone turnover markers
5232201|NCT02551315|urinary pentosidine|urinary pentosidine
5232202|NCT02551289|MRI|mri
5232203|NCT02551289|Gluten|gluten
5232204|NCT02551289|Imaging|imaging
5232205|NCT02551289|Enteropathy-Associated T-Cell Lymphoma|enteropathy-associated t-cell lymphoma
5232206|NCT02551263|Breast Cancer|breast cancer
5232207|NCT02551263|Eribulin|eribulin
5232208|NCT02551263|HER2-negative|her2-negative
5232209|NCT02551263|hormone-resistant|hormone-resistant
5232210|NCT02551263|inoperable|inoperable
5232211|NCT02551263|recurrent metastatic|recurrent metastatic
5232212|NCT02551250|hepatocellular carcinoma|hepatocellular carcinoma
5232213|NCT02551250|surveillance|surveillance
5232214|NCT02551250|liver cirrhosis|liver cirrhosis
5232215|NCT02551250|ultrasonography|ultrasonography
5220218|NCT02622516|Physical Therapy Specialty|physical therapy specialty
5220220|NCT02622516|Vertigo|vertigo
5232216|NCT02551250|magnetic resonance imaging|magnetic resonance imaging
5232217|NCT02551237|Elderly patient|elderly patient
5232218|NCT02551237|Radiotherapy|radiotherapy
5232219|NCT02551237|Radio chemotherapy|radio chemotherapy
5232220|NCT02551237|Neoadjuvant treatment|neoadjuvant treatment
5232221|NCT02551224|COPD|copd
5232222|NCT02551198|polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
5232223|NCT02551198|oral sulfate solution|oral sulfate solution
5232224|NCT02551198|bowel preparation|bowel preparation
5232225|NCT02551159|programmed cell death ligand 1 (PD-L1), MEDI4736, Cytotoxic T-lymphocyte-associated antigen 4 {CTLA-4}, PFS, SCCHN|programmed cell death ligand 1 (pd-l1), medi4736, cytotoxic t-lymphocyte-associated antigen 4 {ctla-4}, pfs, scchn
5232226|NCT02551133|Dexamethasone|dexamethasone
5232227|NCT02551133|mastectomy|mastectomy
5232228|NCT02551133|persistent surgical pain|persistent surgical pain
5232229|NCT02551120|Idiopathic hypoparathyroidism|idiopathic hypoparathyroidism
5232230|NCT02551120|Autosomal dominant hypocalcaemia|autosomal dominant hypocalcaemia
5232231|NCT02551120|Pseudohypoparathyroidism|pseudohypoparathyroidism
5232232|NCT02551120|Quality of Life|quality of life
5232233|NCT02551120|Bone Mineral Density|bone mineral density
5232234|NCT02551120|Muscle strength|muscle strength
5232235|NCT02551120|Cardiovascular indices|cardiovascular indices
5232236|NCT02551055|Drug Therapy|drug therapy
5232237|NCT02551042|Digital Ulcers|digital ulcers
5232238|NCT02551042|Raynauds Phenomenon|raynauds phenomenon
5232239|NCT02551042|Factor XIII|factor xiii
5232240|NCT02551029|Magnetic Resonance Imaging|magnetic resonance imaging
5232241|NCT02551029|Brainstem|brainstem
5232242|NCT02551029|Solitary Nucleus|solitary nucleus
5232243|NCT02551029|Visceral Nervous System|visceral nervous system
5232244|NCT02551029|Transient Receptor Potential Channels|transient receptor potential channels
5232245|NCT02550977|Contraception|contraception
5232246|NCT02550977|Transdermal contraceptive patch|transdermal contraceptive patch
5232248|NCT02550977|Efficacy|efficacy
5232249|NCT02550977|Pharmacokinetic|pharmacokinetic
5232250|NCT02550964|Autoimmune Disease|autoimmune disease
5232251|NCT02550964|Rheumatoid Arthritis|rheumatoid arthritis
5232252|NCT02550964|Systemic Lupus Erythematosus|systemic lupus erythematosus
5232253|NCT02550964|Hydroxychloroquine(HCQ)|hydroxychloroquine(hcq)
5232254|NCT02550964|Chloroquine(CQ)|chloroquine(cq)
5232255|NCT02550964|Toxic Maculopathy|toxic maculopathy
5232256|NCT02550925|Cancer survivors|cancer survivors
5232257|NCT02550886|Work Burden|work burden
5232258|NCT02550886|Ambulatory Orthopedic Surgery|ambulatory orthopedic surgery
5232259|NCT02550886|Anesthesiology|anesthesiology
5232260|NCT02550886|Perioperative Care|perioperative care
5232261|NCT02550860|intravenous fat emulsions|intravenous fat emulsions
5232262|NCT02550860|parenteral nutrition|parenteral nutrition
5232263|NCT02550860|skin barrier function|skin barrier function
5232264|NCT02550860|essential fatty acids|essential fatty acids
5232265|NCT02550860|transepidermal water loss|transepidermal water loss
5232267|NCT02550847|pancreatic cancer|pancreatic cancer
5962746|NCT04278976|Quality assurance, Health care|quality assurance, health care
5232268|NCT02550834|Core stability|core stability
5232269|NCT02550834|Indoors curling exercises|indoors curling exercises
5232270|NCT02550834|Motivation|motivation
5232271|NCT02550821|Physical activity levels|physical activity levels
5232272|NCT02550821|Bronchiectasis|bronchiectasis
5232273|NCT02550782|perineural dexmedetomidine|perineural dexmedetomidine
5232274|NCT02550782|infraclavicular perineural catheter|infraclavicular perineural catheter
5232275|NCT02550782|postoperative analgesia|postoperative analgesia
5232276|NCT02550769|Transanal NOTES|transanal notes
5232277|NCT02550769|Transanal TME|transanal tme
5232278|NCT02550769|Laparoscopic Low Anterior Resection|laparoscopic low anterior resection
5232279|NCT02550769|Surgery|surgery
5232280|NCT02550743|Stage II|stage ii
5232281|NCT02550743|Stage III|stage iii
5232282|NCT02550743|Stage IV|stage iv
5232283|NCT02550743|metastatic|metastatic
5232284|NCT02550717|Low-dose Acetylsalicylic Acid,|low-dose acetylsalicylic acid,
5232285|NCT02550717|Bleeding,|bleeding,
5232286|NCT02550717|The Health Improvement Network (THIN),|the health improvement network (thin),
5232287|NCT02550717|Cardiovascular|cardiovascular
5232288|NCT02550717|Secondary prevention of cardiovascular events|secondary prevention of cardiovascular events
5232289|NCT02550704|Irritable Bowel syndrome|irritable bowel syndrome
5232290|NCT02550704|Intestinal permeability|intestinal permeability
5232291|NCT02550704|Visceral hypersensitivity|visceral hypersensitivity
5232292|NCT02550704|Low grade inflammation|low grade inflammation
5232293|NCT02550678|Untreated nBCC|untreated nbcc
5232294|NCT02550678|Low-Risk|low-risk
5232295|NCT02550665|Alzheimer's disease|alzheimer's disease
5232296|NCT02550665|donepezil|donepezil
5232297|NCT02550626|delirium|delirium
5232298|NCT02550626|alpha synucleinopathy|alpha synucleinopathy
5232299|NCT02550626|spine surgery|spine surgery
5232300|NCT02550613|MR/PET, hepatocellular carcinoma, HCC|mr/pet, hepatocellular carcinoma, hcc
5232301|NCT02550600|ARDS|ards
5232302|NCT02550600|Acute lung impairment|acute lung impairment
5220329|NCT02621827|Africa|africa
5232303|NCT02550600|Extracorporeal lung assist|extracorporeal lung assist
5232304|NCT02550600|ECMO|ecmo
5232305|NCT02550600|ECLA|ecla
5232306|NCT02550600|Murray-score|murray-score
5232307|NCT02550600|SOFA-score|sofa-score
5232308|NCT02550587|Patient Satisfaction|patient satisfaction
5232309|NCT02550587|anesthesia Care|anesthesia care
5232310|NCT02550561|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
5232311|NCT02550561|PTNS|ptns
5232313|NCT02550548|Incretins|incretins
5232314|NCT02550548|GLP-1|glp-1
5238011|NCT02514447|SCLC|sclc
5232316|NCT02550548|hyperglycemic clamp|hyperglycemic clamp
5232318|NCT02550535|Gene Therapy|gene therapy
5232319|NCT02550535|WT1 TCR|wt1 tcr
5232320|NCT02550535|Gene modified T cels|gene modified t cels
5232321|NCT02550522|without associated head injury|without associated head injury
5232322|NCT02550509|stroke|stroke
5232323|NCT02550509|Botulinum toxin|botulinum toxin
5232324|NCT02550509|Muscle alterations|muscle alterations
5232325|NCT02550483|Healthy volunteers|healthy volunteers
5232326|NCT02550444|Clonidine|clonidine
5232327|NCT02550444|Anesthesia, Obstetrical|anesthesia, obstetrical
5232328|NCT02550379|Social Anxiety|social anxiety
5232329|NCT02550379|Social Phobia|social phobia
5232330|NCT02550379|Depression|depression
5232331|NCT02550379|Emotion Recognition Training|emotion recognition training
5232332|NCT02550366|Cardiac MRI|cardiac mri
5232333|NCT02550366|Accelerate imaging|accelerate imaging
5232334|NCT02550366|coronary artery disease|coronary artery disease
5232335|NCT02550353|lenticule extraction|lenticule extraction
5232336|NCT02550353|femtosecond laser-assisted laser in situ keratomileusis|femtosecond laser-assisted laser in situ keratomileusis
5232337|NCT02550353|tear|tear
5232338|NCT02550353|inflammatory mediators|inflammatory mediators
5232339|NCT02550340|Arrhythmia|arrhythmia
5232340|NCT02550340|Alcohol|alcohol
5232341|NCT02550340|ECG|ecg
5232342|NCT02550327|resectable|resectable
5232343|NCT02550327|potentially resectable|potentially resectable
5232344|NCT02550327|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5232345|NCT02550327|PDAC|pdac
5232346|NCT02550301|mean platelet volume|mean platelet volume
5232347|NCT02550262|Epidural|epidural
5232348|NCT02550262|Labor analgesia|labor analgesia
5126211|NCT03205462|antibiotic resistance|antibiotic resistance
5232349|NCT02550262|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5232350|NCT02550236|Children|children
5232351|NCT02550236|Obesity|obesity
5232352|NCT02550236|Pregnancy|pregnancy
5232353|NCT02550236|Growth|growth
5232354|NCT02550236|Lifestyle|lifestyle
5232355|NCT02550236|Metabolic and cardiovascular health|metabolic and cardiovascular health
5232356|NCT02550236|Birth|birth
5232357|NCT02550236|Development|development
5232358|NCT02550210|Breast Conserving Surgery|breast conserving surgery
5232363|NCT02550197|Trivalent influenza vaccine|trivalent influenza vaccine
5232364|NCT02550184|Patients with symptoms of acute respiratory problems|patients with symptoms of acute respiratory problems
5232366|NCT02550171|Genetics|genetics
5232367|NCT02550171|DNA|dna
5232368|NCT02550171|Cohort|cohort
5232369|NCT02550171|normal control|normal control
5232370|NCT02550158|Crohn's Disease|crohn's disease
5232371|NCT02550158|Ulcerative Colitis|ulcerative colitis
5232372|NCT02550158|Educational program|educational program
5232373|NCT02550158|Inflammatory Bowel Disease|inflammatory bowel disease
5232374|NCT02550158|Psycho-pedagogic score|psycho-pedagogic score
5232375|NCT02550158|IBD|ibd
5232376|NCT02550145|Hyperinsulinemic|hyperinsulinemic
5232377|NCT02550145|post-bariatric surgery|post-bariatric surgery
5232378|NCT02550132|electromyography|electromyography
5232379|NCT02550132|biomechanical phenomena|biomechanical phenomena
5232380|NCT02550132|dose-response relationship|dose-response relationship
5232381|NCT02550132|musculoskeletal manipulations|musculoskeletal manipulations
5232382|NCT02550132|spinal manipulation|spinal manipulation
5232387|NCT02550093|Volunteers|volunteers
5232388|NCT02550067|HIV infection|hiv infection
5232389|NCT02550067|DepoLevonorgestrel|depolevonorgestrel
5232390|NCT02550067|Contraception|contraception
5232391|NCT02550067|DMPA|dmpa
5232392|NCT02550067|Copper IUD|copper iud
5232393|NCT02550067|Levonorgestrel implant|levonorgestrel implant
5232394|NCT02550067|IUD|iud
5232395|NCT02550041|Bronchitis aspergillus|bronchitis aspergillus
5232396|NCT02550041|cystic fibrosis|cystic fibrosis
5232397|NCT02550028|Neonates|neonates
5232398|NCT02550028|Seizure|seizure
5232399|NCT02550015|Exercise training|exercise training
5232400|NCT02550015|Oxygen consumption|oxygen consumption
5232401|NCT02549989|LY3023414|ly3023414
5232402|NCT02549989|15-079|15-079
5232403|NCT02549989|Persistent Endometrial Cancer|persistent endometrial cancer
5232404|NCT02549976|Crohn's Disease|crohn's disease
5232405|NCT02549976|Digestive Damage|digestive damage
5232406|NCT02549976|Lemann Index|lemann index
5232407|NCT02549950|Accelerated orthodontic tooth movement (AOTM)|accelerated orthodontic tooth movement (aotm)
5232408|NCT02549950|Peizo-corticission|peizo-corticission
5232409|NCT02549937|biliary|biliary
5232410|NCT02549937|pancreatic|pancreatic
5232411|NCT02549937|neuroendocrine|neuroendocrine
5232412|NCT02549937|carcinoid|carcinoid
5232413|NCT02549937|PNET|pnet
5232414|NCT02549937|EP-NET|ep-net
5232415|NCT02549937|extrapancreatic|extrapancreatic
5232416|NCT02549937|sarcoma|sarcoma
5232417|NCT02549937|soft tissue sarcoma|soft tissue sarcoma
5232418|NCT02549937|STS|sts
5232419|NCT02549937|BTC|btc
5232420|NCT02549924|Resveratrol|resveratrol
5232421|NCT02549924|Glycemic Variability|glycemic variability
5232422|NCT02549924|MAGE|mage
5232423|NCT02549911|chemotherapy|chemotherapy
5232424|NCT02549911|surgery|surgery
5232425|NCT02549911|Surgically-Created Resection Cavity|surgically-created resection cavity
5232426|NCT02549911|Adverse Reaction to Drug|adverse reaction to drug
5232427|NCT02549885|Migraine disorders|migraine disorders
5232428|NCT02549885|Muscle stretching exercises|muscle stretching exercises
5232429|NCT02549872|Dementia|dementia
5232430|NCT02549872|Validity|validity
5232431|NCT02549872|Mortality|mortality
5232432|NCT02549872|Electronic health records|electronic health records
5232433|NCT02549859|DBS|dbs
5232434|NCT02549859|Low frequency stimulation|low frequency stimulation
5232435|NCT02549859|Dysphagia|dysphagia
5232436|NCT02549859|Freezing of gait|freezing of gait
5232437|NCT02549833|low-grade glioma|low-grade glioma
5232438|NCT02549833|WHO grade II|who grade ii
5232439|NCT02549833|vaccine|vaccine
5232440|NCT02549833|immunotherapy|immunotherapy
5232441|NCT02549833|glioma|glioma
5232442|NCT02549820|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5232443|NCT02549820|Tracheal Occlusion|tracheal occlusion
5232444|NCT02549807|Vascular hemiplegia|vascular hemiplegia
5232445|NCT02549807|2D ultrasound|2d ultrasound
5232446|NCT02549807|Muscle elasticity|muscle elasticity
5232447|NCT02549807|Pennation angle|pennation angle
5232448|NCT02549794|low concentration contrast agent|low concentration contrast agent
5232449|NCT02549794|Low dose contrast agent|low dose contrast agent
5232450|NCT02549794|computed tomography|computed tomography
5232451|NCT02549781|pathological gambler|pathological gambler
5232452|NCT02549781|Go-Nogo test|go-nogo test
5232453|NCT02549768|Dexmedetomidine|dexmedetomidine
5232454|NCT02549768|Pituitary|pituitary
5126300|NCT03204968|vagus nerve|vagus nerve
5232455|NCT02549768|Transsphenoidal|transsphenoidal
5232456|NCT02549768|Cortisol|cortisol
5232457|NCT02549742|Electrochemotherapy|electrochemotherapy
5232458|NCT02549742|head neck cancer|head neck cancer
5232459|NCT02549742|bleomycin|bleomycin
5232460|NCT02549716|Acetaminophen|acetaminophen
5232461|NCT02549716|interleukin-6|interleukin-6
5232462|NCT02549716|interleukin-1|interleukin-1
5232463|NCT02549716|thromboxane A2|thromboxane a2
5232464|NCT02549703|multiple sclerosis|multiple sclerosis
5232465|NCT02549703|progressive multiple sclerosis|progressive multiple sclerosis
5232466|NCT02549703|mitochondria|mitochondria
5232467|NCT02549703|neurodegeneration|neurodegeneration
5232468|NCT02549690|IVF, Testosterone gel, DHEA, poor responder.|ivf, testosterone gel, dhea, poor responder.
5232469|NCT02549664|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
5232471|NCT02549651|DLBCL|dlbcl
5232472|NCT02549651|MEDI4736|medi4736
5232473|NCT02549651|durvalumab|durvalumab
5232474|NCT02549651|tremelimumab|tremelimumab
5232475|NCT02549651|AZD9150|azd9150
5232476|NCT02549651|anti-PD-L1|anti-pd-l1
5232477|NCT02549651|anti-CTLA-4|anti-ctla-4
5232478|NCT02549651|immunotherapy|immunotherapy
5232479|NCT02549651|IMTC|imtc
5232480|NCT02549651|STAT3|stat3
5232481|NCT02549625|Single right ventricular failure|single right ventricular failure
5232482|NCT02549612|Conductive hearing loss|conductive hearing loss
5232483|NCT02549612|middle ear pressure equalization|middle ear pressure equalization
5232484|NCT02549612|middle ear effusion|middle ear effusion
5232485|NCT02549599|Digital and mobile health|digital and mobile health
5232486|NCT02549599|Sexual and reproductive health|sexual and reproductive health
5232487|NCT02549599|Adolescents and young adults|adolescents and young adults
5232488|NCT02549586|solid organ transplant|solid organ transplant
5232489|NCT02549586|immune tolerance|immune tolerance
5232490|NCT02549586|autologous stem cell transplant|autologous stem cell transplant
5232491|NCT02549586|blood and marrow transplant|blood and marrow transplant
5232492|NCT02549586|autoimmune disease|autoimmune disease
5232493|NCT02549573|Motor Symptoms|motor symptoms
5232494|NCT02549573|Parkinson's disease|parkinson's disease
5232495|NCT02549573|Apokyn|apokyn
5232496|NCT02549573|Apomorphine|apomorphine
5232498|NCT02549560|tDCS|tdcs
5232499|NCT02549560|Cardiac Surgery|cardiac surgery
5232500|NCT02549547|anxiety|anxiety
5232501|NCT02549547|depression|depression
5232502|NCT02549547|exercise|exercise
5232503|NCT02549547|group|group
5232504|NCT02549547|group medical visit|group medical visit
5232505|NCT02549547|mood disorder|mood disorder
5232506|NCT02549547|physical activity|physical activity
5232507|NCT02549547|primary care|primary care
5232508|NCT02549534|Taxane|taxane
5232509|NCT02549534|Neuropathy|neuropathy
5232510|NCT02549534|Chemotherapy-Induced Peripheral Neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
5232511|NCT02549534|Breast Cancer|breast cancer
5220535|NCT02620631|TKA|tka
5232512|NCT02549534|Local skin heating|local skin heating
5232513|NCT02549534|Axon reflex|axon reflex
5232514|NCT02549534|Axon flare|axon flare
5232515|NCT02549534|Total Neuropathy Score (TNS)|total neuropathy score (tns)
5232516|NCT02549534|Laser Doppler Flowmetry (LDF)|laser doppler flowmetry (ldf)
5232517|NCT02549534|Laser Speckle Contrast Imaging (LSCI)|laser speckle contrast imaging (lsci)
5232518|NCT02549534|Full-field laser perfusion imaging (FLPI)|full-field laser perfusion imaging (flpi)
5232519|NCT02549534|Paclitaxel|paclitaxel
5232520|NCT02549534|Taxol|taxol
5232521|NCT02549521|calcium|calcium
5232522|NCT02549521|magnesium|magnesium
5232523|NCT02549521|vitamin D|vitamin d
5232524|NCT02549521|bone turnover markers|bone turnover markers
5232525|NCT02549482|Central volume deficit|central volume deficit
5232526|NCT02549482|Head-up tilt|head-up tilt
5232527|NCT02549482|Systolic pressure variation|systolic pressure variation
5232528|NCT02549456|natural orifice surgery|natural orifice surgery
5232529|NCT02549456|natural orifice specimen extraction|natural orifice specimen extraction
5232530|NCT02549456|taTME|tatme
5232531|NCT02549443|Catabolic response|catabolic response
5232532|NCT02549443|Amino Acids|amino acids
5232533|NCT02549443|Insulin|insulin
5232534|NCT02549430|Advanced breast cancer|advanced breast cancer
5232535|NCT02549430|Postmenopausal|postmenopausal
5232536|NCT02549430|ER positive|er positive
5232537|NCT02549430|Her2 negative|her2 negative
5232538|NCT02549378|microcirculation|microcirculation
5232539|NCT02549378|confocal microscopy|confocal microscopy
5232540|NCT02549378|hypocapnia|hypocapnia
5232541|NCT02549326|Vitamin D|vitamin d
5232542|NCT02549313|brain lesion|brain lesion
5232543|NCT02549313|intracranial pressure|intracranial pressure
5232544|NCT02549313|cerebral perfusion pressure|cerebral perfusion pressure
5232545|NCT02549300|connective tissue massage|connective tissue massage
5232546|NCT02549300|adolescent tension-type headache|adolescent tension-type headache
5232547|NCT02549274|Cervicalgia|cervicalgia
5232548|NCT02549274|self-rehabilitation|self-rehabilitation
5232549|NCT02549274|physiotherapy|physiotherapy
5232550|NCT02549261|nimotuzumab|nimotuzumab
5232551|NCT02549261|non-small cell lung cancer|non-small cell lung cancer
5232552|NCT02549261|radiochemotherapy|radiochemotherapy
5232553|NCT02549261|stage IIIA/IIIB non-small cell lung cancer|stage iiia/iiib non-small cell lung cancer
5232554|NCT02549248|Interstitial Lung Diseases|interstitial lung diseases
5232555|NCT02549248|nanoparticles|nanoparticles
5232556|NCT02549248|lung|lung
5232557|NCT02549248|broncho-alveolar lavage|broncho-alveolar lavage
5232558|NCT02549248|bronchial washings|bronchial washings
5232559|NCT02549235|IVF/ICSI|ivf/icsi
5232560|NCT02549235|Infertility|infertility
5232561|NCT02549235|Septate uterus|septate uterus
5232562|NCT02549235|3D|3d
5232563|NCT02549235|Ultrasound|ultrasound
5232564|NCT02549235|Arcuate uterus|arcuate uterus
5232565|NCT02549222|pathogen reduction|pathogen reduction
5232566|NCT02549222|INTERCEPT|intercept
5232567|NCT02549222|platelet|platelet
5232568|NCT02549222|pulmonary|pulmonary
5232569|NCT02549222|ARDS|ards
5232570|NCT02549222|hematology|hematology
5232571|NCT02549222|oncology|oncology
5232572|NCT02549222|assisted ventilation|assisted ventilation
5232573|NCT02549222|transfusion of platelet components|transfusion of platelet components
5101923|NCT03361098|brain|brain
5111860|NCT03298256|AIS|ais
5232574|NCT02549222|hematology-oncology patients|hematology-oncology patients
5232575|NCT02549209|Pembrolizumab|pembrolizumab
5232576|NCT02549209|Keytruda|keytruda
5232577|NCT02549209|Anti-Programmed [Cell] Death Protein 1 (PD-1) Antibody|anti-programmed [cell] death protein 1 (pd-1) antibody
5232578|NCT02549209|Carboplatin|carboplatin
5232579|NCT02549209|Paclitaxel|paclitaxel
5232580|NCT02549183|Spinal Cord Stimulation|spinal cord stimulation
5232581|NCT02549170|Autoimmune Diseases|autoimmune diseases
5232582|NCT02549170|Polyneuropathies|polyneuropathies
5232583|NCT02549170|Nervous System Diseases|nervous system diseases
5232584|NCT02549170|Peripheral Nervous System Diseases|peripheral nervous system diseases
5232585|NCT02549170|Polyradiculoneuropathy|polyradiculoneuropathy
5232834|NCT02547597|Beta-blockers|beta-blockers
5232586|NCT02549170|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5232587|NCT02549170|Immunoglobulins|immunoglobulins
5232588|NCT02549170|Immune System Diseases|immune system diseases
5232589|NCT02549170|Demyelinating Diseases|demyelinating diseases
5232590|NCT02549170|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
5232591|NCT02549170|Neuromuscular Diseases|neuromuscular diseases
5232592|NCT02549144|HDL biochemical composition and function|hdl biochemical composition and function
5232593|NCT02549105|EMLA CREAM|emla cream
5232594|NCT02549105|LIDOCAINE INFILTERATION|lidocaine infilteration
5232595|NCT02549105|PAIN RELIEF|pain relief
5232596|NCT02549092|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5232597|NCT02549092|levodopa|levodopa
5232598|NCT02549092|carbidopa|carbidopa
5232599|NCT02549092|Advanced Parkinson's Disease|advanced parkinson's disease
5232600|NCT02549092|Non-Motor Symptom Scale NMSS|non-motor symptom scale nmss
5232601|NCT02549092|Parkinson's Disease Sleep Scale PDSS-2|parkinson's disease sleep scale pdss-2
5232602|NCT02549092|efficacy|efficacy
5232603|NCT02549066|cardiopulmonary bypass|cardiopulmonary bypass
5232604|NCT02549066|renal blood flow|renal blood flow
5232605|NCT02549066|renal function|renal function
5232606|NCT02549066|renal oxygenation|renal oxygenation
5232607|NCT02549001|Onychomycosis|onychomycosis
5232608|NCT02549001|Nail fungus|nail fungus
5232609|NCT02548975|Cardiac surgery|cardiac surgery
5232610|NCT02548975|Risk factors|risk factors
5232611|NCT02548975|Postoperative delirium|postoperative delirium
5232612|NCT02548962|Multiple Myeloma|multiple myeloma
5232613|NCT02548962|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5232614|NCT02548962|PCI-32765|pci-32765
5232615|NCT02548962|Pomalidomide|pomalidomide
5232616|NCT02548962|Dexamethasone|dexamethasone
5126493|NCT03203655|Mobile text|mobile text
5232617|NCT02548962|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5232618|NCT02548962|Ibrutinib|ibrutinib
5232619|NCT02548936|Cholesterol, LDL|cholesterol, ldl
5232620|NCT02548936|Carotid Intima-Media Thickness|carotid intima-media thickness
5232621|NCT02548936|Atherosclerosis|atherosclerosis
5232622|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination
5232623|NCT02548936|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5232624|NCT02548897|Parkinson's Disease with Freezing of Gait Symptoms|parkinson's disease with freezing of gait symptoms
5232625|NCT02548858|Perineorrhaphy|perineorrhaphy
5232626|NCT02548858|Pelvic organ prolapse|pelvic organ prolapse
5232627|NCT02548858|Vaginal or abdominal reconstruction|vaginal or abdominal reconstruction
5232629|NCT02548845|hyponatremia|hyponatremia
5232630|NCT02548845|SIADH|siadh
5232631|NCT02548845|Oncologic patients|oncologic patients
5232632|NCT02548832|Berberine|berberine
5232633|NCT02548832|Bezafibrate|bezafibrate
5232634|NCT02548806|Clonidine|clonidine
5232635|NCT02548793|Cardiac Arrest|cardiac arrest
5232636|NCT02548793|CPR|cpr
5232637|NCT02548793|Family-centered Care|family-centered care
5232638|NCT02548793|Health Literacy|health literacy
5232639|NCT02548793|Health Education|health education
5232640|NCT02548793|Education Dissemination|education dissemination
5232641|NCT02548780|unresectable|unresectable
5232642|NCT02548767|High fructose corn syrup|high fructose corn syrup
5232643|NCT02548767|Sugar|sugar
5232644|NCT02548754|atrial fibrillation|atrial fibrillation
5232645|NCT02548754|neuromodulation|neuromodulation
5232646|NCT02548754|inflammation|inflammation
5232647|NCT02548741|Metformin|metformin
5232650|NCT02548741|diabetes complications|diabetes complications
5232652|NCT02548741|Prediabetes|prediabetes
5232653|NCT02548728|Opioid Dependence|opioid dependence
5232654|NCT02548728|Opioid Withdrawal|opioid withdrawal
5232655|NCT02548728|Opioid|opioid
5232656|NCT02548728|Oxytocin|oxytocin
5232657|NCT02548728|OT (oxytocin)|ot (oxytocin)
5232658|NCT02548728|Intranasal administration|intranasal administration
5232659|NCT02548715|thyroxine|thyroxine
5232660|NCT02548715|Otolaryngology|otolaryngology
5232661|NCT02548702|Sport|sport
5232662|NCT02548702|type 2 diabetes|type 2 diabetes
5962747|NCT04278976|Intensive Care|intensive care
5232663|NCT02548702|community intervention programme|community intervention programme
5232664|NCT02548702|Fit4life|fit4life
5232665|NCT02548702|Exercise|exercise
5232666|NCT02548689|alopecia|alopecia
5962748|NCT04278976|Cobatrice|cobatrice
5232667|NCT02548689|hair loss|hair loss
5232668|NCT02548663|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5232669|NCT02548663|sport therapy|sport therapy
5232670|NCT02548663|osteopathic manual treatment|osteopathic manual treatment
5232671|NCT02548663|muscle oxidative metabolism|muscle oxidative metabolism
5232672|NCT02548650|myocardial infarction|myocardial infarction
5232673|NCT02548650|diabetes mellitus|diabetes mellitus
5232674|NCT02548650|vorapaxar|vorapaxar
5232675|NCT02548650|peripheral arterial disease|peripheral arterial disease
5232676|NCT02548585|MEDI0382, diabetes|medi0382, diabetes
5232677|NCT02548572|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
5232678|NCT02548572|TES|tes
5232679|NCT02548572|Retinitis Pigmentosa|retinitis pigmentosa
5232680|NCT02548572|RP|rp
5232681|NCT02548416|Atelectasis|atelectasis
5232682|NCT02548416|Positive End-Expiratory Pressure|positive end-expiratory pressure
5232683|NCT02548416|Oxygenation|oxygenation
5232684|NCT02548416|Anaesthesia|anaesthesia
5232685|NCT02548416|Computed tomography|computed tomography
5232686|NCT02548403|Bowel preparation|bowel preparation
5232687|NCT02548403|Simethicone|simethicone
5232688|NCT02548403|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
5232689|NCT02548390|Phase 1/1b|phase 1/1b
5232690|NCT02548390|open-label|open-label
5232691|NCT02548390|dose-escalation|dose-escalation
5232692|NCT02548390|pharmacokinetics|pharmacokinetics
5232693|NCT02548390|solid tumor|solid tumor
5232694|NCT02548390|metastatic cancer|metastatic cancer
5232695|NCT02548390|chemotherapy|chemotherapy
5232696|NCT02548390|nano formulation|nano formulation
5232697|NCT02548390|alkylator|alkylator
5232698|NCT02548377|Head and Neck Neoplasms|head and neck neoplasms
5232699|NCT02548377|Surgical Flaps|surgical flaps
5232700|NCT02548377|Ischemic Preconditioning|ischemic preconditioning
5232701|NCT02548377|Hemostasis|hemostasis
5232702|NCT02548377|Thrombosis|thrombosis
5232703|NCT02548377|Immune System|immune system
5232704|NCT02548377|Reperfusion Injury|reperfusion injury
5310065|NCT02129426|MRI|mri
5232705|NCT02548364|Vitamin D|vitamin d
5232706|NCT02548364|Myocardial Infarction|myocardial infarction
5232707|NCT02548364|Ventricular remodeling|ventricular remodeling
5232708|NCT02548364|Biomarkers|biomarkers
5232710|NCT02548312|Readers' perceptions|readers' perceptions
5232711|NCT02548299|Diabetes|diabetes
5232712|NCT02548299|Cooking|cooking
5232713|NCT02548299|Nutrition|nutrition
5232714|NCT02548299|Lifestyle Medicine|lifestyle medicine
5232715|NCT02548286|Hypertension|hypertension
5232716|NCT02548286|Healthy male volunteer|healthy male volunteer
5232717|NCT02548286|Candesartan, Amlodipine|candesartan, amlodipine
5232718|NCT02548273|Corneal endothelium|corneal endothelium
5232719|NCT02548273|phacoemulsification|phacoemulsification
5232720|NCT02548247|Stool frequency|stool frequency
5232721|NCT02548247|Bowel motor function|bowel motor function
5232723|NCT02548247|Dietary Fiber|dietary fiber
5232724|NCT02548234|Stroke|stroke
5232725|NCT02548234|Randomized control trial|randomized control trial
5232726|NCT02548234|Mirror therapy|mirror therapy
5232727|NCT02548234|Bilateral arm training|bilateral arm training
5232728|NCT02548234|Comparative efficacy research|comparative efficacy research
5232729|NCT02548234|Neurorehabilitation|neurorehabilitation
5232730|NCT02548221|Thoracentesis|thoracentesis
5232731|NCT02548221|Pleural Effusions|pleural effusions
5233031|NCT02546375|Bosutinib|bosutinib
5232732|NCT02548221|Transthoracic echocardiogram|transthoracic echocardiogram
5232733|NCT02548221|Lung volume measurements|lung volume measurements
5232734|NCT02548195|GEMOX|gemox
5232735|NCT02548195|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5232736|NCT02548195|adjuvant therapy|adjuvant therapy
5232737|NCT02548195|oxaliplatin|oxaliplatin
5232738|NCT02548195|gemcitabine|gemcitabine
5232739|NCT02548195|capecitabine|capecitabine
5232740|NCT02548195|curative surgery|curative surgery
5232741|NCT02548169|Dendritic Cell Vaccine|dendritic cell vaccine
5232742|NCT02548169|FOLFIRINOX|folfirinox
5232743|NCT02548169|nab-paclitaxel|nab-paclitaxel
5232744|NCT02548169|gemcitabine|gemcitabine
5232747|NCT02548117|finasteride|finasteride
5232748|NCT02548091|non invasive ventilation|non invasive ventilation
5232749|NCT02548091|reperfusion pulmonary edema|reperfusion pulmonary edema
5232750|NCT02548091|chronic thrombolic pulmonary hypertension|chronic thrombolic pulmonary hypertension
5232751|NCT02548091|pulmonary artery angioplasty|pulmonary artery angioplasty
5232752|NCT02548078|Protection against Ebola Zaire virus|protection against ebola zaire virus
5232753|NCT02548065|Fibromyalgia Syndrome|fibromyalgia syndrome
5232754|NCT02548065|Balneotherapy|balneotherapy
5232755|NCT02548065|Vetriolo Water|vetriolo water
5232756|NCT02548052|retinoic acid receptor-related orphan receptor (ROR) gamma inverse agonist|retinoic acid receptor-related orphan receptor (ror) gamma inverse agonist
5232757|NCT02548052|Plaque type psoriasis|plaque type psoriasis
5232758|NCT02548052|psoriasis plaque test|psoriasis plaque test
5232759|NCT02548052|Topical|topical
5232760|NCT02548052|GSK2981278|gsk2981278
5232761|NCT02548039|Anovulatory|anovulatory
5232762|NCT02548039|Clomiphene|clomiphene
5232763|NCT02548026|meal frequency|meal frequency
5232764|NCT02548026|eating frequency|eating frequency
5112054|NCT03296670|STEMI|stemi
5232765|NCT02548026|ingestive frequency|ingestive frequency
5232766|NCT02548026|positive energy balance|positive energy balance
5232767|NCT02548026|satiety|satiety
5232768|NCT02548026|appetite|appetite
5232769|NCT02548026|hunger|hunger
5232770|NCT02547987|breast cancer|breast cancer
5232771|NCT02547987|triple negative|triple negative
5232772|NCT02547987|TNBC|tnbc
5232773|NCT02547987|triple negative breast cancer|triple negative breast cancer
5232774|NCT02547974|Safety|safety
5232775|NCT02547974|Immunogenicity|immunogenicity
5232776|NCT02547974|Reactogenicity|reactogenicity
5232777|NCT02547961|breast cancer|breast cancer
5232778|NCT02547961|HER2|her2
5232779|NCT02547961|CAR-T cell|car-t cell
5232780|NCT02547948|CD19|cd19
5232781|NCT02547948|CAR T Cells|car t cells
5232782|NCT02547948|Lymphoma|lymphoma
5232783|NCT02547922|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult|lupus, nephritis, randomized, placebo, anifrolumab, safety, efficacy, adult
5232784|NCT02547896|codeine|codeine
5232785|NCT02547896|diclofenac|diclofenac
5232786|NCT02547896|impacted third molar tooth|impacted third molar tooth
5232787|NCT02547883|Statins|statins
5232788|NCT02547883|Elderly|elderly
5232789|NCT02547883|Mortality|mortality
5232790|NCT02547883|Quality of life|quality of life
5232791|NCT02547883|Randomized trial|randomized trial
5232792|NCT02547883|Cost effectiveness study|cost effectiveness study
5232793|NCT02547883|Primary care|primary care
5232794|NCT02547870|Rilpivirine|rilpivirine
5232795|NCT02547870|Healthy participants|healthy participants
5232796|NCT02547857|Pelvic ultrasound|pelvic ultrasound
5232797|NCT02547857|Transvaginal ultrasound|transvaginal ultrasound
5232798|NCT02547818|Early stage AD|early stage ad
5232799|NCT02547818|MCI|mci
5232800|NCT02547818|aMCI|amci
5232801|NCT02547818|prodromal|prodromal
5232802|NCT02547818|Memory loss|memory loss
5232803|NCT02547818|Memory problems|memory problems
5232804|NCT02547818|Aging|aging
5232805|NCT02547818|Early Alzheimer's Disease|early alzheimer's disease
5232806|NCT02547818|Early AD|early ad
5232807|NCT02547805|Urine Oxalate|urine oxalate
5126701|NCT03202589|Surgery|surgery
5232808|NCT02547805|Nephrolithiasis|nephrolithiasis
5232809|NCT02547805|Kidney Stones|kidney stones
5232810|NCT02547805|Hyperoxaluria|hyperoxaluria
5232811|NCT02547805|Enteric Hyperoxaluria|enteric hyperoxaluria
5232812|NCT02547805|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
5232813|NCT02547805|Urological Diseases|urological diseases
5232814|NCT02547805|Kidney Diseases|kidney diseases
5232815|NCT02547805|Supersaturation|supersaturation
5232816|NCT02547805|Dietary Oxalate|dietary oxalate
5232817|NCT02547792|Influenza B|influenza b
5232818|NCT02547779|crystalloid|crystalloid
5232819|NCT02547779|acute kidney injury|acute kidney injury
5232822|NCT02547753|Tooth extraction|tooth extraction
5232823|NCT02547753|Antibiotic prophylaxis|antibiotic prophylaxis
5232824|NCT02547753|Postoperative complications|postoperative complications
5232825|NCT02547740|macula|macula
5232826|NCT02547740|visual fields|visual fields
5232827|NCT02547740|optical coherence tomography|optical coherence tomography
5232828|NCT02547740|glaucoma progression|glaucoma progression
5232829|NCT02547740|retinal ganglion cells|retinal ganglion cells
5232830|NCT02547727|rabies vaccination|rabies vaccination
5232831|NCT02547714|cyclosporine A|cyclosporine a
5232832|NCT02547610|MR/PET in the evaluation|mr/pet in the evaluation
5232833|NCT02547610|patients|patients
5232835|NCT02547597|Anti-anginal effect|anti-anginal effect
5232836|NCT02547597|Lipid metabolism|lipid metabolism
5232837|NCT02547597|Glucose metabolism|glucose metabolism
5232838|NCT02547571|Outpatient|outpatient
5232839|NCT02547558|Indacaterol|indacaterol
5232840|NCT02547558|Pulmonary gas exchange|pulmonary gas exchange
5232841|NCT02547558|Long-acting bronchodilators|long-acting bronchodilators
5232842|NCT02547532|COPD|copd
5232843|NCT02547532|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5232845|NCT02547519|Type 1 diabetes|type 1 diabetes
5232847|NCT02547519|diabetes mellitus|diabetes mellitus
5232848|NCT02547519|oral insulin|oral insulin
5232849|NCT02547519|oral tolerance|oral tolerance
5232850|NCT02547519|autoantigen|autoantigen
5232851|NCT02547519|self tolerance|self tolerance
5232852|NCT02547519|prevention|prevention
5232853|NCT02547519|at risk for developing type 1 diabetes|at risk for developing type 1 diabetes
5232854|NCT02547519|juvenile diabetes|juvenile diabetes
5232855|NCT02547506|cardiorespiratory fitness|cardiorespiratory fitness
5232856|NCT02547506|group exercise|group exercise
5232857|NCT02547493|Vaccination against Pneumococcal|vaccination against pneumococcal
5232858|NCT02547493|Naïve Abatacept patients|naïve abatacept patients
5232859|NCT02547480|liver|liver
5232860|NCT02547480|metastatic|metastatic
5232861|NCT02547467|mortality|mortality
5232862|NCT02547415|Pain, Chronic|pain, chronic
5232863|NCT02547415|children|children
5232864|NCT02547376|Telomeres|telomeres
5232865|NCT02547376|Telomerase|telomerase
5232866|NCT02547376|Alternative lengthening of Telomeres Mechanism|alternative lengthening of telomeres mechanism
5962749|NCT04278950|Betadine|betadine
5232867|NCT02547285|biomechanics of walking|biomechanics of walking
5232868|NCT02547285|footwear|footwear
5232869|NCT02547272|Intensive care|intensive care
5232870|NCT02547272|S Aureus|s aureus
5232874|NCT02547246|bulimia|bulimia
5232875|NCT02547246|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5232876|NCT02547194|coronary artery bypass grafting|coronary artery bypass grafting
5232877|NCT02547194|saphenous vein|saphenous vein
5232878|NCT02547194|no-touch technique|no-touch technique
5232879|NCT02547181|Fracture|fracture
5232880|NCT02547181|Follow-up|follow-up
5232881|NCT02547181|metacarpal|metacarpal
5232882|NCT02547168|Atrial Fibrillation|atrial fibrillation
5232883|NCT02547168|Symptomatic Atrial Fibrillation|symptomatic atrial fibrillation
5232884|NCT02547168|Asymptomatic Atrial Fibrillation|asymptomatic atrial fibrillation
5232885|NCT02547168|Lung Resection|lung resection
5232886|NCT02547168|Ambulatory Cardiac Monitor|ambulatory cardiac monitor
5232887|NCT02547142|Prospective Pre-Post Evaluation|prospective pre-post evaluation
5232888|NCT02547142|Early Palliative care|early palliative care
5232889|NCT02547142|FACT-E questionnaire|fact-e questionnaire
5232890|NCT02547142|HADS questionnaire|hads questionnaire
5232891|NCT02547142|Patient Health Questionnaire-9 (PHQ-9)|patient health questionnaire-9 (phq-9)
5232892|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate
5232893|NCT02547103|Mupirocin ointment|mupirocin ointment
5232894|NCT02547103|Normal saline|normal saline
5232895|NCT02547103|Peritonitis|peritonitis
5232896|NCT02547103|Peritoneal dialysis|peritoneal dialysis
5232897|NCT02547064|intubation|intubation
5232898|NCT02547064|stylet|stylet
5232899|NCT02547064|videolaryngoscope|videolaryngoscope
5232900|NCT02547038|Helicobacter pylori|helicobacter pylori
5232901|NCT02547038|Eradication rate|eradication rate
5232902|NCT02547025|Helicobacter pylori|helicobacter pylori
5232903|NCT02547025|third-line therapy|third-line therapy
5232904|NCT02547025|antibiotic susceptibility|antibiotic susceptibility
5220915|NCT02618460|healthy volunteers|healthy volunteers
5220917|NCT02618460|renal perfusion|renal perfusion
5220918|NCT02618369|High Intensity Focused Ultrasound|high intensity focused ultrasound
5220919|NCT02618317|renal dialysis|renal dialysis
5232905|NCT02547025|Eradication|eradication
5232906|NCT02547012|Helicobacter pylori|helicobacter pylori
5232907|NCT02547012|Eradication rate|eradication rate
5232908|NCT02547012|Rescue treatment|rescue treatment
5232909|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a
5232910|NCT02546999|Walking|walking
5232911|NCT02546986|CC-486|cc-486
5232912|NCT02546986|Azacitidine|azacitidine
5232913|NCT02546986|Oral azacitidine|oral azacitidine
5232914|NCT02546986|Methyltransferase inhibitor|methyltransferase inhibitor
5232915|NCT02546986|Hypomethylation|hypomethylation
5232916|NCT02546986|Hypomethylating agent|hypomethylating agent
5232917|NCT02546986|Epigenetic|epigenetic
5232918|NCT02546986|MK-3475|mk-3475
5232919|NCT02546986|Pembrolizumab|pembrolizumab
5232920|NCT02546986|Keytruda|keytruda
5232921|NCT02546986|PD-1|pd-1
5232922|NCT02546986|PD-L1|pd-l1
5232923|NCT02546986|ImmunotherapyAdvanced non-small cell lung cancer|immunotherapyadvanced non-small cell lung cancer
5232924|NCT02546986|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
5232925|NCT02546986|Non-small cell lung cancer|non-small cell lung cancer
5232926|NCT02546986|NSCLC|nsclc
5232927|NCT02546986|Merck Pembrolizumab (Keynote-117)|merck pembrolizumab (keynote-117)
5232928|NCT02546960|Healthy|healthy
5232929|NCT02546960|JNJ-63871860|jnj-63871860
5232930|NCT02546960|ExPEC4V|expec4v
5232931|NCT02546947|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5232932|NCT02546947|Neuromuscular Blocking Agents|neuromuscular blocking agents
5232933|NCT02546947|Atracurium|atracurium
5232934|NCT02546947|Mechanical ventilation|mechanical ventilation
5232935|NCT02546947|ARDS|ards
5232936|NCT02546947|partial pressure of oxygen(PaO2) /inspired oxygen (FiO2) < 200|partial pressure of oxygen(pao2) /inspired oxygen (fio2) < 200
5232937|NCT02546947|Positive End Expiratory Pressure (PEEP) > 5 since less than 48 hrs|positive end expiratory pressure (peep) > 5 since less than 48 hrs
5232938|NCT02546934|triple negative breast cancer|triple negative breast cancer
5232939|NCT02546934|fine line chemotherapy|fine line chemotherapy
5232940|NCT02546921|IgE antibody|ige antibody
5232941|NCT02546921|Folate receptor|folate receptor
5232942|NCT02546921|Cancer Immunotherapy|cancer immunotherapy
5232943|NCT02546921|First in class|first in class
5232944|NCT02546908|Prostatic Neoplasms|prostatic neoplasms
5232945|NCT02546908|Non-interventional|non-interventional
5232946|NCT02546908|Observational|observational
5232947|NCT02546895|head and neck cancer patients|head and neck cancer patients
5232948|NCT02546895|clinical data|clinical data
5232949|NCT02546895|tissue collection|tissue collection
5232950|NCT02546895|prospective registration|prospective registration
5232951|NCT02546895|patients|patients
5232952|NCT02546882|stromal vascular fraction|stromal vascular fraction
5232953|NCT02546882|skin graft|skin graft
5232954|NCT02546843|rocuronium|rocuronium
5232955|NCT02546843|sugammadex|sugammadex
5232956|NCT02546843|pediatric anesthesia|pediatric anesthesia
5232957|NCT02546843|cisatracurium|cisatracurium
5232958|NCT02546843|surgical conditions|surgical conditions
5232960|NCT02546817|Tx|tx
5232961|NCT02546817|Prevent|prevent
5962750|NCT04278950|Poviodine Iodine|poviodine iodine
5232962|NCT02546778|Radio frequency|radio frequency
5232963|NCT02546778|Female|female
5232964|NCT02546778|Humans|humans
5232965|NCT02546778|Esthetics|esthetics
5232966|NCT02546765|analgesics|analgesics
5232967|NCT02546765|cardiac surgery|cardiac surgery
5232968|NCT02546765|sedation|sedation
5232969|NCT02546739|Leukemia|leukemia
5232970|NCT02546739|Lymphoma|lymphoma
5232971|NCT02546739|CAR T|car t
5232972|NCT02546726|heat therapy|heat therapy
5232973|NCT02546726|steam-room|steam-room
5232974|NCT02546726|aerobic exercise|aerobic exercise
5232975|NCT02546726|hypertension|hypertension
5232976|NCT02546726|multiple behavior change|multiple behavior change
5232977|NCT02546726|lifestyle modification|lifestyle modification
5232978|NCT02546713|dental implants|dental implants
5232979|NCT02546687|Anastomotic Leak|anastomotic leak
5232980|NCT02546687|Esophagectomy Gastric Pull-up|esophagectomy gastric pull-up
5232981|NCT02546674|Chronic Myeloid Leukemia|chronic myeloid leukemia
5232982|NCT02546674|Nilotinib|nilotinib
5232983|NCT02546674|Molecular Response|molecular response
5232984|NCT02546674|MR4.5|mr4.5
5232985|NCT02546661|Durvalumab|durvalumab
5232986|NCT02546661|Olaparib|olaparib
5232987|NCT02546661|Vistusertib|vistusertib
5232988|NCT02546661|Selumetinib|selumetinib
5232989|NCT02546661|Muscle invasive bladder cancer|muscle invasive bladder cancer
5232990|NCT02546661|MIBC|mibc
5232991|NCT02546661|BISCAY|biscay
5232992|NCT02546661|MEDI4736|medi4736
5232993|NCT02546661|AZD4547|azd4547
5232995|NCT02546661|AZD1775|azd1775
5232996|NCT02546661|AZD2014|azd2014
5232997|NCT02546661|AZD9150|azd9150
5232998|NCT02546661|AZD6244|azd6244
5232999|NCT02546622|Factor|factor
5233000|NCT02546622|Coagulation|coagulation
5233001|NCT02546622|Inhibitor|inhibitor
5233002|NCT02546622|HTC|htc
5233003|NCT02546622|Bleeding|bleeding
5233004|NCT02546557|CABG|cabg
5233005|NCT02546557|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5233006|NCT02546544|Linsitinib|linsitinib
5233007|NCT02546544|anti-IGF-1R/IR|anti-igf-1r/ir
5233008|NCT02546544|Ewing Sarcoma|ewing sarcoma
5233009|NCT02546544|dual IGF-1R/IR inhibition|dual igf-1r/ir inhibition
5233010|NCT02546544|Relapsed Ewing Sarcoma|relapsed ewing sarcoma
5233011|NCT02546544|Refractory Ewing Sarcoma|refractory ewing sarcoma
5233012|NCT02546544|Metastatic Ewing Sarcoma|metastatic ewing sarcoma
5233013|NCT02546518|Conductive hearing loss|conductive hearing loss
5233014|NCT02546518|Middle ear effusion|middle ear effusion
5233015|NCT02546518|Middle ear pressure equalization|middle ear pressure equalization
5233016|NCT02546505|Consumer behavior|consumer behavior
5233017|NCT02546505|Nutrition Labeling|nutrition labeling
5233018|NCT02546479|Mortality|mortality
5233019|NCT02546479|Radiation|radiation
5233020|NCT02546479|Spine deformities|spine deformities
5233021|NCT02546466|low back pain|low back pain
5233022|NCT02546466|functional taping|functional taping
5233023|NCT02546466|balance|balance
5233024|NCT02546466|posture|posture
5233025|NCT02546466|rehabilitation|rehabilitation
5233026|NCT02546466|psychosocial factors|psychosocial factors
5233027|NCT02546466|minimal intervention strategy|minimal intervention strategy
5233028|NCT02546453|high risk solid tumor pediatric, genetic alteration, Metastatic solid tumor pediatric|high risk solid tumor pediatric, genetic alteration, metastatic solid tumor pediatric
5233029|NCT02546414|Platelet count/spleen diameter ratio|platelet count/spleen diameter ratio
5233032|NCT02546375|chronic myeloid leukaemia|chronic myeloid leukaemia
5233033|NCT02546375|retrospective|retrospective
5233034|NCT02546375|observational|observational
5233035|NCT02546349|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5233036|NCT02546349|airway inflammation|airway inflammation
5233037|NCT02546349|eosinophilic airway inflammation|eosinophilic airway inflammation
5233038|NCT02546349|exhaled nitric oxide|exhaled nitric oxide
5233039|NCT02546336|Ultrasound Guidance|ultrasound guidance
5233040|NCT02546336|Cooled Radiofrequency|cooled radiofrequency
5233041|NCT02546336|Hip Denervation|hip denervation
5233042|NCT02546323|Rosuvastatin 20 mg treatment, Carotid Intima-Media Thickness, Chinese subjects, Subclinical atherosclerosis|rosuvastatin 20 mg treatment, carotid intima-media thickness, chinese subjects, subclinical atherosclerosis
5233043|NCT02546297|LAMA,ICS+LABA,LAMA+LABA|lama,ics+laba,lama+laba
5233045|NCT02546258|Fungal Nail|fungal nail
5233046|NCT02546232|locally advanced breast cancer|locally advanced breast cancer
5233047|NCT02546232|metastatic breast cancer|metastatic breast cancer
5233048|NCT02546219|eosinophilic esophagitis|eosinophilic esophagitis
5233049|NCT02546219|EoE|eoe
5233050|NCT02546219|integrins|integrins
5233051|NCT02546206|Bifidobacterium|bifidobacterium
5233052|NCT02546206|Gingivitis|gingivitis
5233053|NCT02546206|Gingival crevicular fluid|gingival crevicular fluid
5233054|NCT02546206|Interleukin-1beta|interleukin-1beta
5233055|NCT02546206|Probiotics|probiotics
5233056|NCT02546180|Patient education|patient education
5233057|NCT02546180|Preoperative anxiety|preoperative anxiety
5233058|NCT02546154|Iron|iron
5233059|NCT02546154|Anaemia|anaemia
5233060|NCT02546154|Anaemia, Iron-Deficiency|anaemia, iron-deficiency
5230463|NCT02561780|Stigma|stigma
5233062|NCT02546154|Inflammatory Bowel Diseases|inflammatory bowel diseases
5112364|NCT03294759|amion|amion
5233063|NCT02546154|Fatigue|fatigue
5233064|NCT02546076|Keloid|keloid
5233065|NCT02546076|Hypertrophic scars|hypertrophic scars
5233066|NCT02546076|Er-YAG Lasers|er-yag lasers
5233067|NCT02546050|Gut microbiota|gut microbiota
5233068|NCT02546050|metformin|metformin
5233069|NCT02546050|Metabolism|metabolism
5233070|NCT02546050|Metagenomics|metagenomics
5233071|NCT02546050|Metabolomics|metabolomics
5233072|NCT02546037|coagulation|coagulation
5233073|NCT02546037|haemodialysis|haemodialysis
5233074|NCT02546024|Major depressive disorder|major depressive disorder
5233075|NCT02546024|late-onset|late-onset
5233076|NCT02546024|treatment response|treatment response
5233077|NCT02546024|predictors|predictors
5233078|NCT02546024|moderators|moderators
5233079|NCT02545998|Telehealthcare|telehealthcare
5233080|NCT02545985|sirolimus|sirolimus
5233081|NCT02545985|coronary stent|coronary stent
5233082|NCT02545985|Prolim|prolim
5233083|NCT02545972|immunosuppression|immunosuppression
5233084|NCT02545959|Intrathecal Rituximab|intrathecal rituximab
5233085|NCT02545959|intrathecal chemotherapy|intrathecal chemotherapy
5233086|NCT02545959|cerebrospinal fluid|cerebrospinal fluid
5233087|NCT02545959|lumbar puncture|lumbar puncture
5233088|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs
5233089|NCT02545959|Rituximab|rituximab
5233090|NCT02545946|traditional incision and drainage|traditional incision and drainage
5221110|NCT02617160|Pump Advisor|pump advisor
5221111|NCT02617108|uterine septum|uterine septum
5221112|NCT02617108|intrauterine adhesions|intrauterine adhesions
5233091|NCT02545946|minimally invasive incision and drainage|minimally invasive incision and drainage
5233092|NCT02545946|vessel loop|vessel loop
5233093|NCT02545946|emergency department|emergency department
5233094|NCT02545946|pediatrics|pediatrics
5233095|NCT02545933|prasugrel|prasugrel
5233096|NCT02545933|ticagrelor|ticagrelor
5233097|NCT02545933|vorapaxar|vorapaxar
5127119|NCT03199807|HCC|hcc
5233098|NCT02545920|haemodialysis|haemodialysis
5233099|NCT02545920|hypotension|hypotension
5233100|NCT02545907|Amyloidosis|amyloidosis
5233101|NCT02545907|AL Amyloidosis|al amyloidosis
5233102|NCT02545855|myAIRVO2|myairvo2
5233103|NCT02545855|high-flow nasal cannula therapy|high-flow nasal cannula therapy
5233104|NCT02545855|home oxygen therapy|home oxygen therapy
5233106|NCT02545790|coarctation of aorta|coarctation of aorta
5233107|NCT02545790|aortic stenosis|aortic stenosis
5233108|NCT02545790|biomarkers|biomarkers
5233109|NCT02545790|cardiac hypertrophy|cardiac hypertrophy
5233110|NCT02545777|Acute gouty arthritis|acute gouty arthritis
5233111|NCT02545777|tonifying spleen and descending the turbid|tonifying spleen and descending the turbid
5233112|NCT02545777|soaking|soaking
5233113|NCT02545777|wet wrapping|wet wrapping
5233114|NCT02545764|Gait Analysis|gait analysis
5233115|NCT02545764|Knee Adduction Moment|knee adduction moment
5233116|NCT02545764|Physiotherapy|physiotherapy
5233117|NCT02545764|Obesity|obesity
5233118|NCT02545751|Esophageal cancer|esophageal cancer
5233119|NCT02545751|Metastatic esophageal cancer|metastatic esophageal cancer
5233120|NCT02545751|Radiotherapy|radiotherapy
5233121|NCT02545751|Thymalfasin|thymalfasin
5233122|NCT02545751|ZADAXIN's®|zadaxin's®
5233123|NCT02545751|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5233124|NCT02545725|Colorectal Cancer|colorectal cancer
5233125|NCT02545725|Quality of life|quality of life
5233126|NCT02545725|Questionnaires|questionnaires
5233127|NCT02545712|Ethanol|ethanol
5233128|NCT02545712|Propylene glycol|propylene glycol
5233129|NCT02545712|Benzyl alcohol|benzyl alcohol
5233130|NCT02545712|Acesulfam potassium|acesulfam potassium
5233131|NCT02545712|Aspartame|aspartame
5233132|NCT02545712|Glycerin|glycerin
5233133|NCT02545712|Sorbitol|sorbitol
5233134|NCT02545712|Methyl-p-hydroxybenzoate|methyl-p-hydroxybenzoate
5233135|NCT02545712|Propanyl-p-hydroxybenzoate|propanyl-p-hydroxybenzoate
5233136|NCT02545712|Patients|patients
5233137|NCT02545699|Adenoma|adenoma
5233138|NCT02545699|Polyp|polyp
5233140|NCT02545699|Colonoscopy|colonoscopy
5233141|NCT02545699|Detection Yield|detection yield
5233142|NCT02545673|Intervention Studies|intervention studies
5233143|NCT02545673|Access to Health Care|access to health care
5233144|NCT02545673|Social Stigma|social stigma
5233145|NCT02545673|Social Support|social support
5233146|NCT02545634|probiotic|probiotic
5233147|NCT02545634|ADHD|adhd
5233148|NCT02545634|anxiety|anxiety
5233149|NCT02545634|digestive health|digestive health
5233150|NCT02545634|children|children
5233151|NCT02545634|attention deficit|attention deficit
5233152|NCT02545634|gut brain axis|gut brain axis
5233153|NCT02545634|nutritional supplement|nutritional supplement
5233154|NCT02545634|microbiome|microbiome
5233155|NCT02545621|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5233156|NCT02545621|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5233157|NCT02545621|Monocyte/Macrophage activation|monocyte/macrophage activation
5233158|NCT02545621|Fluorescence-Activated Cell Sorting (FACS) analysis|fluorescence-activated cell sorting (facs) analysis
5962751|NCT04278950|CRS|crs
5962752|NCT04278950|Biofilm|biofilm
5112552|NCT03293602|PET|pet
5233159|NCT02545621|Thioredoxin interacting protein (TXNIP)|thioredoxin interacting protein (txnip)
5233160|NCT02545621|NOD-like receptor family, pyrin domain containing 3 (NLRP3)|nod-like receptor family, pyrin domain containing 3 (nlrp3)
5233161|NCT02545621|Inflammasome|inflammasome
5233162|NCT02545595|General anaesthesia|general anaesthesia
5233163|NCT02545595|Curarization with rocuronium|curarization with rocuronium
5233164|NCT02545556|Liver Cancer|liver cancer
5233165|NCT02545556|HepaSphere|hepasphere
5233166|NCT02545556|cryosurgery|cryosurgery
5233167|NCT02545530|renal dialysis|renal dialysis
5233168|NCT02545530|hypertension|hypertension
5233169|NCT02545530|clonidine|clonidine
5233170|NCT02545517|Rabies disease|rabies disease
5233171|NCT02545517|Pre-exposure (PrEP) or post exposure prophylaxis (PEP)|pre-exposure (prep) or post exposure prophylaxis (pep)
5233172|NCT02545517|Long-term Immunogenicity|long-term immunogenicity
5233173|NCT02545504|Gastroesophageal junction (GEJ)|gastroesophageal junction (gej)
5233174|NCT02545504|Stomach cancer|stomach cancer
5233175|NCT02545491|CCD|ccd
5233176|NCT02545491|Child development|child development
5233177|NCT02545491|daycare|daycare
5233178|NCT02545491|caregiver|caregiver
5233179|NCT02545478|septic shock|septic shock
5233180|NCT02545478|infection|infection
5233181|NCT02545478|inflammation|inflammation
5233182|NCT02545478|pathologic process|pathologic process
5233183|NCT02545478|biomarkers|biomarkers
5233184|NCT02545465|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5233185|NCT02545465|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
5233186|NCT02545465|Persistent Chronic Thromboembolic Pulmonary Hypertension|persistent chronic thromboembolic pulmonary hypertension
5233187|NCT02545465|Recurrent Chronic Thromboembolic Pulmonary Hypertension|recurrent chronic thromboembolic pulmonary hypertension
5233188|NCT02545465|Switch of therapy|switch of therapy
5233189|NCT02545465|Titration phase|titration phase
5233190|NCT02545465|Retrospective chart review|retrospective chart review
5233191|NCT02545439|Alkermes|alkermes
5233192|NCT02545439|Samidorphan|samidorphan
5233193|NCT02545439|ALKS 5461|alks 5461
5233194|NCT02545439|Healthy Volunteer|healthy volunteer
5233195|NCT02545439|Pharmacokinetics|pharmacokinetics
5233196|NCT02545426|myocardial stunning|myocardial stunning
5233197|NCT02545426|dialysate calcium concentration|dialysate calcium concentration
5233198|NCT02545426|nutritional status|nutritional status
5233199|NCT02545426|hemodinamic|hemodinamic
5233200|NCT02545426|hemodialysis|hemodialysis
5233201|NCT02545374|chronic wound|chronic wound
5233203|NCT02545374|telemedicine|telemedicine
5233204|NCT02545374|wounds consultation|wounds consultation
5233205|NCT02545374|Smartphone|smartphone
5233206|NCT02545296|In-vitro Diagnostics|in-vitro diagnostics
5233207|NCT02545296|paediatrics|paediatrics
5233208|NCT02545270|Surgery, Laparoscopic|surgery, laparoscopic
5233209|NCT02545270|surgical rating scale|surgical rating scale
5233210|NCT02545257|Aged people|aged people
5233211|NCT02545257|Home care|home care
5233212|NCT02545257|Drug related problems, DRPs|drug related problems, drps
5233213|NCT02545257|Coordinated medication management model|coordinated medication management model
5233214|NCT02545244|Gingivitis, Black Tea, Green Tea,Chlorhexidine, Biofilm,|gingivitis, black tea, green tea,chlorhexidine, biofilm,
5233215|NCT02545218|Perineum. Perineorraphy. Pelvic floor exercise.|perineum. perineorraphy. pelvic floor exercise.
5233216|NCT02545205|Rehabilitation|rehabilitation
5233217|NCT02545205|Robotics|robotics
5233218|NCT02545192|PTSD|ptsd
5233219|NCT02545166|Stroke|stroke
5233220|NCT02545166|Purines|purines
5233221|NCT02545166|SMARTChip|smartchip
5233222|NCT02545166|Ischaemia|ischaemia
5233223|NCT02545166|Carotid endarterectomy|carotid endarterectomy
5233224|NCT02545166|Biosensor|biosensor
5233622|NCT02542618|Treatment|treatment
5233225|NCT02545140|risk factors|risk factors
5233226|NCT02545140|screening|screening
5233227|NCT02545140|adolescents|adolescents
5233228|NCT02545127|inadequate milk production|inadequate milk production
5233229|NCT02545114|Hyponatremia|hyponatremia
5233251|NCT02544932|endothelium|endothelium
5233252|NCT02544919|SMOF|smof
5233253|NCT02544919|neurological complications|neurological complications
5233254|NCT02544919|neurotoxicity|neurotoxicity
5233255|NCT02544919|liver transplantation|liver transplantation
5233256|NCT02544919|Lipid emulsions|lipid emulsions
5233257|NCT02544906|recipients|recipients
5233268|NCT02544854|Pharmacokinetics, pharmacodynamics, propofol, pediatrics|pharmacokinetics, pharmacodynamics, propofol, pediatrics
5233269|NCT02544828|Osteoarthritis|osteoarthritis
5233270|NCT02544828|knee arthroplasty|knee arthroplasty
5233271|NCT02544828|iron|iron
5233272|NCT02544815|digoxin, eficacy, safety|digoxin, eficacy, safety
5233273|NCT02544776|pco|pco
5233274|NCT02544776|Amlodipine|amlodipine
5233275|NCT02544737|Esophageal cancer|esophageal cancer
5233276|NCT02544737|Metastatic esophageal cancer|metastatic esophageal cancer
5233277|NCT02544737|Apatinib|apatinib
5233278|NCT02544724|Relapsed|relapsed
5233279|NCT02544724|Refractory|refractory
5233280|NCT02544724|DLBCL|dlbcl
5962753|NCT04278950|Postoperative|postoperative
5233281|NCT02544724|Chemotherapy|chemotherapy
5233285|NCT02544698|vaccine|vaccine
5102619|NCT03356587|NGS|ngs
5233286|NCT02544698|safety|safety
5233287|NCT02544685|Febrile neutropenia|febrile neutropenia
5233288|NCT02544685|Synbiotic|synbiotic
5233290|NCT02544685|Prebiotic|prebiotic
5233291|NCT02544685|Safety|safety
5233292|NCT02544685|Cancer|cancer
5233293|NCT02544685|Oncology|oncology
5233294|NCT02544685|Chemotherapy|chemotherapy
5233295|NCT02544685|Symbiotic|symbiotic
5233296|NCT02544659|Treatment|treatment
5233297|NCT02544659|Bisphosphonates|bisphosphonates
5233298|NCT02544659|Response rate|response rate
5233300|NCT02544633|Mirati|mirati
5233301|NCT02544633|MGCD265|mgcd265
5233302|NCT02544633|MET|met
5233303|NCT02544633|NSCLC|nsclc
5233304|NCT02544607|Ketamine|ketamine
5233305|NCT02544607|Depression|depression
5233306|NCT02544607|Anxious Depression|anxious depression
5233307|NCT02544607|MRI|mri
5233308|NCT02544568|high fat|high fat
5233309|NCT02544568|high protein|high protein
5233310|NCT02544568|high carbohydrate|high carbohydrate
5233311|NCT02544568|insulin|insulin
5233312|NCT02544568|glucose|glucose
5233313|NCT02544555|Peripheral arterial disease|peripheral arterial disease
5233314|NCT02544555|Atherosclerosis|atherosclerosis
5233315|NCT02544555|Intraluminal approach|intraluminal approach
5233316|NCT02544555|Subintimal approach|subintimal approach
5233317|NCT02544542|Mild Hypothermia|mild hypothermia
5233318|NCT02544542|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
5233319|NCT02544516|Schizophrenia|schizophrenia
5233320|NCT02544516|motor and sensory perceptions|motor and sensory perceptions
5233321|NCT02544490|Sepsis|sepsis
5233322|NCT02544490|MicroRNAs|micrornas
5233323|NCT02544490|Diagnosis|diagnosis
5233324|NCT02544490|Prognosis|prognosis
5233325|NCT02544464|osteoarthritis|osteoarthritis
5233326|NCT02544464|knee arthroplasty|knee arthroplasty
5233327|NCT02544464|iron|iron
5233328|NCT02544412|Mindfulness|mindfulness
5233329|NCT02544412|School Teachers|school teachers
5233330|NCT02544412|preservice teachers|preservice teachers
5233331|NCT02544412|teacher education|teacher education
5233332|NCT02544399|Bone microarchitecture|bone microarchitecture
5233345|NCT02544360|photoaging mobile apps|photoaging mobile apps
5233346|NCT02544360|adolescent smoking|adolescent smoking
5233347|NCT02544360|tobacco prevention|tobacco prevention
5233348|NCT02544360|school-based prevention|school-based prevention
5233349|NCT02544360|adolescent health|adolescent health
5233350|NCT02544360|school health|school health
5233351|NCT02544360|smoking|smoking
5233352|NCT02544360|tobacco|tobacco
5233353|NCT02544347|vaspin|vaspin
5233354|NCT02544347|omentin|omentin
5233355|NCT02544347|diabetes mellitus|diabetes mellitus
5233356|NCT02544347|chronic periodontitis|chronic periodontitis
5233357|NCT02544347|tumor-necrosis factor alfa|tumor-necrosis factor alfa
5233358|NCT02544347|gingival crevicular fluid|gingival crevicular fluid
5233359|NCT02544334|Rheumatoid arthritis|rheumatoid arthritis
5233360|NCT02544334|Metagenome|metagenome
5233361|NCT02544334|microbiome|microbiome
5233362|NCT02544308|Solitary, Bone|solitary, bone
5233363|NCT02544282|Analgesics|analgesics
5233364|NCT02544282|Opioid|opioid
5233365|NCT02544282|Mastectomy|mastectomy
5233366|NCT02544282|Segmental Mastectomy|segmental mastectomy
5233367|NCT02544282|Pecs II|pecs ii
5233368|NCT02544269|Lumbosacral plexus blockade|lumbosacral plexus blockade
5233369|NCT02544269|Continuous spinal anesthesia|continuous spinal anesthesia
5233374|NCT02544256|Aneurysmal Clipping|aneurysmal clipping
5233375|NCT02544256|Vasospasms|vasospasms
5233376|NCT02544230|granulocyte transfusions|granulocyte transfusions
5233377|NCT02544191|azoospermia nonobstructive|azoospermia nonobstructive
5233378|NCT02544191|male infertility|male infertility
5233379|NCT02544178|radiotherapy|radiotherapy
5233380|NCT02544178|neurocognitive defect|neurocognitive defect
5233381|NCT02544178|leukoencephalopathy|leukoencephalopathy
5233382|NCT02544165|smoking|smoking
5233383|NCT02544165|caffeine intake|caffeine intake
5233384|NCT02544165|haemodynamic parameters|haemodynamic parameters
5233385|NCT02544165|Advanced Glycation End Products (AGEs)|advanced glycation end products (ages)
5233386|NCT02544165|Non-invasive measurements devices|non-invasive measurements devices
5233387|NCT02544087|fire-heat syndrome|fire-heat syndrome
5233388|NCT02544087|blood stasis syndrome|blood stasis syndrome
5233389|NCT02544087|method of clearing heat|method of clearing heat
5233390|NCT02544087|method of promoting blood circulation|method of promoting blood circulation
5233391|NCT02544061|NM-IL-12, HemaMax, Safety, Stoma Takedown, Wound closure|nm-il-12, hemamax, safety, stoma takedown, wound closure
5233392|NCT02544048|Immune|immune
5233393|NCT02544048|Parasitemia|parasitemia
5233394|NCT02544048|Menactra|menactra
5233395|NCT02544048|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5233396|NCT02544048|Coartem|coartem
5233397|NCT02544035|Childhood Growth and Development|childhood growth and development
5962754|NCT04278937|cerclage|cerclage
5233398|NCT02544035|Development|development
5233415|NCT02543957|ERCP|ercp
5233416|NCT02543957|Cholangitis|cholangitis
5233417|NCT02543957|Bacteremia|bacteremia
5233418|NCT02543957|Antibiotics|antibiotics
5233419|NCT02543931|turmeric|turmeric
5233420|NCT02543931|curcumin|curcumin
5102718|NCT03355846|pain|pain
5233421|NCT02543931|curcuminoids|curcuminoids
5233422|NCT02543931|arthritis|arthritis
5233423|NCT02543931|methotrexate|methotrexate
5233424|NCT02543892|Vaccine|vaccine
5233428|NCT02543879|Acute Leukemia|acute leukemia
5233429|NCT02543879|Myelodysplastic Syndrome|myelodysplastic syndrome
5233430|NCT02543879|NHL|nhl
5233431|NCT02543879|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5233432|NCT02543840|Quality Improvement|quality improvement
5233433|NCT02543840|Organization of Services|organization of services
5233434|NCT02543840|Implementation|implementation
5233436|NCT02543827|Recurrent Urinary Tract Infections (RUTI)|recurrent urinary tract infections (ruti)
5233437|NCT02543788|optic neuritis|optic neuritis
5233438|NCT02543788|vision|vision
5233439|NCT02543788|quality of life|quality of life
5233440|NCT02543788|pathophysiology|pathophysiology
5233441|NCT02543775|Cervical Cancer|cervical cancer
5233442|NCT02543775|Sentinel Lymph Node|sentinel lymph node
5233443|NCT02543775|Lymphadenectomy|lymphadenectomy
5233444|NCT02543762|Chromoendoscopy|chromoendoscopy
5233445|NCT02543762|Ulcerative Colitis|ulcerative colitis
5233446|NCT02543762|Crohn disease|crohn disease
5233447|NCT02543762|Colorectal Neoplasia|colorectal neoplasia
5233448|NCT02543749|CML|cml
5233449|NCT02543749|DC vaccine|dc vaccine
5221405|NCT02615041|pharmacokinetics|pharmacokinetics
5221406|NCT02615041|pharmacodynamics|pharmacodynamics
5221407|NCT02615028|Force plate, Balance ability|force plate, balance ability
5221408|NCT02615015|Deoxyribonuclease|deoxyribonuclease
5221413|NCT02614989|Thalamotomy|thalamotomy
5221414|NCT02614963|Irritable Bowel Syndrome|irritable bowel syndrome
5221415|NCT02614963|Clostridium Butyricum|clostridium butyricum
5221416|NCT02614911|Early Onset Entheropathy|early onset entheropathy
5221417|NCT02614833|Hormone receptor positive|hormone receptor positive
5221418|NCT02614820|Ischemic preconditioning|ischemic preconditioning
5221419|NCT02614820|sefety|sefety
5221420|NCT02614820|efficacy|efficacy
5221421|NCT02614820|DMD|dmd
5221422|NCT02614807|Dietary Supplement|dietary supplement
5221444|NCT02614768|Glucose Monitoring System|glucose monitoring system
5221445|NCT02614755|Older Adults Volunteers|older adults volunteers
5221446|NCT02614755|Seniors|seniors
5221447|NCT02614755|Brain Performance Test|brain performance test
5221448|NCT02614729|High Protein|high protein
5221449|NCT02614729|Satiety|satiety
5221450|NCT02614729|Appetite Control|appetite control
5221451|NCT02614729|Protein Distribution|protein distribution
5221452|NCT02614729|Cognitive Function|cognitive function
5221453|NCT02614729|Ad libitum Food Intake|ad libitum food intake
5221454|NCT02614729|Obesity prevention|obesity prevention
5221455|NCT02614729|Obesity treatment|obesity treatment
5233450|NCT02543723|medication adherence, telehealth strategies, nurse coaching|medication adherence, telehealth strategies, nurse coaching
5233451|NCT02543684|glycemic response|glycemic response
5233452|NCT02543684|diabetes|diabetes
5233453|NCT02543684|insulinemic response|insulinemic response
5233454|NCT02543684|mixed meals|mixed meals
5233455|NCT02543684|glycemic index|glycemic index
5233456|NCT02543671|vitamin D status|vitamin d status
5233457|NCT02543671|25-hydroxyvitamin D|25-hydroxyvitamin d
5233458|NCT02543671|cheese|cheese
5233459|NCT02543671|Randomized controlled trial|randomized controlled trial
5233460|NCT02543671|postmenopausal women|postmenopausal women
5233461|NCT02543671|enriched|enriched
5233462|NCT02543671|vitamin D3|vitamin d3
5233463|NCT02543658|Acute Pancreatitis|acute pancreatitis
5233464|NCT02543658|Intra-abdominal hypertension|intra-abdominal hypertension
5233465|NCT02543658|Abdominal compartment syndrome|abdominal compartment syndrome
5233466|NCT02543658|Curative Effect|curative effect
5233467|NCT02543658|Security|security
5233468|NCT02543658|Neostigmine|neostigmine
5233469|NCT02543632|heart failure|heart failure
5233470|NCT02543632|parachute|parachute
5233471|NCT02543632|partitioning device|partitioning device
5233472|NCT02543593|tDCS|tdcs
5233473|NCT02543580|mastectomy|mastectomy
5233474|NCT02543580|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5233475|NCT02543580|acute pain|acute pain
5233476|NCT02543580|chronic pain|chronic pain
5233477|NCT02543567|Ebola viruses|ebola viruses
5233478|NCT02543567|Ebola virus disease (EVD)|ebola virus disease (evd)
5233479|NCT02543567|Filoviruses|filoviruses
5233480|NCT02543567|Monovalent vaccine|monovalent vaccine
5233481|NCT02543567|Safety|safety
5233482|NCT02543567|Immunogenicity|immunogenicity
5233483|NCT02543567|Ebola vaccine|ebola vaccine
5233484|NCT02543567|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5233485|NCT02543567|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
5233486|NCT02543567|Healthy participants|healthy participants
5233487|NCT02543541|Palliative Care|palliative care
5233488|NCT02543541|Supportive Care|supportive care
5233489|NCT02543541|Caregiver|caregiver
5233490|NCT02543541|Phase I|phase i
5233491|NCT02543515|following hysteroscopy|following hysteroscopy
5962755|NCT04278937|azithromycin|azithromycin
5112804|NCT03292094|Young|young
5233492|NCT02543502|Periodontitis|periodontitis
5233493|NCT02543502|atherosclerosis|atherosclerosis
5233494|NCT02543502|Heart Disease|heart disease
5230905|NCT02559102|Infants|infants
5233495|NCT02543476|PD-L1 status, biomarkers, prevalence, SCCHN, overall survival|pd-l1 status, biomarkers, prevalence, scchn, overall survival
5233496|NCT02543450|Chronic stroke|chronic stroke
5233497|NCT02543450|Participation|participation
5233498|NCT02543450|Walking ability|walking ability
5233500|NCT02543385|Morphine|morphine
5233501|NCT02543385|Consumption|consumption
5233502|NCT02543372|concerned significant other|concerned significant other
5233503|NCT02543372|problem gambling|problem gambling
5233504|NCT02543372|internet-delivered cognitive-behavioral therapy|internet-delivered cognitive-behavioral therapy
5233505|NCT02543372|behavioral couples therapy|behavioral couples therapy
5233506|NCT02543359|Training|training
5233507|NCT02543359|Implementation|implementation
5233508|NCT02543359|Community-Based Mental Health Services|community-based mental health services
5233509|NCT02543359|Parent-Child Interaction Therapy|parent-child interaction therapy
5233510|NCT02543359|Children|children
5233511|NCT02543333|Acute Asthma,|acute asthma,
5233512|NCT02543307|Hip Replacement|hip replacement
5233513|NCT02543307|Spinal Diseases|spinal diseases
5233514|NCT02543307|Rotator Cuff Reconstruction|rotator cuff reconstruction
5233515|NCT02543307|Nursing|nursing
5233516|NCT02543307|Nurse-led|nurse-led
5233517|NCT02543307|Pathways|pathways
5233518|NCT02543307|Patient Satisfaction|patient satisfaction
5233519|NCT02543307|Quality of Nursing Care|quality of nursing care
5233520|NCT02543294|Heart Failure|heart failure
5233521|NCT02543294|Echocardiogram|echocardiogram
5233522|NCT02543294|ECHO|echo
5233523|NCT02543294|Electrocardiogram|electrocardiogram
5233524|NCT02543294|ECG|ecg
5233525|NCT02543294|Questionnaire|questionnaire
5233526|NCT02543294|Survey|survey
5233527|NCT02543294|Telephone Follow-Up|telephone follow-up
5233529|NCT02543294|Cancer treatment induced left ventricular dysfunction|cancer treatment induced left ventricular dysfunction
5233530|NCT02543294|CILVD|cilvd
5233531|NCT02543294|Left ventricular ejection fraction|left ventricular ejection fraction
5233532|NCT02543294|LVEF|lvef
5233533|NCT02543268|Ebola viruses|ebola viruses
5233534|NCT02543268|Ebola virus disease (EVD)|ebola virus disease (evd)
5233535|NCT02543268|Filoviruses|filoviruses
5233536|NCT02543268|Monovalent vaccine|monovalent vaccine
5233537|NCT02543268|Safety|safety
5233538|NCT02543268|Immunogenicity|immunogenicity
5233539|NCT02543268|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5233540|NCT02543268|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector (MVA‐BN Filo)|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector (mva‐bn filo)
5233541|NCT02543268|Healthy participants|healthy participants
5233542|NCT02543255|High risk|high risk
5233543|NCT02543242|Urinary Incontinence|urinary incontinence
5233544|NCT02543242|Stress Urinary Incontinence|stress urinary incontinence
5233545|NCT02543242|Urge Incontinence|urge incontinence
5233546|NCT02543242|Mixed Urinary Incontience|mixed urinary incontience
5233547|NCT02543242|Female Pelvic Health|female pelvic health
5233548|NCT02543216|fatty acids, FADS gene, genotype, diet|fatty acids, fads gene, genotype, diet
5233549|NCT02543203|Relaxation|relaxation
5233550|NCT02543190|Care Transition|care transition
5233551|NCT02543190|Readmission|readmission
5233552|NCT02543190|Rehospitalization|rehospitalization
5233553|NCT02543177|NSTEMI, CKD|nstemi, ckd
5233554|NCT02543164|Glycemic Index|glycemic index
5233555|NCT02543164|glycemic response|glycemic response
5233556|NCT02543151|Biliary stricture|biliary stricture
5233557|NCT02543151|Cholangioscopy|cholangioscopy
5233558|NCT02543151|Spyglass|spyglass
5233559|NCT02543151|Liver transplant|liver transplant
5233560|NCT02543125|very low birth weight|very low birth weight
5233561|NCT02543125|respiratory distress|respiratory distress
5233562|NCT02543125|NHFOV|nhfov
5233563|NCT02543125|NIPPV|nippv
5233564|NCT02543099|endothelial function|endothelial function
5233565|NCT02543099|policosanol|policosanol
5233566|NCT02543099|efficacy|efficacy
5233567|NCT02543099|safety|safety
5233568|NCT02543086|Phase 1, malaria, inoculum, P. falciparum, KAE609, Piperaquine|phase 1, malaria, inoculum, p. falciparum, kae609, piperaquine
5233569|NCT02543021|Colitis|colitis
5233570|NCT02543021|Dysplasia|dysplasia
5233571|NCT02543021|Chromoendoscopy|chromoendoscopy
5233572|NCT02543008|Asymptomatic individuals|asymptomatic individuals
5233573|NCT02542982|tDCS|tdcs
5233574|NCT02542982|motor recovery|motor recovery
5233575|NCT02542956|Tummy tuck (abdominoplasty)|tummy tuck (abdominoplasty)
5233576|NCT02542956|Breast Surgery|breast surgery
5233577|NCT02542930|Non-small cell lung cancer|non-small cell lung cancer
5233578|NCT02542930|Metastatic Non-small cell lung cancer|metastatic non-small cell lung cancer
5233579|NCT02542930|Radiotherapy|radiotherapy
5233580|NCT02542930|Thymalfasin|thymalfasin
5233581|NCT02542930|ZADAXIN's®|zadaxin's®
5233582|NCT02542891|e-health|e-health
5311177|NCT02124213|PET|pet
5962756|NCT04278924|Drug Therapy|drug therapy
5962757|NCT04278898|Magnetic Resonance Imaging|magnetic resonance imaging
5221605|NCT02613793|Preterm pre-eclampsia|preterm pre-eclampsia
5221606|NCT02613793|Neurological dysfunction|neurological dysfunction
5221607|NCT02613793|Saccadic reaction time|saccadic reaction time
5233583|NCT02542891|depressive disorder|depressive disorder
5233584|NCT02542891|cost-effectiveness|cost-effectiveness
5233585|NCT02542891|Cognitive behavioral treatment|cognitive behavioral treatment
5233586|NCT02542878|myofascial release|myofascial release
5233587|NCT02542878|back extensors endurance|back extensors endurance
5233588|NCT02542878|foam roller|foam roller
5233589|NCT02542878|sport|sport
5233590|NCT02542852|HIV-1|hiv-1
5233591|NCT02542839|Botulinum Toxin|botulinum toxin
5233592|NCT02542839|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5233593|NCT02542826|Pulmonary Rehabilitation|pulmonary rehabilitation
5233594|NCT02542826|3-minute constant rate shuttle walk test|3-minute constant rate shuttle walk test
5233595|NCT02542826|3-minute constant rate step test|3-minute constant rate step test
5233596|NCT02542826|Dyspnea|dyspnea
5233597|NCT02542813|Pharmacokinetics|pharmacokinetics
5233598|NCT02542813|safety|safety
5233599|NCT02542813|tolerability|tolerability
5233600|NCT02542813|oxytocin|oxytocin
5233601|NCT02542787|MS|ms
5233602|NCT02542787|Spasticity|spasticity
5233603|NCT02542787|VSN16R|vsn16r
5233604|NCT02542774|Diabetes mellitus|diabetes mellitus
5233605|NCT02542774|Stroke|stroke
5233606|NCT02542774|Myocardial infarction|myocardial infarction
5233607|NCT02542774|Stable angina pectoris|stable angina pectoris
5233608|NCT02542774|Heart failure|heart failure
5233609|NCT02542774|Quality of care|quality of care
5233610|NCT02542748|norepinephrine|norepinephrine
5233611|NCT02542748|ephedrine|ephedrine
5233612|NCT02542722|lifestyle modification|lifestyle modification
5233613|NCT02542722|olive oil|olive oil
5233614|NCT02542722|Mediterranean diet|mediterranean diet
5233615|NCT02542683|congenital heart diseases|congenital heart diseases
5233616|NCT02542683|cognition|cognition
5233617|NCT02542683|adaptive behavior|adaptive behavior
5233618|NCT02542683|physical activity|physical activity
5233619|NCT02542683|neurodevelopment|neurodevelopment
5233620|NCT02542644|Fuchs' Endothelial Dystrophy, DMEK|fuchs' endothelial dystrophy, dmek
5233623|NCT02542618|IBSR|ibsr
5233625|NCT02542605|Migraine|migraine
5233626|NCT02542605|Headache|headache
5233627|NCT02542605|Migraine Headache|migraine headache
5233628|NCT02542605|Headache, Migraine|headache, migraine
5233629|NCT02542605|Amgen|amgen
5233630|NCT02542592|Glucocorticoids|glucocorticoids
5233631|NCT02542592|Immune Signaling|immune signaling
5233632|NCT02542592|Recovery|recovery
5233633|NCT02542592|Hip arthroplasty, total|hip arthroplasty, total
5233634|NCT02542579|Helicobacter pylori|helicobacter pylori
5233635|NCT02542579|Dyspepsia|dyspepsia
5233636|NCT02542540|Osteogenesis Imperfecta|osteogenesis imperfecta
5233637|NCT02542540|physical exercise training|physical exercise training
5233638|NCT02542540|Wii|wii
5233639|NCT02542540|muscular strength|muscular strength
5233640|NCT02542514|PCNSL|pcnsl
5233641|NCT02542514|IOL|iol
5233642|NCT02542462|mechanisms for intussusception|mechanisms for intussusception
5233643|NCT02542462|rotavirus vaccine|rotavirus vaccine
5233644|NCT02542449|Green tea|green tea
5233645|NCT02542449|weight maintenance|weight maintenance
5233646|NCT02542449|obesity|obesity
5233647|NCT02542449|fat mass|fat mass
5233648|NCT02542384|abdominal surgery|abdominal surgery
5233649|NCT02542384|laparoscopy|laparoscopy
5233650|NCT02542384|Hysterectomy|hysterectomy
5233651|NCT02542384|Prostatectomy|prostatectomy
5233652|NCT02542384|Hemi-colectomy|hemi-colectomy
5233653|NCT02542384|Ventral Hernia repair|ventral hernia repair
5233654|NCT02542384|CR845|cr845
5233655|NCT02542384|analgesic|analgesic
5233656|NCT02542384|kappa opioid|kappa opioid
5233657|NCT02542384|partial bowel resection|partial bowel resection
5233658|NCT02542384|difelikefalin|difelikefalin
5233659|NCT02542371|HIV|hiv
5233660|NCT02542371|Atherosclerosis|atherosclerosis
5233661|NCT02542371|Tilmanocept|tilmanocept
5233662|NCT02542345|Cardiac Multislice CT|cardiac multislice ct
5233663|NCT02542345|MRI coronarography|mri coronarography
5233664|NCT02542332|lung cancer screening|lung cancer screening
5233665|NCT02542332|statistical background|statistical background
5233666|NCT02542306|Blood loss|blood loss
5233667|NCT02542306|coagulopathy|coagulopathy
5233668|NCT02542306|fibrinogen concentrate|fibrinogen concentrate
5233669|NCT02542306|transfusion|transfusion
5233670|NCT02542293|NSCLC|nsclc
5233671|NCT02542293|PDL1|pdl1
5233672|NCT02542293|TMB|tmb
5233673|NCT02542293|MEDI4736|medi4736
5233674|NCT02542293|Durvalumab|durvalumab
5233675|NCT02542293|Tremelimumab|tremelimumab
5233676|NCT02542293|OS|os
5233677|NCT02542267|Bare Metal Stent|bare metal stent
5233678|NCT02542267|In-Stent Restenosis|in-stent restenosis
5233679|NCT02542241|Open abdomen|open abdomen
5233680|NCT02542241|hypertonic saline solution|hypertonic saline solution
5311309|NCT02123498|ETD|etd
5221698|NCT02612987|Internet based|internet based
5221699|NCT02612974|Qurse mafasil|qurse mafasil
5221700|NCT02612974|leech therapy|leech therapy
5221701|NCT02612974|Hirudinaria granulosa|hirudinaria granulosa
5113043|NCT03290391|HIV|hiv
5233681|NCT02542241|intensive care|intensive care
5233682|NCT02542228|Immune Deficiency, antibody|immune deficiency, antibody
5233683|NCT02542228|Quality of Life survey|quality of life survey
5233684|NCT02542176|Metabolic Syndrome|metabolic syndrome
5233685|NCT02542176|Grape|grape
5233686|NCT02542176|HDL|hdl
5233687|NCT02542176|Lipoproteins|lipoproteins
5233688|NCT02542137|Small cell lung cancer|small cell lung cancer
5233689|NCT02542137|Metastatic small cell lung cancer|metastatic small cell lung cancer
5233691|NCT02542137|radiotherapy|radiotherapy
5233692|NCT02542137|Thymalfasin|thymalfasin
5233693|NCT02542124|CTCL|ctcl
5233694|NCT02542124|Total Skin Electron Beam Therapy (TSEBT)|total skin electron beam therapy (tsebt)
5233695|NCT02542124|Mycosis fungoides|mycosis fungoides
5233696|NCT02542124|Sézary syndrome|sézary syndrome
5127750|NCT03195634|Cirrhosis|cirrhosis
5233697|NCT02542124|recombinant human Interleukin-12 (rHuIL-12)|recombinant human interleukin-12 (rhuil-12)
5233698|NCT02542124|T Cell|t cell
5233699|NCT02542111|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5233700|NCT02542085|incisional hernia|incisional hernia
5233701|NCT02542085|laparoscopic repair|laparoscopic repair
5233702|NCT02542085|hybrid repair|hybrid repair
5233703|NCT02542085|seroma|seroma
5233704|NCT02542085|recurrent hernia|recurrent hernia
5233705|NCT02542033|postprandial glycemia; apple juice; sugar reduction; glucose oxidase|postprandial glycemia; apple juice; sugar reduction; glucose oxidase
5233706|NCT02542007|intracoronary stent|intracoronary stent
5233707|NCT02542007|drug eluting stent|drug eluting stent
5233708|NCT02542007|sirolimus|sirolimus
5233709|NCT02542007|endothelial progenitor cells|endothelial progenitor cells
5233710|NCT02541981|Heart transplant|heart transplant
5233711|NCT02541981|renal insufficiency|renal insufficiency
5233712|NCT02541955|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5233713|NCT02541955|Musculoskeletal ultrasound (MSUS)|musculoskeletal ultrasound (msus)
5233714|NCT02541929|Alzheimer's disease|alzheimer's disease
5233715|NCT02541929|Docosahexaenoic acid|docosahexaenoic acid
5233716|NCT02541929|brain health|brain health
5233717|NCT02541929|memory|memory
5233718|NCT02541929|fish oil|fish oil
5233719|NCT02541929|cognition|cognition
5233721|NCT02541929|omega 3 fatty acid|omega 3 fatty acid
5233722|NCT02541929|brain|brain
5233728|NCT02541916|Gene Expression|gene expression
5233729|NCT02541916|Immunosuppression|immunosuppression
5233730|NCT02541916|Immunology|immunology
5233731|NCT02541916|Multiplex Polymerase Chain Reaction|multiplex polymerase chain reaction
5233732|NCT02541916|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
5233737|NCT02541890|Rehabilitation|rehabilitation
5233738|NCT02541890|Return to Work|return to work
5233739|NCT02541864|Helicobacter pylori|helicobacter pylori
5233740|NCT02541864|Hybrid therapy|hybrid therapy
5233741|NCT02541864|Bismuth containing quadruple therapy|bismuth containing quadruple therapy
5233742|NCT02541864|Eradication|eradication
5233743|NCT02541838|Autonomic Neuropathy|autonomic neuropathy
5233744|NCT02541838|diabetes|diabetes
5233745|NCT02541838|balance control|balance control
5233746|NCT02541825|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5233747|NCT02541812|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5233748|NCT02541812|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5233749|NCT02541812|Error processing|error processing
5233750|NCT02541799|informed consent|informed consent
5233751|NCT02541799|telemedicine|telemedicine
5233752|NCT02541799|research methods|research methods
5233753|NCT02541786|dexlansoprazole MR|dexlansoprazole mr
5233754|NCT02541786|rabeprazole|rabeprazole
5233755|NCT02541786|Helicobacter pylori|helicobacter pylori
5233756|NCT02541786|triple therapy|triple therapy
5233757|NCT02541773|Chronic Heart Failure|chronic heart failure
5233758|NCT02541773|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5233759|NCT02541773|Vascular Biomarker|vascular biomarker
5233760|NCT02541773|miRNA|mirna
5233761|NCT02541773|Extracellular Matrix|extracellular matrix
5233762|NCT02541773|Brain Natruetic Peptide|brain natruetic peptide
5233763|NCT02541773|Growth Degradation Factor-15|growth degradation factor-15
5233764|NCT02541773|Body Composition|body composition
5233765|NCT02541734|SPECT|spect
5233766|NCT02541734|radiopeptides|radiopeptides
5233767|NCT02541734|gelofusine|gelofusine
5233768|NCT02541734|Beta cell|beta cell
5233769|NCT02541695|Experimental challenge trial|experimental challenge trial
5233770|NCT02541669|Drug therapy|drug therapy
5233771|NCT02541656|Preload dependence indices|preload dependence indices
5233772|NCT02541656|pulse pressure variation|pulse pressure variation
5233773|NCT02541656|plethysmographic waveform of pulse oximetry variation|plethysmographic waveform of pulse oximetry variation
5221796|NCT02612480|placebo|placebo
5221797|NCT02612467|start back tool|start back tool
5221798|NCT02612467|stratified care|stratified care
5221799|NCT02612467|targeted treatment|targeted treatment
5221800|NCT02612454|Eczema|eczema
5221801|NCT02612441|stroke|stroke
5221802|NCT02612389|COPD|copd
5221803|NCT02612389|Qigong|qigong
5221804|NCT02612389|ANS|ans
5962758|NCT04278898|N-acetylcysteine|n-acetylcysteine
5113167|NCT03289494|SDS|sds
5221808|NCT02612389|Nicotine|nicotine
5233774|NCT02541656|stroke volume variation|stroke volume variation
5233775|NCT02541656|laparoscopy|laparoscopy
5233776|NCT02541656|pneumoperitoneum|pneumoperitoneum
5233777|NCT02541643|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5233778|NCT02541630|Mindfulness|mindfulness
5233779|NCT02541591|post cardiac arrest|post cardiac arrest
5233780|NCT02541591|hemodynamics|hemodynamics
5233781|NCT02541578|stroke, acute; gait, complexity|stroke, acute; gait, complexity
5127842|NCT03195062|Metabolism|metabolism
5233782|NCT02541552|Knee arthroscopy|knee arthroscopy
5233783|NCT02541552|Quadriceps weakness|quadriceps weakness
5233785|NCT02541552|saphenous nerve block|saphenous nerve block
5233786|NCT02541552|Adductor canal|adductor canal
5233787|NCT02541526|amphetamine type stimulant dependence|amphetamine type stimulant dependence
5233788|NCT02541526|mirtazepine|mirtazepine
5233789|NCT02541513|paliparidone|paliparidone
5233790|NCT02541513|amphetamine type stimulant dependence|amphetamine type stimulant dependence
5233791|NCT02541500|minocycline|minocycline
5233792|NCT02541500|amphetamine type stimulant dependence|amphetamine type stimulant dependence
5233793|NCT02541474|Controlled trial|controlled trial
5233794|NCT02541474|Matched|matched
5233795|NCT02541474|Before-After design|before-after design
5233796|NCT02541474|Prospective|prospective
5233797|NCT02541474|complex interventions|complex interventions
5233798|NCT02541461|Body composition measurement|body composition measurement
5233799|NCT02541461|Lipid profile|lipid profile
5233800|NCT02541461|Weight loss|weight loss
5233801|NCT02541461|Gastrectomy|gastrectomy
5233802|NCT02541435|Radiotherapy|radiotherapy
5233803|NCT02541435|Biological markers|biological markers
5233804|NCT02541435|Magnetic resonance imaging|magnetic resonance imaging
5233805|NCT02541435|Echocardiography|echocardiography
5233806|NCT02541435|Tomography, X-Ray Computed|tomography, x-ray computed
5233807|NCT02541435|Risk factors|risk factors
5233808|NCT02541435|Heart|heart
5233809|NCT02541435|Quality of Life|quality of life
5233810|NCT02541409|directly observed therapy|directly observed therapy
5233811|NCT02541409|sofosbuvir|sofosbuvir
5233812|NCT02541409|ribavirin|ribavirin
5233813|NCT02541409|pegylated interferon|pegylated interferon
5233822|NCT02541318|sleep disturbances|sleep disturbances
5233823|NCT02541318|Dao-in exercise|dao-in exercise
5233824|NCT02541318|body constitution|body constitution
5233825|NCT02541305|falls prevention|falls prevention
5233826|NCT02541305|proprioception|proprioception
5233827|NCT02541305|physical condition|physical condition
5233828|NCT02541266|Imaging|imaging
5233829|NCT02541266|Questionnaire|questionnaire
5233830|NCT02541240|resilience|resilience
5233831|NCT02541240|optimism|optimism
5233832|NCT02541240|stress|stress
5233833|NCT02541240|coping|coping
5233834|NCT02541240|curriculum|curriculum
5233835|NCT02541201|Plant sterols|plant sterols
5233836|NCT02541201|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5233837|NCT02541201|Phytosterols|phytosterols
5233838|NCT02541188|Breast cancer|breast cancer
5233839|NCT02541175|Electrocardiography|electrocardiography
5233840|NCT02541175|Automation|automation
5233841|NCT02541175|Arrhythmias, Cardiac|arrhythmias, cardiac
5233842|NCT02541175|Atrial Fibrillation|atrial fibrillation
5233843|NCT02541175|Atrial Flutter|atrial flutter
5233844|NCT02541175|Atrial Premature Complexes|atrial premature complexes
5233845|NCT02541175|Esophagus|esophagus
5233846|NCT02541136|exercise|exercise
5233847|NCT02541136|resilience|resilience
5233848|NCT02541136|physiotherapy|physiotherapy
5233849|NCT02541136|fMRI|fmri
5233850|NCT02541123|Traumatic Brain Injury|traumatic brain injury
5233851|NCT02541123|Head Injury|head injury
5233852|NCT02541084|Age-related macular degeneration|age-related macular degeneration
5233853|NCT02541084|Caregiver burden|caregiver burden
5233854|NCT02541084|Anti-vascular endothelial growth factor (VEGF) therapy|anti-vascular endothelial growth factor (vegf) therapy
5233855|NCT02541058|Velocardiofacial Syndrome|velocardiofacial syndrome
5233856|NCT02541058|Shprintzen Syndrome|shprintzen syndrome
5233857|NCT02541058|Conotruncal Defects|conotruncal defects
5233858|NCT02541058|Chromosomal Abnormalities|chromosomal abnormalities
5233859|NCT02541058|22q, 22q.11.2|22q, 22q.11.2
5233860|NCT02541058|deletion|deletion
5233861|NCT02541058|duplication|duplication
5233866|NCT02541019|C23.888.821.712.700|c23.888.821.712.700
5233867|NCT02541006|FEV1|fev1
5233869|NCT02541006|AUC 0-24|auc 0-24
5233870|NCT02541006|bronchodilator efficacy|bronchodilator efficacy
5233871|NCT02541006|tiotropium|tiotropium
5233872|NCT02540993|Type 2 Diabetes|type 2 diabetes
5233873|NCT02540993|Kidney diseases|kidney diseases
5233874|NCT02540967|Contrast enhancement in the following MR imaging|contrast enhancement in the following mr imaging
5233875|NCT02540967|Brain and spine|brain and spine
5233876|NCT02540967|Body and extremities|body and extremities
5233877|NCT02540967|Gadobutrol|gadobutrol
5233882|NCT02540902|Knee replacement|knee replacement
5962759|NCT04278898|Restricted and Repetitive Behaviors|restricted and repetitive behaviors
5233883|NCT02540902|Knee arthroplasty|knee arthroplasty
5233884|NCT02540902|All-polyethylene tibia|all-polyethylene tibia
5233885|NCT02540902|Bone density|bone density
5233886|NCT02540863|myofascial pain syndrome|myofascial pain syndrome
5233887|NCT02540863|exercise therapy|exercise therapy
5233888|NCT02540863|randomized controlled trial|randomized controlled trial
5233889|NCT02540850|septin 9|septin 9
5233891|NCT02540850|colorectal cancer|colorectal cancer
5233892|NCT02540850|CRC|crc
5233893|NCT02540850|screening|screening
5233894|NCT02540850|methylation|methylation
5233895|NCT02540850|adenoma|adenoma
5233896|NCT02540850|polyps|polyps
5233897|NCT02540850|FIT|fit
5233898|NCT02540850|FOBT|fobt
5233899|NCT02540850|colonoscopy|colonoscopy
5233903|NCT02540824|Non-small Cell Lung Cancer|non-small cell lung cancer
5233904|NCT02540798|Anxiety|anxiety
5233905|NCT02540798|Urodynamics|urodynamics
5233906|NCT02540798|Symptom reproducibility|symptom reproducibility
5233907|NCT02540798|Lower urinary tract symptoms|lower urinary tract symptoms
5233908|NCT02540798|Women|women
5233909|NCT02540785|Refractive Surgical Procedures|refractive surgical procedures
5233910|NCT02540785|small-incision lenticule extraction|small-incision lenticule extraction
5233911|NCT02540785|lenticule extraction|lenticule extraction
5233912|NCT02540785|inflammatory mediators|inflammatory mediators
5233913|NCT02540772|Confabulations|confabulations
5342992|NCT01981252|Ultherapy™ Treatment|ultherapy™ treatment
5233917|NCT02540759|vegetable oil|vegetable oil
5233918|NCT02540759|omega-3 fatty acids|omega-3 fatty acids
5233919|NCT02540759|participants|participants
5233920|NCT02540746|Emotional Dysregulation|emotional dysregulation
5233921|NCT02540746|Early Intervention|early intervention
5233922|NCT02540746|Youth Mental Health|youth mental health
5233923|NCT02540746|Staging|staging
5233924|NCT02540746|Motivational Enhancement|motivational enhancement
5233925|NCT02540746|Family Connections|family connections
5233926|NCT02540746|Family Skills Training|family skills training
5233927|NCT02540733|cerebral infarction|cerebral infarction
5233928|NCT02540733|diabetes|diabetes
5233929|NCT02540733|rehabilitation|rehabilitation
5233931|NCT02540681|Transtibial amputation|transtibial amputation
5233932|NCT02540681|Prosthetic fit|prosthetic fit
5233933|NCT02540681|Prosthetic alignment|prosthetic alignment
5233934|NCT02540655|Stem Cells|stem cells
5233935|NCT02540655|Adult Stem Cells|adult stem cells
5233936|NCT02540655|Spinocerebellar Ataxia|spinocerebellar ataxia
5233937|NCT02540655|Steminent|steminent
5233938|NCT02540629|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5233939|NCT02540629|Emergency Medicine|emergency medicine
5233940|NCT02540616|MdDS|mdds
5233941|NCT02540616|TES|tes
5233942|NCT02540616|TMS|tms
5233943|NCT02540590|microcirculation|microcirculation
5233944|NCT02540590|wound healing|wound healing
5233945|NCT02540590|tunnel technique|tunnel technique
5233946|NCT02540590|gingival recession|gingival recession
5233947|NCT02540590|Mucograft|mucograft
5233948|NCT02540590|laser speckle contrast analyzer|laser speckle contrast analyzer
5233949|NCT02540538|Adjuvants, immunologic|adjuvants, immunologic
5233950|NCT02540538|Interleukin-2|interleukin-2
5233951|NCT02540538|Hepatitis B vaccines|hepatitis b vaccines
5233952|NCT02540538|Non-responders|non-responders
5233953|NCT02540525|stress incontinence|stress incontinence
5233954|NCT02540525|transobturator sling|transobturator sling
5233955|NCT02540525|single-incision mini-sling|single-incision mini-sling
5233956|NCT02540499|lung cancer|lung cancer
5233957|NCT02540499|breath hold|breath hold
5233958|NCT02540499|radiotherapy|radiotherapy
5233959|NCT02540486|Type 2 diabetes|type 2 diabetes
5233960|NCT02540486|T2DM|t2dm
5233961|NCT02540473|Resilience|resilience
5233962|NCT02540447|Liver transplantation|liver transplantation
5233963|NCT02540447|Graft rinse|graft rinse
5233964|NCT02540447|Ischemia reperfusion injury|ischemia reperfusion injury
5233965|NCT02540434|Hypofibrinogenemia|hypofibrinogenemia
5233966|NCT02540434|ROTEM|rotem
5233967|NCT02540434|Cardiac Surgery|cardiac surgery
5233968|NCT02540434|Concentrated Fibrinogen|concentrated fibrinogen
5233969|NCT02540421|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5233970|NCT02540421|human papillomavirus|human papillomavirus
5233971|NCT02540421|conization|conization
5233972|NCT02540408|Occupational COPD|occupational copd
5233973|NCT02540408|Pathophysiology|pathophysiology
5233974|NCT02540408|Exercise limitation|exercise limitation
5221997|NCT02611089|Small leucine-rich proteoglycans|small leucine-rich proteoglycans
5221998|NCT02611089|Limb development|limb development
5221999|NCT02611076|smoking cessation|smoking cessation
5233975|NCT02540408|Pulmonary hyperinflation|pulmonary hyperinflation
5233976|NCT02540408|Arterial stiffness|arterial stiffness
5233977|NCT02540395|Kidney transplantation|kidney transplantation
5233978|NCT02540395|Immunosuppression|immunosuppression
5233980|NCT02540382|TIPS|tips
5233981|NCT02540382|Hepatocellular Carcinoma|hepatocellular carcinoma
5233982|NCT02540382|Portasystemic Shunt|portasystemic shunt
5233983|NCT02540369|Diabetic macular edema|diabetic macular edema
5233984|NCT02540369|Wet Age-related macular degeneration|wet age-related macular degeneration
5233985|NCT02540343|Translation|translation
5233986|NCT02540343|Validation|validation
5233987|NCT02540343|Orebro-G|orebro-g
5233991|NCT02540265|Bunion|bunion
5233992|NCT02540265|Bunionectomy|bunionectomy
5233993|NCT02540265|Pain|pain
5233994|NCT02540265|Analgesia|analgesia
5233995|NCT02540265|N1539|n1539
5233996|NCT02540252|Lower Limb Amputation|lower limb amputation
5233997|NCT02540252|Nutrition|nutrition
5233998|NCT02540252|Eating|eating
5233999|NCT02540252|Inflammation|inflammation
5234000|NCT02540252|Nursing|nursing
5234002|NCT02540226|Total Knee Arthroplasty|total knee arthroplasty
5234003|NCT02540226|Total Knee Replacement|total knee replacement
5234004|NCT02540187|haemophilia|haemophilia
5234005|NCT02540187|TFPI|tfpi
5234006|NCT02540187|thrombin generation|thrombin generation
5234007|NCT02540187|hemorrhagic score|hemorrhagic score
5234008|NCT02540174|alcohol and tobacco consumption|alcohol and tobacco consumption
5234009|NCT02540174|addiction treatment|addiction treatment
5234010|NCT02540161|Sym004|sym004
5234011|NCT02540161|Glioblastoma|glioblastoma
5234012|NCT02540161|Desjardins|desjardins
5234013|NCT02540161|Pro00063483|pro00063483
5234014|NCT02540161|Symphogen|symphogen
5234015|NCT02540161|Duke Cancer Institute|duke cancer institute
5234016|NCT02540135|high grade glioma|high grade glioma
5234017|NCT02540135|glioblastoma multiforme|glioblastoma multiforme
5234018|NCT02540135|anaplastic astrocytoma|anaplastic astrocytoma
5234019|NCT02540135|flourescein|flourescein
5234020|NCT02540135|flourescence-guided surgery|flourescence-guided surgery
5234021|NCT02540135|intraoperative MRI|intraoperative mri
5234022|NCT02540135|iMRI|imri
5234023|NCT02540109|Stroke|stroke
5234024|NCT02540109|Anomia|anomia
5234025|NCT02540096|mental practice|mental practice
5234026|NCT02540096|motor imagery|motor imagery
5234027|NCT02540096|hemiparesis|hemiparesis
5234028|NCT02540096|stroke|stroke
5234029|NCT02540096|gait|gait
5234030|NCT02540096|mobility|mobility
5234031|NCT02540070|Adductor canal Block|adductor canal block
5234032|NCT02540070|ultrasound|ultrasound
5234033|NCT02540070|periarticular injections|periarticular injections
5234034|NCT02540070|Dexmedetomidine|dexmedetomidine
5234035|NCT02540018|DEB, drug-eluting balloon, Paclitaxel, peripheral artery disease|deb, drug-eluting balloon, paclitaxel, peripheral artery disease
5234036|NCT02539979|IV Paracetamol|iv paracetamol
5234037|NCT02539979|Radiofrequency Lesion/Ablation of medial branch nerve|radiofrequency lesion/ablation of medial branch nerve
5234038|NCT02539979|Preventative Pain Management|preventative pain management
5234039|NCT02539940|Below-the-knee|below-the-knee
5234040|NCT02539914|Virtual reality|virtual reality
5234041|NCT02539914|Motor and cognitive rehabilitation|motor and cognitive rehabilitation
5234042|NCT02539914|Positive emotion stimuli|positive emotion stimuli
5234043|NCT02539901|cochlear implant|cochlear implant
5234044|NCT02539901|Developmental Psychology|developmental psychology
5234045|NCT02539901|cognitive development|cognitive development
5234046|NCT02539901|communicative development|communicative development
5234047|NCT02539901|perceptual development|perceptual development
5234048|NCT02539901|deaf child|deaf child
5234049|NCT02539875|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
5234050|NCT02539862|Insomnia|insomnia
5234051|NCT02539862|behavioral and cognitive therapies|behavioral and cognitive therapies
5234052|NCT02539836|children's obesity|children's obesity
5234053|NCT02539836|gut microbiome|gut microbiome
5234054|NCT02539836|body mass index|body mass index
5234055|NCT02539836|fruit and vegetable fermentation extraction|fruit and vegetable fermentation extraction
5234056|NCT02539836|dietary nutrition intervention|dietary nutrition intervention
5234057|NCT02539784|stimulation|stimulation
5234058|NCT02539771|vaso-occlusive crisis|vaso-occlusive crisis
5234059|NCT02539771|obstructive sleep apnea|obstructive sleep apnea
5234060|NCT02539771|priapism|priapism
5234061|NCT02539758|acute angle closure|acute angle closure
5234062|NCT02539758|ocular massage|ocular massage
5234063|NCT02539745|vitamin D|vitamin d
5234064|NCT02539745|primary open- angle glaucoma|primary open- angle glaucoma
5222096|NCT02610452|clown therapy|clown therapy
5222097|NCT02610387|tDCS|tdcs
5222098|NCT02610387|stroke|stroke
5234065|NCT02539732|Weaning|weaning
5234066|NCT02539732|Spontaneous breathing trial|spontaneous breathing trial
5234067|NCT02539732|Neurally-adjusted ventilator assist|neurally-adjusted ventilator assist
5234068|NCT02539732|Electrical activity of the diaphragm|electrical activity of the diaphragm
5234069|NCT02539719|Platinum-Resistant|platinum-resistant
5234070|NCT02539719|Refractory|refractory
5234071|NCT02539680|Phosphate transporter|phosphate transporter
5234073|NCT02539680|duodenal biopsies|duodenal biopsies
5234074|NCT02539602|High school|high school
5234075|NCT02539602|Longitudnal|longitudnal
5234076|NCT02539602|Sexual initiation|sexual initiation
5234077|NCT02539602|Contraception|contraception
5234078|NCT02539602|Adolescents|adolescents
5234079|NCT02539602|Pregnancy prevention|pregnancy prevention
5234080|NCT02539602|Sexual health|sexual health
5234081|NCT02539576|pharmacokinetics|pharmacokinetics
5234082|NCT02539576|Healthy subjects|healthy subjects
5234083|NCT02539576|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
5234084|NCT02539576|Japanese|japanese
5234085|NCT02539576|Fixed-dose combination|fixed-dose combination
5234086|NCT02539576|safety|safety
5234087|NCT02539563|labor duration|labor duration
5234088|NCT02539550|PF-06266047|pf-06266047
5234089|NCT02539550|safety|safety
5234090|NCT02539550|tolerability|tolerability
5234091|NCT02539550|pharmacokinetics|pharmacokinetics
5234093|NCT02539550|healthy volunteers|healthy volunteers
5234094|NCT02539550|PDE4|pde4
5234095|NCT02539550|phosphodiesterase-4|phosphodiesterase-4
5234096|NCT02539537|locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
5234097|NCT02539537|FOLFIRINOX|folfirinox
5234098|NCT02539524|clinical impact|clinical impact
5234099|NCT02539524|anxiety|anxiety
5234100|NCT02539524|quality of life|quality of life
5234101|NCT02539524|Yoga|yoga
5234102|NCT02539498|Primary Hyperparathyroidism|primary hyperparathyroidism
5234103|NCT02539498|Parathyroid Hormone|parathyroid hormone
5234104|NCT02539498|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
5234105|NCT02539498|Bone densitometry|bone densitometry
5234106|NCT02539498|Bone microarchitecture|bone microarchitecture
5234107|NCT02539446|Aging|aging
5234108|NCT02539446|External focus|external focus
5234109|NCT02539446|Internal focus|internal focus
5234110|NCT02539446|Attention|attention
5234111|NCT02539446|Posture balance|posture balance
5234112|NCT02539446|Parkinson's disease|parkinson's disease
5234113|NCT02539407|β-lactam antibiotics|β-lactam antibiotics
5234114|NCT02539407|Children|children
5234115|NCT02539407|Anti-infectives|anti-infectives
5234116|NCT02539407|Aminoglycosides, glycopeptides|aminoglycosides, glycopeptides
5234117|NCT02539407|Fluoroquinolone|fluoroquinolone
5234118|NCT02539407|Fungal|fungal
5234119|NCT02539407|Antiviral|antiviral
5234120|NCT02539394|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5234121|NCT02539394|Dysphagia|dysphagia
5234122|NCT02539394|ACDF|acdf
5234123|NCT02539368|CT-P13|ct-p13
5234124|NCT02539368|Inflectra|inflectra
5234125|NCT02539368|Remicade|remicade
5234126|NCT02539368|Infliximab|infliximab
5234127|NCT02539368|Observational|observational
5234128|NCT02539368|Follow-up|follow-up
5234129|NCT02539368|Safety|safety
5234130|NCT02539368|Effectiveness|effectiveness
5234131|NCT02539355|Insulin resistance|insulin resistance
5234132|NCT02539355|Diabetes|diabetes
5234133|NCT02539355|Cancer|cancer
5234134|NCT02539355|Obesity|obesity
5234135|NCT02539355|Inflammation|inflammation
5234136|NCT02539342|Oral Mucositis|oral mucositis
5234137|NCT02539342|Cancer|cancer
5234138|NCT02539342|Chemotherapy|chemotherapy
5234139|NCT02539329|neuropathy|neuropathy
5234140|NCT02539329|antibodies antiFGFR3|antibodies antifgfr3
5234141|NCT02539329|Biological diagnostic criteria|biological diagnostic criteria
5234142|NCT02539316|Parenteral Nutrition|parenteral nutrition
5234143|NCT02539290|Unexplained infertility|unexplained infertility
5234144|NCT02539290|Infertility|infertility
5234145|NCT02539290|Tubal flushing|tubal flushing
5234146|NCT02539290|Uterine flushing|uterine flushing
5234147|NCT02539290|Live birth|live birth
5234148|NCT02539290|Pregnancy|pregnancy
5234149|NCT02539290|Randomized controlled trial|randomized controlled trial
5234150|NCT02539290|Saline|saline
5234151|NCT02539290|Physiological saline|physiological saline
5234152|NCT02539264|All patients registered for A PSG|all patients registered for a psg
5234153|NCT02539264|polysomnography|polysomnography
5234154|NCT02539251|Early Child Development|early child development
5234155|NCT02539251|Ages and Stages Questionnaire _3|ages and stages questionnaire _3
5234156|NCT02539251|Validation|validation
5234157|NCT02539238|Medical Education|medical education
5234158|NCT02539238|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5234159|NCT02539238|feedback|feedback
5234160|NCT02539238|cost-effectiveness analysis|cost-effectiveness analysis
5234161|NCT02539212|microwave|microwave
5234162|NCT02539212|radiofrequency|radiofrequency
5234163|NCT02539212|ablation|ablation
5234164|NCT02539160|coronary artery disease|coronary artery disease
5234165|NCT02539160|diabetes mellitus|diabetes mellitus
5234166|NCT02539160|chronic kidney disease|chronic kidney disease
5234167|NCT02539160|ticagrelor|ticagrelor
5234168|NCT02539147|lipopolysaccharide|lipopolysaccharide
5234169|NCT02539147|sepsis|sepsis
5234170|NCT02539147|caspase-4 and -5|caspase-4 and -5
5234171|NCT02539147|monocytes|monocytes
5234172|NCT02539147|IL-1β and IL-1α|il-1β and il-1α
5234173|NCT02539134|Drug therapy|drug therapy
5234174|NCT02539121|Labor|labor
5234175|NCT02539121|Acupuncture|acupuncture
5234176|NCT02539121|Postpartum hemorrhage|postpartum hemorrhage
5234177|NCT02539121|Placental expulsion time|placental expulsion time
5234178|NCT02539121|Postpartum blood loss|postpartum blood loss
5234179|NCT02539108|Influenza|influenza
5234180|NCT02539108|Influenza virus vaccine|influenza virus vaccine
5234181|NCT02539108|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
5234182|NCT02539095|intra-articular injection|intra-articular injection
5234183|NCT02539095|intra-articular collagen injection|intra-articular collagen injection
5234184|NCT02539095|collagen|collagen
5234185|NCT02539095|knee joint pain|knee joint pain
5234186|NCT02539082|collagen|collagen
5113665|NCT03286543|TKA pain|tka pain
5234187|NCT02539082|collagen injection|collagen injection
5234188|NCT02539082|plantar fasciitis|plantar fasciitis
5234189|NCT02539069|cartilage defects|cartilage defects
5234190|NCT02539069|Chondron|chondron
5231613|NCT02554708|pCONus|pconus
5234191|NCT02539069|Autologous cultured Chondrocyte|autologous cultured chondrocyte
5234192|NCT02539069|arthroscopy|arthroscopy
5234193|NCT02539056|cartilage defects|cartilage defects
5234194|NCT02539056|Chondron|chondron
5234195|NCT02539056|Autologous cultured Chondrocyte|autologous cultured chondrocyte
5234196|NCT02539043|Lipolysis|lipolysis
5234197|NCT02539043|Subcutaneous Fat, Abdominal/metabolism|subcutaneous fat, abdominal/metabolism
5234198|NCT02539043|Subcutaneous Fat, Abdominal/ultrasonography|subcutaneous fat, abdominal/ultrasonography
5234199|NCT02539043|High-Intensity Focused Ultrasound Ablation/methods|high-intensity focused ultrasound ablation/methods
5234200|NCT02539043|Waist Circumference|waist circumference
5234201|NCT02539043|Pilot Projects|pilot projects
5234202|NCT02539043|Subcutaneous Fat|subcutaneous fat
5234203|NCT02539043|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
5234204|NCT02539043|Adiposity|adiposity
5234205|NCT02539030|Cartilage defect of knee|cartilage defect of knee
5234206|NCT02539030|microfracture|microfracture
5234207|NCT02539030|modified microfracture|modified microfracture
5234208|NCT02539030|collagen|collagen
5234209|NCT02539017|cellular immune therapy|cellular immune therapy
5234210|NCT02539017|triple negative breast cancer|triple negative breast cancer
5234211|NCT02539017|adjuvant therapy|adjuvant therapy
5234212|NCT02539004|kidney stones|kidney stones
5234213|NCT02539004|ureteral stones|ureteral stones
5234214|NCT02538991|Bulkamid|bulkamid
5234215|NCT02538991|Tension-Free Vaginal Tape|tension-free vaginal tape
5234218|NCT02538965|Lenalidomide|lenalidomide
5234219|NCT02538965|Revlimid|revlimid
5234220|NCT02538965|Pediatric|pediatric
5234221|NCT02538965|Relapsed or Refractory|relapsed or refractory
5234222|NCT02538965|Acute Myeloid Leukemia|acute myeloid leukemia
5234223|NCT02538965|Leukemia|leukemia
5234224|NCT02538952|GeneXpert|genexpert
5234225|NCT02538952|Tuberculosis|tuberculosis
5234226|NCT02538952|Human immunodeficiency virus|human immunodeficiency virus
5234227|NCT02538952|Diagnostic accuracy|diagnostic accuracy
5234228|NCT02538952|Impact|impact
5234229|NCT02538939|Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate|calcific tendinitis, shoulder, needle lavage, sodium thiosulfate
5234230|NCT02538913|Exercise|exercise
5234231|NCT02538913|Pelvic floor|pelvic floor
5234232|NCT02538913|Prehabilitation|prehabilitation
5234233|NCT02538913|Fecal incontinence|fecal incontinence
5234234|NCT02538913|Urinary incontinence|urinary incontinence
5234235|NCT02538913|Sexual dysfunction, physiological|sexual dysfunction, physiological
5234236|NCT02538900|peripheral arterial disease, peripheral artery disease, PAD, exercise|peripheral arterial disease, peripheral artery disease, pad, exercise
5234237|NCT02538822|aortic aneurysm|aortic aneurysm
5234238|NCT02538822|thoracic ascending aorta|thoracic ascending aorta
5234240|NCT02538822|dynamic imaging|dynamic imaging
5234241|NCT02538822|mechanical testing|mechanical testing
5234242|NCT02538796|Anorexia Nervosa|anorexia nervosa
5234243|NCT02538796|Cognition|cognition
5234244|NCT02538796|Conscious|conscious
5234245|NCT02538796|Non-Conscious|non-conscious
5234246|NCT02538705|Diabetic foot syndrome|diabetic foot syndrome
5234247|NCT02538705|Ulcers|ulcers
5234248|NCT02538679|transversus abdominis plane block|transversus abdominis plane block
5234249|NCT02538679|tap block|tap block
5234250|NCT02538679|regional anesthesia|regional anesthesia
5234251|NCT02538679|colorectal surgery|colorectal surgery
5234252|NCT02538653|glycemic & insulin response, SDS, cereal product, Nutrition|glycemic & insulin response, sds, cereal product, nutrition
5234253|NCT02538640|Nutrition, glycemic response, cereal products|nutrition, glycemic response, cereal products
5234254|NCT02538627|Heregulin-positive|heregulin-positive
5234255|NCT02538627|EGFR|egfr
5234256|NCT02538627|ErbB3|erbb3
5234257|NCT02538627|Phase I|phase i
5234258|NCT02538627|Oncology|oncology
5234259|NCT02538627|Cancer|cancer
5234260|NCT02538627|IGF-1|igf-1
5234261|NCT02538627|MEKinhibitor|mekinhibitor
5234262|NCT02538627|IGF-1R inhibitor|igf-1r inhibitor
5234263|NCT02538627|KRAS|kras
5234264|NCT02538627|NRAS|nras
5234265|NCT02538601|Post Traumatic Stress Disorder|post traumatic stress disorder
5234266|NCT02538601|PTSD|ptsd
5234267|NCT02538601|Cigarette Smoking|cigarette smoking
5234268|NCT02538601|Lower Respiratory Symptoms|lower respiratory symptoms
5234269|NCT02538601|Cognitive Behavioral Therapy|cognitive behavioral therapy
5234270|NCT02538601|CBT|cbt
5234271|NCT02538601|Transdiagnostic Treatments|transdiagnostic treatments
5234272|NCT02538601|World Trade Center|world trade center
5234273|NCT02538588|Healthy Volunteers|healthy volunteers
5234274|NCT02538575|Cystic Fibrosis|cystic fibrosis
5234275|NCT02538575|Adults|adults
5234276|NCT02538575|6-minute walk test|6-minute walk test
5234277|NCT02538497|NBO|nbo
5234278|NCT02538497|The Newborn Behavioral Observation|the newborn behavioral observation
5234279|NCT02538497|postpartum depression|postpartum depression
5962760|NCT04278898|electroencephalography|electroencephalography
5234280|NCT02538497|postnatal depression|postnatal depression
5234281|NCT02538497|child development|child development
5234282|NCT02538497|parent-child interaction|parent-child interaction
5234283|NCT02538458|Saline Solution, Hypertonic (3 %)|saline solution, hypertonic (3 %)
5234284|NCT02538458|Infant|infant
5234285|NCT02538445|Schizophrenia|schizophrenia
5234286|NCT02538445|Memory|memory
5234287|NCT02538445|Cognition|cognition
5234288|NCT02538432|Disease Progression|disease progression
5234289|NCT02538432|Non-Responsive Disease|non-responsive disease
5234290|NCT02538432|Advanced Disease|advanced disease
5234291|NCT02538406|Adenoma|adenoma
5234292|NCT02538406|withdrawal time|withdrawal time
5234293|NCT02538406|Colonoscopy|colonoscopy
5234294|NCT02538380|Lung cancer|lung cancer
5234295|NCT02538380|Adrenal gland metastasis|adrenal gland metastasis
5234296|NCT02538354|Riboflavin (vitamin B2)|riboflavin (vitamin b2)
5234297|NCT02538354|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
5234298|NCT02538328|laparoscopy|laparoscopy
5234299|NCT02538328|obesity|obesity
5234300|NCT02538328|harmonic scalpel|harmonic scalpel
5234301|NCT02538328|ligasure|ligasure
5234302|NCT02538315|[18F]FODPA, Parkinson's, PET/CT, Stem Cell transplantation|[18f]fodpa, parkinson's, pet/ct, stem cell transplantation
5234303|NCT02538302|Minirin|minirin
5234304|NCT02538302|Oxybutynin|oxybutynin
5234305|NCT02538302|Nocturnal enuresis|nocturnal enuresis
5234306|NCT02538289|Dyspnea|dyspnea
5234307|NCT02538289|Palliative Care|palliative care
5234308|NCT02538289|Heart Failure|heart failure
5234309|NCT02538289|Chronic Pulmonary Disease|chronic pulmonary disease
5234310|NCT02538289|Opioids|opioids
5234311|NCT02538276|carotid endarterectomy, carotid stenosis, carotid stenting|carotid endarterectomy, carotid stenosis, carotid stenting
5234312|NCT02538250|Oral nutritional supplement|oral nutritional supplement
5234313|NCT02538250|supplementation|supplementation
5234314|NCT02538250|adult patients|adult patients
5234315|NCT02538224|Periodontitis|periodontitis
5234316|NCT02538224|doxycycline/ketoprofen topical gel therapeutic|doxycycline/ketoprofen topical gel therapeutic
5234317|NCT02538198|lenalidomide (CC-5013)|lenalidomide (cc-5013)
5234318|NCT02538198|maintenance|maintenance
5234319|NCT02538198|15-129|15-129
5234320|NCT02538172|Cell-mediated immunity|cell-mediated immunity
5234321|NCT02538172|Antiviral prophylaxis|antiviral prophylaxis
5234322|NCT02538172|Transplantation|transplantation
5234323|NCT02538159|Non-tunneled Central venous catheter|non-tunneled central venous catheter
5234324|NCT02538159|Bacteraemia|bacteraemia
5234325|NCT02538159|Peripherally inserted central venous catheter|peripherally inserted central venous catheter
5234326|NCT02538146|pain|pain
5234327|NCT02538146|depression|depression
5234328|NCT02538146|cytokines|cytokines
5234329|NCT02538146|well-being|well-being
5234330|NCT02538133|99mTc-Exametazime (HMPAO)-Labeled Leukocytes|99mtc-exametazime (hmpao)-labeled leukocytes
5234331|NCT02538133|suspected subdiaphragmatic vascular prosthesis infection|suspected subdiaphragmatic vascular prosthesis infection
5234332|NCT02538133|diagnosis|diagnosis
5234333|NCT02538094|Cognitive Enhancement|cognitive enhancement
5234334|NCT02538094|tDCS|tdcs
5234335|NCT02538094|stimulation|stimulation
5234336|NCT02538094|MS|ms
5234337|NCT02538094|Multiple Sclerosis|multiple sclerosis
5234338|NCT02538094|Encephalitis|encephalitis
5234339|NCT02538081|schizophrenia|schizophrenia
5234340|NCT02538081|olanzapine|olanzapine
5234341|NCT02538081|risperidone|risperidone
5234342|NCT02538081|alpha 7 nicotinic receptors|alpha 7 nicotinic receptors
5234343|NCT02538081|cognition|cognition
5234344|NCT02538068|Purpose in Life|purpose in life
5234345|NCT02538068|Self-determination|self-determination
5234346|NCT02538068|Physical activity|physical activity
5234347|NCT02538068|Self-monitoring|self-monitoring
5234348|NCT02538068|Behavior change|behavior change
5234349|NCT02538055|Community Health Workers|community health workers
5234350|NCT02538055|Diabetes Mellitus|diabetes mellitus
5234351|NCT02538055|Chronic Pain|chronic pain
5234352|NCT02538029|Dual tasking|dual tasking
5234354|NCT02538016|Kidney Stones|kidney stones
5234355|NCT02537964|chlorhexidine|chlorhexidine
5234356|NCT02537951|autofluorescent flavoprotein imaging, capsaicin|autofluorescent flavoprotein imaging, capsaicin
5234357|NCT02537925|COX-2 inhibitors|cox-2 inhibitors
5234358|NCT02537925|radiosensitivity|radiosensitivity
5234359|NCT02537925|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5234360|NCT02537912|peanut skin|peanut skin
5234361|NCT02537912|body fat|body fat
5234362|NCT02537912|blood glucose|blood glucose
5234363|NCT02537912|waistline|waistline
5234364|NCT02537912|body weight|body weight
5234365|NCT02537886|PCOR|pcor
5234366|NCT02537873|Cocaine Use Disorder|cocaine use disorder
5234367|NCT02537847|Sitafloxacin|sitafloxacin
5234368|NCT02537847|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
5234369|NCT02537847|Treatment for Acute Pyelonephritis|treatment for acute pyelonephritis
5234370|NCT02537847|Ertapenem|ertapenem
5234371|NCT02537795|Deep Brain Stimulation|deep brain stimulation
5128504|NCT03191266|neuroimaging|neuroimaging
5234372|NCT02537795|Anterior Capsulotomy|anterior capsulotomy
5234373|NCT02537782|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5234374|NCT02537782|Heart Failure|heart failure
5234375|NCT02537782|Left ventricular dyssynchrony|left ventricular dyssynchrony
5234376|NCT02537782|Echocardiography|echocardiography
5234377|NCT02537782|Apical rocking|apical rocking
5234378|NCT02537782|Septal flash|septal flash
5234379|NCT02537769|LVAD|lvad
5234380|NCT02537769|Tricuspid regurgitation|tricuspid regurgitation
5234381|NCT02537769|Heart failure|heart failure
5234382|NCT02537769|Transplant|transplant
5234383|NCT02537769|3D transesophageal echocardiography (TEE)|3d transesophageal echocardiography (tee)
5234384|NCT02537769|2D transesophageal echocardiography (TEE)|2d transesophageal echocardiography (tee)
5234386|NCT02537769|Moderate|moderate
5234387|NCT02537743|Patient Reported Outcomes|patient reported outcomes
5234388|NCT02537704|Obesity|obesity
5234389|NCT02537704|Translational|translational
5234390|NCT02537704|Diabetes Prevention Program|diabetes prevention program
5234391|NCT02537704|Group Lifestyle Balance Program|group lifestyle balance program
5234392|NCT02537652|Central blood pressure|central blood pressure
5234393|NCT02537652|Transient ischaemic attack|transient ischaemic attack
5234394|NCT02537639|Simulator in transesophageal echocardiography|simulator in transesophageal echocardiography
5234395|NCT02537613|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5234396|NCT02537600|BRAF mutation|braf mutation
5234397|NCT02537600|Brain metastasis|brain metastasis
5234398|NCT02537600|Cobimetinib + Vemurafenib combination treatment|cobimetinib + vemurafenib combination treatment
5234399|NCT02537587|Blood glucose|blood glucose
5234400|NCT02537587|Blood insulin|blood insulin
5234401|NCT02537587|Humans|humans
5234402|NCT02537587|Postprandial|postprandial
5234403|NCT02537587|Carbohydrate|carbohydrate
5234404|NCT02537587|Protein|protein
5234405|NCT02537587|Resistant starch|resistant starch
5234406|NCT02537587|Sugar|sugar
5234407|NCT02537574|Alkermes|alkermes
5234408|NCT02537574|Buprenorphine|buprenorphine
5234409|NCT02537574|Naltrexone|naltrexone
5234410|NCT02537574|Vivitrol|vivitrol
5234411|NCT02537574|Opioid Use|opioid use
5234412|NCT02537574|Opiates|opiates
5234413|NCT02537574|Dependence|dependence
5234414|NCT02537574|Abuse|abuse
5234415|NCT02537574|Heroin|heroin
5234416|NCT02537574|Painkillers|painkillers
5234417|NCT02537574|Substance Abuse|substance abuse
5234418|NCT02537496|Alzheimer's Disease|alzheimer's disease
5234419|NCT02537496|Brain stimulation|brain stimulation
5234420|NCT02537496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5234421|NCT02537496|Neuroplasticity|neuroplasticity
5234422|NCT02537496|cognitive enhancement|cognitive enhancement
5234423|NCT02537496|TMS-EEG|tms-eeg
5234424|NCT02537496|rTMS|rtms
5234426|NCT02537431|KRN23|krn23
5234427|NCT02537431|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
5234428|NCT02537431|XLH|xlh
5234429|NCT02537431|X-linked Hypophosphatemia|x-linked hypophosphatemia
5234430|NCT02537379|Hepatitis C virus|hepatitis c virus
5234431|NCT02537379|observational|observational
5234432|NCT02537379|post-marketing|post-marketing
5234433|NCT02537379|sofosbuvir|sofosbuvir
5234434|NCT02537353|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5234435|NCT02537353|Hemospray|hemospray
5234436|NCT02537353|Endoscopic hemostasis|endoscopic hemostasis
5234437|NCT02537340|PET/MR|pet/mr
5234438|NCT02537340|MRI|mri
5234439|NCT02537340|Rectal cancer|rectal cancer
5234440|NCT02537340|EMVI|emvi
5234441|NCT02537340|FDG|fdg
5234442|NCT02537327|Recurrent caries|recurrent caries
5234443|NCT02537327|Secondary caries|secondary caries
5234444|NCT02537327|Dental composite|dental composite
5234445|NCT02537327|Dental amalgam|dental amalgam
5234446|NCT02537314|Normal Body Weight|normal body weight
5234447|NCT02537301|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5234448|NCT02537301|social networking|social networking
5234449|NCT02537301|group chat|group chat
5234450|NCT02537288|VA106483|va106483
5234451|NCT02537288|fedovapagon|fedovapagon
5234452|NCT02537288|males|males
5234453|NCT02537288|females|females
5234454|NCT02537288|moxifloxacin|moxifloxacin
5234456|NCT02537288|QT/QTC|qt/qtc
5234457|NCT02537288|ECG|ecg
5234458|NCT02537288|Nocturia|nocturia
5234459|NCT02537262|carbohydrate|carbohydrate
5234460|NCT02537262|quality of recovery(QOR) 40|quality of recovery(qor) 40
5234461|NCT02537262|enhanced recovery after surgery(ERAS)|enhanced recovery after surgery(eras)
5234462|NCT02537249|dexmedetomidine|dexmedetomidine
5234463|NCT02537249|quality of recovery|quality of recovery
5234464|NCT02537236|Omega-3 Fatty Acids|omega-3 fatty acids
5234465|NCT02537236|Therapeutic Lifestyle Changes|therapeutic lifestyle changes
5234466|NCT02537236|Human Immunodeficiency Virus|human immunodeficiency virus
5234467|NCT02537236|Cardiac Risk|cardiac risk
5234468|NCT02537236|Dyslipidemia|dyslipidemia
5234469|NCT02537171|Apatinib|apatinib
5234470|NCT02537171|Locally Advanced Gastric Cancer|locally advanced gastric cancer
5234471|NCT02537171|Metastatic Gastric Cancer|metastatic gastric cancer
5234472|NCT02537158|sorafenib|sorafenib
5234473|NCT02537158|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5234474|NCT02537158|hepatocellular carcinoma|hepatocellular carcinoma
5234475|NCT02537158|microvascular invasion|microvascular invasion
5234476|NCT02537145|compliance|compliance
5234477|NCT02537145|do-it-yourself methodology|do-it-yourself methodology
5234478|NCT02537145|pilot|pilot
5234479|NCT02537145|human microbiome|human microbiome
5234480|NCT02537132|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
5234481|NCT02537132|Amyotrophic Lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5234482|NCT02537132|adaptation|adaptation
5234483|NCT02537132|home care|home care
5234484|NCT02537106|Brain Tumors|brain tumors
5234485|NCT02537106|Microcirculation|microcirculation
5234486|NCT02537106|Osmotherapy|osmotherapy
5234487|NCT02537106|Hypertonic NaCl|hypertonic nacl
5234488|NCT02537106|Natremia|natremia
5234489|NCT02537080|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5234490|NCT02537080|Nimodipin|nimodipin
5234491|NCT02537080|Anesthesia|anesthesia
5234492|NCT02537067|a partial cartilage defect of ankle|a partial cartilage defect of ankle
5234493|NCT02537067|Chondron|chondron
5234494|NCT02537067|Autologus Chondrocyte|autologus chondrocyte
5234495|NCT02537054|Choroidal neovascularization|choroidal neovascularization
5234496|NCT02537054|Angioid streaks|angioid streaks
5234497|NCT02537054|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
5234498|NCT02537054|vascular endothelial growth factor|vascular endothelial growth factor
5234500|NCT02537028|MSC2364447C|msc2364447c
5234501|NCT02537028|Phase 1|phase 1
5234502|NCT02537028|BTK inhibitor|btk inhibitor
5234503|NCT02537028|Systemic Lupus Erythematosus|systemic lupus erythematosus
5234504|NCT02537028|M2951|m2951
5234505|NCT02537028|Lupus|lupus
5234506|NCT02537002|PF-05230907|pf-05230907
5234507|NCT02537002|Pharmacokinetics|pharmacokinetics
5234508|NCT02537002|Pharmacodynamic|pharmacodynamic
5234509|NCT02537002|Immunogenicity|immunogenicity
5234510|NCT02536989|peptic ulcer bleeding|peptic ulcer bleeding
5234511|NCT02536989|blood clot|blood clot
5234512|NCT02536989|dose|dose
5234513|NCT02536976|mirabegron|mirabegron
5234514|NCT02536950|bionic pancreas|bionic pancreas
5234515|NCT02536950|closed-loop control|closed-loop control
5234516|NCT02536950|artificial pancreas|artificial pancreas
5234517|NCT02536885|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5234518|NCT02536885|Blood pressure|blood pressure
5234519|NCT02536885|Anesthesia|anesthesia
5234520|NCT02536872|infection overactive bladder|infection overactive bladder
5234521|NCT02536846|Healthy volunteers|healthy volunteers
5234522|NCT02536846|antipsychotic drugs|antipsychotic drugs
5234523|NCT02536846|brain metabolism|brain metabolism
5234524|NCT02536833|OA|oa
5234525|NCT02536833|Samumed|samumed
5234526|NCT02536781|Anthocyanin|anthocyanin
5234527|NCT02536781|Inflammation|inflammation
5234528|NCT02536781|Orthodontic treatment|orthodontic treatment
5234529|NCT02536768|Medication adherence|medication adherence
5234530|NCT02536768|ART|art
5234531|NCT02536768|Counseling|counseling
5234532|NCT02536768|Adherence Guidelines for Chronic Diseases (HIV, TB and NCDs)|adherence guidelines for chronic diseases (hiv, tb and ncds)
5234533|NCT02536742|Breast Cancer|breast cancer
5234534|NCT02536742|Metastatic|metastatic
5234535|NCT02536742|HER2 negative|her2 negative
5234536|NCT02536742|Palbociclib|palbociclib
5234537|NCT02536716|Dental Implant|dental implant
5234538|NCT02536690|propofol|propofol
5234539|NCT02536690|midazolam|midazolam
5234540|NCT02536690|remifentanil|remifentanil
5234541|NCT02536690|combination|combination
5234542|NCT02536690|synergic|synergic
5234543|NCT02536690|pharmacodynamics|pharmacodynamics
5234544|NCT02536690|Loss of consciousness|loss of consciousness
5234545|NCT02536677|Acute Chest Pain|acute chest pain
5222607|NCT02607332|open-label|open-label
5222608|NCT02607332|phase II|phase ii
5222609|NCT02607319|Recurrent Implantation Failure|recurrent implantation failure
5234546|NCT02536677|Acute Coronary Syndrome|acute coronary syndrome
5234547|NCT02536677|Evaluation and Management|evaluation and management
5234548|NCT02536677|Decision Aid|decision aid
5234549|NCT02536677|Healthcare Utilization|healthcare utilization
5234550|NCT02536651|validation studies, patient-reported outcome measures|validation studies, patient-reported outcome measures
5234551|NCT02536638|urine protein|urine protein
5234552|NCT02536638|pregnancy|pregnancy
5234553|NCT02536638|pyelonephritis|pyelonephritis
5234554|NCT02536638|kidney infection|kidney infection
5234555|NCT02536625|everolimus|everolimus
5234556|NCT02536625|NK|nk
5234557|NCT02536625|metastatic|metastatic
5234558|NCT02536612|Motivation|motivation
5234559|NCT02536612|Behavioral Economics|behavioral economics
5234560|NCT02536612|Conditional Economic Incentives|conditional economic incentives
5234561|NCT02536612|Conditional cash transfers|conditional cash transfers
5234562|NCT02536612|Contingency management|contingency management
5234563|NCT02536599|Febrile Neutropenia|febrile neutropenia
5234564|NCT02536599|Childhood Cancer|childhood cancer
5234565|NCT02536599|Pediatric Oncology|pediatric oncology
5234566|NCT02536599|Fever|fever
5234567|NCT02536599|Neutropenia|neutropenia
5234568|NCT02536573|Total hip replacement|total hip replacement
5234569|NCT02536560|intestinal microbiota|intestinal microbiota
5234570|NCT02536560|antibiotics|antibiotics
5234571|NCT02536560|infant|infant
5234572|NCT02536560|allergy|allergy
5234573|NCT02536547|Clinical pulmonary infection score|clinical pulmonary infection score
5234574|NCT02536547|sepsis|sepsis
5234575|NCT02536547|lung ultrasound|lung ultrasound
5234576|NCT02536547|ventilator-associated pneumonia|ventilator-associated pneumonia
5234577|NCT02536534|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5234578|NCT02536534|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5234579|NCT02536456|screening|screening
5234580|NCT02536456|counseling|counseling
5234581|NCT02536456|follow-up|follow-up
5234582|NCT02536456|cardiovascular disease|cardiovascular disease
5234583|NCT02536456|population-based project|population-based project
5234584|NCT02536456|China|china
5234585|NCT02536443|heart failure|heart failure
5234586|NCT02536443|prognosis|prognosis
5234587|NCT02536443|clinical characteristics|clinical characteristics
5234588|NCT02536430|Infra alveolar nerve block|infra alveolar nerve block
5234589|NCT02536430|Ketorolac|ketorolac
5234590|NCT02536430|Success rate|success rate
5234591|NCT02536417|Melatonin|melatonin
5234592|NCT02536417|Delirium prevention|delirium prevention
5234594|NCT02536352|Fluoride Supplementation|fluoride supplementation
5234595|NCT02536352|Prenatal Vitamin|prenatal vitamin
5234597|NCT02536352|Prenatal Nutrition|prenatal nutrition
5234598|NCT02536287|secondary hyperparathyroidism|secondary hyperparathyroidism
5234599|NCT02536287|total parathyroidectomy|total parathyroidectomy
5234600|NCT02536287|autotransplantation|autotransplantation
5234601|NCT02536287|morbidity|morbidity
5234602|NCT02536287|recurrence|recurrence
5234603|NCT02536287|postoperative hypocalcemia|postoperative hypocalcemia
5234604|NCT02536261|Prolactinoma|prolactinoma
5234605|NCT02536261|dopamine agonist|dopamine agonist
5234606|NCT02536261|withdrawal|withdrawal
5234607|NCT02536261|cavernous sinus|cavernous sinus
5234608|NCT02536248|sitagliptin|sitagliptin
5234609|NCT02536248|diabetes|diabetes
5234910|NCT02533986|Polyphenols|polyphenols
5234610|NCT02536248|inflammation|inflammation
5234611|NCT02536196|Cerebral protection, aortic stenosis, transcatheter aortic valve implantation, TAVI, TriGuard, Keystone Heart|cerebral protection, aortic stenosis, transcatheter aortic valve implantation, tavi, triguard, keystone heart
5234612|NCT02536183|Solid tumors|solid tumors
5234613|NCT02536183|relapsed pediatric solid tumors|relapsed pediatric solid tumors
5234614|NCT02536183|high intensity focused ultrasound|high intensity focused ultrasound
5234615|NCT02536183|Lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
5234616|NCT02536183|ThermoDox|thermodox
5234617|NCT02536183|relapsed sarcoma|relapsed sarcoma
5234618|NCT02536183|Ewing Sarcoma family of tumors|ewing sarcoma family of tumors
5234619|NCT02536183|Osteosarcoma|osteosarcoma
5234620|NCT02536183|Neuroblastoma|neuroblastoma
5234621|NCT02536183|Wilms Tumor|wilms tumor
5234622|NCT02536183|Hepatic Tumor|hepatic tumor
5234623|NCT02536183|Germ Cell Tumors|germ cell tumors
5234624|NCT02536170|Arginine Therapy|arginine therapy
5234625|NCT02536157|Volar plate|volar plate
5234626|NCT02536157|Splint|splint
5234627|NCT02536157|Proximal interphalangeal joint|proximal interphalangeal joint
5234628|NCT02536157|Palmar plate|palmar plate
5234629|NCT02536157|Hyperextension injury|hyperextension injury
5234630|NCT02536144|colon capsule|colon capsule
5234631|NCT02536144|magnetic|magnetic
5234632|NCT02536144|maneuverability|maneuverability
5234633|NCT02536144|colonoscopy|colonoscopy
5234634|NCT02536131|Psychosomatics|psychosomatics
5234635|NCT02536131|Gastroenterology|gastroenterology
5234636|NCT02536131|Psychoneuroimmunology|psychoneuroimmunology
5234637|NCT02536105|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5234638|NCT02536105|ADHD|adhd
5234639|NCT02536053|[E04.100.814.603]|[e04.100.814.603]
5234640|NCT02536040|silver diamine fluoride|silver diamine fluoride
5234641|NCT02536040|diammine silver fluoride|diammine silver fluoride
5234642|NCT02536040|children|children
5234643|NCT02536027|continuous venovenous hemofiltration|continuous venovenous hemofiltration
5234644|NCT02536027|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5234645|NCT02536027|sepsis|sepsis
5234646|NCT02536027|acute kidney injury|acute kidney injury
5234647|NCT02536014|Dexmedetomidine|dexmedetomidine
5234648|NCT02536014|pneumoperitoneum|pneumoperitoneum
5234649|NCT02536014|trendelenburg position|trendelenburg position
5234650|NCT02536014|QTc interval|qtc interval
5234651|NCT02536014|Tp-e interval|tp-e interval
5234652|NCT02536014|robotic prostatectomy|robotic prostatectomy
5234653|NCT02536001|Vaginal mesh|vaginal mesh
5234654|NCT02536001|Total vaginal length|total vaginal length
5234655|NCT02536001|Quality of life|quality of life
5234656|NCT02535988|Colorectal Cancer|colorectal cancer
5234657|NCT02535988|Metastatic Colorectal Cancer|metastatic colorectal cancer
5234658|NCT02535988|ZADAXIN|zadaxin
5234659|NCT02535988|Abscopal Effect|abscopal effect
5234660|NCT02535988|Radiotherapy|radiotherapy
5234661|NCT02535962|PFAPA|pfapa
5234662|NCT02535936|Cerebral Palsy|cerebral palsy
5234663|NCT02535923|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
5234664|NCT02535923|Mental Disorders|mental disorders
5234665|NCT02535923|Insomnia Disorder|insomnia disorder
5234666|NCT02535910|vitamin D3|vitamin d3
5234667|NCT02535910|25(OH)D3|25(oh)d3
5234668|NCT02535910|vitamin D status|vitamin d status
5234669|NCT02535910|risk factors of cardiovascular diease|risk factors of cardiovascular diease
5234670|NCT02535884|Huntington Disease|huntington disease
5234672|NCT02535884|Chorea|chorea
5234673|NCT02535858|Anxiety|anxiety
5234674|NCT02535832|Rheumatoid Arthritis|rheumatoid arthritis
5234675|NCT02535819|Cataract surgery|cataract surgery
5234676|NCT02535806|Relapsed, Refractory|relapsed, refractory
5234678|NCT02535741|Knee Replacement|knee replacement
5234679|NCT02535741|Arthroplasty|arthroplasty
5234680|NCT02535728|Frail Elderly|frail elderly
5234681|NCT02535728|Cardiac Surgical Procedure|cardiac surgical procedure
5234682|NCT02535728|Risk Assessment|risk assessment
5234683|NCT02535728|Quality of Life|quality of life
5234684|NCT02535715|Oral Insulin|oral insulin
5234687|NCT02535689|Anti-DNA Antibody|anti-dna antibody
5234688|NCT02535689|Tofacitinib|tofacitinib
5234690|NCT02535689|Safety|safety
5234691|NCT02535676|schizophrenia|schizophrenia
5234692|NCT02535676|transcranial stimulation|transcranial stimulation
5234693|NCT02535663|rhamnogalacturonan|rhamnogalacturonan
5234694|NCT02535663|Natural killer cell activity|natural killer cell activity
5234695|NCT02535663|interleukin-12|interleukin-12
5234696|NCT02535663|interferon-gamma|interferon-gamma
5234697|NCT02535663|immune function|immune function
5234698|NCT02535663|inflammatory|inflammatory
5234699|NCT02535572|Electroconvulsive Therapy|electroconvulsive therapy
5234700|NCT02535546|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5234701|NCT02535546|Streptococcus pneumoniae|streptococcus pneumoniae
5234702|NCT02535546|Pneumonia|pneumonia
5234703|NCT02535546|Pneumococcal conjugate vaccine-13 (PCV-13)|pneumococcal conjugate vaccine-13 (pcv-13)
5234911|NCT02533986|Appetite|appetite
5234704|NCT02535546|Pneumococcal polysaccharide vaccine-23 (PPV-23)|pneumococcal polysaccharide vaccine-23 (ppv-23)
5234705|NCT02535546|Pneumococcal vaccine|pneumococcal vaccine
5234706|NCT02535533|Kidney cancer|kidney cancer
5234707|NCT02535533|Selenium (Se)|selenium (se)
5234708|NCT02535507|pyrotinib|pyrotinib
5234709|NCT02535507|HER2|her2
5234710|NCT02535507|Non-small Cell Lung Cancer|non-small cell lung cancer
5234711|NCT02535507|Phase II|phase ii
5234712|NCT02535481|epidermal graft|epidermal graft
5234713|NCT02535481|suction blister|suction blister
5234714|NCT02535481|blister graft|blister graft
5234715|NCT02535481|suction graft|suction graft
5234716|NCT02535481|Epidermis/su, tr [Surgery, Transplantation]|epidermis/su, tr [surgery, transplantation]
5234717|NCT02535390|cognitive remediation|cognitive remediation
5234718|NCT02535390|vocational outcomes|vocational outcomes
5234719|NCT02535377|Cryodamage|cryodamage
5234720|NCT02535377|microarrays|microarrays
5234721|NCT02535377|Insemination|insemination
5234722|NCT02535377|sperm|sperm
5234723|NCT02535364|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5234725|NCT02535364|chimeric antigen receptor|chimeric antigen receptor
5234726|NCT02535364|CAR|car
5234727|NCT02535364|CAR T cells|car t cells
5234728|NCT02535364|JCAR015|jcar015
5234729|NCT02535364|autologous T cell therapy|autologous t cell therapy
5234730|NCT02535364|cell therapy|cell therapy
5234731|NCT02535351|Clear cell Metastatic renal cell carcinoma|clear cell metastatic renal cell carcinoma
5234732|NCT02535351|Cytoreductive nephrectomy|cytoreductive nephrectomy
5234733|NCT02535351|First line treatment|first line treatment
5234734|NCT02535299|telomere-telomerase|telomere-telomerase
5234735|NCT02535299|Par-4|par-4
5234736|NCT02535299|GLP-1|glp-1
5234737|NCT02535299|metformin|metformin
5234738|NCT02535273|dexmedetomidine|dexmedetomidine
5234739|NCT02535273|prone position|prone position
5234740|NCT02535273|spine surgery|spine surgery
5234741|NCT02535273|Minimally invasive|minimally invasive
5234742|NCT02535273|local anesthesia|local anesthesia
5234743|NCT02535260|Pregnancy|pregnancy
5234744|NCT02535221|Premenopausal Patients|premenopausal patients
5234745|NCT02535221|Estrogen Receptor-Positive HER2 negative|estrogen receptor-positive her2 negative
5234746|NCT02535169|at risk for type 2 diabetes|at risk for type 2 diabetes
5234747|NCT02535169|currently has type 2 diabetes|currently has type 2 diabetes
5234748|NCT02535078|IMCgp100|imcgp100
5234749|NCT02535078|gp100|gp100
5234750|NCT02535078|metastatic cutaneous melanoma|metastatic cutaneous melanoma
5234751|NCT02535078|checkpoint inhibitor|checkpoint inhibitor
5234752|NCT02535078|PD-1|pd-1
5234753|NCT02535078|PD-L1|pd-l1
5234754|NCT02535078|CTLA-4|ctla-4
5234755|NCT02535078|durvalumab|durvalumab
5234756|NCT02535078|tremelimumab|tremelimumab
5234757|NCT02535065|Low Profile|low profile
5234758|NCT02535065|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5234759|NCT02535065|Endovascular|endovascular
5234760|NCT02535039|Elderly|elderly
5234761|NCT02535039|cognitive retention disorder|cognitive retention disorder
5234762|NCT02535039|methylprednisolone|methylprednisolone
5234763|NCT02534974|Critical care|critical care
5234764|NCT02534974|Trauma patients|trauma patients
5234765|NCT02534961|Hepatocellular carcinoma|hepatocellular carcinoma
5234766|NCT02534961|Radiofrequency ablation|radiofrequency ablation
5234767|NCT02534961|Antibiotics|antibiotics
5234768|NCT02534948|mindfulness|mindfulness
5234769|NCT02534948|MABT|mabt
5234770|NCT02534948|social anxiety|social anxiety
5234771|NCT02534948|mindfulness and acceptance|mindfulness and acceptance
5234772|NCT02534948|group therapy|group therapy
5234773|NCT02534935|Phase 2 Immunogenicity|phase 2 immunogenicity
5234774|NCT02534935|Safety|safety
5234775|NCT02534935|Tolerability Study|tolerability study
5234776|NCT02534935|rLP2086 Vaccine|rlp2086 vaccine
5234777|NCT02534935|Healthy Toddlers|healthy toddlers
5234778|NCT02534935|Neisseria meningitidis|neisseria meningitidis
5234779|NCT02534935|Duration of Immunogenicity|duration of immunogenicity
5234782|NCT02534857|randomized double blinded study|randomized double blinded study
5234783|NCT02534857|live birth rate|live birth rate
5234813|NCT02534558|MicroRNA-29|microrna-29
5234814|NCT02534558|shoulder stiffness|shoulder stiffness
5234815|NCT02534558|mir-29a|mir-29a
5234816|NCT02534545|Intracranial atherosclerotic stenosis|intracranial atherosclerotic stenosis
5234817|NCT02534545|ischemia|ischemia
5234818|NCT02534545|remote ischemic conditioning|remote ischemic conditioning
5234819|NCT02534545|stroke|stroke
5234820|NCT02534532|Atrial fibrillation screening|atrial fibrillation screening
5234821|NCT02534506|Advanced malignant tumors|advanced malignant tumors
5234822|NCT02534506|Metastatic malignant tumors|metastatic malignant tumors
5234823|NCT02534480|Amyloid|amyloid
5234824|NCT02534415|Antiinflammatory|antiinflammatory
5234825|NCT02534415|Gingiva|gingiva
5234826|NCT02534415|Hyaluronic acid|hyaluronic acid
5234828|NCT02534415|Transplants|transplants
5234829|NCT02534415|Wound healing|wound healing
5234830|NCT02534402|Biomarkers|biomarkers
5234831|NCT02534402|Genomics|genomics
5234832|NCT02534402|Prednisone|prednisone
5234833|NCT02534389|rectal cancer|rectal cancer
5234834|NCT02534389|inflammation|inflammation
5234835|NCT02534389|omega-3|omega-3
5234836|NCT02534389|fish oil|fish oil
5234837|NCT02534389|nutritional status|nutritional status
5234838|NCT02534376|prostatectomy, cholesterol, statin|prostatectomy, cholesterol, statin
5234839|NCT02534363|Cognition|cognition
5234840|NCT02534363|Psychosis|psychosis
5234841|NCT02534363|Antipsychotic Agents|antipsychotic agents
5234842|NCT02534363|Treatment|treatment
5234843|NCT02534363|Effectiveness|effectiveness
5234844|NCT02534363|Aripiprazole|aripiprazole
5234845|NCT02534363|Quetiapine|quetiapine
5234846|NCT02534363|Ziprasidone|ziprasidone
5234847|NCT02534363|Neurocognition|neurocognition
5234848|NCT02534350|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5234849|NCT02534350|Antiviral|antiviral
5234850|NCT02534350|Lung Transplant|lung transplant
5234851|NCT02534324|Hypertension|hypertension
5234852|NCT02534324|Emergency|emergency
5234853|NCT02534298|single sided deafness.|single sided deafness.
5234854|NCT02534298|Auditory plasticity|auditory plasticity
5234855|NCT02534298|Asymmetrical hearing loss|asymmetrical hearing loss
5234856|NCT02534298|Cochlear implants|cochlear implants
5234857|NCT02534298|Inter hemispheric asymmetry|inter hemispheric asymmetry
5234858|NCT02534298|Lateralization index|lateralization index
5234859|NCT02534298|Dichotic hearing|dichotic hearing
5234860|NCT02534285|Anesthesia, Inhalation|anesthesia, inhalation
5234861|NCT02534285|Hearing|hearing
5234862|NCT02534285|Noise, Occupational|noise, occupational
5234863|NCT02534246|Core tissue biopsy|core tissue biopsy
5234864|NCT02534246|Core needle biopsy|core needle biopsy
5234865|NCT02534246|EUS|eus
5234866|NCT02534246|Fine needle biopsy|fine needle biopsy
5234867|NCT02534246|Fine needle aspiration|fine needle aspiration
5234868|NCT02534233|barrett's esophagus with dysplasia|barrett's esophagus with dysplasia
5234869|NCT02534233|early esophageal cancer|early esophageal cancer
5234870|NCT02534220|Toothbrushing|toothbrushing
5234871|NCT02534220|Oral hygiene|oral hygiene
5234872|NCT02534220|Dental hygiene|dental hygiene
5234873|NCT02534194|Gestation|gestation
5234874|NCT02534194|Premature|premature
5234875|NCT02534194|Infants|infants
5234876|NCT02534181|Refeeding Syndrome|refeeding syndrome
5234877|NCT02534181|Cancer|cancer
5234878|NCT02534168|genetic polymorphisms|genetic polymorphisms
5234879|NCT02534155|MitraClip®|mitraclip®
5234880|NCT02534155|MR|mr
5234881|NCT02534155|DMR|dmr
5234882|NCT02534155|high-risk patients|high-risk patients
5234883|NCT02534155|mitral regurgitation|mitral regurgitation
5234884|NCT02534155|surgery|surgery
5234885|NCT02534155|intermediate risk patients|intermediate risk patients
5234886|NCT02534129|breast cancer|breast cancer
5234887|NCT02534129|radiation|radiation
5234888|NCT02534129|dermatitis|dermatitis
5234889|NCT02534116|abdominal reconstruction|abdominal reconstruction
5234890|NCT02534090|Premature|premature
5234891|NCT02534090|Preterm|preterm
5234892|NCT02534090|Necrotizing|necrotizing
5234893|NCT02534090|Enterocolitis|enterocolitis
5234894|NCT02534090|NIRS|nirs
5234895|NCT02534077|omegaven|omegaven
5234896|NCT02534077|cholestasis|cholestasis
5962761|NCT04278885|FXII-associated cold autoinflammatory syndrome (FACAS)|fxii-associated cold autoinflammatory syndrome (facas)
5234897|NCT02534077|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5234898|NCT02534064|Menopause|menopause
5234899|NCT02534064|Osteoporosis|osteoporosis
5234900|NCT02534064|Hip fractures|hip fractures
5234901|NCT02534064|vitamin D deficiency|vitamin d deficiency
5234902|NCT02534051|clinical care path|clinical care path
5234903|NCT02534051|care pathway|care pathway
5234904|NCT02534051|obesity|obesity
5234905|NCT02534051|pregnancy|pregnancy
5234906|NCT02534038|Disinhibition|disinhibition
5234907|NCT02533986|Berry|berry
5234908|NCT02533986|Inflammation|inflammation
5234909|NCT02533986|Cognition|cognition
5234912|NCT02533986|Glucose metabolism|glucose metabolism
5232317|NCT02550548|Glucagon|glucagon
5234913|NCT02533960|Registry of Acute Stroke Under Novel Oral Anticoagulants|registry of acute stroke under novel oral anticoagulants
5234914|NCT02533947|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5234915|NCT02533947|Hematological Malignancies|hematological malignancies
5234916|NCT02533947|Exercise Intervention|exercise intervention
5234917|NCT02533947|Cognitive Function|cognitive function
5234918|NCT02533947|Fatigue|fatigue
5234919|NCT02533947|Randomized Controlled Trial|randomized controlled trial
5234920|NCT02533934|HIV|hiv
5234921|NCT02533934|Hepatitis C|hepatitis c
5234922|NCT02533934|Liver Disease|liver disease
5234923|NCT02533934|HCV Treatment|hcv treatment
5234924|NCT02533934|transplant|transplant
5234925|NCT02533921|Palliative Care|palliative care
5234926|NCT02533921|Parkinson's Disease|parkinson's disease
5234927|NCT02533869|low-dose computed tomography|low-dose computed tomography
5234928|NCT02533817|Fructose|fructose
5234930|NCT02533817|Postprandial lipemia|postprandial lipemia
5234931|NCT02533817|Ambulatory blood pressure|ambulatory blood pressure
5234932|NCT02533817|Ethnicity|ethnicity
5234933|NCT02533804|health|health
5234934|NCT02533804|wellness|wellness
5234935|NCT02533804|life expectancy|life expectancy
5234936|NCT02533804|quality of life|quality of life
5234937|NCT02533804|performance|performance
5234938|NCT02533804|religion|religion
5234939|NCT02533804|skin|skin
5234940|NCT02533804|cardiovascular|cardiovascular
5234941|NCT02533804|joints|joints
5234942|NCT02533804|bone|bone
5234943|NCT02533804|respiration|respiration
5234944|NCT02533804|pain|pain
5234945|NCT02533804|nervous system diseases|nervous system diseases
5234946|NCT02533804|oral health|oral health
5234947|NCT02533804|behavior|behavior
5234948|NCT02533804|child|child
5234949|NCT02533804|depression|depression
5234950|NCT02533804|mood|mood
5234951|NCT02533804|panic|panic
5234952|NCT02533804|sleep|sleep
5234953|NCT02533804|stress|stress
5234954|NCT02533804|nutrition|nutrition
5234955|NCT02533804|exercise|exercise
5234956|NCT02533804|life change events|life change events
5234957|NCT02533804|personality|personality
5234958|NCT02533804|employment|employment
5234959|NCT02533804|social networking|social networking
5234960|NCT02533804|time management|time management
5234961|NCT02533804|residence characteristics|residence characteristics
5234962|NCT02533791|Safety|safety
5234963|NCT02533791|immunogenicity|immunogenicity
5234964|NCT02533791|Ebola vaccine|ebola vaccine
5234965|NCT02533791|boosting|boosting
5234966|NCT02533765|Cisplatin-resistant|cisplatin-resistant
5234967|NCT02533765|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5234968|NCT02533765|Salvage treatment|salvage treatment
5234969|NCT02533765|olaparib|olaparib
5234970|NCT02533752|Left Atrial Appendage Closure|left atrial appendage closure
5234971|NCT02533752|Watchman device|watchman device
5234972|NCT02533752|LAA Closure|laa closure
5234973|NCT02533726|Bed Sores|bed sores
5234974|NCT02533726|Bedsores|bedsores
5234975|NCT02533726|Decubitus Ulcer|decubitus ulcer
5234976|NCT02533726|Pressure Sore|pressure sore
5234977|NCT02533713|rehabilitation|rehabilitation
5234978|NCT02533713|bone strength|bone strength
5234979|NCT02533713|quality of life|quality of life
5234980|NCT02533687|prostate|prostate
5234981|NCT02533687|transurethral resection|transurethral resection
5234982|NCT02533687|bipolar|bipolar
5234983|NCT02533687|monopolar|monopolar
5234984|NCT02533661|Effectiveness|effectiveness
5234985|NCT02533661|Genes|genes
5234986|NCT02533661|Intervention|intervention
5234987|NCT02533661|Neurodevelopment|neurodevelopment
5234988|NCT02533661|Prematurity|prematurity
5234989|NCT02533661|Preschool Age|preschool age
5234990|NCT02533648|Type 2 diabetes mellitus, oxidative stress|type 2 diabetes mellitus, oxidative stress
5234991|NCT02533648|insulin sensitivity|insulin sensitivity
5234992|NCT02533648|insulin resistance|insulin resistance
5234997|NCT02533622|progressive mobility|progressive mobility
5234998|NCT02533583|pulse oximetry|pulse oximetry
5234999|NCT02533583|clinical assessment|clinical assessment
5235000|NCT02533583|neonate|neonate
5235001|NCT02533583|lung disease|lung disease
5235002|NCT02533570|Lupus|lupus
5235003|NCT02533557|brachial plexus block|brachial plexus block
5235004|NCT02533557|nerve stimulator|nerve stimulator
5235005|NCT02533557|ultrasound|ultrasound
5235006|NCT02533544|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5235007|NCT02533505|Respiratory|respiratory
5235008|NCT02533505|COPD|copd
5235009|NCT02533505|O2 Consumption|o2 consumption
5235010|NCT02533492|total knee replacement|total knee replacement
5235011|NCT02533492|vicryl plus|vicryl plus
5235012|NCT02533492|surgical site infection|surgical site infection
5235013|NCT02533453|Type 2 Diabetes Mellitus, T2DM, GLP-1, GLP-1 Once weekly, Exenatide|type 2 diabetes mellitus, t2dm, glp-1, glp-1 once weekly, exenatide
5235014|NCT02533414|kidney stone|kidney stone
5235309|NCT02531867|HPP|hpp
5235015|NCT02533414|retrograde intrarenal surgery|retrograde intrarenal surgery
5235016|NCT02533414|ureteral access sheath|ureteral access sheath
5235017|NCT02533414|kidney function|kidney function
5235018|NCT02533388|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5235019|NCT02533388|stress response|stress response
5235022|NCT02533349|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
5235023|NCT02533349|prokinetics|prokinetics
5235024|NCT02533349|proton pump inhibitor|proton pump inhibitor
5235025|NCT02533336|Malaria control|malaria control
5235026|NCT02533336|Insecticide treated durable Wall Liners|insecticide treated durable wall liners
5235027|NCT02533336|Malaria incidence|malaria incidence
5235028|NCT02533336|Randomized Trial|randomized trial
5235029|NCT02533323|NK/T-cell lymphoma|nk/t-cell lymphoma
5235030|NCT02533323|induction chemotherapy|induction chemotherapy
5235031|NCT02533323|survival|survival
5235032|NCT02533310|Specific phobia|specific phobia
5235033|NCT02533310|Exposure therapy|exposure therapy
5235034|NCT02533310|Virtual reality|virtual reality
5235035|NCT02533310|Randomized controlled trial|randomized controlled trial
5235036|NCT02533297|standardization,|standardization,
5235037|NCT02533297|performance clinical skills|performance clinical skills
5235038|NCT02533297|nursing|nursing
5235039|NCT02533297|learning curve|learning curve
5235040|NCT02533271|rectal cancer|rectal cancer
5235041|NCT02533271|short-term radiotherapy|short-term radiotherapy
5235042|NCT02533271|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5235043|NCT02533271|total mesorectal excision|total mesorectal excision
5235044|NCT02533258|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha|advanced renal cell carcinoma, disease progression, sunitinib, interferon alpha
5235045|NCT02533245|Exercise Training|exercise training
5235046|NCT02533245|Quality of Life|quality of life
5235047|NCT02533245|Patient Reported Outcomes|patient reported outcomes
5235048|NCT02533245|Organ Transplantation|organ transplantation
5235049|NCT02533232|Schizophrenia|schizophrenia
5235050|NCT02533232|Anti-inflammatory|anti-inflammatory
5235051|NCT02533232|Clozapine|clozapine
5235052|NCT02533232|Minocycline|minocycline
5235053|NCT02533232|Psychosis NOS|psychosis nos
5235054|NCT02533219|Hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
5235055|NCT02533219|PET/CT|pet/ct
5235056|NCT02533219|PET/MRI|pet/mri
5235057|NCT02533219|[18F]-DOPA|[18f]-dopa
5235058|NCT02533219|PET/MR|pet/mr
5235059|NCT02533219|Congenital Hyperinsulinism|congenital hyperinsulinism
5235060|NCT02533193|enhanced recovery after surgery protocal|enhanced recovery after surgery protocal
5235061|NCT02533193|laparoscopic hepatectomy|laparoscopic hepatectomy
5235062|NCT02533180|Liver allograft recipient|liver allograft recipient
5235063|NCT02533180|Immunosuppression withdrawal|immunosuppression withdrawal
5235064|NCT02533180|Calcineurin inhibitor (CNI) based immunosuppression|calcineurin inhibitor (cni) based immunosuppression
5235065|NCT02533180|Living Donor (of the Respective Liver Transplant Recipient)|living donor (of the respective liver transplant recipient)
5235067|NCT02533128|Intraoperative blood pressure|intraoperative blood pressure
5235068|NCT02533128|Triple low|triple low
5235069|NCT02533128|Anesthetic overdose|anesthetic overdose
5235070|NCT02533128|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5235071|NCT02533128|Myocardial injury after noncardiac surgery (MINS)|myocardial injury after noncardiac surgery (mins)
5235072|NCT02533128|Perioperative risk stratification|perioperative risk stratification
5235073|NCT02533128|Brain-type natriuretic peptide (BNP)|brain-type natriuretic peptide (bnp)
5235074|NCT02533128|High-sensitivity cardiac Troponin I (hs-cTnI)|high-sensitivity cardiac troponin i (hs-ctni)
5235075|NCT02533115|VYXEOS|vyxeos
5235076|NCT02533102|Pharmacokinetics|pharmacokinetics
5235079|NCT02533050|obstructive sleep apnea|obstructive sleep apnea
5235080|NCT02533050|acute coronary event|acute coronary event
5235081|NCT02533050|cognitive functions|cognitive functions
5235082|NCT02533050|Continuous positive airway pressure night|continuous positive airway pressure night
5235083|NCT02533011|Sepsis|sepsis
5235084|NCT02533011|Heparin Binding Protein|heparin binding protein
5235085|NCT02532998|Pharmacodynamics|pharmacodynamics
5235086|NCT02532998|AZD9977|azd9977
5235087|NCT02532998|Safety|safety
5235088|NCT02532998|Tolerability|tolerability
5235089|NCT02532998|Pharmacokinetics|pharmacokinetics
5235090|NCT02532998|Eplerenone|eplerenone
5235091|NCT02532998|Fludrocortisone|fludrocortisone
5235092|NCT02532985|Gastrointestinal tolerability|gastrointestinal tolerability
5235093|NCT02532985|dietary fiber|dietary fiber
5235094|NCT02532985|clinical trial|clinical trial
5235095|NCT02532985|healthy subjects|healthy subjects
5235096|NCT02532933|Replacement, Knee|replacement, knee
5235097|NCT02532920|Natural history|natural history
5235098|NCT02532920|Atopic dermatitis|atopic dermatitis
5235099|NCT02532920|Atopic march|atopic march
5235100|NCT02532907|HCV|hcv
5235101|NCT02532894|endothelial dysfunction|endothelial dysfunction
5235102|NCT02532894|microvesicles|microvesicles
5235103|NCT02532894|endothelial progenitor cells|endothelial progenitor cells
5235104|NCT02532894|electronic cigarettes|electronic cigarettes
5235105|NCT02532842|Schizophrenia|schizophrenia
5235106|NCT02532842|Paliperidone palmitate|paliperidone palmitate
5235107|NCT02532816|stunting|stunting
5235108|NCT02532816|indonesia|indonesia
5235109|NCT02532803|Cancer|cancer
5235110|NCT02532803|Rectum|rectum
5235111|NCT02532803|Rectal Cancer|rectal cancer
5235112|NCT02532803|Polyps|polyps
5235114|NCT02532764|cystic fibrosis|cystic fibrosis
5235115|NCT02532764|ΔF508|δf508
5235116|NCT02532764|RNA therapies|rna therapies
5235117|NCT02532764|antisense oligonucleotide|antisense oligonucleotide
5235119|NCT02532764|F508del|f508del
5235120|NCT02532764|CF|cf
5235121|NCT02532764|RNA therapy|rna therapy
5235122|NCT02532738|efficacy of MSC|efficacy of msc
5235123|NCT02532738|refractory|refractory
5235124|NCT02532725|heat stress response|heat stress response
5235125|NCT02532725|cardiopulmonary exercise test|cardiopulmonary exercise test
5235126|NCT02532725|men|men
5235127|NCT02532725|middle aged|middle aged
5235128|NCT02532725|heat-shock response|heat-shock response
5235129|NCT02532712|EC-18|ec-18
5235130|NCT02532712|Hematology|hematology
5235131|NCT02532712|Cancer|cancer
5235132|NCT02532712|Neutropenia|neutropenia
5235133|NCT02532699|Antrodia cinnamomea mycelia|antrodia cinnamomea mycelia
5235134|NCT02532699|blood pressure|blood pressure
5235135|NCT02532699|adenosine|adenosine
5235136|NCT02532699|antrosterol|antrosterol
5235137|NCT02532699|clinical trial|clinical trial
5235138|NCT02532699|gamma-aminobutyric acid|gamma-aminobutyric acid
5235139|NCT02532686|Treatment resistant|treatment resistant
5235140|NCT02532686|DAAOI|daaoi
5235141|NCT02532686|NMDA|nmda
5235142|NCT02532634|ramosetron|ramosetron
5235143|NCT02532634|palonosetron|palonosetron
5235144|NCT02532634|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5235145|NCT02532582|nerve compression|nerve compression
5235146|NCT02532530|Aortic valve replacement with or without CABG|aortic valve replacement with or without cabg
5235147|NCT02532517|CODMAN ENTERPRISE® Vascular Reconstruction Device|codman enterprise® vascular reconstruction device
5235148|NCT02532517|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
5235149|NCT02532517|Cerebral Aneurysms|cerebral aneurysms
5235150|NCT02532504|postnatal depression|postnatal depression
5235151|NCT02532504|Cognitive behaviour Therapy|cognitive behaviour therapy
5235152|NCT02532504|Traditional Birth Attendants|traditional birth attendants
5235153|NCT02532504|low income country|low income country
5235154|NCT02532491|Psychosis|psychosis
5235155|NCT02532491|Antipsychotic Agents|antipsychotic agents
5235156|NCT02532491|Treatment|treatment
5235157|NCT02532491|Effectiveness|effectiveness
5235158|NCT02532491|Aripiprazole|aripiprazole
5235159|NCT02532491|Risperidone|risperidone
5235160|NCT02532452|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5235161|NCT02532452|Adenovirus (ADV)|adenovirus (adv)
5235162|NCT02532452|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5235163|NCT02532452|T-Cells|t-cells
5235164|NCT02532452|Donor|donor
5223178|NCT02603705|moderate to severe|moderate to severe
5223179|NCT02603692|Newly diagnosed brain tumor|newly diagnosed brain tumor
5223180|NCT02603692|Progressive brain tumor|progressive brain tumor
5223181|NCT02603692|PROMIS|promis
5223182|NCT02603692|Quality of life|quality of life
5235165|NCT02532452|BK virus (BKV)|bk virus (bkv)
5235166|NCT02532439|fracture osteoporosis|fracture osteoporosis
5235167|NCT02532439|bone microarchitecture|bone microarchitecture
5235168|NCT02532439|Inflammatory joint diseases|inflammatory joint diseases
5235169|NCT02532439|Bone fragility|bone fragility
5235170|NCT02532439|Rheumatoid Arthritis|rheumatoid arthritis
5235171|NCT02532439|Spondyloarthritis|spondyloarthritis
5235172|NCT02532439|Primary Hyperparathyroidism|primary hyperparathyroidism
5235173|NCT02532439|constitutional thinness|constitutional thinness
5235174|NCT02532439|anorexia nervosa|anorexia nervosa
5235181|NCT02532400|Breast Neoplasms|breast neoplasms
5235182|NCT02532400|Neoadjuvant Endocrine Therapy|neoadjuvant endocrine therapy
5235183|NCT02532400|Ovarian Function Suppression|ovarian function suppression
5235184|NCT02532400|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5235191|NCT02532361|Hysteroscopic Device Placement|hysteroscopic device placement
5235192|NCT02532361|Tubal Ligation|tubal ligation
5235193|NCT02532348|Human Immunodeficiency Virus|human immunodeficiency virus
5235194|NCT02532348|HIV|hiv
5235195|NCT02532348|antiretroviral therapy|antiretroviral therapy
5235196|NCT02532348|platelets|platelets
5235197|NCT02532348|Immune activation|immune activation
5235198|NCT02532348|Inflammatory state|inflammatory state
5235199|NCT02532335|FXR|fxr
5235200|NCT02532335|bile acids|bile acids
5235201|NCT02532335|FGF19|fgf19
5235202|NCT02532335|C4|c4
5235203|NCT02532335|gut microbiota|gut microbiota
5962762|NCT04278833|corticosteroid injection|corticosteroid injection
5962763|NCT04278833|particulate steroid|particulate steroid
5235204|NCT02532335|Pharmacodynamics of FXR activation in the small bowel|pharmacodynamics of fxr activation in the small bowel
5235205|NCT02532309|Rosuvastatin|rosuvastatin
5235206|NCT02532309|Carotid Atherosclerosis plaque|carotid atherosclerosis plaque
5235207|NCT02532309|Crestor|crestor
5235208|NCT02532309|Rosuvastatin calcium|rosuvastatin calcium
5235209|NCT02532283|Influenza A virus|influenza a virus
5235210|NCT02532283|JNJ-63623872|jnj-63623872
5235211|NCT02532283|Oseltamivir|oseltamivir
5235212|NCT02532270|obstetric|obstetric
5235213|NCT02532270|anesthesia|anesthesia
5235214|NCT02532270|hypotension|hypotension
5235215|NCT02532270|arterial pressure|arterial pressure
5235216|NCT02532270|measurement techniques|measurement techniques
5235218|NCT02532192|Lymphoma|lymphoma
5235219|NCT02532192|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5235220|NCT02532192|DLBCL|dlbcl
5235221|NCT02532192|Relapsed|relapsed
5235222|NCT02532192|Refractory|refractory
5235224|NCT02532192|Rituximab|rituximab
5235225|NCT02532192|Rituxan|rituxan
5235226|NCT02532192|Cisplatin|cisplatin
5235227|NCT02532192|Platinol-AQ|platinol-aq
5235228|NCT02532192|Platinol|platinol
5235229|NCT02532192|CDDP|cddp
5235230|NCT02532192|Cytarabine|cytarabine
5235231|NCT02532192|Ara-C|ara-c
5235232|NCT02532192|Cytosar|cytosar
5235233|NCT02532192|DepoCyt|depocyt
5235234|NCT02532192|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5235235|NCT02532192|Dexamethasone|dexamethasone
5235236|NCT02532192|Decadron|decadron
5235237|NCT02532192|Ciprofloxacin|ciprofloxacin
5235238|NCT02532192|Ciprofloxacin hydrochloride|ciprofloxacin hydrochloride
5235239|NCT02532192|Cipro|cipro
5235240|NCT02532192|Fluconazole|fluconazole
5235241|NCT02532192|Diflucan|diflucan
5235242|NCT02532179|subcutaneous immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
5235243|NCT02532179|glycerinated mouse allergenic extract|glycerinated mouse allergenic extract
5235245|NCT02532179|mouse specific IgG and IgG4|mouse specific igg and igg4
5235246|NCT02532179|mouse prick skin test wheal|mouse prick skin test wheal
5235247|NCT02532166|narrow band imaging|narrow band imaging
5235248|NCT02532166|Chromoendoscopy|chromoendoscopy
5235249|NCT02532166|Lugol|lugol
5235250|NCT02532153|Suicidal Ideation|suicidal ideation
5235251|NCT02532153|Suicide|suicide
5235252|NCT02532153|Suicidal Thoughts|suicidal thoughts
5235253|NCT02532153|Depression|depression
5235254|NCT02532153|Ketamine|ketamine
5235255|NCT02532127|Low-dose risk|low-dose risk
5235256|NCT02532075|COPD|copd
5235257|NCT02532075|Respiratory Muscle Warm Up|respiratory muscle warm up
5235258|NCT02532062|lung cancer risk|lung cancer risk
5235259|NCT02532062|cigarette smokers|cigarette smokers
5235260|NCT02532049|Malaria|malaria
5235261|NCT02532049|Vaccine|vaccine
5235262|NCT02532049|Immune Response|immune response
5235263|NCT02532036|MVA85A|mva85a
5235264|NCT02532036|Tuberculosis|tuberculosis
5235265|NCT02532036|Vaccine|vaccine
5235266|NCT02532036|Aerosol|aerosol
5235267|NCT02532023|omega 3 fatty acid|omega 3 fatty acid
5235268|NCT02532023|curcumin|curcumin
5235269|NCT02532023|COX-2|cox-2
5235270|NCT02532023|iNOs|inos
5235271|NCT02532023|VCAM-1|vcam-1
5235272|NCT02532023|ICAM-1|icam-1
5235273|NCT02532023|IL-1β|il-1β
5235274|NCT02532023|IL-6|il-6
5235275|NCT02532023|TNF-α|tnf-α
5235276|NCT02532023|hsCRP|hscrp
5235277|NCT02532023|migraine|migraine
5235278|NCT02531997|self-image|self-image
5235288|NCT02531997|progressive muscle relaxation|progressive muscle relaxation
5235289|NCT02531971|Bioequivalence|bioequivalence
5235290|NCT02531971|Therapeutic Equivalency|therapeutic equivalency
5235291|NCT02531945|topography|topography
5235292|NCT02531945|cobb angle|cobb angle
5235293|NCT02531932|advanced triple negative breast cancer|advanced triple negative breast cancer
5235294|NCT02531919|tumor acidity|tumor acidity
5235295|NCT02531893|Irritability|irritability
5235296|NCT02531893|Disruptive Mood|disruptive mood
5235297|NCT02531893|Tantrums|tantrums
5235298|NCT02531893|Frustration|frustration
5235299|NCT02531893|Interpretation Bias|interpretation bias
5235300|NCT02531893|Emotional Judgment|emotional judgment
5235301|NCT02531893|Cognitive-Behavioral|cognitive-behavioral
5235302|NCT02531893|Exposure|exposure
5235303|NCT02531893|Research Psychotherapy|research psychotherapy
5235310|NCT02531867|Bone Disease|bone disease
5235311|NCT02531867|Soft Bones|soft bones
5235312|NCT02531867|Low Alkaline Phosphatase|low alkaline phosphatase
5235313|NCT02531867|Genetic Metabolic Disorder|genetic metabolic disorder
5235314|NCT02531867|Alkaline Phosphatase|alkaline phosphatase
5235315|NCT02531867|Rickets|rickets
5235316|NCT02531867|Osteomalacia|osteomalacia
5235317|NCT02531815|safety|safety
5235318|NCT02531815|tolerability|tolerability
5235319|NCT02531815|pharmacokinetics|pharmacokinetics
5235320|NCT02531815|pharmacodynamics|pharmacodynamics
5235321|NCT02531815|Phase 1|phase 1
5235322|NCT02531815|first in human|first in human
5235323|NCT02531815|monoclonal antibody|monoclonal antibody
5235324|NCT02531815|tissue factor pathway inhibitor|tissue factor pathway inhibitor
5235325|NCT02531815|japanese|japanese
5235326|NCT02531802|ETEC diarrhea|etec diarrhea
5114939|NCT03278483|rifampin,|rifampin,
5235327|NCT02531802|Escherichia Coli (ETEC)|escherichia coli (etec)
5235328|NCT02531776|Diabetes|diabetes
5235329|NCT02531776|Needle|needle
5235330|NCT02531776|Pen needle|pen needle
5235331|NCT02531763|mHealth|mhealth
5235332|NCT02531763|behavioral economics|behavioral economics
5235333|NCT02531763|social incentives|social incentives
5235334|NCT02531750|Metabolism|metabolism
5235335|NCT02531750|Bone metabolism|bone metabolism
5235336|NCT02531750|Glucose Metabolism|glucose metabolism
5235337|NCT02531750|Lipid metabolism|lipid metabolism
5235338|NCT02531750|Low grade inflamation|low grade inflamation
5235339|NCT02531724|acute kidney injury|acute kidney injury
5235340|NCT02531724|cardiac surgery|cardiac surgery
5235341|NCT02531724|renal blood flow|renal blood flow
5235342|NCT02531724|levosimendan|levosimendan
5235343|NCT02531711|Lumbosacral|lumbosacral
5235344|NCT02531711|radicular|radicular
5235352|NCT02531672|15-117|15-117
5235353|NCT02531646|pulmonary nodule|pulmonary nodule
5235354|NCT02531633|Giant Cell Arteritis, Sirukumab, Prednisone|giant cell arteritis, sirukumab, prednisone
5235355|NCT02531620|prehabilitation|prehabilitation
5235356|NCT02531620|colorectal surgery|colorectal surgery
5235357|NCT02531555|chronic periodontitis|chronic periodontitis
5235358|NCT02531555|dental scaling|dental scaling
5235359|NCT02531555|gingival crevicular fluid|gingival crevicular fluid
5235360|NCT02531555|lasers|lasers
5235361|NCT02531555|periodontal pocket|periodontal pocket
5235362|NCT02531555|root planing|root planing
5235363|NCT02531516|Prostatic neoplasms|prostatic neoplasms
5235364|NCT02531516|Prostate Cancer|prostate cancer
5235365|NCT02531516|High-Risk prostate cancer|high-risk prostate cancer
5235366|NCT02531516|JNJ-56021927|jnj-56021927
5235367|NCT02531516|Apalutamide|apalutamide
5235369|NCT02531516|Radiation|radiation
5235370|NCT02531516|Long-term hormone therapy|long-term hormone therapy
5235371|NCT02531516|Localized or locally advanced prostate cancer|localized or locally advanced prostate cancer
5235372|NCT02531516|Janssen|janssen
5235373|NCT02531503|Asthma remission|asthma remission
5235374|NCT02531503|Predicting factors|predicting factors
5235375|NCT02531503|Children|children
5235376|NCT02531464|family caregiver|family caregiver
5235377|NCT02531464|quality of life|quality of life
5235378|NCT02531464|supportive care|supportive care
5235379|NCT02531464|distress screening|distress screening
5235380|NCT02531464|needs assessment|needs assessment
5235381|NCT02531451|Muscle mass|muscle mass
5235382|NCT02531451|strength|strength
5235383|NCT02531451|NSAID|nsaid
5235384|NCT02531451|Ibuprofen|ibuprofen
5235385|NCT02531451|resistance exercise|resistance exercise
5235386|NCT02531425|TNBC|tnbc
5235387|NCT02531425|Triple Negative Breast Cancer|triple negative breast cancer
5235388|NCT02531412|Acute kidney injury|acute kidney injury
5235389|NCT02531412|Critically ill cancer patients|critically ill cancer patients
5235390|NCT02531412|Spironolactone|spironolactone
5235391|NCT02531399|flicker induced changes|flicker induced changes
5235392|NCT02531399|total volumetric retinal blood flow|total volumetric retinal blood flow
5235393|NCT02531308|diffuse large b-cell lymphoma (DLBCL),|diffuse large b-cell lymphoma (dlbcl),
5235394|NCT02531308|lymphoma|lymphoma
5235395|NCT02531282|Patient education as topic|patient education as topic
5235396|NCT02531282|Health promotion|health promotion
5235397|NCT02531282|Patient participation|patient participation
5235398|NCT02531282|Self efficacy|self efficacy
5235399|NCT02531256|Laryngeal Mask Airway|laryngeal mask airway
5235400|NCT02531243|prodrome|prodrome
5235401|NCT02531243|family therapy|family therapy
5235402|NCT02531243|clinical high risk|clinical high risk
5235403|NCT02531204|ASP1585|asp1585
5235404|NCT02531204|Bioequivalence|bioequivalence
5235405|NCT02531204|Pharmacodynamic|pharmacodynamic
5235406|NCT02531204|Phosphate binder|phosphate binder
5235407|NCT02531204|Bixalomer|bixalomer
5235408|NCT02531204|urinary phosphorus excretion|urinary phosphorus excretion
5235409|NCT02531191|ASP015K|asp015k
5235410|NCT02531191|bioequivalence study|bioequivalence study
5235411|NCT02531191|JAK inhibitor|jak inhibitor
5235412|NCT02531178|Rheumatoid Arthritis|rheumatoid arthritis
5235413|NCT02531139|Cerebrovascular Circulation|cerebrovascular circulation
5235414|NCT02531139|Anesthesia|anesthesia
5235415|NCT02531139|Blood pressure|blood pressure
5235416|NCT02531139|Peripheral Arterial Diseases|peripheral arterial diseases
5235417|NCT02531074|Mobile Applications|mobile applications
5235418|NCT02531061|Rheumatoid Arthritis|rheumatoid arthritis
5235419|NCT02531061|bDMARDs|bdmards
5235420|NCT02531061|biotherapy|biotherapy
5235421|NCT02531061|remission|remission
5235422|NCT02531061|erosion|erosion
5235423|NCT02531048|healthy volunteers|healthy volunteers
5235424|NCT02530957|Intubation|intubation
5235425|NCT02530957|Preoxygenation|preoxygenation
5235426|NCT02530957|Complications|complications
5129604|NCT03184389|Mobile Apps|mobile apps
5235427|NCT02530957|Non invasive ventilation|non invasive ventilation
5235428|NCT02530957|High flow nasal cannula|high flow nasal cannula
5962764|NCT04278833|non-particulate steroid|non-particulate steroid
5235429|NCT02530944|Lupus|lupus
5235430|NCT02530944|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5235431|NCT02530944|genetic|genetic
5115040|NCT03277560|ISS|iss
5235432|NCT02530944|online|online
5235433|NCT02530944|genome wide association|genome wide association
5235434|NCT02530944|systemic lupus erythematosus|systemic lupus erythematosus
5235435|NCT02530944|genome wide association study (GWAS)|genome wide association study (gwas)
5235436|NCT02530918|DS-7080a Monoclonal Antibody|ds-7080a monoclonal antibody
5235437|NCT02530905|Duchenne muscular dystrophy|duchenne muscular dystrophy
5235438|NCT02530905|Exon Skipping|exon skipping
5235439|NCT02530892|embryo|embryo
5235440|NCT02530892|in vitro fertilization|in vitro fertilization
5235442|NCT02530840|imbalanced diabetic patients|imbalanced diabetic patients
5235443|NCT02530840|HbA1c|hba1c
5235444|NCT02530840|peers|peers
5235445|NCT02530827|energy expenditure|energy expenditure
5235446|NCT02530827|doubly labeled water|doubly labeled water
5235447|NCT02530827|accelerometer|accelerometer
5235449|NCT02530827|lipodystrophy syndrome.|lipodystrophy syndrome.
5235450|NCT02530814|organochlorine compounds|organochlorine compounds
5235451|NCT02530814|pesticides|pesticides
5235452|NCT02530788|Heart Failure|heart failure
5235453|NCT02530788|Cardiac Surgery|cardiac surgery
5235454|NCT02530788|Ventricular Assist Device|ventricular assist device
5235455|NCT02530788|Selenium|selenium
5235456|NCT02530762|Gastrointestinal tolerability|gastrointestinal tolerability
5235457|NCT02530762|dietary fiber|dietary fiber
5235458|NCT02530762|clinical trial|clinical trial
5235459|NCT02530762|healthy subjects|healthy subjects
5235460|NCT02530749|Surgery|surgery
5235461|NCT02530749|Frailty|frailty
5235462|NCT02530736|Gait speed|gait speed
5235463|NCT02530736|Pulmonary Rehabilitation|pulmonary rehabilitation
5235464|NCT02530723|power training|power training
5235465|NCT02530723|high-speed training|high-speed training
5235466|NCT02530723|high-velocity training|high-velocity training
5235467|NCT02530723|function|function
5235468|NCT02530723|older adults|older adults
5235469|NCT02530723|older women|older women
5235470|NCT02530697|Leishmaniasis|leishmaniasis
5235471|NCT02530697|Mucocutaneous|mucocutaneous
5235472|NCT02530697|Miltefosine|miltefosine
5235473|NCT02530697|Pentoxifylline|pentoxifylline
5235474|NCT02530671|multi-directional power toothbrush|multi-directional power toothbrush
5235475|NCT02530671|manual toothbrush|manual toothbrush
5903683|NCT00340860|Disease Activity|disease activity
5235479|NCT02530658|Heritable Disease|heritable disease
5235480|NCT02530658|Cancer Risk|cancer risk
5235481|NCT02530658|Genetic Counseling|genetic counseling
5235483|NCT02530658|Clinical Genomics|clinical genomics
5235484|NCT02530658|Clinical Decision-Making|clinical decision-making
5235485|NCT02530658|Treatment Planning|treatment planning
5235486|NCT02530658|Germline|germline
5235487|NCT02530632|microperfusion|microperfusion
5235488|NCT02530632|temperature|temperature
5235489|NCT02530632|near-infrared spectroscopy|near-infrared spectroscopy
5235490|NCT02530632|anesthesia|anesthesia
5235491|NCT02530632|total intravenous anaesthesia|total intravenous anaesthesia
5235492|NCT02530580|GABA modulator|gaba modulator
5235494|NCT02530580|Object manipulation|object manipulation
5235495|NCT02530580|Cutaneous sensation|cutaneous sensation
5235496|NCT02530580|Manual dexterity|manual dexterity
5235497|NCT02530567|portal pressure|portal pressure
5235498|NCT02530567|portosystemic pressure gradient|portosystemic pressure gradient
5235499|NCT02530567|azygos blood flow|azygos blood flow
5235500|NCT02530554|Pilot Projects|pilot projects
5235501|NCT02530476|Leukemia|leukemia
5235502|NCT02530476|Acute myeloid leukemia|acute myeloid leukemia
5235504|NCT02530476|Relapsed/Refractory|relapsed/refractory
5235505|NCT02530476|FLT3-ITD mutation|flt3-itd mutation
5235506|NCT02530476|FLT3-mutated high-risk myelodysplastic syndrome|flt3-mutated high-risk myelodysplastic syndrome
5235507|NCT02530476|MDS|mds
5235508|NCT02530476|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5235509|NCT02530476|CMML|cmml
5235510|NCT02530476|Selinexor|selinexor
5235511|NCT02530476|KPT-330|kpt-330
5235512|NCT02530476|Sorafenib|sorafenib
5235513|NCT02530476|Nexavar|nexavar
5235514|NCT02530476|BAY 43-9006|bay 43-9006
5235515|NCT02530476|FLT3-inhibitor therapy|flt3-inhibitor therapy
5235516|NCT02530463|Leukemia|leukemia
5235517|NCT02530463|Myelodysplastic syndrome|myelodysplastic syndrome
5235518|NCT02530463|MDS|mds
5235519|NCT02530463|Nivolumab|nivolumab
5235520|NCT02530463|BMS-936558|bms-936558
5235521|NCT02530463|Opdivo|opdivo
5235522|NCT02530463|Ipilimumab|ipilimumab
5235523|NCT02530463|Yervoy|yervoy
5235524|NCT02530463|BMS-734016|bms-734016
5235525|NCT02530463|MDX010|mdx010
5962765|NCT04278794|Older adults|older adults
5235526|NCT02530463|5-azacitidine|5-azacitidine
5235527|NCT02530463|Azacitidine|azacitidine
5235528|NCT02530463|5-AZA|5-aza
5235529|NCT02530463|Vidaza|vidaza
5235530|NCT02530463|5-AZC|5-azc
5235531|NCT02530463|AZA-CR|aza-cr
5235532|NCT02530463|Ladakamycin|ladakamycin
5235533|NCT02530463|NSC-102816|nsc-102816
5235534|NCT02530463|Azacytidine|azacytidine
5235535|NCT02530450|children|children
5235536|NCT02530450|poor adherence|poor adherence
5235537|NCT02530450|continuous glucose monitoring|continuous glucose monitoring
5235538|NCT02530424|HER2-positive|her2-positive
5115126|NCT03276962|RTS,S/AS01|rts,s/as01
5235539|NCT02530424|ER-positive|er-positive
5235540|NCT02530424|invasive|invasive
5235541|NCT02530424|CDK4,6|cdk4,6
5235542|NCT02530424|Palbociclib|palbociclib
5235543|NCT02530424|neoadjuvant treatment|neoadjuvant treatment
5235544|NCT02530411|Hormone resistance|hormone resistance
5235545|NCT02530411|vandetanib|vandetanib
5235546|NCT02530411|fulvestrant|fulvestrant
5235547|NCT02530359|septic acute kidney injury|septic acute kidney injury
5235548|NCT02530359|pirfenidone|pirfenidone
5235552|NCT02530307|Stroke,|stroke,
5235553|NCT02530307|Rehabilitation|rehabilitation
5235554|NCT02530307|Ischemic|ischemic
5235555|NCT02530307|fMRI|fmri
5235556|NCT02530268|psoriatic arthritis|psoriatic arthritis
5235557|NCT02530268|spondyloarthritis|spondyloarthritis
5235558|NCT02530268|disease registry|disease registry
5235559|NCT02530255|retinal amyloid|retinal amyloid
5235560|NCT02530255|Retinal amyloid index|retinal amyloid index
5235561|NCT02530255|Alzheimer disease|alzheimer disease
5235562|NCT02530255|telomere attrition|telomere attrition
5235563|NCT02530255|telomere activation|telomere activation
5235564|NCT02530242|Sickle Cell Anemia|sickle cell anemia
5235565|NCT02530229|periprosthetic joint infection|periprosthetic joint infection
5235566|NCT02530229|septic arthritis|septic arthritis
5235567|NCT02530203|post-operative atrial fibrillation|post-operative atrial fibrillation
5235568|NCT02530203|spinal cord stimulation|spinal cord stimulation
5235570|NCT02530177|Alopecia|alopecia
5235571|NCT02530177|Skin Aging|skin aging
5235572|NCT02530177|Nail Changes|nail changes
5235573|NCT02530177|Hair Changes|hair changes
5235574|NCT02530177|15-198|15-198
5235575|NCT02530164|tDCS|tdcs
5235576|NCT02530164|SSRI|ssri
5235577|NCT02530151|Hip arthroscopy|hip arthroscopy
5235578|NCT02530151|Intra-articular injection|intra-articular injection
5235579|NCT02530151|Morphine|morphine
5235580|NCT02530151|Clonidine|clonidine
5235588|NCT02530060|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5235589|NCT02530047|Ovarian cancer|ovarian cancer
5235590|NCT02530047|Epithelial ovarian cancer|epithelial ovarian cancer
5235591|NCT02530047|Mesenchymal Stem Cells Secreting Interferon Beta|mesenchymal stem cells secreting interferon beta
5235592|NCT02530047|MSC-INFb|msc-infb
5235593|NCT02530047|Questionnaires|questionnaires
5235594|NCT02530047|Surveys|surveys
5235595|NCT02530021|Ischemic heart disease|ischemic heart disease
5235596|NCT02530021|Heart rate variability|heart rate variability
5235597|NCT02530021|Exercise Strss Test|exercise strss test
5235598|NCT02529956|Psoriasis|psoriasis
5235599|NCT02529956|UCB4940|ucb4940
5235600|NCT02529943|Spinal Stenosis|spinal stenosis
5235601|NCT02529943|Motor Evoked Potential|motor evoked potential
5235602|NCT02529930|HSIL|hsil
5235603|NCT02529930|CIN 2/3|cin 2/3
5235604|NCT02529930|Therapeutic DNA vaccine|therapeutic dna vaccine
5235605|NCT02529930|Human Papillomavirus|human papillomavirus
5235606|NCT02529930|Immunotherapy|immunotherapy
5235607|NCT02529891|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5235608|NCT02529891|COPD|copd
5235609|NCT02529891|Volatile Organic Compounds|volatile organic compounds
5235610|NCT02529891|Exacerbation|exacerbation
5235611|NCT02529878|gastric caner|gastric caner
5235612|NCT02529878|Apatinib|apatinib
5235614|NCT02529878|conversion therapy|conversion therapy
5235615|NCT02529878|metastatic gastric cancer|metastatic gastric cancer
5235616|NCT02529865|Cell Transplantation|cell transplantation
5235617|NCT02529852|Lymphoma|lymphoma
5235618|NCT02529852|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5235619|NCT02529852|DLBCL|dlbcl
5235620|NCT02529852|Lenalidomide|lenalidomide
5235621|NCT02529852|CC-5013|cc-5013
5235622|NCT02529852|Revlimid|revlimid
5235623|NCT02529852|Obinutuzumab|obinutuzumab
5235624|NCT02529852|GA101|ga101
5235625|NCT02529852|Gazyva|gazyva
5235626|NCT02529852|Cyclophosphamide|cyclophosphamide
5235627|NCT02529852|Cytoxan|cytoxan
5235628|NCT02529852|Neosar|neosar
5235629|NCT02529852|Doxorubicin|doxorubicin
5235630|NCT02529852|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5235631|NCT02529852|Adriamycin PFS|adriamycin pfs
5235632|NCT02529852|Adriamycin RDF|adriamycin rdf
5235633|NCT02529852|Adriamycin|adriamycin
5235634|NCT02529852|Rubex|rubex
5235635|NCT02529852|Vincristine|vincristine
5235636|NCT02529852|Prednisone|prednisone
5235637|NCT02529839|MS|ms
5235638|NCT02529839|BMT|bmt
5235639|NCT02529826|Cancer-affected prepubertal boys|cancer-affected prepubertal boys
5235640|NCT02529761|HCC|hcc
5235641|NCT02529761|sorafenib|sorafenib
5235642|NCT02529761|TACE|tace
5235643|NCT02529761|overall survival|overall survival
5235644|NCT02529735|blood pressure|blood pressure
5235645|NCT02529735|alternative measure|alternative measure
5235646|NCT02529696|accelerometer|accelerometer
5235647|NCT02529696|RASS|rass
5235648|NCT02529683|Nuvaring|nuvaring
5962766|NCT04278794|Multimorbidity|multimorbidity
5235649|NCT02529683|contraceptive vaginal ring|contraceptive vaginal ring
5235650|NCT02529683|Kenya|kenya
5235651|NCT02529683|adherence|adherence
5235652|NCT02529683|acceptability|acceptability
5962767|NCT04278794|Transitional care|transitional care
5104981|NCT03340948|Mastery|mastery
5235653|NCT02529683|immunological effects|immunological effects
5235654|NCT02529670|Low Level Laser Therapy|low level laser therapy
5235655|NCT02529670|Low Back Pain|low back pain
5235656|NCT02529670|Diagnosis|diagnosis
5235657|NCT02529670|Genetic|genetic
5235658|NCT02529670|Clinical trial|clinical trial
5235659|NCT02529657|Lower Level Laser Therapy (LLLT)|lower level laser therapy (lllt)
5235660|NCT02529657|inflammation|inflammation
5235661|NCT02529657|cytokines|cytokines
5235662|NCT02529657|wound healing|wound healing
5235663|NCT02529657|laminectomy|laminectomy
5235664|NCT02529657|clinical study|clinical study
5235665|NCT02529644|HIV Screening|hiv screening
5235666|NCT02529644|African American|african american
5235667|NCT02529644|Church|church
5235668|NCT02529631|Polyglucosamine|polyglucosamine
5235669|NCT02529631|L 112|l 112
5235670|NCT02529631|overweight,|overweight,
5235671|NCT02529631|obesity|obesity
5235672|NCT02529631|orlistat|orlistat
5235673|NCT02529631|weight reduction|weight reduction
5235674|NCT02529605|dietary supplement|dietary supplement
5235675|NCT02529605|pharmacokinetics|pharmacokinetics
5235676|NCT02529605|Healthy Volunteers|healthy volunteers
5235677|NCT02529592|Sickness behavior|sickness behavior
5235678|NCT02529592|Cytokines|cytokines
5235679|NCT02529592|Psychoneuroimmunology|psychoneuroimmunology
5235680|NCT02529579|adoptive Cellular Immunotherapy|adoptive cellular immunotherapy
5235681|NCT02529579|patient safety|patient safety
5235682|NCT02529579|therapeutic effect|therapeutic effect
5235683|NCT02529566|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
5342993|NCT01981252|Ulthera, Inc.|ulthera, inc.
5329198|NCT02043639|joint|joint
5235684|NCT02529566|Degenerative Spinal Conditions|degenerative spinal conditions
5235685|NCT02529566|Adjacent Segment Disease|adjacent segment disease
5235686|NCT02529566|Autologous Bone Marrow|autologous bone marrow
5235687|NCT02529566|Lower Back Pain|lower back pain
5235688|NCT02529566|Chronic Lower Back Pain|chronic lower back pain
5235689|NCT02529566|Stem Cells|stem cells
5235690|NCT02529566|Lumbar disk|lumbar disk
5235691|NCT02529566|Mesenchymal Stem Cells|mesenchymal stem cells
5235692|NCT02529566|Stabilization|stabilization
5235693|NCT02529566|CLBP|clbp
5235694|NCT02529566|Autograft|autograft
5235695|NCT02529566|Allograft|allograft
5235696|NCT02529566|Autograft versus Allograft|autograft versus allograft
5235697|NCT02529566|Facet Joint|facet joint
5235698|NCT02529566|Radicular Pain|radicular pain
5235699|NCT02529566|Adipose|adipose
5235700|NCT02529566|Disc Replacement|disc replacement
5235701|NCT02529566|Facet Joint Replacement|facet joint replacement
5235702|NCT02529553|bladder cancer|bladder cancer
5235703|NCT02529540|Myopia|myopia
5235704|NCT02529540|self-refraction|self-refraction
5235705|NCT02529540|glasses|glasses
5235706|NCT02529540|spectacles|spectacles
5235707|NCT02529514|Baclofen|baclofen
5235708|NCT02529514|Cardiac Surgery|cardiac surgery
5235709|NCT02529514|Polysomnography|polysomnography
5235710|NCT02529514|Intensive Care Units|intensive care units
5235712|NCT02529449|ASP1941|asp1941
5235713|NCT02529449|type 1 diabetes mellitus|type 1 diabetes mellitus
5235714|NCT02529449|SGLT2 inhibitor|sglt2 inhibitor
5235715|NCT02529436|overuse antidepressant|overuse antidepressant
5235716|NCT02529436|dementia|dementia
5235717|NCT02529423|food intake|food intake
5235718|NCT02529423|food-related behaviour|food-related behaviour
5235719|NCT02529423|obesity|obesity
5235720|NCT02529423|socioeconomic environment|socioeconomic environment
5235721|NCT02529423|depression|depression
5235722|NCT02529423|nutritional strategies|nutritional strategies
5235723|NCT02529397|Working Memory Training, Weight Loss,|working memory training, weight loss,
5235724|NCT02529384|Breast magnetic resonance imaging|breast magnetic resonance imaging
5235725|NCT02529384|Diffusion-weighted imaging|diffusion-weighted imaging
5235726|NCT02529384|Multiple b-value diffusion weighted imaging|multiple b-value diffusion weighted imaging
5235727|NCT02529358|Maintenance intervention|maintenance intervention
5235728|NCT02529358|Text messages|text messages
5235729|NCT02529358|Emotion Regulation|emotion regulation
5235730|NCT02529332|Endoscopic Sellar/Parasellar Tumor Resection|endoscopic sellar/parasellar tumor resection
5235731|NCT02529319|atrial fibrillation|atrial fibrillation
5235732|NCT02529319|ablation|ablation
5235733|NCT02529306|men|men
5235734|NCT02529280|Latinas|latinas
5235735|NCT02529280|Breast Cancer|breast cancer
5235736|NCT02529280|Clinical Trials|clinical trials
5235737|NCT02529280|Participation|participation
5235738|NCT02529267|Cohort Studies|cohort studies
5235739|NCT02529267|intimate partner violence|intimate partner violence
5235740|NCT02529267|orthopaedic surgery|orthopaedic surgery
5235741|NCT02529267|epidemiology|epidemiology
5235742|NCT02529267|outcomes in fracture care|outcomes in fracture care
5962768|NCT04278781|Chondrosarcoma|chondrosarcoma
5235743|NCT02529254|post graduate surgical education|post graduate surgical education
5235744|NCT02529254|video coaching|video coaching
5235745|NCT02529254|Surgical education|surgical education
5235746|NCT02529254|coaching|coaching
5235747|NCT02529202|Dexmedetomidine|dexmedetomidine
5235748|NCT02529202|Neonate|neonate
5235749|NCT02529202|Pharmacokinetics|pharmacokinetics
5115327|NCT03275558|Gliomas|gliomas
5235750|NCT02529202|Therapeutic Hypothermia|therapeutic hypothermia
5235751|NCT02529202|Hypoxic-ischemic Encephalopathy|hypoxic-ischemic encephalopathy
5235752|NCT02529202|Adrenergic Agents|adrenergic agents
5235753|NCT02529202|Adrenergic Agonists|adrenergic agonists
5235754|NCT02529202|Analgesics|analgesics
5235755|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
5235756|NCT02529202|Central Nervous System Agents|central nervous system agents
5235757|NCT02529202|Central Nervous System Depressants|central nervous system depressants
5235758|NCT02529189|Stable Angina|stable angina
5235759|NCT02529189|Angioplasty|angioplasty
5235760|NCT02529189|Optical Coherence Tomography|optical coherence tomography
5235761|NCT02529189|Nitrate|nitrate
5235762|NCT02529176|telemetry|telemetry
5235763|NCT02529176|cardiac monitoring|cardiac monitoring
5235764|NCT02529163|Integrated Care Pathway|integrated care pathway
5235765|NCT02529163|Acute Psychotic Episode|acute psychotic episode
5235766|NCT02529163|Randomised Control Trial|randomised control trial
5235767|NCT02529124|Ageing|ageing
5235768|NCT02529124|Body Composition|body composition
5235769|NCT02529124|Nutrition|nutrition
5235770|NCT02529124|Physical Activity|physical activity
5235771|NCT02529111|Atrial Septal Defects (ASD)|atrial septal defects (asd)
5235772|NCT02529111|Percutaneous closure|percutaneous closure
5235773|NCT02529098|functional magnetic resonance imaging|functional magnetic resonance imaging
5235774|NCT02529098|Lens implantation|lens implantation
5235775|NCT02529098|pseudophakia|pseudophakia
5235776|NCT02529020|mouthguard|mouthguard
5235777|NCT02529020|ventilation|ventilation
5235778|NCT02529020|anaerobic power|anaerobic power
5903684|NCT00340860|Pregnancy|pregnancy
5235782|NCT02529007|cancer screening|cancer screening
5235783|NCT02528994|Dietary supplements|dietary supplements
5235786|NCT02528981|Probiotics|probiotics
5235787|NCT02528981|Group B Streptococcal|group b streptococcal
5235788|NCT02528981|Pregnancy|pregnancy
5235789|NCT02528968|Pharmacokinetic dosing|pharmacokinetic dosing
5235791|NCT02528955|Head and neck cancer|head and neck cancer
5235792|NCT02528955|postoperative|postoperative
5235793|NCT02528955|radiotherapy|radiotherapy
5235794|NCT02528955|de-intensification|de-intensification
5235798|NCT02528890|group B streptococcus|group b streptococcus
5235799|NCT02528890|GBS|gbs
5235800|NCT02528864|biomarker|biomarker
5235801|NCT02528864|cancer metabolism|cancer metabolism
5235802|NCT02528864|chemical exchange saturation transfer|chemical exchange saturation transfer
5235803|NCT02528864|endometrial cancer|endometrial cancer
5235804|NCT02528864|diffusion-weighted imaging|diffusion-weighted imaging
5235805|NCT02528864|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5235806|NCT02528864|uterine malignancy|uterine malignancy
5235807|NCT02528851|CPAP|cpap
5235808|NCT02528851|preterm|preterm
5235809|NCT02528851|cardiac output|cardiac output
5235810|NCT02528838|Myeloma|myeloma
5235811|NCT02528838|Non-interventional|non-interventional
5235812|NCT02528838|Observational|observational
5235813|NCT02528838|Lenalidomide|lenalidomide
5235814|NCT02528838|REVIEW|review
5235815|NCT02528838|Post-authorization|post-authorization
5235816|NCT02528838|Netherlands|netherlands
5235817|NCT02528786|Drug therapy|drug therapy
5235818|NCT02528734|pneumothorax|pneumothorax
5235819|NCT02528708|fibrinogen concentrate|fibrinogen concentrate
5235820|NCT02528708|coagulation|coagulation
5235821|NCT02528695|18F-FDG PET/CT|18f-fdg pet/ct
5235822|NCT02528695|Adipose tissue|adipose tissue
5235823|NCT02528695|type 2 diabetes|type 2 diabetes
5235824|NCT02528682|dendritic cells|dendritic cells
5235825|NCT02528682|PD-L1/L2 silencing|pd-l1/l2 silencing
5235826|NCT02528682|vaccination|vaccination
5235827|NCT02528682|stem cell transplantation|stem cell transplantation
5235828|NCT02528682|minor histocompatibility antigens|minor histocompatibility antigens
5235829|NCT02528669|accelerometer|accelerometer
5235830|NCT02528669|patient ambulation|patient ambulation
5235831|NCT02528656|Pectus Excavatum|pectus excavatum
5235832|NCT02528656|Pectus Carinatum|pectus carinatum
5235833|NCT02528656|Vacuum Bell|vacuum bell
5235834|NCT02528656|Dynamic compression system|dynamic compression system
5235835|NCT02528656|Hearth variability|hearth variability
5235836|NCT02528656|Autonomic Nervous System|autonomic nervous system
5235838|NCT02528643|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5235839|NCT02528643|enzalutamide|enzalutamide
5235840|NCT02528643|Xtandi|xtandi
5235841|NCT02528643|ASP9785|asp9785
5235842|NCT02528604|Catheter Ablation|catheter ablation
5235843|NCT02528604|Permanent pacemaker|permanent pacemaker
5235844|NCT02528604|AV node ablation|av node ablation
5235845|NCT02528604|Electrical Cardioversion|electrical cardioversion
5235846|NCT02528604|Implantable loop recorder|implantable loop recorder
5235847|NCT02528591|patient|patient
5235848|NCT02528591|renal transplant|renal transplant
5235849|NCT02528578|healthy volunteers|healthy volunteers
5235850|NCT02528539|Prevention|prevention
5235851|NCT02528539|lymphedema|lymphedema
5235852|NCT02528539|acupuncture|acupuncture
5962769|NCT04278781|Chondrosarcoma, Grade 2|chondrosarcoma, grade 2
5235853|NCT02528539|self-management|self-management
5235854|NCT02528526|Hypoxia|hypoxia
5235855|NCT02528526|Pancreatic Neoplasms|pancreatic neoplasms
5235856|NCT02528526|Hepatocellular Cancer|hepatocellular cancer
5235857|NCT02528526|Cholangiocarcinoma|cholangiocarcinoma
5235858|NCT02528526|Colorectal Neoplasms|colorectal neoplasms
5235859|NCT02528526|Treatment|treatment
5235860|NCT02528513|sedation|sedation
5235861|NCT02528513|Midazolam|midazolam
5235862|NCT02528513|Propofol|propofol
5235863|NCT02528513|Dexmedetomidine|dexmedetomidine
5235864|NCT02528487|Pulmonary Rehabilitation|pulmonary rehabilitation
5235865|NCT02528487|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5235866|NCT02528487|Psychiatric Disorders|psychiatric disorders
5235867|NCT02528461|Sofosbuvir|sofosbuvir
5235868|NCT02528461|Direct acting anti-viral treatment|direct acting anti-viral treatment
5235869|NCT02528461|liver cirrhosis|liver cirrhosis
5235870|NCT02528448|Vasoactive hormones|vasoactive hormones
5235871|NCT02528448|bio markers|bio markers
5235872|NCT02528448|salt regulation|salt regulation
5235873|NCT02528448|Renal variables|renal variables
5235874|NCT02528435|Methotrexate|methotrexate
5235875|NCT02528383|Postmenopausal Women on Aromatase Inhibitors|postmenopausal women on aromatase inhibitors
5235876|NCT02528383|Vagifem|vagifem
5235906|NCT02528279|non-falciparum malaria|non-falciparum malaria
5235910|NCT02528201|Ankylosing Spondylitis|ankylosing spondylitis
5235911|NCT02528201|Celecoxib|celecoxib
5235912|NCT02528201|Diclofenac|diclofenac
5235913|NCT02528162|gestational diabetes|gestational diabetes
5235914|NCT02528162|education|education
5235915|NCT02528149|Fibromuscular Dysplasia|fibromuscular dysplasia
5235916|NCT02528149|dysplastic renal artery aneurysm|dysplastic renal artery aneurysm
5235917|NCT02528149|renal artery aneurysms|renal artery aneurysms
5241448|NCT02495220|pov|pov
5235918|NCT02528149|non atheromatous|non atheromatous
5235919|NCT02528149|dysplastic|dysplastic
5235920|NCT02528149|anatomopathologic|anatomopathologic
5235921|NCT02528149|genetic|genetic
5235924|NCT02528084|rotator cuff, shoulder, rehabilitation, yoga|rotator cuff, shoulder, rehabilitation, yoga
5235925|NCT02528071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5235926|NCT02528071|ALS|als
5235927|NCT02528071|Diaphragmatic Endurance Test|diaphragmatic endurance test
5235928|NCT02528058|Myopic traction maculopathy|myopic traction maculopathy
5235929|NCT02528045|Myopic traction maculopathy|myopic traction maculopathy
5235930|NCT02528032|Left ventricular dysfunction|left ventricular dysfunction
5235931|NCT02528032|Other cardiac dysrhythmias|other cardiac dysrhythmias
5235932|NCT02528006|Spasmodic Dysphonia|spasmodic dysphonia
5235933|NCT02528006|Type 2 Thyroplasty|type 2 thyroplasty
5235934|NCT02528006|Titanium Bridges|titanium bridges
5235935|NCT02528006|Operation|operation
5235936|NCT02527980|electronic cigarettes|electronic cigarettes
5235937|NCT02527980|nicotine dependence|nicotine dependence
5235938|NCT02527980|smoking|smoking
5235939|NCT02527980|tobacco use|tobacco use
5235940|NCT02527967|colorectal cancer|colorectal cancer
5235941|NCT02527967|enhanced recovery after surgery|enhanced recovery after surgery
5235942|NCT02527967|perioperative care|perioperative care
5235943|NCT02527967|fast-track surgery|fast-track surgery
5235944|NCT02527967|laparoscopy|laparoscopy
5235945|NCT02527967|minimally invasive surgery|minimally invasive surgery
5235946|NCT02527967|complications|complications
5235947|NCT02527954|Y-chromosome microdeletions|y-chromosome microdeletions
5235948|NCT02527954|aneuploidy|aneuploidy
5235949|NCT02527954|embryos|embryos
5235950|NCT02527954|spermatozoa|spermatozoa
5235951|NCT02527941|Genital immunology|genital immunology
5235952|NCT02527941|HIV susceptibility|hiv susceptibility
5235953|NCT02527941|Microbiome|microbiome
5235954|NCT02527941|Bacterial vaginosis|bacterial vaginosis
5235955|NCT02527941|Virus entry assay|virus entry assay
5235956|NCT02527928|pharmacoeconomics|pharmacoeconomics
5235957|NCT02527902|IGA Glomerulonephritis|iga glomerulonephritis
5235958|NCT02527902|Autonomic nervous system|autonomic nervous system
5235959|NCT02527902|ANS|ans
5235960|NCT02527889|Exercise|exercise
5235961|NCT02527889|blood flow velocity|blood flow velocity
5235962|NCT02527889|tissue oxygenation|tissue oxygenation
5235963|NCT02527889|BCRL|bcrl
5235964|NCT02527876|Exercise|exercise
5235965|NCT02527876|Smoking|smoking
5235966|NCT02527863|Tolvaptan|tolvaptan
5235967|NCT02527863|L-NMMA|l-nmma
5235968|NCT02527863|ADPKD|adpkd
5235969|NCT02527824|biliary tract neoplasm|biliary tract neoplasm
5235970|NCT02527824|oxaliplatin|oxaliplatin
5235971|NCT02527824|irinotecan|irinotecan
5235972|NCT02527824|S-1|s-1
5235973|NCT02527811|ulinastatin|ulinastatin
5235974|NCT02527811|CPB|cpb
5235975|NCT02527811|pediatric|pediatric
5235976|NCT02527785|stomach neoplasm|stomach neoplasm
5235983|NCT02527720|Breathing-based mindfulness training|breathing-based mindfulness training
5235984|NCT02527694|Emergency medical services|emergency medical services
5235985|NCT02527694|Resuscitation|resuscitation
5235986|NCT02527512|Scoliosis|scoliosis
5235987|NCT02527512|Spine fusion|spine fusion
5235988|NCT02527512|0.35% povidone-iodine|0.35% povidone-iodine
5235989|NCT02527486|COPD|copd
5235990|NCT02527486|Asthma|asthma
5235991|NCT02527486|ACOS|acos
5235992|NCT02527486|Bronchiectasis|bronchiectasis
5235993|NCT02527460|Inflammation|inflammation
5235994|NCT02527460|Cognitive Function|cognitive function
5235995|NCT02527460|HIV|hiv
5235996|NCT02527447|Measurable Residual Disease|measurable residual disease
5235997|NCT02527447|Relapsed/Refractory AML|relapsed/refractory aml
5235998|NCT02527447|Salvage Chemotherapy|salvage chemotherapy
5236000|NCT02527395|Experimental pain|experimental pain
5236001|NCT02527395|Men|men
5236002|NCT02527369|Fat Reduction|fat reduction
5236003|NCT02527369|Lipolysis|lipolysis
5236004|NCT02527330|Myocardial iron deposition|myocardial iron deposition
5236005|NCT02527330|T2* imaging|t2* imaging
5236006|NCT02527330|heart failure|heart failure
5236007|NCT02527317|Early|early
5236008|NCT02527291|Cytomegalovirus|cytomegalovirus
5236009|NCT02527291|Interleukin|interleukin
5236010|NCT02527291|Polymerase Chain Reaction|polymerase chain reaction
5236011|NCT02527291|CMV antibodies|cmv antibodies
5236012|NCT02527252|Massage|massage
5236013|NCT02527252|Craniosacral|craniosacral
5236014|NCT02527252|Disability Evaluation|disability evaluation
5236015|NCT02527252|Randomized Controlled Trial|randomized controlled trial
5236016|NCT02527187|Immune System Diseases|immune system diseases
5236017|NCT02527187|Prick Test|prick test
5236018|NCT02527187|Betula verrucosa|betula verrucosa
5236019|NCT02527135|SMS|sms
5236020|NCT02527135|Text messages|text messages
5236021|NCT02527135|Young women|young women
5236022|NCT02527135|HIV|hiv
5236023|NCT02527122|Immune System Diseases|immune system diseases
5236024|NCT02527122|Prick Test|prick test
5236025|NCT02527122|Dermatophagoides pteronyssinus|dermatophagoides pteronyssinus
5236026|NCT02527122|Dermatophagoides farinae|dermatophagoides farinae
5236027|NCT02527096|dolutegravir(Tivicay®)|dolutegravir(tivicay®)
5236028|NCT02527096|lamivudine(Epivir®)|lamivudine(epivir®)
5236029|NCT02527096|HIV-1|hiv-1
5236030|NCT02527096|efficacy|efficacy
5236031|NCT02527096|safety|safety
5236032|NCT02527057|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
5236033|NCT02527057|Preoperative concurrent chemoradiation|preoperative concurrent chemoradiation
5236034|NCT02527057|Response|response
5236035|NCT02527044|Coronary Artery Bypass|coronary artery bypass
5236036|NCT02527044|Flow Reserve|flow reserve
5236037|NCT02527031|Emergency Medical Services|emergency medical services
5236038|NCT02527031|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5236039|NCT02527018|OBGYN|obgyn
5236040|NCT02527018|Nexfin|nexfin
5236041|NCT02527018|Hypertensive|hypertensive
5236042|NCT02527018|Hemodynamic|hemodynamic
5236043|NCT02527005|IPT|ipt
5223983|NCT02599064|Age-related macular degeneration|age-related macular degeneration
5223984|NCT02599064|RXI-109|rxi-109
5223985|NCT02599064|NVAMD|nvamd
5223986|NCT02599064|Retinal scarring|retinal scarring
5223987|NCT02599064|Subretinal scarring|subretinal scarring
5223988|NCT02599064|Retinal fibrosis|retinal fibrosis
5223989|NCT02599064|Subretinal fibrosis|subretinal fibrosis
5223990|NCT02599064|Eye diseases|eye diseases
5223991|NCT02599038|NAFLD|nafld
5223992|NCT02599038|NASH|nash
5223993|NCT02599038|Serine|serine
5236044|NCT02527005|malaria|malaria
5236045|NCT02527005|pregnant|pregnant
5236046|NCT02527005|HIV positive|hiv positive
5236047|NCT02526979|OAB|oab
5236048|NCT02526979|overactive bladder|overactive bladder
5236049|NCT02526979|Myrbetric|myrbetric
5236050|NCT02526979|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5236051|NCT02526979|Betanis|betanis
5236052|NCT02526979|Myrbetriq|myrbetriq
5236053|NCT02526979|NDO|ndo
5236054|NCT02526979|YM178|ym178
5236055|NCT02526979|mirabegron|mirabegron
5236056|NCT02526979|Betmiga|betmiga
5236057|NCT02526953|anal cancer|anal cancer
5236058|NCT02526953|chemoradiation|chemoradiation
5236059|NCT02526953|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5236060|NCT02526953|paclitaxel|paclitaxel
5236061|NCT02526940|Human Immunodeficiency Virus|human immunodeficiency virus
5236062|NCT02526940|HIV|hiv
5236063|NCT02526940|HAART|haart
5236064|NCT02526940|Highly Active antiretroviral therapy|highly active antiretroviral therapy
5236065|NCT02526940|GALT|galt
5236066|NCT02526940|Gut Associated Lymphoid Tissue|gut associated lymphoid tissue
5236067|NCT02526940|reservoir|reservoir
5236068|NCT02526940|rectum|rectum
5236069|NCT02526927|Anorexia Nervosa|anorexia nervosa
5236070|NCT02526927|microarchitecture|microarchitecture
5236071|NCT02526927|prepubertal|prepubertal
5236072|NCT02526914|social cognition|social cognition
5236073|NCT02526914|oxytocin|oxytocin
5236074|NCT02526914|vasopressin|vasopressin
5236075|NCT02526914|decision making|decision making
5236076|NCT02526914|social decision making|social decision making
5236080|NCT02526875|hypertension, Telmisartan/S-Amlodipine|hypertension, telmisartan/s-amlodipine
5236081|NCT02526862|noninvasive mechanical ventilation (NIVM)|noninvasive mechanical ventilation (nivm)
5236082|NCT02526862|continuous positive airway pressure (CPAP) ventilation|continuous positive airway pressure (cpap) ventilation
5236083|NCT02526862|bilevel positive airway pressure (BIPAP) ventilation|bilevel positive airway pressure (bipap) ventilation
5236084|NCT02526862|pressure ulcer (PU)|pressure ulcer (pu)
5236085|NCT02526862|nursing assessment|nursing assessment
5236086|NCT02526849|Fecal Microbiota Transplantation|fecal microbiota transplantation
5236087|NCT02526849|Slow Transit Constipation|slow transit constipation
5236088|NCT02526849|Randomized Controlled Trial|randomized controlled trial
5236089|NCT02526836|colon cancer mesocolic excision central ligation|colon cancer mesocolic excision central ligation
5236090|NCT02526810|glargine|glargine
5236091|NCT02526810|continuous subcutaneous insulin injection|continuous subcutaneous insulin injection
5236092|NCT02526810|blood glucose control|blood glucose control
5236093|NCT02526810|blood glucose fluctuation|blood glucose fluctuation
5236094|NCT02526810|Oxidative Stress|oxidative stress
5236095|NCT02526797|prostate biopsy|prostate biopsy
5236096|NCT02526797|prostate cancer|prostate cancer
5236097|NCT02526797|Magnetic resonance imaging|magnetic resonance imaging
5236098|NCT02526797|Neoplasm staging|neoplasm staging
5236099|NCT02526771|lymph node dissection|lymph node dissection
5236100|NCT02526758|Pulmonary disease|pulmonary disease
5236101|NCT02526758|chronic obstructive|chronic obstructive
5236102|NCT02526758|small airway|small airway
5236103|NCT02526745|vaccine|vaccine
5236104|NCT02526745|safety|safety
5236105|NCT02526745|immunogenicity|immunogenicity
5236106|NCT02526732|NASH|nash
5236107|NCT02526732|fatty Liver|fatty liver
5236108|NCT02526732|VO2 max|vo2 max
5236109|NCT02526732|M30 antigen|m30 antigen
5236110|NCT02526719|bilateral prophylactic mastectomies|bilateral prophylactic mastectomies
5236111|NCT02526719|immediate breast reconstruction|immediate breast reconstruction
5236112|NCT02526719|nipple sparing|nipple sparing
5236113|NCT02526719|BRCA1 Protein|brca1 protein
5236114|NCT02526706|Bleb filtration|bleb filtration
5236115|NCT02526706|VisionBlue|visionblue
5236116|NCT02526693|glaucoma|glaucoma
5236215|NCT02526160|X-linked hypophosphatemia|x-linked hypophosphatemia
5236117|NCT02526693|relative afferent pupillary defect|relative afferent pupillary defect
5236118|NCT02526693|pupillography|pupillography
5236119|NCT02526680|OrCam|orcam
5224082|NCT02598570|Relapsed Lymphoma|relapsed lymphoma
5236120|NCT02526680|Low-vision device|low-vision device
5236121|NCT02526680|End-stage glaucoma|end-stage glaucoma
5236122|NCT02526641|Direct acting antiviral treatment|direct acting antiviral treatment
5236123|NCT02526641|sCD163|scd163
5236124|NCT02526641|Portal hypertension|portal hypertension
5236125|NCT02526641|Metabolic liver function|metabolic liver function
5236126|NCT02526641|Cirrhosis|cirrhosis
5236127|NCT02526628|Testosterone|testosterone
5236128|NCT02526628|Neurocognition|neurocognition
5236129|NCT02526615|rosiglitazone|rosiglitazone
5236130|NCT02526615|metformin|metformin
5236131|NCT02526615|muscle|muscle
5236132|NCT02526576|Facial Atrophy|facial atrophy
5236133|NCT02526576|Autologous|autologous
5236134|NCT02526576|Adult|adult
5236135|NCT02526576|Adipose Derived Stem Cells|adipose derived stem cells
5236136|NCT02526576|Stromal Vascular Fraction|stromal vascular fraction
5236137|NCT02526576|Collagenase|collagenase
5236138|NCT02526550|Live attenuated Japanese Encephalitis vaccine|live attenuated japanese encephalitis vaccine
5236139|NCT02526550|IMOJEV|imojev
5236140|NCT02526550|CD.JEVAX|cd.jevax
5236141|NCT02526550|Booster|booster
5236142|NCT02526550|Thai children|thai children
5236143|NCT02526550|Immunogenicity|immunogenicity
5236144|NCT02526550|Safety|safety
5236145|NCT02526550|Interchangeability|interchangeability
5236146|NCT02526550|Hepatitis A vaccine|hepatitis a vaccine
5236147|NCT02526550|Vaccination or Other Immunization Procedure|vaccination or other immunization procedure
5236148|NCT02526537|Gefitinib|gefitinib
5236149|NCT02526537|NSCLC|nsclc
5236150|NCT02526537|postoperative|postoperative
5236151|NCT02526537|stage Ib|stage ib
5236152|NCT02526537|Relapse Free Survival in 2 years|relapse free survival in 2 years
5236156|NCT02526472|embryo transfer, in vitro fertilization|embryo transfer, in vitro fertilization
5236157|NCT02526446|Chinese|chinese
5236158|NCT02526446|caregiver stress|caregiver stress
5236159|NCT02526446|self-administered acupressure|self-administered acupressure
5236160|NCT02526433|depression|depression
5236161|NCT02526433|mental wellbeing|mental wellbeing
5236162|NCT02526433|motherhood|motherhood
5236163|NCT02526433|music|music
5236164|NCT02526433|alternative therapies|alternative therapies
5236165|NCT02526420|VRS-317|vrs-317
5236166|NCT02526420|Long Acting Growth Hormone|long acting growth hormone
5236167|NCT02526420|Versartis|versartis
5236168|NCT02526420|somavaratan|somavaratan
5236169|NCT02526420|Growth Hormone Deficiency|growth hormone deficiency
5903685|NCT00340860|Exposure|exposure
5236171|NCT02526420|AGHD|aghd
5236172|NCT02526420|Growth Hormone Replacement|growth hormone replacement
5236173|NCT02526420|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5236174|NCT02526420|XTEN|xten
5236175|NCT02526407|postnatal depression|postnatal depression
5236176|NCT02526407|mental wellbeing|mental wellbeing
5236177|NCT02526407|baby blues|baby blues
5236178|NCT02526407|mothers|mothers
5236179|NCT02526407|music|music
5236180|NCT02526407|alternative therapies|alternative therapies
5236181|NCT02526355|Maternal depression|maternal depression
5236182|NCT02526355|Mobile phone based intervention|mobile phone based intervention
5236183|NCT02526355|Learning Through Play|learning through play
5236184|NCT02526355|CBT|cbt
5236185|NCT02526355|Intelligent Real Time Therapy|intelligent real time therapy
5236186|NCT02526316|cervical cancer|cervical cancer
5236187|NCT02526316|vulvar cancer|vulvar cancer
5236188|NCT02526316|vaginal cancer|vaginal cancer
5236189|NCT02526316|penile cancer|penile cancer
5236190|NCT02526316|anal cancer|anal cancer
5236191|NCT02526316|head and neck cancer|head and neck cancer
5236193|NCT02526264|stoma|stoma
5236194|NCT02526264|quality of life|quality of life
5236195|NCT02526251|IBD|ibd
5236196|NCT02526251|Fecal calprotectin|fecal calprotectin
5236197|NCT02526251|Microbiome|microbiome
5236198|NCT02526251|Dysbiosis|dysbiosis
5236199|NCT02526251|Disease activity|disease activity
5236200|NCT02526251|telemedicine|telemedicine
5236201|NCT02526238|transcranial magnetic stimulation|transcranial magnetic stimulation
5236202|NCT02526238|trunk rotation|trunk rotation
5236203|NCT02526225|acute ischemic stroke|acute ischemic stroke
5236204|NCT02526225|safety and effectiveness|safety and effectiveness
5236205|NCT02526225|Ginkgo diterpene lactone meglumine injection|ginkgo diterpene lactone meglumine injection
5236206|NCT02526212|opioid use disorder|opioid use disorder
5236207|NCT02526212|group counseling|group counseling
5236208|NCT02526212|office-based buprenorphine treatment|office-based buprenorphine treatment
5236209|NCT02526199|Local anesthetics|local anesthetics
5236210|NCT02526199|Perineural nerve blocks|perineural nerve blocks
5236211|NCT02526199|Perineurial Dexamethasone|perineurial dexamethasone
5236212|NCT02526160|KRN23|krn23
5236213|NCT02526160|Fibroblast growth factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
5236214|NCT02526160|XLH|xlh
5236463|NCT02524509|Microfracture|microfracture
5236216|NCT02526160|burosumab|burosumab
5236217|NCT02526160|Crysvita|crysvita
5236218|NCT02526134|Laying of medical devices (radio opaque markers)|laying of medical devices (radio opaque markers)
5236219|NCT02526095|Esophagus|esophagus
5236221|NCT02526082|cardiovascular disease|cardiovascular disease
5236223|NCT02526082|quality of life|quality of life
5236224|NCT02526082|mortality|mortality
5236225|NCT02526082|prevention|prevention
5236226|NCT02526030|psychosis|psychosis
5236227|NCT02526030|antipsychotic agents|antipsychotic agents
5236228|NCT02526030|treatment|treatment
5236229|NCT02526030|effectiveness|effectiveness
5236230|NCT02526004|Cystic Fibrosis|cystic fibrosis
5236231|NCT02526004|Microbiome|microbiome
5236232|NCT02526004|Stratified Antibacterial therapy|stratified antibacterial therapy
5236233|NCT02526004|Resistance|resistance
5236234|NCT02526004|Pathogen Host Interaction|pathogen host interaction
5236235|NCT02525991|schizophrenia|schizophrenia
5236236|NCT02525991|bipolar disorder|bipolar disorder
5236237|NCT02525978|Heart Rate|heart rate
5236238|NCT02525965|Wide resection margin|wide resection margin
5236239|NCT02525965|Recurrence|recurrence
5236240|NCT02525965|Early-stage hepatocellular carcinoma|early-stage hepatocellular carcinoma
5236241|NCT02525952|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5236242|NCT02525952|Hepatectomy|hepatectomy
5236243|NCT02525952|Transarterial Chemoembolization|transarterial chemoembolization
5236244|NCT02525952|Scoring System|scoring system
5236246|NCT02525913|Mastectomy|mastectomy
5236247|NCT02525874|Tecfidera|tecfidera
5236248|NCT02525874|DMF|dmf
5236249|NCT02525874|dimethyl fumarate|dimethyl fumarate
5236250|NCT02525757|Lung Cancer|lung cancer
5236251|NCT02525757|Non-small cell lung cancer|non-small cell lung cancer
5236252|NCT02525757|NSCLC|nsclc
5236253|NCT02525757|Unresectable|unresectable
5236254|NCT02525757|MPDL3280A|mpdl3280a
5236255|NCT02525757|Carboplatin|carboplatin
5236256|NCT02525757|Paraplatin|paraplatin
5236257|NCT02525757|Paclitaxel|paclitaxel
5236258|NCT02525757|Taxol|taxol
5236259|NCT02525757|Radiation therapy|radiation therapy
5236260|NCT02525757|XRT|xrt
5236261|NCT02525731|HIV Infection|hiv infection
5236262|NCT02525731|Pain|pain
5236263|NCT02525731|Chronic Opioid Therapy|chronic opioid therapy
5236264|NCT02525731|Addiction|addiction
5236265|NCT02525731|Analgesics, Opioid|analgesics, opioid
5236266|NCT02525718|Breast Reconstruction|breast reconstruction
5236267|NCT02525718|Mastectomy|mastectomy
5236268|NCT02525705|infants|infants
5236269|NCT02525705|oesophageal atresia|oesophageal atresia
5236270|NCT02525705|dumping syndrome|dumping syndrome
5236271|NCT02525705|prevalence|prevalence
5236272|NCT02525705|Type III and IV|type iii and iv
5236273|NCT02525705|Oral glucose tolerance test|oral glucose tolerance test
5236274|NCT02525705|early hyperglycemia|early hyperglycemia
5236275|NCT02525705|late hypoglycemia|late hypoglycemia
5236276|NCT02525653|Albumin-Bound|albumin-bound
5236277|NCT02525653|Paclitaxel|paclitaxel
5236278|NCT02525653|Gemcitabine|gemcitabine
5236279|NCT02525653|15-054|15-054
5236280|NCT02525640|Single sided hearing loss|single sided hearing loss
5236281|NCT02525640|Single sided deafness|single sided deafness
5236282|NCT02525640|Hearing loss music appreciation|hearing loss music appreciation
5236283|NCT02525536|Drug Therapy|drug therapy
5962770|NCT04278781|Chondrosarcoma, Grade 3|chondrosarcoma, grade 3
5236284|NCT02525510|Mild Hypothermia|mild hypothermia
5236285|NCT02525510|Machine Perfusion|machine perfusion
5236286|NCT02525510|Kidney Transplantation|kidney transplantation
5236287|NCT02525497|Automated PD|automated pd
5236288|NCT02525497|Effectiveness|effectiveness
5236289|NCT02525497|Safety|safety
5236290|NCT02525497|Manipulability|manipulability
5236291|NCT02525458|antimicrobial|antimicrobial
5236292|NCT02525458|biofilms|biofilms
5236293|NCT02525458|acrylic resin|acrylic resin
5236294|NCT02525458|polymethyl methacrylate|polymethyl methacrylate
5236295|NCT02525458|confocal laser scanning microscopy|confocal laser scanning microscopy
5236296|NCT02525458|split-mouth design|split-mouth design
5236297|NCT02525458|quaternary ammonium methacryloxy silicate|quaternary ammonium methacryloxy silicate
5236298|NCT02525445|placebo effects|placebo effects
5236299|NCT02525445|communication|communication
5236300|NCT02525445|acupuncture therapy|acupuncture therapy
5236301|NCT02525445|relaxation|relaxation
5236302|NCT02525432|Mesenchymal Stromal Cells, Multipotent|mesenchymal stromal cells, multipotent
5236303|NCT02525432|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
5236304|NCT02525432|Stem Cells, Mesenchymal|stem cells, mesenchymal
5236305|NCT02525393|Rehabilitation|rehabilitation
5236306|NCT02525393|Non Invasive Brain Stimulation|non invasive brain stimulation
5236307|NCT02525380|Transarterial chemoembolization|transarterial chemoembolization
5236308|NCT02525380|Doxorubicin-Eluting-Bead Embolization|doxorubicin-eluting-bead embolization
5236309|NCT02525380|DC Bead TACE|dc bead tace
5236310|NCT02525380|Hepatocellular carcinoma|hepatocellular carcinoma
5236311|NCT02525367|Parkinson's disease|parkinson's disease
5236312|NCT02525367|Multiple Sclerosis|multiple sclerosis
5236313|NCT02525367|Depressed Elderly|depressed elderly
5236314|NCT02525367|Cognitive Dysfunction|cognitive dysfunction
5236315|NCT02525367|Online Cognitive Training|online cognitive training
5236316|NCT02525354|arachidonic aci|arachidonic aci
5224272|NCT02597374|Sensorimotor Cortex|sensorimotor cortex
5224273|NCT02597374|Unilateral Cerebral Palsy|unilateral cerebral palsy
5224274|NCT02597374|Child|child
5224277|NCT02597348|Liver|liver
5224325|NCT02596893|IBD|ibd
5236317|NCT02525354|adiposity|adiposity
5236318|NCT02525354|atopy|atopy
5236319|NCT02525341|Yoga|yoga
5236320|NCT02525341|exercises|exercises
5236321|NCT02525341|knee osteoarthritis|knee osteoarthritis
5236322|NCT02525341|older adults|older adults
5236323|NCT02525328|Constitutional Thinness|constitutional thinness
5236324|NCT02525328|linkage study|linkage study
5236325|NCT02525328|genome wide scan (GWAS)|genome wide scan (gwas)
5236326|NCT02525315|Schizophrenia|schizophrenia
5130557|NCT03178487|ABT-494|abt-494
5236327|NCT02525315|auditory hallucinations|auditory hallucinations
5236328|NCT02525315|TMS|tms
5236329|NCT02525302|DMD|dmd
5236330|NCT02525302|neuromuscular|neuromuscular
5236331|NCT02525302|Duchenne|duchenne
5236332|NCT02525289|mobility|mobility
5236333|NCT02525289|coronary artery bypass|coronary artery bypass
5236334|NCT02525289|positioning|positioning
5236335|NCT02525289|body|body
5236336|NCT02525263|Neo-Kidney Augment|neo-kidney augment
5236337|NCT02525263|Type 2 Diabetes|type 2 diabetes
5236338|NCT02525263|Chronic Kidney Disease|chronic kidney disease
5236339|NCT02525263|Cell Therapy|cell therapy
5236340|NCT02525250|Acute myeloid leukemia or myelodysplasic syndrome|acute myeloid leukemia or myelodysplasic syndrome
5236341|NCT02525198|Mild cognitive impairment|mild cognitive impairment
5236342|NCT02525198|Subjective memory impairment|subjective memory impairment
5236343|NCT02525198|Dementia|dementia
5236344|NCT02525198|Flavonoids|flavonoids
5236345|NCT02525198|Fatty acids|fatty acids
5236346|NCT02525198|Cognition|cognition
5236347|NCT02525198|Gut microflora|gut microflora
5236348|NCT02525172|immune modulation therapy|immune modulation therapy
5236349|NCT02525172|acid α-glucosidase|acid α-glucosidase
5236350|NCT02525172|antibody|antibody
5236351|NCT02525159|3,3'-diindolylmethane|3,3'-diindolylmethane
5236352|NCT02525159|premenopause|premenopause
5236353|NCT02525159|2-hydroxyestrone|2-hydroxyestrone
5236355|NCT02525146|Reengagement in HIV Care|reengagement in hiv care
5236356|NCT02525146|ARTAS|artas
5236357|NCT02525133|post operative pain|post operative pain
5236358|NCT02525133|hernioplasty|hernioplasty
5236359|NCT02525133|bupivacaine|bupivacaine
5236360|NCT02525120|Disc herniation|disc herniation
5236361|NCT02525120|Herniated disc|herniated disc
5236362|NCT02525120|Triojection|triojection
5236363|NCT02525120|Ozone|ozone
5236364|NCT02525120|Lumbar spine|lumbar spine
5236365|NCT02525120|Leg pain|leg pain
5236366|NCT02525107|Prevention of Vaso Occlusive Painful Crisis|prevention of vaso occlusive painful crisis
5236367|NCT02525094|Eczema|eczema
5236368|NCT02525081|Microvascular Angina|microvascular angina
5330122|NCT02039726|AML|aml
5236369|NCT02525081|therapy|therapy
5236370|NCT02525068|enzalutamide|enzalutamide
5236371|NCT02525068|AZD5363|azd5363
5236372|NCT02525068|Prostate|prostate
5236373|NCT02525055|Flu|flu
5236374|NCT02525055|Influenza|influenza
5236375|NCT02525055|Human Viral Challenge Model|human viral challenge model
5236376|NCT02525055|Wild-Type|wild-type
5236377|NCT02525055|H3N2|h3n2
5236378|NCT02525055|Universal Influenza Vaccine|universal influenza vaccine
5236379|NCT02525055|Intra-seasonal vaccines|intra-seasonal vaccines
5115964|NCT03271255|FOLFIRI|folfiri
5236380|NCT02525055|Antiviral|antiviral
5236381|NCT02525042|Ankylosing Spondylitis|ankylosing spondylitis
5236382|NCT02525042|Dendritic cells (DC)|dendritic cells (dc)
5236383|NCT02525042|RNA|rna
5236384|NCT02525042|Axial spondyloarthritis|axial spondyloarthritis
5236385|NCT02525042|Lod score|lod score
5236386|NCT02525042|Human leucocyte antigen (HLA-B27)|human leucocyte antigen (hla-b27)
5236387|NCT02525029|GVHD|gvhd
5236388|NCT02525016|Bariatric surgery, lidocaine, plasmatic concentration, MonoEthylGlycineXylidide (MEGx), safety|bariatric surgery, lidocaine, plasmatic concentration, monoethylglycinexylidide (megx), safety
5236389|NCT02525003|vitamin D|vitamin d
5236390|NCT02525003|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
5236391|NCT02525003|vitamin D2|vitamin d2
5236392|NCT02525003|UV-irradiated yeast|uv-irradiated yeast
5236393|NCT02525003|serum 25-hydroxyvitamin D3|serum 25-hydroxyvitamin d3
5236394|NCT02525003|serum 25-hydroxyvitamin D2|serum 25-hydroxyvitamin d2
5236395|NCT02525003|randomized controlled trial|randomized controlled trial
5236396|NCT02525003|vitamin D3|vitamin d3
5236397|NCT02525003|bioavailability|bioavailability
5236398|NCT02524990|Medical abortion|medical abortion
5236399|NCT02524990|pregnancy tests|pregnancy tests
5236400|NCT02524964|left ventricular remodeling|left ventricular remodeling
5236401|NCT02524964|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5236402|NCT02524964|acute myocardial infarction|acute myocardial infarction
5236403|NCT02524938|Dietary polyphenols|dietary polyphenols
5236404|NCT02524938|Protein glycation|protein glycation
5236405|NCT02524925|fast track surgery|fast track surgery
5236406|NCT02524925|eras program|eras program
5236407|NCT02524925|hepatectomy|hepatectomy
5236408|NCT02524925|pancreatectomy|pancreatectomy
5236409|NCT02524925|NPY|npy
5236410|NCT02524925|ACTH/Cortsiosol|acth/cortsiosol
5236411|NCT02524925|postoperative stress|postoperative stress
5236412|NCT02524899|Schizotypal Personality Disorder|schizotypal personality disorder
5236413|NCT02524899|SPD|spd
5236414|NCT02524899|cognitive remediation therapy|cognitive remediation therapy
5236415|NCT02524899|CRT|crt
5236416|NCT02524899|guanfacine|guanfacine
5236515|NCT02524158|VA patients|va patients
5236417|NCT02524899|cognitive impairment|cognitive impairment
5236418|NCT02524899|working memory|working memory
5236419|NCT02524899|pharmacological cognitive enhancing agent|pharmacological cognitive enhancing agent
5236420|NCT02524899|neuropsychological testing|neuropsychological testing
5236421|NCT02524899|schizophrenia spectrum disorders|schizophrenia spectrum disorders
5236422|NCT02524899|Personality Disorders|personality disorders
5236423|NCT02524886|Deep Brain Simulation|deep brain simulation
5236424|NCT02524886|Psychiatric|psychiatric
5236425|NCT02524886|Side-effects|side-effects
5236426|NCT02524860|Prostate Cancer|prostate cancer
5236427|NCT02524860|Biopsy|biopsy
5236428|NCT02524860|Focal Healthcare|focal healthcare
5236429|NCT02524860|Fusion Targeted Biopsy|fusion targeted biopsy
5236430|NCT02524860|High Risk Cancer|high risk cancer
5236432|NCT02524860|Diagnostic|diagnostic
5236433|NCT02524860|Ultrasound|ultrasound
5236434|NCT02524860|Multiparametric Magnetic Resonance Imaging (MP-MRI)|multiparametric magnetic resonance imaging (mp-mri)
5236435|NCT02524860|MRI-Ultrasound Fusion|mri-ultrasound fusion
5236436|NCT02524860|Focal-Fusion Bx|focal-fusion bx
5236437|NCT02524834|Thoracoabdominal lesions|thoracoabdominal lesions
5236438|NCT02524795|Omega 3, Cytokines, Adipokines, Systemic lupus erythematosus|omega 3, cytokines, adipokines, systemic lupus erythematosus
5236439|NCT02524782|MEDI-4166, diabetes|medi-4166, diabetes
5236440|NCT02524769|Urge Urinary Incontinence|urge urinary incontinence
5236441|NCT02524769|Urinary Incontinence|urinary incontinence
5236442|NCT02524756|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
5236443|NCT02524743|Rocuronium|rocuronium
5236444|NCT02524743|lidocaine|lidocaine
5236445|NCT02524743|acetaminophen,|acetaminophen,
5236446|NCT02524743|pain|pain
5236447|NCT02524743|injection|injection
5236448|NCT02524717|Hepatic Impairment|hepatic impairment
5236449|NCT02524717|JNJ-56021927|jnj-56021927
5236450|NCT02524704|Cystic fibrosis|cystic fibrosis
5236451|NCT02524704|Electrical Impedance Tomography|electrical impedance tomography
5236452|NCT02524626|Vagus nerve stimulation|vagus nerve stimulation
5236453|NCT02524626|Postoperative ileus|postoperative ileus
5236454|NCT02524561|mammographic density|mammographic density
5236455|NCT02524561|abnormal mammogram|abnormal mammogram
5236456|NCT02524561|biopsy|biopsy
5236457|NCT02524548|Aromatase inhibitors|aromatase inhibitors
5236458|NCT02524548|Reminder Systems|reminder systems
5236459|NCT02524522|Integrated Pulmonary Index|integrated pulmonary index
5903686|NCT00340860|Norway Mother and Child Study|norway mother and child study
5236464|NCT02524509|autologous cultured chondrocyte|autologous cultured chondrocyte
5236465|NCT02524509|cartilage defect of knee|cartilage defect of knee
5236466|NCT02524444|Intermittent preventive therapy|intermittent preventive therapy
5236468|NCT02524444|pregnant|pregnant
5236469|NCT02524444|HIV positive|hiv positive
5236470|NCT02524444|Prevention|prevention
5236471|NCT02524431|Mitochondria|mitochondria
5236472|NCT02524431|trabeculectomy|trabeculectomy
5236473|NCT02524431|trabecular meshwork|trabecular meshwork
5962771|NCT04278781|IDH1 Gene Mutation|idh1 gene mutation
5236474|NCT02524431|Glaucoma surgery|glaucoma surgery
5236475|NCT02524418|Main Pancreatic Duct|main pancreatic duct
5236476|NCT02524392|independent medical evaluation|independent medical evaluation
5236477|NCT02524392|sick leave|sick leave
5236478|NCT02524392|sickness absence|sickness absence
5236479|NCT02524392|physician primary care|physician primary care
5236480|NCT02524392|general practitioner|general practitioner
5236481|NCT02524392|family physician|family physician
5236482|NCT02524366|Stress Urinary Incontinence|stress urinary incontinence
5236483|NCT02524366|Artificial Urinary Sphincter|artificial urinary sphincter
5236484|NCT02524353|cardiac surgery|cardiac surgery
5236486|NCT02524340|Arthritis|arthritis
5236487|NCT02524340|pcJIA|pcjia
5236488|NCT02524340|PCATS|pcats
5236489|NCT02524301|anorexia nervosa|anorexia nervosa
5236490|NCT02524301|opioid receptors|opioid receptors
5236491|NCT02524301|Positron emission tomography (PET)|positron emission tomography (pet)
5236492|NCT02524301|diprenorphine|diprenorphine
5236493|NCT02524262|atrohpic gastritis|atrohpic gastritis
5236494|NCT02524262|acetaldehyde|acetaldehyde
5236495|NCT02524262|ethanol|ethanol
5236496|NCT02524262|L-cysteine|l-cysteine
5236497|NCT02524236|BPH, OAB, Botox, dose response|bph, oab, botox, dose response
5236498|NCT02524223|medically assisted procreation|medically assisted procreation
5236501|NCT02524197|Knee|knee
5236502|NCT02524197|Arthritis|arthritis
5236503|NCT02524197|pain|pain
5236504|NCT02524197|CR845|cr845
5236505|NCT02524197|kappa opioid|kappa opioid
5236511|NCT02524158|Yoga|yoga
5236512|NCT02524158|Mind-Body Therapies|mind-body therapies
5224469|NCT02596126|Cardiovascular Disease in the Elderly|cardiovascular disease in the elderly
5224471|NCT02596126|SECURE|secure
5224472|NCT02596126|Elderly|elderly
5236513|NCT02524158|Chronic Low Back Pain|chronic low back pain
5236514|NCT02524158|Military Veterans|military veterans
5236516|NCT02524080|Ambulance|ambulance
5236517|NCT02524080|Trust|trust
5236518|NCT02524080|Patients|patients
5236519|NCT02524080|Healthcare chain|healthcare chain
5236520|NCT02524054|Dyspnea|dyspnea
5236521|NCT02524054|Hospitalized patients|hospitalized patients
5236522|NCT02524054|Ambulatory outpatients|ambulatory outpatients
5236523|NCT02524054|Shortness of breath|shortness of breath
5236524|NCT02524054|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5236525|NCT02524054|Pulmonary disease|pulmonary disease
5130758|NCT03177161|PROMIS|promis
5236526|NCT02524041|Hyperparathyroidism|hyperparathyroidism
5236527|NCT02524041|microarchitecture|microarchitecture
5236528|NCT02524041|periostin|periostin
5236529|NCT02524028|Atrial Fibrillation|atrial fibrillation
5236530|NCT02524028|fMRI|fmri
5236531|NCT02524015|stroke|stroke
5236532|NCT02524015|pusher syndrome|pusher syndrome
5236533|NCT02524015|contraversive pushing|contraversive pushing
5236534|NCT02524015|lateropulsion|lateropulsion
5236535|NCT02524015|rehabilitation|rehabilitation
5236536|NCT02524015|physical therapy|physical therapy
5236537|NCT02524002|Abnormal Labor|abnormal labor
5236538|NCT02524002|Prolonged Induction|prolonged induction
5236539|NCT02524002|Ketosis|ketosis
5236540|NCT02524002|Diet|diet
5236541|NCT02523989|arsenic|arsenic
5236542|NCT02523989|heavy metal|heavy metal
5236543|NCT02523976|Acute|acute
5236544|NCT02523976|Leukemia|leukemia
5236545|NCT02523976|Lymphoid|lymphoid
5236546|NCT02523976|Philadelphia chromosome|philadelphia chromosome
5236547|NCT02523976|dasatinib|dasatinib
5236548|NCT02523963|family work shop|family work shop
5236549|NCT02523937|Pulmonary Embolism|pulmonary embolism
5236550|NCT02523937|Deep Venous Thrombosis|deep venous thrombosis
5236551|NCT02523937|Soluble Fibrin|soluble fibrin
5236552|NCT02523937|D-Dimers|d-dimers
5236553|NCT02523937|Low and intermediate clinical probability|low and intermediate clinical probability
5236554|NCT02523911|Suprep|suprep
5236555|NCT02523911|Simethicone|simethicone
5236556|NCT02523911|Colorectal cancer screening|colorectal cancer screening
5236557|NCT02523911|Routine colonoscopy|routine colonoscopy
5236558|NCT02523911|sodium sulfate/potassium sulfate/magnesium sulfate|sodium sulfate/potassium sulfate/magnesium sulfate
5236559|NCT02523911|Bowel cleansing|bowel cleansing
5236560|NCT02523911|Mass screening|mass screening
5236561|NCT02523898|Clomiphene|clomiphene
5236562|NCT02523898|infertility|infertility
5236563|NCT02523898|insuline resistant|insuline resistant
5236564|NCT02523898|metformine|metformine
5236565|NCT02523898|PCOS|pcos
5236566|NCT02523885|Pneumonia, Bacterial [C01.252.620]|pneumonia, bacterial [c01.252.620]
5236567|NCT02523885|Bronchopneumonia [C08.381.677.127]|bronchopneumonia [c08.381.677.127]
5236568|NCT02523885|Pleuropneumonia [C08.730.610.473]|pleuropneumonia [c08.730.610.473]
5236569|NCT02523885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5236570|NCT02523872|Fluid overload|fluid overload
5236571|NCT02523872|Acute respiratory failure|acute respiratory failure
5236572|NCT02523872|Acute respiratory distress syndrome|acute respiratory distress syndrome
5236573|NCT02523872|Medication administration|medication administration
5236574|NCT02523846|IV-Patient Controlled Analgesia (IV-PCA)|iv-patient controlled analgesia (iv-pca)
5236575|NCT02523846|background morphine infusion|background morphine infusion
5236576|NCT02523846|patient re-education|patient re-education
5236577|NCT02523781|preeclampsia|preeclampsia
5236578|NCT02523781|information pamphlet|information pamphlet
5236579|NCT02523781|patient education|patient education
5236580|NCT02523755|epidural analgesia for labor|epidural analgesia for labor
5236581|NCT02523755|respiratory function|respiratory function
5236582|NCT02523755|electrical impedance tomography|electrical impedance tomography
5236583|NCT02523729|lactation|lactation
5236584|NCT02523729|human milk|human milk
5236585|NCT02523729|maltz|maltz
5236586|NCT02523729|antioxidant|antioxidant
5236587|NCT02523716|Hypoxic conditioning|hypoxic conditioning
5236588|NCT02523716|Cardio pulmonary exercise testing|cardio pulmonary exercise testing
5236589|NCT02523651|Periodontal Diseases|periodontal diseases
5236590|NCT02523651|Bone Regeneration|bone regeneration
5236591|NCT02523651|Dental Pulp Stem Cell|dental pulp stem cell
5236592|NCT02523638|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
5236593|NCT02523638|Polycythemia Vera|polycythemia vera
5236594|NCT02523638|PEN-PV|pen-pv
5236595|NCT02523638|PROUD-PV|proud-pv
5236596|NCT02523638|CONTINUATION-PV|continuation-pv
5236597|NCT02523638|AOP Orphan|aop orphan
5236598|NCT02523638|Polycythemia|polycythemia
5236599|NCT02523638|Hematologic Diseases|hematologic diseases
5236600|NCT02523638|Myeloproliferative Disorders|myeloproliferative disorders
5236601|NCT02523638|Bone Marrow Diseases|bone marrow diseases
5236602|NCT02523638|Interferon-alpha|interferon-alpha
5236603|NCT02523638|Peginterferon alfa-2b|peginterferon alfa-2b
5236604|NCT02523625|Ultrasound|ultrasound
5236605|NCT02523599|post operative pain|post operative pain
5236606|NCT02523599|hernioplasty|hernioplasty
5236607|NCT02523599|bupivacaine|bupivacaine
5236608|NCT02523586|oxygen concentration|oxygen concentration
5236609|NCT02523586|oxygen therapy|oxygen therapy
5236610|NCT02523586|oxygen delivery|oxygen delivery
5236611|NCT02523586|oxygen masks|oxygen masks
5236612|NCT02523560|Telerehabilitation|telerehabilitation
5236613|NCT02523560|Home Monitoring|home monitoring
5236614|NCT02523560|Heart Failure|heart failure
5236615|NCT02523547|entecavir|entecavir
5130853|NCT03176485|melanoma|melanoma
5236616|NCT02523495|Molecular Targeted Therapy|molecular targeted therapy
5236617|NCT02523495|metastasis colorectal cancer|metastasis colorectal cancer
5236618|NCT02523495|biomarker|biomarker
5236619|NCT02523482|Prescriptions|prescriptions
5236620|NCT02523482|Epidemiology|epidemiology
5236621|NCT02523482|STOPP/START Criteria|stopp/start criteria
5236622|NCT02523482|Beers Criteria|beers criteria
5236623|NCT02523456|Early warning score|early warning score
5236624|NCT02523456|Cardiac arrest|cardiac arrest
5236625|NCT02523443|Epidural Analgesia|epidural analgesia
5236626|NCT02523443|Intravenous Patient Controlled|intravenous patient controlled
5236628|NCT02523430|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5236629|NCT02523430|HepaSphere|hepasphere
5236630|NCT02523417|Breast Cancer|breast cancer
5236631|NCT02523417|HepaSphere|hepasphere
5236632|NCT02523404|Lung Cancer|lung cancer
5236633|NCT02523404|HepaSphere|hepasphere
5236634|NCT02523378|Advanced Cancers|advanced cancers
5236635|NCT02523378|Recurrent|recurrent
5236636|NCT02523378|Locally advanced|locally advanced
5236637|NCT02523378|Metastatic|metastatic
5236638|NCT02523378|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
5236639|NCT02523378|ESAS|esas
5236640|NCT02523378|Survey|survey
5236641|NCT02523378|Interview|interview
5236642|NCT02523378|Symptom questionnaire|symptom questionnaire
5236643|NCT02523365|Cervical Carcinoma|cervical carcinoma
5236644|NCT02523365|HepaSphere|hepasphere
5236645|NCT02523326|Genomic DNA|genomic dna
5236646|NCT02523326|chronic periodontitis|chronic periodontitis
5236647|NCT02523326|saliva|saliva
5236648|NCT02523326|mouthwash|mouthwash
5236650|NCT02523326|genotyping|genotyping
5236651|NCT02523326|sequencing|sequencing
5236652|NCT02523235|moderate pain|moderate pain
5236653|NCT02523235|severe pain|severe pain
5236654|NCT02523235|surgery|surgery
5236655|NCT02523235|postop analgesia|postop analgesia
5236656|NCT02523235|TKA|tka
5236657|NCT02523235|adductor catheter|adductor catheter
5236658|NCT02523235|poplital catheter|poplital catheter
5236659|NCT02523235|foot/ankle surgery|foot/ankle surgery
5236660|NCT02523222|dextrose gel|dextrose gel
5236661|NCT02523222|newborn hypoglycemia|newborn hypoglycemia
5236662|NCT02523222|late preterm infant|late preterm infant
5236663|NCT02523222|large for gestational age|large for gestational age
5236664|NCT02523222|small for gestational age|small for gestational age
5236665|NCT02523222|prophylactic|prophylactic
5236666|NCT02523222|neonatal hypoglycemia|neonatal hypoglycemia
5236667|NCT02523209|Osteoporosis|osteoporosis
5236668|NCT02523209|chronic kidney disease|chronic kidney disease
5236669|NCT02523209|kidney transplantation|kidney transplantation
5236670|NCT02523209|fracture risk|fracture risk
5236671|NCT02523196|Hepatic Venous Pressure Gradient (HVPG) testing|hepatic venous pressure gradient (hvpg) testing
5236672|NCT02523196|HepQuant-SHUNT|hepquant-shunt
5236673|NCT02523196|Liver Function|liver function
5236674|NCT02523183|Epilepsy|epilepsy
5236675|NCT02523183|Marijuana|marijuana
5236676|NCT02523144|Transthoracic echocardiography|transthoracic echocardiography
5116304|NCT03269019|Thrombosis|thrombosis
5236677|NCT02523144|echo|echo
5236678|NCT02523144|TTE|tte
5236679|NCT02523131|Type 1 diabetes|type 1 diabetes
5236680|NCT02523131|Closed-loop glucose control|closed-loop glucose control
5236681|NCT02523131|Artificial Pancreas|artificial pancreas
5236682|NCT02523131|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5236683|NCT02523131|Continuous glucose monitoring|continuous glucose monitoring
5236684|NCT02523131|threshold suspend|threshold suspend
5236685|NCT02523131|predictive low glucose suspend|predictive low glucose suspend
5236686|NCT02523092|sarcoidosis|sarcoidosis
5236687|NCT02523092|Acthar|acthar
5236688|NCT02523092|CXCL9|cxcl9
5236689|NCT02523092|chemokine ligand 9|chemokine ligand 9
5236690|NCT02523053|Hepatocellular Carcinoma|hepatocellular carcinoma
5236691|NCT02523053|Recurrence|recurrence
5236692|NCT02523053|Microvascular Invasion|microvascular invasion
5236693|NCT02523053|5-Fluorouracil|5-fluorouracil
5236694|NCT02523040|Langerhans cell histiocytosis (LCH)|langerhans cell histiocytosis (lch)
5236695|NCT02523040|Erdheim-Chester disease (ECD)|erdheim-chester disease (ecd)
5236696|NCT02523040|Histiocytic Sarcoma (HS)|histiocytic sarcoma (hs)
5236697|NCT02522988|cancer-related fatigue|cancer-related fatigue
5236698|NCT02522975|biosimilar epoetin|biosimilar epoetin
5236701|NCT02522975|immunogenicity|immunogenicity
5236702|NCT02522975|renal anaemia|renal anaemia
5236703|NCT02522962|physical therapy|physical therapy
5236704|NCT02522962|group-based|group-based
5236705|NCT02522962|core stability|core stability
5236706|NCT02522962|balance|balance
5236707|NCT02522962|movement quality|movement quality
5236708|NCT02522962|somatosensory stimulation|somatosensory stimulation
5236709|NCT02522962|coordination|coordination
5236710|NCT02522923|Physical Therapy Modalities|physical therapy modalities
5236711|NCT02522923|Primary Care|primary care
5236712|NCT02522923|Health Services Research|health services research
5236713|NCT02522884|Angioplasty|angioplasty
5236714|NCT02522884|Peripheral Artery Disease|peripheral artery disease
5236716|NCT02522884|Lesion|lesion
5236717|NCT02522884|Claudication|claudication
5236718|NCT02522858|premedication|premedication
5236719|NCT02522858|dexmedetomidine|dexmedetomidine
5236720|NCT02522858|anesthesia, spinal|anesthesia, spinal
5236721|NCT02522845|Varicose Veins|varicose veins
5236722|NCT02522845|Compression Stockings|compression stockings
5236723|NCT02522845|Laser Ablation|laser ablation
5236724|NCT02522845|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5236725|NCT02522819|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5236726|NCT02522819|acute stroke|acute stroke
5236727|NCT02522819|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
5236728|NCT02522806|Endometrial biopsy|endometrial biopsy
5236729|NCT02522806|previous ovarian hyperstimulation cycle|previous ovarian hyperstimulation cycle
5236730|NCT02522806|first IVF|first ivf
5236731|NCT02522806|antagonist protocol|antagonist protocol
5236732|NCT02522806|clinical pregnancy rate|clinical pregnancy rate
5236733|NCT02522793|skin lesion|skin lesion
5236734|NCT02522728|Knee|knee
5236735|NCT02522728|Arthroplasty|arthroplasty
5236736|NCT02522728|Implant|implant
5236737|NCT02522689|kidney stone|kidney stone
5236738|NCT02522689|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
5236739|NCT02522689|ultra-mini PCNL|ultra-mini pcnl
5236740|NCT02522689|micro PCNL|micro pcnl
5236741|NCT02522676|kidney stone|kidney stone
5236742|NCT02522676|percutaneous nephrolithotripsy|percutaneous nephrolithotripsy
5236743|NCT02522676|retrograde intrarenal surgery|retrograde intrarenal surgery
5236744|NCT02522676|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
5236745|NCT02522676|mini PCNL|mini pcnl
5236746|NCT02522676|ultra-mini PCNL|ultra-mini pcnl
5236747|NCT02522676|micro PCNL|micro pcnl
5236748|NCT02522663|telephone support|telephone support
5236749|NCT02522663|discharge management|discharge management
5236750|NCT02522663|readmission|readmission
5236751|NCT02522663|aortic valve replacement|aortic valve replacement
5236752|NCT02522650|amiloride|amiloride
5236753|NCT02522650|proteinuric kidney disease|proteinuric kidney disease
5236754|NCT02522650|urokinase plasminogen activator receptor|urokinase plasminogen activator receptor
5236755|NCT02522650|proteinuria|proteinuria
5236756|NCT02522637|exercise|exercise
5236757|NCT02522637|training|training
5236758|NCT02522637|endurance|endurance
5236759|NCT02522624|Health insurance|health insurance
5236760|NCT02522624|Health services accessibility|health services accessibility
5236761|NCT02522624|Decision making|decision making
5236762|NCT02522624|Health literacy|health literacy
5236763|NCT02522611|Palliative Care|palliative care
5236764|NCT02522611|Adults|adults
5236765|NCT02522611|Cancer Pain|cancer pain
5236766|NCT02522611|Nerve Block|nerve block
5236767|NCT02522611|Quality of Life|quality of life
5236768|NCT02522585|expectant management|expectant management
5236769|NCT02522585|p16|p16
5236770|NCT02522585|immunohistochemistry|immunohistochemistry
5236771|NCT02522585|regression|regression
5236772|NCT02522585|progression|progression
5236773|NCT02522585|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5962772|NCT04278781|IDH1 Mutant Chondrosarcoma|idh1 mutant chondrosarcoma
5962773|NCT04278781|AG-120|ag-120
5236774|NCT02522572|Renal Transplantation|renal transplantation
5236775|NCT02522572|Desensitization|desensitization
5236776|NCT02522572|plerixafor|plerixafor
5236777|NCT02522572|bortezomib|bortezomib
5236778|NCT02522520|Undergoing chemotherapy|undergoing chemotherapy
5236779|NCT02522520|Exercise intervention|exercise intervention
5236780|NCT02522520|Health counselling|health counselling
5236781|NCT02522520|Symptom management|symptom management
5236782|NCT02522481|Lumason|lumason
5236783|NCT02522481|Dobutamine stress echo|dobutamine stress echo
5236784|NCT02522481|stress echo|stress echo
5236785|NCT02522481|coronary artery disease|coronary artery disease
5236786|NCT02522455|Flow-cycled pressure-support ventilation|flow-cycled pressure-support ventilation
5236787|NCT02522403|distal radius fracture|distal radius fracture
5236788|NCT02522403|laser acupuncture|laser acupuncture
5236789|NCT02522403|rehabilitation|rehabilitation
5236790|NCT02522390|data collection|data collection
5236791|NCT02522390|personal health services|personal health services
5236792|NCT02522390|personal health records|personal health records
5236793|NCT02522390|do-it-yourself|do-it-yourself
5236794|NCT02522390|nutrition researchers|nutrition researchers
5236795|NCT02522390|cohort studies|cohort studies
5236796|NCT02522390|databases, factual|databases, factual
5236797|NCT02522390|self-quantification methods|self-quantification methods
5236799|NCT02522377|Electroconvulsive Therapy|electroconvulsive therapy
5236800|NCT02522377|Major Depressive Disorder|major depressive disorder
5236801|NCT02522377|Treatment Resistant Depression|treatment resistant depression
5236802|NCT02522377|electroconvulsive treatment|electroconvulsive treatment
5236803|NCT02522377|Severe depression|severe depression
5236804|NCT02522364|Postoperative atrial fibrillation|postoperative atrial fibrillation
5131058|NCT03175081|Ropivacaine|ropivacaine
5236805|NCT02522364|Dysfunction Following Cardiac Surgery|dysfunction following cardiac surgery
5236806|NCT02522312|Dry Eye|dry eye
5236807|NCT02522299|double-blind|double-blind
5236808|NCT02522299|PI3Kdelta|pi3kdelta
5236809|NCT02522299|GSK2269557|gsk2269557
5236810|NCT02522299|exacerbation|exacerbation
5236811|NCT02522299|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5236812|NCT02522299|randomised|randomised
5236813|NCT02522299|placebo-controlled|placebo-controlled
5236814|NCT02522286|patient engagement|patient engagement
5236815|NCT02522286|physician's role|physician's role
5236816|NCT02522286|patient- centered care|patient- centered care
5236817|NCT02522286|communication|communication
5236818|NCT02522273|Obstetric|obstetric
5236819|NCT02522273|Midwifery|midwifery
5236820|NCT02522273|Fetal blood sample|fetal blood sample
5236821|NCT02522273|Lactate|lactate
5236822|NCT02522273|Handheld meter|handheld meter
5236823|NCT02522260|Breast cancer, chemotherapy, symptoms, optimal training|breast cancer, chemotherapy, symptoms, optimal training
5236824|NCT02522234|Neutropenia|neutropenia
5236825|NCT02522234|Chemotherapy|chemotherapy
5236826|NCT02522221|chronic anticoagulation|chronic anticoagulation
5236827|NCT02522221|vitamin K antagonist|vitamin k antagonist
5236828|NCT02522221|mechanical heart valve|mechanical heart valve
5236829|NCT02522221|CYP2C9|cyp2c9
5236830|NCT02522221|warfarin|warfarin
5236831|NCT02522221|tecarfarin|tecarfarin
5236832|NCT02522221|chronic kidney disease|chronic kidney disease
5236833|NCT02522195|shift work|shift work
5236834|NCT02522195|nutritional status|nutritional status
5236835|NCT02522195|nursing professionals|nursing professionals
5236836|NCT02522195|meal distribution|meal distribution
5236837|NCT02522195|food intake|food intake
5236838|NCT02522182|Cardiovascular Secondary Prevention|cardiovascular secondary prevention
5236839|NCT02522182|Nurse's Role|nurse's role
5236840|NCT02522143|self-harm|self-harm
5236841|NCT02522143|self-mutilation|self-mutilation
5236842|NCT02522143|cutting|cutting
5236843|NCT02522117|Kidney Transplantation|kidney transplantation
5236844|NCT02522117|Atorvastatin|atorvastatin
5236845|NCT02522117|Human Leukocyte Antigens|human leukocyte antigens
5236846|NCT02522117|Interleukin|interleukin
5236847|NCT02522104|Pharmacokinetics of Hydroxyurea|pharmacokinetics of hydroxyurea
5236848|NCT02522078|misoprostol|misoprostol
5236849|NCT02522078|abortion|abortion
5236850|NCT02522065|Hypokinesia|hypokinesia
5330726|NCT02036970|PAH|pah
5236851|NCT02522065|Patient Outcome Assessment|patient outcome assessment
5236852|NCT02522013|post-dural puncture headache|post-dural puncture headache
5236853|NCT02522013|Aminophylline|aminophylline
5236854|NCT02521948|MANTA|manta
5236855|NCT02521948|Arterial Closure Device|arterial closure device
5236856|NCT02521948|Large Bore Closure Device|large bore closure device
5236857|NCT02521909|Root Canal length|root canal length
5236858|NCT02521909|Electronic apex locator|electronic apex locator
5236859|NCT02521909|Endodontics|endodontics
5236860|NCT02521870|Skin Cancer|skin cancer
5236861|NCT02521870|Skin Tumors|skin tumors
5236862|NCT02521870|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5236863|NCT02521870|Cancer Immunotherapy|cancer immunotherapy
5236864|NCT02521857|Alkermes|alkermes
5236865|NCT02521857|Samidorphan|samidorphan
5236866|NCT02521857|ALKS 5461|alks 5461
5236867|NCT02521857|Healthy Volunteer|healthy volunteer
5236868|NCT02521857|Pharmacokinetics|pharmacokinetics
5236869|NCT02521844|solid tumors|solid tumors
5236870|NCT02521844|responsive to Wnt signalling regulation|responsive to wnt signalling regulation
5236872|NCT02521844|Porcupine|porcupine
5236873|NCT02521844|PD-1|pd-1
5236874|NCT02521844|MSS|mss
5236875|NCT02521844|CRC|crc
5236876|NCT02521844|endometrial cancer|endometrial cancer
5236877|NCT02521844|ovarian cancer|ovarian cancer
5236878|NCT02521831|Circumcision|circumcision
5236879|NCT02521818|cognition|cognition
5236880|NCT02521818|dementia|dementia
5236881|NCT02521818|neuropsychological|neuropsychological
5236882|NCT02521818|elderly|elderly
5236883|NCT02521818|nutrition|nutrition
5236884|NCT02521818|diet|diet
5236885|NCT02521805|Appetite|appetite
5236886|NCT02521805|Protein|protein
5236887|NCT02521805|Protein quality|protein quality
5236888|NCT02521805|Dietary fibre|dietary fibre
5236889|NCT02521805|Satiety|satiety
5236890|NCT02521792|Open-label study|open-label study
5236891|NCT02521792|Clinical trial Phase 2|clinical trial phase 2
5236892|NCT02521792|Efficacy and safety|efficacy and safety
5236895|NCT02521792|Flare-up|flare-up
5236896|NCT02521792|Palovarotene|palovarotene
5236897|NCT02521792|Retinoic acid receptor agonist|retinoic acid receptor agonist
5236898|NCT02521792|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
5236901|NCT02521792|Munchmeyer's Disease|munchmeyer's disease
5236902|NCT02521792|FOP|fop
5236903|NCT02521779|Inflammation|inflammation
5236904|NCT02521779|Endotoxemia|endotoxemia
5131140|NCT03174522|Angiogenesis|angiogenesis
5236905|NCT02521779|Lipopolysaccharide|lipopolysaccharide
5236906|NCT02521779|Diet|diet
5236907|NCT02521779|Fat|fat
5236908|NCT02521779|Postprandial|postprandial
5236909|NCT02521753|Polycystic ovary syndrome|polycystic ovary syndrome
5236910|NCT02521753|Obesity|obesity
5236911|NCT02521753|Metformin|metformin
5236912|NCT02521753|Magnesium|magnesium
5236913|NCT02521753|Polyunsaturated fatty acids|polyunsaturated fatty acids
5236914|NCT02521740|biological marker|biological marker
5236915|NCT02521740|frailty|frailty
5236916|NCT02521740|burden|burden
5236917|NCT02521740|nutrition|nutrition
5236918|NCT02521740|elderly|elderly
5236919|NCT02521714|Revlimid|revlimid
5236920|NCT02521714|lenalidomide|lenalidomide
5236921|NCT02521714|bioavailability|bioavailability
5236922|NCT02521714|healthy volunteers|healthy volunteers
5236923|NCT02521714|food effect|food effect
5236924|NCT02521714|pharmacokinetics|pharmacokinetics
5236925|NCT02521662|Electronic Cigarettes|electronic cigarettes
5236926|NCT02521662|Nicotine Patch|nicotine patch
5236927|NCT02521662|Smoking Cessation|smoking cessation
5236928|NCT02521649|Gastric Cancer|gastric cancer
5236929|NCT02521649|G17DT|g17dt
5236930|NCT02521649|PAS|pas
5236931|NCT02521649|Insegia|insegia
5236932|NCT02521649|Gastrimmune|gastrimmune
5236933|NCT02521623|Acelullar Dermal Matrix|acelullar dermal matrix
5236934|NCT02521623|Immediate Breast Reconstruction|immediate breast reconstruction
5236936|NCT02521584|Liver transplant recipient|liver transplant recipient
5236937|NCT02521558|Cognitive rehabilitation|cognitive rehabilitation
5236938|NCT02521558|Mobile electronic application|mobile electronic application
5236939|NCT02521558|Memory tasks|memory tasks
5236940|NCT02521545|Oral Remyelination|oral remyelination
5236941|NCT02521519|Facet induced pain|facet induced pain
5236942|NCT02521519|Myofascial pain|myofascial pain
5236943|NCT02521519|Trigger points|trigger points
5236944|NCT02521519|Low back pain|low back pain
5236945|NCT02521454|policing|policing
5236946|NCT02521454|resilience|resilience
5236947|NCT02521454|implicit bias|implicit bias
5236948|NCT02521454|violence|violence
5236949|NCT02521441|Neutropenia|neutropenia
5236950|NCT02521441|Myelotoxic Chemotherapy|myelotoxic chemotherapy
5236951|NCT02521441|G-CSF|g-csf
5236952|NCT02521363|Implantable Microdevice|implantable microdevice
5236953|NCT02521363|In Vivo Drug Sensitivity Testing|in vivo drug sensitivity testing
5236954|NCT02521363|HER2-Positive|her2-positive
5236955|NCT02521363|Triple Negative|triple negative
5236956|NCT02521363|15-127|15-127
5236957|NCT02521350|Acute Kidney Injury|acute kidney injury
5236958|NCT02521350|Surgery|surgery
5236959|NCT02521350|Perioperative care|perioperative care
5236963|NCT02521259|anesthetic depth|anesthetic depth
5236964|NCT02521259|emergence agitation|emergence agitation
5236965|NCT02521220|L-citrulline|l-citrulline
5236966|NCT02521220|Endothelial dysfunction|endothelial dysfunction
5236967|NCT02521194|Advanced Cancers|advanced cancers
5236968|NCT02521194|Inpatient occupational therapy|inpatient occupational therapy
5236969|NCT02521194|Questionnaire|questionnaire
5236970|NCT02521194|Survey|survey
5236971|NCT02521168|euthyroid sick syndrome|euthyroid sick syndrome
5236972|NCT02521168|cardiopulmonary bypass|cardiopulmonary bypass
5236973|NCT02521168|congenital heart disease|congenital heart disease
5236974|NCT02521168|time to extubation|time to extubation
5236975|NCT02521155|Oral health literacy intervention|oral health literacy intervention
5236976|NCT02521155|oral hygiene behavior|oral hygiene behavior
5236977|NCT02521142|OCT Angiography|oct angiography
5236978|NCT02521116|retinal oxygenation|retinal oxygenation
5236979|NCT02521116|retinal vessel diameters|retinal vessel diameters
5236980|NCT02521116|Dynamic vessel analyzer (DVA)|dynamic vessel analyzer (dva)
5236982|NCT02521077|Ascorbic Acid|ascorbic acid
5236983|NCT02521077|Breast Neoplasms|breast neoplasms
5236984|NCT02521077|Fatigue|fatigue
5236985|NCT02521064|IBD|ibd
5236986|NCT02521064|enteral nutrition|enteral nutrition
5236987|NCT02521064|corticosteroids|corticosteroids
5236988|NCT02521051|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5236989|NCT02521051|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
5236990|NCT02521051|ALK|alk
5236991|NCT02521051|Brain metastases|brain metastases
5224955|NCT02593266|Intervention|intervention
5236992|NCT02521012|Depression|depression
5236993|NCT02521012|Depressive symptoms|depressive symptoms
5236994|NCT02521012|Vitamin D|vitamin d
5236995|NCT02521012|Intervention|intervention
5236996|NCT02520986|Sexually transmitted disease|sexually transmitted disease
5236997|NCT02520986|Genital Warts|genital warts
5236998|NCT02520986|Venereal Warts|venereal warts
5236999|NCT02520960|Catheter Ablation|catheter ablation
5237000|NCT02520960|Pulmonary Vein Isolation|pulmonary vein isolation
5237001|NCT02520960|Radiofrequency|radiofrequency
5237004|NCT02520947|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5131255|NCT03173638|safety|safety
5237005|NCT02520934|Enzyme Replacement Therapy|enzyme replacement therapy
5237006|NCT02520934|Miglustat|miglustat
5237007|NCT02520934|Gaucher Disease|gaucher disease
5237008|NCT02520921|Diabetes mellitus|diabetes mellitus
5237009|NCT02520921|Acute coronary syndrome|acute coronary syndrome
5237010|NCT02520921|Coronary artery disease|coronary artery disease
5237011|NCT02520921|Aspirin|aspirin
5237012|NCT02520921|Secondary prevention|secondary prevention
5237013|NCT02520895|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5237014|NCT02520895|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5237015|NCT02520895|Follicular Lymphoma|follicular lymphoma
5237016|NCT02520895|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5237017|NCT02520895|MALT Lymphoma|malt lymphoma
5237018|NCT02520895|T Cell Lymphoma|t cell lymphoma
5237019|NCT02520895|Immune Repertoire|immune repertoire
5237020|NCT02520895|Infection|infection
5237021|NCT02520895|relapse|relapse
5237022|NCT02520895|survival|survival
5237023|NCT02520895|treatment response|treatment response
5237024|NCT02520895|VJ rearrangement|vj rearrangement
5237025|NCT02520882|PET/CT|pet/ct
5237026|NCT02520882|Bombesin|bombesin
5237027|NCT02520882|gastrin-releasing peptide receptor|gastrin-releasing peptide receptor
5237028|NCT02520882|68Gallium labeling|68gallium labeling
5237029|NCT02520830|blueberry polyphenols|blueberry polyphenols
5237030|NCT02520830|Polyphenol metabolites|polyphenol metabolites
5237031|NCT02520830|endothelial function|endothelial function
5237032|NCT02520830|Molecular mechanisms of action|molecular mechanisms of action
5237033|NCT02520830|Vascular function|vascular function
5237034|NCT02520830|Healthy men|healthy men
5237035|NCT02520817|Antioxidants|antioxidants
5237037|NCT02520817|Truck drivers|truck drivers
5237038|NCT02520804|balanced salt solution|balanced salt solution
5237039|NCT02520765|Obesity Index, ICSI|obesity index, icsi
5237040|NCT02520752|cMET, INC280, caffeine, midazolam|cmet, inc280, caffeine, midazolam
5237041|NCT02520739|olive oil|olive oil
5237042|NCT02520739|phenolic compounds|phenolic compounds
5237043|NCT02520739|triterpenes|triterpenes
5237044|NCT02520739|oxidation and inflammation|oxidation and inflammation
5237045|NCT02520726|Posttraumatic stress disorder|posttraumatic stress disorder
5237046|NCT02520726|PTSD|ptsd
5237047|NCT02520726|Sertraline|sertraline
5237048|NCT02520726|Burns|burns
5237054|NCT02520609|Metabolomics|metabolomics
5237055|NCT02520609|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5237056|NCT02520609|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5237057|NCT02520609|Energy Expenditure|energy expenditure
5237058|NCT02520596|Raspberries|raspberries
5237059|NCT02520596|Anthocyanins|anthocyanins
5237060|NCT02520596|Ellagitannins|ellagitannins
5237061|NCT02520596|Metabolites|metabolites
5237062|NCT02520557|Epilepsy|epilepsy
5237063|NCT02520557|Genetic associations with severe Cutaneous Adverse Reactions|genetic associations with severe cutaneous adverse reactions
5237064|NCT02520492|intracranial pressure|intracranial pressure
5237065|NCT02520479|extranodal natural killer/T-cell lymphoma|extranodal natural killer/t-cell lymphoma
5237066|NCT02520479|nasal type|nasal type
5237067|NCT02520479|radiotherapy|radiotherapy
5237068|NCT02520479|chemotherapy|chemotherapy
5237069|NCT02520440|Citrulline|citrulline
5237070|NCT02520440|GIF|gif
5237071|NCT02520440|MOF|mof
5237072|NCT02520440|Calprotectina|calprotectina
5237073|NCT02520440|intraabdominal pressure|intraabdominal pressure
5237074|NCT02520427|Amgen|amgen
5237075|NCT02520427|Phase 1|phase 1
5237076|NCT02520427|Clinical Trial|clinical trial
5237077|NCT02520427|Oncology/Hematology|oncology/hematology
5237078|NCT02520427|Relapsed/Refractory AML|relapsed/refractory aml
5237079|NCT02520427|Immunotherapy|immunotherapy
5237080|NCT02520310|Mitral Regurgitation|mitral regurgitation
5237081|NCT02520310|mitral valve surgery|mitral valve surgery
5237082|NCT02520310|AVJ-514 Delivery System|avj-514 delivery system
5237083|NCT02520310|Symptomatic Heart Failure|symptomatic heart failure
5237084|NCT02520310|Heart Valve Disease|heart valve disease
5237085|NCT02520297|Pain|pain
5237086|NCT02520297|Long bone|long bone
5237087|NCT02520297|Fracture|fracture
5237088|NCT02520271|Mood Disorders|mood disorders
5237089|NCT02520271|Motivational Interview|motivational interview
5237090|NCT02520271|Behavioral Activation|behavioral activation
5237091|NCT02520258|artificial sweeteners|artificial sweeteners
5237092|NCT02520258|obesity|obesity
5225051|NCT02592772|smoking|smoking
5225052|NCT02592772|cigarette|cigarette
5225053|NCT02592772|cigarettes|cigarettes
5225054|NCT02592772|men smoking|men smoking
5225055|NCT02592772|smoking research|smoking research
5225056|NCT02592772|nicotine dependence|nicotine dependence
5225057|NCT02592720|Acute Coronary Syndromes|acute coronary syndromes
5237093|NCT02520258|diabetes|diabetes
5237094|NCT02520258|metabolic syndrome|metabolic syndrome
5237095|NCT02520258|aspartame|aspartame
5237096|NCT02520232|chronic exercise|chronic exercise
5237097|NCT02520232|genetic polymorphisms|genetic polymorphisms
5237098|NCT02520232|brain imagery|brain imagery
5237100|NCT02520232|alzheimer's disease|alzheimer's disease
5237101|NCT02520219|Peripheral T-cell lymphomas,Endostar|peripheral t-cell lymphomas,endostar
5237102|NCT02520193|Early mobilisation|early mobilisation
5237103|NCT02520193|Invasive ventilation|invasive ventilation
5237104|NCT02520193|Ventilator free days|ventilator free days
5237105|NCT02520193|Intensive Care Unit|intensive care unit
5237106|NCT02520167|Gestational weight gain|gestational weight gain
5237107|NCT02520128|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5237108|NCT02520128|Radiotherapy|radiotherapy
5237109|NCT02520089|platelet-rich plasma|platelet-rich plasma
5237110|NCT02520089|bone grafting|bone grafting
5237111|NCT02520089|pseudoarthrosis|pseudoarthrosis
5237112|NCT02520076|Islet Transplantation|islet transplantation
5237113|NCT02520063|hormone-receptor positive breast cancer|hormone-receptor positive breast cancer
5237114|NCT02520063|Her2 negative breast cancer|her2 negative breast cancer
5237116|NCT02520063|everolimus|everolimus
5237117|NCT02520063|TRC105|trc105
5237118|NCT02520063|letrozole|letrozole
5237119|NCT02520050|Type 2 diabetes|type 2 diabetes
5237120|NCT02520050|Obesity|obesity
5237121|NCT02520050|Nutrition|nutrition
5237122|NCT02520050|Medical Nutrition Therapy|medical nutrition therapy
5237123|NCT02520037|Fluid responsiveness|fluid responsiveness
5237124|NCT02520037|Volume responsiveness|volume responsiveness
5237125|NCT02520037|Hemodynamics|hemodynamics
5237126|NCT02520024|self-directed care|self-directed care
5237127|NCT02520024|serious mental illness|serious mental illness
5237128|NCT02520011|Refractory AML|refractory aml
5237129|NCT02520011|Relapsed AML|relapsed aml
5237130|NCT02520011|AML|aml
5237131|NCT02519998|Biomarkers|biomarkers
5237132|NCT02519998|Electrocardiography|electrocardiography
5237133|NCT02519998|Balance|balance
5237134|NCT02519998|Neuropsychiatric assessment|neuropsychiatric assessment
5237135|NCT02519998|Cortisol|cortisol
5237136|NCT02519998|Calcitonin-gene-related peptide|calcitonin-gene-related peptide
5237137|NCT02519998|Electroencephalography|electroencephalography
5237138|NCT02519998|Optical coherence tomography|optical coherence tomography
5237139|NCT02519998|Von Frey Testing|von frey testing
5237150|NCT02519946|Heart Transplantation|heart transplantation
5237151|NCT02519946|Tonometry|tonometry
5237152|NCT02519946|Exercise Test|exercise test
5237153|NCT02519946|Diet|diet
5237154|NCT02519946|Cardiovascular Physiology|cardiovascular physiology
5237155|NCT02519946|Telemedicine|telemedicine
5237156|NCT02519946|Pediatrics|pediatrics
5237157|NCT02519946|Health Behavior|health behavior
5237158|NCT02519946|Physical Fitness|physical fitness
5237159|NCT02519946|Exercise Movement Techniques|exercise movement techniques
5237160|NCT02519946|Adolescent Behavior|adolescent behavior
5237161|NCT02519946|Child Behavior|child behavior
5237162|NCT02519933|hemodialysis|hemodialysis
5237163|NCT02519933|vascular access|vascular access
5237164|NCT02519881|cartilage defect in ankle|cartilage defect in ankle
5237165|NCT02519881|microfracture|microfracture
5237166|NCT02519881|modified microfracture using collagen|modified microfracture using collagen
5237167|NCT02519881|collagen|collagen
5237168|NCT02519868|Neuromodulation|neuromodulation
5237169|NCT02519868|Local anaesthetics|local anaesthetics
5237170|NCT02519829|Suture|suture
5237171|NCT02519829|Skin staples|skin staples
5237172|NCT02519829|Vicryl|vicryl
5237173|NCT02519829|Monocryl|monocryl
5237174|NCT02519816|post stem cell transplantation|post stem cell transplantation
5237175|NCT02519816|Steroid refractory|steroid refractory
5237176|NCT02519816|dependent chronic|dependent chronic
5237177|NCT02519790|Pregnancy|pregnancy
5237178|NCT02519790|Depression|depression
5237179|NCT02519790|Anxiety|anxiety
5237180|NCT02519790|Mental Health|mental health
5237181|NCT02519790|Women|women
5237182|NCT02519777|HIV-Associated Neurocognitive Disorder|hiv-associated neurocognitive disorder
5237183|NCT02519764|volunteer runners who are participating in the 2015 Mont Blanc Ultra Trail|volunteer runners who are participating in the 2015 mont blanc ultra trail
5237184|NCT02519764|hydration protocol|hydration protocol
5237185|NCT02519764|natremia|natremia
5237186|NCT02519764|Volunteers|volunteers
5237187|NCT02519725|Family|family
5237188|NCT02519725|PTSD|ptsd
5237189|NCT02519725|Anxiety disorders|anxiety disorders
5237190|NCT02519725|Depression disorders|depression disorders
5237191|NCT02519725|Qualitative research|qualitative research
5237192|NCT02519712|Induction Chemotherapy|induction chemotherapy
5237193|NCT02519712|G-CSF-Mobilized Stem Cells|g-csf-mobilized stem cells
5131449|NCT03172312|thyroid cancer|thyroid cancer
5237194|NCT02519712|Haploidentical Related Donors|haploidentical related donors
5237195|NCT02519712|15-141|15-141
5237196|NCT02519660|Ralydan|ralydan
5237197|NCT02519660|EMLA cream|emla cream
5237198|NCT02519660|Procedural pain|procedural pain
5237199|NCT02519660|Phlebotomy|phlebotomy
5237200|NCT02519660|Child|child
5237201|NCT02519634|Super-Mini Percutaneous Nephrolithotomy|super-mini percutaneous nephrolithotomy
5237203|NCT02519634|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
5237204|NCT02519634|RIRS|rirs
5237205|NCT02519634|Randomized Controlled Trial|randomized controlled trial
5237206|NCT02519634|RCT|rct
5237207|NCT02519621|diabetic ulcer|diabetic ulcer
5237208|NCT02519621|pressure ulcer|pressure ulcer
5237209|NCT02519621|chronic or traumatic wound|chronic or traumatic wound
5237210|NCT02519621|sub-acute or dehisced wound|sub-acute or dehisced wound
5237211|NCT02519608|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5237212|NCT02519608|stable coronary artery disease|stable coronary artery disease
5237213|NCT02519608|ticagrelor|ticagrelor
5237214|NCT02519608|clopidogrel|clopidogrel
5237215|NCT02519608|endothelial function|endothelial function
5237216|NCT02519608|inflammation|inflammation
5237217|NCT02519608|platelet reactivity|platelet reactivity
5237218|NCT02519595|Procedural sedation|procedural sedation
5237219|NCT02519595|ketamine|ketamine
5237220|NCT02519595|children|children
5237221|NCT02519582|Colorectal Cancer|colorectal cancer
5237222|NCT02519582|S100A4|s100a4
5237223|NCT02519556|Probiotics|probiotics
5237224|NCT02519556|Inflammation|inflammation
5237225|NCT02519556|Awareness|awareness
5237226|NCT02519556|Immune tolerance|immune tolerance
5237227|NCT02519543|insulin resistance|insulin resistance
5237228|NCT02519530|Positive Youth Development|positive youth development
5237229|NCT02519530|Teen Outreach|teen outreach
5237230|NCT02519530|Teen Pregnancy Prevention|teen pregnancy prevention
5237231|NCT02519504|Galactose-1-phosphate uridylyltransferase deficiency|galactose-1-phosphate uridylyltransferase deficiency
5237232|NCT02519504|Cognitive disorders|cognitive disorders
5237233|NCT02519478|football|football
5237234|NCT02519478|Training Techniques|training techniques
5237235|NCT02519478|education|education
5237236|NCT02519478|Athletic Injuries|athletic injuries
5237237|NCT02519478|Brain Concussion|brain concussion
5237238|NCT02519465|nasal cannula|nasal cannula
5237239|NCT02519465|Inhalation Devices|inhalation devices
5237240|NCT02519452|Multiple Myeloma|multiple myeloma
5237241|NCT02519452|Daratumumab (JNJ-54767414)|daratumumab (jnj-54767414)
5237247|NCT02519439|ganaxolone|ganaxolone
5237248|NCT02519439|neurosteroid|neurosteroid
5237249|NCT02519439|Marinus|marinus
5237250|NCT02519439|epilepsy|epilepsy
5237251|NCT02519426|Third molar|third molar
5237252|NCT02519426|Classification|classification
5237253|NCT02519426|Inferior alveolar nerve|inferior alveolar nerve
5237254|NCT02519426|Lingual nerve injuries|lingual nerve injuries
5237255|NCT02519426|Mandibular canal|mandibular canal
5237256|NCT02519413|lymphocyte|lymphocyte
5237257|NCT02519413|serious infections|serious infections
5237258|NCT02519413|opportunistic infections|opportunistic infections
5237259|NCT02519413|Relapsing Forms|relapsing forms
5237260|NCT02519400|amitriptyline|amitriptyline
5237261|NCT02519400|cyp2d6|cyp2d6
5237262|NCT02519400|cyp2c19|cyp2c19
5237263|NCT02519374|Fiber tolerability|fiber tolerability
5237264|NCT02519374|Children|children
5237265|NCT02519361|elderly|elderly
5237266|NCT02519361|immune response|immune response
5237267|NCT02519361|acute infection|acute infection
5237268|NCT02519348|Hepatocellular Carcinoma|hepatocellular carcinoma
5237269|NCT02519348|Immunotherapy|immunotherapy
5237270|NCT02519348|Antibodies, Monoclonal|antibodies, monoclonal
5237271|NCT02519348|Tremelimumab|tremelimumab
5237272|NCT02519348|MEDI4736|medi4736
5237273|NCT02519348|Durvalumab|durvalumab
5237274|NCT02519335|cardiopulmonary bypass|cardiopulmonary bypass
5237275|NCT02519335|ischemia reperfusion injury|ischemia reperfusion injury
5237276|NCT02519283|AHF|ahf
5237277|NCT02519283|HF|hf
5237278|NCT02519283|ED|ed
5237279|NCT02519283|ER|er
5237280|NCT02519283|Emergency Department|emergency department
5237281|NCT02519283|Emergency Room|emergency room
5237282|NCT02519257|CAD|cad
5237283|NCT02519257|VHD|vhd
5237284|NCT02519257|Thy-1|thy-1
5237285|NCT02519244|Multiple Sclerosis|multiple sclerosis
5237286|NCT02519244|Ambulation|ambulation
5237287|NCT02519244|Rehabilitation|rehabilitation
5237288|NCT02519244|Wearable Robotic Devices|wearable robotic devices
5237289|NCT02519231|IUD|iud
5237290|NCT02519231|naproxen|naproxen
5237291|NCT02519231|bleeding|bleeding
5237292|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
5237293|NCT02519153|PDE5i|pde5i
5237294|NCT02519153|Sildinafil|sildinafil
5237295|NCT02519140|Gastric cancer|gastric cancer
5237296|NCT02519140|colon cancer|colon cancer
5237298|NCT02519140|biopsy|biopsy
5237299|NCT02519140|bariatric surgery|bariatric surgery
5237300|NCT02519114|M Myeloma|m myeloma
5237301|NCT02519114|KIR ligand mismatch|kir ligand mismatch
5237302|NCT02519114|Haploidentical|haploidentical
5237303|NCT02519088|Homologous Blood Transfusion|homologous blood transfusion
5237304|NCT02519088|Total Hip Replacement|total hip replacement
5237305|NCT02519088|Patient Blood Management|patient blood management
5237306|NCT02519075|Hepatocarcinoma|hepatocarcinoma
5237307|NCT02519075|TARE|tare
5237308|NCT02519075|response assessment|response assessment
5237309|NCT02519062|Carcinoma|carcinoma
5237310|NCT02519062|Non-Small-Cell Lung|non-small-cell lung
5237311|NCT02519062|FDG PET|fdg pet
5237312|NCT02519062|hypoxia markers|hypoxia markers
5237607|NCT02517151|fatigue|fatigue
5237313|NCT02519062|immune markers|immune markers
5237314|NCT02519049|Mesothelioma|mesothelioma
5237315|NCT02519049|11C-methionine PET|11c-methionine pet
5237316|NCT02519049|talc pleurodesis|talc pleurodesis
5237317|NCT02519036|Huntington's Disease|huntington's disease
5237318|NCT02519036|HTTRx|httrx
5237319|NCT02519036|Early Manifest Huntington's Disease|early manifest huntington's disease
5237320|NCT02518997|Preterm Infants|preterm infants
5237321|NCT02518997|Bedside Reading aloud|bedside reading aloud
5237322|NCT02518997|Parental wellbeing|parental wellbeing
5237323|NCT02518997|Parental Bonding|parental bonding
5237324|NCT02518997|cardio-respiratory stability|cardio-respiratory stability
5237325|NCT02518945|Type 1 Diabetes|type 1 diabetes
5237326|NCT02518945|Liraglutide|liraglutide
5237327|NCT02518945|Dapagliflozin|dapagliflozin
5237328|NCT02518945|Triple Therapy|triple therapy
5237329|NCT02518919|Children|children
5237330|NCT02518919|Emergency Department|emergency department
5237331|NCT02518919|Sedation|sedation
5237337|NCT02518893|Military Personnel|military personnel
5237338|NCT02518893|Air Force Personnel|air force personnel
5237339|NCT02518893|Army Personnel|army personnel
5237340|NCT02518893|Navy Personnel|navy personnel
5237341|NCT02518893|Armed Forces Personnel|armed forces personnel
5237342|NCT02518893|Marines|marines
5237343|NCT02518893|Soldiers|soldiers
5237344|NCT02518893|Sailors|sailors
5237345|NCT02518893|Airmen|airmen
5237346|NCT02518893|Decision Making|decision making
5237347|NCT02518893|Research Subjects|research subjects
5237348|NCT02518893|Life Experiences|life experiences
5237349|NCT02518893|Patient Participation|patient participation
5237350|NCT02518893|Refusal to Participate|refusal to participate
5237351|NCT02518893|Healthcare Research|healthcare research
5237352|NCT02518893|Qualitative Research|qualitative research
5237353|NCT02518893|Interview|interview
5237354|NCT02518893|Interviews, Telephone|interviews, telephone
5237355|NCT02518893|Ethics, Research|ethics, research
5237360|NCT02518828|Acute Heart Failure|acute heart failure
5237361|NCT02518802|Gefitinib|gefitinib
5237362|NCT02518802|Pemetrexed|pemetrexed
5237363|NCT02518802|Synchronous therapy|synchronous therapy
5237364|NCT02518802|Adjuvent therapy|adjuvent therapy
5237365|NCT02518789|myoclonus|myoclonus
5237366|NCT02518789|Etomidate|etomidate
5237367|NCT02518789|Dexmedetomidine|dexmedetomidine
5237368|NCT02518750|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5237369|NCT02518750|Salvage Regimen|salvage regimen
5237370|NCT02518750|Re-Induction Therapy|re-induction therapy
5237371|NCT02518750|Multi-agent chemotherapy|multi-agent chemotherapy
5237372|NCT02518737|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
5237373|NCT02518737|Receptor Deficiency|receptor deficiency
5237374|NCT02518711|symptoms of ADHD|symptoms of adhd
5237375|NCT02518698|Castrated resistant prostate cancer|castrated resistant prostate cancer
5237376|NCT02518698|Patients with bone metastases|patients with bone metastases
5237377|NCT02518685|Obesity|obesity
5237378|NCT02518685|Weight loss|weight loss
5237379|NCT02518685|Device|device
5237380|NCT02518685|Non-surgical|non-surgical
5237381|NCT02518685|Endoscopic|endoscopic
5237382|NCT02518685|TransPyloric Shuttle|transpyloric shuttle
5237384|NCT02518659|hypomagnesemia|hypomagnesemia
5237385|NCT02518659|hypocalcemia|hypocalcemia
5237386|NCT02518659|inulin|inulin
5237388|NCT02518659|PPI|ppi
5237389|NCT02518659|proton-pump inhibitors|proton-pump inhibitors
5237390|NCT02518646|Delirium|delirium
5237391|NCT02518646|Intensive care unit|intensive care unit
5237392|NCT02518646|Adult|adult
5237393|NCT02518646|Clinical prediction|clinical prediction
5237394|NCT02518633|obesity|obesity
5237395|NCT02518633|hypoxia|hypoxia
5237396|NCT02518633|adipose tissue|adipose tissue
5237397|NCT02518607|Safety and Tolerability|safety and tolerability
5237398|NCT02518607|Male Volunteers|male volunteers
5237403|NCT02518516|Statins, HMG-CoA|statins, hmg-coa
5237404|NCT02518516|Acute kidney injury|acute kidney injury
5237405|NCT02518516|Kidney diseases|kidney diseases
5237406|NCT02518516|Renal failure|renal failure
5237407|NCT02518503|Diabetes Mellitus|diabetes mellitus
5962774|NCT04278781|locally advanced chondrosarcoma|locally advanced chondrosarcoma
5117132|NCT03263637|B-cell Non-Hodgkin Lymphoma (B-cell NHL)|b-cell non-hodgkin lymphoma (b-cell nhl)
5237409|NCT02518503|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5237410|NCT02518477|breast cancer surgery|breast cancer surgery
5237411|NCT02518477|axillary lymph node dissection|axillary lymph node dissection
5237412|NCT02518477|resistance training|resistance training
5237413|NCT02518477|breast cancer related lymphedema|breast cancer related lymphedema
5237414|NCT02518464|headache|headache
5237416|NCT02518464|migraine|migraine
5237417|NCT02518464|right to left shunt|right to left shunt
5237418|NCT02518451|antihypertensive|antihypertensive
5237419|NCT02518451|bioequivalence|bioequivalence
5237420|NCT02518451|formulation|formulation
5237421|NCT02518451|pharmakokinetic|pharmakokinetic
5237422|NCT02518451|valsartan|valsartan
5237423|NCT02518451|subjects|subjects
5237424|NCT02518451|Fasting conditions|fasting conditions
5237425|NCT02518438|Tramadol|tramadol
5237426|NCT02518438|Postoperative analgesia|postoperative analgesia
5237427|NCT02518438|Infiltration|infiltration
5237428|NCT02518438|Cesarean section|cesarean section
5237429|NCT02518412|Alzheimers disease|alzheimers disease
5237430|NCT02518412|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5237433|NCT02518399|Blood vessels|blood vessels
5237434|NCT02518399|Heat|heat
5237435|NCT02518399|Cardiovascular diseases|cardiovascular diseases
5237436|NCT02518386|emergency department|emergency department
5237437|NCT02518386|epidemiology|epidemiology
5237438|NCT02518386|prehospital care|prehospital care
5237439|NCT02518386|dispatch|dispatch
5237440|NCT02518386|acute self poisoning|acute self poisoning
5237441|NCT02518360|NON SPECIFIC LOW BACK PAIN|non specific low back pain
5237442|NCT02518360|OSTEOPATHY|osteopathy
5237443|NCT02518360|FOOT PRESSURE PLATFORM|foot pressure platform
5237444|NCT02518360|POSTURAL BALANCE|postural balance
5237450|NCT02518321|Assistive Devices|assistive devices
5237451|NCT02518321|Activities of Daily Living|activities of daily living
5237452|NCT02518282|high-sensitivity troponin T|high-sensitivity troponin t
5237453|NCT02518282|Acute myocardial infarction|acute myocardial infarction
5237454|NCT02518282|Heart valvular surgery|heart valvular surgery
5237455|NCT02518282|Cardiac surgery|cardiac surgery
5237456|NCT02518269|hip|hip
5237457|NCT02518269|arthroplasty|arthroplasty
5237458|NCT02518269|G7|g7
5237459|NCT02518269|EchoBimetric|echobimetric
5237460|NCT02518269|E1|e1
5237461|NCT02518269|ceramic|ceramic
5237462|NCT02518269|Arcom XL|arcom xl
5237463|NCT02518256|Neoplasms|neoplasms
5237464|NCT02518256|Glandular and Epithelial|glandular and epithelial
5237465|NCT02518256|Ovarian Neoplasms|ovarian neoplasms
5237466|NCT02518256|Ovarian cancer|ovarian cancer
5237467|NCT02518204|cognitive assessment|cognitive assessment
5237468|NCT02518204|neuropsychological assessment|neuropsychological assessment
5237469|NCT02518204|Brain Performance Test|brain performance test
5237470|NCT02518204|computerized assessment|computerized assessment
5237471|NCT02518191|GnRHa|gnrha
5237472|NCT02518191|ovarian function|ovarian function
5237473|NCT02518191|anti-mullerian hormone|anti-mullerian hormone
5237474|NCT02518178|NFC|nfc
5237475|NCT02518178|randomization|randomization
5237476|NCT02518178|RCT|rct
5237477|NCT02518178|mHealth|mhealth
5237478|NCT02518178|maternal and child health|maternal and child health
5237479|NCT02518165|Cognitive Domain: Speed|cognitive domain: speed
5237480|NCT02518165|Cognitive Domain: Reaction Time|cognitive domain: reaction time
5237481|NCT02518165|Cognitive Domain: Attention|cognitive domain: attention
5237482|NCT02518165|Cognitive Domain: Executive Function|cognitive domain: executive function
5237483|NCT02518165|Cognitive Domain Memory|cognitive domain memory
5237484|NCT02518165|Sleep Quality|sleep quality
5237485|NCT02518165|Sleep Efficiency|sleep efficiency
5237486|NCT02518139|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5237487|NCT02518126|LIF IUGR|lif iugr
5237488|NCT02518087|CPB|cpb
5237489|NCT02518087|oXiris®|oxiris®
5237490|NCT02518087|CS-AKI|cs-aki
5237491|NCT02518087|SIRS|sirs
5237492|NCT02518087|Cytokines|cytokines
5237493|NCT02518087|LPS|lps
5237494|NCT02518087|AKI|aki
5237495|NCT02518074|volunteers|volunteers
5237496|NCT02518061|Glioma; 11C-Methionine PET|glioma; 11c-methionine pet
5237497|NCT02518048|Psoriasis|psoriasis
5237498|NCT02518022|Type 1 Diabetes mellitus|type 1 diabetes mellitus
5237499|NCT02518022|Hypoglycemia|hypoglycemia
5237500|NCT02518022|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5237501|NCT02518022|Alcohol|alcohol
5237502|NCT02518022|continuous glucose monitoring system|continuous glucose monitoring system
5237503|NCT02518022|Nutrition|nutrition
5237504|NCT02517983|chronic respiratory diseases phenotyping|chronic respiratory diseases phenotyping
5237505|NCT02517970|infant feeding|infant feeding
5237506|NCT02517970|breast-feeding|breast-feeding
5237507|NCT02517970|bottle-feeding|bottle-feeding
5237508|NCT02517970|feeding interactions|feeding interactions
5225455|NCT02590458|SBMRI|sbmri
5962775|NCT04278781|metastatic chondrosarcoma|metastatic chondrosarcoma
5117255|NCT03262805|Knee OA|knee oa
5237509|NCT02517970|maternal feeding practices|maternal feeding practices
5237510|NCT02517957|Xiashi surgical|xiashi surgical
5237511|NCT02517944|Familial hypercholesterolemia|familial hypercholesterolemia
5237512|NCT02517918|Advanced solid tumor|advanced solid tumor
5237513|NCT02517918|Bone metastasis and advanced pretreated osteosarcoma|bone metastasis and advanced pretreated osteosarcoma
5237514|NCT02517918|Phase I trial|phase i trial
5237515|NCT02517918|Dose escalation and expansion cohort|dose escalation and expansion cohort
5237516|NCT02517918|Biomarkers study|biomarkers study
5237517|NCT02517879|ITNs|itns
5237518|NCT02517879|malaria prevention|malaria prevention
5237519|NCT02517866|Drug therapy|drug therapy
5237520|NCT02517827|common femoral artery|common femoral artery
5237521|NCT02517827|drug-coated balloon|drug-coated balloon
5237522|NCT02517827|surgical endarterectomy|surgical endarterectomy
5237523|NCT02517801|anthocyanins|anthocyanins
5237524|NCT02517801|Post-menopausal women|post-menopausal women
5237525|NCT02517801|endothelial function|endothelial function
5237526|NCT02517801|vascular function|vascular function
5237527|NCT02517775|polyphenols|polyphenols
5237528|NCT02517775|vascular function|vascular function
5237529|NCT02517775|endothelial function|endothelial function
5237530|NCT02517775|cranberry|cranberry
5237537|NCT02517684|pediatric|pediatric
5237538|NCT02517684|infliximab|infliximab
5237539|NCT02517684|top-down|top-down
5237541|NCT02517671|Fitness|fitness
5237542|NCT02517671|Run time|run time
5237543|NCT02517671|VO2max|vo2max
5237544|NCT02517671|VEGF|vegf
5237545|NCT02517671|Central blood pressure|central blood pressure
5237546|NCT02517671|Augmentation Index|augmentation index
5237547|NCT02517671|Pulse wave analysis|pulse wave analysis
5237548|NCT02517632|Physical activity|physical activity
5237549|NCT02517632|Cardiac rehabilitation|cardiac rehabilitation
5237550|NCT02517619|Iontophoresis|iontophoresis
5237551|NCT02517619|Ophthalmology|ophthalmology
5237552|NCT02517619|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
5237553|NCT02517593|BCRAT|bcrat
5237554|NCT02517593|IBIS|ibis
5237555|NCT02517593|PRS|prs
5237556|NCT02517593|breast cancer|breast cancer
5237557|NCT02517593|Tyrer-Cuzick|tyrer-cuzick
5237558|NCT02517554|meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers|meet national comprehensive cancer network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers
5237559|NCT02517528|HCV Infection|hcv infection
5237560|NCT02517528|Compensated Cirrhosis|compensated cirrhosis
5237561|NCT02517515|HCV Infection|hcv infection
5237562|NCT02517515|Chronic Hepatitis C Virus|chronic hepatitis c virus
5237563|NCT02517515|Hepatitis C Virus (HCV) Genotype 1b|hepatitis c virus (hcv) genotype 1b
5237565|NCT02517502|Omega-3|omega-3
5237566|NCT02517502|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5237567|NCT02517502|chemotherapy|chemotherapy
5237568|NCT02517502|breast cancer|breast cancer
5237569|NCT02517489|Community-Acquired Pneumonia (CAP)|community-acquired pneumonia (cap)
5237570|NCT02517489|Hydrocortisone|hydrocortisone
5237571|NCT02517489|Corticosteroids|corticosteroids
5237572|NCT02517463|Emergency contraception|emergency contraception
5237573|NCT02517463|ulipristal acetate|ulipristal acetate
5237574|NCT02517463|efficacy|efficacy
5237575|NCT02517450|Subjects|subjects
5237576|NCT02517424|PTSD|ptsd
5237577|NCT02517411|COPD|copd
5237578|NCT02517411|physiotherapy|physiotherapy
5237579|NCT02517411|Stable disease|stable disease
5237580|NCT02517398|Solid tumor|solid tumor
5237581|NCT02517398|MSB0011359C (M7824)|msb0011359c (m7824)
5237582|NCT02517398|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
5237583|NCT02517398|Bintrafusp alfa|bintrafusp alfa
5237584|NCT02517398|INTR@PID|intr@pid
5237585|NCT02517346|CPAP compliance|cpap compliance
5237586|NCT02517346|Telemonitoring|telemonitoring
5237587|NCT02517346|Standard management|standard management
5237588|NCT02517346|Cost effectiveness|cost effectiveness
5237589|NCT02517333|Motor skill proficiency|motor skill proficiency
5237590|NCT02517333|movement difficulties|movement difficulties
5237591|NCT02517333|Developmental Coordination Disorder (DCD)|developmental coordination disorder (dcd)
5237592|NCT02517333|Low physical fitness|low physical fitness
5237593|NCT02517320|Diabetic Nephropathy|diabetic nephropathy
5237594|NCT02517294|Nasotracheal intubation|nasotracheal intubation
5237595|NCT02517294|adenoid size|adenoid size
5237596|NCT02517294|epistaxis|epistaxis
5237597|NCT02517294|nasopharyngeal mucosal injury|nasopharyngeal mucosal injury
5237598|NCT02517255|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
5237599|NCT02517255|Failed Thrombolysis|failed thrombolysis
5237600|NCT02517255|Rescue Percutaneous Coronary Intervention|rescue percutaneous coronary intervention
5237601|NCT02517255|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5237602|NCT02517229|volunteers|volunteers
5237603|NCT02517216|volunteers|volunteers
5237604|NCT02517190|volunteers|volunteers
5237605|NCT02517177|volunteers|volunteers
5237606|NCT02517151|iron|iron
5237608|NCT02517151|crohn's disease|crohn's disease
5962776|NCT04278781|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5962777|NCT04278781|19-393|19-393
5237609|NCT02517151|ulcerative colitis|ulcerative colitis
5237611|NCT02517138|volunteers|volunteers
5237612|NCT02517112|volunteers|volunteers
5237613|NCT02517099|Preschool|preschool
5237614|NCT02517099|Wheeze|wheeze
5237615|NCT02517099|Moderate|moderate
5237616|NCT02517099|Severe|severe
5237617|NCT02517086|blood circulation|blood circulation
5237618|NCT02517073|mechanical ventilation|mechanical ventilation
5237619|NCT02517073|epidemiology|epidemiology
5237620|NCT02517073|intensive care unit|intensive care unit
5237621|NCT02517073|national survey|national survey
5237622|NCT02517060|Social perceptions|social perceptions
5237623|NCT02517008|non-monetary incentive|non-monetary incentive
5237624|NCT02517008|institutional delivery|institutional delivery
5237625|NCT02516982|mHealth|mhealth
5237626|NCT02516982|Telemedicine|telemedicine
5237627|NCT02516982|Perinatal depression|perinatal depression
5237628|NCT02516982|Screening|screening
5237629|NCT02516982|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
5237630|NCT02516982|Whooley Questions|whooley questions
5237631|NCT02516982|Data collection|data collection
5237632|NCT02516982|Mood disorders|mood disorders
5237633|NCT02516982|Mental health|mental health
5237634|NCT02516982|Antenatal care|antenatal care
5237636|NCT02516956|Breakfast|breakfast
5237642|NCT02516956|Attention|attention
5237643|NCT02516956|Glucose|glucose
5237644|NCT02516956|Insulin|insulin
5237645|NCT02516956|fMRI|fmri
5237646|NCT02516943|Arterial blood gas analysis|arterial blood gas analysis
5237647|NCT02516930|health promotion|health promotion
5237648|NCT02516930|crowdsourcing|crowdsourcing
5237649|NCT02516904|Subjects|subjects
5237650|NCT02516891|treatment|treatment
5237651|NCT02516891|stent|stent
5237652|NCT02516891|coronary bifurcations lesions|coronary bifurcations lesions
5237653|NCT02516878|acupuncture|acupuncture
5237654|NCT02516878|Chinese Medicine|chinese medicine
5237655|NCT02516878|obesity|obesity
5237656|NCT02516865|postpartum|postpartum
5237657|NCT02516865|physical activity|physical activity
5237658|NCT02516852|community development; poultry; animal-source food; stunting|community development; poultry; animal-source food; stunting
5237659|NCT02516839|Overweight|overweight
5237660|NCT02516839|Obesity|obesity
5237661|NCT02516839|Overeating|overeating
5237662|NCT02516839|Body Mass Index|body mass index
5237663|NCT02516839|Weight|weight
5237664|NCT02516839|Treatment|treatment
5237665|NCT02516839|Cravings|cravings
5237666|NCT02516839|Intervention|intervention
5237667|NCT02516839|Behavioral Treatment|behavioral treatment
5237673|NCT02516787|volunteers|volunteers
5237674|NCT02516761|Fibromyalgia|fibromyalgia
5237675|NCT02516748|optical diagnosis|optical diagnosis
5237676|NCT02516748|narrow band image|narrow band image
5237677|NCT02516644|Parkinson Disease|parkinson disease
5237678|NCT02516644|Mobility|mobility
5237679|NCT02516644|Balance|balance
5237680|NCT02516644|Virtual Reality|virtual reality
5237681|NCT02516644|treadmill training|treadmill training
5237682|NCT02516631|Labour, induced|labour, induced
5237683|NCT02516631|Misoprostol|misoprostol
5237684|NCT02516631|Pharmacokinetics|pharmacokinetics
5237685|NCT02516631|Cardiotocography|cardiotocography
5237686|NCT02516631|Safety|safety
5237687|NCT02516605|Primary Biliary Cirrhosis, PBC|primary biliary cirrhosis, pbc
5237688|NCT02516605|Primary Biliary Cholangitis|primary biliary cholangitis
5237689|NCT02516566|Positive end-expiratory pressure ventilation|positive end-expiratory pressure ventilation
5237690|NCT02516566|Optic nerve sheath diameter|optic nerve sheath diameter
5237691|NCT02516553|NUT midline carcinoma|nut midline carcinoma
5237692|NCT02516540|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
5237693|NCT02516540|BRCA1/2 mutation carriers|brca1/2 mutation carriers
5237694|NCT02516540|Mediterranean diet|mediterranean diet
5237695|NCT02516540|Structured exercise training|structured exercise training
5237696|NCT02516540|prevention|prevention
5237697|NCT02516514|Blood culture|blood culture
5237698|NCT02516514|Bacteremia|bacteremia
5237699|NCT02516514|Single sampling|single sampling
5237700|NCT02516501|Ketogenic Diet|ketogenic diet
5237701|NCT02516501|Body composition|body composition
5237702|NCT02516501|Radiation therapy|radiation therapy
5237703|NCT02516436|Bunavail|bunavail
5237704|NCT02516436|Suboxone|suboxone
5237705|NCT02516436|Heroin|heroin
5237706|NCT02516436|Zubsolv|zubsolv
5237707|NCT02516436|Buprenorphine|buprenorphine
5237708|NCT02516436|Naloxone|naloxone
5237709|NCT02516436|Opioids|opioids
5237710|NCT02516436|Addiction|addiction
5237711|NCT02516436|Induction|induction
5237712|NCT02516397|body fat mass reduction|body fat mass reduction
5237713|NCT02516384|Fecal Microbiota Transplantation|fecal microbiota transplantation
5237714|NCT02516384|Ulcerative Colitis|ulcerative colitis
5237715|NCT02516345|Physical activity|physical activity
5237716|NCT02516345|Financial incentives|financial incentives
5237717|NCT02516345|Children|children
5237718|NCT02516345|Parents|parents
5237719|NCT02516345|RCT|rct
5237720|NCT02516345|Wireless pedometer|wireless pedometer
5237721|NCT02516306|Presbyopia|presbyopia
5107182|NCT03327831|pdt|pdt
5117480|NCT03261284|INR|inr
5237722|NCT02516306|Vision|vision
5237723|NCT02516306|UNR844|unr844
5237724|NCT02516280|Total knee replacement|total knee replacement
5237725|NCT02516280|Cold|cold
5237726|NCT02516280|Neurocryostimulation|neurocryostimulation
5237727|NCT02516280|CO2 cryotherapy|co2 cryotherapy
5237728|NCT02516280|mobility|mobility
5237729|NCT02516267|platelet aggregability|platelet aggregability
5237730|NCT02516267|acute coronary syndrome|acute coronary syndrome
5237731|NCT02516267|coronary artery bypass graft|coronary artery bypass graft
5237732|NCT02516254|vitamin D|vitamin d
5237733|NCT02516254|fortified bread|fortified bread
5237734|NCT02516254|efficacy|efficacy
5237735|NCT02516254|Vitamin D Deficiency|vitamin d deficiency
5237736|NCT02516241|Urothelial Cancer|urothelial cancer
5237737|NCT02516241|Phase III|phase iii
5237738|NCT02516189|Microcirculation|microcirculation
5237739|NCT02516189|Electromyography|electromyography
5237740|NCT02516189|Motor Activity|motor activity
5237742|NCT02516176|cerebral vascular accident|cerebral vascular accident
5237743|NCT02516176|balance|balance
5237744|NCT02516176|treadmill|treadmill
5237745|NCT02516176|falls|falls
5237746|NCT02516176|hemiparesis|hemiparesis
5237747|NCT02516150|Type 1 Diabetes|type 1 diabetes
5237748|NCT02516150|Bionic Pancreas|bionic pancreas
5237750|NCT02516150|Insulin|insulin
5237751|NCT02516150|Glucagon|glucagon
5237752|NCT02516150|Alcohol|alcohol
5237753|NCT02516150|Alcohol Clamp|alcohol clamp
5237754|NCT02516137|Dry needling|dry needling
5237755|NCT02516124|Autoimmune diseases|autoimmune diseases
5237756|NCT02516124|Systemic sclerosis|systemic sclerosis
5237757|NCT02516124|Autologous Hematopoietic stem cell transplant|autologous hematopoietic stem cell transplant
5237758|NCT02516072|remote ischemic preconditioning|remote ischemic preconditioning
5237759|NCT02516059|thoracic epidural analgesia|thoracic epidural analgesia
5237760|NCT02516059|oxycodone|oxycodone
5237761|NCT02516059|oral naloxone|oral naloxone
5237762|NCT02516059|radical cystectomy|radical cystectomy
5237763|NCT02516059|bowel function|bowel function
5237764|NCT02516059|pain|pain
5237765|NCT02516033|Atrial Fibrillation|atrial fibrillation
5237766|NCT02516033|Hybrid Ablation|hybrid ablation
5237767|NCT02516033|Efficacy|efficacy
5237768|NCT02516033|Risk Profile|risk profile
5237769|NCT02516033|Biomarkers|biomarkers
5237771|NCT02516020|ICSI|icsi
5237772|NCT02516020|culture media|culture media
5237773|NCT02516020|sequential|sequential
5237774|NCT02515981|tobacco dependence|tobacco dependence
5237775|NCT02515981|smoking cessation|smoking cessation
5237776|NCT02515981|mental health|mental health
5237777|NCT02515981|cardiovascular disease|cardiovascular disease
5237778|NCT02515981|obesity|obesity
5237779|NCT02515955|Healthy|healthy
5237780|NCT02515955|JNJ-54175446|jnj-54175446
5237781|NCT02515942|Geographic atrophy (GA)|geographic atrophy (ga)
5237782|NCT02515942|Macular degeneration|macular degeneration
5237783|NCT02515942|Dry age-related macular degeneration (AMD)|dry age-related macular degeneration (amd)
5237784|NCT02515942|Intravitreal (IVT)|intravitreal (ivt)
5237785|NCT02515942|Retinal diseases|retinal diseases
5237786|NCT02515942|Fundus auto fluorescence (FAF)|fundus auto fluorescence (faf)
5237787|NCT02515929|Oligomeric Proanthocyanidins|oligomeric proanthocyanidins
5237788|NCT02515929|Periodontal Disease|periodontal disease
5237789|NCT02515903|Endoscopy|endoscopy
5237790|NCT02515903|Intracerebral hemorrhage|intracerebral hemorrhage
5237791|NCT02515903|surgery|surgery
5237792|NCT02515903|stereotactic aspiration|stereotactic aspiration
5237793|NCT02515903|Key-hole approach|key-hole approach
5237794|NCT02515903|Intracerebral hemorrhage surgical treatment|intracerebral hemorrhage surgical treatment
5237795|NCT02515903|Transparent endoscopic sheath|transparent endoscopic sheath
5237796|NCT02515903|Agitation-aspiration device|agitation-aspiration device
5237797|NCT02515890|midazolam|midazolam
5237798|NCT02515890|dexmedetomidine|dexmedetomidine
5237799|NCT02515890|memory|memory
5132123|NCT03167476|miRNA|mirna
5237800|NCT02515890|ketamine|ketamine
5237801|NCT02515864|Male and Female Volunteers|male and female volunteers
5237802|NCT02515786|Chronic respiratory failure|chronic respiratory failure
5237803|NCT02515786|Oxygen therapy|oxygen therapy
5237804|NCT02515786|Nasal catheter|nasal catheter
5237805|NCT02515786|Mucociliary clearance|mucociliary clearance
5237806|NCT02515747|Lipoprotein(a)|lipoprotein(a)
5237807|NCT02515747|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
5237808|NCT02515747|apo(a)|apo(a)
5237809|NCT02515747|prognosis|prognosis
5237810|NCT02515747|myocardial infarction|myocardial infarction
5237811|NCT02515747|cardiovascular death|cardiovascular death
5238110|NCT02513862|transfusion|transfusion
5237812|NCT02515747|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5237813|NCT02515734|FOLFOXIRI|folfoxiri
5962778|NCT04278768|Acute Myelogenous Leukemia|acute myelogenous leukemia
5237814|NCT02515734|Bmab|bmab
5237815|NCT02515734|Cmab|cmab
5316433|NCT02101840|Placebo|placebo
5962779|NCT04278768|Myelodysplastic Syndrome|myelodysplastic syndrome
5225729|NCT02589015|difficult laryngoscopy|difficult laryngoscopy
5225730|NCT02589002|sucralose|sucralose
5237816|NCT02515617|Ventilator-associated pneumonia|ventilator-associated pneumonia
5117638|NCT03260205|SPD489|spd489
5237817|NCT02515617|Subglottic-secretions drainage|subglottic-secretions drainage
5237818|NCT02515617|Critically ill patients|critically ill patients
5237819|NCT02515617|Cost-utility analysis|cost-utility analysis
5237820|NCT02515617|Prevention|prevention
5237821|NCT02515591|Healthy volunteer|healthy volunteer
5237822|NCT02515591|Respiratory|respiratory
5237823|NCT02515591|Bronchoalveolar lavage|bronchoalveolar lavage
5237824|NCT02515578|Primary Health Care|primary health care
5237825|NCT02515578|Cardiovascular Diseases|cardiovascular diseases
5237826|NCT02515578|Quality Improvement|quality improvement
5237827|NCT02515565|pneumonia|pneumonia
5237828|NCT02515565|Exacerbation|exacerbation
5237829|NCT02515565|physiotherapy|physiotherapy
5237830|NCT02515565|hospitalization|hospitalization
5237831|NCT02515539|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
5237832|NCT02515539|Mitral Regurgitation|mitral regurgitation
5237833|NCT02515539|Mitral Insufficiency|mitral insufficiency
5237834|NCT02515539|Transapical|transapical
5237835|NCT02515539|Transfemoral|transfemoral
5237836|NCT02515513|Pancreas|pancreas
5237837|NCT02515513|Pancreas Cancer|pancreas cancer
5237838|NCT02515513|Muscle Biopsy|muscle biopsy
5237839|NCT02515513|Cachexia|cachexia
5237840|NCT02515513|Muscle Cachexia|muscle cachexia
5237841|NCT02515500|cigarette reduction|cigarette reduction
5237842|NCT02515500|digital health|digital health
5237843|NCT02515500|mobile health|mobile health
5237844|NCT02515500|technology|technology
5237845|NCT02515500|Quitbit|quitbit
5237846|NCT02515500|mHealth|mhealth
5237847|NCT02515500|smoking cessation|smoking cessation
5237848|NCT02515500|quit smoking|quit smoking
5237849|NCT02515500|self-regulation|self-regulation
5237850|NCT02515487|Post-chemotherapy|post-chemotherapy
5237851|NCT02515487|cognitive impairment|cognitive impairment
5237852|NCT02515474|Cholangiopancreatography|cholangiopancreatography
5237853|NCT02515474|Endoscopic|endoscopic
5237854|NCT02515474|Common bile duct|common bile duct
5237855|NCT02515474|Complication|complication
5237856|NCT02515474|Recurrence|recurrence
5237857|NCT02515474|Laparoscopic|laparoscopic
5237858|NCT02515461|Diabetes mellitus|diabetes mellitus
5237859|NCT02515461|Low energy shockwave therapy|low energy shockwave therapy
5237860|NCT02515461|Chronic Renal Insufficiency|chronic renal insufficiency
5237862|NCT02515448|Critical care|critical care
5237863|NCT02515448|Pharmacokinetics|pharmacokinetics
5237864|NCT02515448|Gentamicin|gentamicin
5237865|NCT02515435|apatinib|apatinib
5237866|NCT02515435|NSCLC|nsclc
5237867|NCT02515435|safety|safety
5237868|NCT02515435|efficacy|efficacy
5237869|NCT02515422|Caesarean Section|caesarean section
5237870|NCT02515409|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
5237871|NCT02515409|Heated Humidified High Flow Nasal Cannula (HHHNC)|heated humidified high flow nasal cannula (hhhnc)
5237872|NCT02515409|Continues positive airway pressure (CPAP)|continues positive airway pressure (cpap)
5237873|NCT02515409|Children|children
5237874|NCT02515409|Non invasive ventilation|non invasive ventilation
5237875|NCT02515409|Treatment|treatment
5237876|NCT02515383|Adolescent Cancer|adolescent cancer
5237877|NCT02515383|MD Anderson Symptom Inventory (modified for adolescent use)|md anderson symptom inventory (modified for adolescent use)
5237878|NCT02515383|MDASI|mdasi
5237879|NCT02515383|Surveys|surveys
5237880|NCT02515383|Questionnaires|questionnaires
5237881|NCT02515383|Interviews|interviews
5237882|NCT02515383|Symptoms|symptoms
5237883|NCT02515370|Option B plus|option b plus
5237884|NCT02515370|HIV infected women|hiv infected women
5237885|NCT02515357|Sleep Disorders|sleep disorders
5237886|NCT02515357|Metabolic Syndrome|metabolic syndrome
5237887|NCT02515357|Mediterranean Diet|mediterranean diet
5237888|NCT02515357|Mediterranean Lifestyle|mediterranean lifestyle
5237889|NCT02515344|Patients|patients
5237890|NCT02515344|early detection of cancer|early detection of cancer
5237891|NCT02515344|patient compliance|patient compliance
5237892|NCT02515331|resistant hypertension|resistant hypertension
5237893|NCT02515318|COPD|copd
5237894|NCT02515318|Exacerbation|exacerbation
5237895|NCT02515318|Hospitalisation|hospitalisation
5237896|NCT02515318|Physiotherapy|physiotherapy
5237897|NCT02515292|IUGR (intrauterine growth restriction)|iugr (intrauterine growth restriction)
5237898|NCT02515292|IGF2 (insulin-like growth factor 2)|igf2 (insulin-like growth factor 2)
5237899|NCT02515292|morbidity|morbidity
5237900|NCT02515266|protein|protein
5237901|NCT02515266|growth|growth
5237902|NCT02515266|head circumference|head circumference
5237903|NCT02515253|Breast Pain|breast pain
5237904|NCT02515253|Mastalgia|mastalgia
5237905|NCT02515253|Bras|bras
5237906|NCT02515253|Breast Support|breast support
5237907|NCT02515227|peptide|peptide
5962780|NCT04278768|AML|aml
5237908|NCT02515227|vaccine|vaccine
5225820|NCT02588469|rostral fluid shift|rostral fluid shift
5237909|NCT02515227|Montanide ISA-51|montanide isa-51
5237910|NCT02515227|pembrolizumab|pembrolizumab
5237911|NCT02515227|PD-1|pd-1
5237912|NCT02515227|KEYTRUDA|keytruda
5237913|NCT02515214|bariatric surgery|bariatric surgery
5237914|NCT02515214|reproduction|reproduction
5237916|NCT02515175|Herpes|herpes
5237917|NCT02515175|Genital Herpes|genital herpes
5237918|NCT02515175|Vaccine|vaccine
5237919|NCT02515162|conization|conization
5237920|NCT02515162|LLETZ|lletz
5237921|NCT02515162|cervical dysplasia|cervical dysplasia
5237922|NCT02515162|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5237923|NCT02515162|Fischer cone biopsy excisor|fischer cone biopsy excisor
5237924|NCT02515162|loop electrosurgical excision procedure|loop electrosurgical excision procedure
5237925|NCT02515149|linkage to care|linkage to care
5237926|NCT02515149|point of care diagnostics|point of care diagnostics
5237927|NCT02515149|point of care CD4|point of care cd4
5237928|NCT02515149|HIV care cascade|hiv care cascade
5237929|NCT02515149|Kenya|kenya
5237930|NCT02515123|intensive care unit|intensive care unit
5237931|NCT02515123|malnutrition|malnutrition
5237932|NCT02515123|GI motility|gi motility
5237933|NCT02515123|nutritional intake|nutritional intake
5237934|NCT02515110|lumpectomy|lumpectomy
5237935|NCT02515110|mastectomy without reconstruction|mastectomy without reconstruction
5237936|NCT02515110|mastectomy with reconstruction|mastectomy with reconstruction
5237937|NCT02515110|Estrogen Receptor Negative|estrogen receptor negative
5237938|NCT02515110|Estrogen Receptor Positive|estrogen receptor positive
5237939|NCT02515110|HER2/Neu Negative|her2/neu negative
5237940|NCT02515110|HER2/Neu Positive|her2/neu positive
5235368|NCT02531516|ATLAS|atlas
5237941|NCT02515110|Progesterone Receptor Negative|progesterone receptor negative
5237942|NCT02515110|Progesterone Receptor Positive|progesterone receptor positive
5237943|NCT02515110|Stage IA Breast Cancer|stage ia breast cancer
5237944|NCT02515110|Stage IB Breast Cancer|stage ib breast cancer
5237945|NCT02515110|Stage IIA Breast Cancer|stage iia breast cancer
5237946|NCT02515110|Stage IIB Breast Cancer|stage iib breast cancer
5237947|NCT02515110|Stage IIIA Breast Cancer|stage iiia breast cancer
5237948|NCT02515084|recurrence Thyroid cancer|recurrence thyroid cancer
5237949|NCT02515084|18F-FDG PET-CT|18f-fdg pet-ct
5237950|NCT02515084|diffusion-weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5237951|NCT02515045|Cataract|cataract
5237952|NCT02515045|Surgery|surgery
5237953|NCT02515045|Prophylaxis|prophylaxis
5237954|NCT02515019|Anaesthetics inhalation|anaesthetics inhalation
5237955|NCT02515019|Bispectral index|bispectral index
5237956|NCT02515019|Cardiopulmonary bypass|cardiopulmonary bypass
5237957|NCT02514993|Sternal fracture|sternal fracture
5237958|NCT02514993|Thoracic spine fracture|thoracic spine fracture
5237959|NCT02514993|Thoracic cage injury|thoracic cage injury
5237960|NCT02514967|SLE|sle
5237961|NCT02514967|Lupus|lupus
5237962|NCT02514967|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5237963|NCT02514967|Autoimmune Diseases|autoimmune diseases
5237964|NCT02514967|A-623|a-623
5237965|NCT02514967|Blisibimod|blisibimod
5237966|NCT02514967|Nephritis|nephritis
5237967|NCT02514902|Lateral Flow Device (LFD)|lateral flow device (lfd)
5237968|NCT02514902|Acute Stroke|acute stroke
5237969|NCT02514902|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
5237970|NCT02514902|Point of Care (POC)|point of care (poc)
5237971|NCT02514902|Biomarker|biomarker
5237972|NCT02514824|recurrent merkel cell carcinoma|recurrent merkel cell carcinoma
5237973|NCT02514824|metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
5237974|NCT02514798|COPD|copd
5237975|NCT02514798|HFNC|hfnc
5237976|NCT02514798|work of breathing|work of breathing
5237977|NCT02514746|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
5237978|NCT02514746|Flavivirus Infections|flavivirus infections
5237979|NCT02514733|kidney|kidney
5237980|NCT02514733|transplant|transplant
5237981|NCT02514655|Tracheal intubation|tracheal intubation
5237982|NCT02514655|Cuff pressure|cuff pressure
5237983|NCT02514655|Ventilator-acquired pneumonia|ventilator-acquired pneumonia
5237984|NCT02514655|Intensive care unit|intensive care unit
5237985|NCT02514655|Tracheal injuries|tracheal injuries
5237986|NCT02514629|Hypogonadism|hypogonadism
5237987|NCT02514629|Obesity|obesity
5237988|NCT02514629|Erectile Dysfunction|erectile dysfunction
5237989|NCT02514629|Testosterone|testosterone
5237990|NCT02514629|Metformin|metformin
5237991|NCT02514629|Weight Loss|weight loss
5237992|NCT02514629|Insulin Resistance|insulin resistance
5237993|NCT02514616|Reflux|reflux
5237994|NCT02514616|Reflux disease|reflux disease
5237995|NCT02514616|Gastroesophageal reflux disease|gastroesophageal reflux disease
5237996|NCT02514616|Lower esophageal sphincter stimulation|lower esophageal sphincter stimulation
5237997|NCT02514603|Neoplasm metastasis|neoplasm metastasis
5237998|NCT02514603|Checkpoint Kinase 1|checkpoint kinase 1
5237999|NCT02514603|CHK1|chk1
5238000|NCT02514603|CHK1 inhibitor|chk1 inhibitor
5238001|NCT02514551|stomach cancer|stomach cancer
5238002|NCT02514512|Lung Cancer|lung cancer
5238003|NCT02514512|Stereotactic Ablative Radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
5238004|NCT02514512|MLC Tracking|mlc tracking
5238005|NCT02514512|Radiotherapy|radiotherapy
5238006|NCT02514499|patients|patients
5238007|NCT02514460|stents|stents
5238008|NCT02514460|atherectomy|atherectomy
5238009|NCT02514460|femoral artery|femoral artery
5238111|NCT02513849|esophagus|esophagus
5238010|NCT02514460|popliteal artery|popliteal artery
5238012|NCT02514421|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5238013|NCT02514421|electrochemotherapy|electrochemotherapy
5238014|NCT02514421|electroporation|electroporation
5238015|NCT02514421|radiogenomics|radiogenomics
5238016|NCT02514421|imaging|imaging
5238017|NCT02514421|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5238018|NCT02514395|linguistic validation|linguistic validation
5238019|NCT02514395|KOOS|koos
5238020|NCT02514395|Marathi translation|marathi translation
5238021|NCT02514356|behavioral economics|behavioral economics
5238022|NCT02514356|antiretroviral adherence|antiretroviral adherence
5238024|NCT02514356|mobile health (mHealth)|mobile health (mhealth)
5238025|NCT02514356|Adolescents|adolescents
5238026|NCT02514356|Uganda|uganda
5238028|NCT02514343|radius fracture|radius fracture
5238029|NCT02514343|magnesium sulfate|magnesium sulfate
5238030|NCT02514343|rehabilitation|rehabilitation
5238031|NCT02514343|bupivacaine|bupivacaine
5238032|NCT02514330|Drop Jump|drop jump
5238045|NCT02514252|Recurrent cancer|recurrent cancer
5238046|NCT02514252|Incurable cancer|incurable cancer
5238047|NCT02514252|Fentanyl sublingual spray|fentanyl sublingual spray
5238048|NCT02514252|FSS|fss
5238049|NCT02514252|Questionnaires|questionnaires
5238050|NCT02514252|Surveys|surveys
5238051|NCT02514252|Mental ability tests|mental ability tests
5238052|NCT02514252|Phone calls|phone calls
5238053|NCT02514252|Study diary|study diary
5238054|NCT02514252|Pain control|pain control
5238055|NCT02514226|microbiology|microbiology
5238056|NCT02514226|halitosis|halitosis
5238057|NCT02514213|PSA|psa
5238058|NCT02514187|Osteogenesis|osteogenesis
5238059|NCT02514161|Smokers|smokers
5238060|NCT02514161|Maximum Inspiratory Pressure|maximum inspiratory pressure
5238061|NCT02514148|patient education|patient education
5238062|NCT02514148|therapeutic exercise|therapeutic exercise
5238063|NCT02514148|manual therapy|manual therapy
5238064|NCT02514109|neuronopathy|neuronopathy
5238065|NCT02514109|antibodies|antibodies
5238066|NCT02514109|Clinical and biological diagnostic criteria|clinical and biological diagnostic criteria
5238067|NCT02514083|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5238068|NCT02514083|Hematopoietic Neoplasms|hematopoietic neoplasms
5238069|NCT02514083|Tumors of B cells|tumors of b cells
5238070|NCT02514070|LDL-C|ldl-c
5238071|NCT02514070|Omega-3 Fatty Acid|omega-3 fatty acid
5238072|NCT02514070|PCSK9|pcsk9
5238073|NCT02514070|HDL-C|hdl-c
5238074|NCT02514018|Varicella-Zoster Virus|varicella-zoster virus
5238075|NCT02514018|Immune Activation|immune activation
5238076|NCT02514018|HIV Vaccine|hiv vaccine
5238077|NCT02514018|Mucosal Immunity|mucosal immunity
5238078|NCT02514005|Trigger points|trigger points
5238079|NCT02514005|Manual therapy|manual therapy
5238080|NCT02514005|Patellofemoral syndrome|patellofemoral syndrome
5238081|NCT02514005|Dry needling|dry needling
5238082|NCT02513992|ictal SPECT|ictal spect
5238083|NCT02513979|Angiotensin type II receptor (AT2R) antagonists|angiotensin type ii receptor (at2r) antagonists
5238084|NCT02513979|Acute postoperative pain|acute postoperative pain
5238085|NCT02513979|Chronic postoperative pain|chronic postoperative pain
5238086|NCT02513979|Abdominal surgery|abdominal surgery
5238087|NCT02513953|Endometriosis|endometriosis
5238088|NCT02513953|Mesosalpinx|mesosalpinx
5238089|NCT02513953|Broad Ligament|broad ligament
5238090|NCT02513953|Laparoscopy|laparoscopy
5238091|NCT02513940|Torsades de pointes|torsades de pointes
5238092|NCT02513940|Testosterone|testosterone
5238093|NCT02513940|Progesterone|progesterone
5238094|NCT02513940|Clinical trial|clinical trial
5238095|NCT02513940|Risk reduction|risk reduction
5238096|NCT02513940|Electrocardiography|electrocardiography
5238097|NCT02513927|Blood pressure variability|blood pressure variability
5238098|NCT02513927|CCB|ccb
5238099|NCT02513927|beta-receptor blockers|beta-receptor blockers
5238100|NCT02513927|heart rate|heart rate
5238101|NCT02513914|endovascular neurosurgery|endovascular neurosurgery
5238102|NCT02513901|Chidamide|chidamide
5238103|NCT02513901|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5238104|NCT02513901|HIV-1 Reservoir|hiv-1 reservoir
5238105|NCT02513901|Chronic HIV infections|chronic hiv infections
5238106|NCT02513901|Antiretroviral Therapy|antiretroviral therapy
5238107|NCT02513901|HIV Eradication|hiv eradication
5238108|NCT02513862|autologous platelet rich plasma|autologous platelet rich plasma
5238109|NCT02513862|deep hypothermic circulatory arrest|deep hypothermic circulatory arrest
5238112|NCT02513849|gastroscopy|gastroscopy
5238113|NCT02513849|tamoxifen|tamoxifen
5238114|NCT02513836|opioids|opioids
5238115|NCT02513823|blood pressure|blood pressure
5238116|NCT02513823|vitamin D|vitamin d
5238117|NCT02513784|Microbiome|microbiome
5238123|NCT02513771|Immune activation|immune activation
5238124|NCT02513771|Viral suppression|viral suppression
5238126|NCT02513771|Immunology biomarkers|immunology biomarkers
5238127|NCT02513771|sCD14|scd14
5238128|NCT02513758|HIV patients|hiv patients
5238129|NCT02513758|Genital HIV penetration|genital hiv penetration
5238130|NCT02513745|cataract|cataract
5238131|NCT02513745|toric|toric
5117960|NCT03258190|Recurrence|recurrence
5238132|NCT02513745|phacoemulsification|phacoemulsification
5238133|NCT02513732|Drug Eluting Stent|drug eluting stent
5238134|NCT02513732|Coronary Stent|coronary stent
5238135|NCT02513732|Everolimus|everolimus
5238136|NCT02513732|Stent Thrombosis|stent thrombosis
5238137|NCT02513719|drug eluting stent|drug eluting stent
5238138|NCT02513719|stent|stent
5238139|NCT02513719|real world|real world
5238140|NCT02513693|Anesthesia|anesthesia
5238141|NCT02513693|Rocuronium|rocuronium
5238142|NCT02513693|Sugammadex|sugammadex
5238143|NCT02513693|Neostigmine|neostigmine
5238144|NCT02513693|TOF|tof
5238145|NCT02513693|Radical Prostatectomy|radical prostatectomy
5238146|NCT02513693|Robotic Surgery|robotic surgery
5238147|NCT02513693|Accelerometry|accelerometry
5238148|NCT02513680|Skin Aging|skin aging
5238149|NCT02513680|laser phototherapy|laser phototherapy
5238150|NCT02513680|Rejuvenation|rejuvenation
5238151|NCT02513680|Infrared Rays/therapeutic use|infrared rays/therapeutic use
5238152|NCT02513680|Female|female
5238153|NCT02513680|Humans|humans
5238154|NCT02513680|Esthetics|esthetics
5238155|NCT02513680|Phototherapy|phototherapy
5238156|NCT02513680|facial rejuvenation|facial rejuvenation
5238157|NCT02513654|tolerability|tolerability
5238158|NCT02513654|repeat dosing|repeat dosing
5238159|NCT02513654|safety|safety
5238160|NCT02513654|healthy Chinese subjects|healthy chinese subjects
5238161|NCT02513654|Pharmacokinetics|pharmacokinetics
5238162|NCT02513654|lamotrigine|lamotrigine
5238163|NCT02513628|Cardiac arrest|cardiac arrest
5238164|NCT02513628|neuroprognostication|neuroprognostication
5238165|NCT02513628|optic nerve sheath diameter|optic nerve sheath diameter
5238167|NCT02513628|ultrasonography|ultrasonography
5238168|NCT02513615|Fibrosis|fibrosis
5238169|NCT02513615|Peritoneal Dialysis|peritoneal dialysis
5238170|NCT02513615|Epigenetics|epigenetics
5238171|NCT02513615|Peritoneal membrane injury|peritoneal membrane injury
5238172|NCT02513615|Glucose exposure|glucose exposure
5238173|NCT02513602|implantology|implantology
5238174|NCT02513602|kidney|kidney
5238175|NCT02513602|renal disease|renal disease
5238176|NCT02513602|edentulism|edentulism
5238177|NCT02513602|tooth loss|tooth loss
5238178|NCT02513589|Positron emission tomography|positron emission tomography
5238179|NCT02513589|Carotid plaque|carotid plaque
5238180|NCT02513589|Inflammation|inflammation
5238181|NCT02513589|Stroke|stroke
5238182|NCT02513576|Sternal instability|sternal instability
5238183|NCT02513576|physical therapy|physical therapy
5238184|NCT02513576|Respiratory muscle strength|respiratory muscle strength
5238185|NCT02513563|Squamous cell lung cancer|squamous cell lung cancer
5238186|NCT02513524|hypertension|hypertension
5238187|NCT02513524|adherence|adherence
5238188|NCT02513524|resistant hypertension|resistant hypertension
5238189|NCT02513524|blood pressure|blood pressure
5238190|NCT02513524|non-adherence|non-adherence
5238191|NCT02513511|difficult airway|difficult airway
5238193|NCT02513485|Inflammation|inflammation
5238194|NCT02513485|Anhedonia|anhedonia
5238195|NCT02513485|Psychomotor retardation|psychomotor retardation
5238200|NCT02513459|ABBV-066|abbv-066
5238201|NCT02513459|BI 655066|bi 655066
5238202|NCT02513459|risankizumab|risankizumab
5238203|NCT02513433|Lumbar epidural anaesthesia|lumbar epidural anaesthesia
5238204|NCT02513420|levator ani avulsion|levator ani avulsion
5238205|NCT02513420|perineal muscle training|perineal muscle training
5238206|NCT02513420|pelvic floor ultrasound|pelvic floor ultrasound
5238207|NCT02513394|HR+/HER2- breast cancer|hr+/her2- breast cancer
5238208|NCT02513394|Palbociclib|palbociclib
5238209|NCT02513368|aesthetic|aesthetic
5238210|NCT02513368|connective tissue graft|connective tissue graft
5238211|NCT02513368|mucosa thickness|mucosa thickness
5238212|NCT02513355|Non-small cell lung cancer,Endostar|non-small cell lung cancer,endostar
5238213|NCT02513342|Endostar,Advanced lung squamous carcinoma|endostar,advanced lung squamous carcinoma
5238214|NCT02513329|Breast Cancer|breast cancer
5238215|NCT02513329|Anti-estrogens|anti-estrogens
5238216|NCT02513329|Hot Flushes|hot flushes
5238217|NCT02513329|Tamoxifen|tamoxifen
5238218|NCT02513329|Aromatase inhibitors|aromatase inhibitors
5238219|NCT02513329|Hot Flashes|hot flashes
5238220|NCT02513316|Microbleeds|microbleeds
5238221|NCT02513303|Dialysis|dialysis
5238222|NCT02513303|End Stage Renal Disease|end stage renal disease
5238223|NCT02513303|End Stage Kidney Disease|end stage kidney disease
5238224|NCT02513303|ESRD|esrd
5238225|NCT02513303|Chronic Kidney Failure|chronic kidney failure
5238226|NCT02513303|Chronic Renal Failure|chronic renal failure
5238227|NCT02513303|Chronic Kidney Disease|chronic kidney disease
5238228|NCT02513303|Hemodialysis|hemodialysis
5238229|NCT02513303|Vascular Access|vascular access
5238230|NCT02513303|Arteriovenous Fistula|arteriovenous fistula
5962781|NCT04278768|MDS|mds
5238231|NCT02513303|AV Fistula|av fistula
5238233|NCT02513303|Nephrology|nephrology
5238234|NCT02513303|Vascular Surgery|vascular surgery
5238235|NCT02513303|Dialysis Access|dialysis access
5238236|NCT02513290|quality of life|quality of life
5238245|NCT02513277|screening|screening
5238246|NCT02513277|prevention|prevention
5238247|NCT02513277|lifestyle education|lifestyle education
5238248|NCT02513264|Registry|registry
5238249|NCT02513264|Asthma|asthma
5238250|NCT02513264|Inner City Asthma Consortium (ICAC) study eligibility|inner city asthma consortium (icac) study eligibility
5238251|NCT02513212|Sensitivity|sensitivity
5238252|NCT02513199|Hepatocellular Carcinoma|hepatocellular carcinoma
5238253|NCT02513199|Trans-Arterial Chemoembolization|trans-arterial chemoembolization
5238254|NCT02513199|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5238255|NCT02513199|HCC|hcc
5238256|NCT02513199|TACE|tace
5238257|NCT02513199|SBRT|sbrt
5238258|NCT02513173|low back pain|low back pain
5238259|NCT02513173|verbal instruction|verbal instruction
5238260|NCT02513173|lumbar multifidus|lumbar multifidus
5238261|NCT02513173|ultrasound imaging|ultrasound imaging
5238262|NCT02513173|Muscle thickness|muscle thickness
5238263|NCT02513134|IOL power calculations|iol power calculations
5238264|NCT02513134|Intraoperative|intraoperative
5238265|NCT02513134|OCT|oct
5238266|NCT02513134|Refractive outcome|refractive outcome
5238267|NCT02513134|Biometry|biometry
5238268|NCT02513121|NAFLD|nafld
5238269|NCT02513121|Steatohepatitis|steatohepatitis
5238270|NCT02513121|Nonalcoholic Steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5238271|NCT02513121|Liver|liver
5238272|NCT02513121|Diet|diet
5238273|NCT02513121|Pediatric|pediatric
5238274|NCT02513121|Adolescent|adolescent
5238275|NCT02513056|non-conditional pacemakers|non-conditional pacemakers
5238276|NCT02513056|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5238277|NCT02513017|partially randomized clinical trial|partially randomized clinical trial
5238278|NCT02513017|cardiovascular disease|cardiovascular disease
5238280|NCT02513017|preference|preference
5238281|NCT02513017|acceptability|acceptability
5238282|NCT02512978|myocardial infarction|myocardial infarction
5238283|NCT02512978|hypothyroidism|hypothyroidism
5238284|NCT02512978|levothyroxine|levothyroxine
5238285|NCT02512978|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5238286|NCT02512978|myocardial perfusion/metabolism radionuclide imaging|myocardial perfusion/metabolism radionuclide imaging
5238287|NCT02512978|myocardial fibrosis|myocardial fibrosis
5238288|NCT02512978|myocardial perfusion/metabolism|myocardial perfusion/metabolism
5238289|NCT02512978|cardiac function|cardiac function
5238290|NCT02512952|Periodontal regeneration|periodontal regeneration
5238291|NCT02512952|Growth factors|growth factors
5238292|NCT02512939|tuberculosis|tuberculosis
5238293|NCT02512939|diagnostic test|diagnostic test
5238294|NCT02512926|Solid Tumors|solid tumors
5238295|NCT02512926|Leukemia|leukemia
5238296|NCT02512926|Relapsed|relapsed
5238297|NCT02512926|Refractory|refractory
5238299|NCT02512913|Intervention|intervention
5238300|NCT02512913|Pregnancy|pregnancy
5238301|NCT02512913|Postnatal|postnatal
5238302|NCT02512900|Asthma|asthma
5238311|NCT02512861|Bupivacaine|bupivacaine
5238312|NCT02512861|Cardiac Surgery|cardiac surgery
5238313|NCT02512861|Pediatrics|pediatrics
5238314|NCT02512861|Nerve Block|nerve block
5238315|NCT02512848|postmenopause|postmenopause
5238316|NCT02512848|endometrial sampling|endometrial sampling
5238317|NCT02512848|vaginal bleeding|vaginal bleeding
5238318|NCT02512835|Primary health care|primary health care
5238319|NCT02512835|Public health|public health
5238320|NCT02512835|Medical Informatics|medical informatics
5238321|NCT02512835|Social Determinants of Health|social determinants of health
5238322|NCT02512822|radiofrequency|radiofrequency
5238323|NCT02512822|submental fat|submental fat
5238324|NCT02512822|fat reduction|fat reduction
5238325|NCT02512822|body contouring|body contouring
5238326|NCT02512796|Liver transplantation|liver transplantation
5238327|NCT02512796|Renal transplantation|renal transplantation
5238328|NCT02512796|Pancreas transplantation|pancreas transplantation
5238329|NCT02512783|Propofol|propofol
5238330|NCT02512783|Lidocaine|lidocaine
5238331|NCT02512783|Intravenous propofol|intravenous propofol
5238332|NCT02512757|Neoplasms, Lung|neoplasms, lung
5238333|NCT02512757|Pulmonary Neoplasms|pulmonary neoplasms
5238334|NCT02512757|Pulmonary Cancer|pulmonary cancer
5238335|NCT02512744|Tracheostomy|tracheostomy
5238336|NCT02512744|Decannulation|decannulation
5238337|NCT02512744|Adult airway management|adult airway management
5238338|NCT02512718|intravenous fat emulsions|intravenous fat emulsions
5238339|NCT02512718|fish oil lipid emulsion|fish oil lipid emulsion
5238340|NCT02512692|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5238341|NCT02512692|cholangiocarcinoma|cholangiocarcinoma
5238342|NCT02512692|90Y TARE|90y tare
5238343|NCT02512692|radioembolization|radioembolization
5238344|NCT02512692|gemcitabine and cisplatin|gemcitabine and cisplatin
5238345|NCT02512679|Hematopoietic Stem Cell Transplantation Pediatrics,|hematopoietic stem cell transplantation pediatrics,
5238346|NCT02512679|stem cell transplantation|stem cell transplantation
5238347|NCT02512679|bone marrow transplantation|bone marrow transplantation
5238348|NCT02512679|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5238349|NCT02512679|Allogeneic Transplantation|allogeneic transplantation
5962782|NCT04278768|IRAK4|irak4
5238350|NCT02512679|pediatrics|pediatrics
5238351|NCT02512679|Combined Immune Deficiency|combined immune deficiency
5238352|NCT02512679|Chronic Granulomatous disease|chronic granulomatous disease
5238353|NCT02512666|Hematologic malignancy|hematologic malignancy
5238354|NCT02512653|Allergy to Cupressus pollen|allergy to cupressus pollen
5238355|NCT02512640|Pressure-controlled ventilation|pressure-controlled ventilation
5238356|NCT02512640|Volume-controlled ventilation|volume-controlled ventilation
5238357|NCT02512640|Laparoscopy|laparoscopy
5238358|NCT02512640|Oxidative stress|oxidative stress
5238359|NCT02512627|mild cognitive impairment|mild cognitive impairment
5238360|NCT02512627|exercise|exercise
5238361|NCT02512627|cognitive training|cognitive training
5238363|NCT02512575|Healthy subjects|healthy subjects
5238364|NCT02512575|Phase 1|phase 1
5238365|NCT02512575|placebo controlled|placebo controlled
5238366|NCT02512575|single ascending dose|single ascending dose
5238367|NCT02512575|Pharmacokinetics|pharmacokinetics
5238368|NCT02512575|Pharmacodynamics|pharmacodynamics
5238369|NCT02512575|Rheumatoid Arthritis|rheumatoid arthritis
5238370|NCT02512549|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5238371|NCT02512549|rehabiltation|rehabiltation
5238372|NCT02512523|Type 2 diabetes mellitus|type 2 diabetes mellitus
5238373|NCT02512523|CGMS|cgms
5238374|NCT02512523|Teneligliptin|teneligliptin
5238375|NCT02512523|Sitagliptin|sitagliptin
5238376|NCT02512510|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5238377|NCT02512497|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5238378|NCT02512497|CTCL|ctcl
5238379|NCT02512497|T-Prolymphocytic Leukemia|t-prolymphocytic leukemia
5238380|NCT02512497|T-PLL|t-pll
5235790|NCT02528968|Haemophilia|haemophilia
5238381|NCT02512497|T-Large Granulocytic Leukemia|t-large granulocytic leukemia
5238383|NCT02512497|T-Lymphoblastic Leukemia/Lymphoma|t-lymphoblastic leukemia/lymphoma
5238384|NCT02512497|T-ALL|t-all
5238385|NCT02512497|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5238386|NCT02512497|PTCL|ptcl
5238387|NCT02512497|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5238388|NCT02512497|Romidepsin|romidepsin
5238389|NCT02512497|Istodax|istodax
5238390|NCT02512497|Depsipeptide|depsipeptide
5238391|NCT02512497|FK228|fk228
5238392|NCT02512497|Busulfan|busulfan
5238393|NCT02512497|Busulfex|busulfex
5238394|NCT02512497|Myleran|myleran
5238395|NCT02512497|Fludarabine|fludarabine
5238396|NCT02512497|Fludarabine phosphate|fludarabine phosphate
5238397|NCT02512497|Fludara|fludara
5238398|NCT02512484|tuberculosis|tuberculosis
5238399|NCT02512484|accident and emergency|accident and emergency
5238400|NCT02512471|minimum effective volume|minimum effective volume
5238401|NCT02512471|ropivacaine|ropivacaine
5238402|NCT02512471|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
5238403|NCT02512419|Physical Activity|physical activity
5238404|NCT02512419|Latinos|latinos
5238405|NCT02512419|Mexican American Men|mexican american men
5238406|NCT02512419|Spanish-Language|spanish-language
5238407|NCT02512419|Text-Message|text-message
5238408|NCT02512406|Tourette Syndrome|tourette syndrome
5238409|NCT02512406|Tics|tics
5238410|NCT02512341|Computer Aided Auscultation (CAA)|computer aided auscultation (caa)
5238411|NCT02512341|Electronic Stethoscope|electronic stethoscope
5238412|NCT02512341|Phonocardiography|phonocardiography
5238717|NCT02510391|anxiety|anxiety
5238413|NCT02512341|Heart Auscultation|heart auscultation
5238414|NCT02512328|Colonoscopy|colonoscopy
5238415|NCT02512328|new media|new media
5238416|NCT02512328|APP|app
5238417|NCT02512328|colonoscopy preparation|colonoscopy preparation
5238418|NCT02512328|SPA|spa
5238419|NCT02512328|smartphone application|smartphone application
5132764|NCT03163121|PfSPZ Vaccine|pfspz vaccine
5238420|NCT02512315|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5238421|NCT02512315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5238422|NCT02512315|Concurrent chemoradiation|concurrent chemoradiation
5238423|NCT02512315|Distant metastasis|distant metastasis
5238424|NCT02512315|Survival|survival
5238425|NCT02512302|COPD|copd
5238426|NCT02512276|Medication Non-adherence|medication non-adherence
5238427|NCT02512276|Hyperlipidemia|hyperlipidemia
5238428|NCT02512276|Diabetes|diabetes
5238429|NCT02512276|Hypertension|hypertension
5238430|NCT02512237|HER2|her2
5238431|NCT02512237|breast cancer|breast cancer
5238432|NCT02512237|ADC|adc
5238433|NCT02512237|antibody drug conjugate|antibody drug conjugate
5238434|NCT02512237|elevated HER2 expression|elevated her2 expression
5238435|NCT02512224|parenteral nutrition|parenteral nutrition
5238436|NCT02512224|enteral nutrition|enteral nutrition
5238437|NCT02512211|Hemophilia|hemophilia
5238438|NCT02512211|Validation|validation
5238439|NCT02512211|Questionnaires|questionnaires
5238440|NCT02512211|Activities|activities
5238441|NCT02512211|Sport|sport
5238442|NCT02512211|Patients|patients
5238443|NCT02512198|Professional Practice|professional practice
5238444|NCT02512198|General Practitioners|general practitioners
5238445|NCT02512198|Inappropriate Prescribing|inappropriate prescribing
5238446|NCT02512198|Persuasive Communication|persuasive communication
5962783|NCT04278742|patient education|patient education
5238447|NCT02512198|Information Theory|information theory
5238448|NCT02512198|Feedback|feedback
5238449|NCT02512185|Prostate cancer|prostate cancer
5238450|NCT02512185|Chemotherapy|chemotherapy
5238451|NCT02512185|mCRPC|mcrpc
5238452|NCT02512159|Diabetic foot ulcer|diabetic foot ulcer
5238453|NCT02512159|Foot care|foot care
5238454|NCT02512159|Wound management|wound management
5238455|NCT02512146|IBS|ibs
5238456|NCT02512146|Ionotropic glutamate receptors|ionotropic glutamate receptors
5238457|NCT02512133|MIGS|migs
5238458|NCT02512133|SLT|slt
5238459|NCT02512094|Barthel index|barthel index
5238460|NCT02512094|Hip fracture|hip fracture
5238461|NCT02512094|Validity|validity
5238462|NCT02512094|Reliability|reliability
5238463|NCT02512081|Sciatica|sciatica
5238464|NCT02512081|Patient Experience|patient experience
5238465|NCT02512081|Investigations|investigations
5238466|NCT02512081|Qualitative Research|qualitative research
5238467|NCT02512016|Pelvic floor|pelvic floor
5238468|NCT02511990|HIV|hiv
5238469|NCT02511990|10-1074|10-1074
5238470|NCT02511990|Monoclonal Antibody|monoclonal antibody
5238471|NCT02511977|Dental Prosthesis|dental prosthesis
5238472|NCT02511977|Implant-Supported|implant-supported
5238473|NCT02511964|Aerobic Exercise|aerobic exercise
5238474|NCT02511964|HIT,|hit,
5238475|NCT02511964|VO2Max|vo2max
5238476|NCT02511964|Performance|performance
5238477|NCT02511951|postoperative pancreatic fistula|postoperative pancreatic fistula
5238478|NCT02511951|postoperative hospital stay time|postoperative hospital stay time
5238479|NCT02511951|anastomosis time|anastomosis time
5238480|NCT02511951|reoperation rate|reoperation rate
5238481|NCT02511951|morbidity|morbidity
5238482|NCT02511951|pancreaticojejunostomy|pancreaticojejunostomy
5238483|NCT02511951|pancreaticoduodenectomy|pancreaticoduodenectomy
5238484|NCT02511938|childhood obesity|childhood obesity
5238485|NCT02511938|restaurant|restaurant
5238486|NCT02511938|away from home foods|away from home foods
5238487|NCT02511925|Critical care|critical care
5238488|NCT02511925|Feedback|feedback
5238489|NCT02511899|Microcirculation|microcirculation
5238490|NCT02511899|Endothelial function|endothelial function
5238491|NCT02511899|Metabolism|metabolism
5238492|NCT02511899|Cardiovascular Disease|cardiovascular disease
5238493|NCT02511899|human study|human study
5238494|NCT02511899|healthy subjects|healthy subjects
5238495|NCT02511899|Mangifera indica|mangifera indica
5238496|NCT02511899|Careless|careless
5238497|NCT02511886|Alcoholism|alcoholism
5238498|NCT02511886|Alcohol Abuse|alcohol abuse
5238499|NCT02511886|Alcohol Addiction|alcohol addiction
5238500|NCT02511886|Alcohol Dependence|alcohol dependence
5238501|NCT02511886|Alcohol Induced Disorders|alcohol induced disorders
5238502|NCT02511886|Alcoholic Intoxication|alcoholic intoxication
5238503|NCT02511873|Fycompa|fycompa
5238504|NCT02511873|Small Fiber Neuropathy|small fiber neuropathy
5238506|NCT02511873|Neuropathy|neuropathy
5238507|NCT02511873|Pain|pain
5238508|NCT02511847|Breast Cancer|breast cancer
5238509|NCT02511847|EGFR|egfr
5238510|NCT02511847|Afatinib|afatinib
5238511|NCT02511847|Paclitaxel|paclitaxel
5238512|NCT02511847|Pathologic complete remission|pathologic complete remission
5238513|NCT02511808|Drinking|drinking
5238514|NCT02511808|Alcohol Problems|alcohol problems
5238515|NCT02511808|Alcoholism|alcoholism
5238516|NCT02511808|Reduced Drinking|reduced drinking
5238718|NCT02510391|preschool|preschool
5238517|NCT02511808|Problematic Drinking|problematic drinking
5238518|NCT02511808|Non-Abstinence-based Drinking|non-abstinence-based drinking
5238519|NCT02511808|Controlled Drinking|controlled drinking
5238520|NCT02511808|Heavy Drinking|heavy drinking
5238522|NCT02511795|Olaparib|olaparib
5238523|NCT02511795|AZD1775 plus Olaparib|azd1775 plus olaparib
5238524|NCT02511795|Refractory Solid Tumours|refractory solid tumours
5238525|NCT02511795|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5238526|NCT02511795|Relapsed Small Cell Lung Cancer|relapsed small cell lung cancer
5238527|NCT02511782|children|children
5238528|NCT02511782|bone marrow transplant|bone marrow transplant
5238529|NCT02511782|GVHD|gvhd
5238530|NCT02511756|Perfusion-computed tomography|perfusion-computed tomography
5238531|NCT02511730|Mammography|mammography
5226405|NCT02584439|aging|aging
5238532|NCT02511704|Nicotine|nicotine
5238533|NCT02511704|Electronic cigarette|electronic cigarette
5238534|NCT02511704|Cigarette|cigarette
5238535|NCT02511639|Hormone receptor positive|hormone receptor positive
5238536|NCT02511639|HER2 negative|her2 negative
5238537|NCT02511626|endometriosis|endometriosis
5238538|NCT02511626|quality of life|quality of life
5238539|NCT02511626|professional activity|professional activity
5238540|NCT02511626|pain|pain
5238541|NCT02511626|infertility|infertility
5238542|NCT02511626|sexuality|sexuality
5238543|NCT02511626|partnership|partnership
5238544|NCT02511626|anxiety|anxiety
5238545|NCT02511626|depression|depression
5238546|NCT02511626|stress|stress
5238547|NCT02511626|childhood trauma|childhood trauma
5238548|NCT02511626|medical support|medical support
5238549|NCT02511626|dyspareunia|dyspareunia
5238550|NCT02511600|Lung Diseases|lung diseases
5238551|NCT02511600|Mesothelioma|mesothelioma
5238552|NCT02511600|Pleurectomy decortication|pleurectomy decortication
5238553|NCT02511600|Progel|progel
5238554|NCT02511600|Talcum powder|talcum powder
5238555|NCT02511600|Pain questionnaires|pain questionnaires
5238556|NCT02511600|Surveys|surveys
5238557|NCT02511600|Intraoperative air leaks|intraoperative air leaks
5238558|NCT02511600|IAL|ial
5238559|NCT02511574|progesterone|progesterone
5238560|NCT02511574|uterine cervix|uterine cervix
5238561|NCT02511574|cervical pessary|cervical pessary
5238562|NCT02511561|Otitis externa|otitis externa
5238563|NCT02511561|Swimmer's ear|swimmer's ear
5238564|NCT02511561|Ear infection|ear infection
5238565|NCT02511509|Schizophrenia|schizophrenia
5238566|NCT02511509|Electroconvulsive Therapy|electroconvulsive therapy
5238567|NCT02511509|Bifrontal ECT|bifrontal ect
5238568|NCT02511509|Bitemporal ECT|bitemporal ect
5238569|NCT02511509|Cognitive functions|cognitive functions
5238570|NCT02511509|Postictal delirium|postictal delirium
5238571|NCT02511483|COMT|comt
5238572|NCT02511483|Beta-blocker|beta-blocker
5238573|NCT02511483|Hemicolectomy|hemicolectomy
5238574|NCT02511470|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5238575|NCT02511470|Pediatric simulation study|pediatric simulation study
5238576|NCT02511470|Metronome|metronome
5238577|NCT02511444|GBS|gbs
5238578|NCT02511444|GBS culture|gbs culture
5238579|NCT02511444|GBS PCR|gbs pcr
5238580|NCT02511444|GBS colonization|gbs colonization
5238581|NCT02511431|Delta Hepatitis|delta hepatitis
5238582|NCT02511431|Hepatitis D|hepatitis d
5238583|NCT02511431|Liver Disease|liver disease
5238584|NCT02511431|Hepatitis D Virus|hepatitis d virus
5238585|NCT02511431|Chronic Hepatitis|chronic hepatitis
5238586|NCT02511405|rGBM|rgbm
5238587|NCT02511405|Recurrent Glioblastoma|recurrent glioblastoma
5238588|NCT02511405|Recurrent GBM|recurrent gbm
5238589|NCT02511366|ileal brake|ileal brake
5238590|NCT02511353|malaria|malaria
5238591|NCT02511353|plasmodium|plasmodium
5238592|NCT02511353|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5238593|NCT02511353|ivermectin|ivermectin
5238594|NCT02511327|Pertussis|pertussis
5238595|NCT02511327|Pregnancy|pregnancy
5238596|NCT02511327|Vaccination|vaccination
5238597|NCT02511327|Preterm|preterm
5238598|NCT02511327|Breast milk|breast milk
5238599|NCT02511327|Humoral immune response|humoral immune response
5238600|NCT02511327|Cellular immune response|cellular immune response
5238601|NCT02511327|Maternal antibodies|maternal antibodies
5238602|NCT02511314|Nursing homes|nursing homes
5238603|NCT02511314|quasi-experimental|quasi-experimental
5238604|NCT02511314|mixed methods|mixed methods
5238605|NCT02511314|parallel study|parallel study
5238606|NCT02511314|urinary incontinence|urinary incontinence
5238607|NCT02511288|Hematologic test|hematologic test
5238608|NCT02511288|Liquid biopsy|liquid biopsy
5238609|NCT02511275|parenchymal clamping|parenchymal clamping
5238610|NCT02511275|microdialysis technique|microdialysis technique
5238611|NCT02511275|partial nephrectomy|partial nephrectomy
5238612|NCT02511249|neonatal arterial ischemic stroke|neonatal arterial ischemic stroke
5238613|NCT02511249|language development|language development
5238614|NCT02511249|global intellectual functioning|global intellectual functioning
5238616|NCT02511197|PET|pet
5238617|NCT02511197|lung injury|lung injury
5238618|NCT02511197|integrin receptor|integrin receptor
5238619|NCT02511184|crizotinib|crizotinib
5238620|NCT02511184|pembrolizumab|pembrolizumab
5238621|NCT02511184|ALK-positive NSCLC|alk-positive nsclc
5238622|NCT02511184|Lung Cancer|lung cancer
5238623|NCT02511184|ALK-translocated NSCLC|alk-translocated nsclc
5238624|NCT02511184|Non Small Cell Lung Cancer|non small cell lung cancer
5356846|NCT01917760|Glucagon|glucagon
5238625|NCT02511158|Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament|anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament, lateral collateral ligament
5238626|NCT02511145|volunteers|volunteers
5238627|NCT02511132|Ewing's Sarcoma Family of Tumors, ESFT, Sarcoma|ewing's sarcoma family of tumors, esft, sarcoma
5238628|NCT02511132|Soft Tissue Sarcoma|soft tissue sarcoma
5342994|NCT01981252|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
5226512|NCT02583776|neonatal hypoglycemia|neonatal hypoglycemia
5226513|NCT02583776|very low birth weight infants (VLBWI)|very low birth weight infants (vlbwi)
5226514|NCT02583776|preterm infants|preterm infants
5226523|NCT02583737|bone|bone
5238635|NCT02511080|Spot-on; perioperative hypothermia.|spot-on; perioperative hypothermia.
5238636|NCT02511054|Immunogenicity|immunogenicity
5238637|NCT02511054|Liver Stage|liver stage
5238638|NCT02511054|Parasites|parasites
5238639|NCT02511054|Blood|blood
5238640|NCT02511054|Infection|infection
5238641|NCT02511041|CDG|cdg
5238642|NCT02511041|PGM3|pgm3
5238643|NCT02511041|Immune|immune
5238657|NCT02510989|Syndromic obesity|syndromic obesity
5238658|NCT02510989|Genes|genes
5238659|NCT02510989|Exome|exome
5238660|NCT02510963|Vertical infection transmission|vertical infection transmission
5238661|NCT02510963|Tenofovir|tenofovir
5238662|NCT02510937|pulmonary fibrosis|pulmonary fibrosis
5962784|NCT04278664|telemedicine|telemedicine
5238663|NCT02510937|pharmacokinetic|pharmacokinetic
5238664|NCT02510937|pharmacodynamics|pharmacodynamics
5238665|NCT02510937|CC-90001|cc-90001
5238666|NCT02510937|Safety|safety
5238667|NCT02510924|Intubation|intubation
5238668|NCT02510924|Airtraq|airtraq
5238669|NCT02510924|General anesthesia|general anesthesia
5238670|NCT02510924|Difficult airway|difficult airway
5238671|NCT02510911|colectomy|colectomy
5238672|NCT02510911|laparoscopy|laparoscopy
5238673|NCT02510911|caffeine|caffeine
5238674|NCT02510885|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5238675|NCT02510885|age-related macular degeneration|age-related macular degeneration
5238676|NCT02510885|diabetic retinopathy|diabetic retinopathy
5238677|NCT02510885|SD-OCT|sd-oct
5238678|NCT02510885|Angiography|angiography
5238679|NCT02510885|diabetic macular edema|diabetic macular edema
5238680|NCT02510846|Polyhandicap|polyhandicap
5238681|NCT02510846|Behavior disorders|behavior disorders
5238682|NCT02510846|Educative program|educative program
5238683|NCT02510846|Caregivers|caregivers
5238684|NCT02510846|Quality of life.|quality of life.
5238685|NCT02510833|Parkinson Disease|parkinson disease
5238686|NCT02510833|Physical Therapy Modalities|physical therapy modalities
5238687|NCT02510833|Quality of Life|quality of life
5238688|NCT02510833|Self Care|self care
5238689|NCT02510768|alba|alba
5238692|NCT02510651|: non-segmental vitiligo|: non-segmental vitiligo
5238693|NCT02510651|melanocyte-keratinocyte suspension|melanocyte-keratinocyte suspension
5238694|NCT02510651|cryoblebbing|cryoblebbing
5238695|NCT02510651|CO2 laser|co2 laser
5238696|NCT02510612|Dexmedetomidine|dexmedetomidine
5238697|NCT02510612|Diabetic|diabetic
5238698|NCT02510612|glycometabolism|glycometabolism
5238699|NCT02510612|sedation|sedation
5238700|NCT02510599|NASH|nash
5238701|NCT02510599|Liver disease|liver disease
5238702|NCT02510508|addiction|addiction
5238703|NCT02510508|substance abuse|substance abuse
5238705|NCT02510508|drugs|drugs
5238706|NCT02510508|community reinforcement|community reinforcement
5238707|NCT02510508|family treatment|family treatment
5238708|NCT02510508|randomized control trial|randomized control trial
5238709|NCT02510495|Sphincterotomy|sphincterotomy
5238710|NCT02510495|Dilatation|dilatation
5238711|NCT02510495|Common bile duct|common bile duct
5238712|NCT02510495|Pancreatitis|pancreatitis
5238713|NCT02510482|cardiac biomarkers|cardiac biomarkers
5238714|NCT02510443|Permanent contraception method|permanent contraception method
5238715|NCT02510443|Contraceptive device|contraceptive device
5238716|NCT02510391|modular|modular
5238719|NCT02510391|exposure and response prevention|exposure and response prevention
5238720|NCT02510391|Cognitive behavioral therapy|cognitive behavioral therapy
5238721|NCT02510352|Rotator cuff tear|rotator cuff tear
5238722|NCT02510352|MRI|mri
5238723|NCT02510287|analgesia, epidural|analgesia, epidural
5238725|NCT02510287|patient satisfaction|patient satisfaction
5238726|NCT02510274|Hyperphosphatemia|hyperphosphatemia
5238727|NCT02510274|ASP3325|asp3325
5226604|NCT02583243|Severe mental illness|severe mental illness
5226605|NCT02583243|Injection Drug Use|injection drug use
5226606|NCT02583230|Antidepressant Medication|antidepressant medication
5226607|NCT02583230|Adherence|adherence
5226608|NCT02583230|Mobile Smartphone Intervention|mobile smartphone intervention
5226612|NCT02583217|Ketamine|ketamine
5238728|NCT02510274|Chronic Kidney Disease|chronic kidney disease
5333130|NCT02025777|IBD|ibd
5238729|NCT02510274|pharmacodynamics|pharmacodynamics
5238730|NCT02510274|pharmacokinetics|pharmacokinetics
5238731|NCT02510261|RNAi therapeutic|rnai therapeutic
5238733|NCT02510261|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5238734|NCT02510261|TTR|ttr
5238735|NCT02510261|Transthyretin|transthyretin
5238736|NCT02510261|Amyloidosis|amyloidosis
5238737|NCT02510235|Dry Eye|dry eye
5238738|NCT02510222|child|child
5238739|NCT02510209|Teen pregnancy|teen pregnancy
5238740|NCT02510183|Acupressure|acupressure
5238741|NCT02510183|Perioperative Care|perioperative care
5238742|NCT02510183|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5238743|NCT02510183|Nursing Care Management|nursing care management
5238744|NCT02510170|Fetus|fetus
5238745|NCT02510170|Skull|skull
5238746|NCT02510170|ultrasonography|ultrasonography
5238747|NCT02510157|sugammadex|sugammadex
5238748|NCT02510157|dexamethasone|dexamethasone
5238749|NCT02510157|neuromuscular blockade|neuromuscular blockade
5238750|NCT02510118|ChangTai Keli|changtai keli
5238751|NCT02510118|Colon cancer|colon cancer
5238752|NCT02510105|Critical Care|critical care
5238753|NCT02510105|ARDS|ards
5238754|NCT02510105|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
5238755|NCT02510105|VDR4|vdr4
5238756|NCT02510105|Lung aeration|lung aeration
5238757|NCT02510105|CT scan|ct scan
5238758|NCT02510066|Pancreatic Cancer|pancreatic cancer
5238759|NCT02510066|Pain|pain
5238760|NCT02510066|Acupuncture|acupuncture
5238761|NCT02510040|Convergence Insufficiency|convergence insufficiency
5238762|NCT02510040|Divergence Insufficiency|divergence insufficiency
5238763|NCT02510040|Small-angle Hypertropia|small-angle hypertropia
5238764|NCT02510040|Strabismus|strabismus
5238765|NCT02510027|HPV testing|hpv testing
5238766|NCT02510027|Triage|triage
5238767|NCT02510027|Mexico|mexico
5238768|NCT02510027|Cervical cancer screening|cervical cancer screening
5238769|NCT02510001|RASMT CRC|rasmt crc
5238770|NCT02510001|RASWT/c-MET CRC|raswt/c-met crc
5238771|NCT02510001|Dose Escalation|dose escalation
5238772|NCT02510001|Histologically or cytologically confirmed|histologically or cytologically confirmed
5238773|NCT02510001|Dose Expansion|dose expansion
5238774|NCT02509988|Nutrition|nutrition
5238775|NCT02509988|Glucose metabolism|glucose metabolism
5238776|NCT02509988|Body composition|body composition
5238777|NCT02509975|embolization|embolization
5238778|NCT02509975|prostate|prostate
5238779|NCT02509962|Energy metabolism|energy metabolism
5238780|NCT02509962|Glucose tolerance|glucose tolerance
5238781|NCT02509962|Blood pressure|blood pressure
5238782|NCT02509962|Immunoregulation|immunoregulation
5238783|NCT02509923|Male Subjects|male subjects
5238784|NCT02509910|Major abdominal surgery|major abdominal surgery
5238785|NCT02509910|Goal directed therapy|goal directed therapy
5238786|NCT02509897|Hypoxia training|hypoxia training
5238787|NCT02509897|Activity energy expenditure|activity energy expenditure
5238788|NCT02509897|Immunoregulation|immunoregulation
5238789|NCT02509897|Energy Metabolism|energy metabolism
5238790|NCT02509897|Exercise|exercise
5238791|NCT02509884|Alveolar Echinococcosis (AE)|alveolar echinococcosis (ae)
5238792|NCT02509884|Echinococcus multilocularis|echinococcus multilocularis
5238793|NCT02509884|antiparasitic treatment|antiparasitic treatment
5238794|NCT02509884|surgery|surgery
5238795|NCT02509884|classification|classification
5238796|NCT02509884|staging|staging
5238797|NCT02509884|prospective cohort study|prospective cohort study
5238798|NCT02509871|Body composition|body composition
5236245|NCT02525913|Breast|breast
5238799|NCT02509858|Diabetes mellitus, thyroxine|diabetes mellitus, thyroxine
5238800|NCT02509832|Therapeutic Hypothermia (TH)|therapeutic hypothermia (th)
5238801|NCT02509832|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5238802|NCT02509832|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5238803|NCT02509819|rehabilitation|rehabilitation
5238804|NCT02509819|IDEO|ideo
5238805|NCT02509780|Vichy|vichy
5238806|NCT02509780|urine alkalization|urine alkalization
5238807|NCT02509767|Contraceptive Methods|contraceptive methods
5238808|NCT02509767|Female Contraception|female contraception
5238809|NCT02509767|Contraceptive satisfaction|contraceptive satisfaction
5238810|NCT02509767|Injectable contraception|injectable contraception
5238811|NCT02509767|Birth control|birth control
5238812|NCT02509754|atrial fibrillation|atrial fibrillation
5238813|NCT02509754|congestive heart failure|congestive heart failure
5238815|NCT02509754|rate control|rate control
5238816|NCT02509754|left ventricular function|left ventricular function
5238817|NCT02509741|obesity|obesity
5238818|NCT02509741|nutrition|nutrition
5238819|NCT02509741|intervention|intervention
5238820|NCT02509741|food replacement|food replacement
5238821|NCT02509741|IOT|iot
5238822|NCT02509728|choline|choline
5238823|NCT02509728|docosahexaenoic acid|docosahexaenoic acid
5238824|NCT02509715|thyroidectomy|thyroidectomy
5238825|NCT02509715|nerve monitoring|nerve monitoring
5238826|NCT02509702|Mobile health|mobile health
5903695|NCT00340457|Case-Control Study|case-control study
5238827|NCT02509702|Screening|screening
5238828|NCT02509702|Early detection of cancer|early detection of cancer
5238829|NCT02509702|HPV|hpv
5238830|NCT02509702|SMS intervention|sms intervention
5238831|NCT02509702|RCT|rct
5238832|NCT02509702|Tanzania|tanzania
5238833|NCT02509689|mTBI|mtbi
5238834|NCT02509689|cognition disorders|cognition disorders
5238835|NCT02509689|post-concussive syndrome|post-concussive syndrome
5238836|NCT02509689|neuroplasticity|neuroplasticity
5238837|NCT02509689|EEG|eeg
5238838|NCT02509689|biofeedback|biofeedback
5238839|NCT02509689|stress disorder/post-traumatic|stress disorder/post-traumatic
5238840|NCT02509689|depression|depression
5238841|NCT02509676|dynamic stretching training|dynamic stretching training
5238842|NCT02509676|muscle tendon unit|muscle tendon unit
5238843|NCT02509676|ultrasound|ultrasound
5238844|NCT02509650|Exome sequencing|exome sequencing
5238845|NCT02509650|Skin disease|skin disease
5238846|NCT02509650|Familial lipomatosis|familial lipomatosis
5238847|NCT02509637|Respiratory System|respiratory system
5238848|NCT02509637|Physical Therapy Modalities|physical therapy modalities
5238849|NCT02509611|Yoga|yoga
5238850|NCT02509611|Parkinson's disease|parkinson's disease
5238851|NCT02509611|redox status|redox status
5238852|NCT02509611|motor function|motor function
5238853|NCT02509559|Receptors, Adrenergic|receptors, adrenergic
5238854|NCT02509559|Propranolol|propranolol
5238855|NCT02509533|Vacuum Assisted Closure|vacuum assisted closure
5238856|NCT02509520|Nutritional supplementation|nutritional supplementation
5238857|NCT02509520|Neuromuscular Electric Stimulation|neuromuscular electric stimulation
5238858|NCT02509520|ICU acquired weakness|icu acquired weakness
5238859|NCT02509520|Post ICU Syndrome|post icu syndrome
5238860|NCT02509520|sarcopenia|sarcopenia
5238861|NCT02509507|Liver tumours|liver tumours
5238862|NCT02509494|Vaccine|vaccine
5238863|NCT02509494|Ebola|ebola
5238864|NCT02509494|Ebola virus disease|ebola virus disease
5238865|NCT02509494|EVD|evd
5238866|NCT02509494|Hemorrhagic fever|hemorrhagic fever
5238867|NCT02509494|Sierra Leone|sierra leone
5238868|NCT02509494|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
5238869|NCT02509494|Safety|safety
5238870|NCT02509494|Immunogenicity|immunogenicity
5238871|NCT02509494|Modified Vaccinia Virus Ankara ‐ Bavarian Nordic Filo‐vector|modified vaccinia virus ankara ‐ bavarian nordic filo‐vector
5238872|NCT02509494|(MVA‐BN Filo)|(mva‐bn filo)
5238873|NCT02509481|malaria|malaria
5238874|NCT02509481|lymphatic filariasis|lymphatic filariasis
5238875|NCT02509481|mosquito|mosquito
5238876|NCT02509481|ivermectin|ivermectin
5238877|NCT02509481|mass drug administration|mass drug administration
5238878|NCT02509455|Balance control|balance control
5238879|NCT02509455|Body-mounted sensors|body-mounted sensors
5238880|NCT02509455|Balance Measures|balance measures
5238881|NCT02509442|mapping brain functions|mapping brain functions
5238882|NCT02509442|Direct electric stimulation (DES)|direct electric stimulation (des)
5238883|NCT02509442|potential evoked|potential evoked
5238884|NCT02509429|T1DM|t1dm
5238885|NCT02509429|Type 1 Diabetes|type 1 diabetes
5238886|NCT02509429|Artificial Pancreas|artificial pancreas
5238887|NCT02509429|DiAs platform|dias platform
5238888|NCT02509416|endoscopic ultrasound|endoscopic ultrasound
5238889|NCT02509416|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5238890|NCT02509416|competency|competency
5238891|NCT02509403|Perineal hygiene|perineal hygiene
5238892|NCT02509403|Hygiene wipes|hygiene wipes
5238893|NCT02509403|Hygiene Towels|hygiene towels
5238894|NCT02509403|Safety|safety
5238895|NCT02509403|Essential oils|essential oils
5238896|NCT02509403|Natural Health Product|natural health product
5238897|NCT02509390|Fibrinogen level|fibrinogen level
5238898|NCT02509390|Hyperfibrinogenemia|hyperfibrinogenemia
5238900|NCT02509390|Thrombosis risk|thrombosis risk
5238901|NCT02509377|Fetal Surgery|fetal surgery
5238902|NCT02509377|Open Fetal Surgery|open fetal surgery
5238903|NCT02509377|Elevated BMI|elevated bmi
5238904|NCT02509377|Body Mass Index|body mass index
5238905|NCT02509377|Spina Bifida|spina bifida
5238906|NCT02509364|AE-IPF|ae-ipf
5238907|NCT02509312|Analgesia, Obstetrical|analgesia, obstetrical
5238908|NCT02509312|Blood Loss, Surgical|blood loss, surgical
5238909|NCT02509312|Analgesics, Opioid/administration & dosage|analgesics, opioid/administration & dosage
5238910|NCT02509312|Cyclooxygenase Inhibitors/administration & dosage|cyclooxygenase inhibitors/administration & dosage
5238911|NCT02509312|Cesarean Section|cesarean section
5238912|NCT02509312|Female|female
5238913|NCT02509312|Humans|humans
5133335|NCT03159676|Proton|proton
5238914|NCT02509312|Ketorolac/administration & dosage|ketorolac/administration & dosage
5238915|NCT02509312|Hydromorphone/administration & dosage|hydromorphone/administration & dosage
5238916|NCT02509312|Pain, Postoperative/drug therapy|pain, postoperative/drug therapy
5238917|NCT02509312|Pregnancy|pregnancy
5238918|NCT02509312|Morphine/administration & dosage|morphine/administration & dosage
5238919|NCT02509299|COPD|copd
5238920|NCT02509299|NEMS|nems
5238922|NCT02509286|gastro-esophageal junction neoplasms|gastro-esophageal junction neoplasms
5238923|NCT02509286|adenocarcinoma|adenocarcinoma
5238924|NCT02509286|esophagectomy|esophagectomy
5238925|NCT02509286|surgery|surgery
5238926|NCT02509286|radiotherapy|radiotherapy
5238927|NCT02509286|chemotherapy|chemotherapy
5238929|NCT02509247|sleep apnea|sleep apnea
5238930|NCT02509247|CPAP|cpap
5238931|NCT02509247|telemonitoring|telemonitoring
5238932|NCT02509247|telecare|telecare
5238933|NCT02509234|pediatric sarcomas|pediatric sarcomas
5238934|NCT02509234|Ewing sarcoma|ewing sarcoma
5238935|NCT02509234|rhabdomyosarcoma|rhabdomyosarcoma
5238936|NCT02509234|soft tissue sarcoma|soft tissue sarcoma
5238937|NCT02509208|iliac crest bone graft|iliac crest bone graft
5238938|NCT02509208|ICBG|icbg
5238939|NCT02509208|pelvic osteotomy|pelvic osteotomy
5238940|NCT02509208|spinal fusion|spinal fusion
5238941|NCT02509208|hemostasis|hemostasis
5238942|NCT02509208|haemostasis|haemostasis
5238943|NCT02509208|hemostatic|hemostatic
5238944|NCT02509208|haemostatic|haemostatic
5238945|NCT02509208|dextran|dextran
5238946|NCT02509208|SurgiClot|surgiclot
5238947|NCT02509208|cancellous bone bleeding|cancellous bone bleeding
5238948|NCT02509182|Hyperoxia|hyperoxia
5238949|NCT02509182|One-Lung Ventilation|one-lung ventilation
5238950|NCT02509182|Thoracic Surgery|thoracic surgery
5238951|NCT02509182|Anesthesiology|anesthesiology
5238952|NCT02509156|Cardiomyopathy|cardiomyopathy
5238953|NCT02509156|AIC|aic
5238954|NCT02509156|Anthracyclines|anthracyclines
5238955|NCT02509156|Chemotherapy|chemotherapy
5238956|NCT02509156|Allogeneic|allogeneic
5238957|NCT02509156|Mesenchymal stem cells|mesenchymal stem cells
5238958|NCT02509156|MSCs|mscs
5238959|NCT02509156|Cancer survivors|cancer survivors
5238960|NCT02509156|Breast Cancer|breast cancer
5238961|NCT02509156|Leukemia|leukemia
5238962|NCT02509156|Lymphoma|lymphoma
5238963|NCT02509156|Sarcoma|sarcoma
5238964|NCT02509143|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5238965|NCT02509143|Colorectal Neoplasms|colorectal neoplasms
5238966|NCT02509130|Severe Asthma|severe asthma
5238967|NCT02509130|Asthma|asthma
5238968|NCT02509130|Specialised Asthma Care|specialised asthma care
5238969|NCT02509130|Asthma Care|asthma care
5238970|NCT02509117|Alzheimer's disease|alzheimer's disease
5238971|NCT02509104|Bioavailability|bioavailability
5238972|NCT02509104|Dutasteride|dutasteride
5238973|NCT02509104|Healthy Male Subjects|healthy male subjects
5238974|NCT02509104|Fixed Dose Combination|fixed dose combination
5238975|NCT02509078|ARDS|ards
5238976|NCT02509078|neuromuscular blocker|neuromuscular blocker
5238977|NCT02509078|cisatracurium|cisatracurium
5238978|NCT02509065|bionic pancreas|bionic pancreas
5238979|NCT02509065|artificial pancreas|artificial pancreas
5238980|NCT02509065|insulin|insulin
5238981|NCT02509065|glucagon|glucagon
5238982|NCT02509065|continuous glucose monitor (CGM)|continuous glucose monitor (cgm)
5238983|NCT02509065|insulin pump|insulin pump
5238984|NCT02509065|outpatient|outpatient
5238986|NCT02509039|Phase1|phase1
5238987|NCT02509039|solid tumor|solid tumor
5238988|NCT02509039|non-Hodgkin's lymphom|non-hodgkin's lymphom
5238989|NCT02509026|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis
5238990|NCT02509013|chronic kidney disease|chronic kidney disease
5238991|NCT02509013|stable coronary heart disease|stable coronary heart disease
5238992|NCT02509013|prevalence|prevalence
5238993|NCT02508987|Obesity|obesity
5238994|NCT02508987|oxidative stress|oxidative stress
5238995|NCT02508987|antioxidants|antioxidants
5238996|NCT02508987|periodontal disease|periodontal disease
5238997|NCT02508961|Physical Activity|physical activity
5238998|NCT02508961|Exercise|exercise
5238999|NCT02508961|Physiotherapy|physiotherapy
5239000|NCT02508948|airway management|airway management
5239001|NCT02508948|critically ill|critically ill
5239002|NCT02508948|hemodynamic management|hemodynamic management
5239003|NCT02508948|intubation|intubation
5239004|NCT02508948|prospective study|prospective study
5239005|NCT02508948|risk factors|risk factors
5239006|NCT02508909|Videoassisted surgery|videoassisted surgery
5239007|NCT02508883|Cancer|cancer
5239008|NCT02508883|hemorrhage|hemorrhage
5239009|NCT02508883|endoscopy|endoscopy
5239010|NCT02508883|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5239011|NCT02508857|pain, postoperative|pain, postoperative
5226892|NCT02581436|Transplant follow-up|transplant follow-up
5226893|NCT02581436|Chronic index|chronic index
5226894|NCT02581436|Graft Function|graft function
5226895|NCT02581410|Zostavax®|zostavax®
5226896|NCT02581410|≥ 65 years of age|≥ 65 years of age
5226897|NCT02581410|Herpes Zoster|herpes zoster
5239012|NCT02508857|anesthesia adjuvants|anesthesia adjuvants
5239013|NCT02508857|magnesium sulfate|magnesium sulfate
5239014|NCT02508844|Probiotics|probiotics
5239015|NCT02508844|Vivomixx®|vivomixx®
5239016|NCT02508844|Microbiota|microbiota
5239017|NCT02508831|Bilateral amputation|bilateral amputation
5239018|NCT02508831|upper limb|upper limb
5239019|NCT02508831|allograft|allograft
5239020|NCT02508779|Diabetes|diabetes
5239021|NCT02508779|Blood Glucose Management|blood glucose management
5239022|NCT02508779|Preconception|preconception
5239023|NCT02508779|Hypoglycemia|hypoglycemia
5239024|NCT02508779|Women with diabetes|women with diabetes
5239028|NCT02508753|QT/QTc Intervals|qt/qtc intervals
5239030|NCT02508701|Message Design|message design
5239031|NCT02508701|Adolescent Males|adolescent males
5239032|NCT02508688|hepatic hydrothorax|hepatic hydrothorax
5239033|NCT02508688|thoracoscopic surgery|thoracoscopic surgery
5239034|NCT02508688|diaphragmatic defect|diaphragmatic defect
5239035|NCT02508675|injury|injury
5239036|NCT02508675|risk factors|risk factors
5239037|NCT02508675|outcome|outcome
5239038|NCT02508675|costs|costs
5239039|NCT02508662|Advanced Cancers|advanced cancers
5239040|NCT02508662|Solid Tumors|solid tumors
5239041|NCT02508662|Genomic Mutations|genomic mutations
5239042|NCT02508662|FDA Approved Off-Label Chemotherapy|fda approved off-label chemotherapy
5239043|NCT02508662|Refractory|refractory
5239044|NCT02508623|Portal hypertension|portal hypertension
5239045|NCT02508623|liver cirrhosis|liver cirrhosis
5239046|NCT02508623|Rifaximin|rifaximin
5239047|NCT02508597|Smoking cessation intervention|smoking cessation intervention
5239048|NCT02508571|Infant, Premature|infant, premature
5239049|NCT02508571|Intervention Studies|intervention studies
5239050|NCT02508571|Bottle feeding|bottle feeding
5239051|NCT02508532|2L GIST|2l gist
5239052|NCT02508532|GIST second line|gist second line
5239053|NCT02508532|GIST gleevec|gist gleevec
5239054|NCT02508532|GIST imatinib|gist imatinib
5239055|NCT02508532|Second-line GIST clinical trial|second-line gist clinical trial
5239056|NCT02508532|BLU-285|blu-285
5239057|NCT02508532|BLU 285|blu 285
5239058|NCT02508532|BLUE-285|blue-285
5239059|NCT02508532|BLUE 285|blue 285
5239060|NCT02508532|Avapritinib|avapritinib
5239061|NCT02508532|GIST imatinib relapse|gist imatinib relapse
5239062|NCT02508532|GIST gleevec relapse|gist gleevec relapse
5239063|NCT02508532|GIST KIT|gist kit
5239064|NCT02508532|GIST relapse|gist relapse
5239065|NCT02508532|GIST refractory|gist refractory
5239066|NCT02508532|GIST imatinib intolerance|gist imatinib intolerance
5239067|NCT02508532|GIST TKI treatment|gist tki treatment
5239068|NCT02508532|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
5239069|NCT02508532|GIST TKI|gist tki
5239070|NCT02508532|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
5239071|NCT02508532|Advanced GIST|advanced gist
5239072|NCT02508532|GIST mutations|gist mutations
5239073|NCT02508532|GIST treatments|gist treatments
5239074|NCT02508532|Blueprint GIST|blueprint gist
5239075|NCT02508532|Relapsed GIST clinical trial|relapsed gist clinical trial
5239076|NCT02508532|Refractory GIST clinical trial|refractory gist clinical trial
5239077|NCT02508532|KIT-mutant GIST|kit-mutant gist
5239078|NCT02508532|cancer gist|cancer gist
5239079|NCT02508532|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5239080|NCT02508532|gist cancer|gist cancer
5239081|NCT02508532|PDGFRA|pdgfra
5239082|NCT02508506|ALKS 5461|alks 5461
5239083|NCT02508506|Alkermes|alkermes
5239084|NCT02508506|Samidorphan|samidorphan
5239085|NCT02508506|Renal Impairment|renal impairment
5239086|NCT02508506|Pharmacokinetics|pharmacokinetics
5239087|NCT02508506|Buprenorphine|buprenorphine
5239088|NCT02508480|Stigma|stigma
5239089|NCT02508480|Community Integration|community integration
5239090|NCT02508467|Liver cancer|liver cancer
5239091|NCT02508467|FGF19 gene amplification|fgf19 gene amplification
5239092|NCT02508467|FGF19 overexpression|fgf19 overexpression
5239093|NCT02508467|FGF19 upregulation|fgf19 upregulation
5239094|NCT02508467|Cyclin D1 (CCND1) gene amplification|cyclin d1 (ccnd1) gene amplification
5239095|NCT02508467|Cyclin D1 (CCND1) copy number gain|cyclin d1 (ccnd1) copy number gain
5239096|NCT02508467|BLU-554|blu-554
5239097|NCT02508467|FGFR4|fgfr4
5239098|NCT02508467|Hepatocellular carcinoma|hepatocellular carcinoma
5239099|NCT02508467|Liver Disease|liver disease
5239100|NCT02508467|Liver Neoplasms|liver neoplasms
5239104|NCT02508441|Neoplasms|neoplasms
5239105|NCT02508441|Solid Tumors|solid tumors
5239106|NCT02508441|Advanced Malignancy|advanced malignancy
5226992|NCT02580994|Extended Disease Small Cell Lung Cancer|extended disease small cell lung cancer
5226993|NCT02580994|phase II|phase ii
5226994|NCT02580994|randomized|randomized
5226995|NCT02580994|pembrolizumab|pembrolizumab
5226996|NCT02580994|cross-over|cross-over
5226997|NCT02580994|etoposide|etoposide
5226998|NCT02580994|cisplatin|cisplatin
5226999|NCT02580994|carboplatin|carboplatin
5227000|NCT02580994|rechallenge|rechallenge
5227001|NCT02580981|Cancer|cancer
5227004|NCT02580981|ALL|all
5239107|NCT02508441|Cancer|cancer
5239108|NCT02508428|Osteolysis|osteolysis
5239109|NCT02508428|Polyethylene|polyethylene
5239110|NCT02508428|Crosslinked Polyethylene|crosslinked polyethylene
5239111|NCT02508428|Total Hip Replacement|total hip replacement
5239112|NCT02508428|Marathon|marathon
5239113|NCT02508415|obesity|obesity
5239114|NCT02508415|periodontal disease|periodontal disease
5239115|NCT02508415|intervention|intervention
5239116|NCT02508389|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5239117|NCT02508389|oral cavity|oral cavity
5239118|NCT02508389|oropharynx|oropharynx
5239119|NCT02508389|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5239120|NCT02508389|chemotherapy|chemotherapy
5239121|NCT02508389|oral mucositis|oral mucositis
5239122|NCT02508389|superoxide dismutase|superoxide dismutase
5239123|NCT02508389|radioprotection|radioprotection
5239124|NCT02508376|adjuvants|adjuvants
5239125|NCT02508376|AP10-602|ap10-602
5239126|NCT02508376|GLA-SE|gla-se
5239127|NCT02508376|ID93|id93
5239128|NCT02508376|Tuberculosis|tuberculosis
5239129|NCT02508376|vaccine|vaccine
5239130|NCT02508363|Taxi drivers|taxi drivers
5244545|NCT02476955|AKT1|akt1
5239131|NCT02508363|Health care access|health care access
5239132|NCT02508363|15-163|15-163
5239133|NCT02508311|Tetraplegia|tetraplegia
5239134|NCT02508311|High Paraplegia|high paraplegia
5239135|NCT02508298|ICG|icg
5239136|NCT02508298|ARFI|arfi
5239137|NCT02508298|portal hypertension|portal hypertension
5239138|NCT02508298|cirrhosis|cirrhosis
5239139|NCT02508298|diagnostic study|diagnostic study
5239140|NCT02508272|Transcriptome profiling|transcriptome profiling
5239141|NCT02508259|mitochondria|mitochondria
5239142|NCT02508259|purinergic signaling|purinergic signaling
5239143|NCT02508259|cell danger response|cell danger response
5239144|NCT02508194|RSV|rsv
5239145|NCT02508194|Older adults|older adults
5239146|NCT02508194|MEDI7510|medi7510
5239147|NCT02508194|Vaccine|vaccine
5239148|NCT02508194|Efficacy|efficacy
5239149|NCT02508181|intra ocular pressure|intra ocular pressure
5239151|NCT02508181|LMA Supreme|lma supreme
5239152|NCT02508181|strabismus surgery|strabismus surgery
5239153|NCT02508168|Drug therapy|drug therapy
5239154|NCT02508129|Insomnia|insomnia
5239155|NCT02508129|hypertension|hypertension
5239156|NCT02508129|blood pressure|blood pressure
5239157|NCT02508129|sleep|sleep
5239158|NCT02508129|behavioral treatment|behavioral treatment
5239159|NCT02508129|Cognitive Behavioral Treatment of Insomnia (CBTI)|cognitive behavioral treatment of insomnia (cbti)
5239160|NCT02508129|Brief Behavioral Treatment of Insomnia (BBTI)|brief behavioral treatment of insomnia (bbti)
5239161|NCT02508129|pragmatic trial|pragmatic trial
5239162|NCT02508129|internet|internet
5239163|NCT02508116|pharmacogenetics|pharmacogenetics
5239164|NCT02508116|clopidogrel|clopidogrel
5239165|NCT02508116|genotype|genotype
5239166|NCT02508103|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5239167|NCT02508103|Premenstrual Syndrome|premenstrual syndrome
5239168|NCT02508103|PMS|pms
5239169|NCT02508103|PMDD|pmdd
5239170|NCT02508038|alpha beta depleted|alpha beta depleted
5239171|NCT02508038|alphabeta|alphabeta
5239172|NCT02508038|TCR alpha beta depleted|tcr alpha beta depleted
5239173|NCT02508038|alpha beta|alpha beta
5239174|NCT02508038|haploidentical|haploidentical
5239175|NCT02508038|Zoledronate|zoledronate
5239176|NCT02508038|Zoledronic acid|zoledronic acid
5239177|NCT02508038|Pediatric cancers|pediatric cancers
5239178|NCT02508038|alfa beta|alfa beta
5239179|NCT02508038|αβ T cell depleted HSCT|αβ t cell depleted hsct
5239180|NCT02508038|alpha beta T cell and B cell depleted HSCT|alpha beta t cell and b cell depleted hsct
5239181|NCT02508038|haploidentical HSCT|haploidentical hsct
5239182|NCT02508025|disability evaluation|disability evaluation
5239183|NCT02508025|psychosocial factors|psychosocial factors
5239184|NCT02508012|anti-TNF|anti-tnf
5239185|NCT02508012|Immuno-monitoring|immuno-monitoring
5239186|NCT02508012|Anti-drug antibody (ADAb)|anti-drug antibody (adab)
5239187|NCT02508012|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5239188|NCT02508012|Crohn's disease|crohn's disease
5239189|NCT02508012|Ulcerative colitis|ulcerative colitis
5239190|NCT02507973|Mechanical Ventilation|mechanical ventilation
5239191|NCT02507973|Intracranial Pressure|intracranial pressure
5239192|NCT02507973|Airway Pressure Release Ventilation|airway pressure release ventilation
5239193|NCT02507934|Dry Eye|dry eye
5239194|NCT02507908|neuroendocrine tumors|neuroendocrine tumors
5239195|NCT02507908|5-hydroxyindolacetic acid|5-hydroxyindolacetic acid
5239196|NCT02507908|serotonin|serotonin
5239197|NCT02507908|isotope-dilution massa-spectrometer|isotope-dilution massa-spectrometer
5239198|NCT02507895|Stroke|stroke
5239199|NCT02507895|lower extremeties|lower extremeties
5239200|NCT02507895|Brain-computer interface|brain-computer interface
5239201|NCT02507895|Motor imagery|motor imagery
5239202|NCT02507895|Rehabilitation|rehabilitation
5239203|NCT02507895|TMS|tms
5239204|NCT02507843|Vitamin D|vitamin d
5239205|NCT02507817|LIF,Magnesium Sulphate|lif,magnesium sulphate
5239206|NCT02507791|Fitbit|fitbit
5239207|NCT02507791|Obesity|obesity
5239208|NCT02507791|Pediatrics|pediatrics
5239209|NCT02507778|Lung|lung
5239210|NCT02507778|Cancer|cancer
5239211|NCT02507778|Biomarkers|biomarkers
5239212|NCT02507778|Early detection|early detection
5239213|NCT02507778|Circulating tumor cell|circulating tumor cell
5239214|NCT02507765|SBRT|sbrt
5239215|NCT02507713|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5239216|NCT02507713|Ultrasonography|ultrasonography
5239217|NCT02507713|Motor neurons|motor neurons
5239218|NCT02507713|Neuromuscular diseases|neuromuscular diseases
5239219|NCT02507713|Fasciculation|fasciculation
5239220|NCT02507700|nerve block|nerve block
5239221|NCT02507674|appendicitis|appendicitis
5239222|NCT02507674|pediatric|pediatric
5239223|NCT02507674|ultrasound|ultrasound
5239224|NCT02507635|cytokines|cytokines
5240111|NCT02502617|Cognition|cognition
5903696|NCT00340457|Renal Cell Carcinoma|renal cell carcinoma
5239229|NCT02507583|Newly Diagnosed|newly diagnosed
5239230|NCT02507557|Therapy, Fluid|therapy, fluid
5239231|NCT02507557|Digestive System Surgical Procedures|digestive system surgical procedures
5239232|NCT02507557|Postoperative Complications|postoperative complications
5239238|NCT02507518|lung cancer, PET, progression free survival|lung cancer, pet, progression free survival
5239243|NCT02507414|Mesenteric Traction Syndrome|mesenteric traction syndrome
5239244|NCT02507414|Upper gastrointestinal cancer surgery|upper gastrointestinal cancer surgery
5239245|NCT02507388|AMD|amd
5239246|NCT02507388|nAMD|namd
5239247|NCT02507388|wetAMD|wetamd
5239248|NCT02507388|Age-Related Macular Degeneration|age-related macular degeneration
5239249|NCT02507375|Non-Squamous|non-squamous
5239250|NCT02507362|keratoconus , corneal collagen cross-linking|keratoconus , corneal collagen cross-linking
5239251|NCT02507349|serious mental illness|serious mental illness
5239252|NCT02507349|mental health services research|mental health services research
5239253|NCT02507349|measurement-based care|measurement-based care
5239254|NCT02507349|shared decision making|shared decision making
5239255|NCT02507349|psychiatric medication management|psychiatric medication management
5239256|NCT02507349|community psychiatry|community psychiatry
5239257|NCT02507349|comparative effectiveness research|comparative effectiveness research
5239258|NCT02507349|mixed methods research|mixed methods research
5239259|NCT02507336|Mantle Cell Lymphoma (MCL)|mantle cell lymphoma (mcl)
5239260|NCT02507336|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5239261|NCT02507258|osteoarthritis|osteoarthritis
5239262|NCT02507258|avascular necrosis|avascular necrosis
5239263|NCT02507258|correction of functional deformity|correction of functional deformity
5239264|NCT02507258|painful hip dysplasia|painful hip dysplasia
5239265|NCT02507258|protrusio acetabuli|protrusio acetabuli
5239266|NCT02507258|rheumatoid arthritis|rheumatoid arthritis
5239267|NCT02507258|ankylosis|ankylosis
5239268|NCT02507245|GHD|ghd
5239269|NCT02507232|glioma|glioma
5239270|NCT02507232|temozolomide|temozolomide
5239271|NCT02507232|brain|brain
5239272|NCT02507232|NovoTTF-200A|novottf-200a
5239273|NCT02507232|cancer|cancer
5239274|NCT02507232|low-grade glioma|low-grade glioma
5239275|NCT02507206|schizotypal personality disorder|schizotypal personality disorder
5239276|NCT02507206|cognitive impairment|cognitive impairment
5239277|NCT02507206|working memory|working memory
5239278|NCT02507206|Dopamine Agonists|dopamine agonists
5239279|NCT02507206|Cognition Disorders|cognition disorders
5239280|NCT02507206|Personality Disorders|personality disorders
5239281|NCT02507206|Delirium|delirium
5239282|NCT02507206|Dementia|dementia
5239283|NCT02507206|Amnestic|amnestic
5239284|NCT02507206|Cognitive Disorders|cognitive disorders
5239285|NCT02507206|Mental Disorders|mental disorders
5239286|NCT02507206|Dihydrexidine|dihydrexidine
5239287|NCT02507206|Dopamine A|dopamine a
5239293|NCT02507154|cetuximab|cetuximab
5239294|NCT02507154|NK cells|nk cells
5239295|NCT02507154|nasopharyngeal cancer|nasopharyngeal cancer
5239296|NCT02507154|head and neck squamous cell cancer|head and neck squamous cell cancer
5239297|NCT02507141|Reflectance Confocal Microscopy|reflectance confocal microscopy
5239298|NCT02507141|15-128|15-128
5239299|NCT02507050|Ivabradine|ivabradine
5239300|NCT02507050|Microvascular dysfunction|microvascular dysfunction
5239301|NCT02507050|PCI|pci
5239302|NCT02507050|Procedural related myocardial injury|procedural related myocardial injury
5239303|NCT02507050|IMR|imr
5239304|NCT02507050|Index of Microvascular Resistance|index of microvascular resistance
5239305|NCT02506998|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5239306|NCT02506998|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
5239307|NCT02506985|Rivaroxaban|rivaroxaban
5239308|NCT02506985|CDT (Catheter directed thrombolysis)|cdt (catheter directed thrombolysis)
5239309|NCT02506985|PE (pulmonary embolism)|pe (pulmonary embolism)
5239310|NCT02506985|NETs|nets
5239311|NCT02506985|factor Xa|factor xa
5239312|NCT02506972|Blood glucose|blood glucose
5239313|NCT02506972|Humans|humans
5239314|NCT02506972|Postprandial|postprandial
5239315|NCT02506972|Sugar|sugar
5239316|NCT02506972|Carbohydrate|carbohydrate
5903697|NCT00340457|Kidney Cancer|kidney cancer
5903698|NCT00340457|Diet|diet
5239317|NCT02506972|Oat beta-glucan|oat beta-glucan
5239318|NCT02506946|Polycystic Ovary Syndrome|polycystic ovary syndrome
5239515|NCT02505659|Knee functional performance|knee functional performance
5239319|NCT02506946|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5239320|NCT02506946|Adolescents|adolescents
5239321|NCT02506946|Young Women|young women
5239322|NCT02506946|MRI|mri
5239323|NCT02506946|MRS|mrs
5239324|NCT02506946|DXA|dxa
5239325|NCT02506946|Hirsutism|hirsutism
5239326|NCT02506946|Amenorrhea|amenorrhea
5239327|NCT02506946|Metabolic syndrome|metabolic syndrome
5239328|NCT02506946|Dyslipidemia|dyslipidemia
5239329|NCT02506946|Percentage liver fat|percentage liver fat
5239330|NCT02506920|Postprandial lipemia|postprandial lipemia
5239331|NCT02506920|glycemic response|glycemic response
5239332|NCT02506881|darbepoetin alfa|darbepoetin alfa
5239333|NCT02506881|pharmacokinetics|pharmacokinetics
5239334|NCT02506881|pharmacodynamics|pharmacodynamics
5239335|NCT02506881|healthy volunteers|healthy volunteers
5239336|NCT02506868|darbepoetin alfa|darbepoetin alfa
5239337|NCT02506842|Pancreatic Cancer|pancreatic cancer
5239338|NCT02506842|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5239339|NCT02506842|AG|ag
5239340|NCT02506842|OFF|off
5239341|NCT02506842|Second-Line Adjuvant Therapy|second-line adjuvant therapy
5239342|NCT02506829|Inpatients|inpatients
5239343|NCT02506790|Melatonin, metformin, toremifene|melatonin, metformin, toremifene
5239344|NCT02506777|Melatonin, metformin, chemotherapy|melatonin, metformin, chemotherapy
5239345|NCT02506738|telemonitoring|telemonitoring
5239346|NCT02506738|mHealth|mhealth
5239347|NCT02506738|functional status|functional status
5239348|NCT02506738|older people|older people
5239349|NCT02506725|prenatal care|prenatal care
5239350|NCT02506725|pregnancy|pregnancy
5239351|NCT02506725|prematurity|prematurity
5239352|NCT02506673|Audiovisual Aids|audiovisual aids
5239353|NCT02506673|Perioperative Period|perioperative period
5239354|NCT02506673|Anxiety|anxiety
5239355|NCT02506634|symptom|symptom
5239356|NCT02506608|Neuroplasticty, Sensory Feedback|neuroplasticty, sensory feedback
5239357|NCT02506556|Pi3K pathway|pi3k pathway
5239358|NCT02506543|Adolescent Health|adolescent health
5239359|NCT02506543|Ethiopia|ethiopia
5239360|NCT02506543|Sexual Violence|sexual violence
5239361|NCT02506530|lymphedema|lymphedema
5239362|NCT02506530|breast cancer|breast cancer
5239363|NCT02506517|HER pathway aberrations|her pathway aberrations
5239364|NCT02506439|Vitamin D|vitamin d
5239365|NCT02506439|Cholecalciferol|cholecalciferol
5239366|NCT02506439|Dose-response|dose-response
5239367|NCT02506439|Randomized Controlled Trial|randomized controlled trial
5239368|NCT02506439|Pregnancy|pregnancy
5239369|NCT02506439|Cord blood|cord blood
5239370|NCT02506439|Serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
5239371|NCT02506439|Vitamin D Deficiency|vitamin d deficiency
5239372|NCT02506439|Nutrition|nutrition
5239373|NCT02506439|Dietary intervention study|dietary intervention study
5239374|NCT02506426|Chronic Sinusitis|chronic sinusitis
5239375|NCT02506426|Chronic Rhinosinusitis|chronic rhinosinusitis
5239376|NCT02506426|Endoscopic sinus surgery|endoscopic sinus surgery
5239377|NCT02506426|Septoplasty|septoplasty
5239378|NCT02506413|Maternal and Newborn Health|maternal and newborn health
5239380|NCT02506361|anthracyclines|anthracyclines
5239381|NCT02506361|taxanes|taxanes
5239382|NCT02506361|non dose-dense chemotherapy|non dose-dense chemotherapy
5239383|NCT02506335|Liver disease|liver disease
5239384|NCT02506335|cardiomyopathy|cardiomyopathy
5239385|NCT02506335|congenital heart disease|congenital heart disease
5239386|NCT02506322|Bipolar I Disorder|bipolar i disorder
5239387|NCT02506322|Bipolar II Disorder|bipolar ii disorder
5239388|NCT02506322|Relapse Prevention|relapse prevention
5239389|NCT02506296|type 2 diabetes|type 2 diabetes
5239390|NCT02506296|endogenous insulin secretion|endogenous insulin secretion
5239391|NCT02506283|cryotherapy|cryotherapy
5239392|NCT02506283|recovery|recovery
5239393|NCT02506283|athletic performance|athletic performance
5239394|NCT02506283|maximum voluntary contraction|maximum voluntary contraction
5227290|NCT02579408|NAFLD|nafld
5227291|NCT02579408|LDLT|ldlt
5227292|NCT02579408|steatosis|steatosis
5227294|NCT02579408|transient elastography|transient elastography
5239395|NCT02506283|rated perceived exertion|rated perceived exertion
5239396|NCT02506283|delayed onset muscle soreness|delayed onset muscle soreness
5239397|NCT02506283|jump performance|jump performance
5239398|NCT02506244|Atrial Fibrillation|atrial fibrillation
5239399|NCT02506244|Wearable device|wearable device
5239401|NCT02506244|ECG Patch|ecg patch
5239402|NCT02506244|Strokes|strokes
5239403|NCT02506244|Asymptomatic|asymptomatic
5239404|NCT02506244|Heart Rhythm|heart rhythm
5239405|NCT02506244|Home Monitoring|home monitoring
5133883|NCT03156998|Compliance|compliance
5239406|NCT02506231|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5239407|NCT02506231|GVHD prophylaxis|gvhd prophylaxis
5239408|NCT02506231|Methotrexate|methotrexate
5239409|NCT02506231|Folinic acid|folinic acid
5239410|NCT02506231|Leucovorin|leucovorin
5239411|NCT02506231|Mucositis|mucositis
5239412|NCT02506192|Gulf War Illness|gulf war illness
5239413|NCT02506192|Chronic Inflammation|chronic inflammation
5903699|NCT00340457|Occupation|occupation
5239414|NCT02506192|Delayed-Release Prednisone|delayed-release prednisone
5239415|NCT02506192|Health-Related Quality of Life|health-related quality of life
5239416|NCT02506179|Real-life effect|real-life effect
5239417|NCT02506179|Adalimumab|adalimumab
5239418|NCT02506179|Patient reported outcomes (PRO)|patient reported outcomes (pro)
5239419|NCT02506179|Moderate to severe ulcerative colitis (UC)|moderate to severe ulcerative colitis (uc)
5239420|NCT02506179|Ulcerative colitis (UC)|ulcerative colitis (uc)
5239421|NCT02506166|sleep apnea|sleep apnea
5239422|NCT02506166|sleep disordered breathing|sleep disordered breathing
5239423|NCT02506166|sudden cardiac death|sudden cardiac death
5239424|NCT02506166|heart failure|heart failure
5239425|NCT02506166|ischemic cardiomyopathy|ischemic cardiomyopathy
5239426|NCT02506166|implantable cardioverter-defibrillator (ICD) therapy|implantable cardioverter-defibrillator (icd) therapy
5239427|NCT02506166|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5239429|NCT02506166|positive airway pressure therapy|positive airway pressure therapy
5239430|NCT02506166|SERVE-HF|serve-hf
5239431|NCT02506140|minor stroke|minor stroke
5239432|NCT02506140|transient ischemic attack|transient ischemic attack
5239433|NCT02506140|ticagrelor|ticagrelor
5239434|NCT02506140|clopidogrel|clopidogrel
5239435|NCT02506140|dual anti-platelet therapy|dual anti-platelet therapy
5239436|NCT02506140|platelet reactivity|platelet reactivity
5239437|NCT02506127|TBS, MDD, Sham-controlled, neuromodulation, TMS|tbs, mdd, sham-controlled, neuromodulation, tms
5239438|NCT02506114|prostate|prostate
5239439|NCT02506062|ischemic preconditioning|ischemic preconditioning
5239440|NCT02506062|Raynaud's Phenomenon|raynaud's phenomenon
5239441|NCT02506062|(RP)|(rp)
5239442|NCT02506036|Treatment|treatment
5239443|NCT02506036|Social-Cognitive Training|social-cognitive training
5239444|NCT02506036|Web-based|web-based
5239445|NCT02506036|Right Hemisphere Stroke|right hemisphere stroke
5239446|NCT02506036|Frontotemporal Dementia|frontotemporal dementia
5962785|NCT04278664|Type 1 diabetes in pregnancy|type 1 diabetes in pregnancy
5119317|NCT03249935|Facilities|facilities
5239447|NCT02506036|Right Sided Cerebral Hemisphere Cerebrovascular Accident|right sided cerebral hemisphere cerebrovascular accident
5239448|NCT02506023|Factor VIII antigen|factor viii antigen
5239449|NCT02506023|von Willebrand factor (vWF) antigen|von willebrand factor (vwf) antigen
5239450|NCT02506023|Mutation type|mutation type
5239451|NCT02506010|Hypoxia|hypoxia
5239452|NCT02505984|oxytocin, bonding|oxytocin, bonding
5239453|NCT02505984|child development|child development
5239454|NCT02505971|hemangioma, propranolol, nadolol|hemangioma, propranolol, nadolol
5239455|NCT02505958|insulin resistance, obesity, caloric intake|insulin resistance, obesity, caloric intake
5239456|NCT02505945|Esophageal Reflux|esophageal reflux
5239457|NCT02505945|Gastric Acid Reflux Disease|gastric acid reflux disease
5239458|NCT02505945|Heartburn|heartburn
5239459|NCT02505932|Shoulder instability|shoulder instability
5239460|NCT02505919|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5239461|NCT02505906|Late toxicity|late toxicity
5239462|NCT02505906|Simultaneous integrated boost (SIB)|simultaneous integrated boost (sib)
5239463|NCT02505906|Radiotherapy|radiotherapy
5239464|NCT02505880|Hypnosis|hypnosis
5239465|NCT02505880|Pediatric surgery|pediatric surgery
5239466|NCT02505880|Anesthesia|anesthesia
5239467|NCT02505854|Obesity|obesity
5239468|NCT02505854|Probiotic|probiotic
5239469|NCT02505854|Symbiotic|symbiotic
5239470|NCT02505854|Weight loss|weight loss
5239471|NCT02505854|Gut microbiota|gut microbiota
5239472|NCT02505854|Bifidobacterium lactis|bifidobacterium lactis
5239473|NCT02505854|Fructooligosaccharide|fructooligosaccharide
5239474|NCT02505854|Blood sugar|blood sugar
5239475|NCT02505854|Lipemia|lipemia
5239476|NCT02505854|Metabolome|metabolome
5239477|NCT02505841|Appendectomy|appendectomy
5239478|NCT02505841|Laparoscopy|laparoscopy
5239479|NCT02505841|pediatric surgery|pediatric surgery
5239480|NCT02505828|Arthritis|arthritis
5239481|NCT02505828|septic|septic
5239482|NCT02505828|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5239483|NCT02505828|diagnosis|diagnosis
5239484|NCT02505828|proteomic|proteomic
5239485|NCT02505828|cytokine|cytokine
5239486|NCT02505828|monocytes|monocytes
5239487|NCT02505802|Stroke|stroke
5239488|NCT02505802|Botulinum Toxins|botulinum toxins
5239489|NCT02505802|Muscle Spasticity|muscle spasticity
5239490|NCT02505802|Gait|gait
5239491|NCT02505789|Epstein-Barr Virus|epstein-barr virus
5239492|NCT02505789|Post-transplant lymphoproliferative disease (PTLD)|post-transplant lymphoproliferative disease (ptld)
5239493|NCT02505789|Infection|infection
5239494|NCT02505789|Cell Transplants|cell transplants
5239495|NCT02505789|Herpesvirus 4, Human|herpesvirus 4, human
5239497|NCT02505711|Food|food
5239498|NCT02505711|Micronutrients|micronutrients
5239499|NCT02505711|Pregnancy|pregnancy
5239500|NCT02505711|Infants|infants
5239501|NCT02505711|Women's groups|women's groups
5239502|NCT02505711|Bangladesh|bangladesh
5239503|NCT02505698|Breast Imaging|breast imaging
5239504|NCT02505698|Mammography|mammography
5239505|NCT02505698|Anatomical Imaging|anatomical imaging
5239506|NCT02505685|Lung|lung
5239507|NCT02505685|Cancer|cancer
5239508|NCT02505685|Biomarkers|biomarkers
5239509|NCT02505685|PET-CT|pet-ct
5239510|NCT02505685|Early detection|early detection
5239511|NCT02505672|Vestibular function|vestibular function
5239512|NCT02505672|chemoradiotherapy|chemoradiotherapy
5239513|NCT02505659|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
5239514|NCT02505659|Preoperative re-education|preoperative re-education
5239815|NCT02504164|midazolam|midazolam
5239516|NCT02505659|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
5239517|NCT02505659|Single-leg hop for distance test performance|single-leg hop for distance test performance
5239518|NCT02505646|circulatory failure|circulatory failure
5239519|NCT02505646|fluid responsiveness|fluid responsiveness
5239520|NCT02505646|abdominal compression|abdominal compression
5239521|NCT02505633|brachial plexus block|brachial plexus block
5239522|NCT02505633|nerve stimulator|nerve stimulator
5239523|NCT02505633|ultrasound|ultrasound
5239524|NCT02505620|Neurocognitive function|neurocognitive function
5239525|NCT02505620|OSAS|osas
5239526|NCT02505594|Obstructive Sleep Apnea|obstructive sleep apnea
5239527|NCT02505594|Vasoreactivity|vasoreactivity
5239528|NCT02505594|Endothelial function|endothelial function
5239529|NCT02505594|Exercise|exercise
5239530|NCT02505581|Postoperative Wound Infection|postoperative wound infection
5239531|NCT02505581|Surgical Wound Infection|surgical wound infection
5239532|NCT02505581|Colorectal Surgery Infection Prophylaxis|colorectal surgery infection prophylaxis
5239533|NCT02505568|Behcet Disease|behcet disease
5239534|NCT02505568|Infliximab|infliximab
5239535|NCT02505568|Adult participants|adult participants
5239536|NCT02505555|feasibility|feasibility
5239537|NCT02505555|accuracy|accuracy
5239538|NCT02505555|tolerability|tolerability
5239539|NCT02505555|four dimensional hysterosalpingo-contrast sonography|four dimensional hysterosalpingo-contrast sonography
5239540|NCT02505542|Axial Spondyloarthritis|axial spondyloarthritis
5239541|NCT02505542|axSpA|axspa
5962786|NCT04278612|Quality improvement|quality improvement
5962787|NCT04278612|Integrated care|integrated care
5239542|NCT02505542|Ankylosing Spondylitis|ankylosing spondylitis
5239543|NCT02505542|Anti TNF-alpha|anti tnf-alpha
5239544|NCT02505542|Certolizumab Pegol|certolizumab pegol
5239545|NCT02505542|Remission|remission
5239546|NCT02505542|Spondylarthropathies|spondylarthropathies
5239547|NCT02505542|Arthritis|arthritis
5239548|NCT02505542|Spinal Diseases|spinal diseases
5239549|NCT02505542|Immunosuppressive Agents|immunosuppressive agents
5239550|NCT02505529|Aging|aging
5239551|NCT02505529|Muscle|muscle
5239552|NCT02505529|Weakness|weakness
5239553|NCT02505529|Sarcopenia|sarcopenia
5239554|NCT02505529|Dynapenia|dynapenia
5239555|NCT02505516|pathology|pathology
5239556|NCT02505503|Claudication|claudication
5239557|NCT02505503|Footwear|footwear
5239558|NCT02505503|Shoes|shoes
5239559|NCT02505503|Walking capacity|walking capacity
5239560|NCT02505503|Walking distance|walking distance
5239561|NCT02505490|Lunch|lunch
5239562|NCT02505490|Television|television
5239563|NCT02505490|Macaroni and Cheese|macaroni and cheese
5239564|NCT02505490|Salad tossed in dressing|salad tossed in dressing
5239565|NCT02505477|schiozphrenia|schiozphrenia
5239566|NCT02505477|cognition|cognition
5239567|NCT02505477|negative symptoms|negative symptoms
5239568|NCT02505477|glutamate|glutamate
5239569|NCT02505477|glutathione|glutathione
5239570|NCT02505477|N-acetylcysteine|n-acetylcysteine
5239571|NCT02505451|Metabolic syndrome|metabolic syndrome
5239572|NCT02505451|diabetes|diabetes
5239573|NCT02505451|myocardial function|myocardial function
5239574|NCT02505451|dobutamine|dobutamine
5239575|NCT02505399|Rotational Atherectomy|rotational atherectomy
5239576|NCT02505399|clopidogrel|clopidogrel
5239577|NCT02505399|thrombosis|thrombosis
5239578|NCT02505399|ticagrelor|ticagrelor
5239579|NCT02505386|Ertapenem|ertapenem
5227494|NCT02578355|Coronary Artery Disease|coronary artery disease
5227495|NCT02578355|Cardiovascular Disease|cardiovascular disease
5227894|NCT02576301|AML|aml
5239580|NCT02505386|Subcutaneously|subcutaneously
5239581|NCT02505386|Aged|aged
5239582|NCT02505386|Elderly|elderly
5239583|NCT02505386|Pharmacokinetics|pharmacokinetics
5239584|NCT02505373|Brief Therapy|brief therapy
5239585|NCT02505373|Attempted Suicide|attempted suicide
5239586|NCT02505373|Therapeutic Alliance|therapeutic alliance
5239587|NCT02505373|Suicidal Ideation|suicidal ideation
5239588|NCT02505373|Suicide|suicide
5239589|NCT02505373|ASSIP|assip
5239590|NCT02505321|insulin resistance|insulin resistance
5239591|NCT02505321|physiology|physiology
5239592|NCT02505321|genetics|genetics
5237036|NCT02520817|Zinc|zinc
5239593|NCT02505321|gene variants|gene variants
5239594|NCT02505321|pathogenesis|pathogenesis
5239595|NCT02505321|type 2 diabetes|type 2 diabetes
5239597|NCT02505321|polygenic lipodystrophy|polygenic lipodystrophy
5239598|NCT02505308|insulin|insulin
5239599|NCT02505308|proinsulin|proinsulin
5239600|NCT02505308|genotype|genotype
5239601|NCT02505308|beta cells|beta cells
5239602|NCT02505308|physiology|physiology
5239603|NCT02505308|genetics|genetics
5239604|NCT02505308|pathogenesis|pathogenesis
5239605|NCT02505308|rare variants|rare variants
5239606|NCT02505308|type 2 diabetes|type 2 diabetes
5239607|NCT02505282|Orthostatic hypotension|orthostatic hypotension
5239608|NCT02505282|Vitamin K|vitamin k
5239609|NCT02505269|limited stage|limited stage
5239610|NCT02505269|Hodgkin's disease|hodgkin's disease
5239611|NCT02505269|non-bulky|non-bulky
5239616|NCT02505217|platelet reactivity, thrombin generation|platelet reactivity, thrombin generation
5239618|NCT02505204|paravertebral block|paravertebral block
5239619|NCT02505204|hemodynamic stability|hemodynamic stability
5239620|NCT02505191|Pharmacokinetics|pharmacokinetics
5239621|NCT02505178|Depression|depression
5239622|NCT02505178|Depressive Disorder|depressive disorder
5239623|NCT02505178|Depressive Disorder, Major|depressive disorder, major
5239624|NCT02505178|Mental Disorders|mental disorders
5239625|NCT02505178|Mood Disorders|mood disorders
5239626|NCT02505178|Behavioural Symptoms|behavioural symptoms
5239627|NCT02505178|Problem Solving Therapy|problem solving therapy
5239628|NCT02505165|Intervention|intervention
5239629|NCT02505165|Illness Uncertainty|illness uncertainty
5239630|NCT02505165|Childhood Cancer|childhood cancer
5239631|NCT02505165|Solid Tumor|solid tumor
5239632|NCT02505165|Leukemia|leukemia
5239633|NCT02505165|Lymphoma|lymphoma
5239636|NCT02505165|Parental uncertainty management intervention|parental uncertainty management intervention
5239638|NCT02505165|Oncology|oncology
5239639|NCT02505165|Pediatric|pediatric
5239640|NCT02505152|Hypertension, Portal|hypertension, portal
5239641|NCT02505152|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
5239642|NCT02505152|Portosystemic shunt|portosystemic shunt
5239643|NCT02505152|Radiology, Interventional|radiology, interventional
5239644|NCT02505139|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5239645|NCT02505139|distant metastasis|distant metastasis
5239646|NCT02505139|circulating tumor cells|circulating tumor cells
5239647|NCT02505139|outcome prediction|outcome prediction
5239648|NCT02505113|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
5239649|NCT02505113|Hypertension, Portal|hypertension, portal
5239650|NCT02505100|threat of premature birth|threat of premature birth
5239651|NCT02505087|Selenoprotein N-related myopathy|selenoprotein n-related myopathy
5239652|NCT02505087|biomarkers|biomarkers
5239653|NCT02505087|washout|washout
5239654|NCT02505087|N-ACETYLCYSTEINE|n-acetylcysteine
5239655|NCT02505074|mitral valve|mitral valve
5239656|NCT02505074|tricuspid valve|tricuspid valve
5239657|NCT02505074|Melody valve|melody valve
5239658|NCT02505035|Palliative care|palliative care
5239659|NCT02505035|Pragmatic trial|pragmatic trial
5239660|NCT02505022|Cognition|cognition
5239661|NCT02505022|Early mental illness|early mental illness
5239662|NCT02505022|Role functioning|role functioning
5239663|NCT02505009|Therapeutic Uses|therapeutic uses
5239664|NCT02505009|Entecavir|entecavir
5239665|NCT02505009|Tenofovir|tenofovir
5239666|NCT02505009|Engerix-B|engerix-b
5239667|NCT02505009|DNA Virus Infections|dna virus infections
5239668|NCT02505009|Antiviral Agents|antiviral agents
5239669|NCT02505009|Vaccination|vaccination
5239670|NCT02504996|sciatalgia|sciatalgia
5239671|NCT02504996|emergency department|emergency department
5239672|NCT02504996|paracetamol|paracetamol
5239673|NCT02504996|morphine|morphine
5239674|NCT02504983|SNPs|snps
5239675|NCT02504970|Anesthesia|anesthesia
5239676|NCT02504970|Quality Improvement|quality improvement
5239677|NCT02504957|Photodynamic therapy|photodynamic therapy
5239678|NCT02504944|Retinopathy of prematurity|retinopathy of prematurity
5239679|NCT02504944|Propranolol|propranolol
5239680|NCT02504944|Newborn|newborn
5239681|NCT02504944|Eye Drops|eye drops
5239682|NCT02504944|Retinal angiogenesis|retinal angiogenesis
5227587|NCT02577705|TANF|tanf
5227588|NCT02577705|assets|assets
5227589|NCT02577705|depression|depression
5227590|NCT02577705|randomized control trial|randomized control trial
5227591|NCT02577679|Dentistry|dentistry
5227592|NCT02577653|balance, postural|balance, postural
5227593|NCT02577653|postural equilibrium|postural equilibrium
5227594|NCT02577614|Cardiopulmonary Bypass|cardiopulmonary bypass
5239683|NCT02504944|Retinal neovascularization|retinal neovascularization
5239684|NCT02504931|PTSD|ptsd
5239685|NCT02504931|Alcohol|alcohol
5239686|NCT02504931|Dual Diagnosis|dual diagnosis
5239687|NCT02504931|Sertraline|sertraline
5239688|NCT02504931|SSRI|ssri
5239689|NCT02504918|Plasmodium Falciparum|plasmodium falciparum
5239690|NCT02504918|Regulatory|regulatory
5239691|NCT02504918|Chemoprevention|chemoprevention
5239692|NCT02504918|Coartem|coartem
5239693|NCT02504918|Parasitemia|parasitemia
5239694|NCT02504905|Parietal Lobe|parietal lobe
5239695|NCT02504905|Plasticity|plasticity
5239696|NCT02504905|Cerebellum|cerebellum
5239697|NCT02504905|Dystonia|dystonia
5239698|NCT02504905|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5239699|NCT02504892|Overall Response Rate|overall response rate
5239700|NCT02504892|Hereditary Cancer Syndrome|hereditary cancer syndrome
5239701|NCT02504892|mTOR Therapy Naive|mtor therapy naive
5334339|NCT02020148|mood|mood
5239710|NCT02504840|Multiple Sclerosis|multiple sclerosis
5239711|NCT02504840|Clinically Isolated Syndrome|clinically isolated syndrome
5239712|NCT02504840|CNS Inflammatory Demyellnation|cns inflammatory demyellnation
5239713|NCT02504840|Radiologically Isolated Syndrome|radiologically isolated syndrome
5239714|NCT02504827|pharmacokinetics|pharmacokinetics
5239715|NCT02504827|ceftazidime/avibactam|ceftazidime/avibactam
5239716|NCT02504814|nasal high flow|nasal high flow
5239717|NCT02504801|primary lung cancer patients|primary lung cancer patients
5239718|NCT02504788|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
5239719|NCT02504788|Neurocognitive Functions (NCFs)|neurocognitive functions (ncfs)
5239720|NCT02504788|Hippocampus|hippocampus
5239721|NCT02504788|Hippocampus Sparing during Whole Brain Radiotherapy (HS-WBRT)|hippocampus sparing during whole brain radiotherapy (hs-wbrt)
5239722|NCT02504749|GIT motility|git motility
5239723|NCT02504749|General anaesthesia|general anaesthesia
5239724|NCT02504749|spinal anaesthesia|spinal anaesthesia
5239725|NCT02504736|LDL cholesterol|ldl cholesterol
5239726|NCT02504736|A1c|a1c
5239727|NCT02504736|High risk South Asians|high risk south asians
5239728|NCT02504736|Colesevelam|colesevelam
5239729|NCT02504723|Gastric varices|gastric varices
5239730|NCT02504723|cyanoacrylate|cyanoacrylate
5239731|NCT02504723|carvedilol|carvedilol
5239732|NCT02504710|Musculoskeletal Manipulations|musculoskeletal manipulations
5239733|NCT02504710|Learning|learning
5239734|NCT02504710|Feedback|feedback
5239735|NCT02504710|Kinematics|kinematics
5239737|NCT02504684|varicose veins|varicose veins
5239738|NCT02504684|endovenous laser treatment|endovenous laser treatment
5239739|NCT02504684|endovenous thermal ablation|endovenous thermal ablation
5239740|NCT02504684|saphenous vein|saphenous vein
5239741|NCT02504671|DMARD-IR|dmard-ir
5239742|NCT02504671|GSK3196165|gsk3196165
5239743|NCT02504671|Rheumatoid Arthritis|rheumatoid arthritis
5239744|NCT02504658|adolescents text messages eating exercise self-efficacy diabetes|adolescents text messages eating exercise self-efficacy diabetes
5239745|NCT02504632|platelet activation|platelet activation
5962788|NCT04278612|Maternal health|maternal health
5239746|NCT02504632|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5239747|NCT02504593|Quality Assurance|quality assurance
5239748|NCT02504593|Monitoring & Evaluation|monitoring & evaluation
5239749|NCT02504593|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
5239750|NCT02504593|Community-based malaria diagnosis|community-based malaria diagnosis
5239751|NCT02504593|Community health workers|community health workers
5239752|NCT02504567|Catheter Ablation|catheter ablation
5239753|NCT02504567|Radiofrequency|radiofrequency
5239754|NCT02504567|Laser|laser
5239755|NCT02504567|Atrial Fibrillation|atrial fibrillation
5239756|NCT02504554|children|children
5239757|NCT02504541|Hypogonadism|hypogonadism
5239758|NCT02504541|Testosterone enanthate|testosterone enanthate
5239759|NCT02504528|asthma|asthma
5239760|NCT02504528|allergy|allergy
5239761|NCT02504528|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5239762|NCT02504528|provocation|provocation
5239763|NCT02504502|Whole Genome Sequencing|whole genome sequencing
5239764|NCT02504502|Laboratory Report|laboratory report
5239765|NCT02504502|Patient Centered|patient centered
5239766|NCT02504502|Communication of Results|communication of results
5239767|NCT02504502|Patient Provider Communication|patient provider communication
5239768|NCT02504476|Schizophrenia or Schizoaffective Disorder|schizophrenia or schizoaffective disorder
5227682|NCT02577250|central nervous system agents|central nervous system agents
5227683|NCT02577250|central nervous system depressants|central nervous system depressants
5239769|NCT02504463|Alkermes|alkermes
5239770|NCT02504463|Samidorphan|samidorphan
5239771|NCT02504463|ALKS 33|alks 33
5239772|NCT02504463|Healthy Volunteer|healthy volunteer
5239773|NCT02504463|Pharmacokinetics|pharmacokinetics
5239774|NCT02504450|Bipolar 1 disorder|bipolar 1 disorder
5239775|NCT02504450|schizophrenia|schizophrenia
5239776|NCT02504424|Tissue Expansion|tissue expansion
5239777|NCT02504424|Tissue Expander|tissue expander
5239778|NCT02504424|Breast Tissue Expansion|breast tissue expansion
5239779|NCT02504424|Breast Tissue Expander|breast tissue expander
5239780|NCT02504424|Breast Reconstruction|breast reconstruction
5239781|NCT02504424|2 Stage Breast Reconstruction|2 stage breast reconstruction
5239782|NCT02504372|NSCLC|nsclc
5239783|NCT02504372|PDL1|pdl1
5239784|NCT02504372|PD-L1|pd-l1
5239785|NCT02504372|PDL|pdl
5239786|NCT02504359|BEAM|beam
5239787|NCT02504359|allogeneic|allogeneic
5239788|NCT02504359|myeloma|myeloma
5239789|NCT02504359|ixazomib|ixazomib
5239790|NCT02504359|transplant|transplant
5239791|NCT02504359|plasma cell leukemia|plasma cell leukemia
5239792|NCT02504333|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5239793|NCT02504333|Nab-paclitaxel|nab-paclitaxel
5239794|NCT02504333|Gemcitabine|gemcitabine
5239795|NCT02504333|modified FOLFOX|modified folfox
5239802|NCT02504216|Xarelto|xarelto
5334464|NCT02019576|mRCC|mrcc
5239803|NCT02504216|Aspirin|aspirin
5239804|NCT02504216|Acetylic salicylic acid|acetylic salicylic acid
5239805|NCT02504216|Anticoagulant|anticoagulant
5239806|NCT02504216|Peripheral artery disease|peripheral artery disease
5239807|NCT02504216|Peripheral arterial disease|peripheral arterial disease
5239808|NCT02504216|Revascularization|revascularization
5239809|NCT02504216|Acute limb ischemia|acute limb ischemia
5239810|NCT02504216|Amputation|amputation
5239811|NCT02504216|Cardiovascular events|cardiovascular events
5239812|NCT02504190|Lymphoma|lymphoma
5239813|NCT02504190|TEAM conditioning|team conditioning
5239814|NCT02504190|autologous stem cells transplantation|autologous stem cells transplantation
5239816|NCT02504164|satisfaction|satisfaction
5239817|NCT02504164|endoscopic submucosal dissection|endoscopic submucosal dissection
5239818|NCT02504099|Chronic Hepatitis C Infection|chronic hepatitis c infection
5239819|NCT02504099|Early Stage Hepatocellular Carcinoma|early stage hepatocellular carcinoma
5239820|NCT02504073|Clinical Reasoning|clinical reasoning
5239821|NCT02504073|Physiotherapists|physiotherapists
5239822|NCT02504060|diarrhea|diarrhea
5239823|NCT02504060|abdominal pain|abdominal pain
5239824|NCT02504047|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5239825|NCT02504034|Portal Vein, Cavernous Transformation Of|portal vein, cavernous transformation of
5239826|NCT02504034|Hypertension, Portal|hypertension, portal
5239827|NCT02504034|Radiology, Interventional|radiology, interventional
5239828|NCT02504034|Portalsystemic shunt|portalsystemic shunt
5239829|NCT02504008|bisphosphonate|bisphosphonate
5239830|NCT02504008|CRPS|crps
5239831|NCT02504008|RSD|rsd
5239832|NCT02504008|non-opioid|non-opioid
5239833|NCT02504008|CRPS-1|crps-1
5239834|NCT02504008|acute on chronic pain|acute on chronic pain
5239835|NCT02504008|chronic pain|chronic pain
5239836|NCT02504008|zoledronic acid|zoledronic acid
5239837|NCT02503969|Colorectal Cancer|colorectal cancer
5239838|NCT02503969|Mass Screening|mass screening
5239839|NCT02503969|Uptake|uptake
5239840|NCT02503969|Morbidity|morbidity
5239841|NCT02503969|Mental Health|mental health
5239842|NCT02503943|GLP-1|glp-1
5239843|NCT02503943|Masked hypertension|masked hypertension
5239844|NCT02503943|Lipid metabolism|lipid metabolism
5239845|NCT02503917|Imaging, Ultrasound|imaging, ultrasound
5239846|NCT02503917|Image-guided radiotherapy|image-guided radiotherapy
5239847|NCT02503917|Cancer|cancer
5239848|NCT02503904|Pharmacology|pharmacology
5239849|NCT02503904|Lidocaine|lidocaine
5239850|NCT02503904|Epinephrine|epinephrine
5239851|NCT02503904|Cefazolin|cefazolin
5239852|NCT02503904|Metronidazole|metronidazole
5239853|NCT02503904|Infection|infection
5239854|NCT02503904|prevention|prevention
5239855|NCT02503904|prophylaxis|prophylaxis
5239856|NCT02503904|SSI|ssi
5239857|NCT02503904|Surgery|surgery
5239858|NCT02503904|Complications|complications
5239859|NCT02503865|Metabolic syndrome|metabolic syndrome
5239860|NCT02503865|Diabetes mellitus,|diabetes mellitus,
5239861|NCT02503865|Hypertension|hypertension
5239862|NCT02503865|Overweight|overweight
5239863|NCT02503865|analimentary detoxication|analimentary detoxication
5239864|NCT02503852|Female Pattern Baldness|female pattern baldness
5239865|NCT02503852|Male Pattern Baldness|male pattern baldness
5239866|NCT02503852|Genetic Alopecia|genetic alopecia
5239867|NCT02503852|Androgenic Alopecia|androgenic alopecia
5239868|NCT02503852|Hair Loss|hair loss
5239869|NCT02503839|Host-modulating therapy|host-modulating therapy
5239870|NCT02503839|Vaccine|vaccine
5239871|NCT02503839|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
5239872|NCT02503813|brain death|brain death
5239873|NCT02503813|apnea challenge test|apnea challenge test
5239874|NCT02503787|chronic pain|chronic pain
5239875|NCT02503787|intractable pain|intractable pain
5239876|NCT02503787|failed back surgery syndrome|failed back surgery syndrome
5445369|NCT01522118|High Intensity Focused Ultrasound|high intensity focused ultrasound
5445478|NCT01521572|Diagnostic Techniques, Respiratory System|diagnostic techniques, respiratory system
5239877|NCT02503774|Solid Tumors, MEDI9447, oleclumab, MEDI4736, durvalumab, CD73, PD-L1, EGFRm NSCLC, immunotherapy, pancreatic, colorectal|solid tumors, medi9447, oleclumab, medi4736, durvalumab, cd73, pd-l1, egfrm nsclc, immunotherapy, pancreatic, colorectal
5239878|NCT02503761|meropenem|meropenem
5239879|NCT02503761|infusion|infusion
5239880|NCT02503761|late-onset sepsis|late-onset sepsis
5239881|NCT02503761|newborn|newborn
5239882|NCT02503761|management|management
5239883|NCT02503735|CKD|ckd
5239884|NCT02503735|HCV|hcv
5239885|NCT02503696|Inflammatory Bowel Disease|inflammatory bowel disease
5239886|NCT02503696|Cancer|cancer
5239887|NCT02503696|Colorectal Cancer|colorectal cancer
5239888|NCT02503696|Neoplasm|neoplasm
5237387|NCT02518659|FOS|fos
5239890|NCT02503696|Intestinal Neoplasms|intestinal neoplasms
5239891|NCT02503696|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5239892|NCT02503696|Digestive System Neoplasms|digestive system neoplasms
5239893|NCT02503696|Neoplasms by Site|neoplasms by site
5239894|NCT02503696|Neoplasms|neoplasms
5239895|NCT02503696|Digestive System Diseases|digestive system diseases
5239896|NCT02503696|Gastrointestinal Diseases|gastrointestinal diseases
5239897|NCT02503696|Colonic Diseases|colonic diseases
5239898|NCT02503696|Intestinal Diseases|intestinal diseases
5239899|NCT02503696|Rectal Diseases|rectal diseases
5239900|NCT02503683|RNAi therapeutic|rnai therapeutic
5239902|NCT02503683|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5239903|NCT02503657|tipelukast|tipelukast
5239904|NCT02503657|IPF|ipf
5239905|NCT02503657|fibrosis|fibrosis
5239906|NCT02503657|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5239907|NCT02503644|diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
5239908|NCT02503644|scleroderma|scleroderma
5239909|NCT02503644|IVA337|iva337
5239910|NCT02503644|dcSSc|dcssc
5239911|NCT02503644|lanifibranor|lanifibranor
5239912|NCT02503631|Cancer|cancer
5239913|NCT02503631|Colorectal Cancer|colorectal cancer
5239914|NCT02503631|Neoplasm|neoplasm
5240013|NCT02503111|Anal cancer|anal cancer
5239915|NCT02503631|Colorectal Neoplasm|colorectal neoplasm
5239916|NCT02503631|Intestinal Neoplasms|intestinal neoplasms
5239917|NCT02503631|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5239918|NCT02503631|Digestive System Neoplasms|digestive system neoplasms
5239919|NCT02503631|Neoplasms by Site|neoplasms by site
5239920|NCT02503631|Neoplasms|neoplasms
5239921|NCT02503631|Digestive System Diseases|digestive system diseases
5239922|NCT02503631|Gastrointestinal Diseases|gastrointestinal diseases
5239923|NCT02503631|Colonic Diseases|colonic diseases
5239924|NCT02503631|Intestinal Diseases|intestinal diseases
5239925|NCT02503631|Rectal Diseases|rectal diseases
5239926|NCT02503605|Biosimilar|biosimilar
5239927|NCT02503605|ovarian stimulation|ovarian stimulation
5239928|NCT02503605|oocyte donor|oocyte donor
5239929|NCT02503579|Brain-derived neurotropic factor|brain-derived neurotropic factor
5239930|NCT02503579|Executive function|executive function
5239931|NCT02503566|CAV|cav
5239932|NCT02503566|OCT|oct
5239933|NCT02503566|heart rate|heart rate
5239934|NCT02503566|antibodies|antibodies
5239935|NCT02503553|option grid|option grid
5239936|NCT02503553|neurosurgery|neurosurgery
5239937|NCT02503553|cerebral aneurysm|cerebral aneurysm
5239938|NCT02503540|macular edema|macular edema
5239939|NCT02503540|rvo|rvo
5239940|NCT02503540|diabetic macular edema|diabetic macular edema
5239941|NCT02503527|Enteral nutrition|enteral nutrition
5239942|NCT02503527|Tube feeding|tube feeding
5239943|NCT02503527|Diet, carbohydrate-restricted|diet, carbohydrate-restricted
5239944|NCT02503527|Diabetes|diabetes
5962789|NCT04278612|Child health|child health
5239945|NCT02503527|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
5239946|NCT02503527|Blood glucose|blood glucose
5239947|NCT02503527|Insulin|insulin
5239948|NCT02503501|Memory|memory
5239949|NCT02503501|Insulin glulisine|insulin glulisine
5239950|NCT02503501|Alzheimer's disease|alzheimer's disease
5239951|NCT02503501|Mild Cognitive Impairment|mild cognitive impairment
5239952|NCT02503501|Intranasal insulin|intranasal insulin
5239953|NCT02503501|Cognition Disorders|cognition disorders
5239954|NCT02503488|Appetitive Aggression|appetitive aggression
5239955|NCT02503462|HIV|hiv
5239956|NCT02503462|darunavir|darunavir
5239957|NCT02503462|ritonavir|ritonavir
5239958|NCT02503462|cobicistat|cobicistat
5239959|NCT02503462|CSF|csf
5239960|NCT02503462|pharmacokinetics|pharmacokinetics
5239961|NCT02503449|Pulmonary Cryptococcosis|pulmonary cryptococcosis
5239962|NCT02503436|Ovarian Cancer, Fallopian Tube Cancer, primary peritoneal cancer, BRCA1 Gene, BRCA2 Gene|ovarian cancer, fallopian tube cancer, primary peritoneal cancer, brca1 gene, brca2 gene
5239963|NCT02503423|cervical cancer|cervical cancer
5239964|NCT02503423|HNSCC|hnscc
5239965|NCT02503423|CTCL|ctcl
5239966|NCT02503423|PTCL|ptcl
5239967|NCT02503423|DLBCL|dlbcl
5239968|NCT02503410|lower back|lower back
5239969|NCT02503410|pain|pain
5239970|NCT02503345|Kidney Stones|kidney stones
5239971|NCT02503345|Nephrolithiasis|nephrolithiasis
5239972|NCT02503345|Urine Oxalate|urine oxalate
5239973|NCT02503345|Hyperoxaluria|hyperoxaluria
5239974|NCT02503345|Enteric Hyperoxaluria|enteric hyperoxaluria
5239975|NCT02503345|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
5239976|NCT02503345|Urological Diseases|urological diseases
5239977|NCT02503345|Kidney Diseases|kidney diseases
5239978|NCT02503345|Dietary Oxalate|dietary oxalate
5239979|NCT02503280|Cardiovascular|cardiovascular
5239980|NCT02503280|Secondary|secondary
5239981|NCT02503267|antithrombin III deficiency|antithrombin iii deficiency
5239982|NCT02503267|congenital heart diseases|congenital heart diseases
5239983|NCT02503254|Smoking|smoking
5239984|NCT02503254|Modified risk tobacco product|modified risk tobacco product
5239985|NCT02503254|Conventional cigarette|conventional cigarette
5239986|NCT02503254|Reduced exposure|reduced exposure
5239987|NCT02503254|Confinement|confinement
5239989|NCT02503215|Hemodialysis|hemodialysis
5239990|NCT02503215|Obstructive sleep apnea|obstructive sleep apnea
5239991|NCT02503215|Compression stockings|compression stockings
5239992|NCT02503189|Dry eye syndromes|dry eye syndromes
5239993|NCT02503189|Corneal diseases|corneal diseases
5239994|NCT02503189|Conjunctival diseases|conjunctival diseases
5239995|NCT02503176|Dry eye syndromes|dry eye syndromes
5239996|NCT02503176|Corneal diseases|corneal diseases
5239999|NCT02503163|Corneal diseases|corneal diseases
5240000|NCT02503163|Conjunctival diseases|conjunctival diseases
5240001|NCT02503150|Colorectal Cancer|colorectal cancer
5240002|NCT02503150|Tumor Therapeutic Vaccine|tumor therapeutic vaccine
5240003|NCT02503150|Dendritic Cell|dendritic cell
5240007|NCT02503111|Men who have sex with men|men who have sex with men
5240008|NCT02503111|Human immunodeficiency virus|human immunodeficiency virus
5240009|NCT02503111|Human papillomavirus|human papillomavirus
5240010|NCT02503111|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
5240011|NCT02503111|Squamous cell carcinoma|squamous cell carcinoma
5240012|NCT02503111|High-resolution anoscopy|high-resolution anoscopy
5240014|NCT02503111|High-risk oncogenic|high-risk oncogenic
5240015|NCT02503111|Intraepithelial lesion|intraepithelial lesion
5240016|NCT02503111|Low-risk non-oncogenic|low-risk non-oncogenic
5240017|NCT02503111|Dysplasia|dysplasia
5240018|NCT02503111|High-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5240019|NCT02503111|Low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5240020|NCT02503111|Ablative therapy|ablative therapy
5240021|NCT02503111|Electrocautery|electrocautery
5240022|NCT02503111|Infrared coagulation|infrared coagulation
5240023|NCT02503111|Active surveillance|active surveillance
5240024|NCT02503098|Eating Disorders|eating disorders
5240025|NCT02503098|Cognitive Behavioral Therapy|cognitive behavioral therapy
5240026|NCT02503098|Mobile Phone|mobile phone
5240027|NCT02503098|Smartphone|smartphone
5240029|NCT02503098|Binge Eating Disorder|binge eating disorder
5240030|NCT02503098|Bulimia Nervosa|bulimia nervosa
5240031|NCT02503098|Signal Detection Analysis|signal detection analysis
5240040|NCT02502981|spironolactone|spironolactone
5240041|NCT02502955|Quality Control|quality control
5240042|NCT02502955|Cardiosurgery|cardiosurgery
5240043|NCT02502955|Cardiology|cardiology
5240044|NCT02502955|Vascular Surgery|vascular surgery
5240045|NCT02502955|ICU|icu
5240046|NCT02502942|Obstructive Sleep Apnea|obstructive sleep apnea
5240047|NCT02502942|Exercise|exercise
5240048|NCT02502942|Upper airway muscle|upper airway muscle
5240049|NCT02502929|Diabetes|diabetes
5240050|NCT02502929|Depression|depression
5240051|NCT02502929|Medication therapy management|medication therapy management
5240052|NCT02502929|Community health workers|community health workers
5240053|NCT02502929|Cambodian|cambodian
5240054|NCT02502929|Refugee|refugee
5240055|NCT02502929|Prevention|prevention
5240056|NCT02502890|asthma|asthma
5240057|NCT02502890|nested case-control study|nested case-control study
5240058|NCT02502890|difficult-to-control asthma|difficult-to-control asthma
5240059|NCT02502890|asthma exacerbations|asthma exacerbations
5240060|NCT02502890|cold symptoms|cold symptoms
5240061|NCT02502890|gene expression|gene expression
5240062|NCT02502864|senior adult|senior adult
5240063|NCT02502864|postmenopausal|postmenopausal
5240064|NCT02502838|overactive bladder|overactive bladder
5240065|NCT02502838|pelvic organ prolapse|pelvic organ prolapse
5240066|NCT02502838|TVT|tvt
5240067|NCT02502812|bioequivalence|bioequivalence
5240068|NCT02502812|SB224326|sb224326
5240069|NCT02502812|clopidogrel|clopidogrel
5240070|NCT02502812|Relative bioavailability|relative bioavailability
5240071|NCT02502786|Humanized Monoclonal Antibody 3F8 (Hu3F8)|humanized monoclonal antibody 3f8 (hu3f8)
5240072|NCT02502786|Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)|granulocyte-macrophage colony stimulating factor (gm-csf)
5240073|NCT02502786|15-096|15-096
5240074|NCT02502773|Goal-directed therapy|goal-directed therapy
5240075|NCT02502773|Fluid loading|fluid loading
5240076|NCT02502773|Abdominal surgery|abdominal surgery
5240077|NCT02502773|Postoperative morbidity|postoperative morbidity
5240078|NCT02502773|Postoperative mortality|postoperative mortality
5240079|NCT02502773|Individualized goal-directed fluid therapy|individualized goal-directed fluid therapy
5240080|NCT02502773|Elective or emergency abdominal surgery|elective or emergency abdominal surgery
5240081|NCT02502773|General Anesthesia|general anesthesia
5240082|NCT02502773|Moderate-to-high risk surgical patients|moderate-to-high risk surgical patients
5240083|NCT02502760|Postoperative Complications|postoperative complications
5240084|NCT02502760|Perioperative Care|perioperative care
5240085|NCT02502760|Colorectal Surgery|colorectal surgery
5240086|NCT02502760|Frail Elderly|frail elderly
5240087|NCT02502734|inhaled corticosteroids|inhaled corticosteroids
5240088|NCT02502734|pediatric subjects|pediatric subjects
5240089|NCT02502734|asthma|asthma
5240090|NCT02502734|fluticasone furoate|fluticasone furoate
5240091|NCT02502721|Male|male
5240092|NCT02502708|glioblastoma multiforme|glioblastoma multiforme
5240093|NCT02502708|glioma|glioma
5240094|NCT02502708|gliosarcoma|gliosarcoma
5240095|NCT02502708|malignant brain tumor|malignant brain tumor
5240096|NCT02502708|ependymoma|ependymoma
5240097|NCT02502708|medulloblastoma|medulloblastoma
5240098|NCT02502695|VATS Lobectomy and Segmentectomy for Lung Cancer|vats lobectomy and segmentectomy for lung cancer
5240099|NCT02502695|Lung Cancer|lung cancer
5240100|NCT02502682|Chlorhexidine bathing|chlorhexidine bathing
5240101|NCT02502669|acne|acne
5240102|NCT02502669|nodulocystic|nodulocystic
5240103|NCT02502669|finasteride|finasteride
5240104|NCT02502669|5 alpha reductase inhibitor|5 alpha reductase inhibitor
5240105|NCT02502656|RAS mutation|ras mutation
5240106|NCT02502656|DNA|dna
5240107|NCT02502656|Colorectal Cancer|colorectal cancer
5240108|NCT02502643|Safety and Efficacy|safety and efficacy
5240109|NCT02502643|Thoracic Surgery|thoracic surgery
5240110|NCT02502617|Psychopathology|psychopathology
5240112|NCT02502617|Depression|depression
5240113|NCT02502617|Nutrition|nutrition
5240114|NCT02502617|Cortisol|cortisol
5240115|NCT02502617|Anorexia nervosa|anorexia nervosa
5240116|NCT02502604|Cognitive Remediation|cognitive remediation
5240117|NCT02502604|Goal Management Training|goal management training
5240118|NCT02502604|Major Depressive Disorder|major depressive disorder
5240119|NCT02502604|Post-traumatic Stress Disorder|post-traumatic stress disorder
5240120|NCT02502604|Neuropsychological Functioning|neuropsychological functioning
5245522|NCT02471690|Volunteers|volunteers
5240121|NCT02502578|Triglyceride Deposit Cardiomyovasculopathy|triglyceride deposit cardiomyovasculopathy
5240122|NCT02502552|Crohn's Disease|crohn's disease
5240123|NCT02502552|Ulcerative Colitis|ulcerative colitis
5240124|NCT02502552|Inflammatory Bowel Disease|inflammatory bowel disease
5240125|NCT02502552|anti-glycan antibodies|anti-glycan antibodies
5240126|NCT02502552|antibodies stability|antibodies stability
5240127|NCT02502552|mucosal healing|mucosal healing
5240128|NCT02502552|predictive markers|predictive markers
5240129|NCT02502539|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5240130|NCT02502539|Physical exercise|physical exercise
5240131|NCT02502539|Pro-anti-inflammatory balance|pro-anti-inflammatory balance
5240132|NCT02502539|Interleukins|interleukins
5240134|NCT02502539|Calgranulins|calgranulins
5240135|NCT02502487|Analgesia|analgesia
5240136|NCT02502487|Cystoscopy|cystoscopy
5240137|NCT02502487|Dorsal nerve of penis|dorsal nerve of penis
5240138|NCT02502487|Nerve block|nerve block
5240139|NCT02502487|Ropivacaine|ropivacaine
5240140|NCT02502474|staphylococcus aureus|staphylococcus aureus
5240141|NCT02502474|digestive carriage|digestive carriage
5240142|NCT02502474|mucosal colonization|mucosal colonization
5240143|NCT02502448|rotational thromboelastometry|rotational thromboelastometry
5240144|NCT02502448|cardiac surgery|cardiac surgery
5240145|NCT02502448|acute normovolemic hemodilution|acute normovolemic hemodilution
5240146|NCT02502422|Laryngeal mask airway|laryngeal mask airway
5240147|NCT02502409|Hemophilia B|hemophilia b
5240148|NCT02502409|Hemophilia B with Inhibitors|hemophilia b with inhibitors
5240149|NCT02502396|Cancer|cancer
5962790|NCT04278612|HIV/AIDS|hiv/aids
5109621|NCT03312712|FDG|fdg
5120165|NCT03244046|SE|se
5240150|NCT02502396|Deep-vein thrombosis of the lower and upper extremities|deep-vein thrombosis of the lower and upper extremities
5240151|NCT02502396|Pulmonary embolism|pulmonary embolism
5240152|NCT02502396|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5240153|NCT02502396|Chart review|chart review
5240154|NCT02502396|VTE|vte
5240155|NCT02502396|NVAF|nvaf
5240156|NCT02502396|Rivaroxaban|rivaroxaban
5240157|NCT02502383|Adolescent|adolescent
5240158|NCT02502383|Overweight|overweight
5240159|NCT02502383|Obesity|obesity
5240160|NCT02502383|Weight loss|weight loss
5240161|NCT02502383|Nutrition|nutrition
5240162|NCT02502383|Physical Activity|physical activity
5240163|NCT02502383|School-based|school-based
5240164|NCT02502383|Primary care|primary care
5240165|NCT02502383|Motivational Interviewing|motivational interviewing
5240166|NCT02502357|pain control|pain control
5240167|NCT02502357|healing statements|healing statements
5240168|NCT02502357|pelvic prolapse|pelvic prolapse
5240169|NCT02502344|insulin resistance|insulin resistance
5240170|NCT02502344|abnormal glucose tolerance|abnormal glucose tolerance
5240171|NCT02502344|DM prevention|dm prevention
5240172|NCT02502331|Oral Cholera Vaccine|oral cholera vaccine
5240173|NCT02502331|immunogenicity|immunogenicity
5240174|NCT02502331|safety|safety
5240175|NCT02502318|Proven or suspected lung cancer treated by lobectomy|proven or suspected lung cancer treated by lobectomy
5240176|NCT02502305|health literacy|health literacy
5240177|NCT02502305|attitude|attitude
5240178|NCT02502305|motivation|motivation
5240179|NCT02502292|Health Literacy|health literacy
5240180|NCT02502292|Health Ageing|health ageing
5240181|NCT02502292|Health Literacy Interventions|health literacy interventions
5240182|NCT02502292|IROHLA|irohla
5240183|NCT02502292|Photo Novel Study|photo novel study
5240184|NCT02502240|ALK|alk
5240185|NCT02502240|Latin American|latin american
5240186|NCT02502227|mindfulness|mindfulness
5240187|NCT02502227|psychological stress|psychological stress
5240188|NCT02502227|wellness programs|wellness programs
5240189|NCT02502227|cortisol|cortisol
5240190|NCT02502214|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5240191|NCT02502214|PGD|pgd
5240192|NCT02502214|Next-Generation Sequencing|next-generation sequencing
5240193|NCT02502214|NGS|ngs
5240194|NCT02502214|Single-Gene disorders|single-gene disorders
5240195|NCT02502214|Cystic Fibrosis|cystic fibrosis
5240196|NCT02502214|CFTR|cftr
5240197|NCT02502214|Single-cell analysis|single-cell analysis
5240198|NCT02502214|PCR|pcr
5240199|NCT02502214|SNP|snp
5240200|NCT02502214|Whole Genome Amplification|whole genome amplification
5240201|NCT02502201|six-minute walk|six-minute walk
5240202|NCT02502188|Healthy Subjects|healthy subjects
5240203|NCT02502188|Severe Plaque Psoriasis|severe plaque psoriasis
5240204|NCT02502188|Moderate|moderate
5240205|NCT02502188|Phase 1|phase 1
5240206|NCT02502188|Safety|safety
5240207|NCT02502188|Tolerability|tolerability
5240208|NCT02502188|CC-90005|cc-90005
5240209|NCT02502175|Opium tincture|opium tincture
5240210|NCT02502175|opium|opium
5240211|NCT02502175|methadone|methadone
5240212|NCT02502175|opioid dependence|opioid dependence
5240213|NCT02502175|opiate dependence|opiate dependence
5240214|NCT02502175|clinical trial|clinical trial
5240215|NCT02502175|Iran|iran
5240216|NCT02502149|rFVIIIFc|rfviiifc
5240217|NCT02502149|Eloctate|eloctate
5240218|NCT02502149|Hemophilia|hemophilia
5240219|NCT02502136|CO2 insufflation|co2 insufflation
5240220|NCT02502110|Atrial Fibrillation|atrial fibrillation
5240221|NCT02502110|statin|statin
5240222|NCT02502110|radiofrequency ablation|radiofrequency ablation
5240223|NCT02502006|Non-steroidal Anti-inflammatory Drugs|non-steroidal anti-inflammatory drugs
5240224|NCT02502006|Healthy volunteers|healthy volunteers
5240225|NCT02502006|Celecoxib|celecoxib
5240226|NCT02502006|Naproxen|naproxen
5240227|NCT02502006|Prostaglandin|prostaglandin
5240228|NCT02502006|Cyclooxygenase|cyclooxygenase
5240229|NCT02501980|Screening|screening
5240230|NCT02501980|Hepatocellular Cancer|hepatocellular cancer
5240231|NCT02501980|Biomarker|biomarker
5240232|NCT02501980|Mortality rate|mortality rate
5240233|NCT02501967|multiple chronic conditions|multiple chronic conditions
5240234|NCT02501941|Ketamine|ketamine
5240235|NCT02501941|Cortical Spreading Depolarization|cortical spreading depolarization
5240236|NCT02501941|Cortical Spreading Depression|cortical spreading depression
5240237|NCT02501928|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5240238|NCT02501928|fesoterodine|fesoterodine
5240240|NCT02501915|Muscle|muscle
5240241|NCT02501902|Ibrance, palbociclib, Abraxane, nab-paclitaxel, pancreas,|ibrance, palbociclib, abraxane, nab-paclitaxel, pancreas,
5240242|NCT02501889|obesity|obesity
5962791|NCT04278612|South Africa|south africa
5240243|NCT02501889|overweight|overweight
5240244|NCT02501889|weight loss|weight loss
5240245|NCT02501889|satiety|satiety
5240246|NCT02501889|walnuts|walnuts
5240247|NCT02501889|gastrointestinal peptides|gastrointestinal peptides
5240248|NCT02501876|The risk of progession|the risk of progession
5240249|NCT02501876|patients|patients
5120201|NCT03243838|pCR|pcr
5240250|NCT02501850|Lipoprotein (a)|lipoprotein (a)
5240251|NCT02501837|Healthy women|healthy women
5240252|NCT02501811|Heart Failure|heart failure
5240253|NCT02501811|Ischemia|ischemia
5240254|NCT02501811|Autologous Stem Cells|autologous stem cells
5240255|NCT02501811|LV dysfunction|lv dysfunction
5240256|NCT02501811|Mesenchymal Stem Cells|mesenchymal stem cells
5240257|NCT02501811|c-kit+ Cells|c-kit+ cells
5240258|NCT02501811|Combination Cell Therapy|combination cell therapy
5240259|NCT02501811|LV function|lv function
5240260|NCT02501811|Functional status|functional status
5240261|NCT02501798|ADHD|adhd
5240262|NCT02501798|Methylphenidate|methylphenidate
5240263|NCT02501798|Academic|academic
5240264|NCT02501798|Motivation|motivation
5240265|NCT02501785|Quality of Life|quality of life
5240266|NCT02501785|Patient care givers|patient care givers
5240267|NCT02501785|15-145|15-145
5240268|NCT02501785|Ambulatory Extended Recovery|ambulatory extended recovery
5240269|NCT02501746|Group medical care|group medical care
5240270|NCT02501746|Microfinance|microfinance
5240271|NCT02501746|Hypertension|hypertension
5240272|NCT02501746|Community-based intervention|community-based intervention
5240273|NCT02501746|Global health|global health
5240274|NCT02501733|Total Knee Replacement|total knee replacement
5240275|NCT02501733|Total Knee Arthroplasty|total knee arthroplasty
5240276|NCT02501720|burn|burn
5240277|NCT02501720|hand|hand
5240278|NCT02501720|flexion contracture|flexion contracture
5240279|NCT02501720|tourniquet|tourniquet
5240280|NCT02501720|tumescent technique|tumescent technique
5240281|NCT02501720|children|children
5240282|NCT02501707|echocardiography|echocardiography
5240283|NCT02501707|radiation-induced lung injury|radiation-induced lung injury
5240284|NCT02501707|prognostic|prognostic
5240285|NCT02501707|chemo radiotherapy|chemo radiotherapy
5240286|NCT02501707|non-small cell lung cancer|non-small cell lung cancer
5240287|NCT02501707|NSCLC|nsclc
5240288|NCT02501681|sublingual microcirculation|sublingual microcirculation
5240289|NCT02501681|cardiovascular surgery|cardiovascular surgery
5240290|NCT02501629|Asthma|asthma
5240291|NCT02501629|Elevated Blood Eosinophils|elevated blood eosinophils
5240292|NCT02501629|Oral corticosteroid dependence|oral corticosteroid dependence
5240293|NCT02501629|Reslizumab|reslizumab
5240294|NCT02501616|SGLT2 inhibitor|sglt2 inhibitor
5240295|NCT02501564|Osteoarthritis|osteoarthritis
5240296|NCT02501564|NAPROXEN SODIUM|naproxen sodium
5240297|NCT02501551|Malignant melanoma|malignant melanoma
5240298|NCT02501551|C-KIT mutation|c-kit mutation
5240299|NCT02501525|renal stone|renal stone
5240300|NCT02501525|retrograde intrarenal surgery|retrograde intrarenal surgery
5240301|NCT02501525|ureteral access sheath|ureteral access sheath
5240302|NCT02501525|pain|pain
5240303|NCT02501512|transesophageal signal|transesophageal signal
5240304|NCT02501512|swallowing|swallowing
5240305|NCT02501512|newborn|newborn
5240306|NCT02501486|adrenal insufficiency|adrenal insufficiency
5240307|NCT02501486|adverse drug reaction|adverse drug reaction
5240308|NCT02501486|corticosteroid|corticosteroid
5240309|NCT02501473|follicular lymphoma|follicular lymphoma
5240310|NCT02501473|FL|fl
5240311|NCT02501473|low-grade lymphoma|low-grade lymphoma
5240312|NCT02501473|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5240313|NCT02501473|follicular NHL|follicular nhl
5240314|NCT02501473|Marginal Zone|marginal zone
5240315|NCT02501460|Adult cancer survivors|adult cancer survivors
5240316|NCT02501460|Exercise|exercise
5240317|NCT02501460|Dietary supplementation|dietary supplementation
5240318|NCT02501434|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5240319|NCT02501434|unfractionated heparin|unfractionated heparin
5240320|NCT02501434|neurobehavioral manifestations|neurobehavioral manifestations
5240322|NCT02501434|cerebral aneurysm|cerebral aneurysm
5240323|NCT02501434|coil embolization|coil embolization
5240324|NCT02501434|Montreal Cognitive Assessment|montreal cognitive assessment
5240326|NCT02501421|influenza vector|influenza vector
5240327|NCT02501421|tuberculosis|tuberculosis
5240328|NCT02501382|Fasciitis|fasciitis
5240329|NCT02501382|Fasciitis, Necrotizing|fasciitis, necrotizing
5240330|NCT02501382|Soft tissue infections|soft tissue infections
5240331|NCT02501382|Fournier's gangrene|fournier's gangrene
5240332|NCT02501382|Immunopathogenesis|immunopathogenesis
5240333|NCT02501356|prebiotic|prebiotic
5240334|NCT02501356|dietary supplement|dietary supplement
5240335|NCT02501343|Glucose metabolism|glucose metabolism
5240336|NCT02501343|Potential renal acid load|potential renal acid load
5240337|NCT02501343|Postprandial glycemia|postprandial glycemia
5240338|NCT02501343|Body acid-base homeostasis|body acid-base homeostasis
5240339|NCT02501343|Sodium bicarbonate|sodium bicarbonate
5240340|NCT02501330|Drug use investigation in Japan|drug use investigation in japan
5240341|NCT02501317|urinary incontinence|urinary incontinence
5240342|NCT02501317|physical therapy|physical therapy
5240343|NCT02501317|rehabilitation|rehabilitation
5240344|NCT02501317|pelvic floor|pelvic floor
5240345|NCT02501317|perineum|perineum
5240346|NCT02501317|conservative treatment|conservative treatment
5240347|NCT02501265|Nicotine addiction|nicotine addiction
5962792|NCT04278612|Growth Monitoring|growth monitoring
5240348|NCT02501265|Cigarette smoking|cigarette smoking
5240349|NCT02501265|Bupropion|bupropion
5240350|NCT02501265|Varenicline|varenicline
5240351|NCT02501265|Adaptive Approach|adaptive approach
5240352|NCT02501265|Nicotine Patch|nicotine patch
5240354|NCT02501252|Community|community
5240355|NCT02501252|Skilled birth attendance|skilled birth attendance
5240356|NCT02501252|Rural|rural
5240357|NCT02501252|Ethiopia|ethiopia
5240358|NCT02501226|Psychiatry|psychiatry
5240359|NCT02501226|Depression|depression
5240360|NCT02501226|Psychoeducation|psychoeducation
5240361|NCT02501226|Randomized controlled trial|randomized controlled trial
5240362|NCT02501226|Treatment adherence|treatment adherence
5240363|NCT02501226|Remission|remission
5240364|NCT02501213|Diuretic|diuretic
5240365|NCT02501213|Malignant ascites|malignant ascites
5240366|NCT02501200|Dyslipidemia|dyslipidemia
5240368|NCT02501200|Atorvastatin|atorvastatin
5240369|NCT02501200|Ezetimibe|ezetimibe
5240370|NCT02501174|Geriatric oncology|geriatric oncology
5240371|NCT02501148|Embolic protection|embolic protection
5240372|NCT02501148|Carotid artery stenting|carotid artery stenting
5240373|NCT02501135|Femoral nerve blocks|femoral nerve blocks
5240374|NCT02501135|children|children
5240375|NCT02501135|knee and thigh surgery|knee and thigh surgery
5240376|NCT02501122|Quality|quality
5240377|NCT02501122|hospital care|hospital care
5240378|NCT02501122|adenotonsillectomy|adenotonsillectomy
5240379|NCT02501109|Aripiprazole|aripiprazole
5240380|NCT02501109|Oral Soluble Film|oral soluble film
5240381|NCT02501109|Schizophrenia|schizophrenia
5240382|NCT02501096|Lenvatinib|lenvatinib
5240383|NCT02501096|Lenvima|lenvima
5240384|NCT02501096|E7080|e7080
5240385|NCT02501096|Phase 1b/2|phase 1b/2
5240386|NCT02501096|Pembrolizumab|pembrolizumab
5240387|NCT02501096|Keytruda|keytruda
5240388|NCT02501096|Solid tumors|solid tumors
5240389|NCT02501083|cardiomyopathy|cardiomyopathy
5240390|NCT02501083|echocardiography|echocardiography
5240391|NCT02501083|prognosis|prognosis
5240392|NCT02501083|respiratory|respiratory
5240393|NCT02501083|home mechanical ventilation|home mechanical ventilation
5240394|NCT02501083|vital capacity|vital capacity
5240395|NCT02501083|maximal inspiratory pressure|maximal inspiratory pressure
5240396|NCT02501083|maximal expiratory pressure|maximal expiratory pressure
5240397|NCT02501070|Percutaneous Coronary Intervention|percutaneous coronary intervention
5240398|NCT02501070|Angioplasty|angioplasty
5240399|NCT02501070|Stent|stent
5240400|NCT02501070|Community Networks|community networks
5240402|NCT02501057|Unsafe Drinking|unsafe drinking
5240403|NCT02501057|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
5240404|NCT02501031|Flaxseed|flaxseed
5240405|NCT02501031|Postmenopause|postmenopause
5240406|NCT02501031|Hormones|hormones
5240407|NCT02501031|Lignans|lignans
5240408|NCT02501031|No Evidence of Disease|no evidence of disease
5240409|NCT02501018|CLI, ASO, TAO|cli, aso, tao
5240410|NCT02500979|Type 1 Diabetes Mellitus; Pramlintide|type 1 diabetes mellitus; pramlintide
5240411|NCT02500966|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5240412|NCT02500966|stenosis|stenosis
5240413|NCT02500966|cervix|cervix
5240414|NCT02500966|medical device|medical device
5240415|NCT02500966|inventories|inventories
5240416|NCT02500966|Uterine Cervix|uterine cervix
5240417|NCT02500966|Intrauterine Devices|intrauterine devices
5240418|NCT02500966|intrauterine|intrauterine
5240419|NCT02500966|conization|conization
5245834|NCT02469766|SWL|swl
5240420|NCT02500966|loop electrosurgical excision|loop electrosurgical excision
5240421|NCT02500953|ASP3325|asp3325
5240422|NCT02500953|pharmacokinetics|pharmacokinetics
5240423|NCT02500953|pharmacodynamics|pharmacodynamics
5240424|NCT02500927|ASP8273|asp8273
5240425|NCT02500927|Non-Small Cell Lung Cancer|non-small cell lung cancer
5240426|NCT02500927|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
5240427|NCT02500927|EGFR Mutation|egfr mutation
5240428|NCT02500914|small cell lung cancer|small cell lung cancer
5240429|NCT02500901|Enzalutamide|enzalutamide
5240430|NCT02500901|Niraparib|niraparib
5240431|NCT02500901|PARP-1 inhibitor|parp-1 inhibitor
5240432|NCT02500901|PARP-2 inhibitor|parp-2 inhibitor
5240433|NCT02500901|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5240434|NCT02500888|OCD|ocd
5240435|NCT02500888|Neurosurgery|neurosurgery
5240436|NCT02500888|Radiosurgery|radiosurgery
5240437|NCT02500875|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5240438|NCT02500875|Topical Negative Pressure Therapy|topical negative pressure therapy
5240439|NCT02500875|Sodium Hypochlorite|sodium hypochlorite
5240440|NCT02500862|Eye|eye
5240441|NCT02500862|Imaging|imaging
5240442|NCT02500849|Gene therapy|gene therapy
5240443|NCT02500849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5240444|NCT02500849|HIV Infections|hiv infections
5240445|NCT02500849|Retroviridae Infections|retroviridae infections
5240446|NCT02500849|RNA Virus Infections|rna virus infections
5240447|NCT02500849|Virus Diseases|virus diseases
5240448|NCT02500849|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5120400|NCT03242512|RANKL|rankl
5240449|NCT02500849|Sexually Transmitted Diseases|sexually transmitted diseases
5240450|NCT02500849|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5240451|NCT02500849|Immune System Diseases|immune system diseases
5240452|NCT02500849|Busulfan|busulfan
5240453|NCT02500849|Pharmacologic Actions|pharmacologic actions
5240454|NCT02500836|Ear|ear
5240455|NCT02500836|Nose|nose
5240456|NCT02500836|Throat|throat
5240457|NCT02500823|Mitochondrial DNA copy number|mitochondrial dna copy number
5240458|NCT02500823|Peripheral blood cells|peripheral blood cells
5240459|NCT02500810|neurotoxicity|neurotoxicity
5240460|NCT02500810|chemotherapy|chemotherapy
5240461|NCT02500810|monosialoganglioside|monosialoganglioside
5240462|NCT02500810|prevention|prevention
5240463|NCT02500758|Surgical scrubbing|surgical scrubbing
5228385|NCT02573766|CIPN|cipn
5228386|NCT02573740|Mild Cognitive Impairment|mild cognitive impairment
5228387|NCT02573740|Alzheimer's Disease|alzheimer's disease
5240464|NCT02500758|Chlorhexidine digluconate|chlorhexidine digluconate
5240465|NCT02500758|Parachlorometaxylenol|parachlorometaxylenol
5240466|NCT02500719|Posttraumatic Stress Disorder|posttraumatic stress disorder
5240467|NCT02500719|Neurofeedback|neurofeedback
5240468|NCT02500719|fMRI|fmri
5240469|NCT02500719|Skin Conductance Response|skin conductance response
5240470|NCT02500693|Lung Cancer, Screening, COPD|lung cancer, screening, copd
5240471|NCT02500680|Influenza|influenza
5240472|NCT02500680|Adjuvant|adjuvant
5240473|NCT02500667|N91115|n91115
5240474|NCT02500667|Rifampin|rifampin
5240475|NCT02500667|drug interaction|drug interaction
5240476|NCT02500667|Cavosonstat|cavosonstat
5240477|NCT02500654|Peri-implantitis|peri-implantitis
5240478|NCT02500654|Regenerative therapy|regenerative therapy
5240479|NCT02500654|Surgical therapy|surgical therapy
5240480|NCT02500654|Enamel matrix derivative|enamel matrix derivative
5240481|NCT02500654|Peri-implant microflora|peri-implant microflora
5240482|NCT02500654|Peri-implant fluid|peri-implant fluid
5240483|NCT02500641|Biological Markers|biological markers
5240495|NCT02500641|Tumor Necrosis Factor|tumor necrosis factor
5240496|NCT02500641|Arthritis|arthritis
5240497|NCT02500641|Hyperuricemia|hyperuricemia
5240498|NCT02500628|metformin|metformin
5240499|NCT02500628|mitochondria|mitochondria
5240500|NCT02500628|complex 1|complex 1
5240501|NCT02500628|fibromyalgia|fibromyalgia
5240502|NCT02500628|neurogenic pain|neurogenic pain
5240503|NCT02500628|diabetes|diabetes
5240504|NCT02500628|tardive dyskinesia|tardive dyskinesia
5240505|NCT02500628|heart rate variability|heart rate variability
5240506|NCT02500602|PTSD|ptsd
5240507|NCT02500602|alcohol use disorders|alcohol use disorders
5240508|NCT02500602|posttraumatic stress disorder|posttraumatic stress disorder
5240509|NCT02500602|AUD|aud
5240510|NCT02500602|Veteran|veteran
5240511|NCT02500602|substance use disorders|substance use disorders
5240512|NCT02500602|SUD|sud
5240513|NCT02500589|smoking|smoking
5240514|NCT02500589|tobacco|tobacco
5240522|NCT02500485|SHR3824 SP2086 drug-drug interaction|shr3824 sp2086 drug-drug interaction
5240523|NCT02500472|Tobacco|tobacco
5240524|NCT02500472|Smoking|smoking
5240525|NCT02500459|Topotecan|topotecan
5240526|NCT02500459|Cleveland Multiport Catheter|cleveland multiport catheter
5240527|NCT02500459|Cancer|cancer
5240528|NCT02500433|Cerebral palsy|cerebral palsy
5240529|NCT02500433|child|child
5240530|NCT02500433|rehabilitation|rehabilitation
5240531|NCT02500433|video games|video games
5240532|NCT02500433|virtual reality.|virtual reality.
5240533|NCT02500420|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5240534|NCT02500420|Stress MRI|stress mri
5240535|NCT02500420|Cardiac MRI|cardiac mri
5240536|NCT02500420|Stress echocardiography|stress echocardiography
5240547|NCT02500381|Duchenne|duchenne
5240548|NCT02500342|Thyroid Dysfunction|thyroid dysfunction
5240549|NCT02500342|Fatigue|fatigue
5240550|NCT02500342|Randomized Controlled Trial|randomized controlled trial
5240551|NCT02500342|Thyroxine|thyroxine
5240552|NCT02500342|Hypothyroidism|hypothyroidism
5240553|NCT02500316|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
5240554|NCT02500316|r-hGH|r-hgh
5240555|NCT02500316|Long-acting|long-acting
5240556|NCT02500303|Amputation|amputation
5240557|NCT02500290|ACS|acs
5240558|NCT02500277|thoracoscopy|thoracoscopy
5240559|NCT02500277|pleuroscopy|pleuroscopy
5240560|NCT02500277|semirigid thoracoscopy|semirigid thoracoscopy
5240561|NCT02500277|flexible cryoprobe|flexible cryoprobe
5240562|NCT02500277|cryobiopsy|cryobiopsy
5240563|NCT02500277|pleural biopsy|pleural biopsy
5240564|NCT02500251|Transplantation|transplantation
5240565|NCT02500251|belimumab|belimumab
5240566|NCT02500251|Velcade|velcade
5240567|NCT02500225|Etomidate|etomidate
5240568|NCT02500225|Sevoflurane|sevoflurane
5962793|NCT04278612|Child Growth|child growth
5240570|NCT02500173|radiotherapy|radiotherapy
5240571|NCT02500173|side effects|side effects
5240572|NCT02500147|Polycystic Ovary Syndrome|polycystic ovary syndrome
5240573|NCT02500147|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5240574|NCT02500147|Adolescents|adolescents
5240575|NCT02500147|Young Women|young women
5240576|NCT02500147|MRI|mri
5240577|NCT02500147|MRS|mrs
5240578|NCT02500147|DXA|dxa
5240579|NCT02500147|PNPLA3|pnpla3
5240580|NCT02500147|Metformin|metformin
5240581|NCT02500147|Randomized Clinical Trial|randomized clinical trial
5240582|NCT02500147|Placebo|placebo
5240583|NCT02500147|Hirsutism|hirsutism
5240584|NCT02500147|Acne|acne
5240585|NCT02500147|Amenorrhea|amenorrhea
5240586|NCT02500147|Metabolic Syndrome|metabolic syndrome
5240587|NCT02500147|Dyslipidemia|dyslipidemia
5240588|NCT02500147|Percentage liver fat|percentage liver fat
5335535|NCT02014896|RNA|rna
5240589|NCT02500121|Pembrolizumab|pembrolizumab
5228481|NCT02573246|Emotional Memory Task|emotional memory task
5228482|NCT02573246|Reappraisal|reappraisal
5228483|NCT02573246|Distraction|distraction
5228484|NCT02573194|Appetite|appetite
5228485|NCT02573194|Amino acids|amino acids
5228486|NCT02573194|Protein Source|protein source
5228487|NCT02573168|Pharmacogenomic|pharmacogenomic
5228497|NCT02573155|AZD8871|azd8871
5240590|NCT02500121|PD-1 Inhibitor|pd-1 inhibitor
5240591|NCT02500108|Domperidone|domperidone
5240592|NCT02500108|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
5240593|NCT02500108|Sudden cardiac death|sudden cardiac death
5240594|NCT02500108|Pharmacotherapy|pharmacotherapy
5240595|NCT02500108|Adverse events|adverse events
5240596|NCT02500082|citrate transporter deficiency|citrate transporter deficiency
5240597|NCT02500082|SLC13A5 gene|slc13a5 gene
5240598|NCT02500082|citric acid cycle|citric acid cycle
5240599|NCT02500082|energy metabolism|energy metabolism
5240600|NCT02500056|Inguinal hernia|inguinal hernia
5240601|NCT02500056|Chronic pain|chronic pain
5240602|NCT02500056|Mesh|mesh
5240603|NCT02500056|Lichtenstein hernioplasty|lichtenstein hernioplasty
5240604|NCT02500043|Gastric Cancer|gastric cancer
5240605|NCT02500043|Metastatic Gastric Cancer|metastatic gastric cancer
5240606|NCT02499965|Topical Anesthetic|topical anesthetic
5240607|NCT02499965|Ethyl Chloride|ethyl chloride
5240608|NCT02499965|Pain Reduction|pain reduction
5240609|NCT02499965|IV cannulation|iv cannulation
5240610|NCT02499952|Pembrolizumab|pembrolizumab
5240611|NCT02499952|MK-3475|mk-3475
5240612|NCT02499952|PMNSGCT|pmnsgct
5240613|NCT02499952|PD-L1|pd-l1
5240614|NCT02499952|Non Seminomatous Germ Cell Tumors|non seminomatous germ cell tumors
5240615|NCT02499848|MRI Lesion|mri lesion
5240616|NCT02499848|transperineal injection|transperineal injection
5240617|NCT02499848|prostate biopsies|prostate biopsies
5240618|NCT02499822|Hypertension|hypertension
5240619|NCT02499822|Blood pressure variability|blood pressure variability
5240620|NCT02499822|Home systolic blood pressure|home systolic blood pressure
5240623|NCT02499822|Ramipril|ramipril
5240624|NCT02499809|Vibration therapy|vibration therapy
5240625|NCT02499809|Recovery from exercise|recovery from exercise
5240626|NCT02499796|Invasive mechanical ventilation|invasive mechanical ventilation
5240627|NCT02499796|Humidifying devices|humidifying devices
5240628|NCT02499796|Respiratory mechanics|respiratory mechanics
5240629|NCT02499783|China|china
5240630|NCT02499783|Tumor necrosis factor (TNF)-alpha|tumor necrosis factor (tnf)-alpha
5240631|NCT02499783|Biologic|biologic
5246029|NCT02468778|MCS|mcs
5240646|NCT02499718|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5240647|NCT02499718|quality of life|quality of life
5240648|NCT02499718|long-term oxygen therapy|long-term oxygen therapy
5240649|NCT02499666|Exercise Capacity|exercise capacity
5240650|NCT02499666|Chronic Total Occlusion|chronic total occlusion
5240651|NCT02499653|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5240652|NCT02499653|Non Invasive Ventilation (NIV)|non invasive ventilation (niv)
5240653|NCT02499653|Acceptance|acceptance
5240654|NCT02499653|Adherence|adherence
5240655|NCT02499653|Clinical Psychology|clinical psychology
5240656|NCT02499640|Recovery of function|recovery of function
5240657|NCT02499640|Autonomic nervous system|autonomic nervous system
5240658|NCT02499640|Heart rate variability|heart rate variability
5240659|NCT02499640|Cryotherapy|cryotherapy
5240660|NCT02499640|Immersion|immersion
5240661|NCT02499627|Lymphoma|lymphoma
5240663|NCT02499627|PTCL|ptcl
5240664|NCT02499627|CD30+|cd30+
5240665|NCT02499614|MET amplification|met amplification
5240666|NCT02499614|ROS1 translocation|ros1 translocation
5240667|NCT02499614|Crizotinib|crizotinib
5240668|NCT02499601|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5240669|NCT02499601|Heart Failure (HF)|heart failure (hf)
5240670|NCT02499601|New York Heart Association functional Class (NYHA f. Cl)|new york heart association functional class (nyha f. cl)
5240671|NCT02499575|Exparel|exparel
5240672|NCT02499575|bupivacaine|bupivacaine
5240673|NCT02499575|Hallux valgus deformity|hallux valgus deformity
5240674|NCT02499575|bunionectomy|bunionectomy
5240675|NCT02499536|Atelectasis|atelectasis
5240676|NCT02499536|Postoperative|postoperative
5240677|NCT02499536|Lung ultrasound|lung ultrasound
5240678|NCT02499510|femoropopliteal disease|femoropopliteal disease
5240679|NCT02499510|restenosis|restenosis
5240680|NCT02499497|Prostate Cancer|prostate cancer
5240681|NCT02499432|Evidence Based Psychotherapy|evidence based psychotherapy
5240682|NCT02499432|Implementation|implementation
5240683|NCT02499432|PTSD|ptsd
5240684|NCT02499393|newborn|newborn
5240689|NCT02499380|LVRC|lvrc
5240690|NCT02499380|PneumRx|pneumrx
5240691|NCT02499367|triple negative|triple negative
5240692|NCT02499367|metastatic|metastatic
5240693|NCT02499341|Tramadol|tramadol
5240694|NCT02499341|Ketamine|ketamine
5240695|NCT02499341|Morphine|morphine
5240696|NCT02499328|Carcinoma of the Head and Neck|carcinoma of the head and neck
5240697|NCT02499276|mechanical ventilation|mechanical ventilation
5240698|NCT02499276|pressure support ventilation|pressure support ventilation
5240699|NCT02499276|NAVA|nava
5240701|NCT02499276|variable ventilation|variable ventilation
5240702|NCT02499276|patient ventilator asynchrony|patient ventilator asynchrony
5240703|NCT02499263|Adalimumab trough level|adalimumab trough level
5240704|NCT02499263|Fecal Calprotectin|fecal calprotectin
5240705|NCT02499263|Fecal microbiota|fecal microbiota
5240706|NCT02499250|refractory angina pectoris|refractory angina pectoris
5240707|NCT02499250|remote ischemic conditioning|remote ischemic conditioning
5240708|NCT02499250|life quality|life quality
5240709|NCT02499250|anxiety|anxiety
5240710|NCT02499250|depression|depression
5240711|NCT02499250|inflammation|inflammation
5240712|NCT02499237|osteoporosis|osteoporosis
5240713|NCT02499237|denosumab|denosumab
5240714|NCT02499237|zoledronic acid|zoledronic acid
5240715|NCT02499237|bone mineral density|bone mineral density
5240716|NCT02499237|bone markers|bone markers
5240717|NCT02499211|obesity|obesity
5240718|NCT02499211|health disparities|health disparities
5240719|NCT02499211|healthy food marketing|healthy food marketing
5240720|NCT02499211|food environments|food environments
5246162|NCT02468128|SDE|sde
5240721|NCT02499211|marketing environments|marketing environments
5240723|NCT02499211|food purchase decision making|food purchase decision making
5240724|NCT02499185|Biomarker|biomarker
5240725|NCT02499185|Intra Abdominal Surgery|intra abdominal surgery
5240726|NCT02499185|AKI|aki
5240727|NCT02499172|Adverse pregnancy outcome|adverse pregnancy outcome
5240728|NCT02499159|Exparel|exparel
5240729|NCT02499159|Thoracoscopy|thoracoscopy
5240730|NCT02499159|Bupivicaine|bupivicaine
5240731|NCT02499159|Liposomal|liposomal
5240732|NCT02499146|Palbociclib|palbociclib
5240733|NCT02499146|PD-0332991|pd-0332991
5240734|NCT02499146|pharmacokinetics|pharmacokinetics
5240735|NCT02499146|breast cancer patients|breast cancer patients
5240736|NCT02499146|Chinese|chinese
5240737|NCT02499120|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer|palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer
5240739|NCT02499107|satiety|satiety
5240740|NCT02499107|blood glucose|blood glucose
5240741|NCT02499107|potato|potato
5240742|NCT02499107|insulin|insulin
5240743|NCT02499081|Relapsed|relapsed
5240744|NCT02499081|Refractory|refractory
5240745|NCT02499081|Proteasome Inhibitor|proteasome inhibitor
5240746|NCT02499055|anxiety|anxiety
5240747|NCT02499055|behaviour therapy|behaviour therapy
5240748|NCT02499055|computer assisted therapy|computer assisted therapy
5240749|NCT02499055|psychotherapy|psychotherapy
5240750|NCT02499042|post-resuscitation|post-resuscitation
5240751|NCT02499042|oxygen therapy|oxygen therapy
5240752|NCT02499042|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5240753|NCT02499016|Appendicitis|appendicitis
5240754|NCT02499016|Appendectomy|appendectomy
5240755|NCT02499016|Single-incision|single-incision
5240759|NCT02498977|Liver|liver
5240760|NCT02498977|Transplant|transplant
5240761|NCT02498977|Immunosuppression|immunosuppression
5240762|NCT02498964|cardiac anesthesia simulation,NASA task load index|cardiac anesthesia simulation,nasa task load index
5240763|NCT02498938|Pulmonary disease,chronic obstructive,|pulmonary disease,chronic obstructive,
5240764|NCT02498938|generalized chronic periodontitis|generalized chronic periodontitis
5240765|NCT02498938|SERPINA1 gene polymorphism|serpina1 gene polymorphism
5240766|NCT02498912|T Cells|t cells
5240767|NCT02498912|Cyclophosphamide|cyclophosphamide
5240768|NCT02498912|MUC16ecto antigen|muc16ecto antigen
5240769|NCT02498912|Intraperitoneal Infusion|intraperitoneal infusion
5240770|NCT02498912|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
5240771|NCT02498912|15-014|15-014
5240772|NCT02498899|Advanced Cancers|advanced cancers
5240773|NCT02498899|Video|video
5240774|NCT02498899|Questionnaires|questionnaires
5240775|NCT02498899|Surveys|surveys
5240776|NCT02498873|VO2Max|vo2max
5240777|NCT02498873|Physical Conditioning|physical conditioning
5240778|NCT02498873|Aerobic Exercise|aerobic exercise
5240779|NCT02498873|Performance|performance
5240780|NCT02498860|adenocarcinoma|adenocarcinoma
5240781|NCT02498860|lung|lung
5240782|NCT02498860|adjuvant chemotherapy|adjuvant chemotherapy
5240783|NCT02498860|pemetrexed|pemetrexed
5240784|NCT02498860|cisplatin|cisplatin
5240785|NCT02498860|surgery|surgery
5240786|NCT02498834|Communication|communication
5240787|NCT02498834|provider|provider
5240788|NCT02498834|caregiver|caregiver
5240789|NCT02498834|adolescent|adolescent
5240790|NCT02498821|PICC|picc
5240791|NCT02498821|central catheter|central catheter
5240792|NCT02498821|vascular access|vascular access
5240793|NCT02498808|Interferon lambda|interferon lambda
5240794|NCT02498808|Interleukin-29|interleukin-29
5240795|NCT02498808|Neutrophil|neutrophil
5240796|NCT02498795|Intratissue Percutaneous Electrolysis|intratissue percutaneous electrolysis
5240797|NCT02498795|Dry needling|dry needling
5240798|NCT02498795|Eccentric exercise|eccentric exercise
5240800|NCT02498782|Chagas Disease|chagas disease
5240801|NCT02498782|Dosage forms|dosage forms
5240802|NCT02498782|Regimens|regimens
5240803|NCT02498769|Cardiac Surgery|cardiac surgery
5240804|NCT02498769|Postoperative Complications|postoperative complications
5240805|NCT02498769|Autonomic Nerve Block|autonomic nerve block
5240806|NCT02498730|bipolar disorder|bipolar disorder
5240807|NCT02498730|VO2max|vo2max
5240808|NCT02498730|aerobic exercise|aerobic exercise
5240809|NCT02498691|endometriosis|endometriosis
5240810|NCT02498691|preterm delivery|preterm delivery
5240811|NCT02498691|caesarean|caesarean
5240812|NCT02498691|Pregnancy outcomes of women with or without endometriosis|pregnancy outcomes of women with or without endometriosis
5240813|NCT02498665|Wilms' Tumor 1|wilms' tumor 1
5240814|NCT02498665|Vaccine|vaccine
5240815|NCT02498665|Neoplasms|neoplasms
5240816|NCT02498639|balloon aortic valvuloplasty|balloon aortic valvuloplasty
5241019|NCT02497378|Bortezomib|bortezomib
5240817|NCT02498639|rapid ventricular pacing|rapid ventricular pacing
5240818|NCT02498639|outcome|outcome
5240819|NCT02498626|mixed venous saturation|mixed venous saturation
5240820|NCT02498626|open heart surgery|open heart surgery
5240821|NCT02498626|children|children
5423252|NCT01616472|systemic lupus erythematosus|systemic lupus erythematosus
5240822|NCT02498600|Phase II Randomized Trial of Nivolumab with or without Ipilimumab in Patients with Persistent or Recurrent Epithelial Ovarian|phase ii randomized trial of nivolumab with or without ipilimumab in patients with persistent or recurrent epithelial ovarian
5240823|NCT02498600|Primary Peritoneal or Fallopian|primary peritoneal or fallopian
5240824|NCT02498600|Tube Cancer|tube cancer
5240825|NCT02498587|Severe Acute Respiratory Infection|severe acute respiratory infection
5240826|NCT02498496|COPD|copd
5240827|NCT02498496|AECOPD|aecopd
5240828|NCT02498496|Magnesium Sulfate|magnesium sulfate
5240829|NCT02498496|Acute exacerbation of COPD|acute exacerbation of copd
5240830|NCT02498496|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5240831|NCT02498496|ED|ed
5240832|NCT02498496|ER|er
5240833|NCT02498496|Emergency Department|emergency department
5240834|NCT02498483|Infant pain|infant pain
5240835|NCT02498483|Acetaminophen|acetaminophen
5240836|NCT02498483|Circumcision|circumcision
5240837|NCT02498457|maintenance hemodialysis patients|maintenance hemodialysis patients
5240838|NCT02498457|coronary artery calcification|coronary artery calcification
5240839|NCT02498457|low calcium dialysate|low calcium dialysate
5240840|NCT02498457|effects|effects
5240841|NCT02498457|safety|safety
5240842|NCT02498444|Fontan|fontan
5240843|NCT02498444|Treprostinil|treprostinil
5240844|NCT02498444|Remodulin|remodulin
5240845|NCT02498444|Single ventricle|single ventricle
5240846|NCT02498431|irisin|irisin
5240847|NCT02498431|myocardial infarction|myocardial infarction
5240848|NCT02498431|coronary|coronary
5240849|NCT02498392|Major Depressive Disorder|major depressive disorder
5240850|NCT02498392|Depression|depression
5240851|NCT02498392|Anxiety symptoms|anxiety symptoms
5240852|NCT02498392|JNJ-42165279|jnj-42165279
5240853|NCT02498379|novel radiotracer|novel radiotracer
5240854|NCT02498379|biodistribution|biodistribution
5240855|NCT02498379|safety|safety
5240856|NCT02498340|G6PD|g6pd
5240857|NCT02498340|genotype|genotype
5240858|NCT02498340|phenotype|phenotype
5240859|NCT02498340|diet restriction|diet restriction
5240860|NCT02498327|Chronic|chronic
5240861|NCT02498314|Manual therapy|manual therapy
5240862|NCT02498314|Hip osteoarthritis|hip osteoarthritis
5240863|NCT02498314|Mobilization|mobilization
5240864|NCT02498301|travelers' diarrhea|travelers' diarrhea
5240865|NCT02498301|military|military
5240866|NCT02498301|enteric illness|enteric illness
5240867|NCT02498301|gastrointestinal|gastrointestinal
5240868|NCT02498288|capsule|capsule
5240869|NCT02498288|Isotretinoin|isotretinoin
5240870|NCT02498288|Bioequivalence|bioequivalence
5240871|NCT02498262|Severe Mobility and Manipulation Impairments|severe mobility and manipulation impairments
5240872|NCT02498249|Low-Level Laser Therapy|low-level laser therapy
5240873|NCT02498249|trapezius muscle|trapezius muscle
5240874|NCT02498249|neck pain|neck pain
5240875|NCT02498236|Psychosis|psychosis
5240876|NCT02498236|Schizophrenia|schizophrenia
5240877|NCT02498236|Oxytocin|oxytocin
5240878|NCT02498210|IVM|ivm
5240879|NCT02498210|HIPPO signaling|hippo signaling
5240880|NCT02498171|Labour analgesia|labour analgesia
5240881|NCT02498171|Intrathecal morphine|intrathecal morphine
5240882|NCT02498171|Bupivacaine|bupivacaine
5240883|NCT02498171|Fentanyl|fentanyl
5240884|NCT02498132|Mobile Technologies|mobile technologies
5240885|NCT02498119|Type 2 DM|type 2 dm
5240886|NCT02498119|lipid bodies|lipid bodies
5240887|NCT02498106|nutrition|nutrition
5240888|NCT02498106|aggression|aggression
5240889|NCT02498106|n-3 fatty acids|n-3 fatty acids
5240890|NCT02498106|psychiatry|psychiatry
5240891|NCT02498106|inpatients admitted >2 years|inpatients admitted >2 years
5240892|NCT02498093|Resistance training|resistance training
5240893|NCT02498093|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5240894|NCT02498093|Professional-Patient Relations|professional-patient relations
5240895|NCT02498093|Evidence-based practice|evidence-based practice
5240896|NCT02498080|Drug eluting balloons|drug eluting balloons
5240897|NCT02498080|Critical limb ischemia|critical limb ischemia
5240898|NCT02498080|Infra-popliteal arteries|infra-popliteal arteries
5240899|NCT02498080|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5240900|NCT02498041|Ultrathin Nasal Endoscopy|ultrathin nasal endoscopy
5240901|NCT02498041|Barrett's Esophagus|barrett's esophagus
5240902|NCT02498041|Transnasal Endoscopy|transnasal endoscopy
5240903|NCT02498028|cervical fusion|cervical fusion
5240904|NCT02498028|cervical arthroplasty|cervical arthroplasty
5240905|NCT02498028|cervicobrachial pain|cervicobrachial pain
5240906|NCT02498002|Diet|diet
5240907|NCT02498002|Fasting|fasting
5240908|NCT02498002|Intermittent Fasting|intermittent fasting
5240909|NCT02498002|Alternate-day Fasting|alternate-day fasting
5240910|NCT02498002|Physical Activity|physical activity
5240911|NCT02498002|Glucose|glucose
5240912|NCT02498002|Insulin|insulin
5240913|NCT02498002|Appetite|appetite
5240914|NCT02497989|Male circumcision|male circumcision
5240915|NCT02497989|Demand creation|demand creation
5240916|NCT02497976|Interstitial|interstitial
5240917|NCT02497976|Cystitis|cystitis
5240919|NCT02497976|Pain|pain
5240920|NCT02497950|HeartMate 3|heartmate 3
5240921|NCT02497950|LVAS|lvas
5240922|NCT02497950|LVAD|lvad
5240923|NCT02497950|Heart-assist devices|heart-assist devices
5240924|NCT02497950|Thoratec Corporation|thoratec corporation
5240926|NCT02497937|TRPV4 Channel Blocker|trpv4 channel blocker
5240927|NCT02497937|Pharmacodynamics|pharmacodynamics
5240928|NCT02497937|Adults|adults
5240929|NCT02497937|Congestive Heart Failure|congestive heart failure
5240930|NCT02497911|Adductor Canal Catheter|adductor canal catheter
5240931|NCT02497911|Intraarticular Catheter|intraarticular catheter
5240932|NCT02497911|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5240933|NCT02497885|MERS|mers
5240934|NCT02497885|healthcare personnel|healthcare personnel
5240935|NCT02497859|Weight Reduction|weight reduction
5240936|NCT02497859|Weight Loss Diet|weight loss diet
5240937|NCT02497859|Satiety Response|satiety response
5240938|NCT02497859|Insulin|insulin
5240939|NCT02497859|Glucagon-Like Peptide 1|glucagon-like peptide 1
5240940|NCT02497859|PYY (3-36) peptide|pyy (3-36) peptide
5240941|NCT02497859|Ghrelin|ghrelin
5240942|NCT02497859|Glucose|glucose
5240943|NCT02497859|Eggs|eggs
5240944|NCT02497859|Protein|protein
5240945|NCT02497859|Energy Intake|energy intake
5240946|NCT02497859|Breakfast|breakfast
5240947|NCT02497846|Hyaluronic acid|hyaluronic acid
5240948|NCT02497846|MiconJet needle|miconjet needle
5240949|NCT02497807|Tourette syndrome|tourette syndrome
5240950|NCT02497807|Iron deficiency|iron deficiency
5240951|NCT02497794|chew gum|chew gum
5240952|NCT02497794|bowel movements|bowel movements
5240953|NCT02497794|cesarean section|cesarean section
5240954|NCT02497781|Complicated urinary tract infections (cUTIs)|complicated urinary tract infections (cutis)
5240955|NCT02497768|mastication|mastication
5240956|NCT02497768|pistachios|pistachios
5240957|NCT02497768|brazils|brazils
5240958|NCT02497768|participants|participants
5240959|NCT02497729|Endotracheal Intubation|endotracheal intubation
5240960|NCT02497729|Checklist|checklist
5240961|NCT02497729|Positioning|positioning
5240962|NCT02497690|Cochlear Implant|cochlear implant
5240963|NCT02497690|Hearing Aid|hearing aid
5240964|NCT02497690|Telemedicine|telemedicine
5240965|NCT02497677|parental sensitivity|parental sensitivity
5240966|NCT02497677|child attachment|child attachment
5240967|NCT02497664|Radiotherapy|radiotherapy
5240968|NCT02497664|Active Breathing Control Technique|active breathing control technique
5240969|NCT02497651|Smoking|smoking
5240970|NCT02497651|Diabetes|diabetes
5240971|NCT02497651|Incretin hormones|incretin hormones
5240972|NCT02497651|Glucose tolerance|glucose tolerance
5240973|NCT02497638|metformin|metformin
5240974|NCT02497638|atorvastatin|atorvastatin
5240975|NCT02497638|prostate-specific antigen|prostate-specific antigen
5240976|NCT02497638|biochemical recurrence|biochemical recurrence
5240977|NCT02497625|Low back pain|low back pain
5240978|NCT02497625|Empathy|empathy
5240979|NCT02497625|Subgroups|subgroups
5240980|NCT02497625|Minimal intervention|minimal intervention
5240981|NCT02497547|Atrophy|atrophy
5240982|NCT02497547|Pathological Conditions, Anatomical|pathological conditions, anatomical
5240983|NCT02497547|Oxytocin|oxytocin
5240984|NCT02497547|Oxytocics|oxytocics
5240985|NCT02497534|ataxia|ataxia
5240986|NCT02497534|neuromuscular|neuromuscular
5240987|NCT02497521|polycystic kidney disease|polycystic kidney disease
5240988|NCT02497521|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5110445|NCT03307356|MRKH|mrkh
5240989|NCT02497521|ADPKD|adpkd
5228869|NCT02571153|Postoperative pain|postoperative pain
5240990|NCT02497521|Tolvaptan|tolvaptan
5240991|NCT02497521|Jinarc|jinarc
5240992|NCT02497508|progressive disease after at least 1 course of chemotherapy|progressive disease after at least 1 course of chemotherapy
5240993|NCT02497495|Immersion|immersion
5240994|NCT02497495|Recovery of Function|recovery of function
5240995|NCT02497495|Lactate|lactate
5240996|NCT02497495|Creatine Kinase|creatine kinase
5240997|NCT02497495|Musculoskeletal Pain|musculoskeletal pain
5240998|NCT02497469|Drug Therapy|drug therapy
5241000|NCT02497456|Counselling|counselling
5241001|NCT02497456|Care|care
5241002|NCT02497456|antiretroviral therapy|antiretroviral therapy
5241003|NCT02497456|linkage|linkage
5241004|NCT02497456|Uganda|uganda
5241005|NCT02497456|Africa|africa
5241006|NCT02497443|drug-resistant symptomatic epilepsy|drug-resistant symptomatic epilepsy
5241007|NCT02497443|seizure|seizure
5241008|NCT02497443|autologous mesenchymal stem cells|autologous mesenchymal stem cells
5241009|NCT02497443|safety|safety
5241010|NCT02497443|remission|remission
5241011|NCT02497443|electroencephalography|electroencephalography
5241012|NCT02497443|refractory symptomatic epilepsy|refractory symptomatic epilepsy
5241013|NCT02497443|autologous MSC|autologous msc
5241014|NCT02497443|efficacy|efficacy
5241015|NCT02497417|ARIES Clostridium difficile|aries clostridium difficile
5241016|NCT02497378|Multiple Myeloma|multiple myeloma
5241017|NCT02497378|Daratumumab|daratumumab
5241018|NCT02497378|JNJ-54767414|jnj-54767414
5241020|NCT02497378|Dexamethasone|dexamethasone
5241021|NCT02497365|keratits|keratits
5241022|NCT02497365|besifloxacin|besifloxacin
5241023|NCT02497339|Smoking cessation interventions|smoking cessation interventions
5241024|NCT02497339|mindfulness training|mindfulness training
5241025|NCT02497326|second degree burns|second degree burns
5241026|NCT02497326|heparin|heparin
5241027|NCT02497326|topical|topical
5241028|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists
5241029|NCT02497300|Mineralocorticoid Effects|mineralocorticoid effects
5241030|NCT02497287|Treatment-resistant Depression|treatment-resistant depression
5241031|NCT02497287|Esketamine|esketamine
5241032|NCT02497287|Oral Antidepressant|oral antidepressant
5241033|NCT02497274|bariatric surgery|bariatric surgery
5241034|NCT02497274|taste perception|taste perception
5241035|NCT02497274|lipid receptors|lipid receptors
5241036|NCT02497261|Food Allergy|food allergy
5241037|NCT02497261|Peanut|peanut
5241038|NCT02497261|Sensitization|sensitization
5241039|NCT02497261|Child|child
5862734|NCT00001532|Alpha 1-Antitrypsin|alpha 1-antitrypsin
5241040|NCT02497261|Double-blind placebo-controlled challenge|double-blind placebo-controlled challenge
5241042|NCT02497248|Atrial Fibrillation|atrial fibrillation
5241043|NCT02497248|Pulmonary Vein Ablation|pulmonary vein ablation
5241044|NCT02497248|Mitral stenosis|mitral stenosis
5241045|NCT02497248|Body surface mapping|body surface mapping
5241046|NCT02497235|Drug therapy, Positron Emission Tomography, Brain enzyme occupancy, Cholesterol 24S-hydroxylase, CH24H|drug therapy, positron emission tomography, brain enzyme occupancy, cholesterol 24s-hydroxylase, ch24h
5241047|NCT02497196|TPCS|tpcs
5241048|NCT02497196|tDCS|tdcs
5241049|NCT02497196|visceral pain|visceral pain
5241050|NCT02497196|pancreatitis|pancreatitis
5241051|NCT02497196|healthy subjects|healthy subjects
5241052|NCT02497196|pelvic pain|pelvic pain
5241053|NCT02497196|neuromodulation|neuromodulation
5241054|NCT02497196|non-invasive brain stimulation|non-invasive brain stimulation
5241055|NCT02497157|bevacizumab|bevacizumab
5241056|NCT02497157|oxaliplatin|oxaliplatin
5241057|NCT02497157|irinotecan|irinotecan
5241058|NCT02497157|hydrochloride hydrate|hydrochloride hydrate
5241059|NCT02497157|fluorouracil|fluorouracil
5241060|NCT02497157|levofolinate calcium|levofolinate calcium
5241061|NCT02497144|interstitial lung disease|interstitial lung disease
5241062|NCT02497144|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5241063|NCT02497144|exercise capacity|exercise capacity
5241064|NCT02497144|quality of life|quality of life
5241065|NCT02497131|PTCL|ptcl
5241066|NCT02497131|CD30+|cd30+
5241067|NCT02497118|lung cancer Anti angiogenesis therapy survival|lung cancer anti angiogenesis therapy survival
5241068|NCT02497105|Epilepsy|epilepsy
5241069|NCT02497105|Intractable Seizures|intractable seizures
5241070|NCT02497105|Ketogenic Diet|ketogenic diet
5241071|NCT02497105|Biochemical Profiles|biochemical profiles
5241072|NCT02497079|Bronchoscopy|bronchoscopy
5241073|NCT02497079|Ultrasonography|ultrasonography
5241074|NCT02497079|Tuberculous lymphadenitis|tuberculous lymphadenitis
5241075|NCT02497079|Polymerase chain reaction|polymerase chain reaction
5241076|NCT02497079|Sensitivity and specificity|sensitivity and specificity
5241077|NCT02497066|topical|topical
5241078|NCT02497066|compound|compound
5241079|NCT02497066|pain|pain
5241080|NCT02497053|MPM|mpm
5241081|NCT02497040|anaesthesia|anaesthesia
5241082|NCT02497040|local anaesthesia|local anaesthesia
5241083|NCT02497040|hemodynamics|hemodynamics
5241084|NCT02497040|bupivacaine|bupivacaine
5241085|NCT02497040|levobupivacaine|levobupivacaine
5962794|NCT04278612|Nutrition|nutrition
5121044|NCT03238612|clarithromycin|clarithromycin
5241086|NCT02497027|pharmacogenetic, pharmacogenomic, depressive, mental health|pharmacogenetic, pharmacogenomic, depressive, mental health
5241087|NCT02496988|Cytokine-Induced Killer Cells|cytokine-induced killer cells
5241088|NCT02496988|Milignant Gliomas|milignant gliomas
5241089|NCT02496988|Temozolomide|temozolomide
5241090|NCT02496962|sleep deprivation|sleep deprivation
5241091|NCT02496936|Energy Expenditure|energy expenditure
5241092|NCT02496936|Appetite|appetite
5241093|NCT02496936|Satiety|satiety
5241094|NCT02496923|prophylactic NHFO|prophylactic nhfo
5241095|NCT02496923|risk of developing postoperative pulmonary complications|risk of developing postoperative pulmonary complications
5241096|NCT02496923|reduces hospital length of stay|reduces hospital length of stay
5241097|NCT02496884|chronic kidney disease|chronic kidney disease
5241098|NCT02496884|. α2δ ligands|. α2δ ligands
5241099|NCT02496884|mirogabalin|mirogabalin
5241100|NCT02496884|pain relief|pain relief
5241101|NCT02496884|kidney metabolism|kidney metabolism
5241102|NCT02496858|Young Patient|young patient
5241103|NCT02496858|Genetic Characteristics|genetic characteristics
5241104|NCT02496832|Hypoxia|hypoxia
5241105|NCT02496832|18F-FAZA|18f-faza
5241106|NCT02496832|18F-Fluoroazomycin arabinoside|18f-fluoroazomycin arabinoside
5241107|NCT02496832|Positron emission tomography|positron emission tomography
5241109|NCT02496832|Participating in study EMR200592-001|participating in study emr200592-001
5241110|NCT02496819|Children|children
5241111|NCT02496806|Polyphenols|polyphenols
5241112|NCT02496806|Absorption|absorption
5241113|NCT02496806|Metabolism|metabolism
5241114|NCT02496806|Phlorotannins|phlorotannins
5241115|NCT02496806|Seaweeds|seaweeds
5241116|NCT02496767|fast skeletal troponin activator|fast skeletal troponin activator
5241117|NCT02496767|tirasemtiv|tirasemtiv
5241118|NCT02496767|CK-2017357|ck-2017357
5241119|NCT02496767|double-blind|double-blind
5241120|NCT02496767|randomized|randomized
5241121|NCT02496767|placebo-controlled|placebo-controlled
5241135|NCT02496728|Glucose|glucose
5241136|NCT02496728|Text|text
5241137|NCT02496728|Facebook|facebook
5241138|NCT02496728|Instagram|instagram
5241139|NCT02496728|Push Notifications|push notifications
5241140|NCT02496728|Ecological Momentary Assessment|ecological momentary assessment
5241141|NCT02496702|exergaming|exergaming
5241142|NCT02496702|Senior Fitness Test|senior fitness test
5241143|NCT02496689|HPP|hpp
5241144|NCT02496689|Bone Disease|bone disease
5241145|NCT02496689|Soft Bones|soft bones
5241146|NCT02496689|Low Alkaline Phosphatase|low alkaline phosphatase
5241147|NCT02496689|genetic metabolic disorder|genetic metabolic disorder
5241148|NCT02496689|alkaline phosphatase|alkaline phosphatase
5241149|NCT02496689|rickets|rickets
5241150|NCT02496689|osteomalacia|osteomalacia
5241152|NCT02496676|MAGT1 Gene|magt1 gene
5241153|NCT02496676|Intracellular Magnesium|intracellular magnesium
5241154|NCT02496650|alcohol withdrawal state|alcohol withdrawal state
5241155|NCT02496650|dexmedetomidine|dexmedetomidine
5241156|NCT02496650|benzodiasepines|benzodiasepines
5241157|NCT02496650|intensive care|intensive care
5241158|NCT02496637|Obesity|obesity
5241159|NCT02496637|Eating Disorders|eating disorders
5241160|NCT02496637|Appetite regulation|appetite regulation
5241161|NCT02496637|Eating Regulation|eating regulation
5241162|NCT02496611|Obesity|obesity
5241163|NCT02496611|Pharmacotherapy|pharmacotherapy
5241164|NCT02496611|GLP-1|glp-1
5241165|NCT02496611|Children|children
5241166|NCT02496611|Exenatide|exenatide
5241167|NCT02496611|BYDUREON|bydureon
5241168|NCT02496611|Weight Loss|weight loss
5241169|NCT02496611|Maintenance|maintenance
5241170|NCT02496598|Reproductive Techniques, Assisted|reproductive techniques, assisted
5241171|NCT02496598|Ovarian Follicle|ovarian follicle
5241172|NCT02496585|Nintedanib (BIBF 1120)|nintedanib (bibf 1120)
5241173|NCT02496585|Prednisone|prednisone
5241174|NCT02496585|Radiation Pneumonitis|radiation pneumonitis
5241175|NCT02496572|Tuberculosis, multidrug resistant|tuberculosis, multidrug resistant
5241176|NCT02496572|Short-course regimen|short-course regimen
5241177|NCT02496572|Medecins sans Frontieres, MSF|medecins sans frontieres, msf
5241178|NCT02496572|Uzbekistan, Ministry of Health|uzbekistan, ministry of health
5241179|NCT02496559|C-reactive Protein|c-reactive protein
5241180|NCT02496559|Primary Health Care|primary health care
5241193|NCT02496507|desks|desks
5241194|NCT02496507|workplace|workplace
5241195|NCT02496507|cardiovascular|cardiovascular
5241196|NCT02496507|metabolic|metabolic
5241197|NCT02496507|qualitative|qualitative
5241198|NCT02496507|randomised controlled trial|randomised controlled trial
5241199|NCT02496468|childhood asthma|childhood asthma
5962795|NCT04278521|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5241200|NCT02496468|preschool wheeze|preschool wheeze
5241201|NCT02496468|adult asthma|adult asthma
5241202|NCT02496468|transition|transition
5241203|NCT02496468|phenotype|phenotype
5241204|NCT02496468|endotype|endotype
5241205|NCT02496468|trajectory|trajectory
5241206|NCT02496455|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
5241207|NCT02496455|pain, postoperative|pain, postoperative
5241208|NCT02496455|cesarean section|cesarean section
5241209|NCT02496442|Transurethral Resection of Prostate|transurethral resection of prostate
5229065|NCT02569970|placebo|placebo
5229066|NCT02569970|SpO2|spo2
5229075|NCT02569879|Bagota|bagota
5241210|NCT02496442|Cystoscopy|cystoscopy
5241211|NCT02496442|PCNL|pcnl
5241212|NCT02496442|RERAS|reras
5241213|NCT02496442|Urethroscopy|urethroscopy
5241214|NCT02496403|buprenorphine-naloxone combination|buprenorphine-naloxone combination
5241215|NCT02496403|Suboxone|suboxone
5241216|NCT02496403|Buprenorphine|buprenorphine
5241217|NCT02496403|Substance Use|substance use
5241218|NCT02496403|Behavioral intervention|behavioral intervention
5241219|NCT02496403|Opioid partial agonist|opioid partial agonist
5241220|NCT02496403|medication assisted therapy|medication assisted therapy
5241221|NCT02496403|opioid addiction|opioid addiction
5241222|NCT02496390|Fecal Microbial Transplantation|fecal microbial transplantation
5246631|NCT02465528|IMT|imt
5241224|NCT02496390|Metabolic disorders|metabolic disorders
5241226|NCT02496377|Anaemia|anaemia
5241227|NCT02496377|Iron deficiency|iron deficiency
5241228|NCT02496377|Ferric carboxymaltose|ferric carboxymaltose
5241229|NCT02496377|Patient blood management|patient blood management
5241230|NCT02496377|Hip arthroplasty|hip arthroplasty
5241231|NCT02496377|Knee arthroplasty|knee arthroplasty
5241232|NCT02496364|Tranexamic Acid|tranexamic acid
5241233|NCT02496364|Scoliosis|scoliosis
5241234|NCT02496364|bleeding control|bleeding control
5241235|NCT02496351|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5241236|NCT02496338|Menopause|menopause
5241237|NCT02496338|Quality of Life|quality of life
5241238|NCT02496338|Marital Satisfaction|marital satisfaction
5241239|NCT02496338|training|training
5241240|NCT02496325|Pudendal nerve block|pudendal nerve block
5241241|NCT02496325|Ultrasound guided|ultrasound guided
5241242|NCT02496325|Transperineal puncture|transperineal puncture
5241243|NCT02496325|Perineal surgery|perineal surgery
5241244|NCT02496325|children|children
5241245|NCT02496312|Apathy|apathy
5241246|NCT02496312|Goal-directed behavior|goal-directed behavior
5241247|NCT02496312|Quantitative evaluation|quantitative evaluation
5241248|NCT02496312|Sensor|sensor
5241249|NCT02496312|Ethogram|ethogram
5241250|NCT02496299|COMPARISSON|comparisson
5241251|NCT02496299|CAUDAL BLOCK|caudal block
5241252|NCT02496299|BUPIVACAINE|bupivacaine
5241253|NCT02496299|DEXAMETHASONE|dexamethasone
5241254|NCT02496286|Necessary paracentesis for symptom control|necessary paracentesis for symptom control
5241255|NCT02496273|Dendritic Cells|dendritic cells
5241256|NCT02496273|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
5241257|NCT02496273|Adeno-Associated Virus|adeno-associated virus
5241258|NCT02496260|Magnetic resonance imaging|magnetic resonance imaging
5241259|NCT02496260|Cardiac function|cardiac function
5241260|NCT02496260|Breast Cancer|breast cancer
5241261|NCT02496247|malnutrition|malnutrition
5241262|NCT02496247|undernutrition|undernutrition
5241264|NCT02496247|Guinea-Bissau|guinea-bissau
5241265|NCT02496247|food aid|food aid
5241266|NCT02496234|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5241267|NCT02496234|Acute kidney injury|acute kidney injury
5241268|NCT02496234|Renal failure|renal failure
5241269|NCT02496234|Biomarker|biomarker
5241270|NCT02496221|Cholecystokinin|cholecystokinin
5241271|NCT02496221|ultrasonography|ultrasonography
5241272|NCT02496221|Albiglutide|albiglutide
5241273|NCT02496221|Gallbladder ejection fraction|gallbladder ejection fraction
5241274|NCT02496169|PTCA|ptca
5241275|NCT02496169|stenosis|stenosis
5241276|NCT02496169|sirolimus|sirolimus
5241277|NCT02496169|stent|stent
5241278|NCT02496156|type 1 diabetes mellitus|type 1 diabetes mellitus
5241279|NCT02496156|adolescence|adolescence
5241280|NCT02496156|adherence|adherence
5241281|NCT02496156|insulin pump|insulin pump
5241282|NCT02496156|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5241283|NCT02496156|continuous glucose monitor|continuous glucose monitor
5241284|NCT02496156|shared medical decision making|shared medical decision making
5241285|NCT02496143|Healthy Volunteers|healthy volunteers
5241286|NCT02496143|Phase I|phase i
5241287|NCT02496143|Placebo controlled|placebo controlled
5241288|NCT02496143|Single Ascending Dose|single ascending dose
5241289|NCT02496143|PK|pk
5241290|NCT02496143|Oral administration|oral administration
5241291|NCT02496143|Softgel|softgel
5241292|NCT02496130|minilaparotomy|minilaparotomy
5241293|NCT02496130|morcellation|morcellation
5241294|NCT02496130|laparoscopy|laparoscopy
5241295|NCT02496104|Preterm|preterm
5241296|NCT02496104|Infant|infant
5241297|NCT02496104|Habituation|habituation
5241298|NCT02496104|APIB|apib
5241299|NCT02496065|breast cancer|breast cancer
5241300|NCT02496065|BLZ-100|blz-100
5241301|NCT02496065|Tumor Paint|tumor paint
5241302|NCT02496065|breast tumors|breast tumors
5241303|NCT02496052|amnion graft|amnion graft
5241304|NCT02496052|New biological barrier system|new biological barrier system
5241305|NCT02496039|PBA|pba
5229163|NCT02569307|Prodromal Phase|prodromal phase
5229165|NCT02569294|group interventions|group interventions
5229166|NCT02569294|emotional distress|emotional distress
5229167|NCT02569294|breast cancer|breast cancer
5229168|NCT02569294|yoga|yoga
5229188|NCT02569216|uterus|uterus
5241306|NCT02496039|involuntary crying|involuntary crying
5241307|NCT02496039|involuntary laughing|involuntary laughing
5241308|NCT02496000|Diabetes Mellitus type 2|diabetes mellitus type 2
5241309|NCT02496000|Metformin|metformin
5241310|NCT02496000|oral insulin|oral insulin
5241311|NCT02495974|Xtandi|xtandi
5241312|NCT02495974|Enzalutamide|enzalutamide
5241313|NCT02495974|Prostate cancer|prostate cancer
5241314|NCT02495974|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5241315|NCT02495961|hyperlipidemias|hyperlipidemias
5241316|NCT02495961|hyperglycemia|hyperglycemia
5241317|NCT02495961|hypertension|hypertension
5241318|NCT02495961|leptin|leptin
5241319|NCT02495961|hyperhomocysteinemia|hyperhomocysteinemia
5241320|NCT02495935|TES|tes
5241321|NCT02495935|Transcorneal Electrical Stimulation|transcorneal electrical stimulation
5241322|NCT02495935|Amblyopia|amblyopia
5246731|NCT02464865|Thai|thai
5241323|NCT02495909|paediatric schistosomiasis|paediatric schistosomiasis
5241325|NCT02495909|immunology|immunology
5241326|NCT02495883|Essential Tremor|essential tremor
5241327|NCT02495883|Magnetic Resonance Imaging|magnetic resonance imaging
5241328|NCT02495883|Therapy|therapy
5241329|NCT02495883|Alcohol|alcohol
5241330|NCT02495883|Propranolol|propranolol
5241331|NCT02495844|UCB0942|ucb0942
5241332|NCT02495844|Treatment-resistant focal epilepsy|treatment-resistant focal epilepsy
5241333|NCT02495844|Partial seizures|partial seizures
5241334|NCT02495844|Seizure therapy|seizure therapy
5241335|NCT02495831|PK study|pk study
5241336|NCT02495818|Rotator cuff syndrome|rotator cuff syndrome
5241337|NCT02495818|supraspinatus tendonitis|supraspinatus tendonitis
5241338|NCT02495818|suprascapular nerve block|suprascapular nerve block
5241339|NCT02495818|ultrasound guided|ultrasound guided
5241340|NCT02495818|supraspinatus|supraspinatus
5241341|NCT02495805|a continuous proximal adductor canal block (ACB)|a continuous proximal adductor canal block (acb)
5241342|NCT02495805|continuous femoral nerve block (FNB)|continuous femoral nerve block (fnb)
5241343|NCT02495779|PrEP|prep
5241344|NCT02495779|HIV|hiv
5241345|NCT02495779|MSM|msm
5241346|NCT02495779|Men Having Sex With Men|men having sex with men
5241347|NCT02495779|Episodic PrEP|episodic prep
5241348|NCT02495779|Adherence|adherence
5241349|NCT02495779|Episodic HIV Risk|episodic hiv risk
5241350|NCT02495766|Multiple sclerosis|multiple sclerosis
5241351|NCT02495766|Bone marrow mesenchymal stromal cells|bone marrow mesenchymal stromal cells
5241352|NCT02495766|Stem cells|stem cells
5241353|NCT02495766|Nervous System Diseases|nervous system diseases
5241354|NCT02495766|Demyelinating Diseases|demyelinating diseases
5241355|NCT02495766|Autoimmune Diseases|autoimmune diseases
5241356|NCT02495753|cesarean section|cesarean section
5241357|NCT02495753|wound infection|wound infection
5241358|NCT02495753|vaginal cleansing|vaginal cleansing
5241359|NCT02495753|endometritis|endometritis
5241360|NCT02495727|Step-reduction model|step-reduction model
5241361|NCT02495727|Reduced activity|reduced activity
5241362|NCT02495727|Atrophy|atrophy
5241363|NCT02495727|Skeletal Muscle|skeletal muscle
5241364|NCT02495727|Sarcopenia|sarcopenia
5241365|NCT02495727|Dynapenia|dynapenia
5241366|NCT02495714|Exercise|exercise
5241367|NCT02495714|Diet|diet
5241368|NCT02495714|Learning|learning
5241369|NCT02495688|General Anesthesia|general anesthesia
5241370|NCT02495688|Regional Anesthesia|regional anesthesia
5241371|NCT02495662|Vascular access|vascular access
5241372|NCT02495662|Hemodialysis|hemodialysis
5241373|NCT02495662|Arteriovenous shunt|arteriovenous shunt
5241374|NCT02495662|Arteriovenous fistula|arteriovenous fistula
5241375|NCT02495662|Maturation|maturation
5241376|NCT02495662|Liposomal prednisolone|liposomal prednisolone
5241377|NCT02495662|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
5241378|NCT02495662|Radio-cephalic|radio-cephalic
5241379|NCT02495662|Shunt|shunt
5241380|NCT02495610|NPH|nph
5241381|NCT02495610|Gait analysis|gait analysis
5241382|NCT02495610|neuropsychology|neuropsychology
5241383|NCT02495610|micturition diary|micturition diary
5241384|NCT02495610|MRI|mri
5241385|NCT02495597|bronchial inflammation|bronchial inflammation
5241386|NCT02495597|Bronchiolitis obliterans|bronchiolitis obliterans
5241387|NCT02495597|Sputum|sputum
5241388|NCT02495597|Blood|blood
5241389|NCT02495597|Inflammation|inflammation
5241390|NCT02495597|adaptive immune system|adaptive immune system
5241391|NCT02495597|innate immune system|innate immune system
5241392|NCT02495584|Vitamin D|vitamin d
5241393|NCT02495584|Fortified milk|fortified milk
5241394|NCT02495584|Supplementation|supplementation
5241395|NCT02495584|UV exposure|uv exposure
5241396|NCT02495584|Winter|winter
5241397|NCT02495584|Healthy adults|healthy adults
5241398|NCT02495584|Body Composition|body composition
5241399|NCT02495584|Muscle function|muscle function
5241400|NCT02495584|Blood pressure|blood pressure
5241401|NCT02495571|ALS and Dysphagia|als and dysphagia
5241402|NCT02495571|ALS and cough|als and cough
5241403|NCT02495571|cough reflex test|cough reflex test
5121384|NCT03236402|Opinion|opinion
5241404|NCT02495558|Cough Reflex test|cough reflex test
5241405|NCT02495558|Decannulation|decannulation
5241406|NCT02495545|spinal cord injury (SCI)|spinal cord injury (sci)
5241407|NCT02495532|Neoplasm Metastasis|neoplasm metastasis
5241408|NCT02495532|Colorectal Neoplasms|colorectal neoplasms
5241409|NCT02495532|Lymph Nodes|lymph nodes
5241410|NCT02495532|Lymph Node Revealing Solution|lymph node revealing solution
5241411|NCT02495506|Cardiac surgery|cardiac surgery
5241412|NCT02495506|bleeding|bleeding
5241413|NCT02495506|platelet transfusion|platelet transfusion
5241414|NCT02495480|disposable sheath|disposable sheath
5241415|NCT02495480|intubation|intubation
5241416|NCT02495480|colonoscopy|colonoscopy
5241417|NCT02495428|Bandage|bandage
5241418|NCT02495428|Treadmill|treadmill
5241419|NCT02495428|Lactate Acid|lactate acid
5241420|NCT02495389|urinary urgency incontinence|urinary urgency incontinence
5241421|NCT02495376|YACS|yacs
5241422|NCT02495376|cancer|cancer
5241423|NCT02495376|MBSR|mbsr
5241424|NCT02495311|adenomyosis|adenomyosis
5241425|NCT02495311|uterine myoma|uterine myoma
5241426|NCT02495311|lower urinary tract symptoms|lower urinary tract symptoms
5241427|NCT02495311|sexual dysfunction|sexual dysfunction
5241428|NCT02495311|gastrointestinal symptom|gastrointestinal symptom
5241429|NCT02495298|Fascial manipulation|fascial manipulation
5241430|NCT02495298|Carpal Tunnel Syndrome|carpal tunnel syndrome
5241431|NCT02495285|pediatric patients gelatine|pediatric patients gelatine
5241432|NCT02495272|Postpartum hemorrhage|postpartum hemorrhage
5241433|NCT02495272|Third stage of labour|third stage of labour
5241434|NCT02495272|Oxytocin|oxytocin
5241435|NCT02495272|Uterotonics|uterotonics
5241436|NCT02495272|Active management of third stage of labour|active management of third stage of labour
5241437|NCT02495259|Double-lumen endobronchial tube|double-lumen endobronchial tube
5241438|NCT02495259|Laryngoscopy|laryngoscopy
5241439|NCT02495259|intubating stylet|intubating stylet
5241440|NCT02495233|Erlotinib|erlotinib
5241441|NCT02495233|ASP2215|asp2215
5241442|NCT02495233|NSCLC|nsclc
5241443|NCT02495233|Gilteritinib|gilteritinib
5241444|NCT02495233|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5241445|NCT02495220|dexmedetomidine|dexmedetomidine
5241446|NCT02495220|subtenon anesthesia|subtenon anesthesia
5241447|NCT02495220|postoperative pain|postoperative pain
5241449|NCT02495194|Promotion of psychological well-being|promotion of psychological well-being
5241450|NCT02495194|Horticultural therapy|horticultural therapy
5241451|NCT02495194|Randomized Controlled Trial|randomized controlled trial
5241452|NCT02495194|Gardening|gardening
5241453|NCT02495194|Elderly|elderly
5241454|NCT02495129|Primary Sjögren's syndrome|primary sjögren's syndrome
5241455|NCT02495129|Sicca syndrome|sicca syndrome
5241456|NCT02495129|Salivary glands|salivary glands
5241457|NCT02495129|Positron Emission Tomography|positron emission tomography
5241458|NCT02495129|B cell depletion|b cell depletion
5241459|NCT02495103|Dose-Escalation|dose-escalation
5241460|NCT02495103|Maximum Tolerated Dose|maximum tolerated dose
5241462|NCT02495103|Overall Response|overall response
5241463|NCT02495090|Hypospadias|hypospadias
5241464|NCT02495090|exome sequencing|exome sequencing
5241465|NCT02495090|genital malformation|genital malformation
5241466|NCT02495077|Kidney Transplantation|kidney transplantation
5241467|NCT02495077|infliximab|infliximab
5241468|NCT02495077|Tissue Donors|tissue donors
5241469|NCT02495077|Remicade|remicade
5241470|NCT02495077|Induction Therapy|induction therapy
5241471|NCT02495077|Deceased Donor Kidney Transplant Recipients|deceased donor kidney transplant recipients
5241472|NCT02495051|gastroesophageal reflux|gastroesophageal reflux
5241473|NCT02495051|barrett esophagus|barrett esophagus
5241474|NCT02495038|combination|combination
5241475|NCT02495038|rocuronium|rocuronium
5241476|NCT02495038|cisatracurium|cisatracurium
5241477|NCT02495038|neuromuscular blockade monitoring|neuromuscular blockade monitoring
5241478|NCT02495038|drug synergism|drug synergism
5241479|NCT02495012|efficacy|efficacy
5241480|NCT02495012|safety|safety
5241481|NCT02495012|STEMI|stemi
5241482|NCT02494999|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5241483|NCT02494999|immunogenicity|immunogenicity
5241484|NCT02494999|safety|safety
5241485|NCT02494986|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
5241486|NCT02494986|Rilpivirine|rilpivirine
5241487|NCT02494986|Roll-over study|roll-over study
5241488|NCT02494986|Pediatrics|pediatrics
5241489|NCT02494960|smoking cessation intervention|smoking cessation intervention
5241490|NCT02494947|Coronary Angiography|coronary angiography
5241491|NCT02494947|Exercise|exercise
5241492|NCT02494921|Metastatic|metastatic
5241493|NCT02494921|Castration-Resistant|castration-resistant
5241494|NCT02494908|Parkinson Disease|parkinson disease
5241495|NCT02494908|MRI|mri
5241496|NCT02494882|Ruxolitinib|ruxolitinib
5241497|NCT02494882|Dasatinib|dasatinib
5962796|NCT04278482|Vegetarian diets|vegetarian diets
5241498|NCT02494882|Dexamethasone|dexamethasone
5241499|NCT02494882|14-272|14-272
5241500|NCT02494869|Aerobic Training|aerobic training
5241501|NCT02494869|Exercise|exercise
5241502|NCT02494869|Gene Expression|gene expression
5121464|NCT03236038|malnutrition|malnutrition
5241503|NCT02494869|15-093|15-093
5241504|NCT02494856|Naproxen|naproxen
5241505|NCT02494856|Lower third molar|lower third molar
5241506|NCT02494856|Oral Surgery|oral surgery
5241507|NCT02494856|Esomeprazole|esomeprazole
5241508|NCT02494830|Anesthetic Drugs|anesthetic drugs
5241509|NCT02494817|HIV prevention|hiv prevention
5241510|NCT02494817|Toolkit|toolkit
5241511|NCT02494817|Male couples|male couples
5241512|NCT02494817|Sexual agreements|sexual agreements
5241513|NCT02494804|Cytokine-Induced Killer Cells|cytokine-induced killer cells
5241514|NCT02494804|Milignant Gliomas|milignant gliomas
5241515|NCT02494804|Temozolomide|temozolomide
5241516|NCT02494778|Huntington's disease, pridopidine|huntington's disease, pridopidine
5241517|NCT02494765|I-gelTM|i-geltm
5241518|NCT02494765|Ambu® AuraOnceTM|ambu® auraoncetm
5241519|NCT02494765|supraglottic devices|supraglottic devices
5241520|NCT02494765|laryngeal mask effects on airway|laryngeal mask effects on airway
5241521|NCT02494765|3D magnetic resonance imaging|3d magnetic resonance imaging
5241522|NCT02494752|Contour deformities of face|contour deformities of face
5241523|NCT02494752|autologous fat grafting|autologous fat grafting
5241524|NCT02494752|Post traumatic facial contour defects|post traumatic facial contour defects
5241525|NCT02494739|antioxidant|antioxidant
5241526|NCT02494739|oxidative stress|oxidative stress
5241527|NCT02494739|inflammation|inflammation
5241528|NCT02494739|polyphenols|polyphenols
5241529|NCT02494739|yogurt|yogurt
5241530|NCT02494726|Ischemic stroke|ischemic stroke
5241531|NCT02494726|ICH stroke|ich stroke
5241533|NCT02494726|Thromboelastography|thromboelastography
5241534|NCT02494726|Stroke|stroke
5241535|NCT02494713|Advanced Prostate Cancer|advanced prostate cancer
5241536|NCT02494713|Neoadjuvant|neoadjuvant
5241537|NCT02494713|Hormone therapy|hormone therapy
5241538|NCT02494713|ADT|adt
5241539|NCT02494713|Androgen Deprivation Therapy|androgen deprivation therapy
5241540|NCT02494713|Chemotherapy|chemotherapy
5241541|NCT02494713|Radical Prostatectomy|radical prostatectomy
5241542|NCT02494661|Public Health|public health
5241543|NCT02494661|Community|community
5241544|NCT02494661|Obesity|obesity
5241545|NCT02494661|Hispanic|hispanic
5241546|NCT02494661|Women|women
5241547|NCT02494661|Nutrition|nutrition
5241548|NCT02494661|Mindfulness and stress|mindfulness and stress
5241549|NCT02494661|Food shopping|food shopping
5241550|NCT02494648|Obstructive sleep apnea|obstructive sleep apnea
5241551|NCT02494648|Resistive inspiratory muscle training|resistive inspiratory muscle training
5241552|NCT02494648|Coronary artery disease|coronary artery disease
5241553|NCT02494648|Cardiac rehabilitation|cardiac rehabilitation
5241554|NCT02494583|Gastric carcinoma|gastric carcinoma
5241555|NCT02494583|Gastric cancer|gastric cancer
5241556|NCT02494583|Gastroesophageal junction cancer|gastroesophageal junction cancer
5241557|NCT02494583|Gastroesophageal junction carcinoma|gastroesophageal junction carcinoma
5241558|NCT02494583|Programmed Cell Death-1 (PD1, PD-1),|programmed cell death-1 (pd1, pd-1),
5241559|NCT02494583|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5241560|NCT02494583|Programmed Cell Death Receptor Ligand 2 (PDL2, PD-L2)|programmed cell death receptor ligand 2 (pdl2, pd-l2)
5241562|NCT02494544|knee replacement|knee replacement
5241563|NCT02494544|total knee replacement|total knee replacement
5241564|NCT02494531|Alzheimer Disease|alzheimer disease
5241565|NCT02494531|PET|pet
5241566|NCT02494531|diagnosis|diagnosis
5241567|NCT02494531|MCI|mci
5241568|NCT02494531|illiterate|illiterate
5241569|NCT02494518|stroke|stroke
5241570|NCT02494518|aerobic exercise|aerobic exercise
5241571|NCT02494518|forced exercise|forced exercise
5241572|NCT02494518|repetitive task practice|repetitive task practice
5241573|NCT02494518|arm function|arm function
5241574|NCT02494518|upper extremity|upper extremity
5241575|NCT02494505|chronic inflammatory demyelinating polyradiculopathy|chronic inflammatory demyelinating polyradiculopathy
5241579|NCT02494505|Clinical trial|clinical trial
5241581|NCT02494492|Uveitis|uveitis
5241582|NCT02494492|Lymphocyte cells|lymphocyte cells
5241583|NCT02494492|lymphocyte T regulator|lymphocyte t regulator
5241584|NCT02494492|vitreous haze|vitreous haze
5241585|NCT02494492|intravitreal injection|intravitreal injection
5241586|NCT02494479|Psoriasis|psoriasis
5241587|NCT02494479|Topical Psoriasis|topical psoriasis
5241588|NCT02494479|Mild Psoriasis|mild psoriasis
5241589|NCT02494479|Moderate Psoriasis|moderate psoriasis
5241590|NCT02494479|Active Psoriasis|active psoriasis
5241591|NCT02494479|Plaque Psoriasis|plaque psoriasis
5241592|NCT02494479|Skin Diseases|skin diseases
5229463|NCT02567773|Selective Androgen Receptor Modulator|selective androgen receptor modulator
5229465|NCT02567773|Pharmacokinetics|pharmacokinetics
5229466|NCT02567773|Tolerability|tolerability
5229467|NCT02567760|MP1|mp1
5229468|NCT02567760|cognitive enhancing effect|cognitive enhancing effect
5229469|NCT02567760|menopausal women|menopausal women
5229471|NCT02567747|otitis|otitis
5241593|NCT02494466|Airway Resistance|airway resistance
5241594|NCT02494466|montelukast sodium|montelukast sodium
5962797|NCT04278482|Plant-based diets|plant-based diets
5241595|NCT02494466|laryngeal mask airway|laryngeal mask airway
5241597|NCT02494427|Inlays|inlays
5241598|NCT02494427|Onlays|onlays
5241599|NCT02494414|Cardiac arrest|cardiac arrest
5241600|NCT02494414|outcome|outcome
5241601|NCT02494414|neurological status|neurological status
5241602|NCT02494401|systemic sclerosis|systemic sclerosis
5241603|NCT02494401|ssc|ssc
5241604|NCT02494375|Sleep|sleep
5241605|NCT02494375|glycemic control|glycemic control
5241606|NCT02494375|type 1 diabetes|type 1 diabetes
5241607|NCT02494375|amylase|amylase
5241608|NCT02494375|body composition|body composition
5241609|NCT02494375|lean|lean
5241610|NCT02494375|overweight|overweight
5241611|NCT02494375|obese|obese
5241612|NCT02494362|Hand exercises|hand exercises
5241613|NCT02494362|Hand function|hand function
5241614|NCT02494362|Computer based exercises|computer based exercises
5241615|NCT02494362|Therapeutic gaming|therapeutic gaming
5241616|NCT02494349|α1-blockers|α1-blockers
5241617|NCT02494349|antimuscarinic agent|antimuscarinic agent
5241618|NCT02494323|Dual Channel Functional Electrical Stimulation|dual channel functional electrical stimulation
5241619|NCT02494323|dropfoot, balanced dorsiflexion|dropfoot, balanced dorsiflexion
5241620|NCT02494284|Coronary artery disease|coronary artery disease
5241925|NCT02492581|EQ5D|eq5d
5241621|NCT02494284|Dual antiplatelet platelet therapy|dual antiplatelet platelet therapy
5241622|NCT02494284|Drug eluting stent|drug eluting stent
5241623|NCT02494258|CC-486|cc-486
5241624|NCT02494258|Oral Azacitidine|oral azacitidine
5241625|NCT02494258|Solid tumors|solid tumors
5241627|NCT02494258|rollover study|rollover study
5241628|NCT02494245|Rehabilitation|rehabilitation
5241629|NCT02494245|Intervention|intervention
5241630|NCT02494245|Walking|walking
5241631|NCT02494232|minor blunt thoracic trauma|minor blunt thoracic trauma
5241632|NCT02494232|physical examination|physical examination
5241633|NCT02494219|Group A streptococcal pharyngitis|group a streptococcal pharyngitis
5241634|NCT02494219|Rapid streptococcal test|rapid streptococcal test
5241635|NCT02494219|Throat swab culture|throat swab culture
5241636|NCT02494206|QBX258|qbx258
5241637|NCT02494206|human monoclonal antibodies|human monoclonal antibodies
5241638|NCT02494206|VAK694|vak694
5241639|NCT02494206|QAX576|qax576
5241640|NCT02494206|15-085|15-085
5241641|NCT02494180|fentanyl|fentanyl
5241642|NCT02494180|midazolam|midazolam
5241643|NCT02494180|pethidine|pethidine
5241644|NCT02494180|diazepam|diazepam
5241648|NCT02494128|Child health service|child health service
5241649|NCT02494128|Family health|family health
5241650|NCT02494128|Nurse|nurse
5241651|NCT02494128|Education|education
5241652|NCT02494128|Parental group|parental group
5241653|NCT02494128|Group leadership|group leadership
5241654|NCT02494128|Health promotion|health promotion
5241655|NCT02494102|Obstructive Sleep Apnea|obstructive sleep apnea
5241656|NCT02494102|General Anesthesia|general anesthesia
5241657|NCT02494102|Modafinil|modafinil
5241663|NCT02494063|cervical cancer|cervical cancer
5241664|NCT02494063|sentinel lymph node|sentinel lymph node
5241665|NCT02494063|lymphadenectomy|lymphadenectomy
5241666|NCT02494050|Depression|depression
5241667|NCT02494050|Bipolar Disorder|bipolar disorder
5241668|NCT02494050|Anhedonia|anhedonia
5241669|NCT02494050|Women|women
5241670|NCT02494024|PSP|psp
5241671|NCT02494024|C2N-8E12|c2n-8e12
5241672|NCT02494024|tauopathy|tauopathy
5241673|NCT02494024|Progressive Supranuclear Palsy|progressive supranuclear palsy
5241674|NCT02494024|Steele Richardson Olszewski Syndrome|steele richardson olszewski syndrome
5241675|NCT02494024|Humanized anti-tau antibody|humanized anti-tau antibody
5241676|NCT02494011|Colles' Fracture; CKCE; Russian current|colles' fracture; ckce; russian current
5241677|NCT02493998|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
5241678|NCT02493985|Brain physiology|brain physiology
5229558|NCT02567214|dyspnea|dyspnea
5229559|NCT02567214|exercise|exercise
5229560|NCT02567214|shuttle test|shuttle test
5229561|NCT02567214|long-acting β2-agonists|long-acting β2-agonists
5229562|NCT02567214|longacting muscarinic antagonist|longacting muscarinic antagonist
5229563|NCT02567214|indacaterol|indacaterol
5229564|NCT02567214|glycopyrronium|glycopyrronium
5229565|NCT02567214|tiotropium|tiotropium
5241679|NCT02493985|Intracranial pressure|intracranial pressure
5241680|NCT02493985|Cognition|cognition
5241681|NCT02493985|Cerebrovascular|cerebrovascular
5241682|NCT02493985|Head down tilt|head down tilt
5241683|NCT02493985|Space flight|space flight
5241684|NCT02493972|ovarian cancer|ovarian cancer
5241685|NCT02493972|peritoneal carcinosis|peritoneal carcinosis
5241686|NCT02493972|manual exploration|manual exploration
5241687|NCT02493972|surgery|surgery
5241688|NCT02493972|GelPort|gelport
5241689|NCT02493959|PYY|pyy
5241690|NCT02493959|Degradation|degradation
5241691|NCT02493959|kinetics|kinetics
5241692|NCT02493959|men|men
5241693|NCT02493920|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
5241694|NCT02493920|Delivery Room|delivery room
5241695|NCT02493920|Resuscitation|resuscitation
5241696|NCT02493920|Premature birth|premature birth
5121704|NCT03234712|Cancer|cancer
5241697|NCT02493920|Infant, Newborn|infant, newborn
5241698|NCT02493920|Respiration Artificial|respiration artificial
5241699|NCT02493894|Bowel preparation|bowel preparation
5241700|NCT02493894|perioperative bleeding|perioperative bleeding
5241701|NCT02493894|lumbar fusion|lumbar fusion
5241702|NCT02493881|Motor function of the extralaryngeal branches|motor function of the extralaryngeal branches
5241703|NCT02493881|intraoperative neuromonitoring|intraoperative neuromonitoring
5241704|NCT02493881|recurrent laryngeal nerve|recurrent laryngeal nerve
5241705|NCT02493868|Treatment-resistant Depression|treatment-resistant depression
5241706|NCT02493868|Esketamine|esketamine
5241707|NCT02493868|Placebo|placebo
5241708|NCT02493868|Oral Antidepressant|oral antidepressant
5241709|NCT02493868|Relapse prevention|relapse prevention
5241710|NCT02493855|Treatment naive|treatment naive
5241711|NCT02493855|HCV|hcv
5241712|NCT02493855|Interferon free|interferon free
5241713|NCT02493855|Hepatitis C Genotype 1a|hepatitis c genotype 1a
5241714|NCT02493855|Chronic Hepatitis C|chronic hepatitis c
5241715|NCT02493855|Hepatitis C|hepatitis c
5241716|NCT02493842|Nerve Stimulation|nerve stimulation
5241717|NCT02493842|Neuroplasticity|neuroplasticity
5241718|NCT02493842|Sensory Feedback|sensory feedback
5241719|NCT02493790|cognitive dysfunction|cognitive dysfunction
5241720|NCT02493790|Activity of Daily Living|activity of daily living
5241721|NCT02493790|interference|interference
5241722|NCT02493790|rehabilitation|rehabilitation
5241723|NCT02493790|cognitive-motor dual task|cognitive-motor dual task
5241724|NCT02493751|Cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib|cancer, renal cell cancer, kidney disease, kidney neoplasms, axitinib
5241725|NCT02493673|Continuous Positive Airway Pressure|continuous positive airway pressure
5241726|NCT02493673|Stroke|stroke
5241727|NCT02493673|Cerebrovascular reactivity|cerebrovascular reactivity
5241728|NCT02493673|Brain oxygenation|brain oxygenation
5241729|NCT02493660|Massive Rotator Cuff Tear|massive rotator cuff tear
5241730|NCT02493660|Arthroscopy|arthroscopy
5241731|NCT02493660|Shoulder Joint|shoulder joint
5241732|NCT02493660|Rotator cuff partial repair|rotator cuff partial repair
5241733|NCT02493634|Magnetic Resonance spectroscopy|magnetic resonance spectroscopy
5241734|NCT02493634|Aortic Arch|aortic arch
5241735|NCT02493621|Pain, Postoperative|pain, postoperative
5241736|NCT02493621|Nerve Block|nerve block
5241737|NCT02493621|Anesthesia, Epidural|anesthesia, epidural
5241738|NCT02493582|CIK|cik
5241739|NCT02493582|Apatinib|apatinib
5241740|NCT02493582|Lung Adenocarcinoma|lung adenocarcinoma
5241741|NCT02493569|Breast cancer, hospital, epidemiology, diagnosis, treatment|breast cancer, hospital, epidemiology, diagnosis, treatment
5241742|NCT02493556|Phototherapy|phototherapy
5241743|NCT02493556|Plyometric exercise|plyometric exercise
5241744|NCT02493556|Muscle recovery|muscle recovery
5241745|NCT02493543|autoantibodies|autoantibodies
5241746|NCT02493530|MDS/MPN|mds/mpn
5241747|NCT02493504|Heparin|heparin
5241748|NCT02493491|dysphonia|dysphonia
5241749|NCT02493491|dysphagia|dysphagia
5241750|NCT02493491|neurogenic|neurogenic
5241751|NCT02493491|vocal fold augmentation|vocal fold augmentation
5241752|NCT02493491|VFA|vfa
5241753|NCT02493491|vocal fold insufficiency|vocal fold insufficiency
5241754|NCT02493491|Prolaryn|prolaryn
5241755|NCT02493491|Radiesse|radiesse
5241756|NCT02493491|Coaptite|coaptite
5241757|NCT02493491|voice|voice
5241758|NCT02493491|Parkinson's Disease|parkinson's disease
5241759|NCT02493491|Multiple Sclerosis|multiple sclerosis
5241760|NCT02493491|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5229652|NCT02566720|tractography|tractography
5229653|NCT02566720|mri|mri
5229654|NCT02566720|coma|coma
5229655|NCT02566720|abi|abi
5229656|NCT02566720|tbi|tbi
5229659|NCT02566668|Asthma|asthma
5241761|NCT02493491|ALS|als
5241762|NCT02493491|MS|ms
5241763|NCT02493491|calcium hydroxylapatite|calcium hydroxylapatite
5241764|NCT02493491|hyaluronic acid|hyaluronic acid
5241765|NCT02493478|Intubation|intubation
5241766|NCT02493478|Advanced airway intervention|advanced airway intervention
5241767|NCT02493478|Intensive care unit|intensive care unit
5241768|NCT02493465|everolimus|everolimus
5241769|NCT02493465|left ventricular hypertrophy|left ventricular hypertrophy
5241770|NCT02493439|Best Possible Self|best possible self
5241771|NCT02493439|Positive Psychology|positive psychology
5241772|NCT02493439|Romanian Immigrants|romanian immigrants
5241773|NCT02493439|Optimism|optimism
5241774|NCT02493439|Future Thinking|future thinking
5241775|NCT02493413|psychoneuroimmunology|psychoneuroimmunology
5241776|NCT02493413|stress|stress
5241777|NCT02493413|lymphocyte population|lymphocyte population
5241778|NCT02493413|personality type|personality type
5962798|NCT04278482|Vegetarians|vegetarians
5241779|NCT02493413|obesity|obesity
5241780|NCT02493413|heart rate variability|heart rate variability
5241781|NCT02493413|awareness|awareness
5241782|NCT02493400|Follow up|follow up
5241783|NCT02493400|Exercise|exercise
5241784|NCT02493400|Rehabilitation|rehabilitation
5241785|NCT02493387|Physiotherapist led group-based exercise|physiotherapist led group-based exercise
5241786|NCT02493387|Physical activity|physical activity
5241787|NCT02493387|Atrial fibrillation|atrial fibrillation
5111326|NCT03301714|elderly|elderly
5121829|NCT03234036|PK|pk
5241788|NCT02493348|Fibromyalgia|fibromyalgia
5241789|NCT02493348|Rhythmic Sensory Stimulation|rhythmic sensory stimulation
5241790|NCT02493348|Gamma Stimulation|gamma stimulation
5241791|NCT02493283|dapsone|dapsone
5241792|NCT02493283|blood leucocytes|blood leucocytes
5241793|NCT02493283|pharmacokinetics|pharmacokinetics
5241794|NCT02493283|metabolism|metabolism
5241795|NCT02493270|smoking cessation|smoking cessation
5241796|NCT02493270|tobacco|tobacco
5241797|NCT02493270|dental|dental
5241798|NCT02493270|periodontal|periodontal
5241799|NCT02493257|nonallergic irritant rhinitis|nonallergic irritant rhinitis
5241800|NCT02493257|nasal congestion|nasal congestion
5241801|NCT02493257|rhinorrhea|rhinorrhea
5241802|NCT02493218|mindfulness|mindfulness
5241803|NCT02493218|intervention|intervention
5241804|NCT02493218|african american|african american
5241805|NCT02493218|youth|youth
5241806|NCT02493218|stress|stress
5241807|NCT02493218|poverty|poverty
5241808|NCT02493205|Implantable Cardiac Monitor|implantable cardiac monitor
5241809|NCT02493205|Stent|stent
5241810|NCT02493192|Parturition|parturition
5241811|NCT02493192|Humanizing Deliver|humanizing deliver
5241812|NCT02493192|Labor Pain|labor pain
5241813|NCT02493192|Natural Childbirth|natural childbirth
5241814|NCT02493192|Labor Onset|labor onset
5241815|NCT02493192|First Labor Stage|first labor stage
5241816|NCT02493192|Birth ball|birth ball
5241817|NCT02493192|meperidine|meperidine
5241818|NCT02493192|pethidine|pethidine
5241819|NCT02493140|Weight management|weight management
5241820|NCT02493140|cashew apple extract|cashew apple extract
5241821|NCT02493140|overweight|overweight
5241822|NCT02493101|Periostin staining|periostin staining
5241823|NCT02493101|Urine periostin level|urine periostin level
5241824|NCT02493101|Lupus nephritis|lupus nephritis
5241825|NCT02493101|IgA nephropathy|iga nephropathy
5241826|NCT02493075|atrial fibrillation|atrial fibrillation
5241827|NCT02493075|Catheter Ablation|catheter ablation
5241828|NCT02493075|contact force|contact force
5241829|NCT02493075|Chinese-specific|chinese-specific
5241830|NCT02493062|Hysterotomy|hysterotomy
5241831|NCT02493062|Myelomeningocele|myelomeningocele
5241832|NCT02493062|Open fetal surgery|open fetal surgery
5241833|NCT02493062|Sonohysterogram|sonohysterogram
5241834|NCT02493049|Multiple Sclerosis|multiple sclerosis
5241835|NCT02493049|Domperidone|domperidone
5241836|NCT02493049|Relapsing-Remitting MS|relapsing-remitting ms
5241837|NCT02493049|Demyelinating disease|demyelinating disease
5241838|NCT02493049|Remyelination|remyelination
5241839|NCT02493023|Bronchoscopy|bronchoscopy
5241840|NCT02493023|Bronchoscopes|bronchoscopes
5241841|NCT02493010|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5241843|NCT02493010|Public Speaking|public speaking
5241844|NCT02493010|Social Phobia|social phobia
5241845|NCT02493010|Biofeedback|biofeedback
5241846|NCT02492997|body fat|body fat
5241847|NCT02492984|FVIII inhibitor|fviii inhibitor
5241848|NCT02492971|Assistive technology|assistive technology
5241849|NCT02492971|functional needs|functional needs
5241850|NCT02492971|system usability|system usability
5241851|NCT02492945|Tennis elbow|tennis elbow
5241852|NCT02492945|Polydeoxyribonucleotides|polydeoxyribonucleotides
5229752|NCT02566070|Enteral feeding|enteral feeding
5229753|NCT02566070|Continuous gastric feeding|continuous gastric feeding
5229754|NCT02566070|Bolus gastric feeding|bolus gastric feeding
5229755|NCT02566044|Cystic Fibrosis|cystic fibrosis
5241853|NCT02492945|Prolotherapy|prolotherapy
5241854|NCT02492945|Randomized controlled trial|randomized controlled trial
5241855|NCT02492945|Visual analogue scale|visual analogue scale
5241856|NCT02492945|disability|disability
5241857|NCT02492945|ultrasonography|ultrasonography
5241858|NCT02492919|cardiac surgery|cardiac surgery
5241859|NCT02492919|risk factors|risk factors
5241860|NCT02492919|infection|infection
5241861|NCT02492880|stimulation|stimulation
5241862|NCT02492880|implantable|implantable
5241863|NCT02492880|pulse generator|pulse generator
5241864|NCT02492880|back pain|back pain
5241865|NCT02492880|chronic pain|chronic pain
5241866|NCT02492880|leg pain|leg pain
5241867|NCT02492854|Lower Extremity Bypass|lower extremity bypass
5241868|NCT02492854|Surgical Site Infection|surgical site infection
5241869|NCT02492854|Wound Dressing|wound dressing
5241870|NCT02492854|Negative Pressure Wound Dressing|negative pressure wound dressing
5241871|NCT02492841|dentin substitute|dentin substitute
5962799|NCT04278482|Vegans|vegans
5962800|NCT04278482|docosahexaenoic acid|docosahexaenoic acid
5241872|NCT02492841|vital pulp therapy|vital pulp therapy
5241873|NCT02492841|Biodentine|biodentine
5241874|NCT02492841|caries|caries
5241875|NCT02492789|immunotherapy|immunotherapy
5241876|NCT02492789|solid tumor|solid tumor
5241877|NCT02492789|PD-1 blockade|pd-1 blockade
5241878|NCT02492776|Volunteers|volunteers
5241879|NCT02492737|acute myeloid leukemia|acute myeloid leukemia
5241880|NCT02492737|AML|aml
5241881|NCT02492737|myelodysplastic syndrome|myelodysplastic syndrome
5241882|NCT02492737|MDS|mds
5241883|NCT02492737|dual mutation|dual mutation
5241884|NCT02492737|MPN|mpn
5241885|NCT02492737|AITL|aitl
5241886|NCT02492737|hematologic malignancies|hematologic malignancies
5241887|NCT02492737|IDH1|idh1
5241888|NCT02492737|IDH2|idh2
5241889|NCT02492737|AG-881|ag-881
5241890|NCT02492724|cervical spine|cervical spine
5241891|NCT02492724|total disc replacement (cTDR)|total disc replacement (ctdr)
5241892|NCT02492724|degenerative disc disease|degenerative disc disease
5241893|NCT02492724|activ® C|activ® c
5241894|NCT02492724|clinical outcome|clinical outcome
5241895|NCT02492724|long-term results|long-term results
5241896|NCT02492724|NDI|ndi
5241897|NCT02492724|VAS|vas
5241898|NCT02492724|heterotopic ossification (HO)|heterotopic ossification (ho)
5241899|NCT02492724|range of motion (ROM)|range of motion (rom)
5241900|NCT02492724|adjacent segment degeneration|adjacent segment degeneration
5241901|NCT02492698|Probiotic|probiotic
5241902|NCT02492698|Weight loss|weight loss
5241903|NCT02492698|Lp-PLA2|lp-pla2
5241904|NCT02492685|Quantitative analysis|quantitative analysis
5241905|NCT02492685|contrast enhanced endoscopic ultrasonography|contrast enhanced endoscopic ultrasonography
5241906|NCT02492659|femtosecond laser|femtosecond laser
5241907|NCT02492633|Smoking cessation|smoking cessation
5241908|NCT02492633|Smoke-free housing|smoke-free housing
5241909|NCT02492633|Affordable housing|affordable housing
5241910|NCT02492633|Second-hand smoke|second-hand smoke
5241911|NCT02492633|Tobacco control|tobacco control
5241912|NCT02492620|ferric citrate|ferric citrate
5241913|NCT02492620|phosphate|phosphate
5241914|NCT02492620|kidney|kidney
5241915|NCT02492607|Women|women
5241916|NCT02492607|DCIS grade I and II|dcis grade i and ii
5241917|NCT02492607|Active surveillance|active surveillance
5241918|NCT02492607|Standard treatment|standard treatment
5241919|NCT02492581|Selincro|selincro
5241920|NCT02492581|cohort|cohort
5241921|NCT02492581|real-life|real-life
5241922|NCT02492581|total alcohol consumption|total alcohol consumption
5241923|NCT02492581|heavy drinking days|heavy drinking days
5241924|NCT02492581|clinical global impression-severity|clinical global impression-severity
5241926|NCT02492581|AQoLS|aqols
5241927|NCT02492581|Sheehan disability scale|sheehan disability scale
5241928|NCT02492568|recurrent|recurrent
5241929|NCT02492568|NSCLC|nsclc
5136570|NCT03138889|NSCLC|nsclc
5241930|NCT02492568|pembrolizumab|pembrolizumab
5241931|NCT02492568|SBRT|sbrt
5241932|NCT02492555|IBD|ibd
5241935|NCT02492555|Disease activity|disease activity
5241936|NCT02492555|fecal calprotectin|fecal calprotectin
5241937|NCT02492542|electrical stimulation|electrical stimulation
5241938|NCT02492542|urinary incontinence|urinary incontinence
5241939|NCT02492529|Alzheimer, Recognition Memory, Mild Cognitive Impairment, fMRI|alzheimer, recognition memory, mild cognitive impairment, fmri
5239428|NCT02506166|risk stratification|risk stratification
5241940|NCT02492516|adipose tissue mesenchymal stem cell intravenous injection ALS|adipose tissue mesenchymal stem cell intravenous injection als
5241942|NCT02492490|Kidney transplantation|kidney transplantation
5241943|NCT02492490|DCD|dcd
5241944|NCT02492490|Stromal Vascular Fraction|stromal vascular fraction
5241945|NCT02492490|MSC|msc
5241946|NCT02492451|intrauterine insemination|intrauterine insemination
5229849|NCT02565498|Preoperative radiotherapy|preoperative radiotherapy
5229850|NCT02565498|Postoperative radiotherapy|postoperative radiotherapy
5229851|NCT02565485|pulse pressure|pulse pressure
5229852|NCT02565485|fetal heart rate|fetal heart rate
5229855|NCT02565485|preload|preload
5241947|NCT02492451|pregnancy rate|pregnancy rate
5241948|NCT02492451|endometrial injury|endometrial injury
5241949|NCT02492438|pneumococcal vaccination|pneumococcal vaccination
5241950|NCT02492438|dialysis|dialysis
5241951|NCT02492438|immune response|immune response
5241952|NCT02492425|Community Acquired Pneumonia|community acquired pneumonia
5241953|NCT02492425|Healthcare Associated Pneumonia|healthcare associated pneumonia
5241954|NCT02492399|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5241955|NCT02492399|mitral valve|mitral valve
5241956|NCT02492399|SAM syndrome|sam syndrome
5241957|NCT02492386|bioabsorbable vascular scaffold|bioabsorbable vascular scaffold
5241958|NCT02492386|erectile dysfunction|erectile dysfunction
5241959|NCT02492373|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
5241960|NCT02492373|topical high potency steroid|topical high potency steroid
5241961|NCT02492373|Qs NdYAG laser|qs ndyag laser
5241962|NCT02492360|Peripheral Neuropathies|peripheral neuropathies
5241963|NCT02492360|Testicular Cancer|testicular cancer
5241964|NCT02492360|Cisplatin|cisplatin
5241965|NCT02492360|Pharmacogenomics|pharmacogenomics
5241966|NCT02492308|kidney|kidney
5241967|NCT02492308|transplantation|transplantation
5241968|NCT02492308|MSC|msc
5241969|NCT02492217|Ankylosing Spondylitis|ankylosing spondylitis
5241970|NCT02492217|adalimumab|adalimumab
5241971|NCT02492217|TNF-alpha agents|tnf-alpha agents
5241972|NCT02492217|spondyloarthritis|spondyloarthritis
5241973|NCT02492217|biologic therapies|biologic therapies
5241974|NCT02492217|AS|as
5241975|NCT02492217|biomarkers|biomarkers
5241976|NCT02492217|efficacy prediction|efficacy prediction
5241977|NCT02492191|Smart Phones|smart phones
5241978|NCT02492191|Ambulatory Care|ambulatory care
5241979|NCT02492191|Outcome and Process Assessment|outcome and process assessment
5241980|NCT02492165|Japanese Encephalitis|japanese encephalitis
5241981|NCT02492165|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5241982|NCT02492165|IMOJEV®|imojev®
5241983|NCT02492165|Live attenuated vaccine|live attenuated vaccine
5241984|NCT02492152|women|women
5241985|NCT02492152|active labor|active labor
5241986|NCT02492126|Chronic Cough|chronic cough
5241987|NCT02492126|Gastroesophageal Reflux|gastroesophageal reflux
5241988|NCT02492126|Esophageal Motility|esophageal motility
5241989|NCT02492126|Cough Sensitivity|cough sensitivity
5241990|NCT02492113|Mechanical ventilation|mechanical ventilation
5241991|NCT02492113|Positive end-expiratory pressure|positive end-expiratory pressure
5241992|NCT02492113|Work of breathing|work of breathing
5241993|NCT02492113|Morbidly obese|morbidly obese
5241994|NCT02492100|Sexual Dysfunction Post-Bone Marrow Transplant|sexual dysfunction post-bone marrow transplant
5241995|NCT02492087|topical|topical
5241996|NCT02492087|tranexamic acid|tranexamic acid
5241997|NCT02492087|haemostasis|haemostasis
5241998|NCT02492087|caesarean section|caesarean section
5241999|NCT02492087|bleeding|bleeding
5242000|NCT02492087|postpartum hemorrhage|postpartum hemorrhage
5242001|NCT02492087|prophylactic|prophylactic
5242002|NCT02492074|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
5242003|NCT02492074|cannabidiol|cannabidiol
5242004|NCT02492074|COMT|comt
5242005|NCT02492061|couples' HCT married couples|couples' hct married couples
5242006|NCT02492061|Rakai|rakai
5242007|NCT02492061|Uganda|uganda
5242008|NCT02492035|Hypertension|hypertension
5242009|NCT02492035|lifestyle|lifestyle
5242010|NCT02492035|clinical trials|clinical trials
5242011|NCT02492035|primary care setting|primary care setting
5242012|NCT02491996|desire model|desire model
5242013|NCT02491983|metastatic breast cancer|metastatic breast cancer
5242014|NCT02491983|Endocrine receptors positive|endocrine receptors positive
5242015|NCT02491983|HER-2 negative|her-2 negative
5242016|NCT02491957|Energy Expenditure|energy expenditure
5242017|NCT02491957|Physical Endurance|physical endurance
5242018|NCT02491957|Muscle Stength|muscle stength
5242019|NCT02491957|Metabolism|metabolism
5242020|NCT02491931|Cardiac Surgical Procedures|cardiac surgical procedures
5242219|NCT02490540|analgesia|analgesia
5242021|NCT02491931|Cardiovascular Surgical Procedures|cardiovascular surgical procedures
5247440|NCT02461004|CKD-391|ckd-391
5242022|NCT02491931|Dietary Supplements|dietary supplements
5242023|NCT02491931|Glutamine|glutamine
5242024|NCT02491931|TROPONIN I|troponin i
5242025|NCT02491931|cardiopulmonary bypass|cardiopulmonary bypass
5245098|NCT02473679|BLS|bls
5242028|NCT02491879|ketoprofen|ketoprofen
5242030|NCT02491840|gastric cancer|gastric cancer
5229943|NCT02564952|Cannabidiol (CBD)|cannabidiol (cbd)
5229944|NCT02564952|GWP42003-P|gwp42003-p
5229945|NCT02564952|Clobazam|clobazam
5229946|NCT02564952|Epidiolex|epidiolex
5229947|NCT02564939|prevention|prevention
5229949|NCT02564913|tongue diagnosis|tongue diagnosis
5229950|NCT02564913|heart rate variability|heart rate variability
5229951|NCT02564913|nailfold videocapillaroscopy|nailfold videocapillaroscopy
5229952|NCT02564900|Advanced solid tumors|advanced solid tumors
5229953|NCT02564900|phase 1|phase 1
5229954|NCT02564900|oncology|oncology
5229955|NCT02564900|HER2|her2
5229956|NCT02564900|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5229957|NCT02564887|dysphagia|dysphagia
5229958|NCT02564887|oral pharyngeal cancer|oral pharyngeal cancer
5229959|NCT02564887|Iowa Oral Performance Instrument (IOPI)|iowa oral performance instrument (iopi)
5229960|NCT02564887|IOPI|iopi
5242031|NCT02491840|cardia cancer|cardia cancer
5242032|NCT02491827|optical biopsy|optical biopsy
5242033|NCT02491814|Dairy|dairy
5242034|NCT02491814|Breakfast cereal|breakfast cereal
5242035|NCT02491814|Postprandial Glycemia|postprandial glycemia
5242036|NCT02491814|Satiety|satiety
5242037|NCT02491814|Food Intake|food intake
5242038|NCT02491814|Milk|milk
5242039|NCT02491814|Yogurt|yogurt
5242040|NCT02491814|Soy|soy
5242041|NCT02491814|Almond|almond
5242042|NCT02491801|Dairy|dairy
5242043|NCT02491801|Milk|milk
5242044|NCT02491801|Yogurt|yogurt
5242045|NCT02491801|Cheese|cheese
5242046|NCT02491801|Postprandial glycaemia|postprandial glycaemia
5242047|NCT02491801|Satiety|satiety
5242048|NCT02491801|Food Intake|food intake
5242049|NCT02491801|Elderly|elderly
5242050|NCT02491801|Prevention and Treatment|prevention and treatment
5242051|NCT02491762|Serratus Anterior|serratus anterior
5242052|NCT02491762|Accessory Respiratory|accessory respiratory
5242053|NCT02491762|Tissue Expander|tissue expander
5242054|NCT02491762|Respiratory Function Tests|respiratory function tests
5242055|NCT02491749|Cardiac anesthesia|cardiac anesthesia
5242056|NCT02491749|ultra fast track|ultra fast track
5242057|NCT02491749|ICU stay|icu stay
5242058|NCT02491710|Surgical education|surgical education
5242059|NCT02491710|Laparoscopy|laparoscopy
5242060|NCT02491710|Laparoscopic suturing|laparoscopic suturing
5242061|NCT02491697|DC-CIK|dc-cik
5242062|NCT02491697|Breast cancer|breast cancer
5242063|NCT02491697|Capecitabine|capecitabine
5242064|NCT02491684|asthma|asthma
5242065|NCT02491684|Upper Respiratory Tract Infection|upper respiratory tract infection
5242066|NCT02491684|exacerbation|exacerbation
5242067|NCT02491684|Interferon|interferon
5242068|NCT02491684|efficacy|efficacy
5242069|NCT02491684|safety|safety
5242070|NCT02491684|prevention|prevention
5242071|NCT02491671|Prevention PAL Prolonged Air Leak (PAL)|prevention pal prolonged air leak (pal)
5337339|NCT02007070|PD1|pd1
5242072|NCT02491671|Lung Resection|lung resection
5242073|NCT02491671|Thoracic Surgery|thoracic surgery
5242074|NCT02491671|Post-operative Thoracic Air Leak|post-operative thoracic air leak
5242075|NCT02491645|Autistic spectrum disorder|autistic spectrum disorder
5242076|NCT02491645|Sensory processing abnormalities|sensory processing abnormalities
5242077|NCT02491645|Sensory interventions|sensory interventions
5242078|NCT02491645|occupational therapy|occupational therapy
5242079|NCT02491619|Angle class III|angle class iii
5242080|NCT02491619|tomography|tomography
5242081|NCT02491619|tooth inclination|tooth inclination
5242082|NCT02491619|bone thickness|bone thickness
5242083|NCT02491593|fecal occult blood|fecal occult blood
5242084|NCT02491554|Deep Brain Stimulation|deep brain stimulation
5242085|NCT02491554|Essential tremor|essential tremor
5242086|NCT02491554|DISTINCT|distinct
5242087|NCT02491554|MR-tractography guided DBS implantation|mr-tractography guided dbs implantation
5242088|NCT02491554|Conventional AC-PC based DBS implantation|conventional ac-pc based dbs implantation
5242089|NCT02491515|Osteoporosis|osteoporosis
5242090|NCT02491515|BMD|bmd
5242091|NCT02491515|denosumab|denosumab
5242092|NCT02491515|previous therapy|previous therapy
5230041|NCT02564302|Atrial Fibrillation|atrial fibrillation
5230042|NCT02564302|MUSE Headband|muse headband
5230043|NCT02564302|Mindfulness|mindfulness
5230044|NCT02564289|microvesicles, microparticles|microvesicles, microparticles
5242093|NCT02491489|Manual therapy|manual therapy
5242095|NCT02491476|Electrodes|electrodes
5242096|NCT02491476|Device|device
5242097|NCT02491476|StereoElectroencephalograph|stereoelectroencephalograph
5242098|NCT02491476|Epileptogenic zone|epileptogenic zone
5242099|NCT02491476|Fast ripples|fast ripples
5242100|NCT02491463|Reactogenicity|reactogenicity
5242101|NCT02491463|Safety|safety
5242102|NCT02491463|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5242103|NCT02491463|Vaccine|vaccine
5242104|NCT02491463|Immunogenicity|immunogenicity
5242106|NCT02491424|Direct skeletal attachment|direct skeletal attachment
5242107|NCT02491385|Thoracic epidural analgesia|thoracic epidural analgesia
5242108|NCT02491385|bowel function recovery|bowel function recovery
5242109|NCT02491333|polycystic ovary syndrome|polycystic ovary syndrome
5242111|NCT02491333|insulin resistance|insulin resistance
5242112|NCT02491333|HOMA-IR|homa-ir
5242113|NCT02491333|metformin|metformin
5242114|NCT02491320|polycystic ovary syndrome|polycystic ovary syndrome
5242115|NCT02491320|acupuncture|acupuncture
5242116|NCT02491320|pre-treatment|pre-treatment
5242117|NCT02491320|Letrozole|letrozole
5242118|NCT02491320|Live Birth|live birth
5242119|NCT02491294|School|school
5242120|NCT02491294|Family|family
5242121|NCT02491294|Fruit and Vegetables|fruit and vegetables
5242122|NCT02491294|Cooking|cooking
5242123|NCT02491294|Physical Activity|physical activity
5242124|NCT02491281|Primary Osteoarthritis, Total Knee Replacement, cartilage|primary osteoarthritis, total knee replacement, cartilage
5242126|NCT02491242|dolutegravir|dolutegravir
5242127|NCT02491242|intolerance|intolerance
5242128|NCT02491242|dual therapies|dual therapies
5242129|NCT02491229|non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5242130|NCT02491229|Obesity|obesity
5242131|NCT02491229|Hepafast|hepafast
5242132|NCT02491216|Frailty|frailty
5242133|NCT02491216|Frail elderly|frail elderly
5242134|NCT02491216|Acupressure|acupressure
5242135|NCT02491216|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
5242136|NCT02491203|Virtual reality|virtual reality
5242137|NCT02491203|telerehabilitation|telerehabilitation
5242138|NCT02491203|Stroke rehabilitation|stroke rehabilitation
5242139|NCT02491177|HIV Transmission|hiv transmission
5242140|NCT02491177|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5242141|NCT02491177|Linkage to care|linkage to care
5242142|NCT02491177|Retention in care|retention in care
5242143|NCT02491177|Community Mentor Mothers|community mentor mothers
5242144|NCT02491177|Mobile phone text messaging|mobile phone text messaging
5242145|NCT02491177|Antiretroviral therapy adherence|antiretroviral therapy adherence
5242146|NCT02491177|Infant Health|infant health
5242147|NCT02491177|Maternal CD4/viral loads|maternal cd4/viral loads
5242148|NCT02491177|Early infant diagnosis|early infant diagnosis
5242149|NCT02491177|Acceptability of interventions|acceptability of interventions
5242150|NCT02491177|Vertical transmission|vertical transmission
5242151|NCT02491138|participants|participants
5242152|NCT02491086|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots|intervention, nicotine replacement sampling, smoking cessation, smoking hotspots
5242153|NCT02491034|Depression|depression
5242154|NCT02491034|Hispanics|hispanics
5242155|NCT02491034|Stigma|stigma
5242156|NCT02491034|Barriers to Treatment|barriers to treatment
5962801|NCT04278482|DHA|dha
5122191|NCT03231475|NSCLC|nsclc
5242157|NCT02491008|Thyroid Dysfunction|thyroid dysfunction
5242158|NCT02491008|Bone mineral density|bone mineral density
5242159|NCT02491008|Osteoporosis|osteoporosis
5242160|NCT02491008|Fractures, Bone|fractures, bone
5242161|NCT02491008|Randomized Controlled Trial|randomized controlled trial
5242162|NCT02490995|children|children
5242163|NCT02490969|copeptin|copeptin
5674157|NCT00604747|motor learning|motor learning
5242164|NCT02490969|rule out marker, emergency department, cheast pain unit|rule out marker, emergency department, cheast pain unit
5242166|NCT02490969|chest pain unit|chest pain unit
5242167|NCT02490956|Diagnostic immunization with rabies vaccine|diagnostic immunization with rabies vaccine
5242168|NCT02490956|Primary immunodeficiency|primary immunodeficiency
5242169|NCT02490943|peginterferon beta-1a|peginterferon beta-1a
5242170|NCT02490943|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5242171|NCT02490943|Injection Site Reaction Erythema|injection site reaction erythema
5242172|NCT02490930|lymphopenia|lymphopenia
5242173|NCT02490917|Female urinary incontinence|female urinary incontinence
5242174|NCT02490917|Sphincter deficiency|sphincter deficiency
5242175|NCT02490904|Kidney transplantation|kidney transplantation
5242176|NCT02490904|Eplerenone|eplerenone
5230131|NCT02563743|Problem solving therapy|problem solving therapy
5230132|NCT02563743|Occupational Health Services|occupational health services
5230133|NCT02563743|Randomized controlled trial|randomized controlled trial
5230134|NCT02563743|Intervention studies|intervention studies
5230135|NCT02563743|Occupational stress|occupational stress
5230145|NCT02563704|Quinine|quinine
5242177|NCT02490891|Lymphoma, angiogenesis, PET scan|lymphoma, angiogenesis, pet scan
5242178|NCT02490839|Helicobacter pylori|helicobacter pylori
5242179|NCT02490839|high dose dual therapy|high dose dual therapy
5242180|NCT02490839|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
5242181|NCT02490839|antibiotic resistance|antibiotic resistance
5242182|NCT02490826|Speech Sound Disorders|speech sound disorders
5242183|NCT02490826|Tabletop|tabletop
5242184|NCT02490826|Digital|digital
5242185|NCT02490813|Fish allergy|fish allergy
5242186|NCT02490813|shrimp allergy|shrimp allergy
5242187|NCT02490813|crab allergy|crab allergy
5242188|NCT02490813|traditional Chinese medicine|traditional chinese medicine
5242189|NCT02490761|Geriatrics|geriatrics
5242190|NCT02490761|Nutritional Status|nutritional status
5242191|NCT02490761|Hospitalisation|hospitalisation
5242192|NCT02490722|Patient education|patient education
5242193|NCT02490722|Empowerment|empowerment
5242194|NCT02490709|Rectal neoplasms|rectal neoplasms
5242195|NCT02490709|Colorectal neoplasms|colorectal neoplasms
5242196|NCT02490709|Local excision|local excision
5242197|NCT02490696|PET scan|pet scan
5242198|NCT02490696|FAZA|faza
5242199|NCT02490696|F-Miso|f-miso
5242200|NCT02490696|hypoxia|hypoxia
5242201|NCT02490696|lung cancer|lung cancer
5242203|NCT02490605|Postural balance|postural balance
5242204|NCT02490605|Temporomandibular disorders|temporomandibular disorders
5242205|NCT02490605|Splints|splints
5242206|NCT02490579|video messaging|video messaging
5242207|NCT02490579|exercise|exercise
5242208|NCT02490579|diet|diet
5242209|NCT02490579|weight gain|weight gain
5242210|NCT02490579|pregnancy|pregnancy
5242211|NCT02490566|chronic condition|chronic condition
5242212|NCT02490566|telehealth|telehealth
5242213|NCT02490566|nutrition|nutrition
5242214|NCT02490566|exercise|exercise
5242215|NCT02490553|air pollution|air pollution
5242216|NCT02490553|epidemiological survey|epidemiological survey
5242217|NCT02490553|representative sample|representative sample
5242218|NCT02490540|opioids|opioids
5242220|NCT02490540|pain|pain
5242221|NCT02490540|anesthesia|anesthesia
5242222|NCT02490527|myopathy|myopathy
5242223|NCT02490527|muscular weakness|muscular weakness
5242224|NCT02490527|cramping|cramping
5242225|NCT02490527|fatigue|fatigue
5242226|NCT02490488|ovarian cancer|ovarian cancer
5242227|NCT02490488|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5242228|NCT02490462|Cerebral Palsy|cerebral palsy
5242229|NCT02490462|Physical Therapy|physical therapy
5242230|NCT02490462|Family-centered Care|family-centered care
5242231|NCT02490384|Cervical cerclage|cervical cerclage
5242232|NCT02490345|gabapentin|gabapentin
5242233|NCT02490319|radiation pneumonitis|radiation pneumonitis
5242234|NCT02490319|lung cancer|lung cancer
5242235|NCT02490319|prediction models|prediction models
5242236|NCT02490319|genetic variants|genetic variants
5242237|NCT02490241|pregnant|pregnant
5242238|NCT02490241|female|female
5242239|NCT02490241|women|women
5242240|NCT02490241|lithium|lithium
5242241|NCT02490241|bipolar|bipolar
5242242|NCT02490228|female|female
5242243|NCT02490228|minimally invasive surgery|minimally invasive surgery
5242244|NCT02490150|Corifollitropin alfa|corifollitropin alfa
5242245|NCT02490150|Stimulation protocol|stimulation protocol
5242246|NCT02490124|Diabetes Type 1|diabetes type 1
5242247|NCT02490124|Vascular Function|vascular function
5242248|NCT02490098|Type 1 diabetes|type 1 diabetes
5242249|NCT02490098|Closed-loop system|closed-loop system
5242250|NCT02490098|Artificial pancreas|artificial pancreas
5962802|NCT04278482|omega-3 fatty acids|omega-3 fatty acids
5242251|NCT02490098|Insulin|insulin
5242252|NCT02490098|Glucagon|glucagon
5242253|NCT02490098|Hypoglycemia|hypoglycemia
5242254|NCT02490098|Postprandial glucose|postprandial glucose
5242255|NCT02490085|Type 2 diabetes|type 2 diabetes
5242256|NCT02490085|Closed-loop strategy|closed-loop strategy
5242257|NCT02490085|Artificial pancreas|artificial pancreas
5242258|NCT02490085|Insulin|insulin
5242259|NCT02490085|Elderly|elderly
5242260|NCT02490085|Multiple daily injections|multiple daily injections
5242261|NCT02490085|Hypoglycemia|hypoglycemia
5242262|NCT02490046|D mannose|d mannose
5242263|NCT02490046|multiple sclerosis|multiple sclerosis
5242264|NCT02490046|recurrent urinary infections|recurrent urinary infections
5242266|NCT02490020|mesenchymal stem cell|mesenchymal stem cell
5242267|NCT02490020|Transplantation Rejection|transplantation rejection
5242268|NCT02490020|donation after cardiac death|donation after cardiac death
5322185|NCT02075112|Soy|soy
5242269|NCT02490007|Acellular pertussis vaccine|acellular pertussis vaccine
5242270|NCT02490007|whole cell pertussis vaccine|whole cell pertussis vaccine
5242271|NCT02490007|IgE-mediated food allergy|ige-mediated food allergy
5242272|NCT02489916|Metastatic Colorectal Cancer|metastatic colorectal cancer
5242273|NCT02489916|CM4307|cm4307
5242274|NCT02489916|Previously treated metastatic colorectal cancer|previously treated metastatic colorectal cancer
5242275|NCT02489903|Epigenetics|epigenetics
5242276|NCT02489903|resensitization|resensitization
5242277|NCT02489903|Platinum doublets|platinum doublets
5242278|NCT02489903|lung cancer|lung cancer
5242279|NCT02489903|Ovarian epithelial cancer|ovarian epithelial cancer
5242280|NCT02489877|multiple sclerosis|multiple sclerosis
5242281|NCT02489877|HERV-W virus|herv-w virus
5242282|NCT02489877|Herpesviridae family|herpesviridae family
5242283|NCT02489864|Terlipressin|terlipressin
5242284|NCT02489864|mean arterial pressure|mean arterial pressure
5242285|NCT02489864|type 2 HRS|type 2 hrs
5242286|NCT02489838|Liver Neoplasma|liver neoplasma
5242287|NCT02489838|Lung Radiation dose|lung radiation dose
5242288|NCT02489825|randomized controlled trial|randomized controlled trial
5242289|NCT02489825|vertebral fracture|vertebral fracture
5242290|NCT02489825|osteoporosis|osteoporosis
5242291|NCT02489825|vertebroplasty|vertebroplasty
5242292|NCT02489825|augmentation|augmentation
5242293|NCT02489812|children|children
5242294|NCT02489812|behavior|behavior
5242295|NCT02489812|anxiety|anxiety
5242296|NCT02489812|dentistry|dentistry
5242297|NCT02489799|advance care planning|advance care planning
5242298|NCT02489773|Lucica|lucica
5242299|NCT02489773|glycated albumin|glycated albumin
5242300|NCT02489773|GA|ga
5242301|NCT02489773|fructosamine|fructosamine
5242302|NCT02489760|Etanercept|etanercept
5242303|NCT02489760|Adalimumab|adalimumab
5242304|NCT02489760|Ankylosing Spondylitis|ankylosing spondylitis
5242305|NCT02489760|Switch Study|switch study
5242306|NCT02489747|cognitive function|cognitive function
5242307|NCT02489747|CNT|cnt
5242308|NCT02489747|memory function|memory function
5242309|NCT02489747|Triticum aestivum L|triticum aestivum l
5242310|NCT02489747|wheat bran|wheat bran
5242311|NCT02489734|sevoflurane|sevoflurane
5242312|NCT02489734|emergence delirium|emergence delirium
5242313|NCT02489734|preschool|preschool
5242314|NCT02489721|peripherally inserted central venous catheter|peripherally inserted central venous catheter
5242315|NCT02489721|depp vein thrombosis|depp vein thrombosis
5242316|NCT02489721|related blood stream infections|related blood stream infections
5242317|NCT02489721|midline|midline
5242318|NCT02489708|Bronchiolitis|bronchiolitis
5242319|NCT02489708|Cough|cough
5242320|NCT02489708|Ear Infection|ear infection
5242321|NCT02489708|Respiratory Infection|respiratory infection
5242322|NCT02489708|Wheezing|wheezing
5242323|NCT02489708|Clinical Decision Support Systems|clinical decision support systems
5242325|NCT02489656|Double loop ureteral stent|double loop ureteral stent
5242326|NCT02489656|USSQ|ussq
5242327|NCT02489656|Quality of life|quality of life
5242328|NCT02489656|Pain|pain
5242329|NCT02489604|neuroendocrine tumors|neuroendocrine tumors
5242330|NCT02489578|Community Acquired Pneumonia|community acquired pneumonia
5242331|NCT02489578|health care associated pneumonia|health care associated pneumonia
5242332|NCT02489565|Coronary Artery Disease|coronary artery disease
5242333|NCT02489565|stable|stable
5242334|NCT02489565|Telemedicine|telemedicine
5242335|NCT02489565|Patient Discharge|patient discharge
5242336|NCT02489539|Aortic aneurysm|aortic aneurysm
5242337|NCT02489539|Abdominal aorta|abdominal aorta
5242338|NCT02489539|Stent graft|stent graft
5242339|NCT02489539|Aneurysm|aneurysm
5242340|NCT02489539|Vascular Diseases|vascular diseases
5242341|NCT02489539|Cardiovascular Diseases|cardiovascular diseases
5242342|NCT02489500|AL Amyloidosis|al amyloidosis
5242343|NCT02489500|Stem Cell Transplantation|stem cell transplantation
5242344|NCT02489461|HIV|hiv
5242345|NCT02489448|Breast Cancer|breast cancer
5242346|NCT02489383|Asthma|asthma
5242347|NCT02489383|Continuous Exercise Training|continuous exercise training
5242348|NCT02489383|interval Exercise Training|interval exercise training
5242349|NCT02489383|Clinical Control|clinical control
5242350|NCT02489383|Inflammation|inflammation
5175355|NCT02895217|Women|women
5242351|NCT02489370|home care|home care
5242352|NCT02489370|telecare|telecare
5242353|NCT02489370|telehealth|telehealth
5242354|NCT02489370|telemonitoring|telemonitoring
5242355|NCT02489370|chronic heart failure|chronic heart failure
5242356|NCT02489370|randomized controlled trial|randomized controlled trial
5242357|NCT02489370|Congestive Heart Failure|congestive heart failure
5242358|NCT02489370|telemedicine|telemedicine
5242359|NCT02489331|Dyslipidemias|dyslipidemias
5242360|NCT02489318|Prostate Cancer|prostate cancer
5242361|NCT02489318|JNJ-56021927|jnj-56021927
5674158|NCT00604747|hemiplegia|hemiplegia
5337720|NCT02005289|CLL|cll
5242362|NCT02489318|Androgen Deprivation Therapy|androgen deprivation therapy
5242363|NCT02489318|ARN-509|arn-509
5242364|NCT02489318|Apalutamide|apalutamide
5242365|NCT02489318|TITAN|titan
5230321|NCT02562651|STEMI, adverse LVR (left ventricular remodeling), MMPs, Doxycycline|stemi, adverse lvr (left ventricular remodeling), mmps, doxycycline
5230323|NCT02562638|NBM|nbm
5230324|NCT02562638|pre-procedure|pre-procedure
5230325|NCT02562638|cardiac|cardiac
5230326|NCT02562599|Induction Chemotherapy|induction chemotherapy
5230327|NCT02562599|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5230328|NCT02562586|Suction|suction
5230329|NCT02562586|Arthroplasty|arthroplasty
5230330|NCT02562586|Replacement|replacement
5230331|NCT02562586|Hip|hip
5230332|NCT02562534|ECG|ecg
5230333|NCT02562534|MRI|mri
5242366|NCT02489318|Metastatic Hormone-sensitive Prostate Cancer|metastatic hormone-sensitive prostate cancer
5137167|NCT03134651|Anxiety|anxiety
5242367|NCT02489305|Depressive Disorder, Major|depressive disorder, major
5242368|NCT02489305|Depression|depression
5242369|NCT02489305|Anti-Depressant|anti-depressant
5242370|NCT02489305|Observational|observational
5242371|NCT02489292|Urea Cycle Disorder|urea cycle disorder
5242372|NCT02489292|UCD|ucd
5242373|NCT02489292|cell therapy|cell therapy
5242374|NCT02489292|stem cell|stem cell
5242375|NCT02489279|Attention deficit hyperactivity disorder.|attention deficit hyperactivity disorder.
5242376|NCT02489279|Attention training|attention training
5242377|NCT02489279|Mobile devices|mobile devices
5242378|NCT02489279|Brain training|brain training
5242379|NCT02489266|Melanoma|melanoma
5242380|NCT02489266|Immunotherapy|immunotherapy
5242381|NCT02489227|PsO|pso
5242382|NCT02489214|donafenib|donafenib
5242383|NCT02489201|donafenib|donafenib
5242384|NCT02489188|gait asymmetry|gait asymmetry
5242385|NCT02489188|joint angles|joint angles
5242396|NCT02489110|Alzheimer's Disease|alzheimer's disease
5242397|NCT02489110|Dementia|dementia
5242398|NCT02489110|caregiving|caregiving
5242399|NCT02489110|caregiver|caregiver
5242400|NCT02489110|coping|coping
5242401|NCT02489110|coping with caregiving|coping with caregiving
5242402|NCT02489110|stress|stress
5242403|NCT02489110|Hispanic caregiver|hispanic caregiver
5242404|NCT02489110|Latino caregiver|latino caregiver
5242405|NCT02489084|Head and Neck neoplasms|head and neck neoplasms
5242406|NCT02489084|Genome-wide association study|genome-wide association study
5242407|NCT02489084|Polymorphism, single nucleotide|polymorphism, single nucleotide
5242408|NCT02489084|Toxicity|toxicity
5242409|NCT02489019|Anesthesia|anesthesia
5242410|NCT02489019|Fentanyl|fentanyl
5242411|NCT02489019|Elderly|elderly
5242412|NCT02488980|Falciparum Parasitaemia, Malaria|falciparum parasitaemia, malaria
5242413|NCT02488954|Ulcerative colitis|ulcerative colitis
5242414|NCT02488954|Probiotics|probiotics
5242415|NCT02488954|treatments|treatments
5242416|NCT02488954|Propionibacterium freudenreichii|propionibacterium freudenreichii
5242417|NCT02488941|Liver Function Tests|liver function tests
5242418|NCT02488941|Blood Coagulation|blood coagulation
5242419|NCT02488928|NSCLC|nsclc
5242420|NCT02488928|EBUS|ebus
5242421|NCT02488928|elastography|elastography
5242422|NCT02488928|predictive value|predictive value
5242423|NCT02488928|strain|strain
5242424|NCT02488915|Brain|brain
5242425|NCT02488915|Brain Clot|brain clot
5242426|NCT02488915|Brain Diseases|brain diseases
5242450|NCT02488850|T cell activation|t cell activation
5242451|NCT02488850|early stage|early stage
5242452|NCT02488837|Deep Brain Stimulation|deep brain stimulation
5242453|NCT02488824|Quadriplegia|quadriplegia
5242454|NCT02488824|Paraplegia|paraplegia
5242455|NCT02488824|Spinal Cord Injury|spinal cord injury
5242456|NCT02488824|Body Temperature Regulation|body temperature regulation
5242457|NCT02488824|Mild Cognitive Impairment|mild cognitive impairment
5242458|NCT02488785|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5242459|NCT02488785|Telehealth|telehealth
5242460|NCT02488785|Hispanics|hispanics
5242461|NCT02488785|Latinos|latinos
5242462|NCT02488785|Self-Care|self-care
5242463|NCT02488785|Mobile Health|mobile health
5962803|NCT04278482|algae|algae
5337838|NCT02004756|fontan|fontan
5242464|NCT02488785|mHealth|mhealth
5242465|NCT02488772|sleep quality|sleep quality
5242466|NCT02488772|emergency department|emergency department
5242467|NCT02488733|type 2 diabetes mellitus|type 2 diabetes mellitus
5242468|NCT02488733|obesity|obesity
5242469|NCT02488733|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5962804|NCT04278482|supplementation|supplementation
5242470|NCT02488733|bariatric surgery|bariatric surgery
5242471|NCT02488733|metabolic surgery|metabolic surgery
5242472|NCT02488720|amyloid imaging|amyloid imaging
5242474|NCT02488720|cognition|cognition
5242475|NCT02488720|longitudinal|longitudinal
5242476|NCT02488720|cognitive decline|cognitive decline
5242477|NCT02488720|observational|observational
5242478|NCT02488707|low rectal cancer|low rectal cancer
5242479|NCT02488707|minimally invasive colorectal surgery|minimally invasive colorectal surgery
5242480|NCT02488707|trans-anal endoscopic microsurgery|trans-anal endoscopic microsurgery
5242481|NCT02488707|TEM|tem
5242482|NCT02488707|intersphincteric resection|intersphincteric resection
5242483|NCT02488707|ISR|isr
5242484|NCT02488707|subtotal intersphincteric resection|subtotal intersphincteric resection
5242485|NCT02488707|total intersphincteric resection|total intersphincteric resection
5242486|NCT02488707|trans-anal trans-abdominal resection|trans-anal trans-abdominal resection
5242487|NCT02488707|laparoscopic intersphincteric resection|laparoscopic intersphincteric resection
5242488|NCT02488707|anal sphincter preservation|anal sphincter preservation
5242489|NCT02488707|total mesorectal excision|total mesorectal excision
5242490|NCT02488707|TME|tme
5242491|NCT02488707|TATA|tata
5242492|NCT02488707|laparoscopic total mesorectal excision|laparoscopic total mesorectal excision
5242493|NCT02488707|external sphincter preservation|external sphincter preservation
5242494|NCT02488707|Neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
5242495|NCT02488707|fit patients for minimally invasive surgery|fit patients for minimally invasive surgery
5242496|NCT02488668|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
5242497|NCT02488668|Neuroplasticity|neuroplasticity
5242499|NCT02488642|Isosorbide dinitrate gel solution|isosorbide dinitrate gel solution
5242500|NCT02488642|late intrauterine death|late intrauterine death
5242502|NCT02488629|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5242503|NCT02488616|Closed-loop system|closed-loop system
5242504|NCT02488616|Artificial pancreas|artificial pancreas
5242505|NCT02488616|Type 1 diabetes|type 1 diabetes
5242506|NCT02488616|Hypoglycemia|hypoglycemia
5242507|NCT02488616|Insulin|insulin
5242508|NCT02488603|Breast Neoplasms|breast neoplasms
5242509|NCT02488603|Tamoxifen|tamoxifen
5242510|NCT02488603|Decision Aids|decision aids
5242511|NCT02488564|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5242512|NCT02488564|operable breast cancer|operable breast cancer
5242513|NCT02488564|locally advanced breast cancer|locally advanced breast cancer
5242514|NCT02488564|no prior therapy|no prior therapy
5242516|NCT02488525|Acquired Von Willebrand|acquired von willebrand
5242517|NCT02488525|Gastro-intestinal bleeding|gastro-intestinal bleeding
5242518|NCT02488525|LVAD|lvad
5242620|NCT02487940|IVF|ivf
5242621|NCT02487940|ICSI|icsi
5242519|NCT02488512|Relapsed/refractory diffuse large b cell|relapsed/refractory diffuse large b cell
5242520|NCT02488512|Relapsed/refractory mantle cell lymphomas|relapsed/refractory mantle cell lymphomas
5242521|NCT02488512|DLBCL|dlbcl
5242522|NCT02488512|MCL|mcl
5242523|NCT02488512|90Y-DOTATOC|90y-dotatoc
5242524|NCT02488512|SSR-positive tumour|ssr-positive tumour
5242525|NCT02488499|Disruptive Behaviour Disorder|disruptive behaviour disorder
5242526|NCT02488499|Psychosocial|psychosocial
5242527|NCT02488499|Group Treatment|group treatment
5242528|NCT02488473|Volunteers|volunteers
5242529|NCT02488460|Motor Activity|motor activity
5242530|NCT02488460|Cognition|cognition
5242531|NCT02488460|Academic Acheivement|academic acheivement
5242532|NCT02488460|Preadolescent Children|preadolescent children
5242533|NCT02488447|Allergy|allergy
5242534|NCT02488447|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5242535|NCT02488447|Immunotherapy|immunotherapy
5242536|NCT02488447|Life Quality|life quality
5242537|NCT02488447|Adherence|adherence
5242538|NCT02488434|ICSI|icsi
5242539|NCT02488434|sperm selection|sperm selection
5242540|NCT02488434|fertile chip|fertile chip
5242541|NCT02488434|ıcsı outcomes|ıcsı outcomes
5242542|NCT02488395|Parkinson's disease|parkinson's disease
5242543|NCT02488395|Non-motor symptoms|non-motor symptoms
5242544|NCT02488395|Visual deficits|visual deficits
5242545|NCT02488395|Superior colliculus|superior colliculus
5242546|NCT02488395|fMRI|fmri
5242547|NCT02488382|lymphoma|lymphoma
5242548|NCT02488382|multiple myeloma|multiple myeloma
5242549|NCT02488382|stem cell mobilization|stem cell mobilization
5242550|NCT02488382|autologous stem cell transplantation|autologous stem cell transplantation
5242551|NCT02488369|Children and adolescents|children and adolescents
5242552|NCT02488343|Multiple Sclerosis|multiple sclerosis
5242557|NCT02488317|Hemodialysis|hemodialysis
5242558|NCT02488317|Peritoneal Dialysis|peritoneal dialysis
5242559|NCT02488304|HRCT|hrct
5242560|NCT02488304|High Resolution Computed Tomography scans|high resolution computed tomography scans
5242561|NCT02488304|Functional Respiratory Imaging|functional respiratory imaging
5242562|NCT02488304|FRI|fri
5242563|NCT02488304|Computed Tomography|computed tomography
5242564|NCT02488304|CT|ct
5242565|NCT02488304|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5242566|NCT02488304|BOS|bos
5242567|NCT02488304|Lung Transplant|lung transplant
5242568|NCT02488291|Epidural|epidural
5242569|NCT02488291|Analgesia labor|analgesia labor
5242570|NCT02488291|Perinatal|perinatal
5242571|NCT02488291|anesthesia|anesthesia
5242572|NCT02488278|Glucose blood measurements, glucometers ,audio communication|glucose blood measurements, glucometers ,audio communication
5242573|NCT02488265|Parkinson´s disease|parkinson´s disease
5242574|NCT02488265|Physicaltherapy|physicaltherapy
5242575|NCT02488265|Postural Balance|postural balance
5242576|NCT02488265|Gait|gait
5242577|NCT02488265|Rehabilitation|rehabilitation
5242578|NCT02488252|Chinese Medicine|chinese medicine
5242579|NCT02488252|ACEI|acei
5242580|NCT02488252|ARB|arb
5242581|NCT02488252|Pragmatic trial|pragmatic trial
5242582|NCT02488213|Nutritional Counseling|nutritional counseling
5242583|NCT02488213|Diet|diet
5242584|NCT02488187|Breast Cancer|breast cancer
5242585|NCT02488187|MRI|mri
5242586|NCT02488187|Mammogram|mammogram
5242587|NCT02488187|Whole Breast Sonogram|whole breast sonogram
5242588|NCT02488187|ABUS|abus
5242589|NCT02488161|Colorectal cancer|colorectal cancer
5242590|NCT02488161|Risk factors|risk factors
5242591|NCT02488161|Adverse events|adverse events
5242592|NCT02488161|Predictive models|predictive models
5242593|NCT02488122|Bone Mineral Density|bone mineral density
5242594|NCT02488122|Isometric Exercise|isometric exercise
5242595|NCT02488122|Bone Growth|bone growth
5242596|NCT02488109|anorexia nervosa|anorexia nervosa
5242597|NCT02488109|eating disorders|eating disorders
5242608|NCT02488005|Crohn's Disease|crohn's disease
5242609|NCT02488005|Small Bowel Ultrasound|small bowel ultrasound
5242611|NCT02487966|Mirror Therapy|mirror therapy
5242612|NCT02487966|Phantom Limb Pain|phantom limb pain
5242613|NCT02487966|Traumatic amputation|traumatic amputation
5242614|NCT02487953|Nicotine addiction|nicotine addiction
5242615|NCT02487953|Cigarette smoking|cigarette smoking
5242616|NCT02487953|Smoking cessation|smoking cessation
5242617|NCT02487953|Nicotine patches|nicotine patches
5242618|NCT02487953|E-cigarettes|e-cigarettes
5242619|NCT02487940|Recurrent implantation failure|recurrent implantation failure
5242622|NCT02487940|Intralipid|intralipid
5242623|NCT02487914|Drug Delivery|drug delivery
5242624|NCT02487914|Iontophoresis|iontophoresis
5242625|NCT02487914|Lidocaine|lidocaine
5242626|NCT02487914|Pressure|pressure
5242627|NCT02487914|Tactile perception|tactile perception
5242628|NCT02487901|arthrodesiss|arthrodesiss
5242629|NCT02487901|cervical vertebra|cervical vertebra
5242630|NCT02487901|laminoplasty|laminoplasty
5242631|NCT02487888|Genetic Variation|genetic variation
5242632|NCT02487888|Genetic Polymorphism|genetic polymorphism
5242633|NCT02487888|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5242634|NCT02487888|Genetic Association Studies|genetic association studies
5242635|NCT02487888|Healthcare Utilization|healthcare utilization
5242636|NCT02487875|Sit-to-stand test|sit-to-stand test
5242637|NCT02487875|Muscle strength|muscle strength
5242638|NCT02487875|Pulmonary rehabilitation|pulmonary rehabilitation
5242639|NCT02487836|Laying of the biliary stent|laying of the biliary stent
5242641|NCT02487771|childhood development|childhood development
5242642|NCT02487745|Cocaine|cocaine
5242643|NCT02487745|Methadone|methadone
5242644|NCT02487745|Employment|employment
5242645|NCT02487745|Opioids|opioids
5242646|NCT02487732|Diabetic Patients With Non-ST Elevation|diabetic patients with non-st elevation
5242647|NCT02487719|Iron deficiecy|iron deficiecy
5242648|NCT02487719|pregnancy|pregnancy
5242649|NCT02487719|prenatal care|prenatal care
5242650|NCT02487706|Hemodialysis|hemodialysis
5242651|NCT02487706|HIV-infection|hiv-infection
5242668|NCT02487615|Carotid Plaque|carotid plaque
5242669|NCT02487615|Intima Media Thickness|intima media thickness
5242670|NCT02487615|Ankle Brachial Index|ankle brachial index
5242671|NCT02487615|Exercise Stress Test|exercise stress test
5242672|NCT02487615|Coronary Calcium Score|coronary calcium score
5242673|NCT02487615|Insulinemia|insulinemia
5242675|NCT02487615|Inflammation|inflammation
5242676|NCT02487615|Resistin|resistin
5242677|NCT02487615|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
5242678|NCT02487615|Phospholipase A2, Group VII|phospholipase a2, group vii
5242679|NCT02487615|Body Mass Index|body mass index
5242680|NCT02487615|Adipose Tissue Function|adipose tissue function
5242681|NCT02487615|Single Gene Polymorphism|single gene polymorphism
5242682|NCT02487589|Falls|falls
5242683|NCT02487589|Elderly|elderly
5242684|NCT02487589|e-Health|e-health
5242685|NCT02487589|Telemedicine|telemedicine
5242686|NCT02487563|Isolated thrombocytopenia|isolated thrombocytopenia
5242687|NCT02487563|decitabine|decitabine
5242688|NCT02487563|rhTPO|rhtpo
5242692|NCT02487524|Neuropathic Pain|neuropathic pain
5242693|NCT02487524|Breast Cancer|breast cancer
5242694|NCT02487524|Post surgical|post surgical
5242695|NCT02487498|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5242696|NCT02487472|France|france
5242697|NCT02487472|Post-herpetic neuralgia|post-herpetic neuralgia
5242698|NCT02487472|Herpes zoster|herpes zoster
5242699|NCT02487472|Economic burden of disease|economic burden of disease
5242700|NCT02487459|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5242701|NCT02487459|acute myeloid leukemia|acute myeloid leukemia
5242702|NCT02487459|chronic myeloid leukemia|chronic myeloid leukemia
5242703|NCT02487459|myelodysplastic syndrome|myelodysplastic syndrome
5242704|NCT02487459|non-hodgkin lymphoma|non-hodgkin lymphoma
5242705|NCT02487459|hodgkin lymphoma|hodgkin lymphoma
5242706|NCT02487446|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5242707|NCT02487433|food effect|food effect
5242708|NCT02487433|pharmacokinetics|pharmacokinetics
5242709|NCT02487433|healthy volunteers|healthy volunteers
5242710|NCT02487381|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
5242711|NCT02487381|cannabidiol|cannabidiol
5242712|NCT02487381|COMT|comt
5137483|NCT03132571|Obesity|obesity
5242713|NCT02487381|Volunteers|volunteers
5242714|NCT02487355|dexmedetomidine|dexmedetomidine
5242715|NCT02487355|magnesium sulphate|magnesium sulphate
5242716|NCT02487342|Dairy|dairy
5242717|NCT02487342|appetite|appetite
5242718|NCT02487342|feeding behaviour|feeding behaviour
5242719|NCT02487329|Direct pulp capping|direct pulp capping
5242720|NCT02487329|Er,Cr:YSGG laser|er,cr:ysgg laser
5242721|NCT02487329|Tricalcium silicate|tricalcium silicate
5242722|NCT02487316|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5242723|NCT02487316|anaplastic lymphoma kinase rearrangement|anaplastic lymphoma kinase rearrangement
5242724|NCT02487316|crizotinib|crizotinib
5242725|NCT02487316|CHOP chemotherapy|chop chemotherapy
5242726|NCT02487303|Acetaminophen|acetaminophen
5242727|NCT02487303|Pain, Postoperative|pain, postoperative
5240239|NCT02501928|Japan|japan
5242731|NCT02487290|Endoleak|endoleak
5242732|NCT02487277|Pancreatic|pancreatic
5242733|NCT02487251|Obesity|obesity
5242734|NCT02487251|Family Mealtimes|family mealtimes
5242735|NCT02487251|Prevention|prevention
5242736|NCT02487238|Microbiome|microbiome
5242737|NCT02487238|Microbiota|microbiota
5242738|NCT02487238|Fecal Microbial Transplant|fecal microbial transplant
5242739|NCT02487238|Fecal Microbiota Transplant|fecal microbiota transplant
5242741|NCT02487238|Gastroenterology|gastroenterology
5242742|NCT02487238|IBD|ibd
5242743|NCT02487238|Inflammatory Bowel Disease|inflammatory bowel disease
5242744|NCT02487238|Ulcerative Colitis|ulcerative colitis
5242745|NCT02487238|UC|uc
5242746|NCT02487238|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
5242747|NCT02487238|IBD-U|ibd-u
5242748|NCT02487238|Rebiotix|rebiotix
5242749|NCT02487238|RBX2660|rbx2660
5242750|NCT02487238|Pediatrics|pediatrics
5242751|NCT02487238|McMaster Children's Hospital|mcmaster children's hospital
5674159|NCT00604747|stroke|stroke
5242752|NCT02487238|Centre Hospitalier Universitaire Sainte-Justine|centre hospitalier universitaire sainte-justine
5242753|NCT02487238|Children's Hospital at London Health Sciences Centre|children's hospital at london health sciences centre
5242754|NCT02487225|Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) pancreatitis|post-endoscopic retrograde cholangiopancreatography (ercp) pancreatitis
5242755|NCT02487212|fractional laser|fractional laser
5242756|NCT02487212|hypertrophic scar|hypertrophic scar
5242757|NCT02487212|topical corticosteroid|topical corticosteroid
5242758|NCT02487212|laser assisted delivery systems|laser assisted delivery systems
5242759|NCT02487199|hepatitis C infection|hepatitis c infection
5242760|NCT02487199|hepatitis C|hepatitis c
5242761|NCT02487199|severe kidney disease|severe kidney disease
5242762|NCT02487199|chronic kidney disease|chronic kidney disease
5242763|NCT02487199|Genotype 1a|genotype 1a
5242764|NCT02487199|Genotype 4|genotype 4
5242765|NCT02487199|treatment experienced|treatment experienced
5242766|NCT02487199|interferon|interferon
5242768|NCT02487199|pegIFN|pegifn
5242769|NCT02487186|Chronic periodontitis|chronic periodontitis
5242770|NCT02487186|Local doxycycline|local doxycycline
5242771|NCT02487186|Ultrasonic debridement|ultrasonic debridement
5242772|NCT02487186|PLGA microspheres|plga microspheres
5242773|NCT02487186|Microbiologic assessment|microbiologic assessment
5242774|NCT02487147|Live Attenuated Influenza Vaccine (FluMist)|live attenuated influenza vaccine (flumist)
5242775|NCT02487147|Free Air Portable Air Powered Respirator|free air portable air powered respirator
5242776|NCT02487147|N95 Respirator|n95 respirator
5242777|NCT02487147|Personal Protective Equipment|personal protective equipment
5242778|NCT02487147|Viral Transmission|viral transmission
5242779|NCT02487121|weight loss|weight loss
5230705|NCT02560402|Renal Resistive Index (RRI)|renal resistive index (rri)
5230706|NCT02560389|Posttraumatic Stress Disorder|posttraumatic stress disorder
5230707|NCT02560389|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5230708|NCT02560389|Levodopa (L-DOPA)|levodopa (l-dopa)
5230709|NCT02560389|Exposure Therapy|exposure therapy
5230710|NCT02560389|Fear Extinction|fear extinction
5230711|NCT02560376|PET/CT|pet/ct
5242785|NCT02487082|Autism Spectrum Disorder|autism spectrum disorder
5242786|NCT02487082|Children|children
5242787|NCT02487082|Melatonin|melatonin
5242788|NCT02487082|Donepezil|donepezil
5242789|NCT02487082|Sleep disorder|sleep disorder
5242790|NCT02487056|Heart Failure|heart failure
5242791|NCT02487056|Diagnosis|diagnosis
5242792|NCT02487056|Management|management
5242793|NCT02487043|Caries prevention|caries prevention
5242794|NCT02487043|Early Childhood Caries|early childhood caries
5242795|NCT02487030|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
5242796|NCT02487030|HCV|hcv
5242797|NCT02487030|Sustained Virologic Response|sustained virologic response
5242798|NCT02487030|Direct Acting Antiviral|direct acting antiviral
5242799|NCT02487030|Combination Therapy|combination therapy
5242800|NCT02487030|GS-7977|gs-7977
5242802|NCT02487030|Ribavirin|ribavirin
5242803|NCT02487030|Sofosbuvir|sofosbuvir
5242804|NCT02487030|ledipasvir|ledipasvir
5242805|NCT02487030|Hepatitis C|hepatitis c
5242806|NCT02487030|Hepatitis C, Chronic|hepatitis c, chronic
5242807|NCT02487030|Liver Diseases|liver diseases
5242808|NCT02487030|Virus Diseases|virus diseases
5242809|NCT02487030|Antiviral Agents|antiviral agents
5242810|NCT02486965|VAS|vas
5242811|NCT02486965|thermode test|thermode test
5242812|NCT02486965|training program|training program
5242813|NCT02486965|6MWT|6mwt
5242814|NCT02486913|Primary prevention|primary prevention
5242815|NCT02486913|National Health Service Health Check|national health service health check
5242816|NCT02486900|Craving|craving
5242817|NCT02486900|Cue Reactivity|cue reactivity
5242818|NCT02486900|Neurofeedback|neurofeedback
5242819|NCT02486887|telemonitoring|telemonitoring
5242820|NCT02486874|Human acellular dermal matrix, burns, wound healing|human acellular dermal matrix, burns, wound healing
5240353|NCT02501265|Chantix|chantix
5242821|NCT02486861|Tomography, Optical Coherence|tomography, optical coherence
5242822|NCT02486848|Hairloss|hairloss
5242823|NCT02486848|Female Pattern Hair Loss|female pattern hair loss
5242824|NCT02486848|Androgenetic Alopecia|androgenetic alopecia
5242825|NCT02486848|Minoxidil|minoxidil
5242826|NCT02486822|Labor scale|labor scale
5242827|NCT02486822|Partograph|partograph
5242828|NCT02486822|Spontaneous labor|spontaneous labor
5242829|NCT02486822|Primigravida|primigravida
5242830|NCT02486744|Acthar|acthar
5242831|NCT02486744|Dialysis|dialysis
5242832|NCT02486744|Kidney|kidney
5242833|NCT02486744|Non-Diabetic|non-diabetic
5242834|NCT02486731|Hormonal sensitivity|hormonal sensitivity
5242835|NCT02486731|bone growth|bone growth
5242836|NCT02486705|ptsd|ptsd
5242837|NCT02486705|family|family
5242838|NCT02486705|caregiver|caregiver
5242839|NCT02486705|burden|burden
5242840|NCT02486692|Mental Health|mental health
5242841|NCT02486692|PTSD|ptsd
5242842|NCT02486692|Stigma|stigma
5242843|NCT02486692|Peer Education|peer education
5242844|NCT02486692|Web Education|web education
5242845|NCT02486692|Self Help|self help
5242846|NCT02486666|Enoxaparin|enoxaparin
5242847|NCT02486666|thrombosis|thrombosis
5242848|NCT02486666|neonate|neonate
5242849|NCT02486666|children|children
5242851|NCT02486653|tamsulosin|tamsulosin
5242852|NCT02486653|randomized controlled trials as topic|randomized controlled trials as topic
5242853|NCT02486653|double-blind method|double-blind method
5242854|NCT02486653|random allocation|random allocation
5242855|NCT02486653|placebos|placebos
5242856|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5242857|NCT02486653|urinary retention|urinary retention
5242858|NCT02486653|urinary tract infections|urinary tract infections
5242859|NCT02486653|urinary catheters|urinary catheters
5242860|NCT02486653|catheter-related infections|catheter-related infections
5242861|NCT02486653|postoperative complications|postoperative complications
5242862|NCT02486640|RRMS, CIS|rrms, cis
5242863|NCT02486627|cUTI|cuti
5242864|NCT02486627|AP|ap
5242865|NCT02486627|ACHN-490|achn-490
5242866|NCT02486627|anti-infective|anti-infective
5242867|NCT02486627|anti-bacterial|anti-bacterial
5242868|NCT02486627|antibiotic|antibiotic
5242869|NCT02486627|anti-microbial|anti-microbial
5230808|NCT02559791|Eosinophils|eosinophils
5230809|NCT02559791|Asthma|asthma
5230810|NCT02559791|Airway inflammation|airway inflammation
5230811|NCT02559791|Prednisone|prednisone
5230812|NCT02559765|physiotherapy|physiotherapy
5230813|NCT02559765|progressive multiple sclerosis|progressive multiple sclerosis
5230814|NCT02559765|rehabilitation|rehabilitation
5230815|NCT02559765|rehabilitation services|rehabilitation services
5230824|NCT02559726|Hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing|hypertrophic cardiomyopathy, hyper-synchronicity, outflow-tract obstruction, dual chamber pacing
5230825|NCT02559713|Lactation|lactation
5230826|NCT02559713|Lactating Women|lactating women
5230827|NCT02559713|Vedolizumab|vedolizumab
5230830|NCT02559713|Crohn's|crohn's
5242871|NCT02486627|bacterial infection|bacterial infection
5242872|NCT02486627|Gram-negative|gram-negative
5242873|NCT02486588|Financial incentives|financial incentives
5242874|NCT02486588|Messaging|messaging
5242875|NCT02486575|Residents|residents
5242876|NCT02486575|Training|training
5242877|NCT02486575|simulation|simulation
5242878|NCT02486575|mentoring|mentoring
5242879|NCT02486575|proctor|proctor
5242880|NCT02486562|Multiple Sclerosis|multiple sclerosis
5242881|NCT02486562|MS|ms
5242882|NCT02486549|Pain|pain
5242883|NCT02486549|Anesthesia Recovery Period|anesthesia recovery period
5242884|NCT02486549|Brachial Plexus|brachial plexus
5242885|NCT02486536|capsule endoscopy|capsule endoscopy
5112494|NCT03293953|HCV|hcv
5242886|NCT02486536|polyethylene glycol|polyethylene glycol
5242887|NCT02486536|bowel preparation solutions|bowel preparation solutions
5242888|NCT02486523|SAM, severe acute malnutrition|sam, severe acute malnutrition
5242889|NCT02486510|HIV-1|hiv-1
5242890|NCT02486510|CCR5 coreceptors|ccr5 coreceptors
5242891|NCT02486510|Maraviroc|maraviroc
5242892|NCT02486497|Pancreatic cancer|pancreatic cancer
5242893|NCT02486497|Adjuvant chemotherapy|adjuvant chemotherapy
5242894|NCT02486497|hENT1|hent1
5242895|NCT02486497|Gemcitabine|gemcitabine
5242896|NCT02486484|macular degeneration|macular degeneration
5242897|NCT02486484|diabetic retinopathy|diabetic retinopathy
5242898|NCT02486484|macular edema|macular edema
5242899|NCT02486484|retinal vein occlusion|retinal vein occlusion
5242900|NCT02486484|choroidal neovascularization|choroidal neovascularization
5242901|NCT02486471|cervical dysplasia|cervical dysplasia
5242902|NCT02486471|colposcopy|colposcopy
5242903|NCT02486471|haemostatic procedure|haemostatic procedure
5242904|NCT02486471|biopsy of the cervix uteri|biopsy of the cervix uteri
5242905|NCT02486458|Fluoride|fluoride
5242906|NCT02486458|Biofilm fluid|biofilm fluid
5242907|NCT02486458|Calcium fluoride|calcium fluoride
5242909|NCT02486445|Deep venous thrombosis|deep venous thrombosis
5242910|NCT02486445|Rivaroxaban|rivaroxaban
5242911|NCT02486406|Hepatitis C Virus|hepatitis c virus
5242912|NCT02486406|Hepatitis C Genotype 1|hepatitis c genotype 1
5242922|NCT02486315|coronary bifurcation|coronary bifurcation
5242923|NCT02486315|coronary stent|coronary stent
5242924|NCT02486289|Mercury toxicity poisoning|mercury toxicity poisoning
5242925|NCT02486263|infant|infant
5242926|NCT02486263|esophagitis|esophagitis
5242927|NCT02486263|neonate|neonate
5242928|NCT02486263|GERD|gerd
5242929|NCT02486237|diabetes mellitus|diabetes mellitus
5242930|NCT02486237|complications|complications
5242931|NCT02486237|prevalence|prevalence
5242932|NCT02486224|deep sea mineral water|deep sea mineral water
5242933|NCT02486224|exercise recovery|exercise recovery
5242934|NCT02486224|hydration|hydration
5242935|NCT02486224|salivary osmolar concentration|salivary osmolar concentration
5242936|NCT02486224|urinary osmolar concentration|urinary osmolar concentration
5242937|NCT02486211|heart arrest|heart arrest
5242938|NCT02486211|resuscitation|resuscitation
5242939|NCT02486211|seizures|seizures
5242940|NCT02486211|hypothermia, induced|hypothermia, induced
5242941|NCT02486211|Amantadine|amantadine
5323056|NCT02070978|LTE|lte
5230898|NCT02559115|68Ga-RM2|68ga-rm2
5230899|NCT02559115|PET/CT scan|pet/ct scan
5230900|NCT02559115|Gastrin Releasing Peptide Receptor (GRPr)|gastrin releasing peptide receptor (grpr)
5230901|NCT02559115|14-146|14-146
5230902|NCT02559102|Dexmedetomidine sedation|dexmedetomidine sedation
5242942|NCT02486198|Gastrointestinal cancer|gastrointestinal cancer
5242943|NCT02486198|oxaliplatin|oxaliplatin
5242944|NCT02486198|neurotoxicity|neurotoxicity
5242945|NCT02486120|Genetic Counseling|genetic counseling
5242946|NCT02486120|Clinical Decision-Making|clinical decision-making
5242947|NCT02486107|cervical vertebra|cervical vertebra
5242948|NCT02486107|surgery|surgery
5242949|NCT02486107|tubular retractor|tubular retractor
5242957|NCT02486081|Assistive device|assistive device
5242958|NCT02486081|the disabled|the disabled
5242959|NCT02486081|special education|special education
5242960|NCT02486081|movement analysis|movement analysis
5242961|NCT02486081|system development|system development
5242962|NCT02486055|Study safety of BPM31510 in healthy subjects|study safety of bpm31510 in healthy subjects
5242963|NCT02486042|ROP|rop
5242964|NCT02486042|Premature infant|premature infant
5242965|NCT02486016|Bioequivalence|bioequivalence
5242966|NCT02486016|Therapeutic Equivalency|therapeutic equivalency
5242967|NCT02485990|Fallopian Tube|fallopian tube
5242968|NCT02485990|Epithelial Ovarian|epithelial ovarian
5242969|NCT02485990|EOC|eoc
5242970|NCT02485977|Pulmonary hypertension|pulmonary hypertension
5242971|NCT02485977|Magnetic Resonance Imaging|magnetic resonance imaging
5242972|NCT02485964|Vaccine|vaccine
5242973|NCT02485951|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
5242974|NCT02485951|big-bubble technique|big-bubble technique
5242975|NCT02485951|peripheral air injection|peripheral air injection
5242976|NCT02485951|keratoconus|keratoconus
5242977|NCT02485938|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5242978|NCT02485938|Cardiomyopathy|cardiomyopathy
5242979|NCT02485925|Interventional|interventional
5242980|NCT02485925|Radiofrequency ablation|radiofrequency ablation
5242981|NCT02485925|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5242982|NCT02485925|Catheter ablation|catheter ablation
5242983|NCT02485912|Ebola|ebola
5242984|NCT02485912|vaccine|vaccine
5242985|NCT02485912|safety|safety
5242986|NCT02485912|immunogenicity|immunogenicity
5242987|NCT02485899|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
5242988|NCT02485899|LINCL|lincl
5242989|NCT02485899|NCL2|ncl2
5242990|NCT02485899|CLN2|cln2
5242991|NCT02485899|Jansky-Bielschowsky disease|jansky-bielschowsky disease
5242992|NCT02485886|PET|pet
5123135|NCT03225703|DXA|dxa
5242993|NCT02485886|interstitial pulmonary fibrosis (IPF)|interstitial pulmonary fibrosis (ipf)
5242994|NCT02485886|cysteine cathepsins|cysteine cathepsins
5242995|NCT02485886|macrophage|macrophage
5242996|NCT02485873|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
5242997|NCT02485873|Pevention|pevention
5242998|NCT02485873|Stroke|stroke
5243003|NCT02485847|Eye Diseases|eye diseases
5243004|NCT02485821|Estradiol|estradiol
5243005|NCT02485821|Misoprostol|misoprostol
5243006|NCT02485821|Induction of labor|induction of labor
5243007|NCT02485821|Cervical ripening|cervical ripening
5243019|NCT02485756|Drug interactions|drug interactions
5243022|NCT02485743|weight loss|weight loss
5243023|NCT02485743|maintained weight loss|maintained weight loss
5243024|NCT02485730|Prevention|prevention
5243025|NCT02485730|Cohort Analysis|cohort analysis
5243026|NCT02485730|Healthy Participants|healthy participants
5243029|NCT02485665|Prostate cancer|prostate cancer
5243030|NCT02485665|Robot-assisted laparoscopic surgery|robot-assisted laparoscopic surgery
5243031|NCT02485665|Radical prostatectomy|radical prostatectomy
5243032|NCT02485665|Post-prostatectomy incontinence|post-prostatectomy incontinence
5243033|NCT02485665|Pelvic floor muscle exercise|pelvic floor muscle exercise
5243034|NCT02485665|Extracorporeal biofeedback device|extracorporeal biofeedback device
5243035|NCT02485652|NSCLC|nsclc
5243036|NCT02485652|EGFR-TKI|egfr-tki
5243037|NCT02485652|non small cell lung cancer|non small cell lung cancer
5243038|NCT02485652|HM61713|hm61713
5323193|NCT02070289|PK|pk
5230992|NCT02558673|Biomarkers|biomarkers
5230993|NCT02558673|Production|production
5230996|NCT02558673|Healthy|healthy
5243039|NCT02485652|T790M-positive|t790m-positive
5243040|NCT02485652|lung cancer|lung cancer
5243041|NCT02485652|Phase II|phase ii
5243042|NCT02485652|Olmutinib|olmutinib
5243057|NCT02485574|Arthrodesis|arthrodesis
5243059|NCT02485574|Cage|cage
5243060|NCT02485561|Colon cancer screening|colon cancer screening
5243061|NCT02485561|Colorectal cancer screening|colorectal cancer screening
5243062|NCT02485561|Colonoscopy|colonoscopy
5243063|NCT02485561|Sigmoidoscopy|sigmoidoscopy
5243064|NCT02485561|Stool blood test|stool blood test
5243065|NCT02485561|Narrative|narrative
5243066|NCT02485522|fecal incontinence|fecal incontinence
5243067|NCT02485522|diet|diet
5243068|NCT02485522|nutrition|nutrition
5243069|NCT02485522|metabolites|metabolites
5243070|NCT02485522|stool|stool
5243071|NCT02485522|FI|fi
5243072|NCT02485379|Prostate cancer|prostate cancer
5243073|NCT02485379|Multiparametric MRI|multiparametric mri
5243074|NCT02485379|Prostate biopsy|prostate biopsy
5243075|NCT02485379|Targeted biopsy|targeted biopsy
5243076|NCT02485379|Comparative study|comparative study
5243077|NCT02485366|Rejuvenated packed red blood cells|rejuvenated packed red blood cells
5243078|NCT02485353|Vosaroxin|vosaroxin
5243079|NCT02485353|Cytarabine|cytarabine
5243080|NCT02485353|Remission Induction|remission induction
5243081|NCT02485353|Safety|safety
5243082|NCT02485353|Progression-Free Survival|progression-free survival
5243083|NCT02485353|Mortality Rate|mortality rate
5243084|NCT02485353|Length of Stay|length of stay
5243085|NCT02485314|children|children
5243086|NCT02485314|disability|disability
5243087|NCT02485314|family|family
5243088|NCT02485314|participation|participation
5243089|NCT02485301|Protection against Ebola Zaire virus|protection against ebola zaire virus
5243090|NCT02485275|AIS|ais
5243091|NCT02485275|ICAS|icas
5243092|NCT02485275|CSVD|csvd
5243093|NCT02485262|Protease inhibitor treatment|protease inhibitor treatment
5243094|NCT02485249|Iontophoresis|iontophoresis
5243095|NCT02485249|Macular Edema|macular edema
5243096|NCT02485249|Ophthalmology|ophthalmology
5243097|NCT02485223|Multiple Sclerosis|multiple sclerosis
5243098|NCT02485223|MS|ms
5243099|NCT02485223|Diagnostic test|diagnostic test
5243100|NCT02485223|Central veins|central veins
5243101|NCT02485223|MRI|mri
5243102|NCT02485210|photodynamic therapy , Endodontic treatment|photodynamic therapy , endodontic treatment
5243103|NCT02485197|Muscle Metabolic Function|muscle metabolic function
5243104|NCT02485197|Vitamin D Status|vitamin d status
5243105|NCT02485197|25(OH)D|25(oh)d
5243106|NCT02485197|Older Adults|older adults
5243107|NCT02485158|Subjective Effects|subjective effects
5243108|NCT02485158|Alcohol|alcohol
5243109|NCT02485158|Amphetamine|amphetamine
5243111|NCT02485158|Personality|personality
5243112|NCT02485145|Topical|topical
5243113|NCT02485145|Hand osteoarthritis|hand osteoarthritis
5243114|NCT02485132|Type 2 diabetes|type 2 diabetes
5243115|NCT02485132|Sulfonylurea|sulfonylurea
5243116|NCT02485132|Hypoglycemia|hypoglycemia
5243117|NCT02485132|Quality of life|quality of life
5243118|NCT02485119|BAY 94-9343|bay 94-9343
5243119|NCT02485119|Anetumab ravtansine|anetumab ravtansine
5243120|NCT02485119|ADC (Antibody Drug Conjugate)|adc (antibody drug conjugate)
5243121|NCT02485119|Phase I|phase i
5243122|NCT02485119|Japan|japan
5243123|NCT02485119|solid cancers|solid cancers
5243324|NCT02484131|Women|women
5243124|NCT02485119|Advanced, refractory solid tumors|advanced, refractory solid tumors
5243125|NCT02485119|mesothelin|mesothelin
5243126|NCT02485119|endometrial|endometrial
5243127|NCT02485119|adenocarcinoma of lung|adenocarcinoma of lung
5243128|NCT02485119|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers|gastrointestinal, ovarian, pancreatic, cholangio, mesothelioma and triple negative breast cancers
5243129|NCT02485080|hepatitis C|hepatitis c
5243130|NCT02485080|liver transplantation|liver transplantation
5243131|NCT02485080|genotype 1|genotype 1
5243132|NCT02485067|Overactive Bladder|overactive bladder
5243133|NCT02485067|Tolterodine (Detrusitol)|tolterodine (detrusitol)
5243134|NCT02485067|Pilocarpine|pilocarpine
5243135|NCT02485041|Dapoxetine|dapoxetine
5243136|NCT02485041|Mirodenafil|mirodenafil
5243137|NCT02485041|DDI study|ddi study
5243138|NCT02485028|Dapoxetine|dapoxetine
5243139|NCT02485028|Mirodenafil|mirodenafil
5243140|NCT02485028|DDI study|ddi study
5243141|NCT02485015|CIK|cik
5243142|NCT02485015|gastric cancer|gastric cancer
5243143|NCT02485015|Apatinib|apatinib
5243144|NCT02485002|kidney|kidney
5243145|NCT02485002|kidney stone|kidney stone
5243146|NCT02485002|NGAL|ngal
5243147|NCT02485002|ureterorenoscopy|ureterorenoscopy
5243148|NCT02485002|intrarenal surgery|intrarenal surgery
5243149|NCT02485002|kidney function|kidney function
5243150|NCT02484976|Family Based Behavioral Treatment|family based behavioral treatment
5243151|NCT02484976|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5243152|NCT02484976|Childhood Obesity|childhood obesity
5243153|NCT02484976|Satiety|satiety
5243154|NCT02484976|BMI z-score|bmi z-score
5243155|NCT02484976|Impulsive|impulsive
5243156|NCT02484976|Non-obese controls|non-obese controls
5243157|NCT02484976|Visual food cues|visual food cues
5243158|NCT02484976|Leptin|leptin
5243159|NCT02484976|Hormones|hormones
5243160|NCT02484950|Mesenchymal stem cells|mesenchymal stem cells
5243161|NCT02484937|Pain management|pain management
5243162|NCT02484911|chemotherapy nausea vomiting|chemotherapy nausea vomiting
5243163|NCT02484885|Magnetic Resonance Imaging|magnetic resonance imaging
5243164|NCT02484885|Pulmonary Function|pulmonary function
5243165|NCT02484872|Inflammation|inflammation
5243166|NCT02484872|Glasgow score|glasgow score
5243167|NCT02484872|Intensive Care Unit|intensive care unit
5243168|NCT02484872|Emergency|emergency
5243169|NCT02484859|Drug: remifentanil|drug: remifentanil
5243170|NCT02484859|Drug: tramadol|drug: tramadol
5243171|NCT02484859|Drug: metoprolol|drug: metoprolol
5243172|NCT02484859|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5243173|NCT02484859|Controlled hypotension|controlled hypotension
5243174|NCT02484833|First line|first line
5243175|NCT02484833|metastatic colorectal cancer|metastatic colorectal cancer
5243176|NCT02484833|Cetuximab|cetuximab
5243177|NCT02484833|strategy study|strategy study
5243178|NCT02484820|Preterm Birth|preterm birth
5243179|NCT02484820|pessary|pessary
5243180|NCT02484820|threatened preterm labor|threatened preterm labor
5243181|NCT02484794|Eating Disorders|eating disorders
5243182|NCT02484794|Smartphone|smartphone
5243183|NCT02484794|App|app
5243184|NCT02484794|Mobile Health|mobile health
5243185|NCT02484794|Recovery Record|recovery record
5243186|NCT02484794|Cognitive Behavioural Therapy|cognitive behavioural therapy
5243187|NCT02484794|Outpatient Program|outpatient program
5243188|NCT02484794|Self Monitoring|self monitoring
5243189|NCT02484781|Gait disorder|gait disorder
5243190|NCT02484781|Resurfacing Hip Arthroplasty|resurfacing hip arthroplasty
5243191|NCT02484781|Total Hip Arthroplasty|total hip arthroplasty
5243192|NCT02484729|AZD9977|azd9977
5243193|NCT02484729|Safety|safety
5243194|NCT02484729|Tolerability|tolerability
5243195|NCT02484729|Pharmacokinetics|pharmacokinetics
5243196|NCT02484729|First-in-human|first-in-human
5243197|NCT02484729|Single Ascending Dose|single ascending dose
5243198|NCT02484729|Regional absorption|regional absorption
5243199|NCT02484729|Healthy male subjects|healthy male subjects
5243200|NCT02484716|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5243201|NCT02484716|Antiangiogenic therapy|antiangiogenic therapy
5243202|NCT02484716|Timolol|timolol
5243203|NCT02484651|deep neuromuscular block|deep neuromuscular block
5243204|NCT02484651|sugammadex|sugammadex
5243205|NCT02484651|stability of anesthesia|stability of anesthesia
5243206|NCT02484651|suppression of EMG activity|suppression of emg activity
5243207|NCT02484651|PQRS|pqrs
5240722|NCT02499211|food access|food access
5243208|NCT02484651|General Anesthesia|general anesthesia
5243209|NCT02484651|Quality of Recovery|quality of recovery
5243210|NCT02484625|snacking|snacking
5243211|NCT02484625|food intake|food intake
5243212|NCT02484625|satiety|satiety
5243213|NCT02484625|obesity|obesity
5243214|NCT02484625|type-2 diabetes|type-2 diabetes
5243215|NCT02484599|Eating Disorders|eating disorders
5243216|NCT02484599|Anorexia Nervosa|anorexia nervosa
5243217|NCT02484599|Attention bias|attention bias
5243218|NCT02484599|Attention bias modification|attention bias modification
5243219|NCT02484586|Presbyopia|presbyopia
5243220|NCT02484586|Refractive error|refractive error
5243221|NCT02484586|Contact lens|contact lens
5243222|NCT02484573|Cirrhosis|cirrhosis
5243223|NCT02484573|Variceal Bleeding|variceal bleeding
5243224|NCT02484573|Non-selective beta blocker|non-selective beta blocker
5243225|NCT02484573|Intestinal Permeability|intestinal permeability
5243226|NCT02484573|Gene expression|gene expression
5243227|NCT02484573|Bacterial translocation|bacterial translocation
5243228|NCT02484560|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5243229|NCT02484560|Neuromuscular Diseases|neuromuscular diseases
5243230|NCT02484560|Muscular Dystrophy|muscular dystrophy
5243231|NCT02484560|Genetic Diseases, X-linked|genetic diseases, x-linked
5243232|NCT02484560|Musculoskeletal Diseases|musculoskeletal diseases
5243233|NCT02484560|Nervous System Diseases|nervous system diseases
5243234|NCT02484547|Aducanumab|aducanumab
5243235|NCT02484547|BIIB037|biib037
5243236|NCT02484534|Coagulation Factor|coagulation factor
5243237|NCT02484534|cirrhosis|cirrhosis
5243238|NCT02484508|Guli capsule|guli capsule
5243239|NCT02484508|knee osteoarthritis|knee osteoarthritis
5243240|NCT02484508|Changing of WOMAC and VAS score|changing of womac and vas score
5243241|NCT02484495|Complementary feeding recommendation|complementary feeding recommendation
5243242|NCT02484495|Program evaluation|program evaluation
5243243|NCT02484495|Process and impact evaluation|process and impact evaluation
5231183|NCT02557360|liver injury|liver injury
5231184|NCT02557360|detoxification|detoxification
5231185|NCT02557360|S-adenosyl-L-methionine|s-adenosyl-l-methionine
5231186|NCT02557360|quality of life|quality of life
5231187|NCT02557334|Strawberry Powder|strawberry powder
5231188|NCT02557334|Cardiovascular Disease Risk Factors|cardiovascular disease risk factors
5231189|NCT02557269|Pollenosis|pollenosis
5231190|NCT02557269|Congestion|congestion
5243244|NCT02484456|Major Depression|major depression
5243245|NCT02484456|Glycine Receptor Antagonist|glycine receptor antagonist
5243246|NCT02484456|4-Chlorokyneurenine|4-chlorokyneurenine
5243247|NCT02484456|Treatment Resistant|treatment resistant
5243248|NCT02484456|Glutamatergic System|glutamatergic system
5243249|NCT02484417|Neutralizing Antibody|neutralizing antibody
5243250|NCT02484417|Viral Shedding|viral shedding
5243251|NCT02484417|Mucosal Immune Reponse|mucosal immune reponse
5243253|NCT02484417|Healthy Volunteer|healthy volunteer
5243254|NCT02484404|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5243255|NCT02484404|PARP Inhibitor|parp inhibitor
5243256|NCT02484404|VEGFR Inhibitor|vegfr inhibitor
5243257|NCT02484378|ACS|acs
5243258|NCT02484378|IVUS|ivus
5243259|NCT02484378|HDL|hdl
5243260|NCT02484365|Hemoglobins|hemoglobins
5243261|NCT02484365|Monitoring, Outpatient|monitoring, outpatient
5243262|NCT02484365|Preoperative Period|preoperative period
5243263|NCT02484365|Pediatrics|pediatrics
5243264|NCT02484352|dosage of oxycodone during intubation|dosage of oxycodone during intubation
5243265|NCT02484326|ST-elevation myocardial infarction|st-elevation myocardial infarction
5243266|NCT02484326|Cardiac rupture|cardiac rupture
5243267|NCT02484326|Risk assessment|risk assessment
5243268|NCT02484300|loop gain|loop gain
5243269|NCT02484300|chemoreflex control|chemoreflex control
5243270|NCT02484300|melatonin|melatonin
5243271|NCT02484300|antioxidant|antioxidant
5243272|NCT02484300|obstructive sleep apnea|obstructive sleep apnea
5243273|NCT02484300|ventilatory control|ventilatory control
5243274|NCT02484274|iron-deficiency|iron-deficiency
5243275|NCT02484274|iron-deficiency anemia|iron-deficiency anemia
5243276|NCT02484274|infants and toddlers|infants and toddlers
5243277|NCT02484274|industrialised countries|industrialised countries
5243278|NCT02484274|population-based study|population-based study
5243279|NCT02484274|prevalence and risk factors|prevalence and risk factors
5243280|NCT02484274|screening strategies|screening strategies
5243281|NCT02484274|diagnosis markers|diagnosis markers
5243282|NCT02484274|primary prevention|primary prevention
5243283|NCT02484261|childhood leukemia|childhood leukemia
5243284|NCT02484261|relapsed leukemia|relapsed leukemia
5243285|NCT02484261|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5243286|NCT02484248|pediatric|pediatric
5243287|NCT02484248|eosinophilia|eosinophilia
5243288|NCT02484248|duodenal|duodenal
5243289|NCT02484248|ketotifen|ketotifen
5243290|NCT02484248|functional dyspepsia|functional dyspepsia
5243291|NCT02484235|obesity|obesity
5243292|NCT02484235|exercise|exercise
5243293|NCT02484235|HIIT|hiit
5243294|NCT02484235|Vo2|vo2
5243295|NCT02484235|kinetics|kinetics
5243296|NCT02484222|adenotonsillectomy|adenotonsillectomy
5243297|NCT02484222|fentanyl|fentanyl
5243298|NCT02484209|diabetes|diabetes
5243299|NCT02484209|frailty|frailty
5243301|NCT02484209|metformin|metformin
5243302|NCT02484209|sulphonylurea|sulphonylurea
5243303|NCT02484209|hypoglycaemia|hypoglycaemia
5243304|NCT02484183|bubble continuous positive airway pressure (CPAP)|bubble continuous positive airway pressure (cpap)
5243305|NCT02484183|pneumonia|pneumonia
5243306|NCT02484183|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5243307|NCT02484183|malnutrition|malnutrition
5243308|NCT02484183|Malawi|malawi
5243309|NCT02484183|Africa|africa
5243310|NCT02484183|Noninvasive Ventilation|noninvasive ventilation
5243311|NCT02484183|child|child
5243312|NCT02484183|pediatric|pediatric
5243313|NCT02484183|hypoxemia|hypoxemia
5243314|NCT02484170|Mannitol|mannitol
5243315|NCT02484170|cream|cream
5243316|NCT02484170|neuropathic pain|neuropathic pain
5243317|NCT02484157|Whole Blood Coagulation Time|whole blood coagulation time
5243318|NCT02484157|cardiac surgery|cardiac surgery
5243319|NCT02484144|information|information
5243320|NCT02484144|coronarography|coronarography
5243321|NCT02484144|understanding|understanding
5243322|NCT02484131|Osteoporosis|osteoporosis
5243323|NCT02484131|DXA Screening|dxa screening
5243325|NCT02484131|Breast Cancer|breast cancer
5243326|NCT02484131|Survivors|survivors
5243327|NCT02484131|Educational materials|educational materials
5243328|NCT02484131|Personal choices on delivery methods|personal choices on delivery methods
5243329|NCT02484092|Hemophilia B|hemophilia b
5243330|NCT02484092|Blood Coagulation Disorders|blood coagulation disorders
5248746|NCT02452983|Anemia|anemia
5243331|NCT02484092|Gene Therapy|gene therapy
5243332|NCT02484092|Gene Transfer|gene transfer
5243333|NCT02484092|Factor IX Deficiency|factor ix deficiency
5243334|NCT02484092|Factor IX Gene|factor ix gene
5243335|NCT02484092|Factor IX Protein|factor ix protein
5243336|NCT02484092|Vector|vector
5243338|NCT02484066|Virtual bronchoscopic navigation|virtual bronchoscopic navigation
5243339|NCT02484066|Endobronchial ultrasound|endobronchial ultrasound
5243340|NCT02484066|Guide Sheath|guide sheath
5243341|NCT02484066|Transbronchial biopsy|transbronchial biopsy
5243342|NCT02484066|Peripheral pulmonary lesions|peripheral pulmonary lesions
5243343|NCT02484053|adult and pediatric cancers|adult and pediatric cancers
5243344|NCT02484053|blood disorders|blood disorders
5243345|NCT02484053|lymphoma|lymphoma
5243346|NCT02484053|graft-versus-host-disease|graft-versus-host-disease
5243347|NCT02484053|diseases of the immune system|diseases of the immune system
5243348|NCT02484040|tumor response|tumor response
5243349|NCT02484040|toxicity|toxicity
5243350|NCT02484040|recurrence|recurrence
5243351|NCT02484040|chemoradiotherpy|chemoradiotherpy
5243352|NCT02484040|rectum|rectum
5243353|NCT02484027|acute ischemic stroke|acute ischemic stroke
5243354|NCT02484027|mRS|mrs
5243355|NCT02484027|rosuvastatin|rosuvastatin
5243356|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate
5243357|NCT02484001|BIA 2-093|bia 2-093
5243358|NCT02484001|Epilepsy|epilepsy
5243359|NCT02483988|NUsurface|nusurface
5243360|NCT02483988|Meniscus|meniscus
5243361|NCT02483988|prosthesis|prosthesis
5243362|NCT02483988|KOOS|koos
5243363|NCT02483975|Fluticasone Furoate|fluticasone furoate
5243364|NCT02483975|Asthma|asthma
5243365|NCT02483975|HPA axis|hpa axis
5243366|NCT02483975|Children|children
5243367|NCT02483975|Inhaled corticosteroid|inhaled corticosteroid
5243368|NCT02483962|Chronic|chronic
5243369|NCT02483923|serratus anterior block|serratus anterior block
5243370|NCT02483923|ultrasound|ultrasound
5243371|NCT02483923|breast cancer|breast cancer
5243372|NCT02483923|postoperative pain|postoperative pain
5243373|NCT02483910|School-age children|school-age children
5243374|NCT02483910|Pediatrics|pediatrics
5243375|NCT02483910|Direct Instruction-Language for Learning|direct instruction-language for learning
5243376|NCT02483884|Bombesin|bombesin
5243377|NCT02483884|Gastrin-Releasing Peptide|gastrin-releasing peptide
5243378|NCT02483884|Prostatic Neoplasms|prostatic neoplasms
5243379|NCT02483884|Genital Diseases, Male|genital diseases, male
5243380|NCT02483884|Genital Neoplasms, Male|genital neoplasms, male
5243381|NCT02483884|Neoplasms|neoplasms
5243382|NCT02483884|Neoplasms by Site|neoplasms by site
5243383|NCT02483884|Urogenital Neoplasms|urogenital neoplasms
5243384|NCT02483884|Gastrointestinal Agents|gastrointestinal agents
5243385|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5243386|NCT02483884|Neurotransmitter Agents|neurotransmitter agents
5243387|NCT02483884|Pharmacologic Actions|pharmacologic actions
5243388|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs
5243389|NCT02483884|Therapeutic Uses|therapeutic uses
5243390|NCT02483871|Estrogen Receptor Positive|estrogen receptor positive
5243391|NCT02483858|oncology, solid tumors|oncology, solid tumors
5243392|NCT02483819|Elderly patient|elderly patient
5243393|NCT02483819|NICOM|nicom
5243394|NCT02483819|TURP|turp
5243395|NCT02483767|Premenopausal Breast Cancer|premenopausal breast cancer
5243396|NCT02483767|Preservation of Ovarian Function|preservation of ovarian function
5243397|NCT02483767|Gonadotropin-Releasing Hormone Agonist|gonadotropin-releasing hormone agonist
5243398|NCT02483728|Metal Allergy|metal allergy
5243399|NCT02483715|Helicobacter pylori|helicobacter pylori
5243400|NCT02483715|high dose dual therapy|high dose dual therapy
5243401|NCT02483715|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
5243402|NCT02483715|antibiotic resistance|antibiotic resistance
5243403|NCT02483702|Irradiated Blood|irradiated blood
5243404|NCT02483702|Non-Irradiated Blood|non-irradiated blood
5243405|NCT02483702|graft versus host disease|graft versus host disease
5243406|NCT02483702|TA-GVHD|ta-gvhd
5243407|NCT02483702|potassium|potassium
5243408|NCT02483702|Blood transfusion|blood transfusion
5243409|NCT02483689|Post Operative Pain|post operative pain
5243411|NCT02483689|Appendectomy|appendectomy
5243412|NCT02483689|Local Anesthetic|local anesthetic
5243413|NCT02483689|Saline|saline
5243414|NCT02483689|Pain Management|pain management
5243415|NCT02483689|Surgery|surgery
5243416|NCT02483689|Recovery|recovery
5243417|NCT02483676|Rehabilitation|rehabilitation
5243418|NCT02483676|Robotics|robotics
5243419|NCT02483676|Gait|gait
5243420|NCT02483663|Twins|twins
5243421|NCT02483663|Obesity|obesity
5243422|NCT02483663|Appetite|appetite
5243423|NCT02483637|spray cryotherapy|spray cryotherapy
5243424|NCT02483637|cryotherapy|cryotherapy
5243425|NCT02483637|chronic bronchitis|chronic bronchitis
5243426|NCT02483637|airflow restrictions|airflow restrictions
5243427|NCT02483611|Onset|onset
5243428|NCT02483611|Recovery|recovery
5243429|NCT02483611|Lidocaine|lidocaine
5243430|NCT02483611|Cisatracurium|cisatracurium
5243433|NCT02483598|buspirone|buspirone
5243434|NCT02483598|pharmacokinetics|pharmacokinetics
5243435|NCT02483598|Cytochrome P450 3A4|cytochrome p450 3a4
5243436|NCT02483585|Migraine|migraine
5243437|NCT02483585|Headache|headache
5243438|NCT02483585|Episodic|episodic
5243439|NCT02483585|Prevention|prevention
5243440|NCT02483585|Prophylaxis|prophylaxis
5243441|NCT02483559|Sleep|sleep
5243442|NCT02483559|Photoreceptor Cells, Vertebrate|photoreceptor cells, vertebrate
5243443|NCT02483559|Melatonin|melatonin
5243444|NCT02483546|Medical education|medical education
5243445|NCT02483546|simulation|simulation
5243446|NCT02483546|ACLS|acls
5243447|NCT02483520|Family caregiver|family caregiver
5339195|NCT01998477|Flu|flu
5243448|NCT02483507|Ultrasound guidance|ultrasound guidance
5243449|NCT02483507|Vascular access|vascular access
5243450|NCT02483507|Pediatric anesthesia|pediatric anesthesia
5243451|NCT02483494|Telemedicine|telemedicine
5243452|NCT02483494|Advanced Practice Nurse|advanced practice nurse
5243453|NCT02483481|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
5243454|NCT02483481|ultrasound elastography|ultrasound elastography
5243455|NCT02483481|bone marrow transplant|bone marrow transplant
5243456|NCT02483429|Vertigo|vertigo
5243457|NCT02483429|Dizziness|dizziness
5243458|NCT02483429|Unsteadiness|unsteadiness
5243459|NCT02483429|Stroke|stroke
5243460|NCT02483429|Vestibular neuritis|vestibular neuritis
5243461|NCT02483429|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5243462|NCT02483429|Vestibulo-ocular reflex|vestibulo-ocular reflex
5243463|NCT02483429|Video-oculography|video-oculography
5243464|NCT02483429|Emergency department|emergency department
5243465|NCT02483403|Magnetic Resonance Imaging|magnetic resonance imaging
5243466|NCT02483403|Pulmonary Function|pulmonary function
5243467|NCT02483403|Volunteers|volunteers
5243468|NCT02483390|palliative care|palliative care
5243469|NCT02483390|e-health|e-health
5243470|NCT02483390|e-therapy|e-therapy
5243471|NCT02483390|psychosocial services|psychosocial services
5243472|NCT02483377|Sign or Symptom|sign or symptom
5243473|NCT02483351|Blood Transfusion|blood transfusion
5243474|NCT02483338|Psychometric validity|psychometric validity
5243475|NCT02483338|Pain scale|pain scale
5243476|NCT02483338|Postoperative|postoperative
5243477|NCT02483338|Children|children
5243478|NCT02483312|Recurrent|recurrent
5243479|NCT02483299|response to therapy|response to therapy
5243480|NCT02483286|Osteoporosis|osteoporosis
5243481|NCT02483286|Fall|fall
5243482|NCT02483286|Fracture|fracture
5243483|NCT02483286|sarcopenia|sarcopenia
5243484|NCT02483286|Exercise|exercise
5243485|NCT02483273|Conjunctival microcirculation|conjunctival microcirculation
5243486|NCT02483273|Sublingual microcirculation|sublingual microcirculation
5243487|NCT02483273|Sidestream Dark Field (SDF) microscopy|sidestream dark field (sdf) microscopy
5243488|NCT02483247|Neoplasms|neoplasms
5243489|NCT02483195|Hair loss|hair loss
5243490|NCT02483195|Post Menopausal|post menopausal
5243491|NCT02483182|Herpes labialis, Cold sores, ZEP-3 ointment|herpes labialis, cold sores, zep-3 ointment
5243492|NCT02483169|ischemic stroke|ischemic stroke
5243493|NCT02483169|intracranial hemorrhage|intracranial hemorrhage
5243494|NCT02483169|cilostazol|cilostazol
5243495|NCT02483169|probucol|probucol
5243496|NCT02483169|intima media thickness|intima media thickness
5243497|NCT02483156|HCV|hcv
5243498|NCT02483156|Sofosbuvir|sofosbuvir
5243499|NCT02483156|Ribavirin|ribavirin
5243500|NCT02483143|contrast media|contrast media
5243501|NCT02483143|pulmonary embolism|pulmonary embolism
5243502|NCT02483143|N-acetylcysteine|n-acetylcysteine
5243503|NCT02483104|ABT-888|abt-888
5243516|NCT02483091|Feasibility outcomes|feasibility outcomes
5243517|NCT02483065|dementia|dementia
5243518|NCT02483065|hospital admission|hospital admission
5243519|NCT02483065|mortality|mortality
5243520|NCT02483065|health-related quality of life|health-related quality of life
5243521|NCT02483065|activities of daily living|activities of daily living
5243522|NCT02483052|lobectomy|lobectomy
5243523|NCT02483052|spray cryotherapy|spray cryotherapy
5243524|NCT02483052|lung cancer|lung cancer
5243525|NCT02483039|Acute kidney injury|acute kidney injury
5243526|NCT02483039|Chronic kidney disease|chronic kidney disease
5243527|NCT02483039|Quality improvement|quality improvement
5243528|NCT02483013|whitening dentifrices|whitening dentifrices
5243533|NCT02482987|socket preservation|socket preservation
5243534|NCT02482987|ridge preservation|ridge preservation
5243535|NCT02482987|implant site preparation|implant site preparation
5243536|NCT02482974|Liver transplantation|liver transplantation
5243538|NCT02482974|Sirolimus|sirolimus
5243539|NCT02482974|Treatment outcome|treatment outcome
5243540|NCT02482974|Safety|safety
5243541|NCT02482948|Debridement|debridement
5243542|NCT02482948|collagenase|collagenase
5243543|NCT02482948|leptospermum honey|leptospermum honey
5243544|NCT02482922|feasibility studies|feasibility studies
5243545|NCT02482922|intervention|intervention
5243546|NCT02482922|Pre-Hypertensive|pre-hypertensive
5243547|NCT02482922|Pre-Hyperlipidemia|pre-hyperlipidemia
5243548|NCT02482844|TAVI|tavi
5243549|NCT02482844|de novo and persistent LBBB|de novo and persistent lbbb
5243550|NCT02482844|electrophysiology|electrophysiology
5243551|NCT02482844|Holter|holter
5243552|NCT02482844|pacemaker|pacemaker
5243553|NCT02482831|Sciatic nerve block|sciatic nerve block
5243554|NCT02482831|block duration|block duration
5243555|NCT02482831|Semmes Weinstein monofilaments|semmes weinstein monofilaments
5243556|NCT02482831|fasting blood glucose|fasting blood glucose
5243557|NCT02482831|nerve block|nerve block
5243558|NCT02482831|sensory block duration|sensory block duration
5243559|NCT02482831|motor block duration|motor block duration
5243560|NCT02482818|chronic cough|chronic cough
5243561|NCT02482818|cough hypersensitivity|cough hypersensitivity
5243562|NCT02482818|Lyrica|lyrica
5243563|NCT02482818|Pregabalin|pregabalin
5243564|NCT02482818|cough reflex sensitivity|cough reflex sensitivity
5243565|NCT02482792|Musculoskeletal disorders|musculoskeletal disorders
5243566|NCT02482792|Psychosomatic|psychosomatic
5243567|NCT02482792|Pain|pain
5243568|NCT02482753|Chidamide|chidamide
5243569|NCT02482753|breast cancer|breast cancer
5243570|NCT02482753|exemestane|exemestane
5243571|NCT02482753|Estrogen Receptor|estrogen receptor
5243572|NCT02482740|Uterine Cervical Neoplasms|uterine cervical neoplasms
5243573|NCT02482740|antiestrogens|antiestrogens
5243574|NCT02482727|Blood Flow Restriction|blood flow restriction
5243575|NCT02482727|Occlusion training|occlusion training
5243576|NCT02482727|Distal radius fracture|distal radius fracture
5243577|NCT02482714|Quality of Life|quality of life
5243578|NCT02482714|Physical Activity|physical activity
5243579|NCT02482701|EMR|emr
5243580|NCT02482701|EAC|eac
5243581|NCT02482701|Barrett's Neoplasia|barrett's neoplasia
5243582|NCT02482701|Multiband Mucosectomy|multiband mucosectomy
5243583|NCT02482675|Dairy|dairy
5243584|NCT02482675|Milk|milk
5243585|NCT02482675|Glucose|glucose
5243586|NCT02482675|Postprandial|postprandial
5243587|NCT02482675|Hyperglycemia|hyperglycemia
5243588|NCT02482675|Prediabetes|prediabetes
5243589|NCT02482675|Blood glucose|blood glucose
5243590|NCT02482675|Oxidative stress|oxidative stress
5243591|NCT02482675|Vascular health|vascular health
5243592|NCT02482675|Vascular function|vascular function
5243593|NCT02482662|Diagnosis|diagnosis
5243594|NCT02482636|infant immunisations|infant immunisations
5243595|NCT02482636|vaccines|vaccines
5243596|NCT02482636|paediatric|paediatric
5243598|NCT02482636|meningococcal|meningococcal
5243600|NCT02482623|neuropsychiatric symptoms|neuropsychiatric symptoms
5243601|NCT02482623|implementation science|implementation science
5243602|NCT02482623|depression|depression
5243603|NCT02482623|pain|pain
5243604|NCT02482610|Dairy|dairy
5243605|NCT02482610|Milk|milk
5243606|NCT02482610|Glucose|glucose
5243607|NCT02482610|Postprandial|postprandial
5243608|NCT02482610|Hyperglycemia|hyperglycemia
5243609|NCT02482610|Prediabetes|prediabetes
5243610|NCT02482610|Blood glucose|blood glucose
5243611|NCT02482610|Oxidative stress|oxidative stress
5243612|NCT02482610|Vascular health|vascular health
5243613|NCT02482610|Vascular function|vascular function
5243614|NCT02482571|Functional MRS|functional mrs
5243615|NCT02482571|Glutamate|glutamate
5243616|NCT02482558|Glycaemic Index|glycaemic index
5243617|NCT02482558|NAFLD|nafld
5243618|NCT02482558|Glycogen|glycogen
5243619|NCT02482558|Liver|liver
5243620|NCT02482558|Diet|diet
5243621|NCT02482532|Melanoma|melanoma
5243622|NCT02482532|metastatic|metastatic
5243623|NCT02482532|relapsed|relapsed
5243624|NCT02482532|refractory|refractory
5243628|NCT02482480|SLEEP|sleep
5243629|NCT02482480|APNEA|apnea
5243630|NCT02482480|EXERCISE|exercise
5243631|NCT02482467|ovarian cyst|ovarian cyst
5243632|NCT02482467|prenatal diagnosis|prenatal diagnosis
5243633|NCT02482467|puberty|puberty
5243634|NCT02482454|radiofrequency ablation|radiofrequency ablation
5243635|NCT02482454|cytokine-induced killer cells|cytokine-induced killer cells
5243636|NCT02482454|cholangiocarcinoma|cholangiocarcinoma
5243637|NCT02482441|Advanced Solid Tumors and in Combination|advanced solid tumors and in combination
5231574|NCT02554994|multifactorial intervention|multifactorial intervention
5231575|NCT02554994|Medicaid services|medicaid services
5231576|NCT02554994|Geriatric disorder|geriatric disorder
5231577|NCT02554994|Short Physical Performance Battery|short physical performance battery
5243638|NCT02482441|FOLFIRI for Patients with Previously Treated Metastatic|folfiri for patients with previously treated metastatic
5243639|NCT02482441|Colorectal Cancer|colorectal cancer
5243640|NCT02482428|human papilloma virus (HPV), Genital Warts, Sexually transmitted disease (STD), viral disease|human papilloma virus (hpv), genital warts, sexually transmitted disease (std), viral disease
5243641|NCT02482415|Palliative Care|palliative care
5243642|NCT02482415|Randomized controlled trial|randomized controlled trial
5243643|NCT02482415|Family caregivers|family caregivers
5243644|NCT02482415|Intervention|intervention
5243646|NCT02482415|Intervention studies|intervention studies
5243647|NCT02482415|Home Care|home care
5243649|NCT02482311|Ovarian cancer (BRCA1/2 mutation)|ovarian cancer (brca1/2 mutation)
5243650|NCT02482311|Ovarian cancer (PARP-failure)|ovarian cancer (parp-failure)
5243651|NCT02482311|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5243652|NCT02482311|Small-cell lung cancer (SCLC)|small-cell lung cancer (sclc)
5243653|NCT02482311|Solid tumours|solid tumours
5243654|NCT02482298|Sickle cell disease|sickle cell disease
5243655|NCT02482298|Young adults|young adults
5243656|NCT02482298|Hestia2|hestia2
5243657|NCT02482298|Ticagrelor|ticagrelor
5243658|NCT02482233|electronic cigarette|electronic cigarette
5243659|NCT02482233|nicotine replacement therapy|nicotine replacement therapy
5243660|NCT02482233|smoking cessation|smoking cessation
5243661|NCT02482233|perioperative|perioperative
5243662|NCT02482194|Spinal cord injury|spinal cord injury
5243663|NCT02482194|mesenchymal stem cells|mesenchymal stem cells
5243664|NCT02482194|transplantation|transplantation
5243665|NCT02482181|diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
5243666|NCT02482168|immunotherapy|immunotherapy
5243667|NCT02482168|CD40|cd40
5243668|NCT02482155|pharmacokinetics|pharmacokinetics
5243669|NCT02482155|MOMENTACT|momentact
5243670|NCT02482155|ibuprofen 400 mg|ibuprofen 400 mg
5243671|NCT02482155|oral|oral
5243672|NCT02482155|granules|granules
5243673|NCT02482142|phosphorus|phosphorus
5243674|NCT02482142|lean|lean
5243675|NCT02482142|obese|obese
5243676|NCT02482142|energy expenditure|energy expenditure
5243677|NCT02482129|Acute anterior uveitis|acute anterior uveitis
5243678|NCT02482129|LME636|lme636
5243679|NCT02482116|malaria|malaria
5243680|NCT02482116|pneumonia|pneumonia
5243681|NCT02482116|Nigeria|nigeria
5243682|NCT02482116|IMCI|imci
5243683|NCT02482116|diagnosis|diagnosis
5243684|NCT02482103|Therapy resistant hypertension|therapy resistant hypertension
5243685|NCT02482051|Carbapenem-resistant Enterobacteriaceae|carbapenem-resistant enterobacteriaceae
5243686|NCT02482051|Accelerate ID/AST|accelerate id/ast
5243687|NCT02482025|Medications|medications
5243688|NCT02482025|Hospitalization|hospitalization
5243689|NCT02482025|Electronic medical records|electronic medical records
5243690|NCT02482012|research|research
5243691|NCT02482012|vulnerable population|vulnerable population
5243692|NCT02482012|45 CFR 46.406|45 cfr 46.406
5243693|NCT02481999|Depth of anesthesia|depth of anesthesia
5243694|NCT02481973|PMS|pms
5243695|NCT02481973|Homoeopathy|homoeopathy
5243697|NCT02481934|Recurrent multiple myeloma|recurrent multiple myeloma
5243698|NCT02481934|NK cells|nk cells
5243699|NCT02481934|cell therapy|cell therapy
5243700|NCT02481934|NKAE|nkae
5243701|NCT02481934|Relapsed multiple myeloma|relapsed multiple myeloma
5243702|NCT02481921|heart failure|heart failure
5243703|NCT02481921|self-management|self-management
5243704|NCT02481921|group intervention|group intervention
5243705|NCT02481908|AECOPD|aecopd
5243706|NCT02481908|left ventricular dysfunction|left ventricular dysfunction
5243707|NCT02481908|valsalva maneuver|valsalva maneuver
5243708|NCT02481908|systolic time intervals|systolic time intervals
5243709|NCT02481895|cognition|cognition
5243710|NCT02481895|psychosocial functioning|psychosocial functioning
5243711|NCT02481869|Closed|closed
5243712|NCT02481869|unilateral|unilateral
5243713|NCT02481869|pilon|pilon
5243714|NCT02481843|Hyperoxia|hyperoxia
5243715|NCT02481843|Microcirculation|microcirculation
5243716|NCT02481843|Erythropoietin|erythropoietin
5243717|NCT02481843|Normobaric Oxygen Paradox|normobaric oxygen paradox
5243718|NCT02481804|diet|diet
5243719|NCT02481804|vitamin|vitamin
5243720|NCT02481778|Radiotherapy|radiotherapy
5243721|NCT02481778|Cardiac|cardiac
5243722|NCT02481778|Toxicity|toxicity
5243723|NCT02481752|Tobacco Use|tobacco use
5243724|NCT02481752|Nicotine Dependence|nicotine dependence
5243725|NCT02481739|endometriosis|endometriosis
5243726|NCT02481739|fertility|fertility
5243727|NCT02481739|endometriosis surgery|endometriosis surgery
5243729|NCT02481726|Alfatide II|alfatide ii
5243730|NCT02481726|RGD|rgd
5243731|NCT02481726|αvβ3|αvβ3
5243732|NCT02481726|PET/CT|pet/ct
5243733|NCT02481713|psychosis|psychosis
5243734|NCT02481713|adherence|adherence
5243735|NCT02481713|motivation|motivation
5243736|NCT02481674|Prodromal Stage|prodromal stage
5243737|NCT02481674|Early Manifest Stage|early manifest stage
5243738|NCT02481635|Blood Vessels|blood vessels
5243739|NCT02481635|Reconstructive Surgery|reconstructive surgery
5243740|NCT02481622|HIV infection|hiv infection
5243741|NCT02481622|vaginal tissues|vaginal tissues
5243742|NCT02481622|uterine tissues|uterine tissues
5243743|NCT02481609|Loss of Smell|loss of smell
5243744|NCT02481609|Olfaction|olfaction
5243745|NCT02481609|Hyposmia|hyposmia
5243748|NCT02481596|diet|diet
5243749|NCT02481596|exercise|exercise
5243750|NCT02481596|social|social
5243751|NCT02481583|levosulpiride|levosulpiride
5243752|NCT02481583|pharmacokinetics|pharmacokinetics
5243753|NCT02481583|adverse effects|adverse effects
5243757|NCT02481570|Pharmacokinetic simulation|pharmacokinetic simulation
5243758|NCT02481518|Cisplatin nephrotoxicity|cisplatin nephrotoxicity
5243760|NCT02481492|Circumcision, Male|circumcision, male
5243761|NCT02481492|Shang Ring|shang ring
5243762|NCT02481492|Children|children
5243763|NCT02481492|Foreskin|foreskin
5243764|NCT02481466|Arterial plaque|arterial plaque
5243765|NCT02481466|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5243766|NCT02481466|Portfolio diet|portfolio diet
5243767|NCT02481466|Dietary modification|dietary modification
5243768|NCT02481466|Dietary trials|dietary trials
5243769|NCT02481466|hypercholesterolemia|hypercholesterolemia
5243770|NCT02481466|diabetes|diabetes
5243771|NCT02481466|exercise|exercise
5243772|NCT02481466|cardiovascular disease risk|cardiovascular disease risk
5243773|NCT02481466|glycemic index (GI)|glycemic index (gi)
5243774|NCT02481466|Carotid Ultrasound|carotid ultrasound
5243775|NCT02481466|Dietary Approaches to Stop Hypertension (DASH) diet|dietary approaches to stop hypertension (dash) diet
5243776|NCT02481440|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5243777|NCT02481440|spinal cord injury|spinal cord injury
5243778|NCT02481427|Total|total
5243779|NCT02481427|Unicondylar|unicondylar
5243780|NCT02481427|Osteoarthritis|osteoarthritis
5243781|NCT02481427|Arthroplasty|arthroplasty
5243782|NCT02481427|Replacement|replacement
5243783|NCT02481427|Knee|knee
5243785|NCT02481401|cardiovascular health|cardiovascular health
5243786|NCT02481401|behavior change|behavior change
5243787|NCT02481401|community-based|community-based
5243788|NCT02481401|family-based|family-based
5243789|NCT02481401|prevention|prevention
5243790|NCT02481375|iron|iron
5243791|NCT02481375|ferritin|ferritin
5243792|NCT02481375|soluble transferrin receptor|soluble transferrin receptor
5243793|NCT02481375|hepcidin|hepcidin
5243794|NCT02481375|reticulocyte count|reticulocyte count
5243795|NCT02481375|hemoglobin|hemoglobin
5243796|NCT02481375|supplementation|supplementation
5243797|NCT02481336|Chemotherapy|chemotherapy
5243798|NCT02481336|Peripheral Neuropathy|peripheral neuropathy
5243799|NCT02481323|cerebral small vessel disease|cerebral small vessel disease
5243800|NCT02481323|cerebrovascular reactivity|cerebrovascular reactivity
5243801|NCT02481323|cilostazol|cilostazol
5243802|NCT02481323|isosorbide mononitrate|isosorbide mononitrate
5243803|NCT02481297|Leukemia|leukemia
5243804|NCT02481297|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5243805|NCT02481297|CLL|cll
5243806|NCT02481297|Refractory/Relapsed|refractory/relapsed
5243808|NCT02481297|Small lymphocytic leukemia|small lymphocytic leukemia
5243809|NCT02481297|SLL|sll
5243810|NCT02481297|Lirilumab|lirilumab
5243811|NCT02481297|Rituximab|rituximab
5243812|NCT02481297|Rituxan|rituxan
5243813|NCT02481284|Breast reconstruction|breast reconstruction
5243814|NCT02481284|Deep inferior epigastric artery perforator flap|deep inferior epigastric artery perforator flap
5243815|NCT02481284|Skin perfusion|skin perfusion
5243816|NCT02481284|Plastic and reconstructive surgery|plastic and reconstructive surgery
5243817|NCT02481271|cholecystectomy|cholecystectomy
5243818|NCT02481258|Stenosis|stenosis
5243819|NCT02481258|Aortic Valve|aortic valve
5243820|NCT02481258|Aorta|aorta
5243821|NCT02481258|Calcified|calcified
5243822|NCT02481258|Calcific|calcific
5243823|NCT02481258|Calcification|calcification
5243824|NCT02481245|Bipolar Disorder|bipolar disorder
5243825|NCT02481245|Bezafibrate|bezafibrate
5243826|NCT02481245|Depressive Episode|depressive episode
5243827|NCT02481219|Polyps|polyps
5243828|NCT02481219|Capsule endoscopy|capsule endoscopy
5243829|NCT02481219|Bowel preparation regimen|bowel preparation regimen
5243830|NCT02481219|Average risk patients for colorectal cancer screening|average risk patients for colorectal cancer screening
5243831|NCT02481206|Ventricular Tachycardia|ventricular tachycardia
5243832|NCT02481193|Cisatracurium|cisatracurium
5243833|NCT02481193|Myalgia|myalgia
5243834|NCT02481193|Fasciculation|fasciculation
5231769|NCT02553811|accuracy|accuracy
5231770|NCT02553811|ultrasonography|ultrasonography
5231771|NCT02553811|electromyography|electromyography
5231772|NCT02553811|electrodiagnostic testing|electrodiagnostic testing
5231773|NCT02553785|BioVentrix|bioventrix
5243835|NCT02481193|Succinylcholine|succinylcholine
5243836|NCT02481167|Aged|aged
5243837|NCT02481167|Meibomian Glands|meibomian glands
5243838|NCT02481167|dry eye|dry eye
5243839|NCT02481167|Elderly|elderly
5243845|NCT02481128|lymphoscintigraphy|lymphoscintigraphy
5243846|NCT02481128|sentinel lymph node biopsy|sentinel lymph node biopsy
5243847|NCT02481076|malleolar fractures|malleolar fractures
5243848|NCT02481076|ORIF|orif
5243849|NCT02481076|compression|compression
5243850|NCT02481076|infection|infection
5243851|NCT02481076|wound dehisence|wound dehisence
5243852|NCT02481063|Eccentric|eccentric
5243853|NCT02481063|Running|running
5243854|NCT02481063|Muscle|muscle
5243855|NCT02481063|Tendon|tendon
5243856|NCT02481063|Ultrasound|ultrasound
5243857|NCT02481063|Thermography|thermography
5243858|NCT02481050|Eribulin Mesylate|eribulin mesylate
5243859|NCT02481050|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
5243860|NCT02481050|Metastatic Breast Cancer|metastatic breast cancer
5243861|NCT02481050|HER2-Negative|her2-negative
5243862|NCT02481024|Qualitative|qualitative
5243863|NCT02481024|Care transition|care transition
5243864|NCT02481024|Medication|medication
5243865|NCT02481011|Fibrinolytic agents|fibrinolytic agents
5243866|NCT02481011|Adverse effects|adverse effects
5243867|NCT02481011|Registries|registries
5243868|NCT02481011|Incidence|incidence
5243869|NCT02481011|Risk assessment|risk assessment
5243870|NCT02480985|Pituitary Disorders|pituitary disorders
5243871|NCT02480985|Traumatic Brain Injury|traumatic brain injury
5243872|NCT02480985|Critical Care|critical care
5243873|NCT02480985|Outcome Research|outcome research
5243874|NCT02480985|Risk Factors|risk factors
5243875|NCT02480985|Patient Oriented Research|patient oriented research
5243876|NCT02480972|fibrosis|fibrosis
5243877|NCT02480972|cirrhosis|cirrhosis
5243879|NCT02480946|Rheumatoid Arthritis|rheumatoid arthritis
5243880|NCT02480946|Osteoclastogenesis inhibitor|osteoclastogenesis inhibitor
5243881|NCT02480946|Anti-Inflammatory Agent|anti-inflammatory agent
5243882|NCT02480946|Musculoskeletal Diseases|musculoskeletal diseases
5243883|NCT02480946|Joint Diseases|joint diseases
5243884|NCT02480920|Atrial fibrillation Drug Adherence|atrial fibrillation drug adherence
5243885|NCT02480920|New Oral Anticoagulants|new oral anticoagulants
5243886|NCT02480920|Drug Adherence|drug adherence
5243887|NCT02480907|eating disorders|eating disorders
5243888|NCT02480907|caregivers|caregivers
5243889|NCT02480907|parents|parents
5243890|NCT02480907|skills training|skills training
5243891|NCT02480907|workshops|workshops
5243892|NCT02480907|support|support
5243893|NCT02480907|internet|internet
5243894|NCT02480907|online|online
5243895|NCT02480907|family|family
5243896|NCT02480868|Primary or secondary osteoarthritis|primary or secondary osteoarthritis
5243897|NCT02480868|fusion of the ankle|fusion of the ankle
5243898|NCT02480855|work related stress|work related stress
5243899|NCT02480855|questionnaire|questionnaire
5243900|NCT02480855|early identification|early identification
5243901|NCT02480842|Breast Neoplasms|breast neoplasms
5243902|NCT02480842|Mammaplasty|mammaplasty
5243903|NCT02480842|Breast Implantation|breast implantation
5243904|NCT02480842|Range of Motion, Articular|range of motion, articular
5243905|NCT02480842|Shoulder Joint|shoulder joint
5243906|NCT02480842|Physical Therapy Modalities|physical therapy modalities
5243907|NCT02480803|Parkinson|parkinson
5243908|NCT02480803|Parkinson's Disease|parkinson's disease
5243909|NCT02480803|Deep Brain Stimulation|deep brain stimulation
5243910|NCT02480803|levodopa-carbidopa|levodopa-carbidopa
5243912|NCT02480803|continuous intrajejunal infusion|continuous intrajejunal infusion
5243913|NCT02480764|Drug therapy|drug therapy
5243914|NCT02480751|Chronic Renal Failure|chronic renal failure
5243915|NCT02480751|Prostaglandin|prostaglandin
5243916|NCT02480751|Prostacyclin|prostacyclin
5243917|NCT02480751|Glomerular Disease; Nephrosclerosis|glomerular disease; nephrosclerosis
5243918|NCT02480738|subjective cognitive impairment|subjective cognitive impairment
5243919|NCT02480725|CJD|cjd
5243920|NCT02480725|CSF|csf
5243921|NCT02480725|prion|prion
5243922|NCT02480725|thrombin|thrombin
5243923|NCT02480673|Metabolic Syndrome X|metabolic syndrome x
5243924|NCT02480673|Chia|chia
5243925|NCT02480673|Dyslipidemia|dyslipidemia
5243926|NCT02480660|Hospitalized|hospitalized
5243927|NCT02480660|adolescents|adolescents
5243928|NCT02480660|knowledge|knowledge
5243929|NCT02480660|transition|transition
5243930|NCT02480660|educational intervention|educational intervention
5324421|NCT02064699|CMV|cmv
5243931|NCT02480634|zoledronic acid|zoledronic acid
5243932|NCT02480634|radiotherapy|radiotherapy
5243933|NCT02480595|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5243934|NCT02480595|AAA|aaa
5243935|NCT02480595|Endovascular|endovascular
5243936|NCT02480595|EVAR|evar
5243937|NCT02480595|Stent|stent
5243938|NCT02480595|Stent Graft|stent graft
5243939|NCT02480595|High Angle|high angle
5243940|NCT02480595|Tortuous|tortuous
5243941|NCT02480556|blood loss; caesarean section ; manual placental separation|blood loss; caesarean section ; manual placental separation
5243942|NCT02480530|Medication Adherence|medication adherence
5243943|NCT02480530|Reciprocal Peer|reciprocal peer
5243944|NCT02480530|Telemonitoring|telemonitoring
5243945|NCT02480517|Hypertension|hypertension
5243946|NCT02480517|Renal Denervation|renal denervation
5243947|NCT02480478|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
5243955|NCT02480361|Acupuncture|acupuncture
5243956|NCT02480361|Gastric cancer|gastric cancer
5243957|NCT02480322|metabolic alterations|metabolic alterations
5243958|NCT02480257|intervention|intervention
5243959|NCT02480257|emotion regulation|emotion regulation
5243960|NCT02480257|fMRI|fmri
5243961|NCT02480257|mindfulness|mindfulness
5243962|NCT02480257|yoga-based movement|yoga-based movement
5243963|NCT02480231|Tension-Free Vaginal Tape|tension-free vaginal tape
5243964|NCT02480231|Suburethral Slings|suburethral slings
5243965|NCT02480231|Midurethral Slings|midurethral slings
5243966|NCT02480231|Mid-urethral sling|mid-urethral sling
5243967|NCT02480231|urinary retention|urinary retention
5243968|NCT02480218|cognition|cognition
5243969|NCT02480218|tamoxifen|tamoxifen
5243970|NCT02480218|aromatase inhibitors|aromatase inhibitors
5243971|NCT02480205|CPAP|cpap
5243972|NCT02480205|NIV|niv
5243973|NCT02480205|NIPPV|nippv
5243974|NCT02480205|Edi|edi
5243975|NCT02480192|Vasomotor|vasomotor
5243976|NCT02480192|Symptoms|symptoms
5243977|NCT02480179|functional MRI|functional mri
5243978|NCT02480179|appetite|appetite
5243979|NCT02480179|neurofeedback|neurofeedback
5243980|NCT02480166|hepatitis C, genotype 6|hepatitis c, genotype 6
5243981|NCT02480153|Phase 3|phase 3
5243982|NCT02480153|adalimumab|adalimumab
5243983|NCT02480153|rheumatoid arthritis|rheumatoid arthritis
5243984|NCT02480140|Self-regulation|self-regulation
5243985|NCT02480140|Constraint-induced movement therapy|constraint-induced movement therapy
5243986|NCT02480140|Stroke|stroke
5243987|NCT02480140|Functional recovery|functional recovery
5243988|NCT02480140|Randomized controlled trial|randomized controlled trial
5243989|NCT02480101|influenza vaccine pandemic|influenza vaccine pandemic
5243990|NCT02480075|Genetic Variation|genetic variation
5243991|NCT02480075|Genetic Polymorphism|genetic polymorphism
5243992|NCT02480075|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5243993|NCT02480075|Genetic Association Studies|genetic association studies
5243994|NCT02480062|Decision Support System|decision support system
5243995|NCT02480062|mHealth|mhealth
5243996|NCT02480062|Primary Health Care|primary health care
5243997|NCT02480062|Non-communicable diseases|non-communicable diseases
5243998|NCT02480036|IORT|iort
5243999|NCT02480036|Kyphoplasty|kyphoplasty
5244000|NCT02480036|Spine|spine
5244001|NCT02480036|Cancer|cancer
5244002|NCT02479997|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5244003|NCT02479997|Indocyanine green (ICG)|indocyanine green (icg)
5244004|NCT02479997|Radioisotope (RI)|radioisotope (ri)
5244005|NCT02479997|Near infrared fluorescence camera|near infrared fluorescence camera
5244006|NCT02479984|staging laparoscopy|staging laparoscopy
5244007|NCT02479984|pancreatic cancer|pancreatic cancer
5244008|NCT02479984|biliary cancer|biliary cancer
5244009|NCT02479958|Photochemotherapy|photochemotherapy
5244010|NCT02479958|Bacteria|bacteria
5244011|NCT02479932|Extra-peritoneal cesarean|extra-peritoneal cesarean
5244012|NCT02479932|Intra-peritoneal cesarean|intra-peritoneal cesarean
5244013|NCT02479919|theta burst stimulation|theta burst stimulation
5244016|NCT02479919|transcranial magnetic stimulation|transcranial magnetic stimulation
5244017|NCT02479906|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5244018|NCT02479906|PTSD|ptsd
5244019|NCT02479906|dTMS|dtms
5244020|NCT02479893|cold snare polypectomy|cold snare polypectomy
5244021|NCT02479893|APC|apc
5244022|NCT02479893|hot snare polypectomy|hot snare polypectomy
5244023|NCT02479815|Complementary feeding recommendation|complementary feeding recommendation
5244024|NCT02479815|Program evaluation|program evaluation
5244025|NCT02479815|Process and impact evaluation|process and impact evaluation
5244026|NCT02479815|Micronutrient powder (MNP) safety|micronutrient powder (mnp) safety
5244027|NCT02479802|plasma exchange|plasma exchange
5244028|NCT02479802|albumin|albumin
5244029|NCT02479789|Intravenous Lidocaine|intravenous lidocaine
5244030|NCT02479789|Recurrent laryngeal nerve|recurrent laryngeal nerve
5244031|NCT02479789|Intra operative nerve monitoring|intra operative nerve monitoring
5244032|NCT02479789|Thyroidectomy|thyroidectomy
5244033|NCT02479763|Epidural waveform analysis|epidural waveform analysis
5244034|NCT02479763|Loss of resistance|loss of resistance
5244035|NCT02479737|Chest tube|chest tube
5244036|NCT02479737|chest drainage|chest drainage
5244333|NCT02478099|MPDL3280A|mpdl3280a
5244037|NCT02479737|retained blood complications|retained blood complications
5244038|NCT02479737|chest tube clogging|chest tube clogging
5244039|NCT02479737|hemothorax|hemothorax
5244040|NCT02479737|tamponade|tamponade
5244042|NCT02479737|pleural effusion|pleural effusion
5244043|NCT02479737|intensive care|intensive care
5244044|NCT02479724|continuous, non-invasive|continuous, non-invasive
5244045|NCT02479711|glass ionomer|glass ionomer
5244046|NCT02479711|bulk fill composite|bulk fill composite
5244047|NCT02479672|breathing tube placement|breathing tube placement
5244048|NCT02479672|VideoTrac® laryngoscope|videotrac® laryngoscope
5244049|NCT02479672|direct laryngoscopy|direct laryngoscopy
5244050|NCT02479659|Immunizations|immunizations
5244051|NCT02479646|Pegfilgrastim|pegfilgrastim
5244052|NCT02479646|G-CSF|g-csf
5244053|NCT02479646|Pharmacokinetics|pharmacokinetics
5244054|NCT02479646|Pharmacodynamics|pharmacodynamics
5244055|NCT02479633|prognostic factors|prognostic factors
5244057|NCT02479607|Cytostatic Agents|cytostatic agents
5244058|NCT02479607|Nursing|nursing
5244059|NCT02479607|Health Literacy|health literacy
5244060|NCT02479607|Quality of Life|quality of life
5244061|NCT02479607|Oncology Nursing|oncology nursing
5244062|NCT02479607|Self Care|self care
5244063|NCT02479607|Symptom Management|symptom management
5244064|NCT02479607|Participatory Care|participatory care
5244065|NCT02479607|Person-centered Care|person-centered care
5244066|NCT02479607|Information and Communication Technology|information and communication technology
5244067|NCT02479607|Patient-reported symptoms|patient-reported symptoms
5244068|NCT02479607|Mobile device|mobile device
5244069|NCT02479594|competence-feedback|competence-feedback
5244070|NCT02479581|Enhanced Recovery after Surgery|enhanced recovery after surgery
5244071|NCT02479568|Cardiovascular disease|cardiovascular disease
5244072|NCT02479568|biomarkers|biomarkers
5244073|NCT02479568|transcriptomics|transcriptomics
5244074|NCT02479568|orange juice|orange juice
5244075|NCT02479568|hesperidin|hesperidin
5244076|NCT02479568|systolic blood pressure|systolic blood pressure
5244077|NCT02479568|metabolomics|metabolomics
5244078|NCT02479568|cardiovascular risk factor|cardiovascular risk factor
5244079|NCT02479542|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5244080|NCT02479542|Wound Healing|wound healing
5244081|NCT02479542|Global Health|global health
5244082|NCT02479542|Cameroon|cameroon
5244083|NCT02479516|Diabetes screening|diabetes screening
5244084|NCT02479516|Health Promotion|health promotion
5244085|NCT02479516|Low and Middle Income Countries|low and middle income countries
5244086|NCT02479516|CHAP|chap
5244087|NCT02479503|antibiotic prophylaxis heart transplantation|antibiotic prophylaxis heart transplantation
5244088|NCT02479490|metastatic renal cancer|metastatic renal cancer
5244089|NCT02479490|failure of VEGFR_TKI|failure of vegfr_tki
5244090|NCT02479490|prednisone|prednisone
5244091|NCT02479490|everolimus|everolimus
5244092|NCT02479477|Public Health|public health
5244093|NCT02479477|Nursing Staff, Hospital|nursing staff, hospital
5244094|NCT02479464|AssureRx|assurerx
5244095|NCT02479464|Algorithm|algorithm
5244096|NCT02479464|Major depressive disorder|major depressive disorder
5244097|NCT02479451|End stage renal disease|end stage renal disease
5244098|NCT02479451|Olfaction|olfaction
5244099|NCT02479451|Dialysis|dialysis
5244100|NCT02479451|Hemodialysis|hemodialysis
5244101|NCT02479451|Malnutrition|malnutrition
5244102|NCT02479425|pressure ulcer|pressure ulcer
5244103|NCT02479425|Positioning|positioning
5244104|NCT02479412|Mild to moderate asthma|mild to moderate asthma
5244105|NCT02479412|FEV1|fev1
5244106|NCT02479412|efficacy|efficacy
5244107|NCT02479412|safety|safety
5244108|NCT02479399|Suglat|suglat
5244109|NCT02479399|SGLT-2 inhibitor|sglt-2 inhibitor
5244110|NCT02479399|Ipragliflozin L-Proline|ipragliflozin l-proline
5244111|NCT02479399|ASP1941 long-term use|asp1941 long-term use
5244112|NCT02479347|General surgery|general surgery
5244113|NCT02479347|Postoperative|postoperative
5244114|NCT02479334|Spices|spices
5244115|NCT02479334|Functional food|functional food
5244116|NCT02479334|Cardiometabolic risk|cardiometabolic risk
5244117|NCT02479334|Metabolic syndrome|metabolic syndrome
5244118|NCT02479334|Inflammation|inflammation
5244119|NCT02479334|Peripheral blood mononuclear cell|peripheral blood mononuclear cell
5244120|NCT02479334|Acute|acute
5244121|NCT02479321|Perioperative Goal-Directed Hemodynamic Therapy|perioperative goal-directed hemodynamic therapy
5244122|NCT02479321|Fluid therapy|fluid therapy
5244123|NCT02479321|Aged|aged
5244124|NCT02479321|Perioperative complications|perioperative complications
5244125|NCT02479321|Survival|survival
5244126|NCT02479308|Alkermes|alkermes
5244127|NCT02479308|Samidorphan|samidorphan
5244128|NCT02479308|ALKS 5461|alks 5461
5244129|NCT02479308|QT/QTc|qt/qtc
5244130|NCT02479308|Buprenorphine|buprenorphine
5244131|NCT02479308|Pharmacodynamics|pharmacodynamics
5232079|NCT02552017|Endocuff|endocuff
5244132|NCT02479269|Brain Natriuretic Peptide|brain natriuretic peptide
5244133|NCT02479269|aerobic execise|aerobic execise
5244134|NCT02479269|C- Reactive Protein|c- reactive protein
5244135|NCT02479256|PCOS|pcos
5244136|NCT02479256|Induction of ovulation|induction of ovulation
5244137|NCT02479256|Clomiphene citrate|clomiphene citrate
5244138|NCT02479256|Tamoxifen|tamoxifen
5244139|NCT02479243|Arterial Spin Labeling|arterial spin labeling
5244143|NCT02479243|Ischemic stroke|ischemic stroke
5244144|NCT02479230|vaccine|vaccine
5244145|NCT02479230|breast cancer|breast cancer
5244146|NCT02479230|metastatic|metastatic
5244147|NCT02479204|safety|safety
5244148|NCT02479204|heart rate|heart rate
5244149|NCT02479204|pharmacokinetics|pharmacokinetics
5244150|NCT02479191|Abdominal|abdominal
5244151|NCT02479191|Aortic|aortic
5244152|NCT02479191|Aneurysm|aneurysm
5244153|NCT02479152|Mechanical CPR|mechanical cpr
5244154|NCT02479152|Hemodynamics|hemodynamics
5244155|NCT02479126|Interstitial Lung Disease|interstitial lung disease
5244156|NCT02479126|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5244157|NCT02479126|Electronic Health Records|electronic health records
5244159|NCT02479126|Mortality|mortality
5244160|NCT02479126|Hospitalization|hospitalization
5244161|NCT02479126|Acute care visits|acute care visits
5244162|NCT02479126|Anti-inflammatory drug therapies|anti-inflammatory drug therapies
5244163|NCT02479113|GDM|gdm
5244164|NCT02479113|Maternal Hypertriglyceridaemia|maternal hypertriglyceridaemia
5244165|NCT02479100|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
5244166|NCT02479100|Breast|breast
5244167|NCT02479100|Cancer|cancer
5244168|NCT02479100|Diagnosis|diagnosis
5244169|NCT02479100|Patient management|patient management
5244170|NCT02479087|von Willebrand Factor|von willebrand factor
5244171|NCT02479087|Factor VIII|factor viii
5244172|NCT02479087|Hemorrhage|hemorrhage
5244173|NCT02479087|Immune Tolerance|immune tolerance
5244174|NCT02479087|Hemophilia A|hemophilia a
5244175|NCT02479074|Chronic|chronic
5244176|NCT02479061|Observationnal study|observationnal study
5244177|NCT02479061|Prevalence|prevalence
5244178|NCT02479061|Palliative care|palliative care
5244179|NCT02479061|Anti cancer center|anti cancer center
5244180|NCT02479048|satiety/appetite|satiety/appetite
5244181|NCT02479048|glycemic response|glycemic response
5244182|NCT02479048|cardiometabolic risk|cardiometabolic risk
5244183|NCT02479035|insulin sensitive|insulin sensitive
5244184|NCT02479035|insulin resistant|insulin resistant
5244185|NCT02479035|red raspberry|red raspberry
5244186|NCT02479035|polyphenols|polyphenols
5244187|NCT02479035|bioavailability|bioavailability
5244188|NCT02478996|perioperative|perioperative
5244189|NCT02478996|internet-based|internet-based
5244190|NCT02478996|exercise program|exercise program
5244191|NCT02478957|mastocytosis|mastocytosis
5244192|NCT02478957|cromolyn sodium|cromolyn sodium
5244193|NCT02478944|Inflammatory bowel disease|inflammatory bowel disease
5244194|NCT02478944|Manometry|manometry
5244195|NCT02478892|high risk|high risk
5244196|NCT02478892|specifically those with BRCA1/2 mutations|specifically those with brca1/2 mutations
5244197|NCT02478827|Cognitive Training|cognitive training
5244198|NCT02478827|Working Memory|working memory
5244199|NCT02478827|Processing Speed|processing speed
5244200|NCT02478788|ADHD|adhd
5244201|NCT02478775|obesity|obesity
5244202|NCT02478775|fertility|fertility
5244203|NCT02478775|infertility|infertility
5244204|NCT02478775|reproductive hormones|reproductive hormones
5244205|NCT02478762|Foetal glycated hemoglobin|foetal glycated hemoglobin
5244206|NCT02478762|Glycemic objectives treatment|glycemic objectives treatment
5244207|NCT02478736|postoperative delirium|postoperative delirium
5244208|NCT02478736|on-pump cardiac surgery|on-pump cardiac surgery
5244209|NCT02478736|cerebral oximetry|cerebral oximetry
5244210|NCT02478736|cerebral blood flow velosity|cerebral blood flow velosity
5244211|NCT02478723|requiring therapy|requiring therapy
5244212|NCT02478723|Teeth|teeth
5244213|NCT02478697|tobacco smoking behavior|tobacco smoking behavior
5244215|NCT02478697|job-seeking|job-seeking
5244216|NCT02478697|tobacco cessation|tobacco cessation
5244217|NCT02478697|transtheoretical model|transtheoretical model
5244218|NCT02478697|behavior change|behavior change
5244219|NCT02478684|delayed cord clamping|delayed cord clamping
5244220|NCT02478684|premature infants|premature infants
5244221|NCT02478684|randomized study|randomized study
5244222|NCT02478684|hematocrit|hematocrit
5244223|NCT02478658|irisin|irisin
5244224|NCT02478658|resistance training|resistance training
5244225|NCT02478658|physical fitness|physical fitness
5244226|NCT02478658|Volunteers|volunteers
5244227|NCT02478632|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5244228|NCT02478632|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
5244229|NCT02478632|two-drug regimen|two-drug regimen
5244230|NCT02478632|bone mineral density|bone mineral density
5232169|NCT02551510|Port Incisions|port incisions
5244231|NCT02478632|dual energy X-ray absorptiometry (DEXA)|dual energy x-ray absorptiometry (dexa)
5244232|NCT02478632|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
5244233|NCT02478632|nucleoside reverse transcriptase inhibitor -sparing regimen|nucleoside reverse transcriptase inhibitor -sparing regimen
5244234|NCT02478632|integrase inhibitor|integrase inhibitor
5244235|NCT02478619|Obesity|obesity
5244236|NCT02478619|Respiratory Muscle Training|respiratory muscle training
5244237|NCT02478619|Bariatric Surgery|bariatric surgery
5244238|NCT02478619|Breathing exercises|breathing exercises
5244239|NCT02478619|Gastroplasty|gastroplasty
5244240|NCT02478606|Lower Extremity|lower extremity
5244241|NCT02478606|Muscle Stretching Exercises|muscle stretching exercises
5244242|NCT02478606|Muscle Strength|muscle strength
5244243|NCT02478606|Static Stretching|static stretching
5244244|NCT02478606|Proprioceptive Neuromuscular Facilitation (PNF) Stretching|proprioceptive neuromuscular facilitation (pnf) stretching
5244249|NCT02478593|Prevalence|prevalence
5244250|NCT02478580|Obstructive Sleep Apnea|obstructive sleep apnea
5244251|NCT02478580|Anesthesia Recovery Period|anesthesia recovery period
5244252|NCT02478554|Fetal growth restriction|fetal growth restriction
5244253|NCT02478554|macrosomia|macrosomia
5244254|NCT02478541|triglycerides|triglycerides
5244255|NCT02478541|glucose|glucose
5244256|NCT02478541|fructose|fructose
5244257|NCT02478541|fatty acids|fatty acids
5244258|NCT02478515|ranibizumab|ranibizumab
5244259|NCT02478515|PRN regimen|prn regimen
5244260|NCT02478515|macular edema|macular edema
5244261|NCT02478515|branch retinal vein occlusion|branch retinal vein occlusion
5244262|NCT02478502|testicular cancer|testicular cancer
5244263|NCT02478502|cisplatin resistancy|cisplatin resistancy
5244264|NCT02478489|alcohol|alcohol
5244265|NCT02478489|heavy drinking|heavy drinking
5244266|NCT02478489|naltrexone|naltrexone
5244267|NCT02478489|hospital|hospital
5244268|NCT02478489|alcohol use disorder|alcohol use disorder
5244269|NCT02478489|alcohol dependence|alcohol dependence
5244270|NCT02478489|comparative effectiveness|comparative effectiveness
5244271|NCT02478463|Cabotegravir|cabotegravir
5244272|NCT02478463|Pharmacokinetic|pharmacokinetic
5244273|NCT02478463|Healthy Adult Volunteers|healthy adult volunteers
5244274|NCT02478463|GSK1265744|gsk1265744
5244275|NCT02478437|Lumbar Facet Syndrome|lumbar facet syndrome
5244276|NCT02478411|muscle weakness|muscle weakness
5244277|NCT02478411|rehabilitation|rehabilitation
5244278|NCT02478411|intensive care|intensive care
5244279|NCT02478411|mechanical ventilation|mechanical ventilation
5244280|NCT02478411|cyclo ergometer|cyclo ergometer
5244281|NCT02478411|physiotherapy|physiotherapy
5244282|NCT02478385|Birth environment|birth environment
5244283|NCT02478385|oxytocin|oxytocin
5244284|NCT02478385|epidural|epidural
5244285|NCT02478385|analgesia|analgesia
5244286|NCT02478385|home-like|home-like
5244287|NCT02478372|local infiltration analgesia|local infiltration analgesia
5244288|NCT02478372|Epidural|epidural
5244289|NCT02478372|Enhanced Recovery|enhanced recovery
5244290|NCT02478372|Total Knee Arthroplasty|total knee arthroplasty
5244291|NCT02478333|Healthy|healthy
5244292|NCT02478333|ALS-008176|als-008176
5244293|NCT02478333|Japanese adult participants|japanese adult participants
5244294|NCT02478320|Advanced Cancers|advanced cancers
5244295|NCT02478320|CDKN2A-Deficient Advanced Solid Cancers|cdkn2a-deficient advanced solid cancers
5244296|NCT02478320|Advanced or metastatic cancer.|advanced or metastatic cancer.
5244297|NCT02478320|Ilorasertib|ilorasertib
5244298|NCT02478320|ABT-348|abt-348
5244299|NCT02478307|chronic low back pain|chronic low back pain
5244300|NCT02478307|mindfulness meditation|mindfulness meditation
5244301|NCT02478307|cognitive therapy|cognitive therapy
5244302|NCT02478307|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5244303|NCT02478307|efficacy|efficacy
5244304|NCT02478307|mechanisms|mechanisms
5244305|NCT02478307|coping|coping
5244306|NCT02478294|Atrial Fibrillation|atrial fibrillation
5244307|NCT02478294|Stroke|stroke
5244308|NCT02478294|Systemic embolism|systemic embolism
5244309|NCT02478294|Left atrial appendage excision|left atrial appendage excision
5244310|NCT02478294|Warfarin|warfarin
5244311|NCT02478268|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5139138|NCT03120988|Knee OA|knee oa
5244313|NCT02478255|Radiation induced lung injury|radiation induced lung injury
5244315|NCT02478255|hyperpolarized|hyperpolarized
5244316|NCT02478229|Liver transplant|liver transplant
5244317|NCT02478229|Genotype 1 HCV infection|genotype 1 hcv infection
5244318|NCT02478229|Sofosbuvir (SOF)/ Ledipasvir (LDV)|sofosbuvir (sof)/ ledipasvir (ldv)
5244319|NCT02478229|Sustained virological response (SVR12 )|sustained virological response (svr12 )
5244320|NCT02478203|Airtraq|airtraq
5244321|NCT02478203|Glidescope|glidescope
5244322|NCT02478203|pediatric|pediatric
5244323|NCT02478203|face-to-face|face-to-face
5244328|NCT02478151|Deceased donor liver transplant|deceased donor liver transplant
5244329|NCT02478151|Normothermic machine perfusion|normothermic machine perfusion
5244330|NCT02478125|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5244331|NCT02478112|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5244332|NCT02478112|Balloon implant|balloon implant
5244334|NCT02478099|solid tumors|solid tumors
5244335|NCT02478086|amino acids|amino acids
5244336|NCT02478086|renal function|renal function
5244337|NCT02478086|extreme premature|extreme premature
5244338|NCT02478060|Allergy|allergy
5244339|NCT02478060|Birch|birch
5244340|NCT02478060|Rhinitis|rhinitis
5244341|NCT02478060|Rhinoconjuntivitis|rhinoconjuntivitis
5244342|NCT02478060|SPIRE|spire
5244343|NCT02478060|Toleromune|toleromune
5674160|NCT00604747|practice|practice
5244345|NCT02478021|effects of cortisol on cognition|effects of cortisol on cognition
5244346|NCT02478008|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
5244347|NCT02478008|Mitral Regurgitation|mitral regurgitation
5244348|NCT02478008|Mitral Insufficiency|mitral insufficiency
5244349|NCT02478008|Transapical|transapical
5244350|NCT02477995|Immunogenicity|immunogenicity
5244352|NCT02477995|DTaP Vaccine|dtap vaccine
5244353|NCT02477982|Propofol|propofol
5244354|NCT02477982|Cardiopulmonary Bypass|cardiopulmonary bypass
5244355|NCT02477982|Pharmacokinetics|pharmacokinetics
5244356|NCT02477982|Obesity|obesity
5244357|NCT02477956|vitamin D|vitamin d
5244358|NCT02477956|obesity|obesity
5244359|NCT02477956|bariatric surgery|bariatric surgery
5244360|NCT02477943|Concussion|concussion
5244361|NCT02477943|Mild Traumatic Brain Injury|mild traumatic brain injury
5244362|NCT02477943|Sport Related Concussion|sport related concussion
5244363|NCT02477917|allergy|allergy
5244364|NCT02477917|SCIT|scit
5244365|NCT02477904|Autism|autism
5244366|NCT02477904|Autism Spectrum Disorder|autism spectrum disorder
5244367|NCT02477904|Ketogenic Diet|ketogenic diet
5244368|NCT02477904|Biochemical Profiles|biochemical profiles
5244369|NCT02477891|Multiple myeloma|multiple myeloma
5244370|NCT02477891|Daratumumab|daratumumab
5244371|NCT02477891|Early access|early access
5244372|NCT02477878|Adult leukemias and myelodysplasia|adult leukemias and myelodysplasia
5244373|NCT02477878|Adult lymphomas|adult lymphomas
5244374|NCT02477878|Adult multiple myeloma|adult multiple myeloma
5244375|NCT02477878|allogeneic stem cell transplant|allogeneic stem cell transplant
5244376|NCT02477878|donor lymphocyte infusion|donor lymphocyte infusion
5244377|NCT02477852|tuberculosis|tuberculosis
5244378|NCT02477852|spinal|spinal
5244379|NCT02477852|general|general
5244380|NCT02477852|operation|operation
5244381|NCT02477852|drug|drug
5244382|NCT02477852|therapy|therapy
5244384|NCT02477800|BIIB037|biib037
5244385|NCT02477800|Aducanumab|aducanumab
5244386|NCT02477787|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
5244387|NCT02477787|natural killer cells|natural killer cells
5244389|NCT02477670|Negative Symptoms|negative symptoms
5244390|NCT02477670|Schizophrenia|schizophrenia
5244391|NCT02477670|AVP-786|avp-786
5244392|NCT02477657|Adult patients with refractory malignant ascites secondary to GU or GI malignancy.|adult patients with refractory malignant ascites secondary to gu or gi malignancy.
5244393|NCT02477644|Advanced FIGO IIIB|advanced figo iiib
5244394|NCT02477644|IV high grade serious ovarian cancer|iv high grade serious ovarian cancer
5244395|NCT02477644|endometrioid ovarian cancer|endometrioid ovarian cancer
5244396|NCT02477644|standard first-line treatment|standard first-line treatment
5244397|NCT02477644|platinum-taxane chemotherapy|platinum-taxane chemotherapy
5244398|NCT02477644|bevacizumab|bevacizumab
5244399|NCT02477644|olaparib|olaparib
5244400|NCT02477644|placebo|placebo
5244401|NCT02477631|Myelodysplastic syndrome|myelodysplastic syndrome
5244402|NCT02477631|oxidative stress|oxidative stress
5244403|NCT02477631|labile plasma iron|labile plasma iron
5244404|NCT02477592|long standing persistent atrial fibrillation|long standing persistent atrial fibrillation
5244405|NCT02477592|novel approach|novel approach
5244406|NCT02477592|ablation|ablation
5244407|NCT02477566|pcos|pcos
5244408|NCT02477566|Long acting Triptorelin|long acting triptorelin
5244409|NCT02477566|Short acting Triptorelin|short acting triptorelin
5244410|NCT02477566|In Vitro Fertilization|in vitro fertilization
5244411|NCT02477553|decision aid|decision aid
5244412|NCT02477553|cancer screening|cancer screening
5241933|NCT02492555|Telemedicine|telemedicine
5244413|NCT02477553|colorectal neoplasm|colorectal neoplasm
5244414|NCT02477553|decision making|decision making
5244415|NCT02477553|risk communication|risk communication
5244417|NCT02477553|health literacy|health literacy
5244418|NCT02477527|atripla|atripla
5244419|NCT02477527|stribild|stribild
5244420|NCT02477527|dreams|dreams
5244421|NCT02477501|Spinal anesthesia|spinal anesthesia
5244422|NCT02477501|cesarean|cesarean
5244423|NCT02477501|blood pressure|blood pressure
5244424|NCT02477501|Norepinephrine|norepinephrine
5244425|NCT02477501|Ephedrine|ephedrine
5244426|NCT02477488|Allopurinol|allopurinol
5244427|NCT02477488|Renal Dialysis|renal dialysis
5244428|NCT02477475|reflux esophagitis|reflux esophagitis
5244429|NCT02477475|Nexium|nexium
5244430|NCT02477449|safety|safety
5244431|NCT02477449|istaroxime|istaroxime
5244432|NCT02477423|Microbiome|microbiome
5244433|NCT02477423|Antibiotics|antibiotics
5324961|NCT02062203|TQT|tqt
5232359|NCT02550210|Breast Imaging|breast imaging
5232360|NCT02550210|Breast Diagnostics|breast diagnostics
5232361|NCT02550197|Influenza|influenza
5232362|NCT02550197|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
5244434|NCT02477410|porcine protein|porcine protein
5244435|NCT02477410|appetite|appetite
5244436|NCT02477410|muscle protein synthesis|muscle protein synthesis
5244437|NCT02477410|gastrointestinal hormones|gastrointestinal hormones
5244438|NCT02477397|Spiromax|spiromax
5244439|NCT02477397|Budesonide/formoterol|budesonide/formoterol
5244440|NCT02477397|COPD|copd
5244441|NCT02477397|exacerbations|exacerbations
5244442|NCT02477397|SMART|smart
5244443|NCT02477345|Cholestasis|cholestasis
5244444|NCT02477345|Parenteral Nutrition|parenteral nutrition
5244445|NCT02477345|Liver disease|liver disease
5244446|NCT02477332|QGE031|qge031
5244447|NCT02477332|ligelizumab|ligelizumab
5244448|NCT02477332|omalizumab|omalizumab
5244449|NCT02477332|chronic|chronic
5244450|NCT02477332|spontaneous|spontaneous
5244451|NCT02477332|urticaria|urticaria
5244452|NCT02477332|adults|adults
5244453|NCT02477332|CSU|csu
5244454|NCT02477293|Hyeonggaeyeongyo-tang|hyeonggaeyeongyo-tang
5244455|NCT02477293|Chronic rhinitis|chronic rhinitis
5114087|NCT03283501|TAVI|tavi
5244456|NCT02477293|Pattern identification|pattern identification
5244457|NCT02477293|Korean medicine|korean medicine
5244458|NCT02477254|lupus|lupus
5244459|NCT02477241|overactive bladder syndrome|overactive bladder syndrome
5244460|NCT02477241|urgency urinary incontinence|urgency urinary incontinence
5244461|NCT02477241|fMRI|fmri
5244462|NCT02477241|urodynamics|urodynamics
5244463|NCT02477215|Multiple Myeloma|multiple myeloma
5244464|NCT02477202|Mirena® IUD's|mirena® iud's
5244465|NCT02477202|Women|women
5244466|NCT02477202|risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
5244467|NCT02477202|risk-reducing salpingectomy|risk-reducing salpingectomy
5244468|NCT02477163|Nephropathy induced by drugs medicaments and biological substances|nephropathy induced by drugs medicaments and biological substances
5244469|NCT02477163|Other nephritis and nephropathy not specified as acute or chronic|other nephritis and nephropathy not specified as acute or chronic
5244470|NCT02477150|lupus|lupus
5244471|NCT02477137|Prostate Cancer|prostate cancer
5244472|NCT02477137|Nursing|nursing
5244473|NCT02477137|Health Literacy|health literacy
5244474|NCT02477137|Quality of Life|quality of life
5244475|NCT02477137|Radiotherapy|radiotherapy
5244476|NCT02477137|Oncology Nursing|oncology nursing
5244477|NCT02477137|Self Care|self care
5244478|NCT02477137|Symptom Management|symptom management
5244479|NCT02477137|Participatory Care|participatory care
5244480|NCT02477137|Person-centered Care|person-centered care
5244481|NCT02477137|Information and Communication Technology|information and communication technology
5244482|NCT02477137|Patient-reported symptoms|patient-reported symptoms
5244483|NCT02477137|Mobile device|mobile device
5244484|NCT02477111|Endovascular repair|endovascular repair
5244485|NCT02477098|rectus sheath block|rectus sheath block
5244486|NCT02477098|cytokines|cytokines
5244487|NCT02477098|sleep|sleep
5244488|NCT02477085|Labor|labor
5244489|NCT02477085|induction|induction
5244490|NCT02477085|delivery|delivery
5244491|NCT02477085|prostaglandins|prostaglandins
5244492|NCT02477085|oxytocin|oxytocin
5244493|NCT02477085|amniotomy|amniotomy
5244494|NCT02477085|balloon catheter|balloon catheter
5244495|NCT02477059|Hand OA|hand oa
5244496|NCT02477059|Tocilizumab|tocilizumab
5244497|NCT02477059|Osteoarthritis|osteoarthritis
5244498|NCT02477059|Interleukin-6|interleukin-6
5244499|NCT02477020|Drug Therapy|drug therapy
5244500|NCT02477007|Paediatric emergency|paediatric emergency
5244501|NCT02477007|pain|pain
5244502|NCT02477007|long-bones fractures|long-bones fractures
5244503|NCT02477007|morphine|morphine
5244504|NCT02477007|ibuprofen|ibuprofen
5244505|NCT02477007|paracetamol|paracetamol
5244506|NCT02477007|children|children
5244507|NCT02476994|Essential Fatty Acids (EFA)|essential fatty acids (efa)
5244508|NCT02476994|Parenteral Nutrition|parenteral nutrition
5244509|NCT02476994|Clinolipid/Clinoleic|clinolipid/clinoleic
5244510|NCT02476994|Parenteral Nutrition Associated Cholestasis (PNAC)|parenteral nutrition associated cholestasis (pnac)
5244511|NCT02476994|Parenteral Nutrition Associated Liver Disease (PNALD)|parenteral nutrition associated liver disease (pnald)
5244512|NCT02476994|Intestinal Failure Associated Liver Disease (IFALD)|intestinal failure associated liver disease (ifald)
5244513|NCT02476994|Phytosterols|phytosterols
5244515|NCT02476994|Infants/Preterm Infants|infants/preterm infants
5244516|NCT02476994|FADS1 and FADS2|fads1 and fads2
5244517|NCT02476994|Short Bowel Syndrome|short bowel syndrome
5244518|NCT02476994|Cancer Nutrition|cancer nutrition
5244519|NCT02476994|Olive Oil Emulsion|olive oil emulsion
5244520|NCT02476994|Soybean Oil Emulsion|soybean oil emulsion
5244521|NCT02476955|ARQ 092|arq 092
5244526|NCT02476955|Molecular therapy|molecular therapy
5244527|NCT02476955|Tyrosine kinase inhibitor (TKI)|tyrosine kinase inhibitor (tki)
5244528|NCT02476955|Receptor tyrosine kinase (RTK)|receptor tyrosine kinase (rtk)
5244529|NCT02476955|Biomarkers|biomarkers
5244530|NCT02476955|Phase 1 - Phase I|phase 1 - phase i
5244531|NCT02476955|Solid tumors|solid tumors
5244532|NCT02476955|Metastatic solid tumors|metastatic solid tumors
5244533|NCT02476955|Recurrent solid tumors|recurrent solid tumors
5244534|NCT02476955|Ovarian cancer|ovarian cancer
5244535|NCT02476955|Endometrial cancer|endometrial cancer
5244536|NCT02476955|Cervical cancer|cervical cancer
5244537|NCT02476955|Triple-negative breast cancer|triple-negative breast cancer
5244538|NCT02476955|AKT kinases|akt kinases
5244539|NCT02476955|AKT pathway|akt pathway
5244540|NCT02476955|AKT signaling|akt signaling
5244541|NCT02476955|AKT inhibitor|akt inhibitor
5244542|NCT02476955|AKT pan inhibitor|akt pan inhibitor
5244544|NCT02476955|PI3K/AKT/mTOR signaling pathway|pi3k/akt/mtor signaling pathway
5244547|NCT02476955|AKT3|akt3
5244548|NCT02476955|Phase I Clinical Trial|phase i clinical trial
5244549|NCT02476955|Clinical oncology|clinical oncology
5244550|NCT02476955|Tumor|tumor
5244551|NCT02476955|AKT1 inhibitor|akt1 inhibitor
5244552|NCT02476955|AKT2 inhibitor|akt2 inhibitor
5244553|NCT02476955|AKT3 inhibitor|akt3 inhibitor
5244554|NCT02476955|AKT1 mutation|akt1 mutation
5244555|NCT02476955|AKT2 mutation|akt2 mutation
5244556|NCT02476955|AKT3 mutation|akt3 mutation
5244557|NCT02476955|AKT1 amplification|akt1 amplification
5244558|NCT02476955|AKT2 amplification|akt2 amplification
5244559|NCT02476955|AKT3 amplification|akt3 amplification
5244560|NCT02476955|Anastrozole|anastrozole
5244561|NCT02476955|Estrogen receptor positive|estrogen receptor positive
5244562|NCT02476955|PIK3CA mutation|pik3ca mutation
5244563|NCT02476929|Electronic nose|electronic nose
5244564|NCT02476929|Nasal nitrous oxide|nasal nitrous oxide
5244565|NCT02476929|Allergic Rhinitis|allergic rhinitis
5244566|NCT02476929|Non-Allergic Rhinitis|non-allergic rhinitis
5244567|NCT02476929|Nasal polyps|nasal polyps
5244572|NCT02476877|comorbidity|comorbidity
5244573|NCT02476877|epidemiology|epidemiology
5244574|NCT02476877|mental illness|mental illness
5244575|NCT02476877|drug abuse|drug abuse
5244576|NCT02476864|macitentan|macitentan
5244577|NCT02476864|biocomparison|biocomparison
5244579|NCT02476851|Blood Donation|blood donation
5244580|NCT02476851|Whole Blood|whole blood
5244581|NCT02476838|hand injury|hand injury
5244582|NCT02476838|hand amputation|hand amputation
5244583|NCT02476838|hand amputee|hand amputee
5244584|NCT02476838|hand surgery|hand surgery
5244585|NCT02476825|volunteers|volunteers
5244586|NCT02476773|Hookworm Vaccine|hookworm vaccine
5244587|NCT02476773|Na-APR-1 (M74)/Alhydrogel® Hookworm Vaccine|na-apr-1 (m74)/alhydrogel® hookworm vaccine
5244588|NCT02476773|Na-GST-1/Alhydrogel® Hookworm Vaccine|na-gst-1/alhydrogel® hookworm vaccine
5244589|NCT02476760|Incretins|incretins
5244590|NCT02476760|Antidiabetic agents|antidiabetic agents
5244591|NCT02476760|Pancreatitis|pancreatitis
5244592|NCT02476747|Colonic polyp|colonic polyp
5244593|NCT02476734|REDIRECTED AUTOLOGOUS CART- 19 T-CELL IMMUNOTHERAPY|redirected autologous cart- 19 t-cell immunotherapy
5244594|NCT02476721|pulmonary embolism|pulmonary embolism
5244595|NCT02476721|emergency department|emergency department
5244596|NCT02476708|schizophrenia|schizophrenia
5244597|NCT02476708|schizoaffective disorder|schizoaffective disorder
5244598|NCT02476708|cognition|cognition
5244599|NCT02476708|curcumin|curcumin
5244600|NCT02476695|CHB|chb
5244601|NCT02476682|Sessile serrated polyps|sessile serrated polyps
5244602|NCT02476682|Advanced mucosal neoplasia|advanced mucosal neoplasia
5244603|NCT02476669|plasma EBV DNA|plasma ebv dna
5244604|NCT02476669|biomarker|biomarker
5244605|NCT02476669|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5244606|NCT02476617|Treatment naive|treatment naive
5244607|NCT02476617|Interferon free|interferon free
5244608|NCT02476617|HCV|hcv
5244609|NCT02476617|Chronic Hepatitis C|chronic hepatitis c
5244610|NCT02476617|Hepatitis C Genotype 1a|hepatitis c genotype 1a
5244611|NCT02476617|Hepatitis C|hepatitis c
5244612|NCT02476617|pegylated-interferon (pegIFN)/ribavirin (RBV) experienced|pegylated-interferon (pegifn)/ribavirin (rbv) experienced
5244613|NCT02476604|prevention|prevention
5244614|NCT02476604|adult|adult
5244615|NCT02476604|student|student
5244616|NCT02476591|Resource utilization|resource utilization
5244617|NCT02476591|intensive care unit|intensive care unit
5244618|NCT02476578|Hypocholesterolemia|hypocholesterolemia
5244619|NCT02476578|Frail Elderly|frail elderly
5244620|NCT02476578|Aged|aged
5244621|NCT02476578|Aged, 80 and over|aged, 80 and over
5244622|NCT02476578|Cholesterol|cholesterol
5244623|NCT02476578|Clinical Laboratory Information Systems|clinical laboratory information systems
5244624|NCT02476578|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5244625|NCT02476578|diet therapy|diet therapy
5244626|NCT02476578|Anticholesteremic Agents|anticholesteremic agents
5244627|NCT02476578|Health Services for the Aged|health services for the aged
5244628|NCT02476578|Hypoglycemic Agents|hypoglycemic agents
5244629|NCT02476578|Hypoglycemia|hypoglycemia
5244630|NCT02476565|Intubation|intubation
5244631|NCT02476461|percutanepus needle fasciotomy|percutanepus needle fasciotomy
5244632|NCT02476461|xiapex|xiapex
5244633|NCT02476461|clostridium histolyticum|clostridium histolyticum
5244634|NCT02476448|ureteral jet|ureteral jet
5244635|NCT02476448|pelvic surgery|pelvic surgery
5244636|NCT02476448|cystoscopy|cystoscopy
5244637|NCT02476435|Depersonalization|depersonalization
5244638|NCT02476435|Derealization|derealization
5244639|NCT02476435|Embodiment|embodiment
5244640|NCT02476435|Emotional numbing|emotional numbing
5250032|NCT02444858|stem cell therapy|stem cell therapy
5244641|NCT02476435|Transcranial magnetic stimulation|transcranial magnetic stimulation
5244642|NCT02476435|Angular gyrus|angular gyrus
5244643|NCT02476435|Temporo-parietal junction|temporo-parietal junction
5244644|NCT02476422|Diclofenac potassium|diclofenac potassium
5244645|NCT02476422|Post-operative dental pain|post-operative dental pain
5244646|NCT02476422|Moderate to severe pain|moderate to severe pain
5244647|NCT02476409|congestive heart failure|congestive heart failure
5244648|NCT02476409|tolvaptan|tolvaptan
5244649|NCT02476409|copeptin|copeptin
5244650|NCT02476331|Cognitive training|cognitive training
5244651|NCT02476331|Working memory|working memory
5244652|NCT02476331|Emotion regulation|emotion regulation
5244653|NCT02476266|resistance training|resistance training
5244654|NCT02476266|strength training|strength training
5244656|NCT02476266|muscle strength|muscle strength
5244657|NCT02476253|acidosis|acidosis
5244658|NCT02476253|shock|shock
5244659|NCT02476253|sodium bicarbonate|sodium bicarbonate
5244660|NCT02476253|renal replacement therapy|renal replacement therapy
5244661|NCT02476240|Exercise|exercise
5244662|NCT02476240|Attention|attention
5244663|NCT02476227|atrial fibrillation|atrial fibrillation
5244664|NCT02476227|pulmonary vein isolation|pulmonary vein isolation
5244665|NCT02476227|RF ablation|rf ablation
5244666|NCT02476214|group prenatal care, group guidance|group prenatal care, group guidance
5244667|NCT02476201|Heart Failure|heart failure
5244668|NCT02476201|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5244669|NCT02476201|Quadripolar Left Ventricular Lead|quadripolar left ventricular lead
5244670|NCT02476201|Multipoint Pacing|multipoint pacing
5244671|NCT02476201|Hemodynamic Response|hemodynamic response
5244672|NCT02476188|Neutrophil extracellular traps, stroke|neutrophil extracellular traps, stroke
5244673|NCT02476175|mirabegron|mirabegron
5244674|NCT02476175|antimuscarinics|antimuscarinics
5244675|NCT02476175|beta 3 agonist|beta 3 agonist
5244676|NCT02476175|overactive bladder|overactive bladder
5244677|NCT02476175|children|children
5244678|NCT02476162|Childhood Cancer Survivor|childhood cancer survivor
5244679|NCT02476162|Cancer Prevention and Control|cancer prevention and control
5244680|NCT02476162|Blood Pressure Monitoring|blood pressure monitoring
5244681|NCT02476162|Pre-Hypertension|pre-hypertension
5244682|NCT02476136|individual patient data meta-analysis|individual patient data meta-analysis
5244683|NCT02476136|anxiety disorder|anxiety disorder
5244684|NCT02476136|antidepressants|antidepressants
5244685|NCT02476136|selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
5244686|NCT02476136|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
5244687|NCT02476110|Oral nutritive supplements|oral nutritive supplements
5244688|NCT02476110|Nutritional risk screening|nutritional risk screening
5244689|NCT02476110|Homecare|homecare
5244690|NCT02476097|esomeprazole randomized study|esomeprazole randomized study
5244691|NCT02476097|proton pump inhibitor|proton pump inhibitor
5244692|NCT02476097|gastric acid rebound|gastric acid rebound
5244693|NCT02476097|randomized study|randomized study
5244694|NCT02476097|esomeprazole|esomeprazole
5244695|NCT02476071|HIV prevention|hiv prevention
5244696|NCT02476071|Demand for voluntary male circumcision|demand for voluntary male circumcision
5244697|NCT02476058|Major Depressive Disorder|major depressive disorder
5244698|NCT02476058|JNJ-42847922|jnj-42847922
5244699|NCT02476058|Diphenhydramine|diphenhydramine
5244700|NCT02476058|Placebo|placebo
5244701|NCT02476045|metastatic colorectal cancer|metastatic colorectal cancer
5244702|NCT02476045|RAS wild-type|ras wild-type
5244703|NCT02476045|maintenance therapy|maintenance therapy
5244704|NCT02476045|panitumumab|panitumumab
5244705|NCT02476019|Obesity|obesity
5244706|NCT02476019|Energy Expenditure|energy expenditure
5244707|NCT02475993|Sickle Cell Disease|sickle cell disease
5244708|NCT02475980|Adolescent|adolescent
5244709|NCT02475980|Contraception|contraception
5244710|NCT02475980|Counseling|counseling
5244711|NCT02475967|E-Learning|e-learning
5244712|NCT02475967|coronary artery disease|coronary artery disease
5244714|NCT02475967|e-health|e-health
5244715|NCT02475954|Depression|depression
5232649|NCT02548741|type 2 diabetes|type 2 diabetes
5232651|NCT02548741|methylglyoxal|methylglyoxal
5244716|NCT02475954|Telehealth|telehealth
5244717|NCT02475954|Parkinson's Disease|parkinson's disease
5244718|NCT02475954|Veterans|veterans
5244719|NCT02475954|Care-partners|care-partners
5244720|NCT02475954|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5244721|NCT02475954|Caregiver|caregiver
5244722|NCT02475941|geriatric fractures|geriatric fractures
5244723|NCT02475915|Treatment interruption|treatment interruption
5244724|NCT02475915|Controlling HIV|controlling hiv
5244725|NCT02475902|prevention and control|prevention and control
5244733|NCT02475798|Iliac aneurysm|iliac aneurysm
5244734|NCT02475798|Branch|branch
5244735|NCT02475798|Connections|connections
5244736|NCT02475798|Endovascular graft|endovascular graft
5244737|NCT02475798|Graft-iliac bifurcation|graft-iliac bifurcation
5244738|NCT02475798|Aneurysm|aneurysm
5244739|NCT02475798|Vascular Diseases|vascular diseases
5244740|NCT02475798|Cardiovascular Diseases|cardiovascular diseases
5244741|NCT02475785|Forsus Fatigue Resistant Device|forsus fatigue resistant device
5244742|NCT02475785|Class II|class ii
5244764|NCT02475577|heart failure|heart failure
5244765|NCT02475577|home blood pressure monitoring|home blood pressure monitoring
5244766|NCT02475564|resveratrol|resveratrol
5244767|NCT02475512|elderly|elderly
5244768|NCT02475512|long-term care|long-term care
5244769|NCT02475499|Incretins|incretins
5244770|NCT02475499|Antidiabetic agents|antidiabetic agents
5244771|NCT02475499|Pancreatic Cancer|pancreatic cancer
5244772|NCT02475486|Rheumatoid Arthritis|rheumatoid arthritis
5244773|NCT02475486|sympathetic nervous system|sympathetic nervous system
5244776|NCT02475473|Volunteers|volunteers
5244777|NCT02475460|HeartMate 3|heartmate 3
5244778|NCT02475460|LVAS|lvas
5244779|NCT02475460|LVAD|lvad
5244780|NCT02475460|Heart-assist Devices|heart-assist devices
5244781|NCT02475460|Advanced|advanced
5178234|NCT02876796|DNL|dnl
5244782|NCT02475460|Ventricular Dysfunction|ventricular dysfunction
5244783|NCT02475460|refractory left ventricular|refractory left ventricular
5244784|NCT02475460|Thoratec Corporation|thoratec corporation
5244785|NCT02475434|Human Milk|human milk
5244786|NCT02475434|Prematurity|prematurity
5244787|NCT02475434|Nutrition|nutrition
5244788|NCT02475434|Human Milk Cream|human milk cream
5244789|NCT02475421|Diabetes|diabetes
5244790|NCT02475421|Glucagon|glucagon
5244791|NCT02475421|Metabolic clearance rate of glucagon|metabolic clearance rate of glucagon
5244792|NCT02475408|Circulation, Collateral|circulation, collateral
5244793|NCT02475408|Coronary Artery Disease|coronary artery disease
5244794|NCT02475408|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
5244795|NCT02475408|Ischemia|ischemia
5244796|NCT02475395|Male Fertility|male fertility
5244797|NCT02475395|Male Infertility|male infertility
5244798|NCT02475395|Fertility|fertility
5244799|NCT02475395|Sperm|sperm
5244800|NCT02475395|Sperm Concentration|sperm concentration
5244801|NCT02475369|pancreatic enzyme supplementation|pancreatic enzyme supplementation
5244802|NCT02475356|Mirena|mirena
5244803|NCT02475356|Heavy Menstrual Bleeding|heavy menstrual bleeding
5244804|NCT02475356|Dysmenorrhea|dysmenorrhea
5244805|NCT02475356|Japan|japan
5244806|NCT02475356|Post-marketing surveillance|post-marketing surveillance
5244807|NCT02475317|Volunteer|volunteer
5244808|NCT02475278|Drug therapy|drug therapy
5244809|NCT02475265|Anorexia Nervosa|anorexia nervosa
5244810|NCT02475265|Osteoporosis|osteoporosis
5244811|NCT02475265|Eating Disorder|eating disorder
5244812|NCT02475265|Disordered Eating|disordered eating
5244813|NCT02475265|Estrogen|estrogen
5244814|NCT02475265|Bone|bone
5244815|NCT02475239|Benign Paroxysmal Positional Vertigo, Postural Restriction|benign paroxysmal positional vertigo, postural restriction
5244816|NCT02475226|Traumatic Brain Injury|traumatic brain injury
5244817|NCT02475226|Brain Damage|brain damage
5244818|NCT02475226|Mortality|mortality
5244819|NCT02475226|C10.228.140.199|c10.228.140.199
5244822|NCT02475187|TEG|teg
5244823|NCT02475187|MEA|mea
5244824|NCT02475187|Thrombotic events|thrombotic events
5244825|NCT02475187|VTE|vte
5244826|NCT02475187|LMWH|lmwh
5244827|NCT02475187|Hip fractures|hip fractures
5244828|NCT02475161|Healthy|healthy
5244829|NCT02475161|Rabeprazole|rabeprazole
5244830|NCT02475161|JNJ-42847922|jnj-42847922
5244831|NCT02475148|JNJ-54175446|jnj-54175446
5244832|NCT02475148|Healthy|healthy
5244833|NCT02475135|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
5244834|NCT02475135|Immunodeficiency Virus Type 2, Human|immunodeficiency virus type 2, human
5244835|NCT02475135|Darunavir|darunavir
5244836|NCT02475135|Cobicistat|cobicistat
5244837|NCT02475135|Tenofovir Alafenamide|tenofovir alafenamide
5244838|NCT02475135|Emtricitabine|emtricitabine
5244839|NCT02475135|Elvitegravir|elvitegravir
5244840|NCT02475122|Measurement of azygos blood flow|measurement of azygos blood flow
5232745|NCT02548117|Testosterone therapy|testosterone therapy
5232746|NCT02548117|erythrocytosis|erythrocytosis
5244866|NCT02474979|Pressure ulcer|pressure ulcer
5244868|NCT02474979|Pressure mapping|pressure mapping
5244869|NCT02474953|Curcumin|curcumin
5244870|NCT02474953|Pharmacokinetic|pharmacokinetic
5244871|NCT02474940|Multiple Sclerosis|multiple sclerosis
5244872|NCT02474940|Chronic Pain|chronic pain
5244873|NCT02474940|Chronic Fatigue|chronic fatigue
5244874|NCT02474940|Autoimmune Diseases|autoimmune diseases
5244875|NCT02474940|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5244876|NCT02474940|Central Nervous System Diseases|central nervous system diseases
5244877|NCT02474940|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5244878|NCT02474940|Demyelinating Diseases|demyelinating diseases
5244879|NCT02474927|antibody-mediated rejection|antibody-mediated rejection
5244880|NCT02474927|lung transplant|lung transplant
5244881|NCT02474927|Carfilzomib|carfilzomib
5244882|NCT02474901|Shedding|shedding
5244883|NCT02474901|Immunogenicity|immunogenicity
5244884|NCT02474901|Safety|safety
5244885|NCT02474901|HIV infected|hiv infected
5244886|NCT02474901|Children|children
5244887|NCT02474901|Young adults|young adults
5244888|NCT02474875|Fibromyalgia|fibromyalgia
5244889|NCT02474875|Patient education|patient education
5244890|NCT02474875|Central sensitization|central sensitization
5244891|NCT02474836|Allergy|allergy
5244892|NCT02474810|central venous catheters|central venous catheters
5244893|NCT02474810|hemodialysis|hemodialysis
5244894|NCT02474810|thrombosis|thrombosis
5244895|NCT02474810|tissue plasminogen activator|tissue plasminogen activator
5244896|NCT02474797|Ultrasonography|ultrasonography
5244897|NCT02474797|Diaphragm|diaphragm
5244898|NCT02474797|Lung ultrasound|lung ultrasound
5244899|NCT02474797|Sepsis|sepsis
5244900|NCT02474797|Critical care|critical care
5244901|NCT02474797|Chest physiotherapy|chest physiotherapy
5244902|NCT02474745|second stage of labor|second stage of labor
5244903|NCT02474745|pushing techniques|pushing techniques
5244904|NCT02474719|nephrology|nephrology
5244905|NCT02474719|extra-renal purification|extra-renal purification
5244907|NCT02474706|cefoxitin Patient safety|cefoxitin patient safety
5244908|NCT02474706|Infectious diseases|infectious diseases
5244909|NCT02474706|Extended-Spectrum β-lactamases E.coli|extended-spectrum β-lactamases e.coli
5244910|NCT02474706|Antibiotics|antibiotics
5244911|NCT02474680|depression|depression
5244912|NCT02474680|Major Depressive Disorder|major depressive disorder
5244913|NCT02474680|MDD|mdd
5244914|NCT02474680|mental health|mental health
5244915|NCT02474680|pharmacogenomics|pharmacogenomics
5244916|NCT02474680|personalized medicine|personalized medicine
5244917|NCT02474680|precision medicine|precision medicine
5244918|NCT02474680|anti-depressants|anti-depressants
5244920|NCT02474667|Delayed Graft Function|delayed graft function
5244921|NCT02474667|Renal Transplantation|renal transplantation
5244922|NCT02474667|Deseased Donor Kidney|deseased donor kidney
5244923|NCT02474667|BB3|bb3
5244924|NCT02474667|Kidney Transplantation|kidney transplantation
5244925|NCT02474667|Acute Kidney Injury|acute kidney injury
5244926|NCT02474641|Breast cancer|breast cancer
5244927|NCT02474641|Hypofractionation with SIB|hypofractionation with sib
5244928|NCT02474641|Non-inferiority|non-inferiority
5244929|NCT02474641|adjuvant radiotherapy with simultaneous integrated boost|adjuvant radiotherapy with simultaneous integrated boost
5244930|NCT02474628|Physiological Phenomena|physiological phenomena
5244931|NCT02474615|Apicoectomy|apicoectomy
5244932|NCT02474615|Oral surgery|oral surgery
5244933|NCT02474615|Biocompatible materials|biocompatible materials
5244934|NCT02474615|Dental Cements|dental cements
5244935|NCT02474615|Translational Medical Research|translational medical research
5232844|NCT02547532|microbioma|microbioma
5244936|NCT02474602|phototherapy|phototherapy
5244937|NCT02474602|strength training|strength training
5244938|NCT02474602|photobiostimulation|photobiostimulation
5244939|NCT02474602|muscle development|muscle development
5244940|NCT02474589|Treatment|treatment
5244941|NCT02474589|orthopoxvirus|orthopoxvirus
5244942|NCT02474589|smallpox|smallpox
5244943|NCT02474563|Multiple Myeloma|multiple myeloma
5244944|NCT02474563|Bortezomib|bortezomib
5244945|NCT02474563|Melphalan|melphalan
5244946|NCT02474563|Prednisone|prednisone
5244947|NCT02474550|diffuse large b cell lymphoma|diffuse large b cell lymphoma
5244948|NCT02474550|peg-filgrastim|peg-filgrastim
5244949|NCT02474550|febrile neutropenia|febrile neutropenia
5244950|NCT02474537|hepatic impairment,|hepatic impairment,
5244952|NCT02474537|Oral cMET Inhibitor,|oral cmet inhibitor,
5244953|NCT02474537|Non-Cancer|non-cancer
5244954|NCT02474524|Psychosis|psychosis
5244955|NCT02474524|Schizophrenia|schizophrenia
5244956|NCT02474524|Self-management|self-management
5244957|NCT02474524|Recovery|recovery
5244958|NCT02474524|Tablet computer|tablet computer
5244959|NCT02474524|Digital health|digital health
5244960|NCT02474524|Internet|internet
5244961|NCT02474524|Online|online
5244962|NCT02474524|Peer support|peer support
5244963|NCT02474498|Regenerative therapy|regenerative therapy
5244964|NCT02474498|Randomized clinical trial (RCT)|randomized clinical trial (rct)
5244965|NCT02474498|Enamel matrix derivative|enamel matrix derivative
5244966|NCT02474498|Hydroxyapatite-beta tricalcium phosphate|hydroxyapatite-beta tricalcium phosphate
5244967|NCT02474498|Buccal furcation|buccal furcation
5244968|NCT02474485|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5244969|NCT02474485|Absorb|absorb
5244970|NCT02474485|drug eluting balloon|drug eluting balloon
5244971|NCT02474485|percutaneous coronary intervention|percutaneous coronary intervention
5244972|NCT02474459|Deep Brain Stimulation|deep brain stimulation
5244973|NCT02474459|DBS|dbs
5244974|NCT02474459|STN|stn
5244975|NCT02474459|GPi|gpi
5244976|NCT02474459|Globus pallidus|globus pallidus
5244977|NCT02474459|Subthalamic nucleus|subthalamic nucleus
5244978|NCT02474459|Neuromodulation|neuromodulation
5244979|NCT02474407|Seizures|seizures
5244980|NCT02474407|Epilepsy|epilepsy
5244981|NCT02474355|NSCLC|nsclc
5244982|NCT02474355|EGFRm|egfrm
5244983|NCT02474355|T790M|t790m
5244984|NCT02474329|Parkinson's disease|parkinson's disease
5244985|NCT02474329|Ambulatory monitoring|ambulatory monitoring
5244986|NCT02474329|Disease progression|disease progression
5244987|NCT02474303|Truvada|truvada
5244988|NCT02474303|EMTRICITABINE/TENOFOVIR DISPROXIL FUMARATE|emtricitabine/tenofovir disproxil fumarate
5244989|NCT02474303|HIV PREEXPOSURE PROPHYLAXIS (PrEP)|hiv preexposure prophylaxis (prep)
5244990|NCT02474303|Female Sex Workers|female sex workers
5244991|NCT02474290|Acute Myeloid Leukemia|acute myeloid leukemia
5244992|NCT02474290|FLT3-ITD|flt3-itd
5244993|NCT02474290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5244994|NCT02474238|Iridotomy|iridotomy
5244995|NCT02474225|intraocular pressure|intraocular pressure
5244996|NCT02474225|intravitreal|intravitreal
5244997|NCT02474212|Venous thromboembolism|venous thromboembolism
5244998|NCT02474212|pulmonary embolism|pulmonary embolism
5244999|NCT02474212|thromboprophylaxis|thromboprophylaxis
5245000|NCT02474212|anticoagulant|anticoagulant
5245001|NCT02474212|anti-FXa|anti-fxa
5245002|NCT02474212|low-molecular weight heparin|low-molecular weight heparin
5245003|NCT02474212|enoxaparin|enoxaparin
5245004|NCT02474199|Regulatory T Cells ( Treg)|regulatory t cells ( treg)
5245005|NCT02474199|Donor Alloantigen Reactive Tregs (darTregs)|donor alloantigen reactive tregs (dartregs)
5245006|NCT02474199|Liver Transplant|liver transplant
5245007|NCT02474199|Alloantigen Reactive Tregs|alloantigen reactive tregs
5245008|NCT02474199|Calcineurin Inhibitors (CNI)|calcineurin inhibitors (cni)
5245009|NCT02474199|immunosuppressants (IS)|immunosuppressants (is)
5245010|NCT02474186|breast|breast
5245011|NCT02474186|cancer|cancer
5245012|NCT02474186|metastatic|metastatic
5245013|NCT02474186|breast cancer|breast cancer
5245014|NCT02474186|metastatic breast cancer|metastatic breast cancer
5245015|NCT02474186|radiation|radiation
5245016|NCT02474186|radiotherapy|radiotherapy
5245028|NCT02474186|paclitaxel|paclitaxel
5245029|NCT02474186|other solid metastatic tumor|other solid metastatic tumor
5245030|NCT02474108|atrial fibrillation|atrial fibrillation
5245031|NCT02474108|radiofrequency ablation|radiofrequency ablation
5245032|NCT02474108|prevention of AF|prevention of af
5245033|NCT02474108|mitral valve|mitral valve
5245034|NCT02474108|left atrium enlargement|left atrium enlargement
5245035|NCT02474108|cryoablation|cryoablation
5245036|NCT02474069|skin condition|skin condition
5245037|NCT02474069|skin disease|skin disease
5245038|NCT02474069|itching condition|itching condition
5245039|NCT02474069|psoriasis vulgaris|psoriasis vulgaris
5245040|NCT02474069|relapsing psoriasis|relapsing psoriasis
5245041|NCT02474069|remitting psoriasis|remitting psoriasis
5245042|NCT02474069|immune-mediated systemic disease|immune-mediated systemic disease
5245043|NCT02474069|skin lesions, red skin lesions|skin lesions, red skin lesions
5245044|NCT02474069|scaly patches|scaly patches
5245045|NCT02474069|papules, plaques|papules, plaques
5245047|NCT02474069|auto-immune|auto-immune
5245048|NCT02474069|plaque-type psoriasis|plaque-type psoriasis
5245049|NCT02474069|plaque|plaque
5245050|NCT02474056|decreased blood volume vein volume flow ultrasound exam|decreased blood volume vein volume flow ultrasound exam
5245051|NCT02474043|Injection drug use|injection drug use
5245052|NCT02474017|Inhaler|inhaler
5245053|NCT02474017|Adolescent|adolescent
5245054|NCT02473978|During Labor|during labor
5245055|NCT02473978|Complicating Anesthesia or Other Sedation|complicating anesthesia or other sedation
5245056|NCT02473978|Cerebral|cerebral
5245057|NCT02473926|Physical Activity|physical activity
5245058|NCT02473926|Physical Function|physical function
5245059|NCT02473926|Physical Impairment|physical impairment
5245060|NCT02473926|Sedentary Lifestyle|sedentary lifestyle
5245061|NCT02473887|ondansetron|ondansetron
5245062|NCT02473887|palatability|palatability
5245063|NCT02473887|vomiting|vomiting
5245064|NCT02473861|exercise training|exercise training
5245065|NCT02473861|breast cancer|breast cancer
5245066|NCT02473861|taxane chemotherapy|taxane chemotherapy
5245067|NCT02473861|peripheral neuropathy|peripheral neuropathy
5245068|NCT02473861|fatigue|fatigue
5245069|NCT02473861|autonomic function|autonomic function
5245070|NCT02473835|T-lymphocyte|t-lymphocyte
5245071|NCT02473835|Adipose tissue|adipose tissue
5245072|NCT02473835|Inflammation|inflammation
5245073|NCT02473835|Calorie restriction|calorie restriction
5245074|NCT02473822|anterior cruciate ligament|anterior cruciate ligament
5245075|NCT02473822|Tape Locking Screw|tape locking screw
5245077|NCT02473822|joint trauma|joint trauma
5245078|NCT02473796|home based child care|home based child care
5245079|NCT02473770|Registry|registry
5245080|NCT02473770|Exposures|exposures
5245081|NCT02473770|Biological Specimens|biological specimens
5245082|NCT02473770|Occupational Health|occupational health
5245083|NCT02473770|Exposure|exposure
5245084|NCT02473757|Recombinant DNA Product|recombinant dna product
5245085|NCT02473757|Laboratory Evaluation|laboratory evaluation
5245086|NCT02473757|NIH Office of Biotechnology Activities|nih office of biotechnology activities
5245087|NCT02473757|Gamma-Retroviral Vectors|gamma-retroviral vectors
5245088|NCT02473744|lower limb edema|lower limb edema
5245089|NCT02473744|subcutaneous drainage|subcutaneous drainage
5245090|NCT02473744|bioelectrical impedance|bioelectrical impedance
5245091|NCT02473744|quality of life|quality of life
5245092|NCT02473731|CDX3379|cdx3379
5245093|NCT02473705|Geriatric|geriatric
5245094|NCT02473705|bicarbonate|bicarbonate
5245095|NCT02473705|omega polyunsaturated fatty acids|omega polyunsaturated fatty acids
5245096|NCT02473705|exercise capacity|exercise capacity
5245097|NCT02473679|First Responder|first responder
5245100|NCT02473679|Resuscitation|resuscitation
5245101|NCT02473666|Patient Blood Management|patient blood management
5245102|NCT02473666|Red Blood Cells|red blood cells
5245103|NCT02473666|Platelet|platelet
5245104|NCT02473627|Pharmacokinetics|pharmacokinetics
5245105|NCT02473601|mivacurium chloramine|mivacurium chloramine
5245106|NCT02473601|patients with liver cirrhosis|patients with liver cirrhosis
5245107|NCT02473601|muscle relaxation effect|muscle relaxation effect
5245108|NCT02473575|Caffeine, running, performance|caffeine, running, performance
5245110|NCT02473562|Varenicline|varenicline
5245111|NCT02473562|Excessive daytime sleepiness|excessive daytime sleepiness
5245112|NCT02473549|motor|motor
5245113|NCT02473549|rehabilitation|rehabilitation
5245114|NCT02473549|transcranial direct current stimulation|transcranial direct current stimulation
5245115|NCT02473523|Fatigue|fatigue
5245116|NCT02473523|Pain Alleviation|pain alleviation
5245117|NCT02473523|Emotional Wellbeing|emotional wellbeing
5245118|NCT02473523|Physical Wellbeing|physical wellbeing
5245119|NCT02473523|Yoga|yoga
5245120|NCT02473510|Trivalent|trivalent
5245121|NCT02473510|Influenza|influenza
5245122|NCT02473510|FluMist Quadrivalent|flumist quadrivalent
5245123|NCT02473510|Vaccine|vaccine
5245124|NCT02473510|Prevention|prevention
5245125|NCT02473510|Healthy|healthy
5245126|NCT02473497|chromosomal rearrangement|chromosomal rearrangement
5245127|NCT02473497|activating mutation|activating mutation
5245128|NCT02473497|activating genetic alteration|activating genetic alteration
5245129|NCT02473497|genetic aberration|genetic aberration
5245131|NCT02473497|ROS1|ros1
5245132|NCT02473497|cMET|cmet
5245133|NCT02473497|crizotinib|crizotinib
5245134|NCT02473497|oral formulation|oral formulation
5245135|NCT02473484|High Grade Glioma|high grade glioma
5245136|NCT02473484|Proteomics|proteomics
5245137|NCT02473484|MALDI-MSI|maldi-msi
5245138|NCT02473471|Micro-Osteoperforation (MOPs)|micro-osteoperforation (mops)
5245139|NCT02473471|regional acceleratory phenomenon (RAP)|regional acceleratory phenomenon (rap)
5245140|NCT02473471|Malocculsion|malocculsion
5245141|NCT02473458|Licorice|licorice
5245142|NCT02473458|Glycyrrhizic acid|glycyrrhizic acid
5245143|NCT02473458|Ischemic Stroke|ischemic stroke
5245144|NCT02473458|Acute|acute
5245145|NCT02473445|Inherited mitochondrial disease|inherited mitochondrial disease
5245146|NCT02473445|Leigh Syndrome|leigh syndrome
5245147|NCT02473445|Leber's Hereditary Optic Neuropathy (LHON)|leber's hereditary optic neuropathy (lhon)
5245148|NCT02473445|Myoclonic epilepsy and ragged-red fibers (MERFF)|myoclonic epilepsy and ragged-red fibers (merff)
5245149|NCT02473445|Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (MELAS)|mitochondrial encephalomyopathy, lactic acidosis, and stroke-like syndrome (melas)
5245150|NCT02473445|Kearn-Sayre syndrome|kearn-sayre syndrome
5245151|NCT02473445|Polymerase gamma (POLG) -related disorders|polymerase gamma (polg) -related disorders
5245152|NCT02473445|Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)|mitochondrial neurogastrointestinal encephalopathy syndrome (mngie)
5245153|NCT02473432|respiratory muscle training|respiratory muscle training
5245154|NCT02473432|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5245155|NCT02473432|oropharyngeal dysphagia|oropharyngeal dysphagia
5208954|NCT02689752|14C|14c
5245156|NCT02473432|stroke|stroke
5245157|NCT02473432|rehabilitation|rehabilitation
5245158|NCT02473419|Medical food|medical food
5245159|NCT02473419|ADHD|adhd
5245160|NCT02473419|Vayarin|vayarin
5245161|NCT02473419|Fish Oil|fish oil
5245162|NCT02473406|Acute Pancreatitis, prevent,Necrotizing|acute pancreatitis, prevent,necrotizing
5245163|NCT02473380|glioma|glioma
5245164|NCT02473380|fluorescence spectroscopy|fluorescence spectroscopy
5245165|NCT02473341|Bovine Colostrum|bovine colostrum
5245166|NCT02473341|Corticosteriods|corticosteriods
5245167|NCT02473341|Endotoxin|endotoxin
5245168|NCT02473341|MELD|meld
5245170|NCT02473328|dose reduction study|dose reduction study
5245171|NCT02473289|Depressive disorder, major|depressive disorder, major
5245172|NCT02473289|Sirukumab|sirukumab
5245173|NCT02473263|Severe septic syndrome|severe septic syndrome
5245174|NCT02473263|mobile intensive care unit|mobile intensive care unit
5245175|NCT02473263|strategy|strategy
5245176|NCT02473263|antibiotics|antibiotics
5245177|NCT02473263|hemodynamic optimization|hemodynamic optimization
5245178|NCT02473237|COPD|copd
5245179|NCT02473237|biomass|biomass
5245180|NCT02473224|challenge|challenge
5245181|NCT02473224|GII.2|gii.2
5245182|NCT02473224|HID50|hid50
5245183|NCT02473224|Norovirus|norovirus
5245184|NCT02473224|Snow Mountain filtrate|snow mountain filtrate
5245185|NCT02473198|Total Knee Arthroplasty|total knee arthroplasty
5245186|NCT02473198|Amide Local Anesthetic|amide local anesthetic
5245187|NCT02473172|Weaning from mechanical ventilation|weaning from mechanical ventilation
5245188|NCT02473159|Near-infrared fluorescence|near-infrared fluorescence
5245189|NCT02473159|Indocyanine green, ICG|indocyanine green, icg
5245190|NCT02473159|breast cancer|breast cancer
5245191|NCT02473146|AML|aml
5245192|NCT02473146|untreated|untreated
5245193|NCT02473146|60-80 years old|60-80 years old
5245194|NCT02473146|favorable and intermediate karyotype|favorable and intermediate karyotype
5245195|NCT02473133|radiotherapy|radiotherapy
5245196|NCT02473133|dose redistribution|dose redistribution
5245197|NCT02473133|boost|boost
5245198|NCT02473120|metastatic|metastatic
5245199|NCT02473120|ESR1|esr1
5245200|NCT02473120|aromatase inhibitor|aromatase inhibitor
5245201|NCT02473120|breast cancer|breast cancer
5245202|NCT02473107|Dental caries|dental caries
5245203|NCT02473107|Primary tooth|primary tooth
5245204|NCT02473107|Caries Detection|caries detection
5245205|NCT02473094|Metformin|metformin
5245207|NCT02473094|Rectum|rectum
5245208|NCT02473094|Radiotherapy|radiotherapy
5245209|NCT02473094|Capecitabine|capecitabine
5245211|NCT02473094|Adenocarcinoma|adenocarcinoma
5245212|NCT02473094|Carcinoma|carcinoma
5245213|NCT02473081|Type 2 diabetes|type 2 diabetes
5245214|NCT02473081|Minimal psychological intervention|minimal psychological intervention
5245215|NCT02473081|Glycemic control|glycemic control
5245216|NCT02473081|Depressive symptoms|depressive symptoms
5245217|NCT02473081|Problem Area in Diabetes|problem area in diabetes
5245218|NCT02473081|Middle-aged and older adults|middle-aged and older adults
5245219|NCT02473081|HbA1c protein, human|hba1c protein, human
5245220|NCT02473068|CPAP|cpap
5245222|NCT02473055|sleep|sleep
5245223|NCT02473055|heart rate|heart rate
5245224|NCT02473055|respiratory rate|respiratory rate
5245225|NCT02473055|preterm infant|preterm infant
5245226|NCT02473042|Post-operative nausea and vomiting|post-operative nausea and vomiting
5245228|NCT02473042|Breast cancer|breast cancer
5245229|NCT02473042|Neuromuscular blockade monitor|neuromuscular blockade monitor
5245230|NCT02473042|NMBM|nmbm
5245231|NCT02473042|Breast cancer surgery|breast cancer surgery
5245232|NCT02473042|Prophylactic anti-emetics|prophylactic anti-emetics
5245233|NCT02473042|Electrical stimulation|electrical stimulation
5245235|NCT02473042|Ondansetron|ondansetron
5245236|NCT02473042|Dexamethasone|dexamethasone
5245237|NCT02473042|Decadron|decadron
5245238|NCT02473042|Phenergan|phenergan
5245239|NCT02473042|Promethazine|promethazine
5245240|NCT02473042|Phenazine|phenazine
5245241|NCT02473042|Phencen|phencen
5245242|NCT02473042|Prometh|prometh
5245243|NCT02473042|Prorex|prorex
5245244|NCT02473042|V-Gan|v-gan
5245245|NCT02473042|Pepcid|pepcid
5245246|NCT02473042|Famotidine|famotidine
5245247|NCT02473042|Questionnaire|questionnaire
5245248|NCT02473042|Survey|survey
5245249|NCT02473016|Classical Trigeminal Neuralgia|classical trigeminal neuralgia
5245250|NCT02473003|Breast cancer|breast cancer
5245251|NCT02473003|prostate cancer|prostate cancer
5245252|NCT02473003|colorectal cancer|colorectal cancer
5245253|NCT02473003|fatigue|fatigue
5245254|NCT02473003|physical exercise|physical exercise
5245255|NCT02473003|randomised trial|randomised trial
5245256|NCT02473003|intervention|intervention
5245258|NCT02472990|morphological predictive factors|morphological predictive factors
5245259|NCT02472990|Mechanical|mechanical
5245260|NCT02472938|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5245261|NCT02472912|Pharmacokinetics|pharmacokinetics
5245262|NCT02472912|Adalimumab|adalimumab
5245263|NCT02472912|Biosimilar Pharmaceuticals|biosimilar pharmaceuticals
5245264|NCT02472899|Geriatrics|geriatrics
5245265|NCT02472899|Neurocognitive Disorder|neurocognitive disorder
5245266|NCT02472899|Biomarkers|biomarkers
5245267|NCT02472899|Immunology|immunology
5245268|NCT02472886|HCV genotype 1|hcv genotype 1
5245269|NCT02472886|HCV|hcv
5245270|NCT02472886|Sustained Virologic Response|sustained virologic response
5245271|NCT02472886|Direct Acting Antiviral|direct acting antiviral
5245272|NCT02472886|Combination Therapy|combination therapy
5245273|NCT02472886|GS-7977|gs-7977
5245274|NCT02472886|GS-5885|gs-5885
5245275|NCT02472886|Ribavirin|ribavirin
5245276|NCT02472886|Sofosbuvir|sofosbuvir
5245277|NCT02472886|ledipasvir|ledipasvir
5245278|NCT02472886|Hepatitis C|hepatitis c
5245279|NCT02472886|Hepatitis C, Chronic|hepatitis c, chronic
5245280|NCT02472886|Liver Diseases|liver diseases
5245281|NCT02472886|Virus Diseases|virus diseases
5245282|NCT02472886|Antiviral Agents|antiviral agents
5245283|NCT02472886|HCV/HIV co-infection|hcv/hiv co-infection
5245284|NCT02472873|endometrioma|endometrioma
5245285|NCT02472873|endometriosis|endometriosis
5245286|NCT02472873|sclerotherapy|sclerotherapy
5245287|NCT02472873|ethanol|ethanol
5245288|NCT02472873|aspiration|aspiration
5245289|NCT02472873|laparoscopy|laparoscopy
5245290|NCT02472860|Autism Spectrum Disorder|autism spectrum disorder
5245291|NCT02472860|Neuroplasticity-based Cognitive Training|neuroplasticity-based cognitive training
5245292|NCT02472847|Marinol|marinol
5245293|NCT02472847|Dronabinol|dronabinol
5245294|NCT02472847|Fear extinction|fear extinction
5245295|NCT02472847|Healthy volunteers|healthy volunteers
5245296|NCT02472834|Carbamylation|carbamylation
5245297|NCT02472834|Albumin|albumin
5245298|NCT02472834|Protein structure|protein structure
5245299|NCT02472834|Kidney disease|kidney disease
5245301|NCT02472782|osteoporosis|osteoporosis
5245302|NCT02472782|quality of life|quality of life
5245303|NCT02472782|adherence|adherence
5245304|NCT02472782|treatment|treatment
5245305|NCT02472743|Phototherapy|phototherapy
5245306|NCT02472730|Colonoscopy|colonoscopy
5245307|NCT02472730|Training Techniques|training techniques
5245308|NCT02472730|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5245309|NCT02472717|liraglutide, GLP-1 receptor agonists|liraglutide, glp-1 receptor agonists
5245310|NCT02472704|celiac disease|celiac disease
5245311|NCT02472704|lymphocytic enteritis|lymphocytic enteritis
5245312|NCT02472704|non-celiac gluten sensitivity|non-celiac gluten sensitivity
5245313|NCT02472704|double-blind gluten rechallenge|double-blind gluten rechallenge
5245314|NCT02472691|relapse after allogeneic transplantation|relapse after allogeneic transplantation
5245318|NCT02472691|DLI|dli
5245319|NCT02472691|Azacitidine|azacitidine
5245320|NCT02472691|Lenalidomide|lenalidomide
5245321|NCT02472691|C04.557.337.539.275|c04.557.337.539.275
5245322|NCT02472691|C15.378.190.625|c15.378.190.625
5245323|NCT02472691|C04.557.337.539.522|c04.557.337.539.522
5245324|NCT02472665|pediatric|pediatric
5245325|NCT02472665|plasma-derived FVIII concentrate|plasma-derived fviii concentrate
5245326|NCT02472613|Post－Stroke Depression|post－stroke depression
5245327|NCT02472613|Acupunture|acupunture
5245328|NCT02472613|Fluoxetine|fluoxetine
5245329|NCT02472613|RCT|rct
5245330|NCT02472600|extended spectrum beta-lactamase producing enterobacteriaceae|extended spectrum beta-lactamase producing enterobacteriaceae
5245331|NCT02472600|carbapenemase producing enterobacteriaceae|carbapenemase producing enterobacteriaceae
5245332|NCT02472600|multidrug resistant bacteria|multidrug resistant bacteria
5233230|NCT02545114|SIADH, stroke|siadh, stroke
5233231|NCT02545114|SAH; ICH|sah; ich
5233232|NCT02545114|AIS|ais
5233233|NCT02545101|Hyponatremia due to SIADH|hyponatremia due to siadh
5233234|NCT02545101|tolvaptan|tolvaptan
5233235|NCT02545088|Rehabilitation|rehabilitation
5233236|NCT02545088|Robotics|robotics
5233239|NCT02545036|chronic kidney disease|chronic kidney disease
5233240|NCT02545036|Daycare|daycare
5233241|NCT02545036|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
5233242|NCT02544984|prophylactic macrolides|prophylactic macrolides
5233243|NCT02544984|RSV|rsv
5233244|NCT02544984|chronic lung disease|chronic lung disease
5233245|NCT02544984|respiratory infections|respiratory infections
5233246|NCT02544958|Enlarged pores|enlarged pores
5233247|NCT02544958|Er:YAG laser|er:yag laser
5233248|NCT02544945|Radiotherapy|radiotherapy
5233249|NCT02544932|anticoagulant|anticoagulant
5233250|NCT02544932|atherosclerosis|atherosclerosis
5245333|NCT02472574|Intracerebral Hemorrhage|intracerebral hemorrhage
5245334|NCT02472574|minimally invasive surgery|minimally invasive surgery
5245335|NCT02472574|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5245336|NCT02472574|Dose-effect Relationship|dose-effect relationship
5245337|NCT02472561|Cardiology|cardiology
5245338|NCT02472561|Vascular|vascular
5245339|NCT02472561|Peripheral Artery Disease|peripheral artery disease
5245340|NCT02472561|Artery|artery
5245341|NCT02472561|Mobile Health|mobile health
5245342|NCT02472561|Exercise|exercise
5245343|NCT02472561|PAD|pad
5245344|NCT02472535|HoFH|hofh
5245345|NCT02472509|Ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
5245346|NCT02472509|White blood cells (WBC)|white blood cells (wbc)
5245347|NCT02472509|Alanine Transaminase (ALT)|alanine transaminase (alt)
5245348|NCT02472509|Alkaline Phosphatase (ALP)|alkaline phosphatase (alp)
5245349|NCT02472509|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
5245350|NCT02472509|Gamma-Glutamyl Transpeptidase (GGT)|gamma-glutamyl transpeptidase (ggt)
5245351|NCT02472509|Lactate dehydrogenase (LDH)|lactate dehydrogenase (ldh)
5245352|NCT02472509|Low-Density Lipoprotein (LDL)|low-density lipoprotein (ldl)
5245353|NCT02472509|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
5245354|NCT02472509|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
5245355|NCT02472509|Ultrasound (US)|ultrasound (us)
5245356|NCT02472470|rTMS|rtms
5245357|NCT02472470|Depression|depression
5245358|NCT02472470|Youth|youth
5245359|NCT02472470|TBS|tbs
5245360|NCT02472470|Brain Stimulation|brain stimulation
5245361|NCT02472470|Electrophysiology|electrophysiology
5245362|NCT02472470|Imaging|imaging
5245363|NCT02472431|ADRC|adrc
5245364|NCT02472431|Adipose-Derived Regenerative Cells|adipose-derived regenerative cells
5245365|NCT02472431|Fat Tissue|fat tissue
5245366|NCT02472431|Stem Cells|stem cells
5245367|NCT02472431|Erectile Dysfunction|erectile dysfunction
5245368|NCT02472431|Arteriogenic Impotence|arteriogenic impotence
5245369|NCT02472431|Venogenic Impotence|venogenic impotence
5245370|NCT02472431|Vasculogenic Impotence|vasculogenic impotence
5245371|NCT02472431|Male Impotence|male impotence
5245372|NCT02472431|Male Sexual Impotence|male sexual impotence
5245373|NCT02472392|EWINGS, SARCOMA|ewings, sarcoma
5245374|NCT02472379|Immune System|immune system
5245375|NCT02472379|Behavioral Sciences|behavioral sciences
5245376|NCT02472379|Women's Health|women's health
5245377|NCT02472379|Health Psychology|health psychology
5245378|NCT02472379|Writing|writing
5245379|NCT02472353|breast|breast
5245380|NCT02472353|cancer|cancer
5245381|NCT02472353|doxorubicin|doxorubicin
5245382|NCT02472353|metformin|metformin
5245383|NCT02472353|cardiotoxicity|cardiotoxicity
5245384|NCT02472353|ejection fraction|ejection fraction
5245385|NCT02472353|LVEF|lvef
5245386|NCT02472288|urinary retention|urinary retention
5245387|NCT02472288|poststroke|poststroke
5245388|NCT02472288|electroacupuncture|electroacupuncture
5245389|NCT02472288|randomized controlled trial|randomized controlled trial
5245390|NCT02472288|effectiveness|effectiveness
5245391|NCT02472288|safety|safety
5245394|NCT02472249|TACE|tace
5233334|NCT02544399|Walkers|walkers
5233335|NCT02544386|bone microarchitecture|bone microarchitecture
5233336|NCT02544386|hemiplegia|hemiplegia
5233338|NCT02544373|Obstructive Sleep Apnea|obstructive sleep apnea
5233339|NCT02544373|Cognition|cognition
5233340|NCT02544373|Cognitive Dysfunction|cognitive dysfunction
5233341|NCT02544373|Memory|memory
5233342|NCT02544373|Positive Aiway Pressure|positive aiway pressure
5233343|NCT02544373|CPAP|cpap
5233344|NCT02544373|MS|ms
5233425|NCT02543879|AML|aml
5245395|NCT02472249|CT perfusion|ct perfusion
5245396|NCT02472249|Liver blood flow|liver blood flow
5245397|NCT02472236|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5245398|NCT02472223|"Pink Eye"|"pink eye"
5245399|NCT02472197|Endometrial polyp|endometrial polyp
5245400|NCT02472197|Hysteroscopic resection|hysteroscopic resection
5245401|NCT02472197|Morcellation|morcellation
5245402|NCT02472184|Office hysteroscopy|office hysteroscopy
5245403|NCT02472184|Endometrial biopsy|endometrial biopsy
5245404|NCT02472184|Abnormal uterine bleeding|abnormal uterine bleeding
5245405|NCT02472184|Uterine fibroids|uterine fibroids
5245406|NCT02472171|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5245407|NCT02472171|blueberries|blueberries
5245408|NCT02472158|Bandages|bandages
5245409|NCT02472158|Central Venous Catheters|central venous catheters
5245410|NCT02472158|Catheter-Related Infections|catheter-related infections
5245411|NCT02472145|Leukemia, myeloid, acute|leukemia, myeloid, acute
5245412|NCT02472145|DACOGEN|dacogen
5245413|NCT02472145|Decitabine|decitabine
5245414|NCT02472145|JNJ-56022473|jnj-56022473
5245415|NCT02472145|CLS362|cls362
5245416|NCT02472132|Central Venous Catheter|central venous catheter
5245417|NCT02472132|Point Of Care Ultra Sound|point of care ultra sound
5245418|NCT02472132|Sub Clavian Vein|sub clavian vein
5245419|NCT02472132|Internal Jugular Vein|internal jugular vein
5341639|NCT01986920|SK|sk
5245420|NCT02472132|Trans Thoracic Echocardiography|trans thoracic echocardiography
5245421|NCT02472119|Celiac disease|celiac disease
5245422|NCT02472119|Gluten-free diet|gluten-free diet
5245423|NCT02472119|Wheat flour treatment|wheat flour treatment
5140304|NCT03113695|CLL|cll
5245424|NCT02472119|Microbial transglutaminase|microbial transglutaminase
5245425|NCT02472119|Lysine Ethyl Ester|lysine ethyl ester
5245426|NCT02472119|Celiac Disease Treatment|celiac disease treatment
5245427|NCT02472106|Aortic Valve|aortic valve
5245428|NCT02472106|TAVI|tavi
5245429|NCT02472106|Stenosis|stenosis
5245430|NCT02472093|Postural exercise|postural exercise
5245431|NCT02472093|Back pain|back pain
5245432|NCT02472093|Tender points|tender points
5245433|NCT02472093|Fibromyalgia|fibromyalgia
5245434|NCT02472093|Perceptive rehabilitation|perceptive rehabilitation
5245435|NCT02472067|Musculoskeletal Injury|musculoskeletal injury
5245436|NCT02472067|physical therapy|physical therapy
5245437|NCT02472067|psychological intervention|psychological intervention
5245438|NCT02472067|risk factors|risk factors
5245439|NCT02472054|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5245440|NCT02472054|Alemtuzumab (CAMPATH®)|alemtuzumab (campath®)
5245441|NCT02472041|chest drain|chest drain
5245442|NCT02472028|Cerebrovascular Disorders|cerebrovascular disorders
5245443|NCT02472028|Stroke|stroke
5245444|NCT02472028|Antihypertensive Agents|antihypertensive agents
5245445|NCT02472028|Arterial Pressure|arterial pressure
5245446|NCT02472028|Memory Disorders|memory disorders
5245447|NCT02472015|neuropsychiatric symptoms|neuropsychiatric symptoms
5245448|NCT02472015|dementia|dementia
5245449|NCT02472015|telemedicine|telemedicine
5245450|NCT02472015|long-term care facilities|long-term care facilities
5245451|NCT02472002|Transplant coronary diseases|transplant coronary diseases
5245452|NCT02472002|Mesenchymal cell therapy|mesenchymal cell therapy
5245453|NCT02472002|Administration of CSM by NOGA system|administration of csm by noga system
5245454|NCT02472002|Coronary disease in heart transplant patients|coronary disease in heart transplant patients
5245455|NCT02471989|FODMAP|fodmap
5245456|NCT02471989|Diet|diet
5245457|NCT02471989|pH-impedance monitoring|ph-impedance monitoring
5245458|NCT02471976|Leonetti law|leonetti law
5245459|NCT02471976|palliative care|palliative care
5245460|NCT02471963|Empagliflozin|empagliflozin
5245461|NCT02471963|Diabetes mellitus|diabetes mellitus
5245462|NCT02471963|Macro- and Microcirculation|macro- and microcirculation
5245463|NCT02471963|Vascular Improvement|vascular improvement
5245464|NCT02471963|Endothelium function|endothelium function
5245469|NCT02471937|meningitis|meningitis
5245470|NCT02471937|Clonal Complex CC17|clonal complex cc17
5245471|NCT02471937|microbiota|microbiota
5245472|NCT02471937|next generation sequencing (NGS)|next generation sequencing (ngs)
5245473|NCT02471924|Pregnant women|pregnant women
5245474|NCT02471911|DLBCL|dlbcl
5245475|NCT02471911|Aggressive|aggressive
5245476|NCT02471911|Diffuse|diffuse
5245477|NCT02471911|Large|large
5245478|NCT02471885|remote ischaemic conditioning|remote ischaemic conditioning
5245479|NCT02471885|remote ischemic conditioning|remote ischemic conditioning
5245482|NCT02471885|troponin|troponin
5245483|NCT02471885|chemotherapy|chemotherapy
5245484|NCT02471885|myocardial reperfusion injury|myocardial reperfusion injury
5245485|NCT02471833|Hypertension|hypertension
5245486|NCT02471833|Prevention|prevention
5245487|NCT02471833|Family History|family history
5245488|NCT02471833|inflammation|inflammation
5245489|NCT02471833|blood brain barrier|blood brain barrier
5245490|NCT02471833|amyloid|amyloid
5245491|NCT02471820|Multiple Myeloma|multiple myeloma
5245492|NCT02471794|Type II Diabetes|type ii diabetes
5245493|NCT02471794|Personalized Health Planning|personalized health planning
5245494|NCT02471794|Shared Medical Appointments|shared medical appointments
5245495|NCT02471781|Aortic Aneurysm|aortic aneurysm
5245496|NCT02471781|Aneurysm|aneurysm
5245497|NCT02471781|Vascular Prosthesis|vascular prosthesis
5245498|NCT02471781|Vascular Disease|vascular disease
5245499|NCT02471781|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5245500|NCT02471768|central pressure|central pressure
5245501|NCT02471768|Gensini score|gensini score
5245502|NCT02471768|pulsatility|pulsatility
5245503|NCT02471768|coronary artery disease|coronary artery disease
5245504|NCT02471755|electro-acupuncture|electro-acupuncture
5245505|NCT02471755|menopause|menopause
5245506|NCT02471755|menopausal transition symptoms|menopausal transition symptoms
5245507|NCT02471755|efficacy|efficacy
5245509|NCT02471755|placebo control|placebo control
5245510|NCT02471729|Cardio-Renal Syndrome|cardio-renal syndrome
5245511|NCT02471729|Chronic Heart Failure|chronic heart failure
5245512|NCT02471729|Renal Denervation|renal denervation
5245513|NCT02471729|Sympathetic activation|sympathetic activation
5245514|NCT02471729|Heart Failure|heart failure
5245515|NCT02471729|Cardiovascular Diseases|cardiovascular diseases
5245516|NCT02471729|Heart Diseases|heart diseases
5245517|NCT02471716|Diffuse Type Tenosynovial Giant Cell Tumor (dt-TGCT)|diffuse type tenosynovial giant cell tumor (dt-tgct)
5245518|NCT02471703|Total Hip Arthroplasty|total hip arthroplasty
5245519|NCT02471703|Total Hip Replacement|total hip replacement
5245520|NCT02471703|Inflammatory Joint Disease|inflammatory joint disease
5245528|NCT02471664|Percutaneous mitral valve repair|percutaneous mitral valve repair
5245529|NCT02471664|Coronary sinus annuloplasty|coronary sinus annuloplasty
5245530|NCT02471664|Mitral loop cerclage|mitral loop cerclage
5245531|NCT02471625|Controls|controls
5245532|NCT02471599|IgA nephropathy|iga nephropathy
5245533|NCT02471599|tonsillitis|tonsillitis
5245534|NCT02471599|tonsil provocation test|tonsil provocation test
5245535|NCT02471599|Tonsillectomy|tonsillectomy
5245537|NCT02471573|Freeze-all|freeze-all
5245544|NCT02471547|Recurrence|recurrence
5245545|NCT02471495|NMIBC|nmibc
5245546|NCT02471495|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
5245547|NCT02471495|Nonmuscle Invasive Bladder Cancer|nonmuscle invasive bladder cancer
5245548|NCT02471495|BCG refractory|bcg refractory
5245549|NCT02471495|BCG failure|bcg failure
5245550|NCT02471495|Carcinoma in situ|carcinoma in situ
5245551|NCT02471495|CIS|cis
5245552|NCT02471482|Near Infra Red Spectrometry|near infra red spectrometry
5245553|NCT02471482|Cerebral oxygenation|cerebral oxygenation
5245554|NCT02471482|Mozart music|mozart music
5245555|NCT02471404|Diabetes Mellitus Type 2,|diabetes mellitus type 2,
5245556|NCT02471404|metformin,|metformin,
5245557|NCT02471404|saxagliptin,|saxagliptin,
5245558|NCT02471404|dapagliflozin,|dapagliflozin,
5245559|NCT02471404|glimepiride,|glimepiride,
5245560|NCT02471404|inadequate glycaemic control|inadequate glycaemic control
5245579|NCT02471326|HIV Neutralizing Antibodies|hiv neutralizing antibodies
5245580|NCT02471326|HIV Therapy|hiv therapy
5245581|NCT02471313|Cross-Sectional Imaging|cross-sectional imaging
5245582|NCT02471313|Chemoembolization|chemoembolization
5245583|NCT02471313|Radiation Therapy|radiation therapy
5245584|NCT02471313|Tumor Hypoxia|tumor hypoxia
5245585|NCT02471313|PET Imaging|pet imaging
5245586|NCT02471300|Asthma|asthma
5245587|NCT02471300|Inflammasome|inflammasome
5245588|NCT02471300|Fasting|fasting
5245589|NCT02471300|Airflow Obstruction|airflow obstruction
5245590|NCT02471287|Rare|rare
5245591|NCT02471287|Ocular|ocular
5245592|NCT02471144|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept|pediatric, chronic severe plaque psoriasis, secukinumab, etanercept
5245593|NCT02471131|WATCHMAN|watchman
5245594|NCT02471131|Atrial Fibrillation|atrial fibrillation
5245595|NCT02471131|Hybrid Ablation|hybrid ablation
5245596|NCT02471131|Safety|safety
5245597|NCT02471131|Feasibility|feasibility
5245598|NCT02471131|Stroke Prevention|stroke prevention
5245599|NCT02471118|Inflammatory Type|inflammatory type
5245600|NCT02471092|satiety|satiety
5245601|NCT02471092|glycemia|glycemia
5245602|NCT02471092|milk protein|milk protein
5245603|NCT02471079|Radiation-induced health problems|radiation-induced health problems
5245604|NCT02471079|Cardiovascular events|cardiovascular events
5245605|NCT02471079|Lung toxicity|lung toxicity
5245606|NCT02471053|Exercise|exercise
5245607|NCT02471053|Quality of Life|quality of life
5245608|NCT02471053|Complementary Therapies|complementary therapies
5245609|NCT02471053|Neoadjuvant Therapy|neoadjuvant therapy
5245610|NCT02471053|Feasibility Studies|feasibility studies
5245611|NCT02471040|brain metabolism|brain metabolism
5245612|NCT02471040|cognitive function|cognitive function
5245613|NCT02471027|Locally advanced cervical cancer|locally advanced cervical cancer
5245614|NCT02471027|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5245615|NCT02471027|Disease-free survival|disease-free survival
5245616|NCT02471027|Overall survival|overall survival
5245617|NCT02471014|Pneumovax23|pneumovax23
5245619|NCT02471001|concentration|concentration
5245620|NCT02471001|Isoflurane|isoflurane
5245621|NCT02471001|cardioprotective|cardioprotective
5245622|NCT02471001|cardioplegia|cardioplegia
5245623|NCT02471001|heart surgery|heart surgery
5245624|NCT02471001|Disorder|disorder
5245626|NCT02471001|Functional|functional
5245627|NCT02471001|Postoperative|postoperative
5245628|NCT02470949|body weight|body weight
5245629|NCT02470949|Hispanics|hispanics
5245630|NCT02470949|Energy Intake|energy intake
5245631|NCT02470949|Social Status|social status
5245632|NCT02470923|Smoking cessation|smoking cessation
5245633|NCT02470923|Nicotine|nicotine
5245634|NCT02470923|Spirometry|spirometry
5245635|NCT02470923|Internal medicine|internal medicine
5245636|NCT02470910|Prostate Cancer|prostate cancer
5245637|NCT02470910|Stage I-III prostate adenocarcinoma|stage i-iii prostate adenocarcinoma
5245638|NCT02470806|Venous leg ulcer|venous leg ulcer
5245639|NCT02470806|ulcer|ulcer
5245640|NCT02470806|venous stasis|venous stasis
5245641|NCT02470806|compression|compression
5245642|NCT02470806|diabetic foot ulcers|diabetic foot ulcers
5245644|NCT02470806|vlu|vlu
5245645|NCT02470793|Corneal Endothelial Cell Loss|corneal endothelial cell loss
5245646|NCT02470793|Fuchs' Endothelial Dystrophy|fuchs' endothelial dystrophy
5245647|NCT02470793|Lamellar Keratoplasty|lamellar keratoplasty
5245648|NCT02470793|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
5245653|NCT02470728|pain centers|pain centers
5245654|NCT02470728|multidisciplinary pain clinics|multidisciplinary pain clinics
5245655|NCT02470728|multidisciplinary pain centers|multidisciplinary pain centers
5245656|NCT02470728|pain clinics|pain clinics
5245657|NCT02470728|hospital readmission|hospital readmission
5245658|NCT02470728|emergencies|emergencies
5245659|NCT02470728|emergency medicine|emergency medicine
5245660|NCT02470728|critical care|critical care
5245661|NCT02470728|emergency treatment|emergency treatment
5245662|NCT02470728|opioid|opioid
5245663|NCT02470728|acute pain service|acute pain service
5245664|NCT02470715|genetic sequencing|genetic sequencing
5245665|NCT02470715|genome|genome
5245666|NCT02470715|cancer|cancer
5245667|NCT02470715|DNA|dna
5245668|NCT02470715|RNA|rna
5245669|NCT02470715|protein|protein
5245670|NCT02470715|metabolite|metabolite
5245671|NCT02470702|Volunteers|volunteers
5245672|NCT02470650|comparative effectiveness|comparative effectiveness
5245673|NCT02470598|Automated Peritoneal Dialysis|automated peritoneal dialysis
5245674|NCT02470598|Adapted APD (aAPD)|adapted apd (aapd)
5245675|NCT02470598|Hydration status|hydration status
5245676|NCT02470598|Residual Renal Function|residual renal function
5245677|NCT02470598|Ultrafiltration|ultrafiltration
5245678|NCT02470585|Veliparib|veliparib
5245679|NCT02470585|Carboplatin|carboplatin
5245680|NCT02470585|Paclitaxel|paclitaxel
5245681|NCT02470585|Overall Survival|overall survival
5245682|NCT02470585|ABT-888|abt-888
5245683|NCT02470585|Randomized|randomized
5245684|NCT02470585|Poly Adenosine Diphosphate (ADP) - Ribose Polymerase (PARP)|poly adenosine diphosphate (adp) - ribose polymerase (parp)
5245685|NCT02470585|Ovarian|ovarian
5245686|NCT02470585|BRCA|brca
5245687|NCT02470585|VELIA|velia
5245688|NCT02470546|Hepatic encephalopathy|hepatic encephalopathy
5245689|NCT02470546|Metformin|metformin
5245690|NCT02470546|Liver cirrhosis|liver cirrhosis
5233621|NCT02542618|Depression|depression
5245691|NCT02470481|Psoriatic arthritis|psoriatic arthritis
5245692|NCT02470468|Immunotherapy|immunotherapy
5245693|NCT02470468|Metastatic|metastatic
5245694|NCT02470468|NSCLC|nsclc
5245695|NCT02470468|Biological|biological
5245696|NCT02470468|Lung Cancer|lung cancer
5245697|NCT02470468|Vaccine|vaccine
5245698|NCT02470455|Atorvastatin|atorvastatin
5245699|NCT02470455|Prediabetics|prediabetics
5245700|NCT02470455|HbA1c|hba1c
5245701|NCT02470416|duodenal|duodenal
5245702|NCT02470416|ampulla|ampulla
5245703|NCT02470403|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus|dysglycemic, normoglycemic, prediabetes, type 2 diabetes mellitus
5245704|NCT02470390|Volunteer|volunteer
5245705|NCT02470390|Pharmacokenetics (PK) (plasma and Cerebrospinal Fluid [CSF])|pharmacokenetics (pk) (plasma and cerebrospinal fluid [csf])
5245706|NCT02470377|MdDS|mdds
5245707|NCT02470377|TMS|tms
5245708|NCT02470377|fMRI|fmri
5245709|NCT02470377|EEG|eeg
5245710|NCT02470364|Myasthenia gravis|myasthenia gravis
5245711|NCT02470364|Quality of life|quality of life
5245712|NCT02470325|Cerebral palsy|cerebral palsy
5245713|NCT02470325|Genetic neurodegenerative diseases|genetic neurodegenerative diseases
5245714|NCT02470312|utility of MediGuide system|utility of mediguide system
5245716|NCT02470312|EP|ep
5245723|NCT02470273|Melanoma|melanoma
5245724|NCT02470260|Diabetes|diabetes
5245725|NCT02470260|Pre-diabetes|pre-diabetes
5245726|NCT02470260|Cognition|cognition
5245727|NCT02470260|Depressive symptoms|depressive symptoms
5245728|NCT02470247|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5245730|NCT02470234|Children|children
5245731|NCT02470234|Pharmacokinetics|pharmacokinetics
5245732|NCT02470221|goal-directed fluid therapy|goal-directed fluid therapy
5245733|NCT02470221|intraoperative hemodynamics|intraoperative hemodynamics
5245734|NCT02470221|postoperative complications|postoperative complications
5245735|NCT02470208|Cytomegalovirus reactivation in stem cell transplant|cytomegalovirus reactivation in stem cell transplant
5245736|NCT02470182|sleep apnea|sleep apnea
5245737|NCT02470182|snoring|snoring
5245738|NCT02470156|community based participatory research|community based participatory research
5245739|NCT02470156|healthy eating|healthy eating
5245740|NCT02470156|physical activity|physical activity
5245741|NCT02470156|obesity|obesity
5245742|NCT02470143|Human-computer interaction|human-computer interaction
5245743|NCT02470143|Fear|fear
5245744|NCT02470143|Motivation|motivation
5245745|NCT02470143|Usability|usability
5245746|NCT02470130|simulation|simulation
5245747|NCT02470130|anxiety|anxiety
5245748|NCT02470130|debriefing|debriefing
5245749|NCT02470130|memorization|memorization
5245750|NCT02470104|children|children
5245751|NCT02470104|bone marrow transplant|bone marrow transplant
5245753|NCT02470104|allogeneic|allogeneic
5245754|NCT02470104|breastmilk|breastmilk
5245755|NCT02470104|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5245756|NCT02470078|extubation|extubation
5245757|NCT02470065|NSCLC|nsclc
5245758|NCT02470065|Early stage|early stage
5245759|NCT02470065|Phase II|phase ii
5245760|NCT02470065|Randomized|randomized
5245761|NCT02470065|EGFR mutated|egfr mutated
5245762|NCT02470052|Endobronchial Valves|endobronchial valves
5245763|NCT02470052|Intrabronchial Valves|intrabronchial valves
5245764|NCT02470052|Bronchial Valve|bronchial valve
5245765|NCT02470052|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5245766|NCT02470052|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5245767|NCT02470052|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5245768|NCT02470052|Emphysema|emphysema
5245769|NCT02470052|Pulmonary Emphysema|pulmonary emphysema
5245770|NCT02470052|Lung Diseases|lung diseases
5245771|NCT02470052|Respiratory Tract Disease|respiratory tract disease
5245772|NCT02470013|Malnutrition|malnutrition
5245773|NCT02470013|Geriatrics|geriatrics
5245774|NCT02470013|Enteral Nutrition|enteral nutrition
5245775|NCT02470000|myofascial pain|myofascial pain
5245776|NCT02470000|neck|neck
5245777|NCT02470000|laser|laser
5245778|NCT02470000|elastography|elastography
5245779|NCT02470000|shear wave velocity|shear wave velocity
5245780|NCT02470000|randomized control trial|randomized control trial
5245781|NCT02470000|Intravascular Laser Irradiation of Blood|intravascular laser irradiation of blood
5245782|NCT02469987|safety|safety
5245783|NCT02469987|tolerability|tolerability
5245784|NCT02469987|immunogenicity|immunogenicity
5245785|NCT02469987|MYL-1402O|myl-1402o
5245786|NCT02469987|PK|pk
5245787|NCT02469987|Avastin®|avastin®
5245788|NCT02469987|biosimilarity|biosimilarity
5245789|NCT02469987|male|male
5245790|NCT02469974|Myelofibrosis|myelofibrosis
5245791|NCT02469974|RUXOLITINIB|ruxolitinib
5245792|NCT02469974|Autologous stem cell transplant|autologous stem cell transplant
5245793|NCT02469948|spasticity|spasticity
5245794|NCT02469948|botulinum toxin|botulinum toxin
5245795|NCT02469948|ultrasonography guidance|ultrasonography guidance
5233723|NCT02541916|Transplantation Tolerance|transplantation tolerance
5233724|NCT02541916|Immune Tolerance|immune tolerance
5233725|NCT02541916|Transplantation|transplantation
5233726|NCT02541916|Liver Transplantation|liver transplantation
5233727|NCT02541916|Biological Markers|biological markers
5245796|NCT02469948|electric stimulation guidance|electric stimulation guidance
5245798|NCT02469935|Validation|validation
5245799|NCT02469935|Surgeon-performed ultrasound|surgeon-performed ultrasound
5245800|NCT02469935|Gallstones|gallstones
5245801|NCT02469909|Decannulation|decannulation
5245802|NCT02469909|tracheostomy|tracheostomy
5245803|NCT02469896|ALS|als
5245804|NCT02469896|tocilizumab|tocilizumab
5245805|NCT02469896|biomarker|biomarker
5245806|NCT02469870|Parents of children who have autism|parents of children who have autism
5245807|NCT02469870|video-conferencing|video-conferencing
5245808|NCT02469870|Applied Behavior Analysis|applied behavior analysis
5245809|NCT02469870|Acceptance Commitment Training|acceptance commitment training
5245810|NCT02469870|optimism training|optimism training
5245811|NCT02469870|Positive Behavior Support|positive behavior support
5245812|NCT02469857|AB103|ab103
5245813|NCT02469857|Necrotizing fasciitis|necrotizing fasciitis
5245814|NCT02469818|pocus|pocus
5245815|NCT02469818|ultrasonography|ultrasonography
5243337|NCT02484092|AAV|aav
5245818|NCT02469792|Ligament rupture|ligament rupture
5245819|NCT02469792|Intraarticular injection|intraarticular injection
5245820|NCT02469792|ADRC|adrc
5245821|NCT02469792|Adipose-derived regenerative cells|adipose-derived regenerative cells
5245822|NCT02469792|Adipose tissue|adipose tissue
5245824|NCT02469779|Tobacco Prevention|tobacco prevention
5245825|NCT02469779|ASPIRE Website|aspire website
5245828|NCT02469779|Focus Groups|focus groups
5245829|NCT02469779|Health Interactive Website|health interactive website
5245830|NCT02469766|ureteral stones|ureteral stones
5245832|NCT02469766|ureteroscopy|ureteroscopy
5245833|NCT02469766|flexible|flexible
5245835|NCT02469753|NSAIDs|nsaids
5245836|NCT02469753|Anti-TNF|anti-tnf
5245837|NCT02469753|syndesmophytes|syndesmophytes
5245838|NCT02469753|mSASSS|msasss
5245839|NCT02469740|Ticagrelor|ticagrelor
5245840|NCT02469740|Clopidogrel|clopidogrel
5245841|NCT02469740|Coronary Artery Disease|coronary artery disease
5245842|NCT02469740|Percutaneous Coronary Intervention|percutaneous coronary intervention
5245843|NCT02469740|Acute Coronary Syndrome|acute coronary syndrome
5245844|NCT02469714|Patient Navigator|patient navigator
5245845|NCT02469714|Integrated Care|integrated care
5245846|NCT02469714|Latino|latino
5245847|NCT02469714|Mental health and wellness|mental health and wellness
5245848|NCT02469714|Physical health and wellness|physical health and wellness
5245849|NCT02469688|cedar pollinosis|cedar pollinosis
5245850|NCT02469688|immunological response,|immunological response,
5245851|NCT02469688|ASP4070|asp4070
5245852|NCT02469688|vaccine|vaccine
5245853|NCT02469675|Spinal Cord Injuries|spinal cord injuries
5245854|NCT02469675|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5245855|NCT02469675|Transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
5245856|NCT02469675|non-invasive brain stimulation|non-invasive brain stimulation
5245857|NCT02469662|Total Elbow Arthroplasty|total elbow arthroplasty
5245858|NCT02469662|TEA|tea
5245859|NCT02469662|Elbow Arthroplasty|elbow arthroplasty
5245860|NCT02469662|Elbow Replacement|elbow replacement
5245861|NCT02469662|Advanced Rheumatoid Arthritis|advanced rheumatoid arthritis
5245862|NCT02469662|Post-Traumatic Arthritis|post-traumatic arthritis
5245863|NCT02469662|Degenerative Arthritis|degenerative arthritis
5245864|NCT02469662|Elbow Joint Destruction|elbow joint destruction
5245865|NCT02469662|Post-Traumatic Lesions or Bone Loss|post-traumatic lesions or bone loss
5245866|NCT02469662|Ankylosed Joints|ankylosed joints
5245867|NCT02469662|Acute Comminuted Articular Fracture|acute comminuted articular fracture
5245868|NCT02469662|Significantly compromises daily living activities|significantly compromises daily living activities
5245869|NCT02469662|Joint or soft tissue damage|joint or soft tissue damage
5245870|NCT02469662|Precludes less radical procedures|precludes less radical procedures
5245871|NCT02469662|13-C3 fractures of the distal humerus|13-c3 fractures of the distal humerus
5245872|NCT02469610|Post surgical pain|post surgical pain
5245873|NCT02469584|prolapse|prolapse
5245874|NCT02469584|anterior colporrhaphy|anterior colporrhaphy
5245875|NCT02469545|depression|depression
5245876|NCT02469545|microbiota-gut-brain axis|microbiota-gut-brain axis
5245877|NCT02469545|Lactobacillus Plantarum 299v|lactobacillus plantarum 299v
5245878|NCT02469545|probiotic|probiotic
5245879|NCT02469480|MCRC|mcrc
5245880|NCT02469480|iron substitution|iron substitution
5245881|NCT02469480|iron deficiency anemia|iron deficiency anemia
5233814|NCT02541409|resource-limited setting|resource-limited setting
5233815|NCT02541396|Bunion|bunion
5233816|NCT02541396|Bunionectomy|bunionectomy
5233817|NCT02541383|Untreated Multiple Myeloma|untreated multiple myeloma
5233818|NCT02541383|daratumumab|daratumumab
5233819|NCT02541357|Colorectal Surgery|colorectal surgery
5233820|NCT02541331|IgE-dependent asthma|ige-dependent asthma
5233821|NCT02541318|peri-menopausal women|peri-menopausal women
5245882|NCT02469467|phosphate binder|phosphate binder
5245883|NCT02469467|dialysis|dialysis
5245884|NCT02469454|etonogestrel-implant|etonogestrel-implant
5245885|NCT02469454|newborn|newborn
5245886|NCT02469454|growth|growth
5245887|NCT02469454|Child Development|child development
5245888|NCT02469441|coffee|coffee
5245889|NCT02469441|postoperative ileus|postoperative ileus
5245890|NCT02469441|colorectal surgery|colorectal surgery
5245891|NCT02469428|Controlled human exposure study|controlled human exposure study
5245892|NCT02469428|Ozone|ozone
5245893|NCT02469428|Inflammation|inflammation
5245894|NCT02469415|Leukemia|leukemia
5245895|NCT02469415|Myelodysplastic syndromes|myelodysplastic syndromes
5245896|NCT02469415|MDS|mds
5245897|NCT02469415|Lower-risk|lower-risk
5245898|NCT02469415|Pacritinib|pacritinib
5245899|NCT02469415|5-azacitidine|5-azacitidine
5245900|NCT02469415|Azacitidine|azacitidine
5245901|NCT02469415|5-azacytidine|5-azacytidine
5245902|NCT02469415|Vidaza|vidaza
5245903|NCT02469415|5-AZC|5-azc
5245905|NCT02469415|Ladakamycin|ladakamycin
5245906|NCT02469415|NSC-102816|nsc-102816
5245913|NCT02469402|Alpha-lactalbumin|alpha-lactalbumin
5245914|NCT02469402|infant|infant
5245917|NCT02469363|Macintosh laryngoscope|macintosh laryngoscope
5245918|NCT02469363|McCoy laryngoscope|mccoy laryngoscope
5245919|NCT02469363|C-Mac videolaryngoscope|c-mac videolaryngoscope
5245920|NCT02469363|McGrath videolaryngoscope|mcgrath videolaryngoscope
5245921|NCT02469363|Hemodynamic parameters|hemodynamic parameters
5245922|NCT02469350|Gait and balance disorders|gait and balance disorders
5245923|NCT02469350|serious game|serious game
5245924|NCT02469311|infection; arthroplasty; chlorhexidine; hip; knee|infection; arthroplasty; chlorhexidine; hip; knee
5246228|NCT02467764|Knee|knee
5245925|NCT02469298|acute, uncomplicated influenza|acute, uncomplicated influenza
5245926|NCT02469298|Danirixin|danirixin
5245927|NCT02469298|oseltamivir|oseltamivir
5245928|NCT02469285|Fatty acids|fatty acids
5245929|NCT02469285|Lipids|lipids
5245930|NCT02469285|Nitroso compounds|nitroso compounds
5245931|NCT02469285|Lipid metabolism|lipid metabolism
5245932|NCT02469285|Gut metabolism|gut metabolism
5245933|NCT02469259|oxytocin|oxytocin
5245934|NCT02469259|PTSD|ptsd
5245935|NCT02469259|Alcohol Use Disorder|alcohol use disorder
5245936|NCT02469259|social cognition|social cognition
5245937|NCT02469259|craving|craving
5245938|NCT02469259|fear-potentiated startle|fear-potentiated startle
5245940|NCT02469246|HIV-1 Positive|hiv-1 positive
5245941|NCT02469246|Virologically-Suppressed|virologically-suppressed
5245942|NCT02469220|Diet|diet
5245943|NCT02469220|low FODMAP|low fodmap
5245944|NCT02469220|UC|uc
5245945|NCT02469220|IBS|ibs
5245946|NCT02469207|regenerative medicine|regenerative medicine
5245947|NCT02469207|stem cells|stem cells
5245948|NCT02469207|immunomodulatory|immunomodulatory
5245949|NCT02469207|induced pluripotent stem cells|induced pluripotent stem cells
5245950|NCT02469207|gut physiology|gut physiology
5245951|NCT02469129|positron emission tomography (PET) imaging|positron emission tomography (pet) imaging
5245952|NCT02469129|poly(ADP-ribose) polymerase 1 (PARP1)|poly(adp-ribose) polymerase 1 (parp1)
5245953|NCT02469129|[18F]FluorThanatrace ([18F]FTT)|[18f]fluorthanatrace ([18f]ftt)
5245954|NCT02469129|PARP1 inhibitors|parp1 inhibitors
5245955|NCT02469129|cancer treatments|cancer treatments
5245956|NCT02469103|capsule colonoscopy|capsule colonoscopy
5245957|NCT02469103|ulcerative colitis|ulcerative colitis
5245958|NCT02469090|Parkinson Disease, off episodes|parkinson disease, off episodes
5245959|NCT02469077|Chronic Low Back Pain|chronic low back pain
5245960|NCT02469064|mechanical ventilation|mechanical ventilation
5245961|NCT02469064|respiratory muscle|respiratory muscle
5245962|NCT02469064|weaning|weaning
5245963|NCT02469064|training|training
5245964|NCT02469064|Intensive care|intensive care
5245965|NCT02469012|chronic hepatitis C|chronic hepatitis c
5245966|NCT02469012|antiviral treatment|antiviral treatment
5245967|NCT02469012|interferon-free|interferon-free
5245968|NCT02469012|neurocognitive performance|neurocognitive performance
5233914|NCT02540772|Neuropsychological rehabilitation|neuropsychological rehabilitation
5233915|NCT02540772|Memory|memory
5233916|NCT02540759|Buglossoides arvensis|buglossoides arvensis
5245969|NCT02469012|emotional state|emotional state
5245970|NCT02469012|quality of life|quality of life
5245971|NCT02468999|Intranasal insulin|intranasal insulin
5245972|NCT02468986|Rheumatoid Arthritis|rheumatoid arthritis
5245973|NCT02468973|health behavior|health behavior
5245974|NCT02468973|consultation|consultation
5245975|NCT02468973|undergraduate|undergraduate
5245976|NCT02468960|Coronary Artery Disease|coronary artery disease
5245977|NCT02468960|OPN NC|opn nc
5245978|NCT02468960|Angina|angina
5245979|NCT02468960|Stable|stable
5245980|NCT02468960|Unstable|unstable
5245981|NCT02468947|Neonatal sepsis|neonatal sepsis
5245982|NCT02468934|electrical stimulation|electrical stimulation
5245983|NCT02468934|neurostimulation|neurostimulation
5245984|NCT02468934|neuromodulation|neuromodulation
5245985|NCT02468934|TKA pain|tka pain
5245986|NCT02468934|pain following total knee replacement|pain following total knee replacement
5245987|NCT02468934|total knee arthroplasty|total knee arthroplasty
5245988|NCT02468921|Goitre|goitre
5245989|NCT02468921|thyroid disease|thyroid disease
5245990|NCT02468921|struma|struma
5245991|NCT02468895|Myositis|myositis
5245992|NCT02468895|Idiopathic inflammatory myopathy|idiopathic inflammatory myopathy
5245993|NCT02468895|Antibodies|antibodies
5245994|NCT02468895|Genetics|genetics
5245995|NCT02468895|Biomarkers|biomarkers
5245996|NCT02468882|Breast cancer|breast cancer
5245997|NCT02468882|Radiotherapy|radiotherapy
5245998|NCT02468882|Toxicity|toxicity
5245999|NCT02468882|Outcomes|outcomes
5246000|NCT02468882|Watercress|watercress
5246001|NCT02468869|Recall|recall
5246002|NCT02468869|Discharge communication|discharge communication
5246004|NCT02468869|Adherence|adherence
5246005|NCT02468869|Information structuring|information structuring
5246006|NCT02468869|Empathy skills|empathy skills
5246007|NCT02468843|Deep brain stimulation|deep brain stimulation
5246008|NCT02468843|DBS|dbs
5246009|NCT02468843|Dystonia|dystonia
5246010|NCT02468843|DYT1|dyt1
5246011|NCT02468830|mirabegron|mirabegron
5246012|NCT02468830|antimuscarinics|antimuscarinics
5246013|NCT02468830|beta 3 agonist|beta 3 agonist
5246014|NCT02468830|overactive bladder|overactive bladder
5246015|NCT02468830|children|children
5246016|NCT02468817|parathyroid hormone (PTH)|parathyroid hormone (pth)
5126353|NCT03204617|HTI|hti
5246017|NCT02468817|bone mineral density (BMD)|bone mineral density (bmd)
5246018|NCT02468804|Parkinson's|parkinson's
5246019|NCT02468804|Non-parkinsons|non-parkinsons
5246020|NCT02468791|Rheumatoid Arthritis|rheumatoid arthritis
5246021|NCT02468791|Autoimmune Diseases|autoimmune diseases
5246022|NCT02468791|Rituximab|rituximab
5246023|NCT02468791|Immune System Diseases|immune system diseases
5246024|NCT02468791|Joint Diseases|joint diseases
5246025|NCT02468791|Rheumatic Diseases|rheumatic diseases
5246026|NCT02468778|HeartMate PHP|heartmate php
5246027|NCT02468778|High Risk PCI|high risk pci
5246039|NCT02468713|TPN|tpn
5246040|NCT02468687|Relapsed/Refractory|relapsed/refractory
5342995|NCT01981239|voice analysis aspiration prediction|voice analysis aspiration prediction
5342996|NCT01981213|Acetaminophen|acetaminophen
5246041|NCT02468674|Sarcopenia, muscle wasting, elderly, strength, physical function, lean body mass, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, lean body mass, gait speed
5246050|NCT02468648|Oral Therapy|oral therapy
5246051|NCT02468648|Liver Biopsy|liver biopsy
5246052|NCT02468648|Chronic Hepatitis C|chronic hepatitis c
5246053|NCT02468635|Pulmonary rehabilitation|pulmonary rehabilitation
5246054|NCT02468635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5246055|NCT02468635|physical ability|physical ability
5246056|NCT02468635|pulmonary function|pulmonary function
5246057|NCT02468635|quality of daily life|quality of daily life
5246058|NCT02468596|Axonal excitability|axonal excitability
5246059|NCT02468596|Neuropathy|neuropathy
5246060|NCT02468596|QTRAC|qtrac
5246061|NCT02468596|anti-MAG|anti-mag
5246062|NCT02468596|Electrophysiology|electrophysiology
5246063|NCT02468583|Osteoarthritis|osteoarthritis
5246064|NCT02468583|Post-traumatic|post-traumatic
5246065|NCT02468583|Knee|knee
5246066|NCT02468583|Pain|pain
5246067|NCT02468583|Corticosteroid|corticosteroid
5246068|NCT02468583|Intra-articular|intra-articular
5246069|NCT02468583|Injection|injection
5246070|NCT02468570|PKU|pku
5246071|NCT02468570|PEG-PAL|peg-pal
5246072|NCT02468570|Pegvaliase|pegvaliase
5246073|NCT02468570|BMN 165|bmn 165
5246075|NCT02468570|PRISM 302|prism 302
5246076|NCT02468570|PRISM 303|prism 303
5246077|NCT02468570|BioMarin|biomarin
5246078|NCT02468570|165-302|165-302
5246079|NCT02468557|Relapsed/refractory pancreatic ductal adenocarcinoma|relapsed/refractory pancreatic ductal adenocarcinoma
5246080|NCT02468557|Previously untreated pancreatic ductal adenocarcinoma|previously untreated pancreatic ductal adenocarcinoma
5246081|NCT02468544|Engagement in care|engagement in care
5246082|NCT02468544|mHealth|mhealth
5246083|NCT02468531|Xenon|xenon
5246084|NCT02468531|Standford A acute aortic dissection|standford a acute aortic dissection
5246085|NCT02468505|Structured transition support program|structured transition support program
5246086|NCT02468505|Transition 'as usual'|transition 'as usual'
5246087|NCT02468492|Knee Osteoarthritis|knee osteoarthritis
5246088|NCT02468492|Platelet Rich Plasma|platelet rich plasma
5246089|NCT02468492|Mechanism of Action|mechanism of action
5246090|NCT02468492|Stem Cells|stem cells
5246091|NCT02468492|Synovial Fluid|synovial fluid
5246092|NCT02468479|Liver cirrhosis|liver cirrhosis
5246093|NCT02468466|suicide|suicide
5246094|NCT02468466|prevention|prevention
5246095|NCT02468453|velos|velos
5246096|NCT02468453|Vascular|vascular
5246097|NCT02468453|Rejuvenation|rejuvenation
5246098|NCT02468440|renal insufficiency|renal insufficiency
5246099|NCT02468440|kidney transplant|kidney transplant
5246100|NCT02468440|educational therapy|educational therapy
5246101|NCT02468414|Peritoneal Dialysis|peritoneal dialysis
5246102|NCT02468414|End Stage Renal Disease|end stage renal disease
5246103|NCT02468414|Anemia|anemia
5246104|NCT02468388|maltitol|maltitol
5246105|NCT02468388|xylitol|xylitol
5246106|NCT02468388|quantitative light-induced fluorescence|quantitative light-induced fluorescence
5246107|NCT02468388|saliva pH|saliva ph
5246108|NCT02468388|re-mineralization|re-mineralization
5246109|NCT02468388|dental caries|dental caries
5246110|NCT02468362|Intersphincteric resection|intersphincteric resection
5246111|NCT02468362|laparoscopic rectal rescetion|laparoscopic rectal rescetion
5246112|NCT02468362|total mesorectal excsison|total mesorectal excsison
5246113|NCT02468349|Acute Myocardial Infarction|acute myocardial infarction
5246114|NCT02468349|Telemedicine|telemedicine
5246115|NCT02468349|Readmissions|readmissions
5246116|NCT02468336|Physiology|physiology
5246117|NCT02468323|PONV|ponv
5246118|NCT02468323|Palonosetron|palonosetron
5246119|NCT02468323|Ondansetron|ondansetron
5246120|NCT02468323|Cesarean section|cesarean section
5246121|NCT02468310|Maternal mortality|maternal mortality
5246122|NCT02468310|Neonatal mortality|neonatal mortality
5246123|NCT02468310|Neonatal morbidity|neonatal morbidity
5246124|NCT02468310|Text messaging|text messaging
5246125|NCT02468310|Clinical decision making|clinical decision making
5246126|NCT02468310|Maternal Morbidity|maternal morbidity
5246127|NCT02468271|Clinimetrics|clinimetrics
5246142|NCT02468219|aortic stenosis|aortic stenosis
5246143|NCT02468219|aortic valve replacement|aortic valve replacement
5246144|NCT02468219|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5246145|NCT02468219|frailty|frailty
5246146|NCT02468219|cardiac rehabilitation|cardiac rehabilitation
5246147|NCT02468193|Cushing's syndrome|cushing's syndrome
5246148|NCT02468193|osilodrostat|osilodrostat
5246149|NCT02468193|LCI699|lci699
5246150|NCT02468193|ectopic corticotropin syndrome|ectopic corticotropin syndrome
5246151|NCT02468193|adrenal adenoma|adrenal adenoma
5246152|NCT02468193|adrenal carcinoma|adrenal carcinoma
5246153|NCT02468193|ACTH-Independent Macronodular Adrenal Hyperplasia|acth-independent macronodular adrenal hyperplasia
5246154|NCT02468193|AIMAH|aimah
5246155|NCT02468193|Primary Pigmented Nodular Adrenal Dysplasia|primary pigmented nodular adrenal dysplasia
5246156|NCT02468193|PPNAD|ppnad
5246157|NCT02468128|Analgesic|analgesic
5246158|NCT02468128|Opioids|opioids
5246159|NCT02468128|Pain relief after surgery|pain relief after surgery
5246160|NCT02468128|Dinalbuphine|dinalbuphine
5246161|NCT02468128|Sebacoyl Dinalbuphine Ester|sebacoyl dinalbuphine ester
5246163|NCT02468128|SDN|sdn
5246164|NCT02468128|LT1001|lt1001
5246177|NCT02468076|ERCP|ercp
5246178|NCT02468076|radiofrequency ablation|radiofrequency ablation
5246179|NCT02468076|obstructive jaundice|obstructive jaundice
5246180|NCT02468050|Anxiety|anxiety
5246181|NCT02468050|Depression|depression
5246182|NCT02468050|Exercise|exercise
5246183|NCT02468050|Breast Cancer|breast cancer
5246184|NCT02468050|Biopsy|biopsy
5246185|NCT02468050|Screening|screening
5246186|NCT02468050|Diagnosis|diagnosis
5246187|NCT02468037|iron|iron
5246188|NCT02468037|diabetes|diabetes
5246189|NCT02468037|phlebotomy|phlebotomy
5246190|NCT02467998|meaningful use|meaningful use
5246191|NCT02467998|electronic health records|electronic health records
5246192|NCT02467998|structured language|structured language
5246193|NCT02467998|NPWT|npwt
5246194|NCT02467998|PQRS|pqrs
5246195|NCT02467985|gynecological laparoscopic surgery|gynecological laparoscopic surgery
5246196|NCT02467972|Hunger and satiety|hunger and satiety
5246197|NCT02467972|Hormones gastrointestinal|hormones gastrointestinal
5246198|NCT02467972|Bowel movements|bowel movements
5246202|NCT02467920|exenatide|exenatide
5246203|NCT02467920|glargine|glargine
5246204|NCT02467920|aspart 30|aspart 30
5246205|NCT02467894|Adherence|adherence
5246206|NCT02467894|Exercise|exercise
5246207|NCT02467881|Physical Activity|physical activity
5246208|NCT02467881|Sedentary|sedentary
5246209|NCT02467881|Lifestyle Intervention|lifestyle intervention
5246210|NCT02467868|Pegfilgrastim|pegfilgrastim
5246211|NCT02467868|Granulocyte Colony Stimulating Factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
5246212|NCT02467868|Breast Cancer|breast cancer
5246213|NCT02467868|Neutropenia|neutropenia
5246214|NCT02467855|Drug therapy|drug therapy
5246215|NCT02467842|Influenza vaccine|influenza vaccine
5246216|NCT02467842|Quadrivalent|quadrivalent
5246217|NCT02467842|Inactivated cell culture-derived|inactivated cell culture-derived
5246218|NCT02467829|Cerebral Palsy|cerebral palsy
5246219|NCT02467829|Walking Aids|walking aids
5246220|NCT02467816|Secondary schools|secondary schools
5246221|NCT02467816|School lunch|school lunch
5246222|NCT02467816|Plate waste|plate waste
5246223|NCT02467803|humeral fracture|humeral fracture
5246224|NCT02467803|exercise|exercise
5246225|NCT02467803|musculoskeletal manipulations|musculoskeletal manipulations
5246226|NCT02467777|orthopaedics|orthopaedics
5246227|NCT02467777|post-operative warming|post-operative warming
5246229|NCT02467764|Knee osteoarthritis|knee osteoarthritis
5246230|NCT02467764|Knee replacement|knee replacement
5246232|NCT02467764|Hip osteoarthritis|hip osteoarthritis
5246233|NCT02467764|Hip replacement|hip replacement
5246234|NCT02467725|Preimplantation Embryo Development|preimplantation embryo development
5246235|NCT02467712|Fongal infection|fongal infection
5246236|NCT02467712|joint prosthesis|joint prosthesis
5246237|NCT02467712|prosthetic reconstruction|prosthetic reconstruction
5246238|NCT02467699|Knee|knee
5246239|NCT02467699|Knee osteoarthritis|knee osteoarthritis
5246240|NCT02467699|Knee replacement|knee replacement
5246241|NCT02467621|Stress ulcer prophylaxis|stress ulcer prophylaxis
5246242|NCT02467621|Proton pump inhibitor|proton pump inhibitor
5246243|NCT02467621|Pneumonia|pneumonia
5246244|NCT02467621|Clostridium difficile infection|clostridium difficile infection
5246245|NCT02467608|HUEXC030|huexc030
5246246|NCT02467608|Pulmonary Tuberculosis|pulmonary tuberculosis
5246247|NCT02467595|no muscle relaxant|no muscle relaxant
5246248|NCT02467595|rocuronium|rocuronium
5246249|NCT02467595|intubation condition|intubation condition
5246250|NCT02467595|tracheal intubation|tracheal intubation
5246251|NCT02467595|operating room time|operating room time
5246252|NCT02467595|low-dose rocuronium|low-dose rocuronium
5246254|NCT02467582|colon cancer|colon cancer
5246255|NCT02467582|stage II|stage ii
5246256|NCT02467582|stage III|stage iii
5246257|NCT02467582|PIK3CA|pik3ca
5246258|NCT02467582|double-blind|double-blind
5246259|NCT02467582|placebo|placebo
5246260|NCT02467582|Adjuvant Treatment|adjuvant treatment
5246261|NCT02467556|CRPS|crps
5246262|NCT02467556|intervention|intervention
5246263|NCT02467556|multimodal|multimodal
5246264|NCT02467543|Primary dysmenorrhea|primary dysmenorrhea
5246265|NCT02467543|Viburnum opulus 3X|viburnum opulus 3x
5246266|NCT02467543|Homoeopathic|homoeopathic
5246267|NCT02467530|end stage renal disease|end stage renal disease
5246268|NCT02467530|peritoneal dialysis (PD)|peritoneal dialysis (pd)
5246269|NCT02467530|advanced glycation end products|advanced glycation end products
5246270|NCT02467530|Gut Microbiota Inflammation|gut microbiota inflammation
5246271|NCT02467517|Neuropathic pain|neuropathic pain
5246272|NCT02467517|Ketamine|ketamine
5246273|NCT02467517|Magnesium sulfate|magnesium sulfate
5246274|NCT02467517|Quality of life|quality of life
5246275|NCT02467517|Anxiety and depression|anxiety and depression
5246276|NCT02467517|Mood and sleep|mood and sleep
5246277|NCT02467491|Exercise|exercise
5246278|NCT02467491|Technology|technology
5246279|NCT02467491|Aging|aging
5246280|NCT02467478|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5246281|NCT02467478|Endothelial cells|endothelial cells
5246282|NCT02467478|Cellular biomarker|cellular biomarker
5246283|NCT02467478|endothelial dysfunction|endothelial dysfunction
5246284|NCT02467478|CD34+|cd34+
5246285|NCT02467478|Impaired renal function|impaired renal function
5246286|NCT02467465|Fasciosis plantar|fasciosis plantar
5246287|NCT02467465|physiotherapy|physiotherapy
5246288|NCT02467465|fascitis plantar|fascitis plantar
5246289|NCT02467465|dry needling|dry needling
5246290|NCT02467439|unaware intervention;|unaware intervention;
5246291|NCT02467439|contract sexual partner referral|contract sexual partner referral
5246292|NCT02467439|peer referral|peer referral
5246293|NCT02467426|Mesothelioma, malignant|mesothelioma, malignant
5246294|NCT02467426|Chemotherapy|chemotherapy
5246295|NCT02467413|Alzheimer's Disease|alzheimer's disease
5246296|NCT02467413|Vascular Dementia|vascular dementia
5246297|NCT02467400|bone formation|bone formation
5246298|NCT02467387|Non-ischemic Heart Failure|non-ischemic heart failure
5246299|NCT02467387|Stem Cells|stem cells
5246301|NCT02467374|Neuroimaging|neuroimaging
5246302|NCT02467374|Fear Extinction|fear extinction
5246303|NCT02467374|Behavior Therapy|behavior therapy
5246304|NCT02467361|Neoplasms|neoplasms
5246305|NCT02467296|Sodium|sodium
5246306|NCT02467296|outcomes|outcomes
5246307|NCT02467283|chronic periodontitis|chronic periodontitis
5246308|NCT02467283|genetics|genetics
5246309|NCT02467283|microarray analysis|microarray analysis
5234216|NCT02538991|Women|women
5246310|NCT02467283|gingiva|gingiva
5246311|NCT02467283|genes|genes
5246312|NCT02467283|inflammation|inflammation
5246313|NCT02467270|Chronic Phase Chronic Myeloid Leukemia|chronic phase chronic myeloid leukemia
5246314|NCT02467270|Molecular Response|molecular response
5246315|NCT02467270|CML|cml
5246316|NCT02467270|Leukemia|leukemia
5246317|NCT02467270|Leukemia, Myeloid|leukemia, myeloid
5246318|NCT02467270|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5246319|NCT02467270|Neoplasms by Histologic Type|neoplasms by histologic type
5246320|NCT02467270|Neoplasms|neoplasms
5246321|NCT02467270|Myeloproliferative Disorders|myeloproliferative disorders
5246322|NCT02467270|Bone Marrow Diseases|bone marrow diseases
5246323|NCT02467270|Hematologic Diseases|hematologic diseases
5246324|NCT02467270|CP-CML|cp-cml
5246325|NCT02467244|Hypothyroidism|hypothyroidism
5246326|NCT02467244|Serum adiponectin|serum adiponectin
5246327|NCT02467244|hsCRP|hscrp
5246328|NCT02467244|Homeostatic Model Assessment (HOMA-IR)|homeostatic model assessment (homa-ir)
5246329|NCT02467244|Quantitative Insulin Sensitivity Check Index (QUICKI)|quantitative insulin sensitivity check index (quicki)
5246330|NCT02467244|Cardiovascular risk assessment scoring (Framingham scoring)|cardiovascular risk assessment scoring (framingham scoring)
5246331|NCT02467244|Levothyroxin|levothyroxin
5246332|NCT02467231|new diagnosis of cancer|new diagnosis of cancer
5246333|NCT02467231|chemotherapy|chemotherapy
5246334|NCT02467231|oncofertility|oncofertility
5246335|NCT02467231|alkylating agent|alkylating agent
5246336|NCT02467231|fertility preservation|fertility preservation
5246337|NCT02467231|fertility after cancer|fertility after cancer
5246338|NCT02467231|late effects|late effects
5246339|NCT02467218|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
5246340|NCT02467218|Fibromyalgia|fibromyalgia
5246341|NCT02467218|Global Function|global function
5246342|NCT02467218|Sleep|sleep
5246343|NCT02467218|Chronic Pain|chronic pain
5246344|NCT02467218|Depression|depression
5246345|NCT02467218|Anxiety|anxiety
5246346|NCT02467205|Physical Activity|physical activity
5246352|NCT02467166|atrial fibrillation ablation|atrial fibrillation ablation
5246353|NCT02467166|radio frequency catheter ablation|radio frequency catheter ablation
5246354|NCT02467166|esophageal lesion|esophageal lesion
5246355|NCT02467166|arrhythmia|arrhythmia
5246356|NCT02467166|atrial fibrillation|atrial fibrillation
5246357|NCT02467166|AF|af
5246358|NCT02467166|esophageal damage|esophageal damage
5246359|NCT02467153|Sarcopenia|sarcopenia
5246360|NCT02467153|Older adult|older adult
5246361|NCT02467153|Vitamin D|vitamin d
5246362|NCT02467153|Physical activity|physical activity
5246363|NCT02467153|Muscle atrophy|muscle atrophy
5246364|NCT02467153|Muscle strength|muscle strength
5246365|NCT02467153|Physical function|physical function
5246366|NCT02467153|Frailty|frailty
5246367|NCT02467153|Osteoporosis|osteoporosis
5246368|NCT02467140|Inguinal hernia repair|inguinal hernia repair
5246369|NCT02467140|Hernia|hernia
5246370|NCT02467140|ProGrib self-fixating mesh|progrib self-fixating mesh
5246371|NCT02467140|Biological mesh|biological mesh
5246372|NCT02467140|Tack fixation|tack fixation
5246373|NCT02467101|cicatricial alopecia|cicatricial alopecia
5246374|NCT02467101|treatment|treatment
5246375|NCT02467101|placebo|placebo
5246376|NCT02467101|double-blind|double-blind
5246377|NCT02467088|PMS|pms
5246378|NCT02467088|Individualised homoeopathic treatment|individualised homoeopathic treatment
5246379|NCT02467088|Indian females|indian females
5246380|NCT02467075|CT, iodinated contrast, contrast-induced AKI, kidney injury|ct, iodinated contrast, contrast-induced aki, kidney injury
5246381|NCT02467062|4D flow|4d flow
5246382|NCT02467049|ECG|ecg
5246383|NCT02467049|Ultrasound|ultrasound
5246384|NCT02467049|Peripherally Inserted Central Catheters|peripherally inserted central catheters
5246385|NCT02467049|PICC|picc
5246386|NCT02467036|overweight children|overweight children
5246387|NCT02467036|overweight parents|overweight parents
5246388|NCT02467036|eating in the absence of hunger|eating in the absence of hunger
5246389|NCT02467036|families with overweight child|families with overweight child
5246390|NCT02467036|bmi|bmi
5246391|NCT02467036|body mass index|body mass index
5246392|NCT02467036|treatment|treatment
5246395|NCT02467036|experiments|experiments
5246396|NCT02467036|intervention|intervention
5246397|NCT02467036|psychophysiological response to food cues|psychophysiological response to food cues
5246398|NCT02467023|chronic critical illness|chronic critical illness
5246399|NCT02467023|strength training|strength training
5246400|NCT02467023|exercise|exercise
5246401|NCT02467023|sepsis|sepsis
5246402|NCT02467023|mechanical ventilation|mechanical ventilation
5246403|NCT02467010|Bortezomib|bortezomib
5246404|NCT02467010|cyclophosphamide|cyclophosphamide
5246405|NCT02467010|dexamethason|dexamethason
5246406|NCT02467010|multiple myeloma|multiple myeloma
5246408|NCT02466997|Tacrolimus|tacrolimus
5246409|NCT02466997|Face|face
5246410|NCT02466984|metoclopramide|metoclopramide
5246411|NCT02466984|subcutaneous route|subcutaneous route
5246412|NCT02466984|palliative care|palliative care
5246413|NCT02466984|pharmacology|pharmacology
5246414|NCT02466984|bioavailability|bioavailability
5246415|NCT02466984|nausea|nausea
5246416|NCT02466984|vomiting|vomiting
5246417|NCT02466958|depressed|depressed
5246418|NCT02466958|older adults|older adults
5246419|NCT02466958|antidepressants|antidepressants
5246420|NCT02466958|depression|depression
5246422|NCT02466919|Helicobacter pylori|helicobacter pylori
5246423|NCT02466906|Stage III colon cancer|stage iii colon cancer
5246424|NCT02466906|rhGM-CSF|rhgm-csf
5246425|NCT02466906|Immunotherapy|immunotherapy
5246426|NCT02466906|Surgery|surgery
5246427|NCT02466906|Adjuvant chemotherapy|adjuvant chemotherapy
5246428|NCT02466880|Type 2|type 2
5246429|NCT02466880|NIDDM|niddm
5246431|NCT02466854|Bleeding|bleeding
5246432|NCT02466854|Acute Coronary Syndrome|acute coronary syndrome
5246433|NCT02466854|percutaneous coronary intervention|percutaneous coronary intervention
5246434|NCT02466854|1 year follow up|1 year follow up
5246435|NCT02466815|Healthy|healthy
5246436|NCT02466815|JNJ-42756493|jnj-42756493
5246438|NCT02466789|Bleeding Disorder, inherited|bleeding disorder, inherited
5246439|NCT02466789|Von Willebrands Disease|von willebrands disease
5246440|NCT02466789|Hematologic Test|hematologic test
5246441|NCT02466789|VWF|vwf
5246442|NCT02466789|VWD|vwd
5246443|NCT02466763|round window|round window
5246444|NCT02466763|cochlear implants|cochlear implants
5246445|NCT02466763|cochleostomy|cochleostomy
5246446|NCT02466737|axillary surgery|axillary surgery
5246447|NCT02466737|sentinel lymph node biopsy|sentinel lymph node biopsy
5246448|NCT02466711|gastric motility|gastric motility
5243952|NCT02480400|MDD|mdd
5246450|NCT02466698|Surgical Procedures, Operative|surgical procedures, operative
5246451|NCT02466685|Bipolar|bipolar
5246452|NCT02466685|Depression|depression
5246453|NCT02466685|Cognition|cognition
5246454|NCT02466685|Cognitive|cognitive
5246455|NCT02466659|IXT|ixt
5246456|NCT02466646|Periodontal Debridement|periodontal debridement
5246457|NCT02466646|Gingival Crevicular Fluid|gingival crevicular fluid
5246458|NCT02466646|Aggressive Periodontitis|aggressive periodontitis
5246459|NCT02466646|Interleukin-1beta|interleukin-1beta
5246460|NCT02466646|Interleukin-17|interleukin-17
5246461|NCT02466620|Body Weight|body weight
5246462|NCT02466620|Resuscitation|resuscitation
5246463|NCT02466620|Pediatric weight estimation|pediatric weight estimation
5246464|NCT02466607|Retinal function|retinal function
5246465|NCT02466568|advanced|advanced
5246466|NCT02466568|metastatic|metastatic
5246467|NCT02466568|lung disease|lung disease
5246468|NCT02466568|adenocarcinoma|adenocarcinoma
5246469|NCT02466568|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5246470|NCT02466542|Esmolol|esmolol
5246471|NCT02466542|Pain|pain
5246472|NCT02466542|Anesthesia|anesthesia
5246473|NCT02466542|Analgesia|analgesia
5246474|NCT02466529|type 1 spinal muscular atrophy (SMA)|type 1 spinal muscular atrophy (sma)
5246475|NCT02466516|GS-4997|gs-4997
5246476|NCT02466516|Non-alcoholic fatty liver disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5246477|NCT02466516|Fibrosis|fibrosis
5246478|NCT02466516|Simtuzumab (SIM)|simtuzumab (sim)
5246479|NCT02466516|Apoptosis signal-regulating kinase 1|apoptosis signal-regulating kinase 1
5246480|NCT02466516|ASK1 inhibitor|ask1 inhibitor
5246481|NCT02466477|Pharmacogenomic|pharmacogenomic
5246482|NCT02466477|Pharmacogenomic Testing|pharmacogenomic testing
5246483|NCT02466477|Pharmacogenomics|pharmacogenomics
5246484|NCT02466477|Genetic Testing|genetic testing
5246485|NCT02466477|Genetics|genetics
5246486|NCT02466477|Major Depressive Disorder|major depressive disorder
5246487|NCT02466477|GeneSight|genesight
5246488|NCT02466477|Enhanced GeneSight|enhanced genesight
5246489|NCT02466477|Psychotropic|psychotropic
5246490|NCT02466438|Antibiotics|antibiotics
5246491|NCT02466438|Piperacillin-tazobactam|piperacillin-tazobactam
5246492|NCT02466438|Resistant bacteria|resistant bacteria
5246493|NCT02466412|smoking|smoking
5246494|NCT02466412|nicotine absorption|nicotine absorption
5246495|NCT02466412|potential modified risk tobacco product|potential modified risk tobacco product
5246496|NCT02466412|cigarette|cigarette
5246497|NCT02466412|Carbon Heated Tobacco Product|carbon heated tobacco product
5246498|NCT02466373|clonidine|clonidine
5246499|NCT02466373|pharmacodynamics|pharmacodynamics
5246500|NCT02466373|pharmacokinetics|pharmacokinetics
5246501|NCT02466373|intensive care|intensive care
5246502|NCT02466373|delirium|delirium
5246503|NCT02466360|Non-specific chronic lower back pain|non-specific chronic lower back pain
5246504|NCT02466360|Physical activity|physical activity
5246505|NCT02466360|Self-exercises|self-exercises
5246506|NCT02466360|Brakes|brakes
5246507|NCT02466360|Levers|levers
5246508|NCT02466360|Adhesion|adhesion
5246509|NCT02466360|Self-care|self-care
5246510|NCT02466321|Inverse Reverse Shoulder|inverse reverse shoulder
5246511|NCT02466308|sustained acoustic medicine|sustained acoustic medicine
5246512|NCT02466308|therapeutic ultrasound|therapeutic ultrasound
5246513|NCT02466308|SAM|sam
5246514|NCT02466308|LITUS|litus
5246515|NCT02466269|Facial Nerve Injuries|facial nerve injuries
5246516|NCT02466256|Intraocular lens implantation|intraocular lens implantation
5246517|NCT02466243|JBT-101, lenabasum, dermatomyositis|jbt-101, lenabasum, dermatomyositis
5246518|NCT02466230|Magnetic stimulation of the brain|magnetic stimulation of the brain
5246519|NCT02466230|Antidepressant mechanisms|antidepressant mechanisms
5246520|NCT02466217|Auto-immune disease|auto-immune disease
5246521|NCT02466217|Auto-inflammatory disease|auto-inflammatory disease
5246522|NCT02466217|Omics|omics
5246523|NCT02466217|System biology|system biology
5246524|NCT02466191|nystagmus|nystagmus
5246525|NCT02466191|pharmacological trial|pharmacological trial
5246526|NCT02466191|multiple sclerosis|multiple sclerosis
5246527|NCT02466191|oscillopsia|oscillopsia
5246528|NCT02466165|cardiometabolic risk|cardiometabolic risk
5246529|NCT02466165|physical exercise|physical exercise
5246530|NCT02466152|PK|pk
5246531|NCT02466152|GSK2894512|gsk2894512
5246532|NCT02466152|Atopic Dermatitis|atopic dermatitis
5246533|NCT02466139|microbiology|microbiology
5246534|NCT02466139|c reactive protein|c reactive protein
5246535|NCT02466139|urgent cardiac surgery|urgent cardiac surgery
5246536|NCT02466126|Depression|depression
5246537|NCT02466126|brief Cognitive Behavioral Therapy (bCBT)|brief cognitive behavioral therapy (bcbt)
5246538|NCT02466126|Randomized Controlled Trial|randomized controlled trial
5246539|NCT02466074|Acetazolamide|acetazolamide
5246540|NCT02466074|Lesions|lesions
5246541|NCT02466074|Neurodegeneration|neurodegeneration
5246542|NCT02466074|Repair|repair
5246543|NCT02466061|BMI >= 30 kg/m2|bmi >= 30 kg/m2
5246544|NCT02466048|spinal fusion|spinal fusion
5246545|NCT02466048|bone graft|bone graft
5246546|NCT02466048|collagen|collagen
5246547|NCT02466009|Colorectal cancer|colorectal cancer
5246550|NCT02465996|barrier dysfunction|barrier dysfunction
5246551|NCT02465996|functional dyspepsia|functional dyspepsia
5246552|NCT02465996|Confocal Laser Endomicroscopic|confocal laser endomicroscopic
5246553|NCT02465996|therapeutic response|therapeutic response
5246554|NCT02465983|Pancreatic Cancer|pancreatic cancer
5246556|NCT02465983|T cells|t cells
5246557|NCT02465983|Immunotherapy|immunotherapy
5246558|NCT02465983|Gene therapy|gene therapy
5246559|NCT02465983|Redirected T cells|redirected t cells
5246560|NCT02465983|Autologous T cells|autologous t cells
5246561|NCT02465970|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5246562|NCT02465957|Merkel Cell Carcinoma|merkel cell carcinoma
5246563|NCT02465957|Neukoplast|neukoplast
5246564|NCT02465957|NK-92|nk-92
5246565|NCT02465957|Natural Killer Cell|natural killer cell
5246566|NCT02465957|MCC|mcc
5246567|NCT02465957|aNK|ank
5246568|NCT02465944|inflammation|inflammation
5246569|NCT02465931|Informed Consent|informed consent
5180391|NCT02862717|ESRD|esrd
5126869|NCT03201367|acute|acute
5246570|NCT02465931|Fragile X Syndrome|fragile x syndrome
5246571|NCT02465931|Tablets|tablets
5246572|NCT02465931|Decisional Capacity|decisional capacity
5246573|NCT02465892|cancer|cancer
5246574|NCT02465892|stress|stress
5246575|NCT02465892|chronic pain|chronic pain
5246576|NCT02465892|anxiety|anxiety
5246577|NCT02465892|coping|coping
5246578|NCT02465892|balance|balance
5246579|NCT02465892|online course|online course
5246580|NCT02465892|psychosocial|psychosocial
5246581|NCT02465892|support|support
5246582|NCT02465892|tools|tools
5246583|NCT02465879|Psoriatic arthritis|psoriatic arthritis
5246584|NCT02465879|Ankylosing spondylitis|ankylosing spondylitis
5246585|NCT02465879|Rheumatoid arthritis|rheumatoid arthritis
5246586|NCT02465879|Seronegative|seronegative
5246587|NCT02465866|Plasma concentration|plasma concentration
5246588|NCT02465866|Time to plasma concentration|time to plasma concentration
5246589|NCT02465866|Elimination rate constant|elimination rate constant
5246590|NCT02465866|Elimination half life|elimination half life
5246591|NCT02465866|Area under the curve|area under the curve
5246592|NCT02465853|hemiplegic shoulder pain|hemiplegic shoulder pain
5246593|NCT02465853|quality of Life|quality of life
5246594|NCT02465853|stroke|stroke
5246603|NCT02465762|non-invasive|non-invasive
5246604|NCT02465749|Retinitis Pigmentosa|retinitis pigmentosa
5246605|NCT02465749|oxygen|oxygen
5246606|NCT02465749|blue light|blue light
5246607|NCT02465723|Intravoxel Incoherent Motion (IVIM)|intravoxel incoherent motion (ivim)
5246608|NCT02465723|Diffusion-weighted Magnetic Resonance|diffusion-weighted magnetic resonance
5246609|NCT02465723|Acid Sphingomyelinase/Ceramide Pathway Activation|acid sphingomyelinase/ceramide pathway activation
5246610|NCT02465723|15-104|15-104
5246611|NCT02465710|pelvic organ prolapse|pelvic organ prolapse
5246612|NCT02465710|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
5246613|NCT02465710|transvaginal mesh surgery|transvaginal mesh surgery
5246614|NCT02465710|Women|women
5246616|NCT02465697|Borderline Personality Disorder|borderline personality disorder
5246617|NCT02465697|Avoidant Personality Disorder|avoidant personality disorder
5246618|NCT02465697|Brain Imaging|brain imaging
5246619|NCT02465658|uterine prolapse|uterine prolapse
5246620|NCT02465658|cervical elongation|cervical elongation
5246621|NCT02465658|pelvic floor reconstruction surgery|pelvic floor reconstruction surgery
5246622|NCT02465541|Cancer Survivors|cancer survivors
5246623|NCT02465541|Yoga|yoga
5246624|NCT02465541|Endometrial Cancer|endometrial cancer
5246625|NCT02465528|ALK|alk
5246626|NCT02465528|GBM|gbm
5246627|NCT02465528|hematological malignancy|hematological malignancy
5246628|NCT02465528|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5246640|NCT02465489|deferiprone extended release formulation|deferiprone extended release formulation
5246641|NCT02465489|pharmacokinetics|pharmacokinetics
5246642|NCT02465476|skin disease|skin disease
5246643|NCT02465476|telemedicine|telemedicine
5246644|NCT02465463|fecal microbiota transplant|fecal microbiota transplant
5246645|NCT02465463|probiotic|probiotic
5246646|NCT02465450|JBT-101, Lenabasum, Cystic Fibrosis|jbt-101, lenabasum, cystic fibrosis
5246647|NCT02465437|JBT-101, Lenabasum, Systemic Sclerosis|jbt-101, lenabasum, systemic sclerosis
5246648|NCT02465424|quality of life questionnaires|quality of life questionnaires
5246649|NCT02465398|Fracture shoulder arthroplasty|fracture shoulder arthroplasty
5246650|NCT02465398|Three or four part fracture|three or four part fracture
5246651|NCT02465398|Hemiarthroplasty|hemiarthroplasty
5246652|NCT02465398|Multi-center|multi-center
5246653|NCT02465398|Europe|europe
5246654|NCT02465398|Non-controlled|non-controlled
5246655|NCT02465398|Anatomical reconstruction|anatomical reconstruction
5246656|NCT02465398|Proximal|proximal
5246657|NCT02465372|Physical Activity|physical activity
5246658|NCT02465372|Youth|youth
5246659|NCT02465372|School Health|school health
5246660|NCT02465346|acute stroke|acute stroke
5246661|NCT02465346|prehospital|prehospital
5246662|NCT02465346|treatment|treatment
5246663|NCT02465333|heel|heel
5246664|NCT02465333|atrophy|atrophy
5246665|NCT02465333|fat|fat
5246666|NCT02465333|adipose tissue|adipose tissue
5246667|NCT02465333|fat pad|fat pad
5246678|NCT02465294|Probiotics|probiotics
5246679|NCT02465294|Weight loss|weight loss
5246680|NCT02465294|Body composition|body composition
5246681|NCT02465255|Acute Abdominal Pain|acute abdominal pain
5246682|NCT02465255|Sublingual Analgesia|sublingual analgesia
5246683|NCT02465255|Children|children
5246684|NCT02465255|Ketorolac|ketorolac
5246685|NCT02465255|Tramadol|tramadol
5246686|NCT02465255|Paracetamol|paracetamol
5246687|NCT02465255|Analgesia|analgesia
5246688|NCT02465216|Tuberculosis|tuberculosis
5246689|NCT02465216|TB|tb
5246690|NCT02465216|Pulmonary|pulmonary
5246691|NCT02465216|Vaccine|vaccine
5246692|NCT02465216|Adjuvant|adjuvant
5246693|NCT02465203|Hepatitis C, chronic|hepatitis c, chronic
5246694|NCT02465190|Vaccine|vaccine
5246695|NCT02465190|Effectiveness|effectiveness
5246696|NCT02465190|Influenza|influenza
5136881|NCT03136692|app|app
5246697|NCT02465177|Unhealthy alcohol use|unhealthy alcohol use
5246698|NCT02465177|ICU survivors|icu survivors
5246699|NCT02465177|Alcohol use disorder|alcohol use disorder
5246700|NCT02465177|SBIRT|sbirt
5246701|NCT02465177|Screening, brief intervention, and referral to treatment|screening, brief intervention, and referral to treatment
5246705|NCT02465021|Satiety|satiety
5246706|NCT02465021|Food intake|food intake
5246707|NCT02465021|Breakfast cereals/snacks|breakfast cereals/snacks
5246708|NCT02465021|Postprandial glycemia|postprandial glycemia
5246709|NCT02465008|postoperative|postoperative
5246710|NCT02465008|Patient-reported|patient-reported
5246711|NCT02464995|Asthma,|asthma,
5246712|NCT02464995|Asthma exacerbation|asthma exacerbation
5246713|NCT02464995|Bronchial thermoplasty|bronchial thermoplasty
5246714|NCT02464969|VTE, thromboembolism, thrombosis, embolism, apixaban, Eliquis|vte, thromboembolism, thrombosis, embolism, apixaban, eliquis
5246715|NCT02464943|Aorta|aorta
5246716|NCT02464943|Thoracic|thoracic
5246717|NCT02464943|Aortic dissection|aortic dissection
5246718|NCT02464943|Type B|type b
5246719|NCT02464943|DeBakey type III|debakey type iii
5246720|NCT02464943|Endovascular|endovascular
5246721|NCT02464930|Blood|blood
5246722|NCT02464930|Cytology|cytology
5246723|NCT02464930|Esophagus|esophagus
5246724|NCT02464930|microRNA|microrna
5246725|NCT02464891|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5246726|NCT02464891|CCX168|ccx168
5246727|NCT02464891|dialysis|dialysis
5246728|NCT02464891|C5aR antagonist|c5ar antagonist
5246729|NCT02464865|thiamine deficiency|thiamine deficiency
5246732|NCT02464839|Fungal nails and feet infection|fungal nails and feet infection
5246733|NCT02464839|Onychomycosis|onychomycosis
5246734|NCT02464839|Hallux valgus|hallux valgus
5246735|NCT02464826|Onychomycosis|onychomycosis
5246736|NCT02464826|Chronic paronychia|chronic paronychia
5246737|NCT02464826|Treatment|treatment
5246738|NCT02464813|pregabalin|pregabalin
5246739|NCT02464813|idiopathic scoliosis|idiopathic scoliosis
5246740|NCT02464800|diabetic retinopathy|diabetic retinopathy
5246741|NCT02464787|antioxidants|antioxidants
5246742|NCT02464787|carotenoids|carotenoids
5246743|NCT02464787|diet|diet
5246744|NCT02464774|Breast Cancer|breast cancer
5246745|NCT02464774|Triple-Negative Breast Cancer|triple-negative breast cancer
5246746|NCT02464774|Breast-Conserving Therapy|breast-conserving therapy
5246747|NCT02464774|Mastectomy|mastectomy
5246748|NCT02464774|Recurrence|recurrence
5246749|NCT02464735|Sleep disruption|sleep disruption
5246750|NCT02464735|Spontaneous breathing trial|spontaneous breathing trial
5246751|NCT02464735|Weaning|weaning
5246752|NCT02464722|Remifentanil|remifentanil
5246753|NCT02464722|Dexmedetomidine|dexmedetomidine
5246754|NCT02464722|Endoscopic sinus surgery|endoscopic sinus surgery
5246755|NCT02464709|Actinic Keratosis|actinic keratosis
5246756|NCT02464709|Photodynamic Therapy|photodynamic therapy
5246757|NCT02464709|Natural Daylight|natural daylight
5246758|NCT02464696|Hematological Malignancies|hematological malignancies
5246759|NCT02464696|Hypoxemic Respiratory Failure|hypoxemic respiratory failure
5246760|NCT02464696|Blood cancer|blood cancer
5246761|NCT02464696|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5246762|NCT02464696|NIPPV|nippv
5246763|NCT02464696|High flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
5246764|NCT02464670|Ebola|ebola
5246765|NCT02464670|Vaccine|vaccine
5246766|NCT02464657|Leukemia|leukemia
5246767|NCT02464657|Acute myeloid leukemia|acute myeloid leukemia
5246768|NCT02464657|AML|aml
5246769|NCT02464657|Myelodysplastic Syndrome|myelodysplastic syndrome
5246770|NCT02464657|MDS|mds
5246771|NCT02464657|High-risk|high-risk
5246772|NCT02464657|Nivolumab|nivolumab
5246773|NCT02464657|BMS-936558|bms-936558
5246774|NCT02464657|Opdivo|opdivo
5246775|NCT02464657|Idarubicin|idarubicin
5246776|NCT02464657|Idamycin|idamycin
5246777|NCT02464657|Cytarabine|cytarabine
5246778|NCT02464657|Ara-C|ara-c
5246779|NCT02464657|Cytosar|cytosar
5246780|NCT02464657|DepoCyt|depocyt
5246781|NCT02464657|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5246782|NCT02464657|Solu-Medrol|solu-medrol
5246783|NCT02464657|Methylprednisolone|methylprednisolone
5246784|NCT02464657|Depo-Medrol|depo-medrol
5246785|NCT02464657|Medrol|medrol
5246786|NCT02464657|Dexamethasone|dexamethasone
5246787|NCT02464657|Decadron|decadron
5246788|NCT02464644|On-line Questionnaire|on-line questionnaire
5246789|NCT02464644|No travel|no travel
5246790|NCT02464644|Health|health
5246791|NCT02464644|Medicines|medicines
5246792|NCT02464644|Drugs|drugs
5246793|NCT02464644|Lifestyle|lifestyle
5246794|NCT02464644|Family|family
5246795|NCT02464644|Help for others|help for others
5246796|NCT02464644|Rare condition|rare condition
5246797|NCT02464644|General population|general population
5246798|NCT02464618|Colonoscopy|colonoscopy
5246799|NCT02464618|Upper endoscopy|upper endoscopy
5246800|NCT02464618|Adherence|adherence
5246801|NCT02464618|Disparities|disparities
5246802|NCT02464592|Cryoprobes|cryoprobes
5246803|NCT02464592|Transbronchial lung biopsy|transbronchial lung biopsy
5246804|NCT02464592|Cryobiopsy|cryobiopsy
5246805|NCT02464579|breastfeeding rate|breastfeeding rate
5246806|NCT02464579|preterm infant|preterm infant
5246807|NCT02464579|neonatal intensive care unit|neonatal intensive care unit
5246808|NCT02464553|Low Back Pain Pain|low back pain pain
5246809|NCT02464553|Periradicular therapy|periradicular therapy
5246810|NCT02464553|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
5246813|NCT02464527|Stimulus-stimulus pairing|stimulus-stimulus pairing
5246814|NCT02464514|Obesity|obesity
5246815|NCT02464514|Orexigen|orexigen
5246816|NCT02464514|Insulin|insulin
5246817|NCT02464514|Leptin|leptin
5246818|NCT02464514|Adiponectin|adiponectin
5246819|NCT02464514|Growth hormone replacement|growth hormone replacement
5246821|NCT02464501|COPPER-A|copper-a
5246822|NCT02464501|Peripheral Arterial Disease|peripheral arterial disease
5246823|NCT02464501|OPC|opc
5246824|NCT02464501|Occlusion Perfusion Catheter|occlusion perfusion catheter
5246825|NCT02464501|Paclitaxel|paclitaxel
5246826|NCT02464501|Pressana|pressana
5246827|NCT02464501|Precision Delivery System|precision delivery system
5246828|NCT02464488|Anticoagulants|anticoagulants
5246829|NCT02464488|Factor Xa Inhibitors|factor xa inhibitors
5246830|NCT02464488|Antithrombins|antithrombins
5246831|NCT02464488|Pharmacokinetics|pharmacokinetics
5246832|NCT02464488|Aged, 80 years and older|aged, 80 years and older
5246833|NCT02464475|osteopathic manipulative treatment|osteopathic manipulative treatment
5246834|NCT02464475|interoception|interoception
5246835|NCT02464462|serum calcidiol|serum calcidiol
5246836|NCT02464462|T2DM|t2dm
5246837|NCT02464462|vitamin D3 supplementation|vitamin d3 supplementation
5246838|NCT02464462|post-menopausal women|post-menopausal women
5246839|NCT02464462|ethnic diverse|ethnic diverse
5246840|NCT02464462|calcium supplementation|calcium supplementation
5246841|NCT02464449|Cognitive Behavioral Therapy|cognitive behavioral therapy
5246842|NCT02464449|Mobile Health Technology|mobile health technology
5246843|NCT02464449|Patient Care Management|patient care management
5246845|NCT02464410|Opioid analgesics|opioid analgesics
5246846|NCT02464410|Primary care|primary care
5246847|NCT02464410|Veterans|veterans
5246848|NCT02464410|Motivational interviewing|motivational interviewing
5246849|NCT02464410|Cognitive behavioral therapy|cognitive behavioral therapy
5246850|NCT02464410|Self-efficacy|self-efficacy
5246851|NCT02464410|Behavioral symptoms|behavioral symptoms
5246852|NCT02464410|Injuries|injuries
5246853|NCT02464410|Opioid Safety|opioid safety
5246854|NCT02464397|Vascular healing of coronary stents in patients with acute coronary syndrome|vascular healing of coronary stents in patients with acute coronary syndrome
5246855|NCT02464384|ultrasound and cartilage biodegradation markers|ultrasound and cartilage biodegradation markers
5246856|NCT02464371|muscle weakness|muscle weakness
5246857|NCT02464371|microRNAs|micrornas
5246858|NCT02464371|septic shock|septic shock
5246859|NCT02464358|HPV|hpv
5246860|NCT02464345|BED|bed
5246861|NCT02464345|Binge Eating Disorer|binge eating disorer
5246862|NCT02464345|BN|bn
5246863|NCT02464345|Bulimia Nervosa|bulimia nervosa
5246864|NCT02464345|Obesity|obesity
5246865|NCT02464332|soft tissue sarcoma|soft tissue sarcoma
5246866|NCT02464332|BLZ-100|blz-100
5246867|NCT02464332|Tumor Paint|tumor paint
5246868|NCT02464306|recipients|recipients
5246869|NCT02464293|depression|depression
5246870|NCT02464293|anxiety|anxiety
5246871|NCT02464293|stress|stress
5246872|NCT02464280|Tomosynthesis|tomosynthesis
5246873|NCT02464280|osteosynthetic implant|osteosynthetic implant
5246874|NCT02464280|CT|ct
5246875|NCT02464280|monitoring|monitoring
5246876|NCT02464267|patient reported outcome instrument|patient reported outcome instrument
5246877|NCT02464254|Physical activity, positive affect, older adults, aging|physical activity, positive affect, older adults, aging
5246878|NCT02464228|PTCL|ptcl
5246879|NCT02464228|Lymphoma|lymphoma
5246880|NCT02464228|AITL|aitl
5246881|NCT02464215|gastric cancer|gastric cancer
5246882|NCT02464215|D2|d2
5246883|NCT02464215|laparoscopic|laparoscopic
5246884|NCT02464215|open|open
5246885|NCT02464215|surgery|surgery
5246886|NCT02464202|Tooth autotransplantation|tooth autotransplantation
5246887|NCT02464202|stereolithography tooth replica|stereolithography tooth replica
5246888|NCT02464202|CBCT|cbct
5246889|NCT02464202|Outcome|outcome
5246890|NCT02464176|Arthroplasty, Hip, Replacement|arthroplasty, hip, replacement
5246891|NCT02464176|Anesthesia, Local|anesthesia, local
5246892|NCT02464176|Anesthesia Conduction|anesthesia conduction
5246893|NCT02464176|Bupivacaine|bupivacaine
5246894|NCT02464176|Dexamethasone|dexamethasone
5246895|NCT02464176|Preanesthetic Medications|preanesthetic medications
5246896|NCT02464176|Nerve Block|nerve block
5246897|NCT02464176|Lumbar Plexus Block|lumbar plexus block
5246898|NCT02464176|Analgesia|analgesia
5246899|NCT02464176|Glucocorticoids|glucocorticoids
5246900|NCT02464176|Local Anesthetics|local anesthetics
5246901|NCT02464163|Influenza|influenza
5246902|NCT02464150|gluten|gluten
5246903|NCT02464150|antigen-specific T cells|antigen-specific t cells
5246904|NCT02464150|transcriptome|transcriptome
5246905|NCT02464098|Hematological Malignancies|hematological malignancies
5246906|NCT02464098|Solid Tumors|solid tumors
5246907|NCT02464098|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5246908|NCT02464098|Childhood Cancer|childhood cancer
5246909|NCT02464098|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5246910|NCT02464085|Stroke|stroke
5246911|NCT02464085|Upper limb|upper limb
5246912|NCT02464085|Neuroplastic change|neuroplastic change
5246913|NCT02464085|Longitudinal|longitudinal
5246914|NCT02464085|Function|function
5246915|NCT02464072|Parathyroidectomy|parathyroidectomy
5246916|NCT02464072|Renal Insufficiency, Chronic|renal insufficiency, chronic
5246917|NCT02464059|cathelicidin|cathelicidin
5246919|NCT02464046|Insomnia|insomnia
5246920|NCT02464046|JNJ-42847922|jnj-42847922
5246921|NCT02464046|Placebo|placebo
5246922|NCT02464033|Diamyd|diamyd
5246923|NCT02464033|Diabetes|diabetes
5246924|NCT02464033|Juvenile Diabetes|juvenile diabetes
5246925|NCT02464033|Diabetes Type 1|diabetes type 1
5246926|NCT02464033|Type 1 Diabetes|type 1 diabetes
5246927|NCT02464033|Autoimmune Diabetes|autoimmune diabetes
5246928|NCT02464033|Insulin Dependent Diabetes|insulin dependent diabetes
5246929|NCT02464033|Type 1 Diabetes MellitusType 1 Diabetes Mellitus|type 1 diabetes mellitustype 1 diabetes mellitus
5246930|NCT02464033|rhGAD65|rhgad65
5246931|NCT02464033|GAD65|gad65
5246932|NCT02464033|GAD-Alum|gad-alum
5246933|NCT02464033|Diabetes Mellitus|diabetes mellitus
5246934|NCT02464033|Diabetes mellitus Type 1|diabetes mellitus type 1
5246935|NCT02464033|Glucose Metabolism Disorders|glucose metabolism disorders
5246936|NCT02464033|Metabolic Diseases|metabolic diseases
5246937|NCT02464033|Vitamin D|vitamin d
5246938|NCT02464033|Etanercept|etanercept
5246939|NCT02463955|flexible endoscopy|flexible endoscopy
5246940|NCT02463929|Diphenhydramine|diphenhydramine
5234784|NCT02534857|IVF treatment|ivf treatment
5234785|NCT02534857|brief incubation of oocytes and sperm|brief incubation of oocytes and sperm
5234801|NCT02534701|clot retrieval system|clot retrieval system
5234802|NCT02534701|recanalization|recanalization
5234803|NCT02534649|Molecular profiling|molecular profiling
5234804|NCT02534649|Genomic alteration|genomic alteration
5234805|NCT02534649|Advanced cancer|advanced cancer
5234806|NCT02534610|preemptive|preemptive
5234807|NCT02534610|postoperative pain|postoperative pain
5234808|NCT02534610|etoricoxib|etoricoxib
5234809|NCT02534584|acute kidney injury|acute kidney injury
5234810|NCT02534584|outcome|outcome
5234811|NCT02534584|mortality|mortality
5234812|NCT02534584|care-bundle|care-bundle
5246941|NCT02463929|emergence agitation|emergence agitation
5246942|NCT02463929|pediatric anesthesia|pediatric anesthesia
5246943|NCT02463929|PAEDS|paeds
5246944|NCT02463929|Withdrawal|withdrawal
5246945|NCT02463903|Adaptation, Psychological|adaptation, psychological
5246946|NCT02463903|Heart Failure|heart failure
5246947|NCT02463903|Intervention Studies|intervention studies
5246948|NCT02463903|Quality of Life|quality of life
5246949|NCT02463903|Hospital Readmission|hospital readmission
5246950|NCT02463903|Depression|depression
5246951|NCT02463903|Anxiety|anxiety
5246952|NCT02463890|Sleep Apnea Syndromes|sleep apnea syndromes
5246953|NCT02463890|Sleep Apnea, Obstructives|sleep apnea, obstructives
5246954|NCT02463890|Training|training
5246955|NCT02463864|frailty|frailty
5246956|NCT02463864|older adult|older adult
5246957|NCT02463864|hospital|hospital
5246958|NCT02463864|exercise|exercise
5246959|NCT02463864|randomised control trial|randomised control trial
5246960|NCT02463864|functional decline|functional decline
5246961|NCT02463851|Ablation|ablation
5246962|NCT02463851|Multi-electrode catheter PVAC|multi-electrode catheter pvac
5246963|NCT02463851|Single-tip catheter Contact Force|single-tip catheter contact force
5246964|NCT02463851|Holter|holter
5246965|NCT02463838|Medi-Cal|medi-cal
5246966|NCT02463838|Health Plan|health plan
5246967|NCT02463838|Frequent Users|frequent users
5246968|NCT02463838|Heavy users|heavy users
5246969|NCT02463838|Care Coordination|care coordination
5246970|NCT02463838|Managed Care|managed care
5246971|NCT02463838|Case Management|case management
5246972|NCT02463838|Mental Health|mental health
5246973|NCT02463838|Substance Use|substance use
5246975|NCT02463799|prostatic neoplasms|prostatic neoplasms
5246976|NCT02463799|castration-resistant|castration-resistant
5246977|NCT02463799|bone metastasis|bone metastasis
5246978|NCT02463799|radium-223|radium-223
5246979|NCT02463799|sipuleucel-T|sipuleucel-t
5246980|NCT02463773|ARDS, PEEP, Critical Care Ultrasound|ards, peep, critical care ultrasound
5246981|NCT02463747|Neutropenic fever|neutropenic fever
5246982|NCT02463747|extended infusion|extended infusion
5246983|NCT02463747|beta-lactam|beta-lactam
5246984|NCT02463747|empiric antibiotic treatment|empiric antibiotic treatment
5246985|NCT02463721|sbp|sbp
5246986|NCT02463721|culture|culture
5246987|NCT02463708|Care Giver|care giver
5246988|NCT02463708|Dementia|dementia
5246989|NCT02463695|partial vestibular deficit|partial vestibular deficit
5246990|NCT02463695|cortical vestibular evoked potential|cortical vestibular evoked potential
5246991|NCT02463682|Artificial Pancreas|artificial pancreas
5246992|NCT02463682|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5246993|NCT02463682|Autoimmune Diseases|autoimmune diseases
5246994|NCT02463682|Diabetes Mellitus|diabetes mellitus
5246995|NCT02463682|Endocrine System Diseases|endocrine system diseases
5246996|NCT02463682|Glucose Metabolism Disorders|glucose metabolism disorders
5246997|NCT02463682|Immune System Diseases|immune system diseases
5246998|NCT02463682|Metabolic Diseases|metabolic diseases
5246999|NCT02463669|Point-of-care ultrasound|point-of-care ultrasound
5247000|NCT02463630|basilar invagination|basilar invagination
5247001|NCT02463630|atlantoaxial dislocation|atlantoaxial dislocation
5247002|NCT02463630|surgery|surgery
5142013|NCT03103685|Dental procedure|dental procedure
5247003|NCT02463630|restoration technique|restoration technique
5247004|NCT02463591|Direct Thrombin Inhibitor|direct thrombin inhibitor
5247005|NCT02463591|Prothrombin Complex Concentrate|prothrombin complex concentrate
5247006|NCT02463591|Dabigatran Etexilate|dabigatran etexilate
5247007|NCT02463591|Beriplex|beriplex
5247008|NCT02463591|Shed Blood|shed blood
5247009|NCT02463591|Washed Blood|washed blood
5247010|NCT02463591|Fibrinopeptide A|fibrinopeptide a
5247011|NCT02463578|Pneumococcal infection|pneumococcal infection
5247012|NCT02463578|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
5247013|NCT02463578|Pneumococcal vaccine|pneumococcal vaccine
5247014|NCT02463578|Vaccinology|vaccinology
5247015|NCT02463578|Immunocompromised|immunocompromised
5247016|NCT02463578|Auto-immune diseases|auto-immune diseases
5247017|NCT02463578|Systemic vasculitis|systemic vasculitis
5247018|NCT02463578|ANCA-associated vasculitis|anca-associated vasculitis
5247019|NCT02463565|nutritional assessment|nutritional assessment
5247020|NCT02463565|food survey|food survey
5247021|NCT02463565|hospitalized patients|hospitalized patients
5247022|NCT02463565|hospital food|hospital food
5247023|NCT02463539|Pneumococcal infection|pneumococcal infection
5247024|NCT02463539|Invasive pneumococcal disease (IPD)|invasive pneumococcal disease (ipd)
5247025|NCT02463539|Pneumococcal vaccine|pneumococcal vaccine
5247026|NCT02463539|Systemic vasculitis|systemic vasculitis
5247027|NCT02463539|ANCA-associated vasculitis|anca-associated vasculitis
5247028|NCT02463539|Vaccinology|vaccinology
5247029|NCT02463539|Immunocompromised|immunocompromised
5247030|NCT02463539|Auto-immune disease|auto-immune disease
5247136|NCT02462772|long-acting injectable|long-acting injectable
5247031|NCT02463526|Shoulder Impingement Syndrome|shoulder impingement syndrome
5247032|NCT02463526|Mulligan's Mobilization with Movement|mulligan's mobilization with movement
5247033|NCT02463526|Physical Therapy|physical therapy
5247034|NCT02463513|Riboflavin|riboflavin
5247035|NCT02463513|Blood pressure|blood pressure
5247036|NCT02463513|MTHFR|mthfr
5247037|NCT02463513|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
5247038|NCT02463448|Underactive Bladder|underactive bladder
5247039|NCT02463435|nutritional management|nutritional management
5247040|NCT02463435|olive oil|olive oil
5247041|NCT02463435|weight loss|weight loss
5247042|NCT02463435|body composition|body composition
5247043|NCT02463435|nutrigenomics|nutrigenomics
5247044|NCT02463435|polymorphisms|polymorphisms
5247045|NCT02463435|cardiovascular risk|cardiovascular risk
5247046|NCT02463435|sarcopenia|sarcopenia
5247047|NCT02463435|inflammation|inflammation
5247048|NCT02463435|food intake|food intake
5247049|NCT02463435|sedentary lifestyle|sedentary lifestyle
5247050|NCT02463435|patient adherence|patient adherence
5247051|NCT02463435|bone density|bone density
5247052|NCT02463396|MBCT|mbct
5247053|NCT02463396|Mindfulness|mindfulness
5247054|NCT02463396|ADHD|adhd
5247055|NCT02463383|PPAR-gamma|ppar-gamma
5247056|NCT02463383|estrogens|estrogens
5247057|NCT02463383|NSAIDS|nsaids
5247058|NCT02463383|polymorphism|polymorphism
5247059|NCT02463383|metabolomics|metabolomics
5247060|NCT02463357|Exercise, Aerobic|exercise, aerobic
5247061|NCT02463357|Cognitive Function|cognitive function
5247062|NCT02463344|Dry AMD|dry amd
5247063|NCT02463344|Geographic atrophy|geographic atrophy
5247064|NCT02463344|ASP7316|asp7316
5247065|NCT02463331|autoimmune hepatitis|autoimmune hepatitis
5247066|NCT02463331|chloroquine|chloroquine
5247067|NCT02463331|treatment|treatment
5244543|NCT02476955|Chemotherapy|chemotherapy
5247068|NCT02463318|Multiple sclerosis|multiple sclerosis
5247070|NCT02463318|MnSOD|mnsod
5247071|NCT02463318|Catalase|catalase
5247072|NCT02463318|Oxidative stress|oxidative stress
5247073|NCT02463318|Antioxidant enzyme|antioxidant enzyme
5247074|NCT02463305|Colitis, ulcerative|colitis, ulcerative
5247075|NCT02463305|Inflammatory bowel diseases|inflammatory bowel diseases
5247076|NCT02463292|quality of life|quality of life
5247077|NCT02463292|young adults|young adults
5247078|NCT02463292|congenital heart disease|congenital heart disease
5247079|NCT02463266|Primary Care|primary care
5247080|NCT02463266|Elderly|elderly
5247081|NCT02463266|Depression|depression
5247082|NCT02463253|Renal Biopsy|renal biopsy
5247083|NCT02463253|elevated serum creatinine|elevated serum creatinine
5247084|NCT02463253|proteinuria|proteinuria
5247085|NCT02463201|Sleep Apnea, Obstructive|sleep apnea, obstructive
5247086|NCT02463201|Pediatric Obesity|pediatric obesity
5247087|NCT02463188|Sleep|sleep
5247088|NCT02463188|Substance Use|substance use
5247089|NCT02463188|Adolescents|adolescents
5247090|NCT02463175|Fluid Therapy;|fluid therapy;
5247091|NCT02463175|Transesophageal Doppler|transesophageal doppler
5247092|NCT02463149|School health|school health
5247093|NCT02463136|Adolescence|adolescence
5247094|NCT02463136|Brain Development|brain development
5247095|NCT02463136|Neuroimaging|neuroimaging
5247096|NCT02463136|Neurofeedback|neurofeedback
5247097|NCT02463136|Anxiety|anxiety
5247098|NCT02463110|Acute Coronary Syndrome|acute coronary syndrome
5247099|NCT02463110|Depression|depression
5247100|NCT02463110|Coronary Artery Disease|coronary artery disease
5247101|NCT02463110|Myocardial Infarction|myocardial infarction
5247102|NCT02463110|Percutaneous Coronary Intervention|percutaneous coronary intervention
5247103|NCT02463019|hepatitis B virus|hepatitis b virus
5247104|NCT02463019|tenofovir|tenofovir
5247105|NCT02462967|Liver Cirrhosis|liver cirrhosis
5247106|NCT02462954|Contraception|contraception
5247107|NCT02462954|Vaginal Gel|vaginal gel
5247108|NCT02462954|Diaphragm|diaphragm
5234993|NCT02533648|mitochondrial dysfunction|mitochondrial dysfunction
5234994|NCT02533648|skeletal muscle|skeletal muscle
5234995|NCT02533648|xanthine oxidase|xanthine oxidase
5234996|NCT02533648|allopurinol|allopurinol
5247109|NCT02462941|Heart transplant|heart transplant
5247110|NCT02462941|Adenosine|adenosine
5247111|NCT02462941|Pediatrics|pediatrics
5247112|NCT02462863|Diabetes|diabetes
5247113|NCT02462863|fish oil|fish oil
5247114|NCT02462863|arginine|arginine
5247115|NCT02462863|hyperglycemia|hyperglycemia
5247116|NCT02462850|Pain|pain
5247117|NCT02462850|Nausea|nausea
5247118|NCT02462850|Vomiting|vomiting
5247119|NCT02462837|Ureteral Stents|ureteral stents
5247120|NCT02462837|Pain and Discomfort|pain and discomfort
5247121|NCT02462837|Bladder Storage Symptoms|bladder storage symptoms
5247122|NCT02462824|Peripheral Artery Disease|peripheral artery disease
5247123|NCT02462824|Peripheral Arterial Disease|peripheral arterial disease
5247125|NCT02462811|Pain|pain
5247126|NCT02462811|Nausea|nausea
5247127|NCT02462811|Vomiting|vomiting
5247128|NCT02462785|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5247129|NCT02462785|Adolescents|adolescents
5247130|NCT02462785|Carbohydrate Counting|carbohydrate counting
5247131|NCT02462785|Glycemic Control|glycemic control
5247132|NCT02462785|Self-Management|self-management
5247133|NCT02462785|T1DM|t1dm
5247134|NCT02462772|Cabotegravir|cabotegravir
5247135|NCT02462772|safety|safety
5247237|NCT02462239|PET imaging|pet imaging
5247137|NCT02462772|HIV prevention|hiv prevention
5247138|NCT02462772|acceptability|acceptability
5247140|NCT02462759|SMA|sma
5247141|NCT02462746|Postpartum|postpartum
5247142|NCT02462746|Dietary Supplements|dietary supplements
5247143|NCT02462746|Breastfeeding Women|breastfeeding women
5247144|NCT02462733|Self-control|self-control
5247145|NCT02462733|Preschoolers|preschoolers
5247146|NCT02462733|Tools of the Mind|tools of the mind
5247147|NCT02462733|Playing to Learn|playing to learn
5247148|NCT02462681|ketamine|ketamine
5247149|NCT02462681|adjuvant|adjuvant
5247150|NCT02462681|paravertebral block|paravertebral block
5247151|NCT02462668|Bronchoscopy|bronchoscopy
5247152|NCT02462668|Intubation|intubation
5247153|NCT02462668|Noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5247154|NCT02462642|Brahmi, Cognition, Anxiety, Pharmacokinetics|brahmi, cognition, anxiety, pharmacokinetics
5247155|NCT02462629|central nervous system tumor|central nervous system tumor
5247156|NCT02462629|BLZ-100|blz-100
5247157|NCT02462629|pediatrics|pediatrics
5247158|NCT02462629|Tumor Paint|tumor paint
5247159|NCT02462629|brain cancer|brain cancer
5247160|NCT02462629|tozuleristide|tozuleristide
5247161|NCT02462616|risk analysis|risk analysis
5247162|NCT02462616|general Chinese population|general chinese population
5247163|NCT02462616|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5247164|NCT02462603|Parkinson's Disease|parkinson's disease
5247165|NCT02462603|PD|pd
5247166|NCT02462603|EPI-589|epi-589
5247167|NCT02462603|EPI589|epi589
5247168|NCT02462590|Probiotics|probiotics
5244655|NCT02476266|balance|balance
5247183|NCT02462512|Elastography|elastography
5247184|NCT02462512|Thyroid nodule|thyroid nodule
5247185|NCT02462473|Schizophrenia|schizophrenia
5247186|NCT02462473|Schizoaffective Disorder|schizoaffective disorder
5247187|NCT02462473|Aripiprazole|aripiprazole
5247188|NCT02462473|Olanzapine|olanzapine
5247189|NCT02462473|Paliperidone|paliperidone
5247190|NCT02462473|Quetiapine|quetiapine
5247191|NCT02462473|Risperidone|risperidone
5247192|NCT02462473|Liquid Chromatography-Tandem Mass Spectrometry|liquid chromatography-tandem mass spectrometry
5247193|NCT02462460|Breast MRI|breast mri
5247194|NCT02462460|T1 weighted and diffusion weighted MR|t1 weighted and diffusion weighted mr
5247195|NCT02462460|screening pancreatic|screening pancreatic
5247196|NCT02462460|screening ovarian|screening ovarian
5247197|NCT02462460|15-120|15-120
5247198|NCT02462447|prostate|prostate
5247199|NCT02462447|cancer|cancer
5247200|NCT02462447|biopsy|biopsy
5247201|NCT02462447|PET|pet
5235078|NCT02533102|Healthy Subjects|healthy subjects
5247202|NCT02462434|Pediatric palliative care|pediatric palliative care
5247203|NCT02462421|SGLT2|sglt2
5247204|NCT02462421|SLC5A2|slc5a2
5247205|NCT02462421|SLC5A4|slc5a4
5247206|NCT02462421|SLC5A9|slc5a9
5247207|NCT02462421|SLC2A9|slc2a9
5247208|NCT02462421|GLUT9|glut9
5247209|NCT02462421|SGLT3|sglt3
5247210|NCT02462421|SGLT4|sglt4
5247211|NCT02462421|pharmacogenomics|pharmacogenomics
5247212|NCT02462356|CVATS|cvats
5247213|NCT02462356|UVATS|uvats
5247214|NCT02462356|perioperative effect|perioperative effect
5247215|NCT02462356|ergonomic influence|ergonomic influence
5247216|NCT02462330|Mesenchymal stem cells|mesenchymal stem cells
5247217|NCT02462330|ischemic cardiomyopathy|ischemic cardiomyopathy
5247218|NCT02462330|NogaStar XP system catheter|nogastar xp system catheter
5247219|NCT02462317|Spasticity|spasticity
5247220|NCT02462317|Post stroke motor recovery|post stroke motor recovery
5247222|NCT02462317|Baclofen|baclofen
5247223|NCT02462317|Pharmacological modulation|pharmacological modulation
5247224|NCT02462304|Diabetic Macula Edema|diabetic macula edema
5247225|NCT02462304|End-Point-Management|end-point-management
5247226|NCT02462304|ranibizumab|ranibizumab
5247227|NCT02462304|bevacizumab|bevacizumab
5247228|NCT02462291|Neurological Disorders|neurological disorders
5247229|NCT02462291|Non Pharmacological Treatment|non pharmacological treatment
5247230|NCT02462291|Ecological Therapy|ecological therapy
5247231|NCT02462278|Fertility|fertility
5247232|NCT02462278|Continuous temperature monitor|continuous temperature monitor
5247233|NCT02462278|Basal Body Temperature|basal body temperature
5247234|NCT02462278|Natural family planning|natural family planning
5247235|NCT02462239|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
5247236|NCT02462239|Bladder cancer|bladder cancer
5247238|NCT02462239|FDG|fdg
5247239|NCT02462213|Cardiac amyloidosis|cardiac amyloidosis
5247240|NCT02462213|Cardiac MRI|cardiac mri
5247241|NCT02462213|Infiltrative cardiomyopathies|infiltrative cardiomyopathies
5247242|NCT02462187|genital warts|genital warts
5247243|NCT02462187|perianal warts|perianal warts
5247244|NCT02462174|anesthesia|anesthesia
5247245|NCT02462174|analgesia|analgesia
5247246|NCT02462174|caudal|caudal
5247247|NCT02462174|ketamine|ketamine
5247248|NCT02462174|bupivacaine|bupivacaine
5247249|NCT02462148|Anesthesia|anesthesia
5247250|NCT02462148|Anesthesia, Conduction|anesthesia, conduction
5247251|NCT02462148|Anesthesia, Local|anesthesia, local
5247252|NCT02462148|Bupivacaine|bupivacaine
5247253|NCT02462148|Dexamethasone|dexamethasone
5247255|NCT02462148|Adductor Canal|adductor canal
5247256|NCT02462148|Nerve Block|nerve block
5247257|NCT02462148|Analgesia|analgesia
5247258|NCT02462148|Preanesthetic Medication|preanesthetic medication
5247259|NCT02462148|Perioperative Period|perioperative period
5247260|NCT02462148|Peripheral Nerve Block|peripheral nerve block
5247261|NCT02462135|Mild cognitive impairment|mild cognitive impairment
5247262|NCT02462135|Memory training|memory training
5247263|NCT02462135|Randomized controlled study|randomized controlled study
5247264|NCT02462044|Computed tomography|computed tomography
5247265|NCT02462044|Coronary CTA|coronary cta
5247266|NCT02462044|Contrast media|contrast media
5247267|NCT02462018|Cerebral Palsy|cerebral palsy
5247268|NCT02462018|Muscle Spasticity|muscle spasticity
5247269|NCT02462018|Orthoses|orthoses
5247270|NCT02462018|Functional Electrical Stimulation|functional electrical stimulation
5247271|NCT02462018|Prospective|prospective
5247272|NCT02461992|FVIII activity|fviii activity
5247273|NCT02461953|hemodialysis|hemodialysis
5247274|NCT02461953|hemoperfusion|hemoperfusion
5247275|NCT02461953|quality of life|quality of life
5247276|NCT02461940|Sexual behavior|sexual behavior
5247277|NCT02461940|condom use|condom use
5247278|NCT02461940|secondary abstinence|secondary abstinence
5247279|NCT02461914|Type 2 diabetes mellitus|type 2 diabetes mellitus
5247280|NCT02461901|clostridium difficile|clostridium difficile
5247281|NCT02461901|environment|environment
5247282|NCT02461901|contamination|contamination
5247283|NCT02461901|fidaxomicin|fidaxomicin
5247284|NCT02461888|Relapsed|relapsed
5247285|NCT02461888|Refractory|refractory
5247286|NCT02461888|Cyclophosphamide|cyclophosphamide
5247287|NCT02461888|Dexamethasone|dexamethasone
5247288|NCT02461875|OHSS|ohss
5247289|NCT02461875|Infertility|infertility
5247290|NCT02461875|Cabergoline|cabergoline
5247291|NCT02461875|GnRH antagonist|gnrh antagonist
5247292|NCT02461875|IVF-ET|ivf-et
5247293|NCT02461862|Contraception|contraception
5247294|NCT02461862|Contraception Behavior|contraception behavior
5247295|NCT02461862|Intra uterine device|intra uterine device
5247296|NCT02461862|Intra uterine System|intra uterine system
5247297|NCT02461862|IUD|iud
5247298|NCT02461862|IUS|ius
5247299|NCT02461862|Acute Pain|acute pain
5247300|NCT02461771|AMD|amd
5247301|NCT02461771|Wet AMD|wet amd
5247302|NCT02461771|Neovascular AMD|neovascular amd
5343862|NCT01977157|alcohol|alcohol
5235175|NCT02532426|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5235176|NCT02532426|Muscle biopsy|muscle biopsy
5235177|NCT02532426|Chronic hypoxia|chronic hypoxia
5235178|NCT02532426|OXYPHEN|oxyphen
5235179|NCT02532426|Oxydative phenotype|oxydative phenotype
5235180|NCT02532426|Exercise|exercise
5235190|NCT02532361|Sterilization|sterilization
5247303|NCT02461745|VIEKIRA PAK|viekira pak
5247304|NCT02461732|posttraumatic stress disorder|posttraumatic stress disorder
5247305|NCT02461732|PTSD|ptsd
5247306|NCT02461732|substance dependence|substance dependence
5247307|NCT02461732|substance use|substance use
5247308|NCT02461706|Drug resistant epilepsy|drug resistant epilepsy
5247309|NCT02461693|Vigilance|vigilance
5247310|NCT02461693|Mood|mood
5247311|NCT02461693|Randomized Controlled Trial|randomized controlled trial
5247312|NCT02461693|Probability|probability
5247313|NCT02461680|partial section of the flexor tendons|partial section of the flexor tendons
5247314|NCT02461667|alendronate, metformin|alendronate, metformin
5247315|NCT02461641|amniotic tissue|amniotic tissue
5247316|NCT02461641|diabetic foot ulcer|diabetic foot ulcer
5247317|NCT02461641|Affinity|affinity
5247318|NCT02461641|NuShield|nushield
5247319|NCT02461628|Malaria|malaria
5247320|NCT02461628|Antimalarial subsidy|antimalarial subsidy
5247321|NCT02461628|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
5247322|NCT02461628|Public-private partnership|public-private partnership
5247323|NCT02461628|Community health workers|community health workers
5247324|NCT02461615|Pulmonary Surfactant|pulmonary surfactant
5247325|NCT02461615|Rare Lung Disease|rare lung disease
5247326|NCT02461615|Registry|registry
5247327|NCT02461602|Warfarin|warfarin
5247328|NCT02461576|HIV-1|hiv-1
5247329|NCT02461550|Irreversible Electroporation Ablation|irreversible electroporation ablation
5247330|NCT02461550|15-001|15-001
5247331|NCT02461498|Warfarin|warfarin
5247332|NCT02461485|adults|adults
5247333|NCT02461485|moderate constipation|moderate constipation
5247334|NCT02461472|risk factors|risk factors
5247335|NCT02461472|risk analysis|risk analysis
5247336|NCT02461472|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
5247337|NCT02461472|general Chinese population|general chinese population
5247338|NCT02461459|Tuberous Sclerosis Complex|tuberous sclerosis complex
5247339|NCT02461459|TSC|tsc
5247340|NCT02461459|Autism|autism
5247341|NCT02461459|ASD|asd
5247342|NCT02461459|Intellectual Disability|intellectual disability
5247344|NCT02461459|MRI|mri
5247345|NCT02461446|germline heterozygous PTEN mutations|germline heterozygous pten mutations
5247346|NCT02461446|MRI|mri
5247347|NCT02461446|10q23.3|10q23.3
5247348|NCT02461446|ASD|asd
5247349|NCT02461446|Autism|autism
5247351|NCT02461446|PTEN Hamartoma Tumor Syndrome|pten hamartoma tumor syndrome
5247352|NCT02461446|PTEN|pten
5247353|NCT02461433|Obesity|obesity
5247354|NCT02461433|Obese|obese
5247355|NCT02461433|surgical site infection|surgical site infection
5247356|NCT02461433|closed incisions|closed incisions
5247357|NCT02461433|negative pressure therapy|negative pressure therapy
5247358|NCT02461420|Phelan-McDermid Syndrome|phelan-mcdermid syndrome
5247360|NCT02461420|Genotype|genotype
5247361|NCT02461420|Phenotype|phenotype
5247362|NCT02461420|Natural History|natural history
5247363|NCT02461420|Mapping|mapping
5247364|NCT02461420|22q13 Deletion Syndrome|22q13 deletion syndrome
5247365|NCT02461420|SHANK3|shank3
5247366|NCT02461420|Autism Spectrum Disorder|autism spectrum disorder
5247367|NCT02461420|ASD|asd
5247368|NCT02461420|Intellectual Disability|intellectual disability
5247369|NCT02461420|ID|id
5247370|NCT02461381|Bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance|bayesian estimation, short-term heart rate variability, diabetic cardiovascular autonomic neuropathy, diagnostic performance
5247371|NCT02461381|Diagnostic performance|diagnostic performance
5247372|NCT02461381|short-term heart rate variability|short-term heart rate variability
5247373|NCT02461381|diabetic cardiovascular autonomic neuropathy|diabetic cardiovascular autonomic neuropathy
5247374|NCT02461381|DCAN|dcan
5247375|NCT02461342|Genetic|genetic
5247376|NCT02461342|environment|environment
5247377|NCT02461342|interaction analysis|interaction analysis
5247378|NCT02461342|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5247379|NCT02461342|CAN|can
5247380|NCT02461329|Hip Replacement, Total|hip replacement, total
5247381|NCT02461329|Gelatine solution|gelatine solution
5247382|NCT02461329|Balanced Crystaloid Solution|balanced crystaloid solution
5247383|NCT02461329|Volume therapy|volume therapy
5247384|NCT02461329|Platelet aggregation|platelet aggregation
5247385|NCT02461303|Klinefelter|klinefelter
5235279|NCT02531997|sexual health|sexual health
5235280|NCT02531997|breast cancer|breast cancer
5235281|NCT02531997|gynecologic cancer|gynecologic cancer
5235282|NCT02531997|ovarian cancer|ovarian cancer
5235283|NCT02531997|cervical cancer|cervical cancer
5235284|NCT02531997|uterine cancer|uterine cancer
5235285|NCT02531997|mind body|mind body
5235286|NCT02531997|hypnotic relaxation therapy|hypnotic relaxation therapy
5235287|NCT02531997|hypnosis|hypnosis
5247386|NCT02461303|Spermatogenesis|spermatogenesis
5247387|NCT02461303|Puberty|puberty
5247388|NCT02461303|Fertility|fertility
5247389|NCT02461277|postoperative care|postoperative care
5247390|NCT02461277|exercise test|exercise test
5247391|NCT02461277|early ambulation|early ambulation
5247392|NCT02461277|Fast-track|fast-track
5247393|NCT02461251|Thromboelastometry|thromboelastometry
5247394|NCT02461251|Obstetric Hemorrhage|obstetric hemorrhage
5247395|NCT02461251|Blood Component Transfusion|blood component transfusion
5247396|NCT02461212|HepaFat-Scan|hepafat-scan
5247397|NCT02461212|Liver Disease|liver disease
5247398|NCT02461212|Pediatrics|pediatrics
5342997|NCT01981213|Suicide|suicide
5247399|NCT02461199|Fecal microbiota transplantation|fecal microbiota transplantation
5247400|NCT02461199|Gut colonization|gut colonization
5247401|NCT02461199|Multidrug-resistant bacteria|multidrug-resistant bacteria
5247402|NCT02461199|Blood disorders|blood disorders
5247403|NCT02461199|Drug Resistance, Multiple|drug resistance, multiple
5247404|NCT02461199|Disease Eradication|disease eradication
5247405|NCT02461186|Arterolane-piperaquine|arterolane-piperaquine
5247406|NCT02461186|Dehydroartemisinin-piperaquine|dehydroartemisinin-piperaquine
5247407|NCT02461186|therapeutic efficacy|therapeutic efficacy
5247408|NCT02461186|Uncomplicated falciparum malaria|uncomplicated falciparum malaria
5247409|NCT02461186|Artemisinin-resistant|artemisinin-resistant
5247410|NCT02461160|Drug therapy|drug therapy
5247411|NCT02461134|GVHD|gvhd
5247412|NCT02461134|ponesimod|ponesimod
5247413|NCT02461121|Acute Myeloid Leukemia|acute myeloid leukemia
5247414|NCT02461121|microtransplantationHLA-mismatched microtransplantation|microtransplantationhla-mismatched microtransplantation
5247415|NCT02461121|nonmyeloablative stem cell transplantation|nonmyeloablative stem cell transplantation
5247416|NCT02461121|graft-versus-host disease|graft-versus-host disease
5247417|NCT02461108|Public policy|public policy
5247424|NCT02461069|dimethyl fumarate|dimethyl fumarate
5247425|NCT02461056|ibuprofen|ibuprofen
5247426|NCT02461056|hydromorphone|hydromorphone
5247427|NCT02461056|drug interactions|drug interactions
5247428|NCT02461043|esophageal cancer|esophageal cancer
5247429|NCT02461043|adjuvant chemotherapy|adjuvant chemotherapy
5247430|NCT02461043|esophageal surgery|esophageal surgery
5247431|NCT02461043|paclitaxel|paclitaxel
5247432|NCT02461030|Dentin hypersensitivity|dentin hypersensitivity
5247433|NCT02461030|Periodontal disease|periodontal disease
5247434|NCT02461030|Arginine|arginine
5247435|NCT02461017|intubation|intubation
5247436|NCT02461017|ventilation|ventilation
5247437|NCT02461017|airway|airway
5247438|NCT02461017|airleak|airleak
5247441|NCT02461004|Atorvastatin|atorvastatin
5247443|NCT02460978|Dapagliflozin|dapagliflozin
5247444|NCT02460978|Efficacy|efficacy
5247446|NCT02460978|Add on to insulin|add on to insulin
5247447|NCT02460978|Oral Antidiabetic|oral antidiabetic
5247448|NCT02460978|Type 1 diabetes|type 1 diabetes
5247449|NCT02460952|Pulmonary Embolism;|pulmonary embolism;
5247450|NCT02460952|perioperative period;|perioperative period;
5247451|NCT02460952|general anesthesia|general anesthesia
5247452|NCT02460939|Pulmonary Vessel Disease|pulmonary vessel disease
5247453|NCT02460939|metabolism of small molecules|metabolism of small molecules
5247454|NCT02460926|Scaling and root planning|scaling and root planning
5247455|NCT02460926|C-reactive protein|c-reactive protein
5247459|NCT02460887|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5247460|NCT02460887|induction chemotherapy|induction chemotherapy
5247461|NCT02460874|Brain Metastases|brain metastases
5247462|NCT02460874|Stereotactic Radiosurgery|stereotactic radiosurgery
5247463|NCT02460874|Glyburide|glyburide
5247464|NCT02460861|Prostate Cancer|prostate cancer
5247465|NCT02460861|Molecular staging|molecular staging
5247466|NCT02460861|GSTP1|gstp1
5247467|NCT02460861|Surgical margins|surgical margins
5247468|NCT02460861|prostatovesiculectomy|prostatovesiculectomy
5247469|NCT02460848|Malnutrition|malnutrition
5247470|NCT02460848|Severe Acute Malnutrition|severe acute malnutrition
5247471|NCT02460848|Cash Transfer|cash transfer
5247472|NCT02460848|Democratic Republic of Congo|democratic republic of congo
5247474|NCT02460796|Parkinson's disease|parkinson's disease
5247475|NCT02460796|Quality of life|quality of life
5247476|NCT02460796|Gait velocity|gait velocity
5247477|NCT02460796|Capacity|capacity
5247478|NCT02460783|Biomarkers|biomarkers
5247479|NCT02460783|Diabetes|diabetes
5247480|NCT02460783|Obesity|obesity
5247481|NCT02460783|Dementia of the Alzheimer Type|dementia of the alzheimer type
5247482|NCT02460783|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5247483|NCT02460770|Left Ventricular Assist Device|left ventricular assist device
5247484|NCT02460770|stem cell therapy|stem cell therapy
5247485|NCT02460770|ischemic heart failure|ischemic heart failure
5247486|NCT02460757|glottic movement|glottic movement
5247487|NCT02460757|emphysema|emphysema
5247488|NCT02460757|copd|copd
5247489|NCT02460757|vocal cord|vocal cord
5247490|NCT02460744|Breast cancer|breast cancer
5247491|NCT02460744|hypofractionation|hypofractionation
5247492|NCT02460744|radiotherapy|radiotherapy
5247494|NCT02460731|Young Plasma|young plasma
5247495|NCT02460718|diabetes mellitus|diabetes mellitus
5247496|NCT02460718|peer support|peer support
5247497|NCT02460718|pragmatic clinical trial|pragmatic clinical trial
5247498|NCT02460666|depressed|depressed
5247499|NCT02460666|older adults|older adults
5247500|NCT02460666|Major Depressive Disorder|major depressive disorder
5247501|NCT02460666|Tai-Chi|tai-chi
5247502|NCT02460666|geriatric|geriatric
5247503|NCT02460653|High flow nasal cannula|high flow nasal cannula
5247504|NCT02460653|Oxygen therapy|oxygen therapy
5247505|NCT02460653|Ventilation|ventilation
5247506|NCT02460640|Minimally invasive surgery|minimally invasive surgery
5247507|NCT02460640|Partial nephrectomy|partial nephrectomy
5247508|NCT02460627|Arthroscopy|arthroscopy
5247509|NCT02460627|Meniscus|meniscus
5247510|NCT02460627|Lidocaine|lidocaine
5247511|NCT02460614|bronchiolitis|bronchiolitis
5247512|NCT02460614|respiratory physiotherapy|respiratory physiotherapy
5247513|NCT02460614|pediatrics|pediatrics
5247514|NCT02460614|rhinopharyngeal clearance|rhinopharyngeal clearance
5247516|NCT02460562|resin denture base|resin denture base
5247517|NCT02460549|therapeutic patient education|therapeutic patient education
5247518|NCT02460549|insulinoresistance|insulinoresistance
5247530|NCT02460458|Factor VIII|factor viii
5247531|NCT02460458|Hemorrhage|hemorrhage
5247532|NCT02460458|von Willebrand Diseases|von willebrand diseases
5247533|NCT02460458|von Willebrand Factor|von willebrand factor
5247534|NCT02460445|Functional hyperandrogenism|functional hyperandrogenism
5247535|NCT02460445|Polycystic ovary syndrome|polycystic ovary syndrome
5247536|NCT02460445|Idiopathic hyperandrogenism|idiopathic hyperandrogenism
5247537|NCT02460445|Iron tissue depots|iron tissue depots
5247538|NCT02460445|Phlebotomy|phlebotomy
5247539|NCT02460445|Insulin resistance|insulin resistance
5247540|NCT02460445|Carbohydrate metabolism|carbohydrate metabolism
5247541|NCT02460445|Blood pressure|blood pressure
5247542|NCT02460445|Autonomic dysfunction|autonomic dysfunction
5247543|NCT02460445|Oxidative stress|oxidative stress
5247544|NCT02460445|Blood clotting tests|blood clotting tests
5247545|NCT02460445|Efficacy|efficacy
5247546|NCT02460445|Side effects|side effects
5247547|NCT02460445|Randomized clinical trial|randomized clinical trial
5247548|NCT02460432|Drug-eluting Biliary stent|drug-eluting biliary stent
5247549|NCT02460432|Covered metalic stent|covered metalic stent
5247550|NCT02460419|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5247551|NCT02460419|metastasis|metastasis
5247552|NCT02460419|capecitabine|capecitabine
5247553|NCT02460406|strength training|strength training
5247554|NCT02460406|virtual reality|virtual reality
5247555|NCT02460406|plyometric exercises|plyometric exercises
5247556|NCT02460406|cerebral palsy|cerebral palsy
5245046|NCT02474069|itching|itching
5247557|NCT02460406|hemiplegic|hemiplegic
5247558|NCT02460393|tolerance|tolerance
5247559|NCT02460393|safety and pharmacokinetic characteristics|safety and pharmacokinetic characteristics
5247560|NCT02460367|Non-small Cell Lung Cancer|non-small cell lung cancer
5247561|NCT02460367|Vaccine Therapy|vaccine therapy
5247562|NCT02460367|Immunotherapy|immunotherapy
5247563|NCT02460367|Second line therapy|second line therapy
5247564|NCT02460367|Progressive|progressive
5247565|NCT02460367|Relapsed|relapsed
5247567|NCT02460367|IDO Inhibitor|ido inhibitor
5247568|NCT02460354|Congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
5247569|NCT02460341|fMRI|fmri
5247570|NCT02460341|Brain function|brain function
5247571|NCT02460341|Sensory processing|sensory processing
5247572|NCT02460315|time of cholecystectomy after ERCP|time of cholecystectomy after ercp
5247573|NCT02460276|Mantle cell lymphoma|mantle cell lymphoma
5247574|NCT02460276|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
5247575|NCT02460276|Lenalidomide|lenalidomide
5247576|NCT02460276|Rituximab|rituximab
5247577|NCT02460276|Ibrutinib|ibrutinib
5247578|NCT02460276|Response duration|response duration
5247579|NCT02460276|Complete remission rate|complete remission rate
5247580|NCT02460276|Quality of life|quality of life
5235476|NCT02530658|Genetic Predisposition|genetic predisposition
5235477|NCT02530658|Pediatric|pediatric
5235478|NCT02530658|Genomic Analysis|genomic analysis
5247581|NCT02460276|Overall survival|overall survival
5247582|NCT02460276|Safety|safety
5247583|NCT02460250|Tissue and Organ Harvesting|tissue and organ harvesting
5247584|NCT02460250|Liver graft|liver graft
5247585|NCT02460250|Brain Death|brain death
5247586|NCT02460250|FibroScan®|fibroscan®
5247595|NCT02460211|Cardiovascular Disease|cardiovascular disease
5247596|NCT02460211|Vitamin D|vitamin d
5247597|NCT02460211|Open Heart Surgery|open heart surgery
5247602|NCT02460172|bi lateral|bi lateral
5247603|NCT02460172|knee surgery|knee surgery
5247604|NCT02460172|arthroplasty|arthroplasty
5247605|NCT02460172|orthopedics|orthopedics
5247606|NCT02460081|PDA-002|pda-002
5247607|NCT02460081|Diabetic Foot Ulcer|diabetic foot ulcer
5247608|NCT02460081|Peripheral arterial disease|peripheral arterial disease
5247609|NCT02460081|Phase 2|phase 2
5247610|NCT02460081|Randomized|randomized
5247611|NCT02460068|melanoma brain metastases|melanoma brain metastases
5247612|NCT02460068|nivolumab|nivolumab
5247613|NCT02460068|ipilimumab|ipilimumab
5247614|NCT02460055|EGD Dysphagia|egd dysphagia
5247615|NCT02460055|ETT Intubation dysphagia|ett intubation dysphagia
5247616|NCT02459990|Hypertension malformation fetal mortality|hypertension malformation fetal mortality
5247617|NCT02459964|Advanced Cancers|advanced cancers
5247618|NCT02459964|Pain|pain
5247619|NCT02459964|Fentanyl nasal spray|fentanyl nasal spray
5247620|NCT02459964|Hydromorphone hydrochloride|hydromorphone hydrochloride
5247621|NCT02459964|Phone call|phone call
5247622|NCT02459964|Numeric Rating Scale|numeric rating scale
5247624|NCT02459951|Muscle Spasticity|muscle spasticity
5247625|NCT02459951|Botox A|botox a
5247626|NCT02459951|Upper limb hemiplegia|upper limb hemiplegia
5247627|NCT02459912|Prostate|prostate
5247628|NCT02459912|Minimally|minimally
5247629|NCT02459912|Low-Risk|low-risk
5247630|NCT02459912|Invasive|invasive
5247631|NCT02459912|Cancer|cancer
5247632|NCT02459886|alpha synuclein|alpha synuclein
5247633|NCT02459886|PD|pd
5247634|NCT02459860|depression|depression
5247635|NCT02459860|randomized behavioral trial|randomized behavioral trial
5247636|NCT02459860|aged|aged
5247637|NCT02459860|Latinos|latinos
5247638|NCT02459860|Spanish-speaking|spanish-speaking
5247639|NCT02459860|chronic medical conditions|chronic medical conditions
5247640|NCT02459834|Allulose|allulose
5247641|NCT02459834|Fructose|fructose
5247642|NCT02459834|Dose Response|dose response
5247643|NCT02459834|Catalytic Dose|catalytic dose
5247644|NCT02459834|Carbohydrate metabolism|carbohydrate metabolism
5247645|NCT02459834|Randomized clinical trials|randomized clinical trials
5247646|NCT02459821|Multiple sclerosis|multiple sclerosis
5247647|NCT02459821|Gait rehabilitation|gait rehabilitation
5247648|NCT02459821|Quality of life|quality of life
5247649|NCT02459821|Stair climbing|stair climbing
5247650|NCT02459821|Robotic|robotic
5247651|NCT02459782|Ultrasound guided peribulbar anesthesia|ultrasound guided peribulbar anesthesia
5247652|NCT02459756|anthocyanins|anthocyanins
5247653|NCT02459756|bioavailability|bioavailability
5247654|NCT02459743|Hematological malignancies|hematological malignancies
5247655|NCT02459743|Next Generation Sequencing|next generation sequencing
5247656|NCT02459743|Genotype-phenotype correlations|genotype-phenotype correlations
5247657|NCT02459743|Prognosis|prognosis
5247658|NCT02459743|Diagnosis|diagnosis
5247659|NCT02459730|Dental caries|dental caries
5247660|NCT02459730|glass ionomer cement|glass ionomer cement
5247661|NCT02459730|ART|art
5247662|NCT02459704|Gingival Recession|gingival recession
5247663|NCT02459704|Semilunar flap|semilunar flap
5247664|NCT02459704|Enamel matrix derivative|enamel matrix derivative
5247665|NCT02459704|Periodontal regeneration|periodontal regeneration
5247666|NCT02459691|prediabetes|prediabetes
5247667|NCT02459691|metabolic syndrome|metabolic syndrome
5247668|NCT02459691|lifestyle|lifestyle
5247669|NCT02459691|behavior change|behavior change
5247670|NCT02459691|primary care|primary care
5247672|NCT02459691|diet|diet
5247673|NCT02459691|physical activity|physical activity
5247674|NCT02459652|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
5247675|NCT02459639|Chronic Widespread Pain|chronic widespread pain
5247676|NCT02459639|Telomere length|telomere length
5247677|NCT02459639|Multimodal rehabilitation|multimodal rehabilitation
5247678|NCT02459639|Integrative care|integrative care
5247679|NCT02459639|Existential aspects|existential aspects
5247680|NCT02459613|Radionuclide imaging|radionuclide imaging
5247681|NCT02459613|Annexin|annexin
5247682|NCT02459600|Eye surgery|eye surgery
5247683|NCT02459600|Children|children
5247684|NCT02459587|Self-Injurious Behavior|self-injurious behavior
5247685|NCT02459587|suicide prevention|suicide prevention
5247686|NCT02459574|Heart Failure|heart failure
5235584|NCT02530060|Healthy|healthy
5235585|NCT02530060|Rilpivirine|rilpivirine
5235586|NCT02530060|Tenofovir|tenofovir
5235587|NCT02530060|Emtricitabine|emtricitabine
5247687|NCT02459561|Obesity|obesity
5247688|NCT02459561|Diabetes|diabetes
5247689|NCT02459561|Overweight|overweight
5247690|NCT02459561|Medical device|medical device
5247691|NCT02459561|Endobarrier|endobarrier
5247692|NCT02459561|Clinical trial|clinical trial
5247693|NCT02459561|Diet|diet
5247694|NCT02459561|Exercise|exercise
5247695|NCT02459561|Body weight|body weight
5247696|NCT02459561|Medical therapy|medical therapy
5247697|NCT02459561|Medicine|medicine
5247698|NCT02459561|Device|device
5247699|NCT02459561|Randomised|randomised
5247700|NCT02459561|Control|control
5247701|NCT02459561|Intervention|intervention
5247702|NCT02459561|EndoBarrier Medical device|endobarrier medical device
5247704|NCT02459548|CPAP treatment|cpap treatment
5247705|NCT02459548|Primary care|primary care
5247706|NCT02459548|Efficacy|efficacy
5247707|NCT02459535|incretin release|incretin release
5247708|NCT02459522|Bayesian estimation|bayesian estimation
5247709|NCT02459522|short-term heart rate variability|short-term heart rate variability
5247710|NCT02459522|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5247711|NCT02459522|diagnostic performance|diagnostic performance
5247712|NCT02459509|Sedation|sedation
5247713|NCT02459509|dexmedetomidine|dexmedetomidine
5247714|NCT02459509|pediatric|pediatric
5247715|NCT02459509|preoperative period|preoperative period
5247716|NCT02459470|Fluid Responsiveness|fluid responsiveness
5247717|NCT02459470|Pulse Pressure Variation|pulse pressure variation
5247718|NCT02459470|Stroke Volume Variation|stroke volume variation
5247719|NCT02459457|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5247720|NCT02459457|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5247721|NCT02459457|paclitaxel|paclitaxel
5247730|NCT02459418|Afolia|afolia
5247731|NCT02459418|Follitropin|follitropin
5247732|NCT02459405|Colorectal surgery|colorectal surgery
5247733|NCT02459405|Near infrared|near infrared
5247734|NCT02459405|Indocyanine green|indocyanine green
5247735|NCT02459405|anastomotic leak|anastomotic leak
5247736|NCT02459405|Prevention of leak|prevention of leak
5247737|NCT02459392|Epiduroscopy,|epiduroscopy,
5247738|NCT02459392|Failed back surgery syndrome|failed back surgery syndrome
5247739|NCT02459392|Spinal Stenosis with neurologic changes|spinal stenosis with neurologic changes
5247740|NCT02459366|Thoracolumbar fascia|thoracolumbar fascia
5247741|NCT02459366|Mechanical properties|mechanical properties
5247742|NCT02459366|Low back pain|low back pain
5247743|NCT02459353|dapagliflozin|dapagliflozin
5247744|NCT02459353|glucose variability|glucose variability
5247745|NCT02459327|Infant behavior|infant behavior
5247746|NCT02459327|Child behavior|child behavior
5247747|NCT02459327|Parenting|parenting
5247748|NCT02459327|Child rearing|child rearing
5247749|NCT02459327|Depression|depression
5247750|NCT02459327|Personal satisfaction|personal satisfaction
5247751|NCT02459327|Randomized controlled trials|randomized controlled trials
5247752|NCT02459327|Intervention studies|intervention studies
5247753|NCT02459327|Behavioral symptoms|behavioral symptoms
5247754|NCT02459327|Social behavior|social behavior
5247755|NCT02459288|Acute coronary syndrome|acute coronary syndrome
5247756|NCT02459288|Chronic kidney disease|chronic kidney disease
5247757|NCT02459288|End-Stage Renal Disease|end-stage renal disease
5247758|NCT02459288|eGFR|egfr
5247759|NCT02459288|Ticagrelor|ticagrelor
5247760|NCT02459288|Clopidogrel|clopidogrel
5247761|NCT02459275|feeding protocol|feeding protocol
5247762|NCT02459275|enteral nutrition protocol|enteral nutrition protocol
5247763|NCT02459275|critically ill|critically ill
5247764|NCT02459275|surgical ICU|surgical icu
5247765|NCT02459275|enteral nutrition|enteral nutrition
5247766|NCT02459275|nutrition therapy|nutrition therapy
5247767|NCT02459223|Nutritional intervention|nutritional intervention
5247768|NCT02459223|iron deficiency anemia|iron deficiency anemia
5247769|NCT02459210|clinical high risk for psychosis|clinical high risk for psychosis
5247770|NCT02459210|psychosis prodrome|psychosis prodrome
5247771|NCT02459210|cognitive remediation|cognitive remediation
5245257|NCT02472990|DMD|dmd
5247772|NCT02459210|psychosis prevention|psychosis prevention
5247774|NCT02459184|preventive medicine|preventive medicine
5247775|NCT02459184|social determinants of health|social determinants of health
5247776|NCT02459184|primary health care|primary health care
5247777|NCT02459184|poverty|poverty
5247778|NCT02459184|income|income
5247779|NCT02459184|health promotion|health promotion
5247780|NCT02459132|High-intensity interval training|high-intensity interval training
5247781|NCT02459132|VO2peak|vo2peak
5247782|NCT02459132|Brachial flow-mediated dilation|brachial flow-mediated dilation
5247783|NCT02459132|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
5247784|NCT02459132|Carotid intima-media thickness|carotid intima-media thickness
5247785|NCT02459132|Carotid distensibility|carotid distensibility
5247786|NCT02459132|Respiratory sinus arrhythmia|respiratory sinus arrhythmia
5247787|NCT02459119|urothelial cancer|urothelial cancer
5247788|NCT02459119|Regorafenib|regorafenib
5247789|NCT02459106|micro-RNA|micro-rna
5247790|NCT02459106|insulin resistance|insulin resistance
5247791|NCT02459093|wound complications|wound complications
5247792|NCT02459080|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5247793|NCT02459054|Artificial Heart|artificial heart
5247794|NCT02459054|Biventricular Heart Failure|biventricular heart failure
5247795|NCT02459054|SynCardia|syncardia
5247799|NCT02458989|Thyroidectomy|thyroidectomy
5247800|NCT02458989|Thyroid surgery|thyroid surgery
5247801|NCT02458989|Scalpel|scalpel
5247802|NCT02458989|Electrocautery|electrocautery
5247803|NCT02458976|Scar|scar
5247804|NCT02458976|Pulsed-dye laser|pulsed-dye laser
5247806|NCT02458963|PCOS|pcos
5247807|NCT02458963|Clomiphene citrate resistant|clomiphene citrate resistant
5247808|NCT02458963|Gonadotropin|gonadotropin
5247809|NCT02458963|IVF|ivf
5247810|NCT02458950|Anorexia nervosa|anorexia nervosa
5247811|NCT02458950|Siriraj Hospital|siriraj hospital
5247812|NCT02458950|Thai|thai
5247813|NCT02458937|Leukemia|leukemia
5247814|NCT02458937|Hodgkin Disease|hodgkin disease
5247815|NCT02458937|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5247816|NCT02458937|Sickle Cell Disease|sickle cell disease
5247823|NCT02458872|Patient Safety|patient safety
5247824|NCT02458859|Chronic|chronic
5247825|NCT02458859|Subacute|subacute
5247826|NCT02458833|Obesity|obesity
5247827|NCT02458833|Nutrition|nutrition
5247828|NCT02458833|Home Food Preparation|home food preparation
5247829|NCT02458833|Home Food Environment|home food environment
5247830|NCT02458833|Peer Mentoring|peer mentoring
5247831|NCT02458833|Early Head Start|early head start
5247832|NCT02458833|Cooking|cooking
5247833|NCT02458833|Diet|diet
5247834|NCT02458820|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5247835|NCT02458820|Return of Spontaneous Circulation|return of spontaneous circulation
5247836|NCT02458820|ROSC|rosc
5247837|NCT02458820|Electroencephalogram|electroencephalogram
5247838|NCT02458742|spinal anesthesia|spinal anesthesia
5247839|NCT02458742|intrathecal morphine|intrathecal morphine
5247840|NCT02458742|transurethral resection of prostate|transurethral resection of prostate
5247841|NCT02458742|postoperative pain|postoperative pain
5247842|NCT02458729|Tranexamic Acid|tranexamic acid
5247843|NCT02458729|Total Knee Arthroplasty|total knee arthroplasty
5247844|NCT02458729|Rivaroxaban|rivaroxaban
5247845|NCT02458703|workload|workload
5247846|NCT02458703|oxygen level|oxygen level
5247847|NCT02458703|oxygen consumption|oxygen consumption
5247848|NCT02458703|breathing reserve|breathing reserve
5247849|NCT02458703|ventilatory efficiency|ventilatory efficiency
5247850|NCT02458690|Primary Care|primary care
5247851|NCT02458690|Older Adults|older adults
5247852|NCT02458690|Antidepressant Medications|antidepressant medications
5247853|NCT02458690|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5247854|NCT02458690|Computer-Based Psychotherapy|computer-based psychotherapy
5247855|NCT02458612|cerebral palsy|cerebral palsy
5247856|NCT02458612|mirror therapy|mirror therapy
5247857|NCT02458612|strength training|strength training
5247858|NCT02458560|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5247859|NCT02458560|Aortic Stenosis|aortic stenosis
5247860|NCT02458534|Simulated manikin|simulated manikin
5247861|NCT02458508|MC4R|mc4r
5247862|NCT02458508|chemotherapy|chemotherapy
5247863|NCT02458508|radiotherapy|radiotherapy
5247864|NCT02458495|Internet|internet
5247865|NCT02458495|Mobile Health|mobile health
5247866|NCT02458495|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5247867|NCT02458495|Medication Adherence|medication adherence
5247868|NCT02458495|Psychological Theory|psychological theory
5247869|NCT02458482|Children|children
5247870|NCT02458482|Positive Airway Pressure|positive airway pressure
5247871|NCT02458482|Nebulizer|nebulizer
5247872|NCT02458482|Moderate|moderate
5247873|NCT02458482|Acute|acute
5247874|NCT02458482|AccuPAP|accupap
5247875|NCT02458417|Ablative laser|ablative laser
5247876|NCT02458417|Fractional laser|fractional laser
5247877|NCT02458417|Vitiligo|vitiligo
5247878|NCT02458417|Piebaldism|piebaldism
5247879|NCT02458417|Cell suspension grafting|cell suspension grafting
5247880|NCT02458391|Breast Cancer|breast cancer
5247881|NCT02458391|Lymphedema|lymphedema
5247882|NCT02458365|Violence|violence
5247883|NCT02458365|Bullying|bullying
5247884|NCT02458365|Social skills|social skills
5247885|NCT02458365|Prevention & control|prevention & control
5247886|NCT02458365|Adolescent|adolescent
5247887|NCT02458339|Brain tumor|brain tumor
5247888|NCT02458339|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
5247889|NCT02458326|Migraine|migraine
5247890|NCT02458326|Fibromyalgia|fibromyalgia
5247891|NCT02458326|Aerobic exercise|aerobic exercise
5247892|NCT02458300|Bronchiolitis|bronchiolitis
5247893|NCT02458300|Chest|chest
5247894|NCT02458300|Physical therapy|physical therapy
5247895|NCT02458287|mixed dyslipidemia|mixed dyslipidemia
5235779|NCT02529020|ergogenic effects|ergogenic effects
5235780|NCT02529007|Colonoscopy|colonoscopy
5235781|NCT02529007|early cancer detection|early cancer detection
5235784|NCT02528994|Metabolism|metabolism
5344621|NCT01973543|AADC|aadc
5247896|NCT02458248|Chronic Kidney Disease|chronic kidney disease
5247897|NCT02458248|Sodium Reduction|sodium reduction
5247898|NCT02458248|eGFR 30-60ml/min/1.73m2|egfr 30-60ml/min/1.73m2
5247899|NCT02458235|pediatric leukemia myelodysplastic syndrome azacitidine|pediatric leukemia myelodysplastic syndrome azacitidine
5247900|NCT02458209|PK, bococizumab, comparability, LDL-C|pk, bococizumab, comparability, ldl-c
5247901|NCT02458196|IgG4 related disease|igg4 related disease
5247902|NCT02458196|IgG4-RD|igg4-rd
5247903|NCT02458196|Response rate|response rate
5247904|NCT02458196|Relapse|relapse
5247905|NCT02458170|Rheumatoid arthritis|rheumatoid arthritis
5247906|NCT02458170|Synovial tissue|synovial tissue
5247907|NCT02458170|Joint destruction|joint destruction
5247908|NCT02458170|Inflammation|inflammation
5247915|NCT02458131|community-based participatory research|community-based participatory research
5247916|NCT02458131|adolescents|adolescents
5247917|NCT02458118|chronic|chronic
5247918|NCT02458118|pancreatitis|pancreatitis
5247919|NCT02458118|secretin|secretin
5247920|NCT02458118|Blood flow|blood flow
5247921|NCT02458105|Acceptance and commitment therapy|acceptance and commitment therapy
5247922|NCT02458105|Cognitive behavior therapy|cognitive behavior therapy
5247923|NCT02458053|African American|african american
5142963|NCT03097562|FSL|fsl
5247924|NCT02458053|male|male
5247925|NCT02458053|couples|couples
5247926|NCT02458053|randomized control trial|randomized control trial
5247927|NCT02457975|Diabetic Macular Edema|diabetic macular edema
5247928|NCT02457975|Photobiomodulation|photobiomodulation
5247929|NCT02457975|Phototherapy|phototherapy
5247930|NCT02457949|Social Assistance|social assistance
5247931|NCT02457949|Drug Use|drug use
5247932|NCT02457949|Drug-Related harm|drug-related harm
5247933|NCT02457923|mobile phone counselling|mobile phone counselling
5247934|NCT02457923|infant feeding|infant feeding
5247935|NCT02457923|nutrition|nutrition
5247936|NCT02457897|Brown Adipose Tissue|brown adipose tissue
5247937|NCT02457897|Liothyronine|liothyronine
5247938|NCT02457897|Insulin Receptors|insulin receptors
5247939|NCT02457884|Diabetic macular oedema|diabetic macular oedema
5247940|NCT02457884|Perceptual learning|perceptual learning
5247989|NCT02457676|Neuroimaging|neuroimaging
5247990|NCT02457676|Response Inhibition|response inhibition
5247991|NCT02457676|Behavioral Regulation|behavioral regulation
5247992|NCT02457676|Emotional Regulation|emotional regulation
5247993|NCT02457663|Burns|burns
5247994|NCT02457637|acute-on-chronic liver disease|acute-on-chronic liver disease
5247995|NCT02457637|acute decompensation|acute decompensation
5247996|NCT02457637|multiple organ failures|multiple organ failures
5247997|NCT02457637|acute on chronic liver failure|acute on chronic liver failure
5247998|NCT02457624|gastric cancer|gastric cancer
5247999|NCT02457624|chronic atrophic gastritis|chronic atrophic gastritis
5248000|NCT02457624|intestinal metaplasia|intestinal metaplasia
5248001|NCT02457546|Fibrin sealant|fibrin sealant
5248002|NCT02457546|CSF leak|csf leak
5248003|NCT02457494|CALVIH|calvih
5248004|NCT02457494|Renal stone|renal stone
5248005|NCT02457494|HIV1|hiv1
5248006|NCT02457494|Renal colic|renal colic
5248007|NCT02457494|Atazanavir|atazanavir
5248008|NCT02457494|Crystalluria|crystalluria
5248009|NCT02457494|Chronic Kidney Disease|chronic kidney disease
5248010|NCT02457494|Calcium Oxalate|calcium oxalate
5248011|NCT02457481|Embryo Culture Techniques|embryo culture techniques
5248012|NCT02457481|Embryonic Development|embryonic development
5248013|NCT02457468|coflex|coflex
5248014|NCT02457468|interlaminar stabilization|interlaminar stabilization
5248015|NCT02457468|lumbar spinal stenosis|lumbar spinal stenosis
5248016|NCT02457468|neurogenic claudication|neurogenic claudication
5248017|NCT02457468|decompression|decompression
5248018|NCT02457455|inflight emergencies|inflight emergencies
5248019|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation
5248020|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous
5248021|NCT02457442|Analgesics, Opioid|analgesics, opioid
5248022|NCT02457429|Gastro-oesophageal reflux|gastro-oesophageal reflux
5248023|NCT02457429|Children|children
5248024|NCT02457429|Dx-pH Pharyngeal probe|dx-ph pharyngeal probe
5248025|NCT02457429|GORD|gord
5248026|NCT02457429|Trans-nasal catheter|trans-nasal catheter
5248027|NCT02457416|Peanut allergy|peanut allergy
5248033|NCT02457377|recurrent abortion|recurrent abortion
5248034|NCT02457377|cerclage|cerclage
5248035|NCT02457377|laparoscopy|laparoscopy
5248036|NCT02457377|cervical imcompetence|cervical imcompetence
5235879|NCT02528370|Intervention Studies|intervention studies
5235880|NCT02528370|Patient Readmission|patient readmission
5235893|NCT02528344|High Intensity Interval Training|high intensity interval training
5235894|NCT02528331|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5235895|NCT02528331|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5235896|NCT02528305|High-intensity Interval Training|high-intensity interval training
5235897|NCT02528292|Rheumatoid Arthritis|rheumatoid arthritis
5235898|NCT02528292|Anti-TNF|anti-tnf
5235899|NCT02528292|Ultrasound|ultrasound
5235900|NCT02528292|Synovial histomorphology|synovial histomorphology
5235901|NCT02528292|Ectopic Lymphoneogenesis|ectopic lymphoneogenesis
5235902|NCT02528279|Plasmodium ovale|plasmodium ovale
5235903|NCT02528279|relapse|relapse
5248037|NCT02457364|non-operative management|non-operative management
5248038|NCT02457351|Phase 1|phase 1
5248039|NCT02457351|Advanced solid tumor|advanced solid tumor
5248142|NCT02456779|NERD|nerd
5248040|NCT02457351|pan-CDK inhibitor|pan-cdk inhibitor
5248041|NCT02457351|Drug-drug Interaction|drug-drug interaction
5248042|NCT02457338|C-section|c-section
5248043|NCT02457338|Infants|infants
5248044|NCT02457338|Probiotic|probiotic
5248045|NCT02457338|B. infantis|b. infantis
5248046|NCT02457338|Microbiota|microbiota
5248047|NCT02457338|Gut|gut
5248048|NCT02457338|Breast milk|breast milk
5248049|NCT02457338|Vaginal|vaginal
5248050|NCT02457325|Articaine|articaine
5248051|NCT02457325|Lower third molar|lower third molar
5248052|NCT02457325|Oral Surgery|oral surgery
5248053|NCT02457299|Esophagectomy|esophagectomy
5248054|NCT02457299|Gastric Conduit|gastric conduit
5248055|NCT02457299|Esophageal Cancer|esophageal cancer
5143069|NCT03097016|CC-122|cc-122
5248056|NCT02457273|PDNC(Poorly Differentiated Neuroendocrine Carcinomas)|pdnc(poorly differentiated neuroendocrine carcinomas)
5248057|NCT02457273|TLC-388 (Lipotecan®)|tlc-388 (lipotecan®)
5248058|NCT02457247|Drug therapy|drug therapy
5248059|NCT02457234|fruits and vegetables|fruits and vegetables
5248060|NCT02457234|cultural immersion|cultural immersion
5248061|NCT02457221|Tacrolimus|tacrolimus
5248062|NCT02457221|Cyclophosphamide|cyclophosphamide
5248064|NCT02457221|lupus nephritis|lupus nephritis
5248065|NCT02457208|pharmacokinetics|pharmacokinetics
5248066|NCT02457195|PONV|ponv
5248067|NCT02457195|anesthesia|anesthesia
5248068|NCT02457195|granisetron|granisetron
5248069|NCT02457156|Pancreatico-jejunostomy|pancreatico-jejunostomy
5248070|NCT02457156|Pancreato-duodenectomy|pancreato-duodenectomy
5248071|NCT02457156|Cattell-Warren anastomosis|cattell-warren anastomosis
5248072|NCT02457156|Blumgart anastomosis|blumgart anastomosis
5248073|NCT02457143|recall|recall
5248074|NCT02457143|income-related disparities|income-related disparities
5248075|NCT02457143|cancer screening|cancer screening
5248076|NCT02457117|CyberKnife|cyberknife
5248077|NCT02457117|Partial breast irradiation|partial breast irradiation
5248078|NCT02457117|accelerated partial breast irradiation|accelerated partial breast irradiation
5248079|NCT02457117|breast sbrt|breast sbrt
5248080|NCT02457091|multiple sclerosis|multiple sclerosis
5248081|NCT02457091|exercise|exercise
5248082|NCT02457091|home-based|home-based
5248083|NCT02457091|training|training
5248084|NCT02457091|fitness|fitness
5248085|NCT02457078|nutritional supplements|nutritional supplements
5248086|NCT02457078|lutein|lutein
5248087|NCT02457078|DHA|dha
5248088|NCT02457078|vitamin E|vitamin e
5248089|NCT02457078|infant brain development|infant brain development
5248090|NCT02457065|survivors|survivors
5248091|NCT02457065|family|family
5248092|NCT02457052|Medical device|medical device
5248093|NCT02457039|Chemo-brain|chemo-brain
5248094|NCT02457039|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5248095|NCT02457039|Mild Cognitive Impairment|mild cognitive impairment
5248096|NCT02457039|Breast cancer|breast cancer
5248097|NCT02457026|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5248098|NCT02457026|age-related macular degeneration|age-related macular degeneration
5248099|NCT02457026|verteporfin|verteporfin
5248100|NCT02457026|persistent disease activity|persistent disease activity
5248101|NCT02457026|photodynamic therapy|photodynamic therapy
5248102|NCT02457026|Aflibercept|aflibercept
5248103|NCT02457000|Sleep|sleep
5248104|NCT02457000|Skin|skin
5235977|NCT02527785|oxaliplatin|oxaliplatin
5235978|NCT02527785|irinotecan|irinotecan
5235979|NCT02527785|S-1|s-1
5245541|NCT02471560|DMF|dmf
5248107|NCT02456961|Standard corneal crosslinking (CXL)|standard corneal crosslinking (cxl)
5248108|NCT02456961|Transepithelial CXL|transepithelial cxl
5248109|NCT02456961|Iontophoresis|iontophoresis
5248110|NCT02456961|Riboflavin|riboflavin
5248111|NCT02456948|treatment resistant depression|treatment resistant depression
5248112|NCT02456948|inflammation|inflammation
5248113|NCT02456948|microglia|microglia
5248114|NCT02456948|minocycline|minocycline
5248115|NCT02456922|Type 1 Diabetes|type 1 diabetes
5248116|NCT02456922|Type 2 Diabetes|type 2 diabetes
5248117|NCT02456922|Harmony 1|harmony 1
5248118|NCT02456896|Oxcarbazepine|oxcarbazepine
5248119|NCT02456896|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
5248120|NCT02456896|Bipolar disorder|bipolar disorder
5248121|NCT02456896|Neuroprotection|neuroprotection
5248122|NCT02456883|ASP2215|asp2215
5248123|NCT02456883|14C-labeled gilteritinib|14c-labeled gilteritinib
5248124|NCT02456883|Advanced Solid Tumors|advanced solid tumors
5248125|NCT02456883|Pharmacokinetics|pharmacokinetics
5248126|NCT02456883|gilteritinib|gilteritinib
5248127|NCT02456870|Adipose tissue|adipose tissue
5248128|NCT02456870|Overfeeding|overfeeding
5248129|NCT02456818|Colonization|colonization
5248130|NCT02456818|Multi-resistant gram negative bacteria|multi-resistant gram negative bacteria
5248131|NCT02456818|Infection control measures|infection control measures
5248132|NCT02456818|Hand hygiene program|hand hygiene program
5248133|NCT02456818|Contact precautions|contact precautions
5248134|NCT02456818|Immunocompromised host|immunocompromised host
5248135|NCT02456792|PCOS|pcos
5248136|NCT02456792|Clomiphene citrate resistant|clomiphene citrate resistant
5248137|NCT02456792|LOD|lod
5248138|NCT02456792|IVF|ivf
5248139|NCT02456779|pepsin|pepsin
5248140|NCT02456779|peptest|peptest
5248141|NCT02456779|GERD|gerd
5248154|NCT02456740|Prevention|prevention
5248155|NCT02456740|Prophylaxis|prophylaxis
5248156|NCT02456727|Acupuncture|acupuncture
5248157|NCT02456727|Group/Community Acupuncture|group/community acupuncture
5248158|NCT02456727|Individual Acupuncture|individual acupuncture
5248159|NCT02456727|Chronic Pain|chronic pain
5248160|NCT02456727|Underserved|underserved
5248161|NCT02456727|Urban Primary Care|urban primary care
5248162|NCT02456727|Osteoarthritis|osteoarthritis
5248163|NCT02456727|Back Pain|back pain
5248164|NCT02456727|Neck Pain|neck pain
5143182|NCT03096574|Pregnancy|pregnancy
5248165|NCT02456714|Cholangiocarcinoma|cholangiocarcinoma
5248167|NCT02456714|Phase II study|phase ii study
5248168|NCT02456701|CDX3379|cdx3379
5248169|NCT02456675|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
5248170|NCT02456675|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
5248171|NCT02456649|lumpectomy margins|lumpectomy margins
5248172|NCT02456636|Weight loss|weight loss
5248173|NCT02456636|Weight management|weight management
5248174|NCT02456636|Diabetes|diabetes
5248175|NCT02456636|Heart disease|heart disease
5248176|NCT02456597|Peripheral Nerve Blocks|peripheral nerve blocks
5248177|NCT02456584|depot medroxyprogesterone acetate (DMPA)|depot medroxyprogesterone acetate (dmpa)
5248178|NCT02456584|confidence interval (CI)|confidence interval (ci)
5248179|NCT02456584|Subcutaneous (sub-Q)|subcutaneous (sub-q)
5248180|NCT02456584|Intrauterine device (IUD)|intrauterine device (iud)
5248181|NCT02456584|Levonorgestrel (LNG)|levonorgestrel (lng)
5248182|NCT02456584|intrauterine system (IUS)|intrauterine system (ius)
5248183|NCT02456558|HIV infection|hiv infection
5248184|NCT02456558|antiretroviral drugs|antiretroviral drugs
5248185|NCT02456558|deferiprone|deferiprone
5248186|NCT02456558|pharmacokinetics|pharmacokinetics
5248187|NCT02456519|children|children
5248188|NCT02456519|surgery|surgery
5248189|NCT02456428|Incretins|incretins
5248190|NCT02456428|Antidiabetic Agents|antidiabetic agents
5248191|NCT02456428|Heart Failure|heart failure
5248202|NCT02456376|Sensor Fusion|sensor fusion
5248203|NCT02456376|Stochastic Resonance Stimulation|stochastic resonance stimulation
5248204|NCT02456376|Sensory deficits|sensory deficits
5248205|NCT02456376|Postural Control|postural control
5248206|NCT02456363|Adalimumab|adalimumab
5248207|NCT02456363|NSAIDs|nsaids
5248208|NCT02456363|safety|safety
5248209|NCT02456363|efficacy|efficacy
5248210|NCT02456337|Gingival Recession|gingival recession
5248211|NCT02456337|Coronally advanced flap|coronally advanced flap
5248212|NCT02456337|Periodontal regeneration|periodontal regeneration
5248213|NCT02456324|Fistula, Anorectal|fistula, anorectal
5248214|NCT02456311|VATS|vats
5248215|NCT02456311|Energy sealing|energy sealing
5248216|NCT02456298|Telehealth|telehealth
5236077|NCT02526914|economic games|economic games
5236078|NCT02526888|pharmacokinetic|pharmacokinetic
5248217|NCT02456298|Applied behavior analysis|applied behavior analysis
5248218|NCT02456272|Otosclerosis|otosclerosis
5248220|NCT02456272|Hearing aids|hearing aids
5248221|NCT02456259|internal jugular vein patency|internal jugular vein patency
5248222|NCT02456259|MICS|mics
5248223|NCT02456259|neck cannula|neck cannula
5248224|NCT02456259|Jugular veins|jugular veins
5248225|NCT02456246|Stereotactive Body Radiation Therapy (SBRT)|stereotactive body radiation therapy (sbrt)
5248226|NCT02456246|Lung Fibrosis|lung fibrosis
5248227|NCT02456246|FLT-PET|flt-pet
5248228|NCT02456246|NSCLC|nsclc
5248229|NCT02456233|rotor|rotor
5248230|NCT02456233|FIRM|firm
5248231|NCT02456233|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5248232|NCT02456233|persistent atrial fibrillation|persistent atrial fibrillation
5248233|NCT02456233|atrial tachyarrhythmia|atrial tachyarrhythmia
5248234|NCT02456233|ablation|ablation
5248235|NCT02456233|contact mapping|contact mapping
5248236|NCT02456233|clinical trial|clinical trial
5248237|NCT02456233|signal processing|signal processing
5248238|NCT02456220|Herbst appliance|herbst appliance
5248239|NCT02456220|Computed tomography|computed tomography
5248240|NCT02456220|3D imaging|3d imaging
5248241|NCT02456220|Growth and development|growth and development
5248242|NCT02456220|Orthodontic Appliances, Functional|orthodontic appliances, functional
5248243|NCT02456168|Lupus|lupus
5248244|NCT02456168|SLE|sle
5248245|NCT02456155|bedside placement|bedside placement
5248246|NCT02456155|nasal jejunal tube|nasal jejunal tube
5248247|NCT02456155|ultrasound|ultrasound
5248248|NCT02456155|severe acute pancreatitis|severe acute pancreatitis
5248249|NCT02456155|endoscope|endoscope
5248250|NCT02456155|efficacy|efficacy
5248251|NCT02456155|safety|safety
5248252|NCT02456129|Clinical Trial, Phase I|clinical trial, phase i
5248253|NCT02456077|MCV4: Meningococcal Conjugate Vaccine|mcv4: meningococcal conjugate vaccine
5248254|NCT02456077|HPV: Human Papillomavirus|hpv: human papillomavirus
5248255|NCT02456051|Pancreatic Carcinoma|pancreatic carcinoma
5248256|NCT02456051|New-Onset Diabetes|new-onset diabetes
5248257|NCT02456051|Adrenomedullin|adrenomedullin
5248258|NCT02456051|Early Diagnosis|early diagnosis
5248259|NCT02456051|Biological Markers|biological markers
5342998|NCT01981213|Attempts|attempts
5248260|NCT02456012|peptic ulcer hemorrhage|peptic ulcer hemorrhage
5248261|NCT02456012|comorbidity|comorbidity
5248262|NCT02456012|clinical trial|clinical trial
5248264|NCT02455973|overweight|overweight
5248265|NCT02455947|Burnout|burnout
5248266|NCT02455947|Teachers|teachers
5248267|NCT02455947|Meditation|meditation
5248268|NCT02455947|IBSR|ibsr
5248269|NCT02455947|"The Work"|"the work"
5248270|NCT02455947|Byron Katie|byron katie
5248271|NCT02455895|Blepharitis|blepharitis
5248272|NCT02455856|Healthy|healthy
5248273|NCT02455856|Itraconazole|itraconazole
5248274|NCT02455856|JNJ-42847922|jnj-42847922
5248275|NCT02455843|microwave ablation|microwave ablation
5248276|NCT02455843|chemotherapy|chemotherapy
5248277|NCT02455830|Neonatal encephalopathy|neonatal encephalopathy
5248278|NCT02455830|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5248279|NCT02455830|Newborn infants|newborn infants
5248280|NCT02455830|Cytokines|cytokines
5248281|NCT02455830|Trophic factors|trophic factors
5248282|NCT02455791|Breast Cancer|breast cancer
5248283|NCT02455791|Triple negative breast cancer|triple negative breast cancer
5248284|NCT02455791|HER2 amplified breast cancer|her2 amplified breast cancer
5248285|NCT02455791|Ultrasound-guided biopsy|ultrasound-guided biopsy
5248286|NCT02455791|Fine needle aspirate|fine needle aspirate
5248287|NCT02455791|FNA|fna
5248288|NCT02455791|Core biopsy|core biopsy
5248289|NCT02455752|LE-TME|le-tme
5248290|NCT02455752|Laparoscopic rectal resection|laparoscopic rectal resection
5248291|NCT02455752|Retroperitoneal resection|retroperitoneal resection
5248292|NCT02455739|intestinal function|intestinal function
5248293|NCT02455739|chewing gum|chewing gum
5248294|NCT02455726|Peripheral Arterial Disease|peripheral arterial disease
5248295|NCT02455726|Magnesium Oxide|magnesium oxide
5248296|NCT02455726|Pain|pain
5248297|NCT02455687|Bronchial Asthma|bronchial asthma
5248298|NCT02455687|Intravenous magnesium sulfate|intravenous magnesium sulfate
5248299|NCT02455687|Inhaled budesonide|inhaled budesonide
5248300|NCT02455674|weight estimation|weight estimation
5248301|NCT02455674|emergency|emergency
5248302|NCT02455674|child|child
5248303|NCT02455635|Office Hysteroscopy|office hysteroscopy
5248304|NCT02455635|tubal patency|tubal patency
5248305|NCT02455635|infertility|infertility
5248306|NCT02455635|Lower Abdominal Pain|lower abdominal pain
5248307|NCT02455609|dexmedetomidine|dexmedetomidine
5248308|NCT02455609|ketamine|ketamine
5248309|NCT02455609|postoperative pain|postoperative pain
5248310|NCT02455596|Novaferon|novaferon
5236170|NCT02526420|Adult Growth Hormone Deficiency|adult growth hormone deficiency
5248311|NCT02455596|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
5248313|NCT02455596|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
5248314|NCT02455583|HIV prevention|hiv prevention
5248315|NCT02455583|Sexual activity biomarker|sexual activity biomarker
5248316|NCT02455583|Youth|youth
5248317|NCT02455583|Adolescents|adolescents
5248318|NCT02455570|Endoscopic Ultrasound|endoscopic ultrasound
5248319|NCT02455570|Quality Management|quality management
5248320|NCT02455570|Education and training|education and training
5248321|NCT02455570|Safety|safety
5248322|NCT02455570|Learning curve|learning curve
5248323|NCT02455544|Urine congophilia|urine congophilia
5248324|NCT02455518|pain|pain
5248325|NCT02455505|Cancer Care and Bereavement|cancer care and bereavement
5248326|NCT02455505|Supportive Care|supportive care
5248327|NCT02455505|15-095|15-095
5248328|NCT02455492|Mortality|mortality
5248329|NCT02455492|Perioperative period|perioperative period
5248330|NCT02455492|Elective surgical procedures|elective surgical procedures
5248331|NCT02455479|cocaine vaccine|cocaine vaccine
5248332|NCT02455479|cocaine dependence|cocaine dependence
5248333|NCT02455479|Cocaine|cocaine
5248334|NCT02455440|esmolol|esmolol
5248335|NCT02455440|anesthetics|anesthetics
5248336|NCT02455427|transcranial direct current stimulation|transcranial direct current stimulation
5248337|NCT02455427|conventional physical therapy|conventional physical therapy
5248338|NCT02455401|Postoperative Vomiting|postoperative vomiting
5248339|NCT02455388|Nutrition|nutrition
5248340|NCT02455388|Obesity|obesity
5248341|NCT02455388|Pediatric|pediatric
5248342|NCT02455375|Puumala virus|puumala virus
5248343|NCT02455375|diagnostic|diagnostic
5248344|NCT02455375|France|france
5248345|NCT02455336|tetraplegia|tetraplegia
5248346|NCT02455336|paraplegia|paraplegia
5248347|NCT02455336|hypertriglyceridemia|hypertriglyceridemia
5248348|NCT02455336|hyperlipidemia|hyperlipidemia
5248349|NCT02455336|peroxisome proliferator-activated receptor alpha|peroxisome proliferator-activated receptor alpha
5248350|NCT02455323|Efficacy|efficacy
5248351|NCT02455323|Tension-type headache|tension-type headache
5248352|NCT02455323|Manual therapy|manual therapy
5248353|NCT02455284|MRI|mri
5248354|NCT02455284|Tractography|tractography
5248355|NCT02455284|white|white
5248356|NCT02455284|physiology|physiology
5248357|NCT02455284|analysis|analysis
5248358|NCT02455284|matter|matter
5248359|NCT02455284|tracts|tracts
5248360|NCT02455271|Insomnia|insomnia
5248361|NCT02455258|Inactivity|inactivity
5248362|NCT02455180|Critical Care|critical care
5248363|NCT02455167|HCV|hcv
5248364|NCT02455167|Hepatitis C|hepatitis c
5248365|NCT02455154|Chinese Traditional Medicine|chinese traditional medicine
5248366|NCT02455154|Osteoporosis|osteoporosis
5248367|NCT02455154|adjuvant endocrine therapy|adjuvant endocrine therapy
5248368|NCT02455154|early breast cancer|early breast cancer
5248369|NCT02455141|chemptherapy|chemptherapy
5248370|NCT02455141|triple negative|triple negative
5248371|NCT02455141|taxanes|taxanes
5248372|NCT02455141|carboplatin|carboplatin
5248373|NCT02455128|Anxiety|anxiety
5248374|NCT02455128|Fear|fear
5248375|NCT02455128|Colorectal Surgery|colorectal surgery
5248376|NCT02455128|Colorectal Neoplasms|colorectal neoplasms
5248377|NCT02455115|Acute kidney injury|acute kidney injury
5248378|NCT02455115|Liver transplantation|liver transplantation
5248383|NCT02455115|Norepinephrine|norepinephrine
5248385|NCT02455102|Anticoagulation|anticoagulation
5248386|NCT02455102|Electronic warning system|electronic warning system
5248387|NCT02455089|Flare|flare
5248388|NCT02455089|Therapeutic adjustments|therapeutic adjustments
5248389|NCT02455089|Biological Marker|biological marker
5248390|NCT02455089|Immunologic Marker|immunologic marker
5248391|NCT02455089|Prognosis|prognosis
5248392|NCT02455076|Hypoglycemia|hypoglycemia
5248393|NCT02455037|Concussion|concussion
5248394|NCT02455037|Contact sport|contact sport
5248395|NCT02455037|Collision sport|collision sport
5248396|NCT02455037|Neck strengthening|neck strengthening
5248397|NCT02455024|Leukemia|leukemia
5248398|NCT02455024|Leukemia, Myeloid|leukemia, myeloid
5248399|NCT02455024|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5248400|NCT02455024|ponatinib|ponatinib
5248401|NCT02455024|Pharmacologic Actions|pharmacologic actions
5248402|NCT02455024|Protein Kinase Inhibitors|protein kinase inhibitors
5248403|NCT02455024|Risk factor|risk factor
5248404|NCT02455024|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
5248405|NCT02455024|CML|cml
5248406|NCT02455024|CP-CML|cp-cml
5248407|NCT02455024|Iclusig|iclusig
5248408|NCT02455024|AP24534|ap24534
5248409|NCT02455024|AP-CML|ap-cml
5248410|NCT02455024|BP-CML|bp-cml
5248411|NCT02455024|Ph+ALL|ph+all
5248412|NCT02454998|Unilateral complete cleft lip|unilateral complete cleft lip
5248413|NCT02454998|Alveolar bone graft|alveolar bone graft
5248414|NCT02454946|Blood Group Antigens|blood group antigens
5248415|NCT02454946|erectile dysfunction|erectile dysfunction
5248416|NCT02454933|Phase III Open Label Study; AZD9291 plus MEDI4736 versus AZD9291 Monotherapy; NSCLC After Previous EGFR TKI Therapy; T790M Mutation Positive Tumours.|phase iii open label study; azd9291 plus medi4736 versus azd9291 monotherapy; nsclc after previous egfr tki therapy; t790m mutation positive tumours.
5248418|NCT02454920|Optical Coherence Tomography|optical coherence tomography
5248419|NCT02454920|Extraocular muscles|extraocular muscles
5248420|NCT02454868|Remifentanil|remifentanil
5248421|NCT02454868|Intubation|intubation
5248422|NCT02454868|Children|children
5248423|NCT02454855|quality of life|quality of life
5248424|NCT02454855|melatonin|melatonin
5248425|NCT02454855|Elderly patient|elderly patient
5248427|NCT02454842|low-oxygen conditions|low-oxygen conditions
5248428|NCT02454842|hypoxia|hypoxia
5248429|NCT02454842|non-small cell lung cancer|non-small cell lung cancer
5248430|NCT02454842|NSCLC|nsclc
5248431|NCT02454842|squamous cell carcinoma|squamous cell carcinoma
5248432|NCT02454842|Tarloxotinib|tarloxotinib
5248684|NCT02453425|blood pressure|blood pressure
5248433|NCT02454829|Ovarian cortex cryopreservation|ovarian cortex cryopreservation
5248434|NCT02454829|ovarian function|ovarian function
5248435|NCT02454790|Acute toxicity|acute toxicity
5248436|NCT02454790|Late toxicity|late toxicity
5248437|NCT02454790|Prediction models|prediction models
5248438|NCT02454738|pulmonary tuberculosis|pulmonary tuberculosis
5248439|NCT02454738|chest|chest
5248440|NCT02454738|ultralow dose computed tomography|ultralow dose computed tomography
5248441|NCT02454725|HIV Testing|hiv testing
5248442|NCT02454725|Latino|latino
5248443|NCT02454712|Prodrug|prodrug
5248444|NCT02454712|PF614|pf614
5248445|NCT02454712|oxycodone extended-release|oxycodone extended-release
5248446|NCT02454712|oral|oral
5248447|NCT02454699|antiviral|antiviral
5248448|NCT02454699|ascending dose|ascending dose
5248449|NCT02454699|Cytomegalovirus|cytomegalovirus
5248450|NCT02454699|food effect|food effect
5248451|NCT02454699|Herpesviridae|herpesviridae
5248452|NCT02454699|MBX-400|mbx-400
5248453|NCT02454686|Complications after hepatectomy|complications after hepatectomy
5248454|NCT02454673|Radiotherapy|radiotherapy
5248455|NCT02454673|Neoadjuvant therapy|neoadjuvant therapy
5248456|NCT02454673|Pharmacodynamics|pharmacodynamics
5248457|NCT02454673|Pharmacokinetics|pharmacokinetics
5248458|NCT02454673|Nonlinear Dynamics|nonlinear dynamics
5248459|NCT02454660|adherence|adherence
5248460|NCT02454660|hypertension|hypertension
5248461|NCT02454660|mobile technology|mobile technology
5248462|NCT02454660|intervention|intervention
5248463|NCT02454647|Radiotherapy|radiotherapy
5248464|NCT02454647|Neoadjuvant therapy|neoadjuvant therapy
5248465|NCT02454647|Induction chemotherapy|induction chemotherapy
5248466|NCT02454647|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5248467|NCT02454647|Preoperative factors|preoperative factors
5248468|NCT02454647|Dynamic factors|dynamic factors
5248469|NCT02454647|Prognostic Factor|prognostic factor
5248470|NCT02454634|IDH1R132H|idh1r132h
5248471|NCT02454634|peptide vaccine|peptide vaccine
5253734|NCT02424279|pain|pain
5248478|NCT02454543|androgen deprivation|androgen deprivation
5248479|NCT02454543|best systemic therapy|best systemic therapy
5248480|NCT02454504|Sugammadex|sugammadex
5143496|NCT03094663|PAI|pai
5248481|NCT02454504|Delayed Emergence from Anesthesia|delayed emergence from anesthesia
5248482|NCT02454504|Curare|curare
5248483|NCT02454504|Robotic Surgical Procedures|robotic surgical procedures
5248484|NCT02454491|percutaneous coronary interventions|percutaneous coronary interventions
5248485|NCT02454491|radial artery access|radial artery access
5248486|NCT02454491|access site complications|access site complications
5248487|NCT02454491|verapamil|verapamil
5248488|NCT02454491|heparin|heparin
5248489|NCT02454478|lenvatinib|lenvatinib
5248490|NCT02454478|Everolimus|everolimus
5248491|NCT02454478|Carcinoma|carcinoma
5248492|NCT02454478|Unresectable advanced renal cell carcinoma|unresectable advanced renal cell carcinoma
5248493|NCT02454478|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5248494|NCT02454452|Varicose Veins|varicose veins
5248495|NCT02454439|Heart Failure with reduced ejection fraction (<35%)|heart failure with reduced ejection fraction (<35%)
5248496|NCT02454439|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5248497|NCT02454439|Non specific intraventricular conduction|non specific intraventricular conduction
5248498|NCT02454439|Efficacy|efficacy
5248499|NCT02454439|Life expectancy expected to exceed one year with a good functional status|life expectancy expected to exceed one year with a good functional status
5248500|NCT02454439|QRS morphology : NICD according to the AHA/ACCF/HRS Recommendations (non-LBBB and non-RBBB):|qrs morphology : nicd according to the aha/accf/hrs recommendations (non-lbbb and non-rbbb):
5248501|NCT02454439|QRS duration > 130 ms|qrs duration > 130 ms
5248502|NCT02454426|Depression|depression
5248503|NCT02454426|Heart disease|heart disease
5248504|NCT02454413|dentures hygiene|dentures hygiene
5248505|NCT02454413|biofilm formation|biofilm formation
5248506|NCT02454413|oral health|oral health
5248507|NCT02454400|physical therapy|physical therapy
5248508|NCT02454400|lumbar spine surgery|lumbar spine surgery
5248509|NCT02454400|pre-surgical intervention|pre-surgical intervention
5248510|NCT02454400|RCT|rct
5248511|NCT02454374|Physiotherapy|physiotherapy
5248512|NCT02454374|Knee Loading|knee loading
5248513|NCT02454374|Randomised Controlled Trial|randomised controlled trial
5248514|NCT02454374|Pain|pain
5248515|NCT02454361|Safety|safety
5248516|NCT02454361|tolerability|tolerability
5248517|NCT02454361|pharmacokinetics|pharmacokinetics
5248518|NCT02454361|KBP-7072|kbp-7072
5248519|NCT02454348|septic shock|septic shock
5248520|NCT02454348|vasopressin|vasopressin
5248521|NCT02454348|norepinephrine|norepinephrine
5248522|NCT02454296|Laminaria|laminaria
5248523|NCT02454270|First-in-Human|first-in-human
5248525|NCT02454270|Diffuse Large-Cell Lymphoma|diffuse large-cell lymphoma
5248526|NCT02454270|Follicular Lymphoma|follicular lymphoma
5248527|NCT02454270|Mantle-Cell Lymphoma|mantle-cell lymphoma
5248528|NCT02454270|Acute Lymphoid Leukemia|acute lymphoid leukemia
5248529|NCT02454270|Dose Escalation Study|dose escalation study
5248530|NCT02454270|Duvortuxizumab|duvortuxizumab
5248531|NCT02454231|EPC|epc
5248532|NCT02454231|CD34+|cd34+
5248533|NCT02454231|CD14+CD34low|cd14+cd34low
5248534|NCT02454218|Fibromyalgia|fibromyalgia
5248535|NCT02454218|Transcranial direct current stimulation|transcranial direct current stimulation
5248536|NCT02454192|Evidence-based intervention|evidence-based intervention
5248537|NCT02454192|Implementation|implementation
5248538|NCT02454192|Underserved communities|underserved communities
5248539|NCT02454127|nutrition|nutrition
5248540|NCT02454127|popular diets|popular diets
5248541|NCT02454127|weight loss|weight loss
5248542|NCT02454127|lifestyle|lifestyle
5248543|NCT02454127|counseling|counseling
5248544|NCT02454114|Pneumonia|pneumonia
5248545|NCT02454114|Community|community
5248546|NCT02454114|Hospital|hospital
5248547|NCT02454114|Respiratory|respiratory
5248548|NCT02454114|Infection|infection
5248549|NCT02454088|Volume|volume
5248550|NCT02454088|Hands|hands
5248551|NCT02454088|Filler|filler
5248552|NCT02454088|Radiesse|radiesse
5248553|NCT02454088|Calcium hydroxylapatite|calcium hydroxylapatite
5248554|NCT02454075|YF476|yf476
5248555|NCT02454075|netazepide|netazepide
5248556|NCT02454075|gastric carcinoids|gastric carcinoids
5248557|NCT02454075|Zollinger-Ellison syndrome|zollinger-ellison syndrome
5248558|NCT02454062|Phase I|phase i
5248559|NCT02454062|Solid Tumors|solid tumors
5248574|NCT02453971|binge drinking|binge drinking
5248575|NCT02453971|web-based personalized feedback program|web-based personalized feedback program
5248576|NCT02453971|students|students
5248577|NCT02453958|Injury|injury
5248578|NCT02453958|Brain|brain
5248579|NCT02453958|Traumatic Mild|traumatic mild
5248580|NCT02453958|Mild Traumatic Brain Injury|mild traumatic brain injury
5248581|NCT02453945|pain|pain
5248582|NCT02453945|comfort|comfort
5248583|NCT02453945|healing|healing
5248584|NCT02453945|quality of life|quality of life
5248585|NCT02453932|Vascular dementia|vascular dementia
5248586|NCT02453932|Tianzhi granule|tianzhi granule
5248587|NCT02453932|Herbal medicine|herbal medicine
5248588|NCT02453932|Randomized controlled trial|randomized controlled trial
5248589|NCT02453932|Three arms|three arms
5248590|NCT02453919|functional cardiac abnormality|functional cardiac abnormality
5248591|NCT02453919|morphologic cardiac abnormality|morphologic cardiac abnormality
5248592|NCT02453919|blood pressure abnormality|blood pressure abnormality
5248593|NCT02453893|Iloperidone|iloperidone
5248594|NCT02453893|Risperidone|risperidone
5248595|NCT02453893|PANSS|panss
5248596|NCT02453880|anxiety|anxiety
5248597|NCT02453880|depression|depression
5248598|NCT02453880|chronic illness|chronic illness
5248599|NCT02453880|teen|teen
5248600|NCT02453880|young adult|young adult
5248601|NCT02453867|kidney transplantation|kidney transplantation
5248602|NCT02453867|senior kidney transplant recipients|senior kidney transplant recipients
5248603|NCT02453867|tacrolimus once daily|tacrolimus once daily
5248604|NCT02453867|reduced immunosuppression|reduced immunosuppression
5248605|NCT02453867|recipients >65 years|recipients >65 years
5248606|NCT02453867|Senior|senior
5248607|NCT02453802|Tranexamic Acid|tranexamic acid
5248608|NCT02453802|Total Knee Arthroplasty|total knee arthroplasty
5248609|NCT02453802|Rivaroxaban|rivaroxaban
5248610|NCT02453789|alginate oligosaccharide|alginate oligosaccharide
5248611|NCT02453789|cystic fibrosis|cystic fibrosis
5248612|NCT02453789|Burkholderia|burkholderia
5248613|NCT02453789|aztreonam|aztreonam
5248614|NCT02453776|Crohns Disease|crohns disease
5248615|NCT02453776|Ulcerative Colitis|ulcerative colitis
5248616|NCT02453776|Infliximab|infliximab
5248617|NCT02453776|Sustained|sustained
5248618|NCT02453776|Remission|remission
5248619|NCT02453776|Inflammatory bowel disease|inflammatory bowel disease
5248620|NCT02453776|IBD|ibd
5248621|NCT02453763|Transcranial direct current stimulation|transcranial direct current stimulation
5248622|NCT02453763|Noninvasive brain stimulation|noninvasive brain stimulation
5248623|NCT02453763|Brain|brain
5236460|NCT02524522|automated protocol-driven weaning|automated protocol-driven weaning
5236461|NCT02524522|pulmonary recruitment maneuver|pulmonary recruitment maneuver
5236467|NCT02524444|malaria|malaria
5248624|NCT02453763|Central Nervous System Diseases|central nervous system diseases
5248625|NCT02453763|Nervous System Diseases|nervous system diseases
5248626|NCT02453763|Parkinson disease|parkinson disease
5248627|NCT02453763|Stroke|stroke
5248628|NCT02453763|Epilepsy|epilepsy
5248629|NCT02453763|Depression|depression
5248630|NCT02453763|Schizophrenia|schizophrenia
5248631|NCT02453763|Brain imaging|brain imaging
5248632|NCT02453763|Electrical impedance tomography|electrical impedance tomography
5248633|NCT02453763|Magnetic resonance electrical impedance tomography|magnetic resonance electrical impedance tomography
5246074|NCT02468570|rAv-PAL PEG|rav-pal peg
5248638|NCT02453750|Airway Inflammation|airway inflammation
5248639|NCT02453750|Asthma|asthma
5248640|NCT02453750|Hypersaline|hypersaline
5248641|NCT02453750|Pediatrics|pediatrics
5248642|NCT02453737|Proton|proton
5248643|NCT02453737|Brachytherapy|brachytherapy
5248644|NCT02453737|Partial Breast Irradiation|partial breast irradiation
5253938|NCT02423187|Rabeprazole|rabeprazole
5248650|NCT02453698|Stop task|stop task
5248651|NCT02453698|modulatory effect of MPH|modulatory effect of mph
5248652|NCT02453698|bottom-up and top-down|bottom-up and top-down
5248653|NCT02453698|cognitive processes|cognitive processes
5248654|NCT02453633|Appointment reminder|appointment reminder
5248655|NCT02453633|Attendance|attendance
5248657|NCT02453594|PD1|pd1
5248658|NCT02453594|PD-1|pd-1
5248659|NCT02453594|PDL1|pdl1
5248660|NCT02453594|PD-L1|pd-l1
5248661|NCT02453542|hemophilia|hemophilia
5248662|NCT02453542|inhibitors|inhibitors
5248663|NCT02453542|thrombin|thrombin
5248664|NCT02453529|plasma concentration|plasma concentration
5248665|NCT02453529|pulmonary concentration|pulmonary concentration
5248666|NCT02453516|Serratus Block|serratus block
5248667|NCT02453516|Breast Surgery|breast surgery
5248668|NCT02453503|Lichen planus|lichen planus
5248669|NCT02453503|Mucoadhesive film|mucoadhesive film
5248670|NCT02453503|licorice|licorice
5248671|NCT02453490|Colorectal Cancer|colorectal cancer
5248672|NCT02453490|liver metastasis|liver metastasis
5248673|NCT02453490|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5248674|NCT02453477|Beta thalassemia|beta thalassemia
5248675|NCT02453477|Gene therapy|gene therapy
5248676|NCT02453477|Lentiviral vector|lentiviral vector
5248677|NCT02453451|MitraClip|mitraclip
5248678|NCT02453451|atrial septal defect|atrial septal defect
5248679|NCT02453451|iatrogenic|iatrogenic
5248680|NCT02453425|renal blood flow|renal blood flow
5248681|NCT02453425|renal oxygenation|renal oxygenation
5248682|NCT02453425|glomerular filtration rate|glomerular filtration rate
5248683|NCT02453425|filtration fraction|filtration fraction
5248685|NCT02453412|Arteriovenous fistulae (AVFs)|arteriovenous fistulae (avfs)
5248686|NCT02453412|Non-maturation|non-maturation
5248687|NCT02453412|Computational simulation|computational simulation
5248688|NCT02453386|Motor fluctuations|motor fluctuations
5248689|NCT02453386|Off time|off time
5248690|NCT02453386|On time|on time
5248691|NCT02453386|Dyskinesia|dyskinesia
5248692|NCT02453360|Anesthesia|anesthesia
5248693|NCT02453360|Analgesia|analgesia
5248694|NCT02453347|Stable chronic medical conditions|stable chronic medical conditions
5248695|NCT02453347|No current alcohol or substance abuse|no current alcohol or substance abuse
5248696|NCT02453347|Alpha Stim|alpha stim
5248697|NCT02453321|Continuous Femoral Nerve Block|continuous femoral nerve block
5248698|NCT02453321|Continuous Adductor Canal Block|continuous adductor canal block
5248699|NCT02453308|Artemisinin combination Therapies|artemisinin combination therapies
5248700|NCT02453295|Lymphedema|lymphedema
5248701|NCT02453295|Arm Disability|arm disability
5248702|NCT02453295|Cancer Survivorship|cancer survivorship
5248703|NCT02453295|Intervention|intervention
5248704|NCT02453282|NSCLC, PD-L1, MEDI4736, Tremelimumab, PFS, OS|nsclc, pd-l1, medi4736, tremelimumab, pfs, os
5248705|NCT02453269|Obesity|obesity
5248706|NCT02453269|Children|children
5248707|NCT02453269|Health Colective|health colective
5248708|NCT02453243|Suicide screening in the ED|suicide screening in the ed
5248709|NCT02453243|Safety Planning|safety planning
5248710|NCT02453217|severe mental illness|severe mental illness
5248711|NCT02453217|physical health screening|physical health screening
5248712|NCT02453217|randomised controlled trial|randomised controlled trial
5248713|NCT02453217|health behaviour change|health behaviour change
5248714|NCT02453178|physical activity|physical activity
5248715|NCT02453178|aging|aging
5248716|NCT02453178|cognition|cognition
5248718|NCT02453178|exercise|exercise
5248719|NCT02453165|vaginal dehiscence|vaginal dehiscence
5248720|NCT02453152|myotubular myopathy|myotubular myopathy
5248721|NCT02453152|respiratory muscles|respiratory muscles
5248722|NCT02453152|natural history|natural history
5248723|NCT02453126|Eosinophilic Esophagitis|eosinophilic esophagitis
5248724|NCT02453126|Esophageal Stricture|esophageal stricture
5248725|NCT02453048|Pertussis|pertussis
5248726|NCT02453048|Colonization|colonization
5248727|NCT02453048|Vaccine|vaccine
5248728|NCT02453048|Immune response|immune response
5248729|NCT02453048|BPZE1|bpze1
5248730|NCT02453048|Infection|infection
5248731|NCT02453048|Bordetella pertussis|bordetella pertussis
5248732|NCT02453048|B. pertussis|b. pertussis
5248733|NCT02453048|respiratory Tract Infection|respiratory tract infection
5248734|NCT02453035|bioresorbable scaffold|bioresorbable scaffold
5248735|NCT02453035|CAD|cad
5248736|NCT02453022|Bioavailability|bioavailability
5248738|NCT02453022|Danirixin|danirixin
5248739|NCT02453022|Food Effect|food effect
5254034|NCT02422784|calcium|calcium
5248740|NCT02453022|Pharmacokinetics|pharmacokinetics
5248741|NCT02452996|GNbAC1|gnbac1
5248742|NCT02452996|Multiple Sclerosis|multiple sclerosis
5248743|NCT02452996|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
5248744|NCT02452996|MSRV-Envelope protein|msrv-envelope protein
5248745|NCT02452996|Monoclonal antibody|monoclonal antibody
5248747|NCT02452983|Leukemia|leukemia
5248748|NCT02452983|Hematologic diseases|hematologic diseases
5248749|NCT02452983|Cytopenias|cytopenias
5248750|NCT02452983|Bone marrow diseases|bone marrow diseases
5248751|NCT02452983|Preleukemia|preleukemia
5674161|NCT00604747|physiotherapy|physiotherapy
5248752|NCT02452944|nerve stimulator, obturator nerve, ultrasound|nerve stimulator, obturator nerve, ultrasound
5248753|NCT02452918|skin infection|skin infection
5248754|NCT02452892|Depression|depression
5248755|NCT02452892|Major depression|major depression
5248756|NCT02452892|Low-field magnetic stimulation|low-field magnetic stimulation
5248757|NCT02452892|LFMS|lfms
5248758|NCT02452840|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5248759|NCT02452840|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5248760|NCT02452840|verteporfin|verteporfin
5248761|NCT02452840|photodynamic therapy|photodynamic therapy
5248762|NCT02452840|persistent disease activity|persistent disease activity
5248763|NCT02452710|Fatigue in Cancer Survivors|fatigue in cancer survivors
5248764|NCT02452697|Nonmyeloablative|nonmyeloablative
5248765|NCT02452697|Stem Cell|stem cell
5248766|NCT02452697|Transplant|transplant
5248767|NCT02452684|Insomnia|insomnia
5248768|NCT02452658|Fast food literacy|fast food literacy
5248769|NCT02452645|Food|food
5248770|NCT02452645|Nutrition|nutrition
5248771|NCT02452645|Physical Activity|physical activity
5248772|NCT02452645|Family|family
5248773|NCT02452645|Child Care|child care
5248774|NCT02452645|Home|home
5248775|NCT02452645|Environment|environment
5248776|NCT02452632|ASP1941|asp1941
5248777|NCT02452632|Type 2 diabetes mellitus|type 2 diabetes mellitus
5248778|NCT02452619|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5248779|NCT02452619|brain trauma|brain trauma
5248780|NCT02452619|cognitive impairment|cognitive impairment
5248781|NCT02452606|Stalevo|stalevo
5248782|NCT02452606|sleep disturbance|sleep disturbance
5248783|NCT02452606|central circadian clock|central circadian clock
5248784|NCT02452606|narcolepsy|narcolepsy
5248785|NCT02452593|incontinence; pelvic floor exercises; neuromodulation|incontinence; pelvic floor exercises; neuromodulation
5248786|NCT02452580|Kangaroo Mother Care|kangaroo mother care
5248787|NCT02452580|Neonatal Intensive Care Units|neonatal intensive care units
5248788|NCT02452580|Postnatal growth|postnatal growth
5248789|NCT02452541|Traumatic Brain Injury|traumatic brain injury
5248790|NCT02452541|Critically ill Patients|critically ill patients
5248791|NCT02452541|Death|death
5248792|NCT02452541|Head Injury|head injury
5248793|NCT02452541|TBI-Prognosis|tbi-prognosis
5248794|NCT02452541|Critical Care Medicine|critical care medicine
5248795|NCT02452541|Withdrawal of Life Sustaining Therapy|withdrawal of life sustaining therapy
5248796|NCT02452541|Prognosis|prognosis
5248797|NCT02452541|Prognostic Evaluation|prognostic evaluation
5248798|NCT02452541|Outcome Research|outcome research
5248799|NCT02452541|Mortality|mortality
5248800|NCT02452541|Decision-making|decision-making
5248801|NCT02452528|Hepatitis B Virus|hepatitis b virus
5248802|NCT02452528|Chronic Hepatitis B|chronic hepatitis b
5248803|NCT02452528|HBV|hbv
5248804|NCT02452502|stroke|stroke
5248805|NCT02452502|thrombolytic therapy|thrombolytic therapy
5248806|NCT02452502|atorvastatin|atorvastatin
5248807|NCT02452489|Different acupoints compatibility|different acupoints compatibility
5248808|NCT02452437|oxycodone|oxycodone
5248809|NCT02452437|hemodialysis|hemodialysis
5248810|NCT02452411|Internet|internet
5248811|NCT02452411|Adjustment disorders|adjustment disorders
5248812|NCT02452411|Homework assignments|homework assignments
5248813|NCT02452411|Cognitive-Behavioral treatment|cognitive-behavioral treatment
5248815|NCT02452411|Emotional Regulation|emotional regulation
5248816|NCT02452411|ICT's|ict's
5248817|NCT02452398|Hair removal|hair removal
5248818|NCT02452398|depilation|depilation
5248819|NCT02452398|epilation|epilation
5248820|NCT02452372|RNAi therapeutic|rnai therapeutic
5248821|NCT02452372|Porphyria|porphyria
5248822|NCT02452372|AIP|aip
5248823|NCT02452359|stretch marks|stretch marks
5248824|NCT02452346|MDS|mds
5248825|NCT02452333|Excisional breast biopsy|excisional breast biopsy
5248826|NCT02452333|Oncoplastic surgery|oncoplastic surgery
5248827|NCT02452333|Oncoplastic reconstruction|oncoplastic reconstruction
5248828|NCT02452333|Breast conserving surgery|breast conserving surgery
5248829|NCT02452333|Tezel method of breast volume measurement|tezel method of breast volume measurement
5248830|NCT02452320|bariatric|bariatric
5248831|NCT02452320|Post-operative nausea and vomiting|post-operative nausea and vomiting
5248832|NCT02452320|laparoscopic Sleeve gastrectomy|laparoscopic sleeve gastrectomy
5248836|NCT02452281|Stage III or Stage IV|stage iii or stage iv
5248837|NCT02452281|Malignant Melanoma|malignant melanoma
5248838|NCT02452281|Advanced Melanoma|advanced melanoma
5248840|NCT02452203|interoception|interoception
5248841|NCT02452177|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5248842|NCT02452177|vitamin D|vitamin d
5248843|NCT02452177|short bowel syndrome|short bowel syndrome
5248844|NCT02452177|farnesoid X receptor|farnesoid x receptor
5248845|NCT02452177|cholestasis|cholestasis
5248846|NCT02452164|otoscopy|otoscopy
5248847|NCT02452164|otitis media|otitis media
5248848|NCT02452164|cellphone|cellphone
5248849|NCT02452164|family|family
5248850|NCT02452151|Inflectra|inflectra
5248851|NCT02452151|Infliximab|infliximab
5248852|NCT02452151|Biosimilar|biosimilar
5248853|NCT02452099|DMSO|dmso
5248854|NCT02452099|cryopreservation|cryopreservation
5248855|NCT02452099|autologous transplantation|autologous transplantation
5248856|NCT02452099|hematopoietic stem cells|hematopoietic stem cells
5248857|NCT02452099|hematological malignancies|hematological malignancies
5248858|NCT02452073|low triiodothyronine syndrome|low triiodothyronine syndrome
5248859|NCT02452073|chronic radiation enteritis|chronic radiation enteritis
5248860|NCT02452073|triiodothyronine|triiodothyronine
5248861|NCT02452073|thyroxine|thyroxine
5248862|NCT02452073|thyroid stimulating hormone|thyroid stimulating hormone
5248863|NCT02452060|perioperative period|perioperative period
5248864|NCT02452060|pain|pain
5248865|NCT02452060|gastric bypass|gastric bypass
5248866|NCT02452008|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5248867|NCT02452008|enzalutamide|enzalutamide
5248868|NCT02452008|LY2157299|ly2157299
5248869|NCT02452008|TGF-β receptor inhibitor|tgf-β receptor inhibitor
5248870|NCT02451943|leiomyosarcoma|leiomyosarcoma
5248871|NCT02451943|soft tissue sarcoma (STS)|soft tissue sarcoma (sts)
5248872|NCT02451943|advanced soft tissue sarcoma|advanced soft tissue sarcoma
5248873|NCT02451943|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
5248874|NCT02451943|liposarcoma|liposarcoma
5248875|NCT02451943|undifferentiated pleomorphic sarcoma|undifferentiated pleomorphic sarcoma
5248876|NCT02451943|doxorubicin|doxorubicin
5248877|NCT02451917|Glargine insulin|glargine insulin
5248878|NCT02451917|Chronic Kidney Disease|chronic kidney disease
5248879|NCT02451917|CGMS|cgms
5248880|NCT02451904|Pathogenesis|pathogenesis
5248881|NCT02451904|Microvascular function|microvascular function
5248882|NCT02451904|Metabolic dysregulation|metabolic dysregulation
5248883|NCT02451904|Metabolomics|metabolomics
5248884|NCT02451878|shyness|shyness
5248885|NCT02451878|internet|internet
5248886|NCT02451878|self-help|self-help
5248887|NCT02451878|psychology|psychology
5248888|NCT02451878|wellbeing|wellbeing
5248889|NCT02451839|Crohn Disease|crohn disease
5248890|NCT02451839|Arthritis, Rheumatoid|arthritis, rheumatoid
5248891|NCT02451839|Psoriasis|psoriasis
5248892|NCT02451839|Patient Outcome Assessment|patient outcome assessment
5248893|NCT02451839|Adalimumab|adalimumab
5248894|NCT02451839|Global Health|global health
5248895|NCT02451839|Quality of Life|quality of life
5248896|NCT02451826|ovulation inhibition|ovulation inhibition
5248897|NCT02451826|endometrial changes|endometrial changes
5118618|NCT03254472|INR|inr
5129390|NCT03185832|ICD|icd
5248898|NCT02451826|bleeding patterns|bleeding patterns
5248899|NCT02451813|opening injection pressure|opening injection pressure
5248900|NCT02451813|femoral nerve block|femoral nerve block
5248901|NCT02451813|fascia iliaca|fascia iliaca
5248902|NCT02451813|ultrasound guided nerve block|ultrasound guided nerve block
5248903|NCT02451774|pediatric|pediatric
5248904|NCT02451774|apoptosis|apoptosis
5248905|NCT02451761|chromosomal rearrangement|chromosomal rearrangement
5248906|NCT02451761|next generation sequencing|next generation sequencing
5248907|NCT02451761|intellectual disability|intellectual disability
5248908|NCT02451761|multiple congenital anomalies|multiple congenital anomalies
5248909|NCT02451761|gene disruption|gene disruption
5248910|NCT02451735|female breast cancer|female breast cancer
5248911|NCT02451735|bilateral breast cancer|bilateral breast cancer
5248912|NCT02451735|triple negative breast cancer|triple negative breast cancer
5248913|NCT02451735|breast cancer diagnosis|breast cancer diagnosis
5248914|NCT02451735|BRCA 1|brca 1
5248915|NCT02451735|BRCA 2|brca 2
5248916|NCT02451735|psychoeducational intervention (PEI)|psychoeducational intervention (pei)
5248917|NCT02451735|genetic counseling|genetic counseling
5248918|NCT02451735|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
5248919|NCT02451735|cancer education materials|cancer education materials
5248920|NCT02451683|SCI|sci
5248921|NCT02451631|Mobile Application|mobile application
5248922|NCT02451631|Diabetes management|diabetes management
5248923|NCT02451618|Perinatal Depression|perinatal depression
5248924|NCT02451605|surgery|surgery
5248926|NCT02451592|Hematologic malignancies|hematologic malignancies
5248927|NCT02451579|Actinic Keratoses|actinic keratoses
5248928|NCT02451579|Photodynamic Therapy|photodynamic therapy
5248929|NCT02451579|PDT|pdt
5248930|NCT02451579|Blue Light|blue light
5248931|NCT02451566|Abdominal|abdominal
5248936|NCT02451540|Computed Tomography scan|computed tomography scan
5248941|NCT02451540|PRO|pro
5248942|NCT02451514|Antibody persistence|antibody persistence
5248943|NCT02451514|Young Adults|young adults
5248946|NCT02451514|Booster response|booster response
5248947|NCT02451514|MenABCWY+OMV|menabcwy+omv
5248948|NCT02451475|Pregabalin|pregabalin
5248949|NCT02451475|Fibromyalgia|fibromyalgia
5248950|NCT02451462|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5248951|NCT02451462|bone marrow transplant|bone marrow transplant
5248952|NCT02451449|Celiac disease|celiac disease
5248953|NCT02451449|Infertility|infertility
5248954|NCT02451449|Prevalence study|prevalence study
5248956|NCT02451423|Non-metastatic|non-metastatic
5248957|NCT02451423|Bladder|bladder
5248958|NCT02451410|Nutrition|nutrition
5248959|NCT02451410|Physical activity|physical activity
5248960|NCT02451410|Overweight|overweight
5248961|NCT02451410|Obesity|obesity
5248962|NCT02451410|Malnutrition|malnutrition
5248963|NCT02451371|Schizophrenia|schizophrenia
5248964|NCT02451371|Refractory auditory hallucination|refractory auditory hallucination
5248965|NCT02451371|tDCS|tdcs
5248966|NCT02451358|Influenza|influenza
5248967|NCT02451358|Quadrivalent Inactivated Influenza Vaccine (QIV)|quadrivalent inactivated influenza vaccine (qiv)
5248968|NCT02451345|Prostate cancer|prostate cancer
5248969|NCT02451345|Tranformative Impact Award|tranformative impact award
5248970|NCT02451345|Early stage|early stage
5248971|NCT02451345|Active Surveillance|active surveillance
5248972|NCT02451345|Decision aid|decision aid
5248973|NCT02451345|Coaching session|coaching session
5248974|NCT02451345|Personalized|personalized
5248975|NCT02451345|UCSF|ucsf
5248976|NCT02451345|validation|validation
5248977|NCT02451319|RIRS, holmium, 1-2 cm,stones,kidney|rirs, holmium, 1-2 cm,stones,kidney
5248978|NCT02451293|Depression|depression
5248979|NCT02451293|Acute Coronary Syndrome|acute coronary syndrome
5248980|NCT02451293|Anxiety|anxiety
5248981|NCT02451293|Sleep|sleep
5248982|NCT02451293|Circadian|circadian
5248983|NCT02451280|stroke rehabilitation|stroke rehabilitation
5248984|NCT02451280|robot-assisted therapy|robot-assisted therapy
5248985|NCT02451280|hybrid therapy|hybrid therapy
5248986|NCT02451267|neck pain|neck pain
5248987|NCT02451267|aerobic exercise|aerobic exercise
5248988|NCT02451267|cervical pain|cervical pain
5248989|NCT02451241|Acupuncture|acupuncture
5248990|NCT02451228|Pharmacokinetics|pharmacokinetics
5248991|NCT02451228|Pharmacodynamics|pharmacodynamics
5248992|NCT02451228|Preterm labor|preterm labor
5248993|NCT02451228|Preterm birth|preterm birth
5248994|NCT02451228|Estradiol|estradiol
5248995|NCT02451228|Indomethacin|indomethacin
5248996|NCT02451228|Pregnancy|pregnancy
5248997|NCT02451228|Short Cervix|short cervix
5248998|NCT02451228|CYP2C9 Genotype|cyp2c9 genotype
5248999|NCT02451202|"surgical conditions"|"surgical conditions"
5249000|NCT02451202|"deep neuromuscular blockade"|"deep neuromuscular blockade"
5249001|NCT02451202|"deep neuromuscular paralysis"|"deep neuromuscular paralysis"
5249002|NCT02451189|Obesity|obesity
5249003|NCT02451189|Weight maintenance|weight maintenance
5249004|NCT02451189|Appetite|appetite
5249005|NCT02451189|Energy intake|energy intake
5249006|NCT02451189|Dietary fibre|dietary fibre
5249007|NCT02451189|Short-chain fatty acids|short-chain fatty acids
5249008|NCT02451189|Fermentation|fermentation
5249010|NCT02451150|Drug therapy|drug therapy
5249011|NCT02451124|Barrett|barrett
5249012|NCT02451124|Cancer|cancer
5249013|NCT02451124|Screening|screening
5249017|NCT02451085|hip|hip
5249018|NCT02451085|surgery|surgery
5249019|NCT02451085|Replacement|replacement
5249020|NCT02451059|community resource|community resource
5249021|NCT02451059|well-child care visit|well-child care visit
5249023|NCT02451046|Liver transplantation|liver transplantation
5249024|NCT02451046|Primary dysfunction|primary dysfunction
5249025|NCT02451033|Regenerative medicine|regenerative medicine
5249026|NCT02451020|healthy volunteers|healthy volunteers
5249027|NCT02451020|acclimatization|acclimatization
5249028|NCT02451020|sleep|sleep
5249029|NCT02451020|hypoxia|hypoxia
5249030|NCT02450994|airway disease|airway disease
5249031|NCT02450994|bronchitis|bronchitis
5249032|NCT02450994|emphysema|emphysema
5249033|NCT02450994|lung|lung
5249034|NCT02450994|treatment|treatment
5249035|NCT02450994|sleep|sleep
5249036|NCT02450968|airway disease|airway disease
5249037|NCT02450968|bronchitis|bronchitis
5249038|NCT02450968|emphysema|emphysema
5249039|NCT02450968|lung|lung
5249040|NCT02450968|treatment|treatment
5249041|NCT02450955|Tension-type headache|tension-type headache
5249042|NCT02450955|manual therapy|manual therapy
5249043|NCT02450955|disability|disability
5249045|NCT02450929|post operative|post operative
5249054|NCT02450916|psychological|psychological
5249055|NCT02450916|policy|policy
5249056|NCT02450903|Non-Small-Cell Lung Cancer, ALK, LDK378|non-small-cell lung cancer, alk, ldk378
5249057|NCT02450890|ORADUR®-Methylphenidate|oradur®-methylphenidate
5249058|NCT02450877|Children|children
5249059|NCT02450877|Young Adults|young adults
5249060|NCT02450877|Azacitidine|azacitidine
5249061|NCT02450877|Acute Myeloid Leukemia|acute myeloid leukemia
5249062|NCT02450877|Molecular Relapse|molecular relapse
5249063|NCT02450877|Vidaza|vidaza
5249064|NCT02450877|AZA-AML-004|aza-aml-004
5249065|NCT02450864|Stiffness of Shoulder, Not Elsewhere Classified|stiffness of shoulder, not elsewhere classified
5249066|NCT02450851|Rare Diseases|rare diseases
5249067|NCT02450851|Undiagnosed Disease|undiagnosed disease
5249068|NCT02450838|Dengue Vaccine|dengue vaccine
5249070|NCT02450773|postpartum|postpartum
5249071|NCT02450773|preeclampsia|preeclampsia
5249072|NCT02450773|gestational hypertension|gestational hypertension
5249073|NCT02450747|Visual Acuity|visual acuity
5249074|NCT02450734|ultrasound-guided intermediate cervical plexus block|ultrasound-guided intermediate cervical plexus block
5249075|NCT02450721|atherosclerosis|atherosclerosis
5249076|NCT02450721|biomarkers|biomarkers
5249077|NCT02450721|carotid artery stenosis|carotid artery stenosis
5249078|NCT02450721|ischemic stroke.|ischemic stroke.
5249079|NCT02450708|Allogeneic Hematopoietic Cell Donors|allogeneic hematopoietic cell donors
5249080|NCT02450708|KIR and HLA Genotypes|kir and hla genotypes
5249081|NCT02450708|15-059|15-059
5249082|NCT02450695|rTMS|rtms
5249083|NCT02450695|treatment refractory|treatment refractory
5249084|NCT02450695|treatment resistant|treatment resistant
5249085|NCT02450695|SSRI|ssri
5249086|NCT02450695|clomipramine|clomipramine
5249087|NCT02450669|Intubation|intubation
5249088|NCT02450669|Extubation|extubation
5249089|NCT02450669|Weaning|weaning
5249090|NCT02450669|Mechanical ventilation|mechanical ventilation
5249091|NCT02450617|Complex PTSD|complex ptsd
5249092|NCT02450604|Prevalence Study|prevalence study
5249093|NCT02450604|Fabry's disease|fabry's disease
5249094|NCT02450604|Chronic pain|chronic pain
5249095|NCT02450591|Sensitizing EGFR Mutations|sensitizing egfr mutations
5249096|NCT02450591|Erlotinib|erlotinib
5249097|NCT02450591|Surgery|surgery
5249098|NCT02450591|Radiation Therapy|radiation therapy
5249099|NCT02450591|15-067|15-067
5249100|NCT02450552|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5249101|NCT02450552|ALS|als
5249102|NCT02450552|Lou Gehrig|lou gehrig
5249103|NCT02450539|patient reported outcomes (PRO)|patient reported outcomes (pro)
5249104|NCT02450539|patient focused outcomes (PFO)|patient focused outcomes (pfo)
5249105|NCT02450539|biomarkers|biomarkers
5249106|NCT02450539|CDK 4 and 6|cdk 4 and 6
5249107|NCT02450513|adalimumab|adalimumab
5249108|NCT02450513|anti-TNF|anti-tnf
5249109|NCT02450513|pharmacokinetics|pharmacokinetics
5249110|NCT02450513|trough level|trough level
5249111|NCT02450513|immunogenicity|immunogenicity
5249112|NCT02450487|Piroxicam|piroxicam
5249113|NCT02450487|Pharmacogenetic|pharmacogenetic
5249114|NCT02450487|Lower Third molar|lower third molar
5249115|NCT02450448|Renal Neoplasms|renal neoplasms
5249116|NCT02450448|Circulating Tumor Cells|circulating tumor cells
5249117|NCT02450435|Prostatic Neoplasms|prostatic neoplasms
5249118|NCT02450435|Circulating TUmor Cells|circulating tumor cells
5249119|NCT02450422|Colorectal Neoplasms|colorectal neoplasms
5249120|NCT02450422|Circulating Tumor Cells|circulating tumor cells
5249121|NCT02450409|Total knee arthroplasty|total knee arthroplasty
5118749|NCT03253757|HIV|hiv
5249122|NCT02450409|Midflexion instability|midflexion instability
5249123|NCT02450409|Gap technique|gap technique
5249124|NCT02450409|Anatomical alignment|anatomical alignment
5249125|NCT02450396|Rare diseases|rare diseases
5249126|NCT02450396|pregnancy|pregnancy
5249127|NCT02450396|pregnancy,|pregnancy,
5249128|NCT02450357|Breast Neoplasms|breast neoplasms
5249129|NCT02450357|Circulating Tumor Cells|circulating tumor cells
5249130|NCT02450279|Aerosol delivery|aerosol delivery
5249131|NCT02450279|Invasive mechanical ventilation|invasive mechanical ventilation
5249132|NCT02450279|Jet Nebulizer|jet nebulizer
5249133|NCT02450279|Vibrating-Mesh nebulizer|vibrating-mesh nebulizer
5249134|NCT02450266|Primary disease|primary disease
5249135|NCT02450266|multiparametric MRI|multiparametric mri
5249136|NCT02450266|targeted prostate biopsy|targeted prostate biopsy
5249137|NCT02450266|MRI/ultrasound fusion-guided prostate biopsy|mri/ultrasound fusion-guided prostate biopsy
5249138|NCT02450266|systematic transrectal ultrasound-guided prostate biopsy|systematic transrectal ultrasound-guided prostate biopsy
5249139|NCT02450253|Vascular cognitive impairment|vascular cognitive impairment
5249140|NCT02450240|Depression|depression
5249141|NCT02450240|Anxiety|anxiety
5249142|NCT02450240|Eating Disorders|eating disorders
5249143|NCT02450240|Substance Use|substance use
5249144|NCT02450240|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5249145|NCT02450240|Genetics|genetics
5249146|NCT02450240|Behavior|behavior
5249147|NCT02450240|Mental Health|mental health
5249148|NCT02450214|Ketamine|ketamine
5249149|NCT02450214|Magnesium|magnesium
5249150|NCT02450214|Analgesia|analgesia
5249151|NCT02450214|Liposuction|liposuction
5249152|NCT02450214|Lipoabdominoplasty|lipoabdominoplasty
5249153|NCT02450214|Preemptive analgesia|preemptive analgesia
5249154|NCT02450188|Erectile Dysfunction|erectile dysfunction
5249155|NCT02450188|PDE5 inhibitors|pde5 inhibitors
5249156|NCT02450188|Cognitive-behavioral Sex Therapy|cognitive-behavioral sex therapy
5249157|NCT02450175|Platelet Activation|platelet activation
5249158|NCT02450175|metastasis|metastasis
5249159|NCT02450110|spinal cord stimulation|spinal cord stimulation
5249160|NCT02450110|heart failure|heart failure
5249161|NCT02450110|autonomic regulation|autonomic regulation
5249163|NCT02450110|left ventricle systolic dysfunction|left ventricle systolic dysfunction
5249164|NCT02450071|Pre-hospital|pre-hospital
5249165|NCT02450071|Out-of-hospital|out-of-hospital
5249166|NCT02450071|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
5249167|NCT02450071|Emergency medical services (MeSH)|emergency medical services (mesh)
5249168|NCT02450071|Helicopter emergency medical service|helicopter emergency medical service
5249169|NCT02450071|Critical care (MeSH)|critical care (mesh)
5249170|NCT02450071|Airway management (MeSH)|airway management (mesh)
5249171|NCT02450071|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
5249172|NCT02450071|Difficult endotracheal intubation|difficult endotracheal intubation
5249173|NCT02450071|Complications (MeSH)|complications (mesh)
5249174|NCT02450071|Patient safety|patient safety
5249175|NCT02450058|early breast cancer|early breast cancer
5249176|NCT02450058|adjuvant chemotherapy|adjuvant chemotherapy
5249177|NCT02450058|FEC|fec
5249178|NCT02450058|paclitaxel|paclitaxel
5249179|NCT02449993|diagnostic study|diagnostic study
5249180|NCT02449993|analysis of estrogen receptor|analysis of estrogen receptor
5249181|NCT02449993|progesterone receptor|progesterone receptor
5249182|NCT02449993|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5249183|NCT02449993|Ki-67|ki-67
5249184|NCT02449980|Spontaneous Pneumothorax|spontaneous pneumothorax
5249185|NCT02449980|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
5249186|NCT02449980|Tube Thoracostomy|tube thoracostomy
5249187|NCT02449980|Pediatric Surgery|pediatric surgery
5249188|NCT02449967|Pancreatic Cancer|pancreatic cancer
5249189|NCT02449967|HepaSphere|hepasphere
5249190|NCT02449954|Stress and Immune Responses|stress and immune responses
5249191|NCT02449954|morphine|morphine
5249192|NCT02449954|tramadol|tramadol
5249193|NCT02449954|ketorolac|ketorolac
5249194|NCT02449941|Stomach Neoplasms|stomach neoplasms
5249195|NCT02449941|proton pump inhibitor|proton pump inhibitor
5249196|NCT02449941|endoscopic submucosal dissection|endoscopic submucosal dissection
5249197|NCT02449941|Helicobacter pylori|helicobacter pylori
5249198|NCT02449941|Gastritis, Atrophic|gastritis, atrophic
5249199|NCT02449928|Severe Sepsis with Septic Shock, Lactate|severe sepsis with septic shock, lactate
5249200|NCT02449915|sacrocolpopexy|sacrocolpopexy
5249201|NCT02449915|rectocele repair|rectocele repair
5249202|NCT02449902|VVA|vva
5249203|NCT02449902|Postmenopausal|postmenopausal
5249204|NCT02449902|Painful Sex|painful sex
5249205|NCT02449863|Lung ultrasound|lung ultrasound
5249206|NCT02449863|Mechanical ventilation|mechanical ventilation
5144303|NCT03089775|Allergic|allergic
5249207|NCT02449863|Respiratory distress syndrome|respiratory distress syndrome
5249208|NCT02449863|Transient tachypnea of the newborn|transient tachypnea of the newborn
5249209|NCT02449850|In-utero environment|in-utero environment
5249210|NCT02449850|Asthma|asthma
5249211|NCT02449850|Allergic diseases|allergic diseases
5129691|NCT03183947|fMRI|fmri
5249212|NCT02449850|Food allergy|food allergy
5249213|NCT02449850|Birth cohort study|birth cohort study
5249214|NCT02449850|Primary prevention|primary prevention
5237049|NCT02520713|Pediatric Solid Tumor|pediatric solid tumor
5237050|NCT02520648|Back pain|back pain
5237051|NCT02520648|Manual therapy|manual therapy
5237052|NCT02520635|prognosis|prognosis
5237053|NCT02520635|supra-early chemotherapy|supra-early chemotherapy
5249215|NCT02449850|Intervention study|intervention study
5249216|NCT02449850|Atopic dermatitis|atopic dermatitis
5249217|NCT02449850|Rhinitis|rhinitis
5249219|NCT02449850|Lung function|lung function
5249220|NCT02449850|Non-communicable diseases|non-communicable diseases
5249221|NCT02449850|Foetal growth|foetal growth
5249222|NCT02449850|Obesity|obesity
5249223|NCT02449850|Cardiovascular disease|cardiovascular disease
5249224|NCT02449850|Diabetes|diabetes
5249225|NCT02449850|Blood pressure|blood pressure
5249226|NCT02449850|Anthropometric|anthropometric
5249227|NCT02449850|Trans epidermic water loss|trans epidermic water loss
5249228|NCT02449824|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5249229|NCT02449824|magnetic resonance imaging|magnetic resonance imaging
5249230|NCT02449798|Difficult IV access|difficult iv access
5249231|NCT02449798|AccuCath|accucath
5249232|NCT02449798|IV outcomes|iv outcomes
5249233|NCT02449798|patient satisfaction|patient satisfaction
5249234|NCT02449785|Cystic fibrosis|cystic fibrosis
5249237|NCT02449785|CT|ct
5249238|NCT02449785|Exacerbation|exacerbation
5249239|NCT02449785|Quality of life|quality of life
5249240|NCT02449785|Pulmonary function|pulmonary function
5249241|NCT02449772|N04.452.442.422.336|n04.452.442.422.336
5249242|NCT02449746|Schizophrenia|schizophrenia
5249243|NCT02449746|Psychosis|psychosis
5249244|NCT02449746|Mental Health|mental health
5249245|NCT02449746|Autoimmunity|autoimmunity
5249246|NCT02449746|Psychoneuroimmunology|psychoneuroimmunology
5249247|NCT02449733|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
5249248|NCT02449733|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
5249249|NCT02449733|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5249250|NCT02449733|homosexuality|homosexuality
5249251|NCT02449733|male|male
5249252|NCT02449733|South Africa|south africa
5249253|NCT02449720|intraperitoneal|intraperitoneal
5249254|NCT02449720|ropivacaine|ropivacaine
5249255|NCT02449720|bowel resection|bowel resection
5249256|NCT02449720|local anaesthetic|local anaesthetic
5249257|NCT02449720|recovery|recovery
5249258|NCT02449681|squamous cell carcinoma|squamous cell carcinoma
5249259|NCT02449681|the head and neck|the head and neck
5249260|NCT02449681|skin|skin
5249261|NCT02449681|TH-4000|th-4000
5249262|NCT02449681|Hypoxia|hypoxia
5249263|NCT02449681|Tarloxotinib|tarloxotinib
5249264|NCT02449668|Acupuncture|acupuncture
5249265|NCT02449668|Shoulder pain|shoulder pain
5249266|NCT02449668|Impingement syndrome|impingement syndrome
5249267|NCT02449668|Rotator cuff tendinitis|rotator cuff tendinitis
5249268|NCT02449668|Traditional Chinese medicine (TCM)|traditional chinese medicine (tcm)
5249269|NCT02449642|luteinizing hormone pulsatility|luteinizing hormone pulsatility
5249270|NCT02449642|estradiol level|estradiol level
5249271|NCT02449642|progesterone level|progesterone level
5249272|NCT02449629|HIV|hiv
5249273|NCT02449629|Transgender|transgender
5249274|NCT02449629|HIV Continuum of Care|hiv continuum of care
5249275|NCT02449616|Sickle cell|sickle cell
5249276|NCT02449616|vaso-occlusive crisis|vaso-occlusive crisis
5249277|NCT02449603|Chinese population|chinese population
5249278|NCT02449590|Onion|onion
5249279|NCT02449590|Cardiovascular disease|cardiovascular disease
5249280|NCT02449590|metabolomics|metabolomics
5249281|NCT02449590|Gene expression|gene expression
5249282|NCT02449590|Biomarker|biomarker
5249283|NCT02449577|Metabolomics|metabolomics
5249284|NCT02449577|Beer|beer
5249285|NCT02449577|Biomarker|biomarker
5249286|NCT02449577|Glucose response|glucose response
5249287|NCT02449577|Insulin response|insulin response
5249288|NCT02449486|Requirement of postoperative pain medication|requirement of postoperative pain medication
5249289|NCT02449473|Asthma|asthma
5249290|NCT02449473|Reactive Airways|reactive airways
5249291|NCT02449473|Respiratory Tract Disease|respiratory tract disease
5249292|NCT02449473|Obstructive Tract Disease|obstructive tract disease
5249293|NCT02449473|Lung Diseases|lung diseases
5249294|NCT02449460|hypertension|hypertension
5249295|NCT02449460|epidemiology|epidemiology
5249296|NCT02449460|glucose|glucose
5249297|NCT02449460|body mass index|body mass index
5249298|NCT02449460|lipids|lipids
5249299|NCT02449460|smoking|smoking
5249300|NCT02449460|coronary artery disease|coronary artery disease
5249301|NCT02449460|arterial stiffness|arterial stiffness
5249302|NCT02449460|carotid ultrasound|carotid ultrasound
5249303|NCT02449447|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5249304|NCT02449447|Blended treatment|blended treatment
5249305|NCT02449447|Cognitive behavior Therapy (CBT)|cognitive behavior therapy (cbt)
5237148|NCT02519972|Low dose CT screening|low dose ct screening
5129801|NCT03183193|Epigenetics|epigenetics
5237149|NCT02519972|Family history of lung cancer|family history of lung cancer
5249306|NCT02449447|Face-to-face|face-to-face
5249307|NCT02449447|internet-based treatment|internet-based treatment
5249308|NCT02449421|trauma|trauma
5249432|NCT02448641|chronic stroke|chronic stroke
5249309|NCT02449382|continuous venovenous hemofiltration|continuous venovenous hemofiltration
5249310|NCT02449382|conventional treatment|conventional treatment
5249311|NCT02449382|mortality|mortality
5249312|NCT02449382|acute severe hypernatremia|acute severe hypernatremia
5249313|NCT02449356|Prone position ventilation|prone position ventilation
5249314|NCT02449356|Endotracheal intubation|endotracheal intubation
5249315|NCT02449356|Displacement|displacement
5249316|NCT02449317|contrast induced acute kidney injury|contrast induced acute kidney injury
5249317|NCT02449317|bioimpedance|bioimpedance
5249318|NCT02449304|endometrial ablation, heavy menstrual bleeding, novosure|endometrial ablation, heavy menstrual bleeding, novosure
5249319|NCT02449278|advanced-stage DLBCL|advanced-stage dlbcl
5249320|NCT02449278|ISRT|isrt
5249321|NCT02449278|chemotherapy|chemotherapy
5249323|NCT02449265|consolidation involved-site radiotherapy|consolidation involved-site radiotherapy
5249324|NCT02449265|Chemotherapy|chemotherapy
5249325|NCT02449252|limited stage FL|limited stage fl
5249326|NCT02449252|Involved-site Radiotherapy|involved-site radiotherapy
5249327|NCT02449252|Chemotherapy|chemotherapy
5249328|NCT02449239|Urinary Bladder Cancer|urinary bladder cancer
5249329|NCT02449239|Non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5423254|NCT01616472|Steroid|steroid
5249330|NCT02449239|Bladder Neoplasm|bladder neoplasm
5249331|NCT02449239|Bladder Tumor|bladder tumor
5249332|NCT02449239|CIS|cis
5250225|NCT02443610|Pregnancy|pregnancy
5249333|NCT02449239|Papillary bladder cancer|papillary bladder cancer
5249334|NCT02449239|High grade bladder cancer|high grade bladder cancer
5249335|NCT02449200|cervical radiculopathy|cervical radiculopathy
5249336|NCT02449200|exercise|exercise
5249337|NCT02449200|manual therapy|manual therapy
5249338|NCT02449200|tape|tape
5249339|NCT02449174|C. difficile|c. difficile
5249340|NCT02449174|Fecal Microbiota transplantation|fecal microbiota transplantation
5249341|NCT02449161|endometrial ablation|endometrial ablation
5249342|NCT02449148|energy restriction|energy restriction
5249343|NCT02449148|fasting|fasting
5249344|NCT02449148|intermittent fast|intermittent fast
5249345|NCT02449148|cancer prevention|cancer prevention
5249346|NCT02449148|subcutaneous fat tissue gene expression|subcutaneous fat tissue gene expression
5249347|NCT02449135|Pancreatic Cancer|pancreatic cancer
5249348|NCT02449135|Nano drug|nano drug
5249349|NCT02449122|Lung Cancer|lung cancer
5249350|NCT02449122|Nano drug|nano drug
5249351|NCT02449109|Liver Cancer|liver cancer
5249352|NCT02449109|Nano drug|nano drug
5249353|NCT02449083|MRI|mri
5249354|NCT02449083|Shunt|shunt
5249355|NCT02449083|COPD|copd
5249356|NCT02449083|Dynamic T2 Preparation Puls|dynamic t2 preparation puls
5249357|NCT02449083|new sequences|new sequences
5249358|NCT02449083|magnet resonance imaging|magnet resonance imaging
5249359|NCT02449083|ventricular septal defect|ventricular septal defect
5249360|NCT02449083|Atrial septal defect|atrial septal defect
5249361|NCT02449070|Nicorandil|nicorandil
5249362|NCT02449070|Cardiac MRI|cardiac mri
5249363|NCT02449044|Hyponatremia|hyponatremia
5249364|NCT02449018|COPD,|copd,
5249365|NCT02449018|chronic bronchitis,|chronic bronchitis,
5249366|NCT02449018|inflammation,|inflammation,
5249367|NCT02449018|airway,|airway,
5249368|NCT02449018|LCI,|lci,
5249369|NCT02449018|pulmonary function test,|pulmonary function test,
5249370|NCT02449018|lung function,|lung function,
5249371|NCT02449018|controlled clinical trial,|controlled clinical trial,
5249372|NCT02449018|randomized,|randomized,
5249373|NCT02449018|airflow,|airflow,
5249374|NCT02449018|smoker|smoker
5249375|NCT02449005|regeneration|regeneration
5249376|NCT02449005|stem cells|stem cells
5249377|NCT02449005|infrabony periodontal defect|infrabony periodontal defect
5249378|NCT02449005|fibrin glue|fibrin glue
5249379|NCT02449005|collagen fleece|collagen fleece
5249380|NCT02448992|Neurobehavioral Assessments|neurobehavioral assessments
5249381|NCT02448992|Neurocognitive Functions (NCF)|neurocognitive functions (ncf)
5249382|NCT02448992|Prophylactic Cranial Irradiation (PCI)|prophylactic cranial irradiation (pci)
5249383|NCT02448992|Hippocampus|hippocampus
5144502|NCT03088553|Ganciclovir|ganciclovir
5249384|NCT02448992|Hippocampal-Sparing PCI|hippocampal-sparing pci
5249385|NCT02448953|Without cervical lymph node involvement|without cervical lymph node involvement
5249386|NCT02448940|probiotics|probiotics
5249387|NCT02448940|Lactobacillus|lactobacillus
5249388|NCT02448940|obesity|obesity
5249389|NCT02448940|body composition|body composition
5249390|NCT02448927|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5249391|NCT02448927|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
5237242|NCT02519452|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
5237243|NCT02519439|Partial Onset Seizures|partial onset seizures
5237244|NCT02519439|complex partial seizures|complex partial seizures
5119031|NCT03251755|Dao-in|dao-in
5129908|NCT03182686|OAK|oak
5237245|NCT02519439|simple partial seizures|simple partial seizures
5237246|NCT02519439|anticonvulsant|anticonvulsant
5249392|NCT02448927|Aortic stenosis|aortic stenosis
5249393|NCT02448927|TAVI|tavi
5249394|NCT02448927|TAVR (transcatheter aortic valve replacement)|tavr (transcatheter aortic valve replacement)
5249395|NCT02448927|CoreValve|corevalve
5249396|NCT02448927|BAV|bav
5249397|NCT02448927|Evolut R|evolut r
5249398|NCT02448862|IV-PCA|iv-pca
5249399|NCT02448862|Elderly patients|elderly patients
5249400|NCT02448862|Yound adults|yound adults
5249401|NCT02448862|Side effect|side effect
5249402|NCT02448862|Postoperative pain|postoperative pain
5249403|NCT02448862|Postoperative nausea and vomiting|postoperative nausea and vomiting
5249404|NCT02448849|Autologous|autologous
5249405|NCT02448849|nonunion fracture|nonunion fracture
5249406|NCT02448849|bone marrow|bone marrow
5249407|NCT02448849|mesenchymal|mesenchymal
5249408|NCT02448849|stromal cell|stromal cell
5249409|NCT02448849|platelet lysate product|platelet lysate product
5249410|NCT02448823|HIV|hiv
5249411|NCT02448823|combined prevention|combined prevention
5249412|NCT02448823|demand generation|demand generation
5249413|NCT02448784|Donepezil Hydrochloride|donepezil hydrochloride
5249414|NCT02448784|ARICEPT|aricept
5249415|NCT02448784|Dementia|dementia
5249416|NCT02448784|Lewy bodies|lewy bodies
5249417|NCT02448784|Dementia with Lewy bodies|dementia with lewy bodies
5249418|NCT02448784|Post-marketing surveillance|post-marketing surveillance
5249419|NCT02448771|Unresectable locally advanced invasive breast cancer|unresectable locally advanced invasive breast cancer
5249420|NCT02448771|Metastatic invasive breast cancer|metastatic invasive breast cancer
5249421|NCT02448758|mutation|mutation
5249422|NCT02448732|ACM-1|acm-1
5249423|NCT02448732|intravitreal injection|intravitreal injection
5249424|NCT02448732|neovascularization|neovascularization
5249425|NCT02448706|hearing aid|hearing aid
5249426|NCT02448693|endoscopic mucosal resection|endoscopic mucosal resection
5249427|NCT02448693|piecemeal polypectomy scar|piecemeal polypectomy scar
5423255|NCT01616472|diabetes|diabetes
5249440|NCT02448615|Cohort|cohort
5674375|NCT00603811|Influenza vaccines|influenza vaccines
5249441|NCT02448602|Different acupoints compatibility|different acupoints compatibility
5249448|NCT02448576|phase 3 randomized controlled trial|phase 3 randomized controlled trial
5249449|NCT02448576|prophylactic cranial irradiation|prophylactic cranial irradiation
5249450|NCT02448576|triple negative breast cancer|triple negative breast cancer
5249451|NCT02448576|brain metastasis|brain metastasis
5249452|NCT02448576|advanced breast cancer|advanced breast cancer
5249453|NCT02448563|Pregnancy|pregnancy
5249454|NCT02448563|African American|african american
5249455|NCT02448563|Weight Management Program|weight management program
5249456|NCT02448563|Behavioral Modifications|behavioral modifications
5249457|NCT02448537|Metastatic Sarcoma|metastatic sarcoma
5249458|NCT02448537|Unresectable Sarcoma|unresectable sarcoma
5249459|NCT02448537|PM01183|pm01183
5249460|NCT02448524|Treatment|treatment
5249461|NCT02448524|patients|patients
5249462|NCT02448524|primary in situ CHD (de novo) lesions|primary in situ chd (de novo) lesions
5249463|NCT02448511|ozone gas|ozone gas
5249464|NCT02448511|ulcer|ulcer
5249465|NCT02448511|infected ulcer|infected ulcer
5249466|NCT02448433|Phototherapy|phototherapy
5249467|NCT02448433|Light|light
5249468|NCT02448433|Depression|depression
5249469|NCT02448433|Sleep and circadian disturbances|sleep and circadian disturbances
5249470|NCT02448433|Youth|youth
5249471|NCT02448407|Knee osteoarthritis|knee osteoarthritis
5249472|NCT02448407|Platelet-rich plasma|platelet-rich plasma
5249473|NCT02448407|Pain's treatment|pain's treatment
5249474|NCT02448394|community support workers|community support workers
5249475|NCT02448394|retention in care|retention in care
5249476|NCT02448381|CTCL|ctcl
5249477|NCT02448381|Mycosis fungoides|mycosis fungoides
5249478|NCT02448381|Hypericin|hypericin
5249479|NCT02448381|SGX301|sgx301
5249481|NCT02448355|OCT|oct
5249482|NCT02448342|Heart Failure|heart failure
5249483|NCT02448342|Remote Patient Monitoring|remote patient monitoring
5249484|NCT02448342|Non Invasive Lung Fluid Status Monitor|non invasive lung fluid status monitor
5249485|NCT02448290|gastric adenocarcinoma patients with low/high MEK signature,|gastric adenocarcinoma patients with low/high mek signature,
5249486|NCT02448277|Macintosh laryngoscope, Pentax, Glidescope|macintosh laryngoscope, pentax, glidescope
5249487|NCT02448264|kallikrein inhibitor|kallikrein inhibitor
5249488|NCT02448264|oral prophylaxis|oral prophylaxis
5249489|NCT02448264|BioCryst|biocryst
5249490|NCT02448264|first-in-human|first-in-human
5249491|NCT02448264|hereditary angioedema|hereditary angioedema
5249492|NCT02448238|Human Immunodeficiency Virus|human immunodeficiency virus
5249493|NCT02448238|probiotic|probiotic
5249494|NCT02448238|microbial translocation|microbial translocation
5249495|NCT02448238|immune activation|immune activation
5249496|NCT02448238|inflammation|inflammation
5249497|NCT02448238|VSL#3|vsl#3
5249498|NCT02448238|Mali|mali
5249499|NCT02448238|Africa|africa
5249500|NCT02448212|PET|pet
5249501|NCT02448212|Receptor Occupancy|receptor occupancy
5249502|NCT02448199|pain|pain
5249503|NCT02448199|Knee|knee
5249504|NCT02448147|Heart failure|heart failure
5249505|NCT02448147|Exercise|exercise
5249506|NCT02448147|Biomarkers|biomarkers
5249507|NCT02448147|Sympathetic Nervous System|sympathetic nervous system
5249508|NCT02448147|MicroRNA|microrna
5249509|NCT02448121|Cell therapy|cell therapy
5249510|NCT02448121|Sickle cell disease|sickle cell disease
5249511|NCT02448121|Hip Osteonecrosis|hip osteonecrosis
5249512|NCT02448121|Autologous implantation|autologous implantation
5249513|NCT02448121|Mesenchymal stromal cell|mesenchymal stromal cell
5249514|NCT02448121|Humeral Osteonecrosis|humeral osteonecrosis
5249515|NCT02448121|Knee Osteonecrosis|knee osteonecrosis
5249516|NCT02448121|Ankle Osteonecrosis|ankle osteonecrosis
5249517|NCT02448095|Chronic myeloid leukemia|chronic myeloid leukemia
5249518|NCT02448095|Philadelphia positive|philadelphia positive
5249519|NCT02448095|Compassionate use|compassionate use
5249520|NCT02448082|Dandruff|dandruff
5249521|NCT02448082|Pityriasis capitis|pityriasis capitis
5249522|NCT02448082|Ichthyol® Pale|ichthyol® pale
5249523|NCT02448082|Sodium shale oil sulponate 1%|sodium shale oil sulponate 1%
5249524|NCT02448043|brittleness|brittleness
5249525|NCT02448030|Metaboreflex|metaboreflex
5249526|NCT02448030|Variation of blood flow|variation of blood flow
5249527|NCT02448030|Functional electrical stimulation|functional electrical stimulation
5249528|NCT02448030|Isometric exercise.|isometric exercise.
5249530|NCT02448004|JNJ-63623872|jnj-63623872
5249531|NCT02448004|14C-JNJ-63623872|14c-jnj-63623872
5249532|NCT02447965|Rectus Sheath Blocks|rectus sheath blocks
5249533|NCT02447965|Abdominal Surgery|abdominal surgery
5249534|NCT02447952|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5249535|NCT02447952|Biotelemetry|biotelemetry
5249536|NCT02447939|pharmacokinetics|pharmacokinetics
5249537|NCT02447939|trametinib|trametinib
5249538|NCT02447939|cutaneous melanoma|cutaneous melanoma
5249539|NCT02447939|dabrafenib|dabrafenib
5249540|NCT02447939|safety|safety
5249541|NCT02447926|leukapheresis|leukapheresis
5249542|NCT02447926|regulatory T cells|regulatory t cells
5249543|NCT02447926|liver transplantation|liver transplantation
5249544|NCT02447913|Family planning|family planning
5249545|NCT02447913|Voucher|voucher
5249546|NCT02447913|Immunisations|immunisations
5249547|NCT02447835|Metabolic Disorders|metabolic disorders
5249548|NCT02447809|microRNA|microrna
5249549|NCT02447809|Platelet|platelet
5249550|NCT02447809|Clopidogrel low response|clopidogrel low response
5249551|NCT02447796|(AVF)|(avf)
5249552|NCT02447796|surgery|surgery
5249553|NCT02447783|Flavanols|flavanols
5249554|NCT02447783|Cocoa flavanols|cocoa flavanols
5249555|NCT02447783|Blood pressure|blood pressure
5249556|NCT02447783|Platelet Function|platelet function
5249557|NCT02447770|Flavanols|flavanols
5249558|NCT02447770|Cocoa flavanols|cocoa flavanols
5249559|NCT02447770|Blood pressure|blood pressure
5249560|NCT02447770|Platelet Function|platelet function
5249561|NCT02447757|Remifentanil, delivery, childbirth, analgesia, parturition, confinement|remifentanil, delivery, childbirth, analgesia, parturition, confinement
5249562|NCT02447744|depression|depression
5249563|NCT02447744|anxiety|anxiety
5249564|NCT02447744|early life stress|early life stress
5249565|NCT02447731|respiratory insufficiency|respiratory insufficiency
5249566|NCT02447692|Proportional Assist Ventilation|proportional assist ventilation
5249567|NCT02447692|Pressure Support Ventilation|pressure support ventilation
5249568|NCT02447692|Weaning|weaning
5249569|NCT02447666|Azacitidine|azacitidine
5249570|NCT02447666|Myelodysplastic syndrome|myelodysplastic syndrome
5249571|NCT02447666|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5249572|NCT02447666|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5249573|NCT02447666|Vidaza|vidaza
5249574|NCT02447666|Hypomethylating agent|hypomethylating agent
5249575|NCT02447640|Volunteers|volunteers
5249576|NCT02447614|follow up|follow up
5249577|NCT02447614|Primary Snoring|primary snoring
5249578|NCT02447614|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5144708|NCT03087227|mHealth|mhealth
5249579|NCT02447588|intrauterine insemination|intrauterine insemination
5249580|NCT02447588|progesterone|progesterone
5249581|NCT02447549|IMRT|imrt
5249582|NCT02447549|IGRT|igrt
5249583|NCT02447549|Muscle invasive|muscle invasive
5249584|NCT02447549|Adaptive Radiotherapy|adaptive radiotherapy
5249585|NCT02447536|Immunization|immunization
5249586|NCT02447536|Morbidity|morbidity
5249587|NCT02447536|Mortality|mortality
5249589|NCT02447484|female sex workers|female sex workers
5249590|NCT02447484|HIV sexual risk reduction|hiv sexual risk reduction
5249591|NCT02447484|behavior maintenance|behavior maintenance
5237445|NCT02518334|type two diabetes|type two diabetes
5237446|NCT02518334|glycemic control|glycemic control
5237447|NCT02518321|Toileting|toileting
5237448|NCT02518321|Technology-Assisted Toilets|technology-assisted toilets
5237449|NCT02518321|Rehabilitation|rehabilitation
5249592|NCT02447484|text messaging|text messaging
5249593|NCT02447458|Drug therapy|drug therapy
5249594|NCT02447432|Invasive disease by Streptococcus pneumoniae (S. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)|invasive disease by streptococcus pneumoniae (s. pneumoniae) (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media)
5249595|NCT02447432|Infants|infants
5249596|NCT02447432|Multidose|multidose
5249597|NCT02447432|Haemophilus influenzae|haemophilus influenzae
5249598|NCT02447432|Streptococcus pneumoniae|streptococcus pneumoniae
5249599|NCT02447432|Preservative|preservative
5249600|NCT02447432|Safety|safety
5249601|NCT02447432|Pneumonia|pneumonia
5249602|NCT02447432|Immunogenicity|immunogenicity
5249603|NCT02447432|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5249604|NCT02447432|Acute otitis media caused by non-typeable Haemophilus influenzae (NTHi).|acute otitis media caused by non-typeable haemophilus influenzae (nthi).
5249605|NCT02447432|Respiratory tract infections|respiratory tract infections
5249606|NCT02447367|α1-blockers|α1-blockers
5249607|NCT02447367|antimuscarinic agent|antimuscarinic agent
5249608|NCT02447315|Pilocarpine|pilocarpine
5249609|NCT02447289|Dental caries|dental caries
5249610|NCT02447289|Moderate sedation|moderate sedation
5249611|NCT02447263|Liver Cancer|liver cancer
5249612|NCT02447263|HepaSphere|hepasphere
5249613|NCT02447250|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5249614|NCT02447250|very low birth weight|very low birth weight
5249615|NCT02447250|albuterol|albuterol
5249616|NCT02447250|pulmonary function test|pulmonary function test
5249618|NCT02447237|solid diet|solid diet
5249619|NCT02447224|appendicitis|appendicitis
5249620|NCT02447224|non operative management|non operative management
5249621|NCT02447224|appendectomy|appendectomy
5249622|NCT02447185|Lucentis|lucentis
5249623|NCT02447185|Ranibizumab|ranibizumab
5249624|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide
5249625|NCT02447185|Vitrectomy|vitrectomy
5249626|NCT02447185|PDR|pdr
5423256|NCT01616472|cataracts|cataracts
5249630|NCT02447159|Hospitals, Maternity/Utilization|hospitals, maternity/utilization
5249631|NCT02447159|Hospitals/Economics|hospitals/economics
5249633|NCT02447133|no known ocular pathology|no known ocular pathology
5249634|NCT02447120|Volunteers with Healthy Eyes|volunteers with healthy eyes
5249635|NCT02447107|Chronic Pain|chronic pain
5249636|NCT02447107|Technology|technology
5249637|NCT02447107|Mobile Phone Applications|mobile phone applications
5249638|NCT02447094|ischemic|ischemic
5249639|NCT02447094|tPA|tpa
5249640|NCT02447094|tele-medicine|tele-medicine
5249642|NCT02447094|tele-stroke|tele-stroke
5249643|NCT02447042|sepsis|sepsis
5249644|NCT02447042|Fluids|fluids
5249645|NCT02447042|Mean systemic filling pressure|mean systemic filling pressure
5249646|NCT02447029|abortion|abortion
5249647|NCT02447029|pain management|pain management
5249652|NCT02446977|ischemic|ischemic
5249653|NCT02446977|stroke|stroke
5249654|NCT02446977|vitamin B2|vitamin b2
5249655|NCT02446938|mechanical ventilation|mechanical ventilation
5249656|NCT02446938|esophageal pressure|esophageal pressure
5249657|NCT02446938|catheter position|catheter position
5249658|NCT02446938|validation|validation
5249659|NCT02446912|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
5249660|NCT02446899|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
5249661|NCT02446886|Multiple Sclerosis|multiple sclerosis
5249662|NCT02446886|MS|ms
5249663|NCT02446886|RRMS|rrms
5249664|NCT02446886|SPMS|spms
5249665|NCT02446886|ACTH|acth
5249666|NCT02446873|children|children
5249667|NCT02446873|Ecuador|ecuador
5249668|NCT02446873|rural|rural
5249669|NCT02446873|poor|poor
5249670|NCT02446847|HIV|hiv
5249671|NCT02446847|3BNC117|3bnc117
5249672|NCT02446847|Broadly neutralizing antibody|broadly neutralizing antibody
5249673|NCT02446834|PCOS|pcos
5249674|NCT02446834|intensive lifestyle intervention|intensive lifestyle intervention
5249675|NCT02446834|IGT|igt
5249676|NCT02446834|drugs treatment|drugs treatment
5249677|NCT02446795|Renal cell carcinoma|renal cell carcinoma
5249678|NCT02446795|Isoquercetin|isoquercetin
5249679|NCT02446795|kidney cancer|kidney cancer
5249680|NCT02446795|sunitinib|sunitinib
5249681|NCT02446795|fatigue|fatigue
5249682|NCT02446782|thoracoscopy|thoracoscopy
5249683|NCT02446782|pleuroscopy|pleuroscopy
5249684|NCT02446782|antibiotic prophylaxis|antibiotic prophylaxis
5249685|NCT02446782|pleural effusion|pleural effusion
5249686|NCT02446756|Osteoarthritis|osteoarthritis
5249687|NCT02446756|MRI|mri
5249688|NCT02446756|Cartilage|cartilage
5249689|NCT02446756|Acupuncture|acupuncture
5249690|NCT02446743|Nervous System Diseases|nervous system diseases
5249691|NCT02446743|Meningitis|meningitis
5249692|NCT02446743|Central Nervous System Diseases|central nervous system diseases
5249693|NCT02446717|Hepatitis C|hepatitis c
5249694|NCT02446717|HCV Genotype 6|hcv genotype 6
5249695|NCT02446717|HCV GT1|hcv gt1
5249696|NCT02446717|Interferon (IFN) free|interferon (ifn) free
5249697|NCT02446717|HCV Genotype 5|hcv genotype 5
5249698|NCT02446717|HCV|hcv
5249699|NCT02446717|HCV GT4|hcv gt4
5249700|NCT02446717|HCV Genotype 4|hcv genotype 4
5249701|NCT02446717|Chronic Hepatitis C|chronic hepatitis c
5249702|NCT02446717|Chronic HCV|chronic hcv
5249703|NCT02446717|Hepatitis C Genotype 1|hepatitis c genotype 1
5249704|NCT02446717|HCV GT5|hcv gt5
5249705|NCT02446717|HCV Genotype 1|hcv genotype 1
5249706|NCT02446704|Small Cell Lung Cancer|small cell lung cancer
5249707|NCT02446704|SCLC|sclc
5249708|NCT02446678|Gastrointestinal bleeding|gastrointestinal bleeding
5249709|NCT02446678|emergency department|emergency department
5249710|NCT02446678|PillCam ESO2|pillcam eso2
5249711|NCT02446652|Advanced cervical cancer|advanced cervical cancer
5249712|NCT02446652|Epigenetic therapy|epigenetic therapy
5249713|NCT02446652|Randomized phase III|randomized phase iii
5249714|NCT02446626|Lyme Disease|lyme disease
5249715|NCT02446626|Ixodes scapularis|ixodes scapularis
5249716|NCT02446626|Borrelia Burgdorferi|borrelia burgdorferi
5249717|NCT02446626|Post treatment|post treatment
5249718|NCT02446626|Infection|infection
5249719|NCT02446613|Allergic Rhinitis|allergic rhinitis
5249720|NCT02446613|Nasal allergen challenge|nasal allergen challenge
5249721|NCT02446613|Allergic Asthma|allergic asthma
5249722|NCT02446613|Effect on Allergen Reactivity|effect on allergen reactivity
5249723|NCT02446587|endovascular therapy|endovascular therapy
5249724|NCT02446587|thrombectomy|thrombectomy
5249725|NCT02446587|selection|selection
5249726|NCT02446587|imaging|imaging
5249727|NCT02446587|perfusion|perfusion
5249728|NCT02446587|collaterals|collaterals
5249729|NCT02446587|ASPECTS|aspects
5249730|NCT02446574|chemoradiation|chemoradiation
5249731|NCT02446574|dose escalation|dose escalation
5249732|NCT02446561|Healthy Volunteer|healthy volunteer
5249733|NCT02446561|Pharmacokinetics|pharmacokinetics
5249734|NCT02446548|direct renin inhibitor|direct renin inhibitor
5249735|NCT02446548|kidney transplantation|kidney transplantation
5249736|NCT02446548|albuminuria|albuminuria
5249737|NCT02446496|Bioequivalence|bioequivalence
5249738|NCT02446496|film coated tablets|film coated tablets
5249739|NCT02446496|cefadroxil|cefadroxil
5249741|NCT02446483|PARIET 20 mg|pariet 20 mg
5249742|NCT02446483|Rabeprazole|rabeprazole
5249743|NCT02446483|bioequivalence|bioequivalence
5249744|NCT02446470|calcaneus|calcaneus
5249745|NCT02446470|fracture fixation, internal|fracture fixation, internal
5249746|NCT02446444|High risk|high risk
5249747|NCT02446444|clinically localised prostate cancer|clinically localised prostate cancer
5249748|NCT02446431|Metronomic Drug Therapy|metronomic drug therapy
5249749|NCT02446418|dry powder inahler|dry powder inahler
5249750|NCT02446418|vilanerol|vilanerol
5249751|NCT02446418|efficacy|efficacy
5249752|NCT02446418|safety|safety
5249753|NCT02446418|fluticasone furoate|fluticasone furoate
5249754|NCT02446418|quality of life|quality of life
5249755|NCT02446405|metastatic prostate cancer|metastatic prostate cancer
5249756|NCT02446405|prostate cancer|prostate cancer
5249757|NCT02446405|prostate cancer treatment|prostate cancer treatment
5249758|NCT02446405|enzalutamide|enzalutamide
5249759|NCT02446353|Male Volunteers|male volunteers
5249760|NCT02446340|ShK-186|shk-186
5249761|NCT02446340|dalazatide|dalazatide
5249762|NCT02446340|Kv1.3|kv1.3
5249763|NCT02446340|SHK|shk
5249764|NCT02446301|Nalbuphine|nalbuphine
5249765|NCT02446301|SDE|sde
5249766|NCT02446301|dinalbuphine|dinalbuphine
5249767|NCT02446301|SDN|sdn
5249768|NCT02446301|pain|pain
5249769|NCT02446301|LT1001|lt1001
5249770|NCT02446275|efficacy, manual therapy, migraine, quality of life|efficacy, manual therapy, migraine, quality of life
5249771|NCT02446262|Pain|pain
5249772|NCT02446262|Visual Analogue Pain Scale|visual analogue pain scale
5249773|NCT02446262|Placebo|placebo
5249774|NCT02446262|Affective Neuroscience|affective neuroscience
5249775|NCT02446262|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5249776|NCT02446249|Gene Therapy|gene therapy
5249777|NCT02446249|Xerostomia|xerostomia
5249778|NCT02446223|Actinic Keratosis AKs Chest Pre-Cancer|actinic keratosis aks chest pre-cancer
5249779|NCT02446210|SCI|sci
5249780|NCT02446210|Neural Control|neural control
5249781|NCT02446210|Bilateral Movement|bilateral movement
5249782|NCT02446210|TMS|tms
5249783|NCT02446184|urethral obstruction|urethral obstruction
5249784|NCT02446184|posterior urethral valves|posterior urethral valves
5249785|NCT02446184|lower urinary tract obstruction|lower urinary tract obstruction
5249786|NCT02446171|naloxegol tablet crushed|naloxegol tablet crushed
5249787|NCT02446171|naloxegol oral solution|naloxegol oral solution
5249788|NCT02446171|naloxegol whole tablet|naloxegol whole tablet
5237637|NCT02516956|Food choices|food choices
5237638|NCT02516956|Lunch|lunch
5237639|NCT02516956|Eating habits|eating habits
5237640|NCT02516956|Appetite|appetite
5237641|NCT02516956|Neural activation|neural activation
5249789|NCT02446171|relative bioavailability|relative bioavailability
5249790|NCT02446171|Phase I|phase i
5249791|NCT02446171|healthy subjects|healthy subjects
5249792|NCT02446106|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
5249793|NCT02446106|Satiety|satiety
5249794|NCT02446106|Soups|soups
5249795|NCT02446106|Energy Intake|energy intake
5249796|NCT02446106|Snack Intake|snack intake
5249797|NCT02446093|pancreas cancer|pancreas cancer
5249798|NCT02446093|immunotherapy|immunotherapy
5249799|NCT02446093|GMCI|gmci
5249800|NCT02446093|AdV-tk|adv-tk
5249801|NCT02446093|aglatimagene besadenovec|aglatimagene besadenovec
5249802|NCT02446080|Constipation|constipation
5249803|NCT02446080|Probiotics|probiotics
5249804|NCT02446080|Women|women
5249805|NCT02446067|Transcranial Doppler (TCD) sonography|transcranial doppler (tcd) sonography
5249806|NCT02446067|rTMS|rtms
5249807|NCT02446067|Cerebral hemodynamics|cerebral hemodynamics
5249808|NCT02446054|T2DM, type II diabetes Mellitus, HbA1c|t2dm, type ii diabetes mellitus, hba1c
5249809|NCT02446041|COPD|copd
5249810|NCT02446041|Chronic Bronchitis|chronic bronchitis
5249811|NCT02446041|Pulmonary Emphysema|pulmonary emphysema
5249812|NCT02446002|Volunteer|volunteer
5249814|NCT02445989|Contraceptive Vaginal Ring|contraceptive vaginal ring
5249815|NCT02445989|Bacterial Vaginosis|bacterial vaginosis
5249816|NCT02445976|mCRPC|mcrpc
5249817|NCT02445976|metastatic|metastatic
5249818|NCT02445976|castration-resistant prostate cancer|castration-resistant prostate cancer
5249819|NCT02445950|Coaching|coaching
5249820|NCT02445950|Well-being|well-being
5249821|NCT02445950|Digital Health|digital health
5249822|NCT02445950|Profiling|profiling
5249823|NCT02445950|Customer Satisfaction|customer satisfaction
5249824|NCT02445950|User Experience|user experience
5249825|NCT02445950|Occupational Health|occupational health
5249826|NCT02445950|Lifestyle|lifestyle
5249827|NCT02445950|Psychological Stress|psychological stress
5249832|NCT02445937|surrogate decision making|surrogate decision making
5249833|NCT02445937|patient centered care|patient centered care
5249835|NCT02445924|genetic signature|genetic signature
5249836|NCT02445924|non-small cell lung cancer|non-small cell lung cancer
5249837|NCT02445924|micro RNA|micro rna
5249838|NCT02445898|Glucocorticoid|glucocorticoid
5249839|NCT02445898|Orthostatic Intolerance|orthostatic intolerance
5249840|NCT02445898|Heart Rate Variability|heart rate variability
5249841|NCT02445898|Hip arthroplasty, total|hip arthroplasty, total
5249842|NCT02445885|Myocardial infarction|myocardial infarction
5249843|NCT02445885|Late presenters|late presenters
5249844|NCT02445885|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5249845|NCT02445885|Reperfusion|reperfusion
5249846|NCT02445885|Angioplasty|angioplasty
5249847|NCT02445885|Duration of ischemia|duration of ischemia
5249848|NCT02445885|Cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
5249850|NCT02445872|Vomiting|vomiting
5249851|NCT02445872|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5249852|NCT02445872|CINV|cinv
5249853|NCT02445872|Aprepitant|aprepitant
5249854|NCT02445872|Lung cancer|lung cancer
5249855|NCT02445859|Antibiotic|antibiotic
5249856|NCT02445859|prophylaxis|prophylaxis
5249857|NCT02445859|surgical site infection|surgical site infection
5249858|NCT02445833|Obesity|obesity
5249859|NCT02445833|Internet intervention|internet intervention
5249860|NCT02445833|Cardiovascular disease|cardiovascular disease
5249861|NCT02445833|Hypertension|hypertension
5249862|NCT02445833|Lifestyle intervention|lifestyle intervention
5249863|NCT02445833|Weight loss treatment|weight loss treatment
5249864|NCT02445755|Neonates|neonates
5249865|NCT02445755|Bilicare System|bilicare system
5249866|NCT02445742|Chronic Myeloblastic Leukaemia|chronic myeloblastic leukaemia
5249867|NCT02445729|Cesarean Section|cesarean section
5249868|NCT02445729|Wound Healing|wound healing
5249869|NCT02445677|TENS|tens
5249870|NCT02445677|chronic pain|chronic pain
5145001|NCT03085485|COPD|copd
5249871|NCT02445677|rehabilitation|rehabilitation
5249872|NCT02445664|Patient education|patient education
5249873|NCT02445664|Video intervention|video intervention
5249874|NCT02445651|Integrative Medicine|integrative medicine
5249875|NCT02445651|Alternative Medicine|alternative medicine
5249876|NCT02445651|Complementary Medicine|complementary medicine
5249877|NCT02445651|Parkinson's disease|parkinson's disease
5237741|NCT02516176|stroke|stroke
5249878|NCT02445651|Neurodegenerative Diseases|neurodegenerative diseases
5249879|NCT02445651|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5249880|NCT02445651|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
5249881|NCT02445651|Central Nervous System Diseases|central nervous system diseases
5249882|NCT02445651|Movement Disorders|movement disorders
5249883|NCT02445651|Nervous System Diseases|nervous system diseases
5249884|NCT02445651|Brain Diseases|brain diseases
5249885|NCT02445651|Oral supplements|oral supplements
5249886|NCT02445651|N-acetyl cysteine|n-acetyl cysteine
5249887|NCT02445612|fundus flavimaculatus|fundus flavimaculatus
5249888|NCT02445612|ASP7316|asp7316
5249889|NCT02445612|SMD|smd
5249890|NCT02445612|long term follow-up|long term follow-up
5249891|NCT02445612|juvenile macular dystrophy|juvenile macular dystrophy
5249892|NCT02445599|thoracotomy|thoracotomy
5249893|NCT02445599|pain management|pain management
5249894|NCT02445599|analgesia|analgesia
5249895|NCT02445599|postoperative care|postoperative care
5249896|NCT02445599|premedication|premedication
5249897|NCT02445599|preventive|preventive
5249898|NCT02445573|stress urinary incontinence|stress urinary incontinence
5249899|NCT02445573|electroacupuncture|electroacupuncture
5249900|NCT02445573|efficacy|efficacy
5249901|NCT02445560|probiotics|probiotics
5249902|NCT02445560|prebiotics|prebiotics
5249903|NCT02445560|high protein diet|high protein diet
5249904|NCT02445560|microbiota|microbiota
5249905|NCT02445534|Cell Therapy|cell therapy
5249906|NCT02445456|Rectal cancer|rectal cancer
5249907|NCT02445456|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5249908|NCT02445417|Perinatal depression|perinatal depression
5249909|NCT02445378|Aromatherapy|aromatherapy
5249910|NCT02445378|essential oils|essential oils
5249911|NCT02445378|Acute Leukemia|acute leukemia
5249912|NCT02445365|Ulcerative colitis|ulcerative colitis
5249913|NCT02445365|Remote ischemic conditioning|remote ischemic conditioning
5249914|NCT02445339|Alcohol Dependence|alcohol dependence
5249915|NCT02445339|Alcohol Use Disorder|alcohol use disorder
5249916|NCT02445339|Care Management|care management
5249917|NCT02445339|Case Management|case management
5247418|NCT02461108|Food choice|food choice
5249929|NCT02445339|XR-NTX|xr-ntx
5249930|NCT02445339|XR-NTX+CM|xr-ntx+cm
5249931|NCT02445339|Alcoholism|alcoholism
5249932|NCT02445339|Alcohol-Related Disorders|alcohol-related disorders
5249933|NCT02445339|Central Nervous System Agents|central nervous system agents
5249934|NCT02445339|Chemically-Induced Disorders|chemically-induced disorders
5249935|NCT02445339|Clinical Trial|clinical trial
5249936|NCT02445339|Emergency Medicine|emergency medicine
5249937|NCT02445339|Mental Disorders|mental disorders
5249941|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs
5249942|NCT02445339|Sensory System Agents|sensory system agents
5249943|NCT02445339|Substance-Related Disorders|substance-related disorders
5249944|NCT02445300|dressing|dressing
5249946|NCT02445261|MOBILE PHONE ON AND IN AND|mobile phone on and in and
5249947|NCT02445261|UMBILICAL ARTERY DOPPLER|umbilical artery doppler
5249948|NCT02445261|FETAL CARDIOTOCOGRAPHY|fetal cardiotocography
5249949|NCT02445261|GROWTH RESTRICTED FETUS|growth restricted fetus
5249950|NCT02445261|NORMAL GROWTH FETUS|normal growth fetus
5249959|NCT02445235|pain|pain
5249960|NCT02445235|wound care|wound care
5249961|NCT02445235|fungal infections|fungal infections
5249962|NCT02445235|scars|scars
5249963|NCT02445235|chronic pain|chronic pain
5249964|NCT02445235|outcomes|outcomes
5249965|NCT02445235|PRO|pro
5249966|NCT02445209|HER2-negative gastric and GEJ adenocarcinoma|her2-negative gastric and gej adenocarcinoma
5249967|NCT02445209|first-line palliative chemotherapy|first-line palliative chemotherapy
5249968|NCT02445209|EOX|eox
5249969|NCT02445209|mDCF|mdcf
5249970|NCT02445209|efficacy|efficacy
5249971|NCT02445209|safety|safety
5249972|NCT02445170|Diabetes|diabetes
5249973|NCT02445170|amputation|amputation
5249974|NCT02445170|below-knee|below-knee
5249975|NCT02445170|transmetatarsal|transmetatarsal
5249976|NCT02445170|[M01.150.100]|[m01.150.100]
5249977|NCT02445170|[C19.246.099]|[c19.246.099]
5249978|NCT02445157|Gait speed|gait speed
5249979|NCT02445157|Functional outcome measure|functional outcome measure
5249980|NCT02445144|Inflammation|inflammation
5249981|NCT02445144|Blood Flow|blood flow
5249982|NCT02445144|Cognition|cognition
5249983|NCT02445131|CLL|cll
5249984|NCT02445118|adipose, allograft|adipose, allograft
5249985|NCT02445092|Intrauterine insemination|intrauterine insemination
5249986|NCT02445092|Insemination catheter prewashing|insemination catheter prewashing
5249987|NCT02445092|Pregnancy outcome|pregnancy outcome
5249988|NCT02445066|Vitamin D|vitamin d
5249989|NCT02445053|Cystic Fibrosis|cystic fibrosis
5249990|NCT02445040|High Frequency Oscillatory Ventilation|high frequency oscillatory ventilation
5249991|NCT02445040|Infant, Very Low Birth Weight|infant, very low birth weight
5249992|NCT02445040|Periventricular Leukomalacia|periventricular leukomalacia
5249993|NCT02445040|Intraventricular Hemorrhage|intraventricular hemorrhage
5249994|NCT02445040|multi-center study|multi-center study
5249995|NCT02445027|Primary Care|primary care
5249996|NCT02445027|Healthy|healthy
5249997|NCT02445014|Barrett's|barrett's
5249998|NCT02445014|GERD|gerd
5249999|NCT02445014|Capsule|capsule
5250000|NCT02445014|SECM|secm
5250001|NCT02444988|crystalloid|crystalloid
5250002|NCT02444988|acute kidney injury|acute kidney injury
5250003|NCT02444975|Urinary Tract Infections|urinary tract infections
5250004|NCT02444975|Water intake|water intake
5250005|NCT02444936|solid tumor|solid tumor
5250006|NCT02444936|chemotherapy|chemotherapy
5250007|NCT02444936|vaccine|vaccine
5250008|NCT02444923|Corneal rigid gas permeable contact lenses|corneal rigid gas permeable contact lenses
5250009|NCT02444923|Scleral rigid gas permeable contact lenses|scleral rigid gas permeable contact lenses
5250010|NCT02444923|Custom Scleral contact lenses|custom scleral contact lenses
5250011|NCT02444923|Keratoconus|keratoconus
5250012|NCT02444923|Irregular cornea|irregular cornea
5250013|NCT02444923|Pellucid marginal degeneration|pellucid marginal degeneration
5250014|NCT02444923|Post keratoplasty irregular cornea|post keratoplasty irregular cornea
5250015|NCT02444923|Post refractive surgery irregular cornea|post refractive surgery irregular cornea
5250017|NCT02444910|KDT501|kdt501
5250018|NCT02444910|Diabetes|diabetes
5250019|NCT02444910|Diabetes Mellitus|diabetes mellitus
5250020|NCT02444910|Type 2|type 2
5250021|NCT02444910|KinDex|kindex
5130574|NCT03178422|NRT|nrt
5250022|NCT02444897|Gastric cancer|gastric cancer
5250023|NCT02444897|epidural|epidural
5250024|NCT02444897|PCA|pca
5250025|NCT02444897|laparoscopy|laparoscopy
5250026|NCT02444871|IgM-enriched immunoglobulins|igm-enriched immunoglobulins
5250027|NCT02444871|endotoxin activity assay|endotoxin activity assay
5250028|NCT02444871|thrombelastometry|thrombelastometry
5250029|NCT02444871|aggregometry|aggregometry
5250030|NCT02444858|paraquat poisoning|paraquat poisoning
5250031|NCT02444858|lung injury|lung injury
5250226|NCT02443597|ultrasound|ultrasound
5423257|NCT01616459|Streptococcus pneumoniae|streptococcus pneumoniae
5250033|NCT02444858|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
5250034|NCT02444858|phase 1/2 clinical study|phase 1/2 clinical study
5250035|NCT02444858|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5250037|NCT02444819|Epidermal Growth Factor Receptor mutation positive NSCLC|epidermal growth factor receptor mutation positive nsclc
5250038|NCT02444819|olmutinib|olmutinib
5250039|NCT02444806|Sleep disordered breathing|sleep disordered breathing
5250040|NCT02444806|Domiciliary NIV|domiciliary niv
5250041|NCT02444728|thrombocytopenia|thrombocytopenia
5250042|NCT02444728|systemic lupus erythematosus|systemic lupus erythematosus
5250043|NCT02444728|hydroxychloroquine|hydroxychloroquine
5250044|NCT02444728|cyclophosphamide|cyclophosphamide
5250045|NCT02444728|remission|remission
5250046|NCT02444715|Lifestyle coaching|lifestyle coaching
5250047|NCT02444715|Phone-based system|phone-based system
5250048|NCT02444715|CVD prevention|cvd prevention
5250049|NCT02444715|Patient-centered decision support|patient-centered decision support
5250050|NCT02444702|spinal stenosis, clinical predictors rules, MRI, fusion, low back pain|spinal stenosis, clinical predictors rules, mri, fusion, low back pain
5250051|NCT02444689|Blood pressure|blood pressure
5250052|NCT02444689|Cardiovascular disease|cardiovascular disease
5250053|NCT02444689|Children|children
5250054|NCT02444689|Adolescent|adolescent
5250055|NCT02444689|Pediatrics|pediatrics
5250056|NCT02444689|End-organ damage|end-organ damage
5250057|NCT02444650|Correlation|correlation
5250058|NCT02444650|pulse wave velocity measurement|pulse wave velocity measurement
5250059|NCT02444650|tonometry|tonometry
5250060|NCT02444624|necrotizing enterocolitis|necrotizing enterocolitis
5250061|NCT02444624|Clostridium|clostridium
5250062|NCT02444624|premature birth|premature birth
5250063|NCT02444611|neonates|neonates
5250064|NCT02444611|BCG|bcg
5250065|NCT02444611|Hepatitis B vaccine|hepatitis b vaccine
5250066|NCT02444611|vaccines|vaccines
5250067|NCT02444611|immunity|immunity
5250068|NCT02444611|immune response|immune response
5250069|NCT02444611|Bacille- Calmette-Guerin|bacille- calmette-guerin
5250070|NCT02444598|wounds|wounds
5250071|NCT02444598|negative-pressure wound therapy|negative-pressure wound therapy
5250072|NCT02444598|conflict|conflict
5250073|NCT02444598|gunshot wound|gunshot wound
5250074|NCT02444598|blast injuries|blast injuries
5250075|NCT02444598|civilian|civilian
5250076|NCT02444598|war|war
5250079|NCT02444559|Volunteers|volunteers
5250080|NCT02444533|Liposomal Bupivacaine|liposomal bupivacaine
5250081|NCT02444520|Medically unexplained symptoms|medically unexplained symptoms
5250082|NCT02444520|Primary care|primary care
5250083|NCT02444520|Cognitive behaviour therapy skills|cognitive behaviour therapy skills
5250084|NCT02444520|Cluster randomised controlled trial|cluster randomised controlled trial
5250085|NCT02444520|Feasibility|feasibility
5250086|NCT02444481|Mycotic Vaginitis|mycotic vaginitis
5250087|NCT02444455|cellular therapy|cellular therapy
5250088|NCT02444455|acute lung injury|acute lung injury
5250089|NCT02444455|acute respiratory distress snydrome|acute respiratory distress snydrome
5250090|NCT02444455|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
5250091|NCT02444455|phase 1/2 clinical study|phase 1/2 clinical study
5250092|NCT02444455|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5250093|NCT02444455|ALI|ali
5250094|NCT02444455|ARDS|ards
5250095|NCT02444442|Renal denervation|renal denervation
5250096|NCT02444442|Blood pressure|blood pressure
5250097|NCT02444442|Cardiovascular risk|cardiovascular risk
5250098|NCT02444442|Target organ damage|target organ damage
5250099|NCT02444442|Sympathetic activity|sympathetic activity
5250100|NCT02444442|Non-compliance|non-compliance
5250101|NCT02444429|Screening renal biopsy|screening renal biopsy
5250102|NCT02444429|Immunosuppression|immunosuppression
5250103|NCT02444403|HIV|hiv
5250104|NCT02444403|Viral hepatitis|viral hepatitis
5250105|NCT02444403|HCV|hcv
5250106|NCT02444403|Needle-stick injury|needle-stick injury
5250107|NCT02444403|Needle/syringes|needle/syringes
5250108|NCT02444403|Structural intervention|structural intervention
5250109|NCT02444403|Stepped wedge|stepped wedge
5250110|NCT02444403|Police|police
5250111|NCT02444403|Occupational safety|occupational safety
5250112|NCT02444403|Police Training|police training
5247623|NCT02459964|NRS|nrs
5250119|NCT02444325|CenteringPregnancy|centeringpregnancy
5250120|NCT02444325|diabetes|diabetes
5250121|NCT02444312|Caregiving|caregiving
5250122|NCT02444312|Benefit Finding|benefit finding
5250123|NCT02444312|Writing Intervention|writing intervention
5250124|NCT02444273|liver diseases|liver diseases
5250125|NCT02444273|liver transplantation|liver transplantation
5250126|NCT02444273|preoperative care|preoperative care
5250127|NCT02444273|physical therapy|physical therapy
5250128|NCT02444260|Inguinal Hernia,|inguinal hernia,
5250129|NCT02444260|Local Anesthesia|local anesthesia
5250130|NCT02444260|Randomized Clinical trial|randomized clinical trial
5250131|NCT02444260|HERNIOPLASTY|hernioplasty
5250132|NCT02444221|Atrial Fibrillation|atrial fibrillation
5250133|NCT02444221|Rivaroxaban|rivaroxaban
5250134|NCT02444221|Stroke|stroke
5250135|NCT02444195|gynecologic cancer|gynecologic cancer
5250136|NCT02444195|guided imagery|guided imagery
5250137|NCT02444195|postoperative distress|postoperative distress
5250138|NCT02444195|perioperative distress|perioperative distress
5250139|NCT02444143|Kidney|kidney
5250140|NCT02444143|Immunosuppression|immunosuppression
5250141|NCT02444143|Transplant|transplant
5250142|NCT02444130|multifocality|multifocality
5250143|NCT02444130|monovision|monovision
5250144|NCT02444117|neurophysiology|neurophysiology
5250145|NCT02444104|Left Ventricular Assist Device|left ventricular assist device
5250146|NCT02444091|Chronic Fatigue Syndrome|chronic fatigue syndrome
5250147|NCT02444091|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
5250148|NCT02444091|Cyclophosphamide|cyclophosphamide
5250149|NCT02444091|Immunomodulatory treatment|immunomodulatory treatment
5250151|NCT02444078|Alzheimer Disease|alzheimer disease
5250152|NCT02444078|Dementia|dementia
5250153|NCT02444078|Physical activity|physical activity
5250154|NCT02444078|Functional ability|functional ability
5250155|NCT02444078|Disability|disability
5250156|NCT02444078|Functional limitation|functional limitation
5250157|NCT02444065|Cognitive behavior therapy|cognitive behavior therapy
5250158|NCT02444065|Motivational interviewing|motivational interviewing
5250159|NCT02444065|Bulimia nervosa|bulimia nervosa
5250160|NCT02444065|Rapid response|rapid response
5250161|NCT02444013|Contrast induced nephropathy|contrast induced nephropathy
5250162|NCT02444000|chemotherapy|chemotherapy
5250163|NCT02444000|PCV|pcv
5250164|NCT02444000|radiotherapy|radiotherapy
5250165|NCT02444000|post operative treatment|post operative treatment
5250166|NCT02444000|anaplastic gliomas|anaplastic gliomas
5250167|NCT02444000|1p/19q codeletion|1p/19q codeletion
5250168|NCT02444000|cognition|cognition
5250169|NCT02443987|Tension-Free Vaginal Tape|tension-free vaginal tape
5250170|NCT02443961|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5250171|NCT02443961|pulmonary hypertension|pulmonary hypertension
5238033|NCT02514330|High Intensity Interval Training|high intensity interval training
5238034|NCT02514330|Muscle Fatigue|muscle fatigue
5238035|NCT02514330|Aerobic Performance|aerobic performance
5238042|NCT02514265|pelvic pain, bladder pain|pelvic pain, bladder pain
5238043|NCT02514252|Advanced Cancers|advanced cancers
5238044|NCT02514252|Metastatic|metastatic
5250172|NCT02443961|stem cell therapy|stem cell therapy
5250173|NCT02443961|mesenchymal stem cells|mesenchymal stem cells
5250174|NCT02443961|very low weight preterm babies|very low weight preterm babies
5250175|NCT02443922|type 2 diabetes|type 2 diabetes
5250176|NCT02443922|beta cell function|beta cell function
5250177|NCT02443922|meal tolerance test (MTT)|meal tolerance test (mtt)
5250178|NCT02443922|maximal stimulation test (MaxStim)|maximal stimulation test (maxstim)
5250179|NCT02443922|method standardization|method standardization
5250180|NCT02443922|insulin secretion|insulin secretion
5250181|NCT02443922|prediabetes|prediabetes
5250182|NCT02443922|insulin sensitivity|insulin sensitivity
5250183|NCT02443922|glimepiride|glimepiride
5250184|NCT02443922|sitagliptin|sitagliptin
5250185|NCT02443922|metformin|metformin
5250186|NCT02443909|Holmium Laser|holmium laser
5250187|NCT02443909|Kidney Stones|kidney stones
5250188|NCT02443909|RIRS|rirs
5250189|NCT02443883|stomach cancer|stomach cancer
5250190|NCT02443844|BPH|bph
5250191|NCT02443844|bladder cancer|bladder cancer
5250192|NCT02443844|treatment|treatment
5250193|NCT02443844|recurrence|recurrence
5250194|NCT02443844|progression|progression
5250195|NCT02443831|high risk relapsed CD19+ hematological malignancies|high risk relapsed cd19+ hematological malignancies
5250196|NCT02443766|Integrative Medicine|integrative medicine
5250197|NCT02443766|Alternative Medicine|alternative medicine
5250202|NCT02443766|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5250204|NCT02443766|General Health|general health
5250205|NCT02443740|First in human|first in human
5250206|NCT02443740|Single Ascending Dose Study|single ascending dose study
5250207|NCT02443740|Safety and Tolerability|safety and tolerability
5250208|NCT02443740|Pharmacokinetics|pharmacokinetics
5250209|NCT02443740|Plasma|plasma
5250210|NCT02443740|Cerebrospinal Fluid|cerebrospinal fluid
5250211|NCT02443714|Needle-Free Jet Injection|needle-free jet injection
5250212|NCT02443714|Insulin Lispro|insulin lispro
5250213|NCT02443714|pharmacokinetics|pharmacokinetics
5250214|NCT02443714|pharmacodynamics|pharmacodynamics
5250215|NCT02443636|Depression|depression
5250216|NCT02443636|Mental Health|mental health
5250217|NCT02443636|Registry|registry
5250218|NCT02443636|Reliability|reliability
5250219|NCT02443636|Post Traumatic Stress Disorder|post traumatic stress disorder
5250220|NCT02443636|Bipolar Disorder|bipolar disorder
5250221|NCT02443636|Mood disorder|mood disorder
5250223|NCT02443610|Postpartum Hemorrhage|postpartum hemorrhage
5250224|NCT02443610|Venous Thromboembolism|venous thromboembolism
5250249|NCT02443519|Cognitive Therapy|cognitive therapy
5250250|NCT02443519|Disability|disability
5250251|NCT02443428|Breast Cancer|breast cancer
5250252|NCT02443402|Non diabetic hyperglycemia|non diabetic hyperglycemia
5250302|NCT02443012|Nepafenac|nepafenac
5250303|NCT02443012|Laser therapy|laser therapy
5250304|NCT02443012|Clinically significant macular edema|clinically significant macular edema
5250305|NCT02443012|Adjunct Treatment|adjunct treatment
5250306|NCT02443012|Topical Nepafenac|topical nepafenac
5250307|NCT02442986|weaning failure|weaning failure
5250308|NCT02442986|polyneuropathy|polyneuropathy
5250309|NCT02442986|encephalopathy|encephalopathy
5250310|NCT02442986|sepsis|sepsis
5250311|NCT02442947|stress when dressed|stress when dressed
5250312|NCT02442947|protective garment|protective garment
5250313|NCT02442947|work clothes|work clothes
5250314|NCT02442934|Critical Care|critical care
5250315|NCT02442934|Critical Care Nursing|critical care nursing
5250316|NCT02442934|Discomfort|discomfort
5250317|NCT02442934|Sleep deprivation|sleep deprivation
5250318|NCT02442934|Noise|noise
5250319|NCT02442934|Thirst|thirst
5250320|NCT02442934|Pain|pain
5250321|NCT02442895|mature oocytes|mature oocytes
5250322|NCT02442895|antral follicles count|antral follicles count
5250323|NCT02442895|follicle stimulating hormone|follicle stimulating hormone
5250324|NCT02442895|antimullerian hormone|antimullerian hormone
5250325|NCT02442882|Brain Concussion|brain concussion
5250326|NCT02442882|Balance|balance
5250327|NCT02442882|Locomotion|locomotion
5250328|NCT02442882|Mild Traumatic Brain Injury|mild traumatic brain injury
5250329|NCT02442869|Suicide|suicide
5250330|NCT02442817|DPP-4 Inhibitor|dpp-4 inhibitor
5250332|NCT02442817|SDF1-α|sdf1-α
5250333|NCT02442804|Pomegranate|pomegranate
5250334|NCT02442804|Stroke|stroke
5250335|NCT02442804|Neuropsychology|neuropsychology
5250336|NCT02442791|Cardiac arrest|cardiac arrest
5250337|NCT02442791|GLP-1|glp-1
5250338|NCT02442791|Neuroprotection|neuroprotection
5250339|NCT02442752|Drug therapy|drug therapy
5250340|NCT02442739|Ketamine|ketamine
5250341|NCT02442739|Prevention of depression|prevention of depression
5250342|NCT02442726|Heat Injury|heat injury
5250343|NCT02442726|Humans|humans
5250344|NCT02442726|Laser Stimulation|laser stimulation
5250345|NCT02442726|Quantitative Sensory Testing|quantitative sensory testing
5250346|NCT02442726|Reaction Time|reaction time
5250347|NCT02442726|Secondary Hyperalgesia|secondary hyperalgesia
5250348|NCT02442726|Thermal Thresholds|thermal thresholds
5250349|NCT02442713|Polysomnograph|polysomnograph
5250350|NCT02442713|fluvoxamine|fluvoxamine
5250351|NCT02442700|HIV-infected patients with dyslipidemia and receiving atazanavir/ritonavir|hiv-infected patients with dyslipidemia and receiving atazanavir/ritonavir
5250352|NCT02442674|Hyponatremia|hyponatremia
5250353|NCT02442674|Euvolemic|euvolemic
5250354|NCT02442674|Hypervolemic|hypervolemic
5250355|NCT02442674|Serum sodium|serum sodium
5250356|NCT02442674|Dilutional hyponatremia|dilutional hyponatremia
5250357|NCT02442674|Electrolyte abnormality|electrolyte abnormality
5145430|NCT03082495|Quality of life|quality of life
5250358|NCT02442674|Electrolyte imbalance|electrolyte imbalance
5250359|NCT02442674|Metabolic disease|metabolic disease
5250360|NCT02442674|Water-Electrolyte Imbalance|water-electrolyte imbalance
5250361|NCT02442648|Renal Transplantation|renal transplantation
5250362|NCT02442648|Carfilzomib|carfilzomib
5250363|NCT02442648|Kyprolis|kyprolis
5250364|NCT02442648|Desensitization|desensitization
5250368|NCT02442622|de Quervain's treatment|de quervain's treatment
5250370|NCT02442609|anesthesia|anesthesia
5250371|NCT02442609|information|information
5250372|NCT02442609|surgery|surgery
5250373|NCT02442609|question|question
5250374|NCT02442596|Abdominal sepsis|abdominal sepsis
5250375|NCT02442596|Sepsis|sepsis
5250376|NCT02442596|Septic shock|septic shock
5250377|NCT02442596|Epidemiology|epidemiology
5250378|NCT02442596|Etiology|etiology
5250379|NCT02442596|Microbiology|microbiology
5250380|NCT02442596|Abdomen|abdomen
5250381|NCT02442596|Intra-abdominal|intra-abdominal
5250382|NCT02442596|Infection|infection
5250383|NCT02442596|Gastrointestinal tract|gastrointestinal tract
5250384|NCT02442596|Perforation|perforation
5250385|NCT02442596|Peritonitis|peritonitis
5250386|NCT02442596|Pancreas|pancreas
5250387|NCT02442596|Biliary tract|biliary tract
5250388|NCT02442596|Megacolon|megacolon
5250389|NCT02442583|colorectal cancer|colorectal cancer
5250390|NCT02442583|survivor|survivor
5250391|NCT02442583|exercise|exercise
5250392|NCT02442583|physical activity|physical activity
5250393|NCT02442583|sedentary|sedentary
5250394|NCT02442570|alpha B-crystallin|alpha b-crystallin
5250395|NCT02442570|immune tolerance|immune tolerance
5250396|NCT02442557|alpha B-crystallin|alpha b-crystallin
5130890|NCT03176277|MER|mer
5250397|NCT02442557|immune tolerance|immune tolerance
5250398|NCT02442518|placenta accreta|placenta accreta
5250399|NCT02442518|placenta previa|placenta previa
5250400|NCT02442518|ultrasound|ultrasound
5250401|NCT02442505|Atrial Fibrillation; Pacemaker; Device-detected; Sensitivity; Specificity|atrial fibrillation; pacemaker; device-detected; sensitivity; specificity
5250402|NCT02442492|sildenafil|sildenafil
5250403|NCT02442492|IUGR|iugr
5250404|NCT02442492|FGR|fgr
5250405|NCT02442492|STRIDER|strider
5250406|NCT02442479|exercise|exercise
5250407|NCT02442479|resistance training|resistance training
5250408|NCT02442479|muscle strength|muscle strength
5250409|NCT02442479|muscle hypertrophy|muscle hypertrophy
5250410|NCT02442440|anisodamine|anisodamine
5250411|NCT02442440|septic shock|septic shock
5250412|NCT02442427|Respiratory syncytial virus|respiratory syncytial virus
5250413|NCT02442427|Palivizumab|palivizumab
5250414|NCT02442427|Bronchiolitis|bronchiolitis
5250415|NCT02442427|Treatment|treatment
5250416|NCT02442414|Cancer|cancer
5250417|NCT02442414|Advanced Solid Tumors|advanced solid tumors
5250418|NCT02442414|EGFR|egfr
5250419|NCT02442414|HER2|her2
5250420|NCT02442414|HER3|her3
5250421|NCT02442414|HER4|her4
5250422|NCT02442414|ALK mutations|alk mutations
5250423|NCT02442414|irreversible tyrosine kinase inhibitor|irreversible tyrosine kinase inhibitor
5250424|NCT02442414|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
5250425|NCT02442414|Gastric Cancer|gastric cancer
5250426|NCT02442414|Colorectal Cancer|colorectal cancer
5250427|NCT02442388|pain|pain
5250428|NCT02442388|root canal therapy|root canal therapy
5250429|NCT02442388|endodontics|endodontics
5250430|NCT02442388|file|file
5250431|NCT02442375|head and neck cancer|head and neck cancer
5250432|NCT02442375|accelerated radiotherapy|accelerated radiotherapy
5238237|NCT02513290|allergic rhinitis|allergic rhinitis
5238238|NCT02513290|bilastine|bilastine
5238239|NCT02513290|loratadine|loratadine
5238240|NCT02513290|clinical trial|clinical trial
5238241|NCT02513277|type 2 diabetes|type 2 diabetes
5238242|NCT02513277|impaired glucose regulation|impaired glucose regulation
5238243|NCT02513277|intellectual disability|intellectual disability
5238244|NCT02513277|learning disability|learning disability
5250433|NCT02442375|dose reduction|dose reduction
5250435|NCT02442375|elective lymph nodes|elective lymph nodes
5250436|NCT02442375|FDG-PET|fdg-pet
5250437|NCT02442349|Phase II, Open Label, Single-arm study, Safety and Efficacy of AZD9291, Asia Pacific, NSCLC with T790M mutation within the Epidermal Growth Factor Receptor Gene|phase ii, open label, single-arm study, safety and efficacy of azd9291, asia pacific, nsclc with t790m mutation within the epidermal growth factor receptor gene
5250438|NCT02442310|deferiprone|deferiprone
5250439|NCT02442310|deferiprone delayed release formulation|deferiprone delayed release formulation
5250440|NCT02442310|pharmacokinetics|pharmacokinetics
5250441|NCT02442297|CNS Tumors|cns tumors
5250442|NCT02442297|T cells Expressing HER2-specific Chimeric Antigen Receptors|t cells expressing her2-specific chimeric antigen receptors
5250443|NCT02442297|HER2-specific T cells|her2-specific t cells
5250444|NCT02442297|intracranial injection|intracranial injection
5250445|NCT02442284|Chronic Hepatitis C|chronic hepatitis c
5250446|NCT02442284|Interferon-Free|interferon-free
5250447|NCT02442284|Hepatitis C Genotype 1|hepatitis c genotype 1
5250448|NCT02442284|Hepatitis C Virus|hepatitis c virus
5250449|NCT02442284|Hepatitis C|hepatitis c
5250450|NCT02442284|Cirrhosis|cirrhosis
5250451|NCT02442271|Chronic Hepatitis C|chronic hepatitis c
5247911|NCT02458157|CRRT|crrt
5250452|NCT02442271|Hepatitis C Treatment Naive|hepatitis c treatment naive
5250453|NCT02442271|Hepatitis C Genotype 1|hepatitis c genotype 1
5250454|NCT02442271|Hepatitis C Treatment Experienced|hepatitis c treatment experienced
5250455|NCT02442271|Hepatitis C Virus|hepatitis c virus
5250456|NCT02442258|Renal Impairment|renal impairment
5250457|NCT02442219|gluten|gluten
5250458|NCT02442219|Tetramer|tetramer
5250459|NCT02442206|QVA149, cardiac function, ventricular enddiastolic volume, hyperinflated COPD patients|qva149, cardiac function, ventricular enddiastolic volume, hyperinflated copd patients
5250460|NCT02442154|early tracheostomy|early tracheostomy
5250461|NCT02442154|severe head injury|severe head injury
5250462|NCT02442154|endotracheal intubation|endotracheal intubation
5250463|NCT02442141|Near-Infrared Spectroscopy|near-infrared spectroscopy
5250464|NCT02442141|Cerebral|cerebral
5250465|NCT02442141|Infants|infants
5250466|NCT02442141|Anesthesia|anesthesia
5250467|NCT02442141|Neurodevelopmental|neurodevelopmental
5250469|NCT02442128|intubation|intubation
5250470|NCT02442128|sevoflurane|sevoflurane
5250471|NCT02442128|children|children
5250472|NCT02442128|Propofol|propofol
5250473|NCT02442115|Autism|autism
5250474|NCT02442115|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5250475|NCT02442115|Tummy Troubles|tummy troubles
5250476|NCT02442115|Constipation|constipation
5250477|NCT02442115|GI Disorders|gi disorders
5250478|NCT02442115|Gastrointestinal Disorders|gastrointestinal disorders
5250479|NCT02442115|Gastrointestinal|gastrointestinal
5250480|NCT02442115|Oxidative Stress|oxidative stress
5250481|NCT02442115|Stomach problems|stomach problems
5250482|NCT02442115|Behaviors|behaviors
5250483|NCT02442115|Autistic|autistic
5250484|NCT02442115|ASD|asd
5250485|NCT02442115|MET gene|met gene
5250486|NCT02442115|GID|gid
5250487|NCT02442115|Pediatric|pediatric
5250488|NCT02442115|Pediatric GI disorders|pediatric gi disorders
5250489|NCT02442115|Children with Autism|children with autism
5250490|NCT02442115|functional constipation|functional constipation
5250491|NCT02442102|deglutition disorders|deglutition disorders
5250492|NCT02442102|therapeutics|therapeutics
5250493|NCT02442102|rehabilitation|rehabilitation
5250494|NCT02442102|outcome assessment|outcome assessment
5250495|NCT02442102|intubation|intubation
5250496|NCT02442102|critical care|critical care
5250497|NCT02442102|larynx|larynx
5250498|NCT02442102|voice|voice
5250499|NCT02442089|mHealth|mhealth
5250500|NCT02442089|eHealth|ehealth
5250501|NCT02442089|Health Systems|health systems
5250502|NCT02442089|Health Technology|health technology
5250503|NCT02442089|No Show|no show
5250504|NCT02442089|Non-attendance|non-attendance
5250505|NCT02442089|Chile|chile
5250506|NCT02442089|Randomized controlled trial|randomized controlled trial
5250507|NCT02442089|Efficiency, Organizational|efficiency, organizational
5250508|NCT02442089|Pediatric Hospitals|pediatric hospitals
5250509|NCT02442089|Global Health|global health
5250510|NCT02442089|Referral and Consultation|referral and consultation
5250511|NCT02442089|Health Care Systems|health care systems
5250512|NCT02442089|Community Health Systems|community health systems
5250513|NCT02442089|Health Information Systems|health information systems
5250514|NCT02442089|Integrated Health Care Systems|integrated health care systems
5250515|NCT02442089|Community Medicine|community medicine
5250516|NCT02442076|Skin vibration|skin vibration
5250517|NCT02442076|Acupuncture needle vibration|acupuncture needle vibration
5250518|NCT02442050|CABG|cabg
5250519|NCT02442050|valve surgery|valve surgery
5250520|NCT02442050|cardioplegia|cardioplegia
5250521|NCT02442050|heart surgery|heart surgery
5250522|NCT02442050|cardiac surgery|cardiac surgery
5250523|NCT02442050|Cardio-Pulmonary Bypass|cardio-pulmonary bypass
5250524|NCT02442050|myocardial arrest|myocardial arrest
5250525|NCT02442050|coronary artery bypass graft|coronary artery bypass graft
5250526|NCT02442050|CPB|cpb
5250527|NCT02442037|cellular therapy|cellular therapy
5250528|NCT02442037|active ulcerative colitis|active ulcerative colitis
5250531|NCT02442037|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5250533|NCT02442024|diabetes mellitus|diabetes mellitus
5250534|NCT02442024|diet|diet
5250535|NCT02442024|nutrient sensing|nutrient sensing
5250536|NCT02442011|Hematology Biobank|hematology biobank
5250537|NCT02441998|Colorectal Cancer|colorectal cancer
5250538|NCT02441998|Diminutive Polyps|diminutive polyps
5250539|NCT02441998|Narrow Band Imaging|narrow band imaging
5250540|NCT02441998|Colonic Polyps|colonic polyps
5250541|NCT02441998|colonoscopy|colonoscopy
5250542|NCT02441998|diagnostic imaging|diagnostic imaging
5250543|NCT02441998|optical diagnosis|optical diagnosis
5250544|NCT02441985|Primary orthostatic tremor|primary orthostatic tremor
5250545|NCT02441946|cyclin-dependent kinase (CDK) 4/6 inhibitor|cyclin-dependent kinase (cdk) 4/6 inhibitor
5250546|NCT02441946|CDK 4 and 6 inhibitor|cdk 4 and 6 inhibitor
5250547|NCT02441907|Diabetic Macular Edema|diabetic macular edema
5250548|NCT02441907|Ocular Cytokines|ocular cytokines
5250549|NCT02441907|Triamcinolone Acetonide|triamcinolone acetonide
5250550|NCT02441881|Radiofrequency ablation|radiofrequency ablation
5250551|NCT02441881|varicose veins|varicose veins
5250552|NCT02441881|endothermal ablation|endothermal ablation
5250553|NCT02441881|RFITT|rfitt
5250556|NCT02441842|ACE inhibitor|ace inhibitor
5250557|NCT02441842|Stress|stress
5250558|NCT02441842|Craniotomy|craniotomy
5250559|NCT02441842|Postop hypertension|postop hypertension
5250560|NCT02441842|neurosurgical patients|neurosurgical patients
5250561|NCT02441829|Renal Impairment|renal impairment
5250562|NCT02441816|wet AMD|wet amd
5250563|NCT02441816|neovascular AMD|neovascular amd
5250564|NCT02441803|Leukemia|leukemia
5250565|NCT02441803|Acute myeloid leukemia|acute myeloid leukemia
5250566|NCT02441803|AML|aml
5250567|NCT02441803|Refractory|refractory
5250568|NCT02441803|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5250569|NCT02441803|AHSCT|ahsct
5250570|NCT02441803|Busulfan|busulfan
5250571|NCT02441803|Busulfex|busulfex
5250572|NCT02441803|Myleran|myleran
5250573|NCT02441803|Fludarabine|fludarabine
5250574|NCT02441803|Fludarabine Phosphate|fludarabine phosphate
5250575|NCT02441803|Fludara|fludara
5250576|NCT02441803|Clofarabine|clofarabine
5250577|NCT02441803|Clofarex|clofarex
5250578|NCT02441803|Clolar|clolar
5250579|NCT02441803|Total body irradiation|total body irradiation
5250580|NCT02441803|TBI|tbi
5250581|NCT02441803|XRT|xrt
5250582|NCT02441803|Thymoglobulin|thymoglobulin
5250583|NCT02441803|ATG (Rabbit)|atg (rabbit)
5250584|NCT02441803|Rabbit antithymocyte Globulin|rabbit antithymocyte globulin
5250585|NCT02441803|Rabbit Antilymphocyte Globulin|rabbit antilymphocyte globulin
5250586|NCT02441803|Rabbit ATG|rabbit atg
5250587|NCT02441803|rATG|ratg
5250588|NCT02441803|Stem cell infusion|stem cell infusion
5250589|NCT02441803|Cyclophosphamide|cyclophosphamide
5250590|NCT02441803|Cytoxan|cytoxan
5250591|NCT02441803|Neosar|neosar
5250592|NCT02441803|Tacrolimus|tacrolimus
5250593|NCT02441803|Prograf|prograf
5250594|NCT02441803|Mycophenolate mofetil|mycophenolate mofetil
5250595|NCT02441803|MMF|mmf
5250596|NCT02441803|CellCept|cellcept
5250597|NCT02441803|Decitabine|decitabine
5250598|NCT02441803|Dacogen|dacogen
5250599|NCT02441803|Cytarabine|cytarabine
5250600|NCT02441803|Ara-C|ara-c
5250601|NCT02441803|Cytosar|cytosar
5250602|NCT02441803|DepoCyt|depocyt
5250603|NCT02441803|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5250604|NCT02441803|Idarubicin|idarubicin
5250605|NCT02441803|Idamycin|idamycin
5250606|NCT02441790|5th metacarpal|5th metacarpal
5250607|NCT02441790|EAROM|earom
5250608|NCT02441790|standard immobilization|standard immobilization
5250609|NCT02441790|Boxer's Fracture|boxer's fracture
5250610|NCT02441790|hand function|hand function
5250611|NCT02441790|DASH|dash
5250612|NCT02441790|trauma|trauma
5250613|NCT02441777|retinal imaging|retinal imaging
5250614|NCT02441777|optical imaging|optical imaging
5250615|NCT02441777|optical coherence tomography|optical coherence tomography
5250616|NCT02441777|polarization sensitive coherence tomography|polarization sensitive coherence tomography
5250617|NCT02441764|Halaven|halaven
5250618|NCT02441764|Eribulin Mesylate|eribulin mesylate
5250619|NCT02441764|locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5250620|NCT02441751|Electrocardiography|electrocardiography
5250621|NCT02441751|Hemorrhage|hemorrhage
5250622|NCT02441751|Monitoring, Intraoperative|monitoring, intraoperative
5250623|NCT02441738|Atrial Fibrillation|atrial fibrillation
5250624|NCT02441738|Hybrid Ablation|hybrid ablation
5250625|NCT02441738|Catheter Ablation|catheter ablation
5250626|NCT02441686|Multiple Myeloma|multiple myeloma
5250627|NCT02441673|Postanaesthetic shivering|postanaesthetic shivering
5250628|NCT02441673|Subarachnoid block|subarachnoid block
5250629|NCT02441673|Tramadol|tramadol
5250630|NCT02441673|Nefopam|nefopam
5250631|NCT02441621|fluid responsiveness|fluid responsiveness
5250632|NCT02441621|diastolic dysfunction|diastolic dysfunction
5250633|NCT02441621|left ventricular|left ventricular
5250634|NCT02441556|thrombectomy|thrombectomy
5250635|NCT02441556|rt-PA|rt-pa
5250636|NCT02441556|stroke|stroke
5250637|NCT02441556|endovascular treatment|endovascular treatment
5250638|NCT02441556|randomized|randomized
5250639|NCT02441530|vitamin D|vitamin d
5250640|NCT02441517|Xtandi|xtandi
5250641|NCT02441517|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5250642|NCT02441517|Metastatic|metastatic
5250643|NCT02441517|Prostate Cancer|prostate cancer
5250644|NCT02441517|Chemotherapy|chemotherapy
5250645|NCT02441517|Castration-resistant|castration-resistant
5250646|NCT02441517|Enzalutamide|enzalutamide
5250647|NCT02441504|Exercise training|exercise training
5250648|NCT02441504|microvascular rarefaction|microvascular rarefaction
5250649|NCT02441478|cooperative behavior, therapy adherence, fMRI|cooperative behavior, therapy adherence, fmri
5250650|NCT02441452|Nuss procedure|nuss procedure
5250651|NCT02441452|postoperative care|postoperative care
5250652|NCT02441452|early ambulation|early ambulation
5250653|NCT02441426|Cognitive development|cognitive development
5250654|NCT02441426|Diarrheal disease|diarrheal disease
5250655|NCT02441426|Enteric infections|enteric infections
5250656|NCT02441426|Malnutrition|malnutrition
5250657|NCT02441426|Vaccine Response|vaccine response
5250658|NCT02441426|Enteropathy|enteropathy
5250659|NCT02441426|Antibiotic use|antibiotic use
5250660|NCT02441426|Micronutrients|micronutrients
5250661|NCT02441426|Breast feeding|breast feeding
5250662|NCT02441426|Gut inflammation|gut inflammation
5250664|NCT02441413|High Resolution Computed Tomography scans|high resolution computed tomography scans
5250665|NCT02441413|Functional Respiratory Imaging|functional respiratory imaging
5250667|NCT02441413|Computed Tomography|computed tomography
5250668|NCT02441413|CT|ct
5674377|NCT00603798|Actinic keratosis|actinic keratosis
5250669|NCT02441413|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5250670|NCT02441413|BOS|bos
5250671|NCT02441413|Lung Transplant|lung transplant
5250672|NCT02441400|GERD|gerd
5250673|NCT02441400|LES Pressure|les pressure
5250674|NCT02441400|Electrical Stimulation|electrical stimulation
5250675|NCT02441387|depression|depression
5250676|NCT02441387|elderly|elderly
5250677|NCT02441387|remission|remission
5250678|NCT02441387|treatment response|treatment response
5250679|NCT02441387|predictors of response|predictors of response
5250680|NCT02441387|cognitive decline|cognitive decline
5250681|NCT02441387|structural neuroimage|structural neuroimage
5250682|NCT02441387|genetic polymorphism|genetic polymorphism
5250683|NCT02441387|psychoeducation|psychoeducation
5250684|NCT02441374|Stroke|stroke
5250685|NCT02441374|Hemiparesis|hemiparesis
5250686|NCT02441374|Upper limb|upper limb
5250687|NCT02441348|Voice Therapy|voice therapy
5250688|NCT02441348|Muscle Tension Dysphonia|muscle tension dysphonia
5250689|NCT02441348|Lesions|lesions
5250690|NCT02441309|Metastatic and/or Recurrent Osteosarcoma|metastatic and/or recurrent osteosarcoma
5250691|NCT02441283|Chronic hepatitis C|chronic hepatitis c
5250692|NCT02441283|Hepatitis C virus|hepatitis c virus
5250693|NCT02441283|Sustained virologic response|sustained virologic response
5250694|NCT02441283|Hepatitis C|hepatitis c
5250695|NCT02441283|Direct Acting Antiviral|direct acting antiviral
5250696|NCT02441257|Gastroesophageal Reflux|gastroesophageal reflux
5250697|NCT02441257|Laryngeal Mask Airway|laryngeal mask airway
5250698|NCT02441257|Control Ventilation|control ventilation
5250699|NCT02441257|Spontaneous Ventilation|spontaneous ventilation
5250700|NCT02441205|High Intensity Interval Training|high intensity interval training
5250701|NCT02441192|physical training|physical training
5250702|NCT02441192|aerobic training|aerobic training
5250703|NCT02441192|resistance training|resistance training
5250704|NCT02441179|acute intermittent hypoxia|acute intermittent hypoxia
5250705|NCT02441179|rehabilitation|rehabilitation
5250706|NCT02441179|spinal cord injury|spinal cord injury
5250707|NCT02441166|Bone marrow tryptase|bone marrow tryptase
5250708|NCT02441166|cutaneous mastocytosis|cutaneous mastocytosis
5250709|NCT02441140|Stage III Ovarian Cancer|stage iii ovarian cancer
5250710|NCT02441140|Stage IV Ovarian Cancer|stage iv ovarian cancer
5250711|NCT02441127|free gingival graft|free gingival graft
5250712|NCT02441127|diode laser|diode laser
5250713|NCT02441127|donor site|donor site
5250714|NCT02441127|mucogingival surgery|mucogingival surgery
5250715|NCT02441101|Cardiac Resynchronization therapy|cardiac resynchronization therapy
5250716|NCT02441075|patients|patients
5250717|NCT02441075|BMT|bmt
5250718|NCT02441075|cyclosporine|cyclosporine
5250719|NCT02441075|tacrolimus|tacrolimus
5250720|NCT02441075|HSCT|hsct
5250721|NCT02441049|Latino|latino
5250722|NCT02441049|Hispanic|hispanic
5250723|NCT02441049|Diet|diet
5250724|NCT02441049|Family health|family health
5250725|NCT02441049|Promotora|promotora
5250726|NCT02441049|Intervention|intervention
5250727|NCT02441036|Gene expression and protein production|gene expression and protein production
5250728|NCT02441023|type 2 diabetes mellitus|type 2 diabetes mellitus
5250729|NCT02441023|nutritional therapy|nutritional therapy
5250730|NCT02441023|health education|health education
5250731|NCT02441023|self-management|self-management
5250732|NCT02441023|multimedia|multimedia
5250733|NCT02440997|aromatherapy, peppermint|aromatherapy, peppermint
5250734|NCT02440984|enteric nervous system|enteric nervous system
5250735|NCT02440984|anorectal disorder|anorectal disorder
5250736|NCT02440984|barostat anorectal|barostat anorectal
5250737|NCT02440984|physiology|physiology
5250738|NCT02440984|spina bifida|spina bifida
5250739|NCT02440971|Adaptive Servo Ventilation|adaptive servo ventilation
5250740|NCT02440971|Acute decompensated heart failure|acute decompensated heart failure
5250741|NCT02440971|SleepMinder|sleepminder
5250742|NCT02440971|ApneaLink Plus|apnealink plus
5250743|NCT02440971|Sleep disordered breathing|sleep disordered breathing
5250744|NCT02440971|Natriuretic peptide|natriuretic peptide
5250745|NCT02440932|low Phenylalanine diet|low phenylalanine diet
5250746|NCT02440932|PKU supplements|pku supplements
5250747|NCT02440932|diet induced thermogenesis|diet induced thermogenesis
5250748|NCT02440932|appetite|appetite
5250749|NCT02440932|body weight|body weight
5250750|NCT02440919|Respiratory mechanics|respiratory mechanics
5250751|NCT02440919|Oxygenation|oxygenation
5250752|NCT02440919|Suction|suction
5250753|NCT02440919|Mechanical ventilation|mechanical ventilation
5250754|NCT02440919|Respiratory therapy|respiratory therapy
5250759|NCT02440906|Intracranial Injury|intracranial injury
5250760|NCT02440906|Neoplasms|neoplasms
5250761|NCT02440906|Heart Failure|heart failure
5250762|NCT02440906|HIV/AIDs|hiv/aids
5250763|NCT02440906|Hereditary and Degenerative Diseases of the Central Nervous System|hereditary and degenerative diseases of the central nervous system
5250764|NCT02440906|Disorders of the Peripheral Nervous System|disorders of the peripheral nervous system
5250765|NCT02440906|Rheumatoid Arthritis and Other Inflammatory Polyarthropathies|rheumatoid arthritis and other inflammatory polyarthropathies
5250766|NCT02440906|History of hepatitis C|history of hepatitis c
5250767|NCT02440906|Schizophrenia|schizophrenia
5250768|NCT02440906|Episodic Mood Disorders|episodic mood disorders
5250769|NCT02440906|Delusional Disorders|delusional disorders
5250770|NCT02440906|Other Non-Organic Psychoses|other non-organic psychoses
5250771|NCT02440906|Organic Psychotic Conditions|organic psychotic conditions
5250772|NCT02440906|Neurotic Disorders|neurotic disorders
5250773|NCT02440906|Other Non-Psychotic Mental Disorders|other non-psychotic mental disorders
5250774|NCT02440893|Corus CAD|corus cad
5250775|NCT02440893|ASGES|asges
5250776|NCT02440893|Age/Sex/Gene Expression Score|age/sex/gene expression score
5250777|NCT02440893|Gene Expression|gene expression
5250778|NCT02440893|GES|ges
5250779|NCT02440893|CAD|cad
5250780|NCT02440893|CVD|cvd
5250781|NCT02440893|CHD|chd
5250782|NCT02440893|Precision Medicine|precision medicine
5250783|NCT02440893|Coronary Artery Disease|coronary artery disease
5250784|NCT02440893|Angina Pectoris|angina pectoris
5250785|NCT02440893|Chest Pain|chest pain
5250786|NCT02440893|Cardiovascular Disease|cardiovascular disease
5250787|NCT02440893|Coronary Heart Disease|coronary heart disease
5250789|NCT02440867|theta burst stimulation|theta burst stimulation
5250790|NCT02440867|Social Cognition|social cognition
5250791|NCT02440867|MRSI|mrsi
5250792|NCT02440867|Schizophrenia|schizophrenia
5250793|NCT02440867|transcranial magnetic stimulation|transcranial magnetic stimulation
5250794|NCT02440841|VA106483|va106483
5250795|NCT02440841|fedovapagon|fedovapagon
5250796|NCT02440841|drug-drug interaction|drug-drug interaction
5250797|NCT02440841|DDI|ddi
5250798|NCT02440841|males|males
5250799|NCT02440841|rifampicin|rifampicin
5250800|NCT02440841|rifampin|rifampin
5250801|NCT02440841|itraconazole|itraconazole
5250802|NCT02440841|CYP3A4|cyp3a4
5250803|NCT02440841|pharmacokinetics|pharmacokinetics
5250804|NCT02440841|PK|pk
5250805|NCT02440815|Psychotherapy|psychotherapy
5250806|NCT02440815|Problem Solving Therapy (PST)|problem solving therapy (pst)
5250807|NCT02440815|Depression|depression
5250808|NCT02440815|Major Depression|major depression
5250809|NCT02440815|Major Depressive Disorder|major depressive disorder
5238629|NCT02511106|Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm+; Ex19Del; L858R; AZD9291; Phase III, adjuvant chemotherapy; complete tumour resection; EGFR-TKI|stage ib-iia-iiia non-small cell lung cancer; egfrm+; ex19del; l858r; azd9291; phase iii, adjuvant chemotherapy; complete tumour resection; egfr-tki
5238630|NCT02511093|Hypertension|hypertension
5238631|NCT02511093|Team-based care|team-based care
5238632|NCT02511093|Collaboration|collaboration
5238633|NCT02511093|Healthcare professionals|healthcare professionals
5238634|NCT02511093|Healthcare services|healthcare services
5250810|NCT02440815|Late Life Depression|late life depression
5250811|NCT02440815|Multimodal imaging|multimodal imaging
5250812|NCT02440815|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5250813|NCT02440815|Cerebral blood flow|cerebral blood flow
5250814|NCT02440815|Cortical atrophy|cortical atrophy
5250815|NCT02440815|White matter lesion|white matter lesion
5250816|NCT02440763|Natural History|natural history
5250817|NCT02440737|Newly diagnosed|newly diagnosed
5145924|NCT03079791|OCT|oct
5250818|NCT02440737|Cancer patient|cancer patient
5250819|NCT02440737|Caregiver|caregiver
5250820|NCT02440737|Support person|support person
5250821|NCT02440724|winged stents|winged stents
5250822|NCT02440724|Self-expandable Metal Stents(SEMS)|self-expandable metal stents(sems)
5250823|NCT02440724|partial covered|partial covered
5250824|NCT02440724|uncovered|uncovered
5250825|NCT02440724|endoscopic insertion|endoscopic insertion
5250826|NCT02440685|DLBCL|dlbcl
5250827|NCT02440685|FL|fl
5250828|NCT02440685|MCL|mcl
5250829|NCT02440685|PTCL|ptcl
5250830|NCT02440685|MF|mf
5250831|NCT02440685|CLL|cll
5250832|NCT02440672|Osteoarthritis|osteoarthritis
5250833|NCT02440672|TKA|tka
5250834|NCT02440672|Degenerative Knee Disease|degenerative knee disease
5250835|NCT02440659|Chronic Kidney Disease|chronic kidney disease
5250836|NCT02440659|Hemodialysis|hemodialysis
5250837|NCT02440659|Peritoneal Dialysis|peritoneal dialysis
5250838|NCT02440646|Computed tomography angiography|computed tomography angiography
5250839|NCT02440646|Quantitative coronary angiography|quantitative coronary angiography
5248382|NCT02455115|Vasopressor|vasopressor
5250845|NCT02440646|Glagovian artery remodeling|glagovian artery remodeling
5250846|NCT02440646|Radiation dose|radiation dose
5250847|NCT02440646|SYNTAX score|syntax score
5250848|NCT02440646|Fractional flow reserve|fractional flow reserve
5250849|NCT02440620|Heart failure related to medical treatment of breast cancer|heart failure related to medical treatment of breast cancer
5250850|NCT02440607|Randomization|randomization
5250851|NCT02440607|cognitive aids types|cognitive aids types
5250853|NCT02440594|Primary Care|primary care
5250854|NCT02440594|Depression|depression
5250855|NCT02440594|Elderly|elderly
5250856|NCT02440555|diabetes, capillary blood glucose, self-administered questionnaire|diabetes, capillary blood glucose, self-administered questionnaire
5250857|NCT02440542|Nerve block|nerve block
5250858|NCT02440542|Ankle|ankle
5250859|NCT02440542|Talus|talus
5250860|NCT02440542|Pain, Postoperative|pain, postoperative
5250861|NCT02440516|Standardized|standardized
5250862|NCT02440516|Physical therapy|physical therapy
5250863|NCT02440516|occupational therapy|occupational therapy
5250864|NCT02440516|quality of life|quality of life
5250865|NCT02440516|disability|disability
5250866|NCT02440516|activities of daily living|activities of daily living
5250867|NCT02440516|ambulatory therapy|ambulatory therapy
5250868|NCT02440516|multiple sclerosis|multiple sclerosis
5250869|NCT02440464|Multiple Myeloma|multiple myeloma
5250870|NCT02440464|Allogeneic Transplant|allogeneic transplant
5250871|NCT02440464|Maintenance Therapy|maintenance therapy
5250872|NCT02440464|Anti-Myeloma Agents|anti-myeloma agents
5250873|NCT02440464|Hematologic Disorders|hematologic disorders
5250874|NCT02440438|Clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis|clostridium difficile, recurrence, relapse, antibodies, immune response, prognosis
5250875|NCT02440425|platinum resistant|platinum resistant
5250876|NCT02440425|recurrent|recurrent
5250877|NCT02440425|persistent|persistent
5250878|NCT02440425|epithelial|epithelial
5250879|NCT02440425|ovarian|ovarian
5250880|NCT02440425|fallopian tube|fallopian tube
5250881|NCT02440425|primary peritoneal|primary peritoneal
5250882|NCT02440425|carcinoma|carcinoma
5250883|NCT02440412|Massage|massage
5250884|NCT02440412|Stress|stress
5250885|NCT02440412|salivary cortisol|salivary cortisol
5250886|NCT02440360|chronic homelessness|chronic homelessness
5250887|NCT02440347|local anesthesia|local anesthesia
5250888|NCT02440347|articaine|articaine
5250889|NCT02440347|AMSA|amsa
5250890|NCT02440334|cryosurgery|cryosurgery
5250891|NCT02440334|ultrasonography|ultrasonography
5250892|NCT02440282|patients|patients
5250893|NCT02440256|Cost-effectiveness|cost-effectiveness
5250894|NCT02440256|Opioid substitution treatment|opioid substitution treatment
5250895|NCT02440256|Integrated care|integrated care
5250896|NCT02440256|HIV|hiv
5250897|NCT02440256|HAART|haart
5250898|NCT02440256|Testing|testing
5250899|NCT02440256|Linkage to care|linkage to care
5250900|NCT02440256|Treatment adherence|treatment adherence
5250901|NCT02440230|adjuvant endocrine therapy|adjuvant endocrine therapy
5250902|NCT02440230|safety|safety
5250903|NCT02440230|Exemestane|exemestane
5250904|NCT02440230|ovarian function suppression|ovarian function suppression
5250905|NCT02440230|anastrozole|anastrozole
5250906|NCT02440204|sevoflurane|sevoflurane
5250907|NCT02440204|remifentanil|remifentanil
5250908|NCT02440204|intubation without using muscle relaxants|intubation without using muscle relaxants
5250909|NCT02440178|leukemia|leukemia
5250910|NCT02440178|induction|induction
5250911|NCT02440178|prophylaxis|prophylaxis
5250912|NCT02440178|antifungal|antifungal
5250913|NCT02440178|micafungin|micafungin
5250914|NCT02440178|phase II|phase ii
5250915|NCT02440165|nutrition|nutrition
5250916|NCT02440165|nurse|nurse
5250917|NCT02440165|intervention|intervention
5250918|NCT02440165|malnutrition|malnutrition
5250919|NCT02440126|Multiple Sclerosis|multiple sclerosis
5250920|NCT02440126|immunological|immunological
5250921|NCT02440126|biomarkers|biomarkers
5250922|NCT02440126|observational|observational
5250923|NCT02440126|Relapsing|relapsing
5250924|NCT02440126|Remitting Multiple Sclerosis|remitting multiple sclerosis
5250927|NCT02440100|safety, tolerability, PK|safety, tolerability, pk
5250928|NCT02440100|plasma and CSF abeta|plasma and csf abeta
5250929|NCT02440100|drug interaction|drug interaction
5250930|NCT02440074|Lumbar pain|lumbar pain
5250931|NCT02440074|Mesenchymal Stem Cells|mesenchymal stem cells
5250933|NCT02440061|age, BMI, and gender matched controls|age, bmi, and gender matched controls
5250948|NCT02439944|Nicotine|nicotine
5250949|NCT02439944|Tobacco|tobacco
5250950|NCT02439944|Transdermal Nicotine Replacement Therapy|transdermal nicotine replacement therapy
5250951|NCT02439944|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5250952|NCT02439944|Neuroimaging|neuroimaging
5250953|NCT02439944|Cue Reactivity|cue reactivity
5250954|NCT02439944|Resting State|resting state
5250955|NCT02439944|BOLD fMRI|bold fmri
5250956|NCT02439905|inflammatory cytokine|inflammatory cytokine
5250957|NCT02439905|protective effect|protective effect
5250958|NCT02439905|Dexmedetomidine|dexmedetomidine
5250959|NCT02439905|Precedex|precedex
5250960|NCT02439905|one lung ventilation|one lung ventilation
5250961|NCT02439905|ischemia-reperfusion|ischemia-reperfusion
5250962|NCT02439892|Radiotherapy|radiotherapy
5250963|NCT02439892|Exercise|exercise
5250964|NCT02439892|Diet therapy|diet therapy
5250965|NCT02439892|Rehabilitation|rehabilitation
5250966|NCT02439892|Patient Compliance|patient compliance
5250967|NCT02439892|Feasibility Studies|feasibility studies
5250968|NCT02439892|Sample Size|sample size
5250969|NCT02439892|Patient satisfaction|patient satisfaction
5250970|NCT02439853|primary progressive aphasia|primary progressive aphasia
5250971|NCT02439853|progressive nonfluent aphasia|progressive nonfluent aphasia
5250972|NCT02439853|progressive aphasia|progressive aphasia
5250973|NCT02439853|frontotemporal dementia|frontotemporal dementia
5250974|NCT02439853|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5250975|NCT02439827|Lifestyle|lifestyle
5250976|NCT02439827|Intervention|intervention
5250977|NCT02439827|Motor Activity|motor activity
5250978|NCT02439827|Mediating Variables|mediating variables
5250979|NCT02439827|Mental Health|mental health
5250980|NCT02439827|Obesity|obesity
5250981|NCT02439827|Adolescent Health|adolescent health
5250982|NCT02439827|School|school
5250983|NCT02439827|Health Promotion|health promotion
5250984|NCT02439827|Brazil|brazil
5250985|NCT02439801|PEEP|peep
5250986|NCT02439801|compliance|compliance
5250987|NCT02439801|peak airway pressures|peak airway pressures
5250988|NCT02439788|Neuroblastoma|neuroblastoma
5250989|NCT02439788|Natural Killer T Cells|natural killer t cells
5250990|NCT02439788|Gene Therapy|gene therapy
5333209|NCT02025543|MRI|mri
5250991|NCT02439788|Chimeric Antigen Receptor|chimeric antigen receptor
5250992|NCT02439775|Uncontrolled hypertension|uncontrolled hypertension
5250993|NCT02439775|Renal denervation|renal denervation
5250994|NCT02439762|Veterans|veterans
5250995|NCT02439762|Cognitive Behavioral Therapy|cognitive behavioral therapy
5250996|NCT02439749|Uncontrolled hypertension|uncontrolled hypertension
5250997|NCT02439749|Renal denervation|renal denervation
5250998|NCT02439736|Traumatic Brain Injury|traumatic brain injury
5250999|NCT02439736|Head Injury|head injury
5251000|NCT02439723|Regorafenib|regorafenib
5251001|NCT02439723|Lean body mass|lean body mass
5251002|NCT02439723|Proton pump inhibitors pharmacokinetics|proton pump inhibitors pharmacokinetics
5251003|NCT02439684|HbA1c|hba1c
5251004|NCT02439684|Diagnostic accuracy|diagnostic accuracy
5251005|NCT02439684|Diabetes Mellitus|diabetes mellitus
5251006|NCT02439684|Chinese|chinese
5251007|NCT02439684|Impaired fasting glucose|impaired fasting glucose
5251008|NCT02439671|Transition Support Program for young adults|transition support program for young adults
5251009|NCT02439658|genetic research|genetic research
5251010|NCT02439645|genetic research|genetic research
5251011|NCT02439606|GlideRite|gliderite
5251012|NCT02439606|Stylet|stylet
5251013|NCT02439606|Parker|parker
5251014|NCT02439606|orotracheal|orotracheal
5251015|NCT02439606|intubation|intubation
5251016|NCT02439606|GlideScope|glidescope
5251017|NCT02439593|Pancreas|pancreas
5251018|NCT02439593|chemoradiotherapy|chemoradiotherapy
5251024|NCT02439567|Clinically significant portal hypertension|clinically significant portal hypertension
5251026|NCT02439567|Elastography|elastography
5251027|NCT02439567|Antiviral therapy|antiviral therapy
5251028|NCT02439541|cellular therapy|cellular therapy
5251429|NCT02436993|Paclitaxel|paclitaxel
5251029|NCT02439541|Chronic ischemic heart disease|chronic ischemic heart disease
5251030|NCT02439541|phase 1/2 clinical study|phase 1/2 clinical study
5251031|NCT02439541|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
5251032|NCT02439541|ischemic heart disease|ischemic heart disease
5251033|NCT02439541|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5251034|NCT02439528|pulmonary fibrosis|pulmonary fibrosis
5251035|NCT02439528|syndrome|syndrome
5251036|NCT02439528|genetic|genetic
5251037|NCT02439528|emphysema|emphysema
5251038|NCT02439515|post-acute stroke|post-acute stroke
5251039|NCT02439515|functional electrical stimulation|functional electrical stimulation
5251040|NCT02439515|biofeedback|biofeedback
5251041|NCT02439515|balance|balance
5251042|NCT02439515|cycling|cycling
5251043|NCT02439515|rehabilitation|rehabilitation
5251044|NCT02439515|gait|gait
5251045|NCT02439476|Multiple myeloma|multiple myeloma
5251046|NCT02439476|ASCT|asct
5251047|NCT02439476|plerixafor|plerixafor
5251048|NCT02439476|stem cell mobilization|stem cell mobilization
5251049|NCT02439476|Salvage ASCT using plerixafor-based stem cell mobilization in relapsed multiple myeloma|salvage asct using plerixafor-based stem cell mobilization in relapsed multiple myeloma
5251050|NCT02439450|lung|lung
5251051|NCT02439450|cancer|cancer
5251052|NCT02439450|gp96|gp96
5251053|NCT02439450|vaccine|vaccine
5251054|NCT02439450|immunotherapy|immunotherapy
5251055|NCT02439450|Heat Biologics|heat biologics
5251056|NCT02439450|Nivolumab|nivolumab
5251057|NCT02439450|checkpoint inhibitor|checkpoint inhibitor
5251058|NCT02439385|Curcumin|curcumin
5251060|NCT02439385|FOLFIRI|folfiri
5251061|NCT02439385|Colorectal cancer|colorectal cancer
5251062|NCT02439385|Unresectable metastasis|unresectable metastasis
5251063|NCT02439346|Advanced solid tumors|advanced solid tumors
5251064|NCT02439346|Docetaxel|docetaxel
5251065|NCT02439346|mitogen-activated protein (MAP) kinase-interacting serine / threonine-protein kinase 1, also known as Mnk1 (MKNK1 inhibitor)|mitogen-activated protein (map) kinase-interacting serine / threonine-protein kinase 1, also known as mnk1 (mknk1 inhibitor)
5251066|NCT02439346|Taxanes|taxanes
5251067|NCT02439346|Non-small cell lung cancer|non-small cell lung cancer
5251068|NCT02439333|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
5251069|NCT02439333|Nasal high flow therapy|nasal high flow therapy
5251070|NCT02439333|Oxygen therapy|oxygen therapy
5251071|NCT02439307|Rifaximin|rifaximin
5251072|NCT02439307|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5251073|NCT02439294|Recent acute myocardial infarction|recent acute myocardial infarction
5251074|NCT02439294|Obstructive sleep apnée (syndrome)|obstructive sleep apnée (syndrome)
5251075|NCT02439294|Ventricular remodeling|ventricular remodeling
5251076|NCT02439294|Continuous Positive Airway Pressure|continuous positive airway pressure
5251077|NCT02439281|Ropivacaine|ropivacaine
5251078|NCT02439281|Anesthesia adjuncts|anesthesia adjuncts
5251079|NCT02439281|clonidine|clonidine
5251080|NCT02439281|laparoscopic appendectomy|laparoscopic appendectomy
5251081|NCT02439281|rectus sheath block|rectus sheath block
5238921|NCT02509286|Esophageal neoplasms|esophageal neoplasms
5251082|NCT02439242|stroke volume, haemodynamic, fluid resucitation|stroke volume, haemodynamic, fluid resucitation
5251083|NCT02439216|Muscular Dystrophies|muscular dystrophies
5251084|NCT02439216|Musculoskeletal Diseases|musculoskeletal diseases
5251085|NCT02439216|Nervous System Diseases|nervous system diseases
5251086|NCT02439216|Neuromuscular Diseases|neuromuscular diseases
5251087|NCT02439216|Duchenne muscular dystrophy|duchenne muscular dystrophy
5251089|NCT02439216|dystrophin|dystrophin
5251090|NCT02439216|dystrophy|dystrophy
5251091|NCT02439216|Duchenne|duchenne
5251092|NCT02439203|Parkinson Disease|parkinson disease
5251093|NCT02439203|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
5251094|NCT02439203|Dyskinesia|dyskinesia
5251095|NCT02439177|Blood glucose monitoring system|blood glucose monitoring system
5251096|NCT02439177|System Accuracy|system accuracy
5251097|NCT02439164|sedation|sedation
5251098|NCT02439164|eloquent area glioma|eloquent area glioma
5251099|NCT02439164|neurologic function|neurologic function
5251100|NCT02439151|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5251101|NCT02439138|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5251102|NCT02439125|levodopa|levodopa
5251103|NCT02439125|dyskinesia|dyskinesia
5251104|NCT02439125|parkinsons disease|parkinsons disease
5251105|NCT02439125|PD|pd
5251106|NCT02439112|Exercise|exercise
5251107|NCT02439112|Physical Function|physical function
5251108|NCT02439112|Physical Activity|physical activity
5251109|NCT02439112|Quality of Life|quality of life
5251110|NCT02439112|Pain|pain
5251111|NCT02439112|Bone Disease|bone disease
5251112|NCT02439086|rectal cancer|rectal cancer
5251113|NCT02439086|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5251114|NCT02439086|long course radiotherapy|long course radiotherapy
5251116|NCT02439047|reconstructive surgery|reconstructive surgery
5251117|NCT02439047|abdominal surgery|abdominal surgery
5251118|NCT02439034|pain management|pain management
5251119|NCT02439034|brachytherapy|brachytherapy
5251120|NCT02439008|liver metastases of colorectal cancer|liver metastases of colorectal cancer
5251430|NCT02436993|Pertuzumab|pertuzumab
5251121|NCT02439008|metastases of melanoma or renal cancer|metastases of melanoma or renal cancer
5251122|NCT02438969|Alcohol|alcohol
5251123|NCT02438969|Alcohol Dependence|alcohol dependence
5251124|NCT02438969|Stress|stress
5251125|NCT02438969|Fear Conditioning|fear conditioning
5251126|NCT02438917|Hepatitis C|hepatitis c
5251127|NCT02438917|Cirrhosis|cirrhosis
5251128|NCT02438917|Biomarkers|biomarkers
5251129|NCT02438917|Fibrosis|fibrosis
5251130|NCT02438904|Blood And Marrow Transplantation|blood and marrow transplantation
5251131|NCT02438904|Stem cell transplantation|stem cell transplantation
5251132|NCT02438904|SCT|sct
5251133|NCT02438904|Poor graft function|poor graft function
5251134|NCT02438904|CD34+ cell infusion|cd34+ cell infusion
5251135|NCT02438865|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
5251136|NCT02438865|Intravesical Chemotherapy|intravesical chemotherapy
5251137|NCT02438865|Epirubicin|epirubicin
5251138|NCT02438865|Urothelial Carcinoma|urothelial carcinoma
5251139|NCT02438800|Postpartum Period|postpartum period
5251140|NCT02438787|Ankylosing Spondylitis|ankylosing spondylitis
5251141|NCT02438787|Ustekinumab|ustekinumab
5251142|NCT02438787|Golimumab|golimumab
5251143|NCT02438787|STELARA|stelara
5251144|NCT02438774|Post-harvest practices , complementary foods|post-harvest practices , complementary foods
5251145|NCT02438774|aflatoxins and fumonisins exposure,|aflatoxins and fumonisins exposure,
5251146|NCT02438774|Maize, breast milk|maize, breast milk
5251147|NCT02438774|child growth, Tanzania|child growth, tanzania
5251148|NCT02438761|Acute Myeloid Leukemia|acute myeloid leukemia
5251149|NCT02438761|Myelodysplastic Syndrome|myelodysplastic syndrome
5251150|NCT02438761|PIK/Akt/mTor|pik/akt/mtor
5251151|NCT02438748|Oxidized Phosphatidylcholines|oxidized phosphatidylcholines
5251152|NCT02438748|Oxylipins|oxylipins
5251153|NCT02438735|ovarian endometriomas|ovarian endometriomas
5251154|NCT02438735|AMH|amh
5251155|NCT02438735|ovarian reserve|ovarian reserve
5251156|NCT02438670|Artificial Pancreas|artificial pancreas
5251157|NCT02438670|Type 1 Diabetes|type 1 diabetes
5251158|NCT02438670|MPC|mpc
5251159|NCT02438670|PID|pid
5251160|NCT02438631|placenta|placenta
5251161|NCT02438631|placental passage|placental passage
5251162|NCT02438605|Nellix|nellix
5251163|NCT02438605|EVAS|evas
5251164|NCT02438605|EVAR|evar
5251165|NCT02438605|Dynamic CT|dynamic ct
5251166|NCT02438605|Dyna CT|dyna ct
5251167|NCT02438592|Continuum of care|continuum of care
5251168|NCT02438579|Hypertonic saline|hypertonic saline
5251169|NCT02438579|nasal irrigation|nasal irrigation
5251170|NCT02438579|gargling|gargling
5251171|NCT02438579|URTI|urti
5251172|NCT02438566|Tranexamic Acid|tranexamic acid
5251173|NCT02438566|Blood Loss|blood loss
5251174|NCT02438566|Total Hip Replacement|total hip replacement
5251175|NCT02438566|Bilateral Knee Replacement|bilateral knee replacement
5251176|NCT02438540|acupuncture|acupuncture
5251177|NCT02438540|obesity|obesity
5239025|NCT02508766|Postural Control|postural control
5239026|NCT02508766|Plantar Stimulation|plantar stimulation
5239027|NCT02508766|Volunteers|volunteers
5251178|NCT02438540|type 2 diabetic mellitus|type 2 diabetic mellitus
5251179|NCT02438540|insulin sensitivity|insulin sensitivity
5251180|NCT02438540|metformin|metformin
5251181|NCT02438540|inflammatory factor|inflammatory factor
5251182|NCT02438540|adipokines|adipokines
5251183|NCT02438540|lipid profile|lipid profile
5251184|NCT02438501|low-dose involved field radiotherapy|low-dose involved field radiotherapy
5251185|NCT02438501|recurrent|recurrent
5251186|NCT02438501|advanced|advanced
5251187|NCT02438501|follicular lymphoma|follicular lymphoma
5251188|NCT02438462|Pulmonary Embolism|pulmonary embolism
5251189|NCT02438462|Soluble Fibrin|soluble fibrin
5251190|NCT02438462|D-Dimers|d-dimers
5251191|NCT02438462|Clinical Probability Score|clinical probability score
5251193|NCT02438449|breast reconstruction|breast reconstruction
5251194|NCT02438449|mastectomy|mastectomy
5251195|NCT02438449|health-related quality of life|health-related quality of life
5251196|NCT02438449|Health Utilities Index|health utilities index
5251197|NCT02438449|HUI|hui
5251198|NCT02438449|prospective|prospective
5251199|NCT02438449|quality-adjusted life years|quality-adjusted life years
5251200|NCT02438449|QALY|qaly
5251201|NCT02438410|infliximab|infliximab
5251202|NCT02438410|remicade|remicade
5251203|NCT02438410|IBD|ibd
5251204|NCT02438410|Colitis, Ulcerative|colitis, ulcerative
5251205|NCT02438371|pregnancy|pregnancy
5251206|NCT02438371|preterm labor|preterm labor
5251207|NCT02438371|tocolysis|tocolysis
5251208|NCT02438293|rhinovirus|rhinovirus
5251209|NCT02438293|cardiac surgery|cardiac surgery
5251210|NCT02438293|paediatric|paediatric
5251211|NCT02438293|respiratory infection|respiratory infection
5251212|NCT02438293|children|children
5251213|NCT02438280|Orthodontic|orthodontic
5251214|NCT02438280|Orthodontic treatment|orthodontic treatment
5251215|NCT02438280|Accelerated orthodontics|accelerated orthodontics
5251216|NCT02438280|Vibration|vibration
5251217|NCT02438241|Pain Measurement|pain measurement
5251218|NCT02438241|Electric Stimulation|electric stimulation
5251219|NCT02438241|Spirometry|spirometry
5251220|NCT02438241|Manometry|manometry
5251221|NCT02438228|cardiac output|cardiac output
5251222|NCT02438228|transpulmonary thermodilution|transpulmonary thermodilution
5251223|NCT02438228|pulse contour analysis|pulse contour analysis
5251224|NCT02438228|G09.330.380.124|g09.330.380.124
5251226|NCT02438215|Parkinson's Disease|parkinson's disease
5251227|NCT02438189|Type 1 Diabetes|type 1 diabetes
5251228|NCT02438189|Hypoglycemia|hypoglycemia
5251229|NCT02438189|Hyperglycemia|hyperglycemia
5251230|NCT02438189|Artificial Pancreas|artificial pancreas
5251231|NCT02438163|Theta Burst Stimulation|theta burst stimulation
5251232|NCT02438150|Disaster|disaster
5251233|NCT02438150|Training|training
5251234|NCT02438137|Obstructive Sleep Apnea|obstructive sleep apnea
5251235|NCT02438137|OSA|osa
5251236|NCT02438137|sleep apnea|sleep apnea
5251237|NCT02438137|snoring|snoring
5251238|NCT02438137|dimethyl fumarate|dimethyl fumarate
5251239|NCT02438137|CPAP|cpap
5251240|NCT02438137|continuous positive airway pressure|continuous positive airway pressure
5251241|NCT02438124|Parkinson's disease|parkinson's disease
5251242|NCT02438124|Rhythmic auditory stimulation|rhythmic auditory stimulation
5251243|NCT02438124|Gait|gait
5251244|NCT02438098|Rivaroxaban|rivaroxaban
5251245|NCT02438098|Obesity|obesity
5251246|NCT02438098|Bariatric surgery|bariatric surgery
5251247|NCT02438098|Pharmacokinetics|pharmacokinetics
5251248|NCT02438098|Pharmacodynamics|pharmacodynamics
5251249|NCT02438085|acute coronary syndromes|acute coronary syndromes
5251250|NCT02438085|outcome|outcome
5251251|NCT02438085|medical management|medical management
5251252|NCT02438085|comorbidities|comorbidities
5251253|NCT02438085|registry|registry
5251254|NCT02438072|antidepressive agent|antidepressive agent
5251255|NCT02438072|drug metabolism|drug metabolism
5251256|NCT02438072|CYP450|cyp450
5251257|NCT02438072|P-glycoprotein|p-glycoprotein
5251258|NCT02438072|Phenotypic study|phenotypic study
5251259|NCT02438059|Inequality in health|inequality in health
5251260|NCT02438059|workplace health promotion|workplace health promotion
5251261|NCT02438059|internet|internet
5251262|NCT02438059|mobile app|mobile app
5251263|NCT02438059|weight loss|weight loss
5251264|NCT02438059|intervention|intervention
5251265|NCT02438059|randomized controlled trial|randomized controlled trial
5251266|NCT02438046|Connective Tissue Grafts|connective tissue grafts
5251267|NCT02438046|Wound healing|wound healing
5251268|NCT02438046|Biomaterials|biomaterials
5251269|NCT02438046|Pain|pain
5251270|NCT02438046|Clinical Trials|clinical trials
5251271|NCT02438046|Mucogingival Surgery|mucogingival surgery
5251272|NCT02438033|Deep Brain Stimulation|deep brain stimulation
5251273|NCT02438033|Globus Pallidus|globus pallidus
5251274|NCT02438033|GPi|gpi
5251275|NCT02438033|PC+S|pc+s
5251276|NCT02438020|Acanthosis nigricans|acanthosis nigricans
5251277|NCT02438020|obesity|obesity
5251278|NCT02438020|children|children
5251279|NCT02438020|metformin|metformin
5251280|NCT02437942|Athletic injuries|athletic injuries
5251281|NCT02437942|chronic|chronic
5251282|NCT02437942|rehabilitation|rehabilitation
5251283|NCT02437942|diagnosis|diagnosis
5251284|NCT02437942|biomechanics|biomechanics
5251285|NCT02437916|Melanoma|melanoma
5251286|NCT02437916|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5251287|NCT02437916|Squamous Cell Carcinoma|squamous cell carcinoma
5251288|NCT02437916|Carcinoma|carcinoma
5251289|NCT02437916|Head and Neck|head and neck
5251290|NCT02437916|Transitional Cell Carinoma (TCC)|transitional cell carinoma (tcc)
5251291|NCT02437916|Bladder|bladder
5251292|NCT02437916|Colorectal|colorectal
5251293|NCT02437916|Colorectal Cancer (CRC)|colorectal cancer (crc)
5251294|NCT02437903|voluma temporal, facial, volume loss|voluma temporal, facial, volume loss
5251295|NCT02437877|Respiration|respiration
5251296|NCT02437877|Learning|learning
5251297|NCT02437877|Speech|speech
5251298|NCT02437877|Language and Hearing Sciences|language and hearing sciences
5251299|NCT02437799|Pulse oximeter|pulse oximeter
5251300|NCT02437799|Caesarean section|caesarean section
5251301|NCT02437799|hypotension|hypotension
5251302|NCT02437799|Spinal anaesthesia|spinal anaesthesia
5251303|NCT02437773|OCD|ocd
5251304|NCT02437747|clinical trial|clinical trial
5251305|NCT02437708|regenerative endodontics|regenerative endodontics
5251306|NCT02437708|platelet rich fibrin|platelet rich fibrin
5251307|NCT02437695|Robotic Surgical Procedures|robotic surgical procedures
5251312|NCT02437669|Hydromorphone|hydromorphone
5251313|NCT02437669|Pediatric|pediatric
5251314|NCT02437669|Emergency department|emergency department
5251315|NCT02437656|Radiochemotherapy|radiochemotherapy
5251316|NCT02437656|Metformin|metformin
5251319|NCT02437617|Tumor tissue|tumor tissue
5251320|NCT02437617|Genomic profile test|genomic profile test
5251321|NCT02437617|Analysis of treatment outcomes|analysis of treatment outcomes
5251322|NCT02437617|Molecular profiling|molecular profiling
5251323|NCT02437617|Molecular alteration|molecular alteration
5251324|NCT02437591|ASP2819|asp2819
5251325|NCT02437591|PAR-101|par-101
5251326|NCT02437591|OPT-80|opt-80
5251327|NCT02437591|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5251328|NCT02437591|Clostridium difficile Infection (CDI)|clostridium difficile infection (cdi)
5251329|NCT02437591|fidaxomicin|fidaxomicin
5251330|NCT02437591|Dificlir|dificlir
5251331|NCT02437578|vitamin d|vitamin d
5251332|NCT02437578|fertility|fertility
5251333|NCT02437578|markers|markers
5251334|NCT02437578|endocrine disruption|endocrine disruption
5251335|NCT02437578|reproduction|reproduction
5251336|NCT02437552|Cardiac Surgery, Coronary Artery Bypass, Exercise Movement Techniques|cardiac surgery, coronary artery bypass, exercise movement techniques
5251337|NCT02437526|Cure|cure
5251338|NCT02437526|Analytic treatment interruption|analytic treatment interruption
5251339|NCT02437513|Dysphagia|dysphagia
5251340|NCT02437513|Aspiration|aspiration
5251341|NCT02437513|Laryngeal cancer|laryngeal cancer
5251342|NCT02437474|vegan diet|vegan diet
5251343|NCT02437474|lacto-ovo-vegetarian diet|lacto-ovo-vegetarian diet
5251344|NCT02437474|cancer|cancer
5251345|NCT02437474|tumor remission|tumor remission
5251346|NCT02437461|knee synovitis|knee synovitis
5251347|NCT02437461|triamcinolone hexacetonide|triamcinolone hexacetonide
5251348|NCT02437461|treatment response|treatment response
5251349|NCT02437448|Mass spectrometry|mass spectrometry
5251350|NCT02437448|Exhaled breath analysis|exhaled breath analysis
5251351|NCT02437435|assisted reproduction|assisted reproduction
5251352|NCT02437435|physical therapy|physical therapy
5251353|NCT02437435|manual therapy|manual therapy
5251354|NCT02437435|uterine artery|uterine artery
5251355|NCT02437435|Vascularization Index (VI)|vascularization index (vi)
5251356|NCT02437435|Doppler ultrasonography|doppler ultrasonography
5251357|NCT02437435|vocal|vocal
5251358|NCT02437409|Ischemic, Acute|ischemic, acute
5251359|NCT02437357|Psychotherapy, Group|psychotherapy, group
5251360|NCT02437357|Metacognition|metacognition
5251361|NCT02437357|Cognitive Bias|cognitive bias
5251362|NCT02437331|Advanced heart failure|advanced heart failure
5251363|NCT02437331|diseased experience|diseased experience
5251364|NCT02437318|BYL719|byl719
5251365|NCT02437318|HR+|hr+
5251366|NCT02437318|HER2-negative|her2-negative
5251367|NCT02437318|advanced breast cancer|advanced breast cancer
5251368|NCT02437318|alpelisib|alpelisib
5251369|NCT02437318|fulvestrant|fulvestrant
5251370|NCT02437318|PI3K|pi3k
5251371|NCT02437318|Phase III|phase iii
5251372|NCT02437318|ER+|er+
5251373|NCT02437318|PgR+|pgr+
5251374|NCT02437318|men|men
5251375|NCT02437318|postmenopausal|postmenopausal
5251376|NCT02437318|aromatase inhibitor|aromatase inhibitor
5251377|NCT02437318|neoplasms|neoplasms
5239225|NCT02507635|persistent allergic rhinitis|persistent allergic rhinitis
5239226|NCT02507635|H1 antihistamines|h1 antihistamines
5239227|NCT02507583|Brain Tumor|brain tumor
5239228|NCT02507583|Glioma|glioma
5251378|NCT02437305|Melanoma|melanoma
5251379|NCT02437305|People of Color|people of color
5251380|NCT02437279|Palpable|palpable
5251381|NCT02437279|Stage III|stage iii
5251382|NCT02437279|Skin melanoma|skin melanoma
5251383|NCT02437279|Ipilimumab|ipilimumab
5251384|NCT02437279|Nivolumab|nivolumab
5251385|NCT02437279|Surgery|surgery
5251386|NCT02437253|Mucopolysaccharidosis|mucopolysaccharidosis
5251387|NCT02437253|Inflammation|inflammation
5251388|NCT02437253|Tumor necrosis factor - alpha inhibitor|tumor necrosis factor - alpha inhibitor
5251389|NCT02437240|Pilates-based exercise|pilates-based exercise
5251390|NCT02437240|respiratory mechanics|respiratory mechanics
5251391|NCT02437240|cardiopulmonary physical therapy|cardiopulmonary physical therapy
5251392|NCT02437240|sternotomy|sternotomy
5251393|NCT02437175|pelvic pain|pelvic pain
5251394|NCT02437175|quality of life|quality of life
5251395|NCT02437175|adenomyosis|adenomyosis
5251396|NCT02437162|Axial Spondyloarthritis|axial spondyloarthritis
5251397|NCT02437162|Ustekinumab|ustekinumab
5251398|NCT02437162|Golimumab|golimumab
5251399|NCT02437162|Stelara|stelara
5251400|NCT02437149|Texting and driving|texting and driving
5251401|NCT02437149|Teenager and driving|teenager and driving
5248932|NCT02451566|Aortic|aortic
5251402|NCT02437149|Distracted Driving Campaign|distracted driving campaign
5251403|NCT02437123|mHealth|mhealth
5251404|NCT02437123|Indigenous|indigenous
5251405|NCT02437123|HIV prevention|hiv prevention
5251406|NCT02437123|substance use|substance use
5251407|NCT02437110|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5251408|NCT02437110|Antiretroviral Therapy|antiretroviral therapy
5251409|NCT02437110|Virus|virus
5251410|NCT02437071|Radiotherapy|radiotherapy
5251411|NCT02437071|Ablation|ablation
5251412|NCT02437071|Pembrolizumab|pembrolizumab
5251413|NCT02437071|15-069|15-069
5251414|NCT02437071|Metastatic Colorectal Cancer Patients|metastatic colorectal cancer patients
5251415|NCT02437032|GDF-9|gdf-9
5251416|NCT02437032|BMP-15|bmp-15
5251417|NCT02437032|Steroids|steroids
5251421|NCT02437019|Ibrutinib|ibrutinib
5251422|NCT02437019|Early access program|early access program
5251423|NCT02437019|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5251424|NCT02437019|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
5251425|NCT02437006|stroke|stroke
5251426|NCT02437006|exercise capacity|exercise capacity
5251427|NCT02436993|Neoadjuvant Treatment|neoadjuvant treatment
5251428|NCT02436993|Carboplatin|carboplatin
5251431|NCT02436993|Trastuzumab|trastuzumab
5251432|NCT02436993|Bevacizumab|bevacizumab
5251433|NCT02436980|premedication|premedication
5251434|NCT02436980|ERCP|ercp
5251435|NCT02436980|midazolam|midazolam
5251436|NCT02436980|tramadol|tramadol
5251437|NCT02436980|cognitive|cognitive
5251438|NCT02436928|H7N9 Influenza|h7n9 influenza
5251439|NCT02436928|Avian influenza A|avian influenza a
5251440|NCT02436928|cell culture derived|cell culture derived
5251441|NCT02436915|Slow gait|slow gait
5251442|NCT02436915|Executive function|executive function
5251443|NCT02436915|Transcranial direct current stimulation|transcranial direct current stimulation
5251444|NCT02436876|Osteosynthesis|osteosynthesis
5251445|NCT02436876|Complications|complications
5251446|NCT02436876|Infection or Inflammation|infection or inflammation
5251447|NCT02436876|Orthopedic|orthopedic
5251448|NCT02436876|Device|device
5251449|NCT02436876|Fracture|fracture
5251450|NCT02436876|Osteomyelitis|osteomyelitis
5251451|NCT02436863|Laminectomy|laminectomy
5251452|NCT02436863|Laminoplasty|laminoplasty
5251453|NCT02436863|Internal fixation|internal fixation
5251454|NCT02436863|deformity|deformity
5251455|NCT02436850|Thoracentesis|thoracentesis
5251456|NCT02436850|Pocket Ultrasound Device|pocket ultrasound device
5251457|NCT02436850|Ultrasound|ultrasound
5251458|NCT02436850|Soroka University Medical Center|soroka university medical center
5251459|NCT02436850|Physical Examination|physical examination
5251460|NCT02436850|Ethical Committee|ethical committee
5251461|NCT02436824|topical patch|topical patch
5251462|NCT02436824|chronic low back pain|chronic low back pain
5251463|NCT02436811|Health literacy|health literacy
5251464|NCT02436811|Pregnant women|pregnant women
5251465|NCT02436811|Feeding behaviour|feeding behaviour
5251466|NCT02436811|Oral health|oral health
5251467|NCT02436811|Child|child
5251468|NCT02436798|QT prolongation|qt prolongation
5251469|NCT02436798|Genomic biomarkers|genomic biomarkers
5251470|NCT02436785|music therapy|music therapy
5251471|NCT02436785|pain management|pain management
5251472|NCT02436785|self efficacy|self efficacy
5251473|NCT02436785|patient education|patient education
5251474|NCT02436785|relaxation|relaxation
5251475|NCT02436746|Von Recklinghausen's disease|von recklinghausen's disease
5251476|NCT02436746|Bourneville's disease|bourneville's disease
5251477|NCT02436746|Cognitive variability|cognitive variability
5251478|NCT02436746|Loss of heterozygosity|loss of heterozygosity
5251479|NCT02436733|pleural mesothelioma|pleural mesothelioma
5251480|NCT02436733|phase II|phase ii
5251481|NCT02436733|randomized|randomized
5251482|NCT02436733|surgery|surgery
5251483|NCT02436733|chemotherapy|chemotherapy
5251484|NCT02436733|feasibility|feasibility
5251485|NCT02436694|Dexamethasone|dexamethasone
5251486|NCT02436694|Perineural|perineural
5251487|NCT02436655|aortic stenosis|aortic stenosis
5251488|NCT02436655|normal ejection fraction|normal ejection fraction
5251489|NCT02436655|asymptomatic|asymptomatic
5251490|NCT02436629|Red beetroot juice|red beetroot juice
5251491|NCT02436629|High intensity intermittent exercise|high intensity intermittent exercise
5251492|NCT02436629|Nitrite|nitrite
5251493|NCT02436629|Soccer|soccer
5251495|NCT02436616|Preterm Infants|preterm infants
5251496|NCT02436616|Neonate|neonate
5251497|NCT02436616|wireless|wireless
5251498|NCT02436603|Irritable Bowel Syndrome|irritable bowel syndrome
5251499|NCT02436603|IBS|ibs
5251500|NCT02436603|Mind-Body Training|mind-body training
5251501|NCT02436603|Integrative Medicine|integrative medicine
5251502|NCT02436603|FODMAP|fodmap
5251503|NCT02436590|osteoarthritis|osteoarthritis
5251504|NCT02436590|knee|knee
5251505|NCT02436590|pulsed electromagnetic fields|pulsed electromagnetic fields
5251506|NCT02436590|PEMF|pemf
5251507|NCT02436577|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
5251508|NCT02436577|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
5251509|NCT02436577|bioequivalence|bioequivalence
5251510|NCT02436577|Phase I|phase i
5251511|NCT02436577|healthy Japanese subjects|healthy japanese subjects
5251512|NCT02436564|pancreas|pancreas
5251513|NCT02436564|stem cells|stem cells
5251514|NCT02436564|tumours|tumours
5251515|NCT02436564|in vitro models|in vitro models
5251516|NCT02436564|organoids|organoids
5251517|NCT02436564|cancer,|cancer,
5251518|NCT02436564|bile duct|bile duct
5251519|NCT02436564|liver|liver
5256841|NCT02407626|ischemia|ischemia
5251520|NCT02436538|anti-Müllerian hormone (AMH)|anti-müllerian hormone (amh)
5251521|NCT02436538|Mullerian anomalies|mullerian anomalies
5251522|NCT02436538|ICSI|icsi
5251523|NCT02436447|Renal Impairment, Renal function, MTP-131, Bendavia™|renal impairment, renal function, mtp-131, bendavia™
5251524|NCT02436434|Pulsed radiofrequency, osteoarthritis|pulsed radiofrequency, osteoarthritis
5251525|NCT02436395|gastric cancer|gastric cancer
5251526|NCT02436395|gastrectomy|gastrectomy
5251527|NCT02436395|laparotomy|laparotomy
5251528|NCT02436395|SSIs|ssis
5251529|NCT02436395|povidone-iodine|povidone-iodine
5251530|NCT02436395|normal saline|normal saline
5251531|NCT02436369|diabetic patients|diabetic patients
5251532|NCT02436369|flaxseed|flaxseed
5251533|NCT02436369|lipid profile|lipid profile
5251833|NCT02434601|Randomized|randomized
5251534|NCT02436369|cardiovascular risc factors|cardiovascular risc factors
5251535|NCT02436343|left ventricular functions|left ventricular functions
5251536|NCT02436343|pregnancy|pregnancy
5251537|NCT02436343|obesity|obesity
5251538|NCT02436330|Exergaming, Weight management|exergaming, weight management
5251539|NCT02436317|Point Of Care Ultrasonography|point of care ultrasonography
5251540|NCT02436317|Soroka University Medical Center|soroka university medical center
5251541|NCT02436317|Heart Failure|heart failure
5251542|NCT02436317|cardiovascular|cardiovascular
5251543|NCT02436278|Gait speed|gait speed
5251544|NCT02436278|Mortality|mortality
5251545|NCT02436278|Morbidity|morbidity
5251546|NCT02436265|Neuraxial|neuraxial
5251547|NCT02436265|Caudal|caudal
5251548|NCT02436265|Block|block
5251549|NCT02436265|Anesthesia|anesthesia
5251550|NCT02436265|Dexamethasone|dexamethasone
5251551|NCT02436252|Myelodysplastic Syndrome|myelodysplastic syndrome
5251552|NCT02436252|MDS|mds
5251553|NCT02436226|PCOS|pcos
5251554|NCT02436226|Clomiphene citrate resistant|clomiphene citrate resistant
5251555|NCT02436226|HCG|hcg
5251556|NCT02436213|workload|workload
5251557|NCT02436213|oxygen level|oxygen level
5251558|NCT02436213|oxygen consumption|oxygen consumption
5251559|NCT02436213|breathing reserve|breathing reserve
5251560|NCT02436213|ventilatory efficiency|ventilatory efficiency
5251561|NCT02436200|Intermittent Claudication|intermittent claudication
5251563|NCT02436200|Peripheral Arterial Disease|peripheral arterial disease
5251564|NCT02436200|Peripheral Vascular Disease|peripheral vascular disease
5251565|NCT02436200|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5251566|NCT02436187|NSTEMI|nstemi
5251567|NCT02436187|excess mortality|excess mortality
5251568|NCT02436187|evidence-based care|evidence-based care
5251569|NCT02436187|MINAP|minap
5251570|NCT02436161|Heart Failure|heart failure
5251571|NCT02436161|Comorbidity|comorbidity
5251572|NCT02436161|Patient Care Management|patient care management
5251573|NCT02436161|Primary Health Care|primary health care
5251574|NCT02436161|Delivery of Health Care, Integrated|delivery of health care, integrated
5251575|NCT02436148|PEQ validation study, Finland|peq validation study, finland
5251576|NCT02436122|Prostate cancer|prostate cancer
5251577|NCT02436122|Preoperative|preoperative
5251578|NCT02436122|Glycemic control|glycemic control
5251579|NCT02436122|Hemoglobin A1c|hemoglobin a1c
5251580|NCT02436122|Pathologic outcomes|pathologic outcomes
5251581|NCT02436122|Oncological outcomes|oncological outcomes
5251582|NCT02436122|Treatment Outcome|treatment outcome
5251583|NCT02436122|Hemoglobin A1c Protein, Human|hemoglobin a1c protein, human
5251584|NCT02436096|Pain|pain
5251585|NCT02436096|Sleep|sleep
5251586|NCT02436070|Pediatrics|pediatrics
5251587|NCT02436070|Emergency Medicine|emergency medicine
5251588|NCT02436070|Text messaging|text messaging
5251589|NCT02436044|Hepatocellular Carcinoma|hepatocellular carcinoma
5251590|NCT02436044|Locally advanced stge|locally advanced stge
5251591|NCT02436044|HAIC|haic
5251592|NCT02436044|FOLFOX4|folfox4
5251593|NCT02436044|Locally advanced|locally advanced
5251594|NCT02436018|Sedation|sedation
5251595|NCT02436018|Low pulse oximetry|low pulse oximetry
5251596|NCT02436018|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5251597|NCT02436018|WEI NASAL JET|wei nasal jet
5251598|NCT02435979|wrist|wrist
5251599|NCT02435979|proximal strengthening|proximal strengthening
5251600|NCT02435979|hand therapy|hand therapy
5251601|NCT02435953|Hepatocellular Carcinoma,TACE,Chemoembolization, RFA,Intermediate-stage|hepatocellular carcinoma,tace,chemoembolization, rfa,intermediate-stage
5251602|NCT02435940|inherited retinal degenerative disease|inherited retinal degenerative disease
5251603|NCT02435940|retinitis pigmentosa|retinitis pigmentosa
5251604|NCT02435940|Usher|usher
5251605|NCT02435940|Leber|leber
5251606|NCT02435940|Bardet-Biedl|bardet-biedl
5251607|NCT02435940|Batten|batten
5251609|NCT02435940|cone dystrophy|cone dystrophy
5251610|NCT02435940|cone-rod dystrophy|cone-rod dystrophy
5146762|NCT03075072|SRS|srs
5251611|NCT02435940|choroideremia|choroideremia
5251612|NCT02435940|congenital night blindness|congenital night blindness
5251613|NCT02435940|enhanced s-cone|enhanced s-cone
5251614|NCT02435940|cone monochromacy|cone monochromacy
5251615|NCT02435940|Goldmann-Favre|goldmann-favre
5251616|NCT02435940|Kearns-Sayre|kearns-sayre
5251617|NCT02435940|Refsum|refsum
5251618|NCT02435940|retinoschisis|retinoschisis
5251619|NCT02435940|rod-cone dystrophy|rod-cone dystrophy
5251620|NCT02435940|rod dystrophy|rod dystrophy
5251621|NCT02435940|rod monochromacy|rod monochromacy
5251622|NCT02435940|Sorsby pseudoinflammatory dystrophy|sorsby pseudoinflammatory dystrophy
5251623|NCT02435940|stargardt|stargardt
5251624|NCT02435940|achromatopsia|achromatopsia
5251625|NCT02435940|juvenile inherited macular degeneration|juvenile inherited macular degeneration
5251626|NCT02435940|cone dichromacy|cone dichromacy
5251627|NCT02435940|cone trichromacy|cone trichromacy
5251628|NCT02435940|Charcot-Marie-Tooth|charcot-marie-tooth
5251629|NCT02435940|albipunctate dystrophy|albipunctate dystrophy
5251630|NCT02435901|Reduced Intensity Conditioning Regimen|reduced intensity conditioning regimen
5251631|NCT02435888|Resting energy expenditure|resting energy expenditure
5251636|NCT02435875|baroreflex sensitivity|baroreflex sensitivity
5251637|NCT02435862|Vitreolysis of the Vitreous|vitreolysis of the vitreous
5251643|NCT02435797|nicorandil|nicorandil
5251644|NCT02435797|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5251645|NCT02435797|acute ST segment elevation myocardial infarction|acute st segment elevation myocardial infarction
5251646|NCT02435797|thrombus aspiration|thrombus aspiration
5251647|NCT02435784|2-COM|2-com
5251648|NCT02435745|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5251649|NCT02435745|Obstructive Sleep Apnea|obstructive sleep apnea
5251650|NCT02435745|Prevalence|prevalence
5251651|NCT02435745|Aortic Aneurysm|aortic aneurysm
5251652|NCT02435719|HCAIs|hcais
5251653|NCT02435719|Handgel|handgel
5251654|NCT02435719|Hospital|hospital
5251655|NCT02435719|Effectiveness|effectiveness
5251656|NCT02435706|Dental implants|dental implants
5251657|NCT02435706|surgical flap|surgical flap
5251658|NCT02435706|esthetics|esthetics
5251659|NCT02435706|alveolar process|alveolar process
5251660|NCT02435693|pharmaceutical care|pharmaceutical care
5251661|NCT02435680|MCS110; carboplatin; gemcitabine; TNBC; TAMs|mcs110; carboplatin; gemcitabine; tnbc; tams
5251662|NCT02435667|Resistance Training|resistance training
5251663|NCT02435667|Exercise|exercise
5251664|NCT02435667|Heart Failure preserved Ejection Fraction|heart failure preserved ejection fraction
5251665|NCT02435654|Genes Polymorphisms|genes polymorphisms
5251666|NCT02435654|Plasma Concentration|plasma concentration
5251667|NCT02435602|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5251668|NCT02435602|cancer screening|cancer screening
5251669|NCT02435576|Acute toxicity|acute toxicity
5251670|NCT02435576|Late toxicity|late toxicity
5251671|NCT02435576|NTCP models|ntcp models
5251672|NCT02435563|Anti-HIV Agents|anti-hiv agents
5251673|NCT02435563|cardiovascular agents|cardiovascular agents
5251674|NCT02435563|drug interactions|drug interactions
5251675|NCT02435537|analgesia|analgesia
5251676|NCT02435537|intrathecal|intrathecal
5251677|NCT02435537|opioids|opioids
5251678|NCT02435537|morphine|morphine
5251679|NCT02435537|dexmedetomidine|dexmedetomidine
5251680|NCT02435524|Breast Feeding, Exclusive|breast feeding, exclusive
5251681|NCT02435524|Infant Nutrition|infant nutrition
5251682|NCT02435524|Burkina Faso|burkina faso
5251683|NCT02435511|agent-based modeling|agent-based modeling
5251684|NCT02435511|community resources|community resources
5251685|NCT02435511|simulation modeling|simulation modeling
5251686|NCT02435511|information intervention|information intervention
5251687|NCT02435511|clinic-to-community linkages|clinic-to-community linkages
5251688|NCT02435485|degerative lumbar spondylolisthesis|degerative lumbar spondylolisthesis
5251689|NCT02435485|rehabilitation|rehabilitation
5251690|NCT02435485|balance|balance
5251691|NCT02435472|Active Surveillance|active surveillance
5251692|NCT02435472|Exercise|exercise
5251693|NCT02435472|Prostate cancer|prostate cancer
5251694|NCT02435472|Life style|life style
5251695|NCT02435472|Survey|survey
5251696|NCT02435472|Personalized exercise|personalized exercise
5251697|NCT02435472|Exercise trainer|exercise trainer
5251698|NCT02435433|liver cancer|liver cancer
5251699|NCT02435420|Total Hip Arthroplasty|total hip arthroplasty
5251700|NCT02435420|EMPERION Modular Stem|emperion modular stem
5251701|NCT02435420|Survivorship|survivorship
5251702|NCT02435355|Sleep apnea|sleep apnea
5251703|NCT02435355|education|education
5251704|NCT02435355|compliance|compliance
5251705|NCT02435355|CPAP|cpap
5251706|NCT02435342|ShK-186|shk-186
5251707|NCT02435342|dalazatide|dalazatide
5251708|NCT02435342|psoriasis|psoriasis
5251709|NCT02435342|Kv1.3,|kv1.3,
5251710|NCT02435342|autoimmune|autoimmune
5251711|NCT02435316|Education|education
5251712|NCT02435290|prediction|prediction
5251713|NCT02435290|prescribing error|prescribing error
5146879|NCT03074344|CoQ10|coq10
5251714|NCT02435290|risk factors|risk factors
5251715|NCT02435277|Diabetes|diabetes
5251716|NCT02435212|New formulation|new formulation
5251717|NCT02435212|deferasirox|deferasirox
5251718|NCT02435212|chelation|chelation
5251719|NCT02435212|iron overload|iron overload
5251720|NCT02435212|compliance|compliance
5251721|NCT02435212|satisfaction|satisfaction
5251722|NCT02435212|palatability|palatability
5251723|NCT02435212|PRO|pro
5251724|NCT02435212|PK|pk
5251725|NCT02435212|safety|safety
5251726|NCT02435212|PK/PD|pk/pd
5251727|NCT02435212|ICL670|icl670
5251728|NCT02435186|p53 gene|p53 gene
5251729|NCT02435186|chemotherapy|chemotherapy
5251730|NCT02435186|recurrent|recurrent
5251731|NCT02435186|epithelial|epithelial
5251732|NCT02435186|ovarian cancer|ovarian cancer
5251733|NCT02435186|fallopian tube cancer|fallopian tube cancer
5251734|NCT02435186|primary peritoneal cancer|primary peritoneal cancer
5251735|NCT02435173|APDS PASLI PI3Kdelta|apds pasli pi3kdelta
5251736|NCT02435108|MET poisitivity is defined as at least half of tumor cells show weak, moderate or high staining|met poisitivity is defined as at least half of tumor cells show weak, moderate or high staining
5251737|NCT02435095|Schizophrenia|schizophrenia
5251738|NCT02435095|Maintenance treatment, Intermittent treatment|maintenance treatment, intermittent treatment
5251739|NCT02435095|Brain volume|brain volume
5251740|NCT02435095|Antipsychotics|antipsychotics
5251741|NCT02435082|Concussion|concussion
5251742|NCT02435082|Vascular Assessment|vascular assessment
5251743|NCT02435082|Vascular Regulation|vascular regulation
5251744|NCT02435082|mild Traumatic Brain Injury, mTBI|mild traumatic brain injury, mtbi
5251745|NCT02435082|Traumatic Brain Injury, TBI|traumatic brain injury, tbi
5251746|NCT02435082|Cerebrovascular Regulation|cerebrovascular regulation
5251747|NCT02435082|Cerebral Blood Flow|cerebral blood flow
5251748|NCT02435082|Cerebral Blood Flow Velocity, CBFV|cerebral blood flow velocity, cbfv
5251749|NCT02435082|Cerebral Blood Flow Velocity Variability|cerebral blood flow velocity variability
5251750|NCT02435082|Cerebrovascular Assessment|cerebrovascular assessment
5251751|NCT02435069|cecostomy|cecostomy
5251752|NCT02435069|appendicostomy|appendicostomy
5251753|NCT02435056|medication overuse headache|medication overuse headache
5251754|NCT02435056|health care system|health care system
5251757|NCT02435030|lysosomal storage disorder|lysosomal storage disorder
5251758|NCT02435030|lysosomal storage disease|lysosomal storage disease
5251759|NCT02435030|NPC2|npc2
5251760|NCT02435030|NPC1|npc1
5251761|NCT02435030|Niemann-Pick Type C|niemann-pick type c
5251762|NCT02435030|Niemann-Pick,|niemann-pick,
5251763|NCT02435030|Arimoclomol|arimoclomol
5251764|NCT02435017|kidney disease|kidney disease
5251765|NCT02435017|recommended dietary allowances|recommended dietary allowances
5251766|NCT02435017|nutrition assessment|nutrition assessment
5251767|NCT02435017|food|food
5251768|NCT02435017|dietary proteins|dietary proteins
5251769|NCT02435017|Vitamin D|vitamin d
5251770|NCT02435017|dietary fats|dietary fats
5251771|NCT02435017|ethnology|ethnology
5251772|NCT02435017|Continental Population Groups|continental population groups
5251773|NCT02435017|Phosphorus, dietary|phosphorus, dietary
5251774|NCT02435017|Phosphorus/analysis|phosphorus/analysis
5251775|NCT02434991|trouble swallowing|trouble swallowing
5251776|NCT02434991|food sticking|food sticking
5251777|NCT02434991|Achalasia|achalasia
5251778|NCT02434965|Neonates|neonates
5239612|NCT02505243|ribavirin|ribavirin
5239613|NCT02505243|direct-acting antivirals|direct-acting antivirals
5239614|NCT02505243|pharmacokinetics|pharmacokinetics
5239615|NCT02505243|therapeutic drug monitoring|therapeutic drug monitoring
5239617|NCT02505204|clonidine|clonidine
5251779|NCT02434965|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5251780|NCT02434965|human placental-derived stem cells|human placental-derived stem cells
5251781|NCT02434965|autologous|autologous
5251782|NCT02434952|Malaria, Falciparum|malaria, falciparum
5251783|NCT02434952|G6PD deficiency|g6pd deficiency
5251784|NCT02434952|Primaquine|primaquine
5251785|NCT02434952|Asia|asia
5251786|NCT02434926|fetoscopy|fetoscopy
5251787|NCT02434926|fetal surgery|fetal surgery
5251788|NCT02434926|anesthetic complications|anesthetic complications
5251789|NCT02434913|Proximal interphalangeal joint deformity|proximal interphalangeal joint deformity
5251790|NCT02434913|Arthroplasty|arthroplasty
5251791|NCT02434822|Cholera|cholera
5251792|NCT02434822|Shanchol™|shanchol™
5251793|NCT02434822|Cholera Vaccine|cholera vaccine
5251794|NCT02434809|Respiratory Motion-Corrected Cone-Beam CT|respiratory motion-corrected cone-beam ct
5251795|NCT02434809|Radiation|radiation
5251796|NCT02434809|14-225|14-225
5251797|NCT02434796|Intimate Partner Violence|intimate partner violence
5251798|NCT02434796|Gender-Based Violence|gender-based violence
5251799|NCT02434796|Gender|gender
5251801|NCT02434783|Blood circulation|blood circulation
5251802|NCT02434783|Blood vessels|blood vessels
5251803|NCT02434783|Mitochondria|mitochondria
5251804|NCT02434783|Muscle, skeletal|muscle, skeletal
5251805|NCT02434783|Legs|legs
5251806|NCT02434783|Energy metabolism|energy metabolism
5251807|NCT02434731|Procedural pain|procedural pain
5251808|NCT02434731|Phlebotomy|phlebotomy
5251809|NCT02434731|Intellectual Disability|intellectual disability
5251810|NCT02434731|Child|child
5251811|NCT02434731|Buzzy|buzzy
5251819|NCT02434679|antibiotics resistance integrons|antibiotics resistance integrons
5251820|NCT02434679|neonatology newborns|neonatology newborns
5251821|NCT02434679|digestive acquisition|digestive acquisition
5251822|NCT02434679|dynamic of the acquisition of integrons|dynamic of the acquisition of integrons
5251823|NCT02434627|Becker|becker
5251824|NCT02434627|Dystrophy|dystrophy
5251825|NCT02434601|Non-carious cervical lesions|non-carious cervical lesions
5251826|NCT02434601|Randomized clinical trial|randomized clinical trial
5251827|NCT02434601|Permanent dental restoration|permanent dental restoration
5251828|NCT02434601|Dentin|dentin
5251829|NCT02434601|Adhesion|adhesion
5251830|NCT02434601|Restoration|restoration
5251831|NCT02434601|Sensitivity|sensitivity
5251832|NCT02434601|Prophylaxis|prophylaxis
5251835|NCT02434575|Prostatic artery embolisation|prostatic artery embolisation
5251836|NCT02434575|Transurethral resection of the prostate|transurethral resection of the prostate
5251837|NCT02434575|Benign prostatic hyperplasia|benign prostatic hyperplasia
5251838|NCT02434575|Benign prostatic enlargement|benign prostatic enlargement
5251839|NCT02434549|Randomized Controlled Trial|randomized controlled trial
5251841|NCT02434549|Double Blinded|double blinded
5251842|NCT02434549|Botulinum Toxin Type A|botulinum toxin type a
5251843|NCT02434549|Adults|adults
5251844|NCT02434549|Pain|pain
5251845|NCT02434549|Spasticity|spasticity
5251846|NCT02434549|Cerebral Palsy, Spastic|cerebral palsy, spastic
5251847|NCT02434549|Dysport|dysport
5251848|NCT02434536|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5251849|NCT02434536|Disease Exacerbation Clinical Prediction Rule|disease exacerbation clinical prediction rule
5251850|NCT02434536|Decision Analysis|decision analysis
5251851|NCT02434523|laryngeal sensory neuropathy|laryngeal sensory neuropathy
5251852|NCT02434510|Infection|infection
5251853|NCT02434510|Total Knee Arthroplasty|total knee arthroplasty
5251854|NCT02434510|Total Hip Arthroplasty|total hip arthroplasty
5251855|NCT02434510|Splash Basins|splash basins
5251856|NCT02434497|LDL-C|ldl-c
5251857|NCT02434497|HoFH|hofh
5251858|NCT02434497|Hyperlipidemia|hyperlipidemia
5251859|NCT02434484|Symbenda|symbenda
5251860|NCT02434484|Non-Hodgkin's lymphomas|non-hodgkin's lymphomas
5251861|NCT02434484|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5251862|NCT02434484|Multiple myeloma|multiple myeloma
5251863|NCT02434484|Bendamustine Hydrochloride|bendamustine hydrochloride
5251864|NCT02434458|fibromyalgia,|fibromyalgia,
5251865|NCT02434458|polyneuropathy|polyneuropathy
5251866|NCT02434458|small fiber neuropathy|small fiber neuropathy
5251867|NCT02434458|rheumatoid arthritis|rheumatoid arthritis
5251868|NCT02434458|sudomotor|sudomotor
5251869|NCT02434406|Anxiety|anxiety
5251870|NCT02434406|Anxiety disorders|anxiety disorders
5251871|NCT02434406|Mental health|mental health
5251872|NCT02434406|Postpartum period|postpartum period
5251873|NCT02434406|maternal welfare|maternal welfare
5251874|NCT02434406|internet|internet
5251875|NCT02434406|intervention studies|intervention studies
5251876|NCT02434406|feasibility studies|feasibility studies
5251877|NCT02434406|randomized controlled trial|randomized controlled trial
5251878|NCT02434406|patient acceptance of health care|patient acceptance of health care
5251879|NCT02434393|Depression|depression
5251880|NCT02434393|Late Life Depression|late life depression
5251881|NCT02434393|LLD|lld
5251882|NCT02434393|amyloid imaging|amyloid imaging
5251883|NCT02434393|biomarkers|biomarkers
5251884|NCT02434380|Vitamin D|vitamin d
5251885|NCT02434380|Bone mineral content|bone mineral content
5251886|NCT02434380|Knee-heel length|knee-heel length
5251887|NCT02434380|Middle East|middle east
5251888|NCT02434367|Cancer|cancer
5251889|NCT02434354|Clinical stage III (nodal and/or intransit disease) or resectable stage IV melanoma (MEL), with or without prior treatment|clinical stage iii (nodal and/or intransit disease) or resectable stage iv melanoma (mel), with or without prior treatment
5251890|NCT02434328|AMD|amd
5251891|NCT02434328|CNV|cnv
5251892|NCT02434328|IVT|ivt
5251893|NCT02434315|Diabetes Mellitus|diabetes mellitus
5251894|NCT02434315|Sensing Technology|sensing technology
5251895|NCT02434289|Older adults|older adults
5251896|NCT02434289|Dietary protein|dietary protein
5251897|NCT02434289|Resistance exercise|resistance exercise
5251898|NCT02434289|Feasibility study|feasibility study
5251899|NCT02434289|Physical functioning|physical functioning
5251900|NCT02434289|Real-life setting|real-life setting
5251901|NCT02434250|Open angle glaucoma|open angle glaucoma
5251902|NCT02434250|Ocular hypertension|ocular hypertension
5251903|NCT02434250|Cataract|cataract
5249428|NCT02448693|colorectal neoplasms|colorectal neoplasms
5251904|NCT02434250|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5251905|NCT02434250|Eximer Laser Trabeculectomy|eximer laser trabeculectomy
5251906|NCT02434250|Phacoemulsification Cataract Extraction|phacoemulsification cataract extraction
5251907|NCT02434224|Music therapy|music therapy
5251908|NCT02434224|premature infant|premature infant
5251909|NCT02434224|brain development|brain development
5251910|NCT02434198|pulmonary rehabilitation|pulmonary rehabilitation
5251911|NCT02434198|balance assessment|balance assessment
5251912|NCT02434198|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5251913|NCT02434185|Musculoskeletal Physiological Phenomena|musculoskeletal physiological phenomena
5251914|NCT02434185|Postmenopause|postmenopause
5251915|NCT02434185|Muscle Strength|muscle strength
5251916|NCT02434185|Absorptiometry, Photon|absorptiometry, photon
5251917|NCT02434172|HIV|hiv
5251918|NCT02434172|Cryptococcus|cryptococcus
5251919|NCT02434172|Lateral Flow Assay|lateral flow assay
5251920|NCT02434172|sub-Saharan Africa|sub-saharan africa
5251921|NCT02434172|Screening|screening
5251922|NCT02434172|treatment|treatment
5251923|NCT02434172|cryptococcal meningitis|cryptococcal meningitis
5251926|NCT02434107|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5251927|NCT02434107|Lymph Node Excision|lymph node excision
5251928|NCT02434094|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5251929|NCT02434094|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5251930|NCT02434094|Insulin Pump|insulin pump
5251931|NCT02434094|Human Factors|human factors
5251932|NCT02434094|Focus Group|focus group
5251933|NCT02434094|Artificial Pancreas (AP)|artificial pancreas (ap)
5251934|NCT02434094|eDAPT (electronic Diabetes Artificial Pancreas Training)|edapt (electronic diabetes artificial pancreas training)
5251936|NCT02434081|IIIA/B|iiia/b
5251937|NCT02434068|kidney calculi|kidney calculi
5251938|NCT02434068|followup studies|followup studies
5251939|NCT02434042|probiotic|probiotic
5251940|NCT02434042|children|children
5251941|NCT02434042|gastrointestinal|gastrointestinal
5251942|NCT02434042|upper respiratory|upper respiratory
5251943|NCT02434016|Diaphragm|diaphragm
5251944|NCT02434016|Mechanical ventilation|mechanical ventilation
5251945|NCT02434003|3D reconstruction|3d reconstruction
5251946|NCT02434003|AIS|ais
5251947|NCT02434003|Computer models|computer models
5251948|NCT02434003|Spinal Deformity|spinal deformity
5251949|NCT02433990|Congenital Heart Disease|congenital heart disease
5251950|NCT02433990|Acquired Cardiovascular Disease|acquired cardiovascular disease
5251951|NCT02433977|Asthma|asthma
5251952|NCT02433977|Obesity|obesity
5251953|NCT02433977|conjugated linolenic acid|conjugated linolenic acid
5251954|NCT02433977|nitrate|nitrate
5251955|NCT02433977|nitrite|nitrite
5251956|NCT02433977|nutritional supplements|nutritional supplements
5251957|NCT02433964|laser|laser
5251959|NCT02433964|PRICE|price
5251960|NCT02433964|pain|pain
5251961|NCT02433964|edema|edema
5251962|NCT02433951|exercise tolerance|exercise tolerance
5251963|NCT02433925|resveratrol|resveratrol
5251964|NCT02433925|oxidative stress|oxidative stress
5251965|NCT02433925|inflammation|inflammation
5251966|NCT02433873|Microbiota|microbiota
5251967|NCT02433873|Body weight|body weight
5251968|NCT02433873|Digestive system|digestive system
5251969|NCT02433847|mosapride|mosapride
5251970|NCT02433821|Mechanical Neck Pain|mechanical neck pain
5251971|NCT02433821|Pain|pain
5251972|NCT02433821|Function|function
5251973|NCT02433821|Quality of life|quality of life
5251974|NCT02433821|Pilates|pilates
5251975|NCT02433795|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5251976|NCT02433795|bendamustine plus rituximab|bendamustine plus rituximab
5251977|NCT02433782|Haemophilia|haemophilia
5251978|NCT02433782|Arthropathy|arthropathy
5251979|NCT02433782|Pain|pain
5251980|NCT02433782|Range of motion|range of motion
5251981|NCT02433782|Miofascial techniques|miofascial techniques
5251982|NCT02433743|HIV/AIDS|hiv/aids
5251983|NCT02433743|RUTF|rutf
5251984|NCT02433743|fat free mass|fat free mass
5251985|NCT02433743|anemia|anemia
5251986|NCT02433743|zinc|zinc
5251987|NCT02433743|Senegal|senegal
5251988|NCT02433717|schizophrenia|schizophrenia
5251989|NCT02433717|schizoaffective disorder|schizoaffective disorder
5251990|NCT02433717|pharmacogenetics|pharmacogenetics
5251991|NCT02433717|pharmacokinetics|pharmacokinetics
5251992|NCT02433717|event-related potentials|event-related potentials
5251993|NCT02433717|paliperidone|paliperidone
5251994|NCT02433691|(An)aerobic exercise|(an)aerobic exercise
5251995|NCT02433691|memory training|memory training
5251996|NCT02433691|cognitive benefits|cognitive benefits
5251997|NCT02433652|Dengue Vaccine|dengue vaccine
5251998|NCT02433639|advanced biliary tract cancer, TH-302|advanced biliary tract cancer, th-302
5251999|NCT02433613|Pulmonary Vein Isolation|pulmonary vein isolation
5252000|NCT02433613|Phased Radiofrequency Ablation|phased radiofrequency ablation
5252001|NCT02433574|radiosurgery|radiosurgery
5252002|NCT02433574|Neoadjuvant Therapy|neoadjuvant therapy
5252003|NCT02433548|Analgesia|analgesia
5252004|NCT02433548|Emergency medicine|emergency medicine
5252005|NCT02433548|Anesthesia, Regional|anesthesia, regional
5252006|NCT02433535|severe asthma|severe asthma
5252007|NCT02433535|simvastatin|simvastatin
5252008|NCT02433535|allergic airway inflammation|allergic airway inflammation
5252009|NCT02433522|ANCA-associated vasculitides|anca-associated vasculitides
5252010|NCT02433522|Maintenance treatment|maintenance treatment
5252012|NCT02433522|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5252013|NCT02433522|Microscopic polyangiitis|microscopic polyangiitis
5252014|NCT02433509|acute ischemic stroke|acute ischemic stroke
5252015|NCT02433509|umbilical cord blood|umbilical cord blood
5252016|NCT02433496|Opioid|opioid
5252017|NCT02433483|Adolescent|adolescent
5252018|NCT02433483|Children|children
5252019|NCT02433483|Microtransplant|microtransplant
5252020|NCT02433483|Leukemia|leukemia
5252021|NCT02433457|Healthy Volunteers|healthy volunteers
5252022|NCT02433457|CC-292|cc-292
5252023|NCT02433457|Open-Label|open-label
5252024|NCT02433457|Bioavailability Pharmacokinetics|bioavailability pharmacokinetics
5252025|NCT02433457|Phase I|phase i
5252026|NCT02433444|Biosensing Techniques|biosensing techniques
5252027|NCT02433431|mindfulness|mindfulness
5252028|NCT02433431|psychological stress|psychological stress
5252029|NCT02433431|immune marker|immune marker
5252038|NCT02433392|drug-eluting beads|drug-eluting beads
5252039|NCT02433392|irinotecan hydrochloride|irinotecan hydrochloride
5252041|NCT02433353|posttraumatic stress disorder|posttraumatic stress disorder
5252042|NCT02433353|venlafaxine|venlafaxine
5252043|NCT02433353|EMDR|emdr
5252044|NCT02433353|eye movement desensitization reprocessing|eye movement desensitization reprocessing
5252045|NCT02433353|antidepressant|antidepressant
5252046|NCT02433353|psychotherapy|psychotherapy
5252047|NCT02433340|Tolerability|tolerability
5252048|NCT02433340|Methotrexate|methotrexate
5252049|NCT02433340|Safety|safety
5252050|NCT02433327|Paediatric Early Warning System|paediatric early warning system
5252051|NCT02433327|trigger tool|trigger tool
5252052|NCT02433327|screening tool|screening tool
5252053|NCT02433327|risk assessment|risk assessment
5252054|NCT02433327|early recognition|early recognition
5252055|NCT02433301|chemotherapy|chemotherapy
5252056|NCT02433301|GEJ cancer|gej cancer
5252057|NCT02433301|PET/MR-imaging|pet/mr-imaging
5252058|NCT02433288|smart phone-based|smart phone-based
5252059|NCT02433288|rosuvastatin|rosuvastatin
5252060|NCT02433288|duration of treatment|duration of treatment
5252061|NCT02433288|Treatment adherence|treatment adherence
5252062|NCT02433223|outreach nursing|outreach nursing
5252063|NCT02433223|respiratory nursing guidelines|respiratory nursing guidelines
5252064|NCT02433197|Testicular cancer|testicular cancer
5252065|NCT02433197|Germ cell cancer|germ cell cancer
5252066|NCT02433197|Physical exercise|physical exercise
5252067|NCT02433197|Cancer-related fatigue|cancer-related fatigue
5252068|NCT02433197|Chemotherapy|chemotherapy
5252069|NCT02433197|Clinical rules|clinical rules
5252070|NCT02433197|Metabolomics|metabolomics
5252072|NCT02433184|treat to target|treat to target
5252073|NCT02433184|Disease Modifying Antirheumatic Drugs (DMARDs)|disease modifying antirheumatic drugs (dmards)
5252074|NCT02433171|regrowth|regrowth
5252075|NCT02433171|radiosurgery|radiosurgery
5252076|NCT02433171|radiation necrosis|radiation necrosis
5252082|NCT02433145|ADHD in preschoolers|adhd in preschoolers
5252083|NCT02433145|neuropsychological functions|neuropsychological functions
5252084|NCT02433145|behavior inhibition|behavior inhibition
5252085|NCT02433145|family function and parenting|family function and parenting
5252086|NCT02433132|Cystic fibrosis|cystic fibrosis
5252087|NCT02433132|Adults|adults
5252088|NCT02433132|Atypical form|atypical form
5252089|NCT02433132|Nasal brushing|nasal brushing
5252090|NCT02433132|Epithelial cells|epithelial cells
5252091|NCT02433132|Ion transport|ion transport
5252092|NCT02433106|Balance|balance
5252093|NCT02433106|Exercise|exercise
5252098|NCT02433041|Postoperative delirium|postoperative delirium
5252099|NCT02433041|Cortisol|cortisol
5252101|NCT02433041|S-100beta|s-100beta
5252102|NCT02433041|MMSE|mmse
5252103|NCT02433041|Nu-DESC|nu-desc
5252104|NCT02433041|ICDSC|icdsc
5252105|NCT02433041|DOS|dos
5252106|NCT02433041|Haloperidol|haloperidol
5252107|NCT02433041|Ketamine|ketamine
5252108|NCT02433041|Combination of Haloperidol and Ketamine|combination of haloperidol and ketamine
5252109|NCT02433041|Placebo|placebo
5252110|NCT02433041|Prevention of|prevention of
5252111|NCT02433028|MS key phases of disease evolution|ms key phases of disease evolution
5252112|NCT02433028|MS New Treatment Options|ms new treatment options
5252113|NCT02433015|Electronic Cigarette|electronic cigarette
5252114|NCT02433002|eGFR|egfr
5252115|NCT02433002|CKD|ckd
5252116|NCT02433002|Cystatin|cystatin
5252117|NCT02433002|Creatinine|creatinine
5252118|NCT02433002|Albuminuria|albuminuria
5252119|NCT02432989|Exercise Therapy|exercise therapy
5252120|NCT02432989|Concussion Management|concussion management
5252121|NCT02432989|Concussion Recovery|concussion recovery
5252122|NCT02432976|Quality of Life|quality of life
5252123|NCT02432976|Cardiac Surgery|cardiac surgery
5252124|NCT02432976|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5252125|NCT02432976|Incretin mimetic|incretin mimetic
5252128|NCT02432937|hypertension|hypertension
5147284|NCT03071757|Merkel cell carcinoma|merkel cell carcinoma
5252129|NCT02432885|cardiac magnetic resonance|cardiac magnetic resonance
5252130|NCT02432885|myocardial fibrosis|myocardial fibrosis
5252131|NCT02432885|muscular dystrophies|muscular dystrophies
5252132|NCT02432820|Prostate Cancer|prostate cancer
5252133|NCT02432768|Anaplerotic diet|anaplerotic diet
5252134|NCT02432768|McArdle Disease|mcardle disease
5252135|NCT02432768|Glycogen Storage Disease|glycogen storage disease
5252136|NCT02432768|Triheptanoin|triheptanoin
5252137|NCT02432755|home-based rehabilitation|home-based rehabilitation
5252138|NCT02432755|stroke|stroke
5252139|NCT02432755|combination therapy|combination therapy
5252140|NCT02432755|client-centered approach|client-centered approach
5252141|NCT02432755|post-acute|post-acute
5252142|NCT02432742|hyaluronic acid, comparative study, NLF|hyaluronic acid, comparative study, nlf
5252143|NCT02432729|smoking cessation|smoking cessation
5252144|NCT02432729|smoking abstinence|smoking abstinence
5257446|NCT02404077|ICU|icu
5252145|NCT02432729|clinical, biological and functional changes|clinical, biological and functional changes
5252147|NCT02432729|healthy smokers|healthy smokers
5252148|NCT02432729|quit smoking|quit smoking
5252149|NCT02432703|Social Anxiety Disorder|social anxiety disorder
5252150|NCT02432703|JNJ-42165279|jnj-42165279
5252151|NCT02432690|Neoplasms|neoplasms
5252152|NCT02432677|tDCS|tdcs
5252153|NCT02432677|Opioid|opioid
5252154|NCT02432677|Pain|pain
5252155|NCT02432677|Pain threshold|pain threshold
5252156|NCT02432651|oxidative stress|oxidative stress
5252157|NCT02432651|hops|hops
5252158|NCT02432651|xanthohumol|xanthohumol
5252159|NCT02432651|DNA damage|dna damage
5252160|NCT02432651|cancer|cancer
5252161|NCT02432625|Osteogenesis Imperfecta|osteogenesis imperfecta
5252162|NCT02432625|Collagen|collagen
5252163|NCT02432625|Brittle Bone Disorder|brittle bone disorder
5252164|NCT02432625|Rare Disease Clinical Research Network|rare disease clinical research network
5252165|NCT02432625|COL1A2|col1a2
5252166|NCT02432599|F18-choline|f18-choline
5252167|NCT02432586|T1DM|t1dm
5252168|NCT02432586|Diabetes|diabetes
5252169|NCT02432586|Child|child
5252170|NCT02432586|Toddler|toddler
5252171|NCT02432573|timing|timing
5252172|NCT02432560|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5252173|NCT02432560|LAM|lam
5252174|NCT02432560|rare lung|rare lung
5252175|NCT02432560|Rare Lung Disease|rare lung disease
5252176|NCT02432547|Diabetic|diabetic
5252178|NCT02432547|Retinopathy|retinopathy
5252179|NCT02432521|stroke|stroke
5252180|NCT02432521|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5252181|NCT02432521|Electroencephalography (EEG)|electroencephalography (eeg)
5252182|NCT02432521|Cerebrovascular Accident|cerebrovascular accident
5252183|NCT02432521|Brain Vascular Accident|brain vascular accident
5252184|NCT02432508|acupuncture|acupuncture
5252185|NCT02432508|laser|laser
5252186|NCT02432508|uremic pruritus|uremic pruritus
5252187|NCT02432508|randomized clinical trial|randomized clinical trial
5239997|NCT02503176|Conjunctival diseases|conjunctival diseases
5239998|NCT02503163|Dry eye syndromes|dry eye syndromes
5252188|NCT02432482|Tobacco|tobacco
5252189|NCT02432482|Cigarette|cigarette
5252190|NCT02432482|HIV|hiv
5252191|NCT02432482|Treatment|treatment
5252192|NCT02432482|Mobile|mobile
5252193|NCT02432482|Smartphone|smartphone
5252194|NCT02432469|coronary artery bypass|coronary artery bypass
5252195|NCT02432469|medication adherence|medication adherence
5252196|NCT02432469|secondary prevention|secondary prevention
5252197|NCT02432469|mobile applications|mobile applications
5252198|NCT02432443|Motor Skills|motor skills
5252199|NCT02432443|Pre-literacy Skills|pre-literacy skills
5252200|NCT02432443|Early Intervention|early intervention
5252201|NCT02432430|N05.300.150.410|n05.300.150.410
5252202|NCT02432430|practice guideline|practice guideline
5252203|NCT02432430|D20.215.894.899.290.130|d20.215.894.899.290.130
5252204|NCT02432430|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5252205|NCT02432417|Glioblastoma|glioblastoma
5252206|NCT02432417|Autophagy|autophagy
5252207|NCT02432417|EGFR|egfr
5252208|NCT02432417|EGFRvIII|egfrviii
5252209|NCT02432417|Chloroquine|chloroquine
5252210|NCT02432417|Radiotherapy|radiotherapy
5252211|NCT02432417|Temozolomide|temozolomide
5252212|NCT02432404|HSV-2|hsv-2
5252213|NCT02432404|Contraceptive Vaginal Ring|contraceptive vaginal ring
5252214|NCT02432365|Paclitaxel|paclitaxel
5252215|NCT02432365|Cisplatin|cisplatin
5252216|NCT02432365|Cervical cancer|cervical cancer
5252217|NCT02432365|Radical hysterectomy|radical hysterectomy
5252218|NCT02432365|Neoadjuvant|neoadjuvant
5252219|NCT02432339|immune system|immune system
5252220|NCT02432339|RENIN-ANGIOTENSIN SYSTEM|renin-angiotensin system
5252221|NCT02432326|Neoplasms|neoplasms
5252222|NCT02432300|Traumatic Brain Injury|traumatic brain injury
5252223|NCT02432300|Alexithymia|alexithymia
5252224|NCT02432300|Emotions|emotions
5252226|NCT02432287|metformin|metformin
5252227|NCT02432287|prediabetes|prediabetes
5252233|NCT02432261|spermatogenesis|spermatogenesis
5252234|NCT02432261|androgen|androgen
5252235|NCT02432261|male contraception|male contraception
5252236|NCT02432248|DHEA|dhea
5147413|NCT03071055|AMD|amd
5252237|NCT02432248|live birth rate|live birth rate
5252238|NCT02432248|poor ovarian responder|poor ovarian responder
5252240|NCT02432196|Mitral Valve Repair|mitral valve repair
5252241|NCT02432196|Transapical|transapical
5252242|NCT02432196|artificial chordae|artificial chordae
5252243|NCT02432183|individual|individual
5252244|NCT02432144|MPS 7|mps 7
5252245|NCT02432144|Sly Syndrome|sly syndrome
5252246|NCT02432144|MPS VII|mps vii
5252247|NCT02432144|Enzyme Replacement Therapy|enzyme replacement therapy
5252248|NCT02432144|Rare Disease|rare disease
5252249|NCT02432144|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
5252250|NCT02432144|Lysosomal Storage Disease|lysosomal storage disease
5252251|NCT02432144|Metabolic Disorder|metabolic disorder
5252252|NCT02432092|Cardiomegaly|cardiomegaly
5252253|NCT02432092|Cardiovascular Diseases|cardiovascular diseases
5252254|NCT02432092|Heart Diseases|heart diseases
5252255|NCT02432092|Systolic dysfunction|systolic dysfunction
5252256|NCT02432092|Diastolic dysfunction|diastolic dysfunction
5252257|NCT02432092|Ventricular hypertrophy|ventricular hypertrophy
5252258|NCT02432092|Heart failure|heart failure
5252259|NCT02432079|Abnormalities, Multiple|abnormalities, multiple
5252260|NCT02432079|Asplenia|asplenia
5252261|NCT02432079|Bilary Atresia|bilary atresia
5252262|NCT02432079|Birth Defect|birth defect
5252263|NCT02432079|Cardiovascular Abnormalities|cardiovascular abnormalities
5252264|NCT02432079|Cardiovascular Diseases|cardiovascular diseases
5252265|NCT02432079|Congenital Abnormalities|congenital abnormalities
5252266|NCT02432079|Congenital Heart Disease|congenital heart disease
5252267|NCT02432079|Dextrocardia Syndrome|dextrocardia syndrome
5252268|NCT02432079|Disturbed Internal Organ Positioning|disturbed internal organ positioning
5252269|NCT02432079|Genetics|genetics
5252270|NCT02432079|Genetic Testing|genetic testing
5252271|NCT02432079|Heart Defects, Congenital|heart defects, congenital
5252272|NCT02432079|Heart Diseases|heart diseases
5252273|NCT02432079|Heterotaxy syndrome|heterotaxy syndrome
5252274|NCT02432079|Intestinal malrotation|intestinal malrotation
5252275|NCT02432079|Laterality|laterality
5252276|NCT02432079|Left Atrial Isomerism|left atrial isomerism
5252277|NCT02432079|Pediatrics|pediatrics
5252278|NCT02432079|Polysplenia|polysplenia
5252279|NCT02432079|Right Atrial Isomerism|right atrial isomerism
5252280|NCT02432079|Splenic Diseases|splenic diseases
5252282|NCT02432079|Situs inversus|situs inversus
5252283|NCT02432079|Dextrocardia|dextrocardia
5252284|NCT02432066|Smoking|smoking
5252285|NCT02432066|Smoking Cessation|smoking cessation
5252286|NCT02432053|FK506|fk506
5252287|NCT02432053|Advagraf|advagraf
5252288|NCT02432053|Tacrolimus|tacrolimus
5252289|NCT02432053|Transplantation|transplantation
5252290|NCT02432040|chronic plaque psoriasis|chronic plaque psoriasis
5252291|NCT02432040|psoriasis|psoriasis
5252292|NCT02432040|atorvastatin|atorvastatin
5252293|NCT02432040|psoriasis area and severity index|psoriasis area and severity index
5252294|NCT02432040|betamethasone valerate|betamethasone valerate
5252295|NCT02431988|Relapsed|relapsed
5252296|NCT02431988|refractory|refractory
5252297|NCT02431988|DLBCL|dlbcl
5252298|NCT02431975|HIV|hiv
5252299|NCT02431975|infant|infant
5252300|NCT02431975|antiretroviral therapy, highly active|antiretroviral therapy, highly active
5252301|NCT02431975|antiretroviral agents|antiretroviral agents
5252302|NCT02431962|Lung Cancer|lung cancer
5252303|NCT02431962|Screening|screening
5252304|NCT02431962|Computed Tomography|computed tomography
5252305|NCT02431949|Music|music
5252306|NCT02431949|Amusia|amusia
5252307|NCT02431936|Stress|stress
5252308|NCT02431936|Blood Pressure|blood pressure
5252309|NCT02431936|Salt Sensitivity|salt sensitivity
5252310|NCT02431936|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
5252311|NCT02431936|Sympathetic Nervous System|sympathetic nervous system
5252312|NCT02431923|Sequelae|sequelae
5252313|NCT02431923|Seroprevalence|seroprevalence
5252314|NCT02431923|Household Contacts|household contacts
5252315|NCT02431910|Electromyography|electromyography
5252316|NCT02431910|Baropodometry|baropodometry
5252317|NCT02431910|Torque|torque
5252318|NCT02431897|Pelvic Organ Prolapse|pelvic organ prolapse
5252319|NCT02431897|Pelvic Floor Disorders|pelvic floor disorders
5252320|NCT02431897|Therapy, Estrogen Replacement|therapy, estrogen replacement
5252321|NCT02431897|Estrogens, Conjugated|estrogens, conjugated
5252322|NCT02431871|Developmental dysplasia of the hip|developmental dysplasia of the hip
5252323|NCT02431871|Hip dysplasia|hip dysplasia
5252324|NCT02431871|Occlusal defect|occlusal defect
5252325|NCT02431858|Nerve block|nerve block
5252326|NCT02431858|Catheter|catheter
5252327|NCT02431858|Catheter over needle|catheter over needle
5252328|NCT02431858|Femoral Nerve|femoral nerve
5252329|NCT02431858|Anaesthesia|anaesthesia
5252330|NCT02431858|[E04.525.210.550]|[e04.525.210.550]
5252331|NCT02431858|[E02.148]|[e02.148]
5252332|NCT02431845|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5252333|NCT02431845|Pharmaco(epi)genetics|pharmaco(epi)genetics
5252334|NCT02431832|Elderly|elderly
5252339|NCT02431780|Decision Support Algorithm|decision support algorithm
5252340|NCT02431780|EEG|eeg
5252341|NCT02431741|Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment|presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
5252342|NCT02431728|Melatonin|melatonin
5252343|NCT02431728|Post-acute withdrawal symptoms|post-acute withdrawal symptoms
5252344|NCT02431728|Anxiety|anxiety
5252345|NCT02431728|Depression|depression
5252346|NCT02431728|Insomnia|insomnia
5252347|NCT02431728|Stress|stress
5252348|NCT02431728|Substance withdrawal syndrome|substance withdrawal syndrome
5252349|NCT02431702|Paliperidone Palmitate|paliperidone palmitate
5252350|NCT02431702|Oral Antipsychotics|oral antipsychotics
5252351|NCT02431702|Schizophrenia|schizophrenia
5252352|NCT02431702|Psychotic Disorders|psychotic disorders
5252353|NCT02431702|Cognition in Schizophrenia|cognition in schizophrenia
5252354|NCT02431702|Brain intracortical myelin volume|brain intracortical myelin volume
5252355|NCT02431702|Personal and Social Performance|personal and social performance
5252356|NCT02431702|Disease Modification|disease modification
5252357|NCT02431663|refractory convulsive status epilepticus|refractory convulsive status epilepticus
5252358|NCT02431663|ketamine|ketamine
5252359|NCT02431663|conventional anesthetics|conventional anesthetics
5252360|NCT02431663|children|children
5252361|NCT02431650|Induced blood stage malaria|induced blood stage malaria
5252362|NCT02431650|Transmission|transmission
5252363|NCT02431650|Mosquito feeding|mosquito feeding
5252364|NCT02431650|OZ439|oz439
5252365|NCT02431650|Primaquine|primaquine
5252366|NCT02431650|Piperaquine|piperaquine
5252367|NCT02431650|Artefonomel|artefonomel
5252368|NCT02431637|Induced blood stage malaria|induced blood stage malaria
5252369|NCT02431637|Transmission|transmission
5252370|NCT02431637|Standard membrane feeding assay|standard membrane feeding assay
5252371|NCT02431624|Healthy Volunteer|healthy volunteer
5252372|NCT02431585|abdominal pain|abdominal pain
5252373|NCT02431585|gluten free diet|gluten free diet
5252374|NCT02431585|functional gastrointestinal disorders|functional gastrointestinal disorders
5252375|NCT02431572|Intracranial Tumors|intracranial tumors
5252376|NCT02431572|Glioblastoma|glioblastoma
5252377|NCT02431572|Melanoma|melanoma
5252378|NCT02431559|Ovarian Cancer|ovarian cancer
5252379|NCT02431559|Motolimod|motolimod
5252380|NCT02431559|Immunotherapy|immunotherapy
5252381|NCT02431559|PD-L1|pd-l1
5252382|NCT02431559|MEDI4736|medi4736
5252383|NCT02431559|Pegylated|pegylated
5252384|NCT02431559|Liposomal|liposomal
5252385|NCT02431559|Doxorubicin|doxorubicin
5252387|NCT02431559|TLR-8|tlr-8
5252388|NCT02431559|Durvalumab|durvalumab
5252389|NCT02431546|Cardiology|cardiology
5252390|NCT02431546|Vascular|vascular
5252391|NCT02431546|CAD|cad
5252392|NCT02431546|Duke|duke
5252393|NCT02431546|Cardiac Rehabilitation|cardiac rehabilitation
5252394|NCT02431546|Prevention|prevention
5252395|NCT02431546|CVD|cvd
5252396|NCT02431546|Mobile Health|mobile health
5252397|NCT02431546|Exercise|exercise
5252398|NCT02431533|IBS-D|ibs-d
5252399|NCT02431533|diarrhea predominant|diarrhea predominant
5252400|NCT02431520|Patient Compliance|patient compliance
5252401|NCT02431520|HPV-DNA probes|hpv-dna probes
5252402|NCT02431520|Papanicolaou test|papanicolaou test
5252403|NCT02431520|Cervical cancer|cervical cancer
5252404|NCT02431507|apnea|apnea
5252405|NCT02431507|sleep apnea|sleep apnea
5252406|NCT02431507|magnetic sleep apnea device|magnetic sleep apnea device
5252407|NCT02431507|hyoid bone|hyoid bone
5252408|NCT02431455|Bariatric Surgery|bariatric surgery
5252409|NCT02431455|obesity, morbid|obesity, morbid
5252410|NCT02431455|incentive spirometry|incentive spirometry
5252411|NCT02431442|Heterozygous|heterozygous
5252412|NCT02431442|MC4R deficiency|mc4r deficiency
5252413|NCT02431442|associated|associated
5252414|NCT02431429|leishmaniasis|leishmaniasis
5252415|NCT02431429|miltefosine|miltefosine
5252416|NCT02431429|spermiogram|spermiogram
5252417|NCT02431416|females|females
5252418|NCT02431416|ghrelin|ghrelin
5252419|NCT02431416|GnRH|gnrh
5252420|NCT02431416|randomized, controlled study|randomized, controlled study
5252421|NCT02431416|children|children
5252422|NCT02431390|RAPAELⓇ Smart Glove digital treatment system|rapaelⓡ smart glove digital treatment system
5252423|NCT02431390|Rehabilitation|rehabilitation
5252424|NCT02431390|Stroke|stroke
5252425|NCT02431390|Upper limbs|upper limbs
5252426|NCT02431377|infant formula|infant formula
5252427|NCT02431364|KPT-335|kpt-335
5252428|NCT02431364|Verdinexor|verdinexor
5252429|NCT02431364|Karyopharm|karyopharm
5252430|NCT02431364|First-in-Human|first-in-human
5252432|NCT02431351|KPT-330|kpt-330
5252433|NCT02431351|Karyopharm|karyopharm
5252435|NCT02431351|SIER|sier
5252436|NCT02431351|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5252437|NCT02431351|Erythropoietin (EPO)|erythropoietin (epo)
5252438|NCT02431351|Refractory|refractory
5252439|NCT02431338|Remote ischemic conditioning|remote ischemic conditioning
5252440|NCT02431338|Cost-effectiveness analysis|cost-effectiveness analysis
5252441|NCT02431325|HIV|hiv
5252442|NCT02431325|Atherosclerosis|atherosclerosis
5252443|NCT02431325|Microbial Translocation|microbial translocation
5252444|NCT02431325|Teduglutide|teduglutide
5252445|NCT02431325|Gastrointestinal Permeability|gastrointestinal permeability
5252446|NCT02431325|Inflammation|inflammation
5252447|NCT02431312|Chronic HBV|chronic hbv
5252448|NCT02431312|immunotherapy|immunotherapy
5252449|NCT02431312|DNA vaccine|dna vaccine
5252450|NCT02431312|electroporation|electroporation
5252468|NCT02431260|Non-small cell lung cancer|non-small cell lung cancer
5252469|NCT02431260|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5252470|NCT02431260|castration-resistant prostate cancer|castration-resistant prostate cancer
5252471|NCT02431260|breast cancer|breast cancer
5252472|NCT02431260|NUT midline carcinoma|nut midline carcinoma
5252473|NCT02431260|leukemia|leukemia
5252474|NCT02431260|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5252475|NCT02431260|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5252476|NCT02431260|myeloproliferative neoplasms|myeloproliferative neoplasms
5252477|NCT02431260|myelofibrosis (MF)|myelofibrosis (mf)
5252478|NCT02431260|multiple myeloma (MM)|multiple myeloma (mm)
5252479|NCT02431260|MDS/MPN|mds/mpn
5252480|NCT02431247|Immunodeficiency Virus Type 1, Human|immunodeficiency virus type 1, human
5252481|NCT02431247|Darunavir|darunavir
5252482|NCT02431247|Cobicistat|cobicistat
5252483|NCT02431247|Tenofovir Alafenamide|tenofovir alafenamide
5252484|NCT02431247|Emtricitabine|emtricitabine
5252485|NCT02431247|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5252486|NCT02431234|Type 2 diabetes|type 2 diabetes
5252487|NCT02431234|Arterial calcification|arterial calcification
5252488|NCT02431234|Mediacalcosis|mediacalcosis
5252489|NCT02431234|Calcium score|calcium score
5252490|NCT02431221|perhexiline|perhexiline
5252491|NCT02431221|HCM|hcm
5252492|NCT02431221|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5252493|NCT02431221|CPEX|cpex
5252494|NCT02431195|obesity|obesity
5252495|NCT02431195|bariatric surgery|bariatric surgery
5252496|NCT02431195|physical activity|physical activity
5252497|NCT02431195|eating habits|eating habits
5252498|NCT02431156|presbyopia|presbyopia
5252499|NCT02431156|monovision|monovision
5252500|NCT02431156|activities of daily living,|activities of daily living,
5252501|NCT02431156|pseudophakic|pseudophakic
5252502|NCT02431130|Training Program|training program
5252503|NCT02431091|Optical Coherence Tomography|optical coherence tomography
5252504|NCT02431078|CTCs|ctcs
5252505|NCT02431078|ZEB1|zeb1
5252506|NCT02431078|gastric cancer|gastric cancer
5252507|NCT02431065|Rectus sheath block|rectus sheath block
5252508|NCT02431065|Single port laparoscopy|single port laparoscopy
5252509|NCT02431026|induced mild hypothermia|induced mild hypothermia
5252510|NCT02431026|cervical cooling collar|cervical cooling collar
5252511|NCT02431026|mri brain thermometry|mri brain thermometry
5252512|NCT02431026|MRI thermometry|mri thermometry
5252513|NCT02431026|rate-of-cooling|rate-of-cooling
5252514|NCT02431026|Excel Cryo Cooling Collar|excel cryo cooling collar
5252515|NCT02431013|Drug-drug interaction|drug-drug interaction
5252516|NCT02431013|Pharmacokinetics|pharmacokinetics
5252517|NCT02430987|menopause|menopause
5252518|NCT02430987|hypoative sexual desire disorder|hypoative sexual desire disorder
5252519|NCT02430987|metabolic syndrome|metabolic syndrome
5252520|NCT02430987|obesity|obesity
5252521|NCT02430961|Critical Care|critical care
5252522|NCT02430961|Palliative Care|palliative care
5252523|NCT02430948|Screening|screening
5252524|NCT02430948|Shared Decision Making|shared decision making
5252525|NCT02430935|Psychosis|psychosis
5252526|NCT02430935|Psychosis NOS|psychosis nos
5252527|NCT02430935|Schizophrenia|schizophrenia
5252528|NCT02430935|Schizoaffective Disorder|schizoaffective disorder
5252529|NCT02430935|Early Intervention|early intervention
5252530|NCT02430896|Neuropsychological|neuropsychological
5252531|NCT02430896|neuroimaging|neuroimaging
5252532|NCT02430896|genetic markers|genetic markers
5252533|NCT02430896|treatment response predictor|treatment response predictor
5252542|NCT02430818|orthopedics|orthopedics
5252543|NCT02430805|hypertension|hypertension
5252544|NCT02430805|microinflammation and oxidative stress|microinflammation and oxidative stress
5252545|NCT02430805|renal disease|renal disease
5252546|NCT02430805|heart failure|heart failure
5252547|NCT02430805|genetics markers|genetics markers
5252548|NCT02430805|genomics markers|genomics markers
5252549|NCT02430805|proteomics markers|proteomics markers
5252550|NCT02430792|Prostatic Neoplasms|prostatic neoplasms
5252551|NCT02430792|Exercise|exercise
5252552|NCT02430792|Football|football
5252553|NCT02430792|Quality of Life|quality of life
5252554|NCT02430779|irreversible electroporation|irreversible electroporation
5252555|NCT02430779|Unresectable Renal Pelvic and Ureteral Neoplasms|unresectable renal pelvic and ureteral neoplasms
5252556|NCT02430766|irreversible electroporation|irreversible electroporation
5252557|NCT02430766|Unresectable Lymph Node Metastases|unresectable lymph node metastases
5252558|NCT02430753|irreversible electroporation|irreversible electroporation
5252560|NCT02430753|Respiratory Function Insufficiency|respiratory function insufficiency
5252561|NCT02430740|Fertilization in Vitro|fertilization in vitro
5252562|NCT02430740|antagonist protocol|antagonist protocol
5252563|NCT02430740|antral follicle count|antral follicle count
5252564|NCT02430740|Anti-Mullerian Hormone|anti-mullerian hormone
5252565|NCT02430740|Reproductive Techniques, Assisted|reproductive techniques, assisted
5252566|NCT02430714|Thyroid Cancer|thyroid cancer
5252568|NCT02430714|Post-marketing surveillance|post-marketing surveillance
5252569|NCT02430714|LEN01T|len01t
5252570|NCT02430714|All-Patient Investigation|all-patient investigation
5252571|NCT02430714|Lenvatinib Mesylate|lenvatinib mesylate
5252572|NCT02430701|irreversible electroporation|irreversible electroporation
5252573|NCT02430701|Unresectable Esophageal Neoplasms|unresectable esophageal neoplasms
5252574|NCT02430688|irreversible electroporation|irreversible electroporation
5252575|NCT02430688|Unresectable Extremities|unresectable extremities
5252576|NCT02430675|irreversible electroporation|irreversible electroporation
5252577|NCT02430675|Unresectable Laryngeal Neoplasms|unresectable laryngeal neoplasms
5252578|NCT02430662|irreversible electroporation|irreversible electroporation
5252579|NCT02430662|Unresectable Gallbladder Neoplasms|unresectable gallbladder neoplasms
5252580|NCT02430649|irreversible electroporation|irreversible electroporation
5252581|NCT02430649|Unresectable Prostatic Neoplasms|unresectable prostatic neoplasms
5252582|NCT02430636|irreversible electroporation|irreversible electroporation
5252583|NCT02430636|Unresectable Stomach Neoplasms|unresectable stomach neoplasms
5252584|NCT02430623|irreversible electroporation|irreversible electroporation
5252585|NCT02430623|Unresectable Urinary Neoplasms|unresectable urinary neoplasms
5252586|NCT02430610|irreversible electroporation|irreversible electroporation
5252587|NCT02430610|Unresectable Uterine Cervical Neoplasms|unresectable uterine cervical neoplasms
5252588|NCT02430597|irreversible electroporation|irreversible electroporation
5252589|NCT02430597|Hilus Pulmonary Neoplasms|hilus pulmonary neoplasms
5252590|NCT02430545|Glasdegib|glasdegib
5252591|NCT02430545|PF-04449913|pf-04449913
5252592|NCT02430545|Drug-drug interaction|drug-drug interaction
5252593|NCT02430545|CYP3A4 inducer|cyp3a4 inducer
5252594|NCT02430545|Pharmacokinetics|pharmacokinetics
5252595|NCT02430532|INSPIRE|inspire
5252596|NCT02430532|SPMS|spms
5252597|NCT02430532|Tecfidera|tecfidera
5252598|NCT02430532|BG00012|bg00012
5252599|NCT02430519|Chronic Periodontitis|chronic periodontitis
5252600|NCT02430519|Clinical Parameters|clinical parameters
5252601|NCT02430519|Furcation defects|furcation defects
5252602|NCT02430519|Radiographic bone fill|radiographic bone fill
5252603|NCT02430493|ACS|acs
5252604|NCT02430480|Multiparametric MRI|multiparametric mri
5252605|NCT02430480|Prostatectomy|prostatectomy
5252606|NCT02430480|Focal Prostate Cancer|focal prostate cancer
5252607|NCT02430480|Normal Testosterone|normal testosterone
5252608|NCT02430480|Non Metastatic|non metastatic
5252609|NCT02430454|ICU|icu
5252610|NCT02430454|decision making|decision making
5252611|NCT02430402|Climatotherapy|climatotherapy
5252612|NCT02430389|hemodynamic stability|hemodynamic stability
5252613|NCT02430389|remifentanil|remifentanil
5252614|NCT02430376|Non-Muscle Myosin|non-muscle myosin
5252615|NCT02430363|pembrolizumab|pembrolizumab
5252616|NCT02430363|MK-3475|mk-3475
5252617|NCT02430363|Glioblastoma|glioblastoma
5252618|NCT02430363|Gliosarcoma|gliosarcoma
5252619|NCT02430363|Suppressor of the PI3K/Akt pathways|suppressor of the pi3k/akt pathways
5252620|NCT02430363|Pictilisib|pictilisib
5252621|NCT02430363|GDC-0941|gdc-0941
5252622|NCT02430363|BEZ235|bez235
5252623|NCT02430363|NVP-BEZ235|nvp-bez235
5252624|NCT02430363|Ipatasertib|ipatasertib
5252625|NCT02430363|GDC-0068|gdc-0068
5252626|NCT02430311|Chinese Patients|chinese patients
5252627|NCT02430285|biliary stone|biliary stone
5252628|NCT02430285|cholelithiasis|cholelithiasis
5252629|NCT02430285|pancreatitis|pancreatitis
5252630|NCT02430285|EUS|eus
5252631|NCT02430285|ERCP|ercp
5252632|NCT02430285|early|early
5252633|NCT02430285|choledocholithiasis|choledocholithiasis
5252634|NCT02430272|Child|child
5252635|NCT02430272|outpatient|outpatient
5252636|NCT02430272|premedication|premedication
5252637|NCT02430259|rifapentine|rifapentine
5252638|NCT02430259|isoniazid|isoniazid
5252639|NCT02430259|QuantiFERON Gold In-Tube|quantiferon gold in-tube
5252640|NCT02430259|tuberculin skin test|tuberculin skin test
5252641|NCT02430207|Pulmonary Embolism|pulmonary embolism
5252642|NCT02430207|Temporary Pacing|temporary pacing
5252643|NCT02430207|Femoral Vein|femoral vein
5252644|NCT02430207|Subclavian Vein|subclavian vein
5252645|NCT02430168|Stone|stone
5252646|NCT02430168|RIRs|rirs
5252647|NCT02430168|PCNL|pcnl
5252648|NCT02430168|Pain|pain
5252685|NCT02430025|Myocardial Ischemia|myocardial ischemia
5252686|NCT02430025|Pathologic Processes|pathologic processes
5252687|NCT02430012|coronary artery bypass grafting|coronary artery bypass grafting
5252688|NCT02430012|quality improvement|quality improvement
5252689|NCT02430012|secondary preventions|secondary preventions
5252690|NCT02429986|Adaptive Servo-Ventilation|adaptive servo-ventilation
5252691|NCT02429986|Chronic Heart Failure|chronic heart failure
5252692|NCT02429986|Central Sleep Apnea Syndrome|central sleep apnea syndrome
5252693|NCT02429986|Central and Obstructive Sleep Apnea Syndrome|central and obstructive sleep apnea syndrome
5335444|NCT02015208|CLL|cll
5240484|NCT02500641|Cardiovascular disease|cardiovascular disease
5240486|NCT02500641|Pulse Wave Velocity|pulse wave velocity
5240487|NCT02500641|Cardiovascular risk factors|cardiovascular risk factors
5240488|NCT02500641|Allopurinol|allopurinol
5240489|NCT02500641|Pulse Wave Analysis|pulse wave analysis
5240490|NCT02500641|Thiazoles|thiazoles
5240491|NCT02500641|Inflammation|inflammation
5240492|NCT02500641|Uric acid|uric acid
5240493|NCT02500641|Febuxostat|febuxostat
5240494|NCT02500641|Oxidative stress|oxidative stress
5252694|NCT02429986|Complex Sleep Apnea Syndrome|complex sleep apnea syndrome
5252695|NCT02429986|Hunter-Cheyne-Stokes Breathing|hunter-cheyne-stokes breathing
5252696|NCT02429986|Periodic Breathing|periodic breathing
5252697|NCT02429973|Osteosarcoma|osteosarcoma
5252698|NCT02429960|Nociception|nociception
5252700|NCT02429960|Intraoperative|intraoperative
5252701|NCT02429960|Monitoring|monitoring
5252702|NCT02429947|Charcot Marie Tooth disease|charcot marie tooth disease
5252703|NCT02429947|CMT|cmt
5252704|NCT02429947|HMSN|hmsn
5252705|NCT02429947|HMN|hmn
5252706|NCT02429947|HSN|hsn
5252707|NCT02429934|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5252708|NCT02429934|Abatacept (Orencia)|abatacept (orencia)
5252709|NCT02429934|Arthritis|arthritis
5252710|NCT02429921|dietary intervention|dietary intervention
5252711|NCT02429921|arsenic poisoning|arsenic poisoning
5252712|NCT02429921|high-Se lentils|high-se lentils
5252713|NCT02429895|Methotrexate|methotrexate
5252714|NCT02429895|Efficacy|efficacy
5252715|NCT02429895|Safety|safety
5252716|NCT02429882|Ankylosing Spondyloarthritis; non-radiographic axial spondyloarthritis|ankylosing spondyloarthritis; non-radiographic axial spondyloarthritis
5252717|NCT02429843|Non-squamous cell lung cancer|non-squamous cell lung cancer
5252718|NCT02429843|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
5252719|NCT02429843|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5252720|NCT02429843|TRC105|trc105
5252721|NCT02429830|gastroesophageal reflux disease|gastroesophageal reflux disease
5252722|NCT02429830|GERD|gerd
5252723|NCT02429830|obesity|obesity
5252724|NCT02429830|LSG|lsg
5252725|NCT02429830|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5252726|NCT02429817|Pulmonary aerosol distribution|pulmonary aerosol distribution
5252727|NCT02429817|SPECT-CT analysis|spect-ct analysis
5252728|NCT02429817|High flow nasal cannula|high flow nasal cannula
5252729|NCT02429817|Vibrating-mesh nebulizer|vibrating-mesh nebulizer
5252730|NCT02429817|Jet nebulizer|jet nebulizer
5252731|NCT02429791|two-drug regimen|two-drug regimen
5252732|NCT02429791|virologically-suppressed|virologically-suppressed
5252733|NCT02429791|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
5252734|NCT02429791|integrase inhibitor|integrase inhibitor
5252735|NCT02429791|protease inhibitor|protease inhibitor
5252736|NCT02429791|NNRTI-sparing|nnrti-sparing
5252737|NCT02429791|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5252738|NCT02429791|HIV|hiv
5252739|NCT02429791|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
5252740|NCT02429752|inspiratory muscle training|inspiratory muscle training
5252741|NCT02429752|low back pain|low back pain
5252742|NCT02429752|respiration|respiration
5252743|NCT02429752|breathing|breathing
5252744|NCT02429739|Working Memory Training, computerized|working memory training, computerized
5252745|NCT02429739|Dyslexia|dyslexia
5252746|NCT02429739|Reading fluency|reading fluency
5252747|NCT02429739|Reading comprehension|reading comprehension
5252748|NCT02429726|malignant pleural effusion, p53 gene therapy, cisplatin|malignant pleural effusion, p53 gene therapy, cisplatin
5252749|NCT02429713|tourniquet|tourniquet
5252750|NCT02429713|total knee arthroplasty|total knee arthroplasty
5252751|NCT02429713|blood loss|blood loss
5252752|NCT02429674|Depression|depression
5252753|NCT02429674|Adolescence|adolescence
5252754|NCT02429648|AF|af
5252755|NCT02429635|Exercise|exercise
5252756|NCT02429635|lifestyle diseases|lifestyle diseases
5252757|NCT02429635|well-being|well-being
5252758|NCT02429596|antiepileptic drugs|antiepileptic drugs
5252759|NCT02429596|generic substitution|generic substitution
5252760|NCT02429570|meclofenamate|meclofenamate
5252761|NCT02429570|15-068|15-068
5252762|NCT02429557|autonomic failure|autonomic failure
5252763|NCT02429557|orthostatic hypotension|orthostatic hypotension
5252764|NCT02429557|compression garments|compression garments
5252765|NCT02429557|treatment|treatment
5252766|NCT02429544|Breast cancer|breast cancer
5252767|NCT02429544|Stage IV breast cancer|stage iv breast cancer
5252768|NCT02429544|Metastatic|metastatic
5252769|NCT02429544|Residential group programs|residential group programs
5252770|NCT02429544|Questionnaires|questionnaires
5252771|NCT02429544|Surveys|surveys
5252772|NCT02429544|EEG|eeg
5252773|NCT02429544|Computer testing|computer testing
5252774|NCT02429544|Saliva test|saliva test
5252775|NCT02429544|Study diary|study diary
5252776|NCT02429544|Actigraph|actigraph
5252777|NCT02429531|Pneumovax 23|pneumovax 23
5252778|NCT02429531|Typhim Vi|typhim vi
5252779|NCT02429531|allohemagglutinins|allohemagglutinins
5252780|NCT02429518|leishmaniasis|leishmaniasis
5252781|NCT02429518|miltefosine|miltefosine
5252782|NCT02429518|EKG|ekg
5252783|NCT02429492|Pathophysiology|pathophysiology
5252784|NCT02429492|Spinal interneurons|spinal interneurons
5252785|NCT02429492|Electrophysiology|electrophysiology
5252786|NCT02429492|EMG|emg
5252787|NCT02429492|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5252788|NCT02429479|Advance Care Planning|advance care planning
5252789|NCT02429479|Living Will|living will
5252790|NCT02429479|Family Caregiver|family caregiver
5252791|NCT02429479|Advance Directive|advance directive
5252792|NCT02429479|Surrogate Decision Maker|surrogate decision maker
5252793|NCT02429479|Proxy|proxy
5252794|NCT02429479|Self-Efficacy|self-efficacy
5252795|NCT02429466|testicular germ cell tumor|testicular germ cell tumor
5250331|NCT02442817|Linagliptin|linagliptin
5252797|NCT02429466|platinum refractory|platinum refractory
5252798|NCT02429466|cisplatin|cisplatin
5252799|NCT02429466|SGI110|sgi110
5252800|NCT02429466|Guadecitabine|guadecitabine
5252801|NCT02429453|Warfarin|warfarin
5252802|NCT02429453|Traumatic intracranial hemorrhage|traumatic intracranial hemorrhage
5252803|NCT02429453|prothrombin complex concentrate|prothrombin complex concentrate
5252804|NCT02429453|fresh frozen plasma|fresh frozen plasma
5252805|NCT02429453|Spontaneous intracranial hemorrhage|spontaneous intracranial hemorrhage
5252806|NCT02429427|Primary Breast Cancer|primary breast cancer
5252807|NCT02429427|Celecoxib|celecoxib
5252808|NCT02429414|Surgical Procedure|surgical procedure
5252809|NCT02429414|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
5252811|NCT02429414|Non-Video Double Lumen Tube|non-video double lumen tube
5252812|NCT02429414|DLT|dlt
5252813|NCT02429414|Video Double Lumen Tube|video double lumen tube
5252814|NCT02429414|VDLT|vdlt
5252815|NCT02429401|binge drinking|binge drinking
5252816|NCT02429401|heavy drinking|heavy drinking
5252817|NCT02429388|Heart failure|heart failure
5252818|NCT02429388|Spironolactone|spironolactone
5252819|NCT02429388|Diuretics|diuretics
5252820|NCT02429375|Mocetinostat (MGCD0103)|mocetinostat (mgcd0103)
5252821|NCT02429375|Brentuximab Vedotin (SGN-35)|brentuximab vedotin (sgn-35)
5252822|NCT02429375|Relapsed|relapsed
5252823|NCT02429375|Refractory|refractory
5252824|NCT02429323|induction|induction
5252825|NCT02429323|pediatrics|pediatrics
5252826|NCT02429323|sevoflurane|sevoflurane
5252827|NCT02429323|intubation time|intubation time
5252828|NCT02429310|Intermittent Claudication|intermittent claudication
5252829|NCT02429310|IC|ic
5252830|NCT02429310|Peripheral Arterial Disease|peripheral arterial disease
5252831|NCT02429310|Peripheral Vascular Disease|peripheral vascular disease
5252832|NCT02429310|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5252838|NCT02429297|Diabetes|diabetes
5252839|NCT02429297|mHealth|mhealth
5252840|NCT02429297|Interactive Voice Response|interactive voice response
5252841|NCT02429297|Bolivia|bolivia
5252842|NCT02429297|Chronic disease|chronic disease
5252843|NCT02429284|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5252844|NCT02429284|Pulmonary Endarterectomy (PEA)|pulmonary endarterectomy (pea)
5252845|NCT02429284|Pulmonary Thromboendarterectomy (PTE)|pulmonary thromboendarterectomy (pte)
5252846|NCT02429284|Pulmonary Hypertension|pulmonary hypertension
5252847|NCT02429284|Balloon Pulmonary Angioplasty (BPA)|balloon pulmonary angioplasty (bpa)
5252848|NCT02429271|undergoing thrombolysis|undergoing thrombolysis
5252849|NCT02429245|Knee|knee
5252850|NCT02429245|Knee osteoarthritis|knee osteoarthritis
5252851|NCT02429245|Knee replacement|knee replacement
5252852|NCT02429232|Pioglitazone|pioglitazone
5252853|NCT02429232|Linagliptin|linagliptin
5252854|NCT02429232|Diabetes mellitus|diabetes mellitus
5252855|NCT02429232|Diabetic macular edema|diabetic macular edema
5252856|NCT02429232|Kidney|kidney
5252857|NCT02429167|Traumatic Brain Injury|traumatic brain injury
5252858|NCT02429167|Neuromodulation|neuromodulation
5252859|NCT02429167|Chronic Balance Disorder|chronic balance disorder
5252860|NCT02429154|spectroscopy, near-infrared|spectroscopy, near-infrared
5252861|NCT02429154|Infant|infant
5252862|NCT02429154|Anesthesia, general|anesthesia, general
5252863|NCT02429128|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5252865|NCT02429115|chronic kidney disease|chronic kidney disease
5252866|NCT02429115|quality of life|quality of life
5252867|NCT02429115|pcori|pcori
5252868|NCT02429115|caregiver burden|caregiver burden
5252869|NCT02429102|Phase 1|phase 1
5252870|NCT02429102|Healthy subjects|healthy subjects
5252871|NCT02429102|Pharmacokinetics of MT-8554|pharmacokinetics of mt-8554
5240685|NCT02499393|therapeutic hypothermia|therapeutic hypothermia
5240686|NCT02499393|magnesium sulphate|magnesium sulphate
5240687|NCT02499380|RePneu|repneu
5240688|NCT02499380|Coil|coil
5252872|NCT02429089|recurrent|recurrent
5252873|NCT02429089|metastatic|metastatic
5252874|NCT02429063|Solid Tumors|solid tumors
5252875|NCT02429050|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5252876|NCT02429050|Dyspnea|dyspnea
5252877|NCT02429050|Breathlessness|breathlessness
5252878|NCT02429050|Morphine|morphine
5252879|NCT02429050|Opioid|opioid
5252880|NCT02429050|Symptom Management|symptom management
5252881|NCT02429037|p53|p53
5252882|NCT02429037|gene therapy|gene therapy
5252883|NCT02429037|head and neck cancer|head and neck cancer
5252884|NCT02429024|Diabetes Mellitus|diabetes mellitus
5252885|NCT02429024|A1c|a1c
5252886|NCT02429011|depression|depression
5252887|NCT02429011|MRI|mri
5252888|NCT02429011|treatment-resistant|treatment-resistant
5252889|NCT02429011|imaging|imaging
5252890|NCT02429011|ketamine|ketamine
5252897|NCT02428972|brain tumor|brain tumor
5252898|NCT02428972|quality of life|quality of life
5252899|NCT02428972|cognition|cognition
5252900|NCT02428972|anesthetic technique|anesthetic technique
5252901|NCT02428959|Amyl Nitrite|amyl nitrite
5252902|NCT02428959|High Resolution Manometry|high resolution manometry
5252907|NCT02428933|Obesity|obesity
5252908|NCT02428933|Insulin Sensitivity|insulin sensitivity
5252909|NCT02428933|Dopamine|dopamine
5252910|NCT02428920|cardiovascular health|cardiovascular health
5252911|NCT02428920|behavior change|behavior change
5252912|NCT02428920|community-based|community-based
5252913|NCT02428920|prevention|prevention
5252914|NCT02428907|simulation training|simulation training
5252915|NCT02428907|minimal sedation|minimal sedation
5252916|NCT02428907|colonoscopy|colonoscopy
5252917|NCT02428907|patient satisfaction|patient satisfaction
5252918|NCT02428907|teamwork|teamwork
5252919|NCT02428907|team training|team training
5252920|NCT02428907|patient safety|patient safety
5252921|NCT02428881|onabotulinumtoxin A|onabotulinumtoxin a
5252922|NCT02428868|hip fracture|hip fracture
5252923|NCT02428868|anemia|anemia
5252924|NCT02428868|blood transfusion|blood transfusion
5252925|NCT02428868|tranexamic acid|tranexamic acid
5252926|NCT02428868|intravenous iron|intravenous iron
5252927|NCT02428855|Cholangiocarcinoma|cholangiocarcinoma
5252928|NCT02428842|Cervical cancer|cervical cancer
5252929|NCT02428842|Tumor biopsies|tumor biopsies
5252930|NCT02428842|Standard treatment|standard treatment
5252931|NCT02428842|Molecular profile|molecular profile
5252932|NCT02428842|Next Generation Sequencing|next generation sequencing
5252933|NCT02428829|hip|hip
5252934|NCT02428829|replacement|replacement
5252940|NCT02428829|therapy|therapy
5252941|NCT02428816|differential diagnosis|differential diagnosis
5252942|NCT02428816|multimodal MRI|multimodal mri
5252943|NCT02428816|Parkinson's Disease|parkinson's disease
5252944|NCT02428816|Multiple System Atrophy|multiple system atrophy
5252945|NCT02428803|Peritoneal Dialysis|peritoneal dialysis
5252946|NCT02428777|Hysteroscopy|hysteroscopy
5252947|NCT02428751|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5252948|NCT02428751|liposomal doxorubicin|liposomal doxorubicin
5252949|NCT02428751|doxorubicin|doxorubicin
5252950|NCT02428751|event-free survival|event-free survival
5252951|NCT02428738|Influenza Vaccine|influenza vaccine
5252952|NCT02428738|Text Message|text message
5252953|NCT02428673|Osteopenia|osteopenia
5252954|NCT02428673|spinal muscular atrophy|spinal muscular atrophy
5252955|NCT02428673|cerebral palsy|cerebral palsy
5252956|NCT02428673|muscular dystrophy|muscular dystrophy
5252957|NCT02428673|spina bifida|spina bifida
5252958|NCT02428673|Rett Syndrome|rett syndrome
5252959|NCT02428660|Polypharmacy|polypharmacy
5252960|NCT02428660|Chronic conditions|chronic conditions
5252961|NCT02428660|Drug Therapy Problems|drug therapy problems
5252962|NCT02428660|Medication Therapy Management|medication therapy management
5252963|NCT02428660|Medication-Related Problems|medication-related problems
5252964|NCT02428660|CYP3A4|cyp3a4
5252965|NCT02428660|CYP3A5|cyp3a5
5252966|NCT02428660|Drug-drug interactions|drug-drug interactions
5252967|NCT02428660|Drug-gene interactions|drug-gene interactions
5252968|NCT02428660|Drug-drug-gene interactions|drug-drug-gene interactions
5252969|NCT02428660|Adverse Drug Reactions|adverse drug reactions
5252970|NCT02428660|Activities of Daily Living|activities of daily living
5252974|NCT02428634|Children|children
5252975|NCT02428634|School intervention|school intervention
5252976|NCT02428621|early orthodontic treatment|early orthodontic treatment
5252977|NCT02428621|activator|activator
5252978|NCT02428621|removable appliance|removable appliance
5252979|NCT02428621|Twicare®|twicare®
5252980|NCT02428621|Herbst appliance|herbst appliance
5252981|NCT02428608|Glabellar Lines|glabellar lines
5252982|NCT02428608|Botulinum toxin, Type A|botulinum toxin, type a
5252983|NCT02428582|endovascular treatment|endovascular treatment
5252984|NCT02428582|arterial occlusive disease|arterial occlusive disease
5252985|NCT02428582|bare metal stent|bare metal stent
5252986|NCT02428582|polytetrafluoroethylene covered stent|polytetrafluoroethylene covered stent
5252987|NCT02428569|shared decision making|shared decision making
5252988|NCT02428569|patient education|patient education
5252989|NCT02428569|decision aids|decision aids
5252990|NCT02428556|Decision making|decision making
5252991|NCT02428543|FLT3-ITD patients in first complete remission|flt3-itd patients in first complete remission
5252992|NCT02428517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5252993|NCT02428517|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5252994|NCT02428517|alternative hematopoietic stem cell donor|alternative hematopoietic stem cell donor
5252995|NCT02428517|busulfan|busulfan
5252996|NCT02428517|antithymocyte globulin|antithymocyte globulin
5252997|NCT02428504|Questionnaire|questionnaire
5252998|NCT02428491|Diphtheria|diphtheria
5253000|NCT02428491|Pertussis|pertussis
5253001|NCT02428491|Poliomyelitis|poliomyelitis
5253002|NCT02428491|Hepatitis B|hepatitis b
5253003|NCT02428491|Haemophilus Influenzae Type b|haemophilus influenzae type b
5253004|NCT02428491|DTaP-IPV-Hep B-PRP-T Combined Vaccine (Hexaxim®)|dtap-ipv-hep b-prp-t combined vaccine (hexaxim®)
5253005|NCT02428465|Purposeful Parenting|purposeful parenting
5253007|NCT02428465|Social-emotional and linguistic (SEL) skills|social-emotional and linguistic (sel) skills
5253008|NCT02428452|autism|autism
5253009|NCT02428452|Autism SPectrum Disorder|autism spectrum disorder
5253010|NCT02428452|early intervention|early intervention
5253011|NCT02428452|infant|infant
5253012|NCT02428452|toddler|toddler
5253013|NCT02428452|early identification|early identification
5253014|NCT02428452|pivotal response training (PRT)|pivotal response training (prt)
5253015|NCT02428452|control group|control group
5253016|NCT02428452|treatment group|treatment group
5253017|NCT02428452|at risk|at risk
5253018|NCT02428452|social communication|social communication
5253019|NCT02428452|positive affect|positive affect
5253020|NCT02428452|smiling|smiling
5253021|NCT02428439|genetic markers|genetic markers
5253022|NCT02428439|predictors|predictors
5253023|NCT02428439|Antidepressive Agents|antidepressive agents
5253024|NCT02428439|Suicidal Ideation|suicidal ideation
5253025|NCT02428439|Adolescent|adolescent
5253026|NCT02428426|Mucosal Microbiome|mucosal microbiome
5253027|NCT02428426|gastric intestinal metaplasia|gastric intestinal metaplasia
5253028|NCT02428426|duodenum|duodenum
5253326|NCT02426645|Sepsis|sepsis
5253029|NCT02428413|Waste Anesthetic Gas (WAG)|waste anesthetic gas (wag)
5253030|NCT02428387|caregivers|caregivers
5253031|NCT02428387|intervention|intervention
5253032|NCT02428387|health related quality of life|health related quality of life
5253033|NCT02428387|dementia|dementia
5253034|NCT02428374|MRI|mri
5253035|NCT02428374|Ventricular function, left|ventricular function, left
5253036|NCT02428309|active cutaneous lupus|active cutaneous lupus
5253037|NCT02428309|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
5253038|NCT02428309|autologous polyclonal regulatory T cell Therapy|autologous polyclonal regulatory t cell therapy
5253039|NCT02428309|polyclonal Tregs for treatment of lupus|polyclonal tregs for treatment of lupus
5253040|NCT02428296|Clinical Trial|clinical trial
5253041|NCT02428296|Congenital Malformations|congenital malformations
5253042|NCT02428296|Overgrowth|overgrowth
5253043|NCT02428296|Pilot Drug Treatment Trial|pilot drug treatment trial
5253044|NCT02428257|hip fracture|hip fracture
5253045|NCT02428257|elderly|elderly
5253046|NCT02428257|continous spinal anesthesia|continous spinal anesthesia
5253047|NCT02428257|hypobaric bupivacaine|hypobaric bupivacaine
5253048|NCT02428257|isobaric bupivacaine|isobaric bupivacaine
5253049|NCT02428257|hypotension|hypotension
5253050|NCT02428244|Smoking|smoking
5253051|NCT02428244|Cessation|cessation
5253052|NCT02428244|Trauma|trauma
5253053|NCT02428244|Fracture|fracture
5253054|NCT02428244|Complications|complications
5253055|NCT02428218|Randomized|randomized
5253056|NCT02428218|Ages 10-17|ages 10-17
5253057|NCT02428218|Pediatrics|pediatrics
5253058|NCT02428218|Placebo controlled|placebo controlled
5253059|NCT02428218|Relapse-Remitting|relapse-remitting
5253060|NCT02428218|Multiple Sclerosis|multiple sclerosis
5253061|NCT02428218|Safety|safety
5253062|NCT02428218|Efficacy|efficacy
5253063|NCT02428218|BG00012|bg00012
5253064|NCT02428179|Surgical site infection|surgical site infection
5253065|NCT02428179|Intraoperative briefings|intraoperative briefings
5253066|NCT02428179|Mortality|mortality
5253067|NCT02428179|Wound closure|wound closure
5253068|NCT02428179|Surgical procedure|surgical procedure
5253069|NCT02428166|crosslinking|crosslinking
5253070|NCT02428166|keratoconus|keratoconus
5253071|NCT02428166|keratometry|keratometry
5253072|NCT02428166|pachymetry|pachymetry
5253073|NCT02428166|pentacam|pentacam
5253074|NCT02428153|static stretching|static stretching
5253075|NCT02428153|dynamic stretching|dynamic stretching
5253076|NCT02428153|muscle-tendon unit|muscle-tendon unit
5253077|NCT02428153|ultrasound|ultrasound
5253078|NCT02428153|Subjects|subjects
5253079|NCT02428140|ischemic stroke|ischemic stroke
5253080|NCT02428140|atrial fibrillation|atrial fibrillation
5253081|NCT02428140|etiologic investigations|etiologic investigations
5253082|NCT02428140|secondary prevention|secondary prevention
5253083|NCT02428140|anticoagulation|anticoagulation
5253084|NCT02428140|arrhythmias|arrhythmias
5253085|NCT02428140|embolic stroke, undetermined etiology|embolic stroke, undetermined etiology
5253086|NCT02428140|implantable loop recorder|implantable loop recorder
5253087|NCT02428140|external loop recorder|external loop recorder
5253088|NCT02428062|Post-operative complications|post-operative complications
5253089|NCT02428062|Mild cognitive impairment|mild cognitive impairment
5253090|NCT02428062|Delirium|delirium
5253091|NCT02428036|TBI-1401(HF10)|tbi-1401(hf10)
5253094|NCT02428036|Oncolytic virus|oncolytic virus
5253095|NCT02428036|Oncolytic virotherapy|oncolytic virotherapy
5253096|NCT02428036|Phase I|phase i
5253097|NCT02428036|Melanoma|melanoma
5253098|NCT02428036|Intratumoral administration|intratumoral administration
5253099|NCT02428023|Thalassemia|thalassemia
5253100|NCT02428023|trait|trait
5253101|NCT02428023|coronary|coronary
5253102|NCT02428023|stroke|stroke
5253103|NCT02427997|Virtual Reality|virtual reality
5253104|NCT02427997|Treadmill|treadmill
5253105|NCT02427997|Multiple Sclerosis|multiple sclerosis
5253106|NCT02427984|Internal Left Hip Prosthesis|internal left hip prosthesis
5253107|NCT02427984|Internal Right Hip Prosthesis|internal right hip prosthesis
5253108|NCT02427958|Drug Therapy|drug therapy
5253109|NCT02427945|Information provision|information provision
5253110|NCT02427932|Pharmacokinetics (PK)|pharmacokinetics (pk)
5253111|NCT02427932|Pharmacodynamics (PD)|pharmacodynamics (pd)
5253112|NCT02427919|G-CSF|g-csf
5253113|NCT02427919|G-CSF receptor|g-csf receptor
5253114|NCT02427919|AML|aml
5253115|NCT02427919|refractory AML|refractory aml
5253116|NCT02427919|Neutropenic fever|neutropenic fever
5253117|NCT02427919|salvage chemotherapy|salvage chemotherapy
5253118|NCT02427906|cirrhosis|cirrhosis
5253119|NCT02427906|gut microbiota|gut microbiota
5253120|NCT02427906|transjugular portosystemic shunt|transjugular portosystemic shunt
5253121|NCT02427906|hepatic encephalopathy|hepatic encephalopathy
5253122|NCT02427893|immunotherapy|immunotherapy
5253123|NCT02427893|Vemurafenib|vemurafenib
5253124|NCT02427893|Cobimetinib|cobimetinib
5253125|NCT02427880|Edema|edema
5253126|NCT02427880|Nephrotic syndrome|nephrotic syndrome
5253127|NCT02427880|Acetazolamide|acetazolamide
5253128|NCT02427880|Furosemide|furosemide
5253129|NCT02427867|remote ischemic preconditioning|remote ischemic preconditioning
5253137|NCT02427789|Neuroprotection|neuroprotection
5253138|NCT02427789|ergospirometry|ergospirometry
5253139|NCT02427789|Major Depressive Disorder|major depressive disorder
5253140|NCT02427763|Removable Orthodontic Appliance;|removable orthodontic appliance;
5253141|NCT02427763|malocclusion|malocclusion
5253142|NCT02427763|Streptococcus mutans|streptococcus mutans
5253143|NCT02427763|Lactobacillus|lactobacillus
5253144|NCT02427763|Epithelium|epithelium
5253145|NCT02427737|Magnetic Resonance Imaging|magnetic resonance imaging
5253146|NCT02427737|Patient satisfaction|patient satisfaction
5253147|NCT02427737|Diagnostic Imaging|diagnostic imaging
5253148|NCT02427711|Reduction of blood loss for revisions of knee arthroplasty|reduction of blood loss for revisions of knee arthroplasty
5253149|NCT02427711|blood transfusions|blood transfusions
5253150|NCT02427711|Readmission|readmission
5253151|NCT02427711|Bipolar sealer|bipolar sealer
5253152|NCT02427672|antisocial behavior|antisocial behavior
5253153|NCT02427672|aggression|aggression
5253154|NCT02427672|transcranial direct current stimulation|transcranial direct current stimulation
5253155|NCT02427672|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5253156|NCT02427672|associated risk factors|associated risk factors
5253158|NCT02427659|Virtual Reality as Distraction during Procedure|virtual reality as distraction during procedure
5253159|NCT02427659|Burn Wound Care|burn wound care
5253160|NCT02427646|Kinematics|kinematics
5253161|NCT02427646|Botulinum toxin type A|botulinum toxin type a
5253162|NCT02427633|recovery position|recovery position
5253163|NCT02427633|comatose|comatose
5253164|NCT02427633|resource limited|resource limited
5253165|NCT02427607|Epilepsy|epilepsy
5253166|NCT02427607|Perampanel|perampanel
5253167|NCT02427594|Kidney Diseases|kidney diseases
5253168|NCT02427594|Renal Insufficiency, Chronic|renal insufficiency, chronic
5253169|NCT02427594|Dietary nonvolatile acid load|dietary nonvolatile acid load
5253170|NCT02427594|Blood pressure|blood pressure
5253171|NCT02427594|Urine net acid excretion|urine net acid excretion
5253172|NCT02427568|Anxiety|anxiety
5253173|NCT02427568|MDMA|mdma
5253174|NCT02427568|Life-threatening illness|life-threatening illness
5253175|NCT02427568|psychotherapy|psychotherapy
5253176|NCT02427542|Randomized Controlled Trial|randomized controlled trial
5253177|NCT02427529|hcg|hcg
5253182|NCT02427490|Palliative Care|palliative care
5253183|NCT02427490|Caregivers|caregivers
5253184|NCT02427490|Medical Oncology|medical oncology
5253185|NCT02427464|diabetic|diabetic
5253186|NCT02427464|neuropathy|neuropathy
5253187|NCT02427464|shooting pain|shooting pain
5253188|NCT02427464|burning pain|burning pain
5253189|NCT02427464|pins and needles pain|pins and needles pain
5253190|NCT02427464|foot pain|foot pain
5253191|NCT02427464|ViroMed|viromed
5253192|NCT02427438|video|video
5253193|NCT02427438|handout|handout
5253194|NCT02427438|home program|home program
5253195|NCT02427438|stabilization|stabilization
5253196|NCT02427438|strengthening|strengthening
5253197|NCT02427438|core|core
5253198|NCT02427425|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5253199|NCT02427425|Pain|pain
5253200|NCT02427412|Tranexamic Acid|tranexamic acid
5253201|NCT02427412|Knee Arthroplasty|knee arthroplasty
5253202|NCT02427412|Blood loss|blood loss
5253203|NCT02427412|Blood transfusion|blood transfusion
5253204|NCT02427412|Thrombolic complication|thrombolic complication
5253205|NCT02427412|Total blood loss 24 h after ended surgery.|total blood loss 24 h after ended surgery.
5253206|NCT02427412|Total blood loss 2 days after ended surgery.|total blood loss 2 days after ended surgery.
5253207|NCT02427386|Endometriosis|endometriosis
5253208|NCT02427386|Pelvic pain|pelvic pain
5253209|NCT02427386|Homeopathy|homeopathy
5253210|NCT02427386|RCT|rct
5253211|NCT02427373|bioavailability|bioavailability
5253212|NCT02427373|fish oil|fish oil
5253213|NCT02427373|krill oil|krill oil
5253214|NCT02427360|Retrospective Studies|retrospective studies
5253215|NCT02427360|Clinical Efficacy|clinical efficacy
5253216|NCT02427321|Cystoscopy|cystoscopy
5253217|NCT02427321|Bladder cancer|bladder cancer
5253218|NCT02427321|Bladder imaging|bladder imaging
5253219|NCT02427308|leishmaniasis|leishmaniasis
5253220|NCT02427308|miltefosine|miltefosine
5253221|NCT02427308|pregnancy|pregnancy
5253222|NCT02427269|Barrett's Esophagus|barrett's esophagus
5253223|NCT02427269|Esophageal Cancer|esophageal cancer
5253224|NCT02427269|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
5253225|NCT02427230|Pelvic Floor Muscle Training|pelvic floor muscle training
5253226|NCT02427230|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5253227|NCT02427230|Urinary Incontinence|urinary incontinence
5253228|NCT02427230|Spinal Cord Injury|spinal cord injury
5253235|NCT02427178|Stem Cell transplant|stem cell transplant
5253236|NCT02427126|ESUS|esus
5253237|NCT02427126|anticoagulation|anticoagulation
5253240|NCT02427113|Vibroacousitc Therapy|vibroacousitc therapy
5253241|NCT02427100|Homeless|homeless
5253242|NCT02427100|Randomized Controlled Trial|randomized controlled trial
5253243|NCT02427100|Diet|diet
5253244|NCT02427100|Physical Activity|physical activity
5253245|NCT02427087|Nonalcoholic fatty liver|nonalcoholic fatty liver
5253246|NCT02427087|Physical activity|physical activity
5253247|NCT02427087|NAFLD|nafld
5253248|NCT02427087|Anthropometry|anthropometry
5253249|NCT02427087|Body Composition|body composition
5253250|NCT02427048|Clinical Practice Guidelines|clinical practice guidelines
5253251|NCT02427022|evidence based practices, critical time intervention|evidence based practices, critical time intervention
5253252|NCT02426944|atrial fibrillation|atrial fibrillation
5253253|NCT02426944|cardioembolic event|cardioembolic event
5253254|NCT02426944|stroke|stroke
5253255|NCT02426944|left atrial appendage closure|left atrial appendage closure
5253256|NCT02426944|novel anticoagulants|novel anticoagulants
5253257|NCT02426931|retrograde intrarenal surgery|retrograde intrarenal surgery
5253258|NCT02426931|flexible ureteroscopy|flexible ureteroscopy
5253259|NCT02426931|renal calculi|renal calculi
5253267|NCT02426879|three-field lymphadenectomy|three-field lymphadenectomy
5253268|NCT02426879|cervical metastases|cervical metastases
5253269|NCT02426879|esophagectomy|esophagectomy
5253270|NCT02426853|Cancer Prevention|cancer prevention
5253271|NCT02426853|Sun protection|sun protection
5253272|NCT02426853|Photograph|photograph
5253273|NCT02426853|UV photograph|uv photograph
5253274|NCT02426853|Ultraviolet|ultraviolet
5253275|NCT02426853|Pamphlets|pamphlets
5253276|NCT02426853|Handouts|handouts
5253277|NCT02426853|Questionnaires|questionnaires
5253278|NCT02426853|Surveys|surveys
5253279|NCT02426853|Skin cancer risk behaviors|skin cancer risk behaviors
5253280|NCT02426840|Adverse bone health|adverse bone health
5253281|NCT02426840|Bone demineralization|bone demineralization
5253282|NCT02426840|HIV-infection|hiv-infection
5253283|NCT02426840|Children|children
5253284|NCT02426840|Adolescents|adolescents
5253285|NCT02426840|Calcium|calcium
5253286|NCT02426840|Vitamin D|vitamin d
5253287|NCT02426840|Supplementation|supplementation
5253288|NCT02426814|Patient Compliance|patient compliance
5253289|NCT02426814|Mobile Applications|mobile applications
5253290|NCT02426801|Patient Compliance|patient compliance
5253291|NCT02426801|Mobile Applications|mobile applications
5253292|NCT02426801|Medication Adherence|medication adherence
5253293|NCT02426788|medically unexplained|medically unexplained
5253294|NCT02426788|fibromyalgia|fibromyalgia
5253295|NCT02426788|postural orthostatic tachycardia syndrome (PoTs)|postural orthostatic tachycardia syndrome (pots)
5253296|NCT02426788|non-cardiac chest pain|non-cardiac chest pain
5253297|NCT02426788|CFS|cfs
5253298|NCT02426788|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5253299|NCT02426788|functional neurological|functional neurological
5253300|NCT02426788|chronic pain|chronic pain
5253301|NCT02426788|hyperventilation|hyperventilation
5253302|NCT02426788|unexplained cough|unexplained cough
5253303|NCT02426762|skin sealant|skin sealant
5253304|NCT02426762|laparoscopic surgery|laparoscopic surgery
5133999|NCT03156283|smartphone|smartphone
5253305|NCT02426762|surgical site infection|surgical site infection
5253306|NCT02426762|wound healing|wound healing
5253307|NCT02426736|Shoulder Joint|shoulder joint
5253308|NCT02426736|Arthroscopy|arthroscopy
5253309|NCT02426736|Ambulatory surgical procedures|ambulatory surgical procedures
5253310|NCT02426736|Pain, Postoperative|pain, postoperative
5253311|NCT02426736|Brachial Plexus Block|brachial plexus block
5253312|NCT02426736|Corticosteroid|corticosteroid
5253313|NCT02426736|Dexamethasone|dexamethasone
5253314|NCT02426736|Bupivacaine|bupivacaine
5253315|NCT02426736|Perineural|perineural
5253316|NCT02426710|ablation, atrial flutter, intracardiac echocardiography|ablation, atrial flutter, intracardiac echocardiography
5253317|NCT02426697|bone metastasis, radiotherapy, pain, prevention|bone metastasis, radiotherapy, pain, prevention
5253318|NCT02426684|End Stage Renal Disease|end stage renal disease
5253319|NCT02426684|Kidney Transplant|kidney transplant
5253320|NCT02426684|Desensitization|desensitization
5253321|NCT02426684|Highly Sensitized|highly sensitized
5253322|NCT02426684|Antibodies|antibodies
5253323|NCT02426671|neuromodulation|neuromodulation
5253324|NCT02426671|Minimum Masking Level|minimum masking level
5253325|NCT02426645|Biomarkers|biomarkers
5253334|NCT02426606|Glycemic response|glycemic response
5253335|NCT02426606|Insulin response|insulin response
5253336|NCT02426606|Diabetes|diabetes
5253337|NCT02426606|Mixed meal|mixed meal
5253338|NCT02426606|Glycemia|glycemia
5253339|NCT02426606|Slowly digestible starch|slowly digestible starch
5253340|NCT02426606|Post-prandial glycemia|post-prandial glycemia
5253342|NCT02426593|Heart Failure|heart failure
5253343|NCT02426567|Crohn's Disease|crohn's disease
5253344|NCT02426567|Exclusive Enteral Nutrition|exclusive enteral nutrition
5253345|NCT02426567|Dietary Treatment|dietary treatment
5253346|NCT02426567|Gut microbiota|gut microbiota
5253347|NCT02426541|Diabetes Mellitus|diabetes mellitus
5253348|NCT02426541|Dapagliflozin|dapagliflozin
5253350|NCT02426541|Insulin resistance|insulin resistance
5253351|NCT02426541|Insulin sensitivity|insulin sensitivity
5253352|NCT02426476|heart rate variability|heart rate variability
5253353|NCT02426476|biofeedback|biofeedback
5253354|NCT02426476|chronic pain|chronic pain
5253355|NCT02426476|Veterans|veterans
5253356|NCT02426463|Neonatal intensive care|neonatal intensive care
5253357|NCT02426463|need for intratracheal intubation|need for intratracheal intubation
5253358|NCT02426437|Acute Exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
5253360|NCT02426437|Emphysema|emphysema
5253361|NCT02426437|Chronic Bronchitis|chronic bronchitis
5253362|NCT02426424|c-PAP|c-pap
5253363|NCT02426398|EEG|eeg
5253364|NCT02426372|Ulcerative Colitis|ulcerative colitis
5253365|NCT02426372|Inflammatory Bowel Disease|inflammatory bowel disease
5253366|NCT02426346|Adolescent; Adolescent obesity; Community-based; Overweight|adolescent; adolescent obesity; community-based; overweight
5253367|NCT02426307|Thrombosis|thrombosis
5253368|NCT02426307|Cardiovascular disease|cardiovascular disease
5253369|NCT02426307|Oral anticoagulation|oral anticoagulation
5253370|NCT02426307|bioprosthesis|bioprosthesis
5253371|NCT02426307|Multidetector Computed Tomography|multidetector computed tomography
5253372|NCT02426268|cardiac surgery|cardiac surgery
5253373|NCT02426268|cerebral oximetry|cerebral oximetry
5253374|NCT02426268|lower extremity oximetry|lower extremity oximetry
5253375|NCT02426255|Severe trauma|severe trauma
5253376|NCT02426255|traumatic Brain injury|traumatic brain injury
5253377|NCT02426255|Hemorrhage|hemorrhage
5253378|NCT02426242|brain-injury|brain-injury
5253379|NCT02426242|extubation|extubation
5253380|NCT02426229|SSc|ssc
5253381|NCT02426229|systemic sclerosis|systemic sclerosis
5253382|NCT02426229|cutaneous systemic sclerosis|cutaneous systemic sclerosis
5253383|NCT02426216|prostate cancer|prostate cancer
5253384|NCT02426216|chemoprevention|chemoprevention
5253385|NCT02426216|biomarker|biomarker
5253386|NCT02426203|Echocardiography|echocardiography
5253387|NCT02426177|postpartum hypertension|postpartum hypertension
5253388|NCT02426177|labetalol in postpartum hypertension|labetalol in postpartum hypertension
5253389|NCT02426177|nifedipine in postpartum hypertension|nifedipine in postpartum hypertension
5253390|NCT02426125|carcinoma of the bladder|carcinoma of the bladder
5253391|NCT02426125|carcinoma of the urethra|carcinoma of the urethra
5253392|NCT02426125|carcinoma the of ureter|carcinoma the of ureter
5253393|NCT02426125|carcinoma of the renal pelvis|carcinoma of the renal pelvis
5253394|NCT02426125|transitional cell carcinoma|transitional cell carcinoma
5241181|NCT02496559|Child Welfare|child welfare
5241182|NCT02496559|After-Hours Care|after-hours care
5241183|NCT02496559|Anti-Bacterial Agents|anti-bacterial agents
5241184|NCT02496559|Drug Prescriptions|drug prescriptions
5241191|NCT02496507|sitting|sitting
5241192|NCT02496507|intervention|intervention
5253395|NCT02426125|transitional cell tumor|transitional cell tumor
5253396|NCT02426125|RANGE|range
5253397|NCT02426125|bladder cancer|bladder cancer
5253398|NCT02426099|Resistant hypertension|resistant hypertension
5253399|NCT02426099|diabetes mellitus|diabetes mellitus
5253400|NCT02426099|Spironolactone|spironolactone
5253401|NCT02426099|African|african
5253407|NCT02426073|Inflammaging|inflammaging
5253408|NCT02426047|seizures|seizures
5253409|NCT02426047|epilepsy|epilepsy
5253410|NCT02426047|catamenial|catamenial
5253411|NCT02426047|ketogenic diet|ketogenic diet
5253412|NCT02426047|modified Atkins diet|modified atkins diet
5253413|NCT02426047|intractable epilepsy|intractable epilepsy
5253414|NCT02426047|medically refractory epilepsy|medically refractory epilepsy
5253415|NCT02426047|adult|adult
5253416|NCT02426047|medium chain triglyceride|medium chain triglyceride
5253417|NCT02426034|Advanced|advanced
5253418|NCT02426034|Metastatic|metastatic
5253420|NCT02425995|Hidden lesions of the medial meniscus|hidden lesions of the medial meniscus
5253421|NCT02425995|Chronic knee instability|chronic knee instability
5253422|NCT02425995|Intercondylar and posteromedial arthroscopy|intercondylar and posteromedial arthroscopy
5253423|NCT02425995|Arthroscopic Posteromedial and Intercondylar portal|arthroscopic posteromedial and intercondylar portal
5253523|NCT02425358|timing|timing
5250925|NCT02440100|Phase 1|phase 1
5253424|NCT02425995|Diagnosis capacity of hidden lesions of the medial meniscus|diagnosis capacity of hidden lesions of the medial meniscus
5253425|NCT02425982|Tennis Elbow|tennis elbow
5253426|NCT02425982|Lateral elbow pain|lateral elbow pain
5253427|NCT02425982|Latera epicondylitis|latera epicondylitis
5253428|NCT02425930|gastric cancer|gastric cancer
5253429|NCT02425930|complement system|complement system
5253430|NCT02425930|overal survival|overal survival
5253431|NCT02425904|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
5253432|NCT02425865|UC, IBD|uc, ibd
5253433|NCT02425839|shear wave elastography|shear wave elastography
5253434|NCT02425839|surface electromyogram|surface electromyogram
5253435|NCT02425839|masseter|masseter
5253436|NCT02425826|Parapsoriasis|parapsoriasis
5253437|NCT02425826|Plaque Psoriasis|plaque psoriasis
5253438|NCT02425826|CC-10004|cc-10004
5253439|NCT02425826|Apremilast|apremilast
5253440|NCT02425826|Moderate Plaque Psoriasis|moderate plaque psoriasis
5253441|NCT02425826|Safety|safety
5253442|NCT02425787|Loss of a child|loss of a child
5253443|NCT02425787|Grief|grief
5253444|NCT02425774|Prucalopride|prucalopride
5253445|NCT02425774|Vagus Nerve Stimulation|vagus nerve stimulation
5253446|NCT02425774|Postoperative Ileus|postoperative ileus
5253447|NCT02425761|Cerebrospinal Fluid Shunts|cerebrospinal fluid shunts
5253448|NCT02425761|Randomized Controlled Trial|randomized controlled trial
5253449|NCT02425748|γδ T Cell, non small lung cancer, Without EGFR Mutation|γδ t cell, non small lung cancer, without egfr mutation
5253450|NCT02425735|Immunotherapy, γδ T Cell, heptocellular liver cancer|immunotherapy, γδ t cell, heptocellular liver cancer
5253452|NCT02425722|ASP0456|asp0456
5253453|NCT02425722|chronic constipation|chronic constipation
5253454|NCT02425696|right-to-left shunt|right-to-left shunt
5253455|NCT02425696|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
5253456|NCT02425696|migraine|migraine
5253457|NCT02425696|silent cerebral infarction|silent cerebral infarction
5253458|NCT02425683|Colon Cancer|colon cancer
5253459|NCT02425683|Rectal Cancer|rectal cancer
5253460|NCT02425683|Colorectal Cancer|colorectal cancer
5253461|NCT02425683|Stage IIIC Colorectal Cancer|stage iiic colorectal cancer
5253462|NCT02425670|Brain attack|brain attack
5253463|NCT02425670|stroke|stroke
5253464|NCT02425670|Ischemic stroke|ischemic stroke
5253465|NCT02425670|stem cell therapy|stem cell therapy
5253466|NCT02425657|Education|education
5253467|NCT02425657|Training|training
5253468|NCT02425657|Fast track|fast track
5253469|NCT02425657|Colonoscopy|colonoscopy
5253470|NCT02425644|relapsing multiple sclerosis|relapsing multiple sclerosis
5253471|NCT02425631|SI joint fusion|si joint fusion
5253472|NCT02425631|SI joint pain|si joint pain
5253473|NCT02425631|SI joint|si joint
5253474|NCT02425631|SI joint treatment|si joint treatment
5253475|NCT02425631|SI joint disease|si joint disease
5253476|NCT02425631|Sacroiliac joint|sacroiliac joint
5253477|NCT02425631|Simmetry|simmetry
5253478|NCT02425566|autonomic nervous system|autonomic nervous system
5253479|NCT02425566|hypertension|hypertension
5253480|NCT02425566|ganglionic blocker|ganglionic blocker
5253481|NCT02425566|trimethaphan|trimethaphan
5253482|NCT02425566|splanchnic circulation|splanchnic circulation
5336342|NCT02011217|Rye|rye
5253483|NCT02425566|capacitance|capacitance
5253484|NCT02425553|Diet|diet
5253485|NCT02425553|Reflux|reflux
5253486|NCT02425553|Dyspepsia|dyspepsia
5253487|NCT02425553|Symptoms|symptoms
5253488|NCT02425553|Alcohol|alcohol
5253489|NCT02425540|Pelvic MRI|pelvic mri
5253490|NCT02425527|Brain Injuries|brain injuries
5253491|NCT02425527|Traumatic Brain Injury|traumatic brain injury
5253492|NCT02425527|Video Games|video games
5253493|NCT02425514|Anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5253494|NCT02425514|NovoMax|novomax
5253495|NCT02425514|Bioactive Glass-ceramic Intervertebral Spacer|bioactive glass-ceramic intervertebral spacer
5253496|NCT02425501|Aflibercept|aflibercept
5253497|NCT02425501|anti-VEGF|anti-vegf
5253498|NCT02425488|Nursing|nursing
5253499|NCT02425488|Outcome and Process Assessment|outcome and process assessment
5253500|NCT02425488|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
5253501|NCT02425488|Heart Failure|heart failure
5253502|NCT02425488|Education|education
5253503|NCT02425475|Dermoscopy|dermoscopy
5253504|NCT02425449|succinylcholine|succinylcholine
5253505|NCT02425449|depolarizing muscle relaxants|depolarizing muscle relaxants
5253506|NCT02425449|pharmacologic effects|pharmacologic effects
5253507|NCT02425410|Diabetes Mellitus|diabetes mellitus
5253508|NCT02425410|Insulin-Dependent|insulin-dependent
5253509|NCT02425410|Virus Diseases|virus diseases
5253510|NCT02425410|Questionnaires|questionnaires
5253511|NCT02425410|Risk assessment|risk assessment
5253512|NCT02425410|Genome-Wide Association Study|genome-wide association study
5253513|NCT02425397|Ototoxicity|ototoxicity
5253514|NCT02425397|platinum derivatives|platinum derivatives
5253515|NCT02425397|paediatrics|paediatrics
5253516|NCT02425397|oncology|oncology
5253517|NCT02425397|clinical research|clinical research
5253518|NCT02425384|adolescent|adolescent
5253519|NCT02425384|physical activity|physical activity
5253520|NCT02425384|accelerometer|accelerometer
5253521|NCT02425358|cell therapy|cell therapy
5253525|NCT02425345|National Institute of Aging Go4Life|national institute of aging go4life
5253526|NCT02425345|Postmenopausal Women|postmenopausal women
5253527|NCT02425345|Balance|balance
5253528|NCT02425345|Strength|strength
5253529|NCT02425345|Exercise|exercise
5253530|NCT02425345|Cardiovascular Disease|cardiovascular disease
5253531|NCT02425345|Stroke|stroke
5253532|NCT02425345|Mortality|mortality
5253533|NCT02425345|Myocardial Infarction|myocardial infarction
5253534|NCT02425345|Falls|falls
5253535|NCT02425345|Venous Thromboembolic Event|venous thromboembolic event
5253536|NCT02425345|Peripheral Artery Disease|peripheral artery disease
5253537|NCT02425345|Physical Function|physical function
5253538|NCT02425345|Mobility and Independence|mobility and independence
5253539|NCT02425345|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
5253540|NCT02425345|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5253541|NCT02425345|Hip Fractures|hip fractures
5253542|NCT02425345|Cardiovascular Mortality|cardiovascular mortality
5253543|NCT02425345|Clinical (non-hip) Fractures|clinical (non-hip) fractures
5253550|NCT02425306|peptide|peptide
5253551|NCT02425306|vaccine|vaccine
5253552|NCT02425306|adjuvant|adjuvant
5253553|NCT02425306|polyICLC|polyiclc
5253554|NCT02425306|cyclophosphamide|cyclophosphamide
5253555|NCT02425306|Montanide ISA-51|montanide isa-51
5253556|NCT02425267|Telerehabilitation|telerehabilitation
5253557|NCT02425241|Vaccine|vaccine
5253558|NCT02425241|DNA|dna
5253559|NCT02425241|HIV-1|hiv-1
5253560|NCT02425241|Serum amyloid P component (SAP)|serum amyloid p component (sap)
5253561|NCT02425241|Clinical trial|clinical trial
5253562|NCT02425241|Vaccination|vaccination
5253563|NCT02425241|Prophylaxis|prophylaxis
5253564|NCT02425241|Adult male|adult male
5253565|NCT02425228|targeted biopsy|targeted biopsy
5253566|NCT02425228|conventional biopsy|conventional biopsy
5253567|NCT02425228|cognitive biopsy|cognitive biopsy
5253568|NCT02425215|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
5253569|NCT02425215|Late radiation injury|late radiation injury
5253570|NCT02425215|Adult|adult
5253571|NCT02425215|Malignancy|malignancy
5253572|NCT02425215|Quality of Life|quality of life
5253573|NCT02425215|Chronic Pain|chronic pain
5253574|NCT02425202|pediatric|pediatric
5253575|NCT02425202|obstructive sleep apnea|obstructive sleep apnea
5253576|NCT02425202|tonsillectomy|tonsillectomy
5253577|NCT02425202|analgesia|analgesia
5253578|NCT02425176|botulinum toxin|botulinum toxin
5253579|NCT02425176|sialorrhoea|sialorrhoea
5253580|NCT02425176|drooling|drooling
5253581|NCT02425163|Prostate Cancer|prostate cancer
5253582|NCT02425163|Shear Wave Elastography|shear wave elastography
5253583|NCT02425163|Prostate|prostate
5253584|NCT02425163|Prostate Biopsy|prostate biopsy
5253585|NCT02425150|Keratoconus|keratoconus
5253586|NCT02425150|Corneal crosslinking|corneal crosslinking
5253587|NCT02425150|Corneal biomechanics|corneal biomechanics
5253588|NCT02425150|Corneal densitometry|corneal densitometry
5253589|NCT02425150|Scheimpflug photography|scheimpflug photography
5336466|NCT02010671|Survey|survey
5253590|NCT02425111|Drug therapy|drug therapy
5253591|NCT02425098|Vaccine|vaccine
5253592|NCT02425085|retinectomy|retinectomy
5253593|NCT02425085|endodiathermy|endodiathermy
5253594|NCT02425085|inferior|inferior
5253595|NCT02425085|retinal redetachment|retinal redetachment
5253596|NCT02425072|Cancer|cancer
5253597|NCT02425072|Brain|brain
5253598|NCT02425072|Lung|lung
5253599|NCT02425072|Small-cell|small-cell
5253600|NCT02425059|irreversible electroporation|irreversible electroporation
5253601|NCT02425059|Unresectable Rectal Neoplasms|unresectable rectal neoplasms
5253602|NCT02425046|family|family
5253603|NCT02425033|POEM|poem
5253604|NCT02425033|Minimally invasive surgery|minimally invasive surgery
5253605|NCT02425033|Achalasia|achalasia
5253606|NCT02425033|Spastic esophageal disorders|spastic esophageal disorders
5253607|NCT02425020|Supplement|supplement
5253608|NCT02425020|performance|performance
5253609|NCT02425020|whey|whey
5253610|NCT02425020|meat|meat
5253611|NCT02425020|protein|protein
5253612|NCT02424994|Morbidity|morbidity
5253613|NCT02424994|Mortality|mortality
5253614|NCT02424994|Health care utilization|health care utilization
5253615|NCT02424994|Cohort|cohort
5253616|NCT02424994|Epidemiology|epidemiology
5253617|NCT02424994|Cardiovascular diseases|cardiovascular diseases
5253618|NCT02424968|Healthy Stem Cell Donor|healthy stem cell donor
5253619|NCT02424955|Liver cancer|liver cancer
5253620|NCT02424955|Hepatocellular Carcinoma|hepatocellular carcinoma
5253621|NCT02424955|Liver imaging|liver imaging
5253622|NCT02424955|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
5253623|NCT02424955|SABR|sabr
5253624|NCT02424929|Deep Brain Stimulation|deep brain stimulation
5253625|NCT02424916|Onco-dermatology|onco-dermatology
5253626|NCT02424916|Adoptive transfer|adoptive transfer
5253627|NCT02424916|Immunotherapy|immunotherapy
5253628|NCT02424903|infection|infection
5253629|NCT02424903|prosthesis|prosthesis
5253631|NCT02424903|knee|knee
5253632|NCT02424903|shoulder|shoulder
5253633|NCT02424877|rheumatoid arthritis|rheumatoid arthritis
5253634|NCT02424877|drug treatment|drug treatment
5253635|NCT02424877|compliance|compliance
5253636|NCT02424877|outcome|outcome
5253637|NCT02424864|4D PET-CT|4d pet-ct
5253638|NCT02424851|myeloma|myeloma
5253639|NCT02424851|multiple myeloma|multiple myeloma
5253640|NCT02424851|chronic kidney disease|chronic kidney disease
5253641|NCT02424851|renal failure|renal failure
5253642|NCT02424851|bortezomib|bortezomib
5253643|NCT02424851|Velcade|velcade
5253644|NCT02424851|thalidomide|thalidomide
5253645|NCT02424851|bendamustine|bendamustine
5253646|NCT02424851|dexamethasone|dexamethasone
5253647|NCT02424851|serum free light chains|serum free light chains
5253648|NCT02424851|proteosomal inhibition|proteosomal inhibition
5253649|NCT02424851|immunomodulatory|immunomodulatory
5253651|NCT02424825|cooking|cooking
5253652|NCT02424825|multiple sclerosis|multiple sclerosis
5253653|NCT02424825|fatigue|fatigue
5253654|NCT02424812|handwashing|handwashing
5253655|NCT02424812|behavior|behavior
5253656|NCT02424799|Urticaria|urticaria
5253657|NCT02424799|SYK Inhibitor|syk inhibitor
5253658|NCT02424786|Adherence|adherence
5253659|NCT02424786|Polypharmacy|polypharmacy
5253660|NCT02424786|Elderly|elderly
5253661|NCT02424786|Chronic kidney disease|chronic kidney disease
5253662|NCT02424734|Late-onset Sepsis|late-onset sepsis
5253663|NCT02424708|Reduced Glutathione|reduced glutathione
5253664|NCT02424708|Intranasal|intranasal
5253665|NCT02424708|(in)GSH|(in)gsh
5253666|NCT02424708|Parkinson's Disease|parkinson's disease
5253667|NCT02424708|Glutathione|glutathione
5253668|NCT02424708|Uptake|uptake
5253669|NCT02424708|central nervous system|central nervous system
5253670|NCT02424695|Cortical arousal intensity|cortical arousal intensity
5253672|NCT02424695|Heart rate|heart rate
5253673|NCT02424695|Blood pressure|blood pressure
5253674|NCT02424695|PLMs|plms
5253675|NCT02424630|sono-guided interscalene brachial plexus block|sono-guided interscalene brachial plexus block
5253676|NCT02424630|arthroscopy-guided suprascapular nerve block|arthroscopy-guided suprascapular nerve block
5253677|NCT02424630|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5253678|NCT02424630|postoperative pain|postoperative pain
5253679|NCT02424591|Anesthesia Recovery Period|anesthesia recovery period
5253680|NCT02424591|Spinal Fusion|spinal fusion
5253681|NCT02424552|severe asthma|severe asthma
5253682|NCT02424552|vitamin D|vitamin d
5253683|NCT02424552|treatment|treatment
5253684|NCT02424539|Seasonal|seasonal
5253685|NCT02424539|Fluticasone Furoate|fluticasone furoate
5253686|NCT02424539|Perennial|perennial
5253687|NCT02424539|Allergic Rhinitis|allergic rhinitis
5253688|NCT02424539|Nasal Spray|nasal spray
5253689|NCT02424526|cerebral palsy|cerebral palsy
5253690|NCT02424526|treadmill training|treadmill training
5253691|NCT02424526|walking|walking
5253692|NCT02424487|Initial pressure|initial pressure
5253693|NCT02424487|changes of intracuff pressure|changes of intracuff pressure
5253694|NCT02424487|infants and children|infants and children
5253696|NCT02424474|general population|general population
5253697|NCT02424474|screening|screening
5253698|NCT02424474|trisomy 21|trisomy 21
5253699|NCT02424474|IVF|ivf
5253700|NCT02424435|Friedreich Ataxia|friedreich ataxia
5253701|NCT02424435|FRDA|frda
5253702|NCT02424422|Corrective Orthodontics|corrective orthodontics
5253703|NCT02424422|CBCT|cbct
5253704|NCT02424422|Rapid Maxillary Expansion|rapid maxillary expansion
5253705|NCT02424422|Cone Beam Computed Tomography|cone beam computed tomography
5253706|NCT02424422|Hyrax Expansion|hyrax expansion
5253707|NCT02424422|Craniofacial Sutures|craniofacial sutures
5253708|NCT02424409|Asthma|asthma
5253709|NCT02424409|Relapse|relapse
5253710|NCT02424409|Therapeutic counselling|therapeutic counselling
5253711|NCT02424409|Protocol of care|protocol of care
5253712|NCT02424396|Interleukin 2, IL2|interleukin 2, il2
5253713|NCT02424396|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5253714|NCT02424396|Autoimmune diseases|autoimmune diseases
5253715|NCT02424396|Regulatory T cells, Tregs|regulatory t cells, tregs
5253716|NCT02424370|Aortic stenosis|aortic stenosis
5253717|NCT02424370|TAVR|tavr
5253718|NCT02424370|Frailty|frailty
5253719|NCT02424370|Elderly|elderly
5253720|NCT02424357|Adjustable strabismus surgery|adjustable strabismus surgery
5253721|NCT02424357|suture contamination|suture contamination
5253722|NCT02424357|5%povidone iodine|5%povidone iodine
5253723|NCT02424344|COPD|copd
5253724|NCT02424331|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5253725|NCT02424331|Respiratory mechanics|respiratory mechanics
5253726|NCT02424331|Plethysmography|plethysmography
5253727|NCT02424331|Diaphragm|diaphragm
5253728|NCT02424331|Respiratory muscles|respiratory muscles
5253729|NCT02424331|Breathing exercises|breathing exercises
5253730|NCT02424292|Breast cancer|breast cancer
5253735|NCT02424279|splanchnicectomy|splanchnicectomy
5253736|NCT02424266|Tear film|tear film
5253737|NCT02424266|Imaging|imaging
5253738|NCT02424266|Tomogrophy|tomogrophy
5253739|NCT02424266|dry eye|dry eye
5253740|NCT02424201|uterine atony|uterine atony
5253745|NCT02424175|Fecal Transplant|fecal transplant
5253747|NCT02424175|Fecal Microbiota Transplantation|fecal microbiota transplantation
5253748|NCT02424110|bipolar radiofrequency ablation|bipolar radiofrequency ablation
5253749|NCT02424110|argon beam coagulator|argon beam coagulator
5253751|NCT02424071|melatonin's|melatonin's
5253752|NCT02424071|quality of recovery|quality of recovery
5253753|NCT02424032|Neck pain|neck pain
5253754|NCT02424032|stabilization exercise|stabilization exercise
5253755|NCT02424032|connective tissue massage|connective tissue massage
5253756|NCT02424006|keratoplasty|keratoplasty
5253757|NCT02424006|bioengineered cornea|bioengineered cornea
5253758|NCT02424006|donor cornea|donor cornea
5253759|NCT02423993|Type 1 diabetes mellitus|type 1 diabetes mellitus
5253760|NCT02423993|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5253761|NCT02423993|Quality of life|quality of life
5253762|NCT02423993|Therapeutic education|therapeutic education
5253763|NCT02423993|Insulin pump|insulin pump
5253764|NCT02423941|Liver Transplantation|liver transplantation
5253765|NCT02423941|Retrograde Reperfusion|retrograde reperfusion
5253766|NCT02423941|Graft dysfunction|graft dysfunction
5253767|NCT02423941|Randomized study|randomized study
5253768|NCT02423928|immunotherapy|immunotherapy
5253769|NCT02423928|cryoablation|cryoablation
5253770|NCT02423928|prostate cancer|prostate cancer
5253771|NCT02423928|dendritic cell|dendritic cell
5253772|NCT02423915|Leukemia|leukemia
5253773|NCT02423915|Lymphoma|lymphoma
5253774|NCT02423915|Advanced hematologic malignancies|advanced hematologic malignancies
5253775|NCT02423915|Graft versus host disease|graft versus host disease
5253776|NCT02423915|GVHD|gvhd
5253777|NCT02423915|Fucosylated umbilical cord blood Regulatory T cells|fucosylated umbilical cord blood regulatory t cells
5253778|NCT02423915|CB|cb
5253779|NCT02423915|Tregs|tregs
5253780|NCT02423915|T cells|t cells
5253781|NCT02423915|Cord blood transplant|cord blood transplant
5253782|NCT02423915|Total body radiation|total body radiation
5253783|NCT02423915|TBI|tbi
5253784|NCT02423915|Radiation therapy|radiation therapy
5253785|NCT02423915|XRT|xrt
5253786|NCT02423915|Rituximab|rituximab
5253787|NCT02423915|Rituxan|rituxan
5253788|NCT02423915|Fludarabine|fludarabine
5253789|NCT02423915|Fludarabine phosphate|fludarabine phosphate
5253790|NCT02423915|Fludara|fludara
5253791|NCT02423915|Cyclophosphamide|cyclophosphamide
5253792|NCT02423915|Cytoxan|cytoxan
5253793|NCT02423915|Neosar|neosar
5253794|NCT02423915|Mycophenolate|mycophenolate
5253795|NCT02423915|Mycophenolate mofetil|mycophenolate mofetil
5253796|NCT02423915|MMF|mmf
5253797|NCT02423915|CellCept|cellcept
5253798|NCT02423915|Sirolimus|sirolimus
5253799|NCT02423915|Rapamune|rapamune
5253800|NCT02423915|G-CSF|g-csf
5253801|NCT02423915|Filgrastim|filgrastim
5253802|NCT02423915|Neupogen|neupogen
5241576|NCT02494505|intravenous immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
5241577|NCT02494505|withdrawal|withdrawal
5241578|NCT02494505|quality of life|quality of life
5241580|NCT02494505|cost|cost
5253803|NCT02423889|Hypofractionated radiotherapy|hypofractionated radiotherapy
5253804|NCT02423889|SBRT|sbrt
5253805|NCT02423863|Cancer|cancer
5253806|NCT02423863|Immunotherapy|immunotherapy
5253807|NCT02423863|Intratumoral Injection|intratumoral injection
5253808|NCT02423863|Multicenter Study|multicenter study
5253809|NCT02423863|Autovaccination|autovaccination
5253810|NCT02423863|Solid Tumors|solid tumors
5253811|NCT02423863|anti-PD1|anti-pd1
5253812|NCT02423863|anti-PDL1|anti-pdl1
5253813|NCT02423850|Diabetic foot ulcers|diabetic foot ulcers
5253814|NCT02423850|Ulcer healing|ulcer healing
5253815|NCT02423850|Ulcer measurement|ulcer measurement
5253816|NCT02423850|Ulcer area|ulcer area
5253817|NCT02423850|Ulcer volume|ulcer volume
5253818|NCT02423850|3D measurement|3d measurement
5253819|NCT02423837|follicular lymphoma|follicular lymphoma
5253820|NCT02423837|bendamustine|bendamustine
5253821|NCT02423837|rituximab|rituximab
5253822|NCT02423798|Diabetes|diabetes
5253823|NCT02423798|Glucose sensor|glucose sensor
5253824|NCT02423798|Sensor accuracy and performance|sensor accuracy and performance
5253826|NCT02423759|Chemoprevention|chemoprevention
5253827|NCT02423733|depression|depression
5253828|NCT02423733|dysthymia|dysthymia
5253829|NCT02423733|cognitive behavioural therapy|cognitive behavioural therapy
5253830|NCT02423733|CBT|cbt
5253831|NCT02423733|problem-solving therapy|problem-solving therapy
5253832|NCT02423733|PST|pst
5253833|NCT02423733|waitlist|waitlist
5254133|NCT02422433|OFDI|ofdi
5253840|NCT02423668|second eye refinement|second eye refinement
5253841|NCT02423668|effective lens position|effective lens position
5253842|NCT02423642|Acute Kidney Injury Requiring Continuous Renal Replacement Therapy|acute kidney injury requiring continuous renal replacement therapy
5253844|NCT02423616|Hand Grip|hand grip
5253845|NCT02423616|Correlation|correlation
5253846|NCT02423616|Inspiratory Pressure|inspiratory pressure
5253847|NCT02423616|Hand Grip Force|hand grip force
5253859|NCT02423577|antiviral|antiviral
5253860|NCT02423577|influenza|influenza
5253861|NCT02423577|challenge|challenge
5253862|NCT02423564|Probiotic|probiotic
5253863|NCT02423564|Digesta-Lac|digesta-lac
5253864|NCT02423564|Occasional Constipation|occasional constipation
5253865|NCT02423564|Constipation|constipation
5253866|NCT02423551|Gut microbiota|gut microbiota
5253867|NCT02423551|Intestinal permeability|intestinal permeability
5253868|NCT02423551|Gut barrier integrity|gut barrier integrity
5253869|NCT02423525|glioblastoma|glioblastoma
5253870|NCT02423525|astrocytoma|astrocytoma
5253871|NCT02423525|oligodendroglioma|oligodendroglioma
5253872|NCT02423525|mixed oligoastrocytoma|mixed oligoastrocytoma
5253874|NCT02423525|brain metastases|brain metastases
5253875|NCT02423525|meningiomas|meningiomas
5253876|NCT02423525|leptomeningeal metastases|leptomeningeal metastases
5253877|NCT02423512|Inflammatory Bowel Diseases|inflammatory bowel diseases
5253878|NCT02423512|Vedolizumab|vedolizumab
5253879|NCT02423512|Ulcerative Colitis|ulcerative colitis
5253880|NCT02423512|Crohn's Disease|crohn's disease
5253882|NCT02423512|integrin alpha4beta7|integrin alpha4beta7
5253883|NCT02423499|Autism Spectrum Disorder|autism spectrum disorder
5253884|NCT02423499|Bipolar Disorder|bipolar disorder
5253885|NCT02423499|Emotions|emotions
5253886|NCT02423460|Ulcerative Colitis|ulcerative colitis
5253887|NCT02423460|Healthy Controls|healthy controls
5253888|NCT02423460|Crohn's Disease|crohn's disease
5253889|NCT02423434|Corneal Confocal Microscopy|corneal confocal microscopy
5253890|NCT02423434|Diabetes Mellitus|diabetes mellitus
5253891|NCT02423434|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5253892|NCT02423434|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5253893|NCT02423434|Diabetic Neuropathy|diabetic neuropathy
5253894|NCT02423434|Diabetes Complications|diabetes complications
5253895|NCT02423382|silicone oil|silicone oil
5253896|NCT02423382|retinal saturation|retinal saturation
5253897|NCT02423382|retinal blood flow|retinal blood flow
5253898|NCT02423382|retinal detachment|retinal detachment
5253899|NCT02423369|S-100B protein|s-100b protein
5253900|NCT02423369|Neuron-specific Enolase|neuron-specific enolase
5253901|NCT02423356|breast cancer|breast cancer
5253902|NCT02423356|sarcoma|sarcoma
5253903|NCT02423356|lymphoma|lymphoma
5253904|NCT02423356|echocardiography|echocardiography
5253905|NCT02423356|cardiotoxicity|cardiotoxicity
5253906|NCT02423356|pharmacogenetics|pharmacogenetics
5253907|NCT02423356|doxorubicin|doxorubicin
5253908|NCT02423356|chemotherapy|chemotherapy
5253909|NCT02423291|PMLBCL|pmlbcl
5253910|NCT02423291|Brentuximab Vedotin|brentuximab vedotin
5253911|NCT02423291|CD30-positive|cd30-positive
5253912|NCT02423291|Mediastinal Lymphoma|mediastinal lymphoma
5253913|NCT02423278|gastrectomy|gastrectomy
5253914|NCT02423278|lymphadenectomy|lymphadenectomy
5253915|NCT02423278|gastric cancer|gastric cancer
5253916|NCT02423278|adjuvant chemotherapy|adjuvant chemotherapy
5253917|NCT02423278|overall survival|overall survival
5253918|NCT02423265|Chronic total coronary occlusions|chronic total coronary occlusions
5253919|NCT02423265|Ranolazine|ranolazine
5253920|NCT02423252|Critical illness|critical illness
5253921|NCT02423252|Intervention|intervention
5253923|NCT02423252|Relaxation|relaxation
5253924|NCT02423252|Guided imagery|guided imagery
5253925|NCT02423252|Touch/Massage|touch/massage
5253926|NCT02423252|Music listening|music listening
5253927|NCT02423252|Neuropeptides|neuropeptides
5253928|NCT02423252|Inflammatory molecules|inflammatory molecules
5253929|NCT02423252|Post-traumatic stress|post-traumatic stress
5253930|NCT02423252|Critical care nurse|critical care nurse
5253931|NCT02423252|Psychocognitive nursing intervention|psychocognitive nursing intervention
5253932|NCT02423252|Interpersonal support|interpersonal support
5253933|NCT02423213|OCT|oct
5253934|NCT02423213|image-guided surgery|image-guided surgery
5253950|NCT02423096|schizophrenia|schizophrenia
5253951|NCT02423083|Neuroprotection|neuroprotection
5253952|NCT02423083|Multiple Sclerosis|multiple sclerosis
5253953|NCT02423083|Clinical Trial|clinical trial
5253954|NCT02423083|Safety and Tolerability|safety and tolerability
5253960|NCT02423057|Pharmacodynamics|pharmacodynamics
5253961|NCT02423057|DNA Methylation|dna methylation
5253962|NCT02423057|Pharmacokinetics|pharmacokinetics
5253963|NCT02423057|Nucleoside Analogue|nucleoside analogue
5253964|NCT02423057|Epigenetics|epigenetics
5253965|NCT02423044|Anxiety|anxiety
5253966|NCT02423044|fMRI|fmri
5253967|NCT02423044|Virtual Reality|virtual reality
5253968|NCT02423044|Shock Threat|shock threat
5253969|NCT02423044|Healthy Volunteer|healthy volunteer
5253970|NCT02423031|Physiological Measures|physiological measures
5253971|NCT02423031|Emotional Context|emotional context
5253972|NCT02423031|Pediatric|pediatric
5253973|NCT02423031|Distresss Screening|distresss screening
5253974|NCT02423005|Stress urinary incontinence|stress urinary incontinence
5253975|NCT02423005|Neurotech Vital Compact|neurotech vital compact
5253976|NCT02423005|1h Provacative Pad Test|1h provacative pad test
5253977|NCT02423005|Neuroelectrical Muscle Stimulation (NEMS)|neuroelectrical muscle stimulation (nems)
5253978|NCT02422992|Iron metabolism|iron metabolism
5253979|NCT02422992|MRI|mri
5253980|NCT02422992|risk factors|risk factors
5253981|NCT02422992|haptoglobin phenotype|haptoglobin phenotype
5253982|NCT02422953|Stunting|stunting
5253983|NCT02422953|Wasting|wasting
5253984|NCT02422953|Underweight|underweight
5253985|NCT02422927|C-Reactive Protein|c-reactive protein
5253986|NCT02422927|Endothelial Microparticles|endothelial microparticles
5253987|NCT02422927|Endothelium|endothelium
5253988|NCT02422927|Nutraceutical|nutraceutical
5253989|NCT02422927|Cholesterol|cholesterol
5253990|NCT02422888|ST elevation myocardial infarction|st elevation myocardial infarction
5253991|NCT02422888|Percutaneous coronary intervention|percutaneous coronary intervention
5253993|NCT02422888|Ticagrelor|ticagrelor
5253994|NCT02422888|Prasugrel|prasugrel
5253995|NCT02422875|Sjögren's Syndrome|sjögren's syndrome
5253996|NCT02422875|Scleroderma|scleroderma
5253997|NCT02422875|Myositis|myositis
5253998|NCT02422875|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5253999|NCT02422875|Rheumatoid Arthritis|rheumatoid arthritis
5254000|NCT02422875|Inflammatory Arthritis|inflammatory arthritis
5254001|NCT02422875|Undifferentiated Connective Tissue Disease|undifferentiated connective tissue disease
5254002|NCT02422875|Idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5254003|NCT02422875|Graft vs Host Disease|graft vs host disease
5254004|NCT02422875|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5254005|NCT02422875|Immunoglobulin G4 (IgG4)-related disease|immunoglobulin g4 (igg4)-related disease
5254006|NCT02422875|Hepatitis C|hepatitis c
5254007|NCT02422875|Epstein Barr Virus (infectious mononucleosis - EBV)|epstein barr virus (infectious mononucleosis - ebv)
5254008|NCT02422875|Sepsis|sepsis
5254009|NCT02422875|Guillain-Barre syndrome|guillain-barre syndrome
5254010|NCT02422875|Mycoplasma pneumoniae|mycoplasma pneumoniae
5254011|NCT02422875|Human Immunodeficiency Virus|human immunodeficiency virus
5254012|NCT02422862|Physiotherapy|physiotherapy
5254013|NCT02422862|Manual Therapy|manual therapy
5254014|NCT02422849|Patient admission|patient admission
5254015|NCT02422836|photodamage|photodamage
5254016|NCT02422836|fine lines|fine lines
5254017|NCT02422836|wrinkles|wrinkles
5254018|NCT02422836|dyschromia|dyschromia
5254019|NCT02422823|anesthesia|anesthesia
5254020|NCT02422823|volumes|volumes
5254021|NCT02422823|articaine|articaine
5254022|NCT02422823|Inferior alveolar nerve block|inferior alveolar nerve block
5254238|NCT02421861|anxiety|anxiety
5254038|NCT02422758|prevention and control|prevention and control
5674378|NCT00603798|Dermatologic disease|dermatologic disease
5254039|NCT02422745|Cocoa extract multivitamins cardiovascular disease cancer|cocoa extract multivitamins cardiovascular disease cancer
5254044|NCT02422732|Genetic analysis|genetic analysis
5254045|NCT02422719|Chronic myeloid leukemia|chronic myeloid leukemia
5254046|NCT02422719|Intolerance|intolerance
5254047|NCT02422719|Resitance|resitance
5254048|NCT02422719|Radotinib|radotinib
5254049|NCT02422693|hydrotherapy|hydrotherapy
5254050|NCT02422693|aquatic|aquatic
5254051|NCT02422680|Quality assurance|quality assurance
5254052|NCT02422680|Caecum intubation rate|caecum intubation rate
5254053|NCT02422680|Patient satisfaction|patient satisfaction
5254054|NCT02422667|Orthopedics|orthopedics
5254055|NCT02422667|Outcome Assessment|outcome assessment
5254056|NCT02422628|EGFR inhibitor|egfr inhibitor
5254057|NCT02422628|EGFR mutation|egfr mutation
5254058|NCT02422628|EGFR|egfr
5254059|NCT02422628|adenocarcinoma|adenocarcinoma
5254060|NCT02422628|EGFR TKI|egfr tki
5254061|NCT02422628|treatment|treatment
5254062|NCT02422628|Non small cell|non small cell
5254063|NCT02422615|HR-positive|hr-positive
5254064|NCT02422615|HER2-negative|her2-negative
5254065|NCT02422615|Advanced breast cancer|advanced breast cancer
5254066|NCT02422615|LEE011|lee011
5254067|NCT02422615|ribociclib|ribociclib
5254068|NCT02422615|fulvestrant|fulvestrant
5254069|NCT02422615|faslodex|faslodex
5254070|NCT02422615|CDK|cdk
5254071|NCT02422615|CDK4|cdk4
5254072|NCT02422615|CDK6|cdk6
5254073|NCT02422615|CDK4/6|cdk4/6
5254074|NCT02422615|CDK4/6 inhibitor|cdk4/6 inhibitor
5254075|NCT02422615|Phase III|phase iii
5254076|NCT02422615|ER-positive|er-positive
5254077|NCT02422615|PR-positive|pr-positive
5254078|NCT02422615|Postmenopausal|postmenopausal
5254079|NCT02422615|Men|men
5254080|NCT02422615|Breast Neoplasms|breast neoplasms
5254081|NCT02422615|Breast Diseases|breast diseases
5254082|NCT02422615|Neoplasms|neoplasms
5254083|NCT02422615|Neoplasms by Site|neoplasms by site
5254084|NCT02422615|Antineoplastic Agents|antineoplastic agents
5254085|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5254086|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists
5254087|NCT02422615|Hormone Antagonists|hormone antagonists
5254088|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5254089|NCT02422615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5254090|NCT02422615|Pharmacologic Actions|pharmacologic actions
5254091|NCT02422615|Therapeutic Use|therapeutic use
5254092|NCT02422602|Patients|patients
5254093|NCT02422602|treated by Rivaroxaban|treated by rivaroxaban
5254094|NCT02422589|ALK-positive advanced tumors|alk-positive advanced tumors
5254095|NCT02422589|midazolam|midazolam
5254096|NCT02422589|warfarin|warfarin
5254097|NCT02422589|ceritinib|ceritinib
5254098|NCT02422589|ALK|alk
5254099|NCT02422589|CYP3A-4|cyp3a-4
5254100|NCT02422589|Drug drug intereaction|drug drug intereaction
5254101|NCT02422563|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5254102|NCT02422563|FIGO IB2, FIGO IIB|figo ib2, figo iib
5254103|NCT02422563|chemo-radiation|chemo-radiation
5254104|NCT02422563|dose dense chemotherapy|dose dense chemotherapy
5254105|NCT02422563|cisplatin|cisplatin
5254106|NCT02422563|paclitaxel|paclitaxel
5254107|NCT02422563|carboplatin|carboplatin
5254108|NCT02422563|ifosfamide|ifosfamide
5254118|NCT02422511|Genome Sequencing|genome sequencing
5254119|NCT02422511|Exome Sequencing|exome sequencing
5254120|NCT02422511|Newborn Screening|newborn screening
5254121|NCT02422511|Childhood Onset Genetic Conditions|childhood onset genetic conditions
5254122|NCT02422498|Treated with Concurrent Cisplatin|treated with concurrent cisplatin
5254123|NCT02422498|Treated with Radiation Therapy|treated with radiation therapy
5254124|NCT02422498|Homologous Recombination Repair Status|homologous recombination repair status
5254125|NCT02422498|Biomarker of Response|biomarker of response
5254126|NCT02422498|15-032|15-032
5254127|NCT02422498|Patients|patients
5254128|NCT02422485|Salsalate|salsalate
5254129|NCT02422446|Endothelial function|endothelial function
5254130|NCT02422446|Eicosapentaenoic acid|eicosapentaenoic acid
5254131|NCT02422446|Triglycerides|triglycerides
5254132|NCT02422433|EGD|egd
5254134|NCT02422433|Barrett's Esophagus|barrett's esophagus
5254135|NCT02422433|Imaging|imaging
5254136|NCT02422433|Biopsy|biopsy
5254137|NCT02422433|OCT|oct
5254138|NCT02422420|Diabetes Prevention|diabetes prevention
5254139|NCT02422420|Financial Incentives|financial incentives
5254140|NCT02422420|Medicaid|medicaid
5254141|NCT02422420|Motivation|motivation
5254142|NCT02422381|NSCLC|nsclc
5254143|NCT02422381|lung cancer|lung cancer
5254144|NCT02422381|Gemzar|gemzar
5254145|NCT02422381|Pembrolizumab|pembrolizumab
5254146|NCT02422381|Anti-PD-1|anti-pd-1
5254147|NCT02422381|Immunotherapy|immunotherapy
5254148|NCT02422368|Graves' ophthalmopathy|graves' ophthalmopathy
5254149|NCT02422368|Antioxidant|antioxidant
5254150|NCT02422368|Activity|activity
5254151|NCT02422368|Severity|severity
5254153|NCT02422355|femoral neck|femoral neck
5254154|NCT02422355|Garden classification|garden classification
5254155|NCT02422355|healing|healing
5254156|NCT02422355|cut-out|cut-out
5254157|NCT02422355|iatrogenic fracture|iatrogenic fracture
5254158|NCT02422355|implant|implant
5254159|NCT02422355|rotational stability|rotational stability
5254160|NCT02422355|minimal invasive|minimal invasive
5254161|NCT02422329|Advanced Cancers|advanced cancers
5254162|NCT02422329|Constipation|constipation
5254163|NCT02422329|Recurrent cancer|recurrent cancer
5254164|NCT02422329|Locally advanced cancer|locally advanced cancer
5149354|NCT03059121|HIV|hiv
5254165|NCT02422329|Metastatic cancer|metastatic cancer
5254166|NCT02422329|Video|video
5254167|NCT02422329|Fact sheet|fact sheet
5254168|NCT02422329|Questionnaires|questionnaires
5254169|NCT02422329|Surveys|surveys
5254170|NCT02422303|Depression|depression
5254171|NCT02422303|Gynecoligical surgery|gynecoligical surgery
5254172|NCT02422303|Ketamine|ketamine
5254173|NCT02422290|Obsessive Compulsive Disorder|obsessive compulsive disorder
5254174|NCT02422290|Ketamine|ketamine
5254175|NCT02422290|Glutamate|glutamate
5254176|NCT02422290|OCD treatment|ocd treatment
5254177|NCT02422290|OCD medication|ocd medication
5254178|NCT02422277|Cystoprostatectomy|cystoprostatectomy
5254179|NCT02422277|Sexual function|sexual function
5254180|NCT02422277|Phosphodiestrase 5 inhibitors|phosphodiestrase 5 inhibitors
5254181|NCT02422277|Low intensity extracorporeal shock wave therapy|low intensity extracorporeal shock wave therapy
5254182|NCT02422277|Erectile dysfunction|erectile dysfunction
5254183|NCT02422277|Penile rehabilitation|penile rehabilitation
5254184|NCT02422212|metabolism|metabolism
5254185|NCT02422212|Diet Induced Thermogenesis|diet induced thermogenesis
5254186|NCT02422212|weight regain|weight regain
5254187|NCT02422212|energy expenditure|energy expenditure
5254188|NCT02422212|bariatric|bariatric
5254189|NCT02422186|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
5254190|NCT02422186|Esketamine|esketamine
5254191|NCT02422186|Oral Antidepressant|oral antidepressant
5254192|NCT02422186|Elderly Participants|elderly participants
5254193|NCT02422134|Pregnancy|pregnancy
5254194|NCT02422134|implantation|implantation
5254195|NCT02422134|Cytokine|cytokine
5254197|NCT02422082|Osteopenia|osteopenia
5254198|NCT02422082|Lactobacillus reuteri|lactobacillus reuteri
5254199|NCT02422082|Volumetric bone mineral density|volumetric bone mineral density
5254200|NCT02422056|Cleft Palate|cleft palate
5254201|NCT02422056|Hemorrhage|hemorrhage
5254202|NCT02422056|Palatoplasty|palatoplasty
5254203|NCT02422043|adolescence|adolescence
5254204|NCT02422030|Male Volunteers|male volunteers
5254205|NCT02422017|Leg ulcer|leg ulcer
5254207|NCT02422017|topical timolol|topical timolol
5254208|NCT02422004|Rehabilitation|rehabilitation
5254209|NCT02422004|Weight-bearing|weight-bearing
5254210|NCT02422004|Range of motion|range of motion
5254211|NCT02421978|Cognitive dysfunction|cognitive dysfunction
5254212|NCT02421978|Inflammation|inflammation
5254213|NCT02421978|Fatigue|fatigue
5254218|NCT02421965|Major Depressive Disorder|major depressive disorder
5254219|NCT02421965|Mobile Application|mobile application
5254221|NCT02421965|SMI|smi
5254222|NCT02421965|Illness Self-Management|illness self-management
5254223|NCT02421965|EHealth|ehealth
5254224|NCT02421965|E-Health|e-health
5254225|NCT02421965|Health Technology|health technology
5254226|NCT02421965|mHealth|mhealth
5254227|NCT02421965|m-Health|m-health
5254228|NCT02421939|ASP2215|asp2215
5254229|NCT02421939|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5254230|NCT02421939|FLT3 Mutation|flt3 mutation
5254231|NCT02421939|gilteritinib|gilteritinib
5254232|NCT02421939|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5254233|NCT02421939|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5254234|NCT02421939|XOSPATA®|xospata®
5254235|NCT02421874|Patient care team|patient care team
5254236|NCT02421874|Care management|care management
5254237|NCT02421874|Electronic health records|electronic health records
5254239|NCT02421861|intensive care unit|intensive care unit
5254240|NCT02421861|critical care|critical care
5254241|NCT02421848|Body composition|body composition
5254242|NCT02421848|Sarcopenia|sarcopenia
5254243|NCT02421848|Cirrhotic with Ascites|cirrhotic with ascites
5254244|NCT02421796|n Non-Celiac Wheat Sensitivity|n non-celiac wheat sensitivity
5254245|NCT02421796|Malnutrition|malnutrition
5254246|NCT02421796|Celiac disease|celiac disease
5254247|NCT02421796|Irritable Bowel Syndrome|irritable bowel syndrome
5352358|NCT01938274|Hip|hip
5254248|NCT02421783|Non-celiac wheat sensitivity|non-celiac wheat sensitivity
5254249|NCT02421783|Multiple food allergy|multiple food allergy
5254250|NCT02421783|Body mass index|body mass index
5254251|NCT02421783|Osteoporosis|osteoporosis
5254252|NCT02421757|Transcutaneous Magnetic Stimulation|transcutaneous magnetic stimulation
5254253|NCT02421757|placebo|placebo
5254254|NCT02421744|rehabilitation|rehabilitation
5254255|NCT02421744|Multiple Sclerosis|multiple sclerosis
5254256|NCT02421744|mobility|mobility
5254257|NCT02421744|gait|gait
5254258|NCT02421744|task-oriented training|task-oriented training
5254259|NCT02421731|Rehabilitation|rehabilitation
5254260|NCT02421731|Gait|gait
5254261|NCT02421718|Acute toxicity|acute toxicity
5254262|NCT02421718|Late toxicity|late toxicity
5254263|NCT02421718|Prediction models|prediction models
5254264|NCT02421679|PTSD|ptsd
5254265|NCT02421679|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
5149390|NCT03058887|Exercise|exercise
5254266|NCT02421679|open-label extension|open-label extension
5254267|NCT02421653|Micronutrient powders|micronutrient powders
5254268|NCT02421653|MNP|mnp
5254269|NCT02421653|Weaning|weaning
5254270|NCT02421653|Home fortification|home fortification
5254271|NCT02421653|Iodine|iodine
5254272|NCT02421653|Iodine deficiency|iodine deficiency
5254273|NCT02421653|Iodine Deficiency Disorder|iodine deficiency disorder
5254274|NCT02421653|IDD|idd
5254275|NCT02421653|Infant|infant
5254276|NCT02421653|Growth|growth
5254277|NCT02421653|Iodised oil|iodised oil
5254278|NCT02421627|moxibustion|moxibustion
5254279|NCT02421627|irritable bowel syndrome|irritable bowel syndrome
5254280|NCT02421627|Magnetic Resonance Imaging|magnetic resonance imaging
5254281|NCT02421614|acute respiratory failure|acute respiratory failure
5254282|NCT02421614|lung|lung
5254283|NCT02421614|enteral feeding|enteral feeding
5254284|NCT02421614|feeding composition|feeding composition
5254285|NCT02421614|olive|olive
5254286|NCT02421614|high fat|high fat
5254287|NCT02421549|Remote Monitoring|remote monitoring
5254288|NCT02421549|Remote Care|remote care
5254289|NCT02421549|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5254290|NCT02421549|Pacemaker|pacemaker
5254291|NCT02421549|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5254292|NCT02421523|Exercise|exercise
5254293|NCT02421523|Strength training|strength training
5254294|NCT02421510|High level of sugar (glucose) in the blood|high level of sugar (glucose) in the blood
5254295|NCT02421484|Phase I clinical trial|phase i clinical trial
5254296|NCT02421484|stem cell|stem cell
5254297|NCT02421484|mesenchymal stromal cell|mesenchymal stromal cell
5254298|NCT02421484|mesenchymal stem cell|mesenchymal stem cell
5254299|NCT02421471|Actinic Keratosis|actinic keratosis
5254300|NCT02421471|topical treatment|topical treatment
5254301|NCT02421471|ingenol mebutate|ingenol mebutate
5254302|NCT02421432|trananal TME|trananal tme
5254303|NCT02421432|safety|safety
5254304|NCT02421432|efficacy|efficacy
5254305|NCT02421432|difficult cases|difficult cases
5254306|NCT02421419|flexor tendon entrapment|flexor tendon entrapment
5254307|NCT02421419|snapping finger|snapping finger
5254308|NCT02421419|trigger digits|trigger digits
5254310|NCT02421393|Bone quality|bone quality
5254311|NCT02421393|Bone strength|bone strength
5251756|NCT02435030|LSD|lsd
5254312|NCT02421393|Fractures|fractures
5254313|NCT02421393|Muscle strength|muscle strength
5254314|NCT02421393|Gait and balance|gait and balance
5254315|NCT02421393|Musculo-skeletal symptoms|musculo-skeletal symptoms
5254317|NCT02421380|Hyperpolarized Pyruvate|hyperpolarized pyruvate
5254318|NCT02421380|MRI|mri
5254319|NCT02421380|14-205|14-205
5254320|NCT02421341|Heart, Cardiovascular|heart, cardiovascular
5254321|NCT02421341|Pulmonary|pulmonary
5254322|NCT02421341|Skeletal Muscle|skeletal muscle
5254323|NCT02421341|Exercise|exercise
5254324|NCT02421315|OCD|ocd
5254325|NCT02421315|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5254326|NCT02421315|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5254327|NCT02421289|CYP2B6 polymorphism|cyp2b6 polymorphism
5254328|NCT02421289|efavirenz|efavirenz
5254329|NCT02421289|Thai|thai
5254330|NCT02421289|HIV-infected patient|hiv-infected patient
5254331|NCT02421289|pharmacogenomic|pharmacogenomic
5254332|NCT02421263|Psilocybin|psilocybin
5254333|NCT02421263|Pharmacologic Actions|pharmacologic actions
5254334|NCT02421263|Psychotropic Drugs|psychotropic drugs
5254335|NCT02421224|Smoking Cessation|smoking cessation
5254336|NCT02421224|Incentives|incentives
5254337|NCT02421224|Health Behavior|health behavior
5254338|NCT02421224|Smoking|smoking
5254339|NCT02421224|Work-site|work-site
5254348|NCT02421172|Hidradenitis Suppurativa|hidradenitis suppurativa
5254349|NCT02421159|HIV/AIDS|hiv/aids
5254350|NCT02421159|vulnerable populations|vulnerable populations
5254351|NCT02421159|heterosexuals at high risk|heterosexuals at high risk
5254352|NCT02421159|peer-driven intervention|peer-driven intervention
5254353|NCT02421159|tailored intervention|tailored intervention
5903725|NCT00339924|Clinical Decision-Making|clinical decision-making
5254354|NCT02421159|African-American|african-american
5254355|NCT02421159|Latino/Hispanic|latino/hispanic
5254356|NCT02421159|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
5254357|NCT02421159|Brooklyn|brooklyn
5254358|NCT02421133|Care transition program|care transition program
5254359|NCT02421133|Patient readmission|patient readmission
5254360|NCT02421133|Transition Nurse|transition nurse
5254361|NCT02421133|Stepped wedge|stepped wedge
5254362|NCT02421133|elderly|elderly
5254363|NCT02421081|CD34|cd34
5254365|NCT02421081|CD309|cd309
5254366|NCT02421081|Radial Artery|radial artery
5254367|NCT02421081|Ulnar Artery|ulnar artery
5254368|NCT02421081|Lymphoid Cell|lymphoid cell
5254369|NCT02421081|blood levels|blood levels
5254370|NCT02421081|endothelial progenitor cells|endothelial progenitor cells
5254371|NCT02421081|stem cells|stem cells
5254372|NCT02421068|Paracetamol|paracetamol
5254373|NCT02421068|Fentanyl|fentanyl
5254374|NCT02421068|Phenobarbital|phenobarbital
5254375|NCT02421068|Doxapram|doxapram
5254376|NCT02421068|Midazolam|midazolam
5254377|NCT02421068|Sildenafil|sildenafil
5254378|NCT02421068|Levetiracetam|levetiracetam
5254379|NCT02421068|Pharmacokinetics|pharmacokinetics
5254380|NCT02421068|Pharmacology|pharmacology
5254381|NCT02421068|Fluconazole|fluconazole
5254382|NCT02421068|Ibuprofen|ibuprofen
5254383|NCT02421055|Bariatric Surgery|bariatric surgery
5254384|NCT02421055|Gastric Bypass|gastric bypass
5254385|NCT02421055|Sleeve Gastrectomy|sleeve gastrectomy
5254386|NCT02421055|Gastroplasty|gastroplasty
5254387|NCT02421042|Hepatic Impairment|hepatic impairment
5254388|NCT02421042|Hepatic Function|hepatic function
5254389|NCT02421029|gadolinium|gadolinium
5254390|NCT02421029|calcium disodium ethylenediaminetetraacetic acid (EDTA)|calcium disodium ethylenediaminetetraacetic acid (edta)
5254391|NCT02421029|heavy metal toxicity|heavy metal toxicity
5254392|NCT02421016|De novo stenosis|de novo stenosis
5254393|NCT02421016|bioresorbable polymer coating|bioresorbable polymer coating
5254394|NCT02421016|bioresorbable polymer backbone|bioresorbable polymer backbone
5254395|NCT02421003|heart surgery blood|heart surgery blood
5254396|NCT02420990|ADHD|adhd
5254397|NCT02420990|Adolescents|adolescents
5254398|NCT02420990|Substance Use Disorders|substance use disorders
5254399|NCT02420977|radiotracer|radiotracer
5254400|NCT02420964|injectable|injectable
5254401|NCT02420964|teaching methods|teaching methods
5254402|NCT02420951|Knee|knee
5254403|NCT02420951|Arthroplasty|arthroplasty
5254404|NCT02420951|Bupivacaine|bupivacaine
5254405|NCT02420951|Anesthetics, Local|anesthetics, local
5254406|NCT02420938|Leukemia|leukemia
5254407|NCT02420938|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5254408|NCT02420938|CLL|cll
5254409|NCT02420938|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5254410|NCT02420938|SLL|sll
5254411|NCT02420938|Refractory/relapsed|refractory/relapsed
5254412|NCT02420938|High-risk molecular features|high-risk molecular features
5254413|NCT02420938|Rituximab|rituximab
5254414|NCT02420938|Rituxan|rituxan
5254415|NCT02420938|Urelumab|urelumab
5254416|NCT02420925|Gastroparesis|gastroparesis
5259634|NCT02390700|SIMPONI|simponi
5254417|NCT02420925|Celiac Plexus Block|celiac plexus block
5254418|NCT02420899|IVUS|ivus
5254419|NCT02420899|ACS|acs
5254420|NCT02420886|In Vitro culture of human embryos|in vitro culture of human embryos
5254422|NCT02420873|Hematological malignancy|hematological malignancy
5254423|NCT02420873|Myelofibrosis|myelofibrosis
5254424|NCT02420873|MF|mf
5254425|NCT02420873|Blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
5254426|NCT02420873|BPDCN|bpdcn
5254427|NCT02420873|CD56 tumor marker|cd56 tumor marker
5254428|NCT02420873|Acute myeloid leukemia|acute myeloid leukemia
5254429|NCT02420873|AML|aml
5254430|NCT02420873|Natural-killer leukemia|natural-killer leukemia
5254431|NCT02420873|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5254432|NCT02420873|ALL|all
5254433|NCT02420873|CD56 expressing hematological malignancy|cd56 expressing hematological malignancy
5254434|NCT02420873|IMGN901|imgn901
5254435|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine
5254436|NCT02420847|Bladder cancer|bladder cancer
5254437|NCT02420847|Urothelial cancer|urothelial cancer
5254438|NCT02420847|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5254439|NCT02420847|Metastatic|metastatic
5254440|NCT02420847|Locally unresectable|locally unresectable
5254441|NCT02420847|Ixazomib|ixazomib
5254442|NCT02420847|Gemcitabine|gemcitabine
5254443|NCT02420847|Gemcitabine hydrochloride|gemcitabine hydrochloride
5254444|NCT02420847|Gemzar|gemzar
5254445|NCT02420847|Doxorubicin|doxorubicin
5254446|NCT02420847|Doxorubicin hydrochloride|doxorubicin hydrochloride
5254447|NCT02420847|Adriamycin PFS|adriamycin pfs
5254448|NCT02420847|Adriamycin RDF|adriamycin rdf
5254449|NCT02420847|Adriamycin|adriamycin
5254450|NCT02420847|Rubex|rubex
5254451|NCT02420808|CAD|cad
5254452|NCT02420808|STEMI|stemi
5254453|NCT02420808|non STEMI|non stemi
5254454|NCT02420808|Unstable angina|unstable angina
5254455|NCT02420808|Greece|greece
5254456|NCT02420782|Pharmacokinetics|pharmacokinetics
5254457|NCT02420782|ASP6282|asp6282
5254458|NCT02420782|Pharmacodynamics|pharmacodynamics
5254459|NCT02420782|Drug-drug interaction|drug-drug interaction
5254460|NCT02420782|Midazolam|midazolam
5254461|NCT02420782|Safety and tolerability|safety and tolerability
5254462|NCT02420782|Healthy volunteers|healthy volunteers
5254463|NCT02420782|Itraconazole|itraconazole
5254464|NCT02420769|CA 125|ca 125
5242165|NCT02490969|emergency department|emergency department
5254465|NCT02420769|Progesterone|progesterone
5254466|NCT02420769|Doppler|doppler
5254467|NCT02420769|Corpus Luteum|corpus luteum
5254469|NCT02420704|IVF|ivf
5254470|NCT02420704|endometrial thickness|endometrial thickness
5254471|NCT02420704|cleavage stage embryo|cleavage stage embryo
5254472|NCT02420704|blastocyst stage embryo|blastocyst stage embryo
5254473|NCT02420704|Ongoing pregnancy rate|ongoing pregnancy rate
5254474|NCT02420665|Cervical Cancer|cervical cancer
5254475|NCT02420665|Cervical Dysplasia|cervical dysplasia
5254476|NCT02420665|Abnormal Pap test|abnormal pap test
5254477|NCT02420665|Positive human papillomavirus test|positive human papillomavirus test
5254478|NCT02420665|HPV|hpv
5254479|NCT02420665|Visual inspection with acetic acid|visual inspection with acetic acid
5254480|NCT02420665|VIA|via
5254481|NCT02420665|Colposcopy|colposcopy
5254482|NCT02420665|Proflavine|proflavine
5254483|NCT02420665|Acetic acid|acetic acid
5254484|NCT02420665|High-Resolution Microendoscopy|high-resolution microendoscopy
5254485|NCT02420665|HRME|hrme
5254486|NCT02420665|Phone call|phone call
5254487|NCT02420600|Circulating tumor cells|circulating tumor cells
5254488|NCT02420600|Head and neck cancer|head and neck cancer
5254489|NCT02420600|PD-1|pd-1
5254490|NCT02420600|natural killer cells|natural killer cells
5254491|NCT02420600|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5254492|NCT02420587|Prostate Cancer|prostate cancer
5254493|NCT02420587|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5254494|NCT02420587|Castration resistant prostate cancer metastatic to bone|castration resistant prostate cancer metastatic to bone
5254495|NCT02420587|mCRPC|mcrpc
5254496|NCT02420587|AMG 208|amg 208
5254497|NCT02420587|Questionnaire|questionnaire
5254498|NCT02420587|Survey|survey
5254499|NCT02420561|Depression|depression
5254500|NCT02420561|Substance-Related Disorders|substance-related disorders
5254501|NCT02420561|Mental Health|mental health
5254502|NCT02420535|Dementia|dementia
5254503|NCT02420535|Alzheimer's Disease|alzheimer's disease
5254504|NCT02420535|Caregivers|caregivers
5254505|NCT02420535|Behavioral|behavioral
5254506|NCT02420535|Caregiver burden|caregiver burden
5254507|NCT02420496|Parental nutrition|parental nutrition
5254508|NCT02420496|associated|associated
5254509|NCT02420470|diabetes|diabetes
5254510|NCT02420470|neural and vessel alteration|neural and vessel alteration
5254511|NCT02420470|prodromal stage|prodromal stage
5254512|NCT02420457|Fitness devices|fitness devices
5254513|NCT02420418|Tobacco use disorder and bipolar disorders|tobacco use disorder and bipolar disorders
5254514|NCT02420418|N-acetylcysteine|n-acetylcysteine
5254515|NCT02420418|Oxidative stress|oxidative stress
5254516|NCT02420418|inflammation|inflammation
5254517|NCT02420405|Gene testing|gene testing
5254518|NCT02420405|Endobronchial ultrasound (EBUS)|endobronchial ultrasound (ebus)
5254519|NCT02420405|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
5254522|NCT02420379|Duchenne muscular dystrophy|duchenne muscular dystrophy
5254524|NCT02420379|Dystrophin|dystrophin
5254525|NCT02420379|exon 51|exon 51
5254526|NCT02420353|muscle atrophy|muscle atrophy
5254527|NCT02420353|growth hormone|growth hormone
5254528|NCT02420353|ACL tear|acl tear
5254529|NCT02420340|Serious Mental Illness|serious mental illness
5254530|NCT02420340|Psychosocial Rehabilitation|psychosocial rehabilitation
5254531|NCT02420327|nicotine|nicotine
5254532|NCT02420327|galantamine|galantamine
5254533|NCT02420327|attention|attention
5254534|NCT02420327|cognition|cognition
5254535|NCT02420327|non-smoker|non-smoker
5254536|NCT02420314|Ascorbate|ascorbate
5254537|NCT02420314|Ascorbic acid|ascorbic acid
5254538|NCT02420314|Vitamin C|vitamin c
5254539|NCT02420314|NSCLC|nsclc
5254540|NCT02420314|Non Small Cell Lung Cancer|non small cell lung cancer
5254541|NCT02420314|carboplatin|carboplatin
5254542|NCT02420314|paclitaxel|paclitaxel
5254543|NCT02420288|Pregnancy|pregnancy
5254544|NCT02420288|Fetoplacental growth|fetoplacental growth
5254545|NCT02420288|Physical exercise|physical exercise
5254546|NCT02420288|Pregnant|pregnant
5254547|NCT02420288|Placental development|placental development
5254548|NCT02420288|Active pregnancy|active pregnancy
5254549|NCT02420275|brain injury|brain injury
5254550|NCT02420275|blue enriched withe bright light therapy|blue enriched withe bright light therapy
5254551|NCT02420275|sequel fatigue|sequel fatigue
5254552|NCT02420236|Exercise therapy|exercise therapy
5254553|NCT02420236|Resistance training|resistance training
5254554|NCT02420236|Multidisciplinary treatment|multidisciplinary treatment
5254555|NCT02420223|Recipients|recipients
5254556|NCT02420197|Exercise therapy|exercise therapy
5254557|NCT02420197|Resistance training|resistance training
5254558|NCT02420197|Multidisciplinary treatment|multidisciplinary treatment
5254559|NCT02420171|In Vitro|in vitro
5254560|NCT02420171|embryo quality|embryo quality
5254561|NCT02420171|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5254562|NCT02420158|Irritable Bowel Syndrome|irritable bowel syndrome
5242265|NCT02490020|Renal transplantation|renal transplantation
5254563|NCT02420158|Vagal nerve stimulation|vagal nerve stimulation
5254564|NCT02420158|Quality of life|quality of life
5254565|NCT02420119|Iron Therapy|iron therapy
5254566|NCT02420119|serum phosphates|serum phosphates
5254567|NCT02420119|vitamin D|vitamin d
5254568|NCT02420106|cervical dystonia|cervical dystonia
5254569|NCT02420106|neck pain|neck pain
5254571|NCT02420106|spasmodic torticollis|spasmodic torticollis
5254572|NCT02420067|von Hippel-Lindau disease|von hippel-lindau disease
5254573|NCT02420067|Endolymphatic sac tumors|endolymphatic sac tumors
5254574|NCT02420067|Audiological examination|audiological examination
5254575|NCT02420067|MRI|mri
5254576|NCT02420067|Surveillance|surveillance
5254577|NCT02420054|intermittent fasting|intermittent fasting
5254578|NCT02420054|alternate day fasting|alternate day fasting
5254579|NCT02420054|diabetes mellitus|diabetes mellitus
5254580|NCT02420054|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5254581|NCT02420054|insulin sensitivity|insulin sensitivity
5254582|NCT02420041|Sacroiliac Joint Injection|sacroiliac joint injection
5254583|NCT02420041|Fluoroscopy|fluoroscopy
5254584|NCT02420041|Ultrasound|ultrasound
5254585|NCT02419989|Nontuberculous Mycobacteria|nontuberculous mycobacteria
5254586|NCT02419963|microbiome|microbiome
5254587|NCT02419963|biomarkers|biomarkers
5254588|NCT02419963|Vitamin D|vitamin d
5254589|NCT02419963|Serotonin|serotonin
5254590|NCT02419950|inguinal hernia|inguinal hernia
5254591|NCT02419950|TEP|tep
5254592|NCT02419950|chronic pain|chronic pain
5254593|NCT02419950|male sex|male sex
5254594|NCT02419950|mesh fixation|mesh fixation
5254595|NCT02419950|quality of life|quality of life
5254596|NCT02419950|national register|national register
5254597|NCT02419911|gastrointestinal|gastrointestinal
5254598|NCT02419911|gynecologic|gynecologic
5254599|NCT02419911|urologic|urologic
5254600|NCT02419911|bariatric|bariatric
5254601|NCT02419911|laparoscopic surgery|laparoscopic surgery
5254602|NCT02419898|Feasibility|feasibility
5254603|NCT02419885|finger amputation|finger amputation
5254604|NCT02419885|composite graft|composite graft
5254605|NCT02419885|adipo-fascia flap|adipo-fascia flap
5254606|NCT02419859|Diabetes Mellitus|diabetes mellitus
5254607|NCT02419859|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5254608|NCT02419859|Glucose Metabolism Disorders|glucose metabolism disorders
5254609|NCT02419859|Metabolic Diseases|metabolic diseases
5254610|NCT02419859|Endocrine System Diseases|endocrine system diseases
5254612|NCT02419859|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5254613|NCT02419859|Insulin pumps|insulin pumps
5254614|NCT02419846|Informed Decision Making|informed decision making
5254615|NCT02419846|Prostate|prostate
5254616|NCT02419846|Cancer|cancer
5254617|NCT02419833|non-STEMI|non-stemi
5254618|NCT02419833|immediate|immediate
5254619|NCT02419833|delayed|delayed
5254626|NCT02419807|Lumpectomy|lumpectomy
5254627|NCT02419768|Long-range autocorrelations|long-range autocorrelations
5254629|NCT02419768|Physical Exercise|physical exercise
5254630|NCT02419768|Parkinson's Disease|parkinson's disease
5254632|NCT02419755|Infant leukemia|infant leukemia
5254633|NCT02419755|ALL|all
5254634|NCT02419755|AML|aml
5254635|NCT02419755|Biphenotypic leukemia|biphenotypic leukemia
5254636|NCT02419755|Pediatric|pediatric
5254637|NCT02419729|Vulvovaginal atrophy|vulvovaginal atrophy
5254638|NCT02419729|Menopause|menopause
5254639|NCT02419729|Fractional CO2 laser|fractional co2 laser
5254640|NCT02419729|Estrogen cream|estrogen cream
5254641|NCT02419716|colorectal cancer|colorectal cancer
5254642|NCT02419716|Colorectal cancer screening|colorectal cancer screening
5254845|NCT02418637|diabetes|diabetes
5254643|NCT02419677|radiofrequency ablation|radiofrequency ablation
5254644|NCT02419677|cytokine-induced killer cells|cytokine-induced killer cells
5254645|NCT02419677|colorectal cancer iver metastases|colorectal cancer iver metastases
5254646|NCT02419664|pituitary|pituitary
5254647|NCT02419664|pituitary adenomas|pituitary adenomas
5254648|NCT02419664|Ga-PET|ga-pet
5254649|NCT02419664|Acromegaly|acromegaly
5254650|NCT02419664|TSHomas|tshomas
5254651|NCT02419664|Cushing|cushing
5254652|NCT02419651|out patient hysteroscopy|out patient hysteroscopy
5254653|NCT02419638|relapsing-remitting MS|relapsing-remitting ms
5254654|NCT02419638|lesions|lesions
5254655|NCT02419638|treatment|treatment
5254656|NCT02419573|cardiac arrest|cardiac arrest
5254657|NCT02419573|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5254658|NCT02419573|laryngeal tube|laryngeal tube
5254659|NCT02419573|endotracheal intubation|endotracheal intubation
5254660|NCT02419573|non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
5254661|NCT02419560|Relapsed|relapsed
5254662|NCT02419560|Laboratory biomarker research|laboratory biomarker research
5254663|NCT02419560|Pharmacologic study|pharmacologic study
5254664|NCT02419560|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5254665|NCT02419560|BCL-2 inhibitor|bcl-2 inhibitor
5254666|NCT02419547|Ventricular tachycardia|ventricular tachycardia
5254667|NCT02419547|ventricular tachycardia ablation|ventricular tachycardia ablation
5254668|NCT02419547|effects of anesthesia on VT induction|effects of anesthesia on vt induction
5254669|NCT02419547|programed stimulation|programed stimulation
5254670|NCT02419534|Pediatric, fissure in ano|pediatric, fissure in ano
5254671|NCT02419482|Exercise therapy|exercise therapy
5254672|NCT02419482|Reproductive Physiological Processes|reproductive physiological processes
5254673|NCT02419482|Fertility|fertility
5254674|NCT02419469|Leukemia|leukemia
5254675|NCT02419469|Precursor-B acute lymphoblastic leukemia|precursor-b acute lymphoblastic leukemia
5254677|NCT02419469|Lymphoblastic lymphoma|lymphoblastic lymphoma
5254678|NCT02419469|LL|ll
5254679|NCT02419469|Lymphoma|lymphoma
5254680|NCT02419469|Cytarabine|cytarabine
5254681|NCT02419469|Ara-C|ara-c
5254682|NCT02419469|Cytosar|cytosar
5254683|NCT02419469|DepoCyt|depocyt
5254684|NCT02419469|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5254685|NCT02419469|Daunorubicin|daunorubicin
5254686|NCT02419469|Daunorubicin Hydrochloride|daunorubicin hydrochloride
5254687|NCT02419469|Cerubidine|cerubidine
5254688|NCT02419469|Daunomycin|daunomycin
5254689|NCT02419469|DNR|dnr
5254690|NCT02419469|Vincristine|vincristine
5254691|NCT02419469|Prednisone|prednisone
5254692|NCT02419469|PEG asparaginase|peg asparaginase
5254693|NCT02419469|Pegaspargase|pegaspargase
5254694|NCT02419469|Oncaspar|oncaspar
5254695|NCT02419469|Polyethylene glycol conjugated lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
5254696|NCT02419469|Ofatumumab|ofatumumab
5254697|NCT02419469|Arzerra|arzerra
5254698|NCT02419469|Rituximab|rituximab
5254699|NCT02419469|Rituxan|rituxan
5254700|NCT02419469|Methotrexate|methotrexate
5254701|NCT02419469|Cyclophosphamide|cyclophosphamide
5254702|NCT02419469|Cytoxan|cytoxan
5254703|NCT02419469|Neosar|neosar
5254704|NCT02419469|Mercaptopurine|mercaptopurine
5254705|NCT02419469|6-mercaptopurine|6-mercaptopurine
5254706|NCT02419469|Purinethol|purinethol
5254707|NCT02419469|6-MP|6-mp
5254708|NCT02419469|Doxorubicin|doxorubicin
5254709|NCT02419469|Doxorubicin hydrochloride|doxorubicin hydrochloride
5254710|NCT02419469|Adriamycin PFS|adriamycin pfs
5254711|NCT02419469|Adriamycin RDF|adriamycin rdf
5254712|NCT02419469|Adriamycin|adriamycin
5254720|NCT02419430|stress|stress
5254721|NCT02419430|resilience|resilience
5254722|NCT02419430|self-compassion|self-compassion
5254723|NCT02419391|RSV Vaccines|rsv vaccines
5254724|NCT02419391|Respiratory Syncytial Virus Vaccines|respiratory syncytial virus vaccines
5254725|NCT02419365|Primary Ciliary Dyskinesia (PCD)|primary ciliary dyskinesia (pcd)
5254726|NCT02419352|Cognitive function|cognitive function
5254727|NCT02419326|couples|couples
5254728|NCT02419326|relationships|relationships
5254729|NCT02419326|binge eating|binge eating
5254730|NCT02419326|eating disorder|eating disorder
5254731|NCT02419326|couple therapy|couple therapy
5254732|NCT02419313|Tremor|tremor
5254733|NCT02419313|Parkinson|parkinson
5254734|NCT02419313|botulinum|botulinum
5254737|NCT02419287|crizotinib|crizotinib
5254738|NCT02419274|asthma|asthma
5254739|NCT02419274|phenotype|phenotype
5254740|NCT02419274|childhood|childhood
5254741|NCT02419274|adulthood|adulthood
5254742|NCT02419261|knee surgery|knee surgery
5254743|NCT02419261|anterior cruciate ligament surgery|anterior cruciate ligament surgery
5254744|NCT02419261|nerve block|nerve block
5254745|NCT02419235|Refractory hypertension|refractory hypertension
5254746|NCT02419235|Homoeopathy|homoeopathy
5254747|NCT02419235|Homoeopathic complex|homoeopathic complex
5254748|NCT02419235|Amylenum nitrosum 6cH|amylenum nitrosum 6ch
5254749|NCT02419235|Crataegus oxyacantha 6cH|crataegus oxyacantha 6ch
5254750|NCT02419235|Natrum muriaticum 6cH|natrum muriaticum 6ch
5254751|NCT02419235|Scutellaria lateriflora 6cH|scutellaria lateriflora 6ch
5254752|NCT02419209|Low sexual desire|low sexual desire
5254753|NCT02419209|Perimenopause|perimenopause
5254754|NCT02419209|Homeopathy|homeopathy
5674379|NCT00603785|Chronic sinusitis|chronic sinusitis
5254755|NCT02419209|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5254756|NCT02419183|Mild Cognitive Impairment|mild cognitive impairment
5254757|NCT02419183|Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR)|self-administered memory screening test with automated reporting (samstar)
5254758|NCT02419183|Rey Auditory Verbal Learning Test (RAVLT)|rey auditory verbal learning test (ravlt)
5254759|NCT02419183|Word List Recall (WLR)|word list recall (wlr)
5254760|NCT02419157|Cervical lesions|cervical lesions
5254761|NCT02419157|Clinical trial|clinical trial
5254762|NCT02419157|Self-etch adhesive|self-etch adhesive
5254763|NCT02419144|older adults;|older adults;
5254764|NCT02419144|oral hygiene;|oral hygiene;
5254765|NCT02419144|adapted motivational interviewing|adapted motivational interviewing
5254766|NCT02419118|Myeloma|myeloma
5254767|NCT02419118|monoclonal antibody|monoclonal antibody
5254768|NCT02419118|Daratumumab|daratumumab
5254769|NCT02419105|Falls|falls
5254770|NCT02419105|hypogonadal men|hypogonadal men
5254771|NCT02419105|Seniors|seniors
5254772|NCT02419105|Testosterone|testosterone
5254773|NCT02419105|Colecalciferol|colecalciferol
5254774|NCT02419092|Inflammation|inflammation
5254775|NCT02419092|Insulin resistance|insulin resistance
5254776|NCT02419092|Bariatric surgery|bariatric surgery
5254777|NCT02419053|Surgical safety checklist|surgical safety checklist
5254778|NCT02419053|perioperative complications|perioperative complications
5254779|NCT02419053|pediatric|pediatric
5254780|NCT02419040|shoulder pain|shoulder pain
5254781|NCT02419040|rotator cuff|rotator cuff
5254782|NCT02419040|calcific tendonitis|calcific tendonitis
5254783|NCT02419040|barbotage|barbotage
5254784|NCT02419027|GI Flora|gi flora
5254785|NCT02419014|cranial electrotherapy|cranial electrotherapy
5254786|NCT02419014|cranial electrical stimulation|cranial electrical stimulation
5254787|NCT02419014|restless legs syndrome|restless legs syndrome
5254788|NCT02418962|PfSPZ Vaccine|pfspz vaccine
5254789|NCT02418949|hand|hand
5254790|NCT02418949|rehabilitation|rehabilitation
5254791|NCT02418949|active movement training|active movement training
5254792|NCT02418949|passive cyclical stretching|passive cyclical stretching
5254793|NCT02418936|Waardenburg syndrome|waardenburg syndrome
5254794|NCT02418936|Large vestibular aqueduct syndrome|large vestibular aqueduct syndrome
5254795|NCT02418936|Diagnosis|diagnosis
5254796|NCT02418936|copy number variation|copy number variation
5254797|NCT02418936|Multiplex polymerase chain reaction|multiplex polymerase chain reaction
5254798|NCT02418910|bipolar|bipolar
5254799|NCT02418910|self assessment|self assessment
5254800|NCT02418910|prospective randomized trial|prospective randomized trial
5254801|NCT02418897|Fatigue|fatigue
5254802|NCT02418897|multiple sclerosis|multiple sclerosis
5254809|NCT02418832|Azoospermia|azoospermia
5254810|NCT02418832|Rete Testis|rete testis
5254812|NCT02418806|Family Caregivers|family caregivers
5254813|NCT02418806|Psychotherapy Group|psychotherapy group
5254814|NCT02418793|Hemophilia|hemophilia
5254815|NCT02418793|Factor VII|factor vii
5254816|NCT02418793|Factor VIIa|factor viia
5254817|NCT02418793|Inhibitors|inhibitors
5254818|NCT02418793|Long Acting|long acting
5254819|NCT02418728|obesity|obesity
5254820|NCT02418728|adipose tissue lipolysis|adipose tissue lipolysis
5254821|NCT02418728|lipolysis|lipolysis
5254822|NCT02418728|microdialysis|microdialysis
5254823|NCT02418728|atrial natriuretic peptide|atrial natriuretic peptide
5254824|NCT02418702|depression|depression
5254825|NCT02418702|suicide|suicide
5254826|NCT02418702|ketamine|ketamine
5254827|NCT02418702|rapid intravenous bolus|rapid intravenous bolus
5254828|NCT02418702|sub-anesthetic dose|sub-anesthetic dose
5254829|NCT02418702|double-blind placebo control|double-blind placebo control
5254830|NCT02418676|Human insulin|human insulin
5254831|NCT02418676|Hydroxypropyl-beta-cyclodextrin|hydroxypropyl-beta-cyclodextrin
5254832|NCT02418676|Pressure Ulcer|pressure ulcer
5254833|NCT02418676|Wound Healing|wound healing
5254834|NCT02418676|Gel|gel
5254835|NCT02418663|fluid responsiveness|fluid responsiveness
5254836|NCT02418663|enhanced recovery program|enhanced recovery program
5254837|NCT02418650|volunteers|volunteers
5254838|NCT02418637|worksite|worksite
5254839|NCT02418637|screen|screen
5254840|NCT02418637|migrant|migrant
5254841|NCT02418637|agricultural|agricultural
5254842|NCT02418637|worker|worker
5254843|NCT02418637|hypertension|hypertension
5254844|NCT02418637|Hyperlipidemia|hyperlipidemia
5254851|NCT02418624|olaparib|olaparib
5254852|NCT02418598|Adeno-associated virus|adeno-associated virus
5254853|NCT02418598|Aromatic L-amino acid decarboxylase|aromatic l-amino acid decarboxylase
5254854|NCT02418598|AAV-hAADC-2|aav-haadc-2
5254855|NCT02418598|AAV-2|aav-2
5254856|NCT02418598|Gene Therapy|gene therapy
5254857|NCT02418598|Gene Transfer|gene transfer
5254858|NCT02418598|Parkinson Disease|parkinson disease
5254859|NCT02418598|Basal Ganglia Disease|basal ganglia disease
5254860|NCT02418598|Brain Disease|brain disease
5254861|NCT02418585|Treatment-resistant Depression|treatment-resistant depression
5254862|NCT02418585|Esketamine|esketamine
5254863|NCT02418585|Placebo|placebo
5254864|NCT02418585|Oral Antidepressant|oral antidepressant
5254865|NCT02418559|Healthy|healthy
5254866|NCT02418559|JNJ-63623872|jnj-63623872
5254867|NCT02418559|Japanese Adult Participants|japanese adult participants
5254868|NCT02418533|infertility|infertility
5254869|NCT02418533|in vitro fertilization|in vitro fertilization
5254870|NCT02418533|fertility|fertility
5254871|NCT02418533|preimplantation genetic screening|preimplantation genetic screening
5254872|NCT02418533|embryo|embryo
5254873|NCT02418533|PGS|pgs
5254874|NCT02418533|Eeva|eeva
5254875|NCT02418533|IVF|ivf
5254876|NCT02418481|γδ T Cell|γδ t cell
5254877|NCT02418481|breast cancer|breast cancer
5254878|NCT02418481|her2-|her2-
5254879|NCT02418481|er-|er-
5254880|NCT02418481|pr-|pr-
5254881|NCT02418468|COPD, FEV1, indacaterol|copd, fev1, indacaterol
5254882|NCT02418455|MPS 7|mps 7
5254883|NCT02418455|Sly Syndrome|sly syndrome
5254884|NCT02418455|MPS VII|mps vii
5254885|NCT02418455|Enzyme Replacement Therapy|enzyme replacement therapy
5254886|NCT02418455|Rare Disease|rare disease
5242553|NCT02488343|Adherence|adherence
5242554|NCT02488343|Therapies|therapies
5242555|NCT02488343|Psychological Intervention|psychological intervention
5242556|NCT02488317|Chronic Kidney Disease|chronic kidney disease
5254887|NCT02418455|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
5254888|NCT02418455|Lysosomal Storage Disease|lysosomal storage disease
5254889|NCT02418455|Metabolic Disorder|metabolic disorder
5254890|NCT02418442|Systemic Arthritis|systemic arthritis
5254891|NCT02418442|Oligoarthritis|oligoarthritis
5254892|NCT02418442|Polyarthritis (Rheumatoid Factor Negative)|polyarthritis (rheumatoid factor negative)
5254893|NCT02418442|Polyarthritis (Rheumatoid Factor Positive)|polyarthritis (rheumatoid factor positive)
5254894|NCT02418442|Psoriatic Arthritis|psoriatic arthritis
5254895|NCT02418442|Enthesitis Related Arthritis (ERA)|enthesitis related arthritis (era)
5254896|NCT02418442|Undifferianted Arthritis|undifferianted arthritis
5254897|NCT02418442|CARRA Consensus Treatment Plans|carra consensus treatment plans
5254898|NCT02418442|FROST|frost
5254899|NCT02418429|fat oxidation|fat oxidation
5254900|NCT02418429|hunger|hunger
5254901|NCT02418429|resistant starch|resistant starch
5254902|NCT02418429|whey protein|whey protein
5254903|NCT02418377|Obesity|obesity
5254904|NCT02418377|Genetics|genetics
5254905|NCT02418377|Whole exome sequencing|whole exome sequencing
5254906|NCT02418377|Children|children
5254907|NCT02418325|RRMS|rrms
5254908|NCT02418312|histamine-2 receptor antagonist|histamine-2 receptor antagonist
5254910|NCT02418312|thienopyridine|thienopyridine
5254911|NCT02418312|prevention|prevention
5254912|NCT02418299|urinary incontinence|urinary incontinence
5254913|NCT02418299|Er:YAG laser|er:yag laser
5254914|NCT02418286|Low Back Pain|low back pain
5254915|NCT02418286|Korean Rehabilitation Clinic|korean rehabilitation clinic
5254916|NCT02418286|Patient Registry|patient registry
5254917|NCT02418273|denosumab|denosumab
5254918|NCT02418273|pediatric|pediatric
5254919|NCT02418273|rheumatology|rheumatology
5254920|NCT02418273|osteoporosis|osteoporosis
5254921|NCT02418273|glucocorticoid|glucocorticoid
5254922|NCT02418260|Humerus|humerus
5254923|NCT02418260|shaft|shaft
5254924|NCT02418260|diaphyseal|diaphyseal
5254925|NCT02418260|fractures|fractures
5254926|NCT02418247|radioactive iodine therapy|radioactive iodine therapy
5254927|NCT02418247|ablation|ablation
5254928|NCT02418247|thyroid cancer|thyroid cancer
5254929|NCT02418234|Non-small Cell Lung Cancer|non-small cell lung cancer
5254930|NCT02418234|circulating tumor DNA|circulating tumor dna
5254931|NCT02418234|T790M|t790m
5254932|NCT02418234|amplification refractory mutation system|amplification refractory mutation system
5254933|NCT02418234|digital droplet PCR|digital droplet pcr
5254934|NCT02418221|histamine, biogenic amines, diamine oxidase|histamine, biogenic amines, diamine oxidase
5254935|NCT02418195|Depression|depression
5254936|NCT02418195|Ketamine|ketamine
5254937|NCT02418195|Suicide Attempt|suicide attempt
5254938|NCT02418195|Suicidal Ideation|suicidal ideation
5254939|NCT02418195|Suicidality|suicidality
5254947|NCT02418117|Stereolitographic guide|stereolitographic guide
5254948|NCT02418117|flapless surgery|flapless surgery
5254949|NCT02418117|dental implants|dental implants
5862735|NCT00001532|Candidate Genes|candidate genes
5254963|NCT02418013|Umbilical cord blood|umbilical cord blood
5254965|NCT02418013|Randomized trial|randomized trial
5254966|NCT02418013|Double-blinded trial|double-blinded trial
5254967|NCT02418013|Placebo-controlled trial|placebo-controlled trial
5254968|NCT02417974|Prevention|prevention
5254969|NCT02417974|Recurrence|recurrence
5254970|NCT02417974|Fecal Microbiota Therapy|fecal microbiota therapy
5254971|NCT02417961|Asthma,|asthma,
5254972|NCT02417961|Bronchial Diseases,|bronchial diseases,
5254973|NCT02417961|Respiratory Tract Diseases,|respiratory tract diseases,
5254974|NCT02417961|Lung Diseases,|lung diseases,
5254975|NCT02417961|Obstructive Lung Diseases,|obstructive lung diseases,
5254976|NCT02417961|Benralizumab|benralizumab
5254977|NCT02417909|Obesity|obesity
5254978|NCT02417909|quality of life|quality of life
5254979|NCT02417909|teenagers|teenagers
5254980|NCT02417909|psychological impact|psychological impact
5254981|NCT02417896|Acute kidney injury|acute kidney injury
5254982|NCT02417896|Spironolactone|spironolactone
5242661|NCT02487641|Ultrasound|ultrasound
5242662|NCT02487641|mid-trimester|mid-trimester
5242663|NCT02487641|Obesity|obesity
5242664|NCT02487641|pregnancy|pregnancy
5242665|NCT02487615|Glycaemia|glycaemia
5242666|NCT02487615|Subclinical Atherosclerosis|subclinical atherosclerosis
5242667|NCT02487615|Carotid Doppler Ultrasound|carotid doppler ultrasound
5242674|NCT02487615|Leptin|leptin
5254983|NCT02417883|Furosemide|furosemide
5254984|NCT02417883|Interstitial Fibrosis|interstitial fibrosis
5254985|NCT02417870|Transplantation|transplantation
5254986|NCT02417870|interleukin-2|interleukin-2
5254987|NCT02417870|IL-2|il-2
5254988|NCT02417870|Kidney|kidney
5254989|NCT02417870|Renal|renal
5254990|NCT02417857|Single İncision Laparoscopic Surgery|single incision laparoscopic surgery
5254991|NCT02417857|Conventional Laparoscopic Surgery|conventional laparoscopic surgery
5254992|NCT02417792|psoriasis|psoriasis
5254993|NCT02417792|microbiota|microbiota
5254994|NCT02417766|Genetic Testing|genetic testing
5254995|NCT02417766|Secondary Findings|secondary findings
5254996|NCT02417766|Immune-Mediated Disorders|immune-mediated disorders
5254997|NCT02417766|Whole Exome Sequencing|whole exome sequencing
5254998|NCT02417753|PARACENTESIS|paracentesis
5254999|NCT02417753|STAT3 Antisense Oligonucleotide|stat3 antisense oligonucleotide
5255000|NCT02417753|Ascites|ascites
5255001|NCT02417753|AZD9150|azd9150
5255002|NCT02417753|Surgical Resection|surgical resection
5255003|NCT02417740|Portal Hypertension|portal hypertension
5255004|NCT02417740|Portal Fibrosis|portal fibrosis
5255005|NCT02417740|Liver Disease|liver disease
5255006|NCT02417740|Varices|varices
5255007|NCT02417740|Splenomegaly|splenomegaly
5255008|NCT02417727|MEMORY TESTING|memory testing
5255009|NCT02417727|Biomarkers|biomarkers
5255010|NCT02417727|Learning|learning
5255011|NCT02417714|Computed Tomography|computed tomography
5255012|NCT02417714|Radiation Reduction|radiation reduction
5255013|NCT02417714|Iterative Reconstruction|iterative reconstruction
5255014|NCT02417688|carotid atherosclerosis, PET imaging agent|carotid atherosclerosis, pet imaging agent
5255015|NCT02417675|Option B+|option b+
5255016|NCT02417675|Adherence Club|adherence club
5255017|NCT02417675|Postpartum|postpartum
5255018|NCT02417675|Breastfeeding|breastfeeding
5255019|NCT02417675|Mother-to-child transmission|mother-to-child transmission
5255020|NCT02417662|NSCLC|nsclc
5255021|NCT02417662|Stereotactic Ablative Radiotherapy|stereotactic ablative radiotherapy
5255022|NCT02417662|Radiotherapy|radiotherapy
5255023|NCT02417662|Randomised|randomised
5255024|NCT02417662|Controlled|controlled
5255025|NCT02417662|Oligometastatic|oligometastatic
5255032|NCT02417571|ambulatory blood pressure|ambulatory blood pressure
5255033|NCT02417571|glomerular filtration rate|glomerular filtration rate
5255035|NCT02417519|Chlorogenic acid|chlorogenic acid
5255036|NCT02417519|Insulin|insulin
5255037|NCT02417519|Appetite|appetite
5255038|NCT02417519|Metabolomics|metabolomics
5255039|NCT02417506|Acute pain|acute pain
5255040|NCT02417506|Herbal|herbal
5255042|NCT02417506|Stop watch|stop watch
5255043|NCT02417493|Food allergy|food allergy
5255044|NCT02417493|self-management|self-management
5255045|NCT02417493|epinephrine self-injection|epinephrine self-injection
5255046|NCT02417493|ntervention|ntervention
5255047|NCT02417493|adolescents|adolescents
5255048|NCT02417467|Electronic cigarette|electronic cigarette
5255049|NCT02417467|E-cigarette|e-cigarette
5255050|NCT02417467|Smoking cessation|smoking cessation
5255051|NCT02417454|probiotic|probiotic
5255052|NCT02417454|stress|stress
5255053|NCT02417454|emotion psychophysiology|emotion psychophysiology
5255054|NCT02417454|brain-body-gut interactions|brain-body-gut interactions
5255055|NCT02417441|TiLE|tile
5255056|NCT02417441|Embryo Assessment|embryo assessment
5255057|NCT02417441|Pregnancy|pregnancy
5255058|NCT02417441|Implantation|implantation
5255059|NCT02417428|Muscle function|muscle function
5255060|NCT02417428|Functional capacity|functional capacity
5255061|NCT02417415|Supine hypertension|supine hypertension
5255062|NCT02417415|Autonomic failure|autonomic failure
5255063|NCT02417415|Heat intolerance|heat intolerance
5255064|NCT02417415|Orthostatic hypotension|orthostatic hypotension
5255065|NCT02417415|Heat stress|heat stress
5255066|NCT02417402|back pain|back pain
5674380|NCT00603785|Xolair|xolair
5255067|NCT02417402|low back pain|low back pain
5255068|NCT02417402|chronic low back pain|chronic low back pain
5255069|NCT02417389|primary hyperparathyroidism|primary hyperparathyroidism
5255070|NCT02417389|hypercalcemia|hypercalcemia
5255071|NCT02417389|osteoporosis|osteoporosis
5255072|NCT02417389|bone turnover|bone turnover
5255073|NCT02417389|bone mineral density|bone mineral density
5255074|NCT02417389|fractures|fractures
5255075|NCT02417376|Coronary heart disease|coronary heart disease
5255076|NCT02417376|Periodontitis|periodontitis
5255077|NCT02417376|C-reactive protein|c-reactive protein
5255078|NCT02417376|Blood pressure|blood pressure
5255079|NCT02417363|biomarkers|biomarkers
5255080|NCT02417363|renal disease|renal disease
5255081|NCT02417363|periodontitis|periodontitis
5255082|NCT02417324|medulloblastoma|medulloblastoma
5255083|NCT02417324|ependymoma|ependymoma
5255084|NCT02417324|pineoblastoma|pineoblastoma
5255085|NCT02417324|CNS-PNET|cns-pnet
5255086|NCT02417311|Engineered Heart Tissue (EHT)|engineered heart tissue (eht)
5255087|NCT02417311|human induced pluripotent stem cells (hiPSC)|human induced pluripotent stem cells (hipsc)
5255088|NCT02417298|ketamine|ketamine
5255090|NCT02417298|sickle cell disorder|sickle cell disorder
5255091|NCT02417285|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5255092|NCT02417285|Diffused Large B-Cell Lymphoma|diffused large b-cell lymphoma
5255093|NCT02417285|Phase 1B|phase 1b
5255094|NCT02417285|Open-Label|open-label
5255095|NCT02417285|Safety and Efficacy|safety and efficacy
5255096|NCT02417285|CC-122|cc-122
5255097|NCT02417285|Obinutuzumab|obinutuzumab
5255098|NCT02417285|GA101|ga101
5255099|NCT02417285|Relapsed|relapsed
5255100|NCT02417285|Refractory|refractory
5255101|NCT02417272|Total Disc Replacement|total disc replacement
5255102|NCT02417272|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
5255103|NCT02417259|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5255104|NCT02417246|pharmacokinetics|pharmacokinetics
5255105|NCT02417246|pharmacodynamics|pharmacodynamics
5255106|NCT02417246|pharmacogenetics|pharmacogenetics
5255107|NCT02417233|HIV-positive|hiv-positive
5255108|NCT02417233|adherence|adherence
5255109|NCT02417233|engagement to care|engagement to care
5255110|NCT02417233|mobile Health (mHealth)|mobile health (mhealth)
5255112|NCT02417233|peer navigation|peer navigation
5255113|NCT02417233|retention|retention
5255114|NCT02417207|hepatitis B immune globulin (HBIG)|hepatitis b immune globulin (hbig)
5255115|NCT02417207|liver transplantation|liver transplantation
5255117|NCT02417207|entecavir|entecavir
5255118|NCT02417194|Renal cell carcinoma|renal cell carcinoma
5255119|NCT02417194|hemoglobin A1c protein|hemoglobin a1c protein
5255120|NCT02417194|Pathologic outcomes|pathologic outcomes
5255121|NCT02417194|Oncological outcomes|oncological outcomes
5255122|NCT02417194|Nephrectomy|nephrectomy
5255123|NCT02417181|Physician assistants|physician assistants
5255124|NCT02417181|Out-of-hours medical care|out-of-hours medical care
5255125|NCT02417181|Primary healthcare|primary healthcare
5255126|NCT02417181|Emergency Medical Services|emergency medical services
5255127|NCT02417155|Autonomic Nerve System|autonomic nerve system
5255128|NCT02417155|Epinephrin|epinephrin
5255129|NCT02417155|Hyperventilation|hyperventilation
5255130|NCT02417155|Hypoventilation|hypoventilation
5255131|NCT02417064|Treatment-resistant Depression|treatment-resistant depression
5255132|NCT02417064|Esketamine|esketamine
5255133|NCT02417064|Placebo|placebo
5255134|NCT02417064|Oral Antidepressant|oral antidepressant
5255135|NCT02417051|Psychological Resilience|psychological resilience
5255136|NCT02417051|Perceived Stress|perceived stress
5255137|NCT02417051|Psychological Stress|psychological stress
5255138|NCT02417051|Disaster Worker|disaster worker
5255139|NCT02417051|Superstorm Sandy|superstorm sandy
5255140|NCT02417051|Mental Health|mental health
5255141|NCT02417051|Prevention|prevention
5255142|NCT02417038|Postoperative Respiratory Monitoring|postoperative respiratory monitoring
5255143|NCT02417038|Neuraxial Opioid Administration for Cesarean Delivery|neuraxial opioid administration for cesarean delivery
5255144|NCT02417025|Military|military
5255145|NCT02417025|Health Service Delivery|health service delivery
5255146|NCT02417025|Telepsychology|telepsychology
5255147|NCT02417025|Prolonged Exposure|prolonged exposure
5255148|NCT02417025|Off-duty Activity of Military Personnel|off-duty activity of military personnel
5255149|NCT02417012|lifestyle|lifestyle
5255150|NCT02417012|exercise|exercise
5255151|NCT02417012|physical activity|physical activity
5255152|NCT02417012|diet|diet
5255153|NCT02417012|glycemic control|glycemic control
5255154|NCT02417012|hba1c|hba1c
5255155|NCT02417012|glucose lowering drugs|glucose lowering drugs
5255156|NCT02416999|glioma|glioma
5255157|NCT02416999|high-grade glioma|high-grade glioma
5255158|NCT02416960|female infertility|female infertility
5255159|NCT02416960|glycemic index|glycemic index
5255160|NCT02416960|leptin|leptin
5255161|NCT02416960|ghrelin|ghrelin
5255162|NCT02416960|overweight|overweight
5255163|NCT02416960|obesity|obesity
5255164|NCT02416960|in vitro fertilization|in vitro fertilization
5255165|NCT02416947|Soluble Corn Fiber|soluble corn fiber
5255166|NCT02416947|Osteoporosis|osteoporosis
5255167|NCT02416947|Bone Loss|bone loss
5255168|NCT02416921|Facebook|facebook
5255169|NCT02416921|Weight Gain Prevention|weight gain prevention
5255170|NCT02416921|Women's Health|women's health
5255171|NCT02416921|Online|online
5255172|NCT02416921|Weight Gain|weight gain
5255173|NCT02416921|Weight Loss|weight loss
5255174|NCT02416921|Female Contraception|female contraception
5255175|NCT02416921|Obesity|obesity
5255176|NCT02416921|Body Weight|body weight
5255177|NCT02416921|Internet|internet
5255178|NCT02416882|active|active
5255179|NCT02416882|not active|not active
5255180|NCT02416882|normal body weight|normal body weight
5255181|NCT02416869|Dexamethasone|dexamethasone
5255182|NCT02416869|Lower third molar surgery|lower third molar surgery
5255183|NCT02416856|Aphasia|aphasia
5255184|NCT02416856|Brain|brain
5255185|NCT02416856|Stimulation|stimulation
5255186|NCT02416856|Communication|communication
5255187|NCT02416856|Stroke|stroke
5255188|NCT02416856|Speech Disorders|speech disorders
5255189|NCT02416856|Communications Disorders|communications disorders
5255190|NCT02416856|Neurobehavioral Manifestations|neurobehavioral manifestations
5255191|NCT02416856|Neurologic Manifestations|neurologic manifestations
5255192|NCT02416856|Nervous System Diseases|nervous system diseases
5255193|NCT02416856|Signs and Symptoms|signs and symptoms
5255194|NCT02416843|Adipose tissue|adipose tissue
5255195|NCT02416843|metabolism|metabolism
5255196|NCT02416843|inflammation|inflammation
5255197|NCT02416843|post-prandial|post-prandial
5255198|NCT02416843|human|human
5255199|NCT02416830|embolization|embolization
5255200|NCT02416830|visceral Aneurysms|visceral aneurysms
5255201|NCT02416830|Prospective Registry|prospective registry
5255202|NCT02416817|Thrombelastography|thrombelastography
5255203|NCT02416817|Massive Transfusion|massive transfusion
5255204|NCT02416817|Major Trauma|major trauma
5255205|NCT02416817|Blood products|blood products
5255206|NCT02416817|Thromboelastometry|thromboelastometry
5255207|NCT02416804|buprenorphine|buprenorphine
5255208|NCT02416804|transdermal system|transdermal system
5255209|NCT02416804|Pain, postoperative|pain, postoperative
5255210|NCT02416804|Quality of life|quality of life
5255211|NCT02416804|Spinal stenosis|spinal stenosis
5255212|NCT02416804|Posterior lumbar fusion|posterior lumbar fusion
5255213|NCT02416791|robotic therapy|robotic therapy
5255214|NCT02416791|transcranial direct current stimulation|transcranial direct current stimulation
5255215|NCT02416778|COPD|copd
5260462|NCT02385695|DDD|ddd
5255216|NCT02416778|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5255217|NCT02416778|Iron deficiency|iron deficiency
5255218|NCT02416778|6 Minute-Walking-Test|6 minute-walking-test
5255219|NCT02416765|Closed-loop strategy|closed-loop strategy
5255220|NCT02416765|Artificial pancreas|artificial pancreas
5255221|NCT02416765|Postprandial glucose|postprandial glucose
5255222|NCT02416765|Insulin|insulin
5255223|NCT02416765|Glucagon|glucagon
5255224|NCT02416765|Hypoglycemia|hypoglycemia
5255225|NCT02416765|Type 1 diabetes|type 1 diabetes
5255226|NCT02416752|remifentanil|remifentanil
5255227|NCT02416752|head and neck surgery|head and neck surgery
5255228|NCT02416752|recovery pofile|recovery pofile
5255229|NCT02416752|Opioid induced hyperalgesia|opioid induced hyperalgesia
5255230|NCT02416752|post operative pain|post operative pain
5255231|NCT02416739|EGFR mutated lung cancer|egfr mutated lung cancer
5255232|NCT02416726|Gene testing|gene testing
5255233|NCT02416726|Next-generation sequecing|next-generation sequecing
5255234|NCT02416726|Primary tumor|primary tumor
5255235|NCT02416726|Metastatic lymph node|metastatic lymph node
5255236|NCT02416726|Peripheral blood|peripheral blood
5255237|NCT02416713|Driving|driving
5255238|NCT02416713|Teens|teens
5255239|NCT02416713|Texting|texting
5255240|NCT02416713|Cellphone|cellphone
5255242|NCT02416713|Motor vehicle accident|motor vehicle accident
5255243|NCT02416700|Dental prosthesis|dental prosthesis
5255244|NCT02416700|Patients|patients
5255245|NCT02416700|Osseointegrated implants|osseointegrated implants
5255246|NCT02416674|abdominal wall|abdominal wall
5255247|NCT02416674|vascularized composite allotransplantation|vascularized composite allotransplantation
5255740|NCT02414126|sleep|sleep
5255248|NCT02416661|Gaucher Disease type 1|gaucher disease type 1
5255249|NCT02416661|Lymphatic Diseases|lymphatic diseases
5255250|NCT02416661|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5255251|NCT02416661|Lipid Metabolism Disorders|lipid metabolism disorders
5255252|NCT02416661|Lipidoses|lipidoses
5255253|NCT02416648|Adult HIV patients|adult hiv patients
5255254|NCT02416648|Knowledge|knowledge
5255255|NCT02416648|Attitudes|attitudes
5255256|NCT02416648|Sexual behaviors|sexual behaviors
5255257|NCT02416635|Liver Neoplasms|liver neoplasms
5255258|NCT02416635|Circulating Tumor Cells|circulating tumor cells
5255259|NCT02416622|XLRS|xlrs
5255260|NCT02416622|maculoschisis|maculoschisis
5255261|NCT02416622|retinal degeneration|retinal degeneration
5255262|NCT02416622|RS1|rs1
5255263|NCT02416622|adeno-associated virus|adeno-associated virus
5255264|NCT02416622|gene therapy|gene therapy
5255265|NCT02416622|AAV|aav
5255266|NCT02416609|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5242950|NCT02486107|endoscope|endoscope
5242951|NCT02486094|Imaging, Magnetic Resonance|imaging, magnetic resonance
5242952|NCT02486094|Rectal Cancer|rectal cancer
5242953|NCT02486094|Apoptosis|apoptosis
5242954|NCT02486094|Proliferation|proliferation
5242955|NCT02486094|Cancer|cancer
5242956|NCT02486094|Tissue Study|tissue study
5255267|NCT02416609|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5255268|NCT02416609|Chemopotentiator|chemopotentiator
5255269|NCT02416609|Low dose radiotherapy|low dose radiotherapy
5255270|NCT02416609|Hyper-Radiosensitivity|hyper-radiosensitivity
5255271|NCT02416596|ICSI|icsi
5255272|NCT02416596|IVF|ivf
5255273|NCT02416596|hysteroscopy|hysteroscopy
5255274|NCT02416596|Supervision|supervision
5255275|NCT02416596|In-vitro Fertilization|in-vitro fertilization
5255276|NCT02416583|membrane sweeping|membrane sweeping
5255277|NCT02416583|dinoprostone|dinoprostone
5255278|NCT02416583|nulliparas|nulliparas
5255279|NCT02416583|labor induction|labor induction
5255280|NCT02416570|Clarithromycin|clarithromycin
5255281|NCT02416544|Overweight|overweight
5255282|NCT02416544|Obesity|obesity
5255283|NCT02416544|Caloric Restriction|caloric restriction
5255284|NCT02416544|Diet, Reducing|diet, reducing
5255285|NCT02416544|Diet, Sodium-Restricted|diet, sodium-restricted
5255286|NCT02416544|Body Weight Changes|body weight changes
5255287|NCT02416544|Energy intake|energy intake
5255288|NCT02416544|Feeding Behavior|feeding behavior
5255289|NCT02416531|Vulvar lichen sclerosus|vulvar lichen sclerosus
5255290|NCT02416531|Photodynamic therapy|photodynamic therapy
5255291|NCT02416531|Low-level laser therapy|low-level laser therapy
5255292|NCT02416531|Clobetasol propionate|clobetasol propionate
5255293|NCT02416518|Cancer|cancer
5255294|NCT02416518|Malignancy|malignancy
5255295|NCT02416518|Genomic|genomic
5255296|NCT02416518|Molecular|molecular
5255297|NCT02416479|medication adherence|medication adherence
5255298|NCT02416479|outcomes|outcomes
5255299|NCT02416479|intervention|intervention
5255300|NCT02416479|randomized controlled trial|randomized controlled trial
5255301|NCT02416466|Colorectal cancer|colorectal cancer
5255302|NCT02416466|Liver metastases|liver metastases
5255303|NCT02416466|Breast cancer|breast cancer
5255304|NCT02416466|Gastric cancer|gastric cancer
5255305|NCT02416466|Pancreas cancer|pancreas cancer
5255306|NCT02416466|Carcinoembryonic antigen|carcinoembryonic antigen
5255307|NCT02416466|CAR-T|car-t
5255308|NCT02416466|Immunotherapy|immunotherapy
5255309|NCT02416453|Healthy|healthy
5255310|NCT02416453|Ebola viruses|ebola viruses
5255311|NCT02416453|Ebola Viral Disease (EVD)|ebola viral disease (evd)
5255312|NCT02416453|Filoviruses|filoviruses
5255313|NCT02416453|Monovalent vaccine|monovalent vaccine
5423258|NCT01616459|Haemophilus influenzae|haemophilus influenzae
5423259|NCT01616459|Pneumococcal vaccine|pneumococcal vaccine
5862736|NCT00001532|Lung Pathology|lung pathology
5255314|NCT02416453|Human adenovirus serotype 26 (Ad26) encoding the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) encoding the ebola virus mayinga variant glycoprotein (ad26.zebov)
5255317|NCT02416453|Immunogenicity|immunogenicity
5255318|NCT02416453|Inserm and University of Oxford|inserm and university of oxford
5255319|NCT02416440|South African|south african
5255320|NCT02416440|urban African|urban african
5255321|NCT02416440|diabetes|diabetes
5255322|NCT02416440|prevalence|prevalence
5255323|NCT02416440|risk factors|risk factors
5255324|NCT02416440|genetics|genetics
5255325|NCT02416427|Atorvastatin|atorvastatin
5255326|NCT02416427|TAZ|taz
5255327|NCT02416427|Hippo pathway|hippo pathway
5255328|NCT02416427|ki67|ki67
5255329|NCT02416401|healthy|healthy
5255330|NCT02416401|aging|aging
5255331|NCT02416401|cognition|cognition
5124886|NCT03214146|ALS|als
5255332|NCT02416401|age-related cognitive decline|age-related cognitive decline
5255333|NCT02416362|Postural Balance|postural balance
5255334|NCT02416362|Electromyography|electromyography
5255335|NCT02416362|Torque|torque
5255336|NCT02416349|Stroke|stroke
5255337|NCT02416349|Stretching|stretching
5255338|NCT02416349|Respiratory muscle|respiratory muscle
5255339|NCT02416349|Ventilatory pattern|ventilatory pattern
5255340|NCT02416349|Optoelectronic plethysmography|optoelectronic plethysmography
5255341|NCT02416336|sentinel lymph node|sentinel lymph node
5255342|NCT02416336|lymphoscintigraphy|lymphoscintigraphy
5255343|NCT02416336|intraoperative gamma camera|intraoperative gamma camera
5255344|NCT02416310|TEAS|teas
5255345|NCT02416310|cesarean section|cesarean section
5255346|NCT02416310|gastrointestinal function|gastrointestinal function
5255347|NCT02416297|malocclusion|malocclusion
5255352|NCT02416232|melanoma|melanoma
5255353|NCT02416232|dabrafenib|dabrafenib
5255354|NCT02416232|trametinib|trametinib
5255355|NCT02416232|BRAF V600E/K mutation|braf v600e/k mutation
5356868|NCT01917643|COPD, Comparative Effectiveness, Symbicort|copd, comparative effectiveness, symbicort
5243047|NCT02485626|Anthracyclines|anthracyclines
5243054|NCT02485587|Arousal Biofeedback|arousal biofeedback
5243055|NCT02485587|Electrodermal activity|electrodermal activity
5243056|NCT02485574|Bone bridging|bone bridging
5243058|NCT02485574|Lumbar|lumbar
5255356|NCT02416219|Cricoid cartilage, cricoid pressure, obstetric|cricoid cartilage, cricoid pressure, obstetric
5255359|NCT02416193|Diabetes|diabetes
5255360|NCT02416193|Cognition|cognition
5255361|NCT02416193|Functioning|functioning
5255362|NCT02416180|EVOHALER|evohaler
5255363|NCT02416180|Asthma|asthma
5255364|NCT02416180|SERETIDE|seretide
5255365|NCT02416180|DISKUS Inhaler|diskus inhaler
5255366|NCT02416180|MDI|mdi
5255367|NCT02416154|interferon-epsilon|interferon-epsilon
5255368|NCT02416154|female reproductive tract|female reproductive tract
5255369|NCT02416154|neopterin|neopterin
5255370|NCT02416154|menstrual cycle|menstrual cycle
5255375|NCT02416089|Tamponade|tamponade
5255376|NCT02416089|Postpartum hemorrhage|postpartum hemorrhage
5255377|NCT02416076|Ulthera® System|ulthera® system
5255378|NCT02416076|Ultherapy®|ultherapy®
5255379|NCT02416076|Ulthera, Inc.|ulthera, inc.
5255380|NCT02416050|Cocaine|cocaine
5255381|NCT02416050|Dependence|dependence
5255382|NCT02416050|Abstinence|abstinence
5255383|NCT02416050|Prediction|prediction
5255384|NCT02416050|Model|model
5255385|NCT02416050|Humans|humans
5255386|NCT02416050|MRI|mri
5255387|NCT02416050|Cognitive|cognitive
5255388|NCT02416050|Impulsivity|impulsivity
5255389|NCT02416050|Craving|craving
5255390|NCT02416037|ARDS|ards
5255391|NCT02416037|prone position|prone position
5255392|NCT02416037|PEEP|peep
5255393|NCT02416037|mechanical ventilation|mechanical ventilation
5255394|NCT02416024|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5255395|NCT02416024|anesthesia|anesthesia
5255396|NCT02416011|e-cigarette|e-cigarette
5255397|NCT02416011|nicotine dependence|nicotine dependence
5255398|NCT02415998|TEE|tee
5255399|NCT02415985|pharmacokinetics of rifabutin|pharmacokinetics of rifabutin
5255400|NCT02415985|HIV/TB co-infection|hiv/tb co-infection
5255401|NCT02415985|resource limited setting|resource limited setting
5255402|NCT02415985|AUC|auc
5255403|NCT02415985|Cmax|cmax
5255404|NCT02415985|Cmin|cmin
5255405|NCT02415985|Ctrough|ctrough
5255406|NCT02415972|ultrasound imaging|ultrasound imaging
5255407|NCT02415972|acute ischemic stroke|acute ischemic stroke
5255408|NCT02415972|cerebral perfusion measurement in acute ischemic stroke|cerebral perfusion measurement in acute ischemic stroke
5255409|NCT02415959|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5255410|NCT02415946|regenerative medicine|regenerative medicine
5255411|NCT02415946|bone substitutes|bone substitutes
5255412|NCT02415946|sinus floor augmentation|sinus floor augmentation
5255413|NCT02415933|Burkina Faso|burkina faso
5255414|NCT02415933|West Africa|west africa
5255415|NCT02415933|Children|children
5255416|NCT02415933|Child Abuse|child abuse
5255417|NCT02415933|Child Mental Health|child mental health
5255418|NCT02415933|Economic Empowerment|economic empowerment
5255419|NCT02415933|Women's Empowerment|women's empowerment
5255420|NCT02415933|Domestic Violence|domestic violence
5255432|NCT02415842|Exploratory|exploratory
5255433|NCT02415842|Protein epitopes|protein epitopes
5255434|NCT02415842|Laboratory evaluation|laboratory evaluation
5255435|NCT02415842|Retrospective|retrospective
5255436|NCT02415829|Neoajuvant chemotherapy|neoajuvant chemotherapy
5255437|NCT02415816|Pediatric|pediatric
5255438|NCT02415816|Whole body DWI MRI|whole body dwi mri
5255439|NCT02415803|low-dose ticagrelor|low-dose ticagrelor
5255440|NCT02415803|clopidogrel|clopidogrel
5255441|NCT02415803|Chinese patients with NSTE-ACS|chinese patients with nste-acs
5255442|NCT02415803|platelet reactivity|platelet reactivity
5255443|NCT02415803|inhibition of platelet aggregation|inhibition of platelet aggregation
5255445|NCT02415790|Healthy Adult and Elderly Subjects|healthy adult and elderly subjects
5255446|NCT02415790|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5255447|NCT02415738|Near infrared spectroscopy|near infrared spectroscopy
5255448|NCT02415738|Cerebral oxygenation|cerebral oxygenation
5256240|NCT02411071|HIV-1|hiv-1
5255449|NCT02415738|Acute respiratory distress syndrom|acute respiratory distress syndrom
5255450|NCT02415738|Prone positioning|prone positioning
5255451|NCT02415712|Pharmacotherapy|pharmacotherapy
5255452|NCT02415686|Dravet syndrome|dravet syndrome
5255453|NCT02415686|Sudden Unexpected Death in Epilepsy (SUDEP)|sudden unexpected death in epilepsy (sudep)
5255454|NCT02415686|Arrhythmias|arrhythmias
5255455|NCT02415673|Orthodontics|orthodontics
5255456|NCT02415673|Nitinol|nitinol
5255457|NCT02415660|trigger point dry needling|trigger point dry needling
5255458|NCT02415660|thoracic spine manipulation|thoracic spine manipulation
5255459|NCT02415660|deep cervical extensor muscle|deep cervical extensor muscle
5255460|NCT02415660|deep cervical flexor muscle|deep cervical flexor muscle
5255461|NCT02415660|shear wave elastography|shear wave elastography
5255462|NCT02415647|children|children
5255463|NCT02415647|mental health|mental health
5255464|NCT02415647|family genetic study|family genetic study
5255468|NCT02415582|Hypertension|hypertension
5255469|NCT02415582|Bloodpressure|bloodpressure
5255470|NCT02415582|Post-exercise hypotension|post-exercise hypotension
5255471|NCT02415582|Combined exercise|combined exercise
5255472|NCT02415582|Aerobic exercise|aerobic exercise
5255473|NCT02415582|Resistance exercise|resistance exercise
5255475|NCT02415582|Elderly|elderly
5255476|NCT02415582|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5255477|NCT02415569|bowel cleansing|bowel cleansing
5255478|NCT02415569|bisacodyl|bisacodyl
5255479|NCT02415569|polyethyleneglycol|polyethyleneglycol
5255480|NCT02415569|colonoscopy|colonoscopy
5255481|NCT02415569|the bristol stool form scale|the bristol stool form scale
5255482|NCT02415556|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5255483|NCT02415556|Intranasal Insulin|intranasal insulin
5255485|NCT02415556|Memory|memory
5255486|NCT02415556|Gait|gait
5255487|NCT02415556|Non diabetic older controls|non diabetic older controls
5255488|NCT02415517|Cognitive training|cognitive training
5255489|NCT02415517|Cognitive impairment|cognitive impairment
5255490|NCT02415517|Heart failure|heart failure
5255491|NCT02415517|Cognition|cognition
5255492|NCT02415504|Care transition|care transition
5255493|NCT02415504|Behavioural and psychological symptoms of dementia|behavioural and psychological symptoms of dementia
5255494|NCT02415504|BPSD|bpsd
5255495|NCT02415504|Dementia|dementia
5255496|NCT02415504|Persons with dementia|persons with dementia
5255497|NCT02415504|Discharge processes|discharge processes
5255498|NCT02415491|TGA|tga
5255499|NCT02415491|ASO|aso
5255500|NCT02415491|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5255501|NCT02415491|young adulthood|young adulthood
5255502|NCT02415478|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5255503|NCT02415478|endoscopic lung volume reduction|endoscopic lung volume reduction
5255504|NCT02415478|Endobronchial valve|endobronchial valve
5255505|NCT02415478|physical capacity|physical capacity
5255506|NCT02415478|quality of life|quality of life
5255507|NCT02415465|Knee|knee
5255508|NCT02415465|Replacement|replacement
5255509|NCT02415452|relationship|relationship
5150631|NCT03050788|Kaposi Sarcoma|kaposi sarcoma
5255510|NCT02415452|retinal artery lesions|retinal artery lesions
5255511|NCT02415452|long-term outcomes|long-term outcomes
5255512|NCT02415439|Safety|safety
5255513|NCT02415439|tolerability|tolerability
5255514|NCT02415439|pharmacokinetics|pharmacokinetics
5255515|NCT02415439|adult|adult
5255516|NCT02415439|volunteers|volunteers
5423260|NCT01616459|Infants|infants
5255517|NCT02415413|Smoldering multiple myeloma|smoldering multiple myeloma
5255518|NCT02415413|Carfilzomib|carfilzomib
5255519|NCT02415413|Lenalidomide|lenalidomide
5255520|NCT02415413|Melphalan|melphalan
5255521|NCT02415413|Dexamethasone|dexamethasone
5255522|NCT02415413|Autologous stem cell transplantation|autologous stem cell transplantation
5255523|NCT02415361|Parents|parents
5255524|NCT02415361|Follow-Up Studies|follow-up studies
5255525|NCT02415309|Melatonin|melatonin
5255526|NCT02415309|Lumbar medial branch block (LMBB)|lumbar medial branch block (lmbb)
5255527|NCT02415309|Anxiety|anxiety
5255528|NCT02415309|Interventional Pain|interventional pain
5255529|NCT02415309|Pain Procedure|pain procedure
5255530|NCT02415296|gambling disorder|gambling disorder
5255531|NCT02415296|screening model|screening model
5255532|NCT02415296|online gambling|online gambling
5255533|NCT02415296|clinical validation|clinical validation
5255534|NCT02415257|Vestibular schwannoma|vestibular schwannoma
5255535|NCT02415257|acoustic neuroma|acoustic neuroma
5255536|NCT02415257|cerebellopontine angle tumour|cerebellopontine angle tumour
5255537|NCT02415257|gentamicin|gentamicin
5255538|NCT02415257|rehabilitation|rehabilitation
5255539|NCT02415257|postural balance|postural balance
5255540|NCT02415244|ultrasound|ultrasound
5255541|NCT02415231|humor laughter C reactive protein|humor laughter c reactive protein
5255542|NCT02415205|Pain and stress assessment in premature infants|pain and stress assessment in premature infants
5255543|NCT02415192|safety data|safety data
5255544|NCT02415192|hypertension therapy|hypertension therapy
5255545|NCT02415179|Newly diagnosed asthma|newly diagnosed asthma
5255546|NCT02415179|peripheral airway function|peripheral airway function
5255547|NCT02415127|Interferon gamma|interferon gamma
5255548|NCT02415114|Coenzyme Q10|coenzyme q10
5255549|NCT02415114|Resveratrol|resveratrol
5255550|NCT02415114|Statin|statin
5255551|NCT02415101|Adenocarcinoma|adenocarcinoma
5255552|NCT02415101|Squamous cell carcinoma|squamous cell carcinoma
5255553|NCT02415101|Gastroesophageal Junction|gastroesophageal junction
5255554|NCT02415088|Nerve block|nerve block
5356869|NCT01917630|Celiac disease|celiac disease
5255555|NCT02415075|Return to work, state of subjective health, medical rehabilitation, motivational interviewing|return to work, state of subjective health, medical rehabilitation, motivational interviewing
5255556|NCT02415062|Parkinson's disease|parkinson's disease
5255557|NCT02415062|dementia|dementia
5255559|NCT02415036|ICC|icc
5255560|NCT02415036|Percutaneous hepatic perfusion|percutaneous hepatic perfusion
5255561|NCT02414997|RIPC (remote ischemic preconditioning)|ripc (remote ischemic preconditioning)
5255562|NCT02414997|primary hypertension stage I|primary hypertension stage i
5255563|NCT02414997|vascular function|vascular function
5255564|NCT02414997|microRNA-126|microrna-126
5255565|NCT02414997|microRNA-34a|microrna-34a
5255566|NCT02414984|Rheumatoid Arthritis|rheumatoid arthritis
5255567|NCT02414984|Golimumab|golimumab
5255568|NCT02414984|Observational|observational
5255569|NCT02414984|Compliance|compliance
5255570|NCT02414971|cancer related fatigue|cancer related fatigue
5255571|NCT02414971|prostate cancer|prostate cancer
5255572|NCT02414971|mitochondria|mitochondria
5255573|NCT02414932|ketamine|ketamine
5255574|NCT02414932|electroconvulsive therapy|electroconvulsive therapy
5255575|NCT02414932|glutamate|glutamate
5255576|NCT02414906|Goal Directed Therapy|goal directed therapy
5255577|NCT02414906|Acute Kidney Injury|acute kidney injury
5255578|NCT02414880|Sugammadex|sugammadex
5255579|NCT02414880|Neostigmine|neostigmine
5255580|NCT02414880|Rocuronium|rocuronium
5255581|NCT02414880|Cirrhosis|cirrhosis
5255582|NCT02414880|Liver resection|liver resection
5255583|NCT02414880|Neuromuscular|neuromuscular
5255584|NCT02414841|radiocephalic|radiocephalic
5255585|NCT02414841|arteriovenous fistula|arteriovenous fistula
5255586|NCT02414841|AVF|avf
5255587|NCT02414841|hemodialysis|hemodialysis
5255588|NCT02414841|PRT-201|prt-201
5255589|NCT02414841|vonapanitase|vonapanitase
5255590|NCT02414841|vascular access|vascular access
5255591|NCT02414841|kidney|kidney
5255592|NCT02414841|renal|renal
5255593|NCT02414841|PATENCY-2|patency-2
5255594|NCT02414841|secondary patency|secondary patency
5255595|NCT02414841|fistula abandonment|fistula abandonment
5255596|NCT02414841|use for hemodialysis|use for hemodialysis
5255597|NCT02414789|erythema migrans|erythema migrans
5255598|NCT02414789|Lyme|lyme
5255599|NCT02414789|early diagnosis|early diagnosis
5255600|NCT02414789|skin biomarkers|skin biomarkers
5255601|NCT02414789|proteomics diagnostic|proteomics diagnostic
5255602|NCT02414789|mass spectrometry|mass spectrometry
5255603|NCT02414750|Vemurafenib/cobimetinib (GDC-0973)|vemurafenib/cobimetinib (gdc-0973)
5255604|NCT02414750|Melanoma|melanoma
5255605|NCT02414750|Positron Emission Tomography|positron emission tomography
5255606|NCT02414750|Tumor Characteristics|tumor characteristics
5255607|NCT02414750|Response monitoring|response monitoring
5255608|NCT02414750|Resistance prediction|resistance prediction
5255609|NCT02414750|molecular targeted therapy|molecular targeted therapy
5255610|NCT02414711|Depression|depression
5255611|NCT02414711|Primary care|primary care
5255612|NCT02414711|General Practitioners|general practitioners
5423261|NCT01616459|Safety|safety
5423262|NCT01616459|Immunogenicity|immunogenicity
5255616|NCT02414672|caregivers|caregivers
5255617|NCT02414672|self-care|self-care
5255618|NCT02414633|Psoriatic Arthritis|psoriatic arthritis
5255619|NCT02414620|Efficacy|efficacy
5255620|NCT02414620|Dental Vibe Unit|dental vibe unit
5255621|NCT02414620|Reduction|reduction
5255622|NCT02414620|Elimination|elimination
5255626|NCT02414607|Inflammation|inflammation
5255627|NCT02414555|Fluid Management|fluid management
5255628|NCT02414516|HDAC|hdac
5255629|NCT02414516|Epigenetic|epigenetic
5255630|NCT02414516|Histone|histone
5255631|NCT02414516|Acetylation|acetylation
5255632|NCT02414503|oxytocin|oxytocin
5255633|NCT02414503|social cognition|social cognition
5255634|NCT02414490|CIDP|cidp
5255635|NCT02414477|tobacco toxicants|tobacco toxicants
5255636|NCT02414477|smokeless tobacco|smokeless tobacco
5255637|NCT02414477|nitrosamines|nitrosamines
5255638|NCT02414477|tobacco specific nitrosamines (TSNAs)|tobacco specific nitrosamines (tsnas)
5255639|NCT02414464|tooth bleaching|tooth bleaching
5255640|NCT02414464|adolescent|adolescent
5255641|NCT02414464|clinical trial|clinical trial
5255642|NCT02414451|Propranolol|propranolol
5255643|NCT02414425|Fecal Incontinence|fecal incontinence
5255644|NCT02414425|Botulinum Toxin A|botulinum toxin a
5255645|NCT02414425|Rectal injection|rectal injection
5255689|NCT02414256|breast surgery|breast surgery
5255694|NCT02414217|numeracy|numeracy
5255695|NCT02414217|health literacy|health literacy
5255696|NCT02414204|Arteriovenous Fistulas (AVFS)|arteriovenous fistulas (avfs)
5255697|NCT02414204|Hemodialysis Fistula Maturation (HFM)|hemodialysis fistula maturation (hfm)
5255698|NCT02414204|Flow-Mediated Dilation (FMD)|flow-mediated dilation (fmd)
5255699|NCT02414204|Nitroglycerin-Mediated (NMD)|nitroglycerin-mediated (nmd)
5255700|NCT02414204|Venous Plethysmography (VP)|venous plethysmography (vp)
5255701|NCT02414191|Feedback|feedback
5255702|NCT02414191|Temperature management|temperature management
5255703|NCT02414191|Anesthesia|anesthesia
5255704|NCT02414178|Dementia|dementia
5255705|NCT02414178|Brain Diseases|brain diseases
5903726|NCT00339924|Physician Bias|physician bias
5255706|NCT02414178|Central Nervous System Diseases|central nervous system diseases
5255707|NCT02414178|Mild Cognitive Impairment|mild cognitive impairment
5255708|NCT02414178|nervous system diseases|nervous system diseases
5255709|NCT02414178|Neurodegenerative Disease|neurodegenerative disease
5255710|NCT02414165|Recurrence|recurrence
5255736|NCT02414126|Heart failure|heart failure
5255737|NCT02414126|child|child
5255738|NCT02414126|work of breathing|work of breathing
5255739|NCT02414126|cardiac function|cardiac function
5255741|NCT02414126|polysomnography|polysomnography
5255742|NCT02414126|CPAP|cpap
5255743|NCT02414087|flat foot|flat foot
5255744|NCT02414087|therapeutic effect|therapeutic effect
5255745|NCT02414087|insoles|insoles
5255746|NCT02414087|children|children
5255747|NCT02414061|Postprandial glycemia|postprandial glycemia
5255748|NCT02414061|metabolic health measures|metabolic health measures
5255749|NCT02414048|Hypoxia|hypoxia
5255750|NCT02414048|Head and neck cancer|head and neck cancer
5255751|NCT02414035|atrial fibrillation|atrial fibrillation
5255752|NCT02414035|anticoagulation|anticoagulation
5255753|NCT02414035|Dabigatran|dabigatran
5255754|NCT02413996|Virtual Reality Therapy|virtual reality therapy
5255755|NCT02413996|Rehabilitation|rehabilitation
5255756|NCT02413996|Total Knee Replacement|total knee replacement
5255757|NCT02413996|Knee Arthroplasty|knee arthroplasty
5255758|NCT02413996|Exercise|exercise
5255759|NCT02413996|Arthritis|arthritis
5255760|NCT02413996|Rheumatic Disease|rheumatic disease
5255762|NCT02413970|Neurostimulation|neurostimulation
5255763|NCT02413970|Hypoglossal nerve|hypoglossal nerve
5255764|NCT02413970|Tongue|tongue
5255765|NCT02413970|Upper airway stimulation|upper airway stimulation
5255766|NCT02413970|Surgery|surgery
5255767|NCT02413957|Elderly Patients|elderly patients
5255768|NCT02413957|Medication Safety|medication safety
5255769|NCT02413957|Pharmaceutical Care|pharmaceutical care
5255770|NCT02413957|Medication Reconciliation|medication reconciliation
5255771|NCT02413931|tuberculosis|tuberculosis
5255772|NCT02413931|MDR-TB|mdr-tb
5255773|NCT02413918|mixed episode|mixed episode
5255774|NCT02413866|body composition|body composition
5255775|NCT02413866|anthropometry|anthropometry
5255776|NCT02413840|COPD|copd
5255777|NCT02413840|Baduanjin qigong|baduanjin qigong
5255778|NCT02413840|depression|depression
5255779|NCT02413840|anxiety|anxiety
5255780|NCT02413827|Yervoy™, CDX-1401|yervoy™, cdx-1401
5255781|NCT02413801|Psoriasis|psoriasis
5255783|NCT02413788|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5255784|NCT02413788|inflammatory markers|inflammatory markers
5255785|NCT02413788|exercise|exercise
5255786|NCT02413749|Psoriatic Arthritis|psoriatic arthritis
5255787|NCT02413723|intubation|intubation
5255788|NCT02413723|critical care|critical care
5255789|NCT02413723|laryngoscope|laryngoscope
5255790|NCT02413723|videolaryngoscope|videolaryngoscope
5255791|NCT02413723|intratracheal|intratracheal
5255792|NCT02413658|Phenytoin|phenytoin
5255793|NCT02413658|Skin graft donor site|skin graft donor site
5255794|NCT02413658|Clean surgical site|clean surgical site
5255796|NCT02413632|HIV-positive MSM (men who have sex with men)|hiv-positive msm (men who have sex with men)
5255797|NCT02413632|asymptomatic sexually transmitted infections|asymptomatic sexually transmitted infections
5255799|NCT02413606|follow up care|follow up care
5255800|NCT02413606|satisfaction with care|satisfaction with care
5255801|NCT02413593|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5255803|NCT02413593|Sustained Virologic Response|sustained virologic response
5255804|NCT02413593|Direct Acting Antiviral|direct acting antiviral
5255805|NCT02413593|GS-7977|gs-7977
5255806|NCT02413593|GS-5885|gs-5885
5255807|NCT02413593|Ribavirin|ribavirin
5255808|NCT02413593|Sofosbuvir|sofosbuvir
5255809|NCT02413593|Ledipasvir|ledipasvir
5255810|NCT02413593|Hepatitis C|hepatitis c
5255811|NCT02413593|Hepatitis C, Chronic|hepatitis c, chronic
5255812|NCT02413554|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
5255813|NCT02413554|rivastigmine patch|rivastigmine patch
5255814|NCT02413554|post-operational delirium|post-operational delirium
5255815|NCT02413528|Patient Compliance|patient compliance
5255816|NCT02413528|Mobile Applications|mobile applications
5255817|NCT02413489|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5255818|NCT02413489|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5255819|NCT02413489|Lymphoma, Follicular|lymphoma, follicular
5255820|NCT02413489|Daratumumab|daratumumab
5255821|NCT02413476|robotic-assisted gastrectomy|robotic-assisted gastrectomy
5255822|NCT02413476|laparoscopic-assisted gastrectomy|laparoscopic-assisted gastrectomy
5255823|NCT02413476|gastric cancer|gastric cancer
5255824|NCT02413450|induced Pluripotent Stem Cells (iPSC)|induced pluripotent stem cells (ipsc)
5255825|NCT02413450|Channelopathies|channelopathies
5255826|NCT02413450|Catecholaminergic|catecholaminergic
5255827|NCT02413450|Arrhythmogenic|arrhythmogenic
5255828|NCT02413437|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5255829|NCT02413437|biopsy|biopsy
5255830|NCT02413424|sucralose|sucralose
5255831|NCT02413411|Arthroplasty|arthroplasty
5255832|NCT02413411|Osteoarthritis|osteoarthritis
5255833|NCT02413411|Replacement|replacement
5255834|NCT02413411|Intervention|intervention
5255835|NCT02413385|lifestyle intervention|lifestyle intervention
5255836|NCT02413385|physical activity|physical activity
5255837|NCT02413385|exercise|exercise
5255838|NCT02413385|eHealth|ehealth
5255839|NCT02413385|technology|technology
5255840|NCT02413385|coaching|coaching
5255841|NCT02413385|healthy eating|healthy eating
5255842|NCT02413372|First Line Therapy|first line therapy
5255843|NCT02413372|NASH|nash
5255844|NCT02413333|Contact lens solution|contact lens solution
5255845|NCT02413320|TNBC, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide|tnbc, breast cancer, neoadjuvant, carboplatin, docetaxel, paclitaxel, doxorubicin, cyclophosphamide
5255846|NCT02413307|Compassion Focused Therapy|compassion focused therapy
5255847|NCT02413281|Healthy Volunteer|healthy volunteer
5255848|NCT02413281|Abuse Liability|abuse liability
5255849|NCT02413281|ALKS 5461|alks 5461
5255850|NCT02413281|Alkermes|alkermes
5255851|NCT02413255|Drug therapy|drug therapy
5255852|NCT02413242|S. aureus|s. aureus
5255853|NCT02413242|P. aeruginosa|p. aeruginosa
5255854|NCT02413242|Colonization|colonization
5255855|NCT02413242|Pneumonia|pneumonia
5255857|NCT02413216|Tic Disorder|tic disorder
5255858|NCT02413216|Tourette|tourette
5255859|NCT02413216|Motor tic|motor tic
5255860|NCT02413216|Vocal tic|vocal tic
5255861|NCT02413216|Habit reversal training|habit reversal training
5255862|NCT02413216|CBIT|cbit
5255863|NCT02413216|TicHelper|tichelper
5255864|NCT02413216|Behavior Therapy|behavior therapy
5255865|NCT02413203|lipidomics|lipidomics
5255866|NCT02413203|ex vivo human whole blood assay|ex vivo human whole blood assay
5255867|NCT02413203|celecoxib|celecoxib
5255868|NCT02413203|selective COX-2 inhibitor|selective cox-2 inhibitor
5255869|NCT02413164|Schizophrenia|schizophrenia
5255870|NCT02413164|Mental Health|mental health
5255871|NCT02413164|Physical Therapy|physical therapy
5255872|NCT02413164|Quality of life|quality of life
5255873|NCT02413164|Stigma|stigma
5255874|NCT02413164|Positive and negative symptoms|positive and negative symptoms
5255875|NCT02413164|Physical fitness|physical fitness
5255876|NCT02413164|Physical activity|physical activity
5255877|NCT02413151|Exercise training|exercise training
5255878|NCT02413151|Cardiac resynchronization therapy|cardiac resynchronization therapy
5255879|NCT02413151|Autonomic nervous system modulation|autonomic nervous system modulation
5255880|NCT02413151|Chronic Heart failure|chronic heart failure
5255881|NCT02413138|GHD|ghd
5255882|NCT02413112|Aging|aging
5255883|NCT02413112|Sarcopenia|sarcopenia
5255884|NCT02413112|Resistance training|resistance training
5255885|NCT02413112|Strength|strength
5255886|NCT02413112|Muscle mass|muscle mass
5255887|NCT02413086|diabetic foot ulcer|diabetic foot ulcer
5255888|NCT02413086|early-stage amputation|early-stage amputation
5255889|NCT02413086|external therapy of herbs chitosan|external therapy of herbs chitosan
5255890|NCT02413086|wound surface healing|wound surface healing
5253238|NCT02427113|TMD|tmd
5255891|NCT02413073|whole body vibration|whole body vibration
5255893|NCT02413034|antibiotic|antibiotic
5255894|NCT02413021|Acute Myeloid Leukemia|acute myeloid leukemia
5255895|NCT02413021|Acute Lymphoid Leukemia|acute lymphoid leukemia
5255896|NCT02413021|deferasirox|deferasirox
5255897|NCT02413008|vaginal atrophy|vaginal atrophy
5255898|NCT02413008|breast cancer|breast cancer
5255899|NCT02413008|vaginal dryness|vaginal dryness
5255900|NCT02413008|aromatase inhibitor|aromatase inhibitor
5255901|NCT02412995|sea buckthorn|sea buckthorn
5255902|NCT02412995|strawberry|strawberry
5255903|NCT02412995|glucose response|glucose response
5255904|NCT02412995|satiety|satiety
5255905|NCT02412995|metabolomics|metabolomics
5255906|NCT02412995|intake biomarker|intake biomarker
5255907|NCT02412956|mHealth|mhealth
5255908|NCT02412904|follicular stimulating hormone|follicular stimulating hormone
5255909|NCT02412904|human menopausal gonadotrophin|human menopausal gonadotrophin
5255910|NCT02412904|Recombinant follicular stimulating hormone (rFSH)|recombinant follicular stimulating hormone (rfsh)
5255911|NCT02412904|Gonadotrophin releasing hormone (GnRH) antagonists|gonadotrophin releasing hormone (gnrh) antagonists
5255912|NCT02412904|GnRH agonist|gnrh agonist
5255913|NCT02412904|in vitro fertilization|in vitro fertilization
5255914|NCT02412904|controled ovarian stimulation|controled ovarian stimulation
5255915|NCT02412904|number of mature oocytes|number of mature oocytes
5255916|NCT02412891|introduction of urinary catheter|introduction of urinary catheter
5255917|NCT02412865|mhealth|mhealth
5255918|NCT02412852|neuropathy|neuropathy
5255919|NCT02412826|pancreatitis|pancreatitis
5255920|NCT02412826|acoustic|acoustic
5255921|NCT02412826|sensor|sensor
5255922|NCT02412813|hypersensitivity|hypersensitivity
5255923|NCT02412813|metal sensitivity|metal sensitivity
5255925|NCT02412813|implant-related hypersensitivity|implant-related hypersensitivity
5255926|NCT02412813|metal-on-metal implants|metal-on-metal implants
5903727|NCT00339924|Genetics|genetics
5255927|NCT02412813|knee revision|knee revision
5255928|NCT02412800|Extravascular lung water|extravascular lung water
5255929|NCT02412800|Pulmonary vascualr permeability index|pulmonary vascualr permeability index
5255930|NCT02412800|Liver transplantation|liver transplantation
5255931|NCT02412774|diet beverages|diet beverages
5255932|NCT02412774|water|water
5255933|NCT02412774|diabetes|diabetes
5255934|NCT02412774|weight loss|weight loss
5255935|NCT02412774|insulin sensitivity|insulin sensitivity
5255936|NCT02412761|Anti-hypertensive medications|anti-hypertensive medications
5255937|NCT02412761|Pediatrics|pediatrics
5255938|NCT02412761|N-of-1 trial|n-of-1 trial
5255942|NCT02412735|Chronic Lumbar Back Pain|chronic lumbar back pain
5255944|NCT02412735|Back pain|back pain
5255945|NCT02412735|Degenerative Disc Disease|degenerative disc disease
5255946|NCT02412735|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
5255947|NCT02412735|Intervertebral Disc Degeneration|intervertebral disc degeneration
5255948|NCT02412735|Bone Diseases|bone diseases
5255949|NCT02412735|Musculoskeletal Diseases|musculoskeletal diseases
5255950|NCT02412735|Nervous System Diseases|nervous system diseases
5255951|NCT02412735|Neurologic Manifestations|neurologic manifestations
5255952|NCT02412735|Pain|pain
5255953|NCT02412735|Spinal Diseases|spinal diseases
5255954|NCT02412735|Stem Cells|stem cells
5255955|NCT02412735|Adult Stem Cells|adult stem cells
5255956|NCT02412735|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
5255957|NCT02412735|Mesoblast|mesoblast
5255958|NCT02412735|Hyaluronic Acid|hyaluronic acid
5255959|NCT02412735|Pharmaceutical Solutions|pharmaceutical solutions
5151043|NCT03048344|APL|apl
5255960|NCT02412735|Adjuvants, Immunologic|adjuvants, immunologic
5255961|NCT02412735|Immunologic Factors|immunologic factors
5255962|NCT02412735|Pharmacologic Actions|pharmacologic actions
5255963|NCT02412735|Protective Agents|protective agents
5255964|NCT02412735|rexlemestrocel-L|rexlemestrocel-l
5255965|NCT02412735|Viscosupplements|viscosupplements
5255967|NCT02412709|Long QT Syndrome|long qt syndrome
5255968|NCT02412709|LQTS|lqts
5255969|NCT02412709|genetic testing|genetic testing
5255970|NCT02412709|ECG|ecg
5255971|NCT02412709|saliva testing|saliva testing
5255975|NCT02412592|HBeAg positive|hbeag positive
5255976|NCT02412592|interferon|interferon
5255977|NCT02412592|peginterferon|peginterferon
5255978|NCT02412592|HBeAg seroconversion|hbeag seroconversion
5255979|NCT02412592|sustained viral response|sustained viral response
5255980|NCT02412592|relapse|relapse
5255983|NCT02412566|cholestasis|cholestasis
5255984|NCT02412566|growth failure|growth failure
5255985|NCT02412566|intravenous fat emulsion|intravenous fat emulsion
5255986|NCT02412566|SMOF|smof
5255987|NCT02412514|polio|polio
5255988|NCT02412514|inactivated poliovirus vaccine|inactivated poliovirus vaccine
5255989|NCT02412514|oral poliovirus vaccine|oral poliovirus vaccine
5255990|NCT02412514|IPV|ipv
5255991|NCT02412514|OPV|opv
5255992|NCT02412462|Phase I|phase i
5255993|NCT02412462|Clusterin|clusterin
5255994|NCT02412462|Epithelial-to-Mesenchymal Transition (EMT)|epithelial-to-mesenchymal transition (emt)
5255995|NCT02412462|Circulating Tumor Cells (CTC)|circulating tumor cells (ctc)
5253349|NCT02426541|Placebo|placebo
5255997|NCT02412462|Pharmacokinetics|pharmacokinetics
5255998|NCT02412449|Pharmacokinetics|pharmacokinetics
5255999|NCT02412449|Anemia|anemia
5256000|NCT02412449|Chronic kidney disease|chronic kidney disease
5256001|NCT02412449|CKD|ckd
5256002|NCT02412449|Renal impairment|renal impairment
5256003|NCT02412449|Chronic renal insufficiency|chronic renal insufficiency
5256004|NCT02412449|Ferrous sulfate|ferrous sulfate
5256005|NCT02412449|Iron|iron
5256006|NCT02412449|End stage renal disease|end stage renal disease
5256007|NCT02412449|Dialysis|dialysis
5256008|NCT02412449|Oral anemia treatment|oral anemia treatment
5256009|NCT02412449|Bioavailability|bioavailability
5256010|NCT02412449|Erythropoietin|erythropoietin
5256011|NCT02412449|Hypoxia-inducible factor|hypoxia-inducible factor
5256012|NCT02412449|Volunteers|volunteers
5256013|NCT02412410|laborist|laborist
5256014|NCT02412410|efficacy|efficacy
5256015|NCT02412410|sleep|sleep
5256016|NCT02412410|fatigue|fatigue
5256017|NCT02412410|SAFTE|safte
5256018|NCT02412410|cognition|cognition
5256019|NCT02412397|Shoulder|shoulder
5256020|NCT02412384|Lung Neoplasms|lung neoplasms
5256021|NCT02412384|Circulating Tumor Cells|circulating tumor cells
5256022|NCT02412371|veliparib|veliparib
5256023|NCT02412371|PARP inhibitor|parp inhibitor
5256024|NCT02412371|ABT-888|abt-888
5256025|NCT02412371|first line|first line
5256026|NCT02412371|previously untreated|previously untreated
5256027|NCT02412371|stage III|stage iii
5256028|NCT02412371|non-small cell lung cancer|non-small cell lung cancer
5256029|NCT02412371|radiotherapy|radiotherapy
5256030|NCT02412371|paclitaxel|paclitaxel
5256031|NCT02412371|carboplatin|carboplatin
5256032|NCT02412358|toothbrushing|toothbrushing
5256033|NCT02412358|plaque control|plaque control
5256034|NCT02412358|gingivitis|gingivitis
5256035|NCT02412345|Erectile Dysfunction|erectile dysfunction
5256036|NCT02412345|Shockwave therapy|shockwave therapy
5256037|NCT02412345|Renal Transplant|renal transplant
5256038|NCT02412345|Male|male
5256039|NCT02412345|Renal Transplant Recipients|renal transplant recipients
5256040|NCT02412332|advanced COPD (stage III)|advanced copd (stage iii)
5256434|NCT02410057|amino acids|amino acids
5256041|NCT02412332|Adult stem cells|adult stem cells
5256042|NCT02412332|Cell therapy|cell therapy
5256043|NCT02412319|HBeAg positive chronic hepatitis B|hbeag positive chronic hepatitis b
5256044|NCT02412319|HBeAg serum conversion rate|hbeag serum conversion rate
5256045|NCT02412319|HBeAg serum disappearance rate|hbeag serum disappearance rate
5256046|NCT02412319|HBeAg and HBsAg titer|hbeag and hbsag titer
5256047|NCT02412306|Amgen|amgen
5256048|NCT02412293|Perinatal|perinatal
5256049|NCT02412293|neonatal|neonatal
5256050|NCT02412293|newborn|newborn
5256051|NCT02412293|mortality|mortality
5256052|NCT02412189|Anesthesia|anesthesia
5256053|NCT02412189|Blood pressure|blood pressure
5256054|NCT02412189|Plasma volume|plasma volume
5256055|NCT02412189|Vasopressor agents|vasopressor agents
5256056|NCT02412189|Continuous noninvasive hemoglobin measurement|continuous noninvasive hemoglobin measurement
5256057|NCT02412189|Coronary artery bypass|coronary artery bypass
5256058|NCT02412176|pacemaker|pacemaker
5256059|NCT02412176|dyssynchrony|dyssynchrony
5256060|NCT02412176|apical pacing|apical pacing
5256061|NCT02412176|mid-septum|mid-septum
5256062|NCT02412098|Hepatic Impairment|hepatic impairment
5256063|NCT02412085|golimumab|golimumab
5256064|NCT02412085|ulcerative colitis|ulcerative colitis
5256065|NCT02412085|steroid-dependent|steroid-dependent
5256066|NCT02412072|Endometrial hyperplasia|endometrial hyperplasia
5256067|NCT02412072|Progesterone|progesterone
5256068|NCT02412072|LNG-IUS|lng-ius
5256069|NCT02412072|dilatation & curettage|dilatation & curettage
5256070|NCT02412072|endometrial aspiration sampling|endometrial aspiration sampling
5256071|NCT02412046|Pressure ulcer|pressure ulcer
5256072|NCT02412046|Interface pressure|interface pressure
5256073|NCT02412046|Pressure mapping device|pressure mapping device
5256074|NCT02412046|Ischemia reperfusion|ischemia reperfusion
5256075|NCT02412046|Monitoring|monitoring
5256076|NCT02412046|Microvascularization|microvascularization
5256077|NCT02412033|vaginal misoprostol|vaginal misoprostol
5256078|NCT02412007|spastic diplegia;cerebral palsy;activity based therapy|spastic diplegia;cerebral palsy;activity based therapy
5256079|NCT02411981|Lung Clearance Index|lung clearance index
5256080|NCT02411981|Non cystic fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
5256081|NCT02411981|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
5256082|NCT02411968|Cryosurgery|cryosurgery
5256083|NCT02411968|Carcinoma, renal cell|carcinoma, renal cell
5256084|NCT02411968|Diagnostic Imaging|diagnostic imaging
5256085|NCT02411968|Diagnostic techniques, urological|diagnostic techniques, urological
5256086|NCT02411968|Radionuclide imaging|radionuclide imaging
5256087|NCT02411968|Follow up|follow up
5256088|NCT02411903|Clopidogrel-drug interactions|clopidogrel-drug interactions
5256089|NCT02411890|postoperative pain|postoperative pain
5256090|NCT02411890|femoral nerve block|femoral nerve block
5256091|NCT02411890|adductor canal block|adductor canal block
5253451|NCT02425722|linaclotide|linaclotide
5256097|NCT02411877|Cerebral infarction|cerebral infarction
5256098|NCT02411877|Ischemia|ischemia
5256099|NCT02411877|Cerebrovascular disorder|cerebrovascular disorder
5256100|NCT02411877|Brain disease|brain disease
5256101|NCT02411877|Central nervous system disease|central nervous system disease
5256102|NCT02411877|Nervous system disease|nervous system disease
5256103|NCT02411877|Vascular disease|vascular disease
5256104|NCT02411877|Cardiovascular disease|cardiovascular disease
5256105|NCT02411877|Brain infarction|brain infarction
5256106|NCT02411877|Brain ischemia|brain ischemia
5256107|NCT02411877|Pathologic process|pathologic process
5256108|NCT02411877|Body temperature change|body temperature change
5256109|NCT02411877|Signs and symptoms|signs and symptoms
5256110|NCT02411864|IVIM|ivim
5256111|NCT02411864|brain|brain
5256112|NCT02411864|diffusion-weighted imaging|diffusion-weighted imaging
5256113|NCT02411851|Actinic Keratoses|actinic keratoses
5256114|NCT02411838|Multiple sclerosis|multiple sclerosis
5256115|NCT02411838|calorie restriction|calorie restriction
5256116|NCT02411838|adipokines|adipokines
5256117|NCT02411812|Orthodontic Appliances, Functional|orthodontic appliances, functional
5256118|NCT02411812|Herbst Appliance|herbst appliance
5256119|NCT02411812|Malocclusion, Angle Class II|malocclusion, angle class ii
5256121|NCT02411747|Medical|medical
5256122|NCT02411747|Urology|urology
5256123|NCT02411747|Randomized Controlled Trial|randomized controlled trial
5256124|NCT02411747|Endoscopy|endoscopy
5339463|NCT01997372|ATG|atg
5243754|NCT02481583|bioavailability|bioavailability
5243755|NCT02481570|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5243756|NCT02481570|Scoliosis surgery|scoliosis surgery
5243759|NCT02481518|Acute kidney injury|acute kidney injury
5256125|NCT02411747|Cystoscopy|cystoscopy
5256126|NCT02411721|Anxiety|anxiety
5256127|NCT02411721|Dog Intervention|dog intervention
5256128|NCT02411721|MRI|mri
5256129|NCT02411721|Children|children
5256130|NCT02411695|Adolescent|adolescent
5256132|NCT02411695|Brexpiprazole|brexpiprazole
5256133|NCT02411669|Patient centred care|patient centred care
5256134|NCT02411630|PrEP|prep
5256135|NCT02411630|HIV Prevention|hiv prevention
5256136|NCT02411578|T1D|t1d
5256137|NCT02411578|Type 1 diabetes|type 1 diabetes
5256138|NCT02411578|Mini-dose glucagon|mini-dose glucagon
5256139|NCT02411578|adults|adults
5256140|NCT02411578|non-severe hypoglycemia|non-severe hypoglycemia
5256141|NCT02411565|epithelial|epithelial
5256142|NCT02411565|ovarian|ovarian
5256143|NCT02411565|fallopian tube|fallopian tube
5256144|NCT02411565|primary peritoneal carcinoma|primary peritoneal carcinoma
5256145|NCT02411565|peritoneal|peritoneal
5256146|NCT02411565|ovary|ovary
5256147|NCT02411539|HIV|hiv
5256148|NCT02411539|VRC01|vrc01
5256149|NCT02411500|Healthy|healthy
5256150|NCT02411500|Male|male
5256151|NCT02411500|Pharmacokinetics|pharmacokinetics
5256152|NCT02411474|stem cell transplantation (SCT)|stem cell transplantation (sct)
5256153|NCT02411461|Pediatric obesity|pediatric obesity
5256154|NCT02411461|pseudohypoparathyroidism|pseudohypoparathyroidism
5256155|NCT02411461|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5256156|NCT02411435|rifampin|rifampin
5256157|NCT02411435|drug interaction|drug interaction
5256158|NCT02411435|pharmacokinetics|pharmacokinetics
5256159|NCT02411435|cabotegravir|cabotegravir
5256160|NCT02411422|intubation|intubation
5256161|NCT02411422|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5256162|NCT02411422|manikins|manikins
5256163|NCT02411409|Health Information Technology (HIT)|health information technology (hit)
5256164|NCT02411409|self-care|self-care
5256165|NCT02411383|Diaphragm pacing|diaphragm pacing
5256166|NCT02411383|Respiratory assistance|respiratory assistance
5256167|NCT02411383|Lung transplant|lung transplant
5256168|NCT02411357|Contraception|contraception
5256169|NCT02411357|Unintended pregnancy|unintended pregnancy
5256170|NCT02411357|HIV risk|hiv risk
5256171|NCT02411357|Sexually transmitted infections|sexually transmitted infections
5256172|NCT02411357|Women|women
5256173|NCT02411357|Pregnancy|pregnancy
5256174|NCT02411357|Neonatal health|neonatal health
5256175|NCT02411357|Drug use|drug use
5256176|NCT02411357|Drug treatment|drug treatment
5256177|NCT02411357|Opioids|opioids
5256178|NCT02411344|HER2+/HR+|her2+/hr+
5256179|NCT02411344|breast cancer|breast cancer
5256180|NCT02411331|Lock Solution|lock solution
5256181|NCT02411331|Catheter related blood stream infections|catheter related blood stream infections
5256182|NCT02411331|Central venous catheter infection|central venous catheter infection
5256185|NCT02411331|Ethanol lock solution|ethanol lock solution
5256187|NCT02411279|Heart failure|heart failure
5256188|NCT02411279|telemonitoring|telemonitoring
5256189|NCT02411279|intrusive sensors|intrusive sensors
5256190|NCT02411279|intrusive devices|intrusive devices
5256191|NCT02411279|Heart failure stage II|heart failure stage ii
5256192|NCT02411279|Heart failure stage III|heart failure stage iii
5256193|NCT02411279|heart disease|heart disease
5256194|NCT02411253|IL2|il2
5256195|NCT02411253|Interleukin 2|interleukin 2
5256196|NCT02411253|IL-2|il-2
5256197|NCT02411253|Auto-immune disease|auto-immune disease
5256198|NCT02411253|Insulin|insulin
5256199|NCT02411253|Diabetes|diabetes
5256200|NCT02411253|Regulatory T cells|regulatory t cells
5256201|NCT02411253|Treg|treg
5256202|NCT02411253|Immunoregulation|immunoregulation
5256203|NCT02411253|Immune tolerance|immune tolerance
5256204|NCT02411253|Immunotherapy|immunotherapy
5256205|NCT02411240|Air filtration|air filtration
5256206|NCT02411240|cardiovascular health|cardiovascular health
5256207|NCT02411240|cognition|cognition
5256208|NCT02411240|particulate matter|particulate matter
5256209|NCT02411240|mitochondrial DNA|mitochondrial dna
5256210|NCT02411227|Neuropsychologic Testing|neuropsychologic testing
5256211|NCT02411227|Neurocognitive|neurocognitive
5256212|NCT02411227|Virtual Reality|virtual reality
5256213|NCT02411227|Rehabilitation|rehabilitation
5256214|NCT02411227|Driving|driving
5256215|NCT02411175|Constipation|constipation
5256216|NCT02411175|Homeopathy|homeopathy
5256217|NCT02411162|atopic dermatitis|atopic dermatitis
5256218|NCT02411162|FLIM|flim
5256219|NCT02411162|chronic plaque psoriasis|chronic plaque psoriasis
5256220|NCT02411162|healthy volunteers|healthy volunteers
5256221|NCT02411162|GSK2894512|gsk2894512
5256222|NCT02411162|Skin residency|skin residency
5256223|NCT02411149|Adductor Canal Block|adductor canal block
5136971|NCT03136081|Septic shock|septic shock
5256224|NCT02411149|Total Knee Arthroplasty|total knee arthroplasty
5256225|NCT02411123|PGx|pgx
5256226|NCT02411123|pharmacogenetics|pharmacogenetics
5256227|NCT02411123|depression|depression
5256228|NCT02411123|anxiety|anxiety
5256229|NCT02411123|Neuropsychiatric diseases|neuropsychiatric diseases
5256230|NCT02411123|IDgenetix|idgenetix
5256231|NCT02411123|AltheaDx|altheadx
5256232|NCT02411097|Deep venous thromboembolism|deep venous thromboembolism
5256233|NCT02411097|Femoral nerve block|femoral nerve block
5256234|NCT02411097|Total knee arthroplasty|total knee arthroplasty
5256235|NCT02411084|Graft vs Host Disease|graft vs host disease
5256236|NCT02411084|Immune System Diseases|immune system diseases
5256237|NCT02411084|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
5256238|NCT02411084|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5256239|NCT02411084|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5256241|NCT02411071|antiretroviral treatment|antiretroviral treatment
5256242|NCT02411071|low viral load|low viral load
5256243|NCT02411071|low-level viremia|low-level viremia
5256244|NCT02411058|information|information
5256245|NCT02411058|incentives|incentives
5256246|NCT02411045|Indirect incentives|indirect incentives
5256247|NCT02411045|Exercise more|exercise more
5256248|NCT02411019|Phase 2 follow up|phase 2 follow up
5256249|NCT02411019|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5256250|NCT02411019|Adult|adult
5256251|NCT02411019|Safety|safety
5256252|NCT02411019|Efficacy|efficacy
5256253|NCT02410941|Randomized controlled trial|randomized controlled trial
5256254|NCT02410941|Practice management|practice management
5256255|NCT02410941|tomography, x-ray computed/adverse effects|tomography, x-ray computed/adverse effects
5256256|NCT02410941|Clinical decision support|clinical decision support
5256257|NCT02410941|Computerized clinical decision support|computerized clinical decision support
5256258|NCT02410941|Decision support systems, clinical|decision support systems, clinical
5256259|NCT02410941|Health Expenditures|health expenditures
5256260|NCT02410941|Physician's practice patterns|physician's practice patterns
5256261|NCT02410941|Unnecessary Procedures/economics|unnecessary procedures/economics
5256262|NCT02410941|Physician's Practice Patterns/economics|physician's practice patterns/economics
5256263|NCT02410941|Diffusion of innovation|diffusion of innovation
5256264|NCT02410941|Decision Support Models|decision support models
5256265|NCT02410941|Clinical Prediction Rules|clinical prediction rules
5256266|NCT02410915|Rehabilitation|rehabilitation
5256267|NCT02410915|Robotics|robotics
5256268|NCT02410902|Autism|autism
5256269|NCT02410876|Bladder|bladder
5256270|NCT02410876|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5256271|NCT02410876|benign prostatic obstruction|benign prostatic obstruction
5256272|NCT02410863|Stage III or IV with BRAF V600E/K mutation|stage iii or iv with braf v600e/k mutation
5256273|NCT02410850|Oral Appliance|oral appliance
5256274|NCT02410850|objective adherence|objective adherence
5256275|NCT02410850|cardiovascular events|cardiovascular events
5256276|NCT02410850|cardiovascular mortality|cardiovascular mortality
5256277|NCT02410850|cerebrovascular mortality|cerebrovascular mortality
5256278|NCT02410850|cost effectiveness|cost effectiveness
5256279|NCT02410837|lung lesion|lung lesion
5256280|NCT02410837|biopsy|biopsy
5256281|NCT02410837|bronchoscopy|bronchoscopy
5256282|NCT02410811|Sickle Cell Disease (SCD)|sickle cell disease (scd)
5256283|NCT02410811|Cardiac Magnetic Resonance Imaging (CMR)|cardiac magnetic resonance imaging (cmr)
5256285|NCT02410811|Pulmonary Hypertension|pulmonary hypertension
5256286|NCT02410785|obesity,|obesity,
5256287|NCT02410785|body weight,|body weight,
5256288|NCT02410785|overweight,|overweight,
5256289|NCT02410785|weight loss,|weight loss,
5256290|NCT02410785|polyglucosamine,|polyglucosamine,
5256291|NCT02410785|L112|l112
5256292|NCT02410785|caloric restriction|caloric restriction
5256293|NCT02410785|physical activity|physical activity
5256294|NCT02410746|pain|pain
5256295|NCT02410746|surgery|surgery
5256296|NCT02410733|melanoma|melanoma
5256297|NCT02410733|Lipo-MERIT|lipo-merit
5256298|NCT02410733|cancer vaccine|cancer vaccine
5256299|NCT02410733|RB_0003-01|rb_0003-01
5256300|NCT02410733|BioNTech|biontech
5256301|NCT02410733|BioNTech RNA Pharmaceuticals|biontech rna pharmaceuticals
5256302|NCT02410733|BioNTech RNA|biontech rna
5256303|NCT02410733|RNA|rna
5256304|NCT02410720|Colonoscopy Preparation|colonoscopy preparation
5256305|NCT02410720|Polyethylene Glycols|polyethylene glycols
5256306|NCT02410720|Mobile application|mobile application
5256307|NCT02410720|Software|software
5256308|NCT02410720|Compliance|compliance
5256309|NCT02410720|Patient Compliance|patient compliance
5256310|NCT02410720|Adherence|adherence
5256311|NCT02410707|procedural sedation|procedural sedation
5256312|NCT02410707|procedural pain|procedural pain
5256313|NCT02410707|procedural anxiolysis|procedural anxiolysis
5256314|NCT02410655|Uterine atony|uterine atony
5256315|NCT02410655|Postpartum hemorrhage|postpartum hemorrhage
5256316|NCT02410655|Vaginal delivery|vaginal delivery
5256317|NCT02410655|Uterotonic|uterotonic
5137082|NCT03135236|Parent training|parent training
5256320|NCT02410655|Evidence-based|evidence-based
5256321|NCT02410655|Protocol|protocol
5256322|NCT02410642|cardiopulmonary bypass|cardiopulmonary bypass
5256323|NCT02410629|Stroke|stroke
5256324|NCT02410616|Psychotherapy|psychotherapy
5256325|NCT02410616|Comparative Effectiveness Research|comparative effectiveness research
5256326|NCT02410616|Randomized Controlled Trial|randomized controlled trial
5256327|NCT02410616|Secondary Care|secondary care
5256328|NCT02410603|Chemotherapy|chemotherapy
5256329|NCT02410577|89Zr-J591|89zr-j591
5256330|NCT02410577|15-002|15-002
5256331|NCT02410564|insomnia|insomnia
5256332|NCT02410564|Sleep|sleep
5256333|NCT02410564|CBT-I intervention|cbt-i intervention
5256334|NCT02410564|SHUTi|shuti
5256335|NCT02410551|Myeloproliferative Diseases|myeloproliferative diseases
5256336|NCT02410551|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5256337|NCT02410551|MPN|mpn
5256338|NCT02410551|Myelofibrosis|myelofibrosis
5256341|NCT02410551|Essential thrombocythemia|essential thrombocythemia
5256342|NCT02410551|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5256343|NCT02410551|Allo TP|allo tp
5256344|NCT02410551|Pacritinib|pacritinib
5256345|NCT02410551|Busulfan|busulfan
5256346|NCT02410551|Busulfex|busulfex
5256347|NCT02410551|Myleran|myleran
5256348|NCT02410551|Questionnaires|questionnaires
5256349|NCT02410551|Surveys|surveys
5256350|NCT02410551|Phone calls|phone calls
5256351|NCT02410525|hyperlipidemia|hyperlipidemia
5256352|NCT02410525|positron emission tomography|positron emission tomography
5256353|NCT02410499|Drug therapy|drug therapy
5256354|NCT02410473|Congenital Heart Disease|congenital heart disease
5256355|NCT02410473|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
5256356|NCT02410447|Shock waves|shock waves
5256357|NCT02410434|Stigma|stigma
5256358|NCT02410434|lesbian|lesbian
5256360|NCT02410434|bisexual|bisexual
5256361|NCT02410434|transgender|transgender
5256362|NCT02410421|Individualized Medicine|individualized medicine
5256363|NCT02410421|Functional Neuroimaging|functional neuroimaging
5256364|NCT02410421|Robotic Proceedure|robotic proceedure
5151454|NCT03045354|obesity|obesity
5256365|NCT02410421|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5256366|NCT02410421|Transcranial Direct Current Stimulation Monocentric|transcranial direct current stimulation monocentric
5256367|NCT02410421|Compariative Cross-Over 3 Arms Study Randomized, Single-Blind Method|compariative cross-over 3 arms study randomized, single-blind method
5256368|NCT02410408|Patient Safety|patient safety
5256369|NCT02410408|App|app
5256370|NCT02410408|Root Cause Analysis|root cause analysis
5256371|NCT02410408|Patient Safety Certification|patient safety certification
5256372|NCT02410382|cancer|cancer
5256373|NCT02410382|radiation therapy|radiation therapy
5256374|NCT02410382|chemotherapy|chemotherapy
5256375|NCT02410382|dexamethasone|dexamethasone
5256376|NCT02410382|corticosteroids|corticosteroids
5256377|NCT02410343|long acting growth hormone|long acting growth hormone
5256378|NCT02410330|Therapeutic ultrasound|therapeutic ultrasound
5256382|NCT02410317|Postoperative pain|postoperative pain
5256383|NCT02410317|Postoperative morphine consumption|postoperative morphine consumption
5256384|NCT02410317|Emergency cesarean delivery|emergency cesarean delivery
5256385|NCT02410317|Ropivacaine|ropivacaine
5256386|NCT02410317|Local anesthetic wound 48-hours infusion|local anesthetic wound 48-hours infusion
5256389|NCT02410265|guided self-help|guided self-help
5256390|NCT02410265|student mental health|student mental health
5256391|NCT02410265|task shifting|task shifting
5256392|NCT02410265|prevention|prevention
5256393|NCT02410252|continuous temperature monitoring|continuous temperature monitoring
5256394|NCT02410252|patient self-management|patient self-management
5256395|NCT02410252|iThermonitor|ithermonitor
5256396|NCT02410252|Home monitoring|home monitoring
5256397|NCT02410239|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
5256398|NCT02410239|cALD|cald
5256399|NCT02410200|Pediatrics|pediatrics
5256400|NCT02410187|stereotactic body radiotherapy|stereotactic body radiotherapy
5256401|NCT02410174|Renal Cell Carcinoma|renal cell carcinoma
5256402|NCT02410174|RCC|rcc
5256403|NCT02410174|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5256404|NCT02410174|SBRT|sbrt
5256405|NCT02410161|ketone|ketone
5256406|NCT02410161|α-linolenic acid|α-linolenic acid
5256407|NCT02410161|flaxseed|flaxseed
5256408|NCT02410161|aging|aging
5256409|NCT02410161|β-hydroxybutyrate|β-hydroxybutyrate
5256410|NCT02410161|acetoacetate|acetoacetate
5256411|NCT02410161|omega-3 fatty acids|omega-3 fatty acids
5256412|NCT02410161|ketogenesis|ketogenesis
5256413|NCT02410148|open-angle glaucoma|open-angle glaucoma
5256414|NCT02410148|papilledema|papilledema
5256415|NCT02410148|non-invasive ICP|non-invasive icp
5256416|NCT02410148|Intracranial pressure|intracranial pressure
5256417|NCT02410135|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5256418|NCT02410135|Sleep Disturbance|sleep disturbance
5256419|NCT02410096|exercise-induced asthma|exercise-induced asthma
5256420|NCT02410096|cold chamber|cold chamber
5256421|NCT02410096|exercise challenge|exercise challenge
5256422|NCT02410096|cold air challenge|cold air challenge
5256423|NCT02410096|oil supplementation|oil supplementation
5256424|NCT02410096|middle-chain and Polyunsaturated Fatty Acids|middle-chain and polyunsaturated fatty acids
5256425|NCT02410070|Distal radial fracture|distal radial fracture
5256426|NCT02410070|pronator quadratus|pronator quadratus
5256427|NCT02410070|mini-approach|mini-approach
5256428|NCT02410070|volar plating|volar plating
5256429|NCT02410070|open reduction and internal fixation|open reduction and internal fixation
5256430|NCT02410057|growth|growth
5256431|NCT02410057|formula|formula
5256432|NCT02410057|protein|protein
5256433|NCT02410057|alpha-lactalbumin|alpha-lactalbumin
5256435|NCT02410057|metabolomics|metabolomics
5256436|NCT02410057|microbiota|microbiota
5256437|NCT02410044|Patient Reported Outcomes|patient reported outcomes
5256438|NCT02409992|Children with ODD and low prosocial emotions|children with odd and low prosocial emotions
5256439|NCT02409979|colonoscopy|colonoscopy
5256440|NCT02409979|carbon dioxide|carbon dioxide
5256441|NCT02409979|water exchange|water exchange
5256442|NCT02409979|discomfort|discomfort
5256443|NCT02409979|colonoscopy pain|colonoscopy pain
5256444|NCT02409966|periodontitis|periodontitis
5256445|NCT02409966|therapeutics|therapeutics
5256446|NCT02409966|quality of life|quality of life
5256447|NCT02409966|fear|fear
5256448|NCT02409966|anxiety|anxiety
5256449|NCT02409966|pain|pain
5256450|NCT02409953|volunteers|volunteers
5256451|NCT02409927|Medium-chain triglycerides|medium-chain triglycerides
5256452|NCT02409927|Metabolism|metabolism
5256453|NCT02409927|Ketones|ketones
5256454|NCT02409927|Lipids|lipids
5256455|NCT02409927|Emulsification|emulsification
5256456|NCT02409914|Insulin Resistance|insulin resistance
5256457|NCT02409914|Brain metabolism|brain metabolism
5256459|NCT02409914|MRI|mri
5256460|NCT02409901|Physical Activity|physical activity
5256461|NCT02409901|Exercise Rehabilitation|exercise rehabilitation
5256462|NCT02409901|Kidney Function|kidney function
5256463|NCT02409901|Employment|employment
5256464|NCT02409901|Kidney Transplant|kidney transplant
5256465|NCT02409875|early intervention|early intervention
5256466|NCT02409875|obesity|obesity
5256467|NCT02409875|body weight|body weight
5151554|NCT03044743|EBV|ebv
5256468|NCT02409875|body mass index|body mass index
5256469|NCT02409875|overnutrition|overnutrition
5256470|NCT02409875|early promoters, genetic|early promoters, genetic
5256471|NCT02409862|oxytocin|oxytocin
5256472|NCT02409862|socioemotional functioning|socioemotional functioning
5256473|NCT02409862|aging|aging
5256474|NCT02409849|Octreotide LAR|octreotide lar
5256475|NCT02409849|Neuroendocrine carcinomas|neuroendocrine carcinomas
5256476|NCT02409849|unresectable or metastatic|unresectable or metastatic
5256477|NCT02409849|Disease-free survival|disease-free survival
5256478|NCT02409823|adverse drug reactions|adverse drug reactions
5256479|NCT02409823|adherence to treatment|adherence to treatment
5256480|NCT02409823|quality of life|quality of life
5256481|NCT02409823|clinical status|clinical status
5256482|NCT02409784|Brain metabolism|brain metabolism
5256483|NCT02409784|Ketones|ketones
5256484|NCT02409784|Ketogenic diet|ketogenic diet
5256485|NCT02409784|TEP scan|tep scan
5256486|NCT02409758|Voice disorders|voice disorders
5256487|NCT02409758|Hoarseness|hoarseness
5256488|NCT02409758|Therapy|therapy
5256489|NCT02409745|endometrial scratch|endometrial scratch
5256490|NCT02409745|IVF|ivf
5256492|NCT02409745|Prospective controlled trial|prospective controlled trial
5256493|NCT02409745|Different time to perform endometrial scratch|different time to perform endometrial scratch
5256494|NCT02409745|In vitro fertilization|in vitro fertilization
5256495|NCT02409745|embryo transfer|embryo transfer
5256496|NCT02409732|Actinic cheilitis|actinic cheilitis
5256497|NCT02409732|Photodynamic therapy|photodynamic therapy
5256498|NCT02409732|Levulan|levulan
5256499|NCT02409732|Blue light|blue light
5256500|NCT02409719|Arthritis, Degenerative|arthritis, degenerative
5256501|NCT02409719|Recovery of function|recovery of function
5256502|NCT02409706|Paediatric|paediatric
5256503|NCT02409706|Critical care|critical care
5256504|NCT02409706|Micronutrients|micronutrients
5256505|NCT02409680|Preterm birth|preterm birth
5256506|NCT02409680|Low dose aspirin|low dose aspirin
5256507|NCT02409667|plaque, psoriasis|plaque, psoriasis
5256508|NCT02409641|IOL|iol
5256509|NCT02409628|Non-melanoma Skin Cancer|non-melanoma skin cancer
5256510|NCT02409628|Basal Cell Carcinoma|basal cell carcinoma
5256511|NCT02409628|Squamous Cell Carcinoma|squamous cell carcinoma
5256512|NCT02409628|Surgical excision|surgical excision
5256513|NCT02409628|EktoTherix|ektotherix
5256514|NCT02409628|Secondary intention healing|secondary intention healing
5256515|NCT02409628|Acute wound repair|acute wound repair
5256516|NCT02409628|Tissue repair scaffold|tissue repair scaffold
5256517|NCT02409628|Regenerative medicine scaffold|regenerative medicine scaffold
5256518|NCT02409628|Electrospun scaffold|electrospun scaffold
5256519|NCT02409615|Complementary therapies|complementary therapies
5256520|NCT02409615|Hypnosis|hypnosis
5256521|NCT02409615|Healing Touch|healing touch
5256522|NCT02409602|Ultrasonography, Doppler, Color|ultrasonography, doppler, color
5256523|NCT02409602|Postpartum hemorrhage|postpartum hemorrhage
5256524|NCT02409602|Bilateral iliac artery ligation|bilateral iliac artery ligation
5256525|NCT02409602|Dorsal clitoral artery|dorsal clitoral artery
5256527|NCT02409576|RMS|rms
5256528|NCT02409550|Allergic Rhinitis|allergic rhinitis
5256529|NCT02409550|Asthma|asthma
5256530|NCT02409550|Children|children
5256531|NCT02409550|Control|control
5256532|NCT02409537|Asymptomatic hypercholesterolemia,|asymptomatic hypercholesterolemia,
5256533|NCT02409537|cardiovascular risk,|cardiovascular risk,
5256534|NCT02409537|total antioxidant capacity|total antioxidant capacity
5256535|NCT02409537|red wine polyphenol content|red wine polyphenol content
5256536|NCT02409537|vitamin E.|vitamin e.
5256537|NCT02409537|resveratrol|resveratrol
5256538|NCT02409511|Type 1 Diabetic|type 1 diabetic
5256539|NCT02409511|Type 2 Diabetic|type 2 diabetic
5256540|NCT02409511|Hypertension|hypertension
5256541|NCT02409511|Renal Injury|renal injury
5256542|NCT02409511|Diabetic retinopathy|diabetic retinopathy
5256543|NCT02409498|pudendal nerve block|pudendal nerve block
5256544|NCT02409498|vaginal reconstructive surgery|vaginal reconstructive surgery
5256545|NCT02409485|self-management|self-management
5256546|NCT02409485|head and neck cancer|head and neck cancer
5256547|NCT02409485|psychosocial intervention|psychosocial intervention
5256548|NCT02409485|couples|couples
5256549|NCT02409472|randomized clinical trial|randomized clinical trial
5256550|NCT02409433|lacosamide|lacosamide
5256551|NCT02409433|phenytoin|phenytoin
5256552|NCT02409394|Subjects|subjects
5256553|NCT02409303|Autism Spectrum Disorder|autism spectrum disorder
5256554|NCT02409303|Screening|screening
5256555|NCT02409303|Preventive intervention|preventive intervention
5256556|NCT02409303|Risk|risk
5256557|NCT02409277|Self-Management|self-management
5256558|NCT02409277|Asthma|asthma
5256559|NCT02409264|Insomnia|insomnia
5256560|NCT02409264|Females|females
5256561|NCT02409264|Homeopathy|homeopathy
5256562|NCT02409251|Antinuclear antibody (ANA)|antinuclear antibody (ana)
5256563|NCT02409251|Overuse|overuse
5256564|NCT02409251|Rheumatologists|rheumatologists
5256565|NCT02409251|Quality of care|quality of care
5256566|NCT02409238|Mild Cognitive Impairment|mild cognitive impairment
5256567|NCT02409238|Insulin Resistance|insulin resistance
5256568|NCT02409238|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5256569|NCT02409225|remote monitoring|remote monitoring
5256571|NCT02409225|CRT-D|crt-d
5256572|NCT02409199|Gastric Carcinoma|gastric carcinoma
5256573|NCT02409199|apatinib|apatinib
5256574|NCT02409173|Metabolic syndrome|metabolic syndrome
5256575|NCT02409173|Sleep disorders|sleep disorders
5256576|NCT02409173|Bariatric Surgery|bariatric surgery
5256577|NCT02409173|Noninvasive ventilation|noninvasive ventilation
5256578|NCT02409173|Inflammation|inflammation
5256579|NCT02409173|Quality of life|quality of life
5256580|NCT02409160|Severe Obesity|severe obesity
5256581|NCT02409160|Sleep Disorders|sleep disorders
5256582|NCT02409160|Bariatric Surgery|bariatric surgery
5256583|NCT02409160|Inflammation|inflammation
5256584|NCT02409160|Quality of Life|quality of life
5256585|NCT02409134|Bone Marrow Transplantation|bone marrow transplantation
5256586|NCT02409134|Hematologic Malignancies|hematologic malignancies
5256587|NCT02409134|Adults|adults
5256588|NCT02409134|Cognition|cognition
5256589|NCT02409121|hematopoietic cell transplantation|hematopoietic cell transplantation
5256590|NCT02409121|caregivers|caregivers
5256591|NCT02409121|health information technology|health information technology
5256592|NCT02409121|patient-centered care|patient-centered care
5256593|NCT02409069|Transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
5256594|NCT02409069|P300|p300
5256595|NCT02409069|Memory task|memory task
5256596|NCT02409056|intervention|intervention
5256597|NCT02409056|translation|translation
5256598|NCT02409056|workplace|workplace
5256599|NCT02409056|CVD|cvd
5256600|NCT02409056|CDSMP|cdsmp
5256601|NCT02409043|Stroke|stroke
5256602|NCT02409043|Ischemic stroke|ischemic stroke
5256603|NCT02409043|Hemorrhagic stroke|hemorrhagic stroke
5256604|NCT02409043|Biomarkers|biomarkers
5256605|NCT02409043|Angiotensins|angiotensins
5256606|NCT02409017|insulin drip|insulin drip
5256607|NCT02409017|labor|labor
5256608|NCT02409004|Drug-drug interaction|drug-drug interaction
5256609|NCT02408991|Chronic lower limb ischemia|chronic lower limb ischemia
5256610|NCT02408991|Art-Assist Device|art-assist device
5256611|NCT02408991|Neupogen|neupogen
5256612|NCT02408926|Pertussis|pertussis
5256613|NCT02408926|Pregnancy|pregnancy
5256614|NCT02408926|Humoral immune response|humoral immune response
5256615|NCT02408926|Functionality|functionality
5256616|NCT02408926|Vaccination|vaccination
5256617|NCT02408913|Immunity|immunity
5256618|NCT02408913|Ebola Virus|ebola virus
5256619|NCT02408913|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
5256620|NCT02408913|Healthy|healthy
5244245|NCT02478606|Muscle Strength Dynamometer|muscle strength dynamometer
5244246|NCT02478593|Education|education
5244247|NCT02478593|Geriatric|geriatric
5244248|NCT02478593|Benzodiazepine|benzodiazepine
5137402|NCT03133130|Scar|scar
5256621|NCT02408913|Filovirus|filovirus
5256622|NCT02408900|Spasticity|spasticity
5256623|NCT02408900|Primary Lateral Sclerosis|primary lateral sclerosis
5256624|NCT02408900|Elastography|elastography
5256625|NCT02408900|Ultrasound|ultrasound
5256626|NCT02408887|Thyroidectomy|thyroidectomy
5256627|NCT02408887|Serum Thyroglobulin|serum thyroglobulin
5256628|NCT02408887|Quality of Life|quality of life
5256629|NCT02408887|Central Neck Lymph Node Metastasis|central neck lymph node metastasis
5256630|NCT02408887|Central Neck Lymph Node Dissection|central neck lymph node dissection
5256631|NCT02408874|Nanoparticles|nanoparticles
5256632|NCT02408874|Inflammatory Response|inflammatory response
5256633|NCT02408874|Silver|silver
5256634|NCT02408874|Lung Function|lung function
5256635|NCT02408874|Lung Microbiome|lung microbiome
5256636|NCT02408835|negative pressure wound therapy|negative pressure wound therapy
5256637|NCT02408835|lymphadenectomy|lymphadenectomy
5256638|NCT02408835|wound healing|wound healing
5256639|NCT02408809|Orthopaedic Smoking Cessation Discussion|orthopaedic smoking cessation discussion
5256640|NCT02408809|Smoking Cessation|smoking cessation
5256641|NCT02408809|Randomized Controlled Trial|randomized controlled trial
5256642|NCT02408796|Acute otitis media with tympanostomy tubes|acute otitis media with tympanostomy tubes
5256643|NCT02408757|ultrasound|ultrasound
5256644|NCT02408757|cerebral perfusion|cerebral perfusion
5256645|NCT02408757|cerebrospinal fluid drainage|cerebrospinal fluid drainage
5256646|NCT02408744|nephroprotection|nephroprotection
5256647|NCT02408744|pirfenidone|pirfenidone
5256648|NCT02408744|polymorphisms|polymorphisms
5256649|NCT02408718|Mobility|mobility
5256650|NCT02408718|walking aids|walking aids
5256651|NCT02408718|falls|falls
5256652|NCT02408718|gait and balance|gait and balance
5256653|NCT02408705|Endogenous Glucose Production|endogenous glucose production
5256654|NCT02408705|Hypoglycemic clamp|hypoglycemic clamp
5256655|NCT02408705|Tracer to Tracee Technique|tracer to tracee technique
5256656|NCT02408705|Type 1 diabetes mellitus|type 1 diabetes mellitus
5256657|NCT02408692|Emergency contraception|emergency contraception
5256658|NCT02408692|Obese BMI|obese bmi
5256659|NCT02408692|Normal BMI|normal bmi
5256660|NCT02408679|Vitamin D|vitamin d
5256661|NCT02408679|Vitamin D Deficiency|vitamin d deficiency
5256662|NCT02408679|Vitamin D Insufficiency|vitamin d insufficiency
5256663|NCT02408679|Healthy adults|healthy adults
5256664|NCT02408679|Predictive questionnaire|predictive questionnaire
5256665|NCT02408640|Internet-Based|internet-based
5256666|NCT02408640|Treatment|treatment
5256667|NCT02408549|Lacosamide|lacosamide
5256668|NCT02408549|Vimpat|vimpat
5256669|NCT02408549|Epilepsy|epilepsy
5256670|NCT02408549|Children|children
5256671|NCT02408549|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
5256672|NCT02408549|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
5256673|NCT02408549|Adults|adults
5256674|NCT02408536|chemotherapy|chemotherapy
5256675|NCT02408536|hormone therapy|hormone therapy
5256676|NCT02408536|borderline|borderline
5256677|NCT02408536|low-grade|low-grade
5423263|NCT01616446|cyclosporin|cyclosporin
5256680|NCT02408523|Vimpat|vimpat
5256681|NCT02408523|Epilepsy|epilepsy
5256682|NCT02408523|Children|children
5256683|NCT02408523|Primary Generalized Tonic Clonic seizures|primary generalized tonic clonic seizures
5256684|NCT02408523|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
5256685|NCT02408523|Adults|adults
5256686|NCT02408510|Volunteers|volunteers
5256687|NCT02408471|Arthritis|arthritis
5256693|NCT02408471|Immune System Diseases|immune system diseases
5256694|NCT02408471|Joint Diseases|joint diseases
5256695|NCT02408471|Musculoskeletal Diseases|musculoskeletal diseases
5256696|NCT02408471|Rheumatic Diseases|rheumatic diseases
5256697|NCT02408445|body composition|body composition
5256698|NCT02408445|Klinefelter syndrome|klinefelter syndrome
5256700|NCT02408445|sex chromosome variation|sex chromosome variation
5256701|NCT02408445|sex chromsome aneuploidy|sex chromsome aneuploidy
5256702|NCT02408393|Surgery|surgery
5256703|NCT02408393|Paravertebral block|paravertebral block
5256704|NCT02408393|Chronic pain|chronic pain
5256705|NCT02408380|biomarker|biomarker
5256706|NCT02408380|disease progression|disease progression
5256707|NCT02408367|Training|training
5256708|NCT02408367|Cognition|cognition
5256709|NCT02408367|Multiple Sclerosis|multiple sclerosis
5256710|NCT02408341|Propofol, Induction anesthesia, Doppler tissue imaging|propofol, induction anesthesia, doppler tissue imaging
5244344|NCT02478047|to Evaluate the Effectiveness of Acupucnture in the Management of Chemotherapy-induced Nausea and Vomiting|to evaluate the effectiveness of acupucnture in the management of chemotherapy-induced nausea and vomiting
5256711|NCT02408315|induction of labor|induction of labor
5256712|NCT02408315|safety|safety
5256713|NCT02408315|pharmacokinetic|pharmacokinetic
5256714|NCT02408315|misoprostol|misoprostol
5256715|NCT02408250|algorithm|algorithm
5256716|NCT02408250|critical illness|critical illness
5256717|NCT02408250|early exercise|early exercise
5256718|NCT02408250|feasibility|feasibility
5256719|NCT02408250|intensive care unit|intensive care unit
5256720|NCT02408250|physical therapy|physical therapy
5256721|NCT02408237|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5256722|NCT02408237|tDCS for domiciliary use|tdcs for domiciliary use
5256723|NCT02408237|Healthy Participants|healthy participants
5256725|NCT02408185|infections|infections
5256726|NCT02408185|multidrug resistant Gram negative bacteria (MDR-GNB)|multidrug resistant gram negative bacteria (mdr-gnb)
5256727|NCT02408185|Skin infections|skin infections
5256728|NCT02408185|Pneumonia|pneumonia
5256729|NCT02408185|Bacteriemia|bacteriemia
5256730|NCT02408185|Nosocomial infections|nosocomial infections
5256731|NCT02408172|hypertension|hypertension
5256732|NCT02408172|Sleep apnea syndrome|sleep apnea syndrome
5256733|NCT02408172|Amlodipine|amlodipine
5256734|NCT02408172|metoprolol|metoprolol
5256735|NCT02408159|Live, attenuated virus varicella-zoster vaccine|live, attenuated virus varicella-zoster vaccine
5256738|NCT02408159|shingles|shingles
5256739|NCT02408133|Breast Cancer|breast cancer
5256740|NCT02408133|elderly|elderly
5256741|NCT02408133|quality of life|quality of life
5256742|NCT02408133|exercise|exercise
5256745|NCT02408107|Physical activity|physical activity
5256746|NCT02408107|Randomized controlled trial|randomized controlled trial
5256747|NCT02408094|Rheumatoid Arthritis|rheumatoid arthritis
5256748|NCT02408094|Heat-dampness and blood stasis syndrome|heat-dampness and blood stasis syndrome
5256749|NCT02408094|Protein markers|protein markers
5256750|NCT02408081|Depression|depression
5256751|NCT02408081|Family functioning|family functioning
5256752|NCT02408081|Family Focused Nursing|family focused nursing
5256753|NCT02408081|Quality of life|quality of life
5256754|NCT02408068|subjects|subjects
5256755|NCT02408029|Focus|focus
5256756|NCT02408029|Testing Performance|testing performance
5256757|NCT02408029|CORA Hemostasis System|cora hemostasis system
5256758|NCT02408003|Transesophageal|transesophageal
5151901|NCT03042858|PPV|ppv
5256759|NCT02408003|Echocardiography|echocardiography
5256760|NCT02408003|Milrinone|milrinone
5256761|NCT02408003|Levosimendan|levosimendan
5256762|NCT02408003|Strain|strain
5256763|NCT02408003|Deformation|deformation
5256764|NCT02408003|Diastole|diastole
5256765|NCT02408003|Afterload|afterload
5256766|NCT02408003|Preload|preload
5256767|NCT02408003|Systole|systole
5256768|NCT02407964|Drug-Induced Liver Injury|drug-induced liver injury
5256769|NCT02407964|DILI|dili
5256770|NCT02407938|dysphagia|dysphagia
5256771|NCT02407938|reflux symptoms|reflux symptoms
5256772|NCT02407938|retrosternal pain|retrosternal pain
5256773|NCT02407925|Optical diagnosis|optical diagnosis
5256774|NCT02407899|LADA|lada
5256775|NCT02407899|saxagliptin|saxagliptin
5256776|NCT02407899|vitamin D3|vitamin d3
5256777|NCT02407899|C-Peptide|c-peptide
5256778|NCT02407873|aged of 75 years or more|aged of 75 years or more
5256779|NCT02407860|breast feeding|breast feeding
5256780|NCT02407860|sucking|sucking
5256781|NCT02407860|dysfunction|dysfunction
5256782|NCT02407860|Latch assessment tool|latch assessment tool
5256783|NCT02407860|visual analogic scale|visual analogic scale
5256785|NCT02407847|Nurse practitioners|nurse practitioners
5256786|NCT02407847|Primary healthcare|primary healthcare
5256787|NCT02407847|Emergency Medical Services|emergency medical services
5256788|NCT02407847|Substitution of care|substitution of care
5256789|NCT02407834|Biofilms|biofilms
5256790|NCT02407834|Dentures|dentures
5256791|NCT02407834|Denture Cleansers|denture cleansers
5256792|NCT02407834|Castor Oil|castor oil
5256793|NCT02407834|Stomatitis|stomatitis
5256794|NCT02407821|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5256795|NCT02407821|Kidney Failure|kidney failure
5256796|NCT02407821|Renal Insufficiency, Chronic|renal insufficiency, chronic
5256797|NCT02407821|Dialysis, Renal|dialysis, renal
5256798|NCT02407821|Peritoneal Dialysis|peritoneal dialysis
5256799|NCT02407821|Hemodialysis|hemodialysis
5256800|NCT02407821|Depressive Symptoms|depressive symptoms
5256801|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5256802|NCT02407821|Antidepressants|antidepressants
5256803|NCT02407821|Escitalopram|escitalopram
5256804|NCT02407795|stereotactic radiotherapy|stereotactic radiotherapy
5256805|NCT02407795|pain reduction|pain reduction
5256806|NCT02407795|quality of life|quality of life
5256807|NCT02407782|Scabies|scabies
5256808|NCT02407782|children|children
5256809|NCT02407782|cluster|cluster
5256810|NCT02407782|permethrin|permethrin
5256811|NCT02407782|Ivermectin|ivermectin
5256812|NCT02407769|Liver transplantation|liver transplantation
5256813|NCT02407769|Liver cirrhosis|liver cirrhosis
5256814|NCT02407769|Branched chain amino acids|branched chain amino acids
5256815|NCT02407769|Late evening supplementation|late evening supplementation
5256816|NCT02407769|Nutritional status|nutritional status
5256817|NCT02407756|Eczema|eczema
5256818|NCT02407743|postoperative pain|postoperative pain
5256819|NCT02407743|surgery|surgery
5256820|NCT02407743|pain resolution|pain resolution
5256821|NCT02407743|pain intensity|pain intensity
5256822|NCT02407743|persistent postsurgical pain|persistent postsurgical pain
5256823|NCT02407743|pain-related genes|pain-related genes
5256824|NCT02407743|analgesic|analgesic
5256825|NCT02407704|Exercise|exercise
5256826|NCT02407704|Physical activity|physical activity
5256827|NCT02407704|GABA|gaba
5256828|NCT02407704|Venlafaxine|venlafaxine
5256829|NCT02407704|fMRI|fmri
5256830|NCT02407704|Spectroscopy|spectroscopy
5256834|NCT02407704|Cognitive function|cognitive function
5256835|NCT02407704|Biomarkers|biomarkers
5256836|NCT02407704|Aerobic exercise|aerobic exercise
5256837|NCT02407665|Tai Chi|tai chi
5256838|NCT02407665|fMRI|fmri
5256839|NCT02407639|insufflation|insufflation
5256840|NCT02407639|abdominal pain|abdominal pain
5256844|NCT02407626|total intravenous anesthesia|total intravenous anesthesia
5256845|NCT02407613|breast cancer|breast cancer
5256846|NCT02407613|MR-HIFU|mr-hifu
5256847|NCT02407613|ablation|ablation
5256848|NCT02407613|non-invasive treatment|non-invasive treatment
5256849|NCT02407600|EMEND for Injection|emend for injection
5256850|NCT02407600|5HT-3|5ht-3
5256851|NCT02407600|Fosaprepitant|fosaprepitant
5256852|NCT02407561|rectal|rectal
5256853|NCT02407561|adenocarcinoma|adenocarcinoma
5256854|NCT02407561|DecisionDx|decisiondx
5256855|NCT02407548|cholesterol efflux|cholesterol efflux
5256856|NCT02407548|dyslipidemia|dyslipidemia
5256857|NCT02407522|Metabolic Syndrome|metabolic syndrome
5256858|NCT02407522|black rice|black rice
5256859|NCT02407483|Laparoscopy|laparoscopy
5256860|NCT02407483|Training Programs|training programs
5256861|NCT02407470|Severe Aplastic Anemia (SAA), Hematopoietic Stem Cells, HSC Transplantation|severe aplastic anemia (saa), hematopoietic stem cells, hsc transplantation
5256862|NCT02407470|ATG, Mesenchymal Stem Cells, Transdifferentiation,|atg, mesenchymal stem cells, transdifferentiation,
5256863|NCT02407444|Proximal hip fracture|proximal hip fracture
5256864|NCT02407444|Elderly patients|elderly patients
5256865|NCT02407444|Physiotherapy|physiotherapy
5256866|NCT02407444|Leg cycling ergometer|leg cycling ergometer
5256867|NCT02407418|spinal manipulation|spinal manipulation
5256868|NCT02407418|muscle strength dynamometer|muscle strength dynamometer
5256869|NCT02407418|muscle strength|muscle strength
5256870|NCT02407405|Objective Response|objective response
5256871|NCT02407405|pERK inhibition|perk inhibition
5256872|NCT02407405|MEK Inhibition|mek inhibition
5256873|NCT02407405|Biopsy|biopsy
5256874|NCT02407405|Volumetric MRI|volumetric mri
5256875|NCT02407379|Laser|laser
5256876|NCT02407379|periodontitis|periodontitis
5256877|NCT02407379|scaling root planing|scaling root planing
5256878|NCT02407379|bacteria|bacteria
5256880|NCT02407366|Inoperable stage III non-small cell lung cancer|inoperable stage iii non-small cell lung cancer
5256881|NCT02407366|EGFR mutation|egfr mutation
5256882|NCT02407366|Icotinib|icotinib
5256883|NCT02407366|Radiotherapy|radiotherapy
5256884|NCT02407366|Chemoradiotherapy|chemoradiotherapy
5256885|NCT02407353|Phase 1|phase 1
5256886|NCT02407353|Double blind|double blind
5256887|NCT02407353|Placebo-Controlled|placebo-controlled
5256894|NCT02407314|Optical Coherence Tomography|optical coherence tomography
5256895|NCT02407314|Ticagrelor|ticagrelor
5256896|NCT02407314|Aspirin|aspirin
5256897|NCT02407314|Claudication|claudication
5256898|NCT02407314|Clopidogrel|clopidogrel
5256900|NCT02407262|asthma|asthma
5256901|NCT02407262|black seed|black seed
5256902|NCT02407262|Nigella sativa|nigella sativa
5256903|NCT02407262|supplementation|supplementation
5256907|NCT02407223|Nonradiographic Axial Spondylitis, Ankylosing|nonradiographic axial spondylitis, ankylosing
5256908|NCT02407223|Ustekinumab|ustekinumab
5256909|NCT02407210|Azilsartan，Olmesartan Medoxomil|azilsartan，olmesartan medoxomil
5256914|NCT02407184|Microbiota|microbiota
5256915|NCT02407184|Microbiome|microbiome
5256916|NCT02407145|retropubic|retropubic
5256917|NCT02407145|midurethral sling|midurethral sling
5256918|NCT02407145|polyvinylidene fluoride|polyvinylidene fluoride
5256919|NCT02407119|H. pylori eradication|h. pylori eradication
5256920|NCT02407119|Atrophy|atrophy
5256921|NCT02407119|Intestinal metaplasia|intestinal metaplasia
5256922|NCT02407119|Endoscopic resection|endoscopic resection
5256923|NCT02407119|Stomach neoplasm|stomach neoplasm
5256924|NCT02407106|BLIS K12|blis k12
5256925|NCT02407106|streptococcus|streptococcus
5256926|NCT02407093|Body Composition|body composition
5256927|NCT02407093|Military|military
5256928|NCT02407093|High-Intensity Functional Training|high-intensity functional training
5256929|NCT02407093|Army Physical Fitness|army physical fitness
5256930|NCT02407093|CrossFit|crossfit
5256931|NCT02407002|Nitroglycerin|nitroglycerin
5256932|NCT02407002|Safety|safety
5256933|NCT02406976|Exercise|exercise
5256934|NCT02406976|Morbidity Obesity|morbidity obesity
5256935|NCT02406963|telemedicine|telemedicine
5256936|NCT02406950|Sitagliptin|sitagliptin
5256937|NCT02406950|Endothelium|endothelium
5256938|NCT02406950|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
5256939|NCT02406950|human|human
5256940|NCT02406924|pin|pin
5257037|NCT02406157|micropulse|micropulse
5256941|NCT02406924|particulated graft|particulated graft
5256942|NCT02406924|bone augmentation|bone augmentation
5256943|NCT02406924|vertical augmentation|vertical augmentation
5256944|NCT02406924|horizontal augmentation|horizontal augmentation
5256945|NCT02406911|platelet|platelet
5256946|NCT02406911|ticagrelor|ticagrelor
5256947|NCT02406911|clopidogrel|clopidogrel
5256948|NCT02406911|end stage renal disease|end stage renal disease
5256949|NCT02406911|hemodialysis|hemodialysis
5256950|NCT02406859|Spinal Cord Injury|spinal cord injury
5256951|NCT02406859|Constipation|constipation
5256952|NCT02406859|Fecal Incontinence|fecal incontinence
5256953|NCT02406859|Neurogenic Bowel|neurogenic bowel
5256954|NCT02406859|Bowel Biofeedback|bowel biofeedback
5256955|NCT02406859|Manometry|manometry
5256956|NCT02406846|Pancreatic Neoplasms|pancreatic neoplasms
5256957|NCT02406846|Circulating Tumor Cells|circulating tumor cells
5256958|NCT02406833|glaucoma|glaucoma
5256959|NCT02406833|trabeculectomy|trabeculectomy
5256960|NCT02406807|chronic low back pain|chronic low back pain
5256961|NCT02406807|HVLA manipulation|hvla manipulation
5256962|NCT02406794|Breast cancer|breast cancer
5256963|NCT02406794|Hormonal therapy|hormonal therapy
5256964|NCT02406794|Aromatase inhibitors|aromatase inhibitors
5256965|NCT02406794|Estrogen deprivation|estrogen deprivation
5256966|NCT02406794|Myalgia|myalgia
5256967|NCT02406794|Arthralgia|arthralgia
5256968|NCT02406794|Carpal tunnel syndrome|carpal tunnel syndrome
5256969|NCT02406794|Pressure pain threshold|pressure pain threshold
5256970|NCT02406794|Neuromuscular taping|neuromuscular taping
5256971|NCT02406794|Kinesio taping|kinesio taping
5256972|NCT02406781|Efficacy of MK 3475 with Metronomic Cyclophosphamide|efficacy of mk 3475 with metronomic cyclophosphamide
5256973|NCT02406781|Advanced Sarcomas|advanced sarcomas
5256974|NCT02406781|Leiomyosarcoma|leiomyosarcoma
5256975|NCT02406781|Undifferentiated Sarcoma|undifferentiated sarcoma
5256976|NCT02406781|Other Sarcoma|other sarcoma
5256977|NCT02406781|GIST|gist
5256978|NCT02406781|Osteosarcoma|osteosarcoma
5256979|NCT02406768|normal controls|normal controls
5256988|NCT02406703|local anesthesia|local anesthesia
5256989|NCT02406703|regional anesthetic|regional anesthetic
5256990|NCT02406690|Endometrial Insufficiency|endometrial insufficiency
5256991|NCT02406690|Endometrial Receptivity|endometrial receptivity
5423264|NCT01616446|nephrotic syndrome|nephrotic syndrome
5256994|NCT02406638|Mid-Urethral Sling|mid-urethral sling
5256996|NCT02406638|TVT-O|tvt-o
5256997|NCT02406638|TVT-S|tvt-s
5256998|NCT02406612|Vascular Closure Device|vascular closure device
5256999|NCT02406612|Femoral Artery Closure|femoral artery closure
5257000|NCT02406573|Sensitivity|sensitivity
5257001|NCT02406547|Serrated lesion|serrated lesion
5257002|NCT02406547|sessile serrated adenoma|sessile serrated adenoma
5257003|NCT02406547|Narrow Band Imaging|narrow band imaging
5257004|NCT02406547|Colonoscopy|colonoscopy
5257005|NCT02406547|colorectal neoplasms|colorectal neoplasms
5257006|NCT02406521|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5257007|NCT02406521|mRCC|mrcc
5257008|NCT02406482|sex work, Kazakhstan, microfinance, drug use|sex work, kazakhstan, microfinance, drug use
5257009|NCT02406443|Type 2 Diabetes, DPP-4 inhibitors, renal sodium excretion|type 2 diabetes, dpp-4 inhibitors, renal sodium excretion
5257011|NCT02406339|Rehabilitation|rehabilitation
5257012|NCT02406339|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5257013|NCT02406339|Muscle Strength|muscle strength
5257014|NCT02406300|Hip Fracture|hip fracture
5257015|NCT02406300|Regional Anesthesia|regional anesthesia
5257016|NCT02406300|Peripheral Nerve Blocks|peripheral nerve blocks
5257017|NCT02406300|Post-operative Mortality|post-operative mortality
5257018|NCT02406300|Cognitive Dysfunction|cognitive dysfunction
5257019|NCT02406300|Quality of Life|quality of life
5257020|NCT02406274|Mammography|mammography
5257021|NCT02406274|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
5257022|NCT02406274|Palpable Breast Abnormalities|palpable breast abnormalities
5257023|NCT02406274|15-053|15-053
5257024|NCT02406248|NSTEMI|nstemi
5257025|NCT02406222|Relapsed|relapsed
5257026|NCT02406222|Refractory|refractory
5257027|NCT02406222|Pomalidomide|pomalidomide
5257028|NCT02406222|Dexamethasone|dexamethasone
5903728|NCT00339924|Race|race
5257029|NCT02406222|Cyclophosphamide|cyclophosphamide
5257030|NCT02406209|uveitis|uveitis
5257031|NCT02406209|acute uveitis|acute uveitis
5257032|NCT02406209|anterior uveitis|anterior uveitis
5257033|NCT02406209|NS2|ns2
5257034|NCT02406209|Aldeyra|aldeyra
5257035|NCT02406209|prednisolone acetate|prednisolone acetate
5257036|NCT02406157|diabetic macular edema|diabetic macular edema
5257038|NCT02406157|laser|laser
5257039|NCT02406157|subthreshold|subthreshold
5257040|NCT02406144|Multiple Myeloma|multiple myeloma
5257041|NCT02406131|Peripheral Vascular Diseases|peripheral vascular diseases
5257042|NCT02406131|Ischemic Preconditioning|ischemic preconditioning
5257043|NCT02406131|Inflammation|inflammation
5257044|NCT02406131|Angioplasty|angioplasty
5257045|NCT02406131|Restenosis|restenosis
5257046|NCT02406131|RCT|rct
5257047|NCT02406118|transanal TME quality|transanal tme quality
5257048|NCT02406118|CRM|crm
5257049|NCT02406105|tremor|tremor
5257050|NCT02406105|Parkinson disease|parkinson disease
5257051|NCT02406105|functional radioablation|functional radioablation
5257052|NCT02406105|Cyber Knife radiosurgery|cyber knife radiosurgery
5257053|NCT02406079|tracheotomy|tracheotomy
5257054|NCT02406079|procalcitonin|procalcitonin
5257055|NCT02406079|sepsis|sepsis
5257056|NCT02406053|lung cancer|lung cancer
5257057|NCT02406053|antioxidants|antioxidants
5257058|NCT02406053|oxidative damage|oxidative damage
5257059|NCT02406040|Protein synthesis|protein synthesis
5257060|NCT02406040|Protein breakdown|protein breakdown
5257061|NCT02406040|Muscle|muscle
5257062|NCT02406040|Energy restriction|energy restriction
5257063|NCT02406027|Alzheimer's Disease|alzheimer's disease
5257064|NCT02406027|JNJ-54861911|jnj-54861911
5257065|NCT02406027|Placebo|placebo
5257066|NCT02406001|peri-implantitis|peri-implantitis
5257067|NCT02406001|osseous defects|osseous defects
5257068|NCT02406001|implant surface decontamination|implant surface decontamination
5257069|NCT02406001|bone grafting|bone grafting
5257070|NCT02406001|surgical therapy|surgical therapy
5257071|NCT02406001|porous titanium granules|porous titanium granules
5257072|NCT02406001|reconstruction|reconstruction
5257073|NCT02405988|Emergency Treatment|emergency treatment
5257074|NCT02405988|Morphine Derivates|morphine derivates
5257075|NCT02405988|Heroin|heroin
5257076|NCT02405988|Antidotes|antidotes
5257077|NCT02405988|Administration, Intravenous|administration, intravenous
5257078|NCT02405988|Pharmacology|pharmacology
5257079|NCT02405988|Naloxone|naloxone
5257080|NCT02405988|Healthy volunteers|healthy volunteers
5257081|NCT02405962|Acceptance and Commitment Therapy|acceptance and commitment therapy
5257082|NCT02405962|Childhood asthma|childhood asthma
5257083|NCT02405962|Randomized controlled trial|randomized controlled trial
5262253|NCT02376296|CRPC|crpc
5257084|NCT02405962|Training parents|training parents
5257086|NCT02405910|non-squamous|non-squamous
5257087|NCT02405910|first line therapy|first line therapy
5257088|NCT02405897|flexible bronchoscopy|flexible bronchoscopy
5152256|NCT03040687|enteritis|enteritis
5257089|NCT02405897|transbronchial lung biopsy|transbronchial lung biopsy
5257090|NCT02405897|forceps|forceps
5257091|NCT02405884|Glaucoma|glaucoma
5257092|NCT02405884|Renal Insufficiency, Chronic|renal insufficiency, chronic
5257093|NCT02405884|Low Tension Glaucoma|low tension glaucoma
5257094|NCT02405884|Ocular Hypertension|ocular hypertension
5257095|NCT02405858|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5257096|NCT02405858|Abiraterone Acetate|abiraterone acetate
5257097|NCT02405858|ZYTIGA|zytiga
5257098|NCT02405858|Prednisolone|prednisolone
5257099|NCT02405845|Atherosclerosis|atherosclerosis
5257100|NCT02405845|Internal Carotid Artery|internal carotid artery
5257101|NCT02405845|Free-floating thrombus|free-floating thrombus
5257102|NCT02405845|Ulcerated plaque|ulcerated plaque
5257103|NCT02405845|FFT|fft
5257104|NCT02405819|Cancer|cancer
5257105|NCT02405819|Oncology|oncology
5257106|NCT02405819|Survivorship|survivorship
5257107|NCT02405819|Care|care
5257108|NCT02405819|Plan|plan
5257109|NCT02405780|Rheumatoid|rheumatoid
5257110|NCT02405780|Arthritis|arthritis
5257119|NCT02405754|CHD|chd
5257120|NCT02405754|Precision Medicine|precision medicine
5257121|NCT02405754|Clinical Utility|clinical utility
5257122|NCT02405754|Gene Expression|gene expression
5257123|NCT02405754|Coronary Heart Disease|coronary heart disease
5257124|NCT02405754|Cardiovascular Disease|cardiovascular disease
5257125|NCT02405754|Chest Pain|chest pain
5257126|NCT02405754|Coronary Artery Disease|coronary artery disease
5257127|NCT02405754|Angina Pectoris|angina pectoris
5257128|NCT02405754|exercise stress testing|exercise stress testing
5257129|NCT02405754|CT angiography|ct angiography
5257130|NCT02405754|invasive cardiac angiography|invasive cardiac angiography
5257131|NCT02405754|African-American patient|african-american patient
5244727|NCT02475824|Sedation|sedation
5244728|NCT02475824|safety|safety
5244729|NCT02475811|3D ultrasonography|3d ultrasonography
5244730|NCT02475811|fetal Lung Volume|fetal lung volume
5244731|NCT02475811|neonatal respiratory function|neonatal respiratory function
5244732|NCT02475798|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
5244774|NCT02475486|SNA|sna
5257132|NCT02405754|ICA|ica
5257133|NCT02405754|CTA|cta
5257134|NCT02405728|PICC|picc
5257135|NCT02405728|BLOODSTREAM INFECTIONS|bloodstream infections
5257136|NCT02405728|VASCULAR ACCESS|vascular access
5257137|NCT02405728|DEEP VEIN THROMBOSIS|deep vein thrombosis
5257138|NCT02405728|CICC|cicc
5257139|NCT02405702|Infection|infection
5257140|NCT02405702|Knee|knee
5257141|NCT02405702|knee replacement|knee replacement
5257142|NCT02405676|Lymphoma|lymphoma
5257143|NCT02405676|non-Hodgkin|non-hodgkin
5257144|NCT02405676|B-lymphocytes|b-lymphocytes
5257145|NCT02405676|Child|child
5257146|NCT02405676|Multicenter study|multicenter study
5257147|NCT02405663|blood loss|blood loss
5257148|NCT02405663|caesarean section|caesarean section
5257149|NCT02405663|placental delivery|placental delivery
5257150|NCT02405650|CKD, chronic kidney disease, CRIC|ckd, chronic kidney disease, cric
5257151|NCT02405637|Feeding intolerance|feeding intolerance
5257152|NCT02405637|Simulated amniotic fluid|simulated amniotic fluid
5257153|NCT02405637|Necrotizing enterocolitis|necrotizing enterocolitis
5257154|NCT02405585|Pancreatic Cancer|pancreatic cancer
5257155|NCT02405585|Immunotherapy|immunotherapy
5257156|NCT02405585|Vaccine Therapy|vaccine therapy
5257157|NCT02405572|formula-fed|formula-fed
5257158|NCT02405572|infants|infants
5257159|NCT02405546|Nasal intubation|nasal intubation
5257160|NCT02405546|Counterclockwise rotation|counterclockwise rotation
5257161|NCT02405533|AHCC|ahcc
5257162|NCT02405533|nutritional supplement|nutritional supplement
5257164|NCT02405520|human papillomavirus vaccine|human papillomavirus vaccine
5257165|NCT02405520|condylomata acuminata|condylomata acuminata
5257166|NCT02405507|Gastrointestinal Discomfort|gastrointestinal discomfort
5257167|NCT02405507|Wheat germ|wheat germ
5257168|NCT02405507|Constipation|constipation
5257169|NCT02405507|Glycaemic Index|glycaemic index
5257170|NCT02405507|Blood Cholesterol Level|blood cholesterol level
5257171|NCT02405507|Glycaemic Response|glycaemic response
5257172|NCT02405507|Cholesterol|cholesterol
5257173|NCT02405507|PAC-SYM|pac-sym
5257174|NCT02405507|Gut Microbiota|gut microbiota
5257175|NCT02405468|blood microbiota|blood microbiota
5257176|NCT02405468|coronary disease|coronary disease
5257177|NCT02405468|myocardial infarction|myocardial infarction
5257178|NCT02405455|cervical insufficiency|cervical insufficiency
5257179|NCT02405455|cervical cerclage|cervical cerclage
5257180|NCT02405455|cervical pessary|cervical pessary
5257181|NCT02405416|Hepatocellular Carcinoma|hepatocellular carcinoma
5257182|NCT02405416|Blood Loss|blood loss
5257183|NCT02405416|Haemorrhage|haemorrhage
5257184|NCT02405416|Vascular Control|vascular control
5257185|NCT02405403|amyotrophic lateral sclerosis disease|amyotrophic lateral sclerosis disease
5257186|NCT02405403|PET|pet
5257187|NCT02405403|microglial activation|microglial activation
5257188|NCT02405390|Storz C-Mac®|storz c-mac®
5257189|NCT02405390|Pediatric Airway|pediatric airway
5152372|NCT03039907|Knee|knee
5257190|NCT02405390|Cervical Spine Injury|cervical spine injury
5257191|NCT02405390|Trauma Airway Management|trauma airway management
5257192|NCT02405377|contrast-induced nephropathy|contrast-induced nephropathy
5257193|NCT02405377|hydration|hydration
5257194|NCT02405377|Percutaneous coronary intervention|percutaneous coronary intervention
5257195|NCT02405364|Multiple Myeloma|multiple myeloma
5257196|NCT02405364|Carfilzomib|carfilzomib
5257197|NCT02405364|Lenalidomide|lenalidomide
5257198|NCT02405364|Dexamethasone|dexamethasone
5257205|NCT02405325|cost-effectiveness|cost-effectiveness
5257206|NCT02405325|older adults|older adults
5257207|NCT02405312|communication|communication
5257208|NCT02405312|palliative care|palliative care
5257209|NCT02405312|death|death
5257210|NCT02405299|child|child
5257211|NCT02405299|disorders inhibition|disorders inhibition
5257212|NCT02405299|neuropsychology|neuropsychology
5257213|NCT02405299|rehabilitation|rehabilitation
5257214|NCT02405299|ADHD|adhd
5257215|NCT02405299|assessment of neurocognitive rehabilitations in ADHD in children|assessment of neurocognitive rehabilitations in adhd in children
5257216|NCT02405273|Lung Cancer|lung cancer
5257217|NCT02405273|Surgery|surgery
5257218|NCT02405273|COPD|copd
5257219|NCT02405273|Rehabilitation|rehabilitation
5257220|NCT02405247|NSCLC|nsclc
5257221|NCT02405247|T790M|t790m
5257222|NCT02405247|EGFR|egfr
5257223|NCT02405247|TKI|tki
5257224|NCT02405247|Resistance|resistance
5257225|NCT02405247|Non Small Cell Lung Cancer|non small cell lung cancer
5257226|NCT02405247|AZD9291|azd9291
5257227|NCT02405234|Radial Head Arthroplasty|radial head arthroplasty
5257228|NCT02405221|HPV|hpv
5257229|NCT02405221|HPV16|hpv16
5257230|NCT02405221|Cervical Cancer|cervical cancer
5257231|NCT02405221|TA-CIN|ta-cin
5257232|NCT02405221|Vaccine|vaccine
5356006|NCT01921205|Vimpat|vimpat
5257233|NCT02405221|Adjuvant|adjuvant
5257234|NCT02405221|Nickles FaderPI|nickles faderpi
5257235|NCT02405182|Magnetic Resonance Imaging|magnetic resonance imaging
5257236|NCT02405182|MRI|mri
5257237|NCT02405182|Biomarker|biomarker
5257238|NCT02405169|Implantology|implantology
5257239|NCT02405169|oral surgery|oral surgery
5257240|NCT02405169|bone level changes|bone level changes
5257241|NCT02405169|marginal bone level|marginal bone level
5257242|NCT02405156|Letrozole|letrozole
5257243|NCT02405156|misoprostol|misoprostol
5257244|NCT02405156|second trimester miscarriage|second trimester miscarriage
5257245|NCT02405143|Controlled clinical trial|controlled clinical trial
5257246|NCT02405143|Electric Stimulation Therapy|electric stimulation therapy
5257247|NCT02405117|Bipolar Disorder|bipolar disorder
5257248|NCT02405117|Behavior Therapy|behavior therapy
5257249|NCT02405117|Technology Assisted|technology assisted
5257250|NCT02405117|Mobile Phone|mobile phone
5257251|NCT02405117|Smartphone|smartphone
5257252|NCT02405104|osteoarthritis|osteoarthritis
5257253|NCT02405104|hip|hip
5257254|NCT02405104|knee|knee
5257255|NCT02405104|total hip arthroplasty|total hip arthroplasty
5257256|NCT02405104|total knee arthroplasty|total knee arthroplasty
5257257|NCT02405104|post operative pain management|post operative pain management
5257258|NCT02405039|DED|ded
5257259|NCT02405039|Disease|disease
5257260|NCT02405013|Africa|africa
5257261|NCT02405013|Hepatitis C|hepatitis c
5257262|NCT02405013|HIV|hiv
5257263|NCT02405013|Antiviral treatment|antiviral treatment
5257264|NCT02405013|Adults|adults
5257265|NCT02405013|HCV genotype 1|hcv genotype 1
5257266|NCT02405013|HCV genotype 2|hcv genotype 2
5257267|NCT02405013|HCV genotype 4|hcv genotype 4
5257268|NCT02404974|physical activity|physical activity
5257269|NCT02404948|coronary artery disease|coronary artery disease
5257270|NCT02404948|diagnosis|diagnosis
5257271|NCT02404948|non-invasive|non-invasive
5257272|NCT02404935|Metastatic colorectal cancer|metastatic colorectal cancer
5257273|NCT02404935|cetuximab|cetuximab
5257274|NCT02404935|maintenance|maintenance
5257275|NCT02404922|Safety/Efficacy Study|safety/efficacy study
5257276|NCT02404922|Randomized|randomized
5257277|NCT02404922|Double Blind|double blind
5257278|NCT02404883|Cancer|cancer
5257279|NCT02404883|decisional conflict|decisional conflict
5257280|NCT02404883|online|online
5257281|NCT02404883|decision-aid tool|decision-aid tool
5257282|NCT02404870|Diabetes|diabetes
5257283|NCT02404870|Phosphate|phosphate
5257284|NCT02404870|Fibroblast Growth Factor 23 (FGF23)|fibroblast growth factor 23 (fgf23)
5257285|NCT02404870|Vitamin D|vitamin d
5257286|NCT02404870|PTH|pth
5257287|NCT02404857|Post stroke|post stroke
5257288|NCT02404857|BCI|bci
5257289|NCT02404857|Reeducation|reeducation
5257290|NCT02404857|Hand movement|hand movement
5257291|NCT02404831|Physiotherapy|physiotherapy
5257295|NCT02404818|Radiation|radiation
5257296|NCT02404818|Cardiac|cardiac
5257297|NCT02404818|Hodgkin's lymphoma|hodgkin's lymphoma
5257298|NCT02404805|dolutegravir|dolutegravir
5257299|NCT02404805|simeprevir|simeprevir
5257300|NCT02404805|HIV|hiv
5257301|NCT02404805|HCV|hcv
5257308|NCT02404779|Intracranial hypertension|intracranial hypertension
5257309|NCT02404779|Cisatracurium|cisatracurium
5257310|NCT02404779|Neuromuscular Blocking Agent|neuromuscular blocking agent
5257311|NCT02404779|Randomization versus placebo|randomization versus placebo
5257312|NCT02404766|manual therapy|manual therapy
5257313|NCT02404766|cervical|cervical
5257314|NCT02404766|range of movement|range of movement
5257315|NCT02404753|Locally advanced gastric cancer|locally advanced gastric cancer
5257316|NCT02404753|Laparoscopic distal D2 gastrectomy|laparoscopic distal d2 gastrectomy
5257317|NCT02404753|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5257318|NCT02404740|VP shunted|vp shunted
5257319|NCT02404740|Normal intracranial pathology|normal intracranial pathology
5257320|NCT02404740|patients|patients
5257321|NCT02404727|Osteoarthritis, Hip|osteoarthritis, hip
5257322|NCT02404727|acetabular fixation|acetabular fixation
5257323|NCT02404727|dual mobility cup|dual mobility cup
5257324|NCT02404727|Radiostereometric Analysis|radiostereometric analysis
5257325|NCT02404727|Dual-Energy Radiographic Absorptiometry|dual-energy radiographic absorptiometry
5257326|NCT02404727|Accelerometry|accelerometry
5257327|NCT02404727|total hip arthroplasty|total hip arthroplasty
5257328|NCT02404727|intra-prosthetic dislocation|intra-prosthetic dislocation
5257329|NCT02404662|Alcohol use disorder|alcohol use disorder
5257330|NCT02404662|Depression|depression
5257331|NCT02404662|Mood disorders|mood disorders
5257332|NCT02404662|Bipolar disorder|bipolar disorder
5903729|NCT00339924|Ethnicity|ethnicity
5903730|NCT00339924|Human Genetic Variation|human genetic variation
5257333|NCT02404662|Supportive text messages|supportive text messages
5257334|NCT02404623|Vitamin D|vitamin d
5257335|NCT02404623|Respiratory Morbidity|respiratory morbidity
5257336|NCT02404623|prematurity|prematurity
5257337|NCT02404610|propofol|propofol
5257338|NCT02404610|moderate procedural sedation|moderate procedural sedation
5257339|NCT02404610|deep procedural sedation|deep procedural sedation
5257340|NCT02404610|memory|memory
5257341|NCT02404610|emergency department|emergency department
5257342|NCT02404597|Cardiac output|cardiac output
5257343|NCT02404597|Low blood pressure|low blood pressure
5257344|NCT02404597|Total Body Surface Area (TBSA)|total body surface area (tbsa)
5257445|NCT02404077|undergoing|undergoing
5257345|NCT02404584|Metastatic kidney cancer|metastatic kidney cancer
5257346|NCT02404545|Hernia|hernia
5257347|NCT02404545|Mesh|mesh
5257348|NCT02404545|Ileal conduit|ileal conduit
5257349|NCT02404532|OPC-14597 Digital|opc-14597 digital
5257350|NCT02404532|Aripiprazole|aripiprazole
5257351|NCT02404532|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
5257352|NCT02404532|Ingestible Event Marker|ingestible event marker
5257353|NCT02404519|Vitamin K|vitamin k
5257354|NCT02404519|Menaquinone-7|menaquinone-7
5257355|NCT02404519|Matrix Gla Protein|matrix gla protein
5257356|NCT02404519|Vascular stiffness|vascular stiffness
5257357|NCT02404506|Eribulin|eribulin
5257358|NCT02404506|Breast Cancer|breast cancer
5257359|NCT02404506|Elderly Patient|elderly patient
5257360|NCT02404506|Phase II Trial|phase ii trial
5257361|NCT02404506|HER2-neg|her2-neg
5257362|NCT02404506|adenocarcinoma|adenocarcinoma
5257363|NCT02404493|Atopic Dermatitis|atopic dermatitis
5257365|NCT02404428|active surveillance|active surveillance
5257366|NCT02404428|MRI|mri
5257367|NCT02404428|diet|diet
5257368|NCT02404415|catheter ablation|catheter ablation
5257369|NCT02404415|genomics|genomics
5257370|NCT02404402|Traumatic Brain Injury|traumatic brain injury
5257371|NCT02404402|Light Emitting Diodes|light emitting diodes
5257373|NCT02404402|Neuromodulation|neuromodulation
5257374|NCT02404402|PTSD|ptsd
5257375|NCT02404402|Neurorehabilitation|neurorehabilitation
5257376|NCT02404402|Veterans|veterans
5257377|NCT02404402|Sleep|sleep
5257378|NCT02404389|Actinic keratosis, patients, topical, lesion count, clearance rate|actinic keratosis, patients, topical, lesion count, clearance rate
5257379|NCT02404376|STEMI|stemi
5257380|NCT02404376|Reperfusion Injury|reperfusion injury
5257381|NCT02404376|Myocardial Infarction|myocardial infarction
5257382|NCT02404376|Myocardial Ischemia|myocardial ischemia
5257383|NCT02404376|Remote Ischemic Conditioning|remote ischemic conditioning
5257384|NCT02404376|Exenatide|exenatide
5257385|NCT02404376|Glucagon-Like Peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5257392|NCT02404363|Microparticles|microparticles
5257393|NCT02404363|Disease free survival|disease free survival
5257394|NCT02404363|First line chemotherapy|first line chemotherapy
5254803|NCT02418897|neuromuscular junction|neuromuscular junction
5254804|NCT02418897|SFEMG|sfemg
5257395|NCT02404350|Psoriatic Arthritis, Arthritis, Psoriatic, Psoriatic Arthropathy|psoriatic arthritis, arthritis, psoriatic, psoriatic arthropathy
5257397|NCT02404311|AIDS|aids
5257398|NCT02404311|Vaccine|vaccine
5257399|NCT02404298|Transcriptome analysis|transcriptome analysis
5257400|NCT02404298|peripheral blood|peripheral blood
5257401|NCT02404298|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5257402|NCT02404298|auto immune diseases|auto immune diseases
5257403|NCT02404298|IVIg|ivig
5257404|NCT02404272|Neonate|neonate
5257405|NCT02404272|oral feeding disorder|oral feeding disorder
5257406|NCT02404272|full oral feeding|full oral feeding
5257407|NCT02404272|training|training
5257408|NCT02404272|quality of health care|quality of health care
5257409|NCT02404259|pharmacokinetics|pharmacokinetics
5257410|NCT02404259|TDF|tdf
5257411|NCT02404259|HIV-infected children|hiv-infected children
5257412|NCT02404259|Thai|thai
5257413|NCT02404259|non-nucleoside reverse transcriptase inhibitor (NNRTI)|non-nucleoside reverse transcriptase inhibitor (nnrti)
5257414|NCT02404259|ritonavir-boosted protease inhibitor (bPI)|ritonavir-boosted protease inhibitor (bpi)
5257415|NCT02404259|less than eighteen years old|less than eighteen years old
5257416|NCT02404246|Bipolar|bipolar
5257417|NCT02404246|Peers|peers
5257418|NCT02404246|DBSA|dbsa
5257419|NCT02404220|Syk inhibitor|syk inhibitor
5257420|NCT02404220|Blood malignancy|blood malignancy
5257421|NCT02404220|Leukemia|leukemia
5257422|NCT02404207|Prevention|prevention
5257423|NCT02404194|schizophrenia|schizophrenia
5257424|NCT02404194|psychosis|psychosis
5257425|NCT02404194|at risk|at risk
5257426|NCT02404194|prodrome|prodrome
5257427|NCT02404194|attenuated psychosis syndrome|attenuated psychosis syndrome
5257428|NCT02404181|Validation Studies|validation studies
5257430|NCT02404142|Trachel intubation|trachel intubation
5257431|NCT02404142|IDS score|ids score
5257432|NCT02404142|Videoaryngoscopy|videoaryngoscopy
5257433|NCT02404142|Glidescope® Titanium®|glidescope® titanium®
5257434|NCT02404142|NMBA|nmba
5257435|NCT02404142|Curare (Atracurium)|curare (atracurium)
5257436|NCT02404129|Fall|fall
5257437|NCT02404129|Turn 180 test|turn 180 test
5257438|NCT02404129|elderly|elderly
5257439|NCT02404129|balance|balance
5257440|NCT02404090|Obesity|obesity
5257441|NCT02404090|Weight Loss|weight loss
5257442|NCT02404090|Knee Osteoarthritis|knee osteoarthritis
5257443|NCT02404090|Subchondral Mineralization|subchondral mineralization
5257444|NCT02404077|Patients|patients
5257447|NCT02404051|Breast cancer|breast cancer
5257448|NCT02404051|HER2Negative|her2negative
5257449|NCT02404051|hormone receptor positive (HR+)|hormone receptor positive (hr+)
5257450|NCT02404051|Metastatic|metastatic
5257451|NCT02404051|Locally Advanced|locally advanced
5257452|NCT02404051|fulvestrant|fulvestrant
5257453|NCT02404051|everolimus|everolimus
5257454|NCT02404051|exemestane|exemestane
5257455|NCT02404038|choice|choice
5257456|NCT02404038|young women|young women
5257457|NCT02404038|adolescent girls|adolescent girls
5257458|NCT02404038|preference|preference
5257459|NCT02404025|Eltrombopag|eltrombopag
5257460|NCT02404025|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
5257461|NCT02404025|additive effect|additive effect
5257462|NCT02404025|cyclosporine A|cyclosporine a
5257463|NCT02404025|bone marrow|bone marrow
5257464|NCT02404025|hematopoietic stem cells|hematopoietic stem cells
5257465|NCT02404025|pancytopenia|pancytopenia
5257466|NCT02404025|leukopenia|leukopenia
5257467|NCT02404025|platelets|platelets
5257468|NCT02404025|throbocytopenia|throbocytopenia
5257469|NCT02404025|mature blood cells|mature blood cells
5257470|NCT02404025|bone marrow biopsy|bone marrow biopsy
5257471|NCT02404012|iron deficiency|iron deficiency
5257472|NCT02404012|sleeve gastrectomy|sleeve gastrectomy
5257473|NCT02404012|gastric bypass|gastric bypass
5257474|NCT02404012|bariatric surgery|bariatric surgery
5257475|NCT02403973|Patient hotel|patient hotel
5138266|NCT03126942|Overdenture|overdenture
5257476|NCT02403973|Patient Satisfaction|patient satisfaction
5257477|NCT02403973|Perioperative care|perioperative care
5257478|NCT02403973|IN2005E|in2005e
5257479|NCT02403947|Multiple Sclerosis|multiple sclerosis
5257480|NCT02403947|Bone-marrow|bone-marrow
5257481|NCT02403947|Stem cells|stem cells
5257482|NCT02403947|Cell therapy|cell therapy
5257483|NCT02403934|Airway Management|airway management
5257484|NCT02403934|deep sedation|deep sedation
5257485|NCT02403934|Jaw elevation device|jaw elevation device
5257486|NCT02403921|biomarker|biomarker
5257487|NCT02403908|radiofrequency denervation, pulmonary hypertension|radiofrequency denervation, pulmonary hypertension
5257488|NCT02403882|behavioral economics|behavioral economics
5257489|NCT02403882|food pantry|food pantry
5257490|NCT02403882|food choice|food choice
5257491|NCT02403869|Metastatic breast cancer|metastatic breast cancer
5257492|NCT02403869|Monotherapy|monotherapy
5257493|NCT02403869|chemotherapy|chemotherapy
5257494|NCT02403869|second line|second line
5257495|NCT02403869|treatment|treatment
5257496|NCT02403869|Her 2 negative|her 2 negative
5257497|NCT02403856|calcifying tendinitis|calcifying tendinitis
5257498|NCT02403856|Needle lavage|needle lavage
5257499|NCT02403856|Shoulder|shoulder
5257500|NCT02403856|Corticosteroid injection|corticosteroid injection
5257501|NCT02403856|Ultrasound-guided|ultrasound-guided
5257502|NCT02403817|Video Games|video games
5257503|NCT02403804|Dietary supplements|dietary supplements
5257504|NCT02403804|serum choline|serum choline
5257505|NCT02403804|women|women
5257506|NCT02403791|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5257507|NCT02403778|Melanoma|melanoma
5257508|NCT02403778|Malignant Melanoma|malignant melanoma
5257509|NCT02403752|dementia|dementia
5257510|NCT02403752|Alzheimer's disease|alzheimer's disease
5257511|NCT02403752|exercise|exercise
5257512|NCT02403739|Growth|growth
5257513|NCT02403700|bone remodeling|bone remodeling
5257514|NCT02403700|bone resorption|bone resorption
5257515|NCT02403700|three-dimensional imaging|three-dimensional imaging
5257516|NCT02403700|clinical trial|clinical trial
5257517|NCT02403700|dental implant|dental implant
5257518|NCT02403700|maxilla|maxilla
5257519|NCT02403700|bone healing|bone healing
5257520|NCT02403635|HSV|hsv
5257521|NCT02403635|Herpes|herpes
5257522|NCT02403635|volunteers|volunteers
5257523|NCT02403635|drug-drug interaction|drug-drug interaction
5257524|NCT02403609|cognitive assessment|cognitive assessment
5257525|NCT02403609|Brain Performance Test|brain performance test
5257526|NCT02403609|Lumosity|lumosity
5257527|NCT02403609|test-retest reliability|test-retest reliability
5257528|NCT02403609|computerized assessment|computerized assessment
5257529|NCT02403596|Hip replacement|hip replacement
5257530|NCT02403596|rivaroxaban|rivaroxaban
5257531|NCT02403596|exacyl|exacyl
5257532|NCT02403596|blood loss|blood loss
5257533|NCT02403583|HIV Transmission|hiv transmission
5257534|NCT02403583|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5257535|NCT02403583|Serodiscordancy|serodiscordancy
5257536|NCT02403583|Home-based testing|home-based testing
5257537|NCT02403583|Home-based counseling|home-based counseling
5257538|NCT02403583|Linkage to care|linkage to care
5257539|NCT02403583|Couples HIV Testing and Counseling|couples hiv testing and counseling
5257540|NCT02403583|Acceptance of repeat HIV testing during pregnancy|acceptance of repeat hiv testing during pregnancy
5257541|NCT02403583|Retention in care|retention in care
5257542|NCT02403570|Multiple Sclerosis, MRI, rotating frame|multiple sclerosis, mri, rotating frame
5257543|NCT02403544|Clinical Trial, Phase I|clinical trial, phase i
5257544|NCT02403544|Concurrent Chemoradiation|concurrent chemoradiation
5257545|NCT02403544|Oxaliplatin|oxaliplatin
5257546|NCT02403544|Capecitabine|capecitabine
5257547|NCT02403544|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5257548|NCT02403531|Esophageal cancer|esophageal cancer
5257549|NCT02403531|Chemoradiotherapy|chemoradiotherapy
5257550|NCT02403531|induction chemotherapy|induction chemotherapy
5257551|NCT02403505|Prostate Cancer|prostate cancer
5257553|NCT02403505|Single Nucleotide Polymorphism|single nucleotide polymorphism
5257554|NCT02403505|Genetics|genetics
5257555|NCT02403505|Pharmacogenomic|pharmacogenomic
5257556|NCT02403505|Pharmacogenetic|pharmacogenetic
5257557|NCT02403505|gene|gene
5257558|NCT02403505|genome|genome
5257559|NCT02403505|genotype|genotype
5257560|NCT02403505|genotyping|genotyping
5257561|NCT02403505|Oncology|oncology
5257562|NCT02403505|Chemotherapy|chemotherapy
5257563|NCT02403505|Personalize|personalize
5257564|NCT02403505|Individualize|individualize
5257565|NCT02403505|CSPC|cspc
5257566|NCT02403492|Children|children
5257567|NCT02403492|Obesity|obesity
5257568|NCT02403492|Cardiovascular|cardiovascular
5257569|NCT02403492|Sleep|sleep
5257570|NCT02403492|Apnea|apnea
5257571|NCT02403492|Obstructive|obstructive
5257572|NCT02403466|Medical errors|medical errors
5257573|NCT02403466|Communication|communication
5257574|NCT02403466|Resident sign-out|resident sign-out
5257575|NCT02403453|Radiculopathy|radiculopathy
5257576|NCT02403453|Myelopathy|myelopathy
5257577|NCT02403453|Spondylosis|spondylosis
5257578|NCT02403453|Herniated Nucleus Pulposus|herniated nucleus pulposus
5257579|NCT02403453|C3-C7|c3-c7
5257580|NCT02403453|Osteophytes|osteophytes
5257581|NCT02403453|Neurological deficit|neurological deficit
5257582|NCT02403427|Bolus calculator|bolus calculator
5257583|NCT02403427|Insulin pump|insulin pump
5257584|NCT02403427|basal-bolus insulin therapy|basal-bolus insulin therapy
5257585|NCT02403401|Pregnancy prevention|pregnancy prevention
5257586|NCT02403388|Patient safety|patient safety
5257587|NCT02403388|Primary care|primary care
5257588|NCT02403388|Incident reporting|incident reporting
5257589|NCT02403388|Pluridisciplinary care offices|pluridisciplinary care offices
5257590|NCT02403388|Risk management|risk management
5257591|NCT02403388|Assessment|assessment
5257592|NCT02403310|adverse-risk AML|adverse-risk aml
5257593|NCT02403310|poor-risk karyotype|poor-risk karyotype
5257594|NCT02403310|cytogenetic abnormality|cytogenetic abnormality
5257595|NCT02403310|poor-risk mutations|poor-risk mutations
5257596|NCT02403310|antecedent hematologic disorder|antecedent hematologic disorder
5257597|NCT02403310|treatment related AML|treatment related aml
5257598|NCT02403297|Bleeding gums|bleeding gums
5257599|NCT02403297|Gum inflammation|gum inflammation
5257601|NCT02403284|insulin resistance|insulin resistance
5257602|NCT02403284|lipid metabolism|lipid metabolism
5257603|NCT02403284|glucose metabolism|glucose metabolism
5257604|NCT02403284|high fat diets|high fat diets
5257605|NCT02403271|Pharmacyclics|pharmacyclics
5257607|NCT02403271|Ibrutinib|ibrutinib
5257608|NCT02403271|Durvalumab (MEDI4736)|durvalumab (medi4736)
5257609|NCT02403271|Relapsed Refractory Solid Tumor|relapsed refractory solid tumor
5257610|NCT02403271|Non-Small Cell Lung Cancer|non-small cell lung cancer
5257611|NCT02403271|NSCLC|nsclc
5257612|NCT02403271|Squamous|squamous
5257613|NCT02403271|Squamous NSCLC|squamous nsclc
5257614|NCT02403271|Squamous Non-Small Cell Lung Cancer|squamous non-small cell lung cancer
5257615|NCT02403271|Immunotherapy|immunotherapy
5257616|NCT02403271|IMBRUVICA®|imbruvica®
5257617|NCT02403271|Tumor Immunotherapy|tumor immunotherapy
5257618|NCT02403271|Anti-PD-L1|anti-pd-l1
5257619|NCT02403271|Lung Cancer|lung cancer
5257620|NCT02403271|Breast Cancer|breast cancer
5257621|NCT02403271|Triple Negative|triple negative
5257622|NCT02403271|HER2 Positive|her2 positive
5257623|NCT02403271|HER2 + Breast Cancer|her2 + breast cancer
5257624|NCT02403271|Pancreatic Cancer|pancreatic cancer
5257625|NCT02403258|acupuncture|acupuncture
5257626|NCT02403258|plum-blossom needle|plum-blossom needle
5257627|NCT02403258|tourette syndrome|tourette syndrome
5257628|NCT02403258|randomized controlled trial|randomized controlled trial
5245221|NCT02473055|kangaroo care|kangaroo care
5257629|NCT02403245|Social interactions|social interactions
5257630|NCT02403245|Dementia|dementia
5257631|NCT02403245|Social stimulation|social stimulation
5257632|NCT02403245|Direct observation|direct observation
5257633|NCT02403232|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
5257634|NCT02403219|Dry eye|dry eye
5257635|NCT02403219|Botulinum toxin A|botulinum toxin a
5257636|NCT02403219|Orbicularis muscle of the eye|orbicularis muscle of the eye
5257637|NCT02403193|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
5257638|NCT02403193|NSCLC|nsclc
5257639|NCT02403193|PBF-509|pbf-509
5257640|NCT02403193|Immunotherapy|immunotherapy
5257641|NCT02403193|adenosine|adenosine
5257642|NCT02403193|PDR001|pdr001
5257643|NCT02403193|immune checkpoint inhibitors|immune checkpoint inhibitors
5257644|NCT02403193|Programmed Death-1 (PD-1) receptor|programmed death-1 (pd-1) receptor
5257645|NCT02403193|Adenosine A2a receptor (A2AR)|adenosine a2a receptor (a2ar)
5257646|NCT02403180|Visual Performance|visual performance
5257647|NCT02403154|Anterior pelvic ring|anterior pelvic ring
5257648|NCT02403154|Internal fixation|internal fixation
5257649|NCT02403154|External fixation|external fixation
5257650|NCT02403154|Orthopaedic|orthopaedic
5257651|NCT02403154|Orthopedic|orthopedic
5257652|NCT02403154|pubic rami|pubic rami
5257653|NCT02403128|362.17|362.17
5257654|NCT02403102|Magnetic Resonance Imaging|magnetic resonance imaging
5257655|NCT02403102|Myeloma|myeloma
5257656|NCT02403102|Autograft|autograft
5257657|NCT02403089|MAIT (Mucosal-Associated Invariant T) cells|mait (mucosal-associated invariant t) cells
5257658|NCT02403089|Gut microbiota|gut microbiota
5257659|NCT02403089|Preterm birth|preterm birth
5257660|NCT02403089|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5257661|NCT02403089|Microbial infections|microbial infections
5257662|NCT02403050|Neoplasm Staging|neoplasm staging
5257663|NCT02403050|Radiotherapy|radiotherapy
5257664|NCT02403050|Fiducial Markers|fiducial markers
5257665|NCT02403037|Breast Neoplasms|breast neoplasms
5257666|NCT02403037|Auricular Therapy|auricular therapy
5257667|NCT02403037|Acupressure|acupressure
5257668|NCT02403037|Chemotherapy|chemotherapy
5257669|NCT02403037|Nausea|nausea
5257670|NCT02403037|Vomiting|vomiting
5257671|NCT02403024|Colon cancer|colon cancer
5257672|NCT02403024|rectal cancer|rectal cancer
5257673|NCT02403024|exercise|exercise
5257674|NCT02403024|physical activity|physical activity
5257675|NCT02403024|metabolic health|metabolic health
5257676|NCT02403011|Congenital Muscular Torticollis|congenital muscular torticollis
5257677|NCT02403011|Manual Therapy|manual therapy
5257678|NCT02403011|Infant|infant
5257679|NCT02402998|Primacy immune thrombocytopenia|primacy immune thrombocytopenia
5257680|NCT02402998|Adults|adults
5257681|NCT02402998|Eltrombopag|eltrombopag
5257682|NCT02402998|Long-term remission|long-term remission
5257683|NCT02402985|nutritional support|nutritional support
5257684|NCT02402985|diet therapy|diet therapy
5257685|NCT02402985|protein diet|protein diet
5257695|NCT02402959|TCM pattern differentiation|tcm pattern differentiation
5257696|NCT02402907|cesarean section|cesarean section
5257697|NCT02402907|chlorhexidine gluconate|chlorhexidine gluconate
5257698|NCT02402907|CHG|chg
5257699|NCT02402907|surgical site infection|surgical site infection
5257700|NCT02402907|obstetrics|obstetrics
5257701|NCT02402907|infection prevention|infection prevention
5257702|NCT02402907|pregnancy|pregnancy
5257703|NCT02402881|venous thromboembolism|venous thromboembolism
5257704|NCT02402881|deep venous thrombosis|deep venous thrombosis
5257705|NCT02402881|pulmonary embolism|pulmonary embolism
5257706|NCT02402881|blood clots|blood clots
5257707|NCT02402855|Couverture Maladie Universelle|couverture maladie universelle
5255116|NCT02417207|hepatitis B|hepatitis b
5257708|NCT02402855|Couverture Maladie Universelle-Complémentaire|couverture maladie universelle-complémentaire
5257709|NCT02402855|free health care|free health care
5257710|NCT02402842|gastrointestinal oncology|gastrointestinal oncology
5257711|NCT02402842|immunology|immunology
5257712|NCT02402842|taxane|taxane
5257713|NCT02402764|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
5257714|NCT02402764|Breast - Female|breast - female
5257715|NCT02402764|Breast - Male|breast - male
5257716|NCT02402764|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
5257717|NCT02402764|Receptor Tyrosine-protein Kinase erbB-2 (HER2) Negative|receptor tyrosine-protein kinase erbb-2 (her2) negative
5257718|NCT02402764|Erythroblastosis virus oncogene B (erbB)|erythroblastosis virus oncogene b (erbb)
5257719|NCT02402751|Volunteers|volunteers
5257720|NCT02402725|Relapsed Multiple Myeloma|relapsed multiple myeloma
5257721|NCT02402699|HBV|hbv
5257722|NCT02402699|HBC|hbc
5257723|NCT02402647|Hoarding|hoarding
5257724|NCT02402647|Compulsive Hoarding|compulsive hoarding
5257725|NCT02402595|Drug-drug interaction|drug-drug interaction
5257726|NCT02402595|Healthy Volunteers|healthy volunteers
5257727|NCT02402595|Pharmacokinetics|pharmacokinetics
5257728|NCT02402595|deuterated dextromethorphan|deuterated dextromethorphan
5257729|NCT02402595|dextromethorphan|dextromethorphan
5257730|NCT02402595|dextromethorphan with quinidine|dextromethorphan with quinidine
5257731|NCT02402595|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
5257732|NCT02402595|itraconazole|itraconazole
5257733|NCT02402582|Family-Centered Empowerment Model|family-centered empowerment model
5257734|NCT02402582|Quality of life|quality of life
5257735|NCT02402582|Perceived stress|perceived stress
5257736|NCT02402582|Anxiety|anxiety
5257737|NCT02402582|Myocardial infarction|myocardial infarction
5257738|NCT02402582|Clinical trial|clinical trial
5257739|NCT02402582|Iran|iran
5257740|NCT02402543|preemptive analgesia|preemptive analgesia
5257741|NCT02402543|anorectal surgery|anorectal surgery
5257742|NCT02402543|gabapentin|gabapentin
5257743|NCT02402543|neurontin|neurontin
5257744|NCT02402543|ketamine|ketamine
5257745|NCT02402543|acetaminophen|acetaminophen
5257746|NCT02402543|tylenol|tylenol
5257747|NCT02402543|postoperative pain|postoperative pain
5257748|NCT02402543|postoperative narcotic usage|postoperative narcotic usage
5257749|NCT02402543|dexamethasone|dexamethasone
5257750|NCT02402543|decadron|decadron
5257751|NCT02402530|Neridronic Acid|neridronic acid
5257752|NCT02402530|Neridronate|neridronate
5257753|NCT02402530|CRPS|crps
5257754|NCT02402530|RSD|rsd
5257755|NCT02402517|Diabetes Prevention|diabetes prevention
5257756|NCT02402517|Obesity Prevention|obesity prevention
5257757|NCT02402491|Dual Antiplatelet Treatment|dual antiplatelet treatment
5257758|NCT02402491|In-Stent Restenosis|in-stent restenosis
5257759|NCT02402478|Clinical Cohort|clinical cohort
5257760|NCT02402478|Electronic Health Records|electronic health records
5257761|NCT02402478|Prognosis|prognosis
5257762|NCT02402478|Stable Coronary Artery Disease|stable coronary artery disease
5257763|NCT02402439|Type 1 diabetes|type 1 diabetes
5257764|NCT02402439|diabetes mellitus|diabetes mellitus
5257765|NCT02402439|pancreatic islet transplant|pancreatic islet transplant
5257766|NCT02402439|beta cell replacement|beta cell replacement
5257767|NCT02402426|Brain Health|brain health
5257768|NCT02402426|Brain Research|brain research
5257769|NCT02402426|Alzheimer's Disease|alzheimer's disease
5257770|NCT02402426|Neurodegenerative Disease|neurodegenerative disease
5257771|NCT02402426|Parkinson's Disease|parkinson's disease
5257773|NCT02402426|Stroke|stroke
5257774|NCT02402426|PTSD|ptsd
5257775|NCT02402426|Multiple Sclerosis|multiple sclerosis
5257776|NCT02402400|NSTEMI|nstemi
5257777|NCT02402361|Neuropathic pain|neuropathic pain
5257779|NCT02402348|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5257780|NCT02402309|Sjögren-Larsson Syndrome|sjögren-larsson syndrome
5257781|NCT02402309|SLS|sls
5257782|NCT02402309|Ichthyosis|ichthyosis
5257783|NCT02402309|FALDH Deficiency|faldh deficiency
5257784|NCT02402309|Neuro-ichthyosis|neuro-ichthyosis
5257785|NCT02402309|Fatty Alcohol:NAD+ Oxidoreductase Deficiency|fatty alcohol:nad+ oxidoreductase deficiency
5257786|NCT02402309|Fatty Aldehyde Dehydrogenase Deficiency Disease|fatty aldehyde dehydrogenase deficiency disease
5257787|NCT02402309|Congenital Icthyosis Mental Retardation Spasticity Syndrome|congenital icthyosis mental retardation spasticity syndrome
5257788|NCT02402309|Spastic Neurologic Disorder|spastic neurologic disorder
5257789|NCT02402309|Oligophrenia|oligophrenia
5257790|NCT02402283|Bioequivalency|bioequivalency
5257791|NCT02402283|two metronidazole-containing products|two metronidazole-containing products
5257792|NCT02402270|Colonoscopy|colonoscopy
5257793|NCT02402270|Preparation|preparation
5257794|NCT02402257|Central Venous Catheter|central venous catheter
5257795|NCT02402257|Simulation-based Mastery Learning|simulation-based mastery learning
5257796|NCT02402257|Medical Education|medical education
5257797|NCT02402257|Patient Outcomes|patient outcomes
5257798|NCT02402257|Bloodstream Infection Due to Central Venous Catheter|bloodstream infection due to central venous catheter
5257799|NCT02402257|Pneumothorax|pneumothorax
5257800|NCT02402257|Inadvertent Arterial Puncture|inadvertent arterial puncture
5257803|NCT02402192|recombinant FSH|recombinant fsh
5257804|NCT02402192|HP-hMG|hp-hmg
5257805|NCT02402192|time-lapse|time-lapse
5257806|NCT02402192|kinetics of development|kinetics of development
5257807|NCT02402179|protein quality|protein quality
5257808|NCT02402153|Evaluation of subcutaneous EEG recording|evaluation of subcutaneous eeg recording
5257809|NCT02402140|tacrolimus blood concentration|tacrolimus blood concentration
5153041|NCT03035474|Heart Failure|heart failure
5257810|NCT02402140|pharmaceutical intervention|pharmaceutical intervention
5257811|NCT02402140|intrasubject variability|intrasubject variability
5257812|NCT02402127|Contact lenses|contact lenses
5257813|NCT02402127|Lubricity|lubricity
5257814|NCT02402101|tDCS|tdcs
5257815|NCT02402101|Dopamine|dopamine
5257816|NCT02402101|PET|pet
5257817|NCT02402088|stress|stress
5257818|NCT02402088|food cues|food cues
5257819|NCT02402088|obesity|obesity
5356736|NCT01918202|PET|pet
5257820|NCT02402075|muscle motor evoked potentials|muscle motor evoked potentials
5257821|NCT02402075|spinal motor evoked potentials|spinal motor evoked potentials
5257822|NCT02402075|D-wave|d-wave
5257823|NCT02402075|brain tumor surgery|brain tumor surgery
5257824|NCT02402075|intraoperative neuromonitoring|intraoperative neuromonitoring
5257825|NCT02402062|pNET|pnet
5257826|NCT02401997|sperm|sperm
5257827|NCT02401997|oxidative stress|oxidative stress
5257828|NCT02401997|sexual abstinence|sexual abstinence
5257829|NCT02401971|Thalidomide|thalidomide
5257830|NCT02401971|Irinotecan|irinotecan
5257831|NCT02401971|Second Line|second line
5257832|NCT02401945|Macular Degeneration|macular degeneration
5257833|NCT02401919|Nursing|nursing
5257834|NCT02401919|Hospital|hospital
5257835|NCT02401919|Communication|communication
5257836|NCT02401919|Patient Participation|patient participation
5257837|NCT02401919|Individualised Care|individualised care
5257838|NCT02401893|aging|aging
5257839|NCT02401893|influenza vaccine|influenza vaccine
5257840|NCT02401893|immune responses|immune responses
5257859|NCT02401802|Polyethylene glycols|polyethylene glycols
5257860|NCT02401802|Efficacy|efficacy
5257861|NCT02401802|Personal satisfaction|personal satisfaction
5257862|NCT02401802|Colorectal cancer screening|colorectal cancer screening
5257863|NCT02401789|oral surgery|oral surgery
5257864|NCT02401789|Implantology|implantology
5257865|NCT02401776|heart rate|heart rate
5257866|NCT02401776|blood pressure|blood pressure
5257867|NCT02401776|caffeine|caffeine
5257868|NCT02401776|energy drink|energy drink
5257869|NCT02401763|biomarker|biomarker
5257870|NCT02401737|Hepatitis B|hepatitis b
5257871|NCT02401724|Hemispatial neglect|hemispatial neglect
5257872|NCT02401724|Transcranial direct current stimulation|transcranial direct current stimulation
5257873|NCT02401724|Rehabilitation|rehabilitation
5257874|NCT02401698|Stroke|stroke
5257875|NCT02401698|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5257876|NCT02401698|Neuronal Plasticity|neuronal plasticity
5257877|NCT02401698|Rehabilitation|rehabilitation
5257878|NCT02401685|breast cancer|breast cancer
5257879|NCT02401685|sentinel lymph node biopsy|sentinel lymph node biopsy
5257880|NCT02401685|axillary lymph node clearance|axillary lymph node clearance
5257881|NCT02401685|axillary lymph node dissection|axillary lymph node dissection
5257882|NCT02401685|macrometastases|macrometastases
5257883|NCT02401685|axillary radiotherapy|axillary radiotherapy
5257884|NCT02401685|POSNOC|posnoc
5257886|NCT02401672|nicotine dependence|nicotine dependence
5257887|NCT02401672|smoking cessation|smoking cessation
5257888|NCT02401659|remote monitoring|remote monitoring
5257889|NCT02401659|satisfaction|satisfaction
5257890|NCT02401659|telemonitoring|telemonitoring
5257891|NCT02401659|quality of life|quality of life
5257892|NCT02401633|Cardio-Pulmonary-Resuscitation|cardio-pulmonary-resuscitation
5257893|NCT02401633|Advanced Cardiac Life Support|advanced cardiac life support
5257894|NCT02401633|Compression-Only CPR|compression-only cpr
5257895|NCT02401633|Chest compression CPR|chest compression cpr
5257896|NCT02401620|AR: arthritis rheumatoid|ar: arthritis rheumatoid
5257897|NCT02401620|DMARDs: Disease-modifying antirheumatic drugs|dmards: disease-modifying antirheumatic drugs
5257898|NCT02401620|ACR. American College of Rheumatology|acr. american college of rheumatology
5257899|NCT02401620|EULAR: European League against rheumatology|eular: european league against rheumatology
5257901|NCT02401607|emergency physicians|emergency physicians
5257902|NCT02401607|health care workers|health care workers
5257903|NCT02401607|biomarkers|biomarkers
5257904|NCT02401607|questionnaires|questionnaires
5257905|NCT02401607|anxiety|anxiety
5257906|NCT02401607|depression|depression
5257907|NCT02401607|burn-out|burn-out
5257908|NCT02401594|Non-major orthopaedic surgery|non-major orthopaedic surgery
5257909|NCT02401594|deep vein thrombosis|deep vein thrombosis
5257927|NCT02401529|Dexamethasone|dexamethasone
5257928|NCT02401529|Prednisolone|prednisolone
5257929|NCT02401529|Tonsillectomy Nausea|tonsillectomy nausea
5257936|NCT02401516|Blood Pressure|blood pressure
5257937|NCT02401516|Posture|posture
5257938|NCT02401516|Quality Of Life|quality of life
5257939|NCT02401516|General Functional Capacity|general functional capacity
5257940|NCT02401516|Respiratory Muscles Strength|respiratory muscles strength
5257941|NCT02401516|Flexibility|flexibility
5258138|NCT02400203|omega-3|omega-3
5257949|NCT02401425|Letrozole|letrozole
5257950|NCT02401425|Misoprostol|misoprostol
5257951|NCT02401425|First-Trimester|first-trimester
5257952|NCT02401425|Pretreatment|pretreatment
5257953|NCT02401386|Fibromyalgia; Eight Brocades; Baduanjin; Qigong; Pain severity|fibromyalgia; eight brocades; baduanjin; qigong; pain severity
5257954|NCT02401373|Vaccines|vaccines
5257955|NCT02401373|Ebola Virus Disease|ebola virus disease
5257956|NCT02401347|PALB2 mutation|palb2 mutation
5257957|NCT02401347|BRIP1 mutation|brip1 mutation
5257958|NCT02401347|BARD1 mutation|bard1 mutation
5257959|NCT02401347|Rad51c mutation|rad51c mutation
5257960|NCT02401347|PTEN mutation|pten mutation
5257961|NCT02401347|CHEK2 mutation|chek2 mutation
5257962|NCT02401347|ATM mutation|atm mutation
5257963|NCT02401347|NBN mutation|nbn mutation
5257964|NCT02401347|Rad51d mutation|rad51d mutation
5257965|NCT02401347|Rad50 mutation|rad50 mutation
5257966|NCT02401347|MRE11 mutation|mre11 mutation
5257967|NCT02401347|FANC mutation|fanc mutation
5257968|NCT02401347|HRD assay score|hrd assay score
5257969|NCT02401347|ATR mutation|atr mutation
5257970|NCT02401295|Relapsed multiple myeloma|relapsed multiple myeloma
5257971|NCT02401256|Efavirenz|efavirenz
5257972|NCT02401256|metabolism|metabolism
5257973|NCT02401256|pharmacokinetics changes|pharmacokinetics changes
5257974|NCT02401230|Human Immunodeficiency Virus|human immunodeficiency virus
5257975|NCT02401230|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5257976|NCT02401230|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5257977|NCT02401204|Bacterial transmission|bacterial transmission
5257978|NCT02401204|Surveillance|surveillance
5257979|NCT02401204|Neonatal|neonatal
5257980|NCT02401204|Drug Resistance|drug resistance
5257981|NCT02401178|FLG-FADS genes variations-LCPUFA-atopic dermatitis|flg-fads genes variations-lcpufa-atopic dermatitis
5257982|NCT02401165|GADD34|gadd34
5257983|NCT02401165|Unfolded Protein Response|unfolded protein response
5257984|NCT02401165|Anti-citrullinated protein antibodies|anti-citrullinated protein antibodies
5257985|NCT02401100|Rectal Neoplasms|rectal neoplasms
5257987|NCT02401061|Thrombocytopenia|thrombocytopenia
5257993|NCT02401022|smoking|smoking
5257994|NCT02401022|smoking cessation|smoking cessation
5257995|NCT02401022|cigarette|cigarette
5257996|NCT02400996|Endocrine Pancreas|endocrine pancreas
5257997|NCT02400996|Pancreatic Endocrine Neoplasm|pancreatic endocrine neoplasm
5257998|NCT02400983|ACAP, Automatic Algorithm|acap, automatic algorithm
5257999|NCT02400970|Polymerase Chain Reaction|polymerase chain reaction
5258000|NCT02400970|fertility preservation|fertility preservation
5258001|NCT02400957|silver nanoparticles|silver nanoparticles
5258002|NCT02400957|demineralization|demineralization
5258003|NCT02400957|brackets|brackets
5258008|NCT02400905|PVD|pvd
5258009|NCT02400905|SFA stent|sfa stent
5258010|NCT02400879|bispectral index|bispectral index
5258011|NCT02400879|cardiac surgery|cardiac surgery
5258012|NCT02400879|recovery|recovery
5258013|NCT02400879|remifentanil|remifentanil
5258014|NCT02400866|cancer patients receiving moderately emetogenic chemotherapy|cancer patients receiving moderately emetogenic chemotherapy
5258015|NCT02400827|Polymerase Chain Reaction|polymerase chain reaction
5258016|NCT02400827|fertility preservation|fertility preservation
5258017|NCT02400801|endometriosis|endometriosis
5258018|NCT02400801|infertility|infertility
5258019|NCT02400801|assisted reproductive technology|assisted reproductive technology
5258020|NCT02400775|Pharmacotherapy|pharmacotherapy
5258021|NCT02400749|moderate to severe non-pustular palmo-plantar psoriasis|moderate to severe non-pustular palmo-plantar psoriasis
5258022|NCT02400736|Individual Placement and Support|individual placement and support
5258023|NCT02400736|Supported Employment|supported employment
5258024|NCT02400736|Employment|employment
5258025|NCT02400736|Vocational Rehabilitation|vocational rehabilitation
5258026|NCT02400736|Veterans|veterans
5258027|NCT02400736|Patient Aligned Care Team|patient aligned care team
5258028|NCT02400723|behavioral intervention|behavioral intervention
5258029|NCT02400723|relaxation|relaxation
5258030|NCT02400723|Veterans|veterans
5258031|NCT02400723|geriatric|geriatric
5255444|NCT02415790|E2027|e2027
5258032|NCT02400684|AFSr classification|afsr classification
5258033|NCT02400684|laparoscopy|laparoscopy
5258034|NCT02400658|breast cancer|breast cancer
5258035|NCT02400658|early-stage|early-stage
5258037|NCT02400658|brachytherapy|brachytherapy
5258038|NCT02400645|laparoscopic hysterectomy|laparoscopic hysterectomy
5258039|NCT02400645|robotic assisted hysterectomy|robotic assisted hysterectomy
5258040|NCT02400632|drug-eluting balloon|drug-eluting balloon
5258041|NCT02400632|in-stent restenosis|in-stent restenosis
5258042|NCT02400619|shockwaves|shockwaves
5258043|NCT02400619|Physiotherapy|physiotherapy
5258044|NCT02400619|Botulinum toxin|botulinum toxin
5258045|NCT02400606|constructing VPs|constructing vps
5258046|NCT02400606|knowledge and skills transfer|knowledge and skills transfer
5258047|NCT02400580|Laparoscopic Hysterectomy|laparoscopic hysterectomy
5258048|NCT02400580|IV acetaminophen|iv acetaminophen
5258049|NCT02400580|Postoperative pain control|postoperative pain control
5258050|NCT02400580|Surgery|surgery
5258051|NCT02400567|Luminal|luminal
5258052|NCT02400567|Post menopausal|post menopausal
5258053|NCT02400567|Breast conservation|breast conservation
5258054|NCT02400567|Neoadjuvant|neoadjuvant
5258055|NCT02400554|Indian, North American|indian, north american
5258057|NCT02400554|Female|female
5258058|NCT02400554|health promotion|health promotion
5258059|NCT02400541|Anorexia nervosa|anorexia nervosa
5258060|NCT02400541|Cognitive remediation therapy|cognitive remediation therapy
5258062|NCT02400515|Exercise Therapy|exercise therapy
5258063|NCT02400515|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5258064|NCT02400502|Schizophrenia|schizophrenia
5258065|NCT02400502|Treatment|treatment
5258066|NCT02400502|Meditation|meditation
5258067|NCT02400502|Mindfulness|mindfulness
5258068|NCT02400502|Stress reactivity|stress reactivity
5258069|NCT02400502|First Episode Psychosis|first episode psychosis
5258070|NCT02400502|Coping|coping
5258071|NCT02400489|Heart Valve Replacement Surgery|heart valve replacement surgery
5258072|NCT02400489|Perimount|perimount
5258073|NCT02400489|Edwards|edwards
5258074|NCT02400476|HER2 +|her2 +
5258075|NCT02400476|Breast Cancer|breast cancer
5258076|NCT02400476|Neratinib|neratinib
5258077|NCT02400476|Nerlynx|nerlynx
5258078|NCT02400476|Loperamide|loperamide
5258079|NCT02400476|Colestipol|colestipol
5258080|NCT02400476|Budesonide|budesonide
5258081|NCT02400450|Pre-diabetes|pre-diabetes
5258082|NCT02400450|prediabetes|prediabetes
5258083|NCT02400450|glycated hemoglobin|glycated hemoglobin
5258084|NCT02400450|hemoglobin A1c|hemoglobin a1c
5258085|NCT02400450|LDL cholesterol|ldl cholesterol
5258086|NCT02400450|Cholesterol|cholesterol
5258087|NCT02400450|metabolic function|metabolic function
5258088|NCT02400450|vascular function|vascular function
5258089|NCT02400450|functional food|functional food
5258090|NCT02400437|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5258091|NCT02400424|Stereotactic lung radiation therapy|stereotactic lung radiation therapy
5258092|NCT02400424|Radiochemotherapy|radiochemotherapy
5258093|NCT02400424|Unresectable stage III Non-Small Cell lung Carcinoma|unresectable stage iii non-small cell lung carcinoma
5258094|NCT02400424|Peripheral primary tumor|peripheral primary tumor
5258095|NCT02400411|Carbohydrate|carbohydrate
5258096|NCT02400411|Glycemic response|glycemic response
5258097|NCT02400411|insulin|insulin
5258098|NCT02400411|whole grain|whole grain
5258099|NCT02400411|meal|meal
5258100|NCT02400359|fMRI|fmri
5258101|NCT02400359|Magnetic Resonance Imaging|magnetic resonance imaging
5258102|NCT02400359|endocrinology|endocrinology
5258103|NCT02400359|MRI|mri
5258104|NCT02400359|obesity|obesity
5258105|NCT02400359|weight loss|weight loss
5258106|NCT02400359|lorcaserin|lorcaserin
5258107|NCT02400333|ticagrelor orodispersible tablet|ticagrelor orodispersible tablet
5258108|NCT02400333|ticagrelor immediate-release tablet|ticagrelor immediate-release tablet
5258109|NCT02400333|relative bioavailability|relative bioavailability
5258110|NCT02400333|Phase I|phase i
5258111|NCT02400333|healthy subjects|healthy subjects
5258112|NCT02400307|Phase 1|phase 1
5258113|NCT02400307|Renally Impaired|renally impaired
5258114|NCT02400294|Critical care|critical care
5258115|NCT02400294|Mechanical ventilation|mechanical ventilation
5258116|NCT02400294|Ventilator associated pneumonia|ventilator associated pneumonia
5258117|NCT02400294|Oral care|oral care
5258118|NCT02400268|Enterobacteriaceae|enterobacteriaceae
5258119|NCT02400268|Bloodstream|bloodstream
5258120|NCT02400268|Bacteremia|bacteremia
5258121|NCT02400268|Recurrence|recurrence
5258122|NCT02400268|Reinfection|reinfection
5258123|NCT02400229|coronary artery disease|coronary artery disease
5258124|NCT02400229|stable chest pain|stable chest pain
5258125|NCT02400229|intermediate pretest probability|intermediate pretest probability
5258126|NCT02400229|pragmatic randomised controlled trial|pragmatic randomised controlled trial
5258127|NCT02400229|coronary computed tomography|coronary computed tomography
5258128|NCT02400229|angiography|angiography
5258129|NCT02400229|invasive coronary angiography|invasive coronary angiography
5258130|NCT02400216|Chronic Hepatitis C|chronic hepatitis c
5258131|NCT02400216|Cirrhosis|cirrhosis
5258132|NCT02400216|Liver Biopsy|liver biopsy
5258133|NCT02400216|Microbiome|microbiome
5258142|NCT02400190|lumpectomy|lumpectomy
5258143|NCT02400190|favorable biology|favorable biology
5258144|NCT02400190|omission|omission
5258145|NCT02400125|Patient Registry|patient registry
5258146|NCT02400125|Coronary Artery Bypass|coronary artery bypass
5258147|NCT02400125|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
5258148|NCT02400112|Vancomycin|vancomycin
5258149|NCT02400086|neuroligical or neuromuscular diseases|neuroligical or neuromuscular diseases
5258150|NCT02400086|bacterial respiratory tract flora|bacterial respiratory tract flora
5258151|NCT02400086|long term tracheostomy|long term tracheostomy
5258152|NCT02400047|Paediatric surgery|paediatric surgery
5258153|NCT02400034|midurethral sling|midurethral sling
5258154|NCT02400034|Voiding trial|voiding trial
5258155|NCT02400034|stress urinary incontinence|stress urinary incontinence
5258157|NCT02399995|Hepatectomy|hepatectomy
5258158|NCT02399995|15-057|15-057
5258159|NCT02399982|Smartphone Application|smartphone application
5258160|NCT02399982|mobile mental health|mobile mental health
5258161|NCT02399982|Binge Eating|binge eating
5258162|NCT02399982|Cognitive behavioral therapy|cognitive behavioral therapy
5258163|NCT02399982|Eating Disorder treatment|eating disorder treatment
5258164|NCT02399982|Cognitive behavioral therapy guided self-help|cognitive behavioral therapy guided self-help
5258165|NCT02399982|self-monitoring|self-monitoring
5258166|NCT02399982|eating disorders|eating disorders
5258167|NCT02399982|ecological momentary intervention|ecological momentary intervention
5258168|NCT02399969|Low back pain|low back pain
5258169|NCT02399969|Acupuncture therapy|acupuncture therapy
5258170|NCT02399969|Acupuncture, ear|acupuncture, ear
5258171|NCT02399956|Lactation|lactation
5258172|NCT02399956|Pediatric malignancies|pediatric malignancies
5258173|NCT02399956|Cancer survivor|cancer survivor
5258174|NCT02399891|Remodeling|remodeling
5258175|NCT02399891|Prognosis|prognosis
5258176|NCT02399891|Incidence|incidence
5258177|NCT02399891|Quality Assurance|quality assurance
5258178|NCT02399891|Ejection Fraction|ejection fraction
5258179|NCT02399891|Sudden Death|sudden death
5258180|NCT02399800|pancreatitis, chronic|pancreatitis, chronic
5258181|NCT02399800|endosonography|endosonography
5258182|NCT02399761|AADC deficiency, newborn screening|aadc deficiency, newborn screening
5258183|NCT02399735|NK cells|nk cells
5258184|NCT02399735|Liver Transplantation|liver transplantation
5258185|NCT02399735|Hepatocellular Carcinoma Recurrence|hepatocellular carcinoma recurrence
5258186|NCT02399722|Negative Pressure Wound Therapy, polymeric membrane dressing, wounds|negative pressure wound therapy, polymeric membrane dressing, wounds
5258187|NCT02399670|Total hip arthroplasty|total hip arthroplasty
5258188|NCT02399670|degenerative joint disease|degenerative joint disease
5258189|NCT02399670|Femoral offset|femoral offset
5258190|NCT02399670|Patient reported outcome|patient reported outcome
5258191|NCT02399657|diabetes mellitus|diabetes mellitus
5258192|NCT02399657|macular edema|macular edema
5258193|NCT02399657|hard exudate|hard exudate
5258194|NCT02399657|intravitreal injections|intravitreal injections
5258195|NCT02399657|dexamethasone|dexamethasone
5258197|NCT02399644|pain|pain
5258198|NCT02399644|rehabilitation|rehabilitation
5258199|NCT02399644|exercise|exercise
5258200|NCT02399644|psychological|psychological
5258201|NCT02399644|intervention|intervention
5258202|NCT02399631|Perioperative treatment|perioperative treatment
5258203|NCT02399631|Laparoscopic surgery|laparoscopic surgery
5258204|NCT02399618|Clostridium difficile Infection|clostridium difficile infection
5258205|NCT02399618|Fecal Microbiota Transplantation|fecal microbiota transplantation
5258206|NCT02399618|Freeze-dried|freeze-dried
5258207|NCT02399618|Acid-resistant Capsules|acid-resistant capsules
5258208|NCT02399592|Platinum resistant|platinum resistant
5258209|NCT02399579|cat allergy|cat allergy
5258210|NCT02399579|symptom score|symptom score
5258211|NCT02399566|erlotinib|erlotinib
5258212|NCT02399566|pemetrexed|pemetrexed
5258213|NCT02399566|maintenance therapy|maintenance therapy
5258214|NCT02399527|Vascular Anomalies|vascular anomalies
5258215|NCT02399527|Lymphatic Anomalies|lymphatic anomalies
5258216|NCT02399527|Lymphatic Malformation|lymphatic malformation
5258217|NCT02399514|Sleep|sleep
5258218|NCT02399514|emphysema|emphysema
5258219|NCT02399514|coils|coils
5258220|NCT02399514|lung volume reduction|lung volume reduction
5258221|NCT02399501|2D ultrasound|2d ultrasound
5258222|NCT02399501|3D ultrasound|3d ultrasound
5258223|NCT02399501|sonohysterography|sonohysterography
5258224|NCT02399501|hysteroscopy|hysteroscopy
5258225|NCT02399501|Uterine factor of infertility|uterine factor of infertility
5258226|NCT02399475|Levothyroxine|levothyroxine
5258227|NCT02399475|Liothyronine|liothyronine
5258228|NCT02399475|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
5258230|NCT02399475|Hypothyroidism|hypothyroidism
5258231|NCT02399475|Thyroid diseases|thyroid diseases
5258233|NCT02399449|pharmacokinetics|pharmacokinetics
5258234|NCT02399436|Community-Based Participatory Research|community-based participatory research
5258235|NCT02399436|Community-Institutional Relations|community-institutional relations
5258236|NCT02399423|diabetes|diabetes
5258237|NCT02399423|metabolism|metabolism
5258238|NCT02399423|cardiovascular disease|cardiovascular disease
5258239|NCT02399423|weight gain|weight gain
5258240|NCT02399423|weight loss|weight loss
5258241|NCT02399423|european|european
5258242|NCT02399423|south asian|south asian
5258243|NCT02399423|obesity|obesity
5258244|NCT02399410|cytoreductive surgery|cytoreductive surgery
5258245|NCT02399410|hipec|hipec
5258246|NCT02399410|perioperative chemotherapy|perioperative chemotherapy
5258247|NCT02399410|peritoneal carcinomatosis|peritoneal carcinomatosis
5258248|NCT02399410|bevacizumab|bevacizumab
5258249|NCT02399410|colorectal surgery|colorectal surgery
5258250|NCT02399384|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
5258251|NCT02399358|Drug induced Hyponatremia|drug induced hyponatremia
5258252|NCT02399358|Cyclophosphamide|cyclophosphamide
5258253|NCT02399358|Hyponatremia|hyponatremia
5258254|NCT02399358|Cyclophosphamide induced Hyponatremia|cyclophosphamide induced hyponatremia
5258255|NCT02399345|Treatment naive|treatment naive
5258256|NCT02399345|Hepatitis C Genotype 1|hepatitis c genotype 1
5258257|NCT02399319|anterior pelvic ring|anterior pelvic ring
5258258|NCT02399319|symphysis disruption|symphysis disruption
5258259|NCT02399293|Cognitive training|cognitive training
5258260|NCT02399293|Cognitive rehabilitation|cognitive rehabilitation
5258261|NCT02399293|Acquired brain injury|acquired brain injury
5258262|NCT02399293|N-back|n-back
5258263|NCT02399293|Visual Search|visual search
5258264|NCT02399293|Cognitive transfer|cognitive transfer
5258265|NCT02399280|Meal pattern|meal pattern
5258266|NCT02399280|weight loss|weight loss
5258267|NCT02399280|high caloric intake|high caloric intake
5258268|NCT02399280|Dinner|dinner
5258269|NCT02399280|Lunch|lunch
5258270|NCT02399267|mechanical ventilation|mechanical ventilation
5258271|NCT02399267|weaning|weaning
5258272|NCT02399267|critically ill|critically ill
5258273|NCT02399267|spontaneous breathing trial|spontaneous breathing trial
5258274|NCT02399267|screening|screening
5258275|NCT02399267|invasive ventilation|invasive ventilation
5258276|NCT02399267|SBT technique|sbt technique
5258277|NCT02399254|Pulmonary Rehabilitation|pulmonary rehabilitation
5258278|NCT02399228|radiation therapy|radiation therapy
5258279|NCT02399228|chemotherapy|chemotherapy
5258280|NCT02399228|head and neck cancer|head and neck cancer
5258281|NCT02399202|Renal impairment, osilodrostat, LCI699|renal impairment, osilodrostat, lci699
5258282|NCT02399189|Primary central nervous system lymphoma|primary central nervous system lymphoma
5258283|NCT02399189|rituximab|rituximab
5258284|NCT02399189|Methotrexate and Temozolomide|methotrexate and temozolomide
5258285|NCT02399189|autologous stem cell transplantation|autologous stem cell transplantation
5258286|NCT02399189|Carmustine and thiotepa|carmustine and thiotepa
5258287|NCT02399176|Osteoporosis|osteoporosis
5258288|NCT02399176|Yoga|yoga
5258289|NCT02399150|acute abdomen|acute abdomen
5258290|NCT02399150|Pain|pain
5258291|NCT02399150|stress biomarker|stress biomarker
5258292|NCT02399137|Pancreatic Cancer|pancreatic cancer
5258293|NCT02399137|Front-line Pancreatic Cancer|front-line pancreatic cancer
5258294|NCT02399137|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5258295|NCT02399137|Gemcitabine|gemcitabine
5258297|NCT02399137|Abraxane|abraxane
5258298|NCT02399137|Free IGF-1|free igf-1
5258299|NCT02399137|Heregulin|heregulin
5258303|NCT02399111|Prevena Incision Management System (PIMS)|prevena incision management system (pims)
5258304|NCT02399111|Surgical Site Infection (SSI)|surgical site infection (ssi)
5258305|NCT02399085|DLBCL|dlbcl
5258306|NCT02399085|CD19|cd19
5258307|NCT02399085|monoclonal antibody|monoclonal antibody
5258308|NCT02399085|MOR00208|mor00208
5258309|NCT02399085|MOR208|mor208
5258310|NCT02399085|lenalidomide|lenalidomide
5258311|NCT02399059|recurrence|recurrence
5258312|NCT02399033|Xihuang Capsules|xihuang capsules
5258313|NCT02399033|hepatocellular carcinoma|hepatocellular carcinoma
5258314|NCT02399033|Recurrence|recurrence
5258315|NCT02399033|hepatectomy|hepatectomy
5258316|NCT02398994|Clinical Trials Unit|clinical trials unit
5258317|NCT02398994|Pediatric|pediatric
5258318|NCT02398968|Iron|iron
5258319|NCT02398968|RURTIs|rurtis
5258320|NCT02398968|CARIFS|carifs
5258321|NCT02398968|children|children
5258322|NCT02398955|Drug-Eluting Stents|drug-eluting stents
5258323|NCT02398955|Coronary Artery Disease|coronary artery disease
5258324|NCT02398955|Sirolimus|sirolimus
5258325|NCT02398955|Absorbable Implants|absorbable implants
5258326|NCT02398903|Morbid obesity|morbid obesity
5258327|NCT02398903|bariatric surgery|bariatric surgery
5258328|NCT02398903|sleeve gastrectomy|sleeve gastrectomy
5258329|NCT02398903|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5258330|NCT02398903|hormonal contraception|hormonal contraception
5258331|NCT02398903|combined oral contraceptive|combined oral contraceptive
5258332|NCT02398903|progestin contraceptive desogestrel|progestin contraceptive desogestrel
5258333|NCT02398903|pharmacokinetics|pharmacokinetics
5258338|NCT02398825|Imatinib resistant|imatinib resistant
5258339|NCT02398760|Low Back Pain|low back pain
5258340|NCT02398760|Clinical Instability|clinical instability
5258341|NCT02398760|Motor Control Exercises|motor control exercises
5258342|NCT02398760|Clinical Tests|clinical tests
5258344|NCT02398734|carotid endarterectomy|carotid endarterectomy
5258345|NCT02398734|stroke prevention|stroke prevention
5258346|NCT02398734|brain infarction|brain infarction
5258348|NCT02398721|Small Incidental Thyroid Nodules|small incidental thyroid nodules
5258349|NCT02398708|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5258350|NCT02398708|Graft versus Host Disease|graft versus host disease
5258351|NCT02398695|Plaque|plaque
5258352|NCT02398695|Saliva|saliva
5258353|NCT02398695|Caries|caries
5258354|NCT02398682|electronic alerts|electronic alerts
5258355|NCT02398682|acute kidney injury|acute kidney injury
5258356|NCT02398682|NHS|nhs
5258357|NCT02398682|mortality|mortality
5258358|NCT02398669|Obesity|obesity
5258359|NCT02398669|Lorcaserin hydrochloride|lorcaserin hydrochloride
5258360|NCT02398669|APD356|apd356
5258361|NCT02398669|Pediatric|pediatric
5258362|NCT02398669|Pharmacokinetics|pharmacokinetics
5258363|NCT02398656|Minor Ischemic Stroke|minor ischemic stroke
5258364|NCT02398643|Acute Exacerbation of COPD|acute exacerbation of copd
5258365|NCT02398643|COPD|copd
5258366|NCT02398643|Emphysema|emphysema
5258367|NCT02398643|Chronic Bronchitis|chronic bronchitis
5258368|NCT02398630|Histerosalpingography|histerosalpingography
5258369|NCT02398630|MRI|mri
5258370|NCT02398630|Magnetic Resonance Imaging|magnetic resonance imaging
5258371|NCT02398630|HSG|hsg
5258372|NCT02398630|Diagnostico Maipu|diagnostico maipu
5258373|NCT02398630|Imaging|imaging
5258374|NCT02398630|Carrascosa Patricia|carrascosa patricia
5258375|NCT02398617|Heart Failure|heart failure
5258376|NCT02398617|End of Life Care|end of life care
5258377|NCT02398617|Decision Making|decision making
5258378|NCT02398604|Pediatrics|pediatrics
5258379|NCT02398604|HLHS|hlhs
5258380|NCT02398591|Healthy|healthy
5258381|NCT02398591|JNJ 53718678|jnj 53718678
5258382|NCT02398552|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5258383|NCT02398552|sunitinib|sunitinib
5258384|NCT02398552|schedule 2weeks on/1 week off|schedule 2weeks on/1 week off
5258385|NCT02398526|Observational study|observational study
5258386|NCT02398526|Bone metastases|bone metastases
5258387|NCT02398526|Hormone Refractory Prostatic Cancer|hormone refractory prostatic cancer
5258388|NCT02398526|Xofigo|xofigo
5258389|NCT02398526|Radium-223|radium-223
5258390|NCT02398500|First-in-human|first-in-human
5258391|NCT02398500|anti-VEGF|anti-vegf
5258392|NCT02398500|neovascular AMD (nvAMD)|neovascular amd (nvamd)
5258393|NCT02398435|Auto-inflammatory disease|auto-inflammatory disease
5258394|NCT02398435|Still's disease|still's disease
5258395|NCT02398435|Arthritis Rheumatoid|arthritis rheumatoid
5258396|NCT02398435|IL-18|il-18
5258397|NCT02398435|interleukin-18|interleukin-18
5258398|NCT02398435|IL-18 binding protein|il-18 binding protein
5258399|NCT02398422|Autonomic nervous system|autonomic nervous system
5258400|NCT02398422|Auditory processing disorder|auditory processing disorder
5258401|NCT02398422|Social behavior|social behavior
5258402|NCT02398409|stroke|stroke
5258403|NCT02398409|Injury, Brain, Traumatic|injury, brain, traumatic
5258404|NCT02398409|Family Caregivers|family caregivers
5258405|NCT02398409|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5258406|NCT02398409|Informal Caregivers|informal caregivers
5258408|NCT02398357|anticoagulation|anticoagulation
5258409|NCT02398357|Zelen-designed randomized controlled trial|zelen-designed randomized controlled trial
5258415|NCT02398318|neurosurgery|neurosurgery
5258416|NCT02398318|deep brain stimulation|deep brain stimulation
5258417|NCT02398318|exposure response prevention|exposure response prevention
5258418|NCT02398305|Cardiac catheterisation|cardiac catheterisation
5258419|NCT02398305|Radial access|radial access
5258420|NCT02398305|Compression|compression
5258421|NCT02398305|Terumo TR Band|terumo tr band
5258422|NCT02398305|radial artery|radial artery
5258423|NCT02398305|diagnostic|diagnostic
5258424|NCT02398279|schizophrenia|schizophrenia
5258425|NCT02398279|L-Arginine|l-arginine
5258426|NCT02398279|nitric oxide|nitric oxide
5258427|NCT02398279|drug augmentation|drug augmentation
5258428|NCT02398253|weight maintenance|weight maintenance
5258429|NCT02398253|cognitive behavior therapy|cognitive behavior therapy
5258430|NCT02398253|successful weight loss|successful weight loss
5258431|NCT02398227|Battered Women|battered women
5258432|NCT02398227|Trauma|trauma
5258433|NCT02398227|Domestic Violence|domestic violence
5258434|NCT02398214|Sleep|sleep
5258435|NCT02398214|Infants|infants
5258436|NCT02398214|Toddlers|toddlers
5258437|NCT02398214|Behavioral intervention|behavioral intervention
5139434|NCT03119324|LLLT|lllt
5258438|NCT02398175|Pediatric polytrauma|pediatric polytrauma
5258439|NCT02398175|thoracic injuries|thoracic injuries
5258440|NCT02398162|Scrub Typhus in Pediatric|scrub typhus in pediatric
5258441|NCT02398162|Immunology|immunology
5258442|NCT02398136|intervention|intervention
5258443|NCT02398136|ketamine|ketamine
5258444|NCT02398136|PTSD|ptsd
5258445|NCT02398136|treatment|treatment
5258446|NCT02398136|posttraumatic stress disorder|posttraumatic stress disorder
5258447|NCT02398123|Transversus Abdominis Plane|transversus abdominis plane
5258448|NCT02398123|caudal block|caudal block
5258449|NCT02398123|postoperative pain|postoperative pain
5258450|NCT02398123|children|children
5258451|NCT02398084|mastication|mastication
5258452|NCT02398084|cashews|cashews
5258453|NCT02398084|walnuts|walnuts
5258454|NCT02398084|participants|participants
5258455|NCT02398071|Positive Expiratory Pressure|positive expiratory pressure
5258456|NCT02398071|Exercise Recovery|exercise recovery
5258457|NCT02398071|COPD|copd
5258458|NCT02398058|trabectedin|trabectedin
5258459|NCT02398058|olaparib|olaparib
5258461|NCT02398058|bone tumor|bone tumor
5258462|NCT02398045|Obsessive-compulsive disorder|obsessive-compulsive disorder
5258463|NCT02398045|cognitive behavioural therapy|cognitive behavioural therapy
5258464|NCT02398045|computerised|computerised
5258467|NCT02398032|mechanosensitivity|mechanosensitivity
5258468|NCT02398032|chemosensitivity|chemosensitivity
5258469|NCT02398032|adhesion factors|adhesion factors
5258470|NCT02398019|CPB|cpb
5258471|NCT02398019|oXiris®|oxiris®
5258472|NCT02398019|SIRS|sirs
5258473|NCT02398019|AKI|aki
5258474|NCT02398019|Cytokines|cytokines
5258475|NCT02398019|CSA-AKI|csa-aki
5258476|NCT02398006|Clavicle [mh]|clavicle [mh]
5258477|NCT02398006|Fracture Healing [mh]|fracture healing [mh]
5258478|NCT02398006|Fractures, Bone [mh]|fractures, bone [mh]
5258479|NCT02398006|Treatment outcome [mh]|treatment outcome [mh]
5258480|NCT02398006|Conservative treatment [tw]|conservative treatment [tw]
5258481|NCT02397980|Caregivers|caregivers
5258482|NCT02397967|NF1|nf1
5258483|NCT02397967|children|children
5258484|NCT02397967|reading disabilities|reading disabilities
5258485|NCT02397954|idiopathic polypoidal choroidal vasculopathy|idiopathic polypoidal choroidal vasculopathy
5258486|NCT02397954|IPCV|ipcv
5258487|NCT02397954|Zimura™|zimura™
5258488|NCT02397954|Avastin®|avastin®
5258489|NCT02397954|Eylea®|eylea®
5258490|NCT02397954|Lucentis®|lucentis®
5258491|NCT02397928|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5258492|NCT02397928|Treatment|treatment
5258493|NCT02397928|Minimal toxicity|minimal toxicity
5258494|NCT02397928|TTFields|ttfields
5258495|NCT02397928|Tumor Treating Fields|tumor treating fields
5258496|NCT02397928|Novocure|novocure
5258497|NCT02397928|Pemetrexed|pemetrexed
5258498|NCT02397928|Carboplatin|carboplatin
5258499|NCT02397928|Cisplatin|cisplatin
5258500|NCT02397915|Nasal Spray|nasal spray
5258501|NCT02397915|Fluticasone Furoate|fluticasone furoate
5258502|NCT02397915|Attributes|attributes
5258503|NCT02397915|Single Dose|single dose
5258504|NCT02397915|Allergic Rhinitis|allergic rhinitis
5258505|NCT02397915|Mometasone Furoate|mometasone furoate
5258506|NCT02397915|Questionnaire|questionnaire
5258507|NCT02397915|Preference|preference
5258508|NCT02397889|posttraumatic stress disorder|posttraumatic stress disorder
5258509|NCT02397889|PTSD|ptsd
5258510|NCT02397889|ketamine|ketamine
5258511|NCT02397889|trauma|trauma
5258512|NCT02397889|treatment|treatment
5258513|NCT02397889|New York|new york
5258514|NCT02397889|NYC|nyc
5258515|NCT02397876|Food Allergy|food allergy
5258516|NCT02397876|Cows Milk Allergy|cows milk allergy
5258517|NCT02397850|depression, chronic, psychotherapy, telephone, feasibility|depression, chronic, psychotherapy, telephone, feasibility
5258520|NCT02397785|chronic pelvic pain|chronic pelvic pain
5258521|NCT02397785|electrical stimulation|electrical stimulation
5258522|NCT02397785|pelvic floor rehabilitation|pelvic floor rehabilitation
5258523|NCT02397785|neuromodulation|neuromodulation
5258524|NCT02397772|Soil-transmitted helminths|soil-transmitted helminths
5258525|NCT02397772|Intestinal Nematodes|intestinal nematodes
5258526|NCT02397772|Hookworm|hookworm
5258527|NCT02397772|Ascaris|ascaris
5258528|NCT02397772|Mass Treatment|mass treatment
5258529|NCT02397772|Kenya|kenya
5258530|NCT02397746|osteoarthritis|osteoarthritis
5258531|NCT02397746|avascular necrosis|avascular necrosis
5258532|NCT02397746|ankylosis|ankylosis
5258533|NCT02397746|protrusio acetabuli|protrusio acetabuli
5258534|NCT02397746|rheumatoid arthritis|rheumatoid arthritis
5258535|NCT02397746|correction of functional deformity|correction of functional deformity
5258536|NCT02397746|revision procedures|revision procedures
5258537|NCT02397694|Adult|adult
5258538|NCT02397694|HIV|hiv
5258539|NCT02397694|naive|naive
5258540|NCT02397655|stroke|stroke
5258544|NCT02397590|Fimasartan|fimasartan
5258546|NCT02397564|ICD-10 CM:L90.5|icd-10 cm:l90.5
5258547|NCT02397538|Fimasartan|fimasartan
5258548|NCT02397447|Momordica Charantia|momordica charantia
5139354|NCT03119792|Education Intervention|education intervention
5258549|NCT02397447|Insulin secretion|insulin secretion
5258550|NCT02397447|Insulin sensitivity|insulin sensitivity
5258551|NCT02397434|assessment of QOL (EORTC QLQ-C30)|assessment of qol (eortc qlq-c30)
5258552|NCT02397421|Heart failure|heart failure
5258553|NCT02397421|Diabetes|diabetes
5258554|NCT02397421|Left ventricular remodelling|left ventricular remodelling
5258555|NCT02397421|SGLT-2 inhibitors|sglt-2 inhibitors
5258556|NCT02397395|Renal Impairment|renal impairment
5258557|NCT02397395|End-stage Renal Disease|end-stage renal disease
5258558|NCT02397395|Simeprevir|simeprevir
5258559|NCT02397395|Daclatasvir|daclatasvir
5258560|NCT02397382|Psoriasis|psoriasis
5258561|NCT02397382|Guselkumab|guselkumab
5258562|NCT02397382|Cytochromes P450|cytochromes p450
5258563|NCT02397369|Education and evaluate post intervention KAP|education and evaluate post intervention kap
5258564|NCT02397356|ketamine|ketamine
5258565|NCT02397343|Reduction of secondary hyperalgesia and/-or local inflammation|reduction of secondary hyperalgesia and/-or local inflammation
5258566|NCT02397304|Intra-muscular triglyceride use|intra-muscular triglyceride use
5258567|NCT02397291|Pregnancy|pregnancy
5258568|NCT02397291|IUGR|iugr
5258569|NCT02397265|Type 1 diabetes|type 1 diabetes
5258570|NCT02397265|Hypoglycaemia|hypoglycaemia
5258571|NCT02397265|Closed loop insulin pump|closed loop insulin pump
5258572|NCT02397265|Artificial pancreas|artificial pancreas
5258573|NCT02397265|Exercise|exercise
5258574|NCT02397265|Mixed meals|mixed meals
5258575|NCT02397265|Bihormonal pump|bihormonal pump
5258576|NCT02397252|Human Papillomavirus|human papillomavirus
5258577|NCT02397252|Screening|screening
5258578|NCT02397252|Self-collection test|self-collection test
5258579|NCT02397252|Pap test|pap test
5258580|NCT02397226|Radiofrequency ablation|radiofrequency ablation
5258581|NCT02397226|Plethysmography|plethysmography
5258582|NCT02397226|Duplex ultrasound|duplex ultrasound
5258583|NCT02397226|High ligation/stripping|high ligation/stripping
5258584|NCT02397213|Ciclosporin|ciclosporin
5258585|NCT02397213|Acute Kidney injury|acute kidney injury
5258586|NCT02397213|Cardiac surgery|cardiac surgery
5258587|NCT02397213|Ischemia|ischemia
5258588|NCT02397213|Safety|safety
5258589|NCT02397213|Cystatin C|cystatin c
5258594|NCT02397174|Polycystic Ovary syndrome|polycystic ovary syndrome
5258595|NCT02397174|hypocaloric diet|hypocaloric diet
5258596|NCT02397174|Ovarian Cysts|ovarian cysts
5258597|NCT02397174|Ovarian Diseases|ovarian diseases
5258598|NCT02397174|Obesity|obesity
5258599|NCT02397174|Mediterranean Diet|mediterranean diet
5258600|NCT02397135|genomic markers|genomic markers
5258601|NCT02397070|Jaw exercise|jaw exercise
5258602|NCT02397070|Occlusal splint|occlusal splint
5258603|NCT02397070|Treatment|treatment
5258604|NCT02397070|Muscular pain|muscular pain
5258605|NCT02397070|Mandibular movement|mandibular movement
5258606|NCT02397044|Implants, stability, loading|implants, stability, loading
5258607|NCT02397031|borderline personality disorder|borderline personality disorder
5258608|NCT02397031|mindfulness|mindfulness
5258609|NCT02397018|stroke|stroke
5258610|NCT02397018|cord blood|cord blood
5258611|NCT02397018|umbilical cord blood|umbilical cord blood
5258612|NCT02397018|hematopoietic stem cells|hematopoietic stem cells
5258613|NCT02397018|acute ischemic stroke|acute ischemic stroke
5258614|NCT02396992|Oropharyngeal Dysphagia|oropharyngeal dysphagia
5258615|NCT02396992|Aspiration pneumonia|aspiration pneumonia
5258616|NCT02396992|Malnutrition|malnutrition
5258617|NCT02396992|Oral Health|oral health
5258618|NCT02396992|Bacterial colonization|bacterial colonization
5258619|NCT02396992|Aging|aging
5258621|NCT02396940|Three-dimensional|three-dimensional
5258622|NCT02396940|Laparoscopy|laparoscopy
5258623|NCT02396940|Inguinal hernia repair|inguinal hernia repair
5258625|NCT02396927|Three-dimensional|three-dimensional
5258626|NCT02396927|laparoscopy|laparoscopy
5258627|NCT02396927|cholecystectomy|cholecystectomy
5258628|NCT02396901|early goal direct therapy|early goal direct therapy
5258629|NCT02396901|preventive strategies|preventive strategies
5258630|NCT02396901|cardiac surgery|cardiac surgery
5258631|NCT02396888|Blood vessel|blood vessel
5258632|NCT02396888|Fibroplasia|fibroplasia
5258633|NCT02396888|Wound healing|wound healing
5258634|NCT02396888|Insulin|insulin
5258635|NCT02396836|Hand hygiene|hand hygiene
5258636|NCT02396836|Hand decontamination|hand decontamination
5258637|NCT02396836|Microbial load|microbial load
5258638|NCT02396836|Hand coverage|hand coverage
5258639|NCT02396836|Glove juice technique|glove juice technique
5258640|NCT02396836|Ayliffe technique|ayliffe technique
5258641|NCT02396836|6 step technique|6 step technique
5258741|NCT02396264|Treatment|treatment
5258643|NCT02396823|Respiratory Muscle Training|respiratory muscle training
5258644|NCT02396797|Sick leave|sick leave
5258645|NCT02396797|Mental Health|mental health
5258646|NCT02396797|Coping|coping
5258647|NCT02396797|Social Support|social support
5258648|NCT02396797|Subjective Health Complaints|subjective health complaints
5258649|NCT02396784|child overweight|child overweight
5258650|NCT02396784|child obesity|child obesity
5258651|NCT02396784|prevention|prevention
5258652|NCT02396784|targeted intervention|targeted intervention
5258653|NCT02396784|development of overweight|development of overweight
5258655|NCT02396771|Massage|massage
5258656|NCT02396771|Compression|compression
5258657|NCT02396732|Aspirin|aspirin
5258658|NCT02396732|Enoxaparin|enoxaparin
5258659|NCT02396732|Thromboprophylaxis|thromboprophylaxis
5258663|NCT02396693|non invasive ventilation|non invasive ventilation
5258665|NCT02396680|Rhinoconjunctivitis|rhinoconjunctivitis
5258666|NCT02396680|Immunotherapy|immunotherapy
5258667|NCT02396680|Ragweed-SPIRE|ragweed-spire
5258668|NCT02396641|Best Supportive Care|best supportive care
5258669|NCT02396628|Graft-versus-Host Disease (GvHD)|graft-versus-host disease (gvhd)
5258670|NCT02396628|resistance to therapy|resistance to therapy
5258671|NCT02396628|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5258672|NCT02396628|Ruxolitinib|ruxolitinib
5258673|NCT02396615|Ad libitum energy intake|ad libitum energy intake
5258674|NCT02396615|Appetite|appetite
5258675|NCT02396589|stroke rehabilitation|stroke rehabilitation
5258676|NCT02396589|barriers to independence|barriers to independence
5258677|NCT02396589|environmental support|environmental support
5258678|NCT02396550|Expectations|expectations
5258679|NCT02396537|Children|children
5258680|NCT02396537|Midazolam|midazolam
5258681|NCT02396537|Lidocaine|lidocaine
5258682|NCT02396537|Intranasal|intranasal
5258683|NCT02396524|Chronic Disease|chronic disease
5258684|NCT02396524|Lifestyle Intervention|lifestyle intervention
5258685|NCT02396524|Health Promotion|health promotion
5258686|NCT02396524|Sport Mentorship|sport mentorship
5258687|NCT02396524|Men|men
5258688|NCT02396524|Health Technology|health technology
5258689|NCT02396524|Prevention|prevention
5258690|NCT02396524|Exercise|exercise
5258691|NCT02396524|Diet|diet
5258692|NCT02396472|social support|social support
5258693|NCT02396459|Triac|triac
5258694|NCT02396459|MCT8|mct8
5258695|NCT02396459|MCT8 deficiency|mct8 deficiency
5258696|NCT02396459|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
5258697|NCT02396433|Halaven|halaven
5258698|NCT02396433|BRCA|brca
5258699|NCT02396433|E7449|e7449
5258700|NCT02396420|BPH|bph
5258701|NCT02396420|prostatic hyperplasia|prostatic hyperplasia
5258702|NCT02396420|enlarged prostate|enlarged prostate
5258703|NCT02396420|benign prostatic hypertrophy|benign prostatic hypertrophy
5258704|NCT02396407|Chlorine water treatment|chlorine water treatment
5258705|NCT02396407|Point-of-use water treatment|point-of-use water treatment
5258706|NCT02396407|Household water treatment with safe storage|household water treatment with safe storage
5258707|NCT02396407|Handwashing with soap|handwashing with soap
5258708|NCT02396407|Hand hygiene|hand hygiene
5258709|NCT02396407|Latrines|latrines
5258710|NCT02396407|Child potties|child potties
5258711|NCT02396407|Intestinal parasitic infection|intestinal parasitic infection
5258712|NCT02396407|Soil-transmitted helminths|soil-transmitted helminths
5258713|NCT02396407|Water|water
5258714|NCT02396407|Sanitation|sanitation
5258715|NCT02396407|Handwashing|handwashing
5258716|NCT02396407|Diarrhea|diarrhea
5258717|NCT02396407|Herd immunity|herd immunity
5258718|NCT02396407|Helminths|helminths
5258719|NCT02396394|HIV|hiv
5258720|NCT02396394|ART Adherence|art adherence
5258721|NCT02396394|Retention in Care|retention in care
5263888|NCT02366611|EEG|eeg
5258722|NCT02396394|Pregnant Women|pregnant women
5258723|NCT02396394|Postpartum Women|postpartum women
5258724|NCT02396381|Candidate modified risk tobacco product|candidate modified risk tobacco product
5258725|NCT02396381|Conventional cigarette|conventional cigarette
5258726|NCT02396381|Exposure response|exposure response
5258727|NCT02396381|Smoking|smoking
5258728|NCT02396381|Tobacco Heating System|tobacco heating system
5258729|NCT02396368|Prostate cancer|prostate cancer
5258730|NCT02396368|Bone metastatic Castration-Resistant Prostate Cancer|bone metastatic castration-resistant prostate cancer
5258731|NCT02396368|Radium 223|radium 223
5258732|NCT02396368|Tasquinimod|tasquinimod
5258733|NCT02396355|flow cytometry|flow cytometry
5258735|NCT02396303|General: To compare Carbetocin and Oxytocin for the control of PPH.|general: to compare carbetocin and oxytocin for the control of pph.
5258736|NCT02396290|acne scar|acne scar
5258737|NCT02396290|fractional carbon dioxide laser|fractional carbon dioxide laser
5258738|NCT02396290|platelet rich plasma|platelet rich plasma
5258739|NCT02396264|Mediterranean Diet|mediterranean diet
5258740|NCT02396264|Ovarian Cysts|ovarian cysts
5258742|NCT02396264|Ovarian Diseases|ovarian diseases
5258743|NCT02396264|normocaloric diet|normocaloric diet
5258744|NCT02396225|voriconazole|voriconazole
5258745|NCT02396225|inhalation|inhalation
5258746|NCT02396225|aerosol|aerosol
5258747|NCT02396225|epithelial lining fluid|epithelial lining fluid
5258748|NCT02396225|concentration|concentration
5258749|NCT02396225|pharmacokinetic|pharmacokinetic
5258750|NCT02396212|ACZ885|acz885
5258751|NCT02396212|canakinumab|canakinumab
5258752|NCT02396212|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
5258753|NCT02396212|systemic inflammatory disorder|systemic inflammatory disorder
5258754|NCT02396212|painful joints|painful joints
5258755|NCT02396212|inflammation of the synovial membrane|inflammation of the synovial membrane
5258756|NCT02396212|auto-immune rheumatoid disease|auto-immune rheumatoid disease
5258757|NCT02396212|reactive rheumatoid arthritis|reactive rheumatoid arthritis
5258758|NCT02396212|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
5258759|NCT02396212|Japanese patients|japanese patients
5258760|NCT02396199|Abdominal aortic aneurysm|abdominal aortic aneurysm
5258761|NCT02396199|Endovascular|endovascular
5258762|NCT02396199|Juxtarenal|juxtarenal
5258763|NCT02396199|Pararenal|pararenal
5258764|NCT02396199|Fenestrated|fenestrated
5258765|NCT02396173|disability|disability
5258766|NCT02396173|vocational|vocational
5258767|NCT02396173|rehabilitation|rehabilitation
5258768|NCT02396173|prediction|prediction
5258769|NCT02396160|overactive bladder|overactive bladder
5258770|NCT02396160|urinary incontinence|urinary incontinence
5258771|NCT02396160|nocturia|nocturia
5258772|NCT02396160|urinary frequency|urinary frequency
5258773|NCT02396147|Drug therapy|drug therapy
5258776|NCT02396082|care coordination|care coordination
5258777|NCT02396082|quality of life|quality of life
5258778|NCT02396082|community-based|community-based
5258779|NCT02396082|care quality|care quality
5258780|NCT02396082|Long term care placement|long term care placement
5258781|NCT02396082|memory care|memory care
5258782|NCT02396082|Neuropsychiatric behaviors|neuropsychiatric behaviors
5258783|NCT02396056|Guided Bone Regeneration|guided bone regeneration
5258784|NCT02396056|Gingival Mesenchymal Stem Cells|gingival mesenchymal stem cells
5258785|NCT02395991|gadoxetic acid|gadoxetic acid
5258786|NCT02395991|transient dyspnea|transient dyspnea
5258787|NCT02395965|Osteopathic manipulative medicine|osteopathic manipulative medicine
5258788|NCT02395965|Osteopathic manipulative treatment|osteopathic manipulative treatment
5258789|NCT02395952|cornea|cornea
5258790|NCT02395952|epithelial defect|epithelial defect
5258791|NCT02395952|amniotic membrane|amniotic membrane
5258792|NCT02395939|Cryobiopsy|cryobiopsy
5258793|NCT02395939|Radial EBUS|radial ebus
5258794|NCT02395939|Guide Sheath|guide sheath
5258795|NCT02395939|Peripheral pulmonary lesions|peripheral pulmonary lesions
5258796|NCT02395887|Spinal stenosis|spinal stenosis
5258797|NCT02395887|Spinal decompression|spinal decompression
5258798|NCT02395887|Postural balance|postural balance
5258799|NCT02395887|Neurogenic claudication|neurogenic claudication
5258800|NCT02395848|recurrent|recurrent
5258801|NCT02395848|infection|infection
5258802|NCT02395835|body mass index|body mass index
5258803|NCT02395835|methylation|methylation
5258804|NCT02395835|PPAR gamma|ppar gamma
5258805|NCT02395835|pregnancy|pregnancy
5258806|NCT02395822|AML|aml
5258807|NCT02395822|Relapsed|relapsed
5258808|NCT02395822|Refractory|refractory
5258809|NCT02395796|epidural|epidural
5258810|NCT02395796|labor analgesia|labor analgesia
5258811|NCT02395796|pressure monitoring|pressure monitoring
5258812|NCT02395783|Preterm infants|preterm infants
5258813|NCT02395783|diagnosis of cerebral white matter injury|diagnosis of cerebral white matter injury
5258814|NCT02395770|Shoulder|shoulder
5258815|NCT02395770|Rotator cuff|rotator cuff
5258816|NCT02395770|Rehabilitation|rehabilitation
5258817|NCT02395770|Motor control|motor control
5258818|NCT02395757|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5258819|NCT02395757|Microperimetry|microperimetry
5258820|NCT02395757|Diagnostic|diagnostic
5258825|NCT02395731|care needs|care needs
5258826|NCT02395731|health services|health services
5258827|NCT02395731|care management|care management
5258828|NCT02395731|low income|low income
5258829|NCT02395731|Neuropsychiatric behaviors|neuropsychiatric behaviors
5258830|NCT02395718|elderly|elderly
5258831|NCT02395718|quick diagnostic unit|quick diagnostic unit
5258832|NCT02395718|short stay unit|short stay unit
5258833|NCT02395718|randomised controlled trial|randomised controlled trial
5258834|NCT02395679|Dendritic cell-based immunotherapy|dendritic cell-based immunotherapy
5258835|NCT02395666|Neuroblastoma in remission|neuroblastoma in remission
5258836|NCT02395666|Relapsed Neuroblastoma|relapsed neuroblastoma
5258837|NCT02395666|Refractory Neuroblastoma|refractory neuroblastoma
5258838|NCT02395653|Pediatric|pediatric
5258839|NCT02395653|Postoperative|postoperative
5258840|NCT02395653|Pain Management|pain management
5258841|NCT02395627|Hormone Therapy Resistant|hormone therapy resistant
5258842|NCT02395627|Estrogen Receptor-Positive|estrogen receptor-positive
5258843|NCT02395627|Estrogen Receptor-Negative|estrogen receptor-negative
5258844|NCT02395614|tissue expander|tissue expander
5258845|NCT02395614|breast reconstruction|breast reconstruction
5258846|NCT02395601|B-Cell Lymphoma|b-cell lymphoma
5258847|NCT02395601|EZH2 Inhibitor|ezh2 inhibitor
5258848|NCT02395601|Phase 1|phase 1
5258849|NCT02395497|Penile Transplant|penile transplant
5258850|NCT02395497|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
5258851|NCT02395497|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
5258852|NCT02395497|Penis|penis
5258853|NCT02395497|Amputation|amputation
5258854|NCT02395497|Immunosuppression|immunosuppression
5258855|NCT02395497|Composite Tissue|composite tissue
5258856|NCT02395497|Male|male
5258857|NCT02395497|Humans|humans
5258858|NCT02395497|Allotransplantation|allotransplantation
5258863|NCT02395393|Chronic rejection|chronic rejection
5258864|NCT02395393|Confocal microscopy|confocal microscopy
5258866|NCT02395380|Postoperative complication|postoperative complication
5258867|NCT02395380|Length of stay|length of stay
5258868|NCT02395367|Prognosis|prognosis
5258869|NCT02395367|Risk Factors|risk factors
5258870|NCT02395354|Endoscopic treatment|endoscopic treatment
5258871|NCT02395354|Stenosis|stenosis
5258872|NCT02395354|Crohn's Disease|crohn's disease
5258873|NCT02395354|balloon dilatation|balloon dilatation
5258874|NCT02395354|self-expanding metallic stent|self-expanding metallic stent
5258875|NCT02395354|chronic transmural inflammation|chronic transmural inflammation
5258876|NCT02395354|steady narrowing of the intestinal lumen|steady narrowing of the intestinal lumen
5258877|NCT02395341|reproductive hormones|reproductive hormones
5258879|NCT02395341|endocrine function|endocrine function
5258880|NCT02395341|antral follicle counts|antral follicle counts
5258881|NCT02395341|female infertility due to diminished ovarian reserve|female infertility due to diminished ovarian reserve
5258882|NCT02395341|perimenopause|perimenopause
5258883|NCT02395341|premature menopause|premature menopause
5258884|NCT02395328|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
5258885|NCT02395328|Home visiting intervention|home visiting intervention
5258886|NCT02395328|South Africa|south africa
5258887|NCT02395328|Program evaluation|program evaluation
5258888|NCT02395315|Diabetes Mellitus|diabetes mellitus
5258889|NCT02395315|Osseointegration|osseointegration
5258890|NCT02395315|Bone vascularity|bone vascularity
5258891|NCT02395315|Primary implant stability|primary implant stability
5258892|NCT02395289|Cognitive-Based Compassion Training (CBCT)|cognitive-based compassion training (cbct)
5258893|NCT02395289|HIV-related clinical outcomes|hiv-related clinical outcomes
5258894|NCT02395289|Stress and stress-related psychological adjustment|stress and stress-related psychological adjustment
5258895|NCT02395289|Stress-related inflammatory biomarkers|stress-related inflammatory biomarkers
5258896|NCT02395276|Congenital Heart Defects|congenital heart defects
5258897|NCT02395276|Hypoxic Ischemic Brain Injury|hypoxic ischemic brain injury
5258898|NCT02395276|Hypothermia Therapy|hypothermia therapy
5258899|NCT02395276|Pediatrics|pediatrics
5258900|NCT02395237|Fed Conditions|fed conditions
5258901|NCT02395224|Follow-up studies|follow-up studies
5258902|NCT02395224|Prognosis|prognosis
5258903|NCT02395224|Palliative care|palliative care
5258904|NCT02395224|Chemotherapy, adjuvant|chemotherapy, adjuvant
5258905|NCT02395224|Cost-benefit analysis|cost-benefit analysis
5258906|NCT02395224|Population|population
5258907|NCT02395224|Antineoplastic agents/Adverse effects|antineoplastic agents/adverse effects
5258908|NCT02395224|Terminal care|terminal care
5264064|NCT02365519|LME636|lme636
5258911|NCT02395224|Norway|norway
5258912|NCT02395198|hepatitis c virus|hepatitis c virus
5258913|NCT02395198|opioid substitution treatment|opioid substitution treatment
5258914|NCT02395172|Avelumab|avelumab
5258915|NCT02395172|MSB0010718C|msb0010718c
5258916|NCT02395172|Non-Small Cell Lung Cancer|non-small cell lung cancer
5258917|NCT02395172|Anti-PD-L1|anti-pd-l1
5258918|NCT02395159|vascular surgery patients|vascular surgery patients
5258919|NCT02395159|wound management|wound management
5258920|NCT02395133|Eczema|eczema
5258921|NCT02395120|Dental Care|dental care
5258922|NCT02395120|Caregiver Illness Perception|caregiver illness perception
5258923|NCT02395120|Common Sense Model of Self-Regulation|common sense model of self-regulation
5258924|NCT02395120|Dental Access|dental access
5258925|NCT02395120|Referral letter|referral letter
5258926|NCT02395120|Dental Caries|dental caries
5258927|NCT02395107|Aortic Valve Stenosis|aortic valve stenosis
5258928|NCT02395107|Functional Capacity|functional capacity
5258929|NCT02395107|Cardiomyopathies|cardiomyopathies
5258930|NCT02395107|Endomyocardial Fibrosis|endomyocardial fibrosis
5258931|NCT02395107|Cardiovascular Diseases|cardiovascular diseases
5258932|NCT02395107|Heart Diseases|heart diseases
5259325|NCT02392572|Ara-C|ara-c
5258939|NCT02395081|Mongolia|mongolia
5258940|NCT02395081|Vitamin D|vitamin d
5258941|NCT02395081|preeclampsia|preeclampsia
5258942|NCT02395068|Pharmacokinetics|pharmacokinetics
5258943|NCT02395068|Nimotuzumab|nimotuzumab
5258944|NCT02395068|Safety|safety
5258945|NCT02395068|Effcacy|effcacy
5258946|NCT02395068|Irinotecan|irinotecan
5258947|NCT02395029|PD|pd
5258948|NCT02395003|Obesity|obesity
5258949|NCT02395003|Pediatric|pediatric
5258950|NCT02394977|CPR|cpr
5258951|NCT02394977|Cardio first angle|cardio first angle
5258952|NCT02394977|Clinical trial|clinical trial
5258953|NCT02394951|chemotherapy|chemotherapy
5258954|NCT02394938|Music therapy|music therapy
5258955|NCT02394912|vena cava filter|vena cava filter
5258956|NCT02394899|SCD|scd
5258957|NCT02394899|early childhood intervention|early childhood intervention
5258958|NCT02394899|parental stress|parental stress
5258959|NCT02394899|neurocognition|neurocognition
5139789|NCT03117088|ICU|icu
5258960|NCT02394873|Deep Second-Degree Burn Wound|deep second-degree burn wound
5258961|NCT02394847|propofol|propofol
5258962|NCT02394847|electroconvulsive therapy|electroconvulsive therapy
5258963|NCT02394847|anesthesia|anesthesia
5258964|NCT02394834|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
5258965|NCT02394795|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, Bevacizumab|metastatic colorectal cancer, panitumumab, mfolfox6, bevacizumab
5258966|NCT02394782|Multiple sclerosis, relapsing-remitting|multiple sclerosis, relapsing-remitting
5258967|NCT02394782|Rebif|rebif
5258968|NCT02394782|Interferon beta-1a|interferon beta-1a
5258969|NCT02394782|RebiSmart®2.0|rebismart®2.0
5258970|NCT02394782|MSdialog™|msdialog™
5258971|NCT02394769|Colorectal Cancer|colorectal cancer
5258972|NCT02394743|Glomerular Filtration Rate|glomerular filtration rate
5258973|NCT02394730|HIV, d-dimer, hs-CRP, activated T-lymphocytes|hiv, d-dimer, hs-crp, activated t-lymphocytes
5258974|NCT02394704|Rumination|rumination
5258975|NCT02394704|Sensory processing|sensory processing
5258976|NCT02394704|Non-pharmacological intervention|non-pharmacological intervention
5258977|NCT02394704|Depression|depression
5258978|NCT02394704|Anxiety|anxiety
5258979|NCT02394704|PTSD|ptsd
5258980|NCT02394665|Glioblastoma|glioblastoma
5258981|NCT02394665|Gliosarcoma|gliosarcoma
5258983|NCT02394626|Recurrent glioblastoma|recurrent glioblastoma
5258984|NCT02394626|Surgery|surgery
5258985|NCT02394626|Complete resection of enhancing tumor|complete resection of enhancing tumor
5258986|NCT02394626|Survival|survival
5258987|NCT02394626|Quality of life|quality of life
5258988|NCT02394613|Glaucoma|glaucoma
5258989|NCT02394613|DARC|darc
5258990|NCT02394613|Diagnosis|diagnosis
5258991|NCT02394600|rhinitis|rhinitis
5258992|NCT02394600|allergy|allergy
5258993|NCT02394587|mindfulness|mindfulness
5258994|NCT02394587|MBSR|mbsr
5258995|NCT02394587|SCD|scd
5258996|NCT02394587|experimental|experimental
5259001|NCT02394522|Malaria|malaria
5259002|NCT02394522|Spatial Repellents|spatial repellents
5259003|NCT02394522|Plasmodium|plasmodium
5259006|NCT02394496|Fulvestrant|fulvestrant
5259007|NCT02394496|Lapatinib|lapatinib
5259008|NCT02394496|Aromatase Inhibitor|aromatase inhibitor
5259009|NCT02394496|metastatic breast cancer|metastatic breast cancer
5259010|NCT02394483|Single ascending dose|single ascending dose
5259011|NCT02394483|double blind|double blind
5259012|NCT02394470|congestion|congestion
5259013|NCT02394470|total body water|total body water
5259014|NCT02394470|bioimpedentiometry|bioimpedentiometry
5259015|NCT02394470|lung ultrasound|lung ultrasound
5259016|NCT02394470|diuretics|diuretics
5259017|NCT02394470|dyspnea|dyspnea
5259018|NCT02394470|pulmonary B lines|pulmonary b lines
5259019|NCT02394470|deuterium|deuterium
5259020|NCT02394457|Postdural puncture headache|postdural puncture headache
5259021|NCT02394457|Epidural Blood Patch|epidural blood patch
5259022|NCT02394457|Cosyntropin|cosyntropin
5259023|NCT02394457|PDPH|pdph
5259024|NCT02394457|Regional anesthesia|regional anesthesia
5259025|NCT02394457|Lumbar puncture|lumbar puncture
5259026|NCT02394457|ACTH|acth
5259027|NCT02394457|Tetracosactin|tetracosactin
5259028|NCT02394444|Intervention program|intervention program
5259029|NCT02394444|Parenting stress|parenting stress
5259030|NCT02394444|Parental mental health|parental mental health
5259031|NCT02394444|Preterm infant's development|preterm infant's development
5259032|NCT02394431|Sickle Cell Disease|sickle cell disease
5259033|NCT02394431|Echocardiography|echocardiography
5259034|NCT02394431|Speckle tracking|speckle tracking
5259035|NCT02394392|Medication satisfaction|medication satisfaction
5259036|NCT02394392|Quality of life|quality of life
5259037|NCT02394392|Drug compliance|drug compliance
5259038|NCT02394366|Skin oxygenation|skin oxygenation
5259039|NCT02394366|peripheral perfusion|peripheral perfusion
5259040|NCT02394353|bariatrics|bariatrics
5259041|NCT02394353|transient elastography|transient elastography
5259042|NCT02394314|MEDI0382, diabetes|medi0382, diabetes
5259043|NCT02394301|Efficacy of Novel Drug Combinations for Relief of Psoriasis|efficacy of novel drug combinations for relief of psoriasis
5259044|NCT02394288|Cardiac Troponin|cardiac troponin
5259045|NCT02394288|Perioperative Period|perioperative period
5259046|NCT02394288|surgery|surgery
5259047|NCT02394262|Biological Markers|biological markers
5259048|NCT02394262|Multidetector Computed Tomography|multidetector computed tomography
5259049|NCT02394249|Insulin Resistance|insulin resistance
5259050|NCT02394249|Cognition|cognition
5259051|NCT02394249|Affect|affect
5259052|NCT02394249|Insulin|insulin
5259053|NCT02394249|Lipids|lipids
5259054|NCT02394236|exercise training|exercise training
5259055|NCT02394223|Cancer|cancer
5259056|NCT02394223|Prostate|prostate
5259057|NCT02394223|PSA|psa
5259058|NCT02394223|Biopsies|biopsies
5259059|NCT02394223|FFOCT procedure|ffoct procedure
5259060|NCT02394210|Multiple myeloma asymptomatic relapse symptomatic relapse|multiple myeloma asymptomatic relapse symptomatic relapse
5259061|NCT02394210|IMW Consensus Panel|imw consensus panel
5259062|NCT02394210|anti-MM therapy|anti-mm therapy
5139919|NCT03116334|BMI|bmi
5259063|NCT02394197|Plasmodium vivax|plasmodium vivax
5259064|NCT02394197|Mexico|mexico
5259065|NCT02394197|treatment|treatment
5259066|NCT02394197|chloroquine|chloroquine
5259067|NCT02394197|primaquine|primaquine
5259068|NCT02394197|14-day treatment (T14)|14-day treatment (t14)
5259069|NCT02394197|intermittent single doses (ISD)|intermittent single doses (isd)
5259070|NCT02394184|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5259071|NCT02394171|Physical Activity|physical activity
5259072|NCT02394171|Social Cohesion|social cohesion
5259073|NCT02394171|Intervention Development|intervention development
5259074|NCT02394171|Ethnic Minorities|ethnic minorities
5259075|NCT02394171|Nutrition|nutrition
5259076|NCT02394158|Recurrent Gestational Diabetes Mellitus|recurrent gestational diabetes mellitus
5259077|NCT02394158|Prevention|prevention
5259078|NCT02394158|Metformin|metformin
5259079|NCT02394145|platelet|platelet
5259080|NCT02394145|ticagrelor|ticagrelor
5259081|NCT02394145|clopidogrel|clopidogrel
5259082|NCT02394145|end stage renal disease|end stage renal disease
5259083|NCT02394145|hemodialysis|hemodialysis
5259084|NCT02394145|genetics|genetics
5259085|NCT02394132|Lentigo maligna|lentigo maligna
5259086|NCT02394132|Imiquimod|imiquimod
5259087|NCT02394132|Radiotherapy|radiotherapy
5259088|NCT02394054|vasopressin|vasopressin
5259089|NCT02394054|intranasal administration|intranasal administration
5259090|NCT02394054|healthy sample|healthy sample
5259091|NCT02394041|acupuncture|acupuncture
5259092|NCT02394041|cervical dystocia|cervical dystocia
5259093|NCT02394041|caesarean section|caesarean section
5259094|NCT02394041|obstetric labor|obstetric labor
5259095|NCT02394041|randomized controlled trial|randomized controlled trial
5445479|NCT01521546|Duchenne muscular dystrophy|duchenne muscular dystrophy
5259096|NCT02394015|Platinum-sensitive Recurrent Ovarian Cancer|platinum-sensitive recurrent ovarian cancer
5259097|NCT02394002|EEG, burst-suppression, N20, SEP, median nerve, facilitation|eeg, burst-suppression, n20, sep, median nerve, facilitation
5259098|NCT02393911|vestibulitis|vestibulitis
5259099|NCT02393911|microbiome|microbiome
5259100|NCT02393872|Prevention|prevention
5259101|NCT02393859|ALL|all
5259102|NCT02393859|High-risk first relapse B-precursor ALL|high-risk first relapse b-precursor all
5259103|NCT02393859|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
5259104|NCT02393859|Neoplasms|neoplasms
5259105|NCT02393859|Lymphoproliferative Disorders|lymphoproliferative disorders
5259106|NCT02393859|Immunoproliferative Disorders|immunoproliferative disorders
5259107|NCT02393859|Antibodies, Bispecific|antibodies, bispecific
5259108|NCT02393846|ankle sprain|ankle sprain
5259109|NCT02393846|topical ketoprofen|topical ketoprofen
5259110|NCT02393846|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
5259111|NCT02393846|emergency department|emergency department
5259112|NCT02393833|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5259113|NCT02393833|Vascular cell adhesion molecule-1 (VCAM-1)|vascular cell adhesion molecule-1 (vcam-1)
5259114|NCT02393833|HER2-ECD|her2-ecd
5259115|NCT02393807|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5259120|NCT02393781|septic shock|septic shock
5259121|NCT02393781|adrenomedullin|adrenomedullin
5259122|NCT02393781|organ dysfunction|organ dysfunction
5259123|NCT02393703|exosomes|exosomes
5259125|NCT02393664|Thoracoscopy|thoracoscopy
5259126|NCT02393664|Recovery|recovery
5259127|NCT02393664|Tracheal intubation|tracheal intubation
5259128|NCT02393638|Endoscopic Sphincterotomy|endoscopic sphincterotomy
5259129|NCT02393625|NSCLC, ALK-positive|nsclc, alk-positive
5259130|NCT02393586|Tuberculosis|tuberculosis
5259131|NCT02393586|Whole blood Bactericidal Activity|whole blood bactericidal activity
5259132|NCT02393586|WBA|wba
5259133|NCT02393586|Faropenem|faropenem
5259134|NCT02393573|Insulin Resistance|insulin resistance
5259135|NCT02393573|Protein balance|protein balance
5259136|NCT02393573|Surgery|surgery
5259137|NCT02393573|Post operative complications|post operative complications
5259138|NCT02393573|metformin|metformin
5259139|NCT02393573|Pre-diabetes|pre-diabetes
5259140|NCT02393573|Fasting blood glucose|fasting blood glucose
5259141|NCT02393547|obesity|obesity
5259142|NCT02393534|Primary Care|primary care
5259143|NCT02393534|Health Services Research|health services research
5259144|NCT02393534|Telemedicine|telemedicine
5259145|NCT02393521|Vibration|vibration
5259146|NCT02393521|Pressure Pain Threshold|pressure pain threshold
5259147|NCT02393521|Trigger Points|trigger points
5259148|NCT02393521|Neck Pain|neck pain
5259149|NCT02393508|transfusion, red blood cell|transfusion, red blood cell
5259150|NCT02393508|transfusion reaction|transfusion reaction
5259151|NCT02393508|quality of life|quality of life
5259152|NCT02393443|oxytocin|oxytocin
5259153|NCT02393443|healthy sample|healthy sample
5259154|NCT02393443|intranasal administration|intranasal administration
5259155|NCT02393443|learning|learning
5259156|NCT02393417|Verruca vulgaris|verruca vulgaris
5259157|NCT02393417|Common Warts|common warts
5259158|NCT02393378|Drug Therapy|drug therapy
5259159|NCT02393365|Hepatitis C|hepatitis c
5259160|NCT02393365|HCV|hcv
5259161|NCT02393365|screening|screening
5259162|NCT02393352|Body Composition|body composition
5259163|NCT02393352|Autonomic Nervous System|autonomic nervous system
5259164|NCT02393352|Oxygen|oxygen
5259165|NCT02393352|Randomized Controlled Trial|randomized controlled trial
5259169|NCT02393300|intravenous administration|intravenous administration
5259170|NCT02393248|alterations in FGF or FGFR|alterations in fgf or fgfr
5259171|NCT02393248|squamous non-small cell lung cancer|squamous non-small cell lung cancer
5259172|NCT02393248|gastric cancer|gastric cancer
5259173|NCT02393248|urothelial cancer|urothelial cancer
5259174|NCT02393248|endometrial cancer|endometrial cancer
5259175|NCT02393248|multiple myeloma|multiple myeloma
5259176|NCT02393248|MPN|mpn
5259177|NCT02393235|unexplained infertility|unexplained infertility
5259178|NCT02393235|tubal infertility|tubal infertility
5259179|NCT02393235|pulsatility index|pulsatility index
5259180|NCT02393235|resistance index|resistance index
5259181|NCT02393235|fertile women|fertile women
5259182|NCT02393222|Dialysis|dialysis
5259183|NCT02393222|Cerebrovascular disease|cerebrovascular disease
5259185|NCT02393209|Drug therapy|drug therapy
5259186|NCT02393196|colloid preloading|colloid preloading
5259187|NCT02393196|colloid coloading|colloid coloading
5259188|NCT02393183|Antioxidant|antioxidant
5259189|NCT02393183|Graves' ophthalmopathy|graves' ophthalmopathy
5259190|NCT02393183|Thyroid eye disease|thyroid eye disease
5259191|NCT02393183|Severity score|severity score
5259192|NCT02393183|Activity score|activity score
5259193|NCT02393183|Quality of life|quality of life
5259194|NCT02393144|Labor analysis|labor analysis
5259195|NCT02393144|Transperineal ultrasound imaging|transperineal ultrasound imaging
5259196|NCT02393144|Labor curve|labor curve
5259197|NCT02393131|Brain Metastases|brain metastases
5259198|NCT02393131|Whole Brain Radiotherapy|whole brain radiotherapy
5259199|NCT02393131|Neurocognitive function|neurocognitive function
5259200|NCT02393118|Assistive technology|assistive technology
5259201|NCT02393118|Non-surgical visual prosthetic|non-surgical visual prosthetic
5259202|NCT02393118|sensory substitution|sensory substitution
5259203|NCT02393118|BrainPort|brainport
5259204|NCT02393118|Blindness|blindness
5259205|NCT02393118|Assistive device|assistive device
5259206|NCT02393105|Breast Cancer|breast cancer
5259207|NCT02393079|Traumatic Brain Injury|traumatic brain injury
5259208|NCT02393079|Cognitive|cognitive
5259209|NCT02393053|Gingival Recession|gingival recession
5259210|NCT02393053|Case-Control Studies|case-control studies
5259211|NCT02393053|Adipose Tissue|adipose tissue
5259212|NCT02393040|Alopecia|alopecia
5264364|NCT02363673|Children|children
5259213|NCT02393040|Androgenetic Alopecia|androgenetic alopecia
5259214|NCT02393040|Alopecia, Male Pattern|alopecia, male pattern
5259215|NCT02393040|Hair loss|hair loss
5259216|NCT02393040|Platelet-Rich Plasma|platelet-rich plasma
5259217|NCT02393040|Alopecia, Female Pattern|alopecia, female pattern
5259218|NCT02393040|placebo|placebo
5259219|NCT02393040|double-blind|double-blind
5259220|NCT02393014|65 years old or older|65 years old or older
5259221|NCT02393014|hospitalized in|hospitalized in
5259222|NCT02393014|geriatrics|geriatrics
5259223|NCT02393001|skin cancer|skin cancer
5259224|NCT02393001|suspicious lesion|suspicious lesion
5259225|NCT02393001|skin biopsy|skin biopsy
5259226|NCT02393001|noninvasive|noninvasive
5259227|NCT02393001|screening|screening
5259228|NCT02392962|proprioception|proprioception
5259229|NCT02392962|countermovement jump|countermovement jump
5259230|NCT02392962|postural balance|postural balance
5259231|NCT02392949|Spine|spine
5259232|NCT02392949|mobilization|mobilization
5259233|NCT02392936|according to the definition of the Comité Technique des Infections Nosocomiales et Liées aux Soins (2007)|according to the definition of the comité technique des infections nosocomiales et liées aux soins (2007)
5259234|NCT02392923|health related quality of life|health related quality of life
5259235|NCT02392910|Iron Sucrose|iron sucrose
5259236|NCT02392910|Mortality|mortality
5259237|NCT02392910|Hospitalization|hospitalization
5259238|NCT02392897|meal frequency|meal frequency
5259239|NCT02392897|eating frequency|eating frequency
5259240|NCT02392897|ingestive frequency|ingestive frequency
5259241|NCT02392897|Positive energy balance|positive energy balance
5259242|NCT02392897|Satiation|satiation
5259243|NCT02392884|Human Immunodeficiency Virus|human immunodeficiency virus
5259244|NCT02392884|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5259245|NCT02392884|Cognitive Rehabilitation|cognitive rehabilitation
5259246|NCT02392884|Minority Health|minority health
5259247|NCT02392884|Vulnerable Populations|vulnerable populations
5259248|NCT02392884|Underserved, Patients|underserved, patients
5259249|NCT02392884|Medication Adherence|medication adherence
5259250|NCT02392884|Medication Compliance|medication compliance
5259251|NCT02392884|Medication Non-compliance|medication non-compliance
5259252|NCT02392884|Medication Persistence|medication persistence
5259253|NCT02392884|Medication Non-Adherence|medication non-adherence
5259254|NCT02392871|Metastatic melanoma|metastatic melanoma
5259255|NCT02392871|Palliative radiotherapy|palliative radiotherapy
5259256|NCT02392845|Drug combination|drug combination
5259257|NCT02392845|Accelerated chemotherapy|accelerated chemotherapy
5259258|NCT02392845|Mathematical model|mathematical model
5259259|NCT02392845|Hematotoxicity|hematotoxicity
5259260|NCT02392845|Individualized dosage|individualized dosage
5259261|NCT02392832|long-lasting microbial larvicide|long-lasting microbial larvicide
5259262|NCT02392832|intervention|intervention
5259263|NCT02392832|cluster randomised controlled trial|cluster randomised controlled trial
5259264|NCT02392832|Anopheles mosquito|anopheles mosquito
5259265|NCT02392806|Continuous positive airway pressure|continuous positive airway pressure
5259267|NCT02392806|Bubble CPAP|bubble cpap
5259268|NCT02392806|Extubation failure|extubation failure
5259269|NCT02392806|Preterm infant|preterm infant
5259270|NCT02392767|L-Arginine|l-arginine
5259271|NCT02392767|Pycnogenol|pycnogenol
5259272|NCT02392767|vitamin K2|vitamin k2
5259274|NCT02392767|endothelial function|endothelial function
5259275|NCT02392767|hypertension|hypertension
5259276|NCT02392767|Homocystein >10|homocystein >10
5259277|NCT02392754|Screening|screening
5259278|NCT02392754|Atrial Fibrillation|atrial fibrillation
5259279|NCT02392754|ECG|ecg
5259280|NCT02392754|Primary care|primary care
5259281|NCT02392741|Physical Activity|physical activity
5259282|NCT02392741|Microcirculation|microcirculation
5259283|NCT02392741|Pregnancy Outcome|pregnancy outcome
5259284|NCT02392741|Obesity|obesity
5259285|NCT02392741|Pregnancy|pregnancy
5259286|NCT02392715|Inspiratory muscle training|inspiratory muscle training
5259287|NCT02392715|General exercise training|general exercise training
5259288|NCT02392715|pulmonary rehabilitation|pulmonary rehabilitation
5259289|NCT02392715|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5259290|NCT02392702|Subjects|subjects
5259291|NCT02392702|Safety/Efficacy Study|safety/efficacy study
5259292|NCT02392702|Randomized|randomized
5259293|NCT02392702|Open Label|open label
5259294|NCT02392689|procalcitonin|procalcitonin
5259295|NCT02392689|biomarker|biomarker
5259296|NCT02392689|antibiotic therapy|antibiotic therapy
5259297|NCT02392689|emergency department|emergency department
5259298|NCT02392689|cardiology|cardiology
5259299|NCT02392689|in vitro diagnostics|in vitro diagnostics
5259300|NCT02392676|Ovarian cancer|ovarian cancer
5259301|NCT02392676|Platinum|platinum
5259302|NCT02392676|Somatic BRCA mutation|somatic brca mutation
5259303|NCT02392676|Homologous recombination repair|homologous recombination repair
5259304|NCT02392663|Sputum clearance|sputum clearance
5259305|NCT02392663|Cough severity|cough severity
5259306|NCT02392663|Hypertonic saline|hypertonic saline
5259307|NCT02392663|Acid hyaluronic|acid hyaluronic
5259308|NCT02392663|Tolerability|tolerability
5259317|NCT02392572|Myelodysplastic syndrome|myelodysplastic syndrome
5259319|NCT02392572|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5259320|NCT02392572|ALL|all
5259321|NCT02392572|Relapsed|relapsed
5259322|NCT02392572|Refractory|refractory
5259323|NCT02392572|ONC201|onc201
5259324|NCT02392572|Cytarabine|cytarabine
5259328|NCT02392572|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5259329|NCT02392559|Hypercholesterolemia|hypercholesterolemia
5259330|NCT02392559|Elevated Cholesterol|elevated cholesterol
5259331|NCT02392559|High Cholesterol|high cholesterol
5259332|NCT02392559|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5259333|NCT02392559|PCSK9 mutations|pcsk9 mutations
5259334|NCT02392559|Paediatric|paediatric
5259335|NCT02392559|pediatric|pediatric
5259336|NCT02392559|Childhood Familial Hypercholesterolemia|childhood familial hypercholesterolemia
5259337|NCT02392533|ultrasound|ultrasound
5259338|NCT02392520|severe OHSS|severe ohss
5259339|NCT02392520|antagonist administration|antagonist administration
5259340|NCT02392520|conventional treatment|conventional treatment
5259341|NCT02392442|immunophenotypes|immunophenotypes
5259342|NCT02392442|Bronchoalveolar Lavage|bronchoalveolar lavage
5259343|NCT02392442|Bronchoscopy|bronchoscopy
5259344|NCT02392442|Endotoxin Instillation|endotoxin instillation
5259345|NCT02392442|miRNA|mirna
5259346|NCT02392390|Topical Dynamic Phototherapy|topical dynamic phototherapy
5259347|NCT02392390|Microbiota|microbiota
5259350|NCT02392338|Atrial fibrillation|atrial fibrillation
5259351|NCT02392338|Ablation|ablation
5259352|NCT02392338|Hybrid|hybrid
5259353|NCT02392312|kidney transplant|kidney transplant
5259354|NCT02392312|ATG-F|atg-f
5259355|NCT02392286|Corticosteroid|corticosteroid
5259356|NCT02392273|migraine|migraine
5259357|NCT02392273|cluster headache|cluster headache
5259358|NCT02392273|primary headache|primary headache
5259359|NCT02392273|Ausanil|ausanil
5259360|NCT02392273|capsicum annuum|capsicum annuum
5259361|NCT02392221|Crohn's disease (CD)|crohn's disease (cd)
5259362|NCT02392221|Pediatric|pediatric
5259363|NCT02392221|Inflammatory Bowel Disease|inflammatory bowel disease
5259364|NCT02392208|telavancin|telavancin
5259365|NCT02392208|end-stage renal disease|end-stage renal disease
5259366|NCT02392208|ESRD|esrd
5259367|NCT02392208|pharmacokinetics|pharmacokinetics
5259368|NCT02392208|hemodialysis|hemodialysis
5259369|NCT02392208|chronic kidney disease|chronic kidney disease
5259370|NCT02392208|CKD|ckd
5259371|NCT02392208|dialysis|dialysis
5259372|NCT02392208|Vibativ|vibativ
5140208|NCT03114228|ETP|etp
5259382|NCT02392078|Procedural Success|procedural success
5259383|NCT02392078|Progression|progression
5259384|NCT02392078|Quality of Life|quality of life
5259385|NCT02392052|caregivers|caregivers
5259386|NCT02392039|Lymphoma|lymphoma
5259387|NCT02392039|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5259388|NCT02392039|Mantle Cell Lymphoma|mantle cell lymphoma
5259389|NCT02392039|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
5259390|NCT02392039|Burkitt Lymphoma|burkitt lymphoma
5259391|NCT02392039|Peripheral T cell Lymphoma NOS|peripheral t cell lymphoma nos
5259392|NCT02392039|NK/T cell Lymphoma|nk/t cell lymphoma
5259393|NCT02392039|Transformed Lymphoma|transformed lymphoma
5259394|NCT02392039|Aggressive lymphoma|aggressive lymphoma
5259395|NCT02392039|Bone pain|bone pain
5259396|NCT02392039|Pegfilgrastim|pegfilgrastim
5259397|NCT02392039|Neulasta|neulasta
5259398|NCT02392039|PEG-G-CSF|peg-g-csf
5259399|NCT02392039|Loratadine|loratadine
5259401|NCT02392039|Sugar pill|sugar pill
5259402|NCT02392039|Questionnaires|questionnaires
5259403|NCT02392039|Surveys|surveys
5264560|NCT02362490|HBsAg|hbsag
5259404|NCT02392013|older adult falls|older adult falls
5259405|NCT02392013|home hazards|home hazards
5259406|NCT02392013|home barriers|home barriers
5259407|NCT02392000|chronic insomnia|chronic insomnia
5259408|NCT02392000|Veterans Health|veterans health
5259409|NCT02391974|Hyaluronic acid|hyaluronic acid
5259410|NCT02391974|Periodontal pockets|periodontal pockets
5259411|NCT02391974|Periodontitis|periodontitis
5259412|NCT02391948|Cerebral palsy|cerebral palsy
5259413|NCT02391948|Gross motor delay|gross motor delay
5445370|NCT01522118|Magnetic Resonance guided Focused Ultrasound|magnetic resonance guided focused ultrasound
5259414|NCT02391935|Chronic Effect of Ultraviolet Radiation on Normal Skin (Photo-aging)|chronic effect of ultraviolet radiation on normal skin (photo-aging)
5259415|NCT02391922|out of hospital cardiac arrest|out of hospital cardiac arrest
5259416|NCT02391922|first aid|first aid
5259417|NCT02391909|Vaccine|vaccine
5259418|NCT02391883|clopidogrel therapy|clopidogrel therapy
5259419|NCT02391883|platelet aggregation inhibitor|platelet aggregation inhibitor
5259420|NCT02391883|adverse event|adverse event
5259421|NCT02391870|depression|depression
5259422|NCT02391870|mindfulness|mindfulness
5259423|NCT02391870|pregnancy|pregnancy
5259424|NCT02391870|prevention|prevention
5259425|NCT02391870|cognitive behavioral therapy|cognitive behavioral therapy
5259426|NCT02391857|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5259427|NCT02391857|Gastric emptying|gastric emptying
5259428|NCT02391844|Knee|knee
5259429|NCT02391844|Post-Operative Pain|post-operative pain
5259430|NCT02391844|Xartemis|xartemis
5259431|NCT02391831|SMA|sma
5259432|NCT02391831|Spinal Muscular Atrophy|spinal muscular atrophy
5259433|NCT02391831|Neuromuscular disease|neuromuscular disease
5259434|NCT02391818|balance|balance
5259435|NCT02391818|quality of life|quality of life
5259436|NCT02391818|chemotherapy|chemotherapy
5259437|NCT02391818|neuropathy|neuropathy
5259438|NCT02391818|cancer|cancer
5259439|NCT02391779|High normal blood pressure|high normal blood pressure
5259440|NCT02391779|Stage I|stage i
5259441|NCT02391766|Self-management|self-management
5259442|NCT02391766|Caregiving|caregiving
5259443|NCT02391766|Quality of life|quality of life
5259444|NCT02391766|Empowerment|empowerment
5259445|NCT02391753|levator avulsion|levator avulsion
5259446|NCT02391753|transperineal ultrasound|transperineal ultrasound
5259447|NCT02391753|levator hiatus|levator hiatus
5259448|NCT02391727|SYN004|syn004
5259449|NCT02391727|cetuximab|cetuximab
5259450|NCT02391714|pain assessment|pain assessment
5259451|NCT02391714|patient satisfaction|patient satisfaction
5259452|NCT02391714|Visual Analog Scale|visual analog scale
5259453|NCT02391714|contraceptive devices|contraceptive devices
5259454|NCT02391714|nulliparity|nulliparity
5259455|NCT02391662|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
5259456|NCT02391662|Elderly|elderly
5259457|NCT02391662|Nab-paclitaxel|nab-paclitaxel
5259458|NCT02391662|Gemcitabine|gemcitabine
5259459|NCT02391649|schizophrenia|schizophrenia
5259460|NCT02391649|bibliotherapy program|bibliotherapy program
5259461|NCT02391649|problem-solving|problem-solving
5259462|NCT02391649|family caregivers|family caregivers
5259463|NCT02391649|randomized controlled trial|randomized controlled trial
5259464|NCT02391636|Postpartum Hemorrhage|postpartum hemorrhage
5259465|NCT02391636|carbetocin|carbetocin
5259471|NCT02391623|Metabolic Diseases|metabolic diseases
5259472|NCT02391610|birth cohort study|birth cohort study
5259473|NCT02391610|environmental exposures|environmental exposures
5259474|NCT02391610|birth defects|birth defects
5259475|NCT02391610|pregnant outcomes|pregnant outcomes
5259476|NCT02391610|children development|children development
5259477|NCT02391545|Follicular Lymphoma|follicular lymphoma
5259478|NCT02391545|Previously Untreated|previously untreated
5259479|NCT02391519|Pregnancy|pregnancy
5259480|NCT02391519|High altitude|high altitude
5259481|NCT02391519|vasoreactivity|vasoreactivity
5259482|NCT02391519|myometrial arteries|myometrial arteries
5259483|NCT02391506|First CMC joint|first cmc joint
5259484|NCT02391506|Osteoarthritis|osteoarthritis
5259485|NCT02391506|Cartilage Replacement|cartilage replacement
5259486|NCT02391506|First CMC Joint Osteoarthritis|first cmc joint osteoarthritis
5259487|NCT02391506|Damaged Articular Surface|damaged articular surface
5259488|NCT02391493|bilinguals|bilinguals
5259489|NCT02391493|language control|language control
5259490|NCT02391493|executive functions|executive functions
5259491|NCT02391493|functional MRI|functional mri
5259492|NCT02391493|stimulation mapping|stimulation mapping
5259493|NCT02391493|brain tumors|brain tumors
5259495|NCT02391480|Bromodomain Inhibitor|bromodomain inhibitor
5259496|NCT02391454|Neoplasms|neoplasms
5259497|NCT02391454|Cell Phones|cell phones
5259498|NCT02391454|Motor Activity|motor activity
5259499|NCT02391454|Feasibility|feasibility
5259500|NCT02391441|Pulmonary|pulmonary
5259501|NCT02391441|Arterial|arterial
5259502|NCT02391441|Hypertension|hypertension
5259503|NCT02391441|Lung|lung
5259504|NCT02391441|Transplantation|transplantation
5259507|NCT02391428|omega3|omega3
5259508|NCT02391402|Brain injury|brain injury
5259509|NCT02391402|TBI|tbi
5259510|NCT02391402|PTSD|ptsd
5259511|NCT02391402|Polytrauma|polytrauma
5259512|NCT02391389|preterm infant|preterm infant
5259513|NCT02391376|superficial heat|superficial heat
5259514|NCT02391376|hot pack|hot pack
5259515|NCT02391376|thermotherapy|thermotherapy
5259516|NCT02391376|physiotherapy|physiotherapy
5259517|NCT02391376|Schober Test|schober test
5259518|NCT02391363|anxiety|anxiety
5259519|NCT02391363|worry|worry
5259520|NCT02391337|Atrial fibrillation|atrial fibrillation
5259521|NCT02391337|Quality of life|quality of life
5259522|NCT02391337|Left ventricular ejection fraction|left ventricular ejection fraction
5259523|NCT02391337|Diastolic function|diastolic function
5259524|NCT02391337|Echocardiography|echocardiography
5259525|NCT02391337|Beta-blockers|beta-blockers
5259526|NCT02391337|Digoxin|digoxin
5259527|NCT02391311|tDCS|tdcs
5259528|NCT02391311|Cognitive remediation therapy|cognitive remediation therapy
5259529|NCT02391298|Multiple Sclerosis|multiple sclerosis
5259530|NCT02391298|stress|stress
5259531|NCT02391298|meditation|meditation
5259532|NCT02391298|attention|attention
5259537|NCT02391246|[18F]-fluorodeoxyglucose|[18f]-fluorodeoxyglucose
5259538|NCT02391233|Effectiveness intervention|effectiveness intervention
5259539|NCT02391233|Cost-effectiveness intervention|cost-effectiveness intervention
5259540|NCT02391233|HIV prevention|hiv prevention
5259541|NCT02391233|Sexually transmitted infections prevention|sexually transmitted infections prevention
5259542|NCT02391233|Multimedia evidence-based intervention|multimedia evidence-based intervention
5259543|NCT02391233|Drug-users|drug-users
5259544|NCT02391233|Black/African-American women|black/african-american women
5259545|NCT02391233|Probation|probation
5259546|NCT02391233|HIV testing|hiv testing
5259547|NCT02391194|AVB-620|avb-620
5259548|NCT02391194|stage I|stage i
5259549|NCT02391194|newly diagnosed|newly diagnosed
5259550|NCT02391194|breast cancer|breast cancer
5259551|NCT02391194|stage II|stage ii
5259552|NCT02391194|stage III|stage iii
5259553|NCT02391194|ductal carcinoma in situ|ductal carcinoma in situ
5259554|NCT02391181|Bioequivalence|bioequivalence
5259555|NCT02391181|Iron Status|iron status
5259556|NCT02391155|follicular flushing|follicular flushing
5259557|NCT02391155|IVF|ivf
5259558|NCT02391155|poor responders|poor responders
5259559|NCT02391155|oocyte retrival|oocyte retrival
5259560|NCT02391142|heart failure|heart failure
5259561|NCT02391142|cardiac sympathetic nerve block|cardiac sympathetic nerve block
5259562|NCT02391142|sympathetic nervous system|sympathetic nervous system
5259563|NCT02391090|asthma|asthma
5259564|NCT02391090|hypoxia|hypoxia
5259565|NCT02391090|forced exhaled nitric oxide|forced exhaled nitric oxide
5259566|NCT02391090|inflammation|inflammation
5259567|NCT02391077|PrePex|prepex
5259568|NCT02391077|Male Circumcision|male circumcision
5259569|NCT02391077|Bacterial Load|bacterial load
5259570|NCT02391064|cognition|cognition
5259571|NCT02391064|brief computerized cognitive assessment|brief computerized cognitive assessment
5259573|NCT02391051|prostate cancer|prostate cancer
5259574|NCT02391051|focal brachytherapy|focal brachytherapy
5259576|NCT02391051|Biological marker|biological marker
5259577|NCT02391038|MLN0264|mln0264
5259578|NCT02391038|Advanced gastrointestinal carcinoma|advanced gastrointestinal carcinoma
5259579|NCT02391025|Metastatic|metastatic
5259580|NCT02391025|Prostate Cancer|prostate cancer
5259581|NCT02391025|Castrate Resistant|castrate resistant
5259582|NCT02391012|Ulcerative colitis|ulcerative colitis
5259583|NCT02391012|Crohns disease|crohns disease
5259584|NCT02391012|Microbial transplantation|microbial transplantation
5259585|NCT02390986|Cancer|cancer
5259586|NCT02390986|Malignant Neoplasm|malignant neoplasm
5259587|NCT02390986|Anti-cancer drug|anti-cancer drug
5259588|NCT02390947|Colorectal Cancer|colorectal cancer
5259589|NCT02390947|Famitinib|famitinib
5259590|NCT02390934|Radium 223|radium 223
5259591|NCT02390934|bone metastases|bone metastases
5259592|NCT02390908|alcohol use|alcohol use
5259593|NCT02390908|hazardous drinking|hazardous drinking
5259594|NCT02390908|behavioral intervention|behavioral intervention
5259595|NCT02390908|ART adherence|art adherence
5259596|NCT02390908|viral load|viral load
5259598|NCT02390895|Minimally-invasive endoscopic repair|minimally-invasive endoscopic repair
5259599|NCT02390895|fetal surgery|fetal surgery
5259600|NCT02390895|outcome|outcome
5259601|NCT02390895|Foetus|foetus
5259602|NCT02390869|relapse|relapse
5259603|NCT02390869|progression|progression
5259604|NCT02390804|postoperative pain|postoperative pain
5259605|NCT02390804|hysterectomy|hysterectomy
5259606|NCT02390804|single-port access laparoscopy|single-port access laparoscopy
5259607|NCT02390804|multi-port access laparoscopy|multi-port access laparoscopy
5259608|NCT02390804|TLH|tlh
5259609|NCT02390778|secondary traumatic stress|secondary traumatic stress
5259610|NCT02390778|vicarious trauma|vicarious trauma
5259611|NCT02390778|secondary distress|secondary distress
5259617|NCT02390752|Maximum Tolerated Dose|maximum tolerated dose
5259618|NCT02390752|Dose Escalation|dose escalation
5259619|NCT02390752|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5259620|NCT02390752|Acute Myelogenous Leukemia|acute myelogenous leukemia
5259621|NCT02390739|Immunotherapy|immunotherapy
5259622|NCT02390739|Gene Therapy|gene therapy
5259623|NCT02390739|Metastatic Cancer|metastatic cancer
5259624|NCT02390713|hepatectomy|hepatectomy
5259625|NCT02390713|post-operative liver failure|post-operative liver failure
5259626|NCT02390713|portal vein|portal vein
5259627|NCT02390713|portal flow|portal flow
5259628|NCT02390713|portal pressure|portal pressure
5259629|NCT02390713|modulation|modulation
5259630|NCT02390713|surgical device|surgical device
5259631|NCT02390700|Rheumatoid Arthritis|rheumatoid arthritis
5259632|NCT02390700|Observational|observational
5259633|NCT02390700|Golimumab|golimumab
5259635|NCT02390700|Intravenous Infusion|intravenous infusion
5259636|NCT02390661|seroma|seroma
5259637|NCT02390661|accelerated partial breast irradiation (APBI)|accelerated partial breast irradiation (apbi)
5259638|NCT02390661|breast lumpectomy|breast lumpectomy
5259639|NCT02390661|breast cancer|breast cancer
5259640|NCT02390609|Healthy|healthy
5259641|NCT02390609|Ibrutinib|ibrutinib
5259642|NCT02390609|Bioavailability|bioavailability
5259643|NCT02390596|Kawasaki disease|kawasaki disease
5259644|NCT02390596|anti Interleukin 1 treatment|anti interleukin 1 treatment
5259645|NCT02390596|anakinra|anakinra
5259646|NCT02390596|resistance to IVIg|resistance to ivig
5259647|NCT02390596|coronary aneurysms|coronary aneurysms
5259648|NCT02390596|phase II trial|phase ii trial
5259649|NCT02390583|Internet dependence|internet dependence
5259650|NCT02390583|Sleep disorders|sleep disorders
5259651|NCT02390583|pathological gambling|pathological gambling
5259652|NCT02390570|Patient Capacity|patient capacity
5259653|NCT02390544|children|children
5259654|NCT02390544|bone marrow transplant|bone marrow transplant
5259655|NCT02390544|pharmacokinetics|pharmacokinetics
5259656|NCT02390531|Retinopathy of Prematurity|retinopathy of prematurity
5259657|NCT02390531|Bevacizumab|bevacizumab
5259658|NCT02390531|ROP|rop
5259659|NCT02390505|vitamin C|vitamin c
5259660|NCT02390505|CRPS|crps
5259661|NCT02390505|Upper limb surgery|upper limb surgery
5259662|NCT02390479|Sclerostin|sclerostin
5259663|NCT02390479|OPG|opg
5259664|NCT02390479|RANKL|rankl
5259665|NCT02390453|mild cognitive impairment|mild cognitive impairment
5259666|NCT02390453|randomized controlled trial|randomized controlled trial
5259667|NCT02390453|cognitive training|cognitive training
5259668|NCT02390453|exercise training|exercise training
5259669|NCT02390453|cognition|cognition
5259670|NCT02390453|physical performance|physical performance
5259671|NCT02390453|disability|disability
5259672|NCT02390453|mood|mood
5259673|NCT02390440|Pain management|pain management
5259674|NCT02390440|Exparel|exparel
5259675|NCT02390440|Rib fracture|rib fracture
5259676|NCT02390427|Metastatic Breast Cancer|metastatic breast cancer
5259677|NCT02390427|Advanced Breast Cancer|advanced breast cancer
5259678|NCT02390427|Recurrent Breast Cancer|recurrent breast cancer
5259679|NCT02390414|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5259680|NCT02390388|pudendal block|pudendal block
5259681|NCT02390388|Hypospadias|hypospadias
5259682|NCT02390388|caudal block|caudal block
5259683|NCT02390388|child|child
5259684|NCT02390388|analgesia|analgesia
5259685|NCT02390336|Osteoarthritis of the hip|osteoarthritis of the hip
5259686|NCT02390336|Pain|pain
5259687|NCT02390336|Range of Motion|range of motion
5259688|NCT02390336|Physical Function|physical function
5259689|NCT02390336|Manual Therapy|manual therapy
5259690|NCT02390310|male circumcision|male circumcision
5259691|NCT02390310|Shang Ring|shang ring
5259692|NCT02390310|male circumcision device|male circumcision device
5259693|NCT02390310|prevention|prevention
5259694|NCT02390310|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
5259695|NCT02390284|RGCD|rgcd
5259696|NCT02390284|Glaucoma Suspect|glaucoma suspect
5259697|NCT02390232|gut microbiota|gut microbiota
5259698|NCT02390232|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
5259699|NCT02390232|Steatohepatitis|steatohepatitis
5259700|NCT02390232|Escherichia coli|escherichia coli
5259701|NCT02390232|colibactin|colibactin
5259703|NCT02390206|Spasticity|spasticity
5259704|NCT02390206|Botulinum Toxin type A|botulinum toxin type a
5259705|NCT02390206|Dysport|dysport
5259706|NCT02390193|Chronic kidney disease|chronic kidney disease
5259707|NCT02390193|Dialysis|dialysis
5259708|NCT02390193|Sleep|sleep
5259709|NCT02390193|Pulmonary function|pulmonary function
5259710|NCT02390193|Polysomnography|polysomnography
5259711|NCT02390193|Upper airway|upper airway
5259712|NCT02390128|iodine|iodine
5259713|NCT02390128|thyroid|thyroid
5259714|NCT02390128|TSH|tsh
5259715|NCT02390128|pregnancy|pregnancy
5259716|NCT02390128|nutrition|nutrition
5259717|NCT02390128|diet|diet
5259718|NCT02390102|Anemia|anemia
5259719|NCT02390102|Severe aortic stenosis|severe aortic stenosis
5259720|NCT02390102|Red blood cell transfusion|red blood cell transfusion
5259721|NCT02390102|Erythropoietin|erythropoietin
5259722|NCT02390089|Dysphagia|dysphagia
5259724|NCT02390089|Aspiration pneumonia|aspiration pneumonia
5259725|NCT02390024|Mechanical Ventilation|mechanical ventilation
5259726|NCT02390024|Asynchronies|asynchronies
5259727|NCT02390024|Cognition|cognition
5259728|NCT02390011|Advanced Solid Tumor|advanced solid tumor
5259729|NCT02389998|Functional Pain|functional pain
5259730|NCT02389998|Abdominal Pain|abdominal pain
5259731|NCT02389998|Irritable Bowel Syndrome|irritable bowel syndrome
5259732|NCT02389998|IBS|ibs
5259733|NCT02389998|Functional Dyspepsia|functional dyspepsia
5259734|NCT02389998|FGID|fgid
5259735|NCT02389998|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
5259736|NCT02389959|HHT|hht
5259737|NCT02389959|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5259738|NCT02389959|epistaxis|epistaxis
5259739|NCT02389959|nose bleeds|nose bleeds
5259740|NCT02389959|nasal bleeding|nasal bleeding
5259741|NCT02389959|Avastin|avastin
5259742|NCT02389959|bevacizumab|bevacizumab
5259743|NCT02389946|Drug eluting coronary stents|drug eluting coronary stents
5259744|NCT02389946|Sirolimus|sirolimus
5259745|NCT02389946|Bioabsorbable polymer|bioabsorbable polymer
5259746|NCT02389946|DES|des
5259747|NCT02389933|Multiple Patient Program, LCZ696, heart failure, heart failure with reduced ejection fraction, HF-rEF|multiple patient program, lcz696, heart failure, heart failure with reduced ejection fraction, hf-ref
5259748|NCT02389894|Embolic Protection Device|embolic protection device
5259749|NCT02389894|Stroke|stroke
5259750|NCT02389894|Brain Infarction|brain infarction
5259751|NCT02389894|atheroma|atheroma
5259752|NCT02389894|Aortic Valve Replacement|aortic valve replacement
5259753|NCT02389881|Drug therapy|drug therapy
5259754|NCT02389868|Lovastatin|lovastatin
5259755|NCT02389868|Proteome|proteome
5259756|NCT02389868|Blood platelets|blood platelets
5259757|NCT02389855|Progression|progression
5259758|NCT02389855|Quality of Life|quality of life
5259759|NCT02389816|Drug therapy|drug therapy
5259760|NCT02389790|Crohn's Disease|crohn's disease
5259761|NCT02389764|Breast cancer|breast cancer
5259762|NCT02389764|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
5259763|NCT02389764|MIBC|mibc
5259764|NCT02389764|HER2-negative|her2-negative
5259765|NCT02389764|Breast carcinoma|breast carcinoma
5259766|NCT02389764|BIBF 1120|bibf 1120
5259767|NCT02389764|Nintedanib|nintedanib
5259768|NCT02389764|Phone call|phone call
5259769|NCT02389725|peripheral intravenous access|peripheral intravenous access
5259770|NCT02389725|tourniquet techniques|tourniquet techniques
5259771|NCT02389712|Bipolar Disorder|bipolar disorder
5259772|NCT02389712|Mayo Clinic|mayo clinic
5259773|NCT02389699|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
5259774|NCT02389686|Ductal carcinoma in situ （DCIS）|ductal carcinoma in situ （dcis）
5259775|NCT02389686|Nipple-sparing mastectomy (NSM)|nipple-sparing mastectomy (nsm)
5259776|NCT02389686|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
5259777|NCT02389686|INTRABEAM|intrabeam
5259778|NCT02389673|Intermediate and high grade ductal carcinoma in situ （DCIS）|intermediate and high grade ductal carcinoma in situ （dcis）
5259780|NCT02389621|Elective invasive procedures|elective invasive procedures
5259781|NCT02389608|Transcranial direct current stimulation|transcranial direct current stimulation
5259782|NCT02389608|functional electrical stimulation|functional electrical stimulation
5259783|NCT02389608|hemiparesis|hemiparesis
5259784|NCT02389608|electromyography|electromyography
5259786|NCT02389595|HIV|hiv
5259787|NCT02389595|vaccine|vaccine
5259788|NCT02389595|T cell|t cell
5259789|NCT02389582|platelet function; dabigatran;enoxaparin|platelet function; dabigatran;enoxaparin
5259790|NCT02389569|Biomaterial|biomaterial
5259791|NCT02389569|Dental caries|dental caries
5259792|NCT02389569|Composite|composite
5259793|NCT02389543|KPT-330|kpt-330
5259794|NCT02389543|Selinexor|selinexor
5259795|NCT02389543|Multiple Myeloma|multiple myeloma
5259796|NCT02389543|Relapsed/refractory|relapsed/refractory
5259797|NCT02389543|Lenalidomide|lenalidomide
5259798|NCT02389543|Dexamethasone|dexamethasone
5259799|NCT02389543|Karyopharm|karyopharm
5259800|NCT02389530|glioma|glioma
5259801|NCT02389530|neoplasms|neoplasms
5259802|NCT02389504|Exertion|exertion
5259803|NCT02389504|Efficacy of Treatment|efficacy of treatment
5259804|NCT02389491|high density formula|high density formula
5259805|NCT02389491|heart defects|heart defects
5259806|NCT02389491|infant|infant
5259807|NCT02389478|oropharyngeal|oropharyngeal
5259808|NCT02389478|breastmilk|breastmilk
5259809|NCT02389478|colostrum|colostrum
5259810|NCT02389478|human milk|human milk
5259811|NCT02389478|premature infant|premature infant
5259812|NCT02389465|Depression|depression
5259813|NCT02389465|Geriatric|geriatric
5259814|NCT02389465|Inflammation|inflammation
5259815|NCT02389426|Multiple Sclerosis|multiple sclerosis
5259816|NCT02389426|Cerebral hemodynamics|cerebral hemodynamics
5259817|NCT02389426|Cerebral hypoperfusion|cerebral hypoperfusion
5259818|NCT02389426|Cerebral circulation|cerebral circulation
5259819|NCT02389413|PQ912|pq912
5259820|NCT02389413|Glutaminy Cyclase (QC)|glutaminy cyclase (qc)
5259821|NCT02389413|QC - Inhibitor|qc - inhibitor
5259822|NCT02389400|adult with Langerhans cell histiocytosis|adult with langerhans cell histiocytosis
5259823|NCT02389400|newly diagnosed|newly diagnosed
5259824|NCT02389400|methotrexate|methotrexate
5259825|NCT02389400|cytosine arabinoside|cytosine arabinoside
5259826|NCT02389387|Dialysis Facilities|dialysis facilities
5259827|NCT02389387|African Americans|african americans
5259828|NCT02389387|Racial Disparity|racial disparity
5259829|NCT02389387|Kidney Transplantation|kidney transplantation
5259830|NCT02389387|Community-based Participatory Research|community-based participatory research
5259831|NCT02389387|Coalition|coalition
5259833|NCT02389335|type 1diabetes|type 1diabetes
5259834|NCT02389335|IFN γ|ifn γ
5259835|NCT02389335|IL-2|il-2
5259836|NCT02389335|TNF α|tnf α
5259837|NCT02389322|ESAT6|esat6
5259838|NCT02389322|CFP10|cfp10
5259839|NCT02389322|skin test|skin test
5259840|NCT02389322|diagnostic test|diagnostic test
5259841|NCT02389283|Rheumatoid arthritis|rheumatoid arthritis
5259842|NCT02389283|ultrasound joint count|ultrasound joint count
5259843|NCT02389270|Neurotrophins|neurotrophins
5259844|NCT02389270|Nerve Growth Factor|nerve growth factor
5259845|NCT02389270|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5259846|NCT02389270|Urinary Biomarkers|urinary biomarkers
5259847|NCT02389270|Children|children
5259848|NCT02389257|volunteers|volunteers
5259849|NCT02389231|interleukine 2|interleukine 2
5259850|NCT02389231|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
5259851|NCT02389231|CD8 regulatory T cells|cd8 regulatory t cells
5259852|NCT02389218|atrial fibrillation|atrial fibrillation
5259853|NCT02389218|cryoablation|cryoablation
5259854|NCT02389218|catheter ablation|catheter ablation
5259855|NCT02389192|Ebola|ebola
5259856|NCT02389192|Mono-clonal Antibody|mono-clonal antibody
5259857|NCT02389179|Vitamin D Deficiency|vitamin d deficiency
5259858|NCT02389153|secondary prevention coronary heart disease|secondary prevention coronary heart disease
5259859|NCT02389153|myocardial infarction|myocardial infarction
5259860|NCT02389153|cardiovascular risk factors|cardiovascular risk factors
5259861|NCT02389153|collaborative care|collaborative care
5259862|NCT02389153|quality of life|quality of life
5259863|NCT02389153|patients´ satisfaction with treatment|patients´ satisfaction with treatment
5259864|NCT02389140|Blood flow|blood flow
5259865|NCT02389140|Glucose|glucose
5259866|NCT02389140|lactic acid|lactic acid
5259867|NCT02389127|Cirrhosis|cirrhosis
5259868|NCT02389127|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5259869|NCT02389127|Glycosylated hemoglobin A1c|glycosylated hemoglobin a1c
5259870|NCT02389127|Glucose|glucose
5259871|NCT02389101|Lymphoma|lymphoma
5259872|NCT02389101|68Ga-DOTANOC PET/CT|68ga-dotanoc pet/ct
5259873|NCT02389101|Somatostatin receptor|somatostatin receptor
5259874|NCT02389101|MRI|mri
5259875|NCT02389101|Diffusion weighted imaging|diffusion weighted imaging
5259876|NCT02389101|Early treatment response|early treatment response
5259884|NCT02389049|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5259885|NCT02389049|Kartagener Syndrome|kartagener syndrome
5259886|NCT02389023|surgical site infection|surgical site infection
5259887|NCT02389023|infrainguinal bypass|infrainguinal bypass
5259888|NCT02389023|incisional wound vacuum assisted closure|incisional wound vacuum assisted closure
5259889|NCT02389023|Prevena|prevena
5259890|NCT02389010|Umbilical Cord Blood|umbilical cord blood
5259891|NCT02389010|Diabetic Foot|diabetic foot
5259892|NCT02389010|Ulcer|ulcer
5259893|NCT02389010|Cost|cost
5259894|NCT02389010|Effectiveness|effectiveness
5259895|NCT02389010|Safety|safety
5259896|NCT02389010|Platelet Gel|platelet gel
5259897|NCT02389010|Cord Blood Platelet Gel|cord blood platelet gel
5259898|NCT02389010|Adverse Event|adverse event
5259899|NCT02388997|mild asthma|mild asthma
5259900|NCT02388997|young adults|young adults
5259901|NCT02388997|rhinovirus|rhinovirus
5259902|NCT02388971|Drug therapy|drug therapy
5259903|NCT02388919|anlotinib|anlotinib
5259904|NCT02388919|Cancer|cancer
5259905|NCT02388919|NSCLC|nsclc
5259906|NCT02388919|Non-small Cell Lung Cancer|non-small cell lung cancer
5259907|NCT02388880|ITPR|itpr
5259908|NCT02388880|CPP|cpp
5259909|NCT02388880|TBI|tbi
5259910|NCT02388880|traumatic brain injury|traumatic brain injury
5259911|NCT02388880|cerebral perfusion pressure|cerebral perfusion pressure
5259912|NCT02388880|intrathoracic pressure regulator|intrathoracic pressure regulator
5259913|NCT02388841|Pulmonary embolism, Computed tomographic pulmonary|pulmonary embolism, computed tomographic pulmonary
5259914|NCT02388815|Diabetes Mellitus|diabetes mellitus
5259915|NCT02388815|Sensing Technology|sensing technology
5259916|NCT02388802|Infertility|infertility
5259917|NCT02388802|Transplant|transplant
5259918|NCT02388802|IVF|ivf
5259919|NCT02388802|Hysterectomy|hysterectomy
5259920|NCT02388802|Absolute uterine infertility|absolute uterine infertility
5259921|NCT02388789|sensory receptors|sensory receptors
5259922|NCT02388789|balance control|balance control
5259923|NCT02388789|gait|gait
5259924|NCT02388789|temperature|temperature
5259925|NCT02388776|ROTEM|rotem
5259926|NCT02388776|Fibrinogen|fibrinogen
5259927|NCT02388763|Contact lenses|contact lenses
5259928|NCT02388750|nausea|nausea
5259929|NCT02388750|vomiting|vomiting
5259930|NCT02388750|radiation|radiation
5259931|NCT02388750|anti-emetic drug|anti-emetic drug
5259933|NCT02388724|Drug therapy|drug therapy
5259941|NCT02388685|peripheral arterial disease|peripheral arterial disease
5259942|NCT02388685|exercise|exercise
5259943|NCT02388685|perfusion|perfusion
5259944|NCT02388685|energetics|energetics
5259945|NCT02388685|magnetic resonance imaging|magnetic resonance imaging
5259946|NCT02388685|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5259947|NCT02388659|MRS Biomarkers|mrs biomarkers
5259948|NCT02388581|Helicobactor pylori, Hp|helicobactor pylori, hp
5259949|NCT02388581|mucosa-associated lymphoid tissue-type lymphoma, MALToma|mucosa-associated lymphoid tissue-type lymphoma, maltoma
5259950|NCT02388542|cardiovascular disease|cardiovascular disease
5259951|NCT02388542|education|education
5259952|NCT02388542|peer mentor|peer mentor
5259953|NCT02388529|Heart Failure|heart failure
5259954|NCT02388529|Bendavia™|bendavia™
5259955|NCT02388529|MTP-131|mtp-131
5259956|NCT02388516|Bangladesh|bangladesh
5259957|NCT02388516|Vitamin D|vitamin d
5259958|NCT02388516|Acute Respiratory Infections|acute respiratory infections
5259959|NCT02388516|Infancy|infancy
5259960|NCT02388516|Pregnancy|pregnancy
5259961|NCT02388503|Blood glucose|blood glucose
5259962|NCT02388490|Brentuximabvedotin|brentuximabvedotin
5259963|NCT02388490|EBV|ebv
5259964|NCT02388490|Lymphoma|lymphoma
5259965|NCT02388477|rotator cuff repair|rotator cuff repair
5259966|NCT02388477|Doxycycline|doxycycline
5259967|NCT02388464|Congestive Heart Failure|congestive heart failure
5259968|NCT02388464|Bendavia™|bendavia™
5259969|NCT02388464|MTP-131|mtp-131
5259970|NCT02388451|Mild Cognitive Impairment|mild cognitive impairment
5259971|NCT02388438|demineralized bone matrix|demineralized bone matrix
5259972|NCT02388412|Positron emission tomography|positron emission tomography
5259973|NCT02388412|Tissue background ratio|tissue background ratio
5259974|NCT02388412|Optical coherence tomography|optical coherence tomography
5259975|NCT02388412|Thin cap fibroous atheroma|thin cap fibroous atheroma
5259976|NCT02388412|Vulnerability|vulnerability
5259977|NCT02388412|Acute coronary syndrome|acute coronary syndrome
5259978|NCT02388399|Optical coherence tomography|optical coherence tomography
5259979|NCT02388399|Axial Plaque Stress|axial plaque stress
5259980|NCT02388399|Wall Shear Stress|wall shear stress
5259981|NCT02388399|Vulnerability|vulnerability
5259982|NCT02388386|Telemedicine|telemedicine
5259983|NCT02388386|Mobile Health|mobile health
5259984|NCT02388360|Prostaglandin analogs|prostaglandin analogs
5259985|NCT02388360|Corneal biomechanics|corneal biomechanics
5259986|NCT02388360|Corneal Hysteresis|corneal hysteresis
5259987|NCT02388360|Glaucoma, Open-Angle|glaucoma, open-angle
5259988|NCT02388334|Caregivers|caregivers
5259989|NCT02388334|Quality of life|quality of life
5259990|NCT02388334|Quality of care|quality of care
5259991|NCT02388321|Analgesia|analgesia
5259992|NCT02388321|pediatrics|pediatrics
5259993|NCT02388321|pain management|pain management
5259994|NCT02388308|Prostate cancer|prostate cancer
5259995|NCT02388308|Image-guided radiotherapy|image-guided radiotherapy
5259996|NCT02388308|Ultrasound guidance|ultrasound guidance
5259997|NCT02388295|Multiple System Atrophy (MSA), PET imaging, myeloperoxidase (MPO) inhibitor|multiple system atrophy (msa), pet imaging, myeloperoxidase (mpo) inhibitor
5259998|NCT02388282|dynamic intrinsic PEEP|dynamic intrinsic peep
5259999|NCT02388282|diaphragm echography|diaphragm echography
5260000|NCT02388282|respiratory mechanics|respiratory mechanics
5260002|NCT02388256|colorectal|colorectal
5260003|NCT02388256|cancer|cancer
5260004|NCT02388256|neoplasm|neoplasm
5260005|NCT02388243|Brief intervention|brief intervention
5260006|NCT02388243|Low and middle income countries (LMIC)|low and middle income countries (lmic)
5260007|NCT02388243|eLearning|elearning
5260008|NCT02388243|Screening|screening
5260009|NCT02388243|Capacity Building|capacity building
5260010|NCT02388243|Primary Health Care|primary health care
5260011|NCT02388243|Education, Medical|education, medical
5260012|NCT02388243|Education, Nursing|education, nursing
5260013|NCT02388243|Education, Professional|education, professional
5260014|NCT02388243|Community Health Workers|community health workers
5140922|NCT03110354|AML|aml
5260020|NCT02388217|chronic pain|chronic pain
5260021|NCT02388217|cannabis|cannabis
5260022|NCT02388217|Approved for cannabis treatment by Israeli ministry of health|approved for cannabis treatment by israeli ministry of health
5260023|NCT02388217|Unrelieved chronic pain|unrelieved chronic pain
5260024|NCT02388204|Gait|gait
5260025|NCT02388204|Locomotion|locomotion
5260026|NCT02388204|Freezing|freezing
5260027|NCT02388191|Contraception|contraception
5260028|NCT02388191|Naproxen|naproxen
5260029|NCT02388191|Intrauterine devices|intrauterine devices
5260030|NCT02388191|Pain Control|pain control
5260043|NCT02388074|Diagnostic|diagnostic
5260058|NCT02388009|bioconjugate vaccine|bioconjugate vaccine
5260060|NCT02388009|immunogenicity|immunogenicity
5260061|NCT02388009|shigellosis|shigellosis
5260065|NCT02387957|Wet AMD|wet amd
5260066|NCT02387957|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
5260067|NCT02387957|Fovista®|fovista®
5260068|NCT02387957|Avastin®|avastin®
5260069|NCT02387957|Lucentis®|lucentis®
5260070|NCT02387957|Eylea®|eylea®
5260071|NCT02387944|Children|children
5260072|NCT02387944|Cyanotic congenital heart defect|cyanotic congenital heart defect
5260073|NCT02387944|Cardiopulmonary Bypass|cardiopulmonary bypass
5260074|NCT02387944|Thromboelastometry|thromboelastometry
5260075|NCT02387944|Platelet Function Tests|platelet function tests
5260076|NCT02387931|Adolescent|adolescent
5260077|NCT02387931|Endometriosis|endometriosis
5260078|NCT02387931|Diet|diet
5260079|NCT02387931|Nutrition|nutrition
5260080|NCT02387931|Pain|pain
5260081|NCT02387918|Tonsillectomy|tonsillectomy
5260082|NCT02387918|postoperative vomiting (POV)|postoperative vomiting (pov)
5260083|NCT02387918|Dexamethasone|dexamethasone
5260084|NCT02387918|Acupuncture|acupuncture
5260085|NCT02387879|Multiple Myeloma|multiple myeloma
5260086|NCT02387879|PASS|pass
5260087|NCT02387879|Observational|observational
5260088|NCT02387879|Non-interventional|non-interventional
5260089|NCT02387879|Relapse|relapse
5260090|NCT02387879|Refractory|refractory
5260091|NCT02387879|CC-5013|cc-5013
5260092|NCT02387879|Lenalidomide|lenalidomide
5260093|NCT02387879|Turkey|turkey
5260094|NCT02387866|Pharmacokinetic|pharmacokinetic
5260095|NCT02387866|Healthy Volunteers|healthy volunteers
5260096|NCT02387866|Male|male
5260097|NCT02387866|Japanese|japanese
5260098|NCT02387866|Caucasian|caucasian
5260099|NCT02387866|AG-221|ag-221
5260100|NCT02387840|Brain|brain
5260101|NCT02387840|Cancer|cancer
5260102|NCT02387840|Neurofibromatosis type 1|neurofibromatosis type 1
5260103|NCT02387840|NF1|nf1
5260104|NCT02387840|Magnetic resonance fingerprinting|magnetic resonance fingerprinting
5260105|NCT02387840|MRF|mrf
5260106|NCT02387827|long bout physical activity|long bout physical activity
5260107|NCT02387827|short bout physical activity|short bout physical activity
5260108|NCT02387827|Caloric Restriction|caloric restriction
5260109|NCT02387775|esophageal cooling device|esophageal cooling device
5260110|NCT02387775|post cardiac arrest|post cardiac arrest
5260111|NCT02387775|targetted temperature management|targetted temperature management
5260112|NCT02387775|therapeutic hypothermia|therapeutic hypothermia
5260113|NCT02387775|cooling|cooling
5260114|NCT02387775|rewarming|rewarming
5260115|NCT02387762|Acalabrutinib|acalabrutinib
5862737|NCT00001532|Lung Disease|lung disease
5260116|NCT02387749|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5260118|NCT02387736|BPD|bpd
5260119|NCT02387736|DBT|dbt
5260120|NCT02387736|Dialectical Behaviour Therapy|dialectical behaviour therapy
5260121|NCT02387736|Borderline Personality Disorder|borderline personality disorder
5260122|NCT02387736|Suicide|suicide
5260123|NCT02387736|Non-suicidal self injury|non-suicidal self injury
5260124|NCT02387736|NSSI|nssi
5260125|NCT02387736|Randomized Control trials|randomized control trials
5260126|NCT02387736|treatment|treatment
5260127|NCT02387710|arousal threshold|arousal threshold
5260128|NCT02387710|phenotype|phenotype
5260129|NCT02387710|tiagabine|tiagabine
5260130|NCT02387710|slow wave sleep|slow wave sleep
5260131|NCT02387684|chronic hepatitis B|chronic hepatitis b
5260132|NCT02387684|interferon|interferon
5260133|NCT02387684|peginterferon|peginterferon
5260134|NCT02387684|HBsAg loss|hbsag loss
5260135|NCT02387658|peripheral arterial disease|peripheral arterial disease
5260942|NCT02383225|Prevention|prevention
5260141|NCT02387658|pressure gradient|pressure gradient
5265263|NCT02358681|Headache|headache
5260148|NCT02387606|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5260150|NCT02387606|Antiviral activity|antiviral activity
5260151|NCT02387606|JNJ-53718678|jnj-53718678
5260153|NCT02387593|Colonoscopy|colonoscopy
5260154|NCT02387593|Screening|screening
5260155|NCT02387580|Malaria|malaria
5260156|NCT02387580|Bioavailability|bioavailability
5260157|NCT02387580|Formulation|formulation
5260158|NCT02387541|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5260159|NCT02387528|MIndfulness|mindfulness
5260160|NCT02387528|Primary Health Care|primary health care
5260161|NCT02387463|chronic hepatitis B|chronic hepatitis b
5260162|NCT02387463|antiviral therapy|antiviral therapy
5260163|NCT02387463|peginterferon|peginterferon
5260164|NCT02387463|HBeAg seroconversion|hbeag seroconversion
5260165|NCT02387463|HBsAg loss|hbsag loss
5260166|NCT02387450|Claudication|claudication
5260167|NCT02387450|Maximal walking distance|maximal walking distance
5260168|NCT02387450|Morbi-mortality|morbi-mortality
5260169|NCT02387437|ARDS|ards
5260170|NCT02387437|EIT|eit
5260171|NCT02387437|recruitment maneuvers|recruitment maneuvers
5260172|NCT02387424|depression|depression
5260173|NCT02387424|mindfulness|mindfulness
5260174|NCT02387424|pregnancy|pregnancy
5260175|NCT02387424|prevention|prevention
5260176|NCT02387424|cognitive behavioral therapy|cognitive behavioral therapy
5260177|NCT02387411|heart failure|heart failure
5260178|NCT02387411|aerobic exercise|aerobic exercise
5260179|NCT02387411|strength training|strength training
5260180|NCT02387411|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
5260181|NCT02387411|high-intensity exercise training|high-intensity exercise training
5260182|NCT02387333|Radical cystectomy|radical cystectomy
5260183|NCT02387333|Urinary diversion|urinary diversion
5260184|NCT02387333|Ileal conduit|ileal conduit
5260185|NCT02387333|Parastomal hernia|parastomal hernia
5260186|NCT02387333|Prophylactic mesh|prophylactic mesh
5260187|NCT02387333|Mesh stoma reinforcement technique|mesh stoma reinforcement technique
5260188|NCT02387320|Anxiety|anxiety
5260189|NCT02387320|Pain|pain
5260190|NCT02387320|Nausea|nausea
5260191|NCT02387320|Fatigue|fatigue
5260192|NCT02387320|Sleep Disturbance|sleep disturbance
5260193|NCT02387320|Breast Cancer|breast cancer
5260194|NCT02387320|Surgery|surgery
5260195|NCT02387294|immunogenicity|immunogenicity
5260196|NCT02387294|reduced dos|reduced dos
5260197|NCT02387294|Phase III|phase iii
5260198|NCT02387294|tolerability|tolerability
5260199|NCT02387294|safety|safety
5260200|NCT02387281|Freezing of gait|freezing of gait
5260201|NCT02387242|Tuberculosis|tuberculosis
5260202|NCT02387242|Whole blood Bactericidal Activity|whole blood bactericidal activity
5260204|NCT02387242|Rifampicin|rifampicin
5260211|NCT02387216|NSCLC|nsclc
5260212|NCT02387216|Non-Small Cell Lung Cancer|non-small cell lung cancer
5260213|NCT02387216|heregulin|heregulin
5260214|NCT02387216|ErbB3|erbb3
5260215|NCT02387216|docetaxel|docetaxel
5260216|NCT02387203|Pseudomyxoma Peritonei|pseudomyxoma peritonei
5260217|NCT02387203|Appendiceal cancer|appendiceal cancer
5260218|NCT02387203|CRS/HIPEC|crs/hipec
5260219|NCT02387203|PMP|pmp
5260220|NCT02387190|Heart Failure|heart failure
5260221|NCT02387190|Lung function test|lung function test
5260222|NCT02387190|Telenursing|telenursing
5260223|NCT02387190|Morbidity|morbidity
5260224|NCT02387190|Mortality|mortality
5260225|NCT02387190|Quality of life|quality of life
5260226|NCT02387164|Type 1 diabetes|type 1 diabetes
5260227|NCT02387164|Islet autoantibodies|islet autoantibodies
5260228|NCT02387164|glutamate decarboxylase autoantibodies (GADA)|glutamate decarboxylase autoantibodies (gada)
5260229|NCT02387164|Immune tolerance|immune tolerance
5260230|NCT02387164|Prediabetes|prediabetes
5260231|NCT02387164|Glucose tolerance|glucose tolerance
5260232|NCT02387164|glutamate decarboxylase|glutamate decarboxylase
5260233|NCT02387164|Prevention|prevention
5260234|NCT02387164|Children|children
5260235|NCT02387151|Mesenchymal Stromal Cells|mesenchymal stromal cells
5260246|NCT02387086|EGFR mutation|egfr mutation
5260247|NCT02387073|outcome assessment|outcome assessment
5260248|NCT02387073|self-reported|self-reported
5260249|NCT02387073|patient|patient
5260250|NCT02387073|clinical outcome|clinical outcome
5260251|NCT02387060|Anesthesia|anesthesia
5260252|NCT02387060|Spinal and Epidural|spinal and epidural
5260253|NCT02387060|Adverse Effect|adverse effect
5260254|NCT02387060|Complications|complications
5260255|NCT02387034|Osteoarthritis|osteoarthritis
5260256|NCT02387034|Sedentary|sedentary
5260257|NCT02387034|Physical activity|physical activity
5260258|NCT02387034|Health related quality of life|health related quality of life
5260260|NCT02387021|nerve block|nerve block
5260261|NCT02387021|Total knee replacement|total knee replacement
5260262|NCT02386995|depth of anesthesia monitors|depth of anesthesia monitors
5260263|NCT02386995|deep brain stimulation|deep brain stimulation
5260264|NCT02386969|Neuropathic Pain|neuropathic pain
5260265|NCT02386969|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5260266|NCT02386956|manual therapy|manual therapy
5260267|NCT02386956|muscle chains|muscle chains
5260268|NCT02386956|Dynamic stretching|dynamic stretching
5260269|NCT02386956|Active stretching|active stretching
5260270|NCT02386930|Cognitive behavior therapy|cognitive behavior therapy
5260271|NCT02386930|Lifestyle modification|lifestyle modification
5260272|NCT02386930|HbA1c|hba1c
5260273|NCT02386930|Carbohydrates|carbohydrates
5260274|NCT02386891|food intake|food intake
5260275|NCT02386891|indoor thermal environment|indoor thermal environment
5260276|NCT02386878|Orphans and vulnerable children (OVC)|orphans and vulnerable children (ovc)
5260277|NCT02386878|Program Evaluation|program evaluation
5260278|NCT02386878|HIV Prevention|hiv prevention
5260279|NCT02386878|Psychosocial Wellbeing|psychosocial wellbeing
5260280|NCT02386878|Adolescents|adolescents
5260281|NCT02386852|Ginseng|ginseng
5260282|NCT02386852|Ginkgo Biloba|ginkgo biloba
5260283|NCT02386852|cardiovascular reactivity|cardiovascular reactivity
5260284|NCT02386852|cognition|cognition
5260285|NCT02386826|INC280|inc280
5260286|NCT02386826|c-MET Inhibitors|c-met inhibitors
5260287|NCT02386826|bevacizumab|bevacizumab
5260288|NCT02386826|Avastin|avastin
5260289|NCT02386826|C-Met proto-oncogene|c-met proto-oncogene
5260290|NCT02386800|primary myelofibrosis|primary myelofibrosis
5260291|NCT02386800|chronic idiopathic myelofibrosis,|chronic idiopathic myelofibrosis,
5260292|NCT02386800|post polycythemia vera myelofibrosis,|post polycythemia vera myelofibrosis,
5260293|NCT02386800|post essential thrombocythaemia myelofibrosis,|post essential thrombocythaemia myelofibrosis,
5260294|NCT02386800|Steroid Refractory Graft Versus Host Disease|steroid refractory graft versus host disease
5260295|NCT02386787|Ultrasonography|ultrasonography
5260296|NCT02386787|Non-elective surgery|non-elective surgery
5260297|NCT02386787|Anesthesia|anesthesia
5260298|NCT02386774|In vivo confocal microscopy|in vivo confocal microscopy
5260299|NCT02386774|corneal disease|corneal disease
5260300|NCT02386774|Blepharitis|blepharitis
5260301|NCT02386774|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
5260302|NCT02386774|Microscopy, Confocal|microscopy, confocal
5260303|NCT02386748|Cesarean section|cesarean section
5260304|NCT02386748|Chewing gums|chewing gums
5260305|NCT02386748|Intestinal motility|intestinal motility
5260306|NCT02386735|Corticosteroid treatment|corticosteroid treatment
5260307|NCT02386735|COPD|copd
5260308|NCT02386735|Primary Health Care|primary health care
5260309|NCT02386735|Randomized controlled trial|randomized controlled trial
5260310|NCT02386722|Adherence of inhaled medication|adherence of inhaled medication
5260311|NCT02386722|pharmaceutical care intervention|pharmaceutical care intervention
5260312|NCT02386683|Protective mechanical ventilation|protective mechanical ventilation
5260313|NCT02386683|ventilator-induced lung injury|ventilator-induced lung injury
5260314|NCT02386683|neurosurgery|neurosurgery
5260315|NCT02386657|Sickle Cell Disease|sickle cell disease
5260316|NCT02386657|Vaso-occlusive crisis|vaso-occlusive crisis
5260317|NCT02386657|Emergency management|emergency management
5260318|NCT02386631|gait|gait
5260319|NCT02386631|orthotics|orthotics
5260320|NCT02386631|kinetics|kinetics
5260321|NCT02386631|hallux valgus|hallux valgus
5260322|NCT02386631|bunions|bunions
5260324|NCT02386618|laterally spreading tumors|laterally spreading tumors
5260325|NCT02386618|endoscopic mucosal resestion|endoscopic mucosal resestion
5260326|NCT02386618|local residual neoplasia|local residual neoplasia
5260327|NCT02386605|recovery|recovery
5260328|NCT02386605|rehabilitation|rehabilitation
5260329|NCT02386553|NURTURE|nurture
5260330|NCT02386540|Community Health Workers|community health workers
5260331|NCT02386540|Community Health Workers: utilization|community health workers: utilization
5260332|NCT02386540|Emergency Service|emergency service
5262553|NCT02374450|Children|children
5260333|NCT02386540|Primary Health Care/utilization|primary health care/utilization
5260334|NCT02386540|Health Services Accessibility|health services accessibility
5260335|NCT02386514|sexually transmitted infection|sexually transmitted infection
5260340|NCT02386462|circulatory reflexes|circulatory reflexes
5260342|NCT02386436|Dose Escalation|dose escalation
5260343|NCT02386436|Safety|safety
5260344|NCT02386436|First Time in Human|first time in human
5260345|NCT02386436|Pharmacodynamics|pharmacodynamics
5260346|NCT02386436|Pharmacokinetics|pharmacokinetics
5260347|NCT02386423|RLS|rls
5260348|NCT02386423|Willis-Ekbom|willis-ekbom
5260349|NCT02386384|pregnancy failure|pregnancy failure
5260350|NCT02386358|Chronic Chagas Disease|chronic chagas disease
5260351|NCT02386358|Randomized Clinical Trial double blind|randomized clinical trial double blind
5260352|NCT02386358|Benznidazole vs Placebo|benznidazole vs placebo
5260353|NCT02386358|Adult patients|adult patients
5260354|NCT02386345|FIRM procedure|firm procedure
5260355|NCT02386319|Melatonin|melatonin
5260356|NCT02386319|Analgesic|analgesic
5260357|NCT02386319|Surgery|surgery
5260358|NCT02386319|Pharmacokinetic|pharmacokinetic
5260359|NCT02386319|Anxiolytic|anxiolytic
5260360|NCT02386280|Primary Prevention|primary prevention
5260361|NCT02386280|Substance-Related Disorders|substance-related disorders
5260362|NCT02386280|Family|family
5260363|NCT02386254|premorbid|premorbid
5260364|NCT02386254|scoring system|scoring system
5260365|NCT02386254|ECOG|ecog
5260366|NCT02386254|ICU|icu
5260367|NCT02386254|morbidity|morbidity
5260368|NCT02386254|mortality|mortality
5260369|NCT02386241|brain tumor|brain tumor
5260370|NCT02386228|miRNA|mirna
5260371|NCT02386228|posthemorrhagic hydrocephalus (PHH)|posthemorrhagic hydrocephalus (phh)
5260372|NCT02386215|HIV self-testing|hiv self-testing
5260373|NCT02386215|randomized controlled trial|randomized controlled trial
5260374|NCT02386215|Kenya|kenya
5260375|NCT02386189|Continuity of Patient Care|continuity of patient care
5260376|NCT02386189|Health Records, Personal|health records, personal
5260377|NCT02386189|Veterans|veterans
5260378|NCT02386189|Patient Participation|patient participation
5260379|NCT02386189|Chronic Disease|chronic disease
5260380|NCT02386137|MR-HIFU|mr-hifu
5260381|NCT02386137|HIFU|hifu
5260382|NCT02386137|Fibroid treatment|fibroid treatment
5260383|NCT02386137|MR Perfusion|mr perfusion
5260384|NCT02386137|CEUS perfusion|ceus perfusion
5260385|NCT02386137|Diffusion weighted imaging|diffusion weighted imaging
5260386|NCT02386137|ARFI|arfi
5260387|NCT02386137|Fibroid stiffness|fibroid stiffness
5260388|NCT02386124|frailty|frailty
5260389|NCT02386124|elderly|elderly
5260390|NCT02386124|acute coronary syndrome|acute coronary syndrome
5260391|NCT02386124|acute heart failure|acute heart failure
5260392|NCT02386124|arrhythmias|arrhythmias
5260393|NCT02386111|Sutent|sutent
5260394|NCT02386085|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5260395|NCT02386085|Osteopathic Manipulation|osteopathic manipulation
5260396|NCT02386085|adverse effects|adverse effects
5260397|NCT02386085|side effects|side effects
5260398|NCT02386085|undesirable effects|undesirable effects
5260399|NCT02386072|Betanis®|betanis®
5260400|NCT02386072|Myrbetriq®|myrbetriq®
5260401|NCT02386072|Quality of Life|quality of life
5260402|NCT02386072|Antimuscarinics|antimuscarinics
5260403|NCT02386072|Betmiga®|betmiga®
5260404|NCT02386072|Overactive Bladder|overactive bladder
5260405|NCT02386072|Observational|observational
5260406|NCT02386059|ondansetron|ondansetron
5260407|NCT02386059|dexamethasone|dexamethasone
5260408|NCT02386059|vitrectomy|vitrectomy
5260409|NCT02386059|local anesthesia|local anesthesia
5260410|NCT02386046|Caffeine use|caffeine use
5260411|NCT02386046|Normative data|normative data
5260413|NCT02385968|Microbiology|microbiology
5260414|NCT02385968|Immunology|immunology
5260415|NCT02385942|u-health|u-health
5260416|NCT02385942|chronic wound management|chronic wound management
5260417|NCT02385942|pressure ulcer|pressure ulcer
5260418|NCT02385929|Head and Neck Cancer|head and neck cancer
5260419|NCT02385929|Intervention|intervention
5260420|NCT02385929|Rehabilitation|rehabilitation
5260421|NCT02385929|Late Effects|late effects
5260422|NCT02385929|Dysphagia|dysphagia
5260423|NCT02385916|EstroSense|estrosense
5260424|NCT02385916|estrogen|estrogen
5260425|NCT02385903|Flammacerium|flammacerium
5260426|NCT02385903|Ischemic wound|ischemic wound
5260427|NCT02385903|Lower limb|lower limb
5260428|NCT02385903|Arteriopathy|arteriopathy
5260429|NCT02385903|Amputation|amputation
5260430|NCT02385903|Dressing|dressing
5260431|NCT02385838|Nutrition labelling|nutrition labelling
5260432|NCT02385838|Front-of-pack nutrition labels|front-of-pack nutrition labels
5260433|NCT02385838|Purchasing intentions|purchasing intentions
5260434|NCT02385838|Nutritional quality|nutritional quality
5260435|NCT02385838|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5260436|NCT02385812|Lung Cancer|lung cancer
5260437|NCT02385812|Mesothelioma|mesothelioma
5260439|NCT02385812|Screening|screening
5260440|NCT02385799|Autism Spectrum Disorder|autism spectrum disorder
5260441|NCT02385799|Behavior|behavior
5260442|NCT02385799|sertraline|sertraline
5260443|NCT02385799|treatment|treatment
5260444|NCT02385786|mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5260445|NCT02385786|depression|depression
5260446|NCT02385786|treatment|treatment
5260447|NCT02385786|mindfulness meditation|mindfulness meditation
5260448|NCT02385786|psychotherapy|psychotherapy
5260449|NCT02385773|colostrum|colostrum
5260450|NCT02385773|Immunoglobulin Y (IgY)|immunoglobulin y (igy)
5260451|NCT02385760|Facial Acne|facial acne
5260452|NCT02385747|perimenopausal bleeding|perimenopausal bleeding
5260453|NCT02385747|postmenopausal bleeding|postmenopausal bleeding
5260454|NCT02385747|hysteroscopy|hysteroscopy
5260455|NCT02385747|Steroid receptors|steroid receptors
5260456|NCT02385734|Multiple gingival recession|multiple gingival recession
5260457|NCT02385734|Concentrated growth factor|concentrated growth factor
5260458|NCT02385734|Coronally advanced flap|coronally advanced flap
5260459|NCT02385721|Hypertension|hypertension
5260460|NCT02385721|Fimasartan|fimasartan
5260461|NCT02385695|Disc Degeneration Disease|disc degeneration disease
5260463|NCT02385695|multilevel lumbar Disc Degeneration Disease|multilevel lumbar disc degeneration disease
5260464|NCT02385669|vaccine|vaccine
5260465|NCT02385669|peptide|peptide
5260466|NCT02385669|ipilimumab|ipilimumab
5260467|NCT02385669|Yervoy|yervoy
5260468|NCT02385669|Montanide ISA-51|montanide isa-51
5260469|NCT02385643|alcohol dependence|alcohol dependence
5260470|NCT02385643|abstinence|abstinence
5260471|NCT02385643|relapse prevention|relapse prevention
5260472|NCT02385643|mobile support system|mobile support system
5260473|NCT02385630|Longitudinal Studies|longitudinal studies
5260474|NCT02385630|Esophagectomy|esophagectomy
5260475|NCT02385630|Gastrectomy|gastrectomy
5260476|NCT02385630|Hunger|hunger
5260477|NCT02385630|Appetite|appetite
5260478|NCT02385630|Glucagon-like Peptide 1|glucagon-like peptide 1
5260479|NCT02385630|Peptide YY|peptide yy
5260480|NCT02385630|Ghrelin|ghrelin
5260481|NCT02385630|Satiety Response|satiety response
5141296|NCT03107962|RR|rr
5260482|NCT02385630|Feeding Behavior|feeding behavior
5260483|NCT02385630|Meals|meals
5260484|NCT02385630|Postprandial Period|postprandial period
5260485|NCT02385617|Glucagon-Like Peptide 1|glucagon-like peptide 1
5260486|NCT02385617|Peptide YY|peptide yy
5260487|NCT02385617|Ghrelin|ghrelin
5260488|NCT02385617|Satiety Response|satiety response
5260489|NCT02385617|Appetite|appetite
5260490|NCT02385617|Hunger|hunger
5260491|NCT02385617|Somatostatin|somatostatin
5260492|NCT02385617|Octreotide|octreotide
5260493|NCT02385617|Anastomosis, Roux-en-Y|anastomosis, roux-en-y
5260494|NCT02385617|Digestive System Surgical Procedures|digestive system surgical procedures
5260495|NCT02385617|Pharmacologic Actions|pharmacologic actions
5260496|NCT02385617|Physiological Effects of Drugs|physiological effects of drugs
5260497|NCT02385617|Endocrine System Diseases|endocrine system diseases
5260498|NCT02385617|Enteroendocrine Cells|enteroendocrine cells
5260499|NCT02385617|Gastrointestinal Agents|gastrointestinal agents
5260500|NCT02385604|Positron-Emission Tomography|positron-emission tomography
5260501|NCT02385604|Neoadjuvant Therapy|neoadjuvant therapy
5260502|NCT02385604|Chemoradiotherapy|chemoradiotherapy
5260503|NCT02385604|Esophagectomy|esophagectomy
5260504|NCT02385604|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
5260505|NCT02385604|Treatment Outcome|treatment outcome
5260506|NCT02385604|Survival|survival
5260507|NCT02385604|Recurrence|recurrence
5260508|NCT02385604|Disease-Free Survival|disease-free survival
5260509|NCT02385604|Progression-Free Survival|progression-free survival
5260510|NCT02385604|Prognosis|prognosis
5260511|NCT02385604|Neoplasm Grading|neoplasm grading
5260512|NCT02385604|Adenocarcinoma|adenocarcinoma
5260513|NCT02385604|Squamous Cell Carcinoma|squamous cell carcinoma
5260514|NCT02385604|Neoplasm Metastasis|neoplasm metastasis
5260515|NCT02385591|physical activity|physical activity
5260516|NCT02385591|Latinos|latinos
5260517|NCT02385591|overweight|overweight
5260519|NCT02385591|mHealth|mhealth
5260520|NCT02385578|VS (vessel plus surface) classification system|vs (vessel plus surface) classification system
5260521|NCT02385578|Magnified endoscopy with narrow band imaging (ME-NBI)|magnified endoscopy with narrow band imaging (me-nbi)
5260522|NCT02385578|the rate of detection|the rate of detection
5260523|NCT02385552|colonoscopy|colonoscopy
5260524|NCT02385552|quality improvement|quality improvement
5260525|NCT02385552|adenoma detection rate|adenoma detection rate
5260526|NCT02385526|Vagus Nerve Stimulation|vagus nerve stimulation
5260527|NCT02385526|ASCEND|ascend
5260528|NCT02385526|VNS Titration to Improve Tolerance and Accelerate Adaptation|vns titration to improve tolerance and accelerate adaptation
5260532|NCT02385487|Critical Illness|critical illness
5260533|NCT02385487|Necrosis|necrosis
5260535|NCT02385487|Respiratory Insufficiency|respiratory insufficiency
5260536|NCT02385487|Myocardial Ischemia|myocardial ischemia
5260537|NCT02385487|Cardiovascular Diseases|cardiovascular diseases
5260538|NCT02385487|Heart Diseases|heart diseases
5260539|NCT02385487|Vascular Diseases|vascular diseases
5260540|NCT02385474|silver diamine fluoride|silver diamine fluoride
5260541|NCT02385474|randomized clinical trial|randomized clinical trial
5260542|NCT02385474|caries|caries
5260543|NCT02385474|children|children
5260544|NCT02385474|fluoride|fluoride
5260545|NCT02385448|dienogest|dienogest
5260546|NCT02385448|combined oral contraceptive pills|combined oral contraceptive pills
5260547|NCT02385448|endometriosis|endometriosis
5260548|NCT02385435|caudal block|caudal block
5260549|NCT02385422|secondary prophylaxis|secondary prophylaxis
5260550|NCT02385422|Propranolol|propranolol
5260551|NCT02385422|Carvedilol|carvedilol
5260552|NCT02385422|comparative effectiveness research|comparative effectiveness research
5260557|NCT02385396|Polycystic Ovary Syndrome|polycystic ovary syndrome
5260559|NCT02385396|Myo-inositol|myo-inositol
5260560|NCT02385396|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5260561|NCT02385383|Patient Blood Management|patient blood management
5260562|NCT02385383|Preoperative anemia|preoperative anemia
5260563|NCT02385383|IV Iron|iv iron
5260564|NCT02385357|Muscle function|muscle function
5260565|NCT02385357|Anaerobic power|anaerobic power
5260566|NCT02385357|Muscle damage|muscle damage
5260567|NCT02385331|Neutrophils|neutrophils
5260568|NCT02385331|necroptosis|necroptosis
5260569|NCT02385331|apoptosis|apoptosis
5260570|NCT02385305|Pressure support ventilation|pressure support ventilation
5260571|NCT02385305|respiratory drive|respiratory drive
5260572|NCT02385305|Physiology|physiology
5260573|NCT02385279|CAD|cad
5260574|NCT02385279|ACS|acs
5260575|NCT02385279|All comers|all comers
5260576|NCT02385279|PCI|pci
5260577|NCT02385266|Interstitial cystitis with Painful Bladder Syndrome|interstitial cystitis with painful bladder syndrome
5260578|NCT02385266|Urological Chronic Pelvic Pain Syndrome|urological chronic pelvic pain syndrome
5260579|NCT02385253|Training|training
5260580|NCT02385253|Primary Health Care|primary health care
5260581|NCT02385253|Skin Cancer|skin cancer
5260582|NCT02385253|Primary Care Physicians|primary care physicians
5260583|NCT02385253|Surveillance|surveillance
5260584|NCT02385253|Education|education
5260585|NCT02385214|Malignant|malignant
5260586|NCT02385214|Melanoma|melanoma
5260587|NCT02385214|Cancer|cancer
5260588|NCT02385214|Surgery|surgery
5260589|NCT02385188|Extramammary Paget's disease|extramammary paget's disease
5260590|NCT02385188|Vulva|vulva
5260591|NCT02385188|Genital, female|genital, female
5260592|NCT02385188|imiquimod|imiquimod
5260593|NCT02385175|Eustachian tube|eustachian tube
5260594|NCT02385175|test accuracy|test accuracy
5260595|NCT02385175|clinical test|clinical test
5260596|NCT02385175|questionnaire|questionnaire
5260597|NCT02385162|Mucolipidoses|mucolipidoses
5260598|NCT02385162|Metabolic Diseases|metabolic diseases
5260599|NCT02385162|Lysosomal Storage Diseases|lysosomal storage diseases
5260600|NCT02385149|resilience|resilience
5260601|NCT02385149|challenge test|challenge test
5260602|NCT02385149|whole grain wheat|whole grain wheat
5260603|NCT02385149|metabolic flexibility|metabolic flexibility
5260604|NCT02385149|cardio-metabolic|cardio-metabolic
5260605|NCT02385149|liver and adipose tissue|liver and adipose tissue
5260606|NCT02385136|NSCLC|nsclc
5260607|NCT02385136|Radiotherpy|radiotherpy
5260608|NCT02385136|Temozolomide|temozolomide
5260615|NCT02385110|Leukemia|leukemia
5260616|NCT02385110|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5260617|NCT02385110|HLH|hlh
5260618|NCT02385110|Alemtuzumab|alemtuzumab
5260619|NCT02385110|CAMPATH-1H|campath-1h
5260620|NCT02385110|Campath|campath
5260621|NCT02385110|Etoposide|etoposide
5260622|NCT02385110|VePesid|vepesid
5260623|NCT02385110|Dexamethasone|dexamethasone
5260624|NCT02385110|Decadron|decadron
5260625|NCT02385110|Methotrexate|methotrexate
5260626|NCT02385110|Phone call|phone call
5260627|NCT02385071|Healthy|healthy
5260628|NCT02385071|Simeprevir|simeprevir
5260629|NCT02385071|Bioavailability|bioavailability
5260630|NCT02385058|Helminthiasis|helminthiasis
5260631|NCT02385058|Amoebiasis|amoebiasis
5260632|NCT02385058|Mebendazole|mebendazole
5260633|NCT02385058|Quinfamide|quinfamide
5260634|NCT02385058|Mexican population|mexican population
5260635|NCT02385019|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5260636|NCT02385019|Graft vs host disease|graft vs host disease
5260637|NCT02385019|Regulatory T cells|regulatory t cells
5262554|NCT02374450|Infants|infants
5258006|NCT02400944|15-047|15-047
5260639|NCT02385006|simulatneous pancreas-kidney transplantation|simulatneous pancreas-kidney transplantation
5260640|NCT02384993|Alzheimer's Disease|alzheimer's disease
5260642|NCT02384993|aerobic exercise|aerobic exercise
5260643|NCT02384993|physical activity|physical activity
5260644|NCT02384993|exercise|exercise
5260645|NCT02384993|neuroimaging|neuroimaging
5260646|NCT02384980|Intermittent Claudication|intermittent claudication
5260647|NCT02384980|Functional Electrical Stimulation|functional electrical stimulation
5260648|NCT02384954|Lymphoma|lymphoma
5260649|NCT02384954|indolent B Cell|indolent b cell
5260650|NCT02384954|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5260651|NCT02384954|Cancer|cancer
5260652|NCT02384954|Immunotherapy|immunotherapy
5260653|NCT02384954|Relapsed|relapsed
5260654|NCT02384954|Refractory|refractory
5260655|NCT02384954|Rituximab|rituximab
5260656|NCT02384954|Interleukin-15|interleukin-15
5260657|NCT02384954|Absolute Lymphocyte Count|absolute lymphocyte count
5260658|NCT02384954|White Blood Cell|white blood cell
5260659|NCT02384954|Follicular Lymphoma|follicular lymphoma
5260660|NCT02384954|Marginal Zone Lymphoma|marginal zone lymphoma
5260661|NCT02384954|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5260662|NCT02384954|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5260663|NCT02384954|anti-CD20|anti-cd20
5260664|NCT02384928|Acupuncture|acupuncture
5260665|NCT02384928|Pharmacopuncture|pharmacopuncture
5260666|NCT02384928|Usual Care|usual care
5260667|NCT02384902|glycemic index|glycemic index
5260668|NCT02384902|diabetic nephropathy|diabetic nephropathy
5260669|NCT02384902|low glycemic load|low glycemic load
5260670|NCT02384902|inflammation|inflammation
5260671|NCT02384876|pediatric|pediatric
5260672|NCT02384876|intraoperative arterial hypotension|intraoperative arterial hypotension
5260673|NCT02384876|ephedrine|ephedrine
5260674|NCT02384876|general anesthesia|general anesthesia
5260675|NCT02384863|Chest Pain|chest pain
5260676|NCT02384863|Acute Coronary Syndrome|acute coronary syndrome
5260678|NCT02384863|Emergency Department|emergency department
5260679|NCT02384863|Cardiac Testing|cardiac testing
5260680|NCT02384863|Healthcare Utilization|healthcare utilization
5260681|NCT02384863|Patient Centered Outcomes|patient centered outcomes
5260682|NCT02384863|Shared Decision Making|shared decision making
5260683|NCT02384863|Unnecessary hospital admissions|unnecessary hospital admissions
5260684|NCT02384863|Decision Aid|decision aid
5260685|NCT02384850|metastatic|metastatic
5260686|NCT02384837|national Cather Lad|national cather lad
5260687|NCT02384837|Interventional Imaging Training Base|interventional imaging training base
5260688|NCT02384811|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5260689|NCT02384811|postoperative radiotherapy|postoperative radiotherapy
5260690|NCT02384759|cancer, colorectal,|cancer, colorectal,
5260691|NCT02384746|metastatic breast cancer|metastatic breast cancer
5260692|NCT02384746|ER-positive|er-positive
5260693|NCT02384746|HER2-negative|her2-negative
5260694|NCT02384746|Fulvestrant|fulvestrant
5260695|NCT02384746|MLN9708|mln9708
5260697|NCT02384694|cardiorespiratory fitness|cardiorespiratory fitness
5260698|NCT02384694|weight|weight
5260699|NCT02384694|quality of life|quality of life
5260700|NCT02384694|depression|depression
5260701|NCT02384694|menopausal symptoms|menopausal symptoms
5260702|NCT02384694|exercise barriers|exercise barriers
5260703|NCT02384694|executive functions|executive functions
5260704|NCT02384681|Speech intelligibility|speech intelligibility
5260705|NCT02384681|Short-term memory|short-term memory
5260706|NCT02384681|Working memory|working memory
5260707|NCT02384681|Perceived mental task load|perceived mental task load
5260708|NCT02384668|Cholecalciferol|cholecalciferol
5260709|NCT02384668|Vitamin D3|vitamin d3
5260710|NCT02384668|Arterial stiffness|arterial stiffness
5260711|NCT02384668|Quality of Life|quality of life
5260712|NCT02384668|Bone density and geometry|bone density and geometry
5260713|NCT02384668|Muscle strength and balance|muscle strength and balance
5260714|NCT02384655|Preterms|preterms
5260715|NCT02384655|Breastfeeding|breastfeeding
5260716|NCT02384655|Lactation|lactation
5260717|NCT02384655|Macronutrients|macronutrients
5260718|NCT02384642|Adolescent Health|adolescent health
5260719|NCT02384642|Democratic Republic of Congo|democratic republic of congo
5260720|NCT02384642|Sexual Violence|sexual violence
5260721|NCT02384616|Lung Volume Measurements|lung volume measurements
5260722|NCT02384616|airway resistance|airway resistance
5260723|NCT02384616|general anesthesia|general anesthesia
5260724|NCT02384564|Laryngoscopy|laryngoscopy
5260725|NCT02384564|Video Laryngoscopy|video laryngoscopy
5260726|NCT02384564|Tracheal intubation|tracheal intubation
5260727|NCT02384551|GERD|gerd
5260728|NCT02384551|diet|diet
5260729|NCT02384551|carbohydrate|carbohydrate
5260730|NCT02384551|obesity|obesity
5260731|NCT02384538|Osteoarthritis|osteoarthritis
5260732|NCT02384538|Joint diseases|joint diseases
5260733|NCT02384538|Musculoskeletal diseases|musculoskeletal diseases
5260734|NCT02384538|Rheumatic diseases|rheumatic diseases
5260735|NCT02384538|Arthritis|arthritis
5260743|NCT02384512|Rasagiline|rasagiline
5260744|NCT02384512|Combination therapy with L-dopa|combination therapy with l-dopa
5260745|NCT02384512|Wearing-off Questionnaire-32|wearing-off questionnaire-32
5260751|NCT02384460|Recessive Dystrophic|recessive dystrophic
5260752|NCT02384460|Junctional non-Herlitz|junctional non-herlitz
5260753|NCT02384460|Epidermolysis Bullosa|epidermolysis bullosa
5260754|NCT02384460|SD-101 6%|sd-101 6%
5260755|NCT02384460|SD-101-6.0|sd-101-6.0
5260756|NCT02384460|Allantoin 6%|allantoin 6%
5260757|NCT02384460|Zorblisa|zorblisa
5260758|NCT02384447|above knee amputation|above knee amputation
5260759|NCT02384447|sciatic nerve|sciatic nerve
5260760|NCT02384447|ultrasonography|ultrasonography
5260761|NCT02384447|histology|histology
5260762|NCT02384408|menopause|menopause
5260763|NCT02384408|drospirenone|drospirenone
5260764|NCT02384408|tibolone|tibolone
5260766|NCT02384408|steroid receptors|steroid receptors
5260767|NCT02384395|Dolutegravir|dolutegravir
5260768|NCT02384395|Abacavir|abacavir
5260769|NCT02384395|Lamivudine|lamivudine
5260770|NCT02384395|acute HIV infection|acute hiv infection
5260771|NCT02384395|human leukocyte antigen|human leukocyte antigen
5260772|NCT02384395|latent HIV reservoir|latent hiv reservoir
5260773|NCT02384395|integrase-based regimen|integrase-based regimen
5260774|NCT02384395|viremia|viremia
5260775|NCT02384395|antiretroviral therapy|antiretroviral therapy
5260776|NCT02384395|fixed dose combination|fixed dose combination
5260777|NCT02384382|Cancer of the Prostate|cancer of the prostate
5260778|NCT02384356|Non-communicable diseases|non-communicable diseases
5260779|NCT02384356|Chronic disease|chronic disease
5260780|NCT02384356|Mobile health|mobile health
5260781|NCT02384356|Diabetes Mellitus|diabetes mellitus
5260782|NCT02384356|Hypertension|hypertension
5260783|NCT02384356|Bolivia|bolivia
5260784|NCT02384356|Longitudinal survey|longitudinal survey
5260785|NCT02384356|Health indicators|health indicators
5260786|NCT02384356|Primary care|primary care
5260787|NCT02384356|Ambulatory care|ambulatory care
5260788|NCT02384343|Dexmedetomidine|dexmedetomidine
5260789|NCT02384343|Cesarean section|cesarean section
5260790|NCT02384343|Anesthesia, Spinal|anesthesia, spinal
5260791|NCT02384343|Anesthesia, Epidural|anesthesia, epidural
5260792|NCT02384304|randomized controlled trial|randomized controlled trial
5260793|NCT02384304|alcohol|alcohol
5260794|NCT02384304|internet|internet
5260795|NCT02384304|internet based therapy|internet based therapy
5260796|NCT02384304|cognitive behavior therapy|cognitive behavior therapy
5260797|NCT02384278|alcohol use disorder|alcohol use disorder
5260798|NCT02384278|internet|internet
5260799|NCT02384278|cognitive behavior therapy|cognitive behavior therapy
5260800|NCT02384278|relapse prevention|relapse prevention
5156045|NCT03016455|Immunology|immunology
5260808|NCT02384252|obese cardiomyopathy|obese cardiomyopathy
5260809|NCT02384252|mitochondria|mitochondria
5260810|NCT02384252|contractile dysfunction|contractile dysfunction
5260811|NCT02384226|mobile application|mobile application
5260812|NCT02384226|postpartum|postpartum
5260813|NCT02384226|weight loss|weight loss
5260814|NCT02384187|Gabapentin|gabapentin
5260815|NCT02384187|PONV|ponv
5260816|NCT02384187|Adenotonsillectomy|adenotonsillectomy
5260817|NCT02384187|Pediatrics|pediatrics
5260818|NCT02384174|Aging|aging
5260819|NCT02384174|Resistant starch|resistant starch
5260820|NCT02384174|Dietary fibre|dietary fibre
5260821|NCT02384174|Immune system|immune system
5260822|NCT02384174|Bacteria|bacteria
5260823|NCT02384174|older subjects|older subjects
5260824|NCT02384122|Angiodysplasias|angiodysplasias
5260825|NCT02384122|Sandostatin LAR|sandostatin lar
5260826|NCT02384122|Gastrointestinal|gastrointestinal
5260827|NCT02384122|Somatostatin|somatostatin
5260828|NCT02384122|Octreotide|octreotide
5260829|NCT02384096|stimulation|stimulation
5260830|NCT02384096|implantable|implantable
5260831|NCT02384096|pulse generator|pulse generator
5260832|NCT02384096|back pain|back pain
5260833|NCT02384096|chronic pain|chronic pain
5260834|NCT02384096|leg pain|leg pain
5260835|NCT02384083|Multiple Myeloma|multiple myeloma
5260836|NCT02384083|Pethema|pethema
5260837|NCT02384083|Filanesib|filanesib
5260838|NCT02384083|Pomalidomide|pomalidomide
5260839|NCT02384044|Sensitivity|sensitivity
5260840|NCT02383979|Phantom limb pain|phantom limb pain
5260841|NCT02383979|Mirror therapy|mirror therapy
5260842|NCT02383979|Elective amputation|elective amputation
5260843|NCT02383979|Residual limb pain|residual limb pain
5260844|NCT02383979|Functional MRI|functional mri
5260845|NCT02383953|twins|twins
5260846|NCT02383953|IBD|ibd
5260847|NCT02383953|UC|uc
5260848|NCT02383953|CD|cd
5260849|NCT02383875|nutrition economics|nutrition economics
5260850|NCT02383875|food expenditure|food expenditure
5260851|NCT02383875|nutritional quality|nutritional quality
5260852|NCT02383875|low income|low income
5260853|NCT02383862|Sleep|sleep
5260854|NCT02383862|Pain|pain
5260855|NCT02383862|Anxiety|anxiety
5260856|NCT02383862|Depression|depression
5260857|NCT02383862|Fatigue|fatigue
5260858|NCT02383862|PROMIS|promis
5260859|NCT02383862|primary care|primary care
5260860|NCT02383836|Patent Foramen Ovale|patent foramen ovale
5260861|NCT02383823|glucose, cholesterol, estrogen, gender, age|glucose, cholesterol, estrogen, gender, age
5260862|NCT02383810|Chemotherapy Induced Diarrhea (CID)|chemotherapy induced diarrhea (cid)
5260864|NCT02383771|Aspirin|aspirin
5260865|NCT02383771|Peri-operative treatment|peri-operative treatment
5260866|NCT02383758|Behavioral Symptoms|behavioral symptoms
5260867|NCT02383758|Child Development Disorders, Pervasive|child development disorders, pervasive
5260868|NCT02383758|Bowel Incontinence|bowel incontinence
5260869|NCT02383758|Constipation|constipation
5260870|NCT02383745|Acute EEG|acute eeg
5260871|NCT02383745|status epilepticus|status epilepticus
5260872|NCT02383745|seizure|seizure
5260873|NCT02383706|Sleep Apnea, Obstructive|sleep apnea, obstructive
5260874|NCT02383706|Pregnancy|pregnancy
5260875|NCT02383706|Obesity, Morbid|obesity, morbid
5260876|NCT02383706|Complications, pregnancy|complications, pregnancy
5260877|NCT02383693|depression|depression
5260878|NCT02383693|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5260879|NCT02383693|tolerability|tolerability
5260880|NCT02383693|efficiency|efficiency
5260881|NCT02383693|TMS|tms
5260882|NCT02383693|refractory|refractory
5260883|NCT02383680|Methotrexate therapy|methotrexate therapy
5260884|NCT02383654|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5260885|NCT02383654|Autologous Adipose-Tissue Derived Stem Cells (ADSCs)|autologous adipose-tissue derived stem cells (adscs)
5260886|NCT02383641|Wolman disease|wolman disease
5260887|NCT02383641|Biomarker|biomarker
5260888|NCT02383628|ICG Dye|icg dye
5260889|NCT02383628|endoscopic neurosurgery|endoscopic neurosurgery
5260890|NCT02383628|tissue perfusion|tissue perfusion
5260891|NCT02383602|6,000 Thai MSM and TG from study sites in Bangkok, Chiang Mai, Chonburi and Songkhla|6,000 thai msm and tg from study sites in bangkok, chiang mai, chonburi and songkhla
5260892|NCT02383550|Multiple Sclerosis|multiple sclerosis
5260893|NCT02383550|Cognition|cognition
5260894|NCT02383498|Overall Response Rate|overall response rate
5260895|NCT02383498|Immune Activation|immune activation
5260896|NCT02383498|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5260897|NCT02383498|T Cell Response|t cell response
5260898|NCT02383498|Cross-Over|cross-over
5260899|NCT02383485|arterial stiffness|arterial stiffness
5260900|NCT02383472|Concussion|concussion
5260901|NCT02383472|Mild Traumatic Brain Injury|mild traumatic brain injury
5260902|NCT02383472|MTBI|mtbi
5260903|NCT02383472|LED|led
5260904|NCT02383472|Light Emitting Diode|light emitting diode
5260905|NCT02383472|Headache|headache
5260906|NCT02383472|Brain Concussion|brain concussion
5260907|NCT02383446|Echeclon|echeclon
5260908|NCT02383446|Elan|elan
5260909|NCT02383446|TTA|tta
5260910|NCT02383446|Transtibial Amputee|transtibial amputee
5260911|NCT02383394|second trimesteric pregnancy loss|second trimesteric pregnancy loss
5260912|NCT02383368|Pharmacokinetics|pharmacokinetics
5260913|NCT02383368|ASP4132|asp4132
5260914|NCT02383368|Lymphoma|lymphoma
5260915|NCT02383368|Refractory Solid Tumors|refractory solid tumors
5260916|NCT02383355|Persistent immune activation|persistent immune activation
5260917|NCT02383355|Platelet hyperreactivity|platelet hyperreactivity
5260918|NCT02383342|Pain Processing|pain processing
5260919|NCT02383342|Genetic Factors|genetic factors
5260920|NCT02383342|Biomarkers|biomarkers
5260921|NCT02383329|malnutrition|malnutrition
5260922|NCT02383329|Underweight|underweight
5260923|NCT02383329|Oral Nutrition Supplements|oral nutrition supplements
5260924|NCT02383329|Children|children
5260925|NCT02383316|Insulin sensitivity|insulin sensitivity
5260926|NCT02383316|Metabolism|metabolism
5260927|NCT02383316|Noonan syndrome|noonan syndrome
5260929|NCT02383303|savings|savings
5260930|NCT02383303|assets|assets
5260931|NCT02383303|material hardship|material hardship
5260932|NCT02383303|poverty|poverty
5260933|NCT02383303|Individual Development Account|individual development account
5260934|NCT02383264|feeding intolerance|feeding intolerance
5260935|NCT02383264|preterm infants|preterm infants
5260936|NCT02383264|near infrared spectroscopy|near infrared spectroscopy
5260937|NCT02383238|Dapagliflozin|dapagliflozin
5260938|NCT02383238|diabetes mellitus|diabetes mellitus
5260939|NCT02383238|vascular|vascular
5260940|NCT02383225|American Indian|american indian
5260941|NCT02383225|Adolescent|adolescent
5260943|NCT02383212|Advanced cancerous growth|advanced cancerous growth
5260944|NCT02383173|end of life|end of life
5260945|NCT02383173|palliative care|palliative care
5260946|NCT02383173|implementation|implementation
5260947|NCT02383160|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
5260948|NCT02383160|Nonunion|nonunion
5260949|NCT02383160|Scaphoid|scaphoid
5260950|NCT02383160|Operative|operative
5260952|NCT02383147|Aged|aged
5260953|NCT02383147|Alpha Rhythm|alpha rhythm
5260954|NCT02383147|Auditory Cortex|auditory cortex
5260955|NCT02383147|Chronic|chronic
5260956|NCT02383147|Electroencephalography|electroencephalography
5260957|NCT02383147|Female|female
5260974|NCT02383056|secondary intention healing|secondary intention healing
5260976|NCT02383030|Breast cancer|breast cancer
5260977|NCT02383030|Metastatic|metastatic
5260978|NCT02383030|HER2 negative|her2 negative
5260979|NCT02383030|postmenopausal|postmenopausal
5260980|NCT02383030|maintenance therapy|maintenance therapy
5260982|NCT02383017|Multi-ingredient performance supplement, High Intensity Interval Training, Concurrent training|multi-ingredient performance supplement, high intensity interval training, concurrent training
5260983|NCT02383004|myringotomy tubes|myringotomy tubes
5260984|NCT02383004|acupuncture|acupuncture
5260985|NCT02383004|emergence delirium|emergence delirium
5260986|NCT02383004|pediatrics|pediatrics
5260987|NCT02383004|general anesthesia|general anesthesia
5260988|NCT02382991|Moderately active amputees|moderately active amputees
5260989|NCT02382991|C-leg Compact|c-leg compact
5260990|NCT02382991|Knee prosthesis|knee prosthesis
5260991|NCT02382991|Kenevo|kenevo
5260992|NCT02382991|Microprocessor controlled knee|microprocessor controlled knee
5260993|NCT02382991|Amputation|amputation
5260994|NCT02382991|3C60|3c60
5260995|NCT02382991|Timed Get Up and Go (TGUG)|timed get up and go (tgug)
5260996|NCT02382991|Locomotors Capacities Index (LCI)|locomotors capacities index (lci)
5260997|NCT02382991|QUEST|quest
5260998|NCT02382991|Short Form survey (SF-36)|short form survey (sf-36)
5260999|NCT02382952|Abdominal surgery|abdominal surgery
5261000|NCT02382952|Pelvic surgery|pelvic surgery
5261001|NCT02382952|Stoma takedown|stoma takedown
5261002|NCT02382952|Bowel resection|bowel resection
5261003|NCT02382952|Lysis of abdominal adhesions|lysis of abdominal adhesions
5261004|NCT02382926|capacitive electrocardiography|capacitive electrocardiography
5261005|NCT02382926|Eulerian Magnification Method|eulerian magnification method
5261006|NCT02382900|quadrivalent|quadrivalent
5261007|NCT02382900|vaccine|vaccine
5261008|NCT02382887|intubation|intubation
5261009|NCT02382887|difficult airway|difficult airway
5261010|NCT02382887|fiberscopy|fiberscopy
5261011|NCT02382887|Airtraq|airtraq
5261012|NCT02382887|general anesthesia|general anesthesia
5261013|NCT02382874|Idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5261014|NCT02382874|adipose derived mesenchymal stromal cell|adipose derived mesenchymal stromal cell
5261015|NCT02382874|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5261016|NCT02382861|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5261017|NCT02382861|Weaning|weaning
5261018|NCT02382861|Mechanical ventilation|mechanical ventilation
5261019|NCT02382861|Extubation|extubation
5261020|NCT02382848|Eating Disorders|eating disorders
5261021|NCT02382848|Bulimia Nervosa|bulimia nervosa
5261022|NCT02382848|Nightmares|nightmares
5261023|NCT02382848|Post Traumatic Stress Disorder|post traumatic stress disorder
5261024|NCT02382835|metal-on-metal|metal-on-metal
5261025|NCT02382809|Alveolar osteitis|alveolar osteitis
5261026|NCT02382809|Third molar|third molar
5261027|NCT02382809|Dry socket|dry socket
5261028|NCT02382809|Mouthwash|mouthwash
5261029|NCT02382809|third molar extraction|third molar extraction
5261030|NCT02382783|Rheumatoid Arthritis|rheumatoid arthritis
5261031|NCT02382783|Disease Activity|disease activity
5261033|NCT02382783|Management of Flares|management of flares
5261034|NCT02382783|Pfizer|pfizer
5261035|NCT02382744|Saphenous Nerve|saphenous nerve
5261036|NCT02382744|Nerve Block|nerve block
5261037|NCT02382744|Ultrasound guided|ultrasound guided
5261038|NCT02382744|Neurostimulation|neurostimulation
5261039|NCT02382744|Regional Anesthesia|regional anesthesia
5261040|NCT02382744|Ropivacaine|ropivacaine
5261041|NCT02382744|Foot Surgery|foot surgery
5261042|NCT02382744|Nerve Stimulation|nerve stimulation
5261043|NCT02382744|Ankle Surgery|ankle surgery
5261044|NCT02382718|fish allergy|fish allergy
5261045|NCT02382718|parvalbumin|parvalbumin
5261046|NCT02382718|immunotherapy|immunotherapy
5261047|NCT02382718|mCyp c 1|mcyp c 1
5261048|NCT02382705|capsule endoscopy|capsule endoscopy
5261049|NCT02382705|battery life|battery life
5261050|NCT02382705|completion rate|completion rate
5261051|NCT02382705|diagnostic yield|diagnostic yield
5261052|NCT02382640|Drug therapy|drug therapy
5261053|NCT02382614|Endobronchial Valve|endobronchial valve
5261054|NCT02382614|Minimally Invasive|minimally invasive
5261055|NCT02382614|Intrabronchial Valves|intrabronchial valves
5261056|NCT02382614|Digital Thoracic Drainage System|digital thoracic drainage system
5261057|NCT02382614|Spiration Valve System|spiration valve system
5261058|NCT02382614|Prolonged Air Leak|prolonged air leak
5261059|NCT02382614|Persistent Air Leak|persistent air leak
5261060|NCT02382601|Pregnancy|pregnancy
5261061|NCT02382601|IUGR|iugr
5261062|NCT02382601|Small for gestational age|small for gestational age
5261063|NCT02382562|Depression|depression
5261064|NCT02382562|Asthma|asthma
5261065|NCT02382562|Urticaria|urticaria
5261066|NCT02382549|vaccine|vaccine
5261067|NCT02382549|peptide|peptide
5261068|NCT02382549|dabrafenib|dabrafenib
5261069|NCT02382549|trametinib|trametinib
5261070|NCT02382549|Montanide ISA-51|montanide isa-51
5261071|NCT02382549|MEKINIST|mekinist
5261072|NCT02382549|Tafinlar|tafinlar
5261073|NCT02382536|Diabetes|diabetes
5261074|NCT02382536|Insulin therapy|insulin therapy
5261075|NCT02382536|insulin pump|insulin pump
5261076|NCT02382536|Infusion sets|infusion sets
5261077|NCT02382523|acthar|acthar
5261078|NCT02382523|proteinuria|proteinuria
5261079|NCT02382523|IgA nephropathy|iga nephropathy
5261080|NCT02382484|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
5261081|NCT02382471|atherosclerotic|atherosclerotic
5261082|NCT02382471|BDNF|bdnf
5261083|NCT02382471|Follistatin|follistatin
5261084|NCT02382471|Irisin|irisin
5261085|NCT02382432|Anesthesia|anesthesia
5261086|NCT02382432|dexmedetomidine|dexmedetomidine
5261087|NCT02382432|pethidine|pethidine
5261088|NCT02382432|shivering|shivering
5261089|NCT02382432|spinal|spinal
5261090|NCT02382406|MK-3475|mk-3475
5261091|NCT02382406|Pembrolizumab|pembrolizumab
5261092|NCT02382406|Carboplatin|carboplatin
5261093|NCT02382406|Nab-paclitaxel|nab-paclitaxel
5261094|NCT02382393|cognitive assessment|cognitive assessment
5261095|NCT02382393|Brain Performance Test|brain performance test
5261096|NCT02382393|Lumosity|lumosity
5261097|NCT02382393|concurrent validity|concurrent validity
5261098|NCT02382393|computerized assessment|computerized assessment
5261099|NCT02382380|Magnetic Resonance Imaging|magnetic resonance imaging
5261100|NCT02382380|Contrast Agent|contrast agent
5261101|NCT02382380|Gadoterate|gadoterate
5261103|NCT02382341|BIOSURE|biosure
5261104|NCT02382341|HEALICOIL|healicoil
5261105|NCT02382341|PEEK|peek
5261106|NCT02382341|In-Growth|in-growth
5261107|NCT02382315|fear of cancer recurrence|fear of cancer recurrence
5261108|NCT02382315|psychosocial intervention|psychosocial intervention
5261109|NCT02382315|randomized controlled clinical trial|randomized controlled clinical trial
5261110|NCT02382302|U-health|u-health
5261111|NCT02382302|chronic wound management|chronic wound management
5261112|NCT02382289|Radiofrequency|radiofrequency
5261113|NCT02382289|monopolar|monopolar
5261114|NCT02382289|bipolar|bipolar
5261115|NCT02382289|Sacroiliac Joint Arthropathy|sacroiliac joint arthropathy
5261116|NCT02382289|three different modalities|three different modalities
5261117|NCT02382263|Advanced pancreatic cancer|advanced pancreatic cancer
5261118|NCT02382263|Fragile|fragile
5261119|NCT02382263|Nab-paclitaxel|nab-paclitaxel
5261120|NCT02382237|denutrition in Head and Neck cancer or oesophageal cancer|denutrition in head and neck cancer or oesophageal cancer
5360717|NCT01899092|AAV|aav
5261121|NCT02382224|generalized anxiety disorder|generalized anxiety disorder
5261122|NCT02382224|anxiety|anxiety
5261123|NCT02382224|worry exposure|worry exposure
5261124|NCT02382224|treatment|treatment
5261125|NCT02382211|CMV|cmv
5261126|NCT02382198|droooling, sialorrhea, parkinson's disease, parkinsons|droooling, sialorrhea, parkinson's disease, parkinsons
5261127|NCT02382185|Cardiac output|cardiac output
5261128|NCT02382120|carbon dioxide|carbon dioxide
5261129|NCT02382120|cardiac output|cardiac output
5261131|NCT02382120|thermodilution|thermodilution
5261132|NCT02382107|TB|tb
5261133|NCT02382107|Tuberculosis|tuberculosis
5261134|NCT02382107|Diagnostic study|diagnostic study
5261135|NCT02382094|curative intention|curative intention
5261136|NCT02382094|radiation Therapy|radiation therapy
5261137|NCT02382094|health related quality of life|health related quality of life
5261138|NCT02382055|Eating Disorders|eating disorders
5261139|NCT02382055|Psychotherapy|psychotherapy
5261140|NCT02382055|Anorexia Nervosa|anorexia nervosa
5261141|NCT02382055|Treatment|treatment
5261142|NCT02382042|Rural Health|rural health
5261143|NCT02382042|Veterans|veterans
5261148|NCT02381990|Prostate|prostate
5261149|NCT02381990|PSA|psa
5261150|NCT02381990|FUSION|fusion
5261151|NCT02381990|Ultrasound|ultrasound
5261152|NCT02381990|MRI|mri
5261153|NCT02381990|Cancer|cancer
5261154|NCT02381990|Cryotherapy|cryotherapy
5261155|NCT02381990|Outcomes|outcomes
5261156|NCT02381990|Recurrence|recurrence
5261157|NCT02381990|QOL, Quality of Life|qol, quality of life
5261158|NCT02381990|Urinary function|urinary function
5261159|NCT02381990|Sexual Function|sexual function
5261160|NCT02381964|cerebral blood flow|cerebral blood flow
5261161|NCT02381964|cognitive function|cognitive function
5261162|NCT02381964|vitamins|vitamins
5261163|NCT02381964|energy expenditure|energy expenditure
5261164|NCT02381964|NIRS|nirs
5261165|NCT02381964|Indirect calorimetry|indirect calorimetry
5261166|NCT02381938|inactivity|inactivity
5261167|NCT02381938|behavior change|behavior change
5261168|NCT02381938|worksite wellness|worksite wellness
5261169|NCT02381938|child care|child care
5261170|NCT02381925|CT|ct
5261171|NCT02381925|Scintigraphy|scintigraphy
5261172|NCT02381925|Ultrasound|ultrasound
5261173|NCT02381899|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5261174|NCT02381899|bendamustine|bendamustine
5261175|NCT02381899|rituximab|rituximab
5261176|NCT02381886|IDHR132 mutations|idhr132 mutations
5261177|NCT02381886|IDH305|idh305
5261178|NCT02381886|IDH|idh
5261179|NCT02381886|IDH1|idh1
5261180|NCT02381886|AML|aml
5261181|NCT02381886|Acute Myeloid Leukemia|acute myeloid leukemia
5261182|NCT02381886|Leukemia|leukemia
5261183|NCT02381886|Myeloid|myeloid
5261184|NCT02381886|Acute|acute
5261185|NCT02381886|MDS|mds
5261186|NCT02381886|Myelodysplastic Syndrome|myelodysplastic syndrome
5261187|NCT02381886|Glioma|glioma
5261188|NCT02381886|Oligodendroglioma|oligodendroglioma
5261191|NCT02381886|Cholangiocarcinoma|cholangiocarcinoma
5261192|NCT02381886|Solid Tumors|solid tumors
5261193|NCT02381873|Arthroplasty|arthroplasty
5261194|NCT02381873|Replacement|replacement
5261195|NCT02381873|Knee|knee
5261196|NCT02381873|Osteoarthritis|osteoarthritis
5261197|NCT02381847|gastric cancer|gastric cancer
5261198|NCT02381847|intraperitoneal chemoperfusion|intraperitoneal chemoperfusion
5261199|NCT02381834|Urine Specimen Collection|urine specimen collection
5261205|NCT02381821|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5261207|NCT02381717|bupivacaine|bupivacaine
5261208|NCT02381717|femoral nerve block|femoral nerve block
5261209|NCT02381717|pain reduction|pain reduction
5261210|NCT02381678|Heart Valve Replacement|heart valve replacement
5261211|NCT02381678|Perimount 2900|perimount 2900
5261212|NCT02381678|China|china
5261213|NCT02381678|Perimount 6900P|perimount 6900p
5261214|NCT02381626|HEPA filter|hepa filter
5261215|NCT02381626|14-247|14-247
5261216|NCT02381613|Fish|fish
5261217|NCT02381613|Herring|herring
5261218|NCT02381613|Meat|meat
5261219|NCT02381613|Beef|beef
5261220|NCT02381600|vitamin D|vitamin d
5261221|NCT02381600|aging|aging
5261222|NCT02381600|cognitive function|cognitive function
5261223|NCT02381600|depression|depression
5261224|NCT02381600|executive function|executive function
5261225|NCT02381574|Lumbar Total Disk Replacement|lumbar total disk replacement
5261226|NCT02381522|remote ischemic preconditioning|remote ischemic preconditioning
5261227|NCT02381509|inferior vena cava filters|inferior vena cava filters
5261228|NCT02381496|ACT-453859|act-453859
5261229|NCT02381496|ACT-463036|act-463036
5261230|NCT02381496|Setipiprant|setipiprant
5261231|NCT02381496|Tolerability|tolerability
5261232|NCT02381496|safety|safety
5261233|NCT02381496|pharmacodynamics|pharmacodynamics
5261234|NCT02381496|pharmacokinetics|pharmacokinetics
5261235|NCT02381470|Beta lactams|beta lactams
5261236|NCT02381470|adjunctive therapy|adjunctive therapy
5261237|NCT02381470|drug-sensitive tuberculosis|drug-sensitive tuberculosis
5261243|NCT02381444|Advanced Parkinson's Disease|advanced parkinson's disease
5261244|NCT02381444|Levodopa Carbidopa Intestinal Gel|levodopa carbidopa intestinal gel
5261245|NCT02381444|Observational Study|observational study
5261246|NCT02381444|Quality of life|quality of life
5261247|NCT02381444|Jejunal Percutaneous Endoscopic Gastrostomy|jejunal percutaneous endoscopic gastrostomy
5261249|NCT02381431|diagnostic|diagnostic
5261250|NCT02381431|pediatrics|pediatrics
5261251|NCT02381418|Influenza|influenza
5261252|NCT02381418|Vaccine|vaccine
5261253|NCT02381418|Committee for Medicinal Products for Human Use (CHMP) criteria|committee for medicinal products for human use (chmp) criteria
5261254|NCT02381392|emergency medicine|emergency medicine
5261256|NCT02381392|intravenous|intravenous
5261257|NCT02381379|CML|cml
5261258|NCT02381379|peginterferon|peginterferon
5261259|NCT02381379|stop|stop
5261260|NCT02381379|BCR-ABL|bcr-abl
5261261|NCT02381366|Mesenchymal Stem Cells|mesenchymal stem cells
5261262|NCT02381366|Human Umbilical Cord Blood|human umbilical cord blood
5261263|NCT02381366|Premature Infants|premature infants
5261264|NCT02381366|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5261265|NCT02381366|Chronic Lung Disease|chronic lung disease
5261266|NCT02381366|Cell Therapy|cell therapy
5261267|NCT02381353|Enucleation|enucleation
5261268|NCT02381353|Evisceration|evisceration
5261269|NCT02381353|Exparel|exparel
5261270|NCT02381353|bupivacaine|bupivacaine
5261271|NCT02381340|Obesity|obesity
5261272|NCT02381340|Bariatric surgery|bariatric surgery
5261273|NCT02381340|Gastric plication|gastric plication
5261274|NCT02381340|Minimal invasive surgery|minimal invasive surgery
5261275|NCT02381340|gastrointestinal hormones|gastrointestinal hormones
5261276|NCT02381340|food-reward|food-reward
5261277|NCT02381340|satiety|satiety
5261278|NCT02381340|microbiota|microbiota
5261279|NCT02381327|Speed of eating|speed of eating
5261280|NCT02381327|body weight|body weight
5261281|NCT02381327|food intake|food intake
5261282|NCT02381314|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
5261283|NCT02381301|Biological Markers|biological markers
5261284|NCT02381301|Multidetector Computed Tomography|multidetector computed tomography
5261285|NCT02381288|Drug therapy|drug therapy
5261286|NCT02381262|Fitbit|fitbit
5261287|NCT02381249|Esophagectomy|esophagectomy
5261288|NCT02381249|Gastrectomy|gastrectomy
5261289|NCT02381249|Octreotide|octreotide
5261290|NCT02381249|Somatostatin|somatostatin
5261291|NCT02381249|Appetite|appetite
5261292|NCT02381249|Hunger|hunger
5261293|NCT02381249|Glucagon-Like Peptide 1|glucagon-like peptide 1
5261294|NCT02381249|Peptide YY|peptide yy
5261295|NCT02381249|Reinforcement|reinforcement
5261296|NCT02381249|Reward|reward
5261297|NCT02381249|Psychological Phenomena and Processes|psychological phenomena and processes
5261298|NCT02381249|Gastrointestinal Agents|gastrointestinal agents
5261299|NCT02381249|Nutritional Status|nutritional status
5261300|NCT02381249|Pancreaticoduodenectomy|pancreaticoduodenectomy
5258620|NCT02396940|3D|3d
5261301|NCT02381249|Whipple Procedure|whipple procedure
5261302|NCT02381210|Congo Red Dot Test|congo red dot test
5261303|NCT02381197|Congo Red Dot Test|congo red dot test
5261304|NCT02381171|myofacial pain|myofacial pain
5261305|NCT02381171|neuromodulation|neuromodulation
5261306|NCT02381171|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5261307|NCT02381171|electroacupuncture|electroacupuncture
5261308|NCT02381158|Wheezing|wheezing
5261309|NCT02381158|Children|children
5261310|NCT02381145|Polyphenols|polyphenols
5261311|NCT02381145|Resveratrol|resveratrol
5261312|NCT02381145|Epigallocatechin-gallate|epigallocatechin-gallate
5261313|NCT02381145|Insulin sensitivity|insulin sensitivity
5261314|NCT02381145|mitochondrial function|mitochondrial function
5261315|NCT02381145|lipid oxidation|lipid oxidation
5261316|NCT02381145|tissue lipolysis|tissue lipolysis
5261317|NCT02381119|dietary services|dietary services
5261318|NCT02381119|personalized advice|personalized advice
5261319|NCT02381119|biological markers|biological markers
5261320|NCT02381106|arterial contractility|arterial contractility
5261321|NCT02381106|Uterine contractility|uterine contractility
5261322|NCT02381080|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5261323|NCT02381080|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5261324|NCT02381080|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5261325|NCT02381080|Marginal Zone Lymphoma|marginal zone lymphoma
5261326|NCT02381080|Mantle Cell Lymphoma|mantle cell lymphoma
5261327|NCT02381080|Follicular Lymphoma|follicular lymphoma
5261328|NCT02381080|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5261329|NCT02381080|Ibrutinib|ibrutinib
5261330|NCT02381080|IMBRUVICA|imbruvica
5261331|NCT02381080|PCI-32765|pci-32765
5261332|NCT02381080|JNJ-54179060|jnj-54179060
5261333|NCT02381067|Cervical Fusion|cervical fusion
5261335|NCT02381067|Amniotic Allograft|amniotic allograft
5261336|NCT02381067|Prospective|prospective
5261337|NCT02381054|Patient reported outcomes|patient reported outcomes
5261338|NCT02381041|Rhinoplasty|rhinoplasty
5261339|NCT02381041|Topical Vasonconstrictor|topical vasonconstrictor
5261340|NCT02381041|Cocaine|cocaine
5261341|NCT02381041|Adrenaline|adrenaline
5261342|NCT02381028|Atopic eczema|atopic eczema
5261343|NCT02381028|Human milk|human milk
5261344|NCT02381028|Topical treatment|topical treatment
5261345|NCT02381028|Children|children
5261346|NCT02381015|Genetic testing|genetic testing
5261351|NCT02381015|Predictive Genetic Testing|predictive genetic testing
5261352|NCT02381015|Genetic Counseling|genetic counseling
5261353|NCT02381015|Prostate-Specific Antigen|prostate-specific antigen
5262952|NCT02372032|Discectomy|discectomy
5261354|NCT02381002|Serum ferritin, physical exercise, Diet|serum ferritin, physical exercise, diet
5261355|NCT02380989|Ayurveda|ayurveda
5261356|NCT02380989|Acute pain|acute pain
5261357|NCT02380989|Sports Injury|sports injury
5261358|NCT02380963|Soy|soy
5261359|NCT02380963|Obesity|obesity
5261360|NCT02380963|Weight Loss|weight loss
5261361|NCT02380963|Muscle|muscle
5261362|NCT02380963|Cardiovascular Disease|cardiovascular disease
5261363|NCT02380963|Colorado Diet|colorado diet
5261364|NCT02380937|real-time MRI|real-time mri
5261365|NCT02380937|electrophysiology study|electrophysiology study
5261366|NCT02380937|atrial flutter|atrial flutter
5261367|NCT02380937|ablation|ablation
5261368|NCT02380937|active tracking|active tracking
5261369|NCT02380924|subjects|subjects
5261370|NCT02380911|Dyslipidemia|dyslipidemia
5261371|NCT02380911|Global cardiovascular risk|global cardiovascular risk
5261372|NCT02380911|Statins|statins
5261373|NCT02380911|Educational interventions|educational interventions
5261374|NCT02380885|severe mental illness|severe mental illness
5261375|NCT02380885|social cognition|social cognition
5261376|NCT02380885|intervention|intervention
5261377|NCT02380872|Gingival recession|gingival recession
5261378|NCT02380872|fibrin|fibrin
5261379|NCT02380872|connective tissue|connective tissue
5261380|NCT02380872|gingival crevicular fluid|gingival crevicular fluid
5261381|NCT02380872|matrix metalloproteinase|matrix metalloproteinase
5261382|NCT02380872|cytokine|cytokine
5261383|NCT02380859|problems of gait and balance|problems of gait and balance
5261384|NCT02380820|Mattress|mattress
5261385|NCT02380820|Preventing bed sores|preventing bed sores
5261386|NCT02380820|Skin pressure|skin pressure
5261387|NCT02380807|Paraspinal Muscles|paraspinal muscles
5261388|NCT02380807|Trigger Points|trigger points
5261389|NCT02380807|Randomized Controlled Trial|randomized controlled trial
5261390|NCT02380807|Mobility Limitation|mobility limitation
5261391|NCT02380794|Danshen Gegen Capsule|danshen gegen capsule
5261392|NCT02380768|Supraglottic airway|supraglottic airway
5261393|NCT02380768|Laryngeal mask airway|laryngeal mask airway
5261394|NCT02380768|Children|children
5261395|NCT02380755|Flow-mediated dilatation|flow-mediated dilatation
5261396|NCT02380755|Clomiphene citrate|clomiphene citrate
5261397|NCT02380755|sICAM-1|sicam-1
5261398|NCT02380755|sVCAM-1|svcam-1
5261399|NCT02380755|sE- Selectin|se- selectin
5261400|NCT02380755|Endothelial function|endothelial function
5248944|NCT02451514|Healthy Adolescents|healthy adolescents
5248945|NCT02451514|MenABCWY vaccine|menabcwy vaccine
5261404|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators
5261406|NCT02380755|Endothelial Progenitor Cells|endothelial progenitor cells
5261408|NCT02380755|Testosterone|testosterone
5261409|NCT02380742|Pessary|pessary
5261410|NCT02380742|Pain|pain
5261411|NCT02380742|EMLA|emla
5261412|NCT02380742|lidocaine|lidocaine
5261413|NCT02380742|prilocaine|prilocaine
5261414|NCT02380729|Health care delivery|health care delivery
5261415|NCT02380729|Human Phenotype Ontology|human phenotype ontology
5261416|NCT02380729|Mutation prioritization|mutation prioritization
5261417|NCT02380729|Next Generation Sequencing|next generation sequencing
5261418|NCT02380729|Mutation detection|mutation detection
5261419|NCT02380729|Bioinformatic analysis|bioinformatic analysis
5261420|NCT02380729|Quality of life|quality of life
5261421|NCT02380703|aggression|aggression
5261422|NCT02380703|dementia|dementia
5261423|NCT02380703|Alzheimer's disease|alzheimer's disease
5261424|NCT02380703|pain|pain
5261425|NCT02380703|depression|depression
5261426|NCT02380703|caregiver|caregiver
5261427|NCT02380703|behavioral health|behavioral health
5261428|NCT02380703|counseling|counseling
5261429|NCT02380690|self-management|self-management
5261430|NCT02380690|peer support|peer support
5261431|NCT02380690|social support|social support
5261432|NCT02380664|swimmers|swimmers
5261433|NCT02380664|adolescent swimmers|adolescent swimmers
5261434|NCT02380664|whole-body vibration|whole-body vibration
5261435|NCT02380664|bone and bones|bone and bones
5261436|NCT02380664|body composition|body composition
5261437|NCT02380625|Ebola|ebola
5261438|NCT02380625|EVD|evd
5261439|NCT02380625|Adaptive design|adaptive design
5261440|NCT02380625|therapeutics|therapeutics
5261441|NCT02380612|Second Degree Burn Injuries|second degree burn injuries
5261442|NCT02380599|Spinal Manipulation|spinal manipulation
5261443|NCT02380599|Mobilization|mobilization
5261444|NCT02380599|Autonomic Nervous System|autonomic nervous system
5261445|NCT02380573|methylene blue|methylene blue
5261446|NCT02380573|fMRI|fmri
5261447|NCT02380560|myometrial thickness|myometrial thickness
5261448|NCT02380560|Preterm premature rupture of membranes|preterm premature rupture of membranes
5261449|NCT02380560|Preterm Labour|preterm labour
5261450|NCT02380547|Sonography|sonography
5261451|NCT02380547|Diaphragmatic function|diaphragmatic function
5261452|NCT02380547|Non invasive ventilation|non invasive ventilation
5261453|NCT02380547|Critical care patients|critical care patients
5262953|NCT02372032|Ozone|ozone
5261456|NCT02380521|Exenatide once weekly|exenatide once weekly
5261457|NCT02380521|T2DM|t2dm
5261458|NCT02380521|IMT|imt
5261459|NCT02380521|Atherogenic lipoproteins|atherogenic lipoproteins
5261461|NCT02380495|Adolescents|adolescents
5261462|NCT02380495|Respiratory Pathology|respiratory pathology
5261463|NCT02380482|Traumatic brain injury|traumatic brain injury
5261464|NCT02380482|Myocardial dysfunction|myocardial dysfunction
5261465|NCT02380482|Transthoracic echocardiography|transthoracic echocardiography
5261466|NCT02380482|Speckle tracking|speckle tracking
5261467|NCT02380469|Caregivers|caregivers
5261468|NCT02380469|Cancer|cancer
5261469|NCT02380469|Information|information
5261470|NCT02380469|Intervention|intervention
5261471|NCT02380469|Randomised trial|randomised trial
5261472|NCT02380443|colorectal cancer|colorectal cancer
5261473|NCT02380443|KRAS mutant|kras mutant
5261474|NCT02380443|BRAF mutant|braf mutant
5261475|NCT02380443|metastatic|metastatic
5261476|NCT02380443|liver metastasis|liver metastasis
5261477|NCT02380443|AlloStim®|allostim®
5261478|NCT02380443|cryoablation|cryoablation
5261479|NCT02380443|cancer vaccine|cancer vaccine
5261480|NCT02380443|immunotherapy|immunotherapy
5261481|NCT02380443|MSI-S|msi-s
5261482|NCT02380430|Ambulatory surgery|ambulatory surgery
5261483|NCT02380430|Pain management|pain management
5261484|NCT02380430|Nausea and vomiting management|nausea and vomiting management
5261485|NCT02380430|Questionnaire|questionnaire
5261486|NCT02380430|Survey|survey
5261487|NCT02380430|Management|management
5261488|NCT02380404|Edentulous maxilla|edentulous maxilla
5261489|NCT02380391|Platelet reactivity|platelet reactivity
5261490|NCT02380391|Acute coronary syndrome|acute coronary syndrome
5261491|NCT02380391|Antiplatelet treatment|antiplatelet treatment
5261492|NCT02380391|Antiretroviral treatment|antiretroviral treatment
5261493|NCT02380391|HIV|hiv
5261494|NCT02380365|lung transplantation|lung transplantation
5261495|NCT02380365|electrocardiography|electrocardiography
5261496|NCT02380365|macrolides|macrolides
5261503|NCT02380313|Enzalutamide|enzalutamide
5261504|NCT02380313|Abiraterone|abiraterone
5261505|NCT02380313|Dose-Finding|dose-finding
5261508|NCT02380287|maximum tolerated dose|maximum tolerated dose
5261509|NCT02380287|novel monoclonal antibody|novel monoclonal antibody
5261513|NCT02380222|Systemic mastocytosis|systemic mastocytosis
5261514|NCT02380222|Patient-reported outcome (PRO)|patient-reported outcome (pro)
5261516|NCT02380209|CEST MRI|cest mri
5261517|NCT02380183|anesthesia|anesthesia
5261518|NCT02380183|nerve block|nerve block
5261519|NCT02380183|needle guidance|needle guidance
5261520|NCT02380170|sepsis|sepsis
5261521|NCT02380170|urinary tract infection|urinary tract infection
5261522|NCT02380170|resistance|resistance
5261523|NCT02380170|pathogens|pathogens
5261524|NCT02380170|mortality|mortality
5261525|NCT02380170|health economics|health economics
5261526|NCT02380157|Blood pressure|blood pressure
5261527|NCT02380157|Potassium, Dietary|potassium, dietary
5361223|NCT01896219|CT|ct
5261528|NCT02380157|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5261529|NCT02380157|Sympathetic nervous system|sympathetic nervous system
5261530|NCT02380144|carotenoid|carotenoid
5261531|NCT02380144|bioavailability|bioavailability
5261532|NCT02380144|beta-cryptoxanthin|beta-cryptoxanthin
5261533|NCT02380144|flavonoid|flavonoid
5261534|NCT02380144|hesperidin|hesperidin
5261535|NCT02380144|narirutin|narirutin
5261536|NCT02380144|randomized cross-over|randomized cross-over
5261537|NCT02380144|Pharmacokinetics|pharmacokinetics
5261538|NCT02380144|micronutrients|micronutrients
5261539|NCT02380144|Oranges/Orange Juice|oranges/orange juice
5261540|NCT02380131|XELOX|xelox
5261541|NCT02380131|Herceptin|herceptin
5261542|NCT02380131|Potentially Resectable Gastric Cancer|potentially resectable gastric cancer
5261543|NCT02380118|emergency|emergency
5261544|NCT02380118|emergency medicine|emergency medicine
5261545|NCT02380118|sedation|sedation
5261546|NCT02380118|acute agitation|acute agitation
5261547|NCT02380092|Knee|knee
5261548|NCT02380092|Post-Market Surveillance|post-market surveillance
5261549|NCT02380092|Legion|legion
5261550|NCT02380092|Verilast|verilast
5261551|NCT02380092|Degenerative Joint Disease|degenerative joint disease
5261552|NCT02380079|Homozygous Sickle Cell Disease S/Beta 0 Thalassemia|homozygous sickle cell disease s/beta 0 thalassemia
5261553|NCT02380053|Beta-blocker|beta-blocker
5261554|NCT02380053|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5261555|NCT02380027|Prostate biopsy|prostate biopsy
5261557|NCT02380027|transrectal|transrectal
5261558|NCT02380027|Detection|detection
5261559|NCT02380001|Postoperative pain|postoperative pain
5261560|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol
5261561|NCT02380001|third molar surgery|third molar surgery
5261562|NCT02379962|biobanking|biobanking
5261563|NCT02379962|research participation|research participation
5261564|NCT02379962|China|china
5261565|NCT02379949|virtual reality exposure therapy|virtual reality exposure therapy
5261566|NCT02379949|social phobia|social phobia
5261567|NCT02379949|social anxiety disorder|social anxiety disorder
5261568|NCT02379949|cognitive behavioral therapy|cognitive behavioral therapy
5261569|NCT02379936|Classification|classification
5261570|NCT02379936|HIE|hie
5261571|NCT02379936|Infections|infections
5261572|NCT02379936|Lactate dehydrogenase|lactate dehydrogenase
5261573|NCT02379936|Intensive Care|intensive care
5261574|NCT02379884|Mechanical ventilation|mechanical ventilation
5261575|NCT02379884|Elderly|elderly
5261576|NCT02379884|Mortality|mortality
5261577|NCT02379884|Health services|health services
5261578|NCT02379871|Thoracic Spinal Manipulation, Autonomic Nervous System|thoracic spinal manipulation, autonomic nervous system
5261579|NCT02379858|GI Tract Recovery|gi tract recovery
5261580|NCT02379858|Hospital Discharge|hospital discharge
5261581|NCT02379832|preeclampsia|preeclampsia
5261582|NCT02379832|preterm birth|preterm birth
5261583|NCT02379832|pregnancy|pregnancy
5261584|NCT02379832|placenta|placenta
5261585|NCT02379832|intra-uterine growth restriction|intra-uterine growth restriction
5261586|NCT02379832|fetal growth restriction|fetal growth restriction
5261587|NCT02379832|ultrasound|ultrasound
5261588|NCT02379832|doppler|doppler
5261589|NCT02379832|biomarkers|biomarkers
5261590|NCT02379832|serum|serum
5261591|NCT02379832|PAPP-A|papp-a
5261592|NCT02379832|PlGF|plgf
5261593|NCT02379832|sFlt-1|sflt-1
5261594|NCT02379832|endoglin|endoglin
5261595|NCT02379793|LEO 80185 gel|leo 80185 gel
5261596|NCT02379793|calcipotriol|calcipotriol
5261597|NCT02379793|betamethasone|betamethasone
5261598|NCT02379754|vestibular schwannoma|vestibular schwannoma
5261600|NCT02379754|cerebellopontine angle tumour|cerebellopontine angle tumour
5261601|NCT02379754|gentamicin|gentamicin
5261602|NCT02379754|rehabilitation|rehabilitation
5261603|NCT02379754|postural balance|postural balance
5261604|NCT02379741|Antibodies|antibodies
5261605|NCT02379741|Antibodies, Monoclonal|antibodies, monoclonal
5261606|NCT02379741|Antineoplastic agent|antineoplastic agent
5261607|NCT02379741|Physiological effects of drugs|physiological effects of drugs
5261609|NCT02379741|Clinical Trial, Phase I|clinical trial, phase i
5261610|NCT02379741|Immunotherapy, Active|immunotherapy, active
5261611|NCT02379741|CD40 Antigen|cd40 antigen
5261612|NCT02379741|Immunologic Factors|immunologic factors
5261613|NCT02379741|Injections, Intralesional|injections, intralesional
5261614|NCT02379728|positional therapy|positional therapy
5261615|NCT02379728|tennis ball technique|tennis ball technique
5261616|NCT02379728|sleep pregnancy|sleep pregnancy
5261617|NCT02379728|supine position|supine position
5261618|NCT02379728|supine|supine
5261619|NCT02379728|sleep position|sleep position
5261620|NCT02379728|low birth weight|low birth weight
5261621|NCT02379728|stillbirth|stillbirth
5261622|NCT02379728|intrauterine growth restriction|intrauterine growth restriction
5261623|NCT02379715|Remifentanil|remifentanil
5261624|NCT02379715|smooth induction|smooth induction
5261625|NCT02379715|desflurane|desflurane
5261626|NCT02379689|psychosocial state|psychosocial state
5261627|NCT02379637|N-acetylcysteine|n-acetylcysteine
5261628|NCT02379637|adults|adults
5261629|NCT02379637|cough and cold|cough and cold
5261630|NCT02379572|5-ALA|5-ala
5261631|NCT02379572|Intraoperative MRI|intraoperative mri
5261632|NCT02379572|Extent of resection|extent of resection
5261633|NCT02379559|prostate cancer|prostate cancer
5261634|NCT02379559|African-American|african-american
5261635|NCT02379559|Metabolic Syndrome|metabolic syndrome
5261636|NCT02379559|Exercise|exercise
5261637|NCT02379559|Men's Health|men's health
5261638|NCT02379546|reflex, oculocardiac|reflex, oculocardiac
5261639|NCT02379546|monitoring, intraoperative|monitoring, intraoperative
5261640|NCT02379520|recurrent cancer|recurrent cancer
5261641|NCT02379520|refractory cancer|refractory cancer
5261642|NCT02379520|virus specific T-cells|virus specific t-cells
5261643|NCT02379520|gene therapy|gene therapy
5261645|NCT02379507|mild to moderate|mild to moderate
5261646|NCT02379468|Diabetic|diabetic
5261647|NCT02379468|Foot|foot
5261648|NCT02379468|Ulcer|ulcer
5261649|NCT02379455|Polypharmacy|polypharmacy
5261650|NCT02379455|Geriatrics|geriatrics
5261651|NCT02379455|Elderly|elderly
5261652|NCT02379455|Drug review|drug review
5261653|NCT02379442|Graft-Versus-Host Disease|graft-versus-host disease
5261654|NCT02379442|Corticosteroids|corticosteroids
5261655|NCT02379442|Mesenchymal Stromal Cell|mesenchymal stromal cell
5263152|NCT02370745|Amino Acids|amino acids
5261664|NCT02379416|Bcr-Abl Kinase Inhibitors|bcr-abl kinase inhibitors
5261665|NCT02379416|Neoplasms|neoplasms
5261666|NCT02379403|Flavonoid|flavonoid
5261667|NCT02379403|Vascular|vascular
5261668|NCT02379403|Biomarkers|biomarkers
5261669|NCT02379403|Arterial Stiffness|arterial stiffness
5261670|NCT02379403|Nutrigenomics|nutrigenomics
5261671|NCT02379364|Physiotherapy|physiotherapy
5261672|NCT02379364|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5261673|NCT02379364|Manual therapy|manual therapy
5261674|NCT02379351|Non-stress Test|non-stress test
5261675|NCT02379351|Fetal Monitoring|fetal monitoring
5261676|NCT02379351|Telemedicine|telemedicine
5261677|NCT02379338|Dopamine D3 receptor|dopamine d3 receptor
5261678|NCT02379312|Foams|foams
5261679|NCT02379312|Satiety|satiety
5261680|NCT02379312|Appetite|appetite
5261681|NCT02379247|HER-2 Negative|her-2 negative
5261682|NCT02379247|Metastatic Breast Cancer|metastatic breast cancer
5261683|NCT02379234|CVVH|cvvh
5261684|NCT02379234|Renal replacement therapy|renal replacement therapy
5261685|NCT02379234|High fidelity simulation|high fidelity simulation
5261686|NCT02379234|Nurse training|nurse training
5261687|NCT02379208|Visual Field Tests|visual field tests
5261688|NCT02379208|Ocular Hypertension|ocular hypertension
5261689|NCT02379208|Glaucoma, Open-Angle|glaucoma, open-angle
5261690|NCT02379208|Quality of Life|quality of life
5261691|NCT02379208|Glaucoma progression|glaucoma progression
5261692|NCT02379208|Early glaucoma|early glaucoma
5261693|NCT02379208|Frequency Doubling Technology (FDT)|frequency doubling technology (fdt)
5261694|NCT02379208|RareBit|rarebit
5261695|NCT02379208|Octopus 900 perimetry|octopus 900 perimetry
5261696|NCT02379182|dysphagia|dysphagia
5261697|NCT02379182|VitalStim|vitalstim
5261698|NCT02379182|electrical stimulation|electrical stimulation
5261699|NCT02379169|macular pigment optical density, age related macular degeneration, dry eye, vision|macular pigment optical density, age related macular degeneration, dry eye, vision
5261700|NCT02379156|Quadriplegia|quadriplegia
5261701|NCT02379156|Spinal Cord Injury|spinal cord injury
5261702|NCT02379156|Body Temperature Regulation|body temperature regulation
5261703|NCT02379156|Mild Cognitive Impairment|mild cognitive impairment
5261704|NCT02379143|SWD, EPA, SAFE PRACTICE|swd, epa, safe practice
5261705|NCT02379130|Premature|premature
5261706|NCT02379130|Family Nurture Intervention|family nurture intervention
5261707|NCT02379091|Drug therapy|drug therapy
5261708|NCT02379078|Shared decision-making|shared decision-making
5261709|NCT02379078|Priority setting|priority setting
5261710|NCT02379078|Patient decision aid|patient decision aid
5261711|NCT02379078|Interprofessional care|interprofessional care
5261712|NCT02379078|Diabetes mellitus|diabetes mellitus
5261713|NCT02379078|Patient education|patient education
5261718|NCT02379078|Qualitative methods|qualitative methods
5261719|NCT02379013|Fatigue|fatigue
5261720|NCT02379013|functional MRI|functional mri
5261721|NCT02378987|cerebral palsy|cerebral palsy
5261722|NCT02378987|language|language
5261723|NCT02378987|acoustic|acoustic
5261724|NCT02378987|motor speech|motor speech
5261725|NCT02378987|follow-up|follow-up
5261726|NCT02378974|Cerebral Infarction|cerebral infarction
5261727|NCT02378974|Mesenchymal Stem Cells|mesenchymal stem cells
5261728|NCT02378974|Stroke|stroke
5261729|NCT02378948|Esophagectomy|esophagectomy
5261730|NCT02378948|Nutrition|nutrition
5261731|NCT02378948|Oral feeding|oral feeding
5261732|NCT02378948|Enteral feeding|enteral feeding
5261733|NCT02378948|Pulmonary complications|pulmonary complications
5261734|NCT02378948|Anastomotic leakage|anastomotic leakage
5261735|NCT02378948|Quality of life|quality of life
5261736|NCT02378896|Cognitive Behavioral Therapy|cognitive behavioral therapy
5261738|NCT02378883|Onyx|onyx
5261739|NCT02378883|Arteriovenous malformation|arteriovenous malformation
5261741|NCT02378883|Onyx™ Liquid Embolic System|onyx™ liquid embolic system
5261742|NCT02378883|Apollo™ Onyx™ Delivery Microcatheter|apollo™ onyx™ delivery microcatheter
5261743|NCT02378883|Brain Diseases|brain diseases
5261744|NCT02378870|CRPC|crpc
5261745|NCT02378857|Univentricular heart defect|univentricular heart defect
5261746|NCT02378857|Fontan circulation|fontan circulation
5261747|NCT02378831|diagnosing sleep|diagnosing sleep
5261748|NCT02378818|Schizophrenia|schizophrenia
5261749|NCT02378818|Negative symptoms|negative symptoms
5261750|NCT02378818|Lack of motivation|lack of motivation
5261751|NCT02378818|Cognitive characterization|cognitive characterization
5261752|NCT02378818|Computational psychiatry|computational psychiatry
5261753|NCT02378818|Depression|depression
5261754|NCT02378805|Alport syndrome|alport syndrome
5261755|NCT02378805|thin basement membrane disease|thin basement membrane disease
5261756|NCT02378805|familial benign hematuria|familial benign hematuria
5261757|NCT02378792|PINS VNS Refractory Epilepsy|pins vns refractory epilepsy
5261758|NCT02378779|Premature ejaculation|premature ejaculation
5261759|NCT02378779|general practice|general practice
5261760|NCT02378779|sexual dysfunction|sexual dysfunction
5261761|NCT02378766|tailored web-based intervention|tailored web-based intervention
5261762|NCT02378766|health behavior|health behavior
5261763|NCT02378766|hiv comorbidities|hiv comorbidities
5261764|NCT02378766|online trial|online trial
5261765|NCT02378753|Ebola|ebola
5261766|NCT02378753|Sierra Leone|sierra leone
5261767|NCT02378753|vaccine|vaccine
5261768|NCT02378753|rVSVΔG-ZEBOV|rvsvδg-zebov
5261769|NCT02378740|Anesthesia|anesthesia
5261770|NCT02378740|Cervical Fusion|cervical fusion
5261771|NCT02378740|Quality of Recovery|quality of recovery
5261772|NCT02378740|Ketamine Infusion|ketamine infusion
5261773|NCT02378714|Smoking Cessation|smoking cessation
5261774|NCT02378714|Major Depressive Disorder|major depressive disorder
5261775|NCT02378714|Nicotine Dependence|nicotine dependence
5261776|NCT02378714|Varenicline|varenicline
5261777|NCT02378714|Behavioral Activation Therapy|behavioral activation therapy
5261778|NCT02378714|Cigarette Smoking|cigarette smoking
5261779|NCT02378701|Leukemia|leukemia
5261780|NCT02378701|Myelodysplastic syndrome|myelodysplastic syndrome
5261782|NCT02378701|Low- or intermediate-1-risk|low- or intermediate-1-risk
5261783|NCT02378701|Chronic Myelomonocytic Leukemia -1|chronic myelomonocytic leukemia -1
5261784|NCT02378701|CMML-1|cmml-1
5261785|NCT02378701|Quality of Life in Myelodysplasia Scale|quality of life in myelodysplasia scale
5261786|NCT02378701|QUALMS-1|qualms-1
5261787|NCT02378701|Anemia Subset of FACT|anemia subset of fact
5261788|NCT02378701|FACT-An|fact-an
5261789|NCT02378701|Questionnaires|questionnaires
5261790|NCT02378701|Surveys|surveys
5261791|NCT02378688|Crohn's Disease|crohn's disease
5261792|NCT02378675|Adipocytokines|adipocytokines
5261793|NCT02378662|Peritoneal Dialysis|peritoneal dialysis
5261794|NCT02378662|End Stage Renal Disease|end stage renal disease
5261795|NCT02378662|Anemia|anemia
5261796|NCT02378649|Pulmonary Hypertension|pulmonary hypertension
5261797|NCT02378623|paradoxical embolism|paradoxical embolism
5261798|NCT02378623|lead thrombus|lead thrombus
5261799|NCT02378623|ICD|icd
5261800|NCT02378623|Pacemaker|pacemaker
5261801|NCT02378623|Cognitive decline|cognitive decline
5261802|NCT02378623|Stroke|stroke
5261803|NCT02378623|TIA|tia
5261804|NCT02378597|Resiliency burnout stress|resiliency burnout stress
5261805|NCT02378571|Medication adherence|medication adherence
5261806|NCT02378571|Hospital readmissions|hospital readmissions
5261807|NCT02378558|Breast Surgery|breast surgery
5261808|NCT02378545|Sepsis|sepsis
5261809|NCT02378545|Hyperoxia|hyperoxia
5261810|NCT02378545|Sepsis Six|sepsis six
5261811|NCT02378545|Oxygen delivery|oxygen delivery
5261812|NCT02378532|Glioblastoma|glioblastoma
5261813|NCT02378532|Chloroquine|chloroquine
5261814|NCT02378532|Autophagy|autophagy
5261815|NCT02378532|EGFRvIII|egfrviii
5261816|NCT02378532|Radiotherapy|radiotherapy
5261817|NCT02378532|Temozolomide|temozolomide
5261818|NCT02378519|Low back pain,|low back pain,
5261819|NCT02378519|neck pain,|neck pain,
5261820|NCT02378519|chronic pain|chronic pain
5261821|NCT02378519|SSED|ssed
5261822|NCT02378519|Pilot project|pilot project
5261823|NCT02378519|interactive web-based self-help programme|interactive web-based self-help programme
5261824|NCT02378519|CBT-coaching|cbt-coaching
5261825|NCT02378519|physiotherapy|physiotherapy
5261826|NCT02378493|Antibiogramme|antibiogramme
5261827|NCT02378493|Antibiofilmogramme|antibiofilmogramme
5261828|NCT02378467|Cystic Fibrosis|cystic fibrosis
5261829|NCT02378467|Hypertonic Saline|hypertonic saline
5261830|NCT02378467|Inhaled Saline|inhaled saline
5261831|NCT02378467|Digestive System Diseases|digestive system diseases
5261832|NCT02378467|Genetic Diseases, Inborn|genetic diseases, inborn
5261833|NCT02378467|Lung Diseases|lung diseases
5261834|NCT02378467|Pancreatic Diseases|pancreatic diseases
5261835|NCT02378467|Pathologic Processes|pathologic processes
5261836|NCT02378467|Respiratory Tract Diseases|respiratory tract diseases
5261837|NCT02378454|Lung Clearance Index|lung clearance index
5261838|NCT02378454|Cystic Fibrosis|cystic fibrosis
5261839|NCT02378454|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
5261840|NCT02378441|volunteers|volunteers
5261841|NCT02378428|Neuroblastoma|neuroblastoma
5261842|NCT02378415|Depression|depression
5261843|NCT02378402|Creatine|creatine
5261844|NCT02378402|heart failure|heart failure
5261845|NCT02378402|lipid|lipid
5261847|NCT02378402|myocardium|myocardium
5261848|NCT02378324|Attendance|attendance
5261849|NCT02378324|Screening without fee|screening without fee
5261850|NCT02378311|Bike|bike
5261851|NCT02378311|Bicycle|bicycle
5157117|NCT03009890|RCT|rct
5261852|NCT02378311|Scooter|scooter
5261853|NCT02378311|Handlebar|handlebar
5261854|NCT02378285|recent lateral humeral epicondylitis|recent lateral humeral epicondylitis
5261855|NCT02378285|platelet-rich plasma|platelet-rich plasma
5261856|NCT02378285|infiltration|infiltration
5261857|NCT02378285|tennis elbow|tennis elbow
5261858|NCT02378285|ultrasonography|ultrasonography
5261859|NCT02378272|Care Manager|care manager
5261860|NCT02378272|Primary Care|primary care
5261861|NCT02378272|Depressive symptoms|depressive symptoms
5261862|NCT02378272|quality of life|quality of life
5261863|NCT02378272|return to work|return to work
5261864|NCT02378246|Iodine|iodine
5261865|NCT02378246|Double-Blind Method|double-blind method
5261866|NCT02378246|Randomized Controlled Tria|randomized controlled tria
5261867|NCT02378246|Cognitive Development|cognitive development
5261868|NCT02378233|Iodine|iodine
5261869|NCT02378233|Double-Blind Method|double-blind method
5261870|NCT02378233|Randomized Controlled Trial|randomized controlled trial
5261871|NCT02378220|Home Care Agencies|home care agencies
5261872|NCT02378220|Home Health Care Agencies|home health care agencies
5261873|NCT02378220|Home Health Care Nursing|home health care nursing
5261874|NCT02378220|Home Health Nurses|home health nurses
5261875|NCT02378220|CYP 2D6|cyp 2d6
5261876|NCT02378220|CYP 2C9|cyp 2c9
5261877|NCT02378220|CYP 2C19|cyp 2c19
5261878|NCT02378220|CYP 3A4|cyp 3a4
5261879|NCT02378220|CYP 3A5|cyp 3a5
5261880|NCT02378194|in stage 3 or 4 steps|in stage 3 or 4 steps
5261881|NCT02378168|postconditioning|postconditioning
5261882|NCT02378168|six month follow up|six month follow up
5261883|NCT02378168|cardiac event|cardiac event
5261884|NCT02378168|non-cardiac event|non-cardiac event
5261885|NCT02378155|cardioversion|cardioversion
5261886|NCT02378155|atrial fibrillation|atrial fibrillation
5261887|NCT02378129|Dentin Sensitivity|dentin sensitivity
5261888|NCT02378129|Dentin Desensitizing Agents|dentin desensitizing agents
5261889|NCT02378129|Glass Ionomer Cements|glass ionomer cements
5261890|NCT02378129|Randomized Controlled Trial|randomized controlled trial
5261891|NCT02378103|Aortic Dissection|aortic dissection
5261892|NCT02378103|Chinese XinJiang Province|chinese xinjiang province
5261893|NCT02378077|Obesity|obesity
5261894|NCT02378077|Insulin Resistance|insulin resistance
5261895|NCT02378064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5261896|NCT02378064|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
5261897|NCT02378064|Plaque, Atherosclerotic|plaque, atherosclerotic
5261898|NCT02378064|Renin-Angiotensin System|renin-angiotensin system
5261899|NCT02378038|PNT2258|pnt2258
5261900|NCT02378038|Richter's Transformation|richter's transformation
5261901|NCT02378038|NHL|nhl
5261902|NCT02378038|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5261903|NCT02378038|Lymphoma|lymphoma
5261904|NCT02378038|DLBCL|dlbcl
5261905|NCT02378038|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5261906|NCT02378038|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
5261907|NCT02378038|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5261908|NCT02378038|Lymphoma, B-cell|lymphoma, b-cell
5261909|NCT02378025|Chronic Pain|chronic pain
5261910|NCT02378025|Veterans|veterans
5261911|NCT02378025|Gulf War Illness|gulf war illness
5261923|NCT02377960|mHealth|mhealth
5261925|NCT02377947|Lactulose Retention Enema|lactulose retention enema
5261926|NCT02377947|Hepatic Encephalopathy, Grade 3 or 4 West Haven Criteria|hepatic encephalopathy, grade 3 or 4 west haven criteria
5261927|NCT02377947|The Retro Study|the retro study
5261928|NCT02377934|Pulmonary Hypertension|pulmonary hypertension
5261929|NCT02377934|Cardiac MRT|cardiac mrt
5261930|NCT02377934|Radiotherapy|radiotherapy
5261931|NCT02377921|GNE Myopathy|gne myopathy
5261932|NCT02377921|GNEM|gnem
5261933|NCT02377921|HIBM|hibm
5261934|NCT02377921|Nonaka|nonaka
5261935|NCT02377921|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5261936|NCT02377921|DMRV|dmrv
5261937|NCT02377882|Intra-operative neuromonitoring|intra-operative neuromonitoring
5261938|NCT02377882|Neuromuscular blocking agent|neuromuscular blocking agent
5261939|NCT02377882|Rocuronium|rocuronium
5261940|NCT02377882|Thyroid surgery|thyroid surgery
5261941|NCT02377856|acute hepatitis C|acute hepatitis c
5261942|NCT02377856|treatment|treatment
5261944|NCT02377843|vaccine|vaccine
5261945|NCT02377843|physician training|physician training
5261946|NCT02377843|adolescent health|adolescent health
5261947|NCT02377817|positional therapy|positional therapy
5261948|NCT02377817|tennis ball technique|tennis ball technique
5261949|NCT02377817|sleep in pregnancy|sleep in pregnancy
5261950|NCT02377817|supine|supine
5261951|NCT02377817|polysomnography|polysomnography
5261952|NCT02377817|sleep position|sleep position
5261953|NCT02377817|supine position|supine position
5261954|NCT02377804|dry needling|dry needling
5261955|NCT02377804|spasticity|spasticity
5261956|NCT02377804|pain|pain
5261957|NCT02377791|tacrolimus|tacrolimus
5263256|NCT02370173|fMRI|fmri
5261960|NCT02377791|FK506|fk506
5261961|NCT02377791|Prograf|prograf
5261962|NCT02377791|Rejection|rejection
5261963|NCT02377791|Gene Polymorphism|gene polymorphism
5157155|NCT03009656|Stroke|stroke
5261964|NCT02377765|Neuromodulation|neuromodulation
5261965|NCT02377765|Detrusor overactivity|detrusor overactivity
5261966|NCT02377765|Urinary urgency|urinary urgency
5261967|NCT02377765|Urgency urinary incontinence|urgency urinary incontinence
5261968|NCT02377726|Randomized Controlled Trial|randomized controlled trial
5261969|NCT02377726|Alcohol|alcohol
5261970|NCT02377726|Internet|internet
5261971|NCT02377726|Internet based therapy|internet based therapy
5261972|NCT02377726|Cognitive behavioral therapy|cognitive behavioral therapy
5261973|NCT02377713|KHK6640|khk6640
5261974|NCT02377713|Phase 1|phase 1
5261975|NCT02377713|Japanese|japanese
5261976|NCT02377713|single dose|single dose
5261977|NCT02377713|Alzheimer's disease|alzheimer's disease
5261978|NCT02377687|Emergency surgery|emergency surgery
5261979|NCT02377687|HRQoL|hrqol
5261980|NCT02377687|Elderly|elderly
5261981|NCT02377648|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5261982|NCT02377648|Heart Transplant|heart transplant
5261983|NCT02377648|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5261984|NCT02377635|Arsenic|arsenic
5261985|NCT02377635|Arsenicosis|arsenicosis
5261986|NCT02377609|Dry Blood Spot (DBS)|dry blood spot (dbs)
5261987|NCT02377609|Validation|validation
5261988|NCT02377609|Tacrolimus|tacrolimus
5261989|NCT02377609|Bioanalytical assay method cross-validation|bioanalytical assay method cross-validation
5261990|NCT02377596|Feeding|feeding
5261991|NCT02377596|difficulties|difficulties
5261992|NCT02377596|disorders|disorders
5261993|NCT02377596|childhood|childhood
5261994|NCT02377596|eating|eating
5261995|NCT02377557|Dermatologic Agent|dermatologic agent
5261996|NCT02377531|early glucose screen, perinatal outcome|early glucose screen, perinatal outcome
5261999|NCT02377466|Spontaneous Preterm Labor|spontaneous preterm labor
5262000|NCT02377466|GSK221149|gsk221149
5262001|NCT02377466|Retosiban|retosiban
5262002|NCT02377453|stroke|stroke
5262003|NCT02377453|participation|participation
5262004|NCT02377453|brain imaging|brain imaging
5262005|NCT02377453|biomechanical|biomechanical
5262006|NCT02377440|ACE inhibitor|ace inhibitor
5262007|NCT02377427|pharmacokinetics|pharmacokinetics
5262009|NCT02377427|Mepolizumab|mepolizumab
5262010|NCT02377427|subcutaneous|subcutaneous
5262011|NCT02377427|eosinophilic asthma|eosinophilic asthma
5262012|NCT02377427|pharmacodynamics|pharmacodynamics
5262013|NCT02377414|Preterm labor|preterm labor
5262014|NCT02377414|Retosiban|retosiban
5262015|NCT02377414|Pharmacokinetics|pharmacokinetics
5262016|NCT02377414|Safety|safety
5262017|NCT02377414|Infusion|infusion
5262018|NCT02377414|GSK2847065|gsk2847065
5262019|NCT02377401|healthy volunteer|healthy volunteer
5262020|NCT02377401|Zanamivir|zanamivir
5262021|NCT02377401|pharmacokinetics|pharmacokinetics
5262022|NCT02377401|intravenous|intravenous
5262023|NCT02377388|diabetes mellitus|diabetes mellitus
5262024|NCT02377388|platelet function testing|platelet function testing
5262025|NCT02377388|acute coronary syndromes|acute coronary syndromes
5262026|NCT02377388|saxagliptin|saxagliptin
5262027|NCT02377388|sitagliptin|sitagliptin
5262028|NCT02377388|dpp-4 inhibitors|dpp-4 inhibitors
5262029|NCT02377375|Deep Brain Stimulation|deep brain stimulation
5262030|NCT02377375|OCD|ocd
5262031|NCT02377336|GS-6615|gs-6615
5262032|NCT02377336|coronary heart disease|coronary heart disease
5262033|NCT02377336|angina pectoris|angina pectoris
5262034|NCT02377336|late sodium current|late sodium current
5262035|NCT02377336|myocardial ischemia|myocardial ischemia
5262036|NCT02377336|coronary artery disease|coronary artery disease
5262041|NCT02377323|Quality of Life|quality of life
5262042|NCT02377323|Cognition|cognition
5262043|NCT02377323|Rebif|rebif
5262048|NCT02377271|Bosentan|bosentan
5262049|NCT02377258|Lymphoma|lymphoma
5262050|NCT02377258|safety|safety
5262051|NCT02377258|biologic therapies|biologic therapies
5262052|NCT02377245|Juvenile|juvenile
5262053|NCT02377245|Inflammatory|inflammatory
5262054|NCT02377245|Rheumatism|rheumatism
5262055|NCT02377245|Pediatric-Onset inflammatory diseases|pediatric-onset inflammatory diseases
5262056|NCT02377206|PET|pet
5262057|NCT02377206|[18F]DPA-714|[18f]dpa-714
5262058|NCT02377206|cognitive decline|cognitive decline
5262059|NCT02377193|kidney transplant|kidney transplant
5263356|NCT02369510|bupivacaine|bupivacaine
5262060|NCT02377193|luminex method|luminex method
5262061|NCT02377193|simulect ATG|simulect atg
5157295|NCT03008876|neonate|neonate
5262062|NCT02377193|immunosuppression|immunosuppression
5262063|NCT02377180|musculoskeletal pain|musculoskeletal pain
5262064|NCT02377180|regional anesthesia|regional anesthesia
5262065|NCT02377180|diagnostic nerve block|diagnostic nerve block
5262066|NCT02377180|intramuscular capsaicin|intramuscular capsaicin
5262067|NCT02377180|referred pain|referred pain
5262068|NCT02377180|hyperalgesia|hyperalgesia
5262069|NCT02377180|experimental pain|experimental pain
5262070|NCT02377180|central hypersensitivity|central hypersensitivity
5423266|NCT01616446|children|children
5262071|NCT02377180|human experimental pain|human experimental pain
5262072|NCT02377154|keratometry|keratometry
5262073|NCT02377154|verion|verion
5262074|NCT02377154|iol|iol
5262075|NCT02377154|intraocular lens|intraocular lens
5262076|NCT02377154|iolmaster|iolmaster
5262077|NCT02377154|lenstar|lenstar
5262078|NCT02377154|pentacam|pentacam
5262079|NCT02377154|IOL calculation|iol calculation
5262080|NCT02377154|VERION Image Guided System|verion image guided system
5262081|NCT02377141|Oesophageal Variceal Bleed|oesophageal variceal bleed
5262082|NCT02377141|TIPSS|tipss
5262083|NCT02377141|Endoscopic Variceal Band Ligation|endoscopic variceal band ligation
5262084|NCT02377141|Decompensated Liver Disease|decompensated liver disease
5262085|NCT02377128|Study|study
5262086|NCT02377128|focus|focus
5262087|NCT02377128|ovarian|ovarian
5262088|NCT02377128|reserve|reserve
5262089|NCT02377115|Postoperative delirium|postoperative delirium
5262090|NCT02377115|Postoperative cognitive decline|postoperative cognitive decline
5262091|NCT02377115|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5262092|NCT02377115|Risk assessment|risk assessment
5262093|NCT02377115|Tablet computer|tablet computer
5262094|NCT02377115|Clinical screening tool|clinical screening tool
5262095|NCT02377089|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5262096|NCT02377089|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5262097|NCT02377063|colonic flora|colonic flora
5262098|NCT02377063|microbiomes|microbiomes
5262099|NCT02377050|Nutritional support|nutritional support
5262100|NCT02377037|Sitting|sitting
5262101|NCT02377037|Standing|standing
5262102|NCT02377037|Transitions|transitions
5262103|NCT02376998|Thoracic Aorta|thoracic aorta
5262104|NCT02376998|Trauma|trauma
5262105|NCT02376998|Endovascular|endovascular
5262106|NCT02376959|Anxiety|anxiety
5262107|NCT02376959|Complementary Therapies|complementary therapies
5262108|NCT02376959|energy therapies|energy therapies
5262109|NCT02376933|vertebral bodies|vertebral bodies
5262110|NCT02376933|vertebral fracture|vertebral fracture
5262111|NCT02376933|vertebral augmentation|vertebral augmentation
5262112|NCT02376933|radiotherapy|radiotherapy
5262113|NCT02376933|vertebroplasty|vertebroplasty
5262114|NCT02376933|kyphoplasty|kyphoplasty
5262115|NCT02376920|occular melanoma|occular melanoma
5262116|NCT02376920|melanoma of eye|melanoma of eye
5262117|NCT02376920|DecisionDx-UM|decisiondx-um
5262118|NCT02376907|distal malignant biliary obstruction|distal malignant biliary obstruction
5862738|NCT00001532|Cystic Fibrosis|cystic fibrosis
5262119|NCT02376907|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5262121|NCT02376907|gastric outlet obstruction|gastric outlet obstruction
5262122|NCT02376907|stent|stent
5262123|NCT02376881|Erythropoietin -Methanol - Optic Neuropathy|erythropoietin -methanol - optic neuropathy
5262124|NCT02376855|Health Services Accessibility|health services accessibility
5262125|NCT02376842|severe sepsis infection|severe sepsis infection
5262126|NCT02376829|Orthodontic|orthodontic
5262127|NCT02376829|Orthodontic Treatment|orthodontic treatment
5262128|NCT02376829|Clear Aligners|clear aligners
5262129|NCT02376829|Malocclusion|malocclusion
5262130|NCT02376816|DMD|dmd
5262131|NCT02376816|muscular dystrophy|muscular dystrophy
5262132|NCT02376816|dystrophin|dystrophin
5262133|NCT02376803|Randomized controlled trial|randomized controlled trial
5262134|NCT02376803|Warfarin|warfarin
5262135|NCT02376803|Time in therapeutic range|time in therapeutic range
5262136|NCT02376803|Bleeding|bleeding
5262137|NCT02376803|Thromboembolic|thromboembolic
5262138|NCT02376803|Hemorrhage|hemorrhage
5262139|NCT02376803|Anticoagulant|anticoagulant
5262140|NCT02376803|TTR|ttr
5262141|NCT02376803|Chronobiology|chronobiology
5262142|NCT02376803|Chronotherapeutic|chronotherapeutic
5262143|NCT02376803|Coumadin|coumadin
5262144|NCT02376803|INR|inr
5262145|NCT02376803|International normalized ratio|international normalized ratio
5262146|NCT02376803|RCT|rct
5262147|NCT02376790|Psoriatic Arthritis|psoriatic arthritis
5262148|NCT02376790|Arthritis, Psoriasis|arthritis, psoriasis
5262149|NCT02376790|Etanercept|etanercept
5262150|NCT02376790|Enbrel|enbrel
5262151|NCT02376790|Methotrexate|methotrexate
5262152|NCT02376790|Minimal Disease Activity|minimal disease activity
5262153|NCT02376777|Anticoagulants|anticoagulants
5262154|NCT02376777|Antithrombins|antithrombins
5262155|NCT02376777|Atrial Fibrillation|atrial fibrillation
5262156|NCT02376777|Intracranial haemorrhage|intracranial haemorrhage
5262157|NCT02376777|Gastrointestinal haemorrhage|gastrointestinal haemorrhage
5262158|NCT02376777|Myocardial infarction|myocardial infarction
5262159|NCT02376777|Stroke|stroke
5262160|NCT02376777|Venous thrombosis|venous thrombosis
5262161|NCT02376777|Primary care|primary care
5262162|NCT02376751|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
5262163|NCT02376751|Acid lipase disease|acid lipase disease
5262164|NCT02376751|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5262165|NCT02376751|LIPA Deficiency|lipa deficiency
5262166|NCT02376751|Wolman disease|wolman disease
5262167|NCT02376751|Lysosomal Storage Disease|lysosomal storage disease
5262168|NCT02376725|Goniosynechialysis|goniosynechialysis
5262169|NCT02376712|Acute Kidney Injury|acute kidney injury
5423267|NCT01616433|Arthritis|arthritis
5262202|NCT02376582|HIV/AIDS vaccine|hiv/aids vaccine
5262203|NCT02376582|helminth infection|helminth infection
5262204|NCT02376582|Impact of co-infection|impact of co-infection
5262205|NCT02376556|Dry eye syndrome|dry eye syndrome
5262207|NCT02376556|Muller muscle resection surgery|muller muscle resection surgery
5262208|NCT02376517|Health Behavior|health behavior
5262209|NCT02376517|Melanin Index|melanin index
5262210|NCT02376517|Spectrophotometry|spectrophotometry
5262211|NCT02376517|Sun Protective Clothing|sun protective clothing
5262212|NCT02376517|Education|education
5262213|NCT02376517|Primary Prevention|primary prevention
5262214|NCT02376439|siblings|siblings
5262215|NCT02376439|overweight|overweight
5262216|NCT02376439|adolescent|adolescent
5262217|NCT02376426|Healthy|healthy
5262218|NCT02376426|Ebola viruses|ebola viruses
5262219|NCT02376426|Ebola Viral Disease (EVD)|ebola viral disease (evd)
5262220|NCT02376426|Filoviruses|filoviruses
5262221|NCT02376426|Monovalent vaccine|monovalent vaccine
5262222|NCT02376426|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5262223|NCT02376426|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
5262224|NCT02376426|Safety|safety
5262225|NCT02376426|Immunogenicity|immunogenicity
5262226|NCT02376413|Morbidity|morbidity
5262227|NCT02376413|The Breast Cancer Treatment Outcome Scale|the breast cancer treatment outcome scale
5262228|NCT02376413|Disease free survival|disease free survival
5262229|NCT02376413|Positivity cavity margin rate|positivity cavity margin rate
5262230|NCT02376413|Harvard/NSABP/RTOG breast cosmesis grading scale|harvard/nsabp/rtog breast cosmesis grading scale
5262231|NCT02376400|Healthy|healthy
5262232|NCT02376400|Ebola viruses|ebola viruses
5262233|NCT02376400|Ebola Viral Disease (EVD)|ebola viral disease (evd)
5262234|NCT02376400|Filoviruses|filoviruses
5262235|NCT02376400|Monovalent vaccine|monovalent vaccine
5356870|NCT01917630|Gluten-free diet|gluten-free diet
5356871|NCT01917630|Coeliac disease|coeliac disease
5356872|NCT01917630|Celiac sprue|celiac sprue
5262236|NCT02376400|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5259506|NCT02391428|ADHD|adhd
5862745|NCT00001526|Uveitis|uveitis
5262237|NCT02376400|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
5262238|NCT02376400|Safety|safety
5262239|NCT02376400|Immunogenicity|immunogenicity
5262240|NCT02376374|transmission|transmission
5262241|NCT02376374|vaccine|vaccine
5262242|NCT02376361|Surveillance|surveillance
5262243|NCT02376348|VMMC|vmmc
5262244|NCT02376348|Adult males|adult males
5262245|NCT02376348|HIV Prevention|hiv prevention
5262246|NCT02376348|Africa|africa
5262247|NCT02376335|Fatigue|fatigue
5262248|NCT02376335|Primary Biliary Cirrhosis|primary biliary cirrhosis
5262249|NCT02376335|Rituximab|rituximab
5262250|NCT02376335|PBC-40|pbc-40
5262251|NCT02376296|metastatic prostate cancer|metastatic prostate cancer
5263761|NCT02367313|Cold|cold
5262257|NCT02376283|PPCI|ppci
5262258|NCT02376257|Cognitive behavior therapy (CBT)|cognitive behavior therapy (cbt)
5262259|NCT02376257|d-cycloserine (DCS)|d-cycloserine (dcs)
5262260|NCT02376257|Modafinil|modafinil
5423268|NCT01616433|Preventive Behaviors|preventive behaviors
5262266|NCT02376231|EOC Epithelial ovarian cancer|eoc epithelial ovarian cancer
5262267|NCT02376231|Surgery|surgery
5262268|NCT02376231|nil macroscopic residual disease|nil macroscopic residual disease
5262269|NCT02376231|Stage 3/4 Epithelial Ovarian Cancer requiring surgery|stage 3/4 epithelial ovarian cancer requiring surgery
5262270|NCT02376205|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5262271|NCT02376205|Dysphagia|dysphagia
5262272|NCT02376192|Microcirculation|microcirculation
5262273|NCT02376192|Sidestream Dark Field (SDF) Imaging|sidestream dark field (sdf) imaging
5262274|NCT02376192|Spinal Anesthesia|spinal anesthesia
5262275|NCT02376192|Phenylephrine|phenylephrine
5262276|NCT02376166|Prostate Cancer|prostate cancer
5262277|NCT02376140|micronutrient deficiency|micronutrient deficiency
5262278|NCT02376140|24-H recall|24-h recall
5262279|NCT02376140|West Africa|west africa
5262280|NCT02376140|Food consumption|food consumption
5262281|NCT02376127|Dynamic Contrast-Enhanced Perfusion|dynamic contrast-enhanced perfusion
5262282|NCT02376127|14-203|14-203
5262283|NCT02376114|ocular blood flow|ocular blood flow
5262284|NCT02376114|ginkgo biloba|ginkgo biloba
5262285|NCT02376114|glaucoma|glaucoma
5262286|NCT02376114|vasospasm|vasospasm
5262287|NCT02376062|Continuing Medical Education|continuing medical education
5262288|NCT02376062|Chronic Diseases|chronic diseases
5262289|NCT02376062|Nepal|nepal
5262290|NCT02376062|Implementation Research|implementation research
5262291|NCT02376049|Atopic Dermatitis|atopic dermatitis
5262292|NCT02376049|Eczema|eczema
5262294|NCT02376036|Normal healthy volunteer|normal healthy volunteer
5262295|NCT02376023|Cervical Cancer|cervical cancer
5262296|NCT02376023|Women|women
5262297|NCT02376023|Latina|latina
5262298|NCT02376023|Chile|chile
5262299|NCT02376023|Text Message|text message
5262300|NCT02376023|Technology|technology
5262301|NCT02376023|Screening|screening
5262302|NCT02376023|Cancer Prevention|cancer prevention
5262303|NCT02376023|Health Disparities|health disparities
5262304|NCT02376023|Mobile Health|mobile health
5262305|NCT02376010|atherosclerosis|atherosclerosis
5262306|NCT02376010|coronary artery disease|coronary artery disease
5262307|NCT02376010|cardiac CT|cardiac ct
5262308|NCT02376010|computed tomographic angiography|computed tomographic angiography
5262309|NCT02375971|intravitreal ranibizumab|intravitreal ranibizumab
5262310|NCT02375971|laser ablation therapy|laser ablation therapy
5262311|NCT02375971|retinopathy of prematurity|retinopathy of prematurity
5262312|NCT02375971|preterm infants|preterm infants
5262313|NCT02375971|RAINBOW|rainbow
5262319|NCT02375945|lymphedema|lymphedema
5262320|NCT02375945|post operative compression treatment|post operative compression treatment
5262321|NCT02375945|compression therapy|compression therapy
5262322|NCT02375945|adjustable fulcro wraps|adjustable fulcro wraps
5262323|NCT02375945|edema|edema
5262324|NCT02375932|Electronic Medical Records|electronic medical records
5262325|NCT02375932|Primary Health Care|primary health care
5262326|NCT02375932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5262327|NCT02375919|PERC rule|perc rule
5262328|NCT02375919|emergency department|emergency department
5262329|NCT02375919|pulmonary embolism|pulmonary embolism
5262330|NCT02375906|HDV, hepatitis delta|hdv, hepatitis delta
5262331|NCT02375893|Coronary disease|coronary disease
5262332|NCT02375893|Bile acids|bile acids
5262333|NCT02375893|Gut microbiota|gut microbiota
5262334|NCT02375893|Risk factors|risk factors
5262335|NCT02375893|Atherosclerosis|atherosclerosis
5262337|NCT02375854|acute kidney injury|acute kidney injury
5262338|NCT02375854|biomarkers|biomarkers
5262339|NCT02375854|chronic kidney disease|chronic kidney disease
5262340|NCT02375841|Communication|communication
5262341|NCT02375841|Physicians|physicians
5262342|NCT02375841|Patients|patients
5262343|NCT02375841|Caregivers|caregivers
5262344|NCT02375841|15-034|15-034
5262345|NCT02375828|Acceptability|acceptability
5262346|NCT02375828|Phase 3|phase 3
5249849|NCT02445872|Nausea|nausea
5262347|NCT02375828|Neonatal diabetes|neonatal diabetes
5262348|NCT02375815|statin|statin
5262349|NCT02375815|decision aid|decision aid
5262350|NCT02375802|Stem cells|stem cells
5262351|NCT02375789|Migraine Headache|migraine headache
5262352|NCT02375789|Cooling|cooling
5262353|NCT02375789|Intranasal|intranasal
5262354|NCT02375789|Rhinochill|rhinochill
5262355|NCT02375724|COPD|copd
5262356|NCT02375711|Chronic renal disease|chronic renal disease
5262357|NCT02375711|Hepatitis B vaccine|hepatitis b vaccine
5262358|NCT02375711|Biological Aging|biological aging
5262359|NCT02375685|Uveitis|uveitis
5262360|NCT02375685|Non-infectious Uveitis|non-infectious uveitis
5262361|NCT02375685|Intermediate Uveitis|intermediate uveitis
5262362|NCT02375685|Posterior Uveitis|posterior uveitis
5262363|NCT02375685|Behçet's disease uveitis|behçet's disease uveitis
5262364|NCT02375672|Pembrolizumab|pembrolizumab
5262365|NCT02375672|MK-3475|mk-3475
5262366|NCT02375607|Pain management|pain management
5262367|NCT02375581|Radiotherapy|radiotherapy
5262368|NCT02375581|Icotinib|icotinib
5262369|NCT02375568|mesenchymal stem cells|mesenchymal stem cells
5262370|NCT02375555|Multiple Myeloma|multiple myeloma
5262371|NCT02375516|Drug abuse|drug abuse
5262372|NCT02375503|Calcium|calcium
5262373|NCT02375503|Vitamin D|vitamin d
5262374|NCT02375503|Parathyroid Hormone|parathyroid hormone
5262375|NCT02375503|Bone|bone
5262376|NCT02375503|Microarchitecture|microarchitecture
5262377|NCT02375490|Exercise|exercise
5157636|NCT03006250|Desflurane|desflurane
5262378|NCT02375490|Eating Behavior|eating behavior
5262379|NCT02375490|Preschool Child|preschool child
5262380|NCT02375490|Early Childcare Center|early childcare center
5262381|NCT02375490|Obesity|obesity
5262382|NCT02375490|Physical Literacy|physical literacy
5262383|NCT02375477|Clostridium difficile|clostridium difficile
5262384|NCT02375477|C. difficile|c. difficile
5262385|NCT02375477|adherence|adherence
5262386|NCT02375464|neuroendocrine tumor|neuroendocrine tumor
5262387|NCT02375464|carcinoid tumor|carcinoid tumor
5262388|NCT02375438|nutrition|nutrition
5262389|NCT02375438|mitochondrial cytopathy|mitochondrial cytopathy
5262390|NCT02375438|malnutrition|malnutrition
5262391|NCT02375438|energy intake|energy intake
5262392|NCT02375438|nutritional risk|nutritional risk
5262393|NCT02375425|BV, HSV|bv, hsv
5262394|NCT02375425|contraceptive|contraceptive
5262395|NCT02375425|ex vivo challenge model|ex vivo challenge model
5262396|NCT02375412|heart rate variability|heart rate variability
5262397|NCT02375412|post-operative outcome|post-operative outcome
5262398|NCT02375373|Gut Microbiota|gut microbiota
5262399|NCT02375347|Gut Microbiota|gut microbiota
5262401|NCT02375321|Depression|depression
5262402|NCT02375321|Quality of Life|quality of life
5262403|NCT02375321|CPAP|cpap
5262404|NCT02375308|Hypnotherapy; Cognitive Behavioral Therapy; Efficacy|hypnotherapy; cognitive behavioral therapy; efficacy
5262405|NCT02375295|struvite|struvite
5262406|NCT02375295|infection|infection
5262407|NCT02375295|stones|stones
5262408|NCT02375295|calculi|calculi
5262409|NCT02375295|antibiotics|antibiotics
5262410|NCT02375282|ambulation|ambulation
5262411|NCT02375282|cardiac rehabilitation|cardiac rehabilitation
5262412|NCT02375269|Visceral Surgery|visceral surgery
5262413|NCT02375269|Comprehensive Complication Index|comprehensive complication index
5262414|NCT02375269|Patient undergoing abdominal surgery|patient undergoing abdominal surgery
5262415|NCT02375230|Neonatal Resuscitation|neonatal resuscitation
5262416|NCT02375230|Respiratory Function Tests|respiratory function tests
5262417|NCT02375230|Neonatal Simulation|neonatal simulation
5262418|NCT02375230|Resuscitation Teaching|resuscitation teaching
5262419|NCT02375178|anti-infective agents|anti-infective agents
5262420|NCT02375178|local/therapeutic use|local/therapeutic use
5262421|NCT02375178|chlorhexidine|chlorhexidine
5262422|NCT02375178|dental desinfectants|dental desinfectants
5262423|NCT02375178|polyhexamethylene biguanide|polyhexamethylene biguanide
5262424|NCT02375178|mouthrinse|mouthrinse
5262425|NCT02375152|neurosurgery|neurosurgery
5262426|NCT02375152|capsulotomy|capsulotomy
5262427|NCT02375113|Obesity prevention|obesity prevention
5262428|NCT02375113|Soy supplementation|soy supplementation
5262429|NCT02375074|Supported Employment|supported employment
5262430|NCT02375074|Vocational Rehabilitation|vocational rehabilitation
5262431|NCT02375074|Youth|youth
5262432|NCT02375074|Sick leave|sick leave
5262433|NCT02375074|Disability|disability
5262434|NCT02375074|Coping|coping
5262435|NCT02375074|Work|work
5262436|NCT02375074|Occupational|occupational
5262437|NCT02375074|Labor market participation|labor market participation
5262438|NCT02375074|Randomized Controlled Trial|randomized controlled trial
5262439|NCT02375061|Best Possible Self|best possible self
5262440|NCT02375061|Positive Psychology|positive psychology
5262441|NCT02375061|Optimism|optimism
5262442|NCT02375061|Positive Technologies|positive technologies
5262443|NCT02375061|Future thinking|future thinking
5262444|NCT02375061|Pain Catastrophizing|pain catastrophizing
5262445|NCT02374983|Gamma Knife Radiosurgery|gamma knife radiosurgery
5262446|NCT02374983|Radiation Dosimetry|radiation dosimetry
5262447|NCT02374957|leg pain|leg pain
5262448|NCT02374957|claudication|claudication
5262449|NCT02374931|desmoid|desmoid
5262450|NCT02374931|FES-PET|fes-pet
5262451|NCT02374931|aggressive fibromatosis|aggressive fibromatosis
5259723|NCT02390089|Cough|cough
5262452|NCT02374918|Mild traumatic brain injury|mild traumatic brain injury
5262454|NCT02374918|Sleep problems|sleep problems
5262455|NCT02374918|Brain imaging|brain imaging
5262456|NCT02374918|fMRI|fmri
5262457|NCT02374905|drinksmeter|drinksmeter
5262458|NCT02374905|alcohol counselling|alcohol counselling
5262459|NCT02374892|Intervention|intervention
5262460|NCT02374892|Congenital Heart Disease|congenital heart disease
5262461|NCT02374892|Adolescent|adolescent
5262462|NCT02374892|Education|education
5262463|NCT02374892|Self-management|self-management
5262464|NCT02374866|Obesity|obesity
5262465|NCT02374866|Morbid Obesity|morbid obesity
5262466|NCT02374866|Therapeutic education|therapeutic education
5262467|NCT02374840|Pharmacogenomics|pharmacogenomics
5262468|NCT02374840|Adverse Drug Reactions|adverse drug reactions
5262469|NCT02374840|Pharmacogenetics|pharmacogenetics
5262470|NCT02374827|complete salpingectomy|complete salpingectomy
5262471|NCT02374827|standard tubal ligation|standard tubal ligation
5262472|NCT02374827|cesarean delivery|cesarean delivery
5262473|NCT02374827|feasibility|feasibility
5262474|NCT02374827|safety|safety
5262475|NCT02374827|partial salpingectomy|partial salpingectomy
5262476|NCT02374801|CRT-D device|crt-d device
5262477|NCT02374801|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
5262478|NCT02374801|Stable, optimal drug regimen|stable, optimal drug regimen
5262479|NCT02374801|Sinus rhythm|sinus rhythm
5262480|NCT02374801|Heart Failure|heart failure
5262481|NCT02374775|axial plaque stress|axial plaque stress
5262482|NCT02374775|pressure|pressure
5262483|NCT02374775|pressure gradient|pressure gradient
5262484|NCT02374775|coronary plaque|coronary plaque
5262485|NCT02374775|plaque rupture|plaque rupture
5262486|NCT02374775|acute coronary syndrome|acute coronary syndrome
5262487|NCT02374775|acute myocardial infarction|acute myocardial infarction
5262488|NCT02374775|computational fluid dynamics|computational fluid dynamics
5262489|NCT02374775|coronary computed tomography angiography|coronary computed tomography angiography
5262490|NCT02374775|wall shear stress|wall shear stress
5262491|NCT02374762|Arteriovenous Fistula|arteriovenous fistula
5262492|NCT02374762|Hemodialysis|hemodialysis
5262493|NCT02374762|Vascular Access|vascular access
5262494|NCT02374749|Axial Spondyloarthritis|axial spondyloarthritis
5262495|NCT02374749|Education|education
5262496|NCT02374749|Co-morbidities|co-morbidities
5262497|NCT02374749|Nurse|nurse
5262498|NCT02374736|recipients|recipients
5262499|NCT02374736|Subclinical Antibody-mediated rejection (ABMR)|subclinical antibody-mediated rejection (abmr)
5262500|NCT02374736|Intravenous immunoglobulins (IVIg)|intravenous immunoglobulins (ivig)
5262501|NCT02374736|Donor-specific antibodies (DSA)|donor-specific antibodies (dsa)
5262502|NCT02374723|improve|improve
5262503|NCT02374723|vision|vision
5262504|NCT02374697|Second opinion|second opinion
5262505|NCT02374684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5262506|NCT02374671|Near Vision|near vision
5262507|NCT02374671|Reading Vision|reading vision
5262508|NCT02374671|Reading Glasses|reading glasses
5262509|NCT02374671|Reading|reading
5262510|NCT02374671|Readers|readers
5262511|NCT02374671|Presbyopic|presbyopic
5262512|NCT02374671|Presbyopia|presbyopia
5262513|NCT02374619|eccentric exercise|eccentric exercise
5262514|NCT02374619|pro-oxidants|pro-oxidants
5262515|NCT02374619|free radicals|free radicals
5262516|NCT02374619|adults|adults
5262517|NCT02374619|children|children
5262518|NCT02374606|outcomes measures|outcomes measures
5262519|NCT02374606|strength measurement|strength measurement
5262520|NCT02374606|disease progression|disease progression
5262521|NCT02374567|geriatric psychiatry|geriatric psychiatry
5262522|NCT02374567|pharmacovigilance|pharmacovigilance
5262523|NCT02374554|Respiratory Rate|respiratory rate
5262524|NCT02374554|Structured Light Plethysmography|structured light plethysmography
5262525|NCT02374554|Capnography|capnography
5262526|NCT02374541|Patient Navigation|patient navigation
5262527|NCT02374541|Health Disparities|health disparities
5262528|NCT02374541|Coordination of Services|coordination of services
5262529|NCT02374541|Early Intervention (Education)|early intervention (education)
5262530|NCT02374541|Health Services Accessibility|health services accessibility
5199225|NCT02749149|Cardiac|cardiac
5143475|NCT03094832|AKT|akt
5262531|NCT02374541|Patient Advocacy|patient advocacy
5262532|NCT02374528|Negative pressure wound therapy|negative pressure wound therapy
5262533|NCT02374528|wound|wound
5262534|NCT02374528|split-thickness skin grafting|split-thickness skin grafting
5262535|NCT02374502|Spondylarthropathies|spondylarthropathies
5262536|NCT02374502|Motor Activity|motor activity
5262537|NCT02374502|Physical Therapists|physical therapists
5262538|NCT02374502|Accelerometry|accelerometry
5262539|NCT02374476|VT|vt
5262540|NCT02374476|Refractory VT|refractory vt
5262541|NCT02374476|VT Storm|vt storm
5262542|NCT02374476|Ventricular Fibrillation|ventricular fibrillation
5262543|NCT02374476|V Fib|v fib
5262544|NCT02374476|VF|vf
5262545|NCT02374463|Balance|balance
5262546|NCT02374463|Fall Risk|fall risk
5262547|NCT02374463|Older Adults|older adults
5262548|NCT02374463|Tai Chi|tai chi
5262549|NCT02374463|Multimodal Balance Intervention|multimodal balance intervention
5262550|NCT02374450|Malaria|malaria
5262551|NCT02374450|Surveillance study|surveillance study
5262552|NCT02374450|Adverse Events of Specific Interest (AESI)|adverse events of specific interest (aesi)
5262555|NCT02374450|Adverse events (AE) leading to hospitalisation or death|adverse events (ae) leading to hospitalisation or death
5262556|NCT02374450|Meningitis|meningitis
5262557|NCT02374450|Epidemiology|epidemiology
5262558|NCT02374450|Africa|africa
5262559|NCT02374398|Tranexamic Acid|tranexamic acid
5262560|NCT02374398|Blood Loss|blood loss
5262561|NCT02374398|Aquamantys System|aquamantys system
5262564|NCT02374372|beta microglobulin|beta microglobulin
5262565|NCT02374372|amyloidosis|amyloidosis
5262566|NCT02374307|Falls|falls
5262567|NCT02374307|Home care|home care
5262568|NCT02374307|Older people|older people
5262569|NCT02374307|Falls prevention|falls prevention
5262570|NCT02374307|Quality of life|quality of life
5262571|NCT02374307|Exercise|exercise
5262572|NCT02374307|Balance|balance
5262573|NCT02374307|Preventative care|preventative care
5262574|NCT02374307|Community health services|community health services
5262575|NCT02374307|Home-help services|home-help services
5262576|NCT02374281|Newborn|newborn
5262577|NCT02374281|Neonatal Screening|neonatal screening
5262578|NCT02374281|Autonomic Nervous System|autonomic nervous system
5262579|NCT02374281|Pain|pain
5262580|NCT02374281|non-nutritive sucking|non-nutritive sucking
5262581|NCT02374281|sucrose administration|sucrose administration
5262582|NCT02374281|nociceptive action|nociceptive action
5262583|NCT02374281|Electro acoustical characteristics of crying|electro acoustical characteristics of crying
5262584|NCT02374255|Advanced cancer|advanced cancer
5262585|NCT02374255|goals of care|goals of care
5262586|NCT02374255|quality of care|quality of care
5262587|NCT02374255|end of life discussions|end of life discussions
5262588|NCT02374242|Brain|brain
5262589|NCT02374242|Metastases|metastases
5262590|NCT02374242|Immunotherapy|immunotherapy
5262591|NCT02374242|Intracranial response|intracranial response
5262592|NCT02374242|Nivolumab|nivolumab
5262593|NCT02374242|Ipilimumab|ipilimumab
5262594|NCT02374242|Biomarkers|biomarkers
5262595|NCT02374242|Immune related response criteria|immune related response criteria
5262596|NCT02374229|pulmonary hypertension|pulmonary hypertension
5262597|NCT02374229|pulmonary artery denervation|pulmonary artery denervation
5262598|NCT02374229|mitral valve disease|mitral valve disease
5262599|NCT02374216|Dental Implants|dental implants
5262600|NCT02374216|Periodontal Bone Loss|periodontal bone loss
5262601|NCT02374216|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
5262602|NCT02374216|Dental Prosthesis Failure|dental prosthesis failure
5262603|NCT02374203|Indirect Calorimetry|indirect calorimetry
5262604|NCT02374203|Harris-Benedict equation|harris-benedict equation
5262605|NCT02374203|critical elderly|critical elderly
5262606|NCT02374203|mNUTRIC score|mnutric score
5262607|NCT02374203|high nutritional risk|high nutritional risk
5262608|NCT02374164|Drug therapy|drug therapy
5262609|NCT02374151|intrauterine pressure catheter|intrauterine pressure catheter
5262610|NCT02374151|electrohysterography|electrohysterography
5262611|NCT02374138|psychosocial stress|psychosocial stress
5262612|NCT02374099|Breast Cancer|breast cancer
5262613|NCT02374099|Her2 -|her2 -
5262615|NCT02374099|CC-486 (ORAL AZACITIDINE)|cc-486 (oral azacitidine)
5262616|NCT02374099|Metastatic Breast Cancer|metastatic breast cancer
5262617|NCT02374099|Oral Azacitidine|oral azacitidine
5262618|NCT02374099|Fulvestrant|fulvestrant
5262619|NCT02374099|Epigenetics|epigenetics
5262620|NCT02374021|rheumatoid arthritis|rheumatoid arthritis
5262621|NCT02374008|Peripheral nerve block|peripheral nerve block
5262622|NCT02374008|Total knee Arthroplasty|total knee arthroplasty
5262623|NCT02374008|Dexamethasone|dexamethasone
5262624|NCT02373995|Graves|graves
5262625|NCT02373995|Orbithopaty|orbithopaty
5262626|NCT02373995|euthyroidism|euthyroidism
5262627|NCT02373995|microbiome|microbiome
5262628|NCT02373943|vitamin A|vitamin a
5262629|NCT02373943|human|human
5262630|NCT02373943|bioavailability|bioavailability
5262631|NCT02373943|fortified maize|fortified maize
5262632|NCT02373943|cross-over|cross-over
5262633|NCT02373943|beta-carotene|beta-carotene
5262634|NCT02373930|Dolutegravir|dolutegravir
5262635|NCT02373930|safety|safety
5262636|NCT02373930|Rilpivirine|rilpivirine
5262637|NCT02373930|fixed dose combination|fixed dose combination
5262638|NCT02373930|relative bioavailability|relative bioavailability
5262639|NCT02373865|Diabetes mellitus type 2|diabetes mellitus type 2
5262640|NCT02373865|nocturnal hypoglycemia|nocturnal hypoglycemia
5262641|NCT02373865|metformin monotherapy|metformin monotherapy
5262642|NCT02373800|Induced|induced
5262643|NCT02373800|pre-term labor|pre-term labor
5262644|NCT02373787|Resorbable|resorbable
5262645|NCT02373787|Collagen membrane|collagen membrane
5262646|NCT02373787|NobelReplace CC|nobelreplace cc
5262647|NCT02373774|infant|infant
5262648|NCT02373774|lumbar puncture|lumbar puncture
5262649|NCT02373774|patient safety|patient safety
5262650|NCT02373774|ultrasound|ultrasound
5262651|NCT02373735|stroke volume variation|stroke volume variation
5262652|NCT02373735|radical cystectomy|radical cystectomy
5262653|NCT02373735|blood loss|blood loss
5262654|NCT02373735|postoperative complications|postoperative complications
5262655|NCT02373696|Pain|pain
5262661|NCT02373657|water|water
5262682|NCT02373540|failed back surgery syndrome|failed back surgery syndrome
5262684|NCT02373501|uterine incision repair|uterine incision repair
5262685|NCT02373488|Constipation|constipation
5262686|NCT02373488|connective tissue manipulation|connective tissue manipulation
5262687|NCT02373488|abdominal massage|abdominal massage
5262688|NCT02373488|bowel movements|bowel movements
5262689|NCT02373488|quality of life|quality of life
5262690|NCT02373475|spine surgery|spine surgery
5262691|NCT02373475|prone position|prone position
5262692|NCT02373475|intraoperative lung protective strategies|intraoperative lung protective strategies
5262693|NCT02373475|postoperative pulmonary complications|postoperative pulmonary complications
5262694|NCT02373449|Ketamine|ketamine
5262695|NCT02373449|fMRI|fmri
5262696|NCT02373449|refractory neuropathic pain|refractory neuropathic pain
5262697|NCT02373436|Upper Extremity|upper extremity
5262698|NCT02373436|Rehabilitation|rehabilitation
5262699|NCT02373397|Wound healing|wound healing
5262700|NCT02373397|nerve regeneration|nerve regeneration
5262701|NCT02373397|re-epithelialization|re-epithelialization
5262702|NCT02373397|corneal epithelium|corneal epithelium
5262703|NCT02373397|laser corneal surgery|laser corneal surgery
5262704|NCT02373384|Radiolucent renal stones|radiolucent renal stones
5262705|NCT02373384|Oral dissolution therapy|oral dissolution therapy
5262706|NCT02373384|Systemic chemolysis|systemic chemolysis
5262707|NCT02373384|Renal uric acid stones|renal uric acid stones
5262708|NCT02373384|Alkalinization|alkalinization
5262709|NCT02373358|Complex trauma|complex trauma
5262710|NCT02373358|Yoga|yoga
5262711|NCT02373345|psychological factors|psychological factors
5262712|NCT02373345|functional disability|functional disability
5262713|NCT02373345|pain thresholds|pain thresholds
5262714|NCT02373345|tolerance thresholds|tolerance thresholds
5262715|NCT02373345|motor adaptations|motor adaptations
5262716|NCT02373345|natural course|natural course
5262717|NCT02373332|platelets|platelets
5262718|NCT02373332|12-lipoxygenase|12-lipoxygenase
5262719|NCT02373332|fatty acids|fatty acids
5262720|NCT02373332|DGLA|dgla
5262722|NCT02373332|EPA|epa
5262723|NCT02373332|12-LOX|12-lox
5262724|NCT02373319|Cardiovascular risk|cardiovascular risk
5262725|NCT02373319|Cholesterol|cholesterol
5262726|NCT02373319|Hypertension|hypertension
5262727|NCT02373319|Diabetes|diabetes
5262728|NCT02373319|Smoking|smoking
5262729|NCT02373319|Preventive Medicine|preventive medicine
5262730|NCT02373319|Epidemiology|epidemiology
5262731|NCT02373319|Public Health|public health
5262732|NCT02373319|Diet|diet
5262733|NCT02373319|Physical Activity|physical activity
5262734|NCT02373306|Risk stratification|risk stratification
5262735|NCT02373306|ICD intervention|icd intervention
5262736|NCT02373306|occurrence during one-year follow-up after NIPS|occurrence during one-year follow-up after nips
5262737|NCT02373293|Acute pancreatitis|acute pancreatitis
5262738|NCT02373280|Helicobacter pylori|helicobacter pylori
5262739|NCT02373280|tailored therapy|tailored therapy
5262740|NCT02373280|eradication|eradication
5262741|NCT02373241|Anemia, Sickle Cell|anemia, sickle cell
5262742|NCT02373241|Sickle Cell Disease|sickle cell disease
5262743|NCT02373241|Kidney Disease|kidney disease
5262744|NCT02373241|Hypertension|hypertension
5262745|NCT02373241|Proteinuria|proteinuria
5262746|NCT02373241|Losartan|losartan
5262747|NCT02373241|Antihypertensive Agents|antihypertensive agents
5262748|NCT02373241|Blood Pressure|blood pressure
5262749|NCT02373111|Anti-aging|anti-aging
5262750|NCT02373111|Isoflavones|isoflavones
5262751|NCT02373111|Astaxanthine|astaxanthine
5262752|NCT02373111|Skin aging|skin aging
5262753|NCT02373098|Fingolimod,cytokine,chemokine,RRMS|fingolimod,cytokine,chemokine,rrms
5262754|NCT02373085|Asymptomatic Bacteriuria|asymptomatic bacteriuria
5262755|NCT02373085|Kidney transplant recipients|kidney transplant recipients
5262762|NCT02373033|women in childbearing age|women in childbearing age
5262763|NCT02373033|food folate|food folate
5262764|NCT02372994|chronic disease|chronic disease
5262765|NCT02372994|continuity of patient care|continuity of patient care
5262766|NCT02372994|patient engagement|patient engagement
5262767|NCT02372994|cost effectiveness analysis|cost effectiveness analysis
5262768|NCT02372994|user-centred design|user-centred design
5262769|NCT02372994|Interdisciplinary Health Team|interdisciplinary health team
5262770|NCT02372994|Medical Informatics|medical informatics
5262771|NCT02372994|Patient-centred care|patient-centred care
5262772|NCT02372942|efficacy|efficacy
5262773|NCT02372942|prevention|prevention
5262774|NCT02372890|Otorhinolaryngeal Neoplasms|otorhinolaryngeal neoplasms
5262775|NCT02372890|Cancer of Head and Neck|cancer of head and neck
5262776|NCT02372890|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5262777|NCT02372890|Positron Emission Tomography|positron emission tomography
5262779|NCT02372890|FDG|fdg
5262780|NCT02372877|Sickle Cell Disease|sickle cell disease
5262781|NCT02372877|Hemoglobin (Hb) S Disease|hemoglobin (hb) s disease
5262782|NCT02372877|Hb S Disease|hb s disease
5262783|NCT02372877|Congenital Hemolytic Anemia|congenital hemolytic anemia
5262784|NCT02372864|Ovariectomy|ovariectomy
5262785|NCT02372864|Mindfulness|mindfulness
5262786|NCT02372864|Postmenopause|postmenopause
5262787|NCT02372864|Hot Flashes|hot flashes
5262788|NCT02372851|Arsenic|arsenic
5262789|NCT02372851|Household water treatment|household water treatment
5262790|NCT02372851|Point of use water treatment|point of use water treatment
5262791|NCT02372851|Water Quality|water quality
5262792|NCT02372851|Total Urinary Arsenic|total urinary arsenic
5262793|NCT02372851|West Bengal|west bengal
5262794|NCT02372851|Thermotolerant coliforms|thermotolerant coliforms
5262795|NCT02372851|Compliance|compliance
5262796|NCT02372851|Diarrhoea|diarrhoea
5262797|NCT02372825|Free iliac crest transfer|free iliac crest transfer
5262798|NCT02372825|Bone reconstruction|bone reconstruction
5262799|NCT02372825|Ankle reconstruction|ankle reconstruction
5262800|NCT02372825|Heel reconstruction|heel reconstruction
5262801|NCT02372812|effect of dexamethasone|effect of dexamethasone
5262802|NCT02372812|general surgery|general surgery
5262803|NCT02372812|post operative|post operative
5262804|NCT02372786|7% lidocaine / 7% tetracaine cream|7% lidocaine / 7% tetracaine cream
5262805|NCT02372786|2,5% lidocaine / 2,5% prilocaine cream|2,5% lidocaine / 2,5% prilocaine cream
5262806|NCT02372773|Frontotemporal Dementia|frontotemporal dementia
5262807|NCT02372773|MAPT|mapt
5262808|NCT02372773|PGRN|pgrn
5262809|NCT02372773|C9ORF72|c9orf72
5262810|NCT02372760|Bronchoscopic anesthesia lidocaine|bronchoscopic anesthesia lidocaine
5262811|NCT02372760|Spray Catheter|spray catheter
5262812|NCT02372760|brochoalveolar lavage|brochoalveolar lavage
5262813|NCT02372747|Totally laparoscopic gastrectomy|totally laparoscopic gastrectomy
5262814|NCT02372747|laparoscopic distal gastrectomy|laparoscopic distal gastrectomy
5262815|NCT02372747|Intracorporeal anastomosis|intracorporeal anastomosis
5262816|NCT02372747|Delta-Shaped Anastomosis|delta-shaped anastomosis
5262817|NCT02372747|Billroth II Anastomosis|billroth ii anastomosis
5262818|NCT02372747|Gastric cancer|gastric cancer
5262819|NCT02372721|acute kidney injury|acute kidney injury
5262820|NCT02372656|Simvastatin, Metformin, Chronic periodontitis|simvastatin, metformin, chronic periodontitis
5262821|NCT02372643|clitoris|clitoris
5262822|NCT02372643|sexuality|sexuality
5262823|NCT02372643|vascularization|vascularization
5262824|NCT02372643|doppler|doppler
5262825|NCT02372643|ultrasound|ultrasound
5262826|NCT02372643|reference|reference
5262827|NCT02372643|female|female
5262828|NCT02372643|Pilot Projects|pilot projects
5262829|NCT02372643|Vagina/ultrasonography|vagina/ultrasonography
5262830|NCT02372643|Urethra/ultrasonography|urethra/ultrasonography
5262831|NCT02372643|Regional Blood Flow/physiology|regional blood flow/physiology
5262832|NCT02372643|Arteries/ultrasonography|arteries/ultrasonography
5262833|NCT02372643|Clitoris/ultrasonography|clitoris/ultrasonography
5262834|NCT02372643|Reference values|reference values
5262835|NCT02372643|Clitoris/blood supply|clitoris/blood supply
5262836|NCT02372617|cerebral palsy|cerebral palsy
5262837|NCT02372617|hip|hip
5262838|NCT02372617|luxation|luxation
5262839|NCT02372617|subluxation|subluxation
5262840|NCT02372604|Chronic spontaneous urticaria|chronic spontaneous urticaria
5262841|NCT02372604|Levocetirizine|levocetirizine
5262842|NCT02372604|H1-antihistamine|h1-antihistamine
5262843|NCT02372604|Fourfold dosage|fourfold dosage
5260149|NCT02387606|Placebo|placebo
5262846|NCT02372604|UAS7 (Urticaria activity score)|uas7 (urticaria activity score)
5262847|NCT02372604|resistant|resistant
5262848|NCT02372591|Quantitative Sensory Testing|quantitative sensory testing
5262849|NCT02372591|Hydromorphone|hydromorphone
5262850|NCT02372591|Buprenorphine|buprenorphine
5262851|NCT02372578|Painful diabetic peripheral neuropathy (PDPN)|painful diabetic peripheral neuropathy (pdpn)
5262852|NCT02372578|ASP3662|asp3662
5262853|NCT02372565|African American|african american
5262854|NCT02372565|Women|women
5262855|NCT02372565|Physical Activity|physical activity
5262856|NCT02372565|Social Media|social media
5262857|NCT02372565|Exercise|exercise
5262858|NCT02372565|Facebook|facebook
5262859|NCT02372565|Text message|text message
5262860|NCT02372539|dexamethasone|dexamethasone
5262861|NCT02372526|Glucagon-like Peptide-1|glucagon-like peptide-1
5262862|NCT02372526|Glucose-dependent insulinotropic peptide|glucose-dependent insulinotropic peptide
5262863|NCT02372526|Glucagon|glucagon
5262864|NCT02372526|Peptide YY 3-36|peptide yy 3-36
5262865|NCT02372526|Ghrelin|ghrelin
5262866|NCT02372526|Body Weight|body weight
5262867|NCT02372526|Obesity|obesity
5262868|NCT02372526|Overnutrition|overnutrition
5262869|NCT02372526|Overweight|overweight
5262870|NCT02372526|Gastrointestinal Agents|gastrointestinal agents
5262871|NCT02372526|GLP-1 secretagogue|glp-1 secretagogue
5262872|NCT02372513|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
5262873|NCT02372513|Children|children
5262874|NCT02372513|Liver disease|liver disease
5262876|NCT02372474|ESS|ess
5262877|NCT02372474|stem cell therapy|stem cell therapy
5262878|NCT02372461|Amoxicillin|amoxicillin
5262879|NCT02372461|Placebo|placebo
5262880|NCT02372435|PJI|pji
5262881|NCT02372422|Twins|twins
5262882|NCT02372422|Twin gestation|twin gestation
5262883|NCT02372422|Preterm birth|preterm birth
5262884|NCT02372422|Prevention|prevention
5262885|NCT02372396|PTSD|ptsd
5262886|NCT02372396|Psychotherapy|psychotherapy
5262887|NCT02372396|Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF)|operation enduring freedom/operation iraqi freedom (oef/oif)
5262888|NCT02372396|Veterans|veterans
5262889|NCT02372383|Cystic Fibrosis|cystic fibrosis
5262890|NCT02372383|Pharmacokinetics|pharmacokinetics
5262891|NCT02372383|Pharmacodynamics|pharmacodynamics
5262892|NCT02372383|Nontuberculous Mycobacteria|nontuberculous mycobacteria
5262893|NCT02372383|Treatment|treatment
5262894|NCT02372357|chemotherapy|chemotherapy
5262895|NCT02372357|stem cell transplantation|stem cell transplantation
5262896|NCT02372344|the effect of food timing on PK|the effect of food timing on pk
5262897|NCT02372344|the effect of food timing on Safety and Tolerability|the effect of food timing on safety and tolerability
5262898|NCT02372344|AZD0585|azd0585
5262899|NCT02372344|Japanese|japanese
5262900|NCT02372331|pancreaticoduodenectomy|pancreaticoduodenectomy
5262901|NCT02372331|ERAS|eras
5262902|NCT02372331|Whipple's operation|whipple's operation
5262903|NCT02372331|Fast track|fast track
5262904|NCT02372318|opiod receptor modulator nalmefene|opiod receptor modulator nalmefene
5262905|NCT02372318|cue-reactivity|cue-reactivity
5262906|NCT02372318|fMRI|fmri
5262907|NCT02372318|resting-state networks|resting-state networks
5262908|NCT02372292|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure|cardiorenal syndrome, decompensated heart failure, renal resistivity index, venous impedance index, kidney failure
5262909|NCT02372279|Embryo development|embryo development
5262910|NCT02372279|Implantation|implantation
5262911|NCT02372279|In vitro fertilization|in vitro fertilization
5262912|NCT02372266|Infant, Newborn|infant, newborn
5262913|NCT02372266|hospital discharge|hospital discharge
5262914|NCT02372266|Early newborn discharge|early newborn discharge
5262915|NCT02372266|Newborn length of stay|newborn length of stay
5262916|NCT02372266|Maternity length of stay|maternity length of stay
5262917|NCT02372253|verapamil|verapamil
5262918|NCT02372253|type 1 diabetes|type 1 diabetes
5262919|NCT02372253|diabetes|diabetes
5262920|NCT02372253|beta cells|beta cells
5262921|NCT02372253|beta cell function|beta cell function
5262922|NCT02372253|insulin|insulin
5262923|NCT02372214|Endovascular Procedures|endovascular procedures
5262924|NCT02372214|3D printing|3d printing
5262925|NCT02372214|Simulation|simulation
5262926|NCT02372214|Training|training
5262927|NCT02372214|Learning curve|learning curve
5262928|NCT02372214|Education|education
5262929|NCT02372201|irritable bowel disease|irritable bowel disease
5262930|NCT02372201|microbiota|microbiota
5262931|NCT02372201|hydro colon therapy|hydro colon therapy
5262932|NCT02372201|food intolerance|food intolerance
5262933|NCT02372175|Dengue|dengue
5262934|NCT02372162|Hepatocellular Carcinoma|hepatocellular carcinoma
5262935|NCT02372162|Molecular Diagnostics|molecular diagnostics
5262936|NCT02372162|Sorafenib|sorafenib
5262937|NCT02372162|Therapeutic chemoembolization|therapeutic chemoembolization
5262938|NCT02372162|Next-generation sequencing|next-generation sequencing
5262939|NCT02372162|Sequence analysis, DNA|sequence analysis, dna
5262940|NCT02372162|Sequence analysis, RNA|sequence analysis, rna
5262946|NCT02372123|connective tissue massage|connective tissue massage
5262947|NCT02372123|connective tissue manipulation|connective tissue manipulation
5262948|NCT02372084|Hepatic impairment,|hepatic impairment,
5250468|NCT02442128|Fentany|fentany
5262949|NCT02372084|osilodrostat,|osilodrostat,
5262950|NCT02372084|LCI699|lci699
5262951|NCT02372032|Herniation|herniation
5262964|NCT02371928|Exercise|exercise
5262965|NCT02371928|Dislocation|dislocation
5262966|NCT02371928|Recurrence|recurrence
5262967|NCT02371915|Rural access|rural access
5262968|NCT02371915|Telehealth|telehealth
5262969|NCT02371902|Elbow pain|elbow pain
5262970|NCT02371902|lateral epicondylitis|lateral epicondylitis
5262971|NCT02371902|conservative treatment|conservative treatment
5262972|NCT02371902|shock wave treatment|shock wave treatment
5262973|NCT02371902|therapeutic ultrasound|therapeutic ultrasound
5262974|NCT02371850|Bioequivalence|bioequivalence
5262975|NCT02371850|Therapeutic Equivalency|therapeutic equivalency
5262976|NCT02371824|Magnetic Resonance Imaging|magnetic resonance imaging
5262977|NCT02371824|Bone Marrow|bone marrow
5262980|NCT02371785|Peripheral Arterial Disease|peripheral arterial disease
5262981|NCT02371785|Critical Limb Ischemia|critical limb ischemia
5262982|NCT02371785|Claudication|claudication
5262983|NCT02371785|Percutaneous Vascular Intervention|percutaneous vascular intervention
5262984|NCT02371785|Peripheral Vascular Intervention|peripheral vascular intervention
5262985|NCT02371772|Warfarin|warfarin
5262986|NCT02371772|Self Care|self care
5262987|NCT02371772|Conventional care|conventional care
5262988|NCT02371733|pulmonary arterial hypertension|pulmonary arterial hypertension
5262989|NCT02371733|aerobic exercise training|aerobic exercise training
5262990|NCT02371733|upper extremity|upper extremity
5262991|NCT02371733|exercise capacity|exercise capacity
5262992|NCT02371694|Lipid|lipid
5262993|NCT02371694|Carbohydrate counting|carbohydrate counting
5262994|NCT02371694|Adolescent|adolescent
5262995|NCT02371694|Continuous glucose monitoring|continuous glucose monitoring
5262996|NCT02371694|Insulin requirements|insulin requirements
5263007|NCT02371655|Bowel cleansing|bowel cleansing
5263008|NCT02371655|CTcolonography|ctcolonography
5263009|NCT02371655|Bowel preparation|bowel preparation
5263010|NCT02371655|Faecal and fluid tagging|faecal and fluid tagging
5263011|NCT02371642|Echocardiography|echocardiography
5263012|NCT02371629|Anticholinergic|anticholinergic
5263013|NCT02371629|Antimuscarinic|antimuscarinic
5263014|NCT02371629|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5445371|NCT01522118|Non-invasive therapy|non-invasive therapy
5263015|NCT02371629|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5263016|NCT02371629|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5263017|NCT02371629|COPD|copd
5263018|NCT02371629|LAMA|lama
5263019|NCT02371629|Lung Disease|lung disease
5263020|NCT02371629|Lung Diseases, Obstructive|lung diseases, obstructive
5263021|NCT02371629|Lung Function|lung function
5263022|NCT02371629|Muscarinic receptor antagonist|muscarinic receptor antagonist
5263023|NCT02371629|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5263024|NCT02371629|Respiratory Tract Diseases|respiratory tract diseases
5263025|NCT02371603|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5263026|NCT02371603|GSK1278863|gsk1278863
5263027|NCT02371603|Anemia|anemia
5263028|NCT02371603|Drug interaction|drug interaction
5263029|NCT02371590|cancer|cancer
5263030|NCT02371590|lenalidomide|lenalidomide
5263031|NCT02371590|obinutuzumab|obinutuzumab
5263033|NCT02371577|Revlimid|revlimid
5263034|NCT02371551|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5263035|NCT02371551|Medical Sonography|medical sonography
5263036|NCT02371551|Computed Tomography, X-Ray|computed tomography, x-ray
5263037|NCT02371538|stem cell transplant|stem cell transplant
5263038|NCT02371538|human breastmilk|human breastmilk
5263039|NCT02371525|adherence|adherence
5263040|NCT02371525|prevention|prevention
5263041|NCT02371512|Mitral Valve Insufficiency|mitral valve insufficiency
5263042|NCT02371499|Irritable Bowel Syndrome|irritable bowel syndrome
5263043|NCT02371499|Lactobacillus casei dg|lactobacillus casei dg
5263044|NCT02371499|microbiota|microbiota
5263045|NCT02371486|cesarean section defect|cesarean section defect
5263046|NCT02371486|implantation|implantation
5263047|NCT02371486|ivf|ivf
5263048|NCT02371473|Acetazolamide|acetazolamide
5263049|NCT02371473|Central Sleep Apnea|central sleep apnea
5263050|NCT02371473|Opium Abuse|opium abuse
5263051|NCT02371460|Neonatal Prematurity|neonatal prematurity
5263052|NCT02371460|Omega-3 Fatty Acids|omega-3 fatty acids
5263053|NCT02371460|Breastfeeding|breastfeeding
5263054|NCT02371447|bladder cancer|bladder cancer
5263055|NCT02371447|recurrent non-muscle invasive bladder cancer|recurrent non-muscle invasive bladder cancer
5263057|NCT02371447|BCG therapy|bcg therapy
5263058|NCT02371369|PLX3397|plx3397
5263059|NCT02371369|Pexidartinib|pexidartinib
5263060|NCT02371369|Colony Stimulating Factor 1 Receptor (CSF-1R) inhibitor|colony stimulating factor 1 receptor (csf-1r) inhibitor
5263061|NCT02371330|Thrombocytopenia|thrombocytopenia
5263062|NCT02371330|Neonate|neonate
5263063|NCT02371330|PFA-100|pfa-100
5263064|NCT02371330|Neo-BAT|neo-bat
5263065|NCT02371330|Hemorrhage|hemorrhage
5263066|NCT02371317|Randomized clinical trial|randomized clinical trial
5263067|NCT02371317|Early medical intervention|early medical intervention
5263068|NCT02371317|Intervention studies|intervention studies
5263069|NCT02371317|Blood pressure|blood pressure
5263070|NCT02371317|Stress Management|stress management
5263071|NCT02371304|local therapy|local therapy
5263072|NCT02371304|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5263073|NCT02371304|rectal preserving|rectal preserving
5263074|NCT02371291|Memory Flexibility|memory flexibility
5263075|NCT02371278|Leucine|leucine
5263076|NCT02371278|Protein|protein
5263077|NCT02371278|Diet|diet
5263078|NCT02371278|Muscle protein synthesis|muscle protein synthesis
5263080|NCT02371265|Mozambique|mozambique
5263081|NCT02371265|antenatal care|antenatal care
5263082|NCT02371265|adherence|adherence
5263083|NCT02371265|retention|retention
5263084|NCT02371265|pregnancy|pregnancy
5423269|NCT01616420|prevention|prevention
5263085|NCT02371265|HIV-positive mothers retained in ART after 90 days|hiv-positive mothers retained in art after 90 days
5263086|NCT02371252|Osteoporosis|osteoporosis
5263087|NCT02371252|Bisphosphonates|bisphosphonates
5263088|NCT02371252|Alendronate|alendronate
5263089|NCT02371252|Bone mineral density|bone mineral density
5263090|NCT02371252|Bone markers|bone markers
5263091|NCT02371239|Glucose regulation|glucose regulation
5263092|NCT02371239|Glucose|glucose
5263093|NCT02371239|Lipids|lipids
5263094|NCT02371226|MPS I|mps i
5263095|NCT02371213|Social Networking|social networking
5263096|NCT02371213|Mobile phone|mobile phone
5263097|NCT02371213|Antenatal Care|antenatal care
5263098|NCT02371213|Health education|health education
5263099|NCT02371213|Maternal outcome|maternal outcome
5263100|NCT02371213|Neonatal outcome|neonatal outcome
5263101|NCT02371174|HER2-Negative Inoperable or Recurrent Breast Cancer|her2-negative inoperable or recurrent breast cancer
5263102|NCT02371174|Japan|japan
5263103|NCT02371174|Eribulin Mesylate|eribulin mesylate
5263104|NCT02371135|Gut Microbiome|gut microbiome
5263105|NCT02371135|15-016|15-016
5263106|NCT02371083|Pelvic organ prolapse managed by vaginal pessary|pelvic organ prolapse managed by vaginal pessary
5263107|NCT02370979|Dolutegravir|dolutegravir
5263108|NCT02370979|Proviral HIV-1 DNA|proviral hiv-1 dna
5263109|NCT02370979|Reservoir|reservoir
5263110|NCT02370953|Toric IOL alignment|toric iol alignment
5263111|NCT02370953|VERION digital marker|verion digital marker
5263112|NCT02370953|Manual ink-marking|manual ink-marking
5263113|NCT02370953|Randomized controlled trial|randomized controlled trial
5263114|NCT02370940|Iron bioavailability|iron bioavailability
5263115|NCT02370940|phytate|phytate
5263116|NCT02370940|serum iron curve|serum iron curve
5263117|NCT02370940|hepcidin|hepcidin
5263118|NCT02370940|iron status|iron status
5263119|NCT02370914|Concussion|concussion
5263120|NCT02370888|Lenalidomide|lenalidomide
5263121|NCT02370888|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5263122|NCT02370888|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5263123|NCT02370862|Spinal Cord Injury|spinal cord injury
5263124|NCT02370862|Neurogenic Bowel|neurogenic bowel
5263125|NCT02370862|Bowel Evacuation|bowel evacuation
5263126|NCT02370862|Gut Motility|gut motility
5263127|NCT02370849|nimotuzumab|nimotuzumab
5263128|NCT02370849|gastric adenocarcinoma|gastric adenocarcinoma
5263129|NCT02370849|Cisplatin|cisplatin
5263130|NCT02370849|S-1|s-1
5263131|NCT02370849|epidermal growth factor receptor|epidermal growth factor receptor
5263132|NCT02370836|distress|distress
5263133|NCT02370823|Osteoarthritis|osteoarthritis
5263134|NCT02370823|Knee|knee
5263135|NCT02370810|tinnitus treatment, internet-intervention, CBT|tinnitus treatment, internet-intervention, cbt
5263136|NCT02370797|IOERT|ioert
5263137|NCT02370797|Radiation|radiation
5263138|NCT02370797|Single fraction|single fraction
5263139|NCT02370797|Lumpectomy|lumpectomy
5263140|NCT02370797|Radiation therapy|radiation therapy
5263141|NCT02370797|Avera|avera
5263142|NCT02370784|early diffuse scleroderma|early diffuse scleroderma
5263143|NCT02370784|Raynaud|raynaud
5263144|NCT02370758|Quantiferon-CMV|quantiferon-cmv
5263145|NCT02370758|Quantiferon-Monitor|quantiferon-monitor
5263146|NCT02370758|Solid Organ Transplants|solid organ transplants
5263147|NCT02370758|CMV Disease|cmv disease
5263148|NCT02370745|Incretin|incretin
5263149|NCT02370745|GLP-1|glp-1
5263150|NCT02370745|Skeletal muscle metabolism|skeletal muscle metabolism
5263151|NCT02370745|Microvascular recruitment|microvascular recruitment
5263153|NCT02370745|Microvascular blood flow|microvascular blood flow
5263154|NCT02370732|Alcohol|alcohol
5363239|NCT01887600|anemia|anemia
5263156|NCT02370732|Roux en Y Gastric bypass|roux en y gastric bypass
5263157|NCT02370732|Alcohol impairment|alcohol impairment
5263158|NCT02370732|Alcohol reinforcement|alcohol reinforcement
5263159|NCT02370732|Alcohol pharmacokinetics|alcohol pharmacokinetics
5263160|NCT02370719|Diabetes mellitus|diabetes mellitus
5263161|NCT02370719|Randomized controlled trial|randomized controlled trial
5263162|NCT02370719|Primary care|primary care
5263163|NCT02370719|Physical activity|physical activity
5263164|NCT02370719|Lifestyle|lifestyle
5263165|NCT02370719|Blood glucose|blood glucose
5263166|NCT02370719|Mobile health|mobile health
5263168|NCT02370719|Self-management|self-management
5263169|NCT02370706|PIM447|pim447
5263170|NCT02370706|LGH447|lgh447
5263171|NCT02370706|PIM inhibitor|pim inhibitor
5263172|NCT02370706|LEE011|lee011
5263173|NCT02370706|CDK 4/6 inhibitor|cdk 4/6 inhibitor
5263174|NCT02370706|ruxolitinib|ruxolitinib
5263175|NCT02370706|INC424|inc424
5263176|NCT02370706|Jakavi®|jakavi®
5263177|NCT02370706|Jakafi®|jakafi®
5263178|NCT02370706|INCB18424|incb18424
5263179|NCT02370706|JAK inhibitor|jak inhibitor
5263180|NCT02370706|myelofibrosis|myelofibrosis
5263181|NCT02370706|PMF|pmf
5263182|NCT02370706|PPV-MF|ppv-mf
5263183|NCT02370706|PET-MF|pet-mf
5263184|NCT02370693|mycophenolate|mycophenolate
5263185|NCT02370693|lung scarring|lung scarring
5263186|NCT02370680|Antiplatelet|antiplatelet
5263192|NCT02370680|coronary artery disease|coronary artery disease
5263193|NCT02370680|diabetes mellitus|diabetes mellitus
5263194|NCT02370667|Exercise|exercise
5263195|NCT02370667|Magnetic Resonance Imaging|magnetic resonance imaging
5263197|NCT02370654|Tai chi|tai chi
5263198|NCT02370654|Pulmonary rehabilitation|pulmonary rehabilitation
5263199|NCT02370641|urolithin A|urolithin a
5263200|NCT02370641|microflora|microflora
5263201|NCT02370628|percutaneous vertebroplasty|percutaneous vertebroplasty
5263202|NCT02370628|facet block|facet block
5263203|NCT02370602|Drug therapy|drug therapy
5263204|NCT02370589|Ebola|ebola
5263205|NCT02370537|omega-3 carboxylic acid|omega-3 carboxylic acid
5263206|NCT02370498|Gastric cancer|gastric cancer
5263207|NCT02370498|Gastroesophageal junction cancer|gastroesophageal junction cancer
5263208|NCT02370498|PD1|pd1
5263209|NCT02370498|PD-1|pd-1
5263210|NCT02370498|PDL1|pdl1
5263211|NCT02370498|PD-L1|pd-l1
5263212|NCT02370472|Ultrasound|ultrasound
5263213|NCT02370472|Image|image
5263214|NCT02370472|Learning Tool|learning tool
5263215|NCT02370472|Ultrasound Guide Procedures|ultrasound guide procedures
5263216|NCT02370472|Simulated Setting|simulated setting
5263217|NCT02370459|Papillomavirus Vaccines|papillomavirus vaccines
5263218|NCT02370459|Immunization|immunization
5263219|NCT02370459|Quality Improvement|quality improvement
5263220|NCT02370459|Adolescent Health Services|adolescent health services
5263221|NCT02370446|Medication Log|medication log
5263222|NCT02370446|15-008|15-008
5263223|NCT02370433|Spinal Cord Injury|spinal cord injury
5263224|NCT02370433|Neurogenic Bowel|neurogenic bowel
5263225|NCT02370433|Bowel Evacuation|bowel evacuation
5263226|NCT02370420|Platelet-rich plasma|platelet-rich plasma
5263227|NCT02370420|Osteoarthritis|osteoarthritis
5263228|NCT02370407|surgical education|surgical education
5263229|NCT02370407|minimally invasive surgical procedures|minimally invasive surgical procedures
5263230|NCT02370407|laparoscopic simulation|laparoscopic simulation
5263231|NCT02370407|robotic simulation|robotic simulation
5263232|NCT02370407|medical education|medical education
5263233|NCT02370394|Intimate Partner Violence|intimate partner violence
5263234|NCT02370394|Perinatal Women|perinatal women
5263235|NCT02370394|Mental Health|mental health
5263236|NCT02370316|metacognition|metacognition
5263237|NCT02370316|MRI|mri
5263238|NCT02370316|Psychotherapy|psychotherapy
5263239|NCT02370251|Fat Emulsions, Intravenous|fat emulsions, intravenous
5263240|NCT02370251|Parenteral-Nutrition-Associated Liver Disease|parenteral-nutrition-associated liver disease
5263241|NCT02370251|Cholestasis|cholestasis
5263242|NCT02370251|Omegaven|omegaven
5263243|NCT02370251|Fish Oil|fish oil
5263244|NCT02370238|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
5263245|NCT02370238|Cancer Stem Cells|cancer stem cells
5263246|NCT02370225|sjogren's syndrome|sjogren's syndrome
5263247|NCT02370225|aerobic exercise|aerobic exercise
5263248|NCT02370225|fatigue|fatigue
5263249|NCT02370212|Creatine|creatine
5263250|NCT02370212|interval training|interval training
5263251|NCT02370212|effects on performance|effects on performance
5263252|NCT02370173|PTSD|ptsd
5263253|NCT02370173|Stress|stress
5263254|NCT02370173|Sleep Problems|sleep problems
5263255|NCT02370173|Brain imaging|brain imaging
5263259|NCT02370147|randomized controlled trial|randomized controlled trial
5263260|NCT02370147|telephone follow-up intervention|telephone follow-up intervention
5263261|NCT02370121|Gymnema Sylvestre|gymnema sylvestre
5263262|NCT02370121|Insulin Secretion|insulin secretion
5263263|NCT02370121|Insulin Sensitivity|insulin sensitivity
5263265|NCT02370108|electrical muscle stimulation|electrical muscle stimulation
5263266|NCT02370108|parkinson's disease|parkinson's disease
5263267|NCT02370108|rest tremor|rest tremor
5263268|NCT02370108|tremor reduction|tremor reduction
5263270|NCT02370095|Acute Lung Injury|acute lung injury
5263271|NCT02370095|Acute Respiratory Failure|acute respiratory failure
5263272|NCT02370082|lumpectomy|lumpectomy
5263273|NCT02370082|breast conserving surgery|breast conserving surgery
5263274|NCT02370030|sepsis|sepsis
5263275|NCT02370030|citrulline|citrulline
5263276|NCT02370030|endothelial|endothelial
5263277|NCT02370030|toxemia|toxemia
5263278|NCT02370030|endothelial determination of progression|endothelial determination of progression
5263279|NCT02370030|with vs without citrulline|with vs without citrulline
5263280|NCT02370017|Autologous Ex vivo-expanded NK cell enriched lymphocytes|autologous ex vivo-expanded nk cell enriched lymphocytes
5263281|NCT02370004|Asthma|asthma
5263282|NCT02370004|RFST|rfst
5263283|NCT02370004|Bronchial Diseases|bronchial diseases
5263284|NCT02370004|Respiratory Tract Diseases|respiratory tract diseases
5263285|NCT02370004|Lung Diseases, Obstructive|lung diseases, obstructive
5263286|NCT02370004|Lung Diseases|lung diseases
5263287|NCT02369991|latissimus dorsi flap|latissimus dorsi flap
5263288|NCT02369991|bone transport|bone transport
5263289|NCT02369991|bone reconstruction|bone reconstruction
5263290|NCT02369991|tibia|tibia
5263291|NCT02369991|tibial fracture|tibial fracture
5263292|NCT02369978|Trypanocidal therapy|trypanocidal therapy
5263293|NCT02369978|Benznidazole|benznidazole
5263294|NCT02369978|Nifurtimox|nifurtimox
5263295|NCT02369978|Polymerase chain reaction|polymerase chain reaction
5263296|NCT02369978|Randomized trial|randomized trial
5263298|NCT02369965|AIDS|aids
5263299|NCT02369965|Albuvirtide|albuvirtide
5263300|NCT02369965|Treatment-experienced|treatment-experienced
5263301|NCT02369965|Fusion inhibitor|fusion inhibitor
5263302|NCT02369939|anal carcinoma|anal carcinoma
5263303|NCT02369939|hyperthermia|hyperthermia
5263304|NCT02369939|radiotherapy|radiotherapy
5263305|NCT02369939|chemotherapy|chemotherapy
5263306|NCT02369939|radiochemotherapy|radiochemotherapy
5263307|NCT02369926|multiple sclerosis|multiple sclerosis
5263308|NCT02369926|telemedicine|telemedicine
5263309|NCT02369926|remote monitoring|remote monitoring
5263310|NCT02369926|lisinopril|lisinopril
5263311|NCT02369900|Esmolol|esmolol
5263312|NCT02369900|Septic Shock|septic shock
5263313|NCT02369900|Hypotension|hypotension
5263314|NCT02369900|Tachycardia|tachycardia
5263315|NCT02369887|MSM/TG who agree to start PrEP|msm/tg who agree to start prep
5263316|NCT02369874|Head and Neck cancer; MEDI4736; Tremelimumab|head and neck cancer; medi4736; tremelimumab
5263317|NCT02369822|Vitamin C|vitamin c
5263318|NCT02369822|convulsions status|convulsions status
5263319|NCT02369822|EEG|eeg
5263320|NCT02369822|children|children
5263321|NCT02369809|Ischemia|ischemia
5263322|NCT02369796|Drug therapy|drug therapy
5263323|NCT02369770|Acute Stroke|acute stroke
5263324|NCT02369770|Robotic therapy|robotic therapy
5263325|NCT02369770|Ankle impairment|ankle impairment
5263326|NCT02369744|Ureteral calculus|ureteral calculus
5263327|NCT02369744|Ureterolithiasis|ureterolithiasis
5263328|NCT02369744|Ureteral stone|ureteral stone
5263329|NCT02369744|Kidney stone|kidney stone
5263330|NCT02369744|Medical expulsive therapy|medical expulsive therapy
5263331|NCT02369744|tamsulosin|tamsulosin
5263332|NCT02369744|silodosin|silodosin
5263333|NCT02369744|rapaflo|rapaflo
5263334|NCT02369744|flomax|flomax
5263335|NCT02369679|upper limb|upper limb
5263336|NCT02369679|lymphedema|lymphedema
5263337|NCT02369666|Inflammation|inflammation
5263338|NCT02369666|Lycopene|lycopene
5263339|NCT02369666|Exercise|exercise
5263340|NCT02369653|Anticoagulation|anticoagulation
5263341|NCT02369614|rTMS - repetitive transcranial magnetic stimulation|rtms - repetitive transcranial magnetic stimulation
5263342|NCT02369614|CAPS - Clinician Administered PTSD Scale|caps - clinician administered ptsd scale
5263343|NCT02369601|amniorrhexis|amniorrhexis
5263344|NCT02369601|Ruptured membranes|ruptured membranes
5263345|NCT02369601|Alfa-fetoprotein|alfa-fetoprotein
5263346|NCT02369562|Dental implants|dental implants
5263347|NCT02369562|Periodontal Bone Loss|periodontal bone loss
5263351|NCT02369536|NAFLD|nafld
5263352|NCT02369536|nutraceutical mixture|nutraceutical mixture
5263353|NCT02369523|Primary Total Knee Arthroplasty|primary total knee arthroplasty
5263354|NCT02369510|spinal anesthesia|spinal anesthesia
5263355|NCT02369510|epinephrine|epinephrine
5263357|NCT02369510|repeat cesarean|repeat cesarean
5263358|NCT02369484|Stage IIIb/ IV NSCLC harbouring HER2 exon 20 mutations|stage iiib/ iv nsclc harbouring her2 exon 20 mutations
5263359|NCT02369471|Cannabidivarin|cannabidivarin
5263360|NCT02369471|CBDV|cbdv
5263361|NCT02369471|GWP42006|gwp42006
5263362|NCT02369432|Drug carriers|drug carriers
5263363|NCT02369432|Polymeric microparticles|polymeric microparticles
5263364|NCT02369432|Preferential accumulation in inflamed skin|preferential accumulation in inflamed skin
5263365|NCT02369432|Atopic dermatitis|atopic dermatitis
5263366|NCT02369432|Pilosebaceous follicles|pilosebaceous follicles
5263367|NCT02369432|Selective drug delivery|selective drug delivery
5263368|NCT02369432|Drug reservoir|drug reservoir
5263369|NCT02369419|frailty|frailty
5263374|NCT02369406|Antiretroviral Therapy|antiretroviral therapy
5263375|NCT02369393|Internet based treatment|internet based treatment
5263376|NCT02369393|Depression|depression
5263377|NCT02369393|Efficacy|efficacy
5263378|NCT02369393|Cost-effectiveness|cost-effectiveness
5263379|NCT02369393|Behavioral Activation|behavioral activation
5263380|NCT02369393|Self-applied|self-applied
5263381|NCT02369393|Ecological Momentary Assessment|ecological momentary assessment
5263382|NCT02369393|Physical Activity|physical activity
5263383|NCT02369354|Kidney Transplant|kidney transplant
5263384|NCT02369354|African Americans|african americans
5423270|NCT01616420|treatment|treatment
5263387|NCT02369341|Seasonal flu|seasonal flu
5263388|NCT02369341|Fluarix Tetra|fluarix tetra
5263389|NCT02369341|Adults|adults
5263390|NCT02369341|Immunogenicity|immunogenicity
5263391|NCT02369341|Reactogenicity|reactogenicity
5263392|NCT02369341|Influenza|influenza
5263393|NCT02369315|child development|child development
5263394|NCT02369315|music training|music training
5263395|NCT02369315|self-regulation|self-regulation
5263396|NCT02369315|exposure to violence|exposure to violence
5263397|NCT02369276|neck dissection surgery|neck dissection surgery
5263398|NCT02369276|shoulder disability|shoulder disability
5263399|NCT02369276|musculoskeletal ultrasonography|musculoskeletal ultrasonography
5263400|NCT02369263|Deep Vein Thrombosis|deep vein thrombosis
5263402|NCT02369263|Leg Swelling|leg swelling
5263403|NCT02369263|Leg Pain|leg pain
5263404|NCT02369263|Blood Clot|blood clot
5263405|NCT02369250|regeneration|regeneration
5263406|NCT02369250|surgical therapy|surgical therapy
5263407|NCT02369250|furcation defect|furcation defect
5263408|NCT02369211|acetaminophen|acetaminophen
5263409|NCT02369172|Herpes|herpes
5263410|NCT02369172|volunteers|volunteers
5263411|NCT02369172|drug-drug interaction|drug-drug interaction
5263412|NCT02369120|patient education|patient education
5263413|NCT02369120|pain cognitions|pain cognitions
5263414|NCT02369107|acupuncture|acupuncture
5263415|NCT02369107|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5263416|NCT02369094|Frailty|frailty
5263417|NCT02369094|Frail elderly|frail elderly
5263418|NCT02369094|Acupressure|acupressure
5263419|NCT02369094|Pragmatic Randomised Controlled Trial|pragmatic randomised controlled trial
5263420|NCT02369081|Hypertension|hypertension
5263421|NCT02369055|Rehabilitation|rehabilitation
5263422|NCT02369029|Phase I|phase i
5263423|NCT02369029|Dose escalation|dose escalation
5263424|NCT02369029|NUT-midline carcinoma|nut-midline carcinoma
5263425|NCT02369029|Acute Leucemia|acute leucemia
5263426|NCT02369029|Lymphoma|lymphoma
5263427|NCT02369029|Melanoma|melanoma
5263428|NCT02369029|Myeloma|myeloma
5263430|NCT02369029|NSCLC|nsclc
5263433|NCT02369003|Deep Brain Stimulation|deep brain stimulation
5263434|NCT02369003|Schwann Cells|schwann cells
5263435|NCT02368990|NSCLC|nsclc
5263436|NCT02368990|T790M|t790m
5263437|NCT02368990|EGFR|egfr
5263438|NCT02368990|TKI Resistance|tki resistance
5263439|NCT02368990|Non Small Cell Lung Cancer|non small cell lung cancer
5263440|NCT02368990|AZD9291|azd9291
5263441|NCT02368990|Clovis|clovis
5263442|NCT02368977|Colonoscopy|colonoscopy
5263443|NCT02368977|Polyps|polyps
5263444|NCT02368977|Adenomas|adenomas
5263445|NCT02368964|double triggering|double triggering
5263446|NCT02368964|Oocyte maturation|oocyte maturation
5263447|NCT02368964|GNRH Agonist|gnrh agonist
5263448|NCT02368964|hCG|hcg
5263449|NCT02368964|IVF treatment|ivf treatment
5263450|NCT02368964|immature oocytes|immature oocytes
5263451|NCT02368951|Phase 1|phase 1
5263452|NCT02368951|Solid Tumors|solid tumors
5263453|NCT02368951|FGFR2|fgfr2
5263454|NCT02368951|Antibody drug conjugate|antibody drug conjugate
5263455|NCT02368938|Cardiovascular risk factors|cardiovascular risk factors
5263456|NCT02368938|Prospective study|prospective study
5263457|NCT02368938|Mortality|mortality
5263458|NCT02368938|Cardiovascular events|cardiovascular events
5263459|NCT02368938|Asymptomatic target organ damage|asymptomatic target organ damage
5263460|NCT02368938|elderly Chinese|elderly chinese
5263461|NCT02368925|Rhytids|rhytids
5263462|NCT02368925|Skin Laxity|skin laxity
5263463|NCT02368912|Phase 1|phase 1
5263464|NCT02368912|ASP1707|asp1707
5263465|NCT02368912|Dose escalation|dose escalation
5263466|NCT02368912|Food effect|food effect
5263467|NCT02368912|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5263468|NCT02368912|Healthy subjects|healthy subjects
5263469|NCT02368912|Single ascending dose|single ascending dose
5263470|NCT02368912|Multiple ascending dose|multiple ascending dose
5263471|NCT02368899|technology|technology
5263472|NCT02368899|information science|information science
5263473|NCT02368899|health care|health care
5263474|NCT02368873|prevention|prevention
5263475|NCT02368847|Aged|aged
5263476|NCT02368847|Psychiatric Hospitals|psychiatric hospitals
5263477|NCT02368821|cytotrophoblast|cytotrophoblast
5263478|NCT02368821|syncytiotrophoblast|syncytiotrophoblast
5263479|NCT02368821|placentas|placentas
5263480|NCT02368821|intrauterine growth restriction|intrauterine growth restriction
5263481|NCT02368821|preeclampsia|preeclampsia
5263482|NCT02368821|placenta accrete|placenta accrete
5263483|NCT02368808|orphans and vulnerable children|orphans and vulnerable children
5263484|NCT02368808|South Africa|south africa
5263485|NCT02368808|peer support group|peer support group
5263486|NCT02368795|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5263487|NCT02368795|Pancreatic duct stenting|pancreatic duct stenting
5263488|NCT02368795|Post-ERCP pancreatitis|post-ercp pancreatitis
5263495|NCT02368678|Halitosis|halitosis
5263496|NCT02368678|Sulfur compounds|sulfur compounds
5263497|NCT02368678|Periodontitis|periodontitis
5263498|NCT02368678|Periodontal treatment|periodontal treatment
5263499|NCT02368600|lifestyle intervention|lifestyle intervention
5263500|NCT02368600|gestational diabetes mellitus|gestational diabetes mellitus
5263502|NCT02368600|prevention|prevention
5263503|NCT02368587|intracoronary infusion|intracoronary infusion
5263504|NCT02368587|intravenous infusion|intravenous infusion
5263505|NCT02368587|Wharton's jelly-derived mesenchymal stem cells|wharton's jelly-derived mesenchymal stem cells
5263506|NCT02368587|ischemic Cardiomyopathy|ischemic cardiomyopathy
5263507|NCT02368587|heart function|heart function
5263508|NCT02368548|Pharmaceutical care|pharmaceutical care
5263509|NCT02368548|Emergency Service|emergency service
5263510|NCT02368535|teamwork|teamwork
5263511|NCT02368509|sensory test|sensory test
5263512|NCT02368509|olfaction|olfaction
5263513|NCT02368509|gustation|gustation
5263514|NCT02368509|taste|taste
5263515|NCT02368509|cancer|cancer
5263516|NCT02368496|Long-term parenteral nutrition|long-term parenteral nutrition
5263517|NCT02368496|HR-pQCT|hr-pqct
5263519|NCT02368496|Bone trophicity|bone trophicity
5263520|NCT02368457|Mandibular osteoradionecrosis|mandibular osteoradionecrosis
5263521|NCT02368457|Tocopherol|tocopherol
5263522|NCT02368457|pentoxifylline|pentoxifylline
5263523|NCT02368457|vitamine E|vitamine e
5263524|NCT02368457|wounds and injuries|wounds and injuries
5263525|NCT02368457|antioxidants|antioxidants
5263526|NCT02368457|free radical scavengers|free radical scavengers
5263527|NCT02368457|radiation-protective agents|radiation-protective agents
5263528|NCT02368457|vasodilatadors agents|vasodilatadors agents
5263529|NCT02368457|osteonecrosis|osteonecrosis
5263530|NCT02368457|mandible|mandible
5263531|NCT02368457|extraoral fistula|extraoral fistula
5263532|NCT02368457|exposed bone|exposed bone
5263533|NCT02368457|necrotic bone|necrotic bone
5263534|NCT02368457|head and neck radiotherapy|head and neck radiotherapy
5263535|NCT02368444|Posttraumatic Stress|posttraumatic stress
5263536|NCT02368444|Sleep|sleep
5263537|NCT02368431|Alcohol Use Disorder|alcohol use disorder
5263538|NCT02368431|Alcoholism|alcoholism
5263539|NCT02368431|Alcohol Dependence|alcohol dependence
5263540|NCT02368431|Zonisamide|zonisamide
5263541|NCT02368431|Alcoholic Intoxication|alcoholic intoxication
5263542|NCT02368431|Drinking Behaviors|drinking behaviors
5263543|NCT02368431|Anticonvulsants|anticonvulsants
5263544|NCT02368418|Cardiovascular disease|cardiovascular disease
5263545|NCT02368418|Rural health|rural health
5263546|NCT02368418|China|china
5263547|NCT02368418|Cohort study|cohort study
5263548|NCT02368392|in-hospital cardiac arrest|in-hospital cardiac arrest
5263549|NCT02368392|quality of life after cardiac arrest|quality of life after cardiac arrest
5263550|NCT02368392|survival after cardiac arrest|survival after cardiac arrest
5263551|NCT02368392|resources for cardiac arrest|resources for cardiac arrest
5263552|NCT02368379|Metyrapone|metyrapone
5263553|NCT02368379|ACTH stimulation test|acth stimulation test
5263554|NCT02368314|Deep vein thrombosis|deep vein thrombosis
5263555|NCT02368314|Prophylaxis|prophylaxis
5263556|NCT02368314|Sodium enoxaparin|sodium enoxaparin
5263557|NCT02368288|chronic hepatitic B|chronic hepatitic b
5263558|NCT02368288|peginterferon|peginterferon
5263560|NCT02368288|entecavir|entecavir
5263561|NCT02368262|Cerebral Palsy|cerebral palsy
5263562|NCT02368262|Risk factors|risk factors
5263563|NCT02368262|Child|child
5263564|NCT02368262|urinary incontinence|urinary incontinence
5263565|NCT02368236|Early Detection of Cancer|early detection of cancer
5263566|NCT02368236|Intervention Studies|intervention studies
5263567|NCT02368236|Randomized Controlled Trial|randomized controlled trial
5263568|NCT02368236|Colorectal Neoplasms|colorectal neoplasms
5263569|NCT02368236|Colonic Neoplasms|colonic neoplasms
5263570|NCT02368223|Children|children
5263571|NCT02368223|Rehabilitation|rehabilitation
5263572|NCT02368223|Telerehabilitation|telerehabilitation
5263573|NCT02368223|Upper limb therapy|upper limb therapy
5263574|NCT02368197|dialysis fistula|dialysis fistula
5263575|NCT02368197|cephalic arch stenosis|cephalic arch stenosis
5263576|NCT02368197|balloon angioplasty|balloon angioplasty
5263577|NCT02368197|drug eluting balloon|drug eluting balloon
5263578|NCT02368184|noninvasive physiologic monitoring|noninvasive physiologic monitoring
5263599|NCT02368054|Heart Rate|heart rate
5263600|NCT02368054|Hemodynamics|hemodynamics
5263601|NCT02368054|Total Peripheral Resistance|total peripheral resistance
5263602|NCT02368054|Blood Pressure|blood pressure
5263603|NCT02368054|Paracervical block|paracervical block
5263604|NCT02368054|LiDCO|lidco
5263605|NCT02368054|Adrenaline|adrenaline
5263606|NCT02368054|Conization|conization
5263607|NCT02368054|PulsCO|pulsco
5263608|NCT02368028|Plaque|plaque
5263609|NCT02368028|Saliva|saliva
5263610|NCT02368028|Dental Caries|dental caries
5263611|NCT02368015|Penetration|penetration
5263612|NCT02368015|Cefazolin|cefazolin
5263613|NCT02368015|Hepatic cyst|hepatic cyst
5263614|NCT02368002|obesity|obesity
5263615|NCT02368002|diet, reducing|diet, reducing
5263616|NCT02367989|Glucose response|glucose response
5263617|NCT02367989|Insulin response|insulin response
5263618|NCT02367989|Satiety|satiety
5263619|NCT02367963|Peer education|peer education
5263620|NCT02367963|Comprehensive health intervention|comprehensive health intervention
5263621|NCT02367963|Lifestyle|lifestyle
5263622|NCT02367963|Adult|adult
5263623|NCT02367963|Mid age|mid age
5263624|NCT02367963|Male|male
5263625|NCT02367963|Female|female
5263626|NCT02367963|Human|human
5263627|NCT02367963|Clinical trial|clinical trial
5263628|NCT02367963|Prevention and control|prevention and control
5263629|NCT02367963|Cardiovascular Disease|cardiovascular disease
5263630|NCT02367963|Behavior|behavior
5263631|NCT02367963|Risk Factors|risk factors
5158823|NCT02999360|Aphasia|aphasia
5263632|NCT02367963|Healthy lifestyle|healthy lifestyle
5263633|NCT02367963|Healthy people program|healthy people program
5263634|NCT02367963|Peer-group|peer-group
5263635|NCT02367937|Phase I drug-drug interaction|phase i drug-drug interaction
5263636|NCT02367898|Cognitive Training|cognitive training
5263637|NCT02367898|Lumosity|lumosity
5263638|NCT02367898|Crossword Puzzles|crossword puzzles
5263639|NCT02367885|Prevention|prevention
5263640|NCT02367872|Drug therapy|drug therapy
5263641|NCT02367859|ameloblastoma|ameloblastoma
5263642|NCT02367859|BRAF|braf
5263643|NCT02367859|odontogenic cancer|odontogenic cancer
5263644|NCT02367859|adamantinoma|adamantinoma
5263645|NCT02367846|Calcium Tracer|calcium tracer
5263646|NCT02367846|Oral Contraceptives|oral contraceptives
5263647|NCT02367846|Contraceptive Vaginal Ring|contraceptive vaginal ring
5263648|NCT02367846|Impact of contraceptives on bone health using 41Ca|impact of contraceptives on bone health using 41ca
5263649|NCT02367833|Insulin-like growth factor-1|insulin-like growth factor-1
5263650|NCT02367833|Combined oral contraceptive|combined oral contraceptive
5263651|NCT02367833|Contraceptive Vaginal Ring|contraceptive vaginal ring
5263652|NCT02367833|Transdermal Contraceptive|transdermal contraceptive
5263653|NCT02367807|HIV prevention|hiv prevention
5263654|NCT02367807|PrEP|prep
5263655|NCT02367807|young men who have sex with men|young men who have sex with men
5263656|NCT02367807|Truvada|truvada
5263657|NCT02367768|trauma blue|trauma blue
5263658|NCT02367768|major trauma|major trauma
5263659|NCT02367768|cohort study|cohort study
5363863|NCT01884597|PCV|pcv
5263660|NCT02367768|prognostic factor|prognostic factor
5263661|NCT02367768|Healing Time|healing time
5263662|NCT02367768|Post Operative|post operative
5263663|NCT02367755|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5263664|NCT02367755|cardiac arrest|cardiac arrest
5263665|NCT02367755|therapeutic hypothermia|therapeutic hypothermia
5263666|NCT02367755|propofol|propofol
5263667|NCT02367755|lorazepam|lorazepam
5263668|NCT02367755|cerebral perfusion|cerebral perfusion
5263670|NCT02367742|Diet|diet
5263671|NCT02367742|Physical Activity|physical activity
5263672|NCT02367742|NAFLD|nafld
5263673|NCT02367703|Mini-laparoscopy|mini-laparoscopy
5268757|NCT02338622|AZD5363|azd5363
5263674|NCT02367703|hysterectomy|hysterectomy
5263675|NCT02367703|Benign uterine diseases|benign uterine diseases
5263676|NCT02367703|Operative time|operative time
5263678|NCT02367690|Foot Ulcers|foot ulcers
5263679|NCT02367690|DFU|dfu
5263680|NCT02367690|KPT-330|kpt-330
5263681|NCT02367690|Selinexor|selinexor
5263682|NCT02367690|Karyopharm|karyopharm
5263683|NCT02367677|Photo|photo
5263684|NCT02367664|Japanese encephalitis|japanese encephalitis
5263685|NCT02367664|immunogenicity|immunogenicity
5263686|NCT02367664|safety|safety
5263687|NCT02367664|vaccine|vaccine
5263688|NCT02367651|Soft tissue sarcoma|soft tissue sarcoma
5263689|NCT02367651|Pazopanib|pazopanib
5263690|NCT02367651|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5263691|NCT02367599|PrEP|prep
5263692|NCT02367599|Pre exposure Prophylaxis|pre exposure prophylaxis
5263693|NCT02367599|Truvada|truvada
5263694|NCT02367599|CCTG|cctg
5263695|NCT02367599|595|595
5263696|NCT02367599|Vitamin D|vitamin d
5263697|NCT02367599|Bone mineral density|bone mineral density
5263698|NCT02367521|TBI Depression|tbi depression
5263699|NCT02367521|co-morbid psychiatric symptoms|co-morbid psychiatric symptoms
5263700|NCT02367508|advance care planning|advance care planning
5263701|NCT02367508|coping skills|coping skills
5263702|NCT02367508|mindfulness|mindfulness
5263703|NCT02367508|meditation|meditation
5263704|NCT02367508|cancer|cancer
5263705|NCT02367508|adult|adult
5263706|NCT02367508|caregivers|caregivers
5263707|NCT02367508|oncology providers|oncology providers
5263708|NCT02367508|advance directives|advance directives
5263709|NCT02367508|anxiety|anxiety
5263710|NCT02367508|depression|depression
5263711|NCT02367508|quality of life|quality of life
5263712|NCT02367508|pilot project|pilot project
5263713|NCT02367495|Coronary Restenosis|coronary restenosis
5263714|NCT02367495|restenosis|restenosis
5263715|NCT02367495|paclitaxel-coated balloon|paclitaxel-coated balloon
5263716|NCT02367495|drug-eluting stent|drug-eluting stent
5263717|NCT02367495|drug-coated balloon|drug-coated balloon
5263718|NCT02367495|coronary angiography|coronary angiography
5263719|NCT02367482|rGBM|rgbm
5263720|NCT02367482|Recurrent GBM|recurrent gbm
5263721|NCT02367482|Recurrent Glioblastoma|recurrent glioblastoma
5263722|NCT02367469|recurrent brain tumors|recurrent brain tumors
5263723|NCT02367469|brain tumors|brain tumors
5263724|NCT02367469|Newly diagnosed brain tumors|newly diagnosed brain tumors
5263725|NCT02367456|MDS|mds
5263726|NCT02367456|AML|aml
5263727|NCT02367456|CMML|cmml
5263728|NCT02367443|radiotherapy|radiotherapy
5263729|NCT02367443|therapeutic use|therapeutic use
5263730|NCT02367443|Radiation|radiation
5263731|NCT02367443|non-small cell lung cancer|non-small cell lung cancer
5263732|NCT02367443|chemotherapy|chemotherapy
5263733|NCT02367417|Revision|revision
5263734|NCT02367417|Knee Joint|knee joint
5263735|NCT02367417|PMCF|pmcf
5263736|NCT02367417|Endo-Modell SL|endo-modell sl
5263737|NCT02367378|Minimally invasive surgery|minimally invasive surgery
5263738|NCT02367365|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5263739|NCT02367365|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5263740|NCT02367365|neovascular lesion morphology|neovascular lesion morphology
5263741|NCT02367365|indocyanine green angiography|indocyanine green angiography
5263742|NCT02367365|persistent disease activity|persistent disease activity
5263743|NCT02367352|Drug therapy|drug therapy
5263744|NCT02367352|Dose escalation|dose escalation
5263745|NCT02367352|Dose expansion|dose expansion
5263746|NCT02367339|Critical Care|critical care
5263747|NCT02367339|Nursing staff|nursing staff
5263748|NCT02367339|Medical staff|medical staff
5263749|NCT02367339|Extended-spectrum betalactamase|extended-spectrum betalactamase
5263750|NCT02367339|Digestive tract colonization|digestive tract colonization
5263751|NCT02367339|Cross-contamination|cross-contamination
5263752|NCT02367326|score|score
5263753|NCT02367326|inflammatory bowel disease|inflammatory bowel disease
5263754|NCT02367326|crohn's disease|crohn's disease
5263755|NCT02367326|ulcerative colitis|ulcerative colitis
5263756|NCT02367326|clinical response|clinical response
5263757|NCT02367326|thiopurines|thiopurines
5263758|NCT02367313|Symptomatic Human Rhinovirus Infection|symptomatic human rhinovirus infection
5263759|NCT02367313|Moderate to Severe Asthma|moderate to severe asthma
5263760|NCT02367313|Antiviral|antiviral
5263762|NCT02367313|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5263763|NCT02367313|Aviragen Therapeutics|aviragen therapeutics
5263764|NCT02367313|Aviragen|aviragen
5263765|NCT02367287|Diet|diet
5263766|NCT02367287|Phenotype|phenotype
5263767|NCT02367287|Immunology|immunology
5263768|NCT02367287|Microbiota|microbiota
5263769|NCT02367287|Metabolomics|metabolomics
5263770|NCT02367287|Physical activity|physical activity
5263771|NCT02367287|Neuroendocrine system|neuroendocrine system
5263775|NCT02367248|Deferoxamine|deferoxamine
5263776|NCT02367248|Xingnaojing injection|xingnaojing injection
5263777|NCT02367248|Hematoma edema|hematoma edema
5263779|NCT02367235|sacrocolpopexy|sacrocolpopexy
5263780|NCT02367235|Colpassist|colpassist
5263781|NCT02367235|vaginal positioning device|vaginal positioning device
5263782|NCT02367209|FD MRI|fd mri
5263783|NCT02367209|COPD|copd
5263784|NCT02367209|SPECT/CT|spect/ct
5263785|NCT02367209|DCE MRI|dce mri
5263786|NCT02367196|CC-90002|cc-90002
5263787|NCT02367196|Monoclonal|monoclonal
5263788|NCT02367196|Antibody|antibody
5263789|NCT02367196|CD47|cd47
5263790|NCT02367196|Advanced|advanced
5263791|NCT02367196|Solid Cancers|solid cancers
5263792|NCT02367196|Hematologic Cancers|hematologic cancers
5263793|NCT02367183|Crohn's Disease|crohn's disease
5263794|NCT02367183|Active Crohn's Disease|active crohn's disease
5263795|NCT02367183|GED-0301|ged-0301
5263796|NCT02367183|Endoscopic|endoscopic
5263797|NCT02367183|Double-Blind|double-blind
5263799|NCT02367183|Mongersen|mongersen
5263800|NCT02367170|respiratory dysfunction|respiratory dysfunction
5263801|NCT02367170|chronic critical illness|chronic critical illness
5263802|NCT02367170|diaphragm weakness|diaphragm weakness
5263803|NCT02367170|sepsis|sepsis
5263804|NCT02367170|ventilator dependance|ventilator dependance
5263805|NCT02367118|chronic rhinosinusitis without nasal polyps prednisone|chronic rhinosinusitis without nasal polyps prednisone
5263806|NCT02367105|Obesity|obesity
5263807|NCT02367105|Hypogonadism|hypogonadism
5263808|NCT02367105|Frailty|frailty
5263809|NCT02367092|Liver Transplantation|liver transplantation
5263810|NCT02367066|patients|patients
5263811|NCT02367066|glycaemic control on metformin|glycaemic control on metformin
5263812|NCT02367040|Clinical trial, Phase III|clinical trial, phase iii
5263813|NCT02367040|Phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
5263814|NCT02367040|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5263815|NCT02367040|Indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
5263816|NCT02367027|Biological Availability|biological availability
5263817|NCT02367027|Relative Bioavailability Trial|relative bioavailability trial
5263818|NCT02367014|Mitochondrial Myopathy|mitochondrial myopathy
5263819|NCT02367014|Primary Mitochondrial Disease|primary mitochondrial disease
5263820|NCT02367014|Bendavia™|bendavia™
5263821|NCT02367014|elamipretide|elamipretide
5263822|NCT02367001|general practitioner|general practitioner
5263823|NCT02367001|screening|screening
5263824|NCT02367001|participation|participation
5263825|NCT02367001|organized screening|organized screening
5263826|NCT02366988|Chronic pancreatitis|chronic pancreatitis
5263827|NCT02366988|Clinical Trial|clinical trial
5263828|NCT02366988|Bile stricture|bile stricture
5263829|NCT02366988|Endoscopy|endoscopy
5263830|NCT02366988|Surgery|surgery
5263831|NCT02366975|BPH/LUTS|bph/luts
5263833|NCT02366975|Metabolic Syndrome|metabolic syndrome
5263834|NCT02366962|Influenza|influenza
5263835|NCT02366962|Vaccine|vaccine
5263836|NCT02366962|ASP7374|asp7374
5263837|NCT02366949|Phase 1|phase 1
5263838|NCT02366949|Solid tumors|solid tumors
5263839|NCT02366949|Breast cancer|breast cancer
5263840|NCT02366949|Paclitaxel|paclitaxel
5263841|NCT02366949|MPS-1 inhibitor|mps-1 inhibitor
5133232|NCT03160430|ESRD|esrd
5263842|NCT02366949|Oncology|oncology
5263843|NCT02366884|malignant|malignant
5263844|NCT02366884|atavistic chemotherapy|atavistic chemotherapy
5263845|NCT02366884|cancer|cancer
5263846|NCT02366858|19 gauge|19 gauge
5263847|NCT02366858|22 gauge|22 gauge
5263848|NCT02366858|core tissue|core tissue
5263849|NCT02366806|Breast Cancer|breast cancer
5263850|NCT02366806|AJCC Stage 1, 2, 3|ajcc stage 1, 2, 3
5263851|NCT02366806|Educational Design|educational design
5263852|NCT02366806|Radiation Therapy Treatment|radiation therapy treatment
5263853|NCT02366793|accessory mobilization, nerve mobilization.|accessory mobilization, nerve mobilization.
5263854|NCT02366780|Lactation|lactation
5263855|NCT02366780|Breastmilk|breastmilk
5263856|NCT02366780|Macronutrients|macronutrients
5263857|NCT02366767|Insulin Infusion Systems|insulin infusion systems
5263858|NCT02366767|Continuous Glucose Monitors|continuous glucose monitors
5263859|NCT02366754|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5263860|NCT02366741|SCLC|sclc
5263861|NCT02366741|Neuro-cognitive function|neuro-cognitive function
5263862|NCT02366741|PCI|pci
5263863|NCT02366741|Hippocampal sparing|hippocampal sparing
5264062|NCT02365532|DILQTS|dilqts
5263864|NCT02366676|Recurrent cystitis|recurrent cystitis
5263865|NCT02366676|hyaluronic acid|hyaluronic acid
5263866|NCT02366676|chondroitin sulphate|chondroitin sulphate
5263867|NCT02366663|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5263868|NCT02366663|autologous stem cell transplantation|autologous stem cell transplantation
5263870|NCT02366663|Zevalin|zevalin
5263871|NCT02366663|Lymphoma|lymphoma
5263872|NCT02366663|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5263873|NCT02366663|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5263874|NCT02366663|Immune System Diseases|immune system diseases
5263875|NCT02366663|Immunoproliferative Disorders|immunoproliferative disorders
5263885|NCT02366637|COPD|copd
5263886|NCT02366637|Sputum|sputum
5263887|NCT02366611|Cancer Pain|cancer pain
5263889|NCT02366611|fNIRS|fnirs
5263890|NCT02366611|tDCS|tdcs
5263891|NCT02366546|Adoptive cell transfer|adoptive cell transfer
5263892|NCT02366546|Cell therapy|cell therapy
5263893|NCT02366546|Immunotherapy|immunotherapy
5263894|NCT02366546|NY-ESO-1|ny-eso-1
5263895|NCT02366546|Esophageal cancer|esophageal cancer
5263896|NCT02366546|Melanoma|melanoma
5263897|NCT02366546|Head and neck cancer|head and neck cancer
5263898|NCT02366546|Ovarian cancer|ovarian cancer
5263899|NCT02366546|Synovial sarcoma|synovial sarcoma
5263900|NCT02366546|TCR gene therapy|tcr gene therapy
5263901|NCT02366533|Linkage to care|linkage to care
5263902|NCT02366533|HIV|hiv
5263903|NCT02366533|Efficacy of linkage to care program|efficacy of linkage to care program
5263904|NCT02366520|Child|child
5263905|NCT02366520|Child Behavior|child behavior
5263906|NCT02366520|Dental Anxiety/prevention & control|dental anxiety/prevention & control
5263907|NCT02366520|Dental Anxiety/psychology|dental anxiety/psychology
5263908|NCT02366520|Cooperative Behavior|cooperative behavior
5263909|NCT02366520|Dental Care/psychology*|dental care/psychology*
5263910|NCT02366520|Humans|humans
5263911|NCT02366520|Videotape Recording|videotape recording
5263912|NCT02366507|hypotension|hypotension
5263913|NCT02366507|doppler|doppler
5263914|NCT02366507|shock|shock
5263915|NCT02366494|prostate cancer|prostate cancer
5263916|NCT02366494|treatment response|treatment response
5263917|NCT02366494|androgen deprivation therapy|androgen deprivation therapy
5263918|NCT02366481|Vitamin K|vitamin k
5263919|NCT02366481|Vitamin K2|vitamin k2
5263920|NCT02366481|Menaquinone-7|menaquinone-7
5263921|NCT02366481|Osteocalcin|osteocalcin
5263922|NCT02366481|Adults|adults
5263923|NCT02366481|Obesity|obesity
5263924|NCT02366481|Insulin resistance|insulin resistance
5263925|NCT02366481|Insulin sensitivity|insulin sensitivity
5263926|NCT02366481|Beta-cell function|beta-cell function
5263927|NCT02366481|Prediabetes|prediabetes
5263928|NCT02366468|Diabetic macular edema|diabetic macular edema
5263929|NCT02366468|Visual impairment|visual impairment
5263930|NCT02366442|dual/multitasking|dual/multitasking
5263931|NCT02366442|Executive function|executive function
5263932|NCT02366442|Affective function|affective function
5263933|NCT02366442|Balance|balance
5159121|NCT02997566|Heart Rate|heart rate
5263934|NCT02366416|Exercise, Physical|exercise, physical
5263935|NCT02366403|PTSD|ptsd
5263936|NCT02366403|Meditation|meditation
5263937|NCT02366403|Yoga|yoga
5263938|NCT02366403|Cognitive Therapy|cognitive therapy
5263939|NCT02366390|Psychoeducative|psychoeducative
5263940|NCT02366390|HADS|hads
5263941|NCT02366390|COPD|copd
5263942|NCT02366390|dyspnea|dyspnea
5263943|NCT02366364|NRX-1074|nrx-1074
5263944|NCT02366364|NMDA Receptor Modulator|nmda receptor modulator
5263945|NCT02366364|Major Depressive Disorder|major depressive disorder
5263946|NCT02366364|Glycine Site Modulator|glycine site modulator
5263947|NCT02366312|Keratocystic odontogenic tumor|keratocystic odontogenic tumor
5263948|NCT02366312|KCOT|kcot
5263949|NCT02366273|Diabetes|diabetes
5263950|NCT02366273|Psoriasis|psoriasis
5263951|NCT02366273|Inflammation|inflammation
5263952|NCT02366273|Insulin-resistance|insulin-resistance
5263953|NCT02366247|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
5263954|NCT02366247|Adefovir|adefovir
5263955|NCT02366247|Hepatitis B e Antigens positive|hepatitis b e antigens positive
5263956|NCT02366208|Polyethylene Glycol Thymosin alpha1|polyethylene glycol thymosin alpha1
5263957|NCT02366208|Adefovir|adefovir
5263958|NCT02366208|Hepatitis B e Antigens positive|hepatitis b e antigens positive
5263960|NCT02366195|CD8+ cell density|cd8+ cell density
5263961|NCT02366195|objective response rate|objective response rate
5263962|NCT02366195|unresected|unresected
5263963|NCT02366195|Melanoma|melanoma
5263964|NCT02366130|Breast cancer|breast cancer
5263965|NCT02366130|Hormone-positive bone-dominant metastatic breast cancer|hormone-positive bone-dominant metastatic breast cancer
5263966|NCT02366130|Ra-223 dichloride|ra-223 dichloride
5263967|NCT02366130|Xofigo|xofigo
5263973|NCT02366130|Prolia|prolia
5263974|NCT02366130|Hormone therapy|hormone therapy
5263975|NCT02366117|Quirc|quirc
5263976|NCT02366117|Quality Indiciator in Rehabilitative Care|quality indiciator in rehabilitative care
5263977|NCT02366104|Cardiovascular Diseases|cardiovascular diseases
5263978|NCT02366104|Aged|aged
5263979|NCT02366104|Primary Prevention|primary prevention
5263980|NCT02366052|Histologically confirmed NASH|histologically confirmed nash
5263981|NCT02366052|Hepatocyte Injury determined by M30 antigen|hepatocyte injury determined by m30 antigen
5263984|NCT02366013|HIV Prevention|hiv prevention
5263985|NCT02366013|HIV Vaccine|hiv vaccine
5263986|NCT02366013|Healthy|healthy
5263991|NCT02365987|postprandial|postprandial
5263992|NCT02365974|arterial stiffness|arterial stiffness
5263993|NCT02365974|resistant hypertension|resistant hypertension
5263994|NCT02365974|sympathetic system|sympathetic system
5263995|NCT02365974|blood pressure|blood pressure
5263996|NCT02365974|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5263997|NCT02365961|Hip Arthroscopy|hip arthroscopy
5263998|NCT02365948|Pharmacokinetics|pharmacokinetics
5263999|NCT02365948|Certolizumab Pegol|certolizumab pegol
5264000|NCT02365948|Healthy Chinese subjects|healthy chinese subjects
5264001|NCT02365935|adjuvant chemotherapy|adjuvant chemotherapy
5264002|NCT02365922|FTLD, PSP, CBD, PPA, FTD, FTD-ALS, CBS, ALS, svPPA, nfvPPA, oPSP|ftld, psp, cbd, ppa, ftd, ftd-als, cbs, als, svppa, nfvppa, opsp
5264003|NCT02365883|Prostate Cancer|prostate cancer
5264004|NCT02365883|Transrectal Imaging|transrectal imaging
5264005|NCT02365870|Anxiety Disorders|anxiety disorders
5264006|NCT02365870|Parkinson Disease|parkinson disease
5264007|NCT02365870|rotigotine|rotigotine
5264008|NCT02365857|spinal anesthesia|spinal anesthesia
5264009|NCT02365857|caesarian section|caesarian section
5264010|NCT02365857|Dexmedetomidine|dexmedetomidine
5264011|NCT02365844|Narrow Band Imaging|narrow band imaging
5264012|NCT02365844|oropharyngeal carcinoma|oropharyngeal carcinoma
5264013|NCT02365831|MBC|mbc
5264014|NCT02365831|breast|breast
5264015|NCT02365831|metastatic|metastatic
5264016|NCT02365831|cancer|cancer
5264017|NCT02365831|HER2|her2
5264018|NCT02365818|Bladder Cancer|bladder cancer
5264019|NCT02365805|BRCA 1 levels|brca 1 levels
5264020|NCT02365805|HER2 Negative|her2 negative
5264021|NCT02365792|Clinical Decision Support|clinical decision support
5264022|NCT02365792|Clinical Practice Guidelines|clinical practice guidelines
5264023|NCT02365792|Emergency Medical Services|emergency medical services
5264024|NCT02365779|salpingectomy|salpingectomy
5264025|NCT02365779|optical biopsy|optical biopsy
5264026|NCT02365779|Cellvizio®|cellvizio®
5264027|NCT02365766|MK-3475|mk-3475
5264028|NCT02365766|Gemcitabine|gemcitabine
5264029|NCT02365766|Cisplatin|cisplatin
5264030|NCT02365766|Pembrolizumab|pembrolizumab
5264031|NCT02365766|Neoadjuvant Bladder Cancer|neoadjuvant bladder cancer
5264032|NCT02365753|lower transverse cesarean delivery|lower transverse cesarean delivery
5264033|NCT02365753|Pregnant women|pregnant women
5264034|NCT02365740|Type 1 Diabetes mellitus|type 1 diabetes mellitus
5264035|NCT02365740|Gastric Emptying|gastric emptying
5264036|NCT02365740|Insulin Infusion Pump|insulin infusion pump
5264037|NCT02365701|Functional Dyspepsia|functional dyspepsia
5264038|NCT02365688|Open Abdominal Surgical Procedure|open abdominal surgical procedure
5264039|NCT02365675|Pemphigus|pemphigus
5264040|NCT02365675|Pemphigoid|pemphigoid
5264041|NCT02365675|Wound Healing|wound healing
5264042|NCT02365675|Itch|itch
5264043|NCT02365675|Pain|pain
5264044|NCT02365675|Wound dressing|wound dressing
5264045|NCT02365675|Topical treatment|topical treatment
5264046|NCT02365662|Oncology|oncology
5264047|NCT02365662|Cancer|cancer
5264048|NCT02365662|Solid Tumor types likely to exhibit elevated levels of Epidermal Growth Factor Receptor|solid tumor types likely to exhibit elevated levels of epidermal growth factor receptor
5264049|NCT02365662|Solid Tumors|solid tumors
5264050|NCT02365649|Crohn's Disease|crohn's disease
5264051|NCT02365623|Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)|pulmonary multi-drug resistant tuberculosis (mdr-tb)
5264052|NCT02365623|TMC207|tmc207
5264053|NCT02365623|Bedaquiline|bedaquiline
5264054|NCT02365610|Cannabidivarin|cannabidivarin
5264055|NCT02365610|CBDV|cbdv
5264056|NCT02365610|GWP42006|gwp42006
5264057|NCT02365597|Urothelial Cancer|urothelial cancer
5264059|NCT02365597|Erdafitinib|erdafitinib
5264060|NCT02365597|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5264061|NCT02365532|drug-induced long QT syndrome|drug-induced long qt syndrome
5264068|NCT02365506|Congenital Long QT Syndrome|congenital long qt syndrome
5264070|NCT02365506|Long QT2 Syndrome|long qt2 syndrome
5264071|NCT02365506|LQT2|lqt2
5264072|NCT02365506|Sudden Cardiac Death|sudden cardiac death
5264073|NCT02365493|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5264079|NCT02365441|GIST|gist
5264080|NCT02365441|Advanced|advanced
5264081|NCT02365428|Maternal welfare|maternal welfare
5264082|NCT02365402|chronic hepatitis B|chronic hepatitis b
5264083|NCT02365402|peginterferon|peginterferon
5264084|NCT02365402|sustained viral response|sustained viral response
5264085|NCT02365402|entecavir|entecavir
5264086|NCT02365402|HBeAg|hbeag
5264087|NCT02365337|Vitamin D|vitamin d
5264088|NCT02365337|time lapse monitoring|time lapse monitoring
5264089|NCT02365337|embryo|embryo
5264090|NCT02365324|culinary skills|culinary skills
5264091|NCT02365324|menu planning|menu planning
5264092|NCT02365324|grocery shopping|grocery shopping
5264093|NCT02365324|children|children
5264094|NCT02365324|healthy eating|healthy eating
5264095|NCT02365324|physical activity|physical activity
5264096|NCT02365272|pharmacokinetics|pharmacokinetics
5264097|NCT02365272|aminoglycosides|aminoglycosides
5264098|NCT02365246|atopic dermatitis|atopic dermatitis
5264099|NCT02365246|immunoadsorption|immunoadsorption
5264100|NCT02365233|Type II Diabetes|type ii diabetes
5264101|NCT02365233|Nonalcoholic fatty liver|nonalcoholic fatty liver
5264102|NCT02365194|Ventral Hernia|ventral hernia
5264103|NCT02365194|Prehabilitation|prehabilitation
5264104|NCT02365181|Shoulder arthroplasty|shoulder arthroplasty
5264105|NCT02365168|Fish allergy|fish allergy
5264106|NCT02365155|Frailty|frailty
5264107|NCT02365155|Heart failure|heart failure
5264108|NCT02365155|Physical activity|physical activity
5264109|NCT02365155|Cognitive state|cognitive state
5264110|NCT02365142|Knee Osteoarthritis|knee osteoarthritis
5264111|NCT02365142|Mesenchimal stem cell|mesenchimal stem cell
5264112|NCT02365142|Osteoarthritis|osteoarthritis
5264113|NCT02365129|BRITE adipose tissue|brite adipose tissue
5264114|NCT02365129|physical activity|physical activity
5264115|NCT02365129|Thermogenesis|thermogenesis
5264116|NCT02365129|Body Temperature Regulation|body temperature regulation
5264117|NCT02365129|Energy Metabolism|energy metabolism
5264118|NCT02365116|Peer Mentorship|peer mentorship
5264119|NCT02365116|Psychiatric Hospitalization|psychiatric hospitalization
5264120|NCT02365116|Suicide Risk|suicide risk
5264121|NCT02365103|Anemia, Iron-Deficiency|anemia, iron-deficiency
5264122|NCT02365103|Iron, Bioavailability|iron, bioavailability
5264123|NCT02365103|Hepcidins|hepcidins
5264124|NCT02365103|Intestinal, Absorption|intestinal, absorption
5264125|NCT02365103|Isotope Labeling, Stable|isotope labeling, stable
5264126|NCT02365077|Adverse Effect of Glucocorticoids|adverse effect of glucocorticoids
5264127|NCT02365077|Femur Head Necrosis|femur head necrosis
5264128|NCT02365077|Susceptibility|susceptibility
5264129|NCT02365077|GWAS|gwas
5264130|NCT02365025|Sleep patterns|sleep patterns
5264131|NCT02365025|Electronic Media Exposure|electronic media exposure
5264132|NCT02365025|Parental Intervention|parental intervention
5264133|NCT02364934|rocuronium|rocuronium
5264135|NCT02364934|elderly|elderly
5264136|NCT02364934|Close-loop infusion system|close-loop infusion system
5264137|NCT02364921|venous ulcer|venous ulcer
5264138|NCT02364921|wound healing|wound healing
5264139|NCT02364921|compression bandages|compression bandages
5264140|NCT02364908|systemic lupus erythematosus|systemic lupus erythematosus
5264141|NCT02364908|antimalarials|antimalarials
5264142|NCT02364908|therapeutic education|therapeutic education
5264143|NCT02364908|Coping questionnaire|coping questionnaire
5264144|NCT02364908|MASRI questionnaire|masri questionnaire
5264145|NCT02364908|morisky medication adherence scale|morisky medication adherence scale
5264146|NCT02364908|lupus Quality Of Life|lupus quality of life
5264147|NCT02364908|internal medicine|internal medicine
5264148|NCT02364895|Mailed invitation|mailed invitation
5264149|NCT02364895|Fecal Occult Blood Test|fecal occult blood test
5264150|NCT02364895|Screening|screening
5264151|NCT02364869|P-cresyl sulfate|p-cresyl sulfate
5264152|NCT02364869|Indoxyl sulfate|indoxyl sulfate
5264153|NCT02364869|Intestine|intestine
5264154|NCT02364869|Endothelial function|endothelial function
5264155|NCT02364856|Autonomic Nervous System|autonomic nervous system
5264156|NCT02364856|Cerebral Palsy|cerebral palsy
5264157|NCT02364856|Pain|pain
5264158|NCT02364856|Children|children
5264159|NCT02364843|Threonine|threonine
5264160|NCT02364843|enteral feedings|enteral feedings
5264161|NCT02364843|infants|infants
5264162|NCT02364843|amino acid|amino acid
5264163|NCT02364843|requirements|requirements
5264164|NCT02364830|Pimpinella anisum L.|pimpinella anisum l.
5264165|NCT02364830|Peppermint oil|peppermint oil
5364497|NCT01882010|CD4|cd4
5264166|NCT02364830|Irritable Bowel Syndrome|irritable bowel syndrome
5264167|NCT02364817|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5264168|NCT02364817|Alcohol Dependence|alcohol dependence
5264170|NCT02364817|Treatment outcome|treatment outcome
5264171|NCT02364817|Mental Health|mental health
5264172|NCT02364791|pulmonary resection|pulmonary resection
5264173|NCT02364791|chest tube|chest tube
5264174|NCT02364791|segmentectomy|segmentectomy
5264175|NCT02364791|lobectomy|lobectomy
5264177|NCT02364765|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
5264178|NCT02364765|Hemoglobin|hemoglobin
5264179|NCT02364765|Red Blood Cells|red blood cells
5264180|NCT02364765|Hematocrit|hematocrit
5264181|NCT02364765|Blood Platelets|blood platelets
5264182|NCT02364765|Body Weight|body weight
5264183|NCT02364765|Operative Time|operative time
5264184|NCT02364765|Age Groups|age groups
5264185|NCT02364765|Gender|gender
5264186|NCT02364726|Acupuncture|acupuncture
5264187|NCT02364726|Paclitaxel|paclitaxel
5264188|NCT02364726|15-011|15-011
5264189|NCT02364700|stroke, robotics, hand rehabilitation|stroke, robotics, hand rehabilitation
5264190|NCT02364674|HRCT|hrct
5264192|NCT02364674|Functional Respiratory Imaging|functional respiratory imaging
5264193|NCT02364674|FRI|fri
5264194|NCT02364674|Computed Tomography|computed tomography
5264195|NCT02364674|CT|ct
5264196|NCT02364674|Bronchiolitis Obliterans|bronchiolitis obliterans
5264197|NCT02364674|BOS|bos
5264198|NCT02364674|Lung Transplant|lung transplant
5264199|NCT02364661|Hepatitis B virus|hepatitis b virus
5264200|NCT02364661|Metabolovirus|metabolovirus
5264201|NCT02364648|Endothelium, vascular|endothelium, vascular
5264202|NCT02364648|MitoQ|mitoq
5264203|NCT02364648|Mitochondria|mitochondria
5264204|NCT02364648|Oxidative Stress|oxidative stress
5264205|NCT02364648|Chronic Renal Insufficiency|chronic renal insufficiency
5264206|NCT02364648|Cardiovascular Disease|cardiovascular disease
5264207|NCT02364635|Phase I pharmacokinetics and safety study|phase i pharmacokinetics and safety study
5264208|NCT02364622|flexible intubating stylet|flexible intubating stylet
5264209|NCT02364622|double-lumen endobronchial tube|double-lumen endobronchial tube
5264210|NCT02364596|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
5264211|NCT02364596|Staphylococcal infection|staphylococcal infection
5264212|NCT02364570|CVD|cvd
5264213|NCT02364570|Hyperglycemia|hyperglycemia
5264214|NCT02364570|Postprandial|postprandial
5264215|NCT02364570|Vascular Function|vascular function
5264216|NCT02364531|Prostatic Neoplasms|prostatic neoplasms
5264217|NCT02364531|Prostate Cancer|prostate cancer
5264218|NCT02364531|Metastatic|metastatic
5264219|NCT02364531|Observational|observational
5264220|NCT02364531|Abiraterone Acetate|abiraterone acetate
5264221|NCT02364531|ZYTIGA|zytiga
5264222|NCT02364518|Snoring|snoring
5264223|NCT02364518|snoreplasy|snoreplasy
5264224|NCT02364518|Tranquill|tranquill
5264225|NCT02364518|Sutures|sutures
5264226|NCT02364505|caregivers|caregivers
5264227|NCT02364492|[C04.588.180]|[c04.588.180]
5264228|NCT02364479|relapse|relapse
5264229|NCT02364479|Yisaipu|yisaipu
5264230|NCT02364440|skin laxity|skin laxity
5264231|NCT02364440|Ultherapy™ System|ultherapy™ system
5264232|NCT02364440|rhytids|rhytids
5264233|NCT02364427|Pulse wave velocity|pulse wave velocity
5264234|NCT02364427|Arterial stiffness|arterial stiffness
5264235|NCT02364427|AKI|aki
5264236|NCT02364401|Atrial Fibrillation|atrial fibrillation
5264237|NCT02364401|Catheter ablation|catheter ablation
5264238|NCT02364388|breast imaging diagnosis|breast imaging diagnosis
5264239|NCT02364388|breast ultrasound|breast ultrasound
5264240|NCT02364388|Imagio|imagio
5264241|NCT02364388|Seno Medical Instruments, Inc.|seno medical instruments, inc.
5264242|NCT02364388|Seno|seno
5264243|NCT02364388|opto-acoustics|opto-acoustics
5264244|NCT02364388|OA|oa
5264245|NCT02364336|Chronic Hepatitis B|chronic hepatitis b
5264246|NCT02364310|Hypertension|hypertension
5264247|NCT02364310|baroreceptor stimulation|baroreceptor stimulation
5264248|NCT02364310|Hypertension resistant|hypertension resistant
5264249|NCT02364297|Bleeding gastric varices|bleeding gastric varices
5264250|NCT02364297|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
5264251|NCT02364297|Injection of adhesives|injection of adhesives
5159425|NCT02995551|Humans|humans
5264252|NCT02364271|High-sensitive troponin|high-sensitive troponin
5264253|NCT02364271|Coronary Artery Calcium Score|coronary artery calcium score
5264254|NCT02364271|TIMI score|timi score
5264255|NCT02364271|Heart-type fatty acid binding protein|heart-type fatty acid binding protein
5264256|NCT02364271|Major adverse cardiac event|major adverse cardiac event
5264257|NCT02364271|HEART score|heart score
5264258|NCT02364245|Cerebral Palsy.|cerebral palsy.
5264259|NCT02364245|Upper Extremity|upper extremity
5264260|NCT02364245|Kinect|kinect
5264261|NCT02364245|Virtual reality|virtual reality
5264262|NCT02364219|prewarming|prewarming
5264361|NCT02363699|Cytokines|cytokines
5264263|NCT02364219|perioperative hypothermia|perioperative hypothermia
5264264|NCT02364219|microdialysis|microdialysis
5264265|NCT02364219|tissue oxygen saturation|tissue oxygen saturation
5145261|NCT03083678|EGFR|egfr
5264266|NCT02364219|cytoreductive surgery|cytoreductive surgery
5264267|NCT02364206|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5264269|NCT02364206|temozolomide|temozolomide
5264270|NCT02364206|radiotherapy|radiotherapy
5264271|NCT02364193|Intrathoracic blood volume|intrathoracic blood volume
5264272|NCT02364193|Extravascular lung water|extravascular lung water
5264273|NCT02364154|biomarker|biomarker
5264274|NCT02364154|screening|screening
5264275|NCT02364154|coloscopy|coloscopy
5264276|NCT02364141|stroke|stroke
5264277|NCT02364141|upper extremity|upper extremity
5264278|NCT02364141|motor learning|motor learning
5264279|NCT02364141|rehabilitation|rehabilitation
5264280|NCT02364115|Spinal metastases|spinal metastases
5264281|NCT02364115|Spinal metastatic disease|spinal metastatic disease
5264282|NCT02364115|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5264283|NCT02364115|Response|response
5264284|NCT02364115|Bone metastases|bone metastases
5264285|NCT02364089|Adrenal Incidentaloma|adrenal incidentaloma
5264286|NCT02364089|Subclinical Cushing's syndrome|subclinical cushing's syndrome
5264287|NCT02364089|Hypertension|hypertension
5264289|NCT02364089|Metabolic Syndrome|metabolic syndrome
5264290|NCT02364089|Surgery of adrenal tumor|surgery of adrenal tumor
5264291|NCT02364076|Pembrolizumab|pembrolizumab
5264292|NCT02364076|Epacadostat|epacadostat
5264293|NCT02364063|Urinary incontinence|urinary incontinence
5264294|NCT02364063|cerebral palsy|cerebral palsy
5264295|NCT02364063|urotherapy|urotherapy
5264297|NCT02364037|intrauterine device|intrauterine device
5264298|NCT02364037|subdermal implant|subdermal implant
5264299|NCT02364037|contraceptive counseling|contraceptive counseling
5264300|NCT02364024|Colon and rectum carcinoma|colon and rectum carcinoma
5264301|NCT02364024|Immune response|immune response
5264302|NCT02364024|Biomarker|biomarker
5264303|NCT02364024|Prognosis|prognosis
5264304|NCT02364011|Biomechanics|biomechanics
5264305|NCT02364011|Primary Total Knee Arthroplasty|primary total knee arthroplasty
5264306|NCT02364011|TKA Bearings|tka bearings
5264307|NCT02364011|Osteoarthritis|osteoarthritis
5264308|NCT02364011|Total Knee Replacement|total knee replacement
5264309|NCT02363998|detoxification|detoxification
5264310|NCT02363998|agonist taper|agonist taper
5264311|NCT02363998|methadone step down|methadone step down
5264315|NCT02363959|Lung Transplantation|lung transplantation
5264316|NCT02363959|Central Airway Stenosis|central airway stenosis
5264317|NCT02363959|Airway Exudative Plaques|airway exudative plaques
5264318|NCT02363959|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5264319|NCT02363959|Post-Lung Transplantation|post-lung transplantation
5264321|NCT02363959|Endobronchial Biopsy|endobronchial biopsy
5264322|NCT02363959|Bronchoscopy|bronchoscopy
5264323|NCT02363946|alpha-1 antitrypsin|alpha-1 antitrypsin
5264324|NCT02363946|AATD|aatd
5264325|NCT02363933|Perampanel|perampanel
5264326|NCT02363933|Seizures|seizures
5264327|NCT02363920|COPD patients|copd patients
5264328|NCT02363907|diabetes mellitus|diabetes mellitus
5264329|NCT02363907|pediatric|pediatric
5264330|NCT02363907|continuous glucose monitoring system|continuous glucose monitoring system
5264332|NCT02363855|Neoplasm Metastasis|neoplasm metastasis
5264333|NCT02363855|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5264334|NCT02363855|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
5264335|NCT02363842|Pressure Ulcer|pressure ulcer
5264336|NCT02363842|Skin IQ MCM coverlet|skin iq mcm coverlet
5264337|NCT02363842|Pressure redistribution surfaces|pressure redistribution surfaces
5264338|NCT02363829|clinical stages IIA, IIB, IIIA, IIIB, IVA|clinical stages iia, iib, iiia, iiib, iva
5264339|NCT02363829|invasive carcinoma|invasive carcinoma
5264340|NCT02363829|uterine cervix|uterine cervix
5264341|NCT02363790|Ventral Hernia|ventral hernia
5264342|NCT02363790|Laparoscopic|laparoscopic
5264343|NCT02363764|respiratory sampling|respiratory sampling
5264344|NCT02363751|Bellini|bellini
5264345|NCT02363751|Metastatic|metastatic
5264346|NCT02363751|Chemotherapy|chemotherapy
5264347|NCT02363751|Bevacizumab|bevacizumab
5264348|NCT02363738|Bipolar Disorder|bipolar disorder
5264349|NCT02363738|Bipolar Depression|bipolar depression
5264350|NCT02363738|Inflammation|inflammation
5264351|NCT02363738|Bipolar|bipolar
5264352|NCT02363725|Acute myocardial infarction|acute myocardial infarction
5264353|NCT02363725|Inflammation|inflammation
5264354|NCT02363725|CRP|crp
5264355|NCT02363725|Colchicine|colchicine
5264356|NCT02363712|Osteoarthritis, knee|osteoarthritis, knee
5264357|NCT02363712|therapy|therapy
5264358|NCT02363712|shoe|shoe
5264359|NCT02363712|Randomized Controlled Trial|randomized controlled trial
5264360|NCT02363699|cholelithiasis|cholelithiasis
5264365|NCT02363673|Homoeopathy|homoeopathy
5264366|NCT02363660|HIV-uninfected|hiv-uninfected
5269515|NCT02333799|TB|tb
5264367|NCT02363647|medullary thyroid cancer|medullary thyroid cancer
5264368|NCT02363647|thyroid cancer|thyroid cancer
5264369|NCT02363647|personalized therapy|personalized therapy
5264370|NCT02363647|personalized chemotherapy|personalized chemotherapy
5264371|NCT02363647|individualized treatment|individualized treatment
5264372|NCT02363647|colon cancer|colon cancer
5264373|NCT02363647|colorectal cancer|colorectal cancer
5264374|NCT02363634|magnesium status|magnesium status
5264375|NCT02363634|sleep quality|sleep quality
5264376|NCT02363608|Canine-Assisted|canine-assisted
5264377|NCT02363608|15-010|15-010
5264378|NCT02363608|post surgery patients|post surgery patients
5264379|NCT02363595|Genomic Predictors|genomic predictors
5264380|NCT02363595|14-277|14-277
5264381|NCT02363569|post coital bleeding|post coital bleeding
5264382|NCT02363569|vaginal bleeding|vaginal bleeding
5264383|NCT02363556|Cervical Dilation|cervical dilation
5264384|NCT02363556|Dilation and Evacuation|dilation and evacuation
5264385|NCT02363556|Misoprostol|misoprostol
5264386|NCT02363556|Misoprostol-Dilapan|misoprostol-dilapan
5264387|NCT02363556|Abortion|abortion
5264388|NCT02363530|cataract surgery|cataract surgery
5264389|NCT02363530|cornea protect|cornea protect
5264390|NCT02363530|xerophthalmia|xerophthalmia
5264391|NCT02363530|Corneal clarity|corneal clarity
5264392|NCT02363517|Hepatitis|hepatitis
5264393|NCT02363517|Viral|viral
5264394|NCT02363517|Non-A|non-a
5264395|NCT02363517|Non-B|non-b
5264396|NCT02363517|Parenterally-Transmitted|parenterally-transmitted
5264401|NCT02363465|skin thickness|skin thickness
5264402|NCT02363465|high-frequency ultrasound|high-frequency ultrasound
5264403|NCT02363452|Aicardi-Goutières syndrome|aicardi-goutières syndrome
5264404|NCT02363452|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
5264405|NCT02363452|open single study|open single study
5264406|NCT02363452|interferon signature|interferon signature
5264407|NCT02363426|intravaginal culture|intravaginal culture
5264408|NCT02363426|in vitro fertilization|in vitro fertilization
5264409|NCT02363426|blastocyst|blastocyst
5264410|NCT02363426|pregnancy|pregnancy
5264412|NCT02363413|Overlap Syndrom|overlap syndrom
5264413|NCT02363413|home|home
5264414|NCT02363413|hospital|hospital
5264415|NCT02363400|Nasopharyngeal carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5264416|NCT02363400|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
5264417|NCT02363400|radiotherapy (RT)|radiotherapy (rt)
5264418|NCT02363400|Plasma EBV DNA(pEBV DNA)|plasma ebv dna(pebv dna)
5264419|NCT02363400|Adjuvant Chemotherapy|adjuvant chemotherapy
5264420|NCT02363387|HIV|hiv
5264421|NCT02363387|antiretroviral medications|antiretroviral medications
5264422|NCT02363387|incentives|incentives
5264423|NCT02363374|Rectal cancer stage II|rectal cancer stage ii
5264424|NCT02363374|Rectal cancer stage III|rectal cancer stage iii
5264425|NCT02363374|Multimodality treatment of locally advanced rectal cancer|multimodality treatment of locally advanced rectal cancer
5264426|NCT02363348|L arginine|l arginine
5264427|NCT02363348|Preeclampsia|preeclampsia
5264428|NCT02363335|GLP-1|glp-1
5264429|NCT02363335|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
5264430|NCT02363335|GLP|glp
5264431|NCT02363322|Medical Countermeasures|medical countermeasures
5264432|NCT02363322|VHF|vhf
5264433|NCT02363322|EVD|evd
5264439|NCT02363296|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
5264440|NCT02363296|Brain Cooling - Selected|brain cooling - selected
5264441|NCT02363296|Brain Cooling Helmet|brain cooling helmet
5264442|NCT02363296|Repetitive TMS (rTMS)|repetitive tms (rtms)
5264443|NCT02363296|EEG phasxe-triggered TMS|eeg phasxe-triggered tms
5264444|NCT02363270|Analgesia|analgesia
5264445|NCT02363270|ketamine|ketamine
5264446|NCT02363257|Smoke free bus policy|smoke free bus policy
5264447|NCT02363257|BEST commuters|best commuters
5264448|NCT02363257|BEST employee|best employee
5264449|NCT02363244|Pap,HPVDNA|pap,hpvdna
5264450|NCT02363218|Liver Neoplasms|liver neoplasms
5264451|NCT02363218|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5264452|NCT02363218|CyberKnife|cyberknife
5264453|NCT02363192|Pharmacy|pharmacy
5264454|NCT02363179|Emergency Service, Hospital|emergency service, hospital
5264455|NCT02363140|Musculoskeletal System|musculoskeletal system
5264456|NCT02363127|Reproductive Techniques|reproductive techniques
5264457|NCT02363127|Infertility|infertility
5264458|NCT02363127|Reproductive Techniques Assisted|reproductive techniques assisted
5264459|NCT02363088|cervical screening|cervical screening
5264460|NCT02363088|uptake|uptake
5264461|NCT02363088|SMS messages|sms messages
5264462|NCT02363088|text messages|text messages
5264463|NCT02363088|reminder|reminder
5264464|NCT02363075|dexamfetamine sulphate|dexamfetamine sulphate
5264465|NCT02363075|severe asthenia|severe asthenia
5264466|NCT02363075|glioma|glioma
5264467|NCT02363075|MFI-20|mfi-20
5264468|NCT02363075|double-blind|double-blind
5264469|NCT02363075|stabilisation phase|stabilisation phase
5264470|NCT02363062|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5264471|NCT02363062|genes|genes
5264472|NCT02363062|whole exome sequencing|whole exome sequencing
5264473|NCT02363049|Colectomy|colectomy
5264474|NCT02363049|primary tumor resection|primary tumor resection
5264475|NCT02363049|Asymptomatic primary colon cancer|asymptomatic primary colon cancer
5264476|NCT02363049|Unresectable synchronous liver metastasis|unresectable synchronous liver metastasis
5264477|NCT02363049|TNM Staging Primary Tumor (T)|tnm staging primary tumor (t)
5264478|NCT02363049|Unresectable|unresectable
5264479|NCT02363023|Ventilator associated pneumonia|ventilator associated pneumonia
5264480|NCT02363023|Bronchoalveolar lavage|bronchoalveolar lavage
5264481|NCT02363010|Obesity|obesity
5264482|NCT02363010|Weight loss|weight loss
5264483|NCT02363010|Overweight|overweight
5264484|NCT02362997|Classical Hodgkin Lymphoma (cHL)|classical hodgkin lymphoma (chl)
5264485|NCT02362997|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
5264486|NCT02362997|Peripheral T-cell lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
5264487|NCT02362984|DLBS1033|dlbs1033
5264488|NCT02362984|acute ischemic stroke|acute ischemic stroke
5264489|NCT02362984|MRS|mrs
5264490|NCT02362984|mNIHSS|mnihss
5264491|NCT02362919|Influenza vaccination|influenza vaccination
5264492|NCT02362919|Elderly individuals|elderly individuals
5264493|NCT02362919|Prospective cohort study|prospective cohort study
5264494|NCT02362919|response|response
5264495|NCT02362906|pneumonia|pneumonia
5264496|NCT02362906|pediatrics|pediatrics
5264497|NCT02362893|Hypertension|hypertension
5264498|NCT02362893|Adherence|adherence
5862746|NCT00001526|Interleukin 2 Receptor|interleukin 2 receptor
5264499|NCT02362893|Direct Observed Therapy (DOT)|direct observed therapy (dot)
5264501|NCT02362854|dental implant|dental implant
5264502|NCT02362854|laser|laser
5264503|NCT02362854|diode laser|diode laser
5264504|NCT02362854|peri-implantitis|peri-implantitis
5264505|NCT02362854|bacterial count|bacterial count
5264506|NCT02362828|Post-Dural Puncture Headache|post-dural puncture headache
5264507|NCT02362828|Blood Patch, epidural|blood patch, epidural
5264508|NCT02362828|Obstetrics|obstetrics
5264509|NCT02362828|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
5264510|NCT02362828|epidemiology|epidemiology
5264511|NCT02362828|Accidental Dural Puncture (ADP)|accidental dural puncture (adp)
5264512|NCT02362828|Anaesthesia|anaesthesia
5264513|NCT02362828|childbirth complication|childbirth complication
5264514|NCT02362828|epidural analgesia|epidural analgesia
5264515|NCT02362828|postdural puncture headache|postdural puncture headache
5264516|NCT02362828|prophylactic epidural blood patch|prophylactic epidural blood patch
5264517|NCT02362828|epidural|epidural
5264518|NCT02362776|NMR spectroscopy|nmr spectroscopy
5264519|NCT02362776|metabolic changes|metabolic changes
5264520|NCT02362776|blood plasma|blood plasma
5264521|NCT02362776|biomarker|biomarker
5264522|NCT02362776|cancer|cancer
5264523|NCT02362750|comparative effectiveness|comparative effectiveness
5264524|NCT02362750|survivorship|survivorship
5264525|NCT02362750|Patient-Centered Outcomes Research|patient-centered outcomes research
5264526|NCT02362685|Metabolic myopathies|metabolic myopathies
5264527|NCT02362685|Exercise testing|exercise testing
5264528|NCT02362685|Blood sample|blood sample
5264529|NCT02362685|Muscle biopsy|muscle biopsy
5264530|NCT02362685|Genetic analysis|genetic analysis
5264531|NCT02362685|Cycloergometer|cycloergometer
5264532|NCT02362685|Grip-test|grip-test
5264533|NCT02362685|Exercise physiology|exercise physiology
5264534|NCT02362685|Muscle physiology|muscle physiology
5264535|NCT02362659|non-valvular|non-valvular
5264536|NCT02362659|atrial fibrillation|atrial fibrillation
5264537|NCT02362659|percutaneous coronary intervention|percutaneous coronary intervention
5264538|NCT02362646|Heart Failure|heart failure
5264539|NCT02362646|Left Ventricular Assist Device|left ventricular assist device
5264540|NCT02362646|Heart Transplantation|heart transplantation
5264541|NCT02362646|Cardiomyopathy, Destination Therapy|cardiomyopathy, destination therapy
5264542|NCT02362646|Cell Therapy|cell therapy
5264543|NCT02362646|Bridge to Transplant|bridge to transplant
5264544|NCT02362620|metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5264545|NCT02362620|Taxanes|taxanes
5264546|NCT02362620|Biomarkers|biomarkers
5264547|NCT02362594|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
5264548|NCT02362594|Programmed Cell Death 1 (PD1)|programmed cell death 1 (pd1)
5264549|NCT02362594|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5264550|NCT02362594|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5264551|NCT02362581|Prophylaxis treatment|prophylaxis treatment
5264552|NCT02362581|On demand treatment|on demand treatment
5159758|NCT02992925|Hib|hib
5264553|NCT02362581|Severe hemophilia A|severe hemophilia a
5264554|NCT02362581|Moderate hemophilia A|moderate hemophilia a
5264555|NCT02362568|Intubation; Difficult|intubation; difficult
5264575|NCT02362425|Neuromuscular Disease|neuromuscular disease
5264577|NCT02362425|Ryanodine Receptor Type 1|ryanodine receptor type 1
5264578|NCT02362425|Myopathy|myopathy
5264579|NCT02362412|major depressive episodes|major depressive episodes
5264580|NCT02362412|FK949E|fk949e
5264581|NCT02362412|quetiapine|quetiapine
5264582|NCT02362412|bipolar depression|bipolar depression
5264583|NCT02362412|bipolar disorder|bipolar disorder
5264584|NCT02362373|epilepsy|epilepsy
5264585|NCT02362373|contraception|contraception
5264586|NCT02362373|drug interaction|drug interaction
5264587|NCT02362360|Ostomy|ostomy
5145538|NCT03082001|Neonate|neonate
5264588|NCT02362334|dual Sheimpflug analyzer|dual sheimpflug analyzer
5264589|NCT02362334|intraocular lens power|intraocular lens power
5264590|NCT02362334|optical low-coherence reflectometry|optical low-coherence reflectometry
5264591|NCT02362321|[C10.228.140.300.535.450.400.120]|[c10.228.140.300.535.450.400.120]
5264592|NCT02362295|palliative care|palliative care
5264593|NCT02362295|vulnerable population|vulnerable population
5264594|NCT02362295|qualitative research|qualitative research
5264595|NCT02362282|stroke|stroke
5264596|NCT02362282|walking|walking
5264597|NCT02362282|cognition|cognition
5264598|NCT02362282|rehabilitation|rehabilitation
5264599|NCT02362256|Opioid detoxification|opioid detoxification
5264600|NCT02362256|Opioid antagonist induction|opioid antagonist induction
5264601|NCT02362256|Conscious sedation|conscious sedation
5264602|NCT02362243|low back pain|low back pain
5264603|NCT02362243|low back injury|low back injury
5264604|NCT02362243|firefighter|firefighter
5264605|NCT02362243|prevention|prevention
5264606|NCT02362243|physical fitness|physical fitness
5264607|NCT02362243|exercise training|exercise training
5264608|NCT02362243|worksite|worksite
5264609|NCT02362243|web-based|web-based
5264610|NCT02362165|multiple myeloma|multiple myeloma
5264611|NCT02362165|cyclophosphamide|cyclophosphamide
5264612|NCT02362165|bortezomib|bortezomib
5264613|NCT02362165|doxorubicin|doxorubicin
5264614|NCT02362165|peripheral neuropathy|peripheral neuropathy
5264615|NCT02362152|Actinic keratosis|actinic keratosis
5264616|NCT02362152|Solar keratosis|solar keratosis
5264617|NCT02362152|Field treatment|field treatment
5264618|NCT02362152|Ingenol mebutate|ingenol mebutate
5264619|NCT02362152|Picato|picato
5264620|NCT02362126|Endoscopic full thickness resection|endoscopic full thickness resection
5264621|NCT02362126|EFTR|eftr
5264622|NCT02362126|FTRD|ftrd
5264623|NCT02362126|OTSC|otsc
5264624|NCT02362087|pain|pain
5252071|NCT02433184|Etanercept|etanercept
5264625|NCT02362061|junctional zone|junctional zone
5264626|NCT02362061|implantation|implantation
5264627|NCT02362061|three D ultraosund|three d ultraosund
5264628|NCT02362061|Assisted Reproductive Technology|assisted reproductive technology
5264629|NCT02362061|Pregnancy|pregnancy
5264630|NCT02362035|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5264632|NCT02362035|B-Cell Malignancies|b-cell malignancies
5264633|NCT02362035|Mantle Cell|mantle cell
5264634|NCT02362035|Multiple Myeloma|multiple myeloma
5264635|NCT02362035|CLL|cll
5264636|NCT02362035|SLL|sll
5264637|NCT02362035|DLBCL|dlbcl
5264638|NCT02362035|Follicular|follicular
5264639|NCT02362035|Waldenstrom|waldenstrom
5264640|NCT02362035|Burkitt lymphoma|burkitt lymphoma
5264641|NCT02362035|marginal zone lymphomas|marginal zone lymphomas
5264642|NCT02362035|hairy cell leukemia|hairy cell leukemia
5264643|NCT02362035|B cell acute lymphoid leukemia|b cell acute lymphoid leukemia
5264644|NCT02362035|Acalabrutinib|acalabrutinib
5264645|NCT02362035|ACP-196|acp-196
5264646|NCT02362009|Myomas|myomas
5264647|NCT02362009|Leiomyomas|leiomyomas
5264648|NCT02362009|Fibromas|fibromas
5264649|NCT02361970|sepsis|sepsis
5264650|NCT02361970|gamma delta T cells|gamma delta t cells
5264651|NCT02361970|immunosuppression|immunosuppression
5264652|NCT02361944|oxygen|oxygen
5264653|NCT02361944|hyperoxia|hyperoxia
5264654|NCT02361944|reactive oxygen species|reactive oxygen species
5264655|NCT02361944|oxidative stress|oxidative stress
5264656|NCT02361944|oxidative damage|oxidative damage
5264657|NCT02361944|endothelial function|endothelial function
5265063|NCT02359604|infant|infant
5264658|NCT02361944|vascular reactivity|vascular reactivity
5264659|NCT02361944|mitochondrial function|mitochondrial function
5264660|NCT02361944|surgery|surgery
5264661|NCT02361944|anesthesia|anesthesia
5264662|NCT02361944|kidney injury|kidney injury
5264663|NCT02361944|renal failure|renal failure
5264664|NCT02361944|delirium|delirium
5264665|NCT02361944|myocardial injury|myocardial injury
5264666|NCT02361944|arrythmia|arrythmia
5264667|NCT02361931|erythropoietin|erythropoietin
5264668|NCT02361931|diabetic chronic wounds|diabetic chronic wounds
5264669|NCT02361931|wound healing|wound healing
5264670|NCT02361931|chronic wounds|chronic wounds
5264671|NCT02361931|topical treatment|topical treatment
5264672|NCT02361931|re-epithelization|re-epithelization
5264673|NCT02361931|inflammation|inflammation
5264674|NCT02361905|fibroid|fibroid
5264675|NCT02361905|cellular leiomyomas|cellular leiomyomas
5264676|NCT02361905|GnRH analogue|gnrh analogue
5264677|NCT02361905|ulipristal acetate|ulipristal acetate
5264678|NCT02361892|ovarian reserve|ovarian reserve
5264679|NCT02361892|infertility|infertility
5264680|NCT02361892|leiomyomas|leiomyomas
5264681|NCT02361892|ulipristal acetate|ulipristal acetate
5264682|NCT02361879|fibroids|fibroids
5264683|NCT02361879|gnrh analogue|gnrh analogue
5264684|NCT02361879|ulipristal acetate|ulipristal acetate
5264685|NCT02361879|hysteroscopy|hysteroscopy
5264686|NCT02361840|Troponin I|troponin i
5264687|NCT02361840|Pediatric shock|pediatric shock
5264688|NCT02361827|Vitamin D|vitamin d
5201747|NCT02733159|MK-3475|mk-3475
5264689|NCT02361827|IVF outcome|ivf outcome
5264690|NCT02361814|flexor tendon|flexor tendon
5264691|NCT02361814|finger|finger
5264692|NCT02361814|amniotic membrane|amniotic membrane
5264693|NCT02361814|allograft|allograft
5264694|NCT02361814|tendon injury|tendon injury
5264695|NCT02361801|cardiac surgery|cardiac surgery
5264696|NCT02361801|dobutamine|dobutamine
5264697|NCT02361788|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5264698|NCT02361788|etiology|etiology
5264699|NCT02361788|incidence|incidence
5264700|NCT02361788|risk factors|risk factors
5264701|NCT02361762|Executive Function|executive function
5264702|NCT02361762|Theory of Mind|theory of mind
5264703|NCT02361762|Individual Differences|individual differences
5264704|NCT02361762|Social Skills|social skills
5264705|NCT02361762|Executive Control|executive control
5264706|NCT02361723|Advanced Solid Tumors|advanced solid tumors
5264707|NCT02361710|Vitamin D|vitamin d
5264708|NCT02361710|pregnancy rate|pregnancy rate
5264709|NCT02361710|eFET|efet
5264710|NCT02361697|pediatric multiple sclerosis|pediatric multiple sclerosis
5264711|NCT02361697|clinically isolated syndrome in children|clinically isolated syndrome in children
5264712|NCT02361697|biomarker|biomarker
5264713|NCT02361697|magnetic resonance imaging|magnetic resonance imaging
5264714|NCT02361697|diffusion weighted imaging|diffusion weighted imaging
5264715|NCT02361684|cost-effectiveness|cost-effectiveness
5264716|NCT02361684|blended treatment|blended treatment
5264717|NCT02361684|Internet based treatment|internet based treatment
5264718|NCT02361684|Efficacy|efficacy
5264719|NCT02361684|Depression|depression
5264720|NCT02361684|cognitive behavioural therapy|cognitive behavioural therapy
5264721|NCT02361645|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
5264722|NCT02361645|prostaglandin E2|prostaglandin e2
5264723|NCT02361645|vitrectomy|vitrectomy
5264724|NCT02361606|adolescents|adolescents
5252177|NCT02432547|Macular Oedema|macular oedema
5264725|NCT02361606|cognitive behavioral internet intervention|cognitive behavioral internet intervention
5264726|NCT02361593|endoscopic sclerotherapy, esophageal varices, transparent cap|endoscopic sclerotherapy, esophageal varices, transparent cap
5264727|NCT02361567|Post Operative Pain|post operative pain
5264728|NCT02361567|Addiction|addiction
5264729|NCT02361528|Septic shock|septic shock
5264730|NCT02361528|Severe sepsis|severe sepsis
5264731|NCT02361528|GM-CSF|gm-csf
5264732|NCT02361528|Immunosuppression|immunosuppression
5264733|NCT02361528|Hospital-acquired infections|hospital-acquired infections
5264734|NCT02361528|ICU-acquired infections|icu-acquired infections
5264735|NCT02361528|HLA-DR|hla-dr
5264736|NCT02361528|Monocytes|monocytes
5264737|NCT02361515|Prostate|prostate
5264738|NCT02361515|Hypofractionated radiotherapy|hypofractionated radiotherapy
5264739|NCT02361515|Stereotactic irradiation|stereotactic irradiation
5264740|NCT02361515|Spacer|spacer
5264741|NCT02361515|Rectal and bladder toxicities|rectal and bladder toxicities
5264742|NCT02361476|Anaesthesia|anaesthesia
5264743|NCT02361476|Children|children
5264744|NCT02361476|Clonidine|clonidine
5264745|NCT02361476|Sevoflurane|sevoflurane
5264746|NCT02361476|Postoperative agitation|postoperative agitation
5264747|NCT02361476|Prevention|prevention
5264748|NCT02361476|Pharmacokinetics|pharmacokinetics
5264749|NCT02361476|Safety|safety
5264750|NCT02361463|Laparoscopy;|laparoscopy;
5264751|NCT02361463|Training;|training;
5264752|NCT02361463|Three-Dimensional|three-dimensional
5264753|NCT02361450|Faecal incontinence|faecal incontinence
5264754|NCT02361450|Spina Bifida|spina bifida
5264755|NCT02361450|Enema|enema
5264756|NCT02361450|Constipation|constipation
5264757|NCT02361450|Myelomeningocele|myelomeningocele
5264758|NCT02361450|Human|human
5264759|NCT02361437|diabetes type II|diabetes type ii
5264760|NCT02361437|diabetic ulcers|diabetic ulcers
5264761|NCT02361424|PXT00864|pxt00864
5264763|NCT02361424|phase 2a|phase 2a
5264764|NCT02361359|Arthroplasty|arthroplasty
5264765|NCT02361346|CD20|cd20
5264766|NCT02361346|immunotoxin|immunotoxin
5264768|NCT02361346|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5264769|NCT02361346|lymphoma|lymphoma
5264770|NCT02361346|cancer|cancer
5264771|NCT02361346|antibodies|antibodies
5264772|NCT02361346|immunotherapy|immunotherapy
5264773|NCT02361346|safety|safety
5264774|NCT02361346|pharmacokinetics|pharmacokinetics
5264775|NCT02361346|maximum tolerated dose|maximum tolerated dose
5264776|NCT02361346|MT-3724|mt-3724
5264777|NCT02361346|relapsed|relapsed
5264778|NCT02361346|refractory|refractory
5264779|NCT02361346|leukemia|leukemia
5264780|NCT02361346|CLL|cll
5264781|NCT02361346|SLL|sll
5365249|NCT01878942|LSD|lsd
5264782|NCT02361346|DLBCL|dlbcl
5264783|NCT02361346|efficacy|efficacy
5264784|NCT02361320|Pancreatic cancer|pancreatic cancer
5264785|NCT02361320|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5264786|NCT02361320|PDAC|pdac
5264787|NCT02361320|Computed tomography|computed tomography
5264788|NCT02361320|CT|ct
5264789|NCT02361320|Questionnaire|questionnaire
5201883|NCT02732470|Qi Gong|qi gong
5264790|NCT02361320|Survey|survey
5264791|NCT02361268|end-stage renal disease|end-stage renal disease
5264792|NCT02361268|hemodialysis|hemodialysis
5264794|NCT02361268|mind-body medicine|mind-body medicine
5264795|NCT02361268|meditation|meditation
5264796|NCT02361242|PXT00864|pxt00864
5264797|NCT02361242|mild AD|mild ad
5264798|NCT02361242|phase 2a|phase 2a
5264799|NCT02361138|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
5264800|NCT02361125|Fatigue|fatigue
5264801|NCT02361125|Cancer related fatigue|cancer related fatigue
5264802|NCT02361125|Methylphenidate|methylphenidate
5264803|NCT02361125|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5264804|NCT02361125|Ritalin|ritalin
5264805|NCT02361125|Concerta|concerta
5264806|NCT02361125|Fatigue evaluations|fatigue evaluations
5264807|NCT02361086|castration-resistant prostate cancer|castration-resistant prostate cancer
5264808|NCT02361086|CYP17|cyp17
5264809|NCT02361086|P450c17a|p450c17a
5264810|NCT02361086|lyase|lyase
5264811|NCT02361073|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
5264813|NCT02361034|Safety and pharmacokinetics of drug in healthy volunteers|safety and pharmacokinetics of drug in healthy volunteers
5264814|NCT02361021|Critical Care|critical care
5264815|NCT02361021|Non invasive ventilation|non invasive ventilation
5264816|NCT02361021|Electrical impedance tomography|electrical impedance tomography
5264817|NCT02361021|End expiratory lung volume|end expiratory lung volume
5264818|NCT02361021|Lung ultrasound score|lung ultrasound score
5264819|NCT02361008|Infundibular Ventricular Septal Defect|infundibular ventricular septal defect
5264838|NCT02360930|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5264839|NCT02360930|Pharmacokinetics|pharmacokinetics
5264841|NCT02360917|Cognitive Dysfunction|cognitive dysfunction
5264842|NCT02360917|Cancer Survivorship|cancer survivorship
5264843|NCT02360891|multimodal biomarkers|multimodal biomarkers
5264844|NCT02360891|prognosis|prognosis
5264845|NCT02360891|endophenotypes|endophenotypes
5264846|NCT02360878|DJBS|djbs
5264847|NCT02360878|Duodenal-jejunal bypass sleeve|duodenal-jejunal bypass sleeve
5264848|NCT02360878|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
5264849|NCT02360878|Endobarrier|endobarrier
5264850|NCT02360878|Obesity|obesity
5264851|NCT02360878|Type 2 diabetes|type 2 diabetes
5264852|NCT02360878|Incretin hormones|incretin hormones
5264853|NCT02360878|Postprandial glucose metabolism|postprandial glucose metabolism
5264854|NCT02360813|Cognitive remediation therapy|cognitive remediation therapy
5264855|NCT02360813|Psychiatric rehabilitation|psychiatric rehabilitation
5264856|NCT02360813|Forensic mental health|forensic mental health
5264857|NCT02360813|Forensic psychiatry|forensic psychiatry
5264858|NCT02360813|Clinical psychology|clinical psychology
5264859|NCT02360813|Randomized controlled trial|randomized controlled trial
5264860|NCT02360813|Principle driven intervention|principle driven intervention
5264861|NCT02360813|Psychological Intervention|psychological intervention
5264862|NCT02360813|Cognitive enhancement|cognitive enhancement
5264863|NCT02360800|Bleeding|bleeding
5264864|NCT02360800|Heart Surgery|heart surgery
5264865|NCT02360800|Reoperation|reoperation
5264866|NCT02360787|Almonds|almonds
5264867|NCT02360787|Energy restriction|energy restriction
5264868|NCT02360787|Obesity|obesity
5264869|NCT02360787|Body weight|body weight
5264870|NCT02360787|Body fat|body fat
5264871|NCT02360787|Blood pressure|blood pressure
5264872|NCT02360787|Cognitive function|cognitive function
5264873|NCT02360774|Canagliflozin|canagliflozin
5264874|NCT02360774|Obesity|obesity
5264875|NCT02360774|Weight Loss|weight loss
5264876|NCT02360774|Body Weight|body weight
5264877|NCT02360774|Body Weight Changes|body weight changes
5264878|NCT02360774|Overweight|overweight
5264879|NCT02360774|Sodium-glucose transporter subtype 2 inhibitor|sodium-glucose transporter subtype 2 inhibitor
5264880|NCT02360761|Lung cancer;Elderly;Sublobar resection;Lobectomy|lung cancer;elderly;sublobar resection;lobectomy
5264881|NCT02360696|Duodenal Eosinophilia|duodenal eosinophilia
5264882|NCT02360696|Functional Dyspepsia|functional dyspepsia
5264883|NCT02360696|Mucosal Eosinophilia|mucosal eosinophilia
5264884|NCT02360683|Subthalamic neurostimulation|subthalamic neurostimulation
5264885|NCT02360657|Alzheimer's Disease|alzheimer's disease
5264886|NCT02360657|Alzheimer Dementia|alzheimer dementia
5264887|NCT02360657|JNJ-54861911|jnj-54861911
5264888|NCT02360657|Beta Secretase Inhibitor|beta secretase inhibitor
5264889|NCT02360631|smoking|smoking
5264890|NCT02360631|quit smoking|quit smoking
5264891|NCT02360631|smoking treatment|smoking treatment
5264892|NCT02360618|Bladder Cancer|bladder cancer
5264893|NCT02360618|Metformin|metformin
5264894|NCT02360618|Simvastatin|simvastatin
5264895|NCT02360618|Combination Therapy|combination therapy
5262171|NCT02376712|Urinary indices|urinary indices
5264901|NCT02360579|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
5264902|NCT02360579|Cellular Immuno-therapy|cellular immuno-therapy
5264903|NCT02360579|Cell Therapy|cell therapy
5264904|NCT02360579|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5264905|NCT02360579|TIL|til
5264906|NCT02360579|LN-144|ln-144
5264907|NCT02360579|IL-2|il-2
5264908|NCT02360579|Melanoma|melanoma
5264909|NCT02360579|Lifileucel|lifileucel
5264910|NCT02360566|Psychosis|psychosis
5264911|NCT02360566|Schizophrenia|schizophrenia
5264912|NCT02360566|Participatory Video|participatory video
5264913|NCT02360566|Narrative|narrative
5264914|NCT02360540|Pulmonary Embolism|pulmonary embolism
5264915|NCT02360540|Diagnostic strategy|diagnostic strategy
5264916|NCT02360540|Exclusion|exclusion
5264917|NCT02360540|Clinical probability|clinical probability
5264918|NCT02360540|Implicit Judgment (Gestalt)|implicit judgment (gestalt)
5264919|NCT02360540|PERC|perc
5264920|NCT02360501|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5264921|NCT02360501|induction chemotherapy|induction chemotherapy
5264922|NCT02360501|docetaxel|docetaxel
5264923|NCT02360501|xeloda|xeloda
5264924|NCT02360475|Vaccine|vaccine
5264925|NCT02360475|Immunogenicity|immunogenicity
5264926|NCT02360475|Safety|safety
5264927|NCT02360475|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5264928|NCT02360475|Reactogenicity|reactogenicity
5264929|NCT02360462|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5264930|NCT02360462|tDCS|tdcs
5264931|NCT02360462|Hallux Valgus|hallux valgus
5264932|NCT02360462|Chronic Pain|chronic pain
5264933|NCT02360449|Pivotal Response Treatment|pivotal response treatment
5264934|NCT02360449|Applied Behavior Analysis|applied behavior analysis
5264935|NCT02360449|Peer Initiation|peer initiation
5264936|NCT02360449|Social Skills Group|social skills group
5264937|NCT02360436|Rett|rett
5264938|NCT02360436|MeCP2|mecp2
5264939|NCT02360436|Glutathione|glutathione
5264940|NCT02360436|Cysteine|cysteine
5264942|NCT02360384|wireless motility capsule|wireless motility capsule
5264943|NCT02360332|Autism|autism
5264944|NCT02360332|transition to adulthood|transition to adulthood
5264945|NCT02360332|employment|employment
5264946|NCT02360332|High School Seniors|high school seniors
5264947|NCT02360319|First episode or recent onset|first episode or recent onset
5264948|NCT02360293|Exercise|exercise
5264949|NCT02360293|App-mediated|app-mediated
5264950|NCT02360293|Veterans|veterans
5264951|NCT02360280|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
5264952|NCT02360267|Bipolar Disorder|bipolar disorder
5264953|NCT02360267|Pediatric|pediatric
5264954|NCT02360267|Offspring|offspring
5264955|NCT02360267|Depression|depression
5264956|NCT02360267|Mania|mania
5264957|NCT02360267|Children of parents who suffer from Bipolar disorder|children of parents who suffer from bipolar disorder
5264958|NCT02360228|tACS|tacs
5264959|NCT02360228|tDCS|tdcs
5264960|NCT02360228|sham|sham
5264961|NCT02360228|auditory hallucinations|auditory hallucinations
5264962|NCT02360228|Schizophrenia|schizophrenia
5264963|NCT02360228|Schizoaffective Disorder|schizoaffective disorder
5264964|NCT02360176|single port surgery|single port surgery
5264965|NCT02360176|bariatric surgery|bariatric surgery
5264966|NCT02360176|sleeve gastrectomy|sleeve gastrectomy
5264967|NCT02360176|randomise prospective study|randomise prospective study
5264968|NCT02360176|complication rate|complication rate
5264969|NCT02360150|cardiac angiography|cardiac angiography
5264970|NCT02360150|cardiac MRI|cardiac mri
5264971|NCT02360137|carotids|carotids
5264972|NCT02360137|plaque|plaque
5264973|NCT02360137|characteristics|characteristics
5264974|NCT02360137|stroke|stroke
5264975|NCT02360111|GVHD Prophylaxis|gvhd prophylaxis
5264976|NCT02360111|Cyclophosphamide|cyclophosphamide
5264977|NCT02360111|Renal Insufficiency|renal insufficiency
5264978|NCT02360111|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5264979|NCT02360111|14-273|14-273
5264980|NCT02360098|Emergence from Anesthesia|emergence from anesthesia
5264981|NCT02360098|Anterior temporal lobectomy|anterior temporal lobectomy
5264982|NCT02360098|Amygdalohippocampectomy|amygdalohippocampectomy
5264983|NCT02360098|Anesthesia|anesthesia
5264984|NCT02360085|Cervical Myelopathy|cervical myelopathy
5264985|NCT02360085|Hypotension|hypotension
5264986|NCT02360072|child|child
5264987|NCT02360072|allergic rhinitis|allergic rhinitis
5264988|NCT02360072|asthma|asthma
5264990|NCT02360072|bronchial hyper-responsiveness|bronchial hyper-responsiveness
5264991|NCT02360059|Breast cancer|breast cancer
5264993|NCT02360059|Paclitaxel|paclitaxel
5264994|NCT02360059|Metformin|metformin
5264995|NCT02360059|Metformin ER|metformin er
5264996|NCT02360059|Placebo|placebo
5264997|NCT02360059|Sugar pill|sugar pill
5264998|NCT02360059|Questionnaires|questionnaires
5264999|NCT02360059|Sensory tests|sensory tests
5265000|NCT02360059|Fine-motor tests|fine-motor tests
5265001|NCT02360059|Surveys|surveys
5265002|NCT02360020|coronary stent|coronary stent
5265003|NCT02360020|outcome|outcome
5265004|NCT02360007|opioids|opioids
5265005|NCT02360007|buprenorphine|buprenorphine
5265006|NCT02360007|interim treatment|interim treatment
5265007|NCT02360007|opioid dependence|opioid dependence
5265008|NCT02359994|hemostasis|hemostasis
5265009|NCT02359981|Weight loss, Fitness|weight loss, fitness
5265010|NCT02359968|resectable esophageal|resectable esophageal
5265011|NCT02359968|junctional cancer|junctional cancer
5134356|NCT03153813|obesity|obesity
5265012|NCT02359968|FOLFOX|folfox
5265013|NCT02359968|paclitaxel-carboplatin|paclitaxel-carboplatin
5265014|NCT02359942|Helicobacter pylori infection|helicobacter pylori infection
5265015|NCT02359942|Eradication|eradication
5265016|NCT02359942|Urea breath test|urea breath test
5265017|NCT02359929|graft versus host disease|graft versus host disease
5265018|NCT02359929|GVHD|gvhd
5265019|NCT02359890|Interventional|interventional
5265020|NCT02359890|Radiofrequency ablation|radiofrequency ablation
5265021|NCT02359890|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5265022|NCT02359877|pegylated interferon beta|pegylated interferon beta
5265023|NCT02359877|Volunteers|volunteers
5265024|NCT02359864|radiation treatment|radiation treatment
5265025|NCT02359838|Hematologic Malignancy|hematologic malignancy
5265026|NCT02359838|Geriatric Assessment|geriatric assessment
5265027|NCT02359838|Geriatric Oncology|geriatric oncology
5265028|NCT02359838|Frailty|frailty
5265029|NCT02359812|Stroke|stroke
5265030|NCT02359812|Upper extremity|upper extremity
5265031|NCT02359812|Rehabilitation|rehabilitation
5265032|NCT02359812|Robot|robot
5265033|NCT02359812|Hemiplegia|hemiplegia
5265034|NCT02359812|Spasticity|spasticity
5265036|NCT02359812|Hand|hand
5265037|NCT02359799|Cerebral palsy|cerebral palsy
5265038|NCT02359799|Ankle Impairments|ankle impairments
5265039|NCT02359799|Robotic rehabilitation|robotic rehabilitation
5265040|NCT02359773|Magnetocardiography|magnetocardiography
5265041|NCT02359773|Myocardial Infarction|myocardial infarction
5265042|NCT02359773|Non-ischaemic chest pain|non-ischaemic chest pain
5265043|NCT02359760|Rapid orthodontics|rapid orthodontics
5265044|NCT02359760|accelerated orthodontics|accelerated orthodontics
5265045|NCT02359760|Piezocision|piezocision
5265046|NCT02359760|flapless corticotomies|flapless corticotomies
5265047|NCT02359760|minimaly invasive|minimaly invasive
5265048|NCT02359747|free gDNA|free gdna
5265049|NCT02359747|culture media|culture media
5265050|NCT02359734|Patient safety|patient safety
5265051|NCT02359734|Medication errors|medication errors
5265052|NCT02359734|Smart infusion pump|smart infusion pump
5265053|NCT02359721|Colony forming units Antimicrobial agents|colony forming units antimicrobial agents
5265054|NCT02359721|Microbial colonization|microbial colonization
5265055|NCT02359695|Poor ovarian response|poor ovarian response
5265056|NCT02359695|IVF|ivf
5265057|NCT02359695|Growth hormone|growth hormone
5265058|NCT02359643|Kawasaki disease|kawasaki disease
5265059|NCT02359617|continuous glucose sensor|continuous glucose sensor
5265060|NCT02359617|subcutaneous insulin infusion|subcutaneous insulin infusion
5265061|NCT02359617|closed-loop glucose control|closed-loop glucose control
5265062|NCT02359617|type 1 diabetes|type 1 diabetes
5265064|NCT02359604|ppi|ppi
5265065|NCT02359604|proton pump inhibitor|proton pump inhibitor
5265066|NCT02359604|microbiome|microbiome
5265067|NCT02359604|Microbiota|microbiota
5265068|NCT02359578|lymphatic system|lymphatic system
5265069|NCT02359578|occlusion pressure|occlusion pressure
5265070|NCT02359578|Indocyanine Green|indocyanine green
5265071|NCT02359526|Chronic Diabetic Macular Edema|chronic diabetic macular edema
5265072|NCT02359526|Iluvien|iluvien
5265073|NCT02359526|Intra-vitreal injections|intra-vitreal injections
5265074|NCT02359526|Pilot study|pilot study
5265075|NCT02359513|bulimia|bulimia
5265076|NCT02359513|serotoninergic brain activity|serotoninergic brain activity
5265077|NCT02359513|fluoxetine|fluoxetine
5265078|NCT02359513|serotoninergic antidepressant|serotoninergic antidepressant
5160256|NCT02989649|Drug Therapy|drug therapy
5265079|NCT02359513|brain serotonin profile|brain serotonin profile
5265080|NCT02359513|positon emission tomography|positon emission tomography
5265081|NCT02359500|68Ga- DOTATOC|68ga- dotatoc
5265082|NCT02359500|Diagnosis|diagnosis
5265083|NCT02359500|Somatostatin Receptor-Positive Neuroendocrine Tumors|somatostatin receptor-positive neuroendocrine tumors
5265084|NCT02359487|Namibia|namibia
5265085|NCT02359487|Alcohol|alcohol
5265086|NCT02359487|HIV|hiv
5265087|NCT02359487|Sexual risk|sexual risk
5265088|NCT02359474|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
5265089|NCT02359474|trabectedin|trabectedin
5265091|NCT02359461|Pulsatile cuts|pulsatile cuts
5265092|NCT02359461|Type 2 diabetes|type 2 diabetes
5265093|NCT02359461|Endothelium|endothelium
5265094|NCT02359461|Cardiovascular risk|cardiovascular risk
5265095|NCT02359461|Vasomotricity|vasomotricity
5265096|NCT02359461|FMD (Flow Mediated Dilatation)|fmd (flow mediated dilatation)
5265097|NCT02359435|Helicobacter pylori|helicobacter pylori
5265098|NCT02359435|Proton pump inhibitor|proton pump inhibitor
5265099|NCT02359435|Eradication|eradication
5265100|NCT02359396|Randomized open-label study|randomized open-label study
5265101|NCT02359396|Chinese Herbal|chinese herbal
5265102|NCT02359396|Constipation/drug therapy|constipation/drug therapy
5265103|NCT02359383|pleural disease|pleural disease
5265104|NCT02359383|infecTion|infection
5265105|NCT02359383|chest physiotherapy|chest physiotherapy
5265106|NCT02359370|Laryngoscopy|laryngoscopy
5265107|NCT02359370|Tracheal Intubation|tracheal intubation
5265108|NCT02359370|Lidocaine|lidocaine
5265109|NCT02359370|Magnesium Sulphate|magnesium sulphate
5265110|NCT02359370|Cardiovascular Physiological Phenomena|cardiovascular physiological phenomena
5265111|NCT02359331|Helicobacter pylori|helicobacter pylori
5265112|NCT02359331|resistance|resistance
5265113|NCT02359331|rescue therapy|rescue therapy
5265114|NCT02359318|White spot lesion|white spot lesion
5265115|NCT02359318|Resin Infiltration|resin infiltration
5265117|NCT02359318|Debonding|debonding
5265118|NCT02359318|Enamel damages|enamel damages
5265119|NCT02359318|Orthodontic white spots|orthodontic white spots
5265120|NCT02359318|Orthodontics|orthodontics
5265121|NCT02359266|Mood|mood
5265122|NCT02359266|Vitamin D deficiency|vitamin d deficiency
5265123|NCT02359266|Adjuvant treatment|adjuvant treatment
5265124|NCT02359253|Stroke|stroke
5265125|NCT02359253|Spasticity|spasticity
5265126|NCT02359253|Arm|arm
5265127|NCT02359253|Hand|hand
5265128|NCT02359253|Robotic therapy|robotic therapy
5265129|NCT02359227|Chronic Heart Failure|chronic heart failure
5265130|NCT02359227|Natriuretic Peptides|natriuretic peptides
5265131|NCT02359227|Cenderitide|cenderitide
5265132|NCT02359214|Vitamin D|vitamin d
5265133|NCT02359214|Cardiovascular disease|cardiovascular disease
5265134|NCT02359214|Diabetes|diabetes
5265135|NCT02359214|Obesity|obesity
5265136|NCT02359214|Cardiometabolic|cardiometabolic
5265137|NCT02359214|Bone disease|bone disease
5265138|NCT02359201|Nicotine replacement therapy|nicotine replacement therapy
5265139|NCT02359201|craving|craving
5265140|NCT02359201|Healthy moderately dependant smokers|healthy moderately dependant smokers
5265141|NCT02359188|Vagus Nerve Stimulation|vagus nerve stimulation
5265142|NCT02359175|Pain|pain
5265143|NCT02359175|Pain Measurement|pain measurement
5265144|NCT02359175|VAS|vas
5265145|NCT02359175|Visual Analog Pain Scale|visual analog pain scale
5265146|NCT02359175|Analgesics|analgesics
5265147|NCT02359175|Opioid|opioid
5265148|NCT02359175|Epidural analgesia|epidural analgesia
5265149|NCT02359175|VATS|vats
5265150|NCT02359175|Video-assisted Thoracic Surgery|video-assisted thoracic surgery
5265151|NCT02359175|Lobectomy|lobectomy
5265152|NCT02359175|Wedge Resection|wedge resection
5265153|NCT02359175|Segmental Resection|segmental resection
5265154|NCT02359175|Cytokins|cytokins
5265155|NCT02359175|Immune cells|immune cells
5265156|NCT02359162|NK/T-cell lymphoma|nk/t-cell lymphoma
5265157|NCT02359162|induction chemotherapy|induction chemotherapy
5265158|NCT02359162|survival|survival
5265159|NCT02359149|Intravitreal injections|intravitreal injections
5265160|NCT02359149|Nurses|nurses
5265161|NCT02359149|Physicians|physicians
5265162|NCT02359136|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5265163|NCT02359136|Anesthesia, Local|anesthesia, local
5265164|NCT02359136|Ropivacaine|ropivacaine
5265165|NCT02359136|Randomized controlled trial|randomized controlled trial
5265166|NCT02359110|laparoscopy|laparoscopy
5265167|NCT02359110|postoperative pain|postoperative pain
5265168|NCT02359110|gynecology|gynecology
5265169|NCT02359110|gabapentin|gabapentin
5265170|NCT02359084|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5265171|NCT02359084|Family navigation|family navigation
5265172|NCT02359071|handoff|handoff
5265173|NCT02359071|signoff|signoff
5265174|NCT02359071|handover|handover
5265175|NCT02359071|sign-out|sign-out
5265176|NCT02359071|shift change|shift change
5265177|NCT02359071|Emergency Department|emergency department
5265178|NCT02359045|Omega-3-carboxylic acids,|omega-3-carboxylic acids,
5265179|NCT02359045|Phase I,|phase i,
5265180|NCT02359045|Healthy Subjects,|healthy subjects,
5265181|NCT02359045|Pharmacokinetics,|pharmacokinetics,
5265182|NCT02359045|Relative bioavailability|relative bioavailability
5265183|NCT02359032|Healthy subjects|healthy subjects
5265184|NCT02359032|Pharmacokinetics of ASP6858|pharmacokinetics of asp6858
5265185|NCT02359032|ASP6858|asp6858
5265186|NCT02359032|Pharmacodynamics of ASP6858|pharmacodynamics of asp6858
5265187|NCT02359006|Analgesia|analgesia
5265188|NCT02359006|pain analgesia|pain analgesia
5265189|NCT02359006|methadone|methadone
5265190|NCT02359006|opiates|opiates
5265191|NCT02358993|Urinary Tract Infections|urinary tract infections
5265195|NCT02358993|Urinary catheterization|urinary catheterization
5265196|NCT02358993|Post-operative Infections|post-operative infections
5265197|NCT02358993|Methenamine hippurate|methenamine hippurate
5265198|NCT02358980|Multiple Myeloma|multiple myeloma
5265199|NCT02358980|Cast Nephropathy|cast nephropathy
5265203|NCT02358967|ESRD|esrd
5265204|NCT02358967|dyslipidemia|dyslipidemia
5265205|NCT02358967|oxidative stress|oxidative stress
5265206|NCT02358967|inflammation|inflammation
5265207|NCT02358967|Hemodialysis|hemodialysis
5265208|NCT02358967|CKD|ckd
5265209|NCT02358954|quantitative sensory testing|quantitative sensory testing
5265210|NCT02358954|contact heat evoked potentials|contact heat evoked potentials
5265211|NCT02358954|vection stimulation|vection stimulation
5265212|NCT02358954|3D-turntable|3d-turntable
5265213|NCT02358954|Volunteers|volunteers
5265214|NCT02358941|ADHD, neurofeedback, computerized cognitive training, school|adhd, neurofeedback, computerized cognitive training, school
5265215|NCT02358928|NAFLD|nafld
5265216|NCT02358928|Metabolic syndrome|metabolic syndrome
5265217|NCT02358928|Hepatic Magnetic Resonance Spectroscopy|hepatic magnetic resonance spectroscopy
5265219|NCT02358902|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5265220|NCT02358902|Exercise|exercise
5265221|NCT02358902|Fibromyalgia|fibromyalgia
5265222|NCT02358876|Parkinson's disease|parkinson's disease
5265223|NCT02358876|Deep brain stimulation|deep brain stimulation
5265224|NCT02358876|Bradykinesia|bradykinesia
5265225|NCT02358850|Tonsillectomy|tonsillectomy
5265226|NCT02358850|Adenoidectomy|adenoidectomy
5265227|NCT02358837|elastosonography|elastosonography
5265228|NCT02358837|comparing conventional sonography with ductosonography|comparing conventional sonography with ductosonography
5265229|NCT02358824|Hypertension|hypertension
5265230|NCT02358824|CKD-828|ckd-828
5265231|NCT02358824|Telmisartan|telmisartan
5265232|NCT02358824|S-amlodipine|s-amlodipine
5265233|NCT02358824|Pharmacokinetic|pharmacokinetic
5265234|NCT02358811|Obstructive Sleep Apnea|obstructive sleep apnea
5265235|NCT02358811|Voxel-Based Morphometry|voxel-based morphometry
5265236|NCT02358811|Polysomnography|polysomnography
5265237|NCT02358811|Magnetic resonance imaging|magnetic resonance imaging
5265238|NCT02358798|Time evolution of respiratory function|time evolution of respiratory function
5265239|NCT02358798|Longitudinal multicenter monitoring of large cohorts|longitudinal multicenter monitoring of large cohorts
5265240|NCT02358798|Preschool aged children|preschool aged children
5265241|NCT02358798|Detection of cystic fibrosis in neonatal period|detection of cystic fibrosis in neonatal period
5265242|NCT02358772|stroke|stroke
5265243|NCT02358772|thrombolysis|thrombolysis
5265244|NCT02358772|STEMO|stemo
5265245|NCT02358759|Abnormal zygote fertilization|abnormal zygote fertilization
5265246|NCT02358759|3PNs correction|3pns correction
5265247|NCT02358759|Giant oocyte management|giant oocyte management
5265248|NCT02358759|triploidy fertilization|triploidy fertilization
5265249|NCT02358759|Maternal nucleus removal|maternal nucleus removal
5265250|NCT02358746|epicardial catheter ablation|epicardial catheter ablation
5265251|NCT02358733|POR|por
5265252|NCT02358733|IMSI|imsi
5265253|NCT02358720|bone metastases|bone metastases
5265254|NCT02358707|ibuprofen phonophoresis|ibuprofen phonophoresis
5265255|NCT02358707|High performance liquid chromatography|high performance liquid chromatography
5265256|NCT02358694|IBS|ibs
5265257|NCT02358694|IBS-D|ibs-d
5265258|NCT02358694|SBI|sbi
5265259|NCT02358681|Intranasal|intranasal
5265260|NCT02358681|Ketorolac|ketorolac
5265261|NCT02358681|Pediatric|pediatric
5265262|NCT02358681|Migraine|migraine
5265276|NCT02358564|Lactulose|lactulose
5265277|NCT02358564|Mannitol|mannitol
5265278|NCT02358551|Pacemaker|pacemaker
5265279|NCT02358551|Axillary Vein|axillary vein
5265280|NCT02358551|Subclavian vein|subclavian vein
5265281|NCT02358551|Clinical Study|clinical study
5265282|NCT02358551|Cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
5265283|NCT02358538|PCDH19|pcdh19
5265284|NCT02358538|ganaxolone|ganaxolone
5265285|NCT02358538|neurosteroid|neurosteroid
5265286|NCT02358538|CDKL5|cdkl5
5265287|NCT02358538|LGS|lgs
5265288|NCT02358538|CSWS|csws
5265289|NCT02358512|Intensive Care|intensive care
5265290|NCT02358512|Recovery of Function|recovery of function
5265291|NCT02358512|Survivors|survivors
5265292|NCT02358512|Outcome Assessment (Health Care)|outcome assessment (health care)
5265293|NCT02358512|Medical Economics|medical economics
5265301|NCT02358486|Functional Dyspepsia|functional dyspepsia
5265302|NCT02358486|Acupuncture|acupuncture
5265303|NCT02358486|Functional MRI|functional mri
5265304|NCT02358473|Nonsmall Cell Lung Cancer|nonsmall cell lung cancer
5265310|NCT02358460|neonatal|neonatal
5265311|NCT02358460|respiratory|respiratory
5265312|NCT02358460|mechanical ventilation|mechanical ventilation
5265313|NCT02358447|total knee arthroplasty|total knee arthroplasty
5265314|NCT02358447|total knee prothesis|total knee prothesis
5265315|NCT02358447|Spectrometry, X-Ray Emission|spectrometry, x-ray emission
5265316|NCT02358447|SPECT/CT|spect/ct
5265317|NCT02358447|measurement of TKA component position|measurement of tka component position
5265318|NCT02358434|Implant|implant
5265319|NCT02358421|Rotterdam's diagnostic criteria of PCOS|rotterdam's diagnostic criteria of pcos
5265320|NCT02358421|Risk of OHSS|risk of ohss
5265322|NCT02358356|pancreatic|pancreatic
5265323|NCT02358356|neuroendocrine|neuroendocrine
5265324|NCT02358356|advanced|advanced
5265325|NCT02358356|unresectable low|unresectable low
5265326|NCT02358356|intermediate grade|intermediate grade
5265327|NCT02358356|mNETs|mnets
5265328|NCT02358356|pNETs|pnets
5265329|NCT02358343|Comorbid Depression|comorbid depression
5265330|NCT02358343|Major Depressive Disorder|major depressive disorder
5265331|NCT02358343|Dysthymia|dysthymia
5265332|NCT02358343|Cognitive Behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5265333|NCT02358343|Sertraline|sertraline
5265334|NCT02358343|Engagement Interview|engagement interview
5265335|NCT02358343|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5265336|NCT02358343|Hemodialysis|hemodialysis
5265337|NCT02358317|Autism|autism
5265338|NCT02358317|Postural Stability|postural stability
5265339|NCT02358317|Exergaming|exergaming
5265340|NCT02358317|White Matter|white matter
5265341|NCT02358252|Heart Rate Variability|heart rate variability
5265342|NCT02358252|orthostatic hypotension|orthostatic hypotension
5265343|NCT02358252|stroke|stroke
5265344|NCT02358252|integrated intelligent biosensor system|integrated intelligent biosensor system
5265345|NCT02358239|dizziness and vertigo|dizziness and vertigo
5265346|NCT02358239|emergency department (ED)|emergency department (ed)
5265347|NCT02358239|clinical trial|clinical trial
5265348|NCT02358239|acupuncture|acupuncture
5265356|NCT02358213|reproductibility|reproductibility
5265357|NCT02358174|Hemorrhoids|hemorrhoids
5265359|NCT02358174|NGAL|ngal
5265360|NCT02358174|Matrix Metalloproteinases|matrix metalloproteinases
5265361|NCT02358161|Pancreatic cancer|pancreatic cancer
5265362|NCT02358161|LDE225|lde225
5265363|NCT02358161|Gemcitabine|gemcitabine
5265371|NCT02358148|Coronary Artery Disease|coronary artery disease
5265372|NCT02358148|Risk Factors|risk factors
5265373|NCT02358148|Myocardial Infarction|myocardial infarction
5265375|NCT02358135|Equivalency|equivalency
5265376|NCT02358135|Teledermatology|teledermatology
5265377|NCT02358109|Cost-Benefit Analysis, Exercise,Women,Diseases/Prevention|cost-benefit analysis, exercise,women,diseases/prevention
5265378|NCT02358096|Chronic Kidney Disease|chronic kidney disease
5265379|NCT02358096|Type 2 Diabetes|type 2 diabetes
5265380|NCT02358096|ASP8232|asp8232
5265381|NCT02358070|Hepatocellular Carcinoma|hepatocellular carcinoma
5265382|NCT02358057|Deep sedation|deep sedation
5265383|NCT02358057|Dexmedetomidine|dexmedetomidine
5265384|NCT02358057|Emergency Service, Hospital|emergency service, hospital
5265389|NCT02358018|68Ga-DOTATOC|68ga-dotatoc
5265390|NCT02358018|PET/CT scan|pet/ct scan
5265391|NCT02358018|14-226|14-226
5265392|NCT02357992|Lung cancer|lung cancer
5265393|NCT02357992|Non-small cell lung cancer|non-small cell lung cancer
5265394|NCT02357992|NSCLC|nsclc
5265395|NCT02357992|Squamous cell carcinoma|squamous cell carcinoma
5265396|NCT02357992|Adenocarcinoma with or without BAC features|adenocarcinoma with or without bac features
5265397|NCT02357992|Large cell carcinoma with or without neuroendocrine features|large cell carcinoma with or without neuroendocrine features
5265398|NCT02357992|Neuroendocrine carcinoma|neuroendocrine carcinoma
5265399|NCT02357992|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
5265400|NCT02357992|Stereotactic radiotherapy (SRT)|stereotactic radiotherapy (srt)
5265401|NCT02357992|SRT|srt
5265402|NCT02357992|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5265403|NCT02357992|SABR|sabr
5265404|NCT02357992|Radiation therapy|radiation therapy
5265405|NCT02357992|XRT|xrt
5265406|NCT02357979|caries|caries
5265407|NCT02357979|prevention|prevention
5265408|NCT02357979|laser|laser
5265409|NCT02357979|fluoride|fluoride
5265410|NCT02357966|Staph|staph
5265411|NCT02357966|antibody|antibody
5265412|NCT02357940|Eczema|eczema
5265413|NCT02357940|Skin Irritation|skin irritation
5265414|NCT02357927|fears of recurrence|fears of recurrence
5265415|NCT02357927|cancer|cancer
5265416|NCT02357927|brief intervention|brief intervention
5270442|NCT02328118|PDR|pdr
5265417|NCT02357927|telephone counseling|telephone counseling
5265418|NCT02357927|following primary cancer treatment|following primary cancer treatment
5265419|NCT02357914|Ultrasound|ultrasound
5265420|NCT02357914|Shoulder|shoulder
5265421|NCT02357914|Spinal Cord Injury|spinal cord injury
5265422|NCT02357914|Fluoroscopy|fluoroscopy
5265423|NCT02357888|Nicotine replacement therapy|nicotine replacement therapy
5265425|NCT02357862|Cardiovascular Diseases|cardiovascular diseases
5265426|NCT02357862|Heart Valve Diseases|heart valve diseases
5265427|NCT02357862|Mitral Valve Annuloplasty|mitral valve annuloplasty
5160566|NCT02988063|Varithena|varithena
5265428|NCT02357862|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
5265429|NCT02357823|Pneumococcal vaccine|pneumococcal vaccine
5265430|NCT02357823|HIV infection|hiv infection
5265431|NCT02357823|13-valent Pneumococcal Conjugate Vaccine|13-valent pneumococcal conjugate vaccine
5265432|NCT02357823|23-valent Pneumococcal Polysaccharide Vaccine|23-valent pneumococcal polysaccharide vaccine
5265433|NCT02357784|Sacral Neuromodulation|sacral neuromodulation
5265435|NCT02357784|Dual Incontinence|dual incontinence
5265436|NCT02357784|Current Perception Threshold Testing|current perception threshold testing
5265438|NCT02357784|Fecal Incontinence|fecal incontinence
5265439|NCT02357784|Urinary Incontinence|urinary incontinence
5265440|NCT02357784|Afferent Nerve Sensation|afferent nerve sensation
5265441|NCT02357784|InterStim|interstim
5265442|NCT02357771|misalignment of the two dental arches|misalignment of the two dental arches
5265443|NCT02357771|mal-align teeth|mal-align teeth
5265444|NCT02357758|Antibiotic Prophylaxis|antibiotic prophylaxis
5265445|NCT02357758|Urinary Microbiota|urinary microbiota
5265446|NCT02357745|neopterin|neopterin
5265447|NCT02357745|plasma|plasma
5265448|NCT02357745|urine|urine
5265449|NCT02357745|saliva|saliva
5265450|NCT02357745|menopause|menopause
5265451|NCT02357745|periodontitis|periodontitis
5265452|NCT02357732|Metastatic Melanoma|metastatic melanoma
5265453|NCT02357719|Sleep Apnea Syndromes|sleep apnea syndromes
5265455|NCT02357719|Holter ECG|holter ecg
5265456|NCT02357719|Thoracic impedance|thoracic impedance
5265457|NCT02357719|Heart rate variability|heart rate variability
5265458|NCT02357719|Nasal flow|nasal flow
5265459|NCT02357693|nausea, postoperative|nausea, postoperative
5265460|NCT02357693|postoperative nausea|postoperative nausea
5265461|NCT02357693|postoperative vomiting|postoperative vomiting
5265462|NCT02357693|vomiting, postoperative|vomiting, postoperative
5252864|NCT02429115|peer mentoring|peer mentoring
5265463|NCT02357641|acute coronary disease, echographic strain analysis, cut off|acute coronary disease, echographic strain analysis, cut off
5265464|NCT02357602|Participants|participants
5265465|NCT02357602|HIV-1 negative|hiv-1 negative
5265467|NCT02357589|laparoscopy|laparoscopy
5265468|NCT02357589|cholecystectomy|cholecystectomy
5265469|NCT02357563|fibroid|fibroid
5265470|NCT02357563|GnRH analogue|gnrh analogue
5265471|NCT02357563|ulipristal acetate|ulipristal acetate
5265472|NCT02357537|Telemedicine|telemedicine
5265473|NCT02357524|Effects on coagulation tests in healthy volunteers|effects on coagulation tests in healthy volunteers
5265474|NCT02357511|sensitivity|sensitivity
5265475|NCT02357511|specificity|specificity
5265476|NCT02357511|novel blood pressure monitor|novel blood pressure monitor
5265477|NCT02357511|Saturation|saturation
5265478|NCT02357498|pituitary|pituitary
5265479|NCT02357498|adenoma|adenoma
5265480|NCT02357498|transsphenoidal surgery|transsphenoidal surgery
5265481|NCT02357485|ADSC|adsc
5265482|NCT02357485|osteoarthritis|osteoarthritis
5265483|NCT02357485|knee|knee
5265484|NCT02357485|adipose|adipose
5265485|NCT02357472|Reproductive aging|reproductive aging
5265486|NCT02357472|DHEA|dhea
5265487|NCT02357472|poor ovarian responder|poor ovarian responder
5265488|NCT02357459|osteoarthritis|osteoarthritis
5265489|NCT02357459|knee|knee
5265490|NCT02357459|pain|pain
5265491|NCT02357459|corticosteroid|corticosteroid
5265492|NCT02357459|intra-articular|intra-articular
5265493|NCT02357459|injection|injection
5265494|NCT02357420|Diabetes Mellitus|diabetes mellitus
5265495|NCT02357420|Delayed Gastric Emptying|delayed gastric emptying
5265496|NCT02357420|Vomiting|vomiting
5265497|NCT02357420|Gastroparesis|gastroparesis
5265498|NCT02357420|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
5265499|NCT02357407|fluoroquinolones|fluoroquinolones
5265500|NCT02357407|pharmacokinetic|pharmacokinetic
5265501|NCT02357407|infections|infections
5265502|NCT02357394|arabin pessary|arabin pessary
5265503|NCT02357394|short cervix|short cervix
5265504|NCT02357368|HIV-negative|hiv-negative
5265505|NCT02357329|fat taste|fat taste
5265506|NCT02357329|food preference|food preference
5265507|NCT02357329|consumption|consumption
5265508|NCT02357329|free fatty acids|free fatty acids
5265509|NCT02357316|Taste responses of healthy individuals|taste responses of healthy individuals
5265510|NCT02357303|Randomized controlled trial|randomized controlled trial
5265511|NCT02357303|Endoscopy|endoscopy
5265512|NCT02357303|Gastric mucosa|gastric mucosa
5265513|NCT02357303|Simethicone|simethicone
5265514|NCT02357303|Acetylcysteine|acetylcysteine
5265515|NCT02357290|mania|mania
5265516|NCT02357290|temper tantrum|temper tantrum
5265527|NCT02357212|Non-St elevation acute coronary syndrome|non-st elevation acute coronary syndrome
5265528|NCT02357199|Mouth Diseases|mouth diseases
5265529|NCT02357199|Renal Insufficiency, Chronic|renal insufficiency, chronic
5265530|NCT02357199|Intervention Studies|intervention studies
5265531|NCT02357186|Mild head injury - clinical decision rule - Child|mild head injury - clinical decision rule - child
5265532|NCT02357173|smoking|smoking
5265533|NCT02357173|nicotine|nicotine
5265534|NCT02357173|tobacco products|tobacco products
5265535|NCT02357173|electronic cigarette|electronic cigarette
5265536|NCT02357147|Amatuximab|amatuximab
5265537|NCT02357147|Pemetrexed|pemetrexed
5265538|NCT02357147|Cisplatin|cisplatin
5265539|NCT02357147|Unresectable Malignant Pleural Mesothelioma|unresectable malignant pleural mesothelioma
5265540|NCT02357147|ARTEMIS|artemis
5265541|NCT02357108|Supportive Care|supportive care
5265542|NCT02357108|treatment options|treatment options
5265543|NCT02357108|doctor's compassion|doctor's compassion
5265544|NCT02357095|Caesarean Scar Pregnancy|caesarean scar pregnancy
5262778|NCT02372890|PET/CT|pet/ct
5265545|NCT02357095|uterine artery chemo-embolization|uterine artery chemo-embolization
5265547|NCT02357030|Gulf War Illness|gulf war illness
5265548|NCT02357030|nutrients|nutrients
5265549|NCT02357030|methylphenidate|methylphenidate
5265550|NCT02357030|mitochondria|mitochondria
5265551|NCT02356991|Famitinib|famitinib
5265552|NCT02356991|Phase II|phase ii
5265553|NCT02356991|NSCLC|nsclc
5265554|NCT02356978|Rare disease|rare disease
5265555|NCT02356978|Crigler-Najjar disease|crigler-najjar disease
5265556|NCT02356978|Paediatric|paediatric
5265557|NCT02356978|Experimental device|experimental device
5265558|NCT02356965|Third molar extraction|third molar extraction
5265559|NCT02356965|Wisdom tooth extraction|wisdom tooth extraction
5265563|NCT02356952|Randomized Clinical Trial|randomized clinical trial
5265565|NCT02356926|Medical errors|medical errors
5265566|NCT02356926|Emergency department|emergency department
5265567|NCT02356926|Cross checking|cross checking
5265568|NCT02356900|interval training|interval training
5265569|NCT02356900|hyperbaric oxygen|hyperbaric oxygen
5265570|NCT02356900|VO2 max|vo2 max
5265571|NCT02356900|altitude|altitude
5265572|NCT02356900|exercise performance|exercise performance
5252973|NCT02428634|Cardiovascular health promotion|cardiovascular health promotion
5265573|NCT02356900|mitochondrial oxidative capacity|mitochondrial oxidative capacity
5265574|NCT02356900|mitochondrial biogenesis|mitochondrial biogenesis
5265575|NCT02356861|treatment|treatment
5265576|NCT02356861|photobiomodulation|photobiomodulation
5265577|NCT02356861|Veterans|veterans
5265578|NCT02356861|brain-injury|brain-injury
5265579|NCT02356861|TBI|tbi
5265580|NCT02356861|PTSD|ptsd
5265586|NCT02356809|Gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon|gene therapy, plasmid, vegf, systemic scleroderma,secondary raynaud's phenomenon
5265587|NCT02356757|self-care|self-care
5265588|NCT02356757|self-monitoring|self-monitoring
5265589|NCT02356757|medication adherence|medication adherence
5265590|NCT02356757|diet|diet
5265591|NCT02356757|physical activity|physical activity
5265592|NCT02356757|primary prevention|primary prevention
5265593|NCT02356744|Maternal outcome|maternal outcome
5265594|NCT02356744|Fetal outcome|fetal outcome
5265595|NCT02356744|bariatric surgery|bariatric surgery
5265596|NCT02356744|Third Trimester|third trimester
5265597|NCT02356731|seizures,|seizures,
5265598|NCT02356731|quality of life|quality of life
5265599|NCT02356640|Celiac plexus neurolysis|celiac plexus neurolysis
5265600|NCT02356640|Celiac ganglion neurolysis|celiac ganglion neurolysis
5265601|NCT02356640|Pancreatic cancer|pancreatic cancer
5265602|NCT02356627|Occupational therapy|occupational therapy
5265603|NCT02356627|Adaptive intervention|adaptive intervention
5265604|NCT02356627|Home-based|home-based
5265605|NCT02356627|Assistive Technology|assistive technology
5265606|NCT02356627|Home modification|home modification
5265607|NCT02356627|Clinical effectiveness|clinical effectiveness
5265608|NCT02356627|Cost-effectiveness|cost-effectiveness
5265609|NCT02356627|Cost-utility|cost-utility
5265610|NCT02356614|Lap Band|lap band
5265611|NCT02356601|MRI|mri
5265612|NCT02356601|Lumbar spine|lumbar spine
5265613|NCT02356601|Ultrasound|ultrasound
5265614|NCT02356575|surgery|surgery
5265615|NCT02356575|chemotherapy|chemotherapy
5265616|NCT02356575|radiation|radiation
5265617|NCT02356575|Acupuncture|acupuncture
5366310|NCT01874288|NHL|nhl
5265618|NCT02356575|16-947|16-947
5265619|NCT02356562|Hepatitis C|hepatitis c
5265620|NCT02356562|Interferon-Free|interferon-free
5265621|NCT02356562|Treatment Experienced|treatment experienced
5265622|NCT02356562|Chronic Hepatitis C|chronic hepatitis c
5265623|NCT02356562|Hepatitis C Virus|hepatitis c virus
5265624|NCT02356510|myocardial infarction|myocardial infarction
5265625|NCT02356510|TIMI flow|timi flow
5265626|NCT02356510|culprit lesion|culprit lesion
5265627|NCT02356510|culprit vessel|culprit vessel
5265628|NCT02356497|Bone metastases|bone metastases
5265629|NCT02356497|Metastatic bone disease|metastatic bone disease
5265630|NCT02356497|Multi-trial facility|multi-trial facility
5265631|NCT02356458|Mantle cell lymphoma|mantle cell lymphoma
5265632|NCT02356458|Relapsed|relapsed
5265633|NCT02356458|Refractory|refractory
5265634|NCT02356458|Cancer|cancer
5265635|NCT02356458|Lymphoma|lymphoma
5265636|NCT02356458|Ibrutinib Imbruvica|ibrutinib imbruvica
5265637|NCT02356458|Bortezomib Velcade|bortezomib velcade
5265638|NCT02356432|non-valvular atrial fibrillation|non-valvular atrial fibrillation
5265639|NCT02356432|cerebral microbleeds|cerebral microbleeds
5265640|NCT02356432|warfarin|warfarin
5265641|NCT02356432|NOACs|noacs
5265642|NCT02356432|acute ischemic stroke|acute ischemic stroke
5265643|NCT02356406|Radiosurgery|radiosurgery
5265644|NCT02356406|Celiac Plexus|celiac plexus
5265645|NCT02356406|Pain|pain
5265646|NCT02356406|Quality of Life|quality of life
5265647|NCT02356393|Desalinated Sea Water|desalinated sea water
5265648|NCT02356393|Magnesium|magnesium
5265649|NCT02356393|Drinking Water|drinking water
5265650|NCT02356367|telemonitoring|telemonitoring
5265651|NCT02356367|Adaptive servo-ventilation|adaptive servo-ventilation
5262875|NCT02372474|POF|pof
5265653|NCT02356354|cutaneous innervation|cutaneous innervation
5265654|NCT02356354|skin biopsy|skin biopsy
5265655|NCT02356354|post-burn scar|post-burn scar
5265657|NCT02356315|Brain Stem|brain stem
5265658|NCT02356315|Spinal Cord|spinal cord
5265659|NCT02356315|Neurophysiology|neurophysiology
5265660|NCT02356315|Magnetic Resonance Imaging|magnetic resonance imaging
5265661|NCT02356289|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5265662|NCT02356276|locally advanced gastric cancer|locally advanced gastric cancer
5265663|NCT02356276|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5265664|NCT02356276|radical gastrectomy with D2 lymphadenectomy|radical gastrectomy with d2 lymphadenectomy
5265665|NCT02356263|stressful events|stressful events
5265666|NCT02356263|psychological stress|psychological stress
5146615|NCT03076073|Achilles tendon|achilles tendon
5265667|NCT02356263|life experiences|life experiences
5265668|NCT02356250|liver biopsy f 4|liver biopsy f 4
5265669|NCT02356237|Episiotomy|episiotomy
5265670|NCT02356237|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
5265671|NCT02356224|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
5265672|NCT02356211|falls|falls
5265673|NCT02356185|Alcohol Drinking|alcohol drinking
5265674|NCT02356185|Injecting drug|injecting drug
5265675|NCT02356185|Antiretroviral therapy|antiretroviral therapy
5265676|NCT02356185|sub-Saharan Africa|sub-saharan africa
5265677|NCT02356172|Quality of Life|quality of life
5265678|NCT02356172|Depression|depression
5265679|NCT02356172|Kallmann Syndrome|kallmann syndrome
5265680|NCT02356172|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5265681|NCT02356159|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5265682|NCT02356159|Lymphoma|lymphoma
5265683|NCT02356159|Leukemia|leukemia
5265684|NCT02356159|Unrelated Donors|unrelated donors
5265685|NCT02356146|Kidney transplantation|kidney transplantation
5265686|NCT02356146|genotype|genotype
5265687|NCT02356146|tacrolimus|tacrolimus
5265688|NCT02356146|CYP3A5|cyp3a5
5265689|NCT02356133|Near-Infrared Spectroscopy|near-infrared spectroscopy
5265690|NCT02356094|glaucoma|glaucoma
5265691|NCT02356094|primary open angle glaucoma|primary open angle glaucoma
5265692|NCT02356094|cornea|cornea
5265693|NCT02356068|liver transplantation, rotem, bleeding, transfusion|liver transplantation, rotem, bleeding, transfusion
5265694|NCT02356055|activities of daily living|activities of daily living
5265695|NCT02356055|massed practice|massed practice
5265696|NCT02356055|occupational therapy|occupational therapy
5265697|NCT02356029|Cardiopulmonary Arrest|cardiopulmonary arrest
5265698|NCT02356029|Emergency Medical Services|emergency medical services
5265699|NCT02356029|Medical Futility|medical futility
5265700|NCT02356029|Decision Making|decision making
5265701|NCT02356029|Emotional Stress|emotional stress
5265702|NCT02356029|Burnout, Professional|burnout, professional
5265703|NCT02356016|Sarcopenic Obesity|sarcopenic obesity
5265704|NCT02356016|community dwelling elderly women|community dwelling elderly women
5265705|NCT02356016|electromyostimulation|electromyostimulation
5265706|NCT02356016|exercise|exercise
5265707|NCT02356016|dietary supplements|dietary supplements
5265708|NCT02356003|Tourette Syndrome|tourette syndrome
5265709|NCT02356003|Children|children
5265710|NCT02356003|Tics|tics
5265711|NCT02355977|Chronic periodontitis|chronic periodontitis
5265712|NCT02355977|Minocycline|minocycline
5265717|NCT02355912|Transfemoral|transfemoral
5265718|NCT02355873|heparin-coated|heparin-coated
5265719|NCT02355873|surface-treated polyacrylonitrile membrane hemofilter|surface-treated polyacrylonitrile membrane hemofilter
5265720|NCT02355873|critical ill|critical ill
5265721|NCT02355873|acute kidney injury|acute kidney injury
5265722|NCT02355873|chronic kidney disease|chronic kidney disease
5265723|NCT02355873|continuous renal replacement therapy|continuous renal replacement therapy
5265724|NCT02355834|Fecal Incontinence (FI)|fecal incontinence (fi)
5265725|NCT02355834|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5265726|NCT02355834|bowel control|bowel control
5265727|NCT02355834|Chronic diarrhoea|chronic diarrhoea
5265728|NCT02355834|rectal inflammation|rectal inflammation
5265729|NCT02355821|cellular aging|cellular aging
5265730|NCT02355821|vascular aging|vascular aging
5265731|NCT02355821|bone metabolism|bone metabolism
5265732|NCT02355821|collagen type 1 C-telopeptide|collagen type 1 c-telopeptide
5265733|NCT02355821|nuclear factor kappa-B ligand (RANKL)|nuclear factor kappa-b ligand (rankl)
5265734|NCT02355821|pulse wave velocity|pulse wave velocity
5265735|NCT02355821|telomerase activity|telomerase activity
5265736|NCT02355795|weight change|weight change
5265737|NCT02355795|diet|diet
5265738|NCT02355795|dietary fat|dietary fat
5265739|NCT02355795|feeding design|feeding design
5265740|NCT02355782|TMA, aHUS, TTP, stem cell transplant-associated TMA|tma, ahus, ttp, stem cell transplant-associated tma
5265741|NCT02355769|heart failure|heart failure
5265742|NCT02355769|renal failure|renal failure
5265743|NCT02355769|prognosis|prognosis
5265744|NCT02355769|impedance cardiography|impedance cardiography
5265745|NCT02355717|children, bone|children, bone
5265746|NCT02355717|Simple obesity|simple obesity
5265747|NCT02355717|cardiovascular disease|cardiovascular disease
5265748|NCT02355717|osteoporosis|osteoporosis
5265749|NCT02355717|diabetes|diabetes
5265750|NCT02355704|Kidney Transplantation|kidney transplantation
5265751|NCT02355704|Atorvastatin|atorvastatin
5265752|NCT02355704|C-Reactive Protein|c-reactive protein
5265753|NCT02355704|Biopsy|biopsy
5265754|NCT02355704|Interleukin|interleukin
5265755|NCT02355652|Total knee arthroplasty|total knee arthroplasty
5265756|NCT02355652|IKS Score|iks score
5265757|NCT02355652|cemented, uncemented|cemented, uncemented
5265758|NCT02355626|Anxiety|anxiety
5265759|NCT02355626|level of anxiety|level of anxiety
5265760|NCT02355626|delirium|delirium
5265761|NCT02355626|agitation|agitation
5265762|NCT02355626|tools for measuring anxiety|tools for measuring anxiety
5265763|NCT02355626|neuroendocrine system|neuroendocrine system
5265764|NCT02355613|Radiosurgery, brain, metastases|radiosurgery, brain, metastases
5265765|NCT02355600|Oocyte|oocyte
5265766|NCT02355600|Tamoxifen|tamoxifen
5265767|NCT02355600|Fertility preservation|fertility preservation
5265768|NCT02355587|melanoma|melanoma
5265771|NCT02355574|melanoma|melanoma
5265772|NCT02355574|cutaneous melanoma|cutaneous melanoma
5265773|NCT02355574|DecisionDx-Melanoma|decisiondx-melanoma
5265774|NCT02355561|Bioavailability|bioavailability
5265775|NCT02355561|Healthy Participants|healthy participants
5265776|NCT02355561|JNJ-54861911|jnj-54861911
5265777|NCT02355561|Food Effect|food effect
5265778|NCT02355535|refractory|refractory
5265779|NCT02355535|intolerant|intolerant
5265780|NCT02355535|solid tumors|solid tumors
5265781|NCT02355535|PNET|pnet
5265782|NCT02355535|neuroendocrine|neuroendocrine
5265783|NCT02355522|saline infusion sonohysterography|saline infusion sonohysterography
5265784|NCT02355509|Acarbose|acarbose
5265785|NCT02355509|Postprandial lipemia|postprandial lipemia
5265786|NCT02355509|Cardiovascular risk|cardiovascular risk
5265787|NCT02355496|Cost Control|cost control
5265788|NCT02355496|Data Display|data display
5265789|NCT02355496|Diagnostic Tests, Routine|diagnostic tests, routine
5265790|NCT02355496|Physician's Practice Patterns|physician's practice patterns
5265791|NCT02355470|Sexual assault|sexual assault
5265792|NCT02355470|Alcohol consumption|alcohol consumption
5265793|NCT02355470|Intimate partner violence|intimate partner violence
5265794|NCT02355457|troponin|troponin
5265795|NCT02355457|myocardial infarction|myocardial infarction
5265798|NCT02355457|biomarker|biomarker
5265799|NCT02355457|BACC|bacc
5265800|NCT02355457|high-sensitivity|high-sensitivity
5265801|NCT02355431|EGFR|egfr
5265802|NCT02355431|mutation|mutation
5265803|NCT02355405|lung ultrasound|lung ultrasound
5265804|NCT02355405|atelectasis|atelectasis
5265805|NCT02355405|thoracic computed Tomography|thoracic computed tomography
5265806|NCT02355379|Adjuvant chemotherapy in colonic adenocarcinoma in elderly|adjuvant chemotherapy in colonic adenocarcinoma in elderly
5265807|NCT02355366|Offspring|offspring
5265808|NCT02355366|significant mood symptoms|significant mood symptoms
5265809|NCT02355353|DWI-MRI|dwi-mri
5265810|NCT02355353|resectable liver metastases|resectable liver metastases
5265811|NCT02355340|Bone mineral density|bone mineral density
5265812|NCT02355340|Childhood cancer survivors|childhood cancer survivors
5265813|NCT02355314|ICU patients|icu patients
5265814|NCT02355314|Doppler-based renal|doppler-based renal
5265815|NCT02355301|ICF, impairment, activity, satisfaction, quality of care|icf, impairment, activity, satisfaction, quality of care
5265816|NCT02355288|Coronary Artery Disease|coronary artery disease
5265817|NCT02355288|Diabetes Mellitus|diabetes mellitus
5265818|NCT02355288|Minimally Invasive Cardiac Surgery|minimally invasive cardiac surgery
5265819|NCT02355288|Percutaneous Coronary Intervention|percutaneous coronary intervention
5265820|NCT02355275|Home Exercise|home exercise
5265821|NCT02355275|Resistance Exercise|resistance exercise
5265824|NCT02355249|traditional three incisions|traditional three incisions
5265825|NCT02355249|minimally invasive thoracol-laparoscopic esophagectomy|minimally invasive thoracol-laparoscopic esophagectomy
5265827|NCT02355249|esophageal cancer|esophageal cancer
5265828|NCT02355236|Naxozol|naxozol
5265830|NCT02355236|GSRS|gsrs
5265831|NCT02355236|Osteoarthritis|osteoarthritis
5265832|NCT02355236|Gastroprotective|gastroprotective
5265833|NCT02355223|Tuberculosis|tuberculosis
5265834|NCT02355223|Infection Control|infection control
5265835|NCT02355223|Transmission|transmission
5265836|NCT02355197|antioxidants|antioxidants
5265837|NCT02355197|Gestational diabetes mellitus|gestational diabetes mellitus
5265838|NCT02355197|oxidative stress|oxidative stress
5265839|NCT02355158|pain|pain
5160997|NCT02985320|infant|infant
5265840|NCT02355158|diabetic neuropathy|diabetic neuropathy
5265841|NCT02355158|pain in feet|pain in feet
5265842|NCT02355145|type 2 diabetes, add-on diabetes therapy, rationale|type 2 diabetes, add-on diabetes therapy, rationale
5265843|NCT02355132|Medicaid|medicaid
5265844|NCT02355132|public insurance|public insurance
5265845|NCT02355132|cardiovascular disease|cardiovascular disease
5265846|NCT02355132|prevention|prevention
5265847|NCT02355132|community health centers|community health centers
5265848|NCT02355132|electronic health records|electronic health records
5265849|NCT02355132|cancer prevention|cancer prevention
5265850|NCT02355080|HIV|hiv
5265851|NCT02355080|HCV|hcv
5265852|NCT02355067|parenting|parenting
5265861|NCT02355041|meal replacement|meal replacement
5265862|NCT02355028|LHA510|lha510
5265863|NCT02355028|PoC|poc
5265864|NCT02355028|Age-related macular degeneration|age-related macular degeneration
5265865|NCT02354976|omega-3 carboxylic acid|omega-3 carboxylic acid
5265866|NCT02354963|Poor ovarian response|poor ovarian response
5265867|NCT02354963|Salvador/Warts/Hippo pathway|salvador/warts/hippo pathway
5265868|NCT02354963|Follicular activation|follicular activation
5351242|NCT01943396|AMD|amd
5265869|NCT02354963|Poor ovarian reserve|poor ovarian reserve
5265870|NCT02354950|GSK1265744|gsk1265744
5265871|NCT02354950|healthy controls|healthy controls
5265872|NCT02354950|pharmacokinetic|pharmacokinetic
5265873|NCT02354950|Hepatic Impairment|hepatic impairment
5265874|NCT02354937|Pharmacokinetics|pharmacokinetics
5265875|NCT02354937|GSK1265744|gsk1265744
5265876|NCT02354937|Severe Renal Impairment|severe renal impairment
5265877|NCT02354911|Immunomodulation|immunomodulation
5265878|NCT02354872|Nicotine|nicotine
5265879|NCT02354859|Cystic Fibrosis|cystic fibrosis
5265880|NCT02354859|Gallium Nitrate|gallium nitrate
5265881|NCT02354859|IV Gallium|iv gallium
5265882|NCT02354859|Pseudomonas aeruginosa|pseudomonas aeruginosa
5265883|NCT02354833|Hypotension|hypotension
5265884|NCT02354833|Cesarean Delivery|cesarean delivery
5265885|NCT02354833|Phenylephrine|phenylephrine
5265886|NCT02354833|Spinal Anesthesia|spinal anesthesia
5265887|NCT02354833|Norepinephrine|norepinephrine
5265888|NCT02354807|BAT activation|bat activation
5265889|NCT02354807|quantitative PET imaging|quantitative pet imaging
5265890|NCT02354807|Mirabegron effect on BAT|mirabegron effect on bat
5265891|NCT02354794|arginine|arginine
5265892|NCT02354794|supplementation|supplementation
5265893|NCT02354794|metabolic syndrome|metabolic syndrome
5265894|NCT02354794|endothelial function|endothelial function
5265895|NCT02354781|DMD|dmd
5265896|NCT02354781|muscular dystrophy|muscular dystrophy
5265897|NCT02354781|Follistatin|follistatin
5265898|NCT02354742|Echocardiography|echocardiography
5265899|NCT02354742|EGDT|egdt
5265900|NCT02354742|Sepsis|sepsis
5265901|NCT02354716|esophagus|esophagus
5265902|NCT02354716|upper GI|upper gi
5265903|NCT02354716|endoscopy|endoscopy
5265904|NCT02354716|endoFLIP|endoflip
5265905|NCT02354716|functional luminal imaging|functional luminal imaging
5265906|NCT02354716|esophageal stricture|esophageal stricture
5265907|NCT02354716|narrow esophagus|narrow esophagus
5265908|NCT02354716|narrow caliber esophagus|narrow caliber esophagus
5265909|NCT02354716|esophageal narrowing|esophageal narrowing
5265910|NCT02354716|eosinophilic esophagitis|eosinophilic esophagitis
5265911|NCT02354716|Zenkers diverticulum|zenkers diverticulum
5265912|NCT02354716|Schatzki ring|schatzki ring
5265913|NCT02354703|alcoholism, treatment, serotonin transporter|alcoholism, treatment, serotonin transporter
5265914|NCT02354677|Bronchial epithelium|bronchial epithelium
5265915|NCT02354677|COPD|copd
5265916|NCT02354677|Repair|repair
5265917|NCT02354677|Remodelling|remodelling
5265918|NCT02354677|Club Cells|club cells
5265919|NCT02354664|respiratory test|respiratory test
5265920|NCT02354664|respiratory muscle endurance|respiratory muscle endurance
5265921|NCT02354664|spirometry|spirometry
5265922|NCT02354651|Pompe disease|pompe disease
5265923|NCT02354651|mechanical ventilation|mechanical ventilation
5265924|NCT02354651|diaphragm pacing|diaphragm pacing
5265925|NCT02354638|Perceptions|perceptions
5265926|NCT02354638|Education and evaluate post intervention KAP|education and evaluate post intervention kap
5265927|NCT02354625|Schwann cells|schwann cells
5265928|NCT02354599|Randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study|randomized, double-blind, placebo-controlled, single-dose subcutaneous administration study
5265929|NCT02354586|gBRCAmut|gbrcamut
5265930|NCT02354586|BRCA|brca
5265931|NCT02354586|PARP inhibitor|parp inhibitor
5265932|NCT02354586|HRD|hrd
5265933|NCT02354586|Ovarian cancer|ovarian cancer
5265934|NCT02354586|Serous Epithelial|serous epithelial
5265935|NCT02354586|Fallopian Tube|fallopian tube
5265936|NCT02354586|Primary Peritoneal|primary peritoneal
5265937|NCT02354560|Erythromycin|erythromycin
5265938|NCT02354560|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
5265939|NCT02354560|APC gene|apc gene
5265940|NCT02354560|nonsense mutations|nonsense mutations
5265941|NCT02354534|cervical dysplasia|cervical dysplasia
5265942|NCT02354534|HPV|hpv
5265943|NCT02354534|Treatment|treatment
5265944|NCT02354534|preinvasive|preinvasive
5161188|NCT02984046|RSV|rsv
5265945|NCT02354534|cervix|cervix
5265946|NCT02354534|vaginal suppository|vaginal suppository
5265947|NCT02354534|Cornelia Trimble|cornelia trimble
5265948|NCT02354534|abnormal pap|abnormal pap
5265950|NCT02354521|Protein|protein
5265951|NCT02354521|Mechanical ventilation|mechanical ventilation
5265952|NCT02354521|Children|children
5265953|NCT02354521|Outcomes|outcomes
5265954|NCT02354508|acromegaly|acromegaly
5265960|NCT02354508|somatostatin analogues|somatostatin analogues
5265961|NCT02354508|growth disorder|growth disorder
5265962|NCT02354508|gigantism|gigantism
5265963|NCT02354508|Pituitary adenoma|pituitary adenoma
5265964|NCT02354508|pituitary gigantism|pituitary gigantism
5265965|NCT02354495|Indirect calorimetry|indirect calorimetry
5265966|NCT02354495|Protein|protein
5265967|NCT02354495|Mechanical ventilation|mechanical ventilation
5265968|NCT02354495|Respiratory failure|respiratory failure
5265969|NCT02354469|TBI|tbi
5265970|NCT02354469|Mild Traumatic Brain Injury|mild traumatic brain injury
5265971|NCT02354469|Post-Concussion Syndrome|post-concussion syndrome
5265972|NCT02354469|Recovery of Function|recovery of function
5265973|NCT02354469|Motor Activity|motor activity
5265974|NCT02354469|Diffusion Tensor Imaging|diffusion tensor imaging
5265975|NCT02354469|Neural Injury|neural injury
5265976|NCT02354469|Biomarkers|biomarkers
5265977|NCT02354456|atrial fibrillation|atrial fibrillation
5265978|NCT02354456|epidemiology|epidemiology
5265979|NCT02354456|antiocaogulation|antiocaogulation
5265980|NCT02354430|pregnancy|pregnancy
5265981|NCT02354430|low back pain|low back pain
5265982|NCT02354430|sick leave,|sick leave,
5265983|NCT02354430|motor activity|motor activity
5265984|NCT02354404|Ebola virus|ebola virus
5265985|NCT02354404|Filoviridae Infections|filoviridae infections
5265986|NCT02354404|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
5265987|NCT02354404|Viral Diseases|viral diseases
5265988|NCT02354404|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
5265989|NCT02354365|PEEP adjustment|peep adjustment
5265990|NCT02354365|Tidal Volume|tidal volume
5265991|NCT02354365|Driving Pressure|driving pressure
5265992|NCT02354365|Compliance|compliance
5265993|NCT02354339|Metabolic Syndrome|metabolic syndrome
5265994|NCT02354339|Irvingia gabonensis|irvingia gabonensis
5265995|NCT02354339|African mango|african mango
5265996|NCT02354339|Insulin resistance|insulin resistance
5265997|NCT02354313|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
5265998|NCT02354313|Lenalidomide (Len)|lenalidomide (len)
5265999|NCT02354313|Rituximab|rituximab
5266000|NCT02354313|ASCT|asct
5266001|NCT02354313|Revlimid|revlimid
5266002|NCT02354313|High dose chemotherapy|high dose chemotherapy
5266003|NCT02354313|transplant|transplant
5266004|NCT02354261|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
5266005|NCT02354261|BCCNS|bccns
5266006|NCT02354261|BCC|bcc
5266007|NCT02354261|itraconazole|itraconazole
5266008|NCT02354261|basal cell carcinoma|basal cell carcinoma
5266009|NCT02354261|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
5266010|NCT02354248|TST|tst
5266011|NCT02354248|TMS|tms
5266012|NCT02354248|Stroke patients|stroke patients
5266024|NCT02354183|Commitment strategies|commitment strategies
5266025|NCT02354183|Motivation|motivation
5266026|NCT02354183|DBT skills|dbt skills
5266027|NCT02354183|Self-harm|self-harm
5266028|NCT02354183|Brief intervention|brief intervention
5266029|NCT02354170|Central Serous Chorioretinopathy, CSC|central serous chorioretinopathy, csc
5266030|NCT02354157|children dietary pattern|children dietary pattern
5266031|NCT02354157|control rules|control rules
5266032|NCT02354157|instrumental learning|instrumental learning
5266033|NCT02354157|food reinforcement|food reinforcement
5266038|NCT02354131|Ovarian cancer|ovarian cancer
5266039|NCT02354131|Niraparib|niraparib
5266040|NCT02354131|Bevacizumab|bevacizumab
5266041|NCT02354131|PARP|parp
5266042|NCT02354131|Phase 2 randomized|phase 2 randomized
5266043|NCT02354105|Axial Spondyloarthritis|axial spondyloarthritis
5266044|NCT02354105|Radiographic Axial Spondyloarthritis|radiographic axial spondyloarthritis
5266045|NCT02354105|Non-radiographic Axial Spondyloarthritis|non-radiographic axial spondyloarthritis
5266046|NCT02354105|Ankylosing spondylitis|ankylosing spondylitis
5266047|NCT02354105|Diagnosis|diagnosis
5266048|NCT02354105|Cimzia|cimzia
5266049|NCT02354105|CZP|czp
5266050|NCT02354105|Certolizumab Pegol|certolizumab pegol
5266051|NCT02354105|CDP870|cdp870
5266052|NCT02354092|cervical dilation|cervical dilation
5266053|NCT02354092|pain|pain
5266054|NCT02354092|paracervical block|paracervical block
5266055|NCT02354092|osmotic dilators|osmotic dilators
5266056|NCT02354079|Low LDL-C|low ldl-c
5266057|NCT02354079|Target Identification|target identification
5266058|NCT02354079|Genetic|genetic
5266059|NCT02354079|Endocrinology|endocrinology
5266060|NCT02354079|Cardiovascular Disease|cardiovascular disease
5266061|NCT02354066|Hallux valgus surgery|hallux valgus surgery
5266062|NCT02354066|forefoot surgery|forefoot surgery
5266063|NCT02354066|brake response time|brake response time
5266064|NCT02354066|foot orthoses|foot orthoses
5266065|NCT02354053|HIV|hiv
5266066|NCT02354053|Triumeq|triumeq
5161207|NCT02983916|cine-MRI|cine-mri
5266067|NCT02354053|vulnerable populations|vulnerable populations
5266068|NCT02354040|Stroke, Myocardial Infarction, Adherence, Health Literacy, Implementation, Developing Country|stroke, myocardial infarction, adherence, health literacy, implementation, developing country
5266070|NCT02354014|Multidrug-Resistant Tuberculosis|multidrug-resistant tuberculosis
5266072|NCT02354014|TMC207|tmc207
5266073|NCT02354001|schizophrenia|schizophrenia
5266074|NCT02354001|mental illness|mental illness
5266075|NCT02354001|serm|serm
5266076|NCT02354001|raloxifene|raloxifene
5266077|NCT02354001|clinical trial|clinical trial
5266078|NCT02353988|AR-positive|ar-positive
5266079|NCT02353988|Androgen Antagonists|androgen antagonists
5266080|NCT02353988|Bicalutamide|bicalutamide
5266081|NCT02353988|TNBC|tnbc
5266082|NCT02353988|metastatic|metastatic
5266083|NCT02353975|SHR3824|shr3824
5266084|NCT02353975|food effect|food effect
5266085|NCT02353975|mass|mass
5266086|NCT02353975|balance|balance
5266087|NCT02353975|Phase I|phase i
5266088|NCT02353962|neglect|neglect
5266089|NCT02353962|exergames|exergames
5266090|NCT02353949|Mild cognitive impairment|mild cognitive impairment
5266091|NCT02353949|Alzheimer|alzheimer
5266092|NCT02353949|PET|pet
5266093|NCT02353949|Amyloid|amyloid
5266094|NCT02353949|Frontotemporal|frontotemporal
5266095|NCT02353871|Moderate to Severe|moderate to severe
5266096|NCT02353858|Rectal Cancer|rectal cancer
5266097|NCT02353858|Hyperthermia|hyperthermia
5266098|NCT02353858|Radiochemotherapy|radiochemotherapy
5266099|NCT02353858|Chemoradiotherapy|chemoradiotherapy
5266100|NCT02353858|Deep regional hyperthermia|deep regional hyperthermia
5266101|NCT02353858|pathologic complete response|pathologic complete response
5266102|NCT02353858|Regression Grade|regression grade
5266103|NCT02353858|Locally advanced rectal cancer|locally advanced rectal cancer
5266104|NCT02353858|complete response|complete response
5266105|NCT02353806|Amlodipine besylate|amlodipine besylate
5266106|NCT02353806|Breast milk|breast milk
5266107|NCT02353806|Pharmacokinetics|pharmacokinetics
5266108|NCT02353806|Chronic hypertension|chronic hypertension
5266109|NCT02353806|Pregnancy|pregnancy
5266110|NCT02353793|Hypothermia|hypothermia
5266111|NCT02353793|(Poly) Trauma|(poly) trauma
5266112|NCT02353793|Emergency Room|emergency room
5266113|NCT02353793|Warming Blanket|warming blanket
5266114|NCT02353780|Rheumatoid arthritis|rheumatoid arthritis
5266115|NCT02353780|TNF inhibitors|tnf inhibitors
5266116|NCT02353702|Diaphragmatic function|diaphragmatic function
5266117|NCT02353702|sniff-test|sniff-test
5266118|NCT02353702|pulmonary complications|pulmonary complications
5266119|NCT02353702|upper abdominal surgery|upper abdominal surgery
5266120|NCT02353663|Rheumatic heart disease|rheumatic heart disease
5266121|NCT02353663|Rheumatic fever|rheumatic fever
5266122|NCT02353663|Mitral regurgitation|mitral regurgitation
5266123|NCT02353663|Aortic regurgitation|aortic regurgitation
5266124|NCT02353663|Mitral stenosis|mitral stenosis
5266125|NCT02353650|Q10|q10
5266126|NCT02353650|ubiquinol|ubiquinol
5266127|NCT02353611|tooth|tooth
5266128|NCT02353611|bleaching|bleaching
5266129|NCT02353585|vitamin K-antagonist|vitamin k-antagonist
5266130|NCT02353585|novel oral anticoagulants|novel oral anticoagulants
5266131|NCT02353585|apixaban|apixaban
5266132|NCT02353585|dabigatran|dabigatran
5266133|NCT02353585|rivaroxaban|rivaroxaban
5266134|NCT02353585|edoxaban|edoxaban
5266135|NCT02353585|direct oral anticoagulants|direct oral anticoagulants
5266136|NCT02353559|acute leukemia|acute leukemia
5266137|NCT02353559|traumatic stress|traumatic stress
5266138|NCT02353559|quality of life|quality of life
5266139|NCT02353559|symptom burden|symptom burden
5266140|NCT02353559|psychosocial oncology|psychosocial oncology
5266141|NCT02353559|palliative care|palliative care
5266142|NCT02353559|intervention|intervention
5266143|NCT02353559|hematological malignancies|hematological malignancies
5266144|NCT02353559|supportive care|supportive care
5266145|NCT02353546|affective symptoms|affective symptoms
5266146|NCT02353546|cancer|cancer
5266147|NCT02353546|depression|depression
5266148|NCT02353546|palliative care|palliative care
5266149|NCT02353546|pilot trial|pilot trial
5266150|NCT02353546|psychotherapy|psychotherapy
5266151|NCT02353533|adenoma|adenoma
5266152|NCT02353533|EMR|emr
5266153|NCT02353533|FTRD|ftrd
5266154|NCT02353533|non- lifting|non- lifting
5266155|NCT02353533|colon|colon
5266156|NCT02353442|Pain|pain
5266157|NCT02353442|Rotator cuff|rotator cuff
5266158|NCT02353442|Stretching|stretching
5266159|NCT02353442|Mobilization|mobilization
5266160|NCT02353442|Scapula|scapula
5266161|NCT02353442|Posterior capsule|posterior capsule
5266162|NCT02353416|Mediterranean Diet|mediterranean diet
5266179|NCT02353325|Iron encapsulation|iron encapsulation
5266180|NCT02353312|Diastolic|diastolic
5266181|NCT02353312|Biopterin|biopterin
5266182|NCT02353312|Therapeutic Use|therapeutic use
5266183|NCT02353312|Drug Therapy|drug therapy
5266184|NCT02353312|Quality of Life|quality of life
5266185|NCT02353299|Cognition|cognition
5266193|NCT02353221|Early arthritis|early arthritis
5266194|NCT02353221|undiferentiated arthritis|undiferentiated arthritis
5266196|NCT02353182|lower extremity|lower extremity
5266197|NCT02353169|changes in myocardial repolarization in healthy children|changes in myocardial repolarization in healthy children
5266198|NCT02353156|Hemorrhoidectomy|hemorrhoidectomy
5266199|NCT02353156|postoperative pain|postoperative pain
5266200|NCT02353156|Sitz bath|sitz bath
5266201|NCT02353156|Electronic bidet|electronic bidet
5266202|NCT02353143|Acute Myeloid Leukemia|acute myeloid leukemia
5266203|NCT02353143|AML|aml
5266204|NCT02353143|Relapsed|relapsed
5266205|NCT02353143|Refractory|refractory
5266206|NCT02353143|MEN1112|men1112
5266207|NCT02353143|Monoclonal antibody|monoclonal antibody
5266208|NCT02353130|autism spectrum disorders|autism spectrum disorders
5266209|NCT02353130|memantine|memantine
5266210|NCT02353130|cortical metrics|cortical metrics
5266211|NCT02353130|sensory testing|sensory testing
5266212|NCT02353078|Eosinophilic Esophagitis (EOE)|eosinophilic esophagitis (eoe)
5266213|NCT02353065|Colles' Fracture|colles' fracture
5266214|NCT02353065|ultrasonography|ultrasonography
5266215|NCT02353052|morphology standards|morphology standards
5266216|NCT02353013|protein intake|protein intake
5266217|NCT02353013|body composition|body composition
5266234|NCT02352961|Unrecognised condition|unrecognised condition
5266235|NCT02352922|Laparoscopy|laparoscopy
5203504|NCT02722811|TNF-α|tnf-α
5266236|NCT02352922|Robotic Surgical Procedures|robotic surgical procedures
5266237|NCT02352922|Hysterectomy|hysterectomy
5266238|NCT02352922|Anesthetics, Local|anesthetics, local
5266239|NCT02352922|Bupivacaine|bupivacaine
5266240|NCT02352922|Pain, Postoperative|pain, postoperative
5266241|NCT02352896|Leigh syndrome|leigh syndrome
5266242|NCT02352896|Mitochondrial disorders|mitochondrial disorders
5266243|NCT02352896|EPI743|epi743
5266244|NCT02352896|Vincerinone|vincerinone
5266245|NCT02352870|Feasibility study|feasibility study
5266246|NCT02352870|Randomised controlled trial|randomised controlled trial
5266247|NCT02352870|Cognitive behavioural therapy|cognitive behavioural therapy
5266248|NCT02352870|Psychological distress|psychological distress
5266249|NCT02352870|Cognitive illness representations|cognitive illness representations
5903747|NCT00339612|Perinatal|perinatal
5266250|NCT02352870|Common sense model|common sense model
5266251|NCT02352857|Fructo-oligosaccharides|fructo-oligosaccharides
5266252|NCT02352857|Sugar-reduced foods|sugar-reduced foods
5266253|NCT02352857|Postprandial glucose response|postprandial glucose response
5266254|NCT02352805|Extracorporeal circulation, ventricular assist device|extracorporeal circulation, ventricular assist device
5266255|NCT02352792|Local control|local control
5266256|NCT02352779|Cancer Survivor|cancer survivor
5266257|NCT02352766|Thyroid cancer|thyroid cancer
5266258|NCT02352766|Thyroid nodules|thyroid nodules
5266259|NCT02352766|Palpable nodules|palpable nodules
5266260|NCT02352766|FNA|fna
5266261|NCT02352753|Amgen, OI, Bone|amgen, oi, bone
5266262|NCT02352740|arginine|arginine
5266263|NCT02352740|supplementation|supplementation
5266264|NCT02352740|metabolic syndrome|metabolic syndrome
5266265|NCT02352740|nitric oxide|nitric oxide
5266266|NCT02352727|Nocturnal hypokinesia|nocturnal hypokinesia
5266267|NCT02352727|Accelerometers|accelerometers
5266268|NCT02352714|Adolescents|adolescents
5266269|NCT02352714|Women's Health|women's health
5266270|NCT02352714|Contraception|contraception
5266271|NCT02352714|Reproduction|reproduction
5266272|NCT02352714|Comparative Effectiveness Research|comparative effectiveness research
5266273|NCT02352714|Pregnancy Prevention|pregnancy prevention
5266274|NCT02352714|Intrauterine Device|intrauterine device
5266275|NCT02352701|helicobacter pylori|helicobacter pylori
5266276|NCT02352701|ilaprazole|ilaprazole
5266277|NCT02352701|eradication|eradication
5266278|NCT02352701|triple therapy|triple therapy
5266279|NCT02352688|elderly|elderly
5266280|NCT02352688|enhanced recovery after surgery|enhanced recovery after surgery
5266281|NCT02352662|Congenital Heart Disease|congenital heart disease
5266282|NCT02352662|Point-of-care coagulation monitoring|point-of-care coagulation monitoring
5266283|NCT02352662|Rotaional Thromboelastometry|rotaional thromboelastometry
5266284|NCT02352649|Peripheral nerve injury|peripheral nerve injury
5266285|NCT02352649|Neurotmesis|neurotmesis
5266286|NCT02352649|Gene therapy|gene therapy
5266287|NCT02352649|Plasmid|plasmid
5266288|NCT02352649|Nerve regeneration therapy|nerve regeneration therapy
5266289|NCT02352610|carpometacarpal joints|carpometacarpal joints
5266290|NCT02352597|PCOS|pcos
5266297|NCT02352558|Multiple Myeloma|multiple myeloma
5266298|NCT02352558|Lymphoma|lymphoma
5266299|NCT02352558|Acute Myeloid Leukemia|acute myeloid leukemia
5266300|NCT02352558|Myelo-Dysplastic Syndrome|myelo-dysplastic syndrome
5266301|NCT02352558|Chronic Myeloid Leukemia|chronic myeloid leukemia
5266302|NCT02352558|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5266303|NCT02352532|Dry Needling|dry needling
5266304|NCT02352532|Shear Wave Elastography|shear wave elastography
5266305|NCT02352532|Ultrasound|ultrasound
5266306|NCT02352493|PNH|pnh
5266307|NCT02352493|RNAi therapeutic|rnai therapeutic
5266308|NCT02352480|Non Healing Wound|non healing wound
5266309|NCT02352467|Non Healing Wound|non healing wound
5266310|NCT02352454|Non Healing Wound|non healing wound
5266311|NCT02352428|Skin Cancer|skin cancer
5266312|NCT02352428|Secondary Prevention|secondary prevention
5266313|NCT02352428|Population Screening|population screening
5266314|NCT02352402|CABG|cabg
5266315|NCT02352402|Ticagrelor|ticagrelor
5266316|NCT02352402|Graft|graft
5266318|NCT02352389|Childhood|childhood
5266319|NCT02352389|Cancer|cancer
5266320|NCT02352389|Genetic mutations|genetic mutations
5266321|NCT02352376|Noninvasive ventilation|noninvasive ventilation
5266322|NCT02352376|Heart rate variability|heart rate variability
5266323|NCT02352376|Thoracic surgery|thoracic surgery
5266324|NCT02352363|Parkinson's Disease|parkinson's disease
5266325|NCT02352363|Motor fluctuations|motor fluctuations
5266326|NCT02352363|levodopa|levodopa
5266327|NCT02352363|inhaled drugs|inhaled drugs
5266328|NCT02352363|OFF episodes|off episodes
5266329|NCT02352350|Pre-Hospital Cardiac Arrest|pre-hospital cardiac arrest
5266330|NCT02352350|Blood Lactate Level|blood lactate level
5266331|NCT02352350|Neurological Injury|neurological injury
5266332|NCT02352337|cancer|cancer
5266333|NCT02352337|pancreatic cancer|pancreatic cancer
5266334|NCT02352337|metastatic pancreatic cancer|metastatic pancreatic cancer
5266335|NCT02352324|cardiac output|cardiac output
5266336|NCT02352324|coronary artery bypass grafting|coronary artery bypass grafting
5266337|NCT02352324|minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
5266338|NCT02352324|fluid responsiveness|fluid responsiveness
5266339|NCT02352272|sleep extension|sleep extension
5266340|NCT02352272|attention|attention
5266341|NCT02352272|physical performance|physical performance
5266342|NCT02352259|Liver metastases of colorectal cancer Electrochemotherapy|liver metastases of colorectal cancer electrochemotherapy
5266343|NCT02352259|Bleomycin|bleomycin
5266344|NCT02352259|Electrochemotherapy|electrochemotherapy
5266345|NCT02352246|intermittent sprinting|intermittent sprinting
5266346|NCT02352246|abdominal fat mass|abdominal fat mass
5266347|NCT02352246|type 2 diabetes|type 2 diabetes
5266348|NCT02352246|postmenopausal women|postmenopausal women
5266349|NCT02352233|retroview colonoscope|retroview colonoscope
5266350|NCT02352233|retroflexion colonoscopy|retroflexion colonoscopy
5266351|NCT02352233|colonoscopy|colonoscopy
5266352|NCT02352207|Neonatal respiratory distress|neonatal respiratory distress
5266353|NCT02352207|prenatal lung malformation|prenatal lung malformation
5266354|NCT02352207|KRAS mutation|kras mutation
5266355|NCT02352207|pregnant woman|pregnant woman
5266356|NCT02352194|Multiple Sclerosis, Physical therapy, Physical capacity, Fatigue|multiple sclerosis, physical therapy, physical capacity, fatigue
5266357|NCT02352181|Cirrhosis, transplantation, transfusion, Rotem®|cirrhosis, transplantation, transfusion, rotem®
5266360|NCT02352142|Separation stress|separation stress
5266361|NCT02352142|Family Nurture|family nurture
5266362|NCT02352142|Maternal Confidence|maternal confidence
5266363|NCT02352142|Maternal Competence|maternal competence
5266364|NCT02352142|Calming Cycle|calming cycle
5266365|NCT02352142|Kangaroo Care|kangaroo care
5266366|NCT02352142|Infant Neurodevelopment|infant neurodevelopment
5266367|NCT02352142|Infant Psychological Development|infant psychological development
5266368|NCT02352142|Post-partum depression|post-partum depression
5266369|NCT02352142|Mother-infant Co-regulation|mother-infant co-regulation
5266370|NCT02352116|Postoperative Experience|postoperative experience
5266371|NCT02352116|Postoperative Behavioral Changes|postoperative behavioral changes
5266372|NCT02352116|Maladaptive Behavioral Changes|maladaptive behavioral changes
5266373|NCT02352103|prostate cancer|prostate cancer
5266374|NCT02352103|Urinary continence|urinary continence
5266375|NCT02352103|robotic assisted radical prostatectomy|robotic assisted radical prostatectomy
5266376|NCT02352103|Vattikuti Urology Institute (VIP) radical prostatectomy|vattikuti urology institute (vip) radical prostatectomy
5266377|NCT02352103|Retzius sparing radical prostatectomy|retzius sparing radical prostatectomy
5266378|NCT02352090|Contraception, oral|contraception, oral
5266380|NCT02352090|Estradiol Valerate|estradiol valerate
5266382|NCT02352090|Insulin resistance|insulin resistance
5266383|NCT02352090|Chronic inflammation|chronic inflammation
5266384|NCT02352090|Coagulation|coagulation
5266385|NCT02352051|attention deficit-hyperactivity disorder (ADHD).|attention deficit-hyperactivity disorder (adhd).
5266386|NCT02352051|executive functions|executive functions
5266387|NCT02352038|malocclusion|malocclusion
5266388|NCT02352038|low-level laser therapy|low-level laser therapy
5266390|NCT02352025|breast cancer|breast cancer
5266391|NCT02352025|triple negative|triple negative
5161500|NCT02982434|ischemic heart disease|ischemic heart disease
5266392|NCT02352012|Interventional Treatment|interventional treatment
5266393|NCT02352012|Refractory Pneumothorax|refractory pneumothorax
5266394|NCT02352012|Bronchoscope|bronchoscope
5266395|NCT02351999|Atrial fibrillation|atrial fibrillation
5266396|NCT02351999|Transseptal puncture|transseptal puncture
5266397|NCT02351999|Atrial fibrillation ablation|atrial fibrillation ablation
5266398|NCT02351986|subacromial impingement|subacromial impingement
5266399|NCT02351986|physical therapy|physical therapy
5266400|NCT02351986|cryotherapy|cryotherapy
5266401|NCT02351960|Drug therapy|drug therapy
5266402|NCT02351960|GERD|gerd
5266403|NCT02351960|Dexlansoprazole|dexlansoprazole
5266404|NCT02351947|stroke|stroke
5266405|NCT02351947|Cerebrovascular accident|cerebrovascular accident
5266406|NCT02351947|rehabilitation|rehabilitation
5266407|NCT02351947|motor learning|motor learning
5266408|NCT02351947|fMRI|fmri
5266409|NCT02351947|plasticity|plasticity
5266410|NCT02351934|colorectal surgery|colorectal surgery
5266411|NCT02351934|volume status|volume status
5266412|NCT02351921|transcranial magnetic stimulation|transcranial magnetic stimulation
5266413|NCT02351921|spinal cord injury|spinal cord injury
5266414|NCT02351921|motor cortex|motor cortex
5266415|NCT02351921|somatosensory cortex|somatosensory cortex
5266416|NCT02351895|infection control|infection control
5266417|NCT02351895|Prevention of hospital acquired infection|prevention of hospital acquired infection
5266418|NCT02351856|laminopathy|laminopathy
5266419|NCT02351856|ARRY-797|arry-797
5266420|NCT02351804|US-guided peripheral nerve block|us-guided peripheral nerve block
5266421|NCT02351804|Anesthetics, Local|anesthetics, local
5266422|NCT02351804|duration|duration
5266423|NCT02351804|Sensation|sensation
5266424|NCT02351804|adductor canal block|adductor canal block
5266425|NCT02351804|lower limb|lower limb
5266426|NCT02351804|Adjuvants, Anesthesia|adjuvants, anesthesia
5266427|NCT02351778|Developing Countries|developing countries
5266428|NCT02351778|Quality of Life|quality of life
5266429|NCT02351778|Mixed Methods|mixed methods
5266430|NCT02351778|Validation|validation
5266431|NCT02351778|Caregiver Burden|caregiver burden
5266435|NCT02351713|primary prevention|primary prevention
5266436|NCT02351687|Moderate Acute Malnutrition|moderate acute malnutrition
5266449|NCT02351596|Balance|balance
5266450|NCT02351596|Core Control|core control
5266451|NCT02351505|Small Cell Lung Cancer|small cell lung cancer
5266452|NCT02351492|Bile duct obstruction|bile duct obstruction
5266453|NCT02351492|intraoperative cholangiography|intraoperative cholangiography
5266454|NCT02351492|MRCP|mrcp
5266455|NCT02351479|hula|hula
5266456|NCT02351479|breast cancer|breast cancer
5266457|NCT02351479|female|female
5266458|NCT02351479|hawaii|hawaii
5266459|NCT02351479|physical activity|physical activity
5266460|NCT02351479|cervical cancer|cervical cancer
5266461|NCT02351479|ovarian cancer|ovarian cancer
5266462|NCT02351479|endometrial cancer|endometrial cancer
5266463|NCT02351466|Brain Growth and Development|brain growth and development
5266464|NCT02351466|Cognition|cognition
5266465|NCT02351466|Children|children
5266466|NCT02351466|Continuous Glucose Monitoring|continuous glucose monitoring
5266468|NCT02351466|Functional MRI|functional mri
5266469|NCT02351440|duloxetine|duloxetine
5266470|NCT02351414|Osteoarthritis|osteoarthritis
5266471|NCT02351414|Ankylosis|ankylosis
5266472|NCT02351414|Revision procedures|revision procedures
5266473|NCT02351414|Correction of functional deformity|correction of functional deformity
5266474|NCT02351414|Rheumatoid arthritis|rheumatoid arthritis
5266475|NCT02351414|Arthritis|arthritis
5266482|NCT02351375|microbiota|microbiota
5266483|NCT02351375|small intestine|small intestine
5266484|NCT02351375|diet|diet
5266485|NCT02351375|feces|feces
5266486|NCT02351362|Retention|retention
5266487|NCT02351362|Attrition|attrition
5266488|NCT02351362|Incentive|incentive
5266489|NCT02351362|Pregnant women|pregnant women
5266490|NCT02351349|frailty|frailty
5266491|NCT02351349|CKD|ckd
5266492|NCT02351349|Physical Therapy Modalities|physical therapy modalities
5266493|NCT02351349|Elder Nutritional Physiological Phenomena|elder nutritional physiological phenomena
5266494|NCT02351336|Threatened preterm birth|threatened preterm birth
5266495|NCT02351336|Fetal adrenal gland volume|fetal adrenal gland volume
5266496|NCT02351336|Fetal zone enlargement|fetal zone enlargement
5266497|NCT02351336|Prediction of preterm birth|prediction of preterm birth
5266498|NCT02351297|High protein diet|high protein diet
5266499|NCT02351297|Microbiota|microbiota
5266500|NCT02351297|Rectal biopsies|rectal biopsies
5266501|NCT02351297|Metabolomics|metabolomics
5266502|NCT02351297|Bacterial metabolites|bacterial metabolites
5266504|NCT02351284|HIV, vitamin D, osteoporosis|hiv, vitamin d, osteoporosis
5266505|NCT02351258|Pediatrics|pediatrics
5266506|NCT02351258|Medical Oncology|medical oncology
5266507|NCT02351258|Catheters|catheters
5266508|NCT02351258|Infection|infection
5266509|NCT02351206|X-Rays|x-rays
5266510|NCT02351206|Magnetic Resonance Imaging|magnetic resonance imaging
5266511|NCT02351206|Sensitivity and Specificity|sensitivity and specificity
5266512|NCT02351180|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
5266513|NCT02351180|Community-acquired respiratory viral infection|community-acquired respiratory viral infection
5266514|NCT02351167|Smoking cessation|smoking cessation
5266515|NCT02351167|Counseling|counseling
5266516|NCT02351167|Genetics and Genomics|genetics and genomics
5266517|NCT02351141|Noble Gas MRI|noble gas mri
5266518|NCT02351141|Pulmonary Function|pulmonary function
5266519|NCT02351141|Quality of Life Questionnaires|quality of life questionnaires
5266520|NCT02351128|lanreotide|lanreotide
5266521|NCT02351102|Congenital CMV|congenital cmv
5266522|NCT02351102|Congenital Cytomegalovirus|congenital cytomegalovirus
5266523|NCT02351063|Heart failure|heart failure
5266524|NCT02351063|BNP|bnp
5266525|NCT02351063|home testing|home testing
5266526|NCT02351063|remote monitoring|remote monitoring
5266527|NCT02351050|sonolysis, brain infarction, coronary angioplasty|sonolysis, brain infarction, coronary angioplasty
5266528|NCT02351037|Acute Myeloid Leukemia|acute myeloid leukemia
5266530|NCT02351037|Ibrutinib|ibrutinib
5266531|NCT02351037|Cytarabine|cytarabine
5266532|NCT02351037|LD-AraC|ld-arac
5266533|NCT02351037|Azacitidine|azacitidine
5266534|NCT02350985|Migraine|migraine
5266535|NCT02350985|Migrainous Vertigo|migrainous vertigo
5266536|NCT02350985|Headache Disorders|headache disorders
5266537|NCT02350985|Central Nervous System Origin Vertigo|central nervous system origin vertigo
5903748|NCT00339612|HIV|hiv
5367416|NCT01869062|CRT|crt
5266538|NCT02350985|Paroxysmal Vertigo|paroxysmal vertigo
5266539|NCT02350985|Adrenergic beta-Antagonist|adrenergic beta-antagonist
5266540|NCT02350985|Vasodilator Agent|vasodilator agent
5266541|NCT02350985|Anti Arrhythmia Agent|anti arrhythmia agent
5266542|NCT02350985|Serotonin Uptake Inhibitor|serotonin uptake inhibitor
5266543|NCT02350985|Antidepressive Agent|antidepressive agent
5266544|NCT02350985|Propranolol|propranolol
5266545|NCT02350985|Venlafaxine|venlafaxine
5266547|NCT02350959|coronary computed tomography angiography|coronary computed tomography angiography
5266548|NCT02350933|tracheal damages|tracheal damages
5266549|NCT02350920|IBD|ibd
5266554|NCT02350907|point-of-care testing|point-of-care testing
5266555|NCT02350907|Neisseria gonorrhoeae|neisseria gonorrhoeae
5266556|NCT02350868|without Standard Treatment|without standard treatment
5266557|NCT02350855|Nutrition intervention|nutrition intervention
5266558|NCT02350855|Palliative care|palliative care
5266559|NCT02350855|Public Health|public health
5266560|NCT02350855|Quality of life|quality of life
5266561|NCT02350855|Tailored food formula|tailored food formula
5266562|NCT02350855|Body weight|body weight
5266563|NCT02350842|non-Left Bundle Branch Block morphology|non-left bundle branch block morphology
5266564|NCT02350842|Triple-site biventricular pacing|triple-site biventricular pacing
5266565|NCT02350842|cardiac resynchronization therapy|cardiac resynchronization therapy
5266566|NCT02350803|distraction osteogenesis|distraction osteogenesis
5266567|NCT02350803|mini plate|mini plate
5266568|NCT02350803|Lefort 1 osteotomy|lefort 1 osteotomy
5266569|NCT02350790|Robotics|robotics
5266570|NCT02350790|Laparoscopy|laparoscopy
5266571|NCT02350790|Endometriosis|endometriosis
5266572|NCT02350790|Argon|argon
5266573|NCT02350790|Gynecology|gynecology
5266574|NCT02350777|T-cell Depleted Hematopoietic Stem Cell|t-cell depleted hematopoietic stem cell
5266575|NCT02350777|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5266576|NCT02350777|CliniMACS Cell Selection System|clinimacs cell selection system
5266577|NCT02350777|14-228|14-228
5266578|NCT02350777|HSCT|hsct
5266584|NCT02350751|Influenza, Flu, Flu A, Influenza A|influenza, flu, flu a, influenza a
5266585|NCT02350738|Mild cognitive impairment|mild cognitive impairment
5266586|NCT02350738|Dementia|dementia
5266587|NCT02350738|Cognitive training|cognitive training
5266588|NCT02350738|Cognitive rehabilitation|cognitive rehabilitation
5266589|NCT02350738|Cognitive therapy|cognitive therapy
5266590|NCT02350725|Chronic Fluid Overload|chronic fluid overload
5266591|NCT02350712|Recurrent or metastatic squamous cell carcinoma of the head and neck|recurrent or metastatic squamous cell carcinoma of the head and neck
5266592|NCT02350712|SCCHN|scchn
5266593|NCT02350647|Rotator cuff|rotator cuff
5266594|NCT02350647|Ossification|ossification
5266595|NCT02350647|Suture anchors|suture anchors
5266596|NCT02350621|cervical foraminal stenosis minimal invasive foraminotomy|cervical foraminal stenosis minimal invasive foraminotomy
5266597|NCT02350582|breast cancer|breast cancer
5266598|NCT02350582|telerehabilitation|telerehabilitation
5266599|NCT02350582|strength|strength
5266600|NCT02350582|fatigue|fatigue
5266601|NCT02350582|quality of life|quality of life
5266602|NCT02350569|liver transplant|liver transplant
5266613|NCT02350530|Liver metastases|liver metastases
5266614|NCT02350530|Liver resection|liver resection
5266615|NCT02350530|Liver ablation|liver ablation
5266616|NCT02350530|Conversion therapy|conversion therapy
5266617|NCT02350530|FOLFOXIRI|folfoxiri
5266618|NCT02350530|Oxaliplatin|oxaliplatin
5266619|NCT02350530|Irinotecan|irinotecan
5266620|NCT02350530|Fluorouracil|fluorouracil
5266621|NCT02350530|Bevacizumab|bevacizumab
5266622|NCT02350530|RAS mutation|ras mutation
5266623|NCT02350491|Pregnancy|pregnancy
5266624|NCT02350491|miRNA|mirna
5266625|NCT02350491|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5266626|NCT02350491|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5266627|NCT02350465|sarcopenia|sarcopenia
5266628|NCT02350465|aging|aging
5266629|NCT02350465|myosteatosis|myosteatosis
5266630|NCT02350465|exercise|exercise
5266631|NCT02350465|screening|screening
5254040|NCT02422732|NF1|nf1
5266632|NCT02350452|laparoscopic surgery|laparoscopic surgery
5266633|NCT02350452|diode laser|diode laser
5266634|NCT02350452|AMH|amh
5266635|NCT02350452|AFC|afc
5266636|NCT02350439|Coronary artery disease|coronary artery disease
5266637|NCT02350439|Fractional floe reserve|fractional floe reserve
5266638|NCT02350400|Drug eluting beads|drug eluting beads
5266639|NCT02350400|Irinotecan|irinotecan
5903749|NCT00339612|AIDS|aids
5266640|NCT02350400|Pharmacogenetics|pharmacogenetics
5266641|NCT02350400|Pharmacokinetics|pharmacokinetics
5266642|NCT02350374|diabetes|diabetes
5266643|NCT02350374|children|children
5266644|NCT02350361|endostar|endostar
5266645|NCT02350361|angiogenesis|angiogenesis
5266646|NCT02350361|EGFR-TKI|egfr-tki
5266647|NCT02350361|lung caner|lung caner
5266648|NCT02350348|neonates|neonates
5266649|NCT02350348|infants|infants
5266650|NCT02350348|anaesthesia|anaesthesia
5266651|NCT02350348|mortality|mortality
5266652|NCT02350348|adverse effects|adverse effects
5266653|NCT02350348|Epidemiological Study|epidemiological study
5266654|NCT02350348|European Society of Anaesthesiology|european society of anaesthesiology
5266655|NCT02350335|aneurysm|aneurysm
5266656|NCT02350335|nicotine replacement therapy|nicotine replacement therapy
5266657|NCT02350335|cerebral vasospasm|cerebral vasospasm
5266658|NCT02350335|outcome|outcome
5266659|NCT02350322|Diet|diet
5266660|NCT02350322|concentration|concentration
5266661|NCT02350322|seafood|seafood
5266662|NCT02350322|youths|youths
5266663|NCT02350322|Norway|norway
5266664|NCT02350322|Nutrient status in blood|nutrient status in blood
5266665|NCT02350322|Inflammatory markers|inflammatory markers
5266667|NCT02350309|E2006|e2006
5266668|NCT02350309|Multiple Sleep Latency Test|multiple sleep latency test
5266669|NCT02350309|Lemborexant|lemborexant
5266670|NCT02350296|headache|headache
5266671|NCT02350296|dental pain|dental pain
5266672|NCT02350296|neuralgia|neuralgia
5266673|NCT02350296|dysmenorrhoea|dysmenorrhoea
5266674|NCT02350296|muscular and osteoarticular pain|muscular and osteoarticular pain
5266675|NCT02350283|Acute Ischemic Stroke|acute ischemic stroke
5266676|NCT02350283|Endovascular therapy|endovascular therapy
5266677|NCT02350283|Solitaire|solitaire
5266678|NCT02350283|Standard Medical Management|standard medical management
5266679|NCT02350270|cognitively healthy individuals|cognitively healthy individuals
5266680|NCT02350257|cognitive behavior therapy|cognitive behavior therapy
5266681|NCT02350257|child|child
5266682|NCT02350257|randomized controlled trial|randomized controlled trial
5266683|NCT02350257|internet|internet
5266684|NCT02350244|musculoskeletal diseases|musculoskeletal diseases
5266685|NCT02350244|eyestrain|eyestrain
5266686|NCT02350244|occupational diseases|occupational diseases
5266687|NCT02350244|computer work|computer work
5266688|NCT02350244|muscle stretching exercise|muscle stretching exercise
5266689|NCT02350244|computer software application|computer software application
5266690|NCT02350244|MSDs|msds
5266691|NCT02350231|preterm birth|preterm birth
5266697|NCT02350218|Alprostadil|alprostadil
5266698|NCT02350205|Burn wounds|burn wounds
5266699|NCT02350205|Burns|burns
5266700|NCT02350205|Skin substitute|skin substitute
5266701|NCT02350192|ehealth|ehealth
5266702|NCT02350192|intervention|intervention
5266703|NCT02350192|effectiveness|effectiveness
5266704|NCT02350192|randomized controlled trial|randomized controlled trial
5266705|NCT02350166|colorectal cancer|colorectal cancer
5266706|NCT02350166|hepatectomy|hepatectomy
5266707|NCT02350166|laparoscopic surgery|laparoscopic surgery
5266708|NCT02350166|laparotomy|laparotomy
5266709|NCT02350166|complications|complications
5266710|NCT02350153|Mortality|mortality
5266711|NCT02350153|Morbidity|morbidity
5266712|NCT02350153|Incidence|incidence
5266713|NCT02350153|Prevalence|prevalence
5266715|NCT02350140|Prevention of mother-to-child HIV transmission|prevention of mother-to-child hiv transmission
5266716|NCT02350140|PMTCT|pmtct
5266717|NCT02350140|mobile health (mHealth)|mobile health (mhealth)
5266718|NCT02350140|mobile phone|mobile phone
5266719|NCT02350140|text messaging|text messaging
5266720|NCT02350140|short message services (SMS)|short message services (sms)
5266721|NCT02350127|dementia|dementia
5266722|NCT02350127|clinical trial|clinical trial
5266723|NCT02350127|behavioral intervention|behavioral intervention
5266724|NCT02350127|exercise|exercise
5266725|NCT02350127|complementary and alternative medicine|complementary and alternative medicine
5266726|NCT02350127|cognition|cognition
5266727|NCT02350127|function|function
5266728|NCT02350127|quality of life|quality of life
5266729|NCT02350114|Heart failure|heart failure
5266730|NCT02350114|6 Minute Walk Test|6 minute walk test
5254152|NCT02422355|hip|hip
5266731|NCT02350088|fast-track surgery|fast-track surgery
5266732|NCT02350075|short implants|short implants
5266733|NCT02350075|sinus floor elevation|sinus floor elevation
5266734|NCT02350075|randomized controlled trial|randomized controlled trial
5266735|NCT02350036|Preeclampsia|preeclampsia
5266736|NCT02350036|placental protein 13|placental protein 13
5266737|NCT02350036|Uterine artery doppler|uterine artery doppler
5266738|NCT02350023|alopecia areata|alopecia areata
5266739|NCT02350023|betamethasone|betamethasone
5266740|NCT02350023|latanoprost|latanoprost
5266741|NCT02350023|topical steroid|topical steroid
5266742|NCT02350023|prostaglandin|prostaglandin
5266743|NCT02350010|Etiology|etiology
5266744|NCT02350010|Prognostic risk factors|prognostic risk factors
5266745|NCT02350010|Intracerebral Hemorrhage|intracerebral hemorrhage
5266746|NCT02350010|non-invasive imaging|non-invasive imaging
5266747|NCT02350010|CT angiography|ct angiography
5266748|NCT02349997|central sleep apnea|central sleep apnea
5266749|NCT02349997|Cheyne-Stokes respiration|cheyne-stokes respiration
5266953|NCT02348645|Laminectomy|laminectomy
5266751|NCT02349997|chronic heart failure|chronic heart failure
5266753|NCT02349919|postinfectious cough, postviral cough|postinfectious cough, postviral cough
5266754|NCT02349906|non-malignant diseases, allogeneic stem cell transplantation|non-malignant diseases, allogeneic stem cell transplantation
5266755|NCT02349854|pruritus|pruritus
5266756|NCT02349854|itch|itch
5266757|NCT02349854|skin|skin
5266758|NCT02349854|scalp|scalp
5266759|NCT02349854|seborrheic dermatitis|seborrheic dermatitis
5266760|NCT02349828|antiviral|antiviral
5266761|NCT02349828|herpes simplex virus|herpes simplex virus
5266762|NCT02349828|herpes|herpes
5266763|NCT02349828|burn patients|burn patients
5266765|NCT02349828|acyclovir|acyclovir
5266767|NCT02349802|Auto-injector Device, device-related injection, Auto-injector|auto-injector device, device-related injection, auto-injector
5266768|NCT02349789|Gait|gait
5266769|NCT02349789|Cerebellum|cerebellum
5266770|NCT02349789|Non invasive electrical stimulation|non invasive electrical stimulation
5266772|NCT02349789|TMS|tms
5266773|NCT02349789|Balance|balance
5266774|NCT02349763|Dexamethasone|dexamethasone
5266775|NCT02349763|Hypersensitivity reaction|hypersensitivity reaction
5266776|NCT02349763|Paclitaxel|paclitaxel
5266777|NCT02349750|Endometrial Scratch Injury|endometrial scratch injury
5266778|NCT02349750|Unexplained infertility|unexplained infertility
5266779|NCT02349750|intrauterine insemenation|intrauterine insemenation
5266780|NCT02349750|ovulation induction|ovulation induction
5266781|NCT02349737|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
5266782|NCT02349737|Body composition|body composition
5266783|NCT02349737|ICD|icd
5266784|NCT02349724|CEA|cea
5266785|NCT02349724|CAR T|car t
5266786|NCT02349711|probiotic|probiotic
5266787|NCT02349711|allergy|allergy
5266788|NCT02349711|immune|immune
5266790|NCT02349698|Leukemia|leukemia
5263983|NCT02366013|HIV|hiv
5266792|NCT02349685|Helicobacter pylori|helicobacter pylori
5266793|NCT02349685|Personalized therapy|personalized therapy
5266794|NCT02349685|antimicrobial susceptibility|antimicrobial susceptibility
5266795|NCT02349685|rescue therapy|rescue therapy
5266796|NCT02349685|culture|culture
5266797|NCT02349672|HIE|hie
5266798|NCT02349672|Neonates|neonates
5266799|NCT02349633|EGFRm - Epidermal Growth Factor Receptor Mutation|egfrm - epidermal growth factor receptor mutation
5445372|NCT01522118|Focal Disease|focal disease
5266800|NCT02349633|Advanced EGFRm (del19 or L858R +/- T790M NSCLC|advanced egfrm (del19 or l858r +/- t790m nsclc
5266801|NCT02349581|Anesthetics, Local|anesthetics, local
5266802|NCT02349581|Mastectomy|mastectomy
5266803|NCT02349581|Neuralgia|neuralgia
5266804|NCT02349581|Nerve block|nerve block
5266805|NCT02349542|Liposomal Bupivacaine|liposomal bupivacaine
5266806|NCT02349542|Simultaneous Bilateral Total Knee Arthroplasty|simultaneous bilateral total knee arthroplasty
5266807|NCT02349542|Safety|safety
5266808|NCT02349529|Epilepsy|epilepsy
5266809|NCT02349529|psychosocial|psychosocial
5266810|NCT02349503|Adrenocortical function|adrenocortical function
5266811|NCT02349503|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
5266812|NCT02349503|21-hydroxylase deficiency|21-hydroxylase deficiency
5266813|NCT02349503|Adrenogenital Syndrome|adrenogenital syndrome
5266814|NCT02349503|Adolescents|adolescents
5266815|NCT02349503|Female|female
5266816|NCT02349503|Hyperplasia|hyperplasia
5266817|NCT02349503|Adrenal Gland Diseases|adrenal gland diseases
5266818|NCT02349503|Congenital Abnormalities|congenital abnormalities
5266819|NCT02349503|Adrenocortical Hyperfunction|adrenocortical hyperfunction
5266820|NCT02349503|Disorders of Sex Development|disorders of sex development
5266821|NCT02349503|Endocrine System Diseases|endocrine system diseases
5266822|NCT02349503|Genetic Diseases, Inborn|genetic diseases, inborn
5266823|NCT02349503|Gonadal Disorders|gonadal disorders
5266824|NCT02349503|Metabolic Diseases|metabolic diseases
5266825|NCT02349503|Metabolism, Inborn Errors|metabolism, inborn errors
5266826|NCT02349503|Pathologic Processes|pathologic processes
5266827|NCT02349503|Steroid Metabolism, Inborn Errors|steroid metabolism, inborn errors
5266828|NCT02349503|Urogenital Abnormalities|urogenital abnormalities
5266829|NCT02349503|Corticotropin Releasing Factor|corticotropin releasing factor
5266830|NCT02349490|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5266831|NCT02349490|endoscopy|endoscopy
5266832|NCT02349490|hemostasis|hemostasis
5266833|NCT02349451|Safety|safety
5266834|NCT02349451|Efficacy|efficacy
5266835|NCT02349451|Methotrexate|methotrexate
5266836|NCT02349373|Overuse injury|overuse injury
5266837|NCT02349373|Running related injury|running related injury
5266838|NCT02349373|Running pattern|running pattern
5266839|NCT02349360|safety|safety
5266840|NCT02349360|tolerability|tolerability
5266841|NCT02349321|physical or sexual intimate partner violence|physical or sexual intimate partner violence
5266842|NCT02349321|adolescents|adolescents
5266843|NCT02349321|primary prevention|primary prevention
5266844|NCT02349321|randomised controlled trial|randomised controlled trial
5266845|NCT02349321|school|school
5266846|NCT02349321|South Africa|south africa
5266847|NCT02349321|parenting|parenting
5266848|NCT02349282|muscle strength|muscle strength
5266849|NCT02349282|physical performance|physical performance
5266850|NCT02349282|vitamin D3|vitamin d3
5266851|NCT02349282|Cholecalciferol|cholecalciferol
5266852|NCT02349282|Calcifediol|calcifediol
5266853|NCT02349269|Atrial fibrillation|atrial fibrillation
5266854|NCT02349269|CABG|cabg
5266855|NCT02349269|Stroke|stroke
5266856|NCT02349256|MUS|mus
5266857|NCT02349256|British South Asians|british south asians
5266858|NCT02349256|Somatic Symptoms|somatic symptoms
5266859|NCT02349256|Qualitative interviews|qualitative interviews
5266860|NCT02349243|obese|obese
5266861|NCT02349243|weight loss|weight loss
5266862|NCT02349243|entacapone|entacapone
5266863|NCT02349217|Breast cancer|breast cancer
5266864|NCT02349217|Breast cancer survivors|breast cancer survivors
5266865|NCT02349217|Breast cancer partners|breast cancer partners
5266866|NCT02349217|Mindfulness-Based Relationship Enhancement|mindfulness-based relationship enhancement
5266867|NCT02349217|MBRE|mbre
5266869|NCT02349217|Pain Assessment|pain assessment
5266870|NCT02349217|Questionnaires|questionnaires
5266871|NCT02349217|Surveys|surveys
5266872|NCT02349217|Neurocognitive Tests|neurocognitive tests
5266873|NCT02349217|Cortisol Tests|cortisol tests
5266874|NCT02349217|Saliva tests|saliva tests
5266875|NCT02349217|Interviews|interviews
5266876|NCT02349217|Meditation|meditation
5266877|NCT02349217|Yoga|yoga
5266878|NCT02349217|Self-help materials|self-help materials
5266879|NCT02349204|Simulator|simulator
5266880|NCT02349204|Music|music
5266881|NCT02349204|Mozart Effect|mozart effect
5266882|NCT02349191|Alzheimers|alzheimers
5266883|NCT02349191|dementia|dementia
5266884|NCT02349191|omental transposition|omental transposition
5266885|NCT02349191|neurological|neurological
5266886|NCT02349152|Cardiopulmonary bypass|cardiopulmonary bypass
5266887|NCT02349152|Heart surgery|heart surgery
5266888|NCT02349126|Hepatitis B|hepatitis b
5264069|NCT02365506|LQTS|lqts
5266889|NCT02349126|HBV infection|hbv infection
5266890|NCT02349126|Hepatitis B Surface Antigen|hepatitis b surface antigen
5266891|NCT02349113|estrogen, aging|estrogen, aging
5266893|NCT02349087|cardiac arrest|cardiac arrest
5266894|NCT02349087|resuscitation|resuscitation
5266895|NCT02349087|seizures|seizures
5266896|NCT02349061|Systemic Lupus Erythematosus|systemic lupus erythematosus
5266897|NCT02349061|Ustekinumab|ustekinumab
5266898|NCT02349048|Hepatitis C virus|hepatitis c virus
5266899|NCT02349048|Hepatitis C virus genotype 1|hepatitis c virus genotype 1
5266900|NCT02349048|Chronic Hepatitis C Virus Genotype 1 Infection|chronic hepatitis c virus genotype 1 infection
5266901|NCT02349048|Liver fibrosis|liver fibrosis
5266902|NCT02349048|Cirrhosis|cirrhosis
5266903|NCT02349048|Simeprevir|simeprevir
5266904|NCT02349048|Daclatasvir|daclatasvir
5266905|NCT02349048|Sofosbuvir|sofosbuvir
5266906|NCT02349035|Transradial amputee|transradial amputee
5266907|NCT02349022|[89Zr]Df-IAB2M|[89zr]df-iab2m
5266908|NCT02349022|Prostate cancer|prostate cancer
5266909|NCT02349022|PET scan|pet scan
5266910|NCT02349009|systemic sclerosis|systemic sclerosis
5266911|NCT02349009|scleroderma|scleroderma
5266912|NCT02348970|mandibular advancement devices ONIRIS®|mandibular advancement devices oniris®
5266913|NCT02348970|obstructive sleep apnea and hypopneas|obstructive sleep apnea and hypopneas
5266914|NCT02348957|Chronic myeloid leukemia|chronic myeloid leukemia
5266915|NCT02348957|Dasatinib|dasatinib
5266916|NCT02348957|Any line|any line
5266917|NCT02348957|Chronic phase|chronic phase
5266918|NCT02348944|Biological markers|biological markers
5266919|NCT02348944|Cartilage|cartilage
5266920|NCT02348840|Midwives|midwives
5266921|NCT02348840|Pregnant Women|pregnant women
5266922|NCT02348827|Unipolar depression|unipolar depression
5266923|NCT02348827|Family Therapies|family therapies
5266924|NCT02348827|Psychoeducation|psychoeducation
5266925|NCT02348827|Family psychoeducation|family psychoeducation
5266926|NCT02348814|NAFLD, NASH|nafld, nash
5266927|NCT02348788|Vivax|vivax
5266928|NCT02348788|Malaria|malaria
5266929|NCT02348788|artemether-lumefantrine|artemether-lumefantrine
5266930|NCT02348788|chloroquine|chloroquine
5266932|NCT02348749|18F-MFBG Imaging|18f-mfbg imaging
5266933|NCT02348749|14-138|14-138
5266934|NCT02348749|PET/MR|pet/mr
5266935|NCT02348749|PET/CT scan|pet/ct scan
5266936|NCT02348736|airway|airway
5266937|NCT02348736|videolaryngoscope|videolaryngoscope
5266938|NCT02348697|Cartilage Defect in the Knee|cartilage defect in the knee
5266939|NCT02348697|MACT|mact
5266940|NCT02348684|Breast Cancer|breast cancer
5266941|NCT02348658|Pharmacological therapy|pharmacological therapy
5266942|NCT02348645|Pilot projects|pilot projects
5266943|NCT02348645|Feasibility studies|feasibility studies
5266944|NCT02348645|Intervention studies|intervention studies
5266945|NCT02348645|Orthopedics|orthopedics
5266946|NCT02348645|Orthopedic Procedures|orthopedic procedures
5266947|NCT02348645|Neurosurgical Procedures|neurosurgical procedures
5266948|NCT02348645|Neurosurgery|neurosurgery
5266949|NCT02348645|Spine|spine
5266950|NCT02348645|Spinal Fusion|spinal fusion
5266951|NCT02348645|Spondylodesis|spondylodesis
5266952|NCT02348645|Spondylosyndesis|spondylosyndesis
5266955|NCT02348645|Decompression, surgical|decompression, surgical
5266956|NCT02348645|Low Back Pain|low back pain
5266957|NCT02348645|Quality of Life|quality of life
5266958|NCT02348580|teaching|teaching
5266959|NCT02348580|education|education
5266960|NCT02348580|active learning|active learning
5266961|NCT02348580|time on task|time on task
5266962|NCT02348580|financial education|financial education
5266963|NCT02348580|social education|social education
5266964|NCT02348580|rights based education|rights based education
5266965|NCT02348580|primary school|primary school
5266966|NCT02348580|life-skills|life-skills
5445373|NCT01522105|Meningitis|meningitis
5445374|NCT01522105|Central Nervous System Infections|central nervous system infections
5445375|NCT01522105|Pediatrics|pediatrics
5266967|NCT02348567|Health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development|health care, accreditation, unannounced survey, cluster randomized controlled trial, quality improvement, organisational development
5266968|NCT02348554|obesity|obesity
5266969|NCT02348554|energy expenditure|energy expenditure
5266970|NCT02348554|daily living physical activity|daily living physical activity
5266971|NCT02348554|smartphone|smartphone
5266972|NCT02348554|accelerometry|accelerometry
5266973|NCT02348554|prediction algorithm|prediction algorithm
5266974|NCT02348528|Multiple Myeloma|multiple myeloma
5266975|NCT02348528|Relapsed|relapsed
5266976|NCT02348528|Refractory|refractory
5266977|NCT02348528|Lenalidomide|lenalidomide
5266978|NCT02348528|Dexamethasone|dexamethasone
5266979|NCT02348528|open-label|open-label
5266980|NCT02348528|CC-5013-MM-021|cc-5013-mm-021
5266981|NCT02348502|HBsAg loss|hbsag loss
5266982|NCT02348502|interferon|interferon
5266983|NCT02348502|HBV reaction|hbv reaction
5266984|NCT02348502|Hepatitis B|hepatitis b
5266986|NCT02348489|Acute Myeloid Leukemia|acute myeloid leukemia
5266988|NCT02348489|DNA Hypomethylating Agen|dna hypomethylating agen
5266989|NCT02348437|Pronator quadratus|pronator quadratus
5266990|NCT02348437|Distal radius fracture|distal radius fracture
5266991|NCT02348437|Repair|repair
5264169|NCT02364817|Adults|adults
5266993|NCT02348437|PRWE|prwe
5266994|NCT02348424|genitourinary|genitourinary
5266995|NCT02348424|Neisseriaceae|neisseriaceae
5266996|NCT02348424|pharyngeal|pharyngeal
5266997|NCT02348424|Solithromycin|solithromycin
5266998|NCT02348411|Medication-refractory|medication-refractory
5266999|NCT02348398|Cervical Cancer|cervical cancer
5267000|NCT02348398|Recurrent cervical cancer|recurrent cervical cancer
5267001|NCT02348398|Squamous cervical cancer|squamous cervical cancer
5267002|NCT02348398|Adenocarcinoma of the cervix|adenocarcinoma of the cervix
5267003|NCT02348398|Adenosquamous cervical cancer|adenosquamous cervical cancer
5267004|NCT02348398|Persistent cervical cancer|persistent cervical cancer
5267005|NCT02348398|Pazopanib|pazopanib
5267006|NCT02348398|GW786034|gw786034
5267007|NCT02348398|Topotecan|topotecan
5267008|NCT02348398|Hycamtin|hycamtin
5267009|NCT02348385|amphetamine|amphetamine
5267010|NCT02348385|cigarette smokers|cigarette smokers
5267011|NCT02348359|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5267012|NCT02348359|Platelet Derived Growth Factor (PDGF)|platelet derived growth factor (pdgf)
5267013|NCT02348359|AMD|amd
5267014|NCT02348346|self-disinfecting surfaces|self-disinfecting surfaces
5267015|NCT02348346|titanium dioxide|titanium dioxide
5267016|NCT02348281|triple negative breast cancer|triple negative breast cancer
5267017|NCT02348281|androgen receptor|androgen receptor
5267018|NCT02348281|bicalutamide|bicalutamide
5267019|NCT02348268|Neck Pain|neck pain
5267020|NCT02348268|Myofascial release|myofascial release
5267021|NCT02348268|Manual therapy|manual therapy
5267022|NCT02348242|Intensive care|intensive care
5267023|NCT02348242|corneal damage|corneal damage
5267024|NCT02348242|prevention|prevention
5267025|NCT02348242|nursing protocol|nursing protocol
5267026|NCT02348229|Enhanced recovery after surgery|enhanced recovery after surgery
5267027|NCT02348229|laparoscopic gastrectomy|laparoscopic gastrectomy
5267028|NCT02348229|advanced gastric cancer|advanced gastric cancer
5267029|NCT02348229|C-reactive,visceral proteins|c-reactive,visceral proteins
5267030|NCT02348177|Human immunideficiency virus|human immunideficiency virus
5267031|NCT02348177|Tuberculosis|tuberculosis
5267032|NCT02348177|superboosting|superboosting
5267033|NCT02348177|lopinavir/ritonavir 1:1|lopinavir/ritonavir 1:1
5267034|NCT02348177|Pediatric TB/HIV co-infection|pediatric tb/hiv co-infection
5267035|NCT02348164|Carotenoids|carotenoids
5267036|NCT02348164|absorption|absorption
5267037|NCT02348164|citrus|citrus
5267038|NCT02348151|COPD|copd
5267039|NCT02348151|SWTi|swti
5267040|NCT02348151|Treadmill|treadmill
5267041|NCT02348138|Isometric Handgrip|isometric handgrip
5267042|NCT02348112|stress urinary incontinence|stress urinary incontinence
5267043|NCT02348112|Altis 522|altis 522
5267044|NCT02348112|urinary incontinence|urinary incontinence
5267045|NCT02348099|Diabetes|diabetes
5267046|NCT02348099|Lipohypertrophy|lipohypertrophy
5267047|NCT02348099|Ultrasound|ultrasound
5267048|NCT02348073|Epilepsy|epilepsy
5267049|NCT02348073|Attention Deficit Disorders|attention deficit disorders
5267050|NCT02348073|VAYARIN|vayarin
5267052|NCT02348073|Polyunsaturated n-3 fatty acid supplementation|polyunsaturated n-3 fatty acid supplementation
5267053|NCT02348034|Surgical Site Infection (SSI)|surgical site infection (ssi)
5267054|NCT02348034|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
5267055|NCT02348008|MK-3475|mk-3475
5267056|NCT02348008|Pembrolizumab|pembrolizumab
5267057|NCT02348008|Bevacizumab|bevacizumab
5267058|NCT02347995|Exercise|exercise
5267059|NCT02347995|Protein|protein
5267060|NCT02347995|Nutrition|nutrition
5267061|NCT02347995|Stroke|stroke
5267062|NCT02347982|Turkey|turkey
5267063|NCT02347982|Epidemiologic|epidemiologic
5267064|NCT02347969|antioxidant|antioxidant
5267065|NCT02347969|skin radiance|skin radiance
5267066|NCT02347969|skin elasticity|skin elasticity
5267067|NCT02347969|skin firmness|skin firmness
5267068|NCT02347969|skin hydration|skin hydration
5267069|NCT02347956|robot surgery|robot surgery
5267070|NCT02347956|reduced port|reduced port
5204509|NCT02716467|nursing|nursing
5148039|NCT03067298|PlGF|plgf
5267071|NCT02347956|single-site|single-site
5267072|NCT02347956|safety|safety
5267073|NCT02347956|feasibility|feasibility
5267074|NCT02347930|acute kidney injury|acute kidney injury
5267075|NCT02347930|ultrasound technology|ultrasound technology
5267076|NCT02347904|Esophageal cancer|esophageal cancer
5267077|NCT02347904|Adjuvant treatment|adjuvant treatment
5267078|NCT02347904|S-1|s-1
5267079|NCT02347904|Oxaliplatin|oxaliplatin
5267080|NCT02347904|Feasibility|feasibility
5267081|NCT02347891|Inflammatory Myositis|inflammatory myositis
5267082|NCT02347891|Dermatomyositis|dermatomyositis
5267083|NCT02347891|Polymyositis|polymyositis
5267084|NCT02347891|Muscle Pain|muscle pain
5267085|NCT02347891|Myositis|myositis
5267086|NCT02347891|Refractory myositis|refractory myositis
5267087|NCT02347878|leukemia|leukemia
5267088|NCT02347878|lymphoma|lymphoma
5267089|NCT02347878|lumbar puncture|lumbar puncture
5267090|NCT02347878|intrathecal treatment|intrathecal treatment
5267091|NCT02347878|post-lumbar puncture headache|post-lumbar puncture headache
5267092|NCT02347865|osteoporosis post menopausal women|osteoporosis post menopausal women
5267093|NCT02347826|coned wires, wire lift,|coned wires, wire lift,
5267095|NCT02347826|discomfort|discomfort
5267096|NCT02347813|squamous cell carcinoma|squamous cell carcinoma
5267097|NCT02347813|pioglitazone|pioglitazone
5267098|NCT02347813|PPARgamma|ppargamma
5267099|NCT02347813|skin cancer|skin cancer
5267100|NCT02347774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5267101|NCT02347774|COPD|copd
5267102|NCT02347761|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5267103|NCT02347748|Pain|pain
5267104|NCT02347748|Anesthesia Recovery Period|anesthesia recovery period
5267105|NCT02347748|Postoperative Period|postoperative period
5267106|NCT02347748|Adaptation, Psychological|adaptation, psychological
5267107|NCT02347748|Relaxation|relaxation
5267108|NCT02347748|Stress, Psychological|stress, psychological
5267109|NCT02347735|Colorectal carcinoma|colorectal carcinoma
5267110|NCT02347735|Anastomotic leakage|anastomotic leakage
5267111|NCT02347735|Markers|markers
5267112|NCT02347735|Diagnosis|diagnosis
5267113|NCT02347722|biomarkers|biomarkers
5267114|NCT02347722|diagnosis|diagnosis
5267115|NCT02347722|etiology of heart failure|etiology of heart failure
5267116|NCT02347709|Diabetic Foot Ulcer|diabetic foot ulcer
5267117|NCT02347709|DFU|dfu
5267118|NCT02347709|Type 2 Diabetes|type 2 diabetes
5267119|NCT02347709|Neuropathy|neuropathy
5267120|NCT02347696|Diet|diet
5267121|NCT02347696|Physical Activity|physical activity
5267122|NCT02347696|Trial|trial
5267123|NCT02347696|Lipidomics|lipidomics
5267124|NCT02347696|Occidental Diseases|occidental diseases
5267125|NCT02347657|Homozygous for the F508del CFTR Mutation|homozygous for the f508del cftr mutation
5267126|NCT02347566|COPD|copd
5267127|NCT02347566|Physical Activity|physical activity
5267128|NCT02347566|Accelerometer|accelerometer
5267129|NCT02347540|Heart Failure|heart failure
5267130|NCT02347540|Diastolic Dysfunction|diastolic dysfunction
5267131|NCT02347540|Pre-Eclampsia|pre-eclampsia
5267132|NCT02347540|Endothelial dysfunction|endothelial dysfunction
5267133|NCT02347540|Biological Markers|biological markers
5267134|NCT02347540|MicroRNAs|micrornas
5267135|NCT02347540|Circulating cells|circulating cells
5267136|NCT02347488|ETT Holder, bite guard, airway, endotracheal tube|ett holder, bite guard, airway, endotracheal tube
5267137|NCT02347462|BiPAP|bipap
5267138|NCT02347449|Early-stage Breast cancer, node positive|early-stage breast cancer, node positive
5267139|NCT02347449|Prognosis|prognosis
5267140|NCT02347449|Oncotype Dx|oncotype dx
5267141|NCT02347436|Transurethral Resection of Prostate|transurethral resection of prostate
5267142|NCT02347423|Poliomyelitis immunization|poliomyelitis immunization
5267143|NCT02347423|primary series|primary series
5267144|NCT02347371|Heart transplant|heart transplant
5267145|NCT02347371|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
5267146|NCT02347371|Chronic rejection|chronic rejection
5267147|NCT02347371|Immunosuppressant therapy|immunosuppressant therapy
5267148|NCT02347345|HCV, injection drug use|hcv, injection drug use
5267149|NCT02347332|Vinflunin|vinflunin
5267150|NCT02347332|Vinflunin + Methotrexate|vinflunin + methotrexate
5267252|NCT02346786|Drinking Water|drinking water
5267151|NCT02347332|Metastatic Squamous Cell Carcinoma of the Head and Neck|metastatic squamous cell carcinoma of the head and neck
5267152|NCT02347280|clostridium difficile|clostridium difficile
5267153|NCT02347280|colitis|colitis
5267154|NCT02347280|colon|colon
5267155|NCT02347267|Beverages sweetened caloric, no caloric|beverages sweetened caloric, no caloric
5267156|NCT02347267|Weight|weight
5267157|NCT02347267|Fat percentage|fat percentage
5267158|NCT02347267|Body Composition|body composition
5267159|NCT02347267|Blood pressure|blood pressure
5267160|NCT02347267|Sugar|sugar
5267161|NCT02347267|Sodium|sodium
5267162|NCT02347267|Dietary intake|dietary intake
5267163|NCT02347228|OB318|ob318
5267164|NCT02347228|Advanced Solid Malignancies|advanced solid malignancies
5267165|NCT02347228|Antrodia cinnamomea|antrodia cinnamomea
5267166|NCT02347228|Antrodia camphorata|antrodia camphorata
5267167|NCT02347202|Counseling|counseling
5267168|NCT02347163|triple neg|triple neg
5267169|NCT02347163|breast cancer|breast cancer
5267170|NCT02347163|zoledronate|zoledronate
5267171|NCT02347163|mevalonate pathway|mevalonate pathway
5267172|NCT02347124|smoking cessation|smoking cessation
5267173|NCT02347124|oral health care|oral health care
5267174|NCT02347124|tobacco quitlines|tobacco quitlines
5267175|NCT02347098|plaque|plaque
5267177|NCT02347098|statin|statin
5267178|NCT02347098|endothelial|endothelial
5267179|NCT02347098|apheresis|apheresis
5267180|NCT02347098|acute coronary artery syndrome|acute coronary artery syndrome
5267181|NCT02347033|Sertraline|sertraline
5267182|NCT02347033|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
5267183|NCT02347033|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
5267184|NCT02347033|Increasing Access to Psychological Therapies (IAPT)|increasing access to psychological therapies (iapt)
5267185|NCT02347020|Obesity|obesity
5267186|NCT02347020|Metabolic Disorders|metabolic disorders
5267187|NCT02347007|Obesity|obesity
5267188|NCT02347007|Overweight|overweight
5267189|NCT02347007|Body Weight|body weight
5862747|NCT00001526|Daclizumab|daclizumab
5267190|NCT02347007|Cardiovascular Diseases|cardiovascular diseases
5267192|NCT02347007|Almonds|almonds
5267193|NCT02347007|Visceral Adiposity|visceral adiposity
5267194|NCT02347007|Quality of Life|quality of life
5267195|NCT02347007|Hispanic Americans|hispanic americans
5267196|NCT02347007|African Continental Ancestry Group|african continental ancestry group
5267197|NCT02347007|Metabolic Syndrome X|metabolic syndrome x
5267198|NCT02346994|Body Weight|body weight
5267199|NCT02346994|Obesity in Adolescence|obesity in adolescence
5267200|NCT02346994|Obesity in Childhood|obesity in childhood
5267201|NCT02346994|Childhood Onset Obesity|childhood onset obesity
5267202|NCT02346994|Childhood Obesity|childhood obesity
5267203|NCT02346994|Child Obesity|child obesity
5267204|NCT02346994|Adolescent Obesity|adolescent obesity
5267205|NCT02346994|Teenagers|teenagers
5267206|NCT02346994|Teens|teens
5267207|NCT02346994|Youth|youth
5267208|NCT02346994|Adolescents|adolescents
5267209|NCT02346994|Adolescence|adolescence
5267210|NCT02346968|Kidney Transplantation|kidney transplantation
5267211|NCT02346968|Delayed Graft Function|delayed graft function
5267212|NCT02346968|C-terminal fragment of agrin|c-terminal fragment of agrin
5267213|NCT02346968|Dialysis|dialysis
5267214|NCT02346955|Cancer|cancer
5267215|NCT02346955|Oncology|oncology
5267216|NCT02346955|cCAM Biotherapeutics Ltd|ccam biotherapeutics ltd
5267217|NCT02346955|Immunomodulatory therapy|immunomodulatory therapy
5267218|NCT02346955|CM-24|cm-24
5267219|NCT02346955|Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1)|carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1)
5267220|NCT02346955|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
5267221|NCT02346955|Uveal|uveal
5267222|NCT02346955|Acral|acral
5267223|NCT02346955|Mucosal|mucosal
5267224|NCT02346955|Cutaneous|cutaneous
5267225|NCT02346955|Colorectal|colorectal
5267226|NCT02346955|Gastric|gastric
5267227|NCT02346955|Ovarian|ovarian
5267229|NCT02346955|MK-6018-001|mk-6018-001
5267230|NCT02346929|Hematoma block|hematoma block
5267231|NCT02346929|distal radius fracture reduction|distal radius fracture reduction
5267232|NCT02346929|ultrasound|ultrasound
5267233|NCT02346929|ultrasound guided hematoma block|ultrasound guided hematoma block
5267234|NCT02346929|traditional hematoma block for analgesia|traditional hematoma block for analgesia
5267235|NCT02346929|bupivacaine|bupivacaine
5267236|NCT02346929|pain reduction|pain reduction
5267237|NCT02346929|wrist fracture|wrist fracture
5267238|NCT02346890|Volunteer|volunteer
5267239|NCT02346877|Enbrel|enbrel
5267240|NCT02346877|Rheumatoid Arthritis|rheumatoid arthritis
5267241|NCT02346864|head elevated position|head elevated position
5267242|NCT02346864|preterm|preterm
5267243|NCT02346864|three-stair-position|three-stair-position
5267244|NCT02346838|Prediabetes, prebiotics, metabolic endotoxemia|prediabetes, prebiotics, metabolic endotoxemia
5267245|NCT02346825|P-CIMT|p-cimt
5267246|NCT02346825|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
5267247|NCT02346825|Hemiparesis|hemiparesis
5267248|NCT02346825|Cerebral Palsy|cerebral palsy
5267249|NCT02346825|Infants|infants
5267250|NCT02346825|Toddlers|toddlers
5267253|NCT02346786|Mineral water|mineral water
5267254|NCT02346786|Sports|sports
5267255|NCT02346786|Accident prevention|accident prevention
5267256|NCT02346747|Stage III|stage iii
5267257|NCT02346747|Stage IV|stage iv
5267258|NCT02346747|Ovarian Cancer|ovarian cancer
5267259|NCT02346747|Maintenance|maintenance
5267260|NCT02346747|Immunotherapy|immunotherapy
5267261|NCT02346747|primary peritoneal cancer|primary peritoneal cancer
5267262|NCT02346747|fallopian tube cancer|fallopian tube cancer
5445376|NCT01522105|Daptomycin|daptomycin
5267263|NCT02346747|endometrioid ovarian cancer|endometrioid ovarian cancer
5267264|NCT02346747|high-grade serous ovarian cancer|high-grade serous ovarian cancer
5267265|NCT02346734|Multiple Sclerosis|multiple sclerosis
5267266|NCT02346734|Telerehablitation|telerehablitation
5136511|NCT03139344|glucose|glucose
5267267|NCT02346721|Sofosbuvir|sofosbuvir
5267268|NCT02346721|SOF/GS-5816|sof/gs-5816
5267269|NCT02346721|GS-5816|gs-5816
5267270|NCT02346721|Hepatitis C|hepatitis c
5267271|NCT02346721|HCV|hcv
5267272|NCT02346721|Cirrhosis|cirrhosis
5267273|NCT02346721|Velpatasvir|velpatasvir
5267274|NCT02346708|Parkinson's|parkinson's
5267275|NCT02346708|TMS|tms
5267276|NCT02346708|Kluger|kluger
5267277|NCT02346695|LV deformation|lv deformation
5267278|NCT02346695|Endothelial glycocalyx|endothelial glycocalyx
5267279|NCT02346695|Coronary flow reserve|coronary flow reserve
5267280|NCT02346682|major depression disorder|major depression disorder
5267281|NCT02346682|biochemistry|biochemistry
5267282|NCT02346682|TCM diagnosis|tcm diagnosis
5267283|NCT02346682|Neurological|neurological
5267284|NCT02346682|metabonomics|metabonomics
5267285|NCT02346682|neuroimaging|neuroimaging
5267286|NCT02346669|Microbiota|microbiota
5267287|NCT02346669|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5267288|NCT02346669|Obesity|obesity
5267289|NCT02346617|CMV|cmv
5267290|NCT02346617|T cell therapy|t cell therapy
5267291|NCT02346604|exercise|exercise
5267292|NCT02346591|Positive psychology|positive psychology
5267293|NCT02346591|Wellbeing|wellbeing
5267294|NCT02346591|Stress reduction|stress reduction
5267295|NCT02346591|Relaxation|relaxation
5267296|NCT02346591|Gratitude|gratitude
5267297|NCT02346591|Mobile app|mobile app
5267298|NCT02346591|Intervention|intervention
5267299|NCT02346591|Altruism|altruism
5267300|NCT02346591|Psychological well-being|psychological well-being
5267301|NCT02346591|Social well-being|social well-being
5267302|NCT02346591|Physical well-being|physical well-being
5267303|NCT02346591|Workplace engagement|workplace engagement
5267304|NCT02346552|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5267305|NCT02346552|laparoscope holder|laparoscope holder
5267306|NCT02346552|Nissen fundoplication|nissen fundoplication
5267307|NCT02346552|paraesophageal hernia|paraesophageal hernia
5267308|NCT02346552|sleeve surgery|sleeve surgery
5267309|NCT02346539|Nicotine|nicotine
5267310|NCT02346539|Depression|depression
5267311|NCT02346526|Prostate Cancer|prostate cancer
5267312|NCT02346526|Castration-resistant prostate cancer|castration-resistant prostate cancer
5267313|NCT02346526|Castration-resistant prostate cancer metastatic to bone|castration-resistant prostate cancer metastatic to bone
5267314|NCT02346513|Hip Replacement Arthroplasty|hip replacement arthroplasty
5267315|NCT02346513|Ceramic on Metal Articulation|ceramic on metal articulation
5267316|NCT02346513|Serum level of Cobalt and Chromium|serum level of cobalt and chromium
5267317|NCT02346500|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5267318|NCT02346500|Lower urinary tract symptoms|lower urinary tract symptoms
5267319|NCT02346500|Photoselective laser vaporization of the prostate|photoselective laser vaporization of the prostate
5267320|NCT02346500|Transrectal Ultrasound|transrectal ultrasound
5267321|NCT02346487|children|children
5267322|NCT02346474|Subcutaneous Fat|subcutaneous fat
5267323|NCT02346474|Visceral Fat|visceral fat
5267324|NCT02346461|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
5267325|NCT02346461|Sialic Acid (N-acetylneuraminic acid, Neu5Ac)|sialic acid (n-acetylneuraminic acid, neu5ac)
5267326|NCT02346461|GNE Myopathy|gne myopathy
5267327|NCT02346461|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
5267329|NCT02346448|endoscopic sphincterotomy|endoscopic sphincterotomy
5267330|NCT02346448|balloon dilation|balloon dilation
5368353|NCT01864590|Mesh|mesh
5267331|NCT02346448|adverse events|adverse events
5267332|NCT02346448|pancreatitis|pancreatitis
5267333|NCT02346448|bleeding|bleeding
5267334|NCT02346435|small renal mass|small renal mass
5267335|NCT02346435|active surveillance|active surveillance
5267336|NCT02346422|Heart Failure|heart failure
5267337|NCT02346422|Cardiomyopathies|cardiomyopathies
5267338|NCT02346422|Heart Diseases|heart diseases
5267339|NCT02346422|Cardiovascular Diseases|cardiovascular diseases
5267340|NCT02346422|Cardiomegaly|cardiomegaly
5267341|NCT02346422|Gene Therapy|gene therapy
5267342|NCT02346396|neuropathic pain|neuropathic pain
5267343|NCT02346396|neurostimulation|neurostimulation
5267344|NCT02346396|ambulatory use|ambulatory use
5267348|NCT02346383|spinal peripheral neuromodulation|spinal peripheral neuromodulation
5267353|NCT02346357|analgesia|analgesia
5267354|NCT02346344|type 2 diabetes|type 2 diabetes
5267355|NCT02346344|beta cell function|beta cell function
5267356|NCT02346344|meal tolerance test|meal tolerance test
5267357|NCT02346344|maximum stimulation test|maximum stimulation test
5267358|NCT02346344|method standardization|method standardization
5267359|NCT02346344|insulin secretion|insulin secretion
5267360|NCT02346344|prediabetes|prediabetes
5267361|NCT02346344|insulin sensitivity|insulin sensitivity
5267362|NCT02346318|Radiotherapy|radiotherapy
5267363|NCT02346318|Adverse Effect|adverse effect
5267364|NCT02346318|Dermatitis or Eczema|dermatitis or eczema
5267365|NCT02346292|COPD|copd
5267366|NCT02346292|Spirometry|spirometry
5267367|NCT02346292|severe and very severe COPD|severe and very severe copd
5267368|NCT02346292|COPD exacerbations|copd exacerbations
5267369|NCT02346292|therapy schemes|therapy schemes
5267370|NCT02346292|therapy changes|therapy changes
5267371|NCT02346279|Multiple Sclerosis|multiple sclerosis
5267372|NCT02346279|Rehabilitation|rehabilitation
5267373|NCT02346279|Questionnaire|questionnaire
5267374|NCT02346279|Patient-Reported Outcome|patient-reported outcome
5267375|NCT02346279|Responsiveness|responsiveness
5267376|NCT02346279|Minimal Important Clinical Difference|minimal important clinical difference
5267377|NCT02346266|Stroke|stroke
5267378|NCT02346266|Stroke Prevention|stroke prevention
5267379|NCT02346266|Children|children
5267380|NCT02346266|Education|education
5267381|NCT02346240|Certolizumab Pegol|certolizumab pegol
5267382|NCT02346240|Cimzia|cimzia
5267383|NCT02346240|Psoriasis|psoriasis
5267384|NCT02346227|Human Papillomavirus|human papillomavirus
5267385|NCT02346227|Uterine cervix|uterine cervix
5267386|NCT02346227|Infection|infection
5267387|NCT02346227|Antiviral Drug|antiviral drug
5267388|NCT02346227|Therapeutic use|therapeutic use
5267389|NCT02346214|Gestational Age|gestational age
5267390|NCT02346214|Anterior Lens Capsule Vascularity|anterior lens capsule vascularity
5267391|NCT02346214|Preterm|preterm
5267392|NCT02346214|Method-comparison|method-comparison
5267393|NCT02346188|blood lead, iron, zinc, child, cognition, behavior, Mexico|blood lead, iron, zinc, child, cognition, behavior, mexico
5862748|NCT00001526|HAT|hat
5267394|NCT02346175|SHR3824 Type 2 diabetes mellitus SGLT2|shr3824 type 2 diabetes mellitus sglt2
5267396|NCT02346162|Weight management|weight management
5267403|NCT02346123|Chagas disease|chagas disease
5267404|NCT02346123|Polymorphisms|polymorphisms
5267405|NCT02346123|Biomarkers|biomarkers
5267406|NCT02346097|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5267407|NCT02346097|Heart Failure|heart failure
5267408|NCT02346097|Ejection Fraction|ejection fraction
5267409|NCT02346097|Narrow|narrow
5267410|NCT02346097|Pacemaker|pacemaker
5267411|NCT02346097|Electrophysiology|electrophysiology
5267412|NCT02346097|Electrical activation mapping|electrical activation mapping
5267413|NCT02346097|Coronary Sinus|coronary sinus
5267414|NCT02346097|Mapping|mapping
5267416|NCT02346097|QRS width|qrs width
5267417|NCT02346097|Pacing Interval|pacing interval
5267418|NCT02346097|Left Ventricular Lead|left ventricular lead
5267419|NCT02346097|Cardiac CT|cardiac ct
5267420|NCT02346097|Echocardiography|echocardiography
5267421|NCT02346097|Myocardial Scintigraphy|myocardial scintigraphy
5267422|NCT02346097|6 Minutes Walk Test|6 minutes walk test
5267423|NCT02346097|Imaging|imaging
5267424|NCT02346097|Left ventricular ejection fraction|left ventricular ejection fraction
5267425|NCT02346097|Epicardial veins|epicardial veins
5267426|NCT02346097|Resynchronization|resynchronization
5267427|NCT02346097|ImagingCRT|imagingcrt
5267428|NCT02346097|Optimal electrical resynchronization|optimal electrical resynchronization
5267429|NCT02346097|Cardiac computed tomography|cardiac computed tomography
5267430|NCT02346071|Bodily distress syndrome|bodily distress syndrome
5267431|NCT02346071|Medically unexplained symptoms|medically unexplained symptoms
5267432|NCT02346071|Functional somatic symptoms|functional somatic symptoms
5267433|NCT02346071|Functional somatic syndromes|functional somatic syndromes
5267434|NCT02346071|Treatment|treatment
5267435|NCT02346071|Acceptance and Commitment Therapy|acceptance and commitment therapy
5267436|NCT02346045|hypertension|hypertension
5267437|NCT02346032|second line|second line
5267438|NCT02346006|Exercise|exercise
5267439|NCT02346006|Visual Acuity|visual acuity
5267440|NCT02346006|Blood Vessels|blood vessels
5267441|NCT02346006|Retina|retina
5267442|NCT02346006|Choroid|choroid
5267443|NCT02345993|formoterol/beclomethasone in asthmatic crisis|formoterol/beclomethasone in asthmatic crisis
5267444|NCT02345993|asthmatic crisis treatment|asthmatic crisis treatment
5267445|NCT02345967|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
5272428|NCT02317614|eDOT|edot
5267455|NCT02345876|Dyslexia, Medial olivocochlear system, Maturation, Auditory Processing|dyslexia, medial olivocochlear system, maturation, auditory processing
5267462|NCT02345824|LEE011|lee011
5267463|NCT02345824|Recurrent Glioblastoma|recurrent glioblastoma
5267464|NCT02345824|Anaplastic Glioma|anaplastic glioma
5267465|NCT02345824|Ribociclib|ribociclib
5267466|NCT02345759|CKD patients|ckd patients
5267467|NCT02345759|protein-restricted diets|protein-restricted diets
5267468|NCT02345759|compliance|compliance
5267469|NCT02345759|psychological aspects|psychological aspects
5267470|NCT02345707|Cabotegravir|cabotegravir
5267471|NCT02345707|Human Immunodeficiency Virus|human immunodeficiency virus
5267472|NCT02345707|Bioavailability|bioavailability
5267473|NCT02345707|Pharmacokinetics|pharmacokinetics
5267474|NCT02345694|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5267475|NCT02345694|Gait|gait
5267476|NCT02345694|Posture|posture
5267477|NCT02345694|Continuous Positive Airway Pressure|continuous positive airway pressure
5267478|NCT02345681|furosemide|furosemide
5267479|NCT02345681|under strict conditions|under strict conditions
5267480|NCT02345681|normalize|normalize
5267481|NCT02345681|ICU patients|icu patients
5267482|NCT02345681|fluid balance|fluid balance
5267483|NCT02345668|Transdiagnostic Internet-based Protocol|transdiagnostic internet-based protocol
5267484|NCT02345668|Treatment as Usual (TAU)|treatment as usual (tau)
5267485|NCT02345655|Substances consumption|substances consumption
5267486|NCT02345655|Opiate|opiate
5267487|NCT02345655|Family practice|family practice
5267488|NCT02345629|Refractory cancer pain|refractory cancer pain
5267489|NCT02345629|Cordotomy|cordotomy
5267490|NCT02345629|Sharpness pain sensory testing|sharpness pain sensory testing
5267491|NCT02345629|Heat pain sensory testing|heat pain sensory testing
5267492|NCT02345629|Symptom questionnaire|symptom questionnaire
5267493|NCT02345629|Advanced cancers|advanced cancers
5267494|NCT02345629|Pain|pain
5267495|NCT02345616|Cardiac surgery|cardiac surgery
5267496|NCT02345616|Pulmonary hypertension|pulmonary hypertension
5267497|NCT02345616|Nitric oxide|nitric oxide
5267498|NCT02345616|Induction anesthesia|induction anesthesia
5267499|NCT02345577|Kidney transplantation|kidney transplantation
5267500|NCT02345577|Stochastic whole body vibration therapy|stochastic whole body vibration therapy
5267501|NCT02345577|Muscle strength|muscle strength
5267502|NCT02345577|Intramuscular lipid content|intramuscular lipid content
5267503|NCT02345577|Intramyocellular lipid content|intramyocellular lipid content
5267504|NCT02345577|Short Physical Performance Battery Test|short physical performance battery test
5862749|NCT00001526|Zenapax|zenapax
5862750|NCT00001526|Interleukin 2|interleukin 2
5267505|NCT02345577|Prospective, randomised , double blind,placebo-controlled trial|prospective, randomised , double blind,placebo-controlled trial
5267507|NCT02345551|Exercise|exercise
5267508|NCT02345551|Sleep|sleep
5267509|NCT02345551|Telemedicine|telemedicine
5267510|NCT02345551|Behavior|behavior
5267511|NCT02345551|Shift work|shift work
5267512|NCT02345512|Falls|falls
5267513|NCT02345499|Radical cystectomy|radical cystectomy
5267514|NCT02345499|Laparoscopy|laparoscopy
5267515|NCT02345486|Pilot Projects|pilot projects
5267516|NCT02345486|Plasmalyte A|plasmalyte a
5267517|NCT02345486|Ringer's lactate|ringer's lactate
5267518|NCT02345486|Sodium Chloride|sodium chloride
5267519|NCT02345486|Critical Care|critical care
5267520|NCT02345486|"Resuscitation"|"resuscitation"
5267521|NCT02345473|Bladder cancer|bladder cancer
5267522|NCT02345473|Circulating cancer cells|circulating cancer cells
5267523|NCT02345421|LAL D|lal d
5267524|NCT02345421|CESD|cesd
5267525|NCT02345421|NASH|nash
5267526|NCT02345421|NAFLD|nafld
5267527|NCT02345421|Wilson's|wilson's
5267528|NCT02345421|Niemann Pick|niemann pick
5267529|NCT02345421|Familial Hypercholesterolemia|familial hypercholesterolemia
5267530|NCT02345395|Brain Aneurysm|brain aneurysm
5267531|NCT02345395|Pterional Craniotomy|pterional craniotomy
5267532|NCT02345395|MiniPterional Craniotomy|minipterional craniotomy
5267533|NCT02345395|Transpalpebral Approach|transpalpebral approach
5267534|NCT02345395|Unruptured Brain Aneurysm|unruptured brain aneurysm
5267535|NCT02345382|Advanced acute leukemia|advanced acute leukemia
5267536|NCT02345356|Pharmacogenomics|pharmacogenomics
5267537|NCT02345356|Warfarin|warfarin
5267538|NCT02345356|Caribbean Hispanics|caribbean hispanics
5267539|NCT02345356|Polymorphisms|polymorphisms
5267540|NCT02345356|Dosing Algorithm|dosing algorithm
5267541|NCT02345278|Immunotherapy|immunotherapy
5267542|NCT02345278|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
5267545|NCT02345213|DLB|dlb
5267546|NCT02345213|Dementia with Lewy bodies|dementia with lewy bodies
5267547|NCT02345213|Lewy Body Disease|lewy body disease
5267548|NCT02345213|Dementia|dementia
5267549|NCT02345213|E2020|e2020
5267550|NCT02345213|Donepezil|donepezil
5267551|NCT02345213|Aricept|aricept
5267552|NCT02345200|dystrophy|dystrophy
5267553|NCT02345200|body composition|body composition
5267554|NCT02345200|malnutrition|malnutrition
5267555|NCT02345174|zirconium|zirconium
5267556|NCT02345174|oncology|oncology
5267557|NCT02345174|mAb|mab
5267558|NCT02345174|receptor occupancy|receptor occupancy
5267559|NCT02345174|dose|dose
5267561|NCT02345174|HER3|her3
5267562|NCT02345174|89-Zr|89-zr
5267563|NCT02345174|biodistribution|biodistribution
5267564|NCT02345174|tumours|tumours
5267565|NCT02345161|Triple Therapy|triple therapy
5267566|NCT02345161|Formoterol|formoterol
5267567|NCT02345161|Respiratory|respiratory
5267568|NCT02345161|COPD|copd
5267569|NCT02345161|Budesonide|budesonide
5267570|NCT02345161|Vilanterol|vilanterol
5267571|NCT02345161|Fluticasone Furoate|fluticasone furoate
5267572|NCT02345161|Umeclidinium|umeclidinium
5267573|NCT02345161|Lung Function|lung function
5267574|NCT02345148|Healthy|healthy
5267575|NCT02345148|Esketamine|esketamine
5267576|NCT02345148|JNJ-54135419|jnj-54135419
5267577|NCT02345122|At-risk Drinking|at-risk drinking
5267578|NCT02345122|Depression|depression
5267579|NCT02345122|Anxiety|anxiety
5267580|NCT02345122|Alcohol Drinking|alcohol drinking
5267581|NCT02345109|weight|weight
5267582|NCT02345109|total body water|total body water
5267583|NCT02345109|body fat|body fat
5267584|NCT02345109|muscle mass|muscle mass
5267585|NCT02345109|bone mass|bone mass
5267586|NCT02345109|BMI|bmi
5267587|NCT02345109|visceral fat|visceral fat
5267588|NCT02345109|calories|calories
5148570|NCT03064503|myocardial fibrosis|myocardial fibrosis
5148572|NCT03064503|ageing|ageing
5267589|NCT02345083|Frailty|frailty
5267590|NCT02345083|Pre-frailty|pre-frailty
5267591|NCT02345083|Fit|fit
5267592|NCT02345083|Robust|robust
5267593|NCT02345083|Elderly|elderly
5267594|NCT02345083|Sociodemography status|sociodemography status
5267595|NCT02345083|Functional status|functional status
5267596|NCT02345083|Cognitive status|cognitive status
5267597|NCT02345083|Nutrition status|nutrition status
5267598|NCT02345083|Comorbidity|comorbidity
5267599|NCT02345083|Polypharmacy|polypharmacy
5267600|NCT02345083|Mortality|mortality
5267601|NCT02345083|Depression status|depression status
5267602|NCT02345083|Health-related quality of life|health-related quality of life
5267603|NCT02345083|Fall incidence|fall incidence
5267604|NCT02345083|Hospitality|hospitality
5267605|NCT02345057|Diabetic Nephropathy|diabetic nephropathy
5267606|NCT02345057|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5267607|NCT02345057|CS-3150|cs-3150
5267608|NCT02345057|Japanese|japanese
5267609|NCT02345044|Essential hypertension|essential hypertension
5267610|NCT02345044|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5267611|NCT02345044|CS-3150|cs-3150
5267612|NCT02345044|Japanese|japanese
5267613|NCT02345031|hearing loss|hearing loss
5267614|NCT02345031|speech-in-noise|speech-in-noise
5267615|NCT02345018|Mechano-chemical ablation|mechano-chemical ablation
5267616|NCT02345018|Treatment large varicose veins|treatment large varicose veins
5267617|NCT02345018|Below-knee and branches|below-knee and branches
5267618|NCT02345018|Endovenous|endovenous
5267619|NCT02345005|Vascular diseases|vascular diseases
5267620|NCT02345005|Aneurysm|aneurysm
5267621|NCT02345005|Treatment Efficacy|treatment efficacy
5267622|NCT02345005|Medical device|medical device
5267623|NCT02345005|Population Register|population register
5267624|NCT02344979|NSCLC|nsclc
5267625|NCT02344979|Chemotherapy|chemotherapy
5267626|NCT02344979|thrombocytopenia|thrombocytopenia
5267627|NCT02344979|rhTPO|rhtpo
5267628|NCT02344940|operable|operable
5267629|NCT02344940|premenopausal|premenopausal
5267630|NCT02344940|endocrine therapy|endocrine therapy
5267631|NCT02344940|safety|safety
5267632|NCT02344940|tamoxifen|tamoxifen
5267633|NCT02344940|toremifene|toremifene
5267634|NCT02344927|Cancer|cancer
5267635|NCT02344927|End-of-life care|end-of-life care
5267636|NCT02344927|Clinically-assisted hydration|clinically-assisted hydration
5267637|NCT02344914|dental support|dental support
5267638|NCT02344914|second stage of labor|second stage of labor
5267639|NCT02344901|non-valvular atrial fibrillation|non-valvular atrial fibrillation
5267640|NCT02344901|stroke prevention|stroke prevention
5267641|NCT02344901|novel oral anticoagulants|novel oral anticoagulants
5267642|NCT02344901|warfarin|warfarin
5267643|NCT02344888|PCOS|pcos
5267644|NCT02344888|Clomiphene citrate resistant|clomiphene citrate resistant
5267645|NCT02344888|Prednisolone|prednisolone
5267646|NCT02344823|cirrhosis|cirrhosis
5267647|NCT02344823|erectile dysfunction|erectile dysfunction
5267648|NCT02344823|portal hypertension|portal hypertension
5267649|NCT02344797|Perioperative|perioperative
5267650|NCT02344797|Postoperative Complications/prevention & control|postoperative complications/prevention & control
5267651|NCT02344784|ADD|add
5267652|NCT02344784|ADHD|adhd
5267653|NCT02344784|PPI|ppi
5267654|NCT02344771|Endothelial dysfunction|endothelial dysfunction
5267655|NCT02344771|General Surgery|general surgery
5267656|NCT02344771|Perioperative Care|perioperative care
5267657|NCT02344745|Lavender|lavender
5267658|NCT02344745|Aromatherapy|aromatherapy
5267659|NCT02344745|Urodynamics|urodynamics
5267660|NCT02344732|epithelium, cornea, diabetes, vitrectomy, oxygen|epithelium, cornea, diabetes, vitrectomy, oxygen
5267661|NCT02344719|cirrhosis|cirrhosis
5267662|NCT02344719|portal hypertension|portal hypertension
5267663|NCT02344719|taurin|taurin
5267664|NCT02344706|Emergency Care, Prehospital|emergency care, prehospital
5267669|NCT02344654|Cholangiography|cholangiography
5267670|NCT02344654|Indocyanine Green|indocyanine green
5267671|NCT02344654|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
5267672|NCT02344615|nerve stimulator|nerve stimulator
5267673|NCT02344615|ultrasound|ultrasound
5267674|NCT02344602|Diabetic Nephropathy|diabetic nephropathy
5267675|NCT02344602|Diabetes Mellitus|diabetes mellitus
5267676|NCT02344602|Diabetes Complications|diabetes complications
5267677|NCT02344602|Uric Acid|uric acid
5267678|NCT02344602|Febuxostat|febuxostat
5267679|NCT02344602|Uloric|uloric
5267680|NCT02344602|Glomerular Filtration Rate|glomerular filtration rate
5267681|NCT02344602|Kidney Disease|kidney disease
5267682|NCT02344602|Vascular Disease|vascular disease
5267683|NCT02344602|Cardiovascular Diseases|cardiovascular diseases
5267684|NCT02344602|Endothelial Function|endothelial function
5267685|NCT02344602|Arterial Stiffness|arterial stiffness
5267686|NCT02344602|Pharmacologic Actions|pharmacologic actions
5267687|NCT02344602|Gout Suppressants|gout suppressants
5267688|NCT02344602|Therapeutic Uses|therapeutic uses
5267689|NCT02344602|Free Radical Scavengers|free radical scavengers
5267690|NCT02344602|Antioxidants|antioxidants
5267691|NCT02344602|Protective Agents|protective agents
5267692|NCT02344602|Physiological Effects of Drugs|physiological effects of drugs
5267693|NCT02344602|Angiotensin II Infusion|angiotensin ii infusion
5267694|NCT02344602|Flow-mediated Dilation|flow-mediated dilation
5267695|NCT02344602|Flow-mediated Constriction|flow-mediated constriction
5267696|NCT02344602|Nitroglycerin|nitroglycerin
5267697|NCT02344602|Hyperglycemia|hyperglycemia
5267698|NCT02344602|Renin-angiotensin-aldosterone System|renin-angiotensin-aldosterone system
5267699|NCT02344602|Nitric Oxide|nitric oxide
5267700|NCT02344602|cGMP|cgmp
5267701|NCT02344602|Oxidative Stress|oxidative stress
5267702|NCT02344602|Renal Haemodynamic Function|renal haemodynamic function
5267703|NCT02344602|Inulin Clearance|inulin clearance
5267704|NCT02344602|PAH Clearance|pah clearance
5267705|NCT02344602|Skin Biopsy|skin biopsy
5267706|NCT02344602|T1R mRNA Expression|t1r mrna expression
5267707|NCT02344602|Cytokines|cytokines
5267708|NCT02344602|Chemokines|chemokines
5267710|NCT02344589|Adductor Canal Block|adductor canal block
5267711|NCT02344589|Peripheral Nerve Block|peripheral nerve block
5267712|NCT02344576|heart failure|heart failure
5267713|NCT02344576|heart-assist devices|heart-assist devices
5267714|NCT02344576|decision making|decision making
5267715|NCT02344576|decision support techniques|decision support techniques
5267716|NCT02344576|hospice care|hospice care
5267718|NCT02344576|caregivers|caregivers
5267719|NCT02344563|volunteers|volunteers
5267720|NCT02344550|metastatic breast cancer|metastatic breast cancer
5267721|NCT02344550|HER2 negative|her2 negative
5267722|NCT02344550|hormone-receptor positive|hormone-receptor positive
5267723|NCT02344537|Lyme DIsease|lyme disease
5267724|NCT02344537|Kundalini Yoga|kundalini yoga
5267725|NCT02344498|Liver cirrhosis|liver cirrhosis
5267726|NCT02344498|Antiviral agents|antiviral agents
5267727|NCT02344498|Liver diseases|liver diseases
5267729|NCT02344472|HER2|her2
5267730|NCT02344472|CTC|ctc
5267731|NCT02344472|endocrine therapy|endocrine therapy
5267732|NCT02344472|Pertuzumab|pertuzumab
5267733|NCT02344472|Trastuzumab|trastuzumab
5267734|NCT02344472|HER2 therapy|her2 therapy
5267735|NCT02344472|Ribociclib|ribociclib
5267736|NCT02344446|physical therapy intervention|physical therapy intervention
5267737|NCT02344433|Family health history|family health history
5267738|NCT02344433|Genetic literacy|genetic literacy
5267739|NCT02344433|Health literacy|health literacy
5267740|NCT02344433|Relational agent|relational agent
5267741|NCT02344433|Common chronic conditions|common chronic conditions
5267742|NCT02344420|Heart Failure|heart failure
5267743|NCT02344420|CRT|crt
5267744|NCT02344407|Zaire Ebola Virus Disease|zaire ebola virus disease
5267745|NCT02344394|Atrial Fibrillation|atrial fibrillation
5267746|NCT02344394|Anti-Arrhythmia Agents|anti-arrhythmia agents
5267747|NCT02344394|Catheter Ablation|catheter ablation
5267748|NCT02344394|surgical hybrid ablation|surgical hybrid ablation
5267749|NCT02344368|Sucrose|sucrose
5267750|NCT02344368|Anesthesia|anesthesia
5267751|NCT02344368|Blood specimen collection|blood specimen collection
5267753|NCT02344355|Ascorbic Acid|ascorbic acid
5267754|NCT02344355|temozolomide|temozolomide
5267755|NCT02344355|radiation|radiation
5267756|NCT02344342|telemonitoring|telemonitoring
5267758|NCT02344290|Cardiovascular Disease|cardiovascular disease
5267759|NCT02344290|Myocardial Infarction|myocardial infarction
5267760|NCT02344290|Inflammation|inflammation
5267761|NCT02344290|Statin|statin
5272733|NCT02316054|prognosis|prognosis
5267762|NCT02344290|Computerized Tomography|computerized tomography
5267763|NCT02344290|Cholesterol|cholesterol
5267764|NCT02344277|Subcutaneaous Implantable Cardiac Defibrillator|subcutaneaous implantable cardiac defibrillator
5267765|NCT02344277|Brugada syndrome|brugada syndrome
5267766|NCT02344277|Effectiveness|effectiveness
5267767|NCT02344277|Safety|safety
5267768|NCT02344264|US guided nerve block|us guided nerve block
5267769|NCT02344264|Total hip Arthroplasty|total hip arthroplasty
5267770|NCT02344264|NCFL|ncfl
5267771|NCT02344264|nervus cutaneous femoralis lateralis|nervus cutaneous femoralis lateralis
5267772|NCT02344251|Drug study|drug study
5267773|NCT02344251|Medication compliance|medication compliance
5267774|NCT02344238|Medication compliance|medication compliance
5267775|NCT02344238|Technology|technology
5267776|NCT02344238|Drug study|drug study
5267777|NCT02344186|diabetes, endoplasmic reticulum stress, obesity, GLP1 analogs|diabetes, endoplasmic reticulum stress, obesity, glp1 analogs
5267778|NCT02344160|Total Hip Arthroplasty|total hip arthroplasty
5267779|NCT02344160|THA|tha
5267780|NCT02344095|recurrent, persistent|recurrent, persistent
5267781|NCT02344069|Fibrinogen|fibrinogen
5267782|NCT02344056|Having Lunch|having lunch
5267783|NCT02344056|Skipping Lunch|skipping lunch
5267784|NCT02344030|airway|airway
5267785|NCT02344030|videolaryngoscope|videolaryngoscope
5267788|NCT02343978|Chronic Constipation|chronic constipation
5267789|NCT02343978|CC|cc
5267790|NCT02343965|Touch-massage|touch-massage
5267791|NCT02343965|anxiety|anxiety
5267793|NCT02343965|haematology|haematology
5267794|NCT02343965|cancerology|cancerology
5267795|NCT02343965|supportive care|supportive care
5267796|NCT02343965|complementary therapy|complementary therapy
5267797|NCT02343952|Pembrolizumab|pembrolizumab
5267798|NCT02343952|MK-3475|mk-3475
5267799|NCT02343874|Alcohol consumption|alcohol consumption
5267800|NCT02343874|Primary health care|primary health care
5267801|NCT02343874|health care costs|health care costs
5267802|NCT02343874|health service utilization|health service utilization
5267803|NCT02343861|Behavioral Research|behavioral research
5267804|NCT02343861|Emollients|emollients
5267805|NCT02343822|PRP|prp
5267806|NCT02343822|Platelet Rich Plasma|platelet rich plasma
5267807|NCT02343822|Lateral Epicondylitis|lateral epicondylitis
5267808|NCT02343822|Lateral Epicondylopathy|lateral epicondylopathy
5267809|NCT02343822|Lateral Epicondylosis|lateral epicondylosis
5267810|NCT02343822|Chronic Lateral Epicondylitis|chronic lateral epicondylitis
5267811|NCT02343822|PRPLE|prple
5267812|NCT02343822|Multiple PRP Injections|multiple prp injections
5267813|NCT02343822|Multiple PRP|multiple prp
5267814|NCT02343822|Platelet-Rich Plasma|platelet-rich plasma
5267815|NCT02343822|Tennis Elbow|tennis elbow
5267816|NCT02343822|Double Blinded Randomized Controlled|double blinded randomized controlled
5267817|NCT02343822|Multiple vs Single PRP injections|multiple vs single prp injections
5267818|NCT02343822|prp tennis elbow|prp tennis elbow
5267820|NCT02343809|Lateral epicondylitis|lateral epicondylitis
5267821|NCT02343809|Manual therapy|manual therapy
5267822|NCT02343796|Fiberglass reinforced resins|fiberglass reinforced resins
5267823|NCT02343783|Atopic Dermatitis|atopic dermatitis
5267824|NCT02343783|Asthma|asthma
5267825|NCT02343783|Healthy|healthy
5267826|NCT02343783|Skin Blisters|skin blisters
5267827|NCT02343783|Adult Participants|adult participants
5267828|NCT02343744|Generalized Pustular Psoriasis|generalized pustular psoriasis
5267829|NCT02343744|Erythrodermic Psoriasis|erythrodermic psoriasis
5267830|NCT02343744|Guselkumab|guselkumab
5267831|NCT02343744|CNTO1959|cnto1959
5267832|NCT02343731|microbiome|microbiome
5267833|NCT02343731|hygiene hypothesis|hygiene hypothesis
5267834|NCT02343731|human-animal interaction|human-animal interaction
5267835|NCT02343731|microbiota|microbiota
5267836|NCT02343731|connections between human-canine microbiome|connections between human-canine microbiome
5267837|NCT02343653|Malnutrition|malnutrition
5267838|NCT02343653|Muscle mass|muscle mass
5267839|NCT02343653|Nutrition|nutrition
5267840|NCT02343640|Baseball|baseball
5267841|NCT02343640|Ulnar collateral ligament|ulnar collateral ligament
5267842|NCT02343614|Intermediate risk|intermediate risk
5267843|NCT02343614|Cox-2 inhibitors|cox-2 inhibitors
5267844|NCT02343588|Chinese multi-centered school based obesity intervention|chinese multi-centered school based obesity intervention
5267845|NCT02343575|Hyperactive delirium|hyperactive delirium
5267846|NCT02343575|Mixed delirium|mixed delirium
5267847|NCT02343575|Anti-psychotic|anti-psychotic
5267848|NCT02343575|Haldol|haldol
5267849|NCT02343575|Valproic Acid|valproic acid
5267850|NCT02343536|Phase 1|phase 1
5267852|NCT02343536|R-CHOP|r-chop
5267853|NCT02343536|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5267854|NCT02343536|Grade 3B Follicular Lymphoma|grade 3b follicular lymphoma
5267855|NCT02343536|Follicular Lymphoma|follicular lymphoma
5267856|NCT02343536|Transformed Lymphoma|transformed lymphoma
5267857|NCT02343523|Wearable device|wearable device
5267858|NCT02343523|Wrist-watch|wrist-watch
5267859|NCT02343523|Longitudinal monitoring|longitudinal monitoring
5267860|NCT02343523|Congestive Heart Failure|congestive heart failure
5423271|NCT01616420|cost-effectiveness|cost-effectiveness
5267865|NCT02343471|Postprandial lipemia|postprandial lipemia
5267866|NCT02343471|Pre-meal|pre-meal
5267867|NCT02343471|Type 2 diabetes|type 2 diabetes
5267868|NCT02343458|COPD|copd
5267869|NCT02343432|Anesthesia|anesthesia
5267870|NCT02343432|Adverse Effect|adverse effect
5267871|NCT02343432|Spinal|spinal
5267872|NCT02343432|Epidural|epidural
5267873|NCT02343419|Bronchial Hyperreactivity|bronchial hyperreactivity
5267874|NCT02343419|Bronchial Provocation Tests|bronchial provocation tests
5267875|NCT02343419|Methacholine Chloride|methacholine chloride
5267876|NCT02343419|Respiratory Function Tests|respiratory function tests
5267877|NCT02343419|Spirometry|spirometry
5267878|NCT02343419|Airway Resistance|airway resistance
5267879|NCT02343419|Plethysmography|plethysmography
5267880|NCT02343406|Glioblastoma Multiforme|glioblastoma multiforme
5267881|NCT02343406|Epithelial Growth Factor vIII mutation|epithelial growth factor viii mutation
5267882|NCT02343406|Temozolomide|temozolomide
5267883|NCT02343406|Lomustine|lomustine
5267884|NCT02343406|ABT-414|abt-414
5267885|NCT02343406|European Organization for Research and Treatment of Cancer|european organization for research and treatment of cancer
5267886|NCT02343406|recurrent glioblastoma|recurrent glioblastoma
5267887|NCT02343406|Epithelial Growth Factor|epithelial growth factor
5267888|NCT02343406|Brain Tumor|brain tumor
5267889|NCT02343406|Brain Tumor Group|brain tumor group
5267890|NCT02343406|Antibody Drug Conjugate|antibody drug conjugate
5267891|NCT02343406|EORTC|eortc
5267892|NCT02343406|Pediatric High Grade Gliomas|pediatric high grade gliomas
5267893|NCT02343406|Pediatric diffuse Intrinsic Pontine Glioma|pediatric diffuse intrinsic pontine glioma
5267894|NCT02343406|Pediatric WHO grade III glioma|pediatric who grade iii glioma
5267895|NCT02343406|Pediatric WHO grade IV glioma|pediatric who grade iv glioma
5267896|NCT02343406|EGFR amplification|egfr amplification
5267897|NCT02343406|Children|children
5267898|NCT02343393|Endothelial Dysfunction|endothelial dysfunction
5267899|NCT02343393|Biomarkers|biomarkers
5267900|NCT02343393|Hydralazine-Isosorbide Dinitrate|hydralazine-isosorbide dinitrate
5267901|NCT02343380|diet-induced thermogenesis|diet-induced thermogenesis
5267902|NCT02343380|glucose|glucose
5267903|NCT02343380|respiratory quotient|respiratory quotient
5267904|NCT02343367|Hispanic|hispanic
5267905|NCT02343367|overweight|overweight
5267906|NCT02343367|families|families
5267907|NCT02343367|pediatric|pediatric
5267908|NCT02343367|primary care|primary care
5267909|NCT02343354|behavioural|behavioural
5267910|NCT02343354|diabetes prevention|diabetes prevention
5267911|NCT02343354|physical activity|physical activity
5267912|NCT02343354|healthy eating|healthy eating
5267913|NCT02343354|gestational diabetes|gestational diabetes
5267914|NCT02343341|early childhood education|early childhood education
5267915|NCT02343341|cardiovascular health|cardiovascular health
5267916|NCT02343341|behavior change|behavior change
5267917|NCT02343341|community-based|community-based
5267923|NCT02343315|supervised exercise|supervised exercise
5267924|NCT02343315|core stability exercises|core stability exercises
5267925|NCT02343315|spinal stabilization exercises|spinal stabilization exercises
5267927|NCT02343289|Healthy|healthy
5267928|NCT02343289|Pharmacokinetics|pharmacokinetics
5267929|NCT02343289|Esketamine|esketamine
5267930|NCT02343289|JNJ-54135419|jnj-54135419
5267931|NCT02343276|Radial Spasm|radial spasm
5267932|NCT02343263|Tonsillectomy|tonsillectomy
5267933|NCT02343263|Adenotonsillectomy|adenotonsillectomy
5267934|NCT02343263|Pain|pain
5267935|NCT02343263|Hemorrhage|hemorrhage
5267936|NCT02343237|Fibromyalgia syndrome|fibromyalgia syndrome
5267937|NCT02343237|pain|pain
5267938|NCT02343237|quality of life|quality of life
5267939|NCT02343237|osteopathic treatment|osteopathic treatment
5267940|NCT02343211|Paraneoplastic Neurological Syndromes|paraneoplastic neurological syndromes
5267941|NCT02343211|Onconeural antibodies|onconeural antibodies
5267942|NCT02343211|Cancer|cancer
5267943|NCT02343185|diaphragm|diaphragm
5267944|NCT02343185|osteopathic treatment|osteopathic treatment
5267945|NCT02343185|myofascial release|myofascial release
5267951|NCT02343133|HemaMax, NM-IL-12, HSARS, Safety|hemamax, nm-il-12, hsars, safety
5267952|NCT02343107|Obesity|obesity
5267953|NCT02343107|Type 2 diabetes|type 2 diabetes
5267954|NCT02343107|Metabolic syndrome|metabolic syndrome
5267955|NCT02343107|e-coaching|e-coaching
5255371|NCT02416115|PONV|ponv
5255372|NCT02416115|ramosetron|ramosetron
5255373|NCT02416115|naloxone|naloxone
5255374|NCT02416089|Tampostat|tampostat
5267956|NCT02343107|Telehealth|telehealth
5267957|NCT02343094|Proteinuria|proteinuria
5267958|NCT02343094|Lipocalin 2|lipocalin 2
5267959|NCT02343094|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
5267961|NCT02343081|brain neoplasm|brain neoplasm
5267962|NCT02343081|bioequivalence|bioequivalence
5267963|NCT02343081|temozolomide|temozolomide
5267964|NCT02343042|Selinexor|selinexor
5267965|NCT02343042|KCP-330|kcp-330
5267966|NCT02343042|STOMP|stomp
5267967|NCT02343042|Multiple Myeloma|multiple myeloma
5267968|NCT02343042|Relapsed/Refractory|relapsed/refractory
5267969|NCT02343042|Dexamethasone|dexamethasone
5267970|NCT02343042|Pomalidomide|pomalidomide
5267971|NCT02343042|Bortezomib|bortezomib
5267972|NCT02343042|Karyopharm|karyopharm
5267973|NCT02343042|Lenalidomide|lenalidomide
5267974|NCT02343042|Daratumumab|daratumumab
5267975|NCT02343042|Newly Diagnosed|newly diagnosed
5267976|NCT02343042|Carfilzomib|carfilzomib
5267977|NCT02343029|Aerobic Exercise Training|aerobic exercise training
5267978|NCT02343029|prevention|prevention
5267979|NCT02343029|magnetic resonance spectroscopic imaging|magnetic resonance spectroscopic imaging
5267980|NCT02343029|psychometric tests|psychometric tests
5267981|NCT02343029|cognition|cognition
5267982|NCT02343029|dementia|dementia
5267983|NCT02343029|cognitive impairment|cognitive impairment
5445672|NCT01520727|BIA 9-1067|bia 9-1067
5267984|NCT02343003|cooled radiofrequency ablation|cooled radiofrequency ablation
5267985|NCT02343003|knee pain|knee pain
5267986|NCT02343003|osteoarthritis|osteoarthritis
5267987|NCT02343003|pain management|pain management
5267988|NCT02342990|working memory training|working memory training
5267989|NCT02342990|home-based training|home-based training
5267990|NCT02342990|periventricular leukomalacia|periventricular leukomalacia
5267991|NCT02342990|bilateral cerebral palsy|bilateral cerebral palsy
5267992|NCT02342990|neuropsychological profile|neuropsychological profile
5267993|NCT02342990|high density EEG|high density eeg
5267994|NCT02342990|slow waves activities|slow waves activities
5267995|NCT02342977|total hip arthroplasty|total hip arthroplasty
5267996|NCT02342964|Cystic fibrosis|cystic fibrosis
5267997|NCT02342964|hepatic fibrosis|hepatic fibrosis
5267998|NCT02342964|hepatic cirrhosis|hepatic cirrhosis
5267999|NCT02342964|non-invasive methods of measurement|non-invasive methods of measurement
5268000|NCT02342964|hepatic elasticity|hepatic elasticity
5268001|NCT02342951|Cystic fibrosis,|cystic fibrosis,
5268002|NCT02342951|lung clearance index,|lung clearance index,
5268003|NCT02342951|pulmonary function|pulmonary function
5268004|NCT02342938|Epilepsy surgery|epilepsy surgery
5268005|NCT02342938|High frequency activity|high frequency activity
5268006|NCT02342938|icEEG|iceeg
5268007|NCT02342938|fMRI|fmri
5268009|NCT02342886|Tuberculosis|tuberculosis
5268010|NCT02342886|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
5268011|NCT02342886|Drug-sensitive Tuberculosis|drug-sensitive tuberculosis
5268012|NCT02342886|PA-824|pa-824
5268013|NCT02342886|Moxifloxacin|moxifloxacin
5268014|NCT02342886|Pyrazinamide|pyrazinamide
5268015|NCT02342886|Rifampicin|rifampicin
5268016|NCT02342886|Isoniazid|isoniazid
5268017|NCT02342886|Ethambutol|ethambutol
5268018|NCT02342886|HRZE|hrze
5268025|NCT02342860|Water|water
5268026|NCT02342860|sanitation|sanitation
5268027|NCT02342860|hygiene access in school|hygiene access in school
5268028|NCT02342756|ARDS, HFOV|ards, hfov
5268029|NCT02342691|Safety and efficacy of BLXA4|safety and efficacy of blxa4
5268031|NCT02342626|Prostate|prostate
5268032|NCT02342626|Cancer|cancer
5268033|NCT02342626|Adenocarcinoma|adenocarcinoma
5268034|NCT02342587|Lapatinib|lapatinib
5268035|NCT02342561|Infection|infection
5268036|NCT02342561|Drape|drape
5268037|NCT02342561|Ioban|ioban
5268038|NCT02342561|Arthroplasty|arthroplasty
5268039|NCT02342561|Knee|knee
5268040|NCT02342561|Cylinder Sampling|cylinder sampling
5268041|NCT02342561|Bacteria|bacteria
5268042|NCT02342548|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
5268043|NCT02342522|Cardioprotection|cardioprotection
5268044|NCT02342522|STEMI|stemi
5268045|NCT02342522|PPCI|ppci
5268046|NCT02342522|Myocardial reperfusion injury|myocardial reperfusion injury
5268047|NCT02342522|Myocardial infarct size|myocardial infarct size
5268147|NCT02341950|videogame|videogame
5268048|NCT02342522|ST-elevation myocardial infarction|st-elevation myocardial infarction
5268049|NCT02342522|Remote Ischaemic Conditioning|remote ischaemic conditioning
5268050|NCT02342522|Cardiovascular mortality|cardiovascular mortality
5268051|NCT02342509|et Control|et control
5268052|NCT02342509|inhalational sedation|inhalational sedation
5268053|NCT02342509|conserve volatile anesthetics|conserve volatile anesthetics
5268054|NCT02342470|prevention|prevention
5268055|NCT02342470|Recurrent peptic ulcer|recurrent peptic ulcer
5268056|NCT02342444|Trauma|trauma
5268057|NCT02342444|Surgery|surgery
5268058|NCT02342444|Enoxaparin|enoxaparin
5268059|NCT02342444|DVTs|dvts
5268060|NCT02342444|Thromboembolic events|thromboembolic events
5268061|NCT02342431|Thermoregulation|thermoregulation
5268062|NCT02342431|Pediatric Anesthesia|pediatric anesthesia
5268063|NCT02342431|Cardiac Catheterization|cardiac catheterization
5268064|NCT02342405|Oxidative stress|oxidative stress
5268065|NCT02342405|Nitrogen oxide|nitrogen oxide
5268066|NCT02342405|Reactive oxygen species|reactive oxygen species
5268067|NCT02342392|pterygium|pterygium
5268068|NCT02342392|ranibizumab|ranibizumab
5268069|NCT02342392|anti-VEGF|anti-vegf
5268070|NCT02342392|recurrence|recurrence
5268071|NCT02342392|vascularity|vascularity
5268072|NCT02342392|size|size
5268073|NCT02342366|Sodium Oxybate, Altruism, Neurostreroids, Liquid Ecstasy|sodium oxybate, altruism, neurostreroids, liquid ecstasy
5268074|NCT02342340|Beans, Lentils, Bioavailability, Phytochemical Absorption|beans, lentils, bioavailability, phytochemical absorption
5268075|NCT02342288|Intraoperative ocular pressure|intraoperative ocular pressure
5268076|NCT02342275|Infantile hemangioma|infantile hemangioma
5268077|NCT02342275|Propranolol|propranolol
5268078|NCT02342275|Atenolol|atenolol
5268079|NCT02342275|Efficacy|efficacy
5268080|NCT02342275|Safety|safety
5268081|NCT02342249|Influenza A|influenza a
5268082|NCT02342236|Biological Markers|biological markers
5268083|NCT02342223|human immunodeficiency virus|human immunodeficiency virus
5268084|NCT02342223|facial lipoatrophy|facial lipoatrophy
5268085|NCT02342223|facial lipodystrophy|facial lipodystrophy
5268086|NCT02342223|hyaluronic acid|hyaluronic acid
5268087|NCT02342223|dermal filler|dermal filler
5268088|NCT02342223|filler agent|filler agent
5268089|NCT02342210|Mindfulness|mindfulness
5268090|NCT02342210|Group Therapy|group therapy
5268091|NCT02342197|Low responders|low responders
5268092|NCT02342197|Minidose long protocol|minidose long protocol
5268093|NCT02342197|Microdose flare protocol|microdose flare protocol
5268094|NCT02342197|Oocyte yield|oocyte yield
5268095|NCT02342171|Ebola Viral Disease|ebola viral disease
5268096|NCT02342171|Convalescent Plasma|convalescent plasma
5268097|NCT02342171|Developing Countries|developing countries
5268098|NCT02342145|beta-Thalassemia major|beta-thalassemia major
5268099|NCT02342119|kidney transplantation|kidney transplantation
5268100|NCT02342119|race disparities|race disparities
5268101|NCT02342119|living donor kidney transplantation|living donor kidney transplantation
5268102|NCT02342119|transplant evaluation|transplant evaluation
5268103|NCT02342093|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5268104|NCT02342093|Drospirenone|drospirenone
5268105|NCT02342093|Oral contraceptive|oral contraceptive
5268106|NCT02342080|Rehabilitation|rehabilitation
5268107|NCT02342080|Walking|walking
5268108|NCT02342080|Robotics|robotics
5268109|NCT02342080|Neuronal Plasticity|neuronal plasticity
5268110|NCT02342054|Cancer|cancer
5268111|NCT02342054|Prostate Cancer|prostate cancer
5268112|NCT02342054|Brachytherapy|brachytherapy
5268113|NCT02342054|Dose escalation|dose escalation
5268114|NCT02342054|High Dose Rate|high dose rate
5268115|NCT02342054|MRI-TRUS fusion|mri-trus fusion
5268116|NCT02342054|Detection of DILs by MRI|detection of dils by mri
5268117|NCT02342054|SINGLE FRACTION|single fraction
5268118|NCT02342041|SUVN-G3031|suvn-g3031
5268119|NCT02342041|histamine 3 (H3) receptor inverse agonist|histamine 3 (h3) receptor inverse agonist
5268120|NCT02342041|first in human|first in human
5268122|NCT02342041|pharmacokinetics|pharmacokinetics
5268123|NCT02342041|tolerability|tolerability
5268124|NCT02342041|single dose|single dose
5268125|NCT02342041|repeat dose|repeat dose
5268126|NCT02342028|sleep apnea|sleep apnea
5268127|NCT02342028|intermittent hypoxia|intermittent hypoxia
5268128|NCT02342028|regulatory T cell|regulatory t cell
5268129|NCT02342028|autoimmunity|autoimmunity
5268130|NCT02342002|mifepristone|mifepristone
5268131|NCT02342002|misoprostol|misoprostol
5268132|NCT02342002|obstetrics|obstetrics
5268133|NCT02342002|reproductive health|reproductive health
5268134|NCT02342002|pregnancy|pregnancy
5268135|NCT02342002|abortion|abortion
5268136|NCT02342002|missed abortion|missed abortion
5268137|NCT02341989|Chemotherapy, adjuvant|chemotherapy, adjuvant
5268138|NCT02341989|Recurrence|recurrence
5268139|NCT02341989|Carboplatin|carboplatin
5268140|NCT02341989|Bleomycin|bleomycin
5268141|NCT02341989|Etoposide|etoposide
5268142|NCT02341989|Cisplatin|cisplatin
5268143|NCT02341976|whole body vibration|whole body vibration
5268144|NCT02341976|pelvic floor muscle|pelvic floor muscle
5268145|NCT02341976|urinary incontinence|urinary incontinence
5268146|NCT02341976|Urinary sphincter|urinary sphincter
5268148|NCT02341950|health|health
5268149|NCT02341950|behavior|behavior
5268150|NCT02341950|mobile|mobile
5268151|NCT02341950|spinal|spinal
5268152|NCT02341950|cord|cord
5268153|NCT02341950|dysfunction|dysfunction
5268154|NCT02341911|triple negative breast cancer|triple negative breast cancer
5268155|NCT02341911|fine line chemotherapy|fine line chemotherapy
5268156|NCT02341898|nursing home care|nursing home care
5268157|NCT02341898|physical restraints|physical restraints
5268158|NCT02341898|dementia|dementia
5268159|NCT02341898|implementation research|implementation research
5268160|NCT02341898|cluster-randomized controlled trial|cluster-randomized controlled trial
5268161|NCT02341885|Kidney|kidney
5268162|NCT02341885|Renal replacement|renal replacement
5268163|NCT02341885|Acute kidney injury|acute kidney injury
5268164|NCT02341885|chronic kidney disease|chronic kidney disease
5268165|NCT02341885|Epidemiology|epidemiology
5268166|NCT02341885|Prevalence|prevalence
5268167|NCT02341872|White spot lesions|white spot lesions
5268168|NCT02341872|remineralization|remineralization
5268170|NCT02341872|antibacterial|antibacterial
5268171|NCT02341846|cancer pain|cancer pain
5268172|NCT02341833|Anesthetic preconditioning|anesthetic preconditioning
5268173|NCT02341833|Sevoflurane|sevoflurane
5268174|NCT02341833|Liver transplantation|liver transplantation
5268175|NCT02341833|brain-death donors|brain-death donors
5268176|NCT02341820|breast cancer|breast cancer
5268177|NCT02341820|breast conserving surgery|breast conserving surgery
5268178|NCT02341820|cosmesis|cosmesis
5268179|NCT02341807|Choroideremia|choroideremia
5268181|NCT02341807|Gene therapy|gene therapy
5268182|NCT02341807|CHM|chm
5268183|NCT02341807|Adeno-associated virus|adeno-associated virus
5268184|NCT02341807|Adeno-associated viral vector|adeno-associated viral vector
5268185|NCT02341794|intracranial arterial disease|intracranial arterial disease
5268186|NCT02341794|dyslipidemia|dyslipidemia
5268187|NCT02341794|rosuvastatin|rosuvastatin
5268188|NCT02341781|MANTLE CELL LYMPHOMA|mantle cell lymphoma
5268189|NCT02341781|Multicenter|multicenter
5268190|NCT02341781|Observational|observational
5268191|NCT02341781|Lenalidomide (Revlimid®)|lenalidomide (revlimid®)
5268192|NCT02341781|Relapsed or progressed|relapsed or progressed
5268193|NCT02341781|Ibrutinib|ibrutinib
5268194|NCT02341768|clinical and device functional information|clinical and device functional information
5268195|NCT02341768|"real world ICD patient population"|"real world icd patient population"
5268196|NCT02341742|Physical activity|physical activity
5268197|NCT02341742|Bone health|bone health
5268198|NCT02341742|Pediatrics|pediatrics
5268199|NCT02341742|Bone|bone
5268200|NCT02341729|semi-urgent CABG|semi-urgent cabg
5268201|NCT02341729|reanimation|reanimation
5268202|NCT02341729|ticagrelor|ticagrelor
5268203|NCT02341729|crushed tablet|crushed tablet
5268204|NCT02341716|intermittent claudication|intermittent claudication
5268205|NCT02341716|exercise therapy|exercise therapy
5268206|NCT02341716|physiotherapy|physiotherapy
5268207|NCT02341690|Type 2 diabetes|type 2 diabetes
5268208|NCT02341690|Interval Walking Training|interval walking training
5268209|NCT02341690|Motivation|motivation
5268210|NCT02341677|Prostatic Neoplasms|prostatic neoplasms
5268211|NCT02341677|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5268212|NCT02341677|Magnetic Resonance Imaging|magnetic resonance imaging
5268213|NCT02341677|Ultrasonography|ultrasonography
5268214|NCT02341677|Biopsy|biopsy
5265424|NCT02357888|craving|craving
5268224|NCT02341664|Statin|statin
5268225|NCT02341664|Lipid Panel|lipid panel
5268226|NCT02341664|Low Density Lipoprotein-C|low density lipoprotein-c
5268227|NCT02341664|Blood Draw|blood draw
5268228|NCT02341664|ACC/AHA Guidelines|acc/aha guidelines
5268229|NCT02341664|Adult Treatment Panel Guidelines (ATPIII)|adult treatment panel guidelines (atpiii)
5268230|NCT02341664|Atherosclerotic Cardiovascular Disease (ASCVD)|atherosclerotic cardiovascular disease (ascvd)
5268231|NCT02341664|Cholesterol-lowering therapies|cholesterol-lowering therapies
5268232|NCT02341664|Cholesterol Management|cholesterol management
5268233|NCT02341664|Cardiovascular Risk|cardiovascular risk
5268234|NCT02341664|10-year CVD Risk|10-year cvd risk
5268235|NCT02341664|Labs|labs
5268236|NCT02341664|Coronary revascularization|coronary revascularization
5268237|NCT02341664|Arterial revascularization|arterial revascularization
5268238|NCT02341664|Imaging|imaging
5268239|NCT02341651|High blood pressure|high blood pressure
5268240|NCT02341651|Cardiovascular diseases|cardiovascular diseases
5268241|NCT02341651|Antihypertensive agents|antihypertensive agents
5268242|NCT02341651|Pharmacological treatment|pharmacological treatment
5674381|NCT00603785|Nasal Discharge|nasal discharge
5268243|NCT02341651|Non-pharmacological treatment|non-pharmacological treatment
5268244|NCT02341651|Community health care workers|community health care workers
5268245|NCT02341651|Treatment algorithm|treatment algorithm
5268246|NCT02341651|Public and private healthcare providers|public and private healthcare providers
5268247|NCT02341651|Strategy|strategy
5268248|NCT02341651|Referral loops|referral loops
5268249|NCT02341651|Intervention|intervention
5268250|NCT02341612|exercise-induced muscle damage|exercise-induced muscle damage
5268251|NCT02341612|skeletal muscle injury recovery|skeletal muscle injury recovery
5268252|NCT02341612|cryotherapy|cryotherapy
5268253|NCT02341612|recovery of function|recovery of function
5268254|NCT02341612|rehabilitation|rehabilitation
5268255|NCT02341586|Malaria|malaria
5268256|NCT02341586|Cambodia|cambodia
5268262|NCT02341573|Randomized Controlled Trial|randomized controlled trial
5268270|NCT02341482|Itraconazole|itraconazole
5268271|NCT02341482|Healthy Volunteers|healthy volunteers
5268272|NCT02341482|Drug-drug interaction|drug-drug interaction
5268273|NCT02341482|PF-04958242|pf-04958242
5268274|NCT02341469|Burkina Faso|burkina faso
5268275|NCT02341469|cluster randomised|cluster randomised
5268276|NCT02341469|stepped-wedge|stepped-wedge
5268277|NCT02341469|IMCI|imci
5268278|NCT02341443|bilateral double mandibular fractures|bilateral double mandibular fractures
5268279|NCT02341443|rigid fixation|rigid fixation
5268280|NCT02341443|no-rigid fixation|no-rigid fixation
5268281|NCT02341443|jaw|jaw
5268282|NCT02341430|hernia|hernia
5268283|NCT02341430|synthetic mesh|synthetic mesh
5268284|NCT02341417|Chronic Kidney Disease, Dialysis, Secondary Hyperparathyroidism, Pediatric|chronic kidney disease, dialysis, secondary hyperparathyroidism, pediatric
5268285|NCT02341391|chondrocyte cells|chondrocyte cells
5268286|NCT02341391|Osteoarthritis|osteoarthritis
5268287|NCT02341391|gene therapy|gene therapy
5268288|NCT02341378|chondrocyte cells|chondrocyte cells
5268289|NCT02341378|Osteoarthritis|osteoarthritis
5268290|NCT02341378|gene therapy|gene therapy
5268291|NCT02341365|Egg donation|egg donation
5268292|NCT02341365|vitaminD|vitamind
5268293|NCT02341365|ovarian reserve|ovarian reserve
5268294|NCT02341365|ovarian stimulation|ovarian stimulation
5268295|NCT02341326|Lung|lung
5268296|NCT02341326|COPD|copd
5268297|NCT02341326|smoking|smoking
5172146|NCT02916810|MRI|mri
5268298|NCT02341326|Non-smoker|non-smoker
5268299|NCT02341313|Hypoglycaemia|hypoglycaemia
5268300|NCT02341300|Pregnancy|pregnancy
5268301|NCT02341300|Cast-Iron pots|cast-iron pots
5268302|NCT02341300|Iron-deficiency anemia|iron-deficiency anemia
5268303|NCT02341274|Tacrolimus|tacrolimus
5268304|NCT02341274|Drug Formulation|drug formulation
5268305|NCT02341274|Absorption|absorption
5268306|NCT02341274|Bioavailability|bioavailability
5268307|NCT02341274|Healthy Volunteer|healthy volunteer
5268308|NCT02341248|Enteral Nutrition|enteral nutrition
5268309|NCT02341248|Pediatrics|pediatrics
5268310|NCT02341248|Microbiota|microbiota
5268311|NCT02341248|Metabolomics|metabolomics
5268312|NCT02341235|video game|video game
5268313|NCT02341235|narrative|narrative
5268314|NCT02341235|story|story
5268315|NCT02341235|survivorship|survivorship
5265518|NCT02357290|mood|mood
5268316|NCT02341235|cancer survivor|cancer survivor
5268317|NCT02341235|mhealth|mhealth
5268318|NCT02341235|physical activity|physical activity
5268319|NCT02341235|women|women
5268320|NCT02341235|women's health|women's health
5268321|NCT02341222|hernia prosthetic surgery|hernia prosthetic surgery
5268322|NCT02341222|incisional hernia prosthesis|incisional hernia prosthesis
5268323|NCT02341222|prosthesis mesh fixation|prosthesis mesh fixation
5268324|NCT02341222|prosthesis mesh biocompatibility|prosthesis mesh biocompatibility
5268325|NCT02341209|CTCL|ctcl
5268326|NCT02341209|Sezary Syndrome (SS)|sezary syndrome (ss)
5268327|NCT02341209|Mycosis Fungoides (MF)|mycosis fungoides (mf)
5268328|NCT02341209|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5268330|NCT02341209|SS|ss
5268331|NCT02341131|Schizophrenia|schizophrenia
5268332|NCT02341131|Cognitive Remediation|cognitive remediation
5268333|NCT02341131|BDNF|bdnf
5268334|NCT02341118|BRCA1/2 Mutational Status|brca1/2 mutational status
5268335|NCT02341092|Traumatic brain injury|traumatic brain injury
5268336|NCT02341079|Total Knee Arthroplasty|total knee arthroplasty
5268337|NCT02341079|Osteoarthritis|osteoarthritis
5268338|NCT02341079|Femoral Nerve Blockade|femoral nerve blockade
5268339|NCT02341079|Liposomal Bupivacaine|liposomal bupivacaine
5268340|NCT02341066|Cardiovascular risk score|cardiovascular risk score
5268341|NCT02341066|Framingham risk score 2-year|framingham risk score 2-year
5268342|NCT02341066|Endothelial dysfunction|endothelial dysfunction
5268344|NCT02341066|Rheumatoid arthritis|rheumatoid arthritis
5268345|NCT02341053|SMA|sma
5268346|NCT02341053|Neuromuscular disability|neuromuscular disability
5268347|NCT02341040|wheat allergy|wheat allergy
5268361|NCT02341001|Bariatric surgery|bariatric surgery
5268362|NCT02341001|Sleeve gastrectomy|sleeve gastrectomy
5268363|NCT02341001|Text messaging|text messaging
5268364|NCT02341001|Weight loss|weight loss
5268365|NCT02341001|BAROS|baros
5268366|NCT02341001|Follow-up care|follow-up care
5268367|NCT02340975|Gastric Adenocarcinoma|gastric adenocarcinoma
5268368|NCT02340975|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5268369|NCT02340975|Immunotherapy|immunotherapy
5268370|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal
5268371|NCT02340975|Tremelimumab|tremelimumab
5268372|NCT02340975|MEDI4736|medi4736
5268374|NCT02340923|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5268375|NCT02340923|EIM|eim
5268376|NCT02340910|spasticity|spasticity
5268377|NCT02340910|whole body vibration|whole body vibration
5268378|NCT02340910|walking|walking
5268379|NCT02340871|Neurogenetics|neurogenetics
5268380|NCT02340871|genetic testing|genetic testing
5268381|NCT02340845|breast,colon, ovary, uterus, cervix, lung|breast,colon, ovary, uterus, cervix, lung
5268382|NCT02340845|Treatments|treatments
5268383|NCT02340806|epidural bolus|epidural bolus
5268384|NCT02340806|pain management|pain management
5268385|NCT02340806|labor analgesia|labor analgesia
5268386|NCT02340793|Weight loss|weight loss
5268387|NCT02340767|Suspicious Occlusal Caries|suspicious occlusal caries
5268388|NCT02340754|mindfulness|mindfulness
5268389|NCT02340754|meditation|meditation
5268390|NCT02340754|stress, psychological|stress, psychological
5268391|NCT02340754|quality of life|quality of life
5268392|NCT02340754|randomized controlled trial|randomized controlled trial
5268393|NCT02340741|carbon dioxide|carbon dioxide
5268394|NCT02340741|postoperative cerebrovascular complications|postoperative cerebrovascular complications
5268395|NCT02340741|air embolism|air embolism
5268396|NCT02340728|Stent Placement|stent placement
5268397|NCT02340728|Biliary Obstruction|biliary obstruction
5268398|NCT02340728|14-260|14-260
5268399|NCT02340715|Anal canal|anal canal
5268400|NCT02340715|Brain|brain
5268401|NCT02340715|Breast|breast
5268402|NCT02340715|Cervix|cervix
5268403|NCT02340715|Esophagus|esophagus
5268404|NCT02340715|Gynecology|gynecology
5268405|NCT02340715|Head and Neck|head and neck
5268406|NCT02340715|Lung|lung
5268407|NCT02340715|Pancreas|pancreas
5268408|NCT02340715|Primary liver or liver metastases|primary liver or liver metastases
5268409|NCT02340715|Prostate cancer|prostate cancer
5268410|NCT02340715|Sarcoma|sarcoma
5268411|NCT02340702|COPD and heart failure|copd and heart failure
5268412|NCT02340689|PH|ph
5268413|NCT02340689|PH type 1|ph type 1
5268414|NCT02340689|Primary Hyperoxaluria|primary hyperoxaluria
5268415|NCT02340689|Hyperoxaluria|hyperoxaluria
5268416|NCT02340689|Primary Oxalosis|primary oxalosis
5268417|NCT02340689|PH type 2|ph type 2
5268418|NCT02340689|PH type 3|ph type 3
5268419|NCT02340689|Genetic testing for PH|genetic testing for ph
5268420|NCT02340689|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
5268421|NCT02340689|Hereditary study for PH|hereditary study for ph
5268422|NCT02340689|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
5268423|NCT02340689|AGXT|agxt
5268424|NCT02340689|GRHPR|grhpr
5268425|NCT02340689|HOGA1|hoga1
5268426|NCT02340676|chronic graft-versus-host-disease|chronic graft-versus-host-disease
5268427|NCT02340663|dental orthotic|dental orthotic
5268428|NCT02340663|bite splint|bite splint
5268429|NCT02340663|oral parafunction|oral parafunction
5268430|NCT02340663|clenching|clenching
5268434|NCT02340585|Wide Neck, Intracranial, Saccular Aneurysms|wide neck, intracranial, saccular aneurysms
5268435|NCT02340585|Cerebral Aneurysms|cerebral aneurysms
5268436|NCT02340572|Healthy Subjects|healthy subjects
5268437|NCT02340559|meta-cognition|meta-cognition
5268438|NCT02340559|positive symptoms|positive symptoms
5268439|NCT02340559|early phases|early phases
5268440|NCT02340559|schizophrenia|schizophrenia
5268441|NCT02340533|adenomyosis|adenomyosis
5268442|NCT02340481|Diarrhea|diarrhea
5268443|NCT02340481|Flatulence|flatulence
5268444|NCT02340481|Abdominal discomfort|abdominal discomfort
5268445|NCT02340481|Loperamide hydrochloride|loperamide hydrochloride
5268446|NCT02340481|Simethicone|simethicone
5268448|NCT02340442|arteriovenous ratio|arteriovenous ratio
5269249|NCT02335307|Pain|pain
5268449|NCT02340442|retinal flicker stimulation|retinal flicker stimulation
5268450|NCT02340442|Dynamic vessel analyzer|dynamic vessel analyzer
5268451|NCT02340416|orthopedic surgeries|orthopedic surgeries
5268452|NCT02340416|general anesthesia|general anesthesia
5268453|NCT02340403|Neuropathy|neuropathy
5268454|NCT02340403|Oxaliplatin|oxaliplatin
5268455|NCT02340403|Insula|insula
5268456|NCT02340403|choline|choline
5268457|NCT02340390|G7 Acetabular System|g7 acetabular system
5268458|NCT02340377|core body temperature|core body temperature
5268459|NCT02340377|whole-body hyperthermia|whole-body hyperthermia
5268460|NCT02340377|rectal body temperature|rectal body temperature
5268461|NCT02340364|Hospital Readmissions|hospital readmissions
5268462|NCT02340364|Patient Navigation|patient navigation
5268463|NCT02340351|acupuncture|acupuncture
5268464|NCT02340351|auricular acupuncture|auricular acupuncture
5268465|NCT02340351|NADA|nada
5268466|NCT02340351|anxiety|anxiety
5268467|NCT02340351|depression|depression
5268468|NCT02340299|High Frequency Oscillation Ventilation|high frequency oscillation ventilation
5268469|NCT02340299|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
5268470|NCT02340299|Airway Extubation|airway extubation
5268474|NCT02340273|pain|pain
5268475|NCT02340273|heat|heat
5268476|NCT02340273|strength|strength
5268477|NCT02340273|LITUS|litus
5268478|NCT02340273|long duration|long duration
5268479|NCT02340273|therapeutic ultrasound|therapeutic ultrasound
5268480|NCT02340273|tendonopathy|tendonopathy
5268481|NCT02340260|Exercise|exercise
5268482|NCT02340260|Risk factors|risk factors
5268483|NCT02340260|Exercise therapy|exercise therapy
5268484|NCT02340260|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5268485|NCT02340208|Non-Small Cell Lung Cancer|non-small cell lung cancer
5268486|NCT02340208|Neoplasms|neoplasms
5268487|NCT02340208|Immunoconjugate|immunoconjugate
5268488|NCT02340208|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
5268489|NCT02340195|Kidney impairment|kidney impairment
5268490|NCT02340182|gut flora|gut flora
5268491|NCT02340182|antibiotics|antibiotics
5268492|NCT02340182|systemic immune response|systemic immune response
5268493|NCT02340182|Volunteers|volunteers
5268494|NCT02340091|facial nasolabial fold wrinkles|facial nasolabial fold wrinkles
5268495|NCT02340078|the facial nasolabial fold|the facial nasolabial fold
5268496|NCT02340065|colonoscopy|colonoscopy
5268497|NCT02340065|adenoma detection rate|adenoma detection rate
5268498|NCT02340065|Endocuff-assisted colonoscopy|endocuff-assisted colonoscopy
5268499|NCT02340052|postoperative pain treatment|postoperative pain treatment
5268500|NCT02340039|Polyphenol|polyphenol
5268501|NCT02340039|Fruit|fruit
5268502|NCT02340039|Metabolic|metabolic
5268503|NCT02340026|Delay in motor skill development|delay in motor skill development
5268504|NCT02340000|acute sinusitis|acute sinusitis
5268505|NCT02340000|amoxicillin/clavulanate|amoxicillin/clavulanate
5268506|NCT02340000|adults|adults
5268507|NCT02340000|outcomes|outcomes
5268508|NCT02339961|Systemic Sclerosis|systemic sclerosis
5268509|NCT02339961|Pulmonary hypertension|pulmonary hypertension
5268510|NCT02339961|Lung Doppler Signals|lung doppler signals
5268511|NCT02339948|Locally confined|locally confined
5268512|NCT02339935|Autism Spectrum Disorder|autism spectrum disorder
5268513|NCT02339935|Autism|autism
5268514|NCT02339909|Screening|screening
5268515|NCT02339909|Incentives|incentives
5268516|NCT02339896|rabies|rabies
5268517|NCT02339896|modified TRC intradermal rabies vaccine|modified trc intradermal rabies vaccine
5268518|NCT02339896|SPEEDA|speeda
5268519|NCT02339883|Physiological Measures|physiological measures
5268520|NCT02339883|MRI|mri
5268521|NCT02339883|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5268522|NCT02339883|Cognitive Testing|cognitive testing
5268523|NCT02339857|coronary artery bypass grafting|coronary artery bypass grafting
5268524|NCT02339857|saphenous vein|saphenous vein
5268525|NCT02339857|grafts|grafts
5268526|NCT02339844|glutamate|glutamate
5268528|NCT02339844|cognition|cognition
5268529|NCT02339844|cortical thickness|cortical thickness
5268530|NCT02339844|ppi|ppi
5268531|NCT02339844|p50|p50
5268532|NCT02339831|Knee|knee
5268533|NCT02339831|Arthroplasty|arthroplasty
5268534|NCT02339831|CPM|cpm
5268535|NCT02339831|Camoped|camoped
5268536|NCT02339831|Active vs Passive Motion Device|active vs passive motion device
5268537|NCT02339805|Minimal residual disease, NGS, NHL, DNA sequencing|minimal residual disease, ngs, nhl, dna sequencing
5268538|NCT02339792|COMPREHENSIVE GERIATRIC ASSESSMENT (CGA)|comprehensive geriatric assessment (cga)
5268539|NCT02339792|MEDICATION APPROPRIATENESS PRESCRIBING|medication appropriateness prescribing
5268540|NCT02339792|DRUG INTERACTIONS|drug interactions
5268541|NCT02339792|E-LEARNING|e-learning
5268542|NCT02339779|fat grafting|fat grafting
5268543|NCT02339779|fat injection|fat injection
5268544|NCT02339779|lipoaspirate|lipoaspirate
5268545|NCT02339779|fat transfer|fat transfer
5268546|NCT02339779|lipofilling|lipofilling
5268547|NCT02339779|liposculpturing|liposculpturing
5268548|NCT02339779|lipoinjection|lipoinjection
5268549|NCT02339779|lipotransfer|lipotransfer
5268550|NCT02339779|breast reconstruction|breast reconstruction
5268551|NCT02339779|external pre-expansion|external pre-expansion
5268552|NCT02339779|BRAVA|brava
5268553|NCT02339779|EVE|eve
5268554|NCT02339766|Cesarean|cesarean
5268555|NCT02339766|Quadratus Lumborum Block|quadratus lumborum block
5268556|NCT02339766|Analgesia|analgesia
5268557|NCT02339766|Ultrasonography|ultrasonography
5268558|NCT02339727|Omega-3|omega-3
5268559|NCT02339727|Omega-6|omega-6
5268560|NCT02339714|allergic rhinitis|allergic rhinitis
5268561|NCT02339714|acupuncture|acupuncture
5268562|NCT02339714|moxibustion|moxibustion
5268563|NCT02339714|efficacy|efficacy
5268564|NCT02339714|safety|safety
5268565|NCT02339649|sepsis|sepsis
5268566|NCT02339649|septic shock|septic shock
5268567|NCT02339649|ICU|icu
5268568|NCT02339649|long-term outcome|long-term outcome
5268569|NCT02339649|neurocognitive|neurocognitive
5268570|NCT02339649|inflammatory|inflammatory
5268571|NCT02339649|MRI|mri
5268572|NCT02339649|EEG|eeg
5268573|NCT02339649|brain imaging|brain imaging
5268574|NCT02339649|serum biomarkers|serum biomarkers
5268575|NCT02339649|CSF|csf
5268576|NCT02339636|subclinical, enthesitis, synovitis|subclinical, enthesitis, synovitis
5268577|NCT02339623|Threatened preterm birth - fetal adrenal gland volume|threatened preterm birth - fetal adrenal gland volume
5268578|NCT02339610|Osteoarthritis|osteoarthritis
5268579|NCT02339610|Post-traumatic Arthritis|post-traumatic arthritis
5268580|NCT02339584|OAG|oag
5268581|NCT02339584|OHT|oht
5268582|NCT02339532|HER2-positive|her2-positive
5268583|NCT02339532|non-metastatic|non-metastatic
5268584|NCT02339532|TOP2A|top2a
5268585|NCT02339519|Laryngeal Masks|laryngeal masks
5268586|NCT02339506|stress|stress
5268587|NCT02339506|ACTH|acth
5268588|NCT02339506|cosyntropin|cosyntropin
5268589|NCT02339506|baroreflex sensitivity|baroreflex sensitivity
5268590|NCT02339506|cardiovagal|cardiovagal
5268591|NCT02339480|Massage therapy|massage therapy
5268592|NCT02339480|Simple obesity|simple obesity
5268593|NCT02339480|Energy metabolism|energy metabolism
5268594|NCT02339480|Mechanism|mechanism
5268595|NCT02339467|decreased outdoor walking ability|decreased outdoor walking ability
5268596|NCT02339467|Older adult|older adult
5268597|NCT02339454|Cardiac Shock wave therapy|cardiac shock wave therapy
5268598|NCT02339454|stable angina|stable angina
5268599|NCT02339454|exercise tolerance|exercise tolerance
5268600|NCT02339441|Systemic sclerosis|systemic sclerosis
5268601|NCT02339428|Colonoscopy|colonoscopy
5268602|NCT02339428|diagnostic|diagnostic
5268603|NCT02339428|diclophenac|diclophenac
5268604|NCT02339428|randomized controlled trial|randomized controlled trial
5268605|NCT02339402|Cystic fibrosis, Myotonic dystrophy, Noonan, Huntingtons|cystic fibrosis, myotonic dystrophy, noonan, huntingtons
5268606|NCT02339363|mindfulness|mindfulness
5268607|NCT02339363|adolescents|adolescents
5268608|NCT02339363|working memory|working memory
5268609|NCT02339363|stress|stress
5268610|NCT02339363|anxiety|anxiety
5445377|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents
5268611|NCT02339311|The study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the CHRs|the study focus is on lifestyle changes and patient activation in diabetic patients by regular monthly visit by the chrs
5268612|NCT02339298|Music Therapy|music therapy
5268613|NCT02339285|tACS|tacs
5268614|NCT02339285|Major Depressive Disorder|major depressive disorder
5268615|NCT02339285|MDD|mdd
5268616|NCT02339285|mood symptoms|mood symptoms
5268617|NCT02339285|sham|sham
5268618|NCT02339272|meiosis|meiosis
5268619|NCT02339272|synapsis|synapsis
5268620|NCT02339272|recombination|recombination
5268621|NCT02339272|sperm aneuploidy|sperm aneuploidy
5268622|NCT02339259|Rickettsial disease|rickettsial disease
5268623|NCT02339259|Febrile|febrile
5268624|NCT02339259|Murine typhus|murine typhus
5268625|NCT02339259|Scrub typhus|scrub typhus
5268626|NCT02339259|Diagnostic test|diagnostic test
5268627|NCT02339259|Clinical features|clinical features
5268628|NCT02339233|Epidural Stimulation|epidural stimulation
5265829|NCT02355236|LDQ|ldq
5268629|NCT02339220|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5268630|NCT02339220|Physical Therapy|physical therapy
5268631|NCT02339220|Rehabilitation|rehabilitation
5268632|NCT02339220|Occupational Therapy|occupational therapy
5268633|NCT02339220|Fitness Training|fitness training
5268634|NCT02339220|Recovery of Function|recovery of function
5268635|NCT02339220|Neuroplasticity|neuroplasticity
5268636|NCT02339220|Exercise Therapy|exercise therapy
5268637|NCT02339220|Brain Injuries|brain injuries
5268638|NCT02339220|Traumatic Brain Injury|traumatic brain injury
5268639|NCT02339220|Physical Therapy Modalities|physical therapy modalities
5268640|NCT02339220|Neuroimaging|neuroimaging
5268641|NCT02339194|complete denture|complete denture
5268642|NCT02339194|quality of life|quality of life
5268643|NCT02339194|patient satisfaction|patient satisfaction
5268644|NCT02339155|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
5268645|NCT02339155|Raxibacumab|raxibacumab
5268646|NCT02339155|Immunogenicity|immunogenicity
5268647|NCT02339103|arteriovenous anastomoses|arteriovenous anastomoses
5268648|NCT02339103|accidental hypothermia|accidental hypothermia
5268649|NCT02339103|rewarming|rewarming
5268656|NCT02339090|Versartis|versartis
5268657|NCT02339090|Xten|xten
5268658|NCT02339090|Human Growth Hormone|human growth hormone
5268685|NCT02339025|Biobank|biobank
5268694|NCT02338986|High Titer Antibodies|high titer antibodies
5268695|NCT02338986|Convalescent Volunteers|convalescent volunteers
5268696|NCT02338986|Apheresis|apheresis
5268697|NCT02338986|Males|males
5268698|NCT02338986|Quantitative IgG|quantitative igg
5268699|NCT02338973|Macular Edema|macular edema
5268700|NCT02338973|Rod-Cone Dystrophy|rod-cone dystrophy
5268701|NCT02338973|Inherited Retinal Degeneration|inherited retinal degeneration
5268702|NCT02338973|Enhanced S-Cone Syndrome|enhanced s-cone syndrome
5268703|NCT02338973|Interferon Gamma|interferon gamma
5268704|NCT02338960|HSDD Female|hsdd female
5268705|NCT02338960|Sexual Desire Disorder|sexual desire disorder
5268706|NCT02338960|decreased desire|decreased desire
5268707|NCT02338960|female sexual dysfunction|female sexual dysfunction
5268708|NCT02338947|Frail elderly|frail elderly
5268709|NCT02338947|Coronary artery bypass surgery|coronary artery bypass surgery
5268710|NCT02338947|Off-pump|off-pump
5268711|NCT02338947|On-pump|on-pump
5268712|NCT02338947|Randomized controlled trial|randomized controlled trial
5268713|NCT02338921|triple combination therapy|triple combination therapy
5268714|NCT02338921|sitagliptin|sitagliptin
5268715|NCT02338921|dapagliflozin|dapagliflozin
5268716|NCT02338921|lobeglitazone|lobeglitazone
5268717|NCT02338908|dry needling|dry needling
5268718|NCT02338908|trigger point|trigger point
5268719|NCT02338908|eccentric exercise|eccentric exercise
5268720|NCT02338895|acute kidney injury, oliguria,renal ultrasound|acute kidney injury, oliguria,renal ultrasound
5268721|NCT02338882|Lenses|lenses
5268722|NCT02338882|Intraocular|intraocular
5268723|NCT02338856|Obesity|obesity
5268724|NCT02338830|Twins|twins
5268725|NCT02338830|Preterm labor|preterm labor
5268726|NCT02338830|Progesterone|progesterone
5268727|NCT02338830|Short cervix|short cervix
5268728|NCT02338804|mix vaccine, breast neoplasms, immunotherapy|mix vaccine, breast neoplasms, immunotherapy
5268729|NCT02338778|mix vaccine, liver neoplasms, immunotherapy|mix vaccine, liver neoplasms, immunotherapy
5268730|NCT02338752|mix vaccine, pancreatic neoplasms, immunotherapy|mix vaccine, pancreatic neoplasms, immunotherapy
5268731|NCT02338739|Retention|retention
5268732|NCT02338739|Lost to follow up|lost to follow up
5268733|NCT02338739|Adaptive strategies|adaptive strategies
5268734|NCT02338739|Dynamic regime|dynamic regime
5268735|NCT02338739|Sequentially randomized trial|sequentially randomized trial
5268736|NCT02338739|Sequential multiple assignment randomized trial|sequential multiple assignment randomized trial
5268737|NCT02338739|Engagement in care|engagement in care
5268738|NCT02338739|Kenya|kenya
5268739|NCT02338726|urinary incontinence|urinary incontinence
5268740|NCT02338726|pelvic floor|pelvic floor
5268741|NCT02338726|quality of life|quality of life
5268742|NCT02338726|elderly women|elderly women
5268743|NCT02338713|Drug therapy|drug therapy
5163774|NCT02969200|Fabry Disease|fabry disease
5268744|NCT02338700|mix vaccine, prostate carcinoma, immunotherapy|mix vaccine, prostate carcinoma, immunotherapy
5268745|NCT02338687|Calcium|calcium
5268746|NCT02338687|Dietary supplements|dietary supplements
5269250|NCT02335307|CYP2D6|cyp2d6
5268752|NCT02338687|Hospitalization|hospitalization
5268753|NCT02338687|Maternal mortality|maternal mortality
5268754|NCT02338635|ER stress|er stress
5268755|NCT02338635|Peritoneal Dialysis|peritoneal dialysis
5268756|NCT02338622|olaparib|olaparib
5268758|NCT02338622|intrapatient dose escalation|intrapatient dose escalation
5268759|NCT02338622|advanced solid tumours|advanced solid tumours
5268767|NCT02338557|MRP, MIRROR THERAPY, STROKE|mrp, mirror therapy, stroke
5268768|NCT02338518|gastric cancer|gastric cancer
5268769|NCT02338518|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5268770|NCT02338518|efficacy|efficacy
5268771|NCT02338518|safety|safety
5268772|NCT02338505|Robotic Surgery|robotic surgery
5268773|NCT02338505|Telelap-ALFX|telelap-alfx
5268774|NCT02338505|Gynecological disease|gynecological disease
5268775|NCT02338453|Social Anxiety|social anxiety
5268784|NCT02338323|Chronic kidney disease|chronic kidney disease
5268786|NCT02338323|Benzbromarone|benzbromarone
5268787|NCT02338297|Hepatocellular Carcinoma|hepatocellular carcinoma
5268788|NCT02338297|Arterioportal shunts|arterioportal shunts
5268789|NCT02338297|Transarterial Chemoembolization|transarterial chemoembolization
5268790|NCT02338297|Ethanol|ethanol
5268791|NCT02338297|Gelfoam|gelfoam
5268792|NCT02338297|Polyvinyl Alcohol Foam Embolization Particles (PVA)|polyvinyl alcohol foam embolization particles (pva)
5268793|NCT02338284|increased intracranial pressure|increased intracranial pressure
5268794|NCT02338284|optic nerve sheath diameter|optic nerve sheath diameter
5268795|NCT02338271|Low back pain|low back pain
5268796|NCT02338271|Mesenchymal stromal stem cell|mesenchymal stromal stem cell
5268797|NCT02338271|Hyaluronic acid|hyaluronic acid
5268798|NCT02338219|postpartum pelvic floor|postpartum pelvic floor
5268799|NCT02338206|infertility|infertility
5268800|NCT02338193|GDM|gdm
5268801|NCT02338193|T2DM|t2dm
5268802|NCT02338193|prediabetes|prediabetes
5268803|NCT02338180|dental caries|dental caries
5268804|NCT02338180|risk assessment|risk assessment
5268805|NCT02338180|approximal sealant|approximal sealant
5268806|NCT02338180|permanent molar|permanent molar
5268807|NCT02338180|preventive dentistry|preventive dentistry
5268808|NCT02338180|adolescent|adolescent
5268809|NCT02338154|Aortic Valve Replacement|aortic valve replacement
5268810|NCT02338154|Aortic Stenosis|aortic stenosis
5268811|NCT02338154|EDWARDS INTUITY|edwards intuity
5268812|NCT02338141|cervical cancer|cervical cancer
5268813|NCT02338141|colposcopy|colposcopy
5268814|NCT02338141|human papillomavirus|human papillomavirus
5268815|NCT02338141|human immunodeficiency virus|human immunodeficiency virus
5268816|NCT02338128|peritoneal dialysis|peritoneal dialysis
5268817|NCT02338128|hyperuricemia|hyperuricemia
5268822|NCT02338063|Adolescent Risk Behavior|adolescent risk behavior
5268823|NCT02338063|Emotion Regulation|emotion regulation
5268824|NCT02338063|Health Promotion|health promotion
5268825|NCT02338063|Intervention|intervention
5268826|NCT02338063|Mental Health|mental health
5268827|NCT02338050|ALL|all
5268828|NCT02338050|Moxetumomab Pasudotox|moxetumomab pasudotox
5268829|NCT02338050|Moxe|moxe
5268830|NCT02338050|CAT-8015, HA22|cat-8015, ha22
5268831|NCT02338024|Enrollment in HIV care|enrollment in hiv care
5268832|NCT02338024|Recently detected HIV-positive|recently detected hiv-positive
5268833|NCT02338024|specialized health care clinics|specialized health care clinics
5268834|NCT02338024|Ukraine|ukraine
5268835|NCT02337998|Neurology|neurology
5268836|NCT02337998|Sports Medicine|sports medicine
5268837|NCT02337972|diabetic macular edema|diabetic macular edema
5268838|NCT02337972|Intravitreal injection|intravitreal injection
5268839|NCT02337972|conjunctival flora|conjunctival flora
5268840|NCT02337959|Healthy Volunteers|healthy volunteers
5268841|NCT02337946|Metastatic colorectal cancer, Panitumumab, mFOLFOX6, First-line|metastatic colorectal cancer, panitumumab, mfolfox6, first-line
5268842|NCT02337933|Metabolic Syndrome|metabolic syndrome
5268843|NCT02337933|Central Obesity|central obesity
5268844|NCT02337933|Insulin Sensitivity|insulin sensitivity
5268845|NCT02337933|Ursolic Acid|ursolic acid
5268846|NCT02337933|Triterpenoid|triterpenoid
5268847|NCT02337894|Protein kinetics|protein kinetics
5268848|NCT02337894|liver steatosis|liver steatosis
5268849|NCT02337868|dose-ranging|dose-ranging
5268850|NCT02337868|double blind|double blind
5268851|NCT02337868|female|female
5268852|NCT02337868|healthy|healthy
5268853|NCT02337868|HydroVax|hydrovax
5268854|NCT02337868|male|male
5268855|NCT02337868|Placebo-Controlled|placebo-controlled
5268856|NCT02337868|Vaccine|vaccine
5268857|NCT02337868|West Nile Virus|west nile virus
5268858|NCT02337855|Intestinal|intestinal
5268859|NCT02337855|Pichia pastoris|pichia pastoris
5268860|NCT02337855|S. mansoni|s. mansoni
5268861|NCT02337855|Schistosomiasis|schistosomiasis
5268862|NCT02337855|Sm-TSP-2/Alhydrogel|sm-tsp-2/alhydrogel
5268863|NCT02337855|Sm-TSP-2/Alhydrogel/GLA-AF|sm-tsp-2/alhydrogel/gla-af
5268864|NCT02337855|vaccine|vaccine
5445378|NCT01522105|Therapeutic Use|therapeutic use
5268865|NCT02337842|NoV, CIN-1, GII4. Norovirus, challenge, FUT-2 gene, HBGA-blocking Ab|nov, cin-1, gii4. norovirus, challenge, fut-2 gene, hbga-blocking ab
5268866|NCT02337829|Relapsed/refractory CLL|relapsed/refractory cll
5268868|NCT02337829|Btk|btk
5268869|NCT02337829|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5266013|NCT02354248|EMG|emg
5268870|NCT02337829|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5268872|NCT02337829|Lymphoma|lymphoma
5903754|NCT00339534|African Men|african men
5268873|NCT02337829|Lymphocytic|lymphocytic
5268874|NCT02337829|ACP-196|acp-196
5268875|NCT02337829|acalabrutinib|acalabrutinib
5268876|NCT02337829|Treatment naive CLL with 17p deletion, TP53 mutation or NOTCH1 mutation|treatment naive cll with 17p deletion, tp53 mutation or notch1 mutation
5268877|NCT02337829|17p deletion|17p deletion
5268878|NCT02337829|TP53 mutation|tp53 mutation
5268879|NCT02337829|NOTCH1 mutation|notch1 mutation
5268880|NCT02337816|Endometriosis|endometriosis
5268881|NCT02337816|Metabolomics|metabolomics
5268882|NCT02337803|Physical Activity|physical activity
5268883|NCT02337790|Hypertension|hypertension
5268884|NCT02337790|Heart Failure|heart failure
5268885|NCT02337790|Fluids|fluids
5268886|NCT02337777|Magnetic Resonance Imaging|magnetic resonance imaging
5268887|NCT02337777|Magnetic Resonance Angiography|magnetic resonance angiography
5268888|NCT02337777|Diffusion Tensor Imaging|diffusion tensor imaging
5268889|NCT02337777|IDEAL|ideal
5268890|NCT02337777|T2* mapping|t2* mapping
5268891|NCT02337777|Magnetic ResonanceCine|magnetic resonancecine
5268892|NCT02337777|BOLD|bold
5268893|NCT02337777|phase contrast|phase contrast
5268894|NCT02337777|diffusion-weighted imaging|diffusion-weighted imaging
5268895|NCT02337777|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5268896|NCT02337712|Small cell lung cancer|small cell lung cancer
5268897|NCT02337712|Radiotherapy|radiotherapy
5268898|NCT02337712|Dose fractionation|dose fractionation
5268899|NCT02337673|Postoperative Pulmonary Complication|postoperative pulmonary complication
5268900|NCT02337673|Electrical Impedance Tomography|electrical impedance tomography
5268901|NCT02337673|Splenectomy|splenectomy
5268902|NCT02337673|Gastric surgery|gastric surgery
5268903|NCT02337673|Gastrectomy|gastrectomy
5268904|NCT02337673|Pancreatic surgery|pancreatic surgery
5268905|NCT02337673|Pancreatectomy|pancreatectomy
5268906|NCT02337673|Liver surgery|liver surgery
5268907|NCT02337673|Hemihepatectomy|hemihepatectomy
5268908|NCT02337673|Cholecystectomy|cholecystectomy
5268909|NCT02337673|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5268910|NCT02337673|Hypoxemia|hypoxemia
5268911|NCT02337673|Atelectasis|atelectasis
5268913|NCT02337673|Pneumonia|pneumonia
5268914|NCT02337673|Pneumothorax|pneumothorax
5268915|NCT02337673|Pleural effusion|pleural effusion
5268916|NCT02337673|Pulmonary edema|pulmonary edema
5268917|NCT02337621|sunken chest|sunken chest
5268918|NCT02337621|caved-in chest|caved-in chest
5268919|NCT02337621|chest deformity|chest deformity
5268920|NCT02337621|sunken sternum|sunken sternum
5268921|NCT02337608|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5268922|NCT02337608|GLPG1205|glpg1205
5268923|NCT02337595|CD45RA-depletion|cd45ra-depletion
5268924|NCT02337595|TCR-alpha/beta depletion|tcr-alpha/beta depletion
5268925|NCT02337595|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5268926|NCT02337595|immune reconstitution|immune reconstitution
5268927|NCT02337595|Graft Enhancement, Immunologic|graft enhancement, immunologic
5268928|NCT02337595|Immunocompromized Host|immunocompromized host
5268929|NCT02337491|Recurrent|recurrent
5268930|NCT02337413|Constipation|constipation
5268931|NCT02337374|Urodynamics|urodynamics
5268932|NCT02337374|Midurethral sling|midurethral sling
5268933|NCT02337374|Transobturator tape (TOT)|transobturator tape (tot)
5268934|NCT02337374|Tension free vaginal tape (TVT)|tension free vaginal tape (tvt)
5268935|NCT02337361|risky alcohol use|risky alcohol use
5268936|NCT02337361|pregnancy|pregnancy
5268937|NCT02337348|coronary stents|coronary stents
5268938|NCT02337335|Hemodialyisis|hemodialyisis
5268939|NCT02337335|Predictive Model|predictive model
5268940|NCT02337335|ESAs|esas
5268941|NCT02337335|patients|patients
5268942|NCT02337322|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5268944|NCT02337322|HIV-1|hiv-1
5268945|NCT02337322|Antiretroviral treatment|antiretroviral treatment
5268946|NCT02337322|HIV Advanced Disease|hiv advanced disease
5268948|NCT02337322|Dolutegravir|dolutegravir
5268949|NCT02337322|Darunavir|darunavir
5268950|NCT02337296|Motivational Interviewing|motivational interviewing
5268951|NCT02337296|Cognitive Behavioral Therapy|cognitive behavioral therapy
5268952|NCT02337296|Cancer|cancer
5268953|NCT02337296|Oral Agents|oral agents
5268954|NCT02337296|Adherence|adherence
5268955|NCT02337270|Tuberculosis|tuberculosis
5268956|NCT02337270|Vaccine|vaccine
5268957|NCT02337270|Aerosol|aerosol
5268958|NCT02337270|Adenovirus|adenovirus
5268959|NCT02337270|Immunogenicity|immunogenicity
5268960|NCT02337244|Osteoarthritis|osteoarthritis
5268961|NCT02337244|Rheumatoid arthritis|rheumatoid arthritis
5268962|NCT02337244|Traumatic arthritis|traumatic arthritis
5268963|NCT02337244|Polyarthritis|polyarthritis
5268964|NCT02337244|Total knee arthroplasty|total knee arthroplasty
5268965|NCT02337192|Orthodontic, Photochemoterapy|orthodontic, photochemoterapy
5268966|NCT02337166|alveolar bone loss|alveolar bone loss
5268967|NCT02337166|periodontal attachment loss|periodontal attachment loss
5366875|NCT01871714|HED|hed
5268968|NCT02337153|Orthodontique Bone Stretching|orthodontique bone stretching
5268970|NCT02337140|complete AV-block|complete av-block
5370362|NCT01856114|FBT|fbt
5268971|NCT02337140|HV-interval|hv-interval
5268972|NCT02337140|permanent pacemaker|permanent pacemaker
5268973|NCT02337140|valve implantation|valve implantation
5268974|NCT02337140|severe|severe
5268975|NCT02337140|conduction|conduction
5268976|NCT02337140|disorders|disorders
5268977|NCT02337114|Acceptance and Commitment Therapy|acceptance and commitment therapy
5268978|NCT02337101|Brain concussion|brain concussion
5268979|NCT02337101|Mild Traumatic Brain Injury|mild traumatic brain injury
5268980|NCT02337101|Post-concussion symptoms|post-concussion symptoms
5268981|NCT02337101|Therapy|therapy
5268982|NCT02337101|Randomised controlled trial|randomised controlled trial
5268983|NCT02337101|Cognitive assessment|cognitive assessment
5268984|NCT02337088|delayed cord clamping|delayed cord clamping
5268985|NCT02337075|condition|condition
5268986|NCT02337075|preventing|preventing
5268987|NCT02337075|physical activity|physical activity
5268988|NCT02337049|Preeclampsia. Cardiovascular Disease (CVD) Risk.|preeclampsia. cardiovascular disease (cvd) risk.
5268989|NCT02337036|Liver transplantation|liver transplantation
5268990|NCT02337036|Child|child
5268991|NCT02337036|Tacrolimus|tacrolimus
5268992|NCT02337036|Pharmacokinetic|pharmacokinetic
5268993|NCT02337023|Brain scintigraphy|brain scintigraphy
5268994|NCT02336997|skin regeneration|skin regeneration
5268995|NCT02336997|mechanical stretch|mechanical stretch
5268996|NCT02336984|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
5268997|NCT02336958|cervical plexus|cervical plexus
5268998|NCT02336958|regional anesthesia|regional anesthesia
5268999|NCT02336958|ultrasound|ultrasound
5269000|NCT02336958|carotid surgery|carotid surgery
5269001|NCT02336932|vitamin d|vitamin d
5269002|NCT02336932|free hormone|free hormone
5269003|NCT02336932|surgical stress|surgical stress
5269004|NCT02336919|discharge|discharge
5269005|NCT02336919|mHealth|mhealth
5269006|NCT02336919|telehealth|telehealth
5269007|NCT02336919|text messaging|text messaging
5269008|NCT02336906|Lower urinary tract dysfunction|lower urinary tract dysfunction
5269009|NCT02336906|constipation|constipation
5269010|NCT02336893|Communication Barriers|communication barriers
5269014|NCT02336893|Critical Care|critical care
5269015|NCT02336867|Complex anal fistula, clip,|complex anal fistula, clip,
5269016|NCT02336854|pharmacokinetics|pharmacokinetics
5269017|NCT02336841|Guided Self-Help|guided self-help
5269018|NCT02336841|Peer Mentoring|peer mentoring
5269019|NCT02336841|Anorexia Nervosa|anorexia nervosa
5269020|NCT02336841|Eating Disorders|eating disorders
5269044|NCT02336737|breast cancer|breast cancer
5269045|NCT02336737|sentinel lymph node biopsy|sentinel lymph node biopsy
5269057|NCT02336685|Pain|pain
5269058|NCT02336685|Fulranumab|fulranumab
5269059|NCT02336685|JNJ-42160443|jnj-42160443
5269060|NCT02336685|Adjunctive therapy|adjunctive therapy
5269061|NCT02336685|Opioid|opioid
5269063|NCT02336685|Knee|knee
5269064|NCT02336685|Joint replacement surgery|joint replacement surgery
5269065|NCT02336672|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5269066|NCT02336672|Cryothermoablation|cryothermoablation
5269067|NCT02336633|Huntington disease|huntington disease
5269068|NCT02336633|Neurodegenerative disease|neurodegenerative disease
5269069|NCT02336633|Volumetric MRI|volumetric mri
5269070|NCT02336633|31P MR spectroscopy|31p mr spectroscopy
5269071|NCT02336633|metabolism|metabolism
5269072|NCT02336633|Caudate atrophy|caudate atrophy
5269073|NCT02336620|Severe sepsis, Balanced Salt Solution, Normal Saline|severe sepsis, balanced salt solution, normal saline
5269074|NCT02336581|Acceptance and Commitment Therapy|acceptance and commitment therapy
5269075|NCT02336581|Mindfulness|mindfulness
5269076|NCT02336581|Inpatients|inpatients
5269077|NCT02336581|Psychiatric Hospitalization|psychiatric hospitalization
5269078|NCT02336568|PTSD, Oxytocin|ptsd, oxytocin
5269079|NCT02336542|diagnosis of Tuberculosis|diagnosis of tuberculosis
5269080|NCT02336542|ESAT6|esat6
5903755|NCT00339534|Case-Control Study|case-control study
5269081|NCT02336542|CFP10|cfp10
5269082|NCT02336542|skin test|skin test
5269083|NCT02336542|diagnostic test|diagnostic test
5269084|NCT02336529|postoperative|postoperative
5269085|NCT02336477|non-dystrophic myotonias|non-dystrophic myotonias
5269086|NCT02336477|paramyotonia congenita|paramyotonia congenita
5269087|NCT02336477|myotonia congenita|myotonia congenita
5269088|NCT02336477|Mexiletine|mexiletine
5269089|NCT02336477|Randomized clinical trial|randomized clinical trial
5269099|NCT02336425|Asthma|asthma
5269100|NCT02336412|Medication adherence|medication adherence
5269101|NCT02336399|HBsAg loss, interferon, HBV reaction|hbsag loss, interferon, hbv reaction
5269102|NCT02336386|Bortezomib|bortezomib
5269103|NCT02336373|Hemoglobin SC disease|hemoglobin sc disease
5269104|NCT02336373|hydroxyurea|hydroxyurea
5269105|NCT02336373|quality of life|quality of life
5269106|NCT02336373|viscosity|viscosity
5269107|NCT02336373|red cell density|red cell density
5269108|NCT02336347|Pharmacokinetics|pharmacokinetics
5269109|NCT02336347|Healthy Volunteers|healthy volunteers
5269110|NCT02336347|deuterated dextromethorphan|deuterated dextromethorphan
5269111|NCT02336347|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
5269112|NCT02336282|Adult survivor of acute lymphoblastic leukemia|adult survivor of acute lymphoblastic leukemia
5269113|NCT02336282|Executive dysfunction|executive dysfunction
5269114|NCT02336282|Transcranial direct current stimulation|transcranial direct current stimulation
5269115|NCT02336282|Cancer prevention and control|cancer prevention and control
5269116|NCT02336269|Pharmacogenomics|pharmacogenomics
5269117|NCT02336256|inguinal hernia repair|inguinal hernia repair
5269118|NCT02336256|totally extraperitoneal (TEP)|totally extraperitoneal (tep)
5269119|NCT02336256|single incision laparoscopic surgery (SILS)|single incision laparoscopic surgery (sils)
5269120|NCT02336256|plasma total antioxidant status|plasma total antioxidant status
5269121|NCT02336243|docosahexaenoic acid|docosahexaenoic acid
5269122|NCT02336243|premature birth|premature birth
5269123|NCT02336243|placentation disorders|placentation disorders
5269127|NCT02336191|living donor liver transplantation|living donor liver transplantation
5269128|NCT02336191|graft function|graft function
5269129|NCT02336191|thromboelastometry|thromboelastometry
5269130|NCT02336165|Glioblastoma|glioblastoma
5269131|NCT02336165|Immunotherapy|immunotherapy
5269133|NCT02336165|PD-L1|pd-l1
5269134|NCT02336165|MEDI4736|medi4736
5269135|NCT02336165|Radiation|radiation
5269136|NCT02336165|Radiotherapy|radiotherapy
5269138|NCT02336100|Diagnostic technique and procedure|diagnostic technique and procedure
5269139|NCT02336074|HIV|hiv
5269140|NCT02336074|Vaccine|vaccine
5269141|NCT02336074|Cure|cure
5269142|NCT02336074|Early Intervention|early intervention
5269149|NCT02336009|wrist arthritis|wrist arthritis
5269150|NCT02336009|total wrist arthroplasty|total wrist arthroplasty
5269151|NCT02335970|Pain|pain
5269152|NCT02335970|Range of motion|range of motion
5269153|NCT02335970|Quality of life|quality of life
5269154|NCT02335944|non small cell lung cancer|non small cell lung cancer
5269155|NCT02335944|NSCLC|nsclc
5269156|NCT02335944|EGF816|egf816
5269157|NCT02335944|INC280|inc280
5269158|NCT02335944|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5269159|NCT02335944|c-MET|c-met
5269160|NCT02335918|Opdivo®|opdivo®
5269161|NCT02335866|Platelet rich fibrin|platelet rich fibrin
5269162|NCT02335866|Gingival Recession|gingival recession
5269163|NCT02335853|urinary bladder|urinary bladder
5269164|NCT02335853|nerve growth factor|nerve growth factor
5269165|NCT02335853|overactive bladder|overactive bladder
5269166|NCT02335827|irreversible electroporation|irreversible electroporation
5269167|NCT02335827|renal tumor|renal tumor
5269168|NCT02335801|heart failure|heart failure
5269169|NCT02335801|growth hormone|growth hormone
5269170|NCT02335801|testosterone|testosterone
5269171|NCT02335801|insulin resistance|insulin resistance
5269172|NCT02335801|thyroid hormones|thyroid hormones
5269173|NCT02335801|survival|survival
5269174|NCT02335788|Therapeutic|therapeutic
5269175|NCT02335788|Embolization|embolization
5269176|NCT02335736|infertility|infertility
5269177|NCT02335684|Heart-assist devices|heart-assist devices
5269178|NCT02335684|exercise capacity|exercise capacity
5269179|NCT02335671|Early Stage Breast Cancer|early stage breast cancer
5269180|NCT02335671|Breast Conserving Surgery|breast conserving surgery
5269181|NCT02335671|Breast Cancer Stage I|breast cancer stage i
5269182|NCT02335671|Breast Cancer Stage II|breast cancer stage ii
5269183|NCT02335645|ACL reconstruction|acl reconstruction
5269184|NCT02335645|Running Mechanics|running mechanics
5269185|NCT02335645|Physical Therapy|physical therapy
5269186|NCT02335645|Knee|knee
5269187|NCT02335645|Video Analysis|video analysis
5269188|NCT02335645|Body Weight Supported Treadmill|body weight supported treadmill
5269189|NCT02335632|Hepatitis|hepatitis
5269190|NCT02335632|Probiotics|probiotics
5269191|NCT02335632|Lipopolysaccharides|lipopolysaccharides
5269192|NCT02335632|Cytokines|cytokines
5269193|NCT02335632|Alcoholics|alcoholics
5269194|NCT02335593|Hemodialysis patients|hemodialysis patients
5269195|NCT02335593|Zinc|zinc
5269196|NCT02335593|Anemia|anemia
5269197|NCT02335593|Oxidative stress|oxidative stress
5269198|NCT02335580|Prognosis|prognosis
5269199|NCT02335554|Subthreshold|subthreshold
5269200|NCT02335554|Employees|employees
5269201|NCT02335554|Internet|internet
5269202|NCT02335554|Mobile|mobile
5269203|NCT02335554|cognitive-behavioral|cognitive-behavioral
5269204|NCT02335515|Gastroretentive System|gastroretentive system
5269205|NCT02335515|Gastric Retention Time (GRT)|gastric retention time (grt)
5269206|NCT02335515|capsule|capsule
5269207|NCT02335515|Soctec|soctec
5269208|NCT02335515|Gastroenterology|gastroenterology
5269209|NCT02335476|optical coherence tomography|optical coherence tomography
5269210|NCT02335463|optical coherence tomography|optical coherence tomography
5269211|NCT02335450|exercise|exercise
5269212|NCT02335450|motivational interviewing|motivational interviewing
5269213|NCT02335424|P-D1|p-d1
5269214|NCT02335424|PD-1|pd-1
5269216|NCT02335424|P-DL1|p-dl1
5269217|NCT02335424|PD-L1|pd-l1
5269218|NCT02335424|PDL-1|pdl-1
5269219|NCT02335424|PDL1|pdl1
5269220|NCT02335424|Bladder cancer|bladder cancer
5269227|NCT02335398|methadone|methadone
5269232|NCT02335372|Cervical cancer|cervical cancer
5269233|NCT02335372|Cervical neoplasia|cervical neoplasia
5269234|NCT02335372|Cervical cancer screening|cervical cancer screening
5269235|NCT02335372|Colposcopy|colposcopy
5269236|NCT02335372|Wide-field white light imaging|wide-field white light imaging
5269237|NCT02335372|Wide-field fluorescence imaging|wide-field fluorescence imaging
5269239|NCT02335372|Proflavine solution|proflavine solution
5269240|NCT02335333|Delayed Graft Function|delayed graft function
5269241|NCT02335333|Slow Graft Function|slow graft function
5269242|NCT02335333|Renal Transplant|renal transplant
5269243|NCT02335333|Extended Criteria Donor|extended criteria donor
5269244|NCT02335333|Biomarker of Aging|biomarker of aging
5269245|NCT02335333|Kidney Transplant|kidney transplant
5269246|NCT02335320|VHC|vhc
5269247|NCT02335320|IL28-B|il28-b
5269248|NCT02335320|point of care|point of care
5269252|NCT02335294|abdominoplasty|abdominoplasty
5269253|NCT02335294|PCA|pca
5269254|NCT02335281|Standardized Fecal Microbiota Transplantation|standardized fecal microbiota transplantation
5269255|NCT02335281|Inflammatory Bowel Disease|inflammatory bowel disease
5269256|NCT02335281|Ulcerative Colitis|ulcerative colitis
5269257|NCT02335281|Crohn's Disease|crohn's disease
5269258|NCT02335268|MDS classified as IPSS low/int-1|mds classified as ipss low/int-1
5269259|NCT02335242|Sildenafil|sildenafil
5269260|NCT02335242|Magnetic Resonance Imaging|magnetic resonance imaging
5269261|NCT02335242|Dermatology|dermatology
5269262|NCT02335242|Pediatrics|pediatrics
5269263|NCT02335190|Sacroiliac joint|sacroiliac joint
5269264|NCT02335190|Radiofrequency ablation|radiofrequency ablation
5269265|NCT02335190|Ultrasound|ultrasound
5269266|NCT02335177|Falls|falls
5269267|NCT02335177|Elderly|elderly
5269268|NCT02335177|Physical activities|physical activities
5269269|NCT02335177|Technologies for autonomy|technologies for autonomy
5269270|NCT02335177|Impact of intervention|impact of intervention
5269271|NCT02335177|autonomy|autonomy
5269272|NCT02335177|physical activity program|physical activity program
5269273|NCT02335151|Circulating Tumor Cells|circulating tumor cells
5269274|NCT02335151|Anesthesia and immunity|anesthesia and immunity
5269275|NCT02335151|Cell Search System|cell search system
5269276|NCT02335138|HIV|hiv
5269277|NCT02335138|MSM|msm
5269278|NCT02335138|Couples|couples
5269279|NCT02335138|Home Testing|home testing
5269280|NCT02335138|Sexual Agreements|sexual agreements
5269281|NCT02335112|irreversible electroporation|irreversible electroporation
5269282|NCT02335112|Unresectable Head and Neck Neoplasms|unresectable head and neck neoplasms
5269283|NCT02335099|hemodialysis|hemodialysis
5269284|NCT02335099|vascular access|vascular access
5269285|NCT02335099|vascular access patency|vascular access patency
5269286|NCT02335099|ticagrelor|ticagrelor
5269287|NCT02335099|brilinta|brilinta
5269288|NCT02335073|Prognosis|prognosis
5269289|NCT02335060|cannabis|cannabis
5269290|NCT02335060|Marijuana|marijuana
5269291|NCT02335060|THC|thc
5269292|NCT02335060|N-acetylcysteine|n-acetylcysteine
5269293|NCT02335060|Psychotic Disorders|psychotic disorders
5269294|NCT02335047|reliability|reliability
5269295|NCT02335047|clinical test|clinical test
5269296|NCT02335047|physical therapy|physical therapy
5269297|NCT02335034|Osteoarthritis|osteoarthritis
5269298|NCT02335034|Knee|knee
5269299|NCT02335034|Education|education
5269300|NCT02335034|Quality of life|quality of life
5269301|NCT02335034|Treatment outcome|treatment outcome
5269302|NCT02335034|Musculoskeletal pain|musculoskeletal pain
5269303|NCT02334995|solitery rectal ulcer|solitery rectal ulcer
5370755|NCT01854502|xylitol|xylitol
5269304|NCT02334995|biofeedback|biofeedback
5269305|NCT02334995|dissynergy|dissynergy
5269306|NCT02334982|Drug therapy|drug therapy
5269307|NCT02334969|ischemic stroke；Naoxintong Capsule|ischemic stroke；naoxintong capsule
5269308|NCT02334956|MRI|mri
5269309|NCT02334956|Executive Deficits|executive deficits
5269310|NCT02334943|Immune Activation|immune activation
5269311|NCT02334943|HIV-1 infected subjects|hiv-1 infected subjects
5164278|NCT02965651|meditation|meditation
5269312|NCT02334943|Undetectable viral load|undetectable viral load
5269313|NCT02334943|Causes of Immune Activation in HIV-1 infected patients|causes of immune activation in hiv-1 infected patients
5269314|NCT02334943|Forms of Immune Activation|forms of immune activation
5269315|NCT02334943|Emergent non-AIDS related comorbidities|emergent non-aids related comorbidities
5269316|NCT02334930|propranolol|propranolol
5269317|NCT02334930|betablocker|betablocker
5269318|NCT02334930|angiogenesis|angiogenesis
5269319|NCT02334917|Suture Comparison|suture comparison
5269320|NCT02334891|congestive heart failure|congestive heart failure
5269321|NCT02334891|heart failure, diastolic|heart failure, diastolic
5269322|NCT02334891|heart failure, systolic|heart failure, systolic
5269323|NCT02334891|elderly frail|elderly frail
5266439|NCT02351674|outcome|outcome
5269324|NCT02334891|guideline adherence|guideline adherence
5269326|NCT02334878|Mesenchymal|mesenchymal
5269327|NCT02334826|multivessel coronary artery disease|multivessel coronary artery disease
5269328|NCT02334826|revascularization|revascularization
5269329|NCT02334826|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5269330|NCT02334826|percutaneous coronary intervention|percutaneous coronary intervention
5269331|NCT02334826|coronary artery bypass grafting|coronary artery bypass grafting
5269332|NCT02334800|Palbociclib, PD-0332991, Hepatic Impairment|palbociclib, pd-0332991, hepatic impairment
5269333|NCT02334761|Biopsy|biopsy
5269334|NCT02334748|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
5269335|NCT02334748|systemic inflammatory disorder|systemic inflammatory disorder
5269336|NCT02334748|painful joints|painful joints
5269337|NCT02334748|inflammation of the synovial membrane|inflammation of the synovial membrane
5269338|NCT02334748|auto-immune rheumatoid disease|auto-immune rheumatoid disease
5269339|NCT02334748|reactive rheumatoid arthritis|reactive rheumatoid arthritis
5269340|NCT02334748|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
5269341|NCT02334748|Hereditary Periodic Fevers|hereditary periodic fevers
5269342|NCT02334748|Hereditary periodic fever syndrome(HPFS)|hereditary periodic fever syndrome(hpfs)
5269343|NCT02334748|Familial Mediterranean fever syndrome(FMFS)|familial mediterranean fever syndrome(fmfs)
5269344|NCT02334748|Hyperimmunoglobulinemia D|hyperimmunoglobulinemia d
5269345|NCT02334748|Tumor necrosis factor (TNF) receptor-associated periodic syndrome (TRAPS)|tumor necrosis factor (tnf) receptor-associated periodic syndrome (traps)
5269346|NCT02334748|Muckle-Wells syndrome (MWS)|muckle-wells syndrome (mws)
5269347|NCT02334748|Familial cold auto inflammatory syndrome|familial cold auto inflammatory syndrome
5138616|NCT03124368|fD|fd
5269348|NCT02334735|Melanoma|melanoma
5269349|NCT02334735|Immunotherapy|immunotherapy
5269350|NCT02334735|DC Vaccine|dc vaccine
5269351|NCT02334735|Adjuvant Therapy|adjuvant therapy
5269352|NCT02334735|Immunogenicity|immunogenicity
5269353|NCT02334696|Vascular Access|vascular access
5269354|NCT02334683|Comparison|comparison
5269355|NCT02334683|Botulinum toxin treatments|botulinum toxin treatments
5269356|NCT02334683|Ultrasound|ultrasound
5269357|NCT02334683|Electrophysiologic|electrophysiologic
5269358|NCT02334683|Spasticity|spasticity
5269359|NCT02334683|Focal dystonia|focal dystonia
5269360|NCT02334670|cryptococcal meningitis|cryptococcal meningitis
5269361|NCT02334670|HIV|hiv
5269362|NCT02334670|AIDS|aids
5269363|NCT02334670|Fluconazole|fluconazole
5269364|NCT02334657|non-aneurysmal|non-aneurysmal
5269365|NCT02334644|Treatment|treatment
5269366|NCT02334644|Natural Health Product|natural health product
5269367|NCT02334644|Anxiety|anxiety
5269368|NCT02334592|the effect of tanning|the effect of tanning
5269369|NCT02334592|vitamin D production|vitamin d production
5269370|NCT02334579|Radiation|radiation
5269371|NCT02334579|Stereotactic Radiosurgery|stereotactic radiosurgery
5269372|NCT02334579|Radiotherapy|radiotherapy
5269373|NCT02334579|Prostate Tumor|prostate tumor
5269374|NCT02334579|Prostate Surgery|prostate surgery
5269375|NCT02334579|CyberKnife|cyberknife
5269376|NCT02334566|PTSD|ptsd
5269377|NCT02334566|Refugee children mental health|refugee children mental health
5269378|NCT02334566|community health care|community health care
5269379|NCT02334553|COPD|copd
5269380|NCT02334553|Chronic bronchitis|chronic bronchitis
5269381|NCT02334553|Cystic fibrosis|cystic fibrosis
5269382|NCT02334553|Bronchoconstriction|bronchoconstriction
5269383|NCT02334553|Perfluorocarbons|perfluorocarbons
5269384|NCT02334553|Carbon dioxide|carbon dioxide
5269385|NCT02334527|metastatic urothelial carcinoma (UC)|metastatic urothelial carcinoma (uc)
5269386|NCT02334527|LCCC 1406|lccc 1406
5269387|NCT02334527|Lineberger|lineberger
5269388|NCT02334527|palbociclib|palbociclib
5269389|NCT02334514|Influenza|influenza
5269390|NCT02334514|Viral shedding|viral shedding
5269391|NCT02334514|oseltamivir|oseltamivir
5903756|NCT00339534|Prostate Cancer|prostate cancer
5903757|NCT00339534|Cancer|cancer
5269392|NCT02334514|Polymerase Chain Reaction|polymerase chain reaction
5269393|NCT02334501|Healthy Volunteers|healthy volunteers
5269395|NCT02334462|Antibody|antibody
5269396|NCT02334462|Reactogenicity|reactogenicity
5269397|NCT02334462|Mosquito|mosquito
5269398|NCT02334462|Responses|responses
5269399|NCT02334449|healthy volunteers|healthy volunteers
5269400|NCT02334410|fractures|fractures
5269401|NCT02334410|immobilisation|immobilisation
5269402|NCT02334410|paraplegia|paraplegia
5269403|NCT02334410|tetraplegia|tetraplegia
5269404|NCT02334397|Prenatal Exercise|prenatal exercise
5269405|NCT02334397|Prenatal Education|prenatal education
5269406|NCT02334397|Pregnancy|pregnancy
5269407|NCT02334397|Exercise and Birth Outcomes|exercise and birth outcomes
5269408|NCT02334397|Education and Birth Outcomes|education and birth outcomes
5269409|NCT02334397|Maternal Quality of Life|maternal quality of life
5269410|NCT02334397|Birth Satisfaction|birth satisfaction
5269411|NCT02334371|Magnetic Resonance Imaging|magnetic resonance imaging
5269412|NCT02334371|Positron-Emission Tomography|positron-emission tomography
5269413|NCT02334332|Caregiver|caregiver
5269414|NCT02334293|Omegaven|omegaven
5269415|NCT02334293|parenteral nutrition|parenteral nutrition
5269416|NCT02334293|liver disease|liver disease
5269417|NCT02334293|liver injury|liver injury
5269418|NCT02334280|Community mental health|community mental health
5269419|NCT02334280|Health coach|health coach
5269420|NCT02334280|Weight loss|weight loss
5269421|NCT02334280|Fitness|fitness
5269422|NCT02334280|Serious mental illness|serious mental illness
5269423|NCT02334280|Health promotion|health promotion
5269424|NCT02334254|safety|safety
5269425|NCT02334254|rivaroxaban|rivaroxaban
5269426|NCT02334254|ticagrel|ticagrel
5269427|NCT02334254|triple antithrombotic regimen|triple antithrombotic regimen
5269428|NCT02334254|undergoing PCI|undergoing pci
5269429|NCT02334241|Sorbact|sorbact
5269430|NCT02334241|Best local Cares|best local cares
5269431|NCT02334241|DFU|dfu
5269432|NCT02334202|Adolescent|adolescent
5269433|NCT02334202|Obesity/Psychology|obesity/psychology
5269434|NCT02334202|Loss of Control Eating|loss of control eating
5269435|NCT02334202|Child|child
5269436|NCT02334202|Female|female
5269437|NCT02334202|Follow-Up Studies|follow-up studies
5269438|NCT02334202|Health Behavior|health behavior
5269439|NCT02334202|Health Education|health education
5269440|NCT02334202|Humans|humans
5269441|NCT02334202|Intervention Studies|intervention studies
5269442|NCT02334202|Prospective Studies|prospective studies
5269443|NCT02334202|Psychotherapy|psychotherapy
5269444|NCT02334202|Risk Factors|risk factors
5269445|NCT02334202|Weight Loss|weight loss
5269446|NCT02334202|Weight Gain|weight gain
5269447|NCT02334202|Military|military
5269448|NCT02334163|Hepatic Encephalopathy|hepatic encephalopathy
5256831|NCT02407704|Reward system|reward system
5256832|NCT02407704|BDNF|bdnf
5256833|NCT02407704|Sleep|sleep
5256879|NCT02407379|PMN|pmn
5269449|NCT02334163|Nitazoxanide|nitazoxanide
5269450|NCT02334163|Serum ammonia|serum ammonia
5269451|NCT02334150|combined spinal-epidural analgesia|combined spinal-epidural analgesia
5269452|NCT02334150|pelvic floor muscle|pelvic floor muscle
5269453|NCT02334150|postpartum electrophysiological function|postpartum electrophysiological function
5269454|NCT02334111|Parenting Support for Mothers in Recovery|parenting support for mothers in recovery
5269455|NCT02334111|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5269456|NCT02334111|Social Determinants of Health|social determinants of health
5269457|NCT02334111|Child Development|child development
5269458|NCT02334111|Child Abuse|child abuse
5269459|NCT02334111|Child Neglect|child neglect
5269460|NCT02334111|Primary Care|primary care
5269461|NCT02334098|Aggression|aggression
5269462|NCT02334098|Omega-3 supplementation|omega-3 supplementation
5269463|NCT02334098|Neurocognition|neurocognition
5269464|NCT02334098|Attention|attention
5269465|NCT02334098|Antisocial|antisocial
5269466|NCT02334059|opioid sparing|opioid sparing
5269467|NCT02334059|ketamine|ketamine
5269468|NCT02334059|obese|obese
5269469|NCT02334059|magnesium|magnesium
5269470|NCT02334046|tracheal extubation|tracheal extubation
5269471|NCT02334046|remifentanil|remifentanil
5269472|NCT02334033|hypertension|hypertension
5269473|NCT02334033|blood pressure|blood pressure
5269474|NCT02334033|cystatin C|cystatin c
5269475|NCT02334033|real-life|real-life
5269476|NCT02334033|kidney|kidney
5269477|NCT02334020|Mental illness|mental illness
5269478|NCT02334020|training|training
5269479|NCT02334020|support|support
5269480|NCT02334020|Mental Health|mental health
5269481|NCT02334007|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5269482|NCT02334007|deep vein thrombosis|deep vein thrombosis
5269483|NCT02334007|pulmonary embolism|pulmonary embolism
5269484|NCT02334007|lung resection|lung resection
5269485|NCT02334007|low molecular weight heparin|low molecular weight heparin
5269486|NCT02333968|Cancer pain|cancer pain
5269487|NCT02333968|Self-management|self-management
5269488|NCT02333968|Randomized controlled trial|randomized controlled trial
5269489|NCT02333942|Aging|aging
5269490|NCT02333942|Diagnostic Equipment|diagnostic equipment
5269491|NCT02333929|rivaroxaban|rivaroxaban
5269492|NCT02333929|NOAC|noac
5269493|NCT02333929|anti-Xa activity|anti-xa activity
5269494|NCT02333929|method comparison|method comparison
5269495|NCT02333929|LCMS|lcms
5269496|NCT02333903|Obesity|obesity
5269497|NCT02333903|Sleeve gastrectomy|sleeve gastrectomy
5269498|NCT02333903|Personalized physical activity program|personalized physical activity program
5269499|NCT02333903|Body Composition|body composition
5269500|NCT02333903|Fat mass|fat mass
5269501|NCT02333903|Lean mass|lean mass
5269502|NCT02333890|breast|breast
5269503|NCT02333851|Type 2 diabetes mellitus treatment|type 2 diabetes mellitus treatment
5269504|NCT02333851|Hospitalized patients|hospitalized patients
5269505|NCT02333838|Cord Cell Transplantation|cord cell transplantation
5269506|NCT02333838|High risk myeloid malignancies|high risk myeloid malignancies
5269507|NCT02333799|Tuberculosis|tuberculosis
5269508|NCT02333799|MDR-TB|mdr-tb
5269509|NCT02333799|XDR-TB|xdr-tb
5269510|NCT02333799|Multi-drug resistant|multi-drug resistant
5269511|NCT02333799|Extensively drug resistant|extensively drug resistant
5269512|NCT02333799|Bedaquiline|bedaquiline
5269513|NCT02333799|PA-824|pa-824
5269514|NCT02333799|Linezolid|linezolid
5269516|NCT02333799|Pretomanid|pretomanid
5269519|NCT02333773|irreversible electroporation|irreversible electroporation
5269520|NCT02333773|Portal venous tumor emboli|portal venous tumor emboli
5269521|NCT02333734|Type 2 diabetes|type 2 diabetes
5269522|NCT02333734|Interval training|interval training
5269523|NCT02333734|Insulin resistance|insulin resistance
5269524|NCT02333734|fat metabolism|fat metabolism
5269525|NCT02333721|Stomach Neoplasms|stomach neoplasms
5269526|NCT02333721|Laparoscopy|laparoscopy
5269527|NCT02333695|SCI, Spinal Cord Injury, Stroke|sci, spinal cord injury, stroke
5269528|NCT02333669|Lung fluid absorption disorders|lung fluid absorption disorders
5269529|NCT02333669|Neonatal respiratory distress syndrome|neonatal respiratory distress syndrome
5269530|NCT02333669|Single nucleotide polymorphism|single nucleotide polymorphism
5269532|NCT02333630|asthma|asthma
5269533|NCT02333617|Manual Therapy|manual therapy
5269534|NCT02333617|Physical Therapy|physical therapy
5269535|NCT02333617|Dry Needling|dry needling
5269536|NCT02333617|Gluteus Medius|gluteus medius
5269537|NCT02333604|cancer|cancer
5269538|NCT02333604|cancer survivorship|cancer survivorship
5269539|NCT02333604|psychosocial needs|psychosocial needs
5269540|NCT02333604|cancer experience|cancer experience
5269541|NCT02333604|metastatic breast cancer|metastatic breast cancer
5269542|NCT02333604|multiple myeloma|multiple myeloma
5269543|NCT02333604|chronic myeloid leukemia|chronic myeloid leukemia
5269544|NCT02333604|breast cancer|breast cancer
5269545|NCT02333604|Prostate|prostate
5269546|NCT02333604|Colon|colon
5269547|NCT02333604|Kidney|kidney
5269548|NCT02333604|Lung|lung
5150452|NCT03051854|Abuse|abuse
5269549|NCT02333604|Melanoma|melanoma
5269550|NCT02333604|Caregiver|caregiver
5269551|NCT02333604|gastric cancer|gastric cancer
5269552|NCT02333604|stomach cancer|stomach cancer
5269553|NCT02333604|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5269554|NCT02333552|Frailty|frailty
5269555|NCT02333552|Pre-frailty|pre-frailty
5269556|NCT02333552|Fit|fit
5269557|NCT02333552|Robust|robust
5269558|NCT02333552|Elderly|elderly
5269559|NCT02333552|Sociodemography status|sociodemography status
5269560|NCT02333552|Functional status|functional status
5269561|NCT02333552|Cognitive status|cognitive status
5269562|NCT02333552|Nutrition status|nutrition status
5269563|NCT02333552|Comorbidity|comorbidity
5269564|NCT02333552|Mortality|mortality
5269565|NCT02333552|Depression status|depression status
5269566|NCT02333526|ulcerative colitis|ulcerative colitis
5269567|NCT02333526|Clostidium difficile-associated colitis|clostidium difficile-associated colitis
5269568|NCT02333526|Syndecan-1|syndecan-1
5269569|NCT02333526|biomarker|biomarker
5269570|NCT02333474|mix vaccine, lung neoplasms, immunotherapy|mix vaccine, lung neoplasms, immunotherapy
5269571|NCT02333435|Prostatectomy|prostatectomy
5269572|NCT02333435|Omega-3 fatty acids|omega-3 fatty acids
5269573|NCT02333435|Quality of life|quality of life
5269574|NCT02333435|inflammation|inflammation
5269575|NCT02333435|cellular proliferation|cellular proliferation
5269576|NCT02333422|NIRS Neurofeedback|nirs neurofeedback
5269577|NCT02333422|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5269578|NCT02333422|Near Infrared Spectroscopy|near infrared spectroscopy
5269579|NCT02333422|ADHD|adhd
5269580|NCT02333409|Cancer of pancreas|cancer of pancreas
5269581|NCT02333409|Acupuncture|acupuncture
5269582|NCT02333409|Pain|pain
5269583|NCT02333396|Navigator|navigator
5269584|NCT02333396|Intervention Study|intervention study
5269585|NCT02333396|Randomized Controlled Trial|randomized controlled trial
5269586|NCT02333396|Pediatric Intensive Care Unit|pediatric intensive care unit
5269587|NCT02333396|Decision Making|decision making
5269588|NCT02333383|Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score|bath ankylosing spondylitis disease activity index (basdai) score
5269589|NCT02333383|EAMs|eams
5269590|NCT02333383|Adalimumab|adalimumab
5269591|NCT02333370|Advanced breast cancer|advanced breast cancer
5269592|NCT02333370|Hormone receptor positive|hormone receptor positive
5269593|NCT02333370|HER2-negative|her2-negative
5269594|NCT02333370|LEE011,|lee011,
5269595|NCT02333370|Letrozole|letrozole
5269596|NCT02333370|Tamoxifen|tamoxifen
5269597|NCT02333370|Fulvestrant|fulvestrant
5269598|NCT02333370|Postmenopausal Asian women|postmenopausal asian women
5269599|NCT02333370|Pre and Postmenopausal Japanese women|pre and postmenopausal japanese women
5269600|NCT02333344|prosthetic fixation|prosthetic fixation
5269601|NCT02333331|Sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed|sarcopenia, muscle wasting, elderly, strength, physical function, muscle, gait speed
5269602|NCT02333305|Ataxia with Oculomotor Apraxia type 1|ataxia with oculomotor apraxia type 1
5269603|NCT02333305|CoQ10|coq10
5269604|NCT02333305|hypoalbuminemia|hypoalbuminemia
5269605|NCT02333266|Candida bloodstream infection|candida bloodstream infection
5269606|NCT02333266|Detection fungal cells|detection fungal cells
5269607|NCT02333266|Fiber-Optic Surface Plasmon Resonance (FO-SPR)|fiber-optic surface plasmon resonance (fo-spr)
5269608|NCT02333253|poor responders|poor responders
5269609|NCT02333253|GnRH antagonist|gnrh antagonist
5269610|NCT02333253|Conventional protocol|conventional protocol
5269611|NCT02333240|Pregnancy|pregnancy
5269612|NCT02333240|Postnatal Care|postnatal care
5269613|NCT02333240|Blood Pressure Monitoring, Home|blood pressure monitoring, home
5269614|NCT02333240|Self Care|self care
5269615|NCT02333240|Pregnancy Complications, Cardiovascular|pregnancy complications, cardiovascular
5269616|NCT02333240|Qualitative Research|qualitative research
5269617|NCT02333240|Antihypertensive Agents|antihypertensive agents
5269618|NCT02333214|Virtual Reality Therapy|virtual reality therapy
5269619|NCT02333214|Video Game|video game
5269620|NCT02333214|Physical Exercise|physical exercise
5269621|NCT02333214|Aged|aged
5269622|NCT02333214|Frailty|frailty
5269623|NCT02333201|Deglutition Disorders|deglutition disorders
5269624|NCT02333201|Dysphagia|dysphagia
5269625|NCT02333201|Mechanical Ventilation|mechanical ventilation
5269626|NCT02333201|Sepsis|sepsis
5269627|NCT02333175|Parkinson's disease, Late stage|parkinson's disease, late stage
5269628|NCT02333149|Melatonin|melatonin
5269629|NCT02333071|HSDD|hsdd
5269644|NCT02332993|Type II Diabetic|type ii diabetic
5269645|NCT02332954|Depression|depression
5269646|NCT02332954|Major Depressive Disorder|major depressive disorder
5269647|NCT02332954|Cognition|cognition
5269648|NCT02332954|Cognitive symptoms|cognitive symptoms
5269649|NCT02332954|vortioxetine|vortioxetine
5269650|NCT02332954|real life|real life
5269651|NCT02332954|naturalistic|naturalistic
5269652|NCT02332915|apraxia|apraxia
5269653|NCT02332915|aphasia|aphasia
5269654|NCT02332915|rehabilitation|rehabilitation
5269655|NCT02332915|efficacy|efficacy
5269656|NCT02332915|intensity|intensity
5150545|NCT03051256|Antidepressant|antidepressant
5269657|NCT02332902|Neurofibroma|neurofibroma
5269658|NCT02332902|NF-1|nf-1
5269659|NCT02332902|Everolimus|everolimus
5269660|NCT02332902|mTOR inhibitor|mtor inhibitor
5269661|NCT02332863|Pancreatic cancer|pancreatic cancer
5269662|NCT02332863|Image guided radiation therapy|image guided radiation therapy
5269663|NCT02332863|Fiducial marker placement|fiducial marker placement
5269664|NCT02332863|Endoscopic ultrasound|endoscopic ultrasound
5269665|NCT02332850|Relapsed|relapsed
5269666|NCT02332850|Refractory|refractory
5269667|NCT02332837|informed consent, public led trials, shared decision making,|informed consent, public led trials, shared decision making,
5269668|NCT02332824|Pharmacological therapy|pharmacological therapy
5269669|NCT02332798|Multiple ascending doses|multiple ascending doses
5269670|NCT02332798|safety|safety
5269671|NCT02332798|tolerability|tolerability
5269672|NCT02332798|pharmacokinetics|pharmacokinetics
5269673|NCT02332798|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
5269674|NCT02332785|Colon Serrated Polyps|colon serrated polyps
5269675|NCT02332785|Serrated polyp|serrated polyp
5269676|NCT02332785|Hyperplastic polyps above sigmoid colon|hyperplastic polyps above sigmoid colon
5269677|NCT02332785|Sessile serrated adenoma|sessile serrated adenoma
5269678|NCT02332785|Traditional serrated adenoma|traditional serrated adenoma
5269679|NCT02332785|Colonoscopy|colonoscopy
5269680|NCT02332785|Endoscopy|endoscopy
5269681|NCT02332785|Data collection|data collection
5269682|NCT02332785|Data review|data review
5269683|NCT02332772|Colon Polyps|colon polyps
5269684|NCT02332772|Large polyps|large polyps
5269685|NCT02332772|Flat lesions|flat lesions
5269686|NCT02332772|Endoscopy|endoscopy
5269687|NCT02332772|Colonoscopic resection|colonoscopic resection
5269688|NCT02332772|Colonoscopy|colonoscopy
5269689|NCT02332772|Data review|data review
5269690|NCT02332772|Data collection|data collection
5269692|NCT02332668|PD-1|pd-1
5269693|NCT02332668|PDL1|pdl1
5269694|NCT02332668|PD-L1|pd-l1
5269695|NCT02332668|cHL|chl
5269696|NCT02332668|MSI-H|msi-h
5269697|NCT02332655|Sturge-Weber syndrome|sturge-weber syndrome
5269698|NCT02332655|SWS|sws
5269699|NCT02332655|Drug resistant epilepsy|drug resistant epilepsy
5269700|NCT02332629|Glucocorticoid|glucocorticoid
5269701|NCT02332629|Endothelial barrier|endothelial barrier
5269702|NCT02332629|Glycocalyx|glycocalyx
5269703|NCT02332629|Knee arthroplasty, total|knee arthroplasty, total
5269704|NCT02332616|Glucocorticoid|glucocorticoid
5269705|NCT02332616|Complement activation|complement activation
5269706|NCT02332616|Knee arthroplasty, total|knee arthroplasty, total
5269707|NCT02332603|Glucocorticoid|glucocorticoid
5269708|NCT02332603|Glucose homeostasis|glucose homeostasis
5269709|NCT02332603|Knee arthroplasty, total|knee arthroplasty, total
5269710|NCT02332603|Hip arthroplasty, total|hip arthroplasty, total
5269711|NCT02332564|Circulation, Collateral|circulation, collateral
5269712|NCT02332564|Coronary Artery Disease|coronary artery disease
5269713|NCT02332564|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
5269714|NCT02332564|Ischemia|ischemia
5269715|NCT02332538|LASER|laser
5269716|NCT02332538|PROSTATE|prostate
5269717|NCT02332538|BIPOLAR|bipolar
5269718|NCT02332538|HYPERPLASIA|hyperplasia
5269721|NCT02332525|Cognitive Function|cognitive function
5269722|NCT02332525|Mild Cognitive Impairment|mild cognitive impairment
5269723|NCT02332525|cognitive normal elderly|cognitive normal elderly
5269724|NCT02332512|Non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
5269725|NCT02332512|Wild-type EGFR|wild-type egfr
5269726|NCT02332512|3rd/4th line treatment|3rd/4th line treatment
5269728|NCT02332499|Anlotinib|anlotinib
5269729|NCT02332499|Metastatic Colorectal Cancer （mCRC）|metastatic colorectal cancer （mcrc）
5269730|NCT02332499|ALTER0703|alter0703
5269731|NCT02332447|Tonic-clonic seizures|tonic-clonic seizures
5269732|NCT02332447|Naloxone|naloxone
5269733|NCT02332447|SUDEP|sudep
5269734|NCT02332421|canine retraction|canine retraction
5269735|NCT02332421|acceleration of tooth movement|acceleration of tooth movement
5269736|NCT02332421|dentoalveolar distraction osteogenesis|dentoalveolar distraction osteogenesis
5269737|NCT02332408|vertebral hemangioma|vertebral hemangioma
5269738|NCT02332408|conventional radiotherapy|conventional radiotherapy
5269739|NCT02332408|Cyber Knife radiotherapy|cyber knife radiotherapy
5269740|NCT02332408|randomized trial|randomized trial
5269741|NCT02332408|radioablation|radioablation
5269743|NCT02332395|pain catastrophizing|pain catastrophizing
5269744|NCT02332395|cesarean section|cesarean section
5269745|NCT02332369|Cataract|cataract
5269746|NCT02332356|Crohn Disease|crohn disease
5269747|NCT02332356|Inflammatory Bowel Diseases|inflammatory bowel diseases
5269748|NCT02332356|Disease Attributes|disease attributes
5269749|NCT02332343|Retina|retina
5269750|NCT02332343|Retinal pigment epithelium|retinal pigment epithelium
5269751|NCT02332317|Advanced cancer|advanced cancer
5269752|NCT02332317|Early integration|early integration
5269753|NCT02332317|Palliative rehabilitation|palliative rehabilitation
5269754|NCT02332304|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
5269755|NCT02332291|Depression|depression
5269756|NCT02332291|Geriatrics|geriatrics
5269757|NCT02332291|Elderly|elderly
5269759|NCT02332291|Antidepressants|antidepressants
5269760|NCT02332278|Cesarean section|cesarean section
5269761|NCT02332278|Early feeding|early feeding
5269762|NCT02332265|Food Security|food security
5269763|NCT02332265|Microfinance|microfinance
5269764|NCT02332265|Village Savings and Loans|village savings and loans
5269765|NCT02332265|HIV|hiv
5269766|NCT02332265|Quasi-experimental design|quasi-experimental design
5269767|NCT02332265|Malawi|malawi
5269768|NCT02332265|Structural intervention|structural intervention
5269769|NCT02332252|Surgical Wound Infection|surgical wound infection
5269770|NCT02332252|Electrocautery|electrocautery
5269771|NCT02332252|Scalpel|scalpel
5269772|NCT02332239|depression|depression
5269773|NCT02332239|violence|violence
5269774|NCT02332239|emergency department|emergency department
5269775|NCT02332239|mhealth|mhealth
5269776|NCT02332239|text message|text message
5269777|NCT02332213|Volatile organic compounds|volatile organic compounds
5269778|NCT02332213|Nanosensor technology|nanosensor technology
5269779|NCT02332213|GC-MS|gc-ms
5269780|NCT02332213|Breath-testing|breath-testing
5269781|NCT02332213|Digestive cancer|digestive cancer
5269782|NCT02332213|Precancerous lesions|precancerous lesions
5269783|NCT02332213|Colorectal cancer|colorectal cancer
5269784|NCT02332213|Adenoma|adenoma
5269785|NCT02332213|Gastric cancer|gastric cancer
5269786|NCT02332213|Atrophic gastritis|atrophic gastritis
5269787|NCT02332213|OLGIM|olgim
5269788|NCT02332200|Spondylolysis|spondylolysis
5269789|NCT02332200|Spondylolisthesis|spondylolisthesis
5269790|NCT02332200|Low Back Pain|low back pain
5269791|NCT02332174|pharmacokinetics|pharmacokinetics
5269792|NCT02332174|food effect|food effect
5269793|NCT02332174|sex effect|sex effect
5269794|NCT02332174|tolerability|tolerability
5269795|NCT02332135|microwave ablation|microwave ablation
5269796|NCT02332135|maintenance hemodialysis|maintenance hemodialysis
5269797|NCT02332135|mild-to-moderate Secondary Hyperparathyroidism|mild-to-moderate secondary hyperparathyroidism
5269798|NCT02332122|COPD|copd
5269799|NCT02332122|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5269800|NCT02332122|Aspergillus fumigatus|aspergillus fumigatus
5269801|NCT02332122|Bronchiectasis|bronchiectasis
5269802|NCT02332122|Sensitization|sensitization
5269803|NCT02332122|Vitamin D|vitamin d
5269804|NCT02332109|Fuchs endothelial dystrophy|fuchs endothelial dystrophy
5269805|NCT02332109|oedema|oedema
5269806|NCT02332109|sodium chloride|sodium chloride
5269807|NCT02332109|hyaluronan|hyaluronan
5269808|NCT02332109|sodium hyaluronate|sodium hyaluronate
5269809|NCT02332070|acute kidney injury|acute kidney injury
5269810|NCT02332070|coronary angiography|coronary angiography
5269811|NCT02332070|cardiac surgery|cardiac surgery
5269812|NCT02332070|adverse events|adverse events
5269813|NCT02332070|iodinated contrast|iodinated contrast
5269814|NCT02332070|Thoracic Surgery|thoracic surgery
5274717|NCT02304978|TF|tf
5269817|NCT02331992|Continuous Positive Airway Pressure|continuous positive airway pressure
5269819|NCT02331966|GROWTH FACTORS RECEPTORS|growth factors receptors
5269821|NCT02331953|spine surgery|spine surgery
5269822|NCT02331953|cerebral oximetry|cerebral oximetry
5269823|NCT02331953|postoperative delirium|postoperative delirium
5269824|NCT02331940|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5269825|NCT02331940|sleeping oxygen saturation|sleeping oxygen saturation
5269826|NCT02331940|sleep quality|sleep quality
5269827|NCT02331927|colorectal cancer|colorectal cancer
5269830|NCT02331927|aflibercept|aflibercept
5269831|NCT02331927|cytokines|cytokines
5269832|NCT02331927|angiogenic factors|angiogenic factors
5269833|NCT02331927|CAF|caf
5269834|NCT02331914|GIST|gist
5269835|NCT02331914|Bio-databank|bio-databank
5269836|NCT02331862|urinary tract infection|urinary tract infection
5269837|NCT02331862|methylprednisolone|methylprednisolone
5269838|NCT02331849|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
5269839|NCT02331849|GERD|gerd
5269840|NCT02331849|esophageal motility|esophageal motility
5269841|NCT02331836|adenoma detection rate|adenoma detection rate
5270340|NCT02328677|colon|colon
5269842|NCT02331836|polyp detection rate|polyp detection rate
5269843|NCT02331836|withdrawal time|withdrawal time
5269844|NCT02331836|coecal and ileum intubation rate|coecal and ileum intubation rate
5269845|NCT02331797|endoscope|endoscope
5269846|NCT02331797|microscope|microscope
5269847|NCT02331797|transcanal|transcanal
5269848|NCT02331719|intracerebral hemorrhage|intracerebral hemorrhage
5269849|NCT02331719|subcortical intracerebral hemorrhage|subcortical intracerebral hemorrhage
5269851|NCT02331719|parafascicular minimally invasive subcortical access|parafascicular minimally invasive subcortical access
5269852|NCT02331693|EGFR|egfr
5269853|NCT02331693|CAR T cells|car t cells
5269854|NCT02331693|glioma|glioma
5269855|NCT02331680|Undergoing Hemodialysis|undergoing hemodialysis
5269856|NCT02331680|Undergoing Hemodiafiltration|undergoing hemodiafiltration
5269857|NCT02331667|Diet|diet
5269858|NCT02331667|Vitamin-D|vitamin-d
5269859|NCT02331667|Meat|meat
5269860|NCT02331667|Fatty fish|fatty fish
5269861|NCT02331667|Iodine|iodine
5269862|NCT02331667|fatty acid|fatty acid
5269863|NCT02331667|Intervention study|intervention study
5269864|NCT02331667|Wechsler Preschool and Primary Scale of Intelligence|wechsler preschool and primary scale of intelligence
5269865|NCT02331667|Strengths and Difficulties Questionnaire|strengths and difficulties questionnaire
5269866|NCT02331667|Nine hole peg test|nine hole peg test
5269867|NCT02331654|Chronic pain|chronic pain
5269868|NCT02331654|Direct Current Stimulation|direct current stimulation
5269869|NCT02331641|hepatectomy|hepatectomy
5269870|NCT02331641|hepatic resection|hepatic resection
5269871|NCT02331628|TBI Traumatic Brain Injury|tbi traumatic brain injury
5269872|NCT02331628|HO Heterotopic Ossification|ho heterotopic ossification
5269873|NCT02331628|NHO Neurogenic Heterotopic Ossification|nho neurogenic heterotopic ossification
5269874|NCT02331628|ESWT Extracorporeal Shock Wave Therapy|eswt extracorporeal shock wave therapy
5269875|NCT02331615|Traumatic Brain Injury|traumatic brain injury
5269876|NCT02331615|Executive function difficulties|executive function difficulties
5269877|NCT02331615|Transcranial direct current stimulation|transcranial direct current stimulation
5269878|NCT02331602|atrial fibrillation|atrial fibrillation
5269879|NCT02331602|anticoagulation|anticoagulation
5269880|NCT02331602|inflammation|inflammation
5269881|NCT02331589|Fatigue|fatigue
5269882|NCT02331589|Panax ginseng|panax ginseng
5269883|NCT02331589|Chronic hepatitis|chronic hepatitis
5269884|NCT02331589|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5269885|NCT02331589|Adiponectin|adiponectin
5269886|NCT02331563|dexmedetomidine|dexmedetomidine
5269887|NCT02331550|Low-Grade Squamous Intraepithelial Lesions|low-grade squamous intraepithelial lesions
5269888|NCT02331524|exercise|exercise
5269889|NCT02331524|daily activity|daily activity
5269890|NCT02331485|Prevention of wound infection and wound complication|prevention of wound infection and wound complication
5269891|NCT02331472|interstitial cystitis|interstitial cystitis
5269892|NCT02331472|biomarker|biomarker
5269893|NCT02331459|mood|mood
5269894|NCT02331459|cognitive state|cognitive state
5269895|NCT02331459|physical activity|physical activity
5269896|NCT02331459|frailty|frailty
5269897|NCT02331394|Chinese herbs|chinese herbs
5269898|NCT02331394|lung cancer|lung cancer
5269899|NCT02331394|quality of life|quality of life
5269900|NCT02331368|Multiple Myeloma|multiple myeloma
5269901|NCT02331368|Anti-PD-1|anti-pd-1
5269902|NCT02331368|Pembrolizumab|pembrolizumab
5269903|NCT02331368|Post-transplant|post-transplant
5269904|NCT02331368|Maintenance|maintenance
5269908|NCT02331329|precision of NICOM|precision of nicom
5269909|NCT02331316|obesity|obesity
5269910|NCT02331316|diet|diet
5269911|NCT02331316|weight|weight
5269912|NCT02331316|hunger|hunger
5269913|NCT02331316|public led trial|public led trial
5269914|NCT02331264|Cardiac Toxicity|cardiac toxicity
5269915|NCT02331264|Metal on Metal Hip Implants|metal on metal hip implants
5269916|NCT02331186|Obesity|obesity
5269917|NCT02331186|Bariatric surgery|bariatric surgery
5269918|NCT02331186|Urinary incontinence|urinary incontinence
5269919|NCT02331186|Pelvic floor|pelvic floor
5269920|NCT02331173|XLRS|xlrs
5269922|NCT02331173|maculoschisis|maculoschisis
5269923|NCT02331160|Pregnancy|pregnancy
5269924|NCT02331160|Breech Presentation|breech presentation
5269925|NCT02331160|Version, fetal|version, fetal
5269926|NCT02331160|Musculoskeletal Manipulations|musculoskeletal manipulations
5267051|NCT02348073|Children|children
5269927|NCT02331160|Medicine, Traditional|medicine, traditional
5269929|NCT02331134|Hematopoietic Stem Cell|hematopoietic stem cell
5269930|NCT02331134|Melanoma|melanoma
5269931|NCT02331134|Squamous Head and Neck Cancer|squamous head and neck cancer
5269932|NCT02331121|children|children
5269933|NCT02331121|parents|parents
5269934|NCT02331121|internet|internet
5269935|NCT02331121|video|video
5269936|NCT02331121|training|training
5269937|NCT02331121|interactive|interactive
5269938|NCT02331082|Infant Mortality|infant mortality
5269939|NCT02331082|Under-two mortality|under-two mortality
5269940|NCT02331082|Maternal Mortality|maternal mortality
5269941|NCT02331082|Implementation Research|implementation research
5269942|NCT02331082|Health Systems Strengthening|health systems strengthening
5269943|NCT02331082|Chronic Disease Management|chronic disease management
5269944|NCT02331082|Commuity Health Workers|commuity health workers
5269945|NCT02331069|radial neuropathy|radial neuropathy
5269946|NCT02331056|Stroke volume variation|stroke volume variation
5269947|NCT02331056|fluid responsiveness|fluid responsiveness
5269948|NCT02331056|One-lung ventilation|one-lung ventilation
5269949|NCT02331056|thoracotomy|thoracotomy
5269950|NCT02331030|brachio-axillary|brachio-axillary
5269951|NCT02331030|brachio-basilic|brachio-basilic
5269952|NCT02331030|interfascial plane block|interfascial plane block
5269953|NCT02331030|Pecs II block|pecs ii block
5269954|NCT02331030|supraclavicular brachial plexus block|supraclavicular brachial plexus block
5269956|NCT02331017|Cochlear Implant|cochlear implant
5269957|NCT02331017|Hearing aid|hearing aid
5269958|NCT02331017|Auditory Perception|auditory perception
5269959|NCT02331004|Frail Elderly|frail elderly
5269960|NCT02331004|Motor Skills|motor skills
5269961|NCT02331004|Upper Extremity|upper extremity
5269962|NCT02330991|glioblastoma|glioblastoma
5269963|NCT02330991|relapse|relapse
5269964|NCT02330991|Temozolomide|temozolomide
5269965|NCT02330991|glioblastoma at first relapse|glioblastoma at first relapse
5269966|NCT02330965|clinical research|clinical research
5269967|NCT02330965|mechanistic studies|mechanistic studies
5269968|NCT02330965|blood draw|blood draw
5269969|NCT02330965|CSF by lumbar puncture (optional)|csf by lumbar puncture (optional)
5269970|NCT02330952|Double-blind method|double-blind method
5269971|NCT02330952|Randomized Controlled trials|randomized controlled trials
5269972|NCT02330939|Postprandial glycemia|postprandial glycemia
5269973|NCT02330939|Momounsaturated fatty acids|momounsaturated fatty acids
5269974|NCT02330939|Saturated fatty acids|saturated fatty acids
5269975|NCT02330939|Glycemic index|glycemic index
5269976|NCT02330939|Glycemic load|glycemic load
5903758|NCT00339521|Asthma|asthma
5269977|NCT02330939|Sensor augmented pump system|sensor augmented pump system
5269978|NCT02330926|Combined modality treatment|combined modality treatment
5269979|NCT02330926|Diet therapy|diet therapy
5269980|NCT02330926|Exercise therapy|exercise therapy
5269981|NCT02330926|Ibuprofen|ibuprofen
5269982|NCT02330926|Dietary supplements|dietary supplements
5269983|NCT02330913|total gastrectomy|total gastrectomy
5269984|NCT02330913|intracorporeal|intracorporeal
5269985|NCT02330913|totally laparoscopic|totally laparoscopic
5269986|NCT02330913|esophagojejunostomy|esophagojejunostomy
5269987|NCT02330913|anastomosis|anastomosis
5269988|NCT02330900|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5269989|NCT02330900|Electromagnetic interference|electromagnetic interference
5269990|NCT02330900|Cell phone|cell phone
5269991|NCT02330887|Maternal Mortality|maternal mortality
5269992|NCT02330887|Institutional Birth Rate|institutional birth rate
5269993|NCT02330887|Neonatal Mortality Rate|neonatal mortality rate
5269994|NCT02330887|Preterm Birth|preterm birth
5269995|NCT02330887|Stillbirth|stillbirth
5269996|NCT02330887|Infant, Small for Gestational Age|infant, small for gestational age
5269998|NCT02330887|Implementation Research|implementation research
5269999|NCT02330887|Global Health|global health
5270000|NCT02330874|Risk|risk
5270001|NCT02330874|score|score
5270002|NCT02330874|readmission|readmission
5270003|NCT02330874|ICU|icu
5270004|NCT02330861|Coronary Circulation|coronary circulation
5270005|NCT02330848|Obesity|obesity
5270006|NCT02330848|Walnuts|walnuts
5270007|NCT02330848|Endothelial Function|endothelial function
5270008|NCT02330848|Adults at risk|adults at risk
5270009|NCT02330835|school|school
5270010|NCT02330835|bus|bus
5270011|NCT02330835|school bus|school bus
5270012|NCT02330835|driver|driver
5270013|NCT02330835|training|training
5270014|NCT02330835|behavior|behavior
5270015|NCT02330835|management|management
5270016|NCT02330835|interactive|interactive
5270017|NCT02330835|computer|computer
5270018|NCT02330809|headache|headache
5270019|NCT02330809|hunger intensity|hunger intensity
5270020|NCT02330809|public led online trial|public led online trial
5270021|NCT02330809|water intake|water intake
5270022|NCT02330783|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5270023|NCT02330783|Third-line treatment|third-line treatment
5270024|NCT02330783|Sorafenib|sorafenib
5270025|NCT02330783|Bevacizumab|bevacizumab
5270026|NCT02330770|GnRHa trigger|gnrha trigger
5267176|NCT02347098|LDL|ldl
5270027|NCT02330770|Luteal phase support|luteal phase support
5270028|NCT02330770|OHSS|ohss
5270029|NCT02330757|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
5270030|NCT02330757|FET protocols|fet protocols
5270031|NCT02330705|Intrauterine insemination|intrauterine insemination
5270032|NCT02330705|IUI|iui
5270033|NCT02330705|HCG|hcg
5270034|NCT02330679|Major Depression, Neuroimaging, Desvenlafaxine, Machine learning|major depression, neuroimaging, desvenlafaxine, machine learning
5270035|NCT02330653|Colitis|colitis
5270036|NCT02330653|Fecal Microbiota Transplant|fecal microbiota transplant
5270037|NCT02330653|Ulcerative colitis|ulcerative colitis
5270038|NCT02330653|inflammatory bowel disease|inflammatory bowel disease
5270039|NCT02330640|CABG|cabg
5270040|NCT02330640|antiplatelet therapy|antiplatelet therapy
5270041|NCT02330640|ticagrelor|ticagrelor
5270042|NCT02330614|personality|personality
5270043|NCT02330614|bleaching|bleaching
5270044|NCT02330588|Obesity|obesity
5270045|NCT02330588|Prevention|prevention
5270046|NCT02330588|Pediatric|pediatric
5270047|NCT02330588|Parents|parents
5270048|NCT02330588|Primary Care|primary care
5270049|NCT02330588|eHealth|ehealth
5270050|NCT02330588|Internet|internet
5257429|NCT02404181|EEG|eeg
5270051|NCT02330562|Marizomib|marizomib
5270052|NCT02330562|Bevacizumab|bevacizumab
5270053|NCT02330562|Avastin|avastin
5270054|NCT02330562|Grade IV malignant glioma|grade iv malignant glioma
5270055|NCT02330562|proteasome inhibitor|proteasome inhibitor
5139326|NCT03119870|EEG|eeg
5270056|NCT02330562|glioblastoma|glioblastoma
5270057|NCT02330562|brain tumor|brain tumor
5270058|NCT02330562|malignant glioma|malignant glioma
5270059|NCT02330562|brain cancer|brain cancer
5270060|NCT02330562|gliosarcoma|gliosarcoma
5270061|NCT02330562|BEV|bev
5270062|NCT02330536|Circulatory and Respiratory Physiological Phenomena|circulatory and respiratory physiological phenomena
5270063|NCT02330536|Thoracoscopy|thoracoscopy
5270064|NCT02330510|Alzheimer's Disease|alzheimer's disease
5270065|NCT02330510|White Matter Hyperintensities|white matter hyperintensities
5270066|NCT02330510|Vascular Cognitive Impairment|vascular cognitive impairment
5270067|NCT02330510|Amyloid Imaging|amyloid imaging
5270068|NCT02330510|Transient Ischemic Attack|transient ischemic attack
5270069|NCT02330484|Community management， incentives, Medication Adherence|community management， incentives, medication adherence
5270070|NCT02330471|conization|conization
5270071|NCT02330471|LLETZ|lletz
5270072|NCT02330471|cervical dysplasia|cervical dysplasia
5270073|NCT02330471|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5270074|NCT02330458|Inflammatory Bowel Disease|inflammatory bowel disease
5270075|NCT02330458|Crohn's disease|crohn's disease
5270076|NCT02330458|Pediatric IBD|pediatric ibd
5270077|NCT02330458|small bowel ultrasound|small bowel ultrasound
5270078|NCT02330458|infliximab|infliximab
5270079|NCT02330419|Naltrexone|naltrexone
5270080|NCT02330406|Dipeptidyl-Peptidase 4 Inhibitors|dipeptidyl-peptidase 4 inhibitors
5270081|NCT02330406|LDL Cholesterol|ldl cholesterol
5270082|NCT02330406|Glycosylated Hemoglobin|glycosylated hemoglobin
5270083|NCT02330406|Diabetes Mellitus|diabetes mellitus
5270084|NCT02330406|Coronary Disease|coronary disease
5270085|NCT02330380|psoriasis, comparative effects, inflammation|psoriasis, comparative effects, inflammation
5270086|NCT02330354|preschool|preschool
5270087|NCT02330354|behavior change|behavior change
5270088|NCT02330354|social marketing|social marketing
5270089|NCT02330354|child care providers|child care providers
5270090|NCT02330354|nutrition|nutrition
5270091|NCT02330354|child care centers|child care centers
5270092|NCT02330354|physical activity|physical activity
5270093|NCT02330341|Glucose Intolerance|glucose intolerance
5270094|NCT02330341|Artemisia dracunculus|artemisia dracunculus
5270096|NCT02330328|Chest Pain|chest pain
5270097|NCT02330328|Telemetry|telemetry
5270098|NCT02330315|transcranial direct current stimulation|transcranial direct current stimulation
5270099|NCT02330315|transcranial ultrasound|transcranial ultrasound
5270100|NCT02330315|non-invasive brain stimulation|non-invasive brain stimulation
5270101|NCT02330250|Systemic Lupus Erythematosus|systemic lupus erythematosus
5270102|NCT02330250|Pharmaceutical care|pharmaceutical care
5270103|NCT02330250|Pharmaceutical services|pharmaceutical services
5270104|NCT02330250|Medication adherence|medication adherence
5270105|NCT02330224|Blood pressure|blood pressure
5270106|NCT02330224|Lipids|lipids
5270107|NCT02330224|Cardiovascular|cardiovascular
5270108|NCT02330224|Health services|health services
5270109|NCT02330224|Hypertension|hypertension
5270110|NCT02330198|self-reported outcome instrument|self-reported outcome instrument
5270111|NCT02330185|spinal anesthesia|spinal anesthesia
5270112|NCT02330185|ultrasonography|ultrasonography
5270113|NCT02330185|anatomical landmark|anatomical landmark
5270114|NCT02330159|Pilonidal|pilonidal
5270115|NCT02330159|Quality of Life|quality of life
5270116|NCT02330133|mid-life women|mid-life women
5270117|NCT02330133|unintended pregnancy|unintended pregnancy
5270118|NCT02330133|STI/HIV prevention|sti/hiv prevention
5270119|NCT02330133|intervention|intervention
5270120|NCT02330133|interactive|interactive
5270121|NCT02330133|CD-ROM|cd-rom
5270122|NCT02330133|multimedia|multimedia
5270123|NCT02330133|video|video
5270124|NCT02330120|peak airway pressure|peak airway pressure
5270130|NCT02330081|pathogen reduction technology|pathogen reduction technology
5270131|NCT02330081|whole blood|whole blood
5270132|NCT02330081|Platelets|platelets
5270133|NCT02330081|Mirasol|mirasol
5270134|NCT02330042|Diabetes|diabetes
5270136|NCT02330042|Angiography|angiography
5270137|NCT02330042|Diabetic retinopathy|diabetic retinopathy
5270438|NCT02328118|Lucentis|lucentis
5270138|NCT02330029|Irritable bowel syndrome,|irritable bowel syndrome,
5270139|NCT02330029|Pinaverium|pinaverium
5270140|NCT02330029|Herbal medication for IBS,|herbal medication for ibs,
5270141|NCT02330029|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
5270142|NCT02330003|Influenza|influenza
5270143|NCT02330003|Influenza vaccine|influenza vaccine
5270144|NCT02330003|Split influenza vaccine|split influenza vaccine
5270145|NCT02330003|Seasonal influenza vaccine|seasonal influenza vaccine
5270146|NCT02329990|phosphorus intake|phosphorus intake
5270147|NCT02329977|duodenal-biliary reflux|duodenal-biliary reflux
5270148|NCT02329964|Rocuronium|rocuronium
5270149|NCT02329964|Sugammadex|sugammadex
5270150|NCT02329964|Succinylcholine|succinylcholine
5270151|NCT02329964|Cisatracurium|cisatracurium
5270152|NCT02329964|Neostigmine|neostigmine
5270153|NCT02329964|acceleromyography (TOF-Watch®)|acceleromyography (tof-watch®)
5270154|NCT02329912|postoperative ileus|postoperative ileus
5270155|NCT02329912|SmartPill|smartpill
5270156|NCT02329912|gastrointestinal transit|gastrointestinal transit
5270157|NCT02329912|prokinetic drugs|prokinetic drugs
5270158|NCT02329886|chronic diseases|chronic diseases
5270159|NCT02329886|risk factors|risk factors
5270160|NCT02329886|health outcomes|health outcomes
5270161|NCT02329873|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
5270162|NCT02329873|Older adults|older adults
5270163|NCT02329873|Respiratory rehabilitation exercise|respiratory rehabilitation exercise
5270164|NCT02329847|Hematologic Neoplasms|hematologic neoplasms
5270165|NCT02329847|JNJ54179060|jnj54179060
5270166|NCT02329847|Ibrutinib|ibrutinib
5270167|NCT02329847|Nivolumab|nivolumab
5270168|NCT02329821|lactate|lactate
5270169|NCT02329821|hartmann solution|hartmann solution
5270170|NCT02329821|hepatocellular carcinoma|hepatocellular carcinoma
5270171|NCT02329808|TDM|tdm
5270172|NCT02329808|dried blood spot|dried blood spot
5270173|NCT02329808|immunosuppressive|immunosuppressive
5270174|NCT02329808|antifungal|antifungal
5270175|NCT02329769|Duchenne muscular dystrophy|duchenne muscular dystrophy
5270176|NCT02329769|DMD|dmd
5270177|NCT02329769|BioMarin|biomarin
5270178|NCT02329769|PRO044|pro044
5270179|NCT02329756|Tranexamic Acid|tranexamic acid
5270180|NCT02329730|diagnosis of Tuberculosis (TB)|diagnosis of tuberculosis (tb)
5270181|NCT02329730|ESAT6|esat6
5270182|NCT02329730|CFP10|cfp10
5270183|NCT02329730|Phase IIa Clinical Trial|phase iia clinical trial
5270184|NCT02329704|IUI/AIH|iui/aih
5270185|NCT02329704|Semen preparation|semen preparation
5270186|NCT02329704|Semen processing|semen processing
5270187|NCT02329704|ICSI/IVF|icsi/ivf
5270188|NCT02329704|ART|art
5270189|NCT02329704|Density Gradient|density gradient
5270190|NCT02329704|Swimming down|swimming down
5270191|NCT02329704|hyaluronan affinity testing|hyaluronan affinity testing
5270192|NCT02329704|Sperm vitality testin|sperm vitality testin
5270193|NCT02329691|safety climate|safety climate
5270194|NCT02329691|surgery|surgery
5270195|NCT02329678|Apicomarginal defects|apicomarginal defects
5270196|NCT02329678|clinical study/trial|clinical study/trial
5270197|NCT02329678|collagen membrane|collagen membrane
5275112|NCT02302573|MRI|mri
5270198|NCT02329678|guided tissue regeneration|guided tissue regeneration
5270199|NCT02329678|endodontic microsurgery|endodontic microsurgery
5270200|NCT02329652|Neuroprosthesis|neuroprosthesis
5270201|NCT02329652|Functional Electrical Stimulation|functional electrical stimulation
5270202|NCT02329639|bevacizumab|bevacizumab
5270203|NCT02329639|paclitaxel|paclitaxel
5270204|NCT02329639|pharmacogenetics|pharmacogenetics
5270205|NCT02329639|breast cancer|breast cancer
5270206|NCT02329561|Pharmacokinetics|pharmacokinetics
5270208|NCT02329561|Geriatric|geriatric
5270209|NCT02329561|Pharmacodynamics|pharmacodynamics
5270210|NCT02329548|Alizarin|alizarin
5270211|NCT02329548|Orthostatic|orthostatic
5270212|NCT02329548|POTS|pots
5270213|NCT02329548|Tilt table testing|tilt table testing
5270214|NCT02329548|Syncope|syncope
5270215|NCT02329548|Anxiety|anxiety
5270216|NCT02329522|Haemodynamics|haemodynamics
5270217|NCT02329522|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5270218|NCT02329522|Ultrasonic Cardiac Output Monitor|ultrasonic cardiac output monitor
5270219|NCT02329522|severity|severity
5270220|NCT02329509|operative procedures|operative procedures
5270221|NCT02329483|Infertility|infertility
5270222|NCT02329483|Ovulation induction|ovulation induction
5270223|NCT02329483|Low-dose step-up protocol|low-dose step-up protocol
5270224|NCT02329483|Ovarian high responder|ovarian high responder
5270225|NCT02329483|Androgens|androgens
5270226|NCT02329483|Androstenedione|androstenedione
5270227|NCT02329483|Testosterone|testosterone
5270229|NCT02329457|double-blind, randomized, intradermal, VZVv, HSCT|double-blind, randomized, intradermal, vzvv, hsct
5270230|NCT02329431|child mental health, mental health services, Latino families|child mental health, mental health services, latino families
5270231|NCT02329340|child safety|child safety
5270232|NCT02329340|injury|injury
5270233|NCT02329340|prevention|prevention
5270234|NCT02329340|computer|computer
5270235|NCT02329340|internet|internet
5270439|NCT02328118|Ranibizumab|ranibizumab
5270236|NCT02329327|Factor Xa Inhibitors|factor xa inhibitors
5270237|NCT02329327|Major|major
5270238|NCT02329327|Bleeding|bleeding
5270239|NCT02329327|Anticoagulant|anticoagulant
5270240|NCT02329301|malaria|malaria
5270241|NCT02329301|malaria, falciparum|malaria, falciparum
5270242|NCT02329301|antimalarials|antimalarials
5270243|NCT02329262|exercise|exercise
5270244|NCT02329262|mentors|mentors
5270245|NCT02329262|health education|health education
5270246|NCT02329262|obesity|obesity
5270247|NCT02329249|smoking cessation|smoking cessation
5270248|NCT02329249|coach-supported|coach-supported
5270249|NCT02329249|tobacco use cessation|tobacco use cessation
5270250|NCT02329249|online|online
5270251|NCT02329249|internet-based|internet-based
5270252|NCT02329249|tailored|tailored
5270253|NCT02329223|Chronic spontaneous uriticaria|chronic spontaneous uriticaria
5270254|NCT02329223|Omalizumab|omalizumab
5270255|NCT02329197|Infertility|infertility
5270256|NCT02329197|Invitro fertilization|invitro fertilization
5270257|NCT02329145|renal denervation|renal denervation
5270258|NCT02329132|diabetic macular edema|diabetic macular edema
5270259|NCT02329132|VEGF|vegf
5270260|NCT02329132|ranibizumab|ranibizumab
5270261|NCT02329132|oxygen consumption|oxygen consumption
5270262|NCT02329054|Ebola Virus Disease|ebola virus disease
5270263|NCT02329054|Antivirals|antivirals
5270264|NCT02329054|Mortality|mortality
5270265|NCT02329054|Viral load|viral load
5270266|NCT02329054|Proof-of-concept|proof-of-concept
5270267|NCT02329054|Phase II trial|phase ii trial
5270268|NCT02329054|Guinea|guinea
5270269|NCT02329054|Adults|adults
5270270|NCT02329054|Children|children
5270271|NCT02329041|videolaryngoscope|videolaryngoscope
5270272|NCT02329041|double-lumen tube|double-lumen tube
5270273|NCT02329041|intubation|intubation
5903759|NCT00339521|Mexico|mexico
5270274|NCT02329028|Emergency Care, Prehospital|emergency care, prehospital
5270275|NCT02329028|Electroencephalography|electroencephalography
5270276|NCT02329028|Coma|coma
5270277|NCT02329015|stress|stress
5270278|NCT02329015|alternative|alternative
5270279|NCT02329015|complementary|complementary
5270280|NCT02329015|self-regulation|self-regulation
5270281|NCT02329002|Retinoblastoma|retinoblastoma
5270282|NCT02329002|Second primary tumor|second primary tumor
5270283|NCT02329002|Screening|screening
5270284|NCT02329002|Magnetic resonance imaging|magnetic resonance imaging
5270285|NCT02328989|prematurity|prematurity
5270286|NCT02328989|short cervix|short cervix
5270287|NCT02328989|twin pregnancy|twin pregnancy
5270288|NCT02328989|pessary|pessary
5270289|NCT02328963|Cytomegalovirus infection and disease|cytomegalovirus infection and disease
5270290|NCT02328963|CMV-seropositive recipients|cmv-seropositive recipients
5270291|NCT02328963|Everolimus|everolimus
5270292|NCT02328963|preemptive strategy|preemptive strategy
5270293|NCT02328963|mTOR inhibitor|mtor inhibitor
5270294|NCT02328898|Polymer free stent|polymer free stent
5270295|NCT02328898|percutaneous coronary intervention|percutaneous coronary intervention
5270296|NCT02328885|high-risk acute leukemia|high-risk acute leukemia
5270297|NCT02328885|graft versus leukemia|graft versus leukemia
5270304|NCT02328859|Gait|gait
5270305|NCT02328859|Rehabilitation|rehabilitation
5270306|NCT02328859|Virtual Reality|virtual reality
5270307|NCT02328833|Depression|depression
5270308|NCT02328833|Clinical Practice Guideline|clinical practice guideline
5270309|NCT02328833|Implementation|implementation
5270310|NCT02328833|Primary Care|primary care
5270311|NCT02328833|Computerized Guideline|computerized guideline
5270312|NCT02328820|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5270313|NCT02328820|Coronary Flow Reserve|coronary flow reserve
5270314|NCT02328807|adenocarcinoma|adenocarcinoma
5270315|NCT02328807|prostate|prostate
5270316|NCT02328807|ENCAGE™|encage™
5270317|NCT02328807|focal bipolar radiofrequency ablation|focal bipolar radiofrequency ablation
5445379|NCT01522105|Pharmacologic Actions|pharmacologic actions
5270318|NCT02328807|radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5270319|NCT02328807|radiotherapy|radiotherapy
5270320|NCT02328794|smoking cessation|smoking cessation
5270321|NCT02328794|behavioral economics|behavioral economics
5270322|NCT02328794|e-cigarettes|e-cigarettes
5270324|NCT02328781|vertebral artery stenosis|vertebral artery stenosis
5270325|NCT02328781|drug-eluting stent|drug-eluting stent
5270326|NCT02328703|Reiki|reiki
5270327|NCT02328703|Neuropathic Pain|neuropathic pain
5270328|NCT02328703|Military Service Members|military service members
5270329|NCT02328703|Extermity Trauma|extermity trauma
5270330|NCT02328690|binaural beat technology|binaural beat technology
5270331|NCT02328690|sound technology|sound technology
5270332|NCT02328690|cardiovascular stress response|cardiovascular stress response
5270334|NCT02328690|music|music
5270335|NCT02328690|anxiety|anxiety
5270336|NCT02328690|stress|stress
5270337|NCT02328677|Colorectal cancer|colorectal cancer
5270338|NCT02328677|rectosigmoid|rectosigmoid
5270339|NCT02328677|rectum|rectum
5270344|NCT02328651|Mild and Moderate Severe Patients With hand_foot-mouth Disease|mild and moderate severe patients with hand_foot-mouth disease
5270347|NCT02328625|Device|device
5270348|NCT02328625|ADRCs|adrcs
5270349|NCT02328625|adipose derived regenerative cells|adipose derived regenerative cells
5270350|NCT02328625|hand|hand
5270351|NCT02328547|fecal microbiota transplantation|fecal microbiota transplantation
5270352|NCT02328547|diarrhea-predominant|diarrhea-predominant
5270353|NCT02328534|ICSI/IVF|icsi/ivf
5270354|NCT02328534|Semen processing|semen processing
5270355|NCT02328534|Semen preparation|semen preparation
5270356|NCT02328534|Swim down|swim down
5270357|NCT02328534|Density gradient|density gradient
5270358|NCT02328534|Silica solution|silica solution
5270359|NCT02328521|Neointima|neointima
5270360|NCT02328521|Tomography, Optical Coherence|tomography, optical coherence
5270361|NCT02328521|drug-eluting stents|drug-eluting stents
5270362|NCT02328521|Nicorandil|nicorandil
5270363|NCT02328508|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5270364|NCT02328508|diabetic foot ulcer|diabetic foot ulcer
5270365|NCT02328508|wound healing|wound healing
5270366|NCT02328508|inflammation|inflammation
5270367|NCT02328508|glycemic control|glycemic control
5270368|NCT02328508|amputation|amputation
5270369|NCT02328508|bacterial infection|bacterial infection
5270370|NCT02328508|quality of life|quality of life
5270371|NCT02328495|Misoprostol, Office hysteroscopy ,Pain|misoprostol, office hysteroscopy ,pain
5270372|NCT02328469|aseptic meningitis|aseptic meningitis
5270373|NCT02328469|tick-borne encephalitis|tick-borne encephalitis
5270374|NCT02328469|Lyme neuroborreliosis|lyme neuroborreliosis
5270375|NCT02328469|inflammation|inflammation
5270376|NCT02328469|outcome|outcome
5270377|NCT02328443|CYP3A|cyp3a
5270378|NCT02328443|Metabolomics|metabolomics
5270379|NCT02328404|Vitamin D|vitamin d
5270380|NCT02328404|deficiency|deficiency
5270381|NCT02328404|hypovitaminosis D|hypovitaminosis d
5270382|NCT02328404|Biodal|biodal
5270383|NCT02328404|25 hydroxy Vitamin D|25 hydroxy vitamin d
5270384|NCT02328404|25hydroxyvitamin D|25hydroxyvitamin d
5270385|NCT02328404|25(OH)D|25(oh)d
5270386|NCT02328404|PCOS|pcos
5270387|NCT02328404|insulin resistance|insulin resistance
5270388|NCT02328404|BMI|bmi
5270389|NCT02328404|chromium levels|chromium levels
5270390|NCT02328404|vitamin D 3|vitamin d 3
5270391|NCT02328404|cholecalciferol|cholecalciferol
5270392|NCT02328404|50,000 IU|50,000 iu
5270393|NCT02328365|Colorectal Cancer|colorectal cancer
5270394|NCT02328365|Comorbidity|comorbidity
5270395|NCT02328365|Perioperative Care|perioperative care
5270396|NCT02328365|Surgery|surgery
5270397|NCT02328352|Buckypaper (BP) of Multi-Walled Carbon Nanotubes (MWCNTs)|buckypaper (bp) of multi-walled carbon nanotubes (mwcnts)
5270398|NCT02328352|surgical hernia prosthesis|surgical hernia prosthesis
5270399|NCT02328352|abdominal wall defects surgery|abdominal wall defects surgery
5270400|NCT02328352|prosthesis adhesion|prosthesis adhesion
5270401|NCT02328352|disaster preparation and recovery hernia|disaster preparation and recovery hernia
5270402|NCT02328352|Abdominal Wall Disaster Surgery|abdominal wall disaster surgery
5270403|NCT02328352|Fixation of prosthetic materials in general surgery|fixation of prosthetic materials in general surgery
5270404|NCT02328326|Diabetes|diabetes
5270405|NCT02328326|diabetes self-management|diabetes self-management
5270406|NCT02328326|patient activation|patient activation
5270407|NCT02328326|social support|social support
5270408|NCT02328313|Cancer|cancer
5270409|NCT02328313|Breast Cancer|breast cancer
5270410|NCT02328313|Geriatric|geriatric
5270411|NCT02328313|Advance Age|advance age
5270412|NCT02328313|Exercise|exercise
5270413|NCT02328313|Physical Activity|physical activity
5270414|NCT02328313|Genetic Marker|genetic marker
5270415|NCT02328313|p16|p16
5270416|NCT02328313|Chemotherapy|chemotherapy
5270417|NCT02328313|Breast Cancer Treatment|breast cancer treatment
5270423|NCT02328235|skeletal muscle, metabolism, physiology|skeletal muscle, metabolism, physiology
5270424|NCT02328222|Early steroid withdrawal|early steroid withdrawal
5270425|NCT02328222|Acute allograft rejection|acute allograft rejection
5270426|NCT02328222|Mycophenolate|mycophenolate
5270427|NCT02328222|Tacrolimus|tacrolimus
5270428|NCT02328222|Basiliximab|basiliximab
5270429|NCT02328196|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5270430|NCT02328196|Rasch analysis|rasch analysis
5270431|NCT02328196|Meal time performance|meal time performance
5270432|NCT02328183|polymyxin B|polymyxin b
5270433|NCT02328183|carbapenem resistant bacteria|carbapenem resistant bacteria
5267560|NCT02345174|PET|pet
5862751|NCT00001524|Thalidomide|thalidomide
5270436|NCT02328144|Postoperative pain|postoperative pain
5270437|NCT02328144|Metronidazole|metronidazole
5270445|NCT02328066|NICE classification|nice classification
5270446|NCT02328066|deep submucosal invasion|deep submucosal invasion
5270447|NCT02328066|Colonic Polyps [C23.300.825.411.235]|colonic polyps [c23.300.825.411.235]
5270448|NCT02328066|Colonoscopy [E01.370.372.250.250.200]|colonoscopy [e01.370.372.250.250.200]
5270449|NCT02328053|fungal keratitis|fungal keratitis
5270450|NCT02328053|collagen cross linking|collagen cross linking
5270451|NCT02328040|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5270453|NCT02328040|Artificial Pancreas|artificial pancreas
5270454|NCT02328040|Insulin|insulin
5270455|NCT02328040|Sitagliptin|sitagliptin
5270456|NCT02328040|Januvia|januvia
5270457|NCT02328014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5270459|NCT02328014|B-Cell Malignancies|b-cell malignancies
5270460|NCT02328014|Mantle Cell|mantle cell
5270461|NCT02328014|Multiple Myeloma|multiple myeloma
5270462|NCT02328014|CLL|cll
5270463|NCT02328014|SLL|sll
5270464|NCT02328014|DLBCL|dlbcl
5270465|NCT02328014|Follicular|follicular
5270466|NCT02328014|Waldenstrom|waldenstrom
5270467|NCT02328014|B-All|b-all
5270468|NCT02327988|cryotherapy|cryotherapy
5270469|NCT02327988|laser therapy|laser therapy
5270470|NCT02327988|eccentric exercise|eccentric exercise
5270471|NCT02327988|delayed onset muscle soreness|delayed onset muscle soreness
5270472|NCT02327988|muscle damage|muscle damage
5270473|NCT02327988|dynamometry|dynamometry
5270474|NCT02327988|electromyography|electromyography
5270475|NCT02327923|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5270476|NCT02327923|lidocaine infusion|lidocaine infusion
5270477|NCT02327923|Esmolol infusion|esmolol infusion
5270478|NCT02327923|Postoperative opioid consumption|postoperative opioid consumption
5270479|NCT02327923|Multimodal analgesia|multimodal analgesia
5270480|NCT02327910|Elderly patients，|elderly patients，
5270481|NCT02327910|General anesthesia，|general anesthesia，
5270482|NCT02327910|Transcutaneous partial pressure of carbon dioxide(TcPCO2)，|transcutaneous partial pressure of carbon dioxide(tcpco2)，
5270483|NCT02327910|Train-of-four(TOF)，|train-of-four(tof)，
5270484|NCT02327910|Extubation|extubation
5270485|NCT02327910|，Respiratory events|，respiratory events
5270486|NCT02327897|Atopic Asthma|atopic asthma
5270487|NCT02327897|Exposures|exposures
5270488|NCT02327897|Disease Progression|disease progression
5270494|NCT02327871|Therapeutic hypothermia|therapeutic hypothermia
5270495|NCT02327871|patients|patients
5270496|NCT02327871|Safety, Efficacy|safety, efficacy
5270497|NCT02327845|natural history, biomarkers, phenotype, genotype|natural history, biomarkers, phenotype, genotype
5270498|NCT02327832|Confirmation|confirmation
5270499|NCT02327832|safety|safety
5270500|NCT02327793|Perfusion|perfusion
5270501|NCT02327793|Blood pressure|blood pressure
5270502|NCT02327767|Active Assistance|active assistance
5270503|NCT02327767|Resonance|resonance
5270504|NCT02327767|Stroke|stroke
5270505|NCT02327767|Arm Rehabilitation|arm rehabilitation
5270506|NCT02327741|Dual antiplatelet therapy|dual antiplatelet therapy
5270507|NCT02327741|clopidogrel|clopidogrel
5270508|NCT02327741|percutaneous coronary intervention|percutaneous coronary intervention
5270509|NCT02327728|blepharospasm|blepharospasm
5270510|NCT02327728|botulinum A|botulinum a
5270512|NCT02327728|tear|tear
5270513|NCT02327715|Hepatitis B virus|hepatitis b virus
5270514|NCT02327715|Emtricitabine|emtricitabine
5270515|NCT02327715|Pregnancy|pregnancy
5270516|NCT02327715|Vertical transmission|vertical transmission
5270517|NCT02327702|Hepatitis B, chronic|hepatitis b, chronic
5270518|NCT02327702|Emtricitabine|emtricitabine
5270519|NCT02327702|Pregnancy|pregnancy
5270520|NCT02327689|Hepatitis B virus|hepatitis b virus
5270521|NCT02327689|Cirrhosis|cirrhosis
5270522|NCT02327689|Emtricitabine|emtricitabine
5270523|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil
5270524|NCT02327676|Hepatitis B, chronic|hepatitis b, chronic
5270525|NCT02327676|Emtricitabine|emtricitabine
5270526|NCT02327676|Child|child
5270527|NCT02327663|Hepatitis B, chronic|hepatitis b, chronic
5270528|NCT02327663|Emtricitabine|emtricitabine
5270529|NCT02327663|Adefovir dipivixil|adefovir dipivixil
5270530|NCT02327663|HBeAg|hbeag
5270531|NCT02327637|Preterm Premature Rupture of the Membranes|preterm premature rupture of the membranes
5270532|NCT02327637|Bedrest|bedrest
5270533|NCT02327637|Physical Activity|physical activity
5270534|NCT02327585|Executive function training|executive function training
5270535|NCT02327585|child|child
5270536|NCT02327559|childbirth|childbirth
5270537|NCT02327559|mindfulness|mindfulness
5270538|NCT02327559|fear of labor|fear of labor
5270539|NCT02327559|labor pain|labor pain
5270540|NCT02327559|coping|coping
5270541|NCT02327559|self-efficacy|self-efficacy
5267665|NCT02344706|Coma|coma
5270542|NCT02327559|childbirth satisfaction|childbirth satisfaction
5270543|NCT02327559|depression|depression
5270544|NCT02327546|Pharmacokinetics|pharmacokinetics
5270545|NCT02327546|Anemia|anemia
5270546|NCT02327546|Chronic kidney disease|chronic kidney disease
5270547|NCT02327546|CKD|ckd
5270548|NCT02327546|Chronic renal insufficiency|chronic renal insufficiency
5270549|NCT02327546|Renal impairment|renal impairment
5270550|NCT02327546|Ferrous sulfate|ferrous sulfate
5270551|NCT02327546|Iron|iron
5270552|NCT02327546|Drug-drug interaction|drug-drug interaction
5270553|NCT02327546|End stage renal disease|end stage renal disease
5270554|NCT02327546|Dialysis|dialysis
5270555|NCT02327546|Erythropoietin|erythropoietin
5270556|NCT02327546|Oral anemia treatment|oral anemia treatment
5270557|NCT02327546|Hypoxia-induciable factor|hypoxia-induciable factor
5270558|NCT02327546|HIF|hif
5270559|NCT02327546|Hypoxia-induciable factor prolyl-hydroxylase inhibitor|hypoxia-induciable factor prolyl-hydroxylase inhibitor
5270560|NCT02327546|HIF-PHI|hif-phi
5270561|NCT02327533|generalized aggressive periodontitis|generalized aggressive periodontitis
5270562|NCT02327533|microarray analysis|microarray analysis
5270563|NCT02327520|Clostridium difficile infection|clostridium difficile infection
5270564|NCT02327520|burden|burden
5270565|NCT02327520|nationwide study|nationwide study
5270566|NCT02327520|South East Asia|south east asia
5270567|NCT02327520|Thailand|thailand
5270568|NCT02327520|Epidemiology|epidemiology
5270569|NCT02327520|Outcome Assessment (Health Care) [N04.761.559.590]|outcome assessment (health care) [n04.761.559.590]
5270570|NCT02327507|children|children
5270571|NCT02327507|fluoridated toothpaste|fluoridated toothpaste
5270572|NCT02327507|health education|health education
5270573|NCT02327507|Medicaid|medicaid
5270574|NCT02327494|Neuromuscular blockade|neuromuscular blockade
5270575|NCT02327494|Laparoscopy|laparoscopy
5270576|NCT02327494|Oxygen measurements|oxygen measurements
5270577|NCT02327481|Stomach Neoplasms Laparoscopy|stomach neoplasms laparoscopy
5270578|NCT02327442|chemokine receptor|chemokine receptor
5270579|NCT02327442|galium|galium
5270580|NCT02327442|dosimetry|dosimetry
5270581|NCT02327442|glioma|glioma
5270582|NCT02327403|Proteinuria|proteinuria
5270583|NCT02327403|Kidney transplantation|kidney transplantation
5270584|NCT02327403|Allograft dysfunction|allograft dysfunction
5270585|NCT02327403|B7-1|b7-1
5270586|NCT02327403|Belatacept|belatacept
5270587|NCT02327377|Irritable bowel syndrome|irritable bowel syndrome
5903760|NCT00339521|Triads|triads
5270588|NCT02327377|Intervention studies|intervention studies
5270589|NCT02327377|Visceral pain|visceral pain
5270590|NCT02327377|Chronic pain|chronic pain
5270591|NCT02327377|Abdominal pain|abdominal pain
5270592|NCT02327377|Dyspepsia|dyspepsia
5270593|NCT02327377|Nausea|nausea
5270594|NCT02327377|Nociception|nociception
5270595|NCT02327377|Parents|parents
5270596|NCT02327377|Coping behavior|coping behavior
5270597|NCT02327377|Anxiety|anxiety
5270598|NCT02327377|Depression|depression
5270599|NCT02327377|Catastrophization|catastrophization
5270600|NCT02327377|Reinforcement (psychology)|reinforcement (psychology)
5270601|NCT02327377|Self efficacy|self efficacy
5270602|NCT02327377|Health services overutilization|health services overutilization
5270603|NCT02327377|Questionnaires|questionnaires
5270604|NCT02327377|Self report|self report
5270605|NCT02327377|Health surveys|health surveys
5270606|NCT02327377|Prospective studies|prospective studies
5270607|NCT02327377|Adolescent health|adolescent health
5270608|NCT02327377|Mental health services|mental health services
5270609|NCT02327377|Health services accessibility|health services accessibility
5270610|NCT02327377|Health diaries|health diaries
5270614|NCT02327377|Web-based intervention|web-based intervention
5270616|NCT02327325|Low Back Pain|low back pain
5270617|NCT02327325|Exercise|exercise
5270618|NCT02327325|Cognitive Behavioral Therapy|cognitive behavioral therapy
5270619|NCT02327325|Aged|aged
5270620|NCT02327299|Iron deficiency|iron deficiency
5270621|NCT02327299|Iron fortification|iron fortification
5270622|NCT02327286|Diabetes Mellitus|diabetes mellitus
5270623|NCT02327286|Gestational diabetes|gestational diabetes
5270624|NCT02327273|subjects|subjects
5270625|NCT02327221|Crohn Disease|crohn disease
5270626|NCT02327221|Cell therapy|cell therapy
5270627|NCT02327221|Regulatory T lymphocytes|regulatory t lymphocytes
5270628|NCT02327221|Treg|treg
5270629|NCT02327221|Autologous|autologous
5270630|NCT02327221|Antigen specific T regulatory lymphocytes|antigen specific t regulatory lymphocytes
5270631|NCT02327208|Military Training|military training
5270632|NCT02327208|Whey Protein|whey protein
5270633|NCT02327208|Body Composition|body composition
5270634|NCT02327182|MT-4666|mt-4666
5270635|NCT02327182|α7 nicotinic acetylcholine receptor agonist|α7 nicotinic acetylcholine receptor agonist
5270636|NCT02327182|Alzheimer's Disease|alzheimer's disease
5270637|NCT02327182|Cognitive function|cognitive function
5270648|NCT02327091|Muscle strength|muscle strength
5270649|NCT02327091|Sarcopenia|sarcopenia
5270650|NCT02327065|EUS|eus
5270651|NCT02327065|FNA|fna
5270652|NCT02327065|FNB|fnb
5165661|NCT02956993|PAD|pad
5270653|NCT02327052|Chagas disease|chagas disease
5270654|NCT02327052|longitudinal global strain|longitudinal global strain
5270655|NCT02327052|speckle tracking|speckle tracking
5270661|NCT02326961|adipose derived regenerative cells|adipose derived regenerative cells
5270662|NCT02326961|ADRC|adrc
5270663|NCT02326961|Celution|celution
5270664|NCT02326961|arthritis|arthritis
5270665|NCT02326948|Gallbladder cancer|gallbladder cancer
5270666|NCT02326948|Case-control study|case-control study
5270667|NCT02326948|Risk factor|risk factor
5270668|NCT02326948|Alcohol consumption|alcohol consumption
5270669|NCT02326948|Polypoid lesions of gallbladder|polypoid lesions of gallbladder
5270670|NCT02326948|Biliary stone|biliary stone
5270671|NCT02326935|MS|ms
5270672|NCT02326935|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5270673|NCT02326935|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
5270674|NCT02326935|Myelitis|myelitis
5270675|NCT02326922|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5270676|NCT02326922|Metraplant-E|metraplant-e
5270677|NCT02326922|Levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
5270678|NCT02326922|Endometrial decidualization|endometrial decidualization
5258056|NCT02400554|Oklahoma|oklahoma
5270679|NCT02326909|Upper Urinary Tract|upper urinary tract
5270680|NCT02326909|Optical Coherence Tomography|optical coherence tomography
5270681|NCT02326909|Transitional Cell Carcinoma|transitional cell carcinoma
5270682|NCT02326909|Urothelial Cell Carcinoma|urothelial cell carcinoma
5270683|NCT02326909|Diagnostic accuracy|diagnostic accuracy
5270684|NCT02326896|intubation|intubation
5270685|NCT02326896|intensive care unit|intensive care unit
5270686|NCT02326896|MACOCHA Score|macocha score
5270687|NCT02326870|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5270688|NCT02326870|laparoscope holder|laparoscope holder
5270689|NCT02326870|gynecological laparoscopy procedures|gynecological laparoscopy procedures
5270690|NCT02326870|fundoplication surgery|fundoplication surgery
5270691|NCT02326870|laparoscopic adnexal surgery|laparoscopic adnexal surgery
5903761|NCT00339521|Polymorphism|polymorphism
5270692|NCT02326870|excision of endometriosis lesion|excision of endometriosis lesion
5270693|NCT02326870|diagnostic laparoscopy procedures|diagnostic laparoscopy procedures
5270694|NCT02326870|right hemicolectomy|right hemicolectomy
5270695|NCT02326870|Diaphragmatic hernia|diaphragmatic hernia
5270701|NCT02326844|Germline BRCA1/2 Mutations (gBRCAm)|germline brca1/2 mutations (gbrcam)
5270702|NCT02326844|DNA Damaging Agents|dna damaging agents
5270703|NCT02326844|FOX03a, 53BP1 and RAD51|fox03a, 53bp1 and rad51
5270708|NCT02326792|Exercise|exercise
5270709|NCT02326792|Training|training
5270710|NCT02326792|Low back Pain|low back pain
5270711|NCT02326792|Physical Therapy|physical therapy
5270712|NCT02326779|esophageal cancer|esophageal cancer
5270713|NCT02326779|aspirin|aspirin
5270714|NCT02326779|survival|survival
5270730|NCT02326597|Chronic blood transfusion|chronic blood transfusion
5271026|NCT02325128|extinction|extinction
5270731|NCT02326597|Treatment options for sickle cell disease|treatment options for sickle cell disease
5270732|NCT02326597|Decision making|decision making
5270733|NCT02326584|Acute Myeloid Leukemia|acute myeloid leukemia
5270734|NCT02326584|Antibody-Drug Conjugate|antibody-drug conjugate
5270735|NCT02326584|CD33 Antigen|cd33 antigen
5270736|NCT02326584|Drug Therapy|drug therapy
5270737|NCT02326584|Acute Myelogenous Leukemia|acute myelogenous leukemia
5270739|NCT02326571|Cortical Spreading Depression|cortical spreading depression
5270740|NCT02326571|Cerebral Hemorrhage|cerebral hemorrhage
5270741|NCT02326571|miRNA|mirna
5270742|NCT02326571|Reactivity in EEG|reactivity in eeg
5270743|NCT02326571|Multimodal monitoring|multimodal monitoring
5270744|NCT02326558|zero ischemia|zero ischemia
5270745|NCT02326558|microwave|microwave
5270746|NCT02326558|ablation|ablation
5270747|NCT02326558|enucleation|enucleation
5270748|NCT02326558|renal cell carcinoma|renal cell carcinoma
5270749|NCT02326545|Video Games|video games
5270750|NCT02326545|Child|child
5270751|NCT02326545|Adolescent|adolescent
5270752|NCT02326532|Rheumatoid Arthritis|rheumatoid arthritis
5270753|NCT02326532|Veterans|veterans
5270754|NCT02326506|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5270755|NCT02326506|Cardiopulmonary Bypass|cardiopulmonary bypass
5270756|NCT02326493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5270757|NCT02326493|LV lead position|lv lead position
5270758|NCT02326493|Device programming|device programming
5270759|NCT02326493|Optimization|optimization
5270760|NCT02326493|Vectorcardiography|vectorcardiography
5270761|NCT02326480|Childhood Obesity|childhood obesity
5270762|NCT02326480|Genetics|genetics
5270763|NCT02326467|chlorhexidine|chlorhexidine
5270764|NCT02326467|safety|safety
5270765|NCT02326467|bath|bath
5270766|NCT02326467|rash|rash
5270767|NCT02326467|infant|infant
5270769|NCT02326441|refractory therapies|refractory therapies
5270770|NCT02326441|phase 1|phase 1
5270771|NCT02326428|Stroke|stroke
5270772|NCT02326428|Cerebrovascular Accident|cerebrovascular accident
5270773|NCT02326428|Brain ischemia|brain ischemia
5270774|NCT02326428|Intravenous thrombolysis|intravenous thrombolysis
5270775|NCT02326428|Stroke thrombectomy|stroke thrombectomy
5270776|NCT02326428|Stent-retriever|stent-retriever
5270777|NCT02326415|Acute Appendicitis|acute appendicitis
5270778|NCT02326415|Appendectomy|appendectomy
5270779|NCT02326415|Fast-Track|fast-track
5270780|NCT02326415|Clinical Pathway|clinical pathway
5270781|NCT02326402|Circulatory support|circulatory support
5270782|NCT02326402|Extracorporeal circulatory support|extracorporeal circulatory support
5270783|NCT02326402|Extracorporeal bypass|extracorporeal bypass
5270784|NCT02326389|Cognitive functioning|cognitive functioning
5270785|NCT02326363|substance abuse|substance abuse
5270786|NCT02326363|Mental Health Disorders|mental health disorders
5270787|NCT02326350|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
5270788|NCT02326350|Aspirin|aspirin
5270789|NCT02326298|Certolizumab Pegol|certolizumab pegol
5270790|NCT02326298|Cimzia|cimzia
5270791|NCT02326298|Psoriasis|psoriasis
5258156|NCT02399995|Quality of Life|quality of life
5270792|NCT02326285|induction therapy|induction therapy
5270793|NCT02326285|NSCLC|nsclc
5270794|NCT02326285|Non-small Cell Lung Cancer|non-small cell lung cancer
5270795|NCT02326285|curative surgery|curative surgery
5270796|NCT02326272|Certolizumab Pegol|certolizumab pegol
5270797|NCT02326272|Cimzia|cimzia
5270800|NCT02326259|Disease Progression|disease progression
5270801|NCT02326246|MRI|mri
5270802|NCT02326246|active surveillance|active surveillance
5270803|NCT02326207|Infant, Newborn|infant, newborn
5270804|NCT02326207|Neonatal intensive care unit|neonatal intensive care unit
5270805|NCT02326207|Ventilator circuit|ventilator circuit
5270806|NCT02326194|Safety,immunogenicity,Ebola|safety,immunogenicity,ebola
5270807|NCT02326181|respiratory muscle training|respiratory muscle training
5270808|NCT02326181|respiratory muscle strength|respiratory muscle strength
5270809|NCT02326181|respiratory endurance test|respiratory endurance test
5270810|NCT02326181|6-minute walking test|6-minute walking test
5270811|NCT02326142|Premature Obstetric Labor|premature obstetric labor
5270812|NCT02326142|Premature Birth|premature birth
5270813|NCT02326103|alcoholic|alcoholic
5270814|NCT02326103|hepatitis|hepatitis
5270815|NCT02326103|cirrhosis|cirrhosis
5270816|NCT02326103|cholesterol metabolites|cholesterol metabolites
5270817|NCT02326103|ciprofloxacin|ciprofloxacin
5270818|NCT02326077|sonopartogram|sonopartogram
5270819|NCT02326077|transperineal ultrasound|transperineal ultrasound
5270820|NCT02326077|intrapartum ultrasound|intrapartum ultrasound
5270821|NCT02326077|labor|labor
5270822|NCT02326077|delivery|delivery
5270823|NCT02326077|partogram|partogram
5270824|NCT02326077|ultrasound|ultrasound
5270825|NCT02326051|Antiphospholipid syndrome|antiphospholipid syndrome
5270827|NCT02326051|LMWH|lmwh
5270828|NCT02326038|Memory|memory
5270829|NCT02326038|Attention|attention
5270830|NCT02326038|MCI|mci
5270831|NCT02326038|Ritalin|ritalin
5271024|NCT02325128|social anxiety|social anxiety
5270834|NCT02325999|early gastric cancer|early gastric cancer
5270835|NCT02325999|Disease-free survival|disease-free survival
5270837|NCT02325986|esophageal carcinoma|esophageal carcinoma
5270838|NCT02325986|chemotherapy|chemotherapy
5270839|NCT02325973|STEMI|stemi
5270840|NCT02325973|IMR|imr
5270841|NCT02325973|FFR|ffr
5270842|NCT02325973|microcirculatory|microcirculatory
5270843|NCT02325960|exenatide|exenatide
5270844|NCT02325960|insulin glargine|insulin glargine
5270845|NCT02325947|Post stroke hand paresis brain injury|post stroke hand paresis brain injury
5270846|NCT02325934|Stribild|stribild
5270847|NCT02325934|pharmacokinetics|pharmacokinetics
5270848|NCT02325934|Crushing|crushing
5270849|NCT02325934|Drip feed|drip feed
5270853|NCT02325908|Hemodialysis|hemodialysis
5270854|NCT02325908|Estimated Dry Weight|estimated dry weight
5270855|NCT02325895|Osteoporosis|osteoporosis
5270856|NCT02325895|Dried plum|dried plum
5270857|NCT02325895|functional food|functional food
5270858|NCT02325869|Acute Coronary Syndrome, Coronary Occlusion, catheter|acute coronary syndrome, coronary occlusion, catheter
5270859|NCT02325856|Hemodialysis|hemodialysis
5270860|NCT02325856|Body Composition Monitor|body composition monitor
5270861|NCT02325830|Functional mitral regurgitation|functional mitral regurgitation
5270862|NCT02325830|Secondary mitral regurgitation|secondary mitral regurgitation
5270863|NCT02325830|Percutaneous mitral repair|percutaneous mitral repair
5270864|NCT02325817|Bifurcation Lesions|bifurcation lesions
5270865|NCT02325817|drug eluting balloon|drug eluting balloon
5270866|NCT02325817|paclitaxel|paclitaxel
5270867|NCT02325817|drug coated balloon|drug coated balloon
5270868|NCT02325804|overweight and obesity|overweight and obesity
5270869|NCT02325804|adipose tissue|adipose tissue
5270870|NCT02325804|weight loss program|weight loss program
5270871|NCT02325804|low-calorie diet|low-calorie diet
5270872|NCT02325804|circuit-based exercise|circuit-based exercise
5270873|NCT02325804|metabolic cardiovascular syndrome|metabolic cardiovascular syndrome
5270874|NCT02325765|congential cardiac surgery|congential cardiac surgery
5270875|NCT02325765|nuclearsome|nuclearsome
5270876|NCT02325765|systemic inflammation response syndrome|systemic inflammation response syndrome
5270877|NCT02325752|readmission|readmission
5270878|NCT02325752|chronic diseases|chronic diseases
5270880|NCT02325726|Cardiac surgery|cardiac surgery
5270881|NCT02325726|Extracorporeal circulation|extracorporeal circulation
5270882|NCT02325726|Renal failure|renal failure
5270883|NCT02325713|ODT-PZQ|odt-pzq
5270884|NCT02325713|Bio-availability|bio-availability
5270885|NCT02325713|Praziquantel|praziquantel
5270886|NCT02325713|Cysticide|cysticide
5270887|NCT02325713|Pharmacokinetics|pharmacokinetics
5270888|NCT02325687|Obstructive Sleep Apnea|obstructive sleep apnea
5270889|NCT02325687|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5270890|NCT02325687|Cerebrospinal Fluid|cerebrospinal fluid
5270891|NCT02325687|Inflammation|inflammation
5270892|NCT02325687|TNF-alpha|tnf-alpha
5270893|NCT02325687|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5270894|NCT02325687|Interleukin-8 (IL-8)|interleukin-8 (il-8)
5903762|NCT00339521|Genetic Predisposition|genetic predisposition
5270895|NCT02325687|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5270896|NCT02325687|Cytokines|cytokines
5270897|NCT02325687|Neurotrophins|neurotrophins
5270898|NCT02325687|BDNF|bdnf
5270899|NCT02325687|Beta-NGF|beta-ngf
5270900|NCT02325687|Proteomic Analysis|proteomic analysis
5270902|NCT02325674|Metreleptin Registry|metreleptin registry
5270903|NCT02325635|Adenoma Detection|adenoma detection
5270904|NCT02325635|Adenoma Prediction|adenoma prediction
5270905|NCT02325596|Chronic rhinosinusitis|chronic rhinosinusitis
5270906|NCT02325596|microRNA|microrna
5270907|NCT02325596|dendritic cell|dendritic cell
5270908|NCT02325596|helper T cell|helper t cell
5270909|NCT02325583|Intraoral 30% glucose, newborn, MRI|intraoral 30% glucose, newborn, mri
5270910|NCT02325544|dissociative seizures,|dissociative seizures,
5270911|NCT02325544|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
5270912|NCT02325531|implementation strategies|implementation strategies
5270913|NCT02325531|diabetes mellitus|diabetes mellitus
5270914|NCT02325531|cardiovascular disease|cardiovascular disease
5270915|NCT02325531|community health centers|community health centers
5270916|NCT02325531|quality improvement|quality improvement
5270917|NCT02325531|translational medical research|translational medical research
5270918|NCT02325518|Open-angle glaucoma (OAG)|open-angle glaucoma (oag)
5270919|NCT02325518|Ocular hypertension (OHT)|ocular hypertension (oht)
5270920|NCT02325518|AZORGA®|azorga®
5270921|NCT02325518|COSOPT®|cosopt®
5270922|NCT02325492|bariatric surgery|bariatric surgery
5270923|NCT02325492|NASH|nash
5270924|NCT02325492|ARAMCHOL|aramchol
5271025|NCT02325128|exposure therapy|exposure therapy
5270925|NCT02325479|Low Molecular Weight (LMWH) Heparin ICSI Enaoxaprin sodium|low molecular weight (lmwh) heparin icsi enaoxaprin sodium
5270926|NCT02325466|Peripheral Artery Disease|peripheral artery disease
5270927|NCT02325466|Type 2 Diabetes|type 2 diabetes
5270928|NCT02325466|Blood Viscosity|blood viscosity
5270929|NCT02325466|Ticagrelor|ticagrelor
5270930|NCT02325466|Aspirin|aspirin
5270931|NCT02325453|Robotic Surgery|robotic surgery
5270932|NCT02325453|Laparoscopic Surgery|laparoscopic surgery
5270933|NCT02325453|Minimally Invasive Surgery|minimally invasive surgery
5270934|NCT02325453|Robotic Gastrectomy|robotic gastrectomy
5270935|NCT02325453|Laparoscopic Gastrectomy|laparoscopic gastrectomy
5270936|NCT02325453|Open Gastrectomy|open gastrectomy
5270937|NCT02325453|Gastric Surgery|gastric surgery
5270938|NCT02325440|RRMS (relapsing remitting multiple sclerosis)|rrms (relapsing remitting multiple sclerosis)
5270939|NCT02325440|Cluster of differentiation 49d (CD49d)|cluster of differentiation 49d (cd49d)
5270940|NCT02325440|immune function|immune function
5270941|NCT02325440|disease activity|disease activity
5270942|NCT02325427|stroke|stroke
5270943|NCT02325427|rehabilitation|rehabilitation
5270944|NCT02325427|upper limb|upper limb
5270946|NCT02325427|tDCS|tdcs
5270947|NCT02325414|Osteoporosis|osteoporosis
5270948|NCT02325414|Spinal Cord Injury|spinal cord injury
5270949|NCT02325414|Bone Diseases|bone diseases
5270950|NCT02325414|Metabolic Bone Diseases|metabolic bone diseases
5270951|NCT02325414|Musculoskeletal Diseases|musculoskeletal diseases
5270952|NCT02325414|Spinal Cord Diseases|spinal cord diseases
5270953|NCT02325414|Central Nervous System Diseases|central nervous system diseases
5270954|NCT02325414|Nervous System Diseases|nervous system diseases
5270955|NCT02325414|Nervous System|nervous system
5270956|NCT02325414|Wounds and Injuries|wounds and injuries
5270957|NCT02325414|Bone Density Conservation Agents|bone density conservation agents
5270958|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs
5270959|NCT02325414|Pharmacologic Actions|pharmacologic actions
5270960|NCT02325414|Department of Defense|department of defense
5270961|NCT02325388|pressure ulcer|pressure ulcer
5270962|NCT02325388|decubitus ulcer|decubitus ulcer
5270963|NCT02325388|bed sore|bed sore
5270964|NCT02325388|continuous pressure mapping|continuous pressure mapping
5270965|NCT02325388|interface pressure imaging|interface pressure imaging
5862752|NCT00001524|Clinical Trial|clinical trial
5270966|NCT02325375|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5270967|NCT02325375|spinal fluid|spinal fluid
5270968|NCT02325375|CD163|cd163
5270969|NCT02325362|Cystic fibrosis|cystic fibrosis
5270970|NCT02325362|CFTR|cftr
5270971|NCT02325362|F508del mutation|f508del mutation
5270972|NCT02325362|Miglustat|miglustat
5270973|NCT02325362|Total Chloride Secretion|total chloride secretion
5270974|NCT02325362|Nasal Potential Difference|nasal potential difference
5270975|NCT02325349|Angiogenesis|angiogenesis
5270976|NCT02325349|Integrins|integrins
5270977|NCT02325349|RGD PET/CT|rgd pet/ct
5270978|NCT02325349|FDG PET/CT|fdg pet/ct
5270979|NCT02325349|Predictive value|predictive value
5270980|NCT02325349|Therapeutic response|therapeutic response
5270981|NCT02325349|Efficacy|efficacy
5270982|NCT02325349|Tolerability|tolerability
5270983|NCT02325336|Medication Errors|medication errors
5270984|NCT02325336|nurses|nurses
5270985|NCT02325336|hospital|hospital
5270986|NCT02325323|stomach cancer|stomach cancer
5270987|NCT02325323|gastric intestinal metaplasia|gastric intestinal metaplasia
5270988|NCT02325323|prospective cohort|prospective cohort
5270989|NCT02325323|low grade dysplasia|low grade dysplasia
5270990|NCT02325323|high grade dysplasia|high grade dysplasia
5270991|NCT02325323|prognosis factor|prognosis factor
5270992|NCT02325323|gastric cancer risks|gastric cancer risks
5270993|NCT02325310|Vaccine strain excretion in breast milk|vaccine strain excretion in breast milk
5270996|NCT02325310|Measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
5270997|NCT02325310|Breast milk|breast milk
5270998|NCT02325310|Vaccinology|vaccinology
5270999|NCT02325297|Intensive care unit|intensive care unit
5271000|NCT02325258|Sepsis diagnosis|sepsis diagnosis
5271001|NCT02325258|Sepsis drug therapy|sepsis drug therapy
5271002|NCT02325258|Sepsis outcome|sepsis outcome
5271003|NCT02325245|Frailty|frailty
5271004|NCT02325245|Pre-frailty|pre-frailty
5140207|NCT03114228|AML|aml
5151953|NCT03042585|BMT|bmt
5271005|NCT02325245|Metformin|metformin
5271006|NCT02325245|Elderly|elderly
5271007|NCT02325245|Quality of life|quality of life
5271008|NCT02325245|Handgrip|handgrip
5271009|NCT02325245|Gait speed|gait speed
5271010|NCT02325245|Myostatin|myostatin
5271011|NCT02325219|Psoriasis|psoriasis
5271012|NCT02325219|CNTO 1959|cnto 1959
5271013|NCT02325219|Guselkumab|guselkumab
5271014|NCT02325219|Placebo|placebo
5271015|NCT02325180|ACT|act
5271016|NCT02325180|Plasmodium falciparum|plasmodium falciparum
5271017|NCT02325180|malaria|malaria
5271018|NCT02325180|efficacy|efficacy
5271019|NCT02325180|Indonesia|indonesia
5271020|NCT02325167|informal caregivers|informal caregivers
5271021|NCT02325167|mental stress|mental stress
5271022|NCT02325167|quality of life|quality of life
5271023|NCT02325167|psychotherapeutic intervention|psychotherapeutic intervention
5271027|NCT02325128|sleep-dependent memory consolidation|sleep-dependent memory consolidation
5271028|NCT02325115|well-being, mental health, schizophrenia, quality of life|well-being, mental health, schizophrenia, quality of life
5271029|NCT02325089|Elderly|elderly
5271030|NCT02325089|Obstructive Sleep Apnea|obstructive sleep apnea
5271031|NCT02325089|Mandibular advancement oral appliance|mandibular advancement oral appliance
5271032|NCT02325089|Hypertension|hypertension
5271033|NCT02325089|Cardiovascular disease|cardiovascular disease
5271034|NCT02325089|Quality of life|quality of life
5271035|NCT02325076|Airway Management|airway management
5271036|NCT02325076|intubation|intubation
5271037|NCT02325076|pulmonary function test|pulmonary function test
5271038|NCT02325050|Healthy|healthy
5271039|NCT02325050|Ebola viruses|ebola viruses
5271040|NCT02325050|Ebola Viral Disease (EVD)|ebola viral disease (evd)
5271041|NCT02325050|Filoviruses|filoviruses
5271042|NCT02325050|monovalent vaccine|monovalent vaccine
5271043|NCT02325050|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5271044|NCT02325050|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
5271045|NCT02325050|Safety|safety
5271046|NCT02325050|Immunogenicity|immunogenicity
5271047|NCT02325024|Sativex|sativex
5271048|NCT02325024|GW-1000-02|gw-1000-02
5271049|NCT02325024|Nabiximols|nabiximols
5271050|NCT02325024|Pharmacokinetics|pharmacokinetics
5271051|NCT02325024|Renal Insufficiency|renal insufficiency
5271052|NCT02325024|Chronic Kidney Failure|chronic kidney failure
5271053|NCT02325011|Sativex|sativex
5271054|NCT02325011|GW-1000-02|gw-1000-02
5271055|NCT02325011|Nabiximols|nabiximols
5271056|NCT02325011|Fluconazole|fluconazole
5271057|NCT02325011|Pharmacokinetics|pharmacokinetics
5271058|NCT02325011|Drug-drug interaction|drug-drug interaction
5271059|NCT02324998|Radical Prostatectomy|radical prostatectomy
5271060|NCT02324998|Prostate Cancer|prostate cancer
5271061|NCT02324998|PARP inhibition|parp inhibition
5271062|NCT02324998|Olaparib|olaparib
5271063|NCT02324998|Degarelix|degarelix
5271064|NCT02324998|Neoadjuvant|neoadjuvant
5271065|NCT02324998|Pharmacodynamics|pharmacodynamics
5271066|NCT02324998|Pharmacokinetics|pharmacokinetics
5271067|NCT02324998|Biomarkers|biomarkers
5271068|NCT02324985|muscle soreness|muscle soreness
5271069|NCT02324972|Atopic dermatitis|atopic dermatitis
5271070|NCT02324972|Eczema|eczema
5271077|NCT02324920|Syncope|syncope
5271078|NCT02324920|Closed Loop Stimulation|closed loop stimulation
5271079|NCT02324920|CLS|cls
5271080|NCT02324894|screening|screening
5271081|NCT02324894|MRI|mri
5271082|NCT02324881|smartphone|smartphone
5271083|NCT02324881|application|application
5271084|NCT02324881|pain management|pain management
5271085|NCT02324868|Bandages|bandages
5271086|NCT02324868|Catheter|catheter
5271087|NCT02324855|Autogenic drainage|autogenic drainage
5271088|NCT02324855|Positive expiratory pressure|positive expiratory pressure
5271089|NCT02324855|Airway clearance technique|airway clearance technique
5271090|NCT02324855|Quality of life|quality of life
5271091|NCT02324855|Exacerbations|exacerbations
5271092|NCT02324855|Chest physiotherapy|chest physiotherapy
5271093|NCT02324829|Total joint replacement|total joint replacement
5271094|NCT02324829|Physiotherapy|physiotherapy
5258460|NCT02398058|sarcoma|sarcoma
5271095|NCT02324829|Kalman filtering|kalman filtering
5271096|NCT02324829|Kinematic modeling|kinematic modeling
5271097|NCT02324829|Hidden Markov model|hidden markov model
5271098|NCT02324829|Motion segmentation|motion segmentation
5271099|NCT02324790|OSA, Oral Pressure Therapy (OPT)|osa, oral pressure therapy (opt)
5271100|NCT02324764|transradial coronary angiography|transradial coronary angiography
5271101|NCT02324764|radial artery occlusion|radial artery occlusion
5271102|NCT02324764|coronary heart disease|coronary heart disease
5271103|NCT02324764|Glidesheath Slender|glidesheath slender
5271104|NCT02324738|Mefloquine/Dihydroartemisinin-piperaquine|mefloquine/dihydroartemisinin-piperaquine
5271105|NCT02324738|drug interaction|drug interaction
5271107|NCT02324725|neuroimaging|neuroimaging
5271108|NCT02324725|heroin|heroin
5271109|NCT02324725|addiction|addiction
5271110|NCT02324725|dependence|dependence
5271111|NCT02324725|opioid|opioid
5271112|NCT02324725|Vivitrol®|vivitrol®
5271113|NCT02324725|functional magnetic resonance imaging|functional magnetic resonance imaging
5271114|NCT02324699|Vedolizumab|vedolizumab
5271115|NCT02324699|Corticosteroids|corticosteroids
5271116|NCT02324699|Prednisone|prednisone
5271117|NCT02324699|Crohn's disease|crohn's disease
5271118|NCT02324686|Warfarin|warfarin
5271119|NCT02324686|International Normalized Ratio|international normalized ratio
5271120|NCT02324686|Vitamin K|vitamin k
5271121|NCT02324673|Treatment-resistant seizures|treatment-resistant seizures
5271122|NCT02324660|screening procedure|screening procedure
5271123|NCT02324660|peak expiratory flow|peak expiratory flow
5271516|NCT02322489|microcurent|microcurent
5271132|NCT02324595|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5271133|NCT02324595|Robotic|robotic
5271134|NCT02324595|Interval Debulking Surgery|interval debulking surgery
5271135|NCT02324582|Urinary Bladder Neoplasms|urinary bladder neoplasms
5271136|NCT02324582|Mycobacterium bovis|mycobacterium bovis
5271137|NCT02324582|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
5271138|NCT02324582|pembrolizumab|pembrolizumab
5271139|NCT02324569|Pharmacological therapy|pharmacological therapy
5271140|NCT02324556|Rectal Cancer|rectal cancer
5271141|NCT02324556|Surgery|surgery
5271142|NCT02324556|Laparoscopy|laparoscopy
5271143|NCT02324517|response to various potential therapies as managed by lab assays|response to various potential therapies as managed by lab assays
5271147|NCT02324478|autonomic nervous system|autonomic nervous system
5271148|NCT02324478|heart rate variability|heart rate variability
5271149|NCT02324478|laparoscopic surgery|laparoscopic surgery
5271150|NCT02324478|general anesthesia|general anesthesia
5271151|NCT02324478|photoplethysmography|photoplethysmography
5271152|NCT02324439|ovarian cancer|ovarian cancer
5271153|NCT02324439|flaxseed|flaxseed
5271154|NCT02324439|dietary supplement|dietary supplement
5271155|NCT02324439|organic dietary supplement|organic dietary supplement
5271156|NCT02324439|recurrence|recurrence
5271157|NCT02324426|Parkinson's Disease|parkinson's disease
5271158|NCT02324426|Reduced Glutathione|reduced glutathione
5271160|NCT02324426|Glutathione|glutathione
5271161|NCT02324426|Uptake|uptake
5271162|NCT02324426|Intranasal|intranasal
5271163|NCT02324426|(in)GSH|(in)gsh
5271170|NCT02324374|colon cancer|colon cancer
5271171|NCT02324361|Pediatric|pediatric
5271172|NCT02324361|Obesity|obesity
5271173|NCT02324361|Intervention|intervention
5271174|NCT02324361|Information and Communication Technologies|information and communication technologies
5271175|NCT02324361|Social Media|social media
5271176|NCT02324361|Text Messaging|text messaging
5271177|NCT02324361|Mobile Health|mobile health
5271178|NCT02324335|Oral Mucositis|oral mucositis
5271179|NCT02324335|Brilacidin|brilacidin
5271180|NCT02324335|Chemoradiation|chemoradiation
5271181|NCT02324322|Device: Robotic Exoskeleton|device: robotic exoskeleton
5271182|NCT02324296|small cell lung cancer|small cell lung cancer
5271183|NCT02324296|extended disease|extended disease
5271184|NCT02324296|limited disease|limited disease
5271185|NCT02324296|chemotherapy|chemotherapy
5271187|NCT02324296|etoposide|etoposide
5271188|NCT02324296|ifosfamide|ifosfamide
5271189|NCT02324283|one-lung ventilation, oxygenation|one-lung ventilation, oxygenation
5271190|NCT02324270|Pain due to ankle sprain|pain due to ankle sprain
5271191|NCT02324244|Cytomegalovirus|cytomegalovirus
5271192|NCT02324244|critical patient|critical patient
5271193|NCT02324244|ICU|icu
5271194|NCT02324244|immunocompetent|immunocompetent
5271195|NCT02324244|clinical suspicion|clinical suspicion
5271196|NCT02324244|risk factors|risk factors
5271197|NCT02324218|Diabetes mellitus|diabetes mellitus
5271198|NCT02324218|Hepatitis B|hepatitis b
5271199|NCT02324218|Incidence|incidence
5271200|NCT02324192|Ultrasonography|ultrasonography
5271201|NCT02324192|clinical|clinical
5271202|NCT02324192|hand|hand
5271203|NCT02324166|cefazolin|cefazolin
5271204|NCT02324166|lidocaine|lidocaine
5271205|NCT02324153|Post-operative Delirium|post-operative delirium
5271206|NCT02324114|Cancer|cancer
5271207|NCT02324075|sanitation, toilet, urban, behavior change|sanitation, toilet, urban, behavior change
5271209|NCT02324062|Multi-gene cancer panel testing|multi-gene cancer panel testing
5271210|NCT02324049|MPS IIIB|mps iiib
5271236|NCT02323945|incomplete spinal cord injury|incomplete spinal cord injury
5271237|NCT02323945|strength|strength
5271238|NCT02323945|walking|walking
5271239|NCT02323945|breathing|breathing
5271240|NCT02323919|myocardial infarction|myocardial infarction
5271241|NCT02323919|coronary artery bypass graft (CABG)|coronary artery bypass graft (cabg)
5271242|NCT02323919|angioplasty|angioplasty
5271243|NCT02323919|exercise|exercise
5271244|NCT02323919|cardiac patient|cardiac patient
5271245|NCT02323919|physical activity|physical activity
5271246|NCT02323906|Hepatocellular|hepatocellular
5271247|NCT02323906|Carcinoma|carcinoma
5271248|NCT02323906|Phase 1|phase 1
5271249|NCT02323906|CC-122|cc-122
5271250|NCT02323906|Sorafenib,|sorafenib,
5152175|NCT03041311|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5271251|NCT02323906|Nexavar|nexavar
5271252|NCT02323906|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5271253|NCT02323906|Unresectable HCCAdvanced,|unresectable hccadvanced,
5271254|NCT02323906|Hepatocellular Carcinoma|hepatocellular carcinoma
5271255|NCT02323906|liver cancer|liver cancer
5271256|NCT02323893|Positron Emission Tomography|positron emission tomography
5271257|NCT02323893|Cancer Immunotherapy|cancer immunotherapy
5271258|NCT02323867|Transplant|transplant
5271259|NCT02323867|Alternative Donor|alternative donor
5271260|NCT02323854|primary, recurrent, metastatic lung tumor, ablation|primary, recurrent, metastatic lung tumor, ablation
5271261|NCT02323841|cervical cancer|cervical cancer
5271262|NCT02323841|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5271263|NCT02323841|Adverse Effects|adverse effects
5271264|NCT02323815|child acute malnutrition prevention|child acute malnutrition prevention
5271265|NCT02323815|behavior change communication|behavior change communication
5271266|NCT02323815|lipid-based nutrient supplement|lipid-based nutrient supplement
5271267|NCT02323815|screening coverage|screening coverage
5271268|NCT02323763|Magnetic Resonance Imaging|magnetic resonance imaging
5271269|NCT02323763|Bipolar Disorder|bipolar disorder
5271270|NCT02323763|Suicidal Ideation|suicidal ideation
5271271|NCT02323698|hypoxia|hypoxia
5271272|NCT02323698|spinal cord injury|spinal cord injury
5271273|NCT02323698|rehabilitation|rehabilitation
5271274|NCT02323698|strength|strength
5271275|NCT02323698|walk|walk
5271276|NCT02323698|function|function
5271277|NCT02323698|low oxygen|low oxygen
5271278|NCT02323685|DCI|dci
5271279|NCT02323685|Delayed Cerebral Ischemia|delayed cerebral ischemia
5271280|NCT02323685|SAH|sah
5276187|NCT02296385|volunteers|volunteers
5271281|NCT02323685|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5271282|NCT02323685|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
5271283|NCT02323685|Cerebral Ischemia|cerebral ischemia
5271284|NCT02323685|Brain Ischemia|brain ischemia
5271285|NCT02323659|Mycosis Fungoides|mycosis fungoides
5271286|NCT02323659|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5271287|NCT02323659|Interferon|interferon
5271288|NCT02323659|Methotrexate|methotrexate
5271289|NCT02323646|uterine fibroids|uterine fibroids
5271290|NCT02323646|leiomyoma|leiomyoma
5271291|NCT02323646|fibroid tumor|fibroid tumor
5271293|NCT02323633|Pediatric Attention Deficit Hyperactivity Disorder|pediatric attention deficit hyperactivity disorder
5271294|NCT02323620|Acute myocardial Infarction|acute myocardial infarction
5271295|NCT02323620|bone marrow|bone marrow
5271296|NCT02323620|stem cells|stem cells
5271297|NCT02323620|cardiovascular disease|cardiovascular disease
5271298|NCT02323620|mortality|mortality
5271299|NCT02323581|Thoracoabdominal|thoracoabdominal
5271300|NCT02323581|Aneurysm|aneurysm
5271301|NCT02323581|Endovascular|endovascular
5271302|NCT02323581|Stent-Graft|stent-graft
5271303|NCT02323568|ovarian cancer|ovarian cancer
5271304|NCT02323568|quality of life|quality of life
5271305|NCT02323568|remission more than 3 years|remission more than 3 years
5271306|NCT02323555|Cancer|cancer
5271309|NCT02323555|Day Hospital|day hospital
5271311|NCT02323542|cereal products|cereal products
5271312|NCT02323542|glucose kinetics|glucose kinetics
5271313|NCT02323542|blood glucose|blood glucose
5271314|NCT02323542|blood insulin|blood insulin
5271315|NCT02323529|Orfadin|orfadin
5271316|NCT02323529|Nitisinone|nitisinone
5271317|NCT02323529|NTBC|ntbc
5271318|NCT02323503|CRT-D|crt-d
5271319|NCT02323503|replacement|replacement
5271320|NCT02323503|primary prevention|primary prevention
5271321|NCT02323503|ventricular tachyarrhythmias|ventricular tachyarrhythmias
5271322|NCT02323490|meniscus repair|meniscus repair
5271323|NCT02323490|bone marrow stimulation|bone marrow stimulation
5271324|NCT02323477|cellular therapy|cellular therapy
5271325|NCT02323477|chronic ischemic heart disease|chronic ischemic heart disease
5271326|NCT02323477|phase 1/2 clinical study|phase 1/2 clinical study
5271327|NCT02323477|human umbilical cord multipotent stem cell|human umbilical cord multipotent stem cell
5271328|NCT02323477|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
5271330|NCT02323477|bone marrow mononuclear cell|bone marrow mononuclear cell
5271331|NCT02323477|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5271332|NCT02323438|biomarkers of tobacco exposure|biomarkers of tobacco exposure
5271333|NCT02323438|exposure|exposure
5271335|NCT02323438|nicotine|nicotine
5271336|NCT02323438|nicotine gum|nicotine gum
5271337|NCT02323438|electronic cigarette|electronic cigarette
5271338|NCT02323438|e-cig|e-cig
5271339|NCT02323425|stroke|stroke
5271340|NCT02323425|Remote ischemic postconditioning|remote ischemic postconditioning
5271341|NCT02323425|symptomatic atherosclerotic intracranial arterial stenosis|symptomatic atherosclerotic intracranial arterial stenosis
5271342|NCT02323412|Low back pain|low back pain
5271343|NCT02323412|Chronic|chronic
5271344|NCT02323412|Modic Changes|modic changes
5271345|NCT02323412|MRI|mri
5271346|NCT02323412|epigenetics|epigenetics
5271347|NCT02323412|antibiotics|antibiotics
5152304|NCT03040427|PET scan|pet scan
5271348|NCT02323412|randomized placebo controlled trial|randomized placebo controlled trial
5271349|NCT02323386|Dynamic RSA|dynamic rsa
5271350|NCT02323386|Knee|knee
5271351|NCT02323386|Total Knee Arthroplasty|total knee arthroplasty
5271352|NCT02323386|Kinematic Analysis|kinematic analysis
5271353|NCT02323373|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5271354|NCT02323373|Tranexamic Acid|tranexamic acid
5271355|NCT02323373|Drug Administration Routes|drug administration routes
5271356|NCT02323360|SBRT|sbrt
5271357|NCT02323360|TACE|tace
5271358|NCT02323360|TAE|tae
5271359|NCT02323321|heart transplant|heart transplant
5271360|NCT02323321|heart preservation|heart preservation
5271361|NCT02323321|beating heart transplant|beating heart transplant
5271362|NCT02323295|Malignant bone tumors|malignant bone tumors
5271363|NCT02323282|Dose-response relationship|dose-response relationship
5271364|NCT02323282|Drug|drug
5271365|NCT02323256|cochlear implant|cochlear implant
5271366|NCT02323256|deafness|deafness
5271367|NCT02323256|audiometry|audiometry
5271368|NCT02323256|speech perception|speech perception
5271369|NCT02323256|severe to profound deafness restored with cochlear implantation|severe to profound deafness restored with cochlear implantation
5271370|NCT02323243|Detrusor striated sphincter dyssynergia|detrusor striated sphincter dyssynergia
5271371|NCT02323243|Temporary urethral stent|temporary urethral stent
5271372|NCT02323217|Imidazoline Receptor 2|imidazoline receptor 2
5271373|NCT02323217|(4,5-dihydro-1H-imidazol-2-yl)-1-methyl-1H-indole|(4,5-dihydro-1h-imidazol-2-yl)-1-methyl-1h-indole
5271374|NCT02323217|BU99008|bu99008
5271375|NCT02323217|Radionuclide Imaging|radionuclide imaging
5271376|NCT02323217|Molecular Imaging|molecular imaging
5271377|NCT02323217|Healthy Volunteers|healthy volunteers
5271378|NCT02323217|Alzheimer Disease|alzheimer disease
5271379|NCT02323204|posttraumatic stress|posttraumatic stress
5271380|NCT02323178|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5271381|NCT02323178|thrombocytopenia|thrombocytopenia
5271382|NCT02323178|eltrombopag|eltrombopag
5271383|NCT02323152|women|women
5271384|NCT02323152|high risk|high risk
5271385|NCT02323139|High risk MDS|high risk mds
5271386|NCT02323139|Azacitidine|azacitidine
5271387|NCT02323139|LDE255|lde255
5271388|NCT02323126|Non small cell lung cancer,|non small cell lung cancer,
5271389|NCT02323126|NSCLC,|nsclc,
5271390|NCT02323126|EGFR-mutated,|egfr-mutated,
5271391|NCT02323126|EGF816,|egf816,
5271392|NCT02323126|INC280,|inc280,
5271393|NCT02323126|Nivolumab,|nivolumab,
5271394|NCT02323126|EGFR-T790M NSCLC,|egfr-t790m nsclc,
5271395|NCT02323126|EGFR wild-type (wt),|egfr wild-type (wt),
5271396|NCT02323126|cMET positive NSCLC,|cmet positive nsclc,
5271397|NCT02323126|cMET negative NSCLC|cmet negative nsclc
5271398|NCT02323113|Drug therapy|drug therapy
5271399|NCT02323100|cystic fibrosis|cystic fibrosis
5271400|NCT02323100|corrector|corrector
5271401|NCT02323100|glycerol phenylbutyrate|glycerol phenylbutyrate
5271402|NCT02323100|nasal potential difference|nasal potential difference
5271403|NCT02323087|Antibiotic resistance|antibiotic resistance
5271404|NCT02323087|Point of care tests|point of care tests
5271405|NCT02323087|Primary Health Care|primary health care
5271406|NCT02323022|AML|aml
5271407|NCT02323022|cladribine|cladribine
5271408|NCT02323022|induction therapy|induction therapy
5271409|NCT02323009|Transpulmonary pressure|transpulmonary pressure
5271410|NCT02323009|Esophageal balloon|esophageal balloon
5271411|NCT02323009|Esophageal pressure monitoring device|esophageal pressure monitoring device
5271412|NCT02323009|Cstat|cstat
5271413|NCT02323009|Static effective compliance|static effective compliance
5271414|NCT02323009|Ventilator weaning|ventilator weaning
5271415|NCT02323009|Morbidly Obese Ventilator Dependent Tracheotomized Patients|morbidly obese ventilator dependent tracheotomized patients
5271416|NCT02322983|Cerebral Palsy|cerebral palsy
5271417|NCT02322983|Dental Care|dental care
5166397|NCT02952534|BRIP1|brip1
5271418|NCT02322983|Conscious Sedation|conscious sedation
5271419|NCT02322983|Autonomic Nervous System|autonomic nervous system
5271420|NCT02322983|Nitrous Oxide|nitrous oxide
5271421|NCT02322970|intracranial hypertension|intracranial hypertension
5271423|NCT02322970|non invasive|non invasive
5271424|NCT02322970|ICP|icp
5271425|NCT02322944|acute myocardial infarction|acute myocardial infarction
5271426|NCT02322944|quality improvement|quality improvement
5271427|NCT02322944|reperfusion therapy|reperfusion therapy
5271428|NCT02322905|informal caregivers|informal caregivers
5271429|NCT02322905|caregiving|caregiving
5271430|NCT02322905|psychotherapy for caregivers|psychotherapy for caregivers
5271431|NCT02322905|cancer|cancer
5271432|NCT02322905|emotion regulation|emotion regulation
5271433|NCT02322905|distress|distress
5271434|NCT02322905|inflammation|inflammation
5271435|NCT02322892|Thiamine|thiamine
5271436|NCT02322892|Vitamin B1|vitamin b1
5271437|NCT02322892|Coronary artery bypass grafting|coronary artery bypass grafting
5271438|NCT02322892|Cardiac surgery|cardiac surgery
5271439|NCT02322892|Lactate|lactate
5271440|NCT02322892|Pyruvate dehydrogenase|pyruvate dehydrogenase
5271441|NCT02322879|Acetaminophen|acetaminophen
5271442|NCT02322879|Propylene glycol|propylene glycol
5271443|NCT02322866|acne|acne
5271444|NCT02322853|Metastatic breast cancer|metastatic breast cancer
5271445|NCT02322853|p38 map kinase|p38 map kinase
5271446|NCT02322853|tamoxifen|tamoxifen
5271447|NCT02322853|LY2228820|ly2228820
5271448|NCT02322853|Postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (AI)|postmenopausal woman with advanced or metastatic breast cancer progressing on aromatase inhibitors (ai)
5271449|NCT02322827|hiv/aids|hiv/aids
5271450|NCT02322788|Inhalation, Pharmacodynamic, Patients,|inhalation, pharmacodynamic, patients,
5271451|NCT02322775|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases,|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases,
5271452|NCT02322762|Type 2 diabetes mellitus|type 2 diabetes mellitus
5271453|NCT02322762|Anti-diabetic management patterns|anti-diabetic management patterns
5271454|NCT02322749|bioequivalence|bioequivalence
5271455|NCT02322749|bioavailability|bioavailability
5271456|NCT02322749|pharmacokinetics|pharmacokinetics
5271457|NCT02322749|Phase I|phase i
5271458|NCT02322749|AZD6244|azd6244
5271459|NCT02322749|cancer|cancer
5271460|NCT02322736|Metastatic Colorectal Cancer, wild type RAS, Panitumumab, Vectibix, Greece|metastatic colorectal cancer, wild type ras, panitumumab, vectibix, greece
5271461|NCT02322723|Adalimumab|adalimumab
5271462|NCT02322723|real life|real life
5271463|NCT02322723|RA|ra
5271464|NCT02322723|Humira|humira
5271465|NCT02322723|Rheumatoid Arthritis|rheumatoid arthritis
5271466|NCT02322723|effectiveness|effectiveness
5271467|NCT02322710|non-inferiority|non-inferiority
5271468|NCT02322710|randomized|randomized
5271469|NCT02322710|TulleGras|tullegras
5271470|NCT02322710|Urgotul|urgotul
5271471|NCT02322710|healing|healing
5271472|NCT02322710|surgical acute wounds|surgical acute wounds
5271473|NCT02322710|pain|pain
5271474|NCT02322697|Carnitine|carnitine
5271475|NCT02322697|hemodialysis|hemodialysis
5271476|NCT02322697|fatty acid|fatty acid
5271477|NCT02322697|imaging|imaging
5271478|NCT02322697|heart|heart
5271479|NCT02322684|Bougie|bougie
5271480|NCT02322684|Air-Q|air-q
5271481|NCT02322684|Insertion|insertion
5271482|NCT02322671|chewable tablet|chewable tablet
5271483|NCT02322671|montelukast sodium|montelukast sodium
5271484|NCT02322671|healthy adult subjects|healthy adult subjects
5271485|NCT02322671|relative bioavailability|relative bioavailability
5271486|NCT02322671|GW483100|gw483100
5271487|NCT02322593|Gastric Cancer|gastric cancer
5271488|NCT02322593|Gastrointestinal Diseases|gastrointestinal diseases
5271489|NCT02322593|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5271490|NCT02322593|First Line Treatment|first line treatment
5271491|NCT02322593|Antineoplastic Agents|antineoplastic agents
5271492|NCT02322580|anti-TNF|anti-tnf
5271493|NCT02322580|therapeutic drug monitoring|therapeutic drug monitoring
5271494|NCT02322580|immunogenicity|immunogenicity
5271495|NCT02322554|electronic health records|electronic health records
5271496|NCT02322554|Qualified Clinical Data Registry|qualified clinical data registry
5271497|NCT02322554|PQRS|pqrs
5271498|NCT02322554|quality reporting|quality reporting
5271499|NCT02322554|cellular based products|cellular based products
5271500|NCT02322554|bioengieered skin|bioengieered skin
5271502|NCT02322528|Non-invasive instruments|non-invasive instruments
5271503|NCT02322528|Environment|environment
5271504|NCT02322528|Wavefront|wavefront
5271505|NCT02322528|Placido Disk|placido disk
5271506|NCT02322528|Ellipsometer|ellipsometer
5271507|NCT02322528|Thermal Imaging|thermal imaging
5271508|NCT02322515|Knee|knee
5271509|NCT02322515|Proprioception|proprioception
5271510|NCT02322515|Electromyography|electromyography
5271511|NCT02322515|Taping|taping
5271512|NCT02322502|laryngeal mask airway|laryngeal mask airway
5271513|NCT02322502|desflurane|desflurane
5271514|NCT02322502|sevoflurane|sevoflurane
5271515|NCT02322502|propofol|propofol
5271521|NCT02322411|Deglutition|deglutition
5271522|NCT02322411|Deglutition disorders|deglutition disorders
5271523|NCT02322411|Resistance training|resistance training
5271524|NCT02322385|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5271525|NCT02322385|PKD 1 gene|pkd 1 gene
5271526|NCT02322385|PKD 2 gene|pkd 2 gene
5258865|NCT02395380|CRP|crp
5271527|NCT02322385|Truncational mutation|truncational mutation
5271528|NCT02322385|Hypomorphic mutation|hypomorphic mutation
5271529|NCT02322372|femoral blockade|femoral blockade
5271530|NCT02322372|bupivacaine|bupivacaine
5271531|NCT02322346|posttonsillectomy pain|posttonsillectomy pain
5271532|NCT02322346|levobupivacaine|levobupivacaine
5271533|NCT02322320|Multiple Myeloma|multiple myeloma
5271534|NCT02322320|Lenalidomide|lenalidomide
5271535|NCT02322320|Maintenance Therapy|maintenance therapy
5271536|NCT02322320|Progression|progression
5271537|NCT02322320|Long-term|long-term
5271538|NCT02322320|Anti-Myeloma Agents|anti-myeloma agents
5271539|NCT02322320|Hematologic Disorders|hematologic disorders
5271540|NCT02322307|Inflammatory Bowel Disease|inflammatory bowel disease
5271541|NCT02322307|Crohn's Disease|crohn's disease
5271542|NCT02322307|Ulcerative Colitis|ulcerative colitis
5271543|NCT02322307|Colitis|colitis
5271544|NCT02322307|PRO|pro
5152509|NCT03038737|nylon|nylon
5271545|NCT02322307|Patient-centric|patient-centric
5271546|NCT02322307|HealthPROMISE|healthpromise
5271547|NCT02322294|Protein|protein
5271548|NCT02322294|mung bean|mung bean
5271549|NCT02322294|glucose|glucose
5271550|NCT02322294|triglycerides|triglycerides
5271551|NCT02322294|insulin|insulin
5271552|NCT02322294|body weight,|body weight,
5271553|NCT02322294|DXA scan|dxa scan
5271554|NCT02322281|cancer|cancer
5271555|NCT02322281|metastatic|metastatic
5271556|NCT02322281|locally advanced|locally advanced
5271557|NCT02322281|lung|lung
5271558|NCT02322281|non-small cell lung cancer|non-small cell lung cancer
5271559|NCT02322281|NSCLC|nsclc
5271560|NCT02322281|epidermal growth factor receptor|epidermal growth factor receptor
5271561|NCT02322281|EGFR|egfr
5271562|NCT02322281|T790M|t790m
5271563|NCT02322281|CO-1686|co-1686
5271564|NCT02322281|unresectable|unresectable
5271565|NCT02322281|recurrent|recurrent
5271566|NCT02322281|EGFR-directed therapy|egfr-directed therapy
5271567|NCT02322281|irreversible EGFR inhibitor|irreversible egfr inhibitor
5271568|NCT02322281|TIGER|tiger
5271569|NCT02322281|Rociletinib|rociletinib
5271570|NCT02322268|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5271571|NCT02322268|Cosmos Caudatus|cosmos caudatus
5271572|NCT02322268|Ulam Raja|ulam raja
5271573|NCT02322268|Metabolomic profiling|metabolomic profiling
5271574|NCT02322268|antioxidant|antioxidant
5271575|NCT02322255|Natural History Study|natural history study
5271576|NCT02322255|Non-interventional Study|non-interventional study
5271577|NCT02322255|Observational Study|observational study
5271578|NCT02322255|Heterotopic ossification|heterotopic ossification
5271579|NCT02322255|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
5271580|NCT02322255|FOP disease progression|fop disease progression
5271581|NCT02322255|FOP flare-up progression|fop flare-up progression
5271582|NCT02322255|Clementia|clementia
5271583|NCT02322255|Myositosis Ossificans Progressiva|myositosis ossificans progressiva
5271584|NCT02322255|Munchmeyer's Disease|munchmeyer's disease
5271586|NCT02322255|Palovarotene|palovarotene
5271587|NCT02322229|VMT|vmt
5271588|NCT02322229|sVMA|svma
5271589|NCT02322229|vitrectomy|vitrectomy
5271590|NCT02322229|ocriplasmin|ocriplasmin
5271591|NCT02322216|Allergies|allergies
5271592|NCT02322216|Ocular|ocular
5271598|NCT02322190|Steroid Failure|steroid failure
5271599|NCT02322190|Immunomodulation|immunomodulation
5271600|NCT02322190|Corticosteroid Therapy|corticosteroid therapy
5271601|NCT02322177|Inborn Error of Metabolism|inborn error of metabolism
5271602|NCT02322177|Pregnancy|pregnancy
5271603|NCT02322177|Amino acid disorder|amino acid disorder
5674382|NCT00603785|Nasal Obstruction|nasal obstruction
5271604|NCT02322177|Fatty acid oxidation disorder|fatty acid oxidation disorder
5271605|NCT02322177|Organic Acidemia|organic acidemia
5271607|NCT02322164|TEMPERATURE|temperature
5271608|NCT02322164|Placebo|placebo
5271609|NCT02322151|Filgrastim|filgrastim
5271610|NCT02322151|Neupogen|neupogen
5271611|NCT02322151|Transplant|transplant
5271612|NCT02322151|Breast Feeding|breast feeding
5271613|NCT02322151|Concentration|concentration
5271618|NCT02322112|Gastrointestinal Microbiome|gastrointestinal microbiome
5271619|NCT02322112|Overweight and Obesity|overweight and obesity
5271620|NCT02322112|Personalized Nutrition|personalized nutrition
5271621|NCT02322112|Inflammation|inflammation
5271622|NCT02322112|Metabolism|metabolism
5271623|NCT02322099|human immunodeficiency virus|human immunodeficiency virus
5271624|NCT02322099|bone diseases|bone diseases
5271625|NCT02322099|osteopenia|osteopenia
5271626|NCT02322099|osteoporosis|osteoporosis
5271627|NCT02322099|fracture|fracture
5271628|NCT02322099|bone turnover|bone turnover
5271629|NCT02322099|alendronate|alendronate
5271630|NCT02322099|antiretroviral|antiretroviral
5271631|NCT02322060|IVA, ovary tissue grafting, POI, ORS|iva, ovary tissue grafting, poi, ors
5271632|NCT02322034|chronic heart failure|chronic heart failure
5271637|NCT02322034|interval training|interval training
5271643|NCT02321982|Mohs surgery|mohs surgery
5271644|NCT02321982|Preoperative consultation|preoperative consultation
5271645|NCT02321969|Chemoprevention|chemoprevention
5271646|NCT02321969|Colorectal adenomatous polyp|colorectal adenomatous polyp
5271647|NCT02321969|Green tea extract|green tea extract
5271648|NCT02321956|ASA class 1,2|asa class 1,2
5271649|NCT02321956|age 1-6 years|age 1-6 years
5271650|NCT02321956|General anesthesia with ETT|general anesthesia with ett
5271651|NCT02321930|Rheumatoid Arthritis|rheumatoid arthritis
5271652|NCT02321930|Musculoskeletal Ultrasound|musculoskeletal ultrasound
5271653|NCT02321930|Tofacitinib|tofacitinib
5271654|NCT02321930|biomarker|biomarker
5271655|NCT02321904|Confocal microscopy|confocal microscopy
5271656|NCT02321904|Cornea|cornea
5271657|NCT02321904|Neuropathy|neuropathy
5271658|NCT02321904|Detection|detection
5271659|NCT02321904|Diabetes|diabetes
5271660|NCT02321839|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5271661|NCT02321839|Ranibizumab|ranibizumab
5271662|NCT02321839|Treat and extend|treat and extend
5209924|NCT02683538|RFA|rfa
5271663|NCT02321813|quality of life|quality of life
5271664|NCT02321813|colorectal cancer|colorectal cancer
5271665|NCT02321813|definitive RCT|definitive rct
5271666|NCT02321813|complex intervention|complex intervention
5271667|NCT02321800|S-649266|s-649266
5271668|NCT02321800|complicated urinary tract infection|complicated urinary tract infection
5271669|NCT02321800|cefiderocol|cefiderocol
5271670|NCT02321800|acute uncomplicated pyelonephritis|acute uncomplicated pyelonephritis
5271671|NCT02321800|Gram-negative pathogens|gram-negative pathogens
5271672|NCT02321800|imipenem/cilastatin|imipenem/cilastatin
5271673|NCT02321787|Anesthesia, Caudal|anesthesia, caudal
5271674|NCT02321787|Ultrasonography|ultrasonography
5271675|NCT02321774|Stress|stress
5271676|NCT02321774|Virtual Reality|virtual reality
5271677|NCT02321774|Wearable Sensor|wearable sensor
5271678|NCT02321774|Wellness|wellness
5271679|NCT02321761|Amantadine hydrochloride|amantadine hydrochloride
5271680|NCT02321761|Rehabilitation|rehabilitation
5271681|NCT02321761|Acquired Brain Injury|acquired brain injury
5271683|NCT02321748|HSV|hsv
5271684|NCT02321748|Herpes|herpes
5271685|NCT02321748|volunteers|volunteers
5271686|NCT02321748|drug-drug interaction|drug-drug interaction
5271687|NCT02321735|Long-Term Survivor|long-term survivor
5271688|NCT02321735|Genomic|genomic
5271689|NCT02321735|Survivorship|survivorship
5271690|NCT02321735|Quality of Life|quality of life
5271691|NCT02321722|Colonoscopy|colonoscopy
5271692|NCT02321696|physiotherapy|physiotherapy
5271693|NCT02321696|manual therapy|manual therapy
5271694|NCT02321696|acupuncture|acupuncture
5271695|NCT02321696|eccentric exercise|eccentric exercise
5271696|NCT02321670|operative technique|operative technique
5271697|NCT02321644|CC-90001|cc-90001
5271698|NCT02321644|PHARMACOKINETICS|pharmacokinetics
5271699|NCT02321644|PHARMACODYNAMICS|pharmacodynamics
5271700|NCT02321644|HEALTHY SUBJECTS|healthy subjects
5271701|NCT02321644|SINGLE DOSE|single dose
5271702|NCT02321644|MULTIPLE DOSE|multiple dose
5271703|NCT02321644|PUNCH BIOPSY|punch biopsy
5271704|NCT02321631|Malnourished|malnourished
5271705|NCT02321631|Head and Neck Cancer|head and neck cancer
5271706|NCT02321631|Surgery|surgery
5271707|NCT02321618|Hypertension|hypertension
5271708|NCT02321618|High Blood Pressure|high blood pressure
5271709|NCT02321618|African American men|african american men
5271710|NCT02321618|Black men|black men
5271711|NCT02321618|barbershop|barbershop
5271712|NCT02321605|Best Possible Self|best possible self
5271713|NCT02321605|Positive Psychology|positive psychology
5271714|NCT02321605|Optimism|optimism
5271715|NCT02321605|Positive Technology|positive technology
5271716|NCT02321605|Future Thinking|future thinking
5271717|NCT02321592|Hodgkin Lymphoma|hodgkin lymphoma
5271718|NCT02321592|AFM13|afm13
5271719|NCT02321592|Natural Killer Cells|natural killer cells
5271720|NCT02321553|metabolic syndrome|metabolic syndrome
5271722|NCT02321553|cholesterol|cholesterol
5271723|NCT02321553|brown rice|brown rice
5271724|NCT02321553|inflammation|inflammation
5271725|NCT02321553|oxidative stress|oxidative stress
5271726|NCT02321540|Lung Cancer|lung cancer
5271727|NCT02321540|Non-small cell lung cancer|non-small cell lung cancer
5271728|NCT02321540|NSCLC|nsclc
5271729|NCT02321540|Epidermal growth factor receptor mutations|epidermal growth factor receptor mutations
5271730|NCT02321540|EGFR|egfr
5271731|NCT02321540|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5271732|NCT02321540|Ibrutinib|ibrutinib
5271733|NCT02321540|PCI-32765|pci-32765
5271734|NCT02321540|Imbruvica|imbruvica
5271735|NCT02321527|Breast Cancer|breast cancer
5271736|NCT02321527|Microbubble contrast-enhanced ultrasound|microbubble contrast-enhanced ultrasound
5271737|NCT02321527|CEUS|ceus
5271738|NCT02321527|Sentinel lymph nodes|sentinel lymph nodes
5271740|NCT02321527|Perflutren Protein-Type A Microspheres Injectable Suspension|perflutren protein-type a microspheres injectable suspension
5271741|NCT02321527|OPTISON™|optison™
5271742|NCT02321527|Ultrasound|ultrasound
5271743|NCT02321527|Breast biopsy|breast biopsy
5271744|NCT02321527|Radioactive seed|radioactive seed
5271745|NCT02321527|Phone call|phone call
5271746|NCT02321527|Fine needle aspiration|fine needle aspiration
5271748|NCT02321475|Psycho-emotional symptoms|psycho-emotional symptoms
5271749|NCT02321462|preparation|preparation
5271750|NCT02321423|Nail Dystrophy|nail dystrophy
5271751|NCT02321423|Plantar Keratoderma|plantar keratoderma
5271752|NCT02321423|Palmar Keratoderma|palmar keratoderma
5271753|NCT02321423|Leukokeratosis|leukokeratosis
5271754|NCT02321423|Cysts|cysts
5271755|NCT02321423|Pain|pain
5271756|NCT02321423|KRT17|krt17
5271757|NCT02321423|KRT16|krt16
5271758|NCT02321423|KRT6A|krt6a
5271759|NCT02321423|KRT6B|krt6b
5271760|NCT02321423|KRT6C|krt6c
5271761|NCT02321397|oxycodone naloxone combination|oxycodone naloxone combination
5271762|NCT02321397|severe chronic and non-malignant pain|severe chronic and non-malignant pain
5271763|NCT02321397|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
5271764|NCT02321358|Behavior Change|behavior change
5140908|NCT03110419|Elderly|elderly
5271765|NCT02321358|Objectively Measured Physical Activity|objectively measured physical activity
5271766|NCT02321358|Survivorship|survivorship
5271767|NCT02321345|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5271768|NCT02321345|Hematological Malignancies|hematological malignancies
5271769|NCT02321345|Palliative Care|palliative care
5271770|NCT02321345|Supportive care|supportive care
5271771|NCT02321332|Palmar hyperhidrosis|palmar hyperhidrosis
5271772|NCT02321332|Endoscopic thoracic sympathectomy|endoscopic thoracic sympathectomy
5271773|NCT02321319|Pediatric|pediatric
5271774|NCT02321293|curcumin|curcumin
5271775|NCT02321293|lung cancer|lung cancer
5271776|NCT02321293|TKI|tki
5271777|NCT02321267|AMD|amd
5271778|NCT02321267|PCV|pcv
5271779|NCT02321267|RAP|rap
5271780|NCT02321267|RVO|rvo
5271781|NCT02321267|DME|dme
5271782|NCT02321267|ERM|erm
5271783|NCT02321267|MH|mh
5271784|NCT02321267|mCNV|mcnv
5271785|NCT02321254|Stroke|stroke
5271786|NCT02321254|Upper limb|upper limb
5271787|NCT02321254|Robotics|robotics
5271788|NCT02321254|Electromyography|electromyography
5271789|NCT02321254|Rehabilitation|rehabilitation
5271790|NCT02321241|Wet-AMD|wet-amd
5271791|NCT02321241|Refractory patients to ranibizumab|refractory patients to ranibizumab
5271792|NCT02321241|Real life|real life
5271793|NCT02321241|Switch|switch
5271794|NCT02321241|Aflibercept|aflibercept
5271795|NCT02321228|Salpingectomy|salpingectomy
5271796|NCT02321228|Delayed oophorectomy|delayed oophorectomy
5271797|NCT02321228|Salpingo-oophorectomy|salpingo-oophorectomy
5271798|NCT02321228|Quality of life|quality of life
5271799|NCT02321228|Ovarian cancer|ovarian cancer
5271800|NCT02321228|BRCA|brca
5271801|NCT02321215|AECOPD|aecopd
5271802|NCT02321215|COPD|copd
5271803|NCT02321215|education|education
5271804|NCT02321202|omega-3|omega-3
5271805|NCT02321202|Progression|progression
5271806|NCT02321202|parenteral nutrition|parenteral nutrition
5271807|NCT02321150|Pterygium|pterygium
5271808|NCT02321150|Pterygiums|pterygiums
5271809|NCT02321150|Pterygia|pterygia
5271810|NCT02321150|Graft|graft
5271811|NCT02321150|Autograft|autograft
5271812|NCT02321150|Excision|excision
5271813|NCT02321150|Surgery|surgery
5271814|NCT02321150|Eye|eye
5271815|NCT02321150|electrocautery|electrocautery
5271816|NCT02321150|polyglactin|polyglactin
5271817|NCT02321124|Constipation|constipation
5271818|NCT02321124|connective tissue manipulation|connective tissue manipulation
5271819|NCT02321124|conservative therapy|conservative therapy
5271820|NCT02321124|massage|massage
5271821|NCT02321124|randomized controlled trial|randomized controlled trial
5271822|NCT02321111|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
5271823|NCT02321111|Hepatic insulin sensitivity|hepatic insulin sensitivity
5268912|NCT02337673|Pulmonary obstruction|pulmonary obstruction
5271826|NCT02321111|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
5271827|NCT02321098|Onychomycosis|onychomycosis
5271828|NCT02321098|antifungal|antifungal
5271830|NCT02321072|hypoxia|hypoxia
5271831|NCT02321072|hyperoxia|hyperoxia
5271833|NCT02321072|intensive care|intensive care
5271834|NCT02321059|incisional hernia|incisional hernia
5271835|NCT02321059|hernia|hernia
5271836|NCT02321059|abdominal wall strength|abdominal wall strength
5271837|NCT02321059|validation|validation
5271838|NCT02321059|physical activity|physical activity
5271839|NCT02321046|Non-Small Cell Lung Cancer, NSCLC, Epidermal growth factor receptor, EGFR|non-small cell lung cancer, nsclc, epidermal growth factor receptor, egfr
5271840|NCT02321033|glycemic index|glycemic index
5271841|NCT02321033|inactivity|inactivity
5271842|NCT02321033|insulin sensitivity|insulin sensitivity
5271843|NCT02321033|metabolic flexibility|metabolic flexibility
5271844|NCT02321033|arterial stiffness|arterial stiffness
5271845|NCT02321033|young men|young men
5271846|NCT02320994|stroke|stroke
5271847|NCT02320994|aftercare|aftercare
5271848|NCT02320981|GERD|gerd
5271849|NCT02320981|EGD|egd
5271850|NCT02320981|pH testing|ph testing
5271851|NCT02320981|eosinophilic esophagitis|eosinophilic esophagitis
5271852|NCT02320981|impedance testing|impedance testing
5271853|NCT02320955|autologous bone flap|autologous bone flap
5271854|NCT02320955|decompressive craniectomy|decompressive craniectomy
5271855|NCT02320955|malignant brain swelling|malignant brain swelling
5271856|NCT02320955|patient specific implant|patient specific implant
5271857|NCT02320955|bone resorption|bone resorption
5271858|NCT02320955|aseptic bone necrosis|aseptic bone necrosis
5271859|NCT02320942|Bone Marrow Transplantation|bone marrow transplantation
5271860|NCT02320942|Exercise|exercise
5271861|NCT02320942|Rehabilitation|rehabilitation
5271862|NCT02320942|Cancer|cancer
5271863|NCT02320929|irrigation|irrigation
5271864|NCT02320929|tenosynovitis|tenosynovitis
5271865|NCT02320929|purulent|purulent
5271866|NCT02320929|closed-catheter|closed-catheter
5271867|NCT02320929|flexor tendon|flexor tendon
5271868|NCT02320903|Criminal Justice|criminal justice
5271869|NCT02320903|Juvenile Delinquency|juvenile delinquency
5271870|NCT02320890|transcranial direct current stimulation|transcranial direct current stimulation
5271871|NCT02320890|tDCS|tdcs
5271872|NCT02320890|Mild Cognitive Impairment|mild cognitive impairment
5271873|NCT02320890|MCI|mci
5271874|NCT02320864|muscle strength|muscle strength
5271875|NCT02320864|muscle weakness|muscle weakness
5271876|NCT02320864|hospitalization|hospitalization
5271877|NCT02320864|surgery|surgery
5271878|NCT02320864|total knee replacement|total knee replacement
5271879|NCT02320851|Somatoform disorder|somatoform disorder
5271880|NCT02320851|Functional vertigo/dizziness|functional vertigo/dizziness
5271881|NCT02320851|Chronic subjective dizziness|chronic subjective dizziness
5271882|NCT02320838|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5271883|NCT02320838|Electric Stimulation Therapy|electric stimulation therapy
5271884|NCT02320838|Unmodulated Alternating Currents|unmodulated alternating currents
5271885|NCT02320838|Neural Conduction|neural conduction
5271886|NCT02320838|Pain Threshold|pain threshold
5271887|NCT02320825|Stereotactic Radiosurgery (SRS)|stereotactic radiosurgery (srs)
5271888|NCT02320825|Single-Fraction|single-fraction
5271889|NCT02320825|Hypofractionated|hypofractionated
5271890|NCT02320825|Spinal surgery|spinal surgery
5271891|NCT02320825|14-233|14-233
5271892|NCT02320799|interpersonal psychotherapy|interpersonal psychotherapy
5271893|NCT02320799|HIV|hiv
5271894|NCT02320799|women|women
5271895|NCT02320799|gender based violence|gender based violence
5271896|NCT02320799|mental health|mental health
5271897|NCT02320799|africa|africa
5271898|NCT02320799|kenya|kenya
5271899|NCT02320799|global mental health|global mental health
5271900|NCT02320799|HIV treatment adherence|hiv treatment adherence
5271901|NCT02320786|Power mobility|power mobility
5271902|NCT02320786|Wheelchair skills training|wheelchair skills training
5374014|NCT01839838|Women|women
5271903|NCT02320786|Spinal Cord Injury|spinal cord injury
5271904|NCT02320773|Overactive Bladder|overactive bladder
5271905|NCT02320773|Quality of Life|quality of life
5271906|NCT02320773|Betanis®|betanis®
5271907|NCT02320773|Betmiga®|betmiga®
5271908|NCT02320773|Observational|observational
5271909|NCT02320773|Myrbetriq®|myrbetriq®
5271910|NCT02320747|Volunteers|volunteers
5271911|NCT02320734|surgical rating scale|surgical rating scale
5271912|NCT02320734|neuromuscular relaxation|neuromuscular relaxation
5271913|NCT02320734|Anaesthesia|anaesthesia
5271914|NCT02320734|minimally invasive esophagectomy|minimally invasive esophagectomy
5271915|NCT02320708|Molar,third; Teeth,wisdom; Pain, Postoperative; Dental Surgery; Third molar extraction|molar,third; teeth,wisdom; pain, postoperative; dental surgery; third molar extraction
5271916|NCT02320643|Partially absorbable mesh|partially absorbable mesh
5271921|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b
5271922|NCT02320604|AmBisome|ambisome
5271923|NCT02320604|Pharmacokinetics|pharmacokinetics
5271924|NCT02320604|Obesity|obesity
5271925|NCT02320604|Bariatric surgery|bariatric surgery
5271926|NCT02320578|Neoadjuvant Chemoptherapy|neoadjuvant chemoptherapy
5271927|NCT02320578|Laparoscopy 3D|laparoscopy 3d
5271928|NCT02320578|Cervical cancer|cervical cancer
5271929|NCT02320565|Endometrial Cancer|endometrial cancer
5271930|NCT02320565|Laparoscopy 3D|laparoscopy 3d
5271931|NCT02320552|Nutritional assessment|nutritional assessment
5271932|NCT02320539|MicroRNA|microrna
5271933|NCT02320539|Cerebrospinal fluid|cerebrospinal fluid
5271934|NCT02320526|Exercise|exercise
5271935|NCT02320526|Training|training
5271936|NCT02320526|Interval training|interval training
5271937|NCT02320526|Systemic inflammation|systemic inflammation
5271938|NCT02320526|Glucose disposal|glucose disposal
5271939|NCT02320526|Insulin sensitivity|insulin sensitivity
5271940|NCT02320526|Glucose effectiveness|glucose effectiveness
5271941|NCT02320513|Exercise|exercise
5271942|NCT02320461|diabetes mellitus|diabetes mellitus
5271943|NCT02320461|cardiovascular diseases|cardiovascular diseases
5271944|NCT02320461|cohort studies|cohort studies
5271945|NCT02320461|hypertension|hypertension
5271946|NCT02320461|obesity|obesity
5271947|NCT02320461|smoking|smoking
5271948|NCT02320461|social class|social class
5271949|NCT02320422|liver transplant|liver transplant
5271950|NCT02320422|medication adherence|medication adherence
5271951|NCT02320422|intervention|intervention
5271952|NCT02320409|Subjects|subjects
5271953|NCT02320383|CLL|cll
5271954|NCT02320357|Platelet activation|platelet activation
5271955|NCT02320357|CD40 ligand|cd40 ligand
5271956|NCT02320357|CD154|cd154
5271957|NCT02320357|Interferon alpha|interferon alpha
5271958|NCT02320357|clopidogrel|clopidogrel
5271959|NCT02320318|Irritable Bowel Syndrome|irritable bowel syndrome
5271960|NCT02320318|Colon, irritable|colon, irritable
5271961|NCT02320318|Bowel disease|bowel disease
5271962|NCT02320318|Diarrhea|diarrhea
5271963|NCT02320279|Fetal Heart Rate|fetal heart rate
5271964|NCT02320279|Fetal EKG|fetal ekg
5271965|NCT02320279|FHR tracing|fhr tracing
5271966|NCT02320279|fetal R-waves|fetal r-waves
5271967|NCT02320266|Deep Brain Stimulation Surgery|deep brain stimulation surgery
5271968|NCT02320253|Diabetes|diabetes
5271969|NCT02320253|Obesity|obesity
5271970|NCT02320253|Primary Care|primary care
5271971|NCT02320253|Lifestyle Intervention|lifestyle intervention
5271972|NCT02320240|antidepressants|antidepressants
5271973|NCT02320240|acute kidney injury|acute kidney injury
5271974|NCT02320240|SNRI|snri
5271975|NCT02320240|renal failure|renal failure
5271976|NCT02320240|duloxetine|duloxetine
5271977|NCT02320240|CNODES|cnodes
5271978|NCT02320188|modification of treatment planned|modification of treatment planned
5271979|NCT02320188|Exercise|exercise
5271980|NCT02320175|family centered rounds|family centered rounds
5271981|NCT02320175|patient safety|patient safety
5271982|NCT02320175|errors|errors
5271983|NCT02320175|adverse events|adverse events
5271984|NCT02320175|concordance|concordance
5271985|NCT02320175|patient experience|patient experience
5271986|NCT02320149|acne|acne
5271987|NCT02320123|Terminal Care|terminal care
5271988|NCT02320123|Decision Making|decision making
5271989|NCT02320123|Communication|communication
5271990|NCT02320110|Irisin|irisin
5271991|NCT02320110|Adiponectin|adiponectin
5272001|NCT02320084|hypertyrosinemia type 1|hypertyrosinemia type 1
5272002|NCT02320084|Orfadin|orfadin
5272003|NCT02320084|Long term safety|long term safety
5272004|NCT02320084|Hereditary Tyrosinemia Type 1|hereditary tyrosinemia type 1
5272005|NCT02320032|Alkermes|alkermes
5272006|NCT02320032|Schizophrenia|schizophrenia
5272007|NCT02320032|Aripiprazole|aripiprazole
5272008|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil
5272009|NCT02320032|ALKS 9072|alks 9072
5272010|NCT02320006|hydrotubation|hydrotubation
5272011|NCT02320006|incomplete fallopian tube obstructive infertility|incomplete fallopian tube obstructive infertility
5272012|NCT02320006|Acupuncture|acupuncture
5272013|NCT02319993|Suan-Zao-Ren Tang|suan-zao-ren tang
5272014|NCT02319993|Tian-wang-bu-xin-dan|tian-wang-bu-xin-dan
5272015|NCT02319993|Traditional Chinese Medicine|traditional chinese medicine
5272016|NCT02319993|Herbs|herbs
5272017|NCT02319993|Quality of life|quality of life
5272018|NCT02319967|community health worker|community health worker
5272019|NCT02319967|emergency|emergency
5272020|NCT02319967|asthma|asthma
5272021|NCT02319941|Inhibition of Platelet Reactivity|inhibition of platelet reactivity
5272022|NCT02319941|ticagrelor|ticagrelor
5272023|NCT02319941|clopidogrel|clopidogrel
5272024|NCT02319941|Pharmacodynamics|pharmacodynamics
5272025|NCT02319941|Pharmacokinetics|pharmacokinetics
5272026|NCT02319915|tranexamic acid|tranexamic acid
5272027|NCT02319915|knee prosthesis|knee prosthesis
5272028|NCT02319915|pharmacokinetic profile|pharmacokinetic profile
5272029|NCT02319863|hepatocellular carcinoma|hepatocellular carcinoma
5272031|NCT02319850|sarcopenia|sarcopenia
5272032|NCT02319850|screening|screening
5272033|NCT02319850|geriatrics|geriatrics
5272035|NCT02319850|aging|aging
5272036|NCT02319850|ultrasound|ultrasound
5272037|NCT02319798|Crohn's disease|crohn's disease
5272038|NCT02319798|ulcerative colitis|ulcerative colitis
5272039|NCT02319798|Inflammatory bowel disease|inflammatory bowel disease
5272041|NCT02319772|Healthy volunteers|healthy volunteers
5272042|NCT02319772|Ebola virus|ebola virus
5272043|NCT02319772|Filovirus|filovirus
5272044|NCT02319759|Psoriatic Arthritis|psoriatic arthritis
5272045|NCT02319759|Guselkumab|guselkumab
5272046|NCT02319759|Ustekinumab|ustekinumab
5272047|NCT02319759|Placebo|placebo
5272048|NCT02319694|Basal Ganglia|basal ganglia
5272049|NCT02319694|Behavior|behavior
5272050|NCT02319694|Behavioral|behavioral
5272051|NCT02319694|Brain|brain
5272052|NCT02319694|Cognitive|cognitive
5272053|NCT02319694|Computer Simulation|computer simulation
5272054|NCT02319694|Cues|cues
5272055|NCT02319694|Data|data
5272056|NCT02319694|Deep Brain Stimulation|deep brain stimulation
5272057|NCT02319694|Disease|disease
5272058|NCT02319681|Caregivers|caregivers
5272059|NCT02319681|Anxiety|anxiety
5272060|NCT02319681|Depression|depression
5272061|NCT02319655|Epiretinal membrane|epiretinal membrane
5272062|NCT02319655|Macular pucker|macular pucker
5272063|NCT02319655|Membrane peeling|membrane peeling
5272064|NCT02319655|pars plana vitrectomy|pars plana vitrectomy
5272065|NCT02319655|Air|air
5167134|NCT02947685|HR+|hr+
5272066|NCT02319655|balanced salt solution|balanced salt solution
5272067|NCT02319655|Intraoperative OCT|intraoperative oct
5272068|NCT02319655|Hyporeflectivity|hyporeflectivity
5272069|NCT02319655|Retina|retina
5272070|NCT02319642|Rheumatoid Arthritis|rheumatoid arthritis
5272071|NCT02319642|TNFα antagonist|tnfα antagonist
5272072|NCT02319642|Certolizumab pegol|certolizumab pegol
5272073|NCT02319642|Chinese patients|chinese patients
5272074|NCT02319642|Open-label|open-label
5272075|NCT02319629|Morbid obesity,|morbid obesity,
5272076|NCT02319629|Cholelithiasis|cholelithiasis
5272077|NCT02319629|Bariatric surgery|bariatric surgery
5272078|NCT02319629|Ursodiol|ursodiol
5272079|NCT02319577|NSCLC|nsclc
5272080|NCT02319577|EGFR|egfr
5272081|NCT02319577|vinorelbine|vinorelbine
5272082|NCT02319577|gefitinib|gefitinib
5272083|NCT02319564|Wheeze|wheeze
5272084|NCT02319564|Asthma|asthma
5272085|NCT02319564|Randomized Trial|randomized trial
5272086|NCT02319564|Pre-school aged children|pre-school aged children
5272087|NCT02319538|Chronic thyroiditis|chronic thyroiditis
5276984|NCT02292368|MDASI-HN|mdasi-hn
5272088|NCT02319538|Total thyroidectomy|total thyroidectomy
5272089|NCT02319538|Anti-TPO|anti-tpo
5272090|NCT02319538|PROMs|proms
5272091|NCT02319538|SF36|sf36
5272092|NCT02319538|Fatigue questionnaire|fatigue questionnaire
5272093|NCT02319538|Fatigue|fatigue
5272094|NCT02319538|Autoimmune symptoms|autoimmune symptoms
5272095|NCT02319538|HADs|hads
5272097|NCT02319538|fVAS|fvas
5272098|NCT02319525|lupus nephritis|lupus nephritis
5272099|NCT02319525|lupus|lupus
5272100|NCT02319525|decision-making|decision-making
5272101|NCT02319525|minorities|minorities
5272102|NCT02319525|immunosuppressive medications|immunosuppressive medications
5272103|NCT02319525|decision-aid|decision-aid
5272104|NCT02319525|treatment|treatment
5272105|NCT02319525|Decision conflict|decision conflict
5272106|NCT02319525|SLE|sle
5272107|NCT02319486|Retinoblastoma|retinoblastoma
5272108|NCT02319486|carboplatin|carboplatin
5674383|NCT00603785|Facial Pain|facial pain
5374271|NCT01838889|CBT|cbt
5272109|NCT02319473|system of care|system of care
5272110|NCT02319473|acute myocardial infarction|acute myocardial infarction
5272111|NCT02319473|registry|registry
5272112|NCT02319473|Primary PCI|primary pci
5272113|NCT02319473|Fibrinolytic therapy|fibrinolytic therapy
5272114|NCT02319460|Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding|vitamin k reversal antagonist therapy of acute major bleeding
5272115|NCT02319460|Warfarin Reversal|warfarin reversal
5272116|NCT02319447|Living Donation|living donation
5272117|NCT02319447|Kidney Transplantation|kidney transplantation
5272118|NCT02319421|Alarm fatigue|alarm fatigue
5272119|NCT02319395|Parkinson's Disease|parkinson's disease
5272120|NCT02319395|Behaviour addiction|behaviour addiction
5272121|NCT02319395|Dopamine agonist|dopamine agonist
5272122|NCT02319395|Genetic.|genetic.
5272123|NCT02319382|Parkinson Disease|parkinson disease
5272124|NCT02319382|[18F]DPA-714|[18f]dpa-714
5272125|NCT02319382|Positron emission tomography (PET)|positron emission tomography (pet)
5272126|NCT02319382|Neuroinflammation|neuroinflammation
5272127|NCT02319369|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
5272128|NCT02319369|Relapsed/Refractory|relapsed/refractory
5272129|NCT02319369|Newly Diagnosed|newly diagnosed
5272130|NCT02319369|Unfit for Chemotherapy|unfit for chemotherapy
5272132|NCT02319343|Quadriceps muscle function|quadriceps muscle function
5272133|NCT02319343|Knee arthroplasty, total|knee arthroplasty, total
5272136|NCT02319330|Mental health|mental health
5272137|NCT02319330|Depression|depression
5272138|NCT02319330|Women|women
5272139|NCT02319330|Mobile phone technology|mobile phone technology
5272140|NCT02319330|eHealth|ehealth
5272141|NCT02319330|India|india
5272142|NCT02319304|Pelvic Radiotherapy|pelvic radiotherapy
5272143|NCT02319304|Rectal Adenocarcinoma|rectal adenocarcinoma
5272145|NCT02319265|antioxidant|antioxidant
5272146|NCT02319265|melatonin|melatonin
5272147|NCT02319265|inflammation|inflammation
5272148|NCT02319239|Prostate neoplasms|prostate neoplasms
5272149|NCT02319239|Urogenital neoplasms|urogenital neoplasms
5272150|NCT02319239|Genital neoplasms, male|genital neoplasms, male
5272151|NCT02319239|Radiation therapy|radiation therapy
5272152|NCT02319239|PSA|psa
5272153|NCT02319239|DW-MRI, diffusion weighted MRI|dw-mri, diffusion weighted mri
5272154|NCT02319239|Intra-fractional movement|intra-fractional movement
5272155|NCT02319239|Hypofractionated radiotherapy|hypofractionated radiotherapy
5272156|NCT02319239|Stereotactic|stereotactic
5272157|NCT02319239|Toxicity due to radiotherapy|toxicity due to radiotherapy
5272158|NCT02319239|Quality of life|quality of life
5272159|NCT02319213|Intra-abdominal pressure,|intra-abdominal pressure,
5272160|NCT02319213|intraocular pressure,|intraocular pressure,
5272161|NCT02319213|abdominal hypertension,|abdominal hypertension,
5272162|NCT02319213|laparoscopy,|laparoscopy,
5272163|NCT02319213|critical care|critical care
5272164|NCT02319200|Chemoprevention|chemoprevention
5272165|NCT02319200|Decompensation of cirrhosis|decompensation of cirrhosis
5272166|NCT02319200|Hepatocellular Carcinoma|hepatocellular carcinoma
5272167|NCT02319200|Death|death
5272168|NCT02319200|Efficacy|efficacy
5272169|NCT02319200|Safety|safety
5272170|NCT02319187|Esophageal Neoplasms|esophageal neoplasms
5272171|NCT02319161|intravenous regional anesthesia|intravenous regional anesthesia
5272172|NCT02319135|Acute Myeloid Leukemia|acute myeloid leukemia
5272173|NCT02319122|Cerebral Palsy|cerebral palsy
5272174|NCT02319122|Muscle structure|muscle structure
5272175|NCT02319122|Strength training|strength training
5272176|NCT02319096|Whole body vibration therapy|whole body vibration therapy
5272177|NCT02319096|pelvic floor muscle training|pelvic floor muscle training
5272178|NCT02319096|stress urinary incontinence|stress urinary incontinence
5272179|NCT02319083|CABG|cabg
5272180|NCT02319083|Coronary artery bypass surgery|coronary artery bypass surgery
5272181|NCT02319083|Coronary artery bypass grafting|coronary artery bypass grafting
5272182|NCT02319083|Coronary surgery|coronary surgery
5272183|NCT02319083|Myocardial infarction|myocardial infarction
5272184|NCT02319083|Coronary artery disease|coronary artery disease
5153202|NCT03034642|Bronchoscopy|bronchoscopy
5272185|NCT02319083|Off-pump|off-pump
5272186|NCT02319083|EuroSCORE|euroscore
5272187|NCT02319070|Cost|cost
5272188|NCT02319070|Clinical Outcomes|clinical outcomes
5272189|NCT02319070|Quality of Life|quality of life
5272190|NCT02319070|On Demand Treatment|on demand treatment
5272191|NCT02319070|Secondary Prophylaxis|secondary prophylaxis
5272192|NCT02319057|Healthy volunteer study|healthy volunteer study
5272194|NCT02319005|Cardiomyopathy|cardiomyopathy
5272195|NCT02319005|Heart Failure|heart failure
5272197|NCT02319005|Amyloid|amyloid
5272198|NCT02319005|Transthyretin|transthyretin
5272199|NCT02319005|TTR|ttr
5272200|NCT02319005|RNAi therapeutic|rnai therapeutic
5272201|NCT02318953|Telemedicine|telemedicine
5272202|NCT02318953|Ambulatory Surgical Procedures|ambulatory surgical procedures
5272203|NCT02318953|Postoperative Care|postoperative care
5272204|NCT02318953|Cost Effectiveness|cost effectiveness
5272205|NCT02318953|Mobile Applications|mobile applications
5272206|NCT02318953|Health Services Research|health services research
5272207|NCT02318953|Breast Reconstruction|breast reconstruction
5272208|NCT02318940|ultrasound guided|ultrasound guided
5272209|NCT02318940|femoral vein|femoral vein
5272210|NCT02318940|central venous catheter|central venous catheter
5272211|NCT02318940|pediatric|pediatric
5272212|NCT02318927|Deep Brain Stimulation|deep brain stimulation
5272213|NCT02318914|Pyoderma Gangrenosum|pyoderma gangrenosum
5272214|NCT02318914|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
5272215|NCT02318888|Small bowel obstruction, Surgery, Colorectal cancer|small bowel obstruction, surgery, colorectal cancer
5272216|NCT02318875|Inflammation|inflammation
5272217|NCT02318875|swell|swell
5272218|NCT02318875|pain|pain
5272219|NCT02318875|functional impairment|functional impairment
5272220|NCT02318875|stiffness|stiffness
5272221|NCT02318862|reflux|reflux
5272222|NCT02318862|GERD|gerd
5272223|NCT02318862|EGD|egd
5272224|NCT02318862|pH testing|ph testing
5272225|NCT02318849|designated organ donor, college students|designated organ donor, college students
5272226|NCT02318836|hepatic, hepatic impairment, lofexidine|hepatic, hepatic impairment, lofexidine
5272227|NCT02318823|social neuroscience|social neuroscience
5272228|NCT02318823|emotion|emotion
5272229|NCT02318823|face recognition|face recognition
5272230|NCT02318823|empathy|empathy
5272231|NCT02318823|beer|beer
5272233|NCT02318823|social cognition|social cognition
5272234|NCT02318810|Muscle relaxants|muscle relaxants
5272235|NCT02318797|Chronic disease|chronic disease
5272236|NCT02318797|Mental Health|mental health
5272237|NCT02318797|Behavioral Health|behavioral health
5272238|NCT02318797|Community mental health centers|community mental health centers
5272239|NCT02318797|Intervention studies|intervention studies
5272241|NCT02318797|Qualitative research|qualitative research
5272242|NCT02318784|neuroendocrine malignancies|neuroendocrine malignancies
5272243|NCT02318784|pancreatic neuroendocrine tumors (PNETs)|pancreatic neuroendocrine tumors (pnets)
5272244|NCT02318784|gastrointestinal (GI) carcinoids|gastrointestinal (gi) carcinoids
5272245|NCT02318784|carfilzomib|carfilzomib
5272246|NCT02318784|Kyprolis|kyprolis
5272247|NCT02318784|proteasome inhibitors|proteasome inhibitors
5272248|NCT02318758|This is a healthy volunteer study.|this is a healthy volunteer study.
5272249|NCT02318745|Family Therapy|family therapy
5272250|NCT02318745|Substance abuse prevention|substance abuse prevention
5272251|NCT02318745|Minority|minority
5272252|NCT02318745|randomized trials|randomized trials
5272253|NCT02318745|outcome research|outcome research
5272254|NCT02318745|adolescent treatment|adolescent treatment
5272255|NCT02318732|violence|violence
5272256|NCT02318719|Post-Herpetic Neuralgia|post-herpetic neuralgia
5272257|NCT02318719|Developmental Phase III|developmental phase iii
5272258|NCT02318706|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
5272259|NCT02318641|oxygen consumption|oxygen consumption
5272260|NCT02318641|retinal oximetry|retinal oximetry
5272261|NCT02318628|Cardio ankle vascular index|cardio ankle vascular index
5272262|NCT02318628|CAVI|cavi
5272263|NCT02318628|pulse wave velocity|pulse wave velocity
5272264|NCT02318628|PWV|pwv
5272265|NCT02318628|Non invasive arterial structure assessment|non invasive arterial structure assessment
5272266|NCT02318615|Breast Neoplasm|breast neoplasm
5272267|NCT02318615|Lymphedema|lymphedema
5272268|NCT02318615|Autologous flap|autologous flap
5272269|NCT02318615|lattismus dorsi flap|lattismus dorsi flap
5272270|NCT02318602|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5272271|NCT02318602|Dravet syndrome|dravet syndrome
5272272|NCT02318602|Treatment-resistant seizures|treatment-resistant seizures
5272273|NCT02318576|Multiple Sclerosis|multiple sclerosis
5272274|NCT02318563|Treatment-resistant seizures|treatment-resistant seizures
5272275|NCT02318537|Treatment-resistant seizures|treatment-resistant seizures
5272276|NCT02318472|Microdialysis|microdialysis
5272277|NCT02318472|Patient related outcome|patient related outcome
5272278|NCT02318472|Heel rise test|heel rise test
5272279|NCT02318472|Immobilization|immobilization
5272280|NCT02318472|functional mobilization|functional mobilization
5272281|NCT02318472|Ultrasound|ultrasound
5272282|NCT02318446|Anti-epileptic drugs|anti-epileptic drugs
5272283|NCT02318446|Folic acid|folic acid
5272284|NCT02318446|Homocysteine|homocysteine
5272286|NCT02318433|PTOA|ptoa
5272287|NCT02318433|dexamethasone|dexamethasone
5272288|NCT02318420|Obstetrics|obstetrics
5272289|NCT02318420|Partogram|partogram
5272290|NCT02318420|ePartogram|epartogram
5272291|NCT02318420|eHealth|ehealth
5272292|NCT02318420|Low-income|low-income
5272293|NCT02318420|Quality of care|quality of care
5272294|NCT02318420|Perinatal death|perinatal death
5272295|NCT02318420|Maternal death|maternal death
5272296|NCT02318420|Cesarean section|cesarean section
5272297|NCT02318420|Health information technology|health information technology
5272298|NCT02318394|advanced solid tumors; immunotherapy; OX40; immuno-oncology|advanced solid tumors; immunotherapy; ox40; immuno-oncology
5272299|NCT02318381|suprascapular nerve|suprascapular nerve
5272300|NCT02318381|rotator cuff tear|rotator cuff tear
5272301|NCT02318381|suprascapular neuropathy|suprascapular neuropathy
5272302|NCT02318381|superior transverse scapular ligament|superior transverse scapular ligament
5272303|NCT02318355|hemodilution|hemodilution
5272304|NCT02318355|hemorrhage|hemorrhage
5272305|NCT02318355|trauma|trauma
5272306|NCT02318355|lactate|lactate
5272307|NCT02318355|base deficit|base deficit
5272308|NCT02318355|randomized control trial|randomized control trial
5272309|NCT02318329|FGFR2b, FGFR2, FGFR, bladder neoplasms, esophageal cancer|fgfr2b, fgfr2, fgfr, bladder neoplasms, esophageal cancer
5272310|NCT02318316|Exhaled breath condensate|exhaled breath condensate
5272311|NCT02318316|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5272312|NCT02318316|pulmonary complications|pulmonary complications
5272313|NCT02318290|Analgesia|analgesia
5272314|NCT02318290|Critical Care|critical care
5272315|NCT02318290|Hypnotics and Sedatives|hypnotics and sedatives
5272316|NCT02318251|Power, rate of force development|power, rate of force development
5272317|NCT02318251|involuntary|involuntary
5272318|NCT02318251|reflexive|reflexive
5272319|NCT02318238|evaluation|evaluation
5272320|NCT02318238|exercise tolerance|exercise tolerance
5272321|NCT02318238|healthy children|healthy children
5272322|NCT02318238|6MWT|6mwt
5272323|NCT02318225|Misoprostol|misoprostol
5272324|NCT02318225|Office hysteroscopy|office hysteroscopy
5272325|NCT02318225|Pain|pain
5272326|NCT02318212|Cervical dilatation|cervical dilatation
5272327|NCT02318199|emergence agitation|emergence agitation
5272328|NCT02318199|intracranial surgery|intracranial surgery
5272329|NCT02318199|general anesthesia|general anesthesia
5272330|NCT02318199|incidence|incidence
5272331|NCT02318199|risk factor|risk factor
5272332|NCT02318186|pharmacokinetic analysis|pharmacokinetic analysis
5272333|NCT02318186|remodulin|remodulin
5272334|NCT02318186|trepostinil|trepostinil
5272335|NCT02318186|pulmonary arterial hypertension|pulmonary arterial hypertension
5272336|NCT02318173|Cervical dilatation|cervical dilatation
5272337|NCT02318160|Autoimmune Thyroiditis|autoimmune thyroiditis
5272338|NCT02318160|Oxidative Status|oxidative status
5272339|NCT02318160|Children|children
5272340|NCT02318147|Severe acute pancreatitis|severe acute pancreatitis
5272341|NCT02318147|Fecal Microbiota Transplantation|fecal microbiota transplantation
5272342|NCT02318147|Bacterial Translocation|bacterial translocation
5272343|NCT02318147|Infectious Complications|infectious complications
5272344|NCT02318134|Severe acute pancreatitis|severe acute pancreatitis
5272345|NCT02318134|Fecal Microbiota Transplantation|fecal microbiota transplantation
5272346|NCT02318134|Intestinal barrier dysfunction|intestinal barrier dysfunction
5272347|NCT02318134|Intestinal flora|intestinal flora
5272348|NCT02318121|Labor, prolonged labor, augmentation of labor|labor, prolonged labor, augmentation of labor
5272349|NCT02318108|Organizational Innovation|organizational innovation
5272350|NCT02318108|Primary Health Care|primary health care
5272351|NCT02318095|Cancer of the pancreas|cancer of the pancreas
5272352|NCT02318082|Chronic versus Graft Host Disease|chronic versus graft host disease
5272353|NCT02318069|immune response|immune response
5272354|NCT02318069|TBE-vaccine|tbe-vaccine
5272355|NCT02318069|elderly|elderly
5272356|NCT02318069|additional doses|additional doses
5272357|NCT02318056|hand|hand
5272358|NCT02318056|burns|burns
5272359|NCT02318056|thermal|thermal
5272360|NCT02318056|dressing|dressing
5272361|NCT02318056|Aquacel®|aquacel®
5272362|NCT02318056|Mepilex® Transfer Ag|mepilex® transfer ag
5272363|NCT02318056|Xeroform®|xeroform®
5272364|NCT02318056|Bacitracin®|bacitracin®
5272365|NCT02318056|partial thickness|partial thickness
5272366|NCT02318056|epithelialization|epithelialization
5272367|NCT02318056|wound healing|wound healing
5272368|NCT02318056|scar|scar
5272369|NCT02318056|scarring|scarring
5272370|NCT02318043|adenosine monophosphate|adenosine monophosphate
5272371|NCT02318043|histamine|histamine
5272372|NCT02318043|bronchial provocation test|bronchial provocation test
5272373|NCT02318043|asthma symptom score|asthma symptom score
5272374|NCT02318043|asthma control|asthma control
5272375|NCT02318030|Transplant|transplant
5272376|NCT02318030|Adaptive Immunity|adaptive immunity
5272377|NCT02318030|EBV|ebv
5153407|NCT03033342|Phase 1|phase 1
5272378|NCT02318030|Medication Adherence|medication adherence
5272379|NCT02318030|Tacrolimus|tacrolimus
5272380|NCT02318030|PTLD|ptld
5272381|NCT02318017|adhd|adhd
5272382|NCT02318017|global network|global network
5272383|NCT02318017|eeg|eeg
5272384|NCT02318004|telemonitoring|telemonitoring
5272385|NCT02317991|gastroesophageal adenocarcinoma|gastroesophageal adenocarcinoma
5272386|NCT02317991|nab-paclitaxel|nab-paclitaxel
5272387|NCT02317991|Abraxane|abraxane
5272388|NCT02317991|ramucirumab|ramucirumab
5272389|NCT02317991|Cyramza|cyramza
5272390|NCT02317991|GE junction|ge junction
5272391|NCT02317913|Kawasaki disease|kawasaki disease
5272392|NCT02317913|Epidemiology|epidemiology
5272393|NCT02317913|Incidence|incidence
5272394|NCT02317913|Coronary arterial lesions|coronary arterial lesions
5272395|NCT02317913|Shanghai|shanghai
5272396|NCT02317887|Gene Transfer|gene transfer
5272397|NCT02317887|X-Linked|x-linked
5272398|NCT02317887|Retinoschisis|retinoschisis
5272399|NCT02317887|AAV Vector|aav vector
5272400|NCT02317848|Diagnosis|diagnosis
5272401|NCT02317848|prognostic marker|prognostic marker
5272402|NCT02317848|polygraphy|polygraphy
5272403|NCT02317848|echocardiography|echocardiography
5272405|NCT02317809|Healthy|healthy
5272406|NCT02317809|Pergoveris|pergoveris
5272407|NCT02317809|Bioequivalence|bioequivalence
5272408|NCT02317809|Infertility|infertility
5272409|NCT02317770|lidocaine, esophago-gastro-duodenoscopy|lidocaine, esophago-gastro-duodenoscopy
5272410|NCT02317757|elderly cancer patients, chemotherapy toxicity|elderly cancer patients, chemotherapy toxicity
5272411|NCT02317731|bowel preparation|bowel preparation
5272412|NCT02317718|serum vitamin D levels|serum vitamin d levels
5272413|NCT02317718|IVF|ivf
5272414|NCT02317718|ovarian reserve|ovarian reserve
5272415|NCT02317718|25 OHD3|25 ohd3
5272416|NCT02317718|pregnancy outcome|pregnancy outcome
5272417|NCT02317666|polypharmacy|polypharmacy
5272418|NCT02317666|drug burden index|drug burden index
5272419|NCT02317666|aged|aged
5272420|NCT02317666|medication review|medication review
5272421|NCT02317666|cholinergic agents|cholinergic agents
5272422|NCT02317640|Testosterone|testosterone
5272423|NCT02317640|Electrical Stimulation|electrical stimulation
5272424|NCT02317640|Stand Training|stand training
5272425|NCT02317614|Incentives|incentives
5272426|NCT02317614|Smartphone|smartphone
5272431|NCT02317588|Oxylipins|oxylipins
5272432|NCT02317588|Flax oil|flax oil
5272433|NCT02317588|Fish oil|fish oil
5272434|NCT02317562|Peripheral neuropathy|peripheral neuropathy
5272448|NCT02317549|multiorgan failure|multiorgan failure
5272449|NCT02317549|MOF|mof
5272450|NCT02317549|multiorgain dysfunction syndrome|multiorgain dysfunction syndrome
5272451|NCT02317549|MODS|mods
5272452|NCT02317549|hyperlactatemia|hyperlactatemia
5272453|NCT02317549|tissue hypoxia|tissue hypoxia
5272454|NCT02317536|Muscle function|muscle function
5272455|NCT02317536|L-Carnitine|l-carnitine
5272456|NCT02317536|Carnipure|carnipure
5272457|NCT02317536|DXA|dxa
5272458|NCT02317536|anabolism|anabolism
5272459|NCT02317536|6 minute walk|6 minute walk
5272460|NCT02317536|dynamometry|dynamometry
5272461|NCT02317536|muscle biopsy|muscle biopsy
5272462|NCT02317523|Dementia|dementia
5272463|NCT02317523|Caregiver|caregiver
5272464|NCT02317523|Cardiovascular Disease|cardiovascular disease
5272465|NCT02317523|Stress|stress
5272466|NCT02317523|Depression|depression
5272467|NCT02317523|Anxiety|anxiety
5272468|NCT02317523|Heart Disease|heart disease
5272469|NCT02317523|Carer|carer
5272470|NCT02317523|Care Giver|care giver
5272471|NCT02317523|Caregiving|caregiving
5272472|NCT02317523|Psychotherapy|psychotherapy
5272473|NCT02317523|Therapy|therapy
5272474|NCT02317523|Behavioral Activation|behavioral activation
5272475|NCT02317523|Education|education
5272476|NCT02317523|Intervention|intervention
5272477|NCT02317523|CBT|cbt
5272478|NCT02317523|Cognitive-Behavior Therapy|cognitive-behavior therapy
5272479|NCT02317510|Combined anesthesia|combined anesthesia
5272480|NCT02317510|General anesthesia|general anesthesia
5272481|NCT02317510|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5272482|NCT02317497|Neurocritical care|neurocritical care
5272483|NCT02317497|Severe Stroke|severe stroke
5272484|NCT02317497|Ischemic stroke|ischemic stroke
5272485|NCT02317497|Intracerebral hemorrhage|intracerebral hemorrhage
5272486|NCT02317497|Subarachnoid hemorrhage|subarachnoid hemorrhage
5272487|NCT02317497|Sedation|sedation
5272488|NCT02317497|RASS|rass
5272489|NCT02317497|BIS|bis
5272490|NCT02317445|helicobacter pylori|helicobacter pylori
5272491|NCT02317445|eradication therapy|eradication therapy
5272492|NCT02317445|major adverse cardiac events|major adverse cardiac events
5272493|NCT02317445|long-term outcome|long-term outcome
5272494|NCT02317445|To explore the significance of Hp eradication therapy in preventing major adverse cardiac events (MACE) and upper gastrointestinal bleeding (UGIB).|to explore the significance of hp eradication therapy in preventing major adverse cardiac events (mace) and upper gastrointestinal bleeding (ugib).
5272495|NCT02317432|Depression|depression
5272496|NCT02317432|Anxiety|anxiety
5272497|NCT02317432|Disability|disability
5272498|NCT02317432|Ethnic Minority|ethnic minority
5272499|NCT02317432|Elders|elders
5272500|NCT02317419|Solid Cancers|solid cancers
5272501|NCT02317393|Nuclear medicine|nuclear medicine
5272502|NCT02317393|Positron emission tomography|positron emission tomography
5374766|NCT01836757|MSM|msm
5272503|NCT02317393|avb3 integrin expression|avb3 integrin expression
5272504|NCT02317380|Self-Affirmation|self-affirmation
5272505|NCT02317380|Weight Loss|weight loss
5272506|NCT02317380|Self vs. Other|self vs. other
5272507|NCT02317380|Cancer Risk and Prevention|cancer risk and prevention
5272512|NCT02317354|X-Linked|x-linked
5272513|NCT02317354|Retinoschisis|retinoschisis
5272514|NCT02317341|Fatigue|fatigue
5272515|NCT02317341|Ketamine|ketamine
5272516|NCT02317341|Cancer|cancer
5272517|NCT02317328|Eye Disease|eye disease
5272518|NCT02317263|MS|ms
5272519|NCT02317250|Alzheimer's disease|alzheimer's disease
5272520|NCT02317250|Alzheimer disease|alzheimer disease
5272521|NCT02317250|MDC|mdc
5272522|NCT02317250|Mild Decline in Cognition|mild decline in cognition
5272523|NCT02317250|MCI|mci
5272524|NCT02317250|Dementia|dementia
5272525|NCT02317250|PET|pet
5272526|NCT02317250|FDG-PET|fdg-pet
5272527|NCT02317250|FDG|fdg
5269632|NCT02333058|AML|aml
5272628|NCT02316639|Neuromuscular Training|neuromuscular training
5272531|NCT02317250|Coverage with Evidence Development|coverage with evidence development
5272533|NCT02317250|MCI-ID|mci-id
5272534|NCT02317224|3-Hole approach|3-hole approach
5272535|NCT02317224|extended thymectomy|extended thymectomy
5272536|NCT02317224|myasthenia gravis|myasthenia gravis
5272537|NCT02317224|safety|safety
5272538|NCT02317224|effectiveness|effectiveness
5272539|NCT02317198|Elderly|elderly
5272540|NCT02317198|P2Y12 inhibitors|p2y12 inhibitors
5272541|NCT02317198|clopidogrel|clopidogrel
5272542|NCT02317198|ticagrelor|ticagrelor
5272543|NCT02317172|Saliva substitute|saliva substitute
5272544|NCT02317172|Edible gel|edible gel
5272545|NCT02317172|Xerostomia|xerostomia
5272546|NCT02317172|Diabetes Mellitus|diabetes mellitus
5272547|NCT02317172|Hypertension|hypertension
5272548|NCT02317133|Tregs|tregs
5272549|NCT02317133|bacterial translocation|bacterial translocation
5272550|NCT02317133|cytokines|cytokines
5272551|NCT02317107|Gait|gait
5272552|NCT02317107|Mild Traumatic Brain Injury|mild traumatic brain injury
5272553|NCT02317107|Post-Concussion Syndrome|post-concussion syndrome
5272554|NCT02317107|Recovery of Function|recovery of function
5272555|NCT02317107|Locomotion|locomotion
5272556|NCT02317107|Motor Activity|motor activity
5272557|NCT02317068|sick sinus syndrome|sick sinus syndrome
5272558|NCT02317068|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5272559|NCT02317068|atrial pacing|atrial pacing
5272560|NCT02317068|high atrial base rate pacing|high atrial base rate pacing
5272561|NCT02317055|MRI|mri
5272562|NCT02317055|Oxygenation|oxygenation
5272563|NCT02317055|nirs|nirs
5272564|NCT02317029|Cardioversion|cardioversion
5272565|NCT02317029|Cardiac Arrythmias|cardiac arrythmias
5272566|NCT02317029|Myocardial Injury|myocardial injury
5272567|NCT02317029|Defibrillators|defibrillators
5272568|NCT02317029|Biomarkers|biomarkers
5272569|NCT02317016|oncology|oncology
5272570|NCT02317016|cancer|cancer
5272571|NCT02317016|non small cell lung cancer|non small cell lung cancer
5272572|NCT02317016|anticancer drug|anticancer drug
5272573|NCT02317016|pharmacokinetics|pharmacokinetics
5272574|NCT02317016|AZD9291|azd9291
5272575|NCT02317016|rosuvastatin|rosuvastatin
5272576|NCT02317016|EGFR genes|egfr genes
5272577|NCT02317003|physical exercise|physical exercise
5272578|NCT02317003|sedentarity|sedentarity
5272579|NCT02317003|general practice|general practice
5272580|NCT02317003|family medicine|family medicine
5272581|NCT02317003|pedometer|pedometer
5272582|NCT02316977|Reproducibility of Results|reproducibility of results
5272583|NCT02316964|AML|aml
5272584|NCT02316964|acute myeloid leukemia|acute myeloid leukemia
5272585|NCT02316964|decitabine|decitabine
5272586|NCT02316951|Postoperative|postoperative
5272587|NCT02316951|Pain|pain
5272588|NCT02316951|Symptoms|symptoms
5272589|NCT02316951|Video recording|video recording
5272590|NCT02316951|Orthopedic surgery|orthopedic surgery
5272591|NCT02316912|allergy|allergy
5272592|NCT02316899|ASP0456|asp0456
5272593|NCT02316899|constipation|constipation
5272594|NCT02316899|linaclotide|linaclotide
5272595|NCT02316899|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5272596|NCT02316886|coronary intervention|coronary intervention
5272597|NCT02316886|Vulnerable Plaque|vulnerable plaque
5272598|NCT02316886|Insignificant Stenosis|insignificant stenosis
5848935|NCT00032617|Stress Disorder|stress disorder
5272599|NCT02316886|Bioresorbable Vascular Scaffold|bioresorbable vascular scaffold
5272600|NCT02316886|Everolimus Eluting stent|everolimus eluting stent
5272601|NCT02316873|music training, rhythm|music training, rhythm
5272602|NCT02316847|Cluster Seizures|cluster seizures
5272604|NCT02316847|Clusters|clusters
5272605|NCT02316847|Acute repetitive seizures|acute repetitive seizures
5272606|NCT02316821|Diabetes Mellitus|diabetes mellitus
5272607|NCT02316821|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5272608|NCT02316821|Diabetic Nephropathies|diabetic nephropathies
5272609|NCT02316821|Kidney Diseases|kidney diseases
5272610|NCT02316821|Renal Insufficiency, Chronic|renal insufficiency, chronic
5272611|NCT02316821|Diabetes Complications|diabetes complications
5272612|NCT02316821|Endocrine System Diseases|endocrine system diseases
5272613|NCT02316821|Glucose Metabolism Disorders|glucose metabolism disorders
5272614|NCT02316821|Metabolic Diseases|metabolic diseases
5272615|NCT02316821|Renal Insufficiency|renal insufficiency
5272616|NCT02316821|Urologic Diseases|urologic diseases
5272617|NCT02316821|bardoxolone methyl|bardoxolone methyl
5272618|NCT02316756|Phase 1, Single-Dose Escalation, Double Blind, Placebo-Controlled, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, PF-06648671, Plasma Abeta|phase 1, single-dose escalation, double blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics, pf-06648671, plasma abeta
5272619|NCT02316691|Graves Disease|graves disease
5272621|NCT02316678|Patient Preference|patient preference
5272622|NCT02316665|Type 1 diabetes|type 1 diabetes
5272627|NCT02316665|Sleep habits|sleep habits
5272828|NCT02315573|Lidocaine|lidocaine
5272629|NCT02316639|Skeletally Immature|skeletally immature
5272630|NCT02316639|Knee Rehabilitation|knee rehabilitation
5272632|NCT02316600|Robust volunteers for the first phase;|robust volunteers for the first phase;
5272633|NCT02316600|tele-monitoring|tele-monitoring
5272634|NCT02316600|self-management|self-management
5272635|NCT02316600|Patient 65 and over|patient 65 and over
5272636|NCT02316600|Presenting a frailty syndrome for the second phase|presenting a frailty syndrome for the second phase
5272637|NCT02316587|Computerized Tomography|computerized tomography
5272638|NCT02316587|Magnetic Resonance Imaging|magnetic resonance imaging
5272639|NCT02316587|Echocardiography|echocardiography
5272640|NCT02316587|Right Heart Catheterization|right heart catheterization
5272641|NCT02316574|Alcohol dependence|alcohol dependence
5272642|NCT02316574|Cognitive Behavioral Therapy|cognitive behavioral therapy
5272643|NCT02316574|Functional neuroimaging|functional neuroimaging
5272644|NCT02316535|colorectal cancer|colorectal cancer
5272645|NCT02316535|stage II/III|stage ii/iii
5272646|NCT02316535|elderly|elderly
5272647|NCT02316535|adjuvant chemotherapy|adjuvant chemotherapy
5272648|NCT02316535|capecitabine|capecitabine
5272649|NCT02316535|non-inferiority|non-inferiority
5272650|NCT02316496|Cancer|cancer
5272651|NCT02316496|Colorectal|colorectal
5272652|NCT02316496|Metastatic|metastatic
5272653|NCT02316496|Thrid-line|thrid-line
5272654|NCT02316496|Irinotecan|irinotecan
5272655|NCT02316496|Cetuximab|cetuximab
5272656|NCT02316470|Clostridium difficile|clostridium difficile
5272657|NCT02316470|Valneva|valneva
5272658|NCT02316470|Phase 2|phase 2
5272659|NCT02316470|Healthy adults|healthy adults
5272660|NCT02316457|TNBC|tnbc
5272661|NCT02316457|Breast Cancer|breast cancer
5272662|NCT02316457|Warehouse|warehouse
5272663|NCT02316457|Mutanome|mutanome
5272665|NCT02316457|Vaccine|vaccine
5272666|NCT02316444|Hepatitis B vaccine HIV infection|hepatitis b vaccine hiv infection
5272667|NCT02316418|Hairstetics™ anchoring system|hairstetics™ anchoring system
5272668|NCT02316418|hair extensions|hair extensions
5272669|NCT02316392|Helium|helium
5272670|NCT02316392|MRI|mri
5272671|NCT02316392|Lung transplantation|lung transplantation
5272672|NCT02316379|Respiratory|respiratory
5272673|NCT02316314|Friedreich's Ataxia|friedreich's ataxia
5272674|NCT02316314|Cardiomyopathy|cardiomyopathy
5272675|NCT02316301|Misoprostol, pain, office hysteroscopy|misoprostol, pain, office hysteroscopy
5272676|NCT02316249|pelvic organ prolapse|pelvic organ prolapse
5272677|NCT02316249|Atrophy of Vagina|atrophy of vagina
5272678|NCT02316249|Gellhorn pessary|gellhorn pessary
5272679|NCT02316249|Ring with support pessary|ring with support pessary
5272680|NCT02316249|Estrace cream|estrace cream
5272681|NCT02316249|vaginitis with pessary|vaginitis with pessary
5272682|NCT02316249|vaginal ulceration with pessary|vaginal ulceration with pessary
5272683|NCT02316249|vaginal erosion with pessary|vaginal erosion with pessary
5272684|NCT02316249|pessary complications|pessary complications
5272685|NCT02316249|vaginal bleeding with pessary|vaginal bleeding with pessary
5272686|NCT02316223|asthma|asthma
5272687|NCT02316223|high-risk|high-risk
5272688|NCT02316223|adult|adult
5272689|NCT02316223|elderly|elderly
5272690|NCT02316223|care coordination|care coordination
5277610|NCT02288975|ICU|icu
5272697|NCT02316197|Dose escalation|dose escalation
5272698|NCT02316197|Dose expansion|dose expansion
5272699|NCT02316197|Safety profile|safety profile
5272700|NCT02316197|Tolerability|tolerability
5272701|NCT02316197|PK|pk
5272702|NCT02316197|Antitumor activity|antitumor activity
5674384|NCT00603785|Hyposmia|hyposmia
5272703|NCT02316197|Maximum tolerated dose|maximum tolerated dose
5272704|NCT02316197|M3814|m3814
5272705|NCT02316184|Alcohol|alcohol
5272706|NCT02316171|Coxsackievirus A21|coxsackievirus a21
5272707|NCT02316171|bladder cancer|bladder cancer
5272708|NCT02316171|CVA21|cva21
5272709|NCT02316171|CAVATAK|cavatak
5272710|NCT02316158|Burden|burden
5141967|NCT03103997|EUS|eus
5153735|NCT03031132|fMRI|fmri
5272711|NCT02316158|Mental illness|mental illness
5272712|NCT02316158|Stress|stress
5272713|NCT02316158|Social support|social support
5272714|NCT02316145|ADHD|adhd
5272715|NCT02316145|Autism spectrum condition|autism spectrum condition
5272716|NCT02316145|Tourette's disorder|tourette's disorder
5272717|NCT02316145|Internet-based|internet-based
5272718|NCT02316145|chat|chat
5272719|NCT02316145|coach|coach
5272720|NCT02316119|bleeding risk, acute coronary syndrome, platelet agregation,|bleeding risk, acute coronary syndrome, platelet agregation,
5272721|NCT02316106|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
5272722|NCT02316106|Daratumumab|daratumumab
5272723|NCT02316080|dental bleaching|dental bleaching
5272732|NCT02316054|myocardial perfusion imaging|myocardial perfusion imaging
5272734|NCT02316054|atherosclerosis|atherosclerosis
5272735|NCT02316054|myocardial ischemia|myocardial ischemia
5272736|NCT02316054|coronary heart disease|coronary heart disease
5272737|NCT02316041|Femtosecond laser|femtosecond laser
5272738|NCT02316041|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
5272739|NCT02316028|decitabine|decitabine
5272740|NCT02316028|colorectal cancer|colorectal cancer
5272741|NCT02316028|hepatic arterial infusion|hepatic arterial infusion
5272742|NCT02316015|Child, Hospitalized|child, hospitalized
5272743|NCT02316015|Nutritional status|nutritional status
5272744|NCT02315976|chronic stable angina pectoris|chronic stable angina pectoris
5272745|NCT02315976|propatyl nitrate|propatyl nitrate
5272746|NCT02315976|Seattle Angina Questionnaire|seattle angina questionnaire
5272747|NCT02315911|Tonsillectomy|tonsillectomy
5272748|NCT02315911|Adenoidectomy|adenoidectomy
5272749|NCT02315911|Adenoidpharyngoplasty|adenoidpharyngoplasty
5272750|NCT02315911|OSA|osa
5272751|NCT02315898|children, congenital heart disease, metabolomics|children, congenital heart disease, metabolomics
5272752|NCT02315885|healthy volunteers|healthy volunteers
5272753|NCT02315885|social drinkers|social drinkers
5272754|NCT02315885|alcohol|alcohol
5272755|NCT02315872|Multiple Sclerosis|multiple sclerosis
5272756|NCT02315872|Acthar Gel|acthar gel
5272757|NCT02315872|ACTH|acth
5272758|NCT02315872|Fatigue|fatigue
5272759|NCT02315859|suction work|suction work
5272760|NCT02315833|Migraine|migraine
5272761|NCT02315833|Aura|aura
5272762|NCT02315820|Macrosomia|macrosomia
5272763|NCT02315820|Induction of labor|induction of labor
5272764|NCT02315820|Expectant management|expectant management
5272765|NCT02315820|Shoulder dystocia|shoulder dystocia
5272766|NCT02315794|aesthetic outcome|aesthetic outcome
5272767|NCT02315794|titanium abutment|titanium abutment
5272768|NCT02315794|zirconia abutment|zirconia abutment
5272774|NCT02315755|Metastatic renal cell carcinoma, targeted molecular therapy|metastatic renal cell carcinoma, targeted molecular therapy
5272775|NCT02315716|Multiple Myeloma|multiple myeloma
5272776|NCT02315716|Carfilzomib|carfilzomib
5272777|NCT02315703|Healthy|healthy
5272778|NCT02315703|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
5272779|NCT02315703|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
5272780|NCT02315703|adenovirus serotype 26|adenovirus serotype 26
5272781|NCT02315703|Ad26.Mos.HIV|ad26.mos.hiv
5272782|NCT02315703|Modified Vaccinia Ankara|modified vaccinia ankara
5272783|NCT02315703|Glycoprotein|glycoprotein
5272784|NCT02315703|Adjuvant|adjuvant
5272785|NCT02315703|Vaccine|vaccine
5272786|NCT02315703|Placebo|placebo
5272787|NCT02315690|malaria, Swaziland, reactive case detection, focal mass drug administration|malaria, swaziland, reactive case detection, focal mass drug administration
5272788|NCT02315677|Epistaxis|epistaxis
5272789|NCT02315677|Nasal Intubation|nasal intubation
5272790|NCT02315677|Maxillofacial surgery|maxillofacial surgery
5272791|NCT02315664|Physical activity|physical activity
5272792|NCT02315664|Exercise|exercise
5272793|NCT02315664|Osteoarthritis|osteoarthritis
5272794|NCT02315664|Knee|knee
5272795|NCT02315664|Arthritis|arthritis
5272796|NCT02315638|Adeno-associated viral vectors|adeno-associated viral vectors
5272797|NCT02315638|Adeno-associated virus|adeno-associated virus
5272798|NCT02315638|AAV|aav
5272799|NCT02315638|AAV8|aav8
5272800|NCT02315638|ddRNAi|ddrnai
5272801|NCT02315638|shRNA|shrna
5272802|NCT02315638|RNAi|rnai
5272803|NCT02315638|Hepatitis|hepatitis
5272804|NCT02315638|Chronic Hepatitis C|chronic hepatitis c
5272805|NCT02315638|HCV|hcv
5272806|NCT02315638|CHC|chc
5272807|NCT02315638|Genotype 1|genotype 1
5272808|NCT02315625|MEN1|men1
5272809|NCT02315625|VHL|vhl
5272810|NCT02315625|Neoplasm|neoplasm
5272811|NCT02315625|NF1|nf1
5272812|NCT02315625|mTOR|mtor
5272813|NCT02315612|CD-22 Expressing Tumor|cd-22 expressing tumor
5272814|NCT02315612|Chimeric Antigen Receptor|chimeric antigen receptor
5272815|NCT02315612|Adoptive Immunotherapy|adoptive immunotherapy
5272817|NCT02315612|Lymphoma|lymphoma
5272818|NCT02315599|Replication Competent Retrovirus (RCR)|replication competent retrovirus (rcr)
5272819|NCT02315599|Replication Competent Lentivirus (RCL)|replication competent lentivirus (rcl)
5272820|NCT02315599|T Cell Persistence|t cell persistence
5272821|NCT02315586|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5272822|NCT02315586|Apoliprotein A-1|apoliprotein a-1
5272823|NCT02315573|Carpal Tunnel Syndrome|carpal tunnel syndrome
5272824|NCT02315573|Anesthetics, Local|anesthetics, local
5272825|NCT02315573|Pain Perception|pain perception
5272826|NCT02315573|Pain Measurement|pain measurement
5272827|NCT02315573|Analgesia|analgesia
5272830|NCT02315560|bedwetting|bedwetting
5272831|NCT02315547|Microbiota|microbiota
5272832|NCT02315547|Airway infection|airway infection
5272833|NCT02315547|Bronchiectasis|bronchiectasis
5272834|NCT02315547|Airway inflammation|airway inflammation
5272835|NCT02315547|Oxidative stress|oxidative stress
5272836|NCT02315547|Matrix metalloproteinase|matrix metalloproteinase
5272837|NCT02315534|GBM|gbm
5272838|NCT02315534|Malignant Glioma|malignant glioma
5272839|NCT02315521|lower urinary tract obstruction|lower urinary tract obstruction
5272840|NCT02315521|posterior urethral valves|posterior urethral valves
5272841|NCT02315521|urethral atresia|urethral atresia
5272842|NCT02315521|Prune Belly Syndrome|prune belly syndrome
5272843|NCT02315521|Megalo-urethra|megalo-urethra
5272844|NCT02315521|Fetal renal function|fetal renal function
5272845|NCT02315521|Prenatal Diagnosis|prenatal diagnosis
5260203|NCT02387242|WBA|wba
5272846|NCT02315521|Ultrasound|ultrasound
5272847|NCT02315482|autonomic nervous system|autonomic nervous system
5272848|NCT02315482|heart rate variability|heart rate variability
5272849|NCT02315482|prostatectomy|prostatectomy
5272850|NCT02315482|steep trendelenburg|steep trendelenburg
5272851|NCT02315482|pneumoperitoneum|pneumoperitoneum
5272852|NCT02315482|Intervention Affecting Autonomic Nervous System|intervention affecting autonomic nervous system
5272853|NCT02315456|capsulorhexis|capsulorhexis
5272854|NCT02315456|IOL centration|iol centration
5272855|NCT02315443|Stroke|stroke
5272856|NCT02315443|Ischemia|ischemia
5272857|NCT02315443|Prehospital|prehospital
5272858|NCT02315443|NA-1|na-1
5272859|NCT02315443|Modified Rankin Scale|modified rankin scale
5272860|NCT02315443|Haemorrhagic stroke|haemorrhagic stroke
5272861|NCT02315443|Transient ischemic attack|transient ischemic attack
5272862|NCT02315417|Pyoderma Gangrenosum|pyoderma gangrenosum
5272863|NCT02315417|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
5272864|NCT02315404|Obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
5272865|NCT02315404|Overt gastrointestinal bleeding|overt gastrointestinal bleeding
5272866|NCT02315404|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
5272867|NCT02315404|Enteroscopy|enteroscopy
5272868|NCT02315378|Anxiety, Acute Trauma|anxiety, acute trauma
5272869|NCT02315352|Healthy|healthy
5272870|NCT02315352|L-PZQ|l-pzq
5272871|NCT02315352|PZQ|pzq
5272872|NCT02315352|MSC2499550A|msc2499550a
5272873|NCT02315352|Praziquantel|praziquantel
5272874|NCT02315326|Ibrutinib,|ibrutinib,
5272875|NCT02315326|Imbruvica™|imbruvica™
5272876|NCT02315326|Bruton's Tyrosine Kinase (BTK) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
5272877|NCT02315326|HD-MTX|hd-mtx
5272878|NCT02315326|14-184|14-184
5272879|NCT02315300|ECG, CGM, Hypoglycaemia, Sudden Cardiac Death|ecg, cgm, hypoglycaemia, sudden cardiac death
5272880|NCT02315287|Triple combination|triple combination
5272881|NCT02315287|Metformin|metformin
5272882|NCT02315287|Sitagliptin|sitagliptin
5272883|NCT02315287|Pioglitazone|pioglitazone
5272884|NCT02315287|Lobeglitazone|lobeglitazone
5272885|NCT02315274|Type 1 diabetes|type 1 diabetes
5272886|NCT02315274|Pregnancy|pregnancy
5272887|NCT02315274|Glycemic variability|glycemic variability
5272888|NCT02315274|Between visit contact|between visit contact
5272889|NCT02315261|Epidural analgesia|epidural analgesia
5272890|NCT02315261|Pain score|pain score
5272891|NCT02315248|bone density|bone density
5272893|NCT02315222|Dietary supplements|dietary supplements
5272894|NCT02315222|Scaling and root planing|scaling and root planing
5272895|NCT02315222|full mouth disinfection|full mouth disinfection
5272896|NCT02315209|Inguinal Hernia, Quality of Life, Mesh|inguinal hernia, quality of life, mesh
5272897|NCT02315183|Post cardiac surgery|post cardiac surgery
5272898|NCT02315170|diabetic retinopathy|diabetic retinopathy
5272899|NCT02315170|age-related macular edema|age-related macular edema
5272900|NCT02315157|Partial Response|partial response
5272901|NCT02315144|COPD|copd
5272902|NCT02315144|bronchodilation|bronchodilation
5272903|NCT02315092|Diabetic Foot Ulcers|diabetic foot ulcers
5272904|NCT02315092|Bacteria|bacteria
5272905|NCT02315092|Fluorescence|fluorescence
5272906|NCT02315079|Ocular Inflammation|ocular inflammation
5272907|NCT02315079|Matrix Metalloproteinase 9|matrix metalloproteinase 9
5272908|NCT02315066|Immunotherapy|immunotherapy
5272909|NCT02315066|PF-04518600|pf-04518600
5272910|NCT02315066|PF-05082566|pf-05082566
5272911|NCT02315066|solid tumors|solid tumors
5272913|NCT02315066|neoplasm metastasis|neoplasm metastasis
5272914|NCT02315066|Phase 1|phase 1
5272915|NCT02315066|hepatocellular carcinoma|hepatocellular carcinoma
5272916|NCT02315066|HCC|hcc
5272917|NCT02315066|liver cancer|liver cancer
5272918|NCT02315066|ocular melanoma|ocular melanoma
5272919|NCT02315066|melanoma|melanoma
5272920|NCT02315066|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5272921|NCT02315066|RCC|rcc
5272922|NCT02315066|kidney cancer|kidney cancer
5272923|NCT02315066|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5272924|NCT02315066|HNSCC|hnscc
5272925|NCT02315066|head and neck cancer|head and neck cancer
5272926|NCT02315066|cervical cancer|cervical cancer
5272927|NCT02315066|cancer of the cervix|cancer of the cervix
5272930|NCT02315066|non small cell lung cancer|non small cell lung cancer
5272932|NCT02315066|lung cancer|lung cancer
5272933|NCT02315066|urothelial bladder carcinoma|urothelial bladder carcinoma
5272934|NCT02315066|bladder cancer|bladder cancer
5272935|NCT02315066|OX40|ox40
5272936|NCT02315066|4-1BB|4-1bb
5272937|NCT02315053|NSCLC|nsclc
5272938|NCT02315053|CCRT|ccrt
5272939|NCT02315053|FDG PET/CT|fdg pet/ct
5272940|NCT02315040|Intrauterine insemination (IUI)|intrauterine insemination (iui)
5272941|NCT02315040|Insemination method|insemination method
5272942|NCT02315040|Slow release insemination (SRI)|slow release insemination (sri)
5272943|NCT02315040|EVIE|evie
5272944|NCT02315040|Pregnancy rate|pregnancy rate
5272945|NCT02315001|Liraglutide|liraglutide
5272946|NCT02315001|GLP-1|glp-1
5272947|NCT02315001|Ischaemic heart disease|ischaemic heart disease
5272948|NCT02315001|Coronary heart disease|coronary heart disease
5272949|NCT02315001|Chronic stable angina|chronic stable angina
5272950|NCT02314988|Tranexamic acid|tranexamic acid
5272951|NCT02314988|Antifibrinolytic|antifibrinolytic
5272952|NCT02314988|Perioperative blood loss|perioperative blood loss
5272953|NCT02314988|Postoperative drain output|postoperative drain output
5272954|NCT02314988|Allogenic transfusion|allogenic transfusion
5272955|NCT02314949|T-regulatory cells|t-regulatory cells
5272956|NCT02314949|Tolerogenic protocol|tolerogenic protocol
5272957|NCT02314949|immunomodulation|immunomodulation
5272958|NCT02314936|Constipation|constipation
5272959|NCT02314936|Polydextrose|polydextrose
5272960|NCT02314936|Dietary Fiber|dietary fiber
5272961|NCT02314936|PAC-QoL|pac-qol
5272962|NCT02314936|Colonic Transit Time|colonic transit time
5272963|NCT02314936|PAC-SYM|pac-sym
5272964|NCT02314910|Innervation|innervation
5272965|NCT02314910|Jaw Bone|jaw bone
5272966|NCT02314910|Implants|implants
5272967|NCT02314910|Stereognostic|stereognostic
5272968|NCT02314910|Osseoperception|osseoperception
5272969|NCT02314871|perioperative analgesia|perioperative analgesia
5272970|NCT02314871|minimal residual disease|minimal residual disease
5272971|NCT02314871|cancer recurrence|cancer recurrence
5272972|NCT02314871|epidural|epidural
5272973|NCT02314871|morphine|morphine
5272974|NCT02314871|piritramide|piritramide
5272975|NCT02314871|colon|colon
5272976|NCT02314871|cancer|cancer
5272977|NCT02314871|circulating cancer cells|circulating cancer cells
5272978|NCT02314871|colon cancer surgery|colon cancer surgery
5272979|NCT02314845|Pulmonary Atelectasis|pulmonary atelectasis
5272980|NCT02314845|Pulmonary Ventilation|pulmonary ventilation
5272981|NCT02314845|Anesthesia, General|anesthesia, general
5272982|NCT02314845|Electric Impedance|electric impedance
5272983|NCT02314845|Tomography, Spiral Computed|tomography, spiral computed
5272984|NCT02314845|Intraoperative Period|intraoperative period
5272985|NCT02314832|femoral nerve block|femoral nerve block
5272986|NCT02314832|adductor canal block|adductor canal block
5272987|NCT02314832|tinetti score|tinetti score
5272988|NCT02314832|2- Results to time to up and go (TUG ) test|2- results to time to up and go (tug ) test
5272989|NCT02314832|3- Results to Tinetti test|3- results to tinetti test
5272990|NCT02314832|4- Ambulation distance|4- ambulation distance
5272991|NCT02314832|5- Pain scores at rest and with movement|5- pain scores at rest and with movement
5272993|NCT02314793|Pharmacokinetics|pharmacokinetics
5272996|NCT02314741|per oral endoscopic myotomy|per oral endoscopic myotomy
5272997|NCT02314741|achalasia|achalasia
5272998|NCT02314728|Bishop Score|bishop score
5272999|NCT02314728|Induction of Labor|induction of labor
5273000|NCT02314728|Cervical Ripening|cervical ripening
5273001|NCT02314728|Unfavorable Cervix|unfavorable cervix
5273002|NCT02314728|Mode of Delivery|mode of delivery
5273003|NCT02314728|C-Section|c-section
5273004|NCT02314728|Cesarean Section|cesarean section
5273005|NCT02314715|Osteoarthritis Knee|osteoarthritis knee
5273006|NCT02314702|Osteoarthritis|osteoarthritis
5273007|NCT02314702|Avascular necrosis|avascular necrosis
5273008|NCT02314702|Ankylosis|ankylosis
5273009|NCT02314702|Protrusio acetabuli|protrusio acetabuli
5273010|NCT02314702|Painful hip dysplasia|painful hip dysplasia
5273011|NCT02314702|Rheumatoid arthritis|rheumatoid arthritis
5273012|NCT02314702|Correction of functional deformity|correction of functional deformity
5273013|NCT02314702|Revision procedures|revision procedures
5273014|NCT02314663|hypercholesterolaemia|hypercholesterolaemia
5273015|NCT02314663|medication adherence|medication adherence
5273016|NCT02314663|primary health care|primary health care
5273017|NCT02314637|DPP-IV inhibitor|dpp-iv inhibitor
5273018|NCT02314611|osteoarthritis|osteoarthritis
5273019|NCT02314611|avascular necrosis|avascular necrosis
5273020|NCT02314611|ankylosis|ankylosis
5273021|NCT02314611|protrusio acetabuli|protrusio acetabuli
5273022|NCT02314611|painful hip dysplasia|painful hip dysplasia
5273023|NCT02314611|rheumatoid arthritis|rheumatoid arthritis
5273024|NCT02314611|correction of functional deformity|correction of functional deformity
5273025|NCT02314611|revision procedures|revision procedures
5273026|NCT02314572|Multifocal Intraocular Lens|multifocal intraocular lens
5273027|NCT02314572|Binocular Trifocality|binocular trifocality
5273028|NCT02314572|Cataract Surgery|cataract surgery
5273029|NCT02314572|Spectacle Independence|spectacle independence
5273030|NCT02314572|Intermediate Vision|intermediate vision
5273032|NCT02314572|Mesopic Vision|mesopic vision
5273033|NCT02314572|Scotopic Vision|scotopic vision
5273034|NCT02314572|Binocular Vision|binocular vision
5273035|NCT02314559|propofol|propofol
5273036|NCT02314559|colonoscopy|colonoscopy
5273037|NCT02314507|Gua sha|gua sha
5273038|NCT02314481|NSCLC|nsclc
5273039|NCT02314481|Clonal dominance|clonal dominance
5273040|NCT02314481|Clonal evolution|clonal evolution
5273041|NCT02314481|Intratumour heterogeneity|intratumour heterogeneity
5273042|NCT02314481|Genomic instability|genomic instability
5273043|NCT02314481|Drug resistance|drug resistance
5273044|NCT02314481|Immunotherapy|immunotherapy
5260412|NCT02385968|Modic|modic
5273045|NCT02314481|PDL1|pdl1
5273046|NCT02314481|BRAF V600|braf v600
5273049|NCT02314481|HER2 amplification|her2 amplification
5273050|NCT02314481|MPDL3280A|mpdl3280a
5273051|NCT02314481|Vemurafenib|vemurafenib
5273052|NCT02314481|Alectinib|alectinib
5273053|NCT02314481|T-DM1|t-dm1
5273054|NCT02314481|Trastuzumab emtansine|trastuzumab emtansine
5273055|NCT02314481|TRACERX|tracerx
5273056|NCT02314455|Eosinophilic Esophagitis|eosinophilic esophagitis
5273057|NCT02314455|EoE|eoe
5273058|NCT02314455|dysphagia|dysphagia
5273059|NCT02314442|LDL-C|ldl-c
5273060|NCT02314442|RNAi therapeutic|rnai therapeutic
5273061|NCT02314416|wounds, stem cells, collagen matrix, maturation|wounds, stem cells, collagen matrix, maturation
5273062|NCT02314403|ESRD|esrd
5273063|NCT02314390|Depression|depression
5273064|NCT02314390|Mindfulness|mindfulness
5273065|NCT02314390|MBCT|mbct
5273066|NCT02314364|Non-small cell lung cancer|non-small cell lung cancer
5273067|NCT02314364|Metastatic|metastatic
5273068|NCT02314364|EGFR|egfr
5273069|NCT02314364|ALK|alk
5273070|NCT02314364|ROS1|ros1
5273071|NCT02314364|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5273072|NCT02314351|migraine disorders|migraine disorders
5273073|NCT02314351|migraine with aura|migraine with aura
5273074|NCT02314351|migraine without aura|migraine without aura
5273075|NCT02314351|pain management|pain management
5273076|NCT02314351|emergency department|emergency department
5273077|NCT02314325|Factor VIII deficiency|factor viii deficiency
5273078|NCT02314325|Arthropathy|arthropathy
5273079|NCT02314325|MRI|mri
5273080|NCT02314325|XRay|xray
5273081|NCT02314325|Joint|joint
5273082|NCT02314325|HJHS|hjhs
5273083|NCT02314312|Kidney transplantation|kidney transplantation
5273084|NCT02314312|ECD|ecd
5273085|NCT02314299|Macular edema|macular edema
5273086|NCT02314299|Macular degeneration|macular degeneration
5273087|NCT02314299|MTP-131|mtp-131
5273088|NCT02314299|Ocuvia™|ocuvia™
5273089|NCT02314286|Rosuvastatin|rosuvastatin
5273090|NCT02314286|severe preeclampsia|severe preeclampsia
5273091|NCT02314286|48 hours following delivery|48 hours following delivery
5273092|NCT02314260|labour induction|labour induction
5273093|NCT02314260|cervical length|cervical length
5273094|NCT02314260|trans-vaginal assessment of cervical length|trans-vaginal assessment of cervical length
5273095|NCT02314260|Bishop score|bishop score
5273096|NCT02314247|PTCL|ptcl
5273097|NCT02314247|CTCL|ctcl
5273098|NCT02314247|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5273099|NCT02314247|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5273100|NCT02314247|Karyopharm|karyopharm
5273101|NCT02314247|KPT-330|kpt-330
5273102|NCT02314247|Selinexor|selinexor
5273103|NCT02314221|Exoskeletal-assisted walking|exoskeletal-assisted walking
5273104|NCT02314208|spastic paraplegia|spastic paraplegia
5273105|NCT02314208|metabolism|metabolism
5273106|NCT02314208|oxysterols|oxysterols
5273107|NCT02314208|neurogenetics|neurogenetics
5273108|NCT02314195|Obsessive Compulsive Disorder|obsessive compulsive disorder
5273109|NCT02314195|Music Therapy/methods|music therapy/methods
5273110|NCT02314195|Combined Modality Therapy|combined modality therapy
5273111|NCT02314195|Anxiety Disorders/therapy|anxiety disorders/therapy
5273112|NCT02314182|Rectal adenocarcinoma|rectal adenocarcinoma
5273113|NCT02314182|unresectable|unresectable
5273114|NCT02314182|surgery|surgery
5273115|NCT02314182|chemotherapy|chemotherapy
5273116|NCT02314143|dabrafenib|dabrafenib
5273117|NCT02314143|MEK|mek
5273118|NCT02314143|trametinib|trametinib
5273119|NCT02314143|BRAF|braf
5273120|NCT02314143|melanoma|melanoma
5273121|NCT02314143|Oncology|oncology
5273122|NCT02314104|Surgical procedures, Minimally invasive|surgical procedures, minimally invasive
5273123|NCT02314104|Nerve block|nerve block
5273124|NCT02314104|Anesthetics, Local|anesthetics, local
5273125|NCT02314078|Caesarean section|caesarean section
5273126|NCT02314078|Emergency|emergency
5273127|NCT02314078|Anaesthesia|anaesthesia
5273128|NCT02314065|Severe health anxiety|severe health anxiety
5273129|NCT02314065|Somatic symptom disorder|somatic symptom disorder
5273130|NCT02314065|Illness anxiety disorder|illness anxiety disorder
5273131|NCT02314065|Cognitive behavioral therapy|cognitive behavioral therapy
5273132|NCT02314065|Internet|internet
5273133|NCT02314065|Exposure|exposure
5273138|NCT02313961|ST elevation myocardial infarction|st elevation myocardial infarction
5273139|NCT02313961|Reperfusion injury|reperfusion injury
5273140|NCT02313961|Remote ischaemic conditioning|remote ischaemic conditioning
5273141|NCT02313909|Rivaroxaban|rivaroxaban
5273142|NCT02313909|Xarelto|xarelto
5273143|NCT02313909|Aspirin|aspirin
5273144|NCT02313909|Acetylsalicylic acid (ASA)|acetylsalicylic acid (asa)
5273145|NCT02313909|Oral Anticoagulant|oral anticoagulant
5273151|NCT02313909|ESUS|esus
5273152|NCT02313909|Transient Ischemic Attack|transient ischemic attack
5273153|NCT02313909|Thromboembolism|thromboembolism
5273154|NCT02313909|Cerebrovascular Disease|cerebrovascular disease
5273155|NCT02313883|periodontitis|periodontitis
5273156|NCT02313883|taurolidine (PerioSept(r))|taurolidine (periosept(r))
5273157|NCT02313883|scaling and root planing|scaling and root planing
5273158|NCT02313870|Bullous pemphigoid|bullous pemphigoid
5273159|NCT02313870|superpotent topical steroids|superpotent topical steroids
5273160|NCT02313870|methotrexate|methotrexate
5273161|NCT02313870|safety|safety
5273162|NCT02313857|Viralym-C|viralym-c
5273163|NCT02313857|Viral infections post HSCT|viral infections post hsct
5273164|NCT02313857|Virus-specific T cells|virus-specific t cells
5273165|NCT02313844|BK virus|bk virus
5273166|NCT02313844|Virus specific T cells|virus specific t cells
5273167|NCT02313844|Viral infections|viral infections
5273168|NCT02313831|autonomic nervous system|autonomic nervous system
5273169|NCT02313831|ventilatory anaerobic threshold|ventilatory anaerobic threshold
5273170|NCT02313831|oxygen consumption|oxygen consumption
5273171|NCT02313831|metabolic profile|metabolic profile
5273172|NCT02313831|exercise training|exercise training
5273173|NCT02313831|expiratory flow limitation|expiratory flow limitation
5273174|NCT02313818|Posttraumatic Stress Disorder|posttraumatic stress disorder
5273175|NCT02313818|Cognitive Processing Therapy|cognitive processing therapy
5273176|NCT02313818|Active Duty Military|active duty military
5273177|NCT02313805|Insulin initiation|insulin initiation
5273178|NCT02313805|Insulin checklist|insulin checklist
5273179|NCT02313792|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5273180|NCT02313792|Palifermin|palifermin
5273181|NCT02313740|Influenza|influenza
5273182|NCT02313740|Influenza Vaccines|influenza vaccines
5273183|NCT02313714|heart failure, heart transplant, electrical stimulation|heart failure, heart transplant, electrical stimulation
5273184|NCT02313688|adenocarcinomas of esophagogastric junction|adenocarcinomas of esophagogastric junction
5273185|NCT02313688|resection margin|resection margin
5273186|NCT02313688|length|length
5273187|NCT02313688|prognosis|prognosis
5273188|NCT02313675|carpal tunnel syndrome|carpal tunnel syndrome
5273189|NCT02313675|opioid analgesics|opioid analgesics
5848936|NCT00032617|Trauma|trauma
5273190|NCT02313675|postoperative pain|postoperative pain
5273191|NCT02313675|IV tylenol|iv tylenol
5273192|NCT02313675|IV toradol|iv toradol
5273194|NCT02313649|fibrosis|fibrosis
5273195|NCT02313649|elastography|elastography
5273196|NCT02313649|ShearWave Elastography|shearwave elastography
5273197|NCT02313649|ultrasound|ultrasound
5273198|NCT02313610|Retreatment Pulmonary Tuberculosis, Qinbudan,|retreatment pulmonary tuberculosis, qinbudan,
5273199|NCT02313584|dabigatran|dabigatran
5273200|NCT02313571|Epidural Analgesia|epidural analgesia
5273201|NCT02313571|Pain|pain
5273202|NCT02313558|dentifrice|dentifrice
5273203|NCT02313558|gingivitis|gingivitis
5273204|NCT02313558|dental plaque|dental plaque
5273205|NCT02313519|Infections|infections
5273206|NCT02313519|anastomotic leakage|anastomotic leakage
5273207|NCT02313506|Physical activity|physical activity
5273208|NCT02313506|Exercise|exercise
5273209|NCT02313506|Osteoarthritis|osteoarthritis
5273210|NCT02313506|Knee|knee
5273211|NCT02313506|Arthritis|arthritis
5273212|NCT02313454|dry eye syndrome|dry eye syndrome
5273213|NCT02313454|keratoconjunctivitis|keratoconjunctivitis
5273214|NCT02313454|ophthalmic|ophthalmic
5273215|NCT02313454|eye disease|eye disease
5273216|NCT02313454|corneal disease|corneal disease
5273217|NCT02313454|keratitis|keratitis
5273218|NCT02313441|remote ischemic preconditioning|remote ischemic preconditioning
5273224|NCT02313363|Health care systems|health care systems
5273225|NCT02313363|Mobile applications|mobile applications
5273226|NCT02313363|Self-care|self-care
5273227|NCT02313363|Diabetes mellitus|diabetes mellitus
5273228|NCT02313363|Smartphone|smartphone
5273229|NCT02313350|Sciatica,|sciatica,
5273230|NCT02313350|herniated disc,|herniated disc,
5273231|NCT02313350|chemonucleolysis.|chemonucleolysis.
5273232|NCT02313337|Administration route|administration route
5273234|NCT02313337|Sedation|sedation
5273235|NCT02313324|Coccydynia|coccydynia
5273236|NCT02313324|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5273237|NCT02313324|Disability|disability
5273238|NCT02313311|Cleavage pattern, timing parameter, time-lapse|cleavage pattern, timing parameter, time-lapse
5273239|NCT02313272|neoplasms|neoplasms
5273240|NCT02313272|high-grade glioma|high-grade glioma
5273241|NCT02313272|recurrent glioma|recurrent glioma
5273242|NCT02313272|glioma|glioma
5273243|NCT02313272|Hypofractionated Stereotactic Irradiation (HFSRT)|hypofractionated stereotactic irradiation (hfsrt)
5273244|NCT02313272|Bevacizumab|bevacizumab
5273245|NCT02313272|Pembrolizumab|pembrolizumab
5273246|NCT02313272|recurrent high-grade glioma|recurrent high-grade glioma
5273247|NCT02313272|Grade III malignant glioma|grade iii malignant glioma
5273248|NCT02313272|Grade IV malignant glioma|grade iv malignant glioma
5273249|NCT02313272|brain and nervous system|brain and nervous system
5273250|NCT02313220|Obesity|obesity
5273251|NCT02313220|Dapagliflozin|dapagliflozin
5273252|NCT02313220|Exenatide|exenatide
5273253|NCT02313220|Combination treatment|combination treatment
5273254|NCT02313220|Type 2 diabetes|type 2 diabetes
5273255|NCT02313181|breastfeeding|breastfeeding
5273256|NCT02313181|lactation|lactation
5273257|NCT02313181|newborn|newborn
5273258|NCT02313168|difficult airway; prediction, FRONT score.|difficult airway; prediction, front score.
5273259|NCT02313155|Prevention|prevention
5273260|NCT02313129|Infertility|infertility
5273261|NCT02313129|Rheumatoid Arthritis|rheumatoid arthritis
5273262|NCT02313116|Lumpectomy|lumpectomy
5273263|NCT02313116|Breast cancer|breast cancer
5273264|NCT02313116|Optical coherence tomography|optical coherence tomography
5273265|NCT02313116|Tumor margin|tumor margin
5273266|NCT02313116|Imaging|imaging
5273267|NCT02313103|ESRD|esrd
5273268|NCT02313103|End Stage Renal Disease|end stage renal disease
5273269|NCT02313103|Normal Healthy Volunteers|normal healthy volunteers
5273270|NCT02313103|Renally Impaired|renally impaired
5273271|NCT02313077|Healthy|healthy
5273272|NCT02313077|Ebola viruses|ebola viruses
5273273|NCT02313077|Ebola Viral Disease (EVD)|ebola viral disease (evd)
5273274|NCT02313077|Filoviruses|filoviruses
5273275|NCT02313077|monovalent vaccine|monovalent vaccine
5273276|NCT02313077|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5273277|NCT02313077|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
5273278|NCT02313077|Safety|safety
5273279|NCT02313077|Immunogenicity|immunogenicity
5273280|NCT02313051|metastatic breast cancer, everolimus|metastatic breast cancer, everolimus
5273281|NCT02313038|Coronary heart disease|coronary heart disease
5273282|NCT02313038|Percutaneous Coronary Intervention|percutaneous coronary intervention
5273283|NCT02313038|Drug Eluting Stents|drug eluting stents
5273284|NCT02313012|Maximum Tolerated Dose|maximum tolerated dose
5273285|NCT02313012|Solid Tumors|solid tumors
5273286|NCT02313012|Locally Advanced Tumors|locally advanced tumors
5273287|NCT02313012|Metastatic Solid Tumors|metastatic solid tumors
5273288|NCT02313012|Relapsed or refractory, BRAFV600 or RAS-mutated solid tumors|relapsed or refractory, brafv600 or ras-mutated solid tumors
5273289|NCT02313012|Melanoma|melanoma
5273290|NCT02313012|Colorectal Carcinomas Papillary|colorectal carcinomas papillary
5273291|NCT02313012|Thyroid carcinomas|thyroid carcinomas
5273292|NCT02313012|Pancreatic ductal Adenocarcinomas|pancreatic ductal adenocarcinomas
5273293|NCT02313012|Non -small cell lung cancer [NSCLC]|non -small cell lung cancer [nsclc]
5273294|NCT02312999|laparotomy|laparotomy
5273295|NCT02312999|plasma-Lyte|plasma-lyte
5273296|NCT02312999|volulyte|volulyte
5273297|NCT02312999|close loop|close loop
5273298|NCT02312999|abdominal surgery|abdominal surgery
5273299|NCT02312986|infection|infection
5273300|NCT02312986|colonization|colonization
5273301|NCT02312986|antibiotic resistance|antibiotic resistance
5273302|NCT02312973|Chronic kidney disease|chronic kidney disease
5273303|NCT02312973|Pharmacokinetics|pharmacokinetics
5273304|NCT02312973|Hemodialysis|hemodialysis
5273305|NCT02312973|Peritoneal dialysis|peritoneal dialysis
5273306|NCT02312973|Erythropoietin|erythropoietin
5273307|NCT02312934|Chemo brain|chemo brain
5273308|NCT02312934|Chemotherapy-related cognitive impairment|chemotherapy-related cognitive impairment
5273309|NCT02312934|CRCI|crci
5273310|NCT02312934|Breast cancer|breast cancer
5273311|NCT02312934|Chemo fog|chemo fog
5273312|NCT02312934|Nicotine|nicotine
5273313|NCT02312934|Transdermal nicotine|transdermal nicotine
5273314|NCT02312921|managed healthcare|managed healthcare
5273315|NCT02312921|child|child
5273316|NCT02312921|dental care|dental care
5273317|NCT02312908|REM Sleep Behavior Disorder|rem sleep behavior disorder
5273318|NCT02312908|Parkinson Disease|parkinson disease
5273319|NCT02312908|Placebos|placebos
5273320|NCT02312908|Randomized Controlled Trial|randomized controlled trial
5273321|NCT02312908|Double-Blind Method|double-blind method
5273322|NCT02312908|Clinical Trial|clinical trial
5273323|NCT02312869|Mechanical Ventilation|mechanical ventilation
5273325|NCT02312843|Mild Cognitive Impairment|mild cognitive impairment
5273326|NCT02312843|Cognitive disorders|cognitive disorders
5273327|NCT02312843|Prediabetes|prediabetes
5273328|NCT02312843|Exercise|exercise
5273329|NCT02312817|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5273330|NCT02312817|Liver Neoplasms|liver neoplasms
5273331|NCT02312817|Liver Disease|liver disease
5273332|NCT02312817|Early Detection of Cancer|early detection of cancer
5273333|NCT02312817|Comparative Effectiveness Research|comparative effectiveness research
5273334|NCT02312791|Radiation|radiation
5273335|NCT02312791|Prognosis|prognosis
5273336|NCT02312791|Palliative Care|palliative care
5273337|NCT02312778|non-specific low back pain|non-specific low back pain
5273338|NCT02312778|center of pressure|center of pressure
5273339|NCT02312778|spinal lumbar manipulation|spinal lumbar manipulation
5273340|NCT02312778|high velocity and low amplitude manipulation|high velocity and low amplitude manipulation
5273341|NCT02312778|postural control|postural control
5273342|NCT02312752|Intra-epidermal stimulation in healthy control subjects|intra-epidermal stimulation in healthy control subjects
5273343|NCT02312739|pain assessment|pain assessment
5273344|NCT02312739|pain measurement|pain measurement
5273345|NCT02312739|patient satisfaction|patient satisfaction
5273347|NCT02312739|analgesia and anesthesia|analgesia and anesthesia
5273348|NCT02312739|female sterilization|female sterilization
5273349|NCT02312726|mixed methods|mixed methods
5273350|NCT02312726|visual analog scale|visual analog scale
5273351|NCT02312726|verbal rating score|verbal rating score
5273352|NCT02312726|pain assessment|pain assessment
5273353|NCT02312726|patient satisfaction|patient satisfaction
5273354|NCT02312726|contraceptive devices|contraceptive devices
5273355|NCT02312726|postpartum|postpartum
5273356|NCT02312713|Osteoarthritis|osteoarthritis
5273357|NCT02312713|Knee Osteoarthritis|knee osteoarthritis
5273358|NCT02312700|empowerment|empowerment
5273359|NCT02312700|communication|communication
5273360|NCT02312700|shared decision making|shared decision making
5273363|NCT02312687|KRN23|krn23
5273364|NCT02312674|pancreatic carcinoma|pancreatic carcinoma
5273365|NCT02312674|hepatocellular carcinoma|hepatocellular carcinoma
5273366|NCT02312674|palliative therapy|palliative therapy
5273367|NCT02312674|oral nutritional supplements|oral nutritional supplements
5273368|NCT02312674|quality of life|quality of life
5273369|NCT02312674|nutritional status|nutritional status
5273370|NCT02312661|ovarian cancer|ovarian cancer
5273371|NCT02312661|metformin|metformin
5273372|NCT02312661|carboplatin|carboplatin
5273373|NCT02312661|paclitaxel|paclitaxel
5273374|NCT02312648|Functional Capacity|functional capacity
5273375|NCT02312648|Physical Exertion|physical exertion
5273376|NCT02312648|Patient Care|patient care
5273377|NCT02312648|Early mobilization|early mobilization
5273378|NCT02312635|cognitive rehabilitation, traumatic brain injury|cognitive rehabilitation, traumatic brain injury
5273379|NCT02312596|non-healing wound|non-healing wound
5848937|NCT00032591|AF|af
5273380|NCT02312596|diabetic foot ulcer|diabetic foot ulcer
5273381|NCT02312596|platelet rich plasma|platelet rich plasma
5273382|NCT02312583|depression|depression
5273383|NCT02312583|cognitive-behavior intervention|cognitive-behavior intervention
5273384|NCT02312570|non-healing wounds|non-healing wounds
5273385|NCT02312570|pressure ulcer|pressure ulcer
5273386|NCT02312570|platelet rich plasma|platelet rich plasma
5273387|NCT02312531|HBV|hbv
5273388|NCT02312531|Intrauterine infection|intrauterine infection
5273389|NCT02312531|hepatitis B immunoglobulin|hepatitis b immunoglobulin
5273390|NCT02312531|immune barrier|immune barrier
5674385|NCT00603772|Tretinoin|tretinoin
5375969|NCT01831115|BNP|bnp
5273391|NCT02312531|virus replication|virus replication
5273392|NCT02312531|placenta|placenta
5273393|NCT02312518|non-healing wounds|non-healing wounds
5273394|NCT02312518|venous stasis|venous stasis
5273395|NCT02312518|ulcer|ulcer
5273396|NCT02312518|platelet rich plasma|platelet rich plasma
5273397|NCT02312505|cardiac output monitoring|cardiac output monitoring
5273398|NCT02312505|semi-invasive pulse contour analysis|semi-invasive pulse contour analysis
5273399|NCT02312505|transpulmonary thermodilution|transpulmonary thermodilution
5273400|NCT02312492|fatty acid kinetics|fatty acid kinetics
5273401|NCT02312440|tranexamic acid|tranexamic acid
5273402|NCT02312440|blood loss|blood loss
5273403|NCT02312440|topical administration|topical administration
5273404|NCT02312440|intravenous administration|intravenous administration
5273405|NCT02312401|MRI|mri
5273406|NCT02312401|14-172|14-172
5273407|NCT02312388|central venous catheters|central venous catheters
5273408|NCT02312362|HFDS|hfds
5273409|NCT02312362|ab interno|ab interno
5273410|NCT02312362|MIGS|migs
5273411|NCT02312362|surgery|surgery
5273412|NCT02312349|Celiac Disease|celiac disease
5273413|NCT02312349|Gluten free elaborated food|gluten free elaborated food
5273414|NCT02312336|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5273415|NCT02312336|Transcoronary Cooling|transcoronary cooling
5273416|NCT02312258|Drug Therapy|drug therapy
5273418|NCT02312219|Inflammation|inflammation
5273424|NCT02312193|myogenic tone|myogenic tone
5273425|NCT02312167|endomicroscopy|endomicroscopy
5273426|NCT02312167|optical biopsy|optical biopsy
5273427|NCT02312167|exploratory surgery|exploratory surgery
5273428|NCT02312167|resection surgery|resection surgery
5273429|NCT02312167|robot-assisted|robot-assisted
5273430|NCT02312167|peritoneum carcinosis|peritoneum carcinosis
5273431|NCT02312167|inflammatory|inflammatory
5273432|NCT02312167|rectum cancer|rectum cancer
5273433|NCT02312167|liver cancer|liver cancer
5273434|NCT02312167|ovarian cancer|ovarian cancer
5273435|NCT02312167|digestive cancer|digestive cancer
5273436|NCT02312167|pancreas cancer|pancreas cancer
5273437|NCT02312167|duodenum cancer|duodenum cancer
5273438|NCT02312128|distal radius fractures|distal radius fractures
5273439|NCT02312128|early mobilization|early mobilization
5273440|NCT02312128|postoperative treatment|postoperative treatment
5273442|NCT02312115|Renal transplant|renal transplant
5273443|NCT02312115|Kidney transplant|kidney transplant
5273445|NCT02312102|myelodysplastic syndrome|myelodysplastic syndrome
5273446|NCT02312102|acute myeloid leukemia|acute myeloid leukemia
5273447|NCT02312102|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5273448|NCT02312089|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
5273449|NCT02312076|Luteal phase support, ICSI, GnRHa|luteal phase support, icsi, gnrha
5273450|NCT02312063|DPP-4 inhibitor|dpp-4 inhibitor
5273451|NCT02312063|sulfonylurea|sulfonylurea
5273452|NCT02312037|Relapsed CD33 AML|relapsed cd33 aml
5273453|NCT02312037|Refractory CD33 AML|refractory cd33 aml
5273454|NCT02312037|Relapsed CD33 APL|relapsed cd33 apl
5273455|NCT02312037|Refractory CD33 APL|refractory cd33 apl
5273456|NCT02312037|Relapsed CD33 MDS|relapsed cd33 mds
5273457|NCT02312037|Refractory CD33 MDS|refractory cd33 mds
5273458|NCT02312024|CytoSorb adsorber|cytosorb adsorber
5273459|NCT02312024|sepsis|sepsis
5273460|NCT02312024|cytokines|cytokines
5273461|NCT02312024|hemofiltration|hemofiltration
5273462|NCT02312024|hemadsorption|hemadsorption
5273463|NCT02312024|inflammation|inflammation
5273464|NCT02312011|Myotonic Dystrophy|myotonic dystrophy
5273465|NCT02312011|DM1|dm1
5273466|NCT02312011|Adult onset|adult onset
5273467|NCT02312011|Neuromuscular Disease|neuromuscular disease
5273468|NCT02312011|DMPKRx|dmpkrx
5273469|NCT02311985|Liver cirrhosis|liver cirrhosis
5273470|NCT02311985|Blood coagulation|blood coagulation
5273471|NCT02311985|Thromboelastography|thromboelastography
5273472|NCT02311985|Blood transfusion|blood transfusion
5273473|NCT02311985|Catheterization, central venous|catheterization, central venous
5273474|NCT02311959|Breast|breast
5273475|NCT02311959|Invasive carcinoma|invasive carcinoma
5273476|NCT02311959|In situ carcinoma|in situ carcinoma
5273477|NCT02311959|Mastectomy|mastectomy
5273478|NCT02311959|Nipple areola|nipple areola
5273479|NCT02311959|Reconstruction|reconstruction
5273480|NCT02311959|Local recurrence|local recurrence
5273481|NCT02311946|Palbociclib, Rabeprazole, Proton Pump Inhibitor, Drug Interaction Study, DDI|palbociclib, rabeprazole, proton pump inhibitor, drug interaction study, ddi
5273482|NCT02311829|Quality of life, PNES, Epilepsy,|quality of life, pnes, epilepsy,
5273483|NCT02311816|Bacterial infection, empiric antibiotic therapy|bacterial infection, empiric antibiotic therapy
5273484|NCT02311790|cis-C16:1n7 supplement|cis-c16:1n7 supplement
5273485|NCT02311790|trans-C16:1n7 supplement|trans-c16:1n7 supplement
5903767|NCT00339235|Preterm Birth Prevention|preterm birth prevention
5273486|NCT02311790|palmitoleic acid supplement|palmitoleic acid supplement
5273487|NCT02311751|Autism Spectrum Disorder|autism spectrum disorder
5273488|NCT02311751|Executive Function|executive function
5273489|NCT02311751|rTMS (Repetitive Transcranial Magnetic Stimulation)|rtms (repetitive transcranial magnetic stimulation)
5273490|NCT02311751|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5273491|NCT02311751|Healthy Subjects|healthy subjects
5273492|NCT02311738|Exercise and Genes in Obese (EGO)|exercise and genes in obese (ego)
5273493|NCT02311725|narrative communication|narrative communication
5273494|NCT02311725|depression|depression
5273495|NCT02311725|antidepressant augmentation|antidepressant augmentation
5273496|NCT02311725|primary care|primary care
5273497|NCT02311712|Esophageal cancer|esophageal cancer
5273498|NCT02311712|Early detection|early detection
5273499|NCT02311712|Cytological examination|cytological examination
5273500|NCT02311699|Gender|gender
5273501|NCT02311699|Physical Violence|physical violence
5273502|NCT02311699|Sexual Violence|sexual violence
5273503|NCT02311699|HIV|hiv
5273504|NCT02311699|AIDS|aids
5273505|NCT02311699|Prevention|prevention
5273506|NCT02311699|Community Intervention|community intervention
5273507|NCT02311699|Ethiopia|ethiopia
5273525|NCT02311621|pediatric|pediatric
5273526|NCT02311621|young adults|young adults
5273527|NCT02311608|acute variceal hemorrhage|acute variceal hemorrhage
5273528|NCT02311608|terlipressin|terlipressin
5273529|NCT02311608|somatostatin|somatostatin
5273530|NCT02311608|octreotide|octreotide
5273531|NCT02311608|comparative effectiveness research|comparative effectiveness research
5273532|NCT02311595|gastric cancer|gastric cancer
5273533|NCT02311595|laparoscope|laparoscope
5273534|NCT02311569|JAK2|jak2
5273535|NCT02311569|Mirabegron|mirabegron
5273536|NCT02311569|Primary myelofibrosis|primary myelofibrosis
5273537|NCT02311569|beta-3-mimetic drugs|beta-3-mimetic drugs
5273538|NCT02311569|Myeloproliferative neoplasm|myeloproliferative neoplasm
5273539|NCT02311569|Essential thrombocythemia|essential thrombocythemia
5273540|NCT02311569|Polycythemia vera|polycythemia vera
5273541|NCT02311569|Betmiga|betmiga
5273542|NCT02311569|JAK2-V617F|jak2-v617f
5273543|NCT02311543|Axillary Lymph Node Dissection (ALND)|axillary lymph node dissection (alnd)
5273544|NCT02311543|Breast Cancer|breast cancer
5273545|NCT02311543|TachoSil®|tachosil®
5273546|NCT02311543|Lymphatic Drainage|lymphatic drainage
5273547|NCT02311543|Surgical Sealing Patch|surgical sealing patch
5273548|NCT02311491|nano crystalline|nano crystalline
5273549|NCT02311491|archwire|archwire
5273550|NCT02311465|Palliative Care|palliative care
5273551|NCT02311439|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5273552|NCT02311439|Chemotherapy|chemotherapy
5273553|NCT02311439|Radiotherapy|radiotherapy
5273554|NCT02311426|Rehabilitation; Functional outcome|rehabilitation; functional outcome
5273555|NCT02311413|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5273556|NCT02311400|Emotion|emotion
5273557|NCT02311400|Self-Affirmation|self-affirmation
5273558|NCT02311400|Alcohol Consumption|alcohol consumption
5273559|NCT02311387|Incidence|incidence
5273560|NCT02311387|Prevalence|prevalence
5273561|NCT02311387|Human|human
5273562|NCT02311387|Mastomys|mastomys
5273563|NCT02311387|Serosurvey|serosurvey
5273564|NCT02311374|Human Brain|human brain
5273565|NCT02311374|Sleep|sleep
5273567|NCT02311374|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5273568|NCT02311374|Apparent Diffusion Coefficient|apparent diffusion coefficient
5273569|NCT02311361|Anti-PDL1|anti-pdl1
5273570|NCT02311361|Anti-CTLA4|anti-ctla4
5273571|NCT02311361|Streostatic Body Radiation Therapy (SBRT)|streostatic body radiation therapy (sbrt)
5273572|NCT02311361|Monoclonal Antibody|monoclonal antibody
5273573|NCT02311361|Antitumor Immunity|antitumor immunity
5273574|NCT02311348|Biopsy|biopsy
5273575|NCT02311348|Pain|pain
5273576|NCT02311335|Hypertriglyceridemia|hypertriglyceridemia
5273577|NCT02311335|Atherosclerosis|atherosclerosis
5273578|NCT02311335|Genectic Variants|genectic variants
5273579|NCT02311335|Hyperalphalipoproteinemia|hyperalphalipoproteinemia
5273580|NCT02311335|Dyslipidemia|dyslipidemia
5273584|NCT02311244|All-cause mortality|all-cause mortality
5273585|NCT02311244|Cardiovascular mortality|cardiovascular mortality
5903768|NCT00339235|Preterm Birth|preterm birth
5903769|NCT00339235|Pregnancy|pregnancy
5273586|NCT02311244|Myocardial infarction|myocardial infarction
5273588|NCT02311244|Dialysis|dialysis
5273589|NCT02311218|oral, microbiota, lactobacillus reuteri,|oral, microbiota, lactobacillus reuteri,
5273590|NCT02311205|Transarterial Chemoembolization (TACE)|transarterial chemoembolization (tace)
5273591|NCT02311205|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5273592|NCT02311205|Metastasis|metastasis
5273593|NCT02311205|Sorafenib|sorafenib
5273594|NCT02311192|Vitreous Haze|vitreous haze
5273597|NCT02311192|Uveitis|uveitis
5273598|NCT02311179|Prosthesis fixation|prosthesis fixation
5273599|NCT02311179|hip arthroplasty|hip arthroplasty
5273600|NCT02311166|Hip dysplasia|hip dysplasia
5273601|NCT02311166|Soft tissue|soft tissue
5273603|NCT02311166|Self-report|self-report
5273604|NCT02311166|Physical activity|physical activity
5273605|NCT02311140|cystic fibrosis|cystic fibrosis
5273606|NCT02311140|nasal lavage|nasal lavage
5273607|NCT02311140|inflammation|inflammation
5273608|NCT02311140|Interleukin (IL)-6|interleukin (il)-6
5273609|NCT02311140|IL-8|il-8
5273610|NCT02311140|pulmonary function|pulmonary function
5273611|NCT02311127|Peripherally Inserted Central Catheters|peripherally inserted central catheters
5273913|NCT02309437|Oxycodone|oxycodone
5273612|NCT02311127|Securement device|securement device
5273613|NCT02311114|Program Evaluation|program evaluation
5273614|NCT02311114|Telehomecare|telehomecare
5273615|NCT02311114|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5273616|NCT02311114|Heart Failure|heart failure
5273617|NCT02311114|LHINs|lhins
5273618|NCT02311114|Local Health Integrative Network|local health integrative network
5273619|NCT02311114|OTN|otn
5273626|NCT02311062|training, soccer, eccentric, lengthening, unstable, squatting|training, soccer, eccentric, lengthening, unstable, squatting
5273627|NCT02311036|Post Acute Care(PAC)|post acute care(pac)
5273628|NCT02311036|Cerebrovascular diseases|cerebrovascular diseases
5273629|NCT02311010|transplant|transplant
5273630|NCT02311010|immunosuppressive drug|immunosuppressive drug
5273631|NCT02310984|Early breast cancer|early breast cancer
5273632|NCT02310984|Lumpectomy|lumpectomy
5273633|NCT02310984|Breast conserving surgery|breast conserving surgery
5273634|NCT02310984|Radiotherapy|radiotherapy
5273635|NCT02310984|Cosmesis|cosmesis
5273636|NCT02310971|Adenocarcinoma, resected|adenocarcinoma, resected
5273637|NCT02310958|Lapraroscopic surgical procedure|lapraroscopic surgical procedure
5273638|NCT02310958|infant|infant
5273639|NCT02310958|complications|complications
5273640|NCT02310958|inguinal hernia|inguinal hernia
5273641|NCT02310958|hernia recurrence|hernia recurrence
5273643|NCT02310945|central nervous system sensitization|central nervous system sensitization
5273644|NCT02310945|physiotherapy|physiotherapy
5273645|NCT02310932|mental health|mental health
5273646|NCT02310932|cardiovascular disease|cardiovascular disease
5273647|NCT02310932|diabetes|diabetes
5273648|NCT02310932|hypertension|hypertension
5273649|NCT02310932|high blood pressure|high blood pressure
5273650|NCT02310919|Infertility|infertility
5273651|NCT02310919|In vitro fertilization|in vitro fertilization
5273652|NCT02310919|IVF|ivf
5273653|NCT02310906|Duchenne muscular dystrophy|duchenne muscular dystrophy
5273654|NCT02310906|Exon Skipping|exon skipping
5273655|NCT02310906|DMD|dmd
5273656|NCT02310906|Exon 53|exon 53
5273657|NCT02310906|Ambulatory|ambulatory
5273658|NCT02310906|Pediatric|pediatric
5273659|NCT02310867|hand transplantation, amputation|hand transplantation, amputation
5273660|NCT02310854|anterior cruciate ligament rupture|anterior cruciate ligament rupture
5273661|NCT02310854|autograft|autograft
5273662|NCT02310854|reconstruction|reconstruction
5273663|NCT02310854|orthopedic surgery|orthopedic surgery
5273664|NCT02310854|dynamic intraligament stabilization|dynamic intraligament stabilization
5273665|NCT02310828|Cluster headache|cluster headache
5273666|NCT02310828|Migrainous neuralgia|migrainous neuralgia
5273667|NCT02310828|Horton's headache|horton's headache
5273668|NCT02310828|Histaminic cephalalgia|histaminic cephalalgia
5273669|NCT02310802|IVF|ivf
5273670|NCT02310802|ICSI|icsi
5273671|NCT02310763|Duchenne Muscular Dystrophy, myostatin|duchenne muscular dystrophy, myostatin
5273672|NCT02310737|cesarean section|cesarean section
5273673|NCT02310737|facial incision|facial incision
5273674|NCT02310737|postoperative pain|postoperative pain
5273680|NCT02310711|Breast|breast
5273681|NCT02310711|Mastectomy|mastectomy
5273682|NCT02310711|Lumpectomy|lumpectomy
5273683|NCT02310711|Breast Therapy|breast therapy
5273684|NCT02310698|Ultrasound|ultrasound
5273685|NCT02310698|Enhanced Mammography|enhanced mammography
5273686|NCT02310698|14-240|14-240
5273687|NCT02310685|Cardivascular risks (hypertension, sedentary, overweight)|cardivascular risks (hypertension, sedentary, overweight)
5273688|NCT02310685|Cardiovascular age|cardiovascular age
5273689|NCT02310685|E-health wellness program|e-health wellness program
5273690|NCT02310685|Prevention|prevention
5273691|NCT02310685|Community pharmacists|community pharmacists
5273692|NCT02310685|Lifestyle change|lifestyle change
5273693|NCT02310685|Cardiometabolic age|cardiometabolic age
5273694|NCT02310672|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5273695|NCT02310633|TBI|tbi
5273696|NCT02310633|memory disorder|memory disorder
5273697|NCT02310633|injury, brain, traumatic|injury, brain, traumatic
5273698|NCT02310633|rehabilitation|rehabilitation
5273699|NCT02310607|Post-partum women|post-partum women
5273700|NCT02310581|Bunionectomy|bunionectomy
5273701|NCT02310568|PF 06372865|pf 06372865
5270798|NCT02326272|Psoriasis|psoriasis
5273702|NCT02310568|generalized anxiety disorder|generalized anxiety disorder
5273704|NCT02310568|safety|safety
5273705|NCT02310568|efficacy|efficacy
5273706|NCT02310568|suboptimal response|suboptimal response
5273707|NCT02310555|Metabolic surgery|metabolic surgery
5273708|NCT02310529|Maternal depression|maternal depression
5273914|NCT02309437|Opioids|opioids
5273709|NCT02310529|Interpersonal Psycotherapy|interpersonal psycotherapy
5273710|NCT02310503|Mohs Surgery|mohs surgery
5273711|NCT02310490|Nasolabial Folds|nasolabial folds
5273712|NCT02310477|regorafenib, cohort, metastatic colorectal cancer|regorafenib, cohort, metastatic colorectal cancer
5273713|NCT02310438|Music therapy|music therapy
5273714|NCT02310438|stroke|stroke
5273715|NCT02310438|hemiparesis|hemiparesis
5273716|NCT02310438|neurologic music therapy|neurologic music therapy
5273717|NCT02310412|INTERCEPT|intercept
5273718|NCT02310412|platelet|platelet
5273719|NCT02310412|pathogen inactivation|pathogen inactivation
5273720|NCT02310412|platelet components stored|platelet components stored
5273721|NCT02310412|therapeutic efficacy|therapeutic efficacy
5273722|NCT02310399|Auditory Brainstem Implant|auditory brainstem implant
5273723|NCT02310399|Deafness|deafness
5273724|NCT02310399|Hearing Loss|hearing loss
5273725|NCT02310399|ABI|abi
5273726|NCT02310386|Fibromyalgia|fibromyalgia
5273727|NCT02310386|Electromagnetic field therapy|electromagnetic field therapy
5273728|NCT02310386|Randomized controlled trial|randomized controlled trial
5273729|NCT02310373|Nicotine-free hookah|nicotine-free hookah
5273730|NCT02310373|Waterpipe|waterpipe
5273731|NCT02310373|Smoking|smoking
5273732|NCT02310373|Sympathetic|sympathetic
5273733|NCT02310321|Acute Myeloid Leukemia|acute myeloid leukemia
5273734|NCT02310321|Cytarabine|cytarabine
5273735|NCT02310321|Idarubicin|idarubicin
5273736|NCT02310321|ASP2215|asp2215
5273737|NCT02310308|Xylitol|xylitol
5273738|NCT02310308|Magnolia|magnolia
5273739|NCT02310308|chewing gum|chewing gum
5273740|NCT02310295|Diabetic retinopathy|diabetic retinopathy
5273741|NCT02310295|Macular edema|macular edema
5273742|NCT02310295|Anti-VEGF|anti-vegf
5273743|NCT02310295|Triamcinolone|triamcinolone
5273744|NCT02310282|Telemedicine|telemedicine
5273745|NCT02310282|Emergency medicine|emergency medicine
5273746|NCT02310282|Stroke|stroke
5273747|NCT02310282|Stroke syndromes|stroke syndromes
5273748|NCT02310269|Cushing's disease,|cushing's disease,
5273749|NCT02310269|pasireotide s.c.|pasireotide s.c.
5273750|NCT02310269|Signifor|signifor
5273751|NCT02310256|Mitochondria, muscle|mitochondria, muscle
5273752|NCT02310256|Exercise|exercise
5273753|NCT02310256|Blood Flow Velocity|blood flow velocity
5273754|NCT02310243|Acute myeloid leukemia|acute myeloid leukemia
5273755|NCT02310243|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5273756|NCT02310243|MLL-rearranged leukemia|mll-rearranged leukemia
5273757|NCT02310243|Palbociclib (PD-0332991-00)|palbociclib (pd-0332991-00)
5273758|NCT02310230|Endoscopy, Upper|endoscopy, upper
5273759|NCT02310230|Minute Ventilation|minute ventilation
5273760|NCT02310230|Tidal Volume|tidal volume
5273761|NCT02310230|Respiratory Rate|respiratory rate
5273762|NCT02310217|Hypertension|hypertension
5273763|NCT02310217|Cognitive impairment|cognitive impairment
5273764|NCT02310217|Biomarkers|biomarkers
5273765|NCT02310191|ischemic stroke|ischemic stroke
5273766|NCT02310191|carotid stenting|carotid stenting
5273767|NCT02310191|MRI diffusion weighted imaging|mri diffusion weighted imaging
5273768|NCT02310191|Laboratory marker|laboratory marker
5273769|NCT02310178|weight loss|weight loss
5273770|NCT02310178|sleeve gastrectomy|sleeve gastrectomy
5273771|NCT02310178|gastric bypass|gastric bypass
5273772|NCT02310178|gastric banding|gastric banding
5273773|NCT02310178|bariatric procedures|bariatric procedures
5273774|NCT02310178|cohort|cohort
5273775|NCT02310178|morbid obesity|morbid obesity
5273776|NCT02310178|medical and economical impact|medical and economical impact
5273777|NCT02310178|severe obesity|severe obesity
5273778|NCT02310165|Paracentesis|paracentesis
5273779|NCT02310165|Ascites|ascites
5273780|NCT02310152|Child|child
5273781|NCT02310152|Adolescent|adolescent
5273782|NCT02310152|Parents|parents
5273783|NCT02310152|Cognitive Therapy|cognitive therapy
5273784|NCT02310152|Cognitive Behavior Therapy|cognitive behavior therapy
5273785|NCT02310152|Anxiety|anxiety
5273786|NCT02310113|NIRS|nirs
5273787|NCT02310113|transfusion|transfusion
5273788|NCT02310113|RBC|rbc
5273789|NCT02310087|male infertility|male infertility
5273790|NCT02310087|spermatogenesis|spermatogenesis
5273791|NCT02310087|antioxidants|antioxidants
5273792|NCT02310087|DNA damage|dna damage
5273793|NCT02310087|mitochondrial membrane potential|mitochondrial membrane potential
5273794|NCT02310087|apoptosis|apoptosis
5273795|NCT02310061|Dialysis|dialysis
5273796|NCT02310061|ESRD|esrd
5273797|NCT02310061|lung congestion|lung congestion
5273798|NCT02310061|heart failure|heart failure
5273799|NCT02310061|LW-US|lw-us
5273800|NCT02310009|Exercise|exercise
5273801|NCT02310009|IL-1RA|il-1ra
5273802|NCT02310009|Beta-cell function|beta-cell function
5273803|NCT02310009|Type 2 Diabetes|type 2 diabetes
5273806|NCT02309996|Inservice Training|inservice training
5273807|NCT02309996|Personnel Management|personnel management
5273808|NCT02309996|Work place|work place
5273809|NCT02309996|Work accommodation|work accommodation
5273810|NCT02309996|Job modification|job modification
5273811|NCT02309996|Supervision|supervision
5273816|NCT02309996|Risk Management|risk management
5273817|NCT02309996|Organization and Administration|organization and administration
5273818|NCT02309996|Work Disability|work disability
5273819|NCT02309996|Occupational Diseases|occupational diseases
5273820|NCT02309996|Occupational Injury|occupational injury
5273821|NCT02309996|Occupational Health|occupational health
5273822|NCT02309996|Occupational Exposure|occupational exposure
5273823|NCT02309996|Sick Leave|sick leave
5273824|NCT02309996|Absenteeism|absenteeism
5273825|NCT02309996|Employee Health|employee health
5273826|NCT02309983|bone turnover|bone turnover
5273827|NCT02309983|muscle atrophy|muscle atrophy
5273828|NCT02309983|fiber|fiber
5273829|NCT02309957|Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD|knee cartilage repair, osteochondral defects, biomatrix crd
5273830|NCT02309944|Wound Healing|wound healing
5273831|NCT02309944|Obesity|obesity
5273832|NCT02309944|Gynecologic Surgery|gynecologic surgery
5273833|NCT02309944|Gynecologic Neoplasms|gynecologic neoplasms
5273834|NCT02309944|Surgical Complications|surgical complications
5273835|NCT02309931|Right hemicolectomy|right hemicolectomy
5273836|NCT02309931|Side-to-side anastomosis|side-to-side anastomosis
5273837|NCT02309931|Orocecal time|orocecal time
5273838|NCT02309931|Antipersitaltic|antipersitaltic
5273839|NCT02309931|Isoperistaltic|isoperistaltic
5273840|NCT02309931|Laparoscopic colectomy|laparoscopic colectomy
5273841|NCT02309931|Right laparoscopic hemicolectomy|right laparoscopic hemicolectomy
5273842|NCT02309918|acute HCV Genotype 1 Infection|acute hcv genotype 1 infection
5273843|NCT02309918|HCV RNA|hcv rna
5273844|NCT02309918|LDV/SOF FDC|ldv/sof fdc
5273845|NCT02309905|inmates|inmates
5273846|NCT02309905|skin lesion|skin lesion
5273847|NCT02309905|telemedicine|telemedicine
5273852|NCT02309879|Intravenous lidocaine|intravenous lidocaine
5273853|NCT02309879|Magnesium sulphate|magnesium sulphate
5273854|NCT02309879|Mastectomy|mastectomy
5273856|NCT02309827|Inflammatory bowel disease|inflammatory bowel disease
5273857|NCT02309723|Alzheimer's Disease|alzheimer's disease
5273858|NCT02309723|Mild Cognitive Impairment|mild cognitive impairment
5273859|NCT02309723|Neuroimaging|neuroimaging
5273860|NCT02309723|Diagnostic Tool|diagnostic tool
5273861|NCT02309697|Development|development
5273862|NCT02309697|Assessments|assessments
5273863|NCT02309697|Premature birth|premature birth
5273864|NCT02309684|Diabetic Foot Ulcer (DFU)|diabetic foot ulcer (dfu)
5273865|NCT02309684|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
5273866|NCT02309658|cervix neoplasm|cervix neoplasm
5273867|NCT02309658|hENT1 protein, human|hent1 protein, human
5273868|NCT02309658|Chemotherapy|chemotherapy
5273869|NCT02309645|fibrin sealant|fibrin sealant
5273870|NCT02309645|CSF leak|csf leak
5273871|NCT02309619|esophageal cancer|esophageal cancer
5273872|NCT02309619|esophagectomy|esophagectomy
5273873|NCT02309619|quality of life|quality of life
5273874|NCT02309593|osteoarthritis|osteoarthritis
5273875|NCT02309593|avascular necrosis|avascular necrosis
5273876|NCT02309593|ankylosis|ankylosis
5273877|NCT02309593|protrusio acetabuli|protrusio acetabuli
5273878|NCT02309593|painful hip dysplasia|painful hip dysplasia
5273879|NCT02309593|rheumatoid arthritis|rheumatoid arthritis
5273880|NCT02309593|correction of functional deformity|correction of functional deformity
5273881|NCT02309593|revision procedures|revision procedures
5273882|NCT02309580|Ibrutinib|ibrutinib
5273883|NCT02309580|14-227|14-227
5273884|NCT02309567|Anti-p53 antibody|anti-p53 antibody
5273885|NCT02309567|PET/CT|pet/ct
5273886|NCT02309567|Lung Cancer|lung cancer
5273887|NCT02309567|FDG|fdg
5273888|NCT02309554|Contraception|contraception
5903770|NCT00339235|Pregnancy Complications|pregnancy complications
5273889|NCT02309554|Post coital test|post coital test
5273890|NCT02309554|Vaginal|vaginal
5273891|NCT02309554|Diaphragm|diaphragm
5273892|NCT02309541|middle ear implant|middle ear implant
5273893|NCT02309541|feedback manager|feedback manager
5273894|NCT02309541|Sound quality|sound quality
5273895|NCT02309502|diabetic retinopathy|diabetic retinopathy
5273896|NCT02309502|retina|retina
5273897|NCT02309502|Laser|laser
5273898|NCT02309502|Pascal|pascal
5273899|NCT02309489|Family Planning Services|family planning services
5273900|NCT02309489|Maternal Health Services|maternal health services
5273901|NCT02309489|Breast Feeding|breast feeding
5273902|NCT02309489|Contraception|contraception
5273903|NCT02309489|Postnatal care|postnatal care
5273904|NCT02309489|Postpartum contraception|postpartum contraception
5273905|NCT02309489|Exclusive breastfeeding|exclusive breastfeeding
5273906|NCT02309489|Postpartum Period|postpartum period
5273907|NCT02309476|diffuse diabetic macular oedema|diffuse diabetic macular oedema
5273908|NCT02309476|Pascal|pascal
5273911|NCT02309437|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5273915|NCT02309437|Radiation mucositis|radiation mucositis
5273916|NCT02309411|Pediatric|pediatric
5273917|NCT02309385|uveitis|uveitis
5273918|NCT02309385|acute uveitis|acute uveitis
5273919|NCT02309385|anterior uveitis|anterior uveitis
5273920|NCT02309385|dexamethasone sodium phosphate|dexamethasone sodium phosphate
5273921|NCT02309385|non-infectious uveitis|non-infectious uveitis
5273922|NCT02309385|DSP-Visulex|dsp-visulex
5273923|NCT02309385|Aciont|aciont
5273924|NCT02309346|clindamycin|clindamycin
5273925|NCT02309346|septic abortion|septic abortion
5273926|NCT02309307|safety and performance|safety and performance
5273927|NCT02309294|Patch Test|patch test
5273929|NCT02309268|left atrial appendage closure|left atrial appendage closure
5273930|NCT02309255|Secondary coronary prevention|secondary coronary prevention
5273931|NCT02309255|Psychosocial factors|psychosocial factors
5273932|NCT02309255|Cardiac rehabilitation|cardiac rehabilitation
5273933|NCT02309229|sputum colour|sputum colour
5273934|NCT02309229|cystic fibrosis|cystic fibrosis
5273935|NCT02309229|pollution|pollution
5273936|NCT02309190|Transpulmonary pressure - morbid obesity|transpulmonary pressure - morbid obesity
5273937|NCT02309177|Pancreatic Cancer|pancreatic cancer
5273938|NCT02309177|Breast Cancer|breast cancer
5273939|NCT02309177|Metastatic Breast Cancer|metastatic breast cancer
5273940|NCT02309177|nab-Paclitaxel|nab-paclitaxel
5273941|NCT02309177|Gemcitabine|gemcitabine
5273942|NCT02309177|Carboplatin|carboplatin
5273943|NCT02309177|Non-Small Cell Lung Cancer|non-small cell lung cancer
5273944|NCT02309177|Lung Cancer|lung cancer
5273945|NCT02309177|mBC|mbc
5273946|NCT02309177|NSCLC|nsclc
5273947|NCT02309177|Triple-negative Breast Cancer|triple-negative breast cancer
5273948|NCT02309177|Hormone Receptor Positive|hormone receptor positive
5273949|NCT02309177|ER+|er+
5273950|NCT02309177|PR+|pr+
5273951|NCT02309177|TNBC|tnbc
5273952|NCT02309177|Nivolumab|nivolumab
5273953|NCT02309177|PD-1|pd-1
5273954|NCT02309177|Check-point Inhibitor/s|check-point inhibitor/s
5273955|NCT02309177|Immune Check-point Inhibitor/s|immune check-point inhibitor/s
5273956|NCT02309177|Anti-PD-1|anti-pd-1
5273957|NCT02309177|BMS-936558|bms-936558
5273958|NCT02309125|immediate gradual loading|immediate gradual loading
5273959|NCT02309099|Acoustic Neuroma|acoustic neuroma
5273960|NCT02309099|Vestibular Schwannoma|vestibular schwannoma
5273961|NCT02309099|Meniere's Disease|meniere's disease
5273962|NCT02309060|narrative communication|narrative communication
5273963|NCT02309060|depression|depression
5273964|NCT02309060|primary care|primary care
5273965|NCT02309060|treatment development|treatment development
5273966|NCT02309034|Overweight|overweight
5273967|NCT02309034|Obesity|obesity
5273968|NCT02309034|Cardiometabolic risk factors|cardiometabolic risk factors
5273969|NCT02309034|Adolescents|adolescents
5273970|NCT02309034|Exercise|exercise
5273971|NCT02309021|craving|craving
5273972|NCT02309008|Pharmacokinetics|pharmacokinetics
5273973|NCT02308995|Endometriosis|endometriosis
5273974|NCT02308995|Laparoscopy|laparoscopy
5273975|NCT02308995|Barbed sutures|barbed sutures
5273976|NCT02308982|encephalitis|encephalitis
5273977|NCT02308982|meningoencephalitis|meningoencephalitis
5273978|NCT02308982|encephalomyelitis|encephalomyelitis
5273979|NCT02308982|brain inflammation|brain inflammation
5273980|NCT02308982|intravenous immunoglobulin|intravenous immunoglobulin
5273981|NCT02308982|randomised controlled trial|randomised controlled trial
5273982|NCT02308982|Central Nervous System Diseases|central nervous system diseases
5273983|NCT02308982|Central Nervous System Infection|central nervous system infection
5273984|NCT02308969|altered state of consciousness|altered state of consciousness
5849057|NCT00031369|Writer's Cramp|writer's cramp
5273985|NCT02308969|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5273986|NCT02308969|hallucination|hallucination
5273987|NCT02308969|model psychosis|model psychosis
5273988|NCT02308969|serotonin receptor|serotonin receptor
5273990|NCT02308956|task sharing|task sharing
5273991|NCT02308956|task shifting|task shifting
5273992|NCT02308956|community mental health care|community mental health care
5273993|NCT02308956|primary care|primary care
5273994|NCT02308956|Developing country|developing country
5273995|NCT02308956|Sub-Saharan Africa|sub-saharan africa
5273996|NCT02308956|non-inferiority trial|non-inferiority trial
5273998|NCT02308917|Crohn's|crohn's
5273999|NCT02308917|Ulcerative|ulcerative
5274000|NCT02308917|Colitis|colitis
5274001|NCT02308904|Infertility|infertility
5274002|NCT02308904|Thalassemia|thalassemia
5274003|NCT02308904|Iron overload|iron overload
5274004|NCT02308904|Pituitary Iron Load|pituitary iron load
5274005|NCT02308904|Oxidative Stress|oxidative stress
5274006|NCT02308904|REPRODUCTIVE CAPACITY AND ASSOCIATION TO IRON BURDEN AND CHELATION PATTERNS IN THALASSEMIA MAJOR PATIENTS|reproductive capacity and association to iron burden and chelation patterns in thalassemia major patients
5274007|NCT02308891|pancreatitis|pancreatitis
5274008|NCT02308891|ERCP|ercp
5274037|NCT02308683|hgba1c|hgba1c
5274038|NCT02308683|diabetes mellitus|diabetes mellitus
5274039|NCT02308644|Diabetic Retinopathy|diabetic retinopathy
5274040|NCT02308644|intravitreal bevacizumab|intravitreal bevacizumab
5274041|NCT02308644|Contrast Sensitivity|contrast sensitivity
5274042|NCT02308631|Endoscopic, Colostomy, Colopexy|endoscopic, colostomy, colopexy
5274043|NCT02308618|Achilles tendon rupture|achilles tendon rupture
5274044|NCT02308618|Rehabilitation|rehabilitation
5274045|NCT02308618|Immobilization|immobilization
5274046|NCT02308618|Muscle architecture|muscle architecture
5274047|NCT02308618|Functionality|functionality
5274048|NCT02308618|Neuromuscular parameters|neuromuscular parameters
5274049|NCT02308618|Weight-Bearing|weight-bearing
5274050|NCT02308605|SMARTCap|smartcap
5274051|NCT02308592|Pregnancy|pregnancy
5274052|NCT02308592|Depression|depression
5274053|NCT02308592|Antidepressant Use|antidepressant use
5274054|NCT02308592|Decision Aid|decision aid
5274055|NCT02308566|Intracranial Embolism|intracranial embolism
5274056|NCT02308566|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
5274057|NCT02308553|BRAF V600 wildtype|braf v600 wildtype
5274058|NCT02308553|cutaneous malignant melanoma|cutaneous malignant melanoma
5274059|NCT02308553|nintedanib|nintedanib
5274060|NCT02308553|paclitaxel|paclitaxel
5274061|NCT02308553|kinase inhibitor|kinase inhibitor
5274062|NCT02308527|Children|children
5274063|NCT02308527|Young adults|young adults
5274064|NCT02308514|cryostimulation|cryostimulation
5274065|NCT02308488|prone IMRT to breast, level III & Supraclavicular|prone imrt to breast, level iii & supraclavicular
5274066|NCT02308488|acute toxicity of prone IMRT to breast, level III & SCV|acute toxicity of prone imrt to breast, level iii & scv
5274067|NCT02308462|children of mentally ill parents|children of mentally ill parents
5274068|NCT02308462|family intervention|family intervention
5274069|NCT02308462|randomized controlled trial|randomized controlled trial
5274070|NCT02308410|Tourniquet|tourniquet
5274071|NCT02308410|Postoperative outcome|postoperative outcome
5274072|NCT02308410|Total knee arthroplasty|total knee arthroplasty
5274073|NCT02308397|non coeliac gluten sensitivity|non coeliac gluten sensitivity
5274074|NCT02308397|gluten|gluten
5274075|NCT02308397|bread|bread
5274076|NCT02308384|iFOBT|ifobt
5274078|NCT02308384|general practice|general practice
5274079|NCT02308384|early diagnosis|early diagnosis
5274080|NCT02308371|critically ill pediatric patients|critically ill pediatric patients
5271220|NCT02324049|Mucinoses|mucinoses
5274081|NCT02308371|fluid resuscitation|fluid resuscitation
5274082|NCT02308358|Osteochondral Defect|osteochondral defect
5274083|NCT02308358|Femoral condyle osteochondral defect|femoral condyle osteochondral defect
5274084|NCT02308319|Hepatocellular carcinoma, Recurrence|hepatocellular carcinoma, recurrence
5274086|NCT02308306|Opioid analgesics|opioid analgesics
5274087|NCT02308306|Prediction study|prediction study
5274088|NCT02308306|Pharmaco-EEG|pharmaco-eeg
5274089|NCT02308293|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5274090|NCT02308293|Hypoglycemia unawareness|hypoglycemia unawareness
5274091|NCT02308293|Lactate|lactate
5274092|NCT02308293|high intensity interval exercise|high intensity interval exercise
5274093|NCT02308293|MRS|mrs
5274097|NCT02308267|Cystic Fibrosis|cystic fibrosis
5274098|NCT02308267|Mucosal immunity|mucosal immunity
5274099|NCT02308254|Blood pressure|blood pressure
5274100|NCT02308254|Gastric emptying|gastric emptying
5274101|NCT02308254|Glycemia|glycemia
5274102|NCT02308254|Appetite|appetite
5274103|NCT02308254|Incretin Hormones|incretin hormones
5274104|NCT02308254|Superior mesenteric artery blood low|superior mesenteric artery blood low
5274105|NCT02308241|Ribavirin|ribavirin
5274106|NCT02308241|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5274107|NCT02308241|Recurrent/Metastatic (R/M)|recurrent/metastatic (r/m)
5274112|NCT02308228|Strength|strength
5274113|NCT02308228|Muscle|muscle
5274114|NCT02308215|Retina|retina
5274115|NCT02308215|AMD|amd
5274116|NCT02308215|OCT|oct
5274117|NCT02308202|PTSD|ptsd
5274118|NCT02308202|treatment|treatment
5274119|NCT02308202|virtual reality|virtual reality
5274120|NCT02308202|doxazosin|doxazosin
5274121|NCT02308189|Exercise|exercise
5274122|NCT02308163|Rheumatoid Arthritis|rheumatoid arthritis
5274123|NCT02308163|ASP015K|asp015k
5274124|NCT02308150|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5274125|NCT02308150|asian pacific|asian pacific
5274126|NCT02308150|asian|asian
5274131|NCT02308085|Premenopausal|premenopausal
5274132|NCT02308085|endocrine responsive|endocrine responsive
5274133|NCT02308085|Breast|breast
5274134|NCT02308085|Pregnancy|pregnancy
5274135|NCT02308072|Squamous Cell Carcinoma|squamous cell carcinoma
5274136|NCT02308072|Head and Neck Cancer|head and neck cancer
5274137|NCT02308072|Locally Advanced|locally advanced
5274138|NCT02308072|Olaparib|olaparib
5274139|NCT02308072|Cisplatin|cisplatin
5274140|NCT02308072|IMRT|imrt
5274141|NCT02308072|Chemoradiotherapy|chemoradiotherapy
5274142|NCT02308072|PARP|parp
5274143|NCT02308072|HNSCC|hnscc
5274144|NCT02307994|infertility|infertility
5274145|NCT02307942|Randomized Clinical Trials|randomized clinical trials
5274146|NCT02307942|gastric banding|gastric banding
5274147|NCT02307942|calorie restriction|calorie restriction
5274148|NCT02307942|SPPB|sppb
5274149|NCT02307942|physical performance|physical performance
5274150|NCT02307942|elderly|elderly
5274151|NCT02307916|tympanic membrane perforation|tympanic membrane perforation
5274152|NCT02307916|ear drum|ear drum
5274153|NCT02307916|hole|hole
5274154|NCT02307903|end-stage renal failure (ESRF)|end-stage renal failure (esrf)
5274155|NCT02307890|Liver Transplantation|liver transplantation
5274156|NCT02307864|Healthy|healthy
5274157|NCT02307864|QT interval|qt interval
5274158|NCT02307864|QTc interval|qtc interval
5274159|NCT02307864|Electrocardiogram|electrocardiogram
5274160|NCT02307864|Tramadol hydrochloride|tramadol hydrochloride
5274161|NCT02307864|Moxifloxacin|moxifloxacin
5274162|NCT02307864|Placebo|placebo
5274163|NCT02307838|Multiple Sclerosis, MS, RRMS, relapsing forms of multiple sclerosis, fingolimod, FTY720, Gilenya|multiple sclerosis, ms, rrms, relapsing forms of multiple sclerosis, fingolimod, fty720, gilenya
5274164|NCT02307825|Azithromycin|azithromycin
5274165|NCT02307825|Endoscopic sinus surgery|endoscopic sinus surgery
5274166|NCT02307799|tobacco|tobacco
5274167|NCT02307799|spirometry|spirometry
5274168|NCT02307799|cohort study|cohort study
5274169|NCT02307799|case-control study|case-control study
5274170|NCT02307799|prevalence|prevalence
5274171|NCT02307773|Upper Gastrointestinal Endoscopy|upper gastrointestinal endoscopy
5274172|NCT02307773|Pharyngeal Anesthesia|pharyngeal anesthesia
5274173|NCT02307773|Lidocaine|lidocaine
5274174|NCT02307773|Belching|belching
5274175|NCT02307773|Retching|retching
5274176|NCT02307773|Tolerance|tolerance
5274177|NCT02307747|infection in ICU|infection in icu
5274178|NCT02307734|Lay Health Workers|lay health workers
5274179|NCT02307734|Chinese|chinese
5274180|NCT02307734|Vietnamese|vietnamese
5274181|NCT02307734|Tobacco Use|tobacco use
5274182|NCT02307734|Intervention|intervention
5274183|NCT02307734|Behavior Change|behavior change
5274184|NCT02307734|Social Networks|social networks
5274185|NCT02307734|Asians|asians
5274186|NCT02307721|Emergency Treatment|emergency treatment
5274187|NCT02307721|Morphine Derivates|morphine derivates
5274188|NCT02307721|Heroin|heroin
5274189|NCT02307721|Antidotes|antidotes
5274190|NCT02307721|Administration, Intranasal|administration, intranasal
5274192|NCT02307721|Naloxone|naloxone
5271292|NCT02323646|fibroma|fibroma
5274193|NCT02307721|Healthy volunteers|healthy volunteers
5274195|NCT02307695|Type 1 Diabetes|type 1 diabetes
5274196|NCT02307695|Glycemic variability|glycemic variability
5274197|NCT02307695|C-Peptide|c-peptide
5274200|NCT02307682|IVT|ivt
5274201|NCT02307669|Adherence|adherence
5274202|NCT02307669|Inhaler|inhaler
5274203|NCT02307669|GINA|gina
5274204|NCT02307643|Systemic lupus erythematosus|systemic lupus erythematosus
5274205|NCT02307630|124I-Humanized 3F8|124i-humanized 3f8
5274206|NCT02307630|PET Imaging|pet imaging
5274207|NCT02307630|13-147|13-147
5274208|NCT02307617|Major depressive disorder|major depressive disorder
5274209|NCT02307617|MDD|mdd
5274210|NCT02307617|healthy control|healthy control
5274211|NCT02307617|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5274212|NCT02307617|SSRI|ssri
5274213|NCT02307617|depression|depression
5274214|NCT02307617|transcranial magnetic stimulation|transcranial magnetic stimulation
5274215|NCT02307617|TMS|tms
5274216|NCT02307617|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5274217|NCT02307617|MRS|mrs
5274218|NCT02307617|adolescent|adolescent
5274219|NCT02307617|mild MDD|mild mdd
5274220|NCT02307617|mild depression|mild depression
5274221|NCT02307617|cortical excitability|cortical excitability
5274222|NCT02307617|cortical inhibition|cortical inhibition
5274223|NCT02307617|cortical silent period|cortical silent period
5274224|NCT02307617|motor threshold|motor threshold
5274225|NCT02307617|intracortical facilitation|intracortical facilitation
5274226|NCT02307617|intracortical inhibition|intracortical inhibition
5274227|NCT02307617|motor cortex|motor cortex
5274228|NCT02307617|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5274229|NCT02307617|DLPFC|dlpfc
5274230|NCT02307617|thumb twitch|thumb twitch
5274231|NCT02307617|gamma aminobutyric acid|gamma aminobutyric acid
5274232|NCT02307617|GABA|gaba
5274233|NCT02307617|glutamate|glutamate
5274234|NCT02307617|single pulse|single pulse
5274235|NCT02307617|paired pulse|paired pulse
5274236|NCT02307604|Brain tumor|brain tumor
5274237|NCT02307604|Biomarkers|biomarkers
5274238|NCT02307604|Screening|screening
5274239|NCT02307578|Perampanel|perampanel
5274240|NCT02307578|Fycompa|fycompa
5274241|NCT02307578|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
5274242|NCT02307578|E2007-G000-332|e2007-g000-332
5274243|NCT02307578|E2007|e2007
5274244|NCT02307565|Midodrine|midodrine
5274245|NCT02307565|Blood pressure|blood pressure
5274246|NCT02307565|Orthostatic hypotension|orthostatic hypotension
5274247|NCT02307565|Spinal Cord Injury|spinal cord injury
5274248|NCT02307565|Sympathetic vascular control|sympathetic vascular control
5274249|NCT02307565|Cerebral blood flow velocity|cerebral blood flow velocity
5274250|NCT02307565|Cognition function tasks|cognition function tasks
5274251|NCT02307565|Quality of Life|quality of life
5274252|NCT02307565|MRI|mri
5274253|NCT02307565|fMRI|fmri
5274254|NCT02307552|Imaging|imaging
5274255|NCT02307552|ultrasound|ultrasound
5274256|NCT02307552|prostate|prostate
5274257|NCT02307552|cancer|cancer
5274258|NCT02307552|diagnostic tool|diagnostic tool
5274259|NCT02307552|catheter|catheter
5274260|NCT02307552|urethra|urethra
5274261|NCT02307552|digital rectal exam|digital rectal exam
5274262|NCT02307526|Hypotension, Postural|hypotension, postural
5274263|NCT02307513|APREMILAST (CC-10004)|apremilast (cc-10004)
5274264|NCT02307513|CC-10004|cc-10004
5274265|NCT02307513|Efficacy|efficacy
5274266|NCT02307513|Safety|safety
5274267|NCT02307513|Phase 3|phase 3
5274268|NCT02307513|Behçet's Disease|behçet's disease
5274269|NCT02307487|TC-3 Gel|tc-3 gel
5274270|NCT02307487|MMC|mmc
5274271|NCT02307487|NMIBC|nmibc
5274272|NCT02307487|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5274273|NCT02307487|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
5274274|NCT02307487|Drug retention|drug retention
5274275|NCT02307487|Urinary Bladder Neoplasms|urinary bladder neoplasms
5274276|NCT02307487|Urologic Neoplasms|urologic neoplasms
5274277|NCT02307487|Urinary Bladder Diseases|urinary bladder diseases
5274278|NCT02307487|Urologic Diseases|urologic diseases
5274279|NCT02307474|Kidney|kidney
5274280|NCT02307474|Renal Cell Carcinoma|renal cell carcinoma
5274281|NCT02307474|Cancer|cancer
5274282|NCT02307474|Pilot|pilot
5274283|NCT02307474|Pazopanib|pazopanib
5274284|NCT02307474|stereotactic body radiation therapy|stereotactic body radiation therapy
5274285|NCT02307474|SBRT|sbrt
5274286|NCT02307461|Phase 1|phase 1
5274287|NCT02307461|Bioequivalence|bioequivalence
5274288|NCT02307461|Pharmacokinetics|pharmacokinetics
5274289|NCT02307461|Food|food
5274290|NCT02307461|Healthy Adult|healthy adult
5274291|NCT02307435|non union fracture|non union fracture
5274292|NCT02307435|bone defect|bone defect
5274293|NCT02307435|mesenchymal stem cell|mesenchymal stem cell
5274294|NCT02307435|cryopreservation|cryopreservation
5274295|NCT02307383|SDD (Selective Digestive Decolonization)|sdd (selective digestive decolonization)
5274296|NCT02307383|OXA 48|oxa 48
5274297|NCT02307383|carbapenemase|carbapenemase
5274298|NCT02307383|probiotics|probiotics
5274299|NCT02307331|Total Hip Replacement|total hip replacement
5274300|NCT02307318|Radial Artery|radial artery
5274301|NCT02307318|Hemostasis|hemostasis
5274303|NCT02307292|Superficial femoral artery|superficial femoral artery
5274304|NCT02307292|Self Expanding Stent System|self expanding stent system
5274305|NCT02307253|EUS-guided biopsy, EUS-FNB|eus-guided biopsy, eus-fnb
5274306|NCT02307240|TNBC|tnbc
5274307|NCT02307240|HGSOC|hgsoc
5274308|NCT02307240|NMC|nmc
5274309|NCT02307188|Atrial Fibrillation|atrial fibrillation
5274310|NCT02307188|Atrial Flutter|atrial flutter
5274311|NCT02307188|Multipolar Catheter|multipolar catheter
5274312|NCT02307188|Atrial Arrhythmia|atrial arrhythmia
5274313|NCT02307162|COPD|copd
5274314|NCT02307149|melanoma|melanoma
5274315|NCT02307149|ipilimumab|ipilimumab
5274316|NCT02307149|coxsackievirus A21|coxsackievirus a21
5274317|NCT02307149|CAVATAK|cavatak
5274318|NCT02307149|CVA21|cva21
5274319|NCT02307149|checkpoint inhibitors|checkpoint inhibitors
5274320|NCT02307136|intensive care units|intensive care units
5274321|NCT02307136|emergency department|emergency department
5274322|NCT02307123|Prehospital emergency care (MeSH)|prehospital emergency care (mesh)
5274323|NCT02307123|Emergency medical services (MeSH)|emergency medical services (mesh)
5274324|NCT02307123|Helicopter emergency medical service, Critical care (MeSH)|helicopter emergency medical service, critical care (mesh)
5274325|NCT02307123|Airway management (MeSH)|airway management (mesh)
5274326|NCT02307123|Endotracheal intubation (MeSH)|endotracheal intubation (mesh)
5274327|NCT02307123|Patient outcome|patient outcome
5274328|NCT02307110|Diabetes Mellitus 1|diabetes mellitus 1
5274329|NCT02307110|long-term intensified insulin therapy|long-term intensified insulin therapy
5274330|NCT02307110|diabetic retinopathy|diabetic retinopathy
5274331|NCT02307110|diabetic macular edema|diabetic macular edema
5274332|NCT02307097|Randomised Controlled Trial|randomised controlled trial
5274333|NCT02307097|Cognitive-Behavioural Bibliotherapy|cognitive-behavioural bibliotherapy
5274334|NCT02307097|Social Anxiety Disorder|social anxiety disorder
5274335|NCT02307097|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
5274337|NCT02307084|surgical site infection|surgical site infection
5274338|NCT02307084|long saphenous vein|long saphenous vein
5274339|NCT02307084|coronary artery bypass grafting|coronary artery bypass grafting
5274340|NCT02307058|Prostate Cancer|prostate cancer
5274341|NCT02307045|Arterial stiffness|arterial stiffness
5274342|NCT02307045|Endothelial Glycocalyx|endothelial glycocalyx
5274343|NCT02307032|Atrial Fibrillation Relapses Prediction|atrial fibrillation relapses prediction
5274344|NCT02307032|P wave Signal Averaged ECG|p wave signal averaged ecg
5274345|NCT02307032|P wave Wavelets|p wave wavelets
5274346|NCT02307032|Strain|strain
5274347|NCT02307032|Tissue Doppler Imaging|tissue doppler imaging
5274348|NCT02307019|Caregivers|caregivers
5274349|NCT02307019|Apraxias|apraxias
5274350|NCT02307019|Stroke|stroke
5274351|NCT02307019|Cerebral Stroke|cerebral stroke
5274352|NCT02307019|Rehabilitation|rehabilitation
5274353|NCT02307019|Pragmatic Clinical Trials as Topic|pragmatic clinical trials as topic
5274354|NCT02306993|Sickle Cell Disease (SCD)|sickle cell disease (scd)
5274355|NCT02306993|Sickle Cell Trait (SCT)|sickle cell trait (sct)
5274356|NCT02306967|oral cancer|oral cancer
5274357|NCT02306967|oral dysplasia|oral dysplasia
5274358|NCT02306954|Kidney Cancer|kidney cancer
5274359|NCT02306954|High Dose IL-2|high dose il-2
5274360|NCT02306954|SBRT|sbrt
5274361|NCT02306928|Septic shock|septic shock
5274362|NCT02306928|Intensive care unit|intensive care unit
5274363|NCT02306928|Therapeutic drug monitoring|therapeutic drug monitoring
5274364|NCT02306928|Pharmacokinetics|pharmacokinetics
5274365|NCT02306928|Critically ill|critically ill
5274366|NCT02306915|Lipegfilgrastim, Lonquex, Japanese Bridging|lipegfilgrastim, lonquex, japanese bridging
5274367|NCT02306863|Parkinson's Disease|parkinson's disease
5274368|NCT02306863|whole-body vibration|whole-body vibration
5274369|NCT02306863|WBV|wbv
5274370|NCT02306850|immunotherapy|immunotherapy
5274371|NCT02306850|PD-1 inhibitor|pd-1 inhibitor
5274372|NCT02306850|programmed death 1 inhibitor|programmed death 1 inhibitor
5274373|NCT02306850|neoadjuvant|neoadjuvant
5274374|NCT02306850|pembrolizumab|pembrolizumab
5274375|NCT02306850|MK-3475|mk-3475
5274376|NCT02306837|lymphoma, consolidation chemotherapy, auto-HSCT|lymphoma, consolidation chemotherapy, auto-hsct
5274377|NCT02306759|analgesia|analgesia
5274378|NCT02306759|ketamine|ketamine
5274379|NCT02306759|pain|pain
5274380|NCT02306746|Enteral nutrition|enteral nutrition
5274381|NCT02306746|randomised control trial|randomised control trial
5274382|NCT02306746|Critical care|critical care
5274383|NCT02306746|Outcome|outcome
5274384|NCT02306733|Post partum hemorrhage|post partum hemorrhage
5274385|NCT02306733|Ergometrine|ergometrine
5274386|NCT02306733|Oxytocin|oxytocin
5274387|NCT02306733|Obstetrics|obstetrics
5274388|NCT02306694|hemophilia|hemophilia
5274389|NCT02306694|bone disease|bone disease
5274390|NCT02306694|clinical study|clinical study
5274391|NCT02306694|biomarkers|biomarkers
5274392|NCT02306668|Dry eye|dry eye
5274393|NCT02306655|Coital incontinence|coital incontinence
5274394|NCT02306655|Incidence|incidence
5274395|NCT02306655|quality of life|quality of life
5849058|NCT00031369|Movement Disorder|movement disorder
5274396|NCT02306629|Systemic Lupus Erythematosus|systemic lupus erythematosus
5274397|NCT02306590|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5274399|NCT02306590|ALS Functional Rating Scale|als functional rating scale
5274400|NCT02306590|quality of life|quality of life
5274401|NCT02306590|survival|survival
5274402|NCT02306577|STRIBILD|stribild
5274404|NCT02306577|Illicit dgug user|illicit dgug user
5274405|NCT02306564|ICSI|icsi
5274406|NCT02306564|cabergoline|cabergoline
5274407|NCT02306564|Subendometrial vascularity|subendometrial vascularity
5274408|NCT02306551|Offspring|offspring
5274409|NCT02306551|Attachment|attachment
5274410|NCT02306551|Risk development|risk development
5274411|NCT02306551|Resilience|resilience
5274412|NCT02306538|edema|edema
5274413|NCT02306538|inflammation|inflammation
5274414|NCT02306538|scar|scar
5274415|NCT02306538|ejection fraction|ejection fraction
5274416|NCT02306538|volumes|volumes
5274514|NCT02306174|Hoarding|hoarding
5274417|NCT02306512|Melanoma In Situ|melanoma in situ
5274418|NCT02306512|Lentigo Maligna|lentigo maligna
5274419|NCT02306512|Confocal Microscopy|confocal microscopy
5274420|NCT02306512|Direct Immunofluorescence|direct immunofluorescence
5274421|NCT02306499|VARICOCELE-AZOOSPERMIA-ICSI|varicocele-azoospermia-icsi
5274422|NCT02306460|Neurobehavioral Manifestations|neurobehavioral manifestations
5274423|NCT02306460|POCD|pocd
5274424|NCT02306460|Atrial Fibrillation|atrial fibrillation
5274425|NCT02306460|Anti-Arrhythmia|anti-arrhythmia
5274426|NCT02306460|Atrial Appendage Closure|atrial appendage closure
5274427|NCT02306434|childbirth fear|childbirth fear
5274428|NCT02306434|Internet CBT|internet cbt
5274429|NCT02306434|counselling|counselling
5274430|NCT02306434|antenatal care|antenatal care
5274432|NCT02306434|childbirth|childbirth
5274433|NCT02306434|Cognitive behavioural therapy|cognitive behavioural therapy
5274434|NCT02306421|RPH with the simplified Milligan-Morgan surgery|rph with the simplified milligan-morgan surgery
5274435|NCT02306421|mixed hemorrhoids|mixed hemorrhoids
5274436|NCT02306421|the effectiveness and safety|the effectiveness and safety
5274437|NCT02306421|A multi center clinical trial|a multi center clinical trial
5274438|NCT02306395|endometrial local injury|endometrial local injury
5274439|NCT02306395|repeated implatation failure|repeated implatation failure
5274440|NCT02306395|embyo transfer|embyo transfer
5274441|NCT02306382|endoanal ultrasonography|endoanal ultrasonography
5274442|NCT02306382|drainage|drainage
5274443|NCT02306382|perianal abscess|perianal abscess
5274444|NCT02306382|fistulas|fistulas
5274445|NCT02306382|incontience|incontience
5274446|NCT02306369|ICBT|icbt
5274447|NCT02306369|IBS|ibs
5274448|NCT02306369|FGID|fgid
5274449|NCT02306369|functional abdominal pain|functional abdominal pain
5274450|NCT02306369|Adolescents|adolescents
5274451|NCT02306369|Children|children
5274452|NCT02306369|Treatment|treatment
5274453|NCT02306369|CBT|cbt
5274454|NCT02306369|Exposure|exposure
5274455|NCT02306369|Cognitive Behavior Therapy|cognitive behavior therapy
5274456|NCT02306369|Internet|internet
5274457|NCT02306369|Computerized|computerized
5274458|NCT02306369|Abdominal Pain|abdominal pain
5274459|NCT02306369|Functional Pain|functional pain
5274460|NCT02306369|Functional Disorders|functional disorders
5274461|NCT02306343|rapid acting insulin|rapid acting insulin
5274462|NCT02306343|insulin injection|insulin injection
5274463|NCT02306343|insulin delivery|insulin delivery
5274464|NCT02306343|local heating|local heating
5274465|NCT02306343|experimental device|experimental device
5274466|NCT02306343|pre and post meal glucose level|pre and post meal glucose level
5274467|NCT02306330|Malditof|malditof
5274468|NCT02306330|Malditof MS|malditof ms
5274469|NCT02306330|matrix-assisted laser desorption ionization-time|matrix-assisted laser desorption ionization-time
5274470|NCT02306330|identifying pathogens|identifying pathogens
5274471|NCT02306330|randomized diagnostic trial|randomized diagnostic trial
5274472|NCT02306304|Abdominal aortic aneurysm|abdominal aortic aneurysm
5274473|NCT02306304|Abdominal aortic aneurism|abdominal aortic aneurism
5274474|NCT02306304|AAA|aaa
5274475|NCT02306304|Screening|screening
5274476|NCT02306304|duplex ultra sound|duplex ultra sound
5274477|NCT02306304|Israeli Arab men|israeli arab men
5274478|NCT02306304|family physician|family physician
5274479|NCT02306291|AML|aml
5274480|NCT02306291|Acute myeloid leukemia|acute myeloid leukemia
5274481|NCT02306291|E-selectin|e-selectin
5274482|NCT02306291|relapse refractory|relapse refractory
5274483|NCT02306291|elderly newly diagnosed|elderly newly diagnosed
5274484|NCT02306291|induction|induction
5274485|NCT02306278|gabapentin|gabapentin
5274486|NCT02306278|postoperative pain|postoperative pain
5274487|NCT02306278|vomiting|vomiting
5274488|NCT02306278|nausea|nausea
5274489|NCT02306252|Cancer|cancer
5274491|NCT02306252|Geriatric|geriatric
5274492|NCT02306252|Function|function
5274493|NCT02306252|Functional Deficit|functional deficit
5274494|NCT02306252|Occupational Therapy|occupational therapy
5274495|NCT02306252|Physical Therapy|physical therapy
5274496|NCT02306252|Supportive Care|supportive care
5274498|NCT02306252|physiology|physiology
5274499|NCT02306252|Geriatric Assessment|geriatric assessment
5274500|NCT02306252|Health Services for the Aged|health services for the aged
5274501|NCT02306252|Physical Therapy Specialty|physical therapy specialty
5274502|NCT02306226|TAVI|tavi
5274503|NCT02306226|Aortic stenosis|aortic stenosis
5274504|NCT02306226|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5274505|NCT02306226|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5274506|NCT02306226|Transfemoral access|transfemoral access
5274507|NCT02306200|Aorta|aorta
5274508|NCT02306200|Aortic Disease|aortic disease
5274509|NCT02306200|Abdominal Aortic Aneurysm (AAA)|abdominal aortic aneurysm (aaa)
5274510|NCT02306200|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
5274511|NCT02306200|Bicuspid Aortic Valve (BAV)|bicuspid aortic valve (bav)
5274512|NCT02306200|Aortic Dissection|aortic dissection
5274513|NCT02306187|The changes of bone mineral density and bone turnover markers|the changes of bone mineral density and bone turnover markers
5274515|NCT02306135|Cancer|cancer
5274516|NCT02306135|Tumor|tumor
5274517|NCT02306135|Everolimus|everolimus
5274518|NCT02306135|mTOR|mtor
5274519|NCT02306135|Temsirolimus|temsirolimus
5274520|NCT02306135|Sirolimus|sirolimus
5274521|NCT02306135|Rapamycin|rapamycin
5274522|NCT02306122|medication adherence|medication adherence
5274523|NCT02306122|choice architecture|choice architecture
5274524|NCT02306122|pharmacy home|pharmacy home
5274525|NCT02306109|Motor Rehabilitation Treatment|motor rehabilitation treatment
5274526|NCT02306109|Intensive versus standard|intensive versus standard
5274527|NCT02306109|Motor Disability|motor disability
5274528|NCT02306096|prognostic and predictive biomarkers|prognostic and predictive biomarkers
5274529|NCT02306096|RNA-sequencing|rna-sequencing
5274530|NCT02306096|pathological complete response|pathological complete response
5274531|NCT02306096|minimal residual disease|minimal residual disease
5274532|NCT02306096|molecular subtype|molecular subtype
5274533|NCT02306096|gene expression profiling|gene expression profiling
5274534|NCT02306096|mutation screening|mutation screening
5274535|NCT02306096|BRCA|brca
5274536|NCT02306096|translational research|translational research
5274537|NCT02306096|genomics|genomics
5274538|NCT02306096|transcriptomics|transcriptomics
5274539|NCT02306096|proteomics|proteomics
5274540|NCT02306096|metabolomics|metabolomics
5274541|NCT02306096|liquid biopsy|liquid biopsy
5274542|NCT02306096|circulating tumor cells|circulating tumor cells
5274543|NCT02306096|circulating tumor DNA|circulating tumor dna
5274544|NCT02306044|Bleeding|bleeding
5274545|NCT02306044|Platelet indices|platelet indices
5274546|NCT02306044|Platelet aggregometry|platelet aggregometry
5274547|NCT02306044|Bleeding questionnaire|bleeding questionnaire
5274548|NCT02306031|diclofenac|diclofenac
5274549|NCT02306031|macular thickness|macular thickness
5274550|NCT02306031|phacoemulsification|phacoemulsification
5274551|NCT02306031|OCT(Optical coherence tomography )|oct(optical coherence tomography )
5274552|NCT02306031|diabetic|diabetic
5274553|NCT02306018|liver transplantation|liver transplantation
5274554|NCT02306018|cardiac output|cardiac output
5274555|NCT02306005|diabetes mellitus type 1, insulin therapy, lipoproteins, HDL|diabetes mellitus type 1, insulin therapy, lipoproteins, hdl
5274556|NCT02305966|advanced arthritis|advanced arthritis
5274557|NCT02305966|shoulder|shoulder
5274558|NCT02305953|Psoriasis|psoriasis
5274559|NCT02305953|Vascular Inflammation|vascular inflammation
5274560|NCT02305953|Coronary Atherosclerosis|coronary atherosclerosis
5274561|NCT02305953|Ascending aorta|ascending aorta
5274562|NCT02305953|PET scan|pet scan
5274563|NCT02305953|Cytokine|cytokine
5274564|NCT02305953|Chemokine|chemokine
5274565|NCT02305927|Vitamin D|vitamin d
5274566|NCT02305927|Pregnant women|pregnant women
5274567|NCT02305914|acute pancreatitis|acute pancreatitis
5274568|NCT02305914|chronic pancreatitis|chronic pancreatitis
5274569|NCT02305914|pancreatic cancer|pancreatic cancer
5274570|NCT02305914|pancreatic disease-associated portal hypertension|pancreatic disease-associated portal hypertension
5274571|NCT02305914|autoimmune pancreatitis|autoimmune pancreatitis
5274572|NCT02305914|PaO2/FiO2＜200|pao2/fio2＜200
5274573|NCT02305914|diabetes mellitus|diabetes mellitus
5274574|NCT02305914|blood lipid|blood lipid
5274575|NCT02305914|local complications|local complications
5274576|NCT02305914|quality of life|quality of life
5274577|NCT02305862|Coronary Arteriosclerosis|coronary arteriosclerosis
5274578|NCT02305862|Carotid Atherosclerotic Plaque|carotid atherosclerotic plaque
5274579|NCT02305862|Rosuvastatin|rosuvastatin
5274580|NCT02305849|ASP015K|asp015k
5274581|NCT02305849|Rheumatoid Arthritis|rheumatoid arthritis
5274582|NCT02305836|Electroacupuncture|electroacupuncture
5274583|NCT02305836|Donepezil|donepezil
5274584|NCT02305836|Alzheimer's disease|alzheimer's disease
5274586|NCT02305823|psychosis|psychosis
5274587|NCT02305823|antipsychotic agents|antipsychotic agents
5274588|NCT02305823|treatment|treatment
5274589|NCT02305823|effectiveness|effectiveness
5274590|NCT02305784|Cystic fibrosis|cystic fibrosis
5849059|NCT00031369|Gray Matter|gray matter
5274591|NCT02305784|Pulmonary exacerbation|pulmonary exacerbation
5274592|NCT02305784|inflammation|inflammation
5274593|NCT02305784|Chitinase|chitinase
5274594|NCT02305784|cytokine|cytokine
5274595|NCT02305784|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
5274596|NCT02305758|PARP inhibitor|parp inhibitor
5274597|NCT02305758|veliparib|veliparib
5274598|NCT02305758|metastatic colorectal cancer|metastatic colorectal cancer
5274599|NCT02305758|ABT-888|abt-888
5274600|NCT02305758|first line|first line
5274601|NCT02305758|previously untreated|previously untreated
5274602|NCT02305758|colorectal cancer|colorectal cancer
5274603|NCT02305758|colon cancer|colon cancer
5274604|NCT02305758|rectal cancer|rectal cancer
5274605|NCT02305758|FOLFIRI|folfiri
5274606|NCT02305758|fluorouracil|fluorouracil
5274607|NCT02305758|5-FU|5-fu
5274608|NCT02305758|leucovorin|leucovorin
5274609|NCT02305758|irinotecan|irinotecan
5274610|NCT02305732|Chikungunya virus|chikungunya virus
5274611|NCT02305732|CHIKV|chikv
5274612|NCT02305732|Dengue virus|dengue virus
5274613|NCT02305732|DENV|denv
5274818|NCT02304341|monitoring|monitoring
5274628|NCT02305654|Chemoradiotherapy|chemoradiotherapy
5274629|NCT02305654|Surgery|surgery
5274630|NCT02305654|Phase III|phase iii
5274631|NCT02305602|extracellular matrix|extracellular matrix
5274632|NCT02305589|postoperative delirium|postoperative delirium
5274633|NCT02305589|sugammadex|sugammadex
5274634|NCT02305589|cholinesterase inhibitor|cholinesterase inhibitor
5274635|NCT02305589|hip fracture surgery|hip fracture surgery
5274636|NCT02305550|Nitric Oxide|nitric oxide
5262037|NCT02377336|chronic stable angina|chronic stable angina
5262038|NCT02377323|Multiple Sclerosis|multiple sclerosis
5262039|NCT02377323|Patient-reported outcomes|patient-reported outcomes
5262040|NCT02377323|Employment status|employment status
5274637|NCT02305524|endotracheal intubation|endotracheal intubation
5274638|NCT02305511|Catheterization|catheterization
5274639|NCT02305511|Peripheral|peripheral
5274640|NCT02305498|Yoga|yoga
5274641|NCT02305498|14-059|14-059
5274642|NCT02305485|NeoVas|neovas
5274643|NCT02305485|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
5274644|NCT02305485|Sirolimus|sirolimus
5274645|NCT02305485|Randomized Controlled Trial|randomized controlled trial
5274646|NCT02305472|NeoVas|neovas
5274647|NCT02305472|Bioresorbable Coronary Scaffold|bioresorbable coronary scaffold
5274648|NCT02305472|Sirolimus|sirolimus
5274649|NCT02305472|Registry Trial|registry trial
5274650|NCT02305459|SIRT|sirt
5274651|NCT02305459|microcatheter|microcatheter
5274652|NCT02305459|primary liver tumor|primary liver tumor
5274653|NCT02305459|secondary liver tumor|secondary liver tumor
5274654|NCT02305459|radioembolisation|radioembolisation
5274655|NCT02305459|QLQ-C30|qlq-c30
5274656|NCT02305459|CIRSE|cirse
5274670|NCT02305394|ketamine|ketamine
5274671|NCT02305394|Electroconvulsive Therapy|electroconvulsive therapy
5274672|NCT02305394|Cognitive Function|cognitive function
5274673|NCT02305342|Uncomplicated UTI|uncomplicated uti
5274674|NCT02305342|Enoxacin|enoxacin
5274675|NCT02305303|Quality of life|quality of life
5274676|NCT02305303|post-traumatic stress disorder|post-traumatic stress disorder
5274677|NCT02305303|trauma|trauma
5274678|NCT02305238|Eylea,|eylea,
5274679|NCT02305238|Aflibercept|aflibercept
5274680|NCT02305238|Treat and Extend regimen|treat and extend regimen
5274681|NCT02305238|Age-related macular degeneration|age-related macular degeneration
5274682|NCT02305212|Working Memory|working memory
5274683|NCT02305199|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5274684|NCT02305199|Hartmann's solution|hartmann's solution
5274685|NCT02305186|Immunotherapy|immunotherapy
5274686|NCT02305186|Neoadjuvant|neoadjuvant
5274687|NCT02305186|Resectable|resectable
5274688|NCT02305186|Borderline resectable|borderline resectable
5274689|NCT02305173|dexamethasone|dexamethasone
5274690|NCT02305173|pulmonary function|pulmonary function
5274691|NCT02305173|spirometry|spirometry
5274692|NCT02305173|mastectomy|mastectomy
5274693|NCT02305160|Respiratory distress syndrome|respiratory distress syndrome
5274694|NCT02305160|Pulmonary surfactant|pulmonary surfactant
5274695|NCT02305160|Mortality|mortality
5274696|NCT02305160|Prematurity|prematurity
5274697|NCT02305147|Parkinson Disease|parkinson disease
5274698|NCT02305147|Biomarkers|biomarkers
5274699|NCT02305147|Prognostic factors|prognostic factors
5274700|NCT02305147|Prodromal features|prodromal features
5274701|NCT02305147|Disease progression|disease progression
5274702|NCT02305134|Tipepidine, GIRK|tipepidine, girk
5274703|NCT02305121|Trochanteric fracture|trochanteric fracture
5274704|NCT02305121|Nail|nail
5274705|NCT02305121|Fracture reduction|fracture reduction
5274706|NCT02305121|Antirotation|antirotation
5274707|NCT02305121|trochanteric area with diaphyseal extension|trochanteric area with diaphyseal extension
5274708|NCT02305121|trochanteric area with femoral shaft|trochanteric area with femoral shaft
5274709|NCT02305043|non-interventional|non-interventional
5274710|NCT02305043|advanced gastric cancer|advanced gastric cancer
5274711|NCT02305043|Trastuzumab|trastuzumab
5274712|NCT02305043|HER2|her2
5274713|NCT02304991|Peanut|peanut
5274714|NCT02304991|Food Allergy|food allergy
5274718|NCT02304965|LVAD|lvad
5274719|NCT02304952|Lateral epicondylalgia|lateral epicondylalgia
5274720|NCT02304952|Pain|pain
5274721|NCT02304952|Function|function
5274722|NCT02304952|Physiotherapy|physiotherapy
5274723|NCT02304952|Quality of Life|quality of life
5274724|NCT02304939|Norepinephrine|norepinephrine
5274725|NCT02304939|Intensive Care|intensive care
5274726|NCT02304939|Changeovers|changeovers
5274727|NCT02304939|Smart pumps|smart pumps
5274728|NCT02304939|Quick change|quick change
5274729|NCT02304939|Double pumping|double pumping
5274730|NCT02304939|Shock|shock
5274731|NCT02304926|Dyslipidemia|dyslipidemia
5274732|NCT02304926|Simvastatin|simvastatin
5274733|NCT02304926|Ezetimibe|ezetimibe
5274734|NCT02304926|Lipid profile|lipid profile
5274735|NCT02304926|Inflammation|inflammation
5274736|NCT02304926|Oxidative stress|oxidative stress
5274737|NCT02304926|Endothelial function|endothelial function
5274738|NCT02304900|cataract|cataract
5274739|NCT02304887|Osteoporosis|osteoporosis
5274740|NCT02304887|Bone mineral densisty|bone mineral densisty
5274741|NCT02304887|Renal function|renal function
5274742|NCT02304887|CKD-MBD|ckd-mbd
5274743|NCT02304874|Ferritins|ferritins
5274744|NCT02304874|Iron Overload|iron overload
5274745|NCT02304874|Metabolic Syndrome|metabolic syndrome
5274746|NCT02304874|Venesection therapy|venesection therapy
5274747|NCT02304874|Volunteers|volunteers
5274748|NCT02304861|cataract|cataract
5274749|NCT02304861|viscoelastic (OVD) technology|viscoelastic (ovd) technology
5274750|NCT02304861|endothelial cell count|endothelial cell count
5274751|NCT02304861|endothelial cell pattern|endothelial cell pattern
5274752|NCT02304861|central corneal edema|central corneal edema
5274753|NCT02304848|Parkinson's Disease|parkinson's disease
5274754|NCT02304848|DBS|dbs
5274755|NCT02304848|Deep Brain Stimulation|deep brain stimulation
5274756|NCT02304848|Subthalamic Nucleus|subthalamic nucleus
5274757|NCT02304822|kidney stones|kidney stones
5274758|NCT02304822|retrograde intrarenal surgery|retrograde intrarenal surgery
5274759|NCT02304822|ciprofloxacin|ciprofloxacin
5274760|NCT02304822|prophylaxis|prophylaxis
5274761|NCT02304822|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5274762|NCT02304809|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
5274763|NCT02304809|genomic alterations|genomic alterations
5274764|NCT02304809|biological vemurafenib targets BRAF|biological vemurafenib targets braf
5274765|NCT02304809|genomic.|genomic.
5274766|NCT02304796|Anxiety Disorders|anxiety disorders
5274767|NCT02304796|Group Psychotherapy|group psychotherapy
5274768|NCT02304796|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5274769|NCT02304796|Dance/Movement Therapy|dance/movement therapy
5274770|NCT02304796|CBT|cbt
5274771|NCT02304796|DMT|dmt
5274772|NCT02304796|Unified Protocol|unified protocol
5274773|NCT02304783|Renal colic, Piroxicam|renal colic, piroxicam
5274774|NCT02304757|differentiated thyroid cancer|differentiated thyroid cancer
5274775|NCT02304757|bone mineral density|bone mineral density
5274776|NCT02304757|thyroid stimulating hormone suppression|thyroid stimulating hormone suppression
5274777|NCT02304731|Physical Exercise, Atmospheric Pollution, Cognition.|physical exercise, atmospheric pollution, cognition.
5274778|NCT02304718|GDM|gdm
5274779|NCT02304718|pregnancy outcome|pregnancy outcome
5274780|NCT02304718|obesity|obesity
5274781|NCT02304718|exercise|exercise
5274782|NCT02304718|overweight|overweight
5274783|NCT02304640|fatigue|fatigue
5274784|NCT02304640|chemotherapy|chemotherapy
5274785|NCT02304640|breast cancer|breast cancer
5274786|NCT02304640|supportive care|supportive care
5274787|NCT02304640|Singapore|singapore
5274788|NCT02304523|Colonoscopy preparation|colonoscopy preparation
5274789|NCT02304523|Bowel cleansing|bowel cleansing
5274790|NCT02304523|Colon cleansing|colon cleansing
5274791|NCT02304523|Colonoscopy|colonoscopy
5274792|NCT02304523|CDFR0612|cdfr0612
5274793|NCT02304523|CDFR0613|cdfr0613
5274794|NCT02304510|Prevalence|prevalence
5274795|NCT02304510|Menorrhagia|menorrhagia
5274796|NCT02304497|Diabetes mellitus|diabetes mellitus
5274797|NCT02304497|Platelet rich fibrin|platelet rich fibrin
5274798|NCT02304497|growth factor|growth factor
5274799|NCT02304445|Radiotherapy|radiotherapy
5274800|NCT02304445|Chemoembolization|chemoembolization
5274801|NCT02304432|D-cycloserine|d-cycloserine
5274802|NCT02304432|Glycine|glycine
5274803|NCT02304432|Psychosis|psychosis
5274804|NCT02304432|Mutation|mutation
5274805|NCT02304432|GABA|gaba
5274806|NCT02304406|prevalence of ALK rearrangement, NSCLC, MENA|prevalence of alk rearrangement, nsclc, mena
5274811|NCT02304354|rheumatoid arthritis|rheumatoid arthritis
5274812|NCT02304354|T lymphocytes|t lymphocytes
5274813|NCT02304354|rituximab|rituximab
5274814|NCT02304341|critical illness|critical illness
5274815|NCT02304341|disease progression|disease progression
5274816|NCT02304341|child|child
5274817|NCT02304341|severity of illness index|severity of illness index
5274824|NCT02304315|Hepatitis B Immuno Globulin|hepatitis b immuno globulin
5274831|NCT02304263|aging|aging
5274832|NCT02304263|renal function|renal function
5274833|NCT02304263|HIV|hiv
5274834|NCT02304263|frailty|frailty
5274835|NCT02304237|Premature Birth|premature birth
5274853|NCT02304172|Thyroidectomy|thyroidectomy
5274854|NCT02304172|Thunderbeat|thunderbeat
5274855|NCT02304159|HCV|hcv
5274856|NCT02304159|Genotype 3|genotype 3
5274857|NCT02304159|Treatment naive|treatment naive
5274858|NCT02304159|Treatment experienced|treatment experienced
5274859|NCT02304146|Foam|foam
5274860|NCT02304146|UGFS|ugfs
5274861|NCT02304146|Stripping|stripping
5274862|NCT02304146|Incompetence|incompetence
5274863|NCT02304120|proprioception|proprioception
5274864|NCT02304120|postural control|postural control
5274865|NCT02304120|sensorimotor training|sensorimotor training
5274866|NCT02304120|uncontrolled manifold|uncontrolled manifold
5274867|NCT02304029|epilepsy|epilepsy
5274868|NCT02304029|seizures|seizures
5274869|NCT02304003|Shoulder tendinopathy|shoulder tendinopathy
5274870|NCT02304003|Subacromial impingement syndrome|subacromial impingement syndrome
5274871|NCT02304003|Rotator cuff tendinopathy|rotator cuff tendinopathy
5274872|NCT02304003|Supraspinatus tendinopathy|supraspinatus tendinopathy
5274873|NCT02303964|Trauma|trauma
5274874|NCT02303964|Hemorrhage|hemorrhage
5274875|NCT02303964|Plasma|plasma
5274876|NCT02303964|Shock|shock
5274877|NCT02303964|Polytrauma|polytrauma
5274878|NCT02303912|relapsed epithelial ovarian cancer,|relapsed epithelial ovarian cancer,
5274879|NCT02303912|relapsed fallopian tube cancer|relapsed fallopian tube cancer
5274880|NCT02303912|relapsed primary peritoneal cancer.|relapsed primary peritoneal cancer.
5274881|NCT02303860|Healthy volunteer study|healthy volunteer study
5274882|NCT02303808|Hyperosmolar agents|hyperosmolar agents
5274883|NCT02303808|Hypertonic saline|hypertonic saline
5274884|NCT02303808|Airway clearance techniques|airway clearance techniques
5274885|NCT02303808|Positive Expiratory Pressure|positive expiratory pressure
5274886|NCT02303808|Autogenic drainage|autogenic drainage
5274887|NCT02303795|bioprosthetic mitral valve|bioprosthetic mitral valve
5274888|NCT02303795|valvular heart disease|valvular heart disease
5274889|NCT02303795|anticoagulant agents|anticoagulant agents
5274890|NCT02303795|NOACs|noacs
5274891|NCT02303795|rivaroxaban|rivaroxaban
5274892|NCT02303795|warfarin|warfarin
5274893|NCT02303769|Lower Urinary Track Syndrome|lower urinary track syndrome
5274894|NCT02303769|Harnal|harnal
5274895|NCT02303769|Tamsulosin HCL 0.4mg|tamsulosin hcl 0.4mg
5274896|NCT02303743|Bowel preparation; colonoscopy; Smartphone application|bowel preparation; colonoscopy; smartphone application
5274897|NCT02303730|Diabetes|diabetes
5274898|NCT02303730|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5274899|NCT02303717|Left main|left main
5274900|NCT02303717|PCI|pci
5274901|NCT02303717|DES|des
5274902|NCT02303704|Multiperfusion set|multiperfusion set
5274903|NCT02303704|Myocardial protection|myocardial protection
5274904|NCT02303704|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5274905|NCT02303691|anxiety|anxiety
5274906|NCT02303691|attention bias modification|attention bias modification
5274907|NCT02303691|computer|computer
5274908|NCT02303678|D2C7|d2c7
5274909|NCT02303678|Randazzo|randazzo
5274910|NCT02303678|Bigner|bigner
5274911|NCT02303678|Pro00053325|pro00053325
5274912|NCT02303678|recurrent malignant glioma|recurrent malignant glioma
5274913|NCT02303665|TCM multi-channel therapy|tcm multi-channel therapy
5274914|NCT02303665|ART failure|art failure
5274915|NCT02303639|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5274916|NCT02303639|antiarrhythmic medication|antiarrhythmic medication
5274917|NCT02303639|catheter ablation|catheter ablation
5274918|NCT02303626|BCX4161|bcx4161
5274919|NCT02303626|Prophylaxis|prophylaxis
5274920|NCT02303626|Prevention|prevention
5274921|NCT02303626|HAE|hae
5274926|NCT02303587|children|children
5274927|NCT02303574|AZD7986, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect, First-in-human, Single Ascending Dose, Multiple Ascending Dose, Healthy Subjects|azd7986, safety, tolerability, pharmacokinetics, pharmacodynamics, food effect, first-in-human, single ascending dose, multiple ascending dose, healthy subjects
5274928|NCT02303548|Sodium Bicarbonate|sodium bicarbonate
5274929|NCT02303535|Congenital heart disease|congenital heart disease
5274930|NCT02303535|European Paediatric Cardiac Code Short List|european paediatric cardiac code short list
5279756|NCT02276768|barostat|barostat
5274933|NCT02303535|paediatric|paediatric
5274934|NCT02303535|pediatric|pediatric
5271992|NCT02320110|Leptin|leptin
5271995|NCT02320110|Obesity|obesity
5274935|NCT02303522|ALL, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, Precursor Cell|all, pediatric, leukemia, childhood, lymphoblastic, lymphoma, acute, precursor cell
5274936|NCT02303509|Healthy Subjects|healthy subjects
5274937|NCT02303509|Mild to moderate Psoriasis|mild to moderate psoriasis
5274939|NCT02303496|platelet rich plasma|platelet rich plasma
5274940|NCT02303470|Exercise|exercise
5274941|NCT02303457|CO2 laser surgery|co2 laser surgery
5274942|NCT02303457|open surgery|open surgery
5274943|NCT02303457|multicenter prospective|multicenter prospective
5274944|NCT02303457|randomized|randomized
5274945|NCT02303457|controlled clinical studies|controlled clinical studies
5274946|NCT02303457|T1N0 squamous cell carcinoma of glottis with anterior commissure involved|t1n0 squamous cell carcinoma of glottis with anterior commissure involved
5274947|NCT02303444|Progressive radioactive iodine refractory differentiated thyroid carcinoma|progressive radioactive iodine refractory differentiated thyroid carcinoma
5274953|NCT02303418|Obstetrics|obstetrics
5274954|NCT02303405|Glucose Control|glucose control
5274955|NCT02303405|Inflammation|inflammation
5274956|NCT02303379|Training Protocol|training protocol
5274957|NCT02303379|Cardiac Rehabilitation|cardiac rehabilitation
5274958|NCT02303379|High-Intensity Interval Training|high-intensity interval training
5274959|NCT02303379|Continuous Training|continuous training
5274960|NCT02303379|Pyramid Training|pyramid training
5274961|NCT02303379|Physical Performance|physical performance
5274962|NCT02303353|Breast cancer|breast cancer
5274963|NCT02303353|Ovarian cancer|ovarian cancer
5274964|NCT02303353|Lung cancer|lung cancer
5274965|NCT02303353|Colon cancer|colon cancer
5274966|NCT02303353|Gastric cancer|gastric cancer
5274967|NCT02303353|Pancreatic cancer|pancreatic cancer
5262336|NCT02375854|preterm|preterm
5274968|NCT02303353|Rectum cancer|rectum cancer
5274969|NCT02303353|Plasmacytoma|plasmacytoma
5274970|NCT02303340|Cone Beam Computed Tomography|cone beam computed tomography
5274971|NCT02303340|Para Thyroid Hormone|para thyroid hormone
5274972|NCT02303340|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
5274973|NCT02303340|Digital Imaging and Communication in Medicine|digital imaging and communication in medicine
5274974|NCT02303275|Heart Failure|heart failure
5274975|NCT02303275|Congestive Heart Failure|congestive heart failure
5274976|NCT02303275|Lifestyle Change|lifestyle change
5274977|NCT02303236|Exercise|exercise
5274978|NCT02303197|head and neck cancer|head and neck cancer
5274979|NCT02303197|chemoradiotherapy|chemoradiotherapy
5274980|NCT02303197|radioactive stomatitis|radioactive stomatitis
5274981|NCT02303184|RVO|rvo
5274982|NCT02303184|ME|me
5274983|NCT02303184|Central Subfield Thickness|central subfield thickness
5274984|NCT02303184|OCT|oct
5274985|NCT02303184|optical coherence tomography|optical coherence tomography
5274986|NCT02303184|cystoid macular edema|cystoid macular edema
5274987|NCT02303184|subretinal fluid|subretinal fluid
5274988|NCT02303184|Eylea|eylea
5274989|NCT02303184|aflibercept|aflibercept
5274990|NCT02303184|anti-VEGF|anti-vegf
5274991|NCT02303171|Antiphospholipid syndrome|antiphospholipid syndrome
5274992|NCT02303171|APS|aps
5274993|NCT02303171|Warfarin|warfarin
5274994|NCT02303158|Alzheimer's Disease|alzheimer's disease
5274995|NCT02303158|Biomarkers|biomarkers
5274996|NCT02303158|Depression|depression
5274997|NCT02303158|dementia|dementia
5274998|NCT02303158|cerebrospinal fluid|cerebrospinal fluid
5274999|NCT02303158|neuropsychological|neuropsychological
5275000|NCT02303145|Breast Cancer, Survivors|breast cancer, survivors
5275001|NCT02303119|LNH|lnh
5275002|NCT02303119|CD20+|cd20+
5275003|NCT02303119|follicular|follicular
5275004|NCT02303106|AUC exposure to lamotrigine|auc exposure to lamotrigine
5275005|NCT02303080|whey protein microgels|whey protein microgels
5275006|NCT02303080|thermogenesis|thermogenesis
5275007|NCT02303067|Cardiac|cardiac
5275008|NCT02303067|Computed Tomography|computed tomography
5275009|NCT02303067|Coronary Artery Disease|coronary artery disease
5275010|NCT02303054|Prostate Cancer|prostate cancer
5275011|NCT02303054|Focal Ablation|focal ablation
5275012|NCT02303054|MRI-US Fusion Biopsy|mri-us fusion biopsy
5275308|NCT02301624|gMG|gmg
5275013|NCT02303054|Focal Therapy|focal therapy
5275014|NCT02303028|Pediatric|pediatric
5275015|NCT02303028|CNS Tumor|cns tumor
5275016|NCT02303028|Solid Tumour|solid tumour
5275017|NCT02303015|Germ cell cancer|germ cell cancer
5275018|NCT02303015|Late toxicity|late toxicity
5275019|NCT02303015|Renal impairment|renal impairment
5275020|NCT02303015|Cardiovascular disease|cardiovascular disease
5275021|NCT02302963|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
5275022|NCT02302963|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5275023|NCT02302963|Artificial Pancreas (AP) System|artificial pancreas (ap) system
5275024|NCT02302963|Closed-Loop Control (CLC)|closed-loop control (clc)
5275025|NCT02302963|Unified Safety System (USS) Virginia|unified safety system (uss) virginia
5275026|NCT02302963|Sensor Augmented Pump (SAP)|sensor augmented pump (sap)
5275027|NCT02302963|Low Blood Glucose Index (LBGI)|low blood glucose index (lbgi)
5275028|NCT02302963|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5275029|NCT02302963|inControl Diabetes Management Platform|incontrol diabetes management platform
5275030|NCT02302950|HIV infection|hiv infection
5275033|NCT02302937|Inguinal Hernia|inguinal hernia
5275034|NCT02302937|Primary|primary
5275035|NCT02302937|laparoscopic surgery|laparoscopic surgery
5275036|NCT02302937|single port surgery|single port surgery
5275037|NCT02302911|Early intervention|early intervention
5275038|NCT02302898|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
5275039|NCT02302898|Weight Regain|weight regain
5275040|NCT02302885|cancer-free 18-60 year old men and women|cancer-free 18-60 year old men and women
5275041|NCT02302859|Cancer Prevention|cancer prevention
5275042|NCT02302859|Tobacco Use Cessation|tobacco use cessation
5275043|NCT02302859|HIV-positive|hiv-positive
5275044|NCT02302859|Nicotine patch|nicotine patch
5275045|NCT02302859|NRT|nrt
5275046|NCT02302859|Questionnaire|questionnaire
5275047|NCT02302859|Survey|survey
5275048|NCT02302859|Smartphone|smartphone
5275049|NCT02302859|Counseling|counseling
5275050|NCT02302859|Saliva test|saliva test
5275051|NCT02302859|Saliva cotinine test|saliva cotinine test
5275052|NCT02302859|Nicotine replacement therapy|nicotine replacement therapy
5275053|NCT02302859|Smoking abstinence|smoking abstinence
5275054|NCT02302859|Aids|aids
5275055|NCT02302846|Leukemia|leukemia
5275056|NCT02302846|Acute myeloid leukemia|acute myeloid leukemia
5275057|NCT02302846|AML|aml
5275058|NCT02302846|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
5275059|NCT02302846|MDS|mds
5275060|NCT02302846|Ixazomib|ixazomib
5275061|NCT02302846|MLN9708|mln9708
5275062|NCT02302820|Advance Care Planning|advance care planning
5275063|NCT02302820|Nurse Care Coordination|nurse care coordination
5275064|NCT02302820|Comparative Effectiveness|comparative effectiveness
5275066|NCT02302820|Decision Aides|decision aides
5275067|NCT02302781|Reasons for Dropout|reasons for dropout
5275068|NCT02302781|Subfertility|subfertility
5275070|NCT02302781|NON IVF|non ivf
5275071|NCT02302742|Triple Negative Breast Cancer|triple negative breast cancer
5275072|NCT02302742|TNBC|tnbc
5275073|NCT02302742|Hereditary Breast and Ovarian Cancer|hereditary breast and ovarian cancer
5275074|NCT02302742|HBOC|hboc
5275075|NCT02302742|Prospective Registry|prospective registry
5275076|NCT02302729|Micronutrient intervention|micronutrient intervention
5275077|NCT02302729|Responsive feeding intervention|responsive feeding intervention
5275078|NCT02302729|School readiness intervention|school readiness intervention
5275079|NCT02302677|bile acids|bile acids
5275080|NCT02302677|sleeve gastrectomy|sleeve gastrectomy
5275081|NCT02302677|obesity|obesity
5275082|NCT02302677|GLP-1|glp-1
5275083|NCT02302677|FGF-19|fgf-19
5275084|NCT02302664|Achilles|achilles
5275085|NCT02302664|Platelet Rich Plasma|platelet rich plasma
5275086|NCT02302664|Patient reported outcome measure|patient reported outcome measure
5275087|NCT02302664|Orthopaedic trauma|orthopaedic trauma
5275088|NCT02302664|Musculoskeletal|musculoskeletal
5275089|NCT02302664|Tendon|tendon
5275090|NCT02302664|Sports Injury|sports injury
5275091|NCT02302664|Heel-Rise Endurance Test|heel-rise endurance test
5275092|NCT02302651|high intensity focused ultrasound|high intensity focused ultrasound
5275093|NCT02302651|osteoid osteoma|osteoid osteoma
5275094|NCT02302651|bone tumor|bone tumor
5275095|NCT02302638|single-step media|single-step media
5275096|NCT02302638|embryo development|embryo development
5275097|NCT02302638|blastocyst formation|blastocyst formation
5275098|NCT02302638|embryo utilization|embryo utilization
5275099|NCT02302625|Cognitive behavior therapy|cognitive behavior therapy
5275100|NCT02302612|chronic conditions|chronic conditions
5275101|NCT02302612|complex patients|complex patients
5275102|NCT02302612|engagement|engagement
5275103|NCT02302612|activation|activation
5275104|NCT02302586|Thoracic paravertebral block|thoracic paravertebral block
5275105|NCT02302586|Patient controlled analgesia|patient controlled analgesia
5275106|NCT02302586|Video Assisted Thoracoscopic Surgery|video assisted thoracoscopic surgery
5275107|NCT02302586|Postoperative acute pain|postoperative acute pain
5275108|NCT02302586|Chronic pain|chronic pain
5275109|NCT02302573|placenta accreta|placenta accreta
5275110|NCT02302573|contrast-enhanced unltrasound|contrast-enhanced unltrasound
5275111|NCT02302573|pregnancy|pregnancy
5275113|NCT02302573|sonovue|sonovue
5275114|NCT02302547|HIV-DNA|hiv-dna
5275115|NCT02302547|dual therapy|dual therapy
5275116|NCT02302547|NRTI|nrti
5275117|NCT02302547|virological control|virological control
5275118|NCT02302547|truvada®|truvada®
5275119|NCT02302534|scoliosis|scoliosis
5275120|NCT02302534|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5275121|NCT02302521|MRI|mri
5275122|NCT02302508|pharmacokinetics|pharmacokinetics
5275123|NCT02302508|drug metabolism|drug metabolism
5275124|NCT02302508|platelet reactivity|platelet reactivity
5275125|NCT02302508|carboxylesterase|carboxylesterase
5275126|NCT02302508|cytochromes p450|cytochromes p450
5275127|NCT02302508|type 2 diabetes|type 2 diabetes
5275135|NCT02302469|Lenalidomide|lenalidomide
5275136|NCT02302469|Hematology|hematology
5275137|NCT02302469|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5275138|NCT02302456|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
5275139|NCT02302456|tranexamic acid|tranexamic acid
5275140|NCT02302456|prevention|prevention
5275141|NCT02302430|Cohesion|cohesion
5275142|NCT02302430|Oxytocin|oxytocin
5275143|NCT02302430|Trust|trust
5275144|NCT02302430|Virtual-reality|virtual-reality
5275146|NCT02302417|Asthma-COPD Overlap Syndrome|asthma-copd overlap syndrome
5275147|NCT02302417|Clinical Questionnaire|clinical questionnaire
5275148|NCT02302417|COPD|copd
5275149|NCT02302417|ACOS|acos
5275150|NCT02302404|FTIH|ftih
5275151|NCT02302404|pharmacodynamics|pharmacodynamics
5275152|NCT02302404|pharmacokinetics|pharmacokinetics
5275153|NCT02302404|GSK2982772|gsk2982772
5275154|NCT02302404|safety|safety
5275155|NCT02302404|Repeat dose|repeat dose
5275156|NCT02302404|tolerability|tolerability
5275157|NCT02302378|Hypotension|hypotension
5275158|NCT02302378|Anesthesia, Spinal [E03.155.086.331]|anesthesia, spinal [e03.155.086.331]
5275159|NCT02302365|white blood cell depletion|white blood cell depletion
5275160|NCT02302365|apheresis|apheresis
5275161|NCT02302352|Probiotics|probiotics
5275162|NCT02302352|Immune system|immune system
5275163|NCT02302339|Advanced melanoma|advanced melanoma
5275164|NCT02302339|Unresectable melanoma|unresectable melanoma
5275165|NCT02302339|Metastatic melanoma|metastatic melanoma
5275166|NCT02302339|Targeted Treatment for melanoma|targeted treatment for melanoma
5275167|NCT02302339|GPNMB|gpnmb
5275168|NCT02302339|CDX-011|cdx-011
5275169|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin
5275170|NCT02302339|Antibody-drug-conjugate|antibody-drug-conjugate
5275171|NCT02302339|Skin neoplasm|skin neoplasm
5275172|NCT02302339|Varlilumab|varlilumab
5275173|NCT02302339|CDX-1127|cdx-1127
5275182|NCT02302313|healthy volunteers|healthy volunteers
5275183|NCT02302313|critical awareness|critical awareness
5275184|NCT02302313|hypnosis|hypnosis
5275185|NCT02302313|Analgesia Nociception Index|analgesia nociception index
5275186|NCT02302313|numerical verbal scale|numerical verbal scale
5275187|NCT02302313|Determine the validity of the index (ANI)|determine the validity of the index (ani)
5275188|NCT02302313|nociception in critical awareness|nociception in critical awareness
5275189|NCT02302300|Cardiac surgery|cardiac surgery
5275190|NCT02302300|Preventive non-invasive ventilation|preventive non-invasive ventilation
5275191|NCT02302287|Chronic kidney disease|chronic kidney disease
5275192|NCT02302287|mediterranean diet|mediterranean diet
5275193|NCT02302287|low-protein diet|low-protein diet
5275194|NCT02302287|ketoacids|ketoacids
5275195|NCT02302287|intestinal microbiota|intestinal microbiota
5275196|NCT02302274|Brugada Syndrome|brugada syndrome
5275197|NCT02302274|ARVC|arvc
5275198|NCT02302274|flecainide|flecainide
5275199|NCT02302274|ST elevation|st elevation
5275200|NCT02302261|Pulsus paradoxus|pulsus paradoxus
5275201|NCT02302235|Glioblastoma multigorme|glioblastoma multigorme
5275202|NCT02302235|Ketogenic Diet|ketogenic diet
5275203|NCT02302235|radiotherapy|radiotherapy
5275204|NCT02302235|chemotherapy|chemotherapy
5275205|NCT02302235|safety|safety
5275206|NCT02302235|efficiency|efficiency
5275207|NCT02302209|oxytocin|oxytocin
5275208|NCT02302209|schizophrenia|schizophrenia
5275209|NCT02302209|autism spectrum disorder|autism spectrum disorder
5275210|NCT02302183|Hypoxemic, Respiratory distress, infant|hypoxemic, respiratory distress, infant
5275211|NCT02302157|Cervical spinal cord injury|cervical spinal cord injury
5275213|NCT02302157|SCiStar|scistar
5275214|NCT02302157|OPC1|opc1
5275215|NCT02302157|Neural cell|neural cell
5275216|NCT02302157|Trauma spinal cord|trauma spinal cord
5275217|NCT02302157|stemcell transplant|stemcell transplant
5275218|NCT02302157|Cervical spine injury|cervical spine injury
5275219|NCT02302157|Paralysis|paralysis
5275220|NCT02302157|Quadriplegia|quadriplegia
5275221|NCT02302157|Tetraplegia|tetraplegia
5275222|NCT02302157|Spine injury|spine injury
5275223|NCT02302157|oligodendrocyte progenitor cell|oligodendrocyte progenitor cell
5275224|NCT02302157|Subacute spinal cord injury|subacute spinal cord injury
5275225|NCT02302144|Postural Instability (falling)|postural instability (falling)
5275226|NCT02302144|Gait Disturbances (e.g., freezing)|gait disturbances (e.g., freezing)
5275227|NCT02302144|Bradykinesia (slowness of movement), rigidity|bradykinesia (slowness of movement), rigidity
5275228|NCT02302118|esophageal carcinoma|esophageal carcinoma
5275229|NCT02302118|kardia carcinoma|kardia carcinoma
5275230|NCT02302092|Drug Therapy|drug therapy
5275231|NCT02302079|ASP8232|asp8232
5275232|NCT02302079|Diabetes Mellitus|diabetes mellitus
5275233|NCT02302079|ranibizumab|ranibizumab
5275234|NCT02302079|Diabetic Macular Edema|diabetic macular edema
5275236|NCT02302053|Hair thinning, hair loss, alopecia, women, oral supplement|hair thinning, hair loss, alopecia, women, oral supplement
5275237|NCT02302040|Adolescent|adolescent
5275238|NCT02302027|withdrawal therapy|withdrawal therapy
5275239|NCT02302027|oxygen therapy|oxygen therapy
5275240|NCT02302001|Breast augmentation|breast augmentation
5275241|NCT02302001|Breast implants|breast implants
5275242|NCT02302001|Silicone implants|silicone implants
5275243|NCT02302001|Breast surgery|breast surgery
5275244|NCT02301975|Adult|adult
5275245|NCT02301975|asthma|asthma
5275246|NCT02301975|Fluticasone Propionate|fluticasone propionate
5275247|NCT02301975|Adolescents|adolescents
5275248|NCT02301975|Salmeterol|salmeterol
5275250|NCT02301975|ELLIPTA|ellipta
5275251|NCT02301975|ACCUHALER/DISKUS|accuhaler/diskus
5144463|NCT03088891|diet|diet
5275252|NCT02301975|Non-inferior|non-inferior
5275253|NCT02301975|Fluticasone Furoate|fluticasone furoate
5275254|NCT02301962|panitumumab|panitumumab
5275255|NCT02301962|previously treated|previously treated
5275256|NCT02301962|metastatic colorectal cancer|metastatic colorectal cancer
5275257|NCT02301962|fully human antibody|fully human antibody
5275258|NCT02301962|wild-type KRAS and wild-type NRAS|wild-type kras and wild-type nras
5275259|NCT02301949|gastrointestinal bleeding|gastrointestinal bleeding
5275260|NCT02301949|vascular malformation|vascular malformation
5275261|NCT02301949|thalidomide retreatment|thalidomide retreatment
5275262|NCT02301936|Sickle Cell Disease|sickle cell disease
5275263|NCT02301936|Gilead|gilead
5275264|NCT02301936|Hepatitis C|hepatitis c
5275265|NCT02301923|Continuous Positive Airway Pressure|continuous positive airway pressure
5275266|NCT02301910|Myocardial Infarction|myocardial infarction
5275267|NCT02301910|Fibrinolysis|fibrinolysis
5275268|NCT02301910|Fortelyzin|fortelyzin
5275269|NCT02301871|MNP|mnp
5275270|NCT02301871|MET|met
5275271|NCT02301871|Soft tissue mobilization|soft tissue mobilization
5275272|NCT02301871|DNF|dnf
5275273|NCT02301871|Static Stretching|static stretching
5275274|NCT02301858|molecular pathology|molecular pathology
5275275|NCT02301858|functional genomics|functional genomics
5275276|NCT02301858|lung cancer|lung cancer
5275277|NCT02301858|primary tumor|primary tumor
5275278|NCT02301858|metastases|metastases
5275279|NCT02301845|Respiration, artificial|respiration, artificial
5275280|NCT02301832|acute compartment swelling (ACS)|acute compartment swelling (acs)
5275281|NCT02301832|near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5275282|NCT02301767|MRI|mri
5275283|NCT02301767|Risk Factor|risk factor
5275284|NCT02301767|background Parenchymal Enhancement|background parenchymal enhancement
5275285|NCT02301767|(IMAGINE) Study|(imagine) study
5275286|NCT02301741|chronic low back pain|chronic low back pain
5275287|NCT02301728|breast milk|breast milk
5275288|NCT02301728|short chain fatty acids|short chain fatty acids
5275289|NCT02301728|maternal diet|maternal diet
5275290|NCT02301715|Intranasal oxytocin|intranasal oxytocin
5275291|NCT02301715|Emotion regulation|emotion regulation
5275292|NCT02301715|Attachment|attachment
5275293|NCT02301702|Maternal Immunization|maternal immunization
5275294|NCT02301702|Tdap|tdap
5275295|NCT02301702|Td|td
5275296|NCT02301702|Pertussis|pertussis
5275297|NCT02301689|Heart failure|heart failure
5275298|NCT02301689|Chronic heart failure|chronic heart failure
5275299|NCT02301689|Sleep disordered breathing|sleep disordered breathing
5275300|NCT02301689|Sleep apnea|sleep apnea
5275301|NCT02301689|Positive Airway Pressure|positive airway pressure
5275302|NCT02301676|Geriatrics; Cognitive impairment; Interviews, Telephone|geriatrics; cognitive impairment; interviews, telephone
5275303|NCT02301650|Hepatitis B virus|hepatitis b virus
5275304|NCT02301650|pregnancy|pregnancy
5275305|NCT02301650|nucleoside (acid) analogs|nucleoside (acid) analogs
5275306|NCT02301650|children|children
5275307|NCT02301650|safety|safety
5275314|NCT02301598|atomic-force microscopy|atomic-force microscopy
5275315|NCT02301585|shock, septic|shock, septic
5275316|NCT02301585|hemodynamics|hemodynamics
5275317|NCT02301585|algorithms|algorithms
5275318|NCT02301533|HIV infection|hiv infection
5275319|NCT02301533|antiretroviral therapy|antiretroviral therapy
5275320|NCT02301533|adherence|adherence
5275321|NCT02301533|men who have sex with men|men who have sex with men
5275322|NCT02301520|Vitamin D|vitamin d
5275323|NCT02301520|Iodine|iodine
5275324|NCT02301520|Lead|lead
5275325|NCT02301520|Thyroid function|thyroid function
5275326|NCT02301520|point-of-care test|point-of-care test
5275327|NCT02301494|CTCL|ctcl
5275328|NCT02301494|Mycosis Fungoides|mycosis fungoides
5275329|NCT02301494|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5275330|NCT02301494|MF|mf
5275331|NCT02301494|topical therapy|topical therapy
5275332|NCT02301494|early stage|early stage
5275333|NCT02301455|hypertension treatment|hypertension treatment
5275334|NCT02301455|stroke prevention|stroke prevention
5275335|NCT02301403|smoking|smoking
5275336|NCT02301403|cessation|cessation
5275337|NCT02301403|tobacco|tobacco
5275338|NCT02301390|INTERVENE|intervene
5275339|NCT02301390|Ventricular tachycardia|ventricular tachycardia
5275340|NCT02301390|India|india
5275341|NCT02301364|Buparlisib (BKM120)|buparlisib (bkm120)
5275342|NCT02301364|14-177|14-177
5275343|NCT02301338|Videoconferencing|videoconferencing
5275344|NCT02301338|Following Surgery|following surgery
5275345|NCT02301338|14-213|14-213
5275346|NCT02301299|stroke|stroke
5275347|NCT02301299|barriers|barriers
5275348|NCT02301299|community|community
5275349|NCT02301286|Acetylsalicylic acid|acetylsalicylic acid
5275350|NCT02301286|Colon cancer|colon cancer
5275352|NCT02301273|Intensive care unit|intensive care unit
5275353|NCT02301273|Physiotherapy|physiotherapy
5275354|NCT02301273|Upright position|upright position
5275355|NCT02301273|Exercise|exercise
5275356|NCT02301273|Long term follow up of ICU survivors|long term follow up of icu survivors
5275361|NCT02301247|Multiple Sclerosis, Progressive|multiple sclerosis, progressive
5275362|NCT02301247|cognition|cognition
5275363|NCT02301247|memory|memory
5275364|NCT02301247|treatment|treatment
5275365|NCT02301234|Osteoarthritis|osteoarthritis
5275366|NCT02301234|Pain|pain
5275367|NCT02301234|Fulranumab|fulranumab
5275368|NCT02301234|JNJ-42160443|jnj-42160443
5275369|NCT02301234|Adjunctive therapy|adjunctive therapy
5275370|NCT02301234|Celecoxib|celecoxib
5275371|NCT02301234|Hip|hip
5275372|NCT02301234|Knee|knee
5275373|NCT02301234|Joint replacement surgery|joint replacement surgery
5275374|NCT02301221|Fecal Microbiota Transplantation|fecal microbiota transplantation
5275375|NCT02301221|Slow Transit Constipation|slow transit constipation
5275376|NCT02301221|Colonic motility|colonic motility
5275378|NCT02301169|Pain|pain
5275379|NCT02301143|Pancreatic Neoplasms|pancreatic neoplasms
5275380|NCT02301143|Pancreatic Cancer|pancreatic cancer
5275381|NCT02301143|Locally advanced pacriatic cancer|locally advanced pacriatic cancer
5275382|NCT02301143|nab-Paclitaxel|nab-paclitaxel
5275383|NCT02301143|Abraxane|abraxane
5275384|NCT02301143|Gemcitabine|gemcitabine
5275385|NCT02301143|ABI-007|abi-007
5275386|NCT02301130|advanced solid tumors|advanced solid tumors
5275387|NCT02301130|solid tumors|solid tumors
5275388|NCT02301130|mogamulizumab|mogamulizumab
5275389|NCT02301130|MEDI4736 (Durvalumab)|medi4736 (durvalumab)
5275390|NCT02301130|Tremelimumab|tremelimumab
5275391|NCT02301130|POTELIGEO®|poteligeo®
5275392|NCT02301130|KW-0761|kw-0761
5275393|NCT02301117|Renal|renal
5275394|NCT02301117|Kidney Diseases|kidney diseases
5275395|NCT02301117|Urologic Diseases|urologic diseases
5275396|NCT02301117|Renal Insufficiency|renal insufficiency
5275397|NCT02301117|Renal Impairment|renal impairment
5275398|NCT02301117|Pharmacokinetics|pharmacokinetics
5275399|NCT02301117|Advance Solid Tumor|advance solid tumor
5275400|NCT02301117|Creatinine Clearance|creatinine clearance
5275401|NCT02301117|Kidney Neoplasms|kidney neoplasms
5275402|NCT02301117|Renal Tumor|renal tumor
5275403|NCT02301117|Kidney|kidney
5275404|NCT02301117|Urology|urology
5275405|NCT02301117|Pharmacologic Action|pharmacologic action
5275406|NCT02301104|Liver Neoplasms|liver neoplasms
5275407|NCT02301104|Hepatic|hepatic
5275408|NCT02301104|TAS-102|tas-102
5275409|NCT02301104|mCRC|mcrc
5275410|NCT02301104|Liver Impairment|liver impairment
5275411|NCT02301104|Pharmacologic Actions|pharmacologic actions
5275412|NCT02301104|Liver Diseases|liver diseases
5275413|NCT02301104|Liver|liver
5275414|NCT02301104|LFT|lft
5275415|NCT02301104|Advanced Solid Tumor|advanced solid tumor
5275416|NCT02301104|Pharmacokinetics|pharmacokinetics
5275417|NCT02301091|HCC PVTT TACE RFA|hcc pvtt tace rfa
5275418|NCT02301078|Dupuytren disease|dupuytren disease
5275419|NCT02301078|needle aponeurotomy|needle aponeurotomy
5275420|NCT02301078|collagenase|collagenase
5275421|NCT02301065|Viral|viral
5275422|NCT02301065|Infection|infection
5275423|NCT02301065|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5275424|NCT02301052|hemorrhoids|hemorrhoids
5275425|NCT02301052|Allium Ampeloprasum|allium ampeloprasum
5275426|NCT02301052|herbal medicine|herbal medicine
5275427|NCT02301052|traditional persian medicine|traditional persian medicine
5275428|NCT02301000|Clostridium difficile|clostridium difficile
5275429|NCT02301000|Intestinal microbiota therapy|intestinal microbiota therapy
5275430|NCT02300987|Teratoma,|teratoma,
5275431|NCT02300987|Germ Cell tumor,|germ cell tumor,
5275432|NCT02300987|incurable teratoma,|incurable teratoma,
5275433|NCT02300987|CDK4/6,|cdk4/6,
5275434|NCT02300987|LEE011|lee011
5275435|NCT02300948|Pregnancy|pregnancy
5275436|NCT02300948|Perinatal Vitamins|perinatal vitamins
5275437|NCT02300948|folate|folate
5275438|NCT02300935|trametinib|trametinib
5275439|NCT02300935|nab-paclitaxel|nab-paclitaxel
5275440|NCT02300935|Mekinist|mekinist
5275441|NCT02300935|Abraxane|abraxane
5275442|NCT02300935|unresectable|unresectable
5275443|NCT02300935|metastatic|metastatic
5275444|NCT02300896|exercise|exercise
5275445|NCT02300896|physical fitness|physical fitness
5275446|NCT02300896|geriatrics|geriatrics
5275447|NCT02300870|Acute rejection, myocardial blood flow|acute rejection, myocardial blood flow
5275448|NCT02300831|NSCLC|nsclc
5275449|NCT02300831|Lung Cancer|lung cancer
5275450|NCT02300831|SELECT-1|select-1
5275451|NCT02300831|SELECT-2|select-2
5275452|NCT02300831|selumetinib|selumetinib
5275453|NCT02300831|biomarker|biomarker
5275454|NCT02300831|NIS|nis
5275455|NCT02300831|Observational study|observational study
5275456|NCT02300831|Disease registry|disease registry
5275457|NCT02300831|Clinical Outcomes|clinical outcomes
5275458|NCT02300818|Hipertension ocular, Glaucoma, Magnetotherapy, seawater|hipertension ocular, glaucoma, magnetotherapy, seawater
5275459|NCT02300805|Endometrial volume , VOCAL , Endometrial , Metrorrhagia|endometrial volume , vocal , endometrial , metrorrhagia
5275460|NCT02300792|honey, hepatitis A|honey, hepatitis a
5275461|NCT02300779|Colonoscopy|colonoscopy
5275462|NCT02300779|Diabetes Mellitus|diabetes mellitus
5275463|NCT02300779|Diet|diet
5275464|NCT02300779|Polyethylene glycols|polyethylene glycols
5275465|NCT02300779|Efficacy|efficacy
5275467|NCT02300766|Cerebellar Mutism Syndrome|cerebellar mutism syndrome
5275468|NCT02300766|Posterior Fossa Tumor|posterior fossa tumor
5275469|NCT02300766|Pediatric cancer|pediatric cancer
5275470|NCT02300766|Neurosurgical techniques|neurosurgical techniques
5275471|NCT02300727|Mucositis|mucositis
5275472|NCT02300727|Neoplasms|neoplasms
5275473|NCT02300727|CANCER|cancer
5275474|NCT02300727|Curcumin|curcumin
5275475|NCT02300727|Drug Therapy|drug therapy
5275476|NCT02300727|ANTINEOPLASTIC AGENTS|antineoplastic agents
5275477|NCT02300675|therapeutic patient education|therapeutic patient education
5275478|NCT02300675|patient adherence|patient adherence
5275479|NCT02300675|empowerment|empowerment
5275480|NCT02300675|breast cancer|breast cancer
5275481|NCT02300675|oral adjuvant endocrine therapy|oral adjuvant endocrine therapy
5275482|NCT02300675|side effects|side effects
5275483|NCT02300636|Knee joint|knee joint
5275484|NCT02300636|Muscle strength|muscle strength
5275485|NCT02300636|anterior cruciate ligament|anterior cruciate ligament
5275486|NCT02300610|Ureteral Diseases|ureteral diseases
5275487|NCT02300610|Urinary Bladder Diseases|urinary bladder diseases
5275488|NCT02300610|Transitional Cell Carcinoma|transitional cell carcinoma
5275489|NCT02300610|Bladder|bladder
5275490|NCT02300610|Carcinoma|carcinoma
5275491|NCT02300610|Renal|renal
5275492|NCT02300610|Pelvis|pelvis
5275494|NCT02300610|Urethra|urethra
5275495|NCT02300597|ADHD|adhd
5275496|NCT02300597|Autism Spectrum Disorders|autism spectrum disorders
5275497|NCT02300597|controlled|controlled
5275498|NCT02300597|Internet based|internet based
5275499|NCT02300597|coaching|coaching
5275500|NCT02300558|Type 3 long QT syndrome (LQT3)|type 3 long qt syndrome (lqt3)
5275501|NCT02300558|Long QT syndrome|long qt syndrome
5275502|NCT02300558|Congenital long QT|congenital long qt
5275503|NCT02300558|Sudden cardiac death|sudden cardiac death
5275504|NCT02300532|Malignant Glioma|malignant glioma
5275505|NCT02300532|Glioblastoma Multiforme|glioblastoma multiforme
5275506|NCT02300519|Haemophilia|haemophilia
5275507|NCT02300519|numerical models|numerical models
5275508|NCT02300519|thrombin generation|thrombin generation
5275509|NCT02300519|volunteers|volunteers
5275510|NCT02300519|endogenous thrombin potential|endogenous thrombin potential
5275511|NCT02300506|Malignant Glioma|malignant glioma
5275512|NCT02300506|Glioblastoma multiforme|glioblastoma multiforme
5275513|NCT02300493|among college students|among college students
5275514|NCT02300480|pain|pain
5275515|NCT02300480|calot's triangle|calot's triangle
5275516|NCT02300480|local block|local block
5275517|NCT02300480|analgesia|analgesia
5275518|NCT02300480|patient controlled intravenous analgesia|patient controlled intravenous analgesia
5275519|NCT02300454|in-stent restenosis|in-stent restenosis
5275520|NCT02300454|percutaneous coronary intervention|percutaneous coronary intervention
5275521|NCT02300454|balloon|balloon
5275522|NCT02300428|iron deficiency|iron deficiency
5275523|NCT02300389|high risk prostate cancer radiotherapy hypofractionation|high risk prostate cancer radiotherapy hypofractionation
5275524|NCT02300376|GFR|gfr
5275525|NCT02300376|Bayesian model|bayesian model
5275526|NCT02300376|plasma clearance|plasma clearance
5275527|NCT02300376|Calcium edetate de sodium|calcium edetate de sodium
5275528|NCT02300376|Inulin|inulin
5275529|NCT02300337|laryngeal tube|laryngeal tube
5275530|NCT02300337|cuff pressure|cuff pressure
5275531|NCT02300337|leakage|leakage
5275532|NCT02300337|laryngeal mask|laryngeal mask
5275533|NCT02300324|bioavailability|bioavailability
5275534|NCT02300324|Beneforte|beneforte
5275535|NCT02300324|sulforaphane|sulforaphane
5275536|NCT02300272|Practice-related learning|practice-related learning
5275537|NCT02300272|Sleep|sleep
5275538|NCT02300272|Pain|pain
5275539|NCT02300272|Circadian Rhythm|circadian rhythm
5275540|NCT02300272|Older Adults|older adults
5275541|NCT02300246|alveolar socket preservation|alveolar socket preservation
5275542|NCT02300246|tooth extraction|tooth extraction
5275543|NCT02300246|platelet concentrates|platelet concentrates
5275544|NCT02300246|growth factors|growth factors
5275545|NCT02300220|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5275546|NCT02300207|Electroacupuncture|electroacupuncture
5275547|NCT02300207|Cardiovascular function|cardiovascular function
5275548|NCT02300207|Orthostatic tolerance|orthostatic tolerance
5275549|NCT02300207|Head-down bed rest|head-down bed rest
5275550|NCT02300194|Pain management|pain management
5275551|NCT02300168|bariatric surgery; neuromuscular blockade|bariatric surgery; neuromuscular blockade
5275552|NCT02300155|Pregnancy|pregnancy
5275553|NCT02300155|Morning Sickness|morning sickness
5275554|NCT02300155|nausea and vomiting|nausea and vomiting
5275555|NCT02300155|hyperemesis gravidarum|hyperemesis gravidarum
5275556|NCT02300155|perinatal vitamins|perinatal vitamins
5275557|NCT02300142|HSV|hsv
5275558|NCT02300142|Herpes|herpes
5275559|NCT02300142|genital infection|genital infection
5275560|NCT02300142|vaccine|vaccine
5275561|NCT02300090|COPD, Exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough|copd, exacerbation, respiratory disease, lung disease, breathlessness, dyspnoea, sputum, wheezing, cough
5275569|NCT02300012|Anterior cruciate ligament|anterior cruciate ligament
5275570|NCT02300012|Performance based investigations|performance based investigations
5275571|NCT02299973|irritable bowel syndrome|irritable bowel syndrome
5275572|NCT02299973|fecal microbiota transplantation|fecal microbiota transplantation
5275573|NCT02299973|bloating|bloating
5275574|NCT02299960|EndoPAT|endopat
5275575|NCT02299960|NICOM|nicom
5275576|NCT02299960|circulating endothelial cells|circulating endothelial cells
5275577|NCT02299908|Hernia, Inguinal|hernia, inguinal
5275578|NCT02299908|Herniorrhaphy|herniorrhaphy
5275579|NCT02299908|Abdominal Wall|abdominal wall
5275580|NCT02299908|Analgesia|analgesia
5275581|NCT02299908|Pain, Postoperative|pain, postoperative
5275582|NCT02299895|setting approach|setting approach
5275583|NCT02299895|health promotion|health promotion
5275584|NCT02299895|organization|organization
5275585|NCT02299895|implementation research|implementation research
5275586|NCT02299895|qualitative study|qualitative study
5275587|NCT02299895|comparison|comparison
5275588|NCT02299882|Posterior spine surgery|posterior spine surgery
5275589|NCT02299882|infection|infection
5275590|NCT02299882|vancomycin|vancomycin
5275591|NCT02299882|surgical wound infection|surgical wound infection
5275592|NCT02299856|Magnetic Resonance Imaging|magnetic resonance imaging
5275593|NCT02299856|Diagnostic Imaging|diagnostic imaging
5275595|NCT02299843|ALPPS|alpps
5275596|NCT02299843|hepatectomy|hepatectomy
5275597|NCT02299843|morbidity and mortality|morbidity and mortality
5275598|NCT02299830|neoplasm|neoplasm
5275599|NCT02299830|central airway|central airway
5275600|NCT02299830|obstruction|obstruction
5275601|NCT02299791|clinic-level interventions|clinic-level interventions
5275602|NCT02299791|quality improvement|quality improvement
5275603|NCT02299791|translational medical research|translational medical research
5275604|NCT02299791|community health centers|community health centers
5445380|NCT01522092|Exacerbations|exacerbations
5275605|NCT02299765|Advanced Non-small Cell Lung Cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
5275606|NCT02299765|EGFR Mutation|egfr mutation
5275607|NCT02299765|gefitinib|gefitinib
5275608|NCT02299765|chemotherapy|chemotherapy
5275609|NCT02299739|Herbal Medicine|herbal medicine
5275800|NCT02298673|Biomarker|biomarker
5275615|NCT02299726|emergency department|emergency department
5275616|NCT02299713|acupuncture|acupuncture
5275617|NCT02299713|knee pain|knee pain
5275618|NCT02299700|Janssen Autism Knowledge Engine|janssen autism knowledge engine
5275619|NCT02299700|Autism Spectrum Disorder|autism spectrum disorder
5275620|NCT02299661|Hypoxia inducible factor prolyl hydroxylase inhibitor.|hypoxia inducible factor prolyl hydroxylase inhibitor.
5275621|NCT02299661|Erythropoietin stimulating agent|erythropoietin stimulating agent
5275622|NCT02299661|Chronic renal disease|chronic renal disease
5275623|NCT02299661|renal anemia|renal anemia
5275624|NCT02299635|PF-03084014|pf-03084014
5275625|NCT02299635|Notch Alterations|notch alterations
5275626|NCT02299609|C14.280.647.500|c14.280.647.500
5275627|NCT02299596|Colorectal neoplasm|colorectal neoplasm
5275628|NCT02299596|Physical activity|physical activity
5275629|NCT02299583|prevention|prevention
5275630|NCT02299583|early intervention|early intervention
5275631|NCT02299583|trauma-informed practice|trauma-informed practice
5275632|NCT02299570|Clostridium difficile|clostridium difficile
5275633|NCT02299570|C diff|c diff
5275634|NCT02299570|CDI|cdi
5275635|NCT02299570|CDAD|cdad
5275636|NCT02299570|Fecal transplant|fecal transplant
5275637|NCT02299570|Fecal Microbiota Transplant|fecal microbiota transplant
5275638|NCT02299570|Diarrhea|diarrhea
5275639|NCT02299570|FMT|fmt
5275640|NCT02299570|Microbiota restoration therapy|microbiota restoration therapy
5275641|NCT02299570|Microbiota suspension|microbiota suspension
5275642|NCT02299570|Fecal bacteriotherapy|fecal bacteriotherapy
5275643|NCT02299570|C diff diarrhea|c diff diarrhea
5275650|NCT02299492|Mental Health Services|mental health services
5275651|NCT02299479|insulin pump|insulin pump
5275652|NCT02299479|continuous glucose monitor|continuous glucose monitor
5275653|NCT02299479|activity monitor|activity monitor
5275654|NCT02299466|parenteral nutrition|parenteral nutrition
5275655|NCT02299466|complications|complications
5275656|NCT02299466|indications|indications
5275657|NCT02299466|long-term administration|long-term administration
5275658|NCT02299466|HTPN|htpn
5275659|NCT02299453|Telemedicine|telemedicine
5275660|NCT02299453|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
5849060|NCT00031369|Brain Morphology|brain morphology
5275668|NCT02299401|Pregnancy test|pregnancy test
5275669|NCT02299401|Semi-quantitative pregnancy test|semi-quantitative pregnancy test
5275670|NCT02299388|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5275671|NCT02299388|Hypertension|hypertension
5275672|NCT02299388|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5275673|NCT02299388|Endothelial Dysfunction|endothelial dysfunction
5275674|NCT02299388|Pulse pressure|pulse pressure
5275675|NCT02299388|Renin-angiotensin system|renin-angiotensin system
5275676|NCT02299388|heart rate variability|heart rate variability
5275677|NCT02299375|Phase II clinical study|phase ii clinical study
5275679|NCT02299375|exacerbations|exacerbations
5275680|NCT02299375|COPD|copd
5275681|NCT02299375|eosinophil sub-group|eosinophil sub-group
5275682|NCT02299362|Early Onset Scoliosis|early onset scoliosis
5275684|NCT02299362|Pulmonary function|pulmonary function
5275685|NCT02299362|Infantile Idiopathic Scoliosis|infantile idiopathic scoliosis
5275686|NCT02299362|MCGR|mcgr
5275687|NCT02299362|Magnetically controlled growing rods|magnetically controlled growing rods
5275688|NCT02299362|Growing rods|growing rods
5275689|NCT02299362|Growth friendly spine surgery|growth friendly spine surgery
5275690|NCT02299362|Cast|cast
5275691|NCT02299310|Chronic kidney disease, Anti-hypertensive drugs|chronic kidney disease, anti-hypertensive drugs
5275692|NCT02299297|Alopecia Areata|alopecia areata
5275693|NCT02299284|Spastic|spastic
5275694|NCT02299284|Hemiplegia|hemiplegia
5275695|NCT02299245|telomere|telomere
5275696|NCT02299245|telomerase|telomerase
5275697|NCT02299245|statin|statin
5275698|NCT02299245|percutaneous coronary intervention|percutaneous coronary intervention
5275699|NCT02299245|acute coronary syndrome|acute coronary syndrome
5275700|NCT02299232|dexmedetomidine|dexmedetomidine
5275701|NCT02299232|sedation|sedation
5275702|NCT02299232|MRI|mri
5275703|NCT02299219|Adolescent|adolescent
5275704|NCT02299219|Internet Self-Management|internet self-management
5275705|NCT02299219|Managing Cancer|managing cancer
5275706|NCT02299193|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5275719|NCT02299089|neuroendocrine tumour (NET)|neuroendocrine tumour (net)
5275721|NCT02299089|octreotide|octreotide
5275722|NCT02299089|Sandostatin LAR|sandostatin lar
5275723|NCT02299076|Tobacco smoking cessation|tobacco smoking cessation
5275724|NCT02299076|Motivation|motivation
5275725|NCT02299063|Mitochondria|mitochondria
5275726|NCT02299063|Dexmedetomidine|dexmedetomidine
5275727|NCT02299063|Heart Defects, Congenital|heart defects, congenital
5275728|NCT02299050|Type 2 Diabetes|type 2 diabetes
5275729|NCT02299050|T2DM|t2dm
5275730|NCT02299050|Cycloset|cycloset
5275731|NCT02299050|Glycemic Control|glycemic control
5275732|NCT02299050|GLP-1|glp-1
5275733|NCT02299024|opioids|opioids
5275734|NCT02299024|health literacy|health literacy
5275735|NCT02299011|Biomatrix drug eluting stent|biomatrix drug eluting stent
5275736|NCT02299011|Orsiro drug eluting stent|orsiro drug eluting stent
5275737|NCT02299011|Coronary artery disease|coronary artery disease
5275738|NCT02298985|curcumin; schizophrenia; neuroprotection|curcumin; schizophrenia; neuroprotection
5275739|NCT02298946|Anti-PD1 Therapy|anti-pd1 therapy
5275740|NCT02298946|Anti-Tumor Immunity|anti-tumor immunity
5275741|NCT02298946|Liver Metastatic|liver metastatic
5275742|NCT02298946|B7-DC Fc Fusion Protein|b7-dc fc fusion protein
5275743|NCT02298933|Complement Inhibition|complement inhibition
5275744|NCT02298933|Platelet Refractoriness|platelet refractoriness
5275745|NCT02298933|Eculizumab|eculizumab
5275751|NCT02298894|Low Density Lipoprotein (LDL)|low density lipoprotein (ldl)
5275752|NCT02298894|Lipoprotein|lipoprotein
5275753|NCT02298894|Nuclear Magnetic Resonance (NMR)|nuclear magnetic resonance (nmr)
5275754|NCT02298894|Vertical Auto Profile (VAP)|vertical auto profile (vap)
5275755|NCT02298894|Ion mobility|ion mobility
5275756|NCT02298894|Apoliproprotein B (ApoB)|apoliproprotein b (apob)
5275757|NCT02298881|Dry Eye|dry eye
5275758|NCT02298881|Microbiome|microbiome
5275759|NCT02298855|Gynaecological cancer|gynaecological cancer
5275760|NCT02298855|Nurse-led care|nurse-led care
5275761|NCT02298855|Aftercare|aftercare
5275762|NCT02298855|Patient self-management|patient self-management
5275763|NCT02298855|Quality of life|quality of life
5275764|NCT02298855|Relapse free interval|relapse free interval
5275765|NCT02298855|Watch and wait|watch and wait
5275766|NCT02298842|Healthy Adults|healthy adults
5275767|NCT02298829|curvature|curvature
5275768|NCT02298829|bend|bend
5275781|NCT02298790|Dietary Habits|dietary habits
5275782|NCT02298790|Circadian|circadian
5275783|NCT02298790|Metabolism|metabolism
5275784|NCT02298790|Feeding Behavior|feeding behavior
5275785|NCT02298738|Atrial fibrillation, hypertension, vitamin D|atrial fibrillation, hypertension, vitamin d
5275786|NCT02298725|Insulin Resistance|insulin resistance
5275787|NCT02298725|Obesity|obesity
5275788|NCT02298725|US Dietary Guidelines|us dietary guidelines
5275789|NCT02298712|Iduronidase|iduronidase
5275790|NCT02298712|Lysosomal Storage Diseases|lysosomal storage diseases
5275791|NCT02298712|Genetic Diseases, Inborn|genetic diseases, inborn
5275792|NCT02298712|Biomarker|biomarker
5275793|NCT02298712|Hurler-Scheie Syndrome|hurler-scheie syndrome
5275795|NCT02298699|Sly Disease|sly disease
5275796|NCT02298699|Biomarker|biomarker
5275797|NCT02298686|Sanfilippo Disease Type A-B-C-D|sanfilippo disease type a-b-c-d
5275798|NCT02298686|Biomarker|biomarker
5275799|NCT02298673|Mucolipidosis Disorder type I,II,III, IV|mucolipidosis disorder type i,ii,iii, iv
5275801|NCT02298660|Autonomic Dysreflexia|autonomic dysreflexia
5275802|NCT02298660|Spinal Cord Injury|spinal cord injury
5275803|NCT02298660|OnabotulinumtoxinA|onabotulinumtoxina
5275804|NCT02298660|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5275805|NCT02298660|Urodynamics|urodynamics
5275806|NCT02298660|Cardiovascular|cardiovascular
5275807|NCT02298660|Quality of Life|quality of life
5275808|NCT02298660|Blood Pressure|blood pressure
5275809|NCT02298660|24 Hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
5275810|NCT02298647|Gangliosidosis|gangliosidosis
5275811|NCT02298647|Biomarker|biomarker
5275812|NCT02298634|Lysosomal Storage Diseases|lysosomal storage diseases
5275813|NCT02298634|Lipogranulomatosis|lipogranulomatosis
5275814|NCT02298634|Farber disease|farber disease
5275815|NCT02298634|Biomarker|biomarker
5275816|NCT02298608|Renal mass|renal mass
5275817|NCT02298608|Kidney cancer|kidney cancer
5275818|NCT02298608|Irreversibel Electroporation|irreversibel electroporation
5275819|NCT02298608|Ablation|ablation
5275820|NCT02298608|Safety|safety
5275821|NCT02298608|Efficacy|efficacy
5275822|NCT02298608|IRE|ire
5275823|NCT02298595|Carcinoma|carcinoma
5275824|NCT02298595|Squamous|squamous
5275825|NCT02298595|Oropharyngeal|oropharyngeal
5275826|NCT02298595|HPV|hpv
5275827|NCT02298595|Resectable|resectable
5275828|NCT02298582|safety|safety
5275829|NCT02298582|procedural pain|procedural pain
5275830|NCT02298582|intranasal fentanyl|intranasal fentanyl
5275831|NCT02298582|elderly|elderly
5275832|NCT02298569|patient discharge|patient discharge
5275833|NCT02298569|hospital readmission|hospital readmission
5275834|NCT02298569|postnatal care|postnatal care
5275835|NCT02298569|Home Care Services|home care services
5275836|NCT02298569|Cost-Benefit Analysis|cost-benefit analysis
5275837|NCT02298569|Personal satisfaction|personal satisfaction
5275838|NCT02298569|Community Care Networks|community care networks
5275839|NCT02298556|Hypertension|hypertension
5275840|NCT02298556|Diabetes Mellitus|diabetes mellitus
5275841|NCT02298556|ACE Inhibitors|ace inhibitors
5275842|NCT02298556|Calcium Channel Blockers|calcium channel blockers
5275843|NCT02298517|Morbid obesity|morbid obesity
5275844|NCT02298517|bariatric surgery|bariatric surgery
5275845|NCT02298517|Respiratory muscle endurance|respiratory muscle endurance
5275846|NCT02298517|Respiratory muscle strength|respiratory muscle strength
5275847|NCT02298517|spirometry|spirometry
5275848|NCT02298517|physiotherapy|physiotherapy
5275849|NCT02298478|Self-help|self-help
5275850|NCT02298478|Computer-aided Treatment|computer-aided treatment
5275851|NCT02298478|Internet|internet
5275852|NCT02298478|Flying phobia|flying phobia
5275853|NCT02298478|minimal contact therapies|minimal contact therapies
5275854|NCT02298478|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
5275855|NCT02298478|Waiting list control group|waiting list control group
5275856|NCT02298465|ESWL|eswl
5275857|NCT02298465|distal ureteric stone|distal ureteric stone
5275858|NCT02298465|transgluteal|transgluteal
5275859|NCT02298465|supine ESWL|supine eswl
5275860|NCT02298439|NAFLD|nafld
5275861|NCT02298426|Body Constitution Classification|body constitution classification
5275862|NCT02298426|Health Management|health management
5275863|NCT02298426|Obese Population|obese population
5275864|NCT02298374|Rehabilitation|rehabilitation
5275865|NCT02298374|Evaluation studies|evaluation studies
5275866|NCT02298374|Home care services|home care services
5275867|NCT02298361|Adolescent|adolescent
5275868|NCT02298361|Child|child
5275869|NCT02298361|Child Health Services/organization & administration*|child health services/organization & administration*
5275870|NCT02298361|Child, Preschool|child, preschool
5275871|NCT02298361|Cohort Studies|cohort studies
5275872|NCT02298361|Community Health Centers/organization & administration|community health centers/organization & administration
5275873|NCT02298361|Community Health Centers/standards|community health centers/standards
5275874|NCT02298361|Electronic Health Records|electronic health records
5275875|NCT02298361|Feasibility Studies|feasibility studies
5275876|NCT02298361|Female|female
5275877|NCT02298361|Health Services Accessibility/economics|health services accessibility/economics
5275878|NCT02298361|Humans|humans
5275879|NCT02298361|Infant|infant
5275880|NCT02298361|Infant, Newborn|infant, newborn
5275881|NCT02298361|Insurance Coverage|insurance coverage
5275882|NCT02298361|Insurance Coverage/statistics & numerical data|insurance coverage/statistics & numerical data
5275883|NCT02298361|Insurance Coverage/trends|insurance coverage/trends
5275884|NCT02298361|Insurance, Health|insurance, health
5275885|NCT02298361|Insurance, Health/legislation & jurisprudence|insurance, health/legislation & jurisprudence
5275886|NCT02298361|Insurance, Health/statistics & numerical data|insurance, health/statistics & numerical data
5275887|NCT02298361|Insurance, Health/trends|insurance, health/trends
5275888|NCT02298361|Logistic Models|logistic models
5272892|NCT02315222|Nutriomics|nutriomics
5275891|NCT02298361|Medicaid|medicaid
5275892|NCT02298361|Medicaid/statistics & numerical data|medicaid/statistics & numerical data
5275893|NCT02298361|Medicaid/trends|medicaid/trends
5275894|NCT02298361|Medicaid/utilization|medicaid/utilization
5275895|NCT02298361|Medically Uninsured|medically uninsured
5276278|NCT02295956|Walking|walking
5275896|NCT02298361|Medicare/statistics & numerical data|medicare/statistics & numerical data
5275897|NCT02298361|Medicare/trends|medicare/trends
5275898|NCT02298361|Medicare/utilization|medicare/utilization
5275899|NCT02298361|Multivariate Analysis|multivariate analysis
5275900|NCT02298361|Oregon|oregon
5275901|NCT02298361|Patient Protection and Affordable Care Act|patient protection and affordable care act
5275902|NCT02298361|Patient-Centered Care|patient-centered care
5275903|NCT02298361|Pediatrics/legislation & jurisprudence|pediatrics/legislation & jurisprudence
5275904|NCT02298361|Pediatrics/standards|pediatrics/standards
5275905|NCT02298361|Population Surveillance/methods|population surveillance/methods
5275906|NCT02298361|Primary Health Care/economics|primary health care/economics
5275907|NCT02298361|Quality Assurance, Health Care/legislation & jurisprudence|quality assurance, health care/legislation & jurisprudence
5275908|NCT02298361|Quality Assurance, Health Care/methods|quality assurance, health care/methods
5275909|NCT02298361|Quality Indicators, Health Care|quality indicators, health care
5275910|NCT02298361|Retrospective Studies|retrospective studies
5275911|NCT02298361|Socioeconomic Factors|socioeconomic factors
5275912|NCT02298361|United States|united states
5275913|NCT02298361|Young Adult|young adult
5275914|NCT02298348|Neuroblastoma|neuroblastoma
5275916|NCT02298348|Sorafenib|sorafenib
5275917|NCT02298348|Relapse|relapse
5275918|NCT02298335|Prednisone|prednisone
5275919|NCT02298335|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5275920|NCT02298335|prospective|prospective
5275922|NCT02298309|HIV|hiv
5275923|NCT02298309|Test and Treat|test and treat
5275924|NCT02298309|Linkage|linkage
5275925|NCT02298283|Hodgkin lymphoma|hodgkin lymphoma
5275926|NCT02298283|HL|hl
5275927|NCT02298283|brentuximab vedotin|brentuximab vedotin
5275928|NCT02298270|Neurofibromatosis|neurofibromatosis
5275929|NCT02298270|NF I|nf i
5275930|NCT02298270|NF 2|nf 2
5275931|NCT02298270|Schwannomatosis|schwannomatosis
5275932|NCT02298270|Stress Management|stress management
5275933|NCT02298270|Resiliency|resiliency
5275934|NCT02298270|Skype|skype
5275935|NCT02298244|Pulmonary Hypertension|pulmonary hypertension
5275936|NCT02298244|Atrial Fibrillation|atrial fibrillation
5275937|NCT02298244|Pulmonary Arterial Denervation|pulmonary arterial denervation
5275938|NCT02298244|Safety|safety
5275939|NCT02298244|Pulmonary Arterial GP Ablation|pulmonary arterial gp ablation
5275940|NCT02298231|Traumatic Brain Injury|traumatic brain injury
5275941|NCT02298231|Balance|balance
5275942|NCT02298231|TBI|tbi
5275943|NCT02298231|Veterans|veterans
5275944|NCT02298231|Virtual Reality|virtual reality
5275945|NCT02298179|Antibodies|antibodies
5275946|NCT02298179|Respiratory syncytial virus|respiratory syncytial virus
5275947|NCT02298179|Safety|safety
5275948|NCT02298179|Healthy adults|healthy adults
5275949|NCT02298179|Immunogenicity|immunogenicity
5275950|NCT02298166|Acute myeloid leukemia|acute myeloid leukemia
5275952|NCT02298166|Crenolanib|crenolanib
5275953|NCT02298166|Relapsed|relapsed
5275954|NCT02298166|Refractory|refractory
5275955|NCT02298140|SMS reminders|sms reminders
5275956|NCT02298140|Provider's compliance|provider's compliance
5275957|NCT02298140|malaria|malaria
5275958|NCT02298127|smoking cessation|smoking cessation
5275959|NCT02298127|auricular acupressure|auricular acupressure
5275960|NCT02298127|primary care settings|primary care settings
5275961|NCT02298127|randomized controlled trial|randomized controlled trial
5275962|NCT02298114|electrical stimulation|electrical stimulation
5275963|NCT02298114|intensive care unit|intensive care unit
5275964|NCT02298114|muscular atrophy|muscular atrophy
5275965|NCT02298101|Aerosol delivery|aerosol delivery
5275966|NCT02298101|Lung deposition|lung deposition
5275967|NCT02298101|SPECT|spect
5275968|NCT02298101|subjects|subjects
5275969|NCT02298075|Immune thrombocytopenia|immune thrombocytopenia
5275970|NCT02298075|Primary|primary
5275971|NCT02298075|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
5275972|NCT02298062|Kawasaki disease coronary artery lesion, IVIG- resistant, Infliximab|kawasaki disease coronary artery lesion, ivig- resistant, infliximab
5275973|NCT02298049|fMRI|fmri
5275974|NCT02298049|reward|reward
5275975|NCT02298049|satiation|satiation
5275976|NCT02298036|Health Anxiety|health anxiety
5275977|NCT02298036|Urgent Care|urgent care
5275983|NCT02297997|cetylpyridinium chloride|cetylpyridinium chloride
5275985|NCT02297984|HIF-α|hif-α
5275986|NCT02297984|Acute ischemic stroke|acute ischemic stroke
5275987|NCT02297984|Prognosis|prognosis
5275988|NCT02297932|Exercise|exercise
5275989|NCT02297919|Web-based education, Adolescent, Obesity|web-based education, adolescent, obesity
5275990|NCT02297906|Intranasal|intranasal
5275991|NCT02297906|Ketorolac|ketorolac
5275992|NCT02297906|Pharmacokinetics|pharmacokinetics
5275993|NCT02297906|Pediatric|pediatric
5276682|NCT02293746|surgery|surgery
5275995|NCT02297815|antibiotic use|antibiotic use
5275996|NCT02297815|effectiveness|effectiveness
5275997|NCT02297815|acute respiratory infections|acute respiratory infections
5275998|NCT02297815|pediatrics|pediatrics
5275999|NCT02297776|cardiac arrest|cardiac arrest
5276000|NCT02297776|biomarker|biomarker
5276001|NCT02297776|microRNA|microrna
5276004|NCT02297776|CPC|cpc
5276005|NCT02297750|The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.|the focus of the study is double-wire technique versus single wire technique in patients undergoing ercp with biliary cannulation as the primary objective.
5276006|NCT02297737|Tai Chi|tai chi
5276007|NCT02297698|Breast cancer, NeuVax|breast cancer, neuvax
5276008|NCT02297685|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5276009|NCT02297685|Interferential currents therapy|interferential currents therapy
5276010|NCT02297685|Therapeutic exercises|therapeutic exercises
5276011|NCT02297685|Low back pain|low back pain
5276012|NCT02297685|Rehabilitation|rehabilitation
5276013|NCT02297672|breast cancer|breast cancer
5276014|NCT02297672|brachytherapy|brachytherapy
5276015|NCT02297672|partial breast radiotherapy|partial breast radiotherapy
5276016|NCT02297672|palladium 103|palladium 103
5276017|NCT02297659|damage control|damage control
5276018|NCT02297659|resuscitation|resuscitation
5276019|NCT02297659|laparotomy|laparotomy
5276020|NCT02297646|Prevention|prevention
5276021|NCT02297646|Exercise|exercise
5276022|NCT02297646|Health|health
5276023|NCT02297646|Endurance|endurance
5276024|NCT02297633|COPD|copd
5276025|NCT02297633|reactive oxygen metabolites|reactive oxygen metabolites
5276026|NCT02297620|SGLT-2 inhibitor|sglt-2 inhibitor
5276027|NCT02297620|Elderly patients|elderly patients
5276028|NCT02297620|ASP1941|asp1941
5276029|NCT02297607|Esophageal Cancer|esophageal cancer
5276030|NCT02297607|Esophagectomy|esophagectomy
5276031|NCT02297581|Geriatrics [MeSH]|geriatrics [mesh]
5276032|NCT02297581|Osteoporotic fractures [MeSH]|osteoporotic fractures [mesh]
5276033|NCT02297581|Hip fractures [MeSH]|hip fractures [mesh]
5276034|NCT02297581|Cost benefit analysis [MeSH]|cost benefit analysis [mesh]
5276035|NCT02297581|Quality of life [MeSH]|quality of life [mesh]
5276036|NCT02297581|Mortality [MeSH]|mortality [mesh]
5276037|NCT02297581|Complications|complications
5276038|NCT02297568|Breast-fed infant|breast-fed infant
5276039|NCT02297568|vitamin D supplementation|vitamin d supplementation
5276040|NCT02297568|Lactation|lactation
5276041|NCT02297555|Obesity|obesity
5276042|NCT02297555|Metabolic Syndrome|metabolic syndrome
5276043|NCT02297555|ENDOBARRIER®|endobarrier®
5276044|NCT02297542|Influenza Vaccine|influenza vaccine
5276045|NCT02297529|unresected, Melanoma, expanded access, EU|unresected, melanoma, expanded access, eu
5276046|NCT02297490|Environmental Exposure Chamber|environmental exposure chamber
5276047|NCT02297490|Specific Immunotherapy|specific immunotherapy
5276048|NCT02297490|SIT|sit
5276049|NCT02297490|SCIT|scit
5276050|NCT02297464|Risk|risk
5276051|NCT02297438|breast cancer|breast cancer
5276052|NCT02297438|postmenopausal women|postmenopausal women
5276177|NCT02296450|14-236|14-236
5276053|NCT02297438|estrogen-receptor positive|estrogen-receptor positive
5276054|NCT02297438|HER2 negative|her2 negative
5276055|NCT02297438|locoregionally recurrent|locoregionally recurrent
5276056|NCT02297438|metastatic|metastatic
5276057|NCT02297425|NSCLC, Non-Small Cell Lung Cancer, EGFRm, Epidermal Grown Factor Receptor mutation|nsclc, non-small cell lung cancer, egfrm, epidermal grown factor receptor mutation
5276058|NCT02297399|Colonoscopy|colonoscopy
5276059|NCT02297399|Diabetes Mellitus|diabetes mellitus
5276060|NCT02297399|Polyethylene glycols|polyethylene glycols
5276061|NCT02297399|Ascorbate|ascorbate
5276062|NCT02297399|Personal satisfaction|personal satisfaction
5276063|NCT02297386|[18F] Dihydro-testosterone|[18f] dihydro-testosterone
5276064|NCT02297386|PET Scan|pet scan
5276065|NCT02297386|MRI|mri
5276066|NCT02297386|14-185|14-185
5276067|NCT02297360|Hair loss, hair thinning, women, marine protein supplement|hair loss, hair thinning, women, marine protein supplement
5276069|NCT02297334|cytokines|cytokines
5276070|NCT02297334|inflammation|inflammation
5276071|NCT02297334|cardiac surgery|cardiac surgery
5276072|NCT02297334|extracorporeal bypass|extracorporeal bypass
5276073|NCT02297321|tattoos|tattoos
5276074|NCT02297321|laser|laser
5276075|NCT02297321|whitening|whitening
5276076|NCT02297321|patch|patch
5276077|NCT02297295|Sequelae of; Amputation, Traumatic, Limb, Lower|sequelae of; amputation, traumatic, limb, lower
5276080|NCT02297269|Deep vein thrombosis|deep vein thrombosis
5276081|NCT02297269|Surgery|surgery
5276082|NCT02297269|gastrointestinal malignancy|gastrointestinal malignancy
5276083|NCT02297230|Locally Advanced Breast Cancer|locally advanced breast cancer
5276084|NCT02297191|volunteer|volunteer
5276085|NCT02297191|pilot study|pilot study
5276086|NCT02297191|adults|adults
5276087|NCT02297165|anorexic|anorexic
5276088|NCT02297165|olfactory stimulation|olfactory stimulation
5276089|NCT02297165|autobiographical memories recovery|autobiographical memories recovery
5276090|NCT02297152|Premature ejaculation treatment|premature ejaculation treatment
5276092|NCT02297152|Intravaginal Ejaculatory Latency time|intravaginal ejaculatory latency time
5276093|NCT02297152|Masturbation aid|masturbation aid
5276094|NCT02297152|Ejaculatory disorders|ejaculatory disorders
5276095|NCT02297113|patients|patients
5276096|NCT02297113|departement|departement
5157152|NCT03009669|perfusion Index|perfusion index
5276097|NCT02297113|requiring Rapid Sequence Intubation (RSI)|requiring rapid sequence intubation (rsi)
5276098|NCT02297100|women|women
5276099|NCT02297100|interstitial cystitis|interstitial cystitis
5276100|NCT02297100|bladder pain syndrome|bladder pain syndrome
5276101|NCT02297100|botox|botox
5276102|NCT02297100|onabotulinum toxin A|onabotulinum toxin a
5276103|NCT02297074|Bread|bread
5276104|NCT02297074|Glycemic index|glycemic index
5276105|NCT02297074|Glycemic load|glycemic load
5276106|NCT02297074|Insulinemic index|insulinemic index
5276107|NCT02297074|Satiety|satiety
5276108|NCT02297074|Gastrointestinal hormones|gastrointestinal hormones
5276109|NCT02297061|Hip fracture|hip fracture
5276110|NCT02297061|Thrombelastography|thrombelastography
5276111|NCT02297061|Blood loss|blood loss
5276112|NCT02297048|Potassium intake|potassium intake
5276113|NCT02297048|Progesterone|progesterone
5276114|NCT02297048|steroidogenesis|steroidogenesis
5276115|NCT02297048|RU486|ru486
5276116|NCT02297048|Synachtene test|synachtene test
5276117|NCT02297022|Deep Brain Stimulation|deep brain stimulation
5276118|NCT02297022|obesity|obesity
5276119|NCT02297022|Prader-Willi syndrome|prader-willi syndrome
5276120|NCT02296996|BRAF V600|braf v600
5276121|NCT02296996|Rechallenge|rechallenge
5276122|NCT02296996|Combination|combination
5276123|NCT02296996|Dabrafenib|dabrafenib
5276124|NCT02296996|Trametinib|trametinib
5276125|NCT02296944|Childrens|childrens
5276126|NCT02296944|tempanoplasty|tempanoplasty
5276127|NCT02296944|tympanic membrane perforation|tympanic membrane perforation
5276128|NCT02296944|retrospective|retrospective
5276129|NCT02296944|cohort|cohort
5276130|NCT02296918|CLL|cll
5276131|NCT02296918|SLL|sll
5276132|NCT02296918|PLL|pll
5276133|NCT02296918|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5276134|NCT02296918|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5276135|NCT02296918|Prolymphocytic Leukemia|prolymphocytic leukemia
5276136|NCT02296918|ACP-196|acp-196
5276137|NCT02296918|acalabrutinib|acalabrutinib
5276138|NCT02296918|obinutuzumab|obinutuzumab
5276139|NCT02296918|rituximab|rituximab
5276140|NCT02296918|venetoclax|venetoclax
5276141|NCT02296905|Hepatic Impairment|hepatic impairment
5276142|NCT02296905|Hepatitis C Virus Infection|hepatitis c virus infection
5276143|NCT02296892|Remimazolam, midazolam, bronchoscopy, procedural sedation|remimazolam, midazolam, bronchoscopy, procedural sedation
5276144|NCT02296853|Severe Hepatic Impairment|severe hepatic impairment
5276145|NCT02296840|analgesia|analgesia
5276146|NCT02296840|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5276147|NCT02296840|narcotic-containing pain medication|narcotic-containing pain medication
5276148|NCT02296788|Gut Microbiota|gut microbiota
5276149|NCT02296775|Rheumatoid arthritis|rheumatoid arthritis
5276150|NCT02296775|Rituximab|rituximab
5276151|NCT02296775|Pharmacokinetics|pharmacokinetics
5276152|NCT02296736|computerised tomography (CT) scan|computerised tomography (ct) scan
5276153|NCT02296736|diagnostic accuracy|diagnostic accuracy
5276154|NCT02296736|Pancreatic head malignancy|pancreatic head malignancy
5276155|NCT02296710|mitral valve|mitral valve
5276156|NCT02296710|valve surgery|valve surgery
5276157|NCT02296710|echocardiography|echocardiography
5276158|NCT02296697|Pressure Ulcer|pressure ulcer
5276159|NCT02296697|Low Level Laser Therapy|low level laser therapy
5276160|NCT02296697|Dressings|dressings
5276161|NCT02296632|Telemedicine|telemedicine
5276162|NCT02296632|Patient Reported Outcomes|patient reported outcomes
5276163|NCT02296593|lactate|lactate
5276164|NCT02296593|continuous lactate monitoring|continuous lactate monitoring
5276165|NCT02296593|continuous blood glucose monitoring|continuous blood glucose monitoring
5276166|NCT02296593|EIRUS|eirus
5276167|NCT02296593|blood glucose|blood glucose
5276168|NCT02296593|cardiac surgery|cardiac surgery
5276169|NCT02296593|central veinous catheter|central veinous catheter
5276170|NCT02296593|microdialysis|microdialysis
5276171|NCT02296554|SLAP Repair|slap repair
5276172|NCT02296554|Biceps Tenodesis|biceps tenodesis
5276173|NCT02296528|Feeding Tube Dependent|feeding tube dependent
5276174|NCT02296502|DSM Diagnosis|dsm diagnosis
5276175|NCT02296450|Quality of Life (QoL)|quality of life (qol)
5276176|NCT02296450|Assessment|assessment
5276178|NCT02296450|Patients and Survivors|patients and survivors
5276179|NCT02296424|Juvenile Rheumatoid arthritis (JRA) chronic|juvenile rheumatoid arthritis (jra) chronic
5276180|NCT02296424|systemic inflammatory disorder|systemic inflammatory disorder
5276181|NCT02296424|painful joints|painful joints
5276182|NCT02296424|inflammation of the synovial membrane|inflammation of the synovial membrane
5276183|NCT02296424|auto-immune rheumatoid disease|auto-immune rheumatoid disease
5276184|NCT02296424|reactive rheumatoid arthritis|reactive rheumatoid arthritis
5276232|NCT02296164|Valchlor|valchlor
5276233|NCT02296164|Dermatology|dermatology
5276234|NCT02296164|MF-CTCL|mf-ctcl
5276235|NCT02296164|Mycosis Fungoides|mycosis fungoides
5276236|NCT02296164|Oncology|oncology
5276238|NCT02296099|retropubic suburethral sling|retropubic suburethral sling
5276239|NCT02296099|stress urinary incontinence|stress urinary incontinence
5157291|NCT03008915|Emphysema|emphysema
5276240|NCT02296099|liposomal bupivacaine|liposomal bupivacaine
5276241|NCT02296086|Geriatrics [MeSH]|geriatrics [mesh]
5276242|NCT02296086|Hip fractures [MeSH]|hip fractures [mesh]
5276243|NCT02296086|China [MeSH]|china [mesh]
5276244|NCT02296086|Early ambulation [MeSH]|early ambulation [mesh]
5276245|NCT02296086|Immobilization [MeSH]|immobilization [mesh]
5276246|NCT02296073|Pediatric intensive care unit|pediatric intensive care unit
5276247|NCT02296073|Sedation|sedation
5276248|NCT02296073|Dexmedetomidine|dexmedetomidine
5276249|NCT02296073|mechanical ventilation|mechanical ventilation
5276250|NCT02296047|COPD, central drive, bronchodilators|copd, central drive, bronchodilators
5276251|NCT02296021|helicobacter pylori|helicobacter pylori
5276252|NCT02296021|berberine-containing quadruple therapy|berberine-containing quadruple therapy
5276253|NCT02296021|bismuth-containing quadruple therapy|bismuth-containing quadruple therapy
5276254|NCT02296008|high resolution manometry|high resolution manometry
5276255|NCT02296008|children|children
5276256|NCT02296008|congenital anorectal disorder|congenital anorectal disorder
5276257|NCT02296008|surgery|surgery
5276258|NCT02295995|Aged|aged
5276259|NCT02295995|Exercise|exercise
5276260|NCT02295995|Veterans|veterans
5276261|NCT02295995|Adherence|adherence
5276262|NCT02295995|Clinical Trials, Randomized|clinical trials, randomized
5276263|NCT02295982|Laparoscopic nephrectomy|laparoscopic nephrectomy
5276264|NCT02295982|one day surgery|one day surgery
5276265|NCT02295969|Rhinitis|rhinitis
5276266|NCT02295969|Conjunctivitis|conjunctivitis
5276267|NCT02295969|Grass pollen|grass pollen
5276268|NCT02295969|Sublingual tablet|sublingual tablet
5276269|NCT02295969|Allergen immunotherapy|allergen immunotherapy
5276270|NCT02295969|Safety|safety
5276271|NCT02295956|Pancreatic Cancer|pancreatic cancer
5276272|NCT02295956|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5276273|NCT02295956|Preoperative therapy|preoperative therapy
5276274|NCT02295956|Questionnaires|questionnaires
5276275|NCT02295956|Surveys|surveys
5276276|NCT02295956|Exercises|exercises
5276277|NCT02295956|Stretching|stretching
5276279|NCT02295956|Nutrition counseling|nutrition counseling
5276280|NCT02295956|Resistance exercise bands|resistance exercise bands
5276281|NCT02295956|Phone calls|phone calls
5276282|NCT02295956|Booklet|booklet
5276283|NCT02295956|Pamphlet|pamphlet
5276284|NCT02295930|colorectal cancer,|colorectal cancer,
5276285|NCT02295930|bevacizumab|bevacizumab
5276286|NCT02295930|cetuximab|cetuximab
5276287|NCT02295930|folfoxiri|folfoxiri
5276288|NCT02295930|kras wild type|kras wild type
5276290|NCT02295904|videoanalysis|videoanalysis
5276291|NCT02295865|Psoriasis|psoriasis
5276292|NCT02295865|Toreforant|toreforant
5276293|NCT02295865|JNJ-38518168|jnj-38518168
5276294|NCT02295852|Low-sodium calcium enriched diet|low-sodium calcium enriched diet
5276295|NCT02295852|Low-sodium diet|low-sodium diet
5276296|NCT02295852|Glucose and lipid metabolims|glucose and lipid metabolims
5276297|NCT02295839|Sleep|sleep
5276298|NCT02295839|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5276299|NCT02295839|Fatigue|fatigue
5276300|NCT02295839|Sleep hygiene|sleep hygiene
5276301|NCT02295839|Relaxation|relaxation
5276302|NCT02295839|RCT|rct
5276303|NCT02295800|HIV|hiv
5276304|NCT02295800|PMTCT|pmtct
5276305|NCT02295800|Antenatal Care|antenatal care
5276306|NCT02295787|Depression|depression
5276307|NCT02295787|Suicide|suicide
5276308|NCT02295787|Suicidal Ideation|suicidal ideation
5276309|NCT02295787|Ketamine|ketamine
5276310|NCT02295787|Late-Life|late-life
5276311|NCT02295761|motor activity|motor activity
5276312|NCT02295761|obesity|obesity
5276313|NCT02295761|overweight|overweight
5276314|NCT02295761|intervention study|intervention study
5276315|NCT02295761|health promotion|health promotion
5276316|NCT02295761|lifestyle counseling|lifestyle counseling
5276318|NCT02295735|Skin, safety, wounds, intensive care|skin, safety, wounds, intensive care
5276319|NCT02295722|eligible for high-dose therapy and stem cell transplantation|eligible for high-dose therapy and stem cell transplantation
5276320|NCT02295709|ultrasound|ultrasound
5276321|NCT02295709|cervical Transformational Epidural Steroid Injection|cervical transformational epidural steroid injection
5276322|NCT02295696|Adults, dialogue tools, outpatient clinic visits|adults, dialogue tools, outpatient clinic visits
5276323|NCT02295644|Therapeutic ultrasound|therapeutic ultrasound
5276324|NCT02295592|hemorrhoids|hemorrhoids
5276325|NCT02295592|The recurrence rate|the recurrence rate
5276326|NCT02295592|PPH|pph
5276327|NCT02295592|TSTstarr+|tststarr+
5276328|NCT02295566|Nitric Oxide|nitric oxide
5276329|NCT02295566|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5276330|NCT02295566|Biofilm|biofilm
5276331|NCT02295553|Ketamine|ketamine
5276332|NCT02295553|Propofol|propofol
5276333|NCT02295553|Children|children
5276334|NCT02295553|Pediatrics|pediatrics
5276335|NCT02295553|Upper endoscopy|upper endoscopy
5276336|NCT02295514|Sepsis|sepsis
5276337|NCT02295514|Septic shock|septic shock
5276338|NCT02295501|Pathogen inactivation|pathogen inactivation
5276340|NCT02295501|convalescent plasma|convalescent plasma
5276341|NCT02295501|EBOV|ebov
5276342|NCT02295501|amotosalen|amotosalen
5276343|NCT02295501|Provide access to the potential therapeutic benefit of EBOV convalescent plasma containing antibodies to EBOV.|provide access to the potential therapeutic benefit of ebov convalescent plasma containing antibodies to ebov.
5276344|NCT02295488|hymenoptera puncture|hymenoptera puncture
5276345|NCT02295475|Apixaban|apixaban
5276346|NCT02295475|Eliquis|eliquis
5276347|NCT02295462|nursing homes|nursing homes
5276348|NCT02295462|person-centered care|person-centered care
5276349|NCT02295462|inappropriate prescriptions|inappropriate prescriptions
5276350|NCT02295462|cluster-randomised controlled trial|cluster-randomised controlled trial
5276351|NCT02295462|antipsychotic drugs|antipsychotic drugs
5276352|NCT02295449|Prostate cancer|prostate cancer
5276353|NCT02295449|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5276354|NCT02295436|minodronic acid|minodronic acid
5276355|NCT02295436|pharmacokinetics|pharmacokinetics
5276356|NCT02295436|tolerability|tolerability
5276357|NCT02295436|food|food
5276358|NCT02295436|age|age
5276359|NCT02295436|Chinese subjects|chinese subjects
5276360|NCT02295410|Assessment, PTSD, Veterans|assessment, ptsd, veterans
5276361|NCT02295397|Food provocation|food provocation
5276362|NCT02295397|Matrix effect|matrix effect
5276364|NCT02295397|Allergy|allergy
5276365|NCT02295397|Proton Pump Inhibitor|proton pump inhibitor
5276366|NCT02295384|Polypharmacy|polypharmacy
5276367|NCT02295384|Medication Therapy Management|medication therapy management
5276368|NCT02295371|Drug therapy|drug therapy
5276369|NCT02295371|Patient safety|patient safety
5276370|NCT02295371|Polydrug therapy|polydrug therapy
5276371|NCT02295319|Discharge|discharge
5276372|NCT02295319|Acute Admission Unit|acute admission unit
5276373|NCT02295319|Randomized Controlled Trial|randomized controlled trial
5276374|NCT02295306|OSA, polysomnography, ExSpiron monitor|osa, polysomnography, exspiron monitor
5276375|NCT02295293|Rhus|rhus
5276376|NCT02295293|Cholesterol|cholesterol
5276377|NCT02295293|Triglycerides|triglycerides
5276378|NCT02295293|Lipids|lipids
5276379|NCT02295293|Medicine, Traditional|medicine, traditional
5276380|NCT02295293|Herbal medicine|herbal medicine
5276381|NCT02295280|headache|headache
5276382|NCT02295267|Food allergy|food allergy
5276383|NCT02295267|Walnut|walnut
5276384|NCT02295267|Components|components
5276385|NCT02295267|Allergens|allergens
5276386|NCT02295241|Sarcopenia, muscles, aging|sarcopenia, muscles, aging
5276387|NCT02295228|Vitamin D, Vitamin D deficiency, Hip Arthroplasty|vitamin d, vitamin d deficiency, hip arthroplasty
5276388|NCT02295215|chagas disease|chagas disease
5276389|NCT02295215|exercise|exercise
5276390|NCT02295215|baroreflex sensitivity|baroreflex sensitivity
5276391|NCT02295163|Stellate ganglion block|stellate ganglion block
5276392|NCT02295163|hot flushes|hot flushes
5276393|NCT02295163|androgen deprivation therapy|androgen deprivation therapy
5276394|NCT02295163|prostate cancer|prostate cancer
5276395|NCT02295150|Nadroparin|nadroparin
5276396|NCT02295150|Anti-Xa activity|anti-xa activity
5276398|NCT02295111|electro-acupuncture|electro-acupuncture
5276399|NCT02295111|chronic pelvic pain|chronic pelvic pain
5276400|NCT02295111|patient practitioner interactions|patient practitioner interactions
5276401|NCT02295111|TCM health consultation|tcm health consultation
5276402|NCT02295111|meridian balanced method acupuncture|meridian balanced method acupuncture
5276403|NCT02295085|Cohort, Prospective, Biospecimens|cohort, prospective, biospecimens
5276404|NCT02295072|Exercise-based Randomized Controlled Trial|exercise-based randomized controlled trial
5276405|NCT02295072|Brain structure|brain structure
5276406|NCT02295072|Brain function|brain function
5276407|NCT02295072|Cognitive function|cognitive function
5276408|NCT02295072|Physical fitness|physical fitness
5276409|NCT02295072|Body Mass Index|body mass index
5276410|NCT02295072|Cardiovascular disease risk factors|cardiovascular disease risk factors
5276411|NCT02295072|Mental health|mental health
5276412|NCT02295072|Stress|stress
5276413|NCT02295072|Neurology|neurology
5276414|NCT02295072|Obesity|obesity
5276415|NCT02295072|brain|brain
5276416|NCT02295072|risk factors|risk factors
5276417|NCT02295072|bone|bone
5276418|NCT02295072|bones|bones
5276419|NCT02295072|body composition|body composition
5276420|NCT02295059|Breast cancer|breast cancer
5276421|NCT02295059|ERPR negative|erpr negative
5276422|NCT02295059|HER-2/neu overexpression positive or negative|her-2/neu overexpression positive or negative
5276423|NCT02295033|Boost versus no boost irradiation of early breast cancer|boost versus no boost irradiation of early breast cancer
5276424|NCT02294955|catheter ablation|catheter ablation
5276425|NCT02294955|atrial fibrillation|atrial fibrillation
5276427|NCT02294942|RANCAD|rancad
5276428|NCT02294929|catheter ablation|catheter ablation
5276429|NCT02294929|cryoballoon|cryoballoon
5276430|NCT02294903|Focal radiofrequency ablation|focal radiofrequency ablation
5276431|NCT02294903|Prostate cancer|prostate cancer
5276432|NCT02294903|Encage|encage
5276433|NCT02294864|focus: pulsed radiofrequency (E02.779.468.599)|focus: pulsed radiofrequency (e02.779.468.599)
5276434|NCT02294825|deep endometriosis;|deep endometriosis;
5276435|NCT02294825|colorectal endometriosis|colorectal endometriosis
5276436|NCT02294825|surgery|surgery
5276437|NCT02294825|medical treatment|medical treatment
5276438|NCT02294825|fertility|fertility
5276439|NCT02294812|Hearing Loss|hearing loss
5276440|NCT02294812|Speech Perception|speech perception
5276441|NCT02294812|Cognitive Training|cognitive training
5276442|NCT02294812|Cognitive Fitness|cognitive fitness
5276443|NCT02294812|Memory, Short-Term|memory, short-term
5276444|NCT02294799|Temporomandibular Joint Disorders|temporomandibular joint disorders
5276445|NCT02294799|Magnetic Ressonance Imaging|magnetic ressonance imaging
5276446|NCT02294799|Complementary Therapy|complementary therapy
5276447|NCT02294799|Physical Therapy Modalities.|physical therapy modalities.
5276448|NCT02294786|Randomised|randomised
5276449|NCT02294786|Octreotide|octreotide
5276450|NCT02294786|Diarrhoea|diarrhoea
5276451|NCT02294786|Phase II|phase ii
5276452|NCT02294786|Capecitabine|capecitabine
5276453|NCT02294786|Quality of life|quality of life
5276454|NCT02294786|Metastatic breast cancer|metastatic breast cancer
5276455|NCT02294786|HER2|her2
5276456|NCT02294786|Lapatinib|lapatinib
5276457|NCT02294786|Diarrhoea diary|diarrhoea diary
5276458|NCT02294773|Infertility|infertility
5276459|NCT02294773|Intrauterine insemination|intrauterine insemination
5276460|NCT02294773|Luteinizing hormone surge|luteinizing hormone surge
5276461|NCT02294760|Irritable Bowel Syndrome|irritable bowel syndrome
5276462|NCT02294760|Sacral Nerve Stimulation|sacral nerve stimulation
5276463|NCT02294760|Symptoms|symptoms
5276464|NCT02294760|Quality of Life|quality of life
5276465|NCT02294734|functional respiratory capacity|functional respiratory capacity
5276466|NCT02294734|High-resolution computed tomography|high-resolution computed tomography
5276467|NCT02294734|GSK2269557|gsk2269557
5276468|NCT02294734|acute exacerbation of COPD|acute exacerbation of copd
5276469|NCT02294734|lung capacity|lung capacity
5276470|NCT02294708|macula-off retinal detachment|macula-off retinal detachment
5276471|NCT02294708|scleral buckle|scleral buckle
5276472|NCT02294708|persistent sub-foveal fluid|persistent sub-foveal fluid
5276473|NCT02294708|postoperative postures|postoperative postures
5276474|NCT02294708|optical coherence tomography (OCT)|optical coherence tomography (oct)
5276475|NCT02294695|Empiric antibiotic therapy|empiric antibiotic therapy
5276476|NCT02294682|uncomplicated urogenital gonorrhea|uncomplicated urogenital gonorrhea
5276477|NCT02294682|Bacterial Type II Topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
5276478|NCT02294682|antibiotics|antibiotics
5276479|NCT02294682|GSK2140944|gsk2140944
5276480|NCT02294682|N. gonorrhoeae|n. gonorrhoeae
5276481|NCT02294656|CYSTOID MACULAR EDEMA|cystoid macular edema
5276482|NCT02294643|sarpogrelate|sarpogrelate
5276483|NCT02294591|Bipolar Disorder|bipolar disorder
5276484|NCT02294591|Depression|depression
5276485|NCT02294591|Acetylcystein|acetylcystein
5276486|NCT02294591|Oxidative Stress|oxidative stress
5276487|NCT02294591|Urine|urine
5276488|NCT02294578|Biomarkers|biomarkers
5276489|NCT02294578|saliva|saliva
5276490|NCT02294578|mRNA|mrna
5276491|NCT02294565|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5276492|NCT02294565|Breast Cancer|breast cancer
5276493|NCT02294565|Lymphatic Mapping|lymphatic mapping
5276494|NCT02294552|Cyclophosphamide|cyclophosphamide
5276495|NCT02294552|Leukemia|leukemia
5276496|NCT02294552|Lymphoma|lymphoma
5276497|NCT02294552|Myelodysplastic Syndromes|myelodysplastic syndromes
5276498|NCT02294552|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5276499|NCT02294552|Immunosuppressive Agents|immunosuppressive agents
5276500|NCT02294552|Immune System Diseases|immune system diseases
5276501|NCT02294552|Busulfan|busulfan
5276502|NCT02294552|Fludarabine|fludarabine
5276503|NCT02294552|Tacrolimus|tacrolimus
5276504|NCT02294552|Mycophenolate mofetil|mycophenolate mofetil
5276505|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5276506|NCT02294552|Myeloablative Agonists|myeloablative agonists
5276507|NCT02294552|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5276508|NCT02294552|Allogeneic|allogeneic
5276509|NCT02294526|Diet|diet
5276510|NCT02294526|Sardine|sardine
5276511|NCT02294526|Type 2 diabetes|type 2 diabetes
5276512|NCT02294513|Alzheimer disease|alzheimer disease
5276513|NCT02294513|Dementia|dementia
5276514|NCT02294513|Hearing loss|hearing loss
5276515|NCT02294513|Correction of hearing impairment|correction of hearing impairment
5276516|NCT02294513|Hearing aids|hearing aids
5276517|NCT02294513|Communication|communication
5276518|NCT02294513|Family caregivers|family caregivers
5276519|NCT02294513|Third-party disability|third-party disability
5276520|NCT02294500|ovarian function|ovarian function
5276521|NCT02294500|female|female
5276522|NCT02294500|Genital Function|genital function
5276523|NCT02294487|influenza|influenza
5276524|NCT02294487|pneumococcal|pneumococcal
5276525|NCT02294487|pneumonia|pneumonia
5276526|NCT02294487|vaccine|vaccine
5276527|NCT02294487|immunization|immunization
5276528|NCT02294487|#CAImmun|#caimmun
5276529|NCT02294487|Immuno-oncology|immuno-oncology
5276530|NCT02294487|supportive care|supportive care
5276531|NCT02294487|vaccination|vaccination
5276532|NCT02294487|meningococcal|meningococcal
5276534|NCT02294461|Enzalutamide|enzalutamide
5276535|NCT02294461|Androgen receptor|androgen receptor
5276536|NCT02294461|Prostate cancer|prostate cancer
5276537|NCT02294461|Xtandi|xtandi
5276538|NCT02294448|Cervical radiculopathy|cervical radiculopathy
5276539|NCT02294448|Neck pain|neck pain
5276540|NCT02294448|Qishe pill|qishe pill
5276541|NCT02294448|raditional Chinese medicine|raditional chinese medicine
5276542|NCT02294448|healthy Chinese subject|healthy chinese subject
5276543|NCT02294448|Population Pharmacokinetics|population pharmacokinetics
5276544|NCT02294448|Personalized Medicine|personalized medicine
5276545|NCT02294448|Individualized Medicine|individualized medicine
5276546|NCT02294435|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
5276547|NCT02294435|Endovascular|endovascular
5276548|NCT02294435|Ps-ide|ps-ide
5276549|NCT02294435|Early Feasibility|early feasibility
5276550|NCT02294435|Aneurysm|aneurysm
5276551|NCT02294435|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
5276552|NCT02294435|Aortic Aneurysm|aortic aneurysm
5276553|NCT02294435|Aortic Diseases|aortic diseases
5276554|NCT02294435|Cardiovascular Diseases|cardiovascular diseases
5276555|NCT02294435|Vascular Diseases|vascular diseases
5276556|NCT02294435|Pararenal aneurysm|pararenal aneurysm
5276557|NCT02294435|Juxtarenal aneurysm|juxtarenal aneurysm
5276558|NCT02294435|Aortic dissection|aortic dissection
5276559|NCT02294435|Short neck infrarenal aneurysm|short neck infrarenal aneurysm
5276560|NCT02294435|Type 4 thoracoabdominal|type 4 thoracoabdominal
5276562|NCT02294422|Loss of resistance|loss of resistance
5276563|NCT02294422|Pilot balloon|pilot balloon
5276564|NCT02294422|Cuff pressure|cuff pressure
5276565|NCT02294422|Endotracheal tube|endotracheal tube
5276566|NCT02294409|social anxiety|social anxiety
5276567|NCT02294409|psychosis|psychosis
5276569|NCT02294409|randomized|randomized
5276571|NCT02294396|Anticholinergic|anticholinergic
5276572|NCT02294396|Overactive Bladder (OAB)|overactive bladder (oab)
5276573|NCT02294396|Mirabegron|mirabegron
5276574|NCT02294396|YM178|ym178
5276575|NCT02294383|Pelvic Floor Biomechanics|pelvic floor biomechanics
5276576|NCT02294383|Tissue Elasticity|tissue elasticity
5276577|NCT02294383|Tactile Imaging|tactile imaging
5276578|NCT02294370|type 2 diabetes|type 2 diabetes
5276579|NCT02294370|continuous glucose monitoring|continuous glucose monitoring
5276580|NCT02294357|carfilzomib|carfilzomib
5276581|NCT02294357|proteasome inhibitor|proteasome inhibitor
5276582|NCT02294357|multiple myeloma|multiple myeloma
5276583|NCT02294357|relapsed/refractory|relapsed/refractory
5276584|NCT02294344|double filtration plasmapheresis|double filtration plasmapheresis
5276585|NCT02294344|ANCA-Associated Vasculitis|anca-associated vasculitis
5276586|NCT02294305|Depression|depression
5276587|NCT02294305|Social Anxiety|social anxiety
5276588|NCT02294305|Social Phobia|social phobia
5276589|NCT02294305|Major Depression|major depression
5276590|NCT02294305|Vortioxetine|vortioxetine
5276591|NCT02294279|cough, wheeze, dyspnoea|cough, wheeze, dyspnoea
5445381|NCT01522079|spinal muscular atrophy|spinal muscular atrophy
5276592|NCT02294240|Pregnant, malnourished, energy dense biscuits, low birth weight|pregnant, malnourished, energy dense biscuits, low birth weight
5276593|NCT02294227|AIN457|ain457
5276594|NCT02294227|psoriatic arthritis|psoriatic arthritis
5276595|NCT02294227|chronic inflammatory disease|chronic inflammatory disease
5276596|NCT02294227|loading regimen|loading regimen
5276597|NCT02294227|secukinumab|secukinumab
5276598|NCT02294227|self-injection|self-injection
5276599|NCT02294214|malaria|malaria
5276600|NCT02294214|Spatial Repellents|spatial repellents
5276601|NCT02294214|Plasmodium|plasmodium
5276602|NCT02294201|Malaria|malaria
5276603|NCT02294201|Spatial Repellents|spatial repellents
5276604|NCT02294201|Plasmodium|plasmodium
5276605|NCT02294188|Malaria|malaria
5276606|NCT02294188|Spatial Repellents|spatial repellents
5276607|NCT02294188|Plasmodium|plasmodium
5276608|NCT02294175|larva|larva
5276609|NCT02294175|debridement|debridement
5276610|NCT02294175|lower extremity or diabetic foot ulcer|lower extremity or diabetic foot ulcer
5276612|NCT02294175|infection|infection
5276613|NCT02294175|chronic wound|chronic wound
5276614|NCT02294149|chemotherapy|chemotherapy
5276615|NCT02294149|Omega 3|omega 3
5276616|NCT02294136|HIV|hiv
5276617|NCT02294136|HCV|hcv
5276618|NCT02294136|Adherence|adherence
5276619|NCT02294136|Psychiatric|psychiatric
5276620|NCT02294136|Behavioral|behavioral
5276621|NCT02294136|Intervention|intervention
5276622|NCT02294110|failure|failure
5276623|NCT02294110|spinal anesthesia|spinal anesthesia
5276624|NCT02294071|acetaminophen|acetaminophen
5276625|NCT02294071|ibuprofen|ibuprofen
5276626|NCT02294058|MS|ms
5276627|NCT02294058|RMS|rms
5276628|NCT02294058|Multiple Sclerosis|multiple sclerosis
5276629|NCT02294058|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5276630|NCT02294045|Knee|knee
5276631|NCT02294045|Healthy|healthy
5276632|NCT02294045|arthroscopy|arthroscopy
5276633|NCT02294045|MRI|mri
5276634|NCT02294045|amplification|amplification
5276635|NCT02294045|sounds|sounds
5276636|NCT02294045|pre-operative|pre-operative
5276637|NCT02294045|analyzing|analyzing
5276638|NCT02294032|Bcells|bcells
5276639|NCT02294032|kidney allograft dysfunction|kidney allograft dysfunction
5276640|NCT02294032|antibody mediated rejection|antibody mediated rejection
5276641|NCT02294019|ibuprofen 400 mg|ibuprofen 400 mg
5276642|NCT02294019|actual use|actual use
5276643|NCT02294019|compliance|compliance
5276644|NCT02294006|pancreatic|pancreatic
5276645|NCT02294006|neuroendocrine|neuroendocrine
5276646|NCT02294006|everolimus|everolimus
5276647|NCT02294006|metformin|metformin
5276648|NCT02294006|octreotide|octreotide
5276649|NCT02293941|liver inflammation|liver inflammation
5276650|NCT02293928|Hybrid coronary revascularization|hybrid coronary revascularization
5276651|NCT02293928|Antiplatelet therapy|antiplatelet therapy
5276652|NCT02293928|Aspirin|aspirin
5276653|NCT02293928|Clopidogrel|clopidogrel
5276654|NCT02293889|Knee osteoarthritis|knee osteoarthritis
5276655|NCT02293889|Pain|pain
5276656|NCT02293889|Vitamin D|vitamin d
5276657|NCT02293889|Physical activity|physical activity
5276658|NCT02293889|Pilot study|pilot study
5276659|NCT02293889|Qualitative Interview|qualitative interview
5276660|NCT02293889|Obesity|obesity
5276661|NCT02293889|Older adults|older adults
5276662|NCT02293876|Corneal Diseases|corneal diseases
5263982|NCT02366026|HIV|hiv
5276663|NCT02293876|Corneal Ulcer|corneal ulcer
5276664|NCT02293876|Nursing Diagnosis|nursing diagnosis
5276665|NCT02293876|Intensive Care Units|intensive care units
5276666|NCT02293876|Nursing|nursing
5276667|NCT02293876|Randomized Clinical Trial|randomized clinical trial
5276668|NCT02293837|interleukin-6 (IL-6) receptor inhibitor|interleukin-6 (il-6) receptor inhibitor
5276669|NCT02293824|Infant, Premature|infant, premature
5276670|NCT02293824|Caffeine|caffeine
5276671|NCT02293824|Pharmacokinetics|pharmacokinetics
5276672|NCT02293824|Metabolism|metabolism
5276673|NCT02293772|Bedrest|bedrest
5276674|NCT02293772|Appetite|appetite
5276675|NCT02293759|BPH- LASER- PROSTATE- BLEEDING TENDENCY|bph- laser- prostate- bleeding tendency
5276676|NCT02293746|Obstructive Sleep Apnea|obstructive sleep apnea
5276677|NCT02293746|OSA|osa
5276678|NCT02293746|neurostimulation|neurostimulation
5276679|NCT02293746|hypoglossal nerve|hypoglossal nerve
5276680|NCT02293746|tongue|tongue
5276681|NCT02293746|upper airway stimulation|upper airway stimulation
5276683|NCT02293733|Retrospective|retrospective
5276684|NCT02293733|EGFR|egfr
5276685|NCT02293733|mutation|mutation
5276687|NCT02293733|NSCLC|nsclc
5276688|NCT02293707|Castration-resistant prostate cancer|castration-resistant prostate cancer
5276689|NCT02293707|Therapeutic vaccine|therapeutic vaccine
5276690|NCT02293707|Telomerase vaccine|telomerase vaccine
5276691|NCT02293694|DMPA-SC: depo medroxyprogesterone acetate sub-cutaneous|dmpa-sc: depo medroxyprogesterone acetate sub-cutaneous
5276692|NCT02293694|DMPA-IM: depo medroxyprogesterone acetate intramuscular|dmpa-im: depo medroxyprogesterone acetate intramuscular
5276693|NCT02293681|Spondylitis, Ankylosing|spondylitis, ankylosing
5276694|NCT02293681|Infliximab|infliximab
5276695|NCT02293681|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5276696|NCT02293681|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
5276697|NCT02293668|poor responders|poor responders
5276698|NCT02293655|ADHD|adhd
5276699|NCT02293655|inattention|inattention
5276700|NCT02293655|hyperactivity|hyperactivity
5276701|NCT02293655|methylphenidate|methylphenidate
5276702|NCT02293642|primary cancers of the breast|primary cancers of the breast
5276703|NCT02293642|primary cancers of the kidney|primary cancers of the kidney
5276704|NCT02293642|primary cancers of the lung|primary cancers of the lung
5276705|NCT02293642|primary cancers of the prostate|primary cancers of the prostate
5276706|NCT02293629|Subjects|subjects
5276707|NCT02293616|ICU|icu
5276708|NCT02293616|Respiratory Failure|respiratory failure
5276709|NCT02293616|Weakness|weakness
5276710|NCT02293616|Nitrate supplementation|nitrate supplementation
5276711|NCT02293603|cardiomyopathy|cardiomyopathy
5276712|NCT02293603|cardiosphere-derived stem cells|cardiosphere-derived stem cells
5276713|NCT02293603|intracoronary infusion|intracoronary infusion
5276714|NCT02293603|adult stem cells|adult stem cells
5276715|NCT02293603|heart disease|heart disease
5276716|NCT02293603|ventricular dysfunction|ventricular dysfunction
5276717|NCT02293603|pathological processes|pathological processes
5276718|NCT02293603|cardiovascular diseases|cardiovascular diseases
5276719|NCT02293603|heart failure|heart failure
5276720|NCT02293590|Certolizumab pegol|certolizumab pegol
5276721|NCT02293590|DMARD|dmard
5276722|NCT02293590|Joint injection|joint injection
5276723|NCT02293590|Glucocorticoids|glucocorticoids
5276724|NCT02293564|Erosive Osteoarthritis|erosive osteoarthritis
5276725|NCT02293564|Osteoarthritis|osteoarthritis
5276726|NCT02293564|Osteoarthritis of the Hand|osteoarthritis of the hand
5276727|NCT02293538|Symptoms of Contact Lens Related Discomfort|symptoms of contact lens related discomfort
5276728|NCT02293512|Tinnitus|tinnitus
5276729|NCT02293512|Coping|coping
5276730|NCT02293512|Psychoeducational intervention|psychoeducational intervention
5276731|NCT02293499|asthma|asthma
5276732|NCT02293499|adolescent|adolescent
5276733|NCT02293499|intervention|intervention
5276734|NCT02293486|Antioxidants|antioxidants
5276735|NCT02293486|Protein Carbonylation|protein carbonylation
5276736|NCT02293486|Malondialdehyde|malondialdehyde
5276737|NCT02293486|Punicaceae|punicaceae
5276738|NCT02293486|Athletic Performance|athletic performance
5276739|NCT02293460|Peripheral neuropathy|peripheral neuropathy
5276740|NCT02293460|Disimmune disease|disimmune disease
5276741|NCT02293460|Neurology Chronic disease|neurology chronic disease
5276742|NCT02293460|Rare disease|rare disease
5276744|NCT02293447|Fibroid|fibroid
5276745|NCT02293447|Embolization|embolization
5276746|NCT02293447|Leiomyoma|leiomyoma
5276747|NCT02293447|Lidocaine|lidocaine
5276748|NCT02293447|Pain|pain
5276749|NCT02293434|Malnutrition|malnutrition
5276750|NCT02293434|Status Nutritional Weight|status nutritional weight
5276751|NCT02293434|Pediatric intensive care|pediatric intensive care
5276752|NCT02293408|MPS IIIB|mps iiib
5276753|NCT02293408|Mucopolysaccharidosis|mucopolysaccharidosis
5276754|NCT02293408|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
5276755|NCT02293408|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
5276756|NCT02293395|Acute Coronary Syndrome|acute coronary syndrome
5276757|NCT02293395|Myocardial infarction|myocardial infarction
5264078|NCT02365454|TAA|taa
5276758|NCT02293395|Unstable angina|unstable angina
5276759|NCT02293395|Acetylsalicylic acid|acetylsalicylic acid
5276760|NCT02293395|Rivaroxaban|rivaroxaban
5276761|NCT02293395|JNJ-39039039|jnj-39039039
5276762|NCT02293395|Bay 59-7939|bay 59-7939
5276763|NCT02293395|Xarelto|xarelto
5276764|NCT02293395|Clopidogrel|clopidogrel
5276765|NCT02293395|Ticagrelor|ticagrelor
5276766|NCT02293395|Plavix|plavix
5276767|NCT02293395|Brilinta|brilinta
5276768|NCT02293395|Effient|effient
5276769|NCT02293382|MPS IIIB|mps iiib
5276770|NCT02293382|Mucopolysaccharodosis III|mucopolysaccharodosis iii
5276771|NCT02293382|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
5276772|NCT02293382|Sanfilippo Syndrome|sanfilippo syndrome
5276773|NCT02293343|histamine profile|histamine profile
5276774|NCT02293343|IgE Antibodies|ige antibodies
5276775|NCT02293330|continuous versus intermittent bolus sciatic nerve block|continuous versus intermittent bolus sciatic nerve block
5276776|NCT02293317|Influenza Prime universal vaccine M-001 Multimeric|influenza prime universal vaccine m-001 multimeric
5276777|NCT02293291|Gulf war illness|gulf war illness
5276778|NCT02293278|MVPA|mvpa
5276779|NCT02293278|sedentary behaviour|sedentary behaviour
5276780|NCT02293278|PA intervention|pa intervention
5276781|NCT02293278|preschool|preschool
5276782|NCT02293278|gross motor|gross motor
5276783|NCT02293278|anthropometrics|anthropometrics
5276784|NCT02293278|day care|day care
5276785|NCT02293265|mepolizumab|mepolizumab
5276786|NCT02293265|omalizumab|omalizumab
5276787|NCT02293265|SB-240563|sb-240563
5276788|NCT02293265|Severe Asthma|severe asthma
5276789|NCT02293265|reslizumab|reslizumab
5276790|NCT02293252|Home Telemonitoring|home telemonitoring
5276791|NCT02293239|whole-body electromyostimulation|whole-body electromyostimulation
5276792|NCT02293239|cachexia|cachexia
5276793|NCT02293239|cancer|cancer
5276794|NCT02293239|skeletal muscle mass|skeletal muscle mass
5276795|NCT02293239|nutrition|nutrition
5276796|NCT02293213|Category D|category d
5276797|NCT02293213|Category X|category x
5276798|NCT02293213|Electronic Medical Records|electronic medical records
5276924|NCT02292550|ALK translocation|alk translocation
5276799|NCT02293213|Long Acting Reversible Contraception|long acting reversible contraception
5276800|NCT02293187|vitamin D|vitamin d
5276801|NCT02293187|muscle performance|muscle performance
5276802|NCT02293187|falls|falls
5276803|NCT02293161|Interleukin-7 Receptor α|interleukin-7 receptor α
5276804|NCT02293161|monoclonal antibody|monoclonal antibody
5276805|NCT02293148|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5276806|NCT02293148|GSK1278863|gsk1278863
5276807|NCT02293148|Anemia|anemia
5276808|NCT02293148|QTc|qtc
5276809|NCT02293148|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5276810|NCT02293135|Type 2 diabetes ; endothelium stimulation|type 2 diabetes ; endothelium stimulation
5276811|NCT02293122|Agreement|agreement
5276812|NCT02293122|Repeatability|repeatability
5276813|NCT02293122|Reproducibility|reproducibility
5276814|NCT02293096|Genotype|genotype
5276815|NCT02293096|CYP2D6|cyp2d6
5276816|NCT02293096|ADRB1|adrb1
5276817|NCT02293057|Adolescent|adolescent
5276818|NCT02293057|Juvenile Justice|juvenile justice
5276819|NCT02293057|Drug Use|drug use
5276820|NCT02293057|Marijuana|marijuana
5276821|NCT02293057|Gender Responsive|gender responsive
5276822|NCT02293057|Girls|girls
5276823|NCT02293057|HIV|hiv
5276824|NCT02293057|Sexual Risk|sexual risk
5276825|NCT02293044|Sensitivity|sensitivity
5276826|NCT02293031|maxillofacial bone defects|maxillofacial bone defects
5276827|NCT02293031|alveolar ridge atrophy|alveolar ridge atrophy
5276828|NCT02293031|gene-activated matrix|gene-activated matrix
5276829|NCT02293031|VEGF gene|vegf gene
5276830|NCT02293031|DNA plasmid|dna plasmid
5276831|NCT02293031|bone gene therapy|bone gene therapy
5276832|NCT02293005|Lung Cancer|lung cancer
5276833|NCT02293005|Mesothelioma|mesothelioma
5276834|NCT02293005|Unresectable malignant pleural mesothelioma|unresectable malignant pleural mesothelioma
5276835|NCT02293005|MPM|mpm
5276836|NCT02293005|Alisertib|alisertib
5276837|NCT02293005|MLN8237|mln8237
5276838|NCT02292992|Electrical impedance tomography|electrical impedance tomography
5276839|NCT02292992|Nasal Pillow Continuous Positive Airway Pressure(CPAP)|nasal pillow continuous positive airway pressure(cpap)
5276840|NCT02292992|High Flow Nasal Cannula|high flow nasal cannula
5276841|NCT02292992|extubation|extubation
5276843|NCT02292966|Hepatitis C|hepatitis c
5276844|NCT02292966|Hepatitis|hepatitis
5276845|NCT02292966|Asunaprevir|asunaprevir
5276846|NCT02292966|Daclatasvir|daclatasvir
5276847|NCT02292966|Beclabuvir|beclabuvir
5276848|NCT02292966|Neurocognitive function|neurocognitive function
5276849|NCT02292966|Brain metabolites|brain metabolites
5276850|NCT02292966|Direct acting antiviral therapy|direct acting antiviral therapy
5276851|NCT02292953|ICSI|icsi
5276852|NCT02292953|Ovum Pickup|ovum pickup
5276853|NCT02292953|Embryo Transfer|embryo transfer
5276854|NCT02292940|patient outcome assessment|patient outcome assessment
5276855|NCT02292940|electronic health records|electronic health records
5276856|NCT02292888|Doppler VTI TEE SV volume responsiveness|doppler vti tee sv volume responsiveness
5276857|NCT02292875|Grass Allergy|grass allergy
5276858|NCT02292875|Rhinoconjunctivitis|rhinoconjunctivitis
5276859|NCT02292875|Environmental Exposure Unit|environmental exposure unit
5276860|NCT02292875|Immunotherapy|immunotherapy
5276861|NCT02292875|ToleroMune Grass|toleromune grass
5276862|NCT02292849|Depression|depression
5276863|NCT02292823|STEMI|stemi
5276864|NCT02292823|heart attack|heart attack
5276865|NCT02292823|stent|stent
5276866|NCT02292823|Bare Metal Stent|bare metal stent
5276867|NCT02292823|myocardial infarction|myocardial infarction
5276869|NCT02292784|infants|infants
5276870|NCT02292784|retosiban|retosiban
5276871|NCT02292784|Preterm Labor|preterm labor
5276872|NCT02292784|long-term safety follow-up|long-term safety follow-up
5276873|NCT02292771|Spontaneous Preterm Labor|spontaneous preterm labor
5276874|NCT02292771|retosiban|retosiban
5276875|NCT02292771|GSK221149|gsk221149
5276876|NCT02292771|atosiban|atosiban
5276877|NCT02292745|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5276878|NCT02292745|chemotherapy|chemotherapy
5276879|NCT02292745|stereotactic radiotherapy|stereotactic radiotherapy
5277459|NCT02289729|Duodopa|duodopa
5276880|NCT02292732|Pharmacokinetics|pharmacokinetics
5276881|NCT02292732|Solid Tumors|solid tumors
5276882|NCT02292732|Safety|safety
5276883|NCT02292732|Trametinib|trametinib
5276884|NCT02292732|MEK Inhibitor|mek inhibitor
5276885|NCT02292732|Combined Oral Contraceptive|combined oral contraceptive
5276886|NCT02292732|Trametinib's Metabolite M5|trametinib's metabolite m5
5276887|NCT02292732|Norethindrone|norethindrone
5276888|NCT02292732|Ethinyl Estradiol|ethinyl estradiol
5276889|NCT02292719|Hepatitis C Virus|hepatitis c virus
5276890|NCT02292719|Genotype 2|genotype 2
5276891|NCT02292719|Chronic Hepatitis C|chronic hepatitis c
5276892|NCT02292719|Genotype 3|genotype 3
5276893|NCT02292719|Non-cirrhotic|non-cirrhotic
5276894|NCT02292719|Cirrhotic|cirrhotic
5276895|NCT02292706|HCV Cirrhosis registry|hcv cirrhosis registry
5276896|NCT02292706|Cirrhosis|cirrhosis
5276897|NCT02292706|Hepatitis C|hepatitis c
5276898|NCT02292693|intubation|intubation
5276899|NCT02292680|dentin|dentin
5276900|NCT02292680|environmental exposures|environmental exposures
5276901|NCT02292680|neurodevelopmental outcomes|neurodevelopmental outcomes
5276902|NCT02292667|Transversus Abdominis Plane Block|transversus abdominis plane block
5276903|NCT02292667|Postoperative Pain Management|postoperative pain management
5276904|NCT02292667|Open Repair of Aortic Abdominal Aneurysm|open repair of aortic abdominal aneurysm
5276905|NCT02292641|Lower Gastrointestinal Tract|lower gastrointestinal tract
5276906|NCT02292641|Rectum|rectum
5276907|NCT02292641|Diagnostic Imaging|diagnostic imaging
5276908|NCT02292641|Magnetic Resonance Imaging|magnetic resonance imaging
5276909|NCT02292641|Pelvic Exenteration|pelvic exenteration
5276910|NCT02292641|Neoplasms|neoplasms
5276911|NCT02292641|Adenocarcinoma|adenocarcinoma
5276912|NCT02292641|Carcinoma|carcinoma
5276913|NCT02292602|preschool|preschool
5276914|NCT02292602|obesity|obesity
5276922|NCT02292563|Nurse; Colonoscopy; Polyp; Adenoma;|nurse; colonoscopy; polyp; adenoma;
5276925|NCT02292550|ALK-positive|alk-positive
5276926|NCT02292550|NSCLC|nsclc
5276927|NCT02292550|LEE011|lee011
5276928|NCT02292550|CDK4/6 inhibitor|cdk4/6 inhibitor
5276929|NCT02292550|EML4-ALK|eml4-alk
5276930|NCT02292550|cancer|cancer
5276931|NCT02292537|Spinal Muscular Atrophy|spinal muscular atrophy
5276932|NCT02292537|SMA|sma
5276933|NCT02292537|SMN|smn
5276934|NCT02292537|SMNRx|smnrx
5276935|NCT02292537|ISIS-SMNRx|isis-smnrx
5276936|NCT02292537|ISIS-SMN Rx|isis-smn rx
5276937|NCT02292537|ISIS 396443|isis 396443
5276938|NCT02292537|CHERISH|cherish
5276939|NCT02292537|IONIS-SMNRx|ionis-smnrx
5276940|NCT02292537|IONIS-SMN Rx|ionis-smn rx
5276941|NCT02292511|subjective cognitive impairment|subjective cognitive impairment
5276942|NCT02292511|mind-motor intervention|mind-motor intervention
5276943|NCT02292511|square-stepping exercise|square-stepping exercise
5276944|NCT02292511|older adults|older adults
5276945|NCT02292498|imaging, diagnostic|imaging, diagnostic
5276947|NCT02292485|Lung Cancer Screening|lung cancer screening
5276949|NCT02292485|Survey|survey
5276950|NCT02292485|Questionnaire|questionnaire
5276951|NCT02292485|Texas Academy of Family Physicians|texas academy of family physicians
5276952|NCT02292472|masticatory muscles|masticatory muscles
5276953|NCT02292446|Polycythemia Vera|polycythemia vera
5276954|NCT02292446|Hematologic Diseases|hematologic diseases
5276955|NCT02292446|Myeloproliferative Disorders|myeloproliferative disorders
5276956|NCT02292446|INC424|inc424
5276957|NCT02292446|Ruxolitinib|ruxolitinib
5276958|NCT02292446|hydroxyurea resistant|hydroxyurea resistant
5276959|NCT02292446|adult|adult
5276960|NCT02292433|Phase 1|phase 1
5276961|NCT02292433|type 2 diabetes|type 2 diabetes
5276962|NCT02292433|monotherapy|monotherapy
5276963|NCT02292433|PF-04937319|pf-04937319
5276964|NCT02292420|pulse oximetry plethymographic waveform|pulse oximetry plethymographic waveform
5276965|NCT02292420|area under curve|area under curve
5276966|NCT02292420|amplitude|amplitude
5276967|NCT02292394|Depression|depression
5276968|NCT02292394|Depressive symptoms|depressive symptoms
5276969|NCT02292394|Prevention|prevention
5276970|NCT02292394|Caregivers|caregivers
5276971|NCT02292394|Telephone intervention|telephone intervention
5276972|NCT02292368|Head and Neck Cancer|head and neck cancer
5276973|NCT02292368|Xerostomia|xerostomia
5276974|NCT02292368|Radiation-induced Xerostomia|radiation-induced xerostomia
5276975|NCT02292368|Acupuncture|acupuncture
5276976|NCT02292368|Nasopharyngeal cancer|nasopharyngeal cancer
5276977|NCT02292368|Radiation therapy|radiation therapy
5276978|NCT02292368|XRT|xrt
5276979|NCT02292368|Electroencephalogram|electroencephalogram
5276980|NCT02292368|EEG|eeg
5276981|NCT02292368|Xerostomia questionnaire|xerostomia questionnaire
5276982|NCT02292368|XQ|xq
5276992|NCT02292342|Flow mediated dilatation|flow mediated dilatation
5276993|NCT02292329|flow-mediated dilation|flow-mediated dilation
5276994|NCT02292329|Acai polyphenols|acai polyphenols
5276995|NCT02292316|middle-aged and aged adults|middle-aged and aged adults
5276996|NCT02292316|fall in the previous year|fall in the previous year
5276997|NCT02292303|Zinc/pharmacokinetics|zinc/pharmacokinetics
5276998|NCT02292290|Diabetes|diabetes
5276999|NCT02292290|Liraglutide|liraglutide
5277000|NCT02292290|Ramadan|ramadan
5277001|NCT02292290|fasting|fasting
5277002|NCT02292277|Ticagrelor|ticagrelor
5277003|NCT02292277|Pharmacokinetics|pharmacokinetics
5277004|NCT02292277|Platelet Aggregation|platelet aggregation
5277005|NCT02292277|Platelet Function Tests|platelet function tests
5277006|NCT02292251|Stroke|stroke
5277007|NCT02292251|Transcranial direct current stimulation|transcranial direct current stimulation
5277008|NCT02292238|Alzheimer's disease|alzheimer's disease
5277009|NCT02292238|benfotiamine|benfotiamine
5277010|NCT02292238|glucose|glucose
5277011|NCT02292238|Amyloid|amyloid
5277012|NCT02292225|Phase 1b, CLL/SLL, PI3K|phase 1b, cll/sll, pi3k
5277013|NCT02292199|Hypertension|hypertension
5277014|NCT02292199|TENS|tens
5277015|NCT02292199|Sympathetic and Parasympathetic nervous system|sympathetic and parasympathetic nervous system
5277016|NCT02292186|Cardiomyopathy|cardiomyopathy
5281712|NCT02265198|ARDS|ards
5277018|NCT02292186|FAC|fac
5277019|NCT02292186|Amyloid|amyloid
5277020|NCT02292186|Transthyretin|transthyretin
5277021|NCT02292186|TTR|ttr
5277022|NCT02292186|RNAi therapeutic|rnai therapeutic
5277023|NCT02292173|Liver Neoplasms|liver neoplasms
5277024|NCT02292173|Liver Diseases|liver diseases
5277025|NCT02292173|Digestive System Diseases|digestive system diseases
5277026|NCT02292173|Advanced|advanced
5277027|NCT02292173|Mitogen-Activated Protein Kinase (MEK) Inhibitor|mitogen-activated protein kinase (mek) inhibitor
5277028|NCT02292173|Kinase Inhibitor|kinase inhibitor
5277029|NCT02292147|Cerebral anoxia|cerebral anoxia
5277030|NCT02292147|Functional outcome|functional outcome
5277031|NCT02292134|Sleep quality|sleep quality
5277032|NCT02292134|Sleep architecture|sleep architecture
5277033|NCT02292134|Intensive care unit|intensive care unit
5277034|NCT02292134|Light|light
5277035|NCT02292134|Noise|noise
5277036|NCT02292134|Earplug|earplug
5277037|NCT02292134|Sleep mask|sleep mask
5277038|NCT02292121|Obesity|obesity
5277039|NCT02292121|Intestinal permeability|intestinal permeability
5277040|NCT02292121|Adipose tissue inflammation|adipose tissue inflammation
5277041|NCT02292121|Low grade systemic inflammation|low grade systemic inflammation
5277042|NCT02292121|Bariatric surgery|bariatric surgery
5277043|NCT02292108|Hypnosis|hypnosis
5277044|NCT02292108|self-hypnosis|self-hypnosis
5277045|NCT02292108|obesity|obesity
5277046|NCT02292108|high food impulsiveness|high food impulsiveness
5277047|NCT02292095|anesthesia|anesthesia
5277048|NCT02292095|transverse abdominis plane block|transverse abdominis plane block
5277049|NCT02292095|patient controlled intravenous analgesia|patient controlled intravenous analgesia
5277050|NCT02292082|Nerve Block|nerve block
5277051|NCT02292082|Rehabilitation|rehabilitation
5277052|NCT02292082|Knee Replacement, Total|knee replacement, total
5277053|NCT02291991|Safety|safety
5277054|NCT02291991|Tolerability|tolerability
5277055|NCT02291991|Pharmacokinetics|pharmacokinetics
5277056|NCT02291991|Pharmacodynamics|pharmacodynamics
5277062|NCT02291952|Circadian Misalignment, Forced Desynchrony, Metabolism, Meal-timing, Circadian|circadian misalignment, forced desynchrony, metabolism, meal-timing, circadian
5277063|NCT02291926|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
5277064|NCT02291926|Mesenchymal Stem Cell|mesenchymal stem cell
5277065|NCT02291926|Osteoarthritis|osteoarthritis
5277072|NCT02291900|avascular necrosis, talus, medial femoral condyle|avascular necrosis, talus, medial femoral condyle
5277073|NCT02291874|Diabetes|diabetes
5277074|NCT02291874|Ipragliflozin|ipragliflozin
5277075|NCT02291874|GLP-1 receptor agonist|glp-1 receptor agonist
5277076|NCT02291861|Dyskinesias|dyskinesias
5277077|NCT02291861|Movement Disorders|movement disorders
5277078|NCT02291861|Central Nervous System Diseases|central nervous system diseases
5277079|NCT02291861|Nervous System Diseases|nervous system diseases
5277080|NCT02291861|Neurologic Manifestations|neurologic manifestations
5277081|NCT02291861|Signs and Symptoms|signs and symptoms
5277082|NCT02291848|Multiple Myeloma|multiple myeloma
5277083|NCT02291848|Cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
5277084|NCT02291809|HIV/AIDS|hiv/aids
5277085|NCT02291809|Pediatric|pediatric
5277086|NCT02291809|Vaccine|vaccine
5277087|NCT02291809|HIV-1 Immunogen|hiv-1 immunogen
5277088|NCT02291796|Bezafibrate|bezafibrate
5277089|NCT02291796|Hyperfibrinogenemia|hyperfibrinogenemia
5277090|NCT02291796|Inflammatory response|inflammatory response
5277091|NCT02291796|Acute myocardial infarction|acute myocardial infarction
5277092|NCT02291796|Mayor cardiovascular events|mayor cardiovascular events
5277093|NCT02291770|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5277094|NCT02291770|Mesenchymal Stromal Cells|mesenchymal stromal cells
5277095|NCT02291744|TFS (time to failure of strategy)|tfs (time to failure of strategy)
5277096|NCT02291731|Autologous serum eye drops|autologous serum eye drops
5277097|NCT02291731|Silicone-hydrogel contact lens|silicone-hydrogel contact lens
5277098|NCT02291731|Persistent epithelial defects|persistent epithelial defects
5277099|NCT02291731|Corneal epithelial defects|corneal epithelial defects
5277100|NCT02291718|Suspected or confirmed|suspected or confirmed
5277101|NCT02291718|TAA|taa
5277102|NCT02291718|Computed tomography angiography|computed tomography angiography
5277103|NCT02291718|CTA|cta
5277104|NCT02291718|Contrast agent|contrast agent
5277105|NCT02291718|Radiation dose|radiation dose
5277106|NCT02291718|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
5277107|NCT02291705|Ultrasound, rectus sheath block, children, inguinal hernia|ultrasound, rectus sheath block, children, inguinal hernia
5277108|NCT02291666|Cytochromes p450|cytochromes p450
5277109|NCT02291666|drug metabolism|drug metabolism
5277110|NCT02291666|pharmacokinetics|pharmacokinetics
5277111|NCT02291666|diabetes|diabetes
5277112|NCT02291666|probe markers|probe markers
5277113|NCT02291614|Amgen|amgen
5277114|NCT02291614|Phase 1|phase 1
5277115|NCT02291614|Clinical Trial|clinical trial
5277116|NCT02291614|Oncology|oncology
5277117|NCT02291614|GI adenocarcinoma|gi adenocarcinoma
5277118|NCT02291614|Immunotherapy|immunotherapy
5277119|NCT02291549|endoscopic sinus surgery|endoscopic sinus surgery
5277120|NCT02291549|corticosteroid|corticosteroid
5277121|NCT02291549|chronic rhinosinusitis|chronic rhinosinusitis
5277122|NCT02291549|mometasone furoate|mometasone furoate
5277123|NCT02291549|polyposis|polyposis
5277124|NCT02291536|THC and CBD|thc and cbd
5277125|NCT02291536|Attentional blink|attentional blink
5277126|NCT02291523|Fecal transplant|fecal transplant
5277127|NCT02291484|Computed tomography|computed tomography
5277128|NCT02291484|Coronary angiography|coronary angiography
5277129|NCT02291484|Coronary artery disease|coronary artery disease
5277130|NCT02291484|Perfusion imaging|perfusion imaging
5277131|NCT02291484|Comparative effectiveness|comparative effectiveness
5277132|NCT02291484|Randomized controlled trial|randomized controlled trial
5277133|NCT02291484|Cost-effectiveness|cost-effectiveness
5277134|NCT02291445|Peppermint oil|peppermint oil
5277135|NCT02291445|Menthol|menthol
5277136|NCT02291445|Volatile oil|volatile oil
5277137|NCT02291445|Plant oil|plant oil
5277138|NCT02291445|Visceral pain|visceral pain
5277139|NCT02291445|Abdominal pain|abdominal pain
5277140|NCT02291445|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5277141|NCT02291445|Colonic disease|colonic disease
5277142|NCT02291432|Urinary Incontinence, Stress|urinary incontinence, stress
5277143|NCT02291432|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
5277144|NCT02291419|ticagrelor|ticagrelor
5277145|NCT02291419|non-cardiac surgery|non-cardiac surgery
5277146|NCT02291419|elevated troponin|elevated troponin
5277147|NCT02291419|myocardial injury|myocardial injury
5277148|NCT02291406|Hysterectomy|hysterectomy
5277149|NCT02291406|Insulin resistance|insulin resistance
5277150|NCT02291406|Metabolism|metabolism
5277151|NCT02291380|Chronic Migraine|chronic migraine
5277152|NCT02291380|Botulinum Toxin Type A for Injection|botulinum toxin type a for injection
5277153|NCT02291354|Fecal Microbiota Transplantation|fecal microbiota transplantation
5277154|NCT02291354|Soluble Dietary Fiber|soluble dietary fiber
5277155|NCT02291354|Slow Transit Constipation|slow transit constipation
5277156|NCT02291315|Triple Stable Isotope|triple stable isotope
5277159|NCT02291263|IPV|ipv
5277160|NCT02291263|oral polio vaccine|oral polio vaccine
5277161|NCT02291250|anthocyanin|anthocyanin
5277162|NCT02291250|blackcurrant|blackcurrant
5277163|NCT02291250|greencurrant|greencurrant
5277164|NCT02291250|glucose|glucose
5277165|NCT02291250|polyphenol|polyphenol
5277166|NCT02291250|post prandial glucose|post prandial glucose
5277167|NCT02291237|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5277168|NCT02291237|hcm|hcm
5277169|NCT02291237|hocm|hocm
5277170|NCT02291237|hypertrophic myocardiopathy|hypertrophic myocardiopathy
5277171|NCT02291237|hypertrophic obstructive cardiomyopathies|hypertrophic obstructive cardiomyopathies
5277172|NCT02291237|cardiomyopathy|cardiomyopathy
5277173|NCT02291237|hypertrophic|hypertrophic
5277298|NCT02290626|Elemental diet|elemental diet
5277272|NCT02290717|ultraviolet therapy|ultraviolet therapy
5277174|NCT02291237|familial hypertrophic cardiomyopathy|familial hypertrophic cardiomyopathy
5277175|NCT02291237|genetic heart disease|genetic heart disease
5277176|NCT02291237|echocardiography|echocardiography
5277177|NCT02291237|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5277178|NCT02291237|exercise Capacity|exercise capacity
5277179|NCT02291237|heart failure|heart failure
5277180|NCT02291237|angina|angina
5277181|NCT02291237|dyspnea|dyspnea
5277182|NCT02291237|diastolic dysfunction|diastolic dysfunction
5277183|NCT02291237|microvascular ischemia|microvascular ischemia
5277184|NCT02291237|late sodium current inhibitor|late sodium current inhibitor
5277185|NCT02291237|GS-6615|gs-6615
5277186|NCT02291237|late INA|late ina
5277187|NCT02291224|dual protection|dual protection
5277188|NCT02291224|pregnancy|pregnancy
5277189|NCT02291224|reproductive health|reproductive health
5277190|NCT02291224|sexually transmitted diseases|sexually transmitted diseases
5277191|NCT02291224|condoms|condoms
5277192|NCT02291224|contraception|contraception
5277193|NCT02291224|adolescent health services|adolescent health services
5277194|NCT02291198|colorectal cancer|colorectal cancer
5277195|NCT02291198|natural killer cell activity|natural killer cell activity
5277196|NCT02291198|screening|screening
5277197|NCT02291198|NK cells|nk cells
5277198|NCT02291159|stroke|stroke
5277199|NCT02291159|spasticity|spasticity
5277200|NCT02291159|dry needling|dry needling
5277201|NCT02291159|upper motor neuron syndrome|upper motor neuron syndrome
5277202|NCT02291159|motor function|motor function
5277203|NCT02291146|gardening|gardening
5277204|NCT02291146|cooking|cooking
5277205|NCT02291146|nutrition education|nutrition education
5277206|NCT02291146|Hispanic Americans|hispanic americans
5277207|NCT02291133|Primary liver tumors|primary liver tumors
5277208|NCT02291133|Bleomycin|bleomycin
5277209|NCT02291133|Electrochemotherapy|electrochemotherapy
5277210|NCT02291107|Gait orthosis|gait orthosis
5277211|NCT02291107|Lokomat|lokomat
5277212|NCT02291107|Robotic Rehabilitation|robotic rehabilitation
5277213|NCT02291094|Intravenous lidocaine|intravenous lidocaine
5277214|NCT02291094|Mastectomy|mastectomy
5277215|NCT02291094|Pain|pain
5277216|NCT02291081|HIV, AIDS|hiv, aids
5277217|NCT02291081|antiretroviral therapy|antiretroviral therapy
5277218|NCT02291081|aging|aging
5277219|NCT02291081|heart failure|heart failure
5277220|NCT02291081|coronary heart disease|coronary heart disease
5277221|NCT02291081|myocardial infarction|myocardial infarction
5277222|NCT02291081|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
5277223|NCT02291042|Bladder|bladder
5277224|NCT02291042|Surgery|surgery
5277225|NCT02291029|Sjögren's syndrome, CFZ533, ESSDAI|sjögren's syndrome, cfz533, essdai
5277226|NCT02291016|COPD|copd
5277227|NCT02291016|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5277228|NCT02291003|circadian|circadian
5277229|NCT02291003|sleep|sleep
5277230|NCT02290977|RT, TACE|rt, tace
5277231|NCT02290964|Acute normovolemic hemodilution|acute normovolemic hemodilution
5277232|NCT02290964|allogeneic transfusion|allogeneic transfusion
5277233|NCT02290938|adolescents|adolescents
5277234|NCT02290938|Native American|native american
5277235|NCT02290938|alcohol use|alcohol use
5277236|NCT02290938|drug use|drug use
5277237|NCT02290938|cultural|cultural
5277238|NCT02290938|traditional activities|traditional activities
5277239|NCT02290938|cultural identification|cultural identification
5277240|NCT02290925|biscuit containing Salacia reticulate|biscuit containing salacia reticulate
5277241|NCT02290925|randomised controlled trial|randomised controlled trial
5277242|NCT02290912|Alzheimer's disease prevention lifestyle intervention|alzheimer's disease prevention lifestyle intervention
5277243|NCT02290899|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5277244|NCT02290886|safety evaluation|safety evaluation
5277245|NCT02290886|intravenous administration|intravenous administration
5277246|NCT02290886|3 doses of autologous MSC|3 doses of autologous msc
5277247|NCT02290886|ALS|als
5277248|NCT02290834|Chemotherapy related cognitive impairment|chemotherapy related cognitive impairment
5277249|NCT02290834|Chemo-brain|chemo-brain
5277250|NCT02290808|physical|physical
5146427|NCT03077048|CKD|ckd
5158359|NCT03002038|rituximab|rituximab
5277251|NCT02290808|activity|activity
5277252|NCT02290808|exercise|exercise
5277253|NCT02290808|new-parents|new-parents
5277254|NCT02290808|intervention|intervention
5277255|NCT02290808|theory-based|theory-based
5277256|NCT02290795|Vitreopapillary traction|vitreopapillary traction
5277257|NCT02290782|toxicity|toxicity
5277259|NCT02290782|TARGIT|targit
5277260|NCT02290782|quality of life|quality of life
5277261|NCT02290782|intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
5277262|NCT02290769|Guide wire cannulation ERCP|guide wire cannulation ercp
5277263|NCT02290769|Time of cannulation|time of cannulation
5277264|NCT02290769|Rapid exchange guide wire|rapid exchange guide wire
5277265|NCT02290769|Guide wire|guide wire
5277266|NCT02290756|Early child development|early child development
5277267|NCT02290756|Link Workers|link workers
5277268|NCT02290756|Community Birth attendants|community birth attendants
5277269|NCT02290756|Parenting Program|parenting program
5277270|NCT02290730|Lower trapezius|lower trapezius
5277271|NCT02290730|Kinesio taping|kinesio taping
5277273|NCT02290717|non segmental|non segmental
5277274|NCT02290717|vitiligo|vitiligo
5277275|NCT02290717|topical corticosteroid|topical corticosteroid
5277276|NCT02290717|laser|laser
5277277|NCT02290717|fractional|fractional
5277278|NCT02290717|CO2|co2
5277279|NCT02290717|carbon dioxide|carbon dioxide
5277280|NCT02290717|UVB|uvb
5277281|NCT02290704|oxygen saturation|oxygen saturation
5277282|NCT02290704|retinal vessels|retinal vessels
5277283|NCT02290704|thyroid associated ophthalmopathy|thyroid associated ophthalmopathy
5277284|NCT02290691|Needle Free, Influenza|needle free, influenza
5277285|NCT02290678|Pilot Study|pilot study
5277286|NCT02290678|Adventure-based Programming|adventure-based programming
5277287|NCT02290665|enema|enema
5277288|NCT02290652|Sexual function in Orthopaedic patients|sexual function in orthopaedic patients
5277289|NCT02290639|Posttraumatic Stress|posttraumatic stress
5277290|NCT02290639|Posttraumatic Stress Disorder|posttraumatic stress disorder
5277291|NCT02290639|Military|military
5277292|NCT02290639|Primary Care|primary care
5277293|NCT02290639|Cognitive Behavioral Therapy|cognitive behavioral therapy
5277294|NCT02290639|Prolonged Exposure|prolonged exposure
5277295|NCT02290639|Cognitive Processing Therapy|cognitive processing therapy
5277296|NCT02290639|Behavioral Health Optimization Program|behavioral health optimization program
5277297|NCT02290639|Behavioral Health Consultant|behavioral health consultant
5277299|NCT02290626|semi-solid diet|semi-solid diet
5277300|NCT02290626|gastric emptying|gastric emptying
5277301|NCT02290626|GER|ger
5277302|NCT02290626|PEG|peg
5277303|NCT02290613|pulmonary hypertension|pulmonary hypertension
5277304|NCT02290613|systemic sclerosis|systemic sclerosis
5277305|NCT02290587|social cognitive|social cognitive
5277306|NCT02290587|theory of mind|theory of mind
5277307|NCT02290587|cognitive impairment|cognitive impairment
5277308|NCT02290587|functional MRI|functional mri
5277309|NCT02290587|brain activation network|brain activation network
5277310|NCT02290561|Prostatic Neoplasms|prostatic neoplasms
5277311|NCT02290561|Therapeutics|therapeutics
5849061|NCT00031369|Dystonia|dystonia
5277312|NCT02290561|Magnetic Resonance Imaging|magnetic resonance imaging
5277313|NCT02290561|Ultrasonography|ultrasonography
5277314|NCT02290561|High Intensity Focused Ultrasound|high intensity focused ultrasound
5277315|NCT02290561|Image Fusion|image fusion
5277316|NCT02290548|high flow nasal cannula|high flow nasal cannula
5277317|NCT02290548|extubation failure|extubation failure
5277318|NCT02290535|obstructive pulmonary disease|obstructive pulmonary disease
5277319|NCT02290535|children|children
5277320|NCT02290535|teenager|teenager
5277321|NCT02290535|EIT (Electrical Impedance Tomography)|eit (electrical impedance tomography)
5277322|NCT02290496|Insomnia|insomnia
5277323|NCT02290496|Depression|depression
5277325|NCT02290496|SSRI|ssri
5277326|NCT02290496|CBT|cbt
5277327|NCT02290496|Youth|youth
5277328|NCT02290470|Nausea|nausea
5277329|NCT02290470|Vomiting|vomiting
5277330|NCT02290457|resistance training|resistance training
5277331|NCT02290457|trunk muscle strength|trunk muscle strength
5277332|NCT02290457|physical fitness|physical fitness
5277333|NCT02290457|adolescent|adolescent
5277334|NCT02290444|Acute Relapsing Multiple Sclerosis|acute relapsing multiple sclerosis
5277335|NCT02290444|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5277336|NCT02290444|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
5277337|NCT02290431|LBH589|lbh589
5277338|NCT02290431|panobinostat|panobinostat
5277339|NCT02290431|bortezomib|bortezomib
5277340|NCT02290431|dexamethasone|dexamethasone
5277341|NCT02290431|Phase II|phase ii
5277342|NCT02290431|bortezomib and dexamethasone|bortezomib and dexamethasone
5277343|NCT02290431|Japanese patients|japanese patients
5277344|NCT02290431|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5277345|NCT02290431|Panobinostat (PAN)|panobinostat (pan)
5277346|NCT02290418|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5277347|NCT02290418|Omega-Loop Gastric Bypass|omega-loop gastric bypass
5277348|NCT02290418|"Mini-Gastric Bypass"|"mini-gastric bypass"
5277349|NCT02290405|insomnia|insomnia
5277351|NCT02290405|chronic insomnia|chronic insomnia
5277352|NCT02290392|African American|african american
5277353|NCT02290353|Engagement|engagement
5277354|NCT02290353|Motivation|motivation
5277355|NCT02290353|Exergaming|exergaming
5277356|NCT02290340|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
5277357|NCT02290327|Stress ulcer bleeding|stress ulcer bleeding
5277358|NCT02290327|proton pump inhibitors|proton pump inhibitors
5277359|NCT02290327|pneumonia|pneumonia
5277360|NCT02290327|clostridium difficile infection|clostridium difficile infection
5277361|NCT02290262|Heart disease|heart disease
5277362|NCT02290262|Phase one rehabilitation|phase one rehabilitation
5277363|NCT02290223|Chronic pain|chronic pain
5277364|NCT02290223|Analgesics, Opioid|analgesics, opioid
5277365|NCT02290223|Cognitive Therapy|cognitive therapy
5277366|NCT02290223|Behavior Therapy|behavior therapy
5277367|NCT02290223|Mindfulness|mindfulness
5277368|NCT02290223|Psychophysiology|psychophysiology
5277369|NCT02290223|Biofeedback, Psychology|biofeedback, psychology
5277370|NCT02290184|Type 2 diabetes|type 2 diabetes
5277371|NCT02290184|cardiovascular disease prevention|cardiovascular disease prevention
5277372|NCT02290184|weight loss lifestyle intervention|weight loss lifestyle intervention
5277373|NCT02290184|physical activity|physical activity
5277374|NCT02290184|diet|diet
5277375|NCT02290184|Filipinos|filipinos
5277376|NCT02290158|treatment outcomes|treatment outcomes
5277377|NCT02290158|Malocclusion/therapy|malocclusion/therapy
5277378|NCT02290145|docetaxel, cisplatin, 5-FU, cyclinD1|docetaxel, cisplatin, 5-fu, cyclind1
5277379|NCT02290132|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5277380|NCT02290132|lymphoblastic lymphoma|lymphoblastic lymphoma
5277381|NCT02290132|stem-cell transplant|stem-cell transplant
5277382|NCT02290132|T-cell lymphoma|t-cell lymphoma
5277383|NCT02290119|Primary PCL-retaining Total Knee Arthroplasty|primary pcl-retaining total knee arthroplasty
5277384|NCT02290119|Intraoperative Sensors|intraoperative sensors
5277385|NCT02290119|Ligament Balancing|ligament balancing
5277386|NCT02290119|Clinical Outcomes|clinical outcomes
5277387|NCT02290106|obesity|obesity
5277388|NCT02290106|insulin sensitivity|insulin sensitivity
5277389|NCT02290106|statin (HMG-CoA Reductase Inhibitor)|statin (hmg-coa reductase inhibitor)
5277390|NCT02290106|fatty liver|fatty liver
5277391|NCT02290093|Cathartics|cathartics
5277392|NCT02290093|Colonoscopy|colonoscopy
5277393|NCT02290093|Polyethylene Glycols|polyethylene glycols
5277394|NCT02290093|Elderly|elderly
5277395|NCT02290080|acute myocardial infarction (AMI)|acute myocardial infarction (ami)
5277396|NCT02290080|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5277397|NCT02290080|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
5277398|NCT02290080|Non ST-segment elevation myocardial infarction (NSTEMI)|non st-segment elevation myocardial infarction (nstemi)
5277399|NCT02290080|Ischemic Reperfusion injury (IR-injury)|ischemic reperfusion injury (ir-injury)
5277400|NCT02290080|Biomarkers|biomarkers
5277401|NCT02290080|Oxygen|oxygen
5277402|NCT02290080|Apoptosis|apoptosis
5277403|NCT02290080|Fluorescence-activated cell sorting (FACS)|fluorescence-activated cell sorting (facs)
5277404|NCT02290080|Flow cytometry|flow cytometry
5277405|NCT02290080|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
5277406|NCT02290067|blood glucose monitoring system|blood glucose monitoring system
5277407|NCT02290067|system accuracy|system accuracy
5277408|NCT02290054|analgesia, epidural|analgesia, epidural
5277409|NCT02290054|urinary retention|urinary retention
5277410|NCT02290041|mesenchymal stem cells|mesenchymal stem cells
5277411|NCT02290041|HIV Infection|hiv infection
5277412|NCT02290041|discordant immunological response|discordant immunological response
5277413|NCT02290028|CRT-D therapy|crt-d therapy
5277414|NCT02290028|quadripolar left ventricular lead|quadripolar left ventricular lead
5277415|NCT02290015|Single Photon Emission Computed Tomography; Acupuncture|single photon emission computed tomography; acupuncture
5277416|NCT02289989|Atopic dermatitis|atopic dermatitis
5277417|NCT02289989|Oregano|oregano
5277418|NCT02289989|Atopic Dermatitis Quick (ADQ) score|atopic dermatitis quick (adq) score
5277419|NCT02289989|Eczema Area and Severity Index score|eczema area and severity index score
5277420|NCT02289989|Reflectance confocal microscopy|reflectance confocal microscopy
5277421|NCT02289976|talar avascular necrosis|talar avascular necrosis
5277422|NCT02289976|osteochondrosis dissecans|osteochondrosis dissecans
5277423|NCT02289976|femoral condyle|femoral condyle
5277424|NCT02289950|Ovarian Cancer in in first relapse|ovarian cancer in in first relapse
5277425|NCT02289950|Platinum-Sensitive|platinum-sensitive
5277426|NCT02289937|Postoperative pain|postoperative pain
5277427|NCT02289937|regional anaesthesia|regional anaesthesia
5277428|NCT02289937|total hip replacement|total hip replacement
5277429|NCT02289937|nervus cutaneous femoral lateralis|nervus cutaneous femoral lateralis
5277430|NCT02289924|wet AMD|wet amd
5277431|NCT02289911|ultrasound|ultrasound
5277432|NCT02289898|1st-line metastatic pancreatic ductal adenocarcinoma|1st-line metastatic pancreatic ductal adenocarcinoma
5277433|NCT02289885|trauma|trauma
5277434|NCT02289885|examination|examination
5277435|NCT02289885|knowledge|knowledge
5277436|NCT02289885|paramedic|paramedic
5277438|NCT02289820|Older adults|older adults
5277439|NCT02289820|MEDI7510|medi7510
5277440|NCT02289820|Vaccine|vaccine
5277441|NCT02289807|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5277442|NCT02289807|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5277443|NCT02289807|intermediate risk|intermediate risk
5277444|NCT02289807|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5277445|NCT02289794|Bioconjugate vaccine|bioconjugate vaccine
5277446|NCT02289794|Urinary tract infections|urinary tract infections
5277447|NCT02289755|Urine Oxalate|urine oxalate
5277448|NCT02289755|Nephrolithiasis|nephrolithiasis
5277449|NCT02289755|Kidney Stones|kidney stones
5277450|NCT02289755|Hyperoxaluria|hyperoxaluria
5277451|NCT02289755|Enteric Hyperoxaluria|enteric hyperoxaluria
5277452|NCT02289755|Idiopathic Hyperoxaluria|idiopathic hyperoxaluria
5277453|NCT02289755|Urological Diseases|urological diseases
5277454|NCT02289755|Kidney Diseases|kidney diseases
5277455|NCT02289742|Dailies AquaComfort Plus® Multifocal (DACP MF)|dailies aquacomfort plus® multifocal (dacp mf)
5277456|NCT02289742|Dailies AquaComfort Plus® Toric (DACP Toric)|dailies aquacomfort plus® toric (dacp toric)
5277457|NCT02289742|tear film stability|tear film stability
5277458|NCT02289742|Non-Invasive Keratograph Break-Up Time (NIK-BUT)|non-invasive keratograph break-up time (nik-but)
5277460|NCT02289729|Advanced Parkinson's Disease|advanced parkinson's disease
5277461|NCT02289729|Levodopa/Carbidopa intestinal gel|levodopa/carbidopa intestinal gel
5277462|NCT02289716|Osteoarthritis|osteoarthritis
5277464|NCT02289716|Fulranumab|fulranumab
5277465|NCT02289716|JNJ-42160443|jnj-42160443
5277466|NCT02289716|Monotherapy|monotherapy
5277468|NCT02289716|Knee|knee
5277469|NCT02289716|Joint replacement surgery|joint replacement surgery
5277470|NCT02289703|End-Stage Renal Disease|end-stage renal disease
5277471|NCT02289703|Healthy|healthy
5277472|NCT02289703|Rivaroxaban|rivaroxaban
5277473|NCT02289703|BAY 59-7939|bay 59-7939
5277474|NCT02289703|JNJ-39039039|jnj-39039039
5277475|NCT02289703|Xarelto|xarelto
5277476|NCT02289703|Hemodialysis|hemodialysis
5277477|NCT02289703|Blood Coagulation|blood coagulation
5277478|NCT02289703|Pharmacokinetics|pharmacokinetics
5277479|NCT02289690|Extensive Stage Smal Cell Lung Cancer|extensive stage smal cell lung cancer
5277480|NCT02289690|ABT-888|abt-888
5277481|NCT02289690|Veliparib|veliparib
5277482|NCT02289690|PARP - Poly (ADP) ribose polymerase|parp - poly (adp) ribose polymerase
5277483|NCT02289677|intubation|intubation
5277484|NCT02289677|child|child
5277485|NCT02289677|resuscitation|resuscitation
5277486|NCT02289677|simulation|simulation
5277487|NCT02289677|Endotracheal|endotracheal
5277488|NCT02289664|intubation|intubation
5277489|NCT02289651|intubation|intubation
5277490|NCT02289638|intubation|intubation
5277491|NCT02289625|Obstructive Sleep Apnea|obstructive sleep apnea
5277492|NCT02289625|cognition|cognition
5277493|NCT02289625|neurovascular function|neurovascular function
5277494|NCT02289625|brain metabolism|brain metabolism
5277495|NCT02289625|exercise training|exercise training
5277496|NCT02289612|Risk for Type 2 Diabetes Mellitus|risk for type 2 diabetes mellitus
5277497|NCT02289612|Fibre|fibre
5277498|NCT02289612|Postprandial Glucose|postprandial glucose
5277502|NCT02289599|Healthy Japanese Subjects|healthy japanese subjects
5277504|NCT02289599|Pharmacokinetics|pharmacokinetics
5277505|NCT02289547|chemotherapy|chemotherapy
5277506|NCT02289547|stomach neoplasms|stomach neoplasms
5277507|NCT02289521|Transcranial Direct Current stimulation|transcranial direct current stimulation
5277508|NCT02289521|Executive function|executive function
5277509|NCT02289521|Bilingualism|bilingualism
5277510|NCT02289521|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5277511|NCT02289508|Heart Failure|heart failure
5277512|NCT02289508|Hemodynamics|hemodynamics
5277513|NCT02289508|Echocardiography|echocardiography
5277514|NCT02289508|Diagnostic techniques and procedures|diagnostic techniques and procedures
5277515|NCT02289508|Ultrasonography|ultrasonography
5277516|NCT02289508|USCOM|uscom
5277517|NCT02289495|Single Dose Escalation|single dose escalation
5277518|NCT02289495|Repeat Dose Escalation|repeat dose escalation
5277519|NCT02289495|GSK2838232|gsk2838232
5277520|NCT02289495|Ritonavir|ritonavir
5277521|NCT02289482|Ritonavir|ritonavir
5277522|NCT02289482|Safety|safety
5277523|NCT02289482|Continuation Single Dose Escalation|continuation single dose escalation
5277524|NCT02289482|GSK2838232|gsk2838232
5277525|NCT02289456|Phase II, LOCALLY ADVANCED OR METASTATIC NON SMALL|phase ii, locally advanced or metastatic non small
5277526|NCT02289456|CELL LUNG CANCER (NSCLC) AND AN|cell lung cancer (nsclc) and an
5277527|NCT02289456|EASTERN COOPERATIVE ONCOLOGY GROUP|eastern cooperative oncology group
5277528|NCT02289456|PERFORMANCE STATUS OF 2|performance status of 2
5277529|NCT02289456|(ABOUND.PS2)|(abound.ps2)
5277530|NCT02289456|LOCALLY ADVANCED OR METASTATIC NON SMALL|locally advanced or metastatic non small
5277531|NCT02289456|CELL LUNG CANCER (NSCLC) SUBJECTS THAT AE NOT CANDIDATES FOR RADIATION OR CURATIVE SURGERY|cell lung cancer (nsclc) subjects that ae not candidates for radiation or curative surgery
5277532|NCT02289443|complete dentures|complete dentures
5158673|NCT03000257|Ovarian cancer|ovarian cancer
5277533|NCT02289443|10-year follow-up|10-year follow-up
5277534|NCT02289443|patient report outcomes|patient report outcomes
5277535|NCT02289417|Ulcerative Colitis|ulcerative colitis
5277536|NCT02289417|Inflammatory Bowel Disease|inflammatory bowel disease
5277538|NCT02289391|Inflammatory factor|inflammatory factor
5277539|NCT02289391|Inflammatory mediator|inflammatory mediator
5277540|NCT02289391|Cytokines|cytokines
5277541|NCT02289391|Asthma|asthma
5277542|NCT02289365|Radiodermatitis|radiodermatitis
5277543|NCT02289365|Breast cancer|breast cancer
5277544|NCT02289365|Radiotherapy|radiotherapy
5277549|NCT02289287|Self-Management|self-management
5277550|NCT02289287|Stroke|stroke
5277551|NCT02289287|Intervention|intervention
5277552|NCT02289287|Group Processes|group processes
5277553|NCT02289261|Chronic pain|chronic pain
5277554|NCT02289261|Morphine|morphine
5277555|NCT02289261|Dexmedetomidine|dexmedetomidine
5277557|NCT02289235|Medicine, traditional|medicine, traditional
5277558|NCT02289235|Herbal medicine|herbal medicine
5277559|NCT02289222|Relapsed/Refractory|relapsed/refractory
5277560|NCT02289222|MK-3475 & Pomalidomide|mk-3475 & pomalidomide
5277561|NCT02289222|Immunotherapy|immunotherapy
5277562|NCT02289209|head and neck cancer|head and neck cancer
5277563|NCT02289209|reirradiation|reirradiation
5277564|NCT02289209|MK-3475|mk-3475
5381069|NCT01807585|GSV|gsv
5277565|NCT02289209|Anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5277566|NCT02289209|Squamous cell carcinoma|squamous cell carcinoma
5277567|NCT02289209|Keytruda|keytruda
5277568|NCT02289209|pembrolizumab|pembrolizumab
5277569|NCT02289196|Vaccine|vaccine
5277570|NCT02289183|Stomach Neoplasms|stomach neoplasms
5277571|NCT02289183|Laparoscopy|laparoscopy
5277572|NCT02289183|Billroth I Operation|billroth i operation
5277573|NCT02289170|Chronic low back pain|chronic low back pain
5277574|NCT02289170|Heating and cooling combination therapeutic device|heating and cooling combination therapeutic device
5277575|NCT02289170|Heating and cooling combination therapy|heating and cooling combination therapy
5277576|NCT02289170|Contrast therapy|contrast therapy
5277577|NCT02289131|oral care|oral care
5277578|NCT02289105|Advance Directive|advance directive
5277579|NCT02289105|Active Choice|active choice
5277580|NCT02289105|Decision making|decision making
5277581|NCT02289053|Colorectal Cancer|colorectal cancer
5277582|NCT02289040|Acute Kidney Injury|acute kidney injury
5277583|NCT02289040|Microvesicles|microvesicles
5277584|NCT02289040|microRNA|microrna
5277585|NCT02289040|Paediatric cardiac surgery|paediatric cardiac surgery
5277586|NCT02289027|Ebola, Ebolavirus|ebola, ebolavirus
5277587|NCT02289014|online intervention|online intervention
5277588|NCT02289014|stress management|stress management
5277589|NCT02289014|cognitive behavioral therapy|cognitive behavioral therapy
5277590|NCT02289014|acceptance and mindfulness based intervention|acceptance and mindfulness based intervention
5277591|NCT02289001|patient simulation|patient simulation
5277592|NCT02289001|simulation|simulation
5277593|NCT02289001|teamwork|teamwork
5277594|NCT02289001|interdisciplinary health team|interdisciplinary health team
5277595|NCT02289001|healthcare team|healthcare team
5277596|NCT02289001|nursing|nursing
5277597|NCT02289001|training programs|training programs
5277598|NCT02288988|GERD|gerd
5277599|NCT02288988|Short Esophagus|short esophagus
5277600|NCT02288988|Minimally Invasive Surgery|minimally invasive surgery
5277601|NCT02288988|Collis gastroplasty|collis gastroplasty
5277602|NCT02288975|hemoadsorption|hemoadsorption
5277603|NCT02288975|extracorporeal blood purification|extracorporeal blood purification
5277604|NCT02288975|CytoSorb|cytosorb
5277605|NCT02288975|hemofiltration|hemofiltration
5277606|NCT02288975|SIRS|sirs
5277607|NCT02288975|sepsis|sepsis
5277608|NCT02288975|septic shock|septic shock
5277609|NCT02288975|membranes|membranes
5277611|NCT02288975|dialysis|dialysis
5277612|NCT02288975|adsorption|adsorption
5277613|NCT02288962|dopamine agonists|dopamine agonists
5277614|NCT02288962|cabergoline|cabergoline
5277615|NCT02288949|mechanical ventilation, stratificacion, lung severity|mechanical ventilation, stratificacion, lung severity
5277616|NCT02288936|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5277617|NCT02288936|Enzalutamide|enzalutamide
5277618|NCT02288936|TMPRSS2-ETS fusion gene|tmprss2-ets fusion gene
5277619|NCT02288923|Total knee arthroplasty|total knee arthroplasty
5277620|NCT02288923|Femoral nerve block|femoral nerve block
5277621|NCT02288923|Local infiltration analgesia|local infiltration analgesia
5277622|NCT02288910|Liver Perfusion|liver perfusion
5277623|NCT02288910|DynaCT Perfusion|dynact perfusion
5277624|NCT02288910|Radioembolization|radioembolization
5277625|NCT02288910|Chemoembolization|chemoembolization
5277626|NCT02288897|Stage III|stage iii
5277627|NCT02288897|Stage IIIB|stage iiib
5277628|NCT02288897|Stage IIIC|stage iiic
5277629|NCT02288897|Stage IV (M1a)|stage iv (m1a)
5277630|NCT02288897|Stage 3|stage 3
5277631|NCT02288897|Stage 4|stage 4
5277632|NCT02288897|IVM1a|ivm1a
5277633|NCT02288897|IV(M1a)|iv(m1a)
5277634|NCT02288897|IV-M1a|iv-m1a
5277635|NCT02288897|in-transit|in-transit
5277636|NCT02288897|in transit|in transit
5277637|NCT02288897|intransit|intransit
5277638|NCT02288897|satellite|satellite
5277639|NCT02288897|recurrent|recurrent
5277640|NCT02288884|Complications|complications
5277641|NCT02288884|Cesarean Section|cesarean section
5277643|NCT02288884|Infection (Following Delivery)|infection (following delivery)
5277644|NCT02288871|aortic valve replacement|aortic valve replacement
5277645|NCT02288871|aortic valve bioprosthesis|aortic valve bioprosthesis
5277647|NCT02288858|Hair thinning|hair thinning
5277648|NCT02288819|loop diuretics|loop diuretics
5277649|NCT02288819|heart failure|heart failure
5277650|NCT02288819|natriuresis|natriuresis
5277651|NCT02288819|urinary analysis|urinary analysis
5277652|NCT02288793|attitudes|attitudes
5277653|NCT02288793|knowledge|knowledge
5277654|NCT02288793|examination|examination
5277655|NCT02288754|DNA in Tumors|dna in tumors
5277656|NCT02288754|cfDNA|cfdna
5277658|NCT02288754|Advanced stage cancer|advanced stage cancer
5277664|NCT02288728|Proximal gastrectomy|proximal gastrectomy
5277666|NCT02288728|mortality|mortality
5277667|NCT02288728|morbidity|morbidity
5277668|NCT02288715|cerebral perfusion pressure|cerebral perfusion pressure
5277669|NCT02288715|septic encephalopathy|septic encephalopathy
5277677|NCT02288598|Stammering|stammering
5277678|NCT02288598|Brain stimulation|brain stimulation
5277679|NCT02288585|plant sterols|plant sterols
5277680|NCT02288585|blood lipids|blood lipids
5277681|NCT02288572|metabolic syndrome X|metabolic syndrome x
5277682|NCT02288572|obesity|obesity
5277683|NCT02288572|insulin resistance|insulin resistance
5277684|NCT02288572|dyslipidemia|dyslipidemia
5277685|NCT02288572|probiotic bacteria|probiotic bacteria
5277686|NCT02288546|nutritional status|nutritional status
5277687|NCT02288546|pesticides|pesticides
5277688|NCT02288546|nitrate|nitrate
5277689|NCT02288533|Minimally Conscious State|minimally conscious state
5277690|NCT02288533|tDCS|tdcs
5277691|NCT02288520|Methotrexate|methotrexate
5277692|NCT02288520|Therapeutic strategy|therapeutic strategy
5277693|NCT02288507|sorafenib, yttrium-90 radioembolization|sorafenib, yttrium-90 radioembolization
5277694|NCT02288494|hypoalbuminemia|hypoalbuminemia
5277695|NCT02288494|-acid base balance|-acid base balance
5277696|NCT02288494|acid base disorders|acid base disorders
5277697|NCT02288494|critical ill|critical ill
5277698|NCT02288494|Stewart approach|stewart approach
5277699|NCT02288494|human albumin infusion|human albumin infusion
5277700|NCT02288481|Tuberculosis|tuberculosis
5277701|NCT02288481|TBA-354|tba-354
5277702|NCT02288481|Pulmonary Tuberculosis|pulmonary tuberculosis
5277704|NCT02288468|Parkinson's Disease|parkinson's disease
5277705|NCT02288455|SUI, incontinence, sphincter|sui, incontinence, sphincter
5277706|NCT02288429|pharmacokinetics|pharmacokinetics
5277707|NCT02288429|cystic fibrosis|cystic fibrosis
5277708|NCT02288429|critical illness|critical illness
5277709|NCT02288403|Aerobic Exercise|aerobic exercise
5277710|NCT02288403|Oxygen Consumption|oxygen consumption
5277711|NCT02288403|Blood Pressure|blood pressure
5277712|NCT02288390|VAP|vap
5277713|NCT02288390|Oral care|oral care
5277714|NCT02288390|Chlorhexidine|chlorhexidine
5277715|NCT02288390|Miswak (Sewak)|miswak (sewak)
5277716|NCT02288377|Lanreotide|lanreotide
5277717|NCT02288377|Duodeno-pancreatic neuroendocrine tumours|duodeno-pancreatic neuroendocrine tumours
5277718|NCT02288377|Maintenance treatment|maintenance treatment
5277719|NCT02288351|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5277720|NCT02288325|Fetzima|fetzima
5277721|NCT02288325|Relapse-prevention|relapse-prevention
5277722|NCT02288325|Placebo-controlled|placebo-controlled
5277723|NCT02288299|Instrumental cough assistance|instrumental cough assistance
5277724|NCT02288299|positive pressure insufflation maneuver|positive pressure insufflation maneuver
5277725|NCT02288299|home mechanical ventilation|home mechanical ventilation
5277726|NCT02288299|prospective evaluation|prospective evaluation
5277727|NCT02288260|Acute Coronary Syndrome|acute coronary syndrome
5277728|NCT02288260|Russian ACS Registry|russian acs registry
5277729|NCT02288260|ticagrelor|ticagrelor
5277730|NCT02288247|Metastatic|metastatic
5277731|NCT02288247|Castration-resistant|castration-resistant
5277732|NCT02288247|Docetaxel|docetaxel
5277733|NCT02288247|Chemotherapy- Naïve|chemotherapy- naïve
5277734|NCT02288247|Enzalutamide|enzalutamide
5277735|NCT02288247|Prostate Cancer|prostate cancer
5277736|NCT02288247|Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer|chemotherapy naïve metastatic castration resistant prostate cancer
5277737|NCT02288247|Prednisolone|prednisolone
5277738|NCT02288247|Xtandi|xtandi
5277739|NCT02288247|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5277740|NCT02288234|Registry|registry
5277741|NCT02288195|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5277742|NCT02288195|Preoperative radiotherapy|preoperative radiotherapy
5277743|NCT02288195|Chemoradiotherapy|chemoradiotherapy
5277744|NCT02288195|Capecitabine|capecitabine
5277745|NCT02288195|Oxaliplatin|oxaliplatin
5277746|NCT02288182|Sinus augmentation procedure|sinus augmentation procedure
5277747|NCT02288169|Symptom management|symptom management
5277748|NCT02288169|palliative care|palliative care
5277749|NCT02288117|PMCF|pmcf
5277750|NCT02288117|Post Market Clinical Follow up|post market clinical follow up
5277751|NCT02288117|SP-CL|sp-cl
5277752|NCT02288117|anatomic stem|anatomic stem
5277753|NCT02288104|Interventional Radiology|interventional radiology
5277763|NCT02288104|Fluorescein|fluorescein
5277765|NCT02288091|Inosine|inosine
5277766|NCT02288091|Uric acid|uric acid
5277767|NCT02288091|Urate|urate
5277768|NCT02288091|Glutathione|glutathione
5277769|NCT02288091|Biomarker|biomarker
5277770|NCT02288091|Oxidative stress|oxidative stress
5277771|NCT02288091|Oxidative damage|oxidative damage
5277772|NCT02288091|proof-of-concept|proof-of-concept
5277773|NCT02288078|unresectable colorectal cancer|unresectable colorectal cancer
5277774|NCT02288078|regorafenib|regorafenib
5277775|NCT02288078|Steroid|steroid
5277776|NCT02288078|fatigue and malaise|fatigue and malaise
5277777|NCT02288078|Phase 2 randomized, controlled trial (RCT)|phase 2 randomized, controlled trial (rct)
5277778|NCT02288052|Handwriting|handwriting
5277779|NCT02288052|Motor learning|motor learning
5277780|NCT02288039|Pulmonary|pulmonary
5277781|NCT02288026|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5277782|NCT02288026|Lung Neoplasms|lung neoplasms
5277783|NCT02288026|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5277784|NCT02288026|Bronchial Neoplasms|bronchial neoplasms
5277785|NCT02288013|Cesarean section|cesarean section
5277786|NCT02288013|uterine closure technique|uterine closure technique
5277787|NCT02288013|materials used|materials used
5277788|NCT02288000|Alzheimer|alzheimer
5277789|NCT02288000|Memantine|memantine
5277790|NCT02288000|biomarkers|biomarkers
5277791|NCT02288000|battery|battery
5277792|NCT02288000|cognition|cognition
5277793|NCT02288000|imaging|imaging
5277794|NCT02288000|neuropsychology|neuropsychology
5277795|NCT02287987|Renal function|renal function
5277796|NCT02287987|Off-clamp|off-clamp
5277797|NCT02287987|Partial nephrectomy|partial nephrectomy
5277798|NCT02287987|Robotic|robotic
5277799|NCT02287987|Hylar clamping|hylar clamping
5277800|NCT02287948|Balance|balance
5277801|NCT02287948|Multiple Sclerosis|multiple sclerosis
5277802|NCT02287948|Nintendo Wii Fit|nintendo wii fit
5277803|NCT02287935|Karydakis procedure|karydakis procedure
5277804|NCT02287935|Limberg flap|limberg flap
5277805|NCT02287935|recurrent pilonidal sinus|recurrent pilonidal sinus
5277806|NCT02287896|RhD-negative pregnant woman|rhd-negative pregnant woman
5277807|NCT02287896|anti-RhD antibody|anti-rhd antibody
5277808|NCT02287883|Patient activation and engagement|patient activation and engagement
5277809|NCT02287883|Patient reported outcomes|patient reported outcomes
5277810|NCT02287883|Accountable Care Organizations|accountable care organizations
5277811|NCT02287883|Chronic illness|chronic illness
5277812|NCT02287883|Vulnerable population|vulnerable population
5277813|NCT02287883|Comparison of approaches|comparison of approaches
5277814|NCT02287870|Epidural anesthesia|epidural anesthesia
5277815|NCT02287870|Chloroprocaine|chloroprocaine
5277816|NCT02287870|Lidocaine|lidocaine
5277817|NCT02287844|Xylo-oligosaccharides|xylo-oligosaccharides
5277818|NCT02287844|Immunonutrition|immunonutrition
5277819|NCT02287844|Prebiotics|prebiotics
5277820|NCT02287844|Lipopolysaccharides|lipopolysaccharides
5277821|NCT02287844|Cytokines|cytokines
5277822|NCT02287805|craniosynostosis|craniosynostosis
5277823|NCT02287805|simple form|simple form
5277824|NCT02287805|complex form|complex form
5277825|NCT02287805|diagnostic|diagnostic
5277826|NCT02287805|announcement|announcement
5277827|NCT02287805|impacts|impacts
5277828|NCT02287792|Infective endocarditis|infective endocarditis
5277829|NCT02287792|18-FDG PET/CT|18-fdg pet/ct
5277830|NCT02287792|Impact|impact
5277831|NCT02287792|Patient's management|patient's management
5277832|NCT02287792|Diagnostic|diagnostic
5277833|NCT02287753|vascular occlusion test|vascular occlusion test
5277834|NCT02287753|near infrared spectroscopy|near infrared spectroscopy
5277835|NCT02287740|Exercise|exercise
5277836|NCT02287714|Instep plantar fasciotomy|instep plantar fasciotomy
5277837|NCT02287701|bladder cancer|bladder cancer
5277838|NCT02287701|MRI|mri
5277839|NCT02287701|PET|pet
5277840|NCT02287688|safety of Meningococcal quadrivalent CRM-197 conjugate vaccine|safety of meningococcal quadrivalent crm-197 conjugate vaccine
5277841|NCT02287688|Children 2-23 months of age|children 2-23 months of age
5277842|NCT02287675|Sentinel Node|sentinel node
5277843|NCT02287662|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5277844|NCT02287649|Immune thrombocytopenia|immune thrombocytopenia
5277845|NCT02287649|Fc gamma RIIIA V/F158 polymorphism|fc gamma riiia v/f158 polymorphism
5277846|NCT02287649|Rituximab|rituximab
5277850|NCT02287610|Delayed-release prednisone|delayed-release prednisone
5277851|NCT02287610|Immediate-release prednisone|immediate-release prednisone
5277852|NCT02287610|Non-interventional|non-interventional
5277853|NCT02287571|comfort|comfort
5277854|NCT02287571|satisfaction|satisfaction
5277855|NCT02287558|HHT|hht
5277856|NCT02287558|CASE4Z14|case4z14
5277857|NCT02287558|Pomalidomide|pomalidomide
5277858|NCT02287545|open angle glaucoma|open angle glaucoma
5277859|NCT02287545|corneal biomechanics|corneal biomechanics
5277860|NCT02287545|trabeculectomy|trabeculectomy
5277861|NCT02287506|diagnosis, strategy|diagnosis, strategy
5277862|NCT02287480|Ebolavirus Vaccines|ebolavirus vaccines
5277863|NCT02287467|Antiviral|antiviral
5277864|NCT02287467|IVIG|ivig
5277865|NCT02287467|Hemagglutination inhibition (HAI)|hemagglutination inhibition (hai)
5277866|NCT02287467|Antibody|antibody
5277867|NCT02287454|Multiple Sclerosis, cognitive rehabilitation, REHACOP|multiple sclerosis, cognitive rehabilitation, rehacop
5277868|NCT02287376|Migraine with and without aura|migraine with and without aura
5277869|NCT02287350|pain|pain
5277870|NCT02287350|moderate pain|moderate pain
5277871|NCT02287350|mild pain|mild pain
5277872|NCT02287350|acute pain|acute pain
5381434|NCT01805791|UC|uc
5277873|NCT02287350|mild acute pain|mild acute pain
5277874|NCT02287350|moderate acute pain|moderate acute pain
5277875|NCT02287350|mild or moderate acute pain|mild or moderate acute pain
5277876|NCT02287350|NSAID|nsaid
5277877|NCT02287350|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
5277878|NCT02287337|Neck pain|neck pain
5277879|NCT02287324|Cervicalgia|cervicalgia
5277880|NCT02287311|EBV positive diseases|ebv positive diseases
5277881|NCT02287311|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5277882|NCT02287285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5277883|NCT02287285|Gastric Bypass Surgery|gastric bypass surgery
5277884|NCT02287285|Exendin9|exendin9
5277885|NCT02287272|COPD- cimetidine- drug-drug interaction|copd- cimetidine- drug-drug interaction
5277886|NCT02287233|Myelogenous Leukemia|myelogenous leukemia
5277887|NCT02287233|Treatment Naive AML|treatment naive aml
5277888|NCT02287233|Untreated AML|untreated aml
5277889|NCT02287220|Non-Contact Oximetry|non-contact oximetry
5277890|NCT02287220|video plethysmography|video plethysmography
5277891|NCT02287220|oxygen desaturation|oxygen desaturation
5277892|NCT02287168|Peritoneal lavage|peritoneal lavage
5277893|NCT02287168|Dissemination|dissemination
5277894|NCT02287168|Gastrectomy|gastrectomy
5277895|NCT02287168|Cytology|cytology
5277896|NCT02287168|Lavage|lavage
5277897|NCT02287155|Health Promotion|health promotion
5277898|NCT02287155|Intervention Study|intervention study
5277899|NCT02287155|Occupational Therapy|occupational therapy
5277900|NCT02287155|Rural Population|rural population
5277901|NCT02287155|Quality of life|quality of life
5277902|NCT02287155|Sense of coherence|sense of coherence
5277903|NCT02287129|Potentially R0 - resectable AEG and primary tumor category|potentially r0 - resectable aeg and primary tumor category
5849062|NCT00031369|Focal Hand Dystonia|focal hand dystonia
5277904|NCT02287129|Histologically confirmed AEG I-III|histologically confirmed aeg i-iii
5277905|NCT02287129|Functional operability|functional operability
5277906|NCT02287129|Intense FDG tracer uptake of the tumor|intense fdg tracer uptake of the tumor
5277907|NCT02287116|preterm infants|preterm infants
5277908|NCT02287116|CPAP|cpap
5277910|NCT02287116|invasive mechanical ventilation|invasive mechanical ventilation
5277911|NCT02287116|we aimed determine that affect the rate of BPD and death of NCPAP therapy with nasal prongs or nasal mask as the initial treatment for RDS.|we aimed determine that affect the rate of bpd and death of ncpap therapy with nasal prongs or nasal mask as the initial treatment for rds.
5277912|NCT02287103|Skipping Breakfast|skipping breakfast
5277913|NCT02287038|PTSD|ptsd
5277914|NCT02287038|ADHD|adhd
5277915|NCT02287038|Atomoxetine|atomoxetine
5277916|NCT02287038|Combat Trauma|combat trauma
5277917|NCT02287038|Cognitive Deficit|cognitive deficit
5277918|NCT02286986|Epilepsy|epilepsy
5277919|NCT02286986|Dravet syndrome|dravet syndrome
5277920|NCT02286986|Seizures|seizures
5277921|NCT02286986|Intractable Epilepsy|intractable epilepsy
5277922|NCT02286986|Medically Refractory Epilepsy|medically refractory epilepsy
5277923|NCT02286973|Tranexamic acid|tranexamic acid
5277924|NCT02286947|DMD|dmd
5277925|NCT02286947|exon 51|exon 51
5277926|NCT02286947|dystrophin|dystrophin
5277927|NCT02286947|dystrophy|dystrophy
5277928|NCT02286947|eteplirsen|eteplirsen
5277929|NCT02286947|Duchenne|duchenne
5277930|NCT02286934|Carvedilol|carvedilol
5277931|NCT02286934|CYP2D6|cyp2d6
5277932|NCT02286934|Isoproterenol Sensitivity Test|isoproterenol sensitivity test
5277933|NCT02286921|Testosterone|testosterone
5277934|NCT02286921|Enzalutamide|enzalutamide
5277935|NCT02286921|Abiraterone|abiraterone
5277936|NCT02286921|Androgen Ablative Therapies|androgen ablative therapies
5277937|NCT02286921|Bipolar Androgen Therapy|bipolar androgen therapy
5277938|NCT02286908|Ejection fraction, Global Strain, Mechanical dispersion|ejection fraction, global strain, mechanical dispersion
5277942|NCT02286895|EPI vaccines|epi vaccines
5277943|NCT02286882|Single Ascending Dose|single ascending dose
5277944|NCT02286882|healthy subjects|healthy subjects
5277945|NCT02286869|mechanical ventilation|mechanical ventilation
5277946|NCT02286869|autonomic nervous system|autonomic nervous system
5277947|NCT02286869|heart rate variability|heart rate variability
5277948|NCT02286869|cardioventilatory coupling|cardioventilatory coupling
5277949|NCT02286856|malnutrition, diet intervention, Nutritional Assessment|malnutrition, diet intervention, nutritional assessment
5277950|NCT02286843|89Zr-trastuzumab|89zr-trastuzumab
5277953|NCT02286843|89Zr-pertuzumab|89zr-pertuzumab
5277954|NCT02286843|HER2-targeted|her2-targeted
5277955|NCT02286830|osteolysis|osteolysis
5277956|NCT02286830|zoledronic acid|zoledronic acid
5277957|NCT02286830|osteonecrosis|osteonecrosis
5277958|NCT02286830|bone markers|bone markers
5277959|NCT02286830|low-dose CT|low-dose ct
5277960|NCT02286791|Prevention of dementia|prevention of dementia
5277961|NCT02286791|Mindful awareness program|mindful awareness program
5277962|NCT02286791|Mild cognitive impairment|mild cognitive impairment
5277963|NCT02286791|Mindfulness|mindfulness
5277964|NCT02286791|Elderly|elderly
5277965|NCT02286791|Cognitive decline|cognitive decline
5277966|NCT02286765|Ulthera System|ulthera system
5277967|NCT02286765|Ultherapy|ultherapy
5277968|NCT02286739|Total Knee Arthroplasty|total knee arthroplasty
5277969|NCT02286739|Rotational Alignment|rotational alignment
5277970|NCT02286739|Intraoperative Sensors|intraoperative sensors
5277971|NCT02286739|Patient Outcomes|patient outcomes
5277972|NCT02286739|Soft Tissue Balance|soft tissue balance
5277973|NCT02286713|Lung Cancer Screening|lung cancer screening
5277974|NCT02286713|heavy smokers|heavy smokers
5277975|NCT02286713|state-based smoking cessation quitlines|state-based smoking cessation quitlines
5277976|NCT02286713|patient decision aid|patient decision aid
5277977|NCT02286713|low-dose computed tomography|low-dose computed tomography
5277978|NCT02286713|LDCT|ldct
5277979|NCT02286713|standard educational information|standard educational information
5277980|NCT02286700|dermatitis, eczema, itch, moisturizer, amino acid|dermatitis, eczema, itch, moisturizer, amino acid
5277981|NCT02286674|mYpas|mypas
5277982|NCT02286674|anxiety|anxiety
5277983|NCT02286674|distraction|distraction
5277984|NCT02286674|inhalation induction|inhalation induction
5277985|NCT02286648|clinical signs|clinical signs
5277986|NCT02286648|child|child
5277987|NCT02286648|pulpotomy|pulpotomy
5277988|NCT02286583|RTM|rtm
5277989|NCT02286583|Female breast cancer|female breast cancer
5277990|NCT02286557|Methylphenidate|methylphenidate
5277991|NCT02286557|Multiple Sclerosis|multiple sclerosis
5277992|NCT02286557|Cognitive Fatigue|cognitive fatigue
5277993|NCT02286544|Myocardial Infarction|myocardial infarction
5277994|NCT02286544|Oxygen|oxygen
5277995|NCT02286544|Inflammation|inflammation
5277996|NCT02286544|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5277997|NCT02286544|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
5277998|NCT02286544|Reperfusion injury (IR-injury)|reperfusion injury (ir-injury)
5277999|NCT02286544|Biomarkers|biomarkers
5278001|NCT02286544|Salmonella typhi|salmonella typhi
5278002|NCT02286544|Vaccine-induced inflammation|vaccine-induced inflammation
5278003|NCT02286544|Soluble markers of apoptosis|soluble markers of apoptosis
5278004|NCT02286544|Leukocyte subset distribution|leukocyte subset distribution
5278005|NCT02286544|Matrix metalloproteinase (MMP)|matrix metalloproteinase (mmp)
5278006|NCT02286544|Biological Markers|biological markers
5278007|NCT02286531|: Low grade glioma|: low grade glioma
5278008|NCT02286531|PET|pet
5278009|NCT02286531|FET|fet
5278010|NCT02286531|MRI|mri
5278011|NCT02286531|Standardized uptake value|standardized uptake value
5278012|NCT02286453|Osteoarthritis of The knee|osteoarthritis of the knee
5278013|NCT02286453|Benjakul|benjakul
5278014|NCT02286453|Alternative Medicine|alternative medicine
5278015|NCT02286440|Depression|depression
5278016|NCT02286440|Genotyping|genotyping
5278017|NCT02286440|Pharmacokinetic|pharmacokinetic
5278018|NCT02286440|Pharmacodynamic|pharmacodynamic
5278019|NCT02286414|oral anticoagulants|oral anticoagulants
5278020|NCT02286414|Geriatrics|geriatrics
5278021|NCT02286414|General Practitioner|general practitioner
5278022|NCT02286414|Safety|safety
5278023|NCT02286414|Misuse|misuse
5278024|NCT02286401|myocardial perfusion|myocardial perfusion
5278025|NCT02286401|coronary atherosclerosis|coronary atherosclerosis
5278026|NCT02286401|coronary blood flow|coronary blood flow
5278027|NCT02286401|fractional flow reserve|fractional flow reserve
5278028|NCT02286401|coronary flow reserve|coronary flow reserve
5278029|NCT02286388|Deep carious lesion|deep carious lesion
5278030|NCT02286388|incomplete caries removal|incomplete caries removal
5278031|NCT02286388|antibacterial adhesive system|antibacterial adhesive system
5278032|NCT02286388|dental composite resin|dental composite resin
5278033|NCT02286388|pulp vitality preservation|pulp vitality preservation
5278034|NCT02286388|randomized controlled trial|randomized controlled trial
5278037|NCT02286349|Neuromodulation Attention Deficit Hyperactivity Disorder|neuromodulation attention deficit hyperactivity disorder
5278038|NCT02286336|minimum effective concentration|minimum effective concentration
5278039|NCT02286336|ropivacaine|ropivacaine
5278040|NCT02286336|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
5278041|NCT02286323|Intubation, Endotracheal|intubation, endotracheal
5278042|NCT02286310|Exercise|exercise
5278043|NCT02286310|Kinematics|kinematics
5278044|NCT02286297|Intubation|intubation
5278045|NCT02286284|Early severe preeclampsia|early severe preeclampsia
5278046|NCT02286284|Angiogenic factor|angiogenic factor
5278047|NCT02286284|Apheresis|apheresis
5278048|NCT02286271|Seizure detection|seizure detection
5278049|NCT02286258|Inulin|inulin
5278050|NCT02286258|Ca-EDTA|ca-edta
5278051|NCT02286258|Gd-DOTA|gd-dota
5278052|NCT02286258|Chronic kidney disease|chronic kidney disease
5278053|NCT02286258|glomerular filtration rate measurement|glomerular filtration rate measurement
5278054|NCT02286245|Triage|triage
5278055|NCT02286245|Hotline|hotline
5278056|NCT02286245|Primary Health Care|primary health care
5278057|NCT02286245|Emergency Medical Service Communication Systems|emergency medical service communication systems
5278058|NCT02286232|Chronic low back pain|chronic low back pain
5278059|NCT02286232|stretching exercises|stretching exercises
5278060|NCT02286206|Clozapine|clozapine
5278061|NCT02286206|Psychotropic Drugs|psychotropic drugs
5278062|NCT02286206|Antipsychotic Agents|antipsychotic agents
5278063|NCT02286206|Psychotic Disorders|psychotic disorders
5278064|NCT02286206|Schizophrenia|schizophrenia
5278065|NCT02286206|Adverse Effects|adverse effects
5278066|NCT02286206|Drug Monitoring|drug monitoring
5278067|NCT02286180|near infrared spectroscopy|near infrared spectroscopy
5278068|NCT02286180|NIRS|nirs
5278069|NCT02286180|intern|intern
5278070|NCT02286167|modified-Atkins diet|modified-atkins diet
5278071|NCT02286167|ketogenic diet|ketogenic diet
5278072|NCT02286167|central nervous system malignancy|central nervous system malignancy
5278073|NCT02286167|glioma|glioma
5278074|NCT02286154|Hydroxyurea|hydroxyurea
5278075|NCT02286154|Sickle Cell|sickle cell
5278076|NCT02286154|Pharmacokinetics|pharmacokinetics
5278077|NCT02286154|dynamics|dynamics
5278078|NCT02286154|genomics|genomics
5278079|NCT02286128|Type 2 diabetes|type 2 diabetes
5278080|NCT02286128|RAGE|rage
5278081|NCT02286128|osteoblast|osteoblast
5278082|NCT02286115|Chronic Pelvic Pain|chronic pelvic pain
5278083|NCT02286115|Interstitial Cystitis|interstitial cystitis
5278084|NCT02286115|Vulvodynia|vulvodynia
5278085|NCT02286115|Dyspareunia|dyspareunia
5278086|NCT02286115|Pelvic Floor Dysfunction|pelvic floor dysfunction
5278087|NCT02286115|Emotional Processing|emotional processing
5278088|NCT02286089|dry-AMD|dry-amd
5278089|NCT02286089|Geographic Atrophy|geographic atrophy
5278090|NCT02286076|endometrioma|endometrioma
5278091|NCT02286076|laparoscopy|laparoscopy
5278092|NCT02286076|ovarian reserve|ovarian reserve
5278093|NCT02286037|Secondary Hyperalgesia|secondary hyperalgesia
5278094|NCT02286037|Method|method
5278095|NCT02286037|Pin-prick|pin-prick
5278096|NCT02286037|Monofilament|monofilament
5278097|NCT02285998|Influenza|influenza
5278098|NCT02285985|Adipose tissue|adipose tissue
5278099|NCT02285985|Inflammation|inflammation
5278100|NCT02285985|.Obesity|.obesity
5278101|NCT02285933|stroke|stroke
5278102|NCT02285933|physical therapy specialty|physical therapy specialty
5278103|NCT02285933|exercise therapy|exercise therapy
5278104|NCT02285933|virtual reality|virtual reality
5278105|NCT02285933|man-machine systems|man-machine systems
5278106|NCT02285933|randomized control trial|randomized control trial
5278107|NCT02285933|inpatients|inpatients
5278108|NCT02285933|rehabilitation|rehabilitation
5278109|NCT02285920|hemodialysis|hemodialysis
5278110|NCT02285920|spironolactone|spironolactone
5278111|NCT02285920|cardiac fibrosis|cardiac fibrosis
5278112|NCT02285920|diastolic function|diastolic function
5278113|NCT02285881|diabetes treatment|diabetes treatment
5278114|NCT02285881|personalized medicine|personalized medicine
5278115|NCT02285881|shared decision making|shared decision making
5278116|NCT02285881|goal setting|goal setting
5278117|NCT02285868|Orthopedic rehabilitation|orthopedic rehabilitation
5278118|NCT02285868|Rehabilitation outcomes|rehabilitation outcomes
5278119|NCT02285868|Physical therapy|physical therapy
5278120|NCT02285868|Physical therapy outcomes|physical therapy outcomes
5278121|NCT02285855|Lung Cancer|lung cancer
5278122|NCT02285855|Non small cell lung cancer|non small cell lung cancer
5278123|NCT02285855|Stereotactic body radiotherapy|stereotactic body radiotherapy
5278124|NCT02285855|SBRT|sbrt
5278125|NCT02285855|XRT|xrt
5278126|NCT02285855|Radiation therapy|radiation therapy
5278127|NCT02285855|Metformin|metformin
5278128|NCT02285855|Metformin ER|metformin er
5278129|NCT02285855|Placebo|placebo
5278130|NCT02285855|Sugar pill|sugar pill
5278131|NCT02285855|Lung adenocarcinoma|lung adenocarcinoma
5278132|NCT02285855|Genotypes|genotypes
5278133|NCT02285855|Genetic mutations|genetic mutations
5278134|NCT02285842|osteoarthritis|osteoarthritis
5278135|NCT02285842|avascular necrosis|avascular necrosis
5278136|NCT02285842|ankylosis|ankylosis
5278137|NCT02285842|protrusio acetabuli|protrusio acetabuli
5278138|NCT02285842|painful hip dysplasia|painful hip dysplasia
5278139|NCT02285842|rheumatoid arthritis|rheumatoid arthritis
5278140|NCT02285842|correction of functional deformity|correction of functional deformity
5278141|NCT02285842|revision procedures|revision procedures
5278142|NCT02285751|high on treatment platelet reactivity|high on treatment platelet reactivity
5278143|NCT02285751|acetylsalicylic acid|acetylsalicylic acid
5278144|NCT02285751|clopidogrel|clopidogrel
5278145|NCT02285751|prasugrel|prasugrel
5278146|NCT02285751|ticagrelor|ticagrelor
5278147|NCT02285751|critically ill|critically ill
5278148|NCT02285751|pharmacokinetic|pharmacokinetic
5278149|NCT02285751|pharmacodynamics|pharmacodynamics
5278150|NCT02285738|solid tumor, cancer, simvastatin, aspirin, blood clot, VTE, venous thromboembolism|solid tumor, cancer, simvastatin, aspirin, blood clot, vte, venous thromboembolism
5278151|NCT02285712|Peripheral venous catheter|peripheral venous catheter
5278152|NCT02285712|ultrasound|ultrasound
5278153|NCT02285712|nurse|nurse
5278154|NCT02285712|Intensive Care Units|intensive care units
5278155|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5278156|NCT02285686|troponin|troponin
5278157|NCT02285686|biomarkers|biomarkers
5278158|NCT02285686|myocardial infarction|myocardial infarction
5278159|NCT02285686|critical illness|critical illness
5674387|NCT00603772|phototoxicity|phototoxicity
5278160|NCT02285673|umbilical cord, mesenchymal stem cell|umbilical cord, mesenchymal stem cell
5278161|NCT02285621|Scoliosis|scoliosis
5278162|NCT02285621|Spine deformity|spine deformity
5278163|NCT02285621|Brace|brace
5278164|NCT02285621|3D|3d
5278165|NCT02285608|Medication adherence|medication adherence
5278166|NCT02285608|Patient education|patient education
5278167|NCT02285608|Mood disorders|mood disorders
5278168|NCT02285608|Economic assessment|economic assessment
5278169|NCT02285608|Mixed methods|mixed methods
5278170|NCT02285556|drug carving changes during rehabilitation|drug carving changes during rehabilitation
5278171|NCT02285556|community|community
5278172|NCT02285556|DNA|dna
5278173|NCT02285543|TPF induction chemotherapy, randomized, trial,OSCC|tpf induction chemotherapy, randomized, trial,oscc
5278174|NCT02285530|head and neck squamous cell carcinoma, GDF15, TPF|head and neck squamous cell carcinoma, gdf15, tpf
5278175|NCT02285504|Postpartum depression|postpartum depression
5278176|NCT02285465|Healthy volunteers|healthy volunteers
5278177|NCT02285465|Pharmacokinetics|pharmacokinetics
5278178|NCT02285465|Pharmacodynamics|pharmacodynamics
5278179|NCT02285465|ASP3700|asp3700
5278180|NCT02285452|physiologcal phenomena|physiologcal phenomena
5278181|NCT02285452|.HRV Parameters|.hrv parameters
5278182|NCT02285452|respiratory activity|respiratory activity
5278183|NCT02285452|thorax wraps|thorax wraps
5278184|NCT02285439|Pediatric Oncology|pediatric oncology
5278185|NCT02285439|Ras/Raf pathway|ras/raf pathway
5278186|NCT02285439|Low-Grade Glioma|low-grade glioma
5278187|NCT02285439|MEK inhibitor|mek inhibitor
5278188|NCT02285426|i-scan|i-scan
5278189|NCT02285426|histology|histology
5278190|NCT02285413|Melanoma|melanoma
5278191|NCT02285413|Dendritic cells|dendritic cells
5278192|NCT02285413|Cisplatin|cisplatin
5278193|NCT02285413|Vaccine|vaccine
5278194|NCT02285413|Immunotherapy|immunotherapy
5278195|NCT02285400|COPD|copd
5278196|NCT02285400|CPAP|cpap
5278200|NCT02285348|inflammation|inflammation
5278201|NCT02285348|proteomic analysis|proteomic analysis
5278202|NCT02285309|Cardiac Surgery|cardiac surgery
5278203|NCT02285309|Diastolic Dysfunction|diastolic dysfunction
5278204|NCT02285309|Enoximone|enoximone
5278205|NCT02285296|geriatric assessment|geriatric assessment
5278206|NCT02285296|Caregivers|caregivers
5278207|NCT02285296|Needs Assessment|needs assessment
5278208|NCT02285296|oncology nursing|oncology nursing
5278209|NCT02285296|frail elderly|frail elderly
5278210|NCT02285296|Medical, psychologic and sociologic approach|medical, psychologic and sociologic approach
5278211|NCT02285270|Circadian rhythm|circadian rhythm
5278212|NCT02285270|Adipose tissue, brown|adipose tissue, brown
5278213|NCT02285270|Metabolism|metabolism
5278214|NCT02285257|Sepsis, Severe sepsis, septic shock, epidemiology, outcome|sepsis, severe sepsis, septic shock, epidemiology, outcome
5278215|NCT02285231|Anti-hyperglycemic effect|anti-hyperglycemic effect
5278216|NCT02285192|18F-FDG Injection|18f-fdg injection
5278217|NCT02285192|Positron Lymphography|positron lymphography
5278218|NCT02285192|Lymphatic Mapping|lymphatic mapping
5278219|NCT02285192|sentinel lymph nodes|sentinel lymph nodes
5278220|NCT02285192|PET/CT|pet/ct
5278221|NCT02285192|14-222|14-222
5278222|NCT02285179|GDC-0032|gdc-0032
5278223|NCT02285179|Pi3K inhibitor|pi3k inhibitor
5278224|NCT02285179|tamoxifen|tamoxifen
5278225|NCT02285179|hormone receptor positive|hormone receptor positive
5278226|NCT02285179|RECIST|recist
5278227|NCT02285179|pharmacodynamic|pharmacodynamic
5278228|NCT02285166|Pharmaocological therapy|pharmaocological therapy
5278229|NCT02285153|acetylsalicylic acid|acetylsalicylic acid
5278230|NCT02285153|intensive care unit|intensive care unit
5278231|NCT02285153|mortality|mortality
5278232|NCT02285153|Post mortem examination|post mortem examination
5278233|NCT02285153|bleeding|bleeding
5278234|NCT02285114|HIV|hiv
5278235|NCT02285114|emtricitabine|emtricitabine
5278236|NCT02285114|FTC|ftc
5278238|NCT02285114|TDF|tdf
5278239|NCT02285114|TAF|taf
5278240|NCT02285114|antiretroviral|antiretroviral
5278241|NCT02285114|pharmacokinetic|pharmacokinetic
5278242|NCT02285114|PK|pk
5278243|NCT02285114|adolescents|adolescents
5278244|NCT02285114|children|children
5278245|NCT02285114|pediatric|pediatric
5278246|NCT02285114|Gilead|gilead
5278247|NCT02285101|arginine auxotrophic tumors|arginine auxotrophic tumors
5278248|NCT02285101|PEG-BCT-100|peg-bct-100
5278249|NCT02285101|arginase|arginase
5278250|NCT02285075|temocillin|temocillin
5278251|NCT02285075|PD/PD|pd/pd
5278252|NCT02285075|T>MIC|t>mic
5278253|NCT02285062|R-CHOP chemotherapy|r-chop chemotherapy
5278254|NCT02285062|DLBCL front line therapy|dlbcl front line therapy
5278255|NCT02285062|gene expression profiling (GEP) activated B-cell (ABC) type DLBCL biomarkers|gene expression profiling (gep) activated b-cell (abc) type dlbcl biomarkers
5278256|NCT02285062|Activated B-Cell (ABC) type|activated b-cell (abc) type
5278257|NCT02285062|Diffuse Large B-Cell Lymphoma, not otherwise specified|diffuse large b-cell lymphoma, not otherwise specified
5278258|NCT02285062|Diffuse Large B-Cell Lymphoma, associated with chronic inflammation|diffuse large b-cell lymphoma, associated with chronic inflammation
5278259|NCT02285062|Diffuse Large B-Cell Lymphoma, Epstein-Barr virus positive (EBS+) of the elderly|diffuse large b-cell lymphoma, epstein-barr virus positive (ebs+) of the elderly
5278260|NCT02285062|Diffuse Large B-Cell Lymphoma, T-cell / histiocyte-rich|diffuse large b-cell lymphoma, t-cell / histiocyte-rich
5278261|NCT02285049|Chronic urticaria|chronic urticaria
5278262|NCT02285049|Urticaria Control Test|urticaria control test
5278263|NCT02285023|Chronic urticaria|chronic urticaria
5278264|NCT02285023|CU-Q2oL|cu-q2ol
5278265|NCT02285010|pregabalin|pregabalin
5278266|NCT02285010|postoperative pain|postoperative pain
5278267|NCT02285010|abdominal hysterectomy|abdominal hysterectomy
5278268|NCT02284984|Antibodies, Monoclonal|antibodies, monoclonal
5278269|NCT02284984|mabthera|mabthera
5278270|NCT02284984|benlysta|benlysta
5278271|NCT02284984|Antinuclear Antibodies|antinuclear antibodies
5278272|NCT02284958|walking|walking
5278273|NCT02284958|pedometer|pedometer
5278274|NCT02284932|COPD|copd
5278275|NCT02284932|atrophy|atrophy
5278276|NCT02284932|muscle|muscle
5278277|NCT02284906|Drug therapy|drug therapy
5278278|NCT02284867|uterine natural killer cells|uterine natural killer cells
5278279|NCT02284867|CD16|cd16
5278280|NCT02284867|CD56|cd56
5278281|NCT02284867|Preterm labour|preterm labour
5278282|NCT02284815|Gluten|gluten
5278283|NCT02284815|T1D|t1d
5278284|NCT02284815|Remission|remission
5278285|NCT02284789|Hemophilia|hemophilia
5278286|NCT02284776|Therapeutic education|therapeutic education
5278287|NCT02284750|Bifurcation lesion|bifurcation lesion
5278288|NCT02284750|Percutaneous coronary intervention|percutaneous coronary intervention
5278289|NCT02284737|Pulmonary arterial hypertension|pulmonary arterial hypertension
5282993|NCT02257411|Proseal LMA|proseal lma
5278290|NCT02284711|salpingectomy, ovarian reserve, coagulation technique|salpingectomy, ovarian reserve, coagulation technique
5278291|NCT02284685|Mental Health Services|mental health services
5278292|NCT02284646|Ankylosing spondylitis|ankylosing spondylitis
5278293|NCT02284646|Physical training program|physical training program
5278294|NCT02284633|EGFR mutation|egfr mutation
5278295|NCT02284633|Liquid biopsies|liquid biopsies
5278296|NCT02284633|Lung cancer|lung cancer
5278297|NCT02284633|erlotinib|erlotinib
5278298|NCT02284620|anesthesia|anesthesia
5278299|NCT02284620|nerve block|nerve block
5278300|NCT02284620|infltration|infltration
5278301|NCT02284581|MBC|mbc
5278302|NCT02284581|metastatic|metastatic
5278303|NCT02284581|breast|breast
5278304|NCT02284581|observational|observational
5278305|NCT02284581|disease management|disease management
5278306|NCT02284568|multiple sclerosis|multiple sclerosis
5278307|NCT02284568|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5278308|NCT02284568|oral immunomodulator|oral immunomodulator
5278309|NCT02284529|high-risk stage-Ⅱ Colorectal Cancer,Orectalip,oxaliplatin|high-risk stage-ⅱ colorectal cancer,orectalip,oxaliplatin
5278310|NCT02284503|MI reduction|mi reduction
5278311|NCT02284503|intensive statin treatment|intensive statin treatment
5278312|NCT02284503|NSTE-ACS|nste-acs
5278313|NCT02284490|Brain Metastases|brain metastases
5278314|NCT02284477|Insulin resistance|insulin resistance
5278315|NCT02284477|Pulmonary function|pulmonary function
5278316|NCT02284477|Phthalates|phthalates
5278317|NCT02284464|Kidney transplant|kidney transplant
5278318|NCT02284464|Immunosuppression|immunosuppression
5278319|NCT02284464|Steroid withdrawal|steroid withdrawal
5278320|NCT02284464|Donor specific antibodies|donor specific antibodies
5278321|NCT02284451|HIV/AIDS and HIV Testing Knowledge|hiv/aids and hiv testing knowledge
5278322|NCT02284438|ETT|ett
5278323|NCT02284438|Biofilm|biofilm
5278324|NCT02284438|Mechanical ventilation|mechanical ventilation
5278325|NCT02284438|Critical illness|critical illness
5278326|NCT02284438|Ventilator-associated pneumonia|ventilator-associated pneumonia
5278327|NCT02284412|Neostigmine|neostigmine
5278328|NCT02284412|Sugammadex|sugammadex
5278329|NCT02284399|aneuploidy|aneuploidy
5278330|NCT02284399|Trisomy 21|trisomy 21
5278331|NCT02284399|NIPT|nipt
5278332|NCT02284386|Total knee arthroplasty|total knee arthroplasty
5278333|NCT02284360|wound healing|wound healing
5278334|NCT02284360|APOSEC™|aposec™
5278335|NCT02284360|Safety|safety
5278336|NCT02284334|mitochondrial diseases|mitochondrial diseases
5278337|NCT02284334|nutrition|nutrition
5278338|NCT02284334|glycemic index|glycemic index
5278339|NCT02284308|NSCLC|nsclc
5278340|NCT02284295|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5278341|NCT02284295|silica dust|silica dust
5278342|NCT02284295|aromatic hydrocarbons|aromatic hydrocarbons
5278343|NCT02284295|genetic|genetic
5278446|NCT02283580|COPD|copd
5278344|NCT02284295|occupational|occupational
5278345|NCT02284282|Spinal Morphine|spinal morphine
5278346|NCT02284282|Laparoscopic GI-surgery|laparoscopic gi-surgery
5278347|NCT02284282|Post-operative pain|post-operative pain
5278348|NCT02284243|Bunion|bunion
5278349|NCT02284243|Bunionectomy|bunionectomy
5278350|NCT02284243|Pain|pain
5278351|NCT02284243|Analgesia|analgesia
5278352|NCT02284243|dexmedetomidine|dexmedetomidine
5278353|NCT02284243|intranasal|intranasal
5278354|NCT02284191|Radiology|radiology
5278355|NCT02284191|Acute Medicine|acute medicine
5278356|NCT02284191|Emergency Medicine|emergency medicine
5278357|NCT02284191|Cardiology|cardiology
5278358|NCT02284178|mechanical ventilation|mechanical ventilation
5278359|NCT02284178|aspiration|aspiration
5278360|NCT02284178|suctioning|suctioning
5278361|NCT02284178|secretions|secretions
5278362|NCT02284178|ventilator-associated events|ventilator-associated events
5278363|NCT02284152|bottle feeding|bottle feeding
5278364|NCT02284152|feeding behavior|feeding behavior
5278365|NCT02284152|infants|infants
5278366|NCT02284152|mothers|mothers
5278367|NCT02284152|responsive feeding|responsive feeding
5278368|NCT02284152|maternal feeding practices|maternal feeding practices
5278369|NCT02284152|maternal feeding styles|maternal feeding styles
5278370|NCT02284139|EGF ointment|egf ointment
5278371|NCT02284139|EGFR inhibitor|egfr inhibitor
5278372|NCT02284139|Skin side effect|skin side effect
5278373|NCT02284126|Vancomycin|vancomycin
5278374|NCT02284126|Anti-Infective Agents, Local|anti-infective agents, local
5278375|NCT02284126|Craniotomy|craniotomy
5278376|NCT02284126|surgical site infection|surgical site infection
5278377|NCT02284126|wound prophylaxis|wound prophylaxis
5278378|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents
5278379|NCT02284126|Neurosurgical Procedures|neurosurgical procedures
5278380|NCT02284126|Administration, Topical|administration, topical
5278381|NCT02284126|Antibiotic Prophylaxis|antibiotic prophylaxis
5278382|NCT02284126|antibiotics|antibiotics
5278383|NCT02284126|prophylaxis|prophylaxis
5278384|NCT02284126|neurosurgery|neurosurgery
5278385|NCT02284126|Bacterial Infections|bacterial infections
5278386|NCT02284126|Central Nervous System Infections|central nervous system infections
5278387|NCT02284087|transcranial magnetic stimulation|transcranial magnetic stimulation
5278388|NCT02284087|movement disorders|movement disorders
5278389|NCT02284074|Lipopolysaccharide (LPS)|lipopolysaccharide (lps)
5278390|NCT02284074|Biomarkers|biomarkers
5278391|NCT02284074|Chemokines|chemokines
5278392|NCT02284074|Cytokines|cytokines
5278393|NCT02284074|Gene Expression|gene expression
5278394|NCT02284074|Nasal Challenge|nasal challenge
5278395|NCT02284074|Inflammation|inflammation
5278396|NCT02284074|Nasal|nasal
5278397|NCT02284074|Nasosorption|nasosorption
5278398|NCT02284074|Respiratory|respiratory
5278399|NCT02284048|Ticagrelor|ticagrelor
5278400|NCT02284048|Coronary Flow Reserve|coronary flow reserve
5278401|NCT02284009|New-onset type 1 diabetes mellitus|new-onset type 1 diabetes mellitus
5278402|NCT02284009|Albiglutide|albiglutide
5278403|NCT02283996|Adhesive Capsulitis|adhesive capsulitis
5278404|NCT02283996|Frozen Shoulder|frozen shoulder
5278405|NCT02283996|Shoulder Frozen|shoulder frozen
5278406|NCT02283996|Physical Therapy|physical therapy
5278407|NCT02283996|Corticosteroid Injections|corticosteroid injections
5278408|NCT02283996|Hydrodilation, Hydro-dilation|hydrodilation, hydro-dilation
5278409|NCT02283996|Watchful Waiting|watchful waiting
5278410|NCT02283996|Prospective|prospective
5278411|NCT02283996|Glenohumeral Ligament|glenohumeral ligament
5278412|NCT02283905|amphotericin-B|amphotericin-b
5278413|NCT02283905|continuously infused|continuously infused
5278414|NCT02283905|voriconazole|voriconazole
5278415|NCT02283892|respiratory complaints|respiratory complaints
5278416|NCT02283892|dyspnea|dyspnea
5278417|NCT02283892|cough|cough
5278418|NCT02283892|checklist|checklist
5278419|NCT02283879|Human Umbilical Cord Mesenchymal Stem Cell|human umbilical cord mesenchymal stem cell
5278420|NCT02283879|Mesenchymal Stem Cell|mesenchymal stem cell
5278421|NCT02283879|Cerebral hemorrhage|cerebral hemorrhage
5278422|NCT02283853|Pediatrics|pediatrics
5278423|NCT02283749|NCSLC|ncslc
5278424|NCT02283749|lung cancer|lung cancer
5278425|NCT02283749|non small cell lung cancer|non small cell lung cancer
5278426|NCT02283749|bone metastases|bone metastases
5278427|NCT02283749|maintenance|maintenance
5278428|NCT02283736|Chronic periodontitis|chronic periodontitis
5278429|NCT02283736|Probiotics|probiotics
5278430|NCT02283736|Non- surgical treatment|non- surgical treatment
5278431|NCT02283723|older adults, goal attainment, optimal aging|older adults, goal attainment, optimal aging
5278433|NCT02283710|Aminotransferase|aminotransferase
5278434|NCT02283710|Steatohepatitis|steatohepatitis
5278435|NCT02283697|hypertension|hypertension
5278436|NCT02283697|high blood pressure|high blood pressure
5278437|NCT02283697|sodium|sodium
5278438|NCT02283697|prevention|prevention
5278439|NCT02283697|dietary sodium|dietary sodium
5278440|NCT02283697|salt|salt
5278441|NCT02283684|LASER|laser
5278442|NCT02283684|PROSTATE|prostate
5278443|NCT02283684|BIPOLAR|bipolar
5278444|NCT02283684|HYPERPLASIA|hyperplasia
5278445|NCT02283684|VAPORIZATION|vaporization
5278447|NCT02283580|Healthy adults|healthy adults
5278448|NCT02283580|Resistance training|resistance training
5278449|NCT02283580|Elastic bands|elastic bands
5278450|NCT02283580|Limb muscle function|limb muscle function
5278451|NCT02283580|Volunteers|volunteers
5278452|NCT02283554|Periodontal Surgery|periodontal surgery
5278453|NCT02283554|Periodontal Regeneration|periodontal regeneration
5278454|NCT02283554|Growth factors|growth factors
5278455|NCT02283554|Clinical trials|clinical trials
5278457|NCT02283541|late life depression|late life depression
5278458|NCT02283541|mind-body therapies|mind-body therapies
5278459|NCT02283515|chronic periodontitis|chronic periodontitis
5278460|NCT02283515|local drug delivery|local drug delivery
5278461|NCT02283515|rosuvastatin|rosuvastatin
5278462|NCT02283515|osseo-differentiation|osseo-differentiation
5278463|NCT02283502|Uterine fibroid|uterine fibroid
5278464|NCT02283502|magnetic resonance imaging|magnetic resonance imaging
5278465|NCT02283502|ultrasound|ultrasound
5278466|NCT02283502|non-invasive therapy|non-invasive therapy
5278467|NCT02283489|Recombinant Human Endostatin Adenovirus|recombinant human endostatin adenovirus
5278468|NCT02283489|Head and Neck Malignant Tumor|head and neck malignant tumor
5278469|NCT02283489|clinical trial|clinical trial
5278470|NCT02283489|randomized|randomized
5278471|NCT02283489|Endostatin|endostatin
5278472|NCT02283489|gene therapy|gene therapy
5278473|NCT02283476|efficacy and safety|efficacy and safety
5278474|NCT02283437|Bibliotherapy|bibliotherapy
5278475|NCT02283437|Problem-solving|problem-solving
5278476|NCT02283437|Randomized Controlled Trial|randomized controlled trial
5278477|NCT02283437|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
5278478|NCT02283437|Family Caregivers|family caregivers
5278479|NCT02283385|Elder abuse|elder abuse
5278480|NCT02283385|Intervention|intervention
5278481|NCT02283385|Treatment|treatment
5278482|NCT02283385|Detection|detection
5278483|NCT02283359|Distal Esophagus|distal esophagus
5278484|NCT02283359|Esophageal|esophageal
5278485|NCT02283359|Gastric|gastric
5278486|NCT02283359|Carcinoma|carcinoma
5278487|NCT02283359|Adenocarcinoma|adenocarcinoma
5278488|NCT02283359|Stomach|stomach
5278489|NCT02283359|Gastro-esophageal junction|gastro-esophageal junction
5278490|NCT02283359|Recurrent|recurrent
5278491|NCT02283359|Metastatic|metastatic
5278492|NCT02283359|Unresectable|unresectable
5278493|NCT02283346|Prostate Cancer|prostate cancer
5278494|NCT02283346|HDR brachytherapy|hdr brachytherapy
5278495|NCT02283346|hypo fractionated external beam radiotherapy|hypo fractionated external beam radiotherapy
5278496|NCT02283346|toxicity|toxicity
5278497|NCT02283346|biochemical control|biochemical control
5278498|NCT02283333|Behavioral Activation|behavioral activation
5278499|NCT02283333|Therapeutic Exposure|therapeutic exposure
5278500|NCT02283333|Mental Health|mental health
5278501|NCT02283333|Veterans|veterans
5278502|NCT02283333|Complicated Grief|complicated grief
5278503|NCT02283333|Military|military
5278504|NCT02283333|Treatment|treatment
5278505|NCT02283333|Cognitive Therapy|cognitive therapy
5278506|NCT02283333|Bereavement|bereavement
5278507|NCT02283333|Complicated Bereavement|complicated bereavement
5278508|NCT02283255|Fontan|fontan
5278509|NCT02283255|Exercise|exercise
5278510|NCT02283255|Pulmonary Function|pulmonary function
5278511|NCT02283255|Aerobic Capacity|aerobic capacity
5278512|NCT02283255|Skeletal Muscle|skeletal muscle
5278513|NCT02283242|Cholinergic Antagonists|cholinergic antagonists
5278514|NCT02283242|Inflammation|inflammation
5278515|NCT02283242|Oxidative Stress|oxidative stress
5278516|NCT02283229|Plagiocephaly|plagiocephaly
5278517|NCT02283229|torticollis|torticollis
5278518|NCT02283229|occlusal defect|occlusal defect
5278519|NCT02283216|neuromodulation|neuromodulation
5278520|NCT02283216|noninvasive|noninvasive
5278521|NCT02283216|plasticity|plasticity
5278522|NCT02283216|transcranial magnetic stimulation|transcranial magnetic stimulation
5278523|NCT02283216|hearing|hearing
5278524|NCT02283216|hyperacusis|hyperacusis
5278525|NCT02283203|Paracetamol|paracetamol
5278526|NCT02283203|Management of fever|management of fever
5278527|NCT02283203|Infections|infections
5278528|NCT02283190|Asparaginase|asparaginase
5278529|NCT02283190|Glutamine|glutamine
5278530|NCT02283164|Occupational health|occupational health
5278531|NCT02283164|Hazardous material handling|hazardous material handling
5278532|NCT02283151|Very Low Carbohydrate Diet|very low carbohydrate diet
5278533|NCT02283151|Overweight/obese|overweight/obese
5862753|NCT00001524|Tumor Necrosis Factor|tumor necrosis factor
5278540|NCT02283060|Stribild|stribild
5278542|NCT02283060|Sleep architecture|sleep architecture
5278543|NCT02283060|Neuropsychological performance|neuropsychological performance
5278544|NCT02283047|cardiovascular risk, obesity, interval training, diet|cardiovascular risk, obesity, interval training, diet
5278545|NCT02283021|expression of L-type calcium subunits|expression of l-type calcium subunits
5278546|NCT02282995|Functional dyspepsia|functional dyspepsia
5278547|NCT02282995|symptom response|symptom response
5278548|NCT02282982|Immunoprophylaxis|immunoprophylaxis
5278549|NCT02282982|Palivizumab|palivizumab
5278550|NCT02282969|Cancer Prevention|cancer prevention
5278552|NCT02282969|Quit smoking|quit smoking
5278553|NCT02282969|Interviews|interviews
5278554|NCT02282969|Questionnaires|questionnaires
5278555|NCT02282969|Surveys|surveys
5278556|NCT02282969|Lung cancer screening|lung cancer screening
5278557|NCT02282969|Patient decision aid|patient decision aid
5278558|NCT02282943|endometriosis|endometriosis
5278559|NCT02282943|CO2 laser vapourisation|co2 laser vapourisation
5278560|NCT02282943|Harmonic scalpel|harmonic scalpel
5278561|NCT02282943|AFS stage I-III|afs stage i-iii
5278562|NCT02282930|ACTH|acth
5278563|NCT02282930|Acthar|acthar
5278564|NCT02282930|IgA|iga
5278565|NCT02282930|Progressive|progressive
5278566|NCT02282930|Nephropathy|nephropathy
5278567|NCT02282930|renal function|renal function
5278568|NCT02282917|NF2|nf2
5278569|NCT02282917|Vestibular Schwannoma|vestibular schwannoma
5278570|NCT02282917|Schwannoma|schwannoma
5278571|NCT02282917|Meningioma|meningioma
5278572|NCT02282904|Chronic Granulomatous Disease|chronic granulomatous disease
5278573|NCT02282904|Halo-Identical Protocol|halo-identical protocol
5278574|NCT02282904|Transplant|transplant
5278575|NCT02282891|propofol|propofol
5278576|NCT02282891|ketofol|ketofol
5278577|NCT02282878|High Sodium Diet|high sodium diet
5278578|NCT02282878|Low Sodium Diet|low sodium diet
5278579|NCT02282878|MS|ms
5278580|NCT02282865|Emergence agitation, Heart rate variability (HRV)|emergence agitation, heart rate variability (hrv)
5278581|NCT02282839|Head and neck cancer|head and neck cancer
5278582|NCT02282839|Glutamine|glutamine
5278583|NCT02282839|Oral mucositis|oral mucositis
5278584|NCT02282839|Quality of life|quality of life
5278585|NCT02282813|Parathyroid Diseases|parathyroid diseases
5278586|NCT02282813|Renal Insufficiency|renal insufficiency
5278587|NCT02282813|Kidney Failure, Chronic|kidney failure, chronic
5278588|NCT02282813|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5278589|NCT02282813|Vitamin D|vitamin d
5278590|NCT02282813|Hyperparathyroidism|hyperparathyroidism
5278591|NCT02282813|Kidney Diseases|kidney diseases
5278592|NCT02282813|Kidney Failure|kidney failure
5278593|NCT02282813|Renal Insufficiency, Chronic|renal insufficiency, chronic
5278594|NCT02282787|local anesthesia|local anesthesia
5278595|NCT02282787|peribulbar anesthesia|peribulbar anesthesia
5278596|NCT02282787|DEXMEDETOMIDINE|dexmedetomidine
5278597|NCT02282787|vitreoretinal surgery|vitreoretinal surgery
5278598|NCT02282774|Vitreoretinal surgery|vitreoretinal surgery
5278599|NCT02282735|neuroblastoma|neuroblastoma
5278600|NCT02282735|end-of-life|end-of-life
5278601|NCT02282735|decision-making|decision-making
5278602|NCT02282735|parent|parent
5278603|NCT02282735|child|child
5278604|NCT02282735|prognosis|prognosis
5278605|NCT02282735|preferences|preferences
5278606|NCT02282735|childhood cancer|childhood cancer
5278607|NCT02282735|oncology|oncology
5278608|NCT02282722|cancer|cancer
5278609|NCT02282722|palliative|palliative
5278610|NCT02282722|chemotherapy|chemotherapy
5278611|NCT02282722|metastatic|metastatic
5278612|NCT02282722|colorectal|colorectal
5278613|NCT02282722|communication|communication
5278614|NCT02282722|informed consent|informed consent
5278615|NCT02282722|video|video
5278616|NCT02282722|education|education
5278617|NCT02282722|oncology|oncology
5278618|NCT02282722|patient-centered|patient-centered
5278619|NCT02282722|outcomes research|outcomes research
5278620|NCT02282709|Immunity|immunity
5278621|NCT02282657|extracorporreal|extracorporreal
5278622|NCT02282657|CO2 removal|co2 removal
5278623|NCT02282657|ARDS|ards
5278624|NCT02282657|lung|lung
5278625|NCT02282657|Protective ventilation|protective ventilation
5278626|NCT02282631|active school travel|active school travel
5278627|NCT02282631|active travel|active travel
5278628|NCT02282631|incentive scheme|incentive scheme
5278629|NCT02282631|children|children
5278630|NCT02282631|school|school
5278631|NCT02282631|behaviour change|behaviour change
5278632|NCT02282618|Cardiac Sympathetic Blockade|cardiac sympathetic blockade
5278633|NCT02282592|Metabolic syndrome|metabolic syndrome
5278634|NCT02282592|case-control study|case-control study
5278635|NCT02282592|Breast cancer|breast cancer
5278636|NCT02282566|Muscle protein synthesis|muscle protein synthesis
5278637|NCT02282514|Autoimmune Diseases|autoimmune diseases
5278638|NCT02282514|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5278639|NCT02282501|leptin levels|leptin levels
5278640|NCT02282501|ghrelin levels|ghrelin levels
5278641|NCT02282462|Chest tube|chest tube
5278642|NCT02282449|Venous access device|venous access device
5278643|NCT02282449|Port catheters|port catheters
5278644|NCT02282449|Chemotherapy|chemotherapy
5278645|NCT02282410|severe hemophilia A|severe hemophilia a
5278646|NCT02282410|moderately severe hemophilia A|moderately severe hemophilia a
5278647|NCT02282410|Recombinant Human Coagulation Factor VIII|recombinant human coagulation factor viii
5278648|NCT02282410|standard prophylaxis|standard prophylaxis
5278649|NCT02282397|Diabetes Mellitus|diabetes mellitus
5278650|NCT02282371|Cetuximab|cetuximab
5278651|NCT02282371|BYL719|byl719
5278659|NCT02282293|Uganda|uganda
5278660|NCT02282293|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5278661|NCT02282293|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5278662|NCT02282293|Human Immunodeficiency Virus|human immunodeficiency virus
5278663|NCT02282267|Epidermal growth factor receptor|epidermal growth factor receptor
5278664|NCT02282267|Droplet digital PCR|droplet digital pcr
5278665|NCT02282254|Type 1 diabetes|type 1 diabetes
5278666|NCT02282254|Hypoglycemia unawareness|hypoglycemia unawareness
5278667|NCT02282254|Nocturnal hypoglycemia|nocturnal hypoglycemia
5278668|NCT02282254|Closed-loop strategy|closed-loop strategy
5278669|NCT02282254|Artificial pancreas|artificial pancreas
5278670|NCT02282254|Glucagon|glucagon
5278671|NCT02282254|Hypoglycemia|hypoglycemia
5278672|NCT02282254|Insulin|insulin
5278673|NCT02282241|Melatonin|melatonin
5278674|NCT02282241|Sleep|sleep
5278675|NCT02282241|Delirium|delirium
5278676|NCT02282215|Fever|fever
5278677|NCT02282215|Induction chemotherapy|induction chemotherapy
5278678|NCT02282215|Infection|infection
5278679|NCT02282215|Leukemia|leukemia
5278680|NCT02282215|Myeloid progenitor cells|myeloid progenitor cells
5278681|NCT02282215|Neutropenia|neutropenia
5278682|NCT02282202|Sputum|sputum
5278683|NCT02282202|Bronchiectasis|bronchiectasis
5278684|NCT02282202|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5278685|NCT02282202|Airway clearance therapy|airway clearance therapy
5278686|NCT02282202|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
5278687|NCT02282189|Sputum|sputum
5278688|NCT02282189|Airway clearance therapy|airway clearance therapy
5278689|NCT02282189|Oscillatory Positive Expiratory Pressure|oscillatory positive expiratory pressure
5278690|NCT02282189|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5278691|NCT02282176|Neonates|neonates
5278692|NCT02282176|Preterm|preterm
5278693|NCT02282176|Azithromycin|azithromycin
5278694|NCT02282176|Ureaplasma|ureaplasma
5278695|NCT02282176|Chronic Lung disease|chronic lung disease
5278696|NCT02282176|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5278697|NCT02282150|Fatigue|fatigue
5278698|NCT02282150|Quality of Life|quality of life
5278699|NCT02282150|Hydrocortisone|hydrocortisone
5278700|NCT02282150|Ecological Momentary Assessments|ecological momentary assessments
5278701|NCT02282124|weight|weight
5278702|NCT02282124|self-management|self-management
5278703|NCT02282124|exercise|exercise
5278704|NCT02282098|Atrial fibrillation|atrial fibrillation
5278705|NCT02282098|Arrhythmias, Cardiac|arrhythmias, cardiac
5278706|NCT02282098|Stroke|stroke
5278707|NCT02282098|agents, anti inflammatory|agents, anti inflammatory
5278708|NCT02282098|D-dimer|d-dimer
5278709|NCT02282098|C-reactive protein|c-reactive protein
5278710|NCT02282085|Medication Non-Adherence|medication non-adherence
5278711|NCT02282085|Antipsychotic|antipsychotic
5278712|NCT02282046|type 2 diabetes mellitus|type 2 diabetes mellitus
5278713|NCT02282046|dental implant|dental implant
5278714|NCT02282020|BRCA, ovarian, platinum, chemotherapy,|brca, ovarian, platinum, chemotherapy,
5278715|NCT02282007|Quality of life|quality of life
5278716|NCT02281994|PEMF|pemf
5278717|NCT02281994|odontoid fracture|odontoid fracture
5278719|NCT02281994|prospective|prospective
5278727|NCT02281929|Alcoholic hepatitis|alcoholic hepatitis
5278728|NCT02281929|corticotherapy|corticotherapy
5278729|NCT02281929|antibiotherapy|antibiotherapy
5278730|NCT02281929|survival|survival
5278731|NCT02281929|infection|infection
5278732|NCT02281929|hepato renal syndrome|hepato renal syndrome
5278733|NCT02281916|Crohn disease|crohn disease
5278734|NCT02281916|Immunotherapy|immunotherapy
5278735|NCT02281916|Helminth antigen|helminth antigen
5278736|NCT02281890|neurodevelopmental disability|neurodevelopmental disability
5278737|NCT02281877|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5278738|NCT02281877|Gene Expression|gene expression
5278739|NCT02281851|Endogenous antioxidants|endogenous antioxidants
5278740|NCT02281851|Antioxidant supplements|antioxidant supplements
5278741|NCT02281851|Vitamin Supplements|vitamin supplements
5278742|NCT02281851|Exercise adaptations|exercise adaptations
5278743|NCT02281851|Oxidative stress|oxidative stress
5278744|NCT02281851|Redox regulation|redox regulation
5278745|NCT02281851|Cycling - exercise|cycling - exercise
5278746|NCT02281838|Stroke|stroke
5278747|NCT02281838|Hypertension|hypertension
5278748|NCT02281825|Attention-Deficit and Hyperactivity Disorder|attention-deficit and hyperactivity disorder
5278749|NCT02281825|Anxiety|anxiety
5278750|NCT02281825|Impulsivity|impulsivity
5278751|NCT02281825|Computer Games|computer games
5278752|NCT02281825|Depression|depression
5278753|NCT02281812|Ablation Technique|ablation technique
5278754|NCT02281812|Breast cancer|breast cancer
5278756|NCT02281812|Lumpectomy|lumpectomy
5278757|NCT02281799|Azathioprine (AZA)|azathioprine (aza)
5278758|NCT02281799|6-mercaptopurine (6-MP)|6-mercaptopurine (6-mp)
5278759|NCT02281799|Thiopurine-S-methyltransferase (TPMT)|thiopurine-s-methyltransferase (tpmt)
5278760|NCT02281799|Xanthine oxidase (XO)|xanthine oxidase (xo)
5278761|NCT02281799|6-thioguanine (6-TGN)|6-thioguanine (6-tgn)
5278762|NCT02281799|6-methyl-mercaptopurine (6-MMP)|6-methyl-mercaptopurine (6-mmp)
5278763|NCT02281799|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5278764|NCT02281799|acute pancreatitis (AP)|acute pancreatitis (ap)
5278765|NCT02281799|inosine triphosphate pyrophosphohydrolase (ITPA)|inosine triphosphate pyrophosphohydrolase (itpa)
5278766|NCT02281799|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5278767|NCT02281799|systemic lupus erythematosis (SLE)|systemic lupus erythematosis (sle)
5278768|NCT02281799|Crohn's disease (CD)|crohn's disease (cd)
5278769|NCT02281799|ulcerative colitis (UC)|ulcerative colitis (uc)
5278770|NCT02281760|Histiocytosis|histiocytosis
5278771|NCT02281760|Non Langerhans Cell Histiocytosis|non langerhans cell histiocytosis
5278772|NCT02281760|BRAF Inhibitor|braf inhibitor
5278773|NCT02281747|Biologic Therapy|biologic therapy
5278774|NCT02281747|Rheumatoid Arthritis|rheumatoid arthritis
5278775|NCT02281747|Arthroplasty|arthroplasty
5278776|NCT02281708|normogram|normogram
5278777|NCT02281708|recurrence|recurrence
5278778|NCT02281708|adjuvant chemotherapy|adjuvant chemotherapy
5278779|NCT02281708|disease free survival|disease free survival
5278780|NCT02281708|Quality of life|quality of life
5278781|NCT02281565|attitudes|attitudes
5278782|NCT02281565|blood donation|blood donation
5278783|NCT02281565|blood shortage|blood shortage
5278784|NCT02281461|PrePex|prepex
5278785|NCT02281461|Infants|infants
5278786|NCT02281461|Early infants|early infants
5278787|NCT02281461|Children|children
5278788|NCT02281461|Circumcision|circumcision
5278790|NCT02281461|AIDS|aids
5278791|NCT02281461|Non surgical|non surgical
5278792|NCT02281435|Male Circumcision|male circumcision
5278793|NCT02281435|HIV Prevention|hiv prevention
5278794|NCT02281435|Screen Failure Subjects|screen failure subjects
5278795|NCT02281435|PrePex with Incision|prepex with incision
5278796|NCT02281253|L-carnitine|l-carnitine
5278797|NCT02281253|fibre|fibre
5278798|NCT02281253|bakery product|bakery product
5278799|NCT02281253|insulin resistance|insulin resistance
5278800|NCT02281032|Palliative Care|palliative care
5278801|NCT02281032|Nursing Homes|nursing homes
5849063|NCT00031369|Healthy Volunteer|healthy volunteer
5278802|NCT02281032|interRAI Palliative Care instrument|interrai palliative care instrument
5278803|NCT02281032|Older adults|older adults
5278805|NCT02281682|Keratosis, Actinic|keratosis, actinic
5278806|NCT02281682|Treatment Outcome|treatment outcome
5278807|NCT02281682|cost-effectiveness|cost-effectiveness
5278808|NCT02281682|economic evaluation|economic evaluation
5278809|NCT02281682|imiquimod|imiquimod
5278810|NCT02281682|photodynamic therapy|photodynamic therapy
5278811|NCT02281682|topical fluorouracil|topical fluorouracil
5278812|NCT02281682|ingenol mebutate|ingenol mebutate
5278813|NCT02281643|Coinfection|coinfection
5278814|NCT02281643|Buruli ulcer|buruli ulcer
5278815|NCT02281643|Tuberculosis|tuberculosis
5278816|NCT02281643|Mansonella perstans|mansonella perstans
5278817|NCT02281630|Chronic Constipation|chronic constipation
5278819|NCT02281578|Sex Workers|sex workers
5278820|NCT02281578|Prevention|prevention
5278821|NCT02281552|Tofacitinib, CP-690,550, Janis kinase, JAK inhibitor, modified release, Xeljanz|tofacitinib, cp-690,550, janis kinase, jak inhibitor, modified release, xeljanz
5278822|NCT02281539|Phantom Limb Pain|phantom limb pain
5278823|NCT02281539|Augmented Reality|augmented reality
5278824|NCT02281539|Myoelectric control|myoelectric control
5278825|NCT02281539|Virtual reality|virtual reality
5278826|NCT02281539|electromyography|electromyography
5278827|NCT02281539|pattern recognition|pattern recognition
5278828|NCT02281539|neurorehabilitation|neurorehabilitation
5278829|NCT02281513|Nutrition|nutrition
5278830|NCT02281487|tubal carcinoma|tubal carcinoma
5278831|NCT02281487|ovarian carcinoma|ovarian carcinoma
5278832|NCT02281487|tubectomy|tubectomy
5278833|NCT02281487|hysterectomy|hysterectomy
5278834|NCT02281487|dysplastic changes|dysplastic changes
5278835|NCT02281487|Anti Mullerian Hormone|anti mullerian hormone
5278836|NCT02281487|Tubal Intraepithelial Carcinoma|tubal intraepithelial carcinoma
5278837|NCT02281487|Salpingectomy|salpingectomy
5278845|NCT02281370|cyclosporine|cyclosporine
5278846|NCT02281370|drug-drug interaction|drug-drug interaction
5278847|NCT02281370|pharmacokinetics|pharmacokinetics
5278848|NCT02281370|eltrombopag|eltrombopag
5278849|NCT02281370|SB-497115|sb-497115
5278850|NCT02281357|Asthma|asthma
5278851|NCT02281357|Reactive Airways|reactive airways
5278852|NCT02281357|Repiratory Tract Disease|repiratory tract disease
5278853|NCT02281357|Obstructive Lung Disease|obstructive lung disease
5278854|NCT02281357|Lung Diseases|lung diseases
5278855|NCT02281344|induced blood stage malaria infection|induced blood stage malaria infection
5278856|NCT02281318|Asthma control|asthma control
5278857|NCT02281318|Lung function|lung function
5278858|NCT02281318|Health-related quality of life|health-related quality of life
5278859|NCT02281318|Mepolizumab|mepolizumab
5278860|NCT02281318|Severe Eosinophilic asthma|severe eosinophilic asthma
5278861|NCT02281292|Diabetic Macular Edema|diabetic macular edema
5278862|NCT02281292|Intravitreal|intravitreal
5278863|NCT02281292|Retina|retina
5278864|NCT02281292|Ophthalmology|ophthalmology
5278865|NCT02281292|Lucentis|lucentis
5278866|NCT02281292|OCT|oct
5278867|NCT02281240|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5278868|NCT02281214|lung cancer, mutations|lung cancer, mutations
5218570|NCT02631616|PET/CT|pet/ct
5278869|NCT02281214|patients|patients
5278870|NCT02281214|mutations|mutations
5278871|NCT02281175|Benzodiazepine withdrawal|benzodiazepine withdrawal
5278872|NCT02281175|PASSE-65+ program|passe-65+ program
5278873|NCT02281175|Psychosocial (non-pharmacological) intervention|psychosocial (non-pharmacological) intervention
5278874|NCT02281175|Cognitive-Behavioral Therapy (CBT)|cognitive-behavioral therapy (cbt)
5278875|NCT02281175|Older adults|older adults
5278876|NCT02281149|breast cancer|breast cancer
5278877|NCT02281149|radiotherapy|radiotherapy
5278878|NCT02281149|intensity modulation|intensity modulation
5278879|NCT02281149|toxicity|toxicity
5278880|NCT02281136|Actinic keratosis|actinic keratosis
5278881|NCT02281110|Diagnostic coronary catheterization|diagnostic coronary catheterization
5278882|NCT02281110|Multi-vessel coronary disease|multi-vessel coronary disease
5278883|NCT02281110|Percutaneous Coronary Intervention|percutaneous coronary intervention
5278884|NCT02281110|Instantaneous wave free ratio|instantaneous wave free ratio
5278885|NCT02281110|Fractional flow reserve|fractional flow reserve
5278886|NCT02281097|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
5278887|NCT02281097|POTS|pots
5278888|NCT02281097|Vagal Stimulation|vagal stimulation
5278889|NCT02281084|Keywords provided by Celgene:|keywords provided by celgene:
5278890|NCT02281084|myelodysplastic syndromes|myelodysplastic syndromes
5278891|NCT02281084|MDS|mds
5278892|NCT02281084|azacitidine|azacitidine
5278893|NCT02281084|oral azacitidine (CC-486)|oral azacitidine (cc-486)
5278894|NCT02281084|decitabine|decitabine
5278895|NCT02281084|intermediate-1|intermediate-1
5278896|NCT02281084|intermediate-2 and high risk myelodysplastic syndromes (MDS)|intermediate-2 and high risk myelodysplastic syndromes (mds)
5278897|NCT02281084|proliferative chronic myelomonocytic leukemia (CMML)|proliferative chronic myelomonocytic leukemia (cmml)
5278898|NCT02281084|Chronic|chronic
5278899|NCT02281084|iHMA (injectable hypomethylating agents)|ihma (injectable hypomethylating agents)
5278900|NCT02281084|PD-L1|pd-l1
5278901|NCT02280980|Stroke|stroke
5278902|NCT02280980|Postural Balance|postural balance
5278903|NCT02280980|Oculomotor and Gaze Stability Exercises|oculomotor and gaze stability exercises
5278904|NCT02280980|Rehabilitation|rehabilitation
5278905|NCT02280980|Physical therapy|physical therapy
5278906|NCT02280980|Outpatient|outpatient
5278907|NCT02280967|Adolescent|adolescent
5278908|NCT02280967|Attitude|attitude
5278909|NCT02280967|Condom|condom
5278910|NCT02280967|Human Papillomavirus Vaccines|human papillomavirus vaccines
5278911|NCT02280967|Primary prevention|primary prevention
5278912|NCT02280967|School Health|school health
5278913|NCT02280954|Solid Tumor|solid tumor
5278914|NCT02280915|female|female
5278915|NCT02280915|subjects|subjects
5278916|NCT02280902|auto-immune diseases|auto-immune diseases
5278917|NCT02280902|inflammatory diseases|inflammatory diseases
5278918|NCT02280902|risk factors|risk factors
5278919|NCT02280902|infections|infections
5278920|NCT02280902|cohort study|cohort study
5278921|NCT02280889|quality of life|quality of life
5278922|NCT02280889|nevus or scar|nevus or scar
5278923|NCT02280889|stigmatization|stigmatization
5278924|NCT02280889|scar|scar
5278925|NCT02280876|MS|ms
5278926|NCT02280876|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
5278928|NCT02280876|Nervous System Diseases|nervous system diseases
5278929|NCT02280837|GLP-1|glp-1
5278930|NCT02280824|Transcaval|transcaval
5278931|NCT02280824|TAVR|tavr
5278932|NCT02280824|AMPLATZER(R) Occluder|amplatzer(r) occluder
5278933|NCT02280811|HPV positive|hpv positive
5278934|NCT02280811|Metastatic|metastatic
5278935|NCT02280811|Diet|diet
5278936|NCT02280811|Screening|screening
5278937|NCT02280811|Risk Factors|risk factors
5278938|NCT02280811|Colorectal adenoma|colorectal adenoma
5278939|NCT02280811|Refractory|refractory
5278940|NCT02280811|Immunotherapy|immunotherapy
5278941|NCT02280811|Reproductive Cancers|reproductive cancers
5278942|NCT02280798|ERA|era
5278943|NCT02280772|glucomannan|glucomannan
5278944|NCT02280772|obesity|obesity
5278945|NCT02280772|children|children
5278946|NCT02280772|overweight|overweight
5278947|NCT02280772|adolescents|adolescents
5278948|NCT02280772|treatment|treatment
5278949|NCT02280759|diarrhea, gelatin tannate, acute gastroenteritis|diarrhea, gelatin tannate, acute gastroenteritis
5278950|NCT02280733|Qualified Clinical Data Registry|qualified clinical data registry
5278951|NCT02280733|Quality Measures|quality measures
5278952|NCT02280733|Meaningful Use Stage 2|meaningful use stage 2
5278953|NCT02280733|Electronic Health Records|electronic health records
5278954|NCT02280733|Clinical Data Research Network|clinical data research network
5278955|NCT02280733|Real world data|real world data
5278956|NCT02280720|titanium-nitride-oxide-coated stent|titanium-nitride-oxide-coated stent
5278957|NCT02280720|everolimus-eluting stent|everolimus-eluting stent
5278958|NCT02280720|optical coherence tomography|optical coherence tomography
5278959|NCT02280720|strut coverage|strut coverage
5278960|NCT02280681|reproductive medicine|reproductive medicine
5278961|NCT02280681|artificial gametes|artificial gametes
5278962|NCT02280681|patient preference|patient preference
5278963|NCT02280681|decision making|decision making
5278964|NCT02280668|muscle|muscle
5278965|NCT02280668|muscle repair|muscle repair
5278966|NCT02280668|tissue repair|tissue repair
5278967|NCT02280668|eccentric exercise|eccentric exercise
5278968|NCT02280668|force loss|force loss
5278969|NCT02280668|icing|icing
5278970|NCT02280668|cold therapy|cold therapy
5278971|NCT02280668|DOMS|doms
5278972|NCT02280668|soreness|soreness
5278973|NCT02280668|recovery|recovery
5278974|NCT02280655|Blood Transfusions|blood transfusions
5278975|NCT02280642|Human papillomavirus|human papillomavirus
5278976|NCT02280642|Cervical cancer|cervical cancer
5278977|NCT02280642|Genital warts|genital warts
5278978|NCT02280642|Vaccine|vaccine
5278979|NCT02280642|Immunogenicity|immunogenicity
5278980|NCT02280564|motivational interviewing|motivational interviewing
5278981|NCT02280564|problem solving skills|problem solving skills
5278982|NCT02280564|family communication|family communication
5278983|NCT02280564|technology support|technology support
5278984|NCT02280564|cell phone system|cell phone system
5278985|NCT02280551|adolescent|adolescent
5278986|NCT02280551|alcohol|alcohol
5278987|NCT02280551|parent|parent
5278988|NCT02280551|epidemiology|epidemiology
5278989|NCT02280538|Knee Osteoarthritis|knee osteoarthritis
5278990|NCT02280538|Intra-Articular Hyaluronic Acid|intra-articular hyaluronic acid
5278991|NCT02280538|disease modifying|disease modifying
5278992|NCT02280525|Leukemia|leukemia
5278993|NCT02280525|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5278995|NCT02280525|Natural Killer Cells|natural killer cells
5278996|NCT02280525|NK|nk
5278997|NCT02280525|Umbilical Cord Blood|umbilical cord blood
5278998|NCT02280525|UCB|ucb
5849064|NCT00031369|HV|hv
5278999|NCT02280525|Lenalidomide|lenalidomide
5279000|NCT02280525|CC-5013|cc-5013
5279001|NCT02280525|Revlimid|revlimid
5279002|NCT02280525|Rituximab|rituximab
5279003|NCT02280525|Rituxan|rituxan
5279004|NCT02280525|Fludarabine|fludarabine
5279005|NCT02280525|Fludarabine phosphate|fludarabine phosphate
5279006|NCT02280525|Fludara|fludara
5279007|NCT02280525|Cyclophosphamide|cyclophosphamide
5279008|NCT02280525|Cytoxan|cytoxan
5279009|NCT02280525|Neosar|neosar
5279010|NCT02280525|Cytarabine|cytarabine
5279011|NCT02280525|Ara-C|ara-c
5279012|NCT02280525|Cytosar|cytosar
5279013|NCT02280525|DepoCyt|depocyt
5279014|NCT02280525|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5279015|NCT02280512|noninvasive cardiac output measurement(NICOM)|noninvasive cardiac output measurement(nicom)
5279016|NCT02280512|Leg fractures|leg fractures
5279017|NCT02280512|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5279018|NCT02280512|Intensive care unit(ICU)|intensive care unit(icu)
5279019|NCT02280486|saxagliptin|saxagliptin
5279020|NCT02280486|glimepiride|glimepiride
5279021|NCT02280486|metformin monotherapy|metformin monotherapy
5279022|NCT02280421|HSV|hsv
5279023|NCT02280421|Herpes|herpes
5279024|NCT02280421|volunteers|volunteers
5279025|NCT02280421|drug-drug interaction|drug-drug interaction
5279026|NCT02280421|transplant|transplant
5279027|NCT02280382|splinting|splinting
5279028|NCT02280369|posture detection|posture detection
5279029|NCT02280369|healthy subjects|healthy subjects
5279030|NCT02280356|Radiation Therapy|radiation therapy
5279031|NCT02280356|Brachytherapy|brachytherapy
5279032|NCT02280356|14-163|14-163
5279033|NCT02280343|forced oscillation tecnique|forced oscillation tecnique
5279034|NCT02280343|lung function|lung function
5279035|NCT02280343|asbestosis|asbestosis
5279036|NCT02280330|Iodine Deficiency|iodine deficiency
5279037|NCT02280330|Micronutrient Powder|micronutrient powder
5279038|NCT02280330|Hypothyroidism|hypothyroidism
5279039|NCT02280304|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5279040|NCT02280304|Concussion, Mild|concussion, mild
5279041|NCT02280304|Brain Injuries|brain injuries
5279042|NCT02280304|Community Integration|community integration
5266441|NCT02351648|care transition|care transition
5266442|NCT02351635|Calprotectin|calprotectin
5266443|NCT02351635|Diagnosis|diagnosis
5266444|NCT02351609|smoking cessation|smoking cessation
5266445|NCT02351609|patient navigation|patient navigation
5266446|NCT02351609|financial incentives|financial incentives
5266447|NCT02351609|health disparities|health disparities
5266448|NCT02351596|Core Stability|core stability
5279043|NCT02280304|Meditation|meditation
5279044|NCT02280304|Magnetic Resonance Imaging|magnetic resonance imaging
5279045|NCT02280278|colon cancer|colon cancer
5279046|NCT02280278|cytokine-induced killer cell immunotherapy|cytokine-induced killer cell immunotherapy
5279047|NCT02280265|hemophilia A|hemophilia a
5279048|NCT02280265|standard prophylaxis|standard prophylaxis
5279049|NCT02280265|Recombinant Human Coagulation Factor VIII for injection|recombinant human coagulation factor viii for injection
5279051|NCT02280265|Pediatric|pediatric
5279052|NCT02280252|Locally-advanced Breast Cancer|locally-advanced breast cancer
5279053|NCT02280252|LABC|labc
5279054|NCT02280252|breast cancer|breast cancer
5279056|NCT02280252|cancer|cancer
5279057|NCT02280252|metastasis|metastasis
5279058|NCT02280252|metastatic|metastatic
5279059|NCT02280252|tumor|tumor
5279060|NCT02280252|radiation|radiation
5279061|NCT02280252|radiation therapy|radiation therapy
5279062|NCT02280252|radiotherapy|radiotherapy
5279063|NCT02280252|paclitaxel|paclitaxel
5279064|NCT02280239|Fever|fever
5279065|NCT02280239|Acetaminophen|acetaminophen
5279066|NCT02280239|Body Temperature Regulation|body temperature regulation
5279067|NCT02280239|Critical Illness|critical illness
5279068|NCT02280239|Hypotension|hypotension
5279069|NCT02280200|claudication|claudication
5279070|NCT02280200|ankle foot orthoses|ankle foot orthoses
5279071|NCT02280200|community walking exercise|community walking exercise
5279072|NCT02280187|InductOs|inductos
5279073|NCT02280187|rhBMP-2|rhbmp-2
5279074|NCT02280187|Retrospective|retrospective
5279075|NCT02280187|France|france
5279076|NCT02280187|Fusion|fusion
5279077|NCT02280187|real world use|real world use
5279078|NCT02280174|Apo B-48|apo b-48
5279079|NCT02280174|TRL|trl
5279080|NCT02280174|Linagliptin|linagliptin
5279081|NCT02280148|Propofol|propofol
5279082|NCT02280148|gastroscopy and colonoscopy|gastroscopy and colonoscopy
5279083|NCT02280148|driving simulator|driving simulator
5279084|NCT02280148|driving ability|driving ability
5279085|NCT02280148|cognitive function|cognitive function
5279086|NCT02280148|patients|patients
5279087|NCT02280122|activated matrix metalloproteinase 8|activated matrix metalloproteinase 8
5279088|NCT02280122|untreated moderate/severe chronic periodontitis|untreated moderate/severe chronic periodontitis
5279089|NCT02280122|saliva|saliva
5279090|NCT02280122|sensitivity/specificity|sensitivity/specificity
5279091|NCT02280109|Tenofovir|tenofovir
5279092|NCT02280109|Healthy Volunteers|healthy volunteers
5279093|NCT02280109|HIV|hiv
5279094|NCT02280109|pharmacokinetics of tenofovir gel and film|pharmacokinetics of tenofovir gel and film
5279095|NCT02280096|Cognitive function|cognitive function
5279096|NCT02280096|Multiple sclerosis|multiple sclerosis
5279097|NCT02280096|4-aminopyridine|4-aminopyridine
5279098|NCT02280096|Fatigue|fatigue
5279099|NCT02280083|Spasticity, Post-Stroke|spasticity, post-stroke
5279100|NCT02280083|Botulinum toxin type A for Injection|botulinum toxin type a for injection
5279101|NCT02280083|upper limb spasticity|upper limb spasticity
5279102|NCT02280070|resectable rectal cancer|resectable rectal cancer
5279104|NCT02280070|mFOLFOX6|mfolfox6
5279105|NCT02280070|neoadjuvant|neoadjuvant
5279106|NCT02280057|PCOS|pcos
5279107|NCT02280057|metformin|metformin
5279108|NCT02280057|obesity|obesity
5279109|NCT02280057|randomized controlled trial|randomized controlled trial
5279110|NCT02280044|Campylobacter jejuni|campylobacter jejuni
5279111|NCT02280044|rifaximin|rifaximin
5279112|NCT02280044|antibiotic prophylaxis|antibiotic prophylaxis
5279113|NCT02280044|dysentery|dysentery
5279114|NCT02280044|diarrhea|diarrhea
5279115|NCT02280031|Twin Pregnancy|twin pregnancy
5279116|NCT02280031|Pregnancy Complications|pregnancy complications
5279117|NCT02280018|Healthy|healthy
5279118|NCT02280018|JNJ-49122944|jnj-49122944
5279119|NCT02280018|Placebo|placebo
5279120|NCT02280005|Dialysis|dialysis
5279121|NCT02280005|Renal Failure|renal failure
5279122|NCT02280005|Wearable|wearable
5279123|NCT02280005|Artificial Kidney|artificial kidney
5279124|NCT02280005|Hemodialysis|hemodialysis
5279125|NCT02279992|Malignant Glioma|malignant glioma
5279127|NCT02279992|Brain metastasis|brain metastasis
5279129|NCT02279979|Cardiogenic Shock|cardiogenic shock
5279130|NCT02279979|Percutaneous|percutaneous
5279131|NCT02279979|Ventricular Assist|ventricular assist
5279132|NCT02279979|Heart Pump|heart pump
5279133|NCT02279979|Catheter|catheter
5279134|NCT02279979|Thoratec Corporation|thoratec corporation
5279135|NCT02279940|rivaroxaban|rivaroxaban
5279136|NCT02279940|stroke|stroke
5279137|NCT02279940|transient ischemic attack|transient ischemic attack
5279138|NCT02279940|ischemia|ischemia
5279139|NCT02279927|Ureteroscopy|ureteroscopy
5279140|NCT02279901|Obstructive Sleep Apnea|obstructive sleep apnea
5279141|NCT02279901|CPAP|cpap
5279142|NCT02279901|Continuous positive airway pressure|continuous positive airway pressure
5279143|NCT02279901|CPAP compliance|cpap compliance
5279144|NCT02279901|Telemedicine|telemedicine
5279145|NCT02279901|Automated response mechanisms|automated response mechanisms
5279146|NCT02279901|Patient engagement|patient engagement
5279147|NCT02279901|OSA|osa
5279244|NCT02279342|IVUS|ivus
5279148|NCT02279888|Pulmonary Artery Pressure Monitoring|pulmonary artery pressure monitoring
5279149|NCT02279888|Implantable Hemodynamic Monitor|implantable hemodynamic monitor
5279150|NCT02279875|Tuberculosis|tuberculosis
5279151|NCT02279875|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
5279152|NCT02279875|Linezolid|linezolid
5279153|NCT02279875|HRZE (isoniazid, rifampicin, pyrazinamide, ethambutol)|hrze (isoniazid, rifampicin, pyrazinamide, ethambutol)
5279154|NCT02279875|Pulmonary Tuberculosis|pulmonary tuberculosis
5279156|NCT02279849|multi-level intervention|multi-level intervention
5279157|NCT02279849|price discounts|price discounts
5279158|NCT02279849|communication|communication
5279159|NCT02279849|low income population|low income population
5279160|NCT02279849|dietary intervention|dietary intervention
5279161|NCT02279849|obesity prevention|obesity prevention
5279162|NCT02279849|store-based intervention|store-based intervention
5279163|NCT02279836|Patients with any indication for colonoscopy in the U.S.A.|patients with any indication for colonoscopy in the u.s.a.
5279164|NCT02279823|androgen|androgen
5279165|NCT02279823|alopecia|alopecia
5279166|NCT02279823|CB-03-01|cb-03-01
5279167|NCT02279823|solution|solution
5279169|NCT02279810|organ shortage|organ shortage
5279170|NCT02279810|attitudes to organ transplantation|attitudes to organ transplantation
5279171|NCT02279797|bone marrow|bone marrow
5279172|NCT02279797|attitude|attitude
5279173|NCT02279771|colorectal anastomosis|colorectal anastomosis
5279174|NCT02279771|anastomotic leak|anastomotic leak
5279175|NCT02279771|ileostomy|ileostomy
5279176|NCT02279771|complications|complications
5279177|NCT02279758|Neuroendocrine Tumors|neuroendocrine tumors
5279178|NCT02279758|The Mammalian Target of Rapamycin (mTOR)|the mammalian target of rapamycin (mtor)
5279179|NCT02279758|metformin|metformin
5279180|NCT02279693|Raypilot dosimetry|raypilot dosimetry
5279181|NCT02279693|CBCT (cone beam computed tomography)|cbct (cone beam computed tomography)
5279182|NCT02279654|Lenalidomide|lenalidomide
5279183|NCT02279654|Revlimid|revlimid
5279184|NCT02279654|Transfusion-dependent|transfusion-dependent
5279185|NCT02279654|international Prognostic Scoring System (IPSS) low|international prognostic scoring system (ipss) low
5279186|NCT02279654|Intermediate-1-risk|intermediate-1-risk
5279187|NCT02279654|MDS|mds
5279188|NCT02279654|Isolated del(5q)|isolated del(5q)
5279189|NCT02279654|Prospective|prospective
5279190|NCT02279654|Non-interventional|non-interventional
5279191|NCT02279654|Post-authorization safety study (PASS)|post-authorization safety study (pass)
5279192|NCT02279654|Disease registry|disease registry
5279193|NCT02279628|cesarean section|cesarean section
5279194|NCT02279628|spinal anesthesia|spinal anesthesia
5279195|NCT02279628|continuous wound infiltration|continuous wound infiltration
5279196|NCT02279628|intrathecal morphine|intrathecal morphine
5279197|NCT02279628|oral morphine|oral morphine
5279198|NCT02279615|Overactive Bladder|overactive bladder
5279200|NCT02279615|Combination Therapy|combination therapy
5279201|NCT02279615|β3-Adrenoceptor Agonist|β3-adrenoceptor agonist
5279202|NCT02279615|Mirabegron|mirabegron
5279203|NCT02279615|Myrbetriq|myrbetriq
5279204|NCT02279615|α-Adrenoceptor Antagonist|α-adrenoceptor antagonist
5279205|NCT02279615|Tamsulosin|tamsulosin
5279206|NCT02279615|Flomax|flomax
5279207|NCT02279602|Pancreatic|pancreatic
5279208|NCT02279602|Gastrointestional|gastrointestional
5279209|NCT02279589|hyporesponsiveness|hyporesponsiveness
5279210|NCT02279589|vaccination|vaccination
5279211|NCT02279589|recommendations|recommendations
5279212|NCT02279589|improvement|improvement
5279213|NCT02279589|schedule|schedule
5279214|NCT02279589|fractional dose|fractional dose
5279215|NCT02279589|conjugate polysaccharide vaccine|conjugate polysaccharide vaccine
5279216|NCT02279576|Penile squamous cell carcinoma|penile squamous cell carcinoma
5279217|NCT02279576|Pazopanib|pazopanib
5279218|NCT02279576|Weekly paclitaxel|weekly paclitaxel
5279219|NCT02279550|hip fracture, elderly|hip fracture, elderly
5279220|NCT02279537|Wet age-related macular Degeneration (Wet-AMD)|wet age-related macular degeneration (wet-amd)
5279222|NCT02279537|Real life|real life
5279223|NCT02279537|Aflibercept|aflibercept
5279224|NCT02279524|NASH|nash
5279225|NCT02279511|Alzheimer|alzheimer
5279226|NCT02279485|Healthy Subjects|healthy subjects
5279227|NCT02279485|Bioequivalence|bioequivalence
5279228|NCT02279485|Fasted|fasted
5279229|NCT02279485|Fed|fed
5279230|NCT02279433|Neoplasms|neoplasms
5279231|NCT02279433|Lung Neoplasms|lung neoplasms
5279232|NCT02279433|Colorectal Neoplasms|colorectal neoplasms
5279233|NCT02279433|Neuroendocrine Tumors|neuroendocrine tumors
5279234|NCT02279433|Pancreatic Neoplasms|pancreatic neoplasms
5279235|NCT02279407|omega-3 carboxylic acid|omega-3 carboxylic acid
5279236|NCT02279394|Smoldering myeloma|smoldering myeloma
5279237|NCT02279394|Smoldering Multiple Myeloma|smoldering multiple myeloma
5279238|NCT02279381|Chlorhexidine|chlorhexidine
5279239|NCT02279381|Kangaroo mother care|kangaroo mother care
5279240|NCT02279381|RCT|rct
5279241|NCT02279342|Coronary artery disease|coronary artery disease
5279242|NCT02279342|hyperuricemia|hyperuricemia
5279243|NCT02279342|coronary plaque volume|coronary plaque volume
5279245|NCT02279316|Dalcroze eurhythmics|dalcroze eurhythmics
5279246|NCT02279316|home exercise|home exercise
5279247|NCT02279316|vitamin D|vitamin d
5279248|NCT02279316|mild cognitive impairment|mild cognitive impairment
5279249|NCT02279316|MCI|mci
5279250|NCT02279316|mild dementia|mild dementia
5279251|NCT02279290|Childhood trauma|childhood trauma
5279252|NCT02279264|ph|ph
5279253|NCT02279264|RightSpot Infant|rightspot infant
5279254|NCT02279264|Feeding Tube|feeding tube
5279255|NCT02279264|RightBio Metrics|rightbio metrics
5279256|NCT02279264|placement|placement
5279257|NCT02279264|Nasogastric Tube|nasogastric tube
5279258|NCT02279264|NG|ng
5160455|NCT02988518|Global functioning|global functioning
5279259|NCT02279264|infant|infant
5279260|NCT02279251|Anxiety|anxiety
5279261|NCT02279251|adolescents|adolescents
5279262|NCT02279251|school-based|school-based
5279263|NCT02279251|low-intensity CBT|low-intensity cbt
5279264|NCT02279225|Phototherapy|phototherapy
5279265|NCT02279225|Laser|laser
5279266|NCT02279225|Fibromyalgia|fibromyalgia
5279267|NCT02279225|DTM/ TMD|dtm/ tmd
5279268|NCT02279225|Pain|pain
5279269|NCT02279212|Critical illness|critical illness
5279270|NCT02279212|pain|pain
5279271|NCT02279212|quality of life|quality of life
5279272|NCT02279199|hemophilia|hemophilia
5279273|NCT02279199|joint health|joint health
5279274|NCT02279199|motor development|motor development
5279275|NCT02279199|motor proficiency|motor proficiency
5279276|NCT02279173|Pediatric|pediatric
5279277|NCT02279173|Immune Thrombocytopenia|immune thrombocytopenia
5279278|NCT02279173|Amgen|amgen
5279279|NCT02279147|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5279280|NCT02279147|Jaundice, Obstructive|jaundice, obstructive
5279281|NCT02279147|anti-inflammatory|anti-inflammatory
5279282|NCT02279134|StageⅡB-Ⅲ esophageal cancer|stageⅱb-ⅲ esophageal cancer
5279283|NCT02279134|adjuvant radiotherapy|adjuvant radiotherapy
5279284|NCT02279134|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5279285|NCT02279121|central venous catheter|central venous catheter
5279286|NCT02279121|Taurolidine|taurolidine
5279287|NCT02279121|lock-therapy|lock-therapy
5279288|NCT02279108|sentinel lymph node|sentinel lymph node
5279289|NCT02279108|indocyanine green|indocyanine green
5279290|NCT02279108|fluorescence method|fluorescence method
5279291|NCT02279108|radioisotope conventional method|radioisotope conventional method
5279292|NCT02279108|breast cancer|breast cancer
5279293|NCT02279095|Open-label extension study|open-label extension study
5279294|NCT02279095|Clinical trial Phase 2|clinical trial phase 2
5279295|NCT02279095|Efficacy and safety|efficacy and safety
5279296|NCT02279095|Heterotopic ossification|heterotopic ossification
5279297|NCT02279095|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
5279298|NCT02279095|Flare-up|flare-up
5279301|NCT02279095|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
5279302|NCT02279095|Clementia|clementia
5279303|NCT02279095|Myositis Ossificans Progressiva|myositis ossificans progressiva
5279304|NCT02279095|Munchmeyer's Disease|munchmeyer's disease
5279306|NCT02279069|stroke|stroke
5279307|NCT02279069|walking|walking
5279308|NCT02279069|rehabilitation|rehabilitation
5279309|NCT02279043|IUD|iud
5279310|NCT02279043|IUC|iuc
5279311|NCT02279043|birth control|birth control
5279312|NCT02279043|contraception|contraception
5279313|NCT02279043|online|online
5279314|NCT02279030|ablation|ablation
5279315|NCT02279017|Mobile Technology|mobile technology
5279316|NCT02279017|Diet and Fitness|diet and fitness
5279317|NCT02279004|Plasma Genotyping|plasma genotyping
5279318|NCT02279004|NSCLC|nsclc
5279319|NCT02279004|Melanoma|melanoma
5279320|NCT02278978|urothelial carcinoma|urothelial carcinoma
5279321|NCT02278978|BIBF1120|bibf1120
5279322|NCT02278965|Breast Cancer|breast cancer
5279323|NCT02278965|Early Stage|early stage
5279324|NCT02278939|diabetes prevention|diabetes prevention
5279325|NCT02278939|Filipinos|filipinos
5279326|NCT02278939|lifestyle intervention|lifestyle intervention
5279328|NCT02278926|Lypo-hypertrophy|lypo-hypertrophy
5279329|NCT02278913|inpatient|inpatient
5279330|NCT02278913|hospital|hospital
5279331|NCT02278913|randomized trial|randomized trial
5279332|NCT02278913|diabetes|diabetes
5279333|NCT02278913|analogs|analogs
5279334|NCT02278913|human insulin|human insulin
5279335|NCT02278900|communication|communication
5279336|NCT02278900|shared decision-making|shared decision-making
5279337|NCT02278887|melanoma|melanoma
5279338|NCT02278887|TIL treatment|til treatment
5279339|NCT02278887|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
5279341|NCT02278887|interleukin 2|interleukin 2
5279342|NCT02278887|non-myeloablative|non-myeloablative
5279343|NCT02278887|randomization|randomization
5279344|NCT02278874|Trisomy 13|trisomy 13
5279345|NCT02278874|Trisomy 18|trisomy 18
5279346|NCT02278874|Trisomy 21|trisomy 21
5279347|NCT02278874|Sex Chromosome Abnormalities|sex chromosome abnormalities
5279348|NCT02278874|Monosomy X|monosomy x
5279349|NCT02278874|XXX|xxx
5279350|NCT02278874|XXY|xxy
5279351|NCT02278874|XYY|xyy
5279352|NCT02278861|actinic keratosis|actinic keratosis
5279353|NCT02278861|tretinoin|tretinoin
5279354|NCT02278861|isotretinoin|isotretinoin
5279355|NCT02278861|cryotherapy|cryotherapy
5279356|NCT02278861|sun protection factor|sun protection factor
5279357|NCT02278861|clinical clearance|clinical clearance
5279358|NCT02278848|Computerised gait analysis|computerised gait analysis
5279359|NCT02278848|Ultrasound measurement of cerebral pulsatility|ultrasound measurement of cerebral pulsatility
5279360|NCT02278848|MRI flow|mri flow
5279361|NCT02278848|Urinary incontinence scale|urinary incontinence scale
5279362|NCT02278848|Subtractive lumbar puncture|subtractive lumbar puncture
5279363|NCT02278835|Cardiac valve|cardiac valve
5279364|NCT02278809|physical activity|physical activity
5279365|NCT02278809|screen time|screen time
5279366|NCT02278809|vegetables|vegetables
5279367|NCT02278809|fruit|fruit
5279368|NCT02278809|snacks|snacks
5279369|NCT02278809|softdrink|softdrink
5279370|NCT02278809|water|water
5279371|NCT02278809|fruit juice|fruit juice
5279372|NCT02278809|parenting practices|parenting practices
5279373|NCT02278809|online videos|online videos
5279374|NCT02278809|intervention mapping protocol|intervention mapping protocol
5279375|NCT02278796|Diffuse large B-cell lymphomas (DLBC)|diffuse large b-cell lymphomas (dlbc)
5279376|NCT02278796|Follicular lymphomas (FL)|follicular lymphomas (fl)
5279377|NCT02278796|Mantle cell lymphomas (MCL)|mantle cell lymphomas (mcl)
5279378|NCT02278770|diverticular disease|diverticular disease
5279379|NCT02278770|MRI|mri
5279380|NCT02278770|visceral and subcutaneous fat|visceral and subcutaneous fat
5279381|NCT02278770|adipokines|adipokines
5279382|NCT02278757|Metabolic syndrome|metabolic syndrome
5279383|NCT02278757|Weight loss|weight loss
5279384|NCT02278757|Obesity|obesity
5279385|NCT02278757|Hypertension|hypertension
5279386|NCT02278757|Dyslipidemia|dyslipidemia
5279387|NCT02278744|Single-Fraction Stereotactic Radiosurgery|single-fraction stereotactic radiosurgery
5279388|NCT02278744|Salvage Re-Irradiation|salvage re-irradiation
5279389|NCT02278744|14-054|14-054
5279390|NCT02278731|Physical activity|physical activity
5279391|NCT02278731|Rehabilitation|rehabilitation
5279392|NCT02278731|Older adults|older adults
5279393|NCT02278731|Pilates|pilates
5279394|NCT02278731|Proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
5279395|NCT02278705|childhood obesity|childhood obesity
5279396|NCT02278705|childhood overweight|childhood overweight
5279397|NCT02278705|primary care|primary care
5279398|NCT02278705|weight management|weight management
5279399|NCT02278692|Vitamin K|vitamin k
5279400|NCT02278692|Calciphylaxis|calciphylaxis
5279401|NCT02278692|Calcific uremic arteriolopathy|calcific uremic arteriolopathy
5279402|NCT02278692|Dialysis|dialysis
5279403|NCT02278692|End-stage renal disease|end-stage renal disease
5279404|NCT02278653|Restaging|restaging
5279405|NCT02278653|Watchful Waiting|watchful waiting
5279406|NCT02278653|Quality of Life|quality of life
5279407|NCT02278653|Manometry|manometry
5279409|NCT02278575|antithrombin, Atenativ, preeclampsia, blood flow.|antithrombin, atenativ, preeclampsia, blood flow.
5279410|NCT02278549|Spinal kinematics|spinal kinematics
5279411|NCT02278536|Trisomy 13|trisomy 13
5279412|NCT02278536|Trisomy 18|trisomy 18
5279413|NCT02278536|Trisomy 21|trisomy 21
5279414|NCT02278536|Sex Chromosome Abnormalities|sex chromosome abnormalities
5279415|NCT02278536|Monosomy X|monosomy x
5279417|NCT02278536|XXY|xxy
5279418|NCT02278536|XYY|xyy
5279419|NCT02278510|topotecan|topotecan
5279420|NCT02278510|convection-enhanced delivery|convection-enhanced delivery
5279421|NCT02278510|CED|ced
5279422|NCT02278510|High Grade Glioma|high grade glioma
5279423|NCT02278484|sinus infections|sinus infections
5279424|NCT02278484|sinusitis|sinusitis
5279425|NCT02278484|chronic sinusitis|chronic sinusitis
5279426|NCT02278484|rhinosinusitis|rhinosinusitis
5279427|NCT02278484|allergic sinusitis|allergic sinusitis
5279428|NCT02278484|allergic rhinitis|allergic rhinitis
5279429|NCT02278484|chronic rhinosinusitis|chronic rhinosinusitis
5279430|NCT02278484|sinus disease in children|sinus disease in children
5279431|NCT02278484|sinus balloon dilation|sinus balloon dilation
5279432|NCT02278484|balloon dilatation|balloon dilatation
5279433|NCT02278484|sinus disease|sinus disease
5279434|NCT02278484|pediatric|pediatric
5279435|NCT02278471|combination pill|combination pill
5279436|NCT02278471|polypill|polypill
5279437|NCT02278471|primary prevention|primary prevention
5279438|NCT02278445|Systemic Sclerosis|systemic sclerosis
5279439|NCT02278445|Pulmonary hypertension|pulmonary hypertension
5279440|NCT02278445|Lung Doppler Signals|lung doppler signals
5279441|NCT02278432|risk assessment|risk assessment
5279442|NCT02278432|pharmacovigilance|pharmacovigilance
5279443|NCT02278432|pharmacoepidemiology|pharmacoepidemiology
5279444|NCT02278432|drug toxicity|drug toxicity
5279445|NCT02278432|adverse drug reaction reporting system|adverse drug reaction reporting system
5279446|NCT02278432|omeprazole|omeprazole
5279447|NCT02278419|Hepatitis C|hepatitis c
5279448|NCT02278419|Simeprevir|simeprevir
5279449|NCT02278419|Sofosbuvir|sofosbuvir
5279451|NCT02278406|Parkinson's Disease|parkinson's disease
5279452|NCT02278406|Deep brain stimulator|deep brain stimulator
5279453|NCT02278406|dbs|dbs
5279454|NCT02278393|Japanese healthy volunteers|japanese healthy volunteers
5279455|NCT02278393|High LDL-C|high ldl-c
5279456|NCT02278393|dairy drinks|dairy drinks
5279457|NCT02278393|phytosterols|phytosterols
5279458|NCT02278341|ASP1517|asp1517
5279459|NCT02278341|FG-4592|fg-4592
5279460|NCT02278341|Anemia|anemia
5279461|NCT02278341|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5279462|NCT02278341|Erythropoetin Stimulating Agents (ESAs)|erythropoetin stimulating agents (esas)
5279463|NCT02278341|Chronic Kidney Disease|chronic kidney disease
5160672|NCT02987387|Pulmonary Stenosis|pulmonary stenosis
5279464|NCT02278341|Hematopoetic Agents|hematopoetic agents
5279465|NCT02278341|HIF-PH inhibitor|hif-ph inhibitor
5279466|NCT02278341|Hemoglobin|hemoglobin
5279467|NCT02278341|Dialysis|dialysis
5279468|NCT02278341|roxadustat|roxadustat
5279469|NCT02278328|dose titration study|dose titration study
5279470|NCT02278328|electrophysiology|electrophysiology
5279471|NCT02278315|Multiple Myeloma|multiple myeloma
5279472|NCT02278315|Radiopharmaceutical|radiopharmaceutical
5279473|NCT02278315|Therapy|therapy
5279474|NCT02278315|Phase 1|phase 1
5279475|NCT02278263|tranexamic acid|tranexamic acid
5279476|NCT02278263|enhanced recovery|enhanced recovery
5279477|NCT02278263|arthroplasty|arthroplasty
5279478|NCT02278263|perioperative care|perioperative care
5279479|NCT02278250|VX14-803-001|vx14-803-001
5279480|NCT02278250|VX-803|vx-803
5279481|NCT02278250|M4344|m4344
5279482|NCT02278250|Advanced Solid Tumor|advanced solid tumor
5279483|NCT02278250|Cytotoxic Chemotherapy|cytotoxic chemotherapy
5279484|NCT02278250|Gemcitabine|gemcitabine
5279485|NCT02278250|Cisplatin|cisplatin
5279486|NCT02278250|Carboplatin|carboplatin
5279487|NCT02278198|thyroid cancer|thyroid cancer
5279488|NCT02278172|vitamin D|vitamin d
5279489|NCT02278172|athletes|athletes
5279490|NCT02278172|fitness|fitness
5279491|NCT02278159|end-stage kidney disease|end-stage kidney disease
5279492|NCT02278159|peritoneal dialysis|peritoneal dialysis
5279493|NCT02278159|home hemodialysis|home hemodialysis
5279494|NCT02278159|technique survival|technique survival
5279495|NCT02278159|patient survival|patient survival
5279496|NCT02278133|metastatic,|metastatic,
5279497|NCT02278133|Colorectal cancer,|colorectal cancer,
5279498|NCT02278133|WNT974,|wnt974,
5279499|NCT02278133|LGX818,|lgx818,
5279500|NCT02278133|cetuximab,|cetuximab,
5279501|NCT02278133|BRAF-mutant,|braf-mutant,
5279502|NCT02278133|mCRC,|mcrc,
5279503|NCT02278133|BRAFV600-mutant,|brafv600-mutant,
5279504|NCT02278133|KRAS|kras
5279505|NCT02278120|LEE011|lee011
5279506|NCT02278120|ribociclib|ribociclib
5279507|NCT02278120|HR-positive|hr-positive
5279508|NCT02278120|HER2-negative|her2-negative
5279509|NCT02278120|Advanced breast cancer|advanced breast cancer
5279510|NCT02278120|Letrozole|letrozole
5279511|NCT02278120|Anastrozole|anastrozole
5279512|NCT02278120|Tamoxifen|tamoxifen
5279513|NCT02278120|Goserelin|goserelin
5279514|NCT02278120|CDK|cdk
5279515|NCT02278120|CDK4|cdk4
5279516|NCT02278120|CDK6|cdk6
5279517|NCT02278120|CDK4/6|cdk4/6
5279518|NCT02278120|Phase III|phase iii
5279519|NCT02278120|ER-positive|er-positive
5279520|NCT02278120|PR-positive|pr-positive
5279521|NCT02278120|Premenopausal|premenopausal
5279522|NCT02278094|OSAS|osas
5279523|NCT02278094|Adult|adult
5279524|NCT02278094|Home-based|home-based
5279525|NCT02278094|Genioglossus|genioglossus
5279526|NCT02278094|Inspiratory muscle|inspiratory muscle
5279527|NCT02278094|Exercise|exercise
5279528|NCT02278081|Rhinitis (nasal obstruction) and GERD|rhinitis (nasal obstruction) and gerd
5279529|NCT02278068|Type 2 diabetes|type 2 diabetes
5279530|NCT02278055|Radium-223|radium-223
5279531|NCT02278055|14-098|14-098
5279532|NCT02278055|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
5279533|NCT02278016|procalcitonin|procalcitonin
5279534|NCT02278016|interleukin-6|interleukin-6
5279535|NCT02278016|agiotensininⅡ|agiotensininⅱ
5279536|NCT02278003|Amnesic|amnesic
5276611|NCT02294175|biofilm|biofilm
5279537|NCT02278003|Propofol|propofol
5279538|NCT02278003|12-006|12-006
5279540|NCT02277977|septic shock|septic shock
5279541|NCT02277977|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5279542|NCT02277977|microcirculation|microcirculation
5279543|NCT02277964|RRMS|rrms
5279544|NCT02277964|Natalizumab|natalizumab
5279545|NCT02277964|Fingolimod|fingolimod
5279546|NCT02277964|Treatment Change|treatment change
5279547|NCT02277964|Disease Activity|disease activity
5279548|NCT02277925|Pelvic Organ Prolapse|pelvic organ prolapse
5279549|NCT02277925|Vaginal mesh exposure rates|vaginal mesh exposure rates
5279550|NCT02277925|Vaginal suture exposure rates|vaginal suture exposure rates
5279552|NCT02277912|Stroke|stroke
5279553|NCT02277912|Navigated|navigated
5279554|NCT02277912|Placebo|placebo
5279555|NCT02277912|TMS|tms
5279556|NCT02277899|childhood obesity|childhood obesity
5279557|NCT02277899|overweight|overweight
5279558|NCT02277899|communication|communication
5279559|NCT02277899|primary care|primary care
5279560|NCT02277899|weight management|weight management
5279561|NCT02277899|communication methods|communication methods
5174783|NCT02899546|Infections|infections
5279562|NCT02277899|patient-centered communication|patient-centered communication
5279563|NCT02277886|sodium alginate|sodium alginate
5279564|NCT02277886|esomeprazole|esomeprazole
5279565|NCT02277886|GERD|gerd
5279566|NCT02277873|moon|moon
5279567|NCT02277873|parturition|parturition
5279568|NCT02277873|moon phases|moon phases
5279569|NCT02277860|Exercise|exercise
5160774|NCT02986672|ADD|add
5160775|NCT02986672|PUFA|pufa
5279570|NCT02277847|Idarubicin|idarubicin
5279571|NCT02277847|Cytosine arabinoside|cytosine arabinoside
5279572|NCT02277847|Efficacy|efficacy
5279573|NCT02277847|Safety|safety
5279574|NCT02277821|Essential Hypertension|essential hypertension
5279575|NCT02277821|Central Blood Pressure|central blood pressure
5279576|NCT02277821|Microcirculation|microcirculation
5279577|NCT02277821|Endothelium Stimulation|endothelium stimulation
5279578|NCT02277808|Pneumocystis|pneumocystis
5279579|NCT02277808|Nebulizer|nebulizer
5279580|NCT02277808|Pentamidine|pentamidine
5279581|NCT02277795|Early infant male circumcision|early infant male circumcision
5279582|NCT02277795|HIV|hiv
5279583|NCT02277795|Prevention|prevention
5279584|NCT02277795|AccuCirc|accucirc
5279585|NCT02277795|Kenya|kenya
5279586|NCT02277795|Providers|providers
5279587|NCT02277795|Parents|parents
5279588|NCT02277782|Labor|labor
5279589|NCT02277782|Analgesia|analgesia
5279590|NCT02277756|high functioning autism|high functioning autism
5279591|NCT02277756|endogenous modulation systems|endogenous modulation systems
5279592|NCT02277730|Hypotension|hypotension
5279593|NCT02277717|cancer|cancer
5279594|NCT02277717|metastasis|metastasis
5279595|NCT02277717|HER2|her2
5279596|NCT02277717|trastuzumab|trastuzumab
5279597|NCT02277717|duocarmycin|duocarmycin
5279598|NCT02277717|SYD985|syd985
5279599|NCT02277717|antibody-drug conjugate|antibody-drug conjugate
5279600|NCT02277717|ADC|adc
5279601|NCT02277717|trastuzumab vc-seco-DUBA|trastuzumab vc-seco-duba
5279602|NCT02277704|PTSD|ptsd
5279603|NCT02277704|Military-related PTSD and other related conditions|military-related ptsd and other related conditions
5279604|NCT02277691|Pharmacological therapy|pharmacological therapy
5279605|NCT02277691|Drug Therapy|drug therapy
5279606|NCT02277678|Pruritus|pruritus
5279607|NCT02277665|Cannabis Use Disorder|cannabis use disorder
5279608|NCT02277665|Tobacco Use|tobacco use
5279609|NCT02277665|Treatment|treatment
5279610|NCT02277639|Transplant related mortality|transplant related mortality
5279611|NCT02277639|Graft versus host disease|graft versus host disease
5279612|NCT02277639|Bone marrow transplant|bone marrow transplant
5279613|NCT02277613|stem cells|stem cells
5279614|NCT02277587|Plenadren|plenadren
5279615|NCT02277587|Addison's disease|addison's disease
5279616|NCT02277587|Hydrocortisone|hydrocortisone
5279617|NCT02277587|Cortisone Acetate|cortisone acetate
5279618|NCT02277587|Monocytes|monocytes
5279619|NCT02277587|Natural Killer cells|natural killer cells
5279620|NCT02277587|Immunological profile|immunological profile
5279621|NCT02277587|Inflammation|inflammation
5279622|NCT02277574|Rheumatoid arthritis|rheumatoid arthritis
5279623|NCT02277574|Arthritis|arthritis
5279624|NCT02277574|Joint diseases|joint diseases
5279625|NCT02277574|Musculoskeletal diseases|musculoskeletal diseases
5279626|NCT02277548|chemotherapy|chemotherapy
5279627|NCT02277548|radiation therapy|radiation therapy
5279628|NCT02277535|Malnutrition in the ICU (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition|malnutrition in the icu (caloric deficit >4000 kcal or 150 g protein deficit) or >48hrs of admission without receiving nutrition
5279629|NCT02277470|pharmacokinetics, Golimumab, IBD|pharmacokinetics, golimumab, ibd
5279630|NCT02277444|Methotrexate|methotrexate
5279631|NCT02277444|Anti-TNFα Antibody|anti-tnfα antibody
5279632|NCT02277444|Golimumab|golimumab
5279633|NCT02277444|Pediatric Participants|pediatric participants
5279634|NCT02277379|cardiac surgery ; hemorrhage ; transfusion requirements|cardiac surgery ; hemorrhage ; transfusion requirements
5279635|NCT02277366|Lung Neoplasms|lung neoplasms
5279636|NCT02277366|Bronchoscopy|bronchoscopy
5279637|NCT02277366|Early Detection of Cancer|early detection of cancer
5279638|NCT02277353|Fluid responsiveness|fluid responsiveness
5279639|NCT02277353|NICOM|nicom
5279640|NCT02277353|Prone Position|prone position
5279641|NCT02277353|Stroke Volume Variation|stroke volume variation
5279642|NCT02277327|Hospitalization|hospitalization
5279643|NCT02277327|Readmissions|readmissions
5279644|NCT02277327|Medical complexity|medical complexity
5279645|NCT02277301|Pilot study|pilot study
5279646|NCT02277301|Randomised Controlled Trial|randomised controlled trial
5279647|NCT02277301|Parenting|parenting
5279648|NCT02277301|Paediatrics|paediatrics
5279649|NCT02277301|Mental Health|mental health
5279650|NCT02277275|Branched chain amino acid, high protein diet, weight loss|branched chain amino acid, high protein diet, weight loss
5279651|NCT02277262|peritonitis patients|peritonitis patients
5279652|NCT02277236|sarcopenia|sarcopenia
5279653|NCT02277236|aging|aging
5279654|NCT02277236|insulin resistance|insulin resistance
5279655|NCT02277236|screening|screening
5279656|NCT02277184|Intermediate Risk HNSCC|intermediate risk hnscc
5279947|NCT02275286|sarcoma|sarcoma
5279657|NCT02277184|High Risk HNSCC|high risk hnscc
5279658|NCT02277184|Previously Untreated, Locally Advanced HNSCC|previously untreated, locally advanced hnscc
5279659|NCT02277184|Undifferentiated carcinoma|undifferentiated carcinoma
5279660|NCT02277184|Poorly differentiated carcinoma of the oral cavity|poorly differentiated carcinoma of the oral cavity
5279661|NCT02277184|Poorly differentiated carcinoma of the oropharynx|poorly differentiated carcinoma of the oropharynx
5279662|NCT02277184|Poorly differentiated carcinoma of the larynx|poorly differentiated carcinoma of the larynx
5279663|NCT02277184|Poorly differentiated carcinoma of the hypopharynx|poorly differentiated carcinoma of the hypopharynx
5279664|NCT02277158|Rectal cancer|rectal cancer
5279665|NCT02277158|S-1|s-1
5279666|NCT02277158|Chemoradiotherapy|chemoradiotherapy
5279667|NCT02277158|Phase I|phase i
5279668|NCT02277145|radiation-induced pulmonary fibrosis|radiation-induced pulmonary fibrosis
5279669|NCT02277145|MSCs|mscs
5279670|NCT02277132|Fetal growth restriction|fetal growth restriction
5279671|NCT02277132|Sildenafil|sildenafil
5279672|NCT02277080|Pain, opioids, immune system, endocrine system, quality of life|pain, opioids, immune system, endocrine system, quality of life
5279673|NCT02277067|PPH|pph
5279674|NCT02277041|PPH|pph
5279675|NCT02277002|Cabin Air Filtration|cabin air filtration
5279676|NCT02277002|Particulate Matter|particulate matter
5279677|NCT02277002|Commuter Exposure|commuter exposure
5279678|NCT02277002|Traffic Related Air Pollution|traffic related air pollution
5279679|NCT02276989|Chronic Pain|chronic pain
5279680|NCT02276989|Compliance Marker|compliance marker
5279681|NCT02276989|Narcotic Abuse|narcotic abuse
5279682|NCT02276989|Opioid related disorders|opioid related disorders
5279683|NCT02276989|Opiate substitution treatment|opiate substitution treatment
5279684|NCT02276989|Buprenorphrine|buprenorphrine
5279685|NCT02276989|Suboxone|suboxone
5279686|NCT02276989|Lyrica|lyrica
5279687|NCT02276989|Pregabalin|pregabalin
5279688|NCT02276989|Acetazolamide|acetazolamide
5279689|NCT02276989|Quinine|quinine
5279690|NCT02276989|Compliance|compliance
5279691|NCT02276976|crebral white matter lesions|crebral white matter lesions
5279692|NCT02276976|brain networks|brain networks
5279693|NCT02276976|MRI|mri
5279694|NCT02276976|DTI|dti
5279695|NCT02276976|fMRI|fmri
5279696|NCT02276976|cognitive impairment|cognitive impairment
5279697|NCT02276976|gene|gene
5279698|NCT02276963|Transverse myelitis, optic neuritis, neuromyelitis optica|transverse myelitis, optic neuritis, neuromyelitis optica
5279699|NCT02276950|Cardiac Surgery|cardiac surgery
5279700|NCT02276950|Epidemiologic Methods|epidemiologic methods
5279701|NCT02276950|Blood Transfusions|blood transfusions
5279702|NCT02276937|Recombinant Sendai virus|recombinant sendai virus
5279703|NCT02276937|fibroblast growth factor-2|fibroblast growth factor-2
5279704|NCT02276937|treadmill|treadmill
5279705|NCT02276924|Laser Confocal Microscopy|laser confocal microscopy
5279706|NCT02276924|Superior Urinary Tract Tumors|superior urinary tract tumors
5279707|NCT02276898|pediatric|pediatric
5279708|NCT02276898|lung clearance index|lung clearance index
5279709|NCT02276898|Multiple Breath Washout|multiple breath washout
5279710|NCT02276898|Hypertonic Saline|hypertonic saline
5279711|NCT02276885|breast|breast
5279712|NCT02276885|cancer|cancer
5279713|NCT02276885|breast cancer|breast cancer
5279714|NCT02276885|prone|prone
5279715|NCT02276885|partial breast irradiation|partial breast irradiation
5279716|NCT02276885|PBI|pbi
5279717|NCT02276872|pediatric|pediatric
5279718|NCT02276872|treprostinil|treprostinil
5279719|NCT02276872|transition|transition
5279720|NCT02276872|Remodulin|remodulin
5279721|NCT02276859|dual-wave bolus|dual-wave bolus
5279722|NCT02276859|square bolus|square bolus
5279723|NCT02276859|normal bolus|normal bolus
5279724|NCT02276859|standard bolus|standard bolus
5279725|NCT02276859|high-protein meal|high-protein meal
5279726|NCT02276859|prandial insulin requirement|prandial insulin requirement
5279727|NCT02276846|Palpitate-Eluting Balloon|palpitate-eluting balloon
5279728|NCT02276846|Bifurcation|bifurcation
5279729|NCT02276846|OCT|oct
5279730|NCT02276846|Transluminal|transluminal
5279731|NCT02276820|Adenovirus|adenovirus
5279732|NCT02276820|Virus specific T cells|virus specific t cells
5279733|NCT02276820|Viral infections|viral infections
5279734|NCT02276807|Depression|depression
5279743|NCT02276794|Spinal manipulation|spinal manipulation
5279744|NCT02276794|Joint mobilization|joint mobilization
5279745|NCT02276794|Non-thrust manipulation|non-thrust manipulation
5279746|NCT02276794|proprioception|proprioception
5279747|NCT02276794|Postural stability|postural stability
5279748|NCT02276794|Baropodometry|baropodometry
5279750|NCT02276781|Peripheral Arterial Disease|peripheral arterial disease
5279751|NCT02276781|Biomarkers|biomarkers
5279752|NCT02276768|rectal distension|rectal distension
5279753|NCT02276768|rectal compliance|rectal compliance
5279762|NCT02276768|pain management|pain management
5279764|NCT02276768|colon cancer|colon cancer
5279765|NCT02276768|H2S (hydrogen sulfide)|h2s (hydrogen sulfide)
5279766|NCT02276729|Upper limb|upper limb
5279767|NCT02276729|Rehabilitation|rehabilitation
5279768|NCT02276729|Occupational Therapy|occupational therapy
5279769|NCT02276729|Mirror Box Therapy|mirror box therapy
5279770|NCT02276690|iron deficiency|iron deficiency
5174993|NCT02897765|Neoantigen|neoantigen
5279771|NCT02276690|dosage of hepcidin|dosage of hepcidin
5279772|NCT02276690|usual biomarker (ferritin and transferrin saturation)|usual biomarker (ferritin and transferrin saturation)
5279773|NCT02276690|mass spectrometry|mass spectrometry
5160990|NCT02985346|Bone marrow mesenchymal stem cells|bone marrow mesenchymal stem cells
5160991|NCT02985333|paclitaxe,cyclophosphamide,dexamethasone, Multiple Myeloma|paclitaxe,cyclophosphamide,dexamethasone, multiple myeloma
5160992|NCT02985320|Sabin strain|sabin strain
5160994|NCT02985320|poliomyelitis|poliomyelitis
5279774|NCT02276690|immuno-detection|immuno-detection
5279775|NCT02276690|anaemia in intensive care unit|anaemia in intensive care unit
5279776|NCT02276664|lung cancer prevention|lung cancer prevention
5279777|NCT02276560|main tumor ranging from less than 3cm (T1 up to 7cm (T3)|main tumor ranging from less than 3cm (t1 up to 7cm (t3)
5279786|NCT02276495|pain management for total knee arthroplasty|pain management for total knee arthroplasty
5279787|NCT02276469|severe mental illness|severe mental illness
5279788|NCT02276430|Testicular cancer|testicular cancer
5279789|NCT02276430|Survivor|survivor
5279790|NCT02276430|Cardiovascular disease|cardiovascular disease
5279791|NCT02276430|Risk factors|risk factors
5279792|NCT02276417|Sepsis|sepsis
5279793|NCT02276417|Surgical ICU|surgical icu
5279794|NCT02276313|Peripheral|peripheral
5279795|NCT02276313|Infrainguinal|infrainguinal
5279796|NCT02276313|Drug Releasing Balloon|drug releasing balloon
5279797|NCT02276313|Drug Eluting Balloon|drug eluting balloon
5279798|NCT02276287|Adherence|adherence
5279799|NCT02276287|HAART|haart
5279800|NCT02276287|HIV|hiv
5279801|NCT02276287|Illness Perception|illness perception
5279802|NCT02276287|IPQ-R|ipq-r
5279803|NCT02276235|catgut embedding|catgut embedding
5279804|NCT02276235|obese women|obese women
5279805|NCT02276235|obesity-related hormones|obesity-related hormones
5279806|NCT02276222|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5279807|NCT02276222|COPD|copd
5279808|NCT02276157|cholangioscopy|cholangioscopy
5279809|NCT02276105|Carpal Tunnel Syndrome|carpal tunnel syndrome
5279810|NCT02276105|Quality of Life|quality of life
5279811|NCT02276105|EQ-5D|eq-5d
5279812|NCT02276105|SF-12|sf-12
5279813|NCT02276105|Michigan Hand Questionnaire|michigan hand questionnaire
5279814|NCT02276092|Community-acquired pneumonia|community-acquired pneumonia
5279815|NCT02276092|Pragmatic study|pragmatic study
5279816|NCT02276092|Multi-center|multi-center
5279817|NCT02276092|Time-dependent bias|time-dependent bias
5279818|NCT02276092|antimicrobial stewardship|antimicrobial stewardship
5279819|NCT02276092|prospective audit and feedback|prospective audit and feedback
5279823|NCT02276066|kidney dysfunction|kidney dysfunction
5279824|NCT02276066|chronic critical illness|chronic critical illness
5279826|NCT02276066|Glomerular filtration rate|glomerular filtration rate
5279827|NCT02276053|Epilepsy|epilepsy
5279828|NCT02276053|Brain tumor|brain tumor
5279829|NCT02276053|lacosamide (LCM)|lacosamide (lcm)
5279830|NCT02276053|Anti-Epileptic Drugs (AEDs)|anti-epileptic drugs (aeds)
5279831|NCT02276040|Arthroplasty|arthroplasty
5279832|NCT02276040|Knee Replacement|knee replacement
5279833|NCT02276040|Analgesia|analgesia
5279834|NCT02276040|pain|pain
5279836|NCT02276014|Beta carotene|beta carotene
5279837|NCT02276014|Retinol|retinol
5279838|NCT02276001|Adult Volunteers|adult volunteers
5279839|NCT02275988|Adult Volunteers|adult volunteers
5279840|NCT02275975|Adult Volunteers|adult volunteers
5279841|NCT02275962|Adult Volunteers|adult volunteers
5279842|NCT02275949|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
5279843|NCT02275949|Cerebral Vasospasm|cerebral vasospasm
5674495|NCT00603343|antimuscarinics|antimuscarinics
5279849|NCT02275897|Lower Segmental Caesarean Section (LSCS)|lower segmental caesarean section (lscs)
5279853|NCT02275884|Parkinson Disease|parkinson disease
5279855|NCT02275884|Biogenic amines|biogenic amines
5279856|NCT02275884|Xanthines|xanthines
5279857|NCT02275884|Neurodegenerative Diseases|neurodegenerative diseases
5279858|NCT02275871|Breast Cancer|breast cancer
5279859|NCT02275858|balloon assisted enteroscopy|balloon assisted enteroscopy
5279860|NCT02275858|terminal ileum intubation|terminal ileum intubation
5279861|NCT02275845|metformin|metformin
5279862|NCT02275845|prevention|prevention
5279863|NCT02275819|Heart Failure|heart failure
5279864|NCT02275819|Exercise|exercise
5279865|NCT02275819|Echocardiography|echocardiography
5279866|NCT02275741|Vaccine|vaccine
5279867|NCT02275741|Antibody response|antibody response
5279868|NCT02275741|relaps rate|relaps rate
5279869|NCT02275741|expanded disability status scale|expanded disability status scale
5279870|NCT02275728|Menopause|menopause
5279871|NCT02275728|Stress Urinary Incontinence|stress urinary incontinence
5279872|NCT02275728|EMG Biofeedback|emg biofeedback
5279873|NCT02275728|Pelvic Floor Muscle Training|pelvic floor muscle training
5279874|NCT02275728|Quality of life|quality of life
5279875|NCT02275728|Physical Therapie|physical therapie
5279876|NCT02275715|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
5279877|NCT02275715|feeding problems|feeding problems
5962805|NCT04278417|proliferative diabetic retinophathy, retinal neovascularization, anti-VEGF, brolucizumab, intravitreal injection, panretinal photocoagulation|proliferative diabetic retinophathy, retinal neovascularization, anti-vegf, brolucizumab, intravitreal injection, panretinal photocoagulation
5962806|NCT04278378|Blood pressure|blood pressure
5962807|NCT04278378|Central hemodynamics|central hemodynamics
5962808|NCT04278378|Methylenetetrahydrofolate reductase (MTHFR)|methylenetetrahydrofolate reductase (mthfr)
5279878|NCT02275702|Dexamethasone|dexamethasone
5962809|NCT04278378|Folate polymorphism|folate polymorphism
5279879|NCT02275702|Quality of recovery questionnaire|quality of recovery questionnaire
5279880|NCT02275702|QoR-40|qor-40
5279881|NCT02275702|Lung cancer|lung cancer
5279882|NCT02275702|Video-assisted thoracoscopic|video-assisted thoracoscopic
5279883|NCT02275689|Rotator cuff|rotator cuff
5279884|NCT02275689|Tendinosis|tendinosis
5279885|NCT02275689|Impingement|impingement
5279886|NCT02275689|radiofrequency|radiofrequency
5279887|NCT02275676|Inflammatory bowel disease|inflammatory bowel disease
5279888|NCT02275676|Nutritional Status|nutritional status
5279889|NCT02275676|Malnutrition|malnutrition
5279890|NCT02275676|Resting Energy Expenditure|resting energy expenditure
5279891|NCT02275663|relapsed AML|relapsed aml
5279892|NCT02275663|refractory AML|refractory aml
5279893|NCT02275663|azacytidine|azacytidine
5279894|NCT02275650|calcidiol|calcidiol
5279895|NCT02275650|25(oh)d|25(oh)d
5279896|NCT02275650|nbUVB|nbuvb
5279897|NCT02275650|cyp27A1|cyp27a1
5279898|NCT02275650|cyp27B1|cyp27b1
5279899|NCT02275650|vitamin D|vitamin d
5279900|NCT02275637|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
5279901|NCT02275637|Ventricular Fibrillation|ventricular fibrillation
5279902|NCT02275637|ventricular Tachycardia|ventricular tachycardia
5279903|NCT02275611|oxytocin|oxytocin
5279904|NCT02275611|alcohol withdrawal|alcohol withdrawal
5279905|NCT02275611|alcohol dependence|alcohol dependence
5279906|NCT02275611|alcoholism|alcoholism
5279907|NCT02275585|Portal vein|portal vein
5279908|NCT02275585|Thrombosis|thrombosis
5279909|NCT02275585|Cirrhosis|cirrhosis
5279910|NCT02275481|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5279911|NCT02275481|COPD|copd
5279912|NCT02275481|Emphysema|emphysema
5279913|NCT02275481|Chronic bronchitis|chronic bronchitis
5279914|NCT02275468|Chronic Kidney Disease|chronic kidney disease
5279915|NCT02275468|eGFR slope|egfr slope
5279916|NCT02275468|Herbal medicine Fu-zheng-qu-zhuo Oral liquid|herbal medicine fu-zheng-qu-zhuo oral liquid
5279917|NCT02275442|EPICES scale|epices scale
5279918|NCT02275442|Precarious situation|precarious situation
5279919|NCT02275442|Rural parturient women|rural parturient women
5279920|NCT02275442|Access to care|access to care
5279921|NCT02275442|Global Initiative for Sentinel E-health Network on Grid|global initiative for sentinel e-health network on grid
5279922|NCT02275442|General practice|general practice
5279923|NCT02275429|Metabolic Diseases|metabolic diseases
5279924|NCT02275429|Athletes|athletes
5279926|NCT02275429|Selenium|selenium
5279927|NCT02275429|Zinc|zinc
5279928|NCT02275429|Iron Metabolism Disorders|iron metabolism disorders
5279929|NCT02275429|Water-Electrolyte Imbalance|water-electrolyte imbalance
5279930|NCT02275429|Hyperkalemia|hyperkalemia
5279931|NCT02275429|Hypernatremia|hypernatremia
5279932|NCT02275429|Selenium levels before and after the race|selenium levels before and after the race
5279933|NCT02275429|Levels of other electrolytes and markers|levels of other electrolytes and markers
5279934|NCT02275390|mental illness|mental illness
5279935|NCT02275390|psychoeducation|psychoeducation
5279936|NCT02275390|nurse-led clinic|nurse-led clinic
5279937|NCT02275390|randomized controlled trial|randomized controlled trial
5279938|NCT02275377|Breathing Exercises; Autonomic Control; Blood Pressure.|breathing exercises; autonomic control; blood pressure.
5279942|NCT02275325|Posture|posture
5279943|NCT02275325|Unilateral vestibular deafferentation|unilateral vestibular deafferentation
5279944|NCT02275325|Medical management|medical management
5279945|NCT02275325|Preoperative vestibular rehabilitation|preoperative vestibular rehabilitation
5279946|NCT02275325|Neural plasticity|neural plasticity
5279948|NCT02275273|Adnexal Masses|adnexal masses
5279949|NCT02275273|Magnetic Resonance Imaging|magnetic resonance imaging
5279950|NCT02275273|Anatomopathology|anatomopathology
5279951|NCT02275247|Stellate ganglion block|stellate ganglion block
5279952|NCT02275247|Aneurysm surgery|aneurysm surgery
5279953|NCT02275247|Cognitive recovery|cognitive recovery
5279954|NCT02275247|Cerebral vasospasm|cerebral vasospasm
5279955|NCT02275234|cardiac arrest|cardiac arrest
5279956|NCT02275234|psychological intervention|psychological intervention
5279957|NCT02275221|Hepatitis B (HBV)|hepatitis b (hbv)
5279958|NCT02275221|Hepatitis C (HCV)|hepatitis c (hcv)
5279959|NCT02275195|hepatitis|hepatitis
5279961|NCT02275182|Dexmedetomidine|dexmedetomidine
5279962|NCT02275169|follicle stimulating hormone treatment|follicle stimulating hormone treatment
5279963|NCT02275169|azoospermia nonobstructive|azoospermia nonobstructive
5279964|NCT02275169|male infertility|male infertility
5279965|NCT02275169|follicle stimulating hormone|follicle stimulating hormone
5279966|NCT02275156|Subjects with normal renal function or severe renal impairment (RI) or end stage renal disease (ESRD) receiving hemodialysis|subjects with normal renal function or severe renal impairment (ri) or end stage renal disease (esrd) receiving hemodialysis
5279967|NCT02275143|Computed Tomography of Thorax, Abdomen and Pelvis|computed tomography of thorax, abdomen and pelvis
5279968|NCT02275143|cancer patients|cancer patients
5279969|NCT02275143|coronary angiogram evaluation|coronary angiogram evaluation
5279970|NCT02275130|glottic insufficiency|glottic insufficiency
5279971|NCT02275130|calcium hydroxyapatite|calcium hydroxyapatite
5279972|NCT02275130|augmentation of vocal cords with injection technique|augmentation of vocal cords with injection technique
5279973|NCT02275117|Migraine Disorders|migraine disorders
5279974|NCT02275117|ALD403|ald403
5279975|NCT02275104|Ventricular arrhythmias|ventricular arrhythmias
5279976|NCT02275104|Persistent atrial fibrillation|persistent atrial fibrillation
5279977|NCT02275104|Ablation guidance|ablation guidance
5279978|NCT02275104|Software|software
5279979|NCT02275104|MRI (Magnetic resonance imaging)|mri (magnetic resonance imaging)
5279980|NCT02275091|Children|children
5279981|NCT02275091|Cholesterol|cholesterol
5279982|NCT02275078|COPD|copd
5279983|NCT02275078|Action Plan|action plan
5279984|NCT02275078|Telesystem|telesystem
5279985|NCT02275078|New technology|new technology
5279986|NCT02275065|HIV-1 Infected|hiv-1 infected
5279987|NCT02275065|Adults|adults
5279988|NCT02275065|Treatment Naive|treatment naive
5279989|NCT02275052|shuttle walk test|shuttle walk test
5279990|NCT02275052|umeclidinium|umeclidinium
5279991|NCT02275052|beta2-agonist|beta2-agonist
5279992|NCT02275052|exercise endurance time|exercise endurance time
5279993|NCT02275052|anticholinergic|anticholinergic
5279994|NCT02275052|combination product|combination product
5279995|NCT02275052|vilanterol|vilanterol
5279996|NCT02275052|exercise|exercise
5279997|NCT02275052|COPD|copd
5279998|NCT02275026|General Anesthesia, Postoperative Delirium, Recovery|general anesthesia, postoperative delirium, recovery
5279999|NCT02274974|incisional|incisional
5280000|NCT02274974|infiltration|infiltration
5280002|NCT02274974|lidocaine|lidocaine
5280003|NCT02274974|epinephrine|epinephrine
5280004|NCT02274974|Adverse Reaction to Topical or Infiltrative Lidocaine|adverse reaction to topical or infiltrative lidocaine
5280005|NCT02274922|Campylobacter diagnosis,|campylobacter diagnosis,
5280006|NCT02274922|immuno-chromatographic test, ELISA, PCR, culture, stool|immuno-chromatographic test, elisa, pcr, culture, stool
5280007|NCT02274922|ELISA,|elisa,
5280008|NCT02274922|PCR,|pcr,
5280009|NCT02274922|culture, stool|culture, stool
5280010|NCT02274909|electromyography|electromyography
5280011|NCT02274909|aged|aged
5280012|NCT02274909|muscle strength|muscle strength
5280013|NCT02274909|wavelet analysis|wavelet analysis
5280014|NCT02274909|pilates|pilates
5280015|NCT02274909|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
5280016|NCT02274857|Focal Impulse and Rotor Modulation Mapping Catheter (FIRMap)|focal impulse and rotor modulation mapping catheter (firmap)
5280017|NCT02274857|Rotor|rotor
5280018|NCT02274857|FIRM-guided procedure|firm-guided procedure
5280019|NCT02274857|REAFFIRM|reaffirm
5280020|NCT02274805|Brown adipose tissue|brown adipose tissue
5280021|NCT02274805|Neck surgery|neck surgery
5280022|NCT02274779|Prostate Cancer,Oligometastasis,Radiotherapy,Hormonotherapy|prostate cancer,oligometastasis,radiotherapy,hormonotherapy
5280023|NCT02274766|Levodopa-Induced Dyskinesia|levodopa-induced dyskinesia
5280024|NCT02274766|LID|lid
5280025|NCT02274766|Parkinsonism|parkinsonism
5280026|NCT02274766|Parkinson's Disease|parkinson's disease
5280027|NCT02274727|Biomarker|biomarker
5280028|NCT02274727|Stroke|stroke
5280029|NCT02274727|Etiology|etiology
5280030|NCT02274727|Outcome|outcome
5280031|NCT02274675|Stroke|stroke
5280032|NCT02274675|Robot-assisted therapy|robot-assisted therapy
5280033|NCT02274675|Rehabilitation|rehabilitation
5280034|NCT02274623|Bone Neoplasms|bone neoplasms
5280035|NCT02274623|Hypocalcemia|hypocalcemia
5280036|NCT02274623|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5280037|NCT02274610|docetaxel|docetaxel
5280038|NCT02274610|Pharmacokinetic|pharmacokinetic
5280039|NCT02274597|hypothermia|hypothermia
5280040|NCT02274597|pre-hospital|pre-hospital
5280041|NCT02274597|epitympanic|epitympanic
5280042|NCT02274597|temperature|temperature
5280043|NCT02274584|Hodgkin's lymphoma|hodgkin's lymphoma
5280044|NCT02274584|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5280045|NCT02274584|CD30 positive lymphoma|cd30 positive lymphoma
5280046|NCT02274584|Peripheral T/Natural Killer (NK) cell lymphoma|peripheral t/natural killer (nk) cell lymphoma
5280047|NCT02274519|multiple myeloma|multiple myeloma
5280048|NCT02274519|plasma cell disorder|plasma cell disorder
5280049|NCT02274519|autologous stem cell transplant|autologous stem cell transplant
5280050|NCT02274506|Blood And Marrow Transplantation|blood and marrow transplantation
5280051|NCT02274506|Leukemia|leukemia
5280052|NCT02274506|Lymphoma|lymphoma
5280053|NCT02274506|CD19-specific T cells|cd19-specific t cells
5280054|NCT02274506|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5280056|NCT02274506|Biphenotypic leukemia|biphenotypic leukemia
5280057|NCT02274506|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5280059|NCT02274506|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5280060|NCT02274506|Small lymphocytic lymphoma|small lymphocytic lymphoma
5280061|NCT02274506|Follicular lymphoma|follicular lymphoma
5280062|NCT02274506|Mantle cell lymphoma|mantle cell lymphoma
5280063|NCT02274506|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5445382|NCT01522079|heart rate variability|heart rate variability
5280065|NCT02274493|da Vinci® robotic surgical system|da vinci® robotic surgical system
5280066|NCT02274493|latissimus dorsi muscle flap harvest procedures|latissimus dorsi muscle flap harvest procedures
5280067|NCT02274493|breast reconstruction|breast reconstruction
5280068|NCT02274493|scalp reconstruction|scalp reconstruction
5962810|NCT04278378|Riboflavin|riboflavin
5161291|NCT02983344|fentanyl|fentanyl
5280069|NCT02274493|upper extremity reconstruction|upper extremity reconstruction
5280070|NCT02274493|lower extremity reconstruction|lower extremity reconstruction
5280072|NCT02274480|Diffusion Weighted Imaging|diffusion weighted imaging
5280073|NCT02274480|14-191|14-191
5280074|NCT02274467|Tsui Test|tsui test
5280075|NCT02274467|Labour|labour
5280076|NCT02274467|Epidural catheter|epidural catheter
5280077|NCT02274454|Uterine contraction|uterine contraction
5280078|NCT02274454|Oxytocin desensitization|oxytocin desensitization
5280079|NCT02274428|intraventricular hemorrhage|intraventricular hemorrhage
5280080|NCT02274415|Streptococcus pneumoniae|streptococcus pneumoniae
5280081|NCT02274415|Sickle cell disease|sickle cell disease
5280082|NCT02274415|Immunogenicity|immunogenicity
5280083|NCT02274415|Antibody response|antibody response
5280084|NCT02274402|Prednisone|prednisone
5280085|NCT02274402|Glucocorticoids|glucocorticoids
5280086|NCT02274402|pharmacokinetics|pharmacokinetics
5280087|NCT02274389|Pulmonary Multi-drug Resistant Tuberculosis|pulmonary multi-drug resistant tuberculosis
5280088|NCT02274389|Bedaquiline|bedaquiline
5280089|NCT02274389|Sirturo|sirturo
5280090|NCT02274389|Observational|observational
5280091|NCT02274389|Prospective|prospective
5280092|NCT02274363|Psoriasis|psoriasis
5280093|NCT02274363|Plaque|plaque
5280094|NCT02274363|Chronic|chronic
5280095|NCT02274350|prostate cancer|prostate cancer
5280096|NCT02274350|radiation therapy|radiation therapy
5280097|NCT02274350|sexual side effects|sexual side effects
5280098|NCT02274337|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5280099|NCT02274337|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5280100|NCT02274337|T790M mutation|t790m mutation
5280101|NCT02274324|parkinson|parkinson
5280102|NCT02274324|duodopa|duodopa
5280103|NCT02274324|diet|diet
5280104|NCT02274324|proteins|proteins
5280105|NCT02274324|amino acids|amino acids
5280106|NCT02274311|Acromegaly|acromegaly
5280107|NCT02274311|SERM|serm
5280108|NCT02274311|Clomiphene|clomiphene
5280109|NCT02274285|Tetanus|tetanus
5280110|NCT02274285|Diphtheria|diphtheria
5280111|NCT02274285|Pertussis|pertussis
5280112|NCT02274285|Poliomyelitis|poliomyelitis
5280113|NCT02274285|Bacterial meningitis|bacterial meningitis
5280114|NCT02274285|DTaP-IPV/Hib Combination vaccine|dtap-ipv/hib combination vaccine
5280115|NCT02274272|lactobacillus reuteri|lactobacillus reuteri
5280116|NCT02274272|type 2 diabetes|type 2 diabetes
5280117|NCT02274246|Segmentation|segmentation
5280118|NCT02274246|GIMIAS® program|gimias® program
5280119|NCT02274246|Atrial fibrillation|atrial fibrillation
5280120|NCT02274246|Left atrial fibrosis|left atrial fibrosis
5280121|NCT02274246|Healthy volunteers|healthy volunteers
5280123|NCT02274233|Iron Overload|iron overload
5280124|NCT02274233|Thalassemia|thalassemia
5280125|NCT02274233|Transfusion|transfusion
5280126|NCT02274233|Iron Chelation|iron chelation
5280127|NCT02274220|systemic inflammation|systemic inflammation
5280128|NCT02274220|glucose metabolism|glucose metabolism
5280129|NCT02274220|glucose-insulin ratio|glucose-insulin ratio
5280130|NCT02274207|Silver dressing|silver dressing
5280131|NCT02274207|NPWT|npwt
5280132|NCT02274207|DMF|dmf
5280133|NCT02274207|foot|foot
5280134|NCT02274194|obstructive sleep apnoea|obstructive sleep apnoea
5280135|NCT02274194|nasal mask|nasal mask
5280136|NCT02274194|oronasal mask|oronasal mask
5280137|NCT02274194|breathing route|breathing route
5280138|NCT02274194|CPAP|cpap
5280139|NCT02274155|Head and Neck Cancer|head and neck cancer
5280140|NCT02274155|anti-OX40 antibody|anti-ox40 antibody
5280141|NCT02274155|MEDI6469|medi6469
5280143|NCT02274142|dentinal caries|dentinal caries
5280144|NCT02274142|occlusal|occlusal
5280145|NCT02274142|occluso-proximal|occluso-proximal
5280146|NCT02274116|acute intermittent hypoxia|acute intermittent hypoxia
5280148|NCT02274116|spasticity|spasticity
5280149|NCT02274116|incomplete spinal cord injury|incomplete spinal cord injury
5280150|NCT02274116|breathing|breathing
5280151|NCT02274116|strength|strength
5280152|NCT02274090|Metformin|metformin
5280153|NCT02274090|Pocket depth|pocket depth
5280154|NCT02274090|moderate periodontitis|moderate periodontitis
5280155|NCT02274090|severe periodontitis|severe periodontitis
5280156|NCT02274077|length of stay|length of stay
5280157|NCT02274077|nausea|nausea
5280158|NCT02274077|emesis|emesis
5280159|NCT02274077|bowel function|bowel function
5280160|NCT02274077|pain scores|pain scores
5280161|NCT02274077|narcotic pain medication|narcotic pain medication
5280162|NCT02274077|post operative period|post operative period
5280163|NCT02274064|Retention|retention
5280164|NCT02274064|Blood Donor Motivation|blood donor motivation
5280165|NCT02274025|Patient diagnosed with lung cancer|patient diagnosed with lung cancer
5280166|NCT02274012|Gastric|gastric
5445383|NCT01522079|posture|posture
5280167|NCT02274012|Gastroesophageal Junction|gastroesophageal junction
5280168|NCT02274012|Gastroesophageal Cancer|gastroesophageal cancer
5280169|NCT02274012|Esophageal Cancer|esophageal cancer
5280170|NCT02274012|Metastatic|metastatic
5280171|NCT02274012|HER2 amplified|her2 amplified
5962811|NCT04278378|Folic acid|folic acid
5280172|NCT02274012|Afatinib|afatinib
5280173|NCT02273999|pulsed electromagnetic fields|pulsed electromagnetic fields
5280174|NCT02273999|post operative morbidity|post operative morbidity
5280175|NCT02273999|third molar|third molar
5280176|NCT02273999|extraction|extraction
5280177|NCT02273999|pain|pain
5280178|NCT02273986|Adult Volunteers|adult volunteers
5280179|NCT02273934|Home-based rehabilitation|home-based rehabilitation
5280180|NCT02273934|Activities of daily living|activities of daily living
5280181|NCT02273934|Restorative care|restorative care
5280182|NCT02273934|Reablement|reablement
5280183|NCT02273934|Everyday rehabilitation|everyday rehabilitation
5280184|NCT02273921|Dementia, Diagnosis, Electroencephalography|dementia, diagnosis, electroencephalography
5280185|NCT02273908|Low-Back Pain|low-back pain
5280186|NCT02273908|Neuropathic Pain|neuropathic pain
5280187|NCT02273908|Pregabalin|pregabalin
5280188|NCT02273895|Scopolamine, AD, EEG, MCI|scopolamine, ad, eeg, mci
5280189|NCT02273882|RSV|rsv
5280190|NCT02273882|RSVH|rsvh
5280191|NCT02273882|Infant|infant
5280192|NCT02273882|Gestational Age|gestational age
5280193|NCT02273882|wGA|wga
5280194|NCT02273882|PRETERM|preterm
5280195|NCT02273856|Chronic Lymphocytic Leukaemia (CLL)|chronic lymphocytic leukaemia (cll)
5280196|NCT02273856|Indolent Non Hodgkin's Lymphoma (iNHL)|indolent non hodgkin's lymphoma (inhl)
5280197|NCT02273843|Preterm|preterm
5280198|NCT02273843|late-onset sepsis|late-onset sepsis
5280199|NCT02273843|Vitamin D|vitamin d
5280200|NCT02273843|Dose|dose
5280201|NCT02273843|Interleukin-6|interleukin-6
5280202|NCT02273843|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5280203|NCT02273830|oxygen therapy|oxygen therapy
5280204|NCT02273830|COPD|copd
5280205|NCT02273830|exercise|exercise
5280206|NCT02273804|Topiramate|topiramate
5280207|NCT02273804|Obesity|obesity
5280208|NCT02273804|Children|children
5280209|NCT02273804|Adolescents|adolescents
5280210|NCT02273791|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
5280211|NCT02273791|FET protocols|fet protocols
5280212|NCT02273739|solid tumor|solid tumor
5280213|NCT02273739|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5280214|NCT02273739|ICC|icc
5280215|NCT02273739|chondrosarcoma|chondrosarcoma
5280216|NCT02273739|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5280217|NCT02273739|AITL|aitl
5280218|NCT02273739|IDH|idh
5280219|NCT02273739|glioma|glioma
5280220|NCT02273739|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma|solid tumor, including intrahepatic cholangiocarcinoma and chondrosarcoma
5280221|NCT02273726|Anemia|anemia
5280222|NCT02273726|Chronic Kidney Disease|chronic kidney disease
5280223|NCT02273726|Dialysis|dialysis
5280224|NCT02273726|hemodialysis|hemodialysis
5280225|NCT02273726|peritoneal dialysis|peritoneal dialysis
5280226|NCT02273726|hemoglobin|hemoglobin
5280227|NCT02273726|End stage renal disease|end stage renal disease
5280228|NCT02273726|Stable Dialysis|stable dialysis
5280229|NCT02273726|erythropoietins|erythropoietins
5280230|NCT02273726|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5280231|NCT02273713|Esophageal cancer|esophageal cancer
5280232|NCT02273713|Metastasized|metastasized
5280233|NCT02273713|Nab-paclitaxel|nab-paclitaxel
5280234|NCT02273713|Toxicity|toxicity
5280235|NCT02273713|First line treatment|first line treatment
5280236|NCT02273713|Phase Ib/II|phase ib/ii
5280237|NCT02273700|Xarelto®|xarelto®
5280238|NCT02273700|protein/peptide profiles|protein/peptide profiles
5280239|NCT02273687|diaphragm movement|diaphragm movement
5280240|NCT02273687|ultrasound|ultrasound
5280241|NCT02273687|emergency room|emergency room
5280936|NCT02269592|MGUS|mgus
5277324|NCT02290496|Teen|teen
5280242|NCT02273674|Borderline Personality Disorder|borderline personality disorder
5280243|NCT02273674|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5280245|NCT02273648|multicenter|multicenter
5280246|NCT02273648|observational registry|observational registry
5280247|NCT02273648|Orsiro Drug Eluting Stent|orsiro drug eluting stent
5280248|NCT02273648|Stenting Treatment of coronary artery disease|stenting treatment of coronary artery disease
5280249|NCT02273648|coronary revascularization|coronary revascularization
5280251|NCT02273648|STEMI|stemi
5280252|NCT02273648|NSTEMI|nstemi
5280253|NCT02273648|Ischemia|ischemia
5280254|NCT02273648|Angina|angina
5280255|NCT02273648|Acute Myocardial Infarction|acute myocardial infarction
5280256|NCT02273648|Small Vessels|small vessels
5280257|NCT02273648|Chronic Total Occlusion|chronic total occlusion
5280258|NCT02273622|hydroxytyrosol|hydroxytyrosol
5280259|NCT02273622|dietary supplement|dietary supplement
5280260|NCT02273622|gene expression regulation|gene expression regulation
5280261|NCT02273609|Atrial fibrillation|atrial fibrillation
5280262|NCT02273609|Anticoagulation|anticoagulation
5280263|NCT02273609|Vitamin K antagonists|vitamin k antagonists
5280264|NCT02273609|INR control|inr control
5280265|NCT02273583|of the extremity|of the extremity
5280266|NCT02273570|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5280267|NCT02273570|Anemia|anemia
5280268|NCT02273570|Vascular Stiffness|vascular stiffness
5280269|NCT02273570|Vascular Calcification|vascular calcification
5280270|NCT02273323|Flow mediated dilation|flow mediated dilation
5280271|NCT02273323|tea|tea
5280272|NCT02273323|blood pressure|blood pressure
5280273|NCT02273297|Body composition|body composition
5280274|NCT02273297|Body size|body size
5280275|NCT02273284|Pain, Pediatrics, Botulinum Toxin injections, Buzzy|pain, pediatrics, botulinum toxin injections, buzzy
5280276|NCT02273271|FLT-PET|flt-pet
5280277|NCT02273271|DWI-MRI|dwi-mri
5280278|NCT02273232|Peripheral Arterial Disease|peripheral arterial disease
5280279|NCT02273232|Peripheral Vascular Disease|peripheral vascular disease
5280280|NCT02273232|Claudication|claudication
5280281|NCT02273232|Remote Ischemic Preconditioning|remote ischemic preconditioning
5280282|NCT02273232|EQ-5D|eq-5d
5280283|NCT02273232|Symptoms free distance|symptoms free distance
5280284|NCT02273232|ABI|abi
5280285|NCT02273232|micro vessel formation|micro vessel formation
5280286|NCT02273219|Uveal|uveal
5280287|NCT02273219|Melanoma|melanoma
5280288|NCT02273219|Advanced uveal melanoma|advanced uveal melanoma
5280289|NCT02273206|Depression|depression
5280290|NCT02273206|Breast Cancer Screening|breast cancer screening
5280291|NCT02273206|Cervical Cancer Screening|cervical cancer screening
5280292|NCT02273206|Colorectal Cancer Screening|colorectal cancer screening
5280293|NCT02273154|major depressive disorder|major depressive disorder
5280294|NCT02273154|Efficacy and safety of buspirone add-one treatment in patients with major depression disorder|efficacy and safety of buspirone add-one treatment in patients with major depression disorder
5280295|NCT02273154|buspirone|buspirone
5280296|NCT02273154|paroxetine|paroxetine
5280297|NCT02273154|anxiety|anxiety
5280298|NCT02273128|Osteoporosis|osteoporosis
5280299|NCT02273128|Chronic Periodontitis|chronic periodontitis
5280300|NCT02273128|Calcitonin gene Polymorphism|calcitonin gene polymorphism
5280301|NCT02273115|induction|induction
5280302|NCT02273115|Foley catheter|foley catheter
5280303|NCT02273115|oxytocin|oxytocin
5280304|NCT02273102|Acute Myelogenous Leukemia|acute myelogenous leukemia
5280306|NCT02273102|Myelodysplastic Syndromes|myelodysplastic syndromes
5280307|NCT02273102|MDS|mds
5280308|NCT02273102|Tranylcypromine|tranylcypromine
5280309|NCT02273102|TCP|tcp
5280310|NCT02273102|ATRA|atra
5280311|NCT02273102|Tretinoin|tretinoin
5280312|NCT02273089|Obstructive sleep apnea|obstructive sleep apnea
5280313|NCT02273089|arterial stiffness|arterial stiffness
5280314|NCT02273089|CPAP|cpap
5280315|NCT02273089|excessive daytime sleepiness|excessive daytime sleepiness
5280316|NCT02273089|pulse wave velocity|pulse wave velocity
5280317|NCT02273063|PTSD|ptsd
5280318|NCT02273063|MDD|mdd
5280319|NCT02273063|TMS|tms
5280320|NCT02273063|5Hz|5hz
5280321|NCT02273050|Type 2 Diabetes Mellitus, Dipeptidyl-Peptidase 4 Inhibitors, Saxagliptin, Metformin, Endocrine System Diseases|type 2 diabetes mellitus, dipeptidyl-peptidase 4 inhibitors, saxagliptin, metformin, endocrine system diseases
5280322|NCT02273037|Labour|labour
5280323|NCT02273037|Birth asphyxia|birth asphyxia
5280324|NCT02273037|Fetal Heart Rate Monitor|fetal heart rate monitor
5280325|NCT02273037|Doppler Fetal Heart Rate Monitor|doppler fetal heart rate monitor
5280326|NCT02273037|Pinard Horn|pinard horn
5280327|NCT02273037|Pediatrics|pediatrics
5280328|NCT02273037|Uganda|uganda
5280329|NCT02273024|Exercise|exercise
5280330|NCT02273024|Quality of Life|quality of life
5280331|NCT02273024|Fatigue|fatigue
5280332|NCT02273024|Symptoms|symptoms
5280333|NCT02273024|Prehabilitation|prehabilitation
5280334|NCT02273024|Aerobic Capacity|aerobic capacity
5280336|NCT02272985|cerebral blood flow|cerebral blood flow
5280337|NCT02272985|hemodialysis|hemodialysis
5384555|NCT01792453|MRI|mri
5280338|NCT02272972|"fluoroscopy[MeSH], education, medical[MeSH]"|"fluoroscopy[mesh], education, medical[mesh]"
5281039|NCT02269137|outcome|outcome
5277467|NCT02289716|Hip|hip
5280342|NCT02272907|Weight Loss Surgery|weight loss surgery
5280343|NCT02272907|Staple Line Reinforcement|staple line reinforcement
5280344|NCT02272894|Gastric Cancer|gastric cancer
5280345|NCT02272894|D2 Lymphadenectomy|d2 lymphadenectomy
5280346|NCT02272894|Superior Mesenteric Vein Lymph Node|superior mesenteric vein lymph node
5280347|NCT02272855|HF10|hf10
5280348|NCT02272855|HSV-1|hsv-1
5280349|NCT02272855|Ipilimumab|ipilimumab
5280350|NCT02272855|Oncolytic virus|oncolytic virus
5280351|NCT02272855|Phase II|phase ii
5280352|NCT02272855|Stage IIIB melanoma|stage iiib melanoma
5280353|NCT02272855|Stage IIIC melanoma|stage iiic melanoma
5280354|NCT02272855|Stage IV melanoma|stage iv melanoma
5280355|NCT02272855|Unresectable malignant melanoma|unresectable malignant melanoma
5280356|NCT02272855|Metastatic malignant melanoma|metastatic malignant melanoma
5280357|NCT02272855|Combination treatment|combination treatment
5280358|NCT02272855|Intratumoral injection|intratumoral injection
5280359|NCT02272842|Nepal|nepal
5280360|NCT02272842|Cobalamin|cobalamin
5280361|NCT02272842|Neurodevelopment|neurodevelopment
5280362|NCT02272842|Stunting|stunting
5280363|NCT02272842|Growth|growth
5280364|NCT02272790|Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|ovarian, fallopian tube, or primary peritoneal cancer
5280365|NCT02272777|Nilotinib|nilotinib
5280366|NCT02272777|AMN107|amn107
5280367|NCT02272777|Tasigna|tasigna
5280368|NCT02272777|Imatinib|imatinib
5280369|NCT02272777|STI571|sti571
5161605|NCT02981602|Chronic|chronic
5280370|NCT02272777|Gleevec/Glivec|gleevec/glivec
5280371|NCT02272777|BCR-ABL Positive|bcr-abl positive
5280372|NCT02272777|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
5280373|NCT02272777|Chronic myelogenous leukemia|chronic myelogenous leukemia
5280374|NCT02272777|Chronic myeloid leukemia|chronic myeloid leukemia
5280375|NCT02272777|Chronic myelocytic leukemia|chronic myelocytic leukemia
5280376|NCT02272777|Acute Lymphoblastic Leukemia (ALL) Philadelphia chromosome positive|acute lymphoblastic leukemia (all) philadelphia chromosome positive
5280377|NCT02272777|Acute Lymphoid Leukemia|acute lymphoid leukemia
5280378|NCT02272777|suboptimal molecular response|suboptimal molecular response
5280379|NCT02272751|cancer survivorship|cancer survivorship
5280380|NCT02272751|exercise|exercise
5280381|NCT02272751|relaxation|relaxation
5280382|NCT02272751|mindfulness|mindfulness
5280383|NCT02272725|ultramarathon|ultramarathon
5280384|NCT02272725|ibuprofen|ibuprofen
5280385|NCT02272725|acute kidney injury|acute kidney injury
5280386|NCT02272725|exercise-associated hyponatremia|exercise-associated hyponatremia
5280387|NCT02272725|exertion|exertion
5280388|NCT02272712|cancer survivor|cancer survivor
5280389|NCT02272712|computerized treatment|computerized treatment
5280390|NCT02272712|symptom management|symptom management
5280391|NCT02272699|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5280392|NCT02272699|Nimotuzumab|nimotuzumab
5280393|NCT02272699|Neoadjuvant treatment|neoadjuvant treatment
5280394|NCT02272686|Lymphoma|lymphoma
5280395|NCT02272686|Blood And Marrow Transplantation|blood and marrow transplantation
5280396|NCT02272686|Post Autologous Stem Cell Transplantation|post autologous stem cell transplantation
5280397|NCT02272686|SCT|sct
5280398|NCT02272686|B-cell lymphoma|b-cell lymphoma
5280399|NCT02272686|Ibrutinib|ibrutinib
5280400|NCT02272686|PCI-32765|pci-32765
5280401|NCT02272686|Imbruvica|imbruvica
5280402|NCT02272660|preemptive analgesia|preemptive analgesia
5280403|NCT02272660|parecoxib sodium|parecoxib sodium
5280404|NCT02272660|total knee arthroplasty|total knee arthroplasty
5280405|NCT02272660|total hip arthroplasty|total hip arthroplasty
5280406|NCT02272647|Normal Healthy Volunteers|normal healthy volunteers
5280407|NCT02272634|COPD|copd
5280408|NCT02272595|Biologic Markers|biologic markers
5280409|NCT02272595|Molecular testing|molecular testing
5280410|NCT02272595|Advanced cancers|advanced cancers
5280411|NCT02272595|Molecular information|molecular information
5280412|NCT02272595|Molecular profiling|molecular profiling
5280413|NCT02272595|Genetic Mutation|genetic mutation
5280414|NCT02272569|glaucoma|glaucoma
5280415|NCT02272569|glaucoma drainage device|glaucoma drainage device
5280416|NCT02272569|glaucoma shunt|glaucoma shunt
5280417|NCT02272530|Endothelial NO-synthase|endothelial no-synthase
5280418|NCT02272530|red blood cell|red blood cell
5280419|NCT02272530|erythrocytes|erythrocytes
5280420|NCT02272530|Peripheral Blood Mononuclear Cell|peripheral blood mononuclear cell
5280421|NCT02272530|cardiovascular disease|cardiovascular disease
5280422|NCT02272517|Vortioxetine|vortioxetine
5280423|NCT02272517|Cognition|cognition
5280424|NCT02272504|HCC|hcc
5280425|NCT02272504|AFP|afp
5280426|NCT02272504|AFP-L3|afp-l3
5280427|NCT02272504|DCP|dcp
5280429|NCT02272504|biomarkers|biomarkers
5280430|NCT02272478|AML|aml
5280431|NCT02272478|MDS|mds
5280432|NCT02272465|pre-hospital resuscitation, helicopter, trauma|pre-hospital resuscitation, helicopter, trauma
5281617|NCT02265926|N95 masks|n95 masks
5280433|NCT02272452|High resolution magic angle spinning Nuclear magnetic resonance|high resolution magic angle spinning nuclear magnetic resonance
5280434|NCT02272452|Nuclear magnetic resonance|nuclear magnetic resonance
5280435|NCT02272452|Spectroscopy|spectroscopy
5280436|NCT02272452|Primary brain tumors|primary brain tumors
5280437|NCT02272452|Gliomas|gliomas
5280438|NCT02272452|extemporaneous analysis|extemporaneous analysis
5280439|NCT02272439|Bisphenol A|bisphenol a
5280440|NCT02272439|phthalates|phthalates
5280441|NCT02272439|infertility|infertility
5280442|NCT02272439|human|human
5280443|NCT02272426|Stroke|stroke
5280444|NCT02272426|Exercise Training|exercise training
5280445|NCT02272426|Cognitive Training|cognitive training
5280446|NCT02272426|Quality of Life|quality of life
5280447|NCT02272400|image guided radiation therapy|image guided radiation therapy
5280448|NCT02272400|partial breast irradiation|partial breast irradiation
5280449|NCT02272400|breast cancer|breast cancer
5280450|NCT02272400|breast|breast
5280451|NCT02272400|cancer|cancer
5280452|NCT02272400|breast preservation|breast preservation
5280453|NCT02272400|IGRT|igrt
5280454|NCT02272400|PBI|pbi
5280455|NCT02272374|Hemodialysis|hemodialysis
5280456|NCT02272374|Arteriovenous fistula|arteriovenous fistula
5280457|NCT02272374|Tunneled cuffed catheter|tunneled cuffed catheter
5280458|NCT02272374|Arteriovenous graft|arteriovenous graft
5280459|NCT02272374|Elderly|elderly
5962812|NCT04278365|Psychological|psychological
5280460|NCT02272374|Very elderly|very elderly
5280461|NCT02272348|Therapeutic education|therapeutic education
5280462|NCT02272348|Functional insulin therapy|functional insulin therapy
5280463|NCT02272335|Breast Cancer|breast cancer
5280464|NCT02272335|Health Disparities|health disparities
5280465|NCT02272335|Psychosocial Intervention|psychosocial intervention
5280466|NCT02272335|Cancer Survivors|cancer survivors
5280467|NCT02272322|Anterior prolapse|anterior prolapse
5280468|NCT02272296|Injections, Jet|injections, jet
5280469|NCT02272296|pharmacology|pharmacology
5280470|NCT02272296|Insulin Aspart|insulin aspart
5280471|NCT02272296|Equipment and Supplies|equipment and supplies
5280472|NCT02272283|PCI optimization|pci optimization
5280473|NCT02272283|Coronary Remodeling|coronary remodeling
5280474|NCT02272283|Drug-Eluting Stent|drug-eluting stent
5280475|NCT02272283|Optical Coherence Tomography|optical coherence tomography
5280476|NCT02272283|Intravascular Ultrasound|intravascular ultrasound
5280477|NCT02272283|Strut Coverage|strut coverage
5280478|NCT02272283|Strut Apposition|strut apposition
5280479|NCT02272283|Vascular Healing Pattern|vascular healing pattern
5280480|NCT02272257|Musculoskeletal Pain|musculoskeletal pain
5280481|NCT02272257|Physical Therapists|physical therapists
5280482|NCT02272257|Drug Prescriptions|drug prescriptions
5280483|NCT02272257|Humans|humans
5280484|NCT02272257|Physical Therapy Modalities|physical therapy modalities
5280485|NCT02272257|Referral and Consultation|referral and consultation
5280486|NCT02272257|Workers' Compensation|workers' compensation
5280487|NCT02272257|United States|united states
5280488|NCT02272257|Primary Care|primary care
5280489|NCT02272257|Health Services Research|health services research
5280490|NCT02272257|Triage|triage
5280491|NCT02272257|Acute|acute
5280492|NCT02272257|Cost|cost
5280493|NCT02272257|Occupational Health|occupational health
5280494|NCT02272244|Colorectal Cancer|colorectal cancer
5280495|NCT02272244|Cancer Screening|cancer screening
5280496|NCT02272244|Decision Support|decision support
5280497|NCT02272244|Navigation|navigation
5280498|NCT02272231|women's health|women's health
5280499|NCT02272231|vaginosis, bacterial|vaginosis, bacterial
5280500|NCT02272231|african americans|african americans
5280501|NCT02272205|Hip replacement|hip replacement
5280502|NCT02272205|Knee replacement|knee replacement
5280503|NCT02272205|Knee infection|knee infection
5280504|NCT02272205|Hip infection|hip infection
5280505|NCT02272205|Antibiotic prophylaxis|antibiotic prophylaxis
5280506|NCT02272192|autism|autism
5280507|NCT02272192|autism spectrum disorder|autism spectrum disorder
5280508|NCT02272192|intensive intervention|intensive intervention
5280509|NCT02272192|early intervention|early intervention
5280510|NCT02272192|Early Start Denver Model|early start denver model
5280511|NCT02272179|adolescence|adolescence
5280512|NCT02272179|suicidality|suicidality
5280513|NCT02272179|depression|depression
5280514|NCT02272127|EGFR tyrosine kinase inhibitor|egfr tyrosine kinase inhibitor
5280515|NCT02272088|physical activity|physical activity
5280516|NCT02272088|energy expenditure|energy expenditure
5280517|NCT02272088|compensatory mechanisms|compensatory mechanisms
5280518|NCT02272088|adolescent|adolescent
5280519|NCT02272075|screeening|screeening
5280520|NCT02272062|Coronary artery disease|coronary artery disease
5280521|NCT02272062|Angina|angina
5280522|NCT02272062|Shared decision-making|shared decision-making
5280523|NCT02272062|Patient preferences|patient preferences
5280524|NCT02272062|Percutaneous coronary intervention|percutaneous coronary intervention
5280525|NCT02272062|Coronary artery bypass graft|coronary artery bypass graft
5280527|NCT02272036|Colonoscopy|colonoscopy
5280528|NCT02272036|Colonoscopy preparation|colonoscopy preparation
5280529|NCT02272036|screening|screening
5280530|NCT02272036|New media|new media
5280531|NCT02272036|SMS|sms
5280532|NCT02272036|Short message service|short message service
5280533|NCT02272023|alcohol|alcohol
5280534|NCT02272023|women|women
5280535|NCT02272023|motivational interviewing|motivational interviewing
5280536|NCT02271984|Healthy|healthy
5280537|NCT02271984|Praziquantel|praziquantel
5280538|NCT02271984|L-PZQ|l-pzq
5280539|NCT02271984|PZQ|pzq
5280540|NCT02271984|MSC2499550A|msc2499550a
5280541|NCT02271984|Bioavailability|bioavailability
5280542|NCT02271984|Pharmacokinetics|pharmacokinetics
5280543|NCT02271971|Psoriasis|psoriasis
5280544|NCT02271971|Vitamin D|vitamin d
5280545|NCT02271971|Metabolic syndrome|metabolic syndrome
5280546|NCT02271971|Insulin resistance|insulin resistance
5280547|NCT02271971|Cholesterol|cholesterol
5280548|NCT02271971|Methotrexate|methotrexate
5280549|NCT02271971|Dyslipidemia|dyslipidemia
5280550|NCT02271971|PASI|pasi
5280551|NCT02271971|Psoriasis Area Severity Index|psoriasis area severity index
5280552|NCT02271958|Mifepristone|mifepristone
5280553|NCT02271958|Endometriosis|endometriosis
5280554|NCT02271945|aggressive lymphoma, DLBCL, NHL|aggressive lymphoma, dlbcl, nhl
5280555|NCT02271932|appendicitis|appendicitis
5962813|NCT04278326|vaginal organoid|vaginal organoid
5280556|NCT02271932|non-operative management|non-operative management
5280557|NCT02271932|children|children
5280558|NCT02271932|pediatric|pediatric
5280559|NCT02271906|Lung Cancer|lung cancer
5280560|NCT02271906|Non small cell lung cancer|non small cell lung cancer
5280561|NCT02271906|NSCLC|nsclc
5161778|NCT02980575|Exercise|exercise
5280562|NCT02271906|Adenocarcinoma|adenocarcinoma
5280563|NCT02271906|Squamous cell carcinoma|squamous cell carcinoma
5280564|NCT02271906|BIBW 2992|bibw 2992
5280565|NCT02271906|Afatinib|afatinib
5280566|NCT02271893|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5280567|NCT02271880|Medication nonadherence|medication nonadherence
5280568|NCT02271802|Butyrate|butyrate
5280569|NCT02271802|Interorgan metabolism|interorgan metabolism
5280570|NCT02271802|Short-chain fatty acids|short-chain fatty acids
5280571|NCT02271802|Gut production|gut production
5280572|NCT02271776|Insulin Sensitivity|insulin sensitivity
5280573|NCT02271763|cricothyroid membrane|cricothyroid membrane
5280574|NCT02271763|ultrasound|ultrasound
5280575|NCT02271750|IGF, Neurotrophic factors, Dementia, spinal fluid|igf, neurotrophic factors, dementia, spinal fluid
5280576|NCT02271737|Newborn|newborn
5280577|NCT02271737|infection|infection
5280578|NCT02271737|community health|community health
5280579|NCT02271724|CIDP|cidp
5280581|NCT02271724|Spinal fluid|spinal fluid
5280582|NCT02271724|CD163|cd163
5280583|NCT02271724|CD19|cd19
5280584|NCT02271698|Knee arthroplasty|knee arthroplasty
5280585|NCT02271698|Dexamethasone|dexamethasone
5280586|NCT02271698|Acute pain|acute pain
5280587|NCT02271698|Chronic pain|chronic pain
5280588|NCT02271685|Diagnostic Information|diagnostic information
5280589|NCT02271685|Risk Perception|risk perception
5280590|NCT02271659|Prostate|prostate
5280591|NCT02271659|external beam radiotherapy|external beam radiotherapy
5280592|NCT02271659|brachytherapy boost|brachytherapy boost
5280593|NCT02271659|economical evaluation|economical evaluation
5280594|NCT02271646|paravertebral block|paravertebral block
5280595|NCT02271646|ultrasound guided|ultrasound guided
5280596|NCT02271633|Nitrate|nitrate
5280597|NCT02271633|Bioavailability|bioavailability
5280598|NCT02271633|Sports|sports
5280599|NCT02271620|1 prevalence|1 prevalence
5280600|NCT02271620|2 children|2 children
5280601|NCT02271620|3 local allergic rhinitis|3 local allergic rhinitis
5280602|NCT02271607|moxibustion|moxibustion
5280603|NCT02271555|electroconvulsive therapy|electroconvulsive therapy
5280604|NCT02271555|sevoflurane|sevoflurane
5280605|NCT02271555|remifentanil|remifentanil
5280607|NCT02271542|Polymorphism|polymorphism
5280608|NCT02271542|UGT1A9|ugt1a9
5280609|NCT02271542|CYP2B6|cyp2b6
5280610|NCT02271529|Peripheral Vascular Disease|peripheral vascular disease
5280611|NCT02271529|Femoral Artery|femoral artery
5280612|NCT02271529|Drug-Eluting Stent|drug-eluting stent
5280613|NCT02271490|Assisted Reproductive Technique|assisted reproductive technique
5280614|NCT02271490|ICSI|icsi
5280615|NCT02271490|Acrosome Reaction|acrosome reaction
5280616|NCT02271490|Pregnancy outcome|pregnancy outcome
5280617|NCT02271477|Fluid replacement|fluid replacement
5280618|NCT02271477|Trans-Thoracic Echocardiography|trans-thoracic echocardiography
5280619|NCT02271477|Spinal Anesthesia|spinal anesthesia
5280620|NCT02271477|Empirical Volemic Repletion|empirical volemic repletion
5280621|NCT02271464|Metastatic colorectal cancer|metastatic colorectal cancer
5280622|NCT02271464|Ist line therapy|ist line therapy
5280623|NCT02271464|metronimic therapy|metronimic therapy
5280624|NCT02271464|bevacizumab|bevacizumab
5280625|NCT02271451|concussion|concussion
5280626|NCT02271438|Healthy|healthy
5280627|NCT02271438|Ibrutinib|ibrutinib
5280628|NCT02271438|Moxifloxacin|moxifloxacin
5280629|NCT02271438|Cardiac Repolarization|cardiac repolarization
5280630|NCT02271438|Electrocardiogram|electrocardiogram
5280631|NCT02271438|QTc interval|qtc interval
5280632|NCT02271399|venous thromboembolism|venous thromboembolism
5280633|NCT02271399|total knee arthroplasty|total knee arthroplasty
5280634|NCT02271386|Evidence-Based Practice|evidence-based practice
5280635|NCT02271386|Provider Education|provider education
5280636|NCT02271373|Vision, Ocular|vision, ocular
5280637|NCT02271373|Physical activity|physical activity
5280638|NCT02271373|Schoolchildren|schoolchildren
5280639|NCT02271373|Intervention Studies|intervention studies
5280640|NCT02271360|infertility ICSI OHSS Calcium Dobesilate Cabergoline|infertility icsi ohss calcium dobesilate cabergoline
5280641|NCT02271334|Asthma|asthma
5280642|NCT02271334|Albuterol|albuterol
5280643|NCT02271321|dementia|dementia
5280644|NCT02271321|white noise|white noise
5280645|NCT02271321|agitation|agitation
5280646|NCT02271321|saliva cortisol|saliva cortisol
5280647|NCT02271308|elastic band resistance training|elastic band resistance training
5280648|NCT02271308|nursing home residents|nursing home residents
5280649|NCT02271308|muscle strength|muscle strength
5280650|NCT02271308|flexibility|flexibility
5280651|NCT02271308|quality of life|quality of life
5280652|NCT02271308|ease of care|ease of care
5280653|NCT02271295|Cirrhosis|cirrhosis
5280654|NCT02271295|Child B|child b
5280655|NCT02271295|decompensation|decompensation
5280656|NCT02271295|mortality|mortality
5280657|NCT02271295|portal thrombosis|portal thrombosis
5962814|NCT04278326|human papilloma virus|human papilloma virus
5280658|NCT02271295|anticoagulation|anticoagulation
5280659|NCT02271269|glaucoma|glaucoma
5280660|NCT02271269|medication adherence|medication adherence
5280661|NCT02271269|financial incentives|financial incentives
5280662|NCT02271269|behavioral economics|behavioral economics
5280663|NCT02271256|Functional intimate apparel|functional intimate apparel
5280664|NCT02271256|Adolescent Idiopathic scoliosis|adolescent idiopathic scoliosis
5280665|NCT02271243|Central line-associated bloodstream infections|central line-associated bloodstream infections
5280666|NCT02271243|mucosal barrier injury|mucosal barrier injury
5280667|NCT02271243|laboratory-confirmed bloodstream infection|laboratory-confirmed bloodstream infection
5280668|NCT02271217|Post stroke|post stroke
5280669|NCT02271217|Ischemic stroke|ischemic stroke
5280671|NCT02271126|Heparin|heparin
5280672|NCT02271126|Thromboelastography|thromboelastography
5280673|NCT02271126|Bleeding complications|bleeding complications
5280674|NCT02271074|HIV|hiv
5280675|NCT02271074|Care|care
5280676|NCT02271074|Treatment|treatment
5280677|NCT02271074|Retention|retention
5280678|NCT02271074|Implementation Science|implementation science
5280679|NCT02271048|telemedicine|telemedicine
5280680|NCT02271048|ultrasonography|ultrasonography
5280681|NCT02271048|echocardiography|echocardiography
5280682|NCT02271035|VUR|vur
5280683|NCT02271022|ACS, Acute Coronary Syndromes|acs, acute coronary syndromes
5280684|NCT02271022|NSTEMI|nstemi
5280685|NCT02271022|MI, Myocardial Infarction|mi, myocardial infarction
5280686|NCT02270996|antibiotic, antimicrobial, stewardship, child|antibiotic, antimicrobial, stewardship, child
5280687|NCT02270983|Opioid-Induced Constipation|opioid-induced constipation
5280688|NCT02270983|Linaclotide|linaclotide
5280689|NCT02270983|Linzess|linzess
5280690|NCT02270944|GBS|gbs
5280691|NCT02270944|vaccine comparability|vaccine comparability
5280692|NCT02270944|Group B Strep|group b strep
5280693|NCT02270918|Xa inhibitor|xa inhibitor
5280694|NCT02270918|Prothrombin complex concentrate|prothrombin complex concentrate
5280695|NCT02270918|anticoagulation|anticoagulation
5280696|NCT02270905|meniscus|meniscus
5280697|NCT02270905|meniscectomy|meniscectomy
5280698|NCT02270905|decellularised|decellularised
5280699|NCT02270905|xenograft|xenograft
5280700|NCT02270892|Ulthera, Ulthera System, Ultherapy|ulthera, ulthera system, ultherapy
5280701|NCT02270866|aphasia|aphasia
5280702|NCT02270866|stroke|stroke
5280703|NCT02270853|ApneaLink|apnealink
5280704|NCT02270853|bronchial carcinoma|bronchial carcinoma
5280716|NCT02270762|Oxygenation|oxygenation
5280717|NCT02270762|Ventilation|ventilation
5280718|NCT02270684|Total Knee Arthroplasty|total knee arthroplasty
5280719|NCT02270684|Home monitoring|home monitoring
5280720|NCT02270671|Social Anxiety|social anxiety
5280721|NCT02270671|Social Phobia|social phobia
5280722|NCT02270671|Depression|depression
5674496|NCT00603343|children|children
5280723|NCT02270671|Attention Bias Modification Training|attention bias modification training
5280724|NCT02270658|continuous positive airway pressure|continuous positive airway pressure
5280725|NCT02270658|hypertension|hypertension
5280726|NCT02270658|sleep apnea|sleep apnea
5280727|NCT02270606|Rectum|rectum
5280728|NCT02270541|Telemedicine|telemedicine
5280729|NCT02270541|Prehospital|prehospital
5280730|NCT02270541|Emergency Medicine|emergency medicine
5280731|NCT02270541|Stroke|stroke
5280732|NCT02270515|Patient-Centered Care|patient-centered care
5280733|NCT02270515|Medical Home|medical home
5280734|NCT02270502|critically illness|critically illness
5280735|NCT02270502|intensive care unit|intensive care unit
5280736|NCT02270502|outcome|outcome
5280737|NCT02270502|frailty|frailty
5280738|NCT02270476|Cystic Fibrosis|cystic fibrosis
5280739|NCT02270476|Infant|infant
5280740|NCT02270476|Toddler|toddler
5280741|NCT02270476|Children|children
5280742|NCT02270476|Newborn screening|newborn screening
5280743|NCT02270437|total knee arthroplasty|total knee arthroplasty
5280744|NCT02270437|cocktail analgesia|cocktail analgesia
5280745|NCT02270437|morphine consumption|morphine consumption
5280746|NCT02270424|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5280747|NCT02270424|Medicine, Chinese Traditional|medicine, chinese traditional
5280748|NCT02270424|Humans|humans
5280749|NCT02270424|Treatment Outcome|treatment outcome
5280750|NCT02270398|Exercise|exercise
5280751|NCT02270398|Balance|balance
5280752|NCT02270398|Gait|gait
5280753|NCT02270398|Community|community
5280754|NCT02270398|Rehabilitation|rehabilitation
5280755|NCT02270398|Dual-task|dual-task
5280756|NCT02270385|pressure ulcer|pressure ulcer
5280757|NCT02270385|nursing home|nursing home
5280758|NCT02270372|Advanced breast carcinoma|advanced breast carcinoma
5280759|NCT02270372|Advanced ovarian carcinoma|advanced ovarian carcinoma
5280760|NCT02270372|MUC1|muc1
5280761|NCT02270372|vaccine|vaccine
5280762|NCT02270372|Phase 1b|phase 1b
5280763|NCT02270359|Myocardial Infarction|myocardial infarction
5280765|NCT02270346|Allogeneic HSCT, Inspiratory Muscle Training, Exercise Capacity|allogeneic hsct, inspiratory muscle training, exercise capacity
5280766|NCT02270333|sarcoidosis|sarcoidosis
5280767|NCT02270333|inspiratory muscle strength|inspiratory muscle strength
5280768|NCT02270333|exercise capacity|exercise capacity
5280769|NCT02270333|quality of life|quality of life
5280770|NCT02270320|Tai Chi Chuan|tai chi chuan
5280771|NCT02270320|cognitive function|cognitive function
5280772|NCT02270320|motor function|motor function
5280773|NCT02270320|MRI|mri
5280774|NCT02270294|Ischemic stroke|ischemic stroke
5280775|NCT02270294|Thai traditional massage|thai traditional massage
5280776|NCT02270294|Vascular function|vascular function
5280777|NCT02270294|Cerebral blood flow|cerebral blood flow
5280778|NCT02270294|Cerebrovascular reactivity|cerebrovascular reactivity
5280779|NCT02270281|Sepsis|sepsis
5280780|NCT02270281|Sedation|sedation
5280781|NCT02270281|Microcirculation|microcirculation
5280782|NCT02270281|Dexmedetomidine|dexmedetomidine
5280783|NCT02270268|Irritable bowel syndrome|irritable bowel syndrome
5280784|NCT02270268|Gut microbiota|gut microbiota
5280785|NCT02270268|Soluble dietary fiber|soluble dietary fiber
5280786|NCT02270255|embolization|embolization
5280787|NCT02270255|analgesia|analgesia
5280788|NCT02270242|PCI|pci
5280789|NCT02270242|DAPT|dapt
5280790|NCT02270242|ticagrelor|ticagrelor
5280791|NCT02270242|aspirin|aspirin
5280792|NCT02270216|isolated systolic hypertension|isolated systolic hypertension
5280917|NCT02269761|Emergency Departments|emergency departments
5280793|NCT02270216|exercise pressor responses|exercise pressor responses
5280794|NCT02270203|si joint|si joint
5280795|NCT02270203|si joint injury|si joint injury
5280796|NCT02270203|si joint treatment|si joint treatment
5280797|NCT02270203|si joint inflammation|si joint inflammation
5280798|NCT02270203|si joint problems|si joint problems
5280799|NCT02270203|si joint symptoms|si joint symptoms
5280800|NCT02270203|hypermobile joint|hypermobile joint
5280801|NCT02270203|si joint arthritis|si joint arthritis
5280802|NCT02270203|si joint pain treatment|si joint pain treatment
5280803|NCT02270203|inflamed si joint|inflamed si joint
5280804|NCT02270203|si joint sclerosis|si joint sclerosis
5280805|NCT02270203|locked si joint|locked si joint
5280806|NCT02270203|si joint injuries|si joint injuries
5280807|NCT02270203|si joint disease|si joint disease
5280808|NCT02270203|si joint infection|si joint infection
5280809|NCT02270203|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
5280810|NCT02270203|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
5280811|NCT02270203|si joint pain|si joint pain
5280812|NCT02270203|si joint injections|si joint injections
5280813|NCT02270177|Headache|headache
5280814|NCT02270177|Telemedicine|telemedicine
5280815|NCT02270177|Videoconsultation|videoconsultation
5280816|NCT02270177|Headache-referrals|headache-referrals
5280817|NCT02270164|Lipids|lipids
5280818|NCT02270164|Cholesterol|cholesterol
5280819|NCT02270164|Dietary Supplements|dietary supplements
5280820|NCT02270164|Cynara scolymus|cynara scolymus
5280821|NCT02270164|Safety|safety
5280822|NCT02270151|Atrial fibrillation|atrial fibrillation
5280823|NCT02270151|Screening|screening
5280824|NCT02270151|Primary care|primary care
5280825|NCT02270151|Diagnostic|diagnostic
5280826|NCT02270138|physical activity|physical activity
5280827|NCT02270138|music|music
5280828|NCT02270138|sedentary lifestyle|sedentary lifestyle
5280829|NCT02270125|nasal mucosa|nasal mucosa
5280830|NCT02270125|chronic hypertrophic rhinosinusitis|chronic hypertrophic rhinosinusitis
5280831|NCT02270125|mucotomy|mucotomy
5280832|NCT02270125|nanoparticles|nanoparticles
5280833|NCT02270125|scanning electron microscopy|scanning electron microscopy
5282298|NCT02261415|outcome|outcome
5280839|NCT02270112|vascular stiffness|vascular stiffness
5280840|NCT02270073|Psychotherapy process|psychotherapy process
5280841|NCT02270073|Change mechanisms|change mechanisms
5280843|NCT02270073|Micro-interventions|micro-interventions
5280844|NCT02270073|Mindfulness interventions|mindfulness interventions
5280845|NCT02270073|Progressive muscle relaxation|progressive muscle relaxation
5280847|NCT02270060|Sickle Cell Disease|sickle cell disease
5280848|NCT02270060|Pain|pain
5280849|NCT02270047|Ad libitum energy intake|ad libitum energy intake
5280850|NCT02270047|Appetite sensation|appetite sensation
5280851|NCT02270021|Pap smear|pap smear
5280852|NCT02270021|Screening|screening
5280853|NCT02270021|Women|women
5280854|NCT02270021|Human papillomavirus|human papillomavirus
5280855|NCT02270021|Cervical precancer|cervical precancer
5280856|NCT02270021|Guideline adherence|guideline adherence
5280857|NCT02270008|anal incontinence|anal incontinence
5280858|NCT02270008|pregnancy-associated pelvic floor disorders|pregnancy-associated pelvic floor disorders
5280859|NCT02269995|Hepatocellular|hepatocellular
5280860|NCT02269995|Carcinoma|carcinoma
5280861|NCT02269969|Aminoglycoside|aminoglycoside
5280862|NCT02269969|Pharmacokinetics|pharmacokinetics
5280863|NCT02269969|Once daily dosing|once daily dosing
5280864|NCT02269943|Metastatic nasopharyngeal carcinoma|metastatic nasopharyngeal carcinoma
5280865|NCT02269943|oral azacitidine|oral azacitidine
5280866|NCT02269943|oral AZA|oral aza
5280867|NCT02269943|CC-486|cc-486
5280868|NCT02269943|metastatic|metastatic
5280869|NCT02269943|recurrent|recurrent
5280870|NCT02269943|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5280871|NCT02269943|nasal|nasal
5280872|NCT02269943|solid tumors|solid tumors
5280873|NCT02269943|locally advanced|locally advanced
5150200|NCT03053609|apnea|apnea
5280874|NCT02269943|rare head and neck cancer|rare head and neck cancer
5280875|NCT02269943|nasopharynx|nasopharynx
5280876|NCT02269943|single chemotherapy agent|single chemotherapy agent
5280877|NCT02269943|Epstein-Barr Virus (EBV) + nasopharyngeal carcinoma|epstein-barr virus (ebv) + nasopharyngeal carcinoma
5280878|NCT02269943|EBV-DN|ebv-dn
5280879|NCT02269943|Celgene|celgene
5280880|NCT02269943|Sponsor-study|sponsor-study
5280881|NCT02269943|oral chemotherapy|oral chemotherapy
5280882|NCT02269943|phase 2|phase 2
5280883|NCT02269943|oral Vidaza|oral vidaza
5280884|NCT02269943|EBV promoter methylation|ebv promoter methylation
5280885|NCT02269943|hypomethylation|hypomethylation
5280886|NCT02269943|tumor infiltrating lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
5280887|NCT02269943|EBV gene expression|ebv gene expression
5280888|NCT02269943|neoplasms|neoplasms
5280895|NCT02269891|Menopausal symptoms|menopausal symptoms
5280896|NCT02269891|Peri-menopause|peri-menopause
5280897|NCT02269891|Nu Femme|nu femme
5280898|NCT02269891|Labisia pumila|labisia pumila
5280899|NCT02269891|Eurycoma longifolia|eurycoma longifolia
5280900|NCT02269891|Hot flash|hot flash
5280901|NCT02269891|Joint pain|joint pain
5280902|NCT02269852|seasonal trivalent inactivated influenza vaccine|seasonal trivalent inactivated influenza vaccine
5280903|NCT02269852|immunogenicity|immunogenicity
5280904|NCT02269852|safety|safety
5280905|NCT02269852|cross-reactivity|cross-reactivity
5280906|NCT02269852|Northern hemisphere 2013-2014 formulation|northern hemisphere 2013-2014 formulation
5280907|NCT02269839|Tinnitus|tinnitus
5280908|NCT02269839|rTMS|rtms
5280909|NCT02269813|MammaPrint|mammaprint
5280910|NCT02269813|BluePrint|blueprint
5280911|NCT02269813|TargetPrint|targetprint
5280912|NCT02269774|Atrial Fibrillation|atrial fibrillation
5280913|NCT02269774|Obstructive Sleep Apnea|obstructive sleep apnea
5280914|NCT02269774|Atrial Premature Complexes|atrial premature complexes
5280915|NCT02269774|Pulmonary Vein Isolation|pulmonary vein isolation
5280916|NCT02269774|Mueller Manoeuvre|mueller manoeuvre
5280918|NCT02269761|Chest|chest
5280919|NCT02269761|Lung|lung
5280920|NCT02269761|Cough|cough
5280921|NCT02269761|Dyspnea|dyspnea
5280922|NCT02269761|Wheezing|wheezing
5280923|NCT02269761|Ultrasound|ultrasound
5280924|NCT02269761|Ultrasonography|ultrasonography
5280925|NCT02269657|Scoliosis|scoliosis
5280926|NCT02269657|Postural balance|postural balance
5280927|NCT02269657|Lordosis|lordosis
5280928|NCT02269657|Kyphosis|kyphosis
5280929|NCT02269657|X-rays|x-rays
5280930|NCT02269631|Weight loss|weight loss
5280931|NCT02269631|Epidemiology|epidemiology
5280932|NCT02269631|Nutrition|nutrition
5280933|NCT02269618|Telehealth, Home-based, rehabilitation|telehealth, home-based, rehabilitation
5280934|NCT02269605|HIV reservoir|hiv reservoir
5280935|NCT02269605|Bryostatin|bryostatin
5280937|NCT02269592|Smoldering Myeloma|smoldering myeloma
5280938|NCT02269592|Chronic Lymphocytic leukemia|chronic lymphocytic leukemia
5280939|NCT02269592|Acute Myeloid Leukemia|acute myeloid leukemia
5280940|NCT02269592|Myeloproliferative neoplasms|myeloproliferative neoplasms
5280941|NCT02269592|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5280942|NCT02269592|Monoclonal Gammopathy of Undermined Significance|monoclonal gammopathy of undermined significance
5280943|NCT02269592|Monoclonal B cell lymphocytosis|monoclonal b cell lymphocytosis
5280944|NCT02269592|Smoldering Multiple Myeloma|smoldering multiple myeloma
5268343|NCT02341066|EndoPAT|endopat
5280945|NCT02269592|Myelodysplastic syndromes|myelodysplastic syndromes
5280946|NCT02269579|Newly Diagnosed AML|newly diagnosed aml
5280947|NCT02269579|Secondary AML|secondary aml
5280948|NCT02269579|Relapsed/Refractory AML|relapsed/refractory aml
5278000|NCT02286544|Normoxemia|normoxemia
5280950|NCT02269566|allergic rhinitis|allergic rhinitis
5280951|NCT02269566|immunotherapy|immunotherapy
5280952|NCT02269553|Migraine|migraine
5280953|NCT02269553|Headache|headache
5280954|NCT02269514|adoption|adoption
5280955|NCT02269514|electronic cigarettes|electronic cigarettes
5280956|NCT02269514|e-cigarettes|e-cigarettes
5280957|NCT02269514|combustible cigarettes|combustible cigarettes
5280958|NCT02269514|nicotine polacrilex|nicotine polacrilex
5280959|NCT02269514|own brand cigarette|own brand cigarette
5280960|NCT02269514|subjective measures|subjective measures
5280961|NCT02269514|pharmacokinetics|pharmacokinetics
5280962|NCT02269514|pharmacodynamics|pharmacodynamics
5280963|NCT02269488|Safety|safety
5280964|NCT02269488|Tolerability|tolerability
5280965|NCT02269488|MEDI3250|medi3250
5280966|NCT02269488|Japanese children|japanese children
5280967|NCT02269475|Efficacy|efficacy
5280968|NCT02269475|Safety|safety
5280969|NCT02269475|Tolerability|tolerability
5962815|NCT04278326|nucleic acids|nucleic acids
5280970|NCT02269475|MEDI3250|medi3250
5280971|NCT02269475|Japanese children|japanese children
5280972|NCT02269449|transradial intervention|transradial intervention
5280973|NCT02269449|radial artery|radial artery
5280974|NCT02269410|Bariatric Surgery|bariatric surgery
5280975|NCT02269410|Nitrogen Balance|nitrogen balance
5280976|NCT02269410|Body composition|body composition
5280977|NCT02269410|Protein supplementation|protein supplementation
5150288|NCT03053193|stage I|stage i
5280978|NCT02269410|Satiety|satiety
5280979|NCT02269410|Adherence|adherence
5280980|NCT02269397|Epilepsy|epilepsy
5280981|NCT02269397|Seizures|seizures
5280982|NCT02269397|Diagnosis|diagnosis
5280983|NCT02269397|Diagnostic|diagnostic
5280984|NCT02269397|Inflammation|inflammation
5280985|NCT02269384|Pain|pain
5280986|NCT02269384|Memory|memory
5280987|NCT02269384|Pressure Pain Threshold|pressure pain threshold
5280988|NCT02269384|Electromyography|electromyography
5280989|NCT02269384|Heart Rate Variability|heart rate variability
5280990|NCT02269319|ABSSSI|absssi
5280991|NCT02269319|MRX-I|mrx-i
5280992|NCT02269319|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
5280993|NCT02269306|PCOS|pcos
5280994|NCT02269306|clomiphene citrate|clomiphene citrate
5280996|NCT02269306|visceral fat area|visceral fat area
5280997|NCT02269306|HOMA-IR|homa-ir
5280998|NCT02269293|Selinexor (KPT-330)|selinexor (kpt-330)
5280999|NCT02269293|Paclitaxel|paclitaxel
5281000|NCT02269293|Carboplatin|carboplatin
5281001|NCT02269293|14-110|14-110
5281002|NCT02269280|Leukemia|leukemia
5281003|NCT02269280|Myelodysplastic syndrome|myelodysplastic syndrome
5281004|NCT02269280|MDS|mds
5281005|NCT02269280|Low or intermediate-1 risk|low or intermediate-1 risk
5281006|NCT02269280|Transfusion-dependent|transfusion-dependent
5281007|NCT02269280|Transfusion-independent|transfusion-independent
5281008|NCT02269280|Best supportive care|best supportive care
5281009|NCT02269280|BSC|bsc
5281010|NCT02269280|Azacitidine|azacitidine
5281011|NCT02269280|5-Azacytidine|5-azacytidine
5281012|NCT02269280|5-AZA|5-aza
5281013|NCT02269280|Vidaza|vidaza
5281014|NCT02269280|5-AZC|5-azc
5281015|NCT02269280|AZA-CR|aza-cr
5281016|NCT02269280|Ladakamycin|ladakamycin
5281017|NCT02269280|NSC-102816|nsc-102816
5281018|NCT02269280|Azacytidine|azacytidine
5281019|NCT02269280|Decitabine|decitabine
5281020|NCT02269280|Dacogen|dacogen
5281021|NCT02269254|Comparative Study|comparative study
5281022|NCT02269254|Knee Prosthesis|knee prosthesis
5281023|NCT02269254|Prosthesis Design|prosthesis design
5281024|NCT02269254|Treatment Outcome|treatment outcome
5281025|NCT02269254|Follow-Up Studies|follow-up studies
5281026|NCT02269254|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
5281027|NCT02269241|contraception|contraception
5281028|NCT02269241|hormonal oral contraceptive agents|hormonal oral contraceptive agents
5281029|NCT02269241|hormonal oral contraceptive|hormonal oral contraceptive
5281030|NCT02269241|oral contraceptive|oral contraceptive
5281031|NCT02269241|drospirenone|drospirenone
5281032|NCT02269241|LF111|lf111
5281033|NCT02269241|birth control|birth control
5281034|NCT02269150|Recipients|recipients
5281035|NCT02269150|Transplantation|transplantation
5281036|NCT02269137|status epileptics|status epileptics
5281037|NCT02269137|prognosis|prognosis
5281038|NCT02269137|risk factor|risk factor
5281040|NCT02269098|type 2 diabetes|type 2 diabetes
5281041|NCT02269098|hyperglycemia|hyperglycemia
5281042|NCT02269098|Emergency Department|emergency department
5281043|NCT02269098|Patient Education as Topic|patient education as topic
5281044|NCT02269098|Drug Therapy|drug therapy
5281045|NCT02269085|Lymphoma|lymphoma
5281046|NCT02269085|Mantle cell lymphoma|mantle cell lymphoma
5281047|NCT02269085|MCL|mcl
5281048|NCT02269085|Relapsed or refractory|relapsed or refractory
5281049|NCT02269085|Ibrutinib|ibrutinib
5281050|NCT02269085|PCI-32765|pci-32765
5281051|NCT02269085|Imbruvica|imbruvica
5281052|NCT02269085|Carfilzomib|carfilzomib
5281053|NCT02269072|Natriuretic Peptide|natriuretic peptide
5281054|NCT02269046|acupuncture|acupuncture
5281055|NCT02269046|moxibustion|moxibustion
5281059|NCT02269033|Patient Navigation|patient navigation
5281060|NCT02269033|Health Disparities|health disparities
5281062|NCT02269033|Breast Imaging Reporting and Data System, BI-RADS|breast imaging reporting and data system, bi-rads
5281063|NCT02269033|underserved|underserved
5281064|NCT02269020|Squamous Cell Carcinoma of the Epi-larynx|squamous cell carcinoma of the epi-larynx
5281065|NCT02269007|safety, tolerance, quadrivalent influenza vaccine|safety, tolerance, quadrivalent influenza vaccine
5281066|NCT02268994|ferric citrate|ferric citrate
5281067|NCT02268994|Chronic kidney disease|chronic kidney disease
5281068|NCT02268994|Anemia|anemia
5281069|NCT02268981|Oxymizer|oxymizer
5281070|NCT02268981|Oxygen conserving device|oxygen conserving device
5281071|NCT02268981|Conventional nasal cannula (CNC)|conventional nasal cannula (cnc)
5281072|NCT02268981|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5281073|NCT02268968|Topical Lidocaine|topical lidocaine
5281074|NCT02268968|Nasal CPAP|nasal cpap
5281075|NCT02268968|Pain|pain
5281076|NCT02268968|Preterm Infants|preterm infants
5281077|NCT02268968|Salivary cortisol|salivary cortisol
5962816|NCT04278326|cervical dysplasia|cervical dysplasia
5281078|NCT02268955|Biliary Colic|biliary colic
5281079|NCT02268955|Abdominal pain|abdominal pain
5281080|NCT02268955|Intravenous Ibuprofen|intravenous ibuprofen
5281081|NCT02268916|diabetes|diabetes
5281082|NCT02268916|physical activity|physical activity
5281083|NCT02268916|participation|participation
5962817|NCT04278326|cervical cancer|cervical cancer
5281084|NCT02268903|Pulmonary Embolism|pulmonary embolism
5281085|NCT02268903|Right Ventricle failure|right ventricle failure
5281086|NCT02268903|Diuretics|diuretics
5281087|NCT02268890|Multiple Myeloma|multiple myeloma
5281088|NCT02268890|Bortezomib|bortezomib
5281089|NCT02268890|Velcade|velcade
5281090|NCT02268877|ultrasonography|ultrasonography
5281091|NCT02268877|emergency department|emergency department
5281092|NCT02268864|Hepatitis C Chronic|hepatitis c chronic
5281093|NCT02268864|Simeprevir|simeprevir
5281094|NCT02268864|Daclatasvir|daclatasvir
5281095|NCT02268851|Mantle Cell Lymphoma|mantle cell lymphoma
5281096|NCT02268851|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
5281097|NCT02268838|E6007|e6007
5281098|NCT02268838|Healthy Japanese male subjects|healthy japanese male subjects
5281099|NCT02268812|Pain Management|pain management
5281100|NCT02268812|Europe|europe
5281101|NCT02268812|Intrathecal|intrathecal
5281102|NCT02268799|Cardioversion|cardioversion
5281103|NCT02268799|High Sensitivity Troponin T (Hs-Trop T)|high sensitivity troponin t (hs-trop t)
5281104|NCT02268799|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
5281105|NCT02268799|Neutrophil Gelatinase-associated Lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
5281106|NCT02268786|Preimplantation Genetic Screening|preimplantation genetic screening
5281107|NCT02268786|Blastocyst|blastocyst
5281108|NCT02268786|Vitrification|vitrification
5281109|NCT02268786|In vitro fertilization|in vitro fertilization
5281110|NCT02268786|non-invasive prenatal testing|non-invasive prenatal testing
5281111|NCT02268786|next generation sequencing|next generation sequencing
5281112|NCT02268747|skin squamous cell cancer panHER inhibitor Dacomitinib|skin squamous cell cancer panher inhibitor dacomitinib
5281113|NCT02268734|Sporadic Medullary Thyroid Cancer Vandetanib miRNA|sporadic medullary thyroid cancer vandetanib mirna
5281114|NCT02268721|Pilot study|pilot study
5281115|NCT02268721|Frail elderly|frail elderly
5281116|NCT02268721|Malnutrition|malnutrition
5281117|NCT02268721|Functionality|functionality
5281118|NCT02268721|Life quality|life quality
5281119|NCT02268721|Health care technology|health care technology
5281120|NCT02268708|COPD|copd
5281121|NCT02268708|Surgery, Thoracic|surgery, thoracic
5281122|NCT02268695|Recurrent/Metastatic HNSCC|recurrent/metastatic hnscc
5281123|NCT02268695|Taxanes|taxanes
5281124|NCT02268682|Educator-Guided|educator-guided
5281125|NCT02268682|Patient-Guided|patient-guided
5281126|NCT02268682|Standard of Care (Control)|standard of care (control)
5281127|NCT02268669|primary angioplasty|primary angioplasty
5281128|NCT02268669|post-thrombolysis angioplasty|post-thrombolysis angioplasty
5674497|NCT00603343|overactive bladder|overactive bladder
5281129|NCT02268669|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5281130|NCT02268643|breast cancer|breast cancer
5281131|NCT02268643|screening|screening
5281132|NCT02268643|ultrasound|ultrasound
5281133|NCT02268643|risk model|risk model
5281134|NCT02268630|Post-thrombotic syndrome|post-thrombotic syndrome
5281135|NCT02268630|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5281136|NCT02268630|Anticoagulation|anticoagulation
5281137|NCT02268630|Rivaroxaban|rivaroxaban
5281138|NCT02268617|Treadmill|treadmill
5281140|NCT02268617|Gait|gait
5281141|NCT02268617|Exercise|exercise
5281142|NCT02268578|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5281143|NCT02268578|TDCS|tdcs
5281144|NCT02268578|Memory Dysfunction|memory dysfunction
5281145|NCT02268578|Depression|depression
5281146|NCT02268565|sleep, insomnia, inflammation, pain|sleep, insomnia, inflammation, pain
5281147|NCT02268565|Insomnia symptom induction/placebo|insomnia symptom induction/placebo
5281148|NCT02268565|Insomnia symptom induction/aspirin|insomnia symptom induction/aspirin
5281149|NCT02268552|Type 1 Spinal Muscular Atrophy|type 1 spinal muscular atrophy
5281151|NCT02268539|atrial fibrillation|atrial fibrillation
5281152|NCT02268539|ablation|ablation
5281153|NCT02268539|implanted loop recorder|implanted loop recorder
5281154|NCT02268526|Safety, efficacy, pharmacokinetics, CSJ148, HCMV, HCMV viral load,|safety, efficacy, pharmacokinetics, csj148, hcmv, hcmv viral load,
5281155|NCT02268526|immunogenicity|immunogenicity
5281156|NCT02268513|Cardiovascular Disease|cardiovascular disease
5281157|NCT02268513|Social network|social network
5281158|NCT02268513|South Asians|south asians
5281159|NCT02268487|Early Improvement|early improvement
5281160|NCT02268487|Depression|depression
5281161|NCT02268487|Antidepressant|antidepressant
5281162|NCT02268474|532nm|532nm
5281163|NCT02268474|Excel V|excel v
5281164|NCT02268474|Cutera|cutera
5281165|NCT02268474|Laser|laser
5281166|NCT02268474|Laser Light|laser light
5281167|NCT02268474|PDL|pdl
5281168|NCT02268474|595nm|595nm
5281169|NCT02268474|Flash Lamp|flash lamp
5281170|NCT02268461|Post-Stroke Spasticity|post-stroke spasticity
5281171|NCT02268448|itch atopic dermatitis|itch atopic dermatitis
5281172|NCT02268422|Healthy volunteer|healthy volunteer
5281173|NCT02268422|crossover|crossover
5281174|NCT02268422|open-label|open-label
5281175|NCT02268422|randomised|randomised
5281176|NCT02268422|bioequivalence|bioequivalence
5281177|NCT02268422|pharmacokinetic study|pharmacokinetic study
5281178|NCT02268357|Dental Anxiety|dental anxiety
5162397|NCT02977247|Dense Breasts|dense breasts
5162398|NCT02977247|Breast Density|breast density
5162399|NCT02977247|Dense Parenchyma|dense parenchyma
5281179|NCT02268357|Tooth Extraction|tooth extraction
5281180|NCT02268357|Propranolol|propranolol
5281181|NCT02268344|nerve regeneration|nerve regeneration
5281182|NCT02268344|spinal accessory nerve|spinal accessory nerve
5281183|NCT02268344|shoulder function|shoulder function
5281184|NCT02268344|head neck cancer|head neck cancer
5281185|NCT02268344|electrical stimulation|electrical stimulation
5281186|NCT02268318|Japanese Subjects, High LDL-C, fermented-dairy products, phytosterols|japanese subjects, high ldl-c, fermented-dairy products, phytosterols
5281187|NCT02268292|Metabolic syndrome|metabolic syndrome
5281188|NCT02268292|Diabetes|diabetes
5281189|NCT02268292|Muscle strength|muscle strength
5281190|NCT02268292|Aerobic exercise|aerobic exercise
5281191|NCT02268292|Bicycle|bicycle
5281192|NCT02268292|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5281193|NCT02268266|brain injury, early rehabilitation, tilt table|brain injury, early rehabilitation, tilt table
5281194|NCT02268253|MF|mf
5281195|NCT02268253|CMML|cmml
5281196|NCT02268253|CMML-1|cmml-1
5281197|NCT02268253|CMML-2|cmml-2
5281198|NCT02268214|Dapagliflozin|dapagliflozin
5281199|NCT02268214|Efficacy|efficacy
5281200|NCT02268214|Safety|safety
5281201|NCT02268214|Add on to insulin|add on to insulin
5281202|NCT02268214|Oral Antidiabetic|oral antidiabetic
5281203|NCT02268214|Type 1 diabetes|type 1 diabetes
5281204|NCT02268201|tacrolimus|tacrolimus
5281205|NCT02268201|immunosuppressive therapy|immunosuppressive therapy
5281206|NCT02268188|Cancer Survivors|cancer survivors
5281207|NCT02268175|prostate adenocarcinoma|prostate adenocarcinoma
5281208|NCT02268175|advanced prostate cancer|advanced prostate cancer
5281209|NCT02268175|high risk prostate cancer|high risk prostate cancer
5281210|NCT02268162|Lung Neoplasms|lung neoplasms
5281211|NCT02268162|Bronchoscopy|bronchoscopy
5281212|NCT02268162|Virtual Bronchoscopic Navigation(VBN)|virtual bronchoscopic navigation(vbn)
5281213|NCT02268162|Fluoroscopy|fluoroscopy
5281214|NCT02268162|Endobronchial Ultrasonography with a Guide Sheath(EBUS-GS)|endobronchial ultrasonography with a guide sheath(ebus-gs)
5281215|NCT02268162|Diagnosis|diagnosis
5281216|NCT02268123|Male Infertility|male infertility
5281217|NCT02268123|Sperm DNA Fragmentation|sperm dna fragmentation
5281218|NCT02268123|Sperm Abnormality|sperm abnormality
5281219|NCT02268110|diastasis recti|diastasis recti
5281220|NCT02268110|physiotherapy|physiotherapy
5281221|NCT02268110|exercise therapy|exercise therapy
5281222|NCT02268110|abdominal binding|abdominal binding
5281223|NCT02268097|patella|patella
5674498|NCT00603343|propiverine|propiverine
5281224|NCT02268097|total knee arthroplasty|total knee arthroplasty
5281225|NCT02268097|resection|resection
5281226|NCT02268084|PTSD|ptsd
5281227|NCT02268084|TMS|tms
5281228|NCT02268084|EEG|eeg
5281229|NCT02268071|Hypertension|hypertension
5281230|NCT02268071|Stopping antihypertensive treatment|stopping antihypertensive treatment
5281231|NCT02268071|Primary care|primary care
5281232|NCT02268071|White coat hypertension|white coat hypertension
5281233|NCT02268071|Masked Hypertension|masked hypertension
5281234|NCT02268045|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5281235|NCT02268045|DLBCL|dlbcl
5281236|NCT02268045|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5268659|NCT02339090|somavaratan|somavaratan
5268660|NCT02339090|growth failure|growth failure
5268661|NCT02339077|Group B Streptococcus, stillborn|group b streptococcus, stillborn
5268677|NCT02339051|Basic Science|basic science
5268678|NCT02339038|Community Based Research|community based research
5268679|NCT02339038|Hepatitis C Virus and Human Immunodeficiency Virus|hepatitis c virus and human immunodeficiency virus
5268681|NCT02339038|Fixed Dose Combination|fixed dose combination
5268682|NCT02339038|Sustained Viral Response|sustained viral response
5268683|NCT02339025|Cohort|cohort
5268684|NCT02339025|Participation|participation
5281237|NCT02268032|Hormone replacement therapy|hormone replacement therapy
5281238|NCT02268019|hypospadias|hypospadias
5281239|NCT02268019|dehiscence|dehiscence
5281240|NCT02268019|urethral stricture|urethral stricture
5281241|NCT02268019|side effects|side effects
5281242|NCT02268006|rectal carcinoma|rectal carcinoma
5281243|NCT02268006|preoperative radiochemotherapy|preoperative radiochemotherapy
5281244|NCT02268006|IMRT|imrt
5281246|NCT02267980|Electroconvulsive therapy; sevoflurane; ketamine|electroconvulsive therapy; sevoflurane; ketamine
5281247|NCT02267954|Calories|calories
5281248|NCT02267954|Fast Food Literacy|fast food literacy
5281249|NCT02267928|Symptom Assessment|symptom assessment
5281250|NCT02267915|Relapsed or refractory patients with mantle-cell lymphoma|relapsed or refractory patients with mantle-cell lymphoma
5281251|NCT02267915|Progression after high-dose chemotherapy and autologous HPT|progression after high-dose chemotherapy and autologous hpt
5281252|NCT02267902|Volunteers|volunteers
5281253|NCT02267889|Ganglionated plexi|ganglionated plexi
5281254|NCT02267863|AML|aml
5281255|NCT02267863|MDS|mds
5281256|NCT02267863|Leukemia|leukemia
5962818|NCT04278313|Infertility - Ovarian dysfunuction|infertility - ovarian dysfunuction
5962819|NCT04278313|Diminished Ovarian Reserve|diminished ovarian reserve
5962820|NCT04278313|Premature Ovarian Aging (POA)|premature ovarian aging (poa)
5162495|NCT02976701|DLBS1033|dlbs1033
5281257|NCT02267863|Acute Myeloid Leukemia|acute myeloid leukemia
5281258|NCT02267863|Aptose|aptose
5281259|NCT02267863|APTO-253|apto-253
5281260|NCT02267863|Kinase Inhibitor|kinase inhibitor
5281261|NCT02267850|Photobiomodulation|photobiomodulation
5281262|NCT02267850|Orthodontic treatment|orthodontic treatment
5281263|NCT02267850|Malocclusion|malocclusion
5281264|NCT02267850|OrthoPulse™|orthopulse™
5281265|NCT02267837|Alignment phase|alignment phase
5281266|NCT02267837|Photobiomodulation|photobiomodulation
5281267|NCT02267837|Orthodontic treatment|orthodontic treatment
5281268|NCT02267837|Malocclusion|malocclusion
5281269|NCT02267837|OrthoPulse™|orthopulse™
5281270|NCT02267824|Alignment phase|alignment phase
5281271|NCT02267824|Photobiomodulation|photobiomodulation
5281272|NCT02267824|Orthodontic treatment|orthodontic treatment
5281273|NCT02267824|Malocclusion|malocclusion
5281274|NCT02267824|OrthoPulse™|orthopulse™
5281275|NCT02267811|Photobiomodulation|photobiomodulation
5281276|NCT02267811|Orthodontic treatment|orthodontic treatment
5281277|NCT02267811|Malocclusion|malocclusion
5281278|NCT02267811|OrthoPulse™|orthopulse™
5281279|NCT02267798|Stroke|stroke
5281280|NCT02267798|Rehabilitation|rehabilitation
5281281|NCT02267798|Arm motor recovery|arm motor recovery
5281282|NCT02267798|biological biomarkers|biological biomarkers
5281283|NCT02267785|exercise|exercise
5281284|NCT02267785|mild cognitive impairment|mild cognitive impairment
5281285|NCT02267785|Parkinson's Disease|parkinson's disease
5281286|NCT02267720|Dental Atraumatic Restorative Treatment|dental atraumatic restorative treatment
5281287|NCT02267720|Glass ionomer cement|glass ionomer cement
5281288|NCT02267720|Occlusal-proximal leasons|occlusal-proximal leasons
5281289|NCT02267720|Primary molars|primary molars
5281290|NCT02267707|nab®-paclitaxel|nab®-paclitaxel
5281291|NCT02267707|ABI-007|abi-007
5281292|NCT02267707|Abraxane|abraxane
5281293|NCT02267707|Advanced Pancreatic Cancer|advanced pancreatic cancer
5281294|NCT02267707|Cholestatic Hyperbilirubinemia|cholestatic hyperbilirubinemia
5281295|NCT02267707|Bile Duct Obstruction|bile duct obstruction
5281299|NCT02267668|exercise therapy|exercise therapy
5281300|NCT02267655|Inhaled Nitric Oxide (iNO)|inhaled nitric oxide (ino)
5281301|NCT02267655|Pulmonary Hypertension (PH)|pulmonary hypertension (ph)
5281302|NCT02267655|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5281303|NCT02267655|Long Term Oxygen Therapy (LTOT)|long term oxygen therapy (ltot)
5281304|NCT02267655|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5281306|NCT02267616|Levonorgestrel intrauterine device (LNG IUD)|levonorgestrel intrauterine device (lng iud)
5281307|NCT02267616|Etonogestrel (ENG) Implant|etonogestrel (eng) implant
5281308|NCT02267616|Contraception|contraception
5281309|NCT02267564|patellar dislocation|patellar dislocation
5281310|NCT02267564|medial patellofemoral ligament|medial patellofemoral ligament
5281311|NCT02267564|tibial tubercle transfer|tibial tubercle transfer
5281312|NCT02267551|robotic surgery|robotic surgery
5281313|NCT02267551|simulation|simulation
5281314|NCT02267538|Delirium|delirium
5281315|NCT02267538|Cardiac Surgical Procedures|cardiac surgical procedures
5281316|NCT02267538|Postoperative Complications|postoperative complications
5281317|NCT02267538|Dexmedetomidine|dexmedetomidine
5281318|NCT02267538|Prevention|prevention
5281319|NCT02267525|Gastroparesis|gastroparesis
5281320|NCT02267525|Diabetic|diabetic
5281321|NCT02267525|Idiopathic|idiopathic
5281322|NCT02267512|Kidney Transplant Patients|kidney transplant patients
5281323|NCT02267512|ATG-F|atg-f
5281324|NCT02267499|cognitive training|cognitive training
5281325|NCT02267499|physical training|physical training
5281326|NCT02267499|exercise games|exercise games
5281327|NCT02267499|novelty serious games|novelty serious games
5281328|NCT02267499|computer training|computer training
5281329|NCT02267499|mild cognitive impairment|mild cognitive impairment
5281330|NCT02267499|mild dementia|mild dementia
5281331|NCT02267499|healthy elderly|healthy elderly
5281332|NCT02267486|Alzheimer Dementia, AD|alzheimer dementia, ad
5281334|NCT02267486|cognitive|cognitive
5281335|NCT02267460|Peyronie's disease|peyronie's disease
5281336|NCT02267460|penile plaque|penile plaque
5281337|NCT02267460|penile curvature|penile curvature
5281338|NCT02267447|Cardiovascular diseases|cardiovascular diseases
5281339|NCT02267447|Clinical prediction rule|clinical prediction rule
5281340|NCT02267447|Population projection|population projection
5281341|NCT02267447|Risk stratification|risk stratification
5281342|NCT02267447|Health behavior|health behavior
5281343|NCT02267408|Heart valve prosthesis|heart valve prosthesis
5281344|NCT02267408|Anticoagulation|anticoagulation
5281345|NCT02267408|Warfarin|warfarin
5281346|NCT02267395|Musicians, Injuries|musicians, injuries
5281347|NCT02267369|online|online
5281348|NCT02267369|social media|social media
5281349|NCT02267369|online social network|online social network
5281350|NCT02267369|physical activity|physical activity
5281351|NCT02267369|message|message
5281352|NCT02267330|Gonadal Radiation Exposure|gonadal radiation exposure
5281353|NCT02267330|Fluoroscopic Imaging|fluoroscopic imaging
5281354|NCT02267330|Trauma Surgery|trauma surgery
5962821|NCT04278274|Radiomics features|radiomics features
5162593|NCT02976298|cerebellum|cerebellum
5281355|NCT02267330|Pelvis fractures|pelvis fractures
5281356|NCT02267330|Femur fractures|femur fractures
5281357|NCT02267317|Insulin signaling and glucose disposal in muscle|insulin signaling and glucose disposal in muscle
5281358|NCT02267317|Hepatic insulin sensitivity|hepatic insulin sensitivity
5281359|NCT02267317|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
5281360|NCT02267317|Plasma cytokine concentration|plasma cytokine concentration
5281361|NCT02267317|Intramyocellular diacylglycerol and ceramide content|intramyocellular diacylglycerol and ceramide content
5281362|NCT02267304|volunteers|volunteers
5281363|NCT02267291|Cardiac Catheterization|cardiac catheterization
5281364|NCT02267291|Echocardiography|echocardiography
5281365|NCT02267291|Noninvasive Ventilation|noninvasive ventilation
5281366|NCT02267291|Positive-Pressure Respiration|positive-pressure respiration
5281367|NCT02267291|Ventricular Function|ventricular function
5281368|NCT02267278|Myeloproliferative Diseases|myeloproliferative diseases
5281369|NCT02267278|Myelofibrosis|myelofibrosis
5281371|NCT02267278|Primary or post essential thrombocythemia/polycythemia vera|primary or post essential thrombocythemia/polycythemia vera
5281372|NCT02267278|Ruxolitinib|ruxolitinib
5281373|NCT02267278|Jakafi|jakafi
5281374|NCT02267278|INCB018424|incb018424
5281375|NCT02267278|INC424|inc424
5281376|NCT02267278|Pracinostat|pracinostat
5281377|NCT02267278|Questionnaire|questionnaire
5281378|NCT02267278|Survey|survey
5281379|NCT02267265|educational intervention|educational intervention
5281380|NCT02267265|language development|language development
5281381|NCT02267265|universal newborn hearing screening|universal newborn hearing screening
5281382|NCT02267265|postpartum|postpartum
5281383|NCT02267265|parental attachment|parental attachment
5281384|NCT02267265|loss to follow-up|loss to follow-up
5281385|NCT02267265|hearing loss|hearing loss
5281386|NCT02267265|achievement gap|achievement gap
5281387|NCT02267265|language gap|language gap
5281388|NCT02267265|school readiness|school readiness
5281389|NCT02267239|essential oils|essential oils
5281390|NCT02267239|chlorhexidine|chlorhexidine
5281391|NCT02267239|microscopy, confocal|microscopy, confocal
5281392|NCT02267239|immersion|immersion
5281393|NCT02267239|antiseptic|antiseptic
5281394|NCT02267200|biomarkers，pulmonary arterial hypertension|biomarkers，pulmonary arterial hypertension
5281395|NCT02267187|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
5281396|NCT02267187|Battle-injured (BI)|battle-injured (bi)
5281397|NCT02267187|Facial Trauma|facial trauma
5281398|NCT02267187|Fat Grafts|fat grafts
5281399|NCT02267187|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5281400|NCT02267187|Wounded Warriors|wounded warriors
5281401|NCT02267174|Implementation|implementation
5281402|NCT02267174|quality improvement|quality improvement
5281403|NCT02267174|patient safety|patient safety
5281404|NCT02267174|handoffs|handoffs
5281405|NCT02267174|intensive care unit|intensive care unit
5281406|NCT02267174|postoperative care|postoperative care
5281407|NCT02267174|simulation|simulation
5281408|NCT02267161|agenesis|agenesis
5281409|NCT02267161|corpus callosum|corpus callosum
5281410|NCT02267161|prenatal diagnosis|prenatal diagnosis
5281411|NCT02267148|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5281412|NCT02267148|Fatty liver|fatty liver
5281413|NCT02267148|Steatosis|steatosis
5281414|NCT02267148|Fibrosis|fibrosis
5281415|NCT02267148|Liver Stiffness|liver stiffness
5281416|NCT02267148|Cirrhosis|cirrhosis
5281417|NCT02267148|Genetics|genetics
5281418|NCT02267148|Single Nucleotide Polymorphism|single nucleotide polymorphism
5281419|NCT02267135|scalp psoriasis, plaque psoriasis, secukinumab, AIN457, biologic, monoclonal antibody, psoriasis, AIN457A|scalp psoriasis, plaque psoriasis, secukinumab, ain457, biologic, monoclonal antibody, psoriasis, ain457a
5281420|NCT02267096|lung cancer screening|lung cancer screening
5281421|NCT02267083|soft tissue sarcoma|soft tissue sarcoma
5281422|NCT02267070|cognitive training|cognitive training
5281423|NCT02267070|aerobic exercise|aerobic exercise
5281424|NCT02267070|neurotrophic factors|neurotrophic factors
5281425|NCT02267070|randomized controlled trial|randomized controlled trial
5281426|NCT02267057|Pain measurement|pain measurement
5281427|NCT02267057|Pain assessment|pain assessment
5281428|NCT02267057|Pain management|pain management
5281429|NCT02267057|Analgesia|analgesia
5281430|NCT02267057|Analgesics|analgesics
5281431|NCT02267057|Depressive symptoms|depressive symptoms
5281432|NCT02267057|Alzheimer disease|alzheimer disease
5281433|NCT02267057|Vascular dementia|vascular dementia
5281434|NCT02267057|Multi-infarct dementia|multi-infarct dementia
5281435|NCT02267057|Frontotemporal lobar degeneration|frontotemporal lobar degeneration
5281436|NCT02267057|Lewy body disease|lewy body disease
5281437|NCT02267031|cognitive dysfunction|cognitive dysfunction
5281438|NCT02267031|mechanical ventilation|mechanical ventilation
5281439|NCT02267031|hyperoxia|hyperoxia
5281440|NCT02267031|hypocapnia|hypocapnia
5281441|NCT02267018|nCPAP|ncpap
5281442|NCT02267018|High-Frequency Oscillator Ventilation|high-frequency oscillator ventilation
5281443|NCT02267018|Diaphragm Electrical Activity|diaphragm electrical activity
5962822|NCT04278274|Artificial intelligence model|artificial intelligence model
5281444|NCT02266979|peritoneal dialysis|peritoneal dialysis
5281445|NCT02266979|nursing staff|nursing staff
5281446|NCT02266979|nursing activities|nursing activities
5281447|NCT02266979|Personnel Downsizing|personnel downsizing
5281448|NCT02266953|Dietary services|dietary services
5281449|NCT02266953|Public Health Nursing|public health nursing
5281450|NCT02266953|Preschool child|preschool child
5281451|NCT02266940|pharmacokinetics|pharmacokinetics
5281452|NCT02266901|leaks after bariatric surgery|leaks after bariatric surgery
5281453|NCT02266901|fistulae after bariatric surgery|fistulae after bariatric surgery
5281454|NCT02266901|abdominal abcesses and bariatric surgery|abdominal abcesses and bariatric surgery
5281455|NCT02266901|endoscopic drainage of abcesses|endoscopic drainage of abcesses
5281456|NCT02266901|percutaneous drainage of abcesses|percutaneous drainage of abcesses
5281457|NCT02266901|gastric bypass|gastric bypass
5281458|NCT02266901|sleeve gastrectomy|sleeve gastrectomy
5281459|NCT02266901|necrotic collection and bariatric surgery|necrotic collection and bariatric surgery
5281460|NCT02266888|B cells|b cells
5281461|NCT02266888|lung transplant recipient|lung transplant recipient
5281462|NCT02266888|rituximab|rituximab
5281463|NCT02266888|placebo|placebo
5281464|NCT02266888|standard of care|standard of care
5281465|NCT02266836|Stroke|stroke
5281466|NCT02266836|Cerebrovascular accident|cerebrovascular accident
5281467|NCT02266836|Upper Extremity|upper extremity
5281468|NCT02266836|Cerebral Infarction|cerebral infarction
5281469|NCT02266836|Brain Infarction|brain infarction
5281470|NCT02266836|Brain Ischemia|brain ischemia
5281471|NCT02266836|Cerebrovascular Disorders|cerebrovascular disorders
5281472|NCT02266836|Cardiovascular Diseases|cardiovascular diseases
5281473|NCT02266836|Nervous System Diseases|nervous system diseases
5281474|NCT02266836|Central Nervous System Diseases|central nervous system diseases
5281475|NCT02266784|smoking, smoking cessation, contingency management, ADHD|smoking, smoking cessation, contingency management, adhd
5849065|NCT00031369|Normal Control|normal control
5281487|NCT02266693|SAD|sad
5281488|NCT02266693|GAD|gad
5281489|NCT02266693|iCBT|icbt
5281490|NCT02266680|Social Anxiety|social anxiety
5281491|NCT02266680|Yoga|yoga
5281492|NCT02266667|NEMOT device|nemot device
5281493|NCT02266667|pediatrics|pediatrics
5281494|NCT02266667|surgery|surgery
5281495|NCT02266667|progressive scoliosis|progressive scoliosis
5281496|NCT02266654|Emergency Medical Services|emergency medical services
5281497|NCT02266654|Lactic Acid|lactic acid
5281498|NCT02266654|Sepsis|sepsis
5281499|NCT02266641|one-carbon metabolism|one-carbon metabolism
5281500|NCT02266641|folate|folate
5281501|NCT02266641|choline|choline
5281502|NCT02266641|DNA methylation|dna methylation
5281503|NCT02266641|imprint marker|imprint marker
5281504|NCT02266641|cancer risks|cancer risks
5281505|NCT02266602|IORT|iort
5281506|NCT02266602|Breast Cancer|breast cancer
5281507|NCT02266589|coagulopathy|coagulopathy
5281508|NCT02266589|hydrocortisone|hydrocortisone
5281509|NCT02266589|organ failure|organ failure
5281510|NCT02266589|hemodynamic improvement induced by hydrocortisone|hemodynamic improvement induced by hydrocortisone
5281511|NCT02266563|Traumatic Brain Injury|traumatic brain injury
5281512|NCT02266563|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
5281513|NCT02266563|Mild Cognitive Impairment|mild cognitive impairment
5281514|NCT02266563|PET imaging|pet imaging
5281515|NCT02266563|tauopathy|tauopathy
5281517|NCT02266446|anxiety disorders|anxiety disorders
5281518|NCT02266446|cognitive bias modification|cognitive bias modification
5281519|NCT02266446|primary care|primary care
5281520|NCT02266446|attention|attention
5281521|NCT02266446|interpretation|interpretation
5281522|NCT02266446|computer|computer
5281523|NCT02266433|DeQuervains Tenosynovitis|dequervains tenosynovitis
5281524|NCT02266433|Lateral Epicondylitis|lateral epicondylitis
5281525|NCT02266433|Tennis Elbow|tennis elbow
5281526|NCT02266433|Trigger Finger|trigger finger
5281528|NCT02266433|Inflammatory Disease|inflammatory disease
5281529|NCT02266433|Dexamethasone|dexamethasone
5281530|NCT02266433|Ketorolac|ketorolac
5281531|NCT02266433|Toradol|toradol
5281532|NCT02266420|Triple negative breast cancer|triple negative breast cancer
5281533|NCT02266420|immuno-histochemistery|immuno-histochemistery
5281534|NCT02266420|genomic profiles|genomic profiles
5281540|NCT02266381|PCNL|pcnl
5281541|NCT02266381|MPCNL|mpcnl
5281542|NCT02266381|guidance|guidance
5281543|NCT02266381|puncture|puncture
5281544|NCT02266368|Ureteral stents|ureteral stents
5281545|NCT02266368|Double J stent|double j stent
5281546|NCT02266368|Antimicoreal coated stent|antimicoreal coated stent
5281547|NCT02266368|USSQ|ussq
5281549|NCT02266355|Oxaliplatin|oxaliplatin
5281550|NCT02266355|Omalizumab|omalizumab
5281551|NCT02266329|controlled clinical trial|controlled clinical trial
5281552|NCT02266329|randomized controlled clinical trial|randomized controlled clinical trial
5281553|NCT02266290|ADHESIVE TAPE|adhesive tape
5281554|NCT02266290|ANKLE INJURY|ankle injury
5281555|NCT02266290|POSTURAL BALANCE|postural balance
5281556|NCT02266290|FUNCTIONAL ANKLE INSTABILITY|functional ankle instability
5281557|NCT02266277|electronic health record, utilization|electronic health record, utilization
5281558|NCT02266277|randomized controlled trial|randomized controlled trial
5281559|NCT02266277|pragmatic clinical trial|pragmatic clinical trial
5281560|NCT02266277|influenza, prevention and control|influenza, prevention and control
5281561|NCT02266277|pneumococcal vaccines|pneumococcal vaccines
5281562|NCT02266277|qualitative research|qualitative research
5281563|NCT02266225|Chronic disease management|chronic disease management
5281564|NCT02266225|Physical activity|physical activity
5281565|NCT02266225|Fall prevention|fall prevention
5281566|NCT02266225|Strength and balance exercise|strength and balance exercise
5281567|NCT02266199|questionnaire|questionnaire
5281568|NCT02266199|quality assurance|quality assurance
5286248|NCT02240966|Hypogonadism|hypogonadism
5281569|NCT02266199|qualitative Verification|qualitative verification
5281570|NCT02266199|conservative patients|conservative patients
5281572|NCT02266160|tinnitus|tinnitus
5281573|NCT02266160|local anaesthetic|local anaesthetic
5281574|NCT02266160|EMLA cream 5%|emla cream 5%
5281575|NCT02266147|Low Grade B-cell Lymphoma|low grade b-cell lymphoma
5281576|NCT02266134|implementation|implementation
5281577|NCT02266134|measurement based care|measurement based care
5281578|NCT02266134|standardized|standardized
5281579|NCT02266134|tailored|tailored
5281580|NCT02266121|Multiple Sclerosis|multiple sclerosis
5281582|NCT02266121|Cognitive deficits|cognitive deficits
5281583|NCT02266121|Motor deficits|motor deficits
5281584|NCT02266121|Fatigue|fatigue
5281585|NCT02266121|Nervous System Diseases|nervous system diseases
5281586|NCT02266121|Brain Diseases|brain diseases
5281587|NCT02266121|Brain stimulation|brain stimulation
5281588|NCT02266121|Working memory|working memory
5281589|NCT02266121|Motor learning|motor learning
5281590|NCT02266121|Central Nervous System Diseases|central nervous system diseases
5281591|NCT02266121|Neuropsychological rehabilitation|neuropsychological rehabilitation
5281592|NCT02266108|Sexually Transmitted Infections|sexually transmitted infections
5281593|NCT02266108|Female Sex Workers|female sex workers
5281594|NCT02266095|Osteoarthritis|osteoarthritis
5281595|NCT02266095|Thumb spica splint|thumb spica splint
5281596|NCT02266095|Oval-8 splint|oval-8 splint
5281597|NCT02266095|Tee-Pee splint|tee-pee splint
5281598|NCT02266069|implementation|implementation
5281599|NCT02266069|anticipatory care planning|anticipatory care planning
5281600|NCT02266069|symptom assessment|symptom assessment
5281601|NCT02266069|interdisciplinary collaboration|interdisciplinary collaboration
5281602|NCT02266056|deep neuromuscular block|deep neuromuscular block
5281603|NCT02266056|sugammadex|sugammadex
5281604|NCT02266056|laparoscopic colorectal surgery|laparoscopic colorectal surgery
5281605|NCT02266056|hemodynamic change|hemodynamic change
5281606|NCT02266043|Upper airway obstruction|upper airway obstruction
5281607|NCT02266017|pain|pain
5281608|NCT02266017|coping|coping
5281609|NCT02266017|mhealth|mhealth
5281610|NCT02266017|cancer|cancer
5281611|NCT02266004|transcranial direct current stimulation|transcranial direct current stimulation
5281612|NCT02266004|neuromodulation|neuromodulation
5281613|NCT02265978|Emotional Self-Awareness|emotional self-awareness
5281614|NCT02265978|Positive Coping|positive coping
5281615|NCT02265978|Help-Seeking|help-seeking
5281616|NCT02265926|filtering facepiece respirators|filtering facepiece respirators
5281618|NCT02265926|pandemic response|pandemic response
5281619|NCT02265926|pregnant healthcare workers|pregnant healthcare workers
5281620|NCT02265900|Positron Emission Tomography|positron emission tomography
5281621|NCT02265900|Dopamine|dopamine
5281622|NCT02265900|Parkinson's Disease|parkinson's disease
5281623|NCT02265887|Pulmonary Hypertension|pulmonary hypertension
5281624|NCT02265887|Africa|africa
5281625|NCT02265887|Heart Disease|heart disease
5281626|NCT02265887|Echocardiography|echocardiography
5862754|NCT00001524|Delayed Healing|delayed healing
5862755|NCT00001524|Painful Oral Lesions|painful oral lesions
5281627|NCT02265861|Polycystic ovary syndrome; Vascular endothelial growth factor; Angiotensin-Ⅱ; Ovarian hyperstimulation syndrome|polycystic ovary syndrome; vascular endothelial growth factor; angiotensin-ⅱ; ovarian hyperstimulation syndrome
5281629|NCT02265848|Chronic pain|chronic pain
5281630|NCT02265848|Chronic low back pain|chronic low back pain
5281631|NCT02265848|Radiculopathy|radiculopathy
5281632|NCT02265848|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
5281633|NCT02265848|High Frequency stimulation|high frequency stimulation
5281634|NCT02265822|melatonin|melatonin
5281635|NCT02265822|midazolam|midazolam
5281636|NCT02265822|children|children
5281637|NCT02265809|Interleukin 2|interleukin 2
5281638|NCT02265809|Type 1 diabetes|type 1 diabetes
5281639|NCT02265809|T regulatory cells|t regulatory cells
5281640|NCT02265809|Adaptive trial|adaptive trial
5281641|NCT02265796|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
5281642|NCT02265796|fractional flow reserve|fractional flow reserve
5281643|NCT02265783|Focus of Study: Healthy Volunteers|focus of study: healthy volunteers
5281644|NCT02265757|Behavioral Intervention|behavioral intervention
5281645|NCT02265757|Mild Cognitive Impairment|mild cognitive impairment
5281646|NCT02265757|HABIT|habit
5281647|NCT02265757|Cognitive Rehabilitation|cognitive rehabilitation
5281648|NCT02265757|Multi-Component Intervention|multi-component intervention
5281649|NCT02265731|relapsed multiple myeloma|relapsed multiple myeloma
5176941|NCT02885246|Database|database
5281650|NCT02265731|refractory multiple myeloma|refractory multiple myeloma
5281651|NCT02265731|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5281652|NCT02265731|Lymphoproliferative Disorders|lymphoproliferative disorders
5281653|NCT02265731|Lymphatic Diseases|lymphatic diseases
5281654|NCT02265731|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5281655|NCT02265731|small lymphocytic lymphoma|small lymphocytic lymphoma
5281656|NCT02265731|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma
5281657|NCT02265731|refractory small lymphocytic lymphoma|refractory small lymphocytic lymphoma
5281658|NCT02265731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5281659|NCT02265731|acute myeloid leukemia|acute myeloid leukemia
5281660|NCT02265718|Healthy|healthy
5281661|NCT02265718|elderly volunteers|elderly volunteers
5281662|NCT02265614|PGS|pgs
5281663|NCT02265614|blastocyst|blastocyst
5281664|NCT02265614|human|human
5281665|NCT02265614|IVF|ivf
5281666|NCT02265614|vitrification|vitrification
5281667|NCT02265614|single embryo transfer|single embryo transfer
5281668|NCT02265601|advance care planning|advance care planning
5281669|NCT02265601|living wills|living wills
5281670|NCT02265601|end of life|end of life
5281671|NCT02265601|cancer|cancer
5281672|NCT02265588|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5281673|NCT02265588|Ulcerative colitis|ulcerative colitis
5281674|NCT02265588|Crohn's disease|crohn's disease
5281675|NCT02265588|Children|children
5281676|NCT02265588|Adolescents|adolescents
5281677|NCT02265588|Anxiety|anxiety
5281678|NCT02265588|Depression|depression
5281679|NCT02265588|Cognitive behavioral therapy|cognitive behavioral therapy
5281680|NCT02265562|Hysterectomy|hysterectomy
5281681|NCT02265562|Misoprostol|misoprostol
5281682|NCT02265562|Blood loss|blood loss
5281683|NCT02265549|Metastases,|metastases,
5281684|NCT02265549|Neoplasm|neoplasm
5281685|NCT02265549|Cerebral|cerebral
5281686|NCT02265523|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
5281687|NCT02265458|Respiratory failure|respiratory failure
5281688|NCT02265458|NIV|niv
5281689|NCT02265458|Musical intervention|musical intervention
5281690|NCT02265445|Carbapenems therapy/ESBL infections/Deescalation|carbapenems therapy/esbl infections/deescalation
5281691|NCT02265445|due to ESBL-PE|due to esbl-pe
5281692|NCT02265432|Physical activity|physical activity
5281693|NCT02265432|Sedentary behavior|sedentary behavior
5281694|NCT02265419|hyperinflammation, Cytosorb|hyperinflammation, cytosorb
5281695|NCT02265354|Tobacco Smoking Cessation|tobacco smoking cessation
5281696|NCT02265354|Computer tailored health communication|computer tailored health communication
5281697|NCT02265354|messaging|messaging
5281698|NCT02265354|collective intelligence|collective intelligence
5281699|NCT02265354|recommender systems|recommender systems
5281700|NCT02265354|machine learning|machine learning
5281701|NCT02265328|Severe Alcoholic Hepatitis in 'Extremis'|severe alcoholic hepatitis in 'extremis'
5281702|NCT02265328|Bovine Colostrum|bovine colostrum
5281703|NCT02265328|Glucocorticoids|glucocorticoids
5281704|NCT02265276|NAFLD, Diabetes, Glitazone|nafld, diabetes, glitazone
5281705|NCT02265250|magnetic resonance imaging|magnetic resonance imaging
5281706|NCT02265250|positron emission tomography|positron emission tomography
5281707|NCT02265237|Compensated Cirrhosis|compensated cirrhosis
5281708|NCT02265237|Hepatitis C|hepatitis c
5281718|NCT02265146|Vulnerable Plaque|vulnerable plaque
5281719|NCT02265146|Near Infrared Spectroscopy|near infrared spectroscopy
5281720|NCT02265107|endothelial function|endothelial function
5281721|NCT02265107|physical training|physical training
5281722|NCT02265107|exercise|exercise
5281723|NCT02265107|coronary artery bypass|coronary artery bypass
5281724|NCT02265094|Autism Spectrum Disorder|autism spectrum disorder
5281725|NCT02265094|Development|development
5281726|NCT02265094|Memory|memory
5281727|NCT02265094|ERD|erd
5281728|NCT02265068|Acute coronary syndrome (ACS), Ticagrelor|acute coronary syndrome (acs), ticagrelor
5281729|NCT02265029|fibromyalgia|fibromyalgia
5281730|NCT02265029|rheumatism|rheumatism
5281731|NCT02265029|fatigue syndrom|fatigue syndrom
5281732|NCT02265029|pain|pain
5281733|NCT02265029|spa treatment in rheumatology|spa treatment in rheumatology
5281734|NCT02265016|coronary artery disease|coronary artery disease
5281735|NCT02265016|acute coronary syndrome|acute coronary syndrome
5281736|NCT02265016|angina pectoris|angina pectoris
5281737|NCT02265016|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
5281738|NCT02265016|red blood cells|red blood cells
5281739|NCT02265016|erythrocytes|erythrocytes
5281740|NCT02265003|red blood cells|red blood cells
5281741|NCT02265003|endothelial function|endothelial function
5281742|NCT02265003|nitric oxide pool in red blood cells|nitric oxide pool in red blood cells
5281743|NCT02265003|nitric oxide poll in blood plasma|nitric oxide poll in blood plasma
5281744|NCT02265003|nitric oxide synthase III - expression|nitric oxide synthase iii - expression
5281745|NCT02265003|oxidative status|oxidative status
5281746|NCT02265003|nitric oxide signalling|nitric oxide signalling
5281756|NCT02264964|Hemodialysis|hemodialysis
5281757|NCT02264964|End-Stage Kidney Disease|end-stage kidney disease
5281758|NCT02264964|Central Venous Catheterization|central venous catheterization
5281759|NCT02264964|Digital Subtraction Angiography|digital subtraction angiography
5281760|NCT02264951|Short fatty acids|short fatty acids
5281761|NCT02264951|2-oleoyl glycerol|2-oleoyl glycerol
5281762|NCT02264951|GLP-1 secretion|glp-1 secretion
5281763|NCT02264951|C8-diet oil|c8-diet oil
5281764|NCT02264951|GIP secretion|gip secretion
5281765|NCT02264925|Essential tremor|essential tremor
5281766|NCT02264925|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5281767|NCT02264925|Ventral intermediate Thalamus (VIM)|ventral intermediate thalamus (vim)
5281768|NCT02264925|Local field potentials (LFPs)|local field potentials (lfps)
5281769|NCT02264925|Closed loop therapy|closed loop therapy
5423272|NCT01616420|assisted partner notification services|assisted partner notification services
5281770|NCT02264912|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy|antiplatelets, percutanous coronary intervention, acute coronary syndromes, laboratory efficacy
5281771|NCT02264899|Alzheimer's disease|alzheimer's disease
5281772|NCT02264899|Mild Cognitive Impairment|mild cognitive impairment
5281774|NCT02264873|Autologous stem cell transplant|autologous stem cell transplant
5281775|NCT02264847|Clomiphene Citrate|clomiphene citrate
5281776|NCT02264847|Ovulation trigger|ovulation trigger
5281777|NCT02264847|Human chorionic gonadotrophin|human chorionic gonadotrophin
5281778|NCT02264834|epidural|epidural
5281779|NCT02264834|primiparous patient|primiparous patient
5281780|NCT02264834|deambulation|deambulation
5281781|NCT02264821|analgesia|analgesia
5281782|NCT02264821|caesarean|caesarean
5281783|NCT02264821|wound infiltration|wound infiltration
5281784|NCT02264821|intrathecal morphine.|intrathecal morphine.
5281785|NCT02264795|Cesarean section|cesarean section
5281786|NCT02264795|Lidocaine|lidocaine
5281787|NCT02264769|pregnancy|pregnancy
5281788|NCT02264769|postpartum hemorrhage|postpartum hemorrhage
5281789|NCT02264769|Cesarean delivery|cesarean delivery
5281790|NCT02264769|carbetocin|carbetocin
5281791|NCT02264756|Community-acquired pneumonia|community-acquired pneumonia
5281792|NCT02264756|Pragmatic clinical trial|pragmatic clinical trial
5281793|NCT02264756|Antimicrobial stewardship|antimicrobial stewardship
5281794|NCT02264756|length of stay|length of stay
5281795|NCT02264756|stepped-wedge design|stepped-wedge design
5281796|NCT02264756|time-dependent bias|time-dependent bias
5281797|NCT02264704|MS|ms
5281798|NCT02264704|Exercise|exercise
5386434|NCT01783353|verruca|verruca
5281799|NCT02264704|Training|training
5281800|NCT02264704|Multiple sclerosis|multiple sclerosis
5281801|NCT02264704|Immune response|immune response
5281803|NCT02264704|Cytokine|cytokine
5281805|NCT02264678|ATM deficient, ATM proficient, HER2 negative, Breast, Gastric, Head & Neck, Lung|atm deficient, atm proficient, her2 negative, breast, gastric, head & neck, lung
5281806|NCT02264652|Refractory|refractory
5281807|NCT02264652|Partial|partial
5281808|NCT02264652|Epilepsy|epilepsy
5281809|NCT02264626|acute respiratory failure|acute respiratory failure
5281810|NCT02264626|noninvasive ventilation|noninvasive ventilation
5281811|NCT02264626|sedation|sedation
5281812|NCT02264626|patient/ventilator interaction|patient/ventilator interaction
5281813|NCT02264600|Restless Legs Syndrome, Apelin, Oxidative Stress|restless legs syndrome, apelin, oxidative stress
5281814|NCT02264535|Allergy|allergy
5281815|NCT02264535|Skin test|skin test
5281816|NCT02264535|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
5281817|NCT02264509|Arterial Insufficiency|arterial insufficiency
5281818|NCT02264509|Human Immunodeficiency Virus|human immunodeficiency virus
5281819|NCT02264509|Atherosclerosis|atherosclerosis
5281820|NCT02264509|Ankle-brachial index|ankle-brachial index
5281821|NCT02264509|HAART|haart
5281822|NCT02264496|Colorectal cancer|colorectal cancer
5281823|NCT02264496|Exercise|exercise
5281824|NCT02264496|CPEX|cpex
5281825|NCT02264496|Exercise, Physical|exercise, physical
5281827|NCT02264496|Surgery|surgery
5281828|NCT02264483|Pneumonia in COPD exacerbation|pneumonia in copd exacerbation
5281829|NCT02264470|Prediction|prediction
5281830|NCT02264470|Falls|falls
5281831|NCT02264470|Stroke|stroke
5281832|NCT02264457|Lenses, Intraocular|lenses, intraocular
5281833|NCT02264444|Cholecystectomy, visualization, single incision|cholecystectomy, visualization, single incision
5281834|NCT02264431|Obesity|obesity
5281835|NCT02264431|Obstructive Sleep Apnea|obstructive sleep apnea
5281836|NCT02264431|Sleep Habits|sleep habits
5281837|NCT02264431|Bariatric Surgery|bariatric surgery
5281838|NCT02264431|Cohort|cohort
5281839|NCT02264418|Solid tumours|solid tumours
5281840|NCT02264379|Oligometastases|oligometastases
5281841|NCT02264379|Prostate Cancer|prostate cancer
5281842|NCT02264379|Stereotactic Radiotherapy|stereotactic radiotherapy
5281843|NCT02264379|Hypo fractionation|hypo fractionation
5281844|NCT02264379|Normal fractionation|normal fractionation
5281845|NCT02264353|Obstructive|obstructive
5281846|NCT02264353|Sleep Apnea|sleep apnea
5281847|NCT02264353|Arousal threshold|arousal threshold
5281848|NCT02264353|Donepezil|donepezil
5281849|NCT02264340|Tension-type headache|tension-type headache
5151188|NCT03047369|myelin|myelin
5163200|NCT02972606|HIV|hiv
5281850|NCT02264340|relaxation techniques|relaxation techniques
5281851|NCT02264340|physiotherapy|physiotherapy
5281852|NCT02264327|Motivational Interviewing|motivational interviewing
5281853|NCT02264327|Evidence Based Practice|evidence based practice
5281854|NCT02264327|Online Simulation|online simulation
5281855|NCT02264327|Workforce development|workforce development
5281856|NCT02264327|Training|training
5281857|NCT02264314|Aged|aged
5281858|NCT02264314|Hearing Aids|hearing aids
5281859|NCT02264314|Rehabilitation|rehabilitation
5281860|NCT02264288|Peripheral Arterial Disease|peripheral arterial disease
5281861|NCT02264288|Diabetic Foot|diabetic foot
5281862|NCT02264275|Aerobic Exercise|aerobic exercise
5281863|NCT02264275|Exercise|exercise
5281864|NCT02264275|Exergame|exergame
5281865|NCT02264275|Behavior|behavior
5281866|NCT02264275|Video Game|video game
5281871|NCT02264275|Physical Fitness|physical fitness
5281872|NCT02264223|Bioavailability|bioavailability
5281873|NCT02264223|Isoflavones|isoflavones
5281875|NCT02264223|Human|human
5281876|NCT02264223|Processing|processing
5281877|NCT02264223|Cross-over|cross-over
5281878|NCT02263950|Cancer|cancer
5281879|NCT02263950|Malignant Neoplasm|malignant neoplasm
5281880|NCT02263950|Artemether|artemether
5281881|NCT02263950|Sublingual|sublingual
5281882|NCT02263950|Neoplastic disease|neoplastic disease
5281883|NCT02263950|Solid Tumour|solid tumour
5281884|NCT02263950|Anti-cancer drug|anti-cancer drug
5281885|NCT02263950|Chemotherapy|chemotherapy
5281886|NCT02263950|LON002|lon002
5281887|NCT02263885|Parkinson's Disease|parkinson's disease
5281888|NCT02263885|ExAblate|exablate
5281889|NCT02263885|MRgFUS|mrgfus
5281891|NCT02263846|Breast cancer|breast cancer
5281892|NCT02263846|Menopause|menopause
5281893|NCT02263846|Estradiol|estradiol
5281894|NCT02263846|Follicle stimulating hormone|follicle stimulating hormone
5281895|NCT02263820|Acute Kidney Injury|acute kidney injury
5281896|NCT02263820|Acute Renal Failure|acute renal failure
5281897|NCT02263807|Patella luxation|patella luxation
5281898|NCT02263794|Bronchial Thermoplasty|bronchial thermoplasty
5281899|NCT02263755|CHB, cohort, fibroscan|chb, cohort, fibroscan
5281900|NCT02263742|Healthcare choice and outcomes|healthcare choice and outcomes
5281901|NCT02263742|Peer-led whole health|peer-led whole health
5281902|NCT02263742|Mental Illness|mental illness
5281903|NCT02263742|Peer Health Navigation|peer health navigation
5281904|NCT02263742|Health care Coordination|health care coordination
5281905|NCT02263716|Physical Activity|physical activity
5281906|NCT02263716|Intensive Care|intensive care
5269394|NCT02334462|Assays|assays
5281907|NCT02263716|Activities of Daily Living|activities of daily living
5281908|NCT02263716|Delirium|delirium
5281909|NCT02263716|Sepsis|sepsis
5281910|NCT02263716|Mechanical Ventilation|mechanical ventilation
5281911|NCT02263716|Critical Care|critical care
5281912|NCT02263716|Critical Illness|critical illness
5281913|NCT02263716|Aging|aging
5281914|NCT02263716|Accelerometery|accelerometery
5281915|NCT02263703|HPV vaccine, children, immunocompromised|hpv vaccine, children, immunocompromised
5281916|NCT02263677|diabetes|diabetes
5281917|NCT02263677|fatty liver|fatty liver
5281918|NCT02263664|microcirculation|microcirculation
5281919|NCT02263664|esophagectomy|esophagectomy
5281920|NCT02263664|side stream dark field|side stream dark field
5281921|NCT02263664|microcirculatory derangements|microcirculatory derangements
5281922|NCT02263651|Breast cancer|breast cancer
5281923|NCT02263651|Mastectomy|mastectomy
5281924|NCT02263651|Seroma|seroma
5281925|NCT02263651|Quilting suture|quilting suture
5281926|NCT02263638|hereditary haemochromatosis|hereditary haemochromatosis
5281927|NCT02263638|rheumatism|rheumatism
5281928|NCT02263638|anakinra|anakinra
5281929|NCT02263625|Indication|indication
5281930|NCT02263625|Differences|differences
5281931|NCT02263612|Incisional Hernia|incisional hernia
5281932|NCT02263612|Complications|complications
5281934|NCT02263586|Ironman|ironman
5281935|NCT02263586|Triathlon|triathlon
5281936|NCT02263573|PEP'C-R|pep'c-r
5281937|NCT02263573|Endurance parameters|endurance parameters
5281938|NCT02263573|Maximal cardio-respiratory function|maximal cardio-respiratory function
5281939|NCT02263573|Older seniors|older seniors
5281940|NCT02263573|Over 70|over 70
5281941|NCT02263547|teriflunomide|teriflunomide
5281942|NCT02263547|colestipol hcl|colestipol hcl
5281943|NCT02263534|stress urinary incontinence|stress urinary incontinence
5281944|NCT02263534|tension free vaginal tape|tension free vaginal tape
5281945|NCT02263534|single incision minisling|single incision minisling
5962823|NCT04278274|Locally advanced rectal cancer|locally advanced rectal cancer
5281946|NCT02263534|midurethral sling|midurethral sling
5281947|NCT02263508|Talimogene Laherparepvec|talimogene laherparepvec
5281948|NCT02263508|pembrolizumab|pembrolizumab
5281949|NCT02263508|KEYNOTE-034|keynote-034
5281950|NCT02263508|MASTERKEY-265|masterkey-265
5281951|NCT02263495|HER2-Negative|her2-negative
5281952|NCT02263482|muscle training|muscle training
5281953|NCT02263482|walking test|walking test
5281954|NCT02263482|chronic heart failure|chronic heart failure
5163279|NCT02971917|MTF|mtf
5281955|NCT02263482|functional capacity|functional capacity
5281956|NCT02263443|bowel preparation|bowel preparation
5281957|NCT02263443|gynecologic surgery|gynecologic surgery
5281958|NCT02263443|laparotomy|laparotomy
5281959|NCT02263391|transmission|transmission
5281960|NCT02263391|prevention|prevention
5281961|NCT02263391|women|women
5281962|NCT02263391|childbearing age|childbearing age
5281963|NCT02263391|HIV testing|hiv testing
5281964|NCT02263391|testing strategy|testing strategy
5281965|NCT02263378|HPV, L-SIL|hpv, l-sil
5281966|NCT02263352|Diabetes, Periodontitis, Oxidative stress, Antioxidant|diabetes, periodontitis, oxidative stress, antioxidant
5281967|NCT02263339|Exercise|exercise
5281968|NCT02263339|MRI|mri
5281969|NCT02263313|Safety and efficacy|safety and efficacy
5281970|NCT02263313|Combo stent|combo stent
5281971|NCT02263313|Late loss thrombosis|late loss thrombosis
5281972|NCT02263313|Late loss catch up|late loss catch up
5281973|NCT02263300|Fiberoptic Intubation|fiberoptic intubation
5281974|NCT02263300|Medical student|medical student
5281975|NCT02263300|Virtual larynx|virtual larynx
5281976|NCT02263300|Didactic Training|didactic training
5281977|NCT02263300|Medical Education|medical education
5281978|NCT02263287|Alzheimer Disease|alzheimer disease
5281979|NCT02263287|Lewy Body Disease|lewy body disease
5281980|NCT02263261|dermal matrix|dermal matrix
5281981|NCT02263235|Alzheimer disease (AD)|alzheimer disease (ad)
5281982|NCT02263235|diagnosis biomarkers|diagnosis biomarkers
5281983|NCT02263235|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5281984|NCT02263235|targeted quantitative proteomics|targeted quantitative proteomics
5281985|NCT02263235|mass spectrometry|mass spectrometry
5281986|NCT02263235|stable isotope-labelled leucine|stable isotope-labelled leucine
5281987|NCT02263183|Metabolic risk|metabolic risk
5281988|NCT02263183|Abdominally overweight|abdominally overweight
5281989|NCT02263131|Influenza|influenza
5281990|NCT02263131|Influenza vaccine|influenza vaccine
5281991|NCT02263131|Split influenza vaccine|split influenza vaccine
5281992|NCT02263131|Seasonal influenza vaccine|seasonal influenza vaccine
5281993|NCT02263118|breastfeeding|breastfeeding
5281994|NCT02263118|rural|rural
5281995|NCT02263118|m-health|m-health
5281996|NCT02263118|mHealth|mhealth
5281997|NCT02263118|Patojitos|patojitos
5281998|NCT02263118|Guatemala|guatemala
5281999|NCT02263118|exclusive breastfeeding|exclusive breastfeeding
5282000|NCT02263118|mobile|mobile
5282001|NCT02263118|eHealth|ehealth
5282002|NCT02263118|e-health|e-health
5282003|NCT02263105|recurrent high-grade gliomas|recurrent high-grade gliomas
5282004|NCT02263105|cisplatin (CDDP)|cisplatin (cddp)
5282005|NCT02263105|temozolomide (TMZ)|temozolomide (tmz)
5282006|NCT02263092|Cortical excitability|cortical excitability
5282007|NCT02263092|Plasticity|plasticity
5282008|NCT02263092|Healthy subjects|healthy subjects
5282009|NCT02263040|influenza vaccine|influenza vaccine
5282011|NCT02263040|immunogenicity|immunogenicity
5282012|NCT02263040|reactogenicity|reactogenicity
5282013|NCT02263027|influenza vaccine|influenza vaccine
5282014|NCT02263027|adult|adult
5282015|NCT02263027|safety|safety
5282016|NCT02263027|reactogenicity|reactogenicity
5282017|NCT02263014|Breast Cancer|breast cancer
5282018|NCT02263014|Contralateral Prophylactic Mastectomy|contralateral prophylactic mastectomy
5282019|NCT02263014|Questionnaires|questionnaires
5282020|NCT02263014|Surveys|surveys
5282021|NCT02263014|Psychosocial|psychosocial
5282022|NCT02263001|Auricular therapy|auricular therapy
5282023|NCT02263001|Acupuncture|acupuncture
5282024|NCT02263001|Acute, sub-acute pain|acute, sub-acute pain
5282025|NCT02263001|Auricular Acupuncture Needles|auricular acupuncture needles
5282026|NCT02262988|knee|knee
5282027|NCT02262988|joint replacement|joint replacement
5282028|NCT02262988|total knee|total knee
5282029|NCT02262988|cell therapy|cell therapy
5282030|NCT02262975|Alzheimer's disease|alzheimer's disease
5282031|NCT02262936|Aged|aged
5282032|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin
5282033|NCT02262936|Fesoterodine|fesoterodine
5282035|NCT02262910|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5282037|NCT02262897|small cell lung cancer|small cell lung cancer
5282038|NCT02262897|chemotherapy|chemotherapy
5282039|NCT02262897|Nab-paclitaxel|nab-paclitaxel
5282040|NCT02262871|Cystic fibrosis|cystic fibrosis
5282041|NCT02262871|High-flow nasal oxygen cannula|high-flow nasal oxygen cannula
5282042|NCT02262871|Non-invasive ventilation|non-invasive ventilation
5282043|NCT02262871|Respiratory distress|respiratory distress
5282044|NCT02262871|Oxygen therapy|oxygen therapy
5282045|NCT02262832|Diabetes|diabetes
5282046|NCT02262832|Leptin|leptin
5282047|NCT02262832|Lipodystrophy|lipodystrophy
5282048|NCT02262832|Hypertriglyceridemia|hypertriglyceridemia
5282049|NCT02262819|Skin Blister|skin blister
5282050|NCT02262819|Immune Response|immune response
5282051|NCT02262819|Suction Device|suction device
5282052|NCT02262819|Anti-Microbial|anti-microbial
5282053|NCT02262819|Killed Microbe|killed microbe
5962824|NCT04278274|Pathologic complete response|pathologic complete response
5282054|NCT02262806|Lipodystrophy|lipodystrophy
5282055|NCT02262806|Leptin|leptin
5282056|NCT02262806|Hypertriglyceridemia|hypertriglyceridemia
5282057|NCT02262806|Diabetes|diabetes
5445384|NCT01522079|air stacking|air stacking
5445385|NCT01522040|Asthma|asthma
5445386|NCT01522040|Magnesium|magnesium
5282058|NCT02262767|Phase 1, Randomized, Double Blind, Placebo-Controlled, Single-Dose Escalation, Safety, Tolerability, Pharmacokinetic, PF-06649751, Trimethobenzamide|phase 1, randomized, double blind, placebo-controlled, single-dose escalation, safety, tolerability, pharmacokinetic, pf-06649751, trimethobenzamide
5282059|NCT02262728|Hepatitis C, Chronic|hepatitis c, chronic
5282060|NCT02262728|Simeprevir|simeprevir
5282061|NCT02262728|Daclatasvir|daclatasvir
5282062|NCT02262728|Sofosbuvir|sofosbuvir
5282063|NCT02262728|Decompensated Liver Disease|decompensated liver disease
5282064|NCT02262715|Oseltamivir|oseltamivir
5282065|NCT02262715|VX-787|vx-787
5282066|NCT02262689|GSK2256294|gsk2256294
5282067|NCT02262689|normoxic|normoxic
5282068|NCT02262689|hypoxic|hypoxic
5282069|NCT02262689|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
5282070|NCT02262676|Stroke prevention on Atrial Fibrillation|stroke prevention on atrial fibrillation
5282071|NCT02262676|Prevention and Control|prevention and control
5282072|NCT02262676|Stroke|stroke
5282073|NCT02262507|Brain|brain
5282074|NCT02262507|Hearing|hearing
5282075|NCT02262507|MTBI|mtbi
5282076|NCT02262468|retrospective analysis|retrospective analysis
5282077|NCT02262455|Serous tumor|serous tumor
5282078|NCT02262455|Granulosa tumor|granulosa tumor
5282079|NCT02262455|Clear Cell tumor|clear cell tumor
5282080|NCT02262455|Endometrial cancer|endometrial cancer
5282081|NCT02262455|Advanced solid tumors|advanced solid tumors
5282082|NCT02262455|Adenocarcinoma|adenocarcinoma
5282083|NCT02262455|Prostate cancer|prostate cancer
5282084|NCT02262455|Head and Neck cancer|head and neck cancer
5282085|NCT02262455|Lung cancer|lung cancer
5282086|NCT02262455|Non-small cell lung cancer|non-small cell lung cancer
5282087|NCT02262455|Small cell lung cancer|small cell lung cancer
5282088|NCT02262455|Gastric cancer|gastric cancer
5282089|NCT02262455|Kidney cancer|kidney cancer
5282090|NCT02262455|Pancreatic cancer|pancreatic cancer
5282091|NCT02262455|Breast cancer|breast cancer
5282092|NCT02262455|Colorectal cancer|colorectal cancer
5282093|NCT02262455|Bladder cancer|bladder cancer
5282094|NCT02262455|Esophagus cancer|esophagus cancer
5282095|NCT02262455|Liver cancer|liver cancer
5282096|NCT02262455|Hepatobiliary cancer|hepatobiliary cancer
5282097|NCT02262455|Skin cancer|skin cancer
5282098|NCT02262442|flexible bronchoscopy|flexible bronchoscopy
5282099|NCT02262442|anaesthetics|anaesthetics
5282100|NCT02262442|transcutaneous pCO2|transcutaneous pco2
5282101|NCT02262442|capillary pCO2|capillary pco2
5282102|NCT02262442|special atomizing set|special atomizing set
5282103|NCT02262416|GnRH agonist|gnrh agonist
5282104|NCT02262416|IVF|ivf
5282105|NCT02262403|Hookworm|hookworm
5282106|NCT02262403|Helminths|helminths
5282107|NCT02262403|Treg|treg
5282108|NCT02262403|Immune regulation|immune regulation
5282109|NCT02262403|Vietnam|vietnam
5282110|NCT02262403|Allergic diseases|allergic diseases
5282111|NCT02262377|Group Medical Visits|group medical visits
5282112|NCT02262377|Integrative Medicine|integrative medicine
5282113|NCT02262377|Chronic Pain|chronic pain
5282114|NCT02262377|Depression|depression
5282115|NCT02262377|MBSR|mbsr
5282116|NCT02262377|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5282117|NCT02262377|Web based|web based
5282118|NCT02262377|Virtual Patient Advocate|virtual patient advocate
5282119|NCT02262377|Internet Based|internet based
5282120|NCT02262351|Atrial Fibrillation|atrial fibrillation
5282121|NCT02262351|Screening|screening
5282122|NCT02262351|Family Practice|family practice
5282123|NCT02262351|Novel screening technologies|novel screening technologies
5282124|NCT02262338|MPS II|mps ii
5282125|NCT02262338|Hunter Syndrome|hunter syndrome
5282126|NCT02262325|Non-small cell|non-small cell
5282127|NCT02262325|Lung Cancer|lung cancer
5282128|NCT02262325|Chemoradiation|chemoradiation
5282129|NCT02262286|Brain Injury|brain injury
5282130|NCT02262273|women|women
5282133|NCT02262273|serous|serous
5282134|NCT02262273|ovarian cancer|ovarian cancer
5282135|NCT02262273|BRCA|brca
5282136|NCT02262273|PARP|parp
5282137|NCT02262273|Olaparib|olaparib
5282138|NCT02262260|Diabetic macular edema, DME, ranibizumab, wait and extend|diabetic macular edema, dme, ranibizumab, wait and extend
5282139|NCT02262247|Transoral|transoral
5282140|NCT02262247|Oropharynx|oropharynx
5282141|NCT02262247|Hypopharynx|hypopharynx
5282142|NCT02262247|Endoscopic|endoscopic
5282143|NCT02262247|TORS|tors
5282144|NCT02262247|Endoscopic Transoral|endoscopic transoral
5282145|NCT02262247|Larynx|larynx
5282146|NCT02262234|Spinal cord injury|spinal cord injury
5282147|NCT02262234|Chronic pain|chronic pain
5282148|NCT02262234|Education|education
5282149|NCT02262208|Glycemic variability, exercise, diabetes|glycemic variability, exercise, diabetes
5282150|NCT02262182|Atelectasis, Respiratory physiotherapy, end expiratory pressure, EzPAP®, cardiac surgery|atelectasis, respiratory physiotherapy, end expiratory pressure, ezpap®, cardiac surgery
5282151|NCT02262169|Non-Bleeding Peptic Ulcers, DLBS2411, Ulcer Healing|non-bleeding peptic ulcers, dlbs2411, ulcer healing
5282152|NCT02262156|Cognitive Behavioral Therapy|cognitive behavioral therapy
5282153|NCT02262156|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5282154|NCT02262156|depression|depression
5282155|NCT02262156|epilepsy|epilepsy
5282156|NCT02262130|Omalizumab|omalizumab
5282157|NCT02262130|Efficacy|efficacy
5282158|NCT02262130|Safety|safety
5282159|NCT02262117|IVF, pregnancy, immune endometrial profile, personalization of treatment|ivf, pregnancy, immune endometrial profile, personalization of treatment
5282160|NCT02262104|Exercise|exercise
5282161|NCT02262104|dementia|dementia
5282162|NCT02262104|nursing home|nursing home
5282163|NCT02262078|Preserved Ejection Fraction|preserved ejection fraction
5282165|NCT02262065|allergy|allergy
5282166|NCT02262065|particle|particle
5282167|NCT02262065|cytokine|cytokine
5282168|NCT02262052|Deep vein thrombosis|deep vein thrombosis
5282169|NCT02262052|Diagnostic management|diagnostic management
5282170|NCT02262052|Recurrent|recurrent
5282172|NCT02262052|Ipsilateral|ipsilateral
5282173|NCT02262039|living|living
5282174|NCT02262039|kidney|kidney
5282175|NCT02262039|donors|donors
5282176|NCT02262013|Pediatric Obesity|pediatric obesity
5282177|NCT02262013|Lifestyle Intervention|lifestyle intervention
5282178|NCT02262013|Family-based Intervention|family-based intervention
5282179|NCT02262013|Motivational Interviewing|motivational interviewing
5282180|NCT02262000|Non Small Cell Lung Cancer|non small cell lung cancer
5282181|NCT02262000|Surgically inoperable|surgically inoperable
5282182|NCT02262000|Radiation Therapy|radiation therapy
5282183|NCT02261987|Autogenic drainage|autogenic drainage
5282184|NCT02261987|Resistive inspiratory manoeuvre|resistive inspiratory manoeuvre
5282185|NCT02261987|Computerized respiratory sounds|computerized respiratory sounds
5282186|NCT02261987|Airway clearance techniques|airway clearance techniques
5282187|NCT02261987|Mucus clearances|mucus clearances
5282188|NCT02261974|Vaginal laxity|vaginal laxity
5282189|NCT02261974|Sexual Function|sexual function
5282190|NCT02261961|resistance exercise|resistance exercise
5282191|NCT02261961|Juven|juven
5282192|NCT02261961|exercise training|exercise training
5282193|NCT02261961|interleukin-1|interleukin-1
5282194|NCT02261961|insulin-like growth factor|insulin-like growth factor
5282195|NCT02261948|Cardiac Failure|cardiac failure
5282196|NCT02261948|Severe Heart Failure|severe heart failure
5282197|NCT02261935|Family caregiver|family caregiver
5282198|NCT02261935|Home care nursing practice|home care nursing practice
5282200|NCT02261935|End of life care|end of life care
5282201|NCT02261935|Family caregiver quality of life|family caregiver quality of life
5282202|NCT02261935|Family caregiver grief symptoms|family caregiver grief symptoms
5282203|NCT02261935|Family caregiver burden|family caregiver burden
5282204|NCT02261935|Family caregiver preparedness for caregiving|family caregiver preparedness for caregiving
5282205|NCT02261935|Family caregiver perceived social supports|family caregiver perceived social supports
5282206|NCT02261935|Family caregiver health status|family caregiver health status
5282207|NCT02261935|Family caregiver satisfaction with healthcare provided|family caregiver satisfaction with healthcare provided
5282208|NCT02261909|Emergency Medicine|emergency medicine
5282209|NCT02261909|diagnosis|diagnosis
5282210|NCT02261896|cyst|cyst
5282211|NCT02261896|pancreatic cyst|pancreatic cyst
5282212|NCT02261896|EUS-FNA|eus-fna
5282213|NCT02261896|antibiotic prophylaxis|antibiotic prophylaxis
5282214|NCT02261883|PPHN|pphn
5282215|NCT02261870|MRI, T2 quantification|mri, t2 quantification
5282216|NCT02261857|Obstructive Sleep Apnea|obstructive sleep apnea
5282217|NCT02261857|Craniofacial Abnormalities|craniofacial abnormalities
5282218|NCT02261857|Pediatrics|pediatrics
5282219|NCT02261857|Computer-Aided Design|computer-aided design
5282220|NCT02261857|Continuous Positive Airway Pressure|continuous positive airway pressure
5282221|NCT02261857|Three-Dimensional Printing|three-dimensional printing
5282222|NCT02261857|Additive Manufacturing|additive manufacturing
5282224|NCT02261844|Metastatic colorectal cancer|metastatic colorectal cancer
5282226|NCT02261844|Hepatic function|hepatic function
5282227|NCT02261831|bacterial|bacterial
5282228|NCT02261831|gut|gut
5282229|NCT02261831|type 2 diabetes.|type 2 diabetes.
5282230|NCT02261831|16S rDNA gene|16s rdna gene
5282231|NCT02261831|intestinal crypt|intestinal crypt
5282232|NCT02261818|depression|depression
5282233|NCT02261818|aging|aging
5282234|NCT02261818|health services|health services
5282235|NCT02261792|Postural headache treatment|postural headache treatment
5282236|NCT02261792|Spontaneous intracranial hypotension|spontaneous intracranial hypotension
5282237|NCT02261792|Epidural blood patch|epidural blood patch
5282238|NCT02261792|Trendelenburg position|trendelenburg position
5282239|NCT02261792|Head-Down Tilt|head-down tilt
5282240|NCT02261792|Blood Patch, Epidural|blood patch, epidural
5282241|NCT02261753|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia|epilepsy surgery, outcome, ketogenic diet, ortical dysplasia
5282242|NCT02261740|Pelvic Pain|pelvic pain
5282243|NCT02261740|Genital Pain|genital pain
5282244|NCT02261727|COPD|copd
5282245|NCT02261727|Theophylline|theophylline
5282246|NCT02261727|Oral corticosteroids|oral corticosteroids
5282247|NCT02261727|COPD exacerbations|copd exacerbations
5962825|NCT04278274|Neoadjuvant treatment|neoadjuvant treatment
5282248|NCT02261714|Pancreatic cancer, resected|pancreatic cancer, resected
5282249|NCT02261714|Vaccine|vaccine
5282250|NCT02261714|KRAS|kras
5282251|NCT02261701|shoulder surgery|shoulder surgery
5282252|NCT02261701|rotator cuff injury|rotator cuff injury
5282253|NCT02261701|rehabilitation|rehabilitation
5282254|NCT02261701|function|function
5282255|NCT02261701|pain|pain
5282256|NCT02261701|quality of life|quality of life
5282257|NCT02261675|dexmedetomidine|dexmedetomidine
5282258|NCT02261675|sevoflurane|sevoflurane
5282259|NCT02261675|MAC bar|mac bar
5282260|NCT02261675|drug interaction|drug interaction
5282261|NCT02261675|anesthesia|anesthesia
5282262|NCT02261649|Cerebellar tumor|cerebellar tumor
5282263|NCT02261649|Non-malignant low-grade cerebellar astrocytomas|non-malignant low-grade cerebellar astrocytomas
5282264|NCT02261610|PCT algorithm|pct algorithm
5282265|NCT02261610|Antibiotic|antibiotic
5282266|NCT02261610|Pulmonary embolism|pulmonary embolism
5282267|NCT02261597|insomnia, inflammation, stress|insomnia, inflammation, stress
5282268|NCT02261545|n-3 fatty acid|n-3 fatty acid
5282269|NCT02261545|Sirt-1|sirt-1
5282270|NCT02261545|AdipoR1|adipor1
5282271|NCT02261545|AdipoR2|adipor2
5282272|NCT02261545|MCP-1|mcp-1
5282273|NCT02261545|Adiponectin|adiponectin
5282274|NCT02261545|Resistin|resistin
5282275|NCT02261545|T2DM|t2dm
5282276|NCT02261506|Intensive care|intensive care
5282277|NCT02261506|bacteremia|bacteremia
5282278|NCT02261506|bloodstream infection|bloodstream infection
5282279|NCT02261506|antimicrobial|antimicrobial
5282280|NCT02261506|mortality|mortality
5282281|NCT02261506|antimicrobial stewardship|antimicrobial stewardship
5282282|NCT02261480|Parvovirus B19 Infection|parvovirus b19 infection
5282283|NCT02261454|postoperative ileus|postoperative ileus
5282284|NCT02261454|gum chewing|gum chewing
5282285|NCT02261454|postoperative care|postoperative care
5282286|NCT02261454|abdominal surgery|abdominal surgery
5282287|NCT02261454|child|child
5387068|NCT01780441|TSC|tsc
5282288|NCT02261441|Cardiovascular disease|cardiovascular disease
5282289|NCT02261441|Hypertension|hypertension
5282290|NCT02261441|Diabetes|diabetes
5282291|NCT02261441|Smoking|smoking
5282292|NCT02261441|Hypercholesterolemia|hypercholesterolemia
5282293|NCT02261441|Cardiovascular risk factor|cardiovascular risk factor
5282294|NCT02261428|Nasotracheal suction, tracheal access|nasotracheal suction, tracheal access
5282295|NCT02261415|blood transfusion|blood transfusion
5282296|NCT02261415|blood loss|blood loss
5282297|NCT02261415|feasibility|feasibility
5282299|NCT02261415|liver resection|liver resection
5282300|NCT02261402|Adherence|adherence
5282301|NCT02261402|Morisky Medication Adherence Scale|morisky medication adherence scale
5282302|NCT02261402|Beliefs about Medicines Questionnaire|beliefs about medicines questionnaire
5282303|NCT02261402|Medication Possession Ratio|medication possession ratio
5282304|NCT02261402|Medication-Related Problems|medication-related problems
5282305|NCT02261402|Pharmacist|pharmacist
5282306|NCT02261402|Pharmacist Intervention|pharmacist intervention
5282307|NCT02261402|Pharmacy|pharmacy
5282308|NCT02261402|Pharmacy Service|pharmacy service
5282309|NCT02261402|Pharmacy Practice|pharmacy practice
5282310|NCT02261402|Hypertension|hypertension
5282311|NCT02261402|Antihypertensive Agents|antihypertensive agents
5282312|NCT02261402|Anticoagulants|anticoagulants
5282313|NCT02261402|Statins|statins
5282314|NCT02261402|Dyslipidemia|dyslipidemia
5282315|NCT02261389|breast cancer|breast cancer
5282316|NCT02261389|follow-up|follow-up
5282317|NCT02261389|tumor markers|tumor markers
5282318|NCT02261376|pharmacokinetics|pharmacokinetics
5282319|NCT02261337|Sarcopenia|sarcopenia
5282320|NCT02261324|Percutaneous coronary intervention|percutaneous coronary intervention
5282321|NCT02261311|Breast|breast
5282323|NCT02261220|durvalumab|durvalumab
5282324|NCT02261220|tremelimumab|tremelimumab
5282325|NCT02261194|depression|depression
5282326|NCT02261194|age-related macular degeneration|age-related macular degeneration
5282327|NCT02261194|self-care|self-care
5282328|NCT02261194|self-help|self-help
5282329|NCT02261181|head neck cancer XONRID radiation induced dermatitis|head neck cancer xonrid radiation induced dermatitis
5282330|NCT02261168|Circadian Rhythm|circadian rhythm
5282331|NCT02261051|Palliative Care|palliative care
5282332|NCT02261051|Hospice|hospice
5282333|NCT02261051|End of Life|end of life
5282334|NCT02261051|Health Service Utilization|health service utilization
5282335|NCT02261051|Quality of Life|quality of life
5282336|NCT02261038|total knee arthroplasty|total knee arthroplasty
5282337|NCT02261038|total knee prothesis|total knee prothesis
5282338|NCT02261038|X-Ray|x-ray
5282339|NCT02261038|Kanekasu radiographs|kanekasu radiographs
5282340|NCT02261038|femoral component rotation|femoral component rotation
5282341|NCT02261038|effects|effects
5282342|NCT02261025|aspirin|aspirin
5282343|NCT02260908|Trauma|trauma
5282344|NCT02260908|Thromboprophylaxis|thromboprophylaxis
5282345|NCT02260908|Intracranial haemorrhage|intracranial haemorrhage
5282346|NCT02260908|Deep vein thrombosis|deep vein thrombosis
5282347|NCT02260856|RCT|rct
5282348|NCT02260856|Epiphysiodesis|epiphysiodesis
5282349|NCT02260856|Tantalum beads|tantalum beads
5163648|NCT02970006|full body illusion|full body illusion
5163650|NCT02969980|AML progressed from MDS|aml progressed from mds
5163651|NCT02969980|CMML|cmml
5163652|NCT02969967|rehabilitation|rehabilitation
5282350|NCT02260856|Patient centered outcome data|patient centered outcome data
5282351|NCT02260856|Cost effective analysis|cost effective analysis
5282352|NCT02260843|Insomnia|insomnia
5282353|NCT02260843|Sleeping|sleeping
5282354|NCT02260843|Quality|quality
5282355|NCT02260817|Prostate Cancer|prostate cancer
5282356|NCT02260817|11C Choline|11c choline
5282357|NCT02260817|PET Imaging|pet imaging
5282358|NCT02260791|Rheumatoid|rheumatoid
5282359|NCT02260791|Arthritis|arthritis
5282360|NCT02260778|Learning Collaborative|learning collaborative
5282361|NCT02260778|Treat-to-Target|treat-to-target
5282362|NCT02260778|Arthritis, Rheumatoid|arthritis, rheumatoid
5282363|NCT02260765|Treatment as Usual = TAU|treatment as usual = tau
5282364|NCT02260726|femoroacetabular impingement|femoroacetabular impingement
5282365|NCT02260726|morphometry|morphometry
5282366|NCT02260726|dynamic|dynamic
5282367|NCT02260726|magnetic resonance imaging|magnetic resonance imaging
5282368|NCT02260726|ultrasound|ultrasound
5282369|NCT02260726|screening|screening
5282370|NCT02260726|diagnosis|diagnosis
5282371|NCT02260700|Healthy|healthy
5282372|NCT02260700|Bioavailability|bioavailability
5282373|NCT02260700|Alzheimer's Disease|alzheimer's disease
5282374|NCT02260700|JNJ-54861911|jnj-54861911
5282375|NCT02260687|Aflibercept|aflibercept
5282376|NCT02260687|Anti-VEGF|anti-vegf
5282377|NCT02260674|Alzheimer's Disease|alzheimer's disease
5282378|NCT02260674|JNJ-54861911|jnj-54861911
5282379|NCT02260674|Placebo|placebo
5282380|NCT02260661|AZD8835|azd8835
5282381|NCT02260661|Fulvestrant|fulvestrant
5282382|NCT02260661|Breast Cancer|breast cancer
5282383|NCT02260661|PIK3CA Gene Mutation|pik3ca gene mutation
5282384|NCT02260622|Restenosis|restenosis
5282385|NCT02260622|Critical Limb Ischemia|critical limb ischemia
5282386|NCT02260622|Infrainguinal Percutaneous Transluminal Angioplasty|infrainguinal percutaneous transluminal angioplasty
5282387|NCT02260622|Rivaroxaban|rivaroxaban
5282388|NCT02260622|Clopidogrel|clopidogrel
5282389|NCT02260609|Complex Wound|complex wound
5282390|NCT02260609|Diabetic Foot Ulcer|diabetic foot ulcer
5282392|NCT02260609|GrafixCORE|grafixcore
5282393|NCT02260609|Exposed tendon|exposed tendon
5282394|NCT02260609|Exposed bone|exposed bone
5282395|NCT02260609|Allograft tissue|allograft tissue
5282396|NCT02260570|concussion|concussion
5282397|NCT02260570|traumatic brain injury|traumatic brain injury
5282399|NCT02260570|memory|memory
5282400|NCT02260570|tolcapone|tolcapone
5282401|NCT02260557|Systemic Sclerosis|systemic sclerosis
5282402|NCT02260557|Raynaud's Phenomenon|raynaud's phenomenon
5282403|NCT02260531|Metastatic breast cancer and brain metastases|metastatic breast cancer and brain metastases
5282404|NCT02260531|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5282405|NCT02260531|ER-Positive PR-Positive HER-2 Negative Breast Cancer|er-positive pr-positive her-2 negative breast cancer
5282406|NCT02260531|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
5282407|NCT02260518|Gestational weight gain|gestational weight gain
5282408|NCT02260518|Lifestyle intervention|lifestyle intervention
5282409|NCT02260518|Pregnancy|pregnancy
5282410|NCT02260518|Postpartum|postpartum
5282411|NCT02260518|Physical activity|physical activity
5282412|NCT02260518|Nutrition|nutrition
5282413|NCT02260505|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5282414|NCT02260505|Non-metastatic|non-metastatic
5282415|NCT02260505|KIT +|kit +
5282416|NCT02260505|Imatinib|imatinib
5282417|NCT02260505|Adjuvant treatment|adjuvant treatment
5282418|NCT02260505|High risk of recurrence|high risk of recurrence
5282419|NCT02260505|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5282420|NCT02260505|Disease Free Survival|disease free survival
5282421|NCT02260505|Overall survival|overall survival
5282422|NCT02260505|Time To Secondary Resistance|time to secondary resistance
5282423|NCT02260505|Safety profile|safety profile
5282424|NCT02260505|Quality of Life during treatment|quality of life during treatment
5282425|NCT02260479|skin disinfection|skin disinfection
5282426|NCT02260479|bacterial colonization|bacterial colonization
5282427|NCT02260479|perioperative|perioperative
5282428|NCT02260479|chlorehexidine|chlorehexidine
5282429|NCT02260466|Amyloidosis|amyloidosis
5282430|NCT02260466|echocardiography|echocardiography
5282431|NCT02260466|magnetic resonance imaging|magnetic resonance imaging
5282432|NCT02260466|radionuclide imaging|radionuclide imaging
5282433|NCT02260427|elective surgery|elective surgery
5282434|NCT02260427|undergoing general anesthesia|undergoing general anesthesia
5282435|NCT02260427|elderly adult patients|elderly adult patients
5282436|NCT02260414|Endogenous Thrombin Potential|endogenous thrombin potential
5282437|NCT02260414|Lymphoma|lymphoma
5282438|NCT02260414|Multiple Myeloma|multiple myeloma
5962826|NCT04278261|Focal therapy|focal therapy
5962827|NCT04278261|Radical prostatectomy|radical prostatectomy
5962828|NCT04278261|Irreversible electroporation|irreversible electroporation
5962829|NCT04278261|prostate cancer|prostate cancer
5962830|NCT04278235|Expanded Access|expanded access
5282439|NCT02260414|tinzaparin|tinzaparin
5282440|NCT02260414|thrombin generation|thrombin generation
5445387|NCT01522040|Adrenergic Receptor|adrenergic receptor
5282441|NCT02260414|Thromboplastin generation tests|thromboplastin generation tests
5282442|NCT02260388|CSPN|cspn
5282443|NCT02260388|neuropathy|neuropathy
5282444|NCT02260388|pain|pain
5282445|NCT02260388|pain management|pain management
5282446|NCT02260375|Mesenchymal stromal cells; liver transplantation; tolerance.|mesenchymal stromal cells; liver transplantation; tolerance.
5282447|NCT02260349|Prostatic Neoplasms|prostatic neoplasms
5282448|NCT02260349|Prostate cancer|prostate cancer
5282449|NCT02260349|surgical margins|surgical margins
5282450|NCT02260349|indocyanine green|indocyanine green
5282451|NCT02260349|characterization|characterization
5282452|NCT02260349|prostatectomy|prostatectomy
5282453|NCT02260349|peroperative|peroperative
5282454|NCT02260349|detection|detection
5282455|NCT02260297|Actigraphy|actigraphy
5282456|NCT02260297|overweight and obese adults|overweight and obese adults
5282457|NCT02260297|sleep disorders|sleep disorders
5282458|NCT02260258|Cardiac Arrest, NMB, Neuromuscular Blockade, Rocuronium|cardiac arrest, nmb, neuromuscular blockade, rocuronium
5282459|NCT02260219|Ahmed implant|ahmed implant
5282460|NCT02260219|Neovascular Glaucoma|neovascular glaucoma
5282461|NCT02260219|Intraocular pressure|intraocular pressure
5282462|NCT02260206|Pericardial Effusion|pericardial effusion
5282463|NCT02260206|Colchicine|colchicine
5282464|NCT02260206|arrhythmia Recurrence|arrhythmia recurrence
5282465|NCT02260206|pericardiocentesis|pericardiocentesis
5282466|NCT02260193|anemia|anemia
5282467|NCT02260193|end stage renal disease|end stage renal disease
5282468|NCT02260193|chronic kidney disease|chronic kidney disease
5282470|NCT02260193|dialysis|dialysis
5282471|NCT02260193|chronic renal insufficiency|chronic renal insufficiency
5282472|NCT02260193|renal impairment|renal impairment
5282473|NCT02260193|erythropoietin|erythropoietin
5282474|NCT02260193|kidney|kidney
5282475|NCT02260193|oral anemia treatment|oral anemia treatment
5282476|NCT02260193|hemoglobin|hemoglobin
5282477|NCT02260193|hypoxia-inducible factor|hypoxia-inducible factor
5282478|NCT02260193|HIF|hif
5282479|NCT02260193|hypoxia-inducible factor propyl-hydroxylase inhibitor|hypoxia-inducible factor propyl-hydroxylase inhibitor
5282480|NCT02260193|HIF-PHI|hif-phi
5282482|NCT02260154|Duspatalin|duspatalin
5282483|NCT02260154|mebeverine|mebeverine
5282484|NCT02260154|cholecystectomy|cholecystectomy
5282485|NCT02260154|gastrointestinal spasm|gastrointestinal spasm
5282486|NCT02260154|abdominal pain|abdominal pain
5282487|NCT02260154|dyspepsia|dyspepsia
5282488|NCT02260154|antispasmodics|antispasmodics
5282489|NCT02260128|postoperative ileus|postoperative ileus
5282490|NCT02260128|chewing gum|chewing gum
5282491|NCT02259712|Women|women
5282492|NCT02259712|Pelvic floor disorders|pelvic floor disorders
5282493|NCT02259712|Urinary incontinence|urinary incontinence
5282494|NCT02259712|Fecal incontinence|fecal incontinence
5282495|NCT02259712|Physical Therapy Modalities|physical therapy modalities
5282496|NCT02259699|Ovarian Cancer|ovarian cancer
5282497|NCT02259699|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5282498|NCT02259699|Intravenous chemotherapy|intravenous chemotherapy
5282499|NCT02259699|decision making|decision making
5282500|NCT02259686|Apelin|apelin
5282501|NCT02259686|volunteers|volunteers
5282502|NCT02259660|obstructive sleep apnea|obstructive sleep apnea
5282503|NCT02259660|osa|osa
5282504|NCT02259660|breathing|breathing
5282505|NCT02259660|snoring|snoring
5282506|NCT02259660|respiratory|respiratory
5282507|NCT02259660|exercise|exercise
5282508|NCT02259660|inspiratory muscle strength training|inspiratory muscle strength training
5282509|NCT02259660|expiratory muscle strength training|expiratory muscle strength training
5282510|NCT02259634|Patient Navigation|patient navigation
5282511|NCT02259634|Motivational Interviewing|motivational interviewing
5282512|NCT02259634|Formerly Incarcerated|formerly incarcerated
5282513|NCT02259634|Health Education|health education
5282514|NCT02259634|Quality of Life|quality of life
5282515|NCT02259634|Healthcare Utilization|healthcare utilization
5282516|NCT02259608|Trained innate immunity|trained innate immunity
5282517|NCT02259608|Heterologous effects of BCG on immunity|heterologous effects of bcg on immunity
5282518|NCT02259595|Hearing Loss|hearing loss
5862756|NCT00001524|HIV/AIDS|hiv/aids
5282519|NCT02259595|Sensorineural Hearing Loss|sensorineural hearing loss
5282520|NCT02259595|Noise-Induced Hearing Loss|noise-induced hearing loss
5282521|NCT02259595|Antioxidant|antioxidant
5282523|NCT02259595|N-acetylcysteine|n-acetylcysteine
5282524|NCT02259595|HPN-07|hpn-07
5282525|NCT02259582|Phase 2|phase 2
5282526|NCT02259582|histologically|histologically
5282527|NCT02259582|confirmed|confirmed
5282528|NCT02259582|malignancy|malignancy
5282529|NCT02259582|metastatic|metastatic
5282530|NCT02259582|pemetrexed|pemetrexed
5282531|NCT02259582|carboplatin|carboplatin
5282532|NCT02259582|carcinoma|carcinoma
5282533|NCT02259582|non small cell lung|non small cell lung
5282534|NCT02259582|lung neoplasms|lung neoplasms
5282535|NCT02259582|lung diseases|lung diseases
5282536|NCT02259569|Gastric insufflation|gastric insufflation
5282538|NCT02259569|Peak airway pressure|peak airway pressure
5282539|NCT02259569|Pressure-controlled ventilation|pressure-controlled ventilation
5151914|NCT03042793|PD-L1|pd-l1
5282540|NCT02259569|Volume-Controlled Ventilation|volume-controlled ventilation
5282541|NCT02259569|pediatric patient|pediatric patient
5282542|NCT02259543|gingival recession|gingival recession
5282543|NCT02259543|soft tissue|soft tissue
5282544|NCT02259543|root biomodification|root biomodification
5282545|NCT02259543|root coverage|root coverage
5282546|NCT02259543|citric acid|citric acid
5282547|NCT02259543|tetracycline|tetracycline
5282548|NCT02259517|ADHD|adhd
5282549|NCT02259517|Intuniv|intuniv
5282550|NCT02259517|Non-stimulant|non-stimulant
5282551|NCT02259517|Guanfacine extended-release|guanfacine extended-release
5282552|NCT02259517|Vyvanse|vyvanse
5282553|NCT02259517|Stimulant|stimulant
5282554|NCT02259517|Lisdexamfetamine|lisdexamfetamine
5282555|NCT02259504|aneurysms|aneurysms
5282556|NCT02259491|Wound Healing|wound healing
5282558|NCT02259491|Skin Grafts|skin grafts
5282559|NCT02259491|Free tissue transfer|free tissue transfer
5282560|NCT02259478|Intravenous Immunoglobulin (IVIG)|intravenous immunoglobulin (ivig)
5282561|NCT02259478|Hemolysis|hemolysis
5282562|NCT02259478|Transfusion Medicine|transfusion medicine
5282563|NCT02259478|Pharmacovigilance|pharmacovigilance
5282564|NCT02259465|microbiota|microbiota
5282565|NCT02259465|FODMAP|fodmap
5282566|NCT02259465|oligofructose|oligofructose
5282567|NCT02259465|Magnetic Resonance Imaging|magnetic resonance imaging
5282568|NCT02259465|Metabolomics|metabolomics
5282569|NCT02259465|Diet|diet
5282571|NCT02259413|Hemodialysis|hemodialysis
5282572|NCT02259413|End-stage renal disease|end-stage renal disease
5282573|NCT02259413|Exercise|exercise
5282574|NCT02259413|Symptom Burden|symptom burden
5282575|NCT02259400|NIV|niv
5282576|NCT02259400|NSIPPV|nsippv
5282577|NCT02259400|BiPAP|bipap
5282578|NCT02259348|Hematological malignancies|hematological malignancies
5282579|NCT02259348|Allogeneic hematopoietic cell transplant|allogeneic hematopoietic cell transplant
5282580|NCT02259348|Refractory hematologic malignancy|refractory hematologic malignancy
5282581|NCT02259348|Relapsed hematologic malignancy|relapsed hematologic malignancy
5282582|NCT02259335|weaning from mechanical ventilation|weaning from mechanical ventilation
5282583|NCT02259335|extracorporeal CO2 removal|extracorporeal co2 removal
5282584|NCT02259335|post-extubation failure|post-extubation failure
5282585|NCT02259322|Bariatric surgery|bariatric surgery
5282586|NCT02259322|Weight loss surgery|weight loss surgery
5282587|NCT02259322|Behavioral weight loss treatment|behavioral weight loss treatment
5282588|NCT02259322|Cognitive behavioral therapy|cognitive behavioral therapy
5270095|NCT02330341|Insulin|insulin
5282589|NCT02259322|Behavioral treatment|behavioral treatment
5282591|NCT02259322|Morbid obesity|morbid obesity
5282592|NCT02259322|Binge eating|binge eating
5282593|NCT02259322|Binge eating disorder|binge eating disorder
5282594|NCT02259322|Loss of control eating|loss of control eating
5282595|NCT02259322|Overeating|overeating
5282596|NCT02259309|misoprostol|misoprostol
5282597|NCT02259309|mucosal|mucosal
5282598|NCT02259309|cervical|cervical
5282599|NCT02259309|immune|immune
5282600|NCT02259309|buccal|buccal
5282601|NCT02259309|vaginal|vaginal
5282602|NCT02259283|achalasia|achalasia
5282603|NCT02259283|per oral endoscopic myotoymy|per oral endoscopic myotoymy
5282604|NCT02259283|endoscopy|endoscopy
5282605|NCT02259270|Acid suppressive therapy|acid suppressive therapy
5282606|NCT02259270|Appropriateness|appropriateness
5282607|NCT02259270|Long term treatment|long term treatment
5282608|NCT02259270|Risk factors|risk factors
5282609|NCT02259270|Hospitalisation|hospitalisation
5282610|NCT02259270|Non-critically ill|non-critically ill
5282611|NCT02259270|Adult|adult
5282612|NCT02259257|carotid arteriosclerosis|carotid arteriosclerosis
5282613|NCT02259257|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5282614|NCT02259257|neovascularization|neovascularization
5282615|NCT02259257|quantitative analysis|quantitative analysis
5282616|NCT02259257|3D/4D imaging|3d/4d imaging
5282617|NCT02259257|CEUS|ceus
5282618|NCT02259257|Vasa vasorum|vasa vasorum
5282619|NCT02259231|RTA 408|rta 408
5282620|NCT02259231|RTA 408 Capsules|rta 408 capsules
5282621|NCT02259231|Myeloid-derived suppressor cells (MDSDs)|myeloid-derived suppressor cells (mdsds)
5282622|NCT02259231|iNOS|inos
5282628|NCT02259205|platelet activating factor|platelet activating factor
5282629|NCT02259205|inflammatory markers|inflammatory markers
5282630|NCT02259205|yogurt|yogurt
5282631|NCT02259205|olive oil|olive oil
5282632|NCT02259205|platelet aggregation|platelet aggregation
5282633|NCT02259205|oxidative stress|oxidative stress
5282634|NCT02259205|endothelial damage|endothelial damage
5282635|NCT02259205|bioactive lipids|bioactive lipids
5282636|NCT02259192|deaf adult|deaf adult
5962831|NCT04278235|Pre-approval Access|pre-approval access
5282637|NCT02259192|single-sided|single-sided
5282638|NCT02259192|cochlear implant|cochlear implant
5282639|NCT02259179|Obesity|obesity
5282640|NCT02259179|Overweight|overweight
5282641|NCT02259179|Contrave|contrave
5282642|NCT02259179|Antiobesity agents|antiobesity agents
5282643|NCT02259179|Antiobesity drugs|antiobesity drugs
5282644|NCT02259179|Weight loss drug|weight loss drug
5282645|NCT02259179|Bioequivalence|bioequivalence
5282646|NCT02259179|Pharmacokinetic|pharmacokinetic
5282647|NCT02259153|Lipids|lipids
5282648|NCT02259153|Non Cholesterol Sterols|non cholesterol sterols
5282649|NCT02259153|Oxysterols|oxysterols
5282650|NCT02259153|Cholesterol Metabolism|cholesterol metabolism
5282651|NCT02259140|cerebral palsy|cerebral palsy
5282652|NCT02259140|randomized controlled trial|randomized controlled trial
5282653|NCT02259140|hip dislocation|hip dislocation
5282654|NCT02259140|hip subluxation|hip subluxation
5282655|NCT02259140|patient centered outcomes|patient centered outcomes
5282656|NCT02259140|cost effectiveness analysis|cost effectiveness analysis
5282657|NCT02259088|DME|dme
5282658|NCT02259088|macular edema|macular edema
5282659|NCT02259088|vision impairment|vision impairment
5282660|NCT02259088|Chinese|chinese
5282661|NCT02259088|diabetes|diabetes
5282662|NCT02259075|Migraine with aura|migraine with aura
5282663|NCT02259075|Migraine without aura|migraine without aura
5282664|NCT02259075|Headache disorders|headache disorders
5282665|NCT02259075|Botulinum Toxin Type A|botulinum toxin type a
5282666|NCT02259075|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5282667|NCT02259075|Autonomic Nerve Block|autonomic nerve block
5282668|NCT02259036|child anxiety|child anxiety
5282669|NCT02259036|worries|worries
5282670|NCT02259036|fears|fears
5282671|NCT02259036|talk therapy|talk therapy
5282672|NCT02259023|Stress Perception|stress perception
5282673|NCT02259023|Discretionary Calories|discretionary calories
5282674|NCT02259023|Health|health
5282675|NCT02258997|sickle cell disease|sickle cell disease
5282676|NCT02258958|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5282677|NCT02258958|deep venous thrombosis|deep venous thrombosis
5282678|NCT02258958|pulmonary embolus|pulmonary embolus
5282679|NCT02258958|thoracic surgery|thoracic surgery
5282680|NCT02258958|lung resection|lung resection
5282681|NCT02258958|incidence|incidence
5282682|NCT02258945|Type 1 diabetes|type 1 diabetes
5282683|NCT02258945|CSII|csii
5282684|NCT02258945|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5282685|NCT02258945|Insulin pump|insulin pump
5282686|NCT02258945|Nutrition|nutrition
5282687|NCT02258945|Eating behaviours|eating behaviours
5282688|NCT02258945|Quality of life|quality of life
5282689|NCT02258945|Cardiometabolic risks|cardiometabolic risks
5282690|NCT02258945|Liverpool|liverpool
5282691|NCT02258945|NHS|nhs
5282692|NCT02258945|Metabolomics|metabolomics
5282693|NCT02258945|Observational|observational
5282694|NCT02258945|Lipoproteins|lipoproteins
5282695|NCT02258945|Lipids|lipids
5282696|NCT02258945|Food|food
5282697|NCT02258945|Food diary|food diary
5282698|NCT02258945|Cross-Sectional|cross-sectional
5282699|NCT02258932|Type 1 diabetes|type 1 diabetes
5282700|NCT02258932|CSII|csii
5282701|NCT02258932|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5282702|NCT02258932|Insulin pump|insulin pump
5282703|NCT02258932|Nutrition|nutrition
5282704|NCT02258932|Eating behaviours|eating behaviours
5282705|NCT02258932|Quality of life|quality of life
5282706|NCT02258932|Cardiometabolic risks|cardiometabolic risks
5282707|NCT02258932|Liverpool|liverpool
5282708|NCT02258932|NHS|nhs
5282709|NCT02258932|Metabolomics|metabolomics
5282710|NCT02258932|Observational|observational
5282711|NCT02258932|Lipoproteins|lipoproteins
5282712|NCT02258932|Lipids|lipids
5282713|NCT02258932|Food|food
5282714|NCT02258932|Food diary|food diary
5282715|NCT02258932|Longitudinal|longitudinal
5282716|NCT02258919|Intracerebral hemorrhage|intracerebral hemorrhage
5282717|NCT02258919|Decompressive craniectomy|decompressive craniectomy
5282718|NCT02258919|Randomized controlled trial|randomized controlled trial
5282719|NCT02258919|Acute stroke|acute stroke
5282720|NCT02258893|Nitrogen Dioxide|nitrogen dioxide
5279825|NCT02276066|sepsis|sepsis
5282722|NCT02258880|Acute Stroke|acute stroke
5282723|NCT02258880|Outcome Measures|outcome measures
5282724|NCT02258880|Physical Performance|physical performance
5282725|NCT02258867|Uveitis|uveitis
5282726|NCT02258867|Behcet's Disease Uveitis|behcet's disease uveitis
5282727|NCT02258867|Behcet's Disease|behcet's disease
5282728|NCT02258854|Uveitis|uveitis
5282729|NCT02258854|Non-infectious Uveitis|non-infectious uveitis
5282730|NCT02258854|Intermediate Uveitis|intermediate uveitis
5282731|NCT02258854|Posterior Uveitis|posterior uveitis
5282732|NCT02258854|Panuveitis|panuveitis
5282733|NCT02258854|Behçet's disease uveitis|behçet's disease uveitis
5282734|NCT02258841|domestic violence|domestic violence
5282735|NCT02258841|mental health|mental health
5282736|NCT02258841|safety planning|safety planning
5282737|NCT02258815|pediatric|pediatric
5282738|NCT02258815|haploidentical|haploidentical
5282739|NCT02258815|stem cell transplantation|stem cell transplantation
5282740|NCT02258802|psychoeducational intervention|psychoeducational intervention
5282741|NCT02258802|nutrition intervention|nutrition intervention
5282742|NCT02258802|malnutrition|malnutrition
5282743|NCT02258802|micronutrient deficiency|micronutrient deficiency
5282744|NCT02258802|nutrition transition|nutrition transition
5282745|NCT02258789|Stroke, rehabilitation, spatial neglect|stroke, rehabilitation, spatial neglect
5282746|NCT02258763|Pneumonia|pneumonia
5282747|NCT02258763|Child|child
5282748|NCT02258763|Outcome|outcome
5282749|NCT02258763|Antibiotics|antibiotics
5282750|NCT02258763|Etiology|etiology
5282751|NCT02258737|Case management|case management
5282752|NCT02258737|psychiatric hospitalization|psychiatric hospitalization
5282753|NCT02258737|discharge|discharge
5282754|NCT02258724|Adult|adult
5282755|NCT02258724|Registry|registry
5282756|NCT02258724|Grown-up congenital heart disease|grown-up congenital heart disease
5282757|NCT02258711|Bipolar disorder|bipolar disorder
5282758|NCT02258711|Psychoeducation|psychoeducation
5423273|NCT01616420|Kenya|kenya
5282759|NCT02258711|Smart-phone monitoring|smart-phone monitoring
5282760|NCT02258685|Gut microbiota composition|gut microbiota composition
5282761|NCT02258672|Preoperative rehabilitation|preoperative rehabilitation
5282762|NCT02258672|Minimally invasive surgery|minimally invasive surgery
5282763|NCT02258672|Functional capacity|functional capacity
5282764|NCT02258646|Exercise|exercise
5282765|NCT02258646|Rehabilitation|rehabilitation
5282766|NCT02258646|Telemedicine|telemedicine
5282767|NCT02258646|Treatment Outcome|treatment outcome
5282768|NCT02258646|Costs and Cost Analysis|costs and cost analysis
5282769|NCT02258646|Physical Therapists|physical therapists
5282770|NCT02258646|Adaptation, Psychological|adaptation, psychological
5282771|NCT02258568|Cigarette Smoking|cigarette smoking
5282772|NCT02258568|Pregnancy|pregnancy
5282773|NCT02258568|Postpartum smoking relapse|postpartum smoking relapse
5282774|NCT02258568|Romania|romania
5282775|NCT02258555|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5282776|NCT02258555|Follicular lymphoma (FL)|follicular lymphoma (fl)
5282777|NCT02258555|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5282778|NCT02258555|Phosphatidylinositol 3 kinase (PI3K)|phosphatidylinositol 3 kinase (pi3k)
5282779|NCT02258555|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
5282780|NCT02258542|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
5282781|NCT02258529|Cancer|cancer
5282782|NCT02258529|Indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
5282784|NCT02258529|SLL|sll
5282785|NCT02258503|Numerical scale|numerical scale
5282786|NCT02258503|Pain in elderly patients admitted in emergency department|pain in elderly patients admitted in emergency department
5282787|NCT02258490|chronic myeloid leukemia|chronic myeloid leukemia
5282788|NCT02258490|myelodysplastic syndrome|myelodysplastic syndrome
5282789|NCT02258490|acute myeloid leukemia|acute myeloid leukemia
5282790|NCT02258490|CD34+ cell mobilization therapy|cd34+ cell mobilization therapy
5282791|NCT02258490|graft versus host disease|graft versus host disease
5282792|NCT02258490|allogeneic hematopoietic stem cell|allogeneic hematopoietic stem cell
5282793|NCT02258490|G-CSF|g-csf
5282794|NCT02258464|Breast Cancer|breast cancer
5282795|NCT02258451|Breast Cancer|breast cancer
5282796|NCT02258438|Sedentary Behavior|sedentary behavior
5282797|NCT02258425|Homeless Women|homeless women
5282798|NCT02258425|Parolees|parolees
5282799|NCT02258425|Probationers|probationers
5282800|NCT02258425|Community Drug Treatment|community drug treatment
5282801|NCT02258425|Recidivism|recidivism
5282802|NCT02258412|antimicrobial|antimicrobial
5282803|NCT02258412|efficacy|efficacy
5282804|NCT02258412|hand|hand
5282805|NCT02258412|hygiene|hygiene
5282806|NCT02258412|bacteria|bacteria
5282807|NCT02258373|Diabetes Mellitus|diabetes mellitus
5282808|NCT02258373|Continuous Glucose Monitoring|continuous glucose monitoring
5282809|NCT02258360|Thromboelastometry|thromboelastometry
5282810|NCT02258360|Haemostasis|haemostasis
5282811|NCT02258360|Hypothermia|hypothermia
5282812|NCT02258360|Heart Arrest|heart arrest
5282813|NCT02258334|Influenza|influenza
5279925|NCT02275429|Running|running
5282814|NCT02258334|Fluzone® Quadrivalent, Influenza Vaccine|fluzone® quadrivalent, influenza vaccine
5282815|NCT02258334|Fluzone® Intradermal, Influenza Vaccine|fluzone® intradermal, influenza vaccine
5282816|NCT02258334|Fluzone® High-Dose, Influenza Vaccine|fluzone® high-dose, influenza vaccine
5282817|NCT02258295|Lateral Humeral Epicondylitis|lateral humeral epicondylitis
5282818|NCT02258295|Tendinitis|tendinitis
5282819|NCT02258295|Tendinosis|tendinosis
5282820|NCT02258295|Athletic Injuries|athletic injuries
5282821|NCT02258295|Elbow Joint|elbow joint
5282822|NCT02258295|Sports Medicine|sports medicine
5282823|NCT02258204|Cerebral Infarct|cerebral infarct
5282824|NCT02258204|Thrombolysis|thrombolysis
5282825|NCT02258204|Tissue-type plasminogen activator|tissue-type plasminogen activator
5282826|NCT02258204|Neuroprotection|neuroprotection
5282827|NCT02258204|Anesthetic agent|anesthetic agent
5282828|NCT02258204|Magnetic resonance imaging|magnetic resonance imaging
5282830|NCT02258191|COPD|copd
5282831|NCT02258191|telemonitoring|telemonitoring
5282832|NCT02258165|ovarian cancer|ovarian cancer
5282833|NCT02258165|imaging|imaging
5282834|NCT02258165|gated PET/CT scan|gated pet/ct scan
5282835|NCT02258152|PDD|pdd
5282836|NCT02258152|Parkinson's Disease Dementia|parkinson's disease dementia
5962832|NCT04278235|Compassionate Use|compassionate use
5164152|NCT02966249|dexmetomidine, intrathecally, intavenously,anesthesia|dexmetomidine, intrathecally, intavenously,anesthesia
5164153|NCT02966236|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5164154|NCT02966171|Advanced Solid Malignancies|advanced solid malignancies
5282837|NCT02258152|patients taking a cholinesterase inhibitor.|patients taking a cholinesterase inhibitor.
5282838|NCT02258126|overweight children|overweight children
5282839|NCT02258126|hepatic fat|hepatic fat
5282840|NCT02258126|exercise|exercise
5282841|NCT02258126|nutritional education program|nutritional education program
5282842|NCT02258126|cardiometabolic risk|cardiometabolic risk
5282843|NCT02258087|Prostate, Cancer, Brachytherapy, HDR, LDR, monotherapy|prostate, cancer, brachytherapy, hdr, ldr, monotherapy
5282844|NCT02258048|Cirrhosis|cirrhosis
5282845|NCT02258035|vitamin D binding protein (DBP)|vitamin d binding protein (dbp)
5282846|NCT02257996|Psychoanalytic Psychotherapy|psychoanalytic psychotherapy
5282847|NCT02257996|Telepsychology|telepsychology
5282848|NCT02257996|Online Therapy|online therapy
5282849|NCT02257996|Web conferencing|web conferencing
5282850|NCT02257996|RCT|rct
5282863|NCT02257931|autologous|autologous
5282864|NCT02257931|recipients, of all ages, for any indications|recipients, of all ages, for any indications
5282865|NCT02257918|antibiotic|antibiotic
5282866|NCT02257918|antimicrobial|antimicrobial
5282867|NCT02257918|AZD0914|azd0914
5282868|NCT02257918|Ceftriaxone|ceftriaxone
5282869|NCT02257918|drug-resistant|drug-resistant
5282870|NCT02257918|sexually transmitted infection|sexually transmitted infection
5282871|NCT02257918|urogenital gonorrhoea|urogenital gonorrhoea
5282872|NCT02257905|AL Amyloidosis|al amyloidosis
5282873|NCT02257905|Amyloidosis|amyloidosis
5282874|NCT02257905|allogeneic|allogeneic
5282875|NCT02257905|HSCT|hsct
5282876|NCT02257892|CTLA4|ctla4
5282877|NCT02257892|PI3KCD|pi3kcd
5282878|NCT02257892|MAG T1|mag t1
5282879|NCT02257892|Rare Immune Disorders|rare immune disorders
5282880|NCT02257892|Genetic Testing|genetic testing
5282881|NCT02257879|Midazolam|midazolam
5282882|NCT02257879|CYP3A|cyp3a
5282883|NCT02257879|Loperamide|loperamide
5282884|NCT02257866|Autoimmunity|autoimmunity
5282885|NCT02257866|Adult and Pediatric Disease|adult and pediatric disease
5282886|NCT02257866|Vasculitis|vasculitis
5282887|NCT02257866|Rheumatic Disease|rheumatic disease
5282888|NCT02257866|Polyarteritis Nodosa|polyarteritis nodosa
5282889|NCT02257866|Takayasu's Arthritis|takayasu's arthritis
5282890|NCT02257866|Giant Cell Arthritis|giant cell arthritis
5282891|NCT02257866|Relapsing Polychondritis|relapsing polychondritis
5282892|NCT02257866|Antineutrophil Cytoplasmic Antibodies|antineutrophil cytoplasmic antibodies
5282893|NCT02257853|Caregiver Stress|caregiver stress
5282894|NCT02257853|Cancer Caregivers|cancer caregivers
5282992|NCT02257411|ear based|ear based
5282895|NCT02257853|Yoga-Based Stress Reduction Intervention|yoga-based stress reduction intervention
5282896|NCT02257853|HSCT Caregivers|hsct caregivers
5282897|NCT02257827|Hypofractionated schedule|hypofractionated schedule
5282898|NCT02257827|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5282899|NCT02257827|Conformal radiotherapy|conformal radiotherapy
5282900|NCT02257801|Memory|memory
5282901|NCT02257801|Cognition|cognition
5282902|NCT02257801|Execute Function|execute function
5282903|NCT02257801|Attention|attention
5282904|NCT02257801|Mood|mood
5282905|NCT02257762|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
5282906|NCT02257762|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
5282907|NCT02257762|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
5282908|NCT02257762|Complementary feeding|complementary feeding
5282909|NCT02257762|Home fortification|home fortification
5282910|NCT02257762|Efficacy/impact|efficacy/impact
5282911|NCT02257762|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
5282912|NCT02257762|Cambodia|cambodia
5282913|NCT02257762|Cluster randomised controlled trial|cluster randomised controlled trial
5282914|NCT02257749|Concussion|concussion
5282915|NCT02257749|Persistent Symptoms|persistent symptoms
5282916|NCT02257749|Children|children
5282917|NCT02257749|Exercise|exercise
5282918|NCT02257749|Adolescents|adolescents
5282919|NCT02257749|Active Rehabilitation|active rehabilitation
5282920|NCT02257749|Education|education
5282922|NCT02257736|JN56021927|jn56021927
5282923|NCT02257736|ZYTIGA|zytiga
5282924|NCT02257736|Prednisone|prednisone
5282925|NCT02257736|Abiraterone acetate|abiraterone acetate
5282926|NCT02257736|Apalutamide|apalutamide
5282927|NCT02257723|Inpatient care|inpatient care
5282928|NCT02257723|Complementary and alternative medicine|complementary and alternative medicine
5282929|NCT02257723|Integrated medicine|integrated medicine
5282930|NCT02257710|national|national
5282931|NCT02257710|Multicenter|multicenter
5282932|NCT02257710|Observational registry|observational registry
5282933|NCT02257710|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5282934|NCT02257710|Stenting|stenting
5962833|NCT04278235|Special Access Program|special access program
5962834|NCT04278235|Named Patient Basis|named patient basis
5962835|NCT04278235|Special Access Scheme|special access scheme
5962836|NCT04278196|Artificial intelligence|artificial intelligence
5445388|NCT01522014|Joint Replacement|joint replacement
5962837|NCT04278196|Magnet controlled capsule endoscopy|magnet controlled capsule endoscopy
5962838|NCT04278183|endometrial cancer|endometrial cancer
5282935|NCT02257710|Treatment of coronary artery disease|treatment of coronary artery disease
5282936|NCT02257710|Coronary revascularization|coronary revascularization
5282937|NCT02257710|Coronary Intervention|coronary intervention
5282938|NCT02257710|STEMI|stemi
5282939|NCT02257710|NSTEMI|nstemi
5287653|NCT02234453|cancer|cancer
5282946|NCT02257684|LBL|lbl
5282947|NCT02257658|Men who have Sex with Men|men who have sex with men
5282948|NCT02257658|HIV-positive|hiv-positive
5282949|NCT02257658|Syphilis|syphilis
5282950|NCT02257658|Contingency Management|contingency management
5282951|NCT02257619|Stage IIIb, IV, or Recurrent Non-Small Cell Lung Cancer|stage iiib, iv, or recurrent non-small cell lung cancer
5282952|NCT02257593|macronutrient|macronutrient
5282953|NCT02257593|malnutrition|malnutrition
5282954|NCT02257593|birth weight|birth weight
5282955|NCT02257593|protein leverage|protein leverage
5282956|NCT02257580|E-Aminocaproic Acid|e-aminocaproic acid
5282957|NCT02257580|Bilateral Varus Rotational Osteotomy|bilateral varus rotational osteotomy
5282958|NCT02257580|Blood Loss and Transfusion|blood loss and transfusion
5282959|NCT02257580|Complications|complications
5282960|NCT02257580|Safety|safety
5282961|NCT02257554|expectations|expectations
5282962|NCT02257541|BGJ398|bgj398
5282963|NCT02257541|Imatinib Mesylate|imatinib mesylate
5282964|NCT02257541|14-140|14-140
5282965|NCT02257502|aflibercept|aflibercept
5282966|NCT02257502|iodiopathic choroidal neovascularization|iodiopathic choroidal neovascularization
5282967|NCT02257502|young patient|young patient
5282968|NCT02257476|carfilzomib|carfilzomib
5282969|NCT02257476|advanced solid malignancies|advanced solid malignancies
5282970|NCT02257476|advanced solid cancers|advanced solid cancers
5282971|NCT02257476|prostate|prostate
5282972|NCT02257476|bladder|bladder
5282973|NCT02257476|colon|colon
5282974|NCT02257476|breast|breast
5282975|NCT02257476|lung|lung
5282976|NCT02257463|COPD|copd
5282977|NCT02257463|inspiratory muscle training|inspiratory muscle training
5282978|NCT02257463|dyspnea|dyspnea
5282979|NCT02257463|Quality of Life|quality of life
5282980|NCT02257450|Primary Aldosteronism|primary aldosteronism
5282981|NCT02257450|Hyperaldosteronism|hyperaldosteronism
5282982|NCT02257437|Ready-to-use supplementary food (RUSF)|ready-to-use supplementary food (rusf)
5282983|NCT02257437|Lipid-based nutrient supplement (LNS)|lipid-based nutrient supplement (lns)
5282984|NCT02257437|Multiple micronutrients (MMN)|multiple micronutrients (mmn)
5282985|NCT02257437|Complementary feeding|complementary feeding
5282986|NCT02257437|Home fortification|home fortification
5282987|NCT02257437|Acceptability|acceptability
5282988|NCT02257437|Infant and young child feeding (IYCF)|infant and young child feeding (iycf)
5282989|NCT02257437|Cambodia|cambodia
5282990|NCT02257437|Cross-over studies|cross-over studies
5282991|NCT02257411|child|child
5282997|NCT02257385|indacaterol|indacaterol
5282998|NCT02257385|efficacy|efficacy
5282999|NCT02257385|FEV1|fev1
5283000|NCT02257385|ELLIPTA|ellipta
5283001|NCT02257385|non inferiority|non inferiority
5283002|NCT02257385|vilanterol|vilanterol
5283003|NCT02257385|COPD|copd
5283004|NCT02257385|safety|safety
5283005|NCT02257385|tiotropium|tiotropium
5283006|NCT02257385|umeclidinium bromide|umeclidinium bromide
5283007|NCT02257385|GSK573719|gsk573719
5283008|NCT02257372|FEV1|fev1
5283009|NCT02257372|DPI|dpi
5283010|NCT02257372|ICS/LABA|ics/laba
5283011|NCT02257372|UMEC|umec
5283012|NCT02257372|COPD|copd
5283013|NCT02257359|Epelsiban|epelsiban
5283014|NCT02257359|Healthy Female Volunteers|healthy female volunteers
5283015|NCT02257359|Safety|safety
5283016|NCT02257359|Tolerability|tolerability
5283017|NCT02257359|Oxytocin|oxytocin
5283018|NCT02257359|Pharmacokinetics|pharmacokinetics
5283019|NCT02257346|Pregnancy|pregnancy
5283020|NCT02257346|Lidocaine|lidocaine
5283021|NCT02257346|Quality|quality
5283022|NCT02257346|Recovery|recovery
5283023|NCT02257333|Retinal Vein Occlusion|retinal vein occlusion
5283024|NCT02257333|Atherosclerosis|atherosclerosis
5283025|NCT02257333|Risk Factors|risk factors
5283026|NCT02257333|Major Adverse Cardiovascular Events|major adverse cardiovascular events
5283027|NCT02257307|ROP|rop
5283028|NCT02257307|retinopathy|retinopathy
5283029|NCT02257307|Referral warranted retinopathy|referral warranted retinopathy
5283030|NCT02257281|Sodium lauryl sulfate|sodium lauryl sulfate
5283031|NCT02257281|Skin irritants|skin irritants
5283032|NCT02257281|inflammation|inflammation
5283033|NCT02257281|therapeutic ultrasound|therapeutic ultrasound
5283034|NCT02257268|health behavior; risk factors;|health behavior; risk factors;
5283035|NCT02257255|cesarean section|cesarean section
5283036|NCT02257255|pain, postoperative/diagnosis|pain, postoperative/diagnosis
5283037|NCT02257255|pain measurement/methods|pain measurement/methods
5283038|NCT02257242|Bendamustine|bendamustine
5283039|NCT02257242|Rituximab|rituximab
5283040|NCT02257242|Vincristine sulfate|vincristine sulfate
5283041|NCT02257242|Vincristine sulfate liposome injection|vincristine sulfate liposome injection
5283042|NCT02257242|Phase I|phase i
5283043|NCT02257242|Escalation With Overdose Control|escalation with overdose control
5962839|NCT04278183|endometrial intraepithelial neoplasia|endometrial intraepithelial neoplasia
5283044|NCT02257229|Clubfoot, deformity, correction, management, gait|clubfoot, deformity, correction, management, gait
5283045|NCT02257203|Dietary sucrose|dietary sucrose
5283046|NCT02257190|Glycemic control|glycemic control
5283047|NCT02257190|Exercise|exercise
5283048|NCT02257164|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5283049|NCT02257164|femoral nerve block|femoral nerve block
5283050|NCT02257164|articular injection and obturator nerve block|articular injection and obturator nerve block
5283051|NCT02257151|Volunteers|volunteers
5283052|NCT02257125|rehabilitation|rehabilitation
5283053|NCT02257125|virtual reality|virtual reality
5283054|NCT02257125|stroke|stroke
5283055|NCT02257125|upper extremity|upper extremity
5283057|NCT02257125|feedback|feedback
5283058|NCT02257125|reward|reward
5283059|NCT02257060|Endocardial Ablation|endocardial ablation
5283060|NCT02257060|Atrial Flutter|atrial flutter
5283061|NCT02257060|Cavotricuspid Isthmus|cavotricuspid isthmus
5283062|NCT02256995|Pregnancy|pregnancy
5283063|NCT02256995|Preeclampsia|preeclampsia
5283064|NCT02256995|Eclampsia|eclampsia
5283065|NCT02256995|Proteinuria|proteinuria
5283066|NCT02256982|unresectable intrahepatic cholangiocarcinoma|unresectable intrahepatic cholangiocarcinoma
5283067|NCT02256982|resectable intrahepatic cholangiocarcinoma|resectable intrahepatic cholangiocarcinoma
5283068|NCT02256956|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
5283069|NCT02256943|Pharmacogenetics of Amitriptyline|pharmacogenetics of amitriptyline
5283070|NCT02256904|Alignment|alignment
5283071|NCT02256904|Kinematic|kinematic
5283072|NCT02256904|knee|knee
5283073|NCT02256904|satisfaction|satisfaction
5283074|NCT02256904|function|function
5283075|NCT02256904|survivorship|survivorship
5283076|NCT02256891|Rotator cuff tear|rotator cuff tear
5283077|NCT02256891|Rotator cuff injury|rotator cuff injury
5283078|NCT02256891|Shoulder pain|shoulder pain
5283079|NCT02256891|Shoulder injury|shoulder injury
5283084|NCT02256839|Tuberculosis|tuberculosis
5283085|NCT02256839|TB|tb
5283086|NCT02256683|atrial fibrillation|atrial fibrillation
5283087|NCT02256683|atrial flutter|atrial flutter
5283088|NCT02256683|Atrial-Appendage Thrombus|atrial-appendage thrombus
5283089|NCT02256683|Thrombus resolution|thrombus resolution
5283090|NCT02256683|Dabigatran|dabigatran
5283091|NCT02256683|Phenprocoumon|phenprocoumon
5283092|NCT02256683|Transesophageal Echocardiography|transesophageal echocardiography
5283093|NCT02256670|Hormone Receptor Positive|hormone receptor positive
5283388|NCT02255071|GERD|gerd
5283094|NCT02256618|neonatal encephalopathy|neonatal encephalopathy
5283095|NCT02256618|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5283096|NCT02256618|newborn infants|newborn infants
5283097|NCT02256618|neonates|neonates
5283098|NCT02256618|umbilical cord blood cells|umbilical cord blood cells
5283099|NCT02256592|inflammation|inflammation
5283100|NCT02256592|microbiome|microbiome
5283101|NCT02256592|immune activation|immune activation
5283102|NCT02256592|fecal microbiota transplantation|fecal microbiota transplantation
5283103|NCT02256592|dysbiosis|dysbiosis
5283104|NCT02256579|TDF:Tenofovir, Urine beta2microglobulin|tdf:tenofovir, urine beta2microglobulin
5283105|NCT02256566|cognitive training|cognitive training
5283106|NCT02256566|depression|depression
5283107|NCT02256566|bipolar depression|bipolar depression
5283108|NCT02256566|anxiety|anxiety
5283109|NCT02256566|ptsd|ptsd
5283110|NCT02256566|generalized anxiety|generalized anxiety
5283111|NCT02256566|social phobia|social phobia
5283112|NCT02256514|therapeutic vaccine|therapeutic vaccine
5283113|NCT02256501|Dilated cardiomyopathy pediatric heart failure cell therapy|dilated cardiomyopathy pediatric heart failure cell therapy
5283114|NCT02256449|Coronary artery disease; angioplasty; bioresorbable device|coronary artery disease; angioplasty; bioresorbable device
5283115|NCT02256436|P-D1|p-d1
5283116|NCT02256436|PD-1|pd-1
5283117|NCT02256436|PD1|pd1
5283118|NCT02256436|P-DL1|p-dl1
5283119|NCT02256436|PD-L1|pd-l1
5283120|NCT02256436|PDL-1|pdl-1
5283121|NCT02256436|PDL1|pdl1
5283122|NCT02256436|Bladder cancer|bladder cancer
5283123|NCT02256423|Ibuprofen|ibuprofen
5283124|NCT02256423|healthy volunteer study|healthy volunteer study
5283125|NCT02256423|pharmacokinetics|pharmacokinetics
5283126|NCT02256410|low back pain|low back pain
5283127|NCT02256410|chronic pain|chronic pain
5283128|NCT02256410|sensitization|sensitization
5283129|NCT02256410|treatment|treatment
5283130|NCT02256410|trigger points|trigger points
5283131|NCT02256397|Asthma|asthma
5283132|NCT02256384|Respiration Rate|respiration rate
5283134|NCT02256384|postoperative|postoperative
5283135|NCT02256371|Neuropathic pain|neuropathic pain
5283136|NCT02256371|Hypnosis|hypnosis
5283137|NCT02256371|Relaxation|relaxation
5283138|NCT02256358|child, ketamine, midazolam|child, ketamine, midazolam
5283139|NCT02256319|Deep brain stimulation|deep brain stimulation
5283140|NCT02256319|Dexmedetomidine|dexmedetomidine
5283141|NCT02256319|Propofol|propofol
5283142|NCT02256293|Type 1 Diabetes|type 1 diabetes
5283143|NCT02256280|Neuromuscular blockade|neuromuscular blockade
5283144|NCT02256280|Thoracic surgery|thoracic surgery
5283145|NCT02256254|Oxidative stress|oxidative stress
5152524|NCT03038620|Obesity|obesity
5283146|NCT02256254|Simvastatin|simvastatin
5283147|NCT02256228|Analgesia|analgesia
5283148|NCT02256228|Local infiltration analgesia|local infiltration analgesia
5283149|NCT02256228|Pain, relief|pain, relief
5283150|NCT02256228|Pain, Postoperative|pain, postoperative
5283151|NCT02256228|Intra-peritoneal analgesia|intra-peritoneal analgesia
5283152|NCT02256228|Ropivacaine|ropivacaine
5283153|NCT02256228|Saline|saline
5283154|NCT02256228|Therapeutic Uses|therapeutic uses
5283155|NCT02256228|Analgesics, Non-Narcotic|analgesics, non-narcotic
5283156|NCT02256228|Analgesics|analgesics
5283157|NCT02256228|Opioids|opioids
5283158|NCT02256228|Morphine|morphine
5283159|NCT02256228|Pain|pain
5283160|NCT02256228|Postoperative Complications|postoperative complications
5283161|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs
5283162|NCT02256228|Anesthetics, Local|anesthetics, local
5283163|NCT02256228|Anesthetic|anesthetic
5283164|NCT02256228|Cytoreductive|cytoreductive
5283165|NCT02256228|Surgery|surgery
5283166|NCT02256228|Cancer|cancer
5283167|NCT02256215|Vitamin D|vitamin d
5283168|NCT02256163|Thoracic Aortic Aneurysm (TAA)|thoracic aortic aneurysm (taa)
5283169|NCT02256163|gene|gene
5283170|NCT02256163|familial TAA|familial taa
5283171|NCT02256163|blood collection|blood collection
5283172|NCT02256137|Frailty phenotype|frailty phenotype
5283173|NCT02256137|Physical fitness|physical fitness
5283174|NCT02256137|Childhood cancer|childhood cancer
5283175|NCT02256137|Late onset of chronic health conditions|late onset of chronic health conditions
5283176|NCT02256137|Physical frailty|physical frailty
5283177|NCT02256124|Neurofibromatosis type 1|neurofibromatosis type 1
5283178|NCT02256124|NF1|nf1
5283179|NCT02256124|Cognition|cognition
5283180|NCT02256124|Learning problems|learning problems
5283181|NCT02256124|Lamotrigine|lamotrigine
5283182|NCT02256124|Transcranial magnetic stimulation|transcranial magnetic stimulation
5283183|NCT02256124|TMS|tms
5283184|NCT02256098|Comparative Study|comparative study
5283185|NCT02256098|Knee Prosthesis|knee prosthesis
5283186|NCT02256098|Prosthesis Design|prosthesis design
5283187|NCT02256098|Treatment Outcome|treatment outcome
5283188|NCT02256098|Follow-Up Studies|follow-up studies
5283189|NCT02256098|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
5283190|NCT02256085|Dissociative|dissociative
5283191|NCT02256085|Dissociation|dissociation
5283192|NCT02256085|Depersonalization|depersonalization
5283193|NCT02256085|Depersonalization Disorder|depersonalization disorder
5283194|NCT02256085|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5283195|NCT02256085|TMS|tms
5283196|NCT02256085|DPD|dpd
5283197|NCT02256085|rTMS|rtms
5270738|NCT02326571|EEG|eeg
5283198|NCT02256085|Behavioral Symptoms|behavioral symptoms
5283199|NCT02256072|aging, geriatrics, aging in place, home services|aging, geriatrics, aging in place, home services
5283200|NCT02256033|Mild hepatic impairment|mild hepatic impairment
5283201|NCT02256033|Healthy volunteer|healthy volunteer
5283202|NCT02256033|Istradefylline|istradefylline
5283203|NCT02256020|Wheel-chair dependent, music aerobic exercise, depression, insomnia|wheel-chair dependent, music aerobic exercise, depression, insomnia
5283204|NCT02256007|Videogames; stroke|videogames; stroke
5283205|NCT02255981|macular, degeneration, acupuncture, visual acuity, OCT|macular, degeneration, acupuncture, visual acuity, oct
5283206|NCT02255968|Normal Volunteers|normal volunteers
5283207|NCT02255968|Safety|safety
5283208|NCT02255968|Pharmacokinetics|pharmacokinetics
5283209|NCT02255955|naproxen sodium codeine|naproxen sodium codeine
5283210|NCT02255955|paracetamol codeine|paracetamol codeine
5283211|NCT02255955|disk surgery|disk surgery
5283212|NCT02255929|Benign Essential Tremor|benign essential tremor
5283213|NCT02255929|Tremor|tremor
5283214|NCT02255929|Neurologic Manifestations|neurologic manifestations
5283215|NCT02255929|Nervous System Diseases|nervous system diseases
5283216|NCT02255929|Movement Disorders|movement disorders
5283217|NCT02255929|Central Nervous System Diseases|central nervous system diseases
5283218|NCT02255916|oncology|oncology
5283219|NCT02255916|psychology|psychology
5283220|NCT02255916|cancer|cancer
5283221|NCT02255916|music|music
5283222|NCT02255916|sound-bed|sound-bed
5283223|NCT02255877|Bi lateral knee surgery|bi lateral knee surgery
5283224|NCT02255877|uni compartmental|uni compartmental
5283225|NCT02255864|Stents|stents
5283226|NCT02255864|Angioplasty|angioplasty
5283227|NCT02255864|Coronary Vessels|coronary vessels
5283228|NCT02255864|Coronary Artery Disease|coronary artery disease
5283229|NCT02255864|Angina Pectoris|angina pectoris
5283230|NCT02255864|Myocardial Ischemia|myocardial ischemia
5283231|NCT02255864|Myocardial Infarction|myocardial infarction
5283232|NCT02255864|Myocardial Revascularization|myocardial revascularization
5283233|NCT02255851|selected for TAVR by heart team consensus|selected for tavr by heart team consensus
5283234|NCT02255851|treated with CE-Marked TAVR devices|treated with ce-marked tavr devices
5283235|NCT02255799|traumatic brain injury|traumatic brain injury
5283237|NCT02255799|brain injury|brain injury
5283239|NCT02255799|verbal memory deficits|verbal memory deficits
5962840|NCT04278183|weight loss surgery|weight loss surgery
5283240|NCT02255799|memory problems|memory problems
5283241|NCT02255799|cognition|cognition
5283242|NCT02255799|cognitive impairment|cognitive impairment
5283243|NCT02255799|neuropsychiatric symptoms|neuropsychiatric symptoms
5283244|NCT02255799|donepezil|donepezil
5283245|NCT02255799|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5283246|NCT02255786|Group Therapy|group therapy
5283247|NCT02255786|Parents|parents
5283248|NCT02255786|Autism|autism
5283249|NCT02255786|Quality of Life|quality of life
5283250|NCT02255773|Head and Neck Cancer|head and neck cancer
5283252|NCT02255773|Moderate to severe fatigue|moderate to severe fatigue
5283253|NCT02255773|Computerized tasks|computerized tasks
5283254|NCT02255773|Questionnaires|questionnaires
5283255|NCT02255773|Surveys|surveys
5283256|NCT02255773|Disease-free adult males|disease-free adult males
5283257|NCT02255773|Cancer survivors|cancer survivors
5283258|NCT02255760|MEDI3902|medi3902
5283259|NCT02255760|Safety,|safety,
5283260|NCT02255760|Pharmacokinetics,|pharmacokinetics,
5283261|NCT02255760|Healthy Volunteers|healthy volunteers
5283262|NCT02255747|infants and children with constipation|infants and children with constipation
5283263|NCT02255734|Volunteers|volunteers
5283264|NCT02255695|posture|posture
5283265|NCT02255695|child|child
5283266|NCT02255695|prevention|prevention
5283267|NCT02255695|muscle strength|muscle strength
5283268|NCT02255695|muscle stretching exercises|muscle stretching exercises
5283269|NCT02255695|exercise therapy|exercise therapy
5283270|NCT02255695|disease management|disease management
5283271|NCT02255695|musculoskeletal pain|musculoskeletal pain
5283272|NCT02255695|adolescent|adolescent
5283273|NCT02255695|spinal curvatures|spinal curvatures
5283274|NCT02255682|physical activity|physical activity
5283275|NCT02255682|statin therapy|statin therapy
5283276|NCT02255682|diabetes mellitus|diabetes mellitus
5283277|NCT02255682|cardiovascular disease|cardiovascular disease
5283278|NCT02255682|Q10-supplementation|q10-supplementation
5283279|NCT02255643|motor cortex stimulation|motor cortex stimulation
5283280|NCT02255643|chronic neuropathic pain|chronic neuropathic pain
5283281|NCT02255630|salbutamol|salbutamol
5283282|NCT02255630|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5283283|NCT02255630|anaerobic power|anaerobic power
5283284|NCT02255604|Allergic Rhinitis|allergic rhinitis
5283285|NCT02255604|Allergen immunotherapy|allergen immunotherapy
5283286|NCT02255591|Hip surgery anesthesia|hip surgery anesthesia
5283287|NCT02255591|Perioperative analgesia|perioperative analgesia
5283288|NCT02255565|Quillivant|quillivant
5283289|NCT02255552|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
5283290|NCT02255500|Total knee arthroplasty|total knee arthroplasty
5283291|NCT02255487|surgical device|surgical device
5283292|NCT02255487|surgical irrigation device|surgical irrigation device
5283293|NCT02255487|surgical site infection prophylaxis|surgical site infection prophylaxis
5283294|NCT02255474|pediatrics|pediatrics
5283295|NCT02255474|refractive error - myopia|refractive error - myopia
5283296|NCT02255474|contact lenses|contact lenses
5283297|NCT02255474|intervention|intervention
5283298|NCT02255435|RTA 408|rta 408
5283299|NCT02255435|RTA 408 Capsules|rta 408 capsules
5283300|NCT02255435|Oxidative Stress|oxidative stress
5283301|NCT02255435|Mitochondrial dysfunction|mitochondrial dysfunction
5283302|NCT02255435|omaveloxolone|omaveloxolone
5283303|NCT02255422|omaveloxolone|omaveloxolone
5283304|NCT02255422|RTA 408 capsules|rta 408 capsules
5283305|NCT02255422|mitochondrial myopathies|mitochondrial myopathies
5283306|NCT02255383|Osteoarthritis|osteoarthritis
5283307|NCT02255383|Rheumatoid Arthritis|rheumatoid arthritis
5283308|NCT02255383|Traumatic Arthritis|traumatic arthritis
5283309|NCT02255383|Polyarthritis|polyarthritis
5283310|NCT02255383|Total Knee Arthroplasty|total knee arthroplasty
5283311|NCT02255370|Curcumin. Crohn's disease. Post-operative recurrence. Thiopurines . Rutgeerts endoscopic score|curcumin. crohn's disease. post-operative recurrence. thiopurines . rutgeerts endoscopic score
5283312|NCT02255357|Oxytocin|oxytocin
5283313|NCT02255357|Vasopressin|vasopressin
5283314|NCT02255357|Cocaine|cocaine
5283315|NCT02255344|Acute Coronary Syndromes|acute coronary syndromes
5283316|NCT02255344|Risk Model|risk model
5283317|NCT02255344|National Registry|national registry
5283318|NCT02255344|Comprehensive Care Program|comprehensive care program
5283319|NCT02255344|Major Cardiovascular Events|major cardiovascular events
5283320|NCT02255331|Arthroplasty|arthroplasty
5283321|NCT02255331|Replacement|replacement
5283324|NCT02255318|Taurolock®|taurolock®
5283325|NCT02255318|infections related to chambers implantable catheter|infections related to chambers implantable catheter
5283326|NCT02255318|patients with cancer receiving parenteral nutrition|patients with cancer receiving parenteral nutrition
5283328|NCT02255305|C difficile|c difficile
5283329|NCT02255305|C diff|c diff
5283330|NCT02255305|Clostridium difficile|clostridium difficile
5283331|NCT02255253|Telmisartan|telmisartan
5283332|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide
5283333|NCT02255253|Efficacy|efficacy
5283339|NCT02255240|cancer survivor|cancer survivor
5283340|NCT02255240|physical activity|physical activity
5283341|NCT02255240|video game|video game
5283342|NCT02255240|women|women
5283343|NCT02255240|women's health|women's health
5164662|NCT02963064|BMT|bmt
5283344|NCT02255227|vaccination|vaccination
5283345|NCT02255227|randomized|randomized
5283346|NCT02255227|anti-pneumococcal|anti-pneumococcal
5283347|NCT02255227|Pneumo 23|pneumo 23
5283348|NCT02255227|Prevenar 13|prevenar 13
5283349|NCT02255227|Chronic Inflammatory Bowel Disease|chronic inflammatory bowel disease
5283350|NCT02255188|Haemostas, prosthesis|haemostas, prosthesis
5283351|NCT02255175|Reproductive Affective Disorder|reproductive affective disorder
5283352|NCT02255175|Depression|depression
5283353|NCT02255175|Perimenopause|perimenopause
5283354|NCT02255175|Estrogen|estrogen
5283355|NCT02255175|Estradiol treatment|estradiol treatment
5283356|NCT02255175|Mood Disorders|mood disorders
5283357|NCT02255175|Estrogen Replacement Therapy|estrogen replacement therapy
5283358|NCT02255175|Sex Steroids|sex steroids
5283359|NCT02255175|Depressive disorder|depressive disorder
5283360|NCT02255175|Mental Disorders|mental disorders
5283361|NCT02255175|Estradiol|estradiol
5283362|NCT02255175|Hormones|hormones
5283363|NCT02255175|Physiological effects of drugs|physiological effects of drugs
5283364|NCT02255175|Reproductive Control Agents|reproductive control agents
5283365|NCT02255162|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5283366|NCT02255162|Acute Myelocytic Leukemia|acute myelocytic leukemia
5283367|NCT02255162|Acute Myelogenous Leukemia|acute myelogenous leukemia
5283368|NCT02255162|Acute Granulocytic Leukemia|acute granulocytic leukemia
5283369|NCT02255162|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
5283370|NCT02255136|Interleukin|interleukin
5283371|NCT02255136|Immunoglobulin|immunoglobulin
5283372|NCT02255136|Homeopathy|homeopathy
5283373|NCT02255136|Allergic Rhinitis|allergic rhinitis
5283374|NCT02255136|Asthma|asthma
5283375|NCT02255110|Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma|locally advanced unresectable or metastatic soft tissue sarcoma
5283376|NCT02255110|TH-302|th-302
5283377|NCT02255110|Doxorubicin|doxorubicin
5283378|NCT02255110|Evofosfamide|evofosfamide
5283379|NCT02255097|PD-1|pd-1
5283380|NCT02255097|PD1|pd1
5283381|NCT02255097|PD-L1|pd-l1
5283382|NCT02255097|PDL1|pdl1
5283383|NCT02255084|Cervical cancer screening|cervical cancer screening
5283384|NCT02255084|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
5283385|NCT02255084|vaginal self-sampling|vaginal self-sampling
5283386|NCT02255084|pap smear|pap smear
5283387|NCT02255084|general practitioner|general practitioner
5283389|NCT02255071|Neiguan|neiguan
5283390|NCT02255071|Acupressure|acupressure
5283391|NCT02255071|P6|p6
5283392|NCT02255032|uveitis|uveitis
5283393|NCT02255032|macular edema|macular edema
5283395|NCT02255032|posterior uveitis|posterior uveitis
5283396|NCT02255032|anterior uveitis|anterior uveitis
5283397|NCT02255032|panuveitis|panuveitis
5283398|NCT02255032|intermediate uveitis|intermediate uveitis
5283399|NCT02255032|noninfectious uveitis|noninfectious uveitis
5283400|NCT02255032|triamcinolone acetonide|triamcinolone acetonide
5283401|NCT02255032|suprachoroidal space|suprachoroidal space
5283402|NCT02255032|injection|injection
5283403|NCT02255032|microneedle|microneedle
5283404|NCT02255032|intravitreal injection|intravitreal injection
5283405|NCT02255032|corticosteroid|corticosteroid
5283407|NCT02255032|choroid|choroid
5283408|NCT02255032|retina|retina
5283409|NCT02255032|microinjection|microinjection
5283410|NCT02255032|SCS|scs
5283411|NCT02255006|volunteer|volunteer
5283412|NCT02255006|BMI(25 kg/m2)|bmi(25 kg/m2)
5283413|NCT02254980|Total hip arthroplasty|total hip arthroplasty
5283414|NCT02254980|Cemented acetabular cup|cemented acetabular cup
5283415|NCT02254980|Vitamin-E|vitamin-e
5283416|NCT02254980|Radiostereometry|radiostereometry
5283417|NCT02254980|Fixation of cemented acetabular component in total hip arthroplasty|fixation of cemented acetabular component in total hip arthroplasty
5283418|NCT02254967|Aged|aged
5283419|NCT02254967|Fidaxomicin|fidaxomicin
5283420|NCT02254967|Clostridium Difficile|clostridium difficile
5283421|NCT02254967|Vancomycin|vancomycin
5283422|NCT02254954|glioblastoma|glioblastoma
5283423|NCT02254941|Metastatic Colon Cancer|metastatic colon cancer
5283424|NCT02254941|Monoclonal antibodies|monoclonal antibodies
5283425|NCT02254941|Chemotherapy|chemotherapy
5283426|NCT02254941|First line|first line
5283427|NCT02254928|poor ovarian response|poor ovarian response
5283428|NCT02254928|controlled ovarian stimulation|controlled ovarian stimulation
5283429|NCT02254928|randomised clinical trial|randomised clinical trial
5283430|NCT02254928|corifollitropin alfa|corifollitropin alfa
5283431|NCT02254928|recombinant follicle-stimulating hormone (rFSH)|recombinant follicle-stimulating hormone (rfsh)
5283432|NCT02254928|human menopausal gonadotropin (HMG)|human menopausal gonadotropin (hmg)
5283434|NCT02254915|RITE|rite
5283435|NCT02254915|SHTC|shtc
5283436|NCT02254915|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5283437|NCT02254915|NMIBC|nmibc
5283438|NCT02254915|Superficial Bladder Cancer|superficial bladder cancer
5283439|NCT02254915|Urothelial Cell Cancer|urothelial cell cancer
5178905|NCT02871973|parenting|parenting
5283440|NCT02254915|Transitional Cell Cancer|transitional cell cancer
5283441|NCT02254915|Mitomycin|mitomycin
5283442|NCT02254902|sedentary lifestyle|sedentary lifestyle
5962841|NCT04278183|bariatric surgery|bariatric surgery
5164854|NCT02961803|AMN|amn
5283443|NCT02254902|physical activity|physical activity
5283444|NCT02254902|Somali women|somali women
5283445|NCT02254902|prevention|prevention
5283446|NCT02254876|Stroke|stroke
5283447|NCT02254876|Hemiplegia|hemiplegia
5283448|NCT02254876|Painful shoulder Syndrome|painful shoulder syndrome
5283449|NCT02254876|NeuroMuscolar Taping|neuromuscolar taping
5283450|NCT02254863|Adrenoleukodystrophy|adrenoleukodystrophy
5283451|NCT02254863|Batten Disease|batten disease
5283452|NCT02254863|Hunter Syndrome|hunter syndrome
5283453|NCT02254863|Krabbe|krabbe
5283454|NCT02254863|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5283455|NCT02254863|ALD|ald
5283456|NCT02254863|MLD|mld
5283457|NCT02254863|PMD|pmd
5283458|NCT02254850|Mesoglycan|mesoglycan
5283459|NCT02254850|Metabolic Syndrome|metabolic syndrome
5283460|NCT02254850|Flow Mediated Dilation|flow mediated dilation
5283461|NCT02254824|Xuezhikang|xuezhikang
5283462|NCT02254824|atorvastatin|atorvastatin
5283463|NCT02254785|poor prognosis|poor prognosis
5283464|NCT02254785|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5283465|NCT02254785|cabazitaxel|cabazitaxel
5283466|NCT02254785|abiraterone|abiraterone
5283467|NCT02254785|enzalutamide|enzalutamide
5283468|NCT02254733|CBSST|cbsst
5283469|NCT02254733|Schizoaffective Disorder|schizoaffective disorder
5283470|NCT02254733|Psychotic Disorder|psychotic disorder
5283471|NCT02254733|Cognitive Behavioral Therapy|cognitive behavioral therapy
5283472|NCT02254733|Social Skills Training|social skills training
5283473|NCT02254733|Assertive Community Treatment|assertive community treatment
5283474|NCT02254694|sagittal balance|sagittal balance
5283475|NCT02254694|posture|posture
5283476|NCT02254694|lumbar lordosis|lumbar lordosis
5283477|NCT02254694|high heeled shoes|high heeled shoes
5283478|NCT02254681|low-dose radiotherapy|low-dose radiotherapy
5283479|NCT02254681|gemcitabine|gemcitabine
5283480|NCT02254681|cisplatin|cisplatin
5283481|NCT02254681|cholangiocarcinoma|cholangiocarcinoma
5283482|NCT02254668|intima|intima
5283483|NCT02254668|thickness|thickness
5283484|NCT02254668|transplantation|transplantation
5283485|NCT02254668|cardiology|cardiology
5283486|NCT02254668|immunosuppression|immunosuppression
5283487|NCT02254655|puerarin|puerarin
5283488|NCT02254655|rheumatoid arthritis|rheumatoid arthritis
5283489|NCT02254655|atherosclerosis|atherosclerosis
5283490|NCT02254655|carotid intima-media thickness|carotid intima-media thickness
5283781|NCT02252887|14-124|14-124
5283491|NCT02254629|Fecal microflora|fecal microflora
5283493|NCT02254629|Sequential treatment|sequential treatment
5283495|NCT02254629|Laxative|laxative
5283496|NCT02254616|Stroke Rehabilitation|stroke rehabilitation
5283497|NCT02254616|Hybrid therapy|hybrid therapy
5283498|NCT02254616|Mirror Therapy|mirror therapy
5283499|NCT02254616|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5283500|NCT02254603|Obesity, ayuveda yoga exercise, acupuncture.|obesity, ayuveda yoga exercise, acupuncture.
5283501|NCT02254590|IEDL|iedl
5283502|NCT02254590|irrigation endoscopic decompressive laminotomy|irrigation endoscopic decompressive laminotomy
5283503|NCT02254590|irrigation endoscopic decompression|irrigation endoscopic decompression
5283504|NCT02254590|minimally invasive spine surgery|minimally invasive spine surgery
5283505|NCT02254590|endoscopic decompression|endoscopic decompression
5283506|NCT02254590|spinal stenosis|spinal stenosis
5283507|NCT02254577|Infertility|infertility
5283508|NCT02254577|Progesterone|progesterone
5283509|NCT02254577|ART|art
5283510|NCT02254577|IVF|ivf
5283511|NCT02254577|FET|fet
5283512|NCT02254577|FBT|fbt
5283513|NCT02254577|Frozen Embryo Transfer|frozen embryo transfer
5283514|NCT02254551|relapsed multiple myeloma|relapsed multiple myeloma
5283515|NCT02254551|refractory multiple myeloma|refractory multiple myeloma
5283516|NCT02254551|LDE225|lde225
5283517|NCT02254551|Sonidegib|sonidegib
5283518|NCT02254551|bortezomib|bortezomib
5283519|NCT02254551|smoothened (SMO) inhibitors|smoothened (smo) inhibitors
5283520|NCT02254551|Velcade|velcade
5283521|NCT02254473|Knee|knee
5283522|NCT02254473|Osteoarthritis|osteoarthritis
5283523|NCT02254447|relative bio-availability|relative bio-availability
5283524|NCT02254447|fasting|fasting
5283525|NCT02254447|GW615775|gw615775
5283526|NCT02254447|Candesartan cilexetil|candesartan cilexetil
5283527|NCT02254447|ATACAND|atacand
5283528|NCT02254434|eltrombopag 50 mg|eltrombopag 50 mg
5283529|NCT02254434|healthy volunteers|healthy volunteers
5283530|NCT02254434|pharmacokinetic|pharmacokinetic
5283531|NCT02254434|single-dose|single-dose
5283532|NCT02254434|Open-label|open-label
5283533|NCT02254434|fasting|fasting
5283543|NCT02254356|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery|drug-eluting stent, paclitaxel-eluting stent, peripheral artery disease, peripheral vascular disease, superficial femoral artery, popliteal artery
5283545|NCT02254343|robot-assisted therapy|robot-assisted therapy
5283546|NCT02254330|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
5283547|NCT02254317|Impaired Glucose Tolerance|impaired glucose tolerance
5962842|NCT04278183|hysterectomy|hysterectomy
5962843|NCT04278183|obesity|obesity
5224490|NCT02595983|FAP|fap
5164971|NCT02960893|SCA|sca
5283548|NCT02254317|Oral Glucose Tolerance Test|oral glucose tolerance test
5283549|NCT02254317|Grape Seed Extract|grape seed extract
5283550|NCT02254304|Relapsing multiple sclerosis|relapsing multiple sclerosis
5283551|NCT02254304|Clinically isolated syndrome|clinically isolated syndrome
5283553|NCT02254304|CIS|cis
5283554|NCT02254304|RebiSmart™|rebismart™
5283555|NCT02254304|Rebif®|rebif®
5283556|NCT02254304|Interferon beta-1a|interferon beta-1a
5283557|NCT02254252|Slow coronary flow phenomenon|slow coronary flow phenomenon
5283558|NCT02254252|Angina pectoris|angina pectoris
5283559|NCT02254252|chest pain|chest pain
5283560|NCT02254252|nicroandil|nicroandil
5283561|NCT02254213|Intra-individual stability, EEG|intra-individual stability, eeg
5283562|NCT02254200|exercise|exercise
5283563|NCT02254200|fat oxidation|fat oxidation
5283564|NCT02254200|indirect calorimetry|indirect calorimetry
5283565|NCT02254200|insulin sensitivity|insulin sensitivity
5283566|NCT02254200|weight management|weight management
5283567|NCT02253810|Dysplasia, Congenital Hip|dysplasia, congenital hip
5283568|NCT02253810|Osteotomy|osteotomy
5283569|NCT02253810|Blood Transfusion|blood transfusion
5283570|NCT02253810|Tranexamic Acid|tranexamic acid
5283571|NCT02253758|Magnetic Resonance Imaging|magnetic resonance imaging
5283572|NCT02253758|Electroencephalography|electroencephalography
5283573|NCT02253758|Conscious Sedation|conscious sedation
5283574|NCT02253758|Deep Sedation|deep sedation
5283575|NCT02253758|Arousal|arousal
5283576|NCT02253758|Consciousness|consciousness
5283577|NCT02253745|ADHD|adhd
5283578|NCT02253745|Attention Deficit/ Hyperactivity Disorder|attention deficit/ hyperactivity disorder
5283579|NCT02253732|MicroRNAs|micrornas
5283580|NCT02253732|exercise|exercise
5283581|NCT02253732|skeletal muscle|skeletal muscle
5283582|NCT02253732|metabolism|metabolism
5283583|NCT02253719|cervical neoplasia|cervical neoplasia
5283584|NCT02253719|cervical cancer'|cervical cancer'
5283585|NCT02253719|visual inspection acetic acid|visual inspection acetic acid
5283586|NCT02253719|cryotherapy|cryotherapy
5283587|NCT02253706|bronchoscopy|bronchoscopy
5283588|NCT02253706|hypoxia|hypoxia
5283589|NCT02253706|oxygen supplementation|oxygen supplementation
5283590|NCT02253706|safety|safety
5283591|NCT02253693|Hemophilia A|hemophilia a
5283592|NCT02253693|Hemophilic arthropathy|hemophilic arthropathy
5283593|NCT02253693|Accelerometry|accelerometry
5283594|NCT02253680|Osteoarthritis|osteoarthritis
5283595|NCT02253680|Total knee replacement|total knee replacement
5283596|NCT02253680|Enhanced recovery|enhanced recovery
5283597|NCT02253680|Compression bandages|compression bandages
5283598|NCT02253667|Palliative care|palliative care
5283599|NCT02253667|Lung disease|lung disease
5283600|NCT02253667|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5283601|NCT02253667|High-flow oxygen nasal cannula|high-flow oxygen nasal cannula
5283602|NCT02253667|Dyspnoea|dyspnoea
5283603|NCT02253667|Opioids|opioids
5283604|NCT02253654|Chronic Kidney Disease|chronic kidney disease
5283605|NCT02253654|Anemia|anemia
5283606|NCT02253654|Hemodialysis|hemodialysis
5283607|NCT02253654|Red Blood Cell Transfusion|red blood cell transfusion
5283608|NCT02253641|African American, Women|african american, women
5283609|NCT02253641|Weight Loss|weight loss
5283610|NCT02253628|Coffee|coffee
5283611|NCT02253628|Gastrin|gastrin
5283612|NCT02253628|Alpha-amylase|alpha-amylase
5283613|NCT02253628|Cortisol|cortisol
5283614|NCT02253628|Self-reported gastrointestinal symptoms|self-reported gastrointestinal symptoms
5283615|NCT02253628|Self-reported stress|self-reported stress
5283616|NCT02253628|Blood pressure|blood pressure
5283617|NCT02253615|Aging|aging
5283618|NCT02253615|Resistance training|resistance training
5283619|NCT02253615|Muscle strength|muscle strength
5283620|NCT02253615|Functional performance|functional performance
5283621|NCT02253615|Postural balance|postural balance
5283622|NCT02253602|Esophageal Neoplasms|esophageal neoplasms
5283623|NCT02253602|Lymph Nodes|lymph nodes
5283624|NCT02253602|USPIO|uspio
5283625|NCT02253602|Magnetic Resonance Imaging|magnetic resonance imaging
5283626|NCT02253576|infant|infant
5283627|NCT02253576|bronchiolitis|bronchiolitis
5283628|NCT02253576|hypertonic saline|hypertonic saline
5283629|NCT02253537|Tuberculosis|tuberculosis
5283631|NCT02253524|Metoclopramide|metoclopramide
5283632|NCT02253524|Dimenhydrinate|dimenhydrinate
5283633|NCT02253524|emergency medicine|emergency medicine
5283634|NCT02253511|Hepatocellular carcinoma|hepatocellular carcinoma
5283635|NCT02253511|Hepotectomy|hepotectomy
5283636|NCT02253511|Recurrence-free survival|recurrence-free survival
5283637|NCT02253511|Overall survival|overall survival
5283638|NCT02253485|Mother-to-child transmission|mother-to-child transmission
5283639|NCT02253446|Dysmenorrhea|dysmenorrhea
5283640|NCT02253446|Piroxicam|piroxicam
5283641|NCT02253446|Diclofenac Sodium|diclofenac sodium
5283642|NCT02253446|Emergency department|emergency department
5962844|NCT04278170|sleeping disorders|sleeping disorders
5962845|NCT04278170|sleep quality|sleep quality
5283643|NCT02253433|asthma|asthma
5283644|NCT02253433|environmental triggers|environmental triggers
5283645|NCT02253433|home-based intervention|home-based intervention
5164981|NCT02960802|kidney transplant|kidney transplant
5164982|NCT02960802|renal blood flow|renal blood flow
5283646|NCT02253433|asthma home visits|asthma home visits
5283647|NCT02253420|Phase 1|phase 1
5283648|NCT02253420|Advanced solid tumor|advanced solid tumor
5283649|NCT02253420|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5283650|NCT02253420|PI3 Kinase inhibitor|pi3 kinase inhibitor
5283651|NCT02253420|Drug-drug Interaction|drug-drug interaction
5283652|NCT02253394|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5283653|NCT02253394|Ambrisentan|ambrisentan
5283654|NCT02253394|Spironolactone|spironolactone
5283655|NCT02253394|Selective Endothelin A (ETA) inhibition|selective endothelin a (eta) inhibition
5283656|NCT02253394|Aldosterone antagonism|aldosterone antagonism
5283657|NCT02253394|Cardiac output (CO)|cardiac output (co)
5283658|NCT02253394|Right ventricular (RV) function|right ventricular (rv) function
5283659|NCT02253394|Heart failure|heart failure
5283660|NCT02253394|Quality of life|quality of life
5283661|NCT02253394|Pro-inflammatory cytokine|pro-inflammatory cytokine
5283662|NCT02253394|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5283663|NCT02253394|Troponin-I|troponin-i
5283664|NCT02253394|N-terminal pro-brain natriuretic peptide (NT-BNP)|n-terminal pro-brain natriuretic peptide (nt-bnp)
5283665|NCT02253394|Collagen metabolism|collagen metabolism
5283666|NCT02253394|N-terminal procollagen type I|n-terminal procollagen type i
5283667|NCT02253394|Collagen III|collagen iii
5283668|NCT02253394|Echocardiography|echocardiography
5283669|NCT02253394|WHO Functional Class|who functional class
5283670|NCT02253394|Cardiopulmonary Exercise Test with Innocor|cardiopulmonary exercise test with innocor
5283671|NCT02253394|Peak oxygen consumption (pVO2)|peak oxygen consumption (pvo2)
5283672|NCT02253394|Liver function markers (AST/ALT)|liver function markers (ast/alt)
5283673|NCT02253394|Renal function markers (creatinine and potassium)|renal function markers (creatinine and potassium)
5283674|NCT02253381|lateral decubitus position|lateral decubitus position
5283675|NCT02253381|hypotension|hypotension
5283676|NCT02253381|cesarean section|cesarean section
5283677|NCT02253329|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5283679|NCT02253329|Protein ingestion|protein ingestion
5283680|NCT02253316|Multiple Myeloma|multiple myeloma
5283681|NCT02253316|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5283682|NCT02253316|Ixazomib|ixazomib
5283683|NCT02253316|Lenalidomide|lenalidomide
5283684|NCT02253316|Dexamethasone|dexamethasone
5283685|NCT02253277|CML, Ph+ ALL|cml, ph+ all
5283686|NCT02253251|Breast Cancer|breast cancer
5283687|NCT02253251|Cancer Risk|cancer risk
5283688|NCT02253251|Family Breast and Ovarian Cancer|family breast and ovarian cancer
5283689|NCT02253251|Genetic Cancer Risk|genetic cancer risk
5283690|NCT02253251|Cancer Treatment|cancer treatment
5283691|NCT02253251|Familial multiple primary cancer risk|familial multiple primary cancer risk
5283692|NCT02253251|Autoimmunity|autoimmunity
5283693|NCT02253251|Endometriosis|endometriosis
5283694|NCT02253238|Head and Neck Cancer|head and neck cancer
5283695|NCT02253238|Dehydration|dehydration
5283696|NCT02253238|Sensor-based home monitoring|sensor-based home monitoring
5283697|NCT02253238|Radiation therapy|radiation therapy
5283700|NCT02253238|Oropharyngeal cancer|oropharyngeal cancer
5283701|NCT02253238|Hypopharyngeal cancer|hypopharyngeal cancer
5283702|NCT02253238|Nasopharyngeal cancer|nasopharyngeal cancer
5283703|NCT02253238|Salivary gland cancer|salivary gland cancer
5283704|NCT02253238|Oral cavity cancer|oral cavity cancer
5283705|NCT02253238|Questionnaires|questionnaires
5283706|NCT02253238|Surveys|surveys
5283707|NCT02253238|Quality of life|quality of life
5283708|NCT02253238|QOL|qol
5283709|NCT02253238|Phone calls|phone calls
5283710|NCT02253238|Self-monitoring devices|self-monitoring devices
5283711|NCT02253238|CYberinfrastructure for COmparative effectiveness REsearch|cyberinfrastructure for comparative effectiveness research
5283712|NCT02253238|CYCORE|cycore
5283713|NCT02253238|Emergency room visits|emergency room visits
5283714|NCT02253238|ER|er
5283715|NCT02253238|Emergency room visits with hospitalization|emergency room visits with hospitalization
5283716|NCT02253238|ERHV|erhv
5283717|NCT02253225|Bipolar Disorder|bipolar disorder
5283718|NCT02253225|Major Depression|major depression
5283720|NCT02253225|Self Processing|self processing
5283721|NCT02253212|Blood brain barrier (BBB)|blood brain barrier (bbb)
5283722|NCT02253212|Disruption|disruption
5283723|NCT02253212|Low intensity pulsed ultrasound (LIPU)|low intensity pulsed ultrasound (lipu)
5283724|NCT02253212|Sonocloud device|sonocloud device
5283725|NCT02253212|Glioblastoma (GBM)|glioblastoma (gbm)
5283726|NCT02253212|Brain Cancer|brain cancer
5283727|NCT02253212|Carboplatin|carboplatin
5283728|NCT02253212|Therapeutic Ultrasound|therapeutic ultrasound
5283729|NCT02253173|VVA|vva
5283730|NCT02253173|Painful Sex|painful sex
5283731|NCT02253173|Postmenopausal|postmenopausal
5283732|NCT02253160|MNCs|mncs
5283733|NCT02253160|Mononuclear Cells|mononuclear cells
5283734|NCT02253160|Apheresis|apheresis
5283735|NCT02253160|Spectra Optia|spectra optia
5283736|NCT02253147|Nasolabial folds|nasolabial folds
5179205|NCT02870101|Pharynx|pharynx
5962846|NCT04278157|Suicidal Ideation|suicidal ideation
5962847|NCT04278157|Suicide Attempt|suicide attempt
5283737|NCT02253147|Dermal filler|dermal filler
5283738|NCT02253147|Hyaluronic acid (HA)|hyaluronic acid (ha)
5283739|NCT02253147|Wrinkles|wrinkles
5283740|NCT02253134|Syncopal events|syncopal events
5283741|NCT02253134|Palpitation events|palpitation events
5283742|NCT02253121|COPD|copd
5283743|NCT02253121|acute exacerbation|acute exacerbation
5283744|NCT02253121|glucocorticoid therapy|glucocorticoid therapy
5283745|NCT02253121|hyperglycemia|hyperglycemia
5283746|NCT02253108|DES|des
5283747|NCT02253108|Angina pectoris|angina pectoris
5283748|NCT02253108|Stent|stent
5283749|NCT02253108|Optical coherence tomography|optical coherence tomography
5283750|NCT02253108|Stent thrombosis|stent thrombosis
5283751|NCT02253056|Fasting|fasting
5283752|NCT02253056|Caloric Restriction|caloric restriction
5283753|NCT02253056|Focus is to observe effects of fasting in healthy volunteers.|focus is to observe effects of fasting in healthy volunteers.
5283754|NCT02253043|Alzheimer's Disease|alzheimer's disease
5283755|NCT02253030|AMD|amd
5283756|NCT02253030|OCT|oct
5283757|NCT02253030|Angiography|angiography
5283758|NCT02253030|Macular degeneration|macular degeneration
5283759|NCT02253017|Therapeutic strategies|therapeutic strategies
5283760|NCT02253017|Pediatrics|pediatrics
5283761|NCT02253017|Cataract|cataract
5283762|NCT02253017|Surgery|surgery
5283763|NCT02253017|Intra-ocular lens|intra-ocular lens
5283764|NCT02252991|Breast cancer|breast cancer
5283765|NCT02252991|Fatigue|fatigue
5283766|NCT02252991|Physical activity|physical activity
5283767|NCT02252965|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5283768|NCT02252965|Metformin XR|metformin xr
5283769|NCT02252965|Metformin IR|metformin ir
5283770|NCT02252952|Sugar Sweetened Beverages, Diet Beverages, ectopic fat, Functional MRI|sugar sweetened beverages, diet beverages, ectopic fat, functional mri
5283771|NCT02252926|Anesthetics, Local|anesthetics, local
5283772|NCT02252926|Bupivacaine|bupivacaine
5283773|NCT02252926|Lozenge|lozenge
5283774|NCT02252926|Administration, Topical|administration, topical
5283775|NCT02252900|Brain damages|brain damages
5283777|NCT02252900|infectious endocarditis|infectious endocarditis
5283778|NCT02252887|Gemcitabine,|gemcitabine,
5283779|NCT02252887|Trastuzumab|trastuzumab
5283780|NCT02252887|Pertuzumab|pertuzumab
5283782|NCT02252874|balance|balance
5283783|NCT02252874|visual function|visual function
5283784|NCT02252874|community-dwelling older adults|community-dwelling older adults
5283785|NCT02252874|action video-game|action video-game
5283786|NCT02252822|Eating Disorders|eating disorders
5283787|NCT02252822|Self Help|self help
5283788|NCT02252822|Anonymous CBT|anonymous cbt
5283789|NCT02252809|inflammation endotoxin anti-TNF corticosteroids|inflammation endotoxin anti-tnf corticosteroids
5283790|NCT02252796|Non-small Cell Lung Cancer|non-small cell lung cancer
5283791|NCT02252796|Radiotherapy Therapy|radiotherapy therapy
5283792|NCT02252783|Coronary Artery Disease|coronary artery disease
5283793|NCT02252783|Myocardial Ischemia|myocardial ischemia
5283794|NCT02252783|Coronary Disease|coronary disease
5283795|NCT02252783|Heart Diseases|heart diseases
5283796|NCT02252783|Cardiovascular Diseases|cardiovascular diseases
5283797|NCT02252783|Arteriosclerosis|arteriosclerosis
5283798|NCT02252783|Arterial Occlusive Diseases|arterial occlusive diseases
5283799|NCT02252783|Vascular Diseases|vascular diseases
5283800|NCT02252770|ASA|asa
5283801|NCT02252770|ASLD|asld
5283802|NCT02252770|UCD|ucd
5283803|NCT02252757|mHealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea|mhealth, hypertension, atherosclerotic disease, diabetes, obesity, metabolic syndrome, cardiotoxins, cardiomyopathy, dsypnea
5283804|NCT02252744|dry eye disease|dry eye disease
5283805|NCT02252744|rheumatoid arthritis|rheumatoid arthritis
5283806|NCT02252731|Phase I|phase i
5283807|NCT02252731|FG-4592|fg-4592
5283808|NCT02252731|Warfarin|warfarin
5283809|NCT02252731|Pharmacokinetics|pharmacokinetics
5283810|NCT02252731|Pharmacodynamics|pharmacodynamics
5283811|NCT02252705|Pulmonary arterial hypertension|pulmonary arterial hypertension
5283812|NCT02252705|Mortality|mortality
5283813|NCT02252705|Survival|survival
5283814|NCT02252692|Bioavailability|bioavailability
5283815|NCT02252692|pharmacokinetics|pharmacokinetics
5283816|NCT02252692|enalapril|enalapril
5283817|NCT02252692|enalaprilat|enalaprilat
5283818|NCT02252679|Bone Turnover Markers|bone turnover markers
5283822|NCT02252666|standing|standing
5283823|NCT02252666|control|control
5283824|NCT02252666|movement|movement
5283825|NCT02252653|Cardiomyopathy|cardiomyopathy
5283826|NCT02252653|Heart Failure|heart failure
5283828|NCT02252653|Amyloid|amyloid
5283829|NCT02252653|Transthyretin (TTR)|transthyretin (ttr)
5283830|NCT02252640|Plasmodium Falciparum|plasmodium falciparum
5283831|NCT02252640|Malaria|malaria
5283832|NCT02252640|Vaccine|vaccine
5283833|NCT02252640|Plasmodium|plasmodium
5283834|NCT02252640|Falciparum|falciparum
5283835|NCT02252614|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery|naproxen sodium+codein, paracetamol+codein,lumbar disc surgery
5283836|NCT02252601|Cystic Fibrosis|cystic fibrosis
5283837|NCT02252601|Hearing Loss|hearing loss
5179337|NCT02869035|5-HT4R|5-ht4r
5962848|NCT04278157|Latina, Latino, Latinx youth|latina, latino, latinx youth
5283838|NCT02252601|High Frequency Digit Triplet Test|high frequency digit triplet test
5283839|NCT02252588|COPD|copd
5283840|NCT02252588|Bacteria|bacteria
5283841|NCT02252562|Hand hygiene|hand hygiene
5283842|NCT02252562|Hospital acquired infections (HAI)|hospital acquired infections (hai)
5283843|NCT02252562|Healthcare acquired infections (HCAI)|healthcare acquired infections (hcai)
5283844|NCT02252536|alcohol use disorder|alcohol use disorder
5283845|NCT02252536|alcoholism|alcoholism
5283846|NCT02252536|alcohol dependence|alcohol dependence
5283847|NCT02252536|drinking alcohol|drinking alcohol
5283848|NCT02252523|Feasibility study|feasibility study
5283849|NCT02252497|hip arthroplasty|hip arthroplasty
5283850|NCT02252497|Tranexamic acid|tranexamic acid
5283851|NCT02252497|randomized control trial|randomized control trial
5283852|NCT02252484|prostate cancer|prostate cancer
5283853|NCT02252484|prostatectomy|prostatectomy
5283854|NCT02252484|weight loss|weight loss
5283855|NCT02252484|prevent weight gain|prevent weight gain
5283856|NCT02252471|alcohol-exposed pregnancy|alcohol-exposed pregnancy
5283857|NCT02252471|nicotine-exposed pregnancy|nicotine-exposed pregnancy
5283858|NCT02252471|tobacco-exposed pregnancy|tobacco-exposed pregnancy
5283859|NCT02252471|alcohol|alcohol
5283860|NCT02252471|contraception|contraception
5283861|NCT02252471|smoking|smoking
5283862|NCT02252471|pregnancy|pregnancy
5283863|NCT02252471|HIV|hiv
5283864|NCT02252471|prevention|prevention
5283865|NCT02252458|Opioid induced hyperalgesia|opioid induced hyperalgesia
5283866|NCT02252458|Fentanyl|fentanyl
5283867|NCT02252432|KETAMINE|ketamine
5283868|NCT02252432|METHADONE|methadone
5283869|NCT02252432|POSTOPERATIVE PAIN|postoperative pain
5283870|NCT02252432|OPIOID REQUIREMENTS|opioid requirements
5283871|NCT02252432|Length of hospital stay|length of hospital stay
5283872|NCT02252432|Perioperative outcomes|perioperative outcomes
5283873|NCT02252419|Postoperative Period|postoperative period
5283874|NCT02252419|Anesthesia, General|anesthesia, general
5283875|NCT02252419|Intubation, Intratracheal|intubation, intratracheal
5283876|NCT02252419|Dexamethasone|dexamethasone
5283877|NCT02252419|Acetaminophen|acetaminophen
5283878|NCT02252406|Stable Angina|stable angina
5283879|NCT02252406|Metabolic Syndrome|metabolic syndrome
5283880|NCT02252406|Women|women
5283881|NCT02252406|Biomarkers|biomarkers
5283882|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
5283883|NCT02252367|BPH/LUTS|bph/luts
5283884|NCT02252354|Drug therapy|drug therapy
5283885|NCT02252341|smoking|smoking
5283886|NCT02252341|inflammation|inflammation
5283887|NCT02252341|oxidative stress|oxidative stress
5283888|NCT02252341|NAC|nac
5283889|NCT02252341|treatment|treatment
5283890|NCT02252328|Uveitis|uveitis
5283891|NCT02252328|Simvastatin|simvastatin
5283892|NCT02252328|Visual acuity|visual acuity
5283893|NCT02252328|Corticosteroids|corticosteroids
5283894|NCT02252328|Immunosuppression|immunosuppression
5283895|NCT02252302|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5283896|NCT02252302|Air pollution|air pollution
5283897|NCT02252302|Exercise|exercise
5283898|NCT02252302|Inhaled beta-2-agonist|inhaled beta-2-agonist
5283899|NCT02252302|Cognitive Function|cognitive function
5283900|NCT02252289|Asthma|asthma
5283901|NCT02252289|children|children
5283902|NCT02252289|fluctuation analysis|fluctuation analysis
5283903|NCT02252289|exacerbations|exacerbations
5283904|NCT02252276|Manual therapy|manual therapy
5283905|NCT02252276|proprioception|proprioception
5283906|NCT02252276|exercises|exercises
5283907|NCT02252276|ankle sprain|ankle sprain
5283908|NCT02252250|rectal cancer|rectal cancer
5283909|NCT02252250|laparoscopic|laparoscopic
5283910|NCT02252250|NOTES|notes
5283911|NCT02252237|Prednisone|prednisone
5283912|NCT02252237|Prednisolone|prednisolone
5283913|NCT02252237|Methylprednisolone|methylprednisolone
5283914|NCT02252237|Glucocorticoids|glucocorticoids
5283915|NCT02252237|pharmacokinetics|pharmacokinetics
5283916|NCT02252211|EphA2 positive cancer|epha2 positive cancer
5283917|NCT02252211|DS-8895a monoclonal antibody|ds-8895a monoclonal antibody
5283918|NCT02252172|Multiple Myeloma|multiple myeloma
5283919|NCT02252172|Daratumumab|daratumumab
5283920|NCT02252172|JNJ-54767414|jnj-54767414
5283921|NCT02252172|Lenalidomide|lenalidomide
5283922|NCT02252172|Dexamethasone|dexamethasone
5283923|NCT02252159|Polycythemia|polycythemia
5283924|NCT02252159|Polycythemia Vera|polycythemia vera
5283925|NCT02252159|Hematologic Diseases|hematologic diseases
5283926|NCT02252159|Myeloproliferative Disorders|myeloproliferative disorders
5283927|NCT02252159|Bone Marrow Diseases|bone marrow diseases
5283928|NCT02252159|Hydroxyurea|hydroxyurea
5283929|NCT02252159|Antineoplastic Agents|antineoplastic agents
5283930|NCT02252159|Therapeutic Uses|therapeutic uses
5283931|NCT02252159|Pharmacologic Actions|pharmacologic actions
5283932|NCT02252159|Antisickling Agents|antisickling agents
5283933|NCT02252159|Hematologic Agents|hematologic agents
5283934|NCT02252159|Enzyme Inhibitors|enzyme inhibitors
5283935|NCT02252159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5165282|NCT02959047|MRI|mri
5283936|NCT02252159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
5283937|NCT02252146|DLBCL|dlbcl
5283938|NCT02252146|MYD88 L265P|myd88 l265p
5283939|NCT02252146|Lymphoma|lymphoma
5283940|NCT02252146|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5283941|NCT02252146|Idera|idera
5283942|NCT02252146|IMO 8400|imo 8400
5283943|NCT02252133|Contact lenses|contact lenses
5283944|NCT02252133|Myopia|myopia
5283945|NCT02252107|Decitabine|decitabine
5283946|NCT02252107|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5283947|NCT02252107|Conditioning|conditioning
5283948|NCT02252107|AML|aml
5283949|NCT02252081|metformin|metformin
5283950|NCT02252081|cardiovascular disease|cardiovascular disease
5283951|NCT02252081|Chronic Kidney Disease|chronic kidney disease
5283952|NCT02252081|Metabolic Syndrome|metabolic syndrome
5283953|NCT02252042|Squamous cell carcinoma|squamous cell carcinoma
5283954|NCT02252042|Head and neck carcinoma|head and neck carcinoma
5283955|NCT02252042|PD1|pd1
5283956|NCT02252042|PD-1|pd-1
5283957|NCT02252042|PDL1|pdl1
5283958|NCT02252042|PD-L1|pd-l1
5283959|NCT02252029|Rotavirus|rotavirus
5283960|NCT02252029|Vaccine|vaccine
5283961|NCT02252003|Children|children
5283962|NCT02252003|Pain|pain
5283963|NCT02252003|Pain scale evaluation|pain scale evaluation
5283964|NCT02251964|IMID|imid
5283965|NCT02251964|Interstitial Pneumonitis|interstitial pneumonitis
5283966|NCT02251964|rituximab|rituximab
5283967|NCT02251964|Immuno PET|immuno pet
5283968|NCT02251964|PET/CT|pet/ct
5283969|NCT02251951|Cancer|cancer
5283970|NCT02251951|Stomach|stomach
5283971|NCT02251951|Gastro-Esophageal Junction|gastro-esophageal junction
5283972|NCT02251951|Salvage treatment|salvage treatment
5283973|NCT02251951|Nab-paclitaxel|nab-paclitaxel
5283974|NCT02251925|infertility froze emberyo transfer hormone replacement|infertility froze emberyo transfer hormone replacement
5283975|NCT02251912|Alcohol dependence|alcohol dependence
5283976|NCT02251912|Alcohol|alcohol
5283977|NCT02251912|Oxytocin|oxytocin
5283978|NCT02251912|Intranasal administration|intranasal administration
5283979|NCT02251847|cholesterol|cholesterol
5283980|NCT02251834|Healthcare Disparities|healthcare disparities
5283981|NCT02251834|stroke|stroke
5283982|NCT02251834|Hispanic Americans|hispanic americans
5283983|NCT02251834|community health worker|community health worker
5283984|NCT02251834|Mobile Health|mobile health
5283985|NCT02251834|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
5283986|NCT02251834|hypertension|hypertension
5283987|NCT02251834|Randomized Controlled Trial|randomized controlled trial
5283988|NCT02251834|high cholesterol|high cholesterol
5283989|NCT02251834|behavioral|behavioral
5283990|NCT02251834|exercise|exercise
5283991|NCT02251834|diabetes|diabetes
5283993|NCT02251808|Parkinson's Disease, Deep brain stimulation|parkinson's disease, deep brain stimulation
5283994|NCT02251743|ADHD|adhd
5283995|NCT02251743|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5283996|NCT02251743|neurofeedback|neurofeedback
5283997|NCT02251743|EEG|eeg
5283998|NCT02251730|radiation therapy,Smoking pattern,head and neck cancer|radiation therapy,smoking pattern,head and neck cancer
5283999|NCT02251717|renal transplant|renal transplant
5284000|NCT02251704|Malaria|malaria
5284001|NCT02251704|MTI|mti
5284002|NCT02251704|Surveillance study|surveillance study
5284003|NCT02251704|Africa|africa
5284004|NCT02251704|RTS,S/AS01|rts,s/as01
5284005|NCT02251704|Epidemiology|epidemiology
5284006|NCT02251704|Plasmodium falciparum|plasmodium falciparum
5284007|NCT02251704|Malaria control interventions|malaria control interventions
5284008|NCT02251691|Compliance|compliance
5284009|NCT02251678|Plaque|plaque
5284010|NCT02251678|Psoriasis|psoriasis
5284011|NCT02251678|Biomarkers|biomarkers
5284012|NCT02251678|CRP|crp
5284013|NCT02251678|αTNF|αtnf
5284014|NCT02251678|Interleuken|interleuken
5284015|NCT02251665|Acute ischemic stroke|acute ischemic stroke
5284016|NCT02251665|Acute intracerebral hemorrhage|acute intracerebral hemorrhage
5284017|NCT02251665|Transient ischemic attack|transient ischemic attack
5284018|NCT02251652|Actinic|actinic
5284019|NCT02251639|Oral cancer|oral cancer
5284020|NCT02251639|Pre-cancer|pre-cancer
5284021|NCT02251639|Widefield Fluorescence Imaging|widefield fluorescence imaging
5284023|NCT02251639|Point Spectroscopy System|point spectroscopy system
5284024|NCT02251639|Oral brush biopsy|oral brush biopsy
5284025|NCT02251639|Questionnaire|questionnaire
5284026|NCT02251639|Survey|survey
5284027|NCT02251639|Diagnostic aid|diagnostic aid
5284028|NCT02251639|Screening|screening
5284029|NCT02251626|MGH|mgh
5284030|NCT02251626|Burn patient|burn patient
5284031|NCT02251626|Adult|adult
5284032|NCT02251626|CoQ10|coq10
5284033|NCT02251626|Ubiquinol|ubiquinol
5284034|NCT02251600|Pediatric|pediatric
5284035|NCT02251600|Adolescent|adolescent
5284036|NCT02251600|Deflazacort|deflazacort
5284037|NCT02251561|contact lenses|contact lenses
5284038|NCT02251561|contact lens solution|contact lens solution
5284039|NCT02251561|corneal staining|corneal staining
5165373|NCT02958397|CD33|cd33
5284040|NCT02251561|fluorescein|fluorescein
5284041|NCT02251548|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5284042|NCT02251548|Leukemia|leukemia
5284043|NCT02251535|kinematic analysis|kinematic analysis
5284044|NCT02251535|femoral rollback|femoral rollback
5284045|NCT02251535|mobile bearing|mobile bearing
5284046|NCT02251535|cruciate retaining Primary Total Knee Arthroplasty|cruciate retaining primary total knee arthroplasty
5284047|NCT02251496|Malnutrition|malnutrition
5284048|NCT02251496|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5284049|NCT02251496|Nutrition Therapy|nutrition therapy
5284050|NCT02251496|Oral Nutrition Supplement|oral nutrition supplement
5284051|NCT02251496|Food|food
5284052|NCT02251483|DIBS|dibs
5284053|NCT02251483|SIBO|sibo
5284054|NCT02251470|stroke|stroke
5284055|NCT02251470|balance|balance
5284056|NCT02251470|exer-gaming|exer-gaming
5284057|NCT02251470|home-based exercises|home-based exercises
5284058|NCT02251470|Wii|wii
5284059|NCT02251470|postural balance|postural balance
5284060|NCT02251470|Nintendo|nintendo
5284061|NCT02251470|balance board|balance board
5284062|NCT02251470|Wii-Fit|wii-fit
5284063|NCT02251470|home|home
5284064|NCT02251470|feasibility|feasibility
5284065|NCT02251457|Myotonia Congenita|myotonia congenita
5284066|NCT02251457|ranolazine|ranolazine
5284067|NCT02251457|Ohio State|ohio state
5284068|NCT02251457|Open Label|open label
5284069|NCT02251457|Paramyotonia Congenita|paramyotonia congenita
5284070|NCT02251457|Myotonic Dystrophy 1|myotonic dystrophy 1
5284071|NCT02251431|diabetes mellitus|diabetes mellitus
5284072|NCT02251431|chronic kidney disease|chronic kidney disease
5284073|NCT02251431|diastolic function|diastolic function
5284074|NCT02251431|cardiac fibrosis|cardiac fibrosis
5284075|NCT02251431|cardiac strain|cardiac strain
5284076|NCT02251431|cardiac biomarker|cardiac biomarker
5284077|NCT02251431|renal biomarker|renal biomarker
5284078|NCT02251418|Foot ulcer, diabetic|foot ulcer, diabetic
5284079|NCT02251418|ESWT (Extracorporeal Shockwave Therapy)|eswt (extracorporeal shockwave therapy)
5284080|NCT02251418|Endocrinology|endocrinology
5284081|NCT02251418|Dermatology|dermatology
5284082|NCT02251418|Wound healing|wound healing
5284083|NCT02251418|Ischemia|ischemia
5271606|NCT02322164|Skin|skin
5284084|NCT02251418|Neovascularization, Physiologic|neovascularization, physiologic
5284085|NCT02251418|Pain management|pain management
5284086|NCT02251405|Melamine|melamine
5284088|NCT02251392|chamomilla|chamomilla
5284089|NCT02251392|matricaria|matricaria
5284090|NCT02251392|chamomile|chamomile
5284091|NCT02251392|chamomila|chamomila
5284092|NCT02251392|recutita|recutita
5284093|NCT02251392|Breast Neoplasms|breast neoplasms
5284094|NCT02251392|head and neck neoplasms|head and neck neoplasms
5284095|NCT02251392|radiotherapy|radiotherapy
5284096|NCT02251366|Age-Related Macular Degeneration|age-related macular degeneration
5284098|NCT02251314|BRAF mutant melanoma|braf mutant melanoma
5284099|NCT02251314|circulation tumour DNA|circulation tumour dna
5284100|NCT02251314|tumour heterogeneity|tumour heterogeneity
5284101|NCT02251314|liquid biopsy|liquid biopsy
5284102|NCT02251288|H7N9 pandemic|h7n9 pandemic
5284103|NCT02251288|inactivated influenza vaccine (pIIV)|inactivated influenza vaccine (piiv)
5284104|NCT02251288|live attenuated influenza vaccine (pLAIV)|live attenuated influenza vaccine (plaiv)
5284105|NCT02251288|MF59 adjuvant|mf59 adjuvant
5284107|NCT02251262|Pacemaker|pacemaker
5284108|NCT02251262|Endocarditis|endocarditis
5284109|NCT02251262|18FDG-PET-CT|18fdg-pet-ct
5284110|NCT02251262|Diagnostic accuracy|diagnostic accuracy
5284111|NCT02251262|Pacing or defibrillation lead|pacing or defibrillation lead
5284112|NCT02251236|Stribild|stribild
5284113|NCT02251236|Genvoya|genvoya
5284114|NCT02251236|elvitegravir|elvitegravir
5284115|NCT02251236|Cerebrospinal Fluid|cerebrospinal fluid
5284116|NCT02251236|HIV|hiv
5284117|NCT02251093|mycosis|mycosis
5284118|NCT02251093|vulvovaginal candidiasis|vulvovaginal candidiasis
5284119|NCT02251093|lcr35|lcr35
5284120|NCT02251093|Lcr Regenerans®|lcr regenerans®
5284121|NCT02251080|adherence|adherence
5284122|NCT02251080|internet-based|internet-based
5284131|NCT02251015|Postural balance|postural balance
5284132|NCT02251015|Temporomandibular disorders|temporomandibular disorders
5284133|NCT02251015|splints|splints
5284134|NCT02250989|Endothelial disfunction|endothelial disfunction
5284135|NCT02250989|Intercellular Adhesion Molecule-1|intercellular adhesion molecule-1
5284136|NCT02250989|Vascular Cell Adhesion Molecule-1|vascular cell adhesion molecule-1
5284137|NCT02250989|8-epi-prostaglandin F2alpha|8-epi-prostaglandin f2alpha
5284138|NCT02250989|Nitric Oxide|nitric oxide
5284139|NCT02250989|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1
5284140|NCT02250989|Endothelin-1|endothelin-1
5284141|NCT02250989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5284142|NCT02250989|Glucose|glucose
5284143|NCT02250989|Insulin|insulin
5284144|NCT02250989|C-peptide|c-peptide
5284145|NCT02250989|C-reactive protein|c-reactive protein
5284146|NCT02250989|3-nitrotyrosine|3-nitrotyrosine
5962849|NCT04278105|Stroke, Transcranial electrical stimulation, Upper-limb rehabilitation|stroke, transcranial electrical stimulation, upper-limb rehabilitation
5225275|NCT02591654|FLT|flt
5165477|NCT02957786|cytisine|cytisine
5165478|NCT02957786|varenicline|varenicline
5165479|NCT02957786|smoking cessation|smoking cessation
5165480|NCT02957786|indigenous|indigenous
5284147|NCT02250963|Dobutamine Stress Echocardiography|dobutamine stress echocardiography
5284148|NCT02250963|Computed tomography coronary angiography|computed tomography coronary angiography
5284149|NCT02250950|self-determination theory|self-determination theory
5284150|NCT02250950|motivational interviewing|motivational interviewing
5284151|NCT02250950|exercise|exercise
5284152|NCT02250950|physical activity|physical activity
5284153|NCT02250911|Caregivers of patients|caregivers of patients
5284154|NCT02250911|CCC = Care for the Cancer Caregivers|ccc = care for the cancer caregivers
5284155|NCT02250911|MCP-C = Meaning-Centered Psychotherapy for Cancer Caregivers|mcp-c = meaning-centered psychotherapy for cancer caregivers
5284156|NCT02250911|14-208|14-208
5284157|NCT02250898|Post Breast Surgery|post breast surgery
5284158|NCT02250898|Myofascial Massage|myofascial massage
5284159|NCT02250898|Pain|pain
5284160|NCT02250898|Mobility Limitations|mobility limitations
5284161|NCT02250885|Selinexor|selinexor
5284162|NCT02250885|phase 2|phase 2
5284163|NCT02250885|Gabrail|gabrail
5284164|NCT02250872|Cisplatin|cisplatin
5284165|NCT02250872|Nephrotoxicity|nephrotoxicity
5284166|NCT02250872|Gemigliptin|gemigliptin
5284167|NCT02250872|DPP4 inhibitor|dpp4 inhibitor
5284168|NCT02250846|EGFR mutations|egfr mutations
5284169|NCT02250846|asymptomatic brain metastases|asymptomatic brain metastases
5284170|NCT02250846|EGFR-TKI|egfr-tki
5284171|NCT02250846|Erlotinib|erlotinib
5284172|NCT02250833|Hypertension|hypertension
5284173|NCT02250833|CKD-828|ckd-828
5284174|NCT02250833|Telmisartan|telmisartan
5284175|NCT02250833|S-amlodipine|s-amlodipine
5284176|NCT02250833|Pharmacokinetic|pharmacokinetic
5284177|NCT02250820|Pediatric|pediatric
5284178|NCT02250820|Sedation|sedation
5284179|NCT02250820|Transthoracic echocardiography|transthoracic echocardiography
5284180|NCT02250820|TTE|tte
5284181|NCT02250820|Dexmedetomidine|dexmedetomidine
5284182|NCT02250820|Pentobarbital|pentobarbital
5284183|NCT02250807|Chronic hepatitis C|chronic hepatitis c
5284860|NCT02247440|Thailand|thailand
5284184|NCT02250807|Genotype 4 chronic hepatitis C|genotype 4 chronic hepatitis c
5284185|NCT02250807|Simeprevir|simeprevir
5284186|NCT02250807|Sofosbuvir|sofosbuvir
5284187|NCT02250794|diabetes mellitus|diabetes mellitus
5284188|NCT02250794|inpatient management|inpatient management
5284189|NCT02250794|metformin|metformin
5284190|NCT02250794|sitagliptin|sitagliptin
5284191|NCT02250768|GM-CSF, repeated implantation failure|gm-csf, repeated implantation failure
5284192|NCT02250755|MRI perfusion|mri perfusion
5284193|NCT02250755|therapeutic response|therapeutic response
5284194|NCT02250755|chemotherapy|chemotherapy
5284195|NCT02250755|brain metastases|brain metastases
5284196|NCT02250742|ultrasound imaging|ultrasound imaging
5284197|NCT02250742|acupuncture|acupuncture
5284198|NCT02250742|back muscles|back muscles
5284199|NCT02250742|spine|spine
5284200|NCT02250742|muscle strength|muscle strength
5284201|NCT02250729|anaphylaxis|anaphylaxis
5284202|NCT02250729|pholcodine|pholcodine
5284203|NCT02250729|neuromuscular blocking agents|neuromuscular blocking agents
5284204|NCT02250716|CIN1|cin1
5284205|NCT02250716|HIV seropositive women|hiv seropositive women
5284206|NCT02250716|Cryotherapy|cryotherapy
5284207|NCT02250703|Premedication|premedication
5284208|NCT02250690|idiopathic PD|idiopathic pd
5284209|NCT02250690|Hoehn and Yahr stage I to III|hoehn and yahr stage i to iii
5284210|NCT02250690|stable medication usage|stable medication usage
5284211|NCT02250690|age 40 to 80 years|age 40 to 80 years
5284212|NCT02250690|absence of cognitive impairment|absence of cognitive impairment
5284213|NCT02250677|physical activity|physical activity
5284214|NCT02250677|Statin therapy|statin therapy
5284215|NCT02250677|cardiovascular disease|cardiovascular disease
5284216|NCT02250677|diabetes mellitus|diabetes mellitus
5284217|NCT02250664|Biomarkers of exposure|biomarkers of exposure
5288957|NCT02228759|Home regional|home regional
5284218|NCT02250664|Compensatory smoking|compensatory smoking
5284219|NCT02250664|Nicotine dependence|nicotine dependence
5284220|NCT02250664|Reduced nicotine cigarettes|reduced nicotine cigarettes
5284221|NCT02250664|Tobacco withdrawal|tobacco withdrawal
5284222|NCT02250664|Women|women
5284223|NCT02250664|Health disparities|health disparities
5284224|NCT02250664|Vulnerable populations|vulnerable populations
5284225|NCT02250612|SYL040012|syl040012
5284226|NCT02250612|bamosiran|bamosiran
5284227|NCT02250612|siRNA|sirna
5284228|NCT02250612|RNAi|rnai
5284229|NCT02250612|Glaucoma|glaucoma
5284230|NCT02250612|Ocular hypertension|ocular hypertension
5962850|NCT04278066|Hyperoxia|hyperoxia
5962851|NCT04278066|Cardiac surgery|cardiac surgery
5962852|NCT04278066|pulmonary complications|pulmonary complications
5962853|NCT04278066|Lung collapse|lung collapse
5962854|NCT04278066|Post-operative|post-operative
5284231|NCT02250599|Metastatic Nasopharyngeal Carcinoma|metastatic nasopharyngeal carcinoma
5284232|NCT02250599|treatment|treatment
5284233|NCT02250586|concerned significant other|concerned significant other
5962855|NCT04278053|flow-mediated dilation|flow-mediated dilation
5962856|NCT04278053|vasodilation|vasodilation
5284234|NCT02250586|internet-delivered cognitive-behavioral therapy,|internet-delivered cognitive-behavioral therapy,
5284235|NCT02250586|treatment-refusing problem gambler|treatment-refusing problem gambler
5284236|NCT02250534|Biomarkers of exposure|biomarkers of exposure
5284237|NCT02250534|Compensatory smoking|compensatory smoking
5284238|NCT02250534|Nicotine dependence|nicotine dependence
5284239|NCT02250534|Reduced nicotine cigarettes|reduced nicotine cigarettes
5284240|NCT02250534|Tobacco withdrawal|tobacco withdrawal
5284242|NCT02250534|Health disparities|health disparities
5284243|NCT02250534|Vulnerable populations|vulnerable populations
5284244|NCT02250521|BMI < 50 kg/m2|bmi < 50 kg/m2
5284245|NCT02250521|Mallampatti class: III-IV|mallampatti class: iii-iv
5284246|NCT02250521|Reduced mouth opening < 4 cm|reduced mouth opening < 4 cm
5674499|NCT00603343|urinary incontinence|urinary incontinence
5284247|NCT02250521|Neck circumference > 40 cm for females and > 43 cm for males|neck circumference > 40 cm for females and > 43 cm for males
5284248|NCT02250521|Thyromental distance < 6 cm|thyromental distance < 6 cm
5284249|NCT02250521|Ratio of the patient's height to thyromental distance ≥ 23.5|ratio of the patient's height to thyromental distance ≥ 23.5
5284250|NCT02250521|Sternomental distance < 12 cm|sternomental distance < 12 cm
5284251|NCT02250443|Inclusion Body Myositis (IBM)|inclusion body myositis (ibm)
5284252|NCT02250430|acne|acne
5284253|NCT02250365|stroke, acute|stroke, acute
5284254|NCT02250365|upper extremity|upper extremity
5284255|NCT02250365|rehabilitation|rehabilitation
5284256|NCT02250365|electric stimulation therapy|electric stimulation therapy
5284257|NCT02250339|Child Mental Health|child mental health
5284258|NCT02250339|Parenting|parenting
5284259|NCT02250339|Family Issues|family issues
5284260|NCT02250326|Cancer of the lung|cancer of the lung
5284261|NCT02250326|lung neoplasm|lung neoplasm
5284262|NCT02250326|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
5284263|NCT02250326|Nonsquamou|nonsquamou
5284264|NCT02250326|squamous|squamous
5284265|NCT02250326|squamous NSCLC|squamous nsclc
5284266|NCT02250326|Tumor|tumor
5284267|NCT02250326|locally advanced NSCLC|locally advanced nsclc
5284268|NCT02250326|metastatic NSCLC|metastatic nsclc
5284269|NCT02250326|advanced lung cancer|advanced lung cancer
5284270|NCT02250326|metastatic lung cancer|metastatic lung cancer
5284271|NCT02250326|non-squamous NSCLC|non-squamous nsclc
5284272|NCT02250326|lung cancer|lung cancer
5284273|NCT02250326|Abraxane|abraxane
5284274|NCT02250326|ABI-007|abi-007
5284275|NCT02250326|nab-paclitaxel|nab-paclitaxel
5284276|NCT02250326|albumin-bound paclitaxel|albumin-bound paclitaxel
5284277|NCT02250326|taxanes|taxanes
5284278|NCT02250326|CC-486|cc-486
5285350|NCT02245360|GRAZAX|grazax
5284279|NCT02250326|oral azacitidine|oral azacitidine
5284280|NCT02250326|azacitidine|azacitidine
5284281|NCT02250326|second line treatment of lung cancer|second line treatment of lung cancer
5284282|NCT02250326|second line treatment|second line treatment
5284283|NCT02250326|Celgene|celgene
5284284|NCT02250326|abound.2L|abound.2l
5284285|NCT02250326|third line treatment|third line treatment
5284286|NCT02250326|durvalumab|durvalumab
5284287|NCT02250326|immunotherapy|immunotherapy
5284288|NCT02250326|MEDI4736|medi4736
5284289|NCT02250313|prostate cancer|prostate cancer
5284290|NCT02250287|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5284291|NCT02250287|magnetic resonance imaging parameters|magnetic resonance imaging parameters
5284292|NCT02250287|magnetic resonance elastography|magnetic resonance elastography
5284293|NCT02250287|apparent diffusion coefficient|apparent diffusion coefficient
5284294|NCT02250287|blood oxygen level determinations|blood oxygen level determinations
5284295|NCT02250287|diffusion weighted imaging|diffusion weighted imaging
5284296|NCT02250274|Immune response to influenza vaccine|immune response to influenza vaccine
5284297|NCT02250274|PCR confirmed Influenza A virus|pcr confirmed influenza a virus
5284298|NCT02250274|PCR confirmed Influenza B virus|pcr confirmed influenza b virus
5284299|NCT02250261|walking|walking
5284300|NCT02250261|cycling|cycling
5284301|NCT02250261|intervention|intervention
5284302|NCT02250261|physical activity|physical activity
5284303|NCT02250261|environment|environment
5284304|NCT02250261|promotion|promotion
5284305|NCT02250248|Degenerative disc disease|degenerative disc disease
5284306|NCT02250248|Lumbar spine|lumbar spine
5284307|NCT02250209|Gastric Cancer|gastric cancer
5284308|NCT02250209|HER2-positive|her2-positive
5284319|NCT02250144|Patellofemoral pain syndrome|patellofemoral pain syndrome
5284321|NCT02250144|KOOS|koos
5284322|NCT02250131|cardiopulmonary bypass|cardiopulmonary bypass
5284323|NCT02250118|pleural|pleural
5284324|NCT02250118|effusion|effusion
5284325|NCT02250118|breast|breast
5284326|NCT02250118|cancer|cancer
5284327|NCT02250092|Cerebral Palsy|cerebral palsy
5284328|NCT02250092|Hemiparesis|hemiparesis
5284329|NCT02250092|Stroke|stroke
5284330|NCT02250092|Non-Invasive Brain Stimulation|non-invasive brain stimulation
5284331|NCT02250092|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5284332|NCT02250092|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5284333|NCT02250092|Diffusion Tensor Imaging|diffusion tensor imaging
5225499|NCT02590315|BC|bc
5165666|NCT02956993|stenosis|stenosis
5165667|NCT02956993|distal popliteal artery|distal popliteal artery
5165668|NCT02956993|peroneal artery|peroneal artery
5165669|NCT02956993|below the knee|below the knee
5165670|NCT02956993|BTK|btk
5165671|NCT02956993|elastase|elastase
5776827|NCT00212940|HIV|hiv
5284334|NCT02250092|Congenital Hemiparesis|congenital hemiparesis
5284335|NCT02250092|Bimanual Therapy|bimanual therapy
5342999|NCT01981213|Early Predictors of Hepatic Injury|early predictors of hepatic injury
5343000|NCT01981213|Childhood Suicidal Behaviour|childhood suicidal behaviour
5284336|NCT02250053|stage II and stage III colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer|stage ii and stage iii colon cancer survivors, who have completed curative treatment i.e., surgical resection and chemotherapy for their colon cancer
5284338|NCT02250040|Rehabilitation|rehabilitation
5284339|NCT02250040|Physiotherapy|physiotherapy
5284340|NCT02250040|Functional Recovery|functional recovery
5284341|NCT02250027|acute bronchitis|acute bronchitis
5284342|NCT02250027|acute exacerbations of chronic bronchitis|acute exacerbations of chronic bronchitis
5284343|NCT02250001|HCV|hcv
5284344|NCT02249962|prospective|prospective
5284345|NCT02249962|cohort|cohort
5284346|NCT02249936|Volunteers|volunteers
5284347|NCT02249923|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5284348|NCT02249923|Pulmonary Vascular Disease (PVD)|pulmonary vascular disease (pvd)
5284349|NCT02249923|Registry|registry
5284350|NCT02249923|Pediatric|pediatric
5284351|NCT02249884|radiodermatitis|radiodermatitis
5284352|NCT02249884|head and neck neoplasms|head and neck neoplasms
5284353|NCT02249884|Breast Neoplasms|breast neoplasms
5284354|NCT02249884|Urea|urea
5284355|NCT02249884|Matricaria|matricaria
5284356|NCT02249884|chamomilla|chamomilla
5284357|NCT02249884|chamomile|chamomile
5284358|NCT02249858|cervical spine|cervical spine
5284359|NCT02249858|OMT|omt
5284360|NCT02249858|HVLA|hvla
5284361|NCT02249858|ultrasound|ultrasound
5284362|NCT02249845|dehydration|dehydration
5284363|NCT02249845|children|children
5284364|NCT02249845|gastroenteritis|gastroenteritis
5284365|NCT02249832|stroke|stroke
5284366|NCT02249832|CVA|cva
5284367|NCT02249832|cerebrovascular accident|cerebrovascular accident
5284368|NCT02249832|cerebral stroke|cerebral stroke
5284369|NCT02249832|robotic therapy|robotic therapy
5284370|NCT02249832|anklebot|anklebot
5284371|NCT02249832|physical therapy|physical therapy
5284372|NCT02249819|stroke|stroke
5284373|NCT02249819|aphasia|aphasia
5284374|NCT02249819|CVA|cva
5284375|NCT02249819|apraxia|apraxia
5285351|NCT02245347|TB|tb
5284376|NCT02249819|cerebrovascular accident|cerebrovascular accident
5284377|NCT02249819|cerebral stroke|cerebral stroke
5284378|NCT02249819|speech therapy|speech therapy
5284379|NCT02249819|aphasia therapy|aphasia therapy
5284380|NCT02249819|non-invasive brain stimulation|non-invasive brain stimulation
5284381|NCT02249819|transcranial direct current stimulation|transcranial direct current stimulation
5284382|NCT02249819|tDCS|tdcs
5284383|NCT02249806|Pulmonary Hypertension|pulmonary hypertension
5284384|NCT02249806|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5284385|NCT02249806|Pulmonary arterial hypertension|pulmonary arterial hypertension
5284386|NCT02249806|Outcome|outcome
5284387|NCT02249793|circadian|circadian
5284388|NCT02249793|oscillation|oscillation
5284389|NCT02249793|clock|clock
5284390|NCT02249793|human|human
5284391|NCT02249793|social behavior|social behavior
5284392|NCT02249793|cell phone with internet access (so-called smartphone)|cell phone with internet access (so-called smartphone)
5281478|NCT02266758|Obesity|obesity
5284394|NCT02249793|behavioral feature|behavioral feature
5284395|NCT02249793|Ginger.io|ginger.io
5284396|NCT02249793|blood pressure|blood pressure
5284397|NCT02249793|metabolism|metabolism
5284398|NCT02249793|metabolomics|metabolomics
5284399|NCT02249793|gut bacteria|gut bacteria
5284400|NCT02249793|microbiome|microbiome
5284401|NCT02249780|Parathyroid gland angiography|parathyroid gland angiography
5284402|NCT02249780|Parathyroid gland indocyanine green angiography|parathyroid gland indocyanine green angiography
5284403|NCT02249780|Parathyroid gland indocyanine green fluoroscopy|parathyroid gland indocyanine green fluoroscopy
5284404|NCT02249754|Nutrition education|nutrition education
5284405|NCT02249754|Maternal counselling|maternal counselling
5284406|NCT02249754|Complementary feeding|complementary feeding
5284407|NCT02249754|Infant growth|infant growth
5284408|NCT02249754|Micronutrients|micronutrients
5284409|NCT02249754|Tanzania|tanzania
5284410|NCT02249715|Parkinson|parkinson
5284411|NCT02249715|TMS|tms
5962857|NCT04278053|Nitrosigine|nitrosigine
5284412|NCT02249715|BNA|bna
5284413|NCT02249702|trabectedin|trabectedin
5284414|NCT02249702|uterine leiomyosarcoma|uterine leiomyosarcoma
5962858|NCT04278053|Citrulline-Malate|citrulline-malate
5962859|NCT04278040|bronchiectasis|bronchiectasis
5962860|NCT04278040|treatment|treatment
5962861|NCT04278040|inhalation|inhalation
5962862|NCT04278040|low doses|low doses
5962863|NCT04278040|alkylating drugs|alkylating drugs
5962864|NCT04278027|Cognitive Remediation|cognitive remediation
5962865|NCT04278027|Epigenetics|epigenetics
5962866|NCT04278027|BDNF|bdnf
5165773|NCT02956213|COPD|copd
5284415|NCT02249676|Autologous mesenchymal stem cells|autologous mesenchymal stem cells
5284416|NCT02249676|neuromyelitis optica|neuromyelitis optica
5284417|NCT02249676|treatment|treatment
5284418|NCT02249663|Bioequivalence|bioequivalence
5284419|NCT02249650|metastatic colorectal cancer|metastatic colorectal cancer
5284420|NCT02249650|TSB-9-W1|tsb-9-w1
5284421|NCT02249624|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
5284422|NCT02249624|Developmental disabilities|developmental disabilities
5284423|NCT02249624|Magnetic resonance imaging|magnetic resonance imaging
5284424|NCT02249611|Physical activity|physical activity
5284425|NCT02249611|mobile activity sensor and feedback system|mobile activity sensor and feedback system
5284426|NCT02249611|self-management of health|self-management of health
5284427|NCT02249572|Vestibular schwannoma|vestibular schwannoma
5284428|NCT02249572|Radiosurgery|radiosurgery
5284429|NCT02249572|Neurosurgery|neurosurgery
5284430|NCT02249572|Randomized|randomized
5284431|NCT02249533|Spot Light|spot light
5284432|NCT02249533|High School RIO|high school rio
5284433|NCT02249533|Concussion|concussion
5284434|NCT02249533|Injury Prevention|injury prevention
5284435|NCT02249533|Football|football
5284436|NCT02249533|Pop Warner|pop warner
5284437|NCT02249533|High School|high school
5284438|NCT02249533|Middle School|middle school
5284439|NCT02249520|Magnetic Resonance Imaging|magnetic resonance imaging
5284440|NCT02249520|MRI|mri
5284441|NCT02249520|Positron Emission Tomography|positron emission tomography
5284442|NCT02249520|PET|pet
5284443|NCT02249520|PET-MR|pet-mr
5284444|NCT02249520|mMR|mmr
5284445|NCT02249507|Resistant Hypertension|resistant hypertension
5284446|NCT02249507|Aerobic Exercise|aerobic exercise
5284447|NCT02249494|Nutritional Knowledge|nutritional knowledge
5284448|NCT02249494|Nutritional Counseling|nutritional counseling
5284449|NCT02249481|Anaesthetic|anaesthetic
5284450|NCT02249481|total knee replacement|total knee replacement
5284451|NCT02249481|Femoral nerve catheter|femoral nerve catheter
5284452|NCT02249481|Adductor canal catheter|adductor canal catheter
5284453|NCT02249429|Non Hodgkin Lymphoma|non hodgkin lymphoma
5284454|NCT02249377|Baker's Cyst|baker's cyst
5284455|NCT02249325|group B Streptococcus colonization|group b streptococcus colonization
5284456|NCT02249325|Probiotic|probiotic
5284457|NCT02249325|Pregnancy|pregnancy
5284458|NCT02249299|ADHD,|adhd,
5284459|NCT02249299|Cannabis,|cannabis,
5284460|NCT02249299|Sativex,|sativex,
5284461|NCT02249299|Endocannabinoid,|endocannabinoid,
5284462|NCT02249299|Cognition|cognition
5284463|NCT02249286|Child Centered Counseling|child centered counseling
5284464|NCT02249286|Home based food production|home based food production
5284465|NCT02249286|Nutrition|nutrition
5284466|NCT02249286|Health|health
5284467|NCT02249286|IYCF|iycf
5284468|NCT02249260|Exercise, cardiac rehabilitation, quality of life|exercise, cardiac rehabilitation, quality of life
5284469|NCT02249234|Scrotal pain|scrotal pain
5284470|NCT02249234|Botox|botox
5284471|NCT02249221|Influenza vaccine|influenza vaccine
5284472|NCT02249221|Vaccination|vaccination
5285744|NCT02243449|weaning|weaning
5284473|NCT02249221|cell-culture based influenza vaccine|cell-culture based influenza vaccine
5284474|NCT02249221|cell culture derived influenza vaccine|cell culture derived influenza vaccine
5284475|NCT02249221|CCIV|cciv
5284476|NCT02249208|Breast Cancer|breast cancer
5284477|NCT02249208|Sentinel Lymph Node|sentinel lymph node
5284478|NCT02249208|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5284479|NCT02249208|Clinically Node-Positive with biopsy-proven cN1|clinically node-positive with biopsy-proven cn1
5284480|NCT02249208|False-negative Rate|false-negative rate
5284481|NCT02249195|ECG loop recorder, pregnant women, arrhythmias|ecg loop recorder, pregnant women, arrhythmias
5284482|NCT02249169|IBS|ibs
5284483|NCT02249156|Health economics|health economics
5284484|NCT02249156|Financial incentives|financial incentives
5284485|NCT02249156|Health care spending|health care spending
5284486|NCT02249143|Continuous positive airway pressure|continuous positive airway pressure
5284487|NCT02249143|Prematurity|prematurity
5284488|NCT02249143|Respiratory distress syndrome|respiratory distress syndrome
5284489|NCT02249143|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5284490|NCT02249078|Crohn's Disease|crohn's disease
5284491|NCT02249013|Ovarian Cancer|ovarian cancer
5284492|NCT02248974|End-Stage Heart Failure|end-stage heart failure
5284493|NCT02248974|Left Ventricular Assist Device|left ventricular assist device
5284494|NCT02248974|Decision Aid|decision aid
5284495|NCT02248974|Medical Decision-Making|medical decision-making
5284496|NCT02248948|Omega-3|omega-3
5284497|NCT02248948|ADHD|adhd
5284498|NCT02248948|Quality of Life|quality of life
5284499|NCT02248948|Inattention|inattention
5284500|NCT02248948|Hyperactivity|hyperactivity
5284501|NCT02248935|Robotic Assisted Laparoscopic Sacrocolpopexy|robotic assisted laparoscopic sacrocolpopexy
5284502|NCT02248935|Y Mesh|y mesh
5284503|NCT02248935|Pelvic Organ Prolapse|pelvic organ prolapse
5369147|NCT01861093|Unrelated Hematopoietic Stem Cell Transplantation|unrelated hematopoietic stem cell transplantation
5369148|NCT01861093|Cryopreserved Cord Blood Units|cryopreserved cord blood units
5445389|NCT01522014|Health Related Quality of Life|health related quality of life
5284504|NCT02248922|Cystic Fibrosis, Pseudomonas aeruginosa, Lung Clearance Index, Multiple Breath Washout, Inhaled Tobramycin, Inhaled Antibiotics.|cystic fibrosis, pseudomonas aeruginosa, lung clearance index, multiple breath washout, inhaled tobramycin, inhaled antibiotics.
5284505|NCT02248909|COPD, Primary Care, Spirometry, Risk factors|copd, primary care, spirometry, risk factors
5284506|NCT02248870|femoral neck|femoral neck
5284507|NCT02248857|UMS|ums
5284508|NCT02248857|medication schedule|medication schedule
5284509|NCT02248857|diabetes|diabetes
5284510|NCT02248857|drug labeling|drug labeling
5284511|NCT02248831|Dyspnea|dyspnea
5284512|NCT02248831|Acute decompensated heart failure|acute decompensated heart failure
5284513|NCT02248831|Doppler ultrasound|doppler ultrasound
5284514|NCT02248831|Lung Doppler signals|lung doppler signals
5284515|NCT02248805|colon cancer|colon cancer
5284516|NCT02248805|colorectal carcinoma|colorectal carcinoma
5284517|NCT02248805|stage IV colorectal cancer|stage iv colorectal cancer
5284518|NCT02248779|Diabetes Risk|diabetes risk
5284519|NCT02248779|14-202|14-202
5284520|NCT02248753|Atrial fibrillation|atrial fibrillation
5284521|NCT02248753|Electrical cardioversion|electrical cardioversion
5674500|NCT00603343|urotherapy|urotherapy
5284522|NCT02248753|Pharmacological cardioversion|pharmacological cardioversion
5284523|NCT02248753|Rhythm control|rhythm control
5284524|NCT02248753|Rate control|rate control
5284525|NCT02248740|chronic venous insufficiency|chronic venous insufficiency
5284526|NCT02248740|varicose vein|varicose vein
5284527|NCT02248740|small saphenous vein|small saphenous vein
5284528|NCT02248701|Testosterone|testosterone
5284529|NCT02248701|Testosterone enanthate|testosterone enanthate
5284530|NCT02248701|Testosterone undecanoate|testosterone undecanoate
5284531|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
5284532|NCT02248701|Methyltestosterone|methyltestosterone
5284533|NCT02248701|Androgens|androgens
5284534|NCT02248701|Hormones|hormones
5284535|NCT02248701|Hormone Substitutes, and Hormone Antagonists|hormone substitutes, and hormone antagonists
5284536|NCT02248701|Physiologic Effects of Drugs|physiologic effects of drugs
5284537|NCT02248701|Pharmacologic Actions|pharmacologic actions
5284538|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5284539|NCT02248701|Antineoplastic Agents|antineoplastic agents
5284540|NCT02248701|Therapeutic Uses|therapeutic uses
5284541|NCT02248701|Anabolic Agents|anabolic agents
5284542|NCT02248701|Testosterone Replacement Therapy|testosterone replacement therapy
5284543|NCT02248701|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
5284544|NCT02248701|Lean Tissue Mass|lean tissue mass
5284545|NCT02248701|Body Composition|body composition
5284546|NCT02248701|Lipid and Glucose profile|lipid and glucose profile
5284547|NCT02248701|Muscle Strength|muscle strength
5284548|NCT02248701|5-alpha Reductase|5-alpha reductase
5284549|NCT02248701|Muscle Mass|muscle mass
5284550|NCT02248701|Bone Mineral Density|bone mineral density
5284551|NCT02248701|Adipose Tissue|adipose tissue
5284552|NCT02248701|Body Fat|body fat
5284553|NCT02248701|Density, Bone|density, bone
5284554|NCT02248701|Bone Formation|bone formation
5284555|NCT02248701|Bone Resorption|bone resorption
5284556|NCT02248701|Bone Density Conservation Agents|bone density conservation agents
5284557|NCT02248701|Magnetic Resonance Imaging|magnetic resonance imaging
5284558|NCT02248701|Muscle, Skeletal|muscle, skeletal
5284559|NCT02248701|Bone and Bones|bone and bones
5284560|NCT02248701|Gait|gait
5284561|NCT02248701|Walking|walking
5284562|NCT02248701|Locomotion|locomotion
5284563|NCT02248701|Motor Activity|motor activity
5284564|NCT02248688|Bariatric Embolization|bariatric embolization
5284565|NCT02248688|Gastric Artery Emboliziation|gastric artery emboliziation
5284566|NCT02248688|Left Gastric Artery Embolization|left gastric artery embolization
5284567|NCT02248688|Morbid Obesity|morbid obesity
5284569|NCT02248688|Weight Loss|weight loss
5284570|NCT02248688|Ghrelin|ghrelin
5284571|NCT02248688|Embolization|embolization
5284572|NCT02248675|sleep disorders|sleep disorders
5284573|NCT02248675|insomnia|insomnia
5284574|NCT02248675|suicidal ideation|suicidal ideation
5284575|NCT02248675|Depression|depression
5284576|NCT02248675|Depressive disorders|depressive disorders
5284577|NCT02248675|PTSD|ptsd
5284578|NCT02248675|anxiety disorders|anxiety disorders
5284579|NCT02248675|suicide|suicide
5284580|NCT02248675|cognitive behavioral therapy|cognitive behavioral therapy
5284581|NCT02248662|DCIS|dcis
5284582|NCT02248662|PCORI|pcori
5284583|NCT02248662|ductal carcinoma in situ|ductal carcinoma in situ
5284584|NCT02248662|radiation|radiation
5284585|NCT02248662|oncology|oncology
5284586|NCT02248662|patient-centered|patient-centered
5284587|NCT02248662|decision aid|decision aid
5284588|NCT02248662|decision-making|decision-making
5284589|NCT02248649|Parkinson's disease|parkinson's disease
5284590|NCT02248649|Exercise therapy|exercise therapy
5284591|NCT02248649|Mild cognitive impairment|mild cognitive impairment
5284592|NCT02248636|Alzheimer's disease|alzheimer's disease
5284593|NCT02248636|Cholinesterase inhibitor|cholinesterase inhibitor
5284594|NCT02248636|Discontinuation|discontinuation
5284595|NCT02248623|Anaesthesia|anaesthesia
5284596|NCT02248623|Isolated forearm test|isolated forearm test
5284597|NCT02248623|Responsiveness|responsiveness
5284598|NCT02248623|Laryngoscopy|laryngoscopy
5284599|NCT02248623|Intubation|intubation
5284600|NCT02248610|Pulmonary embolism|pulmonary embolism
5284601|NCT02248610|PE|pe
5284602|NCT02248610|Deep vein thrombosis|deep vein thrombosis
5284603|NCT02248610|DVT|dvt
5284604|NCT02248610|Rivaroxaban|rivaroxaban
5284605|NCT02248610|Venous thromboembolism|venous thromboembolism
5284606|NCT02248610|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5284607|NCT02248610|Post thrombotic limb syndrome|post thrombotic limb syndrome
5284608|NCT02248610|Root cause analysis|root cause analysis
5284609|NCT02248571|breast cancer|breast cancer
5284610|NCT02248571|advanced|advanced
5284611|NCT02248571|inoperable|inoperable
5284612|NCT02248571|metastatic|metastatic
5284613|NCT02248571|HER2/neu-negative|her2/neu-negative
5284614|NCT02248571|hormone receptor positive|hormone receptor positive
5284615|NCT02248571|HR+|hr+
5284616|NCT02248571|female|female
5284617|NCT02248571|postmenopausal|postmenopausal
5284618|NCT02248558|Contest|contest
5284619|NCT02248558|Crowdsourcing|crowdsourcing
5284620|NCT02248558|Innovation|innovation
5284621|NCT02248558|Randomized controlled trial|randomized controlled trial
5284622|NCT02248558|China|china
5284623|NCT02248558|Social entrepreneurship|social entrepreneurship
5284624|NCT02248545|Non-Celiac Wheat Sensitivity|non-celiac wheat sensitivity
5284625|NCT02248545|Autoimmune diseases|autoimmune diseases
5284626|NCT02248545|Anti-nuclear antibodies|anti-nuclear antibodies
5284627|NCT02248545|Celiac disease|celiac disease
5284628|NCT02248545|Irritable bowel syndrome|irritable bowel syndrome
5284629|NCT02248519|Gastric cancer|gastric cancer
5284630|NCT02248519|Gastrectomy|gastrectomy
5284631|NCT02248519|Laparoscopy|laparoscopy
5284632|NCT02248506|Candidiasis|candidiasis
5284633|NCT02248493|Pain, Postoperative|pain, postoperative
5284634|NCT02248493|Paracetamol|paracetamol
5284635|NCT02248493|Administration, Intravenous|administration, intravenous
5284636|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5284637|NCT02248493|Child|child
5284638|NCT02248493|Adolescent|adolescent
5284639|NCT02248467|Testosterone replacement therapy|testosterone replacement therapy
5284640|NCT02248428|multiple myeloma|multiple myeloma
5284641|NCT02248428|Clarithromycin|clarithromycin
5284642|NCT02248428|CTd|ctd
5284643|NCT02248415|Cardioplegic Solutions|cardioplegic solutions
5284644|NCT02248415|Myocardial Ischemia|myocardial ischemia
5284645|NCT02248389|carcinoma, renal cell|carcinoma, renal cell
5284646|NCT02248389|ablation|ablation
5284647|NCT02248389|laparoscopic surgery|laparoscopic surgery
5284648|NCT02248389|high intensity focused ultrasound|high intensity focused ultrasound
5284649|NCT02248376|Uterine synechiae Scraping surgery Natural miscarriage|uterine synechiae scraping surgery natural miscarriage
5284650|NCT02248363|Rehabilitation|rehabilitation
5284651|NCT02248363|Effectiveness|effectiveness
5284652|NCT02248363|Determinants|determinants
5284653|NCT02248363|Prediction|prediction
5284654|NCT02248350|prostate cancer|prostate cancer
5284655|NCT02248350|physical activity|physical activity
5284656|NCT02248350|exercise|exercise
5284657|NCT02248350|intervention|intervention
5284658|NCT02248350|side effects|side effects
5284659|NCT02248350|androgen deprivation therapy|androgen deprivation therapy
5284660|NCT02248337|Colon preparation; Colonoscopy; Inflammatory bowel disease|colon preparation; colonoscopy; inflammatory bowel disease
5284757|NCT02247830|Radiodermatitis|radiodermatitis
5284661|NCT02248324|Age-related macular degeneration, genetic polymorphisms|age-related macular degeneration, genetic polymorphisms
5284662|NCT02248298|Ablative fractional laser|ablative fractional laser
5284663|NCT02248298|Actinic keratosis|actinic keratosis
5284664|NCT02248298|Efficacy|efficacy
5284665|NCT02248298|Photodynamic therapy|photodynamic therapy
5284666|NCT02248298|Short incubation time|short incubation time
5284667|NCT02248285|multiplex|multiplex
5284668|NCT02248285|polymerase chain reaction|polymerase chain reaction
5284670|NCT02248285|BioFire Diagnostics|biofire diagnostics
5284671|NCT02248285|Infectious gastroenteritis|infectious gastroenteritis
5284672|NCT02248285|Diarrheal disease|diarrheal disease
5284673|NCT02248285|Emergency department|emergency department
5284674|NCT02248285|rapid diagnostics|rapid diagnostics
5284675|NCT02248285|FilmArray|filmarray
5284676|NCT02248285|FilmArray GI Panel|filmarray gi panel
5284677|NCT02248272|Polycystic ovary syndrome|polycystic ovary syndrome
5284682|NCT02248246|Harmonic ACE®+7 Shears|harmonic ace®+7 shears
5284683|NCT02248246|Laparoscopic|laparoscopic
5284684|NCT02248246|Inferior mesenteric artery|inferior mesenteric artery
5284685|NCT02248246|Inferior mesenteric vein|inferior mesenteric vein
5284686|NCT02248246|Observational|observational
5284687|NCT02248233|nimodipine|nimodipine
5284688|NCT02248233|acute massive cerebral infarction|acute massive cerebral infarction
5284689|NCT02248233|Cerebral Infarction|cerebral infarction
5284694|NCT02248194|Hysteroscopic endometrial ablation|hysteroscopic endometrial ablation
5284695|NCT02248194|Tactile endometrial ablation|tactile endometrial ablation
5284696|NCT02248194|Hysteroscopic difficulties|hysteroscopic difficulties
5284697|NCT02248194|Quality of life|quality of life
5284698|NCT02248194|Satisfaction|satisfaction
5284700|NCT02248090|Safety|safety
5284701|NCT02248090|Tolerability|tolerability
5284702|NCT02248090|Pharmacokinetics|pharmacokinetics
5284703|NCT02248090|Ascending Doses|ascending doses
5284704|NCT02248090|Estrogen Receptor Positive|estrogen receptor positive
5284705|NCT02248090|Her2 Negative|her2 negative
5284706|NCT02248090|Advanced Breast Cancer|advanced breast cancer
5284707|NCT02248064|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5284708|NCT02248064|Long term oxygen therapy|long term oxygen therapy
5284709|NCT02248064|Auto-titrating oxygen system|auto-titrating oxygen system
5284710|NCT02248064|Intelligent oxygen therapy|intelligent oxygen therapy
5284711|NCT02248064|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5284712|NCT02248025|Fluid responsiveness|fluid responsiveness
5284713|NCT02248025|capillary refill time|capillary refill time
5284714|NCT02248025|microcirculation|microcirculation
5284715|NCT02248025|circulatory failure|circulatory failure
5284716|NCT02248025|passive leg raising|passive leg raising
5284717|NCT02248012|Gastroenteropancreatic|gastroenteropancreatic
5284718|NCT02248012|Neuroendocrine carcinoma|neuroendocrine carcinoma
5284719|NCT02248012|Chemotherapy|chemotherapy
5284720|NCT02247999|Cervical Cancer|cervical cancer
5284721|NCT02247999|HIV/AIDS|hiv/aids
5284722|NCT02247999|HPV|hpv
5284723|NCT02247999|Biomarkers|biomarkers
5284724|NCT02247999|Screening|screening
5284725|NCT02247986|Conduct Disorder|conduct disorder
5284726|NCT02247986|Methylphenidate|methylphenidate
5284727|NCT02247986|Disruptive Behavior Disorders|disruptive behavior disorders
5284728|NCT02247947|CPR|cpr
5284729|NCT02247934|Primary sclerosing cholangitis|primary sclerosing cholangitis
5284730|NCT02247934|PSC|psc
5284731|NCT02247921|caregiver delivered rehabilitation|caregiver delivered rehabilitation
5284732|NCT02247921|nurse-organized service|nurse-organized service
5284733|NCT02247921|disabled stroke patients|disabled stroke patients
5284734|NCT02247908|Cigarette smoking|cigarette smoking
5284735|NCT02247908|Smoke|smoke
5284736|NCT02247908|Smoking|smoking
5284737|NCT02247908|Tobacco Use|tobacco use
5284738|NCT02247895|ICU Acquired weakness|icu acquired weakness
5284739|NCT02247895|Critical illness|critical illness
5284740|NCT02247895|Mechanical ventilation|mechanical ventilation
5284741|NCT02247882|Osteoarthritis|osteoarthritis
5284742|NCT02247882|Patient Education|patient education
5284743|NCT02247882|Aquatic Exercise|aquatic exercise
5284744|NCT02247882|kinetic|kinetic
5284745|NCT02247869|HL|hl
5284746|NCT02247869|Hodgkin Lymphoma|hodgkin lymphoma
5284747|NCT02247869|First line therapy|first line therapy
5374523|NCT01837693|CIN|cin
5284748|NCT02247856|nebulizers,|nebulizers,
5284749|NCT02247856|noninvasive ventilation|noninvasive ventilation
5284750|NCT02247856|COPD|copd
5284751|NCT02247856|scintigraphy,|scintigraphy,
5284752|NCT02247856|aerosol|aerosol
5284753|NCT02247843|Sickle Cell Disease (SCD)|sickle cell disease (scd)
5284754|NCT02247843|Gene Therapy|gene therapy
5284755|NCT02247843|Lentiviral Vector|lentiviral vector
5284756|NCT02247843|Beta Globin|beta globin
5284758|NCT02247830|Head and neck neoplasms|head and neck neoplasms
5284759|NCT02247830|Radiotherapy|radiotherapy
5284760|NCT02247830|Urea|urea
5284761|NCT02247830|Matricaria|matricaria
5284762|NCT02247830|Breast Neoplasms|breast neoplasms
5284763|NCT02247830|chamomilla|chamomilla
5284764|NCT02247830|chamomile|chamomile
5284765|NCT02247778|clavicle|clavicle
5284766|NCT02247778|surgical intervention|surgical intervention
5284767|NCT02247778|mini-incision|mini-incision
5284768|NCT02247778|plate osteosynthesis|plate osteosynthesis
5284769|NCT02247752|hepatitis|hepatitis
5284770|NCT02247752|HBV|hbv
5284771|NCT02247752|chronic hepatitis|chronic hepatitis
5284772|NCT02247752|HCC|hcc
5284773|NCT02247752|cirrhosis|cirrhosis
5284774|NCT02247752|quantitative HBsAg|quantitative hbsag
5284775|NCT02247752|HBsAg inactive carriers|hbsag inactive carriers
5284776|NCT02247739|HAE|hae
5284777|NCT02247739|Hereditary Angioedema|hereditary angioedema
5284778|NCT02247739|Prophylaxis|prophylaxis
5284780|NCT02247726|Third Trimester|third trimester
5284781|NCT02247726|Maternal Immunization|maternal immunization
5284782|NCT02247713|PET|pet
5284783|NCT02247713|radiotherapy|radiotherapy
5284784|NCT02247713|international|international
5284785|NCT02247713|NSCLC|nsclc
5284786|NCT02247713|overall survival|overall survival
5289552|NCT02226016|ptosis|ptosis
5284787|NCT02247713|low and middle income countries|low and middle income countries
5284788|NCT02247700|Pediatrics|pediatrics
5284789|NCT02247700|ARDS|ards
5284791|NCT02247700|ALI|ali
5284792|NCT02247700|Respiratory|respiratory
5284793|NCT02247700|Mechanical ventilation|mechanical ventilation
5284794|NCT02247700|Ventilation|ventilation
5284795|NCT02247700|Noninvasive monitoring|noninvasive monitoring
5284796|NCT02247700|electrical impedance tomography|electrical impedance tomography
5284797|NCT02247700|EIT|eit
5284798|NCT02247687|HIV-1|hiv-1
5284799|NCT02247687|antiretroviral treatment|antiretroviral treatment
5284800|NCT02247687|viral load|viral load
5284801|NCT02247674|Stroke, Cerebrovascular accident, Rehabilitation, Upper extremity|stroke, cerebrovascular accident, rehabilitation, upper extremity
5284802|NCT02247661|Femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain|femoral neck fracture,surgical approach, limp, abductor strenght, trochanteric pain
5284803|NCT02247648|tramadol|tramadol
5284804|NCT02247648|shoulder surgery|shoulder surgery
5284805|NCT02247648|pain|pain
5284806|NCT02247648|interscalen block|interscalen block
5284807|NCT02247648|BUPRENORPHINE/HYDROMORPHONE [VA Drug Interaction]|buprenorphine/hydromorphone [va drug interaction]
5284808|NCT02247635|Treatment adherence|treatment adherence
5284809|NCT02247635|Behavioral model of health care|behavioral model of health care
5284810|NCT02247635|Healthy lifestyle|healthy lifestyle
5284811|NCT02247635|Chronic metabolic diseases|chronic metabolic diseases
5284812|NCT02247635|Metabolic syndrome|metabolic syndrome
5284813|NCT02247635|Obesity|obesity
5284814|NCT02247622|telomeres|telomeres
5284815|NCT02247622|PSC|psc
5284816|NCT02247609|B cell lymphoma|b cell lymphoma
5284817|NCT02247609|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5284818|NCT02247609|Burkitt lymphoma|burkitt lymphoma
5284819|NCT02247609|diffused large B cell lymphoma|diffused large b cell lymphoma
5284820|NCT02247609|B cell malignancy|b cell malignancy
5284821|NCT02247596|Resveratrol|resveratrol
5284822|NCT02247596|obesity|obesity
5284823|NCT02247596|insulin resistance|insulin resistance
5284824|NCT02247596|energy expenditure|energy expenditure
5284825|NCT02247596|diabetes|diabetes
5284826|NCT02247570|Vestibular Rehabilitation|vestibular rehabilitation
5284827|NCT02247570|PTSD|ptsd
5284828|NCT02247570|DSM-IV|dsm-iv
5284829|NCT02247557|IC/PBS|ic/pbs
5284830|NCT02247557|VAS|vas
5284831|NCT02247557|Botulinum Toxin A|botulinum toxin a
5284832|NCT02247557|Lipotoxin|lipotoxin
5284833|NCT02247544|STS, leiomyosarcoma, liposarcoma, trabectedin|sts, leiomyosarcoma, liposarcoma, trabectedin
5284834|NCT02247518|Male|male
5284835|NCT02247518|Volunteers|volunteers
5284836|NCT02247492|International|international
5284837|NCT02247492|Multicenter|multicenter
5284838|NCT02247492|Observational registry|observational registry
5284839|NCT02247492|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5284840|NCT02247492|Stenting|stenting
5284841|NCT02247492|Treatment of coronary artery disease|treatment of coronary artery disease
5284842|NCT02247492|Coronary revascularization|coronary revascularization
5284843|NCT02247492|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5284844|NCT02247492|STEMI|stemi
5284845|NCT02247492|NSTEMI|nstemi
5284846|NCT02247492|Ischemia|ischemia
5284847|NCT02247492|Angina|angina
5284848|NCT02247492|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5284849|NCT02247492|Small Vessels|small vessels
5284850|NCT02247492|Chronic Total Occlusion (CTO|chronic total occlusion (cto
5284851|NCT02247466|Neuromuscular Blockade|neuromuscular blockade
5284852|NCT02247466|Laparoscopy|laparoscopy
5284853|NCT02247453|lung cancer|lung cancer
5284854|NCT02247453|clinical trial|clinical trial
5284855|NCT02247453|screening|screening
5284856|NCT02247453|microRNA|microrna
5284857|NCT02247453|biomarkers|biomarkers
5284858|NCT02247440|HCV|hcv
5284859|NCT02247440|HIV|hiv
5284861|NCT02247440|pegylated interferon|pegylated interferon
5284862|NCT02247440|ribavirin|ribavirin
5284863|NCT02247427|Heart failure|heart failure
5284864|NCT02247427|Super responder|super responder
5284865|NCT02247414|Cirrhosis|cirrhosis
5284866|NCT02247414|Hypertension|hypertension
5284867|NCT02247414|venous thrombosis|venous thrombosis
5284868|NCT02247414|Warfarin|warfarin
5284869|NCT02247414|Splenectomy|splenectomy
5284870|NCT02247414|Azygoportal Disconnection|azygoportal disconnection
5284871|NCT02247414|Laparoscopy|laparoscopy
5284872|NCT02247401|Genotype 4|genotype 4
5284873|NCT02247401|non-responder|non-responder
5284874|NCT02247401|treatment experienced|treatment experienced
5284876|NCT02247401|naive|naive
5284877|NCT02247401|relapser|relapser
5284878|NCT02247401|hepatitis infection|hepatitis infection
5284879|NCT02247401|compensated cirrhosis|compensated cirrhosis
5284880|NCT02247401|hepatitis c|hepatitis c
5284881|NCT02247401|Cirrhosis|cirrhosis
5284882|NCT02247401|Egypt|egypt
5284883|NCT02247401|null responder|null responder
5284884|NCT02247401|partial responder|partial responder
5284885|NCT02247388|Alcohol Dependence|alcohol dependence
5284886|NCT02247388|Alcoholism|alcoholism
5284887|NCT02247388|AB-CASI|ab-casi
5284888|NCT02247388|Emergency Department|emergency department
5284889|NCT02247362|Safety|safety
5284890|NCT02247362|Immunogenicity|immunogenicity
5284891|NCT02247336|colorectal cancer|colorectal cancer
5284892|NCT02247336|early detection of cancer|early detection of cancer
5284893|NCT02247297|Pancreatic stone protein (PSP)|pancreatic stone protein (psp)
5284894|NCT02247297|premature rupture of membranes (PPROM)|premature rupture of membranes (pprom)
5284895|NCT02247297|amniotic infection syndrome (AIS)|amniotic infection syndrome (ais)
5285018|NCT02246920|Allergic Rhinitis|allergic rhinitis
5284896|NCT02247297|hemolysis, elevated liver enzymes, and low platelets (HELLP)|hemolysis, elevated liver enzymes, and low platelets (hellp)
5166337|NCT02952989|dMMR|dmmr
5284897|NCT02247297|preeclampsia|preeclampsia
5284898|NCT02247297|pregnancy|pregnancy
5284899|NCT02247271|peer coaches|peer coaches
5284900|NCT02247245|CHF|chf
5284901|NCT02247245|AF|af
5284902|NCT02247245|SR|sr
5284903|NCT02247245|HFREF|hfref
5284904|NCT02247245|CRT|crt
5284905|NCT02247219|Health education|health education
5284906|NCT02247219|Health services research|health services research
5284907|NCT02247206|Tourette Syndrome|tourette syndrome
5284908|NCT02247206|tic disorders|tic disorders
5284909|NCT02247206|behavior therapy|behavior therapy
5284910|NCT02247206|web-based videoconferencing|web-based videoconferencing
5284911|NCT02247206|VoIP|voip
5284912|NCT02247193|Botulinum Toxin|botulinum toxin
5284913|NCT02247193|Botox|botox
5284914|NCT02247193|Craniofacial deformity|craniofacial deformity
5284915|NCT02247167|obstructive sleep apnoea, oxidative stress, FMD|obstructive sleep apnoea, oxidative stress, fmd
5284916|NCT02247128|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
5284917|NCT02247128|Transcatheter Aortic Valve Replacement (TAVR)|transcatheter aortic valve replacement (tavr)
5284918|NCT02247128|Aortic Valve Disease|aortic valve disease
5284919|NCT02247128|Aortic Stenosis|aortic stenosis
5284920|NCT02247128|Myocardial Infarction|myocardial infarction
5284921|NCT02247128|Ischemic stroke|ischemic stroke
5284922|NCT02247128|Bleeding|bleeding
5284923|NCT02247128|Thrombosis|thrombosis
5284924|NCT02247128|Myocardial Ischemia|myocardial ischemia
5284925|NCT02247128|Heart Diseases|heart diseases
5284926|NCT02247128|Cardiovascular Diseases|cardiovascular diseases
5284927|NCT02247128|Vascular Diseases|vascular diseases
5284928|NCT02247128|Embolism and Thrombosis|embolism and thrombosis
5284929|NCT02247128|Aspirin|aspirin
5284930|NCT02247128|Clopidogrel|clopidogrel
5284931|NCT02247128|Prasugrel|prasugrel
5284932|NCT02247128|Ticagrelor|ticagrelor
5284933|NCT02247128|Antithrombotic treatment|antithrombotic treatment
5284934|NCT02247128|Oral anticoagulation|oral anticoagulation
5284935|NCT02247128|Warfarin|warfarin
5284936|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5284937|NCT02247128|Genetic Testing|genetic testing
5284938|NCT02247128|Cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
5284939|NCT02247128|Prostaglandin-endoperoxide synthase 2(PTGS2)|prostaglandin-endoperoxide synthase 2(ptgs2)
5284940|NCT02247115|endoscopic ultrasound|endoscopic ultrasound
5284941|NCT02247115|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5284942|NCT02247115|competency|competency
5284943|NCT02247089|Night Shift work|night shift work
5284944|NCT02247089|Stress|stress
5284945|NCT02247089|Autonomic nervous system (ANS)|autonomic nervous system (ans)
5284946|NCT02247089|Heart rate variability (HRV)|heart rate variability (hrv)
5284947|NCT02247089|Pre-ejection period (PEP)|pre-ejection period (pep)
5284948|NCT02247089|Inflammation|inflammation
5284949|NCT02247089|Pro-inflammatory cytokines|pro-inflammatory cytokines
5284950|NCT02247089|Massage Therapy|massage therapy
5284951|NCT02247050|Costs and Cost Analysis|costs and cost analysis
5284952|NCT02247050|Professional Practice|professional practice
5284953|NCT02247050|Attitude of Health Personnel|attitude of health personnel
5284954|NCT02247050|Health Knowledge, Attitudes, and Practice|health knowledge, attitudes, and practice
5284955|NCT02247050|Decision Making|decision making
5284956|NCT02247050|Practice Guidelines as Topic|practice guidelines as topic
5284957|NCT02247050|Physician-Patient Relations|physician-patient relations
5284958|NCT02247050|Physician's Role|physician's role
5284959|NCT02247050|Health Care|health care
5284960|NCT02247050|Quality of Health Care|quality of health care
5284961|NCT02247050|Quality Assurance|quality assurance
5284962|NCT02247050|Physicians, Primary Care|physicians, primary care
5284963|NCT02247050|Evidence-Based Medicine|evidence-based medicine
5284964|NCT02247050|Evidence-Based Practice|evidence-based practice
5284965|NCT02247050|Decision Support Systems, Clinical|decision support systems, clinical
5284966|NCT02247050|Reminder Systems|reminder systems
5284967|NCT02247050|Judgment|judgment
5284968|NCT02247050|Cognition|cognition
5284969|NCT02247050|Patient Care|patient care
5284970|NCT02247050|Health Services Misuse|health services misuse
5284971|NCT02247050|Unnecessary Procedures|unnecessary procedures
5862757|NCT00001524|Mouth Ulcers|mouth ulcers
5284972|NCT02247050|Prescribing Patterns, Physician|prescribing patterns, physician
5284973|NCT02247050|Inappropriate Prescribing|inappropriate prescribing
5284975|NCT02247050|Low Back Pain|low back pain
5284976|NCT02247050|Sinusitis|sinusitis
5284977|NCT02247050|Infections, Upper Respiratory|infections, upper respiratory
5284978|NCT02247050|Generalized Headache|generalized headache
5284979|NCT02247050|Imaging, Diagnostic|imaging, diagnostic
5284994|NCT02246985|Carotenoids in plasma, urine and faeces|carotenoids in plasma, urine and faeces
5284995|NCT02246985|alpha-carotene|alpha-carotene
5284996|NCT02246985|beta-carotene|beta-carotene
5284997|NCT02246985|Vitamin A|vitamin a
5284998|NCT02246985|Lycopene|lycopene
5284999|NCT02246985|Gut absorption|gut absorption
5285001|NCT02246985|Mayonnaise|mayonnaise
5285002|NCT02246985|Bioavailability|bioavailability
5962867|NCT04278001|Ambulatory blood pressure measurement|ambulatory blood pressure measurement
5154501|NCT03026764|cost|cost
5285003|NCT02246985|Fruits and Vegetables|fruits and vegetables
5285004|NCT02246985|Inflammation|inflammation
5285005|NCT02246985|Oxidative Stress|oxidative stress
5285007|NCT02246972|Military sexual trauma|military sexual trauma
5285008|NCT02246972|Veterans|veterans
5285009|NCT02246972|Women in the military|women in the military
5285010|NCT02246972|Sexual assault|sexual assault
5285011|NCT02246946|pleural effusion|pleural effusion
5285012|NCT02246946|chest tube|chest tube
5285013|NCT02246946|respiratory therapy|respiratory therapy
5285014|NCT02246946|intermittent positive-pressure breathing|intermittent positive-pressure breathing
5285015|NCT02246946|lung function|lung function
5285016|NCT02246946|pulmonary complications|pulmonary complications
5285017|NCT02246920|Bioequivalence|bioequivalence
5285019|NCT02246907|Health related quality of life|health related quality of life
5285020|NCT02246855|Subjects|subjects
5285021|NCT02246842|Volunteers|volunteers
5285022|NCT02246829|wet AMD, SD-OCT, intravitreal injection, central retinal thickness,|wet amd, sd-oct, intravitreal injection, central retinal thickness,
5285023|NCT02246816|Short Bowel Syndrome|short bowel syndrome
5285025|NCT02246816|Chronic Diarrhea|chronic diarrhea
5285026|NCT02246816|Short Bowel|short bowel
5285027|NCT02246816|Short Gut|short gut
5285028|NCT02246816|Short Gut Syndrome|short gut syndrome
5285029|NCT02246816|Anti-Diarrheal|anti-diarrheal
5285030|NCT02246816|Opium Tincture|opium tincture
5285031|NCT02246816|loperamide|loperamide
5285032|NCT02246816|diphenoxylate|diphenoxylate
5285033|NCT02246816|ileostomies|ileostomies
5285034|NCT02246816|tincture of opium|tincture of opium
5285035|NCT02246816|DTO|dto
5285036|NCT02246816|codeine|codeine
5285037|NCT02246816|morphine|morphine
5285038|NCT02246816|opiate|opiate
5285039|NCT02246803|paroxysmal atrial fibrillation, CABG, pulmonary vein isolation|paroxysmal atrial fibrillation, cabg, pulmonary vein isolation
5285040|NCT02246790|ablation, CABG|ablation, cabg
5285041|NCT02246790|Long-standing persistent Atrial Fibrillation|long-standing persistent atrial fibrillation
5285042|NCT02246777|Glaucoma|glaucoma
5285043|NCT02246764|Ocular hypertension.|ocular hypertension.
5285044|NCT02246764|Glaucoma|glaucoma
5285045|NCT02246751|postural control|postural control
5285046|NCT02246751|Targeted Training|targeted training
5285047|NCT02246751|cerebral palsy|cerebral palsy
5285048|NCT02246751|sensorimotor control|sensorimotor control
5285049|NCT02246751|trunk segments|trunk segments
5285745|NCT02243449|elderly|elderly
5285064|NCT02246712|tramadol|tramadol
5285065|NCT02246712|pharmacokinetics|pharmacokinetics
5285066|NCT02246712|enantiomers|enantiomers
5285067|NCT02246712|metabolism|metabolism
5285068|NCT02246712|diabetes|diabetes
5285069|NCT02246699|obesity|obesity
5285070|NCT02246699|overweight|overweight
5285071|NCT02246699|chitosan|chitosan
5285072|NCT02246699|fungal chitosan|fungal chitosan
5285073|NCT02246699|weight management|weight management
5285074|NCT02246686|Iberogast N|iberogast n
5285075|NCT02246686|Mild to moderate ulcerative colitis|mild to moderate ulcerative colitis
5285076|NCT02246686|add-on therapy|add-on therapy
5285077|NCT02246686|efficacy|efficacy
5285078|NCT02246660|Peripheral Artery Disease|peripheral artery disease
5285079|NCT02246660|Peripheral Arterial Disease|peripheral arterial disease
5285080|NCT02246660|PAD|pad
5285081|NCT02246634|Colorectal Neoplasms|colorectal neoplasms
5285082|NCT02246634|Neoplasm Metastases|neoplasm metastases
5285083|NCT02246634|Magnetic Resonance Imaging|magnetic resonance imaging
5285084|NCT02246634|Diffusion Weighted MRI|diffusion weighted mri
5285085|NCT02246634|Hepatic Neoplasms|hepatic neoplasms
5285086|NCT02246634|Tumors|tumors
5285087|NCT02246634|Neoplasms, Rectal|neoplasms, rectal
5285088|NCT02246621|MONARCH 3|monarch 3
5285089|NCT02246595|Sepsis|sepsis
5285090|NCT02246595|Severe Sepsis|severe sepsis
5285091|NCT02246595|Septic Shock|septic shock
5285092|NCT02246595|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5285093|NCT02246595|Organ Dysfunction|organ dysfunction
5285094|NCT02246582|Type 1 Diabetes|type 1 diabetes
5285095|NCT02246582|Type 2 Diabetes|type 2 diabetes
5285096|NCT02246582|Enlite 3|enlite 3
5285097|NCT02246569|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5285098|NCT02246569|endoscopic lung volume reduction|endoscopic lung volume reduction
5285099|NCT02246569|RePneu®Coils|repneu®coils
5285100|NCT02246569|physical capacity|physical capacity
5285101|NCT02246569|quality of life|quality of life
5285102|NCT02246556|Amblyopia|amblyopia
5285103|NCT02246556|Dichoptic|dichoptic
5285104|NCT02246556|Virtual reality|virtual reality
5285105|NCT02246556|Stereopsis|stereopsis
5285106|NCT02246556|Stereo vision|stereo vision
5285107|NCT02246556|Visual acuity|visual acuity
5285108|NCT02246556|Binocular|binocular
5285109|NCT02246543|Appetite|appetite
5285110|NCT02246543|Gut Hormones|gut hormones
5285111|NCT02246543|Protein|protein
5285112|NCT02246543|Energy Density|energy density
5962868|NCT04277988|Maternal Analgesia|maternal analgesia
5285113|NCT02246543|Gastric Emptying|gastric emptying
5285114|NCT02246465|Hypertrophic scar|hypertrophic scar
5285115|NCT02246465|Cicatrix|cicatrix
5285116|NCT02246465|Scar prevention|scar prevention
5285117|NCT02246465|Scar revision|scar revision
5285118|NCT02246452|Children and adolescents|children and adolescents
5285119|NCT02246452|Cancer|cancer
5285120|NCT02246452|Malnutrition|malnutrition
5285121|NCT02246452|BMI percentile|bmi percentile
5285122|NCT02246452|BMI-SDS|bmi-sds
5285123|NCT02246439|Gastroenteritis|gastroenteritis
5285124|NCT02246439|Gastritis|gastritis
5285125|NCT02246439|Vomiting|vomiting
5285126|NCT02246439|Nausea|nausea
5285127|NCT02246439|Diarrhea|diarrhea
5285128|NCT02246413|BMI|bmi
5285129|NCT02246413|Depressive symptoms|depressive symptoms
5285130|NCT02246413|Integrated therapy|integrated therapy
5285131|NCT02246413|Cardiometabolic risk|cardiometabolic risk
5285132|NCT02246413|Self-regulation|self-regulation
5285133|NCT02246413|Behavior change|behavior change
5285134|NCT02246413|Precision medicine|precision medicine
5285135|NCT02246413|Lifestyle|lifestyle
5285136|NCT02246400|eCMP|ecmp
5285137|NCT02246400|eHealth|ehealth
5285138|NCT02246400|mHealth|mhealth
5285139|NCT02246400|Lifestyle intervention|lifestyle intervention
5285140|NCT02246400|Cardiometabolic risk reduction|cardiometabolic risk reduction
5285141|NCT02246400|PAMF|pamf
5285142|NCT02246387|Pelvic Organ Prolapse|pelvic organ prolapse
5285143|NCT02246387|Gynecologic Surgery Procedures|gynecologic surgery procedures
5285144|NCT02246387|Treatment Outcome|treatment outcome
5285145|NCT02246374|Parkinson's Disease|parkinson's disease
5285146|NCT02246374|ExAblate|exablate
5285147|NCT02246374|MRgFUS|mrgfus
5285148|NCT02246361|Ankle sprain|ankle sprain
5285149|NCT02246361|Infectious colitis|infectious colitis
5285150|NCT02246361|Diverticulitis|diverticulitis
5285151|NCT02246361|Pyelonephritis|pyelonephritis
5285152|NCT02246361|Prostatitis|prostatitis
5285153|NCT02246361|Pneumonitis|pneumonitis
5285154|NCT02246361|Patient Information Leaflet (PIL)|patient information leaflet (pil)
5285954|NCT02242565|ShangRing|shangring
5285155|NCT02246361|Doctor Patient Communication|doctor patient communication
5285156|NCT02246361|Adherence|adherence
5285157|NCT02246361|Satisfaction|satisfaction
5285158|NCT02246361|Scale|scale
5285159|NCT02246361|Doctor Patient Communication scale|doctor patient communication scale
5285160|NCT02246361|Adherence scale|adherence scale
5285161|NCT02246361|Satisfaction scale|satisfaction scale
5285162|NCT02246348|Systemic Sclerosis|systemic sclerosis
5285163|NCT02246348|Pulmonary hypertension|pulmonary hypertension
5285164|NCT02246348|Lung Doppler signals|lung doppler signals
5285165|NCT02246322|Pancreatic cancer|pancreatic cancer
5285166|NCT02246322|Neuroendocrine tumors|neuroendocrine tumors
5285167|NCT02246322|Lymphadenopathies|lymphadenopathies
5285168|NCT02246322|GIST|gist
5285169|NCT02246322|Gastrointestinal wall neoplasia|gastrointestinal wall neoplasia
5285170|NCT02246309|Infertility|infertility
5285171|NCT02246309|Embryo Culture|embryo culture
5285172|NCT02246309|Laboratory Technique|laboratory technique
5285173|NCT02246296|severe acute malnutrition|severe acute malnutrition
5285174|NCT02246296|wasting|wasting
5285175|NCT02246296|kwashiorkor|kwashiorkor
5285176|NCT02246296|nutrition|nutrition
5285177|NCT02246296|feeding|feeding
5285178|NCT02246296|milk|milk
5285179|NCT02246283|schizophrenia|schizophrenia
5285188|NCT02246218|Glycerol Phenylbutyrate|glycerol phenylbutyrate
5285189|NCT02246218|Ravicti|ravicti
5285190|NCT02246218|Hyperammonemia|hyperammonemia
5285191|NCT02246218|Sodium Phenylbutyrate|sodium phenylbutyrate
5285192|NCT02246218|GPB|gpb
5285193|NCT02246218|HPN-100|hpn-100
5285194|NCT02246205|pancreaticoduodenectomy|pancreaticoduodenectomy
5285195|NCT02246205|delayed gastric emptying|delayed gastric emptying
5285196|NCT02246205|Roux en-Y reconstruction|roux en-y reconstruction
5285197|NCT02246179|Fractional laser|fractional laser
5285198|NCT02246179|Topical anesthesia|topical anesthesia
5285199|NCT02246179|Drug delivery|drug delivery
5285200|NCT02246153|Laparoscopic gastrectomy|laparoscopic gastrectomy
5285201|NCT02246153|Advanced gastric cancer|advanced gastric cancer
5285202|NCT02246153|Elderly patients|elderly patients
5285203|NCT02246153|Morbidity|morbidity
5285204|NCT02246153|Mortality|mortality
5285205|NCT02246127|advanced pNET|advanced pnet
5285206|NCT02246127|everolimus|everolimus
5285207|NCT02246127|STZ-5FU|stz-5fu
5285208|NCT02246127|treatment sequence|treatment sequence
5285209|NCT02246114|Pregnancy|pregnancy
5285210|NCT02246114|Smoking|smoking
5285211|NCT02246114|Smoking cessation|smoking cessation
5285213|NCT02246101|cardiopulmonary disease|cardiopulmonary disease
5285214|NCT02246101|renal disease|renal disease
5285215|NCT02246101|albuminuria|albuminuria
5285216|NCT02246101|cardiovascular disease|cardiovascular disease
5285217|NCT02246101|CVD|cvd
5285218|NCT02246101|particulate matter|particulate matter
5285219|NCT02246088|Osteoarthritis, Central Nervous System Sensitization|osteoarthritis, central nervous system sensitization
5285220|NCT02246075|Alzheimer's disease|alzheimer's disease
5285221|NCT02246075|Cognition|cognition
5285222|NCT02246075|Alpha-7 nAChR|alpha-7 nachr
5285223|NCT02246062|Anxiety|anxiety
5285224|NCT02246062|Anesthesia|anesthesia
5285225|NCT02246062|Evaluation|evaluation
5285226|NCT02246062|Preoperative care|preoperative care
5285227|NCT02246062|Child|child
5285228|NCT02246049|Metastatic colorectal cancer, bevacizumab, FOLFOXIRI|metastatic colorectal cancer, bevacizumab, folfoxiri
5285229|NCT02246010|diarrhea|diarrhea
5285230|NCT02246010|developing world|developing world
5285231|NCT02246010|lactose-free diet|lactose-free diet
5285232|NCT02246010|Clinical trial|clinical trial
5285233|NCT02245997|Reduced-dose Radiotherapy|reduced-dose radiotherapy
5285234|NCT02245997|14-186|14-186
5285235|NCT02245984|clinical competence, nursing process, nursing student|clinical competence, nursing process, nursing student
5285236|NCT02245945|HIV|hiv
5285237|NCT02245945|prevention|prevention
5285238|NCT02245932|Pulmonary disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5285239|NCT02245932|Cardiovascular diseases|cardiovascular diseases
5285240|NCT02245932|Metabolism|metabolism
5285241|NCT02245932|Resveratrol|resveratrol
5285242|NCT02245919|Low Back Pain|low back pain
5285243|NCT02245919|Chronic Pain|chronic pain
5285244|NCT02245919|Cognitive Behavioral Therapy|cognitive behavioral therapy
5285245|NCT02245919|Primary Health Care|primary health care
5285246|NCT02245919|Physical Therapy|physical therapy
5285247|NCT02245906|Brazilian fruit peel|brazilian fruit peel
5285248|NCT02245906|Functional food|functional food
5285249|NCT02245906|Cardiometabolic risk|cardiometabolic risk
5285250|NCT02245906|Metabolic syndrome|metabolic syndrome
5285251|NCT02245906|Inflammation|inflammation
5285252|NCT02245906|Appetite|appetite
5285253|NCT02245906|Gut hormone|gut hormone
5285254|NCT02245880|cervical spine|cervical spine
5285255|NCT02245880|intubating laryngeal mask airway|intubating laryngeal mask airway
5285256|NCT02245880|Glidescope videolaryngoscope|glidescope videolaryngoscope
5285257|NCT02245880|collar|collar
5285258|NCT02245867|Amyloidosis|amyloidosis
5285259|NCT02245867|Relapse|relapse
5285260|NCT02245867|Refractory|refractory
5285261|NCT02245854|diminutive polyps|diminutive polyps
5285262|NCT02245854|small polyps|small polyps
5285263|NCT02245854|cold snare polypectomy|cold snare polypectomy
5285264|NCT02245854|complications|complications
5285265|NCT02245854|bleeding|bleeding
5285266|NCT02245841|dermatomyositis|dermatomyositis
5285267|NCT02245841|Acthar gel|acthar gel
5285268|NCT02245828|healthy subjects, inhaled|healthy subjects, inhaled
5285269|NCT02245815|Necrotizing enterocolitis|necrotizing enterocolitis
5285270|NCT02245815|Probiotics|probiotics
5285271|NCT02245815|Secreting IgA|secreting iga
5285272|NCT02245815|Preterm newborns|preterm newborns
5285273|NCT02245802|Bleeding peptic ulcer|bleeding peptic ulcer
5285276|NCT02245802|Prediction of in-hospital mortality for bleeding peptic ulcer|prediction of in-hospital mortality for bleeding peptic ulcer
5285278|NCT02245776|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
5285279|NCT02245776|Stem cells|stem cells
5285280|NCT02245750|hysteroscopy - recurrent implantation failure|hysteroscopy - recurrent implantation failure
5285281|NCT02245737|Alzheimer's disease|alzheimer's disease
5285282|NCT02245737|Dementia|dementia
5285283|NCT02245737|Brain Diseases|brain diseases
5285284|NCT02245737|Neurogenerative Diseases|neurogenerative diseases
5285285|NCT02245737|Central Nervous System Diseases|central nervous system diseases
5285286|NCT02245737|Nervous System Diseases|nervous system diseases
5285287|NCT02245737|Mental Disorders|mental disorders
5285288|NCT02245737|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5285289|NCT02245737|Tauopathies|tauopathies
5285290|NCT02245724|Mental retardation|mental retardation
5285291|NCT02245724|Autologous mononuclear cell therapy|autologous mononuclear cell therapy
5285292|NCT02245724|Stem cell|stem cell
5285293|NCT02245711|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
5285294|NCT02245711|Autologous Bone Marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
5285295|NCT02245711|Stem Cell|stem cell
5285296|NCT02245698|Chronic Stroke|chronic stroke
5285297|NCT02245698|Subacute stroke|subacute stroke
5343001|NCT01981200|COPD acute exacerbation|copd acute exacerbation
5390958|NCT01763372|MRI|mri
5285298|NCT02245698|Autologous Bone Marrow Mononuclear Cell therapy|autologous bone marrow mononuclear cell therapy
5285299|NCT02245698|Stem cell|stem cell
5285300|NCT02245685|Substitution Therapy|substitution therapy
5285301|NCT02245685|Specialized Care Center for Addicts|specialized care center for addicts
5285302|NCT02245672|Asthma|asthma
5285303|NCT02245672|fluticasone|fluticasone
5285304|NCT02245672|salmeterol|salmeterol
5285305|NCT02245672|CRC749|crc749
5285306|NCT02245672|Diskus|diskus
5285307|NCT02245672|Advair|advair
5285308|NCT02245672|FEV1|fev1
5285309|NCT02245672|MGR001|mgr001
5285310|NCT02245620|Skeletal muscle dysfunction, MTP-131, Bendavia™|skeletal muscle dysfunction, mtp-131, bendavia™
5285311|NCT02245620|elamipretide|elamipretide
5285312|NCT02245607|Psychotic Disorders|psychotic disorders
5285313|NCT02245607|Cognitive Training|cognitive training
5285314|NCT02245607|Mental Disorders|mental disorders
5285315|NCT02245607|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5285316|NCT02245594|Gastrointestinal motility|gastrointestinal motility
5285317|NCT02245594|Motility Tracking System (MTS)|motility tracking system (mts)
5285318|NCT02245594|Transit time|transit time
5285319|NCT02245594|Sleep pattern|sleep pattern
5285320|NCT02245568|Dementia|dementia
5285321|NCT02245568|Alzheimer Disease|alzheimer disease
5285322|NCT02245568|bvFTD|bvftd
5285323|NCT02245568|Frontotemporal Dementia|frontotemporal dementia
5285324|NCT02245568|Neurodegenerative Diseases|neurodegenerative diseases
5285325|NCT02245568|Brain Diseases|brain diseases
5285326|NCT02245568|Cognitive Disorders|cognitive disorders
5285327|NCT02245516|Intraretinal Fluid|intraretinal fluid
5285328|NCT02245516|Subretinal Fluid|subretinal fluid
5285329|NCT02245516|Retinal Vein Occlusion|retinal vein occlusion
5285330|NCT02245516|Diabetic Macular Edema|diabetic macular edema
5285331|NCT02245477|Serum VEGF, FGR|serum vegf, fgr
5285332|NCT02245425|Neck pain|neck pain
5285333|NCT02245425|Thoracic spine manipulation|thoracic spine manipulation
5285334|NCT02245425|Range of Motion|range of motion
5285335|NCT02245425|Disability|disability
5285336|NCT02245412|GIGVHD|gigvhd
5285337|NCT02245399|Weight loss|weight loss
5285338|NCT02245399|Diabetes|diabetes
5285339|NCT02245399|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
5285340|NCT02245399|Weight loss diet|weight loss diet
5285341|NCT02245399|mediterranean type diet|mediterranean type diet
5285342|NCT02245399|Canola oil|canola oil
5285343|NCT02245399|Low-carbohydrate diet|low-carbohydrate diet
5285344|NCT02245399|Glycemic index|glycemic index
5285345|NCT02245373|Depression|depression
5285346|NCT02245373|Primary Care|primary care
5285347|NCT02245373|Cost-effectiveness|cost-effectiveness
5285348|NCT02245373|Pharmacological treatment|pharmacological treatment
5285349|NCT02245373|Watchful-waiting or Active Monitoring.|watchful-waiting or active monitoring.
5285352|NCT02245347|Tuberculosis|tuberculosis
5285353|NCT02245347|MDR TB|mdr tb
5285354|NCT02245347|Drug resistant TB|drug resistant tb
5285355|NCT02245321|hemoglobin recovery|hemoglobin recovery
5285356|NCT02245321|iron recovery|iron recovery
5285357|NCT02245321|iron supplements|iron supplements
5285358|NCT02245308|Tobacco use cessation|tobacco use cessation
5285359|NCT02245308|Homelessness|homelessness
5285360|NCT02245308|Veterans|veterans
5285361|NCT02245295|Bronchial endoscopy|bronchial endoscopy
5285362|NCT02245295|ultrasound|ultrasound
5285363|NCT02245295|EBUS|ebus
5285364|NCT02245295|anesthesia|anesthesia
5285365|NCT02245295|lung cancer|lung cancer
5285366|NCT02245295|diagnosis including staging|diagnosis including staging
5285367|NCT02245256|delirium|delirium
5285368|NCT02245256|incidence|incidence
5285369|NCT02245256|dexmedetomidine|dexmedetomidine
5285370|NCT02245243|Hepatic Impairment, single dose, intravenous|hepatic impairment, single dose, intravenous
5285371|NCT02245230|Hypertension|hypertension
5285372|NCT02245230|Autonomic Nervous System|autonomic nervous system
5285373|NCT02245230|Renin-Angiotensin System|renin-angiotensin system
5285374|NCT02245230|Angiotensin (1-7)|angiotensin (1-7)
5285375|NCT02245230|Ganglionic Blockers|ganglionic blockers
5285376|NCT02245230|Trimethaphan|trimethaphan
5285377|NCT02245230|Blood Pressure|blood pressure
5285378|NCT02245230|Hemodynamics|hemodynamics
5285379|NCT02245191|Vasopressor|vasopressor
5285380|NCT02245191|Cesarian delivery|cesarian delivery
5285381|NCT02245191|Hypotension|hypotension
5285382|NCT02245191|Maternal cardiac output|maternal cardiac output
5285383|NCT02245191|Uteroplacental blood flow|uteroplacental blood flow
5285384|NCT02245191|Cerebral fetal blood flow|cerebral fetal blood flow
5285385|NCT02245191|Preeclampsia|preeclampsia
5285386|NCT02245165|Nitric oxide|nitric oxide
5285387|NCT02245165|Nitric oxide synthase|nitric oxide synthase
5285388|NCT02245165|Gastrointestinal motility|gastrointestinal motility
5285389|NCT02245165|Gut peptide hormones|gut peptide hormones
5285390|NCT02245152|child acute malnutrition|child acute malnutrition
5285391|NCT02245152|prevention|prevention
5285392|NCT02245152|behavior change communication|behavior change communication
5285393|NCT02245152|lipid-based nutrient supplement|lipid-based nutrient supplement
5903791|NCT00322127|Hematopoietic Stem Cells|hematopoietic stem cells
5285394|NCT02245152|screening coverage|screening coverage
5285395|NCT02245139|diarrhea|diarrhea
5285396|NCT02245139|vomiting|vomiting
5285397|NCT02245139|fever|fever
5285398|NCT02245139|abdominal pain|abdominal pain
5285399|NCT02245139|oliguria|oliguria
5285400|NCT02245126|Pain, Visual analogue scale|pain, visual analogue scale
5285401|NCT02245087|atorvastatin|atorvastatin
5285402|NCT02245087|coronary artery disease|coronary artery disease
5285403|NCT02245087|myocardial infarction|myocardial infarction
5285404|NCT02245087|stroke|stroke
5285406|NCT02245074|Infantile asthma|infantile asthma
5285407|NCT02245074|Induced sputum|induced sputum
5285408|NCT02245074|Phenotypes|phenotypes
5285409|NCT02245074|Eosinophils|eosinophils
5285410|NCT02245074|Neutrophils|neutrophils
5285411|NCT02245061|pharmacoresistant focal epilepsy|pharmacoresistant focal epilepsy
5285412|NCT02245061|cortical excitability|cortical excitability
5285413|NCT02245061|paired pulses|paired pulses
5285415|NCT02245061|SEEG|seeg
5285416|NCT02245061|DES|des
5285417|NCT02245048|Cardiovascular Risk Stratification|cardiovascular risk stratification
5369149|NCT01861093|National Cord Blood Program|national cord blood program
5166868|NCT02949414|Malacia|malacia
5285418|NCT02245048|Carotid intima-media thickness (CIMT)|carotid intima-media thickness (cimt)
5285419|NCT02245048|Stress echocardiography (SE)|stress echocardiography (se)
5285420|NCT02245035|Glutathione|glutathione
5285421|NCT02245035|Dairy consumption|dairy consumption
5285422|NCT02245035|Brain|brain
5285423|NCT02245035|Humans|humans
5285424|NCT02245022|HIV|hiv
5445390|NCT01522014|Functional Outcomes|functional outcomes
5285425|NCT02245022|Prevention of mother to child transmission|prevention of mother to child transmission
5285426|NCT02245022|Africa|africa
5285427|NCT02245022|Uganda|uganda
5285428|NCT02245022|Pharmacokinetics|pharmacokinetics
5285429|NCT02245022|Pregnancy|pregnancy
5285430|NCT02245022|Breastfeeding|breastfeeding
5285431|NCT02244996|Retinitis pigmentosa|retinitis pigmentosa
5285432|NCT02244996|Lycium barbarum|lycium barbarum
5285433|NCT02244996|Antioxidation|antioxidation
5285434|NCT02244996|Visual field|visual field
5285435|NCT02244996|Electroretinogram|electroretinogram
5285436|NCT02244970|Mindfulness|mindfulness
5285437|NCT02244970|Depressive mood|depressive mood
5285438|NCT02244970|anxiety|anxiety
5285439|NCT02244970|early psychosis|early psychosis
5285440|NCT02244944|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5285441|NCT02244944|NAFLD|nafld
5285442|NCT02244931|Spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device|spinal cord injuries, paraplegic, manual wheelchairs, assisting propelling device
5285443|NCT02244905|Positive Deviance|positive deviance
5285444|NCT02244905|Infection Control|infection control
5285445|NCT02244905|Healthcare-Associated Infections|healthcare-associated infections
5285446|NCT02244905|Staff Engagement|staff engagement
5285447|NCT02244905|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5285448|NCT02244892|Disability glare|disability glare
5285449|NCT02244892|Corneal scar|corneal scar
5285463|NCT02244840|Bidet, Sitz bath, Anal resting pressure|bidet, sitz bath, anal resting pressure
5285464|NCT02244814|glucose|glucose
5285465|NCT02244814|insulin resistance|insulin resistance
5285466|NCT02244814|dietary carbohydrate|dietary carbohydrate
5285467|NCT02244814|dietary fat|dietary fat
5285468|NCT02244814|adiposity|adiposity
5285469|NCT02244814|Air displacement plethysmography|air displacement plethysmography
5285470|NCT02244814|Dual X-ray Absorptiometry|dual x-ray absorptiometry
5285471|NCT02244814|continuous glucose monitoring|continuous glucose monitoring
5285472|NCT02244775|osteo-arthritis|osteo-arthritis
5285473|NCT02244775|post traumatic arthritis|post traumatic arthritis
5285474|NCT02244736|Arterial stiffness|arterial stiffness
5285475|NCT02244736|Endothelial glycocalyx|endothelial glycocalyx
5285476|NCT02244736|Coronary flow reserve|coronary flow reserve
5285477|NCT02244723|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5285478|NCT02244723|diagnosis|diagnosis
5285479|NCT02244710|Circulating Endothelial Cells|circulating endothelial cells
5285480|NCT02244710|Endothelial Progenitor Cells|endothelial progenitor cells
5285481|NCT02244710|Acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5285482|NCT02244710|Ticagrelor|ticagrelor
5285483|NCT02244697|Stridor|stridor
5285484|NCT02244697|Vocal Cord Paralysis (VCP)|vocal cord paralysis (vcp)
5285485|NCT02244697|Ultrasound (US)|ultrasound (us)
5285486|NCT02244684|Folate|folate
5285487|NCT02244684|Folic Acid|folic acid
5285488|NCT02244684|One-Carbon Nutrients|one-carbon nutrients
5285489|NCT02244684|Epigenetics|epigenetics
5285490|NCT02244684|Pregnancy|pregnancy
5285491|NCT02244684|Fetal Health|fetal health
5285492|NCT02244658|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
5285493|NCT02244658|recombinant human thrombopoietin|recombinant human thrombopoietin
5285494|NCT02244658|acute myelocytic leukemia|acute myelocytic leukemia
5285495|NCT02244645|Low back pain, physical therapy, yoga.|low back pain, physical therapy, yoga.
5285508|NCT02244619|Hip replacement|hip replacement
5285509|NCT02244619|Knee replacement|knee replacement
5285510|NCT02244619|randomized trial|randomized trial
5285511|NCT02244619|acetaminophen|acetaminophen
5285512|NCT02244619|post-op pain management|post-op pain management
5285513|NCT02244606|Invasive Candidiasis|invasive candidiasis
5285514|NCT02244606|Invasive Candida infections|invasive candida infections
5285515|NCT02244606|Candidemia|candidemia
5285516|NCT02244606|SCY-078|scy-078
5285517|NCT02244606|Micafungin|micafungin
5285518|NCT02244606|Fluconazole|fluconazole
5285519|NCT02244606|Echinocandin|echinocandin
5285520|NCT02244593|breast cancer survivors|breast cancer survivors
5285521|NCT02244593|FAST MRI|fast mri
5285522|NCT02244593|mammography screening|mammography screening
5285523|NCT02244580|Subtyping of Invasive breast cancer|subtyping of invasive breast cancer
5285524|NCT02244567|PCOS|pcos
5285525|NCT02244554|tattoo removal|tattoo removal
5285526|NCT02244554|Q-switched laser|q-switched laser
5285527|NCT02244554|Nd:YAG laser|nd:yag laser
5285528|NCT02244554|nanosecond laser|nanosecond laser
5285529|NCT02244554|picosecond laser|picosecond laser
5285530|NCT02244554|laser therapy|laser therapy
5285531|NCT02244554|tattoo|tattoo
5285532|NCT02244554|pulsed-laser|pulsed-laser
5285533|NCT02244554|laser treatment|laser treatment
5285534|NCT02244554|remove tattoo|remove tattoo
5962869|NCT04277988|Ultrasonography Lumbar Spine|ultrasonography lumbar spine
5285535|NCT02244554|tattoo clearing|tattoo clearing
5285536|NCT02244554|tattoo lightening|tattoo lightening
5285537|NCT02244554|tattoo lighten|tattoo lighten
5285538|NCT02244554|resistant tattoo|resistant tattoo
5285539|NCT02244515|children|children
5285540|NCT02244502|Ovarian Carcinoma|ovarian carcinoma
5285541|NCT02244502|Treatment|treatment
5285542|NCT02244502|Minimal toxicity|minimal toxicity
5285543|NCT02244502|TTFields|ttfields
5285544|NCT02244502|Tumor Treating Fields|tumor treating fields
5285545|NCT02244502|Novocure|novocure
5285546|NCT02244502|Paclitaxel|paclitaxel
5285547|NCT02244502|Weekly paclitaxel|weekly paclitaxel
5285548|NCT02244476|mouth feel|mouth feel
5285549|NCT02244476|acoustic tribology|acoustic tribology
5285550|NCT02244476|vibration spectrum|vibration spectrum
5285551|NCT02244476|sensory perception|sensory perception
5285552|NCT02244463|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5285553|NCT02244463|Thyroid Cancer|thyroid cancer
5285554|NCT02244450|Neonatal screening|neonatal screening
5285555|NCT02244450|severe combined immunodeficiency|severe combined immunodeficiency
5285556|NCT02244450|T-cell Receptor Excision Circle|t-cell receptor excision circle
5285557|NCT02244437|altitude, altitude illnesses, headache|altitude, altitude illnesses, headache
5285558|NCT02244424|Infant|infant
5285559|NCT02244424|Obesity|obesity
5285560|NCT02244424|Adolescent|adolescent
5285561|NCT02244424|Social media|social media
5285562|NCT02244424|Prevention|prevention
5285563|NCT02244411|EQUAL|equal
5285564|NCT02244411|Exercise|exercise
5285565|NCT02244411|Diet|diet
5285566|NCT02244411|Physical activity|physical activity
5285567|NCT02244411|14-164|14-164
5285568|NCT02244385|vascular disease|vascular disease
5285569|NCT02244385|pregnancy|pregnancy
5285570|NCT02244385|chronic hypertension|chronic hypertension
5285571|NCT02244385|diabetes|diabetes
5285572|NCT02244385|obesity|obesity
5285573|NCT02244372|Cordyceps sinensis mycelium culture extract(Paecilomyces hepiali, CBG-CS-2)|cordyceps sinensis mycelium culture extract(paecilomyces hepiali, cbg-cs-2)
5285574|NCT02244372|immunity|immunity
5285575|NCT02244359|Shared Decision making|shared decision making
5285576|NCT02244359|Patient Centred care|patient centred care
5285577|NCT02244359|Interprofessionalism|interprofessionalism
5285578|NCT02244359|Home care|home care
5285579|NCT02244359|Frail elderly|frail elderly
5285580|NCT02244164|Type 2 Diabetes|type 2 diabetes
5285581|NCT02244164|Incretinomimetics|incretinomimetics
5285582|NCT02244164|DPP-4 inhibitors|dpp-4 inhibitors
5285583|NCT02244164|Pancreas|pancreas
5285584|NCT02244164|PanIN|panin
5285587|NCT02244151|ovulation induction,oocyte maturation timing and collection|ovulation induction,oocyte maturation timing and collection
5285588|NCT02244138|Adolescent|adolescent
5285589|NCT02244138|Screening|screening
5285590|NCT02244138|Primary Care|primary care
5285591|NCT02244138|Computer Decision Support Systems|computer decision support systems
5285592|NCT02244125|Myeloma|myeloma
5285593|NCT02244125|Multiple Myeloma|multiple myeloma
5285594|NCT02244125|Relapse|relapse
5285595|NCT02244125|Refractory|refractory
5285596|NCT02244125|PCD|pcd
5285597|NCT02244125|IFM/DFCI 2009|ifm/dfci 2009
5285598|NCT02244125|Transplantation|transplantation
5285599|NCT02244125|Autologous|autologous
5285600|NCT02244125|Pomalidomide|pomalidomide
5285601|NCT02244125|Immunoglobulin|immunoglobulin
5285602|NCT02244125|Ig|ig
5285603|NCT02244125|Free light Chain|free light chain
5285604|NCT02244099|Controlled substance prescribing|controlled substance prescribing
5285605|NCT02244099|Controlled substance treatment agreements|controlled substance treatment agreements
5285606|NCT02244099|Opioid use|opioid use
5285607|NCT02244086|obstetric pain, bupivacaine, analgesic efficacy|obstetric pain, bupivacaine, analgesic efficacy
5285608|NCT02244073|blood glucose target|blood glucose target
5285609|NCT02244073|ICU|icu
5285610|NCT02244073|insulin|insulin
5285611|NCT02244073|hypoglycemia|hypoglycemia
5285612|NCT02244073|hyperglycemia|hyperglycemia
5285613|NCT02244073|glycated hemoglobin|glycated hemoglobin
5285614|NCT02244060|Vignette|vignette
5391314|NCT01761656|PCI|pci
5285615|NCT02244060|Priming effect|priming effect
5285616|NCT02244021|HD|hd
5285617|NCT02244021|Hodgkin's Lymphoma|hodgkin's lymphoma
5285618|NCT02244021|RELAPSED-REFRACTORY|relapsed-refractory
5285619|NCT02244008|Mobilization|mobilization
5285620|NCT02244008|Joint Range of Motion|joint range of motion
5285621|NCT02244008|Ankle|ankle
5285622|NCT02244008|Manual Therapy|manual therapy
5285623|NCT02243995|Training program|training program
5285624|NCT02243995|Resistance training|resistance training
5285625|NCT02243995|Endurance training|endurance training
5285626|NCT02243995|Muscle strength|muscle strength
5285627|NCT02243995|Exercise capacity|exercise capacity
5285629|NCT02243995|Quality of life|quality of life
5285630|NCT02243982|Parkinson, dementia, FDDNP, tau, beta-amyloid|parkinson, dementia, fddnp, tau, beta-amyloid
5285631|NCT02243969|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5285632|NCT02243969|Alpha-linolenic acid|alpha-linolenic acid
5285633|NCT02243969|Blood pressure|blood pressure
5285634|NCT02243969|Vascular function|vascular function
5285635|NCT02243943|Neuromuscular block|neuromuscular block
5227150|NCT02580071|ALL|all
5285636|NCT02243943|neuromuscular reversal|neuromuscular reversal
5285637|NCT02243943|postoperative conditions|postoperative conditions
5285638|NCT02243943|respiratory failure|respiratory failure
5285639|NCT02243930|Sigmoidoscopy with or without cap|sigmoidoscopy with or without cap
5285640|NCT02243930|Pain during sigmoidoscopy|pain during sigmoidoscopy
5285641|NCT02243930|Sigmoidoscopy and time|sigmoidoscopy and time
5285642|NCT02243904|Autonomic nervous function|autonomic nervous function
5285643|NCT02243904|Blood pressure|blood pressure
5285644|NCT02243904|Cardiovascular regulation|cardiovascular regulation
5285645|NCT02243904|Lead|lead
5285646|NCT02243904|Occupational exposure|occupational exposure
5285647|NCT02243904|Renal function|renal function
5285648|NCT02243852|Growth Hormone Deficiency (GHD)|growth hormone deficiency (ghd)
5285649|NCT02243852|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5285650|NCT02243852|Fibroblast Growth Factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
5285651|NCT02243852|Visceral Fat|visceral fat
5285652|NCT02243852|Subcutaneous Fat|subcutaneous fat
5285653|NCT02243839|Prosthetic valve|prosthetic valve
5285654|NCT02243839|Thrombosis|thrombosis
5285655|NCT02243839|Surgery|surgery
5285656|NCT02243839|Thrombolytic therapy|thrombolytic therapy
5285657|NCT02243839|Transesophageal echocardiography|transesophageal echocardiography
5285658|NCT02243826|Lumbar puncture|lumbar puncture
5285659|NCT02243826|Adults|adults
5285660|NCT02243826|Nitrous oxide|nitrous oxide
5285661|NCT02243826|Procedural pain|procedural pain
5285662|NCT02243826|Procedural anxiety|procedural anxiety
5285663|NCT02243813|Psilocybin|psilocybin
5285664|NCT02243813|Pharmacologic Actions|pharmacologic actions
5285665|NCT02243813|Psychotropic Drugs|psychotropic drugs
5285666|NCT02243800|Vitamin D|vitamin d
5285667|NCT02243800|Rheumatoid arthritis|rheumatoid arthritis
5285668|NCT02243800|Cholecalciferol|cholecalciferol
5285669|NCT02243774|Vaccination|vaccination
5285670|NCT02243774|Immunization|immunization
5285671|NCT02243774|Randomized Controlled Trial|randomized controlled trial
5285672|NCT02243774|Prevention & Control|prevention & control
5285673|NCT02243774|Preventive Measures|preventive measures
5285674|NCT02243774|Health Promotion|health promotion
5285675|NCT02243774|Medicare|medicare
5285676|NCT02243774|Intention Prompts|intention prompts
5285677|NCT02243774|Letters|letters
5285678|NCT02243761|Concurrent Disorders|concurrent disorders
5285679|NCT02243761|Mental Health|mental health
5285680|NCT02243761|Addictions|addictions
5285681|NCT02243761|Caregiver Burden|caregiver burden
5285682|NCT02243722|laryngeal electromyography|laryngeal electromyography
5285683|NCT02243722|intrinsic laryngeal muscles|intrinsic laryngeal muscles
5285684|NCT02243722|recurrent laryngeal nerve|recurrent laryngeal nerve
5285685|NCT02243722|superior laryngeal nerve|superior laryngeal nerve
5285686|NCT02243722|laryngeal sensation|laryngeal sensation
5285687|NCT02243722|tone language|tone language
5285688|NCT02243709|Stress, alcohol craving, alcohol use disorders|stress, alcohol craving, alcohol use disorders
5285689|NCT02243670|opioid addiction|opioid addiction
5285690|NCT02243670|opioid substitution therapy|opioid substitution therapy
5285691|NCT02243670|addiction|addiction
5285692|NCT02243670|buprenorphine maintenance treatment|buprenorphine maintenance treatment
5285693|NCT02243670|opioid dependence|opioid dependence
5285694|NCT02243670|substitution treatment|substitution treatment
5285695|NCT02243670|noncompliance|noncompliance
5285696|NCT02243670|opiate addiction|opiate addiction
5285697|NCT02243670|Zubzolv® maintenance|zubzolv® maintenance
5285698|NCT02243670|adherence monitoring|adherence monitoring
5285699|NCT02243670|directly observed therapy|directly observed therapy
5285700|NCT02243670|medication adherence|medication adherence
5285701|NCT02243670|adherence|adherence
5285702|NCT02243670|mobile|mobile
5285703|NCT02243670|electronic monitoring|electronic monitoring
5285704|NCT02243670|wireless|wireless
5285705|NCT02243670|mobile device|mobile device
5285706|NCT02243670|artificial intelligence|artificial intelligence
5903792|NCT00322127|Mobilization|mobilization
5903793|NCT00322127|CXCR4|cxcr4
5391441|NCT01761045|Satiety|satiety
5285707|NCT02243670|facial recognition|facial recognition
5285708|NCT02243670|computer vision|computer vision
5285709|NCT02243670|visual confirmation|visual confirmation
5285710|NCT02243670|sublingual buprenorphine/naloxone|sublingual buprenorphine/naloxone
5285711|NCT02243670|nonadherence|nonadherence
5285712|NCT02243657|ASP3652|asp3652
5285713|NCT02243657|Age|age
5285714|NCT02243657|Gender|gender
5285715|NCT02243657|Pharmacokinetics|pharmacokinetics
5285716|NCT02243657|Pharmacodynamics|pharmacodynamics
5285717|NCT02243657|Phase 1|phase 1
5285718|NCT02243657|Multiple Ascending Doses (MAD)|multiple ascending doses (mad)
5285729|NCT02243514|Nerve remodeling|nerve remodeling
5285730|NCT02243488|Menstruation|menstruation
5285731|NCT02243488|MHM|mhm
5285732|NCT02243488|Menstrual Hygiene Management|menstrual hygiene management
5285733|NCT02243488|Girls Education|girls education
5285734|NCT02243488|Absenteeism|absenteeism
5285735|NCT02243488|Access to Education|access to education
5285736|NCT02243488|Menstrual Health Education|menstrual health education
5962870|NCT04277975|midurethral sling|midurethral sling
5155205|NCT03022175|Safety|safety
5285737|NCT02243488|Reusable Sanitary Product|reusable sanitary product
5285738|NCT02243462|Shivering|shivering
5285739|NCT02243462|Hypothermia|hypothermia
5169081|NCT02934711|Caregivers|caregivers
5285740|NCT02243462|Postoperative|postoperative
5285741|NCT02243462|Temperature|temperature
5285742|NCT02243462|Forced air warmer|forced air warmer
5285743|NCT02243449|mechanical ventilation|mechanical ventilation
5285746|NCT02243449|critically ill|critically ill
5285747|NCT02243449|screening|screening
5285748|NCT02243449|spontaneous breathing trial|spontaneous breathing trial
5285749|NCT02243449|invasive ventilation|invasive ventilation
5285750|NCT02243436|CLASSICAL HODGKIN LYMPHOMA|classical hodgkin lymphoma
5285751|NCT02243436|HODGKIN LYMPHOMA|hodgkin lymphoma
5285752|NCT02243436|LYMPHOMA|lymphoma
5285753|NCT02243436|HL|hl
5285754|NCT02243423|Aortocaval compression|aortocaval compression
5285755|NCT02243423|Cesarean Section|cesarean section
5285756|NCT02243423|Spinal Anesthesia|spinal anesthesia
5285757|NCT02243423|Phenylephrine|phenylephrine
5285758|NCT02243384|Early Hepatocellular Carcinoma|early hepatocellular carcinoma
5285759|NCT02243384|Laparoscopic Hepatectomy|laparoscopic hepatectomy
5285760|NCT02243384|Radiofrequency Ablation|radiofrequency ablation
5285761|NCT02243384|Micrometastases|micrometastases
5285762|NCT02243358|Pancreatic, cancer|pancreatic, cancer
5285763|NCT02243345|decompression|decompression
5285764|NCT02243345|recompression|recompression
5285765|NCT02243345|delayed|delayed
5285766|NCT02243345|late|late
5285767|NCT02243332|Knee|knee
5285768|NCT02243332|Pain|pain
5285769|NCT02243332|Joint|joint
5285770|NCT02243332|Rehabilitation|rehabilitation
5285771|NCT02243332|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5285772|NCT02243332|Anterior Knee Pain Syndrome|anterior knee pain syndrome
5285773|NCT02243332|Knee Pain|knee pain
5285774|NCT02243332|Quadriceps|quadriceps
5285775|NCT02243306|pharmacokinetics|pharmacokinetics
5285776|NCT02243306|Chronic kidney disease|chronic kidney disease
5285777|NCT02243306|peritoneal dialysis|peritoneal dialysis
5285778|NCT02243306|hemoglobin|hemoglobin
5285782|NCT02243306|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5285783|NCT02243293|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5285784|NCT02243293|Hepatitis C|hepatitis c
5285785|NCT02243293|Chronic Hepatitis C|chronic hepatitis c
5285786|NCT02243293|interferon free|interferon free
5285787|NCT02243293|Hepatitis C Genotype 2|hepatitis c genotype 2
5285788|NCT02243293|Hepatitis C Genotype 3|hepatitis c genotype 3
5285789|NCT02243293|Hepatitis C Genotype 4|hepatitis c genotype 4
5285790|NCT02243293|Hepatitis C Genotype 5|hepatitis c genotype 5
5285791|NCT02243293|Hepatitis C Genotype 6|hepatitis c genotype 6
5285793|NCT02243280|Hepatitis C virus|hepatitis c virus
5285794|NCT02243280|HCV GT1|hcv gt1
5285795|NCT02243280|HCV|hcv
5285796|NCT02243280|Compensated Cirrhosis|compensated cirrhosis
5285797|NCT02243280|HCV GT6|hcv gt6
5285798|NCT02243280|Hepatitis C Genotype 4 (GT 4)|hepatitis c genotype 4 (gt 4)
5285799|NCT02243280|Hepatitis C Genotype 1 (GT1)|hepatitis c genotype 1 (gt1)
5285800|NCT02243280|RBV|rbv
5285801|NCT02243280|Cirrhotic|cirrhotic
5285802|NCT02243280|Hepatitis C|hepatitis c
5285803|NCT02243280|Interferon (IFN) Free|interferon (ifn) free
5285804|NCT02243280|IFN free|ifn free
5285805|NCT02243280|HCV GT5|hcv gt5
5285806|NCT02243280|Chronic Hepatitis C|chronic hepatitis c
5285807|NCT02243280|Ribavirin|ribavirin
5903794|NCT00322127|SDF-1|sdf-1
5285808|NCT02243280|Child Pugh A|child pugh a
5285809|NCT02243280|Hepatitis C Genotype 5 (GT 5)|hepatitis c genotype 5 (gt 5)
5285810|NCT02243280|Hepatitis C Genotype 6 (GT 6)|hepatitis c genotype 6 (gt 6)
5285811|NCT02243280|ABT-493|abt-493
5285812|NCT02243280|ABT-530|abt-530
5285813|NCT02243280|glecaprevir|glecaprevir
5285814|NCT02243280|pibrentasvir|pibrentasvir
5285820|NCT02243228|granulocyte-macrophage colony stimulating factor(GM-CSF)|granulocyte-macrophage colony stimulating factor(gm-csf)
5285821|NCT02243228|Autoimmune pulmonary alveolar proteinosis (PAP)|autoimmune pulmonary alveolar proteinosis (pap)
5285823|NCT02243215|Training|training
5285824|NCT02243215|Off-site|off-site
5285825|NCT02243215|Box trainer|box trainer
5285826|NCT02243215|Virtual Reality Simulator|virtual reality simulator
5285827|NCT02243202|Obesity|obesity
5285828|NCT02243202|Overweight|overweight
5285829|NCT02243202|Canagliflozin|canagliflozin
5285830|NCT02243202|Phentermine|phentermine
5285831|NCT02243202|INVOKANA®|invokana®
5285832|NCT02243189|Healthy|healthy
5285833|NCT02243189|Asthma|asthma
5285834|NCT02243189|JNJ-43260295|jnj-43260295
5285835|NCT02243189|Nasal Allergen Challenge|nasal allergen challenge
5285836|NCT02243176|Saxagliptin|saxagliptin
5285837|NCT02243176|Acarbose|acarbose
5285838|NCT02243176|Type 2 Diabetes|type 2 diabetes
5285839|NCT02243176|Metformin|metformin
5285840|NCT02243124|Anemia|anemia
5962871|NCT04277975|opioid|opioid
5285841|NCT02243124|Transfusion|transfusion
5285842|NCT02243124|AML|aml
5285843|NCT02243124|MDS|mds
5285844|NCT02243124|CLL|cll
5285845|NCT02243124|p53|p53
5285846|NCT02243124|erythropoiesis|erythropoiesis
5285847|NCT02243111|Systemic sclerosis, pulmonary hypertension|systemic sclerosis, pulmonary hypertension
5285848|NCT02243072|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
5285849|NCT02243072|family therapy|family therapy
5285850|NCT02243072|adolescents|adolescents
5285851|NCT02243072|regimen adherence|regimen adherence
5285852|NCT02243072|metabolic control|metabolic control
5285853|NCT02243059|Magnetic Resonance Imaging|magnetic resonance imaging
5285854|NCT02243059|Gadofosveset trisodium|gadofosveset trisodium
5285855|NCT02243059|Nodal imaging|nodal imaging
5285856|NCT02243033|Prostate cancer|prostate cancer
5285857|NCT02243033|Focal therapy|focal therapy
5285858|NCT02243033|Laser therapy|laser therapy
5285859|NCT02243033|Transrectal|transrectal
5285860|NCT02243033|MRI-guided|mri-guided
5285861|NCT02243007|Resectable pancreatic cancer|resectable pancreatic cancer
5285862|NCT02243007|Pancreatic Ductal Carcinoma|pancreatic ductal carcinoma
5285863|NCT02242968|Licensed Vaccines|licensed vaccines
5285864|NCT02242968|Blood Draw|blood draw
5285865|NCT02242968|Investigational Vaccines|investigational vaccines
5285866|NCT02242968|Healthy Volunteers|healthy volunteers
5285867|NCT02242968|Eligibility Screening|eligibility screening
5285868|NCT02242955|Alcohol-dependence|alcohol-dependence
5285870|NCT02242955|Detoxification|detoxification
5285871|NCT02242955|Diazepam|diazepam
5285872|NCT02242955|Benzodiazepines|benzodiazepines
5285873|NCT02242955|Anxiety|anxiety
5285874|NCT02242929|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
5285875|NCT02242929|Treatment|treatment
5285876|NCT02242929|Imiquimod|imiquimod
5285877|NCT02242929|Curettage|curettage
5285884|NCT02242890|intrauterine contraception (IUC)|intrauterine contraception (iuc)
5285885|NCT02242890|social networks|social networks
5285886|NCT02242890|social influence|social influence
5285887|NCT02242890|diffusion of innovation|diffusion of innovation
5285888|NCT02242890|intrauterine device (IUD)|intrauterine device (iud)
5285889|NCT02242890|LARC|larc
5285890|NCT02242799|Malaria|malaria
5285891|NCT02242799|HIV|hiv
5285892|NCT02242799|Dolutegravir|dolutegravir
5285893|NCT02242799|Artemisinin|artemisinin
5285894|NCT02242799|Pharmacokinetics|pharmacokinetics
5285895|NCT02242799|Interactions|interactions
5285896|NCT02242773|Prostate Cancer|prostate cancer
5285897|NCT02242773|Active Surveillance|active surveillance
5285898|NCT02242773|MRI-Guided Biopsy|mri-guided biopsy
5285899|NCT02242773|Multi-parametric MRI|multi-parametric mri
5285900|NCT02242773|MP-MRI|mp-mri
5285901|NCT02242760|acne|acne
5285902|NCT02242747|actinic keratosis|actinic keratosis
5285903|NCT02242747|field cancerization|field cancerization
5285904|NCT02242747|ingenol mebutate|ingenol mebutate
5285905|NCT02242747|5-fluorouracil|5-fluorouracil
5285906|NCT02242747|tolerability|tolerability
5285907|NCT02242747|safety|safety
5285908|NCT02242695|vulvovaginal candidiasis|vulvovaginal candidiasis
5285909|NCT02242695|vulvovaginal candidosis|vulvovaginal candidosis
5903795|NCT00322127|Mozobil|mozobil
5285910|NCT02242695|mycotic vaginal infection|mycotic vaginal infection
5285911|NCT02242695|dequalinium chloride|dequalinium chloride
5285912|NCT02242695|Fluomizin|fluomizin
5285913|NCT02242695|clotrimazole|clotrimazole
5285914|NCT02242695|canesten|canesten
5285915|NCT02242656|Short Bowel Syndrome|short bowel syndrome
5285916|NCT02242656|SBS|sbs
5282945|NCT02257684|ALL|all
5285917|NCT02242656|Chronic Diarrhea|chronic diarrhea
5285918|NCT02242656|Short Bowel|short bowel
5285919|NCT02242656|Short Gut|short gut
5285920|NCT02242656|Short Gut Syndrome|short gut syndrome
5285921|NCT02242656|Anti-Diarrheal|anti-diarrheal
5285922|NCT02242656|Opium Tincture|opium tincture
5285923|NCT02242656|loperamide|loperamide
5285924|NCT02242656|diphenoxylate|diphenoxylate
5285925|NCT02242656|ileostomies|ileostomies
5285926|NCT02242656|tincture of opium|tincture of opium
5285927|NCT02242656|DTO|dto
5285928|NCT02242656|codeine|codeine
5285929|NCT02242656|morphine|morphine
5285930|NCT02242656|opiate|opiate
5285931|NCT02242643|Fluzone Quadrivalent|fluzone quadrivalent
5285932|NCT02242643|Comparator|comparator
5285933|NCT02242643|Children|children
5285934|NCT02242643|Seasonal influenza|seasonal influenza
5285935|NCT02242643|Safety|safety
5285936|NCT02242643|Immunogenicity|immunogenicity
5285937|NCT02242630|Subacromial bursitis|subacromial bursitis
5285938|NCT02242630|Triamcinolone|triamcinolone
5285939|NCT02242630|Methylprednisolone|methylprednisolone
5285940|NCT02242630|Shoulder pain|shoulder pain
5285941|NCT02242617|Adherence|adherence
5285942|NCT02242617|CPAP|cpap
5285943|NCT02242617|Oral Appliance|oral appliance
5285944|NCT02242617|Mandibular Advancement Splints|mandibular advancement splints
5285945|NCT02242617|Preference|preference
5285946|NCT02242591|Knee surgery|knee surgery
5285947|NCT02242591|Saphenous nerve|saphenous nerve
5285948|NCT02242591|Perineural block|perineural block
5285949|NCT02242591|Adductor Canal Block|adductor canal block
5285950|NCT02242591|Postoperative Pain|postoperative pain
5285951|NCT02242591|Mobilization|mobilization
5285952|NCT02242578|Negative symptoms|negative symptoms
5285953|NCT02242565|HIV prevention|hiv prevention
5285955|NCT02242565|adverse events|adverse events
5285956|NCT02242565|wound healing|wound healing
5285957|NCT02242565|voluntary medical male circumcision (VMMC)|voluntary medical male circumcision (vmmc)
5285958|NCT02242565|medical device|medical device
5285959|NCT02242565|Zambia|zambia
5285960|NCT02242526|hiatal hernia, recurrence, biologic mesh, synthetic mesh|hiatal hernia, recurrence, biologic mesh, synthetic mesh
5285961|NCT02242513|Pulsed mode radiofrequency|pulsed mode radiofrequency
5285962|NCT02242513|Plantar Fasciitis|plantar fasciitis
5285963|NCT02242513|Ultrasound-guided|ultrasound-guided
5285964|NCT02242500|Gingival recession/surgery|gingival recession/surgery
5285965|NCT02242500|Collagen/therapeutic use|collagen/therapeutic use
5285966|NCT02242500|Root coverage|root coverage
5285967|NCT02242500|Treatment outcome|treatment outcome
5285968|NCT02242487|Parkinson's Disease|parkinson's disease
5285969|NCT02242487|Motor fluctuations|motor fluctuations
5285970|NCT02242487|levodopa|levodopa
5285971|NCT02242487|inhaled drugs|inhaled drugs
5285972|NCT02242487|OFF episodes|off episodes
5285973|NCT02242474|Rheumatoid arthritis|rheumatoid arthritis
5285974|NCT02242474|Surgical Wound Infection|surgical wound infection
5285975|NCT02242474|Surgical Site Infection|surgical site infection
5285976|NCT02242474|Antirheumatic Agents|antirheumatic agents
5285977|NCT02242474|Perioperative Care|perioperative care
5285979|NCT02242474|Anti-TNF-alpha|anti-tnf-alpha
5285980|NCT02242461|COPD, Rhodiola L., clinical trial, biomarkers, spirometry|copd, rhodiola l., clinical trial, biomarkers, spirometry
5285981|NCT02242448|Healthy Volunteer|healthy volunteer
5285982|NCT02242448|Contrast|contrast
5285983|NCT02242409|Metastatic pancreatic cancer|metastatic pancreatic cancer
5285984|NCT02242409|Second Line treatment|second line treatment
5285985|NCT02242409|Gemcitabine|gemcitabine
5285986|NCT02242409|Nab-paclitaxel|nab-paclitaxel
5285987|NCT02242188|Breastfeeding|breastfeeding
5285988|NCT02242188|Iron supplementation|iron supplementation
5285989|NCT02242188|Psychomotor development|psychomotor development
5285990|NCT02242188|Safety|safety
5285991|NCT02242188|infants|infants
5285992|NCT02242162|phrenic nerves magnetic stimulations|phrenic nerves magnetic stimulations
5285993|NCT02242149|Fat liver|fat liver
5285994|NCT02242149|Diabetes|diabetes
5285995|NCT02242149|Diacerein|diacerein
5285996|NCT02242149|Transient elastography|transient elastography
5285997|NCT02242149|Treatment|treatment
5285998|NCT02242136|Posttraumatic Stress Disorder|posttraumatic stress disorder
5285999|NCT02242136|Aggressive Behavior|aggressive behavior
5286000|NCT02242136|Appetitive Aggression|appetitive aggression
5286001|NCT02242136|Treatment|treatment
5286002|NCT02242136|FORNET|fornet
5286003|NCT02242123|Celiac Disease|celiac disease
5286004|NCT02242123|Gluten-free diet|gluten-free diet
5286005|NCT02242123|EmA assay|ema assay
5286006|NCT02242123|Duodenal culture medium|duodenal culture medium
5286007|NCT02242110|Nightmares|nightmares
5286008|NCT02242110|Sleep|sleep
5286009|NCT02242110|PTSD|ptsd
5903796|NCT00322127|Healthy Volunteer|healthy volunteer
5391856|NCT01759017|IBD|ibd
5286010|NCT02242110|Exposure, Relaxation, and Rescripting Therapy|exposure, relaxation, and rescripting therapy
5286011|NCT02242071|Motor Neuron Disease|motor neuron disease
5286012|NCT02242071|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5286013|NCT02242071|Autologous Mononuclear Cell therapy|autologous mononuclear cell therapy
5286014|NCT02242071|Stem cells|stem cells
5286015|NCT02242032|dry eye disease|dry eye disease
5286017|NCT02241993|Inter-sensor distance|inter-sensor distance
5286018|NCT02241967|total knee arthroplasty|total knee arthroplasty
5286019|NCT02241967|pain|pain
5286020|NCT02241967|post-surgical pain|post-surgical pain
5286021|NCT02241967|opioid|opioid
5169383|NCT02932826|Regulatory T Lymphocyte|regulatory t lymphocyte
5286022|NCT02241967|transcranial direct current stimulation|transcranial direct current stimulation
5286023|NCT02241967|tDCS|tdcs
5286024|NCT02241967|brain stimulation|brain stimulation
5286025|NCT02241967|total hip arthroplasty|total hip arthroplasty
5286026|NCT02241967|TKA|tka
5286027|NCT02241967|THA|tha
5286028|NCT02241928|Muscular Dystrophy|muscular dystrophy
5286029|NCT02241928|Autologous Mononuclear cell therapy|autologous mononuclear cell therapy
5286030|NCT02241928|Stem Cell|stem cell
5286031|NCT02241889|diabetes|diabetes
5286032|NCT02241889|closed-loop|closed-loop
5286033|NCT02241889|bi-hormonal|bi-hormonal
5286034|NCT02241889|exercise|exercise
5286035|NCT02241863|bipolar disorders|bipolar disorders
5286036|NCT02241863|medication adherence|medication adherence
5286037|NCT02241863|psychological intervention|psychological intervention
5286038|NCT02241863|multifaceted intervention|multifaceted intervention
5286039|NCT02241850|High Intensity Training|high intensity training
5286040|NCT02241850|Genetic Polymorphisms|genetic polymorphisms
5286041|NCT02241850|Genome Wide association study|genome wide association study
5286042|NCT02241850|Single Nucleotide Polymorphism genotype|single nucleotide polymorphism genotype
5286043|NCT02241850|Subjects|subjects
5286044|NCT02241837|heart failure|heart failure
5286045|NCT02241837|percutaneous|percutaneous
5286046|NCT02241837|interventional cardiology|interventional cardiology
5286047|NCT02241837|apical remodeling|apical remodeling
5286048|NCT02241837|LV dilatation|lv dilatation
5286049|NCT02241837|akinesis|akinesis
5286050|NCT02241837|dyskinesis|dyskinesis
5167496|NCT02945293|Alcohol|alcohol
5286054|NCT02241811|Diabetic|diabetic
5286055|NCT02241811|Foot|foot
5286056|NCT02241811|Wound|wound
5286057|NCT02241811|Sodium pentaborate pentahydrate|sodium pentaborate pentahydrate
5286058|NCT02241811|Hydrogel|hydrogel
5286059|NCT02241798|epilepsy|epilepsy
5286060|NCT02241798|oxygen saturation|oxygen saturation
5286061|NCT02241798|transcutaneous carbon dioxide|transcutaneous carbon dioxide
5286062|NCT02241798|sudep|sudep
5286063|NCT02241798|pre-oxygenation|pre-oxygenation
5286064|NCT02241733|exercise|exercise
5286065|NCT02241733|pulmonary rehabilitation|pulmonary rehabilitation
5286066|NCT02241733|dynamic hyperinflation|dynamic hyperinflation
5286067|NCT02241707|Varicose vein|varicose vein
5286068|NCT02241707|Endovenous ablation|endovenous ablation
5286069|NCT02241707|Compression|compression
5286070|NCT02241681|Medium Chain Triglycerides|medium chain triglycerides
5286071|NCT02241681|Medium Chain Triglycerides metabolites|medium chain triglycerides metabolites
5286072|NCT02241681|Peptamen 1.5|peptamen 1.5
5286073|NCT02241668|Brain tumor|brain tumor
5286085|NCT02241655|Health related quality of life|health related quality of life
5286086|NCT02241642|Percutaneous vascular closure device|percutaneous vascular closure device
5286087|NCT02241642|vascular closure device|vascular closure device
5286088|NCT02241642|Large hole closure device|large hole closure device
5286089|NCT02241629|motion sickness|motion sickness
5286090|NCT02241603|Insulin resistance|insulin resistance
5286091|NCT02241603|Consummatory Reward|consummatory reward
5286092|NCT02241577|peri-implantitis|peri-implantitis
5286093|NCT02241577|dental implants|dental implants
5286094|NCT02241577|randomized controlled trial|randomized controlled trial
5286095|NCT02241577|non-surgical periodontal treatment|non-surgical periodontal treatment
5273587|NCT02311244|Stroke|stroke
5286096|NCT02241577|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.|will be defined by the presence of alveolar bone loss of at least 3mm, pocket depth of at least 5mm and bleeding on probing.
5286097|NCT02241564|Immunosuppression|immunosuppression
5286099|NCT02241551|Resectable|resectable
5286100|NCT02241551|Pancreatic|pancreatic
5286101|NCT02241551|Cancer|cancer
5286102|NCT02241551|Neoadjuvant|neoadjuvant
5286103|NCT02241551|Chemotheraphy|chemotheraphy
5286104|NCT02241551|Gemcitabine|gemcitabine
5903797|NCT00322127|HV|hv
5391951|NCT01758588|PMF|pmf
5286105|NCT02241551|Nab-Paclitaxel|nab-paclitaxel
5286106|NCT02241551|mFOFIRINOX|mfofirinox
5286107|NCT02241551|Sterotatic Body Radiation Therapy|sterotatic body radiation therapy
5286108|NCT02241538|Pilates-based exercises|pilates-based exercises
5286109|NCT02241525|Pulmonary|pulmonary
5286110|NCT02241525|Thromboembolic|thromboembolic
5286111|NCT02241525|Lung|lung
5286125|NCT02241486|Burn pain|burn pain
5286126|NCT02241486|Procedural pain|procedural pain
5286127|NCT02241486|Sublingual fentanyl|sublingual fentanyl
5286128|NCT02241486|Morphine|morphine
5286129|NCT02241473|gait|gait
5286130|NCT02241473|physical activity|physical activity
5286131|NCT02241473|energy cost|energy cost
5286132|NCT02241473|efficiency|efficiency
5286133|NCT02241460|Premature Ejaculation|premature ejaculation
5286134|NCT02241460|Lidocaine|lidocaine
5286135|NCT02241447|aortic valve Stenosis|aortic valve stenosis
5286136|NCT02241447|Echo|echo
5286137|NCT02241447|TAVI|tavi
5286138|NCT02241447|SAVR|savr
5286141|NCT02241434|Autologous Bone marrow Mononuclear cell therapy|autologous bone marrow mononuclear cell therapy
5286142|NCT02241434|Stem Cells|stem cells
5286267|NCT02240914|May-Thurner Syndrome|may-thurner syndrome
5286143|NCT02241421|Impaired glucose tolerance|impaired glucose tolerance
5286144|NCT02241421|Glucose Metabolism Disorders|glucose metabolism disorders
5286145|NCT02241421|Metabolic Diseases|metabolic diseases
5286445|NCT02239913|Topiramate|topiramate
5286146|NCT02241421|Endocrine System Diseases|endocrine system diseases
5286147|NCT02241421|Hyperinsulinism|hyperinsulinism
5286148|NCT02241421|Lipid metabolism|lipid metabolism
5286149|NCT02241421|Anti Bacterial Agents|anti bacterial agents
5286150|NCT02241421|Gastro Intestinal Tract|gastro intestinal tract
5286151|NCT02241395|Cerebral Palsy|cerebral palsy
5286152|NCT02241395|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
5286153|NCT02241395|stem cell|stem cell
5286154|NCT02241369|Aerodigestive Lesions and Malignancies|aerodigestive lesions and malignancies
5286155|NCT02241369|Human Papillomavirus|human papillomavirus
5286156|NCT02241369|Squamous Cell Carcinoma|squamous cell carcinoma
5286157|NCT02241356|Down syndrome|down syndrome
5286158|NCT02241356|visual functions|visual functions
5286159|NCT02241356|bifocals|bifocals
5286160|NCT02241356|children|children
5286161|NCT02241356|visual acuity at near|visual acuity at near
5286162|NCT02241343|Artificially and reversibly achieved with a blood pressure cuff|artificially and reversibly achieved with a blood pressure cuff
5286163|NCT02241330|Zinc|zinc
5286164|NCT02241330|deficiency|deficiency
5286165|NCT02241330|biofortification|biofortification
5286169|NCT02241317|staff training|staff training
5286170|NCT02241317|Education|education
5286171|NCT02241317|blood glucose|blood glucose
5962872|NCT04277936|Hippocampus|hippocampus
5962873|NCT04277923|parenteral nutrition|parenteral nutrition
5167606|NCT02944500|MRI|mri
5286172|NCT02241304|electromyography|electromyography
5286173|NCT02241304|neuromuscular blockade|neuromuscular blockade
5286174|NCT02241291|Percutaneous Coronary Intervention|percutaneous coronary intervention
5286175|NCT02241291|Registries|registries
5286176|NCT02241278|colon surgery|colon surgery
5286177|NCT02241278|ketamine|ketamine
5286178|NCT02241278|patient-controlled-analgesia|patient-controlled-analgesia
5286179|NCT02241278|preemptive analgesia|preemptive analgesia
5286180|NCT02241265|asthma|asthma
5286181|NCT02241265|thermoplasty|thermoplasty
5286182|NCT02241252|ECG|ecg
5286183|NCT02241252|QT interval|qt interval
5286184|NCT02241252|Sotalol|sotalol
5286185|NCT02241252|Dofetilide|dofetilide
5286186|NCT02241252|iPhone|iphone
5286187|NCT02241226|wellbeing|wellbeing
5286188|NCT02241226|meditation|meditation
5286189|NCT02241226|Ayurveda|ayurveda
5286190|NCT02241226|yoga|yoga
5286191|NCT02241226|herbs|herbs
5286192|NCT02241226|health|health
5286193|NCT02241226|longevity|longevity
5286194|NCT02241226|individuals|individuals
5286195|NCT02241213|Stroke|stroke
5286196|NCT02241213|Aphasia|aphasia
5286197|NCT02241213|Broca|broca
5286198|NCT02241187|PEGPH20|pegph20
5286199|NCT02241187|Cetuximab|cetuximab
5286200|NCT02241187|14-039|14-039
5286201|NCT02241174|Atopic Dermatitis|atopic dermatitis
5286202|NCT02241161|skin eythema|skin eythema
5286203|NCT02241161|rejuvenating cream|rejuvenating cream
5286204|NCT02241161|rejuvenating serum|rejuvenating serum
5286205|NCT02241161|antioxidant serum|antioxidant serum
5286206|NCT02241135|Rav G protein|rav g protein
5286207|NCT02241135|rabies|rabies
5286208|NCT02241135|VNT|vnt
5286209|NCT02241135|immunogenicity|immunogenicity
5286210|NCT02241135|PrEP vaccination|prep vaccination
5286211|NCT02241135|mRNA|mrna
5286212|NCT02241135|CV7201|cv7201
5286213|NCT02241122|prostate cancer|prostate cancer
5286214|NCT02241122|PSA|psa
5286215|NCT02241122|MRI|mri
5286216|NCT02241122|biopsy|biopsy
5286217|NCT02241122|biomarker|biomarker
5286218|NCT02241109|aortic stenosis progression|aortic stenosis progression
5286219|NCT02241109|aortic valve sclerosis progression|aortic valve sclerosis progression
5286220|NCT02241109|calcification propensity|calcification propensity
5286221|NCT02241070|mindfulness meditation|mindfulness meditation
5286222|NCT02241070|mental health promotion|mental health promotion
5286223|NCT02241070|worker|worker
5286224|NCT02241057|temperature profile|temperature profile
5286225|NCT02241057|air activated 3-cell patch|air activated 3-cell patch
5286226|NCT02241057|adhesion|adhesion
5286227|NCT02241044|argon plasma coagulation, bleeding peptic ulcer|argon plasma coagulation, bleeding peptic ulcer
5286228|NCT02241031|Megakaryocytic Progenitor Products|megakaryocytic progenitor products
5286229|NCT02241031|Hematological Diseases|hematological diseases
5286230|NCT02241031|Thrombocytopenia|thrombocytopenia
5286231|NCT02241018|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5286232|NCT02241018|Mesenchymal Stem Cells|mesenchymal stem cells
5286233|NCT02241018|CD25 Monoclonal Antibody|cd25 monoclonal antibody
5286234|NCT02241018|Acute Graft-versus-host disease|acute graft-versus-host disease
5286235|NCT02241005|Health-care associated infection|health-care associated infection
5286236|NCT02241005|Skin integrity|skin integrity
5283251|NCT02255773|HNC|hnc
5286240|NCT02240992|Peripheral Blood Stem Cell|peripheral blood stem cell
5286242|NCT02240992|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5286243|NCT02240979|arterial waveform|arterial waveform
5286244|NCT02240979|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5286251|NCT02240953|Anticoagulation|anticoagulation
5286252|NCT02240953|Prosthetic Heart Valves|prosthetic heart valves
5286253|NCT02240953|Acetylsalicylic acid|acetylsalicylic acid
5286254|NCT02240953|Warfarin|warfarin
5286255|NCT02240953|Thrombosis|thrombosis
5286256|NCT02240940|Heart Failure|heart failure
5286257|NCT02240940|Volume Reduction|volume reduction
5286258|NCT02240940|Pressure Reduction|pressure reduction
5286259|NCT02240940|Ischemic Heart Failure|ischemic heart failure
5286260|NCT02240940|LAD Infarct|lad infarct
5286261|NCT02240927|Anticoagulation|anticoagulation
5286262|NCT02240927|Prosthetic Heart Valves|prosthetic heart valves
5286263|NCT02240927|Pregnancy|pregnancy
5286264|NCT02240927|Warfarin|warfarin
5286265|NCT02240927|Thrombosis|thrombosis
5286266|NCT02240914|Iliac Vein Obstruction|iliac vein obstruction
5286268|NCT02240914|Cockett Syndrome|cockett syndrome
5286269|NCT02240914|Vascular Ultrasound|vascular ultrasound
5286270|NCT02240914|IVUS|ivus
5286271|NCT02240901|Laryngeal mask airway|laryngeal mask airway
5286272|NCT02240901|endotracheal intubation|endotracheal intubation
5286273|NCT02240901|postoperative pulmonary complications|postoperative pulmonary complications
5286274|NCT02240901|elderly patients|elderly patients
5286276|NCT02240888|vaccination|vaccination
5286277|NCT02240888|antibody|antibody
5286278|NCT02240888|response|response
5962874|NCT04277923|lipid emulsion|lipid emulsion
5286279|NCT02240888|immunosuppressive|immunosuppressive
5286280|NCT02240888|treatment|treatment
5286281|NCT02240888|inflammatory|inflammatory
5286282|NCT02240888|rheumatic|rheumatic
5286283|NCT02240888|disease|disease
5286284|NCT02240875|Ebola|ebola
5286285|NCT02240875|Zaire|zaire
5286286|NCT02240849|Neck pain|neck pain
5286287|NCT02240849|functional pillow|functional pillow
5286288|NCT02240849|sleep|sleep
5286289|NCT02240849|cervical lordosis|cervical lordosis
5286290|NCT02240823|Erectile Function|erectile function
5286291|NCT02240823|Mesenchymal Stromal Cells|mesenchymal stromal cells
5286292|NCT02240823|Stem Cell|stem cell
5286293|NCT02240797|Anorexia Nervosa|anorexia nervosa
5286294|NCT02240797|Neuroimaging|neuroimaging
5286295|NCT02240797|Positron emission tomography (PET)|positron emission tomography (pet)
5286296|NCT02240797|[11C]PKAB|[11c]pkab
5286303|NCT02240771|Transarterial chemotherapy|transarterial chemotherapy
5286304|NCT02240771|Thalidomide|thalidomide
5286305|NCT02240771|Capecitabine|capecitabine
5286306|NCT02240758|glioma, confocal laser endomicroscopy|glioma, confocal laser endomicroscopy
5286307|NCT02240745|Echocardiography, Stress|echocardiography, stress
5286308|NCT02240745|Echocardiography, Three-Dimensional|echocardiography, three-dimensional
5286309|NCT02240745|Coronary Artery Disease|coronary artery disease
5286310|NCT02240745|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5286311|NCT02240745|Coronary Circulation|coronary circulation
5286312|NCT02240615|Epiphora|epiphora
5286313|NCT02240615|Lacrimal Stent|lacrimal stent
5286314|NCT02240615|Lacrimal System|lacrimal system
5286315|NCT02240602|acute pain|acute pain
5286316|NCT02240602|postoperative|postoperative
5286317|NCT02240602|surgery|surgery
5286318|NCT02240589|Traumatic Brain Injury|traumatic brain injury
5286319|NCT02240589|Memantine|memantine
5286320|NCT02240589|Memory|memory
5286321|NCT02240576|surgery for nasal fracture|surgery for nasal fracture
5286322|NCT02240563|autoimmune thyroiditis|autoimmune thyroiditis
5286323|NCT02240563|LLLT|lllt
5286324|NCT02240563|safety|safety
5286325|NCT02240563|ultrasound|ultrasound
5286326|NCT02240550|Open Inguinal Hernia|open inguinal hernia
5286327|NCT02240537|AML|aml
5286328|NCT02240537|MM|mm
5286329|NCT02240537|MDS|mds
5286330|NCT02240537|sMM|smm
5286331|NCT02240524|Gastric adenocarcinoma|gastric adenocarcinoma
5286332|NCT02240524|HIPEC|hipec
5286333|NCT02240524|Paclitaxel|paclitaxel
5286334|NCT02240524|Oxaliplatin|oxaliplatin
5286335|NCT02240524|Capecitabine|capecitabine
5286336|NCT02240511|Body Composition|body composition
5286337|NCT02240511|Amino Acids Supplementation|amino acids supplementation
5286338|NCT02240511|Resistance Exercise|resistance exercise
5286339|NCT02240498|Abscess|abscess
5286340|NCT02240498|Drainage|drainage
5286341|NCT02240485|Pathological gambling|pathological gambling
5286342|NCT02240485|Treatment|treatment
5286343|NCT02240485|Marital relationship|marital relationship
5286344|NCT02240472|sentinel node biopsy, lymph node metastasis, survival|sentinel node biopsy, lymph node metastasis, survival
5283334|NCT02255253|hypertension|hypertension
5286349|NCT02240420|Type 2 diabetes prevention in the post-partum|type 2 diabetes prevention in the post-partum
5286350|NCT02240420|Behavior change among Latinas,|behavior change among latinas,
5286351|NCT02240420|Health Coaching, Motivational interviewing techniques|health coaching, motivational interviewing techniques
5286352|NCT02240407|Pompe Disease|pompe disease
5286353|NCT02240407|Gene Therapy|gene therapy
5286354|NCT02240407|Repeated dosing|repeated dosing
5286355|NCT02240407|Immune modulation|immune modulation
5286356|NCT02240394|TCD Traumatic brain injury increased intracranial pressure|tcd traumatic brain injury increased intracranial pressure
5286357|NCT02240368|Depth anesthesia monitors|depth anesthesia monitors
5286358|NCT02240368|Children anesthesia|children anesthesia
5286359|NCT02240368|Bispectral monitor|bispectral monitor
5286360|NCT02240368|Entropy monitor|entropy monitor
5286361|NCT02240342|Ovarian reserve|ovarian reserve
5286362|NCT02240342|Poor response|poor response
5286363|NCT02240342|Follicle recruitment|follicle recruitment
5286364|NCT02240342|Bone marrow transplant|bone marrow transplant
5286365|NCT02240329|respiratory|respiratory
5286367|NCT02240303|pain|pain
5286368|NCT02240303|mobility|mobility
5286369|NCT02240303|brain|brain
5286370|NCT02240303|cognition|cognition
5286371|NCT02240290|C14|c14
5286372|NCT02240290|Dosimetry|dosimetry
5286373|NCT02240290|Mass balance|mass balance
5286374|NCT02240290|ADME|adme
5286375|NCT02240277|Septic Shock|septic shock
5286376|NCT02240277|Meropenem|meropenem
5286377|NCT02240277|Ciprofloxacin|ciprofloxacin
5286378|NCT02240277|Pharmacokinetics|pharmacokinetics
5286379|NCT02240264|Omega-3 fatty acids|omega-3 fatty acids
5286380|NCT02240264|Cognitive function|cognitive function
5286381|NCT02240264|Academic performance|academic performance
5286382|NCT02240264|Mental health|mental health
5286383|NCT02240264|Eye tracking|eye tracking
5286384|NCT02240264|Krill oil|krill oil
5286385|NCT02240264|LCPUFA|lcpufa
5286386|NCT02240251|Inferior Vena Cava Filter|inferior vena cava filter
5286387|NCT02240251|IVC Filter|ivc filter
5286388|NCT02240251|IVC filter removal|ivc filter removal
5286389|NCT02240251|Excimer Laser|excimer laser
5286390|NCT02240225|COPD;SRI;Reliability;validity;|copd;sri;reliability;validity;
5167812|NCT02943369|cangrelor|cangrelor
5167813|NCT02943369|ticagrelor|ticagrelor
5167816|NCT02943330|Depression|depression
5286391|NCT02240212|second line treatment|second line treatment
5286392|NCT02240212|oncology|oncology
5286393|NCT02240212|AKT inhibitor|akt inhibitor
5286394|NCT02240212|paclitaxel|paclitaxel
5286395|NCT02240212|HER2 (ErbB2) negative advanced gastric cancer|her2 (erbb2) negative advanced gastric cancer
5286396|NCT02240212|Afuresertib|afuresertib
5286397|NCT02240186|Microprocessor-controlled knee|microprocessor-controlled knee
5286398|NCT02240186|prosthesis|prosthesis
5286399|NCT02240186|amputation|amputation
5286400|NCT02240173|antipsychotic Jobelyn schizophrenia sorghum bicolor|antipsychotic jobelyn schizophrenia sorghum bicolor
5286401|NCT02240160|Sativex|sativex
5286402|NCT02240160|Pharmacokinetics|pharmacokinetics
5286403|NCT02240160|Oral pH|oral ph
5286404|NCT02240147|adult congenital heart disease|adult congenital heart disease
5286405|NCT02240147|exercise capacity|exercise capacity
5286406|NCT02240147|exercise training|exercise training
5286407|NCT02240147|physical activity|physical activity
5286408|NCT02240121|Crohn's Disease|crohn's disease
5286409|NCT02240121|Rifaximin|rifaximin
5286410|NCT02240121|Clinical remission with endoscopic response|clinical remission with endoscopic response
5286411|NCT02240121|Inflammatory Bowel Disease|inflammatory bowel disease
5286412|NCT02240108|Crohn's Disease|crohn's disease
5286413|NCT02240108|Rifaximin|rifaximin
5286414|NCT02240108|Clinical remission with endoscopic response|clinical remission with endoscopic response
5286415|NCT02240108|Inflammatory Bowel Disease|inflammatory bowel disease
5286416|NCT02240082|Shiftwork|shiftwork
5286417|NCT02240082|Sleep disruption|sleep disruption
5286419|NCT02240030|Parkinson's Disease|parkinson's disease
5286420|NCT02240030|Motor fluctuations|motor fluctuations
5286421|NCT02240030|levodopa|levodopa
5286422|NCT02240030|inhaled drugs|inhaled drugs
5286423|NCT02240030|OFF episodes|off episodes
5286424|NCT02240017|Urothelial cancer, renal function impaired.|urothelial cancer, renal function impaired.
5286425|NCT02239991|Point of care|point of care
5286426|NCT02239991|perioperative hemostasis|perioperative hemostasis
5286427|NCT02239991|thromboelastometry|thromboelastometry
5286428|NCT02239991|bleeding risk|bleeding risk
5286429|NCT02239991|end-stage liver disease|end-stage liver disease
5286430|NCT02239991|hepatic coagulopathy|hepatic coagulopathy
5286431|NCT02239991|whole blood coagulation|whole blood coagulation
5286432|NCT02239978|Parkinson Disease|parkinson disease
5181965|NCT02852616|Course|course
5286433|NCT02239978|Posture Balance|posture balance
5286434|NCT02239978|Learning|learning
5286435|NCT02239978|Dopamine|dopamine
5286436|NCT02239965|Neuromuscular blockade|neuromuscular blockade
5286437|NCT02239965|Neuromuscular monitoring|neuromuscular monitoring
5286438|NCT02239965|Focus group interview|focus group interview
5286439|NCT02239965|Clinical observation|clinical observation
5286440|NCT02239939|older adults, body composition, weight loss, muscle mass|older adults, body composition, weight loss, muscle mass
5286441|NCT02239926|IBS-D|ibs-d
5286442|NCT02239913|Cocaine|cocaine
5286443|NCT02239913|Pharmacotherapy|pharmacotherapy
5286444|NCT02239913|Phentermine|phentermine
5286446|NCT02239913|Self-Administration|self-administration
5286447|NCT02239900|Liver Cancer|liver cancer
5286448|NCT02239900|Lung Cancer|lung cancer
5286449|NCT02239900|Adrenal Gland|adrenal gland
5286450|NCT02239900|Metastasis|metastasis
5286451|NCT02239900|Advanced Solid Malignancies|advanced solid malignancies
5286452|NCT02239900|Ipilimumab|ipilimumab
5286453|NCT02239900|Yervoy|yervoy
5286454|NCT02239900|BMS-734016|bms-734016
5286455|NCT02239900|MDX010|mdx010
5286456|NCT02239900|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5286457|NCT02239900|SBRT|sbrt
5286459|NCT02239887|LAA occlusion|laa occlusion
5286460|NCT02239887|Non-valvular Atrial Fibrillation|non-valvular atrial fibrillation
5286461|NCT02239887|Percutaneous|percutaneous
5286462|NCT02239887|Oral Anticoagulation|oral anticoagulation
5286463|NCT02239887|Occluder|occluder
5286464|NCT02239887|WAVECREST|wavecrest
5286465|NCT02239874|mammographic breast density, breast disease, breast tissue|mammographic breast density, breast disease, breast tissue
5286466|NCT02239861|Rhabdomyosarcoma|rhabdomyosarcoma
5286467|NCT02239861|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5286468|NCT02239822|Electrodes, Implanted|electrodes, implanted
5286469|NCT02239822|Electric Stimulation Therapy|electric stimulation therapy
5286470|NCT02239809|Electrodes, Implanted|electrodes, implanted
5286471|NCT02239809|Electric Stimulation Therapy|electric stimulation therapy
5286472|NCT02239796|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
5286473|NCT02239796|Randomised controlled trial|randomised controlled trial
5286474|NCT02239796|Feasibility|feasibility
5286475|NCT02239783|osteoarthritis|osteoarthritis
5286476|NCT02239783|avascular necrosis|avascular necrosis
5286478|NCT02239783|protrusio acetabuli|protrusio acetabuli
5286479|NCT02239783|painful hip dysplasia|painful hip dysplasia
5286480|NCT02239783|rheumatoid arthritis|rheumatoid arthritis
5962875|NCT04277923|SMOF|smof
5962876|NCT04277923|PNALD|pnald
5962877|NCT04277923|oxidative stress|oxidative stress
5962878|NCT04277858|oropharynx cancer|oropharynx cancer
5286481|NCT02239783|correction of functional deformity|correction of functional deformity
5286482|NCT02239783|revision procedures|revision procedures
5286483|NCT02239770|Nicotine|nicotine
5286484|NCT02239770|Random Delivery|random delivery
5286485|NCT02239770|Smoking Cessation|smoking cessation
5286486|NCT02239770|Plasma Nicotine|plasma nicotine
5286487|NCT02239770|Oral Film|oral film
5286488|NCT02239757|Transradial Approach, Primary PCI, ST-segment elevation myocardial infarction|transradial approach, primary pci, st-segment elevation myocardial infarction
5286489|NCT02239744|air pollution|air pollution
5286490|NCT02239744|air purification|air purification
5286491|NCT02239744|intervention|intervention
5286492|NCT02239744|randomized controlled trial|randomized controlled trial
5286493|NCT02239744|cardiovascular health|cardiovascular health
5286494|NCT02239744|pulmonary health|pulmonary health
5286495|NCT02239731|EGFRI|egfri
5286496|NCT02239731|Epidermal Growth Factor Receptor Inhibition|epidermal growth factor receptor inhibition
5286497|NCT02239731|Skin toxicity|skin toxicity
5286498|NCT02239731|Topical|topical
5286499|NCT02239731|Doxycycline|doxycycline
5286500|NCT02239731|Foam|foam
5286501|NCT02239731|Phase II|phase ii
5286502|NCT02239731|Cetuximab|cetuximab
5286503|NCT02239731|Panitumumab|panitumumab
5286504|NCT02239731|Vectibix|vectibix
5286505|NCT02239731|Erbitux|erbitux
5286506|NCT02239731|Rash|rash
5286507|NCT02239718|Resin bonded bridges|resin bonded bridges
5286508|NCT02239718|Clinical trial|clinical trial
5286509|NCT02239718|Prospective|prospective
5286510|NCT02239718|Survival|survival
5286511|NCT02239718|Oral health related quality of life|oral health related quality of life
5286512|NCT02239705|Trans pulmonary thermodilution|trans pulmonary thermodilution
5286513|NCT02239705|Hemodynamic|hemodynamic
5286514|NCT02239679|Actinic Keratosis|actinic keratosis
5286515|NCT02239666|Dermatology, plaque psoriasis, biologic treatment, biologic naive|dermatology, plaque psoriasis, biologic treatment, biologic naive
5286516|NCT02239614|dengue fever|dengue fever
5286517|NCT02239614|dengue|dengue
5286518|NCT02239601|Physical Therapy|physical therapy
5286519|NCT02239601|Physiotherapy|physiotherapy
5286520|NCT02239601|Breast Cancer|breast cancer
5286521|NCT02239601|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
5286522|NCT02239601|Nerve gliding exercises|nerve gliding exercises
5286523|NCT02239601|Nerve Entrapment|nerve entrapment
5286524|NCT02239575|Assorted cancers (oncology)|assorted cancers (oncology)
5286525|NCT02239562|sPIF|spif
5286526|NCT02239562|synthetic PreImplantation Factor|synthetic preimplantation factor
5286527|NCT02239562|Autoimmune|autoimmune
5286528|NCT02239562|Liver|liver
5286529|NCT02239562|Hepatitis|hepatitis
5286530|NCT02239549|Colonic Polyps|colonic polyps
5286531|NCT02239549|Polypectomy|polypectomy
5286532|NCT02239536|neoplastic colorectal polyp|neoplastic colorectal polyp
5286533|NCT02239536|hot snare polypectomy|hot snare polypectomy
5286534|NCT02239536|hot snare polypectomy after saline injection|hot snare polypectomy after saline injection
5286535|NCT02239523|Pathologic fracture|pathologic fracture
5286536|NCT02239523|Insufficiency fracture|insufficiency fracture
5286537|NCT02239523|Secondary fracture|secondary fracture
5286538|NCT02239523|Fracture with bone fragility|fracture with bone fragility
5286539|NCT02239523|Osteoporosis|osteoporosis
5286540|NCT02239523|Bone loss|bone loss
5286541|NCT02239523|Osteopenia|osteopenia
5286542|NCT02239523|Metabolic Bone Disease|metabolic bone disease
5286543|NCT02239523|Fragility fracture|fragility fracture
5286544|NCT02239510|constipation|constipation
5286545|NCT02239510|bowel habits|bowel habits
5286546|NCT02239497|postoperatory pain|postoperatory pain
5286547|NCT02239497|orthopaedic surgery|orthopaedic surgery
5286548|NCT02239497|femoral block|femoral block
5286549|NCT02239432|Adenocarcinoma of the Lung|adenocarcinoma of the lung
5286550|NCT02239432|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
5286551|NCT02239419|Critical Limb Ischemia|critical limb ischemia
5286552|NCT02239419|Limb Ischemia|limb ischemia
5286553|NCT02239419|Wound Care|wound care
5286554|NCT02239419|Hemodialysis|hemodialysis
5286555|NCT02239419|Dialysis|dialysis
5286556|NCT02239419|Skin Ulceration|skin ulceration
5286557|NCT02239406|metal on metal total hip|metal on metal total hip
5286558|NCT02239406|avasuclar necrosis|avasuclar necrosis
5286559|NCT02239406|acetabular revision|acetabular revision
5286560|NCT02239406|bone vascularity|bone vascularity
5286561|NCT02239393|Multiple Sclerosis|multiple sclerosis
5286562|NCT02239393|Mesenchymal Stem Cells|mesenchymal stem cells
5286563|NCT02239393|MSC|msc
5286564|NCT02239380|Lorazepam|lorazepam
5286565|NCT02239380|Status Epilepticus|status epilepticus
5286566|NCT02239341|hospitalized|hospitalized
5286567|NCT02239341|activity restriction|activity restriction
5286568|NCT02239341|bed rest|bed rest
5286569|NCT02239341|antepartum|antepartum
5286570|NCT02239341|pregnant|pregnant
5286571|NCT02239341|high risk|high risk
5286572|NCT02239328|Lung cancer|lung cancer
5286575|NCT02239315|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5286576|NCT02239315|RNA Disruption Assay™ (RDA) score|rna disruption assay™ (rda) score
5369150|NCT01861080|target organ damage|target organ damage
5286577|NCT02239315|Pathological Complete Response (pCR)|pathological complete response (pcr)
5286578|NCT02239315|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
5286579|NCT02239302|Obstructed defaecation syndrome|obstructed defaecation syndrome
5286580|NCT02239302|Transperineal Ultrasound|transperineal ultrasound
5286581|NCT02239302|Endovaginal Ultrasound|endovaginal ultrasound
5286582|NCT02239302|Evacuation Proctography|evacuation proctography
5286583|NCT02239289|Low back pain|low back pain
5286584|NCT02239289|Rehabilitation|rehabilitation
5286585|NCT02239289|Biofeedback|biofeedback
5286586|NCT02239289|Electromyography|electromyography
5286587|NCT02239289|Kinematic|kinematic
5286588|NCT02239276|Stiripentol|stiripentol
5286589|NCT02239276|Dravet syndrome|dravet syndrome
5286590|NCT02239276|Epilepsy|epilepsy
5286591|NCT02239276|Epileptic Encephalopathies|epileptic encephalopathies
5286592|NCT02239250|Child health|child health
5286593|NCT02239250|Pneumonia|pneumonia
5286594|NCT02239250|Diarrhoea|diarrhoea
5286595|NCT02239250|Household air pollution|household air pollution
5286596|NCT02239250|PM2.5|pm2.5
5286597|NCT02239250|Stove intervention|stove intervention
5286598|NCT02239250|Biomass fuel|biomass fuel
5286599|NCT02239250|Monitoring and evaluation|monitoring and evaluation
5286600|NCT02239250|Water filter|water filter
5286601|NCT02239250|Compliance|compliance
5286602|NCT02239250|Thermotolerant coliforms|thermotolerant coliforms
5286603|NCT02239250|Rwanda|rwanda
5286604|NCT02239224|FSHD|fshd
5286605|NCT02239211|BUTEO|buteo
5286606|NCT02239211|Primary sclerosing cholangitis|primary sclerosing cholangitis
5286607|NCT02239211|PSC|psc
5286608|NCT02239211|VAP-1|vap-1
5286609|NCT02239211|BTT1023|btt1023
5286610|NCT02239211|Human monoclonal antibody|human monoclonal antibody
5286612|NCT02239198|nutrition bar|nutrition bar
5286613|NCT02239185|Laparoscopy|laparoscopy
5286614|NCT02239185|purse string|purse string
5286615|NCT02239185|hernial sac|hernial sac
5286616|NCT02239159|transcutaneous electric acupoint stimulation|transcutaneous electric acupoint stimulation
5286617|NCT02239159|elderly patients|elderly patients
5286618|NCT02239133|Pelvic Organ Prolapse|pelvic organ prolapse
5286619|NCT02239133|POP|pop
5286620|NCT02239107|polycystic ovary syndrome|polycystic ovary syndrome
5286621|NCT02239107|laparoscopic drilling|laparoscopic drilling
5286622|NCT02239107|clomiphene citrate|clomiphene citrate
5286623|NCT02239107|n acetyl cysteine|n acetyl cysteine
5286624|NCT02239107|insulin resistance|insulin resistance
5286625|NCT02239094|Bipolar Disorder|bipolar disorder
5286626|NCT02239094|depression|depression
5286627|NCT02239094|Bipolar depression|bipolar depression
5286628|NCT02239081|Pharmacokinetics|pharmacokinetics
5286629|NCT02239081|Safety|safety
5286631|NCT02239055|Borderline Personality Disorder|borderline personality disorder
5286632|NCT02239055|Mentalization Based Treatment|mentalization based treatment
5286633|NCT02239055|MBT Skills Training|mbt skills training
5286634|NCT02239055|Staff Nurse Perceptions|staff nurse perceptions
5286635|NCT02239055|Acute Mental Health|acute mental health
5286636|NCT02239042|Gingival recessions|gingival recessions
5286637|NCT02239029|Platelet rich plasma|platelet rich plasma
5286638|NCT02239029|Osteoarthritis of knee|osteoarthritis of knee
5286639|NCT02239029|Balance|balance
5286640|NCT02239029|Strength|strength
5286646|NCT02238977|ESRD|esrd
5286647|NCT02238977|hemodialysis|hemodialysis
5862758|NCT00001524|Aphthous Ulcers|aphthous ulcers
5862761|NCT00001522|Insulin Resistance|insulin resistance
5286648|NCT02238951|care coordination, mobile health, chemotherapy, technology|care coordination, mobile health, chemotherapy, technology
5286649|NCT02238938|piecemeal polypectomy|piecemeal polypectomy
5286650|NCT02238938|piecemeal endoscopic mucosal resection (EMR)|piecemeal endoscopic mucosal resection (emr)
5286651|NCT02238938|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
5286652|NCT02238938|endoscopic en-bloc resection|endoscopic en-bloc resection
5286653|NCT02238925|Newly Diagnosed AML|newly diagnosed aml
5286655|NCT02238925|Relapsed/Refractory AML|relapsed/refractory aml
5286656|NCT02238925|Relapsed/Refractory ALL|relapsed/refractory all
5286658|NCT02238912|tinea|tinea
5286659|NCT02238886|Quality of Life|quality of life
5286660|NCT02238886|Enteral nutrition|enteral nutrition
5286661|NCT02238886|Nutrition Therapy|nutrition therapy
5286662|NCT02238886|Parenteral nutrition, total|parenteral nutrition, total
5286663|NCT02238873|lymphoma|lymphoma
5286664|NCT02238873|neutropenia|neutropenia
5286665|NCT02238873|pegfilgrastim|pegfilgrastim
5286666|NCT02238860|Hepatitis B|hepatitis b
5286667|NCT02238860|cirrhosis|cirrhosis
5286668|NCT02238860|Entacavir|entacavir
5286669|NCT02238860|enofovir|enofovir
5286674|NCT02238834|Phase I|phase i
5286675|NCT02238834|Safety and tolerability|safety and tolerability
5286676|NCT02238834|Pharmacokinetic|pharmacokinetic
5286677|NCT02238834|Randomized|randomized
5286678|NCT02238834|Double Blind|double blind
5286679|NCT02238834|Placebo-Controlled|placebo-controlled
5291470|NCT02217865|CRC|crc
5286680|NCT02238834|Single- & Multiple Dose Escalation|single- & multiple dose escalation
5286681|NCT02238834|FP-025|fp-025
5286682|NCT02238834|MMP-12 inhibitor|mmp-12 inhibitor
5286683|NCT02238821|resectable colorectal cancer|resectable colorectal cancer
5286684|NCT02238808|ER+ breast cancer|er+ breast cancer
5286685|NCT02238808|Luminal A|luminal a
5286686|NCT02238808|Estradiol|estradiol
5286687|NCT02238795|Purpura fulminans, Sepsis, Epidemiology, Morbidity, Therapy|purpura fulminans, sepsis, epidemiology, morbidity, therapy
5286688|NCT02238782|bioavailability|bioavailability
5286689|NCT02238782|pharmacokinetics|pharmacokinetics
5286690|NCT02238782|I phase|i phase
5286691|NCT02238782|AZD6244|azd6244
5286692|NCT02238782|cancer|cancer
5286693|NCT02238769|Hepatocellular Carcinoma, 18F-FluoroethylCholine PET|hepatocellular carcinoma, 18f-fluoroethylcholine pet
5286694|NCT02238730|Depression|depression
5286695|NCT02238730|Depressive Disorder|depressive disorder
5286696|NCT02238730|Treatment Resistant Depressive Disorder|treatment resistant depressive disorder
5286697|NCT02238730|Bipolar Disorder|bipolar disorder
5286698|NCT02238730|Major Depressive Disorder|major depressive disorder
5286699|NCT02238730|Electroconvulsive therapy|electroconvulsive therapy
5286700|NCT02238717|Pain|pain
5286701|NCT02238717|evoked pain|evoked pain
5286702|NCT02238717|healthy volunteer|healthy volunteer
5286703|NCT02238717|pharmacodynamics|pharmacodynamics
5286704|NCT02238704|Adherence|adherence
5286705|NCT02238704|Calcium supplementation|calcium supplementation
5286706|NCT02238704|Prevention of preeclampsia|prevention of preeclampsia
5286707|NCT02238704|Adherence to calcium supplementation|adherence to calcium supplementation
5286708|NCT02238691|PEEP|peep
5286709|NCT02238691|Air insufflation|air insufflation
5286710|NCT02238691|Mask ventilation|mask ventilation
5286711|NCT02238691|Esophageal manometry|esophageal manometry
5286712|NCT02238691|Esophageal impedance|esophageal impedance
5286713|NCT02238652|Nursing homes|nursing homes
5286714|NCT02238652|Dementia|dementia
5286715|NCT02238652|Quality of Life|quality of life
5286716|NCT02238652|Geriatrics|geriatrics
5286718|NCT02238652|Activities of Daily Living|activities of daily living
5286719|NCT02238652|Pain|pain
5286720|NCT02238652|Pain management|pain management
5286721|NCT02238652|Advance Care Planning|advance care planning
5286722|NCT02238652|Patient Safety|patient safety
5286723|NCT02238652|Costs and Cost Analysis|costs and cost analysis
5286724|NCT02238652|Medication Errors|medication errors
5286725|NCT02238652|Medical Order Entry Systems|medical order entry systems
5286726|NCT02238652|Medication Reconciliation|medication reconciliation
5286727|NCT02238652|Medication Therapy Management|medication therapy management
5286728|NCT02238652|Depression|depression
5286729|NCT02238652|Psychotropic Drugs|psychotropic drugs
5286730|NCT02238652|Informed Consent|informed consent
5286731|NCT02238652|Presumed Consent|presumed consent
5286732|NCT02238652|Anxiety|anxiety
5286733|NCT02238652|Apathy|apathy
5286734|NCT02238652|Hospitalization|hospitalization
5286735|NCT02238652|Mortality|mortality
5286736|NCT02238639|Venous thromboembolism|venous thromboembolism
5286737|NCT02238639|COPD exacerbations|copd exacerbations
5286738|NCT02238639|Anticoagulation|anticoagulation
5286739|NCT02238639|Mortality|mortality
5286740|NCT02238626|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5286741|NCT02238626|pharmacotherapy|pharmacotherapy
5286742|NCT02238626|intervention|intervention
5286743|NCT02238626|prospective|prospective
5286744|NCT02238626|safety endpoint|safety endpoint
5286745|NCT02238626|preliminary efficacy|preliminary efficacy
5286746|NCT02238626|ibudilast|ibudilast
5286747|NCT02238613|Radioactive stents|radioactive stents
5286748|NCT02238613|Brachytherapy|brachytherapy
5286751|NCT02238613|Cholangiocarcinoma of the Extrahepatic Bile Duct|cholangiocarcinoma of the extrahepatic bile duct
5286752|NCT02238613|ampullary carcinoma|ampullary carcinoma
5286753|NCT02238587|Gandoerma Spores Powder Capsules, head-and-neck cancer.|gandoerma spores powder capsules, head-and-neck cancer.
5286754|NCT02238561|non-invasive|non-invasive
5286755|NCT02238561|measurement of oxygen|measurement of oxygen
5286756|NCT02238561|consumption|consumption
5286757|NCT02238561|delivery|delivery
5286758|NCT02238561|post-operative complications|post-operative complications
5286759|NCT02238548|immunity|immunity
5286760|NCT02238548|vaccination|vaccination
5286761|NCT02238548|milk|milk
5286762|NCT02238522|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5286763|NCT02238522|B-prolymphocytic leukemia|b-prolymphocytic leukemia
5286764|NCT02238522|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5286765|NCT02238522|follicular lymphoma|follicular lymphoma
5286766|NCT02238522|mantle cell lymphoma|mantle cell lymphoma
5286767|NCT02238522|marginal zone lymphoma|marginal zone lymphoma
5286768|NCT02238522|small lymphocytic lymphoma|small lymphocytic lymphoma
5286769|NCT02238522|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5286770|NCT02238522|unclassifiable lymphoma|unclassifiable lymphoma
5286771|NCT02238522|T-cell lymphoma|t-cell lymphoma
5286772|NCT02238522|Richter's syndrome|richter's syndrome
5286773|NCT02238522|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5286774|NCT02238509|Breast cancer|breast cancer
5286781|NCT02238509|Lapatinib|lapatinib
5286782|NCT02238509|Trastuzumab|trastuzumab
5286783|NCT02238509|anti HER2 therapies|anti her2 therapies
5286784|NCT02238496|Glioblastoma|glioblastoma
5286785|NCT02238496|Anaplastic Astrocytoma|anaplastic astrocytoma
5286786|NCT02238496|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
5168236|NCT02940574|Oxytocin|oxytocin
5286787|NCT02238496|Mixed Glioma|mixed glioma
5286788|NCT02238496|akt-Oncogene Protein|akt-oncogene protein
5286789|NCT02238496|mTOR Protein|mtor protein
5286791|NCT02238496|Brain Neoplasms|brain neoplasms
5286792|NCT02238496|Brain Tumor, Recurrent|brain tumor, recurrent
5286793|NCT02238483|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5286794|NCT02238483|COPD patients|copd patients
5286795|NCT02238483|Exacerbations|exacerbations
5286796|NCT02238483|ICS|ics
5286797|NCT02238483|LABA|laba
5286798|NCT02238470|Ischemic stroke|ischemic stroke
5286799|NCT02238470|Intracerebral hemorrhage|intracerebral hemorrhage
5286800|NCT02238470|Subdural hemorrhage|subdural hemorrhage
5286801|NCT02238470|Microbleed|microbleed
5286802|NCT02238470|Leukoaraiosis|leukoaraiosis
5286803|NCT02238470|Oral anticoagulants|oral anticoagulants
5286804|NCT02238457|Heart failure|heart failure
5286805|NCT02238457|Losartan|losartan
5286806|NCT02238444|Warfarin|warfarin
5286807|NCT02238444|Portal Vein|portal vein
5286808|NCT02238444|Anticoagulants|anticoagulants
5286809|NCT02238444|Cirrhosis|cirrhosis
5286810|NCT02238444|Hypertension|hypertension
5286811|NCT02238444|Venous Thrombosis|venous thrombosis
5286812|NCT02238444|Splenectomy|splenectomy
5286813|NCT02238431|Lucrin depot,|lucrin depot,
5286814|NCT02238431|frozen embryo transfer,|frozen embryo transfer,
5286815|NCT02238431|artificial cycle,|artificial cycle,
5286816|NCT02238431|pregnancy,|pregnancy,
5286817|NCT02238431|cancellation|cancellation
5286818|NCT02238418|Vitamin D, Calciuria, Paediatrics, Nephrology|vitamin d, calciuria, paediatrics, nephrology
5286819|NCT02238392|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5286820|NCT02238392|pulmonary vein isolation|pulmonary vein isolation
5286821|NCT02238392|adenosine|adenosine
5286822|NCT02238392|AF terminatin|af terminatin
5286823|NCT02238379|Intranasal oxytocin|intranasal oxytocin
5286824|NCT02238379|Social perception|social perception
5286826|NCT02238340|Postoperatory pain|postoperatory pain
5286827|NCT02238340|Oxycodone|oxycodone
5286828|NCT02238327|Antiretroviral therapy|antiretroviral therapy
5286829|NCT02238327|pulmonary function|pulmonary function
5286830|NCT02238327|biomarkers|biomarkers
5286831|NCT02238301|Intrauterine growth restriction|intrauterine growth restriction
5286832|NCT02238301|BOLD effect|bold effect
5286833|NCT02238288|anticoagulation|anticoagulation
5286834|NCT02238288|extraction|extraction
5286835|NCT02238288|epsilon amino caproic|epsilon amino caproic
5286836|NCT02238054|Cardiology|cardiology
5286837|NCT02238054|Intracoronary angioplasty|intracoronary angioplasty
5286838|NCT02238054|Bioresorbable stent|bioresorbable stent
5286839|NCT02238041|Glucose monitoring|glucose monitoring
5286840|NCT02238041|Intensive care unit|intensive care unit
5286841|NCT02238028|Heart rate variability|heart rate variability
5286842|NCT02238028|Blood pressure|blood pressure
5286843|NCT02238028|Circulating biomarkers|circulating biomarkers
5286844|NCT02238028|Respirator|respirator
5286845|NCT02238028|Fine particulate matter|fine particulate matter
5286846|NCT02238015|cataract ,tear film,SS-OCT|cataract ,tear film,ss-oct
5286847|NCT02238002|shallow anterior chamber|shallow anterior chamber
5286848|NCT02238002|narrow angle|narrow angle
5286849|NCT02238002|SS-OCT|ss-oct
5286850|NCT02237989|knee osteoarthritis, native collagen type 2, paracetamol|knee osteoarthritis, native collagen type 2, paracetamol
5286851|NCT02237937|Depression, Affective Disorder|depression, affective disorder
5286852|NCT02237924|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5286853|NCT02237924|endostar|endostar
5286854|NCT02237924|IMRT|imrt
5286855|NCT02237924|chemoradiation|chemoradiation
5286856|NCT02237911|total knee replacement|total knee replacement
5286857|NCT02237911|rehabilitation|rehabilitation
5286858|NCT02237911|exercise program|exercise program
5286859|NCT02237911|total knee arthroplasty|total knee arthroplasty
5286860|NCT02237898|Tobacco cessation|tobacco cessation
5286861|NCT02237885|Military Veterans|military veterans
5286862|NCT02237872|Brown Adipose Tissue|brown adipose tissue
5286863|NCT02237859|cdiff|cdiff
5286864|NCT02237859|vancomycin|vancomycin
5286865|NCT02237859|infection|infection
5286866|NCT02237859|clostridium difficile|clostridium difficile
5286867|NCT02237846|osteoarthritis|osteoarthritis
5286868|NCT02237846|knee|knee
5286869|NCT02237846|stem cells|stem cells
5286870|NCT02237846|mesenchymal|mesenchymal
5286872|NCT02237833|septic shock|septic shock
5286873|NCT02237833|cerebral oximetry|cerebral oximetry
5286874|NCT02237833|vasopressor|vasopressor
5286875|NCT02237833|norepinephrine|norepinephrine
5286876|NCT02237807|Fed Conditions|fed conditions
5286878|NCT02237781|IVF|ivf
5286879|NCT02237781|ovarian stimulation|ovarian stimulation
5286880|NCT02237768|Fasting conditions|fasting conditions
5286881|NCT02237755|Clomiphene citrate|clomiphene citrate
5286882|NCT02237755|IVF|ivf
5286883|NCT02237755|Pregnancy Rates|pregnancy rates
5286884|NCT02237755|Ovarian Reserve|ovarian reserve
5962879|NCT04277858|throat cancer|throat cancer
5286885|NCT02237729|healthy subjects|healthy subjects
5286886|NCT02237729|immunology|immunology
5286887|NCT02237729|PK|pk
5168334|NCT02939820|RNAi therapeutic|rnai therapeutic
5168336|NCT02939820|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
5168337|NCT02939820|TTR|ttr
5168338|NCT02939820|Transthyretin|transthyretin
5168339|NCT02939820|Amyloidosis|amyloidosis
5168340|NCT02939807|Yeliva™|yeliva™
5168341|NCT02939807|hepatocellular carcinoma|hepatocellular carcinoma
5168342|NCT02939807|ABC294640|abc294640
5168343|NCT02939807|hepatic neoplasms|hepatic neoplasms
5168344|NCT02939807|liver neoplasms|liver neoplasms
5168345|NCT02939807|hepatic cancer|hepatic cancer
5168346|NCT02939794|cardiac surgery|cardiac surgery
5168347|NCT02939794|hemoglobin|hemoglobin
5168348|NCT02939794|iron|iron
5168350|NCT02939755|Cancer|cancer
5286888|NCT02237729|Phase 1|phase 1
5170266|NCT02927587|TCI|tci
5286889|NCT02237729|bioequivalence|bioequivalence
5286890|NCT02237729|biosimilarity|biosimilarity
5286891|NCT02237729|adalimumab|adalimumab
5286892|NCT02237729|single dose.|single dose.
5286893|NCT02237703|Post-traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5286894|NCT02237703|Positron emission tomography (PET)|positron emission tomography (pet)
5286895|NCT02237703|Neuroimaging|neuroimaging
5286896|NCT02237703|Kappa opioid receptor (KOR)|kappa opioid receptor (kor)
5286897|NCT02237677|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5286898|NCT02237677|Trauma|trauma
5286899|NCT02237677|Neuroimaging|neuroimaging
5286900|NCT02237677|Positron emission tomography (PET)|positron emission tomography (pet)
5286901|NCT02237677|[11C]OMAR|[11c]omar
5286902|NCT02237677|Endocannabinoid|endocannabinoid
5286903|NCT02237664|Thoracoscopy|thoracoscopy
5286904|NCT02237664|Patient-controlled analgesia|patient-controlled analgesia
5286905|NCT02237664|Paravertebral analgesia|paravertebral analgesia
5286906|NCT02237651|anesthesia|anesthesia
5286907|NCT02237651|bronchosocopy|bronchosocopy
5286908|NCT02237651|lung transplantation|lung transplantation
5286909|NCT02237638|VEGF|vegf
5286910|NCT02237638|Vaccine|vaccine
5286911|NCT02237638|Angiogenesis|angiogenesis
5286912|NCT02237625|Hypophosphatasia|hypophosphatasia
5286913|NCT02237625|HPP|hpp
5286914|NCT02237599|SSEP|ssep
5286915|NCT02237599|neuropraxia|neuropraxia
5286916|NCT02237599|intraoperative|intraoperative
5286917|NCT02237599|automated|automated
5286918|NCT02237586|Plasmodium falciparum malaria|plasmodium falciparum malaria
5286920|NCT02237586|PfSPZ Challenge|pfspz challenge
5286921|NCT02237586|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
5286922|NCT02237586|Sickle Cell Trait|sickle cell trait
5286923|NCT02237586|Sporozoites|sporozoites
5286924|NCT02237573|general practice|general practice
5286925|NCT02237573|viral infections|viral infections
5286926|NCT02237573|consultation reports|consultation reports
5286927|NCT02237573|drug prescription|drug prescription
5286928|NCT02237560|MCI|mci
5286929|NCT02237560|Exergaming|exergaming
5286930|NCT02237560|Cognition|cognition
5286931|NCT02237560|Exercise|exercise
5286932|NCT02237560|Older Adults|older adults
5286933|NCT02237547|spinal cord injury|spinal cord injury
5286934|NCT02237547|mesenchymal|mesenchymal
5286935|NCT02237547|bone marrow|bone marrow
5286936|NCT02237547|mononuclear cells|mononuclear cells
5286937|NCT02237547|stem cells|stem cells
5286938|NCT02237547|umbilical cord|umbilical cord
5286939|NCT02237534|Lanthanum|lanthanum
5286940|NCT02237534|Calcium Carbonate|calcium carbonate
5286941|NCT02237534|Vascular Calcification|vascular calcification
5286942|NCT02237521|Incretin hormones|incretin hormones
5286943|NCT02237521|End-stage renal disease|end-stage renal disease
5286944|NCT02237521|ESRD|esrd
5286945|NCT02237521|GLP-1|glp-1
5286946|NCT02237521|GIP|gip
5286947|NCT02237521|Insulin|insulin
5286948|NCT02237521|Glucagon|glucagon
5286949|NCT02237469|Breast cancer|breast cancer
5286950|NCT02237469|Breast conserving surgery.|breast conserving surgery.
5286951|NCT02237469|Radiotherapy.|radiotherapy.
5286952|NCT02237469|Treatment planning.|treatment planning.
5286953|NCT02237469|Prone.|prone.
5286954|NCT02237456|Myocardial infarction|myocardial infarction
5862762|NCT00001522|Race|race
5286955|NCT02237456|Atherosclerosis|atherosclerosis
5286957|NCT02237456|OCT|oct
5962880|NCT04277858|HPV related throat cancer|hpv related throat cancer
5962881|NCT04277858|tonsil cancer|tonsil cancer
5962882|NCT04277858|base of tongue cancer|base of tongue cancer
5962883|NCT04277832|psoriasis|psoriasis
5962884|NCT04277832|psoriatic arthritis|psoriatic arthritis
5962885|NCT04277832|screening tool|screening tool
5962886|NCT04277793|CBT|cbt
5962887|NCT04277793|Digital|digital
5962888|NCT04277793|Internet-based|internet-based
5962889|NCT04277793|Depression|depression
5962890|NCT04277793|Anxiety|anxiety
5962891|NCT04277793|Self-guided|self-guided
5962892|NCT04277793|Problem Solving|problem solving
5962893|NCT04277793|ICBT|icbt
5962894|NCT04277780|continuous glucose monitoring sensors|continuous glucose monitoring sensors
5286958|NCT02237456|Optical coherence tomography|optical coherence tomography
5286959|NCT02237456|Stent|stent
5286960|NCT02237456|Bioresorbable stents|bioresorbable stents
5286961|NCT02237443|Patient Safety|patient safety
5962895|NCT04277780|hospital readmission|hospital readmission
5962896|NCT04277767|AD EEG OCT biomarker|ad eeg oct biomarker
5962897|NCT04277754|developmet|developmet
5962898|NCT04277754|motor|motor
5962899|NCT04277754|visual|visual
5228779|NCT02571543|IVF|ivf
5286962|NCT02237430|Coronary angiography (CAG)|coronary angiography (cag)
5286963|NCT02237417|MRI|mri
5286964|NCT02237417|Imaging|imaging
5286965|NCT02237417|Antipsychotic|antipsychotic
5286966|NCT02237404|Follow-Up studies|follow-up studies
5286967|NCT02237404|Biological Pacemakers|biological pacemakers
5286968|NCT02237404|Telemedicine|telemedicine
5286969|NCT02237404|Efficiency|efficiency
5286970|NCT02237391|High Frequency Emergency Department Visits|high frequency emergency department visits
5286971|NCT02237391|Healthcare Utilization|healthcare utilization
5286972|NCT02237391|Chronic Pain|chronic pain
5286973|NCT02237391|Interdisciplinary|interdisciplinary
5286974|NCT02237378|FDG lung and RV uptake|fdg lung and rv uptake
5286975|NCT02237365|neurological disability|neurological disability
5286976|NCT02237365|tuberculous meningitis (TBM)|tuberculous meningitis (tbm)
5286978|NCT02237365|aspirin|aspirin
5286979|NCT02237365|efficacy|efficacy
5286980|NCT02237352|Diabetes mellitus|diabetes mellitus
5286981|NCT02237352|Diabetic nephropathy|diabetic nephropathy
5286982|NCT02237352|Social Factors|social factors
5286983|NCT02237352|Biological Factors|biological factors
5286984|NCT02237352|VEGF-A|vegf-a
5286985|NCT02237352|Tenascin C|tenascin c
5286986|NCT02237352|Disease characterization|disease characterization
5286987|NCT02237352|Mechanisms|mechanisms
5286988|NCT02237352|Kidney|kidney
5286989|NCT02237352|Chronic kidney disease|chronic kidney disease
5286990|NCT02237352|Secondary nephropathy|secondary nephropathy
5286991|NCT02237352|South America|south america
5286992|NCT02237352|Hispanics|hispanics
5286993|NCT02237352|Ecuador|ecuador
5286994|NCT02237352|Biomarkers|biomarkers
5286995|NCT02237339|Allopurinol|allopurinol
5286996|NCT02237339|Cardiac MRI (CMR)|cardiac mri (cmr)
5286997|NCT02237339|Flow mediated dilatation (FMD)|flow mediated dilatation (fmd)
5286998|NCT02237339|Pulse wave analysis (PWA)|pulse wave analysis (pwa)
5286999|NCT02237339|Endothelial function|endothelial function
5287000|NCT02237339|Scar|scar
5287001|NCT02237339|Hypertrophy|hypertrophy
5287002|NCT02237339|Hypertension|hypertension
5287003|NCT02237326|Visual Inspection with Acetic Acid|visual inspection with acetic acid
5287004|NCT02237326|Visual Inspection with Lugol's Iodine|visual inspection with lugol's iodine
5287005|NCT02237326|Cervical Intraepithelial neoplasia|cervical intraepithelial neoplasia
5287006|NCT02237326|Cervical Cancer Screening|cervical cancer screening
5287007|NCT02237326|HIV infected women|hiv infected women
5287008|NCT02237313|psychological support|psychological support
5287009|NCT02237313|therapeutic education|therapeutic education
5287010|NCT02237313|vulnerability of patients|vulnerability of patients
5287011|NCT02237300|Bulimia nervosa|bulimia nervosa
5287012|NCT02237300|Binge eating disorder|binge eating disorder
5287013|NCT02237300|Food craving|food craving
5287015|NCT02237300|Bingeing|bingeing
5287016|NCT02237300|Cue Exposure Therapy|cue exposure therapy
5287017|NCT02237300|Virtual Reality|virtual reality
5287018|NCT02237274|Fontan circulation|fontan circulation
5287019|NCT02237274|High altitude exposure|high altitude exposure
5287020|NCT02237261|Newly diagnosed symptomatic multiple myeloma|newly diagnosed symptomatic multiple myeloma
5287021|NCT02237248|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5287022|NCT02237248|Functional Movement Screen|functional movement screen
5287023|NCT02237248|Y Balance Test|y balance test
5287024|NCT02237235|Schizophrenia|schizophrenia
5287025|NCT02237235|Schizoaffective disorder|schizoaffective disorder
5287026|NCT02237235|Cognition|cognition
5287027|NCT02237235|Magnesium|magnesium
5287028|NCT02237235|Imaging|imaging
5287029|NCT02237235|Negative symptoms|negative symptoms
5287030|NCT02237222|Outcome Assessment|outcome assessment
5287031|NCT02237222|Gait|gait
5287032|NCT02237222|Neuromuscular Diseases|neuromuscular diseases
5287033|NCT02237222|Psychometrics|psychometrics
5287034|NCT02237222|Clinical Assessment Tools|clinical assessment tools
5287035|NCT02237196|cat-allergic|cat-allergic
5287036|NCT02237196|cat immunotherapy|cat immunotherapy
5287037|NCT02237196|anti-thymic stromal lymphopoietin (anti-TSLP)|anti-thymic stromal lymphopoietin (anti-tslp)
5287038|NCT02237170|Sipuleucel-T|sipuleucel-t
5287039|NCT02237170|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5287040|NCT02237170|Provenge|provenge
5287041|NCT02237157|pancreatic cancer|pancreatic cancer
5287042|NCT02237157|unresectable|unresectable
5287043|NCT02237157|gemcitabine|gemcitabine
5287044|NCT02237157|device|device
5287045|NCT02237157|local delivery|local delivery
5287046|NCT02237157|chemoembolization|chemoembolization
5287047|NCT02237131|Endometriosis|endometriosis
5287048|NCT02237131|Oral contraceptives|oral contraceptives
5287049|NCT02237131|Laparoscopy|laparoscopy
5287050|NCT02237118|Acute|acute
5287051|NCT02237118|wound|wound
5287052|NCT02237118|management|management
5287053|NCT02237118|measured|measured
5284022|NCT02251639|VELScope|velscope
5287059|NCT02237053|Glucagon|glucagon
5287060|NCT02237053|Octreotide|octreotide
5962900|NCT04277754|infant|infant
5287061|NCT02237053|Weight loss|weight loss
5287062|NCT02237040|Children|children
5287063|NCT02237040|mandible|mandible
5182583|NCT02848521|DCE|dce
5962901|NCT04277702|atherosclerosis|atherosclerosis
5287064|NCT02237040|condylar fracture|condylar fracture
5287065|NCT02237040|conservative treatment|conservative treatment
5287066|NCT02237040|functional treatment|functional treatment
5287067|NCT02237027|HIV|hiv
5287068|NCT02237027|Early treatment as prevention (TasP)|early treatment as prevention (tasp)
5287069|NCT02237027|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5287070|NCT02237027|antiretroviral treatment|antiretroviral treatment
5287071|NCT02237027|prevention|prevention
5287072|NCT02237027|feasibility|feasibility
5287073|NCT02237027|female sex workers|female sex workers
5287074|NCT02237027|Benin|benin
5287075|NCT02237027|West Africa|west africa
5287076|NCT02237001|meniscal|meniscal
5287077|NCT02237001|meniscus|meniscus
5287078|NCT02237001|repair|repair
5287079|NCT02237001|knee|knee
5287080|NCT02237001|arthroscopy knee|arthroscopy knee
5287081|NCT02237001|horizontal|horizontal
5287082|NCT02236988|Apremilast|apremilast
5287083|NCT02236988|Healthy male subjects|healthy male subjects
5287084|NCT02236988|Pharmacokinetics|pharmacokinetics
5287085|NCT02236949|pediatric pain|pediatric pain
5287086|NCT02236949|intervention sustainability|intervention sustainability
5287087|NCT02236936|Squamous Cell Carcinoma|squamous cell carcinoma
5287088|NCT02236936|Head and neck|head and neck
5287089|NCT02236936|SCCHN|scchn
5287090|NCT02236936|Parenteral nutrition|parenteral nutrition
5287091|NCT02236936|Larynx|larynx
5287092|NCT02236936|Hypopharynx|hypopharynx
5287093|NCT02236936|Cavum oris|cavum oris
5287094|NCT02236936|Radiotherapy|radiotherapy
5287095|NCT02236936|Cetuximab|cetuximab
5287096|NCT02236936|Cisplatin|cisplatin
5287097|NCT02236923|cardiovascular|cardiovascular
5287098|NCT02236923|surgery|surgery
5287099|NCT02236923|ascending aorta|ascending aorta
5287100|NCT02236923|aortic dissection|aortic dissection
5287101|NCT02236910|somatostatin receptor positive tumour|somatostatin receptor positive tumour
5287102|NCT02236884|rectal cancer|rectal cancer
5287103|NCT02236884|no scar|no scar
5287104|NCT02236884|NOTES|notes
5287105|NCT02236884|TaTME|tatme
5287106|NCT02236884|feasibility|feasibility
5287107|NCT02236884|safety|safety
5287108|NCT02236871|Adolescents|adolescents
5287109|NCT02236871|Dairy|dairy
5287110|NCT02236871|Bone|bone
5287111|NCT02236858|COPD|copd
5287112|NCT02236845|Insomnia, medical device, sleep latency|insomnia, medical device, sleep latency
5287113|NCT02236806|Breast cancer|breast cancer
5287114|NCT02236806|Adjuvant chemotherapy|adjuvant chemotherapy
5287115|NCT02236806|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5287116|NCT02236806|Cardioprotection|cardioprotection
5287117|NCT02236806|Anthracyclines|anthracyclines
5287118|NCT02236780|in vitro fertilisation|in vitro fertilisation
5287119|NCT02236780|environmental conditions|environmental conditions
5287120|NCT02236780|pregnancy|pregnancy
5287121|NCT02236780|live birth rate|live birth rate
5287122|NCT02236754|dihydrotetrabenazine|dihydrotetrabenazine
5287123|NCT02236754|beta cell mass|beta cell mass
5287124|NCT02236754|diabetes mellitus|diabetes mellitus
5287125|NCT02236702|Major Depressive Disorder|major depressive disorder
5287126|NCT02236702|Anhedonia|anhedonia
5287127|NCT02236702|Positron Emission Tomography (PET)|positron emission tomography (pet)
5287128|NCT02236702|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
5287129|NCT02236676|motor learning TBI|motor learning tbi
5287130|NCT02236663|Intimate Partner Violence|intimate partner violence
5287131|NCT02236663|Dating Violence|dating violence
5287132|NCT02236663|Relationships|relationships
5287133|NCT02236663|Safety Planning|safety planning
5287134|NCT02236663|College|college
5287135|NCT02236663|Student|student
5287137|NCT02236650|Parental Resilience|parental resilience
5287138|NCT02236650|Parental Stress|parental stress
5287139|NCT02236650|Family Adaptation|family adaptation
5287140|NCT02236650|Autistic Disorder|autistic disorder
5287141|NCT02236650|Behavior|behavior
5287142|NCT02236650|Child Behavior|child behavior
5287143|NCT02236650|Child Development Disorders|child development disorders
5287144|NCT02236650|Pervasive Developmental Disabilities|pervasive developmental disabilities
5287145|NCT02236650|Caregivers|caregivers
5287147|NCT02236650|Parenting|parenting
5287148|NCT02236650|Primary Health Care|primary health care
5287149|NCT02236637|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5287150|NCT02236637|Registry|registry
5287151|NCT02236637|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5287152|NCT02236611|COPD|copd
5287153|NCT02236611|inhaler ease of use|inhaler ease of use
5287154|NCT02236611|glycopyrronium|glycopyrronium
5287155|NCT02236611|umeclidinium|umeclidinium
5287156|NCT02236611|novel dry powder inhaler|novel dry powder inhaler
5287157|NCT02236611|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5287158|NCT02236611|inhaler errors|inhaler errors
5287159|NCT02236598|borderline hypokalemia|borderline hypokalemia
5287160|NCT02236598|glucose tolerance|glucose tolerance
5287161|NCT02236598|insulin secretion|insulin secretion
5287162|NCT02236598|insulin sensitivity|insulin sensitivity
5287163|NCT02236598|fasting glucose|fasting glucose
5287164|NCT02236598|African American|african american
5287165|NCT02236585|uterine artery embolization, epidural , patient-controlled analgesia|uterine artery embolization, epidural , patient-controlled analgesia
5287166|NCT02236572|Postmenopausal|postmenopausal
5287167|NCT02236572|ER-positive, PR-positive, HER2-negative|er-positive, pr-positive, her2-negative
5287168|NCT02236572|Low and intermediate risk|low and intermediate risk
5287169|NCT02236559|high flow therapy|high flow therapy
5287170|NCT02236559|high flow nasal cannula|high flow nasal cannula
5287171|NCT02236559|acute respiratory failure|acute respiratory failure
5287172|NCT02236559|noninvasive ventilation|noninvasive ventilation
5287173|NCT02236546|fluorodeoxyglucose|fluorodeoxyglucose
5287174|NCT02236546|FDG|fdg
5287175|NCT02236546|PET/CT|pet/ct
5287177|NCT02236546|imaging biomarkers|imaging biomarkers
5287178|NCT02236546|cancer imaging|cancer imaging
5287179|NCT02236520|Na+ MRI|na+ mri
5287180|NCT02236520|salt stores|salt stores
5287181|NCT02236494|alcoholism|alcoholism
5287182|NCT02236494|dangerous behavior|dangerous behavior
5287183|NCT02236494|aged|aged
5287184|NCT02236494|emergency medicine|emergency medicine
5287185|NCT02236455|complementary medicine|complementary medicine
5287186|NCT02236455|state anxiety|state anxiety
5287187|NCT02236455|acute pain|acute pain
5287188|NCT02236455|self-efficacy|self-efficacy
5287189|NCT02236455|surgery|surgery
5287190|NCT02236455|medical music intervention|medical music intervention
5287191|NCT02236455|nature therapy|nature therapy
5287192|NCT02236455|relaxation technique|relaxation technique
5287193|NCT02236442|Cephalalgia|cephalalgia
5287194|NCT02236442|Headache|headache
5287195|NCT02236442|Migraine|migraine
5287196|NCT02236442|Pain|pain
5287197|NCT02236442|Global|global
5287198|NCT02236442|Treatment|treatment
5287199|NCT02236442|Oxygen|oxygen
5287200|NCT02236442|Emergency|emergency
5287201|NCT02236442|Treatment of cephalalgia in emergency department|treatment of cephalalgia in emergency department
5287202|NCT02236429|bacterial vaginitis|bacterial vaginitis
5287203|NCT02236429|vaginal flora|vaginal flora
5287204|NCT02236429|microbiome|microbiome
5287205|NCT02236416|Dementia|dementia
5287206|NCT02236416|Prevention|prevention
5287207|NCT02236416|Physical Activity|physical activity
5287208|NCT02236403|Blepharitis , Demodex, Ivermectin, Metronidazole|blepharitis , demodex, ivermectin, metronidazole
5393311|NCT01752166|Candida|candida
5287209|NCT02236390|Nightmare|nightmare
5287210|NCT02236390|PTSD|ptsd
5287211|NCT02236390|Sleep|sleep
5287212|NCT02236390|Emotion Regulation|emotion regulation
5287213|NCT02236390|Exposure Relaxation and Rescripting Therapy|exposure relaxation and rescripting therapy
5287214|NCT02236390|Cognitive Processing Therapy|cognitive processing therapy
5287215|NCT02236377|ERRT|errt
5287216|NCT02236377|Nightmares|nightmares
5287217|NCT02236377|Sleep|sleep
5287219|NCT02236377|PTSD|ptsd
5287220|NCT02236351|patching|patching
5287221|NCT02236351|pediatric ophthalmology|pediatric ophthalmology
5287222|NCT02236338|chronic venous insufficiency|chronic venous insufficiency
5287223|NCT02236338|varicose vein|varicose vein
5287224|NCT02236338|greater saphenous vein|greater saphenous vein
5287225|NCT02236299|Right Coronary Artery|right coronary artery
5287226|NCT02236299|Percutaneous Coronary Intervention|percutaneous coronary intervention
5287227|NCT02236299|Diastolic Dysfunction|diastolic dysfunction
5287228|NCT02236299|Glucagon-like peptide-1|glucagon-like peptide-1
5287229|NCT02236299|GLP-1|glp-1
5287230|NCT02236299|Stunning|stunning
5287231|NCT02236299|Cardioprotection|cardioprotection
5287232|NCT02236286|freezing of gait (FOG)|freezing of gait (fog)
5287233|NCT02236286|balance|balance
5287234|NCT02236286|gait|gait
5287235|NCT02236286|exercise|exercise
5287236|NCT02236273|Human papillomavirus|human papillomavirus
5287237|NCT02236273|vaccination|vaccination
5287238|NCT02236273|text message|text message
5287239|NCT02236273|reminder|reminder
5287240|NCT02236247|ivabradine|ivabradine
5287241|NCT02236247|heart rate|heart rate
5287242|NCT02236247|heart failure|heart failure
5287243|NCT02236234|HIV|hiv
5287244|NCT02236234|HPV|hpv
5287245|NCT02236234|Clinical trial|clinical trial
5287246|NCT02236234|outcome|outcome
5287247|NCT02236195|Urothelial|urothelial
5287248|NCT02236195|Bladder|bladder
5287249|NCT02236195|HDAC|hdac
5287250|NCT02236195|MGCD0103|mgcd0103
5287251|NCT02236195|Mocetinostat|mocetinostat
5287252|NCT02236195|CREBBP|crebbp
5287253|NCT02236195|EP300|ep300
5287254|NCT02236195|Mirati|mirati
5287255|NCT02236195|MethylGene|methylgene
5287256|NCT02236143|Healthy|healthy
5287257|NCT02236130|pediatric regional|pediatric regional
5287258|NCT02236117|heart rate variability|heart rate variability
5287260|NCT02236117|progressive test|progressive test
5287261|NCT02236104|neuromuscular disorders|neuromuscular disorders
5287262|NCT02236104|mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
5287263|NCT02236104|respiratory parameters|respiratory parameters
5287264|NCT02236104|plethysmography opto electronic|plethysmography opto electronic
5287265|NCT02236104|Vital capacity|vital capacity
5287266|NCT02236091|cerebral palsy|cerebral palsy
5287267|NCT02236091|stroke|stroke
5168745|NCT02936882|children|children
5287268|NCT02236091|traumatic brain injury|traumatic brain injury
5287269|NCT02236065|Umbilical cord blood|umbilical cord blood
5287270|NCT02236065|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5287271|NCT02236065|Brain injury|brain injury
5287272|NCT02236065|Neurodegenerative disorder|neurodegenerative disorder
5287273|NCT02236065|Efficacy|efficacy
5287274|NCT02236065|Safety|safety
5287275|NCT02236052|Influenza|influenza
5287276|NCT02236052|Human|human
5287277|NCT02236052|RNA Virus Infections|rna virus infections
5287278|NCT02236052|Immunologic|immunologic
5287279|NCT02236052|Immunogenic Factors|immunogenic factors
5287280|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs
5287281|NCT02236052|Virus diseases|virus diseases
5287282|NCT02236052|Orthomyxoviridae Infections|orthomyxoviridae infections
5287283|NCT02236052|Infection|infection
5287284|NCT02236039|Diesel exhaust|diesel exhaust
5287285|NCT02236039|Air pollution|air pollution
5287286|NCT02236039|Airway responsivness|airway responsivness
5287287|NCT02236026|Nestorone use as an IV solution on heart rate;|nestorone use as an iv solution on heart rate;
5287288|NCT02236026|Abnormality in Heart Rate or Rhythm, Unspecified as to Time of Onset|abnormality in heart rate or rhythm, unspecified as to time of onset
5287290|NCT02236013|Daunorubicin|daunorubicin
5287291|NCT02236013|Gilteritinib|gilteritinib
5287292|NCT02236013|Acute Myeloid Leukemia|acute myeloid leukemia
5287293|NCT02236013|Idarubicin|idarubicin
5287294|NCT02236013|Cytarabine|cytarabine
5287295|NCT02236000|NSABP|nsabp
5287296|NCT02236000|Trastuzumab Emtansine|trastuzumab emtansine
5287297|NCT02236000|T DM1|t dm1
5287298|NCT02236000|Neratinib|neratinib
5287299|NCT02236000|Metastatic Breast Cancer|metastatic breast cancer
5287300|NCT02236000|HER2 positive|her2 positive
5287301|NCT02236000|Dose Escalation|dose escalation
5287302|NCT02235974|stroke|stroke
5287303|NCT02235974|critical periods|critical periods
5287304|NCT02235974|sensitive periods|sensitive periods
5287305|NCT02235974|hemiparesis|hemiparesis
5287306|NCT02235974|upper extremity|upper extremity
5287307|NCT02235974|physical rehabilitation|physical rehabilitation
5287308|NCT02235974|arm therapy|arm therapy
5287309|NCT02235974|occupational therapy|occupational therapy
5287310|NCT02235974|physical therapy|physical therapy
5287311|NCT02235974|task oriented training|task oriented training
5287312|NCT02235974|patient focused|patient focused
5287313|NCT02235974|arm function|arm function
5287314|NCT02235974|hand function|hand function
5287315|NCT02235974|neurorehabilitation|neurorehabilitation
5287316|NCT02235974|motor learning|motor learning
5287317|NCT02235974|motor control|motor control
5287318|NCT02235974|motor function|motor function
5287319|NCT02235974|motor recovery|motor recovery
5287320|NCT02235974|skill acquisition|skill acquisition
5287321|NCT02235974|skill training|skill training
5287322|NCT02235948|arsenic induced health problem|arsenic induced health problem
5287323|NCT02235948|modifying effects|modifying effects
5287324|NCT02235948|folic acid|folic acid
5287325|NCT02235948|oxidative damage|oxidative damage
5287326|NCT02235948|clinical trial|clinical trial
5287327|NCT02235922|Aged|aged
5287328|NCT02235922|Exercise|exercise
5287329|NCT02235922|Cognition|cognition
5287330|NCT02235922|Functional capacity|functional capacity
5287331|NCT02235909|Pediatric Hypertension|pediatric hypertension
5287332|NCT02235909|High Blood Pressure|high blood pressure
5287333|NCT02235909|Hypertension|hypertension
5287334|NCT02235909|Pediatric|pediatric
5287335|NCT02235909|Primary Hypertension|primary hypertension
5287336|NCT02235909|Secondary Hypertension|secondary hypertension
5287337|NCT02235896|risk factors, African American, lipids, blood pressure|risk factors, african american, lipids, blood pressure
5287338|NCT02235883|Coronary artery disease|coronary artery disease
5287340|NCT02235883|diagnosis|diagnosis
5287341|NCT02235883|computational model|computational model
5287342|NCT02235883|non-invasive|non-invasive
5287343|NCT02235870|Weight Loss|weight loss
5287344|NCT02235870|Obesity|obesity
5287449|NCT02235454|glaucoma|glaucoma
5287346|NCT02235857|pediatric, renal transplantation, recurrence, drug-resistant|pediatric, renal transplantation, recurrence, drug-resistant
5287347|NCT02235844|Mesenchymal|mesenchymal
5287348|NCT02235844|Stem Cells|stem cells
5287349|NCT02235844|Umbilical Cord|umbilical cord
5287350|NCT02235844|Duchenne's|duchenne's
5287351|NCT02235844|Muscular Dystrophy|muscular dystrophy
5287352|NCT02235831|DACP MF|dacp mf
5287353|NCT02235831|DAILIES AquaComfort Plus® Multifocal|dailies aquacomfort plus® multifocal
5287354|NCT02235831|presbyopia|presbyopia
5287355|NCT02235831|visual performance|visual performance
5862763|NCT00001522|Body Fat|body fat
5287356|NCT02235818|tennis elbow, treatment, lateral epicondylitis, immediate effects|tennis elbow, treatment, lateral epicondylitis, immediate effects
5287357|NCT02235805|Metabolic Syndrome|metabolic syndrome
5287358|NCT02235805|Obesity|obesity
5287359|NCT02235805|Magnesium Supplementation|magnesium supplementation
5287360|NCT02235805|Vascular Stiffness|vascular stiffness
5287361|NCT02235805|Vascular Function|vascular function
5962902|NCT04277702|Peripheral Arterial Disease|peripheral arterial disease
5287363|NCT02235779|Pulmonary fibrosis|pulmonary fibrosis
5287364|NCT02235779|Cryobiopsy|cryobiopsy
5287365|NCT02235779|Transbronchial|transbronchial
5287366|NCT02235766|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5287367|NCT02235766|Satellite Tele-Echocardiography|satellite tele-echocardiography
5287368|NCT02235740|Open label|open label
5287369|NCT02235740|carfilzomib|carfilzomib
5287370|NCT02235740|Phase I|phase i
5287371|NCT02235740|clinical activity|clinical activity
5287372|NCT02235740|pharmacokinetics|pharmacokinetics
5287373|NCT02235740|afuresertib|afuresertib
5287374|NCT02235740|relapsed|relapsed
5287375|NCT02235740|refractory|refractory
5287376|NCT02235740|safety|safety
5287379|NCT02235714|Tetraplegia|tetraplegia
5287380|NCT02235714|Asthma|asthma
5287381|NCT02235714|Exhaled breath condensate|exhaled breath condensate
5287382|NCT02235714|Spirometry|spirometry
5287383|NCT02235714|Pulmonary Function Testing|pulmonary function testing
5287384|NCT02235701|soft tissue sarcoma|soft tissue sarcoma
5287385|NCT02235701|aldoxorubicin|aldoxorubicin
5287386|NCT02235701|ifosfamide|ifosfamide
5287387|NCT02235701|mesna|mesna
5287388|NCT02235701|phase 1|phase 1
5287389|NCT02235701|INNO-206|inno-206
5287390|NCT02235688|aldoxorubicin|aldoxorubicin
5287391|NCT02235688|INNO-206|inno-206
5287392|NCT02235688|solid tumors|solid tumors
5287393|NCT02235688|gemcitabine|gemcitabine
5287394|NCT02235688|phase 1|phase 1
5287395|NCT02235675|Angioplasty|angioplasty
5287396|NCT02235675|Peripheral Artery Disease|peripheral artery disease
5287397|NCT02235675|Critical Limb Ischemia|critical limb ischemia
5287398|NCT02235675|CLI|cli
5287399|NCT02235675|PAD|pad
5287400|NCT02235662|HIV|hiv
5287401|NCT02235662|LNG|lng
5287402|NCT02235662|IVR|ivr
5287403|NCT02235662|Contraception|contraception
5287404|NCT02235662|Prevention|prevention
5287405|NCT02235623|Laparoscopic Surgery|laparoscopic surgery
5287406|NCT02235623|Orchiopexy|orchiopexy
5287407|NCT02235610|Lung Transplantation|lung transplantation
5287408|NCT02235610|Ex Vivo Lung Perfusion|ex vivo lung perfusion
5287409|NCT02235610|EVLP|evlp
5287410|NCT02235597|patient access|patient access
5287411|NCT02235597|patient centered care|patient centered care
5287412|NCT02235597|scheduling|scheduling
5287413|NCT02235597|access barriers|access barriers
5287414|NCT02235597|improve efficiency|improve efficiency
5287415|NCT02235597|decision making tools|decision making tools
5287416|NCT02235597|underserved|underserved
5287417|NCT02235584|Incretin hormones|incretin hormones
5287418|NCT02235584|GLP-1|glp-1
5287419|NCT02235584|GIP|gip
5287420|NCT02235584|Dexamethasone|dexamethasone
5287421|NCT02235558|Acute Ischemic Stoke|acute ischemic stoke
5287422|NCT02235558|Thrombectomy|thrombectomy
5287423|NCT02235558|Intraarterial Pharmacotherapy|intraarterial pharmacotherapy
5287424|NCT02235558|Neuroprotection|neuroprotection
5287426|NCT02235545|ICD|icd
5287427|NCT02235545|CRT-D System|crt-d system
5287428|NCT02235545|Treatment of Heart Failure|treatment of heart failure
5287429|NCT02235545|Treamtent of life-threatening ventricular tachyarrhythmia|treamtent of life-threatening ventricular tachyarrhythmia
5287430|NCT02235545|Optisure|optisure
5287431|NCT02235532|clinical trial|clinical trial
5287432|NCT02235532|oral hygiene|oral hygiene
5287433|NCT02235532|Gingivitis|gingivitis
5287434|NCT02235532|Aloevera|aloevera
5287435|NCT02235532|Toothpaste|toothpaste
5287436|NCT02235532|anti-inflammatory agents|anti-inflammatory agents
5287437|NCT02235493|HPP|hpp
5287438|NCT02235493|Soft Bones|soft bones
5287439|NCT02235493|low Alkaline Phosphatase|low alkaline phosphatase
5287440|NCT02235493|genetic metabolic disorder|genetic metabolic disorder
5287441|NCT02235493|alkaline phosphatase|alkaline phosphatase
5287442|NCT02235493|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5287443|NCT02235493|rickets|rickets
5287444|NCT02235493|osteomalacia|osteomalacia
5287445|NCT02235467|autism|autism
5287446|NCT02235467|videomodeling|videomodeling
5287447|NCT02235467|behavioral therapy|behavioral therapy
5287448|NCT02235467|parental training|parental training
5287450|NCT02235454|OCT|oct
5287451|NCT02235454|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5287452|NCT02235441|Gastrointestinal malignancy|gastrointestinal malignancy
5287453|NCT02235441|Cardiopulmonary fitness|cardiopulmonary fitness
5287454|NCT02235441|Chemoradiation therapy|chemoradiation therapy
5287455|NCT02235376|Critical Care|critical care
5287456|NCT02235376|Brain injured patients|brain injured patients
5287457|NCT02235376|Mechanical Ventilation|mechanical ventilation
5287458|NCT02235376|Weaning|weaning
5287459|NCT02235376|Extubation|extubation
5287460|NCT02235376|Prognostic score|prognostic score
5287461|NCT02235376|Clinical examination|clinical examination
5287462|NCT02235363|face lift|face lift
5287464|NCT02235363|retaining ligament|retaining ligament
5287465|NCT02235363|V-Loc sutures|v-loc sutures
5287467|NCT02235363|FACE-Q|face-q
5287468|NCT02235350|Adult|adult
5287469|NCT02235350|Male|male
5287470|NCT02235350|Female|female
5287471|NCT02235350|Neuronal Plasticity|neuronal plasticity
5369151|NCT01861080|incident hypertension|incident hypertension
5169017|NCT02935088|FFR|ffr
5287472|NCT02235350|Imitative Behavior/physiology|imitative behavior/physiology
5287473|NCT02235350|Magnetic Resonance Imaging|magnetic resonance imaging
5287474|NCT02235350|Psychomotor Disorders/rehabilitation|psychomotor disorders/rehabilitation
5287475|NCT02235350|Follow-up Studies|follow-up studies
5287476|NCT02235350|Video Recording|video recording
5287477|NCT02235350|Physical Therapy Modalities|physical therapy modalities
5287478|NCT02235350|Recovery of Function|recovery of function
5287479|NCT02235350|Action Observation Treatment|action observation treatment
5287480|NCT02235350|Mirror Neuron System|mirror neuron system
5287481|NCT02235350|Stroke/rehabilitation|stroke/rehabilitation
5287482|NCT02235350|Upper Limb|upper limb
5287483|NCT02235337|Concussion|concussion
5287484|NCT02235337|Sports related concussion|sports related concussion
5287485|NCT02235337|mTBI|mtbi
5287486|NCT02235337|Vitamin B|vitamin b
5287487|NCT02235337|Riboflavin|riboflavin
5287488|NCT02235311|Proton pump inhibitor|proton pump inhibitor
5287489|NCT02235311|Upper gastrointestinal bleed|upper gastrointestinal bleed
5287490|NCT02235311|Ulcer healing|ulcer healing
5287491|NCT02235298|epicardial fat|epicardial fat
5287492|NCT02235298|diabetes|diabetes
5287493|NCT02235298|dapagliflozin|dapagliflozin
5287494|NCT02235285|capsular contracture|capsular contracture
5287495|NCT02235285|reoperation|reoperation
5287496|NCT02235285|breast augmentation|breast augmentation
5287497|NCT02235246|perioperative intravenous magnesium|perioperative intravenous magnesium
5287498|NCT02235246|endoscopic submucosal dissection|endoscopic submucosal dissection
5287499|NCT02235220|Bruxism|bruxism
5287500|NCT02235207|sedentary work|sedentary work
5287501|NCT02235207|musculoskeletal pain|musculoskeletal pain
5287502|NCT02235207|neuromuscular exercise|neuromuscular exercise
5287503|NCT02235207|physical fitness|physical fitness
5287504|NCT02235207|quality of life|quality of life
5287505|NCT02235207|work ability|work ability
5287506|NCT02235181|Twin Pregnancy|twin pregnancy
5287507|NCT02235181|Prevention of Preterm birth|prevention of preterm birth
5287508|NCT02235181|Short Cervix|short cervix
5287509|NCT02235181|Arabin cervical pessary|arabin cervical pessary
5287510|NCT02235116|Number of patients|number of patients
5287511|NCT02235116|full body skin exam|full body skin exam
5287512|NCT02235116|Survey|survey
5287513|NCT02235116|preferences|preferences
5287514|NCT02235090|Spinal muscular atrophy|spinal muscular atrophy
5287515|NCT02235090|Neuromuscular disorders|neuromuscular disorders
5287516|NCT02235090|Outcome measures|outcome measures
5287517|NCT02235090|Visit-free clinical trial design|visit-free clinical trial design
5287518|NCT02235077|Heart Failure|heart failure
5287519|NCT02235077|Heart Diseases|heart diseases
5287520|NCT02235077|Cardiovascular Diseases|cardiovascular diseases
5287521|NCT02235077|Spironolactone|spironolactone
5287522|NCT02235077|Aldactone|aldactone
5287523|NCT02235025|mild COPD|mild copd
5287525|NCT02235025|exercise|exercise
5287526|NCT02235025|respiratory mechanics|respiratory mechanics
5287527|NCT02235012|Schizophrenia|schizophrenia
5287528|NCT02235012|Ketamine|ketamine
5287529|NCT02235012|Cognitive biases|cognitive biases
5287530|NCT02235012|Uncertainty|uncertainty
5287531|NCT02234999|Pharmacokinetics, Healthy Subjects|pharmacokinetics, healthy subjects
5287532|NCT02234986|Advanced Fibrolamellar Carcinoma|advanced fibrolamellar carcinoma
5287533|NCT02234947|type 1 diabetes|type 1 diabetes
5287534|NCT02234947|pancreas volume|pancreas volume
5287535|NCT02234934|Gene Therapy|gene therapy
5287536|NCT02234934|X-Linked Chronic Granulomatous Disease (X-CGD)|x-linked chronic granulomatous disease (x-cgd)
5287537|NCT02234934|Lentiviral Vector|lentiviral vector
5287538|NCT02234921|Prostate|prostate
5287539|NCT02234921|Adenocarcinoma|adenocarcinoma
5287540|NCT02234921|Metastatic|metastatic
5287541|NCT02234921|DRibble|dribble
5287542|NCT02234921|Immunotherapy|immunotherapy
5287543|NCT02234921|Microbiome|microbiome
5287544|NCT02234908|Tuberculosis|tuberculosis
5287545|NCT02234908|Drug-resistant tuberculosis|drug-resistant tuberculosis
5287546|NCT02234908|Incentives|incentives
5287547|NCT02234908|Symptom screening|symptom screening
5287548|NCT02234895|osteoarthritis|osteoarthritis
5287549|NCT02234895|knee|knee
5287550|NCT02234895|biomechanics|biomechanics
5287551|NCT02234895|treatment|treatment
5287552|NCT02234895|symptoms|symptoms
5287553|NCT02234869|Peginterferon Beta-1a|peginterferon beta-1a
5287554|NCT02234869|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5287555|NCT02234869|RMS|rms
5287556|NCT02234869|flu-like symptoms|flu-like symptoms
5287557|NCT02234856|Hysterectomy|hysterectomy
5287558|NCT02234856|Laparoscopy|laparoscopy
5287559|NCT02234856|Surgical assessment|surgical assessment
5287560|NCT02234856|Education|education
5287561|NCT02234843|Pediatric|pediatric
5287562|NCT02234830|PCI|pci
5287563|NCT02234804|Coronary angiography (CAG)|coronary angiography (cag)
5287564|NCT02234804|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5287566|NCT02234804|Stent|stent
5287567|NCT02234778|critical limb ischemia|critical limb ischemia
5287568|NCT02234778|autologous stromal vascular fraction|autologous stromal vascular fraction
5962903|NCT04277702|Montelukast|montelukast
5157050|NCT03010332|CMV|cmv
5169060|NCT02934815|attachment|attachment
5169061|NCT02934815|quality of life|quality of life
5169062|NCT02934789|submucosal fibroids|submucosal fibroids
5169065|NCT02934776|DTI|dti
5287569|NCT02234765|OSA|osa
5287570|NCT02234765|OSAS|osas
5287571|NCT02234765|Sleep apnea|sleep apnea
5287572|NCT02234765|Management|management
5287573|NCT02234765|Primary Care|primary care
5287574|NCT02234765|Sleep Unit|sleep unit
5287575|NCT02234765|Cost-Effectiveness|cost-effectiveness
5287576|NCT02234765|ESS|ess
5287577|NCT02234752|Schizophrenia|schizophrenia
5287578|NCT02234752|Schizoaffective Disorder|schizoaffective disorder
5287581|NCT02234752|Galantamine|galantamine
5287582|NCT02234752|Memantine|memantine
5287583|NCT02234739|voriconazole|voriconazole
5287584|NCT02234739|COPD|copd
5287585|NCT02234739|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5287586|NCT02234739|efficacy|efficacy
5287587|NCT02234739|safety|safety
5287588|NCT02234726|child health|child health
5287589|NCT02234726|child development|child development
5287590|NCT02234726|malnutrition|malnutrition
5287591|NCT02234726|stunting|stunting
5287592|NCT02234726|community-based health services|community-based health services
5287593|NCT02234687|post-traumatic stress disorder|post-traumatic stress disorder
5287594|NCT02234674|Pulsating suit|pulsating suit
5287595|NCT02234674|lymphedema|lymphedema
5287596|NCT02234674|leg volume|leg volume
5287597|NCT02234661|Low income|low income
5287598|NCT02234661|Education|education
5287599|NCT02234661|Poverty|poverty
5287600|NCT02234661|Children|children
5287601|NCT02234661|Parents|parents
5287602|NCT02234661|Head Start|head start
5287603|NCT02234648|Vascular Function|vascular function
5287604|NCT02234648|tart Montmorency cherries|tart montmorency cherries
5287605|NCT02234648|Arterial Stiffness|arterial stiffness
5287606|NCT02234648|Blood Flow|blood flow
5287607|NCT02234635|visual acuity|visual acuity
5287608|NCT02234635|objective visual quality|objective visual quality
5287609|NCT02234635|multifocal intraocular lens|multifocal intraocular lens
5287610|NCT02234635|tear-film quality dynamics|tear-film quality dynamics
5287611|NCT02234622|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5287612|NCT02234622|Yoga|yoga
5287613|NCT02234622|Veterans|veterans
5287614|NCT02234609|dentistry|dentistry
5287615|NCT02234609|dental caries|dental caries
5287616|NCT02234609|atraumatic restorative Treatment|atraumatic restorative treatment
5287617|NCT02234609|effectiveness|effectiveness
5287618|NCT02234596|Nintedanib|nintedanib
5287619|NCT02234596|14-094|14-094
5287620|NCT02234583|pain|pain
5275129|NCT02302495|Carfilzomib weekly|carfilzomib weekly
5275130|NCT02302495|and Melphalan and Prednisone|and melphalan and prednisone
5275131|NCT02302482|Alzheimer's disease or related disorders|alzheimer's disease or related disorders
5275132|NCT02302482|Functional autonomy level|functional autonomy level
5275133|NCT02302482|Cognitive function|cognitive function
5275134|NCT02302482|Predictive factors|predictive factors
5287621|NCT02234583|fibromyalgia|fibromyalgia
5287622|NCT02234570|neurocysticercosis|neurocysticercosis
5287623|NCT02234570|pork tapeworm|pork tapeworm
5287624|NCT02234570|Taenia solium|taenia solium
5287625|NCT02234557|Motor Control|motor control
5287626|NCT02234557|Attention|attention
5287627|NCT02234557|Cognitive Control|cognitive control
5287628|NCT02234544|vitamin D|vitamin d
5287629|NCT02234544|absorption|absorption
5287630|NCT02234544|ezetimibe|ezetimibe
5287631|NCT02234531|Virtual Reality,|virtual reality,
5287632|NCT02234531|Enhanced Feedback,|enhanced feedback,
5287633|NCT02234531|Stroke,|stroke,
5287634|NCT02234531|Rehabilitation,|rehabilitation,
5287635|NCT02234531|Motor Learning|motor learning
5287636|NCT02234505|prosthetics|prosthetics
5287637|NCT02234505|amputation|amputation
5287638|NCT02234505|gait stability|gait stability
5287639|NCT02234505|step variability|step variability
5287640|NCT02234505|load cell|load cell
5287641|NCT02234492|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5287642|NCT02234492|Statin therapy|statin therapy
5287643|NCT02234492|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
5287644|NCT02234492|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
5287645|NCT02234492|Positron Emission Tomography (PET)|positron emission tomography (pet)
5287646|NCT02234492|Myocardial contrast echocardiography (MCE)|myocardial contrast echocardiography (mce)
5287647|NCT02234479|Breast Cancer|breast cancer
5287648|NCT02234479|Radiation Dermatitis|radiation dermatitis
5287649|NCT02234466|Quality of Recovery (QOR40)|quality of recovery (qor40)
5287650|NCT02234466|Breast Surgery|breast surgery
5287748|NCT02233946|Substance Abuse|substance abuse
5287660|NCT02234414|vitamin D|vitamin d
5287661|NCT02234401|Cystic Fibrosis|cystic fibrosis
5962904|NCT04277702|Leukotrienes|leukotrienes
5287662|NCT02234401|Noninvasive ventilation|noninvasive ventilation
5287663|NCT02234401|Non invasive ventilation|non invasive ventilation
5369152|NCT01861080|cohort|cohort
5962905|NCT04277676|KOOS|koos
5962906|NCT04277676|Knee|knee
5962907|NCT04277676|Osteoarthritis|osteoarthritis
5962908|NCT04277676|Patient-reported outcome measures|patient-reported outcome measures
5962909|NCT04277676|Psychometrics|psychometrics
5169169|NCT02934256|Vestibular Schwannoma|vestibular schwannoma
5169170|NCT02934256|Other NF2-related tumors|other nf2-related tumors
5169171|NCT02934243|Laryngeal Masks|laryngeal masks
5169172|NCT02934243|Ventilation|ventilation
5169174|NCT02934204|PCNSL|pcnsl
5287664|NCT02234401|Acute respiratory exacerbation|acute respiratory exacerbation
5287665|NCT02234401|Bi level pressure support|bi level pressure support
5287674|NCT02234349|pancreas kidney transplantation|pancreas kidney transplantation
5287676|NCT02234349|intestinal flora|intestinal flora
5287677|NCT02234336|Echocardiography|echocardiography
5287678|NCT02234336|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5287679|NCT02234336|cardiomyopathy|cardiomyopathy
5287680|NCT02234336|magnetic resonance imaging|magnetic resonance imaging
5287681|NCT02234336|contrast|contrast
5287682|NCT02234323|prophylaxis treatment|prophylaxis treatment
5287683|NCT02234323|Hemophilia A|hemophilia a
5287684|NCT02234323|Hemophilia|hemophilia
5287685|NCT02234323|episodic treatment|episodic treatment
5287686|NCT02234310|prophylaxis treatment|prophylaxis treatment
5287687|NCT02234310|episodic treatment|episodic treatment
5287688|NCT02234297|Glioma|glioma
5287690|NCT02234297|BLZ100|blz100
5287691|NCT02234284|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5287692|NCT02234284|Health Coaching|health coaching
5287693|NCT02234284|Health Disparities|health disparities
5287694|NCT02234284|Self-management|self-management
5287695|NCT02234284|Chronic Disease Model|chronic disease model
5287696|NCT02234245|Follow-Up studies|follow-up studies
5287697|NCT02234245|Biological Pacemakers|biological pacemakers
5287698|NCT02234245|Telemedicine|telemedicine
5287699|NCT02234245|Efficiency|efficiency
5287700|NCT02234232|Hemodialysis|hemodialysis
5287701|NCT02234232|Exercise, aerobic|exercise, aerobic
5287702|NCT02234232|Exercise, resistance|exercise, resistance
5287703|NCT02234232|Intradialytic|intradialytic
5287704|NCT02234232|Randomized Controlled Trial|randomized controlled trial
5287705|NCT02234232|Safety|safety
5287706|NCT02234232|Quality of life|quality of life
5287707|NCT02234232|Physical performance|physical performance
5287708|NCT02234206|Hypospermatogenesis, Low Sperm Count, Oligozoospermia|hypospermatogenesis, low sperm count, oligozoospermia
5287709|NCT02234193|wound healing|wound healing
5287716|NCT02234115|Prostate Neoplasm Cancer Carcinoma|prostate neoplasm cancer carcinoma
5183207|NCT02845102|Virtual Counselor|virtual counselor
5287717|NCT02234076|Posttraumatic Stress Disorder|posttraumatic stress disorder
5287718|NCT02234076|Depression|depression
5287719|NCT02234076|Treatment|treatment
5287720|NCT02234076|VRET|vret
5287721|NCT02234063|Hypertension|hypertension
5287722|NCT02234063|Chronic Kidney Disease|chronic kidney disease
5287723|NCT02234063|End Stage Renal Disease|end stage renal disease
5287724|NCT02234063|APOL1|apol1
5287725|NCT02234063|Genomics|genomics
5287726|NCT02234063|Genetics|genetics
5287727|NCT02234063|Community-engaged|community-engaged
5287728|NCT02234050|Grade 2 Chordoid meningioma|grade 2 chordoid meningioma
5287729|NCT02234050|Grade 2 Clear cell meningioma|grade 2 clear cell meningioma
5287730|NCT02234050|Grade 2 Atypical meningioma|grade 2 atypical meningioma
5287731|NCT02234050|Grade 3 Papillary meningioma|grade 3 papillary meningioma
5287732|NCT02234050|Grade 3 Rhabdoid meningioma|grade 3 rhabdoid meningioma
5287733|NCT02234050|Grade 3 Anaplastic meningioma|grade 3 anaplastic meningioma
5287734|NCT02234050|Grade 3 Malignant meningioma|grade 3 malignant meningioma
5287735|NCT02234037|AML|aml
5287736|NCT02233998|Plaque|plaque
5287737|NCT02233998|Bleeding|bleeding
5287738|NCT02233998|Gums|gums
5287739|NCT02233998|Gingiva|gingiva
5287740|NCT02233998|Gingival Inflammation|gingival inflammation
5287741|NCT02233998|Gingival Bleeding|gingival bleeding
5287742|NCT02233985|bronchiolitis|bronchiolitis
5287743|NCT02233985|hypertonic|hypertonic
5287744|NCT02233985|saline|saline
5287745|NCT02233985|salbutamol|salbutamol
5287746|NCT02233972|Pharmacokinetics|pharmacokinetics
5287747|NCT02233972|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
5287759|NCT02233855|Seizures|seizures
5287760|NCT02233855|Cestode|cestode
5287761|NCT02233855|Hydrocephalus|hydrocephalus
5287762|NCT02233855|Taenia Solium|taenia solium
5287763|NCT02233855|Helminth|helminth
5287764|NCT02233842|Qualitative Data|qualitative data
5287765|NCT02233842|Questionnaire|questionnaire
5287769|NCT02233816|Influenza|influenza
5287770|NCT02233816|Human|human
5287771|NCT02233816|RNA Virus Infections|rna virus infections
5287772|NCT02233816|Immunologic|immunologic
5287773|NCT02233816|Immunogenic Factors|immunogenic factors
5287774|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs
5287775|NCT02233816|Virus diseases|virus diseases
5287776|NCT02233816|Orthomyxoviridae Infections|orthomyxoviridae infections
5287777|NCT02233816|Infection|infection
5287778|NCT02233803|tolerability|tolerability
5287779|NCT02233803|NEUMOTEROL|neumoterol
5287780|NCT02233803|efficacy|efficacy
5962910|NCT04277637|NHL|nhl
5962911|NCT04277637|BCL2 Inhibitor|bcl2 inhibitor
5962912|NCT04277637|CLL|cll
5962913|NCT04277637|MCL|mcl
5962914|NCT04277637|MZL|mzl
5962915|NCT04277624|fezolinetant|fezolinetant
5962916|NCT04277624|ESN364|esn364
5962917|NCT04277624|menopause|menopause
5962918|NCT04277611|pain management|pain management
5287781|NCT02233803|budesonide/formoterol fumarate 400/12 mcg|budesonide/formoterol fumarate 400/12 mcg
5287783|NCT02233803|Asthma|asthma
5287784|NCT02233803|pharmacodynamics|pharmacodynamics
5287785|NCT02233790|Myocardial infarction|myocardial infarction
5287786|NCT02233790|No-Reflow Phenomenon|no-reflow phenomenon
5287787|NCT02233790|Ticagrelor|ticagrelor
5287788|NCT02233790|Clopidogrel|clopidogrel
5287789|NCT02233790|Single-Photon Emission Computerized Tomography|single-photon emission computerized tomography
5287790|NCT02233777|Pregabalin|pregabalin
5287791|NCT02233777|Bioequivalence|bioequivalence
5287792|NCT02233777|Bioavailability|bioavailability
5287793|NCT02233777|Pharmacokinetic|pharmacokinetic
5287794|NCT02233777|Antiepileptic|antiepileptic
5287795|NCT02233764|iron|iron
5287796|NCT02233764|zinc|zinc
5287797|NCT02233764|pearl millet|pearl millet
5287798|NCT02233764|India|india
5287799|NCT02233764|children|children
5287800|NCT02233764|trial|trial
5287801|NCT02233764|randomized|randomized
5287802|NCT02233751|Healthy Adult Males|healthy adult males
5287803|NCT02233738|Alcoholism|alcoholism
5287804|NCT02233738|Substance-related disorders|substance-related disorders
5287805|NCT02233738|Dual Diagnosis|dual diagnosis
5287806|NCT02233725|Prostatic Neoplasms|prostatic neoplasms
5287807|NCT02233725|Magnetic Resonance Imaging|magnetic resonance imaging
5287808|NCT02233725|MRI / Ultrasound Fusion|mri / ultrasound fusion
5287809|NCT02233725|Contrast-Enhanced Ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
5287810|NCT02233712|gastric cancer, stomach neoplasms,|gastric cancer, stomach neoplasms,
5287812|NCT02233673|Pregnancy|pregnancy
5287813|NCT02233647|cocaine|cocaine
5287814|NCT02233647|phendimetrazine|phendimetrazine
5287815|NCT02233647|pharmacotherapy|pharmacotherapy
5287816|NCT02233634|Coronary Angiography|coronary angiography
5287817|NCT02233634|Magnetic Resonance Imaging|magnetic resonance imaging
5287818|NCT02233634|Oxygen|oxygen
5287819|NCT02233634|Hyperoxia|hyperoxia
5287820|NCT02233634|Carbon Dioxide|carbon dioxide
5287821|NCT02233634|Apnea|apnea
5287822|NCT02233634|Hyperventilation|hyperventilation
5287823|NCT02233608|Prostate cancer|prostate cancer
5287824|NCT02233608|Radical prostatectomy|radical prostatectomy
5183306|NCT02844530|adults|adults
5287825|NCT02233608|Pelvic floor muscle exercises|pelvic floor muscle exercises
5287826|NCT02233608|Pfilates|pfilates
5287827|NCT02233608|Hypopressives|hypopressives
5287828|NCT02233608|Urinary Incontinence|urinary incontinence
5287830|NCT02233595|PET|pet
5287831|NCT02233595|rectal cancer|rectal cancer
5287832|NCT02233595|adjuvant chemotherapy|adjuvant chemotherapy
5287833|NCT02233582|altitude|altitude
5287834|NCT02233582|mountain sickness|mountain sickness
5287836|NCT02233582|hypoxia|hypoxia
5287837|NCT02233569|Laparoscopic hernia repair|laparoscopic hernia repair
5287838|NCT02233569|Ventral hernia|ventral hernia
5287839|NCT02233569|Incisional hernia|incisional hernia
5287841|NCT02233556|event-related potential|event-related potential
5287842|NCT02233556|mismatch negativity|mismatch negativity
5287843|NCT02233556|NMDA|nmda
5287844|NCT02233556|Glutamate|glutamate
5287845|NCT02233543|COPD|copd
5287846|NCT02233543|QVA149|qva149
5287847|NCT02233543|nocturnal oxygen levels|nocturnal oxygen levels
5287848|NCT02233543|combination bronchodilator|combination bronchodilator
5287849|NCT02233530|Dementia|dementia
5287850|NCT02233530|Cognitive Stimulation Therapy|cognitive stimulation therapy
5287851|NCT02233530|Quality of life|quality of life
5287852|NCT02233530|Cognitive impairment|cognitive impairment
5287853|NCT02233530|Africa|africa
5287854|NCT02233530|Tanzania|tanzania
5287855|NCT02233530|Nigeria|nigeria
5287856|NCT02233530|Low- and Middle-income countries|low- and middle-income countries
5287857|NCT02233530|Non-pharmacological intervention|non-pharmacological intervention
5287858|NCT02233530|Task-shifting|task-shifting
5287859|NCT02233530|Cognitive screening|cognitive screening
5287860|NCT02233517|Veterans|veterans
5287861|NCT02233517|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5287862|NCT02233517|Aggression|aggression
5287863|NCT02233517|Anger|anger
5287864|NCT02233517|Posttraumatic Stress Disorder|posttraumatic stress disorder
5287865|NCT02233517|Combat Disorders|combat disorders
5287866|NCT02233491|PTDM|ptdm
5287867|NCT02233491|kidney transplant|kidney transplant
5287868|NCT02233491|lifestyle intervention|lifestyle intervention
5287869|NCT02233491|diet|diet
5287870|NCT02233491|exercise|exercise
5287871|NCT02233478|Pomegranate polyphenols|pomegranate polyphenols
5287872|NCT02233478|Soy Protein|soy protein
5287873|NCT02233478|Ellagitannins|ellagitannins
5287874|NCT02233465|parastomal|parastomal
5287875|NCT02233465|hernia|hernia
5287876|NCT02233465|mesh|mesh
5287877|NCT02233465|parastomal hernia-repair with mesh|parastomal hernia-repair with mesh
5287878|NCT02233452|Neuropathic pain|neuropathic pain
5287879|NCT02233452|Methadone|methadone
5287880|NCT02233452|Ketamine|ketamine
5287881|NCT02233452|Multimodal analgesia|multimodal analgesia
5287882|NCT02233439|galactagogues|galactagogues
5287883|NCT02233439|herbs|herbs
5287884|NCT02233439|breastfeeding|breastfeeding
5287885|NCT02233439|supplements|supplements
5287886|NCT02233439|Silybum marianum|silybum marianum
5287887|NCT02233439|Galega officinalis|galega officinalis
5287888|NCT02233426|allergic rhinitis|allergic rhinitis
5287889|NCT02233426|nasal steroid|nasal steroid
5284790|NCT02247700|ARF|arf
5287890|NCT02233426|hypertonic saline|hypertonic saline
5287891|NCT02233426|eosinophil|eosinophil
5287892|NCT02233426|symptom score|symptom score
5287893|NCT02233413|Traumatic brain injury|traumatic brain injury
5287894|NCT02233413|TBI|tbi
5287895|NCT02233413|Low-level light therapy|low-level light therapy
5287896|NCT02233413|LLLT|lllt
5287897|NCT02233413|LLLT helmet|lllt helmet
5287898|NCT02233400|Acetaminophen|acetaminophen
5287899|NCT02233400|Gastric Bypass|gastric bypass
5287900|NCT02233400|Sleeve Gastrectomy|sleeve gastrectomy
5287901|NCT02233400|Pain|pain
5287902|NCT02233400|Cost|cost
5287903|NCT02233387|cervix cancer|cervix cancer
5287904|NCT02233387|[18F] HX4 PET imaging|[18f] hx4 pet imaging
5287905|NCT02233387|hypoxia|hypoxia
5287906|NCT02233387|phase II trial|phase ii trial
5287907|NCT02233374|Rectal Cancer|rectal cancer
5287908|NCT02233374|Magnetic Resonance Imaging|magnetic resonance imaging
5287909|NCT02233374|Positron Emission Tomography|positron emission tomography
5287910|NCT02233374|pathologic complete response|pathologic complete response
5287911|NCT02233374|Diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
5287912|NCT02233374|Microstructural Imaging|microstructural imaging
5287913|NCT02233374|FDG PET|fdg pet
5287914|NCT02233361|Hearing rehabilitation|hearing rehabilitation
5287915|NCT02233361|Elderly|elderly
5287916|NCT02233361|Hearing aid use|hearing aid use
5287917|NCT02233322|ADHR|adhr
5287918|NCT02233322|Rickets|rickets
5183390|NCT02844075|pembrolizumab|pembrolizumab
5287919|NCT02233322|Hypophosphatemia|hypophosphatemia
5287920|NCT02233283|LH pulsatility|lh pulsatility
5287921|NCT02233283|Insulin sensitivity|insulin sensitivity
5287922|NCT02233283|Metabolism|metabolism
5287923|NCT02233283|hypercaloric feeding|hypercaloric feeding
5287924|NCT02233257|Adrenoleukodystrophy|adrenoleukodystrophy
5287925|NCT02233257|Lorenzo's oil|lorenzo's oil
5287926|NCT02233257|erucic acid|erucic acid
5287927|NCT02233244|Drug Interaction|drug interaction
5287928|NCT02233205|microbubble|microbubble
5287929|NCT02233205|chemotherapy|chemotherapy
5287930|NCT02233205|alimentary|alimentary
5287931|NCT02233192|PrEP|prep
5287932|NCT02233192|conception|conception
5287933|NCT02233192|HIV|hiv
5287934|NCT02233192|serodiscordant|serodiscordant
5287935|NCT02233179|Diabetic foot ulcer|diabetic foot ulcer
5287936|NCT02233153|Senior|senior
5287937|NCT02233153|Elderly|elderly
5287938|NCT02233153|Acute Care|acute care
5287939|NCT02233153|Emergency Surgery|emergency surgery
5287940|NCT02233140|Diabetes|diabetes
5287941|NCT02233140|Ankle equinus|ankle equinus
5287942|NCT02233140|ankle dorsiflexion|ankle dorsiflexion
5287943|NCT02233140|dynamic plantar pressure|dynamic plantar pressure
5287944|NCT02233140|shockwave therapy|shockwave therapy
5287945|NCT02233127|Birth cohort|birth cohort
5287946|NCT02233127|Pakistan|pakistan
5287947|NCT02233127|Child mortality|child mortality
5287948|NCT02233088|Prediabetic State|prediabetic state
5287949|NCT02233088|Hypertension|hypertension
5287950|NCT02233088|Enlarged Waist Elevated Triglycerides|enlarged waist elevated triglycerides
5287951|NCT02233088|HDL Cholesterol, Low Serum|hdl cholesterol, low serum
5287952|NCT02233062|Crohn's Disease|crohn's disease
5287953|NCT02233062|semen quality|semen quality
5287954|NCT02233062|enteral nutrition|enteral nutrition
5287955|NCT02233062|CDAI score higher than 150|cdai score higher than 150
5287956|NCT02233049|Children|children
5287957|NCT02233049|adolescents|adolescents
5287958|NCT02233049|young adults|young adults
5287959|NCT02233049|newly diagnosed|newly diagnosed
5287960|NCT02233036|Young Adults|young adults
5287961|NCT02233036|Transfer|transfer
5287962|NCT02233036|Chronic Disease|chronic disease
5287963|NCT02232997|Chronic kidney disease|chronic kidney disease
5287964|NCT02232997|contrast induced nephropathy|contrast induced nephropathy
5287965|NCT02232997|diabetes mellitus|diabetes mellitus
5287966|NCT02232997|congestive heart failure|congestive heart failure
5287967|NCT02232997|hypertension|hypertension
5287968|NCT02232984|Heart Failure|heart failure
5287969|NCT02232984|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5287971|NCT02232984|Quadripolar pacing|quadripolar pacing
5287972|NCT02232971|glucagon|glucagon
5287973|NCT02232971|insulin pump|insulin pump
5287974|NCT02232971|artificial pancreas|artificial pancreas
5287975|NCT02232971|closed-loop|closed-loop
5287976|NCT02232958|Hyperbaric Oxygen|hyperbaric oxygen
5287977|NCT02232958|Small Vessel Disease of the Brain|small vessel disease of the brain
5287978|NCT02232958|Impaired Brain Circuit Connections|impaired brain circuit connections
5287979|NCT02232945|influenza A (H1N1,H3N2)|influenza a (h1n1,h3n2)
5287980|NCT02232945|influenza B virus|influenza b virus
5287981|NCT02232932|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
5287982|NCT02232932|Liver transplantation|liver transplantation
5287983|NCT02232932|Radiochemotherapy|radiochemotherapy
5287984|NCT02232919|Deep Brain Stimulation|deep brain stimulation
5287985|NCT02232906|Chronic kidney disease|chronic kidney disease
5157488|NCT03007446|SOX|sox
5287986|NCT02232906|CKD|ckd
5287987|NCT02232906|non-dialysis-dependent|non-dialysis-dependent
5287988|NCT02232906|ND-CKD|nd-ckd
5287989|NCT02232906|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5287990|NCT02232906|Ferric carboxymaltose|ferric carboxymaltose
5287991|NCT02232906|Iron|iron
5288007|NCT02232789|3,4-methylenedioxymethamphetamine|3,4-methylenedioxymethamphetamine
5288008|NCT02232789|Abuse liability|abuse liability
5288009|NCT02232789|Human Pharmacology|human pharmacology
5288010|NCT02232776|Losartan|losartan
5288011|NCT02232776|Ig A nephropathy|ig a nephropathy
5288012|NCT02232776|children|children
5288013|NCT02232776|proteinuria|proteinuria
5288014|NCT02232763|Losartan|losartan
5288015|NCT02232763|children|children
5288016|NCT02232763|proteinuria|proteinuria
5288017|NCT02232737|Biomarkers of exposure|biomarkers of exposure
5288018|NCT02232737|Compensatory smoking|compensatory smoking
5288019|NCT02232737|Nicotine dependence|nicotine dependence
5288020|NCT02232737|Reduced nicotine cigarettes|reduced nicotine cigarettes
5288021|NCT02232737|Tobacco withdrawal|tobacco withdrawal
5288022|NCT02232737|Women|women
5288023|NCT02232737|Health disparaties|health disparaties
5288024|NCT02232737|Vulnerable populations|vulnerable populations
5288025|NCT02232724|Prostate Cancer|prostate cancer
5288026|NCT02232724|Staging|staging
5288027|NCT02232724|PET/CT|pet/ct
5288028|NCT02232711|multiplex, polymerase chain reaction, PCR, BioFire, respiratory infection, infectious disease, point of care, CLIA waived, rapid diagnostics|multiplex, polymerase chain reaction, pcr, biofire, respiratory infection, infectious disease, point of care, clia waived, rapid diagnostics
5288029|NCT02232698|Sensing Technology|sensing technology
5288030|NCT02232698|Type 1 Diabetes,|type 1 diabetes,
5288031|NCT02232685|Prostate cancer|prostate cancer
5288032|NCT02232685|Staging|staging
5288033|NCT02232685|PET/CT|pet/ct
5288034|NCT02232672|Prostate Cancer|prostate cancer
5288035|NCT02232672|Staging|staging
5288036|NCT02232672|PET/CT|pet/ct
5288037|NCT02232659|SynCardia|syncardia
5288038|NCT02232659|Total Artificial Heart|total artificial heart
5288039|NCT02232659|Biventricular heart failure|biventricular heart failure
5288040|NCT02232659|Ineligible for cardiac transplant|ineligible for cardiac transplant
5288041|NCT02232568|Patient blood management|patient blood management
5288042|NCT02232568|RBC transfusion|rbc transfusion
5288043|NCT02232568|Restrictive transfusion strategy|restrictive transfusion strategy
5288044|NCT02232529|modified release formulation|modified release formulation
5288045|NCT02232529|pharmacokinetics|pharmacokinetics
5288046|NCT02232490|AFP|afp
5288047|NCT02232490|alpha-fetoprotein|alpha-fetoprotein
5288048|NCT02232490|cancer vaccine|cancer vaccine
5288049|NCT02232490|cirrhosis|cirrhosis
5288050|NCT02232490|hepatitis|hepatitis
5288051|NCT02232490|HCC|hcc
5288052|NCT02232490|hepatocellular carcinoma|hepatocellular carcinoma
5288053|NCT02232490|immunotherapy|immunotherapy
5288054|NCT02232490|liver tumor|liver tumor
5288055|NCT02232490|Cholangiocarcinoma|cholangiocarcinoma
5288056|NCT02232464|Adult ADHD|adult adhd
5288057|NCT02232464|diffusion spectrum imaging|diffusion spectrum imaging
5288058|NCT02232464|resting-state fMRI|resting-state fmri
5288059|NCT02232464|frontostriatal circuitries|frontostriatal circuitries
5288060|NCT02232464|frontoparietal circuitries|frontoparietal circuitries
5288061|NCT02232464|executive function|executive function
5288063|NCT02232451|ERCP|ercp
5288064|NCT02232451|cannulation|cannulation
5288065|NCT02232451|biliary|biliary
5288066|NCT02232451|wire|wire
5288067|NCT02232438|Depression|depression
5288068|NCT02232438|Psychotherapy|psychotherapy
5288069|NCT02232438|Anxiety|anxiety
5288070|NCT02232438|Cancer|cancer
5288071|NCT02232412|Anemia|anemia
5288072|NCT02232412|NIRS|nirs
5288073|NCT02232412|Near Infrared Spectroscopy|near infrared spectroscopy
5288074|NCT02232412|RBC transfusion|rbc transfusion
5288075|NCT02232412|critical ill|critical ill
5288076|NCT02232412|regional cerebral oxygen saturation|regional cerebral oxygen saturation
5288077|NCT02232412|tissue oxygenation|tissue oxygenation
5288078|NCT02232386|Chronic lymphocyte leukemia|chronic lymphocyte leukemia
5288079|NCT02232386|Adults|adults
5288080|NCT02232386|Ibrutinib|ibrutinib
5288081|NCT02232373|FODMAPs|fodmaps
5288082|NCT02232373|microbiota|microbiota
5288083|NCT02232373|oligofructose|oligofructose
5288084|NCT02232373|IBS|ibs
5288085|NCT02232373|Irritable bowel syndrome|irritable bowel syndrome
5288086|NCT02232360|Atherosclerotic plaque|atherosclerotic plaque
5288087|NCT02232360|Virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
5288088|NCT02232360|Plaque composition|plaque composition
5288089|NCT02232360|Rosuvastatin|rosuvastatin
5288090|NCT02232360|Fenofibrate|fenofibrate
5288091|NCT02232360|Coronary artery disease|coronary artery disease
5288092|NCT02232347|traumatic brain injury|traumatic brain injury
5288093|NCT02232347|ketamine|ketamine
5288094|NCT02232347|microdialysis|microdialysis
5288095|NCT02232347|PtiO2|ptio2
5288096|NCT02232347|glutamate|glutamate
5962919|NCT04277611|Nephrolithotomy|nephrolithotomy
5369153|NCT01861054|Cancer Stem Cells|cancer stem cells
5369154|NCT01861054|Novel targeted therapy|novel targeted therapy
5962920|NCT04277611|QLB|qlb
5170026|NCT02928861|Prognosis|prognosis
5288097|NCT02232334|Idiopathic Gastroparesis, Nausea, Vomiting, Abdominal Pain, Gastrectomy, Osteopathy, Gastroparesis Cardinal Symptom Index, GCSI|idiopathic gastroparesis, nausea, vomiting, abdominal pain, gastrectomy, osteopathy, gastroparesis cardinal symptom index, gcsi
5288098|NCT02232295|Upper extremity, motor imagery, mirror therapy|upper extremity, motor imagery, mirror therapy
5288099|NCT02232282|Painful Bladder Syndrome|painful bladder syndrome
5288100|NCT02232282|Interstitial Cystitis|interstitial cystitis
5288101|NCT02232282|Suprapubic Pain|suprapubic pain
5288102|NCT02232282|Urinary Urgency|urinary urgency
5288103|NCT02232269|Coffee|coffee
5288104|NCT02232269|Grapefruit Juice|grapefruit juice
5288105|NCT02232269|Felodipine|felodipine
5288106|NCT02232269|Calcium Channel Blocker|calcium channel blocker
5288107|NCT02232269|Hemodynamics|hemodynamics
5288108|NCT02232269|CYP3A4|cyp3a4
5288109|NCT02232256|Chronic non-cancer pain|chronic non-cancer pain
5288110|NCT02232256|Insomnia|insomnia
5288111|NCT02232256|California poppy|california poppy
5288112|NCT02232256|Eschscholzia californica|eschscholzia californica
5288113|NCT02232256|Pain|pain
5288114|NCT02232256|Sleep quality|sleep quality
5288115|NCT02232243|Cancer|cancer
5288116|NCT02232243|Surgery|surgery
5288117|NCT02232243|Hydroxychloroquine|hydroxychloroquine
5288118|NCT02232217|Children|children
5288119|NCT02232217|Sleep|sleep
5288120|NCT02232217|Obesity|obesity
5288121|NCT02232204|insomnia|insomnia
5288122|NCT02232204|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5288123|NCT02232204|cardiac arrhythmia|cardiac arrhythmia
5288124|NCT02232204|cognitive behavioral treatment|cognitive behavioral treatment
5288125|NCT02232178|unilateral inguinal hernioplasty|unilateral inguinal hernioplasty
5288126|NCT02232165|acute spinal cord injury|acute spinal cord injury
5288127|NCT02232165|hemodynamic therapy|hemodynamic therapy
5288128|NCT02232165|functional outcome|functional outcome
5288129|NCT02232126|Hospital readmissions|hospital readmissions
5288130|NCT02232126|Randomized controlled trial|randomized controlled trial
5288131|NCT02232126|Older adults|older adults
5288132|NCT02232126|Care transitions|care transitions
5288133|NCT02232126|Social work|social work
5288134|NCT02232113|malnutrition, inflammation, and anemia (MIA) syndrome,|malnutrition, inflammation, and anemia (mia) syndrome,
5288135|NCT02232113|hemodialysis,|hemodialysis,
5288136|NCT02232113|erythropoietin stimulating agent (ESA),|erythropoietin stimulating agent (esa),
5288137|NCT02232113|cost-effectiveness,|cost-effectiveness,
5288138|NCT02232113|pharmacokinetics,|pharmacokinetics,
5288139|NCT02232113|endothelial dysfunction|endothelial dysfunction
5288140|NCT02232100|Attentional bias modification training|attentional bias modification training
5288141|NCT02232100|Chronic pain|chronic pain
5288142|NCT02232100|Visual-probe task|visual-probe task
5288143|NCT02232100|Internet-delivered therapy|internet-delivered therapy
5288144|NCT02232087|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
5288145|NCT02232087|corticosteroid|corticosteroid
5288146|NCT02232087|pMDI|pmdi
5288147|NCT02232087|inhaler|inhaler
5288148|NCT02232074|Patient Navigation|patient navigation
5288149|NCT02232074|Medical Legal Partnership|medical legal partnership
5288154|NCT02232022|Stroke|stroke
5288155|NCT02232022|Ischemic stroke|ischemic stroke
5288156|NCT02232022|Atrial fibrillation|atrial fibrillation
5288157|NCT02232022|Insertable cardiac monitor|insertable cardiac monitor
5288158|NCT02232022|Non-cryptogenic|non-cryptogenic
5288159|NCT02232009|Neonate|neonate
5288160|NCT02232009|Infant|infant
5288161|NCT02231983|Clinical Characteristics|clinical characteristics
5288162|NCT02231983|Genetic Profiles|genetic profiles
5288163|NCT02231970|Obesity|obesity
5288164|NCT02231970|Endoscopic sleeve gastroplasty|endoscopic sleeve gastroplasty
5288165|NCT02231970|Weight loss|weight loss
5288170|NCT02231879|Immunodeficiency|immunodeficiency
5288171|NCT02231879|Neutropenia|neutropenia
5288172|NCT02231879|Mozobil|mozobil
5288173|NCT02231879|Myelokathexis|myelokathexis
5288174|NCT02231879|Warts|warts
5288175|NCT02231866|Filovirus|filovirus
5288176|NCT02231866|Healthy|healthy
5288177|NCT02231866|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
5288178|NCT02231866|Immunity|immunity
5288179|NCT02231866|Ebola Virus|ebola virus
5288190|NCT02231827|subjects|subjects
5288191|NCT02231814|Crohn's disease|crohn's disease
5288192|NCT02231814|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5288193|NCT02231814|Diet|diet
5288194|NCT02231814|Enteral Nutrition|enteral nutrition
5288195|NCT02231801|Preterm|preterm
5288196|NCT02231801|Kangaroo Care|kangaroo care
5288197|NCT02231801|Skin-to-Skin|skin-to-skin
5288198|NCT02231801|Vital Sign|vital sign
5288199|NCT02231801|Heart Rate|heart rate
5288200|NCT02231801|Respiratory Rate|respiratory rate
5288201|NCT02231801|Oxygen Saturation|oxygen saturation
5288202|NCT02231788|Telminuvo|telminuvo
5288203|NCT02231788|Telmitrend|telmitrend
5288204|NCT02231788|Hypertension|hypertension
5288205|NCT02231788|24hr ABPM|24hr abpm
5962921|NCT04277611|ESPB|espb
5288206|NCT02231788|Telmisartan|telmisartan
5288207|NCT02231788|S-amlodipine|s-amlodipine
5288208|NCT02231736|Type 2 Diabetes|type 2 diabetes
5288209|NCT02231736|Chromosomal damage|chromosomal damage
5288210|NCT02231736|Micronuclei|micronuclei
5288211|NCT02231736|DNA damage|dna damage
5288212|NCT02231736|HbA1c|hba1c
5288213|NCT02231736|Comet Assay|comet assay
5288214|NCT02231736|Glycemic control|glycemic control
5288215|NCT02231723|Digestive System Neoplasms|digestive system neoplasms
5288216|NCT02231723|Endocrine Gland Neoplasms|endocrine gland neoplasms
5288217|NCT02231723|Pancreatic neoplasms|pancreatic neoplasms
5288218|NCT02231723|Pancreatic cancer, adult|pancreatic cancer, adult
5288219|NCT02231723|Pancreatic cancer|pancreatic cancer
5288220|NCT02231723|Pancreas cancer|pancreas cancer
5288221|NCT02231723|Pancreatic diseases|pancreatic diseases
5288222|NCT02231723|Adenoma, Islet Cell|adenoma, islet cell
5288223|NCT02231723|Carcinoma, Islet Cell|carcinoma, islet cell
5288224|NCT02231723|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
5288225|NCT02231723|Gemcitabine|gemcitabine
5288226|NCT02231723|Gemzar|gemzar
5288227|NCT02231723|Nab-paclitaxel|nab-paclitaxel
5288228|NCT02231723|Paclitaxel|paclitaxel
5288229|NCT02231723|Abraxane|abraxane
5288230|NCT02231723|Oxaliplatin|oxaliplatin
5288231|NCT02231723|Leucovorin|leucovorin
5288232|NCT02231723|Irinotecan|irinotecan
5288233|NCT02231723|Fluorouracil|fluorouracil
5288234|NCT02231723|5-FU|5-fu
5288235|NCT02231723|MM-398|mm-398
5288236|NCT02231710|Severe Combined Immune Deficiency|severe combined immune deficiency
5288237|NCT02231710|Congenital T-cell Defect|congenital t-cell defect
5288238|NCT02231710|Congenital T-cell Deficiency|congenital t-cell deficiency
5288239|NCT02231710|Chronic Granulomatous Disease|chronic granulomatous disease
5288240|NCT02231710|Shwachman Diamond Syndrome|shwachman diamond syndrome
5288241|NCT02231710|Diamond Blackfan Anemia|diamond blackfan anemia
5288243|NCT02231710|Fanconi Anemia|fanconi anemia
5288244|NCT02231710|Sickle Cell Disease|sickle cell disease
5288245|NCT02231710|Thalassemia|thalassemia
5288246|NCT02231710|Mucopolysaccharidosis|mucopolysaccharidosis
5288247|NCT02231710|Sphingolipidoses|sphingolipidoses
5288248|NCT02231697|XLMTM|xlmtm
5288249|NCT02231645|Parkinson's disease|parkinson's disease
5288250|NCT02231645|Deep brain stimulation|deep brain stimulation
5288251|NCT02231645|Subthalamic nucleus|subthalamic nucleus
5288252|NCT02231645|decision-making|decision-making
5288253|NCT02231645|cognition|cognition
5288254|NCT02231645|behavior|behavior
5288255|NCT02231632|Poliomyelitis|poliomyelitis
5288256|NCT02231632|Vaccine|vaccine
5288257|NCT02231632|Safety|safety
5288258|NCT02231632|efficacy|efficacy
5288259|NCT02231619|feasibility|feasibility
5288260|NCT02231619|self assessment|self assessment
5288261|NCT02231619|medical abortion|medical abortion
5288262|NCT02231619|low sensitivity urine pregnancy test|low sensitivity urine pregnancy test
5288263|NCT02231619|South Africa|south africa
5288264|NCT02231606|Myopia Prevalence|myopia prevalence
5288265|NCT02231606|Proportion of Purchase of free Spectacles|proportion of purchase of free spectacles
5288266|NCT02231606|Proportion of Purchase of update Spectacles|proportion of purchase of update spectacles
5288267|NCT02231606|Proportion of Wearing Spectacles|proportion of wearing spectacles
5288268|NCT02231580|Neurodegenerative genetic disorder|neurodegenerative genetic disorder
5288269|NCT02231567|hip replacement|hip replacement
5288270|NCT02231567|neurocognitive rehabilitation|neurocognitive rehabilitation
5288271|NCT02231567|WOMAC questionnaire|womac questionnaire
5288272|NCT02231554|low back pain|low back pain
5288273|NCT02231554|quality of life|quality of life
5288274|NCT02231554|rehabilitation|rehabilitation
5288275|NCT02231554|exercise|exercise
5288276|NCT02231541|Fibromylgia|fibromylgia
5288280|NCT02231528|anesthesia|anesthesia
5288281|NCT02231528|central venous catheter|central venous catheter
5288282|NCT02231528|jugular vein|jugular vein
5288283|NCT02231528|ultrasound guidance|ultrasound guidance
5288284|NCT02231502|Bioavailability in healthy individuals|bioavailability in healthy individuals
5288285|NCT02231489|Healthy|healthy
5288286|NCT02231489|JNJ-42756493|jnj-42756493
5288287|NCT02231489|JNJ-61818549|jnj-61818549
5288288|NCT02231463|ultrasound|ultrasound
5288289|NCT02231450|AE58054|ae58054
5288290|NCT02231450|Hepatic impairment|hepatic impairment
5288291|NCT02231411|Delayed Cord Clamping|delayed cord clamping
5288292|NCT02231411|Pulmonary Ventilation|pulmonary ventilation
5288293|NCT02231398|Cardiovascular disease|cardiovascular disease
5288294|NCT02231398|Pregnant women|pregnant women
5288295|NCT02231398|Nulliparity|nulliparity
5288296|NCT02231398|Pregnancy outcomes|pregnancy outcomes
5288297|NCT02231398|Pregnancy complications|pregnancy complications
5288298|NCT02231398|Sleep disordered breathing|sleep disordered breathing
5288299|NCT02231385|Colorectal cancer|colorectal cancer
5288300|NCT02231385|Serrated adenomas|serrated adenomas
5288301|NCT02231385|Screening|screening
5288302|NCT02231385|Adenoma detection rate|adenoma detection rate
5288303|NCT02231385|Polypectomy|polypectomy
5288304|NCT02231307|sublingual immunotherapy|sublingual immunotherapy
5288305|NCT02231307|birch pollen|birch pollen
5288306|NCT02231307|allergic rhinitis / rhinoconjunctivitis|allergic rhinitis / rhinoconjunctivitis
5288307|NCT02231307|efficacy|efficacy
5288308|NCT02231281|HIV Infections|hiv infections
5288309|NCT02231281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5962922|NCT04277611|Erector Spinae|erector spinae
5288310|NCT02231281|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5288311|NCT02231281|Immune System Diseases|immune system diseases
5288312|NCT02231281|Lentivirus Infections|lentivirus infections
5288313|NCT02231281|Retroviridae Infections|retroviridae infections
5288314|NCT02231281|Virus Diseases|virus diseases
5288315|NCT02231281|RNA Virus Infections|rna virus infections
5288316|NCT02231281|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5288317|NCT02231281|Slow Virus Diseases|slow virus diseases
5288318|NCT02231281|Therapeutic Uses|therapeutic uses
5288319|NCT02231281|Pharmacologic Actions|pharmacologic actions
5288320|NCT02231281|Antiretroviral therapy|antiretroviral therapy
5288321|NCT02231281|Early therapy|early therapy
5288323|NCT02231242|children|children
5288324|NCT02231242|cerebral palsy|cerebral palsy
5288325|NCT02231242|bone marrow stem cells|bone marrow stem cells
5288326|NCT02231242|intrathecal autologous total nucleated cells|intrathecal autologous total nucleated cells
5288327|NCT02231242|quadriparesis|quadriparesis
5288328|NCT02231229|Pulmonary tuberculosis|pulmonary tuberculosis
5288329|NCT02231229|Mycobacterium tuberculosis (MTB)|mycobacterium tuberculosis (mtb)
5288330|NCT02231229|Drug Resistance (DR)|drug resistance (dr)
5288331|NCT02231229|Isoniazid (INH or H)|isoniazid (inh or h)
5288332|NCT02231229|Rifampicin (RIF or RMP or R)|rifampicin (rif or rmp or r)
5288333|NCT02231229|Pyrazinamide (PZA or Z)|pyrazinamide (pza or z)
5288334|NCT02231229|Ethambutol (EMB or E)|ethambutol (emb or e)
5288336|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide (HRZ)|isoniazid, rifampicin, pyrazinamide (hrz)
5288337|NCT02231229|Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)|isoniazid, rifampicin, pyrazinamide, ethambutol (hrze)
5288338|NCT02231229|drug susceptibility testing (DST)|drug susceptibility testing (dst)
5288339|NCT02231229|Acid-Fast Bacilli (AFB+)|acid-fast bacilli (afb+)
5288340|NCT02231229|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5288341|NCT02231216|rhinoseptoplasty|rhinoseptoplasty
5288342|NCT02231203|fish oil|fish oil
5288343|NCT02231203|omega-3 fatty acids|omega-3 fatty acids
5288344|NCT02231203|postoperative inflammatory response|postoperative inflammatory response
5288345|NCT02231203|erythrocyte function|erythrocyte function
5288346|NCT02231190|muscle soreness|muscle soreness
5288347|NCT02231190|Muscle damage and recovery|muscle damage and recovery
5288348|NCT02231190|muscle function|muscle function
5288349|NCT02231190|eccentric exercise|eccentric exercise
5288350|NCT02231151|CPR quality assessment|cpr quality assessment
5288351|NCT02231151|Visual CPR assessment|visual cpr assessment
5288352|NCT02231151|Position relative to patient|position relative to patient
5288353|NCT02231138|Abelmoschus manihot|abelmoschus manihot
5288354|NCT02231138|Chronic Kidney Disease|chronic kidney disease
5288355|NCT02231138|proteinuria|proteinuria
5288356|NCT02231138|efficacy|efficacy
5288357|NCT02231138|safety|safety
5288358|NCT02231125|Abelmoschus manihot|abelmoschus manihot
5288359|NCT02231125|IgA Nephropathy|iga nephropathy
5288360|NCT02231125|proteinuria|proteinuria
5288361|NCT02231125|efficacy|efficacy
5288362|NCT02231125|safety|safety
5288363|NCT02231112|Korean|korean
5288364|NCT02231112|Left side|left side
5288365|NCT02231099|recurrent pelvic organ prolapse|recurrent pelvic organ prolapse
5288366|NCT02231099|mesh|mesh
5285275|NCT02245802|Mortality|mortality
5288367|NCT02231086|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5288368|NCT02231086|Laparoscopy|laparoscopy
5288369|NCT02231086|Peritoneal Lavage|peritoneal lavage
5288370|NCT02231086|HIPEC|hipec
5288371|NCT02231073|Freezing of gait|freezing of gait
5288372|NCT02231073|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5288373|NCT02231073|Exercise|exercise
5288374|NCT02231073|parkinsonism|parkinsonism
5288375|NCT02231060|Outcome Prediction|outcome prediction
5288376|NCT02231060|Anoxic-Ischemic Encephalopathy|anoxic-ischemic encephalopathy
5288377|NCT02231060|Coma|coma
5288378|NCT02231060|Vegetative State|vegetative state
5288379|NCT02231060|Minimally Conscious State|minimally conscious state
5288380|NCT02231060|Chronic Disorders of Consciousness|chronic disorders of consciousness
5288381|NCT02231047|Diarrhea|diarrhea
5288382|NCT02231047|Pneumonia|pneumonia
5288383|NCT02231047|Child, Preschool|child, preschool
5288384|NCT02231047|Infant|infant
5288385|NCT02231047|Dietary Supplements|dietary supplements
5288386|NCT02231047|Colostrums|colostrums
5288387|NCT02231047|Developing Countries|developing countries
5288388|NCT02231021|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5288389|NCT02231021|alogliptin|alogliptin
5288390|NCT02231021|pioglitazone|pioglitazone
5288391|NCT02231021|DPP4 inhibitor|dpp4 inhibitor
5288392|NCT02231021|thiazolidinedione|thiazolidinedione
5288394|NCT02230969|peginterferon|peginterferon
5288395|NCT02230969|relapsing|relapsing
5288396|NCT02230969|pegylated|pegylated
5288397|NCT02230969|Subcutaneous|subcutaneous
5288398|NCT02230969|Injectable|injectable
5288399|NCT02230969|Multiple Sclerosis|multiple sclerosis
5288400|NCT02230943|rheumatoid|rheumatoid
5288401|NCT02230943|arthritis|arthritis
5288402|NCT02230943|osteoarthritis|osteoarthritis
5288403|NCT02230943|gout|gout
5288404|NCT02230930|Parkinson's disease|parkinson's disease
5169934|NCT02929459|oGTT|ogtt
5288405|NCT02230930|Apomorphine|apomorphine
5288406|NCT02230930|Infusion|infusion
5288407|NCT02230930|Skin reactions|skin reactions
5288408|NCT02230930|Subcutaneous nodules|subcutaneous nodules
5288409|NCT02230930|Hydrocortisone|hydrocortisone
5288410|NCT02230930|Massage|massage
5288411|NCT02230930|Dilution|dilution
5288412|NCT02230904|Rotigotine patch|rotigotine patch
5288413|NCT02230904|Neupro|neupro
5288414|NCT02230904|Parkinson's Disease|parkinson's disease
5288415|NCT02230891|heart failure|heart failure
5288416|NCT02230891|biomarkers|biomarkers
5288417|NCT02230891|troponin|troponin
5288418|NCT02230891|BNP|bnp
5288419|NCT02230891|carvedilol|carvedilol
5288420|NCT02230891|spironolactone|spironolactone
5288421|NCT02230891|prevention|prevention
5288422|NCT02230878|JNJ-42847922|jnj-42847922
5288423|NCT02230878|Phase 1|phase 1
5288424|NCT02230878|Healthy|healthy
5288425|NCT02230878|Placebo|placebo
5288426|NCT02230865|Funnel chest (Pectus excavatum)|funnel chest (pectus excavatum)
5288427|NCT02230852|Telemedicine|telemedicine
5288428|NCT02230852|Prehospital|prehospital
5288429|NCT02230852|Emergency Medicine|emergency medicine
5288430|NCT02230852|Stroke|stroke
5288431|NCT02230839|insulin resistance|insulin resistance
5288432|NCT02230839|muscle|muscle
5288433|NCT02230839|health education|health education
5288434|NCT02230839|exercise|exercise
5288435|NCT02230826|Arthroplasty|arthroplasty
5288436|NCT02230826|Hip Replacement|hip replacement
5288437|NCT02230826|Acetabular cup|acetabular cup
5288438|NCT02230826|Femoral stem|femoral stem
5288439|NCT02230813|Cohort Study,|cohort study,
5288440|NCT02230813|Cellulitis,|cellulitis,
5288441|NCT02230813|Skin and Soft Tissue Infection,|skin and soft tissue infection,
5288442|NCT02230813|Emergency Department,|emergency department,
5288443|NCT02230813|Clinical Prediction Rule|clinical prediction rule
5288444|NCT02230787|Pilot study|pilot study
5288445|NCT02230787|randomized clinical trial|randomized clinical trial
5288446|NCT02230787|periodontal disease|periodontal disease
5288447|NCT02230787|gingival recession|gingival recession
5288448|NCT02230787|Emdogain|emdogain
5288449|NCT02230787|connective tissue|connective tissue
5288450|NCT02230787|wound healing|wound healing
5288451|NCT02230787|inflammation|inflammation
5288452|NCT02230774|hydration|hydration
5288453|NCT02230774|cognitive function|cognitive function
5288454|NCT02230774|doctors|doctors
5288455|NCT02230774|nurses|nurses
5288456|NCT02230774|Nurses and Doctors oncall|nurses and doctors oncall
5288457|NCT02230761|steatoblepharon|steatoblepharon
5288458|NCT02230761|blepharoptosis|blepharoptosis
5288459|NCT02230761|dermatochalasis|dermatochalasis
5288460|NCT02230761|blepharoplasty|blepharoplasty
5288461|NCT02230761|periorbital|periorbital
5288462|NCT02230761|orbital|orbital
5288463|NCT02230761|eyelid|eyelid
5288464|NCT02230761|eyebags|eyebags
5288465|NCT02230761|eye bags|eye bags
5288466|NCT02230748|LAA|laa
5288467|NCT02230748|LAA-Occluder|laa-occluder
5288468|NCT02230748|Atrial Fibrillation|atrial fibrillation
5288469|NCT02230748|AF|af
5288470|NCT02230735|Robotic|robotic
5288471|NCT02230735|Hysterectomy|hysterectomy
5288472|NCT02230735|Uterosacral|uterosacral
5288473|NCT02230735|Bupivacaine|bupivacaine
5288474|NCT02230735|Robotic hysterectomy pain control|robotic hysterectomy pain control
5288475|NCT02230722|opioids|opioids
5288477|NCT02230722|collaborative care|collaborative care
5288478|NCT02230709|Neck pain|neck pain
5288479|NCT02230709|Myofascial pain syndrome|myofascial pain syndrome
5288480|NCT02230709|Soreness|soreness
5288481|NCT02230683|Liver Cirrhosis|liver cirrhosis
5288482|NCT02230683|Hepatic Cirrhosis|hepatic cirrhosis
5288483|NCT02230683|Portal Hypertension|portal hypertension
5288484|NCT02230670|Liver Cirrhosis|liver cirrhosis
5288485|NCT02230670|Hepatic Cirrhosis|hepatic cirrhosis
5288486|NCT02230605|Delirium|delirium
5288487|NCT02230605|Post Operative Delirium|post operative delirium
5288488|NCT02230605|PD|pd
5288489|NCT02230605|POD|pod
5288490|NCT02230605|Anesthesia|anesthesia
5288491|NCT02230605|Anesthesiology|anesthesiology
5288492|NCT02230605|Post Operative Recovery|post operative recovery
5288493|NCT02230605|Post Anesthesia Care Unit|post anesthesia care unit
5288494|NCT02230605|PACU|pacu
5288495|NCT02230605|Cognition|cognition
5288496|NCT02230605|Cognitive Impairment|cognitive impairment
5288497|NCT02230605|Memory|memory
5288498|NCT02230605|Thinking|thinking
5962923|NCT04277611|Quadratus Lumborum|quadratus lumborum
5288499|NCT02230605|Confusion Assessment Method|confusion assessment method
5288500|NCT02230605|CAM|cam
5288501|NCT02230605|Neurobics|neurobics
5288502|NCT02230605|Neuroplasticity|neuroplasticity
5288503|NCT02230605|Lumosity|lumosity
5288504|NCT02230605|Brain Games|brain games
5288505|NCT02230605|Cognitive Exercise|cognitive exercise
5288506|NCT02230605|Cognitive Training|cognitive training
5288507|NCT02230605|Perioperative Cognitive Protection|perioperative cognitive protection
5288508|NCT02230605|Cognitive Reserve|cognitive reserve
5288509|NCT02230605|Neurobics Trial|neurobics trial
5288510|NCT02230605|Surgery|surgery
5288511|NCT02230605|Elderly Patients|elderly patients
5288512|NCT02230592|PET|pet
5288513|NCT02230592|Metabolic Glutamate Receptors|metabolic glutamate receptors
5288514|NCT02230592|Brain Imaging|brain imaging
5288515|NCT02230579|safety|safety
5288516|NCT02230579|tolerability|tolerability
5288517|NCT02230579|malaria|malaria
5288518|NCT02230566|MPS 7|mps 7
5288519|NCT02230566|Sly Syndrome|sly syndrome
5288520|NCT02230566|Mucopolysaccharidosis|mucopolysaccharidosis
5288521|NCT02230566|MPS VII|mps vii
5288522|NCT02230566|Enzyme Replacement Therapy|enzyme replacement therapy
5288523|NCT02230566|Mucopolysaccharidosis type 7|mucopolysaccharidosis type 7
5288524|NCT02230566|rare disease|rare disease
5288525|NCT02230566|lysosomal storage disease|lysosomal storage disease
5288526|NCT02230566|metabolic disorder|metabolic disorder
5288527|NCT02230514|Nonunion fracture|nonunion fracture
5288528|NCT02230514|Long bones|long bones
5288529|NCT02230514|Pseudoarthrosis|pseudoarthrosis
5288530|NCT02230514|Cell therapy|cell therapy
5288531|NCT02230514|Tissue engineering|tissue engineering
5288532|NCT02230514|Mesenchymal stromal cells|mesenchymal stromal cells
5288533|NCT02230488|Inpatient Diabetes Management|inpatient diabetes management
5288534|NCT02230488|Prevent <31 day readmission in patients with Diabetes|prevent <31 day readmission in patients with diabetes
5288535|NCT02230488|CDEs role in transition of care of inpatients with diabetes|cdes role in transition of care of inpatients with diabetes
5288536|NCT02230475|Allergic Rhinitis|allergic rhinitis
5288537|NCT02230475|NMR|nmr
5288538|NCT02230462|patient satisfaction|patient satisfaction
5288539|NCT02230462|Mohs surgery|mohs surgery
5288540|NCT02230436|Pancreatectomy|pancreatectomy
5288541|NCT02230436|Time of drain removal|time of drain removal
5288542|NCT02230423|Functional nasal surgery|functional nasal surgery
5288543|NCT02230423|Empty Nose Syndrome (ENS)|empty nose syndrome (ens)
5288544|NCT02230410|Barrett's|barrett's
5288545|NCT02230410|high grade dysplasia|high grade dysplasia
5288546|NCT02230410|ablation|ablation
5288547|NCT02230410|cyrotherapy|cyrotherapy
5288548|NCT02230397|skin aging|skin aging
5288549|NCT02230397|anti-aging cream|anti-aging cream
5288550|NCT02230397|wrinkles|wrinkles
5288551|NCT02230384|Attempt at Smoking Cessation|attempt at smoking cessation
5288552|NCT02230384|Schizophrenia or Schizoaffective disorder|schizophrenia or schizoaffective disorder
5288553|NCT02230384|Novel nicotinergic drug|novel nicotinergic drug
5288554|NCT02230371|Myofascial pain|myofascial pain
5288555|NCT02230371|TMD|tmd
5288556|NCT02230371|5-HT3|5-ht3
5288557|NCT02230371|Granisetron|granisetron
5288558|NCT02230371|Placebo-controlled|placebo-controlled
5288559|NCT02230371|Patients|patients
5288560|NCT02230371|Randomized|randomized
5288561|NCT02230371|Double-blind|double-blind
5288562|NCT02230358|carotid endarterectomy|carotid endarterectomy
5288563|NCT02230358|cardiac output|cardiac output
5288564|NCT02230358|trans-cranial Doppler|trans-cranial doppler
5288565|NCT02230358|CEA|cea
5288566|NCT02230358|regional anesthesia|regional anesthesia
5288567|NCT02230358|general anesthesia|general anesthesia
5288568|NCT02230345|Probiotic|probiotic
5288569|NCT02230345|Yoghourt|yoghourt
5288570|NCT02230345|Inflammation|inflammation
5288571|NCT02230345|Metabolomics|metabolomics
5288572|NCT02230319|Cryotherapy|cryotherapy
5288573|NCT02230319|Cold therapy|cold therapy
5288574|NCT02230319|Peripheral Neuropathy|peripheral neuropathy
5288575|NCT02230319|Paclitaxel|paclitaxel
5288576|NCT02230319|Breast Cancer|breast cancer
5288577|NCT02230319|Symptom management|symptom management
5288578|NCT02230319|Prevention|prevention
5288579|NCT02230293|ambulatory care,|ambulatory care,
5288580|NCT02230293|hypertension,|hypertension,
5184028|NCT02839993|tDCS effects|tdcs effects
5288581|NCT02230293|health personnel,|health personnel,
5288582|NCT02230293|clinical trial|clinical trial
5288583|NCT02230280|Mobile health technology|mobile health technology
5288584|NCT02230280|Multiple chronic conditions|multiple chronic conditions
5288585|NCT02230280|Older adults|older adults
5288586|NCT02230280|Home and community care|home and community care
5288587|NCT02230280|Effectiveness|effectiveness
5288588|NCT02230280|Cost analysis|cost analysis
5288589|NCT02230280|Interprofessional Stroke Rehabilitation|interprofessional stroke rehabilitation
5288590|NCT02230267|boot camp|boot camp
5288591|NCT02230267|exercise|exercise
5288592|NCT02230267|balance training|balance training
5288593|NCT02230267|fall prevention|fall prevention
5288594|NCT02230267|falling|falling
5288595|NCT02230267|strength training|strength training
5288596|NCT02230254|Coronary Artery Disease|coronary artery disease
5288597|NCT02230241|Dyslipidaemia|dyslipidaemia
5288598|NCT02230241|LDL-C goals|ldl-c goals
5288599|NCT02230241|Guidelines|guidelines
5288600|NCT02230215|Total Knee Replacement|total knee replacement
5288601|NCT02230215|Visionaire|visionaire
5288602|NCT02230189|Asthma|asthma
5288603|NCT02230189|Allergen challenge|allergen challenge
5288604|NCT02230163|Chikungunya virus|chikungunya virus
5288605|NCT02230163|Human anti-CHIKV hyperimmune intravenous immunoglobulins|human anti-chikv hyperimmune intravenous immunoglobulins
5288606|NCT02230163|Neonates|neonates
5288607|NCT02230150|Adhesion, Knowledge, Nursing|adhesion, knowledge, nursing
5288608|NCT02230137|adolescents|adolescents
5288609|NCT02230137|type 1 diabetes|type 1 diabetes
5170140|NCT02928328|burning mouth syndrome|burning mouth syndrome
5170141|NCT02928328|temporomandibular disorders|temporomandibular disorders
5170142|NCT02928276|Rheumakit|rheumakit
5170143|NCT02928276|Rheumatoid Arthritis|rheumatoid arthritis
5170144|NCT02928276|anti-TNF|anti-tnf
5170145|NCT02928237|tDCS|tdcs
5288610|NCT02230137|poorly controlled|poorly controlled
5288611|NCT02230137|SMS|sms
5288612|NCT02230137|Improve glycaemic control|improve glycaemic control
5288613|NCT02230137|HbA1c reduction|hba1c reduction
5288614|NCT02230137|poorly controlled type 1 diabetic adolescents|poorly controlled type 1 diabetic adolescents
5288615|NCT02230124|Hydrocephalus|hydrocephalus
5288616|NCT02230111|Women|women
5288617|NCT02230111|Caloric restriction|caloric restriction
5288618|NCT02230111|Cognitive dietary restraint|cognitive dietary restraint
5288619|NCT02230111|Eating behaviours|eating behaviours
5288620|NCT02230111|Food habits|food habits
5288621|NCT02230111|Appetite sensations|appetite sensations
5288624|NCT02230098|remote ischemic conditioning|remote ischemic conditioning
5288625|NCT02230098|ischemic heart disease|ischemic heart disease
5288626|NCT02230072|myelomeningocele|myelomeningocele
5288628|NCT02230072|NTD|ntd
5288629|NCT02230072|neural|neural
5288630|NCT02230072|defect|defect
5288631|NCT02230072|Spina bifida|spina bifida
5288632|NCT02230072|Neural Tube Defect|neural tube defect
5288633|NCT02230059|Prostatic Neoplasms|prostatic neoplasms
5288634|NCT02230059|observational Study|observational study
5288635|NCT02230059|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5288636|NCT02230046|Healthy,|healthy,
5288637|NCT02230046|Abiraterone Acetate,|abiraterone acetate,
5288638|NCT02230046|Bioequivalence.|bioequivalence.
5288639|NCT02230033|JNJ-56021927|jnj-56021927
5288640|NCT02230033|Itraconazole|itraconazole
5288641|NCT02230033|Gemfibrozil|gemfibrozil
5288642|NCT02229994|Dyspnea|dyspnea
5288643|NCT02229994|Self-administered questionnaire|self-administered questionnaire
5288644|NCT02229994|Chronic respiratory disease|chronic respiratory disease
5288645|NCT02229994|COPD|copd
5288646|NCT02229994|Diffuse interstitial lung diseases|diffuse interstitial lung diseases
5288647|NCT02229994|Pulmonary arterial hypertension|pulmonary arterial hypertension
5288648|NCT02229994|Cystic fibrosis|cystic fibrosis
5288649|NCT02229981|Lymphoma|lymphoma
5288650|NCT02229981|B-cell Lymphomas|b-cell lymphomas
5288651|NCT02229981|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5288652|NCT02229981|Lymphosarcoma|lymphosarcoma
5288653|NCT02229981|Kaposi's Sarcoma-associated Herpesvirus|kaposi's sarcoma-associated herpesvirus
5288654|NCT02229981|KHSV|khsv
5288655|NCT02229981|Human Immunodeficiency Virus|human immunodeficiency virus
5288659|NCT02229981|Kaposi sarcoma|kaposi sarcoma
5288660|NCT02229968|craniosynostosis|craniosynostosis
5288661|NCT02229968|craniofacial|craniofacial
5288662|NCT02229968|amicar|amicar
5288663|NCT02229968|epsilon aminocaproic acid|epsilon aminocaproic acid
5288664|NCT02229968|ε-aminocaproic acid|ε-aminocaproic acid
5288665|NCT02229955|Dry Eye Syndromes|dry eye syndromes
5288666|NCT02229942|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
5288667|NCT02229942|Myalgic Encephalitis (ME)|myalgic encephalitis (me)
5288668|NCT02229942|Rituximab|rituximab
5288669|NCT02229942|B-lymphocyte depletion|b-lymphocyte depletion
5288670|NCT02229942|B-cell depletion|b-cell depletion
5288671|NCT02229929|Pruritus|pruritus
5288672|NCT02229929|uremic pruritus|uremic pruritus
5288673|NCT02229929|kappa opioid|kappa opioid
5288674|NCT02229929|CR845|cr845
5288675|NCT02229916|Testicular Neoplasms|testicular neoplasms
5288676|NCT02229916|Testicular Cancer|testicular cancer
5288677|NCT02229916|Cohort Study|cohort study
5288678|NCT02229903|OCD|ocd
5288679|NCT02229864|Absorb™ BVS|absorb™ bvs
5288680|NCT02229864|Angioplasty|angioplasty
5288681|NCT02229864|Bioabsorbable|bioabsorbable
5288682|NCT02229864|BVS|bvs
5288683|NCT02229864|Coronary Artery Disease|coronary artery disease
5288684|NCT02229864|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5288685|NCT02229864|Coronary artery restenosis|coronary artery restenosis
5288686|NCT02229864|Coronary artery stenosis|coronary artery stenosis
5288687|NCT02229864|Coronary scaffold|coronary scaffold
5288688|NCT02229864|Coronary Stent|coronary stent
5288689|NCT02229864|Drug eluting stents|drug eluting stents
5288690|NCT02229864|Everolimus|everolimus
5288691|NCT02229864|Myocardial ischemia|myocardial ischemia
5288692|NCT02229864|Stent thrombosis|stent thrombosis
5288693|NCT02229864|Stents|stents
5288694|NCT02229708|Pregnancy|pregnancy
5288695|NCT02229708|Weight control|weight control
5288696|NCT02229708|Behavioral|behavioral
5288697|NCT02229708|technology-based intervention|technology-based intervention
5288698|NCT02229695|Trauma|trauma
5288699|NCT02229695|Sepsis|sepsis
5288700|NCT02229695|Temporary abdominal closure|temporary abdominal closure
5962924|NCT04277611|Anesthesia|anesthesia
5962925|NCT04277585|Telehealth|telehealth
5962926|NCT04277585|Specialty Care|specialty care
5962927|NCT04277585|Rural Initiative|rural initiative
5962928|NCT04277559|Patient preferential music|patient preferential music
5962929|NCT04277559|Postoperative anxiety|postoperative anxiety
5962930|NCT04277559|Classical music|classical music
5962931|NCT04277507|Nasal valve|nasal valve
5158166|NCT03003130|NLF|nlf
5170316|NCT02927262|ASP2215|asp2215
5288701|NCT02229695|Bogota bag|bogota bag
5288702|NCT02229695|Vacuum assisted closure|vacuum assisted closure
5288703|NCT02229682|extranodal NK/T-cell lymphoma,nasal-type,|extranodal nk/t-cell lymphoma,nasal-type,
5288704|NCT02229682|radiotherapy,|radiotherapy,
5288705|NCT02229682|intensity-modulated radiation treatment,|intensity-modulated radiation treatment,
5288706|NCT02229682|asparaginase-based chemotherapy,|asparaginase-based chemotherapy,
5288707|NCT02229682|loco-regional control,|loco-regional control,
5288708|NCT02229682|survival|survival
5288709|NCT02229656|olaparib|olaparib
5288710|NCT02229656|radiotherapy|radiotherapy
5288711|NCT02229656|Laryngeal SCC|laryngeal scc
5288712|NCT02229656|oropharyngeal SCC|oropharyngeal scc
5288713|NCT02229643|Traumatic brain injury|traumatic brain injury
5288714|NCT02229643|Neuroglobin|neuroglobin
5288715|NCT02229643|Nogo-A|nogo-a
5288716|NCT02229643|Prognosis|prognosis
5288717|NCT02229630|intra-uterine growth restriction|intra-uterine growth restriction
5288718|NCT02229630|MRI|mri
5288719|NCT02229630|apparent diffusion coefficient|apparent diffusion coefficient
5288720|NCT02229617|Intramuscular testosterone|intramuscular testosterone
5288722|NCT02229604|electroacupuncture|electroacupuncture
5288723|NCT02229604|diminished ovarian reserve|diminished ovarian reserve
5288724|NCT02229604|cohort study|cohort study
5288725|NCT02229578|Burn pain|burn pain
5288726|NCT02229578|lidocaine|lidocaine
5288727|NCT02229578|donor site pain|donor site pain
5288728|NCT02229578|Narcotic use|narcotic use
5288732|NCT02229526|Fish oil supplementation|fish oil supplementation
5288733|NCT02229526|RCT|rct
5288734|NCT02229526|High risk pregnancies|high risk pregnancies
5288735|NCT02229526|Twin pregnancy|twin pregnancy
5288736|NCT02229526|Preterm birth|preterm birth
5288737|NCT02229526|Intrauterine growth retardation|intrauterine growth retardation
5288738|NCT02229526|Pregnancy induced hypertension|pregnancy induced hypertension
5276289|NCT02295904|perineum|perineum
5288739|NCT02229513|postpartum hemorrhage|postpartum hemorrhage
5288740|NCT02229513|uterine atony|uterine atony
5288741|NCT02229513|cesarean section|cesarean section
5288742|NCT02229513|cesarean hysterectomy|cesarean hysterectomy
5288743|NCT02229513|acute blood loss anemia|acute blood loss anemia
5288744|NCT02229513|uterotonics|uterotonics
5288745|NCT02229513|obstetric hemorrhage|obstetric hemorrhage
5288746|NCT02229513|severe hemorrhage|severe hemorrhage
5288747|NCT02229513|blood transfusion|blood transfusion
5288748|NCT02229513|obstetric emergencies|obstetric emergencies
5288749|NCT02229513|obstetrics|obstetrics
5288750|NCT02229513|massive hemorrhage|massive hemorrhage
5288751|NCT02229513|hemorrhage|hemorrhage
5288752|NCT02229513|uterine cooling|uterine cooling
5288753|NCT02229500|Propionate|propionate
5288754|NCT02229500|Microbiome|microbiome
5288755|NCT02229500|Dietary Fibre|dietary fibre
5288756|NCT02229500|Short chain fatty acids|short chain fatty acids
5288757|NCT02229487|Prediabetes|prediabetes
5288758|NCT02229487|Short sleepers|short sleepers
5288759|NCT02229487|GLP-1|glp-1
5288760|NCT02229474|Dementia|dementia
5288761|NCT02229474|Cognitive Stimulation Therapy|cognitive stimulation therapy
5288762|NCT02229474|Quality of life|quality of life
5288763|NCT02229474|Cognitive impairment|cognitive impairment
5288764|NCT02229474|Africa|africa
5288765|NCT02229474|Tanzania|tanzania
5288766|NCT02229474|Nigeria|nigeria
5288767|NCT02229474|Low- and Middle-income countries|low- and middle-income countries
5288768|NCT02229474|Non-pharmacological intervention|non-pharmacological intervention
5288769|NCT02229474|Task-shifting|task-shifting
5288770|NCT02229474|Cognitive screening|cognitive screening
5288771|NCT02229448|Immunoglobulin G|immunoglobulin g
5288772|NCT02229448|focus|focus
5288773|NCT02229448|study|study
5288774|NCT02229448|detect|detect
5288775|NCT02229448|patients|patients
5288776|NCT02229435|Chronic kidney disease|chronic kidney disease
5288777|NCT02229435|Urological care|urological care
5288778|NCT02229435|Nephrological care|nephrological care
5288779|NCT02229409|adults|adults
5288780|NCT02229396|Diabetes Mellitus|diabetes mellitus
5288781|NCT02229396|Exenatide|exenatide
5288782|NCT02229396|Dapagliflozin|dapagliflozin
5288783|NCT02229396|Diabetes medication|diabetes medication
5288787|NCT02229396|Cardiovascular metabolic|cardiovascular metabolic
5288788|NCT02229383|Diabetes Mellitus|diabetes mellitus
5288789|NCT02229383|Exenatide|exenatide
5288790|NCT02229383|Diabetes drug|diabetes drug
5288791|NCT02229383|Treatment efficacy|treatment efficacy
5288792|NCT02229383|Placebo|placebo
5288793|NCT02229383|Metabolism|metabolism
5288794|NCT02229383|Cardiovascilar metabolic|cardiovascilar metabolic
5288795|NCT02229370|extracranial|extracranial
5288796|NCT02229370|carotid|carotid
5288797|NCT02229370|artery|artery
5288798|NCT02229370|aneurysm|aneurysm
5288799|NCT02229370|registry|registry
5962932|NCT04277507|Nasal airway obstruction|nasal airway obstruction
5962933|NCT04277494|cold|cold
5288800|NCT02229370|CAR|car
5288801|NCT02229357|H5N2 Vaccine|h5n2 vaccine
5288802|NCT02229344|colitis, ulcerative|colitis, ulcerative
5288803|NCT02229344|MOSAIK|mosaik
5288804|NCT02229344|REMICADE|remicade
5158263|NCT03002701|RCT|rct
5288805|NCT02229344|Infliximab|infliximab
5288806|NCT02229331|haemophilia|haemophilia
5288807|NCT02229331|arthropathy|arthropathy
5288808|NCT02229331|pediatrics|pediatrics
5288809|NCT02229331|ankle|ankle
5288810|NCT02229331|biomechanics|biomechanics
5288811|NCT02229305|Anxiety|anxiety
5288812|NCT02229305|Trauma|trauma
5288813|NCT02229305|Depression|depression
5288814|NCT02229305|Problem Behavior|problem behavior
5288815|NCT02229305|evidence-based treatments|evidence-based treatments
5288816|NCT02229279|Surgical Procedures, Operative|surgical procedures, operative
5288817|NCT02229266|AML|aml
5288818|NCT02229266|high-risk AML|high-risk aml
5288819|NCT02229266|acute myeloid leukemia|acute myeloid leukemia
5288820|NCT02229266|NK cells|nk cells
5288821|NCT02229266|haploidentical natural killer cells|haploidentical natural killer cells
5288822|NCT02229266|immunotherapy|immunotherapy
5288823|NCT02229240|Albiglutide|albiglutide
5288824|NCT02229240|Add-on to basal-bolus insulin therapy|add-on to basal-bolus insulin therapy
5288825|NCT02229240|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
5288829|NCT02229227|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
5288831|NCT02229227|basal-bolus insulin therapy|basal-bolus insulin therapy
5288832|NCT02229214|Renal function|renal function
5288833|NCT02229214|Glomerular Filtration Rate|glomerular filtration rate
5288834|NCT02229214|Kidney function|kidney function
5288835|NCT02229214|Qsymia|qsymia
5288836|NCT02229214|Iohexol|iohexol
5288837|NCT02229214|Serum Creatinine|serum creatinine
5288838|NCT02229214|Creatinine clearance|creatinine clearance
5288839|NCT02229214|Renal Clearance|renal clearance
5288840|NCT02229214|VI-0521|vi-0521
5288841|NCT02229214|Healthy volunteers|healthy volunteers
5288842|NCT02229201|propofol|propofol
5288843|NCT02229201|sevoflurane|sevoflurane
5288845|NCT02229201|Interleukin 10|interleukin 10
5288846|NCT02229188|Depression; mood; cognitive training|depression; mood; cognitive training
5288847|NCT02229175|Diabetic Macular Edema|diabetic macular edema
5288848|NCT02229175|Diabetic Retinopathy|diabetic retinopathy
5288849|NCT02229175|Type 1 Diabetes|type 1 diabetes
5288850|NCT02229175|Type 2 Diabetes|type 2 diabetes
5288851|NCT02229175|Macular Edema|macular edema
5288852|NCT02229175|bevacizumab|bevacizumab
5288853|NCT02229175|intravitreal injection|intravitreal injection
5288854|NCT02229175|Avastin|avastin
5288855|NCT02229175|PASCAL Endpoint Management (EpM) system|pascal endpoint management (epm) system
5288856|NCT02229175|Subthreshold focal laser treatments|subthreshold focal laser treatments
5288857|NCT02229162|umbilical cord|umbilical cord
5289155|NCT02227888|CF|cf
5288858|NCT02229162|cesarean section|cesarean section
5288859|NCT02229162|Blood Loss, Surgical|blood loss, surgical
5288860|NCT02229149|breast cancer|breast cancer
5288861|NCT02229149|metastatic breast cancer|metastatic breast cancer
5288862|NCT02229149|HER2+ breast cancer|her2+ breast cancer
5288863|NCT02229136|Mouth sores from chemotherapy|mouth sores from chemotherapy
5288864|NCT02229136|mouth sores|mouth sores
5288865|NCT02229136|hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
5288866|NCT02229136|metastatic breast cancer|metastatic breast cancer
5288867|NCT02229123|seizures|seizures
5288868|NCT02229123|neonates|neonates
5288869|NCT02229123|anticonvulsant treatment|anticonvulsant treatment
5288870|NCT02229123|levetiracetam|levetiracetam
5288871|NCT02229123|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5288872|NCT02229123|electroencephalography|electroencephalography
5288873|NCT02229110|type 2 diabetes mellitus|type 2 diabetes mellitus
5288874|NCT02229110|e-Health|e-health
5288875|NCT02229110|allocation of care|allocation of care
5288876|NCT02229110|clinical inertia|clinical inertia
5288877|NCT02229110|quality of care|quality of care
5288878|NCT02229110|patient satisfaction|patient satisfaction
5288879|NCT02229097|type 1 diabetes|type 1 diabetes
5288880|NCT02229071|Donafenib|donafenib
5288881|NCT02229071|HCC|hcc
5288882|NCT02229071|Advanced|advanced
5288883|NCT02229071|inoperable|inoperable
5288884|NCT02229071|Phase 1B|phase 1b
5285779|NCT02243306|Anemia|anemia
5288890|NCT02229045|Albumin Bound Paclitaxel|albumin bound paclitaxel
5288892|NCT02229045|taxanes naive|taxanes naive
5288893|NCT02229032|Dravet Syndrome|dravet syndrome
5288894|NCT02229032|cannabidiol therapy|cannabidiol therapy
5288895|NCT02229032|Charlotte's Web|charlotte's web
5288896|NCT02229019|Volunteers|volunteers
5288897|NCT02229019|Mealtime assistance|mealtime assistance
5288898|NCT02229019|Older adults|older adults
5288899|NCT02229019|Nutrition|nutrition
5288900|NCT02229019|Nursing|nursing
5288901|NCT02229006|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
5288902|NCT02229006|Sodium Fluoride|sodium fluoride
5288903|NCT02229006|Positron Emission Tomography|positron emission tomography
5288904|NCT02228980|Influenza|influenza
5288905|NCT02228980|Trivalent influenza vaccine|trivalent influenza vaccine
5288906|NCT02228980|Sanofi Pasteur Shenzhen trivalent influenza vaccine|sanofi pasteur shenzhen trivalent influenza vaccine
5288907|NCT02228967|Alcohol Use|alcohol use
5288908|NCT02228967|SBIRT|sbirt
5288909|NCT02228967|Military|military
5962934|NCT04277494|spray|spray
5170495|NCT02926209|polyp|polyp
5288910|NCT02228967|Health Behavior|health behavior
5288911|NCT02228967|Emergency Room|emergency room
5288912|NCT02228967|Health Promotion|health promotion
5288913|NCT02228967|Formative Research|formative research
5288914|NCT02228967|Randomized Trial|randomized trial
5288915|NCT02228954|Clear-cell metastatic renal cell carcinoma|clear-cell metastatic renal cell carcinoma
5288916|NCT02228954|Positron-Emission Tomography|positron-emission tomography
5288917|NCT02228928|Peripheral Nerve Injury|peripheral nerve injury
5288918|NCT02228928|Postherpetic Neuralgia|postherpetic neuralgia
5288931|NCT02228850|Raynaud's Disease secondary to systemic sclerosis|raynaud's disease secondary to systemic sclerosis
5288932|NCT02228850|CREST|crest
5288933|NCT02228850|Apricus Biosciences|apricus biosciences
5288934|NCT02228850|laser doppler|laser doppler
5288935|NCT02228850|thermography|thermography
5288936|NCT02228824|Smoking|smoking
5288937|NCT02228824|Non-daily smokers|non-daily smokers
5288938|NCT02228824|Ecological Momentary Assessment|ecological momentary assessment
5288939|NCT02228824|Biomarkers|biomarkers
5288940|NCT02228798|anticoagulant|anticoagulant
5288941|NCT02228798|atrial fibrillation|atrial fibrillation
5288942|NCT02228798|surgery|surgery
5288943|NCT02228798|oral anticoagulant|oral anticoagulant
5288944|NCT02228798|discontinue|discontinue
5288945|NCT02228798|DOAC|doac
5288946|NCT02228798|NOAC|noac
5288947|NCT02228798|blood thinner|blood thinner
5288948|NCT02228798|interruption|interruption
5288949|NCT02228772|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
5288950|NCT02228772|Lymphoblastic lymphoma|lymphoblastic lymphoma
5288951|NCT02228772|B-cell Adult Acute Lymphoblastic Leukemia|b-cell adult acute lymphoblastic leukemia
5288952|NCT02228772|T-cell Adult Acute Lymphoblastic Leukemia|t-cell adult acute lymphoblastic leukemia
5288953|NCT02228759|Ambulatory home regional|ambulatory home regional
5288954|NCT02228759|adductor canal block|adductor canal block
5288959|NCT02228720|Chronic Sinusitis|chronic sinusitis
5288960|NCT02228720|Endoscopic Sinus Surgery|endoscopic sinus surgery
5288962|NCT02228694|Pre installation|pre installation
5288963|NCT02228694|Post installation|post installation
5288964|NCT02228694|Safety|safety
5288965|NCT02228694|Time|time
5288966|NCT02228668|AVANT|avant
5288967|NCT02228668|GERCOR|gercor
5288968|NCT02228668|Follow up|follow up
5288969|NCT02228668|Colon cancer|colon cancer
5288970|NCT02228668|Bevacizumab|bevacizumab
5288971|NCT02228668|Overall survival|overall survival
5288972|NCT02228655|Chronic Kidney Disease|chronic kidney disease
5288974|NCT02228655|Anemia of Chronic Illness|anemia of chronic illness
5288975|NCT02228642|Type 1 diabetes|type 1 diabetes
5288976|NCT02228642|Type 2 diabetes|type 2 diabetes
5288977|NCT02228642|Hypoglycemia|hypoglycemia
5288978|NCT02228642|Cognition disorders|cognition disorders
5288979|NCT02228642|Inpatient|inpatient
5288980|NCT02228629|Diabetes|diabetes
5288981|NCT02228629|Foot complications|foot complications
5288982|NCT02228629|plantar keratoma|plantar keratoma
5288983|NCT02228629|plantar pressure|plantar pressure
5288984|NCT02228616|Constipation|constipation
5288985|NCT02228616|Chronic constipation|chronic constipation
5288986|NCT02228616|Prucalopride|prucalopride
5288987|NCT02228616|Women|women
5288988|NCT02228603|exercise therapy|exercise therapy
5288989|NCT02228603|rehabilitation|rehabilitation
5288990|NCT02228590|Parkinson's Disease|parkinson's disease
5288991|NCT02228564|Lack of perfusion in the extremities|lack of perfusion in the extremities
5288992|NCT02228564|Atherosclerosis|atherosclerosis
5288993|NCT02228564|Intermittent claudication|intermittent claudication
5288994|NCT02228564|BOLSTER|bolster
5288995|NCT02228551|Augmented renal clearance|augmented renal clearance
5288997|NCT02228551|surgery|surgery
5288998|NCT02228551|prevalence|prevalence
5288999|NCT02228551|risk factors|risk factors
5289000|NCT02228538|total knee arthroplasty|total knee arthroplasty
5289001|NCT02228538|osteoarthritis|osteoarthritis
5289002|NCT02228525|Selinexor (KPT-330)|selinexor (kpt-330)
5289003|NCT02228525|Selective Inhibitor of Nuclear Export (SINE)|selective inhibitor of nuclear export (sine)
5289004|NCT02228525|14-005|14-005
5289005|NCT02228512|HHV8|hhv8
5289006|NCT02228512|PEL|pel
5289007|NCT02228512|Immune Modulation|immune modulation
5289008|NCT02228512|CC-4047|cc-4047
5289009|NCT02228512|IMiD|imid
5289010|NCT02228499|asthma|asthma
5289011|NCT02228499|academics|academics
5289012|NCT02228499|GPA|gpa
5289013|NCT02228499|attendance|attendance
5289014|NCT02228460|Venglustat|venglustat
5289015|NCT02228447|Adolescent|adolescent
5289016|NCT02228447|Randomized controlled trial|randomized controlled trial
5289017|NCT02228447|Eating behavior|eating behavior
5289018|NCT02228447|Physical Activity|physical activity
5289019|NCT02228447|Sedentary lifestyle|sedentary lifestyle
5289020|NCT02228434|Childhood obesity, intervention, effectiveness, comparison|childhood obesity, intervention, effectiveness, comparison
5289021|NCT02228408|hemodialysis|hemodialysis
5289022|NCT02228408|ESRD|esrd
5289023|NCT02228408|Cardiovascular Disease|cardiovascular disease
5962935|NCT04277494|muscle|muscle
5289024|NCT02228408|Isosorbide Dinitrate|isosorbide dinitrate
5289025|NCT02228408|Hydralazine|hydralazine
5289026|NCT02228395|Single ascending doses|single ascending doses
5289027|NCT02228395|pharmacokinetics|pharmacokinetics
5289028|NCT02228395|safety|safety
5289029|NCT02228395|tolerability|tolerability
5289030|NCT02228395|healthy volunteers|healthy volunteers
5289031|NCT02228395|cognitive impairment associated with schizophrenia (CIAS)|cognitive impairment associated with schizophrenia (cias)
5289032|NCT02228382|Bosutinib|bosutinib
5289033|NCT02228382|Chronic Myeloid Leukemia|chronic myeloid leukemia
5289034|NCT02228382|CML|cml
5289035|NCT02228382|Leukemia|leukemia
5289036|NCT02228382|Myelogenous|myelogenous
5289037|NCT02228382|Chronic|chronic
5289038|NCT02228382|BC-ABL Positive|bc-abl positive
5289164|NCT02227823|electromyography|electromyography
5289040|NCT02228356|Neoplasm Metastasis|neoplasm metastasis
5289041|NCT02228356|oligometastatic cancer|oligometastatic cancer
5289042|NCT02228356|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5289043|NCT02228356|SBRT|sbrt
5289044|NCT02228356|Real-time Tumor Tracking (RTTT)|real-time tumor tracking (rttt)
5289046|NCT02228356|Internal Target Volume|internal target volume
5289047|NCT02228356|Respiratory Motion Management|respiratory motion management
5289048|NCT02228356|Image-guided Radiotherapy|image-guided radiotherapy
5289049|NCT02228356|IGRT|igrt
5289050|NCT02228330|Transurethral resection of bladder tumors|transurethral resection of bladder tumors
5289051|NCT02228330|Obturator nerve reflex|obturator nerve reflex
5289052|NCT02228330|Obturator nerve block|obturator nerve block
5289053|NCT02228317|Emergency Medical Dispatch|emergency medical dispatch
5289055|NCT02228317|Emergency Medical Services|emergency medical services
5289056|NCT02228317|Pre-hospital|pre-hospital
5289057|NCT02228304|Wet AMD|wet amd
5289058|NCT02228304|Wet Age Related Macular Degeneration|wet age related macular degeneration
5289059|NCT02228304|Recurrent CNV Secondary to AMD|recurrent cnv secondary to amd
5289060|NCT02228304|Active subfoveal CNV|active subfoveal cnv
5289061|NCT02228291|Polyphenols|polyphenols
5289062|NCT02228291|Endothelial function|endothelial function
5289063|NCT02228291|Gut barrier function|gut barrier function
5289064|NCT02228278|Pediatric|pediatric
5289065|NCT02228278|Obesity|obesity
5289066|NCT02228278|Overweight|overweight
5289067|NCT02228278|Texting|texting
5289068|NCT02228278|Text message|text message
5289069|NCT02228278|SMS|sms
5289070|NCT02228278|Diet|diet
5289071|NCT02228278|Weight Loss|weight loss
5289072|NCT02228278|Nutrition|nutrition
5289073|NCT02228278|Physical activity|physical activity
5289074|NCT02228278|BMI z-score|bmi z-score
5289075|NCT02228278|BMI|bmi
5289076|NCT02228252|Proteins|proteins
5289077|NCT02228252|Postprandial lipemia|postprandial lipemia
5289078|NCT02228252|Pre-meal|pre-meal
5289079|NCT02228252|Metabolic syndrome|metabolic syndrome
5289080|NCT02228239|Healthy|healthy
5289081|NCT02228239|Esketamine|esketamine
5289082|NCT02228239|Mirtazapine|mirtazapine
5289083|NCT02228239|Psychomotor.|psychomotor.
5289084|NCT02228226|Arthroscopic Bankart repair|arthroscopic bankart repair
5289085|NCT02228226|Bone hole|bone hole
5289086|NCT02228226|Ossification|ossification
5289087|NCT02228226|Suture anchor|suture anchor
5289088|NCT02228226|Shoulder dislocation|shoulder dislocation
5289089|NCT02228213|multiple sclerosis|multiple sclerosis
5289090|NCT02228213|SPMS|spms
5289091|NCT02228200|Oncology Nursing|oncology nursing
5289092|NCT02228200|Advanced Practice Nursing|advanced practice nursing
5289093|NCT02228200|Nurse-led care|nurse-led care
5289094|NCT02228200|Chemotherapy|chemotherapy
5289095|NCT02228174|Abnormal Uterine Bleeding associated with fibroids|abnormal uterine bleeding associated with fibroids
5289096|NCT02228174|AUB-L|aub-l
5289097|NCT02228174|Fibroids|fibroids
5289109|NCT02228096|relapsed/refractory|relapsed/refractory
5289110|NCT02228096|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5289111|NCT02228096|Pharmaceuticals|pharmaceuticals
5289112|NCT02228096|Philadelphia chromosome positive|philadelphia chromosome positive
5289113|NCT02228096|Acute Lymphoid Leukemia (ALL)|acute lymphoid leukemia (all)
5289114|NCT02228096|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5289116|NCT02228083|epinephrine|epinephrine
5289117|NCT02228083|local anesthetic|local anesthetic
5289118|NCT02228083|lidocaine|lidocaine
5289119|NCT02228083|cardiac arrhythmias|cardiac arrhythmias
5289120|NCT02228083|procedure|procedure
5289121|NCT02228070|strabismus|strabismus
5289122|NCT02228070|oculomotor palsy|oculomotor palsy
5289123|NCT02228070|abducens palsy|abducens palsy
5289124|NCT02228070|trochlear palsy|trochlear palsy
5289125|NCT02228057|arterial patency|arterial patency
5289126|NCT02228057|upper extremity|upper extremity
5289131|NCT02228044|suicide|suicide
5289132|NCT02228044|alcohol|alcohol
5289133|NCT02228044|marijuana|marijuana
5289135|NCT02228044|prevention|prevention
5289136|NCT02228044|adolescent|adolescent
5289137|NCT02228031|Mirror neurons|mirror neurons
5289138|NCT02228031|Imitation|imitation
5289139|NCT02228031|Oxytocin|oxytocin
5289140|NCT02227992|Fibrin Sealant|fibrin sealant
5289141|NCT02227992|Hemostatics|hemostatics
5289142|NCT02227992|Coagulants|coagulants
5962936|NCT04277494|Athletic Injuries|athletic injuries
5289143|NCT02227966|Mild Cognitive Impairment|mild cognitive impairment
5289145|NCT02227966|tDCS|tdcs
5289146|NCT02227966|transcranial Direct Current Stimulation|transcranial direct current stimulation
5289147|NCT02227953|Alzheimer's Disease|alzheimer's disease
5289148|NCT02227953|AD|ad
5289149|NCT02227953|tDCS|tdcs
5289150|NCT02227953|transcranial direct current stimulation|transcranial direct current stimulation
5289156|NCT02227888|F508Del|f508del
5289157|NCT02227888|Cavosonstat|cavosonstat
5289158|NCT02227888|N91115|n91115
5289159|NCT02227849|insulin resistance|insulin resistance
5289160|NCT02227836|Allergy Patch testing|allergy patch testing
5289161|NCT02227836|Eosinophilic Esophagitis|eosinophilic esophagitis
5289162|NCT02227836|EoE|eoe
5289163|NCT02227823|spinal muscular atrophy type 3|spinal muscular atrophy type 3
5289165|NCT02227823|fatigability|fatigability
5289166|NCT02227823|decrement|decrement
5289167|NCT02227810|Prolong mechanical ventilator,|prolong mechanical ventilator,
5289168|NCT02227810|Electrical stimulation,|electrical stimulation,
5289169|NCT02227810|Activities of daily life,|activities of daily life,
5289170|NCT02227810|Hospitalization outcomes.|hospitalization outcomes.
5289171|NCT02227797|stem cell transplant|stem cell transplant
5289172|NCT02227797|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5289173|NCT02227797|fungal infection|fungal infection
5289174|NCT02227797|voriconazole|voriconazole
5289175|NCT02227797|pediatric|pediatric
5289176|NCT02227719|after augmentation|after augmentation
5289177|NCT02227719|procedure|procedure
5289178|NCT02227706|Fibrin Sealant|fibrin sealant
5289179|NCT02227706|Hemostatics|hemostatics
5289180|NCT02227706|Coagulants|coagulants
5289181|NCT02227693|Thrombocytopenia|thrombocytopenia
5289182|NCT02227693|Chronic Liver Disease|chronic liver disease
5289183|NCT02227680|music therapy|music therapy
5289184|NCT02227680|massage therapy|massage therapy
5289185|NCT02227667|MEDI4736|medi4736
5289186|NCT02227667|14-109|14-109
5289187|NCT02227654|Ovary|ovary
5289188|NCT02227654|Cancer|cancer
5289189|NCT02227654|Morphology|morphology
5289190|NCT02227654|Surgery|surgery
5289191|NCT02227641|CMV|cmv
5289192|NCT02227641|Cytomegalovirus|cytomegalovirus
5289193|NCT02227641|EBV|ebv
5289194|NCT02227641|Epstein Barr Virus|epstein barr virus
5289195|NCT02227641|virus|virus
5289196|NCT02227641|T cell|t cell
5289197|NCT02227641|adoptive transfer|adoptive transfer
5289198|NCT02227641|transplantation|transplantation
5289199|NCT02227641|allogeneic|allogeneic
5286076|NCT02241668|FLT PET|flt pet
5289203|NCT02227589|cognitive behavior therapy|cognitive behavior therapy
5289204|NCT02227589|cannabis abuse|cannabis abuse
5289205|NCT02227576|glioblastoma, thrombocytopenia, temozolomide, chemotherapy|glioblastoma, thrombocytopenia, temozolomide, chemotherapy
5289206|NCT02227563|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5289207|NCT02227563|left superior temporal gyrus|left superior temporal gyrus
5289208|NCT02227563|auditory hallucinations|auditory hallucinations
5289209|NCT02227563|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5289210|NCT02227550|Atrilal fibrillation|atrilal fibrillation
5289211|NCT02227550|anticoagulation|anticoagulation
5289212|NCT02227550|prevention of peri-procedural complication|prevention of peri-procedural complication
5289213|NCT02227550|catheter ablation|catheter ablation
5289214|NCT02227537|Adolescence Idiopathic Scoliosis|adolescence idiopathic scoliosis
5289215|NCT02227537|nighttime Bracing|nighttime bracing
5289216|NCT02227537|Providence|providence
5289217|NCT02227524|Multiple Sclerosis|multiple sclerosis
5289218|NCT02227524|Walking|walking
5289219|NCT02227524|Gait|gait
5289220|NCT02227511|fruit, nuts, liver fat, insulin, glucose|fruit, nuts, liver fat, insulin, glucose
5289221|NCT02227511|Focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.|focus of the study is to compare the often given advice to eat fruit, containing large amount of glucose and fructose, with nuts that are more rich in fat.
5289222|NCT02227485|Gingivitis|gingivitis
5289223|NCT02227485|Diabetes mellitus|diabetes mellitus
5289224|NCT02227485|Medicine, Traditional|medicine, traditional
5289225|NCT02227485|Herbal medicine|herbal medicine
5289226|NCT02227485|Punica granatum|punica granatum
5423274|NCT01616420|linkage to HIV care|linkage to hiv care
5289227|NCT02227446|Surgical site infection risk prevention|surgical site infection risk prevention
5289228|NCT02227446|Bacterial species type and antibacterial sensitives|bacterial species type and antibacterial sensitives
5289229|NCT02227433|Hodgkin Lymphoma, Elderly Patients, brentuximab vedotin (BV)|hodgkin lymphoma, elderly patients, brentuximab vedotin (bv)
5289230|NCT02227407|SCI|sci
5289231|NCT02227407|SMA|sma
5289232|NCT02227407|Paralysis|paralysis
5289233|NCT02227394|Asthma|asthma
5289234|NCT02227394|Functional Respiratory Imaging|functional respiratory imaging
5289235|NCT02227394|Computational Fluid Dynamic|computational fluid dynamic
5289236|NCT02227368|Myocardial Infarction|myocardial infarction
5289237|NCT02227368|Peripheral Arterial disease|peripheral arterial disease
5289239|NCT02227368|Heart Diseases|heart diseases
5289240|NCT02227368|Cardiovascular Diseases|cardiovascular diseases
5289241|NCT02227368|Vascular Diseases|vascular diseases
5289242|NCT02227368|Altherosclerosis|altherosclerosis
5289243|NCT02227368|Arteriosclerosis|arteriosclerosis
5289244|NCT02227368|Arterial Occlusive Diseases|arterial occlusive diseases
5289245|NCT02227368|Peripheral Vascular Diseases|peripheral vascular diseases
5289246|NCT02227368|Ticagrelor|ticagrelor
5289247|NCT02227368|Ticlopidine|ticlopidine
5289248|NCT02227368|Platelet Aggregation inhibitors|platelet aggregation inhibitors
5289249|NCT02227368|Hematologic Agents|hematologic agents
5289250|NCT02227368|Therapeutic Uses|therapeutic uses
5289251|NCT02227368|Pharmacologic Actions|pharmacologic actions
5289252|NCT02227368|Purinegic P2Y Receptor Antagonists|purinegic p2y receptor antagonists
5289253|NCT02227368|Purinegic P2 Receptor Antagonists|purinegic p2 receptor antagonists
5289254|NCT02227368|Purinergic Antagonists|purinergic antagonists
5289255|NCT02227368|Purinergic Agents|purinergic agents
5289256|NCT02227368|Neurotransmitter Agents|neurotransmitter agents
5289257|NCT02227368|Molecular Mechanisms of Pharmacological Actions|molecular mechanisms of pharmacological actions
5289258|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs
5289259|NCT02227368|Fibrinolytic Agents|fibrinolytic agents
5289260|NCT02227368|Crardiovascular Agents|crardiovascular agents
5289261|NCT02227355|Parkinson's Disease|parkinson's disease
5289262|NCT02227355|Neupro®|neupro®
5289263|NCT02227355|Rotigotine|rotigotine
5289264|NCT02227355|Transdermal patch|transdermal patch
5289265|NCT02227355|NEUPART|neupart
5289266|NCT02227355|Levodopa|levodopa
5289267|NCT02227355|Noninterventional|noninterventional
5289268|NCT02227355|Combination therapy|combination therapy
5289269|NCT02227329|Home Parenteral Nutrition|home parenteral nutrition
5289270|NCT02227329|Infection Prevention|infection prevention
5289271|NCT02227329|CRBSI|crbsi
5289272|NCT02227329|Ethanol Lock Therapy|ethanol lock therapy
5289273|NCT02227316|Uterine Fibroid Embolization|uterine fibroid embolization
5289274|NCT02227316|Pain|pain
5289275|NCT02227316|UFE|ufe
5289276|NCT02227316|Fibroids|fibroids
5289277|NCT02227316|Adenomyosis|adenomyosis
5289278|NCT02227316|Bleeding|bleeding
5289279|NCT02227316|IV Acetaminophen|iv acetaminophen
5289280|NCT02227316|IV Ibuprofen|iv ibuprofen
5289281|NCT02227316|Menorrhagia|menorrhagia
5289282|NCT02227316|Leiomyoma|leiomyoma
5289283|NCT02227316|Patient Satisfaction|patient satisfaction
5289284|NCT02227290|Tinea Corporis|tinea corporis
5289285|NCT02227290|Ringworm|ringworm
5289287|NCT02227277|HIV-1|hiv-1
5289288|NCT02227277|Pegintron|pegintron
5289289|NCT02227277|Peg-IFN-α2b|peg-ifn-α2b
5289290|NCT02227277|Viral suppression|viral suppression
5289291|NCT02227277|ART cessation|art cessation
5289292|NCT02227277|Immune function|immune function
5289293|NCT02227277|Innate immunity|innate immunity
5289294|NCT02227277|Toxicity|toxicity
5289295|NCT02227277|Immune-based therapy|immune-based therapy
5289296|NCT02227277|Treatment interruption|treatment interruption
5289297|NCT02227277|HIV Cure|hiv cure
5289298|NCT02227277|HIV Eradication|hiv eradication
5289299|NCT02227277|BEAT-HIV|beat-hiv
5289300|NCT02227277|HIV Cure Trial|hiv cure trial
5289301|NCT02227277|Cure Trial|cure trial
5289302|NCT02227264|Primary hyperparathyroidism|primary hyperparathyroidism
5289303|NCT02227264|Calcimimetic Agents|calcimimetic agents
5289304|NCT02227264|Parathyroid adenomectomy|parathyroid adenomectomy
5289305|NCT02227251|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
5289306|NCT02227251|DLBCL|dlbcl
5289307|NCT02227251|Karyopharm|karyopharm
5289308|NCT02227251|KPT-330|kpt-330
5289309|NCT02227251|selinexor|selinexor
5289310|NCT02227238|integrase inhibitor|integrase inhibitor
5289311|NCT02227238|non-inferiority|non-inferiority
5289312|NCT02227238|dolutegravir|dolutegravir
5289313|NCT02227238|lopinavir/ritonavir|lopinavir/ritonavir
5289314|NCT02227238|second-line treatment|second-line treatment
5289315|NCT02227238|HIV-1|hiv-1
5289316|NCT02227238|antiretroviral therapy-experienced|antiretroviral therapy-experienced
5289317|NCT02227225|Postoperative Delirium|postoperative delirium
5289318|NCT02227186|Influenza vaccination rates|influenza vaccination rates
5289319|NCT02227147|Neurotrophic Keratitis|neurotrophic keratitis
5289320|NCT02227108|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, B-cell leukemia, ALL, moxetumomab pasudotox, CD22|pediatric cancer,pediatric acute lymphoblastic leukemia, lymphoblastic lymphoma, b-cell leukemia, all, moxetumomab pasudotox, cd22
5289321|NCT02227082|radiotherapy|radiotherapy
5289327|NCT02227056|Traumatic brain injury|traumatic brain injury
5289328|NCT02227056|Cerebrovascular event|cerebrovascular event
5289329|NCT02227056|Hypoxic ischemic brain injury|hypoxic ischemic brain injury
5289330|NCT02227056|Function (ecologic)|function (ecologic)
5289331|NCT02227004|MRI|mri
5289332|NCT02227004|Magnetic Resonance Imaging|magnetic resonance imaging
5289333|NCT02227004|pacemakers|pacemakers
5289334|NCT02227004|ICD|icd
5289335|NCT02226965|PNT2258|pnt2258
5289336|NCT02226965|DLBCL|dlbcl
5289337|NCT02226965|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5289338|NCT02226965|NHL|nhl
5289339|NCT02226965|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5289340|NCT02226965|Lymphoma|lymphoma
5289341|NCT02226913|Buffered|buffered
5289342|NCT02226913|inferior alveolar nerve block|inferior alveolar nerve block
5170945|NCT02923362|LPR|lpr
5289343|NCT02226913|irreversible pulpitis|irreversible pulpitis
5289344|NCT02226913|local anesthesia|local anesthesia
5289345|NCT02226913|sodium bicarbonate|sodium bicarbonate
5289346|NCT02226900|Multivessel Coronary Artery Disease|multivessel coronary artery disease
5289347|NCT02226900|Hybrid Revascularization|hybrid revascularization
5289348|NCT02226887|Loop ileostomy|loop ileostomy
5289349|NCT02226887|Eventration|eventration
5289350|NCT02226874|Dose Estimation|dose estimation
5289351|NCT02226874|Dose Reconstruction|dose reconstruction
5289352|NCT02226874|Methods|methods
5289353|NCT02226874|Fallout|fallout
5289354|NCT02226874|Radiation Exposure|radiation exposure
5289355|NCT02226861|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5289356|NCT02226861|MDS|mds
5289357|NCT02226861|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5289358|NCT02226861|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5289359|NCT02226861|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5289360|NCT02226848|Endothelial Progenitor Cells|endothelial progenitor cells
5289362|NCT02226848|Traumatic Brain Injury|traumatic brain injury
5289363|NCT02226835|OCT|oct
5289364|NCT02226835|Alzheimer's Disease|alzheimer's disease
5289365|NCT02226835|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5289366|NCT02226822|Type 2 diabetes mellitus|type 2 diabetes mellitus
5289367|NCT02226809|Muscle relaxants|muscle relaxants
5289368|NCT02226809|Postoperative complications, respiratory|postoperative complications, respiratory
5289369|NCT02226809|General anesthesia|general anesthesia
5289370|NCT02226809|Postanesthesia care unit|postanesthesia care unit
5289371|NCT02226809|Neuromuscular block reversal|neuromuscular block reversal
5289372|NCT02226796|Broca's Aphasia|broca's aphasia
5289373|NCT02226796|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5289374|NCT02226783|Phase I|phase i
5289375|NCT02226783|Healthy subjects|healthy subjects
5289376|NCT02226783|PK|pk
5289377|NCT02226783|PD|pd
5289378|NCT02226757|NSCLC|nsclc
5289379|NCT02226757|HER2-expression|her2-expression
5289380|NCT02226757|EGFR-mutation|egfr-mutation
5289381|NCT02226757|Trastuzumab|trastuzumab
5289382|NCT02226757|Paclitaxel|paclitaxel
5289383|NCT02226744|breathing|breathing
5289384|NCT02226744|mind-body practices|mind-body practices
5289385|NCT02226744|yoga|yoga
5289386|NCT02226744|meditation|meditation
5286275|NCT02240888|pneumococcal|pneumococcal
5289387|NCT02226731|Immediate postpartum hemorrhage|immediate postpartum hemorrhage
5289388|NCT02226731|Intrauterine balloon tamponade|intrauterine balloon tamponade
5289389|NCT02226705|Rhinocerebral Mucormycosis|rhinocerebral mucormycosis
5289390|NCT02226705|Surgery|surgery
5289391|NCT02226705|Fungal Infection|fungal infection
5289392|NCT02226705|Survival|survival
5289393|NCT02226692|chronic low back pain|chronic low back pain
5289394|NCT02226692|prognostic factors|prognostic factors
5289395|NCT02226692|disabling low back pain|disabling low back pain
5289396|NCT02226692|lumbar muscle activity|lumbar muscle activity
5289397|NCT02226692|start back screening tool|start back screening tool
5289398|NCT02226692|physical evaluation|physical evaluation
5289399|NCT02226679|crossover|crossover
5289400|NCT02226679|rollover study|rollover study
5289401|NCT02226679|open label|open label
5289402|NCT02226666|MRI|mri
5289403|NCT02226666|Eovist|eovist
5289404|NCT02226666|MultiHance|multihance
5289405|NCT02226601|drowsiness|drowsiness
5289406|NCT02226601|loopiness|loopiness
5289407|NCT02226601|nausea|nausea
5289408|NCT02226575|Sense of coherence|sense of coherence
5289409|NCT02226549|hepatitis C|hepatitis c
5289410|NCT02226549|Gilead|gilead
5289411|NCT02226549|GS-9451|gs-9451
5289412|NCT02226536|Posture|posture
5289413|NCT02226536|Vertigo|vertigo
5289414|NCT02226536|glucose metabolism|glucose metabolism
5289415|NCT02226536|diet|diet
5289416|NCT02226536|scales|scales
5289417|NCT02226536|dinamic posturography|dinamic posturography
5289418|NCT02226523|immunomagnetic reduction|immunomagnetic reduction
5289419|NCT02226523|acute coronary syndrome|acute coronary syndrome
5289420|NCT02226523|serum biomarkers|serum biomarkers
5289421|NCT02226484|Gastroesophageal reflux disease|gastroesophageal reflux disease
5289423|NCT02226484|Acid reflux|acid reflux
5289424|NCT02226484|Reflux|reflux
5289425|NCT02226484|Quercetin|quercetin
5289426|NCT02226458|Autism|autism
5289427|NCT02226458|Mitochondrial Disorders|mitochondrial disorders
5289428|NCT02226458|EPI-743|epi-743
5289429|NCT02226458|EPI743|epi743
5289430|NCT02226458|Rett syndrome|rett syndrome
5289431|NCT02226458|Angelman syndrome|angelman syndrome
5289433|NCT02226445|Outpatients|outpatients
5289434|NCT02226432|Barthel Scale|barthel scale
5289435|NCT02226432|Disability|disability
5289436|NCT02226432|Modified Ashworth Scale|modified ashworth scale
5289437|NCT02226432|Right Arm|right arm
5289438|NCT02226432|Neuromodulation|neuromodulation
5289439|NCT02226432|Spasticity|spasticity
5289440|NCT02226432|Stroke|stroke
5289441|NCT02226419|Fatty acid oxidation disorder|fatty acid oxidation disorder
5289442|NCT02226419|Primary carnitine deficiency|primary carnitine deficiency
5289443|NCT02226419|Exercise|exercise
5962937|NCT04277481|Cold pack|cold pack
5289444|NCT02226419|L-carnitine treatment|l-carnitine treatment
5289445|NCT02226419|Stable isotopes|stable isotopes
5289446|NCT02226419|Carnitine transporter deficiency|carnitine transporter deficiency
5289447|NCT02226406|Early Physical Exercise|early physical exercise
5289448|NCT02226406|Alveolar Recruitment|alveolar recruitment
5289449|NCT02226406|Electrical Impedance Tomography|electrical impedance tomography
5289450|NCT02226406|Oxygenation|oxygenation
5289451|NCT02226406|Ventilation|ventilation
5289452|NCT02226393|Toddlers; Preschoolers; PTSD|toddlers; preschoolers; ptsd
5289453|NCT02226367|prazosin|prazosin
5289454|NCT02226367|alcohol use disorders|alcohol use disorders
5289455|NCT02226367|posttraumatic stress disorder|posttraumatic stress disorder
5289456|NCT02226367|PTSD|ptsd
5289457|NCT02226367|combat trauma|combat trauma
5289458|NCT02226367|military|military
5289459|NCT02226367|alpha-1 adrenoreceptor antagonist|alpha-1 adrenoreceptor antagonist
5289460|NCT02226354|Dietary vegetable oil|dietary vegetable oil
5289461|NCT02226354|Stearidonic acid|stearidonic acid
5289462|NCT02226354|Tissue|tissue
5289463|NCT02226354|Fatty Acid|fatty acid
5289464|NCT02226354|composition|composition
5289465|NCT02226341|Lupus|lupus
5289466|NCT02226341|Lupus Nephritis|lupus nephritis
5289467|NCT02226341|ACTHar|acthar
5289468|NCT02226341|Columbia|columbia
5289469|NCT02226341|Rheumatology|rheumatology
5289470|NCT02226341|CUMC|cumc
5289471|NCT02226341|Autoimmune|autoimmune
5289472|NCT02226341|SLE|sle
5289473|NCT02226341|Proliferative Lupus Nephritis|proliferative lupus nephritis
5289474|NCT02226315|noninvasive prenatal testing|noninvasive prenatal testing
5289475|NCT02226302|Endometrial cancer|endometrial cancer
5289476|NCT02226302|Obesity|obesity
5289477|NCT02226289|bevacizumab|bevacizumab
5289478|NCT02226289|refractory|refractory
5289479|NCT02226289|colorectal cancer|colorectal cancer
5289480|NCT02226289|metastatic|metastatic
5289481|NCT02226263|Necrotizing enterocolitis|necrotizing enterocolitis
5289482|NCT02226263|Probiotics|probiotics
5289483|NCT02226263|Preterm newborns|preterm newborns
5289484|NCT02226250|sugar-based beverage|sugar-based beverage
5289485|NCT02226250|Time Influence|time influence
5289486|NCT02226237|urinary incontinence|urinary incontinence
5289487|NCT02226237|erectile dysfunction|erectile dysfunction
5289488|NCT02226237|Retropubic Prostatectomy|retropubic prostatectomy
5289489|NCT02226237|Physiotherapy|physiotherapy
5289490|NCT02226224|gastrointestinal neoplasms|gastrointestinal neoplasms
5289491|NCT02226224|endosonography|endosonography
5289493|NCT02226224|Staging|staging
5289494|NCT02226198|LDL-C|ldl-c
5289495|NCT02226198|HoFH|hofh
5289496|NCT02226198|Hyperlipidemia|hyperlipidemia
5289497|NCT02226172|Primary myelofibrosis|primary myelofibrosis
5289498|NCT02226172|Secondary myelofibrosis|secondary myelofibrosis
5289499|NCT02226172|PMF|pmf
5289500|NCT02226172|PET-MF|pet-mf
5289501|NCT02226172|PPV-MF|ppv-mf
5289502|NCT02226172|Ruxolitinib resistant or intolerant|ruxolitinib resistant or intolerant
5289503|NCT02226172|previously treated myelofibrosis|previously treated myelofibrosis
5289504|NCT02226172|smoothened inhibitor|smoothened inhibitor
5289505|NCT02226172|oral|oral
5289506|NCT02226172|single agent.|single agent.
5289507|NCT02226159|cervical|cervical
5289508|NCT02226159|radicular pain|radicular pain
5289509|NCT02226159|transforaminal epidural steroid injections|transforaminal epidural steroid injections
5289510|NCT02226146|Pemphigoid Bullous|pemphigoid bullous
5289511|NCT02226146|Bullous|bullous
5289512|NCT02226146|Blisters|blisters
5289513|NCT02226146|SKIN DISEASES|skin diseases
5289514|NCT02226146|BP|bp
5289515|NCT02226120|LCZ696|lcz696
5289516|NCT02226120|chronic heart failure|chronic heart failure
5289517|NCT02226120|ARNI|arni
5289518|NCT02226120|Congestive heart failure (CHF)|congestive heart failure (chf)
5289519|NCT02226120|heart failure (HF)|heart failure (hf)
5289520|NCT02226120|acute heart failure syndrome|acute heart failure syndrome
5289521|NCT02226120|congestive cardiac failure (CCF)|congestive cardiac failure (ccf)
5289522|NCT02226107|Lay health worker|lay health worker
5289523|NCT02226107|Patient navigation|patient navigation
5289524|NCT02226107|Screening colonoscopy|screening colonoscopy
5289525|NCT02226107|Colon cancer|colon cancer
5289526|NCT02226107|Training|training
5289527|NCT02226107|Hispanic|hispanic
5289528|NCT02226107|Latino|latino
5289529|NCT02226094|intra-ocular pressure|intra-ocular pressure
5289530|NCT02226094|primary open-angle glaucoma|primary open-angle glaucoma
5289531|NCT02226094|intra ocular pressure|intra ocular pressure
5289532|NCT02226094|primary open angle glaucoma|primary open angle glaucoma
5289533|NCT02226094|glaucoma|glaucoma
5289534|NCT02226094|deep wave trabeculoplasty|deep wave trabeculoplasty
5289535|NCT02226094|ocular hypertension|ocular hypertension
5289536|NCT02226081|breast lesion|breast lesion
5289537|NCT02226081|ultrasound|ultrasound
5289539|NCT02226081|women|women
5289540|NCT02226081|malignancy|malignancy
5289541|NCT02226068|Atopic dermatitis|atopic dermatitis
5289542|NCT02226068|Ciclosporine|ciclosporine
5289543|NCT02226068|Extracorporal photopheresis|extracorporal photopheresis
5369155|NCT01861054|CXCR1/2 Inhibitors|cxcr1/2 inhibitors
5289544|NCT02226055|Chronic kidney disease of unknown origin|chronic kidney disease of unknown origin
5289545|NCT02226055|Chronic kidney disease of unknown aetiology|chronic kidney disease of unknown aetiology
5289546|NCT02226055|Sri Lanka|sri lanka
5289547|NCT02226055|CKDu|ckdu
5289548|NCT02226055|Arterial stiffness|arterial stiffness
5289549|NCT02226055|Cardiovascular risk|cardiovascular risk
5289750|NCT02225197|Radiation|radiation
5289554|NCT02226016|dermatochalasis|dermatochalasis
5289555|NCT02225990|stroke|stroke
5289556|NCT02225990|stroke rehabilitation|stroke rehabilitation
5289557|NCT02225990|stroke therapy|stroke therapy
5289558|NCT02225964|APOEε4|apoeε4
5289559|NCT02225938|Intensive Care|intensive care
5289560|NCT02225938|Recovery|recovery
5289561|NCT02225938|Long term outcome|long term outcome
5289562|NCT02225938|Function|function
5289567|NCT02225860|ADPKD|adpkd
5289568|NCT02225860|Copeptin|copeptin
5289569|NCT02225860|Vasopressin|vasopressin
5289570|NCT02225860|Diet|diet
5289571|NCT02225860|Water|water
5289572|NCT02225847|Gardening|gardening
5289573|NCT02225847|Therapeutic Horticulture|therapeutic horticulture
5289574|NCT02225847|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5289575|NCT02225847|Psychometric Assessment|psychometric assessment
5289576|NCT02225847|Stress|stress
5289577|NCT02225847|Depression|depression
5289578|NCT02225847|Anxiety|anxiety
5289579|NCT02225847|Quality of Life|quality of life
5289580|NCT02225847|Wellness|wellness
5289581|NCT02225834|Atorvastatin, ischemic stroke, cytokines|atorvastatin, ischemic stroke, cytokines
5289582|NCT02225821|Implant Removal|implant removal
5289583|NCT02225821|Antibiotic Prophylaxis|antibiotic prophylaxis
5289584|NCT02225821|Postoperative wound infection|postoperative wound infection
5289585|NCT02225821|Orthopedics|orthopedics
5289586|NCT02225808|CBT|cbt
5289587|NCT02225808|autism|autism
5289588|NCT02225808|anxiety|anxiety
5289589|NCT02225808|treatment|treatment
5289590|NCT02225808|fMRI|fmri
5185023|NCT02833298|SVR|svr
5289591|NCT02225795|Crohn's Disease|crohn's disease
5289592|NCT02225795|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5289593|NCT02225795|Children|children
5289594|NCT02225795|Young Adults|young adults
5289595|NCT02225782|Alteplase; Hemodialysis Catheter; Occlusion; Renal Failure|alteplase; hemodialysis catheter; occlusion; renal failure
5289596|NCT02225769|fever|fever
5289597|NCT02225769|point-of-care tests|point-of-care tests
5289598|NCT02225769|clinical algorithms|clinical algorithms
5289599|NCT02225769|electronic support|electronic support
5289600|NCT02225769|host biomarkers|host biomarkers
5289603|NCT02225756|Healing|healing
5289604|NCT02225756|Tissue regeneration|tissue regeneration
5289605|NCT02225756|Therapy|therapy
5289606|NCT02225743|Hypothermia|hypothermia
5289607|NCT02225743|Total Hip Joint Prosthesis|total hip joint prosthesis
5289608|NCT02225743|Total Knee Joint Prosthesis|total knee joint prosthesis
5289609|NCT02225717|Preterm labor|preterm labor
5289610|NCT02225717|cervicovaginal secretions|cervicovaginal secretions
5289611|NCT02225717|markers of fetal membranes remodelling|markers of fetal membranes remodelling
5289612|NCT02225717|Multiplex test|multiplex test
5289613|NCT02225691|type 1 diabetes|type 1 diabetes
5289614|NCT02225691|type 2 diabetes|type 2 diabetes
5289615|NCT02225691|paired testing|paired testing
5289616|NCT02225678|healthy volunteers|healthy volunteers
5289617|NCT02225678|asthma|asthma
5289618|NCT02225678|sputum eosinophils|sputum eosinophils
5289619|NCT02225639|ADHD|adhd
5289620|NCT02225639|Adult|adult
5289621|NCT02225613|Cruciate ligament injury|cruciate ligament injury
5289622|NCT02225613|Balance control|balance control
5289623|NCT02225613|Rehabilitation|rehabilitation
5289624|NCT02225613|Spa therapy|spa therapy
5289625|NCT02225613|Sport|sport
5289626|NCT02225600|Borderline Personality Disorder|borderline personality disorder
5289628|NCT02225600|Intranasal oxytocin|intranasal oxytocin
5289633|NCT02225574|Accelerated phase|accelerated phase
5289634|NCT02225574|(AP)|(ap)
5289635|NCT02225574|Blast phase|blast phase
5289636|NCT02225574|(BP)|(bp)
5343002|NCT01981200|Physiotherapy|physiotherapy
5289637|NCT02225574|Philadelphia-positive acute leukemia|philadelphia-positive acute leukemia
5289638|NCT02225574|MEK-162|mek-162
5289639|NCT02225574|Nilotinib|nilotinib
5289640|NCT02225574|AMN107|amn107
5289641|NCT02225574|Tasigna|tasigna
5289642|NCT02225574|Questionnaires|questionnaires
5289643|NCT02225574|Surveys|surveys
5289644|NCT02225561|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5289645|NCT02225561|Nitroprusside|nitroprusside
5289646|NCT02225561|Transthoracic|transthoracic
5289647|NCT02225561|Impedances|impedances
5289648|NCT02225535|low back pain|low back pain
5289649|NCT02225535|telehealth|telehealth
5289650|NCT02225535|videoconferencing|videoconferencing
5289651|NCT02225535|access to physical therapy|access to physical therapy
5289652|NCT02225535|interprofessional care|interprofessional care
5289653|NCT02225535|rural health|rural health
5289654|NCT02225522|Intensive Care Units, Neonatal|intensive care units, neonatal
5289655|NCT02225522|Infant, Newborn|infant, newborn
5289656|NCT02225522|Genetic Diseases, Inborn|genetic diseases, inborn
5289657|NCT02225509|Thyroid cancer|thyroid cancer
5171274|NCT02921828|fatigue|fatigue
5289658|NCT02225509|Thyroid cancer diagnostic|thyroid cancer diagnostic
5289659|NCT02225509|Thyroid nodule|thyroid nodule
5289660|NCT02225509|Fine needle aspiration biopsy|fine needle aspiration biopsy
5289661|NCT02225509|Indeterminate cytological result|indeterminate cytological result
5289662|NCT02225509|Molecular diagnostic|molecular diagnostic
5289663|NCT02225509|Transcriptomics|transcriptomics
5289664|NCT02225509|Molecular signature|molecular signature
5289665|NCT02225496|Oropharyngeal cancer|oropharyngeal cancer
5289666|NCT02225496|Oropharynx|oropharynx
5289667|NCT02225496|Human papilloma virus|human papilloma virus
5289668|NCT02225496|HPV positive|hpv positive
5289669|NCT02225496|Squamous cell carcinoma|squamous cell carcinoma
5289670|NCT02225496|SCC|scc
5289671|NCT02225496|Transoral robotic surgery|transoral robotic surgery
5289672|NCT02225496|TORS|tors
5289673|NCT02225496|Intuitive Surgical da Vinci Surgical System|intuitive surgical da vinci surgical system
5289674|NCT02225496|Modified barium swallow|modified barium swallow
5289675|NCT02225496|MBS|mbs
5289676|NCT02225496|Questionnaires|questionnaires
5289677|NCT02225496|Surveys|surveys
5289678|NCT02225496|Speech and swallowing function|speech and swallowing function
5289679|NCT02225470|Locally Recurrent or Metastatic Breast Cancer|locally recurrent or metastatic breast cancer
5289680|NCT02225457|insulin resistance|insulin resistance
5289681|NCT02225457|type 2 diabetes|type 2 diabetes
5289682|NCT02225457|obesity|obesity
5289683|NCT02225457|polyphenols|polyphenols
5289684|NCT02225457|adipose tissue|adipose tissue
5289685|NCT02225457|overfeeding|overfeeding
5289686|NCT02225444|degenerative lumbosacral spine disease|degenerative lumbosacral spine disease
5289687|NCT02225444|posterolateral fusion evaluation|posterolateral fusion evaluation
5289688|NCT02225444|OsteoAMP|osteoamp
5289689|NCT02225444|autograft|autograft
5289690|NCT02225431|Contrast-induced nephropathy|contrast-induced nephropathy
5185079|NCT02832999|Vildaglipin|vildaglipin
5289691|NCT02225431|Contrast-Induced acute kidney injury|contrast-induced acute kidney injury
5289692|NCT02225431|Contrast media|contrast media
5289693|NCT02225431|Angiography|angiography
5289694|NCT02225431|Coronary percutaneous intervention|coronary percutaneous intervention
5289695|NCT02225418|Laparoscopic|laparoscopic
5289696|NCT02225418|Cholecystectomy|cholecystectomy
5289697|NCT02225418|Postoperative|postoperative
5289698|NCT02225418|Pain|pain
5289699|NCT02225418|Quadratus lumborum|quadratus lumborum
5289700|NCT02225418|Ultrasound|ultrasound
5289701|NCT02225392|Bronchial thermoplasty|bronchial thermoplasty
5289702|NCT02225392|Severe asthma|severe asthma
5289703|NCT02225379|Type 1 Diabetes|type 1 diabetes
5289704|NCT02225379|Hypoglycemia detection|hypoglycemia detection
5289705|NCT02225379|Non-invasive sensor|non-invasive sensor
5289706|NCT02225379|Nocturnal hypoglycemia|nocturnal hypoglycemia
5289707|NCT02225366|Melanoma|melanoma
5289708|NCT02225366|Metastatic|metastatic
5289709|NCT02225366|Antimicrobial peptide|antimicrobial peptide
5289710|NCT02225366|LL37|ll37
5289711|NCT02225366|Photographs|photographs
5289712|NCT02225353|Preterm birth|preterm birth
5289713|NCT02225353|Short cervix|short cervix
5289714|NCT02225353|Cervical Pessaries|cervical pessaries
5289715|NCT02225353|Progesterone|progesterone
5289716|NCT02225314|Parkinson's Disease|parkinson's disease
5289717|NCT02225314|Mild Cognitive Impairment|mild cognitive impairment
5289718|NCT02225301|Child maltreatment|child maltreatment
5289719|NCT02225301|Child Care|child care
5289720|NCT02225301|Knowledge|knowledge
5289721|NCT02225301|Attitude|attitude
5289722|NCT02225288|Healthy Subjects|healthy subjects
5289723|NCT02225288|Japanese|japanese
5289724|NCT02225288|Males|males
5289725|NCT02225262|Prostate cancer|prostate cancer
5289726|NCT02225262|CyberKnife|cyberknife
5289727|NCT02225262|Stereotactic|stereotactic
5289728|NCT02225262|Radiation|radiation
5289729|NCT02225236|executive functioning|executive functioning
5289730|NCT02225236|metacognition|metacognition
5289731|NCT02225236|self-regulation|self-regulation
5289732|NCT02225236|preschoolers|preschoolers
5289733|NCT02225223|metastatic lesions|metastatic lesions
5289734|NCT02225223|vertebral body|vertebral body
5289735|NCT02225223|ablation|ablation
5289736|NCT02225223|radiation|radiation
5289737|NCT02225223|targeted radio-frequency ablation|targeted radio-frequency ablation
5289738|NCT02225223|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
5289739|NCT02225223|radiofrequency kyphoplasty|radiofrequency kyphoplasty
5289740|NCT02225223|spine|spine
5289741|NCT02225223|vertebral augmentation|vertebral augmentation
5289742|NCT02225223|kyphoplasty|kyphoplasty
5289743|NCT02225223|spinal ablation|spinal ablation
5289744|NCT02225223|pain|pain
5289745|NCT02225223|quality of life|quality of life
5289746|NCT02225223|spinal tumors|spinal tumors
5289747|NCT02225210|Dexmedetomidine ,Delirium ,Haemodynamic, Mechanical ventilation|dexmedetomidine ,delirium ,haemodynamic, mechanical ventilation
5289748|NCT02225197|Perioptic|perioptic
5289749|NCT02225197|Stereotactic|stereotactic
5289751|NCT02225197|Benign brain tumor|benign brain tumor
5289752|NCT02225197|Optic apparatus|optic apparatus
5962938|NCT04277481|Muscle|muscle
5289753|NCT02225184|Opioid Dependence|opioid dependence
5289754|NCT02225184|OPRM1|oprm1
5289755|NCT02225184|Outcome|outcome
5289756|NCT02225184|Treatment|treatment
5289757|NCT02225171|Assisted Reproductive Technology|assisted reproductive technology
5289758|NCT02225171|Behavior|behavior
5289759|NCT02225171|Health Care Provider|health care provider
5289760|NCT02225171|Ethical Concerns|ethical concerns
5289761|NCT02225171|Decision Making|decision making
5289762|NCT02225158|Immunity|immunity
5289763|NCT02225158|Co-Infection|co-infection
5289764|NCT02225158|Parasite|parasite
5289765|NCT02225158|Mycobacteria|mycobacteria
5289766|NCT02225145|Bone Marrow Transplant|bone marrow transplant
5289767|NCT02225145|Fertility|fertility
5289768|NCT02225145|Ovary|ovary
5289769|NCT02225132|Hydroxyurea|hydroxyurea
5289770|NCT02225132|Sickle Cell Disease|sickle cell disease
5289771|NCT02225132|Fetal Hemoglobin Induction|fetal hemoglobin induction
5289772|NCT02225119|Retinal Images|retinal images
5289773|NCT02225119|Retinal Pigment Epithelium|retinal pigment epithelium
5289774|NCT02225106|Dopamine Receptors|dopamine receptors
5289775|NCT02225106|Methylphenidate|methylphenidate
5289776|NCT02225106|Traumatic Brain Injury|traumatic brain injury
5289777|NCT02225106|C-11 Raclopride|c-11 raclopride
5289778|NCT02225106|Dopamine Release|dopamine release
5289779|NCT02225093|Safety|safety
5289780|NCT02225093|Dextromethorphan|dextromethorphan
5289781|NCT02225093|CYP2D6|cyp2d6
5289782|NCT02225093|Phase 1|phase 1
5289783|NCT02225093|Prostate cancer|prostate cancer
5289784|NCT02225093|CYP1A2|cyp1a2
5289785|NCT02225093|Pharmacokinetics|pharmacokinetics
5289786|NCT02225093|Drug-drug interactions|drug-drug interactions
5289787|NCT02225093|Caffeine|caffeine
5289788|NCT02225093|Enzalutamide|enzalutamide
5289789|NCT02225067|Patients|patients
5289790|NCT02225067|Volunteers|volunteers
5289791|NCT02225054|duration of analgesia|duration of analgesia
5289792|NCT02225041|intensive care|intensive care
5289793|NCT02225041|critical care|critical care
5289794|NCT02225041|child|child
5289795|NCT02225041|family|family
5289796|NCT02225041|survivors|survivors
5289797|NCT02225028|physical activity|physical activity
5289798|NCT02225028|physical fitness|physical fitness
5289799|NCT02225028|exercise program|exercise program
5289800|NCT02225028|telephone coaching|telephone coaching
5289801|NCT02225028|motivational counseling|motivational counseling
5289802|NCT02225028|stretching|stretching
5289803|NCT02225028|fitness improvement|fitness improvement
5289804|NCT02225028|exercise coaching|exercise coaching
5289811|NCT02225015|Breast cancer|breast cancer
5289812|NCT02225015|Ovarian cancer|ovarian cancer
5289813|NCT02225015|BRCA Mutation|brca mutation
5289814|NCT02225015|BRCA1 Gene Mutation|brca1 gene mutation
5289815|NCT02225015|BRCA2 Gene Mutation|brca2 gene mutation
5289816|NCT02225015|Telephone genetic counselling|telephone genetic counselling
5289817|NCT02225015|Cancer prevention|cancer prevention
5289818|NCT02225002|relapsed|relapsed
5289819|NCT02225002|refractory to standard therapy|refractory to standard therapy
5289820|NCT02225002|no effective therapy exists|no effective therapy exists
5289821|NCT02224976|exercise training|exercise training
5289823|NCT02224963|Macular Degeneration,|macular degeneration,
5289824|NCT02224963|Preparation for Future Care,|preparation for future care,
5289825|NCT02224963|Psychological Well-being,|psychological well-being,
5289826|NCT02224963|Problem Solving|problem solving
5289827|NCT02224963|Prevention|prevention
5289828|NCT02224963|Mental Health Promotion|mental health promotion
5289829|NCT02224950|Atopic dermatitis|atopic dermatitis
5289831|NCT02224950|alternative therapy|alternative therapy
5289832|NCT02224950|complementary therapy|complementary therapy
5289833|NCT02224950|moisturizer|moisturizer
5289834|NCT02224937|Melatonin|melatonin
5289835|NCT02224937|Cognitive parameters|cognitive parameters
5289836|NCT02224937|pharmacodynamic|pharmacodynamic
5289837|NCT02224937|pharmacokinetics|pharmacokinetics
5289838|NCT02224924|Experimental: autologous blood patch injection (ABPI)|experimental: autologous blood patch injection (abpi)
5289839|NCT02224924|Experimental: BioSentry (formerly known as Bio-Seal) hydrogel Tract Plug|experimental: biosentry (formerly known as bio-seal) hydrogel tract plug
5289840|NCT02224924|14-141|14-141
5289841|NCT02224911|focal therapy|focal therapy
5289842|NCT02224911|prostate cancer treatment|prostate cancer treatment
5289843|NCT02224911|laser treatment|laser treatment
5289844|NCT02224885|Interventional radiology|interventional radiology
5289845|NCT02224885|Lung|lung
5289846|NCT02224885|Liver|liver
5289847|NCT02224885|Confocal endomicroscopy|confocal endomicroscopy
5289848|NCT02224885|Optical biopsy|optical biopsy
5289849|NCT02224885|Scanner|scanner
5289850|NCT02224885|Fluoroscopy|fluoroscopy
5289851|NCT02224885|CT|ct
5289852|NCT02224885|Computed Tomography|computed tomography
5289853|NCT02224885|Radiofrequency Ablation|radiofrequency ablation
5289854|NCT02224885|Fluorescein|fluorescein
5289855|NCT02224872|bone marrow transplant|bone marrow transplant
5289856|NCT02224872|thymoglobulin|thymoglobulin
5289857|NCT02224872|cyclophosphamide|cyclophosphamide
5289858|NCT02224872|fludarabine|fludarabine
5289859|NCT02224872|tacrolimus|tacrolimus
5289860|NCT02224872|Mycophenolic Acid Mofetil|mycophenolic acid mofetil
5289861|NCT02224872|chemotherapy|chemotherapy
5289862|NCT02224872|GVHD|gvhd
5289863|NCT02224872|haploidentical|haploidentical
5289864|NCT02224833|appropriateness|appropriateness
5289865|NCT02224833|elderly|elderly
5289866|NCT02224833|polypharmacy|polypharmacy
5289867|NCT02224833|primary care|primary care
5289868|NCT02224820|transplantation|transplantation
5289869|NCT02224820|sensitised patients|sensitised patients
5289870|NCT02224820|HLA-antibodies|hla-antibodies
5289871|NCT02224807|breast cancer|breast cancer
5289872|NCT02224807|diet|diet
5289873|NCT02224807|exercise|exercise
5289874|NCT02224807|weight loss|weight loss
5289875|NCT02224794|abdominal|abdominal
5289876|NCT02224794|aortic|aortic
5289877|NCT02224794|aneurysm|aneurysm
5289878|NCT02224755|Heart Failure|heart failure
5289879|NCT02224755|Left Ventricular Assist Device|left ventricular assist device
5289880|NCT02224755|Ventricular Dysfunction|ventricular dysfunction
5289881|NCT02224755|Cardiomyopathy|cardiomyopathy
5289882|NCT02224755|Heart Disease|heart disease
5289883|NCT02224755|Cardiovascular Disease|cardiovascular disease
5289884|NCT02224755|Heart-assist devices|heart-assist devices
5289885|NCT02224755|Thoratec Corporation|thoratec corporation
5289886|NCT02224703|Cannabidiol|cannabidiol
5289888|NCT02224703|GWP42003-P|gwp42003-p
5289889|NCT02224703|Epidiolex|epidiolex
5289890|NCT02224690|Cannabidiol|cannabidiol
5289891|NCT02224690|CBD|cbd
5289892|NCT02224690|Epidiolex|epidiolex
5289893|NCT02224690|GWP42003-P|gwp42003-p
5289894|NCT02224677|CFM|cfm
5289895|NCT02224677|facial asymmetry|facial asymmetry
5289896|NCT02224677|skin tag|skin tag
5289897|NCT02224677|facial tag|facial tag
5289898|NCT02224677|missing ear|missing ear
5289899|NCT02224677|small ear|small ear
5289900|NCT02224677|anotia|anotia
5289901|NCT02224677|microtia|microtia
5289902|NCT02224677|epibulbar dermoid|epibulbar dermoid
5289903|NCT02224677|coloboma|coloboma
5289904|NCT02224677|macrostomia|macrostomia
5289906|NCT02224677|infant|infant
5289907|NCT02224677|toddler|toddler
5289908|NCT02224677|baby|baby
5289909|NCT02224677|neurodevelopment|neurodevelopment
5289910|NCT02224677|cognition|cognition
5289911|NCT02224677|socialization|socialization
5289912|NCT02224638|skin ulcers|skin ulcers
5289913|NCT02224612|Pediatric Face Masks|pediatric face masks
5289914|NCT02224612|children|children
5289915|NCT02224599|Immunotherapy|immunotherapy
5289916|NCT02224599|TAPA-Pulsed Dendritic Cell Therapy|tapa-pulsed dendritic cell therapy
5289917|NCT02224599|Dendritic Cell Therapy|dendritic cell therapy
5289918|NCT02224573|Cannabidiol|cannabidiol
5289919|NCT02224573|CBD|cbd
5289920|NCT02224573|GWP42003-P|gwp42003-p
5289921|NCT02224573|GWPCARE5|gwpcare5
5289922|NCT02224560|Cannabidiol|cannabidiol
5289924|NCT02224560|Epidiolex|epidiolex
5289925|NCT02224560|GWP42003-P|gwp42003-p
5289926|NCT02224547|non-small cell lung cancer|non-small cell lung cancer
5289927|NCT02224547|lung carcinoma|lung carcinoma
5289928|NCT02224547|NSCLC|nsclc
5289929|NCT02224534|ST elevation myocardial infarction.|st elevation myocardial infarction.
5289930|NCT02224534|Ticagrelor|ticagrelor
5289931|NCT02224534|Left ventricular remodeling|left ventricular remodeling
5289932|NCT02224534|Platelet reactivity|platelet reactivity
5289933|NCT02224521|FLAP inhibitor|flap inhibitor
5289934|NCT02224521|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5289935|NCT02224521|COPD|copd
5289936|NCT02224521|Bioavailability|bioavailability
5289937|NCT02224469|Brain-Computer Interface|brain-computer interface
5289938|NCT02224469|Motor Cortex|motor cortex
5289939|NCT02224469|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5289940|NCT02224469|Quality of Life|quality of life
5289941|NCT02224456|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5289942|NCT02224456|hepatocellular carcinoma|hepatocellular carcinoma
5289943|NCT02224456|chronic hepatitis B|chronic hepatitis b
5289944|NCT02224456|Cirrhosis|cirrhosis
5289945|NCT02224443|Dexmedetomidine,postoperative cognitive dysfunction|dexmedetomidine,postoperative cognitive dysfunction
5289946|NCT02224430|biomarker of relapse|biomarker of relapse
5289947|NCT02224430|schizophrenia|schizophrenia
5289948|NCT02224430|schizoaffective disorder|schizoaffective disorder
5289949|NCT02224430|on-body sensors|on-body sensors
5289950|NCT02224430|smartphone|smartphone
5289951|NCT02224430|observational|observational
5289952|NCT02224417|Diabetes|diabetes
5289953|NCT02224417|Treatment medication adherence|treatment medication adherence
5289954|NCT02224417|Physical activity|physical activity
5289955|NCT02224417|Financial incentives|financial incentives
5289956|NCT02224417|Outcome incentives|outcome incentives
5289957|NCT02224417|Process incentives|process incentives
5289958|NCT02224417|HbA1c|hba1c
5289959|NCT02224378|fluid responsiveness|fluid responsiveness
5289960|NCT02224378|atrial fibrillation|atrial fibrillation
5289961|NCT02224378|passive leg raising|passive leg raising
5289962|NCT02224378|central venous pressure|central venous pressure
5289963|NCT02224378|valvular heart surgery|valvular heart surgery
5289964|NCT02224365|Diabetes|diabetes
5289965|NCT02224365|Arterial Stiffness|arterial stiffness
5369156|NCT01861041|low dose|low dose
5289966|NCT02224365|Blood Pressure|blood pressure
5289967|NCT02224365|Endothelial Function|endothelial function
5289968|NCT02224365|Body Composition|body composition
5289969|NCT02224365|Glycemic Control|glycemic control
5289970|NCT02224365|Apples|apples
5289971|NCT02224365|Functional Foods|functional foods
5289972|NCT02224365|Polyphenols|polyphenols
5289973|NCT02224365|Fiber|fiber
5289974|NCT02224352|Electric Stimulation|electric stimulation
5289975|NCT02224352|Respiration|respiration
5289976|NCT02224352|Abdominal wall|abdominal wall
5289978|NCT02224352|Respiratory Tract Diseases|respiratory tract diseases
5289979|NCT02224352|COPD|copd
5289980|NCT02224339|Atherosclerosis|atherosclerosis
5289981|NCT02224339|carotid plaque|carotid plaque
5289982|NCT02224339|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5289983|NCT02224339|Major Adverse Cardiovascular Events|major adverse cardiovascular events
5289984|NCT02224326|Alzheimer´s disease|alzheimer´s disease
5289985|NCT02224326|early diagnosis|early diagnosis
5289986|NCT02224326|evoked potentials|evoked potentials
5289987|NCT02224326|near-infrared spectroscopy|near-infrared spectroscopy
5289988|NCT02224313|vaginal cytokine|vaginal cytokine
5289989|NCT02224287|Urolithiasis|urolithiasis
5289990|NCT02224287|Kidney Stones|kidney stones
5289991|NCT02224287|Ureteroscopy|ureteroscopy
5289992|NCT02224287|Fluoroscopy|fluoroscopy
5289993|NCT02224274|Antiplatelet Therapy|antiplatelet therapy
5289994|NCT02224274|Cardiac Arrest|cardiac arrest
5289995|NCT02224274|Therapeutic hypothermia|therapeutic hypothermia
5289996|NCT02224274|Myocardial infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)|myocardial infarction (st-elevation myocardial infarction and non-st-elevation myocardial infarction)
5289997|NCT02224261|Axillary web syndrome|axillary web syndrome
5289998|NCT02224261|cording|cording
5289999|NCT02224261|physical therapy|physical therapy
5290000|NCT02224261|breast cancer|breast cancer
5290001|NCT02224248|cardiorespiratory fitness|cardiorespiratory fitness
5286871|NCT02237846|umbilical cord|umbilical cord
5290002|NCT02224248|exercise tolerance|exercise tolerance
5290003|NCT02224248|exercise test|exercise test
5290004|NCT02224248|health behavior|health behavior
5290005|NCT02224248|motor activity|motor activity
5290007|NCT02224248|intention|intention
5290008|NCT02224248|self-rated health|self-rated health
5290009|NCT02224235|Stable angina|stable angina
5290011|NCT02224235|Percutaneous Coronary Intervention|percutaneous coronary intervention
5290012|NCT02224209|Carotid artery stenosis|carotid artery stenosis
5290013|NCT02224209|High risk of hyperperfusion|high risk of hyperperfusion
5290014|NCT02224209|Staged angioplasty|staged angioplasty
5290015|NCT02224209|Routine single-stage stenting|routine single-stage stenting
5290016|NCT02224196|manual ventilation|manual ventilation
5290017|NCT02224196|pressure-controlled ventilation|pressure-controlled ventilation
5290018|NCT02224196|peak airway pressure|peak airway pressure
5290019|NCT02224196|antral area|antral area
5290020|NCT02224183|low back pain|low back pain
5290021|NCT02224183|yoga|yoga
5290022|NCT02224183|education|education
5290023|NCT02224183|Veterans|veterans
5290024|NCT02224183|cost-effectiveness|cost-effectiveness
5290025|NCT02224183|military|military
5294740|NCT02202395|LTS|lts
5290028|NCT02224170|Lidocaine|lidocaine
5290029|NCT02224170|Quality of Recovery|quality of recovery
5290030|NCT02224170|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5290031|NCT02224144|Kidney Transplantation|kidney transplantation
5290032|NCT02224144|Calcitriol|calcitriol
5290033|NCT02224144|Bone Mineral Density|bone mineral density
5290034|NCT02224144|Bone Mass and Strength|bone mass and strength
5290035|NCT02224144|Vascular Calcifications|vascular calcifications
5290036|NCT02224144|Hyperparathyroidism|hyperparathyroidism
5290037|NCT02224144|Parathyroid Hormone|parathyroid hormone
5290038|NCT02224131|platelet function test|platelet function test
5290039|NCT02224131|stent;|stent;
5290040|NCT02224118|Healthy|healthy
5290041|NCT02224118|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5290042|NCT02224118|CNTO 3649|cnto 3649
5290043|NCT02224092|heart health|heart health
5290044|NCT02224092|general well-being|general well-being
5290045|NCT02224066|Aortic stenosis|aortic stenosis
5290046|NCT02224066|TAVI|tavi
5290047|NCT02224066|TAVR|tavr
5290048|NCT02224066|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5290049|NCT02224066|Ticagrelor|ticagrelor
5290050|NCT02224066|Antiplatelet reactivity|antiplatelet reactivity
5290051|NCT02224053|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer|oncology, cancer, non small cell lung cancer, anticancer druge, omeprazole, healthy volunteer
5290052|NCT02224001|tip plasty|tip plasty
5290053|NCT02224001|septal cartilage|septal cartilage
5290060|NCT02223975|Spectrum Analysis, Raman|spectrum analysis, raman
5290061|NCT02223975|Spectrum Analysis|spectrum analysis
5290062|NCT02223975|Fourier transform infrared spectroscopy|fourier transform infrared spectroscopy
5290064|NCT02223975|Optical|optical
5290065|NCT02223975|Diagnosis|diagnosis
5290066|NCT02223975|Cancer|cancer
5290067|NCT02223975|Multivariate analysis|multivariate analysis
5290068|NCT02223975|Vulval Intraepithelial Neoplasia|vulval intraepithelial neoplasia
5962939|NCT04277416|Ortho Development|ortho development
5290069|NCT02223975|Vulvar Neoplasm|vulvar neoplasm
5290070|NCT02223975|Vulva|vulva
5290071|NCT02223975|Vulvar Diseases|vulvar diseases
5290072|NCT02223962|physical activity|physical activity
5290073|NCT02223962|COPD|copd
5290074|NCT02223962|activity monitors|activity monitors
5290075|NCT02223949|Obesity|obesity
5290076|NCT02223949|Labor complications|labor complications
5290077|NCT02223949|Induction of labor|induction of labor
5290078|NCT02223949|Mechanical cervical ripening|mechanical cervical ripening
5290079|NCT02223936|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype|nuchal translucency, neurological developpment, anxiety, depression, prenatal diagnosis, normal karyotype
5290080|NCT02223923|Phase 1|phase 1
5290081|NCT02223923|Maximimum tolerated dose|maximimum tolerated dose
5290082|NCT02223923|ATR Inhibitor|atr inhibitor
5290083|NCT02223923|Radiotherapy|radiotherapy
5290084|NCT02223910|brain computer interface|brain computer interface
5290085|NCT02223910|neurofeedback|neurofeedback
5290086|NCT02223910|functional connectivity|functional connectivity
5290087|NCT02223897|Liver transplantation|liver transplantation
5290088|NCT02223897|Biliary complication|biliary complication
5290089|NCT02223897|mesenchymal stem cells|mesenchymal stem cells
5290090|NCT02223884|Malignant melanoma, second-line treatment, docetaxel, carboplatin|malignant melanoma, second-line treatment, docetaxel, carboplatin
5290091|NCT02223871|Malaria|malaria
5290092|NCT02223871|ACT-451840|act-451840
5290093|NCT02223858|Health Status Disparities|health status disparities
5290094|NCT02223858|Arthritis|arthritis
5290095|NCT02223858|Psychology|psychology
5290096|NCT02223858|Pain Management|pain management
5290097|NCT02223858|Affect|affect
5290098|NCT02223845|Music, Anxiety, IVF|music, anxiety, ivf
5290099|NCT02223832|ACT-128800|act-128800
5290100|NCT02223832|Safety|safety
5290101|NCT02223832|Tolerability|tolerability
5290102|NCT02223832|Pharmacokinetics|pharmacokinetics
5290103|NCT02223819|Crizotinib|crizotinib
5290104|NCT02223819|14-063|14-063
5185492|NCT02830425|STOPP|stopp
5290105|NCT02223806|Postpartum hemorrhage|postpartum hemorrhage
5290106|NCT02223806|Uterine tonus assessment|uterine tonus assessment
5290107|NCT02223806|Active management of third stage of labor|active management of third stage of labor
5290108|NCT02223793|Vascular screening|vascular screening
5290109|NCT02223793|Cardiovascular risk factors|cardiovascular risk factors
5290110|NCT02223793|Blood pressure|blood pressure
5290111|NCT02223793|Lipids|lipids
5290112|NCT02223793|Lifestyle|lifestyle
5290113|NCT02223793|Identifying unknown risk|identifying unknown risk
5290114|NCT02223793|Low socioeconomic status|low socioeconomic status
5290115|NCT02223793|low threshold|low threshold
5290116|NCT02223780|COPD|copd
5290117|NCT02223780|palliative care|palliative care
5290119|NCT02223767|VR|vr
5290120|NCT02223767|Exposure therapy|exposure therapy
5290121|NCT02223767|TMS augmentations of exposure therapy|tms augmentations of exposure therapy
5290125|NCT02223702|Aggressive periodontitis|aggressive periodontitis
5290126|NCT02223702|amoxicillin|amoxicillin
5290127|NCT02223702|metronidazole|metronidazole
5290128|NCT02223702|moxifloxacin|moxifloxacin
5290129|NCT02223702|nonsurgical periodontal debridement.|nonsurgical periodontal debridement.
5290130|NCT02223689|SkinAffix|skinaffix
5290131|NCT02223676|Pharmacy|pharmacy
5290132|NCT02223676|Length-of-stay|length-of-stay
5290133|NCT02223676|Emergency Department|emergency department
5290134|NCT02223650|Intermittent Exotropia|intermittent exotropia
5290135|NCT02223650|IXT|ixt
5290136|NCT02223650|overminus|overminus
5290142|NCT02223611|Stage Ⅱ-ⅢA NSCLC S1 capsule Completely resection|stage ⅱ-ⅲa nsclc s1 capsule completely resection
5343003|NCT01981200|Resistance training|resistance training
5290143|NCT02223598|Lymphoid Hematological Malignancies|lymphoid hematological malignancies
5290144|NCT02223585|Gut microbial|gut microbial
5290145|NCT02223585|response|response
5290146|NCT02223585|to protein-based|to protein-based
5290147|NCT02223585|diet|diet
5290148|NCT02223585|challenges|challenges
5290149|NCT02223585|population|population
5290150|NCT02223533|analgesia|analgesia
5290151|NCT02223533|post-operative|post-operative
5290155|NCT02223520|Infection|infection
5290156|NCT02223520|Colonization|colonization
5290157|NCT02223520|Transmission|transmission
5290158|NCT02223520|Neonate|neonate
5290159|NCT02223468|Intestinal Microbiota|intestinal microbiota
5290160|NCT02223468|Liver Transplant|liver transplant
5290161|NCT02223468|Acute Rejection|acute rejection
5290162|NCT02223468|Infection|infection
5290163|NCT02223455|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5290164|NCT02223455|Infection Control (IC)|infection control (ic)
5290165|NCT02223455|Hospital-associated infections (HAI)|hospital-associated infections (hai)
5290166|NCT02223455|Hand Hygiene (HH)|hand hygiene (hh)
5290167|NCT02223455|Compliance|compliance
5290168|NCT02223455|Health Care Workers (HCWs)|health care workers (hcws)
5290169|NCT02223442|chronic pain|chronic pain
5290170|NCT02223442|central analgesic drugs|central analgesic drugs
5290171|NCT02223442|adherence to therapy|adherence to therapy
5290172|NCT02223442|side effects|side effects
5290173|NCT02223442|quality of life|quality of life
5290174|NCT02223442|MOR-NRI drugs|mor-nri drugs
5171834|NCT02918435|WE CARE|we care
5290175|NCT02223429|Paternal nurturance|paternal nurturance
5290176|NCT02223429|Oxytocin|oxytocin
5290177|NCT02223429|Vasopressin|vasopressin
5290178|NCT02223429|fMRI|fmri
5290179|NCT02223429|Neurobiology|neurobiology
5290180|NCT02223416|female|female
5290181|NCT02223416|volunteers|volunteers
5290182|NCT02223403|Nitrate-rich beetroot juice|nitrate-rich beetroot juice
5290183|NCT02223403|heart failure|heart failure
5290184|NCT02223403|exercise performance|exercise performance
5290185|NCT02223403|oxygen consumption|oxygen consumption
5290186|NCT02223390|South Africa|south africa
5290187|NCT02223390|HIV|hiv
5290188|NCT02223390|Mental health|mental health
5290189|NCT02223390|Trauma|trauma
5290190|NCT02223390|Women|women
5290191|NCT02223351|HSV|hsv
5290192|NCT02223351|HIV|hiv
5290193|NCT02223351|Herpes|herpes
5290194|NCT02223351|volunteers|volunteers
5290195|NCT02223351|drug-drug interaction|drug-drug interaction
5290196|NCT02223325|Elderly|elderly
5290197|NCT02223325|Prognosis|prognosis
5290202|NCT02223286|Corus CAD|corus cad
5290203|NCT02223286|ASGES|asges
5290204|NCT02223286|Age/Sex/Gene Expression Score|age/sex/gene expression score
5290205|NCT02223286|Gene Expression|gene expression
5290206|NCT02223286|GES|ges
5290207|NCT02223286|CAD|cad
5290208|NCT02223286|CVD|cvd
5290209|NCT02223286|CHD|chd
5290210|NCT02223286|Precision Medicine|precision medicine
5290211|NCT02223286|Clinical Utility|clinical utility
5290212|NCT02223286|Coronary Artery Disease|coronary artery disease
5290213|NCT02223286|Angina Pectoris|angina pectoris
5290214|NCT02223286|Chest Pain|chest pain
5290215|NCT02223286|Cardiovascular Disease|cardiovascular disease
5290216|NCT02223286|Coronary Heart Disease|coronary heart disease
5290217|NCT02223286|UCU-CARD|ucu-card
5290218|NCT02223273|stroke,|stroke,
5290219|NCT02223273|quality improvement|quality improvement
5290220|NCT02223247|solid tumors|solid tumors
5290221|NCT02223247|cancer|cancer
5290222|NCT02223221|In Vitro Fertilization|in vitro fertilization
5290223|NCT02223221|Intracytoplasmic Sperm Injections|intracytoplasmic sperm injections
5290224|NCT02223221|Infertility, Female|infertility, female
5290225|NCT02223221|Abortion, Habitual|abortion, habitual
5290226|NCT02223221|recurrent pregnancy loss|recurrent pregnancy loss
5290227|NCT02223221|comprehensive chromosome screening|comprehensive chromosome screening
5290228|NCT02223221|preimplantation genetic screening|preimplantation genetic screening
5290230|NCT02223208|PTCL|ptcl
5290231|NCT02223208|PTCL-NOS|ptcl-nos
5290232|NCT02223208|AITL|aitl
5290233|NCT02223208|ALCL|alcl
5290234|NCT02223195|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5290235|NCT02223195|Saliva|saliva
5290236|NCT02223182|Milk Allergy,|milk allergy,
5290237|NCT02223182|Viaskin Milk,|viaskin milk,
5290238|NCT02223182|Specific Immunotherapy,|specific immunotherapy,
5290239|NCT02223182|Epicutaneous ImmunoTherapy (EPIT)|epicutaneous immunotherapy (epit)
5290240|NCT02223182|IgE-Mediated Cow's Milk Allergy|ige-mediated cow's milk allergy
5290241|NCT02223169|Blood Pressure|blood pressure
5290242|NCT02223169|Hypertension|hypertension
5290246|NCT02223130|Discrimination|discrimination
5290247|NCT02223130|Coping|coping
5290248|NCT02223130|Medical Mistrust|medical mistrust
5290249|NCT02223130|HIV Outcomes|hiv outcomes
5290250|NCT02223130|Cognitive Behavioral Therapy|cognitive behavioral therapy
5290251|NCT02223091|complementary therapies|complementary therapies
5290252|NCT02223091|consultants|consultants
5290253|NCT02223091|medical oncology|medical oncology
5290254|NCT02223091|breast-cancer|breast-cancer
5290255|NCT02223091|education|education
5290256|NCT02223052|CC-486|cc-486
5290257|NCT02223052|Oral Azacitidine|oral azacitidine
5290258|NCT02223052|Soli Tumor Malignancy|soli tumor malignancy
5290259|NCT02223052|Hematological Malignancy|hematological malignancy
5290260|NCT02223052|Leukemia|leukemia
5290261|NCT02223052|Lymphoma|lymphoma
5290262|NCT02223052|Multiple Myeloma|multiple myeloma
5290263|NCT02223052|Acute Myeloid Leukemia|acute myeloid leukemia
5290264|NCT02223052|Myelodysplastic Syndromes|myelodysplastic syndromes
5290265|NCT02223052|Neoplasms|neoplasms
5290266|NCT02223052|Melanoma|melanoma
5290267|NCT02223052|Breast Cancer|breast cancer
5290268|NCT02223052|Metastatic Breast Cancer|metastatic breast cancer
5290269|NCT02223052|Non-Small Cell Lung Cancer|non-small cell lung cancer
5290270|NCT02223052|Small Cell Lung Cancer|small cell lung cancer
5290271|NCT02223052|Renal Cell Carcinoma|renal cell carcinoma
5290272|NCT02223052|Glioblastoma Multiforme|glioblastoma multiforme
5290273|NCT02223052|Brain Cancer|brain cancer
5290274|NCT02223052|Kidney Cancer|kidney cancer
5290275|NCT02223052|Lung cancer|lung cancer
5290276|NCT02223052|Blood Cancer|blood cancer
5962940|NCT04277416|Entrada Hip System|entrada hip system
5290277|NCT02223052|Thyroid Cancer|thyroid cancer
5290278|NCT02223052|Bone Cancer|bone cancer
5290279|NCT02223052|Bone Metastasis|bone metastasis
5290280|NCT02223052|Testicular Cancer|testicular cancer
5290281|NCT02223052|Prostate Cancer|prostate cancer
5290282|NCT02223052|Bladder Cancer|bladder cancer
5290283|NCT02223052|Ovarian Cancer|ovarian cancer
5290284|NCT02223052|Skin Cancer|skin cancer
5290285|NCT02223052|Cancer general|cancer general
5290286|NCT02223052|Survival|survival
5290287|NCT02223052|Chemotherapy|chemotherapy
5290288|NCT02223052|Targeted Therapy|targeted therapy
5290289|NCT02223052|Genitourinary|genitourinary
5290291|NCT02223052|MDS|mds
5290292|NCT02223052|AML|aml
5290293|NCT02223052|NHL|nhl
5290294|NCT02223052|HL|hl
5290295|NCT02223052|MBC|mbc
5290296|NCT02223052|NSCLC|nsclc
5290297|NCT02223052|SCLC|sclc
5290299|NCT02223039|Psoriasis|psoriasis
5290300|NCT02223039|Dermatology|dermatology
5290301|NCT02223039|Monoclonal antibody|monoclonal antibody
5290302|NCT02222935|Balance training|balance training
5290303|NCT02222935|low back pain|low back pain
5290304|NCT02222935|balance test|balance test
5290305|NCT02222935|routine back exercise|routine back exercise
5290306|NCT02222922|ADC|adc
5290307|NCT02222922|PF-06647020|pf-06647020
5290308|NCT02222922|solid tumors|solid tumors
5290309|NCT02222922|tumors|tumors
5290310|NCT02222922|neoplasm metastasis|neoplasm metastasis
5290311|NCT02222922|TNBC|tnbc
5290312|NCT02222922|triple negative breast cancer|triple negative breast cancer
5290313|NCT02222922|NSCLC|nsclc
5290314|NCT02222922|non small cell lung cancer|non small cell lung cancer
5290315|NCT02222922|advanced metastatic breast cancer|advanced metastatic breast cancer
5290316|NCT02222922|ovarian cancer|ovarian cancer
5290317|NCT02222922|OVCA|ovca
5290318|NCT02222909|Community Based Organization|community based organization
5290319|NCT02222909|Reverse Innovation|reverse innovation
5290320|NCT02222909|Social Services|social services
5290321|NCT02222909|Referral|referral
5290322|NCT02222909|Chronic disease|chronic disease
5290323|NCT02222870|Influenza|influenza
5290324|NCT02222870|Influenza virus vaccine|influenza virus vaccine
5445391|NCT01522014|Revision Rate|revision rate
5185701|NCT02829619|Food Timing|food timing
5290325|NCT02222870|Quadrivalent Influenza Virus Vaccine (No Preservative)|quadrivalent influenza virus vaccine (no preservative)
5290326|NCT02222870|Fluzone®|fluzone®
5290327|NCT02222857|Acute retinal necrosis|acute retinal necrosis
5290328|NCT02222857|Retinal detachment|retinal detachment
5290329|NCT02222857|Laser photocoagulation|laser photocoagulation
5290331|NCT02222844|Cancer|cancer
5290332|NCT02222844|Colorectal Neoplasms|colorectal neoplasms
5290333|NCT02222844|Colon, Sigmoid|colon, sigmoid
5290334|NCT02222844|Magnetic Resonance Imaging|magnetic resonance imaging
5290335|NCT02222844|General Surgery|general surgery
5290336|NCT02222844|Postoperative Complications|postoperative complications
5290337|NCT02222831|IVF|ivf
5290338|NCT02222831|Embryo Quality|embryo quality
5290339|NCT02222831|Time Lapse Culture|time lapse culture
5290340|NCT02222831|Preimplantation factor|preimplantation factor
5290341|NCT02222805|Cord clamping|cord clamping
5290342|NCT02222805|Iron deficiency|iron deficiency
5290343|NCT02222805|Anemia|anemia
5290344|NCT02222805|Iron|iron
5290350|NCT02222740|Tolerability|tolerability
5290351|NCT02222740|Pharmacokinetics|pharmacokinetics
5290352|NCT02222714|ischemic stroke|ischemic stroke
5290354|NCT02222714|APC|apc
5290355|NCT02222714|3K3A|3k3a
5290356|NCT02222714|3K3A-APC|3k3a-apc
5290357|NCT02222714|activated protein C|activated protein c
5290358|NCT02222714|RHAPSODY|rhapsody
5290359|NCT02222701|composite|composite
5290360|NCT02222701|dental|dental
5290361|NCT02222701|longevity|longevity
5290362|NCT02222688|cancer|cancer
5290363|NCT02222688|CLL|cll
5290364|NCT02222662|Massage|massage
5290365|NCT02222662|effectiveness|effectiveness
5290366|NCT02222662|autism|autism
5290367|NCT02222662|parent stress|parent stress
5290368|NCT02222649|Elderly|elderly
5290369|NCT02222649|vitamin D insufficiency|vitamin d insufficiency
5290370|NCT02222649|High dose vitamin D3 supplementation|high dose vitamin d3 supplementation
5290371|NCT02222649|Polymorphism of the VDR gene|polymorphism of the vdr gene
5290372|NCT02222636|The efficacy and safety of intranasal dexmedetomidine|the efficacy and safety of intranasal dexmedetomidine
5290373|NCT02222623|insulin|insulin
5290374|NCT02222623|basal|basal
5290375|NCT02222623|diabetes|diabetes
5290376|NCT02222623|hospital|hospital
5290377|NCT02222623|glucose|glucose
5290378|NCT02222623|hypoglycemia|hypoglycemia
5290379|NCT02222623|glargine|glargine
5290380|NCT02222623|NPH|nph
5290381|NCT02222623|neutral protamine hagedorn|neutral protamine hagedorn
5290382|NCT02222610|Radiation Retinopathy|radiation retinopathy
5290383|NCT02222597|head injury|head injury
5290384|NCT02222597|infrascanner|infrascanner
5290385|NCT02222597|intracranial hemorrhage|intracranial hemorrhage
5290386|NCT02222584|inflammatory bowel disease|inflammatory bowel disease
5290387|NCT02222584|physical activity|physical activity
5290388|NCT02222584|disease activity|disease activity
5290389|NCT02222584|quality of life|quality of life
5290390|NCT02222558|hypogonadism|hypogonadism
5290391|NCT02222558|Gonadal Disorders|gonadal disorders
5290392|NCT02222558|Endocrine System Diseases|endocrine system diseases
5290393|NCT02222558|Testosterone|testosterone
5290394|NCT02222558|Testosterone enanthate|testosterone enanthate
5290395|NCT02222558|Testosterone undecanoate|testosterone undecanoate
5290396|NCT02222558|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
5290397|NCT02222558|Methyltestosterone|methyltestosterone
5290398|NCT02222558|Androgens|androgens
5290399|NCT02222558|Hormones|hormones
5290400|NCT02222558|Hormones,|hormones,
5290401|NCT02222558|Hormone Substitutes,|hormone substitutes,
5290402|NCT02222558|Hormone Antagonists|hormone antagonists
5290403|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs
5290404|NCT02222558|Pharmacologic Actions|pharmacologic actions
5290405|NCT02222558|Therapeutic Uses|therapeutic uses
5290406|NCT02222558|Anabolic Agents|anabolic agents
5290407|NCT02222558|dihydrotestosterone|dihydrotestosterone
5290408|NCT02222545|TMA, aHUS, HSCT-associated TMA, TTP|tma, ahus, hsct-associated tma, ttp
5290409|NCT02222532|tetronine|tetronine
5290410|NCT02222532|congenital heart disease|congenital heart disease
5290411|NCT02222532|cardiopulmonary bypass|cardiopulmonary bypass
5290412|NCT02222532|euthyroid sick syndrome|euthyroid sick syndrome
5290413|NCT02222519|statins|statins
5290414|NCT02222519|nondepolarizing muscle relaxants|nondepolarizing muscle relaxants
5290415|NCT02222519|rocuronium|rocuronium
5290416|NCT02222519|myalgia|myalgia
5290417|NCT02222493|Phase 3|phase 3
5290418|NCT02222493|infliximab|infliximab
5290419|NCT02222493|rheumatoid arthritis|rheumatoid arthritis
5290420|NCT02222480|Patients|patients
5290421|NCT02222480|with mild|with mild
5290422|NCT02222480|moderate|moderate
5290423|NCT02222480|essential|essential
5290424|NCT02222441|Palbociclib|palbociclib
5290425|NCT02222441|Modafinil|modafinil
5290426|NCT02222441|Pioglitazone|pioglitazone
5290427|NCT02222441|Pharmacokinetics|pharmacokinetics
5290428|NCT02222441|Drug-Drug Interaction Study|drug-drug interaction study
5290429|NCT02222441|Healthy Volunteers|healthy volunteers
5290430|NCT02222441|CYP3A Inducers|cyp3a inducers
5290431|NCT02222415|Muscle mass|muscle mass
5290432|NCT02222415|Strength|strength
5290433|NCT02222415|Cross-sectional area|cross-sectional area
5290434|NCT02222415|Protein|protein
5290438|NCT02222376|Diabetic ulcer, diabetic foot|diabetic ulcer, diabetic foot
5290439|NCT02222363|Phase I|phase i
5290440|NCT02222363|Iron chelator|iron chelator
5287289|NCT02236013|ASP2215|asp2215
5290442|NCT02222363|Dose escalation study|dose escalation study
5290447|NCT02222350|type 2 diabetes mellitus|type 2 diabetes mellitus
5290448|NCT02222337|behavioral intervention|behavioral intervention
5290449|NCT02222337|quality of life|quality of life
5290450|NCT02222337|breast cancer|breast cancer
5290452|NCT02222337|caregiver|caregiver
5290453|NCT02222337|PCORI|pcori
5290454|NCT02222324|QTc Interval|qtc interval
5290455|NCT02222324|Healthy Subjects|healthy subjects
5290456|NCT02222272|cml|cml
5290457|NCT02222272|chronic myeloid leukemia|chronic myeloid leukemia
5290458|NCT02222272|dasatinib|dasatinib
5290459|NCT02222272|nilotinib|nilotinib
5290460|NCT02222272|tki|tki
5290461|NCT02222272|second generation tki|second generation tki
5290462|NCT02222272|2nd generation tki|2nd generation tki
5290463|NCT02222259|Geriatric Oncology|geriatric oncology
5290464|NCT02222259|Quality of Life|quality of life
5290465|NCT02222259|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5290466|NCT02222259|Functional Status|functional status
5290467|NCT02222259|Chemotherapy|chemotherapy
5290468|NCT02222259|Older Adults|older adults
5290469|NCT02222246|Sickle Cell Disease|sickle cell disease
5290470|NCT02222246|Emergency Department|emergency department
5290471|NCT02222246|Vaso-occlusive Crisis|vaso-occlusive crisis
5290472|NCT02222246|Pain Management|pain management
5290473|NCT02222246|Pilot Project|pilot project
5290474|NCT02222207|neovascular Age-related Macular Degeneration|neovascular age-related macular degeneration
5290475|NCT02222194|Lung cancer|lung cancer
5290476|NCT02222194|Surgery|surgery
5290477|NCT02222194|Videomediastinoscopy|videomediastinoscopy
5290478|NCT02222181|elderly, medication adherence,pharmaceutical care|elderly, medication adherence,pharmaceutical care
5290479|NCT02222155|ANCA-associated vasculitis|anca-associated vasculitis
5290480|NCT02222155|complement|complement
5290481|NCT02222155|vasculitis|vasculitis
5290482|NCT02222155|C5aR|c5ar
5290483|NCT02222142|Ischemic heart disease|ischemic heart disease
5290484|NCT02222142|Off pump coronary artery bypass graft|off pump coronary artery bypass graft
5290485|NCT02222142|Isoflurane|isoflurane
5290486|NCT02222142|Propofol|propofol
5290487|NCT02222129|Randomized controlled trial|randomized controlled trial
5290488|NCT02222129|anesthetics-local|anesthetics-local
5290489|NCT02222129|bupivacaine|bupivacaine
5290490|NCT02222129|analgesia|analgesia
5290491|NCT02222129|Pain, Postoperative|pain, postoperative
5290492|NCT02222116|STEMI|stemi
5290493|NCT02222116|BMS|bms
5290494|NCT02222116|DES|des
5290495|NCT02222116|mesh|mesh
5290496|NCT02222090|patients with atrial fibrillation (AF) recommend the use of novel oral anticoagulants (NOACs) in patients with non-valvular AF|patients with atrial fibrillation (af) recommend the use of novel oral anticoagulants (noacs) in patients with non-valvular af
5290497|NCT02222077|Central blood pressure|central blood pressure
5290498|NCT02222077|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5290499|NCT02222077|Target-organ damage|target-organ damage
5290500|NCT02222077|Adolescents and young adults|adolescents and young adults
5290501|NCT02222051|neck pain|neck pain
5290502|NCT02222051|chronic pain|chronic pain
5290503|NCT02221986|Interdisciplinary rehabilitation|interdisciplinary rehabilitation
5290504|NCT02221986|Neurooncology|neurooncology
5290505|NCT02221986|Physiotherapy|physiotherapy
5290506|NCT02221986|Occupational therapy|occupational therapy
5290507|NCT02221986|Neurorehabilitation|neurorehabilitation
5290508|NCT02221986|Glioma|glioma
5290509|NCT02221960|Recurrent or metastatic solid tumors, MEDI6383, OX40|recurrent or metastatic solid tumors, medi6383, ox40
5290510|NCT02221947|Alzheimer's|alzheimer's
5290511|NCT02221947|bryostatin|bryostatin
5290512|NCT02221947|PKC epsilon|pkc epsilon
5290513|NCT02221934|Pain|pain
5290514|NCT02221934|Chronic|chronic
5290515|NCT02221934|Amputation|amputation
5290516|NCT02221934|Phantom Pain|phantom pain
5290517|NCT02221934|Stump Pain|stump pain
5290518|NCT02221908|Systolic Blood pressure < 100 mm Hg|systolic blood pressure < 100 mm hg
5290519|NCT02221895|postpartum appointment|postpartum appointment
5290520|NCT02221895|breastfeeding|breastfeeding
5290521|NCT02221895|postpartum contraception|postpartum contraception
5290522|NCT02221895|postpartum cervical cancer screening|postpartum cervical cancer screening
5290523|NCT02221895|postpartum depression screening|postpartum depression screening
5290524|NCT02221856|Conventional orthodontic treatment|conventional orthodontic treatment
5290525|NCT02221856|Motion View|motion view
5290526|NCT02221843|sun behavior|sun behavior
5290527|NCT02221843|immunosuppression|immunosuppression
5290528|NCT02221843|skin neoplasms|skin neoplasms
5290529|NCT02221843|sunbit|sunbit
5290530|NCT02221843|uv sensor|uv sensor
5290531|NCT02221843|uv dosimeter|uv dosimeter
5290532|NCT02221843|solar radiation|solar radiation
5290533|NCT02221843|uv exposition|uv exposition
5290534|NCT02221843|uv index|uv index
5290535|NCT02221804|Physical Inactivity|physical inactivity
5290536|NCT02221804|Skeletal Muscle|skeletal muscle
5290537|NCT02221804|Cachexia|cachexia
5290538|NCT02221791|Flavan-3-ol|flavan-3-ol
5290539|NCT02221791|Flavonoids|flavonoids
5290540|NCT02221791|Epicatechin|epicatechin
5290542|NCT02221791|Chocolate|chocolate
5290543|NCT02221791|Endothelial function|endothelial function
5290544|NCT02221791|Bioavailability|bioavailability
5290545|NCT02221778|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5290546|NCT02221778|SBRT|sbrt
5290547|NCT02221765|Obesity|obesity
5290548|NCT02221765|Overnutrition|overnutrition
5290549|NCT02221765|Nutrition Disorders|nutrition disorders
5290550|NCT02221765|Overweight|overweight
5290551|NCT02221765|Body Weight|body weight
5290552|NCT02221765|Signs and Symptoms|signs and symptoms
5290553|NCT02221752|iron deficiency|iron deficiency
5290554|NCT02221752|iron deficiency anemia|iron deficiency anemia
5290555|NCT02221752|infant|infant
5290556|NCT02221752|pregnancy|pregnancy
5290557|NCT02221739|lung cancer|lung cancer
5290558|NCT02221739|NSCLC|nsclc
5290559|NCT02221739|lung|lung
5290560|NCT02221739|cancer|cancer
5290561|NCT02221739|radiation|radiation
5290562|NCT02221739|immunotherapy|immunotherapy
5290563|NCT02221739|metastatic|metastatic
5290564|NCT02221726|Healthy|healthy
5290565|NCT02221726|JNJ-35685-AAA-G-023|jnj-35685-aaa-g-023
5290566|NCT02221726|Placebo|placebo
5290567|NCT02221726|Transdermal delivery device system|transdermal delivery device system
5290568|NCT02221713|diverticulitis|diverticulitis
5290569|NCT02221713|diverticulosis|diverticulosis
5290570|NCT02221713|diverticular disease|diverticular disease
5290571|NCT02221687|synbiotic formula|synbiotic formula
5290572|NCT02221687|infant formula|infant formula
5290573|NCT02221687|diarrhea|diarrhea
5290574|NCT02221674|Post-surgical pain|post-surgical pain
5290575|NCT02221674|Opioid|opioid
5290576|NCT02221661|Alzheimer|alzheimer
5290577|NCT02221661|cognitive impairment|cognitive impairment
5290578|NCT02221661|blood test|blood test
5290579|NCT02221648|Back|back
5290580|NCT02221648|Pain|pain
5290581|NCT02221648|Muscle|muscle
5290582|NCT02221635|Schizoaffective Disorder|schizoaffective disorder
5290583|NCT02221635|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5290584|NCT02221622|Alzheimer's disease|alzheimer's disease
5290585|NCT02221622|Mild Cognitive Impairment|mild cognitive impairment
5290586|NCT02221622|Dementia|dementia
5290587|NCT02221622|Regenerative therapeutic|regenerative therapeutic
5290588|NCT02221609|Low Back Pain, Mechanical Low Back Pain, Low Back Ache, Low Backache, Lower Back Pain, Lumbago|low back pain, mechanical low back pain, low back ache, low backache, lower back pain, lumbago
5290589|NCT02221596|Vitamin D|vitamin d
5290590|NCT02221596|25(OH)D|25(oh)d
5290591|NCT02221596|Aerobic training|aerobic training
5290592|NCT02221596|Near-infrared spectroscopy|near-infrared spectroscopy
5290593|NCT02221596|Diffuse correlation spectroscopy|diffuse correlation spectroscopy
5290594|NCT02221596|MRS|mrs
5290595|NCT02221583|End stage renal disease|end stage renal disease
5290596|NCT02221583|Renal transplant candidate|renal transplant candidate
5290597|NCT02221583|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5290598|NCT02221583|Immunosuppressants|immunosuppressants
5290599|NCT02221544|Parkinson's disease, rTMS, Freezing of Gait|parkinson's disease, rtms, freezing of gait
5290600|NCT02221518|OCD|ocd
5962941|NCT04277403|brain metastases|brain metastases
5233105|NCT02545855|HOT|hot
5172238|NCT02916004|Electromyography|electromyography
5172239|NCT02916004|Electrical stimulation|electrical stimulation
5290601|NCT02221518|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5290602|NCT02221505|LOP628,|lop628,
5290603|NCT02221505|cKit,|ckit,
5290604|NCT02221505|ADC,|adc,
5290605|NCT02221505|Antibody drug conjugates,|antibody drug conjugates,
5290606|NCT02221505|maytansine|maytansine
5290607|NCT02221466|diabetes|diabetes
5290609|NCT02221466|wounds|wounds
5290610|NCT02221466|nitric oxide|nitric oxide
5290611|NCT02221466|endothelium|endothelium
5290612|NCT02221466|infection|infection
5290613|NCT02221466|biological markers|biological markers
5290614|NCT02221466|observational study|observational study
5290615|NCT02221466|hyperbaric oxygen|hyperbaric oxygen
5290616|NCT02221466|ulcers|ulcers
5290617|NCT02221466|cytokines|cytokines
5290618|NCT02221466|inflammation|inflammation
5290619|NCT02221453|Diabetic Macular Edema|diabetic macular edema
5290620|NCT02221453|Ocular Cytokines|ocular cytokines
5290621|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide
5290622|NCT02221427|First time mothers|first time mothers
5290623|NCT02221427|Labour progression|labour progression
5290624|NCT02221427|Prolonged labour|prolonged labour
5290625|NCT02221427|Oxytocin|oxytocin
5290626|NCT02221427|Mode of delivery|mode of delivery
5290627|NCT02221427|Maternal birth outcome|maternal birth outcome
5290628|NCT02221427|Neonatal birth outcome|neonatal birth outcome
5290629|NCT02221349|Sensitivity|sensitivity
5290630|NCT02221336|Bipolar disorder|bipolar disorder
5290631|NCT02221336|Daily electronic monitoring|daily electronic monitoring
5290632|NCT02221336|Smartphones|smartphones
5290633|NCT02221336|Subjective and objective smartphone data|subjective and objective smartphone data
5290634|NCT02221336|Feedback loop|feedback loop
5290635|NCT02221310|targeted therapy|targeted therapy
5290636|NCT02221310|leukemia|leukemia
5290638|NCT02221310|immune therapy|immune therapy
5290639|NCT02221284|Pharmacological therapy|pharmacological therapy
5290640|NCT02221258|Rheumatoid Arthritis|rheumatoid arthritis
5290641|NCT02221258|Rheumatic Disease|rheumatic disease
5290644|NCT02221258|Cell therapy|cell therapy
5290645|NCT02221258|furestem|furestem
5290646|NCT02221258|Umbilical cord Blood|umbilical cord blood
5290647|NCT02221258|hUCB-MSC|hucb-msc
5290648|NCT02221258|UCB-MSC|ucb-msc
5290649|NCT02221245|Esophageal cancer|esophageal cancer
5290650|NCT02221245|Cancer Stem Cell|cancer stem cell
5290652|NCT02221245|Wnt|wnt
5290653|NCT02221245|Hegdehog|hegdehog
5290654|NCT02221245|Notch|notch
5290655|NCT02221245|Signaling|signaling
5290656|NCT02221245|Pathway|pathway
5290657|NCT02221245|Chemo-naive|chemo-naive
5290658|NCT02221232|ZuraPrep|zuraprep
5290659|NCT02221232|Antimicrobial|antimicrobial
5290660|NCT02221232|Bio-Science Laboratories|bio-science laboratories
5291163|NCT02219061|Measles|measles
5290663|NCT02221219|infant|infant
5290664|NCT02221219|brain injury|brain injury
5290665|NCT02221219|renal|renal
5290666|NCT02221219|indomethacin|indomethacin
5290667|NCT02221206|Mini-Screw implant anchorage|mini-screw implant anchorage
5290668|NCT02221206|retraction of maxillary incisors|retraction of maxillary incisors
5290669|NCT02221180|Bioequivalence|bioequivalence
5290670|NCT02221180|Metformin|metformin
5290671|NCT02221180|Canagliflozin|canagliflozin
5290672|NCT02221180|Healthy|healthy
5290673|NCT02221167|breastfeeding|breastfeeding
5290674|NCT02221167|donor milk|donor milk
5290675|NCT02221167|formula|formula
5290676|NCT02221167|exclusive breastfeeding|exclusive breastfeeding
5290677|NCT02221167|newborn|newborn
5290678|NCT02221154|in vitro fertilization|in vitro fertilization
5290679|NCT02221154|ovarian hyperstimulation|ovarian hyperstimulation
5290680|NCT02221154|pregnancy|pregnancy
5290681|NCT02221115|Google Glass device|google glass device
5290682|NCT02221115|Evaluation|evaluation
5290683|NCT02221115|patient's|patient's
5290684|NCT02221115|response|response
5290685|NCT02221115|to new technology|to new technology
5290686|NCT02221115|clinical setting|clinical setting
5290687|NCT02221102|edoxaban|edoxaban
5290688|NCT02221102|aspirin|aspirin
5290689|NCT02221102|new oral anticoagulant|new oral anticoagulant
5290690|NCT02221102|TIA|tia
5290691|NCT02221102|acute minor ischemic stroke|acute minor ischemic stroke
5290692|NCT02221089|Effect of Retaron on imparied retinal vascular reactivity after LPS administration in healthy subjects|effect of retaron on imparied retinal vascular reactivity after lps administration in healthy subjects
5290693|NCT02221076|Cellvizio|cellvizio
5290694|NCT02221076|Endomicroscopy|endomicroscopy
5962942|NCT04277403|hippocampal avoidance|hippocampal avoidance
5290695|NCT02221076|Robot-assisted procedure|robot-assisted procedure
5290696|NCT02221076|Cervix cancer|cervix cancer
5962943|NCT04277403|radiosurgery|radiosurgery
5962944|NCT04277390|periodontal microflora, preeclampsia|periodontal microflora, preeclampsia
5290697|NCT02221076|Endocervix cancer|endocervix cancer
5290698|NCT02221076|Endometrium cancer|endometrium cancer
5290699|NCT02221076|Ovarian cancer|ovarian cancer
5290700|NCT02221076|Tubal cancer|tubal cancer
5290701|NCT02221076|Colposcopy|colposcopy
5962945|NCT04277377|Donor specific antibodies|donor specific antibodies
5172333|NCT02915484|Cognition|cognition
5290702|NCT02221076|Hysteroscopy|hysteroscopy
5290703|NCT02221063|thiamin|thiamin
5290704|NCT02221063|thiamin diphosphate|thiamin diphosphate
5290705|NCT02221063|beriberi|beriberi
5290706|NCT02221063|Cambodia|cambodia
5290707|NCT02221063|fish sauce|fish sauce
5290708|NCT02221063|fortification|fortification
5290709|NCT02221063|pregnancy|pregnancy
5290710|NCT02221063|breastfeeding|breastfeeding
5290711|NCT02221063|childbearing age|childbearing age
5290712|NCT02221037|PaO2/FiO2|pao2/fio2
5290713|NCT02221037|Peri-operative lung injury|peri-operative lung injury
5290714|NCT02221037|EVLWI|evlwi
5290715|NCT02221037|ARDS|ards
5290716|NCT02221037|PVPI|pvpi
5290717|NCT02221037|SOFA scores|sofa scores
5290718|NCT02221037|GSK2862277|gsk2862277
5290719|NCT02221037|Oesophagectomy|oesophagectomy
5290720|NCT02221024|Peripheral intravenous catheter|peripheral intravenous catheter
5290721|NCT02221024|Peripheral intravenous lock|peripheral intravenous lock
5290722|NCT02221024|Normal saline|normal saline
5290723|NCT02221024|Patency|patency
5290724|NCT02221024|Management|management
5290725|NCT02221024|of peripheral|of peripheral
5290726|NCT02221024|intravenous catheter|intravenous catheter
5290727|NCT02221011|Shock wave|shock wave
5290728|NCT02221011|Spasticity|spasticity
5290729|NCT02221011|Effect|effect
5290730|NCT02220998|Hepatitis C|hepatitis c
5290731|NCT02220998|HCV|hcv
5290732|NCT02220998|cirrhosis|cirrhosis
5290733|NCT02220998|Sofosbuvir|sofosbuvir
5290734|NCT02220998|Sovaldi|sovaldi
5290735|NCT02220998|SOF/VEL|sof/vel
5290736|NCT02220998|GS-5816|gs-5816
5290737|NCT02220998|GS-7977|gs-7977
5290738|NCT02220998|liver|liver
5290739|NCT02220998|Treatment naive|treatment naive
5290740|NCT02220998|Treatment Experience|treatment experience
5290741|NCT02220998|genotype 2|genotype 2
5290742|NCT02220972|Epilepsy|epilepsy
5290743|NCT02220972|Partial Onset Seizures|partial onset seizures
5290744|NCT02220972|Insomnia|insomnia
5290745|NCT02220959|morbid obesity surgery|morbid obesity surgery
5290746|NCT02220959|walk test|walk test
5290747|NCT02220959|exercise|exercise
5290748|NCT02220946|Vaginal Electrical Stimulation|vaginal electrical stimulation
5290749|NCT02220933|Multiple Sclerosis|multiple sclerosis
5290752|NCT02220920|insulin resistance|insulin resistance
5290753|NCT02220907|MT-2412|mt-2412
5290754|NCT02220907|MP-513|mp-513
5290755|NCT02220907|TA-7284|ta-7284
5290756|NCT02220907|Teneligliptin|teneligliptin
5290757|NCT02220907|Canagliflozin|canagliflozin
5290762|NCT02220881|Hallux valgus, Mold making silicone toe separator, Toe separator|hallux valgus, mold making silicone toe separator, toe separator
5290763|NCT02220868|HIV|hiv
5290764|NCT02220868|HCV|hcv
5290765|NCT02220868|DAA|daa
5290766|NCT02220829|alpha-blocker|alpha-blocker
5291359|NCT02218294|BioCryst|biocryst
5290772|NCT02220816|Training|training
5290773|NCT02220803|Acetazolamide|acetazolamide
5290774|NCT02220803|Zonegran|zonegran
5290775|NCT02220803|Obstructive Sleep apnea|obstructive sleep apnea
5290776|NCT02220803|Apnea|apnea
5290777|NCT02220803|Respiration Disorders|respiration disorders
5290778|NCT02220803|Sleep Disorders|sleep disorders
5290779|NCT02220803|Cardiovascular|cardiovascular
5290780|NCT02220803|Hypertension|hypertension
5290781|NCT02220803|Carbonic Anhydrase|carbonic anhydrase
5290782|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
5290783|NCT02220803|Enzyme Inhibitors|enzyme inhibitors
5290784|NCT02220803|Sulfonamides|sulfonamides
5290785|NCT02220803|Therapeutic Uses|therapeutic uses
5290786|NCT02220803|Pharmacologic Actions|pharmacologic actions
5290787|NCT02220803|Vascular stifness|vascular stifness
5290788|NCT02220790|IPFN|ipfn
5290789|NCT02220790|Pediatric|pediatric
5290790|NCT02220790|Fungal|fungal
5290791|NCT02220790|Biomarker Assays|biomarker assays
5290792|NCT02220790|Candida|candida
5290793|NCT02220790|Pediatric ICU patient|pediatric icu patient
5290794|NCT02220777|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
5290795|NCT02220777|Food effect|food effect
5290796|NCT02220777|Postmenopausal subjects|postmenopausal subjects
5962946|NCT04277377|Kidney transplantation|kidney transplantation
5290797|NCT02220777|Vasectomized subjects|vasectomized subjects
5290798|NCT02220777|FIH (First In Humans)|fih (first in humans)
5290799|NCT02220777|SAD (Single Ascending Dose)|sad (single ascending dose)
5290800|NCT02220777|DDI (Drug-Drug Interaction)|ddi (drug-drug interaction)
5290801|NCT02220764|prospective study|prospective study
5290802|NCT02220764|chipping|chipping
5290803|NCT02220764|survival rate|survival rate
5290804|NCT02220764|fracture resistance|fracture resistance
5290805|NCT02220764|zirconia|zirconia
5290806|NCT02220751|Periodontal Attachment Loss|periodontal attachment loss
5290807|NCT02220751|Genes|genes
5290808|NCT02220751|Saliva|saliva
5290809|NCT02220751|Diagnosis|diagnosis
5290810|NCT02220738|Alzheimer's Disease|alzheimer's disease
5290811|NCT02220725|Andexanet alpha|andexanet alpha
5290812|NCT02220725|Anticoagulation|anticoagulation
5290813|NCT02220725|Antidote|antidote
5290814|NCT02220725|Rivaroxaban|rivaroxaban
5290815|NCT02220725|Anti-fXa inhibitor|anti-fxa inhibitor
5290816|NCT02220725|PRT4445|prt4445
5290817|NCT02220725|Xarelto|xarelto
5290818|NCT02220725|Reversal agent|reversal agent
5290819|NCT02220712|Aripiprazole|aripiprazole
5290820|NCT02220712|Deltoid|deltoid
5290821|NCT02220699|Ostoporosis|ostoporosis
5290822|NCT02220699|Primary Prevention|primary prevention
5290823|NCT02220699|Health Promotion|health promotion
5290824|NCT02220699|General Practice|general practice
5290825|NCT02220699|Secondary screening|secondary screening
5381928|NCT01803906|melas|melas
5290826|NCT02220699|Patients at increased risk of osteoporosis|patients at increased risk of osteoporosis
5290827|NCT02220686|VAPOR|vapor
5290828|NCT02220686|smoking cessation|smoking cessation
5290829|NCT02220686|PAD|pad
5290830|NCT02220621|Intrauterine adhesion|intrauterine adhesion
5290831|NCT02220621|crosslinked hyaluronan gel|crosslinked hyaluronan gel
5290832|NCT02220621|hysteroscopy|hysteroscopy
5290833|NCT02220621|clinical trial|clinical trial
5290834|NCT02220608|Multiple Myeloma|multiple myeloma
5290835|NCT02220608|G-CSF|g-csf
5290836|NCT02220608|Bortezomib|bortezomib
5290837|NCT02220595|Stenting|stenting
5290838|NCT02220595|Endarterectomy|endarterectomy
5290839|NCT02220595|Cognition|cognition
5290844|NCT02220543|Cognitive behavioral therapy|cognitive behavioral therapy
5290845|NCT02220543|Primary health care|primary health care
5290846|NCT02220543|Physical Therapy|physical therapy
5290847|NCT02220530|Sedation.|sedation.
5290848|NCT02220530|Colonoscopy quality.|colonoscopy quality.
5290849|NCT02220530|Scientific and technical quality.|scientific and technical quality.
5290850|NCT02220530|Perceived quality (patient's satisfaction).|perceived quality (patient's satisfaction).
5290851|NCT02220530|Safety|safety
5290852|NCT02220517|MRI/US fusion-guided prostate biopsy|mri/us fusion-guided prostate biopsy
5290853|NCT02220517|MR-guided in-bore prostate biopsy|mr-guided in-bore prostate biopsy
5290854|NCT02220517|prostate cancer|prostate cancer
5290855|NCT02220504|Treatment|treatment
5295540|NCT02198703|AB-Life|ab-life
5290856|NCT02220504|Maintenance|maintenance
5290857|NCT02220478|hip|hip
5290858|NCT02220478|Signature|signature
5290859|NCT02220465|sedentary|sedentary
5290860|NCT02220465|smoking|smoking
5290861|NCT02220465|cue reactivity|cue reactivity
5290862|NCT02220465|physical activity|physical activity
5290864|NCT02220439|immunogenicity|immunogenicity
5290865|NCT02220439|enteric vaccine|enteric vaccine
5290866|NCT02220439|vaccine immunogenicity|vaccine immunogenicity
5290867|NCT02220439|rotavirus vaccine|rotavirus vaccine
5290868|NCT02220439|gut microbiome|gut microbiome
5290869|NCT02220439|microbiome|microbiome
5290870|NCT02220426|Brown adipose tissue|brown adipose tissue
5290871|NCT02220426|Hyperpolarized xenon gas MRI|hyperpolarized xenon gas mri
5290872|NCT02220413|Breastmilk|breastmilk
5290873|NCT02220413|Lactogenesis|lactogenesis
5397902|NCT01731405|FDA|fda
5290874|NCT02220413|Obesity|obesity
5290875|NCT02220400|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5290876|NCT02220400|Ketamine|ketamine
5290877|NCT02220400|Surgery|surgery
5290878|NCT02220387|occupational COPD|occupational copd
5290879|NCT02220387|phenotype|phenotype
5290880|NCT02220387|genetic|genetic
5290881|NCT02220374|Osteoarthritis|osteoarthritis
5290882|NCT02220374|Finger|finger
5290883|NCT02220374|Supportive|supportive
5290884|NCT02220374|Tape|tape
5290885|NCT02220374|Pain|pain
5290886|NCT02220374|Function|function
5290887|NCT02220374|Trial|trial
5290888|NCT02220348|Linzess|linzess
5290889|NCT02220335|pulmonary hypertension|pulmonary hypertension
5290890|NCT02220335|pulmonary arterial denervation|pulmonary arterial denervation
5290891|NCT02220335|left heart failure|left heart failure
5290892|NCT02220335|6-min walk distance|6-min walk distance
5290893|NCT02220322|cortical thickness|cortical thickness
5290894|NCT02220322|age|age
5290895|NCT02220309|Anxiety|anxiety
5290896|NCT02220309|Depression|depression
5290897|NCT02220309|Social Anxiety Disorder|social anxiety disorder
5290898|NCT02220309|Bipolar disorder II|bipolar disorder ii
5290899|NCT02220309|PTSD|ptsd
5290900|NCT02220309|GAD|gad
5290901|NCT02220309|Phobia|phobia
5290902|NCT02220283|Acute kidney injury,aortic dissection|acute kidney injury,aortic dissection
5290903|NCT02220257|diabetes mellitus type 1|diabetes mellitus type 1
5290904|NCT02220257|remission, honeymoon|remission, honeymoon
5290905|NCT02220257|microangiopathy|microangiopathy
5290906|NCT02220244|multiple sclerosis (MS)|multiple sclerosis (ms)
5290907|NCT02220244|optic neuritis|optic neuritis
5290908|NCT02220244|visual defect|visual defect
5290909|NCT02220244|visual loss|visual loss
5290910|NCT02220244|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5290911|NCT02220244|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
5290912|NCT02220244|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
5290913|NCT02220231|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography|mediastinal mass, one-lung ventilation, capnothorax, transesophageal echocardiography
5290914|NCT02220218|Healthy|healthy
5290915|NCT02220218|Metformin|metformin
5290916|NCT02220218|Canagliflozin|canagliflozin
5290917|NCT02220218|JNJ-28431754|jnj-28431754
5290918|NCT02220205|IUD|iud
5290919|NCT02220205|training|training
5290920|NCT02220205|simulation|simulation
5290921|NCT02220192|cervical neoplasia|cervical neoplasia
5290922|NCT02220192|cervix|cervix
5290923|NCT02220192|high-grade dysplasia|high-grade dysplasia
5290924|NCT02220192|LEEP (loop electrosurgical excision procedure)|leep (loop electrosurgical excision procedure)
5290925|NCT02220192|precancerous cells|precancerous cells
5290926|NCT02220192|colposcopy|colposcopy
5290927|NCT02220166|Celiac Disease|celiac disease
5290928|NCT02220166|Gluten|gluten
5290929|NCT02220166|Gluten free diet|gluten free diet
5290930|NCT02220166|Triticum monococcum|triticum monococcum
5290931|NCT02220153|Monoclonal antibody|monoclonal antibody
5290932|NCT02220153|subjects|subjects
5290933|NCT02220153|First in human|first in human
5290934|NCT02220127|Brain|brain
5290935|NCT02220127|Neoplasm Micrometastasis|neoplasm micrometastasis
5290936|NCT02220127|Gamma Knife Radiosurgery|gamma knife radiosurgery
5290937|NCT02220114|Infantile spasms|infantile spasms
5290938|NCT02220114|vigabatrin|vigabatrin
5290939|NCT02220114|soluble tablets|soluble tablets
5290940|NCT02220114|acceptability|acceptability
5290941|NCT02220114|adherence|adherence
5290942|NCT02220114|pharmacokinetics|pharmacokinetics
5290943|NCT02220101|hypothermia|hypothermia
5290944|NCT02220101|core temperature|core temperature
5290945|NCT02220101|temperature measurement methods|temperature measurement methods
5290946|NCT02220088|Hepatocellular Carcinoma|hepatocellular carcinoma
5290947|NCT02220088|TACE|tace
5290948|NCT02220088|TACE failure|tace failure
5290949|NCT02220088|TACE refractoriness|tace refractoriness
5290950|NCT02220088|TAI|tai
5290951|NCT02220088|Sorafenib|sorafenib
5290952|NCT02220075|fiberoptic, LMA, caudal block|fiberoptic, lma, caudal block
5290953|NCT02220036|Diabetic nephropathy|diabetic nephropathy
5290954|NCT02220036|Renal function|renal function
5290955|NCT02220036|Insulin resistance|insulin resistance
5290956|NCT02220036|Metabolic profile|metabolic profile
5290957|NCT02220036|Serum magnesium level|serum magnesium level
5290958|NCT02220010|Post operative pancreatic fistulas|post operative pancreatic fistulas
5290959|NCT02220010|Pancreatic stenting|pancreatic stenting
5290960|NCT02219997|Cataract|cataract
5290962|NCT02219997|AcrySof|acrysof
5290963|NCT02219984|Anticoagulation|anticoagulation
5290964|NCT02219984|vitamin K antagonists|vitamin k antagonists
5290965|NCT02219984|Warfarin|warfarin
5290966|NCT02219984|low molecular weight heparin|low molecular weight heparin
5290967|NCT02219984|fondaparinux|fondaparinux
5290968|NCT02219984|antithrombotics|antithrombotics
5290969|NCT02219984|Direct oral anticoagulants|direct oral anticoagulants
5290971|NCT02219984|rivaroxaban|rivaroxaban
5290972|NCT02219984|apixaban|apixaban
5290973|NCT02219984|edoxaban|edoxaban
5290974|NCT02219984|atrial fibrillation|atrial fibrillation
5290975|NCT02219984|venous thromboembolism|venous thromboembolism
5290976|NCT02219971|Healthy|healthy
5290977|NCT02219958|Hypertension|hypertension
5290978|NCT02219945|pulmonary tuberculosis; electronic nose; diagnostic accuracy|pulmonary tuberculosis; electronic nose; diagnostic accuracy
5290979|NCT02219932|Fampridine|fampridine
5290980|NCT02219919|Carpal Tunnel Syndrome|carpal tunnel syndrome
5290981|NCT02219919|Pain|pain
5290982|NCT02219919|Sensitivity|sensitivity
5290983|NCT02219919|Pain Thresholds|pain thresholds
5290984|NCT02219919|Sensitization|sensitization
5290985|NCT02219919|Physical Therapy|physical therapy
5290986|NCT02219893|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5290987|NCT02219893|Peritoneal Metastasis|peritoneal metastasis
5290988|NCT02219893|Colorectal Cancer|colorectal cancer
5290989|NCT02219893|Cytoreductive surgery|cytoreductive surgery
5290990|NCT02219893|HIPEC|hipec
5290991|NCT02219893|Intraperitoneal treatment|intraperitoneal treatment
5290992|NCT02219893|Immunotoxin|immunotoxin
5290993|NCT02219893|MOC31PE|moc31pe
5290994|NCT02219880|Kava|kava
5290995|NCT02219880|Anxiety|anxiety
5290996|NCT02219880|Generalized Anxiety Disorder|generalized anxiety disorder
5290997|NCT02219880|Psychiatric|psychiatric
5290998|NCT02219880|Anxiolytic|anxiolytic
5290999|NCT02219880|GABA|gaba
5291000|NCT02219880|Kavalactones|kavalactones
5291001|NCT02219867|ketamine|ketamine
5291002|NCT02219867|MDD|mdd
5291003|NCT02219841|Obesity, low-calorie diet, exercise, atrial fibrillation|obesity, low-calorie diet, exercise, atrial fibrillation
5291004|NCT02219828|pericarditis|pericarditis
5291005|NCT02219828|recurrent pericarditis|recurrent pericarditis
5291006|NCT02219828|corticosteroids|corticosteroids
5291007|NCT02219828|anakinra|anakinra
5291008|NCT02219815|Preoperative Care|preoperative care
5291009|NCT02219815|Exercise Therapy|exercise therapy
5291010|NCT02219815|Cardiac Surgery|cardiac surgery
5291011|NCT02219815|Frailty|frailty
5291012|NCT02219802|Coronary artery disease|coronary artery disease
5291013|NCT02219802|Acute myocardial infarction|acute myocardial infarction
5291014|NCT02219802|Drug-coated balloon|drug-coated balloon
5291015|NCT02219802|Drug-eluting stent|drug-eluting stent
5291016|NCT02219776|Infection,|infection,
5291017|NCT02219776|Proprionbacterium Acne,|proprionbacterium acne,
5291018|NCT02219776|Shoulder,|shoulder,
5291019|NCT02219776|skin preparation|skin preparation
5160382|NCT02988960|Cancer|cancer
5172626|NCT02914054|ITP|itp
5291020|NCT02219750|premix insuiln, basal-plus insulin|premix insuiln, basal-plus insulin
5291021|NCT02219711|MGCD516|mgcd516
5291022|NCT02219711|MET|met
5291023|NCT02219711|AXL|axl
5291024|NCT02219711|RET|ret
5291025|NCT02219711|TRK|trk
5291026|NCT02219711|NTRK|ntrk
5291027|NCT02219711|DDR2|ddr2
5291028|NCT02219711|KDR|kdr
5291029|NCT02219711|VEGFR|vegfr
5291030|NCT02219711|PDGFRA|pdgfra
5291031|NCT02219711|KIT|kit
5291032|NCT02219711|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5291033|NCT02219711|NSCLC|nsclc
5291034|NCT02219711|Non-small cell lung cancer|non-small cell lung cancer
5291035|NCT02219711|Head and neck cancer|head and neck cancer
5291036|NCT02219711|Renal cell carcinoma|renal cell carcinoma
5291037|NCT02219711|Prostate cancer|prostate cancer
5291038|NCT02219711|Phase 1|phase 1
5291039|NCT02219711|CBL|cbl
5291040|NCT02219711|Sitravatinib|sitravatinib
5291041|NCT02219672|Triptolide wilfordii HIV-1 reservoir acute hiv infection|triptolide wilfordii hiv-1 reservoir acute hiv infection
5291042|NCT02219659|sedation strategy|sedation strategy
5291043|NCT02219659|mechanical ventilation|mechanical ventilation
5291044|NCT02219659|ventilator weaning|ventilator weaning
5291045|NCT02219646|T2DM|t2dm
5291046|NCT02219646|ED|ed
5291047|NCT02219620|creative arts|creative arts
5291048|NCT02219620|older adults|older adults
5291049|NCT02219620|intervention study|intervention study
5291050|NCT02219594|gemstone CT|gemstone ct
5291051|NCT02219594|320-detector row spiral CT|320-detector row spiral ct
5291052|NCT02219594|optical coherence tomography(OCT)|optical coherence tomography(oct)
5291053|NCT02219594|in-stent restenosis|in-stent restenosis
5291054|NCT02219594|coronary heart disease|coronary heart disease
5291055|NCT02219581|Osteoarthritis|osteoarthritis
5291056|NCT02219581|Postoperative pain|postoperative pain
5291057|NCT02219581|Total knee arthroplasty|total knee arthroplasty
5291058|NCT02219581|Orthopaedics|orthopaedics
5291059|NCT02219581|Inflammation|inflammation
5291060|NCT02219568|obscure gastrointestinal bleeding, CT enterography|obscure gastrointestinal bleeding, ct enterography
5291062|NCT02219542|cytokine Transversus Abdominis Plane Block|cytokine transversus abdominis plane block
5291063|NCT02219503|Hepatitis C|hepatitis c
5291064|NCT02219503|Chronic Hepatitis C|chronic hepatitis c
5291065|NCT02219503|Compensated Cirrhosis|compensated cirrhosis
5291066|NCT02219503|Cirrhotic|cirrhotic
5291067|NCT02219503|Hepatitis C Genotype 1b|hepatitis c genotype 1b
5291068|NCT02219503|Hepatitis C Virus|hepatitis c virus
5291461|NCT02217878|ticagrelor|ticagrelor
5291072|NCT02219490|Hepatitis C Genotype 1|hepatitis c genotype 1
5291073|NCT02219490|Compensated Cirrhosis|compensated cirrhosis
5291074|NCT02219490|Cirrhosis|cirrhosis
5291076|NCT02219490|Treatment-Experienced|treatment-experienced
5291077|NCT02219490|Relapser|relapser
5291078|NCT02219490|Null responder|null responder
5291079|NCT02219490|Non responder|non responder
5291080|NCT02219477|Cirrhosis|cirrhosis
5291081|NCT02219477|Hepatitis C|hepatitis c
5291082|NCT02219477|Child-Pugh B|child-pugh b
5291083|NCT02219477|Hepatitis C Genotype 4|hepatitis c genotype 4
5291084|NCT02219477|Interferon-Free|interferon-free
5291085|NCT02219477|Hepatitis C Genotype 1|hepatitis c genotype 1
5291086|NCT02219477|Chronic Hepatitis C|chronic hepatitis c
5291087|NCT02219477|Decompensated Cirrhosis|decompensated cirrhosis
5291088|NCT02219477|Hepatitis C Virus|hepatitis c virus
5291089|NCT02219464|nasopharyngeal catheter|nasopharyngeal catheter
5291090|NCT02219464|nasal cannula|nasal cannula
5291091|NCT02219451|Chronic heart failure|chronic heart failure
5291092|NCT02219451|exercise training|exercise training
5291093|NCT02219451|Sympathetic modulation|sympathetic modulation
5291094|NCT02219451|arterial baroreflex control|arterial baroreflex control
5291095|NCT02219425|Infertility|infertility
5291096|NCT02219425|Endometrium|endometrium
5291097|NCT02219425|Endometrial biopsy|endometrial biopsy
5291098|NCT02219425|Gene expression|gene expression
5291099|NCT02219412|ticagrelor|ticagrelor
5291100|NCT02219412|platelet aggregation rate|platelet aggregation rate
5291101|NCT02219412|ADP antagonist|adp antagonist
5291102|NCT02219412|antiplatelet therapy|antiplatelet therapy
5291103|NCT02219399|Pregnancy|pregnancy
5291105|NCT02219399|Gestational Length|gestational length
5291106|NCT02219399|Cognitive Development|cognitive development
5291107|NCT02219386|Myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling|myofascial pain syndromes,physiotherapy,muscle stretching exercises,neck pain,dry needling
5291108|NCT02219360|acute|acute
5291109|NCT02219360|exacerbation|exacerbation
5291110|NCT02219360|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5291111|NCT02219347|rheumatoid arthritis|rheumatoid arthritis
5291112|NCT02219347|biological markers|biological markers
5291113|NCT02219347|remission|remission
5291114|NCT02219347|ultrasonography|ultrasonography
5291115|NCT02219347|microarray|microarray
5291116|NCT02219347|survival analysis|survival analysis
5291117|NCT02219347|T cell|t cell
5962947|NCT04277377|Coated nanoparticles|coated nanoparticles
5291121|NCT02219321|Pain, Opioid dependence, Lidocaine infusion|pain, opioid dependence, lidocaine infusion
5962948|NCT04277364|Dietary Supplementations|dietary supplementations
5172760|NCT02912936|MCT|mct
5291122|NCT02219308|Contraception|contraception
5291123|NCT02219308|Pain|pain
5291124|NCT02219308|Intrauterine Device|intrauterine device
5291125|NCT02219308|Paracervical Block|paracervical block
5291126|NCT02219295|SGLT1 (sodium dependent glucose transporter)|sglt1 (sodium dependent glucose transporter)
5291127|NCT02219295|Glut-transporters|glut-transporters
5291128|NCT02219295|taste receptors genes|taste receptors genes
5291129|NCT02219295|sweet taste receptor T1R2T1R3|sweet taste receptor t1r2t1r3
5291130|NCT02219295|bitter taste receptors of the hTAS2gene family|bitter taste receptors of the htas2gene family
5186475|NCT02824640|Liver Disease|liver disease
5291131|NCT02219282|laryngeal mask airway, edentulate geriatric patients|laryngeal mask airway, edentulate geriatric patients
5291132|NCT02219269|contraception|contraception
5291133|NCT02219269|family planning|family planning
5291134|NCT02219269|complex medical conditions|complex medical conditions
5291135|NCT02219256|Drug therapy|drug therapy
5291136|NCT02219243|Social Anxiety Disorder|social anxiety disorder
5291137|NCT02219243|Cognitive Training|cognitive training
5291138|NCT02219243|Interpretation Modification Program|interpretation modification program
5291139|NCT02219204|Acupuncture|acupuncture
5291140|NCT02219204|Herbal treatment|herbal treatment
5291141|NCT02219191|Puerarin tablet|puerarin tablet
5291142|NCT02219191|rheumatoid arthritis|rheumatoid arthritis
5291143|NCT02219191|metabolism syndrome|metabolism syndrome
5291144|NCT02219165|Paediatrics|paediatrics
5291145|NCT02219165|Toxic Shock Syndrome|toxic shock syndrome
5291146|NCT02219165|Intravenous human immunoglobulin|intravenous human immunoglobulin
5291147|NCT02219165|feasibility|feasibility
5291148|NCT02219139|Edentulous|edentulous
5291150|NCT02219139|SLAclive surface|slaclive surface
5291151|NCT02219139|Titanium/zirconium|titanium/zirconium
5291152|NCT02219113|Damage of articular cartilage|damage of articular cartilage
5291153|NCT02219113|Cartilage degeneration|cartilage degeneration
5291154|NCT02219113|Intraarticular injection|intraarticular injection
5291155|NCT02219113|ADRC|adrc
5291156|NCT02219113|Adipose-derived regenerative cells|adipose-derived regenerative cells
5291157|NCT02219113|Adipose tissue|adipose tissue
5291158|NCT02219113|Stem cells|stem cells
5291159|NCT02219087|Total knee arthroplasty|total knee arthroplasty
5291160|NCT02219087|Total joint arthroplasty|total joint arthroplasty
5291161|NCT02219087|Knee replacement|knee replacement
5291162|NCT02219087|Osteoarthritis of the knee|osteoarthritis of the knee
5291164|NCT02219061|Meningitis C|meningitis c
5291166|NCT02219061|Geometric Mean Titer|geometric mean titer
5291167|NCT02219061|China|china
5291168|NCT02219048|Asthma|asthma
5291169|NCT02219048|Staged withdrawal of background therapy|staged withdrawal of background therapy
5291170|NCT02219035|presentation with|presentation with
5291171|NCT02219022|Rheumatoid arthritis|rheumatoid arthritis
5291172|NCT02219022|Progressive resistance exercise|progressive resistance exercise
5291173|NCT02219022|Pain|pain
5291174|NCT02219022|Functional capacity|functional capacity
5291175|NCT02219022|Quality of life|quality of life
5291176|NCT02219022|Muscle strength|muscle strength
5291177|NCT02219009|OPC-14597 Digital|opc-14597 digital
5291178|NCT02219009|Aripiprazole|aripiprazole
5291179|NCT02219009|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
5291180|NCT02219009|Treatment Adherence|treatment adherence
5291181|NCT02219009|Ingestible Event Marker|ingestible event marker
5291182|NCT02218996|Anxiety|anxiety
5291183|NCT02218996|Children|children
5291184|NCT02218996|Adolescent|adolescent
5291185|NCT02218996|Effectiveness|effectiveness
5291186|NCT02218996|Outpatient|outpatient
5291188|NCT02218983|echo|echo
5291189|NCT02218983|echocardiogram|echocardiogram
5291190|NCT02218983|ultrasound|ultrasound
5291191|NCT02218983|inferior vena cava collapsibility|inferior vena cava collapsibility
5291192|NCT02218970|rehabilitation|rehabilitation
5291193|NCT02218970|strength training|strength training
5291194|NCT02218970|muscle strength|muscle strength
5291195|NCT02218970|physical fitness|physical fitness
5291196|NCT02218957|Bariatric surgery|bariatric surgery
5291197|NCT02218957|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5291198|NCT02218931|Pre-eclampsia|pre-eclampsia
5291199|NCT02218931|Gestational diabetes|gestational diabetes
5291200|NCT02218931|Stillbirth|stillbirth
5291201|NCT02218931|Small for gestational age|small for gestational age
5291202|NCT02218931|Admission to neonatal intensive care unit|admission to neonatal intensive care unit
5291203|NCT02218931|Obesity|obesity
5291204|NCT02218931|Raised Lipids|raised lipids
5291205|NCT02218931|High Blood Pressure|high blood pressure
5291206|NCT02218931|Cardiovascular risk|cardiovascular risk
5291207|NCT02218931|Insulin resistance|insulin resistance
5291208|NCT02218931|Mediterranean dietary pattern|mediterranean dietary pattern
5291209|NCT02218931|Dietary interventions|dietary interventions
5291210|NCT02218918|Ground walk|ground walk
5291211|NCT02218918|treadmill walk|treadmill walk
5291212|NCT02218918|Functional walk capacity|functional walk capacity
5291213|NCT02218918|COPD|copd
5291214|NCT02218918|Quality of Life|quality of life
5291215|NCT02218905|Correlation|correlation
5291216|NCT02218905|Sit to stand repetitions|sit to stand repetitions
5962949|NCT04277364|Athletic Performance|athletic performance
5962950|NCT04277364|Phosphatidic acid|phosphatidic acid
5291217|NCT02218905|Anthropometric variables|anthropometric variables
5291218|NCT02218905|Age|age
5291219|NCT02218905|Height|height
5291220|NCT02218905|weight|weight
5291221|NCT02218905|Gender|gender
5291222|NCT02218905|Regression|regression
5291223|NCT02218866|Bariatric surgery|bariatric surgery
5291224|NCT02218866|Obesity|obesity
5278652|NCT02282371|IMRT (Intensity-Modulated Radiation Therapy)|imrt (intensity-modulated radiation therapy)
5278653|NCT02282371|14-116|14-116
5278654|NCT02282358|Mocetinostat|mocetinostat
5278655|NCT02282358|14-106|14-106
5278656|NCT02282319|spinal or intravenous dexmedetomidine|spinal or intravenous dexmedetomidine
5278657|NCT02282293|Chemoprevention|chemoprevention
5278658|NCT02282293|Malaria|malaria
5291225|NCT02218866|Neuropathy|neuropathy
5291226|NCT02218853|Bipolar disorder|bipolar disorder
5291227|NCT02218853|Psychosis|psychosis
5291228|NCT02218853|Schizophrenia|schizophrenia
5291229|NCT02218840|cigar smoker|cigar smoker
5291230|NCT02218840|smoking|smoking
5291231|NCT02218840|behavioral pharmacology|behavioral pharmacology
5291232|NCT02218840|smoking topography|smoking topography
5291233|NCT02218827|Dry Eye|dry eye
5291234|NCT02218827|Inflammatory reaction|inflammatory reaction
5291235|NCT02218827|steroids|steroids
5291236|NCT02218814|Femoral Nerve Block|femoral nerve block
5291237|NCT02218814|Adductor Canal Nerve Block|adductor canal nerve block
5291238|NCT02218801|Liver metastasis|liver metastasis
5291239|NCT02218801|Colorectal carcinoma|colorectal carcinoma
5291240|NCT02218801|Unresectable|unresectable
5291241|NCT02218801|Borderline resectable|borderline resectable
5291242|NCT02218801|Initially unresectable|initially unresectable
5291243|NCT02218788|Nasolabial folds|nasolabial folds
5291244|NCT02218788|Marionette lines|marionette lines
5291245|NCT02218788|Cheek bones|cheek bones
5291246|NCT02218788|Jaw lines|jaw lines
5291247|NCT02218775|Kappa opioid receptor|kappa opioid receptor
5291248|NCT02218775|Mu opioid receptor|mu opioid receptor
5291249|NCT02218775|LY2456302|ly2456302
5291250|NCT02218775|Anhedonia|anhedonia
5291251|NCT02218775|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
5291252|NCT02218762|Fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
5291253|NCT02218762|replicated cross-over design|replicated cross-over design
5291254|NCT02218762|Respiratory|respiratory
5291255|NCT02218762|asthma|asthma
5291256|NCT02218762|safety|safety
5291257|NCT02218762|pharmacokinetics|pharmacokinetics
5291258|NCT02218762|Fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5291259|NCT02218762|pharmacodynamics|pharmacodynamics
5291260|NCT02218762|Fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
5291262|NCT02218736|Mood and Anxiety Spectrum Disorders|mood and anxiety spectrum disorders
5291263|NCT02218736|CERC-501 (investigational product)|cerc-501 (investigational product)
5291264|NCT02218736|Kappa Opioid Receptor (KOR)|kappa opioid receptor (kor)
5291265|NCT02218723|healthy volunteer|healthy volunteer
5398388|NCT01729104|MCL|mcl
5291266|NCT02218723|Asthma|asthma
5291267|NCT02218723|inhaled corticosteroid|inhaled corticosteroid
5291268|NCT02218723|UD-DPI|ud-dpi
5291269|NCT02218723|ELLIPTA DPI|ellipta dpi
5291270|NCT02218723|Fluticasone furoate|fluticasone furoate
5291271|NCT02218697|Immunogenicity|immunogenicity
5291272|NCT02218697|Influsplit Tetra (Fluarix Tetra) 2014/2015 season|influsplit tetra (fluarix tetra) 2014/2015 season
5291273|NCT02218697|Safety|safety
5291274|NCT02218697|Adults|adults
5291275|NCT02218697|Pneumovax 23/Pneumovax|pneumovax 23/pneumovax
5291276|NCT02218697|Co-administration|co-administration
5291277|NCT02218697|Elderly|elderly
5291278|NCT02218697|Seasonal influenza|seasonal influenza
5291279|NCT02218697|Pneumococcal infection|pneumococcal infection
5291280|NCT02218632|Galactosaemia|galactosaemia
5291281|NCT02218632|Dysglycosylation|dysglycosylation
5291282|NCT02218632|Diet|diet
5291283|NCT02218619|type 1 diabetes (T1D)|type 1 diabetes (t1d)
5291284|NCT02218619|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
5291285|NCT02218619|induced pluripotential stem (iPS) cells|induced pluripotential stem (ips) cells
5291286|NCT02218619|Tauroursodeoxycholic Acid (TUDCA)|tauroursodeoxycholic acid (tudca)
5291287|NCT02218606|Abiraterone Acetate|abiraterone acetate
5291288|NCT02218606|CABAZITAXEL|cabazitaxel
5291289|NCT02218606|CASTRATION RESISTANT|castration resistant
5291290|NCT02218606|14-046|14-046
5291291|NCT02218606|Prostate Cancer Clinical Trials Consortium|prostate cancer clinical trials consortium
5291292|NCT02218580|massage therapy|massage therapy
5291293|NCT02218580|juvenile arthritis|juvenile arthritis
5291294|NCT02218580|pain|pain
5291295|NCT02218554|BRONJ|bronj
5291296|NCT02218528|subjects|subjects
5291297|NCT02218515|Autogenous bone graft|autogenous bone graft
5291298|NCT02218515|Chronic periodontitis|chronic periodontitis
5291299|NCT02218515|Enamel matrix derivatives|enamel matrix derivatives
5291300|NCT02218515|Gingival crevicular fluid|gingival crevicular fluid
5291301|NCT02218515|Periodontal flap surgery|periodontal flap surgery
5291302|NCT02218502|Ovarian cancer|ovarian cancer
5291303|NCT02218502|Diagnosis|diagnosis
5291304|NCT02218502|Risk of Malignancy Index|risk of malignancy index
5172947|NCT02911168|NERVE BLOCK|nerve block
5172957|NCT02911142|PEL|pel
5291306|NCT02218502|Ultrasound|ultrasound
5291307|NCT02218502|Simple ultrasound-based rules|simple ultrasound-based rules
5291308|NCT02218502|DW-MRI|dw-mri
5291309|NCT02218502|Subjective assessment|subjective assessment
5291310|NCT02218489|Pain|pain
5291311|NCT02218489|Corticosteroid|corticosteroid
5291312|NCT02218489|Meibomian Gland Disease|meibomian gland disease
5291313|NCT02218489|Blepharitis|blepharitis
5291314|NCT02218489|Eyelid|eyelid
5291315|NCT02218489|Ocular Discomfort|ocular discomfort
5291316|NCT02218463|Vulvar disease, adhesions, topical therapy|vulvar disease, adhesions, topical therapy
5291317|NCT02218463|Labial adhesions prepubertal girls|labial adhesions prepubertal girls
5291318|NCT02218463|Labial agglutination|labial agglutination
5291319|NCT02218463|Labial fusion|labial fusion
5291320|NCT02218437|Mesenchymal Stem Cells (MSC)|mesenchymal stem cells (msc)
5291321|NCT02218437|Umbilical Cord|umbilical cord
5291322|NCT02218437|thymocyte globulin (ATG)|thymocyte globulin (atg)
5291323|NCT02218437|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
5291324|NCT02218398|airway resistance|airway resistance
5291325|NCT02218398|lung compliance|lung compliance
5291326|NCT02218398|Duration of mechanical ventilation|duration of mechanical ventilation
5291327|NCT02218385|Nipple Aspirate Fluid|nipple aspirate fluid
5291328|NCT02218385|Breast Health Screening|breast health screening
5291329|NCT02218385|Cytology|cytology
5291330|NCT02218372|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
5291331|NCT02218372|vancomycin|vancomycin
5291332|NCT02218372|Clostridium difficile infection|clostridium difficile infection
5291333|NCT02218372|fidaxomicin|fidaxomicin
5291334|NCT02218359|Gram-negative pneumonia|gram-negative pneumonia
5291335|NCT02218359|Aerosol antibiotics|aerosol antibiotics
5291336|NCT02218359|Mechanical ventilation|mechanical ventilation
5291337|NCT02218359|Amikacin|amikacin
5291338|NCT02218359|Fosfomycin|fosfomycin
5291339|NCT02218359|Pneumonia, Bacterial|pneumonia, bacterial
5291340|NCT02218359|Pneumonia|pneumonia
5291341|NCT02218359|Bacterial Infections|bacterial infections
5291342|NCT02218359|Lung Diseases|lung diseases
5291343|NCT02218359|Respiratory Tract Diseases|respiratory tract diseases
5291344|NCT02218359|Respiratory Tract Infections|respiratory tract infections
5291345|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents
5291346|NCT02218359|Anti-Infective Agents|anti-infective agents
5291347|NCT02218359|Therapeutic Uses|therapeutic uses
5291348|NCT02218359|Pharmacologic Actions|pharmacologic actions
5291349|NCT02218359|MRSA|mrsa
5291352|NCT02218320|Gut-associated lymphoid tissue|gut-associated lymphoid tissue
5291354|NCT02218320|Isentress|isentress
5291355|NCT02218320|dolutegravir|dolutegravir
5291356|NCT02218320|Tivicay|tivicay
5291357|NCT02218320|pharmacodynamics|pharmacodynamics
5291358|NCT02218294|BCX4161|bcx4161
5291360|NCT02218294|hereditary angioedema|hereditary angioedema
5291361|NCT02218294|mass balance|mass balance
5291362|NCT02218294|kallikrein inhibitor|kallikrein inhibitor
5291364|NCT02218268|type I diabetes|type i diabetes
5291365|NCT02218268|healthy|healthy
5291366|NCT02218268|children|children
5291367|NCT02218268|adolescents|adolescents
5291368|NCT02218268|young adults|young adults
5291369|NCT02218255|In Vitro Fertilization|in vitro fertilization
5291370|NCT02218242|Lung|lung
5291371|NCT02218242|Cancer|cancer
5291372|NCT02218242|Ultrasound|ultrasound
5291373|NCT02218242|Staging|staging
5291374|NCT02218229|shock wave|shock wave
5291375|NCT02218229|carpal tunnel syndrome|carpal tunnel syndrome
5291376|NCT02218216|Mild Traumatic Brain Injury|mild traumatic brain injury
5291377|NCT02218203|chronic pain|chronic pain
5291378|NCT02218203|central neuropathic pain|central neuropathic pain
5291379|NCT02218203|spinal cord injury|spinal cord injury
5291380|NCT02218203|dextromethorphan|dextromethorphan
5291381|NCT02218203|lidocaine|lidocaine
5291382|NCT02218203|combination therapy|combination therapy
5291383|NCT02218203|analgesia|analgesia
5291384|NCT02218190|Alvimopan|alvimopan
5291385|NCT02218190|Ileus|ileus
5291386|NCT02218190|Posterior spinal fusion|posterior spinal fusion
5291387|NCT02218177|wet Age Related Macular Degeneration|wet age related macular degeneration
5291388|NCT02218177|Ranibizumab|ranibizumab
5291389|NCT02218177|Aflibercept|aflibercept
5291390|NCT02218177|Combination Photodynamic Therapy|combination photodynamic therapy
5291391|NCT02218177|Cytokine analysis|cytokine analysis
5291392|NCT02218164|metastatic|metastatic
5291393|NCT02218164|cutaneous|cutaneous
5291394|NCT02218164|skin cancer|skin cancer
5291395|NCT02218151|Hematopoietic|hematopoietic
5291396|NCT02218151|Stem Cell|stem cell
5291397|NCT02218151|Transplant|transplant
5291398|NCT02218151|patient-centered|patient-centered
5291399|NCT02218151|Microbiota|microbiota
5291400|NCT02218151|GVHD|gvhd
5291401|NCT02218138|Adolescent|adolescent
5291402|NCT02218138|Diabetes|diabetes
5291404|NCT02218138|Obesity|obesity
5291405|NCT02218138|Stress|stress
5291406|NCT02218125|Healthy|healthy
5369157|NCT01861041|different baricity|different baricity
5962951|NCT04277338|99mTc- HE3-G3|99mtc- he3-g3
5962952|NCT04277338|Breast Cancer|breast cancer
5291407|NCT02218125|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
5291408|NCT02218125|Acquired immunodeficiency syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
5291409|NCT02218125|recombinant adenovirus (rAd) vector-based vaccines|recombinant adenovirus (rad) vector-based vaccines
5291410|NCT02218125|Vaccination|vaccination
5291411|NCT02218125|Ad26.ENVA.01|ad26.enva.01
5291412|NCT02218125|Recombinant|recombinant
5291413|NCT02218125|Modified Vaccinia Ankara (MVA) vector-based vaccines|modified vaccinia ankara (mva) vector-based vaccines
5291414|NCT02218112|Blood pressure|blood pressure
5291415|NCT02218112|Obesity|obesity
5291416|NCT02218112|Glomerular filtration rate|glomerular filtration rate
5291417|NCT02218112|Renal Sodium handling|renal sodium handling
5291418|NCT02218099|ASP8232|asp8232
5291419|NCT02218099|Multiple doses|multiple doses
5291420|NCT02218099|Phase 1|phase 1
5291421|NCT02218099|Single dose|single dose
5291422|NCT02218086|postural control|postural control
5291423|NCT02218086|postural balance|postural balance
5291424|NCT02218086|slackline|slackline
5291425|NCT02218073|Healthy|healthy
5291426|NCT02218073|JNJ-42756493|jnj-42756493
5291427|NCT02218073|JNJ-61818549|jnj-61818549
5291428|NCT02218073|Isotope|isotope
5291429|NCT02218047|Pegylated-Proline-interferon alpha-2b (AOP2014)|pegylated-proline-interferon alpha-2b (aop2014)
5291430|NCT02218047|Polycythemia Vera|polycythemia vera
5291431|NCT02218047|PROUD-PV|proud-pv
5291432|NCT02218047|CONTINUATION-PV|continuation-pv
5291433|NCT02218047|AOP Orphan|aop orphan
5291434|NCT02218047|Polycythemia|polycythemia
5291435|NCT02218047|Hematologic Diseases|hematologic diseases
5291436|NCT02218047|Myeloproliferative Disorders|myeloproliferative disorders
5291437|NCT02218047|Bone Marrow Diseases|bone marrow diseases
5291438|NCT02218047|Interferon-alpha|interferon-alpha
5291439|NCT02218047|Peginterferon alfa-2b|peginterferon alfa-2b
5291440|NCT02218021|Alkermes|alkermes
5291441|NCT02218021|ALKS 33|alks 33
5291442|NCT02218021|ALKS 5461|alks 5461
5291443|NCT02218021|Samidorphan|samidorphan
5291444|NCT02218008|Major depressive disorder (MDD)|major depressive disorder (mdd)
5291445|NCT02218008|depression|depression
5291446|NCT02218008|Alkermes|alkermes
5291447|NCT02218008|ALKS 5461|alks 5461
5291448|NCT02218008|samidorphan|samidorphan
5291449|NCT02217995|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5291450|NCT02217995|Mindfulness|mindfulness
5291451|NCT02217969|Anesthesia|anesthesia
5291452|NCT02217969|Hypotension|hypotension
5291453|NCT02217930|TQT|tqt
5291454|NCT02217917|Healthy subjects|healthy subjects
5291455|NCT02217917|Randomized|randomized
5291459|NCT02217878|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5291460|NCT02217878|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
5291463|NCT02217878|pharmacokinetics|pharmacokinetics
5291464|NCT02217878|pharmacodynamics|pharmacodynamics
5291465|NCT02217878|drug interactions|drug interactions
5291466|NCT02217878|VASP assay|vasp assay
5291467|NCT02217878|Multiple Electrode Aggregometry|multiple electrode aggregometry
5291468|NCT02217878|VerifyNow|verifynow
5291469|NCT02217865|Colorectal Cancer|colorectal cancer
5291471|NCT02217865|Curative resection of colorectal cancer|curative resection of colorectal cancer
5291472|NCT02217865|Caregivers|caregivers
5291473|NCT02217865|Interviews|interviews
5291474|NCT02217865|Focus groups|focus groups
5291475|NCT02217865|Questionnaires|questionnaires
5291476|NCT02217865|Surveys|surveys
5291477|NCT02217852|hypertension|hypertension
5291478|NCT02217852|Tibetan|tibetan
5291479|NCT02217852|Nitrendipine|nitrendipine
5291480|NCT02217852|hydrochlorothiazide|hydrochlorothiazide
5291481|NCT02217852|captopril|captopril
5291482|NCT02217852|Beijing hypotensive No.0|beijing hypotensive no.0
5291483|NCT02217774|Computer-Aided Design/instrumentation|computer-aided design/instrumentation
5291484|NCT02217774|Cone-Beam Computed Tomography|cone-beam computed tomography
5291485|NCT02217774|Dental Implant|dental implant
5291486|NCT02217774|MGuide|mguide
5291487|NCT02217761|Pharmacokinetics|pharmacokinetics
5291488|NCT02217761|Antifungal Agents|antifungal agents
5291489|NCT02217735|Parkinson's Disease|parkinson's disease
5291490|NCT02217735|Caregivers|caregivers
5291491|NCT02217735|Expressive Writing|expressive writing
5291492|NCT02217735|Complementary Medicine|complementary medicine
5291493|NCT02217735|Cortisol|cortisol
5291494|NCT02217696|Electroencephalography (EEG)|electroencephalography (eeg)
5291495|NCT02217696|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5291496|NCT02217696|Multimodal Neuroimaging|multimodal neuroimaging
5291497|NCT02217696|Development|development
5291498|NCT02217696|Prediction|prediction
5291499|NCT02217696|Intervention|intervention
5291500|NCT02217683|Catheterization, Swan-Ganz|catheterization, swan-ganz
5291501|NCT02217683|Cardiac Surgical Procedures|cardiac surgical procedures
5291502|NCT02217683|Blood Transfusion|blood transfusion
5186870|NCT02821975|Work|work
5291503|NCT02217683|Nitric Oxide|nitric oxide
5291504|NCT02217657|Smart-Touch|smart-touch
5291505|NCT02217657|Contact force|contact force
5291507|NCT02217605|Oral Fructose Challenge|oral fructose challenge
5291508|NCT02217605|31P MRS|31p mrs
5291509|NCT02217605|Liver|liver
5173155|NCT02910063|SOC|soc
5291510|NCT02217605|Subjects|subjects
5291511|NCT02217579|Weight loss|weight loss
5291512|NCT02217579|Appetite|appetite
5291513|NCT02217579|Overweight|overweight
5291514|NCT02217579|Obesity|obesity
5291515|NCT02217579|Dietary fiber|dietary fiber
5291516|NCT02217579|Dietary protein|dietary protein
5291517|NCT02217566|Prostatic neoplasms|prostatic neoplasms
5291518|NCT02217566|Diethylstilbestrol therapy|diethylstilbestrol therapy
5291519|NCT02217566|Abiraterone acetate|abiraterone acetate
5291520|NCT02217566|Prednisone|prednisone
5291521|NCT02217566|Androgen deprivation therapy|androgen deprivation therapy
5291522|NCT02217553|platelet|platelet
5291523|NCT02217553|P-selectin|p-selectin
5291524|NCT02217553|platelet-fibrinogen binding|platelet-fibrinogen binding
5291525|NCT02217553|platelet-monocye aggregate formation|platelet-monocye aggregate formation
5291526|NCT02217553|vitamin D|vitamin d
5291527|NCT02217540|Shoulder, disability evaluation, physiotherapy modalities|shoulder, disability evaluation, physiotherapy modalities
5291528|NCT02217527|crossover|crossover
5291529|NCT02217501|peripheral arterial disease, antiplatelet therapy|peripheral arterial disease, antiplatelet therapy
5291534|NCT02217423|Physical Therapy Modalities|physical therapy modalities
5291535|NCT02217423|Respiration Disorders|respiration disorders
5291536|NCT02217423|Respiratory Therapy|respiratory therapy
5291537|NCT02217410|renal, de novo,|renal, de novo,
5291538|NCT02217397|Apnea-hyponea Index, CPAP, Obstructive Sleep Apnea, Oral Appliance|apnea-hyponea index, cpap, obstructive sleep apnea, oral appliance
5291539|NCT02217384|Microbiome|microbiome
5291540|NCT02217384|DNA sequencing|dna sequencing
5291541|NCT02217384|Leptin|leptin
5291542|NCT02217384|Adiponectin|adiponectin
5291543|NCT02217384|Insulin|insulin
5291544|NCT02217384|IGF-I|igf-i
5291545|NCT02217371|ADHD Patient|adhd patient
5291546|NCT02217371|Healthy subjects|healthy subjects
5291547|NCT02217371|Sleepiness|sleepiness
5291549|NCT02217371|MWT|mwt
5291550|NCT02217371|EEG|eeg
5291551|NCT02217371|cognitive tests|cognitive tests
5291552|NCT02217358|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5291553|NCT02217358|NBI endoscopy|nbi endoscopy
5291554|NCT02217358|videoendoscopy|videoendoscopy
5296232|NCT02195349|Biopsy|biopsy
5291558|NCT02217332|Sinusitis|sinusitis
5291559|NCT02217332|Rhinosinusitis|rhinosinusitis
5291560|NCT02217332|CRS|crs
5291561|NCT02217332|CRSwNP|crswnp
5291562|NCT02217332|CSNP-E|csnp-e
5291563|NCT02217332|Nasal polyps|nasal polyps
5291564|NCT02217332|Nasal polyposis|nasal polyposis
5291565|NCT02217332|Eosinophilia|eosinophilia
5291567|NCT02217319|Volatile Anesthetic|volatile anesthetic
5291568|NCT02217319|Cardioprotection|cardioprotection
5291569|NCT02217319|Lung surgery|lung surgery
5291570|NCT02217319|non cardiac surgery|non cardiac surgery
5291571|NCT02217293|Pulsed radiofrequency|pulsed radiofrequency
5291572|NCT02217293|Ultrasound-guided|ultrasound-guided
5291573|NCT02217293|Carpal tunnel syndrome|carpal tunnel syndrome
5291574|NCT02217280|Cervical Radiculopathy|cervical radiculopathy
5291575|NCT02217267|Peripheral neuropathy|peripheral neuropathy
5291576|NCT02217215|Spectroscopy|spectroscopy
5291577|NCT02217215|HPV|hpv
5291578|NCT02217202|knee replacement|knee replacement
5291579|NCT02217202|knee arthroplasty|knee arthroplasty
5291580|NCT02217202|revision|revision
5291581|NCT02217202|high risk|high risk
5291582|NCT02217189|Zinc supplementation.|zinc supplementation.
5291583|NCT02217189|Oxidative stress.|oxidative stress.
5291584|NCT02217189|Superoxide radical scavengers.|superoxide radical scavengers.
5291585|NCT02217189|Asthenospermia.|asthenospermia.
5291586|NCT02217189|Oxido-sensitive index.|oxido-sensitive index.
5291587|NCT02217137|Dry Eye|dry eye
5291588|NCT02217137|Rheumatoid Arthritis|rheumatoid arthritis
5291589|NCT02217137|Systemic Lupus Erythematosus|systemic lupus erythematosus
5291590|NCT02217137|Tear cytokines and immune response|tear cytokines and immune response
5291591|NCT02217124|apple|apple
5291592|NCT02217124|high fiber|high fiber
5291593|NCT02217124|body composition|body composition
5291594|NCT02217124|children|children
5291595|NCT02217111|vocal fold nodules|vocal fold nodules
5291596|NCT02217111|pediatric|pediatric
5291597|NCT02217111|voice therapy|voice therapy
5291598|NCT02217111|acoustic|acoustic
5291599|NCT02217111|aerodynamic|aerodynamic
5291600|NCT02217111|quality of life|quality of life
5291601|NCT02217111|Adventures in Voice|adventures in voice
5291602|NCT02217098|ART|art
5291603|NCT02217098|Occlusal|occlusal
5291604|NCT02217098|Occlusoproximal|occlusoproximal
5291605|NCT02217098|Primary teeth|primary teeth
5291606|NCT02217085|Colorectal Cancer Screening|colorectal cancer screening
5291607|NCT02217085|Colon Cancer Screening|colon cancer screening
5291608|NCT02217085|Polyps|polyps
5291609|NCT02217085|Colonoscopy|colonoscopy
5291610|NCT02217072|academic performance|academic performance
5291611|NCT02217072|cognitive development|cognitive development
5291612|NCT02217072|children in care|children in care
5291613|NCT02217072|prevention of school failure|prevention of school failure
5291614|NCT02217059|Emergency Medical Services|emergency medical services
5291615|NCT02217059|Emergency Care|emergency care
5962953|NCT04277338|HER2 expression|her2 expression
5291616|NCT02217059|Hypertension|hypertension
5291617|NCT02217059|BpTRU|bptru
5291618|NCT02217059|Blood pressure|blood pressure
5291619|NCT02217046|Infection|infection
5291620|NCT02217046|prevention|prevention
5291621|NCT02217046|cardiac devices|cardiac devices
5291622|NCT02217033|Breast Cancer|breast cancer
5291623|NCT02217033|Stage I breast cancer|stage i breast cancer
5291624|NCT02217033|Stage II breast cancer|stage ii breast cancer
5291625|NCT02217033|Water study|water study
5291626|NCT02217033|'R'|'r'
5291627|NCT02217033|Electro-kinetically altered beverage|electro-kinetically altered beverage
5291628|NCT02217033|altered beverage|altered beverage
5291629|NCT02217033|Insomnia|insomnia
5291630|NCT02217033|Fatigue|fatigue
5291631|NCT02217033|Depression|depression
5291632|NCT02217033|Adjuvant chemotherapy|adjuvant chemotherapy
5291633|NCT02217020|Rectal Cancer|rectal cancer
5291634|NCT02217020|Locally advanced rectal cancer|locally advanced rectal cancer
5291635|NCT02217020|Neoadjuvant|neoadjuvant
5291636|NCT02217020|chemotherapy|chemotherapy
5291637|NCT02217020|FOLFOXIRI|folfoxiri
5291638|NCT02217007|Tourette|tourette
5291639|NCT02217007|Tourette's|tourette's
5291640|NCT02217007|tic|tic
5291641|NCT02216994|Intestinal dysganglinosis|intestinal dysganglinosis
5291642|NCT02216994|Hirschsprung disease|hirschsprung disease
5291643|NCT02216994|Hirschsprung disease allied disorders|hirschsprung disease allied disorders
5291644|NCT02216994|diagnostic scoring system|diagnostic scoring system
5291645|NCT02216994|Prospective study|prospective study
5291646|NCT02216981|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5291647|NCT02216981|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
5291648|NCT02216981|Intensive therapy|intensive therapy
5291649|NCT02216981|Intensive treatment|intensive treatment
5291650|NCT02216981|Treatment Resistant|treatment resistant
5291651|NCT02216968|vegetables|vegetables
5291652|NCT02216968|Head Start|head start
5291654|NCT02216968|children|children
5291655|NCT02216968|theater|theater
5291656|NCT02216968|puppet|puppet
5291657|NCT02216942|Endodontics|endodontics
5291658|NCT02216942|Deciduous teeth|deciduous teeth
5291659|NCT02216942|Iodoform pastes|iodoform pastes
5291660|NCT02216942|Treatment Refusal|treatment refusal
5291661|NCT02216929|intubation|intubation
5291662|NCT02216929|intensive care|intensive care
5291663|NCT02216929|withholding treatment|withholding treatment
5291668|NCT02216890|Renal Cell Carcinoma|renal cell carcinoma
5291669|NCT02216890|Mantle-Cell Lymphoma|mantle-cell lymphoma
5291670|NCT02216890|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
5291672|NCT02216890|Antibody-Drug Conjugate|antibody-drug conjugate
5291675|NCT02216877|Chronic Kidney Disease|chronic kidney disease
5291676|NCT02216877|Hypomagnesemia|hypomagnesemia
5291677|NCT02216851|hyaluronic acid|hyaluronic acid
5291678|NCT02216851|no-treatment control|no-treatment control
5291679|NCT02216851|enhancement|enhancement
5291680|NCT02216812|Finger stiffness|finger stiffness
5291681|NCT02216812|Range of motion|range of motion
5291682|NCT02216812|Distal radius fracture|distal radius fracture
5291683|NCT02216812|Vitamin C|vitamin c
5291684|NCT02216799|Parenteral nutrition|parenteral nutrition
5291685|NCT02216799|Hyperglycemia|hyperglycemia
5291686|NCT02216799|Glargine insulin|glargine insulin
5291687|NCT02216799|Regular insulin|regular insulin
5291688|NCT02216773|Liver hypertrophy|liver hypertrophy
5291689|NCT02216773|Liver resection|liver resection
5291690|NCT02216773|Liver metastases|liver metastases
5291691|NCT02216773|Portal vein ligation|portal vein ligation
5291692|NCT02216773|Portal vein embolization|portal vein embolization
5291693|NCT02216773|Radiofrequency splitting|radiofrequency splitting
5291694|NCT02216760|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
5291695|NCT02216760|Myocardial infarction|myocardial infarction
5291696|NCT02216760|Dilated cardiomyopathy|dilated cardiomyopathy
5291697|NCT02216760|Catheter ablation|catheter ablation
5291698|NCT02216760|Substrate mapping|substrate mapping
5291699|NCT02216760|Ripple Conduction channels|ripple conduction channels
5291700|NCT02216747|Idiopathic Nephrotic syndrome relapse|idiopathic nephrotic syndrome relapse
5291701|NCT02216734|HIV/AIDS|hiv/aids
5291702|NCT02216734|Prevention of mother-to-child transmission|prevention of mother-to-child transmission
5291703|NCT02216734|Mother support groups|mother support groups
5291704|NCT02216734|Retention-in-care|retention-in-care
5291705|NCT02216734|Male participation|male participation
5291706|NCT02216734|Anti-retroviral treatment|anti-retroviral treatment
5291708|NCT02216721|bone mineral density|bone mineral density
5291709|NCT02216721|bone turnover markers|bone turnover markers
5291710|NCT02216721|primary aldosteronism treatment|primary aldosteronism treatment
5291711|NCT02216708|Severe malnutrition|severe malnutrition
5291712|NCT02216708|severe dehydration|severe dehydration
5291713|NCT02216708|cholera|cholera
5291714|NCT02216695|acute kidney injury|acute kidney injury
5291715|NCT02216695|epidemiology|epidemiology
5291716|NCT02216695|mortality|mortality
5291717|NCT02216682|Acetaminophen|acetaminophen
5291718|NCT02216682|Total knee replacement|total knee replacement
5291719|NCT02216682|Numeric rating scale|numeric rating scale
5291720|NCT02216669|Solid tumors|solid tumors
5234455|NCT02537288|TQT|tqt
5291721|NCT02216669|Head and Neck Neoplasms|head and neck neoplasms
5291727|NCT02216630|COPD|copd
5291728|NCT02216604|Exercise|exercise
5291729|NCT02216604|Pediatric oncology|pediatric oncology
5291730|NCT02216604|Physical Performance|physical performance
5291731|NCT02216604|Quality of Life|quality of life
5291732|NCT02216604|Feasibility|feasibility
5291733|NCT02216604|during primary|during primary
5291734|NCT02216604|anticancer treatment|anticancer treatment
5291735|NCT02216591|HIV|hiv
5291736|NCT02216591|Medication Adherence|medication adherence
5291737|NCT02216591|Working Memory|working memory
5291738|NCT02216578|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5291739|NCT02216578|progressed|progressed
5291740|NCT02216578|(GIST)|(gist)
5291741|NCT02216565|Stroke|stroke
5291742|NCT02216565|Endovascular treatment|endovascular treatment
5291743|NCT02216565|Tandem carotid occlusions|tandem carotid occlusions
5291744|NCT02216565|Fibrinolysis|fibrinolysis
5291745|NCT02216552|Pediatrics|pediatrics
5291746|NCT02216552|Adolescents|adolescents
5291747|NCT02216552|NAFLD|nafld
5291748|NCT02216552|Spectroscopy|spectroscopy
5291749|NCT02216552|Type 2 diabetes|type 2 diabetes
5291750|NCT02216539|All terminal|all terminal
5291751|NCT02216539|leading|leading
5291752|NCT02216539|indication|indication
5291753|NCT02216539|lung transplantation|lung transplantation
5291754|NCT02216526|Skin health|skin health
5291755|NCT02216526|Nursing|nursing
5291756|NCT02216526|Long-term care|long-term care
5291757|NCT02216513|subarachnoid hemorrhage|subarachnoid hemorrhage
5291758|NCT02216513|SAH|sah
5291759|NCT02216513|DFO|dfo
5291760|NCT02216513|cerebral autoregulation|cerebral autoregulation
5291761|NCT02216513|delayed cerebral ischemia|delayed cerebral ischemia
5296451|NCT02194439|GVL|gvl
5291762|NCT02216500|Ketogenic Therapy|ketogenic therapy
5291763|NCT02216500|Ketogenic Diet|ketogenic diet
5291765|NCT02216487|colorectal cancer|colorectal cancer
5291766|NCT02216448|Arthroscopy skills|arthroscopy skills
5291767|NCT02216448|Knee|knee
5291768|NCT02216448|Virtual reality|virtual reality
5291769|NCT02216448|Simulator|simulator
5291770|NCT02216422|Chronic Hepatitis C|chronic hepatitis c
5291771|NCT02216422|Hepatitis C|hepatitis c
5291772|NCT02216422|Hepatitis C Virus|hepatitis c virus
5291773|NCT02216422|Hepatitis C Genotype 1b|hepatitis c genotype 1b
5291774|NCT02216422|Interferon-Free|interferon-free
5288627|NCT02230072|MMC|mmc
5291777|NCT02216396|agitation|agitation
5291778|NCT02216396|coping|coping
5291779|NCT02216383|Post partum haemorrhage|post partum haemorrhage
5291780|NCT02216383|Active Management of Third Stage of Labour|active management of third stage of labour
5291781|NCT02216383|Carbetocin|carbetocin
5291782|NCT02216383|Syntocinon|syntocinon
5291783|NCT02216383|Syntometrine|syntometrine
5291784|NCT02216383|Birth experience|birth experience
5291785|NCT02216383|Labour|labour
5291786|NCT02216370|Cryptogenic stroke /TIA|cryptogenic stroke /tia
5291787|NCT02216370|Atrial Fibrillation|atrial fibrillation
5291788|NCT02216370|Implantable Loop Recorder|implantable loop recorder
5291789|NCT02216370|Genetic Mutation|genetic mutation
5291790|NCT02216357|Samster's triad|samster's triad
5291791|NCT02216357|Acetylsalicylic acid triad|acetylsalicylic acid triad
5291792|NCT02216357|Widal's triad|widal's triad
5291793|NCT02216357|Francis' triad|francis' triad
5291794|NCT02216357|Aspirin triad|aspirin triad
5291795|NCT02216357|Aspirin-induced asthma and rhinitis (AIAR)|aspirin-induced asthma and rhinitis (aiar)
5291796|NCT02216344|Patient safety monitors|patient safety monitors
5291797|NCT02216331|tuberculosis|tuberculosis
5291798|NCT02216331|PK|pk
5291799|NCT02216331|TMC207|tmc207
5291800|NCT02216331|bedaquiline|bedaquiline
5291801|NCT02216331|rifapentine|rifapentine
5291802|NCT02216331|rifampicin|rifampicin
5291803|NCT02216331|drug drug interaction|drug drug interaction
5291804|NCT02216318|sleep|sleep
5291805|NCT02216318|circadian|circadian
5291806|NCT02216318|melatonine|melatonine
5291807|NCT02216318|pupil response|pupil response
5291808|NCT02216305|HAL-RAR|hal-rar
5291809|NCT02216305|Hemorrhoids|hemorrhoids
5291810|NCT02216305|Hemorrhoid artery ligation|hemorrhoid artery ligation
5291811|NCT02216305|Anal repair|anal repair
5291812|NCT02216305|Quality of Life|quality of life
5291813|NCT02216305|Postoperative Complications|postoperative complications
5291814|NCT02216292|preterm single donor milk|preterm single donor milk
5291815|NCT02216292|human milk|human milk
5291816|NCT02216292|very lo birth weight infants|very lo birth weight infants
5291817|NCT02216292|enteral feedings|enteral feedings
5291818|NCT02216292|NEC|nec
5291819|NCT02216279|Pulmonary|pulmonary
5291820|NCT02216279|Hypertension|hypertension
5291821|NCT02216279|PH|ph
5291822|NCT02216279|PulmoBind|pulmobind
5291823|NCT02216279|Imaging|imaging
5291824|NCT02216266|Delirium|delirium
5291825|NCT02216266|CAM-ICU|cam-icu
5291826|NCT02216253|Urinary tract infection|urinary tract infection
5291827|NCT02216253|Pelvic organ prolapse|pelvic organ prolapse
5962954|NCT04277325|Emotionally Focused Therapy|emotionally focused therapy
5291828|NCT02216253|Urinary incontinence|urinary incontinence
5291829|NCT02216253|Stress urinary incontinence|stress urinary incontinence
5291830|NCT02216253|Mixed Urinary incontinence|mixed urinary incontinence
5291831|NCT02216253|L-methionine|l-methionine
5291832|NCT02216253|Placebo|placebo
5291833|NCT02216227|MRSA|mrsa
5291834|NCT02216227|surgical site infection|surgical site infection
5291835|NCT02216214|Urinary Incontinence|urinary incontinence
5291836|NCT02216214|Mirabegron|mirabegron
5291837|NCT02216214|Overactive Bladder|overactive bladder
5291838|NCT02216175|Cow's milk allergy|cow's milk allergy
5291839|NCT02216175|Desensitisation|desensitisation
5291840|NCT02216175|Safety|safety
5291841|NCT02216162|oncogeriatrics|oncogeriatrics
5291842|NCT02216162|adjuvant endocrine therapy|adjuvant endocrine therapy
5291843|NCT02216162|compliance|compliance
5291844|NCT02216162|elderly|elderly
5291845|NCT02216162|Taï Chi|taï chi
5291846|NCT02216162|Physical training|physical training
5291847|NCT02216149|fluoropyrimidine|fluoropyrimidine
5291848|NCT02216149|S-1|s-1
5291849|NCT02216149|Teysuno|teysuno
5291850|NCT02216149|oxaliplatin|oxaliplatin
5291851|NCT02216149|coronary artery flow|coronary artery flow
5291852|NCT02216149|coronary artery dysfunction|coronary artery dysfunction
5291853|NCT02216149|gastrointestinal tract cancer|gastrointestinal tract cancer
5291854|NCT02216136|Mastectomy|mastectomy
5291855|NCT02216136|Breast Cancer|breast cancer
5291856|NCT02216136|Reconstruction|reconstruction
5291857|NCT02216136|Lumpectomy|lumpectomy
5291858|NCT02216136|Breast Conservation Therapy|breast conservation therapy
5291859|NCT02216123|Tafenoquine|tafenoquine
5291860|NCT02216123|Plasmodium vivax|plasmodium vivax
5291861|NCT02216123|Hemolysis|hemolysis
5291862|NCT02216123|Primaquine|primaquine
5291863|NCT02216123|Chloroquine|chloroquine
5291864|NCT02216123|Glucose-6-phosphate dehydrogenase (G6PD)|glucose-6-phosphate dehydrogenase (g6pd)
5291865|NCT02216123|Relapse|relapse
5291870|NCT02216045|Hepatitis C ,Chronic Hepatitis C ,camel milk|hepatitis c ,chronic hepatitis c ,camel milk
5291871|NCT02216019|cardiac surgery|cardiac surgery
5291872|NCT02216019|infectious complication|infectious complication
5291874|NCT02216006|Fresh gas flow|fresh gas flow
5291875|NCT02216006|Prevention|prevention
5291876|NCT02216006|Oxygenation|oxygenation
5291877|NCT02216006|Anaesthesia|anaesthesia
5291878|NCT02215993|Ticagrelor|ticagrelor
5291879|NCT02215993|Prasugrel|prasugrel
5291880|NCT02215993|VerifyNow|verifynow
5291881|NCT02215993|Acute coronary syndrome|acute coronary syndrome
5291886|NCT02215967|Immunotherapy|immunotherapy
5291887|NCT02215967|Anti-BCMA-CAR|anti-bcma-car
5291888|NCT02215967|Gene Therapy|gene therapy
5291889|NCT02215967|Adoptive T Cell Therapy|adoptive t cell therapy
5291890|NCT02215967|Plasma Cell Malignancy|plasma cell malignancy
5291891|NCT02215915|Percutaneous coronary intervention|percutaneous coronary intervention
5291892|NCT02215915|Drug-eluting stent|drug-eluting stent
5291893|NCT02215915|Intravascular ultrasound|intravascular ultrasound
5291894|NCT02215902|ESRD|esrd
5291895|NCT02215902|Hepatitis C|hepatitis c
5291896|NCT02215889|Liver metastases|liver metastases
5291897|NCT02215889|Transplantation|transplantation
5291898|NCT02215876|Her 2-negative breast cancer|her 2-negative breast cancer
5291899|NCT02215876|neoadjuvant doxorubicin/cyclophosphamide followed by Eribulin chemotherapy|neoadjuvant doxorubicin/cyclophosphamide followed by eribulin chemotherapy
5291900|NCT02215863|Immunogenicity, Safety, MF59, Influenza vaccine, Pneumococcal vaccine|immunogenicity, safety, mf59, influenza vaccine, pneumococcal vaccine
5291901|NCT02215837|Gastric cancer|gastric cancer
5291902|NCT02215837|D-CIK|d-cik
5291903|NCT02215837|Autologous tumor lysate|autologous tumor lysate
5291904|NCT02215811|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5291905|NCT02215785|Funtional constipation|funtional constipation
5291906|NCT02215785|Kiwifruit|kiwifruit
5291907|NCT02215785|Health promotion|health promotion
5291908|NCT02215707|PfSPZ Vaccine|pfspz vaccine
5291909|NCT02215707|Plasmodium falciparum|plasmodium falciparum
5291910|NCT02215707|Malaria|malaria
5291911|NCT02215707|Controlled Human Malaria Infection (CHMI)|controlled human malaria infection (chmi)
5291912|NCT02215694|Apolipoprotein A-V|apolipoprotein a-v
5291913|NCT02215694|LDL particle size|ldl particle size
5291914|NCT02215694|probiotic|probiotic
5291915|NCT02215694|triglyceride|triglyceride
5291916|NCT02215681|otitis media with effusion|otitis media with effusion
5291917|NCT02215681|acupuncture|acupuncture
5291918|NCT02215681|inflammatory markers|inflammatory markers
5291919|NCT02215655|phosphate binder adherence|phosphate binder adherence
5291920|NCT02215655|autonomous motivation|autonomous motivation
5291921|NCT02215629|Leukemia|leukemia
5291922|NCT02215629|Acute Leukemia|acute leukemia
5279340|NCT02278887|ipilimumab|ipilimumab
5291923|NCT02215629|Relapsed Leukemia|relapsed leukemia
5291924|NCT02215629|Refractory Leukemia|refractory leukemia
5291925|NCT02215629|Acute Myeloid Leukemia|acute myeloid leukemia
5291926|NCT02215629|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
5291927|NCT02215590|Postural balance|postural balance
5291928|NCT02215590|Motor Learning and Motor Control|motor learning and motor control
5291929|NCT02215590|Community integration|community integration
5291930|NCT02215590|Quality of life|quality of life
5291931|NCT02215590|Functional ambulation|functional ambulation
5291932|NCT02215577|cancer, colorectal|cancer, colorectal
5291933|NCT02215577|hepatectomy|hepatectomy
5291934|NCT02215577|portal vein|portal vein
5291935|NCT02215577|embolization|embolization
5291936|NCT02215577|two-stage|two-stage
5291937|NCT02215564|Bordetella pertussis|bordetella pertussis
5291938|NCT02215564|Carriage rates in young adults|carriage rates in young adults
5291940|NCT02215538|ADHD|adhd
5291941|NCT02215538|adult|adult
5291942|NCT02215538|WRAADDS|wraadds
5291943|NCT02215538|OROS MPH|oros mph
5291944|NCT02215538|emotional dysregulation|emotional dysregulation
5291945|NCT02215525|HCV|hcv
5291946|NCT02215525|UVA|uva
5291947|NCT02215525|Herbal therapy|herbal therapy
5291948|NCT02215499|JZP-386, Xyrem, sodium oxybate|jzp-386, xyrem, sodium oxybate
5291949|NCT02215486|Head massage therapy|head massage therapy
5291950|NCT02215486|Massage therapy|massage therapy
5291951|NCT02215486|Autonomic nervous system (ANS)|autonomic nervous system (ans)
5291952|NCT02215486|Heart rate variability (HRV)|heart rate variability (hrv)
5291953|NCT02215486|Pre-ejection period (PEP)|pre-ejection period (pep)
5291954|NCT02215473|gingivitis|gingivitis
5291955|NCT02215473|periodontitis|periodontitis
5291956|NCT02215473|mouth rinse|mouth rinse
5291957|NCT02215473|bacteremia|bacteremia
5291958|NCT02215447|NAB-paclitaxel|nab-paclitaxel
5423275|NCT01616420|case-finding|case-finding
5291962|NCT02215434|Libido; Sexual Dysfunction; testosterone|libido; sexual dysfunction; testosterone
5291963|NCT02215421|vegetables|vegetables
5291964|NCT02215421|dietary intake|dietary intake
5291965|NCT02215421|preschoolers|preschoolers
5291966|NCT02215421|parents|parents
5291967|NCT02215421|video game|video game
5291968|NCT02215408|Diabetes|diabetes
5291969|NCT02215408|Hyperlipidemia|hyperlipidemia
5291970|NCT02215408|Hypertension|hypertension
5291971|NCT02215408|Cardiovascular Disease|cardiovascular disease
5291972|NCT02215395|Nestorone|nestorone
5291973|NCT02215395|miconazole nitrate|miconazole nitrate
5291974|NCT02215382|two reversal methods|two reversal methods
5291980|NCT02215330|Eplerenone|eplerenone
5291981|NCT02215330|Photodynamic Therapy|photodynamic therapy
5291982|NCT02215330|Macula|macula
5291983|NCT02215330|Retina|retina
5291984|NCT02215317|Sleep Apnea|sleep apnea
5291985|NCT02215317|Stent|stent
5291986|NCT02215317|Coronary Artery Disease|coronary artery disease
5291987|NCT02215317|Percutaneous Coronary Intervention|percutaneous coronary intervention
5291988|NCT02215304|Dietary supplementation|dietary supplementation
5291989|NCT02215304|Probiotics|probiotics
5291990|NCT02215304|Safety/Efficiency|safety/efficiency
5291991|NCT02215304|Healthy infants|healthy infants
5291992|NCT02215291|Undergoing Esophagogastroduodenoscopy (EGD) or endoscopy|undergoing esophagogastroduodenoscopy (egd) or endoscopy
5291993|NCT02215278|iron biofortification|iron biofortification
5291994|NCT02215278|lpa bean|lpa bean
5291995|NCT02215278|stable iron isotope study|stable iron isotope study
5291996|NCT02215278|phytic acid|phytic acid
5291997|NCT02215265|Human papillomavirus HPV positive oropharyngeal cancer|human papillomavirus hpv positive oropharyngeal cancer
5291998|NCT02215239|health lifestyle|health lifestyle
5291999|NCT02215239|health promotion|health promotion
5292000|NCT02215239|occupational health|occupational health
5292001|NCT02215239|Work site health promotion|work site health promotion
5292002|NCT02215226|Group B Streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific|group b streptococcus, early onset disease, late onset disease, anticapsular antibodies, serotype specific
5292003|NCT02215213|Vitamin D|vitamin d
5292004|NCT02215213|pregnancy|pregnancy
5292005|NCT02215213|Pakistan|pakistan
5292006|NCT02215200|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
5292007|NCT02215174|Rosuvastatin|rosuvastatin
5292008|NCT02215174|PK|pk
5292009|NCT02215174|Interethnic|interethnic
5292010|NCT02215174|Morbid obese|morbid obese
5292011|NCT02215135|Corifollitropin alfa|corifollitropin alfa
5292012|NCT02215135|polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5292013|NCT02215135|controlled ovarian hyperstimulation (COS)|controlled ovarian hyperstimulation (cos)
5292014|NCT02215135|GnRH antagonist protocol|gnrh antagonist protocol
5292015|NCT02215135|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
5292016|NCT02215122|Fluticasone Propionate|fluticasone propionate
5292018|NCT02215122|Pharmacokinetics|pharmacokinetics
5292019|NCT02215122|Healthy Subjects|healthy subjects
5292020|NCT02215122|MGR001|mgr001
5292021|NCT02215122|CRC749|crc749
5292022|NCT02215122|Dry Powder Inhaler|dry powder inhaler
5292023|NCT02215122|generic|generic
5292024|NCT02215122|Advair Diskus|advair diskus
5292025|NCT02215122|Seretide Accuhaler|seretide accuhaler
5292026|NCT02215096|enzalutamide|enzalutamide
5292027|NCT02215096|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5292028|NCT02215096|GSK2636771|gsk2636771
5292029|NCT02215096|PI3K-beta|pi3k-beta
5292030|NCT02215096|PTEN deficiency|pten deficiency
5292031|NCT02215083|peripheral neuropathy|peripheral neuropathy
5292032|NCT02215083|breast cancer|breast cancer
5292033|NCT02215083|taxane induced peripheral neuropathy|taxane induced peripheral neuropathy
5173719|NCT02906501|DBD|dbd
5292034|NCT02215083|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5292035|NCT02215070|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5292036|NCT02215070|Acute Myeloid Leukemia|acute myeloid leukemia
5292037|NCT02215070|Acute Lymphoid Leukemia|acute lymphoid leukemia
5292038|NCT02215070|Acute Non-Lymphocytic Leukemia|acute non-lymphocytic leukemia
5292039|NCT02215070|Myelodysplastic Syndrome|myelodysplastic syndrome
5292040|NCT02215070|Chronic Myeloid Leukemia|chronic myeloid leukemia
5292041|NCT02215070|Lymphoma|lymphoma
5292042|NCT02215057|topical anesthesia|topical anesthesia
5292043|NCT02215057|intracameral lidocaine|intracameral lidocaine
5292044|NCT02215057|implantable collamer lens|implantable collamer lens
5292045|NCT02214875|Retention|retention
5423349|NCT01616056|Chronic graft-versus-host disease|chronic graft-versus-host disease
5292046|NCT02214862|Unclassifiable Parkinsonism, [F18]-FDDNP-PET, Tauopathy, PSP,MSA|unclassifiable parkinsonism, [f18]-fddnp-pet, tauopathy, psp,msa
5292047|NCT02214849|Breastfeeding|breastfeeding
5292048|NCT02214849|Breastfeeding peer counseling|breastfeeding peer counseling
5292049|NCT02214849|Exclusive breastfeeding|exclusive breastfeeding
5292050|NCT02214849|Formula supplementation|formula supplementation
5292051|NCT02214849|Mobile health|mobile health
5292052|NCT02214849|WIC program|wic program
5292053|NCT02214836|kidney stones|kidney stones
5292054|NCT02214836|ultrasound imaging|ultrasound imaging
5292055|NCT02214836|ureter stones|ureter stones
5292056|NCT02214810|Bupivacaine|bupivacaine
5292057|NCT02214810|multimodal|multimodal
5292059|NCT02214810|open reduction|open reduction
5292060|NCT02214810|internal fixation|internal fixation
5292061|NCT02214810|post-surgical pain control|post-surgical pain control
5292062|NCT02214797|Presbyopia|presbyopia
5292063|NCT02214797|Refractive Error|refractive error
5292064|NCT02214797|Contact Lenses|contact lenses
5292065|NCT02214784|Stress urinary Incontinence|stress urinary incontinence
5292067|NCT02214784|Continence|continence
5292068|NCT02214771|Clostridium difficile infection CDI|clostridium difficile infection cdi
5292069|NCT02214771|Observational|observational
5292070|NCT02214771|Fidaxomicin recurrence|fidaxomicin recurrence
5292071|NCT02214771|France|france
5292072|NCT02214758|Home care clients, nutrition, oral health, medication|home care clients, nutrition, oral health, medication
5292073|NCT02214745|Israeli Arab population|israeli arab population
5292074|NCT02214745|Israeli/ethnology|israeli/ethnology
5292075|NCT02214732|Pregnancy|pregnancy
5292076|NCT02214732|Postpartum|postpartum
5292077|NCT02214732|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5292078|NCT02214732|Depression|depression
5292079|NCT02214732|Anxiety|anxiety
5292080|NCT02214732|Stress|stress
5292081|NCT02214732|MBCT|mbct
5292082|NCT02214732|Actigraphy|actigraphy
5292083|NCT02214719|type 1 diabetes, insulin therapy, bolus calculator|type 1 diabetes, insulin therapy, bolus calculator
5292084|NCT02214693|patients|patients
5292085|NCT02214680|Pupil diameter|pupil diameter
5292086|NCT02214680|Brimonidine|brimonidine
5292087|NCT02214680|Timolol|timolol
5292088|NCT02214680|Combigan|combigan
5292089|NCT02214667|Jail|jail
5292090|NCT02214667|co-occurring disorders|co-occurring disorders
5292091|NCT02214667|implementation|implementation
5292092|NCT02214667|acceptability|acceptability
5292093|NCT02214667|feasibility|feasibility
5292094|NCT02214667|fidelity|fidelity
5292095|NCT02214628|Wet AMD|wet amd
5292096|NCT02214628|Choroidal neovascularization|choroidal neovascularization
5292097|NCT02214628|Fovista®|fovista®
5292098|NCT02214628|E10030|e10030
5292099|NCT02214628|Avastin®|avastin®
5292100|NCT02214628|Eylea®|eylea®
5292101|NCT02214602|non muscle invasive bladder cancer|non muscle invasive bladder cancer
5292102|NCT02214602|intermediate and high risk|intermediate and high risk
5292103|NCT02214602|immediate single instillation|immediate single instillation
5292104|NCT02214602|Intravesical chemotherapy|intravesical chemotherapy
5292105|NCT02214602|Disease prevention|disease prevention
5292106|NCT02214576|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5292107|NCT02214576|intubation, intratracheal|intubation, intratracheal
5292108|NCT02214576|Oxygen Inhalation Therapy|oxygen inhalation therapy
5292109|NCT02214576|Positive-Pressure Respiration|positive-pressure respiration
5292110|NCT02214576|laryngoscopy|laryngoscopy
5292111|NCT02214563|Vitamin D|vitamin d
5292112|NCT02214563|Cholecalciferol|cholecalciferol
5292113|NCT02214563|Hepcidins|hepcidins
5292114|NCT02214563|Renal Dialysis|renal dialysis
5292115|NCT02214550|Cystitis, Interstitial|cystitis, interstitial
5292116|NCT02214550|Dysmenorrhea|dysmenorrhea
5292117|NCT02214550|Migraine Disorders|migraine disorders
5292118|NCT02214550|Cross Organ Sensitization|cross organ sensitization
5292119|NCT02214550|Pelvic Pain|pelvic pain
5292120|NCT02214550|Endometriosis|endometriosis
5292121|NCT02214550|Contraceptives, Oral|contraceptives, oral
5292122|NCT02214550|Birth Control Pills|birth control pills
5292123|NCT02214550|Painful Bladder Syndrome|painful bladder syndrome
5292124|NCT02214550|Visceral Pain|visceral pain
5292125|NCT02214550|Chronic Pain|chronic pain
5962955|NCT04277325|Spanish Speaking couples|spanish speaking couples
5962956|NCT04277325|Couple therapy|couple therapy
5292126|NCT02214524|perioperative hypothermia|perioperative hypothermia
5292127|NCT02214524|Tympanic temperature|tympanic temperature
5292128|NCT02214524|Blood loss|blood loss
5292129|NCT02214524|Blood Coagulation Disorders|blood coagulation disorders
5292130|NCT02214524|Major surgery|major surgery
5292131|NCT02214511|major depressive disorder|major depressive disorder
5292132|NCT02214511|social rejection|social rejection
5292133|NCT02214511|rapid facial reaction|rapid facial reaction
5292134|NCT02214511|facial mimicry|facial mimicry
5292135|NCT02214511|prosocial behavior|prosocial behavior
5292136|NCT02214511|inflammation|inflammation
5292137|NCT02214511|self esteem|self esteem
5292138|NCT02214498|Dipper|dipper
5292139|NCT02214498|Non-dipper|non-dipper
5292140|NCT02214498|Chronopharmacology|chronopharmacology
5292141|NCT02214485|frailty|frailty
5292142|NCT02214485|exercise|exercise
5292143|NCT02214485|intervention|intervention
5292144|NCT02214472|Rumination síndrome|rumination síndrome
5292148|NCT02214472|Electromyography|electromyography
5292149|NCT02214472|Abdominal accommodation|abdominal accommodation
5292151|NCT02214459|Hypertension|hypertension
5292152|NCT02214459|Mobile|mobile
5292153|NCT02214459|smartphone|smartphone
5292154|NCT02214459|diet|diet
5292155|NCT02214459|lifestyle|lifestyle
5292156|NCT02214459|bluetooth|bluetooth
5292157|NCT02214459|physical acitvity|physical acitvity
5292158|NCT02214459|behavior change|behavior change
5292159|NCT02214459|motivational interviewing|motivational interviewing
5292160|NCT02214446|truth telling|truth telling
5292161|NCT02214446|hope|hope
5292162|NCT02214446|quality of life|quality of life
5292163|NCT02214446|care burden|care burden
5292164|NCT02214446|children with cancer|children with cancer
5292169|NCT02214329|Postural Balance|postural balance
5292170|NCT02214329|Gait|gait
5292171|NCT02214329|Fall risk|fall risk
5292172|NCT02214303|Allergic asthma|allergic asthma
5292173|NCT02214303|Allergic rhinitis|allergic rhinitis
5292174|NCT02214303|Healthy subjects|healthy subjects
5292175|NCT02214290|Cardiovascular|cardiovascular
5292176|NCT02214290|Caffeine|caffeine
5292177|NCT02214290|L-citrulline|l-citrulline
5292178|NCT02214290|Arterial Function|arterial function
5292179|NCT02214290|Hemodynamics|hemodynamics
5292180|NCT02214290|Blood Pressure|blood pressure
5292181|NCT02214290|Pulse Wave Velocity|pulse wave velocity
5292182|NCT02214290|Pulse Wave Analysis|pulse wave analysis
5292183|NCT02214277|Embolic Protection|embolic protection
5292184|NCT02214277|Edwards SAPIEN THV|edwards sapien thv
5292185|NCT02214277|Edwards SAPIEN XT|edwards sapien xt
5292186|NCT02214277|TAVR|tavr
5292187|NCT02214277|Transfemoral|transfemoral
5292188|NCT02214277|Transapical|transapical
5292189|NCT02214277|Heart Valve Diseases|heart valve diseases
5292190|NCT02214277|Heart Diseases|heart diseases
5292191|NCT02214277|TAVI|tavi
5292192|NCT02214277|Aortic Stenosis|aortic stenosis
5292193|NCT02214277|Aortic Valve|aortic valve
5292194|NCT02214277|Transcatheter Heart Valve|transcatheter heart valve
5292195|NCT02214251|Parkinson's disease|parkinson's disease
5292196|NCT02214251|freezing of gait|freezing of gait
5292197|NCT02214251|movement disorders|movement disorders
5292198|NCT02214251|neuroscience|neuroscience
5292199|NCT02214251|neural|neural
5292200|NCT02214251|mechanism|mechanism
5292201|NCT02214212|traumatic brain injury|traumatic brain injury
5292203|NCT02214212|Sleep|sleep
5292204|NCT02214212|Bright White Light Therapy|bright white light therapy
5292205|NCT02214212|Red Light Therapy|red light therapy
5292206|NCT02214212|Recovery|recovery
5292207|NCT02214212|Central Nervous System Diseases|central nervous system diseases
5292208|NCT02214212|Brain Diseases|brain diseases
5292209|NCT02214212|Nervous System Diseases|nervous system diseases
5292210|NCT02214212|Signs and Symptoms|signs and symptoms
5292211|NCT02214212|Rehabilitation|rehabilitation
5292212|NCT02214212|Actigraphy|actigraphy
5292213|NCT02214199|Shoulder Pain|shoulder pain
5292214|NCT02214199|Shoulder Impingement Syndrome|shoulder impingement syndrome
5292215|NCT02214199|Exercise therapy|exercise therapy
5292216|NCT02214199|Randomized Controlled Trial|randomized controlled trial
5292217|NCT02214186|Pre-Eclampsia|pre-eclampsia
5292218|NCT02214186|Acute Kidney Injury|acute kidney injury
5292219|NCT02214186|Fluid Therapy|fluid therapy
5292220|NCT02214186|Anesthesia, Spinal|anesthesia, spinal
5292221|NCT02214173|HIV, BRM4, hydrolyzed rice bran, metabolic syndrome|hiv, brm4, hydrolyzed rice bran, metabolic syndrome
5292222|NCT02214160|Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
5292223|NCT02214160|carnitine palmitoyltransferase (CPT I or CPT II) deficiency|carnitine palmitoyltransferase (cpt i or cpt ii) deficiency
5292224|NCT02214160|very long chain acyl-CoA dehydrogenase (VLCAD) deficiency|very long chain acyl-coa dehydrogenase (vlcad) deficiency
5292225|NCT02214160|long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency|long-chain 3-hydroxy-acyl-coa dehydrogenase (lchad) deficiency
5292226|NCT02214160|trifunctional protein (TFP) deficiency|trifunctional protein (tfp) deficiency
5292227|NCT02214160|carnitine-acylcarnitine translocase (CACT) deficiency|carnitine-acylcarnitine translocase (cact) deficiency
5292228|NCT02214160|Triheptanoin|triheptanoin
5161640|NCT02981381|TMS|tms
5292229|NCT02214160|UX007|ux007
5292230|NCT02214160|C7|c7
5292231|NCT02214147|Drug Therapy|drug therapy
5292232|NCT02214134|Lung cancer|lung cancer
5292233|NCT02214134|Malignant pleural mesothelioma|malignant pleural mesothelioma
5292234|NCT02214134|Thymic malignancy|thymic malignancy
5292235|NCT02214134|Biomarkers|biomarkers
5292236|NCT02214134|Screening|screening
5292237|NCT02214121|sickle cell anemia|sickle cell anemia
5292238|NCT02214121|paediatric|paediatric
5292239|NCT02214108|BMI|bmi
5292240|NCT02214108|Obesity|obesity
5292241|NCT02214108|overweight|overweight
5292242|NCT02214108|child|child
5292243|NCT02214108|Physical activity|physical activity
5292244|NCT02214095|Cytokines|cytokines
5292245|NCT02214095|interleukin-1β|interleukin-1β
5292246|NCT02214095|chronic periodontitis|chronic periodontitis
5292247|NCT02214095|host modulation|host modulation
5292248|NCT02214095|glucosamine sulphate.|glucosamine sulphate.
5292249|NCT02214056|mobile screening team|mobile screening team
5292250|NCT02214056|feasibility|feasibility
5292251|NCT02214030|Femoral compression device|femoral compression device
5292252|NCT02214030|manual compression|manual compression
5292254|NCT02214030|coronary intervention|coronary intervention
5292255|NCT02214030|coronary artery disease|coronary artery disease
5292257|NCT02214017|telemedicine|telemedicine
5292258|NCT02214017|glycemia|glycemia
5292259|NCT02214017|lipids|lipids
5292260|NCT02214017|blood pressure|blood pressure
5292261|NCT02214004|Breast cancer|breast cancer
5292262|NCT02214004|HER2|her2
5292263|NCT02214004|ER|er
5292264|NCT02214004|Postmenopausal|postmenopausal
5292265|NCT02214004|Trastuzumab|trastuzumab
5292266|NCT02214004|Letrozole|letrozole
5292267|NCT02214004|Neoadjuvant endocrine treatment|neoadjuvant endocrine treatment
5292268|NCT02213991|Breast Cancer|breast cancer
5292269|NCT02213991|Breast Conservative Surgery|breast conservative surgery
5292270|NCT02213991|Intraoperative Radiotherapy|intraoperative radiotherapy
5292271|NCT02213991|Local Toxicity|local toxicity
5292272|NCT02213991|Whole breast radiotherapy|whole breast radiotherapy
5292273|NCT02213965|Intravenous Catheter|intravenous catheter
5292274|NCT02213965|Vasofix safety|vasofix safety
5292275|NCT02213965|Introcan safety|introcan safety
5292278|NCT02213939|Myocardial revascularization|myocardial revascularization
5292279|NCT02213939|Cytosorb|cytosorb
5292280|NCT02213939|Inflammatory response|inflammatory response
5292281|NCT02213939|Cardiopulmonary bypass|cardiopulmonary bypass
5292282|NCT02213926|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5292283|NCT02213926|Btk|btk
5292284|NCT02213926|Mantle Cell Lymphoma|mantle cell lymphoma
5292285|NCT02213926|MCL|mcl
5292286|NCT02213926|ACP-196|acp-196
5292287|NCT02213926|Acalabrutinib|acalabrutinib
5292288|NCT02213926|ACE-LY-004|ace-ly-004
5292289|NCT02213926|Calquence|calquence
5292290|NCT02213900|delirium|delirium
5292291|NCT02213900|confusion|confusion
5292292|NCT02213900|surgery|surgery
5292293|NCT02213900|cognitive Impairment|cognitive impairment
5292294|NCT02213900|post-traumatic Stress disorder|post-traumatic stress disorder
5292295|NCT02213900|depression|depression
5292296|NCT02213900|anxiety|anxiety
5292297|NCT02213887|Drug Interactions|drug interactions
5292298|NCT02213887|Pantoprazole|pantoprazole
5292299|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors
5292300|NCT02213887|Psychotropic Drugs|psychotropic drugs
5292301|NCT02213887|Antipsychotic Agents|antipsychotic agents
5292302|NCT02213887|Aripiprazole|aripiprazole
5292303|NCT02213887|Asenapine|asenapine
5292304|NCT02213887|Clozapine|clozapine
5292305|NCT02213887|Lurasidone|lurasidone
5292306|NCT02213887|Olanzapine|olanzapine
5292307|NCT02213887|9-hydroxy-risperidone|9-hydroxy-risperidone
5292308|NCT02213887|Quetiapine|quetiapine
5292309|NCT02213887|Risperidone|risperidone
5292310|NCT02213887|Ziprasidone|ziprasidone
5292311|NCT02213887|Valproic Acid|valproic acid
5292312|NCT02213887|Lithium|lithium
5292313|NCT02213887|Gastrins|gastrins
5292314|NCT02213887|Psychotic Disorders|psychotic disorders
5292315|NCT02213887|Gastroesophageal Reflux|gastroesophageal reflux
5292316|NCT02213874|Pregnant Women|pregnant women
5292317|NCT02213874|Women's Health|women's health
5292318|NCT02213874|Contraception|contraception
5292319|NCT02213874|Trust in Health Care|trust in health care
5292320|NCT02213861|CTCL|ctcl
5292321|NCT02213861|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5292322|NCT02213861|Early-stage|early-stage
5292323|NCT02213861|SHAPE|shape
5292324|NCT02213861|SHP-141|shp-141
5292325|NCT02213861|topical|topical
5292326|NCT02213861|Histone deacetylase inhibitor|histone deacetylase inhibitor
5962957|NCT04277312|Primary School Children|primary school children
5292327|NCT02213861|CAILS|cails
5292328|NCT02213861|mSWAT|mswat
5292329|NCT02213861|mycosis fungoides|mycosis fungoides
5292330|NCT02213848|Neuromuscular blockade reversal|neuromuscular blockade reversal
5292331|NCT02213848|TOF ratio|tof ratio
5292332|NCT02213848|Calcium chloride|calcium chloride
5292333|NCT02213835|Crohn's disease and Ulcerative colitis|crohn's disease and ulcerative colitis
5292334|NCT02213822|genome|genome
5292335|NCT02213822|transcriptome|transcriptome
5292336|NCT02213822|molecular|molecular
5292337|NCT02213822|proteome|proteome
5292338|NCT02213822|oncogenic mutations|oncogenic mutations
5292339|NCT02213822|sequencing|sequencing
5292340|NCT02213822|solid tumor|solid tumor
5292341|NCT02213822|hematological malignancy|hematological malignancy
5292342|NCT02213822|cancer|cancer
5292343|NCT02213822|analysis|analysis
5292344|NCT02213822|genetic|genetic
5292345|NCT02213822|mutation|mutation
5292346|NCT02213796|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics|meropenem, early phase, severe sepsis and septic shock, critically ill, population pharmacokinetics
5292350|NCT02213783|Pharmacodynamic|pharmacodynamic
5292351|NCT02213783|Monte Carlo Simulation|monte carlo simulation
5292352|NCT02213757|Hematuria|hematuria
5292353|NCT02213757|Menopause|menopause
5292354|NCT02213757|Urinalysis|urinalysis
5292355|NCT02213744|HER2-positive|her2-positive
5292356|NCT02213744|HER2+|her2+
5292357|NCT02213744|HER2|her2
5292358|NCT02213744|Locally Advanced Breast Cancer|locally advanced breast cancer
5292359|NCT02213744|Metastatic Breast Cancer|metastatic breast cancer
5292360|NCT02213744|trastuzumab|trastuzumab
5292361|NCT02213744|Herceptin|herceptin
5292362|NCT02213744|pertuzumab|pertuzumab
5292363|NCT02213744|ado-trastuzumab emtansine|ado-trastuzumab emtansine
5292364|NCT02213744|TDM-1|tdm-1
5292365|NCT02213744|Perjeta|perjeta
5292366|NCT02213744|Kadcyla|kadcyla
5292367|NCT02213731|Atrial Fibrillation|atrial fibrillation
5292368|NCT02213731|Persistent Atrial Fibrillation|persistent atrial fibrillation
5292375|NCT02213705|SYSTEMIC SCLERODERMA|systemic scleroderma
5292377|NCT02213705|ALLOGENEIC MESENCHYMAL STEM CELLS|allogeneic mesenchymal stem cells
5292378|NCT02213705|ADULT|adult
5292379|NCT02213692|Liver Resection|liver resection
5292380|NCT02213692|Harmonic Scalpel|harmonic scalpel
5292381|NCT02213692|Crush-clamping|crush-clamping
5292382|NCT02213692|A Prospective Randomized Study|a prospective randomized study
5292383|NCT02213679|Creatine|creatine
5292384|NCT02213679|Guanidinoacetic acid|guanidinoacetic acid
5292385|NCT02213679|Intervention|intervention
5292386|NCT02213679|Fatigue|fatigue
5292387|NCT02213679|Muscle strength|muscle strength
5292388|NCT02213666|Atrial fibrillation ablation|atrial fibrillation ablation
5292389|NCT02213666|Intracardiac echocardiography|intracardiac echocardiography
5292390|NCT02213666|Thrombus|thrombus
5292391|NCT02213666|Left atrial appendage|left atrial appendage
5292392|NCT02213666|Right atrial appendage|right atrial appendage
5292393|NCT02213653|Functional iron deficiency|functional iron deficiency
5292394|NCT02213653|Metastatic|metastatic
5292395|NCT02213640|Neurologic neglect syndrome|neurologic neglect syndrome
5292396|NCT02213640|post stroke|post stroke
5292397|NCT02213640|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5292398|NCT02213640|prismatic adaptation|prismatic adaptation
5292399|NCT02213627|Corifollitropin alfa, recombinant FSH, HP-hMG, apoptosis, oocyte donation|corifollitropin alfa, recombinant fsh, hp-hmg, apoptosis, oocyte donation
5292400|NCT02213601|Yoga|yoga
5292401|NCT02213601|Complementary and Alternative Medicine Interventions|complementary and alternative medicine interventions
5292402|NCT02213601|Treatment|treatment
5292403|NCT02213601|Postpartum Depression|postpartum depression
5292404|NCT02213588|Antioxidant|antioxidant
5292405|NCT02213575|Resistent Hypertension|resistent hypertension
5292406|NCT02213536|Metastatic brain cancer|metastatic brain cancer
5292407|NCT02213536|Whole brain radiotherapy|whole brain radiotherapy
5292408|NCT02213536|Scalp sparing whole brain radiotherapy|scalp sparing whole brain radiotherapy
5292409|NCT02213536|Prophylactic whole brain radiotherapy|prophylactic whole brain radiotherapy
5292410|NCT02213523|antioxidant|antioxidant
5292411|NCT02213510|pacemaker|pacemaker
5292412|NCT02213510|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5279854|NCT02275884|Cacao|cacao
5292414|NCT02213510|surgical wound closure|surgical wound closure
5292415|NCT02213510|sutures|sutures
5292416|NCT02213510|Zipline|zipline
5292417|NCT02213510|Zips|zips
5292418|NCT02213510|CIED|cied
5292419|NCT02213510|cardiovascular implantable electronic devices|cardiovascular implantable electronic devices
5292420|NCT02213510|arrhythmia|arrhythmia
5292421|NCT02213497|Patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.|patients with esophageal cancer to be treated with concurrent preoperative chemoradiation with carboplatin and paclitaxel.
5292422|NCT02213484|aortopathy syndrome|aortopathy syndrome
5292423|NCT02213484|aortic aneurysm|aortic aneurysm
5292424|NCT02213484|aortic dissection|aortic dissection
5292425|NCT02213484|connective tissue disorder|connective tissue disorder
5292426|NCT02213458|Pragmatic Clinical Trial|pragmatic clinical trial
5292427|NCT02213458|Family Caregivers|family caregivers
5292428|NCT02213458|Patient Care Management|patient care management
5292429|NCT02213432|influenza vaccine|influenza vaccine
5292430|NCT02213432|cancer|cancer
5292431|NCT02213419|Cystic Tumors of the Pancreas|cystic tumors of the pancreas
5292432|NCT02213419|Endoscopic Ultrasound|endoscopic ultrasound
5292433|NCT02213419|Ethanol|ethanol
5292434|NCT02213393|undernutrition|undernutrition
5292435|NCT02213393|nutritional status|nutritional status
5962958|NCT04277312|Food Education|food education
5174039|NCT02904538|Dexamethasone|dexamethasone
5174040|NCT02904538|Regional anesthesia|regional anesthesia
5174041|NCT02904538|Front foot surgery|front foot surgery
5174042|NCT02904538|Metacarpal osteotomy|metacarpal osteotomy
5174043|NCT02904525|newly diagnosed|newly diagnosed
5174044|NCT02904525|MRI|mri
5174045|NCT02904499|Atrial Fibrillation|atrial fibrillation
5174046|NCT02904499|Anticoagulants|anticoagulants
5779374|NCT00200369|Adherence|adherence
5174052|NCT02904434|pharmacokinetic|pharmacokinetic
5174053|NCT02904434|grapefruit juice|grapefruit juice
5174054|NCT02904434|bioavailability|bioavailability
5174055|NCT02904434|intestinal first-pass metabolism|intestinal first-pass metabolism
5174056|NCT02904434|pharmacokinetics|pharmacokinetics
5174058|NCT02904421|scoliosis|scoliosis
5292436|NCT02213393|elderly patients|elderly patients
5292437|NCT02213393|protein|protein
5292438|NCT02213393|enriched products|enriched products
5292439|NCT02213393|recovery|recovery
5292440|NCT02213393|physical function|physical function
5292441|NCT02213393|quality of life|quality of life
5292442|NCT02213393|activities of daily living|activities of daily living
5292443|NCT02213380|delirium|delirium
5292444|NCT02213380|general anesthesia|general anesthesia
5292445|NCT02213380|regional anesthesia|regional anesthesia
5292446|NCT02213380|elderly patient|elderly patient
5292447|NCT02213380|hip fracture|hip fracture
5292448|NCT02213354|Influenza, H7N9, Elderly, Vaccine, MF59 Adjuvant|influenza, h7n9, elderly, vaccine, mf59 adjuvant
5292451|NCT02213341|Peanut Allergy|peanut allergy
5292452|NCT02213341|Infant Vaccination|infant vaccination
5292453|NCT02213315|Healthy Volunteers, Rheumatoid Arthritis, mavrilimumab|healthy volunteers, rheumatoid arthritis, mavrilimumab
5292454|NCT02213302|premedication|premedication
5292455|NCT02213302|preoperative anxiety|preoperative anxiety
5292456|NCT02213302|salivary cortisol level|salivary cortisol level
5292457|NCT02213302|anxiety visual analog scale|anxiety visual analog scale
5292460|NCT02213276|Glucose infusion|glucose infusion
5292461|NCT02213276|Bone markers|bone markers
5292462|NCT02213276|Inflammatory markers|inflammatory markers
5292463|NCT02213263|rituximab|rituximab
5292464|NCT02213263|follicular lymphoma|follicular lymphoma
5292465|NCT02213263|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5292466|NCT02213263|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5292467|NCT02213224|Perindopril,Telmisartan, Efficacy, NAFLD|perindopril,telmisartan, efficacy, nafld
5292469|NCT02213211|Case management|case management
5292470|NCT02213211|Rapid diagnostic tests|rapid diagnostic tests
5292471|NCT02213211|Artemether lumefantrine|artemether lumefantrine
5292472|NCT02213211|School children|school children
5292473|NCT02213211|School health services|school health services
5292474|NCT02213211|Attendance|attendance
5292476|NCT02213211|Parasitic diseases|parasitic diseases
5292477|NCT02213198|Serious mental illness transitions shared decision making|serious mental illness transitions shared decision making
5292478|NCT02213185|Sterile water injections|sterile water injections
5292479|NCT02213185|Pain|pain
5292481|NCT02213185|Complementary method|complementary method
5292482|NCT02213172|IBS|ibs
5292483|NCT02213172|Probiotic|probiotic
5292484|NCT02213172|Constipation|constipation
5292485|NCT02213172|Bifidobacterium longum|bifidobacterium longum
5292486|NCT02213172|Lactobacillus paracasei|lactobacillus paracasei
5292487|NCT02213172|Lallemand Health Solutions|lallemand health solutions
5292488|NCT02213159|Dexmedetomidine|dexmedetomidine
5292489|NCT02213159|bariatric surgery|bariatric surgery
5292490|NCT02213159|postoperative pain|postoperative pain
5292491|NCT02213159|morphine consumption|morphine consumption
5292492|NCT02213159|Quality of recovery|quality of recovery
5292493|NCT02213133|Squamous|squamous
5292494|NCT02213133|SCC|scc
5292495|NCT02213133|Carcinoma|carcinoma
5292496|NCT02213133|KPT-330|kpt-330
5292497|NCT02213133|SINE|sine
5292498|NCT02213133|Selinexor|selinexor
5292499|NCT02213133|Karyopharm|karyopharm
5292500|NCT02213133|Karyopharm Therapeutics|karyopharm therapeutics
5292501|NCT02213133|Lung|lung
5292502|NCT02213133|Head|head
5292503|NCT02213133|Neck|neck
5292504|NCT02213133|Esophageal|esophageal
5292505|NCT02213120|Vertigo, Dizziness|vertigo, dizziness
5292506|NCT02213107|prostate|prostate
5292507|NCT02213094|preeclampsia|preeclampsia
5292508|NCT02213094|pregnancy-induced hypertension|pregnancy-induced hypertension
5292509|NCT02213094|nicotinamide|nicotinamide
5292510|NCT02213081|Endometriosis|endometriosis
5962959|NCT04277312|Food Knowledge|food knowledge
5962960|NCT04277312|Childhood Health|childhood health
5962961|NCT04277312|Childhood Wellbeing|childhood wellbeing
5962962|NCT04277273|Head and Neck neoplasm|head and neck neoplasm
5962963|NCT04277273|cleft|cleft
5962964|NCT04277273|maxillofacial prosthesis|maxillofacial prosthesis
5962965|NCT04277234|fatigue|fatigue
5962966|NCT04277234|fatigability|fatigability
5962967|NCT04277234|functional impairment|functional impairment
5962968|NCT04277221|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5962969|NCT04277221|Immunotherapy|immunotherapy
5962970|NCT04277221|Dendritic Cell|dendritic cell
5962971|NCT04277195|Breast Cancer|breast cancer
5962972|NCT04277195|SPAG5|spag5
5962973|NCT04277195|Chemotherapy|chemotherapy
5962974|NCT04277195|Anthracycline|anthracycline
5962975|NCT04277195|Predictive test|predictive test
5962976|NCT04277195|Predictive assay|predictive assay
5962977|NCT04277195|SPerm associated AntiGen 5|sperm associated antigen 5
5279960|NCT02275195|alcohol|alcohol
5292511|NCT02213081|chronic pelvic pain|chronic pelvic pain
5292512|NCT02213081|dysmenorrhea|dysmenorrhea
5292513|NCT02213081|dyschezia|dyschezia
5292514|NCT02213081|bleeding|bleeding
5292515|NCT02213081|ulipristal|ulipristal
5292516|NCT02213081|progesterone|progesterone
5292517|NCT02213068|Kidney|kidney
5292518|NCT02213068|Renal|renal
5292519|NCT02213068|Transplant|transplant
5292520|NCT02213068|EBV|ebv
5292521|NCT02213068|Immunosuppressants|immunosuppressants
5292522|NCT02213068|Belatacept|belatacept
5292523|NCT02213055|Lice|lice
5292524|NCT02213042|biomarker|biomarker
5292525|NCT02213042|Lapatinib|lapatinib
5292526|NCT02213042|Prosigna|prosigna
5292527|NCT02213042|ErbB2|erbb2
5292528|NCT02213042|PAM50|pam50
5292529|NCT02213042|HER2|her2
5292530|NCT02213042|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
5292531|NCT02213042|HER2-enriched|her2-enriched
5292532|NCT02213042|Trastuzumab|trastuzumab
5292533|NCT02213029|epelsiban|epelsiban
5292534|NCT02213029|pharmacokinetics|pharmacokinetics
5292535|NCT02213029|patient reported pain / discomfort|patient reported pain / discomfort
5292536|NCT02213029|pharmacodynamics|pharmacodynamics
5292537|NCT02213029|oxytocin infusions|oxytocin infusions
5292538|NCT02213029|Uterine contractions|uterine contractions
5423350|NCT01616056|eye|eye
5423351|NCT01616043|scar quality|scar quality
5292542|NCT02212990|Antipyretics|antipyretics
5292543|NCT02212990|Acetaminophen|acetaminophen
5292544|NCT02212990|Ibuprofen|ibuprofen
5292545|NCT02212990|Influenza vaccine|influenza vaccine
5292546|NCT02212990|Influenza|influenza
5292547|NCT02212990|Body temperature changes|body temperature changes
5292548|NCT02212990|Signs and symptoms|signs and symptoms
5292549|NCT02212977|Port Catheter|port catheter
5293147|NCT02209766|D5884|d5884
5292550|NCT02212977|Octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
5292551|NCT02212977|2-octylcyanoacrylate|2-octylcyanoacrylate
5292552|NCT02212964|Radiation Injury|radiation injury
5292553|NCT02212964|Radiation Necrosis|radiation necrosis
5292554|NCT02212964|Ultra-high field MRI|ultra-high field mri
5292555|NCT02212964|Susceptibility Weighted Imaging|susceptibility weighted imaging
5292556|NCT02212964|Post-treatment radiographic imaging change|post-treatment radiographic imaging change
5292809|NCT02211430|intervention|intervention
5289422|NCT02226484|GERD|gerd
5292557|NCT02212912|acute ischemic stroke, performance measure, acute treatment|acute ischemic stroke, performance measure, acute treatment
5292558|NCT02212899|Spinal Surgery|spinal surgery
5292559|NCT02212899|Spinal Fusion|spinal fusion
5292560|NCT02212899|Deformity Correction|deformity correction
5292561|NCT02212899|Spinal Instrumentation|spinal instrumentation
5292562|NCT02212886|Glatiramer acetate|glatiramer acetate
5292563|NCT02212886|Copaxone|copaxone
5292564|NCT02212886|Multiple sclerosis|multiple sclerosis
5292565|NCT02212886|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5292566|NCT02212886|RRMS|rrms
5292567|NCT02212886|GA Depot|ga depot
5292568|NCT02212886|Monthly injection|monthly injection
5292569|NCT02212873|school based intervention|school based intervention
5292570|NCT02212873|overweight|overweight
5292571|NCT02212873|obese|obese
5292572|NCT02212873|BMI z score|bmi z score
5292573|NCT02212873|fat mass|fat mass
5292574|NCT02212860|neoadjuvant|neoadjuvant
5292575|NCT02212860|radiation|radiation
5292576|NCT02212860|breast|breast
5292577|NCT02212860|cancer|cancer
5292578|NCT02212860|hypofractionation|hypofractionation
5292579|NCT02212860|stereotactic|stereotactic
5292580|NCT02212860|preoperative|preoperative
5188055|NCT02814929|ROP|rop
5292581|NCT02212834|Breast|breast
5292582|NCT02212834|Cancer|cancer
5292583|NCT02212834|Surveillance|surveillance
5292584|NCT02212834|Imaging|imaging
5292585|NCT02212834|Comparative|comparative
5292586|NCT02212834|Effectiveness|effectiveness
5292587|NCT02212808|Cluster-randomized crossover trial|cluster-randomized crossover trial
5292588|NCT02212808|Antimicrobial stewardship|antimicrobial stewardship
5292589|NCT02212808|Community hospitals|community hospitals
5292590|NCT02212808|Feasibility|feasibility
5292591|NCT02212795|healthy|healthy
5292592|NCT02212782|Healthy|healthy
5292593|NCT02212769|healthy|healthy
5292594|NCT02212756|healthy|healthy
5292595|NCT02212717|Acute cholecystitis|acute cholecystitis
5292596|NCT02212717|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
5292597|NCT02212717|Percutaneous cholecystostomy|percutaneous cholecystostomy
5292598|NCT02212704|vestibular|vestibular
5292599|NCT02212704|proprioception|proprioception
5292600|NCT02212704|spatial orientation|spatial orientation
5292601|NCT02212704|bayesian|bayesian
5292602|NCT02212691|Sickle Cell|sickle cell
5292603|NCT02212652|Bariatric surgery|bariatric surgery
5292604|NCT02212652|Vitamin D deficiency|vitamin d deficiency
5292605|NCT02212652|Vitamin D insufficiency|vitamin d insufficiency
5292606|NCT02212652|Adverse surgical outcomes|adverse surgical outcomes
5292607|NCT02212652|Clinical outcomes|clinical outcomes
5292608|NCT02212639|Kaposi' s sarcoma|kaposi' s sarcoma
5292609|NCT02212639|Digoxin|digoxin
5962978|NCT04277195|ASTRIN|astrin
5174261|NCT02903147|IVDR; driving behavior patterns; Meta-Cognitive Intervention|ivdr; driving behavior patterns; meta-cognitive intervention
5292610|NCT02212613|Major Depressive Disorder|major depressive disorder
5292611|NCT02212613|Mental Disorders, nonpsychotic episode, antipsychotic|mental disorders, nonpsychotic episode, antipsychotic
5292612|NCT02212613|Mood Disorder, psychotic disorder|mood disorder, psychotic disorder
5292613|NCT02212587|inhaled antibiotics|inhaled antibiotics
5292614|NCT02212574|Wnt|wnt
5292615|NCT02212574|Medulloblastoma|medulloblastoma
5292616|NCT02212574|Chemotherapy|chemotherapy
5292617|NCT02212548|SpaceOAR Hydrogel Image Guided Modulated Radiotherapy|spaceoar hydrogel image guided modulated radiotherapy
5292618|NCT02212535|Sickle cell disease|sickle cell disease
5292619|NCT02212535|Open monocenter study|open monocenter study
5292620|NCT02212535|Phase I/II|phase i/ii
5292621|NCT02212535|hematopoietic stem cells|hematopoietic stem cells
5292622|NCT02212535|Plerixafor|plerixafor
5292623|NCT02212522|Diabetes Mellitus|diabetes mellitus
5292624|NCT02212522|Insulin-Dependent|insulin-dependent
5292625|NCT02212522|Genome-Wide Association Study|genome-wide association study
5292626|NCT02212522|Environment-Wide Association Study|environment-wide association study
5292627|NCT02212522|Predisposition|predisposition
5292628|NCT02212522|Complications|complications
5292629|NCT02212483|Asthma|asthma
5292630|NCT02212483|Medical Indoor Environment Counselors|medical indoor environment counselors
5292631|NCT02212483|Pediatric|pediatric
5292632|NCT02212483|Environment|environment
5292633|NCT02212483|Clinical effectiveness|clinical effectiveness
5292634|NCT02212483|Economical impact|economical impact
5292635|NCT02212444|plantar fasciitis|plantar fasciitis
5292636|NCT02212444|dynamic elastomeric fabric orthoses (DEFO)|dynamic elastomeric fabric orthoses (defo)
5292637|NCT02212444|feasibility|feasibility
5292638|NCT02212444|Physiotherapy|physiotherapy
5292639|NCT02212444|Musculoskeletal|musculoskeletal
5292640|NCT02212431|Cystic Fibrosis|cystic fibrosis
5292641|NCT02212431|Cysteamine|cysteamine
5292642|NCT02212431|Pharmacokinetics|pharmacokinetics
5292643|NCT02212405|Deep rTMS|deep rtms
5292644|NCT02212405|Insular cortex|insular cortex
5292648|NCT02212379|Raltegravir|raltegravir
5292649|NCT02212379|Etravirine|etravirine
5292650|NCT02212379|aged, 45 and over|aged, 45 and over
5292651|NCT02212379|Viral load|viral load
5292652|NCT02212379|Efficacy|efficacy
5292653|NCT02212379|Safety|safety
5292654|NCT02212366|TDCS|tdcs
5292655|NCT02212366|Depression|depression
5292656|NCT02212366|Brain Stimulation|brain stimulation
5292657|NCT02212366|Memory|memory
5292658|NCT02212366|Cognition|cognition
5292660|NCT02212340|propofol|propofol
5292661|NCT02212340|desflurane|desflurane
5292669|NCT02212275|typical development|typical development
5292670|NCT02212275|sensory testing|sensory testing
5292671|NCT02212275|the cortical metric|the cortical metric
5292672|NCT02212249|soluble VE-cadherin|soluble ve-cadherin
5292673|NCT02212249|antibody|antibody
5292674|NCT02212249|systemic slerosis|systemic slerosis
5292675|NCT02212236|Distress|distress
5292676|NCT02212236|Depression|depression
5292677|NCT02212236|Anxiety|anxiety
5292678|NCT02212236|Stress|stress
5292679|NCT02212236|Coping|coping
5292680|NCT02212236|Illness perceptions|illness perceptions
5292681|NCT02212236|Stem cell transplantation|stem cell transplantation
5292682|NCT02212236|Bone marrow transplantation|bone marrow transplantation
5292683|NCT02212223|Vitamin D|vitamin d
5292684|NCT02212223|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
5292685|NCT02212223|Dietary supplement|dietary supplement
5292686|NCT02212223|Ethnicity|ethnicity
5292687|NCT02212223|Immigrant|immigrant
5292688|NCT02212197|prostate cancer|prostate cancer
5292689|NCT02212197|leuprolide|leuprolide
5292690|NCT02212184|Diaphragm|diaphragm
5292691|NCT02212184|COPD|copd
5292692|NCT02212184|Musculoskeletal Manipulations|musculoskeletal manipulations
5292693|NCT02212184|Ultrasonography|ultrasonography
5292694|NCT02212184|Optoelectronic Plethysmography.|optoelectronic plethysmography.
5292695|NCT02212158|Type 1 diabetes|type 1 diabetes
5292696|NCT02212158|adolescents|adolescents
5292697|NCT02212158|HA1c|ha1c
5292698|NCT02212158|psychological intervention|psychological intervention
5292699|NCT02212145|prevention|prevention
5292700|NCT02212145|cardiovascular disease|cardiovascular disease
5292701|NCT02212145|risk factors|risk factors
5292702|NCT02212132|metamemory|metamemory
5292703|NCT02212132|memory complaints|memory complaints
5292704|NCT02212132|performance mnemonic|performance mnemonic
5292705|NCT02212132|cancer|cancer
5292706|NCT02212119|Dementia|dementia
5292707|NCT02212119|Paratonia|paratonia
5292708|NCT02212119|Caregiver Burden|caregiver burden
5292709|NCT02212119|Botulinum toxin|botulinum toxin
5292710|NCT02212093|Pneumonia, mechanical ventilation, ICU, mortality|pneumonia, mechanical ventilation, icu, mortality
5292711|NCT02212041|electronic cigarettes|electronic cigarettes
5292712|NCT02212041|smoking|smoking
5292713|NCT02212041|schizophrenia|schizophrenia
5292714|NCT02212041|serious mental illness|serious mental illness
5280147|NCT02274116|walking|walking
5962979|NCT04277182|Burn|burn
5962980|NCT04277182|Burn wound|burn wound
5962981|NCT04277182|Propolis|propolis
5162105|NCT02978651|EDS|eds
5174384|NCT02902393|tPA|tpa
5292715|NCT02212028|ST-elevation myocardial infarction|st-elevation myocardial infarction
5292716|NCT02212028|prasugrel|prasugrel
5292717|NCT02212028|pharmacodynamic|pharmacodynamic
5292718|NCT02212028|pharmacokinetic|pharmacokinetic
5292719|NCT02212002|Group B Streptococcus|group b streptococcus
5292720|NCT02212002|Intrapartum Antibiotic Prophylaxis|intrapartum antibiotic prophylaxis
5292721|NCT02212002|term infants|term infants
5292722|NCT02212002|vaginal delivery|vaginal delivery
5292723|NCT02212002|gut microbiota|gut microbiota
5292724|NCT02212002|feeding|feeding
5292725|NCT02212002|molecular analysis|molecular analysis
5292726|NCT02212002|real-time PCR|real-time pcr
5292727|NCT02211846|Pharmacokinetics|pharmacokinetics
5292728|NCT02211846|Mirabegron|mirabegron
5292729|NCT02211846|Neurogenic detrusor overactivity (NDO)|neurogenic detrusor overactivity (ndo)
5292730|NCT02211846|Overactive bladder (OAB)|overactive bladder (oab)
5292731|NCT02211820|Encephalopathy|encephalopathy
5292732|NCT02211820|Imaging Studies|imaging studies
5292733|NCT02211820|Dementia|dementia
5292734|NCT02211820|Cerebellar Cortical Atrophy|cerebellar cortical atrophy
5292735|NCT02211794|Total Knee Arthroplasty|total knee arthroplasty
5292736|NCT02211794|degenerative joint disease|degenerative joint disease
5292737|NCT02211781|Tribal Communities|tribal communities
5292738|NCT02211781|Radiation|radiation
5292739|NCT02211781|Cancer|cancer
5292740|NCT02211768|Genetic Analysis|genetic analysis
5292741|NCT02211768|Biopsy|biopsy
5292742|NCT02211768|FDG-PET|fdg-pet
5292743|NCT02211768|FLT-PET|flt-pet
5292751|NCT02211742|postprandial glucose excursion|postprandial glucose excursion
5292752|NCT02211742|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
5292753|NCT02211742|euglycemic oral glucose tolerance test|euglycemic oral glucose tolerance test
5292754|NCT02211703|perioperative hypothermia|perioperative hypothermia
5292756|NCT02211703|Tympanic temperature|tympanic temperature
5292757|NCT02211651|adipose tissue|adipose tissue
5292758|NCT02211651|placenta|placenta
5292759|NCT02211651|pregnancy|pregnancy
5292760|NCT02211651|umbilical cord|umbilical cord
5292761|NCT02211638|Drug Therapy|drug therapy
5292762|NCT02211625|Healthy|healthy
5289629|NCT02225574|Leukemia|leukemia
5292763|NCT02211625|Pharmacodynamics (PD)|pharmacodynamics (pd)
5292764|NCT02211625|Pharmacokinetics (PK)|pharmacokinetics (pk)
5292765|NCT02211612|Overfeeding|overfeeding
5292766|NCT02211612|Weight gain|weight gain
5292767|NCT02211612|Liver fat|liver fat
5292768|NCT02211612|Pancreatic fat|pancreatic fat
5292769|NCT02211612|Ectopic fat|ectopic fat
5292770|NCT02211612|Skeletal muscle|skeletal muscle
5292771|NCT02211612|Adipose tissue|adipose tissue
5292772|NCT02211612|Gene expression|gene expression
5292773|NCT02211612|DNA methylation|dna methylation
5292774|NCT02211612|Palmitate|palmitate
5292775|NCT02211612|Linoleic acid|linoleic acid
5292776|NCT02211612|Saturated fat|saturated fat
5292777|NCT02211612|Polyunsaturated fat|polyunsaturated fat
5292778|NCT02211612|Metabolism|metabolism
5292779|NCT02211612|Insulin sensitivity|insulin sensitivity
5292781|NCT02211599|carbohydrate|carbohydrate
5292782|NCT02211599|lipid|lipid
5292783|NCT02211599|oxidation|oxidation
5292784|NCT02211599|fat|fat
5292785|NCT02211599|sugar|sugar
5292786|NCT02211599|juice|juice
5292787|NCT02211599|obesity|obesity
5292788|NCT02211573|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
5292789|NCT02211573|Water Based Physical Training.|water based physical training.
5292790|NCT02211534|Pulsed Electromagnetic Energy Fields|pulsed electromagnetic energy fields
5292791|NCT02211534|Total Knee Arthroplasty|total knee arthroplasty
5292792|NCT02211534|Pain Intensity|pain intensity
5292793|NCT02211521|Osteoarthritis, platelet-rich plasma, hyaluronic acid|osteoarthritis, platelet-rich plasma, hyaluronic acid
5292794|NCT02211508|fibromyalgia|fibromyalgia
5292795|NCT02211508|pain|pain
5292796|NCT02211508|stimulation|stimulation
5292797|NCT02211482|HIV-1 infected patients|hiv-1 infected patients
5292798|NCT02211482|dual therapy|dual therapy
5292799|NCT02211456|Endocardial pacing|endocardial pacing
5292800|NCT02211456|Multi site pacing|multi site pacing
5292801|NCT02211443|Full human anti-EGFR monoclonal antibody (SCT200) ;|full human anti-egfr monoclonal antibody (sct200) ;
5292802|NCT02211443|metastatic colorectal cancer （mCRC）;|metastatic colorectal cancer （mcrc）;
5292803|NCT02211443|Escalating doses ;|escalating doses ;
5292804|NCT02211443|single dose and multiple doses;|single dose and multiple doses;
5292805|NCT02211443|safety, tolerability and pharmacokinetics.|safety, tolerability and pharmacokinetics.
5292806|NCT02211430|smoking cessation|smoking cessation
5292807|NCT02211430|pregnancy|pregnancy
5292808|NCT02211430|postpartum|postpartum
5292810|NCT02211391|Nighttime Eating|nighttime eating
5292811|NCT02211391|Protein|protein
5292812|NCT02211391|Obesity|obesity
5292813|NCT02211391|Lipolysis|lipolysis
5292814|NCT02211391|Metabolism|metabolism
5292815|NCT02211378|stress|stress
5292816|NCT02211378|performance|performance
5292817|NCT02211378|cortisol|cortisol
5292818|NCT02211365|Hypertension|hypertension
5962982|NCT04277182|Wound healing|wound healing
5962983|NCT04277143|daptomycin|daptomycin
5174464|NCT02901808|Angiography|angiography
5174465|NCT02901808|Digital Subtraction Angiography (DSA)|digital subtraction angiography (dsa)
5174466|NCT02901782|Knee|knee
5174467|NCT02901782|Titanium Plate|titanium plate
5174469|NCT02901730|treatment|treatment
5292820|NCT02211352|blood pressure, ginseng|blood pressure, ginseng
5292821|NCT02211339|Social skills|social skills
5292822|NCT02211339|Social communication|social communication
5292823|NCT02211339|Cognitive communication|cognitive communication
5292824|NCT02211339|Traumatic brain injury|traumatic brain injury
5292825|NCT02211339|Acquired brain injury|acquired brain injury
5292826|NCT02211339|Communication partner training|communication partner training
5292827|NCT02211339|Peer partner training|peer partner training
5292828|NCT02211339|Peer mentoring|peer mentoring
5292829|NCT02211339|Rehabilitation|rehabilitation
5292830|NCT02211326|AF or DVT|af or dvt
5292831|NCT02211326|Age Over 18 Years, Acquired|age over 18 years, acquired
5292832|NCT02211300|glucose monitoring|glucose monitoring
5292833|NCT02211300|OptiScanner|optiscanner
5292834|NCT02211287|Dementia|dementia
5292835|NCT02211287|Decision-making|decision-making
5292836|NCT02211287|Communication|communication
5292837|NCT02211287|Advance Care Planning|advance care planning
5292838|NCT02211274|Quality of Life|quality of life
5292839|NCT02211274|Nursing Homes|nursing homes
5292840|NCT02211274|Housing for the Elderly|housing for the elderly
5292841|NCT02211274|Homes for the Aged|homes for the aged
5292849|NCT02211248|multidisciplinary care|multidisciplinary care
5292850|NCT02211248|clinical trial|clinical trial
5292851|NCT02211235|Cystic Fibrosis|cystic fibrosis
5292852|NCT02211235|Healthy Controls|healthy controls
5292853|NCT02211235|Diabetes|diabetes
5292854|NCT02211235|Cystic Fibrosis Related Diabetes (CFRD)|cystic fibrosis related diabetes (cfrd)
5292855|NCT02211235|CFRD|cfrd
5292856|NCT02211222|Thyroid Cancer|thyroid cancer
5292857|NCT02211222|Radioiodine-Refractory|radioiodine-refractory
5292858|NCT02211222|Differentiated|differentiated
5292859|NCT02211183|Massive Rotator Cuff Tear|massive rotator cuff tear
5292860|NCT02211183|Sub-acromial spacer|sub-acromial spacer
5292861|NCT02211183|Best repair of rotator cuff|best repair of rotator cuff
5292862|NCT02211105|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
5292863|NCT02211105|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
5292864|NCT02211105|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
5292865|NCT02211092|Family Caregivers|family caregivers
5292866|NCT02211092|Advanced Cancer|advanced cancer
5292867|NCT02211092|Palliative Care|palliative care
5292868|NCT02211092|Support|support
5292870|NCT02211092|Physical Activity|physical activity
5292871|NCT02211079|Healthy|healthy
5292872|NCT02211079|JNJ-54861911|jnj-54861911
5292873|NCT02211079|Caffeine|caffeine
5292874|NCT02211079|Midazolam|midazolam
5292875|NCT02211079|Tolbutamide|tolbutamide
5292876|NCT02211079|Cytochrome P450 3A4|cytochrome p450 3a4
5292877|NCT02211079|Cytochrome P450 2C9|cytochrome p450 2c9
5292878|NCT02211079|Cytochrome P450 1A2|cytochrome p450 1a2
5292879|NCT02211079|Alzheimer's disease|alzheimer's disease
5292880|NCT02211053|Organ donation|organ donation
5292881|NCT02211053|Brain dead|brain dead
5292882|NCT02211053|Levothyroxine|levothyroxine
5292883|NCT02211040|Intervention Mapping Protocol|intervention mapping protocol
5292884|NCT02211040|physical activity|physical activity
5292885|NCT02211040|fruit intake|fruit intake
5292886|NCT02211040|vegetable intake|vegetable intake
5292887|NCT02211040|computer tailoring|computer tailoring
5292888|NCT02211040|eHealth|ehealth
5292889|NCT02211040|self-regulation|self-regulation
5292890|NCT02211040|goal setting|goal setting
5292891|NCT02211040|problem solving|problem solving
5292892|NCT02211040|general practice|general practice
5292893|NCT02211027|Squamous Cell Carcinoma|squamous cell carcinoma
5292894|NCT02211027|Head & Neck Cancer|head & neck cancer
5292895|NCT02211027|Vaccine|vaccine
5292896|NCT02211027|Carcinoma|carcinoma
5292897|NCT02211027|Immunization|immunization
5292898|NCT02211027|Autologous Tumor|autologous tumor
5292899|NCT02211014|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5292901|NCT02211014|Multiple Myeloma|multiple myeloma
5292902|NCT02211014|MM|mm
5292903|NCT02211014|ACP-196|acp-196
5292904|NCT02211014|acalabrutinib|acalabrutinib
5292905|NCT02211001|Exercise Movement Techniques|exercise movement techniques
5292906|NCT02211001|Exercise Therapy|exercise therapy
5292907|NCT02211001|Physical Therapy Modalities.|physical therapy modalities.
5292908|NCT02210988|Acupuncture therapy, Acute stroke, Randomized controlled trials|acupuncture therapy, acute stroke, randomized controlled trials
5292909|NCT02210975|GERD|gerd
5292910|NCT02210975|LES|les
5292911|NCT02210975|Sleeve Gastrectomy|sleeve gastrectomy
5292912|NCT02210975|Electrical Stimulation Therapy|electrical stimulation therapy
5292913|NCT02210962|early psychosis|early psychosis
5962984|NCT04277143|pharmacokinetics|pharmacokinetics
5962985|NCT04277143|pharmacodynamics|pharmacodynamics
5962986|NCT04277143|critical ill patients|critical ill patients
5962987|NCT04277143|outcome|outcome
5962988|NCT04277130|exergame|exergame
5292914|NCT02210962|chronic schizophrenia|chronic schizophrenia
5962989|NCT04277130|children with intellectual disability|children with intellectual disability
5962990|NCT04277130|physical activity|physical activity
5162314|NCT02977689|IDH1|idh1
5174558|NCT02901158|esophageal pressure|esophageal pressure
5174559|NCT02901158|chest wall elastance|chest wall elastance
5174560|NCT02901158|lung elastance|lung elastance
5174561|NCT02901158|transpulmonary pressure|transpulmonary pressure
5174562|NCT02901145|immunotherapy,solid tumor,pediatric|immunotherapy,solid tumor,pediatric
5174563|NCT02901106|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5174564|NCT02901106|Dimethyl fumarate|dimethyl fumarate
5174565|NCT02901093|Stapes surgery|stapes surgery
5174567|NCT02901093|Inner ear|inner ear
5292915|NCT02210962|first episode psychosis|first episode psychosis
5292916|NCT02210962|omega-3 and omega-6 essential fatty acids|omega-3 and omega-6 essential fatty acids
5292917|NCT02210962|relapse prevention|relapse prevention
5292918|NCT02210962|efficacy|efficacy
5292919|NCT02210949|Blood transfusion|blood transfusion
5292920|NCT02210949|Erythropoietin|erythropoietin
5292921|NCT02210949|Iron suppletion|iron suppletion
5292922|NCT02210923|Baroreflex|baroreflex
5292923|NCT02210923|Electrical stimulation|electrical stimulation
5292924|NCT02210923|Carotid body|carotid body
5292925|NCT02210923|Chemoreceptors|chemoreceptors
5292926|NCT02210923|Resistant hypertension|resistant hypertension
5292927|NCT02210910|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff
5292928|NCT02210884|Vitamin D supplementation|vitamin d supplementation
5292929|NCT02210884|Lactation|lactation
5292930|NCT02210884|25 hydroxyvitamin D|25 hydroxyvitamin d
5292941|NCT02210819|Vascular Diseases|vascular diseases
5292942|NCT02210819|Cardiovascular Diseases|cardiovascular diseases
5292944|NCT02210806|Asthma|asthma
5292945|NCT02210806|Mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
5292946|NCT02210806|Mild asthma|mild asthma
5292947|NCT02210806|Moderate asthma|moderate asthma
5292948|NCT02210806|Persistent asthma|persistent asthma
5292949|NCT02210793|Transepithelial PRK|transepithelial prk
5292950|NCT02210793|Dry eye|dry eye
5292951|NCT02210793|Schirmer test|schirmer test
5292952|NCT02210793|Tear break up time|tear break up time
5292953|NCT02210793|Dry eye after advanced surface ablation technique|dry eye after advanced surface ablation technique
5292954|NCT02210754|Nicotine|nicotine
5292955|NCT02210754|Pharmacokinetics|pharmacokinetics
5292956|NCT02210754|Pharmacodynamics|pharmacodynamics
5292957|NCT02210754|blu e-cigs|blu e-cigs
5292958|NCT02210754|Tolerability|tolerability
5292959|NCT02210754|Safety|safety
5292960|NCT02210754|Smoke urge|smoke urge
5292961|NCT02210741|immune repertoire|immune repertoire
5292962|NCT02210741|Graves' disease|graves' disease
5292963|NCT02210728|cognitive behavioral therapy|cognitive behavioral therapy
5292964|NCT02210728|stimulant medication|stimulant medication
5292965|NCT02210728|efficacy|efficacy
5292966|NCT02210728|symptoms|symptoms
5292967|NCT02210728|functional outcomes|functional outcomes
5292968|NCT02210663|Breast cancer|breast cancer
5292969|NCT02210663|PARP|parp
5292970|NCT02210663|Primary peritoneal cancer|primary peritoneal cancer
5292971|NCT02210663|Fallopian tube|fallopian tube
5292972|NCT02210663|Ovarian cancer|ovarian cancer
5292973|NCT02210663|veliparib|veliparib
5292974|NCT02210663|ABT-888|abt-888
5292975|NCT02210663|BRCA|brca
5292976|NCT02210650|kidney stone|kidney stone
5292977|NCT02210637|Appointments and Schedules|appointments and schedules
5289830|NCT02224950|eczema|eczema
5292978|NCT02210637|Outpatient Clinics, Hospital/Economics|outpatient clinics, hospital/economics
5292979|NCT02210637|Emergency Department|emergency department
5292981|NCT02210637|Mortality|mortality
5292982|NCT02210624|Anoxic Brain Injury|anoxic brain injury
5292983|NCT02210624|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
5292984|NCT02210624|stoke|stoke
5292985|NCT02210598|labor, induced|labor, induced
5292986|NCT02210598|catheter|catheter
5292987|NCT02210598|oxytocin|oxytocin
5292988|NCT02210598|Cesarean section|cesarean section
5292989|NCT02210572|Intestinal microbiota|intestinal microbiota
5292990|NCT02210572|Intestinal gas|intestinal gas
5292991|NCT02210572|Dietary intervention|dietary intervention
5292992|NCT02210572|Low-FODMAPs diet|low-fodmaps diet
5292993|NCT02210572|Prebiotics|prebiotics
5292994|NCT02210559|locally|locally
5292995|NCT02210559|advanced|advanced
5292996|NCT02210559|pancreatic|pancreatic
5292997|NCT02210559|cancer|cancer
5292998|NCT02210559|unresectable|unresectable
5292999|NCT02210559|pancreatic cancer|pancreatic cancer
5293000|NCT02210546|breast cancer|breast cancer
5293001|NCT02210546|intermediate risk|intermediate risk
5293002|NCT02210507|vitamin A|vitamin a
5962991|NCT04277130|motor proficiency|motor proficiency
5962992|NCT04277117|Meals on Wheels|meals on wheels
5962993|NCT04277117|Aging in place|aging in place
5962994|NCT04277117|Homebound|homebound
5962995|NCT04277117|Chronic Disease|chronic disease
5962996|NCT04277117|Food Insecurity|food insecurity
5962997|NCT04277117|Food Delivery Program|food delivery program
5962998|NCT04277091|postprandial metabolism|postprandial metabolism
5962999|NCT04277065|Laproscopic hepatectomy|laproscopic hepatectomy
5963000|NCT04277065|Bulldog|bulldog
5963001|NCT04277065|Vascular occlusion|vascular occlusion
5963002|NCT04277052|Temporomandibular Joint Disorders|temporomandibular joint disorders
5963003|NCT04277052|Ultrasonography|ultrasonography
5174671|NCT02900352|Alcohol Use Disorder|alcohol use disorder
5174672|NCT02900352|Alcoholism|alcoholism
5174673|NCT02900352|Alcohol Dependence|alcohol dependence
5174674|NCT02900352|Zonisamide|zonisamide
5293003|NCT02210507|retinol|retinol
5293004|NCT02210507|carotenoids|carotenoids
5293005|NCT02210481|vitrectomy,|vitrectomy,
5293006|NCT02210481|macular thinning,|macular thinning,
5293007|NCT02210481|retinal detachment,|retinal detachment,
5293008|NCT02210481|epimacular membrane,|epimacular membrane,
5293009|NCT02210481|intravitreal glucose,|intravitreal glucose,
5293010|NCT02210481|OCT|oct
5293011|NCT02210468|Osteoarthritis|osteoarthritis
5293012|NCT02210468|Protease Inhibitors|protease inhibitors
5293013|NCT02210468|Alpha-2-macroglobulin|alpha-2-macroglobulin
5293014|NCT02210468|Autologous treatment|autologous treatment
5293015|NCT02210468|APIC-CF|apic-cf
5293016|NCT02210468|Pain due to Mild to Moderate osteoarthritis (OA) of the knee|pain due to mild to moderate osteoarthritis (oa) of the knee
5293017|NCT02210455|FASD|fasd
5293018|NCT02210455|pFAS|pfas
5293019|NCT02210455|ARND|arnd
5293020|NCT02210455|Fetal Alcohol Syndrome|fetal alcohol syndrome
5293021|NCT02210455|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
5293022|NCT02210455|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
5293023|NCT02210455|Static Encephalopathy (Alcohol Exposed)|static encephalopathy (alcohol exposed)
5293024|NCT02210455|Neurobehavioural Disorder (Alcohol Exposed)|neurobehavioural disorder (alcohol exposed)
5293025|NCT02210442|educational games|educational games
5293026|NCT02210442|clinical practice guideline|clinical practice guideline
5293027|NCT02210442|family medicine|family medicine
5293032|NCT02210429|Pediatric Anesthesia|pediatric anesthesia
5384701|NCT01791686|DDD|ddd
5293033|NCT02210429|Regional Anesthesia|regional anesthesia
5293034|NCT02210429|Supracondylar Elbow Fracture|supracondylar elbow fracture
5293035|NCT02210390|Psycho-education, Bipolar , cultural adaptation, Pakistan|psycho-education, bipolar , cultural adaptation, pakistan
5343004|NCT01981200|Muscle strength|muscle strength
5293036|NCT02210377|Auto-moxibusition, intra-dialytic hypotension, hemodialysis|auto-moxibusition, intra-dialytic hypotension, hemodialysis
5293037|NCT02210325|gonorrhea|gonorrhea
5293038|NCT02210325|chlamydia|chlamydia
5293039|NCT02210325|solithromycin|solithromycin
5293040|NCT02210299|Healthy young children (2-6 months ; 12-18 months)|healthy young children (2-6 months ; 12-18 months)
5293041|NCT02210286|dementia|dementia
5293042|NCT02210286|magnesium|magnesium
5293043|NCT02210286|learning|learning
5293044|NCT02210286|memory|memory
5293148|NCT02209766|Japanese|japanese
5293045|NCT02210286|Alzheimer's disease|alzheimer's disease
5293046|NCT02210273|Stress Urinary Incontinence|stress urinary incontinence
5293047|NCT02210273|SUI|sui
5293048|NCT02210260|Cancer|cancer
5293049|NCT02210260|Colorectal|colorectal
5293050|NCT02210260|Pain relief|pain relief
5293051|NCT02210234|wheat bran|wheat bran
5293052|NCT02210234|healthy immunity|healthy immunity
5293053|NCT02210234|T cells|t cells
5293054|NCT02210221|TBI|tbi
5293055|NCT02210195|Cannabis Treatment|cannabis treatment
5293056|NCT02210195|Alcohol Treatment|alcohol treatment
5293057|NCT02210195|Alcohol-Related Disorders|alcohol-related disorders
5293058|NCT02210195|Cannabis-Related Disorders|cannabis-related disorders
5293059|NCT02210195|Substance-Related Disorders|substance-related disorders
5293060|NCT02210195|Emend|emend
5293061|NCT02210195|NK1 receptor antagonist|nk1 receptor antagonist
5293062|NCT02210195|Alcohol|alcohol
5293063|NCT02210195|Cannabis|cannabis
5293064|NCT02210195|aprepitant|aprepitant
5293065|NCT02210182|Hepatocellular carcinoma|hepatocellular carcinoma
5293066|NCT02210182|Oral Pentamidine|oral pentamidine
5293067|NCT02210182|Endo-exonuclease|endo-exonuclease
5293068|NCT02210156|Respiratory tract infection|respiratory tract infection
5293069|NCT02210156|Incidence|incidence
5293070|NCT02210156|Dietary supplements|dietary supplements
5293071|NCT02210156|Micronutrients|micronutrients
5293072|NCT02210156|Plant extracts|plant extracts
5293073|NCT02210104|Melanoma|melanoma
5293074|NCT02210104|Sarcoma|sarcoma
5293075|NCT02210104|Mixed round cell liposarcoma|mixed round cell liposarcoma
5293079|NCT02210104|Ipilimumab|ipilimumab
5293080|NCT02210104|Yervoy|yervoy
5293081|NCT02210104|BMS-734016|bms-734016
5293082|NCT02210104|MDX010|mdx010
5293083|NCT02210104|Cyclophosphamide|cyclophosphamide
5293084|NCT02210104|Cytoxan|cytoxan
5293085|NCT02210104|Neosar|neosar
5293086|NCT02210104|CD4+T Cells|cd4+t cells
5293087|NCT02210065|Leukemia|leukemia
5293088|NCT02210065|Lymphoma|lymphoma
5293089|NCT02210065|Blood And Marrow Transplantation|blood and marrow transplantation
5293090|NCT02210065|Hematological malignancies|hematological malignancies
5293091|NCT02210065|Cytotoxic T cells|cytotoxic t cells
5293092|NCT02210065|CTL|ctl
5293093|NCT02210065|Cytomegalovirus|cytomegalovirus
5293094|NCT02210065|CMV|cmv
5293095|NCT02210065|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5293096|NCT02210065|HSCT|hsct
5963004|NCT04277052|Cross sectional|cross sectional
5963005|NCT04277039|osteopathic manipulative treatment|osteopathic manipulative treatment
5963006|NCT04277039|cognitive therapy|cognitive therapy
5963007|NCT04277039|chronic low back pain|chronic low back pain
5963008|NCT04277039|pain|pain
5293097|NCT02210052|radiofrequency ablation|radiofrequency ablation
5293098|NCT02210039|SECM|secm
5293099|NCT02210039|Esophagus|esophagus
5293100|NCT02210039|Imaging|imaging
5293101|NCT02210026|bubble nasal continuous positive airway pressure (Bn-CPAP)|bubble nasal continuous positive airway pressure (bn-cpap)
5293102|NCT02210026|work of breathing|work of breathing
5293103|NCT02210026|pressure-rate products|pressure-rate products
5293104|NCT02210013|AMH, AFC, aging, ethnicity|amh, afc, aging, ethnicity
5293105|NCT02210000|repeat dose|repeat dose
5293106|NCT02210000|phase II|phase ii
5293107|NCT02210000|GCSI-DD|gcsi-dd
5293108|NCT02210000|pharmacodynamics|pharmacodynamics
5293109|NCT02210000|gastroparesis|gastroparesis
5293110|NCT02210000|type 1 and type 2 diabetes mellitus|type 1 and type 2 diabetes mellitus
5293111|NCT02210000|camicinal|camicinal
5293112|NCT02210000|GSK962040|gsk962040
5293113|NCT02210000|symptoms|symptoms
5293114|NCT02210000|gut motility|gut motility
5293115|NCT02209974|emphysema|emphysema
5293116|NCT02209974|CRP|crp
5293117|NCT02209974|interleukin-8|interleukin-8
5293118|NCT02209974|dynamic hyperinflation|dynamic hyperinflation
5293119|NCT02209935|pediatric|pediatric
5293120|NCT02209935|acute neurologic disease|acute neurologic disease
5293121|NCT02209935|critical care|critical care
5293122|NCT02209935|rehabilitation|rehabilitation
5293124|NCT02209922|tDCS, stroke, postural control|tdcs, stroke, postural control
5293125|NCT02209909|preoperative aspirin use|preoperative aspirin use
5293126|NCT02209909|platelet activation|platelet activation
5293127|NCT02209909|off pump coronary artery bypass|off pump coronary artery bypass
5293128|NCT02209896|Peripheral Neuropathic Pain|peripheral neuropathic pain
5293129|NCT02209896|PNP|pnp
5293130|NCT02209883|sevoflurane, anesthesia, washout time,COPD|sevoflurane, anesthesia, washout time,copd
5293131|NCT02209870|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5293132|NCT02209870|Teamwork|teamwork
5293133|NCT02209870|electronic checklist|electronic checklist
5293134|NCT02209857|Breastcancer|breastcancer
5293136|NCT02209857|70-gene expression profile|70-gene expression profile
5293137|NCT02209857|MammaPrint|mammaprint
5293138|NCT02209818|Low level laser therapy|low level laser therapy
5293139|NCT02209818|Elastomeric separator|elastomeric separator
5293141|NCT02209818|Visual analog scale|visual analog scale
5293142|NCT02209818|Laser irradiation|laser irradiation
5293143|NCT02209766|Safety|safety
5293144|NCT02209766|Tolerability|tolerability
5293145|NCT02209766|Pharmacokinetics|pharmacokinetics
5293146|NCT02209766|Pharmacodynamics|pharmacodynamics
5293149|NCT02209766|Caucasian|caucasian
5293150|NCT02209740|renal toxicity, HIV, antiretroviral, outcome|renal toxicity, hiv, antiretroviral, outcome
5293151|NCT02209675|hepatitis C recurrence|hepatitis c recurrence
5293152|NCT02209675|Rejection|rejection
5293153|NCT02209675|Liver Transplantation|liver transplantation
5293154|NCT02209675|Liver biopsy|liver biopsy
5293155|NCT02209662|APIC-PRP|apic-prp
5293156|NCT02209662|Chronic Wounds|chronic wounds
5293157|NCT02209662|Diabetic foot ulcer|diabetic foot ulcer
5293158|NCT02209636|hyperphosphatemia|hyperphosphatemia
5293159|NCT02209636|vascular dysfunction|vascular dysfunction
5293160|NCT02209636|chronic kidney disease|chronic kidney disease
5293161|NCT02209636|cardiovascular disease|cardiovascular disease
5293162|NCT02209636|endothelial dysfunction|endothelial dysfunction
5293163|NCT02209610|Heart Failure|heart failure
5293164|NCT02209597|Major Depressive Disorder|major depressive disorder
5293166|NCT02209597|bupropion XL|bupropion xl
5293167|NCT02209597|Wellbutrin XL|wellbutrin xl
5293168|NCT02209571|Breath Tests|breath tests
5293170|NCT02209532|Lymph node mapping|lymph node mapping
5293171|NCT02209532|Endometrial cancer|endometrial cancer
5293172|NCT02209532|Uterine cancer|uterine cancer
5293173|NCT02209532|Cervical cancer|cervical cancer
5293174|NCT02209519|bacterial vaginosis|bacterial vaginosis
5293175|NCT02209519|recurrence|recurrence
5293176|NCT02209519|male partner|male partner
5293177|NCT02209506|MLN3126|mln3126
5293178|NCT02209493|Dietary intervention|dietary intervention
5293179|NCT02209493|Hypercholesterolemic adults|hypercholesterolemic adults
5293180|NCT02209493|Vegetable intake|vegetable intake
5293181|NCT02209493|Functional food|functional food
5293183|NCT02209467|walking|walking
5293184|NCT02209467|postural balance|postural balance
5293185|NCT02209467|falls|falls
5293186|NCT02209454|Dexketoprofen|dexketoprofen
5293187|NCT02209454|Bioavailability|bioavailability
5293188|NCT02209454|Comparative|comparative
5293189|NCT02209454|Pharmacokinetic|pharmacokinetic
5293190|NCT02209441|sorafenib, gastric cancer, FOLFOX4|sorafenib, gastric cancer, folfox4
5293191|NCT02209428|Temozolomide|temozolomide
5293192|NCT02209428|IDH mutation|idh mutation
5293193|NCT02209428|Low grade glioma|low grade glioma
5293194|NCT02209389|breast cancer|breast cancer
5293195|NCT02209389|cancer associated auto antibodies|cancer associated auto antibodies
5293196|NCT02209389|breast cancer blood test|breast cancer blood test
5293197|NCT02209363|Parkinson's disease|parkinson's disease
5293198|NCT02209363|OSA|osa
5293199|NCT02209363|CPAP|cpap
5293200|NCT02209363|cognition|cognition
5293201|NCT02209311|Alveolar Bone Loss|alveolar bone loss
5293202|NCT02209311|Alveolar Bone Atrophy|alveolar bone atrophy
5293203|NCT02209311|Dental Implantation|dental implantation
5293204|NCT02209311|Bone Tissue Reconstruction|bone tissue reconstruction
5293205|NCT02209311|Sinus Lift|sinus lift
5293206|NCT02209311|Autologous Multipotent Mesenchymal Stem Cell|autologous multipotent mesenchymal stem cell
5293207|NCT02209311|Autologous MMSCs|autologous mmscs
5293208|NCT02209311|Synthetic Tricalcium Phosphate|synthetic tricalcium phosphate
5293209|NCT02209311|Tissue Engineered Construction|tissue engineered construction
5293210|NCT02209311|Oral Mucosa|oral mucosa
5293211|NCT02209285|Older adults|older adults
5293212|NCT02209285|Home and community care|home and community care
5293213|NCT02209285|Effectiveness|effectiveness
5293214|NCT02209285|Cost analysis|cost analysis
5293215|NCT02209285|Pragmatic trial|pragmatic trial
5293216|NCT02209285|Self-management|self-management
5293217|NCT02209220|Obstructive sleep apnea|obstructive sleep apnea
5293218|NCT02209220|Treatment compliance|treatment compliance
5293219|NCT02209220|Automatic positive airway pressure|automatic positive airway pressure
5293220|NCT02209220|Continuous positive airway pressure|continuous positive airway pressure
5293221|NCT02209220|Bariatric surgery|bariatric surgery
5293222|NCT02209207|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5293223|NCT02209207|endurance training|endurance training
5293224|NCT02209207|interval training|interval training
5293225|NCT02209207|continuous training|continuous training
5293226|NCT02209207|walking training|walking training
5293227|NCT02209194|aneurysms|aneurysms
5293228|NCT02209194|vascular disease|vascular disease
5293229|NCT02209194|E-liac Stent Graft|e-liac stent graft
5293230|NCT02209194|E-liac Stent Graft System|e-liac stent graft system
5293231|NCT02209194|iliac aneurysm|iliac aneurysm
5293232|NCT02209194|branched stent graft|branched stent graft
5293233|NCT02209194|self expanding stent graft|self expanding stent graft
5293234|NCT02209181|dental pain|dental pain
5293235|NCT02209181|post-surgical dental pain|post-surgical dental pain
5293236|NCT02209168|AMH, ACF, VIT D, Ethnicity|amh, acf, vit d, ethnicity
5293237|NCT02209142|Major depression|major depression
5293238|NCT02209129|digital breast tomosynthesis|digital breast tomosynthesis
5293239|NCT02209116|ADHD|adhd
5293240|NCT02209116|QB Test|qb test
5293241|NCT02209116|Activity|activity
5293242|NCT02209116|Attention|attention
5293243|NCT02209116|Children|children
5188723|NCT02811133|inositol|inositol
5293244|NCT02209116|Clinical Decision Making|clinical decision making
5293245|NCT02209103|Polyphenols|polyphenols
5293246|NCT02209103|Orange|orange
5293247|NCT02209103|Sleep|sleep
5293248|NCT02209103|Fatigue|fatigue
5293249|NCT02209090|occiput-posterior|occiput-posterior
5293250|NCT02209090|occipitoposterior|occipitoposterior
5293251|NCT02209090|labour|labour
5293252|NCT02209064|Subxiphoid|subxiphoid
5293253|NCT02209064|Access|access
5293254|NCT02209051|Diabetic Foot Ulcers|diabetic foot ulcers
5293255|NCT02209051|AMNIOEXCEL|amnioexcel
5293256|NCT02209051|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
5293257|NCT02209051|Wound|wound
5293258|NCT02209051|Foot health|foot health
5293259|NCT02209051|Ulcer|ulcer
5293260|NCT02209051|Foot Ulcer|foot ulcer
5293261|NCT02209051|Diabetic Foot|diabetic foot
5293262|NCT02209051|Foot Diseases|foot diseases
5293263|NCT02209051|Skin Diseases|skin diseases
5293264|NCT02209051|Leg Ulcer|leg ulcer
5293265|NCT02209051|Skin Ulcer|skin ulcer
5293266|NCT02209051|Diabetic Angiopathies|diabetic angiopathies
5293267|NCT02209051|Vascular Diseases|vascular diseases
5293268|NCT02209051|Cardiovascular Diseases|cardiovascular diseases
5293269|NCT02209051|Diabetes Complications|diabetes complications
5293270|NCT02209051|Diabetes Mellitus|diabetes mellitus
5293271|NCT02209051|Endocrine System Diseases|endocrine system diseases
5293272|NCT02209051|Diabetic Neuropathies|diabetic neuropathies
5293273|NCT02209038|end stage renal disease|end stage renal disease
5293274|NCT02209038|hemodialysis|hemodialysis
5293275|NCT02209038|dialysis|dialysis
5293276|NCT02209025|Atherosclerosis|atherosclerosis
5293277|NCT02209025|Cholesterol|cholesterol
5293278|NCT02209025|Cholesterol, HDL|cholesterol, hdl
5293282|NCT02208999|medullary neurostimulation|medullary neurostimulation
5293283|NCT02208999|pain|pain
5293284|NCT02208999|Precision|precision
5293285|NCT02208999|rechargeable|rechargeable
5293286|NCT02208999|implantable|implantable
5293287|NCT02208986|GnRH antagonist|gnrh antagonist
5293288|NCT02208986|GnRH agonist trigger|gnrh agonist trigger
5293289|NCT02208986|Oocyte donor|oocyte donor
5293290|NCT02208973|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
5293291|NCT02208973|adenosine receptor modulator|adenosine receptor modulator
5293292|NCT02208973|Asthma|asthma
5293293|NCT02208973|COPD|copd
5293294|NCT02208960|Neurodevelopment|neurodevelopment
5293295|NCT02208960|Neonatal kit|neonatal kit
5293296|NCT02208960|Kenya|kenya
5293297|NCT02208960|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5293298|NCT02208960|Chlorhexidine|chlorhexidine
5293299|NCT02208960|ThermoSpot|thermospot
5293300|NCT02208947|advance care planning|advance care planning
5293301|NCT02208947|decision making|decision making
5293302|NCT02208947|patient engagement|patient engagement
5293303|NCT02208947|patient education|patient education
5293304|NCT02208947|financial incentives|financial incentives
5293305|NCT02208947|behavioral economics|behavioral economics
5293306|NCT02208934|PDE10 inhibitor|pde10 inhibitor
5293307|NCT02208934|Huntington's disease|huntington's disease
5293308|NCT02208934|phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
5293309|NCT02208934|psychiatric disorders|psychiatric disorders
5293310|NCT02208921|Type 2 Diabetes|type 2 diabetes
5293311|NCT02208908|Oral care|oral care
5293312|NCT02208908|cancer|cancer
5293313|NCT02208908|palliative|palliative
5293314|NCT02208908|training|training
5293315|NCT02208895|pleural|pleural
5293316|NCT02208895|glucose|glucose
5293317|NCT02208895|glucometer|glucometer
5293318|NCT02208895|i-STAT|i-stat
5293319|NCT02208869|familial hypercholesterolemia|familial hypercholesterolemia
5293320|NCT02208869|cholesterol|cholesterol
5293321|NCT02208869|prevention|prevention
5293322|NCT02208869|registry|registry
5293323|NCT02208869|atherosclerosis|atherosclerosis
5293324|NCT02208869|treatment|treatment
5293325|NCT02208869|prevalence|prevalence
5293326|NCT02208830|bronchiectasis|bronchiectasis
5293327|NCT02208830|functional capacity|functional capacity
5293328|NCT02208830|lung functional|lung functional
5293329|NCT02208817|capillary refill|capillary refill
5293330|NCT02208817|paediatric early warning score|paediatric early warning score
5293331|NCT02208817|photoplethysmography|photoplethysmography
5293332|NCT02208804|Colorectal Cancer Liver Metastases|colorectal cancer liver metastases
5293333|NCT02208791|Kidney Transplantation|kidney transplantation
5293334|NCT02208791|Graft Rejection|graft rejection
5293335|NCT02208791|Immunossupression|immunossupression
5293336|NCT02208778|Osteoarthritis|osteoarthritis
5293337|NCT02208778|Chronic Pain|chronic pain
5293338|NCT02208778|Pain relief|pain relief
5293339|NCT02208765|Coronary Circulation|coronary circulation
5293340|NCT02208765|Coronary Artery Disease|coronary artery disease
5293341|NCT02208765|Myocardial perfusion imaging|myocardial perfusion imaging
5293342|NCT02208765|Prognosis|prognosis
5293343|NCT02208752|rotator cuff tears|rotator cuff tears
5293344|NCT02208752|ultrasound measure|ultrasound measure
5293345|NCT02208752|pain|pain
5293346|NCT02208752|range of motion|range of motion
5293347|NCT02208752|muscle force|muscle force
5293348|NCT02208739|Chronic periodontitis|chronic periodontitis
5293349|NCT02208739|periodontal pathogens|periodontal pathogens
5293350|NCT02208739|inflammatory mediators|inflammatory mediators
5293351|NCT02208739|Non surgical periodontal therapy|non surgical periodontal therapy
5293352|NCT02208739|Oral hygiene instructions|oral hygiene instructions
5293353|NCT02208739|Polymerase chain reaction|polymerase chain reaction
5293354|NCT02208739|Elisa|elisa
5293355|NCT02208726|anxiety|anxiety
5293356|NCT02208726|students|students
5293357|NCT02208726|examinations|examinations
5293358|NCT02208726|Homeopathy|homeopathy
5293359|NCT02208713|FSHD muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection|fshd muscle derived stem cell adipose derived mesenchymal stem cell intramuscular injection
5293360|NCT02208687|Social Participation|social participation
5293361|NCT02208687|Fatigue|fatigue
5293362|NCT02208687|Self-Management|self-management
5293363|NCT02208687|Rehabilitation|rehabilitation
5293364|NCT02208687|Physical therapy|physical therapy
5293365|NCT02208687|Occupational therapy|occupational therapy
5293366|NCT02208687|Group intervention|group intervention
5293367|NCT02208687|Exercise|exercise
5293368|NCT02208674|chronic kidney disease|chronic kidney disease
5293369|NCT02208674|albuminuria|albuminuria
5293370|NCT02208674|hypertension|hypertension
5293371|NCT02208674|dyslipidemia|dyslipidemia
5293372|NCT02208674|cardiovascular disease|cardiovascular disease
5293373|NCT02208674|pragmatic trial|pragmatic trial
5290243|NCT02223169|Cardiovascular disease|cardiovascular disease
5293379|NCT02208648|Computed Tomography|computed tomography
5293380|NCT02208648|Coronary artery calcium|coronary artery calcium
5293381|NCT02208648|calcium scores|calcium scores
5293382|NCT02208648|post-operative mortality|post-operative mortality
5293383|NCT02208635|Zinc Absorption|zinc absorption
5293384|NCT02208635|Biofortification|biofortification
5293386|NCT02208635|Zambia|zambia
5293387|NCT02208635|Stable isotopes of Zn|stable isotopes of zn
5293388|NCT02208622|Zinc absorption|zinc absorption
5293389|NCT02208622|Iron Absorption|iron absorption
5293390|NCT02208622|Whey Protein|whey protein
5293391|NCT02208622|Mexico|mexico
5293392|NCT02208622|Stable isotopes|stable isotopes
5293393|NCT02208609|Zinc Absorption|zinc absorption
5293394|NCT02208609|Maize|maize
5293395|NCT02208609|Amaranth|amaranth
5293396|NCT02208609|Guatemala|guatemala
5293397|NCT02208609|Stable isotopes of Zn|stable isotopes of zn
5293398|NCT02208583|Molecular phenotypic；CRPC; personalized treatment|molecular phenotypic；crpc; personalized treatment
5293399|NCT02208570|Hypotension during anesthesia induction|hypotension during anesthesia induction
5293400|NCT02208557|Incisional hernia|incisional hernia
5293401|NCT02208557|prevention|prevention
5293402|NCT02208557|laparotomy closure|laparotomy closure
5293403|NCT02208557|absorbable mesh|absorbable mesh
5293404|NCT02208544|Thyroid Nodule|thyroid nodule
5293405|NCT02208544|Indeterminate Cytology|indeterminate cytology
5293406|NCT02208544|FDG-PET/CT|fdg-pet/ct
5293407|NCT02208544|Diagnostic Thyroid Surgery|diagnostic thyroid surgery
5293408|NCT02208544|Efficacy|efficacy
5293409|NCT02208544|Cost-Effectiveness|cost-effectiveness
5293410|NCT02208544|Quality-of-Life|quality-of-life
5293411|NCT02208544|Thyroidectomy|thyroidectomy
5293412|NCT02208531|Early Childhood Development (ECD)|early childhood development (ecd)
5293413|NCT02208531|Psychosocial stimulation|psychosocial stimulation
5293414|NCT02208531|Malnutrition|malnutrition
5293415|NCT02208531|Bangladesh|bangladesh
5293416|NCT02208531|Scaling up ECD|scaling up ecd
5293417|NCT02208518|Endoscopic Ultrasound elastography|endoscopic ultrasound elastography
5293418|NCT02208518|Quantitative elastography|quantitative elastography
5293419|NCT02208518|Qualitative elastography|qualitative elastography
5293420|NCT02208518|Endoscopic Ultrasound|endoscopic ultrasound
5293421|NCT02208518|Elastography|elastography
5293425|NCT02208479|mechanical ventilation weaning|mechanical ventilation weaning
5293426|NCT02208479|respiratory paralysis|respiratory paralysis
5293427|NCT02208479|muscle weakness|muscle weakness
5293428|NCT02208479|cardiac bypass|cardiac bypass
5293429|NCT02208479|valvular surgery|valvular surgery
5293430|NCT02208479|respiratory insufficiency|respiratory insufficiency
5293431|NCT02208466|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5293432|NCT02208466|rTMS|rtms
5293434|NCT02208466|fluoxetine|fluoxetine
5293435|NCT02208453|Massive Rotator Cuff Tear|massive rotator cuff tear
5293436|NCT02208453|Local anesthesia|local anesthesia
5293437|NCT02208453|Sub-acromial spacer|sub-acromial spacer
5293438|NCT02208440|Full-thickness/Massive Rotator Cuff Tear, Sub-acromial spacer|full-thickness/massive rotator cuff tear, sub-acromial spacer
5293439|NCT02208427|isoniazid, LTBI, rifapentine, TST|isoniazid, ltbi, rifapentine, tst
5293440|NCT02208414|Food Allergies|food allergies
5293441|NCT02208388|Computed tomography perfusion|computed tomography perfusion
5293443|NCT02208362|chimeric antigen receptor|chimeric antigen receptor
5293445|NCT02208349|intubation, laryngoscopy, prehospital, emergency medical services|intubation, laryngoscopy, prehospital, emergency medical services
5293446|NCT02208323|Hypoxia|hypoxia
5293447|NCT02208323|Respiratory Distress|respiratory distress
5293448|NCT02208310|Crohn's disease|crohn's disease
5293449|NCT02208310|Vitamin D deficiency|vitamin d deficiency
5293450|NCT02208284|Single Ascending Dose|single ascending dose
5293451|NCT02208284|healthy subjects|healthy subjects
5293452|NCT02208284|Hyperlipidemia|hyperlipidemia
5293453|NCT02208284|Lipid Metabolism Disorders|lipid metabolism disorders
5293454|NCT02208284|Metabolic Diseases|metabolic diseases
5293455|NCT02208271|tissue necrosis|tissue necrosis
5293456|NCT02208271|metal on metal total hip|metal on metal total hip
5293457|NCT02208271|biomarker|biomarker
5293458|NCT02208258|fecal incontinence, consure medical, semi formed stool, stool management system|fecal incontinence, consure medical, semi formed stool, stool management system
5293459|NCT02208232|IOL rotation|iol rotation
5293460|NCT02208219|Stroke|stroke
5293461|NCT02208219|Paresis|paresis
5293462|NCT02208219|Upper extremity|upper extremity
5293463|NCT02208219|Motor deficits|motor deficits
5293464|NCT02208219|Music Therapy|music therapy
5290349|NCT02222740|Safety|safety
5293472|NCT02208206|Breast cancer|breast cancer
5293473|NCT02208206|Genomics|genomics
5293474|NCT02208206|Quantitative sensory testing|quantitative sensory testing
5293475|NCT02208193|Alzheimer disease Art Healing gardens Discourse analysis|alzheimer disease art healing gardens discourse analysis
5293476|NCT02208180|Return of results|return of results
5293477|NCT02208180|Genomics|genomics
5293478|NCT02208167|Antigen Expanded Specific T Cell Therapy|antigen expanded specific t cell therapy
5293479|NCT02208167|HXTC|hxtc
5293480|NCT02208167|Antiretroviral Therapy|antiretroviral therapy
5293481|NCT02208167|Acute HIV infection|acute hiv infection
5293482|NCT02208167|Chronic HIV infection|chronic hiv infection
5293483|NCT02208167|Leukapheresis|leukapheresis
5293484|NCT02208154|ICU acquired bacteraemia|icu acquired bacteraemia
5293485|NCT02208154|colonization|colonization
5293486|NCT02208154|decolonization|decolonization
5293487|NCT02208154|selective decontamination|selective decontamination
5293488|NCT02208154|multidrug resistant bacteria|multidrug resistant bacteria
5293489|NCT02208141|children|children
5293490|NCT02208141|obesity|obesity
5293491|NCT02208141|adipose tissue dysfunction|adipose tissue dysfunction
5293492|NCT02208141|inflammation|inflammation
5293493|NCT02208141|macrophage infiltration|macrophage infiltration
5293494|NCT02208141|insulin resistance|insulin resistance
5293495|NCT02208141|dyslipidemia|dyslipidemia
5293496|NCT02208128|Renal cell carcinoma|renal cell carcinoma
5293497|NCT02208128|Biomarkers|biomarkers
5293498|NCT02208128|Molecular modifications|molecular modifications
5293499|NCT02208115|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5293500|NCT02208115|Exercise|exercise
5293501|NCT02208115|Appetite|appetite
5293502|NCT02208102|atrial fibrillation, catheter ablation, blood-biomarkers|atrial fibrillation, catheter ablation, blood-biomarkers
5293503|NCT02208089|Keratoconus|keratoconus
5293504|NCT02208089|Corneal collagen cross-linking|corneal collagen cross-linking
5963009|NCT04277039|disability|disability
5293505|NCT02208089|Photorefractive keratectomy|photorefractive keratectomy
5293506|NCT02208076|Growth disorders|growth disorders
5293507|NCT02208076|Saizen|saizen
5293508|NCT02208076|Easypod|easypod
5293509|NCT02208076|Growth hormone|growth hormone
5293510|NCT02208076|Pediatric subject|pediatric subject
5293513|NCT02208050|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5298232|NCT02187029|gout|gout
5293514|NCT02208050|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5293515|NCT02208050|Multiple Sclerosis|multiple sclerosis
5293516|NCT02208050|Upper limb function|upper limb function
5293518|NCT02208050|Fampridine|fampridine
5293519|NCT02208050|DASH|dash
5293520|NCT02208050|AMSQ|amsq
5293521|NCT02208050|MSWS-12|msws-12
5293522|NCT02208050|MSIS-29|msis-29
5293523|NCT02208050|SF-36|sf-36
5293524|NCT02208050|9HPT|9hpt
5293525|NCT02208050|25FTW|25ftw
5293526|NCT02208050|JTT|jtt
5293527|NCT02208037|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5293528|NCT02208037|Acute Myelogenous Leukemia|acute myelogenous leukemia
5293529|NCT02208037|Mantel-Cell Lymphoma|mantel-cell lymphoma
5293530|NCT02208037|Hematopoietic Transplant|hematopoietic transplant
5293531|NCT02208037|GVHD Prophylaxis|gvhd prophylaxis
5293532|NCT02207998|osteoarthritis, physiotherapy, homeopathy, complex|osteoarthritis, physiotherapy, homeopathy, complex
5293533|NCT02207985|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5293534|NCT02207985|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5293535|NCT02207972|Pregnant|pregnant
5293536|NCT02207972|labor|labor
5293539|NCT02207959|Neoplasia|neoplasia
5293540|NCT02207959|Endoscopic imaging|endoscopic imaging
5293541|NCT02207959|In vivo imaging|in vivo imaging
5293542|NCT02207933|anterioposterior|anterioposterior
5293543|NCT02207933|weight|weight
5293544|NCT02207933|shifting|shifting
5293545|NCT02207933|training|training
5293546|NCT02207933|patient|patient
5293547|NCT02207894|Haemophilia A, factor VIII, development of inhibitor|haemophilia a, factor viii, development of inhibitor
5293548|NCT02207881|herpes labialis|herpes labialis
5293549|NCT02207881|cold sore|cold sore
5293550|NCT02207829|COPD|copd
5293551|NCT02207829|inhaler critical errors|inhaler critical errors
5293552|NCT02207829|double-dummy|double-dummy
5293553|NCT02207829|novel dry powder inhaler|novel dry powder inhaler
5293554|NCT02207829|inhaler preference|inhaler preference
5293555|NCT02207829|tiotropium|tiotropium
5293556|NCT02207829|umeclidinium|umeclidinium
5293557|NCT02207829|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5293558|NCT02207816|Infants|infants
5293559|NCT02207816|Efficacy|efficacy
5293560|NCT02207816|Children|children
5293561|NCT02207816|Malaria|malaria
5293563|NCT02207816|Safety|safety
5293564|NCT02207816|Surveillance|surveillance
5293565|NCT02207816|Immunogenicity|immunogenicity
5293566|NCT02207816|RTS,S/AS01E|rts,s/as01e
5293567|NCT02207816|Africa|africa
5293568|NCT02207803|Brain Injuries|brain injuries
5293569|NCT02207803|Caregivers|caregivers
5293570|NCT02207803|Intervention Studies|intervention studies
5293571|NCT02207803|Latin America|latin america
5293572|NCT02207790|Clinical Trial, Phase I|clinical trial, phase i
5293573|NCT02207790|Healthy Volunteers|healthy volunteers
5293574|NCT02207777|Obesity|obesity
5293575|NCT02207777|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
5293576|NCT02207777|Type 2 Diabetes|type 2 diabetes
5293577|NCT02207777|Weight Loss|weight loss
5293578|NCT02207777|Low-Calorie Diet|low-calorie diet
5293579|NCT02207751|Chronic Kidney Disease|chronic kidney disease
5293580|NCT02207751|Peritoneal Dialysis Access|peritoneal dialysis access
5293581|NCT02207751|Peritoneal Dialysis Catheter|peritoneal dialysis catheter
5293582|NCT02207751|Catheter Function|catheter function
5293583|NCT02207738|acne|acne
5293584|NCT02207738|acne scar|acne scar
5293585|NCT02207738|microneedling radiofrequency|microneedling radiofrequency
5293586|NCT02207738|bipolar radiofrequency|bipolar radiofrequency
5293587|NCT02207725|Andexanet alpha|andexanet alpha
5293588|NCT02207725|Anticoagulation|anticoagulation
5293589|NCT02207725|Antidote|antidote
5293590|NCT02207725|Apixaban|apixaban
5293591|NCT02207725|Anti-fXa inhibitor|anti-fxa inhibitor
5293592|NCT02207725|PRT4445|prt4445
5293593|NCT02207725|Eliquis|eliquis
5293594|NCT02207725|Reversal agent|reversal agent
5293595|NCT02207712|Diabetes|diabetes
5293596|NCT02207712|Macular Oedema|macular oedema
5293597|NCT02207712|Diabetic retinopathy|diabetic retinopathy
5293598|NCT02207712|Noctura|noctura
5293599|NCT02207686|CNS hemangioblastoma|cns hemangioblastoma
5293600|NCT02207686|Renal Cell Carcinoma|renal cell carcinoma
5293601|NCT02207686|VHL germline mutation|vhl germline mutation
5293602|NCT02207686|VHL somatic mutation|vhl somatic mutation
5293603|NCT02207686|Tumor development|tumor development
5293604|NCT02207673|epilepsy surgery|epilepsy surgery
5293605|NCT02207673|biomarker|biomarker
5293606|NCT02207673|high frequency oscillations (HFOs)|high frequency oscillations (hfos)
5293607|NCT02207673|acute electrocorticography (aECoG)|acute electrocorticography (aecog)
5293608|NCT02207660|cisplatin|cisplatin
5293609|NCT02207660|Cervical cancer|cervical cancer
5293610|NCT02207660|metastasis|metastasis
5293611|NCT02207660|recurrence|recurrence
5293612|NCT02207634|High cholesterol|high cholesterol
5293613|NCT02207634|Treatment for high cholesterol|treatment for high cholesterol
5293614|NCT02207634|Lowering cholesterol|lowering cholesterol
5293615|NCT02207634|Lowering high cholesterol|lowering high cholesterol
5293616|NCT02207634|Hypercholesterolemia|hypercholesterolemia
5293619|NCT02207608|hyaluronic acid|hyaluronic acid
5293620|NCT02207608|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5293621|NCT02207608|non bacterial cystitis|non bacterial cystitis
5293622|NCT02207582|depression; trns|depression; trns
5293623|NCT02207556|AL amyloidosis|al amyloidosis
5293624|NCT02207556|amyloidosis|amyloidosis
5293625|NCT02207556|light chain amyloidosis|light chain amyloidosis
5293626|NCT02207543|Cancer|cancer
5293627|NCT02207543|Palliative care|palliative care
5293630|NCT02207517|convergence insufficiency|convergence insufficiency
5293631|NCT02207517|vision therapy|vision therapy
5293632|NCT02207517|reading|reading
5293633|NCT02207517|attention|attention
5293634|NCT02207504|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5293635|NCT02207491|Glaucoma|glaucoma
5293636|NCT02207478|Electromagnetic navigation bronchoscopy with a guide sheath|electromagnetic navigation bronchoscopy with a guide sheath
5293639|NCT02207478|Solitary pulmonary nodule|solitary pulmonary nodule
5293640|NCT02207452|Hyperpolarised helium-3|hyperpolarised helium-3
5293641|NCT02207452|Lung Imaging|lung imaging
5293642|NCT02207452|Magnetic Resonance Imaging|magnetic resonance imaging
5293643|NCT02207426|Healthy volunteers|healthy volunteers
5293644|NCT02207413|Quadrivalent influenza vaccine|quadrivalent influenza vaccine
5293645|NCT02207413|Safety|safety
5293646|NCT02207413|Children|children
5293647|NCT02207413|Adults|adults
5293648|NCT02207413|Immunogenicity|immunogenicity
5293649|NCT02207322|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5293650|NCT02207322|autologous stem cell transplant|autologous stem cell transplant
5293651|NCT02207322|allogeneic stem cell transplant|allogeneic stem cell transplant
5293652|NCT02207309|high-risk soft tissue sarcoma|high-risk soft tissue sarcoma
5293653|NCT02207309|pazopanib|pazopanib
5293654|NCT02207309|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
5293655|NCT02207309|visceral soft tissue sarcoma|visceral soft tissue sarcoma
5293656|NCT02207309|votrient|votrient
5293657|NCT02207270|Coronary artery disease|coronary artery disease
5293658|NCT02207270|Costs|costs
5293659|NCT02207270|Cost minimization|cost minimization
5293660|NCT02207270|Percutaneous coronary intervention|percutaneous coronary intervention
5293661|NCT02207270|Risk score|risk score
5293662|NCT02207270|Same day discharge|same day discharge
5293664|NCT02207257|anticoagulation reversal|anticoagulation reversal
5293665|NCT02207257|pharmacokinetics|pharmacokinetics
5293666|NCT02207257|edoxaban|edoxaban
5293667|NCT02207257|whole blood clotting time|whole blood clotting time
5293668|NCT02207257|D-dimer|d-dimer
5293669|NCT02207257|prothrombin fragments 1 and 2|prothrombin fragments 1 and 2
5293670|NCT02207257|tissue factor pathway inhibitor|tissue factor pathway inhibitor
5293671|NCT02207257|prothrombin time|prothrombin time
5293672|NCT02207244|Psoriasis|psoriasis
5293673|NCT02207244|Plaque-type psoriasis|plaque-type psoriasis
5293674|NCT02207244|Guselkumab|guselkumab
5293675|NCT02207244|Adalimumab|adalimumab
5293676|NCT02207244|CNTO 1959|cnto 1959
5293677|NCT02207244|Monoclonal antibody|monoclonal antibody
5293678|NCT02207231|Psoriasis|psoriasis
5293679|NCT02207231|Plaque-type psoriasis|plaque-type psoriasis
5293680|NCT02207231|Guselkumab|guselkumab
5293681|NCT02207231|Adalimumab|adalimumab
5293682|NCT02207231|CNTO 1959|cnto 1959
5293683|NCT02207231|Monoclonal antibody|monoclonal antibody
5293684|NCT02207192|obesity, lung volumes, postural changes|obesity, lung volumes, postural changes
5293685|NCT02207179|Intraoperative|intraoperative
5293686|NCT02207179|Cancer margin|cancer margin
5293687|NCT02207179|Spectroscopy|spectroscopy
5293688|NCT02207179|Polarization|polarization
5293689|NCT02207166|hypertension|hypertension
5293690|NCT02207166|device|device
5293691|NCT02207166|errors|errors
5293692|NCT02207166|human factor engineering|human factor engineering
5293693|NCT02207166|usability engineering|usability engineering
5293694|NCT02207153|Chronic Hemodialysis|chronic hemodialysis
5293695|NCT02207153|Chronic Peritoneal Dialysis|chronic peritoneal dialysis
5293696|NCT02207127|obstructive sleep apnea|obstructive sleep apnea
5293697|NCT02207127|sleep apnea|sleep apnea
5293698|NCT02207114|Sepsis|sepsis
5293699|NCT02207114|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5293700|NCT02207114|Antibiotic use|antibiotic use
5293701|NCT02207114|Intensive Care Unit|intensive care unit
5293702|NCT02207101|Young athletes|young athletes
5293703|NCT02207101|Cardiac endurance|cardiac endurance
5293704|NCT02207101|Herbal|herbal
5293705|NCT02207101|Ejection Fraction|ejection fraction
5293706|NCT02207101|Basic Research|basic research
5293707|NCT02207101|Cardiovascular Injury|cardiovascular injury
5293708|NCT02207088|Chronic Hepatitis C|chronic hepatitis c
5293709|NCT02207088|Hepatitis C|hepatitis c
5293710|NCT02207088|End-stage renal disease|end-stage renal disease
5293711|NCT02207088|Hepatitis C Genotype 1|hepatitis c genotype 1
5293712|NCT02207088|Severe Renal Impairment|severe renal impairment
5293713|NCT02207088|renal disease|renal disease
5293714|NCT02207088|Compensated Cirrhosis|compensated cirrhosis
5293718|NCT02207088|cirrhosis|cirrhosis
5293722|NCT02207036|Tobacco|tobacco
5293723|NCT02207036|cigarettes|cigarettes
5293724|NCT02207036|cessation|cessation
5293725|NCT02207036|intervention|intervention
5293726|NCT02207036|young adults|young adults
5293728|NCT02207036|social media|social media
5293729|NCT02207036|mobile health|mobile health
5293730|NCT02207023|Stroke|stroke
5293731|NCT02207023|Telehealth|telehealth
5293732|NCT02207023|Rehabilitation|rehabilitation
5385564|NCT01787565|low|low
5293733|NCT02207023|Stroke Coach|stroke coach
5293734|NCT02207023|Randomized controlled trial|randomized controlled trial
5293932|NCT02205983|volunteers|volunteers
5293735|NCT02207023|Lifestyle behaviours|lifestyle behaviours
5293736|NCT02207023|Secondary prevention|secondary prevention
5293737|NCT02207023|Chronic disease self-management|chronic disease self-management
5293738|NCT02207010|Glioblastoma|glioblastoma
5293739|NCT02207010|GBM|gbm
5293740|NCT02207010|first recurrence|first recurrence
5293741|NCT02206997|perioperative hypothermia|perioperative hypothermia
5293742|NCT02206997|prewarming|prewarming
5293743|NCT02206997|treatment guideline|treatment guideline
5293744|NCT02206958|Toileting disability|toileting disability
5293745|NCT02206958|Functional urinary incontinence|functional urinary incontinence
5293746|NCT02206958|Urinary incontinence|urinary incontinence
5293747|NCT02206958|Frailty|frailty
5293748|NCT02206958|Physical activity|physical activity
5293749|NCT02206932|Hepatitis C|hepatitis c
5293750|NCT02206932|HIV|hiv
5293751|NCT02206932|Simeprevir|simeprevir
5293752|NCT02206932|Sofosbuvir|sofosbuvir
5293753|NCT02206919|Flow mediated dilation|flow mediated dilation
5293754|NCT02206919|Magnetic Resonance Imaging MRI|magnetic resonance imaging mri
5293755|NCT02206919|Diabetes|diabetes
5293756|NCT02206919|Endothelial dysfunction|endothelial dysfunction
5293757|NCT02206919|Popliteal artery|popliteal artery
5293758|NCT02206919|Atherosclerosis|atherosclerosis
5293759|NCT02206919|Cardiovascular disease|cardiovascular disease
5293760|NCT02206919|Vascular disease|vascular disease
5293761|NCT02206906|Medication Adherence|medication adherence
5293762|NCT02206906|Incentives|incentives
5293763|NCT02206906|Real-time Medication Monitoring|real-time medication monitoring
5293764|NCT02206880|Thoracic Surgery|thoracic surgery
5293765|NCT02206880|Delirium|delirium
5293766|NCT02206880|Cardiopulmonary Bypass|cardiopulmonary bypass
5293767|NCT02206880|Intensive Care|intensive care
5293768|NCT02206854|Pharmakokinetic|pharmakokinetic
5293769|NCT02206854|capsules|capsules
5293770|NCT02206854|R-Flurbiprofen|r-flurbiprofen
5293771|NCT02206841|fibrosis|fibrosis
5293772|NCT02206841|markers|markers
5293773|NCT02206828|HERNIA|hernia
5293774|NCT02206828|SYMCHRO|symchro
5293775|NCT02206828|SOFRADIM|sofradim
5293776|NCT02206828|REGISTRY|registry
5293777|NCT02206828|SYMBOTEX|symbotex
5293778|NCT02206802|Alopecia|alopecia
5293779|NCT02206802|Androgenetic Alopecia|androgenetic alopecia
5293780|NCT02206802|Female Pattern Hair Loss|female pattern hair loss
5293781|NCT02206802|Hair Loss|hair loss
5293782|NCT02206802|Minoxidil|minoxidil
5293783|NCT02206802|Hair Thinning|hair thinning
5293785|NCT02206750|Controlled Human exposure study|controlled human exposure study
5293786|NCT02206750|Air Pollution|air pollution
5293787|NCT02206750|Cardiovascular|cardiovascular
5293788|NCT02206750|Social factors|social factors
5293789|NCT02206750|Cognitive function|cognitive function
5293790|NCT02206724|Metastatic prostate cancer|metastatic prostate cancer
5293791|NCT02206698|Intraabdominal Injury|intraabdominal injury
5293792|NCT02206698|CT Abdomen and Pelvis|ct abdomen and pelvis
5293793|NCT02206698|Pediatric trauma|pediatric trauma
5293794|NCT02206698|blunt abdominal injury|blunt abdominal injury
5293795|NCT02206698|blunt trauma|blunt trauma
5293796|NCT02206698|clinical prediction model|clinical prediction model
5293797|NCT02206633|dehydration|dehydration
5293798|NCT02206607|Phase 1|phase 1
5293799|NCT02206607|bioavailability|bioavailability
5293800|NCT02206607|type 2 diabetes mellitus|type 2 diabetes mellitus
5293801|NCT02206607|PF-04937319|pf-04937319
5293802|NCT02206581|dehydration|dehydration
5293803|NCT02206568|diabetes mellitus|diabetes mellitus
5293804|NCT02206568|phase 1|phase 1
5293805|NCT02206568|insulin lispro|insulin lispro
5293806|NCT02206568|male subjects|male subjects
5293807|NCT02206555|HIV|hiv
5293808|NCT02206555|prevention|prevention
5293809|NCT02206555|prophylaxis|prophylaxis
5293810|NCT02206555|antiretroviral|antiretroviral
5293811|NCT02206555|biomedical|biomedical
5293812|NCT02206555|bio-behavioural|bio-behavioural
5293813|NCT02206555|evaluation|evaluation
5293814|NCT02206555|demonstration study|demonstration study
5293815|NCT02206542|acupuncture,frozen shoulder,robot,sonography,MRI|acupuncture,frozen shoulder,robot,sonography,mri
5293816|NCT02206529|obesity|obesity
5293817|NCT02206529|child|child
5963010|NCT04277013|Anaesthesia|anaesthesia
5293818|NCT02206529|weight management|weight management
5293829|NCT02206490|naltrexone|naltrexone
5293830|NCT02206477|breast capsular contructure|breast capsular contructure
5293831|NCT02206477|dimethyl sulfoxide|dimethyl sulfoxide
5293832|NCT02206477|radiotherapy|radiotherapy
5293833|NCT02206477|breast reconstruction|breast reconstruction
5293834|NCT02206464|A/Anhui/1/2013 (H7N9)|a/anhui/1/2013 (h7n9)
5293835|NCT02206464|Antibody Response|antibody response
5293836|NCT02206464|Avian Influenza|avian influenza
5293933|NCT02205970|TENS|tens
5293837|NCT02206464|A/Shanghai/2/2013 (H7N9)|a/shanghai/2/2013 (h7n9)
5293838|NCT02206464|Immunogenicity|immunogenicity
5293839|NCT02206451|Assay|assay
5293840|NCT02206451|Infection|infection
5293842|NCT02206451|Midgut|midgut
5293843|NCT02206451|Parasite|parasite
5293844|NCT02206438|supraglottic airway devices|supraglottic airway devices
5293845|NCT02206438|the classic laryngeal mask airway|the classic laryngeal mask airway
5293846|NCT02206438|the self-pressurised air-Q intubating laryngeal airway in adult patients|the self-pressurised air-q intubating laryngeal airway in adult patients
5293847|NCT02206438|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway in adult patients
5293848|NCT02206425|multiple myeloma|multiple myeloma
5293849|NCT02206425|Relapsed/refractory|relapsed/refractory
5293850|NCT02206425|Ixazomib|ixazomib
5293851|NCT02206425|Proteasome inhibitor|proteasome inhibitor
5293852|NCT02206425|Oral|oral
5293853|NCT02206412|high mobility group box 1|high mobility group box 1
5293854|NCT02206412|prognostic biomarker|prognostic biomarker
5445392|NCT01522001|Acute Coronary Syndrome|acute coronary syndrome
5293855|NCT02206412|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
5293856|NCT02206412|patients|patients
5293857|NCT02206373|creatinine|creatinine
5293858|NCT02206373|glomerular filtration rate|glomerular filtration rate
5293859|NCT02206373|renal insufficiency, chronic|renal insufficiency, chronic
5293860|NCT02206360|Pancreatic Cancer|pancreatic cancer
5293861|NCT02206360|Pancreatic Cancer Screening|pancreatic cancer screening
5293862|NCT02206360|Pancreas Cancer|pancreas cancer
5293863|NCT02206360|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5293864|NCT02206360|Pancreatic Adenocarcinoma screening|pancreatic adenocarcinoma screening
5293865|NCT02206360|Familial Pancreatic Cancer|familial pancreatic cancer
5293866|NCT02206360|BRCA 1/2|brca 1/2
5293867|NCT02206360|HNPCC|hnpcc
5293868|NCT02206360|Lynch Syndrome|lynch syndrome
5293869|NCT02206360|Hereditary Pancreatitis|hereditary pancreatitis
5293870|NCT02206360|FAMMM|fammm
5293871|NCT02206360|Familial atypical multiple mole melanoma|familial atypical multiple mole melanoma
5293872|NCT02206360|Peutz Jeghers Syndrome|peutz jeghers syndrome
5293874|NCT02206360|Magnetic Resonance Imaging|magnetic resonance imaging
5293875|NCT02206360|EUS|eus
5293876|NCT02206360|Endoscopic Ultrasound|endoscopic ultrasound
5293877|NCT02206360|Early detection|early detection
5293878|NCT02206360|Screening|screening
5293879|NCT02206308|Chimeric anti-CD20 monoclonal antibody(SCT400)|chimeric anti-cd20 monoclonal antibody(sct400)
5293880|NCT02206308|escalating doses|escalating doses
5293881|NCT02206308|safety|safety
5293882|NCT02206308|pharmacokinetics and pharmacodynamics|pharmacokinetics and pharmacodynamics
5293883|NCT02206295|selexipag|selexipag
5293884|NCT02206295|ACT-333679|act-333679
5293885|NCT02206243|Benign prostatic hyperplasia|benign prostatic hyperplasia
5293886|NCT02206243|BPH|bph
5293887|NCT02206230|glioblastoma|glioblastoma
5293888|NCT02206230|radiotherapy|radiotherapy
5293889|NCT02206230|hypofractionated radiotherapy|hypofractionated radiotherapy
5293890|NCT02206204|Selexipag|selexipag
5293891|NCT02206204|ACT-333679|act-333679
5293892|NCT02206152|Diabetes|diabetes
5293893|NCT02206152|Hypoglycemia|hypoglycemia
5293894|NCT02206152|Unawareness|unawareness
5293895|NCT02206152|HAAF|haaf
5293896|NCT02206126|Obstructive sleep apnea|obstructive sleep apnea
5293897|NCT02206126|Weight loss|weight loss
5293898|NCT02206126|Obesity|obesity
5293899|NCT02206126|Sympathetic activity|sympathetic activity
5293900|NCT02206126|Metabolic profile|metabolic profile
5293901|NCT02206126|Endothelial function|endothelial function
5293902|NCT02206113|Standing workstation|standing workstation
5293904|NCT02206100|enoxaparin|enoxaparin
5196872|NCT02763683|PIB|pib
5293905|NCT02206100|anticoagulation reversal|anticoagulation reversal
5293906|NCT02206100|whole blood clotting time|whole blood clotting time
5293907|NCT02206087|PER977|per977
5293908|NCT02206087|heparin|heparin
5293909|NCT02206087|anticoagulation reversal|anticoagulation reversal
5293910|NCT02206087|whole blood clotting time|whole blood clotting time
5293911|NCT02206048|Cervix Carcinoma|cervix carcinoma
5293912|NCT02206048|Cervical adenocarcinoma in situ|cervical adenocarcinoma in situ
5293913|NCT02206048|AIS|ais
5293914|NCT02206048|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5293915|NCT02206048|CIN|cin
5293916|NCT02206048|microinvasive carcinoma of the cervix|microinvasive carcinoma of the cervix
5293917|NCT02206048|cold knife cone of the cervix|cold knife cone of the cervix
5293918|NCT02206048|CKC|ckc
5293919|NCT02206048|High-Resolution Microendoscopy|high-resolution microendoscopy
5293920|NCT02206048|HRME|hrme
5293921|NCT02206048|Proflavine|proflavine
5293922|NCT02206022|Central Venous Catheter|central venous catheter
5293923|NCT02206022|Remifentanil|remifentanil
5293924|NCT02206022|local anesthesia|local anesthesia
5293925|NCT02206022|pain|pain
5293926|NCT02205996|Type 2 diabetes|type 2 diabetes
5293927|NCT02205996|Hypoglycaemia|hypoglycaemia
5293928|NCT02205996|Platelets|platelets
5293929|NCT02205996|Inflammation|inflammation
5293930|NCT02205983|enrolling|enrolling
5293931|NCT02205983|adult|adult
5293934|NCT02205970|Dysmenorrhea|dysmenorrhea
5293935|NCT02205970|analgesia|analgesia
5293936|NCT02205970|interactive|interactive
5293937|NCT02205957|anesthesiology and intensive care, quality, training|anesthesiology and intensive care, quality, training
5293938|NCT02205944|chronic kidney disease|chronic kidney disease
5293939|NCT02205944|hemodialysis|hemodialysis
5293940|NCT02205944|vascular access|vascular access
5293941|NCT02205944|arteriovenous fistula|arteriovenous fistula
5293942|NCT02205944|forearm exercise|forearm exercise
5293943|NCT02205931|Epilepsy|epilepsy
5293944|NCT02205931|Ketogenic diet|ketogenic diet
5293945|NCT02205931|Antiepileptic drugs|antiepileptic drugs
5293946|NCT02205931|Randomised controlled trial|randomised controlled trial
5293947|NCT02205905|PER977|per977
5293948|NCT02205905|metabolic disposition|metabolic disposition
5293949|NCT02205905|mass balance|mass balance
5293950|NCT02205905|metabolites|metabolites
5293951|NCT02205905|radiolabeled|radiolabeled
5293952|NCT02205892|natural product|natural product
5293953|NCT02205892|clinical trial|clinical trial
5293954|NCT02205879|pregabalin|pregabalin
5293955|NCT02205879|patients|patients
5293956|NCT02205879|treatment|treatment
5293957|NCT02205853|Oncology Service Hospital|oncology service hospital
5293958|NCT02205853|Patient-centred|patient-centred
5293959|NCT02205853|Exercise|exercise
5293960|NCT02205853|Neoplasms|neoplasms
5293961|NCT02205853|Rehabilitation|rehabilitation
5293962|NCT02205853|Qualitative Research|qualitative research
5293963|NCT02205853|Health Plan Implementation|health plan implementation
5293964|NCT02205853|Quality of Health Care|quality of health care
5293965|NCT02205853|Guidelines|guidelines
5293966|NCT02205853|Quality of Life|quality of life
5293967|NCT02205827|whole blood clotting time|whole blood clotting time
5293968|NCT02205814|Osteoarthritis, Knee|osteoarthritis, knee
5293969|NCT02205814|Arthritis|arthritis
5293970|NCT02205814|WOMAC|womac
5293971|NCT02205814|Injections, intra-articular|injections, intra-articular
5293972|NCT02205814|Fasitibant|fasitibant
5293973|NCT02205814|MEN 16132|men 16132
5293974|NCT02205762|Langerhans cell histiocytosis|langerhans cell histiocytosis
5293975|NCT02205749|biobanks|biobanks
5293976|NCT02205749|informed consent|informed consent
5293977|NCT02205749|health literacy|health literacy
5293978|NCT02205736|Breast health education|breast health education
5293979|NCT02205736|Latino women|latino women
5293980|NCT02205736|Group education|group education
5293981|NCT02205736|Breast cancer|breast cancer
5293982|NCT02205723|Asthma|asthma
5293983|NCT02205723|Asthma exacerbations|asthma exacerbations
5293984|NCT02205723|Pediatric|pediatric
5293985|NCT02205697|Fruit|fruit
5293986|NCT02205697|Vegetable|vegetable
5293987|NCT02205684|Physical activity|physical activity
5293988|NCT02205684|Exercise|exercise
5293989|NCT02205684|High intensity training|high intensity training
5293990|NCT02205684|Schizophrenia|schizophrenia
5293991|NCT02205684|Symptoms|symptoms
5293992|NCT02205684|Well-being|well-being
5293993|NCT02205684|Cognition|cognition
5293994|NCT02205684|Hippocampal volume|hippocampal volume
5293995|NCT02205684|Neuroplasticity|neuroplasticity
5293996|NCT02205684|Smoking|smoking
5293997|NCT02205684|Substance use|substance use
5293998|NCT02205684|Metabolic indices|metabolic indices
5293999|NCT02205671|caregiving|caregiving
5294000|NCT02205671|chronic illness|chronic illness
5294001|NCT02205671|patient education|patient education
5294002|NCT02205671|self management|self management
5294003|NCT02205658|Sensory Processing|sensory processing
5294004|NCT02205658|Autism|autism
5294005|NCT02205645|medial|medial
5294006|NCT02205645|meniscus|meniscus
5294007|NCT02205645|scaffold|scaffold
5294013|NCT02205619|ultrasonic scaling|ultrasonic scaling
5294014|NCT02205619|air polishing with glycine|air polishing with glycine
5294016|NCT02205593|atopic dermatitis|atopic dermatitis
5294017|NCT02205593|eczema|eczema
5294018|NCT02205593|patient education|patient education
5294019|NCT02205593|stress reduction|stress reduction
5294020|NCT02205593|quality of life|quality of life
5294021|NCT02205554|Analgesia|analgesia
5294022|NCT02205554|Pharmacokinetics|pharmacokinetics
5294023|NCT02205554|Treatment|treatment
5294024|NCT02205541|Eculizumab|eculizumab
5294025|NCT02205541|Shiga-toxin|shiga-toxin
5294026|NCT02205541|hemolytic and uremic syndrome|hemolytic and uremic syndrome
5294027|NCT02205541|pediatric|pediatric
5294028|NCT02205476|Phase 2|phase 2
5294029|NCT02205476|open-label|open-label
5294030|NCT02205476|safety|safety
5294031|NCT02205476|hypertrophic scar revision surgery|hypertrophic scar revision surgery
5294032|NCT02205463|Esophagus|esophagus
5963011|NCT04277013|Obstetric|obstetric
5294033|NCT02205463|Gastroesophageal Junction|gastroesophageal junction
5294034|NCT02205463|Stomach|stomach
5294035|NCT02205463|Gastric|gastric
5294036|NCT02205463|Cancer|cancer
5294037|NCT02205463|HER2|her2
5294038|NCT02205463|Metastatic|metastatic
5294039|NCT02205463|Adenocarcinoma|adenocarcinoma
5294040|NCT02205450|Prader-Willi Syndrome|prader-willi syndrome
5294041|NCT02205450|Growth Hormone|growth hormone
5294042|NCT02205450|Children|children
5294043|NCT02205437|Schizophrenia|schizophrenia
5294044|NCT02205437|Psychosis|psychosis
5294045|NCT02205437|Antipsychotics|antipsychotics
5294046|NCT02205437|Treatment response|treatment response
5294047|NCT02205437|Metabolic side effects|metabolic side effects
5294048|NCT02205437|Gene expression|gene expression
5294049|NCT02205437|RNA|rna
5294050|NCT02205437|Genes|genes
5294056|NCT02205411|heart assist device|heart assist device
5294057|NCT02205411|ventricular assist device|ventricular assist device
5294058|NCT02205398|INC280|inc280
5294059|NCT02205398|c-MET inhibitor|c-met inhibitor
5294060|NCT02205398|cetuximab|cetuximab
5294061|NCT02205398|metastatic colorectal cancer|metastatic colorectal cancer
5294062|NCT02205398|head and neck|head and neck
5294063|NCT02205398|squamous cell carcinoma|squamous cell carcinoma
5294064|NCT02205398|resistance to cetuximab/panitumumab|resistance to cetuximab/panitumumab
5294065|NCT02205398|SCCHN,|scchn,
5294066|NCT02205398|cancer|cancer
5294067|NCT02205398|oral and nasal cavity|oral and nasal cavity
5294068|NCT02205398|paranasal sinuses|paranasal sinuses
5294069|NCT02205398|pharynx|pharynx
5294070|NCT02205398|larynx|larynx
5294071|NCT02205398|parotid glands|parotid glands
5294072|NCT02205398|lympth nodes of neck|lympth nodes of neck
5294073|NCT02205398|mucosal lining|mucosal lining
5294074|NCT02205398|epithelium|epithelium
5294075|NCT02205398|colon|colon
5294076|NCT02205398|large intestine|large intestine
5294077|NCT02205398|rectal cancer|rectal cancer
5294078|NCT02205385|Neuroma|neuroma
5294079|NCT02205385|Amputee|amputee
5294080|NCT02205385|Amputation Stump|amputation stump
5294081|NCT02205385|Assessment, Pain|assessment, pain
5294082|NCT02205372|Diabetic Nephropathy|diabetic nephropathy
5294083|NCT02205359|AdaptivCRT|adaptivcrt
5294084|NCT02205359|aCRT|acrt
5294085|NCT02205346|obstructive sleep apnea|obstructive sleep apnea
5294086|NCT02205333|Advanced Solid tumors|advanced solid tumors
5294087|NCT02205333|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5294088|NCT02205333|programmed death 1|programmed death 1
5294089|NCT02205333|programmed dealth ligand 1|programmed dealth ligand 1
5294090|NCT02205333|cytotoxic T-lymphocyte-associated antigen-4|cytotoxic t-lymphocyte-associated antigen-4
5294091|NCT02205333|OX40 ligand|ox40 ligand
5294092|NCT02205320|Pegfilgrastim|pegfilgrastim
5294093|NCT02205320|Pharmacokinetics|pharmacokinetics
5294094|NCT02205320|Pharmacodynamics|pharmacodynamics
5294095|NCT02205320|Healthy volunteers|healthy volunteers
5294096|NCT02205307|Rectal cancer|rectal cancer
5294097|NCT02205307|Rectal neoplasm|rectal neoplasm
5294098|NCT02205307|Colorectal surgery|colorectal surgery
5294099|NCT02205307|Anastomosis|anastomosis
5294100|NCT02205294|Osteopathic treatment|osteopathic treatment
5294101|NCT02205294|Deep Vein Thrombosis|deep vein thrombosis
5294102|NCT02205294|Proximal Leg DVT|proximal leg dvt
5294103|NCT02205281|Overweight|overweight
5294104|NCT02205281|Obese|obese
5294105|NCT02205281|Pregnancy|pregnancy
5294106|NCT02205281|Weight Gain|weight gain
5294107|NCT02205281|Weight Loss|weight loss
5294108|NCT02205268|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5294109|NCT02205268|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5294110|NCT02205268|Biofeedback|biofeedback
5294112|NCT02205268|Prefrontal Cortex|prefrontal cortex
5294113|NCT02205268|Near infrared spectroscopy|near infrared spectroscopy
5294114|NCT02205255|AECOPD|aecopd
5294115|NCT02205255|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5294116|NCT02205255|Acute exacerbation|acute exacerbation
5294117|NCT02205255|Hospitalization|hospitalization
5294118|NCT02205255|Azithromycin|azithromycin
5294119|NCT02205255|Macrolides|macrolides
5294120|NCT02205255|Randomized Controlled Trial|randomized controlled trial
5294121|NCT02205255|Placebo|placebo
5294122|NCT02205255|Economic Impact|economic impact
5294123|NCT02205255|Cost-effectiveness|cost-effectiveness
5294124|NCT02205255|EQ5D|eq5d
5294125|NCT02205242|AECOPD|aecopd
5294126|NCT02205242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5294128|NCT02205242|Hospitalization|hospitalization
5294129|NCT02205242|Azithromycin|azithromycin
5294130|NCT02205242|Macrolides|macrolides
5294131|NCT02205242|Randomized Controlled Trial|randomized controlled trial
5294132|NCT02205242|Placebo|placebo
5294133|NCT02205242|Physical Activity|physical activity
5294134|NCT02205242|PRO-Active|pro-active
5294135|NCT02205242|Activity Monitor|activity monitor
5294136|NCT02205216|tDCS|tdcs
5294137|NCT02205216|FOG|fog
5294138|NCT02205216|Freezing of Gait|freezing of gait
5294139|NCT02205216|Parkinson|parkinson
5294140|NCT02205216|Rehabilitation|rehabilitation
5294141|NCT02205203|Anxiety|anxiety
5175778|NCT02892786|RT-PCR|rt-pcr
5294147|NCT02205203|Phobia|phobia
5294148|NCT02205203|Panic|panic
5294149|NCT02205203|Agoraphobia|agoraphobia
5294150|NCT02205203|Obsessive Compulsive Disorder|obsessive compulsive disorder
5294152|NCT02205203|Child|child
5294153|NCT02205203|Adolescent|adolescent
5294154|NCT02205203|Smartphone|smartphone
5294155|NCT02205203|Teen|teen
5294156|NCT02205203|Youth|youth
5294157|NCT02205190|Fimasartan|fimasartan
5294158|NCT02205177|Anxiety|anxiety
5294159|NCT02205177|Social Anxiety|social anxiety
5294160|NCT02205177|Social Phobia|social phobia
5294161|NCT02205177|Separation Anxiety|separation anxiety
5294162|NCT02205177|Generalized Anxiety|generalized anxiety
5294163|NCT02205177|GAD|gad
5294164|NCT02205177|Phobia|phobia
5294165|NCT02205177|Panic|panic
5294166|NCT02205177|Agoraphobia|agoraphobia
5294167|NCT02205177|Obsessive Compulsive Disorder|obsessive compulsive disorder
5294168|NCT02205177|OCD|ocd
5294169|NCT02205177|Child|child
5294170|NCT02205177|Adolescent|adolescent
5294171|NCT02205177|Smartphone|smartphone
5294172|NCT02205177|Teen|teen
5294173|NCT02205177|Youth|youth
5294174|NCT02205164|palonosetron|palonosetron
5294175|NCT02205164|aprepitant|aprepitant
5294176|NCT02205164|CINV|cinv
5294177|NCT02205164|AML|aml
5294178|NCT02205164|multiple-days|multiple-days
5294179|NCT02205151|Fimasartan|fimasartan
5294185|NCT02205125|polyp|polyp
5294186|NCT02205125|colon|colon
5294187|NCT02205125|polypectomy|polypectomy
5294188|NCT02205125|snare|snare
5294189|NCT02205112|intravenous nemonoxacin|intravenous nemonoxacin
5294190|NCT02205112|community-acquired pneumonia|community-acquired pneumonia
5294191|NCT02205099|Schizophrenia|schizophrenia
5294192|NCT02205047|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5294193|NCT02205034|Prader Willi|prader willi
5294194|NCT02205008|advanced gastric cancer|advanced gastric cancer
5294195|NCT02205008|serosal invasion|serosal invasion
5294196|NCT02205008|peritoneal recurrence|peritoneal recurrence
5294197|NCT02205008|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5294198|NCT02204995|Osteoarthritis|osteoarthritis
5294199|NCT02204995|Thumb|thumb
5294200|NCT02204995|LRTI|lrti
5294201|NCT02204995|Trapeziectomy|trapeziectomy
5294202|NCT02204982|Phase 3, Follicular Lymphoma, FL, PI3K|phase 3, follicular lymphoma, fl, pi3k
5294203|NCT02204956|Smoking cessation|smoking cessation
5294204|NCT02204956|Tobacco use cessation|tobacco use cessation
5294205|NCT02204956|Psychiatric comorbidity|psychiatric comorbidity
5294206|NCT02204930|Haemostat|haemostat
5294207|NCT02204930|Liver surgery|liver surgery
5294208|NCT02204930|Primary liver cancer|primary liver cancer
5294209|NCT02204930|Metastatic liver cancer|metastatic liver cancer
5294210|NCT02204930|Benign liver disease such as adenoma|benign liver disease such as adenoma
5294211|NCT02204930|Hepatitis-related or alcoholic-related liver cirrhosis|hepatitis-related or alcoholic-related liver cirrhosis
5294212|NCT02204930|Living donation for liver transplant|living donation for liver transplant
5294213|NCT02204917|Ultrasound|ultrasound
5294214|NCT02204917|Ultrasound Contrast Agents|ultrasound contrast agents
5294215|NCT02204917|Optison|optison
5294216|NCT02204917|contrast enhanced Voiding Urosonography (ceVUS)|contrast enhanced voiding urosonography (cevus)
5294217|NCT02204917|ceVUS|cevus
5294218|NCT02204917|Vesicoureteral Reflux|vesicoureteral reflux
5294219|NCT02204917|Children|children
5294220|NCT02204917|Kidney|kidney
5294221|NCT02204917|Bladder|bladder
5294222|NCT02204917|Urethra|urethra
5294223|NCT02204917|Voiding Cystourethrography (VCUG)|voiding cystourethrography (vcug)
5294224|NCT02204917|VCUG|vcug
5294225|NCT02204917|Safety|safety
5294226|NCT02204917|Urinary tract|urinary tract
5294227|NCT02204904|X-linked Adrenoleukodystrophy|x-linked adrenoleukodystrophy
5294228|NCT02204904|Hematopoietic Stem Cells|hematopoietic stem cells
5294229|NCT02204891|Abdominal pain|abdominal pain
5294230|NCT02204891|Abdominal discomfort|abdominal discomfort
5294232|NCT02204891|Diarrhea|diarrhea
5294233|NCT02204891|Bacterial overgrowth|bacterial overgrowth
5294234|NCT02204891|Cytokines|cytokines
5294235|NCT02204865|Sleep-Disordered Breathing|sleep-disordered breathing
5294236|NCT02204865|Sleep Apnoea|sleep apnoea
5294237|NCT02204865|Heart failure|heart failure
5294238|NCT02204839|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
5294239|NCT02204826|Effects of Korean Red Ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study|effects of korean red ginseng on semen parameters in male infertility patients: a randomized, placebo-controlled, double-blind clinical study
5294240|NCT02204813|Gastric Bypass|gastric bypass
5294241|NCT02204813|RYGB|rygb
5294242|NCT02204813|GLP-1|glp-1
5294243|NCT02204813|Xenin|xenin
5294244|NCT02204813|Insulin Secretion|insulin secretion
5294245|NCT02204813|Glucose Homeostasis|glucose homeostasis
5963012|NCT04277013|Diagnostic imaging|diagnostic imaging
5294246|NCT02204813|Vertical Sleeve|vertical sleeve
5294247|NCT02204813|Lap Band|lap band
5294248|NCT02204800|Tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically CRG)|tumor growth rate in maximal dimension, biomarker assessment based on driver gene alterations (specifically crg)
5963013|NCT04277013|Stomach|stomach
5163708|NCT02969655|Safety|safety
5175871|NCT02892149|DD-CKD|dd-ckd
5294249|NCT02204774|aortic aneurysm|aortic aneurysm
5294250|NCT02204774|obstructive sleep apnea|obstructive sleep apnea
5294251|NCT02204735|Meal Time|meal time
5294252|NCT02204735|Weight Loss|weight loss
5294253|NCT02204735|Circadian Rhythm|circadian rhythm
5294254|NCT02204709|obese|obese
5294255|NCT02204709|omega-3 fatty acids|omega-3 fatty acids
5294256|NCT02204709|fish|fish
5294257|NCT02204696|sleep apnea|sleep apnea
5294258|NCT02204696|obstructive sleep apnea|obstructive sleep apnea
5294259|NCT02204696|sleepiness|sleepiness
5294260|NCT02204696|quality of life|quality of life
5294262|NCT02204683|Neovascularization|neovascularization
5294263|NCT02204683|macular degeneration|macular degeneration
5294264|NCT02204683|wet macular degeneration|wet macular degeneration
5294265|NCT02204683|vitrectomy|vitrectomy
5294266|NCT02204670|Irisin|irisin
5294267|NCT02204670|Obesity|obesity
5294268|NCT02204670|Exercise|exercise
5294269|NCT02204670|Myokine|myokine
5294270|NCT02204670|Impaired Glucose Tolerance|impaired glucose tolerance
5294271|NCT02204657|Continuous glucose monitoring in GDM|continuous glucose monitoring in gdm
5294272|NCT02204631|Head and Neck Cancer|head and neck cancer
5294273|NCT02204618|single sided deafness|single sided deafness
5294274|NCT02204618|Asymmetrical hearing loss|asymmetrical hearing loss
5294275|NCT02204618|Cost-utility|cost-utility
5294276|NCT02204618|Tinnitus|tinnitus
5294277|NCT02204618|Cochlear implants|cochlear implants
5294278|NCT02204618|Bone conduction device|bone conduction device
5294279|NCT02204618|Dichotic hearing|dichotic hearing
5294280|NCT02204618|Squelch effect.|squelch effect.
5294281|NCT02204605|patients|patients
5294282|NCT02204605|puzzling|puzzling
5294283|NCT02204605|conditions|conditions
5294284|NCT02204579|Autosomal Dominant Hypocalcemia|autosomal dominant hypocalcemia
5294285|NCT02204579|Hypocalcemia|hypocalcemia
5294287|NCT02204579|Hypoparathyroidism|hypoparathyroidism
5294288|NCT02204566|OFDI|ofdi
5294289|NCT02204566|RF Ablation|rf ablation
5294290|NCT02204566|Atrial Fibrillation|atrial fibrillation
5294291|NCT02204566|Imaging|imaging
5294292|NCT02204566|Esophagus|esophagus
5294293|NCT02204553|Multiple Myeloma|multiple myeloma
5294294|NCT02204553|Panobinostat|panobinostat
5294295|NCT02204553|LBH589|lbh589
5294296|NCT02204553|Expanded Access|expanded access
5294297|NCT02204553|EAP, ETP|eap, etp
5294298|NCT02204553|Expanded Treatment|expanded treatment
5294299|NCT02204553|Bortezomib|bortezomib
5294300|NCT02204553|HDAC|hdac
5294301|NCT02204553|histone deacetylace inhibitor|histone deacetylace inhibitor
5294302|NCT02204540|Webcams, video monitoring, compliance, adherence|webcams, video monitoring, compliance, adherence
5294303|NCT02204527|hypertension|hypertension
5294304|NCT02204527|diabetes mellitus|diabetes mellitus
5294305|NCT02204527|vitamin D|vitamin d
5294306|NCT02204501|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5294307|NCT02204501|Aviragen Therapeutics|aviragen therapeutics
5294308|NCT02204501|Aviragen|aviragen
5294309|NCT02204488|Osteoarthritis|osteoarthritis
5294310|NCT02204488|Thumb|thumb
5294311|NCT02204488|Total joint arthroplasty|total joint arthroplasty
5294312|NCT02204488|Trapeziectomy|trapeziectomy
5294314|NCT02204462|Positron Emission Tomography|positron emission tomography
5294315|NCT02204462|Breast Cancer|breast cancer
5294316|NCT02204462|Imaging|imaging
5294317|NCT02204449|cardiac rehabilitation|cardiac rehabilitation
5294318|NCT02204449|peer mentorship|peer mentorship
5294319|NCT02204449|healthcare utilization|healthcare utilization
5294320|NCT02204449|continuity of cardiac care|continuity of cardiac care
5294321|NCT02204436|hyperpigmentation|hyperpigmentation
5294322|NCT02204436|depigmenting treatment|depigmenting treatment
5294323|NCT02204436|hand|hand
5294327|NCT02204410|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5294328|NCT02204410|DESR|desr
5294329|NCT02204410|Deficient Emotional Self-Regulation|deficient emotional self-regulation
5294330|NCT02204410|Emotional Dysregulation|emotional dysregulation
5294331|NCT02204410|Omega-3 Fatty Acids|omega-3 fatty acids
5294332|NCT02204410|Fish Oil|fish oil
5294333|NCT02204397|Type 1 Diabetes mellitus|type 1 diabetes mellitus
5294334|NCT02204397|INGAP|ingap
5294335|NCT02204397|Ustekinumab|ustekinumab
5294336|NCT02204384|Dietary fiber|dietary fiber
5294337|NCT02204384|Dietary Supplements|dietary supplements
5294338|NCT02204384|Type 2 diabetes|type 2 diabetes
5294339|NCT02204384|Postprandial Period|postprandial period
5294340|NCT02204384|Plasma insulin|plasma insulin
5294341|NCT02204384|Plasma glucose|plasma glucose
5294342|NCT02204384|Area Under Curve|area under curve
5294343|NCT02204384|Soluble fiber|soluble fiber
5294344|NCT02204371|Pazopanib|pazopanib
5963014|NCT04277013|Ultrasonography|ultrasonography
5294345|NCT02204371|hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
5294346|NCT02204371|bleeding|bleeding
5963015|NCT04277000|Injurious falls|injurious falls
5294347|NCT02204319|provoked or non-provoked vulvar vestibulitis|provoked or non-provoked vulvar vestibulitis
5294348|NCT02204319|low level laser light device|low level laser light device
5294349|NCT02204293|Adult-Onset Still´s Disease|adult-onset still´s disease
5294350|NCT02204293|Canakinumab|canakinumab
5294351|NCT02204293|Joint involvement|joint involvement
5294352|NCT02204293|AOSD|aosd
5294353|NCT02204280|UbA52;diabetic nephropathy ;diabetic;ELISA|uba52;diabetic nephropathy ;diabetic;elisa
5294354|NCT02204267|Stroke|stroke
5294355|NCT02204267|atrial fibrillation|atrial fibrillation
5294356|NCT02204267|ECG|ecg
5294357|NCT02204241|Multiple myeloma|multiple myeloma
5294358|NCT02204241|Diagnosis|diagnosis
5294359|NCT02204241|CCyd|ccyd
5294360|NCT02204228|osteoarthritis|osteoarthritis
5294361|NCT02204228|rheumatoid arthritis|rheumatoid arthritis
5294362|NCT02204228|post traumatic arthritis|post traumatic arthritis
5294363|NCT02204228|avascular necrosis|avascular necrosis
5294364|NCT02204228|severe fractures|severe fractures
5294365|NCT02204215|Weakness|weakness
5294366|NCT02204215|Mechanical Ventilation|mechanical ventilation
5294367|NCT02204215|Acupuncture Therapy|acupuncture therapy
5294368|NCT02204202|acute lung transplant rejection|acute lung transplant rejection
5294369|NCT02204202|neutrophilic lung inflammation|neutrophilic lung inflammation
5294370|NCT02204202|positron emission tomography imaging|positron emission tomography imaging
5294371|NCT02204202|[18F] fluorodeoxyglucose|[18f] fluorodeoxyglucose
5294372|NCT02204202|[18F] ISO-1|[18f] iso-1
5294373|NCT02204189|acute pancreatitis|acute pancreatitis
5294374|NCT02204189|gastrointestinal dysfunction|gastrointestinal dysfunction
5294375|NCT02204189|TongFuSan|tongfusan
5294376|NCT02204189|ShenQue acupoint|shenque acupoint
5294377|NCT02204150|Optical Coherence Tomography|optical coherence tomography
5294378|NCT02204150|Barrett's Esophagus|barrett's esophagus
5294379|NCT02204150|Esophagus|esophagus
5294380|NCT02204150|Imaging|imaging
5294381|NCT02204124|Whipple procedure|whipple procedure
5294382|NCT02204111|Palliative Treatment|palliative treatment
5294383|NCT02204111|Trabectedin|trabectedin
5294384|NCT02204111|Patient Reported Outcome|patient reported outcome
5294385|NCT02204085|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
5294386|NCT02204085|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5294387|NCT02204020|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5294388|NCT02204020|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5294389|NCT02204020|allogeneic|allogeneic
5294390|NCT02204020|5-azacytidine (5-aza)|5-azacytidine (5-aza)
5294391|NCT02204020|hematopoietic|hematopoietic
5294392|NCT02204020|transplantation|transplantation
5294393|NCT02204020|transplant|transplant
5294394|NCT02204020|graft-versus-tumor|graft-versus-tumor
5294395|NCT02204020|graft-versus-host disease (GVHD)|graft-versus-host disease (gvhd)
5294396|NCT02204020|epigenetic|epigenetic
5294397|NCT02204020|maintenance|maintenance
5294398|NCT02204020|hypomethylation|hypomethylation
5294399|NCT02204020|relapse|relapse
5294400|NCT02204007|Acetabular Shell|acetabular shell
5294401|NCT02204007|Total Hip Arthroplasty|total hip arthroplasty
5294402|NCT02204007|3D imaging|3d imaging
5294403|NCT02203994|extracorporal shock wave therapy (ESWT)|extracorporal shock wave therapy (eswt)
5294404|NCT02203994|spasticity|spasticity
5294405|NCT02203994|spinal cord injury|spinal cord injury
5294406|NCT02203981|normal Eyes|normal eyes
5294407|NCT02203968|Fibrinogen replacement|fibrinogen replacement
5294408|NCT02203968|Trauma coagulopathy|trauma coagulopathy
5294409|NCT02203968|Hypofibrinogenemia|hypofibrinogenemia
5291261|NCT02218736|Anhedonia|anhedonia
5294410|NCT02203968|Early trauma coagulopathy|early trauma coagulopathy
5294411|NCT02203968|Haemorrhage|haemorrhage
5294412|NCT02203968|Fibrinogen concentrate|fibrinogen concentrate
5294413|NCT02203968|Feasibility trial|feasibility trial
5294419|NCT02203929|Progression|progression
5294420|NCT02203916|Drug therapy|drug therapy
5294421|NCT02203890|Growth|growth
5294422|NCT02203890|Hematology|hematology
5294423|NCT02203890|Hydration|hydration
5294424|NCT02203890|Oxidation|oxidation
5294425|NCT02203890|Infection|infection
5294426|NCT02203890|Inflammation|inflammation
5294427|NCT02203890|Guatemalan children|guatemalan children
5294428|NCT02203851|BI 655066|bi 655066
5294429|NCT02203851|risankizumab|risankizumab
5294430|NCT02203838|Schizophrenia|schizophrenia
5294431|NCT02203838|Schizophrenic|schizophrenic
5294432|NCT02203838|Schizophrenias|schizophrenias
5294433|NCT02203838|Risperidone|risperidone
5294434|NCT02203838|Long-acting Risperidone|long-acting risperidone
5294435|NCT02203838|Atrigel|atrigel
5294436|NCT02203838|Subcutaneous|subcutaneous
5294437|NCT02203825|Acute Myeloid Leukemia|acute myeloid leukemia
5294438|NCT02203825|NKG2D|nkg2d
5294439|NCT02203825|Multiple Myeloma|multiple myeloma
5294440|NCT02203825|Cell Therapy|cell therapy
5294446|NCT02203786|amphetamine|amphetamine
5294447|NCT02203786|d1 and d2 receptors|d1 and d2 receptors
5294448|NCT02203786|dopamine antagonists|dopamine antagonists
5294449|NCT02203786|pathological gambling|pathological gambling
5294450|NCT02203786|priming|priming
5294451|NCT02203786|reinforcement|reinforcement
5294452|NCT02203773|Acute Myelogenous Leukemia|acute myelogenous leukemia
5963016|NCT04277000|Fear of falling|fear of falling
5294453|NCT02203773|AML|aml
5294454|NCT02203773|Myelogenous Leukemia|myelogenous leukemia
5294455|NCT02203773|ABT-199|abt-199
5294456|NCT02203773|GDC-0199|gdc-0199
5294457|NCT02203773|Treatment Naive AML|treatment naive aml
5294458|NCT02203773|Untreated AML|untreated aml
5294459|NCT02203760|Relapsed/metastatic uterine leiomyosarcomas/carcinosarcomas|relapsed/metastatic uterine leiomyosarcomas/carcinosarcomas
5294460|NCT02203734|Pregnancy|pregnancy
5294461|NCT02203734|Depression|depression
5294462|NCT02203734|Massage|massage
5294463|NCT02203708|BPD (Borderline Personality Disorder)|bpd (borderline personality disorder)
5294464|NCT02203708|Mother/child|mother/child
5294465|NCT02203695|Salvage Radiation Therapy (SRT)|salvage radiation therapy (srt)
5294466|NCT02203695|Enzalutamide|enzalutamide
5294467|NCT02203682|Graves' orbitopathy|graves' orbitopathy
5294468|NCT02203682|Graves´ ophthalmopathy|graves´ ophthalmopathy
5294469|NCT02203682|Thyroid eye disease|thyroid eye disease
5294470|NCT02203682|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5294471|NCT02203682|Doxycycline|doxycycline
5294472|NCT02203682|EUGOGO|eugogo
5294473|NCT02203682|CAS|cas
5294474|NCT02203669|breast reconstruction|breast reconstruction
5294475|NCT02203669|occupational therapy|occupational therapy
5294476|NCT02203669|physical therapy|physical therapy
5294477|NCT02203669|upper extremity morbidity|upper extremity morbidity
5294478|NCT02203656|intervention studies|intervention studies
5294479|NCT02203656|nutrition|nutrition
5294480|NCT02203656|exercise|exercise
5294481|NCT02203656|testosterone|testosterone
5294482|NCT02203656|patient readmission|patient readmission
5294483|NCT02203630|Septic shock|septic shock
5294484|NCT02203630|Vasopressor Agents|vasopressor agents
5294485|NCT02203630|Phenylephrine|phenylephrine
5294486|NCT02203630|Norepinephrine|norepinephrine
5294487|NCT02203630|Tachycardia|tachycardia
5294488|NCT02203630|Heart Rate|heart rate
5294489|NCT02203630|Arrhythmia|arrhythmia
5294490|NCT02203630|Catecholamine|catecholamine
5294491|NCT02203617|anticipatory guidance|anticipatory guidance
5294492|NCT02203617|baby books|baby books
5294493|NCT02203617|safety|safety
5294494|NCT02203591|surgical skin prep|surgical skin prep
5294495|NCT02203591|CHG|chg
5294496|NCT02203591|IPA|ipa
5294497|NCT02203552|Breast Cancer|breast cancer
5294498|NCT02203539|circadian rhythm|circadian rhythm
5294499|NCT02203539|light exposure|light exposure
5294500|NCT02203539|exercise capacity|exercise capacity
5294501|NCT02203539|endurance|endurance
5294502|NCT02203539|strength|strength
5294503|NCT02203539|reaction|reaction
5294508|NCT02203513|p53 Dysfunction|p53 dysfunction
5294509|NCT02203513|Cell Cycle Arrest|cell cycle arrest
5294510|NCT02203513|Checkpoint Kinases|checkpoint kinases
5294511|NCT02203513|DNA Damage Repair Pathways|dna damage repair pathways
5294512|NCT02203513|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
5294513|NCT02203461|ART, HIV, insulin resistance|art, hiv, insulin resistance
5294514|NCT02203435|code blue|code blue
5294515|NCT02203435|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5294516|NCT02203435|APACHE|apache
5294517|NCT02203422|Immune Thrombocytopenia|immune thrombocytopenia
5294518|NCT02203422|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
5294519|NCT02203422|Cyclosporin A|cyclosporin a
5294520|NCT02203409|liver tumor|liver tumor
5294521|NCT02203409|Two stage hepatectomy|two stage hepatectomy
5294522|NCT02203409|Hypertrophy|hypertrophy
5294523|NCT02203409|laparoscopy|laparoscopy
5294524|NCT02203409|ALPPS|alpps
5294525|NCT02203396|SAA|saa
5294526|NCT02203396|Immunosuppressive treatment|immunosuppressive treatment
5294531|NCT02203383|Central Sleep Apnoea|central sleep apnoea
5294532|NCT02203383|Sleep Disordered Breathing|sleep disordered breathing
5294533|NCT02203383|Heart Failure|heart failure
5294534|NCT02203383|Hypercapnic Ventilatory Response|hypercapnic ventilatory response
5294535|NCT02203357|hepatitis B|hepatitis b
5294536|NCT02203357|hepatitis B vaccine|hepatitis b vaccine
5294537|NCT02203357|immunogenicity|immunogenicity
5294538|NCT02203357|adults|adults
5294539|NCT02203318|cryptorchidism, undescended testis, hypertrophy of contralateral testis|cryptorchidism, undescended testis, hypertrophy of contralateral testis
5294540|NCT02203305|Unilateral hearing loss|unilateral hearing loss
5294541|NCT02203305|Single Sided Deafness|single sided deafness
5294542|NCT02203305|Asymmetric hearing loss|asymmetric hearing loss
5294543|NCT02203292|Traumatic Brain Injury|traumatic brain injury
5294544|NCT02203292|Blood Transfusion|blood transfusion
5294545|NCT02203279|Chair-side hard relining|chair-side hard relining
5294546|NCT02203279|complete denture|complete denture
5294547|NCT02203279|patients' satisfaction|patients' satisfaction
5294548|NCT02203279|supporting tissues|supporting tissues
5294549|NCT02203279|autopolymerized reline resins|autopolymerized reline resins
5294550|NCT02203279|heat cured relining material|heat cured relining material
5294551|NCT02203266|Medication Adherence|medication adherence
5294552|NCT02203266|Patient Compliance|patient compliance
5294553|NCT02203253|solid tumor|solid tumor
5294554|NCT02203253|chemotherapy-induced delayed nausea and vomiting|chemotherapy-induced delayed nausea and vomiting
5294555|NCT02203253|thalidomide|thalidomide
5294556|NCT02203253|prevention|prevention
5294557|NCT02203240|Cacao|cacao
5294558|NCT02203240|Polyphenols|polyphenols
5963017|NCT04277000|Quality of life|quality of life
5176178|NCT02890446|hemiparesis|hemiparesis
5294559|NCT02203240|Prediabetic State|prediabetic state
5294560|NCT02203240|Blood Glucose|blood glucose
5294561|NCT02203240|Glucose Intolerance|glucose intolerance
5294562|NCT02203240|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5294563|NCT02203240|Obesity|obesity
5294564|NCT02203240|Muscle, Skeletal|muscle, skeletal
5294565|NCT02203240|Endotoxins|endotoxins
5294566|NCT02203240|Gut Permeability|gut permeability
5294567|NCT02203240|Incretins|incretins
5294568|NCT02203240|Metabolic Flexibility|metabolic flexibility
5294569|NCT02203227|Dietary supplements|dietary supplements
5294570|NCT02203227|Cotinine level|cotinine level
5294571|NCT02203227|Malondialdehyde|malondialdehyde
5294572|NCT02203227|Chronic smokers|chronic smokers
5294573|NCT02203227|Hyperlipidemia|hyperlipidemia
5294575|NCT02203214|ACL|acl
5294576|NCT02203214|healing|healing
5294577|NCT02203201|Not-celiac gluten sensitivity|not-celiac gluten sensitivity
5294578|NCT02203201|Celiac Disease|celiac disease
5294579|NCT02203201|Gluten-free diet|gluten-free diet
5294580|NCT02203201|EMA assay|ema assay
5294581|NCT02203201|Duodenal culture medium|duodenal culture medium
5294582|NCT02203175|propofol|propofol
5294583|NCT02203175|pretreatment|pretreatment
5294584|NCT02203175|mixture|mixture
5294585|NCT02203162|cough|cough
5294586|NCT02203162|cough reflex sensitivity|cough reflex sensitivity
5294587|NCT02203162|electronic cigarette|electronic cigarette
5294588|NCT02203162|capsaicin|capsaicin
5294589|NCT02203136|Bladder cancer|bladder cancer
5294590|NCT02203136|Muscle invasive bladder cancer|muscle invasive bladder cancer
5294591|NCT02203136|MIBC|mibc
5294592|NCT02203136|Biopsy specimen molecular profiling|biopsy specimen molecular profiling
5294593|NCT02203136|Bladder surgery|bladder surgery
5294594|NCT02203136|Magnetic resonance imaging|magnetic resonance imaging
5294595|NCT02203136|MRI|mri
5294596|NCT02203136|Trans urethral resection of bladder|trans urethral resection of bladder
5294597|NCT02203110|simultaneous bacterial and viral pneumonia|simultaneous bacterial and viral pneumonia
5294598|NCT02203097|Target controlled infusion|target controlled infusion
5294599|NCT02203097|propofol|propofol
5294600|NCT02203097|cerebral vasoreactivity|cerebral vasoreactivity
5294601|NCT02203097|arterial stiffness|arterial stiffness
5294602|NCT02203097|Transcranial Doppler|transcranial doppler
5294603|NCT02203097|SphygmoCor|sphygmocor
5294604|NCT02203084|Cystic Fibrosis|cystic fibrosis
5294605|NCT02203084|Diabetes Mellitus Type I|diabetes mellitus type i
5294606|NCT02203084|Chronic Renal Insufficiency|chronic renal insufficiency
5294607|NCT02203084|The influence of socioeconomic variables upon outcome in children with three chronic medical diseases.|the influence of socioeconomic variables upon outcome in children with three chronic medical diseases.
5294608|NCT02203071|sports|sports
5294609|NCT02203071|injury|injury
5294610|NCT02203071|knee|knee
5294611|NCT02203071|pain|pain
5294612|NCT02203071|cartilage|cartilage
5294613|NCT02203058|Inspiratory capacity|inspiratory capacity
5294614|NCT02203058|Positive-pressure respiration|positive-pressure respiration
5294615|NCT02203058|Exercise|exercise
5294616|NCT02203058|Activities of daily living|activities of daily living
5294617|NCT02203058|COPD.|copd.
5294618|NCT02203045|Total Knee Arthroplasty|total knee arthroplasty
5294623|NCT02203032|CNTO 1959|cnto 1959
5294624|NCT02203032|Monoclonal antibody|monoclonal antibody
5294625|NCT02203019|Dexmedetomidine|dexmedetomidine
5294626|NCT02203019|Propofol|propofol
5294627|NCT02203019|Sepsis|sepsis
5294628|NCT02203019|Mechanical Ventilation|mechanical ventilation
5294629|NCT02203019|Respiratory Failure|respiratory failure
5294630|NCT02203006|HIV,|hiv,
5294631|NCT02203006|infection,|infection,
5294632|NCT02203006|cohort|cohort
5294633|NCT02202967|Aspirin|aspirin
5294634|NCT02202967|Intestinal bleeding|intestinal bleeding
5294635|NCT02202967|Misoprostol|misoprostol
5294636|NCT02202967|NSAIDs|nsaids
5294637|NCT02202967|Small intestine|small intestine
5294638|NCT02202967|Video capsule endoscopy|video capsule endoscopy
5294639|NCT02202954|Stroke|stroke
5294640|NCT02202954|Muscle Spasticity|muscle spasticity
5294641|NCT02202954|Rehabilitation|rehabilitation
5294642|NCT02202928|Colorectal cancer|colorectal cancer
5294643|NCT02202928|DC-CIK|dc-cik
5294644|NCT02202928|Autologous tumor lysate|autologous tumor lysate
5294645|NCT02202902|Cushing's syndrome|cushing's syndrome
5294646|NCT02202902|cardiac steatosis|cardiac steatosis
5294647|NCT02202902|intramyocardial triglyceride content|intramyocardial triglyceride content
5294648|NCT02202902|1H magnetic resonance spectroscopy and cardiac magnetic resonance imaging|1h magnetic resonance spectroscopy and cardiac magnetic resonance imaging
5294649|NCT02202902|Left Ventricularly hypertrophy|left ventricularly hypertrophy
5294650|NCT02202889|Adolescents|adolescents
5294651|NCT02202889|Bone mass|bone mass
5294652|NCT02202889|Calcium|calcium
5294653|NCT02202889|Perceived milk intolerance|perceived milk intolerance
5294654|NCT02202889|lactose maldigestion|lactose maldigestion
5294655|NCT02202863|Dietary intervention|dietary intervention
5294656|NCT02202863|Wine grape pomace flour|wine grape pomace flour
5294657|NCT02202863|Metabolic Syndrome|metabolic syndrome
5963018|NCT04277000|Physical activity|physical activity
5294658|NCT02202863|Oxidative stress|oxidative stress
5176274|NCT02889965|Neuro-myelitis optica|neuro-myelitis optica
5294659|NCT02202863|Antioxidants|antioxidants
5294660|NCT02202863|Fiber|fiber
5294661|NCT02202785|Drug therapy|drug therapy
5294662|NCT02202772|Urothelial|urothelial
5294663|NCT02202772|Cisplatin|cisplatin
5294664|NCT02202772|Gemcitabine|gemcitabine
5294665|NCT02202772|Cabazitaxel|cabazitaxel
5294666|NCT02202772|Bladder|bladder
5294667|NCT02202772|Carcinoma|carcinoma
5294668|NCT02202772|Bacillus Calmette-Guerin|bacillus calmette-guerin
5294669|NCT02202772|Intravesical|intravesical
5294670|NCT02202772|Recurrent|recurrent
5294671|NCT02202772|Non-muscle|non-muscle
5294672|NCT02202772|Invasive|invasive
5294673|NCT02202772|Cancer|cancer
5294674|NCT02202759|Drug therapy|drug therapy
5294675|NCT02202746|Breast cancer|breast cancer
5294676|NCT02202746|Metastatic breast cancer|metastatic breast cancer
5294677|NCT02202746|MBC|mbc
5294678|NCT02202746|HER2 positive|her2 positive
5294679|NCT02202746|HER2+|her2+
5294680|NCT02202746|Estrogen receptor positive|estrogen receptor positive
5294681|NCT02202746|ER+|er+
5294682|NCT02202746|Triple negative|triple negative
5294683|NCT02202746|FGFR1|fgfr1
5294684|NCT02202746|11q|11q
5294685|NCT02202746|FGF aberrant|fgf aberrant
5294686|NCT02202746|Biomarker negative|biomarker negative
5294687|NCT02202746|FGF non-aberrant|fgf non-aberrant
5294688|NCT02202733|cooking skills|cooking skills
5294689|NCT02202733|eating out|eating out
5294690|NCT02202733|foods prepared away from home|foods prepared away from home
5294691|NCT02202720|Sevoflurane|sevoflurane
5294692|NCT02202720|RASS score|rass score
5294693|NCT02202720|Sedation|sedation
5294694|NCT02202720|Minimal alveolar concentration (MAC)|minimal alveolar concentration (mac)
5294695|NCT02202694|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
5294696|NCT02202681|Duodenum|duodenum
5294697|NCT02202681|Optical Frequency Domain Imaging (OFDI)|optical frequency domain imaging (ofdi)
5294698|NCT02202681|Optical Coherence Tomography|optical coherence tomography
5294699|NCT02202681|Imaging|imaging
5294700|NCT02202681|Celiac Disease|celiac disease
5294701|NCT02202668|Foot ulcer, diabetic|foot ulcer, diabetic
5294702|NCT02202668|Spectrum analysis, Raman|spectrum analysis, raman
5294703|NCT02202655|non- small cell lung cancer;|non- small cell lung cancer;
5294704|NCT02202655|lymphocyte subsets|lymphocyte subsets
5294705|NCT02202616|COPD,|copd,
5294706|NCT02202616|QVA149,|qva149,
5294707|NCT02202616|Tiotropium,|tiotropium,
5294708|NCT02202616|FDC,|fdc,
5294709|NCT02202616|GlycOpyrronium With IndacatERol,|glycopyrronium with indacaterol,
5294710|NCT02202616|POWER|power
5294711|NCT02202590|SECM|secm
5294712|NCT02202590|Esophagus|esophagus
5294713|NCT02202590|Eosinophilic Esophagitis|eosinophilic esophagitis
5294714|NCT02202590|Allergy|allergy
5294715|NCT02202577|Surgical site infection|surgical site infection
5294716|NCT02202577|Surgical site antisepsis|surgical site antisepsis
5294717|NCT02202577|Cesarean Delivery|cesarean delivery
5294720|NCT02202564|adenovirus-thymidine kinase|adenovirus-thymidine kinase
5294721|NCT02202564|gene therapy|gene therapy
5294722|NCT02202551|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
5294724|NCT02202551|Parkinsonism|parkinsonism
5294725|NCT02202551|Parkinson's Disease|parkinson's disease
5294726|NCT02202538|SCI|sci
5294727|NCT02202538|Indego|indego
5294728|NCT02202538|Walking|walking
5294729|NCT02202499|pharmacotherapy|pharmacotherapy
5294730|NCT02202473|Oxymatrine Capsules, lamivudine, chronic Hepatitis B|oxymatrine capsules, lamivudine, chronic hepatitis b
5294731|NCT02202447|EC1169|ec1169
5294732|NCT02202447|prostate cancer|prostate cancer
5294733|NCT02202447|EC0652|ec0652
5294734|NCT02202421|Autism|autism
5294735|NCT02202421|Applied Behavior Analysis|applied behavior analysis
5294736|NCT02202395|Hydroxytriptolide|hydroxytriptolide
5294737|NCT02202395|Rheumatoid Arthritis|rheumatoid arthritis
5294738|NCT02202395|Methotrexate|methotrexate
5294739|NCT02202395|T8|t8
5294741|NCT02202369|Multimodal Analgesia|multimodal analgesia
5294742|NCT02202369|Pain Management|pain management
5294743|NCT02202356|RSV|rsv
5294744|NCT02202356|Respiratory Syncytial Virus|respiratory syncytial virus
5294745|NCT02202343|Nutrition|nutrition
5294746|NCT02202343|Food|food
5294747|NCT02202343|Security|security
5294748|NCT02202343|School|school
5294749|NCT02202343|Health|health
5294750|NCT02202317|Liver Cancer|liver cancer
5294751|NCT02202317|Hepatic Tumors|hepatic tumors
5294752|NCT02202317|Primary Liver Tumors|primary liver tumors
5294753|NCT02202317|Metastatic Liver Tumors|metastatic liver tumors
5294754|NCT02202317|Yttrium-90|yttrium-90
5294755|NCT02202317|Y-90|y-90
5294756|NCT02202291|Raynaud's phenomenon, Vasospasm, Genetics|raynaud's phenomenon, vasospasm, genetics
5294757|NCT02202278|ovarian hyperstimulation|ovarian hyperstimulation
5294758|NCT02202278|Oxidative Stress|oxidative stress
5294759|NCT02202278|IMA|ima
5294760|NCT02202278|OHSS|ohss
5294761|NCT02202278|ICSI|icsi
5294762|NCT02202278|long agonist protocol|long agonist protocol
5294763|NCT02202278|TAC|tac
5963019|NCT04276987|mesenchymal stem cells|mesenchymal stem cells
5963020|NCT04276987|exosome|exosome
5238232|NCT02513303|AVF|avf
5294764|NCT02202278|TOS|tos
5294765|NCT02202278|OSI|osi
5294766|NCT02202278|MDA|mda
5294768|NCT02202252|Patient comfort|patient comfort
5294769|NCT02202252|Drains|drains
5294770|NCT02202252|Breast cancer|breast cancer
5294771|NCT02202252|Modified radical mastectomy|modified radical mastectomy
5294772|NCT02202252|Seroma|seroma
5294773|NCT02202200|Melanoma|melanoma
5294774|NCT02202200|BRAF mutated|braf mutated
5294775|NCT02202174|supraglottic airway|supraglottic airway
5294776|NCT02202174|children|children
5294777|NCT02202174|safety|safety
5294778|NCT02202174|efficacy|efficacy
5294779|NCT02202161|pharmacokinetic|pharmacokinetic
5294780|NCT02202161|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
5294781|NCT02202161|metformin|metformin
5294782|NCT02202161|sitagliptin|sitagliptin
5294783|NCT02202161|GSK2330672|gsk2330672
5294784|NCT02202161|pharmacodynamic|pharmacodynamic
5294785|NCT02202148|Fibroscan|fibroscan
5294786|NCT02202148|alcohol dependence|alcohol dependence
5294787|NCT02202148|alcohol withdrawal|alcohol withdrawal
5294788|NCT02202148|controlled attenuation parameter|controlled attenuation parameter
5294789|NCT02202148|BDNF|bdnf
5294790|NCT02202135|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
5294791|NCT02202135|skin infection|skin infection
5294792|NCT02202135|ceftaroline|ceftaroline
5294793|NCT02202135|wound infection|wound infection
5294794|NCT02202135|cellulitis|cellulitis
5294795|NCT02202135|burn infection|burn infection
5294796|NCT02202135|bacterial infection|bacterial infection
5294797|NCT02202135|vancomycin|vancomycin
5294798|NCT02202122|Femoral Neck Fractures|femoral neck fractures
5294799|NCT02202122|Obstructive Sleep Apnea|obstructive sleep apnea
5294800|NCT02202122|Perioperative Complications|perioperative complications
5294801|NCT02202109|Screen|screen
5294802|NCT02202109|self-sampler|self-sampler
5294803|NCT02202109|cervical, cancer|cervical, cancer
5294804|NCT02202109|women|women
5294805|NCT02202109|community health workers|community health workers
5294806|NCT02202109|Hispanic/ Latinas|hispanic/ latinas
5294807|NCT02202109|Haitian|haitian
5294808|NCT02202109|Focus of study is cervical cancer|focus of study is cervical cancer
5294809|NCT02202083|Oxytocin|oxytocin
5294810|NCT02202083|Cook Balloon|cook balloon
5294811|NCT02202070|onabotulinumtoxinA|onabotulinumtoxina
5294812|NCT02202070|Temporomandibular Joint Disorders|temporomandibular joint disorders
5294813|NCT02202070|Bruxism|bruxism
5294814|NCT02202070|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
5295068|NCT02201095|caesarean section|caesarean section
5294815|NCT02202070|Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint|myofascial pain dysfunction syndrome, temporomandibular joint
5294816|NCT02202057|respiratory sensation|respiratory sensation
5294817|NCT02202057|somatosensation|somatosensation
5294818|NCT02202057|resistive load|resistive load
5294822|NCT02202018|Chronic Kidney Disease|chronic kidney disease
5294823|NCT02202018|Dialysis|dialysis
5294824|NCT02202018|Home dialysis|home dialysis
5291653|NCT02216968|preschool|preschool
5294826|NCT02202005|Bioequivalence|bioequivalence
5294827|NCT02201979|breast|breast
5294828|NCT02201979|ptosis|ptosis
5294829|NCT02201979|sagging|sagging
5294830|NCT02201979|implant|implant
5294831|NCT02201979|lift|lift
5294832|NCT02201966|low back pain|low back pain
5294833|NCT02201966|pediatric|pediatric
5294834|NCT02201966|gymnasts|gymnasts
5294835|NCT02201953|Sofosbuvir|sofosbuvir
5294836|NCT02201953|Velpatasvir|velpatasvir
5294838|NCT02201953|GS-5816|gs-5816
5294839|NCT02201953|Hepatitis C|hepatitis c
5294841|NCT02201953|Cirrhosis|cirrhosis
5294842|NCT02201953|Genotype 3|genotype 3
5294843|NCT02201940|Sofosbuvir|sofosbuvir
5294844|NCT02201940|SOF/VEL|sof/vel
5294847|NCT02201940|HCV|hcv
5294848|NCT02201940|cirrhosis|cirrhosis
5294849|NCT02201927|galvanic vestibular stimulation|galvanic vestibular stimulation
5294850|NCT02201927|right parietal lobe lesion|right parietal lobe lesion
5294851|NCT02201927|egocentric space|egocentric space
5294852|NCT02201901|Sofosbuvir|sofosbuvir
5294853|NCT02201901|Velpatasvir|velpatasvir
5294854|NCT02201901|SOF/VEL|sof/vel
5294855|NCT02201901|GS-5816|gs-5816
5294856|NCT02201901|Hepatitis C|hepatitis c
5294857|NCT02201901|HCV|hcv
5294858|NCT02201901|Cirrhosis|cirrhosis
5294859|NCT02201901|CPT-B|cpt-b
5294860|NCT02201888|Schizophrenia|schizophrenia
5294861|NCT02201888|Rehabilitation|rehabilitation
5294862|NCT02201888|Cognition|cognition
5294863|NCT02201875|hypoxia|hypoxia
5294864|NCT02201875|exercise|exercise
5294865|NCT02201875|periodic breathing|periodic breathing
5294866|NCT02201875|hypercapnia|hypercapnia
5294867|NCT02201875|apneas|apneas
5294868|NCT02201875|cardiac failure|cardiac failure
5963021|NCT04276987|nebulization|nebulization
5294869|NCT02201862|Aneuploidy|aneuploidy
5294870|NCT02201862|Down Syndrome|down syndrome
5294871|NCT02201862|amniocentesis|amniocentesis
5294872|NCT02201862|chronic villus sampling|chronic villus sampling
5294873|NCT02201862|Trisomy|trisomy
5294874|NCT02201862|non-invasive prenatal testing|non-invasive prenatal testing
5294875|NCT02201862|Chromosome disorders|chromosome disorders
5294876|NCT02201849|Alkermes|alkermes
5294877|NCT02201849|ALKS 8700|alks 8700
5294878|NCT02201810|smoking cessation|smoking cessation
5294879|NCT02201810|quit line|quit line
5294880|NCT02201810|nicotine replacement therapy|nicotine replacement therapy
5294881|NCT02201810|tobacco intervention|tobacco intervention
5294882|NCT02201797|Reproducibility of Results|reproducibility of results
5294883|NCT02201797|Liver neoplasm|liver neoplasm
5294884|NCT02201797|Neoplasm metastasis|neoplasm metastasis
5294885|NCT02201797|Regional Perfusion|regional perfusion
5294886|NCT02201797|Perfusion Magnetic Resonance Imaging|perfusion magnetic resonance imaging
5294887|NCT02201784|Subarachnoid block|subarachnoid block
5294888|NCT02201784|intrathecal|intrathecal
5294889|NCT02201784|spinal anesthesia|spinal anesthesia
5294890|NCT02201784|isobaric|isobaric
5294891|NCT02201784|levobupivacaine|levobupivacaine
5294892|NCT02201784|ropivacaine|ropivacaine
5294893|NCT02201771|CABG|cabg
5294894|NCT02201771|Antiplatelet|antiplatelet
5294895|NCT02201771|Ticagrelor|ticagrelor
5294896|NCT02201758|Inflammatory Bowel Disease (IBD), ulcerative colitis (UC), flaxseed lignan-enriched complex (FLC)|inflammatory bowel disease (ibd), ulcerative colitis (uc), flaxseed lignan-enriched complex (flc)
5294897|NCT02201732|Incomplete miscarriage|incomplete miscarriage
5294898|NCT02201732|Hysteroscopy|hysteroscopy
5294899|NCT02201732|curettage, pregnancy|curettage, pregnancy
5294900|NCT02201732|RCT|rct
5294901|NCT02201719|Adenomyosis|adenomyosis
5294902|NCT02201719|Dysmenorrhea|dysmenorrhea
5294903|NCT02201719|Chronic pelvic pain|chronic pelvic pain
5294904|NCT02201719|Infertility|infertility
5294905|NCT02201719|Sensitivity histology|sensitivity histology
5294906|NCT02201719|womens health|womens health
5294907|NCT02201719|junction zone|junction zone
5294908|NCT02201706|Retinal detachment|retinal detachment
5294909|NCT02201706|silicone oil|silicone oil
5294910|NCT02201706|retinectomy|retinectomy
5294911|NCT02201693|Crohn's disease,|crohn's disease,
5294912|NCT02201693|pediatric GETAID (Therapeutic study group of inflammatory bowel diseases of the child),|pediatric getaid (therapeutic study group of inflammatory bowel diseases of the child),
5294913|NCT02201693|enteral nutrition,|enteral nutrition,
5294914|NCT02201693|randomized multicenter study|randomized multicenter study
5294915|NCT02201680|anxiety|anxiety
5299704|NCT02179346|hip|hip
5294916|NCT02201680|preoperative|preoperative
5294917|NCT02201667|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
5294918|NCT02201667|myocardial perfusion|myocardial perfusion
5294919|NCT02201667|magnetic Resonance Imaging|magnetic resonance imaging
5294920|NCT02201667|antiplatelet|antiplatelet
5294923|NCT02201641|periapical radiolucency|periapical radiolucency
5294924|NCT02201641|periapical radiographs|periapical radiographs
5294925|NCT02201641|cone beam computed tomography|cone beam computed tomography
5294926|NCT02201641|calcium silicate cements|calcium silicate cements
5294927|NCT02201641|glass ionomer cements|glass ionomer cements
5294928|NCT02201641|caries|caries
5294929|NCT02201628|Oesophageal|oesophageal
5294930|NCT02201628|Nasopharyngeal|nasopharyngeal
5294935|NCT02201628|Hypothermia|hypothermia
5294936|NCT02201615|Perineal Massage; Episiotomy; Perineal Laceration|perineal massage; episiotomy; perineal laceration
5294937|NCT02201602|sulphonylureas|sulphonylureas
5294938|NCT02201602|gliclazide|gliclazide
5294939|NCT02201602|glibenclamide|glibenclamide
5294941|NCT02201576|Chronic antibody-mediated rejection,|chronic antibody-mediated rejection,
5295045|NCT02201264|Angioplasty|angioplasty
5294942|NCT02201576|transplant rejection, kidney transplantation,|transplant rejection, kidney transplantation,
5294943|NCT02201576|proteasome inhibitor,|proteasome inhibitor,
5294944|NCT02201576|anti-HLA antibodies,|anti-hla antibodies,
5294945|NCT02201576|immunosuppressive agents|immunosuppressive agents
5294946|NCT02201563|Adverse radiation effects (ARE)|adverse radiation effects (are)
5294947|NCT02201563|Radiosurgery|radiosurgery
5294948|NCT02201563|Brain metastases|brain metastases
5294949|NCT02201563|Minocycline|minocycline
5294950|NCT02201537|Ultrasound functional imaging|ultrasound functional imaging
5294951|NCT02201537|Chronic kidney Nephropathy|chronic kidney nephropathy
5294952|NCT02201524|Phase 2|phase 2
5294953|NCT02201524|randomized|randomized
5294954|NCT02201524|double-blind|double-blind
5294955|NCT02201524|placebo|placebo
5294956|NCT02201524|plaque|plaque
5294957|NCT02201524|psoriasis|psoriasis
5294958|NCT02201524|safety|safety
5294959|NCT02201524|efficacy|efficacy
5294961|NCT02201524|janus kinase|janus kinase
5294962|NCT02201524|moderate|moderate
5294963|NCT02201524|severe|severe
5294964|NCT02201511|relative bioavailbility|relative bioavailbility
5294965|NCT02201511|food effect|food effect
5294966|NCT02201511|pharmacokinetics|pharmacokinetics
5294967|NCT02201511|ALTERATION OF COGNITIVE FUNCTIONS|alteration of cognitive functions
5294968|NCT02201485|Budd-Chiari syndrome|budd-chiari syndrome
5294969|NCT02201485|percutaneous recanalization|percutaneous recanalization
5294970|NCT02201485|treatment|treatment
5294971|NCT02201485|reocclusion|reocclusion
5294972|NCT02201485|patency|patency
5294973|NCT02201472|liver|liver
5294974|NCT02201472|mre|mre
5294975|NCT02201472|mri|mri
5294976|NCT02201472|neonatal|neonatal
5294977|NCT02201472|mr touch|mr touch
5294978|NCT02201459|Peg-IFN, nilotinib, MR4.5, CML, chronic phase, first-line|peg-ifn, nilotinib, mr4.5, cml, chronic phase, first-line
5294979|NCT02201433|breastfeeding|breastfeeding
5294980|NCT02201433|fathers|fathers
5294981|NCT02201433|preterm newborns|preterm newborns
5294982|NCT02201433|partner influence|partner influence
5294983|NCT02201394|Antiplatelet|antiplatelet
5294984|NCT02201394|Ticagrelor|ticagrelor
5294985|NCT02201394|Platelets|platelets
5294986|NCT02201394|Thrombosis|thrombosis
5294987|NCT02201394|Coronary artery disease|coronary artery disease
5294988|NCT02201381|Cancer|cancer
5294989|NCT02201381|Cancer Treatments|cancer treatments
5294990|NCT02201381|Cancer Palliative Care|cancer palliative care
5294991|NCT02201381|Metabolic|metabolic
5294992|NCT02201381|Metabolism|metabolism
5294993|NCT02201381|Existing Medicines|existing medicines
5294994|NCT02201381|Licensed Medicines|licensed medicines
5294995|NCT02201381|Real World|real world
5294996|NCT02201381|Breast Cancer|breast cancer
5294997|NCT02201381|Triple Negative Breast Cancer|triple negative breast cancer
5294998|NCT02201381|Colon Cancer|colon cancer
5294999|NCT02201381|Prostrate Cancer|prostrate cancer
5295000|NCT02201381|Brain Cancer|brain cancer
5295001|NCT02201381|Ovarian Cancer|ovarian cancer
5295002|NCT02201381|Pancreatic Cancer|pancreatic cancer
5295004|NCT02201381|CML|cml
5295005|NCT02201381|Leukemea|leukemea
5295006|NCT02201381|Metformin|metformin
5295007|NCT02201381|Statins|statins
5295008|NCT02201381|Mebendazole|mebendazole
5295009|NCT02201381|Doxycycline|doxycycline
5295010|NCT02201381|Ibuprofen|ibuprofen
5295011|NCT02201381|Metastatic|metastatic
5295012|NCT02201368|Triglycerides; Lipid Metabolism; Fatty Acids.|triglycerides; lipid metabolism; fatty acids.
5295013|NCT02201355|Head and Neck cancer|head and neck cancer
5295014|NCT02201342|Fontan|fontan
5295015|NCT02201342|Pharmacokinetics|pharmacokinetics
5295016|NCT02201342|Pharmacodynamics|pharmacodynamics
5295017|NCT02201342|Exercise capacity|exercise capacity
5295018|NCT02201342|Maximal Oxygen Consumption|maximal oxygen consumption
5295019|NCT02201342|Vascular function|vascular function
5295020|NCT02201342|EndoPAT|endopat
5295022|NCT02201316|Healthy adult human subjects|healthy adult human subjects
5295024|NCT02201316|Bioequivalence|bioequivalence
5295025|NCT02201316|Dyspepsia|dyspepsia
5295026|NCT02201303|CD11b|cd11b
5295027|NCT02201303|Neutrophils|neutrophils
5295028|NCT02201303|CXCL1|cxcl1
5295029|NCT02201303|Danirixin|danirixin
5295030|NCT02201303|Respiratory Syncytial Virus|respiratory syncytial virus
5295031|NCT02201303|Children|children
5295032|NCT02201303|CXCR2|cxcr2
5295034|NCT02201277|IVC|ivc
5295035|NCT02201277|IVC Filter|ivc filter
5295036|NCT02201277|Filter|filter
5295037|NCT02201277|Option|option
5295038|NCT02201277|Denali|denali
5295039|NCT02201277|filter tilt|filter tilt
5295040|NCT02201277|filter migration|filter migration
5295041|NCT02201277|filter fracture|filter fracture
5295042|NCT02201277|filter thrombus|filter thrombus
5295043|NCT02201277|filter penetration|filter penetration
5295044|NCT02201264|myocardial infarction|myocardial infarction
5295053|NCT02201212|Tuberous Sclerosis Complex|tuberous sclerosis complex
5295055|NCT02201186|honey enema for pouchitis|honey enema for pouchitis
5295056|NCT02201160|NAFLD|nafld
5295057|NCT02201160|Fatty acid composition|fatty acid composition
5295058|NCT02201160|Omega 3 supplementation|omega 3 supplementation
5295059|NCT02201160|Metabolism|metabolism
5295060|NCT02201134|Cardiac arrest|cardiac arrest
5295061|NCT02201134|Therapeutic hypothermia|therapeutic hypothermia
5295062|NCT02201134|Sevoflurane|sevoflurane
5295063|NCT02201134|Sedation|sedation
5295064|NCT02201134|Patient resuscitated from cardiac arrest|patient resuscitated from cardiac arrest
5295065|NCT02201134|Requiring sedation|requiring sedation
5295066|NCT02201134|Adult patients|adult patients
5295067|NCT02201134|Patient covered by french health care system|patient covered by french health care system
5295069|NCT02201095|perioperative hypothermia|perioperative hypothermia
5295070|NCT02201095|active warming|active warming
5295071|NCT02201095|forced air warming|forced air warming
5295072|NCT02201095|conduction mattress warming|conduction mattress warming
5295073|NCT02201095|thermal comfort|thermal comfort
5295074|NCT02201095|Prevention of|prevention of
5295075|NCT02201069|nutrition|nutrition
5295076|NCT02201069|physical activity|physical activity
5295077|NCT02201069|sleep|sleep
5295078|NCT02201069|weight loss|weight loss
5295079|NCT02201056|Drug Therapy|drug therapy
5295080|NCT02201043|ankylosing spondylitis|ankylosing spondylitis
5295081|NCT02201043|thalidomide|thalidomide
5295082|NCT02200952|OHSS|ohss
5295083|NCT02200952|Oocytes triggering|oocytes triggering
5295084|NCT02200952|GnRh agonist triggering|gnrh agonist triggering
5295085|NCT02200952|Luteal phase supplementation|luteal phase supplementation
5295086|NCT02200952|recombinant LH|recombinant lh
5295087|NCT02200900|High flow nasal cannula|high flow nasal cannula
5295088|NCT02200900|Continuous Positive Airway Pressure|continuous positive airway pressure
5295089|NCT02200900|Respiratory physiology|respiratory physiology
5295090|NCT02200887|Dyskinesia|dyskinesia
5295092|NCT02200874|disease related malnutrition|disease related malnutrition
5295093|NCT02200874|influence of Nutrition Support Team|influence of nutrition support team
5295094|NCT02200874|length of hospital stay|length of hospital stay
5295095|NCT02200874|quality of life|quality of life
5295096|NCT02200874|body composition|body composition
5295097|NCT02200874|health care costs|health care costs
5295098|NCT02200861|sedation,|sedation,
5295099|NCT02200861|tooth extraction,|tooth extraction,
5295100|NCT02200848|Lenalidomide|lenalidomide
5295101|NCT02200848|Ibrutinib|ibrutinib
5295102|NCT02200848|Rituximab|rituximab
5295103|NCT02200848|CLL|cll
5295104|NCT02200848|SLL|sll
5295105|NCT02200835|aortic dissection|aortic dissection
5295106|NCT02200835|Chinese patients|chinese patients
5295107|NCT02200835|gender differences|gender differences
5295108|NCT02200822|neurohumoral blocker therapy|neurohumoral blocker therapy
5295109|NCT02200822|renin-angiotensin-aldosterone system (RAAS)|renin-angiotensin-aldosterone system (raas)
5295110|NCT02200822|RAAS-blocker|raas-blocker
5295111|NCT02200822|beta blocker|beta blocker
5295112|NCT02200822|spironolactone|spironolactone
5295113|NCT02200822|angiotensin converting enzyme inhibitor (ACE-I)|angiotensin converting enzyme inhibitor (ace-i)
5295114|NCT02200822|angiotensin receptor blocker (ARB)|angiotensin receptor blocker (arb)
5295115|NCT02200822|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5295116|NCT02200822|heart failure|heart failure
5295117|NCT02200822|dyssynchrony|dyssynchrony
5295118|NCT02200822|left bundle branch block|left bundle branch block
5295119|NCT02200809|MR-guided therapy|mr-guided therapy
5295120|NCT02200809|Focal laser ablation|focal laser ablation
5295121|NCT02200809|Prostate cancer|prostate cancer
5295122|NCT02200796|Dietary Protein|dietary protein
5295123|NCT02200796|Satiety|satiety
5295124|NCT02200796|Food Intake|food intake
5295126|NCT02200796|Diet Induced Thermogenesis|diet induced thermogenesis
5295127|NCT02200783|Cardiac catheterization|cardiac catheterization
5295128|NCT02200783|Radiation Protection|radiation protection
5295130|NCT02200783|Femoral artery|femoral artery
5295131|NCT02200770|NMO, NMOSD, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders, autoimmune, demyelination, MEDI-551, monoclonal antibody, Devic's syndrome, B-cell|nmo, nmosd, neuromyelitis optica, neuromyelitis optica spectrum disorders, autoimmune, demyelination, medi-551, monoclonal antibody, devic's syndrome, b-cell
5295132|NCT02200744|Procedural sedation|procedural sedation
5291960|NCT02215447|phase II|phase ii
5295133|NCT02200744|emergency department|emergency department
5295134|NCT02200744|adults|adults
5295135|NCT02200744|propofol|propofol
5295136|NCT02200744|recall assessment|recall assessment
5295137|NCT02200731|Childhood cancer|childhood cancer
5295138|NCT02200731|Psychosocial intervention|psychosocial intervention
5295139|NCT02200731|Family|family
5295140|NCT02200731|Siblings|siblings
5295240|NCT02200289|Cook stove|cook stove
5295144|NCT02200718|Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic|multiple sclerosis pediatric ms neurovax vaccine therapeutic
5295146|NCT02200692|plasma transfusion|plasma transfusion
5295147|NCT02200692|allergic transfusion reaction|allergic transfusion reaction
5295148|NCT02200692|transfusion reaction|transfusion reaction
5295149|NCT02200692|blood transfusion|blood transfusion
5295150|NCT02200692|Solvent detergent plasma|solvent detergent plasma
5295151|NCT02200679|Autism spectrum disorders|autism spectrum disorders
5295152|NCT02200679|Prevalence|prevalence
5295153|NCT02200679|Diagnosis|diagnosis
5295155|NCT02200679|Risk Factor|risk factor
5295156|NCT02200679|SRS|srs
5295157|NCT02200679|ASRS|asrs
5295162|NCT02200627|Type 2 diabetes mellitus|type 2 diabetes mellitus
5295163|NCT02200627|Diabetes|diabetes
5295164|NCT02200627|Forxiga|forxiga
5295165|NCT02200627|Elderly|elderly
5295166|NCT02200601|Seipher Wellness|seipher wellness
5295167|NCT02200601|algorithm|algorithm
5295168|NCT02200601|secure samples of SGC waveform|secure samples of sgc waveform
5295169|NCT02200601|volunteers|volunteers
5295170|NCT02200601|validation|validation
5295171|NCT02200601|heart health algorithm|heart health algorithm
5295172|NCT02200588|psychosis|psychosis
5295173|NCT02200588|schizophrenia|schizophrenia
5295174|NCT02200549|pulmonary rehabilitation|pulmonary rehabilitation
5295175|NCT02200549|inspiratory muscle training|inspiratory muscle training
5295176|NCT02200549|exercise training|exercise training
5295177|NCT02200523|EEG|eeg
5295178|NCT02200523|electrode|electrode
5295179|NCT02200510|Anemia, Sickle Cell|anemia, sickle cell
5295180|NCT02200510|Transition to Adult Care|transition to adult care
5295181|NCT02200510|Self Care|self care
5295182|NCT02200510|Personal Electronic Health Records|personal electronic health records
5295183|NCT02200510|Adolescent|adolescent
5295184|NCT02200510|Young Adult|young adult
5295185|NCT02200510|Disease Management|disease management
5295186|NCT02200510|Physician-Patient Relations|physician-patient relations
5295187|NCT02200484|obesity|obesity
5295188|NCT02200484|adolescents, females|adolescents, females
5295189|NCT02200484|child development|child development
5295190|NCT02200484|weight loss programs|weight loss programs
5295191|NCT02200484|child rearing|child rearing
5295192|NCT02200484|parenting|parenting
5282481|NCT02260193|pharmacokinetics|pharmacokinetics
5295193|NCT02200471|Cosmetic dermatology|cosmetic dermatology
5295194|NCT02200471|near-infrared|near-infrared
5295195|NCT02200471|patient preference|patient preference
5295196|NCT02200471|physician preference|physician preference
5295197|NCT02200445|Ulcerative colitis|ulcerative colitis
5295198|NCT02200445|Inflammatory bowel disease|inflammatory bowel disease
5295199|NCT02200445|Interleukin 2|interleukin 2
5295200|NCT02200445|Interleukin-2|interleukin-2
5295201|NCT02200445|IL-2|il-2
5295202|NCT02200445|Regulatory T Cells|regulatory t cells
5295203|NCT02200445|Tregs|tregs
5295204|NCT02200445|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5295205|NCT02200432|Smoking Cessation|smoking cessation
5295206|NCT02200432|Persuasive Communication Tailoring|persuasive communication tailoring
5295207|NCT02200432|Health Behavior Change|health behavior change
5295208|NCT02200432|Patient decision support|patient decision support
5295209|NCT02200419|Rotem|rotem
5295210|NCT02200419|Point of care coagulation tests|point of care coagulation tests
5295211|NCT02200419|Cardiac surgery|cardiac surgery
5295212|NCT02200419|Vascular surgery|vascular surgery
5295213|NCT02200419|Cardiopulmonary bypass|cardiopulmonary bypass
5295214|NCT02200419|Blood products|blood products
5295215|NCT02200419|Transfusion|transfusion
5295216|NCT02200419|Viscoelastic coagulation|viscoelastic coagulation
5295217|NCT02200406|Desvenlafaxine|desvenlafaxine
5295218|NCT02200406|Opioid-dependent|opioid-dependent
5295219|NCT02200406|Addiction|addiction
5295220|NCT02200406|Depression|depression
5295221|NCT02200406|Methadone|methadone
5295222|NCT02200406|Comorbidity|comorbidity
5295223|NCT02200393|Spinal cord injury|spinal cord injury
5295224|NCT02200393|Tetraplegia|tetraplegia
5295225|NCT02200393|Ventilator|ventilator
5295226|NCT02200367|Primary health care|primary health care
5295227|NCT02200367|Computer communication network|computer communication network
5295228|NCT02200367|Depression|depression
5295229|NCT02200328|Clostridium difficile infection|clostridium difficile infection
5295230|NCT02200328|Diarrhea|diarrhea
5295231|NCT02200328|Flagyl|flagyl
5295232|NCT02200328|Metronidazole|metronidazole
5295233|NCT02200315|Stomach neoplasms|stomach neoplasms
5295234|NCT02200315|Surgical site infection|surgical site infection
5295235|NCT02200315|Laparoscopic gastrectomy|laparoscopic gastrectomy
5295236|NCT02200315|Antimicrobial prophylaxis|antimicrobial prophylaxis
5295237|NCT02200289|Birth cohort|birth cohort
5295238|NCT02200289|Ghana|ghana
5295239|NCT02200289|Biomass|biomass
5295249|NCT02200198|undernutrition|undernutrition
5295250|NCT02200198|abdominal surgery|abdominal surgery
5295251|NCT02200198|respiratory muscles|respiratory muscles
5295252|NCT02200198|muscles strength|muscles strength
5295253|NCT02200198|pulmonary complication|pulmonary complication
5295254|NCT02200198|perioperative care|perioperative care
5295255|NCT02200185|post traumatic pain|post traumatic pain
5295256|NCT02200185|titrated morphine|titrated morphine
5295257|NCT02200185|nebulised morphine|nebulised morphine
5295258|NCT02200172|Cancer|cancer
5295259|NCT02200172|Melatonin|melatonin
5295260|NCT02200172|Delirium|delirium
5295261|NCT02200172|Feasibility Studies|feasibility studies
5295262|NCT02200172|Palliative Care|palliative care
5295263|NCT02200159|Sedation|sedation
5295264|NCT02200159|Dexmedetomidine|dexmedetomidine
5295265|NCT02200159|ICU|icu
5295266|NCT02200159|Delirium|delirium
5295267|NCT02200146|sarcoidosis|sarcoidosis
5295268|NCT02200146|treatment|treatment
5295269|NCT02200146|lung|lung
5295270|NCT02200146|glucocorticoids|glucocorticoids
5295271|NCT02200146|hydroxychloroquine|hydroxychloroquine
5295272|NCT02200133|Hematopoietic cell transplant (HCT) survivors|hematopoietic cell transplant (hct) survivors
5295273|NCT02200133|Survivorship Care Plan|survivorship care plan
5295274|NCT02200107|Osteoarthritis Knee|osteoarthritis knee
5295275|NCT02200107|Self Care|self care
5295276|NCT02200107|Treatment Outcome|treatment outcome
5295277|NCT02200107|Patient Education as Topic|patient education as topic
5295278|NCT02200107|Physical Therapy Modalities|physical therapy modalities
5295279|NCT02200081|Extensive disease|extensive disease
5295280|NCT02200081|After first line therapy|after first line therapy
5295281|NCT02200081|Immuno therapy|immuno therapy
5295282|NCT02200068|Perceived Efficacy of Patient Physician Interactions|perceived efficacy of patient physician interactions
5295283|NCT02200068|Patient Reported Outcomes|patient reported outcomes
5295284|NCT02200068|Personal Health Record|personal health record
5295285|NCT02200055|Electrical Bioimpedance|electrical bioimpedance
5295286|NCT02200055|Major Intra-abdominal Surgical Procedures|major intra-abdominal surgical procedures
5295287|NCT02200055|Total Body Volume|total body volume
5295288|NCT02200055|Fluid Resuscitation|fluid resuscitation
5295289|NCT02200029|Intrahepatic Cholestasis|intrahepatic cholestasis
5295290|NCT02200016|Postoperative pain|postoperative pain
5295291|NCT02200016|Regional anesteshia|regional anesteshia
5295292|NCT02200016|Nerve catheters|nerve catheters
5282590|NCT02259322|Obesity|obesity
5295293|NCT02200016|Sciatic nerve catheters|sciatic nerve catheters
5295294|NCT02200003|attention bias modification, anxiety, event-related potentials|attention bias modification, anxiety, event-related potentials
5295295|NCT02199990|cognitive function; propofol; etomidate;|cognitive function; propofol; etomidate;
5176910|NCT02885493|Parkinson march|parkinson march
5295296|NCT02199977|Malaria|malaria
5295297|NCT02199977|Antimalarial subsidy|antimalarial subsidy
5295298|NCT02199977|Malaria rapid diagnostic test (RDT)|malaria rapid diagnostic test (rdt)
5295299|NCT02199977|public-private partnership|public-private partnership
5295305|NCT02199951|Uncomplicated Malaria|uncomplicated malaria
5295306|NCT02199951|dihydroartemisinin|dihydroartemisinin
5295307|NCT02199951|piperaquine|piperaquine
5295308|NCT02199925|Autism|autism
5295309|NCT02199925|Autism spectrum|autism spectrum
5295310|NCT02199925|Autism children|autism children
5295311|NCT02199912|cachexia|cachexia
5295312|NCT02199912|nutrition|nutrition
5295313|NCT02199912|cancer|cancer
5295314|NCT02199912|colorectal tumor|colorectal tumor
5295315|NCT02199834|diabetes|diabetes
5295316|NCT02199834|peer support|peer support
5295317|NCT02199834|personalized feedback report|personalized feedback report
5295318|NCT02199795|stroke|stroke
5295319|NCT02199795|hemiplegia|hemiplegia
5295320|NCT02199795|footdrop|footdrop
5295321|NCT02199795|electrical stimulation|electrical stimulation
5295322|NCT02199769|Clinical decision support|clinical decision support
5295323|NCT02199769|Diabetes screening|diabetes screening
5295324|NCT02199756|Uterine contractions|uterine contractions
5295325|NCT02199756|Indomethacin|indomethacin
5295326|NCT02199756|Nanovectors|nanovectors
5295327|NCT02199743|schizophrenia|schizophrenia
5295328|NCT02199743|schizoaffective|schizoaffective
5295329|NCT02199743|cognition|cognition
5295330|NCT02199743|lurasidone|lurasidone
5295331|NCT02199743|Latuda|latuda
5295332|NCT02199717|Physical Activity|physical activity
5295333|NCT02199717|Accelerometer|accelerometer
5295334|NCT02199717|Exercise|exercise
5295336|NCT02199717|BMI|bmi
5295337|NCT02199704|Parenting|parenting
5295338|NCT02199704|Psychosis|psychosis
5295339|NCT02199704|Schizophrenia|schizophrenia
5295340|NCT02199704|Delusions|delusions
5295341|NCT02199704|Hallucinations|hallucinations
5295342|NCT02199691|Meningitis|meningitis
5295343|NCT02199691|Meningococcal Meningitis|meningococcal meningitis
5295344|NCT02199691|MenACYW conjugate vaccine|menacyw conjugate vaccine
5295345|NCT02199691|MENVEO vaccine|menveo vaccine
5295347|NCT02199691|GARDASIL®|gardasil®
5295348|NCT02199639|Haemophilia|haemophilia
5295349|NCT02199639|Arthropathy|arthropathy
5295350|NCT02199639|Range of Movement|range of movement
5295351|NCT02199639|Strength|strength
5295352|NCT02199639|Proprioception|proprioception
5295353|NCT02199639|Gait|gait
5295354|NCT02199639|Quality of Life|quality of life
5295355|NCT02199613|HIV|hiv
5295356|NCT02199613|antiretroviral therapy|antiretroviral therapy
5295357|NCT02199587|Medical clown|medical clown
5295358|NCT02199587|Growth hormone|growth hormone
5295359|NCT02199587|Precocious puberty|precocious puberty
5295360|NCT02199548|Adolescent|adolescent
5295361|NCT02199548|Decision-making|decision-making
5295362|NCT02199548|Social network|social network
5295363|NCT02199535|operating room,|operating room,
5295364|NCT02199535|risk factors|risk factors
5295365|NCT02199535|anesthesiologists|anesthesiologists
5295366|NCT02199509|Levetiracetam|levetiracetam
5295367|NCT02199509|Cranial Dystonia|cranial dystonia
5295368|NCT02199509|Oromandibular Dystonia|oromandibular dystonia
5295369|NCT02199496|Malabsorption|malabsorption
5295370|NCT02199496|Enteropathy|enteropathy
5295371|NCT02199496|Diarrhea|diarrhea
5295372|NCT02199496|IL-12|il-12
5295373|NCT02199483|Energy Expenditure|energy expenditure
5295374|NCT02199483|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5295375|NCT02199483|Neurocognitive Function|neurocognitive function
5295376|NCT02199483|Weight Loss|weight loss
5295377|NCT02199470|β-CELLS,|β-cells,
5295378|NCT02199470|MIXED MEAL TEST,|mixed meal test,
5295379|NCT02199470|C-PEPTİDE|c-peptide
5295380|NCT02199431|Lu AF11167|lu af11167
5295381|NCT02199431|Interaction|interaction
5295382|NCT02199405|Spondylosis, Massage Therapy, Exercise Therapy ,Treatment Efficacy|spondylosis, massage therapy, exercise therapy ,treatment efficacy
5295383|NCT02199392|P-glycoprotein|p-glycoprotein
5295384|NCT02199392|Healthy Volunteers|healthy volunteers
5295385|NCT02199379|renal impairment|renal impairment
5295386|NCT02199379|disease severity|disease severity
5295387|NCT02199366|Cardiac MRI|cardiac mri
5295388|NCT02199366|Radiation|radiation
5295389|NCT02199366|Proton Radiation|proton radiation
5295390|NCT02199366|Breast Cancer|breast cancer
5295391|NCT02199353|Activities of daily living, Occupational Therapy, Dementia|activities of daily living, occupational therapy, dementia
5295392|NCT02199340|Exercise testing|exercise testing
5295393|NCT02199340|Children|children
5295394|NCT02199340|Exercise capacity|exercise capacity
5295395|NCT02199327|Conjunctival-corneal intraepithelial neoplasia|conjunctival-corneal intraepithelial neoplasia
5295396|NCT02199327|Mitomycin C|mitomycin c
5295397|NCT02199327|Interferon alfa 2b|interferon alfa 2b
5295398|NCT02199314|intra|intra
5295399|NCT02199314|operative|operative
5295400|NCT02199314|neurophysiologic|neurophysiologic
5295401|NCT02199314|monitoring|monitoring
5295402|NCT02199314|transcranial|transcranial
5963022|NCT04276987|SARS-CoV-2|sars-cov-2
5295403|NCT02199314|motor|motor
5295404|NCT02199314|evoked|evoked
5295405|NCT02199314|potential|potential
5295406|NCT02199314|anesthesia|anesthesia
5295407|NCT02199314|pulses|pulses
5295408|NCT02199301|Kidney transplantation|kidney transplantation
5295409|NCT02199301|Tolerance induction|tolerance induction
5295410|NCT02199301|Immunosuppression withdrawal|immunosuppression withdrawal
5295411|NCT02199301|Bone marrow transplantation|bone marrow transplantation
5295412|NCT02199301|Transplantation conditioning|transplantation conditioning
5295413|NCT02199301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5295414|NCT02199301|Living donor|living donor
5295415|NCT02199301|Haplotype|haplotype
5295416|NCT02199301|Immune tolerance|immune tolerance
5295417|NCT02199275|Non-urgent surgery|non-urgent surgery
5295418|NCT02199275|General anesthesia|general anesthesia
5295419|NCT02199275|Enterocyte damage|enterocyte damage
5295420|NCT02199275|Intestinal fatty acid-binding protein|intestinal fatty acid-binding protein
5295421|NCT02199262|Intensive care unit|intensive care unit
5295422|NCT02199262|Incidents|incidents
5295423|NCT02199262|prevention|prevention
5295424|NCT02199262|music|music
5295425|NCT02199262|reflexology|reflexology
5295426|NCT02199249|open anatomic reduction|open anatomic reduction
5295427|NCT02199249|syndesmosis screw fixation, syndesmosis Tightrope fixation|syndesmosis screw fixation, syndesmosis tightrope fixation
5295428|NCT02199236|High-Dose-Rate Brachytherapy|high-dose-rate brachytherapy
5295429|NCT02199236|oral capecitabine|oral capecitabine
5295430|NCT02199236|infusional 5-FU|infusional 5-fu
5295431|NCT02199236|Questionnaires|questionnaires
5295432|NCT02199236|14-104|14-104
5295433|NCT02199210|Massive transfusion protocols|massive transfusion protocols
5300130|NCT02176863|IGIV|igiv
5295434|NCT02199210|Self-regulatory learning|self-regulatory learning
5295436|NCT02199210|Clinical expertise|clinical expertise
5295437|NCT02199210|Simulation|simulation
5295438|NCT02199210|Education|education
5295539|NCT02198703|Probiotics|probiotics
5295439|NCT02199171|hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin|hyperthermic intraoperative intraperitoneal chemotherapy (hipec) carboplatin
5295440|NCT02199171|intraperitoneal (IP) chemotherapy|intraperitoneal (ip) chemotherapy
5295445|NCT02199158|anterior chamber|anterior chamber
5295446|NCT02199158|laser treatment|laser treatment
5295447|NCT02199132|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5295448|NCT02199119|children|children
5295449|NCT02199119|television|television
5295450|NCT02199119|exercise|exercise
5295451|NCT02199119|food intake|food intake
5295452|NCT02199119|appetite|appetite
5295453|NCT02199119|satiation|satiation
5295454|NCT02199093|MeSH terms:|mesh terms:
5295455|NCT02199093|Apraxias|apraxias
5295456|NCT02199093|Apraxia, Ideomotor|apraxia, ideomotor
5295457|NCT02199093|Stroke|stroke
5295458|NCT02199093|Cerebral Stroke|cerebral stroke
5295459|NCT02199093|Rehabilitation|rehabilitation
5295460|NCT02199093|Occupational therapy|occupational therapy
5295461|NCT02199093|Treatment Outcome|treatment outcome
5295462|NCT02199093|Activities of Daily Living|activities of daily living
5295463|NCT02199054|Snack Foods|snack foods
5295464|NCT02199054|Safflower Oil|safflower oil
5295466|NCT02199054|Postmenopausal women|postmenopausal women
5295467|NCT02199054|Metabolic Syndrome|metabolic syndrome
5295468|NCT02199041|Cord Blood|cord blood
5295469|NCT02199041|Haploidentical|haploidentical
5295470|NCT02199041|Reduced Intensity Regimen|reduced intensity regimen
5295471|NCT02199028|hyaluronidase|hyaluronidase
5295472|NCT02199028|infusion sets|infusion sets
5295473|NCT02199028|insulin pump|insulin pump
5295474|NCT02199028|Continuous glucose monitor|continuous glucose monitor
5295475|NCT02199015|Dysarthria|dysarthria
5295476|NCT02199015|Electrical Stimulation|electrical stimulation
5295477|NCT02199015|Lateral Cord Stimulation|lateral cord stimulation
5295478|NCT02199015|Spasticity|spasticity
5295479|NCT02199015|Treatment|treatment
5295480|NCT02199002|acid pocket|acid pocket
5295481|NCT02199002|GERD|gerd
5295482|NCT02199002|Barrett|barrett
5295483|NCT02198963|Skin irritation potential of RUT058-60.|skin irritation potential of rut058-60.
5295484|NCT02198950|sepsis|sepsis
5295485|NCT02198950|diagnosis|diagnosis
5295486|NCT02198950|biomarker|biomarker
5295487|NCT02198937|smokers|smokers
5295488|NCT02198937|non-smokers|non-smokers
5295489|NCT02198924|sequential administration|sequential administration
5295490|NCT02198924|pain control|pain control
5295491|NCT02198924|inflammation control|inflammation control
5295492|NCT02198924|function recovery|function recovery
5295493|NCT02198911|Habituation|habituation
5295494|NCT02198911|Orosensory cues|orosensory cues
5295495|NCT02198911|Satiation|satiation
5295496|NCT02198885|FAST|fast
5295497|NCT02198885|Thoracoabdominal Trauma|thoracoabdominal trauma
5295498|NCT02198885|Prehospital care|prehospital care
5295499|NCT02198885|ultrasound|ultrasound
5295500|NCT02198885|NanoMaxx Ultrasound|nanomaxx ultrasound
5295501|NCT02198885|RP-Xpress|rp-xpress
5295502|NCT02198872|Autonomic Nervous System, Body composition, Oxygen Uptake,|autonomic nervous system, body composition, oxygen uptake,
5369158|NCT01861041|spinal anesthesia|spinal anesthesia
5164916|NCT02961309|THC|thc
5177114|NCT02884063|PGS|pgs
5295503|NCT02198872|Water Based Physical Training, Land Based Physical Training.|water based physical training, land based physical training.
5295504|NCT02198859|Prostate Cancer|prostate cancer
5295505|NCT02198859|Lithium|lithium
5295506|NCT02198859|Androgen|androgen
5295507|NCT02198859|PSA|psa
5295508|NCT02198833|Urinary Tract Infection|urinary tract infection
5295509|NCT02198833|Bacteriuria|bacteriuria
5295510|NCT02198833|Transurethral Foley Catheter|transurethral foley catheter
5295511|NCT02198833|Suprapubic Foley Catheter|suprapubic foley catheter
5295512|NCT02198833|Spinal Cord injury|spinal cord injury
5295513|NCT02198820|Femoral Neck Fractures|femoral neck fractures
5295514|NCT02198820|Perioperative Care|perioperative care
5295515|NCT02198820|Perioperative Period|perioperative period
5295516|NCT02198820|Postoperative Complications|postoperative complications
5295517|NCT02198794|Dyskinesias|dyskinesias
5295518|NCT02198794|Movement Disorders|movement disorders
5295519|NCT02198794|Central Nervous System Diseases|central nervous system diseases
5295520|NCT02198794|Nervous System Diseases|nervous system diseases
5295521|NCT02198794|Neurologic Manifestations|neurologic manifestations
5295522|NCT02198794|Signs and Symptoms|signs and symptoms
5295523|NCT02198781|atrial fibrilation|atrial fibrilation
5295524|NCT02198781|atrial-ventricula|atrial-ventricula
5295525|NCT02198781|right ventricle|right ventricle
5295526|NCT02198781|left ventricle|left ventricle
5295527|NCT02198781|surrogate marker|surrogate marker
5295528|NCT02198781|ventricular dysfunction|ventricular dysfunction
5295529|NCT02198781|pacing|pacing
5295530|NCT02198768|ankle fracture|ankle fracture
5295531|NCT02198768|ankle fracture-dislocation|ankle fracture-dislocation
5295533|NCT02198768|observational|observational
5295534|NCT02198755|high resolution ultrasound|high resolution ultrasound
5295535|NCT02198755|osteomyelitis|osteomyelitis
5295536|NCT02198716|Percutaneous coronary intervention|percutaneous coronary intervention
5295537|NCT02198716|Elderly|elderly
5295538|NCT02198716|Angina|angina
5292413|NCT02213510|ICD|icd
5295541|NCT02198703|LDL-cholesterol|ldl-cholesterol
5295542|NCT02198703|Hypercholesterolemia|hypercholesterolemia
5295543|NCT02198690|Mammography, Older women, decision making|mammography, older women, decision making
5295544|NCT02198664|Characterized Peanut Allergen|characterized peanut allergen
5295545|NCT02198664|Peanut|peanut
5295547|NCT02198664|Oral Desensitization|oral desensitization
5295549|NCT02198664|Peanut-Allergic Children|peanut-allergic children
5295550|NCT02198664|Children|children
5295551|NCT02198664|Peanut-Allergic Adults|peanut-allergic adults
5295552|NCT02198651|Rheumatoid Arthritis|rheumatoid arthritis
5295553|NCT02198651|Adalimumab|adalimumab
5295554|NCT02198651|Taper|taper
5295555|NCT02198651|Flare|flare
5295556|NCT02198651|Arthritis|arthritis
5295557|NCT02198651|Anti-rheumatic drugs|anti-rheumatic drugs
5295558|NCT02198651|Remission|remission
5295559|NCT02198651|Magnetic Resonance Imaging|magnetic resonance imaging
5295560|NCT02198651|Ultrasound|ultrasound
5295561|NCT02198651|Biomarker|biomarker
5295562|NCT02198651|Drug Level|drug level
5295563|NCT02198651|Reduced dose|reduced dose
5295564|NCT02198638|Influenza|influenza
5295565|NCT02198638|Vaccination rate|vaccination rate
5295566|NCT02198638|Hospital acquired infection|hospital acquired infection
5295567|NCT02198625|Moderate FiO2|moderate fio2
5295568|NCT02198625|Protective lung ventilation|protective lung ventilation
5295569|NCT02198625|Postoperative pulmonary complications|postoperative pulmonary complications
5295570|NCT02198625|Positive end-expiratory pressure|positive end-expiratory pressure
5295571|NCT02198625|recruitment maneuvers|recruitment maneuvers
5295572|NCT02198599|Multiple sclerosis|multiple sclerosis
5295573|NCT02198599|Stroke|stroke
5295574|NCT02198599|Nursing|nursing
5295575|NCT02198599|Mobility|mobility
5295576|NCT02198599|Rehabilitation|rehabilitation
5295577|NCT02198586|Alzheimer's, MRI, APOE|alzheimer's, mri, apoe
5295578|NCT02198573|malaria|malaria
5295580|NCT02198573|pfmrp1|pfmrp1
5295581|NCT02198573|Myanmar|myanmar
5295582|NCT02198560|Normal (Eyes without pathologies)|normal (eyes without pathologies)
5295583|NCT02198547|Local anesthetic adjuvant,|local anesthetic adjuvant,
5295584|NCT02198547|Magnesium solfatus,|magnesium solfatus,
5295585|NCT02198547|Sciatic block|sciatic block
5295586|NCT02198534|visual acuity|visual acuity
5295587|NCT02198534|Landolt C|landolt c
5295588|NCT02198534|ETDRS charts|etdrs charts
5295589|NCT02198534|Freiburg Visual Acuity Test|freiburg visual acuity test
5295590|NCT02198534|FrACT|fract
5295591|NCT02198534|Comparison|comparison
5295592|NCT02198534|acceptance|acceptance
5295593|NCT02198534|Test retest reliability|test retest reliability
5295594|NCT02198534|duration|duration
5295595|NCT02198534|questionnaire|questionnaire
5356873|NCT01917604|open versus closed surgical technique|open versus closed surgical technique
5295596|NCT02198521|Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides.|patients undergoing staged bilateral open carpal tunnel release (ctr) have no difference in overall pain intensity of pain between sides.
5963023|NCT04276987|novel coronavirus pneumonia|novel coronavirus pneumonia
5963024|NCT04276688|nCoV|ncov
5963025|NCT04276688|lopinavir/ ritonavir|lopinavir/ ritonavir
5295597|NCT02198482|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5295598|NCT02198482|Volasertib|volasertib
5295599|NCT02198482|High-risk Myelodysplastic Syndrome (MDS)|high-risk myelodysplastic syndrome (mds)
5295600|NCT02198469|actinic cheilitis|actinic cheilitis
5295601|NCT02198469|Er:YAG ablative fractional laser|er:yag ablative fractional laser
5295602|NCT02198469|methyl aminolevulinate photodynamic therapy|methyl aminolevulinate photodynamic therapy
5295603|NCT02198456|pulmonary arterial hypertension|pulmonary arterial hypertension
5295604|NCT02198430|Haemophilia|haemophilia
5295605|NCT02198430|Arthropathy|arthropathy
5295606|NCT02198430|Range of motion|range of motion
5295607|NCT02198430|Strength|strength
5295608|NCT02198430|Proprioception|proprioception
5295609|NCT02198430|Gait|gait
5295610|NCT02198430|Quality of Life.|quality of life.
5295611|NCT02198417|Polycystic Ovary Syndrome|polycystic ovary syndrome
5295612|NCT02198417|PCOS|pcos
5295613|NCT02198417|Acne|acne
5295614|NCT02198417|Infertility|infertility
5295615|NCT02198417|Irregular menses|irregular menses
5295616|NCT02198417|Irregular period|irregular period
5295617|NCT02198417|Mitochondria|mitochondria
5295618|NCT02198417|Metabolism|metabolism
5295619|NCT02198378|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
5295620|NCT02198378|pain|pain
5295621|NCT02198378|prehospital setting|prehospital setting
5295622|NCT02198378|acute coronary syndrome|acute coronary syndrome
5295623|NCT02198365|mRNA,|mrna,
5295624|NCT02198365|DNA,|dna,
5295625|NCT02198365|integrated HPV DNA|integrated hpv dna
5295626|NCT02198365|human papillomavirus,|human papillomavirus,
5295627|NCT02198365|cervical neoplasia|cervical neoplasia
5295628|NCT02198300|dedicated bifurcation stent|dedicated bifurcation stent
5295629|NCT02198300|sirolimus eluting stent|sirolimus eluting stent
5295630|NCT02198261|alopecia|alopecia
5295631|NCT02198261|androgenetic alopecia|androgenetic alopecia
5295632|NCT02198261|hair loss|hair loss
5295633|NCT02198261|minoxidil|minoxidil
5295634|NCT02198261|5% minoxidil foam|5% minoxidil foam
5295635|NCT02198261|male pattern hair loss|male pattern hair loss
5295636|NCT02198209|liraglutide|liraglutide
5292480|NCT02213185|VAS|vas
5295641|NCT02198157|urinary catheterization|urinary catheterization
5295642|NCT02198157|epidural anaesthesia|epidural anaesthesia
5295643|NCT02198144|Hypertension|hypertension
5295644|NCT02198144|High Blood Pressure|high blood pressure
5295645|NCT02198144|African American Men|african american men
5295647|NCT02198118|breast cancer|breast cancer
5295648|NCT02198118|physiotherapy|physiotherapy
5295649|NCT02198118|radiotherapy|radiotherapy
5295651|NCT02198105|femoropoliteal stenosis/occlusion|femoropoliteal stenosis/occlusion
5295652|NCT02198105|cutting-balloon|cutting-balloon
5295653|NCT02198105|drug-coated-balloon|drug-coated-balloon
5295654|NCT02198092|familial adenomatous polyposis|familial adenomatous polyposis
5295655|NCT02198092|multiple adenomatous polyposis|multiple adenomatous polyposis
5295656|NCT02198092|lynch syndrome|lynch syndrome
5295657|NCT02198092|hnpcc|hnpcc
5295658|NCT02198092|colorectal cancer|colorectal cancer
5295659|NCT02198092|genetic syndrome|genetic syndrome
5295660|NCT02198092|epigenomics|epigenomics
5295661|NCT02198092|septin9|septin9
5295662|NCT02198079|non-tuberculous mycobacteria|non-tuberculous mycobacteria
5295663|NCT02198079|Pediatrics|pediatrics
5295664|NCT02198079|Cystic Fibrosis|cystic fibrosis
5295665|NCT02198066|Sternotomy incision|sternotomy incision
5295666|NCT02198066|Silver dressing|silver dressing
5295667|NCT02198066|Sternal wound infection|sternal wound infection
5295668|NCT02198040|Elbow|elbow
5295669|NCT02198040|Joint disease|joint disease
5295670|NCT02198040|Hemophilia|hemophilia
5295671|NCT02198040|Physiotherapy modalities|physiotherapy modalities
5295672|NCT02198027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5295673|NCT02198027|postoperative analgesia|postoperative analgesia
5295674|NCT02198027|peritubal block|peritubal block
5295675|NCT02198027|pain|pain
5295676|NCT02198027|Visual Analog Pain Scale|visual analog pain scale
5295677|NCT02198014|Knee|knee
5295678|NCT02198014|Joint disease|joint disease
5295679|NCT02198014|Haemophilia|haemophilia
5295680|NCT02198014|Physiotherapy modalities|physiotherapy modalities
5295681|NCT02198001|Platelets|platelets
5295682|NCT02198001|fibrin|fibrin
5295683|NCT02198001|growth factors|growth factors
5295684|NCT02198001|bisphosphonates|bisphosphonates
5295685|NCT02198001|tooth extraction|tooth extraction
5295686|NCT02197988|Surgery|surgery
5295687|NCT02197988|Abdominal|abdominal
5295688|NCT02197988|Epidural Anesthesia|epidural anesthesia
5295689|NCT02197988|Transversus Abdominis Plane Block|transversus abdominis plane block
5295690|NCT02197988|TAP block|tap block
5295691|NCT02197975|Healthy Volunteers|healthy volunteers
5295692|NCT02197962|Osteoarthritis|osteoarthritis
5295693|NCT02197962|Radial shockwaves|radial shockwaves
5295694|NCT02197936|Peristalsis|peristalsis
5295695|NCT02197936|ultrasound|ultrasound
5295696|NCT02197923|Menorrhagia|menorrhagia
5295697|NCT02197923|Dysmenorrhea|dysmenorrhea
5295698|NCT02197923|Pelvic pain|pelvic pain
5295699|NCT02197923|expression profiling|expression profiling
5295700|NCT02197923|uterine biopsies|uterine biopsies
5295701|NCT02197923|serum hormones|serum hormones
5295702|NCT02197897|Tamoxifen citrate|tamoxifen citrate
5295703|NCT02197897|Bladder Cancer|bladder cancer
5295704|NCT02197884|Healthy|healthy
5295705|NCT02197884|JNJ-54861911|jnj-54861911
5295706|NCT02197884|Cytochrome P450 3A4 inhibitor|cytochrome p450 3a4 inhibitor
5295707|NCT02197884|Itraconazole|itraconazole
5295708|NCT02197884|Clarithromycin|clarithromycin
5295709|NCT02197884|Alzheimer's disease|alzheimer's disease
5295710|NCT02197871|COPD|copd
5295711|NCT02197871|malnutrition|malnutrition
5295712|NCT02197871|nutrition supplementation|nutrition supplementation
5295713|NCT02197858|invasive arterial pressure|invasive arterial pressure
5295714|NCT02197858|extended hemodynamic monitoring|extended hemodynamic monitoring
5295715|NCT02197858|propofol|propofol
5295716|NCT02197858|remifentanil|remifentanil
5295717|NCT02197845|sickle cell disease|sickle cell disease
5295718|NCT02197845|hydroxyurea|hydroxyurea
5295719|NCT02197845|patient navigator|patient navigator
5295720|NCT02197845|community health worker|community health worker
5295721|NCT02197845|public health worker|public health worker
5295722|NCT02197845|fetal hemoglobin|fetal hemoglobin
5295723|NCT02197845|health services research|health services research
5295724|NCT02197832|Frozen thawed embryo transfer|frozen thawed embryo transfer
5295725|NCT02197832|Endometrial injury|endometrial injury
5295726|NCT02197832|Ongoing pregnancy rates|ongoing pregnancy rates
5295727|NCT02197780|Diagnostic accuracy|diagnostic accuracy
5295728|NCT02197780|Fecal biomarker|fecal biomarker
5295729|NCT02197780|Clinical Decision Rule|clinical decision rule
5295730|NCT02197780|Cohort Study|cohort study
5295731|NCT02197767|fibrillary glomerulonephritis|fibrillary glomerulonephritis
5295733|NCT02197767|Rituxan|rituxan
5295735|NCT02197767|Zytux™|zytux™
5295736|NCT02197754|pharmacokinetics|pharmacokinetics
5295737|NCT02197754|polyphenol metabolites|polyphenol metabolites
5295738|NCT02197754|lean individuals|lean individuals
5295739|NCT02197754|obese individuals|obese individuals
5295740|NCT02197728|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy|hysterectomy, uterine manipulator, thermal damage, laparoscopy, colpotomy
5295741|NCT02197715|Pregnancy|pregnancy
5295742|NCT02197715|Contraceptive Methods|contraceptive methods
5295743|NCT02197715|Family Planning Services|family planning services
5295745|NCT02197702|asthma|asthma
5295746|NCT02197702|pediatric|pediatric
5295747|NCT02197702|virus|virus
5295748|NCT02197702|corticosteroid|corticosteroid
5295749|NCT02197689|Personalized Medication Management|personalized medication management
5295750|NCT02197689|Medication Adherence|medication adherence
5295751|NCT02197689|SMS Medication Reminder|sms medication reminder
5295752|NCT02197663|acupuncture|acupuncture
5295753|NCT02197663|stroke|stroke
5295754|NCT02197663|Randomized Controlled Trial|randomized controlled trial
5295755|NCT02197650|ALL L-asparaginase encapsulated erythrocytes|all l-asparaginase encapsulated erythrocytes
5295756|NCT02197624|Non-heme iron absorption; HFE|non-heme iron absorption; hfe
5295757|NCT02197611|Haemophilia|haemophilia
5295758|NCT02197611|Adherence of Treatment|adherence of treatment
5295759|NCT02197611|Knowledge of Illness|knowledge of illness
5295760|NCT02197611|Medical-patient Relationship|medical-patient relationship
5295761|NCT02197611|Illness Behavior|illness behavior
5295762|NCT02197611|Treatment Difficulties.|treatment difficulties.
5295763|NCT02197598|nalmefene, alcohol consumption, liver effects|nalmefene, alcohol consumption, liver effects
5295764|NCT02197585|Male patients|male patients
5295765|NCT02197585|Age > 18 year|age > 18 year
5295766|NCT02197585|Primary hernia|primary hernia
5295767|NCT02197585|glue|glue
5295768|NCT02197572|Drug therapy|drug therapy
5295769|NCT02197559|Ischemic Stroke, restenosis,bare-metal stents, drug -eluting stents|ischemic stroke, restenosis,bare-metal stents, drug -eluting stents
5295770|NCT02197546|Injection pain|injection pain
5295771|NCT02197546|local anesthesia|local anesthesia
5295772|NCT02197546|acupuncture|acupuncture
5295773|NCT02197481|BiClamp forceps hepatectomy|biclamp forceps hepatectomy
5295774|NCT02197481|Clamp crushing technique|clamp crushing technique
5295775|NCT02197481|Liver parenchyma transection|liver parenchyma transection
5295776|NCT02197481|Randomized controlled trial|randomized controlled trial
5295777|NCT02197468|Gut microbiome|gut microbiome
5295778|NCT02197468|Necrotizing enterocolitis|necrotizing enterocolitis
5295779|NCT02197468|Antibiotics|antibiotics
5295780|NCT02197429|Vulvodynia|vulvodynia
5295781|NCT02197429|Acupuncture|acupuncture
5295782|NCT02197429|Provoked Vestibulodynia|provoked vestibulodynia
5295783|NCT02197429|Vulvar Vestibulitis|vulvar vestibulitis
5295784|NCT02197429|Vulvar Pain|vulvar pain
5295785|NCT02197429|Dyspareunia|dyspareunia
5295786|NCT02197429|Female Sexual Function|female sexual function
5295787|NCT02197403|Dexmedetomidine|dexmedetomidine
5295788|NCT02197403|Sedation|sedation
5295789|NCT02197403|Paradoxical excitement response|paradoxical excitement response
5295790|NCT02197403|Alcohol drinkers|alcohol drinkers
5295791|NCT02197390|Childhood obesity|childhood obesity
5295792|NCT02197390|Latino|latino
5295793|NCT02197390|Hispanic|hispanic
5295794|NCT02197377|Laryngeal mask airway, edentulous geriatric patient|laryngeal mask airway, edentulous geriatric patient
5295795|NCT02197364|Interstitial Lung Disease|interstitial lung disease
5239596|NCT02505321|fat|fat
5295796|NCT02197364|Diagnosis|diagnosis
5295797|NCT02197364|Krebs Von Den Lungen-6|krebs von den lungen-6
5295798|NCT02197351|stomach neoplasms|stomach neoplasms
5295799|NCT02197351|narrow band imaging|narrow band imaging
5295800|NCT02197351|gastroscopy|gastroscopy
5295801|NCT02197338|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
5295802|NCT02197325|NSTEMI and STEMI|nstemi and stemi
5295803|NCT02197312|yttrium-oxide|yttrium-oxide
5295804|NCT02197312|Y-TZP|y-tzp
5295805|NCT02197312|bridge|bridge
5295806|NCT02197312|NobelProcera|nobelprocera
5295807|NCT02197312|Shaded Zirconia|shaded zirconia
5295808|NCT02197273|Total knee arthroplasty|total knee arthroplasty
5295809|NCT02197273|Total shoulder arthroplasty|total shoulder arthroplasty
5295810|NCT02197273|Total hip arthroplasty|total hip arthroplasty
5295811|NCT02197273|Total joint arthroplasty|total joint arthroplasty
5295812|NCT02197273|Hip replacement|hip replacement
5295813|NCT02197273|Knee replacement|knee replacement
5295814|NCT02197273|Shoulder replacement|shoulder replacement
5295815|NCT02197260|Periodontitis|periodontitis
5295816|NCT02197260|amoxicillin|amoxicillin
5295817|NCT02197260|metronidazole|metronidazole
5295818|NCT02197260|case management|case management
5295819|NCT02197247|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, rifampicin, CYP P450 inducer, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, rifampicin, cyp p450 inducer, egfr genes
5295820|NCT02197234|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, simvastatin, EGFR genes|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, simvastatin, egfr genes
5295821|NCT02197208|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
5295822|NCT02197208|natural cycle|natural cycle
5295823|NCT02197208|spontaneous ovulation|spontaneous ovulation
5295824|NCT02197208|hCG induced natural cycles|hcg induced natural cycles
5295825|NCT02197182|Bacterial Vaginosis (BV)|bacterial vaginosis (bv)
5295826|NCT02197182|Amsel's criteria|amsel's criteria
5295827|NCT02197182|Pap smear|pap smear
5295828|NCT02197169|Brain|brain
5295829|NCT02197169|Brain Cancer|brain cancer
5404148|NCT01703663|Stroke|stroke
5295830|NCT02197169|Brain Neoplasms|brain neoplasms
5295831|NCT02197169|Central Nervous System Diseases|central nervous system diseases
5295832|NCT02197169|Central Nervous System Neoplasms|central nervous system neoplasms
5295834|NCT02197169|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
5295835|NCT02197169|DNX-2401|dnx-2401
5295836|NCT02197169|Delta-24-RGD|delta-24-rgd
5295837|NCT02197169|Glioma|glioma
5295838|NCT02197169|Glioblastoma|glioblastoma
5295839|NCT02197169|Gliosarcoma|gliosarcoma
5295840|NCT02197169|Interferon gamma|interferon gamma
5295841|NCT02197169|Malignant brain tumor|malignant brain tumor
5295842|NCT02197169|Neoplasms, Neuroepithelial|neoplasms, neuroepithelial
5295843|NCT02197169|Neuroectodermal Tumors|neuroectodermal tumors
5295844|NCT02197169|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5295845|NCT02197169|Neoplasms by Histologic Type|neoplasms by histologic type
5295846|NCT02197169|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5295847|NCT02197169|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5295848|NCT02197169|Nervous System Diseases|nervous system diseases
5295849|NCT02197169|Alcyone Lifesciences|alcyone lifesciences
5295850|NCT02197169|AMC™|amc™
5295851|NCT02197169|Cannula|cannula
5295852|NCT02197169|Alcyone MEMS Cannula (AMC™) System|alcyone mems cannula (amc™) system
5295853|NCT02197143|esomeprazole|esomeprazole
5295854|NCT02197143|ranitidine|ranitidine
5295855|NCT02197143|hydrotalcid|hydrotalcid
5295856|NCT02197143|treatment of dyspepsia|treatment of dyspepsia
5295857|NCT02197143|emergancy medicine|emergancy medicine
5295858|NCT02197130|Huntington; chorea; total motor score; CAG repeat: total functional capacity; motor cognitive and behavioral symptoms|huntington; chorea; total motor score; cag repeat: total functional capacity; motor cognitive and behavioral symptoms
5295859|NCT02197117|ST-segment elevation myocardial infarction (STEMI); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection|st-segment elevation myocardial infarction (stemi); thrombolysis, remote ischemic conditioning, myocardial infarct size, cardioprotection
5295860|NCT02197065|hip fracture|hip fracture
5295861|NCT02197065|myocardial ischemia|myocardial ischemia
5295862|NCT02197065|statin|statin
5295863|NCT02197065|surgery|surgery
5295864|NCT02197065|troponin|troponin
5295865|NCT02197065|complication|complication
5295866|NCT02197065|arthroplasty|arthroplasty
5295868|NCT02197065|knee|knee
5295869|NCT02197065|orthopedic|orthopedic
5295870|NCT02197065|atorvastatin|atorvastatin
5295871|NCT02197065|cardiovascular|cardiovascular
5295872|NCT02197039|Peptic ulcer hemorrhage, second-look endoscopy|peptic ulcer hemorrhage, second-look endoscopy
5295873|NCT02197000|BRCA mutation|brca mutation
5295874|NCT02197000|Breast cancer|breast cancer
5295875|NCT02197000|Estrogen metabolism|estrogen metabolism
5295876|NCT02197000|3,3-Diindolylmethane|3,3-diindolylmethane
5295877|NCT02197000|Breast density|breast density
5295878|NCT02196987|Pain|pain
5295879|NCT02196987|Catheter|catheter
5295880|NCT02196987|Urethra|urethra
5963026|NCT04276688|IFN-beta|ifn-beta
5165309|NCT02958852|Statins|statins
5177610|NCT02880956|AD|ad
5177611|NCT02880956|Neurodegenerative diseases|neurodegenerative diseases
5177612|NCT02880956|Memory loss|memory loss
5177613|NCT02880956|Nervous system diseases|nervous system diseases
5177614|NCT02880930|vitamin D|vitamin d
5295881|NCT02196987|Urination|urination
5295882|NCT02196974|bronchoscopy|bronchoscopy
5295883|NCT02196974|lung nodule|lung nodule
5295884|NCT02196974|diagnosis|diagnosis
5295885|NCT02196974|cryobiopsy|cryobiopsy
5295886|NCT02196961|Merkel cell carcinoma|merkel cell carcinoma
5295887|NCT02196961|Adjuvant|adjuvant
5295888|NCT02196961|Nivolumab|nivolumab
5295889|NCT02196948|Supraspinatus, tendinopathy, pain, disability, EPTE|supraspinatus, tendinopathy, pain, disability, epte
5295890|NCT02196935|Cholangitis|cholangitis
5295891|NCT02196935|Choledocholithiasis|choledocholithiasis
5295892|NCT02196935|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5295893|NCT02196935|Medically underserved area|medically underserved area
5295894|NCT02196935|Anesthesia|anesthesia
5295895|NCT02196922|Chronic Heart Failure|chronic heart failure
5295896|NCT02196922|Telehealth|telehealth
5295897|NCT02196922|Self Management|self management
5295898|NCT02196909|HIBM|hibm
5295899|NCT02196909|GNE|gne
5295900|NCT02196870|Airway pressure stress index|airway pressure stress index
5295901|NCT02196870|Transpulmonary pressure stress index|transpulmonary pressure stress index
5295902|NCT02196870|Acute Respiratory Failure|acute respiratory failure
5295903|NCT02196870|Chest wall elastance|chest wall elastance
5295904|NCT02196870|Lung stress|lung stress
5295905|NCT02196857|Leukemia|leukemia
5295906|NCT02196857|Acute myeloid leukemia|acute myeloid leukemia
5295907|NCT02196857|AML|aml
5295908|NCT02196857|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5295909|NCT02196857|MDS|mds
5295910|NCT02196857|FLT3-ITD mutation|flt3-itd mutation
5295911|NCT02196857|Azacytidine|azacytidine
5295912|NCT02196857|5-Azacytidine|5-azacytidine
5295913|NCT02196857|5-AZA|5-aza
5295914|NCT02196857|Vidaza|vidaza
5295915|NCT02196857|5-AZC|5-azc
5295926|NCT02196844|Walk Test|walk test
5295927|NCT02196844|Caregiver|caregiver
5295928|NCT02196831|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5295929|NCT02196831|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5295930|NCT02196831|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5295931|NCT02196831|Growth hormone releasing hormone|growth hormone releasing hormone
5295932|NCT02196831|tesamorelin|tesamorelin
5295933|NCT02196805|bioequivalence|bioequivalence
5295934|NCT02196805|imported PROBUCOL table|imported probucol table
5295935|NCT02196805|Lorelco|lorelco
5295936|NCT02196805|marketed PROBUCOL tablet|marketed probucol tablet
5295937|NCT02196805|Chang Tai|chang tai
5295938|NCT02196792|Joint Diseases|joint diseases
5295939|NCT02196792|Musculoskeletal Diseases|musculoskeletal diseases
5295940|NCT02196792|radiostereometric analysis|radiostereometric analysis
5295941|NCT02196792|Total hip arthroplasty|total hip arthroplasty
5295942|NCT02196779|Abdominoplasty|abdominoplasty
5295943|NCT02196779|circulation|circulation
5295944|NCT02196779|skin|skin
5295945|NCT02196779|dissection|dissection
5295946|NCT02196779|laser|laser
5295947|NCT02196779|fluorescence|fluorescence
5295948|NCT02196779|imaging|imaging
5295949|NCT02196753|Positron emission tomography combined with computed tomography|positron emission tomography combined with computed tomography
5295950|NCT02196753|PET CT|pet ct
5295951|NCT02196753|Cardiovascular Implantable Electronic Device|cardiovascular implantable electronic device
5295952|NCT02196753|Infective endocarditis|infective endocarditis
5295953|NCT02196753|Generator pocket infection|generator pocket infection
5295954|NCT02196753|Fever of unknown origin|fever of unknown origin
5295955|NCT02196740|periapical periodontitis,primary teeth|periapical periodontitis,primary teeth
5295956|NCT02196727|Postoperative pain|postoperative pain
5295957|NCT02196727|Multimodal analgesia|multimodal analgesia
5295958|NCT02196727|Bascom Cleft Lift|bascom cleft lift
5295959|NCT02196727|Day-case.|day-case.
5295960|NCT02196714|Japanese Healthy Volunteers|japanese healthy volunteers
5295961|NCT02196701|methotrexate|methotrexate
5295962|NCT02196701|adalimumab|adalimumab
5295963|NCT02196701|biologic|biologic
5295964|NCT02196701|psoriasis|psoriasis
5295965|NCT02196701|Tumor necrosis factor (TNF)-α inhibitor|tumor necrosis factor (tnf)-α inhibitor
5295966|NCT02196688|Colorectal cancer|colorectal cancer
5295967|NCT02196688|Fruquintinib|fruquintinib
5295969|NCT02196610|End-Stage Renal Disease,|end-stage renal disease,
5295970|NCT02196610|arterial or vascular stiffness,|arterial or vascular stiffness,
5295971|NCT02196610|hemodialysis,|hemodialysis,
5295972|NCT02196610|Pulse wave velocity|pulse wave velocity
5295973|NCT02196610|Renal insufficiency,|renal insufficiency,
5963027|NCT04276571|motor abilities|motor abilities
5963028|NCT04276532|Middle-high risk endometrial cancer|middle-high risk endometrial cancer
5963029|NCT04276532|Sentinel lymph node sampling|sentinel lymph node sampling
5963030|NCT04276532|Pelvic lymphadenectomy|pelvic lymphadenectomy
5963031|NCT04276532|Prognosis|prognosis
5963032|NCT04276454|Head and Neck Cancer|head and neck cancer
5295974|NCT02196610|tonometry|tonometry
5295975|NCT02196597|anorectal manometry|anorectal manometry
5295976|NCT02196571|GDM|gdm
5963033|NCT04276454|Lymphedema|lymphedema
5295977|NCT02196571|Exercise|exercise
5295978|NCT02196571|Diabetes|diabetes
5295979|NCT02196571|Pregnancy|pregnancy
5295980|NCT02196558|Rheumatoid Arthritis|rheumatoid arthritis
5295981|NCT02196558|Japanese subjects|japanese subjects
5295982|NCT02196532|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
5295983|NCT02196532|optical coherence tomography|optical coherence tomography
5295984|NCT02196532|migraine|migraine
5295985|NCT02196506|OPC-34712|opc-34712
5295986|NCT02196506|brexpiprazole|brexpiprazole
5295987|NCT02196506|Major Depressive Disorder|major depressive disorder
5295988|NCT02196506|Adjunctive Treatment|adjunctive treatment
5295989|NCT02196506|Anxious Distress|anxious distress
5295990|NCT02196493|Productive|productive
5295991|NCT02196493|Cough|cough
5295992|NCT02196493|Bronchitis|bronchitis
5295993|NCT02196493|Azithromycin|azithromycin
5295994|NCT02196467|myoblast|myoblast
5295995|NCT02196467|transplantation|transplantation
5295996|NCT02196467|strength|strength
5295997|NCT02196467|tacrolimus|tacrolimus
5295998|NCT02196467|immunosuppression|immunosuppression
5295999|NCT02196454|HPV vaccine|hpv vaccine
5296000|NCT02196454|vaccination|vaccination
5296001|NCT02196454|immunization|immunization
5296002|NCT02196454|video|video
5296003|NCT02196454|health education|health education
5296004|NCT02196454|communication|communication
5296005|NCT02196441|deep topical fornix nerve block|deep topical fornix nerve block
5296006|NCT02196441|topical anesthesia|topical anesthesia
5292842|NCT02211261|first in human|first in human
5296013|NCT02196415|Malalignment|malalignment
5296014|NCT02196415|biplanar radiography|biplanar radiography
5296015|NCT02196415|3D measurement|3d measurement
5296016|NCT02196376|Postural orthostatic syndrome|postural orthostatic syndrome
5296017|NCT02196376|orthostatic intolerance|orthostatic intolerance
5296018|NCT02196376|autonomic dysfunction|autonomic dysfunction
5296019|NCT02196350|personalized treatment|personalized treatment
5296020|NCT02196350|prevention|prevention
5296021|NCT02196350|improved diagnosis|improved diagnosis
5296022|NCT02196337|Iodine deficiency|iodine deficiency
5296023|NCT02196324|Prurigo Nodularis|prurigo nodularis
5296024|NCT02196324|Atopic Dermatitis|atopic dermatitis
5296025|NCT02196324|Lichen-simplex chronicus|lichen-simplex chronicus
5296026|NCT02196311|Supracondylar humerus fractures, external fixation, open reduction, and internal fixation.|supracondylar humerus fractures, external fixation, open reduction, and internal fixation.
5296027|NCT02196298|physical therapy|physical therapy
5296028|NCT02196298|gait|gait
5296029|NCT02196298|pediatric rehabilitation|pediatric rehabilitation
5296030|NCT02196298|gross motor function|gross motor function
5296031|NCT02196298|participation|participation
5296032|NCT02196285|Double|double
5296033|NCT02196285|Viral|viral
5296034|NCT02196285|Vaccine|vaccine
5296035|NCT02196285|Measles|measles
5296036|NCT02196285|Rubella|rubella
5296037|NCT02196285|Safety|safety
5296038|NCT02196285|Efficacy|efficacy
5296039|NCT02196285|Imunogenicity|imunogenicity
5296040|NCT02196259|Pre-Post|pre-post
5296041|NCT02196233|Trigger Finger|trigger finger
5296042|NCT02196233|Prospective Clinical Research|prospective clinical research
5296043|NCT02196233|Randomized|randomized
5296044|NCT02196233|Questionnaires|questionnaires
5296045|NCT02196233|Transverse|transverse
5296046|NCT02196233|Longitudinal|longitudinal
5296047|NCT02196207|Severe Hemophilia A|severe hemophilia a
5296048|NCT02196207|Hemophilia Inhibitor Formation|hemophilia inhibitor formation
5296049|NCT02196207|Eloctate|eloctate
5296050|NCT02196207|Emicizumab|emicizumab
5296051|NCT02196207|Inhibitor Prevention|inhibitor prevention
5296052|NCT02196207|Inhibitor Eradication|inhibitor eradication
5296053|NCT02196155|plantar fasciitis|plantar fasciitis
5296054|NCT02196155|Botulinum toxin A|botulinum toxin a
5296055|NCT02196155|Cortisone|cortisone
5296057|NCT02196142|Cortisol|cortisol
5296058|NCT02196142|Alcohol Craving|alcohol craving
5296059|NCT02196142|Alcohol Dependence|alcohol dependence
5296060|NCT02196129|low back pain|low back pain
5296061|NCT02196129|pharmacoacupuncture|pharmacoacupuncture
5296062|NCT02196129|sinbaro-3|sinbaro-3
5296063|NCT02196116|Alzheimer disease|alzheimer disease
5296064|NCT02196116|amyloid load|amyloid load
5296065|NCT02196116|educational level|educational level
5296066|NCT02196116|cognitive performances|cognitive performances
5296067|NCT02196103|TOLAC|tolac
5296068|NCT02196103|PROM|prom
5296069|NCT02196103|Previous Cesarian section|previous cesarian section
5296070|NCT02196103|Mechanical cervical ripening|mechanical cervical ripening
5296071|NCT02196090|OCD, Exposure and Response Prevention, Vagal Stimulation|ocd, exposure and response prevention, vagal stimulation
5296072|NCT02196077|Budesonide and formoterol inhalation aerosol|budesonide and formoterol inhalation aerosol
5296073|NCT02196064|HIV HCV antiretroviral|hiv hcv antiretroviral
5296074|NCT02196051|Insulin resistance|insulin resistance
5296075|NCT02196051|Exercise|exercise
5296076|NCT02196051|de novo lipogenesis|de novo lipogenesis
5296077|NCT02196051|NAFLD|nafld
5296078|NCT02196051|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5296079|NCT02196038|heart failure|heart failure
5296080|NCT02196025|Insomnia|insomnia
5296081|NCT02196012|overweight|overweight
5296082|NCT02196012|obesity|obesity
5296083|NCT02196012|Technology|technology
5296084|NCT02196012|College Students|college students
5296085|NCT02195986|vaginal dryness|vaginal dryness
5296086|NCT02195986|vaginal and/or vulvar irritation/itching|vaginal and/or vulvar irritation/itching
5296087|NCT02195986|dysuria|dysuria
5296088|NCT02195986|vaginal pain and bleeding associated with sexual activity|vaginal pain and bleeding associated with sexual activity
5296089|NCT02195986|vaginal atrophy|vaginal atrophy
5296090|NCT02195973|ovarian cancer|ovarian cancer
5296091|NCT02195973|platinum resistant|platinum resistant
5296092|NCT02195973|LED225|led225
5296093|NCT02195973|Sonidegib|sonidegib
5296094|NCT02195973|Paclitaxel|paclitaxel
5296095|NCT02195960|skin toxicity, radiotherapy, antioxidants|skin toxicity, radiotherapy, antioxidants
5296096|NCT02195947|Growth hormone|growth hormone
5296097|NCT02195947|IVF/ICSI|ivf/icsi
5296101|NCT02195895|Teriparatide|teriparatide
5296102|NCT02195895|Alendronate|alendronate
5296103|NCT02195895|Alendronic Acid|alendronic acid
5296104|NCT02195895|Osteoporosis|osteoporosis
5296105|NCT02195895|Bone Fracture|bone fracture
5296106|NCT02195895|Bone Loss|bone loss
5296107|NCT02195895|Spinal Cord Injury|spinal cord injury
5296108|NCT02195895|Bone Diseases|bone diseases
5296109|NCT02195895|Metabolic Bone Diseases|metabolic bone diseases
5296110|NCT02195895|Musculoskeletal Diseases|musculoskeletal diseases
5296111|NCT02195895|Spinal Cord Diseases|spinal cord diseases
5296112|NCT02195895|Central Nervous System Diseases|central nervous system diseases
5296113|NCT02195895|Nervous System Diseases|nervous system diseases
5296114|NCT02195895|Nervous System|nervous system
5296115|NCT02195895|Wounds and Injuries|wounds and injuries
5296116|NCT02195895|Bone Density Conservation Agents|bone density conservation agents
5296117|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs
5296118|NCT02195895|Pharmacologic Actions|pharmacologic actions
5296119|NCT02195882|strength training|strength training
5296120|NCT02195882|scapular stabilization|scapular stabilization
5296121|NCT02195882|kayakers.|kayakers.
5296122|NCT02195869|PCYC1129|pcyc1129
5296123|NCT02195869|PCYC1129CA|pcyc1129ca
5296124|NCT02195869|1129|1129
5296125|NCT02195869|Ibrutinib|ibrutinib
5296126|NCT02195869|PCI32765|pci32765
5296127|NCT02195869|IMBRUVICA|imbruvica
5296128|NCT02195869|Pharmacyclics|pharmacyclics
5296129|NCT02195869|PCYC|pcyc
5296130|NCT02195869|GVHD|gvhd
5296131|NCT02195869|Steroid dependent|steroid dependent
5296132|NCT02195869|refractory|refractory
5296133|NCT02195869|chronic|chronic
5296134|NCT02195869|graft versus host disease|graft versus host disease
5296135|NCT02195869|chronic graft versus host disease|chronic graft versus host disease
5296136|NCT02195869|immunology|immunology
5296137|NCT02195856|Diabetes|diabetes
5296138|NCT02195856|Nitrate|nitrate
5296139|NCT02195856|Nitrite|nitrite
5296140|NCT02195856|Hepatic|hepatic
5296142|NCT02195856|Incretin|incretin
5296143|NCT02195856|Insulin|insulin
5296144|NCT02195856|Glucose|glucose
5296145|NCT02195843|CRT-D|crt-d
5296146|NCT02195843|Heart Failure|heart failure
5296147|NCT02195843|Middle East|middle east
5296148|NCT02195843|Quadripolar|quadripolar
5296149|NCT02195830|Sepsis|sepsis
5296150|NCT02195830|ultrasound|ultrasound
5296151|NCT02195830|inferior vena cava collapsibility|inferior vena cava collapsibility
5296152|NCT02195778|Health Literacy|health literacy
5296153|NCT02195778|Adult|adult
5296155|NCT02195778|Disease|disease
5296156|NCT02195778|Age|age
5296157|NCT02195765|Chronic Periodontitis|chronic periodontitis
5296158|NCT02195765|Periodontal disease|periodontal disease
5296159|NCT02195752|Compounded pain cream|compounded pain cream
5296160|NCT02195752|Ordinary care|ordinary care
5296161|NCT02195752|Compounding|compounding
5296162|NCT02195752|Topical treatment|topical treatment
5296163|NCT02195752|Analgesia|analgesia
5296164|NCT02195739|smoking|smoking
5296165|NCT02195739|smoking cessation|smoking cessation
5296166|NCT02195739|cardiovascular disease|cardiovascular disease
5296167|NCT02195739|pharmacological intervention|pharmacological intervention
5283492|NCT02254629|IBS|ibs
5296168|NCT02195739|UK primary care population|uk primary care population
5296169|NCT02195739|nicotine replacement therapy|nicotine replacement therapy
5296170|NCT02195700|Dyskinesias|dyskinesias
5296171|NCT02195700|Movement Disorders|movement disorders
5296172|NCT02195700|Central Nervous System Diseases|central nervous system diseases
5296173|NCT02195700|Nervous System Diseases|nervous system diseases
5296174|NCT02195700|Neurologic Manifestations|neurologic manifestations
5296175|NCT02195700|Signs and Symptoms|signs and symptoms
5296176|NCT02195661|Epilepsy|epilepsy
5296177|NCT02195661|Electroencephalogram|electroencephalogram
5296178|NCT02195661|children|children
5296179|NCT02195661|sedation|sedation
5296180|NCT02195648|Tension-Type Headache|tension-type headache
5296181|NCT02195648|Physical Therapy Modalities|physical therapy modalities
5296182|NCT02195648|Musculoskeletal Manipulations|musculoskeletal manipulations
5296183|NCT02195648|Sub-occipital muscle inhibition technique|sub-occipital muscle inhibition technique
5296184|NCT02195609|Vasomotor Symptoms Associated With Menopause|vasomotor symptoms associated with menopause
5296185|NCT02195609|Menopause|menopause
5296186|NCT02195609|Hot Flashes|hot flashes
5296187|NCT02195609|Postmenopausal Women|postmenopausal women
5296188|NCT02195596|Alzheimer disease, exercise, cognition|alzheimer disease, exercise, cognition
5296189|NCT02195570|contingency management|contingency management
5296190|NCT02195570|smoking cessation|smoking cessation
5296191|NCT02195570|prenatal tobacco exposure|prenatal tobacco exposure
5296192|NCT02195570|maternal smoking|maternal smoking
5296194|NCT02195518|Chronic Hepatitis B|chronic hepatitis b
5296195|NCT02195518|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5296196|NCT02195518|Failure of multiple NAs treatment|failure of multiple nas treatment
5296197|NCT02195479|Multiple Myeloma|multiple myeloma
5296198|NCT02195479|Bortezomib|bortezomib
5296199|NCT02195479|Velcade|velcade
5296200|NCT02195479|Melphalan|melphalan
5296201|NCT02195479|Prednisone|prednisone
5296202|NCT02195479|Daratumumab|daratumumab
5296203|NCT02195453|Non-small cell lung cancer|non-small cell lung cancer
5296204|NCT02195453|FACT-L scale|fact-l scale
5296205|NCT02195453|Yangzhengxiaoji|yangzhengxiaoji
5296206|NCT02195440|Hepatitis C virus, cirrhosis|hepatitis c virus, cirrhosis
5296207|NCT02195427|Nasolabial folds|nasolabial folds
5296208|NCT02195427|Dermal filler|dermal filler
5296209|NCT02195427|Hyaluronic acid (HA)|hyaluronic acid (ha)
5296210|NCT02195427|Wrinkles|wrinkles
5296211|NCT02195414|NeoVas|neovas
5296212|NCT02195414|Bioresorbable scaffold|bioresorbable scaffold
5296213|NCT02195414|Sirolimus|sirolimus
5296214|NCT02195414|First-in-Man|first-in-man
5296215|NCT02195401|autism, cleanroom, immune dysregulation, toxins|autism, cleanroom, immune dysregulation, toxins
5296216|NCT02195388|Arterial stiffness,|arterial stiffness,
5296217|NCT02195388|endothelial function,|endothelial function,
5296218|NCT02195388|autonomic nervous system,|autonomic nervous system,
5296219|NCT02195388|acute coronary syndrome,|acute coronary syndrome,
5296220|NCT02195388|arterial hypertension,|arterial hypertension,
5296221|NCT02195388|pulse wave velocity,|pulse wave velocity,
5296222|NCT02195388|augmentation index,|augmentation index,
5296223|NCT02195388|arterial stiffness index,|arterial stiffness index,
5296224|NCT02195388|heart rate variability,|heart rate variability,
5296225|NCT02195388|heart rate turbulence,|heart rate turbulence,
5296226|NCT02195388|vascular endothelial growth factor,|vascular endothelial growth factor,
5296227|NCT02195388|asymmetric dimethylarginine|asymmetric dimethylarginine
5296228|NCT02195375|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5296229|NCT02195375|FEV1 ≤ 50%|fev1 ≤ 50%
5296230|NCT02195349|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
5296231|NCT02195349|Delayed Type Hypersensitivity|delayed type hypersensitivity
5296233|NCT02195349|Induration|induration
5296234|NCT02195349|First time in human|first time in human
5296235|NCT02195349|T-cells|t-cells
5296236|NCT02195349|LAG-3|lag-3
5296237|NCT02195349|safety|safety
5296238|NCT02195349|GSK2831781|gsk2831781
5296239|NCT02195349|psoriasis|psoriasis
5296240|NCT02195323|autologous bone marrow mesenchymal stem cells chronic kidney disease|autologous bone marrow mesenchymal stem cells chronic kidney disease
5296241|NCT02195310|Sternotomy|sternotomy
5296242|NCT02195310|Surgical site Occurences|surgical site occurences
5296243|NCT02195310|Negative Pressure Wound Therapy|negative pressure wound therapy
5296244|NCT02195310|Surgical Site Infection|surgical site infection
5296245|NCT02195297|cellulitis|cellulitis
5296246|NCT02195297|anticellulitis|anticellulitis
5296247|NCT02195284|Inhaler preference|inhaler preference
5296248|NCT02195284|Overall inhaler error|overall inhaler error
5296249|NCT02195284|DISKUS/ACCUHALER|diskus/accuhaler
5296251|NCT02195284|TURBUHALER|turbuhaler
5296252|NCT02195284|ELLIPTA|ellipta
5296253|NCT02195284|Ease of use|ease of use
5296254|NCT02195284|Critical inhaler error|critical inhaler error
5296255|NCT02195271|Melatonin|melatonin
5296256|NCT02195271|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5296257|NCT02195271|Neuroplasticity|neuroplasticity
5296258|NCT02195271|Analgesia|analgesia
5296259|NCT02195271|Pain|pain
5283630|NCT02253537|TB|tb
5296260|NCT02195245|CO2 filter|co2 filter
5296261|NCT02195245|anesthesia|anesthesia
5296262|NCT02195245|device|device
5296263|NCT02195232|Venous Thromboembolic Events in Cancer Patients|venous thromboembolic events in cancer patients
5296264|NCT02195232|Thromboembolism of Vein in Colorectal Cancer|thromboembolism of vein in colorectal cancer
5296265|NCT02195232|Thromboembolism of Vein in Pancreatic Cancer|thromboembolism of vein in pancreatic cancer
5296266|NCT02195232|Thromboembolism of Vein in Non-small Cell Lung Cancer|thromboembolism of vein in non-small cell lung cancer
5296267|NCT02195219|conservative|conservative
5296268|NCT02195219|treatment|treatment
5296269|NCT02195219|surgical|surgical
5296270|NCT02195219|Acromioclavicular|acromioclavicular
5296271|NCT02195219|Joint|joint
5296272|NCT02195219|dislocation|dislocation
5296273|NCT02195206|Hyperpolarized gas magnetic resonance imaging|hyperpolarized gas magnetic resonance imaging
5296274|NCT02195206|Hyperpolarized Xenon-129 magnetic resonance imaging|hyperpolarized xenon-129 magnetic resonance imaging
5296275|NCT02195206|Lung Imaging|lung imaging
5296276|NCT02195206|Healthy Adults|healthy adults
5296277|NCT02195193|Health Services Research|health services research
5296278|NCT02195193|Acute Coronary Syndromes|acute coronary syndromes
5296279|NCT02195193|Depression|depression
5296280|NCT02195193|Integrated care|integrated care
5296281|NCT02195180|Pancreas|pancreas
5296282|NCT02195180|adenocarcinoma|adenocarcinoma
5296283|NCT02195180|cancer|cancer
5296284|NCT02195180|asparaginase|asparaginase
5296285|NCT02195180|erythrocytes|erythrocytes
5296286|NCT02195180|red blood cell|red blood cell
5296287|NCT02195180|Encapsulation|encapsulation
5296288|NCT02195180|folfox|folfox
5296289|NCT02195180|gemcitabine|gemcitabine
5296290|NCT02195154|18F-DTBZ|18f-dtbz
5296291|NCT02195141|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
5296292|NCT02195141|Locally Advanced Rectal Cancer|locally advanced rectal cancer
5296293|NCT02195141|boost|boost
5296294|NCT02195141|IMRT|imrt
5296295|NCT02195102|transcatheter aortic valve Replacement|transcatheter aortic valve replacement
5296296|NCT02195089|Treatment of Cervical Intraepithelial Neoplasia(CIN3)|treatment of cervical intraepithelial neoplasia(cin3)
5296297|NCT02195076|Lung cancer|lung cancer
5296298|NCT02195076|Breast Cancer|breast cancer
5296299|NCT02195076|Biosensors|biosensors
5296300|NCT02195076|Volatile Organic Compounds|volatile organic compounds
5296301|NCT02195076|Odor|odor
5296302|NCT02195076|Urine Sample|urine sample
5296303|NCT02195076|Exhaled Breath Samples|exhaled breath samples
5296304|NCT02195063|Pain management|pain management
5296318|NCT02195011|Metastatic Colorectal Cancer|metastatic colorectal cancer
5296319|NCT02195011|Liver Metastases|liver metastases
5296320|NCT02195011|SIRT|sirt
5296321|NCT02195011|Refractory|refractory
5296322|NCT02194985|Fabry disease|fabry disease
5296323|NCT02194985|Lysosomal storage disease|lysosomal storage disease
5296324|NCT02194985|migalastat HCl|migalastat hcl
5296325|NCT02194985|AT1001|at1001
5296326|NCT02194972|constipation|constipation
5296327|NCT02194972|colon transit time|colon transit time
5296328|NCT02194972|gut microbiota|gut microbiota
5296329|NCT02194972|soluble dietary fiber|soluble dietary fiber
5296330|NCT02194972|disturbance of gut microbiota in constipation|disturbance of gut microbiota in constipation
5296331|NCT02194959|Patient Navigation|patient navigation
5296332|NCT02194959|Screening Colonoscopy|screening colonoscopy
5296333|NCT02194959|Colorectal Cancer Screening|colorectal cancer screening
5296334|NCT02194959|African Americans|african americans
5296335|NCT02194946|Chronic Kidney Disease,|chronic kidney disease,
5296336|NCT02194946|End-Stage Renal Disease,|end-stage renal disease,
5296337|NCT02194946|Traditional Chinese Medicine,|traditional chinese medicine,
5296338|NCT02194946|dialysis initiation.|dialysis initiation.
5296339|NCT02194933|Schizophrenia|schizophrenia
5296340|NCT02194933|Mental Disorders, Antipsychotic,|mental disorders, antipsychotic,
5296341|NCT02194933|Psychotic disorder, Impulsivity|psychotic disorder, impulsivity
5296342|NCT02194907|Emotional Aging|emotional aging
5296343|NCT02194907|Neurofeedback|neurofeedback
5296344|NCT02194894|Acetaminophen, Non-alcoholic Fatty Liver Disease (NAFLD)|acetaminophen, non-alcoholic fatty liver disease (nafld)
5296345|NCT02194881|Cystic fibrosis|cystic fibrosis
5296346|NCT02194881|CFTR|cftr
5296347|NCT02194881|G551D mutation|g551d mutation
5296348|NCT02194881|Novel treatments|novel treatments
5296349|NCT02194881|Potentiator|potentiator
5296350|NCT02194881|Ivacaftor|ivacaftor
5296351|NCT02194868|Allogeneic hematopoietic stem cell transplantation,|allogeneic hematopoietic stem cell transplantation,
5296352|NCT02194868|Immunoregulatory T lymphocytes,|immunoregulatory t lymphocytes,
5296353|NCT02194868|acute graft versus host disease|acute graft versus host disease
5296354|NCT02194855|rocuronium|rocuronium
5296355|NCT02194855|cisatracurium|cisatracurium
5296356|NCT02194855|pharmacokinetic|pharmacokinetic
5296357|NCT02194842|metastatic|metastatic
5296358|NCT02194842|prostate cancer|prostate cancer
5296359|NCT02194816|Parkinson's Disease|parkinson's disease
5296361|NCT02194816|Complementary and Alternative|complementary and alternative
5296363|NCT02194790|Chronic Kidney Disease|chronic kidney disease
5296364|NCT02194790|Diabetic Nephropathy|diabetic nephropathy
5296365|NCT02194790|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
5296366|NCT02194725|Stress and Coping Model|stress and coping model
5296367|NCT02194725|Coping|coping
5296369|NCT02194686|cilostazol|cilostazol
5296370|NCT02194686|progenitor cells|progenitor cells
5296371|NCT02194686|cardiovascular disease|cardiovascular disease
5296372|NCT02194686|risk factors|risk factors
5296373|NCT02194686|angiogenesis|angiogenesis
5296374|NCT02194686|biological markers|biological markers
5296375|NCT02194686|endothelial function|endothelial function
5296389|NCT02194582|FSGS|fsgs
5296390|NCT02194582|NS|ns
5296391|NCT02194582|Kidney disease|kidney disease
5296392|NCT02194582|Kidney failure|kidney failure
5296393|NCT02194582|Renal disease|renal disease
5296394|NCT02194582|nephrotic syndrome|nephrotic syndrome
5296395|NCT02194582|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5296396|NCT02194582|familial kidney disease|familial kidney disease
5296397|NCT02194582|minimal change disease|minimal change disease
5165828|NCT02955849|SLT|slt
5178153|NCT02877290|NIV|niv
5296398|NCT02194582|proteinuria|proteinuria
5296399|NCT02194543|Cataract|cataract
5296400|NCT02194543|HD 3D|hd 3d
5296401|NCT02194543|Microscope|microscope
5296402|NCT02194530|Peanut allergic individuals|peanut allergic individuals
5296403|NCT02194530|Allergic/atopic individuals (not allergic to peanut)|allergic/atopic individuals (not allergic to peanut)
5296404|NCT02194530|Non-allergic individuals|non-allergic individuals
5296405|NCT02194517|diabetes|diabetes
5296406|NCT02194517|diet control toolset|diet control toolset
5296407|NCT02194517|food exchanges|food exchanges
5296408|NCT02194517|CHO|cho
5296409|NCT02194517|FP|fp
5296412|NCT02194504|Abdominal obesity|abdominal obesity
5296413|NCT02194504|Abdominal adiposity|abdominal adiposity
5296414|NCT02194504|Liver fat|liver fat
5296415|NCT02194504|Belly fat|belly fat
5296416|NCT02194491|[11C]AS2471907|[11c]as2471907
5296417|NCT02194491|ASP3662|asp3662
5296418|NCT02194491|Positron Emission Tomography (PET)|positron emission tomography (pet)
5296419|NCT02194491|Brain enzyme occupancy|brain enzyme occupancy
5296420|NCT02194478|Stress|stress
5296421|NCT02194478|Meditation|meditation
5296422|NCT02194478|Mind body|mind body
5296423|NCT02194439|Acute Graft Versus Host Disease|acute graft versus host disease
5296424|NCT02194439|Affect|affect
5296425|NCT02194439|Anti-inflammatory|anti-inflammatory
5296426|NCT02194439|Anti-inflammatory Agents|anti-inflammatory agents
5296427|NCT02194439|Antigen-Presenting Cells|antigen-presenting cells
5296428|NCT02194439|Alloantigen|alloantigen
5296429|NCT02194439|Allogeneic|allogeneic
5296430|NCT02194439|Allograft rejection|allograft rejection
5296431|NCT02194439|Allograft Tolerance|allograft tolerance
5296432|NCT02194439|Antigens|antigens
5296433|NCT02194439|Autoimmunity|autoimmunity
5296434|NCT02194439|Biomarkers|biomarkers
5296435|NCT02194439|Biospecimen Repository|biospecimen repository
5296437|NCT02194439|Bone Marrow Transplantation|bone marrow transplantation
5296438|NCT02194439|Cell Transplantation|cell transplantation
5296439|NCT02194439|Cells|cells
5296440|NCT02194439|Clonal Expansion|clonal expansion
5296441|NCT02194439|Complex|complex
5296442|NCT02194439|Cytokine|cytokine
5296443|NCT02194439|Data|data
5296444|NCT02194439|Development|development
5296445|NCT02194439|Environment|environment
5296446|NCT02194439|Failure (biologic function)|failure (biologic function)
5296447|NCT02194439|Genomics|genomics
5296448|NCT02194439|Graft-vs-Host Disease|graft-vs-host disease
5296449|NCT02194439|Graft-vs-Leukemia|graft-vs-leukemia
5296450|NCT02194439|GVHD|gvhd
5296452|NCT02194439|Hematopoietic|hematopoietic
5296453|NCT02194439|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5296454|NCT02194439|HCT|hct
5296455|NCT02194439|HSCT|hsct
5296456|NCT02194439|IL-33 Receptor|il-33 receptor
5296457|NCT02194439|Immune Reconstitution|immune reconstitution
5296458|NCT02194439|Immune Response|immune response
5296459|NCT02194439|Inflammatory|inflammatory
5296460|NCT02194439|Modeling|modeling
5296461|NCT02194439|Novel|novel
5296462|NCT02194439|Novel therapeutics|novel therapeutics
5296463|NCT02194439|Outcome|outcome
5296464|NCT02194439|Pathway interactions|pathway interactions
5296465|NCT02194439|Peptides|peptides
5296466|NCT02194439|Prevent|prevent
5296467|NCT02194439|Process|process
5296468|NCT02194439|Production|production
5296469|NCT02194439|Proteomics|proteomics
5296470|NCT02194439|Regulatory T-Lymphocyte|regulatory t-lymphocyte
5296471|NCT02194439|Response|response
5296472|NCT02194439|Role|role
5296473|NCT02194439|Signal|signal
5296474|NCT02194439|ST2|st2
5296475|NCT02194439|Transduction|transduction
5296476|NCT02194439|T-cell response|t-cell response
5296477|NCT02194439|T-cell Activation|t-cell activation
5296478|NCT02194439|T-Lymphocytes|t-lymphocytes
5296479|NCT02194439|Tissues|tissues
5296480|NCT02194400|RSLV-132|rslv-132
5296481|NCT02194400|Systemic Lupus Erythematosus|systemic lupus erythematosus
5296482|NCT02194400|Lupus|lupus
5296483|NCT02194400|SLE|sle
5296484|NCT02194400|Resolve|resolve
5296485|NCT02194374|Leukemia|leukemia
5296486|NCT02194374|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5296487|NCT02194374|CLL|cll
5296488|NCT02194374|Small lymphocytic lymphoma|small lymphocytic lymphoma
5296489|NCT02194374|SLL|sll
5296490|NCT02194374|B cell|b cell
5296491|NCT02194374|ROR1-specific T cells|ror1-specific t cells
5296492|NCT02194374|Fludarabine|fludarabine
5963034|NCT04276454|Treatment|treatment
5296493|NCT02194374|Fludarabine Phosphate|fludarabine phosphate
5296494|NCT02194374|Fludara|fludara
5296495|NCT02194374|Cyclophosphamide|cyclophosphamide
5296496|NCT02194374|Cytoxan|cytoxan
5296497|NCT02194374|Neosar|neosar
5296498|NCT02194374|Rituximab|rituximab
5296499|NCT02194374|Rituxan|rituxan
5296500|NCT02194374|Bendamustine|bendamustine
5296501|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride
5296502|NCT02194374|Bendamustine HCL|bendamustine hcl
5296503|NCT02194374|CEP-18083|cep-18083
5296504|NCT02194374|SDX-105|sdx-105
5296505|NCT02194374|Treanda|treanda
5178258|NCT02876601|Defibrotide|defibrotide
5178259|NCT02876601|Fibrinolysis|fibrinolysis
5296506|NCT02194231|Mesothelioma|mesothelioma
5296508|NCT02194231|Trabectedin|trabectedin
5296509|NCT02194192|prevention of hypotension|prevention of hypotension
5296510|NCT02194192|spinal anesthesia|spinal anesthesia
5296511|NCT02194192|cesarean section|cesarean section
5296512|NCT02194192|ephedrine|ephedrine
5296513|NCT02194192|ondansetron|ondansetron
5296514|NCT02194140|ultrasound|ultrasound
5296515|NCT02194140|iodinated contrast material|iodinated contrast material
5296516|NCT02194140|computed tomography|computed tomography
5296517|NCT02194114|Chronic Renal Failure|chronic renal failure
5296518|NCT02194114|End-Stage Renal Disease|end-stage renal disease
5296519|NCT02194114|Nitrogen Balance|nitrogen balance
5296520|NCT02194114|Dietary Protein Intake|dietary protein intake
5296521|NCT02194101|oxygen delivery|oxygen delivery
5296524|NCT02194062|Chronic rhinosinusitis with polyps|chronic rhinosinusitis with polyps
5296526|NCT02194062|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5296527|NCT02194062|SNOT-22|snot-22
5296528|NCT02194062|Lund-Kennedy|lund-kennedy
5296529|NCT02194036|Ownership of body|ownership of body
5296530|NCT02194036|Bodily and mental balance|bodily and mental balance
5296531|NCT02194036|Learning|learning
5296532|NCT02194036|Body image|body image
5296533|NCT02194036|Sensations|sensations
5296534|NCT02194036|Expectations|expectations
5296535|NCT02194023|chlorhexidine digluconate|chlorhexidine digluconate
5296536|NCT02194023|gingivitis|gingivitis
5296537|NCT02194023|cetylpyridinium chloride|cetylpyridinium chloride
5296538|NCT02194023|mouthrinse|mouthrinse
5296539|NCT02194023|dental plaque|dental plaque
5296540|NCT02194023|de novo|de novo
5296541|NCT02194023|in vivo|in vivo
5296542|NCT02194010|Outcome Measure|outcome measure
5296543|NCT02194010|Patient Reported Questionnaires|patient reported questionnaires
5296544|NCT02193984|Diabetes|diabetes
5296545|NCT02193984|Peer support|peer support
5296546|NCT02193984|Hispanic|hispanic
5296547|NCT02193984|Latino|latino
5296548|NCT02193971|Acute coronary syndrome|acute coronary syndrome
5296549|NCT02193971|Drug eluting stent|drug eluting stent
5296550|NCT02193971|Everolimus|everolimus
5296551|NCT02193971|Prasugrel|prasugrel
5296552|NCT02193958|Acute Myeloid Leukemia|acute myeloid leukemia
5296553|NCT02193958|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5296554|NCT02193958|Myelodysplastic Syndrome|myelodysplastic syndrome
5296555|NCT02193932|EEG triggered|eeg triggered
5296556|NCT02193932|fMRI|fmri
5296557|NCT02193932|epilepsy|epilepsy
5296558|NCT02193932|intractable|intractable
5296559|NCT02193919|psoriasis|psoriasis
5296560|NCT02193906|Cognitive training|cognitive training
5296561|NCT02193906|Multiple sclerosis|multiple sclerosis
5296562|NCT02193906|Cognitive deficits|cognitive deficits
5296563|NCT02193893|cell-based therapy|cell-based therapy
5296564|NCT02193893|autologous bone marrow-derived stem/progenitor cells|autologous bone marrow-derived stem/progenitor cells
5296565|NCT02193893|stem cell infusion, stem cell transplantation|stem cell infusion, stem cell transplantation
5296566|NCT02193893|biological therapy with neurotrophic factors|biological therapy with neurotrophic factors
5296567|NCT02193893|bioactive neurotrophic factors|bioactive neurotrophic factors
5296568|NCT02193880|stem cell transplant|stem cell transplant
5296569|NCT02193867|LIPA|lipa
5296570|NCT02193867|Wolman Disease|wolman disease
5296571|NCT02193867|Wolman Phenotype|wolman phenotype
5296572|NCT02193867|Acid Lipase Deficiency|acid lipase deficiency
5296573|NCT02193867|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
5296574|NCT02193867|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
5296575|NCT02193867|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
5296576|NCT02193867|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
5296577|NCT02193867|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
5296578|NCT02193867|LAL Deficiency|lal deficiency
5296579|NCT02193867|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
5296580|NCT02193867|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
5296581|NCT02193867|Related Disorders:|related disorders:
5296582|NCT02193867|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5296583|NCT02193867|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5296584|NCT02193867|Alcoholic Liver Disease|alcoholic liver disease
5296585|NCT02193867|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5296586|NCT02193867|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
5296587|NCT02193867|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
5296588|NCT02193854|Telemedicine|telemedicine
5296589|NCT02193854|Mobile phone|mobile phone
5296590|NCT02193854|Rural physicians|rural physicians
5296591|NCT02193854|Mongolia|mongolia
5296592|NCT02193841|Simple bone cyst|simple bone cyst
5296593|NCT02193841|Unicameral bone cyst|unicameral bone cyst
5296594|NCT02193828|Dupuytren's nodules|dupuytren's nodules
5296595|NCT02193815|psoriasis|psoriasis
5296597|NCT02193815|vulgaris|vulgaris
5296598|NCT02193815|phase 1|phase 1
5296599|NCT02193815|randomized|randomized
5296600|NCT02193815|double-blind|double-blind
5296601|NCT02193815|topical|topical
5296602|NCT02193815|safety|safety
5296603|NCT02193802|Crohn's disease|crohn's disease
5296604|NCT02193802|small bowel (SB)|small bowel (sb)
5296605|NCT02193802|capsule endoscopy|capsule endoscopy
5296606|NCT02193802|ileocolonoscopy|ileocolonoscopy
5296607|NCT02193802|anti-TNF-alpha antibodies|anti-tnf-alpha antibodies
5296608|NCT02193789|Anastomosis site structure|anastomosis site structure
5296609|NCT02193789|Stent insertion|stent insertion
5296610|NCT02193789|Stent migration|stent migration
5296614|NCT02193776|PA-824|pa-824
5296615|NCT02193776|Bedaquiline|bedaquiline
5296616|NCT02193776|Moxifloxacin|moxifloxacin
5296617|NCT02193776|Pyrazinamide|pyrazinamide
5296618|NCT02193776|Quinolone|quinolone
5296619|NCT02193776|Pretomanid|pretomanid
5296620|NCT02193776|NC-005|nc-005
5296621|NCT02193763|pediatric|pediatric
5296622|NCT02193763|lumbar puncture|lumbar puncture
5296623|NCT02193763|ultrasonography|ultrasonography
5296624|NCT02193763|efficacy|efficacy
5296625|NCT02193750|Crohn's Disease|crohn's disease
5296626|NCT02193724|Heritable Retinoblastoma|heritable retinoblastoma
5296627|NCT02193724|Familial Retinoblastoma|familial retinoblastoma
5296628|NCT02193724|Pluripotent Stem Cells|pluripotent stem cells
5296629|NCT02193698|POEMS syndrome|poems syndrome
5296630|NCT02193698|lenalidomide|lenalidomide
5296631|NCT02193685|(HAEC) Hirschsprung Associated Entrocolistis|(haec) hirschsprung associated entrocolistis
5296632|NCT02193685|(HD) Hirschsprung Disease|(hd) hirschsprung disease
5296633|NCT02193685|(IBD) Inflammatory Bowel Disease|(ibd) inflammatory bowel disease
5296634|NCT02193685|Children|children
5296635|NCT02193672|Advanced cancers|advanced cancers
5296636|NCT02193672|PET/CT|pet/ct
5296637|NCT02193672|Positron emission tomography / computed tomography|positron emission tomography / computed tomography
5296638|NCT02193672|[18F]Fluciclatide|[18f]fluciclatide
5296639|NCT02193672|Chemotherapy|chemotherapy
5296640|NCT02193672|Phone calls|phone calls
5296641|NCT02193659|breakfast cereal|breakfast cereal
5296642|NCT02193659|omega-3|omega-3
5296643|NCT02193659|cholesterol|cholesterol
5296644|NCT02193659|lipidic profile|lipidic profile
5296645|NCT02193659|consumption|consumption
5296646|NCT02193659|acceptability|acceptability
5296647|NCT02193646|Colonoscopy|colonoscopy
5296648|NCT02193646|Adenoma|adenoma
5296650|NCT02193646|Screening Colon Cancer|screening colon cancer
5296651|NCT02193620|Analgesic|analgesic
5296652|NCT02193620|Narcotics|narcotics
5296653|NCT02193620|Opioids|opioids
5296654|NCT02193620|Pain relief after surgery|pain relief after surgery
5296655|NCT02193607|Occult stress incontinence|occult stress incontinence
5296656|NCT02193607|Pelvic Organ Prolapse|pelvic organ prolapse
5296657|NCT02193607|Surgical Intervention|surgical intervention
5296658|NCT02193607|TVT-O(Tension-free vaginal tape-obturator)|tvt-o(tension-free vaginal tape-obturator)
5296659|NCT02193607|Improved Reconstructive Pelvic Surgery|improved reconstructive pelvic surgery
5296660|NCT02193607|Combined Surgery|combined surgery
5296661|NCT02193607|Two-step Approach|two-step approach
5296662|NCT02193607|Prophylactic Incontinence Procedure|prophylactic incontinence procedure
5296663|NCT02193607|Randomized Controlled Trial|randomized controlled trial
5296664|NCT02193594|Preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
5296665|NCT02193594|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5296666|NCT02193594|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
5296667|NCT02193568|Supratentorial Glioma|supratentorial glioma
5296668|NCT02193568|Craniotomy|craniotomy
5296669|NCT02193555|Presbyopia|presbyopia
5296670|NCT02193555|Refractive error correction|refractive error correction
5296671|NCT02193555|Contact lenses|contact lenses
5296672|NCT02193542|regional anesthesia|regional anesthesia
5296673|NCT02193542|general anesthesia|general anesthesia
5296674|NCT02193542|obstetric|obstetric
5296675|NCT02193529|sleeve gastrectomy, dietary intake, morbid obesity.|sleeve gastrectomy, dietary intake, morbid obesity.
5296676|NCT02193503|cancer|cancer
5296677|NCT02193503|solid tumors|solid tumors
5296678|NCT02193503|gene therapy|gene therapy
5296679|NCT02193503|cell therapy|cell therapy
5296680|NCT02193503|encapsulation|encapsulation
5296681|NCT02193490|DNase, Pulmozyme, dry eye disease, treatment|dnase, pulmozyme, dry eye disease, treatment
5296682|NCT02193464|inflammatory bowel disease, registry, incidence, Korea|inflammatory bowel disease, registry, incidence, korea
5296683|NCT02193451|Lower urinary tract symptoms|lower urinary tract symptoms
5296684|NCT02193451|Male LUTS|male luts
5296685|NCT02193451|Voiding dysfunction|voiding dysfunction
5296686|NCT02193451|Benign prostate obstruction|benign prostate obstruction
5296687|NCT02193451|Detrusor underactivity|detrusor underactivity
5296688|NCT02193438|Heart rate variability|heart rate variability
5296689|NCT02193438|Resting energy expenditure|resting energy expenditure
5296690|NCT02193438|Facial thermography|facial thermography
5296691|NCT02193438|Blood pressure|blood pressure
5296692|NCT02193438|Spices ingestion|spices ingestion
5296697|NCT02193412|analgesia nociception index|analgesia nociception index
5296698|NCT02193412|heart rate variability|heart rate variability
5296699|NCT02193412|autonomic nervous system|autonomic nervous system
5296700|NCT02193412|specificity|specificity
5296701|NCT02193412|systemic venous return|systemic venous return
5296702|NCT02193412|pulse pressure variation|pulse pressure variation
5296703|NCT02193412|Intraoperative Monitoring|intraoperative monitoring
5296704|NCT02193399|Stem cell transplantation|stem cell transplantation
5296705|NCT02193399|Fatigue|fatigue
5296709|NCT02193399|Psychosocial aspects|psychosocial aspects
5296710|NCT02193386|Cerebral Palsy|cerebral palsy
5296711|NCT02193386|Physical Therapy|physical therapy
5296712|NCT02193386|gait analysis|gait analysis
5296713|NCT02193386|gross motor function|gross motor function
5296714|NCT02193373|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5296715|NCT02193373|Autonomic Nervous System|autonomic nervous system
5296716|NCT02193373|Heart Rate Variability|heart rate variability
5296717|NCT02193373|Sub-Occipital Release|sub-occipital release
5296719|NCT02193373|Stellate Ganglion Release|stellate ganglion release
5296720|NCT02193360|Inflammation|inflammation
5296722|NCT02193347|Immunotherapy|immunotherapy
5296724|NCT02193334|Hepatocyte Growth Factor|hepatocyte growth factor
5296726|NCT02193334|KP-100IT|kp-100it
5296727|NCT02193334|Intrathecal injection|intrathecal injection
5296728|NCT02193321|Atrial Fibrillation|atrial fibrillation
5296729|NCT02193321|Amniotic Membrane|amniotic membrane
5296730|NCT02193295|Weight Reduction|weight reduction
5296731|NCT02193295|Caloric Restriction|caloric restriction
5296732|NCT02193295|Euglycemic Hyperinsulinemic Clamp|euglycemic hyperinsulinemic clamp
5296733|NCT02193295|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5296734|NCT02193269|Abstinent cocaine users|abstinent cocaine users
5296735|NCT02193269|minocycline|minocycline
5296736|NCT02193269|antibiotic|antibiotic
5296737|NCT02193256|varenicline|varenicline
5296738|NCT02193256|prazosin|prazosin
5296739|NCT02193256|cigarette smoking|cigarette smoking
5296740|NCT02193256|alcohol drinking|alcohol drinking
5296741|NCT02193256|sleep|sleep
5296742|NCT02193256|dreams|dreams
5296743|NCT02193243|Congenital Heart Disease|congenital heart disease
5296744|NCT02193243|Six Minute Walk Test|six minute walk test
5296745|NCT02193243|Exercise Testing|exercise testing
5296746|NCT02193243|Peak oxygen uptake|peak oxygen uptake
5296747|NCT02193230|Atopic dermatitis, Feasibility, Adherence to treatment|atopic dermatitis, feasibility, adherence to treatment
5296748|NCT02193204|Alcohol dependence|alcohol dependence
5296749|NCT02193204|Stress|stress
5296750|NCT02193204|Cytokines|cytokines
5296751|NCT02193204|Depressive Symptomatology|depressive symptomatology
5296752|NCT02193191|Plerixafor|plerixafor
5296753|NCT02193191|13-229|13-229
5296757|NCT02193126|Long term foster care|long term foster care
5296758|NCT02193126|child abuse and neglect|child abuse and neglect
5296759|NCT02193126|trauma|trauma
5296760|NCT02193113|Diabetic Macular Edema|diabetic macular edema
5296761|NCT02193113|DME|dme
5296762|NCT02193113|Plasma Kallikrein inhibitor|plasma kallikrein inhibitor
5296763|NCT02193113|KVD001|kvd001
5296764|NCT02193113|KVD001-001|kvd001-001
5296765|NCT02193113|Intravitreal|intravitreal
5296766|NCT02193113|IVT|ivt
5296767|NCT02193113|Diabetes mellitus|diabetes mellitus
5296768|NCT02193087|Drug therapy|drug therapy
5296769|NCT02193074|Spinal Muscular Atrophy|spinal muscular atrophy
5296770|NCT02193074|SMA|sma
5296771|NCT02193074|SMN|smn
5296772|NCT02193074|SMNRx|smnrx
5296773|NCT02193074|ISIS-SMNRx|isis-smnrx
5296774|NCT02193074|ISIS-SMN Rx|isis-smn rx
5296775|NCT02193074|ISIS 396443|isis 396443
5296776|NCT02193074|IONIS-SMNRx|ionis-smnrx
5296777|NCT02193074|IONIS-SMN Rx|ionis-smn rx
5296778|NCT02193074|Spinraza|spinraza
5296779|NCT02193074|ENDEAR|endear
5296780|NCT02193061|Rotavirus|rotavirus
5296781|NCT02193061|immunological behavior|immunological behavior
5296782|NCT02193061|Rotarix|rotarix
5296783|NCT02193061|RotaTeq|rotateq
5296784|NCT02193061|vaccine interchangeability|vaccine interchangeability
5296785|NCT02193035|Microparticles|microparticles
5296786|NCT02193035|Severe aortic stenosis|severe aortic stenosis
5296787|NCT02193035|Calcified aortic stenosis|calcified aortic stenosis
5296788|NCT02193035|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5296789|NCT02193022|Bangladesh, PKDL, Visceral Leishmaniasis, Children, Miltefosine|bangladesh, pkdl, visceral leishmaniasis, children, miltefosine
5296790|NCT02192996|VLBW preterm|vlbw preterm
5296791|NCT02192996|GUT microbiota|gut microbiota
5296792|NCT02192996|probiotics supplementation|probiotics supplementation
5296793|NCT02192996|immune compounds|immune compounds
5296794|NCT02192970|Retinal detachment|retinal detachment
5296795|NCT02192970|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
5296796|NCT02192957|cardioversion|cardioversion
5296797|NCT02192957|electrical cardioversion|electrical cardioversion
5296798|NCT02192957|atrial fibrillation|atrial fibrillation
5296799|NCT02192957|cardioversion protocol|cardioversion protocol
5296801|NCT02192944|Pharmacokinetic profile|pharmacokinetic profile
5296802|NCT02192892|Young children|young children
5296803|NCT02192892|Acceptability|acceptability
5296804|NCT02192892|Food intake|food intake
5296805|NCT02192892|Energy dense porridge|energy dense porridge
5296806|NCT02192879|thoracic epidural|thoracic epidural
5296807|NCT02192879|continuous paravertebral catheter|continuous paravertebral catheter
5296808|NCT02192879|PCA|pca
5296809|NCT02192879|liver resection|liver resection
5296810|NCT02192879|pain management|pain management
5296811|NCT02192853|Diabetes Mellitus|diabetes mellitus
5296812|NCT02192853|Glucagon-like peptide 1|glucagon-like peptide 1
5296813|NCT02192853|Dipeptidyl peptidase 4|dipeptidyl peptidase 4
5296814|NCT02192853|Dipeptidyl peptidase 4 inhibitor|dipeptidyl peptidase 4 inhibitor
5296816|NCT02192853|Enzyme activity|enzyme activity
5296820|NCT02192827|Asthma|asthma
5296821|NCT02192827|Exacerbation|exacerbation
5296826|NCT02192814|Partial-onset seizures|partial-onset seizures
5296827|NCT02192814|iv|iv
5296828|NCT02192801|Classic Bladder Exstrophy|classic bladder exstrophy
5296829|NCT02192801|Renal function|renal function
5296830|NCT02192801|GFR|gfr
5296831|NCT02192801|Proteinuria|proteinuria
5296832|NCT02192788|SBRT|sbrt
5296833|NCT02192788|Oligometastases|oligometastases
5296834|NCT02192788|Prostate Cancer|prostate cancer
5296835|NCT02192775|Measles virus|measles virus
5296836|NCT02192775|Sodium Iodide Symporter|sodium iodide symporter
5296837|NCT02192775|Cyclophosphamide|cyclophosphamide
5296838|NCT02192775|Refractory multiple myeloma|refractory multiple myeloma
5296839|NCT02192749|autism|autism
5296840|NCT02192749|umbilical cord|umbilical cord
5296841|NCT02192749|mesenchymal|mesenchymal
5296842|NCT02192749|stem cells|stem cells
5296843|NCT02192736|asthma|asthma
5296844|NCT02192736|umbilical cord|umbilical cord
5296845|NCT02192736|mesenchymal|mesenchymal
5296846|NCT02192736|stem cells|stem cells
5296847|NCT02192736|trophic factors|trophic factors
5296848|NCT02192710|outpatient surgery|outpatient surgery
5296849|NCT02192710|anaesthesia|anaesthesia
5296850|NCT02192710|midazolam|midazolam
5296851|NCT02192710|electronic tab|electronic tab
5296852|NCT02192697|safety|safety
5296853|NCT02192697|pharmacokinetics|pharmacokinetics
5296854|NCT02192697|tolerability|tolerability
5296855|NCT02192697|ASP8273|asp8273
5296856|NCT02192697|Non-small Cell Lung Cancer|non-small cell lung cancer
5296857|NCT02192697|T790M resistance mutation|t790m resistance mutation
5296858|NCT02192697|NSCLC|nsclc
5296859|NCT02192697|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
5296860|NCT02192697|irreversible EGFR inhibitor|irreversible egfr inhibitor
5296861|NCT02192697|antitumor activity|antitumor activity
5296862|NCT02192697|EGFR|egfr
5296863|NCT02192684|obstructive sleep apnea|obstructive sleep apnea
5296864|NCT02192684|insulin sensitivity|insulin sensitivity
5296865|NCT02192684|cardiovascular risk|cardiovascular risk
5296866|NCT02192684|positive airway pressure therapy|positive airway pressure therapy
5296867|NCT02192671|hepatocellular carcinoma|hepatocellular carcinoma
5296868|NCT02192671|radiofrequency ablation|radiofrequency ablation
5296869|NCT02192671|hepatic resection|hepatic resection
5296870|NCT02192671|portal hypertension|portal hypertension
5296871|NCT02192671|Milan criteria|milan criteria
5296872|NCT02192671|randomized critical trial|randomized critical trial
5296873|NCT02192619|APL|apl
5296874|NCT02192619|acute promyelocytic leukemia|acute promyelocytic leukemia
5296875|NCT02192619|AML M3|aml m3
5296876|NCT02192606|Laparoscopy|laparoscopy
5296877|NCT02192606|3D Visual System|3d visual system
5296878|NCT02192606|Total Hysterectomy|total hysterectomy
5296879|NCT02192567|Advanced solid malignant tumor|advanced solid malignant tumor
5296880|NCT02192567|phase 1|phase 1
5296881|NCT02192567|oncology|oncology
5296882|NCT02192554|OPC-34712|opc-34712
5296883|NCT02192554|brexpiprazole|brexpiprazole
5296884|NCT02192554|Dementia|dementia
5296885|NCT02192554|Alzheimer's Disease|alzheimer's disease
5296886|NCT02192554|Cognitive Disorders|cognitive disorders
5296887|NCT02192554|Memory|memory
5296888|NCT02192554|Agitation|agitation
5296889|NCT02192541|Urothelial Carcinomas|urothelial carcinomas
5296890|NCT02192541|Non-Squamous Non-Small Cell Lung Carcinomas|non-squamous non-small cell lung carcinomas
5296891|NCT02192541|Refractory Gastrointestinal Carcinomas|refractory gastrointestinal carcinomas
5296892|NCT02192541|Hsp90 Inhibitor|hsp90 inhibitor
5296893|NCT02192541|Sarcomas|sarcomas
5296894|NCT02192528|vitamin D|vitamin d
5296895|NCT02192528|25-hydroxyvitamin D|25-hydroxyvitamin d
5296896|NCT02192528|1,25-dihydroxyvitamin D|1,25-dihydroxyvitamin d
5296897|NCT02192528|MACCE|macce
5296898|NCT02192528|mortality|mortality
5296899|NCT02192528|cardiac|cardiac
5296900|NCT02192528|cerebrovascular|cerebrovascular
5296901|NCT02192515|Healthy Subjects|healthy subjects
5296902|NCT02192515|Japanese Adult|japanese adult
5296903|NCT02192489|Chronic Cutaneous Sarcoidosis|chronic cutaneous sarcoidosis
5296904|NCT02192489|Cutaneous Sarcoidosis|cutaneous sarcoidosis
5296905|NCT02192489|Skin Sarcoidosis|skin sarcoidosis
5296906|NCT02192489|Sarcoidosis|sarcoidosis
5296907|NCT02192476|Stroke, subluxation|stroke, subluxation
5296908|NCT02192450|Diabetes Mellitus|diabetes mellitus
5296911|NCT02192450|Metabolic Diseases|metabolic diseases
5296912|NCT02192450|Endocrine System Diseases|endocrine system diseases
5296913|NCT02192450|Autoimmune Diseases|autoimmune diseases
5296915|NCT02192450|Hypoglycaemic Agents|hypoglycaemic agents
5296916|NCT02192450|Physiological Effetcs of Drugs|physiological effetcs of drugs
5296917|NCT02192437|methionine|methionine
5296918|NCT02192437|cysteine|cysteine
5296919|NCT02192437|sulfur amino acid restriction|sulfur amino acid restriction
5296924|NCT02192411|tumescent|tumescent
5296925|NCT02192411|endovenous|endovenous
5296926|NCT02192411|laser|laser
5296927|NCT02192411|pain|pain
5296939|NCT02192320|Atorvastatin and Dexamethasone|atorvastatin and dexamethasone
5296940|NCT02192320|Chronic Subdural Hematoma|chronic subdural hematoma
5296941|NCT02192320|conservative treatment|conservative treatment
5296942|NCT02192307|Sensitivity|sensitivity
5296943|NCT02192294|Bosutinib|bosutinib
5296944|NCT02192294|absolute bioavailability|absolute bioavailability
5296945|NCT02192281|Physical activity|physical activity
5296946|NCT02192281|Recess|recess
5296947|NCT02192281|Accelerometer|accelerometer
5296948|NCT02192281|Play|play
5296949|NCT02192255|diabetes type 2|diabetes type 2
5296950|NCT02192255|primary care|primary care
5296951|NCT02192255|chronic disease care improvement|chronic disease care improvement
5296952|NCT02192255|adherence, randomized trial|adherence, randomized trial
5296953|NCT02192255|BP control|bp control
5296954|NCT02192255|lipid control|lipid control
5296955|NCT02192255|glucose control|glucose control
5296956|NCT02192255|natural language processing.|natural language processing.
5296957|NCT02192242|acute ischemic pain|acute ischemic pain
5296958|NCT02192242|model|model
5296959|NCT02192242|S100|s100
5296960|NCT02192242|interleukine 6|interleukine 6
5296961|NCT02192216|Body composition|body composition
5296962|NCT02192216|Chemotherapy|chemotherapy
5296963|NCT02192216|Muscle mass|muscle mass
5296964|NCT02192216|Muscle function|muscle function
5296965|NCT02192216|Exercise|exercise
5296966|NCT02192177|Apoptosis|apoptosis
5296967|NCT02192177|intrahepatic cholestasis|intrahepatic cholestasis
5296968|NCT02192177|obstetric outcomes|obstetric outcomes
5296969|NCT02192164|plaque psoriasis|plaque psoriasis
5296970|NCT02192164|smoking|smoking
5296971|NCT02192164|etanercept|etanercept
5296972|NCT02192151|Analgesic|analgesic
5296973|NCT02192151|Narcotics|narcotics
5296974|NCT02192151|Opioids|opioids
5296975|NCT02192151|Non-scheduled substanse|non-scheduled substanse
5296976|NCT02192138|Pleural effusion|pleural effusion
5296977|NCT02192138|Pleural fluid|pleural fluid
5296978|NCT02192138|Thoracentesis|thoracentesis
5296979|NCT02192138|Intrapleural pressure|intrapleural pressure
5296980|NCT02192138|Pleural manometry|pleural manometry
5296981|NCT02192125|stroke|stroke
5296982|NCT02192125|rehabilitation|rehabilitation
5296983|NCT02192125|balance|balance
5296984|NCT02192125|training|training
5296985|NCT02192125|posture|posture
5296986|NCT02192086|Kidney transplantation|kidney transplantation
5296987|NCT02192060|Biofilm|biofilm
5296988|NCT02192060|Triclosan|triclosan
5296989|NCT02192060|Crossover|crossover
5296990|NCT02192060|Clinical trial|clinical trial
5296991|NCT02192034|Colonoscopy|colonoscopy
5296992|NCT02192034|Colon cancer|colon cancer
5296993|NCT02192034|screening|screening
5296994|NCT02192034|navigation|navigation
5296995|NCT02192021|CTCL|ctcl
5296996|NCT02192021|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5296997|NCT02192021|Mycosis Fungoides|mycosis fungoides
5296998|NCT02192008|Challenge|challenge
5296999|NCT02192008|Re-challenge|re-challenge
5297000|NCT02192008|Controlled Infection|controlled infection
5297001|NCT02192008|Enteric fever|enteric fever
5297002|NCT02191982|Cancer|cancer
5297003|NCT02191982|Chemotherapy|chemotherapy
5297004|NCT02191982|Fatigue|fatigue
5297005|NCT02191982|Elderly|elderly
5297006|NCT02191982|Geriatric|geriatric
5297007|NCT02191982|Any Cancer|any cancer
5297008|NCT02191982|Cancer Treatment|cancer treatment
5297009|NCT02191982|Weakness|weakness
5297010|NCT02191982|Tiredness|tiredness
5297011|NCT02191969|Chemotherapy|chemotherapy
5297012|NCT02191969|Adjuvant Chemotherapy|adjuvant chemotherapy
5297013|NCT02191969|Cancer Therapy|cancer therapy
5297014|NCT02191969|Fatigue|fatigue
5297122|NCT02191423|attachment|attachment
5297015|NCT02191969|Physical Activity|physical activity
5297016|NCT02191969|Physical Function|physical function
5297017|NCT02191969|Tiredness|tiredness
5297018|NCT02191969|Colon Cancer|colon cancer
5297019|NCT02191969|Rectal Cancer|rectal cancer
5297020|NCT02191969|Walk With Ease|walk with ease
5297021|NCT02191969|Colorectal Cancer|colorectal cancer
5297022|NCT02191969|Geriatric Assessment|geriatric assessment
5297023|NCT02191969|Geriatric|geriatric
5297025|NCT02191956|Disruptive behavior disorders|disruptive behavior disorders
5297027|NCT02191956|Young Children|young children
5297028|NCT02191956|Parenting|parenting
5297029|NCT02191956|Behavioral Parent Training|behavioral parent training
5297030|NCT02191943|caries|caries
5297031|NCT02191943|proximal|proximal
5297032|NCT02191943|non-cavitated|non-cavitated
5297033|NCT02191943|fluoridation|fluoridation
5297034|NCT02191878|Liver Cancer|liver cancer
5192379|NCT02789982|PTSD|ptsd
5297035|NCT02191878|Liver Neoplasms|liver neoplasms
5166480|NCT02951884|Pain|pain
5297036|NCT02191878|Liver Epithelial Neoplasms|liver epithelial neoplasms
5297037|NCT02191878|Liver Cancer, malignant|liver cancer, malignant
5297038|NCT02191839|cardiac surgery|cardiac surgery
5297039|NCT02191839|alpha 1 antitrypsin|alpha 1 antitrypsin
5297040|NCT02191839|inflammation|inflammation
5297041|NCT02191839|post operative bleeding|post operative bleeding
5297042|NCT02191839|organ function|organ function
5297043|NCT02191826|Transthyretin|transthyretin
5297044|NCT02191826|TTR|ttr
5297045|NCT02191826|Amyloidosis|amyloidosis
5297046|NCT02191826|SOM0226|som0226
5297047|NCT02191826|Familiar Amyloid Polyneuropathy|familiar amyloid polyneuropathy
5297048|NCT02191774|Medical abortion|medical abortion
5297049|NCT02191774|Home abortion|home abortion
5297050|NCT02191683|Anaemia|anaemia
5297051|NCT02191683|Pregnancy|pregnancy
5297052|NCT02191683|Foetal programming|foetal programming
5297053|NCT02191683|Epigenetics|epigenetics
5297054|NCT02191683|Non-communicable diseases|non-communicable diseases
5297055|NCT02191683|Tanzania|tanzania
5297056|NCT02191657|HIV|hiv
5297057|NCT02191657|deferiprone|deferiprone
5297058|NCT02191657|iron chelation|iron chelation
5297059|NCT02191631|OCD|ocd
5297060|NCT02191631|adolescents|adolescents
5297061|NCT02191631|pediatric|pediatric
5297062|NCT02191631|internet|internet
5297063|NCT02191631|online|online
5297064|NCT02191631|CBT|cbt
5297065|NCT02191618|Aneurysm|aneurysm
5297066|NCT02191618|Intracranial Aneurysm|intracranial aneurysm
5297067|NCT02191618|Vascular Diseases|vascular diseases
5297068|NCT02191618|Cardiovascular Diseases|cardiovascular diseases
5297069|NCT02191618|Intracranial Arterial Diseases|intracranial arterial diseases
5297070|NCT02191618|Cerebrovascular Disorders|cerebrovascular disorders
5297071|NCT02191618|Brain Diseases|brain diseases
5297072|NCT02191618|Central Nervous System Diseases|central nervous system diseases
5297073|NCT02191618|Nervous System Diseases|nervous system diseases
5297074|NCT02191605|Computerized Brief Intervention|computerized brief intervention
5297075|NCT02191592|Tinnitus|tinnitus
5297076|NCT02191592|EMA|ema
5297077|NCT02191592|Bothersome|bothersome
5297078|NCT02191566|Stomach Cancer|stomach cancer
5297079|NCT02191553|mindfulness meditation|mindfulness meditation
5297080|NCT02191553|alpha rhythm|alpha rhythm
5297081|NCT02191553|EEG|eeg
5297082|NCT02191553|brain mapping|brain mapping
5297083|NCT02191553|emotion|emotion
5297084|NCT02191553|attention|attention
5297085|NCT02191527|PMTCT|pmtct
5297086|NCT02191527|HIV|hiv
5297087|NCT02191527|Syphilis|syphilis
5297088|NCT02191527|Anemia during pregnancy|anemia during pregnancy
5297089|NCT02191527|Point of care diagnostics|point of care diagnostics
5297090|NCT02191514|Prehospital|prehospital
5297091|NCT02191514|EMS|ems
5297092|NCT02191514|EMD|emd
5297093|NCT02191514|Stroke|stroke
5297094|NCT02191514|Dispatch|dispatch
5297095|NCT02191501|Obesity Treatment|obesity treatment
5297096|NCT02191501|Endoscopy|endoscopy
5297097|NCT02191501|Pyloric Suturing|pyloric suturing
5297098|NCT02191501|Pyloric restriction|pyloric restriction
5297099|NCT02191488|Fluorescence|fluorescence
5297100|NCT02191488|Brain Tumors|brain tumors
5297101|NCT02191488|Brain Metastases|brain metastases
5297102|NCT02191488|Malignant Glioma|malignant glioma
5297103|NCT02191488|Brain Lesions|brain lesions
5284337|NCT02250040|Stroke|stroke
5297104|NCT02191475|sepsis shock|sepsis shock
5297105|NCT02191475|Tigecycline|tigecycline
5297106|NCT02191475|Piperacillin / tazobactam|piperacillin / tazobactam
5297107|NCT02191475|Abdominal infection|abdominal infection
5297108|NCT02191462|Pharmacokinetics|pharmacokinetics
5297109|NCT02191462|Niagen|niagen
5297110|NCT02191462|Nicotinamide riboside|nicotinamide riboside
5297111|NCT02191436|Haemophilia|haemophilia
5297112|NCT02191436|Adherence|adherence
5297113|NCT02191436|Family Functioning|family functioning
5297114|NCT02191436|Quality of Life|quality of life
5297115|NCT02191436|Anxiety|anxiety
5297116|NCT02191436|Illness Behavior|illness behavior
5297117|NCT02191436|Coping Strategies|coping strategies
5297118|NCT02191423|postpartum Depression|postpartum depression
5297119|NCT02191423|Diadic psychotherapy|diadic psychotherapy
5297120|NCT02191423|Oxytocin|oxytocin
5297121|NCT02191423|fMRI|fmri
5297126|NCT02191410|continuous positive-airway ventilation|continuous positive-airway ventilation
5297127|NCT02191410|high-frequency positive-pressure ventilation|high-frequency positive-pressure ventilation
5297128|NCT02191410|stroke volume variation|stroke volume variation
5297129|NCT02191410|fluid responsiveness|fluid responsiveness
5297134|NCT02191371|oxygenation|oxygenation
5297135|NCT02191371|microcirculation|microcirculation
5293903|NCT02206100|PER977|per977
5297140|NCT02191358|Drug-gene interaction|drug-gene interaction
5297141|NCT02191358|Drug-drug-gene interaction|drug-drug-gene interaction
5297142|NCT02191358|Drug Metabolism|drug metabolism
5297144|NCT02191358|Geriatric medicine|geriatric medicine
5297145|NCT02191358|Geriatrics|geriatrics
5297146|NCT02191358|Personalized medicine|personalized medicine
5297147|NCT02191358|Pharmacist|pharmacist
5297148|NCT02191358|Pharmacogenetics|pharmacogenetics
5178841|NCT02872467|stress|stress
5297149|NCT02191358|Pharmacogenomics|pharmacogenomics
5297150|NCT02191358|Pharmacokinetics|pharmacokinetics
5297151|NCT02191358|Polymorphism|polymorphism
5297152|NCT02191358|Polypharmacy|polypharmacy
5297153|NCT02191358|Precision medicine|precision medicine
5297154|NCT02191358|Seniors|seniors
5297155|NCT02191358|YouScript|youscript
5297156|NCT02191358|CYP2C9|cyp2c9
5297157|NCT02191358|CYP2C19|cyp2c19
5297158|NCT02191358|CYP2D6|cyp2d6
5297159|NCT02191358|CYP3A4|cyp3a4
5297160|NCT02191358|CYP3A5|cyp3a5
5297161|NCT02191358|VKORC1|vkorc1
5297162|NCT02191358|Amitriptyline|amitriptyline
5297163|NCT02191358|Aripiprazole|aripiprazole
5297164|NCT02191358|Atomoxetine|atomoxetine
5297165|NCT02191358|Carvedilol|carvedilol
5297166|NCT02191358|Celecoxib|celecoxib
5297167|NCT02191358|Citalopram|citalopram
5297168|NCT02191358|Clobazam|clobazam
5297169|NCT02191358|Clomipramine|clomipramine
5297170|NCT02191358|Clopidogrel|clopidogrel
5297171|NCT02191358|Clozapine|clozapine
5297172|NCT02191358|Codeine|codeine
5297173|NCT02191358|Desipramine|desipramine
5297174|NCT02191358|Dextromethorphan|dextromethorphan
5297175|NCT02191358|Diazepam|diazepam
5297176|NCT02191358|Doxepin|doxepin
5297177|NCT02191358|Escitalopram|escitalopram
5297178|NCT02191358|Esomeprazole|esomeprazole
5297179|NCT02191358|Fesoterodine|fesoterodine
5297180|NCT02191358|Flecainide|flecainide
5297181|NCT02191358|Fluoxetine|fluoxetine
5297182|NCT02191358|Flurbiprofen|flurbiprofen
5297183|NCT02191358|Fluvoxamine|fluvoxamine
5297184|NCT02191358|Haloperidol|haloperidol
5297185|NCT02191358|Hydrocodone|hydrocodone
5297186|NCT02191358|Ibuprofen|ibuprofen
5297187|NCT02191358|Iloperidone|iloperidone
5297188|NCT02191358|Imipramine|imipramine
5297189|NCT02191358|Indomethacin|indomethacin
5297190|NCT02191358|Meloxicam|meloxicam
5297191|NCT02191358|Metoprolol|metoprolol
5297192|NCT02191358|Mexiletine|mexiletine
5297193|NCT02191358|Nortriptyline|nortriptyline
5297194|NCT02191358|Omeprazole|omeprazole
5297195|NCT02191358|Oxycodone|oxycodone
5297196|NCT02191358|Paroxetine|paroxetine
5297197|NCT02191358|Perphenazine|perphenazine
5297198|NCT02191358|Phenobarbital|phenobarbital
5297199|NCT02191358|Phenytoin|phenytoin
5297200|NCT02191358|Pimozide|pimozide
5297201|NCT02191358|Piroxicam|piroxicam
5297202|NCT02191358|Proguanil|proguanil
5297203|NCT02191358|Propafenone|propafenone
5297204|NCT02191358|Propranolol|propranolol
5297205|NCT02191358|Risperidone|risperidone
5297206|NCT02191358|Sertraline|sertraline
5297207|NCT02191358|Tetrabenazine|tetrabenazine
5297208|NCT02191358|Thioridazine|thioridazine
5297209|NCT02191358|Timolol|timolol
5297210|NCT02191358|Tolterodine|tolterodine
5297211|NCT02191358|Torsemide|torsemide
5297212|NCT02191358|Tramadol|tramadol
5297213|NCT02191358|Trimipramine|trimipramine
5297214|NCT02191358|Venlafaxine|venlafaxine
5297215|NCT02191358|Voriconazole|voriconazole
5297216|NCT02191358|Vortioxetine|vortioxetine
5297217|NCT02191345|guided imagery|guided imagery
5297218|NCT02191345|burnout|burnout
5297219|NCT02191345|compassion fatigue|compassion fatigue
5297220|NCT02191345|state anxiety|state anxiety
5297221|NCT02191267|CTE|cte
5297222|NCT02191267|Positron Emission Topography|positron emission topography
5297223|NCT02191267|Tau|tau
5297224|NCT02191267|Beta-amyloid|beta-amyloid
5297225|NCT02191267|Magnetic Resonance Imaging|magnetic resonance imaging
5297226|NCT02191267|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5297227|NCT02191267|Diffusion Tensor Imaging|diffusion tensor imaging
5297324|NCT02190617|Guidelines|guidelines
5297325|NCT02190617|Community Health Worker|community health worker
5297523|NCT02189837|Cholesterol|cholesterol
5297228|NCT02191150|Anaemia, Chronic Kidney Disease, Switching, Aranesp, Darbepoetin Alfa, Epoetin Alfa Biosimilars, Haemodialysis.|anaemia, chronic kidney disease, switching, aranesp, darbepoetin alfa, epoetin alfa biosimilars, haemodialysis.
5297229|NCT02191137|Pulmonary Hypertension,Riociguat,Living with Pulmonary Hypertension Questionnaire|pulmonary hypertension,riociguat,living with pulmonary hypertension questionnaire
5297230|NCT02191124|Measurement-based care|measurement-based care
5297231|NCT02191124|Unipolar depression|unipolar depression
5297232|NCT02191124|Outpatients|outpatients
5297234|NCT02191111|Pharmacy practice|pharmacy practice
5297235|NCT02191111|Patient care|patient care
5297236|NCT02191111|Community pharmacy|community pharmacy
5297237|NCT02191111|Hypertension|hypertension
5297238|NCT02191111|Diabetes|diabetes
5297239|NCT02191111|Dyslipidemia|dyslipidemia
5297240|NCT02191111|Pharmaceutical care|pharmaceutical care
5297241|NCT02191098|HIV|hiv
5297242|NCT02191098|ART|art
5297243|NCT02191072|urticaria,omalizumab|urticaria,omalizumab
5297244|NCT02191059|Non Small Cell Lung Cancer|non small cell lung cancer
5297246|NCT02191059|Icotinib|icotinib
5297247|NCT02191059|Second-line Treatment|second-line treatment
5297248|NCT02191046|nasal irrigation|nasal irrigation
5297249|NCT02191046|sinusitis|sinusitis
5297250|NCT02191046|children|children
5297251|NCT02191046|buffered hypertonic saline|buffered hypertonic saline
5297252|NCT02191046|nasal irrigation device|nasal irrigation device
5297253|NCT02191033|cigarette smoking|cigarette smoking
5297254|NCT02191033|tobacco use cessation products|tobacco use cessation products
5297255|NCT02191020|Total Glucosides of Paeony(TGP)|total glucosides of paeony(tgp)
5297256|NCT02191020|Acitretin Capsules|acitretin capsules
5297257|NCT02191020|Psoriasis Vulgaris|psoriasis vulgaris
5297258|NCT02190994|Hydrocortisone|hydrocortisone
5297259|NCT02190994|Pituitary adenomas|pituitary adenomas
5297260|NCT02190994|Replacement therapy|replacement therapy
5297261|NCT02190981|Small bowel obstruction|small bowel obstruction
5297263|NCT02190981|Emergency department|emergency department
5297264|NCT02190968|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5297265|NCT02190968|Internet interventions|internet interventions
5297266|NCT02190968|Residual depressive symptoms|residual depressive symptoms
5297267|NCT02190968|Depressive relapse prevention|depressive relapse prevention
5297268|NCT02190903|delirium|delirium
5297269|NCT02190903|hip fracture|hip fracture
5297270|NCT02190903|general anesthesia|general anesthesia
5297271|NCT02190903|spinal anesthesia|spinal anesthesia
5297272|NCT02190903|postoperative complications|postoperative complications
5297273|NCT02190877|Heart Failure|heart failure
5297274|NCT02190877|Impedance|impedance
5297275|NCT02190877|Fluids|fluids
5297276|NCT02190851|urinary disorders|urinary disorders
5297277|NCT02190851|Parkinson's disease|parkinson's disease
5297278|NCT02190838|Melanoma|melanoma
5297279|NCT02190838|Melatonin|melatonin
5297280|NCT02190838|Metformin|metformin
5297281|NCT02190838|Dacarbazine|dacarbazine
5297282|NCT02190812|wrist muscle strength|wrist muscle strength
5297283|NCT02190799|Corona Virus|corona virus
5297284|NCT02190799|Convalescent plasma|convalescent plasma
5297285|NCT02190799|Serology|serology
5297286|NCT02190786|Hyperuricemia|hyperuricemia
5297287|NCT02190773|Chronic Periodontitis, Aggressive Periodontitis, RANKL/OPG ratio, Gingival crevicular fluid|chronic periodontitis, aggressive periodontitis, rankl/opg ratio, gingival crevicular fluid
5297288|NCT02190747|Intervention study|intervention study
5297289|NCT02190747|Clinical trial Phase 2|clinical trial phase 2
5297290|NCT02190747|Efficacy and safety|efficacy and safety
5297291|NCT02190747|Heterotopic ossification|heterotopic ossification
5297292|NCT02190747|Flare-up|flare-up
5297293|NCT02190747|Palovarotene|palovarotene
5297294|NCT02190747|Retinoic acid receptor agonist|retinoic acid receptor agonist
5297295|NCT02190747|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
5297296|NCT02190747|Clementia|clementia
5297297|NCT02190747|Myositis Ossificans Progressiva|myositis ossificans progressiva
5297298|NCT02190747|Munchmeyer's Disease|munchmeyer's disease
5297299|NCT02190747|FOP|fop
5297300|NCT02190734|Stroke|stroke
5297301|NCT02190734|Pusher Syndrome|pusher syndrome
5297302|NCT02190734|Lateropulsion|lateropulsion
5297303|NCT02190734|Pushing Behaviors|pushing behaviors
5297304|NCT02190734|Burke Lateropulsion Scale|burke lateropulsion scale
5297305|NCT02190721|Neutropenia|neutropenia
5297306|NCT02190708|PQ912|pq912
5297307|NCT02190708|Midazolam|midazolam
5297308|NCT02190708|Omeprazole|omeprazole
5297309|NCT02190708|Pharmacokinetics|pharmacokinetics
5297310|NCT02190708|Drug Interaction|drug interaction
5297311|NCT02190682|postoperative|postoperative
5297312|NCT02190682|chronic|chronic
5297313|NCT02190682|pain|pain
5297314|NCT02190682|software|software
5297315|NCT02190656|Rectal cancer|rectal cancer
5297316|NCT02190656|Anterior Resection Syndrome|anterior resection syndrome
5297317|NCT02190656|Functional outcomes|functional outcomes
5297318|NCT02190643|Smoking|smoking
5297319|NCT02190643|HIV|hiv
5297320|NCT02190643|Latino|latino
5297321|NCT02190643|Cessation|cessation
5297322|NCT02190643|Nicotine patch|nicotine patch
5297323|NCT02190617|Asthma|asthma
5297328|NCT02190604|CFTR - cystic fibrosis transmembrane conductance regulator|cftr - cystic fibrosis transmembrane conductance regulator
5297330|NCT02190604|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
5297332|NCT02190591|pregnant|pregnant
5297333|NCT02190591|Cesarean Section|cesarean section
5297334|NCT02190591|forceps|forceps
5297335|NCT02190591|vaginal|vaginal
5297336|NCT02190565|pregnancy, lactation, food supplement, anaemia|pregnancy, lactation, food supplement, anaemia
5297338|NCT02190552|Brain Clot|brain clot
5297339|NCT02190552|Brain Diseases|brain diseases
5297340|NCT02190552|Brain Infarction|brain infarction
5297341|NCT02190552|Cerebral Ischemia|cerebral ischemia
5297342|NCT02190552|Cerebrovascular Disorders|cerebrovascular disorders
5297343|NCT02190552|EmboTrap® Revascularization Device|embotrap® revascularization device
5297344|NCT02190552|EmboTrap|embotrap
5297345|NCT02190552|Ischemia|ischemia
5297346|NCT02190552|Ischemic|ischemic
5297347|NCT02190552|Ischemic Stroke|ischemic stroke
5297348|NCT02190552|Mechanical Thrombectomy|mechanical thrombectomy
5297349|NCT02190552|Neurovascular Intervention|neurovascular intervention
5297350|NCT02190552|Revascularization|revascularization
5297351|NCT02190552|Stent Retriever|stent retriever
5297353|NCT02190552|Vascular Diseases|vascular diseases
5297354|NCT02190539|Breast cancer|breast cancer
5297355|NCT02190539|complementary medicine|complementary medicine
5297357|NCT02190539|quality of life|quality of life
5297358|NCT02190526|mesalamine|mesalamine
5297359|NCT02190526|amitriptyline|amitriptyline
5297360|NCT02190526|Severity of Illness Index|severity of illness index
5297361|NCT02190500|stroke|stroke
5297362|NCT02190500|tpa|tpa
5297363|NCT02190500|emergency medical service|emergency medical service
5297364|NCT02190500|ems|ems
5297365|NCT02190500|mobile|mobile
5297366|NCT02190500|ct scan|ct scan
5297367|NCT02190474|fibromyalgia|fibromyalgia
5297368|NCT02190474|juvenile fibromyalgia|juvenile fibromyalgia
5297369|NCT02190474|juvenile primary fibromyalgia syndrome (JPFS)|juvenile primary fibromyalgia syndrome (jpfs)
5297370|NCT02190474|adolescent pain|adolescent pain
5297371|NCT02190474|mindfulness|mindfulness
5297372|NCT02190474|MBSR|mbsr
5297373|NCT02190461|Early Respiratory Rehabilitation|early respiratory rehabilitation
5297374|NCT02190461|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5297375|NCT02190461|Re-admitted patients|re-admitted patients
5297376|NCT02190461|Open clinical trial|open clinical trial
5297377|NCT02190461|Exacerbations|exacerbations
5297378|NCT02190448|galactogogue|galactogogue
5297379|NCT02190448|lactation|lactation
5297380|NCT02190448|milk production|milk production
5297381|NCT02190448|breastfeeding|breastfeeding
5297382|NCT02190435|Computer-assisted navigation|computer-assisted navigation
5297383|NCT02190435|ADAPT|adapt
5297384|NCT02190435|Intramedullary nail|intramedullary nail
5297385|NCT02190435|Intertrochanteric femur fracture|intertrochanteric femur fracture
5297386|NCT02190422|reproductive technologies, assisted|reproductive technologies, assisted
5297387|NCT02190422|echocardiography|echocardiography
5297388|NCT02190422|cardiology|cardiology
5297389|NCT02190422|pediatrics|pediatrics
5297390|NCT02190409|Dental Implant,|dental implant,
5297391|NCT02190396|Calcium|calcium
5297392|NCT02190396|Vitamin D|vitamin d
5297393|NCT02190396|Placental calcification.|placental calcification.
5297394|NCT02190383|Tic-Disorder, Tourette-Disorder, Habit Reversal Training|tic-disorder, tourette-disorder, habit reversal training
5297395|NCT02190370|Tic-Disorder, Tourette-Disorder, Resources activation|tic-disorder, tourette-disorder, resources activation
5297396|NCT02190357|Cirrhosis|cirrhosis
5297397|NCT02190344|Eight|eight
5297398|NCT02190344|Channel|channel
5297399|NCT02190344|Paddle|paddle
5297400|NCT02190344|Coil|coil
5297401|NCT02190344|MRI|mri
5297402|NCT02190344|Prostate|prostate
5297403|NCT02190344|Healthy Male|healthy male
5297404|NCT02190331|Detraining|detraining
5297405|NCT02190331|Neck|neck
5297406|NCT02190331|Exercise|exercise
5297407|NCT02190331|Posture|posture
5297408|NCT02190331|Rehabilitation|rehabilitation
5297409|NCT02190318|peritoneal dialysis；|peritoneal dialysis；
5297410|NCT02190318|residual renal function；|residual renal function；
5297411|NCT02190318|RAAS|raas
5297412|NCT02190279|Prostate Specific Membrane Antigen|prostate specific membrane antigen
5297413|NCT02190279|Radiolabeled PET Agent|radiolabeled pet agent
5297414|NCT02190279|Imaging|imaging
5297415|NCT02190279|NaF|naf
5297421|NCT02190253|Renal Threshold|renal threshold
5297422|NCT02190253|Liver Transplant|liver transplant
5297423|NCT02190253|Transplantation|transplantation
5297424|NCT02190253|Hepatitis E|hepatitis e
5297522|NCT02189837|Raised cholesterol|raised cholesterol
5297425|NCT02190240|Complementary and Alternative Medicine|complementary and alternative medicine
5297426|NCT02190240|Integrative Medicine|integrative medicine
5297427|NCT02190240|Pain Management|pain management
5297428|NCT02190227|Breast Cancer|breast cancer
5297429|NCT02190227|Chemotherapy|chemotherapy
5297430|NCT02190227|Neoadjuvant|neoadjuvant
5297431|NCT02190227|RNA Disruption Assay|rna disruption assay
5297432|NCT02190227|Biopsies|biopsies
5297433|NCT02190227|Response|response
5297434|NCT02190214|Hyperthyroidism|hyperthyroidism
5297435|NCT02190214|Hypothyroidism|hypothyroidism
5297436|NCT02190214|Autoimmune thyroid disorders|autoimmune thyroid disorders
5297437|NCT02190214|Iodine deficiency|iodine deficiency
5297438|NCT02190214|Genetic susceptibility|genetic susceptibility
5297439|NCT02190201|videolaryngoscope|videolaryngoscope
5297440|NCT02190201|double lumen intubation|double lumen intubation
5297441|NCT02190188|wedge insoles,|wedge insoles,
5297445|NCT02190162|Patients undergoing tonsillectomy with or without adenoidectomy|patients undergoing tonsillectomy with or without adenoidectomy
5297447|NCT02190149|Factor FIX Deficiency|factor fix deficiency
5297449|NCT02190136|protein-rich whole foods diet|protein-rich whole foods diet
5297450|NCT02190136|aerobic fitness|aerobic fitness
5302069|NCT02166164|Pain|pain
5297466|NCT02190084|Alzheimer's|alzheimer's
5297467|NCT02190084|executive function|executive function
5297468|NCT02190071|EUS-FNA|eus-fna
5297469|NCT02190071|cytopathology|cytopathology
5297470|NCT02190071|slide smear|slide smear
5297471|NCT02190058|safety|safety
5297472|NCT02190058|pharmacokinetics|pharmacokinetics
5297473|NCT02190058|DS-1971a|ds-1971a
5297474|NCT02190045|Balance|balance
5297475|NCT02190045|gait|gait
5297476|NCT02190045|Wii-Fit|wii-fit
5179137|NCT02870491|Child Diarrhea|child diarrhea
5297477|NCT02190019|Mild Cognitive Impairment|mild cognitive impairment
5297478|NCT02190019|apathy|apathy
5297479|NCT02190019|executive function|executive function
5297480|NCT02190006|Polycystic ovarian syndrome|polycystic ovarian syndrome
5297481|NCT02190006|Follicle output rate|follicle output rate
5297482|NCT02190006|preovulatory count|preovulatory count
5297483|NCT02190006|ICSI|icsi
5297484|NCT02189993|Mortality|mortality
5297485|NCT02189993|Long term follow-up|long term follow-up
5297486|NCT02189993|Parenteral Nutrition, Total|parenteral nutrition, total
5297487|NCT02189980|Nausea|nausea
5297488|NCT02189980|Post-operative|post-operative
5297489|NCT02189967|non-small cell lung cancer|non-small cell lung cancer
5297490|NCT02189967|radiotherapy|radiotherapy
5297491|NCT02189967|accelerated fractionation|accelerated fractionation
5297492|NCT02189967|conventional fractionation|conventional fractionation
5297493|NCT02189967|postoperative|postoperative
5297494|NCT02189954|elderly; laryngeal masks; postoperative complications|elderly; laryngeal masks; postoperative complications
5297495|NCT02189941|Deferiprone|deferiprone
5297496|NCT02189941|Deferiprone sustained-release tablets|deferiprone sustained-release tablets
5297497|NCT02189941|Pharmacokinetics|pharmacokinetics
5297498|NCT02189902|Vitamin D|vitamin d
5297499|NCT02189889|Active preoperative anemia management|active preoperative anemia management
5297500|NCT02189889|Erythrocyte transfusion|erythrocyte transfusion
5297501|NCT02189889|RBC transfusion|rbc transfusion
5297502|NCT02189889|Red cell transfusion|red cell transfusion
5297503|NCT02189889|Transfusion in cardiac surgery|transfusion in cardiac surgery
5297504|NCT02189889|Anemia treatment with erythropoietin|anemia treatment with erythropoietin
5297505|NCT02189889|Anemic cardiac surgery patients|anemic cardiac surgery patients
5297506|NCT02189889|Erythrocyte stimulating agent (ESA)|erythrocyte stimulating agent (esa)
5297507|NCT02189889|Iron deficiency anemia|iron deficiency anemia
5297509|NCT02189889|Feraheme|feraheme
5297510|NCT02189876|HIV Prevention|hiv prevention
5297511|NCT02189876|Behavioral Intervention|behavioral intervention
5297512|NCT02189876|Condom Use|condom use
5297513|NCT02189876|African American|african american
5297514|NCT02189876|Sexually Transmitted Disease|sexually transmitted disease
5297515|NCT02189876|Sexually Transmitted Infection|sexually transmitted infection
5297516|NCT02189876|Internet|internet
5297517|NCT02189863|Driving Simulator|driving simulator
5297518|NCT02189863|Air Optix Aqua|air optix aqua
5297519|NCT02189863|AOAMF|aoamf
5297520|NCT02189850|colonoscopy|colonoscopy
5297521|NCT02189850|pediatric|pediatric
5297524|NCT02189837|Elevated Cholesterol|elevated cholesterol
5297525|NCT02189837|Hyperlipidemias|hyperlipidemias
5297526|NCT02189837|Dyslipidemias|dyslipidemias
5297527|NCT02189837|Lipid Metabolism Disorders|lipid metabolism disorders
5297528|NCT02189837|Metabolic Diseases|metabolic diseases
5297529|NCT02189811|IPV|ipv
5297530|NCT02189811|OPV|opv
5297531|NCT02189811|tOPV|topv
5297532|NCT02189811|bOPV|bopv
5297533|NCT02189811|Polio|polio
5297534|NCT02189811|Endgame|endgame
5297535|NCT02189811|Pakistan|pakistan
5297541|NCT02189798|Adults|adults
5297542|NCT02189798|Cochlear Implant Benefit|cochlear implant benefit
5297543|NCT02189798|Electrical Stimulation|electrical stimulation
5297544|NCT02189798|Electro-Acoustic Stimulation (EAS)|electro-acoustic stimulation (eas)
5297546|NCT02189785|rejection|rejection
5297547|NCT02189785|acceptance|acceptance
5297548|NCT02189785|PET|pet
5297549|NCT02189785|opioid|opioid
5297550|NCT02189785|fMRI|fmri
5297551|NCT02189785|reward|reward
5297552|NCT02189785|exclusion|exclusion
5297553|NCT02189772|ADHD|adhd
5297554|NCT02189772|Inattention|inattention
5297555|NCT02189772|MDX|mdx
5297556|NCT02189759|Hypothermia|hypothermia
5297557|NCT02189759|Hyperthermia|hyperthermia
5297558|NCT02189759|Kangaroo Mother Care|kangaroo mother care
5297559|NCT02189759|Newborn|newborn
5297560|NCT02189746|Hypothermia|hypothermia
5297561|NCT02189746|Newborn|newborn
5297562|NCT02189746|Hyperthermia|hyperthermia
5294326|NCT02204410|ADHD|adhd
5297567|NCT02189720|3,4-Diaminopyridine|3,4-diaminopyridine
5297568|NCT02189720|3,4-DAP|3,4-dap
5297570|NCT02189720|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
5297571|NCT02189720|Neuromuscular|neuromuscular
5297572|NCT02189720|Expanded Access|expanded access
5297573|NCT02189720|Firdapse®|firdapse®
5297574|NCT02189707|Gastrointestinal disorder|gastrointestinal disorder
5297575|NCT02189707|Constipation|constipation
5297576|NCT02189707|Probiotics|probiotics
5297577|NCT02189707|Dietary supplement|dietary supplement
5297578|NCT02189694|Type 1 diabetes|type 1 diabetes
5297579|NCT02189694|Hypoglycemia|hypoglycemia
5297580|NCT02189694|Insulin|insulin
5297581|NCT02189694|Glucagon|glucagon
5297582|NCT02189694|Closed-loop system|closed-loop system
5297583|NCT02189694|Artificial pancreas|artificial pancreas
5297584|NCT02189681|spinal anaesthesia|spinal anaesthesia
5297585|NCT02189681|ultrasound|ultrasound
5297586|NCT02189681|paramedian|paramedian
5297587|NCT02189668|Appendicitis|appendicitis
5297588|NCT02189668|Non-operative|non-operative
5297589|NCT02189668|Children|children
5297590|NCT02189668|Appendicolith|appendicolith
5297591|NCT02189668|fecalith|fecalith
5297592|NCT02189668|Pediatrics|pediatrics
5297593|NCT02189655|shivering spinal anesthesia|shivering spinal anesthesia
5297594|NCT02189629|Acne vulgaris|acne vulgaris
5297595|NCT02189629|Safety|safety
5297596|NCT02189629|Face|face
5297597|NCT02189629|Trunk|trunk
5297598|NCT02189616|asthma management|asthma management
5297599|NCT02189616|SMS reminder|sms reminder
5297600|NCT02189616|SMS consultation|sms consultation
5297601|NCT02189603|hepatitis E|hepatitis e
5297602|NCT02189603|Immunogenicity|immunogenicity
5297603|NCT02189603|vaccine|vaccine
5297604|NCT02189603|safety|safety
5297605|NCT02189590|supraglottic airway|supraglottic airway
5297606|NCT02189590|children|children
5297607|NCT02189590|fiberoptic guided tracheal intubation|fiberoptic guided tracheal intubation
5297608|NCT02189590|air-Q|air-q
5297609|NCT02189590|i-gel|i-gel
5297610|NCT02189577|Chronic Obstructive Pulmonary disease|chronic obstructive pulmonary disease
5297611|NCT02189577|COPD|copd
5297612|NCT02189538|Infections, Enteral nutrition, SIRS, critically ill|infections, enteral nutrition, sirs, critically ill
5297613|NCT02189525|traumatic brain injury|traumatic brain injury
5297614|NCT02189525|sports head injury|sports head injury
5297615|NCT02189525|sports concussion|sports concussion
5297616|NCT02189512|brain-death organ donors|brain-death organ donors
5297617|NCT02189512|intestinal manipulation|intestinal manipulation
5297618|NCT02189512|monocytes|monocytes
5297619|NCT02189499|Stents|stents
5297620|NCT02189499|Angioplasty|angioplasty
5297621|NCT02189499|Coronary Vessels|coronary vessels
5297622|NCT02189499|Coronary Artery Disease|coronary artery disease
5297623|NCT02189499|Angina Pectoris|angina pectoris
5297624|NCT02189499|Myocardial Ischemia|myocardial ischemia
5297625|NCT02189499|Myocardial Infarction|myocardial infarction
5297626|NCT02189499|Myocardial Revascularization|myocardial revascularization
5297627|NCT02189486|Prostate Cancer|prostate cancer
5297628|NCT02189486|Radical Prostatectomy|radical prostatectomy
5297645|NCT02189421|ultra-slim upper endoscope|ultra-slim upper endoscope
5297646|NCT02189421|multibending endoscope|multibending endoscope
5297647|NCT02189408|Platelet rich plasma|platelet rich plasma
5297648|NCT02189408|Autologous conditioned plasma|autologous conditioned plasma
5297649|NCT02189408|Outerbridge|outerbridge
5297650|NCT02189395|Type 2 diabetes|type 2 diabetes
5297651|NCT02189395|Uncontrolled blood glucose|uncontrolled blood glucose
5297652|NCT02189395|insulin|insulin
5297653|NCT02189395|glargine|glargine
5297654|NCT02189395|NPH|nph
5297655|NCT02189382|Sensitivity|sensitivity
5297656|NCT02189356|Pregnancy-related low back and pelvic pain|pregnancy-related low back and pelvic pain
5297657|NCT02189356|exercise program|exercise program
5297658|NCT02189356|nurse|nurse
5297659|NCT02189343|Multiple Myeloma|multiple myeloma
5297660|NCT02189343|Relapsed and Refractory|relapsed and refractory
5297661|NCT02189343|Refractory Disease|refractory disease
5297662|NCT02189343|Progressive Disease|progressive disease
5297663|NCT02189343|Pomalidomide|pomalidomide
5297664|NCT02189343|Dexamethasone|dexamethasone
5192920|NCT02786953|Adolescent|adolescent
5297665|NCT02189343|Proteasome Inhibitor|proteasome inhibitor
5297666|NCT02189343|Ricolinostat|ricolinostat
5297667|NCT02189304|Healthy volunteers|healthy volunteers
5297668|NCT02189291|Indwelling catheter|indwelling catheter
5297669|NCT02189291|Hospital stay|hospital stay
5297670|NCT02189291|Urinary tract infection|urinary tract infection
5297671|NCT02189291|Sacrocolpopexy|sacrocolpopexy
5297672|NCT02189278|Breast Cancer|breast cancer
5297673|NCT02189278|Surveillance|surveillance
5297674|NCT02189278|Mammography|mammography
5297675|NCT02189278|Adherence|adherence
5297676|NCT02189265|Live birth [MeSH]|live birth [mesh]
5297677|NCT02189265|Infant [MeSH]|infant [mesh]
5297678|NCT02189265|Infant, newborn [MeSH]|infant, newborn [mesh]
5297679|NCT02189265|Second-hand smoke|second-hand smoke
5297680|NCT02189265|Tobacco smoke pollution [MeSH]|tobacco smoke pollution [mesh]
5297681|NCT02189265|Smoke-free|smoke-free
5297682|NCT02189265|Smoke-free policy [MeSH]|smoke-free policy [mesh]
5297683|NCT02189226|probe-based confocal laser endomicroscopy (pCLE), early gastric cancer (EGC), endoscopic submucosal dissection (ESD), margin|probe-based confocal laser endomicroscopy (pcle), early gastric cancer (egc), endoscopic submucosal dissection (esd), margin
5297684|NCT02189213|anxiety|anxiety
5297685|NCT02189213|SSRI|ssri
5297686|NCT02189213|biomarker|biomarker
5297687|NCT02189213|sleep|sleep
5297688|NCT02189213|children|children
5297689|NCT02189213|adolescents|adolescents
5297690|NCT02189213|young adults|young adults
5297691|NCT02189200|nutritional counseling|nutritional counseling
5297692|NCT02189200|oat bran|oat bran
5297693|NCT02189200|dyslipidemia|dyslipidemia
5297694|NCT02189200|cardiovascular disease|cardiovascular disease
5297695|NCT02189187|Weight Loss|weight loss
5297696|NCT02189187|Body Weight Changes|body weight changes
5297697|NCT02189187|Body Weight|body weight
5297698|NCT02189187|Magnetic Resonance Imaging|magnetic resonance imaging
5297699|NCT02189187|Emotions|emotions
5297700|NCT02189187|Emotion regulation|emotion regulation
5297701|NCT02189187|Health Behavior|health behavior
5297702|NCT02189187|Eating behavior|eating behavior
5297703|NCT02189174|Solid tumor,|solid tumor,
5297704|NCT02189174|breast cancer,|breast cancer,
5297705|NCT02189174|lung cancer,|lung cancer,
5297706|NCT02189174|endometrial cancer|endometrial cancer
5297707|NCT02189161|anal intraepithelial neoplasia|anal intraepithelial neoplasia
5297709|NCT02189161|Radiofrequency Ablation|radiofrequency ablation
5297711|NCT02189148|Prediction|prediction
5297712|NCT02189148|Preeclampsia|preeclampsia
5297713|NCT02189148|Preterm birth|preterm birth
5297714|NCT02189148|Pregnancy|pregnancy
5297715|NCT02189148|Placenta|placenta
5297716|NCT02189148|Intra-uterine growth restriction|intra-uterine growth restriction
5297717|NCT02189148|fetal growth restriction|fetal growth restriction
5297718|NCT02189148|Ultrasound|ultrasound
5297719|NCT02189148|Doppler|doppler
5297720|NCT02189148|Biomarkers|biomarkers
5297721|NCT02189148|PAPP-A|papp-a
5297722|NCT02189148|Placental growth factor (PlGF)|placental growth factor (plgf)
5297723|NCT02189109|glioblastoma|glioblastoma
5297724|NCT02189109|multiforme|multiforme
5297725|NCT02189109|radiation|radiation
5297726|NCT02189109|radiation therapy|radiation therapy
5297727|NCT02189096|Sepsis|sepsis
5297728|NCT02189096|National Early Warning Score|national early warning score
5297729|NCT02189096|Lactate|lactate
5297732|NCT02189083|Randomized Controlled Trial|randomized controlled trial
5297734|NCT02189070|Percutaneous coronary intervention|percutaneous coronary intervention
5297735|NCT02189070|Patient preference|patient preference
5297736|NCT02189070|DUTCH PEERS|dutch peers
5297737|NCT02189070|TWENTE|twente
5297738|NCT02189057|Bipolar|bipolar
5297739|NCT02189057|Unipolar|unipolar
5297740|NCT02189057|Genotyping|genotyping
5297741|NCT02189057|Pharmacokinetic|pharmacokinetic
5297742|NCT02189057|Pharmacodynamic|pharmacodynamic
5297743|NCT02189044|aged;|aged;
5297744|NCT02189044|breathing exercises;|breathing exercises;
5297745|NCT02189044|muscle strength.|muscle strength.
5297749|NCT02189018|Peripheral arterial disease|peripheral arterial disease
5297750|NCT02189018|Endovascular|endovascular
5297751|NCT02189018|Exercise|exercise
5297752|NCT02189018|Perfusion|perfusion
5297753|NCT02189018|Functional capacity|functional capacity
5297754|NCT02189005|High blood sugar|high blood sugar
5297755|NCT02189005|High HbA1C|high hba1c
5297756|NCT02189005|hyperglycemia|hyperglycemia
5297757|NCT02189005|Pre-Diabetes|pre-diabetes
5297758|NCT02189005|Natural Supplement for Diabetes|natural supplement for diabetes
5297760|NCT02188992|Immune activation|immune activation
5297761|NCT02188992|Systemic Inflammation|systemic inflammation
5297762|NCT02188992|Emergency Medicine|emergency medicine
5193007|NCT02786498|Vitamin D|vitamin d
5297763|NCT02188992|Critical Care|critical care
5297764|NCT02188979|airway|airway
5297765|NCT02188979|equipment - laryngoscopes|equipment - laryngoscopes
5297766|NCT02188979|intubation - tracheal|intubation - tracheal
5297767|NCT02188979|obesity.|obesity.
5297768|NCT02188966|Geographic Information System|geographic information system
5297769|NCT02188966|Emergency Care Information Systems|emergency care information systems
5297770|NCT02188966|Telemedicine|telemedicine
5297771|NCT02188966|Emergency Hospital Service|emergency hospital service
5297772|NCT02188953|aflatoxin|aflatoxin
5297773|NCT02188953|Kenya|kenya
5297774|NCT02188940|Asthma|asthma
5297775|NCT02188940|Obesity|obesity
5297776|NCT02188940|Clinical control|clinical control
5297777|NCT02188940|Exercise|exercise
5297778|NCT02188940|Weight-loss|weight-loss
5297779|NCT02188927|Advanced notification letter|advanced notification letter
5297780|NCT02188927|Standard invitation|standard invitation
5297781|NCT02188927|Participation rate|participation rate
5297782|NCT02188927|Colonoscopy|colonoscopy
5297783|NCT02188927|Screening|screening
5297784|NCT02188927|Colorectal Neoplasms|colorectal neoplasms
5297785|NCT02188927|Digestive System Diseases|digestive system diseases
5297786|NCT02188914|Inhalant use disorder|inhalant use disorder
5297787|NCT02188914|Positron emission tomography|positron emission tomography
5297788|NCT02188914|Magnetic Resonance Imaging|magnetic resonance imaging
5297789|NCT02188914|Executive functions assessment|executive functions assessment
5297790|NCT02188914|Transcriptome|transcriptome
5297793|NCT02188901|Ultrasonography|ultrasonography
5297794|NCT02188901|Screening|screening
5297795|NCT02188888|septic shock|septic shock
5297796|NCT02188888|esmolol|esmolol
5297797|NCT02188888|tachycardia|tachycardia
5297798|NCT02188888|betablockers|betablockers
5297799|NCT02188875|Fitbit One|fitbit one
5297800|NCT02188875|wearable sensor|wearable sensor
5297801|NCT02188875|wearable device|wearable device
5297802|NCT02188875|web-based intervention|web-based intervention
5297803|NCT02188875|SMS text messages|sms text messages
5297804|NCT02188875|randomized controlled trial|randomized controlled trial
5297805|NCT02188875|physical activity|physical activity
5297806|NCT02188875|behavioral intervention|behavioral intervention
5297807|NCT02188875|text message prompts|text message prompts
5297808|NCT02188875|text messaging|text messaging
5297809|NCT02188875|technology|technology
5297810|NCT02188875|exercise|exercise
5297811|NCT02188862|Rheumatic heart disease|rheumatic heart disease
5297812|NCT02188862|Acute rheumatic fever|acute rheumatic fever
5297813|NCT02188862|Group A streptococcal disease|group a streptococcal disease
5297814|NCT02188862|Streptococcus pyogenes|streptococcus pyogenes
5297815|NCT02188862|Genetics|genetics
5297816|NCT02188862|Oceania|oceania
5297817|NCT02188849|creatine|creatine
5297818|NCT02188849|resistance training|resistance training
5297819|NCT02188849|older women|older women
5297820|NCT02188849|muscle strength|muscle strength
5297821|NCT02188823|prediabetes|prediabetes
5297822|NCT02188823|obesity|obesity
5297823|NCT02188823|mindful eating|mindful eating
5297824|NCT02188823|positive affect|positive affect
5297825|NCT02188823|low carbohydrate|low carbohydrate
5297826|NCT02188823|ketogenic|ketogenic
5297827|NCT02188823|diet|diet
5297828|NCT02188810|PAL|pal
5297829|NCT02188810|fluviral|fluviral
5297830|NCT02188810|healthy volunteer|healthy volunteer
5297831|NCT02188810|adjuvant|adjuvant
5298333|NCT02186574|Viread|viread
5297837|NCT02188797|sexual risk behavior|sexual risk behavior
5297838|NCT02188797|group motivational interviewing|group motivational interviewing
5297839|NCT02188771|Moderate to Severe OA|moderate to severe oa
5297840|NCT02188771|VAS score of ≥ 5|vas score of ≥ 5
5297841|NCT02188771|grade III-IV Kellgren Lawrence of OA|grade iii-iv kellgren lawrence of oa
5297842|NCT02188771|subjects who failed conservative treatment|subjects who failed conservative treatment
5297843|NCT02188771|subjects who candidates for total knee replacement (TKR)|subjects who candidates for total knee replacement (tkr)
5297844|NCT02188771|subject 45 and 75 years old|subject 45 and 75 years old
5297845|NCT02188771|subject is experiencing pain in the intended study knee with a VAS score of ≥ 5|subject is experiencing pain in the intended study knee with a vas score of ≥ 5
5297846|NCT02188771|subject has a Body Mass Index (BMI) between 18.5 and 35|subject has a body mass index (bmi) between 18.5 and 35
5297847|NCT02188758|iron|iron
5297848|NCT02188758|hepcidin-25|hepcidin-25
5297849|NCT02188758|pulmonary exacerbation|pulmonary exacerbation
5297850|NCT02188758|interleukin-6|interleukin-6
5297856|NCT02188732|Community Mental Health|community mental health
5297857|NCT02188732|Serious Mental Illness|serious mental illness
5297858|NCT02188732|Medical Comorbidity|medical comorbidity
5297859|NCT02188732|Self-Management|self-management
5297860|NCT02188732|Automated Telehealth|automated telehealth
5297861|NCT02188732|Early Mortality|early mortality
5423352|NCT01616030|Hip fractures|hip fractures
5297862|NCT02188719|Donor-Alloantigen-Reactive Regulatory T Cell Therapy|donor-alloantigen-reactive regulatory t cell therapy
5297863|NCT02188719|Tregs|tregs
5297864|NCT02188719|Cell- and Tissue-Based Therapy|cell- and tissue-based therapy
5297865|NCT02188719|Immunotherapy, Adoptive|immunotherapy, adoptive
5297866|NCT02188719|Liver Transplantation|liver transplantation
5297867|NCT02188680|fructose test|fructose test
5297868|NCT02188667|Chronic Noncancer Pain|chronic noncancer pain
5297869|NCT02188667|Musculoskeletal Pain|musculoskeletal pain
5297870|NCT02188667|Neuropathic Pain|neuropathic pain
5297872|NCT02188654|psoriatic arthritis|psoriatic arthritis
5297873|NCT02188654|inflammation|inflammation
5297874|NCT02188654|metabolic syndrome|metabolic syndrome
5297875|NCT02188654|metformin|metformin
5297876|NCT02188641|Psoriatic arthritis|psoriatic arthritis
5297877|NCT02188641|inflammation|inflammation
5297878|NCT02188641|obesity|obesity
5297879|NCT02188641|diet|diet
5297880|NCT02188641|exercise|exercise
5297881|NCT02188628|Motor recovery, robotics, stroke rehabilitation|motor recovery, robotics, stroke rehabilitation
5297882|NCT02188615|Squamous Cell Esophageal Carcinoma|squamous cell esophageal carcinoma
5297883|NCT02188615|minimally invasive esophagectomy|minimally invasive esophagectomy
5297884|NCT02188615|laparoscopy|laparoscopy
5297885|NCT02188615|thoracoscopy|thoracoscopy
5297886|NCT02188576|Craniofacial Surgery|craniofacial surgery
5297889|NCT02188563|Smoking cessation|smoking cessation
5297890|NCT02188563|Head and neck neoplasms|head and neck neoplasms
5297891|NCT02188563|Lung neoplasms|lung neoplasms
5297892|NCT02188563|Thoracic neoplasms|thoracic neoplasms
5297893|NCT02188563|Radiation|radiation
5297894|NCT02188550|relapse or refractory or persistent epithelial ovarian fallopian tube|relapse or refractory or persistent epithelial ovarian fallopian tube
5297895|NCT02188550|primary peritoneal carcinoma or endometrial cancer|primary peritoneal carcinoma or endometrial cancer
5297896|NCT02188537|Myeloma|myeloma
5297897|NCT02188537|proteasome inhibitor-nonresponsive myeloma|proteasome inhibitor-nonresponsive myeloma
5297898|NCT02188537|Nelfinavir|nelfinavir
5297899|NCT02188537|bortezomib|bortezomib
5297900|NCT02188537|bortezomib-sensitizing drug|bortezomib-sensitizing drug
5297901|NCT02188524|balance, exercise, compensatory stepping, tai chi|balance, exercise, compensatory stepping, tai chi
5297902|NCT02188511|E-Cigarettes|e-cigarettes
5297903|NCT02188511|Lung|lung
5297904|NCT02188511|Non-Smokers|non-smokers
5297905|NCT02188511|Lung Biology|lung biology
5297906|NCT02188472|Oxidative Stress|oxidative stress
5297907|NCT02188472|antibiotics|antibiotics
5297908|NCT02188446|Radical cystectomy|radical cystectomy
5297909|NCT02188446|Bladder cancer|bladder cancer
5297910|NCT02188446|Smoking cessation|smoking cessation
5297911|NCT02188446|Alcohol cessation|alcohol cessation
5297912|NCT02188446|Postoperative complications|postoperative complications
5297913|NCT02188433|Effectiveness of quit immediately (QI) and cut down to quit (CDTQ) interventions in achieving smoking abstinence|effectiveness of quit immediately (qi) and cut down to quit (cdtq) interventions in achieving smoking abstinence
5297916|NCT02188420|Stroke|stroke
5297917|NCT02188420|Paired Associative Stimulation|paired associative stimulation
5297918|NCT02188420|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5297919|NCT02188407|thoracotomy|thoracotomy
5299924|NCT02178215|wrinkle|wrinkle
5297920|NCT02188407|one-lung ventilation (OLV)|one-lung ventilation (olv)
5297921|NCT02188407|total intravenous anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
5297922|NCT02188407|volatile induced and maintained anaesthesia (VIMA)|volatile induced and maintained anaesthesia (vima)
5297923|NCT02188407|cytokines|cytokines
5297924|NCT02188407|interleukine (IL)|interleukine (il)
5297925|NCT02188394|migraine,|migraine,
5297926|NCT02188394|pressure pain,|pressure pain,
5297927|NCT02188394|anesthetic blocks|anesthetic blocks
5297928|NCT02188394|patients|patients
5297929|NCT02188381|Resistant Hypertension (RH)|resistant hypertension (rh)
5297930|NCT02188381|Uncontrolled Hypertension|uncontrolled hypertension
5297931|NCT02188368|Pomalidomide|pomalidomide
5297932|NCT02188368|Lenalidomide refractory|lenalidomide refractory
5297933|NCT02188368|multiple myeloma|multiple myeloma
5297934|NCT02188355|Ultimaster|ultimaster
5297935|NCT02188355|registry|registry
5297937|NCT02188355|DAPT|dapt
5297938|NCT02188329|Early care and education|early care and education
5297939|NCT02188329|ECE|ece
5297940|NCT02188329|workforce|workforce
5297941|NCT02188329|child care|child care
5297942|NCT02188329|caregivers|caregivers
5297943|NCT02188329|home-based providers|home-based providers
5297944|NCT02188329|center-based providers|center-based providers
5297945|NCT02188316|Cold forceps polypectomy|cold forceps polypectomy
5297946|NCT02188316|Diminutive colorectal polyp|diminutive colorectal polyp
5297947|NCT02188316|Hot biopsy forceps electrocauterization|hot biopsy forceps electrocauterization
5297948|NCT02188316|Jumbo forceps.|jumbo forceps.
5297949|NCT02188290|Haploidentical donor|haploidentical donor
5297950|NCT02188290|Unrelated donor|unrelated donor
5297951|NCT02188290|Umbilical cord blood|umbilical cord blood
5297952|NCT02188290|Graft versus host disease|graft versus host disease
5297954|NCT02188290|Hematologic malignancy|hematologic malignancy
5297955|NCT02188290|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5297957|NCT02188251|Gynostemma pentaphyllum|gynostemma pentaphyllum
5297958|NCT02188251|Body weight|body weight
5297959|NCT02188251|Fat Loss|fat loss
5193216|NCT02785120|Phase 2|phase 2
5297960|NCT02188251|Metabolic markers|metabolic markers
5297961|NCT02188251|Overweight participants|overweight participants
5297962|NCT02188251|DXA|dxa
5297963|NCT02188251|AMPK|ampk
5297964|NCT02188238|saliva|saliva
5297965|NCT02188238|protein|protein
5297966|NCT02188238|oral health|oral health
5297967|NCT02188238|film|film
5297968|NCT02188238|pellicle|pellicle
5297969|NCT02188225|Hot flash|hot flash
5297970|NCT02188225|Acupuncture|acupuncture
5297971|NCT02188225|Fluoxetine|fluoxetine
5297972|NCT02188225|Quality of life|quality of life
5297973|NCT02188199|Hip|hip
5297974|NCT02188199|Knee|knee
5297975|NCT02188199|Hip replacement|hip replacement
5297976|NCT02188199|Knee replacement|knee replacement
5297977|NCT02188199|Total Joint|total joint
5297978|NCT02188186|triple combination|triple combination
5297979|NCT02188186|metformin|metformin
5297980|NCT02188186|sitagliptin|sitagliptin
5297981|NCT02188186|thiazolidinedione|thiazolidinedione
5297982|NCT02188160|Pain|pain
5297987|NCT02188147|Syncope|syncope
5297988|NCT02188147|Sudden Cardiac Arrest|sudden cardiac arrest
5297989|NCT02188147|Sudden Cardiac Death|sudden cardiac death
5297990|NCT02188147|Cardiac Arrest|cardiac arrest
5297991|NCT02188147|Emergency Service|emergency service
5297992|NCT02188147|Emergency Department|emergency department
5297993|NCT02188147|Ambulatory Electrocardiography|ambulatory electrocardiography
5297994|NCT02188147|Holter|holter
5297995|NCT02188147|Holter Electrocardiography|holter electrocardiography
5297996|NCT02188147|Holter Monitoring|holter monitoring
5297997|NCT02188134|Adverse events,|adverse events,
5297998|NCT02188134|adverse drug reactions,|adverse drug reactions,
5297999|NCT02188134|medication error,|medication error,
5298000|NCT02188134|noncompliance|noncompliance
5298001|NCT02188108|quality of life|quality of life
5298002|NCT02188108|QOL|qol
5298003|NCT02188108|urolithiasis|urolithiasis
5298004|NCT02188108|nephrolithiasis|nephrolithiasis
5298005|NCT02188108|kidney stones|kidney stones
5298006|NCT02188108|patient-reported outcomes|patient-reported outcomes
5298007|NCT02188069|Non-atherosclerotic Coronary Artery Disease|non-atherosclerotic coronary artery disease
5298008|NCT02188056|Venous|venous
5298009|NCT02188056|Thromboembolic|thromboembolic
5298010|NCT02188056|Pulmonary embolism|pulmonary embolism
5298011|NCT02188043|Alcohol use disorder|alcohol use disorder
5298012|NCT02188043|Motivational Intervention|motivational intervention
5298013|NCT02188043|Health expenditures|health expenditures
5298014|NCT02188043|efficacy study|efficacy study
5298015|NCT02188030|musculoskeletal symptom|musculoskeletal symptom
5298016|NCT02188030|industrial workers|industrial workers
5298017|NCT02188030|physical-activity program|physical-activity program
5298018|NCT02188030|resistance training|resistance training
5298019|NCT02188030|randomized controlled trial|randomized controlled trial
5298123|NCT02187640|Sham control group|sham control group
5298020|NCT02188017|prednisone, methotrexate, sarcoidosis, azathioprine|prednisone, methotrexate, sarcoidosis, azathioprine
5298021|NCT02188004|HPV|hpv
5298022|NCT02188004|genital warts|genital warts
5298023|NCT02187991|metastatic breast cancer|metastatic breast cancer
5298024|NCT02187991|Human Epidermal Growth Factor Receptor 2-negative (HER2-) breast cancer|human epidermal growth factor receptor 2-negative (her2-) breast cancer
5298025|NCT02187991|Estrogen Receptor-positive (ER+) breast cancer|estrogen receptor-positive (er+) breast cancer
5298026|NCT02187991|Triple Negative breast cancer|triple negative breast cancer
5298027|NCT02187991|alisertib|alisertib
5298028|NCT02187991|paclitaxel|paclitaxel
5298029|NCT02187978|Early total enteral feeding (ETEF)|early total enteral feeding (etef)
5298030|NCT02187978|Conventional enteral feeding (CEF)|conventional enteral feeding (cef)
5298031|NCT02187978|VLBW infants|vlbw infants
5298032|NCT02187978|NEC|nec
5298033|NCT02187978|Preterm infants|preterm infants
5298034|NCT02187926|Drug therapy|drug therapy
5298035|NCT02187900|Tripterygium Wilfordii HOOK. f.|tripterygium wilfordii hook. f.
5298036|NCT02187900|Mycophenolate mofetil|mycophenolate mofetil
5298037|NCT02187887|alcohol|alcohol
5298038|NCT02187887|young adult veterans|young adult veterans
5298039|NCT02187887|brief intervention|brief intervention
5298040|NCT02187887|online|online
5298041|NCT02187887|perceived norms|perceived norms
5298042|NCT02187835|complexity|complexity
5298043|NCT02187835|electroencephalogram|electroencephalogram
5298044|NCT02187835|entropy|entropy
5298045|NCT02187835|negative symptoms|negative symptoms
5298046|NCT02187835|schizophrenia.|schizophrenia.
5298047|NCT02187822|Brain|brain
5298048|NCT02187822|Advanced solid tumors|advanced solid tumors
5298049|NCT02187822|Fractionated Stereotactic Radiotherapy (FSRT)|fractionated stereotactic radiotherapy (fsrt)
5298051|NCT02187822|Primary solid malignancy|primary solid malignancy
5298052|NCT02187796|HIV|hiv
5298053|NCT02187796|Dementia|dementia
5298054|NCT02187796|HAND|hand
5298055|NCT02187796|COGNISION System|cognision system
5298056|NCT02187796|ERP|erp
5298057|NCT02187796|event-related potentials|event-related potentials
5298058|NCT02187783|Solid malignancy|solid malignancy
5298059|NCT02187783|Hematologic malignancy|hematologic malignancy
5298060|NCT02187783|Mutations|mutations
5298061|NCT02187783|Amplifications|amplifications
5298062|NCT02187783|Signature|signature
5298064|NCT02187783|CDK6|cdk6
5298065|NCT02187783|CDK4/6|cdk4/6
5298066|NCT02187783|Cyclin D1|cyclin d1
5298067|NCT02187783|CCND,|ccnd,
5298068|NCT02187783|Cyclin D3|cyclin d3
5298069|NCT02187783|p16 mutation|p16 mutation
5298070|NCT02187783|CDKN2A|cdkn2a
5298071|NCT02187783|LEE011|lee011
5298072|NCT02187783|Breast cancer|breast cancer
5298073|NCT02187783|Ovarian cancer|ovarian cancer
5298074|NCT02187783|Lymphoma|lymphoma
5298075|NCT02187783|Mesothelioma|mesothelioma
5298076|NCT02187783|Pancreatic neuroendocrine|pancreatic neuroendocrine
5298077|NCT02187783|Leukemia|leukemia
5298078|NCT02187783|Tumor|tumor
5298081|NCT02187757|High LDL|high ldl
5298082|NCT02187757|Triglycerides|triglycerides
5298083|NCT02187744|Biosimilars|biosimilars
5298084|NCT02187744|Non-inferiority|non-inferiority
5298085|NCT02187744|Neoadjuvant Setting|neoadjuvant setting
5298086|NCT02187744|Early Breast Cancer|early breast cancer
5298087|NCT02187744|PK|pk
5298088|NCT02187744|Phase 3|phase 3
5298089|NCT02187744|Trastuzumab|trastuzumab
5298090|NCT02187744|Herceptin|herceptin
5298091|NCT02187744|HER2 Positive|her2 positive
5298092|NCT02187731|Multiple Myeloma|multiple myeloma
5298093|NCT02187731|Functional Imaging|functional imaging
5298094|NCT02187731|PET/CT|pet/ct
5298095|NCT02187731|Diffusion Weighted MRI|diffusion weighted mri
5298096|NCT02187718|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5298097|NCT02187718|Local Anaesthesia|local anaesthesia
5298098|NCT02187692|schizophrenia;|schizophrenia;
5298099|NCT02187692|meta-cognition;|meta-cognition;
5298100|NCT02187692|general functioning;|general functioning;
5298101|NCT02187692|positive symptoms;|positive symptoms;
5298102|NCT02187692|insight;|insight;
5298103|NCT02187679|Tourette Syndrome|tourette syndrome
5298104|NCT02187679|Tourette's Syndrome|tourette's syndrome
5298105|NCT02187679|Chronic Vocal Tic|chronic vocal tic
5298106|NCT02187679|Vocal Tic|vocal tic
5298107|NCT02187666|Cervical|cervical
5298108|NCT02187666|Lumbar|lumbar
5298109|NCT02187666|Spine|spine
5298110|NCT02187666|Spinal Disease|spinal disease
5298111|NCT02187653|IOM|iom
5298112|NCT02187653|IONM|ionm
5298113|NCT02187653|Intraoperative Monitoring|intraoperative monitoring
5298114|NCT02187653|Intraoperative Neuromonitoring|intraoperative neuromonitoring
5298115|NCT02187653|Spine|spine
5298116|NCT02187653|Lumbar|lumbar
5298117|NCT02187653|Cervical|cervical
5298118|NCT02187640|Acupressure|acupressure
5298119|NCT02187640|Self-administration|self-administration
5298120|NCT02187640|Psychiatric in-patients|psychiatric in-patients
5298121|NCT02187640|Constipation|constipation
5298122|NCT02187640|Self-administered acupressure program|self-administered acupressure program
5298124|NCT02187614|Acute Renal colic|acute renal colic
5298125|NCT02187614|Acute Ureteric Colic|acute ureteric colic
5298126|NCT02187614|Renal or Ureteral Calculi|renal or ureteral calculi
5298127|NCT02187614|Urolithiasis|urolithiasis
5298128|NCT02187614|Kidney or Ureteral stones|kidney or ureteral stones
5298129|NCT02187601|CLD|cld
5298130|NCT02187549|Hyaluronic Acid|hyaluronic acid
5298131|NCT02187549|Osteoarthritis|osteoarthritis
5298132|NCT02187549|Knee|knee
5298133|NCT02187549|Hyaluronan|hyaluronan
5298134|NCT02187549|Viscoelastic|viscoelastic
5298135|NCT02187549|Hydrogel|hydrogel
5298136|NCT02187510|Hemodynamics|hemodynamics
5298137|NCT02187510|Premature Infant|premature infant
5298138|NCT02187510|Umbilical cord|umbilical cord
5298139|NCT02187510|Milking|milking
5298140|NCT02187510|Delayed clamping|delayed clamping
5298141|NCT02187471|pain|pain
5298142|NCT02187471|fibromyalgia|fibromyalgia
5298143|NCT02187445|Sickle Cell Disease|sickle cell disease
5298144|NCT02187445|Budesonide inhalation suspension|budesonide inhalation suspension
5298145|NCT02187445|Acute Chest Syndrome|acute chest syndrome
5298146|NCT02187419|Sleep|sleep
5298147|NCT02187419|Menopause|menopause
5298148|NCT02187419|Hypnosis|hypnosis
5298149|NCT02187419|Relaxation|relaxation
5298150|NCT02187419|Hypnotic Relaxation Therapy|hypnotic relaxation therapy
5298151|NCT02187419|Hot Flash|hot flash
5298152|NCT02187406|athletic tape|athletic tape
5298153|NCT02187406|tennis|tennis
5298154|NCT02187406|warm-up exercise|warm-up exercise
5423353|NCT01616030|Strength training|strength training
5423354|NCT01616017|Cardiac output|cardiac output
5298161|NCT02187289|Breast cancer treatment side effects|breast cancer treatment side effects
5298163|NCT02187289|Reid Sleeve|reid sleeve
5298164|NCT02187289|Comprefit|comprefit
5298165|NCT02187289|Medassist|medassist
5298166|NCT02187289|Tribute|tribute
5298167|NCT02187289|Comprilan|comprilan
5298168|NCT02187276|Predictive factors of response|predictive factors of response
5298169|NCT02187276|mild and moderate|mild and moderate
5298170|NCT02187276|Alzheimer disease|alzheimer disease
5298171|NCT02187276|mixed dementia|mixed dementia
5298172|NCT02187276|APOE|apoe
5181540|NCT02855190|FDG|fdg
5298173|NCT02187276|polymorphisms of CYP 2D6|polymorphisms of cyp 2d6
5298174|NCT02187263|hereditary cardiomyopathy,|hereditary cardiomyopathy,
5298175|NCT02187263|inflammatory cardiomyopathy,|inflammatory cardiomyopathy,
5298176|NCT02187263|registry,|registry,
5298177|NCT02187263|biomaterial,|biomaterial,
5298178|NCT02187263|clinical trial|clinical trial
5298179|NCT02187263|Patients|patients
5298180|NCT02187250|PCOS|pcos
5298181|NCT02187250|PDE-4 inhibitor|pde-4 inhibitor
5298182|NCT02187250|roflumilast|roflumilast
5298183|NCT02187250|liraglutide|liraglutide
5298184|NCT02187250|metformin|metformin
5298185|NCT02187250|obesity|obesity
5298186|NCT02187224|Alcohol Dependence|alcohol dependence
5294921|NCT02201641|Indirect pulp capping|indirect pulp capping
5298189|NCT02187211|Alcohol Dependence|alcohol dependence
5298190|NCT02187211|Minocycline|minocycline
5298191|NCT02187198|Opioid Dependence|opioid dependence
5298192|NCT02187198|Buprenorphine|buprenorphine
5298193|NCT02187185|Inflammatory biomarkers|inflammatory biomarkers
5298194|NCT02187185|Periodontitis|periodontitis
5298195|NCT02187172|Psoriasis|psoriasis
5298196|NCT02187172|Cardiovascular Disease|cardiovascular disease
5298197|NCT02187172|Vascular Inflammation|vascular inflammation
5298198|NCT02187172|Lipid Biomarkers|lipid biomarkers
5298199|NCT02187172|FDG-PET/CT|fdg-pet/ct
5298200|NCT02187159|pain|pain
5298201|NCT02187159|fibromyalgia|fibromyalgia
5298202|NCT02187146|Vitamin D|vitamin d
5298203|NCT02187146|Infertility|infertility
5298204|NCT02187146|IVF|ivf
5298205|NCT02187146|ART|art
5298206|NCT02187133|Relapsed|relapsed
5298207|NCT02187133|Refractory|refractory
5298208|NCT02187120|Wounds and Injuries|wounds and injuries
5298209|NCT02187120|Acute Coagulopathy|acute coagulopathy
5298210|NCT02187120|Tranexamic Acid|tranexamic acid
5298211|NCT02187120|Emergency Medical Services|emergency medical services
5298212|NCT02187107|HIV|hiv
5298213|NCT02187107|AIDS|aids
5298214|NCT02187107|TMC114|tmc114
5298215|NCT02187107|Ritonavir|ritonavir
5298216|NCT02187107|Norvir|norvir
5298217|NCT02187107|Darunavir|darunavir
5298218|NCT02187081|HCC|hcc
5298219|NCT02187081|RFA|rfa
5298220|NCT02187081|Sorafenib|sorafenib
5298221|NCT02187081|Tumor recurrence|tumor recurrence
5298222|NCT02187081|Overall survival|overall survival
5298223|NCT02187068|Anaesthetics iv|anaesthetics iv
5298224|NCT02187068|Dexmedetomidine|dexmedetomidine
5298225|NCT02187068|Pharmacokinetic|pharmacokinetic
5298226|NCT02187042|sunitinib|sunitinib
5298227|NCT02187042|call center|call center
5298228|NCT02187042|management of patients|management of patients
5298229|NCT02187042|nurses|nurses
5298234|NCT02187016|Gingivitis|gingivitis
5298235|NCT02187016|plaque|plaque
5298236|NCT02187016|interproximal cleaning|interproximal cleaning
5298237|NCT02187016|dental floss|dental floss
5298238|NCT02187003|Sickle Cell Anemia|sickle cell anemia
5298239|NCT02187003|Sickle Cell Disease|sickle cell disease
5298240|NCT02187003|Sickle Cell Disorders|sickle cell disorders
5298241|NCT02187003|pain crisis|pain crisis
5298242|NCT02187003|vaso-occlusive crisis|vaso-occlusive crisis
5298243|NCT02187003|rivipansel|rivipansel
5298244|NCT02187003|GMI-1070|gmi-1070
5298245|NCT02187003|selectin inhibitor|selectin inhibitor
5298247|NCT02187003|VOC|voc
5298248|NCT02186977|immunogenicity|immunogenicity
5298249|NCT02186977|safety|safety
5298250|NCT02186977|proof of concept|proof of concept
5298251|NCT02186951|ventilator-associated pneumonia|ventilator-associated pneumonia
5298252|NCT02186951|cardiac arrests with shockable rhythm|cardiac arrests with shockable rhythm
5298253|NCT02186951|Mild therapeutic hypothermia|mild therapeutic hypothermia
5302880|NCT02162550|Incretins|incretins
5298254|NCT02186951|preventive antibiotics|preventive antibiotics
5298255|NCT02186938|head and neck cancer|head and neck cancer
5298256|NCT02186938|patients requiring a free flap surgery|patients requiring a free flap surgery
5298257|NCT02186925|Kidney Cancer|kidney cancer
5298258|NCT02186925|Prostate Cancer|prostate cancer
5298259|NCT02186925|Bladder Cancer|bladder cancer
5298260|NCT02186912|edentulous|edentulous
5298261|NCT02186912|Nobel Active|nobel active
5298262|NCT02186912|Nobel Procera|nobel procera
5298264|NCT02186912|CAD/CAM|cad/cam
5298265|NCT02186886|Ulcerative Colitis|ulcerative colitis
5298266|NCT02186886|Golimumab|golimumab
5298267|NCT02186886|Physiological Intermolecular Modification Spectroscopy|physiological intermolecular modification spectroscopy
5298268|NCT02186886|PIMS|pims
5298269|NCT02186873|Ankylosing Spondylitis|ankylosing spondylitis
5298270|NCT02186873|Golimumab|golimumab
5298271|NCT02186873|SIMPONI|simponi
5298272|NCT02186834|Relapsed|relapsed
5298273|NCT02186834|Refractory|refractory
5298275|NCT02186821|hematological malignancy|hematological malignancy
5298276|NCT02186821|solid tumor malignancy|solid tumor malignancy
5298277|NCT02186821|mutation|mutation
5298278|NCT02186821|translocation|translocation
5298279|NCT02186821|rearrangement|rearrangement
5298280|NCT02186821|amplification|amplification
5298281|NCT02186821|ALK|alk
5298282|NCT02186821|ROS1|ros1
5298283|NCT02186821|NSCLC|nsclc
5298284|NCT02186821|B-cell lymphoma|b-cell lymphoma
5298285|NCT02186795|Arthroplasty|arthroplasty
5298286|NCT02186795|Replacement, Hip|replacement, hip
5298287|NCT02186782|Clomiphene citrate|clomiphene citrate
5298288|NCT02186782|Estradiol|estradiol
5298289|NCT02186782|Endometrial thickness|endometrial thickness
5298290|NCT02186756|Fibromyalgia|fibromyalgia
5298291|NCT02186756|Complementary Therapies|complementary therapies
5298292|NCT02186756|Biofeedback|biofeedback
5298293|NCT02186756|Randomized controlled trial|randomized controlled trial
5298294|NCT02186756|Relaxation Therapy|relaxation therapy
5298297|NCT02186743|Diet|diet
5298298|NCT02186743|Food sensitivity|food sensitivity
5298303|NCT02186704|Atrial Fibrillation|atrial fibrillation
5298304|NCT02186704|Implantable Defibrillators|implantable defibrillators
5298305|NCT02186704|Implanted Electrodes|implanted electrodes
5298306|NCT02186691|pulmonary valve replacement|pulmonary valve replacement
5298307|NCT02186691|tetralogy of Fallot|tetralogy of fallot
5298308|NCT02186652|obese|obese
5298309|NCT02186652|children|children
5298310|NCT02186652|adolescents|adolescents
5298311|NCT02186652|GERD|gerd
5298312|NCT02186652|pharmacokinetic|pharmacokinetic
5298313|NCT02186639|exhaled breath|exhaled breath
5298314|NCT02186639|volatile organic compounds (VOCs)|volatile organic compounds (vocs)
5298315|NCT02186639|SESI-MS|sesi-ms
5298316|NCT02186626|West Nile Virus, vaccine|west nile virus, vaccine
5298317|NCT02186613|Breast Feeding|breast feeding
5298318|NCT02186613|Telephone|telephone
5298319|NCT02186613|Education|education
5298320|NCT02186613|Primary Health Care|primary health care
5298321|NCT02186600|Low bone mass|low bone mass
5298322|NCT02186600|Post-menopausal women|post-menopausal women
5298323|NCT02186600|Bone mineral density|bone mineral density
5298324|NCT02186600|Bone structure|bone structure
5298325|NCT02186600|Bone turnover|bone turnover
5298326|NCT02186600|Bone-loading exercises|bone-loading exercises
5298327|NCT02186600|calcium and vitamin D|calcium and vitamin d
5298328|NCT02186600|risedronate|risedronate
5298329|NCT02186574|Non-Hodgkin|non-hodgkin
5298330|NCT02186574|Lymphoma|lymphoma
5298331|NCT02186574|Hepatitis B|hepatitis b
5298332|NCT02186574|Tenofovir|tenofovir
5298334|NCT02186561|Intracranial aneurysm|intracranial aneurysm
5298335|NCT02186561|brain aneurysm|brain aneurysm
5298336|NCT02186522|Sepsis|sepsis
5298337|NCT02186522|Septic shock|septic shock
5298338|NCT02186522|Critical care|critical care
5298339|NCT02186522|Immune dysfunction|immune dysfunction
5298340|NCT02186522|Inflammatory markers|inflammatory markers
5298341|NCT02186522|Neutrophil|neutrophil
5298342|NCT02186522|Monocyte|monocyte
5298343|NCT02186522|Tregs|tregs
5298344|NCT02186470|Breast Cancer|breast cancer
5298345|NCT02186470|Early Stage Breast Cancer|early stage breast cancer
5298346|NCT02186470|Hormone responsive breast cancer|hormone responsive breast cancer
5298347|NCT02186457|Pancreatoduodenectomy|pancreatoduodenectomy
5298348|NCT02186457|Whipple|whipple
5298349|NCT02186444|newly diagnosed prostate cancer|newly diagnosed prostate cancer
5298350|NCT02186444|prostate|prostate
5298351|NCT02186431|Contact lenses|contact lenses
5298352|NCT02186418|sickle cell disease|sickle cell disease
5298353|NCT02186418|sickle cell anemia|sickle cell anemia
5298354|NCT02186418|hemoglobinopathies|hemoglobinopathies
5298355|NCT02186418|hematopoietic stem cell|hematopoietic stem cell
5298356|NCT02186418|gene transfer|gene transfer
5298357|NCT02186418|gene therapy|gene therapy
5298358|NCT02186392|Depression|depression
5298359|NCT02186392|Anxiety|anxiety
5298360|NCT02186392|Stroke|stroke
5298361|NCT02186392|Cerebral Infarction|cerebral infarction
5298362|NCT02186392|Sleep disorders|sleep disorders
5298363|NCT02186392|Circadian Rhythm disorders|circadian rhythm disorders
5298364|NCT02186392|Circadian Light|circadian light
5298365|NCT02186392|Light therapy|light therapy
5298366|NCT02186392|Melatonin|melatonin
5298368|NCT02186392|Sleep apnea|sleep apnea
5298369|NCT02186392|Coagulation disturbances|coagulation disturbances
5298370|NCT02186392|Bone metabolism|bone metabolism
5298371|NCT02186392|Rehabilitation|rehabilitation
5298372|NCT02186392|Mood disorders|mood disorders
5298373|NCT02186392|Mental disorders|mental disorders
5298374|NCT02186392|Neurologic Manifestations|neurologic manifestations
5298375|NCT02186392|Signs and Symptoms Cerebrovascular Disorders|signs and symptoms cerebrovascular disorders
5298376|NCT02186392|Brain Diseases|brain diseases
5298377|NCT02186392|Vascular Disease|vascular disease
5298378|NCT02186392|Brain Infarction|brain infarction
5407311|NCT01689584|VUS|vus
5298379|NCT02186392|Brain Ischemia|brain ischemia
5298380|NCT02186379|Obesity|obesity
5298381|NCT02186379|Obesity Prevention|obesity prevention
5298382|NCT02186379|Childhood obesity prevention|childhood obesity prevention
5298383|NCT02186379|Rapid Eating Style|rapid eating style
5298384|NCT02186366|Anxiety Disorders, Massage Therapy, Treatment Efficacy|anxiety disorders, massage therapy, treatment efficacy
5298385|NCT02186353|Whole grains|whole grains
5298386|NCT02186353|Food processing|food processing
5298387|NCT02186353|Cardiometabolic risk factors|cardiometabolic risk factors
5298388|NCT02186327|Integrative Health Coaching|integrative health coaching
5298389|NCT02186314|atrial fibrillation, heart failure, pacemaker|atrial fibrillation, heart failure, pacemaker
5298391|NCT02186301|metastatic|metastatic
5298392|NCT02186301|locally advanced|locally advanced
5298393|NCT02186301|lung|lung
5298394|NCT02186301|non-small cell lung cancer|non-small cell lung cancer
5298395|NCT02186301|NSCLC|nsclc
5298396|NCT02186301|epidermal growth factor receptor|epidermal growth factor receptor
5298397|NCT02186301|EGFR|egfr
5298398|NCT02186301|T790M|t790m
5298399|NCT02186301|CO-1686|co-1686
5298400|NCT02186301|unresectable|unresectable
5298401|NCT02186301|recurrent|recurrent
5298402|NCT02186301|EGFR-directed therapy|egfr-directed therapy
5298403|NCT02186301|irreversible EGFR inhibitor|irreversible egfr inhibitor
5298404|NCT02186301|TIGER|tiger
5298405|NCT02186301|rociletinib|rociletinib
5298406|NCT02186288|Critical Care|critical care
5298407|NCT02186288|High-flow nasal cannula oxygen|high-flow nasal cannula oxygen
5298408|NCT02186288|Electrical impedance tomography|electrical impedance tomography
5298409|NCT02186288|End expiratory lung volume|end expiratory lung volume
5298410|NCT02186288|End expiratory lung impedance|end expiratory lung impedance
5298411|NCT02186288|Diaphragmatic ultrasound|diaphragmatic ultrasound
5298412|NCT02186275|Crohn|crohn
5298413|NCT02186275|vitamin D|vitamin d
5298414|NCT02186275|remission|remission
5298415|NCT02186275|inflammation|inflammation
5298416|NCT02186275|tolerance|tolerance
5298417|NCT02186262|Glioma|glioma
5298419|NCT02186262|Rotating frame relaxation|rotating frame relaxation
5298420|NCT02186262|DWI|dwi
5298421|NCT02186262|treatment response|treatment response
5298422|NCT02186236|Detection of Oncogenic Tumor Mutations|detection of oncogenic tumor mutations
5298423|NCT02186236|blood|blood
5298424|NCT02186236|urine|urine
5298425|NCT02186236|14-114|14-114
5298426|NCT02186223|Pulmonary Embolism|pulmonary embolism
5298427|NCT02186223|PE|pe
5298428|NCT02186223|DVT|dvt
5298429|NCT02186223|Deep Vein Thrombosis|deep vein thrombosis
5298430|NCT02186223|VTE|vte
5298431|NCT02186223|Venous Thromboembolism|venous thromboembolism
5298432|NCT02186223|prophylaxis|prophylaxis
5298433|NCT02186223|thromboprophylaxis|thromboprophylaxis
5298529|NCT02185859|Functional Recovery|functional recovery
5298434|NCT02186223|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
5298435|NCT02186223|prophylactic|prophylactic
5298436|NCT02186223|prevention|prevention
5298437|NCT02186223|Inferior vena cava filter|inferior vena cava filter
5298438|NCT02186223|IVC filter|ivc filter
5298439|NCT02186223|filter|filter
5298440|NCT02186223|prevention of pulmonary embolism|prevention of pulmonary embolism
5298441|NCT02186223|trauma|trauma
5298442|NCT02186223|critically-ill|critically-ill
5298443|NCT02186210|microcirculation|microcirculation
5298444|NCT02186210|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
5298445|NCT02186210|tissue oxygen saturation|tissue oxygen saturation
5298446|NCT02186210|vascular occlusion test|vascular occlusion test
5298447|NCT02186210|recovery slope|recovery slope
5298448|NCT02186197|Volume Responsiveness|volume responsiveness
5298449|NCT02186184|Myopia progression|myopia progression
5298450|NCT02186184|Orthokeratology|orthokeratology
5298451|NCT02186171|Osteoporosis in men|osteoporosis in men
5298452|NCT02186158|Pneumonia|pneumonia
5298454|NCT02186158|Ascorbic acid|ascorbic acid
5298455|NCT02186158|Vitamin C|vitamin c
5298456|NCT02186158|Hospitalized patient|hospitalized patient
5298457|NCT02186132|heart rate|heart rate
5298458|NCT02186132|neostigmine|neostigmine
5298459|NCT02186132|atropine|atropine
5298460|NCT02186132|dosage|dosage
5303073|NCT02161666|Obesity|obesity
5298461|NCT02186093|Coronary Artery Disease|coronary artery disease
5298463|NCT02186093|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5298464|NCT02186093|Coronary Angiography|coronary angiography
5298465|NCT02186080|diabetes mellitus|diabetes mellitus
5298466|NCT02186080|metabolic endotoxemia|metabolic endotoxemia
5298467|NCT02186080|gemigliptin|gemigliptin
5298468|NCT02186080|DPP-4 inhibitor|dpp-4 inhibitor
5298469|NCT02186067|Hypertension|hypertension
5298470|NCT02186067|Uncontrolled Hypertension|uncontrolled hypertension
5298471|NCT02186054|Abdominal-Pelvic MRI (magnetic resonance image)|abdominal-pelvic mri (magnetic resonance image)
5298472|NCT02186054|T2W (T2 weighted)|t2w (t2 weighted)
5298473|NCT02186054|FSE Flex (recently developed MRI pulse sequence)|fse flex (recently developed mri pulse sequence)
5903807|NCT00303706|CABG, Endoscopic, Radial Artery|cabg, endoscopic, radial artery
5298474|NCT02186054|Enhanced single shot FSE (fast spin echo).|enhanced single shot fse (fast spin echo).
5445393|NCT01522001|Myocardial Ischemia|myocardial ischemia
5298475|NCT02186028|oral daily supplementation with vitamin D for 6 months|oral daily supplementation with vitamin d for 6 months
5298476|NCT02186015|Metastatic Breast Cancer|metastatic breast cancer
5298477|NCT02186015|MBC|mbc
5298478|NCT02186015|Vitamin D Supplementation|vitamin d supplementation
5298479|NCT02186015|Symptom Management|symptom management
5298480|NCT02186002|ACT-451840|act-451840
5298481|NCT02186002|Safety|safety
5298482|NCT02186002|Tolerability|tolerability
5298483|NCT02186002|Pharmacokinetics|pharmacokinetics
5298484|NCT02185989|Critical Illness/*rehabilitation|critical illness/*rehabilitation
5298485|NCT02185989|Humans|humans
5298486|NCT02185989|*Intensive Care Units|*intensive care units
5298487|NCT02185989|Muscle Weakness/diagnosis/*etiology/physiopathology/prevention & control|muscle weakness/diagnosis/*etiology/physiopathology/prevention & control
5298488|NCT02185989|Polyneuropathies/diagnosis/*etiology/physiopathology|polyneuropathies/diagnosis/*etiology/physiopathology
5298489|NCT02185976|preoperative anxiety|preoperative anxiety
5298490|NCT02185976|paediatric patients|paediatric patients
5298491|NCT02185976|Cartoon|cartoon
5298492|NCT02185963|Diabetes|diabetes
5298493|NCT02185963|Dyslipidemia|dyslipidemia
5298494|NCT02185963|HDL function|hdl function
5298495|NCT02185963|Cholesterol efflux|cholesterol efflux
5298497|NCT02185963|MCP-1|mcp-1
5298498|NCT02185950|Burn|burn
5298499|NCT02185950|Skin graft|skin graft
5298500|NCT02185950|Elasticity|elasticity
5298501|NCT02185950|Skin|skin
5298502|NCT02185950|Physical therapy modalities|physical therapy modalities
5298503|NCT02185937|imatinib|imatinib
5298504|NCT02185937|gastrectomy|gastrectomy
5298505|NCT02185937|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5298506|NCT02185937|pharmacokinetics|pharmacokinetics
5298507|NCT02185924|PARECOXIB|parecoxib
5298508|NCT02185924|CONTINUOUS FEMORAL BLOCK|continuous femoral block
5298509|NCT02185911|chronic kidney disease,|chronic kidney disease,
5298510|NCT02185911|anaemia correction/maintenance,|anaemia correction/maintenance,
5298511|NCT02185911|non dialysis,|non dialysis,
5298512|NCT02185898|electronic cigarettes|electronic cigarettes
5298513|NCT02185898|e-cigarettes|e-cigarettes
5298514|NCT02185898|combustible cigarettes|combustible cigarettes
5298515|NCT02185898|second-hand smoke|second-hand smoke
5298516|NCT02185898|environmental tobacco smoke|environmental tobacco smoke
5298517|NCT02185898|tobacco-burning|tobacco-burning
5298518|NCT02185885|Ischemic stroke|ischemic stroke
5298519|NCT02185885|Embolic stroke|embolic stroke
5298520|NCT02185885|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5298521|NCT02185885|Cardiac Bypass Surgery|cardiac bypass surgery
5298522|NCT02185885|Cardiac Anaesthesia|cardiac anaesthesia
5298523|NCT02185872|Exercise|exercise
5298524|NCT02185872|Physical Fitness|physical fitness
5298525|NCT02185872|Body Composition, Beneficial|body composition, beneficial
5298526|NCT02185859|Lidocaine|lidocaine
5298527|NCT02185859|Magnesium|magnesium
5298528|NCT02185859|Mastectomy|mastectomy
5298533|NCT02185820|Relapsed and/or refractory|relapsed and/or refractory
5298534|NCT02185820|CPD|cpd
5298535|NCT02185807|cataract|cataract
5298536|NCT02185807|surgery|surgery
5298537|NCT02185807|consent process|consent process
5298539|NCT02185794|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5298540|NCT02185794|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5298541|NCT02185794|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5298542|NCT02185794|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
5298543|NCT02185794|HCV|hcv
5298544|NCT02185794|Sustained Virologic Response|sustained virologic response
5298545|NCT02185794|Direct Acting Antiviral|direct acting antiviral
5298546|NCT02185794|Combination Therapy|combination therapy
5298547|NCT02185794|Open Label|open label
5298548|NCT02185794|Hepatitis|hepatitis
5298549|NCT02185794|Hepatitis, Chronic|hepatitis, chronic
5298550|NCT02185794|Hepatitis C|hepatitis c
5298551|NCT02185794|Hepatitis C, Chronic|hepatitis c, chronic
5298552|NCT02185794|Liver Diseases|liver diseases
5298553|NCT02185794|Digestive System Diseases|digestive system diseases
5298554|NCT02185794|Hepatitis, Viral, Human|hepatitis, viral, human
5298555|NCT02185794|Virus Diseases|virus diseases
5298556|NCT02185794|Enterovirus Infections|enterovirus infections
5298557|NCT02185794|Picornaviridae Infections|picornaviridae infections
5298558|NCT02185794|RNA Virus Infections|rna virus infections
5298559|NCT02185794|Flaviviridae Infections|flaviviridae infections
5298560|NCT02185794|Antiviral Agents|antiviral agents
5298561|NCT02185794|Anti-Infective Agents|anti-infective agents
5298562|NCT02185794|Therapeutic Uses|therapeutic uses
5298563|NCT02185794|Pharmacologic Actions|pharmacologic actions
5298565|NCT02185794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5298566|NCT02185781|Phase I|phase i
5298567|NCT02185781|Adoptive immunotherapy|adoptive immunotherapy
5298568|NCT02185781|Enriched and expanded autologous natural killer (NK) cells|enriched and expanded autologous natural killer (nk) cells
5298569|NCT02185781|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
5407583|NCT01688336|5FU|5fu
5298570|NCT02185781|≥60 years|≥60 years
5298571|NCT02185781|Not eligible for other post-CHR treatment modalities|not eligible for other post-chr treatment modalities
5298572|NCT02185768|Liver cancer|liver cancer
5445394|NCT01522001|Shared Care|shared care
5298573|NCT02185755|Internet-Based Glucose Monitoring System|internet-based glucose monitoring system
5298574|NCT02185755|Type 2 Diabetes|type 2 diabetes
5298575|NCT02185742|HIV|hiv
5298576|NCT02185742|jail|jail
5298577|NCT02185742|detainee|detainee
5298578|NCT02185742|Linkage and Retention|linkage and retention
5298579|NCT02185742|Treatment as Prevention|treatment as prevention
5298580|NCT02185742|Strength Based Case Management|strength based case management
5298581|NCT02185742|releases|releases
5298582|NCT02185729|Intravenous Feeding|intravenous feeding
5298583|NCT02185729|Lipid Emulsions, Intravenous|lipid emulsions, intravenous
5298584|NCT02185716|Transversus abdominis plane block|transversus abdominis plane block
5298585|NCT02185716|levobupivacaine|levobupivacaine
5298586|NCT02185690|Lung cancer|lung cancer
5298587|NCT02185690|Non small cell lung cancer|non small cell lung cancer
5298588|NCT02185690|non squamous|non squamous
5298589|NCT02185690|pemetrexed|pemetrexed
5298590|NCT02185690|carboplatin|carboplatin
5298591|NCT02185690|binimetinib|binimetinib
5295335|NCT02199717|Obesity|obesity
5298593|NCT02185690|combination chemotherapy|combination chemotherapy
5298594|NCT02185690|Phase 1|phase 1
5298595|NCT02185690|Princess Margaret Cancer Centre|princess margaret cancer centre
5298596|NCT02185690|carcinoma|carcinoma
5298597|NCT02185677|dysexecutive syndrome|dysexecutive syndrome
5298598|NCT02185677|multiple system atrophy|multiple system atrophy
5298599|NCT02185677|imaging study|imaging study
5298600|NCT02185664|internal jugular vein|internal jugular vein
5298601|NCT02185664|landmark|landmark
5298602|NCT02185664|ultrasound|ultrasound
5298603|NCT02185664|static|static
5298604|NCT02185664|cardiac surgery|cardiac surgery
5298605|NCT02185651|Pompe Disease|pompe disease
5298606|NCT02185651|Enzyme Replacement Therapy|enzyme replacement therapy
5298607|NCT02185651|Infusion Associated Reaction|infusion associated reaction
5298608|NCT02185638|obesity|obesity
5298609|NCT02185638|herbal bioactive compounds|herbal bioactive compounds
5298610|NCT02185638|appetite|appetite
5298611|NCT02185638|GLP-1|glp-1
5298612|NCT02185638|ghrelin|ghrelin
5298613|NCT02185638|CCK|cck
5298614|NCT02185599|colposcopy|colposcopy
5298615|NCT02185599|CIN|cin
5298616|NCT02185599|cervical neoplasia|cervical neoplasia
5298617|NCT02185599|cervical dysplasia|cervical dysplasia
5298618|NCT02185599|cervical cancer|cervical cancer
5298619|NCT02185599|CIN2+|cin2+
5298620|NCT02185573|Bulk fill|bulk fill
5298621|NCT02185573|SonicFill|sonicfill
5298622|NCT02185573|resin composite application|resin composite application
5298623|NCT02185573|class II restoration|class ii restoration
5300024|NCT02177656|self-care|self-care
5298637|NCT02185508|Intraoperative Neurophysiological Monitoring|intraoperative neurophysiological monitoring
5298638|NCT02185508|Somatosensory Evoked Potentials|somatosensory evoked potentials
5298639|NCT02185508|Electromyography|electromyography
5298640|NCT02185482|Psychological counselling|psychological counselling
5298641|NCT02185482|Randomized single blind study|randomized single blind study
5298642|NCT02185482|Depression|depression
5298643|NCT02185482|Diabetes|diabetes
5298644|NCT02185469|Corneal Endothelial Cell Loss|corneal endothelial cell loss
5298645|NCT02185469|pneumatic retinopexy|pneumatic retinopexy
5298647|NCT02185443|SBRT|sbrt
5298648|NCT02185443|radiation|radiation
5298649|NCT02185443|Neoplasm Metastasis|neoplasm metastasis
5298650|NCT02185443|Colorectal Neoplasms|colorectal neoplasms
5298651|NCT02185443|Anal Canal|anal canal
5298652|NCT02185443|Neuroendocrine Tumors|neuroendocrine tumors
5298653|NCT02185417|Hypertension|hypertension
5298654|NCT02185417|Diuretic|diuretic
5298655|NCT02185417|Comparative Effectiveness Research|comparative effectiveness research
5298656|NCT02185417|Point of Care Research|point of care research
5298657|NCT02185391|Coronary Disease|coronary disease
5298658|NCT02185391|Audience Response System|audience response system
5298659|NCT02185365|T1-rho MRI|t1-rho mri
5298660|NCT02185365|dGEMRIC MRI|dgemric mri
5298661|NCT02185365|DDH|ddh
5298662|NCT02185365|Developmental dysplasia of the hip|developmental dysplasia of the hip
5298663|NCT02185352|Bevacizumab|bevacizumab
5298665|NCT02185352|Breast Cancer|breast cancer
5298666|NCT02185352|Chemotherapy|chemotherapy
5298667|NCT02185352|Whole Brain Radiotherapy|whole brain radiotherapy
5298668|NCT02185339|Respiratory mechanics|respiratory mechanics
5298669|NCT02185339|Respiratory function test|respiratory function test
5298670|NCT02185339|Hemodynamics|hemodynamics
5298671|NCT02185326|Poor responders|poor responders
5298672|NCT02185326|Poor ovarian response|poor ovarian response
5298673|NCT02185326|IVF/ICSI|ivf/icsi
5298674|NCT02185326|Microflare protocol|microflare protocol
5298675|NCT02185326|Growth hormone|growth hormone
5298676|NCT02185326|Oral contraceptive pills|oral contraceptive pills
5298677|NCT02185300|GSK1349572|gsk1349572
5903808|NCT00303706|Radial Artery Conduit|radial artery conduit
5298678|NCT02185300|granule|granule
5298679|NCT02185300|pediatric|pediatric
5298680|NCT02185300|CONTREX mineral water|contrex mineral water
5298681|NCT02185300|free-acid|free-acid
5298682|NCT02185300|chelating|chelating
5298683|NCT02185300|cations|cations
5298684|NCT02185300|divalent|divalent
5298685|NCT02185300|dolutegravir|dolutegravir
5298686|NCT02185300|dispersible tablet|dispersible tablet
5298687|NCT02185300|relative bioavailability|relative bioavailability
5298696|NCT02185261|Relapse|relapse
5298697|NCT02185261|Minimal residual disease|minimal residual disease
5298698|NCT02185261|Graft-versus-host disease|graft-versus-host disease
5298699|NCT02185261|Acute leukemia|acute leukemia
5298700|NCT02185261|Interferon Alfa-2b|interferon alfa-2b
5298701|NCT02185248|Pediatric Obesity|pediatric obesity
5298702|NCT02185248|Body Mass Index|body mass index
5298703|NCT02185248|Weight Perception|weight perception
5298704|NCT02185248|Counseling|counseling
5298705|NCT02185248|Health Behavior|health behavior
5298706|NCT02185235|Electrical stimulation|electrical stimulation
5298707|NCT02185235|Biofeedback|biofeedback
5298708|NCT02185222|Vitamin D|vitamin d
5298709|NCT02185222|Cholecalciferol|cholecalciferol
5298710|NCT02185222|25-hydroxyvitamin D|25-hydroxyvitamin d
5298711|NCT02185222|Memory complaint|memory complaint
5298712|NCT02185222|Subjective memory complaint|subjective memory complaint
5298713|NCT02185222|Mild cognitive impairment|mild cognitive impairment
5298715|NCT02185222|Cognitive disorders|cognitive disorders
5298716|NCT02185196|Vitamin D,|vitamin d,
5298717|NCT02185196|Severe pneumonia,|severe pneumonia,
5298718|NCT02185196|Under-five children,|under-five children,
5298719|NCT02185196|Randomised|randomised
5298720|NCT02185196|Controlled|controlled
5298721|NCT02185196|Trial (RCT)|trial (rct)
5298722|NCT02185196|Morbidity|morbidity
5298723|NCT02185170|Prostate|prostate
5298724|NCT02185170|Cancer|cancer
5298725|NCT02185170|Medical Device|medical device
5298726|NCT02185170|Fluorescence|fluorescence
5298728|NCT02185157|dual-task training|dual-task training
5298729|NCT02185157|aerobic training|aerobic training
5298730|NCT02185157|gait|gait
5298731|NCT02185157|cognition|cognition
5298732|NCT02185144|HIV, mental health, substance abuse|hiv, mental health, substance abuse
5298733|NCT02185131|Major Depressive Disorder|major depressive disorder
5298734|NCT02185131|Alcohol Use Disorder|alcohol use disorder
5298735|NCT02185092|exacerbations|exacerbations
5298736|NCT02185092|COPD|copd
5298737|NCT02185092|pneumonia|pneumonia
5298738|NCT02185092|probiotic|probiotic
5298739|NCT02185079|labor|labor
5298740|NCT02185079|epidural|epidural
5298741|NCT02185040|Lupus, Systemic Lupus, SLE|lupus, systemic lupus, sle
5298742|NCT02185027|Oral anticoagulants|oral anticoagulants
5298743|NCT02185027|Surgery|surgery
5298744|NCT02185027|Haemorrhage|haemorrhage
5298745|NCT02185027|Emergency|emergency
5298746|NCT02185014|Crohn's Disease|crohn's disease
5298747|NCT02185001|Medial patellofemoral ligament|medial patellofemoral ligament
5298748|NCT02185001|MPFL|mpfl
5298749|NCT02185001|Repair|repair
5298750|NCT02185001|Patellar dislocation|patellar dislocation
5298751|NCT02185001|Knee|knee
5298752|NCT02184988|Glabellar Lines|glabellar lines
5298753|NCT02184988|Botulinum purifies neurotoxin, Type A (DWP-450)|botulinum purifies neurotoxin, type a (dwp-450)
5298754|NCT02184975|cold knife conization|cold knife conization
5298755|NCT02184975|lateral hemostatic sutures|lateral hemostatic sutures
5298756|NCT02184975|cervix|cervix
5298757|NCT02184949|PCI|pci
5298758|NCT02184949|Coronary angioplasty|coronary angioplasty
5298759|NCT02184949|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5298760|NCT02184949|PTCA|ptca
5298761|NCT02184936|CT Angiography, CT Perfusion, Ischemic Stroke, Collaterals|ct angiography, ct perfusion, ischemic stroke, collaterals
5298762|NCT02184910|atrophic gastritis, pepsinogen, Helicobacter pylori|atrophic gastritis, pepsinogen, helicobacter pylori
5298763|NCT02184884|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome|off-pump coronary artery bypass surgery, clopidogrel responsiveness, ischemic outcome
5298764|NCT02184871|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5298765|NCT02184871|RNAseq|rnaseq
5298766|NCT02184871|risk factors|risk factors
5298767|NCT02184871|asbestos|asbestos
5298768|NCT02184845|single tooth implant|single tooth implant
5298771|NCT02184845|mandibular central incisor|mandibular central incisor
5298773|NCT02184845|areas of the mouth|areas of the mouth
5298774|NCT02184819|coronary artery bypass graft|coronary artery bypass graft
5298775|NCT02184819|left ventricular dysfunction|left ventricular dysfunction
5298776|NCT02184819|low cardiac output syndrome|low cardiac output syndrome
5298777|NCT02184819|levosimendan|levosimendan
5298778|NCT02184819|mortality|mortality
5298779|NCT02184819|inotropic agents|inotropic agents
5298780|NCT02184819|cardiac mechanical assist devices|cardiac mechanical assist devices
5298781|NCT02184819|renal replacement therapy|renal replacement therapy
5298787|NCT02184793|semirecumbent position|semirecumbent position
5298788|NCT02184793|electronic monitoring device|electronic monitoring device
5298795|NCT02184754|Magnetic endoscope imaging|magnetic endoscope imaging
5298796|NCT02184754|single-balloon-enteroscopy|single-balloon-enteroscopy
5298797|NCT02184741|IVIG|ivig
5298798|NCT02184741|Unexplained Recurrent miscarriage|unexplained recurrent miscarriage
5298799|NCT02184741|Recurrent abortion|recurrent abortion
5298800|NCT02184741|Intravenous immunoglobulin|intravenous immunoglobulin
5298801|NCT02184728|end-tidal CO2|end-tidal co2
5298802|NCT02184728|capnometer|capnometer
5298803|NCT02184715|virtual reality system, children, developmental delay|virtual reality system, children, developmental delay
5298804|NCT02184676|Type 1 diabetes|type 1 diabetes
5298805|NCT02184676|risk assessment|risk assessment
5298806|NCT02184676|immunological marker|immunological marker
5298807|NCT02184676|children|children
5298808|NCT02184676|relatives|relatives
5298809|NCT02184676|autoantibodies|autoantibodies
5298810|NCT02184676|lymphocytes|lymphocytes
5298811|NCT02184676|T cells|t cells
5298812|NCT02184676|epitopes|epitopes
5298813|NCT02184676|Children born to mother/father with type 1 diabetes and their parents|children born to mother/father with type 1 diabetes and their parents
5298814|NCT02184663|Unresectable|unresectable
5298815|NCT02184663|Pancreatic cancer|pancreatic cancer
5298816|NCT02184663|GERCOR|gercor
5298817|NCT02184663|Adapted physical activity (APA)|adapted physical activity (apa)
5298818|NCT02184663|Quality of life|quality of life
5298819|NCT02184663|Fatigue|fatigue
5298820|NCT02184650|Premature infants|premature infants
5298821|NCT02184650|Nutritional status|nutritional status
5298822|NCT02184650|Polyunsaturated fatty acids status|polyunsaturated fatty acids status
5298823|NCT02184637|Malaria|malaria
5298824|NCT02184637|Artemisinin-based Combination Therapies (ACT)|artemisinin-based combination therapies (act)
5298825|NCT02184624|BREEZHALER|breezhaler
5298826|NCT02184624|DISKUS/ACCUHALER|diskus/accuhaler
5298827|NCT02184624|MDI|mdi
5298828|NCT02184624|Inhaler preference|inhaler preference
5298829|NCT02184624|Overall inhaler error|overall inhaler error
5298830|NCT02184624|HANDIHALER|handihaler
5298831|NCT02184624|Ease of use|ease of use
5298832|NCT02184624|TURBUHALER|turbuhaler
5298833|NCT02184624|ELLIPTA|ellipta
5298834|NCT02184624|Critical inhaler error|critical inhaler error
5298835|NCT02184611|lung function|lung function
5298836|NCT02184611|Umeclidinium|umeclidinium
5298837|NCT02184611|GSK573719|gsk573719
5298838|NCT02184611|anticholinergic|anticholinergic
5298839|NCT02184611|novel dry powder inhaler|novel dry powder inhaler
5298840|NCT02184611|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
5298841|NCT02184611|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5298842|NCT02184598|ADHD|adhd
5298843|NCT02184598|Cognitive training|cognitive training
5298844|NCT02184598|fMRI|fmri
5298845|NCT02184598|Cognitive function|cognitive function
5298846|NCT02184585|bioavailability|bioavailability
5298847|NCT02184585|crossover design|crossover design
5298848|NCT02184585|healthy male volunteers|healthy male volunteers
5298849|NCT02184585|tamsulosin hydrochloride|tamsulosin hydrochloride
5298850|NCT02184585|Dutasteride|dutasteride
5298851|NCT02184572|Rubella|rubella
5298852|NCT02184572|Healthy children|healthy children
5298853|NCT02184572|Measles|measles
5298854|NCT02184572|Safety|safety
5298855|NCT02184572|Mumps|mumps
5298856|NCT02184572|12 to 15 months|12 to 15 months
5298857|NCT02184572|Immunogenicity|immunogenicity
5298858|NCT02184507|insulin resistance|insulin resistance
5298859|NCT02184507|blood glucose|blood glucose
5298860|NCT02184507|CABG|cabg
5298861|NCT02184507|oxidative stress|oxidative stress
5298862|NCT02184494|Parkinson's Disease|parkinson's disease
5298863|NCT02184494|Multiple Sclerosis|multiple sclerosis
5298864|NCT02184494|Fatigue|fatigue
5298865|NCT02184494|Resting Energy Expenditure|resting energy expenditure
5298866|NCT02184494|Whole Body Vibration|whole body vibration
5298867|NCT02184494|Exercise|exercise
5298868|NCT02184494|Blood Lactate|blood lactate
5298869|NCT02184481|Depression|depression
5298870|NCT02184481|Anxiety|anxiety
5298871|NCT02184481|Working memory|working memory
5298872|NCT02184481|Rumination|rumination
5298873|NCT02184481|Cognitive training|cognitive training
5298874|NCT02184481|Executive functioning|executive functioning
5298875|NCT02184468|Cardiac Arrest|cardiac arrest
5298876|NCT02184468|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5298877|NCT02184468|Firefighters|firefighters
5298880|NCT02184468|Survival|survival
5298881|NCT02184455|Diabetic|diabetic
5298882|NCT02184455|Chronic Ulcer|chronic ulcer
5298883|NCT02184455|Wound Healing|wound healing
5298884|NCT02184455|Leg|leg
5298885|NCT02184442|SAPIEN|sapien
5298886|NCT02184442|TAVR|tavr
5298887|NCT02184442|THV|thv
5298888|NCT02184442|Aortic Stenosis|aortic stenosis
5298889|NCT02184442|Heart Valve Disease|heart valve disease
5298890|NCT02184442|Aortic Valve|aortic valve
5298891|NCT02184442|Retroflex|retroflex
5298892|NCT02184442|SAPIEN XT|sapien xt
5298893|NCT02184429|First in human|first in human
5298894|NCT02184429|single ascending dose study|single ascending dose study
5298895|NCT02184429|multiple ascending dose study|multiple ascending dose study
5298896|NCT02184429|safety and tolerability|safety and tolerability
5298897|NCT02184429|pharmacokinetics|pharmacokinetics
5298898|NCT02184429|food effect|food effect
5298899|NCT02184429|Parkinson's Disease|parkinson's disease
5298900|NCT02184416|Inlyta|inlyta
5298901|NCT02184416|axitinib|axitinib
5298902|NCT02184416|Sutent|sutent
5298903|NCT02184416|sunitinib|sunitinib
5298904|NCT02184416|renal|renal
5298905|NCT02184390|Internet|internet
5298906|NCT02184390|Education|education
5298907|NCT02184377|quantitative laryngeal electromyography|quantitative laryngeal electromyography
5298908|NCT02184377|cricothyroid muscle|cricothyroid muscle
5298909|NCT02184377|unilateral vocal fold paralysis|unilateral vocal fold paralysis
5298910|NCT02184377|superior laryngeal nerve|superior laryngeal nerve
5298912|NCT02184377|Mandarin|mandarin
5298913|NCT02184221|Deep-brain magnetic stimulation|deep-brain magnetic stimulation
5298914|NCT02184221|Brain derived neurotropic factor|brain derived neurotropic factor
5298915|NCT02184221|Effectiveness|effectiveness
5298916|NCT02184221|Safety|safety
5298917|NCT02184208|ARDS|ards
5298918|NCT02184208|ALI|ali
5298919|NCT02184208|mechanical ventilation|mechanical ventilation
5299019|NCT02183740|Fecal incontinence|fecal incontinence
5299221|NCT02181270|>5% liver fat|>5% liver fat
5298920|NCT02184195|BRCA, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, PARP inhibitor|brca, metastatic adenocarcinoma pancreas, maintenance olaparib monotherapy, first line platinum chemotherapy, pancreatic cancer, parp inhibitor
5298922|NCT02184169|neonatal|neonatal
5298923|NCT02184169|cardiac disease|cardiac disease
5298924|NCT02184169|congenital heart disease|congenital heart disease
5298925|NCT02184169|volumetric oxygen consumption|volumetric oxygen consumption
5298926|NCT02184117|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5298927|NCT02184117|Adenosine|adenosine
5298928|NCT02184117|Contrast Media|contrast media
5298929|NCT02184104|caffeine|caffeine
5298930|NCT02184104|pharmacokinetics|pharmacokinetics
5298931|NCT02184104|pharmacodynamics|pharmacodynamics
5298932|NCT02184026|nightmare|nightmare
5298933|NCT02184026|PTSD|ptsd
5298934|NCT02184026|trauma|trauma
5298935|NCT02184026|children|children
5298936|NCT02184026|Children Age 8 to 13|children age 8 to 13
5298937|NCT02184013|Atrial fibrillation|atrial fibrillation
5298938|NCT02184013|Catheter ablation|catheter ablation
5298939|NCT02184013|Delayed gadolinium enhanced MRI|delayed gadolinium enhanced mri
5298940|NCT02184013|C-metahydroxyepherdrine (HED) PET scan|c-metahydroxyepherdrine (hed) pet scan
5298941|NCT02184013|ECGI mapping|ecgi mapping
5298942|NCT02184013|Atrial Fibrosis|atrial fibrosis
5298943|NCT02184013|Atrial sympathetic denervation|atrial sympathetic denervation
5298944|NCT02184000|strain elastography|strain elastography
5298945|NCT02184000|hepatopathy|hepatopathy
5298946|NCT02184000|liver fibrosis|liver fibrosis
5298947|NCT02183987|Knowledge Translation|knowledge translation
5298948|NCT02183987|Chronic Kidney Disease|chronic kidney disease
5298949|NCT02183987|Dialysis|dialysis
5298950|NCT02183987|Intent-to-defer|intent-to-defer
5298951|NCT02183987|Early dialysis|early dialysis
5298952|NCT02183987|Cluster randomized trial|cluster randomized trial
5298953|NCT02183974|otitis media with effusion|otitis media with effusion
5298954|NCT02183974|Laryngopharyngeal Reflux|laryngopharyngeal reflux
5298955|NCT02183961|otitis media with effusion|otitis media with effusion
5298956|NCT02183961|peptest|peptest
5168364|NCT02939729|cardiac|cardiac
5180574|NCT02861729|All ceramic|all ceramic
5298957|NCT02183961|restech|restech
5298958|NCT02183961|oropharyngeal pH monitoring|oropharyngeal ph monitoring
5298959|NCT02183961|laryngopharyngeal reflux|laryngopharyngeal reflux
5298960|NCT02183948|treatment|treatment
5298961|NCT02183948|mask face exoressions|mask face exoressions
5298962|NCT02183948|genier|genier
5298963|NCT02183935|Obesity|obesity
5298964|NCT02183935|Diabetes|diabetes
5298965|NCT02183935|Metabolic syndrome|metabolic syndrome
5298966|NCT02183935|Gut hormones|gut hormones
5298967|NCT02183935|Adipokines|adipokines
5298968|NCT02183935|Appetite|appetite
5298969|NCT02183935|Adolescent|adolescent
5298970|NCT02183896|Femoroacetabular impingement (FAI)|femoroacetabular impingement (fai)
5298971|NCT02183896|Chondral lesions|chondral lesions
5298973|NCT02183896|Microfracture|microfracture
5298974|NCT02183896|Platelet-rich plasma (PRP)|platelet-rich plasma (prp)
5298975|NCT02183883|Non-small cell lung cancer|non-small cell lung cancer
5298977|NCT02183883|Afatinib|afatinib
5298978|NCT02183883|Intra-tumour heterogeneity|intra-tumour heterogeneity
5298979|NCT02183883|Clonal dominance|clonal dominance
5298980|NCT02183883|Drug resistance|drug resistance
5298981|NCT02183883|EGFR|egfr
5298982|NCT02183883|HER2|her2
5298983|NCT02183883|Phase 2|phase 2
5298984|NCT02183870|lung cancer|lung cancer
5298985|NCT02183870|adenocarcinoma|adenocarcinoma
5298986|NCT02183870|NSCLC|nsclc
5298987|NCT02183870|ROS1|ros1
5298988|NCT02183870|ROS1 translocation|ros1 translocation
5298989|NCT02183870|crizotinib|crizotinib
5298990|NCT02183870|phase II|phase ii
5298991|NCT02183857|children|children
5298992|NCT02183857|congenital heart disease|congenital heart disease
5298993|NCT02183844|Medical Informatics|medical informatics
5298994|NCT02183844|Patient-Centered|patient-centered
5298995|NCT02183844|Healthcare Preferences|healthcare preferences
5298996|NCT02183844|Health Education|health education
5298997|NCT02183844|Quality Improvement|quality improvement
5298998|NCT02183844|Weight Loss|weight loss
5298999|NCT02183844|Personal Satisfaction|personal satisfaction
5299000|NCT02183844|Humans|humans
5299001|NCT02183844|Cognition|cognition
5299002|NCT02183844|Body Weight|body weight
5299003|NCT02183818|Smoking|smoking
5299004|NCT02183818|COPD|copd
5299005|NCT02183818|Non-Smokers|non-smokers
5299006|NCT02183818|Smokers|smokers
5299007|NCT02183805|triple negative breast cancer|triple negative breast cancer
5299008|NCT02183805|autologous hematopoietic stem-cell transplantation|autologous hematopoietic stem-cell transplantation
5299009|NCT02183779|post-occlusive hyperaemia|post-occlusive hyperaemia
5299010|NCT02183779|laser-speckle contrast imaging|laser-speckle contrast imaging
5299011|NCT02183779|epoxyeicosatrienoic acid|epoxyeicosatrienoic acid
5299012|NCT02183779|nitrous oxide|nitrous oxide
5299013|NCT02183753|LAIV|laiv
5299014|NCT02183753|Flumist|flumist
5299015|NCT02183753|wood smoke|wood smoke
5299016|NCT02183740|Education|education
5299017|NCT02183740|Nurses|nurses
5299018|NCT02183740|Nursing homes|nursing homes
5299020|NCT02183740|Cluster-randomized controlled trial|cluster-randomized controlled trial
5299022|NCT02183727|knee injury|knee injury
5299023|NCT02183727|anterior cruciate ligament|anterior cruciate ligament
5299024|NCT02183597|Magnetic Resonance Imaging|magnetic resonance imaging
5299025|NCT02183597|Data Accuracy|data accuracy
5299026|NCT02183597|Reproducibility of Results|reproducibility of results
5299027|NCT02183597|Diagnosis|diagnosis
5299028|NCT02183558|PCOS|pcos
5299029|NCT02183558|GDM|gdm
5299030|NCT02183558|OGTT|ogtt
5299031|NCT02183558|Glucose metabolism|glucose metabolism
5299032|NCT02183519|Cough|cough
5299033|NCT02183519|Reflex|reflex
5299034|NCT02183519|Voluntary|voluntary
5299035|NCT02183519|Healthy older adults|healthy older adults
5299036|NCT02183519|Parkinson's disease|parkinson's disease
5299037|NCT02183519|Respiratory kinematics|respiratory kinematics
5299038|NCT02183519|Cueing|cueing
5299039|NCT02183454|intracoronary stent|intracoronary stent
5299040|NCT02183454|drug eluting stent|drug eluting stent
5299041|NCT02183454|sirolimus|sirolimus
5299042|NCT02183454|endothelial progenitor cells|endothelial progenitor cells
5299043|NCT02183272|Depression|depression
5299044|NCT02183272|Suicidal Ideation|suicidal ideation
5299045|NCT02183272|Ketamine|ketamine
5299046|NCT02183272|Emergency Department|emergency department
5299047|NCT02183207|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5299048|NCT02183207|Introducer method|introducer method
5299049|NCT02182999|Hallux valgus surgery|hallux valgus surgery
5299050|NCT02182999|wound infiltration|wound infiltration
5299051|NCT02182999|pain|pain
5299052|NCT02182986|Biomarkers|biomarkers
5299053|NCT02182986|Post-Transplant Lymphoproliferative Disorders (PTLDs)|post-transplant lymphoproliferative disorders (ptlds)
5299054|NCT02182973|neonatal abstinence syndrome, infant opiate withdrawal|neonatal abstinence syndrome, infant opiate withdrawal
5963035|NCT04276155|Acute Coronary Syndromes, Atrial Fibrillation, Anticoagulant therapy, Implantable device, Telecardiology.|acute coronary syndromes, atrial fibrillation, anticoagulant therapy, implantable device, telecardiology.
5299055|NCT02182947|Pediatric|pediatric
5963036|NCT04276142|ceprica|ceprica
5299056|NCT02182947|Inflammatory Bowel Disease|inflammatory bowel disease
5299057|NCT02182947|Wirless capsule endoscopy|wirless capsule endoscopy
5299058|NCT02182947|MRE|mre
5299059|NCT02182947|Crohn's Disease|crohn's disease
5299060|NCT02182947|Indeterminant Colitis|indeterminant colitis
5299061|NCT02182947|Small bowel Crohn's Disease|small bowel crohn's disease
5299062|NCT02182908|Aneurysm of abdominal aorta|aneurysm of abdominal aorta
5299063|NCT02182908|18F-fluorodesoxyglucose (FDG-F18)|18f-fluorodesoxyglucose (fdg-f18)
5299064|NCT02182843|Cellentra ACDF|cellentra acdf
5299065|NCT02182817|General Anaesthesia|general anaesthesia
5299066|NCT02182817|Neurocognitive Development|neurocognitive development
5299067|NCT02182817|Behaviour|behaviour
5299068|NCT02182804|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5299069|NCT02182804|Narrow Band Imaging|narrow band imaging
5299070|NCT02182804|Lugol Chromoendoscopy|lugol chromoendoscopy
5299071|NCT02182804|Esophageal Neoplasm|esophageal neoplasm
5299072|NCT02182804|Head and Neck Cancer|head and neck cancer
5299081|NCT02182466|Colonoscopy|colonoscopy
5299082|NCT02182466|Screening colonoscopy|screening colonoscopy
5299084|NCT02182440|Sepsis|sepsis
5299085|NCT02182440|AKI|aki
5299086|NCT02182440|Recombinant Alkaline Phosphatase|recombinant alkaline phosphatase
5299087|NCT02182440|recAP|recap
5299088|NCT02182167|Drug Induced Hepatitis (DIH)|drug induced hepatitis (dih)
5299089|NCT02182167|Toxic Liver|toxic liver
5299090|NCT02182167|Drug Induced Liver Injury (DILI)|drug induced liver injury (dili)
5299091|NCT02182115|Staphylococcus aureus infection|staphylococcus aureus infection
5299092|NCT02182115|Decolonization|decolonization
5299093|NCT02182115|Surgical site infection|surgical site infection
5299094|NCT02181894|Infant|infant
5299095|NCT02181894|Newborn|newborn
5299096|NCT02181894|Neonate|neonate
5299097|NCT02181894|Intubation|intubation
5299098|NCT02181894|Neonatal resuscitation|neonatal resuscitation
5299099|NCT02181842|Pharmacological therapy|pharmacological therapy
5299100|NCT02181829|Whole Lung IMRT|whole lung imrt
5299101|NCT02181829|14-075|14-075
5299102|NCT02181816|Pharmacological therapy|pharmacological therapy
5299103|NCT02181790|psoriasis|psoriasis
5299104|NCT02181790|palmoplantar|palmoplantar
5299105|NCT02181790|acitretin|acitretin
5299106|NCT02181790|retinoids|retinoids
5299107|NCT02181790|laser treatment|laser treatment
5299108|NCT02181777|Psychosis|psychosis
5299109|NCT02181777|Schizophrenia|schizophrenia
5299110|NCT02181777|Social Skills|social skills
5299111|NCT02181777|Therapy|therapy
5299112|NCT02181764|XLH|xlh
5299113|NCT02181751|Child Sexual Abuse|child sexual abuse
5299114|NCT02181751|CSA|csa
5299115|NCT02181751|Treatment|treatment
5299116|NCT02181751|Prevention|prevention
5299117|NCT02181751|PTSD|ptsd
5299122|NCT02181751|Attachment|attachment
5299123|NCT02181751|Cognitive Behavioural Therapy|cognitive behavioural therapy
5299124|NCT02181751|Group Therapy|group therapy
5299125|NCT02181725|Chronic Pain|chronic pain
5299126|NCT02181725|Adolescent|adolescent
5299127|NCT02181725|Graded Exposure|graded exposure
5299128|NCT02181712|Bronchiolitis obliterans|bronchiolitis obliterans
5299129|NCT02181712|lung transplant|lung transplant
5299130|NCT02181712|mesenchymal stem cell|mesenchymal stem cell
5299131|NCT02181712|cell therapy|cell therapy
5299132|NCT02181686|Heart Failure|heart failure
5299133|NCT02181686|Iperia ICD family|iperia icd family
5299134|NCT02181686|Sentus QP left ventricular lead|sentus qp left ventricular lead
5299135|NCT02181686|Quadripolar CRT-D system|quadripolar crt-d system
5299136|NCT02181673|Psoriatic arthritis|psoriatic arthritis
5299137|NCT02181673|Golimumab|golimumab
5299139|NCT02181660|AML|aml
5299140|NCT02181660|Acute myeloid leukemia|acute myeloid leukemia
5299141|NCT02181660|Gilteritinib|gilteritinib
5299142|NCT02181660|ASP2215|asp2215
5299143|NCT02181634|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
5299144|NCT02181634|Metastatic Cholangiocarcinoma|metastatic cholangiocarcinoma
5299145|NCT02181634|CCA|cca
5299146|NCT02181634|Bile Duct Cancer|bile duct cancer
5299147|NCT02181634|Nab-Paclitaxel|nab-paclitaxel
5299148|NCT02181634|Abraxane®|abraxane®
5299149|NCT02181634|Gemcitabine|gemcitabine
5299150|NCT02181634|Gemzar®|gemzar®
5299151|NCT02181608|Alcohol Dependence|alcohol dependence
5299152|NCT02181608|Fear Conditioning|fear conditioning
5299153|NCT02181608|Stress|stress
5299154|NCT02181608|Alcohol|alcohol
5299155|NCT02181595|Reading|reading
5299156|NCT02181595|FACIT-SP|facit-sp
5299157|NCT02181595|Primary Ovarian Insufficiency|primary ovarian insufficiency
5299158|NCT02181582|Health Humans|health humans
5299159|NCT02181582|Receptor Occupancy|receptor occupancy
5299164|NCT02181556|colorectal cancer|colorectal cancer
5299165|NCT02181556|Metastatic|metastatic
5299166|NCT02181543|Clonidine|clonidine
5299167|NCT02181543|Psychomotor agitation|psychomotor agitation
5299168|NCT02181543|Anesthesia recovery period|anesthesia recovery period
5299169|NCT02181543|Tonsillectomy|tonsillectomy
5299170|NCT02181543|Child, preschool|child, preschool
5299171|NCT02181478|Total Body Irradiation|total body irradiation
5299172|NCT02181478|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
5299173|NCT02181478|hMSC|hmsc
5299174|NCT02181478|Cyclophosphamide|cyclophosphamide
5299175|NCT02181478|Fludarabine|fludarabine
5299176|NCT02181478|Dimethyl Sulfoxide|dimethyl sulfoxide
5299177|NCT02181478|DMSO|dmso
5299178|NCT02181478|Cyclosporine|cyclosporine
5299179|NCT02181478|Mycophenolate Mofetil|mycophenolate mofetil
5299180|NCT02181478|MMF|mmf
5299181|NCT02181478|Granulocyte- Colony Stimulating Factor|granulocyte- colony stimulating factor
5408307|NCT01685060|ALK|alk
5299182|NCT02181478|G-CSF|g-csf
5299183|NCT02181478|GVHD|gvhd
5299184|NCT02181478|Cancer|cancer
5299185|NCT02181478|feasibility|feasibility
5299186|NCT02181452|liver|liver
5299187|NCT02181452|fibrosis|fibrosis
5299188|NCT02181452|ShearWave Elastography|shearwave elastography
5299189|NCT02181452|ultrasound|ultrasound
5299190|NCT02181426|Knee Arthroscopy|knee arthroscopy
5299191|NCT02181413|Drug therapy|drug therapy
5299192|NCT02181413|Ixazomib citrate|ixazomib citrate
5299193|NCT02181400|diabetic retinopathy|diabetic retinopathy
5299194|NCT02181400|diabetic macular edema|diabetic macular edema
5299195|NCT02181400|diabetic macular oedema|diabetic macular oedema
5299196|NCT02181400|near infrared light therapy|near infrared light therapy
5299197|NCT02181387|labor pain|labor pain
5299198|NCT02181387|acetaminophen|acetaminophen
5299199|NCT02181374|atrial fibrillation|atrial fibrillation
5299200|NCT02181374|NT-proBNP|nt-probnp
5299201|NCT02181374|Cardioembolic Stroke|cardioembolic stroke
5299202|NCT02181361|atrial fibrillation|atrial fibrillation
5299203|NCT02181361|cardioembolic stroke|cardioembolic stroke
5299204|NCT02181361|Hirudin|hirudin
5299205|NCT02181361|aspirin|aspirin
5299206|NCT02181361|warfarin|warfarin
5299207|NCT02181348|Vitamin E, Hemoglobin, mild anemia|vitamin e, hemoglobin, mild anemia
5299208|NCT02181296|Shoulder arthroscopy|shoulder arthroscopy
5299209|NCT02181296|Interscalene block|interscalene block
5299210|NCT02181296|Drug concentration|drug concentration
5299211|NCT02181296|0.1% ropivacaine or 0.2% ropivacaine|0.1% ropivacaine or 0.2% ropivacaine
5299212|NCT02181283|alcohol|alcohol
5299213|NCT02181283|prescribed drugs|prescribed drugs
5299214|NCT02181283|National Guard|national guard
5299215|NCT02181270|NAFLD|nafld
5299216|NCT02181270|obesity|obesity
5299217|NCT02181270|ck18|ck18
5299218|NCT02181270|blood lipids|blood lipids
5299219|NCT02181270|high intensity exercise training|high intensity exercise training
5299220|NCT02181270|individuals|individuals
5299231|NCT02181231|depression|depression
5299232|NCT02181231|older adult|older adult
5299233|NCT02181231|buprenorphine|buprenorphine
5299234|NCT02181231|Effexor XR|effexor xr
5299235|NCT02181231|treatment resistant|treatment resistant
5299236|NCT02181231|venlafaxine|venlafaxine
5299237|NCT02181231|Saint Louis|saint louis
5299238|NCT02181231|late life|late life
5299239|NCT02181231|major depression|major depression
5299240|NCT02181192|biochemical recurrence|biochemical recurrence
5299241|NCT02181192|prostate carcinoma|prostate carcinoma
5299242|NCT02181192|prostate cancer|prostate cancer
5299243|NCT02181192|PSA|psa
5299244|NCT02181192|postoperative|postoperative
5299245|NCT02181192|radiotherapy|radiotherapy
5299246|NCT02181192|imaging diagnostic|imaging diagnostic
5299247|NCT02181192|PET/CT|pet/ct
5299248|NCT02181192|social economic aspects|social economic aspects
5299249|NCT02181192|quality of life|quality of life
5299250|NCT02181179|yoga|yoga
5299251|NCT02181179|exercise intervention|exercise intervention
5299252|NCT02181179|smoking|smoking
5299253|NCT02181179|stress|stress
5299254|NCT02181179|mind-body|mind-body
5299255|NCT02181179|intervention|intervention
5299256|NCT02181166|Breast Neoplasms|breast neoplasms
5299257|NCT02181166|Mastectomy|mastectomy
5299258|NCT02181166|Myofascial pain syndromes|myofascial pain syndromes
5299259|NCT02181166|Physical Therapy Modalities|physical therapy modalities
5299260|NCT02181153|inflammatory bowel disease|inflammatory bowel disease
5299261|NCT02181153|siblings|siblings
5299262|NCT02181140|fine needle aspiration|fine needle aspiration
5299263|NCT02181140|core biopsy|core biopsy
5299264|NCT02181140|endoscopic ultrasound|endoscopic ultrasound
5299265|NCT02181140|space occupying process mediastinal, perigastral, perihilar|space occupying process mediastinal, perigastral, perihilar
5299266|NCT02181140|suspect lymph nodes mediastinal, perigastral or perihilar|suspect lymph nodes mediastinal, perigastral or perihilar
5299267|NCT02181140|diagnostic accuracy of EUS guided core biopsy|diagnostic accuracy of eus guided core biopsy
5299268|NCT02181127|bionic pancreas|bionic pancreas
5299269|NCT02181127|artificial pancreas|artificial pancreas
5299270|NCT02181127|insulin|insulin
5299271|NCT02181127|glucagon|glucagon
5299272|NCT02181127|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5299273|NCT02181127|outpatient|outpatient
5299274|NCT02181127|insulin pump|insulin pump
5299275|NCT02181127|glucagon pump|glucagon pump
5299276|NCT02181114|Coaching|coaching
5299277|NCT02181114|Educational Materials|educational materials
5299278|NCT02181114|Expert System|expert system
5299279|NCT02181114|Living Donor Kidney Transplant|living donor kidney transplant
5299280|NCT02181088|Malaria|malaria
5299281|NCT02181088|Plasmodium falciparum|plasmodium falciparum
5299282|NCT02181088|RH5|rh5
5299283|NCT02181075|ThermoDox|thermodox
5299284|NCT02181075|High Intensity Focused Ultrasound|high intensity focused ultrasound
5299285|NCT02181075|Lyso thermosensitive Liposomal|lyso thermosensitive liposomal
5299286|NCT02181075|Non invasive drug delivery|non invasive drug delivery
5299287|NCT02181075|Hepatic metastatic disease|hepatic metastatic disease
5299288|NCT02181075|Liver tumour(s)|liver tumour(s)
5903809|NCT00303706|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5299289|NCT02181075|Targeted Release of Chemotherapy|targeted release of chemotherapy
5299290|NCT02181062|Stroke|stroke
5299291|NCT02181062|Stroke prevention|stroke prevention
5299292|NCT02181062|older adults|older adults
5299293|NCT02181062|self efficacy|self efficacy
5299294|NCT02181062|walking|walking
5299295|NCT02181062|minorities|minorities
5299296|NCT02181062|minority older adults|minority older adults
5299297|NCT02181062|hypertension|hypertension
5299298|NCT02181062|high blood pressure|high blood pressure
5299299|NCT02181062|elderly|elderly
5299300|NCT02181062|sedentary lifestyle|sedentary lifestyle
5299301|NCT02181049|Childhood cancer survivors|childhood cancer survivors
5299302|NCT02181049|Cardiac|cardiac
5299303|NCT02181049|Vascular|vascular
5299304|NCT02181049|Cardiovascular|cardiovascular
5299305|NCT02181049|Late-sequelae|late-sequelae
5299306|NCT02181036|Family work shop|family work shop
5299307|NCT02181036|speech developmental delays|speech developmental delays
5299308|NCT02181036|children|children
5299309|NCT02181023|COPD|copd
5299310|NCT02181023|Hyperinflation|hyperinflation
5299311|NCT02181023|Aclidinium|aclidinium
5299312|NCT02181023|Glycopyrronium|glycopyrronium
5299313|NCT02181023|Volume distribution|volume distribution
5299314|NCT02181023|Anticholinergic|anticholinergic
5299315|NCT02181023|Pharmacokinetics|pharmacokinetics
5299316|NCT02181023|Single Breath Nitrogen Test|single breath nitrogen test
5299317|NCT02181023|Phase III|phase iii
5299318|NCT02181010|African American|african american
5299319|NCT02181010|Adolescents|adolescents
5299320|NCT02181010|Urban|urban
5299321|NCT02181010|Food Desert|food desert
5299322|NCT02181010|Food Insecurity|food insecurity
5299323|NCT02181010|Obesity|obesity
5299324|NCT02181010|Baltimore City|baltimore city
5299325|NCT02181010|Peer mentors|peer mentors
5299326|NCT02181010|Multi level|multi level
5299327|NCT02181010|Policy|policy
5299328|NCT02181010|Caregivers|caregivers
5299329|NCT02181010|Systems|systems
5299330|NCT02181010|Agent Based Model|agent based model
5299331|NCT02181010|Systems Dynamic Model|systems dynamic model
5299332|NCT02181010|Corner Store|corner store
5299333|NCT02181010|Carryout|carryout
5299334|NCT02181010|Recreation Center|recreation center
5299335|NCT02181010|Text Messaging|text messaging
5299336|NCT02181010|Social Media|social media
5299337|NCT02181010|Mapping|mapping
5299338|NCT02180997|α1-blockers|α1-blockers
5299339|NCT02180997|antimuscarinic agent|antimuscarinic agent
5299340|NCT02180984|Binge Eating|binge eating
5299341|NCT02180984|Obesity|obesity
5299342|NCT02180984|TMS|tms
5299343|NCT02180984|Neuroimage|neuroimage
5299344|NCT02180984|Neuromodulation|neuromodulation
5299345|NCT02180984|Biomarkers|biomarkers
5299346|NCT02180984|Eating Disorders|eating disorders
5299347|NCT02180984|Cognition|cognition
5299348|NCT02180984|Endocrine|endocrine
5299349|NCT02180984|Hormones|hormones
5299350|NCT02180984|BDNF|bdnf
5299351|NCT02180984|Inflammatory biomarkers|inflammatory biomarkers
5299352|NCT02180971|Multi-detector computed tomography angiography|multi-detector computed tomography angiography
5299353|NCT02180971|Coronary vessel distensibility|coronary vessel distensibility
5299354|NCT02180971|Coronary spasm|coronary spasm
5299355|NCT02180958|cerebral arteriovenous malformations|cerebral arteriovenous malformations
5299356|NCT02180958|cAVM|cavm
5299357|NCT02180958|ONYX|onyx
5299358|NCT02180945|dAVF|davf
5299359|NCT02180945|Arteriovenous fistula|arteriovenous fistula
5299360|NCT02180945|ONYX|onyx
5299361|NCT02180919|Telemonitoring|telemonitoring
5299362|NCT02180919|COPD|copd
5299363|NCT02180919|Heart failure|heart failure
5299364|NCT02180919|Exacerbation|exacerbation
5299365|NCT02180919|Respiratory failure|respiratory failure
5299366|NCT02180919|Prevention|prevention
5299367|NCT02180919|Self monitoring|self monitoring
5299368|NCT02180906|Fasciitis|fasciitis
5299369|NCT02180906|Gangrene|gangrene
5299370|NCT02180906|Fasciitis, Necrotizing|fasciitis, necrotizing
5299371|NCT02180906|Soft Tissue Infections|soft tissue infections
5299372|NCT02180906|Fournier's Gangrene|fournier's gangrene
5299373|NCT02180906|Streptococcal septic shock syndrome|streptococcal septic shock syndrome
5299374|NCT02180906|Flesh eating bacteria|flesh eating bacteria
5299375|NCT02180906|Meleneys ulcer|meleneys ulcer
5299376|NCT02180906|Wounds and Injuries|wounds and injuries
5299377|NCT02180906|Streptococcus pyogenes|streptococcus pyogenes
5299378|NCT02180906|Staphylococcus aureus|staphylococcus aureus
5299379|NCT02180906|Immunopathogenesis|immunopathogenesis
5299380|NCT02180906|Soft Tissue Infections/blood|soft tissue infections/blood
5299381|NCT02180906|Necrosis/blood|necrosis/blood
5299382|NCT02180906|Necrosis/diagnosis|necrosis/diagnosis
5299383|NCT02180906|Necrosis/mortality|necrosis/mortality
5299384|NCT02180906|Necrosis/surgery|necrosis/surgery
5299385|NCT02180906|Prognosis|prognosis
5299386|NCT02180906|Risk Factors|risk factors
5299387|NCT02180906|Bacterial Infections|bacterial infections
5299388|NCT02180906|Infection|infection
5299389|NCT02180906|Skin Diseases, Bacterial|skin diseases, bacterial
5299390|NCT02180906|Observational study|observational study
5299391|NCT02180906|Biological markers|biological markers
5299392|NCT02180880|Neuralgia|neuralgia
5299393|NCT02180880|Spinal cord|spinal cord
5299394|NCT02180880|Oxcarbazepine|oxcarbazepine
5299395|NCT02180880|Pregabalin|pregabalin
5299396|NCT02180880|Drug therapy|drug therapy
5299397|NCT02180880|Algorithms|algorithms
5299398|NCT02180854|Early warning score|early warning score
5299399|NCT02180854|Rapid response systems|rapid response systems
5299400|NCT02180854|Medical emergency team|medical emergency team
5299402|NCT02180841|hypertension|hypertension
5299403|NCT02180841|HDL-C|hdl-c
5299404|NCT02180841|cholesterol efflux|cholesterol efflux
5299405|NCT02180841|cardiovascular disease|cardiovascular disease
5299406|NCT02180815|Obstructive Sleep Apnea|obstructive sleep apnea
5299407|NCT02180815|Obstructive Sleep Apnea due to primary tongue base closure|obstructive sleep apnea due to primary tongue base closure
5299408|NCT02180815|Minimally invasive surgery|minimally invasive surgery
5299409|NCT02180815|ReVENT Sleep Apnea System|revent sleep apnea system
5299410|NCT02180815|Tongue implants|tongue implants
5299411|NCT02180802|obese adolescents|obese adolescents
5299412|NCT02180802|BMI ≥ 95th percentile for age and gender|bmi ≥ 95th percentile for age and gender
5299413|NCT02180789|tamsulosin,|tamsulosin,
5194646|NCT02777307|reoperation|reoperation
5299414|NCT02180789|benign prostatic hyperplasia,|benign prostatic hyperplasia,
5299415|NCT02180789|α1-adrenoceptor antagonists|α1-adrenoceptor antagonists
5299416|NCT02180763|Primary Immunodeficiency, PID|primary immunodeficiency, pid
5299417|NCT02180750|Children|children
5299419|NCT02180750|orphans|orphans
5299420|NCT02180737|dexmedetomedine|dexmedetomedine
5299421|NCT02180737|sedation|sedation
5299422|NCT02180737|interventional radiology|interventional radiology
5299423|NCT02180724|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5299424|NCT02180724|Btk|btk
5299425|NCT02180724|Waldenström Macroglobulinemia|waldenström macroglobulinemia
5299426|NCT02180724|WM|wm
5299427|NCT02180724|Waldenström|waldenström
5299428|NCT02180724|Macroglobulinemia|macroglobulinemia
5299429|NCT02180711|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5299430|NCT02180711|Btk|btk
5299431|NCT02180711|Follicular Lymphoma|follicular lymphoma
5299432|NCT02180711|FL|fl
5299433|NCT02180711|acalabrutinib|acalabrutinib
5299434|NCT02180711|ACP-196|acp-196
5299436|NCT02180711|Marginal Zone Lymphoma|marginal zone lymphoma
5299437|NCT02180672|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5299438|NCT02180672|OSA|osa
5299439|NCT02180672|sleep apnea|sleep apnea
5299440|NCT02180672|nasal steroids|nasal steroids
5299441|NCT02180672|corticosteroids|corticosteroids
5299442|NCT02180646|GLP-1|glp-1
5299443|NCT02180646|GIP|gip
5299444|NCT02180646|second meal phenomena|second meal phenomena
5299445|NCT02180646|type 2 diabetes|type 2 diabetes
5299446|NCT02180633|Idiopathic Macular Hole|idiopathic macular hole
5299447|NCT02180620|GIP|gip
5299448|NCT02180620|GLP-1|glp-1
5299449|NCT02180620|exercise timing|exercise timing
5299450|NCT02180620|resistance exercise|resistance exercise
5299451|NCT02180620|glucose concentrations|glucose concentrations
5299452|NCT02180607|depression|depression
5299453|NCT02180607|social|social
5299454|NCT02180607|rejection|rejection
5299455|NCT02180607|acceptance|acceptance
5299456|NCT02180607|fMRI|fmri
5299457|NCT02180607|reward|reward
5299458|NCT02180607|exclusion|exclusion
5299459|NCT02180581|Infections|infections
5299460|NCT02180581|Allergy|allergy
5299461|NCT02180581|Immune function|immune function
5299462|NCT02180581|Microbiota|microbiota
5299463|NCT02180581|Infant|infant
5299464|NCT02180568|Ground-glass-opacity (GGO)|ground-glass-opacity (ggo)
5299465|NCT02180568|Lung localization|lung localization
5299466|NCT02180568|Lipiodol|lipiodol
5299467|NCT02180568|Hook wire|hook wire
5299468|NCT02180568|Video assisted thoracic surgery (VATS)|video assisted thoracic surgery (vats)
5299469|NCT02180542|stroke|stroke
5299470|NCT02180542|Ischemic stroke|ischemic stroke
5299471|NCT02180542|Cerebral infarction|cerebral infarction
5299472|NCT02180542|recurrent stroke|recurrent stroke
5299473|NCT02180542|atrial fibrillation|atrial fibrillation
5299474|NCT02180542|premature atrial complexes|premature atrial complexes
5299475|NCT02180542|heart rhythm monitoring|heart rhythm monitoring
5299476|NCT02180542|left atrial function|left atrial function
5299477|NCT02180542|carotid artery|carotid artery
5299478|NCT02180542|plaque morphology|plaque morphology
5299479|NCT02180529|methylphenidate, elderly, mild cognitive impairment|methylphenidate, elderly, mild cognitive impairment
5299480|NCT02180464|psoriasis, topical|psoriasis, topical
5299481|NCT02180438|HIV-2|hiv-2
5299482|NCT02180425|acne|acne
5299483|NCT02180425|lipid|lipid
5299484|NCT02180425|tretinoin|tretinoin
5299485|NCT02180425|isotretinoin|isotretinoin
5299486|NCT02180412|Acute porphyria|acute porphyria
5299490|NCT02180399|Serial measurement of capillary|serial measurement of capillary
5963037|NCT04276142|online intervention|online intervention
5181125|NCT02857972|Menstruation, Female Barrier, Sanitary pads|menstruation, female barrier, sanitary pads
5181126|NCT02857933|Motor Impairments|motor impairments
5299491|NCT02180386|Audiovisual distraction|audiovisual distraction
5299492|NCT02180386|Pediatric dentistry|pediatric dentistry
5299493|NCT02180360|Capoeira training|capoeira training
5299495|NCT02180360|Flexibility|flexibility
5299496|NCT02180360|beginners|beginners
5299497|NCT02180347|Pediatrics|pediatrics
5299498|NCT02180347|Contact lenses|contact lenses
5299499|NCT02180334|Gastric Emptying|gastric emptying
5299500|NCT02180334|Gastrointestinal Motility|gastrointestinal motility
5299501|NCT02180334|Incretins|incretins
5299502|NCT02180334|Glucagon-Like Peptide 1|glucagon-like peptide 1
5299503|NCT02180334|Diabetes Mellitus|diabetes mellitus
5299504|NCT02180321|Tranexamic acid|tranexamic acid
5299505|NCT02180321|pharmacokinetics|pharmacokinetics
5299506|NCT02180321|craniosynostosis|craniosynostosis
5299507|NCT02180308|Head cancer|head cancer
5299508|NCT02180308|Neck cancer|neck cancer
5299510|NCT02180308|PET|pet
5299511|NCT02180282|Acne Treatment|acne treatment
5299512|NCT02180269|Healthy|healthy
5299513|NCT02180269|JNJ-54861911|jnj-54861911
5299514|NCT02180269|Alzheimer's disease|alzheimer's disease
5299515|NCT02180256|IVF|ivf
5299516|NCT02180256|ICSI|icsi
5299517|NCT02180256|Embryo transfer|embryo transfer
5299518|NCT02180256|Assisted reproduction|assisted reproduction
5299519|NCT02180256|Endometrial injury|endometrial injury
5299520|NCT02180256|Endometrial scratching|endometrial scratching
5299521|NCT02180243|meditation|meditation
5299522|NCT02180243|acupuncture|acupuncture
5299523|NCT02180243|Gulf War Veterans' Illness|gulf war veterans' illness
5299524|NCT02180243|Gulf War health education|gulf war health education
5299525|NCT02180243|iRest yoga|irest yoga
5299526|NCT02180230|Short implants|short implants
5299527|NCT02180230|prospective multicenter study|prospective multicenter study
5299528|NCT02180230|maxilla & mandible|maxilla & mandible
5299532|NCT02180204|Ischemic Stroke|ischemic stroke
5299533|NCT02180204|Thrombolysis|thrombolysis
5299534|NCT02180191|Gut microbiota|gut microbiota
5299535|NCT02180178|microvascular disease|microvascular disease
5299536|NCT02180178|coronary artery disease|coronary artery disease
5299537|NCT02180178|Coronary artery disease, with or without microvascular dysfuntion|coronary artery disease, with or without microvascular dysfuntion
5299538|NCT02180152|Perinatal outcomes|perinatal outcomes
5299539|NCT02180113|Cirrhotic patients|cirrhotic patients
5299540|NCT02180113|Fibroscan|fibroscan
5299541|NCT02180113|Liver Stiffness Measurement|liver stiffness measurement
5299542|NCT02180113|Oesophageal Varices|oesophageal varices
5286611|NCT02239198|HDL|hdl
5299543|NCT02180113|Portal Hypertension|portal hypertension
5299544|NCT02180113|Spleen Stiffness Measurement|spleen stiffness measurement
5299545|NCT02180087|Cardiac surgery|cardiac surgery
5299546|NCT02180087|Post-operative pain|post-operative pain
5299547|NCT02180087|Kétoprofène|kétoprofène
5299548|NCT02180087|Minimum analgesic dose|minimum analgesic dose
5299549|NCT02180087|Morphin consumption|morphin consumption
5299550|NCT02180087|Morphin secondary effects|morphin secondary effects
5299551|NCT02180087|Patient comfort and satisfaction|patient comfort and satisfaction
5299552|NCT02180087|Renal fonction|renal fonction
5299553|NCT02180074|Hydrogen Sulfide Pools,|hydrogen sulfide pools,
5299554|NCT02180061|PD1|pd1
5299555|NCT02180061|PD-1|pd-1
5299556|NCT02180061|PDL1|pdl1
5299557|NCT02180061|PD-L1|pd-l1
5299558|NCT02180035|diet therapy|diet therapy
5299559|NCT02180035|symbiotic|symbiotic
5299560|NCT02180035|dyslipidemia|dyslipidemia
5299561|NCT02180035|gastrointestinal symptoms|gastrointestinal symptoms
5299562|NCT02180035|body composition|body composition
5299563|NCT02180035|adherence|adherence
5299564|NCT02180035|HIV|hiv
5299575|NCT02179983|rehabilitation|rehabilitation
5299576|NCT02179983|exercise|exercise
5299577|NCT02179983|exacerbations|exacerbations
5299578|NCT02179970|Advanced pancreatic cancer|advanced pancreatic cancer
5299579|NCT02179970|Advanced ovarian cancer|advanced ovarian cancer
5299580|NCT02179970|Advanced colorectal cancer|advanced colorectal cancer
5299581|NCT02179970|Metastatic pancreatic cancer|metastatic pancreatic cancer
5299582|NCT02179970|Metastatic ovarian cancer|metastatic ovarian cancer
5299583|NCT02179970|Metastatic colorectal cancer|metastatic colorectal cancer
5299584|NCT02179957|Stenoses|stenoses
5299585|NCT02179957|Ischaemia|ischaemia
5299586|NCT02179957|haemodynamics|haemodynamics
5299592|NCT02179918|Advanced Solid Tumors|advanced solid tumors
5299593|NCT02179905|MRI|mri
5299594|NCT02179905|Heart rate variability|heart rate variability
5299599|NCT02179879|labor,epidural,analgesia|labor,epidural,analgesia
5299601|NCT02179853|Anakinra|anakinra
5299602|NCT02179853|IL-1|il-1
5299603|NCT02179840|Cerebral microvascular circulation|cerebral microvascular circulation
5299604|NCT02179840|Cerebral autoregulation|cerebral autoregulation
5299605|NCT02179814|bulimia nervosa|bulimia nervosa
5963038|NCT04276142|headache|headache
5963039|NCT04276090|hepatic artery infusion pump|hepatic artery infusion pump
5299606|NCT02179814|dopamine|dopamine
5299607|NCT02179814|reward|reward
5963040|NCT04276090|colorectal liver metastases|colorectal liver metastases
5963041|NCT04276090|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5168981|NCT02935374|antimicrobial course|antimicrobial course
5299608|NCT02179814|catechol-O-methyltransferase|catechol-o-methyltransferase
5299609|NCT02179814|gene|gene
5299610|NCT02179814|catecholamines|catecholamines
5299611|NCT02179814|alpha-methyl-para-tyrosine|alpha-methyl-para-tyrosine
5299612|NCT02179814|magnetic resonance imaging|magnetic resonance imaging
5299613|NCT02179801|Abdominal aortic aneurysm|abdominal aortic aneurysm
5299614|NCT02179801|AAA|aaa
5299615|NCT02179801|Screening|screening
5299616|NCT02179788|lactation|lactation
5299617|NCT02179788|breastfeeding|breastfeeding
5299618|NCT02179788|human milk|human milk
5299619|NCT02179788|insulin|insulin
5299620|NCT02179788|metformin|metformin
5299621|NCT02179788|prediabetes|prediabetes
5299622|NCT02179788|pre-diabetes|pre-diabetes
5299623|NCT02179788|insulin resistance|insulin resistance
5299624|NCT02179762|cancer survivor|cancer survivor
5299625|NCT02179762|prostate cancer|prostate cancer
5299626|NCT02179762|exercise|exercise
5299627|NCT02179762|Active surveillance|active surveillance
5299628|NCT02179762|EASE|ease
5299923|NCT02178215|sebum|sebum
5299636|NCT02179736|Correction of moderate to severe nasolabial folds|correction of moderate to severe nasolabial folds
5299637|NCT02179723|wound healing|wound healing
5299638|NCT02179723|cosmetic results|cosmetic results
5299639|NCT02179723|trocar incision|trocar incision
5299640|NCT02179710|adherence|adherence
5299641|NCT02179710|cystic fibrosis|cystic fibrosis
5299642|NCT02179710|adolescents|adolescents
5299643|NCT02179710|adults|adults
5299644|NCT02179697|Groups:|groups:
5299645|NCT02179697|Group 1 (2 Treatment Arms (Randomized between 2 treatments))|group 1 (2 treatment arms (randomized between 2 treatments))
5299646|NCT02179697|Treatment 1: Surgery + Bracing|treatment 1: surgery + bracing
5299647|NCT02179697|Treatment 2: Bracing Alone|treatment 2: bracing alone
5299648|NCT02179697|Group 2|group 2
5299649|NCT02179697|The patient will decide which group is best for themselves.|the patient will decide which group is best for themselves.
5299650|NCT02179684|Cranial Nerve fascial paresis|cranial nerve fascial paresis
5299651|NCT02179671|Lung cancer; NSCLC|lung cancer; nsclc
5299652|NCT02179658|Clostridium|clostridium
5299653|NCT02179658|Infections|infections
5299654|NCT02179658|Difficile|difficile
5299655|NCT02179658|Vancomycin|vancomycin
5299656|NCT02179658|Fidaxomicin|fidaxomicin
5299657|NCT02179632|disclosure|disclosure
5299658|NCT02179632|conflicts of interest|conflicts of interest
5299659|NCT02179632|trust|trust
5299660|NCT02179632|patient doctor relationship|patient doctor relationship
5299661|NCT02179593|Maxillary expansion|maxillary expansion
5299662|NCT02179593|Orthognathic surgery|orthognathic surgery
5299663|NCT02179593|Symmetry|symmetry
5299664|NCT02179593|Palatal expansion technique|palatal expansion technique
5299665|NCT02179593|Maxilla abnormality|maxilla abnormality
5299666|NCT02179580|Traditional Chinese Medicine|traditional chinese medicine
5299667|NCT02179580|Clinical trial|clinical trial
5299668|NCT02179580|Good Clinical Practice|good clinical practice
5299669|NCT02179567|Metastatic NSCLC|metastatic nsclc
5299672|NCT02179567|Bevacizumab-based treatment|bevacizumab-based treatment
5299673|NCT02179541|Otitis media with effusion, viscosity, RGB (red-green-blue).|otitis media with effusion, viscosity, rgb (red-green-blue).
5299674|NCT02179515|Immune Response|immune response
5299675|NCT02179515|Maximum Tolerated Dose|maximum tolerated dose
5299676|NCT02179515|Vaccine Therapy|vaccine therapy
5299677|NCT02179515|Increased Expression of Brachyury|increased expression of brachyury
5299678|NCT02179515|Immunotherapy|immunotherapy
5299679|NCT02179489|Peritoneal carcinomatosis|peritoneal carcinomatosis
5299681|NCT02179489|controlled clinical trial|controlled clinical trial
5299682|NCT02179489|colorectal cancer|colorectal cancer
5299683|NCT02179476|Facet joint|facet joint
5299684|NCT02179476|facet joint pain|facet joint pain
5299685|NCT02179476|facet joint disease|facet joint disease
5299686|NCT02179476|lumbar pain|lumbar pain
5299687|NCT02179476|back pain|back pain
5299688|NCT02179463|Gastric Cancer|gastric cancer
5299689|NCT02179463|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5304252|NCT02156089|fMRI|fmri
5299690|NCT02179463|Response Evaluation|response evaluation
5299691|NCT02179437|TIVA|tiva
5299692|NCT02179437|Propofol|propofol
5299693|NCT02179437|Postoperative pain|postoperative pain
5299694|NCT02179437|Liver resection surgery|liver resection surgery
5299695|NCT02179437|Retrospective study|retrospective study
5299696|NCT02179424|smoking cessation interventions|smoking cessation interventions
5299697|NCT02179398|Fever without source|fever without source
5299698|NCT02179398|Antibiotic prescription|antibiotic prescription
5299699|NCT02179398|Serious bacterial infection|serious bacterial infection
5299700|NCT02179385|Type 2 diabetes|type 2 diabetes
5299701|NCT02179385|Type II diabetes|type ii diabetes
5299702|NCT02179359|Stem Cell Transplant|stem cell transplant
5299703|NCT02179346|cartilage defect|cartilage defect
5299705|NCT02179346|impingement|impingement
5299706|NCT02179320|Myofascial Pain Syndrome|myofascial pain syndrome
5299707|NCT02179320|Dry needling|dry needling
5299708|NCT02179320|Clinical Trial|clinical trial
5299709|NCT02179307|muscle hypertrophy|muscle hypertrophy
5963042|NCT04276090|FUDR|fudr
5963043|NCT04276090|floxuridine|floxuridine
5299710|NCT02179307|strength|strength
5299711|NCT02179307|resistance training|resistance training
5299712|NCT02179307|exercise|exercise
5299713|NCT02179307|physical fitness|physical fitness
5299714|NCT02179307|health|health
5299715|NCT02179307|physical conditioning|physical conditioning
5299716|NCT02179294|Pain relief|pain relief
5299717|NCT02179294|Labour|labour
5299718|NCT02179294|Child birth|child birth
5299719|NCT02179294|Anaesthetics|anaesthetics
5299720|NCT02179268|Antidepressants|antidepressants
5299721|NCT02179268|bone mineral density|bone mineral density
5299722|NCT02179268|bone turnover markers|bone turnover markers
5299729|NCT02179242|KCCQ|kccq
5299730|NCT02179242|6 minute walk test|6 minute walk test
5299731|NCT02179242|readmission|readmission
5299732|NCT02179229|Kidney transplantation|kidney transplantation
5299733|NCT02179229|pCresol|pcresol
5299734|NCT02179229|Immunosuppressant drugs|immunosuppressant drugs
5299735|NCT02179216|Orthostatic hypotension in the elderly|orthostatic hypotension in the elderly
5299736|NCT02179216|Efficacity of Hydration|efficacity of hydration
5299737|NCT02179216|Difference between hydratation and venous contention|difference between hydratation and venous contention
5299738|NCT02179177|Vaso-occlusive crisis|vaso-occlusive crisis
5299739|NCT02179177|Reduction in hospitalizations|reduction in hospitalizations
5299740|NCT02179177|Sickle Cell Disease|sickle cell disease
5299741|NCT02179151|Prader-Willi Syndrome|prader-willi syndrome
5194948|NCT02775656|CZP|czp
5299742|NCT02179151|Obesity|obesity
5299743|NCT02179151|Hyperphagia|hyperphagia
5299744|NCT02179125|COPD|copd
5299745|NCT02179125|Endobronchial treatment|endobronchial treatment
5299746|NCT02179112|Surgery|surgery
5299747|NCT02179112|Specialties, Surgical|specialties, surgical
5299748|NCT02179112|Geography, Medical|geography, medical
5299749|NCT02179112|Developing Countries|developing countries
5299750|NCT02179112|Developed Countries|developed countries
5299751|NCT02179112|Laparotomy|laparotomy
5299752|NCT02179112|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5299753|NCT02179112|Treatment Outcome|treatment outcome
5299754|NCT02179112|Quality of Health Care|quality of health care
5299755|NCT02179099|overactive bladder|overactive bladder
5286825|NCT02238379|EEG/ERP|eeg/erp
5299756|NCT02179099|OAB|oab
5299757|NCT02179099|urgency|urgency
5299758|NCT02179099|botulinum toxin|botulinum toxin
5299759|NCT02179099|BTX|btx
5299760|NCT02179099|botox|botox
5299761|NCT02179099|intravesical|intravesical
5299762|NCT02179099|TheraCoat|theracoat
5299763|NCT02179099|TCGel|tcgel
5299764|NCT02179099|TC-3 Gel|tc-3 gel
5299765|NCT02179060|Sudden cardiac arrest, RhinoChill -cooling, MRI|sudden cardiac arrest, rhinochill -cooling, mri
5299767|NCT02179034|tobacco|tobacco
5299768|NCT02179034|electronic cigarettes|electronic cigarettes
5299769|NCT02179034|menthol|menthol
5299770|NCT02179034|flavors|flavors
5299771|NCT02179021|Thromboelastometry|thromboelastometry
5299772|NCT02179021|Haemostasis|haemostasis
5299773|NCT02179021|Hypothermia|hypothermia
5299774|NCT02179021|Heart arrest|heart arrest
5299775|NCT02179008|Santen|santen
5299776|NCT02179008|Eye|eye
5299777|NCT02179008|Glaucoma|glaucoma
5299778|NCT02179008|Ocular hypertension|ocular hypertension
5299779|NCT02178982|mechanical ventilation|mechanical ventilation
5299780|NCT02178982|ARDS|ards
5299781|NCT02178982|Ventilator strategy|ventilator strategy
5299782|NCT02178982|outcome|outcome
5299783|NCT02178943|Molecular Diagnostics|molecular diagnostics
5299784|NCT02178943|Heart Transplantation|heart transplantation
5299785|NCT02178943|Risk Factors|risk factors
5299786|NCT02178943|Prognosis|prognosis
5299787|NCT02178930|HIV|hiv
5299788|NCT02178930|cardiovascular disease|cardiovascular disease
5299789|NCT02178930|self-management|self-management
5299790|NCT02178930|HIV co-morbidities|hiv co-morbidities
5299791|NCT02178930|self-efficacy|self-efficacy
5299792|NCT02178930|coronary heart disease risk|coronary heart disease risk
5299793|NCT02178930|quality of life|quality of life
5299794|NCT02178904|Ischemia|ischemia
5299795|NCT02178904|Dual Energy Computed Tomography|dual energy computed tomography
5299796|NCT02178904|Computed Tomographic Perfusion|computed tomographic perfusion
5299797|NCT02178904|Fractional Flow Rate|fractional flow rate
5299798|NCT02178904|Invasive Coronary Angiography|invasive coronary angiography
5299801|NCT02178891|Nobel Biocare|nobel biocare
5299802|NCT02178891|partially edentulous|partially edentulous
5299803|NCT02178891|maxilla or mandible|maxilla or mandible
5299804|NCT02178878|Labor pain and progress, variation, genetic|labor pain and progress, variation, genetic
5299805|NCT02178865|translocation|translocation
5299806|NCT02178839|Non Alcoholic Fatty Liver Disease(NAFLD)|non alcoholic fatty liver disease(nafld)
5299807|NCT02178839|β- glucan|β- glucan
5299808|NCT02178839|Appetite|appetite
5299809|NCT02178839|Insulin Resistance|insulin resistance
5299810|NCT02178826|Nocturnal Enuresis|nocturnal enuresis
5299811|NCT02178826|Rapid Maxillary Expansion|rapid maxillary expansion
5299812|NCT02178826|Orthodontics|orthodontics
5299813|NCT02178826|Polysomnography|polysomnography
5299814|NCT02178826|Quality of life|quality of life
5299815|NCT02178813|Minocycline|minocycline
5299816|NCT02178813|Neuroprotection|neuroprotection
5299817|NCT02178813|Stroke|stroke
5299818|NCT02178787|cerebral blood flow|cerebral blood flow
5299819|NCT02178787|near infrared spectroscopy|near infrared spectroscopy
5299820|NCT02178787|transcranial Doppler|transcranial doppler
5299821|NCT02178787|diabetes mellitus|diabetes mellitus
5299822|NCT02178787|cerebral autoregulation|cerebral autoregulation
5299823|NCT02178774|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5299824|NCT02178774|spinal anesthesia|spinal anesthesia
5299827|NCT02178761|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5299828|NCT02178761|Peripheral Arterial Disease|peripheral arterial disease
5299829|NCT02178761|Angioplasty|angioplasty
5299830|NCT02178761|Multidetector Computed Tomography|multidetector computed tomography
5299831|NCT02178748|Tuberculosis|tuberculosis
5299832|NCT02178748|Phase II|phase ii
5299833|NCT02178748|MVA85A|mva85a
5299834|NCT02178748|Schistosoma mansoni|schistosoma mansoni
5299835|NCT02178735|pelvic organ prolapse, vaginal mesh, urodynamic studies|pelvic organ prolapse, vaginal mesh, urodynamic studies
5299839|NCT02178683|TACROLIMUS|tacrolimus
5299840|NCT02178683|MYCOPHENOLATE MOFETIL|mycophenolate mofetil
5299841|NCT02178683|FLUDARABINE|fludarabine
5299842|NCT02178683|HLA-MATCHED|hla-matched
5299843|NCT02178683|MIS-MATCHED|mis-matched
5299844|NCT02178657|Stroke|stroke
5299845|NCT02178657|Cell therapy|cell therapy
5299846|NCT02178657|Bone marrow|bone marrow
5299847|NCT02178605|rhBMP-2|rhbmp-2
5299848|NCT02178605|arthrodesis|arthrodesis
5299849|NCT02178605|cervical|cervical
5299850|NCT02178592|integrase inhibitor|integrase inhibitor
5299851|NCT02178592|Mycobacterium tuberculosis|mycobacterium tuberculosis
5299852|NCT02178592|rifampicin-sensitive|rifampicin-sensitive
5299853|NCT02178592|dolutegravir|dolutegravir
5299854|NCT02178592|antiretroviral therapy-naïve|antiretroviral therapy-naïve
5299855|NCT02178592|HIV-1 infection|hiv-1 infection
5299856|NCT02178592|efavirenz|efavirenz
5299857|NCT02178592|co-infection|co-infection
5299858|NCT02178579|Heart Failure|heart failure
5299859|NCT02178579|Cardiac Toxicity|cardiac toxicity
5299860|NCT02178579|Multiple Myeloma|multiple myeloma
5299861|NCT02178579|Bortezomib|bortezomib
5299862|NCT02178579|Carfilzomib|carfilzomib
5299863|NCT02178566|COPD|copd
5299864|NCT02178566|Trepostinil|trepostinil
5299865|NCT02178566|Pulmonary Rehabilitation|pulmonary rehabilitation
5299866|NCT02178553|Thoracotomy|thoracotomy
5299867|NCT02178553|Pain|pain
5299868|NCT02178540|Human factors, TOBI® Podhaler™, Instructions For use, IFU, CF patients|human factors, tobi® podhaler™, instructions for use, ifu, cf patients
5299869|NCT02178527|Geriatrics|geriatrics
5299870|NCT02178527|Accidental Falls|accidental falls
5299871|NCT02178527|Podiatry|podiatry
5299872|NCT02178527|Exercise Therapy|exercise therapy
5299873|NCT02178527|Orthotic Devices|orthotic devices
5299874|NCT02178527|Foot|foot
5299875|NCT02178501|OMEGA-3 PUFA|omega-3 pufa
5299876|NCT02178501|type 2 diabetes|type 2 diabetes
5299877|NCT02178501|cardiovascular diseases|cardiovascular diseases
5299879|NCT02178475|Breast Cancer|breast cancer
5299880|NCT02178423|children, ultrasound, central catheter|children, ultrasound, central catheter
5299881|NCT02178410|Atrial Fibrillation|atrial fibrillation
5299882|NCT02178410|Vitamin D3|vitamin d3
5299883|NCT02178410|Omega-3 fatty acids|omega-3 fatty acids
5299884|NCT02178410|Fish oil|fish oil
5299885|NCT02178397|erlotinib|erlotinib
5299886|NCT02178397|lung cancer|lung cancer
5299887|NCT02178397|EGFR mutation|egfr mutation
5299888|NCT02178384|Loading Forces|loading forces
5299889|NCT02178384|Removable partial dentures|removable partial dentures
5299890|NCT02178384|Bilateral distal extension|bilateral distal extension
5299891|NCT02178371|Upper extremity|upper extremity
5299892|NCT02178371|Physical therapy modalities|physical therapy modalities
5299893|NCT02178358|transforming growth factor beta (TGF-β)|transforming growth factor beta (tgf-β)
5299895|NCT02178345|14-126|14-126
5299896|NCT02178332|Children|children
5299897|NCT02178332|socio-emotional|socio-emotional
5299898|NCT02178332|socio-emotional skills|socio-emotional skills
5299899|NCT02178332|psychiatric symptoms|psychiatric symptoms
5299900|NCT02178332|SDQ|sdq
5299901|NCT02178332|Finland|finland
5299902|NCT02178332|School|school
5299903|NCT02178332|School community|school community
5299904|NCT02178332|Teacher|teacher
5299905|NCT02178332|Whole school approach|whole school approach
5299906|NCT02178332|Intervention|intervention
5299907|NCT02178332|Effectiveness study|effectiveness study
5299908|NCT02178332|Cluster randomised trial|cluster randomised trial
5299909|NCT02178319|portal hypertension|portal hypertension
5299910|NCT02178319|Randomized clinical trial|randomized clinical trial
5299911|NCT02178319|laparoscopic|laparoscopic
5299912|NCT02178319|open|open
5299913|NCT02178267|Newborn, preterm, probiotic, resistant microorganisms|newborn, preterm, probiotic, resistant microorganisms
5299914|NCT02178254|Pseudomonas aeruginosa, ZTI-101, phosphonic acid derivative, Monurol, fosfomycin tromethamine|pseudomonas aeruginosa, zti-101, phosphonic acid derivative, monurol, fosfomycin tromethamine
5299915|NCT02178228|Anastomotic Leaks|anastomotic leaks
5299916|NCT02178228|Bowel Resection|bowel resection
5299917|NCT02178228|Postoperative Complication|postoperative complication
5299918|NCT02178215|atopic dermatitis|atopic dermatitis
5299919|NCT02178215|skin barrier function|skin barrier function
5299920|NCT02178215|transepidermal water loss|transepidermal water loss
5299921|NCT02178215|skin pH|skin ph
5299922|NCT02178215|stratum corneum hydration|stratum corneum hydration
5299925|NCT02178202|Harmonic technique, Low Back Pain, McKenzie exercise, Pain, Disability|harmonic technique, low back pain, mckenzie exercise, pain, disability
5299926|NCT02178189|prenatal opioid exposure|prenatal opioid exposure
5299927|NCT02178189|infant|infant
5299928|NCT02178189|weight gain|weight gain
5299929|NCT02178189|infant formula|infant formula
5299930|NCT02178150|Magnesium|magnesium
5299931|NCT02178150|Insulin Resistance|insulin resistance
5299932|NCT02178150|Lipid profile|lipid profile
5299933|NCT02178150|Sex hormones|sex hormones
5299934|NCT02178150|Inflammatory factors|inflammatory factors
5299935|NCT02178111|episiotomy, vaginal delivery, randomized, perineum|episiotomy, vaginal delivery, randomized, perineum
5299937|NCT02178098|Cholesterol|cholesterol
5299938|NCT02178085|glaucoma|glaucoma
5299939|NCT02178085|phase-contrast MRI|phase-contrast mri
5299940|NCT02178085|blood flow|blood flow
5299941|NCT02178085|cerebrospinal fluid|cerebrospinal fluid
5299942|NCT02178072|HNSCC|hnscc
5299943|NCT02178059|Healthy volunteers, pharmacokinetic, inhalation|healthy volunteers, pharmacokinetic, inhalation
5299944|NCT02178046|Gingivitis|gingivitis
5299945|NCT02178033|adenoma detection rate, screening colonoscopy|adenoma detection rate, screening colonoscopy
5299946|NCT02178020|Knee Arthroplasty|knee arthroplasty
5299947|NCT02178020|Osteolysis|osteolysis
5299948|NCT02178020|Radiolucent Lines|radiolucent lines
5299949|NCT02177994|Elective Cesarean Section|elective cesarean section
5299950|NCT02177994|Antibiotic prophylaxis|antibiotic prophylaxis
5299951|NCT02177994|Timing of Antibiotic prophylaxis|timing of antibiotic prophylaxis
5299952|NCT02177994|post cesarean section infection|post cesarean section infection
5299953|NCT02177981|Remote Ischemic Preconditioning|remote ischemic preconditioning
5299954|NCT02177981|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5299955|NCT02177981|Diffusion Weighted Magnetic Resonance Imaging|diffusion weighted magnetic resonance imaging
5287014|NCT02237300|Anxiety|anxiety
5299956|NCT02177981|Resting State Functional Magnetic Resonance Imaging|resting state functional magnetic resonance imaging
5299957|NCT02177981|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5299958|NCT02177968|fall|fall
5299959|NCT02177968|elderly|elderly
5299960|NCT02177968|characteristics|characteristics
5299961|NCT02177955|Third Molar|third molar
5299962|NCT02177955|Anty-anxiety drugs|anty-anxiety drugs
5299963|NCT02177955|hemodynamic|hemodynamic
5299964|NCT02177955|Benzodiazepines|benzodiazepines
5299965|NCT02177929|Spinal cord injury,|spinal cord injury,
5299966|NCT02177929|adaptive sport,|adaptive sport,
5299967|NCT02177929|dynamometry,|dynamometry,
5299968|NCT02177929|electromyography,|electromyography,
5299969|NCT02177929|force platform.|force platform.
5299970|NCT02177916|lung transplantation|lung transplantation
5299971|NCT02177903|hypothermia|hypothermia
5299972|NCT02177903|surgical site infection|surgical site infection
5299974|NCT02177903|blood loss|blood loss
5299975|NCT02177903|pain severity|pain severity
5299976|NCT02177903|anxiety|anxiety
5299977|NCT02177903|Length of Stay|length of stay
5299978|NCT02177877|Epilepsy|epilepsy
5299979|NCT02177877|Seizures|seizures
5299980|NCT02177877|Wrist accelerometer|wrist accelerometer
5299981|NCT02177877|Epilepsy diary|epilepsy diary
5299982|NCT02177877|Seizure detection|seizure detection
5299983|NCT02177877|Biosensor|biosensor
5299984|NCT02177851|Iron bio-availability|iron bio-availability
5299985|NCT02177851|Hepcidin|hepcidin
5299986|NCT02177851|Iron absorption|iron absorption
5299987|NCT02177812|Oncology|oncology
5299988|NCT02177812|LSD1|lsd1
5299989|NCT02177812|GSK2879552|gsk2879552
5299990|NCT02177812|Acute myeloid leukemia|acute myeloid leukemia
5299991|NCT02177799|Gastroenteritis|gastroenteritis
5299992|NCT02177799|Hospitalized|hospitalized
5299993|NCT02177799|Children|children
5299994|NCT02177786|Diabetic Kidney Disease|diabetic kidney disease
5299995|NCT02177786|Gilead|gilead
5299996|NCT02177760|SCID|scid
5300012|NCT02177695|Coexpression Extrapolation|coexpression extrapolation
5300013|NCT02177695|COXEN|coxen
5300014|NCT02177695|S1314|s1314
5300015|NCT02177695|SWOG|swog
5300016|NCT02177682|AKT inhibitor|akt inhibitor
5300017|NCT02177682|Afuresertib|afuresertib
5300018|NCT02177682|multiple myeloma|multiple myeloma
5300019|NCT02177669|Normal, healthy individuals without ocular disease|normal, healthy individuals without ocular disease
5300020|NCT02177669|Ages 20-89|ages 20-89
5300021|NCT02177669|English speaking|english speaking
5300022|NCT02177669|Visual acuity better than 20/25|visual acuity better than 20/25
5300023|NCT02177656|heart failure|heart failure
5300025|NCT02177656|self-care maintenance|self-care maintenance
5300026|NCT02177656|self-care management|self-care management
5300027|NCT02177656|self-efficacy|self-efficacy
5300028|NCT02177656|quality of life|quality of life
5300029|NCT02177656|symptoms|symptoms
5300030|NCT02177643|Diabetes|diabetes
5300031|NCT02177643|Diacerein|diacerein
5300032|NCT02177630|myocarditis, myocardial inflammation, imaging, magnetic resonance|myocarditis, myocardial inflammation, imaging, magnetic resonance
5300033|NCT02177617|Cervical Dystonia|cervical dystonia
5300034|NCT02177617|Botox|botox
5300035|NCT02177578|Subventricular Zone|subventricular zone
5300036|NCT02177578|progenitor cell|progenitor cell
5300037|NCT02177578|radiation therapy|radiation therapy
5300038|NCT02177578|temozolomide|temozolomide
5300039|NCT02177565|Non-union|non-union
5300040|NCT02177565|fracture|fracture
5300041|NCT02177565|bone marrow stem cells|bone marrow stem cells
5300042|NCT02177552|Esophageal cancer|esophageal cancer
5300043|NCT02177552|Gastric cancer|gastric cancer
5300044|NCT02177539|cycloplegia|cycloplegia
5300045|NCT02177539|refraction in children|refraction in children
5300046|NCT02177539|cycloplegic agents|cycloplegic agents
5300047|NCT02177539|cycloplegic schemes|cycloplegic schemes
5300048|NCT02177539|cyclopentolate|cyclopentolate
5300051|NCT02177513|Cannabis|cannabis
5300052|NCT02177513|Pharmacodynamics|pharmacodynamics
5300053|NCT02177513|Marijuana|marijuana
5300054|NCT02177513|Cannabinoids|cannabinoids
5300055|NCT02177513|Vaporized|vaporized
5300056|NCT02177474|depressive symptoms|depressive symptoms
5300057|NCT02177474|perceived social support|perceived social support
5300058|NCT02177474|coronary heart disease|coronary heart disease
5300059|NCT02177474|peer support|peer support
5300060|NCT02177474|women|women
5300061|NCT02177279|Wheat bran cereals, bran phytochemicals, phytochemicals bioavailability|wheat bran cereals, bran phytochemicals, phytochemicals bioavailability
5300062|NCT02177240|GlideScope®|glidescope®
5300063|NCT02177240|GlideRite®|gliderite®
5300064|NCT02177240|Flex-it®|flex-it®
5300065|NCT02177240|Difficult intubation|difficult intubation
5300066|NCT02177227|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5300067|NCT02177227|Attune|attune
5300068|NCT02177227|Primary Total Knee Prosthesis|primary total knee prosthesis
5300069|NCT02177227|TruMatch|trumatch
5300070|NCT02177188|Hypovolaemic shock|hypovolaemic shock
5300071|NCT02177188|Monitoring|monitoring
5300072|NCT02177188|Haemorrhage|haemorrhage
5300073|NCT02177188|Transthoracic Echocardiography|transthoracic echocardiography
5300074|NCT02177175|Carvedilol|carvedilol
5300075|NCT02177175|Anthracycline|anthracycline
5300076|NCT02177175|HER2|her2
5300077|NCT02177175|14-099|14-099
5300078|NCT02177136|PSC|psc
5300079|NCT02177123|glaucoma shunt|glaucoma shunt
5300080|NCT02177123|glaucoma drainage device|glaucoma drainage device
5300085|NCT02177097|Pain|pain
5300086|NCT02177097|Infection|infection
5300087|NCT02177097|Inflammation|inflammation
5300088|NCT02177097|Prosthesis|prosthesis
5300089|NCT02177084|PTNS|ptns
5300090|NCT02177084|rectal cancer|rectal cancer
5300091|NCT02177084|low anterior resection syndrome|low anterior resection syndrome
5300092|NCT02177071|CROHN DISEASE|crohn disease
5300093|NCT02177071|INFLIXIMAB|infliximab
5300094|NCT02177071|COMBINATION THERAPY|combination therapy
5300095|NCT02177071|steroid free remission|steroid free remission
5300100|NCT02177032|intradermal|intradermal
5300101|NCT02177032|human rabies immunoglobulins|human rabies immunoglobulins
5300102|NCT02177019|frequent headaches|frequent headaches
5300103|NCT02177019|personalized health plan|personalized health plan
5300104|NCT02176993|Acute stroke|acute stroke
5300105|NCT02176993|Therapeutic Hypothermia|therapeutic hypothermia
5300107|NCT02176980|hepatitis C|hepatitis c
5300108|NCT02176980|alcohol|alcohol
5300109|NCT02176980|integrated care|integrated care
5300110|NCT02176941|Telomere Length|telomere length
5300111|NCT02176941|Arterial Aging|arterial aging
5300112|NCT02176941|Endothelial Progenitor Cells|endothelial progenitor cells
5300113|NCT02176941|Inflammation|inflammation
5300114|NCT02176941|Atherosclerosis|atherosclerosis
5300115|NCT02176889|Lactospore|lactospore
5300116|NCT02176889|Bacillus coagulans|bacillus coagulans
5300117|NCT02176889|Safety|safety
5300118|NCT02176889|Probiotic|probiotic
5300119|NCT02176889|Healthy Adults|healthy adults
5300120|NCT02176889|Tolerability|tolerability
5300121|NCT02176876|rheumatoid arthritis|rheumatoid arthritis
5300122|NCT02176876|RA|ra
5300123|NCT02176876|GS-5745|gs-5745
5300124|NCT02176876|MMP9|mmp9
5300125|NCT02176876|phase 1|phase 1
5300126|NCT02176863|FORCE|force
5300127|NCT02176863|post-polio syndrome|post-polio syndrome
5300128|NCT02176863|Flebogamma|flebogamma
5300129|NCT02176863|Immune Globulin Intravenous|immune globulin intravenous
5300131|NCT02176837|subarachnoid hemorrhage|subarachnoid hemorrhage
5300132|NCT02176837|vasospasm|vasospasm
5300133|NCT02176837|nitrite|nitrite
5300134|NCT02176837|sodium nitrite|sodium nitrite
5300135|NCT02176811|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5300136|NCT02176811|Betatrophin|betatrophin
5300137|NCT02176785|Sleep|sleep
5300138|NCT02176785|Transcranial Electric Stimulation|transcranial electric stimulation
5300139|NCT02176720|Glioma|glioma
5300140|NCT02176720|Glioblastoma|glioblastoma
5300141|NCT02176720|Glioblastoma multiforme|glioblastoma multiforme
5300142|NCT02176720|GBM|gbm
5300143|NCT02176720|Recurrence|recurrence
5300144|NCT02176720|PET|pet
5300145|NCT02176720|FDOPA|fdopa
5300146|NCT02176707|Lung Function|lung function
5300147|NCT02176707|Exercise Capacity|exercise capacity
5300148|NCT02176694|persistent asthma|persistent asthma
5300149|NCT02176694|adherence|adherence
5300150|NCT02176694|text message reminders|text message reminders
5300151|NCT02176655|Delayed Alcohol Induced Headache|delayed alcohol induced headache
5300152|NCT02176642|Urinary Urge Incontinence|urinary urge incontinence
5300153|NCT02176642|Posterior Tibial Nerve Stimulation|posterior tibial nerve stimulation
5300154|NCT02176642|PTNS|ptns
5300155|NCT02176642|Neuromodulation|neuromodulation
5300156|NCT02176642|Oxybutynin|oxybutynin
5300157|NCT02176642|Anticholinergic Medication|anticholinergic medication
5300158|NCT02176629|Virtual Reality|virtual reality
5300159|NCT02176629|mild cognitive impairment|mild cognitive impairment
5300160|NCT02176629|Alzheimer's disease|alzheimer's disease
5300161|NCT02176603|phenylketonuria, endothelial dysfunction, CKD|phenylketonuria, endothelial dysfunction, ckd
5300162|NCT02176590|PATHS Social Emotional Learning|paths social emotional learning
5300163|NCT02176590|Coping Power|coping power
5300164|NCT02176590|Power PATH|power path
5300165|NCT02176590|Head Start|head start
5300166|NCT02176486|Drug Therapy|drug therapy
5300167|NCT02176473|Depression|depression
5300168|NCT02176460|Knee Osteoarthritis|knee osteoarthritis
5300169|NCT02176460|Double-blind|double-blind
5300170|NCT02176460|placebo-controlled|placebo-controlled
5300171|NCT02176460|randomized|randomized
5300172|NCT02176460|colchicine|colchicine
5300173|NCT02176434|End stage renal disease|end stage renal disease
5300174|NCT02176434|Transplantation|transplantation
5300175|NCT02176434|Tolerance|tolerance
5300176|NCT02176408|Major Depressive Disorder|major depressive disorder
5300177|NCT02176408|Depression|depression
5300179|NCT02176408|Exercise|exercise
5300180|NCT02176408|Physical Activity|physical activity
5300181|NCT02176408|Treatment|treatment
5300182|NCT02176408|Behavioral Activation|behavioral activation
5300183|NCT02176395|Acute Ischemic Stroke|acute ischemic stroke
5300184|NCT02176395|Randomized Controlled Trial|randomized controlled trial
5300185|NCT02176395|Traditional Chinese Medicine|traditional chinese medicine
5300186|NCT02176395|Proteomics|proteomics
5300187|NCT02176369|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
5300188|NCT02176369|Lung tumor in advanced phase|lung tumor in advanced phase
5300189|NCT02176343|Cataract|cataract
5300190|NCT02176343|Intraocular lens|intraocular lens
5300191|NCT02176343|ACRYSOF IQ ReSTOR + 2.5 D Multifocal Toric IOL|acrysof iq restor + 2.5 d multifocal toric iol
5300192|NCT02176330|Randomised Controlled Trial|randomised controlled trial
5300193|NCT02176330|Virtual Clinic|virtual clinic
5300194|NCT02176330|ePAQ-PF|epaq-pf
5300195|NCT02176330|Pelvic Floor Disorders|pelvic floor disorders
5296819|NCT02192827|Pediatric|pediatric
5300197|NCT02176317|Autism Spectrum Disorder|autism spectrum disorder
5300198|NCT02176317|ASD|asd
5300199|NCT02176317|Umbilical cord blood|umbilical cord blood
5300200|NCT02176317|Autologous cord blood|autologous cord blood
5300201|NCT02176317|cord blood|cord blood
5300202|NCT02176304|knee|knee
5300203|NCT02176304|arthritis|arthritis
5300204|NCT02176304|injections|injections
5300205|NCT02176304|corticosteroids|corticosteroids
5300206|NCT02176291|Buprenorphine|buprenorphine
5300207|NCT02176291|Receptors, opioid|receptors, opioid
5300208|NCT02176291|Receptors, opioid kappa and mu|receptors, opioid kappa and mu
5300209|NCT02176278|Diabetic Kidney Disease|diabetic kidney disease
5300210|NCT02176278|Diabetes|diabetes
5300212|NCT02176278|Joint Asia Diabetes Evaluation (JADE) Program|joint asia diabetes evaluation (jade) program
5300213|NCT02176265|CAD|cad
5300214|NCT02176265|PCI|pci
5300215|NCT02176265|bioactive coronary stent|bioactive coronary stent
5300216|NCT02176265|OCT|oct
5300217|NCT02176226|Major Depressive Disorder|major depressive disorder
5300218|NCT02176226|Anxiety Disorders|anxiety disorders
5300219|NCT02176226|Behavior Therapy|behavior therapy
5300220|NCT02176226|Technology Assisted|technology assisted
5300221|NCT02176226|Mobile Phone|mobile phone
5300222|NCT02176226|Cellular Phone|cellular phone
5300223|NCT02176226|Smartphone|smartphone
5300224|NCT02176226|App|app
5300225|NCT02176213|Relapsed|relapsed
5300226|NCT02176213|Refractory|refractory
5300227|NCT02176213|Multiple Myeloma|multiple myeloma
5300228|NCT02176213|Pomalidomide|pomalidomide
5300229|NCT02176213|Cyclophosphamide|cyclophosphamide
5300230|NCT02176213|Dexamethasone|dexamethasone
5300231|NCT02176174|Ethnic group|ethnic group
5300232|NCT02176174|Cardiovascular disease|cardiovascular disease
5300233|NCT02176174|Atherosclerosis|atherosclerosis
5300234|NCT02176161|Prostate Cancer|prostate cancer
5300235|NCT02176161|Prostate Cancer Recurrent|prostate cancer recurrent
5300236|NCT02176148|cutaneous lupus|cutaneous lupus
5300237|NCT02176148|systemic lupus|systemic lupus
5300238|NCT02176148|systemic therapy|systemic therapy
5300239|NCT02176148|medication|medication
5300241|NCT02176135|HAART suppressed|haart suppressed
5300242|NCT02176135|Auranofin|auranofin
5300243|NCT02176135|HIV latent reservoir|hiv latent reservoir
5300244|NCT02176057|trachoma|trachoma
5244775|NCT02475486|fatigue|fatigue
5169580|NCT02931721|Micro Dissection Testicular Sperm Extraction|micro dissection testicular sperm extraction
5169583|NCT02931721|MRI|mri
5300245|NCT02176044|Nitric Oxide|nitric oxide
5300246|NCT02176044|Sodium Nitroprusside|sodium nitroprusside
5300247|NCT02176044|Spatial Working Memory|spatial working memory
5300248|NCT02176044|Psychosis|psychosis
5300249|NCT02176044|Schizophrenia|schizophrenia
5300250|NCT02176031|Graft Versus Host Disease|graft versus host disease
5300251|NCT02176018|Episodic Migraine|episodic migraine
5300252|NCT02176018|Migraine|migraine
5300253|NCT02176018|Headache|headache
5300254|NCT02175979|postoperative ileus|postoperative ileus
5300255|NCT02175979|anastomotic leak|anastomotic leak
5300256|NCT02175979|colorectal surgery|colorectal surgery
5300257|NCT02175979|inflammation|inflammation
5300258|NCT02175953|caregiver burden|caregiver burden
5300259|NCT02175953|stress|stress
5300260|NCT02175953|depression|depression
5300261|NCT02175953|dementia|dementia
5300262|NCT02175927|Helicobacter pylori|helicobacter pylori
5300263|NCT02175927|Treatment Failure|treatment failure
5300264|NCT02175927|second-line therapy|second-line therapy
5300265|NCT02175914|Erythromycin|erythromycin
5300266|NCT02175914|Familial Adenomatous Polyposis (FAP).|familial adenomatous polyposis (fap).
5300267|NCT02175914|APC gene|apc gene
5300268|NCT02175914|nonsense mutations|nonsense mutations
5300269|NCT02175901|helicobacter pylori eradication|helicobacter pylori eradication
5300270|NCT02175901|antibiotic|antibiotic
5300271|NCT02175888|Iron bio availability|iron bio availability
5300272|NCT02175888|Hepcidin|hepcidin
5300273|NCT02175888|Iron absorption|iron absorption
5300274|NCT02175875|ticagrelor|ticagrelor
5300275|NCT02175875|platelet function test|platelet function test
5300276|NCT02175875|comatose|comatose
5300277|NCT02175875|PCI|pci
5300278|NCT02175875|naso-gastric tube|naso-gastric tube
5300279|NCT02175862|Helicopter Emergency Medical Service|helicopter emergency medical service
5300280|NCT02175862|Trauma|trauma
5300281|NCT02175862|Early retirement|early retirement
5287339|NCT02235883|FFR|ffr
5300282|NCT02175862|ISS|iss
5300283|NCT02175862|Quality of life|quality of life
5300284|NCT02175849|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
5300285|NCT02175849|Social Network Analysis|social network analysis
5300286|NCT02175836|Arrhythmic Sudden Cardiac Death|arrhythmic sudden cardiac death
5300287|NCT02175836|Heart Failure|heart failure
5300288|NCT02175836|Risk Stratification|risk stratification
5300289|NCT02175836|Autonomic Nervous System|autonomic nervous system
5300290|NCT02175836|Heart Rate|heart rate
5300291|NCT02175836|Repolarization|repolarization
5300292|NCT02175823|Cancer survivors|cancer survivors
5300293|NCT02175823|circadian rhythm|circadian rhythm
5300294|NCT02175823|Elderly Patients|elderly patients
5300295|NCT02175823|frailty|frailty
5300296|NCT02175810|Obesity|obesity
5300297|NCT02175810|Bariatric surgery|bariatric surgery
5300298|NCT02175810|physical activity|physical activity
5300299|NCT02175810|cardiopulmonary exercise test|cardiopulmonary exercise test
5300300|NCT02175797|Pacemaker, leads and MRI exam|pacemaker, leads and mri exam
5300301|NCT02175784|Blood glucose|blood glucose
5300302|NCT02175784|insulin|insulin
5300303|NCT02175784|ipragliflozin|ipragliflozin
5409692|NCT01679067|HIV|hiv
5300304|NCT02175784|SGLT2 inhibitor|sglt2 inhibitor
5300305|NCT02175732|Type 1 Diabetes|type 1 diabetes
5300306|NCT02175732|Distress|distress
5300307|NCT02175719|Torticollis|torticollis
5300308|NCT02175719|rimabotulinumtoxinB|rimabotulinumtoxinb
5300309|NCT02175693|Torticollis|torticollis
5300310|NCT02175693|rimabotulinumtoxinB|rimabotulinumtoxinb
5300311|NCT02175680|HIV-1|hiv-1
5300312|NCT02175680|HIV|hiv
5300313|NCT02175680|Treatment Substitution|treatment substitution
5300314|NCT02175680|PRO 140|pro 140
5300315|NCT02175680|PRO140|pro140
5300316|NCT02175680|CytoDyn|cytodyn
5300317|NCT02175680|Amarex|amarex
5300318|NCT02175667|Global postural reeducation|global postural reeducation
5300319|NCT02175667|Stabilometry|stabilometry
5300320|NCT02175667|Postural Sway|postural sway
5300321|NCT02175667|Range of motion|range of motion
5300322|NCT02175667|Personality traits|personality traits
5300323|NCT02175654|metastatic colorectal cancer|metastatic colorectal cancer
5300324|NCT02175654|RAS/BRAF mutation|ras/braf mutation
5300325|NCT02175654|Regorafenib|regorafenib
5300326|NCT02175654|FOLFOXIRI|folfoxiri
5300327|NCT02175654|Bevacizumab|bevacizumab
5300328|NCT02175641|Healthy lifestyle Intervention|healthy lifestyle intervention
5300329|NCT02175641|Serious Mental Illness|serious mental illness
5300330|NCT02175641|Effectiveness trial|effectiveness trial
5300331|NCT02175641|Supportive housing|supportive housing
5300332|NCT02175641|Racial and Ethnic Health Disparities|racial and ethnic health disparities
5300333|NCT02175628|Ultrasound|ultrasound
5300335|NCT02175628|Angiography|angiography
5300336|NCT02175615|CYCLOSPORINE|cyclosporine
5300337|NCT02175615|ACUTE GRAFT VERSUS HOST DISEASE|acute graft versus host disease
5963044|NCT04275895|Prematurely born children|prematurely born children
5963045|NCT04275895|Attention function|attention function
5963046|NCT04275895|Posture|posture
5963047|NCT04275895|Mobility|mobility
5963048|NCT04275869|infertility|infertility
5300338|NCT02175615|PROPHYLAXIS|prophylaxis
5300339|NCT02175615|CHILDREN|children
5300340|NCT02175615|HAEMATOPOIETIC STEM CELL TRANSPLANT|haematopoietic stem cell transplant
5300341|NCT02175589|Familial Mediterranean Fever|familial mediterranean fever
5300342|NCT02175589|Monozygous|monozygous
5300343|NCT02175589|MEFV|mefv
5300344|NCT02175589|Colchicine|colchicine
5300345|NCT02175589|Serum Amyloid A|serum amyloid a
5300346|NCT02175563|Chest|chest
5300347|NCT02175563|Compression|compression
5300348|NCT02175550|partially edentulous|partially edentulous
5300349|NCT02175550|maxilla|maxilla
5300350|NCT02175550|implants|implants
5300351|NCT02175550|Conical connection|conical connection
5300352|NCT02175550|Nobel Biocare|nobel biocare
5300353|NCT02175550|NobelReplace|nobelreplace
5300354|NCT02175550|Immediate loading|immediate loading
5300355|NCT02175550|One- stage surgery|one- stage surgery
5300356|NCT02175550|Two- stage surgery|two- stage surgery
5300357|NCT02175550|supported restoration|supported restoration
5300358|NCT02175550|patients|patients
5300359|NCT02175537|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5300360|NCT02175537|Disease management|disease management
5300361|NCT02175537|Obesity|obesity
5300362|NCT02175537|Social Network|social network
5300363|NCT02175537|Chronic disease|chronic disease
5300364|NCT02175537|Prevention and control|prevention and control
5300365|NCT02175537|Education|education
5300366|NCT02175524|nut chewing|nut chewing
5300367|NCT02175511|Home Blood Pressure|home blood pressure
5300368|NCT02175511|Computerized physician order entry (CPOE)|computerized physician order entry (cpoe)
5300369|NCT02175511|Telemonitoring|telemonitoring
5300370|NCT02175511|Hypertension|hypertension
5300371|NCT02175498|Homoeopathy Similimum female infertility|homoeopathy similimum female infertility
5300372|NCT02175472|Parkinson's disease|parkinson's disease
5300373|NCT02175472|Light therapy|light therapy
5300374|NCT02175472|Circadian rhythm|circadian rhythm
5300375|NCT02175446|Breast cancer|breast cancer
5300376|NCT02175446|HER2Negative|her2negative
5300377|NCT02175446|Second line treatment|second line treatment
5300378|NCT02175446|HER2-|her2-
5300380|NCT02175446|Metastatic|metastatic
5300381|NCT02175446|Metastatic breast cancer|metastatic breast cancer
5300382|NCT02175446|bevacizumab|bevacizumab
5300383|NCT02175446|eribulin|eribulin
5300384|NCT02175446|Human Epidermal Growth Factor Receptor 2-Negative|human epidermal growth factor receptor 2-negative
5300385|NCT02175433|Refractory or relapsed chronic lymphocytic leukemia (CLL) prolymphocytic leukemia (PLL)|refractory or relapsed chronic lymphocytic leukemia (cll) prolymphocytic leukemia (pll)
5300386|NCT02175433|Relapsed lymphoid malignancy|relapsed lymphoid malignancy
5300387|NCT02175433|Refractory lymphoid malignancy|refractory lymphoid malignancy
5300388|NCT02175433|Pharmacokinetics of AGS67E|pharmacokinetics of ags67e
5300389|NCT02175433|hairy cell leukemia (HCL)|hairy cell leukemia (hcl)
5300390|NCT02175433|AGS67C|ags67c
5300391|NCT02175433|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5300392|NCT02175433|AGS67E|ags67e
5300393|NCT02175420|BCG|bcg
5300394|NCT02175420|Salmonella|salmonella
5300395|NCT02175420|Trained immunity|trained immunity
5300396|NCT02175420|Non-specific effect vaccines|non-specific effect vaccines
5300397|NCT02175407|Healthy subjects|healthy subjects
5300398|NCT02175407|ASP1707|asp1707
5300399|NCT02175407|Itraconazole|itraconazole
5300400|NCT02175381|Metastatic NSCLC|metastatic nsclc
5300401|NCT02175381|Elderly|elderly
5903810|NCT00303706|Endoscopic technique|endoscopic technique
5300402|NCT02175381|1st Line|1st line
5300405|NCT02175368|direct filling therapy|direct filling therapy
5300406|NCT02175329|CAD/CAM, three-unit posterior bridges, zirconia framework|cad/cam, three-unit posterior bridges, zirconia framework
5300407|NCT02175277|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5300408|NCT02175277|Darbepoetin alfa|darbepoetin alfa
5300409|NCT02175277|low risk MDS|low risk mds
5300410|NCT02175277|intermediate-1 risk MDS|intermediate-1 risk mds
5300411|NCT02175277|International Prognostic Scoring System (IPSS)|international prognostic scoring system (ipss)
5300412|NCT02175264|Isolated non syndromic CDH|isolated non syndromic cdh
5300414|NCT02175251|Schizophrenia|schizophrenia
5300415|NCT02175251|high frequency rTMS|high frequency rtms
5300416|NCT02175251|low frequency rTMS|low frequency rtms
5300417|NCT02175251|AHRS|ahrs
5300418|NCT02175251|SAPS SANS PANSS|saps sans panss
5300420|NCT02175251|UKU|uku
5300421|NCT02175225|Brain hemorrhage|brain hemorrhage
5300422|NCT02175225|Cerebral hemorrhage|cerebral hemorrhage
5300423|NCT02175225|Bleeding in the brain|bleeding in the brain
5300424|NCT02175225|Deferoxamine|deferoxamine
5300425|NCT02175225|iDEF trial|idef trial
5300426|NCT02175212|Patients with prostate adenocarcinoma|patients with prostate adenocarcinoma
5300427|NCT02175199|Contact lens|contact lens
5300428|NCT02175199|Vision care|vision care
5300429|NCT02175199|Daily wear|daily wear
5300430|NCT02175199|Color contact lens|color contact lens
5300431|NCT02175186|Gastritis|gastritis
5300432|NCT02175186|Gastroduodenal Ulcer|gastroduodenal ulcer
5300433|NCT02175186|Percutaneous Coronary Revascularization|percutaneous coronary revascularization
5300434|NCT02175186|Dual Antiplatelet Therapy|dual antiplatelet therapy
5300435|NCT02175173|Epileptic encephalopathy, Lennox-Gastaut type|epileptic encephalopathy, lennox-gastaut type
5300436|NCT02175160|Driver reaction time|driver reaction time
5300437|NCT02175134|tuberculosis|tuberculosis
5300438|NCT02175134|peritonitis|peritonitis
5300439|NCT02175134|laparoscopy|laparoscopy
5300440|NCT02175108|Cerebral palsy|cerebral palsy
5300441|NCT02175108|Adolescents|adolescents
5300442|NCT02175108|Adults|adults
5300443|NCT02175108|Diet|diet
5300444|NCT02175108|Activity|activity
5300445|NCT02175108|Metabolic Syndrome|metabolic syndrome
5300446|NCT02175095|regorafenib|regorafenib
5300447|NCT02175095|fluorothymidine|fluorothymidine
5300448|NCT02175095|positron emission tomography|positron emission tomography
5300449|NCT02175095|metastatic colorectal cancer|metastatic colorectal cancer
5300450|NCT02175082|Parkinson Disease|parkinson disease
5300451|NCT02175082|Exercise|exercise
5300452|NCT02175082|Rehabilitation|rehabilitation
5300453|NCT02175082|Physical Therapy|physical therapy
5300454|NCT02175082|Cycling|cycling
5300455|NCT02175069|Shoulder surgery|shoulder surgery
5300456|NCT02175056|First In Human|first in human
5300457|NCT02175056|CAPS, SoJIA, AOSD, Bechet Disease, Rheumatoid arthritis|caps, sojia, aosd, bechet disease, rheumatoid arthritis
5300458|NCT02175043|atrial fibrillation, catheter ablation, recurrence|atrial fibrillation, catheter ablation, recurrence
5300459|NCT02175030|Emergency contraception|emergency contraception
5300460|NCT02175030|Levonorgestrel IUD|levonorgestrel iud
5300461|NCT02175030|Copper IUD|copper iud
5300462|NCT02175017|ONO-4538|ono-4538
5300463|NCT02175017|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5300464|NCT02175004|FAP|fap
5300465|NCT02175004|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5300466|NCT02175004|TTR|ttr
5300467|NCT02175004|Transthyretin|transthyretin
5300468|NCT02175004|Amyloidosis|amyloidosis
5300469|NCT02174978|Malaria vaccine|malaria vaccine
5300470|NCT02174952|Parenting interventions|parenting interventions
5300471|NCT02174952|ADHD|adhd
5300472|NCT02174952|Family functioning|family functioning
5300473|NCT02174952|Parent Training|parent training
5300474|NCT02174939|cilostazol|cilostazol
5300475|NCT02174939|progenitor cells|progenitor cells
5300476|NCT02174939|coronary artery disease|coronary artery disease
5300477|NCT02174939|myocardial infarction|myocardial infarction
5300478|NCT02174939|angiogenesis|angiogenesis
5300479|NCT02174939|biological markers|biological markers
5300480|NCT02174939|endothelial function|endothelial function
5300481|NCT02174913|Awakening time|awakening time
5300482|NCT02174913|Bispectral index|bispectral index
5300483|NCT02174913|clinical signs|clinical signs
5300484|NCT02174913|neurophysiologic monitoring|neurophysiologic monitoring
5300485|NCT02174913|spine surgery|spine surgery
5300486|NCT02174900|G6PD deficiency|g6pd deficiency
5300488|NCT02174900|transmission|transmission
5300489|NCT02174887|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5300490|NCT02174887|liver metastases|liver metastases
5300491|NCT02174861|Chronic Migraine|chronic migraine
5300492|NCT02174848|Pantothenate Kinase-Associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
5300493|NCT02174848|PKAN|pkan
5300494|NCT02174848|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
5300499|NCT02174835|Healthy Volunteers|healthy volunteers
5300500|NCT02174835|deuterated dextromethorphan|deuterated dextromethorphan
5300501|NCT02174835|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
5300502|NCT02174822|Drug-drug interaction|drug-drug interaction
5300503|NCT02174822|Pharmacokinetics|pharmacokinetics
5300504|NCT02174822|Healthy Volunteers|healthy volunteers
5300505|NCT02174822|deuterated dextromethorphan|deuterated dextromethorphan
5300506|NCT02174822|deuterated dextromethorphan with quinidine|deuterated dextromethorphan with quinidine
5300507|NCT02174809|Pregnancy|pregnancy
5300508|NCT02174809|Gestational Weight Gain|gestational weight gain
5300509|NCT02174809|Primary Care|primary care
5300510|NCT02174809|Guidelines|guidelines
5300511|NCT02174796|Pectus excavatum|pectus excavatum
5300512|NCT02174796|cardiac output|cardiac output
5300513|NCT02174796|transthoracic impedancemetry|transthoracic impedancemetry
5300514|NCT02174783|Weight Loss|weight loss
5300515|NCT02174783|Diet, Mediterranean|diet, mediterranean
5300516|NCT02174783|Diet, Reducing|diet, reducing
5300517|NCT02174783|protein sparing modified diet|protein sparing modified diet
5300518|NCT02174744|Pain in elderly patients having communication disorders|pain in elderly patients having communication disorders
5300519|NCT02174744|Numerical scale|numerical scale
5300520|NCT02174744|Algoplus® scale|algoplus® scale
5300521|NCT02174744|Doloplus® scale|doloplus® scale
5300522|NCT02174731|Renal,|renal,
5300523|NCT02174731|CKD,|ckd,
5300524|NCT02174731|Epoetin alfa,|epoetin alfa,
5300525|NCT02174731|Roxadustat,|roxadustat,
5300526|NCT02174731|dialysis,|dialysis,
5300527|NCT02174731|anemia|anemia
5300528|NCT02174718|Cholecalciferol|cholecalciferol
5300529|NCT02174718|Transdermal patch|transdermal patch
5300530|NCT02174705|vaccination|vaccination
5300531|NCT02174705|pain management|pain management
5300532|NCT02174705|sucrose|sucrose
5300533|NCT02174705|rotavirus|rotavirus
5300534|NCT02174666|Aglycones|aglycones
5300535|NCT02174666|Isoflavones|isoflavones
5300536|NCT02174666|Red clover|red clover
5300537|NCT02174666|Osteopenia|osteopenia
5300538|NCT02174666|Menopause|menopause
5300539|NCT02174666|Bone turnover|bone turnover
5300540|NCT02174666|Bone mineral density|bone mineral density
5300541|NCT02174640|Coffee|coffee
5300542|NCT02174640|Polyphenolics|polyphenolics
5300543|NCT02174627|Renal,|renal,
5300544|NCT02174627|CKD,|ckd,
5300545|NCT02174627|Roxadustat,|roxadustat,
5300546|NCT02174627|anemia,|anemia,
5300547|NCT02174627|non-dialysis|non-dialysis
5300548|NCT02174614|Cocaine use disorder|cocaine use disorder
5300549|NCT02174601|bowel preparation|bowel preparation
5300550|NCT02174601|coolprep|coolprep
5300551|NCT02174601|colonoscopy|colonoscopy
5300552|NCT02174601|prediction model|prediction model
5300553|NCT02174588|sedation, propofol, midazolam|sedation, propofol, midazolam
5300554|NCT02174575|Hepatectomy|hepatectomy
5300555|NCT02174562|Type 2 diabetes|type 2 diabetes
5300556|NCT02174562|Mild Cognitive Impairment|mild cognitive impairment
5300557|NCT02174549|Hypoxia|hypoxia
5300558|NCT02174549|Embolization|embolization
5300559|NCT02174549|Tirapazamine|tirapazamine
5300560|NCT02174523|pharmacokinetic|pharmacokinetic
5300561|NCT02174523|lurasidone|lurasidone
5300562|NCT02174523|multiple dose|multiple dose
5300563|NCT02174510|pharmacokinetic|pharmacokinetic
5300564|NCT02174510|lurasidone|lurasidone
5300565|NCT02174510|single dose|single dose
5300566|NCT02174497|Pediatric Colonoscopy|pediatric colonoscopy
5300567|NCT02174497|Bowel Preparation|bowel preparation
5300568|NCT02174497|Safety|safety
5300569|NCT02174497|Tolerability|tolerability
5300570|NCT02174484|Pacemaker|pacemaker
5300571|NCT02174484|Remote monitoring|remote monitoring
5300572|NCT02174484|Remote follow-up|remote follow-up
5300573|NCT02174484|Home monitoring|home monitoring
5300574|NCT02174484|Periodic IEGM|periodic iegm
5300575|NCT02174484|Intracardiac electrogram|intracardiac electrogram
5300576|NCT02174471|Aortic Stenosis|aortic stenosis
5300577|NCT02174471|Aortic Valve Replacement|aortic valve replacement
5300579|NCT02174471|Extracellular Volume Fraction|extracellular volume fraction
5300580|NCT02174471|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5300581|NCT02174471|Diffuse Myocardial Fibrosis|diffuse myocardial fibrosis
5300582|NCT02174458|Bariatric surgery; Body contouring; Quality of life|bariatric surgery; body contouring; quality of life
5300583|NCT02174445|Patients with CML in chronic phase|patients with cml in chronic phase
5300584|NCT02174445|Imatinib|imatinib
5300585|NCT02174445|Nilotinib|nilotinib
5300586|NCT02174432|Itch|itch
5300587|NCT02174432|Chronic Itch|chronic itch
5300588|NCT02174432|Nalbupine|nalbupine
5300589|NCT02174419|Itch|itch
5300590|NCT02174419|Chronic Itch|chronic itch
5300591|NCT02174419|nalbuphine|nalbuphine
5300592|NCT02174406|Ultrasound|ultrasound
5300593|NCT02174406|Digital Breast Tomosynthesis|digital breast tomosynthesis
5300594|NCT02174406|14-119|14-119
5300595|NCT02174367|Chronic plaque psoriasis|chronic plaque psoriasis
5300596|NCT02174367|Liver fibrosis|liver fibrosis
5300597|NCT02174367|Fatty liver disease|fatty liver disease
5300598|NCT02174367|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5300600|NCT02174367|Fibroscan|fibroscan
5300601|NCT02174367|Procollagen-3 N-Terminal peptide|procollagen-3 n-terminal peptide
5300602|NCT02174367|Alanine aminotransferase|alanine aminotransferase
5300603|NCT02174367|Liver function tests|liver function tests
5300604|NCT02174354|Psoriasis|psoriasis
5300605|NCT02174354|Methotrexate|methotrexate
5300606|NCT02174354|Methotrexate Polyglutamates|methotrexate polyglutamates
5300607|NCT02174354|Injury of Liver|injury of liver
5300608|NCT02174341|Chikungunya fever|chikungunya fever
5300609|NCT02174341|Chikungunya Virus|chikungunya virus
5300610|NCT02174328|See incidence of Pre-Eclampsia in acetylsalicylic acid group|see incidence of pre-eclampsia in acetylsalicylic acid group
5300611|NCT02174328|See incidence of Pre-Eclampsia in placebo group|see incidence of pre-eclampsia in placebo group
5300612|NCT02174289|Heart Failure|heart failure
5300613|NCT02174289|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5300614|NCT02174289|Transseptal left ventricular endocardial lead|transseptal left ventricular endocardial lead
5300616|NCT02174237|Phase 1, safety, tolerability, PK, PD|phase 1, safety, tolerability, pk, pd
5300617|NCT02174224|Violence|violence
5300618|NCT02174224|At-risk youth|at-risk youth
5300619|NCT02174224|Intentional Injury|intentional injury
5300620|NCT02174224|Violence Intervention|violence intervention
5300621|NCT02174224|Youth|youth
5300622|NCT02174224|recidivism|recidivism
5300623|NCT02174198|Immediate implant|immediate implant
5300624|NCT02174198|bone graft|bone graft
5300625|NCT02174198|immediate restoration|immediate restoration
5300626|NCT02174185|bladder cancer|bladder cancer
5300627|NCT02174185|conduit diversion|conduit diversion
5300628|NCT02174185|orthotopic neobladder|orthotopic neobladder
5300629|NCT02174185|health-related quality of life|health-related quality of life
5300630|NCT02174185|validated questionnaire|validated questionnaire
5300631|NCT02174146|leptin|leptin
5300632|NCT02174146|visfatin|visfatin
5300633|NCT02174146|chronic periodontitis|chronic periodontitis
5300634|NCT02174146|diabetes mellitus|diabetes mellitus
5300635|NCT02174146|non-surgical periodontal therapy|non-surgical periodontal therapy
5300636|NCT02174133|left ventricular assist device|left ventricular assist device
5300637|NCT02174133|endothelial function|endothelial function
5300638|NCT02174133|microvascular perfusion|microvascular perfusion
5300639|NCT02174133|microparticles|microparticles
5300640|NCT02174107|Health economics|health economics
5300641|NCT02174107|Percutaneous vertebroplasty|percutaneous vertebroplasty
5300642|NCT02174107|Radiation therapy|radiation therapy
5300643|NCT02174107|Painful spine metastases|painful spine metastases
5300644|NCT02174081|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
5300645|NCT02174068|Paracetamol|paracetamol
5300646|NCT02174068|Nefopam|nefopam
5300647|NCT02174068|Pharmacokinetic|pharmacokinetic
5300648|NCT02174068|Drug interaction|drug interaction
5300649|NCT02174055|Depression|depression
5300650|NCT02174055|14-101|14-101
5300651|NCT02174029|Atrophy|atrophy
5300652|NCT02174029|Ventilator|ventilator
5300653|NCT02174029|Induced|induced
5300654|NCT02174029|Diaphragm|diaphragm
5300655|NCT02174029|Dysfunction|dysfunction
5300656|NCT02174016|Intensive Care Units|intensive care units
5300657|NCT02174016|Pediatric|pediatric
5300658|NCT02174003|whole body hyperthermia|whole body hyperthermia
5300659|NCT02174003|depression|depression
5300660|NCT02174003|fibromyalgia|fibromyalgia
5300661|NCT02174003|rheumatoid arthritis|rheumatoid arthritis
5300662|NCT02174003|perimenopausal symptoms|perimenopausal symptoms
5300663|NCT02174003|open treatment|open treatment
5300664|NCT02173990|adenocarcinoma|adenocarcinoma
5300665|NCT02173990|colon and/or rectum|colon and/or rectum
5300666|NCT02173977|GnRH Agonist|gnrh agonist
5300667|NCT02173977|GnRH Antagonist|gnrh antagonist
5300668|NCT02173977|OHSS|ohss
5300669|NCT02173964|fluorodeoxyglucose|fluorodeoxyglucose
5300670|NCT02173964|positron emission tomography|positron emission tomography
5300671|NCT02173964|computed tomography|computed tomography
5300672|NCT02173964|bowel|bowel
5300673|NCT02173964|pinaverium bromide|pinaverium bromide
5300674|NCT02173951|young minimally transfused beta thalassemia major|young minimally transfused beta thalassemia major
5300675|NCT02173951|labile plasma iron (LPI)|labile plasma iron (lpi)
5300676|NCT02173951|Transferrin saturation (TSAT)|transferrin saturation (tsat)
5300677|NCT02173951|Deferiprone|deferiprone
5300678|NCT02173951|Transfusional iron loading rate|transfusional iron loading rate
5300679|NCT02173951|Transfusion units|transfusion units
5300680|NCT02173938|Smokers|smokers
5300681|NCT02173938|outpatient|outpatient
5300682|NCT02173938|Tobacco Dependence Treatment Program|tobacco dependence treatment program
5300683|NCT02173873|Age related macular degeneration|age related macular degeneration
5300684|NCT02173873|central retinal vein occlusion|central retinal vein occlusion
5300685|NCT02173860|Coronary artery disease|coronary artery disease
5300686|NCT02173860|Valvular heart disease|valvular heart disease
5300687|NCT02173860|Fractional flow reserve|fractional flow reserve
5300688|NCT02173860|Coronary artery bypass surgery|coronary artery bypass surgery
5297352|NCT02190552|Stroke|stroke
5300704|NCT02173704|Meningococcal B Recombinant Vaccine|meningococcal b recombinant vaccine
5300706|NCT02173613|infection lung elderly patients|infection lung elderly patients
5300707|NCT02173600|Cardiovascular risk|cardiovascular risk
5300708|NCT02173600|Primary prevention|primary prevention
5300709|NCT02173600|Intensive dietary counselling|intensive dietary counselling
5300710|NCT02173600|Physical exercise|physical exercise
5300711|NCT02173587|Anti-inflammation, Rheumatoid arthritis, Thick shell mussel lipid extract, Chinese|anti-inflammation, rheumatoid arthritis, thick shell mussel lipid extract, chinese
5300712|NCT02173574|Hepatitis C Virus, Viral, Antiviral, Infection, Infectious disease, alisporivir, EDP239, DEB025|hepatitis c virus, viral, antiviral, infection, infectious disease, alisporivir, edp239, deb025
5300713|NCT02173561|Posttraumatic Stress Disorder|posttraumatic stress disorder
5300714|NCT02173561|Cognitive Processing Therapy|cognitive processing therapy
5300715|NCT02173561|combat|combat
5300716|NCT02173561|military|military
5300718|NCT02173561|group therapy|group therapy
5300719|NCT02173548|heart failure|heart failure
5300720|NCT02173548|HFpEF|hfpef
5300721|NCT02173548|diastole|diastole
5300722|NCT02173548|diastolic heart failure|diastolic heart failure
5300723|NCT02173548|inflammation|inflammation
5300724|NCT02173548|interleukin-1|interleukin-1
5300725|NCT02173548|C-reactive protein|c-reactive protein
5300726|NCT02173522|Prostate cancer|prostate cancer
5300727|NCT02173522|Prostate artery embolization|prostate artery embolization
5300728|NCT02173522|Robot-assisted laparoscopic radical prostatectomy|robot-assisted laparoscopic radical prostatectomy
5300729|NCT02173496|Wet age-related macular degeneration|wet age-related macular degeneration
5300730|NCT02173496|Assessment modalities for preclinical, pre-symptomatic ARMD|assessment modalities for preclinical, pre-symptomatic armd
5300731|NCT02173457|Chiglitazar|chiglitazar
5300732|NCT02173457|Sitagliptin|sitagliptin
5300733|NCT02173457|diabetes|diabetes
5300734|NCT02173457|type 2 diabetes|type 2 diabetes
5300735|NCT02173444|in-vitro fertilization|in-vitro fertilization
5300736|NCT02173444|ovarian stimulation|ovarian stimulation
5300737|NCT02173431|BMI|bmi
5300738|NCT02173431|Pressure|pressure
5300739|NCT02173431|Bedsore|bedsore
5300740|NCT02173418|Postoperative pain|postoperative pain
5300741|NCT02173418|Acute postoperative pain|acute postoperative pain
5300742|NCT02173418|Chronic postoperative pain|chronic postoperative pain
5300743|NCT02173418|Shoulder pain|shoulder pain
5300744|NCT02173418|Thoracotomy|thoracotomy
5300745|NCT02173418|Thoracoscopy|thoracoscopy
5300746|NCT02173405|Myofascial Pain Syndromes|myofascial pain syndromes
5300747|NCT02173405|Pelvic pain|pelvic pain
5300748|NCT02173405|Trigger points + injections|trigger points + injections
5300749|NCT02173405|Myofascial Trigger Point Pain|myofascial trigger point pain
5300750|NCT02173405|Trigger Point Pain, Myofascial|trigger point pain, myofascial
5300751|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a
5300752|NCT02173405|Botulinum Neurotoxin A|botulinum neurotoxin a
5300753|NCT02173405|Botulinum Toxin Type A|botulinum toxin type a
5300754|NCT02173405|Clostridium botulinum A Toxin|clostridium botulinum a toxin
5300755|NCT02173405|Clostridium Botulinum Toxin Type A|clostridium botulinum toxin type a
5300756|NCT02173405|Oculinum|oculinum
5300757|NCT02173379|Absorb™ BVS|absorb™ bvs
5300758|NCT02173379|Angioplasty|angioplasty
5300759|NCT02173379|Bioabsorbable|bioabsorbable
5300760|NCT02173379|BVS|bvs
5300761|NCT02173379|Coronary Artery Disease|coronary artery disease
5300762|NCT02173379|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5300763|NCT02173379|Coronary artery restenosis|coronary artery restenosis
5297453|NCT02190136|glycemia|glycemia
5300770|NCT02173379|Stent thrombosis|stent thrombosis
5300771|NCT02173379|Stents|stents
5300772|NCT02173353|Ultrasound use during radiation therapy for Pancreas cancer|ultrasound use during radiation therapy for pancreas cancer
5300773|NCT02173314|Long term foster care|long term foster care
5300774|NCT02173314|child abuse and neglect|child abuse and neglect
5300775|NCT02173262|Breast|breast
5300776|NCT02173236|Dental Implant Platform Switching|dental implant platform switching
5300777|NCT02173236|Early Dental Implant Loading|early dental implant loading
5300778|NCT02173210|Premature birth|premature birth
5300779|NCT02173210|Premature delivery|premature delivery
5300780|NCT02173210|Metabolomics|metabolomics
5300781|NCT02173210|Microbiota|microbiota
5300782|NCT02173210|Genetics|genetics
5300783|NCT02173210|17 hydroxyprogesterone caproate|17 hydroxyprogesterone caproate
5300784|NCT02173197|Occupational Therapy|occupational therapy
5300785|NCT02173197|Complex patients|complex patients
5300786|NCT02173197|Occupational performance problem|occupational performance problem
5300787|NCT02173197|Rehabilitation Complexity Scale|rehabilitation complexity scale
5300788|NCT02173184|bacterial vaginosis|bacterial vaginosis
5300789|NCT02173184|Gynevac Lactobacillus vaccine|gynevac lactobacillus vaccine
5300790|NCT02173171|Melanoma|melanoma
5300791|NCT02173171|talimogene laherparepvec|talimogene laherparepvec
5300792|NCT02173145|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5300794|NCT02173145|immunomodulation|immunomodulation
5300795|NCT02173145|macrolide|macrolide
5300796|NCT02173119|Hepatocellular|hepatocellular
5300797|NCT02173119|Carcinoma|carcinoma
5300798|NCT02173119|HCC|hcc
5300799|NCT02173119|lipiodol|lipiodol
5300800|NCT02173093|Neuroblastoma|neuroblastoma
5300801|NCT02173093|Solid tumor|solid tumor
5300802|NCT02173093|Immunotherapy targeting GD2|immunotherapy targeting gd2
5300803|NCT02173093|Bispecific antibodies|bispecific antibodies
5300804|NCT02173093|Activated T cells|activated t cells
5300805|NCT02173080|autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
5300806|NCT02173080|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5300807|NCT02173080|quality of life|quality of life
5300808|NCT02173080|patient reported outcome tool|patient reported outcome tool
5300809|NCT02173067|Diabetes mellitus|diabetes mellitus
5300810|NCT02173067|Epinephrine|epinephrine
5300811|NCT02173067|Anesthesia, Dental|anesthesia, dental
5300812|NCT02173067|lidocaine|lidocaine
5300813|NCT02173067|Ambulatory Surgical Procedures|ambulatory surgical procedures
5300814|NCT02173054|Acne|acne
5300815|NCT02173054|Moisturizer|moisturizer
5300816|NCT02173054|Efficacy|efficacy
5300817|NCT02173054|Irritation|irritation
5300818|NCT02173041|Prevention and Awareness Groups (PAG),|prevention and awareness groups (pag),
5300819|NCT02173041|Substance Use Disorder,|substance use disorder,
5300820|NCT02173041|Community based intervention|community based intervention
5300821|NCT02173028|Beta Blocker Intolerance;|beta blocker intolerance;
5300822|NCT02173028|Remote Patient Management system;|remote patient management system;
5300823|NCT02173028|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5300824|NCT02173015|accidental falls|accidental falls
5300825|NCT02173015|older adults|older adults
5300826|NCT02173015|long-term care|long-term care
5300827|NCT02173015|nursing home|nursing home
5300828|NCT02173015|postural balance|postural balance
5300829|NCT02173002|Telemedicine|telemedicine
5300830|NCT02173002|Patient empowerment|patient empowerment
5300831|NCT02173002|Integrated care|integrated care
5300832|NCT02172989|Near-infrared fluorescence|near-infrared fluorescence
5300833|NCT02172989|Indocyanine green, ICG|indocyanine green, icg
5300834|NCT02172989|Radio-guided surgery|radio-guided surgery
5300835|NCT02172989|breast cancer|breast cancer
5300836|NCT02172976|pancreas cancer|pancreas cancer
5300837|NCT02172976|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5300838|NCT02172976|Folfirinox|folfirinox
5300839|NCT02172976|gemcitabine|gemcitabine
5300840|NCT02172963|Stem Cell Transplantation|stem cell transplantation
5300841|NCT02172963|Decidual Stromal Cells|decidual stromal cells
5300842|NCT02172937|Stem Cell Transplantation|stem cell transplantation
5300843|NCT02172937|Decidual Stromal Cells|decidual stromal cells
5300844|NCT02172924|Stem Cell Transplantation|stem cell transplantation
5300845|NCT02172924|Decidual Stromal Cells|decidual stromal cells
5300846|NCT02172911|Cervical cancer|cervical cancer
5300847|NCT02172911|Papillomavirus|papillomavirus
5300848|NCT02172911|Chemoradiation|chemoradiation
5300849|NCT02172911|Recurrent cervical cancer|recurrent cervical cancer
5300850|NCT02172911|Persistent cervical cancer|persistent cervical cancer
5300851|NCT02172885|Mesenchymal stem cell based therapy|mesenchymal stem cell based therapy
5300852|NCT02172885|cell infusion|cell infusion
5300853|NCT02172872|Newly diagnosed|newly diagnosed
5300855|NCT02172872|Elderly|elderly
5300856|NCT02172872|Decitabine|decitabine
5300857|NCT02172872|Transplant|transplant
5300858|NCT02172859|lumiVida™, cognition, mood, sleep, tryptophane|lumivida™, cognition, mood, sleep, tryptophane
5300859|NCT02172820|cardiac rehabilitation|cardiac rehabilitation
5300860|NCT02172820|contingency management|contingency management
5300861|NCT02172768|pharmacokinetics|pharmacokinetics
5300862|NCT02172768|alternate dosing|alternate dosing
5300863|NCT02172768|micafungin|micafungin
5300864|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate
5300865|NCT02172755|BIA 2-093|bia 2-093
5300866|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate
5300867|NCT02172742|BIA 2-093|bia 2-093
5903811|NCT00297752|facial burns|facial burns
5300868|NCT02172729|adductor canal block|adductor canal block
5305457|NCT02150239|pain|pain
5300869|NCT02172729|healthy volunteers|healthy volunteers
5300870|NCT02172729|US-guided peripheral nerve block|us-guided peripheral nerve block
5300871|NCT02172729|lower limb|lower limb
5300872|NCT02172729|duration|duration
5300873|NCT02172729|Muscle Strength|muscle strength
5300874|NCT02172729|Anesthetics, Local|anesthetics, local
5300875|NCT02172729|Sensation|sensation
5300877|NCT02172703|SAH|sah
5300878|NCT02172703|ICP|icp
5300879|NCT02172703|non invasive measurement|non invasive measurement
5300880|NCT02172690|Gastric Cancer|gastric cancer
5300881|NCT02172690|Laparoscopic Staging|laparoscopic staging
5300882|NCT02172690|Cytology|cytology
5300883|NCT02172690|Peritoneal Metastases|peritoneal metastases
5300884|NCT02172664|noncarious cervical lesions|noncarious cervical lesions
5300885|NCT02172664|dental adhesive|dental adhesive
5300886|NCT02172664|retention|retention
5300887|NCT02172664|enamel margin discoloration|enamel margin discoloration
5300888|NCT02172664|self etch|self etch
5300889|NCT02172664|selective etch procedures|selective etch procedures
5300890|NCT02172651|Vitamin D|vitamin d
5300891|NCT02172651|Stage I-III colon cancer|stage i-iii colon cancer
5300892|NCT02172651|Stage IV colon cancer|stage iv colon cancer
5300893|NCT02172651|Resectable liver metastases|resectable liver metastases
5300894|NCT02172638|Enhanced Recovery After Surgery|enhanced recovery after surgery
5300895|NCT02172638|ERAS|eras
5300896|NCT02172638|Fast-Track|fast-track
5300897|NCT02172638|Ovarian cancer|ovarian cancer
5300898|NCT02172638|Gynecologic surgery|gynecologic surgery
5300899|NCT02172638|Gynecology oncology|gynecology oncology
5300900|NCT02172638|Median length of stay|median length of stay
5300901|NCT02172638|Readmission rate|readmission rate
5300902|NCT02172638|Surgery related complications|surgery related complications
5300903|NCT02172638|Cost|cost
5300904|NCT02172625|Athletic performance|athletic performance
5300905|NCT02172625|Running|running
5300906|NCT02172625|Dietary supplementation|dietary supplementation
5300907|NCT02172625|Quality of life|quality of life
5300908|NCT02172625|Running performance|running performance
5300909|NCT02172625|oxidative damage|oxidative damage
5300910|NCT02172612|Anticholinergic drugs|anticholinergic drugs
5300911|NCT02172599|sit-stand workstation|sit-stand workstation
5300912|NCT02172599|workplace|workplace
5300913|NCT02172599|multi-component intervention|multi-component intervention
5300914|NCT02172599|randomised control trial design|randomised control trial design
5300915|NCT02172599|physical activity|physical activity
5300916|NCT02172599|sitting|sitting
5300917|NCT02172599|sedentary behaviour|sedentary behaviour
5300918|NCT02172599|process evaluation|process evaluation
5300919|NCT02172599|health|health
5300920|NCT02172365|Chronic myeloid leukemia|chronic myeloid leukemia
5300921|NCT02172365|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5300922|NCT02172365|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5300923|NCT02172365|TKI failure|tki failure
5300924|NCT02172183|cognitive-behavioral therapy, adolescents, ADHD.|cognitive-behavioral therapy, adolescents, adhd.
5300925|NCT02172092|Diabetes|diabetes
5300926|NCT02172092|Ketoacidosis|ketoacidosis
5300927|NCT02172092|fluid shift|fluid shift
5300928|NCT02172079|shoulder impingement, manual therapy, pain, motion.|shoulder impingement, manual therapy, pain, motion.
5300929|NCT02172066|Posttraumatic Stress Disorder|posttraumatic stress disorder
5300930|NCT02172066|Childhood maltreatment|childhood maltreatment
5300931|NCT02172053|Workplace|workplace
5300932|NCT02172053|Industrial workers|industrial workers
5300933|NCT02172053|Resistance exercise|resistance exercise
5300934|NCT02172053|Fatigue|fatigue
5300935|NCT02172053|Occupational risk|occupational risk
5300936|NCT02172053|Physical therapy|physical therapy
5300937|NCT02172040|High blood pressure|high blood pressure
5300938|NCT02172040|Systolic blood pressure|systolic blood pressure
5300939|NCT02172040|Diastolic blood pressure|diastolic blood pressure
5300940|NCT02172040|Antihypertensive|antihypertensive
5300941|NCT02172014|Mechanical Ventilation|mechanical ventilation
5300942|NCT02172014|Sedation|sedation
5300943|NCT02172014|Fentanyl|fentanyl
5300944|NCT02172014|Midazolam|midazolam
5300945|NCT02172014|Comfort behavior scale|comfort behavior scale
5300946|NCT02172001|IDA|ida
5300948|NCT02172001|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anemia and who are intolerant or unresponsive to oral iron therapy
5300949|NCT02171988|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
5300950|NCT02171988|propranolol|propranolol
5300951|NCT02171988|bisoprolol|bisoprolol
5300952|NCT02171988|pyridostigmine|pyridostigmine
5300953|NCT02171975|Spinal anaesthesia|spinal anaesthesia
5300954|NCT02171975|Ultrasound pre-procedure guided|ultrasound pre-procedure guided
5300955|NCT02171975|Paramedian spinal|paramedian spinal
5300956|NCT02171962|Zilver® PTX® Drug-Eluting Peripheral Stent|zilver® ptx® drug-eluting peripheral stent
5300957|NCT02171962|Above-the-Knee Femoropopliteal Artery|above-the-knee femoropopliteal artery
5300958|NCT02171962|Chinese patient|chinese patient
5300959|NCT02171949|Chronic hepatitis|chronic hepatitis
5300960|NCT02171949|Hepatic cirrhosis|hepatic cirrhosis
5300961|NCT02171936|Pain|pain
5300962|NCT02171936|Precariousness|precariousness
5300963|NCT02171936|EPICES Score|epices score
5300965|NCT02171923|depression|depression
5300966|NCT02171910|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5300967|NCT02171910|Sedation|sedation
5300968|NCT02171871|EFFECTS,|effects,
5300969|NCT02171871|PASSIVE SMOKING ,|passive smoking ,
5300970|NCT02171871|RESPIRATORY SYSTEM MECHANICS,|respiratory system mechanics,
5300971|NCT02171871|DIFFERENT BODY POSITIONS.|different body positions.
5300972|NCT02171858|Stroke|stroke
5300973|NCT02171858|National Institutes of Health Stroke Scale|national institutes of health stroke scale
5300974|NCT02171858|Serum high sensitivity C-Reactive Protein|serum high sensitivity c-reactive protein
5300975|NCT02171845|Male foetuses of 10 to 37 weeks|male foetuses of 10 to 37 weeks
5300976|NCT02171819|Influenza|influenza
5300977|NCT02171819|Avian|avian
5300978|NCT02171819|H5N1|h5n1
5300979|NCT02171819|Vaccine|vaccine
5300980|NCT02171390|Hypogonadism|hypogonadism
5300981|NCT02171390|Endothelial dysfunction|endothelial dysfunction
5300982|NCT02171390|Insulin resistance|insulin resistance
5300983|NCT02171390|Inflammation|inflammation
5300984|NCT02171390|Testosterone replacement therapy|testosterone replacement therapy
5300985|NCT02171377|COPD|copd
5300986|NCT02171377|electrical stimulation|electrical stimulation
5300987|NCT02171377|Rehabilitation|rehabilitation
5300988|NCT02171377|exercise test|exercise test
5300989|NCT02171364|Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data|atrial fibrillation, virtual ablation, electrocardiography, electroanatomical mapping data
5300990|NCT02171351|sympathetic nerve reactivity|sympathetic nerve reactivity
5300991|NCT02171351|neuromuscular electrostimulation|neuromuscular electrostimulation
5300992|NCT02171338|Procalcitonin|procalcitonin
5300993|NCT02171338|Antibiotic therapy|antibiotic therapy
5301192|NCT02170285|tDCS|tdcs
5300994|NCT02171338|Lower respiratory tract diseases|lower respiratory tract diseases
5300995|NCT02171325|irinotecan|irinotecan
5300996|NCT02171325|Small Cell Lung Cancer|small cell lung cancer
5300997|NCT02171312|Dizziness|dizziness
5300998|NCT02171312|Imbalance|imbalance
5300999|NCT02171286|KRAS|kras
5301000|NCT02171286|EGFR|egfr
5301001|NCT02171286|BRAF|braf
5301002|NCT02171286|NRAS and HRAS|nras and hras
5301003|NCT02171286|PIK3CA|pik3ca
5301004|NCT02171286|RAS-RAF-MEK-MAPK|ras-raf-mek-mapk
5301005|NCT02171286|HER2|her2
5301006|NCT02171286|IDH1 and IDH2|idh1 and idh2
5301007|NCT02171286|ALK|alk
5301008|NCT02171286|TP53|tp53
5301009|NCT02171286|c-KIT|c-kit
5301010|NCT02171286|STAT1&3|stat1&3
5301011|NCT02171286|PDGFRA|pdgfra
5301012|NCT02171286|Metastatic colorectal cancer|metastatic colorectal cancer
5301013|NCT02171286|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5301014|NCT02171286|Advanced melanoma|advanced melanoma
5301015|NCT02171286|Gastrointestingal Struma Tumor|gastrointestingal struma tumor
5301016|NCT02171286|Candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours|candidate genes implicated as potential prognostic and predictive biomarkers in patients with solid tumours
5301017|NCT02171286|Circulating Tumor DNA|circulating tumor dna
5301018|NCT02171273|Sleep|sleep
5301019|NCT02171273|Aging|aging
5301020|NCT02171273|Metabolism|metabolism
5301021|NCT02171273|Circadian|circadian
5301023|NCT02171273|Alertness|alertness
5301024|NCT02171260|Tumors|tumors
5301025|NCT02171260|Lymphomas|lymphomas
5301026|NCT02171260|Solid Tumors|solid tumors
5301027|NCT02171260|Pediatric|pediatric
5301028|NCT02171247|coronary computed tomographic angiography|coronary computed tomographic angiography
5301029|NCT02171247|contrast|contrast
5301030|NCT02171234|Epilepsy|epilepsy
5301031|NCT02171234|BIA 2-093|bia 2-093
5301032|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate
5301033|NCT02171221|Refractory or relapsed tumors|refractory or relapsed tumors
5301034|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5301035|NCT02171221|Fluorouracil|fluorouracil
5301036|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate
5301038|NCT02171195|Epilepsy|epilepsy
5301039|NCT02171182|Qutenza|qutenza
5301040|NCT02171182|8% capsaicin patch|8% capsaicin patch
5301041|NCT02171182|Non-interventional|non-interventional
5301042|NCT02171182|Post-operative peripheral neuropathic pain|post-operative peripheral neuropathic pain
5301043|NCT02171182|Observational|observational
5301044|NCT02171182|Czech Republic|czech republic
5301045|NCT02171143|ASP2409|asp2409
5301046|NCT02171143|Rheumatoid Arthritis|rheumatoid arthritis
5301047|NCT02171143|methotrexate|methotrexate
5301048|NCT02171130|Diabetes Mellitus|diabetes mellitus
5301049|NCT02171130|Hypoglycemia|hypoglycemia
5301050|NCT02171130|Glucagon|glucagon
5301051|NCT02171130|Anti-glucagon Antibody|anti-glucagon antibody
5301052|NCT02171130|Immunogenicity|immunogenicity
5301053|NCT02171117|Acute Myeloid Leukemia|acute myeloid leukemia
5301054|NCT02171117|microtransplantation|microtransplantation
5301055|NCT02171117|elderly patients|elderly patients
5301056|NCT02171117|HLA-mismatched|hla-mismatched
5301057|NCT02171117|donor|donor
5301058|NCT02171117|Peripheral|peripheral
5301059|NCT02171117|stem cell|stem cell
5301060|NCT02171117|infusion|infusion
5301308|NCT02169700|Ischemic compression|ischemic compression
5301061|NCT02171104|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5301062|NCT02171104|bone marrow transplantation|bone marrow transplantation
5301063|NCT02171104|IMD|imd
5301064|NCT02171104|AMACRD|amacrd
5301065|NCT02171104|MNGIE|mngie
5301066|NCT02171104|HDLS|hdls
5301067|NCT02171104|OP|op
5301068|NCT02171104|ALD|ald
5301069|NCT02171091|endotracheal|endotracheal
5301070|NCT02171091|intubation|intubation
5301071|NCT02171091|airway|airway
5301072|NCT02171091|inflammation|inflammation
5301073|NCT02171078|Breast Cancer|breast cancer
5301074|NCT02171078|Breast Neoplasms|breast neoplasms
5301075|NCT02171078|Health Services Research|health services research
5301076|NCT02171078|Surveillance|surveillance
5301077|NCT02171078|Diagnostic Imaging|diagnostic imaging
5301078|NCT02171078|Magnetic Resonance Imaging|magnetic resonance imaging
5301079|NCT02171078|Mammography|mammography
5301080|NCT02171078|Toxicity|toxicity
5301081|NCT02171078|Adverse Effects|adverse effects
5301082|NCT02171078|Side Effects|side effects
5301083|NCT02171078|Recurrence|recurrence
5301084|NCT02171065|NIRS/IVUS|nirs/ivus
5301085|NCT02171065|multimodality imaging|multimodality imaging
5301086|NCT02171065|PROSPECT|prospect
5301087|NCT02170961|Acute heart failure|acute heart failure
5301088|NCT02170961|RAAS|raas
5301089|NCT02170961|MMP3|mmp3
5301090|NCT02170961|MMP12|mmp12
5301091|NCT02170961|Polymorphysm|polymorphysm
5301092|NCT02170948|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5301093|NCT02170948|nerve block|nerve block
5301094|NCT02170948|ankle block|ankle block
5301095|NCT02170948|dexmedetomidine|dexmedetomidine
5301096|NCT02170948|Precedex|precedex
5301097|NCT02170948|ankle surgery|ankle surgery
5301098|NCT02170948|forefoot surgery|forefoot surgery
5301099|NCT02170948|duration|duration
5301100|NCT02170948|anesthetic duration following ankle block for forefoot surgery|anesthetic duration following ankle block for forefoot surgery
5301101|NCT02170883|asthma|asthma
5301102|NCT02170883|mHealth|mhealth
5301103|NCT02170883|cluster randomized controlled trial|cluster randomized controlled trial
5301104|NCT02170883|pharmacy practice|pharmacy practice
5301105|NCT02170883|pharmacist|pharmacist
5301106|NCT02170857|Hyaluronic acid|hyaluronic acid
5301107|NCT02170857|infra-bony defects|infra-bony defects
5301108|NCT02170857|chronic periodontitis|chronic periodontitis
5301109|NCT02170857|experimental|experimental
5301110|NCT02170857|radiographic|radiographic
5301111|NCT02170857|clinical|clinical
5301112|NCT02170857|periodontal surgical treatment|periodontal surgical treatment
5301113|NCT02170857|open flap curettage|open flap curettage
5301114|NCT02170818|Education|education
5301115|NCT02170818|Curriculum|curriculum
5301116|NCT02170818|Anesthesiology|anesthesiology
5301117|NCT02170818|Operating Rooms|operating rooms
5301118|NCT02170779|multiple sclerosis|multiple sclerosis
5301119|NCT02170779|spasticity|spasticity
5301120|NCT02170779|stretching|stretching
5301121|NCT02170779|exercise|exercise
5301122|NCT02170779|rehabilitation|rehabilitation
5301123|NCT02170714|Acute severe colitis|acute severe colitis
5301124|NCT02170714|Children|children
5301125|NCT02170714|Infliximab|infliximab
5301126|NCT02170714|colectomy|colectomy
5301127|NCT02170688|IV contrast|iv contrast
5301128|NCT02170688|contrast dosing|contrast dosing
5301129|NCT02170662|male pattern hair loss|male pattern hair loss
5301130|NCT02170662|androgenetic alopecia|androgenetic alopecia
5301131|NCT02170662|bimatoprost|bimatoprost
5301132|NCT02170649|BIA 2-093|bia 2-093
5301133|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate
5301134|NCT02170558|Trabecular Metal|trabecular metal
5301135|NCT02170558|Metal reduction CT|metal reduction ct
5301136|NCT02170558|TM- Ardis|tm- ardis
5301137|NCT02170545|avascular necrosis|avascular necrosis
5196402|NCT02766296|PTSD|ptsd
5301138|NCT02170545|humeral head fracture|humeral head fracture
5301139|NCT02170545|proximal arm fracture|proximal arm fracture
5301140|NCT02170545|arthroplasty|arthroplasty
5301141|NCT02170532|asthma|asthma
5301142|NCT02170519|pulmonary hypertension|pulmonary hypertension
5301143|NCT02170493|Insole Sensor|insole sensor
5301146|NCT02170493|IIIC|iiic
5301147|NCT02170493|Lower Extremity Fractures|lower extremity fractures
5301148|NCT02170467|Intestinal permeability - Anorexia nervosa- Re feeding - auto-antibodies α-MSH|intestinal permeability - anorexia nervosa- re feeding - auto-antibodies α-msh
5301149|NCT02170454|neuromodulation|neuromodulation
5301150|NCT02170454|swallowing|swallowing
5301151|NCT02170454|magnetic stimulation|magnetic stimulation
5301152|NCT02170454|healthy subjects|healthy subjects
5301153|NCT02170441|Tuberculosis|tuberculosis
5301154|NCT02170441|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
5301155|NCT02170441|Extensively drug-resistant tuberculosis|extensively drug-resistant tuberculosis
5301156|NCT02170441|Drug-resistant tuberculosis|drug-resistant tuberculosis
5301157|NCT02170441|Mycobacterial Growth Indicator Tube Drug Susceptibility Test|mycobacterial growth indicator tube drug susceptibility test
5301158|NCT02170441|Line Probe Assay|line probe assay
5301163|NCT02170428|children,|children,
5301164|NCT02170428|diet,|diet,
5301165|NCT02170428|breastfeeding|breastfeeding
5301166|NCT02170428|complementary feeding|complementary feeding
5301167|NCT02170428|early life programming|early life programming
5301168|NCT02170428|tracking|tracking
5301169|NCT02170428|physical activity|physical activity
5301170|NCT02170415|Persistent post-surgical pain|persistent post-surgical pain
5301171|NCT02170415|Breast surgery|breast surgery
5301172|NCT02170415|Complex intervention|complex intervention
5301173|NCT02170415|Pain treatment|pain treatment
5301174|NCT02170376|Parkinson's disease (PD)|parkinson's disease (pd)
5301175|NCT02170376|BIA 9-1067|bia 9-1067
5301176|NCT02170376|Opicapone|opicapone
5301177|NCT02170363|Heart Failure|heart failure
5301178|NCT02170363|Ventricular Dysfunction|ventricular dysfunction
5301179|NCT02170363|Cardiomyopathies|cardiomyopathies
5301180|NCT02170363|Heart Disease|heart disease
5301181|NCT02170363|Cardiovascular Disease|cardiovascular disease
5301182|NCT02170363|Heart-assist devices|heart-assist devices
5301183|NCT02170363|Thoratec Corporation|thoratec corporation
5301184|NCT02170311|Z-213, Ferric carboxymaltose, Iron, Iron-deficiency-anemia|z-213, ferric carboxymaltose, iron, iron-deficiency-anemia
5301185|NCT02170298|ADHD|adhd
5301186|NCT02170298|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5301187|NCT02170298|Vyvanse|vyvanse
5301188|NCT02170298|Lisdexamfetamine|lisdexamfetamine
5301189|NCT02170285|perinatal stroke|perinatal stroke
5301190|NCT02170285|hemiparetic cerebral palsy|hemiparetic cerebral palsy
5301191|NCT02170285|brain stimulation|brain stimulation
5301194|NCT02170285|hand arm bimanual intensive therapy|hand arm bimanual intensive therapy
5301195|NCT02170259|Tension-type headache|tension-type headache
5301196|NCT02170259|Depression|depression
5301197|NCT02170259|Anxiety|anxiety
5301198|NCT02170259|Manual therapy|manual therapy
5301199|NCT02170259|Spinal manipulation|spinal manipulation
5301200|NCT02170259|Patients diagnosed with tension-type headache|patients diagnosed with tension-type headache
5301201|NCT02170246|Acute HIV infection|acute hiv infection
5301202|NCT02170246|Central nervous system|central nervous system
5301203|NCT02170246|Antiretroviral therapy|antiretroviral therapy
5301204|NCT02170246|Telmisartan|telmisartan
5301205|NCT02170246|Cerebrospinal fluid|cerebrospinal fluid
5301206|NCT02170220|Drug therapy|drug therapy
5301207|NCT02170207|Pharmacological therapy|pharmacological therapy
5301208|NCT02170194|smart phone apps|smart phone apps
5301209|NCT02170194|subthreshold PTSD|subthreshold ptsd
5301210|NCT02170194|resilience enhancement|resilience enhancement
5301211|NCT02170194|military veterans|military veterans
5301212|NCT02170194|natural disasters|natural disasters
5301213|NCT02170194|terrorism|terrorism
5301214|NCT02170194|shootings|shootings
5301215|NCT02170194|fMRI|fmri
5301216|NCT02170194|physiology|physiology
5301217|NCT02170181|SBRT|sbrt
5301218|NCT02170181|prostate cancer|prostate cancer
5301219|NCT02170181|lung cancer|lung cancer
5301220|NCT02170181|bladder cancer|bladder cancer
5301221|NCT02170181|kidney cancer|kidney cancer
5301222|NCT02170181|oligometastatic disease|oligometastatic disease
5301223|NCT02170168|Community health services|community health services
5301224|NCT02170168|Models, organizational|models, organizational
5301225|NCT02170168|Referral and consultation|referral and consultation
5301226|NCT02170168|Palliative medicine|palliative medicine
5301227|NCT02170168|Terminal care|terminal care
5301228|NCT02170142|MRI|mri
5301229|NCT02170142|perinatal brain|perinatal brain
5301230|NCT02170142|development, neonates|development, neonates
5301231|NCT02170103|segment elevation myocardial infarctions (STEMIs),|segment elevation myocardial infarctions (stemis),
5301232|NCT02170103|sonothrombolysis|sonothrombolysis
5301233|NCT02170103|reperfusion|reperfusion
5301234|NCT02170103|percutaneous intervention (PCI),|percutaneous intervention (pci),
5301235|NCT02170103|antithrombotic therapy,|antithrombotic therapy,
5301236|NCT02170103|antiplatelet therapy,|antiplatelet therapy,
5301237|NCT02170090|adjuvant chemotherapy|adjuvant chemotherapy
5301238|NCT02170090|cholangiocarcinoma|cholangiocarcinoma
5297953|NCT02188290|Transplant-related mortality|transplant-related mortality
5301240|NCT02170090|translational research|translational research
5301241|NCT02170090|multidisciplinary|multidisciplinary
5301242|NCT02170090|AIO, DGAV, DGVS|aio, dgav, dgvs
5301243|NCT02170077|Epilepsy|epilepsy
5301244|NCT02170077|BIA 2-093|bia 2-093
5301245|NCT02170064|Epilepsy|epilepsy
5301246|NCT02170064|BIA 2-093|bia 2-093
5301247|NCT02170051|negative symptoms|negative symptoms
5301248|NCT02170051|cognition|cognition
5301249|NCT02170051|functioning|functioning
5301250|NCT02170051|defeatist attitudes|defeatist attitudes
5301251|NCT02170051|psychosocial treatment|psychosocial treatment
5301252|NCT02170038|Drug Kinetics|drug kinetics
5301254|NCT02170025|delta F508|delta f508
5301255|NCT02170025|Safety|safety
5301256|NCT02170025|Tolerability|tolerability
5301257|NCT02170025|Sweat Chloride|sweat chloride
5301258|NCT02170025|Pharmacokinetics|pharmacokinetics
5301259|NCT02170012|Multiple dose|multiple dose
5301260|NCT02170012|safety|safety
5301261|NCT02170012|tolerability|tolerability
5301262|NCT02170012|PK|pk
5301263|NCT02169973|Healthy|healthy
5301264|NCT02169973|Positron Emission Tomography|positron emission tomography
5301265|NCT02169973|11C-MK-3168|11c-mk-3168
5301266|NCT02169973|JNJ-42165279|jnj-42165279
5301267|NCT02169973|Human Brain|human brain
5301268|NCT02169895|Parkinson's disease (PD)|parkinson's disease (pd)
5301269|NCT02169895|Opicapone|opicapone
5301270|NCT02169895|Bia 9-1067|bia 9-1067
5301271|NCT02169882|Tuberculous meningitis|tuberculous meningitis
5301272|NCT02169882|Rifampicin|rifampicin
5301273|NCT02169882|Dose finding study|dose finding study
5301274|NCT02169882|Pharmacokinetics|pharmacokinetics
5301275|NCT02169869|intrauterine device, postpartum, contraception, Mirena, Paragard, intrauterine system|intrauterine device, postpartum, contraception, mirena, paragard, intrauterine system
5301276|NCT02169856|Cholecystectomy|cholecystectomy
5301277|NCT02169856|Laparoscopic|laparoscopic
5301278|NCT02169856|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5301279|NCT02169843|Dexmedetomidine,|dexmedetomidine,
5301280|NCT02169843|agitation,|agitation,
5301281|NCT02169843|AFPS,|afps,
5301282|NCT02169843|NRS,|nrs,
5301283|NCT02169843|mean arterial pressure|mean arterial pressure
5301284|NCT02169843|heart rate(HR)|heart rate(hr)
5301285|NCT02169830|vestibular migraines, nortriptyline and topiramate|vestibular migraines, nortriptyline and topiramate
5301287|NCT02169778|Weight loss|weight loss
5301288|NCT02169778|Intermittent energy restriction|intermittent energy restriction
5301289|NCT02169778|Metabolic compensation|metabolic compensation
5301290|NCT02169778|Diet therapy|diet therapy
5301291|NCT02169765|Hepatocellular Carcinoma|hepatocellular carcinoma
5301292|NCT02169765|Liver Cancer|liver cancer
5301293|NCT02169752|Pre-Pulmonary Atrial Hypertension|pre-pulmonary atrial hypertension
5301294|NCT02169739|ischemic preconditioning|ischemic preconditioning
5301295|NCT02169739|remote ischemic preconditioning|remote ischemic preconditioning
5301296|NCT02169739|ischemic stroke|ischemic stroke
5301297|NCT02169739|white matter disease|white matter disease
5301298|NCT02169739|cerebral small vessel disease|cerebral small vessel disease
5301299|NCT02169739|cognitive decline|cognitive decline
5301300|NCT02169739|leukoaraiosis|leukoaraiosis
5301301|NCT02169739|diffusion tensor imaging|diffusion tensor imaging
5301302|NCT02169739|white matter hyper intensity score|white matter hyper intensity score
5301303|NCT02169739|European scale of age-related white matter change|european scale of age-related white matter change
5301304|NCT02169713|Healthy subjects|healthy subjects
5301305|NCT02169713|Mirabegron|mirabegron
5301306|NCT02169713|Solifenacin|solifenacin
5301307|NCT02169713|Tamsulosin HCl|tamsulosin hcl
5301309|NCT02169700|Myofascial trigger points|myofascial trigger points
5301310|NCT02169700|Post-needling soreness|post-needling soreness
5301311|NCT02169687|Thyroid, HIFU, hyperfunctioning, autonomous|thyroid, hifu, hyperfunctioning, autonomous
5301312|NCT02169674|Hepatitis B|hepatitis b
5301313|NCT02169674|Vaccine|vaccine
5301314|NCT02169674|Immunogenicity|immunogenicity
5301315|NCT02169661|Oxidative stress|oxidative stress
5301316|NCT02169661|Lipid peroxides|lipid peroxides
5301317|NCT02169661|Phytochemicals|phytochemicals
5301318|NCT02169661|Ready meals|ready meals
5301319|NCT02169661|Beetroot|beetroot
5301320|NCT02169661|Blood pressure|blood pressure
5301321|NCT02169648|macular edema|macular edema
5196583|NCT02765451|non-academic|non-academic
5301322|NCT02169648|branch retinal vein occlusion|branch retinal vein occlusion
5301323|NCT02169648|central retinal vein occlusion|central retinal vein occlusion
5301324|NCT02169648|ranibizumab|ranibizumab
5301325|NCT02169648|cytokines|cytokines
5301326|NCT02169648|visual acuity|visual acuity
5301327|NCT02169648|central macular thickness|central macular thickness
5301328|NCT02169635|macular buckle|macular buckle
5301329|NCT02169635|high myopia|high myopia
5301330|NCT02169635|posterior staphyloma|posterior staphyloma
5301331|NCT02169609|Neuroblastoma|neuroblastoma
5301332|NCT02169609|Immunotherapy|immunotherapy
5301333|NCT02169609|Dinutuximab|dinutuximab
5301334|NCT02169596|Acute Coronary Syndrome|acute coronary syndrome
5301335|NCT02169596|Nitric oxide|nitric oxide
5301336|NCT02169596|Ticagrelor|ticagrelor
5301346|NCT02169570|Calcium|calcium
5903812|NCT00297752|cerium flammazine|cerium flammazine
5301347|NCT02169531|Diabetes Mellitus Type 2|diabetes mellitus type 2
5301348|NCT02169531|Hyperglycemia|hyperglycemia
5301349|NCT02169531|Immunotherapy|immunotherapy
5301353|NCT02169518|LDL oxidation|ldl oxidation
5301354|NCT02169518|Diabetes Mellitus Type 1|diabetes mellitus type 1
5301355|NCT02169518|Obesity|obesity
5301356|NCT02169518|Diabetes Mellitus Type 2|diabetes mellitus type 2
5301357|NCT02169518|Bariatric Surgery|bariatric surgery
5301358|NCT02169505|Lymphoma|lymphoma
5301359|NCT02169505|Hodgkin lymphoma|hodgkin lymphoma
5301361|NCT02169505|CD30 positive Hodgkin Lymphoma|cd30 positive hodgkin lymphoma
5301362|NCT02169505|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5301363|NCT02169505|ALCL|alcl
5301364|NCT02169505|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5301365|NCT02169505|ASCT|asct
5301366|NCT02169505|Graft-versus-host disease|graft-versus-host disease
5301367|NCT02169505|GVHD|gvhd
5301368|NCT02169505|Brentuximab Vedotin|brentuximab vedotin
5301369|NCT02169505|SGN-35|sgn-35
5301370|NCT02169505|Adcetris|adcetris
5301371|NCT02169492|Thrombectomy|thrombectomy
5301372|NCT02169492|Stroke|stroke
5301373|NCT02169492|ReVive SE|revive se
5301374|NCT02169479|Parkinson's disease (PD)|parkinson's disease (pd)
5301375|NCT02169479|Opicapone|opicapone
5301376|NCT02169479|BIA 9-1067|bia 9-1067
5301377|NCT02169466|Parkinson's disease (PD)|parkinson's disease (pd)
5301378|NCT02169466|Opicapone|opicapone
5301379|NCT02169466|BIA 9-1067|bia 9-1067
5301380|NCT02169453|Parkinson's disease (PD)|parkinson's disease (pd)
5301381|NCT02169453|BIA 9-1067|bia 9-1067
5301382|NCT02169453|Opicapone|opicapone
5301383|NCT02169440|Parkinson's disease (PD)|parkinson's disease (pd)
5301384|NCT02169440|BIA 9-1067|bia 9-1067
5301385|NCT02169440|Opicapone|opicapone
5301386|NCT02169427|Parkinson's disease (PD)|parkinson's disease (pd)
5301387|NCT02169427|BIA 9-1067|bia 9-1067
5301388|NCT02169427|Opicapone|opicapone
5301389|NCT02169414|Parkinson's disease (PD)|parkinson's disease (pd)
5301390|NCT02169414|BIA 9-1067|bia 9-1067
5301391|NCT02169414|Opicapone|opicapone
5301392|NCT02169388|Gut microflora|gut microflora
5301393|NCT02169388|colorectal cancer|colorectal cancer
5301394|NCT02169388|Chemotherapy|chemotherapy
5301395|NCT02169388|Immunity|immunity
5301396|NCT02169388|Nutrition|nutrition
5301397|NCT02169362|Burns|burns
5301398|NCT02169362|Thermal burns|thermal burns
5301399|NCT02169362|Second degree burns|second degree burns
5301400|NCT02169362|Partial thickness burns|partial thickness burns
5301401|NCT02169362|Deep partial thickness burns|deep partial thickness burns
5301402|NCT02169362|Acute burns|acute burns
5301403|NCT02169362|Burn wounds|burn wounds
5301404|NCT02169336|Bunion|bunion
5301405|NCT02169336|Bunionectomy|bunionectomy
5301406|NCT02169336|Pain|pain
5301407|NCT02169336|Analgesia|analgesia
5301408|NCT02169336|dexmedetomidine|dexmedetomidine
5301409|NCT02169336|intranasal|intranasal
5301410|NCT02169323|Non-eosinophilic Asthma|non-eosinophilic asthma
5301411|NCT02169323|Inhaled corticosteroids|inhaled corticosteroids
5301412|NCT02169323|Step-down|step-down
5301413|NCT02169310|Traumatic Brain Injury|traumatic brain injury
5301414|NCT02169310|Decision-Making|decision-making
5301415|NCT02169310|Dopaminergic Network|dopaminergic network
5301416|NCT02169310|Brain Imaging|brain imaging
5301417|NCT02169310|Non-Invasive Brain Stimulation|non-invasive brain stimulation
5301418|NCT02169297|Pain Management|pain management
5301419|NCT02169297|Anesthesia: Nerve Block|anesthesia: nerve block
5301420|NCT02169258|coronary artery disease|coronary artery disease
5301421|NCT02169258|peripheral artery disease|peripheral artery disease
5301422|NCT02169258|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5301423|NCT02169258|coronary angiography|coronary angiography
5301424|NCT02169258|revascularization|revascularization
5301425|NCT02169258|gene polymorphisms|gene polymorphisms
5301426|NCT02169258|microRNAs|micrornas
5301427|NCT02169232|Awake intubation|awake intubation
5301428|NCT02169232|Videolaryngoscope|videolaryngoscope
5301429|NCT02169232|Fiberoptic|fiberoptic
5301430|NCT02169206|Frozen shoulder|frozen shoulder
5301431|NCT02169206|scapulothoracic angle|scapulothoracic angle
5301432|NCT02169206|scapulohumeral angle|scapulohumeral angle
5963049|NCT04275869|obesity|obesity
5301433|NCT02169206|acromiohumeral distance|acromiohumeral distance
5301434|NCT02169206|center equator distance|center equator distance
5301435|NCT02169206|shoulder radiography|shoulder radiography
5301436|NCT02169193|microaspiration|microaspiration
5301437|NCT02169193|mechanical ventilation|mechanical ventilation
5301438|NCT02169193|enteral feeding|enteral feeding
5301439|NCT02169193|99m technetium|99m technetium
5301441|NCT02169180|Ibrutinib|ibrutinib
5301442|NCT02169180|IMBRUVICA|imbruvica
5301443|NCT02169180|PCI-32765|pci-32765
5301444|NCT02169180|JNJ-54179060|jnj-54179060
5301445|NCT02169180|Lymphoma, Mantle-cell|lymphoma, mantle-cell
5301446|NCT02169167|Diabetes complications|diabetes complications
5301447|NCT02169167|Diabetic foot|diabetic foot
5301448|NCT02169167|Foot ulcer|foot ulcer
5301449|NCT02169167|Wound healing|wound healing
5301450|NCT02169167|Wound infection|wound infection
5301451|NCT02169141|pharmacokinetics|pharmacokinetics
5301452|NCT02169141|pharmacodynamics|pharmacodynamics
5301454|NCT02169141|Levofloxacin|levofloxacin
5301455|NCT02169141|Capreomycin|capreomycin
5301456|NCT02169102|Low power laser|low power laser
5301457|NCT02169102|Pulpitis|pulpitis
5301458|NCT02169102|Pain|pain
5301459|NCT02169076|Ventricular Assist Device, Cardiac Resynchronization Therapy|ventricular assist device, cardiac resynchronization therapy
5301460|NCT02169050|Vitamin D deficiency|vitamin d deficiency
5301461|NCT02169050|Inflammation|inflammation
5301462|NCT02169050|Obesity|obesity
5301463|NCT02169037|Rotor|rotor
5301464|NCT02169037|FIRM|firm
5301465|NCT02169037|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5301466|NCT02169037|Atrial tachyarrhythmia|atrial tachyarrhythmia
5301467|NCT02169037|Ablation|ablation
5301468|NCT02169037|Contact mapping|contact mapping
5301469|NCT02169037|Clinical trial|clinical trial
5301470|NCT02169037|Signal processing.|signal processing.
5301471|NCT02169024|prenatal care|prenatal care
5301472|NCT02169024|group care|group care
5301473|NCT02169024|Expect With Me|expect with me
5301474|NCT02169024|evaluation studies|evaluation studies
5301475|NCT02169024|group prenatal care|group prenatal care
5301476|NCT02169011|Breast reconstruction|breast reconstruction
5301477|NCT02169011|Breast cancer|breast cancer
5301478|NCT02168998|Medical clown|medical clown
5301479|NCT02168998|Pediatric emergency medicine|pediatric emergency medicine
5301480|NCT02168985|Child violence|child violence
5301481|NCT02168985|HIV AIDS conflicted couples|hiv aids conflicted couples
5301482|NCT02168985|Intimate partner violence|intimate partner violence
5301483|NCT02168985|Tanzania|tanzania
5301484|NCT02168985|Marriage counseling|marriage counseling
5301485|NCT02168985|Child maltreatment|child maltreatment
5301486|NCT02168985|Couples communication|couples communication
5301487|NCT02168972|atrial fibrillation|atrial fibrillation
5301488|NCT02168972|global|global
5301489|NCT02168972|radiofrequency RF ablation|radiofrequency rf ablation
5302365|NCT02164630|TMD|tmd
5301490|NCT02168972|left atrium anatomical and electrophysiological mapping|left atrium anatomical and electrophysiological mapping
5301491|NCT02168959|Femoral Nerve Block|femoral nerve block
5301492|NCT02168959|Pain Control|pain control
5301493|NCT02168959|Tibial Plateau Fracture|tibial plateau fracture
5301494|NCT02168959|Prospective|prospective
5301495|NCT02168959|Randomized|randomized
5301496|NCT02168933|psoriasis|psoriasis
5301497|NCT02168933|nail|nail
5301498|NCT02168933|laser|laser
5301499|NCT02168933|excimer|excimer
5301500|NCT02168933|treatment|treatment
5301501|NCT02168920|Alzeheimer|alzeheimer
5301502|NCT02168894|Peripheral neuropathy|peripheral neuropathy
5301503|NCT02168894|Chemotherapy-Induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
5301504|NCT02168894|Cancer Survivors|cancer survivors
5301505|NCT02168894|Acupuncture|acupuncture
5301506|NCT02168894|Electrical stimulation|electrical stimulation
5301507|NCT02168894|Nerve function tests|nerve function tests
5301508|NCT02168894|Hand function tests|hand function tests
5301509|NCT02168894|Balance tests|balance tests
5301510|NCT02168894|Questionnaires|questionnaires
5301511|NCT02168894|Surveys|surveys
5301512|NCT02168881|labour|labour
5301513|NCT02168881|induction|induction
5301514|NCT02168881|misoprostol|misoprostol
5301515|NCT02168881|dinoprostone|dinoprostone
5301516|NCT02168868|Autoimmune Diseases|autoimmune diseases
5301517|NCT02168868|Child Development Disorders, Pervasive|child development disorders, pervasive
5301518|NCT02168868|Inflammation|inflammation
5301519|NCT02168868|Risk Factors|risk factors
5301520|NCT02168855|Smoking cessation|smoking cessation
5301521|NCT02168855|Non-daily smokers|non-daily smokers
5301522|NCT02168855|Ecological Momentary Assessment|ecological momentary assessment
5301523|NCT02168855|nicotine replacement therapy|nicotine replacement therapy
5301524|NCT02168842|Parkinson|parkinson
5301525|NCT02168842|Parkinson Disease|parkinson disease
5301526|NCT02168842|Parkinson's Disease|parkinson's disease
5301527|NCT02168829|AF ablation|af ablation
5301528|NCT02168829|Anticoagulation AF ablation|anticoagulation af ablation
5301529|NCT02168829|Stroke prevention|stroke prevention
5301530|NCT02168816|Osteomyelitis|osteomyelitis
5301532|NCT02168816|Foot Infection|foot infection
5298263|NCT02186912|IBO|ibo
5301533|NCT02168803|abnormal cholesterol|abnormal cholesterol
5301534|NCT02168790|amniotic membrane holder, aminiotic membrane transplantation|amniotic membrane holder, aminiotic membrane transplantation
5301535|NCT02168777|Patients with Cancer|patients with cancer
5301536|NCT02168751|one lung ventilation|one lung ventilation
5301537|NCT02168751|inflammatory response|inflammatory response
5301538|NCT02168751|thoracic surgery|thoracic surgery
5301539|NCT02168738|nutrition|nutrition
5301540|NCT02168725|briciclib|briciclib
5301541|NCT02168725|Dose escalation|dose escalation
5301542|NCT02168725|Maximum tolerated dose|maximum tolerated dose
5301543|NCT02168712|Coronary Heart Disease|coronary heart disease
5301544|NCT02168712|Interval exercise training|interval exercise training
5301545|NCT02168712|Continuous exercise training|continuous exercise training
5301546|NCT02168712|Quality of life|quality of life
5301549|NCT02168699|infants|infants
5301550|NCT02168699|musculocutaneous nerve|musculocutaneous nerve
5301551|NCT02168699|ultrasonography|ultrasonography
5301552|NCT02168686|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5301553|NCT02168686|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
5301554|NCT02168686|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
5301555|NCT02168686|alpha1AT|alpha1at
5301556|NCT02168686|A1AT|a1at
5301557|NCT02168686|ADVM-043|advm-043
5301558|NCT02168686|AAVrh.10halpha1AT|aavrh.10halpha1at
5301559|NCT02168686|AAVrh.10hA1AT|aavrh.10ha1at
5301560|NCT02168686|Gene transfer vector|gene transfer vector
5301561|NCT02168686|Gene therapy|gene therapy
5301562|NCT02168686|Lung disease|lung disease
5301563|NCT02168686|Emphysema|emphysema
5301564|NCT02168686|COPD|copd
5301565|NCT02168686|ADVANCE study|advance study
5301566|NCT02168686|ADVM-043-01|advm-043-01
5301567|NCT02168673|COPD|copd
5301568|NCT02168673|Cigarette Smoke|cigarette smoke
5301569|NCT02168673|Smoker|smoker
5301570|NCT02168673|Nonsmoker|nonsmoker
5301571|NCT02168673|ODF2|odf2
5301572|NCT02168673|Cilia|cilia
5301573|NCT02168660|Obesity|obesity
5301574|NCT02168660|Insulin Resistance|insulin resistance
5301575|NCT02168660|Vitamin D Deficiency|vitamin d deficiency
5301576|NCT02168660|Children|children
5301577|NCT02168660|Adolescents|adolescents
5301578|NCT02168647|Excessive gestational weight gain|excessive gestational weight gain
5301579|NCT02168647|Insulin resistance|insulin resistance
5301580|NCT02168647|Physical activity|physical activity
5301581|NCT02168647|Behavioral prenatal lifestyle intervention|behavioral prenatal lifestyle intervention
5301582|NCT02168647|Reduced carbohydrate intake|reduced carbohydrate intake
5301583|NCT02168647|Self-determination theory|self-determination theory
5301584|NCT02168647|Motivational interviewing|motivational interviewing
5301585|NCT02168621|Chronic periodontitis|chronic periodontitis
5301586|NCT02168621|Non-surgical therapy|non-surgical therapy
5301587|NCT02168621|Ultrasonic debridement|ultrasonic debridement
5301590|NCT02168608|ischemia precondition|ischemia precondition
5301591|NCT02168608|remote ischemia precondition|remote ischemia precondition
5301592|NCT02168608|anti-inflammation|anti-inflammation
5301593|NCT02168595|healthy volunteers, GMI-1271|healthy volunteers, gmi-1271
5301594|NCT02168582|Physical Therapy Modalities|physical therapy modalities
5301595|NCT02168582|Prognosis|prognosis
5301596|NCT02168582|Patient Selection|patient selection
5301597|NCT02168569|treatment|treatment
5301598|NCT02168569|artemisin-based combinations|artemisin-based combinations
5301599|NCT02168569|children|children
5301600|NCT02168556|Urodynamics, Anxiety|urodynamics, anxiety
5301601|NCT02168517|Obesity|obesity
5301602|NCT02168517|Pain|pain
5301603|NCT02168517|Fertility|fertility
5301604|NCT02168478|Neo-Synalar|neo-synalar
5301605|NCT02168478|Patch Test|patch test
5301606|NCT02168478|Sodium lauryl sulfate|sodium lauryl sulfate
5301607|NCT02168478|Saline|saline
5301608|NCT02168478|Presensitization|presensitization
5301609|NCT02168465|self-efficacy|self-efficacy
5301610|NCT02168465|self-management|self-management
5301611|NCT02168465|web-based intervention research|web-based intervention research
5301612|NCT02168452|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5301613|NCT02168452|Indocyanine green (ICG)|indocyanine green (icg)
5301614|NCT02168452|Radioisotope (RI)|radioisotope (ri)
5301615|NCT02168452|Near infrared fluorescence camera|near infrared fluorescence camera
5301616|NCT02168439|Dexmedetomidine|dexmedetomidine
5301617|NCT02168439|Midazolam|midazolam
5301618|NCT02168413|cortical excitability|cortical excitability
5301619|NCT02168413|robotized TMS|robotized tms
5301620|NCT02168413|EEG|eeg
5301621|NCT02168413|EMG|emg
5301622|NCT02168387|atelectasis|atelectasis
5301623|NCT02168387|continuous high frequency oscillator|continuous high frequency oscillator
5301624|NCT02168387|acetylcysteine|acetylcysteine
5301625|NCT02168387|dornase alfa|dornase alfa
5301626|NCT02168374|Glass ionomer cement|glass ionomer cement
5301627|NCT02168374|Indirect pulp therapy|indirect pulp therapy
5301628|NCT02168361|cirrhosis|cirrhosis
5301629|NCT02168322|growth factors|growth factors
5301630|NCT02168322|periodontal regeneration|periodontal regeneration
5301631|NCT02168322|modefied perforated membranes|modefied perforated membranes
5298367|NCT02186392|Sleep|sleep
5301633|NCT02168296|Blood glucose|blood glucose
5301634|NCT02168296|subjects|subjects
5301637|NCT02168257|Nasal Cannula|nasal cannula
5301638|NCT02168244|psoriasis|psoriasis
5301639|NCT02168244|biologics|biologics
5301640|NCT02168244|subcutaneous|subcutaneous
5301642|NCT02168244|heat|heat
5301643|NCT02168244|ice|ice
5301644|NCT02168231|Complex abdominal wall hernia|complex abdominal wall hernia
5301645|NCT02168231|Biologic mesh|biologic mesh
5301646|NCT02168231|Strattice|strattice
5301647|NCT02168218|protein synthesis|protein synthesis
5301648|NCT02168218|intrahepatic fat|intrahepatic fat
5301649|NCT02168218|lean body mass|lean body mass
5301650|NCT02168218|IGF1|igf1
5301651|NCT02168218|energy metabolism|energy metabolism
5301663|NCT02168166|Neurological Disorders|neurological disorders
5301664|NCT02168166|Neuroscience|neuroscience
5301665|NCT02168166|Neuropsychology|neuropsychology
5301666|NCT02168166|EEG|eeg
5301667|NCT02168166|Cognitive remediation|cognitive remediation
5301668|NCT02168166|Cognitive Response|cognitive response
5301669|NCT02168153|Chiropractic Manipulative Therapy|chiropractic manipulative therapy
5301670|NCT02168153|Reaction Times|reaction times
5301671|NCT02168153|Response Times|response times
5301672|NCT02168153|Special Forces|special forces
5301673|NCT02168153|Biomechanical Assessments|biomechanical assessments
5301674|NCT02168114|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5301675|NCT02168114|Exercise|exercise
5301676|NCT02168114|Optical Imaging|optical imaging
5301677|NCT02168114|Magnetic Resonance|magnetic resonance
5301683|NCT02168088|Sudden unexplained death|sudden unexplained death
5301684|NCT02168049|cardiac, respiratory, monitoring|cardiac, respiratory, monitoring
5301685|NCT02168036|lung disease|lung disease
5301686|NCT02168036|mediastinal lymph node|mediastinal lymph node
5301687|NCT02168036|bronchoscopy|bronchoscopy
5301688|NCT02168036|Endobronchial-Guided Transbronchial Needle Aspiration|endobronchial-guided transbronchial needle aspiration
5301689|NCT02168023|surgical site infection|surgical site infection
5301690|NCT02168023|dialkylcarbamoylchloride impregnated dressing|dialkylcarbamoylchloride impregnated dressing
5301691|NCT02168023|caesarean section|caesarean section
5301692|NCT02168023|wound dehiscence|wound dehiscence
5301693|NCT02167984|esophageal swallow|esophageal swallow
5301694|NCT02167984|gastroesophageal reflux|gastroesophageal reflux
5301695|NCT02167984|esophageal impedance|esophageal impedance
5301696|NCT02167984|newborn|newborn
5301697|NCT02167984|preterm|preterm
5301698|NCT02167971|traumatic brain injury|traumatic brain injury
5301699|NCT02167971|diffuse axonal injury|diffuse axonal injury
5301700|NCT02167971|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5301701|NCT02167971|neuromodulation|neuromodulation
5301702|NCT02167971|cognitive rehabilitation|cognitive rehabilitation
5301703|NCT02167945|Hepatitis C Genotype 1|hepatitis c genotype 1
5301704|NCT02167945|Compensated Cirrhosis|compensated cirrhosis
5301705|NCT02167945|Cirrhosis|cirrhosis
5301706|NCT02167945|Naïve|naïve
5301707|NCT02167945|Hepatitis C|hepatitis c
5301708|NCT02167945|Hepatitis C Virus|hepatitis c virus
5301709|NCT02167945|Treatment-Experienced|treatment-experienced
5301710|NCT02167945|Relapser|relapser
5301711|NCT02167945|Null responder|null responder
5301712|NCT02167945|Non responder|non responder
5301713|NCT02167932|Breast Cancer|breast cancer
5301714|NCT02167932|Walk With Ease|walk with ease
5301715|NCT02167932|Physical Activity|physical activity
5301716|NCT02167932|Walking|walking
5301717|NCT02167932|Younger Women|younger women
5301718|NCT02167932|Cancer|cancer
5301719|NCT02167932|p16|p16
5301720|NCT02167932|Aging|aging
5301721|NCT02167932|Biomarkers|biomarkers
5301722|NCT02167932|Biomarkers of Aging|biomarkers of aging
5301723|NCT02167932|Chemotherapy|chemotherapy
5301724|NCT02167932|Chemotherapy Treatment|chemotherapy treatment
5301725|NCT02167932|Adjuvant Chemotherapy|adjuvant chemotherapy
5301726|NCT02167932|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5301727|NCT02167919|Prostate|prostate
5301728|NCT02167919|Men|men
5301729|NCT02167919|Hyperplasia|hyperplasia
5301730|NCT02167893|Pharmacological therapy|pharmacological therapy
5301731|NCT02167867|body contouring|body contouring
5301732|NCT02167867|circumference reduction|circumference reduction
5301733|NCT02167867|body shaping|body shaping
5301734|NCT02167867|low level laser|low level laser
5301735|NCT02167854|LJM716|ljm716
5301736|NCT02167854|BYL719 [Alpelisib]|byl719 [alpelisib]
5301737|NCT02167854|TRASTUZUMAB|trastuzumab
5301738|NCT02167854|HER2+|her2+
5301739|NCT02167854|14-057|14-057
5301740|NCT02167841|Breech presentation,|breech presentation,
5301741|NCT02167841|External cephalic version,|external cephalic version,
5301742|NCT02167841|Maternal posture,|maternal posture,
5301743|NCT02167841|Pregnancy,|pregnancy,
5301744|NCT02167841|Caesarean section.|caesarean section.
5301745|NCT02167828|HIV|hiv
5301747|NCT02167828|treatment adherence|treatment adherence
5301748|NCT02167828|social network|social network
5301749|NCT02167802|severe infection, pediatrics, sub-optimal care, term care|severe infection, pediatrics, sub-optimal care, term care
5301750|NCT02167789|HF, diagnosis|hf, diagnosis
5301753|NCT02167763|copper|copper
5301754|NCT02167750|cognitive|cognitive
5301755|NCT02167750|phytochmicals|phytochmicals
5301756|NCT02167750|caffeine|caffeine
5301757|NCT02167750|cognitive performance after ingestion of test beverage|cognitive performance after ingestion of test beverage
5301758|NCT02167737|Accident Prevention|accident prevention
5301759|NCT02167737|Accidental Falls|accidental falls
5301760|NCT02167737|Geriatric Health Services|geriatric health services
5301761|NCT02167737|Gender Differences|gender differences
5301762|NCT02167698|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
5301763|NCT02167698|Mechanical ventilation|mechanical ventilation
5301764|NCT02167698|Airway pressure release ventilation|airway pressure release ventilation
5301765|NCT02167698|Conventional low-tidal volume ventilation|conventional low-tidal volume ventilation
5301766|NCT02167672|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy|total abdominal hysterectomy, total laparoscopic hysterectomy, vaginal hysterectomy
5301767|NCT02167659|Lymphedema|lymphedema
5301768|NCT02167659|Breast cancer|breast cancer
5301769|NCT02167659|Bioimpedance Spectroscopy|bioimpedance spectroscopy
5301770|NCT02167659|L-Dex|l-dex
5301771|NCT02167646|Soft tissue defect|soft tissue defect
5301772|NCT02167646|dorsal branch of the digital nerve|dorsal branch of the digital nerve
5301773|NCT02167646|dorsal branch of the digital artery|dorsal branch of the digital artery
5301774|NCT02167646|dorsal digital flap|dorsal digital flap
5301775|NCT02167633|Radiosurgery|radiosurgery
5301776|NCT02167633|Laminectomy|laminectomy
5301777|NCT02167633|Radiotherapy|radiotherapy
5301778|NCT02167633|Spinal Cord Compression|spinal cord compression
5301779|NCT02167633|Neoplasm Metastasis|neoplasm metastasis
5301780|NCT02167633|Randomized Controlled Trial|randomized controlled trial
5301781|NCT02167607|Purple Potatoes|purple potatoes
5302366|NCT02164630|Hope|hope
5301782|NCT02167607|Polyphenolics|polyphenolics
5301783|NCT02167581|Maxillofacial surgery|maxillofacial surgery
5301784|NCT02167581|Epithelial odontogenic tumours|epithelial odontogenic tumours
5301785|NCT02167568|corpus callosum agenesis/dysgenesis|corpus callosum agenesis/dysgenesis
5301786|NCT02167568|mental deficiency/ Intellectual deficiency|mental deficiency/ intellectual deficiency
5301787|NCT02167568|genetic and phenotypic characterization|genetic and phenotypic characterization
5301788|NCT02167555|Wild Blueberries|wild blueberries
5301789|NCT02167555|Polyphenolics|polyphenolics
5301790|NCT02167542|Severe hypoxemic respiratory failure|severe hypoxemic respiratory failure
5301791|NCT02167542|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
5301792|NCT02167542|Noninvasive possitive pressure ventilation|noninvasive possitive pressure ventilation
5301793|NCT02167542|Continuous positive airway pressure|continuous positive airway pressure
5301794|NCT02167529|Quality of life-Thyroidectomy-Morbidity|quality of life-thyroidectomy-morbidity
5301795|NCT02167516|Xinfeng capsule|xinfeng capsule
5301796|NCT02167516|Knee osteoarthritis|knee osteoarthritis
5301797|NCT02167516|Randomized controlled trials|randomized controlled trials
5301798|NCT02167516|Double-blind|double-blind
5301799|NCT02167490|BC; conservative surgery; SNB; AD; axillary US imaging|bc; conservative surgery; snb; ad; axillary us imaging
5301801|NCT02167464|Hypertension|hypertension
5301802|NCT02167451|stem cell transplant|stem cell transplant
5301803|NCT02167451|GVHD prevention|gvhd prevention
5301804|NCT02167438|Cesarean|cesarean
5301805|NCT02167438|Section|section
5301806|NCT02167438|second|second
5301807|NCT02167438|stage|stage
5301808|NCT02167438|labor|labor
5301809|NCT02167425|People who Inject Drugs|people who inject drugs
5301810|NCT02167425|HIV|hiv
5301811|NCT02167425|Methadone|methadone
5301812|NCT02167425|Sub Saharan Africa|sub saharan africa
5301813|NCT02167425|Tanzania|tanzania
5301814|NCT02167425|Implementation Science|implementation science
5301815|NCT02167412|POTS|pots
5301816|NCT02167412|Syncope|syncope
5301817|NCT02167386|Men who have sex with men (MSM)|men who have sex with men (msm)
5301818|NCT02167386|Black/African-American|black/african-american
5301819|NCT02167360|adult patients|adult patients
5301820|NCT02167360|B-cell ALL|b-cell all
5301821|NCT02167360|chemo-refractory|chemo-refractory
5301822|NCT02167360|relapsed after allogeneic SCT|relapsed after allogeneic sct
5301823|NCT02167360|ineligible for allogeneic SCT|ineligible for allogeneic sct
5301824|NCT02167347|CBT, Psychosis, cultural adaptation, Pakistan|cbt, psychosis, cultural adaptation, pakistan
5301825|NCT02167334|panendoscopy|panendoscopy
5301826|NCT02167334|preoxygenation|preoxygenation
5301827|NCT02167334|non invasive ventilation|non invasive ventilation
5301828|NCT02167295|betel nut|betel nut
5301829|NCT02167295|dependence|dependence
5301830|NCT02167295|withdraw|withdraw
5301831|NCT02167295|deprivation test|deprivation test
5301832|NCT02167269|enclosed afferent reservoir|enclosed afferent reservoir
5301833|NCT02167269|Jackson Rees system|jackson rees system
5301834|NCT02167269|anesthesia breathing circuit|anesthesia breathing circuit
5301838|NCT02167230|Percutaneous Coronary Intervention|percutaneous coronary intervention
5301839|NCT02167230|Bifurcation|bifurcation
5301840|NCT02167230|Jailed-balloon technique|jailed-balloon technique
5301841|NCT02167217|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5301842|NCT02167217|Corticosteroids|corticosteroids
5301843|NCT02167217|Infants|infants
5301846|NCT02167165|Atrial Fibrillation|atrial fibrillation
5301847|NCT02167165|Digoxin|digoxin
5301848|NCT02167165|SNP|snp
5301849|NCT02167139|Rheumatoid Arthritis, Adalimumab|rheumatoid arthritis, adalimumab
5301850|NCT02167126|Athletic Performance;|athletic performance;
5301851|NCT02167126|Muscle Strength;|muscle strength;
5301852|NCT02167126|Isometric Contraction;|isometric contraction;
5301853|NCT02167126|Kinesio Taping|kinesio taping
5301854|NCT02167100|HIV|hiv
5301855|NCT02167100|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5301856|NCT02167100|Patient Care|patient care
5301857|NCT02167100|Patient Care Management|patient care management
5301858|NCT02167100|Lost to Follow-Up|lost to follow-up
5301859|NCT02167087|Sentinel node mapping|sentinel node mapping
5301860|NCT02167087|lymphatic mapping|lymphatic mapping
5301861|NCT02167087|lymphatic metastasis|lymphatic metastasis
5301862|NCT02167087|Aberrant lymphatic drainage|aberrant lymphatic drainage
5301863|NCT02167087|indocyanine green|indocyanine green
5301864|NCT02167087|ICG|icg
5301865|NCT02167087|near infrared|near infrared
5301866|NCT02167087|colon cancer|colon cancer
5301867|NCT02167087|laparoscopic surgery|laparoscopic surgery
5301868|NCT02167074|Diagnostic accuracy|diagnostic accuracy
5301869|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
5301870|NCT02167074|EUS-FNA|eus-fna
5301871|NCT02167074|Endoscopic Ultrasound-Guided Fine Needle Biopsy|endoscopic ultrasound-guided fine needle biopsy
5301872|NCT02167074|EUS-FNB|eus-fnb
5301873|NCT02167074|Pancreatic mass|pancreatic mass
5301874|NCT02167074|Lymph node|lymph node
5301875|NCT02167048|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5301876|NCT02167048|Executive Function|executive function
5301877|NCT02167048|Methylphenidate|methylphenidate
5301878|NCT02167048|Psychostimulants|psychostimulants
5301879|NCT02167048|Adolescent|adolescent
5301880|NCT02167048|Child|child
5301881|NCT02167048|Working Memory|working memory
5301882|NCT02167048|Prefrontal Cortex|prefrontal cortex
5301883|NCT02167048|Attention|attention
5301884|NCT02167048|Cognitive Function|cognitive function
5301885|NCT02167048|Inhibition|inhibition
5301886|NCT02167035|Open-Angle Glaucoma|open-angle glaucoma
5301887|NCT02167035|Ocular Hypertension|ocular hypertension
5301888|NCT02167022|intense therapy|intense therapy
5301889|NCT02167022|brain plasticity|brain plasticity
5301890|NCT02167022|Perception-Action approach|perception-action approach
5301891|NCT02167009|ARTERY EMBOLIZATION|artery embolization
5301892|NCT02167009|BPH|bph
5301893|NCT02166970|Hilar tumor|hilar tumor
5301894|NCT02166970|Metal stent|metal stent
5301895|NCT02166970|Single|single
5301896|NCT02166970|Multiple|multiple
5301897|NCT02166957|Esophageal disruption|esophageal disruption
5301898|NCT02166957|anterograde-retrograde endoscopy|anterograde-retrograde endoscopy
5301899|NCT02166957|rendez-vous technique|rendez-vous technique
5301900|NCT02166957|NOTES|notes
5301901|NCT02166957|recanalization|recanalization
5301902|NCT02166957|dilatations|dilatations
5301903|NCT02166957|Stenting|stenting
5301904|NCT02166957|radiation therapy|radiation therapy
5301905|NCT02166957|head and neck carcinoma|head and neck carcinoma
5301906|NCT02166944|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5301907|NCT02166944|ALS functional ration scale|als functional ration scale
5301908|NCT02166944|TAR-DNA-binding protein-43|tar-dna-binding protein-43
5301909|NCT02166944|tamoxifen|tamoxifen
5301910|NCT02166944|mTOR|mtor
5301911|NCT02166931|Essence of Chicken|essence of chicken
5301912|NCT02166931|stress|stress
5301913|NCT02166931|cognitive function|cognitive function
5301914|NCT02166918|Schizophrenia|schizophrenia
5301915|NCT02166918|Real-Life Functioning|real-life functioning
5301916|NCT02166918|Schizophrenia Endophenotypes|schizophrenia endophenotypes
5301917|NCT02166892|Childhood obesity|childhood obesity
5301918|NCT02166892|Plate|plate
5301919|NCT02166892|Food consumption|food consumption
5301920|NCT02166879|Obstructive Sleep Apnea-Hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
5301921|NCT02166879|Obstructive sleep apnea|obstructive sleep apnea
5301922|NCT02166879|OSA|osa
5301923|NCT02166879|Chart review|chart review
5301924|NCT02166879|Questionnaire|questionnaire
5301925|NCT02166879|Survey|survey
5301926|NCT02166853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5301927|NCT02166853|Sevoflurane|sevoflurane
5301928|NCT02166853|Mechanical ventilation|mechanical ventilation
5301929|NCT02166853|Intensive Care Unit (ICU)|intensive care unit (icu)
5301930|NCT02166853|Prospective study|prospective study
5301931|NCT02166853|Lung injury|lung injury
5301932|NCT02166853|Gas exchange|gas exchange
5301933|NCT02166853|Inflammation|inflammation
5301934|NCT02166853|Receptor for advanced glycation end-produts (RAGE)|receptor for advanced glycation end-produts (rage)
5301935|NCT02166853|sRAGE|srage
5301936|NCT02166827|TMS|tms
5301937|NCT02166827|Cognitive Stimulation|cognitive stimulation
5301938|NCT02166827|NeuroAD|neuroad
5301939|NCT02166801|Cerebral palsy|cerebral palsy
5301940|NCT02166801|Children|children
5301945|NCT02166788|metastatic melanoma|metastatic melanoma
5301946|NCT02166788|groin lymph nodes|groin lymph nodes
5301947|NCT02166788|surgery|surgery
5963050|NCT04275869|physical activity|physical activity
5301948|NCT02166788|lymphadenectomy|lymphadenectomy
5301949|NCT02166762|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5301950|NCT02166762|Biventricular implantable cardioverter defibrillators|biventricular implantable cardioverter defibrillators
5301951|NCT02166762|Heart failure|heart failure
5301952|NCT02166762|Cardiomyopathy|cardiomyopathy
5301953|NCT02166762|QLV|qlv
5301954|NCT02166762|LV lead placement|lv lead placement
5301955|NCT02166762|Arrhythmia|arrhythmia
5301956|NCT02166749|Hysterectomy, long term follow up, subjective outcome|hysterectomy, long term follow up, subjective outcome
5301957|NCT02166736|Instantaneous wave Free Ratio|instantaneous wave free ratio
5301958|NCT02166736|Fractional Flow Reserve|fractional flow reserve
5301959|NCT02166723|persistent atrial fibrillation|persistent atrial fibrillation
5301960|NCT02166723|Cryoballoon ablation|cryoballoon ablation
5301961|NCT02166710|Knee arthroplasty|knee arthroplasty
5301962|NCT02166710|Adductor canal block|adductor canal block
5301963|NCT02166710|Quadriceps strength|quadriceps strength
5301964|NCT02166697|Pharmacological therapy|pharmacological therapy
5301965|NCT02166684|Do-it-yourself devices|do-it-yourself devices
5301966|NCT02166684|User-experiences|user-experiences
5301967|NCT02166684|Health behavior|health behavior
5301968|NCT02166684|Self-measurement|self-measurement
5301969|NCT02166684|Methodology, Evaluation|methodology, evaluation
5301970|NCT02166684|Personal health records|personal health records
5301971|NCT02166684|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5301972|NCT02166684|Self Blood Pressure Monitoring|self blood pressure monitoring
5301973|NCT02166658|Patients with breast or lung cancer and recurrent or progressive brain|patients with breast or lung cancer and recurrent or progressive brain
5301974|NCT02166658|metastases|metastases
5301975|NCT02166645|patient positioning|patient positioning
5301976|NCT02166645|premature infant|premature infant
5301977|NCT02166645|mechanical ventilation|mechanical ventilation
5301978|NCT02166645|airway extubation|airway extubation
5301979|NCT02166632|Knee arthroplasty|knee arthroplasty
5301980|NCT02166632|Exparel|exparel
5301981|NCT02166632|Bupivacaine liposome|bupivacaine liposome
5301982|NCT02166632|Total knee replacement|total knee replacement
5301983|NCT02166632|Pain control|pain control
5301984|NCT02166619|Stroke|stroke
5301985|NCT02166619|Rehabilitation|rehabilitation
5301986|NCT02166619|Electric stimulation therapy|electric stimulation therapy
5301987|NCT02166619|Neuroplasticity|neuroplasticity
5301988|NCT02166567|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5301989|NCT02166567|Male infertility|male infertility
5301990|NCT02166567|apoptosis|apoptosis
5301991|NCT02166567|flow cytometry and sorting|flow cytometry and sorting
5301992|NCT02166567|DNA fragmentation|dna fragmentation
5301993|NCT02166554|Adhesions|adhesions
5301994|NCT02166554|Hyaluronan|hyaluronan
5301995|NCT02166554|Gynaecological surgery|gynaecological surgery
5301996|NCT02166554|Clinical outcomes|clinical outcomes
5301997|NCT02166541|cerebral palsy, spastic, diplegic,|cerebral palsy, spastic, diplegic,
5301998|NCT02166541|children,|children,
5301999|NCT02166541|intervention study,|intervention study,
5302000|NCT02166541|manipulation, spinal|manipulation, spinal
5302001|NCT02166541|randomized controlled trial|randomized controlled trial
5302002|NCT02166528|female pelvic floor dysfunction|female pelvic floor dysfunction
5302003|NCT02166528|pelvic organ prolaps|pelvic organ prolaps
5302004|NCT02166528|urinary incontinence|urinary incontinence
5302005|NCT02166528|massively parallel sequencing|massively parallel sequencing
5302006|NCT02166515|cervical cancer|cervical cancer
5302007|NCT02166515|ovarian cancer|ovarian cancer
5302008|NCT02166515|endometrial cancer|endometrial cancer
5302009|NCT02166515|high-throughput sequencing|high-throughput sequencing
5302010|NCT02166502|pediatric|pediatric
5302012|NCT02166502|prevention|prevention
5302013|NCT02166502|prophylaxis|prophylaxis
5302014|NCT02166502|nevirapine|nevirapine
5302015|NCT02166489|autologous mesenchymal stem cells|autologous mesenchymal stem cells
5302016|NCT02166489|polycystic kidney disease|polycystic kidney disease
5302017|NCT02166489|intravenous injection|intravenous injection
5302018|NCT02166489|CRF|crf
5302019|NCT02166450|Denture stomatitis|denture stomatitis
5302020|NCT02166450|Dentures|dentures
5302021|NCT02166450|Denture wearers|denture wearers
5302022|NCT02166437|osteoporosis|osteoporosis
5302023|NCT02166437|BMD|bmd
5302024|NCT02166437|teriparatide|teriparatide
5302025|NCT02166437|bisphosphonate|bisphosphonate
5289144|NCT02227966|MCI|mci
5302026|NCT02166437|denosmab|denosmab
5302027|NCT02166424|Pregnancy|pregnancy
5302028|NCT02166424|Depression|depression
5302029|NCT02166424|omega-3 fatty acids|omega-3 fatty acids
5302030|NCT02166411|Myomectomy ,Laparoscopy , Barbed sutures|myomectomy ,laparoscopy , barbed sutures
5302031|NCT02166398|Amlodipine basylate, Losartan potassium|amlodipine basylate, losartan potassium
5302033|NCT02166359|Triglyceride|triglyceride
5302034|NCT02166346|Transverse myelitis|transverse myelitis
5302035|NCT02166333|vitamin D|vitamin d
5302036|NCT02166333|falls|falls
5302037|NCT02166333|high risk of falling|high risk of falling
5302038|NCT02166333|insufficient or deficient serum vitamin D levels|insufficient or deficient serum vitamin d levels
5302039|NCT02166333|10-29 ng/ml|10-29 ng/ml
5963051|NCT04275869|nutrition|nutrition
5302040|NCT02166307|formaldehyde; Maillard Reaction; cross-linkage; human aging|formaldehyde; maillard reaction; cross-linkage; human aging
5302041|NCT02166294|Foot|foot
5302042|NCT02166294|Ulcer|ulcer
5302043|NCT02166294|Diabetes|diabetes
5302044|NCT02166294|Amputation|amputation
5302045|NCT02166294|Limb salvage|limb salvage
5302046|NCT02166281|Insomnia|insomnia
5302047|NCT02166281|Anxiety|anxiety
5302048|NCT02166281|Depression|depression
5302049|NCT02166281|Restless leg syndrome|restless leg syndrome
5302050|NCT02166281|Aromatase inhibitor|aromatase inhibitor
5302051|NCT02166281|Body composition|body composition
5302052|NCT02166268|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5302053|NCT02166268|Allergic rhinitis|allergic rhinitis
5302054|NCT02166268|Allergy|allergy
5302055|NCT02166268|Grass pollen|grass pollen
5302056|NCT02166242|non-small cell lung cancer|non-small cell lung cancer
5302057|NCT02166242|thioredoxin reductase|thioredoxin reductase
5302058|NCT02166216|Prolonged high intensity exercise|prolonged high intensity exercise
5302059|NCT02166216|Healthy subjects|healthy subjects
5302060|NCT02166216|Cardiovascular risk markers|cardiovascular risk markers
5302061|NCT02166216|Troponin|troponin
5302062|NCT02166216|Leisure sports athletes|leisure sports athletes
5302063|NCT02166216|Cycling|cycling
5302064|NCT02166216|CT coronary angiography|ct coronary angiography
5302065|NCT02166216|Outcomes|outcomes
5302066|NCT02166190|Pancreatic cancer|pancreatic cancer
5302067|NCT02166190|cholangiocarcinoma|cholangiocarcinoma
5302068|NCT02166190|radiofrequency ablation|radiofrequency ablation
5302070|NCT02166164|Secondary hyperalgesia|secondary hyperalgesia
5302071|NCT02166164|thermal sensitization|thermal sensitization
5302072|NCT02166164|Catastrophization|catastrophization
5302073|NCT02166164|Anxiety|anxiety
5302074|NCT02166125|gastric bypass|gastric bypass
5302075|NCT02166125|sleeve gastrectomy|sleeve gastrectomy
5302076|NCT02166125|esophageal stent|esophageal stent
5302077|NCT02166125|suturing|suturing
5302078|NCT02166112|Hernia of Abdominal Wall|hernia of abdominal wall
5302079|NCT02166112|Biologic implant|biologic implant
5302080|NCT02166112|Infected Hernioplasty Mesh|infected hernioplasty mesh
5302081|NCT02166047|Hepatitis B|hepatitis b
5302083|NCT02166047|GS-9620|gs-9620
5302084|NCT02166047|TLR-7 Agonist|tlr-7 agonist
5302085|NCT02166034|children|children
5302086|NCT02166034|fruit|fruit
5302087|NCT02166034|vegetable|vegetable
5302088|NCT02166034|diet|diet
5302089|NCT02166034|school|school
5302090|NCT02166034|garden|garden
5302091|NCT02166021|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5302092|NCT02166021|Stem Cells|stem cells
5302093|NCT02166008|Repamipide|repamipide
5302094|NCT02166008|Dual antiplatelet|dual antiplatelet
5302095|NCT02166008|Peptic ulcer|peptic ulcer
5302096|NCT02165995|Brain Tumor|brain tumor
5302097|NCT02165995|Glioma|glioma
5302098|NCT02165995|Tumor resection|tumor resection
5302099|NCT02165995|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
5302100|NCT02165995|nTMS|ntms
5302101|NCT02165995|Brain mapping|brain mapping
5302102|NCT02165995|Motor function|motor function
5302103|NCT02165995|Speech function|speech function
5302104|NCT02165995|Speech mapping|speech mapping
5302105|NCT02165969|tumor|tumor
5302106|NCT02165969|inflammatory process|inflammatory process
5302107|NCT02165969|fracture|fracture
5302108|NCT02165969|defect|defect
5302109|NCT02165956|Cereals|cereals
5302110|NCT02165956|Obesity|obesity
5302111|NCT02165956|Complementary Feeding|complementary feeding
5302112|NCT02165930|Bioavailability|bioavailability
5302113|NCT02165930|oxycodone|oxycodone
5302114|NCT02165930|ethanol interaction|ethanol interaction
5302115|NCT02165930|healthy volunteers|healthy volunteers
5302116|NCT02165917|Endometriosis|endometriosis
5302117|NCT02165917|Adhesions|adhesions
5302118|NCT02165917|Hyalobarrier®|hyalobarrier®
5302119|NCT02165917|Hyaluronic acid|hyaluronic acid
5302120|NCT02165917|Antiadhesion agent|antiadhesion agent
5302121|NCT02165917|Adhesionbarrier|adhesionbarrier
5302122|NCT02165917|Pregnancy rate|pregnancy rate
5343005|NCT01981200|Handheld dynamometer|handheld dynamometer
5903813|NCT00297752|quality of life|quality of life
5302123|NCT02165904|Analyze clinical efficacy of subarachnoid administration of|analyze clinical efficacy of subarachnoid administration of
5289238|NCT02227368|Mycardial Ischemia|mycardial ischemia
5302124|NCT02165904|"autologous BMSC expanded in vitro"|"autologous bmsc expanded in vitro"
5302125|NCT02165878|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
5302126|NCT02165865|hand transplantation|hand transplantation
5302127|NCT02165865|hand allotransplantation|hand allotransplantation
5302128|NCT02165865|upper extremity transplantation|upper extremity transplantation
5197401|NCT02760641|obesity|obesity
5302131|NCT02165865|vascularized composite allotransplantation|vascularized composite allotransplantation
5302132|NCT02165865|composite tissue allotransplantation|composite tissue allotransplantation
5302133|NCT02165865|variance component analysis (VCA)|variance component analysis (vca)
5302134|NCT02165865|composite tissue allograft (CTA)|composite tissue allograft (cta)
5302135|NCT02165852|ampulla of Vater|ampulla of vater
5302137|NCT02165852|papillectomy|papillectomy
5302138|NCT02165852|injection|injection
5302139|NCT02165852|non-injection|non-injection
5302140|NCT02165826|Drug therapy|drug therapy
5302141|NCT02165774|sacral neuromodulation, neurogenic lower urinary tract dysfunction|sacral neuromodulation, neurogenic lower urinary tract dysfunction
5302142|NCT02165761|Hemodialysis|hemodialysis
5302143|NCT02165761|End Stage Renal Disease|end stage renal disease
5302144|NCT02165761|Vascular Graft|vascular graft
5302145|NCT02165722|Influenza|influenza
5302146|NCT02165722|HPV|hpv
5302147|NCT02165722|Tdap|tdap
5302148|NCT02165722|MCV|mcv
5302149|NCT02165722|vaccination|vaccination
5302150|NCT02165722|adolescents|adolescents
5302151|NCT02165696|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.|compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
5302152|NCT02165683|Cancer|cancer
5302153|NCT02165683|Pediatric|pediatric
5302154|NCT02165683|PET Scan|pet scan
5302155|NCT02165670|Ischemic heart disesase|ischemic heart disesase
5302156|NCT02165670|Myocardial infarction|myocardial infarction
5302157|NCT02165670|Angina pectoris|angina pectoris
5302158|NCT02165657|Excimer laser|excimer laser
5302159|NCT02165657|UVB|uvb
5302160|NCT02165657|Psoriasis|psoriasis
5302161|NCT02165644|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5302162|NCT02165644|Vasospasm|vasospasm
5302163|NCT02165644|Acetazolamide|acetazolamide
5302164|NCT02165618|frailty|frailty
5302165|NCT02165618|geriatric, elderly|geriatric, elderly
5302166|NCT02165618|polypharmacy|polypharmacy
5302167|NCT02165605|external beam radiotherapy|external beam radiotherapy
5302184|NCT02165566|blood glucose concentration>180 mg/dl|blood glucose concentration>180 mg/dl
5302185|NCT02165553|Hibiscus sabdariffa calyces|hibiscus sabdariffa calyces
5302186|NCT02165553|Blood Pressure|blood pressure
5302187|NCT02165553|Vascular Function|vascular function
5302188|NCT02165553|Inflammation|inflammation
5302189|NCT02165553|Cardiometabolic risk markers|cardiometabolic risk markers
5302190|NCT02165553|Systemic antioxidant capacity|systemic antioxidant capacity
5302191|NCT02165540|Doula|doula
5302192|NCT02165540|Pain management|pain management
5302193|NCT02165540|Miscarriage|miscarriage
5302194|NCT02165540|Abortion|abortion
5302195|NCT02165514|spinal curvatures|spinal curvatures
5302196|NCT02165488|ketamine|ketamine
5302197|NCT02165488|abuse|abuse
5302198|NCT02165488|abdominal discomfort|abdominal discomfort
5302199|NCT02165488|cholangiopathy|cholangiopathy
5302200|NCT02165462|Haemophilia|haemophilia
5302201|NCT02165462|Arthropathy|arthropathy
5302202|NCT02165462|Bilateral deficit phenomenon|bilateral deficit phenomenon
5302203|NCT02165462|Proprioception|proprioception
5302204|NCT02165449|ketamine|ketamine
5302205|NCT02165449|major depression|major depression
5302206|NCT02165449|imaging|imaging
5302207|NCT02165449|gene expression|gene expression
5302208|NCT02165423|pediatric|pediatric
5302209|NCT02165423|solid organ transplant|solid organ transplant
5302210|NCT02165423|parents|parents
5302211|NCT02165423|heart|heart
5302212|NCT02165423|kidney|kidney
5302213|NCT02165423|liver|liver
5302214|NCT02165410|Autism, mental retardation, Magnetic Resonance Imaging|autism, mental retardation, magnetic resonance imaging
5302227|NCT02165384|tympanostomy|tympanostomy
5302228|NCT02165384|myringotomy|myringotomy
5302229|NCT02165384|otitis media|otitis media
5302230|NCT02165384|ear tubes|ear tubes
5302231|NCT02165384|ear infection|ear infection
5302232|NCT02165358|BMD|bmd
5302233|NCT02165358|LGMD2I|lgmd2i
5302234|NCT02165358|Calf enlargement|calf enlargement
5302235|NCT02165358|Muscular dystrophy|muscular dystrophy
5302236|NCT02165358|MRI|mri
5302237|NCT02165306|epilepsy|epilepsy
5302238|NCT02165280|Pelvic Organ Prolapse|pelvic organ prolapse
5302239|NCT02165280|Surgery|surgery
5302240|NCT02165254|physical activity|physical activity
5302241|NCT02165254|coronary heart disease|coronary heart disease
5302242|NCT02165254|exercise|exercise
5302243|NCT02165254|affect|affect
5302244|NCT02165254|mind/body therapies|mind/body therapies
5302245|NCT02165254|stress, psychological|stress, psychological
5302246|NCT02165241|Hypertension|hypertension
5302247|NCT02165241|Cardiac remodeling|cardiac remodeling
5302248|NCT02165241|Immune system|immune system
5302249|NCT02165202|HIV Pre-exposure Prophylaxis;|hiv pre-exposure prophylaxis;
5302250|NCT02165202|long-acting injectable;|long-acting injectable;
5302251|NCT02165202|HIV PrEP;|hiv prep;
5302265|NCT02165150|Depression|depression
5302280|NCT02165111|Scleroderma, Systemic|scleroderma, systemic
5302281|NCT02165111|Raynaud Disease|raynaud disease
5302282|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a
5302283|NCT02165085|Biomarkers|biomarkers
5298972|NCT02183896|Hip|hip
5302295|NCT02165020|Prostate|prostate
5302296|NCT02165020|Hypofractionated radiotherapy|hypofractionated radiotherapy
5302297|NCT02165020|Hyaluronic acid|hyaluronic acid
5302298|NCT02165020|Spacer|spacer
5302299|NCT02165020|Rectum toxicity|rectum toxicity
5302300|NCT02165020|Rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk Prostate Cancer|rectal toxicities after hypofractionated irradiation and injection of hyaluronic acid in patients with low- to intermediate-risk prostate cancer
5963052|NCT04275869|internet|internet
5183627|NCT02842788|ICU|icu
5302301|NCT02164994|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
5302302|NCT02164968|Device investigation|device investigation
5302303|NCT02164955|Pomalidomide|pomalidomide
5302304|NCT02164955|Multiple Myeloma|multiple myeloma
5302305|NCT02164955|Relapsed, Refractory|relapsed, refractory
5302306|NCT02164955|Observational|observational
5302307|NCT02164955|Imnovid|imnovid
5302308|NCT02164955|Registry|registry
5302309|NCT02164955|Post-approval|post-approval
5302310|NCT02164955|Safety|safety
5302311|NCT02164929|TAP block|tap block
5302312|NCT02164929|Paravertebral block|paravertebral block
5302313|NCT02164929|Epidural|epidural
5302314|NCT02164929|Laparoscopic colectomy|laparoscopic colectomy
5302315|NCT02164916|BRAF Mutant|braf mutant
5302316|NCT02164916|Metastatic|metastatic
5302317|NCT02164903|Quality of Life|quality of life
5302318|NCT02164903|Chronic Myeloid Leukemia|chronic myeloid leukemia
5302319|NCT02164903|Imatinib|imatinib
5302320|NCT02164903|Dasatinib|dasatinib
5302321|NCT02164877|Dietary fiber|dietary fiber
5302322|NCT02164851|shock, emergencies, inflammation, infection|shock, emergencies, inflammation, infection
5302323|NCT02164851|pathologic process|pathologic process
5302324|NCT02164799|Shock|shock
5302325|NCT02164799|Predicting diagnosis|predicting diagnosis
5302326|NCT02164799|Predicting adverse outcomes|predicting adverse outcomes
5302327|NCT02164786|Acute severe disease|acute severe disease
5302328|NCT02164786|Intensive care unit|intensive care unit
5302329|NCT02164786|adult|adult
5302330|NCT02164786|cohort study|cohort study
5302331|NCT02164786|metabolomics|metabolomics
5302333|NCT02164786|High Performance Liquid Chromatography|high performance liquid chromatography
5302334|NCT02164773|sevoflurane|sevoflurane
5302335|NCT02164773|pediatric|pediatric
5302336|NCT02164773|lower abdominal surgery|lower abdominal surgery
5302337|NCT02164773|caudal|caudal
5302338|NCT02164773|magnesium sulfate|magnesium sulfate
5302339|NCT02164773|Magnesium Sulfate Causing Adverse Effects in Therapeutic Use|magnesium sulfate causing adverse effects in therapeutic use
5302340|NCT02164773|Agitation States as Acute Reaction to Exceptional Stress|agitation states as acute reaction to exceptional stress
5302347|NCT02164734|surfactant|surfactant
5302348|NCT02164721|Heart failure|heart failure
5302349|NCT02164721|Chemotherapy-induced cardiomyopathy|chemotherapy-induced cardiomyopathy
5302350|NCT02164721|Cardiac resynchronization therapy|cardiac resynchronization therapy
5302351|NCT02164708|mindfulness meditation, mental health, self-criticism|mindfulness meditation, mental health, self-criticism
5306936|NCT02143817|obesity|obesity
5302352|NCT02164695|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5302354|NCT02164695|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5302355|NCT02164695|Cardiac magnetic resonance|cardiac magnetic resonance
5302356|NCT02164682|Hypospadias repair|hypospadias repair
5302357|NCT02164682|Caudal block|caudal block
5302358|NCT02164682|Postoperative complications|postoperative complications
5302359|NCT02164669|Inflammation|inflammation
5302360|NCT02164669|Coronary artery bypass graft|coronary artery bypass graft
5302361|NCT02164669|Magnetic Resonance Imaging|magnetic resonance imaging
5302362|NCT02164643|Alzheimer's disease|alzheimer's disease
5302363|NCT02164643|Mild Cognitive Impairment|mild cognitive impairment
5302364|NCT02164630|Temporomandibular Joint Disorder|temporomandibular joint disorder
5302367|NCT02164630|Resilience|resilience
5302368|NCT02164630|Cognitive Behavior Therapy|cognitive behavior therapy
5302369|NCT02164617|Dementia|dementia
5302370|NCT02164617|Wheelchair-bound seniors|wheelchair-bound seniors
5299075|NCT02182687|Bridge to transplant|bridge to transplant
5302371|NCT02164617|Long-term care facilities|long-term care facilities
5302372|NCT02164617|Elastic band exercise|elastic band exercise
5289432|NCT02226445|Adults|adults
5302373|NCT02164617|Functional fitness|functional fitness
5302374|NCT02164617|Daily life function|daily life function
5302375|NCT02164617|Depression|depression
5302376|NCT02164617|Problem behaviors|problem behaviors
5302377|NCT02164604|ranibizumab|ranibizumab
5302378|NCT02164604|intravitreal therapy|intravitreal therapy
5302380|NCT02164604|Plus disease|plus disease
5302381|NCT02164604|stage 3 plus|stage 3 plus
5302382|NCT02164591|gastroparesis|gastroparesis
5302383|NCT02164591|gastric electrical stimulator|gastric electrical stimulator
5302384|NCT02164591|GES|ges
5302385|NCT02164591|vomiting|vomiting
5302386|NCT02164591|nausea|nausea
5197603|NCT02759588|cancer|cancer
5302387|NCT02164591|bloating|bloating
5302388|NCT02164591|postprandial fullness|postprandial fullness
5302389|NCT02164591|epigastric pain|epigastric pain
5302390|NCT02164552|PCOS|pcos
5302391|NCT02164552|vitamin D|vitamin d
5302392|NCT02164552|insulin resistance|insulin resistance
5302393|NCT02164552|glycemic control|glycemic control
5302394|NCT02164539|GSK573719|gsk573719
5302395|NCT02164539|asthma|asthma
5302396|NCT02164539|UMEC|umec
5302397|NCT02164539|FF|ff
5302398|NCT02164539|GSK2829332|gsk2829332
5302399|NCT02164539|persistent obstruction|persistent obstruction
5302400|NCT02164539|GW685698|gw685698
5302401|NCT02164539|Fluticasone Furoate|fluticasone furoate
5963053|NCT04275726|LANDMARK Trial|landmark trial
5302402|NCT02164539|COPD|copd
5302403|NCT02164539|umeclidinium bromide|umeclidinium bromide
5302404|NCT02164526|Pulmonary Hypertension|pulmonary hypertension
5302405|NCT02164526|Left Heart Disease|left heart disease
5302406|NCT02164526|Heart failure|heart failure
5302407|NCT02164526|Registry|registry
5302408|NCT02164526|China|china
5302409|NCT02164513|COPD|copd
5302410|NCT02164513|umeclidinium|umeclidinium
5302411|NCT02164513|fluticasone furoate|fluticasone furoate
5302412|NCT02164513|vilanterol|vilanterol
5302413|NCT02164513|triple therapy|triple therapy
5302414|NCT02164513|exacerbation|exacerbation
5302415|NCT02164487|B1 adolescents Eating disorders Thaimine|b1 adolescents eating disorders thaimine
5302416|NCT02164461|Adenocarcinoma|adenocarcinoma
5302417|NCT02164461|Carcinoma|carcinoma
5302418|NCT02164461|Carcinoma, Squamous Cell|carcinoma, squamous cell
5302419|NCT02164461|Uterine Cervical Neoplasms|uterine cervical neoplasms
5302420|NCT02164461|Small Cell Lung Carcinoma|small cell lung carcinoma
5302421|NCT02164461|Carcinoma, Small Cell|carcinoma, small cell
5302422|NCT02164461|Carcinoma, Adenosquamous|carcinoma, adenosquamous
5302423|NCT02164461|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5302424|NCT02164461|Neoplasms by Histologic Type|neoplasms by histologic type
5302425|NCT02164461|Neoplasms|neoplasms
5302426|NCT02164461|Neoplasms, Squamous Cell|neoplasms, squamous cell
5302427|NCT02164461|Uterine Neoplasms|uterine neoplasms
5302428|NCT02164461|Genital Neoplasms, Female|genital neoplasms, female
5302429|NCT02164461|Urogenital Neoplasms|urogenital neoplasms
5302430|NCT02164461|Neoplasms by Site|neoplasms by site
5302431|NCT02164461|Uterine Cervical Diseases|uterine cervical diseases
5302432|NCT02164461|Uterine Diseases|uterine diseases
5302433|NCT02164461|Genital Diseases, Female|genital diseases, female
5302434|NCT02164448|dexmedetomidine|dexmedetomidine
5302435|NCT02164448|postoperative bowel movement|postoperative bowel movement
5302436|NCT02164448|laparoscopic gastrectomy|laparoscopic gastrectomy
5302437|NCT02164435|Uncontrolled hypertension|uncontrolled hypertension
5302438|NCT02164435|Renal denervation|renal denervation
5302439|NCT02164435|Renal artery|renal artery
5302440|NCT02164422|Alcohol|alcohol
5302441|NCT02164422|Drinkers|drinkers
5302442|NCT02164422|Guanfacine|guanfacine
5302443|NCT02164383|Smoking Cessation|smoking cessation
5302444|NCT02164383|Smoking|smoking
5302445|NCT02164383|Nicotine|nicotine
5302446|NCT02164357|Ischaemic Stroke|ischaemic stroke
5302447|NCT02164357|Main artery occlusion|main artery occlusion
5302448|NCT02164357|Endovascular treatment|endovascular treatment
5302449|NCT02164357|Intravenous Thrombolytic Therapy|intravenous thrombolytic therapy
5302451|NCT02164344|Gut|gut
5302452|NCT02164344|probiotics|probiotics
5302453|NCT02164344|immune activation|immune activation
5302454|NCT02164305|Rotator cuff muscle|rotator cuff muscle
5302455|NCT02164305|Excitability|excitability
5302456|NCT02164305|Proprioception|proprioception
5302457|NCT02164305|Kinematics|kinematics
5302458|NCT02164305|Muscle activity|muscle activity
5302459|NCT02164305|Electromyography|electromyography
5302460|NCT02164292|Liver tumor|liver tumor
5302461|NCT02164292|ALPPS|alpps
5302462|NCT02164292|Two-stage hepatectomy|two-stage hepatectomy
5302463|NCT02164292|Morbidity|morbidity
5302464|NCT02164292|Hypertrophy|hypertrophy
5302465|NCT02164279|Microalbuminuria|microalbuminuria
5302466|NCT02164279|diabetic nephropathy|diabetic nephropathy
5302467|NCT02164279|type I diabetes|type i diabetes
5302778|NCT02162914|Placebo|placebo
5302468|NCT02164279|early predictive urinary biomarkers|early predictive urinary biomarkers
5302469|NCT02164240|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5302470|NCT02164227|anxiety|anxiety
5302471|NCT02164227|breathing exercise|breathing exercise
5302472|NCT02164227|labour|labour
5302473|NCT02164201|Type A Aortic Dissection (where the use of BioFoam is limited to the anastomotic site)|type a aortic dissection (where the use of biofoam is limited to the anastomotic site)
5302474|NCT02164188|Stress|stress
5302475|NCT02164188|Well-being|well-being
5302476|NCT02164188|Functional magnetic resonance imaging|functional magnetic resonance imaging
5302477|NCT02164188|Positive psychology|positive psychology
5302478|NCT02164175|HeRO Graft|hero graft
5302479|NCT02164162|Parkinson's disease, Lokomat, gait training, rehabilitation.|parkinson's disease, lokomat, gait training, rehabilitation.
5302480|NCT02164149|Colon cancer|colon cancer
5302481|NCT02164149|Quality of surgery|quality of surgery
5445395|NCT01522001|Rehabilitation|rehabilitation
5302482|NCT02164149|Length of tumour feeding artery|length of tumour feeding artery
5302483|NCT02164123|Autonomic effects|autonomic effects
5302484|NCT02164123|spinal mobilization|spinal mobilization
5302485|NCT02164123|clinical trial|clinical trial
5302486|NCT02164097|ICE|ice
5302487|NCT02164097|ODSH|odsh
5302488|NCT02164097|platelet recovery|platelet recovery
5302489|NCT02164097|recurrent solid tumor|recurrent solid tumor
5302490|NCT02164084|acne|acne
5302491|NCT02164071|Haematological malignancy|haematological malignancy
5302492|NCT02164071|Elderly|elderly
5302493|NCT02164071|Health Status|health status
5302494|NCT02164071|Scale validation|scale validation
5302495|NCT02164058|Myocardial infarction|myocardial infarction
5302496|NCT02164058|STEMI|stemi
5302497|NCT02164058|ST elevation MI|st elevation mi
5302498|NCT02164058|Acute MI|acute mi
5302499|NCT02164019|Pathologic Fractures|pathologic fractures
5302500|NCT02164019|hip replacements|hip replacements
5302501|NCT02164019|12-287|12-287
5302502|NCT02164006|Hodgkin's|hodgkin's
5302503|NCT02163980|dexmedetomidine|dexmedetomidine
5302504|NCT02163980|caudal block|caudal block
5302505|NCT02163980|children|children
5302506|NCT02163980|children (1-6 years) undergoing ambulatory orchipexy|children (1-6 years) undergoing ambulatory orchipexy
5302507|NCT02163967|cranial electrical stimulation|cranial electrical stimulation
5302508|NCT02163967|CES|ces
5302509|NCT02163967|heart rate variability|heart rate variability
5302510|NCT02163967|parasympathetic|parasympathetic
5302511|NCT02163967|Vagal|vagal
5302512|NCT02163954|platelet|platelet
5302513|NCT02163954|ticagrelor|ticagrelor
5302514|NCT02163954|clopidogrel|clopidogrel
5302515|NCT02163954|end stage renal disease|end stage renal disease
5302516|NCT02163954|hemodialysis|hemodialysis
5302517|NCT02163941|PTSD|ptsd
5302518|NCT02163941|empathy|empathy
5302519|NCT02163941|meditation|meditation
5302520|NCT02163941|compassion|compassion
5302521|NCT02163941|inflammation|inflammation
5302522|NCT02163941|oxytocin|oxytocin
5302523|NCT02163941|fMRI|fmri
5302524|NCT02163928|Antioxidants|antioxidants
5302525|NCT02163928|Carotenoids|carotenoids
5302526|NCT02163928|Diet|diet
5302527|NCT02163915|Drug therapy|drug therapy
5302528|NCT02163889|Candida|candida
5302529|NCT02163889|Blood culture|blood culture
5302530|NCT02163889|Antifungal therapy|antifungal therapy
5302531|NCT02163889|Sepsis|sepsis
5302532|NCT02163876|spine|spine
5302533|NCT02163876|injury|injury
5302534|NCT02163876|trauma|trauma
5302535|NCT02163876|spine injury|spine injury
5302536|NCT02163876|cervical spine injury|cervical spine injury
5302537|NCT02163876|cervical spine|cervical spine
5302538|NCT02163876|stemcells transplantation|stemcells transplantation
5302539|NCT02163863|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
5302540|NCT02163863|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
5302541|NCT02163863|Biomimetic stent|biomimetic stent
5302542|NCT02163863|Helical centerline|helical centerline
5302543|NCT02163837|sleep quality|sleep quality
5302544|NCT02163837|physical activity|physical activity
5302545|NCT02163837|daytime sleepiness|daytime sleepiness
5302546|NCT02163837|actigraphy|actigraphy
5302547|NCT02163837|quality of life|quality of life
5302548|NCT02163824|postsurgical|postsurgical
5302549|NCT02163824|postoperative|postoperative
5302550|NCT02163824|ocular|ocular
5302551|NCT02163824|cataract|cataract
5302552|NCT02163824|inflammation|inflammation
5302553|NCT02163824|pain|pain
5302554|NCT02163824|corticosteroid|corticosteroid
5302555|NCT02163811|Self-management|self-management
5302556|NCT02163811|Functional status|functional status
5302557|NCT02163811|Depression|depression
5302558|NCT02163798|Tai Chi|tai chi
5302559|NCT02163798|Walking|walking
5302560|NCT02163798|Physical activity|physical activity
5302561|NCT02163798|Randomized controlled trial|randomized controlled trial
5302562|NCT02163798|Chinese population|chinese population
5302563|NCT02163798|Exercise|exercise
5302564|NCT02163798|Body composition|body composition
5302565|NCT02163798|Cardiovascular risk factor|cardiovascular risk factor
5302566|NCT02163798|Energy expenditure|energy expenditure
5302567|NCT02163798|Fitness|fitness
5302568|NCT02163798|SF-12|sf-12
5302569|NCT02163785|Inferior rectal cancer|inferior rectal cancer
5302570|NCT02163785|Abdominoperineal resection|abdominoperineal resection
5302571|NCT02163785|Miles operation|miles operation
5302572|NCT02163785|Supine Miles operation|supine miles operation
5302573|NCT02163785|Prone Miles operation|prone miles operation
5302574|NCT02163785|Total mesorectal excision|total mesorectal excision
5302575|NCT02163785|Circumferential radial margin|circumferential radial margin
5302576|NCT02163746|Hidradenitis suppurativa|hidradenitis suppurativa
5302577|NCT02163733|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, EGFR sensitivity mutation, food effect|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, egfr sensitivity mutation, food effect
5302578|NCT02163720|ovarian cancer|ovarian cancer
5302579|NCT02163720|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
5302580|NCT02163720|relapse|relapse
5302581|NCT02163720|platinum-sensitive|platinum-sensitive
5302582|NCT02163720|Yondelis®-Caelyx®|yondelis®-caelyx®
5302583|NCT02163707|Psilocybin|psilocybin
5302584|NCT02163707|Pharmacokinetics|pharmacokinetics
5302585|NCT02163694|PARP Inhibitor|parp inhibitor
5302586|NCT02163694|Veliparib|veliparib
5302587|NCT02163694|BRCA1|brca1
5302588|NCT02163694|BRCA2|brca2
5302589|NCT02163694|HER2-negative|her2-negative
5302590|NCT02163694|Locally recurrent|locally recurrent
5302591|NCT02163694|Breast Cancer|breast cancer
5302592|NCT02163694|Metastatic Breast Cancer|metastatic breast cancer
5302593|NCT02163694|ABT-888|abt-888
5302594|NCT02163694|Genetic breast cancer|genetic breast cancer
5302595|NCT02163694|Paclitaxel|paclitaxel
5302596|NCT02163694|BRCA Mutation|brca mutation
5171801|NCT02918734|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
5302597|NCT02163694|PARP|parp
5302598|NCT02163694|Carboplatin|carboplatin
5302599|NCT02163694|BROCADE3|brocade3
5302600|NCT02163668|Yoga|yoga
5302601|NCT02163668|Bone turnover markers|bone turnover markers
5302602|NCT02163668|Bone strength|bone strength
5302603|NCT02163668|Bone mineral density|bone mineral density
5302604|NCT02163655|preeclampsia, very high blood pressure, diuretics|preeclampsia, very high blood pressure, diuretics
5302605|NCT02163642|Bronchiectasis|bronchiectasis
5302606|NCT02163642|Immunity|immunity
5302607|NCT02163629|Psychotherapeutic intervention|psychotherapeutic intervention
5302608|NCT02163629|stress management|stress management
5302609|NCT02163629|cardiac transplantation|cardiac transplantation
5302610|NCT02163629|quality of life|quality of life
5302611|NCT02163616|Primary postpartum hemorrhage|primary postpartum hemorrhage
5302612|NCT02163616|PPH|pph
5302613|NCT02163616|uterine atony|uterine atony
5302614|NCT02163616|high fever|high fever
5302615|NCT02163616|hyperpyrexia|hyperpyrexia
5302616|NCT02163616|shock index|shock index
5302617|NCT02163590|Spinal mobilisation|spinal mobilisation
5302618|NCT02163590|Pressure pain threshold|pressure pain threshold
5302619|NCT02163590|Thoracic spine|thoracic spine
5302620|NCT02163577|X-linked hypophosphatemia|x-linked hypophosphatemia
5302621|NCT02163577|XLH|xlh
5302622|NCT02163577|FGF23|fgf23
5302623|NCT02163577|KRN23|krn23
5302624|NCT02163564|Adolescent|adolescent
5302625|NCT02163564|Depression|depression
5302626|NCT02163564|Insomnia|insomnia
5302627|NCT02163551|dyspnea|dyspnea
5302628|NCT02163551|respiratory sensation|respiratory sensation
5302629|NCT02163551|event-related potentials|event-related potentials
5302630|NCT02163551|spinal cord injury|spinal cord injury
5302631|NCT02163538|energy device|energy device
5302632|NCT02163538|laparoscopic|laparoscopic
5302633|NCT02163538|hysterectomy|hysterectomy
5302634|NCT02163538|enseal|enseal
5302635|NCT02163538|ligasure|ligasure
5302636|NCT02163538|raw tlx|raw tlx
5302637|NCT02163525|Fibroids|fibroids
5302638|NCT02163525|Myomas|myomas
5302639|NCT02163525|leiomyomata|leiomyomata
5302640|NCT02163525|menorrhagia|menorrhagia
5302641|NCT02163525|Acessa Procedure|acessa procedure
5302642|NCT02163525|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
5302643|NCT02163525|GFA|gfa
5302644|NCT02163525|Acessa|acessa
5302645|NCT02163512|Hepatic cirrhosis|hepatic cirrhosis
5302646|NCT02163512|Ascites|ascites
5302647|NCT02163512|Beta blockers treatment|beta blockers treatment
5302648|NCT02163486|I-gel|i-gel
5302649|NCT02163486|oropharyngeal leak pressure|oropharyngeal leak pressure
5302650|NCT02163486|head position|head position
5302651|NCT02163460|ventral hernia|ventral hernia
5302652|NCT02163460|seroma|seroma
5302654|NCT02163460|infection|infection
5302655|NCT02163447|Chemoprevention|chemoprevention
5302656|NCT02163447|Malaria|malaria
5302657|NCT02163447|Uganda|uganda
5302658|NCT02163447|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5302659|NCT02163447|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5302660|NCT02163434|pregnancy|pregnancy
5302661|NCT02163434|nausea|nausea
5302662|NCT02163434|vomiting|vomiting
5302663|NCT02163434|hyperemesis|hyperemesis
5302664|NCT02163434|treatment|treatment
5302665|NCT02163434|gabapentin|gabapentin
5302666|NCT02163434|metoclopramide|metoclopramide
5302667|NCT02163434|safety|safety
5302668|NCT02163421|Drug therapy|drug therapy
5302669|NCT02163408|MRI|mri
5302670|NCT02163408|Plaque Characterization|plaque characterization
5302671|NCT02163395|Ceramic implant|ceramic implant
5302672|NCT02163382|Nava|nava
5302675|NCT02163356|recurrent|recurrent
5302676|NCT02163356|resistant|resistant
5302677|NCT02163343|Serum metal ion levels|serum metal ion levels
5302678|NCT02163343|Cathcart/Corail hemiarthroplasty|cathcart/corail hemiarthroplasty
5302679|NCT02163343|Hip replacement|hip replacement
5302684|NCT02163278|DBPR108|dbpr108
5302685|NCT02163278|DPP4|dpp4
5302686|NCT02163278|Diabetes|diabetes
5302687|NCT02163278|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5302688|NCT02163278|Incretins|incretins
5302689|NCT02163239|FloShield|floshield
5302690|NCT02163239|MID|mid
5302691|NCT02163239|Minimally invasive surgery|minimally invasive surgery
5302692|NCT02163239|Minimally Invasive devices|minimally invasive devices
5445396|NCT01522001|Community|community
5302693|NCT02163239|Robot-assisted Laparoscopic Surgery|robot-assisted laparoscopic surgery
5302694|NCT02163239|Single-site Laparoscopic Surgery|single-site laparoscopic surgery
5302695|NCT02163239|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
5302696|NCT02163239|Cannula|cannula
5302697|NCT02163239|Blunt Obturator|blunt obturator
5302698|NCT02163239|Cholecystectomy|cholecystectomy
5302699|NCT02163239|Benign hysterectomy|benign hysterectomy
5302700|NCT02163239|Salpingo-oophorectomy|salpingo-oophorectomy
5302701|NCT02163226|Bone metastases|bone metastases
5302702|NCT02163226|Hypofractionated Radiation Therapy|hypofractionated radiation therapy
5302703|NCT02163226|Standard Radiation Therapy|standard radiation therapy
5302704|NCT02163226|XRT|xrt
5963054|NCT04275726|Trial to evaluate safety & effectiveness of Myval THV|trial to evaluate safety & effectiveness of myval thv
5171898|NCT02918097|Depressive episodes|depressive episodes
5171899|NCT02918097|Quality of Life|quality of life
5302705|NCT02163226|Pain control|pain control
5302706|NCT02163226|Palliation of symptoms|palliation of symptoms
5302707|NCT02163226|Questionnaire|questionnaire
5302708|NCT02163226|Survey|survey
5302709|NCT02163213|diarrhea|diarrhea
5302710|NCT02163213|irritable bowel syndrome|irritable bowel syndrome
5302711|NCT02163200|Bedsores|bedsores
5302712|NCT02163200|pressure|pressure
5302713|NCT02163200|hip|hip
5302714|NCT02163187|Neuromodulation (SNM)|neuromodulation (snm)
5302715|NCT02163187|sphincter preservation|sphincter preservation
5302716|NCT02163187|rectal polyp|rectal polyp
5302717|NCT02163187|InterStimTM|interstimtm
5302718|NCT02163187|14-100|14-100
5302719|NCT02163174|neonatal|neonatal
5302720|NCT02163174|pentoxifylline|pentoxifylline
5302721|NCT02163174|randomized controlled trial|randomized controlled trial
5302722|NCT02163161|Phase I|phase i
5302723|NCT02163161|Open Label|open label
5302724|NCT02163161|Single dose|single dose
5302725|NCT02163161|Crossover|crossover
5302726|NCT02163161|Bioavailability|bioavailability
5302727|NCT02163161|Fasting|fasting
5302728|NCT02163161|Fed|fed
5302729|NCT02163161|PF-04965842|pf-04965842
5302730|NCT02163161|Healthy|healthy
5302731|NCT02163122|Cat Allergy|cat allergy
5302732|NCT02163122|Feld1|feld1
5302733|NCT02163109|Oxygen consumption|oxygen consumption
5302734|NCT02163109|Pulmonary gas exchange|pulmonary gas exchange
5302735|NCT02163109|Cardiac output|cardiac output
5302736|NCT02163070|whey protein|whey protein
5302737|NCT02163070|malnutrition|malnutrition
5302738|NCT02163070|oxidative stress|oxidative stress
5302739|NCT02163070|hemodialysis|hemodialysis
5302740|NCT02163057|Head and neck squamous cell cancer|head and neck squamous cell cancer
5302741|NCT02163057|Papillomavirus|papillomavirus
5302742|NCT02163031|heart transplant|heart transplant
5302743|NCT02163031|radial approach|radial approach
5302744|NCT02163031|catheterization|catheterization
5302745|NCT02163005|GDL contrast agent|gdl contrast agent
5302746|NCT02162992|Antibodies, Antinuclear|antibodies, antinuclear
5302747|NCT02162992|SS-A antigen|ss-a antigen
5302748|NCT02162992|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5302749|NCT02162992|Atrioventricular Block|atrioventricular block
5302750|NCT02162992|Sudden death|sudden death
5302751|NCT02162979|Parkinson's disease|parkinson's disease
5302752|NCT02162979|PD|pd
5302753|NCT02162979|dyskinesia|dyskinesia
5302754|NCT02162979|treatment|treatment
5302755|NCT02162979|motor complications|motor complications
5302756|NCT02162966|colistin|colistin
5302757|NCT02162966|ICU|icu
5302758|NCT02162966|critical care|critical care
5302762|NCT02162940|low back pain|low back pain
5302763|NCT02162940|epidural steroid injection|epidural steroid injection
5302764|NCT02162940|statin|statin
5302765|NCT02162940|quality of life|quality of life
5302766|NCT02162927|muscular strength|muscular strength
5302767|NCT02162927|muscular endurance|muscular endurance
5302768|NCT02162927|muscular power|muscular power
5302769|NCT02162927|rowing|rowing
5302770|NCT02162927|CrossFit|crossfit
5302771|NCT02162927|dietary nitrate|dietary nitrate
5302772|NCT02162914|Intra-hepatic|intra-hepatic
5302773|NCT02162914|Hilar|hilar
5302774|NCT02162914|Locally Advanced|locally advanced
5302775|NCT02162914|Non Resectable|non resectable
5302776|NCT02162914|Metastatic|metastatic
5302777|NCT02162914|Regorafenib|regorafenib
5302779|NCT02162901|Diabetes prevention|diabetes prevention
5302780|NCT02162875|Schistosoma mansoni|schistosoma mansoni
5302781|NCT02162875|treatment|treatment
5302782|NCT02162875|school children|school children
5302784|NCT02162862|Inflammatory Bowel Disease|inflammatory bowel disease
5302785|NCT02162862|Physical Illness|physical illness
5302786|NCT02162862|Wellbutrin|wellbutrin
5302793|NCT02162849|Nicotine patch|nicotine patch
5302794|NCT02162849|Placebo patch|placebo patch
5302795|NCT02162849|Placebo pill|placebo pill
5302796|NCT02162849|Sugar pill|sugar pill
5302797|NCT02162849|Varenicline|varenicline
5302798|NCT02162849|Chantix|chantix
5302799|NCT02162849|Questionnaires|questionnaires
5302800|NCT02162849|Surveys|surveys
5302801|NCT02162849|Saliva test|saliva test
5302802|NCT02162836|Prostatic Neoplasms, Castration-Resistant|prostatic neoplasms, castration-resistant
5445397|NCT01522001|Cardiac Rehabilitation|cardiac rehabilitation
5302803|NCT02162836|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5302804|NCT02162836|Prostate Cancer|prostate cancer
5302805|NCT02162836|Androgen Receptor|androgen receptor
5302806|NCT02162836|JNJ-56021927|jnj-56021927
5302807|NCT02162823|The MeSH name is Carcinoma, Pancreatic Ductal|the mesh name is carcinoma, pancreatic ductal
5302808|NCT02162810|hypospadias|hypospadias
5302810|NCT02162797|AIDS|aids
5302811|NCT02162797|zinc|zinc
5302812|NCT02162797|zinc supplement|zinc supplement
5302813|NCT02162797|immunological deficiency|immunological deficiency
5302814|NCT02162771|Advanced Follicular Lymphoma|advanced follicular lymphoma
5302815|NCT02162758|Drug therapy|drug therapy
5302816|NCT02162745|Bronchiolitis|bronchiolitis
5963055|NCT04275726|CE Approved Myval THV Series|ce approved myval thv series
5963056|NCT04275687|loco-regionally recurrent non-small cell lung cancer|loco-regionally recurrent non-small cell lung cancer
5171994|NCT02917707|CRC|crc
5302817|NCT02162745|Normal saline solution|normal saline solution
5302818|NCT02162745|Hypertonic solution|hypertonic solution
5302819|NCT02162745|Nasal irrigation|nasal irrigation
5302820|NCT02162680|local anesthesia|local anesthesia
5302821|NCT02162680|intravenous catheter|intravenous catheter
5302822|NCT02162654|neuroprotection|neuroprotection
5302823|NCT02162654|ischemic preconditioning|ischemic preconditioning
5302824|NCT02162654|cerebral aneurysm|cerebral aneurysm
5302825|NCT02162628|Pelvic Floor Disorder|pelvic floor disorder
5302826|NCT02162628|Pelvic Organ Prolapse|pelvic organ prolapse
5302827|NCT02162628|Sexual Dysfunction|sexual dysfunction
5302828|NCT02162628|Mesh|mesh
5302830|NCT02162628|Transvaginal|transvaginal
5302831|NCT02162628|Total Repair|total repair
5302832|NCT02162628|Uterine Prolapse|uterine prolapse
5302833|NCT02162628|Cystocele|cystocele
5302834|NCT02162628|Rectocele|rectocele
5302835|NCT02162628|Enterocele|enterocele
5302836|NCT02162628|Vaginal Vault Prolapse|vaginal vault prolapse
5302837|NCT02162628|Native Tissue Repair|native tissue repair
5302838|NCT02162628|Repair Augmented with Mesh|repair augmented with mesh
5302839|NCT02162628|Pathological Conditions, Anatomical|pathological conditions, anatomical
5302840|NCT02162628|Exair Prolapse Repair System|exair prolapse repair system
5302841|NCT02162628|Vaginal Mesh|vaginal mesh
5302842|NCT02162628|Transvaginal Mesh|transvaginal mesh
5302843|NCT02162615|Pelvic Floor Disorder|pelvic floor disorder
5302844|NCT02162615|Pelvic Organ Prolapse|pelvic organ prolapse
5302845|NCT02162615|Sexual Dysfunction|sexual dysfunction
5302846|NCT02162615|Mesh|mesh
5302847|NCT02162615|POP|pop
5302848|NCT02162615|Transvaginal|transvaginal
5302849|NCT02162615|Anterior|anterior
5302850|NCT02162615|Posterior|posterior
5302851|NCT02162615|Apical|apical
5302852|NCT02162615|Uterine Prolapse|uterine prolapse
5302853|NCT02162615|Cystocele|cystocele
5302854|NCT02162615|Rectocele|rectocele
5302855|NCT02162615|Enterocele|enterocele
5302856|NCT02162615|Vaginal Vault Prolapse|vaginal vault prolapse
5302857|NCT02162615|Native Tissue Repair|native tissue repair
5302858|NCT02162615|Repair Augmented with Mesh|repair augmented with mesh
5302859|NCT02162615|Pathological Conditions, Anatomical|pathological conditions, anatomical
5302860|NCT02162615|Restorelle Direct Fix|restorelle direct fix
5302861|NCT02162615|Vaginal Mesh|vaginal mesh
5302862|NCT02162615|Transvaginal Mesh|transvaginal mesh
5302863|NCT02162576|asthma|asthma
5302864|NCT02162576|asthma control|asthma control
5302865|NCT02162576|healthcare utilization costs|healthcare utilization costs
5302866|NCT02162576|community hotspots|community hotspots
5302867|NCT02162576|public health research|public health research
5302868|NCT02162563|Colorectal cancer|colorectal cancer
5302869|NCT02162563|Chemotherapy|chemotherapy
5302870|NCT02162563|Anti-EGFR|anti-egfr
5302871|NCT02162563|Liver metastases|liver metastases
5302872|NCT02162563|R0 R1 liver resection|r0 r1 liver resection
5302873|NCT02162563|Resectability of liver|resectability of liver
5302874|NCT02162563|Liver expert panel|liver expert panel
5302875|NCT02162550|Type 2 Diabetes|type 2 diabetes
5302876|NCT02162550|Cardiovascular Disease|cardiovascular disease
5302877|NCT02162550|Hyperglycemia|hyperglycemia
5302888|NCT02162524|energy balance|energy balance
5302889|NCT02162511|Haplocompatible|haplocompatible
5302890|NCT02162511|Stem cell transplant|stem cell transplant
5302891|NCT02162511|Borderline organ function|borderline organ function
5302892|NCT02162511|Alternative donor stem cell transplant|alternative donor stem cell transplant
5302893|NCT02162498|Peer support|peer support
5302895|NCT02162498|Exclusive breastfeeding|exclusive breastfeeding
5302896|NCT02162498|Early infant diagnosis|early infant diagnosis
5302897|NCT02162498|Stigma and disclosure|stigma and disclosure
5302899|NCT02162459|Adolescent|adolescent
5302900|NCT02162459|supplements|supplements
5302901|NCT02162459|strength|strength
5302902|NCT02162459|whey protein|whey protein
5302903|NCT02162459|bench press strength|bench press strength
5302904|NCT02162459|squat strength|squat strength
5302905|NCT02162420|severe aplastic anemia|severe aplastic anemia
5302906|NCT02162420|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5302907|NCT02162381|Humphrey visual fields|humphrey visual fields
5302908|NCT02162381|methylphenidate|methylphenidate
5302909|NCT02162381|attention deficit disorder|attention deficit disorder
5302910|NCT02162381|MoCa questionnaire|moca questionnaire
5302911|NCT02162368|laryngeal mask, prone position, spine surgery|laryngeal mask, prone position, spine surgery
5302912|NCT02162342|upper extremity|upper extremity
5302913|NCT02162342|muscle activity|muscle activity
5302914|NCT02162342|kinematics|kinematics
5302915|NCT02162342|motion capture|motion capture
5302916|NCT02162342|Electromyography|electromyography
5302917|NCT02162329|Breast Cancer|breast cancer
5302918|NCT02162329|Cognitive function|cognitive function
5302919|NCT02162329|Questionnaires|questionnaires
5302920|NCT02162329|Surveys|surveys
5302921|NCT02162329|Electroencephalography|electroencephalography
5302922|NCT02162329|EEG|eeg
5302923|NCT02162329|Magnetic resonance imaging|magnetic resonance imaging
5302924|NCT02162329|fMRI|fmri
5963057|NCT04275687|thoracic irradiation|thoracic irradiation
5302925|NCT02162329|Tibetan meditation|tibetan meditation
5302926|NCT02162329|Quality of life|quality of life
5302927|NCT02162329|QOL|qol
5302936|NCT02162277|To decrease|to decrease
5302937|NCT02162277|number|number
5302938|NCT02162277|osteoporotic|osteoporotic
5302939|NCT02162277|patients in|patients in
5302940|NCT02162277|Kami-Ina area|kami-ina area
5302941|NCT02162277|Nagano prefecture|nagano prefecture
5302942|NCT02162264|Alzheimer's Disease|alzheimer's disease
5302943|NCT02162264|donepezil hydrochloride|donepezil hydrochloride
5302944|NCT02162251|Alzheimer's Disease|alzheimer's disease
5302945|NCT02162251|donepezil hydrochloride|donepezil hydrochloride
5302947|NCT02162238|diet|diet
5302948|NCT02162238|water|water
5302949|NCT02162238|morbidity|morbidity
5302950|NCT02162238|growth|growth
5302951|NCT02162225|Erythrocyte Deformability|erythrocyte deformability
5302952|NCT02162225|Platelet Activation|platelet activation
5302953|NCT02162225|Platelet Aggregation|platelet aggregation
5302954|NCT02162225|Nitrite|nitrite
5302955|NCT02162225|Sickle Cell Anemia|sickle cell anemia
5302956|NCT02162225|Diet Therapy|diet therapy
5302957|NCT02162199|Antibiotic|antibiotic
5302958|NCT02162199|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
5302959|NCT02162186|Arthroplasty, Replacement, Hip/methods|arthroplasty, replacement, hip/methods
5302960|NCT02162186|Hip Joint/physiopathology|hip joint/physiopathology
5302961|NCT02162186|Hip Joint/radiography|hip joint/radiography
5302962|NCT02162186|Hip Joint/surgery|hip joint/surgery
5302963|NCT02162186|Hip Prosthesis|hip prosthesis
5302964|NCT02162186|Outcome Assessment (Health Care)|outcome assessment (health care)
5302965|NCT02162186|Female|female
5302966|NCT02162186|Male|male
5302967|NCT02162186|Adult|adult
5302968|NCT02162173|Familial adenomatous polyposis syndrome|familial adenomatous polyposis syndrome
5302969|NCT02162173|Non-ampullary polyp|non-ampullary polyp
5302970|NCT02162173|Ampullary polyp|ampullary polyp
5302971|NCT02162173|Narrow band imaging endoscopy|narrow band imaging endoscopy
5302972|NCT02162173|Confocal laser endomicroscopy|confocal laser endomicroscopy
5302973|NCT02162160|probiotic|probiotic
5302974|NCT02162160|post-menopausal|post-menopausal
5302975|NCT02162160|atrophic vaginitis|atrophic vaginitis
5302976|NCT02162147|patient safety|patient safety
5302977|NCT02162147|pediatrics|pediatrics
5302978|NCT02162147|emergency medicine|emergency medicine
5302979|NCT02162134|cholecystectomy|cholecystectomy
5302980|NCT02162134|laparoscopic|laparoscopic
5302981|NCT02162134|postoperative|postoperative
5302982|NCT02162134|ileus|ileus
5302983|NCT02162134|chewing gum|chewing gum
5302989|NCT02162043|Diagnostic self-evaluation|diagnostic self-evaluation
5302991|NCT02162043|Visual fields|visual fields
5302992|NCT02162017|Acute ischemic stroke|acute ischemic stroke
5302993|NCT02162017|Acute intracerebral haemorrhage|acute intracerebral haemorrhage
5302994|NCT02162017|Head position|head position
5302995|NCT02162017|Lying flat head position|lying flat head position
5302996|NCT02162017|Sitting up head position|sitting up head position
5302997|NCT02162017|Death|death
5302998|NCT02162017|Disability|disability
5302999|NCT02162017|Clinical trial|clinical trial
5303000|NCT02162004|Type 1 diabetes|type 1 diabetes
5303001|NCT02162004|Continuous Glucose Monitoring|continuous glucose monitoring
5303002|NCT02162004|Insulin pump|insulin pump
5303003|NCT02162004|Sensor-augmented pump|sensor-augmented pump
5303004|NCT02162004|Continuous correction of high blood glucose|continuous correction of high blood glucose
5303005|NCT02161991|aprepitant|aprepitant
5303006|NCT02161991|non-small cell lung cancer|non-small cell lung cancer
5303009|NCT02161978|vascular|vascular
5303010|NCT02161978|biomarker|biomarker
5303011|NCT02161978|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5303012|NCT02161965|Anticoagulation|anticoagulation
5303013|NCT02161965|Coronary and peripheral calcification|coronary and peripheral calcification
5303014|NCT02161965|Arterial stiffness|arterial stiffness
5303015|NCT02161965|Biomarker|biomarker
5303016|NCT02161952|Fibrosis, necroinflammation, hepatitis C chronic|fibrosis, necroinflammation, hepatitis c chronic
5303017|NCT02161926|Obesity|obesity
5303018|NCT02161926|dietary restrictions|dietary restrictions
5303019|NCT02161926|metabolism|metabolism
5303020|NCT02161926|nutrition|nutrition
5303021|NCT02161926|elderly|elderly
5303022|NCT02161874|edentulism|edentulism
5303023|NCT02161874|dental implants|dental implants
5303024|NCT02161874|clinical study|clinical study
5303025|NCT02161874|endosseous|endosseous
5303026|NCT02161874|randomized|randomized
5303027|NCT02161874|crestal bone level|crestal bone level
5303028|NCT02161874|T3|t3
5303029|NCT02161874|Nanotite Certain|nanotite certain
5303030|NCT02161874|Nanotite Certain Prevail|nanotite certain prevail
5303031|NCT02161874|Tapered|tapered
5303032|NCT02161861|tripeptide FEE|tripeptide fee
5303033|NCT02161861|fertilization rates|fertilization rates
5303034|NCT02161861|embryos|embryos
5303035|NCT02161861|oocytes|oocytes
5303036|NCT02161835|Congenital myotonia|congenital myotonia
5303037|NCT02161835|Myotonia congenita|myotonia congenita
5303038|NCT02161835|Thomsons disease|thomsons disease
5303039|NCT02161835|Becker type|becker type
5303040|NCT02161835|Training|training
5303041|NCT02161835|Exercise|exercise
5303042|NCT02161822|locally advanced rectal cancer, neoadjuvant chemoradiation|locally advanced rectal cancer, neoadjuvant chemoradiation
5303043|NCT02161809|MVPA|mvpa
5303044|NCT02161809|Healthy Eating|healthy eating
5303045|NCT02161809|children|children
5303046|NCT02161809|childhood obesity|childhood obesity
5303047|NCT02161796|Phase 1|phase 1
5303048|NCT02161796|FG-4592|fg-4592
5303049|NCT02161796|Age/gender comparison|age/gender comparison
5303050|NCT02161783|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5303051|NCT02161770|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, AZD9291, solid tumour, mild hepatic impairment, moderate hepatic impairment|oncology, cancer, neoplasm, anticancer drug, pharmacokinetics, area under curve, azd9291, solid tumour, mild hepatic impairment, moderate hepatic impairment
5303052|NCT02161757|Asthma|asthma
5303053|NCT02161757|Reactive Airways|reactive airways
5303054|NCT02161757|Respiratory Tract Disease|respiratory tract disease
5303055|NCT02161757|Obstructive Lung Disease|obstructive lung disease
5303056|NCT02161757|Lung Diseases|lung diseases
5303057|NCT02161744|Adipose derived stem cells|adipose derived stem cells
5303058|NCT02161744|Stromal vascular fraction cells|stromal vascular fraction cells
5303059|NCT02161744|Pulmonary Function Tests|pulmonary function tests
5303060|NCT02161744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5303061|NCT02161718|Alkermes|alkermes
5303062|NCT02161718|Schizophrenia|schizophrenia
5303063|NCT02161718|Alcohol Use Disorder|alcohol use disorder
5303064|NCT02161718|ALKS 3831|alks 3831
5303068|NCT02161679|Antibody drug conjugate|antibody drug conjugate
5303069|NCT02161679|IMMU-132|immu-132
5303070|NCT02161679|Triple-negative breast cancer|triple-negative breast cancer
5303071|NCT02161679|Safety and tolerability|safety and tolerability
5303072|NCT02161679|Progression Free Survival (PFS)|progression free survival (pfs)
5303074|NCT02161666|Gastric Bypass|gastric bypass
5303075|NCT02161666|Bariatric Surgery|bariatric surgery
5303076|NCT02161666|Incretin Function|incretin function
5303077|NCT02161666|Islet Function|islet function
5303078|NCT02161653|Severe alcoholic hepatitis|severe alcoholic hepatitis
5303079|NCT02161653|survival|survival
5303080|NCT02161653|oxidative stress|oxidative stress
5303081|NCT02161627|spinal cord stimulation|spinal cord stimulation
5303082|NCT02161627|automatic control|automatic control
5303083|NCT02161614|hormone replacement therapy|hormone replacement therapy
5303084|NCT02161614|Dopplervelocimetry|dopplervelocimetry
5303085|NCT02161614|Flow-mediated dilation|flow-mediated dilation
5303086|NCT02161614|menopause|menopause
5303087|NCT02161614|Estradiol valerate|estradiol valerate
5303088|NCT02161601|Cricoid pressure|cricoid pressure
5303089|NCT02161601|Rapid Sequence Induction|rapid sequence induction
5303090|NCT02161575|Macular degeneration|macular degeneration
5303091|NCT02161575|age-related macular degeneration (ARMD)|age-related macular degeneration (armd)
5303092|NCT02161575|vision loss|vision loss
5303093|NCT02161575|macula damage|macula damage
5303094|NCT02161575|retina damage|retina damage
5303095|NCT02161575|dry macular degeneration|dry macular degeneration
5303096|NCT02161575|wet macular degeneration|wet macular degeneration
5303097|NCT02161575|AMD|amd
5303098|NCT02161562|chronic spontaneous urticaria, CSU, chronic idiopathic urticaria, CIU, hives, angioedema, itch|chronic spontaneous urticaria, csu, chronic idiopathic urticaria, ciu, hives, angioedema, itch
5356874|NCT01917604|impacted maxillary canine|impacted maxillary canine
5303099|NCT02161523|mast cells, lung cancer, cancer associated fibroblasts (CAF)|mast cells, lung cancer, cancer associated fibroblasts (caf)
5303100|NCT02161497|Medical History Taking|medical history taking
5303101|NCT02161497|Electronic Health Records|electronic health records
5303102|NCT02161497|Pediatrics|pediatrics
5303103|NCT02161497|Parents|parents
5303104|NCT02161484|Peripheral Nerve Block|peripheral nerve block
5303105|NCT02161484|Total Hip Replacement|total hip replacement
5303106|NCT02161471|Atria, Heart|atria, heart
5303107|NCT02161471|Function, Atrial|function, atrial
5303108|NCT02161471|Heart Defects, Congenital|heart defects, congenital
5303109|NCT02161471|Cardiovascular Abnormalities|cardiovascular abnormalities
5303110|NCT02161471|Congenital Abnormalities|congenital abnormalities
5303111|NCT02161471|Tetralogy, Fallot|tetralogy, fallot
5303112|NCT02161471|Transposition of Great Arteries|transposition of great arteries
5303113|NCT02161471|Coarctation of the Aorta|coarctation of the aorta
5281548|NCT02266368|UTI|uti
5303114|NCT02161458|Escitalopram|escitalopram
5303115|NCT02161458|Amyloid Beta|amyloid beta
5303116|NCT02161458|Cerebrospinal Fluid|cerebrospinal fluid
5303117|NCT02161445|impedance|impedance
5303118|NCT02161445|pep|pep
5303119|NCT02161445|tevg|tevg
5303120|NCT02161445|dyspnea|dyspnea
5303121|NCT02161445|AHF|ahf
5303122|NCT02161445|BNP|bnp
5303123|NCT02161419|Small Cell Lung Carcinoma,|small cell lung carcinoma,
5303124|NCT02161419|First line|first line
5303125|NCT02161419|Extensive disease|extensive disease
5303126|NCT02161419|Small cell lung cancer|small cell lung cancer
5303128|NCT02161393|Physical Activity|physical activity
5303129|NCT02161393|Pulmonary Rehabilitation|pulmonary rehabilitation
5303130|NCT02161393|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5303131|NCT02161380|Gene therapy|gene therapy
5303132|NCT02161380|Mitochondrial Genes|mitochondrial genes
5303133|NCT02161380|Leber's|leber's
5303134|NCT02161380|AAV2 Viral vectors|aav2 viral vectors
5303135|NCT02161367|colorectal surgery|colorectal surgery
5303136|NCT02161367|postoperative ileus|postoperative ileus
5303137|NCT02161367|simethicone|simethicone
5303138|NCT02161367|randomized controlled trial|randomized controlled trial
5303139|NCT02161367|double blind|double blind
5303140|NCT02161367|pilot study|pilot study
5303141|NCT02161367|anti-foaming agent|anti-foaming agent
5303142|NCT02161367|abdominal pain|abdominal pain
5303143|NCT02161367|abdominal distention|abdominal distention
5303144|NCT02161367|nausea vomiting|nausea vomiting
5303145|NCT02161367|flatus|flatus
5303146|NCT02161367|bowel movement|bowel movement
5303147|NCT02161367|placebo|placebo
5303148|NCT02161367|postoperative complications|postoperative complications
5303149|NCT02161367|polydimethylsiloxane|polydimethylsiloxane
5303150|NCT02161367|hydrated silica gel|hydrated silica gel
5303151|NCT02161367|gas bubbles|gas bubbles
5303152|NCT02161367|intestinal tract|intestinal tract
5303153|NCT02161354|Dental Pain|dental pain
5303154|NCT02161354|Acute Pain|acute pain
5303155|NCT02161354|Mild Pain|mild pain
5303156|NCT02161354|Moderate Pain|moderate pain
5303157|NCT02161341|Bacterial microbiome|bacterial microbiome
5303158|NCT02161341|Gene expression|gene expression
5303159|NCT02161315|SAID, Progestogens, nSAID-resistanced, LSBC|said, progestogens, nsaid-resistanced, lsbc
5303160|NCT02161302|Endometriosis|endometriosis
5303161|NCT02161302|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5303162|NCT02161302|tDCS|tdcs
5303163|NCT02161302|Near Infrared Spectroscopy|near infrared spectroscopy
5303164|NCT02161302|NIRS|nirs
5303165|NCT02161302|Chronic Pelvic Pain|chronic pelvic pain
5303166|NCT02161289|100 HIV-negagtve MSM|100 hiv-negagtve msm
5303167|NCT02161263|LASIK|lasik
5303168|NCT02161263|Satisfaction|satisfaction
5303169|NCT02161237|Acute rejection|acute rejection
5303170|NCT02161237|Advagraf|advagraf
5303171|NCT02161237|Renal function|renal function
5303172|NCT02161224|Phase 1|phase 1
5303173|NCT02161224|FG-4592|fg-4592
5303174|NCT02161224|Single dose|single dose
5303175|NCT02161224|Moderate hepatic impairment|moderate hepatic impairment
5303176|NCT02161211|alcohol|alcohol
5303177|NCT02161211|anxiety|anxiety
5303178|NCT02161198|Panax ginseng CA|panax ginseng ca
5303179|NCT02161198|ginsan|ginsan
5303180|NCT02161198|polysaccharide|polysaccharide
5303181|NCT02161198|immunity|immunity
5303182|NCT02161198|natural killer cell|natural killer cell
5303183|NCT02161185|Epilepsy|epilepsy
5303184|NCT02161185|seizure cluster|seizure cluster
5303185|NCT02161185|acute repetitive seizures|acute repetitive seizures
5303186|NCT02161185|open-label|open-label
5303187|NCT02161185|intranasal Midazolam|intranasal midazolam
5303188|NCT02161185|USL261|usl261
5303189|NCT02161185|Upsher-Smith|upsher-smith
5303190|NCT02161172|Mild traumatic brain injury|mild traumatic brain injury
5303191|NCT02161172|Cognitive outcome|cognitive outcome
5303192|NCT02161172|Psychological outcome|psychological outcome
5303193|NCT02161133|Veterans|veterans
5303194|NCT02161133|neuropsychology|neuropsychology
5303195|NCT02161133|fatigue|fatigue
5303196|NCT02161133|Chronic Multisymptom Illness|chronic multisymptom illness
5303197|NCT02161133|Gulf War Illness|gulf war illness
5303198|NCT02161133|behavioral treatment|behavioral treatment
5862764|NCT00001522|Body Composition|body composition
5303207|NCT02161081|Coronary artery disease|coronary artery disease
5303208|NCT02161081|Myocardial CT perfusion|myocardial ct perfusion
5303209|NCT02161081|Modified scan protocol|modified scan protocol
5303210|NCT02161081|Diagnostic performance|diagnostic performance
5303212|NCT02161068|ADPKD|adpkd
5303213|NCT02161068|Chart Review|chart review
5303214|NCT02161068|PKD Genotyping|pkd genotyping
5303215|NCT02161055|Insulin|insulin
5303216|NCT02161055|Hyperglycemia|hyperglycemia
5303217|NCT02161055|Postoperative Mortality|postoperative mortality
5303218|NCT02161055|Intensive insulin therapy|intensive insulin therapy
5303219|NCT02161055|Non-intensive insulin therapy|non-intensive insulin therapy
5303220|NCT02161055|Brain Injuries|brain injuries
5303221|NCT02161055|Wounds and Injuries|wounds and injuries
5303222|NCT02161055|Craniocerebral Trauma|craniocerebral trauma
5303223|NCT02161055|Trauma, Nervous System|trauma, nervous system
5303224|NCT02161042|Blood transfusion|blood transfusion
5303225|NCT02161042|Storage Lesion|storage lesion
5303226|NCT02161042|Endothelial dysfunction|endothelial dysfunction
5303227|NCT02161042|Nitric Oxide|nitric oxide
5303228|NCT02161029|Gastric tumor|gastric tumor
5303229|NCT02161003|Fecal Incontinence|fecal incontinence
5303230|NCT02161003|Posterior Sagittal Ano-rectoplasty|posterior sagittal ano-rectoplasty
5303231|NCT02161003|Mesenchymal Stem Cell|mesenchymal stem cell
5303232|NCT02160990|Obesity|obesity
5303233|NCT02160977|Surgical procedures|surgical procedures
5303234|NCT02160977|Minimally invasive|minimally invasive
5303235|NCT02160977|Arthroplasty|arthroplasty
5303236|NCT02160977|Knee|knee
5303237|NCT02160964|Inferior Vena Cava|inferior vena cava
5303238|NCT02160951|Multiple Myeloma,|multiple myeloma,
5303239|NCT02160951|Phase I,|phase i,
5303240|NCT02160951|PIM,|pim,
5303241|NCT02160951|Japanese patients,|japanese patients,
5303242|NCT02160951|LGH447|lgh447
5303243|NCT02160938|microarray|microarray
5303244|NCT02160938|prenatal|prenatal
5303245|NCT02160938|copy number variant|copy number variant
5303247|NCT02160938|microdeletion|microdeletion
5303248|NCT02160938|microduplication|microduplication
5303249|NCT02160938|genetic|genetic
5303250|NCT02160899|High Lipoprotein(a)|high lipoprotein(a)
5303251|NCT02160847|children|children
5303252|NCT02160847|pediatric obesity|pediatric obesity
5303253|NCT02160847|parent training|parent training
5303254|NCT02160847|home-based|home-based
5303255|NCT02160847|nutrition|nutrition
5303256|NCT02160847|physical activity|physical activity
5303257|NCT02160847|parent-child interaction|parent-child interaction
5303258|NCT02160847|parenting|parenting
5303259|NCT02160834|Sedentary behavior|sedentary behavior
5303260|NCT02160834|Physical activity|physical activity
5303261|NCT02160834|Obesity|obesity
5303262|NCT02160834|Mobile health|mobile health
5303263|NCT02160834|Smartphone|smartphone
5303264|NCT02160834|Time spent sedentary|time spent sedentary
5303265|NCT02160821|Transversus Abdominis Plane Block|transversus abdominis plane block
5303266|NCT02160821|Caudal Epidural|caudal epidural
5303267|NCT02160821|Pediatric Pain control|pediatric pain control
5303268|NCT02160821|Pain control for Lower Abdominal Surgery|pain control for lower abdominal surgery
5303269|NCT02160795|Periconceptional|periconceptional
5303270|NCT02160795|Folic Acid|folic acid
5303271|NCT02160795|Leukemia|leukemia
5303272|NCT02160795|Childhood Cancer|childhood cancer
5303288|NCT02160652|nephrostomy tube|nephrostomy tube
5303289|NCT02160639|diabetes self management education|diabetes self management education
5303290|NCT02160639|diabetes self management support|diabetes self management support
5303291|NCT02160639|type 2 diabetes|type 2 diabetes
5303292|NCT02160626|Seborrheic keratosis|seborrheic keratosis
5303293|NCT02160626|A101|a101
5303294|NCT02160613|Osteoprotegerin|osteoprotegerin
5303295|NCT02160613|Biomarker|biomarker
5303296|NCT02160613|Chronic periodontitis|chronic periodontitis
5303297|NCT02160613|Open flap debridement|open flap debridement
5303298|NCT02160561|mechanical|mechanical
5303299|NCT02160561|ventilation|ventilation
5303300|NCT02160561|acute|acute
5303301|NCT02160561|respiratory|respiratory
5303302|NCT02160561|failure|failure
5303303|NCT02160548|Organophosphate, insectiside, Salbutamol, Atropine|organophosphate, insectiside, salbutamol, atropine
5303304|NCT02160535|Mild Traumatic Brain Injury|mild traumatic brain injury
5303306|NCT02160535|Post Concussive Headache|post concussive headache
5303307|NCT02160522|Intubation|intubation
5303308|NCT02160522|cuff|cuff
5303309|NCT02160522|cuffed|cuffed
5303310|NCT02160522|endotracheal|endotracheal
5303311|NCT02160522|tube|tube
5303312|NCT02160522|pressure|pressure
5303313|NCT02160522|pediatric|pediatric
5303314|NCT02160522|child|child
5303315|NCT02160522|children|children
5303316|NCT02160522|emergency|emergency
5303317|NCT02160509|real time, ultrasonography, handheld|real time, ultrasonography, handheld
5303318|NCT02160496|Weight Loss|weight loss
5303319|NCT02160496|Obesity|obesity
5303320|NCT02160496|Overweight|overweight
5303321|NCT02160496|Diet, Reducing|diet, reducing
5303322|NCT02160496|Lipids|lipids
5303323|NCT02160483|Chronic pelvic pain|chronic pelvic pain
5303324|NCT02160483|Endometriosis|endometriosis
5303325|NCT02160457|Cerebral palsy|cerebral palsy
5303326|NCT02160457|Instrumented gait analysis|instrumented gait analysis
5303327|NCT02160457|Gait Deviation Index|gait deviation index
5303328|NCT02160444|CBT|cbt
5303329|NCT02160444|Parent Training|parent training
5303330|NCT02160444|Anxiety Disorders in Children|anxiety disorders in children
5303331|NCT02160431|Children|children
5303332|NCT02160431|OCD|ocd
5303333|NCT02160431|CBT|cbt
5445398|NCT01522001|Hospital|hospital
5303334|NCT02160431|Neuropsychological profiles|neuropsychological profiles
5303335|NCT02160405|Iron levels|iron levels
5303336|NCT02160392|HIV|hiv
5303337|NCT02160392|female|female
5303338|NCT02160392|genital tract|genital tract
5303339|NCT02160379|roux-en-Y-gastric bypass|roux-en-y-gastric bypass
5303340|NCT02160379|brain responses to food|brain responses to food
5303341|NCT02160379|gastrointestinal hormones|gastrointestinal hormones
5303342|NCT02160379|bile acids|bile acids
5303343|NCT02160366|Advanced Cancers|advanced cancers
5303344|NCT02160366|Molecular profiling|molecular profiling
5303345|NCT02160366|Biomarker data|biomarker data
5303346|NCT02160366|Data analysis|data analysis
5303347|NCT02160366|Tumor marker|tumor marker
5303348|NCT02160340|Posterior Vitreous Detachment|posterior vitreous detachment
5303349|NCT02160340|Vitreomacular Traction|vitreomacular traction
5303350|NCT02160340|Vitreous|vitreous
5303351|NCT02160314|stress urinary incontinence, SUI, pessary|stress urinary incontinence, sui, pessary
5303352|NCT02160301|pain|pain
5303353|NCT02160301|postoperative|postoperative
5303354|NCT02160301|multimodal|multimodal
5303355|NCT02160301|satisfaction|satisfaction
5303356|NCT02160301|narcotic|narcotic
5303357|NCT02160288|Botox|botox
5303358|NCT02160288|Obstructed Defecation Syndrome|obstructed defecation syndrome
5303359|NCT02160288|ODS|ods
5303360|NCT02160288|Outlet-Type Constipation|outlet-type constipation
5303361|NCT02160288|injection|injection
5303362|NCT02160275|Artificial pancreas|artificial pancreas
5303363|NCT02160275|Bi-hormonal closed loop|bi-hormonal closed loop
5303364|NCT02160275|Diabetes Type 1|diabetes type 1
5303365|NCT02160249|Schizophrenia|schizophrenia
5303366|NCT02160249|Psychotic disorders|psychotic disorders
5303367|NCT02160249|Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using DSM-IV criteria|schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder) using dsm-iv criteria
5303368|NCT02160236|dexketoprofen trometamol|dexketoprofen trometamol
5303369|NCT02160236|tenoxicam|tenoxicam
5303370|NCT02160236|postoperative pain|postoperative pain
5303371|NCT02160223|sugammadex|sugammadex
5303372|NCT02160223|neostigmine|neostigmine
5303373|NCT02160223|obstructive sleep apnea|obstructive sleep apnea
5303374|NCT02160197|Ankle Fractures|ankle fractures
5303375|NCT02160197|Fracture Fixation|fracture fixation
5303376|NCT02160197|Early Ambulation|early ambulation
5303377|NCT02160197|Fracture Healing|fracture healing
5303378|NCT02160197|Return to Work|return to work
5303379|NCT02160171|Decision Support Algorithm|decision support algorithm
5303380|NCT02160171|Neonatal Seizures|neonatal seizures
5303381|NCT02160171|EEG|eeg
5303382|NCT02160158|Fesoterodine|fesoterodine
5303383|NCT02160158|SR3|sr3
5303384|NCT02160158|SR4|sr4
5303385|NCT02160158|bioavailability|bioavailability
5303386|NCT02160158|pharmacokinetics|pharmacokinetics
5303387|NCT02160158|sprinkle|sprinkle
5303388|NCT02160158|applesauce|applesauce
5303389|NCT02160145|Chronic Kidney Disease|chronic kidney disease
5303390|NCT02160145|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5303391|NCT02160119|Autism Spectrum Disorders|autism spectrum disorders
5303392|NCT02160119|Emotion|emotion
5303393|NCT02160119|Attention|attention
5303394|NCT02160119|Event-related potential|event-related potential
5303395|NCT02160119|Functional neuroimaging|functional neuroimaging
5303396|NCT02160119|Diffusion Tensor Imaging|diffusion tensor imaging
5303397|NCT02160119|Development|development
5303398|NCT02160106|Cancer|cancer
5303399|NCT02160106|advanced solid tumors|advanced solid tumors
5303400|NCT02160106|metastatic|metastatic
5303401|NCT02160106|phase I|phase i
5862765|NCT00001522|Obesity|obesity
5303402|NCT02160106|transforming growth factor beta|transforming growth factor beta
5303404|NCT02160106|first-in-human|first-in-human
5303405|NCT02160106|TEW-7197|tew-7197
5303406|NCT02160106|activin receptor-like kinase 5|activin receptor-like kinase 5
5303407|NCT02160106|ALK5|alk5
5303408|NCT02160106|Smad2|smad2
5303409|NCT02160106|Smad3|smad3
5303410|NCT02160106|phospho-Smad|phospho-smad
5303411|NCT02160106|phospho Smad|phospho smad
5303412|NCT02160106|psmad|psmad
5303413|NCT02160106|serine / threonine kinase inhibitor|serine / threonine kinase inhibitor
5303414|NCT02160106|pharmacokinetics|pharmacokinetics
5303415|NCT02160106|MedPacto|medpacto
5303416|NCT02160106|National OncoVenture|national oncoventure
5303417|NCT02160093|sarcopenia|sarcopenia
5303418|NCT02160093|frailty|frailty
5303419|NCT02160093|chronic disease control|chronic disease control
5303420|NCT02160093|aging psychology|aging psychology
5303421|NCT02160080|Boceprevir;|boceprevir;
5303422|NCT02160080|Liver pre-transplant|liver pre-transplant
5303423|NCT02160067|Healthy Volunteers|healthy volunteers
5303424|NCT02160067|Pharmacokinetics|pharmacokinetics
5303425|NCT02160054|tacrolimus|tacrolimus
5303426|NCT02160054|cyclosporine|cyclosporine
5303427|NCT02160054|Graceptor®|graceptor®
5303428|NCT02160054|kidney transplantation|kidney transplantation
5303429|NCT02160041|Solid tumor malignancy|solid tumor malignancy
5303430|NCT02160041|hematologic malignancy|hematologic malignancy
5303431|NCT02160041|mutation|mutation
5303432|NCT02160041|translocations|translocations
5303433|NCT02160041|amplifications,|amplifications,
5303434|NCT02160041|fusions|fusions
5303435|NCT02160041|signature|signature
5303436|NCT02160041|FGFR|fgfr
5303437|NCT02160041|ligand|ligand
5303438|NCT02160041|BGJ398|bgj398
5303439|NCT02160028|Information|information
5303440|NCT02160028|Pain|pain
5303441|NCT02160028|Stress|stress
5303442|NCT02160028|Fear|fear
5303443|NCT02160028|Placebo analgesia|placebo analgesia
5303444|NCT02160002|Incubator Weaning|incubator weaning
5303445|NCT02160002|Moderately Preterm Infants|moderately preterm infants
5303446|NCT02160002|Growth Velocity|growth velocity
5303447|NCT02159976|Helicobacter pylori|helicobacter pylori
5303448|NCT02159963|FSHD|fshd
5303449|NCT02159963|HIT|hit
5303450|NCT02159963|Training|training
5303451|NCT02159963|Exercise|exercise
5303452|NCT02159963|10-20-30 interval training|10-20-30 interval training
5303453|NCT02159937|cancer|cancer
5303454|NCT02159937|in vitro|in vitro
5303455|NCT02159937|peptides|peptides
5303456|NCT02159937|dendritic cells|dendritic cells
5303457|NCT02159924|Smartphone measurements|smartphone measurements
5303458|NCT02159924|Orientation|orientation
5303459|NCT02159924|Range of motion|range of motion
5963058|NCT04275687|hypofraction|hypofraction
5184652|NCT02835664|Obesity|obesity
5303460|NCT02159924|Median nerve neurodynamic test|median nerve neurodynamic test
5303461|NCT02159924|Posture|posture
5303462|NCT02159924|Thoracic spine|thoracic spine
5303463|NCT02159924|Shoulder girdle|shoulder girdle
5303464|NCT02159911|Cervical|cervical
5303465|NCT02159911|Hysteroscopy|hysteroscopy
5303466|NCT02159911|Misoprostol|misoprostol
5303467|NCT02159911|Oral|oral
5303468|NCT02159898|Esophageal Cancer|esophageal cancer
5303469|NCT02159898|Dysphagia|dysphagia
5303470|NCT02159898|Regurgitation|regurgitation
5303471|NCT02159885|obstructive sleep apnea|obstructive sleep apnea
5303472|NCT02159885|adherence|adherence
5303473|NCT02159885|telemedicine|telemedicine
5303474|NCT02159885|auto-titrating continuous positive airway pressure|auto-titrating continuous positive airway pressure
5303476|NCT02159872|Myelodysplastic Syndrome|myelodysplastic syndrome
5303481|NCT02159859|ertapenem|ertapenem
5303482|NCT02159859|pharmacokinetic|pharmacokinetic
5303483|NCT02159859|pharmacodynamics|pharmacodynamics
5303484|NCT02159859|hemodialysis|hemodialysis
5303485|NCT02159859|requires hemodialysis three times a week|requires hemodialysis three times a week
5303486|NCT02159846|Herbs|herbs
5303487|NCT02159846|Diabetes Mellitus|diabetes mellitus
5303488|NCT02159846|HbA1c|hba1c
5303489|NCT02159846|Lipid Profile|lipid profile
5303490|NCT02159833|Food allergy|food allergy
5303491|NCT02159833|Diagnosis|diagnosis
5303492|NCT02159807|Pain control|pain control
5303493|NCT02159807|labor|labor
5303494|NCT02159807|epidural|epidural
5303495|NCT02159807|pregnant|pregnant
5303496|NCT02159794|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5303497|NCT02159794|Aortic valve stenosis|aortic valve stenosis
5303498|NCT02159794|Severe aortic stenosis|severe aortic stenosis
5303499|NCT02159768|tracheal intubation|tracheal intubation
5303500|NCT02159742|Adult subjects|adult subjects
5303501|NCT02159742|history|history
5303502|NCT02159742|treatment|treatment
5303503|NCT02159742|photodynamic therapy|photodynamic therapy
5303504|NCT02159716|Subjects|subjects
5303505|NCT02159703|T1-2 N2 M0,|t1-2 n2 m0,
5303506|NCT02159703|stage IVa SCCA|stage iva scca
5303507|NCT02159703|oropharynx|oropharynx
5303508|NCT02159703|negative for PNI,|negative for pni,
5303509|NCT02159703|negative surgical margins|negative surgical margins
5303510|NCT02159690|prostate cancer|prostate cancer
5303511|NCT02159690|prostatectomy|prostatectomy
5303512|NCT02159690|localized prostate cancer|localized prostate cancer
5303514|NCT02159664|didgeridoo|didgeridoo
5303515|NCT02159664|sleep apnea|sleep apnea
5303516|NCT02159664|drug induced sleep endoscopy|drug induced sleep endoscopy
5303517|NCT02159651|tacrolimus|tacrolimus
5303518|NCT02159651|interstitial pneumonia|interstitial pneumonia
5303519|NCT02159651|prograf|prograf
5303520|NCT02159638|Diabetes Mellitus|diabetes mellitus
5303521|NCT02159638|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5303522|NCT02159638|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5303523|NCT02159638|Endocrine System Diseases|endocrine system diseases
5303524|NCT02159638|Blood glucose|blood glucose
5303525|NCT02159638|Blood Glucose, Self-Monitoring|blood glucose, self-monitoring
5303526|NCT02159625|Abdominal Compression Elastic Support|abdominal compression elastic support
5303527|NCT02159625|Hemodialysis|hemodialysis
5303528|NCT02159625|hypotension|hypotension
5303529|NCT02159625|occurrence rate|occurrence rate
5303530|NCT02159612|FSHD|fshd
5303531|NCT02159612|MRI|mri
5303532|NCT02159612|Disease progression|disease progression
5303533|NCT02159586|gastroparesis|gastroparesis
5303534|NCT02159586|gastric electrical stimulator|gastric electrical stimulator
5303535|NCT02159586|GES|ges
5303536|NCT02159586|vomiting|vomiting
5303537|NCT02159586|nausea|nausea
5303538|NCT02159586|bloating|bloating
5303539|NCT02159586|postprandial fullness|postprandial fullness
5303540|NCT02159586|epigastric pain|epigastric pain
5303541|NCT02159547|migraine, emergency department, dexketoprofen, placebo|migraine, emergency department, dexketoprofen, placebo
5303545|NCT02159508|nutritional status|nutritional status
5303546|NCT02159508|nutritional intervention|nutritional intervention
5303547|NCT02159508|handgrip strength|handgrip strength
5303548|NCT02159508|patient-generated subjective global assessment|patient-generated subjective global assessment
5303549|NCT02159508|chemoradiotherapy|chemoradiotherapy
5303550|NCT02159508|survival|survival
5303551|NCT02159469|Hypogonadism|hypogonadism
5303552|NCT02159469|Testosterone enanthate|testosterone enanthate
5303553|NCT02159443|Hu14.18K322A|hu14.18k322a
5303554|NCT02159443|Human anti-human antibodies (HAHA)|human anti-human antibodies (haha)
5303555|NCT02159443|Pretreatment anti-therapeutic antibodies (PATA)|pretreatment anti-therapeutic antibodies (pata)
5303556|NCT02159417|Evolution of the sport, HbA1C, IMC|evolution of the sport, hba1c, imc
5303557|NCT02159391|Accident Prevention|accident prevention
5303558|NCT02159391|Alcohol Drinking|alcohol drinking
5303559|NCT02159391|Substance-Related Disorders|substance-related disorders
5303560|NCT02159391|Motivational Interviewing|motivational interviewing
5303561|NCT02159391|Adult|adult
5303562|NCT02159391|Humans|humans
5963059|NCT04275518|APG-115|apg-115
5963060|NCT04275518|AML|aml
5172685|NCT02913625|Coracoid|coracoid
5303563|NCT02159391|Intervention Studies|intervention studies
5303564|NCT02159391|Recurrence|recurrence
5303565|NCT02159391|Risk Factors|risk factors
5303566|NCT02159391|Trauma Centers|trauma centers
5303567|NCT02159391|Wounds and Injuries/epidemiology|wounds and injuries/epidemiology
5303568|NCT02159391|Wounds and Injuries/etiology*|wounds and injuries/etiology*
5423355|NCT01616017|ultrasound dilution|ultrasound dilution
5303569|NCT02159391|Wounds and Injuries/prevention & control*|wounds and injuries/prevention & control*
5303571|NCT02159378|Fructosamines|fructosamines
5303572|NCT02159378|Insulin treatment|insulin treatment
5303573|NCT02159339|DNA methylation|dna methylation
5303574|NCT02159313|Biological Availability|biological availability
5303575|NCT02159300|Fibromyalgia|fibromyalgia
5303576|NCT02159300|Pain|pain
5303577|NCT02159287|ischemic stroke|ischemic stroke
5303578|NCT02159287|atrial fibrillation|atrial fibrillation
5303579|NCT02159287|bridging therapy|bridging therapy
5303580|NCT02159274|Late symptoms|late symptoms
5303581|NCT02159274|Shoulder function|shoulder function
5303582|NCT02159274|Cosmetic results|cosmetic results
5303583|NCT02159274|EORTC|eortc
5303584|NCT02159274|Lymphoedema|lymphoedema
5303585|NCT02159261|Personal Satisfaction|personal satisfaction
5303586|NCT02159248|pancreatic, gemcitabine, radiation, tolfenamic acid|pancreatic, gemcitabine, radiation, tolfenamic acid
5303587|NCT02159235|cadmium|cadmium
5303588|NCT02159235|lead|lead
5303589|NCT02159235|mercury|mercury
5303590|NCT02159235|zinc|zinc
5303591|NCT02159235|endostatin|endostatin
5303592|NCT02159235|angiostatin|angiostatin
5303593|NCT02159235|VEGF|vegf
5303594|NCT02159235|CAD|cad
5303595|NCT02159235|osteopontin|osteopontin
5303596|NCT02159209|Acute Kidney Injury|acute kidney injury
5303597|NCT02159209|Adverse Drug Reaction|adverse drug reaction
5303598|NCT02159209|Acute Kidney Failure|acute kidney failure
5303599|NCT02159209|Kidney|kidney
5303600|NCT02159209|Kidneys|kidneys
5303601|NCT02159196|mechanical ventilation|mechanical ventilation
5303602|NCT02159196|nebulisation|nebulisation
5303603|NCT02159196|respiratory failure|respiratory failure
5303604|NCT02159170|Use of NGF injection as a model of non-inflammatory neuropathic pain in healthy subjects|use of ngf injection as a model of non-inflammatory neuropathic pain in healthy subjects
5303605|NCT02159157|breast cancer, exercise|breast cancer, exercise
5303606|NCT02159144|Brown adipose tissue|brown adipose tissue
5303607|NCT02159144|Subcutaneous white adipose tissue|subcutaneous white adipose tissue
5303608|NCT02159144|White adipose tissue|white adipose tissue
5303612|NCT02159131|oral contraceptive|oral contraceptive
5303613|NCT02159131|oral contraceptive containing levonorgestrel and ethinyl estradiol|oral contraceptive containing levonorgestrel and ethinyl estradiol
5303614|NCT02159131|levonorgestrel|levonorgestrel
5303615|NCT02159118|bone marrow aspiration|bone marrow aspiration
5303616|NCT02159118|bone marrow biopsy|bone marrow biopsy
5303617|NCT02159118|OnControl|oncontrol
5303618|NCT02159118|powered bone marrow aspiration and biopsy device|powered bone marrow aspiration and biopsy device
5303619|NCT02159118|standard manual bone marrow aspiration and biopsy device|standard manual bone marrow aspiration and biopsy device
5303620|NCT02159105|postpartum hemorrhage|postpartum hemorrhage
5303621|NCT02159105|postsurgical bleeding|postsurgical bleeding
5303622|NCT02159105|abdominal ultrasound|abdominal ultrasound
5303623|NCT02159105|FAST scan|fast scan
5303624|NCT02159105|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
5303625|NCT02159092|Waterpipe|waterpipe
5303626|NCT02159092|Smoking cessation|smoking cessation
5303627|NCT02159092|Contingency management|contingency management
5303628|NCT02159092|Dependence|dependence
5303629|NCT02159079|Sepsis|sepsis
5303630|NCT02159079|Severe Sepsis|severe sepsis
5303631|NCT02159079|Septic Shock|septic shock
5303632|NCT02159079|Conservative Fluid Management|conservative fluid management
5303633|NCT02159079|Fluid Balance|fluid balance
5303634|NCT02159079|Fluid Restriction|fluid restriction
5303635|NCT02159066|Melanoma|melanoma
5303636|NCT02159053|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
5303637|NCT02159040|Int-2 MDS|int-2 mds
5303638|NCT02159027|Human Immunodeficiency Virus|human immunodeficiency virus
5303639|NCT02159027|AIDS Dementia Complex|aids dementia complex
5303640|NCT02159014|Physical activity intervention|physical activity intervention
5303641|NCT02159014|Aerobic dance|aerobic dance
5303642|NCT02159014|Nutritional intervention|nutritional intervention
5303643|NCT02159014|Online participation|online participation
5303644|NCT02159014|Primary Care settings|primary care settings
5303645|NCT02159014|General Practice Physical Activity Questionnaire GPPAQ|general practice physical activity questionnaire gppaq
5303646|NCT02159014|Qrisk2|qrisk2
5303647|NCT02159014|QDS Diabetes|qds diabetes
5303648|NCT02159001|clozapine|clozapine
5303649|NCT02159001|ECT|ect
5303650|NCT02159001|PANSS|panss
5303651|NCT02159001|schizoaffective disorder|schizoaffective disorder
5303652|NCT02159001|schizophrenia|schizophrenia
5303653|NCT02159001|treatment|treatment
5963061|NCT04275518|MDS|mds
5963062|NCT04275440|Caloric Restriction|caloric restriction
5303654|NCT02158988|Gastric cancer|gastric cancer
5303655|NCT02158988|cancer of the esophagogastric junction|cancer of the esophagogastric junction
5303656|NCT02158988|peritoneal carcinomatosis|peritoneal carcinomatosis
5303657|NCT02158988|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5303658|NCT02158988|HIPEC|hipec
5303664|NCT02158949|SBIRT|sbirt
5303665|NCT02158936|thrombocytopenia|thrombocytopenia
5303666|NCT02158936|myelodysplastic syndromes|myelodysplastic syndromes
5303668|NCT02158936|thrombopoietin|thrombopoietin
5303669|NCT02158936|azacitidine|azacitidine
5303670|NCT02158936|Eltrombopag|eltrombopag
5303671|NCT02158936|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5303672|NCT02158923|ventilation|ventilation
5303673|NCT02158923|lung|lung
5303674|NCT02158923|lung complications|lung complications
5303675|NCT02158923|postoperative complications|postoperative complications
5303676|NCT02158923|perioperative lung protective ventilation|perioperative lung protective ventilation
5303677|NCT02158910|Alzheimer's disease|alzheimer's disease
5303678|NCT02158884|Major extremity trauma|major extremity trauma
5303679|NCT02158884|wounded warriors|wounded warriors
5303680|NCT02158884|IDEO|ideo
5303681|NCT02158884|return to run|return to run
5303682|NCT02158871|Education|education
5303683|NCT02158871|Early intervention|early intervention
5303684|NCT02158871|Workplace|workplace
5303685|NCT02158871|Stigma|stigma
5303686|NCT02158871|Mental Health Literacy|mental health literacy
5303687|NCT02158858|Phase 1|phase 1
5303688|NCT02158858|Phase 2|phase 2
5303689|NCT02158858|Oncology|oncology
5303690|NCT02158858|BET Inhibitor|bet inhibitor
5303691|NCT02158858|Ruxolitinib|ruxolitinib
5303692|NCT02158845|endometriosis|endometriosis
5303693|NCT02158845|blood coagulation|blood coagulation
5303694|NCT02158845|levonorgestrel|levonorgestrel
5303695|NCT02158845|GnRH agonist|gnrh agonist
5303696|NCT02158845|progesterone-releasing intrauterine device|progesterone-releasing intrauterine device
5303697|NCT02158832|Lymphoedema|lymphoedema
5303698|NCT02158832|Edema|edema
5303699|NCT02158832|Oedema|oedema
5303700|NCT02158832|Cancer|cancer
5303701|NCT02158832|Breast Cancer|breast cancer
5303702|NCT02158819|Visionaire|visionaire
5303703|NCT02158819|Health Economics|health economics
5303704|NCT02158819|Degenerative arthritis|degenerative arthritis
5303705|NCT02158819|total knee arthroplasty|total knee arthroplasty
5303707|NCT02158793|face transplant|face transplant
5303708|NCT02158793|Craniomaxillofacial Allotransplantation|craniomaxillofacial allotransplantation
5303709|NCT02158793|facial disfigurement|facial disfigurement
5303710|NCT02158793|facial trauma|facial trauma
5303711|NCT02158754|Corus CAD|corus cad
5303712|NCT02158754|ASGES|asges
5303713|NCT02158754|Coronary Artery Disease|coronary artery disease
5303714|NCT02158754|Gene Expression|gene expression
5303715|NCT02158754|Age/Sex/Gene Expression Score|age/sex/gene expression score
5303716|NCT02158754|GES|ges
5303717|NCT02158754|Angina Pectoris|angina pectoris
5303718|NCT02158754|Chest Pain|chest pain
5198903|NCT02751216|EEG|eeg
5303719|NCT02158754|Cardiovascular Disease|cardiovascular disease
5303720|NCT02158754|CAD|cad
5303721|NCT02158754|CVD|cvd
5303722|NCT02158754|CHD|chd
5303723|NCT02158754|Coronary Heart Disease|coronary heart disease
5303724|NCT02158754|Precision Medicine|precision medicine
5303725|NCT02158754|Clinical Utility|clinical utility
5303726|NCT02158741|Self-Management|self-management
5303727|NCT02158741|Home Visits|home visits
5303728|NCT02158702|Relapsed Myeloma Patients|relapsed myeloma patients
5303729|NCT02158702|Relapsed after use of Bortezomib and Lenalidomide|relapsed after use of bortezomib and lenalidomide
5303730|NCT02158702|Pomalidomide and Dexamethasone|pomalidomide and dexamethasone
5303731|NCT02158702|Efficacy and Safety|efficacy and safety
5303732|NCT02158689|Poor responders|poor responders
5303733|NCT02158689|letrozole|letrozole
5303734|NCT02158689|human menopausal gonadotropin|human menopausal gonadotropin
5303735|NCT02158676|Roux-en-y gastric bypass|roux-en-y gastric bypass
5303736|NCT02158676|Inflammatory markers|inflammatory markers
5303737|NCT02158676|Nutritional status|nutritional status
5303738|NCT02158676|Fatty acids|fatty acids
5303739|NCT02158676|Glucose|glucose
5303740|NCT02158676|Prebiotic|prebiotic
5303741|NCT02158676|Synbiotic|synbiotic
5303742|NCT02158663|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5303743|NCT02158663|TMS|tms
5303744|NCT02158663|PTSD|ptsd
5303745|NCT02158650|informed consent|informed consent
5303746|NCT02158650|video-based|video-based
5303747|NCT02158637|PRO-CTCAE|pro-ctcae
5303748|NCT02158637|Patient-Reported Outcomes|patient-reported outcomes
5303749|NCT02158637|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
5303750|NCT02158637|Questionnaire|questionnaire
5303751|NCT02158637|Adverse Events|adverse events
5303752|NCT02158637|Symptoms|symptoms
5303753|NCT02158611|Individual Counseling service|individual counseling service
5308325|NCT02137317|Tropical Climate|tropical climate
5303754|NCT02158611|Group Counseling service|group counseling service
5303755|NCT02158585|Lamotrigine|lamotrigine
5303756|NCT02158585|Lamictal|lamictal
5303757|NCT02158585|Anticonvulsant|anticonvulsant
5963063|NCT04275440|Exercise|exercise
5303758|NCT02158585|Ménière's disease|ménière's disease
5303759|NCT02158585|Vertigo attack|vertigo attack
5303760|NCT02158585|Dizziness|dizziness
5303761|NCT02158585|Vestibular disorder|vestibular disorder
5303762|NCT02158572|prevention of pregnancy|prevention of pregnancy
5303763|NCT02158546|Major Depressive Disorder|major depressive disorder
5303764|NCT02158546|Depression|depression
5303765|NCT02158546|Alkermes|alkermes
5674501|NCT00603330|Mesenchymal stem cells|mesenchymal stem cells
5303777|NCT02158507|estrogen receptor (ER) negative|estrogen receptor (er) negative
5303778|NCT02158507|progesterone receptor (PR) negative|progesterone receptor (pr) negative
5303779|NCT02158507|human epidermal growth factor receptor 2 (HER-2-Neu) negative|human epidermal growth factor receptor 2 (her-2-neu) negative
5303780|NCT02158494|Cranial Nerve Noninvasive Neuromodulation|cranial nerve noninvasive neuromodulation
5303781|NCT02158494|Portable Neuromodulation Stimulator (PoNS)|portable neuromodulation stimulator (pons)
5303782|NCT02158494|Balance and Gait Training|balance and gait training
5303783|NCT02158494|Breathing Awareness Training|breathing awareness training
5303784|NCT02158481|Vascular function|vascular function
5303785|NCT02158481|Dietary ingredients|dietary ingredients
5303786|NCT02158481|Acute glucose load|acute glucose load
5303787|NCT02158481|Oxidative stress|oxidative stress
5303788|NCT02158468|STEMI, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage|stemi, reperfusion, preconditioning, postconditioning, reperfusion injury, myocardial salvage
5303790|NCT02158455|Saphenous vein|saphenous vein
5303791|NCT02158455|Radial artery|radial artery
5303792|NCT02158442|Diabetes|diabetes
5303793|NCT02158442|Lower limb infection|lower limb infection
5303794|NCT02158442|Significant wound infections|significant wound infections
5303795|NCT02158442|Intravenous antibiotics|intravenous antibiotics
5303796|NCT02158442|Timentin|timentin
5303797|NCT02158429|substance use disorders|substance use disorders
5303798|NCT02158429|pregnancy|pregnancy
5303799|NCT02158429|maternal attachment|maternal attachment
5303800|NCT02158429|paternal attachment|paternal attachment
5303801|NCT02158429|three dimensional ultrasound|three dimensional ultrasound
5303802|NCT02158416|platelet|platelet
5303803|NCT02158416|transfusion|transfusion
5303804|NCT02158416|ThromboLUX|thrombolux
5303805|NCT02158416|corrected count increment|corrected count increment
5303807|NCT02158403|HeartMate II|heartmate ii
5303808|NCT02158403|heart assist device|heart assist device
5303809|NCT02158403|pump thrombosis|pump thrombosis
5303810|NCT02158403|hypercoagulable disorder|hypercoagulable disorder
5303811|NCT02158403|thrombus|thrombus
5303812|NCT02158403|Thoratec Corporation|thoratec corporation
5303813|NCT02158390|Down syndrome|down syndrome
5303814|NCT02158390|Language intervention|language intervention
5303815|NCT02158390|Communication intervention|communication intervention
5303816|NCT02158377|Dental implants|dental implants
5303817|NCT02158377|Trabecular Metal dental implants|trabecular metal dental implants
5303818|NCT02158377|TSV dental implants|tsv dental implants
5303819|NCT02158377|Zimmer Dental|zimmer dental
5303820|NCT02158377|Implant stability|implant stability
5303821|NCT02158377|Implant stability quotient (ISQ)|implant stability quotient (isq)
5303822|NCT02158377|Resonance Frequency Analysis (RFA)|resonance frequency analysis (rfa)
5303823|NCT02158364|Pharmacological therapy|pharmacological therapy
5303824|NCT02158351|Simple steatosis (SS)|simple steatosis (ss)
5303825|NCT02158351|Non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5303826|NCT02158351|Gut microbiota (GM)|gut microbiota (gm)
5303827|NCT02158351|Non alcoholic fatty liver disease (NAFLD)|non alcoholic fatty liver disease (nafld)
5303828|NCT02158338|asthma|asthma
5303829|NCT02158338|maternal bonding|maternal bonding
5303830|NCT02158338|maternal bonding disruptions|maternal bonding disruptions
5303831|NCT02158338|mother-infant interaction|mother-infant interaction
5303832|NCT02158312|neuroplasticity|neuroplasticity
5303833|NCT02158273|Alcohol|alcohol
5303834|NCT02158273|Relapse|relapse
5303835|NCT02158260|Capsule endoscopy|capsule endoscopy
5303836|NCT02158260|Patient position changing|patient position changing
5303848|NCT02158208|before any treatment|before any treatment
5303849|NCT02158208|at the diagnosis|at the diagnosis
5303850|NCT02158182|Hepatic Encephalopathy|hepatic encephalopathy
5303851|NCT02158182|Acute Variceal Bleeding|acute variceal bleeding
5303852|NCT02158182|Cirrhosis|cirrhosis
5303853|NCT02158130|Physical Inactivity|physical inactivity
5303854|NCT02158130|Aerobic Exercise Detraining|aerobic exercise detraining
5303855|NCT02158130|Body Weight|body weight
5303856|NCT02158130|Energy Expenditure|energy expenditure
5303857|NCT02158130|Metabolic Syndrome|metabolic syndrome
5303858|NCT02158117|Emergency Treatment|emergency treatment
5303859|NCT02158117|Morphine Derivates|morphine derivates
5303860|NCT02158117|Heroin|heroin
5303861|NCT02158117|Antidotes|antidotes
5303862|NCT02158117|Administration, Intranasal|administration, intranasal
5303863|NCT02158091|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5303864|NCT02158078|Diabetes Mellitus|diabetes mellitus
5303865|NCT02158078|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5303866|NCT02158078|Glucose Metabolism Disorders|glucose metabolism disorders
5303867|NCT02158078|Metabolic Diseases|metabolic diseases
5303868|NCT02158078|Endocrine System Diseases|endocrine system diseases
5172972|NCT02911090|Dyspareunia|dyspareunia
5303870|NCT02158078|Continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5303871|NCT02158078|Insulin pumps|insulin pumps
5303872|NCT02158065|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5303873|NCT02158065|physical activity|physical activity
5303874|NCT02158065|PROactive|proactive
5303875|NCT02158065|telecoaching|telecoaching
5303876|NCT02158052|HLA matched|hla matched
5303877|NCT02158052|bone marrow transplantation|bone marrow transplantation
5303878|NCT02158052|kidney transplantation|kidney transplantation
5303879|NCT02158039|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5303880|NCT02158039|Mucinous Cystic Neoplasm|mucinous cystic neoplasm
5303881|NCT02158039|Endoscopic Ultrasound|endoscopic ultrasound
5303882|NCT02158039|Ethanol|ethanol
5303883|NCT02158026|Follicular sensitivity index|follicular sensitivity index
5303884|NCT02158026|ICSI|icsi
5303885|NCT02158026|IVF|ivf
5303886|NCT02157987|telangietasia hereditary hemorragic|telangietasia hereditary hemorragic
5303887|NCT02157987|epistaxis|epistaxis
5303888|NCT02157987|safety|safety
5303889|NCT02157987|quality of life|quality of life
5303890|NCT02157987|bevacizumab|bevacizumab
5303891|NCT02157987|spray|spray
5303892|NCT02157948|postmenopausal osteoporosis|postmenopausal osteoporosis
5303893|NCT02157948|osteoporosis|osteoporosis
5303894|NCT02157948|postmenopausal|postmenopausal
5303895|NCT02157948|denosumab|denosumab
5303896|NCT02157948|women|women
5303897|NCT02157935|COPD, turbuhaler, pMDI|copd, turbuhaler, pmdi
5303898|NCT02157922|Cystic fibrosis|cystic fibrosis
5303899|NCT02157922|mucolytic|mucolytic
5303900|NCT02157922|mucociliary clearance|mucociliary clearance
5303901|NCT02157922|lung clearance|lung clearance
5303902|NCT02157909|Lens fit|lens fit
5303903|NCT02157909|contact lenses|contact lenses
5303904|NCT02157909|myopia|myopia
5303905|NCT02157896|Acute ischemic stroke|acute ischemic stroke
5303906|NCT02157896|Vascular endothelial growth factor|vascular endothelial growth factor
5303907|NCT02157896|Endostatin|endostatin
5300615|NCT02174250|PD|pd
5862769|NCT00001516|Case Study Design|case study design
5862770|NCT00001516|Rehabilitation|rehabilitation
5303908|NCT02157883|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, AZD9291, intraconazole, EGFR sensitivity mutation|oncology, cancer, non small cell lung cancer, anticancer drug, pharmacokinetics, azd9291, intraconazole, egfr sensitivity mutation
5303910|NCT02157844|Obstructive Sleep Apnea|obstructive sleep apnea
5303911|NCT02157844|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5303912|NCT02157844|Obesity|obesity
5303913|NCT02157844|Hepatic fat metabolism|hepatic fat metabolism
5303914|NCT02157844|fat digestion|fat digestion
5303915|NCT02157844|whole body protein synthesis|whole body protein synthesis
5303916|NCT02157844|protein digestion|protein digestion
5303917|NCT02157844|amino acid metabolism|amino acid metabolism
5303918|NCT02157844|adipose tissue fat metabolism|adipose tissue fat metabolism
5303919|NCT02157844|lipolysis|lipolysis
5303920|NCT02157831|Subjects with Clinical Benefit After a Single Infusion of CP - 870, 893|subjects with clinical benefit after a single infusion of cp - 870, 893
5303921|NCT02157805|Meat processes|meat processes
5303922|NCT02157805|Amino acids bioavailability|amino acids bioavailability
5303923|NCT02157805|Digestion rate|digestion rate
5303924|NCT02157805|Protein synthesis|protein synthesis
5303925|NCT02157805|Aging|aging
5303926|NCT02157805|Sarcopenia|sarcopenia
5303927|NCT02157792|Solid Tumor|solid tumor
5303928|NCT02157792|Advanced Solid Tumor|advanced solid tumor
5303929|NCT02157792|VX12-970-001|vx12-970-001
5303930|NCT02157792|M6620|m6620
5303931|NCT02157792|VX-970|vx-970
5303932|NCT02157792|Gemcitabine|gemcitabine
5303933|NCT02157792|Cisplatin|cisplatin
5303934|NCT02157792|Etoposide|etoposide
5303935|NCT02157792|Carboplatin|carboplatin
5303936|NCT02157792|Irinotecan|irinotecan
5303937|NCT02157779|Veterans|veterans
5303938|NCT02157779|Anger|anger
5303939|NCT02157779|Cognitive Behavioral Therapy|cognitive behavioral therapy
5303940|NCT02157779|Treatment|treatment
5303941|NCT02157766|Mental Health|mental health
5303942|NCT02157766|Asthma|asthma
5303943|NCT02157766|Mindfulness|mindfulness
5303944|NCT02157766|Compassion|compassion
5303945|NCT02157766|Meditation|meditation
5303946|NCT02157753|Osteoporotic fracture|osteoporotic fracture
5303947|NCT02157753|treatment for osteoporosis|treatment for osteoporosis
5303948|NCT02157753|adherence and compliance|adherence and compliance
5303949|NCT02157701|Dietary herbs|dietary herbs
5303950|NCT02157701|Polyherbal capsule|polyherbal capsule
5303951|NCT02157701|Functional exercise capacity|functional exercise capacity
5303952|NCT02157701|Joint health|joint health
5303953|NCT02157688|folliculitis decalvans|folliculitis decalvans
5303954|NCT02157688|Staphylococcus Aureus|staphylococcus aureus
5303955|NCT02157688|antibiotics|antibiotics
5303956|NCT02157675|Delayed onset muscle soreness|delayed onset muscle soreness
5303957|NCT02157675|Muscle damage|muscle damage
5303958|NCT02157675|Eccentric exercise|eccentric exercise
5303959|NCT02157636|Phase 1|phase 1
5963064|NCT04275440|Young Adult|young adult
5303960|NCT02157636|Oncology|oncology
5303961|NCT02157636|BET Inhibitor|bet inhibitor
5303962|NCT02157623|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5303963|NCT02157623|Gorlin's Syndrome|gorlin's syndrome
5303964|NCT02157610|Cervical Cancer|cervical cancer
5303965|NCT02157610|Cervical Cancer Survivors|cervical cancer survivors
5303966|NCT02157610|Smoking Cessation|smoking cessation
5303967|NCT02157610|Motivation And Problem-Solving|motivation and problem-solving
5303968|NCT02157610|MAPS|maps
5303969|NCT02157610|Saliva test|saliva test
5303970|NCT02157610|Self help materials|self help materials
5303971|NCT02157610|Pamphlets|pamphlets
5303972|NCT02157610|Texas Quitline|texas quitline
5303973|NCT02157610|Nicotine patch|nicotine patch
5303974|NCT02157610|Questionnaires|questionnaires
5303975|NCT02157610|Surveys|surveys
5303976|NCT02157610|Telephone counseling sessions|telephone counseling sessions
5303977|NCT02157571|prulifloxacin|prulifloxacin
5303978|NCT02157571|AECB|aecb
5303979|NCT02157571|Levofloxacin|levofloxacin
5303980|NCT02157545|muscle relaxants|muscle relaxants
5303981|NCT02157545|pyridostigmine|pyridostigmine
5303982|NCT02157545|pharmacodynamics|pharmacodynamics
5303983|NCT02157545|potency|potency
5303984|NCT02157532|Severe stroke|severe stroke
5303985|NCT02157532|IV tPA|iv tpa
5303986|NCT02157532|mechanical thrombectomy|mechanical thrombectomy
5303987|NCT02157519|Oral Chemotherapy|oral chemotherapy
5303988|NCT02157519|Cancer|cancer
5303989|NCT02157506|Acute Heart failure|acute heart failure
5303990|NCT02157506|Hemodynamics|hemodynamics
5303991|NCT02157506|Pharmacokinetics|pharmacokinetics
5303992|NCT02157506|Renal Function|renal function
5303993|NCT02157493|American Indian|american indian
5303994|NCT02157493|Adolescents|adolescents
5303995|NCT02157493|Entrepreneurship|entrepreneurship
5303996|NCT02157493|Paraprofessional|paraprofessional
5303997|NCT02157493|Life skills|life skills
5303998|NCT02157480|glucose profile|glucose profile
5303999|NCT02157480|continuous glucose monitoring|continuous glucose monitoring
5304000|NCT02157480|electrostimulation|electrostimulation
5304001|NCT02157441|Postpartum Hemorrhage|postpartum hemorrhage
5304002|NCT02157441|Placenta Previa|placenta previa
5304003|NCT02157441|uterine cavity|uterine cavity
5304005|NCT02157376|SUP|sup
5304006|NCT02157376|Upper GI bleeding|upper gi bleeding
5304007|NCT02157376|Seriously ill patients|seriously ill patients
5304008|NCT02157350|Eye Diseases|eye diseases
5304009|NCT02157350|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5304010|NCT02157350|Retinal Vessel Geometry|retinal vessel geometry
5304011|NCT02157350|Retinal Oxymetry|retinal oxymetry
5304012|NCT02157350|Retina Ischemia|retina ischemia
5199188|NCT02749461|assessment|assessment
5304013|NCT02157350|Panretinal Photocoagulation|panretinal photocoagulation
5304014|NCT02157350|Lasers, Semiconductor|lasers, semiconductor
5304015|NCT02157350|Fluorescein Angiography|fluorescein angiography
5304016|NCT02157337|aortic surgery|aortic surgery
5304017|NCT02157337|postoperative acute kidney injury|postoperative acute kidney injury
5304018|NCT02157337|statin|statin
5304019|NCT02157337|the patient undergoing aortic surgery|the patient undergoing aortic surgery
5304020|NCT02157324|Bruton tyrosine kinase inhibitor|bruton tyrosine kinase inhibitor
5304021|NCT02157324|Btk|btk
5304022|NCT02157311|HIV-1|hiv-1
5304023|NCT02157311|simplification,|simplification,
5304024|NCT02157311|treatment discontinuation|treatment discontinuation
5304025|NCT02157311|virological success|virological success
5304026|NCT02157311|four days a week|four days a week
5304027|NCT02157298|Japanese patients with type 2 diabetes with inadequate glycemic control on insulin|japanese patients with type 2 diabetes with inadequate glycemic control on insulin
5304028|NCT02157285|Unintended pregnancy in adolescence|unintended pregnancy in adolescence
5304029|NCT02157285|LARC|larc
5304030|NCT02157285|contraception|contraception
5304031|NCT02157272|Antiphospholipid|antiphospholipid
5304032|NCT02157272|Syndrome|syndrome
5304033|NCT02157272|Rivaroxaban|rivaroxaban
5304034|NCT02157272|Warfarin|warfarin
5304035|NCT02157272|Thrombosis|thrombosis
5304036|NCT02157272|Treatment|treatment
5304037|NCT02157246|hypoxia|hypoxia
5304038|NCT02157246|rectal cancer|rectal cancer
5304039|NCT02157207|antioxidants|antioxidants
5304040|NCT02157207|Caucasians|caucasians
5304041|NCT02157207|healthy|healthy
5304042|NCT02157207|African Americans|african americans
5304043|NCT02157207|vascular|vascular
5304044|NCT02157207|aging|aging
5304045|NCT02157207|racial differences|racial differences
5304046|NCT02157181|HCL variant|hcl variant
5304047|NCT02157181|HCL relapse|hcl relapse
5304048|NCT02157181|Risk stratified|risk stratified
5304049|NCT02157168|Affordable Care Act|affordable care act
5304050|NCT02157168|Medically underserved minorities|medically underserved minorities
5304051|NCT02157168|Community health workers|community health workers
5304147|NCT02156635|Direct Current Stimulation|direct current stimulation
5304052|NCT02157168|Health disparities among Mexican origin|health disparities among mexican origin
5304053|NCT02157142|Severe aortic stenosis|severe aortic stenosis
5304054|NCT02157142|Aortic valve stenosis|aortic valve stenosis
5304055|NCT02157142|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5304056|NCT02157129|Tracheostomy|tracheostomy
5304057|NCT02157129|inflammation|inflammation
5304058|NCT02157129|mucous congestion|mucous congestion
5304059|NCT02157129|inhalation therapy|inhalation therapy
5304060|NCT02157129|phospholipids|phospholipids
5304061|NCT02157116|Dose-Dense Chemotherapy|dose-dense chemotherapy
5304063|NCT02157103|Glioblastoma|glioblastoma
5304064|NCT02157103|Bevacizumab|bevacizumab
5304065|NCT02157103|Avastin|avastin
5304066|NCT02157103|Subcutaneous|subcutaneous
5304067|NCT02157090|HSL of lips|hsl of lips
5304068|NCT02157090|perioral skin|perioral skin
5304069|NCT02157090|duration of HSL symptoms not more than three days|duration of hsl symptoms not more than three days
5304070|NCT02157090|not acyclovir or other cold sore therapies|not acyclovir or other cold sore therapies
5304071|NCT02157077|Eye diseases|eye diseases
5304072|NCT02157077|Vision Impairment and Blindness|vision impairment and blindness
5304073|NCT02157077|Eyes and Vision|eyes and vision
5304074|NCT02157077|Seniors|seniors
5304075|NCT02157077|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
5304076|NCT02157077|Retinal Disease|retinal disease
5304077|NCT02157038|whiplash|whiplash
5304078|NCT02157038|neck pain|neck pain
5304079|NCT02157038|chronic pain|chronic pain
5304080|NCT02157038|motor vehicle accident|motor vehicle accident
5304081|NCT02157038|car accident|car accident
5304083|NCT02157038|DNA|dna
5304084|NCT02157038|RNA|rna
5304085|NCT02157025|Humphrey visual fields|humphrey visual fields
5304086|NCT02157025|perimetry|perimetry
5304087|NCT02157025|pediatrics|pediatrics
5304088|NCT02156973|cardiac computed tomography|cardiac computed tomography
5304089|NCT02156973|Image quality|image quality
5304090|NCT02156947|Power Doppler sonography|power doppler sonography
5304091|NCT02156947|cholecystitis, adhesion|cholecystitis, adhesion
5304092|NCT02156934|autologous stress urinary incontinence muscle derived cells|autologous stress urinary incontinence muscle derived cells
5304093|NCT02156908|cognitive remediation|cognitive remediation
5304094|NCT02156895|Korean PMS of Axitinib|korean pms of axitinib
5304095|NCT02156895|Metastatic RCC ; 2nd line only|metastatic rcc ; 2nd line only
5304096|NCT02156882|TB|tb
5304097|NCT02156882|Tuberculosis|tuberculosis
5300793|NCT02173145|cough|cough
5445399|NCT01521988|Atrial flutter|atrial flutter
5304098|NCT02156882|MaTuTU - Maputo Tuberculosis Trial Unit|matutu - maputo tuberculosis trial unit
5304099|NCT02156882|Clinical Trial Capacity Development|clinical trial capacity development
5304100|NCT02156869|Prostate cancer|prostate cancer
5304101|NCT02156869|Screening|screening
5304102|NCT02156869|Decision aids|decision aids
5304103|NCT02156856|hemodynamic monitoring|hemodynamic monitoring
5304104|NCT02156856|cardiac output|cardiac output
5304105|NCT02156856|cardiac surgery|cardiac surgery
5304106|NCT02156843|Diabetic Kidney Disease|diabetic kidney disease
5304107|NCT02156843|Nephropathy|nephropathy
5304108|NCT02156843|Diabetic Nephropathy|diabetic nephropathy
5304109|NCT02156843|Kidney Disease|kidney disease
5304110|NCT02156843|Type 2 Diabetes|type 2 diabetes
5304111|NCT02156817|Amplitude integrated electroencephalogram|amplitude integrated electroencephalogram
5304112|NCT02156817|Heart rate variability|heart rate variability
5304113|NCT02156817|Respiratory rate variability|respiratory rate variability
5304114|NCT02156817|Preterm Infants|preterm infants
5304115|NCT02156817|Length of Hospital Stay|length of hospital stay
5304116|NCT02156791|Seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5304117|NCT02156791|Grass pollen|grass pollen
5304118|NCT02156791|Allergen specific immunotherapy|allergen specific immunotherapy
5304119|NCT02156778|Post-Stroke Disease Management|post-stroke disease management
5304120|NCT02156778|Post-Stroke Complication|post-stroke complication
5304121|NCT02156778|Risk Factor Control|risk factor control
5304122|NCT02156778|Quality-of-Life|quality-of-life
5304123|NCT02156765|Atrial Fibrillation|atrial fibrillation
5304124|NCT02156765|Screening|screening
5304125|NCT02156765|Stroke patients|stroke patients
5304126|NCT02156726|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5304127|NCT02156726|fludarabine|fludarabine
5304128|NCT02156726|rituximab|rituximab
5304129|NCT02156726|elderly|elderly
5304130|NCT02156726|comorbid|comorbid
5304131|NCT02156726|FCR|fcr
5304132|NCT02156726|CIRS|cirs
5304133|NCT02156713|Hemiparesis|hemiparesis
5304134|NCT02156713|Occupational Therapy|occupational therapy
5304135|NCT02156700|shear wave elastography|shear wave elastography
5304136|NCT02156700|haemangiomas|haemangiomas
5304137|NCT02156700|metastases|metastases
5304138|NCT02156700|hepatocellular carcinoma|hepatocellular carcinoma
5304139|NCT02156700|focal nodular hyperplasia|focal nodular hyperplasia
5304140|NCT02156700|cholangiocellular carcinoma|cholangiocellular carcinoma
5304141|NCT02156674|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
5304142|NCT02156674|mucopolysaccharide VI|mucopolysaccharide vi
5304143|NCT02156674|MPS VI|mps vi
5304144|NCT02156648|Invasive ductal|invasive ductal
5304145|NCT02156648|HER2-neu positive|her2-neu positive
5304146|NCT02156635|Rehabilitation|rehabilitation
5304152|NCT02156622|Outcomes|outcomes
5304153|NCT02156622|Viral load|viral load
5304154|NCT02156609|HeartMate PHP|heartmate php
5304155|NCT02156609|HeartMate PHP CE Mark|heartmate php ce mark
5304156|NCT02156609|Percutaneous coronary intervention|percutaneous coronary intervention
5304158|NCT02156609|Percutaneous ventricular assist|percutaneous ventricular assist
5304159|NCT02156609|Thoratec Corporation|thoratec corporation
5304161|NCT02156596|nebulised morphine|nebulised morphine
5304162|NCT02156596|Intravenous NSAID|intravenous nsaid
5304163|NCT02156583|Ventricular Assist Device|ventricular assist device
5304164|NCT02156583|Skeletal Muscle|skeletal muscle
5304165|NCT02156583|Frailty|frailty
5304166|NCT02156583|Older adults|older adults
5304167|NCT02156570|Hepatitis C|hepatitis c
5304168|NCT02156570|Acute/early chronic|acute/early chronic
5304169|NCT02156570|Recently acquired|recently acquired
5304170|NCT02156570|Directly acting antiviral therapy|directly acting antiviral therapy
5304171|NCT02156570|Sofosbuvir|sofosbuvir
5304172|NCT02156570|Ribavirin|ribavirin
5304173|NCT02156531|Anxiety|anxiety
5304174|NCT02156531|Youth Anxiety|youth anxiety
5304175|NCT02156531|CBM|cbm
5304176|NCT02156531|Cognitive Bias Modification|cognitive bias modification
5304177|NCT02156531|Adolescents|adolescents
5304178|NCT02156518|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises|radiation therapy, laryngeal cancer, voice therapy, vocal function exercises
5304179|NCT02156505|stent|stent
5304180|NCT02156505|gastric outlet obstruction|gastric outlet obstruction
5304181|NCT02156505|restenosis|restenosis
5304182|NCT02156479|CMV|cmv
5304183|NCT02156479|T-Track CMV|t-track cmv
5304184|NCT02156479|allo-HSCT|allo-hsct
5304185|NCT02156479|CMI|cmi
5304186|NCT02156466|Psoriasis|psoriasis
5304187|NCT02156466|MSB0010841|msb0010841
5304188|NCT02156466|Anti-IL17A/F Nanobody|anti-il17a/f nanobody
5304189|NCT02156466|M1095|m1095
5304190|NCT02156453|Functional recovery|functional recovery
5304191|NCT02156453|Total knee arthroplasty|total knee arthroplasty
5304192|NCT02156440|Ostearthritis|ostearthritis
5304193|NCT02156440|Knee|knee
5304194|NCT02156440|SierraSil|sierrasil
5304195|NCT02156414|Prostatectomy|prostatectomy
5304196|NCT02156414|Extended Lymphadenectomy|extended lymphadenectomy
5304197|NCT02156414|Pelvic lymph node dissection|pelvic lymph node dissection
5304198|NCT02156414|Prostatic Neoplasm|prostatic neoplasm
5304199|NCT02156414|Prospective Studies|prospective studies
5304200|NCT02156401|Venous thromboembolism|venous thromboembolism
5304201|NCT02156401|Deep vein thrombosis|deep vein thrombosis
5304202|NCT02156401|Pulmonary embolism|pulmonary embolism
5304203|NCT02156401|Cohort study/epidemiology|cohort study/epidemiology
5304205|NCT02156401|Prognosis|prognosis
5304206|NCT02156375|Healthy|healthy
5304207|NCT02156375|Ustekinumab|ustekinumab
5304208|NCT02156375|STELARA®|stelara®
5304209|NCT02156362|Thyroid carcinoma|thyroid carcinoma
5304210|NCT02156362|predictive factors|predictive factors
5304211|NCT02156362|refractory|refractory
5304212|NCT02156362|Differentiated|differentiated
5304213|NCT02156362|follicular origin|follicular origin
5304214|NCT02156349|Diabetes|diabetes
5304215|NCT02156336|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
5304216|NCT02156336|Ranexa|ranexa
5304217|NCT02156336|Ranolazine|ranolazine
5304218|NCT02156336|Neurology|neurology
5304219|NCT02156284|Fear; Thoracic Surgery; Nursing Care; Preoperative Care|fear; thoracic surgery; nursing care; preoperative care
5304220|NCT02156271|Insomnia|insomnia
5304221|NCT02156258|Imaging|imaging
5304222|NCT02156258|Mammography|mammography
5304223|NCT02156232|hepatic encephalopathy (HE)|hepatic encephalopathy (he)
5304224|NCT02156232|vericeal bleeding|vericeal bleeding
5304225|NCT02156232|spontaneous portosystemic shunts (SPSS)|spontaneous portosystemic shunts (spss)
5304226|NCT02156232|transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
5304227|NCT02156232|embolization|embolization
5304228|NCT02156180|exhaled breath|exhaled breath
5304229|NCT02156180|volatile organic compounds|volatile organic compounds
5304230|NCT02156180|surgery|surgery
5304231|NCT02156180|chemotherapy|chemotherapy
5304232|NCT02156180|radiotherapy|radiotherapy
5304233|NCT02156167|Otosclerosis, cochlear implant, acoustic stimulation|otosclerosis, cochlear implant, acoustic stimulation
5304234|NCT02156141|Kennedy's disease|kennedy's disease
5304235|NCT02156141|Spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
5304236|NCT02156141|High Intensity Training|high intensity training
5304237|NCT02156141|High Intensity Interval Training|high intensity interval training
5304238|NCT02156141|HIT|hit
5304239|NCT02156141|HIIT|hiit
5304240|NCT02156141|Training|training
5304241|NCT02156141|Exercise|exercise
5304242|NCT02156141|10-20-30|10-20-30
5304243|NCT02156128|Cognitive therapy|cognitive therapy
5304257|NCT02156063|Recurrent Pregnancy Loss|recurrent pregnancy loss
5304258|NCT02156063|Recurrent Miscarriage|recurrent miscarriage
5304260|NCT02156063|Pregnancy Loss|pregnancy loss
5304261|NCT02156063|Repeated Pregnancy Loss|repeated pregnancy loss
5304262|NCT02156037|Hispanic|hispanic
5304263|NCT02156037|clinical decision support|clinical decision support
5304264|NCT02156037|diabetes|diabetes
5304265|NCT02156037|Hba1c|hba1c
5304266|NCT02156037|psychosocial|psychosocial
5304267|NCT02156024|clinical trials|clinical trials
5304268|NCT02156024|Gastrodia and Uncaria Drink|gastrodia and uncaria drink
5304269|NCT02156011|In vivo knee joint kinematics|in vivo knee joint kinematics
5308828|NCT02134600|DHA|dha
5304275|NCT02156011|Electromyography|electromyography
5674502|NCT00603330|Graft-versus-host disease|graft-versus-host disease
5304276|NCT02155998|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen|prostate adenocarcinoma, locally advanced prostate cancer with high and very high risk of recurrence, adjuvant endocrine treatment, prostate specific antigen
5304278|NCT02155972|Depression|depression
5304279|NCT02155972|Probiotic|probiotic
5304280|NCT02155972|ALIGN|align
5304281|NCT02155972|HAMD|hamd
5304282|NCT02155972|STAI|stai
5304283|NCT02155972|YMRS|ymrs
5304284|NCT02155972|CGI|cgi
5304285|NCT02155972|SDS|sds
5304286|NCT02155972|WHOQOL-BREF|whoqol-bref
5304287|NCT02155972|C-SSRS|c-ssrs
5304288|NCT02155972|TSES|tses
5304289|NCT02155959|astigmatism|astigmatism
5304290|NCT02155959|cataract|cataract
5304291|NCT02155959|toric|toric
5304292|NCT02155959|lens|lens
5304293|NCT02155946|Aging|aging
5304294|NCT02155946|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
5304295|NCT02155946|Cognitive Disorders|cognitive disorders
5304296|NCT02155946|Imaging|imaging
5304297|NCT02155946|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5304298|NCT02155946|Neurology|neurology
5304299|NCT02155946|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
5304300|NCT02155946|transcranial direct current stimulation|transcranial direct current stimulation
5304301|NCT02155920|Ependymoma|ependymoma
5304302|NCT02155920|Anaplastic Ependymoma|anaplastic ependymoma
5304303|NCT02155894|Rheumatoid arthritis, treat to target, telemedicine|rheumatoid arthritis, treat to target, telemedicine
5304304|NCT02155881|Drug therapy|drug therapy
5304305|NCT02155868|Cerebral near-infrared spectroscopy monitoring|cerebral near-infrared spectroscopy monitoring
5304306|NCT02155868|Postoperative complications|postoperative complications
5304307|NCT02155868|Cardiac surgery|cardiac surgery
5304308|NCT02155855|type 1 diabetes, home glucose monitor, upload, cloud|type 1 diabetes, home glucose monitor, upload, cloud
5304309|NCT02155842|exercise therapy|exercise therapy
5304310|NCT02155829|PTSD|ptsd
5304311|NCT02155829|TBI|tbi
5304312|NCT02155829|Riluzole|riluzole
5304313|NCT02155829|Rilutek|rilutek
5304314|NCT02155829|augmentation|augmentation
5304315|NCT02155829|supplement|supplement
5304316|NCT02155829|double blinded|double blinded
5304317|NCT02155829|clinical trial|clinical trial
5304318|NCT02155829|placebo|placebo
5304319|NCT02155829|RCT|rct
5304320|NCT02155829|Randomized Control Trial|randomized control trial
5304321|NCT02155816|inflammation|inflammation
5304322|NCT02155816|lipoproteins|lipoproteins
5304323|NCT02155816|omega 3|omega 3
5304324|NCT02155816|omega 7|omega 7
5304325|NCT02155803|Sarcoidosis-Associated Calcium Dysregulation|sarcoidosis-associated calcium dysregulation
5304326|NCT02155803|Sarcoidosis-Associated hypercalciuria|sarcoidosis-associated hypercalciuria
5304327|NCT02155803|hypercalcemia|hypercalcemia
5304328|NCT02155803|hypercalciuria|hypercalciuria
5304329|NCT02155803|nephrocalcinosis|nephrocalcinosis
5304330|NCT02155803|nephrolithiasis|nephrolithiasis
5304331|NCT02155803|interstitial nephritis|interstitial nephritis
5304332|NCT02155803|glomerulonephritis|glomerulonephritis
5304333|NCT02155803|acute kidney disease|acute kidney disease
5304334|NCT02155803|chronic kidney disease|chronic kidney disease
5304335|NCT02155790|safety, performance, hypertension, renal denervation|safety, performance, hypertension, renal denervation
5304336|NCT02155777|BRCA1|brca1
5304337|NCT02155777|BRCA2|brca2
5304338|NCT02155777|Risk-reducing surgery|risk-reducing surgery
5304339|NCT02155777|Oral Contraceptives|oral contraceptives
5304340|NCT02155764|tooth|tooth
5304341|NCT02155764|extraction|extraction
5304342|NCT02155764|alveolar socket|alveolar socket
5304343|NCT02155764|socket preservation|socket preservation
5304344|NCT02155764|ridge preservation|ridge preservation
5304345|NCT02155764|bone graft|bone graft
5304346|NCT02155764|tricalcium phosphate|tricalcium phosphate
5304347|NCT02155764|octacalcium phosphate|octacalcium phosphate
5304348|NCT02155764|xenograft|xenograft
5304349|NCT02155764|bio oss|bio oss
5304350|NCT02155751|Obesity prevention|obesity prevention
5304351|NCT02155751|Nutrition and exercise in pregnancy|nutrition and exercise in pregnancy
5304352|NCT02155751|Postpartum|postpartum
5304353|NCT02155751|Maternal obesity risk|maternal obesity risk
5304354|NCT02155738|IV acetaminophen|iv acetaminophen
5304355|NCT02155738|Postoperative pain|postoperative pain
5304356|NCT02155738|Pelvic organ prolapse surgery|pelvic organ prolapse surgery
5304357|NCT02155738|Pelvic organ prolapse repair|pelvic organ prolapse repair
5304361|NCT02155699|UHR, Remediation, Exercise, Intervention, Psychosis|uhr, remediation, exercise, intervention, psychosis
5304363|NCT02155686|Prevention|prevention
5304364|NCT02155686|Multiple chronic disease|multiple chronic disease
5304365|NCT02155686|Telemonitoring|telemonitoring
5304366|NCT02155686|Geriatric teleexpertise|geriatric teleexpertise
5304367|NCT02155686|Home heath care|home heath care
5185509|NCT02830334|Youth Suicide|youth suicide
5304368|NCT02155686|Medico-economics|medico-economics
5304369|NCT02155660|Obstructive Lung Diseases|obstructive lung diseases
5304370|NCT02155660|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5304371|NCT02155660|Lung Disease|lung disease
5304372|NCT02155660|Bronchial Diseases|bronchial diseases
5304373|NCT02155660|COPD Exacerbation|copd exacerbation
5304374|NCT02155660|Respiratory Tract Diseases|respiratory tract diseases
5304375|NCT02155647|Carcinoma, Merkel Cell|carcinoma, merkel cell
5304376|NCT02155647|MSB0010718C|msb0010718c
5304377|NCT02155647|avelumab|avelumab
5304378|NCT02155647|Bavencio|bavencio
5304379|NCT02155647|anti PD-L1|anti pd-l1
5304380|NCT02155647|JAVELIN Merkel 200|javelin merkel 200
5304381|NCT02155634|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5304382|NCT02155634|Multiple Myeloma|multiple myeloma
5304383|NCT02155634|Lenalidomide|lenalidomide
5304384|NCT02155634|Revlimid|revlimid
5304385|NCT02155634|Phase III|phase iii
5304386|NCT02155634|Phase IIIb|phase iiib
5304387|NCT02155634|Plasma Cell Dyscrasia|plasma cell dyscrasia
5304388|NCT02155621|cancer genomics|cancer genomics
5304389|NCT02155621|precision medicine|precision medicine
5304390|NCT02155621|metastatic cancer|metastatic cancer
5304391|NCT02155621|clinical decision-making|clinical decision-making
5304392|NCT02155608|ADHD|adhd
5304393|NCT02155608|neuromodulation|neuromodulation
5304394|NCT02155608|trigeminal nerve stimulation|trigeminal nerve stimulation
5304395|NCT02155608|cognition|cognition
5304396|NCT02155582|Solid tumors|solid tumors
5304397|NCT02155569|Cesarean, extraperitoneal|cesarean, extraperitoneal
5304398|NCT02155569|Cesarean|cesarean
5304399|NCT02155569|Pain|pain
5304400|NCT02155517|TCI,Schnider Model, Cortinez Model, BIS, Cardiac Output.|tci,schnider model, cortinez model, bis, cardiac output.
5304401|NCT02155504|Healthy volunteers|healthy volunteers
5304402|NCT02155504|Pharmacokinetics|pharmacokinetics
5304403|NCT02155504|ASP3700|asp3700
5304404|NCT02155504|Itraconazole|itraconazole
5304405|NCT02155504|Drug-drug interaction|drug-drug interaction
5304406|NCT02155491|venous, thromboembolism, embolism, DVT, Pulmonary Embolism, thrombosis|venous, thromboembolism, embolism, dvt, pulmonary embolism, thrombosis
5304407|NCT02155465|Ruxolitinib|ruxolitinib
5304408|NCT02155465|Erlotinib|erlotinib
5304409|NCT02155465|EGFR-mutant|egfr-mutant
5304410|NCT02155465|14-043|14-043
5304411|NCT02155452|ALA|ala
5304412|NCT02155452|Malignant gliomas|malignant gliomas
5304413|NCT02155439|Prospective, randomized controlled trial - pilot study|prospective, randomized controlled trial - pilot study
5304419|NCT02155400|thermal compression|thermal compression
5304420|NCT02155400|forced air warming|forced air warming
5304421|NCT02155387|EVLW|evlw
5304422|NCT02155387|EVLWI|evlwi
5304423|NCT02155387|PVPI|pvpi
5304424|NCT02155387|MICS|mics
5304425|NCT02155374|Glucocorticoid induced hyperglycemia, insulin, chemotherapy|glucocorticoid induced hyperglycemia, insulin, chemotherapy
5304426|NCT02155361|Diabetes mellitus|diabetes mellitus
5304427|NCT02155361|Diabetes complications|diabetes complications
5304428|NCT02155361|Pain|pain
5304429|NCT02155309|scopolamine|scopolamine
5304431|NCT02155309|sickness|sickness
5304432|NCT02155296|positive youth development|positive youth development
5304433|NCT02155296|restorative practices|restorative practices
5304434|NCT02155296|school climate|school climate
5304435|NCT02155296|social competency|social competency
5304436|NCT02155283|Chronic Low Back Pain|chronic low back pain
5304437|NCT02155283|Mild-to-Moderate Chronic Low Back Pain|mild-to-moderate chronic low back pain
5304438|NCT02155283|Continuous Passive Motion Devices|continuous passive motion devices
5304439|NCT02155270|Cataract|cataract
5304440|NCT02155270|Incision|incision
5304441|NCT02155270|Precut|precut
5304445|NCT02155270|Imaging|imaging
5304446|NCT02155270|Astigmatism|astigmatism
5304447|NCT02155270|Clear corneal incision|clear corneal incision
5304448|NCT02155257|Osteoarthritis|osteoarthritis
5304449|NCT02155257|Knee pain|knee pain
5304450|NCT02155257|Hip pain|hip pain
5304451|NCT02155257|Total Knee Replacement Surgery|total knee replacement surgery
5304452|NCT02155244|CBDS|cbds
5304453|NCT02155244|ERCP|ercp
5304454|NCT02155244|Dindo-Clavien classification|dindo-clavien classification
5423276|NCT01616407|Effects of psychostimulants on emotion recognition and empathy|effects of psychostimulants on emotion recognition and empathy
5304457|NCT02155218|Contrast Media|contrast media
5304458|NCT02155192|CNTO1959PSO2001|cnto1959pso2001
5304459|NCT02155192|C0743T08|c0743t08
5304460|NCT02155192|C0743T09|c0743t09
5304461|NCT02155192|C0743T12|c0743t12
5304462|NCT02155192|Psoriasis|psoriasis
5304463|NCT02155192|Pharmacogenomics|pharmacogenomics
5304464|NCT02155166|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
5304465|NCT02155166|anesthesia|anesthesia
5304466|NCT02155166|pain|pain
5304467|NCT02155166|nulliparous|nulliparous
5304468|NCT02155140|enteral feeding|enteral feeding
5304469|NCT02155140|Discharged|discharged
5304470|NCT02155140|surgical resection of an upper gastrointestinal malignancy|surgical resection of an upper gastrointestinal malignancy
5963065|NCT04275271|skill based intervention,|skill based intervention,
5249945|NCT02445300|TKA|tka
5185606|NCT02829918|refractory biliary tract cancer|refractory biliary tract cancer
5185607|NCT02829918|digestive diseases|digestive diseases
5185611|NCT02829905|radiography|radiography
5304471|NCT02155140|Nutritional supplementation via a jejunostomy|nutritional supplementation via a jejunostomy
5304472|NCT02155127|chronic kidney disease|chronic kidney disease
5304473|NCT02155127|physical function|physical function
5304474|NCT02155114|Hepcidins|hepcidins
5304475|NCT02155114|Homeostasis|homeostasis
5304476|NCT02155114|Iron/administration & dosage|iron/administration & dosage
5304477|NCT02155114|Biological Markers/blood|biological markers/blood
5304478|NCT02155101|Efficacy|efficacy
5304479|NCT02155101|Safety|safety
5304480|NCT02155101|Darunavir|darunavir
5304481|NCT02155101|HIV-1 RNA level|hiv-1 rna level
5304482|NCT02155101|Cameroon|cameroon
5304483|NCT02155088|Locally Advanced|locally advanced
5304484|NCT02155088|Metastatic|metastatic
5304485|NCT02155088|Recurrent|recurrent
5304486|NCT02155088|Pancreas|pancreas
5304487|NCT02155075|Breast neoplasm|breast neoplasm
5304488|NCT02155075|Breast implants|breast implants
5304489|NCT02155075|Mammography|mammography
5304490|NCT02155075|Breast imaging|breast imaging
5304491|NCT02155075|Imaging augmented breast|imaging augmented breast
5304492|NCT02155062|Nutritional biomarker|nutritional biomarker
5304493|NCT02155062|Dietary assessment|dietary assessment
5304494|NCT02155062|Whole grain|whole grain
5304495|NCT02155062|Wheat|wheat
5304497|NCT02155062|Alkylresorcinol|alkylresorcinol
5304498|NCT02155062|Urine|urine
5304499|NCT02155049|TED|ted
5304500|NCT02155049|Prostaglandin Analogues|prostaglandin analogues
5304501|NCT02155036|exercise|exercise
5304502|NCT02155036|rehabilitation|rehabilitation
5304503|NCT02155036|kidney function|kidney function
5304504|NCT02155036|cardiovascular disease risk|cardiovascular disease risk
5304505|NCT02155010|Dexmedetomidine|dexmedetomidine
5304506|NCT02155010|Spinal anesthesia|spinal anesthesia
5304510|NCT02154958|Follicular output rate|follicular output rate
5304511|NCT02154958|IVF|ivf
5304512|NCT02154958|ICSI|icsi
5304513|NCT02154932|Myomectomy, Misoprostol|myomectomy, misoprostol
5304514|NCT02154906|periodontal disease|periodontal disease
5304515|NCT02154906|periodontitis|periodontitis
5304516|NCT02154893|Ultrasound|ultrasound
5304517|NCT02154893|Laser|laser
5304518|NCT02154893|Therapeutic exercise|therapeutic exercise
5304519|NCT02154893|Rehabilitation|rehabilitation
5304522|NCT02154880|lung|lung
5304523|NCT02154880|aging|aging
5304524|NCT02154867|IBS-D|ibs-d
5304525|NCT02154867|FMT|fmt
5304526|NCT02154867|metagenomics|metagenomics
5304527|NCT02154867|gut microbiome|gut microbiome
5304528|NCT02154854|Renal|renal
5304529|NCT02154854|Transplantation|transplantation
5304530|NCT02154854|Tacrolimus|tacrolimus
5304531|NCT02154854|Arterial stiffness|arterial stiffness
5304532|NCT02154854|Vascular fibrose plasma markers|vascular fibrose plasma markers
5304533|NCT02154841|Postoperative|postoperative
5304534|NCT02154841|nutrition|nutrition
5304535|NCT02154841|taste|taste
5304536|NCT02154841|perception|perception
5304537|NCT02154841|preference|preference
5304538|NCT02154841|choice|choice
5304539|NCT02154828|Children|children
5304540|NCT02154828|aged|aged
5304541|NCT02154828|3 to 6 years|3 to 6 years
5304542|NCT02154815|End Stage Renal Disease|end stage renal disease
5304543|NCT02154815|Renal transplantation|renal transplantation
5304544|NCT02154815|Dialysis|dialysis
5304545|NCT02154815|Pre-emptive transplantation|pre-emptive transplantation
5304752|NCT02153788|Insomnia|insomnia
5304546|NCT02154815|Psychological adjustment|psychological adjustment
5304547|NCT02154815|Quality of life.|quality of life.
5304548|NCT02154776|LEE011,|lee011,
5304549|NCT02154776|buparlisib,|buparlisib,
5304550|NCT02154776|letrozole,|letrozole,
5304551|NCT02154776|HR +,|hr +,
5304552|NCT02154776|HER2 - negative,|her2 - negative,
5304553|NCT02154776|post-menopausal,|post-menopausal,
5304554|NCT02154776|breast cancer,|breast cancer,
5304555|NCT02154776|CDK 4/6,|cdk 4/6,
5304556|NCT02154776|PI3K,|pi3k,
5304557|NCT02154776|MTD|mtd
5304562|NCT02154763|Intraperitoneal|intraperitoneal
5304563|NCT02154750|Atrioventricular delay|atrioventricular delay
5304564|NCT02154750|AV delay|av delay
5304565|NCT02154750|Pacemaker|pacemaker
5304566|NCT02154750|Sick Sinus Syndrome|sick sinus syndrome
5304567|NCT02154750|Bradycardia|bradycardia
5304568|NCT02154750|PR interval|pr interval
5304569|NCT02154750|Atrioventricular block|atrioventricular block
5304570|NCT02154750|AV block|av block
5304571|NCT02154750|Echocardiography|echocardiography
5304572|NCT02154750|Arrhythmia|arrhythmia
5304573|NCT02154750|AV optimization|av optimization
5304574|NCT02154737|Pancreatic|pancreatic
5304575|NCT02154737|Gemcitabine|gemcitabine
5304576|NCT02154737|Gemzar|gemzar
5304577|NCT02154737|erlotinib|erlotinib
5304578|NCT02154737|Tarceva|tarceva
5963066|NCT04275271|IMB model,|imb model,
5963067|NCT04275271|Professional Competence,|professional competence,
5963068|NCT04275271|Sexual Health.|sexual health.
5963069|NCT04275206|medicinal water,inflammation,biomarker,inflammatory disease|medicinal water,inflammation,biomarker,inflammatory disease
5963070|NCT04274686|Tegaderm bandage|tegaderm bandage
5304579|NCT02154711|mitochondrial disease|mitochondrial disease
5304580|NCT02154711|magnetic resonance imaging|magnetic resonance imaging
5304581|NCT02154711|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5304582|NCT02154711|creatine|creatine
5304583|NCT02154711|phosphocreatine|phosphocreatine
5304584|NCT02154685|Smoking|smoking
5304585|NCT02154685|Nicotine|nicotine
5304586|NCT02154685|Addiction|addiction
5304587|NCT02154685|Cessation|cessation
5304588|NCT02154620|Distal radius fracture|distal radius fracture
5304589|NCT02154620|wrist fracture|wrist fracture
5304590|NCT02154620|volar plate|volar plate
5304591|NCT02154620|surgical treatment|surgical treatment
5304592|NCT02154620|plaster immobilisation|plaster immobilisation
5304593|NCT02154607|oral lichen planus|oral lichen planus
5304594|NCT02154607|recurrence|recurrence
5304595|NCT02154607|Treatment|treatment
5304596|NCT02154607|cancer|cancer
5304597|NCT02154607|Primary disease Management|primary disease management
5304598|NCT02154594|Acacia|acacia
5304599|NCT02154594|Chlorhexidine|chlorhexidine
5304600|NCT02154594|Gingivitis|gingivitis
5304601|NCT02154594|Orthodontic appliances.|orthodontic appliances.
5304602|NCT02154581|Dental implants|dental implants
5304603|NCT02154581|Esthetic score|esthetic score
5304604|NCT02154581|Immediate implants|immediate implants
5304605|NCT02154581|Gingival biotype|gingival biotype
5304606|NCT02154568|Hyperpolarized gas MRI|hyperpolarized gas mri
5304607|NCT02154542|Nava|nava
5304608|NCT02154542|Mechanical ventilation|mechanical ventilation
5304609|NCT02154477|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5304610|NCT02154464|Morphine-sparing|morphine-sparing
5304611|NCT02154464|Paracetamol|paracetamol
5304612|NCT02154464|Obesity|obesity
5304613|NCT02154464|Gastric banding|gastric banding
5304614|NCT02154425|Cimzia®|cimzia®
5304615|NCT02154425|CZP|czp
5304616|NCT02154425|Breastfeeding|breastfeeding
5304617|NCT02154425|Nursing|nursing
5304618|NCT02154425|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
5304619|NCT02154412|Respiration|respiration
5304620|NCT02154412|Motor control|motor control
5304621|NCT02154412|Blood Pressure|blood pressure
5304622|NCT02154412|Orthostatic Hypotension|orthostatic hypotension
5304623|NCT02154386|bone augmentation|bone augmentation
5304624|NCT02154386|tooth extraction|tooth extraction
5304625|NCT02154386|dental implant|dental implant
5304626|NCT02154360|HIV infection|hiv infection
5304627|NCT02154360|NK-1R antagonists|nk-1r antagonists
5304628|NCT02154360|aprepitant|aprepitant
5304629|NCT02154360|ritonavir boosting|ritonavir boosting
5304633|NCT02154334|Healthy|healthy
5304634|NCT02154334|Esketamine|esketamine
5304635|NCT02154334|Mometasone|mometasone
5304636|NCT02154334|Oxymetazoline|oxymetazoline
5304637|NCT02154334|Phase 1|phase 1
5304638|NCT02154308|Influenza|influenza
5304639|NCT02154308|Influenza vaccine|influenza vaccine
5304640|NCT02154308|Split influenza vaccine|split influenza vaccine
5304641|NCT02154308|Seasonal influenza vaccine|seasonal influenza vaccine
5304642|NCT02154282|hepatic encephalopathy|hepatic encephalopathy
5304643|NCT02154282|covert hepatic encephalopathy|covert hepatic encephalopathy
5304644|NCT02154282|cirrhosis|cirrhosis
5304645|NCT02154269|Chagas disease|chagas disease
5304646|NCT02154269|G-CSF|g-csf
5304647|NCT02154269|Cell therapy|cell therapy
5304648|NCT02154256|walking|walking
5304649|NCT02154256|incentives|incentives
5304650|NCT02154256|exercise|exercise
5304651|NCT02154256|habits|habits
5304652|NCT02154230|weight loss|weight loss
5304662|NCT02154178|invasive fungal infection|invasive fungal infection
5304663|NCT02154178|Candida|candida
5304664|NCT02154165|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5304665|NCT02154165|Phototherapy|phototherapy
5304666|NCT02154165|Light emitting diodes|light emitting diodes
5304667|NCT02154165|Blue light|blue light
5309217|NCT02133092|RSV|rsv
5304668|NCT02154165|Turquoise light|turquoise light
5304669|NCT02154152|Bed wetting|bed wetting
5304670|NCT02154152|Primary Enuresis|primary enuresis
5304671|NCT02154152|Frequency|frequency
5304672|NCT02154152|Efficacy|efficacy
5304673|NCT02154152|Homoeopathic Medicine|homoeopathic medicine
5304674|NCT02154152|Causticum 200c|causticum 200c
5304675|NCT02154139|Pharmacological therapy|pharmacological therapy
5304676|NCT02154113|Syneron|syneron
5304677|NCT02154113|Velashape|velashape
5304678|NCT02154113|ELOS|elos
5304679|NCT02154113|Ultrashape|ultrashape
5304680|NCT02154100|Metabolic Syndrome|metabolic syndrome
5304681|NCT02154100|Arterial Stiffness|arterial stiffness
5304682|NCT02154100|Blood Pressure|blood pressure
5304683|NCT02154100|Endothelial Function|endothelial function
5304684|NCT02154100|Tart Cherries|tart cherries
5304685|NCT02154087|Venous leg ulcer|venous leg ulcer
5304686|NCT02154087|Ulcer|ulcer
5304687|NCT02154087|Venous stasis|venous stasis
5304688|NCT02154087|Compression|compression
5343006|NCT01981161|progressive multifocal leucoencephalopathy|progressive multifocal leucoencephalopathy
5304689|NCT02154074|Dexmedetomidine perioperative blood glucose and insulin|dexmedetomidine perioperative blood glucose and insulin
5304690|NCT02154061|Flu Vaccine, Intestinal Microbiome, Antibiotics|flu vaccine, intestinal microbiome, antibiotics
5304691|NCT02154035|Viral Suppression|viral suppression
5304692|NCT02154035|Functional Cure|functional cure
5304699|NCT02153996|Malaria Immunity Longevity|malaria immunity longevity
5304700|NCT02153983|Obesity|obesity
5304701|NCT02153983|Colchicine|colchicine
5304702|NCT02153983|Inflammation|inflammation
5304703|NCT02153983|Metabolic Syndrome|metabolic syndrome
5304704|NCT02153983|Dyslipidemia|dyslipidemia
5304705|NCT02153970|Clinical Outcomes Measures|clinical outcomes measures
5304706|NCT02153970|Proxy Reported Outcome|proxy reported outcome
5304707|NCT02153970|Pediatric|pediatric
5304708|NCT02153970|Neuromuscular Disease|neuromuscular disease
5304709|NCT02153970|Cerebral Palsy|cerebral palsy
5304715|NCT02153944|Startle|startle
5304716|NCT02153944|Induced-Threat|induced-threat
5304717|NCT02153944|Memory|memory
5304718|NCT02153944|Stimulant|stimulant
5304719|NCT02153944|Cognitive Interference|cognitive interference
5199851|NCT02745132|MRI functional|mri functional
5304720|NCT02153931|Children's Tumor Foundation|children's tumor foundation
5304721|NCT02153931|Social Support|social support
5304722|NCT02153931|Online|online
5304723|NCT02153931|Anxiety|anxiety
5304724|NCT02153931|Depression|depression
5304725|NCT02153918|Surgery|surgery
5304726|NCT02153918|Neoadjuvant|neoadjuvant
5304727|NCT02153918|CD8 Cell Infiltrate Response|cd8 cell infiltrate response
5304728|NCT02153918|CD4 Cell Infiltrate Response|cd4 cell infiltrate response
5304729|NCT02153918|Vaccine|vaccine
5304730|NCT02153905|Melanoma|melanoma
5304731|NCT02153905|Immunotherapy|immunotherapy
5304732|NCT02153905|Metastatic Cancer|metastatic cancer
5304733|NCT02153905|Gene Therapy|gene therapy
5304734|NCT02153905|T Cells|t cells
5304735|NCT02153892|Functional Mitral Regurgitation|functional mitral regurgitation
5304736|NCT02153892|Heart Failure|heart failure
5304737|NCT02153892|Ventricular Reshaping|ventricular reshaping
5304738|NCT02153879|HDL|hdl
5304739|NCT02153879|Niacin|niacin
5304740|NCT02153879|Fenofibrate|fenofibrate
5304741|NCT02153879|Diabetes|diabetes
5304742|NCT02153879|Metabolomics|metabolomics
5304743|NCT02153866|rotavirus vaccine|rotavirus vaccine
5304744|NCT02153840|Stable Plaque Psoriasis|stable plaque psoriasis
5304745|NCT02153827|Shoulder|shoulder
5304746|NCT02153827|Eccentric Training|eccentric training
5304747|NCT02153827|Subacromial Impingement Syndrome|subacromial impingement syndrome
5304749|NCT02153814|In vitro fertilization|in vitro fertilization
5304750|NCT02153814|Endometrial injury|endometrial injury
5304751|NCT02153801|High Ligation, Low ligation, Genito-urinary function, laparoscopy, rectal cancer, aterior resection, Total mesorectal Excision, anastomotic leak.|high ligation, low ligation, genito-urinary function, laparoscopy, rectal cancer, aterior resection, total mesorectal excision, anastomotic leak.
5304753|NCT02153788|HIV|hiv
5304754|NCT02153775|Progressive muscle relaxation|progressive muscle relaxation
5304755|NCT02153775|Cigarette|cigarette
5304756|NCT02153775|Smoking|smoking
5304758|NCT02153762|Atopic Dermatitis|atopic dermatitis
5304759|NCT02153762|AD|ad
5304760|NCT02153723|Treatment trial, Rett syndrome, Glatiramer acetate|treatment trial, rett syndrome, glatiramer acetate
5304761|NCT02153710|Aphasia|aphasia
5304762|NCT02153710|Anomia|anomia
5304763|NCT02153697|solar lentigines|solar lentigines
5304764|NCT02153697|Q-switches Laser|q-switches laser
5304765|NCT02153697|bleaching cream|bleaching cream
5304766|NCT02153684|smoking|smoking
5304767|NCT02153684|small airway dysfunction|small airway dysfunction
5304768|NCT02153684|mild COPD|mild copd
5304769|NCT02153684|dyspnea|dyspnea
5304770|NCT02153684|exercise|exercise
5304771|NCT02153684|clinical outcomes|clinical outcomes
5304772|NCT02153671|LAIV H5N2|laiv h5n2
5304773|NCT02153671|Influenza vaccine|influenza vaccine
5304774|NCT02153671|Russia|russia
5304775|NCT02153658|PrePex|prepex
5304776|NCT02153658|Odor|odor
5304777|NCT02153658|Cleaning technique|cleaning technique
5304778|NCT02153658|Male Circumcision|male circumcision
5304779|NCT02153658|HIV|hiv
5304780|NCT02153658|AIDS|aids
5304781|NCT02153658|Chlorhexidine|chlorhexidine
5304782|NCT02153658|Soap|soap
5304783|NCT02153645|Parkinson's Disease|parkinson's disease
5304784|NCT02153645|Levodopa Induced Dyskinesias (LID)|levodopa induced dyskinesias (lid)
5304785|NCT02153645|Dyskinesias|dyskinesias
5304786|NCT02153645|Parkinsonism|parkinsonism
5304787|NCT02153632|Parkinson's Disease|parkinson's disease
5304788|NCT02153632|Levodopa Induced Dyskinesia (LID)|levodopa induced dyskinesia (lid)
5304789|NCT02153632|LID|lid
5304790|NCT02153632|Parkinsonism|parkinsonism
5304791|NCT02153632|Dyskinesia|dyskinesia
5304792|NCT02153619|Grief|grief
5304793|NCT02153619|bereavement|bereavement
5304794|NCT02153619|questionnaires|questionnaires
5304795|NCT02153619|therapy sessions|therapy sessions
5304796|NCT02153619|14-102|14-102
5304797|NCT02153606|Glycerin Suppositories|glycerin suppositories
5304798|NCT02153606|Enteral Nutrition|enteral nutrition
5304799|NCT02153606|Enterocolitis, Necrotizing|enterocolitis, necrotizing
5304800|NCT02153606|Infant, Premature|infant, premature
5304801|NCT02153606|Meconium|meconium
5304802|NCT02153593|Clinical trial|clinical trial
5304803|NCT02153593|Randomized|randomized
5304804|NCT02153593|Fibrin glue|fibrin glue
5304805|NCT02153593|Tranexamic acid|tranexamic acid
5265796|NCT02355457|acs|acs
5304806|NCT02153593|Blood loss|blood loss
5304807|NCT02153567|Functional dyspepsia|functional dyspepsia
5304808|NCT02153567|symptom response|symptom response
5304809|NCT02153567|postprandial fullness|postprandial fullness
5304811|NCT02153567|Depression|depression
5304812|NCT02153528|Bangladesh|bangladesh
5304813|NCT02153528|Rimfapicin|rimfapicin
5304814|NCT02153515|Finger prick with diabetic lancet|finger prick with diabetic lancet
5304815|NCT02153515|Fingerprick|fingerprick
5304816|NCT02153515|Fresh|fresh
5304817|NCT02153515|Your own blood|your own blood
5304818|NCT02153515|autologous blood|autologous blood
5304819|NCT02153515|Dry eyes|dry eyes
5304820|NCT02153515|Sjogren's disease with dry eyes|sjogren's disease with dry eyes
5304821|NCT02153515|Persistent corneal epithelial defects|persistent corneal epithelial defects
5304822|NCT02153515|Chronic corneal ulcers|chronic corneal ulcers
5199939|NCT02744677|TPV|tpv
5304823|NCT02153463|Tourette Syndrome|tourette syndrome
5304824|NCT02153463|Persistent Tic Disorder|persistent tic disorder
5304825|NCT02153463|Physical Activity|physical activity
5304826|NCT02153463|Quality of Life|quality of life
5304827|NCT02153450|pancreatic cancer|pancreatic cancer
5304828|NCT02153450|Radiation|radiation
5304829|NCT02153450|Metformin|metformin
5304830|NCT02153450|Pancreatic Adenocarcinomas|pancreatic adenocarcinomas
5304831|NCT02153411|Asthma control|asthma control
5304832|NCT02153398|Gastric ulcer (GU)|gastric ulcer (gu)
5304833|NCT02153398|Duodenal ulcer (DU)|duodenal ulcer (du)
5304834|NCT02153398|Anastomotic ulcer (AU)|anastomotic ulcer (au)
5304835|NCT02153398|Non-erosive reflux esophagitis disease (NERD)|non-erosive reflux esophagitis disease (nerd)
5304836|NCT02153398|Reflux esophagitis (RE)|reflux esophagitis (re)
5304837|NCT02153398|Zollinger-Ellison syndrome|zollinger-ellison syndrome
5304838|NCT02153385|Yoga, heart rate variability, stress, mood, women|yoga, heart rate variability, stress, mood, women
5304839|NCT02153372|large bone defect, bone marrow-derived mononuclear cells|large bone defect, bone marrow-derived mononuclear cells
5304840|NCT02153359|asthma|asthma
5304841|NCT02153359|HEPA|hepa
5304842|NCT02153359|air pollutants|air pollutants
5304843|NCT02153359|lung function|lung function
5304844|NCT02153359|home environment|home environment
5304845|NCT02153359|respiratory symptoms|respiratory symptoms
5304846|NCT02153346|indirect cost|indirect cost
5304847|NCT02153346|asthma|asthma
5304848|NCT02153333|Human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
5304849|NCT02153333|Serologic response|serologic response
5304850|NCT02153333|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
5304851|NCT02153333|Laboratory evaluations|laboratory evaluations
5304951|NCT02152761|hip fracture|hip fracture
5304853|NCT02153320|Persistence of the immune response|persistence of the immune response
5304854|NCT02153320|Adjuvants|adjuvants
5304855|NCT02153294|low tidal volume|low tidal volume
5304856|NCT02153294|high tidal volume|high tidal volume
5304857|NCT02153294|protective ventilation|protective ventilation
5304858|NCT02153294|ARDS|ards
5304859|NCT02153281|Depression|depression
5304860|NCT02153281|Positron Emission Tomography (PET)|positron emission tomography (pet)
5304861|NCT02153281|MAO-B|mao-b
5304862|NCT02153268|Safety|safety
5304863|NCT02153268|efficacy|efficacy
5304864|NCT02153268|BonoFill|bonofill
5304865|NCT02153268|bone filler|bone filler
5304866|NCT02153268|autologous adipose tissue derived cells (HATDCs)|autologous adipose tissue derived cells (hatdcs)
5304867|NCT02153268|Bone augmentation|bone augmentation
5304868|NCT02153268|sinus augmentation|sinus augmentation
5304869|NCT02153268|Bone grafting after removal of cysts from jaws|bone grafting after removal of cysts from jaws
5304870|NCT02153255|Morquio|morquio
5304871|NCT02153255|Mucopolysaccharidosis|mucopolysaccharidosis
5304872|NCT02153255|Galactosamine-6-Sulfatase|galactosamine-6-sulfatase
5304873|NCT02153255|GALNS|galns
5304874|NCT02153242|Pacing|pacing
5304875|NCT02153242|Haemodynamics|haemodynamics
5304876|NCT02153242|Pilot|pilot
5304877|NCT02153229|Histological diagnosis of MPM|histological diagnosis of mpm
5304878|NCT02153229|epitheliod subtype|epitheliod subtype
5304879|NCT02153229|limited to the hemithorax|limited to the hemithorax
5304880|NCT02153229|macroscopically complete resection of the tumor|macroscopically complete resection of the tumor
5304881|NCT02153203|Autism spectrum disorder|autism spectrum disorder
5304882|NCT02153203|Problem behavior|problem behavior
5304883|NCT02153190|Type 1 Diabetes,|type 1 diabetes,
5304884|NCT02153190|T1DM,|t1dm,
5304885|NCT02153190|Artificial Pancreas|artificial pancreas
5304886|NCT02153177|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5304888|NCT02153177|rotator cuff tear|rotator cuff tear
5304889|NCT02153177|NSAIDs|nsaids
5304890|NCT02153177|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5304891|NCT02153177|rotator cuff repair|rotator cuff repair
5304892|NCT02153164|Enthalpy|enthalpy
5304893|NCT02153164|Trendelenberg position|trendelenberg position
5304894|NCT02153164|Mechanical ventilation|mechanical ventilation
5304895|NCT02153138|vegetarian diet|vegetarian diet
5304896|NCT02153138|vegan|vegan
5304897|NCT02153138|cardiovascular diseases|cardiovascular diseases
5304898|NCT02153138|endothelial function|endothelial function
5200017|NCT02744261|User Experience|user experience
5963071|NCT04274686|Bag mask ventilation|bag mask ventilation
5304899|NCT02153138|carotid intima-media thickness|carotid intima-media thickness
5304900|NCT02153112|Drug therapy|drug therapy
5304901|NCT02153099|Drug therapy|drug therapy
5304902|NCT02153086|Pharmacological therapy|pharmacological therapy
5304903|NCT02153073|Pharmacological therapy|pharmacological therapy
5304904|NCT02153060|immune thrombocytopenia|immune thrombocytopenia
5304905|NCT02153060|dexamethasone|dexamethasone
5304906|NCT02153060|efficacy|efficacy
5304907|NCT02153060|safety|safety
5304908|NCT02153047|Smoking cessation|smoking cessation
5304909|NCT02153047|Spirometry|spirometry
5304910|NCT02153047|Primary health care|primary health care
5304911|NCT02153034|Buruli ulcer|buruli ulcer
5304912|NCT02153034|Mycobacterium ulcerans disease|mycobacterium ulcerans disease
5304913|NCT02153034|M. ulcerans disease|m. ulcerans disease
5304914|NCT02153021|anthropometric parameters;|anthropometric parameters;
5304915|NCT02153021|biochemical parameters;|biochemical parameters;
5304916|NCT02153021|inflammatory markers|inflammatory markers
5304917|NCT02153021|neuropeptide markers|neuropeptide markers
5304918|NCT02153021|phototherapy|phototherapy
5304919|NCT02153008|Strep throat|strep throat
5304921|NCT02152956|leukemia|leukemia
5304922|NCT02152956|myelogenous|myelogenous
5304923|NCT02152956|myeloid|myeloid
5304924|NCT02152956|refractory|refractory
5304925|NCT02152930|Fish oil supplements|fish oil supplements
5304926|NCT02152930|Supervised Exercise Training|supervised exercise training
5304927|NCT02152930|Walking distance|walking distance
5304928|NCT02152930|Hemorheological factors|hemorheological factors
5304929|NCT02152930|Cardiovascular risk|cardiovascular risk
5304930|NCT02152904|Peptic ulcer bleeding|peptic ulcer bleeding
5304931|NCT02152904|rebleeding|rebleeding
5304932|NCT02152904|mortality|mortality
5304933|NCT02152904|nationwide|nationwide
5304934|NCT02152891|Emergency Medical Services|emergency medical services
5304935|NCT02152891|Elderly|elderly
5304936|NCT02152878|transcranial direct current stimulation|transcranial direct current stimulation
5304937|NCT02152878|non invasive brain stimulation|non invasive brain stimulation
5304938|NCT02152878|bipolar disorder|bipolar disorder
5304939|NCT02152878|depression|depression
5304940|NCT02152865|medication|medication
5304941|NCT02152852|Type 2 Diabetes|type 2 diabetes
5304942|NCT02152826|Sensitivity|sensitivity
5301548|NCT02168699|children|children
5399253|NCT01725269|PAH|pah
5304954|NCT02152761|randomized|randomized
5304955|NCT02152761|muscle wasting|muscle wasting
5304956|NCT02152761|atrophy|atrophy
5304957|NCT02152748|glioblastoma|glioblastoma
5304958|NCT02152748|morphological and molecular changes|morphological and molecular changes
5304959|NCT02152748|progression|progression
5304960|NCT02152748|therapy-resistance|therapy-resistance
5304961|NCT02152722|Breath test|breath test
5304962|NCT02152722|Volatile Organic Compounds|volatile organic compounds
5304963|NCT02152722|VOC|voc
5304964|NCT02152722|oxidative stress|oxidative stress
5304965|NCT02152722|radiation biodosimetry|radiation biodosimetry
5304966|NCT02152722|metabolomics|metabolomics
5304967|NCT02152722|GCxGC TOF-MS|gcxgc tof-ms
5304968|NCT02152709|Safety|safety
5304969|NCT02152709|Immunogenicity|immunogenicity
5304970|NCT02152709|Vaccine|vaccine
5304971|NCT02152709|Hepatitis B|hepatitis b
5304972|NCT02152657|Spinal cord injury|spinal cord injury
5304973|NCT02152657|Stem cell transplantation|stem cell transplantation
5304974|NCT02152657|Mesenchymal stem cell|mesenchymal stem cell
5304975|NCT02152644|amyloidosis-carpal tunnel|amyloidosis-carpal tunnel
5304976|NCT02152631|Therapy, Platinum, Kras +|therapy, platinum, kras +
5304977|NCT02152618|Serious emotional disturbance|serious emotional disturbance
5304978|NCT02152618|foster care|foster care
5304979|NCT02152618|child protective services|child protective services
5304980|NCT02152605|SGRQ|sgrq
5304981|NCT02152605|vilanterol|vilanterol
5304982|NCT02152605|long-acting beta2-agonist|long-acting beta2-agonist
5304983|NCT02152605|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5304984|NCT02152605|COPD|copd
5304985|NCT02152605|umeclidinium|umeclidinium
5304986|NCT02152592|Postoperative pain|postoperative pain
5304987|NCT02152592|Ambulatory surgery|ambulatory surgery
5304988|NCT02152592|NSAIDS|nsaids
5304989|NCT02152592|CR Oxycodone|cr oxycodone
5304990|NCT02152592|Compliance to study medication|compliance to study medication
5304991|NCT02152579|Stable Angina|stable angina
5304992|NCT02152553|Biomarker|biomarker
5304993|NCT02152553|Glucocorticoids|glucocorticoids
5304994|NCT02152553|Metabolism|metabolism
5304995|NCT02152553|Pharmacology|pharmacology
5304996|NCT02152553|Metabolomics|metabolomics
5304997|NCT02152540|TBI|tbi
5304998|NCT02152540|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5304999|NCT02152540|magnetic resonance imaging functional|magnetic resonance imaging functional
5305000|NCT02152540|Quality of life|quality of life
5305001|NCT02152540|Executive Function|executive function
5305002|NCT02152540|Veterans|veterans
5305003|NCT02152501|obese|obese
5305004|NCT02152501|overweight|overweight
5305005|NCT02152501|exercise|exercise
5305006|NCT02152501|energy expenditure differences|energy expenditure differences
5305007|NCT02152501|relative reinforcing values (RRV)|relative reinforcing values (rrv)
5305008|NCT02152501|food|food
5305009|NCT02152501|physical activity|physical activity
5305010|NCT02152501|biological|biological
5305011|NCT02152501|neurobehavioral|neurobehavioral
5305012|NCT02152501|behavioral|behavioral
5305013|NCT02152488|cerebral blood flow|cerebral blood flow
5305014|NCT02152488|position|position
5305015|NCT02152488|cervical spine|cervical spine
5305016|NCT02152475|Blue-LED|blue-led
5305017|NCT02152475|Curcumin|curcumin
5305018|NCT02152475|PDT|pdt
5305019|NCT02152475|Oral disinfection|oral disinfection
5305020|NCT02152462|exergaming|exergaming
5305021|NCT02152462|breast cancer|breast cancer
5305022|NCT02152462|African American women|african american women
5305023|NCT02152462|obesity|obesity
5305024|NCT02152423|enoxaparin|enoxaparin
5305025|NCT02152423|Enoxamed|enoxamed
5305026|NCT02152423|lovenox|lovenox
5305027|NCT02152423|anti Xa|anti xa
5305028|NCT02152423|acute coronary syndrome|acute coronary syndrome
5305029|NCT02152410|acupuncture|acupuncture
5305030|NCT02152410|renal colic|renal colic
5305031|NCT02152358|Cytomegalovirus|cytomegalovirus
5305032|NCT02152358|Herpes simplex virus|herpes simplex virus
5305033|NCT02152358|ICU|icu
5305034|NCT02152358|mechanical ventilation|mechanical ventilation
5305035|NCT02152358|mortality|mortality
5305037|NCT02152358|PCR|pcr
5305038|NCT02152345|kidney|kidney
5305039|NCT02152345|renal|renal
5305040|NCT02152345|transplant|transplant
5305041|NCT02152345|belatacept|belatacept
5305042|NCT02152345|delayed graft function|delayed graft function
5305043|NCT02152345|thymoglobulin|thymoglobulin
5305044|NCT02152345|tacrolimus|tacrolimus
5305045|NCT02152345|kidney function|kidney function
5305046|NCT02152345|immunosuppression|immunosuppression
5305047|NCT02152345|NGAL|ngal
5305048|NCT02152332|JNJ-54861912|jnj-54861912
5305049|NCT02152332|RSC-385896|rsc-385896
5305050|NCT02152332|MTS-0385896A|mts-0385896a
5305051|NCT02152332|Phase 1|phase 1
5305052|NCT02152332|Moxifloxacin|moxifloxacin
5305053|NCT02152332|Placebo|placebo
5305054|NCT02152332|Healthy|healthy
5305055|NCT02152319|Parkinson's disease|parkinson's disease
5305056|NCT02152319|Telemedicine|telemedicine
5305058|NCT02152319|Kinesia|kinesia
5305061|NCT02152319|Dyskinesia|dyskinesia
5305062|NCT02152306|Fimasartan|fimasartan
5305063|NCT02152306|Fimasartan and Amlodipine|fimasartan and amlodipine
5305064|NCT02152306|Antihypertension|antihypertension
5305065|NCT02152267|Temporomandibular|temporomandibular
5305066|NCT02152267|Musculoskeletal Diseases|musculoskeletal diseases
5305067|NCT02152267|Electrical Stimulation of the Brain|electrical stimulation of the brain
5305068|NCT02152267|Prefrontal Cortex|prefrontal cortex
5305070|NCT02152241|Crohn|crohn
5305071|NCT02152241|Colitis|colitis
5305072|NCT02152241|Function|function
5305073|NCT02152176|pain|pain
5305074|NCT02152176|analgesia|analgesia
5305075|NCT02152176|morphine|morphine
5305076|NCT02152176|PCA|pca
5305077|NCT02152176|Nurse|nurse
5305078|NCT02152163|Assessing the efficacy of IV Ibuprofen for Treatment of Pain in Orthopedic Trauma Patients|assessing the efficacy of iv ibuprofen for treatment of pain in orthopedic trauma patients
5305079|NCT02152150|iron|iron
5305080|NCT02152150|anemia|anemia
5305081|NCT02152150|bio-fortification|bio-fortification
5305082|NCT02152150|children|children
5305083|NCT02152150|India|india
5305084|NCT02152124|Acromegaly|acromegaly
5305085|NCT02152124|Acromegaly treatment|acromegaly treatment
5305086|NCT02152124|Long-acting somatostatin analogs|long-acting somatostatin analogs
5305087|NCT02152124|Pegvisomant|pegvisomant
5305088|NCT02152124|Insulin sensitivity|insulin sensitivity
5305089|NCT02152124|Gut hormones|gut hormones
5305090|NCT02152124|Lipid metabolism|lipid metabolism
5305091|NCT02152124|Adipokines|adipokines
5305092|NCT02152111|Obesity|obesity
5305093|NCT02152111|Coconut flour|coconut flour
5305094|NCT02152111|Diet quality|diet quality
5305095|NCT02152111|Cardiovascular risk factor|cardiovascular risk factor
5305096|NCT02152085|Walking|walking
5305097|NCT02152085|Mobility|mobility
5305098|NCT02152085|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5305099|NCT02152085|Multiple sclerosis|multiple sclerosis
5305100|NCT02152059|Small cell lung cancer|small cell lung cancer
5305101|NCT02152059|BIBF1120|bibf1120
5305102|NCT02152059|nintedanib|nintedanib
5305103|NCT02152059|platinum-sensitive|platinum-sensitive
5305104|NCT02152033|Substance Abuse|substance abuse
5305105|NCT02152033|Continuing Care|continuing care
5305106|NCT02152033|Recovery|recovery
5305107|NCT02152033|Substance Abuse Treatment|substance abuse treatment
5305109|NCT02152033|Family|family
5305110|NCT02152033|Young Adult|young adult
5305111|NCT02152007|pachyonychia congenita|pachyonychia congenita
5305112|NCT02151994|BIA 5-1058|bia 5-1058
5305113|NCT02151994|hypertension|hypertension
5305114|NCT02151994|chronic heart failure|chronic heart failure
5305115|NCT02151994|cardiovascular disorders|cardiovascular disorders
5305117|NCT02151942|elective endovascular AAA repair|elective endovascular aaa repair
5305118|NCT02151929|myocardial infarction|myocardial infarction
5174151|NCT02903862|Caregivers|caregivers
5305119|NCT02151929|primary PCI|primary pci
5305120|NCT02151929|stent|stent
5305121|NCT02151916|dental caries|dental caries
5305122|NCT02151916|early childhood caries|early childhood caries
5305123|NCT02151916|topical fluorides|topical fluorides
5305124|NCT02151916|fluoride varnish|fluoride varnish
5305125|NCT02151903|NHL|nhl
5305126|NCT02151903|Immunocytokine|immunocytokine
5305127|NCT02151903|Lymphoma|lymphoma
5305128|NCT02151903|Non-Hodgkin|non-hodgkin
5305129|NCT02151903|B-cell|b-cell
5305130|NCT02151903|IL (interleukin)|il (interleukin)
5305131|NCT02151890|POF|pof
5305132|NCT02151890|ESS|ess
5305133|NCT02151890|stem cell|stem cell
5305134|NCT02151877|Ischemia/reperfusion injury|ischemia/reperfusion injury
5305135|NCT02151864|liver cancer|liver cancer
5305136|NCT02151864|cirrhosis|cirrhosis
5305137|NCT02151864|Child-Pugh A|child-pugh a
5305138|NCT02151864|Hedgehog|hedgehog
5305139|NCT02151851|Rheumatoid Arthritis|rheumatoid arthritis
5305140|NCT02151851|TNFα antagonist|tnfα antagonist
5305141|NCT02151851|Certolizumab Pegol|certolizumab pegol
5305142|NCT02151851|Chinese patients|chinese patients
5305143|NCT02151838|HIV-infected pregnant women who request HAART from the TRCSPMTCT|hiv-infected pregnant women who request haart from the trcspmtct
5305144|NCT02151825|Gut microbiota|gut microbiota
5305149|NCT02151825|Lactobacillus acidophilus LA-5|lactobacillus acidophilus la-5
5305150|NCT02151825|Lactobacillus casei 431|lactobacillus casei 431
5305151|NCT02151825|Inulin|inulin
5305152|NCT02151825|GOS|gos
5305153|NCT02151825|Body Weight|body weight
5305154|NCT02151825|Overweight|overweight
5305155|NCT02151825|Adiposity|adiposity
5305156|NCT02151825|Obesity|obesity
5305157|NCT02151825|ANGPTL4|angptl4
5305158|NCT02151786|Pharmacological therapy|pharmacological therapy
5305159|NCT02151773|Pharmacological therapy|pharmacological therapy
5305160|NCT02151760|Metastatic Prostate Cancer|metastatic prostate cancer
5305162|NCT02151721|Vorinostat|vorinostat
5305163|NCT02151721|Gefitinib|gefitinib
5305164|NCT02151721|BIM polymorphism|bim polymorphism
5305165|NCT02151721|EGFR-TKI resistance|egfr-tki resistance
5305166|NCT02151708|accommodation, emptying,motilitone|accommodation, emptying,motilitone
5305167|NCT02151682|chronic pain|chronic pain
5305168|NCT02151682|opioid|opioid
5305169|NCT02151669|Mediterranean diet|mediterranean diet
5305170|NCT02151669|Smoking/tobacco|smoking/tobacco
5305171|NCT02151669|Spirometry|spirometry
5305172|NCT02151656|Schizophrenia|schizophrenia
5305173|NCT02151656|Mental disorders|mental disorders
5305174|NCT02151656|Antipsychotic Drugs|antipsychotic drugs
5305175|NCT02151643|Dialysis Dependent Chronic Kidney Disease|dialysis dependent chronic kidney disease
5305176|NCT02151630|wart|wart
5305177|NCT02151630|verruca vulgaris|verruca vulgaris
5305178|NCT02151630|topical therapy|topical therapy
5305179|NCT02151630|pyruvic acid|pyruvic acid
5305180|NCT02151630|salicylic acid|salicylic acid
5305181|NCT02151617|Multiple dose|multiple dose
5305182|NCT02151617|safety|safety
5305183|NCT02151617|tolerability|tolerability
5305184|NCT02151617|PK|pk
5305187|NCT02151578|Impact of home management of malaria and pneumonia on child mortality|impact of home management of malaria and pneumonia on child mortality
5305188|NCT02151578|home management of malaria and pneumonia|home management of malaria and pneumonia
5305189|NCT02151565|back pain|back pain
5305190|NCT02151565|sciatica|sciatica
5305191|NCT02151565|electrotherapy|electrotherapy
5305192|NCT02151565|HTEMS|htems
5305193|NCT02151565|TENS|tens
5305194|NCT02151552|lung inflammation|lung inflammation
5305195|NCT02151552|positron emission tomography|positron emission tomography
5305196|NCT02151552|inducible nitric oxide synthase|inducible nitric oxide synthase
5305197|NCT02151513|Cancer-associated pain|cancer-associated pain
5305198|NCT02151513|Immune function|immune function
5305199|NCT02151500|Medically Unexplained Symptoms (MUPS)|medically unexplained symptoms (mups)
5305200|NCT02151500|Somatoform disorders|somatoform disorders
5305201|NCT02151500|Chronic pain|chronic pain
5305202|NCT02151500|Somatic symptoms|somatic symptoms
5305203|NCT02151500|Emotional processing|emotional processing
5305204|NCT02151500|Primary Care|primary care
5305205|NCT02151487|Supraclavicular block|supraclavicular block
5305206|NCT02151487|Ropivacaine|ropivacaine
5305207|NCT02151487|Dexamethasone|dexamethasone
5305208|NCT02151487|Clonidine|clonidine
5305209|NCT02151487|Postoperative analgesia|postoperative analgesia
5305210|NCT02151461|Diabetes|diabetes
5305211|NCT02151461|Type 2 Diabetes|type 2 diabetes
5305212|NCT02151435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5305213|NCT02151435|Biomarkers|biomarkers
5305214|NCT02151435|Forced Vital Capacity|forced vital capacity
5305215|NCT02151435|Diffusion Capacity for Carbon Monoxide|diffusion capacity for carbon monoxide
5305216|NCT02151435|Prognosis|prognosis
5305217|NCT02151422|Adults|adults
5305218|NCT02151422|age 18-65|age 18-65
5305219|NCT02151422|physician-diagnosed|physician-diagnosed
5305220|NCT02151422|persistent asthma|persistent asthma
5305221|NCT02151396|ADHD, hyperactivity, inattention, working memory|adhd, hyperactivity, inattention, working memory
5963072|NCT04274218|Stability|stability
5963073|NCT04274218|Locomotion|locomotion
5305222|NCT02151383|Acute heart failure|acute heart failure
5305223|NCT02151383|RELAX−AHF−PEDIATRIC PK|relax−ahf−pediatric pk
5305224|NCT02151383|AHF|ahf
5305225|NCT02151357|first in man|first in man
5305226|NCT02151357|dose escalating|dose escalating
5305227|NCT02151357|MTD|mtd
5305228|NCT02151357|DLT|dlt
5305229|NCT02151331|Chronic care model|chronic care model
5305230|NCT02151331|Mood disorders|mood disorders
5305231|NCT02151331|Adaptive implementation|adaptive implementation
5305232|NCT02151279|Shrimp allergy|shrimp allergy
5305233|NCT02151279|Chitosan|chitosan
5305234|NCT02151279|fining agent|fining agent
5305235|NCT02151266|Heart failure|heart failure
5305236|NCT02151266|Exercise|exercise
5305237|NCT02151266|Cognitive training|cognitive training
5305238|NCT02151253|Nocturia|nocturia
5305239|NCT02151253|Daytime sleepiness|daytime sleepiness
5305240|NCT02151240|herpes zoster, Foscarnet Sodium, Acyclovir, Postherpetic neuralgia|herpes zoster, foscarnet sodium, acyclovir, postherpetic neuralgia
5305241|NCT02151227|Meta-Analysis|meta-analysis
5305242|NCT02151227|Metabolic Syndrome|metabolic syndrome
5305243|NCT02151227|Magnesium|magnesium
5305244|NCT02151227|Dose Response Effect|dose response effect
5305245|NCT02151227|Systematic Review|systematic review
5305246|NCT02151214|Palliative Phase of Cancer|palliative phase of cancer
5305247|NCT02151214|Quality of life|quality of life
5305248|NCT02151214|Parenteral nutrition|parenteral nutrition
5305249|NCT02151214|Undernutrition|undernutrition
5305250|NCT02151201|pregnancy vaccination influenza education|pregnancy vaccination influenza education
5305251|NCT02151149|NSCLC advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel|nsclc advanced non-small cell lung cancer squamous adenocarcinoma large cell carcinoma lung cancer elderly first line treatment abraxane carbo nab-paclitaxel
5305252|NCT02151136|Sucrose|sucrose
5305253|NCT02151136|Pain|pain
5305254|NCT02151123|Colonic Neoplasms|colonic neoplasms
5305255|NCT02151123|Colon Cancer|colon cancer
5305256|NCT02151123|Microbiome|microbiome
5305257|NCT02151110|Healthy Male|healthy male
5305258|NCT02151110|Healthy Female of non child bearing potential|healthy female of non child bearing potential
5305259|NCT02151097|Prostatectomy|prostatectomy
5305260|NCT02151097|Prostate cancer|prostate cancer
5305261|NCT02151097|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
5305262|NCT02151084|randomized|randomized
5305263|NCT02151084|selumetinib|selumetinib
5305264|NCT02151084|tablets|tablets
5305265|NCT02151084|cisplatin|cisplatin
5305266|NCT02151084|gemcitabine|gemcitabine
5305267|NCT02151084|non-resectable|non-resectable
5305268|NCT02151084|recurrent|recurrent
5305269|NCT02151084|metstatic|metstatic
5305270|NCT02151071|Breast Cancer|breast cancer
5305271|NCT02151071|Mastectomy, Segmental|mastectomy, segmental
5305272|NCT02151071|Breast Conserving Surgery|breast conserving surgery
5305273|NCT02151071|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
5305274|NCT02151071|Beta particle detection|beta particle detection
5305275|NCT02151058|Staining|staining
5305276|NCT02151058|Intensity|intensity
5305277|NCT02151058|Area|area
5305278|NCT02151045|Epidural infiltration of Corticoids|epidural infiltration of corticoids
5305279|NCT02151045|L3-L4 stage|l3-l4 stage
5305280|NCT02151045|On contact of disco radicular conflict|on contact of disco radicular conflict
5305281|NCT02151045|Scan control|scan control
5305282|NCT02151032|Colorectal Cancer|colorectal cancer
5305283|NCT02151032|Colorectal cancer screening|colorectal cancer screening
5305284|NCT02151032|Multimedia|multimedia
5305285|NCT02151032|Booklet|booklet
5305286|NCT02151032|Pamphlet|pamphlet
5305287|NCT02151032|Audio CD|audio cd
5305288|NCT02151032|Video with animated images|video with animated images
5305289|NCT02151032|Video with non-moving images|video with non-moving images
5305290|NCT02151032|Questionnaires|questionnaires
5305291|NCT02151032|Surveys|surveys
5305292|NCT02151006|DHEA|dhea
5305294|NCT02151006|ICSI|icsi
5305295|NCT02150993|Africa|africa
5305296|NCT02150993|Antiretroviral Treatment|antiretroviral treatment
5305297|NCT02150993|HIV-2|hiv-2
5305298|NCT02150993|firsts line ART|firsts line art
5305299|NCT02150993|Adults|adults
5305300|NCT02150980|Fractures|fractures
5305301|NCT02150980|burden of fractures|burden of fractures
5305302|NCT02150980|orthopaedic fractures|orthopaedic fractures
5305303|NCT02150980|orthopaedic injuries|orthopaedic injuries
5305304|NCT02150980|orthopaedic trauma|orthopaedic trauma
5305305|NCT02150980|observational study|observational study
5305306|NCT02150980|outcomes of fracture care|outcomes of fracture care
5305307|NCT02150980|epidemiology|epidemiology
5305308|NCT02150967|cholangiocarcinoma,|cholangiocarcinoma,
5305309|NCT02150967|FGFR2 gene fusion,|fgfr2 gene fusion,
5305310|NCT02150967|FGFR genetic alteration|fgfr genetic alteration
5305311|NCT02150954|induction of labor|induction of labor
5305312|NCT02150954|pitocin|pitocin
5305313|NCT02150954|foley bulb|foley bulb
5305439|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone
5305314|NCT02150941|Upper gastrointestinal tract|upper gastrointestinal tract
5305315|NCT02150941|Endoscopy|endoscopy
5305316|NCT02150941|Endoscopic Hemostasis|endoscopic hemostasis
5305317|NCT02150915|Acupoints|acupoints
5305318|NCT02150915|Acupuncture therapy|acupuncture therapy
5305319|NCT02150915|Median nerve|median nerve
5305320|NCT02150915|Biomechanics|biomechanics
5305321|NCT02150902|Catheter ablation for atrial fibrillation|catheter ablation for atrial fibrillation
5305322|NCT02150902|treatment for atrial fibrillation|treatment for atrial fibrillation
5305323|NCT02150902|comparison of catheter ablation techniques for atrial fibrillation|comparison of catheter ablation techniques for atrial fibrillation
5305324|NCT02150889|insulin resistance|insulin resistance
5305325|NCT02150889|lipid metabolism|lipid metabolism
5305326|NCT02150889|diabetes|diabetes
5305328|NCT02150876|SDF|sdf
5305329|NCT02150876|MACE|mace
5305330|NCT02150876|SYNERGY|synergy
5305331|NCT02150863|actinic keratosis|actinic keratosis
5305332|NCT02150863|field cancerization|field cancerization
5305333|NCT02150863|organ transplant patients|organ transplant patients
5305334|NCT02150850|Femoral Fractures|femoral fractures
5305335|NCT02150850|Subtrochanteric Fractures|subtrochanteric fractures
5305336|NCT02150850|Osteoporotic Fractures|osteoporotic fractures
5305337|NCT02150850|Fractures, Spontaneous|fractures, spontaneous
5305338|NCT02150850|Stress Fractures|stress fractures
5305339|NCT02150850|Bone Fractures|bone fractures
5305340|NCT02150850|Hip Fractures|hip fractures
5305341|NCT02150850|Osteoporosis|osteoporosis
5305342|NCT02150837|Obesity|obesity
5305343|NCT02150837|Weight Loss|weight loss
5305344|NCT02150837|Meal replacements|meal replacements
5305345|NCT02150837|Weight maintenance|weight maintenance
5305346|NCT02150798|Diet Therapy|diet therapy
5305347|NCT02150798|Diet, Carbohydrate Restricted|diet, carbohydrate restricted
5305348|NCT02150798|Fatty Acids, Omega 3|fatty acids, omega 3
5305349|NCT02150798|Oximetry|oximetry
5305350|NCT02150798|phase angle|phase angle
5305351|NCT02150798|Triglycerides, blood|triglycerides, blood
5305352|NCT02150798|Lipids, blood|lipids, blood
5305353|NCT02150798|Hand Strength|hand strength
5305354|NCT02150798|Body Composition|body composition
5305355|NCT02150798|Electric Impedance|electric impedance
5305356|NCT02150785|Thrombolysis|thrombolysis
5305357|NCT02150785|Safety of Streptokinase|safety of streptokinase
5305358|NCT02150785|tissue plasminogen activator tPA|tissue plasminogen activator tpa
5305359|NCT02150785|Stroke treatment|stroke treatment
5305360|NCT02150759|Dexmedetomidine|dexmedetomidine
5305361|NCT02150759|Ketamine|ketamine
5305362|NCT02150759|Pain|pain
5305363|NCT02150746|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5305364|NCT02150746|Pancreatic cancer|pancreatic cancer
5305365|NCT02150746|PDAC|pdac
5305366|NCT02150746|Circulating tumor cells|circulating tumor cells
5305367|NCT02150720|Hip fractures|hip fractures
5305368|NCT02150720|Clinical Trial|clinical trial
5305369|NCT02150720|Randomized|randomized
5305370|NCT02150720|Fibrin glue|fibrin glue
5305371|NCT02150720|Tranexamic acid|tranexamic acid
5305372|NCT02150720|Blood loss|blood loss
5305373|NCT02150681|preconception|preconception
5305374|NCT02150681|pregnancy|pregnancy
5305375|NCT02150681|postpartum|postpartum
5305376|NCT02150681|women|women
5305377|NCT02150668|ADHD|adhd
5305378|NCT02150668|Homework|homework
5305379|NCT02150668|School|school
5305380|NCT02150668|Organization|organization
5305381|NCT02150668|Time-management|time-management
5305382|NCT02150616|Pulmonary hypertension|pulmonary hypertension
5305383|NCT02150616|Interstitial lung disease|interstitial lung disease
5305384|NCT02150616|Pulmonary fibrosis|pulmonary fibrosis
5305385|NCT02150603|Heart defects, congenital|heart defects, congenital
5309912|NCT02129933|EAC|eac
5305386|NCT02150603|Patient-reported outcomes|patient-reported outcomes
5305387|NCT02150603|Health status|health status
5305388|NCT02150603|Factors, psychosocial|factors, psychosocial
5305389|NCT02150603|Health behavior|health behavior
5305390|NCT02150603|Quality of life|quality of life
5305391|NCT02150603|Sense of coherence|sense of coherence
5305392|NCT02150603|Illness perceptions|illness perceptions
5305393|NCT02150603|Depression|depression
5305394|NCT02150603|Anxiety|anxiety
5305395|NCT02150590|airway disease|airway disease
5305396|NCT02150590|bronchitis|bronchitis
5305397|NCT02150590|emphysema|emphysema
5305398|NCT02150590|lung|lung
5305399|NCT02150577|Screening|screening
5305400|NCT02150577|Mood Stabilizers|mood stabilizers
5305401|NCT02150577|Computer delivered psychotherapy|computer delivered psychotherapy
5305402|NCT02150577|Peer Support|peer support
5305403|NCT02150577|Telepsychiatry|telepsychiatry
5305404|NCT02150577|Implementation|implementation
5305405|NCT02150577|Rural|rural
5305406|NCT02150564|Malignant gliomas|malignant gliomas
5305407|NCT02150564|Sono RCT|sono rct
5305408|NCT02150551|Crohn disease|crohn disease
5305409|NCT02150551|ulcerative colitis|ulcerative colitis
5305410|NCT02150551|mesenchymal stromal cells|mesenchymal stromal cells
5200588|NCT02740634|PCA|pca
5305411|NCT02150551|inflammatory bowel diseases|inflammatory bowel diseases
5305412|NCT02150538|Cardiac Resynchronization therapy|cardiac resynchronization therapy
5305413|NCT02150538|Minimized Right ventricular pacing|minimized right ventricular pacing
5305414|NCT02150538|Prolonged AV conduction|prolonged av conduction
5305415|NCT02150525|breast cancer|breast cancer
5963074|NCT04274218|Motor Control|motor control
5305416|NCT02150525|vaginal dryness|vaginal dryness
5305417|NCT02150525|dyspareunia|dyspareunia
5305418|NCT02150525|genital irritation|genital irritation
5305419|NCT02150512|Septic shock|septic shock
5305420|NCT02150512|Critically ill patients|critically ill patients
5305421|NCT02150512|Transpulmonary thermodilution|transpulmonary thermodilution
5305422|NCT02150512|Fluid resuscitation|fluid resuscitation
5305423|NCT02150499|Acute Asthma exacerbation|acute asthma exacerbation
5305424|NCT02150473|rheumatoid Arthritis|rheumatoid arthritis
5305425|NCT02150460|ophthalmic surgery, peribulbar local anaesthesia|ophthalmic surgery, peribulbar local anaesthesia
5305426|NCT02150447|Gastric cancer bleeding|gastric cancer bleeding
5305427|NCT02150447|Proton pump inhibitor|proton pump inhibitor
5305428|NCT02150434|Oxygen therapy|oxygen therapy
5305429|NCT02150434|Hypoxemia|hypoxemia
5305430|NCT02150434|COPD|copd
5305431|NCT02150434|Closed-loop|closed-loop
5305432|NCT02150434|Automated titration,|automated titration,
5305433|NCT02150382|hypertension|hypertension
5305434|NCT02150382|rural|rural
5305435|NCT02150382|China|china
5305436|NCT02150382|protocol-based treatment|protocol-based treatment
5305437|NCT02150343|Cat allergy|cat allergy
5305438|NCT02150343|Rhinoconjunctivitis|rhinoconjunctivitis
5305441|NCT02150330|Gene expression of cumulus cells.|gene expression of cumulus cells.
5305442|NCT02150330|Folliculogenesis.|folliculogenesis.
5305443|NCT02150330|Oocyte maturation.|oocyte maturation.
5305444|NCT02150330|Ovarian hyper-stimulation protocol.|ovarian hyper-stimulation protocol.
5305445|NCT02150330|Artificial reproduction technology.|artificial reproduction technology.
5305446|NCT02150317|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5305447|NCT02150317|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5305448|NCT02150317|Sorafenib|sorafenib
5305449|NCT02150278|Driving|driving
5305450|NCT02150278|Alcohol consumption|alcohol consumption
5305451|NCT02150278|Risk perception|risk perception
5305452|NCT02150252|Clinical trial|clinical trial
5305453|NCT02150252|Ischemic stroke|ischemic stroke
5305454|NCT02150252|Bu-Yang-Huan-Wu Tang (BYHWT）|bu-yang-huan-wu tang (byhwt）
5305455|NCT02150252|Gait parameter|gait parameter
5305456|NCT02150252|Quality of life|quality of life
5305458|NCT02150239|postoperative|postoperative
5305459|NCT02150213|Adrenocortical Adenoma,|adrenocortical adenoma,
5305460|NCT02150213|Endometrial Stromal sarcomas|endometrial stromal sarcomas
5305461|NCT02150213|BGG492|bgg492
5305462|NCT02150187|Androgenetic Alopecia|androgenetic alopecia
5305463|NCT02150187|Male|male
5305464|NCT02150187|Baldness|baldness
5305465|NCT02150187|hair loss pattern|hair loss pattern
5305466|NCT02150174|Schizophrenia|schizophrenia
5305467|NCT02150174|Episodic memory deficits|episodic memory deficits
5305468|NCT02150148|breast cancer|breast cancer
5305469|NCT02150148|prostate cancer|prostate cancer
5305470|NCT02150148|colorectal cancer|colorectal cancer
5305471|NCT02150148|small intestine cancer|small intestine cancer
5305472|NCT02150148|thyroid cancer|thyroid cancer
5305473|NCT02150148|Hodgkin lymphoma|hodgkin lymphoma
5305474|NCT02150148|non-Hodgkin lymphoma|non-hodgkin lymphoma
5305475|NCT02150148|endometrial cancer|endometrial cancer
5305476|NCT02150148|kidney cancer|kidney cancer
5305477|NCT02150148|cervical cancer|cervical cancer
5305478|NCT02150148|diet|diet
5305479|NCT02150148|exercise|exercise
5305480|NCT02150148|physical activity|physical activity
5305481|NCT02150148|garden|garden
5305482|NCT02150135|Pancreatic cancer|pancreatic cancer
5305483|NCT02150135|Quality of life|quality of life
5305484|NCT02150135|Pain|pain
5305485|NCT02150122|Vitamin D|vitamin d
5423277|NCT01616355|denture, complete;|denture, complete;
5305488|NCT02150096|chronic non-specific low back pain|chronic non-specific low back pain
5305490|NCT02150096|disability|disability
5305491|NCT02150096|women|women
5305492|NCT02150083|midurethral sling|midurethral sling
5305493|NCT02150083|voiding study|voiding study
5305494|NCT02150083|voiding trial|voiding trial
5305495|NCT02150083|retrograde voiding trial|retrograde voiding trial
5305496|NCT02150070|Healthy subjects|healthy subjects
5305497|NCT02150070|ASP2408|asp2408
5305498|NCT02150070|Rheumatoid arthritis|rheumatoid arthritis
5305499|NCT02150070|Safety and Tolerability|safety and tolerability
5305500|NCT02150070|Pharmacokinetics|pharmacokinetics
5305501|NCT02150057|knee osteoarthritis unicompartmental unloading brace|knee osteoarthritis unicompartmental unloading brace
5305502|NCT02150031|prevention and control|prevention and control
5305503|NCT02150031|chlorhexidine|chlorhexidine
5305504|NCT02150031|therapeutic irrigation|therapeutic irrigation
5305505|NCT02150031|mouthwashes|mouthwashes
5305506|NCT02150031|culture|culture
5305507|NCT02150018|- Critical Care|- critical care
5305508|NCT02150018|Non invasive ventilation|non invasive ventilation
5200645|NCT02740270|lymphomas|lymphomas
5305509|NCT02150018|Electrical impedance tomography|electrical impedance tomography
5305510|NCT02150018|End expiratory lung volume|end expiratory lung volume
5305511|NCT02150018|End expiratory lung impedance|end expiratory lung impedance
5305512|NCT02150005|periodontal diseases|periodontal diseases
5305513|NCT02150005|cardiovascular diseases|cardiovascular diseases
5305514|NCT02150005|periodontitis treatment|periodontitis treatment
5305515|NCT02149992|gestational diabetes|gestational diabetes
5174593|NCT02900924|PAD|pad
5305516|NCT02149992|myoinositol|myoinositol
5305517|NCT02149979|Incision|incision
5305518|NCT02149979|Wound Closure|wound closure
5305519|NCT02149979|Laser Tissue Soldering|laser tissue soldering
5305520|NCT02149966|safety and tolerability|safety and tolerability
5305521|NCT02149966|pharmacokinetic study|pharmacokinetic study
5305522|NCT02149953|Pregnancy|pregnancy
5305523|NCT02149953|Glycine requirements|glycine requirements
5305524|NCT02149953|Indicator Amino Acid Oxidation (IAAO) method|indicator amino acid oxidation (iaao) method
5305525|NCT02149953|Stable isotopes|stable isotopes
5305526|NCT02149940|Elderly|elderly
5305527|NCT02149940|Frailty|frailty
5305528|NCT02149940|Polypharmacy|polypharmacy
5305529|NCT02149940|Medication review|medication review
5305530|NCT02149940|Clinical pharmacy services|clinical pharmacy services
5305531|NCT02149927|EEG|eeg
5305532|NCT02149927|fMRI|fmri
5305533|NCT02149927|connectivity|connectivity
5305534|NCT02149927|sevoflurane|sevoflurane
5305535|NCT02149914|Ryodoraku|ryodoraku
5305536|NCT02149914|Meridian energy|meridian energy
5305537|NCT02149914|Heart rate variability|heart rate variability
5305538|NCT02149914|Autonomic Nervous System|autonomic nervous system
5305552|NCT02149862|Bladder cancer|bladder cancer
5305554|NCT02149862|Infrared|infrared
5305555|NCT02149862|Spectrum|spectrum
5305556|NCT02149862|Urina|urina
5305557|NCT02149862|Patients with an indication of partial or total bladder resection|patients with an indication of partial or total bladder resection
5305558|NCT02149862|or|or
5305559|NCT02149862|"Lithiasic patients should be operated a urinary calculation, without catheter double J"|"lithiasic patients should be operated a urinary calculation, without catheter double j"
5305560|NCT02149849|Ipsilateral shoulder pain|ipsilateral shoulder pain
5305561|NCT02149849|Surgical positioning|surgical positioning
5305562|NCT02149849|Lung cancer|lung cancer
5305563|NCT02149849|Thoracotomy|thoracotomy
5305564|NCT02149849|Video assisted thoracic surgery|video assisted thoracic surgery
5305565|NCT02149836|major depressive disorder|major depressive disorder
5305566|NCT02149836|depression|depression
5305567|NCT02149836|treatment resistent depression|treatment resistent depression
5305568|NCT02149823|Oxytocin, Social Cognition|oxytocin, social cognition
5305569|NCT02149823|Borderline Personality Disorder|borderline personality disorder
5305570|NCT02149823|Schizotypal Personality Disorder|schizotypal personality disorder
5305571|NCT02149823|Social Cognition|social cognition
5305572|NCT02149823|BPD|bpd
5305573|NCT02149823|SPD|spd
5305574|NCT02149823|MASC|masc
5305575|NCT02149823|Autism Spectrum Disorder|autism spectrum disorder
5305576|NCT02149823|Schizophrenia|schizophrenia
5310109|NCT02129309|Apelin|apelin
5305577|NCT02149823|Schizoaffective Disorder|schizoaffective disorder
5305578|NCT02149823|Bipolar Disorder|bipolar disorder
5305579|NCT02149810|MDD|mdd
5305580|NCT02149784|Metastasis colorectal cancer|metastasis colorectal cancer
5305581|NCT02149784|Chemotherapy|chemotherapy
5305582|NCT02149784|Resection of primary tumor|resection of primary tumor
5305583|NCT02149771|hepatocellular carcinoma|hepatocellular carcinoma
5305584|NCT02149771|portal vein tumor thrombosis|portal vein tumor thrombosis
5305585|NCT02149771|stents|stents
5305586|NCT02149771|chemoembolization|chemoembolization
5305587|NCT02149758|Cyclooxygenase two inhibitors|cyclooxygenase two inhibitors
5305588|NCT02149758|Etoricoxib|etoricoxib
5305589|NCT02149758|Periodontitis|periodontitis
5305590|NCT02149758|Superoxide dismutase|superoxide dismutase
5305591|NCT02149758|Saliva|saliva
5305592|NCT02149732|Limbal stem cell deficiency|limbal stem cell deficiency
5305593|NCT02149732|Cultivated oral mucosal cell sheet transplantation|cultivated oral mucosal cell sheet transplantation
5305594|NCT02149732|Ocular surface reconstruction|ocular surface reconstruction
5305595|NCT02149719|Peanut allergy|peanut allergy
5305596|NCT02149719|Desensitisation|desensitisation
5305597|NCT02149719|Safety|safety
5305598|NCT02149706|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
5305599|NCT02149706|SPMS|spms
5305600|NCT02149706|Multiple Sclerosis|multiple sclerosis
5305601|NCT02149706|NeuroVax|neurovax
5305602|NCT02149693|Flipped classroom|flipped classroom
5305603|NCT02149693|High-fidelity simulation|high-fidelity simulation
5305604|NCT02149693|Medical education reform|medical education reform
5305605|NCT02149693|Medical teamwork|medical teamwork
5305606|NCT02149693|Resuscitation training|resuscitation training
5305607|NCT02149680|Post-dural puncture headache|post-dural puncture headache
5305608|NCT02149680|epidural blood patch|epidural blood patch
5305609|NCT02149680|labour analgesia|labour analgesia
5305610|NCT02149680|epidural analgesia|epidural analgesia
5305611|NCT02149667|osteoarthritis|osteoarthritis
5305612|NCT02149667|avascular necrosis|avascular necrosis
5305613|NCT02149667|ankylosis|ankylosis
5305614|NCT02149667|protrusio acetabuli|protrusio acetabuli
5305615|NCT02149667|painful hip dysplasia|painful hip dysplasia
5305616|NCT02149667|rheumatoid arthritis|rheumatoid arthritis
5305617|NCT02149667|correction of functional deformity|correction of functional deformity
5305619|NCT02149654|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5963075|NCT04274218|Trip|trip
5963076|NCT04274218|Falls|falls
5305620|NCT02149654|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5305621|NCT02149654|Engager transcatheter aortic valve implantation system|engager transcatheter aortic valve implantation system
5305622|NCT02149654|Engager bioprosthesis|engager bioprosthesis
5305623|NCT02149615|idiopathic intracranial hypertension|idiopathic intracranial hypertension
5305624|NCT02149615|optic disc swelling|optic disc swelling
5305625|NCT02149615|antiacne medication|antiacne medication
5305627|NCT02149602|involvement of bilateral parapharyngeal spaces|involvement of bilateral parapharyngeal spaces
5305628|NCT02149589|ARDS|ards
5305629|NCT02149589|PEEP|peep
5305630|NCT02149589|Recruitment manoeuvres|recruitment manoeuvres
5305631|NCT02149589|Lung Morphology|lung morphology
5305632|NCT02149576|Retrospective Review|retrospective review
5305633|NCT02149576|Pilot Study|pilot study
5305634|NCT02149576|Early Stage NSCLC|early stage nsclc
5305635|NCT02149576|Post-Surgical Surveillance|post-surgical surveillance
5305636|NCT02149576|Re-intervention Rates|re-intervention rates
5305637|NCT02149550|Plasmodium falciparum|plasmodium falciparum
5305638|NCT02149550|malaria|malaria
5305639|NCT02149537|sickle cell disease|sickle cell disease
5305640|NCT02149537|sickle cell anemia|sickle cell anemia
5400110|NCT01721239|ICU|icu
5292645|NCT02212405|PET|pet
5292646|NCT02212405|[11C]-PHNO|[11c]-phno
5292647|NCT02212392|acute pancreatitis|acute pancreatitis
5305641|NCT02149537|hydroxyurea|hydroxyurea
5305642|NCT02149537|Nigeria|nigeria
5305643|NCT02149537|low income country|low income country
5305644|NCT02149537|middle income country|middle income country
5305645|NCT02149537|developing country|developing country
5305646|NCT02149524|HER2 Positive Breast Cancer|her2 positive breast cancer
5305647|NCT02149524|Trastuzumab|trastuzumab
5305648|NCT02149524|Biosimilar|biosimilar
5305649|NCT02149498|Parkinson|parkinson
5305652|NCT02149485|PGD,|pgd,
5305653|NCT02149485|follow up|follow up
5305654|NCT02149459|Radiotherapy|radiotherapy
5305655|NCT02149459|Ketosis|ketosis
5305656|NCT02149459|Metformin|metformin
5305657|NCT02149459|Magnetic Resonance Imaging|magnetic resonance imaging
5305658|NCT02149459|Metabolome|metabolome
5305659|NCT02149459|Insulin|insulin
5305660|NCT02149459|recurrent brain tumors|recurrent brain tumors
5305661|NCT02149459|gliomas|gliomas
5305662|NCT02149459|glioblastomas|glioblastomas
5305663|NCT02149459|astrocytomas|astrocytomas
5305664|NCT02149446|Left sided pancreatic resections|left sided pancreatic resections
5305665|NCT02149446|Distal pancreatic resections|distal pancreatic resections
5305666|NCT02149446|Reinforced staple line|reinforced staple line
5305667|NCT02149446|Post operative pancreatic fistula|post operative pancreatic fistula
5305668|NCT02149433|Pneumocystis Jiroveci|pneumocystis jiroveci
5305669|NCT02149433|Steroids|steroids
5305670|NCT02149433|Infants|infants
5305671|NCT02149420|primary Sjögren's syndrome, pharmacodynamics|primary sjögren's syndrome, pharmacodynamics
5305676|NCT02149394|Recovery Room|recovery room
5305677|NCT02149381|Depression|depression
5305678|NCT02149381|treatment as usual|treatment as usual
5305679|NCT02149381|CBASP|cbasp
5305680|NCT02149381|befriending|befriending
5305681|NCT02149355|teeth position|teeth position
5305682|NCT02149355|jaw alignment|jaw alignment
5305683|NCT02149342|Actinic keratoses|actinic keratoses
5305684|NCT02149342|Daylight-PDT|daylight-pdt
5305685|NCT02149342|Hexylaminolaevulinate|hexylaminolaevulinate
5305686|NCT02149342|HAL|hal
5305687|NCT02149342|Methylaminolaevulinate|methylaminolaevulinate
5305688|NCT02149342|MAL|mal
5305689|NCT02149342|Hyperspectral imaging|hyperspectral imaging
5305690|NCT02149329|fever|fever
5305691|NCT02149329|neutropenia|neutropenia
5305692|NCT02149329|febrile neutropenia|febrile neutropenia
5305693|NCT02149329|carbapenem|carbapenem
5305694|NCT02149329|imipenem|imipenem
5305695|NCT02149329|meropenem|meropenem
5305696|NCT02149329|antibiotic stewardship|antibiotic stewardship
5305697|NCT02149329|hematology|hematology
5305698|NCT02149329|oncology|oncology
5305699|NCT02149290|Heart Failure|heart failure
5305700|NCT02149290|Six minute walk test|six minute walk test
5305701|NCT02149277|Infertility|infertility
5305702|NCT02149277|IVF|ivf
5305703|NCT02149277|Embryo transfer|embryo transfer
5305704|NCT02149251|Pre-genetic diagnosis|pre-genetic diagnosis
5305705|NCT02149251|ICSI|icsi
5305706|NCT02149238|flavanols|flavanols
5305707|NCT02149238|cardiovascular effects|cardiovascular effects
5305708|NCT02149238|nutrition-nutrition interaction|nutrition-nutrition interaction
5305709|NCT02149225|Actively personalized peptide vaccinations|actively personalized peptide vaccinations
5305710|NCT02149225|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
5305711|NCT02149225|Concurrent to first line temozolomide maintenance therapy|concurrent to first line temozolomide maintenance therapy
5305712|NCT02149212|Iliac|iliac
5305713|NCT02149212|Vein|vein
5305714|NCT02149212|Stent|stent
5305715|NCT02149160|Histone deacetylase inhibitor|histone deacetylase inhibitor
5305716|NCT02149160|Frontotemporal dementia|frontotemporal dementia
5305718|NCT02149147|physical activity|physical activity
5305719|NCT02149147|environmental factors|environmental factors
5305720|NCT02149147|variety|variety
5305721|NCT02149147|MVPA|mvpa
5305722|NCT02149095|treprostinil|treprostinil
5305723|NCT02149082|Intracranial hematoma|intracranial hematoma
5305724|NCT02149082|traumatic brain injury|traumatic brain injury
5305725|NCT02149082|Near infrared spectroscopy|near infrared spectroscopy
5305726|NCT02149082|NIRS|nirs
5305727|NCT02149056|Platelets/Lymphocytes Rate;Serological Index;|platelets/lymphocytes rate;serological index;
5305728|NCT02149043|Inflammatory bowel disease|inflammatory bowel disease
5305729|NCT02149043|Ulcerative Colitis|ulcerative colitis
5305730|NCT02149043|Thermography|thermography
5305731|NCT02149043|Endoscopy|endoscopy
5305732|NCT02149043|CRP|crp
5305733|NCT02149043|Fecal Calprotectin|fecal calprotectin
5305734|NCT02149017|amyloid plaque|amyloid plaque
5305735|NCT02149017|Positron-Emission Tomography|positron-emission tomography
5305736|NCT02149017|radiopharmaceuticals|radiopharmaceuticals
5305737|NCT02149004|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5305738|NCT02149004|Prevention|prevention
5305739|NCT02149004|Long-term life|long-term life
5292750|NCT02211742|fasting glucose|fasting glucose
5292755|NCT02211703|Epidemiology|epidemiology
5305740|NCT02149004|Cure|cure
5305741|NCT02149004|Cohort|cohort
5305742|NCT02148965|motor activity|motor activity
5305743|NCT02148965|clinical trials|clinical trials
5305744|NCT02148965|pregnancy|pregnancy
5305745|NCT02148965|hypertension|hypertension
5305746|NCT02148965|cohort studies|cohort studies
5305747|NCT02148952|Maternal Health|maternal health
5305748|NCT02148952|Maternal Death|maternal death
5305749|NCT02148952|Maternal Morbidity|maternal morbidity
5305750|NCT02148952|Stillbirth|stillbirth
5305751|NCT02148952|Neonatal Mortality|neonatal mortality
5305752|NCT02148952|Quality Improvement|quality improvement
5305753|NCT02148952|Resource Limited Settings|resource limited settings
5305754|NCT02148952|Checklist|checklist
5305755|NCT02148952|Safe Childbirth|safe childbirth
5305756|NCT02148939|ischemic stroke|ischemic stroke
5305757|NCT02148939|Antiplatelet Effects|antiplatelet effects
5305758|NCT02148939|aspirin|aspirin
5305759|NCT02148939|metamizole|metamizole
5305760|NCT02148939|dipyrone|dipyrone
5305761|NCT02148900|Marfan syndrome|marfan syndrome
5305762|NCT02148900|blood test|blood test
5305763|NCT02148900|aortic root size|aortic root size
5305764|NCT02148900|Marfan related disorders|marfan related disorders
5305765|NCT02148874|pregnant|pregnant
5305766|NCT02148874|flu shot|flu shot
5305767|NCT02148874|influenza|influenza
5305768|NCT02148874|vaccine|vaccine
5305769|NCT02148848|Osteoporosis|osteoporosis
5305770|NCT02148848|Femoral neck fracture|femoral neck fracture
5305771|NCT02148848|hemiarthroplasty|hemiarthroplasty
5305775|NCT02148835|Docosahexaenoic acid|docosahexaenoic acid
5305776|NCT02148835|Fortified food|fortified food
5305777|NCT02148822|Visceral leishmaniasis|visceral leishmaniasis
5305778|NCT02148822|kala azar|kala azar
5305779|NCT02148822|malnutrition|malnutrition
5305780|NCT02148822|stunting|stunting
5305781|NCT02148822|thinness|thinness
5305782|NCT02148822|Leishmania donovani|leishmania donovani
5305783|NCT02148796|Wheezing|wheezing
5305784|NCT02148796|Lower respiratory tract illness|lower respiratory tract illness
5305785|NCT02148796|Asthma|asthma
5305786|NCT02148796|Atopy|atopy
5305787|NCT02148783|Traumatic brain injury|traumatic brain injury
5305788|NCT02148783|Attention deficit and memory problems|attention deficit and memory problems
5305789|NCT02148783|Methylphenidate|methylphenidate
5305790|NCT02148783|Dopamine receptor imaging|dopamine receptor imaging
5305791|NCT02148783|Motivation and reward|motivation and reward
5305792|NCT02148783|Positron emission tomography|positron emission tomography
5305793|NCT02148783|Transcranial magnetic stimulation|transcranial magnetic stimulation
5305794|NCT02148770|rt-fmri|rt-fmri
5305795|NCT02148770|self-control|self-control
5305796|NCT02148770|eating behaviour|eating behaviour
5305797|NCT02148770|overweight|overweight
5305798|NCT02148770|neurofeedback|neurofeedback
5305800|NCT02148731|Colon cancer|colon cancer
5305801|NCT02148731|Elderly patients|elderly patients
5305802|NCT02148718|Crohn's Disease|crohn's disease
5305803|NCT02148705|fire/flame|fire/flame
5305804|NCT02148705|scalds|scalds
5305805|NCT02148705|contact|contact
5305806|NCT02148679|Heart Failure|heart failure
5305807|NCT02148679|Diet|diet
5200923|NCT02738359|colonoscopy|colonoscopy
5305808|NCT02148653|Cardiometabolic risk|cardiometabolic risk
5305809|NCT02148653|Diet|diet
5305810|NCT02148653|Dietary prevention|dietary prevention
5305811|NCT02148653|Functional diet|functional diet
5305812|NCT02148653|Functional foods|functional foods
5305813|NCT02148653|Metabolic Syndrome|metabolic syndrome
5305814|NCT02148653|Overweight|overweight
5305815|NCT02148627|antibody|antibody
5305816|NCT02148627|autoimmune|autoimmune
5305817|NCT02148601|Fecal microbiota transplantation|fecal microbiota transplantation
5305818|NCT02148601|Recurrent C. difficile infection|recurrent c. difficile infection
5305819|NCT02148601|Colonoscopy|colonoscopy
5302450|NCT02164344|HIV|hiv
5305820|NCT02148601|Randomized clinical trial|randomized clinical trial
5305821|NCT02148588|Central Post Stroke Pain|central post stroke pain
5305822|NCT02148588|Nerve block|nerve block
5963077|NCT04274218|Upper Limb Loss|upper limb loss
5186938|NCT02821494|HPV|hpv
5305823|NCT02148575|Palliative Care|palliative care
5305824|NCT02148575|Self-management|self-management
5305825|NCT02148575|Breast Cancer|breast cancer
5305826|NCT02148549|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
5305827|NCT02148549|R0 resection|r0 resection
5305828|NCT02148549|Resection rate|resection rate
5305829|NCT02148549|Optimal schedule|optimal schedule
5305830|NCT02148523|Medication Adherence|medication adherence
5305831|NCT02148523|High Blood Pressure|high blood pressure
5305832|NCT02148523|Diabetes|diabetes
5305833|NCT02148523|Statins|statins
5305834|NCT02148510|human|human
5305835|NCT02148510|sleep apnea|sleep apnea
5305836|NCT02148510|adults|adults
5305837|NCT02148510|oral appliance|oral appliance
5305838|NCT02148510|efficacy|efficacy
5305839|NCT02148510|safety|safety
5305840|NCT02148510|polygraphy|polygraphy
5305841|NCT02148510|bruxism|bruxism
5305842|NCT02148510|cost|cost
5305843|NCT02148497|volunteers|volunteers
5305844|NCT02148484|PTSD|ptsd
5305845|NCT02148484|Cognitive Behavioral Treatment|cognitive behavioral treatment
5305846|NCT02148484|Child Sexual Abuse|child sexual abuse
5305847|NCT02148471|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5305848|NCT02148471|Steatosis|steatosis
5305852|NCT02148458|overweight|overweight
5305853|NCT02148458|Calorie restriction|calorie restriction
5305854|NCT02148445|smoking cessation|smoking cessation
5305855|NCT02148445|tobacco use cessation products|tobacco use cessation products
5305856|NCT02148445|nicotine|nicotine
5305857|NCT02148432|sleep apnea syndrome, fiberoptic bronchoscopy, IV sedation|sleep apnea syndrome, fiberoptic bronchoscopy, iv sedation
5305858|NCT02148419|quality of life|quality of life
5305859|NCT02148419|maltreatment|maltreatment
5305861|NCT02148419|childhood|childhood
5305862|NCT02148406|Yoga|yoga
5305863|NCT02148406|Mind-body therapies|mind-body therapies
5305864|NCT02148406|Fatigue|fatigue
5305865|NCT02148406|Colorectal cancer|colorectal cancer
5305866|NCT02148406|Depressive symptoms|depressive symptoms
5305867|NCT02148380|Lung adenocarcinoma,EGFR mutation, chemotherapy, gefitinib|lung adenocarcinoma,egfr mutation, chemotherapy, gefitinib
5305868|NCT02148367|Traumatic brain injury|traumatic brain injury
5305869|NCT02148367|Endothelial progenitor cells|endothelial progenitor cells
5305870|NCT02148367|Cerebrovascular reactivity|cerebrovascular reactivity
5305871|NCT02148367|Angiogenesis|angiogenesis
5305872|NCT02148354|Depression|depression
5305873|NCT02148354|Self-applied treatment|self-applied treatment
5305874|NCT02148354|Internet|internet
5305875|NCT02148354|Support by the therapist|support by the therapist
5305876|NCT02148354|Cognitive-Behavioural Treatment|cognitive-behavioural treatment
5305877|NCT02148354|Positive Psychology|positive psychology
5305878|NCT02148354|Behavioral Activation|behavioral activation
5305879|NCT02148328|Healthy participants|healthy participants
5305880|NCT02148328|Immunogenicity|immunogenicity
5305881|NCT02148328|Influenza|influenza
5305882|NCT02148328|Prevention|prevention
5305883|NCT02148328|Safety|safety
5305884|NCT02148315|physical activity|physical activity
5305885|NCT02148315|children|children
5305886|NCT02148315|school|school
5305887|NCT02148315|garden|garden
5305888|NCT02148302|Venous Leg Ulcerations|venous leg ulcerations
5305889|NCT02148302|Epidermal Grafts|epidermal grafts
5305890|NCT02148302|Chronic wounds|chronic wounds
5305891|NCT02148302|Clinical trial|clinical trial
5305892|NCT02148302|Protease levels in chronic wounds|protease levels in chronic wounds
5305893|NCT02148289|COPD, beetroot, dietary nitrate, nitric oxide|copd, beetroot, dietary nitrate, nitric oxide
5305894|NCT02148276|Social harm detection|social harm detection
5305895|NCT02148276|Instrument development|instrument development
5305896|NCT02148276|HIV-related clinical trials|hiv-related clinical trials
5305897|NCT02148276|Substance abuse|substance abuse
5305898|NCT02148276|Research participation|research participation
5305899|NCT02148263|Contact Lenses|contact lenses
5305900|NCT02148263|Neophytes|neophytes
5305901|NCT02148263|Contact Lens Adaptation|contact lens adaptation
5305902|NCT02148263|Randomized|randomized
5305907|NCT02148237|Breastfeeding duration|breastfeeding duration
5305908|NCT02148237|Puerto Rican mothers|puerto rican mothers
5305909|NCT02148237|WIC program|wic program
5201026|NCT02737683|combine|combine
5305910|NCT02148237|Home-based individual breastfeeding consultation|home-based individual breastfeeding consultation
5305911|NCT02148224|glycemic index|glycemic index
5305912|NCT02148224|body composition|body composition
5305913|NCT02148211|Fluarix Quadrivalent|fluarix quadrivalent
5305914|NCT02148211|Fluarix|fluarix
5305915|NCT02148211|FluLaval|flulaval
5305916|NCT02148211|FluLaval Quadrivalent|flulaval quadrivalent
5305917|NCT02148211|Pregnancy Registry|pregnancy registry
5305918|NCT02148211|Pregnancy outcome|pregnancy outcome
5305919|NCT02148185|Crohn's disease|crohn's disease
5305920|NCT02148172|Knee|knee
5305921|NCT02148172|plyometrics|plyometrics
5305922|NCT02148172|motor learning|motor learning
5305923|NCT02148172|psychological factors|psychological factors
5305924|NCT02148159|anorexia|anorexia
5305925|NCT02148159|cachexia|cachexia
5305926|NCT02148159|cancer|cancer
5963078|NCT04274218|Prosthesis|prosthesis
5963079|NCT04274218|Arm|arm
5305927|NCT02148159|unintentional weigh loss|unintentional weigh loss
5305928|NCT02148159|gastrointestinal tract|gastrointestinal tract
5305930|NCT02148146|short bowel syndrome|short bowel syndrome
5305931|NCT02148146|intestinal failure|intestinal failure
5305932|NCT02148146|total parenteral nutrition associated cholestasis|total parenteral nutrition associated cholestasis
5305933|NCT02148133|Eltrombopag|eltrombopag
5305934|NCT02148133|Aplastic Anemia (AA)|aplastic anemia (aa)
5305935|NCT02148133|Thrombocytopenia|thrombocytopenia
5305936|NCT02148133|Thrombopoietin|thrombopoietin
5305937|NCT02148133|Bone Marrow|bone marrow
5305938|NCT02148133|Bone Marrow Biopsy|bone marrow biopsy
5305939|NCT02148133|Hematopoietic Stem Cells|hematopoietic stem cells
5305940|NCT02148133|Mature Blood Cells|mature blood cells
5305941|NCT02148133|Pancytopenia|pancytopenia
5305942|NCT02148133|Leukopenia|leukopenia
5305943|NCT02148133|Platelets|platelets
5305945|NCT02148094|AIDS|aids
5305947|NCT02148094|Prevention|prevention
5305948|NCT02148094|Female sex workers|female sex workers
5305949|NCT02148094|PrEP|prep
5305950|NCT02148094|Pre-exposure prophylaxis|pre-exposure prophylaxis
5305951|NCT02148094|Truvada|truvada
5305952|NCT02148094|Tenofovir|tenofovir
5305953|NCT02148081|pediatrics, critical illness, recovery, function, health|pediatrics, critical illness, recovery, function, health
5305954|NCT02148068|Obesity|obesity
5305955|NCT02148068|Bariatric Surgery|bariatric surgery
5305956|NCT02148068|Roux-en-y Gastric Bypass|roux-en-y gastric bypass
5305957|NCT02148068|Sleeve Gastrectomy|sleeve gastrectomy
5305958|NCT02148055|spontaneous intrauterine death|spontaneous intrauterine death
5305959|NCT02148055|fetal MRI|fetal mri
5305960|NCT02148055|autopsy|autopsy
5305961|NCT02148042|Anorexia|anorexia
5305962|NCT02148042|Generalized anxiety|generalized anxiety
5305963|NCT02148042|Fear|fear
5305964|NCT02148029|Deep vein thrombosis|deep vein thrombosis
5305965|NCT02148029|Post thrombotic syndrome|post thrombotic syndrome
5305966|NCT02148029|Thrombus resolution|thrombus resolution
5305967|NCT02148016|Corneal disorders|corneal disorders
5305968|NCT02148016|Chemical injury|chemical injury
5305969|NCT02148016|Pterygium|pterygium
5305970|NCT02148016|Refractive error|refractive error
5305971|NCT02148016|Myopia|myopia
5305972|NCT02148016|Hyperopia|hyperopia
5305973|NCT02148016|Cornea|cornea
5305974|NCT02148016|Monocular|monocular
5305975|NCT02148016|Transparent|transparent
5305976|NCT02148016|Transplantation|transplantation
5305977|NCT02148016|Visual function|visual function
5305979|NCT02147990|metastatic|metastatic
5305980|NCT02147990|locally advanced|locally advanced
5305981|NCT02147990|lung|lung
5305982|NCT02147990|non-small cell lung cancer|non-small cell lung cancer
5305983|NCT02147990|NSCLC|nsclc
5305984|NCT02147990|epidermal growth factor receptor|epidermal growth factor receptor
5305985|NCT02147990|EGFR|egfr
5305986|NCT02147990|T790M|t790m
5305987|NCT02147990|CO-1686|co-1686
5305988|NCT02147990|unresectable|unresectable
5305989|NCT02147990|recurrent|recurrent
5305990|NCT02147990|EGFR-directed therapy|egfr-directed therapy
5305991|NCT02147990|irreversible EGFR inhibitor|irreversible egfr inhibitor
5305992|NCT02147990|TIGER|tiger
5305993|NCT02147990|Rociletinib|rociletinib
5305994|NCT02147977|Renal Dialysis|renal dialysis
5305995|NCT02147977|Arrhythmias Cardiac|arrhythmias cardiac
5305996|NCT02147977|Death Sudden Cardiac|death sudden cardiac
5305997|NCT02147977|Fatty Acids Omega 3|fatty acids omega 3
5305998|NCT02147964|intratesticular androgens|intratesticular androgens
5305999|NCT02147964|testosterone|testosterone
5306000|NCT02147964|dutasteride|dutasteride
5306001|NCT02147964|gonadotropin suppression|gonadotropin suppression
5306002|NCT02147964|male contraception|male contraception
5306003|NCT02147964|spermatogenesis|spermatogenesis
5306004|NCT02147951|Melanoma|melanoma
5306005|NCT02147938|France|france
5306006|NCT02147938|Tacrolimus|tacrolimus
5306007|NCT02147938|Prograf|prograf
5306008|NCT02147938|Observational|observational
5306009|NCT02147938|Advagraf|advagraf
5306010|NCT02147925|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5306011|NCT02147925|Glucagon-like peptide-1 receptor agonists|glucagon-like peptide-1 receptor agonists
5306012|NCT02147925|Diabetes mellitus, type 2|diabetes mellitus, type 2
5306013|NCT02147912|Depression|depression
5306014|NCT02147912|COPD|copd
5306015|NCT02147912|Aerobic Exercise|aerobic exercise
5306016|NCT02147912|Anxiety|anxiety
5306017|NCT02147912|Quality of life|quality of life
5306018|NCT02147912|neurocognitive functioning|neurocognitive functioning
5306019|NCT02147886|Bioblast, Randomized, parallel-group, and dose-controlled|bioblast, randomized, parallel-group, and dose-controlled
5306020|NCT02147873|MDS|mds
5306021|NCT02147873|CMML|cmml
5306022|NCT02147873|myelodysplastic syndrome|myelodysplastic syndrome
5306023|NCT02147873|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5306024|NCT02147873|TL32711|tl32711
5306025|NCT02147873|TL32711-0094|tl32711-0094
5306026|NCT02147873|azacitidine|azacitidine
5306027|NCT02147873|birinapant|birinapant
5306028|NCT02147873|higher risk|higher risk
5306029|NCT02147873|naive|naive
5306030|NCT02147873|double blind|double blind
5306032|NCT02147873|placebo controlled|placebo controlled
5306033|NCT02147873|randomized|randomized
5306034|NCT02147860|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5306035|NCT02147860|Artificial Pancreas Project (APP)|artificial pancreas project (app)
5306036|NCT02147860|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5306037|NCT02147860|Closed-Loop Control (CLC)|closed-loop control (clc)
5306038|NCT02147860|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5306039|NCT02147860|Insulin Pump|insulin pump
5306040|NCT02147847|Presbycusis|presbycusis
5306041|NCT02147847|Hearing In Noise|hearing in noise
5306042|NCT02147847|Hearing Impairment|hearing impairment
5306043|NCT02147847|Hearing Loss|hearing loss
5306044|NCT02147847|Aging|aging
5306045|NCT02147847|Plasticity|plasticity
5306046|NCT02147847|Video Games|video games
5306047|NCT02147847|Perceptual Learning|perceptual learning
5306050|NCT02147795|Patient Blood Management|patient blood management
5306051|NCT02147795|Red Blood Cell Transfusion Practice|red blood cell transfusion practice
5306052|NCT02147795|Patient Safety|patient safety
5306053|NCT02147795|Anemia|anemia
5306054|NCT02147795|Clinical Outcome|clinical outcome
5306055|NCT02147795|perioperative care|perioperative care
5306056|NCT02147782|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function|chronic renal insufficient, renal osteodystrophy, bone mineral density, bone turnover, kidney function
5306057|NCT02147769|cerebral autoregulation|cerebral autoregulation
5306058|NCT02147769|preterm|preterm
5306059|NCT02147769|near-infrared spectroscopy|near-infrared spectroscopy
5306060|NCT02147756|Skin pigmentation, skin texture disorders, fractional laser, CO2, fractional CO2, Syneron, Solta.|skin pigmentation, skin texture disorders, fractional laser, co2, fractional co2, syneron, solta.
5306061|NCT02147743|Adolescents|adolescents
5306062|NCT02147743|Family-Based treatment|family-based treatment
5306063|NCT02147743|Multidimensional Family Therapy|multidimensional family therapy
5306064|NCT02147730|chronic pain|chronic pain
5306065|NCT02147717|preterm newborns|preterm newborns
5306066|NCT02147717|Transfontanellar ultrafast doppler|transfontanellar ultrafast doppler
5306067|NCT02147717|Acupuncture|acupuncture
5306068|NCT02147717|perioperative pain|perioperative pain
5306069|NCT02147717|surgery of the ductus arteriosus|surgery of the ductus arteriosus
5306071|NCT02147665|waterpipe|waterpipe
5306072|NCT02147665|smoking|smoking
5306073|NCT02147665|sympathetic|sympathetic
5306074|NCT02147652|moderate dementia|moderate dementia
5306075|NCT02147652|severe dementia|severe dementia
5310606|NCT02127034|Digoxin|digoxin
5306076|NCT02147652|Alzheimer's disease|alzheimer's disease
5306077|NCT02147652|Vascular dementia|vascular dementia
5306078|NCT02147652|agitation|agitation
5306079|NCT02147652|personalized music therapy|personalized music therapy
5306080|NCT02147626|preeclampsia|preeclampsia
5306081|NCT02147626|cardiovascular disease|cardiovascular disease
5306082|NCT02147626|health behaviors|health behaviors
5306083|NCT02147626|behavioral intervention|behavioral intervention
5306084|NCT02147626|web-based|web-based
5306085|NCT02147626|Hypertension|hypertension
5306086|NCT02147626|Post-partum Weight Retention|post-partum weight retention
5306087|NCT02147600|adalimumab|adalimumab
5306088|NCT02147600|biologicals|biologicals
5306089|NCT02147600|immunogenicity|immunogenicity
5306090|NCT02147574|slow-transit constipation|slow-transit constipation
5306091|NCT02147574|laparoscope Sub-total Colectomy|laparoscope sub-total colectomy
5306092|NCT02147574|anti-peristaltic anastomosis|anti-peristaltic anastomosis
5306093|NCT02147522|community health worker|community health worker
5306094|NCT02147522|promotoras|promotoras
5445400|NCT01521988|Atrial fibrillation|atrial fibrillation
5306095|NCT02147522|self-care behaviors activation|self-care behaviors activation
5306096|NCT02147522|depression|depression
5306097|NCT02147522|low-income patients|low-income patients
5306098|NCT02147522|safety-net care|safety-net care
5306099|NCT02147509|Dry eye|dry eye
5306100|NCT02147509|Therapeutic bandage contact lenses|therapeutic bandage contact lenses
5306101|NCT02147509|The quality of life|the quality of life
5306102|NCT02147496|Food intake|food intake
5306103|NCT02147496|Appetite|appetite
5306104|NCT02147496|Blood glucose|blood glucose
5306105|NCT02147496|Insulin|insulin
5306106|NCT02147496|Dairy|dairy
5306107|NCT02147496|Milk|milk
5306108|NCT02147483|Mindfulness|mindfulness
5306109|NCT02147483|Alcohol use disorders|alcohol use disorders
5306110|NCT02147470|cirrhosis of the liver|cirrhosis of the liver
5306111|NCT02147470|Acute kidney injury|acute kidney injury
5306112|NCT02147457|Prematurity|prematurity
5306113|NCT02147457|Extremely low birth weight|extremely low birth weight
5306114|NCT02147457|Phenotyping|phenotyping
5306115|NCT02147444|Rivaroxaban|rivaroxaban
5306116|NCT02147444|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5306117|NCT02147444|NOAC|noac
5306118|NCT02147444|Xa inhibitor|xa inhibitor
5306119|NCT02147418|Head and neck cancer|head and neck cancer
5306120|NCT02147418|Throat cancer|throat cancer
5306121|NCT02147418|Human papillomavirus|human papillomavirus
5306123|NCT02147418|Exosome|exosome
5306124|NCT02147418|Diagnostic|diagnostic
5306125|NCT02147418|Early Detection|early detection
5306129|NCT02147392|PET Imaging|pet imaging
5306130|NCT02147379|Bipolar Disorder|bipolar disorder
5306132|NCT02147379|Euthymic|euthymic
5306133|NCT02147379|Lurasidone|lurasidone
5306134|NCT02147366|Hypertension,ambulatory pressure,autonomic function,music|hypertension,ambulatory pressure,autonomic function,music
5306135|NCT02147353|External Genital Warts|external genital warts
5306136|NCT02147353|Sinecatechins|sinecatechins
5306137|NCT02147353|Cryotherapy|cryotherapy
5306138|NCT02147340|Heart Failure patients|heart failure patients
5306139|NCT02147340|Remote Patient Management|remote patient management
5306140|NCT02147340|External Sensors|external sensors
5306141|NCT02147327|vitamin D|vitamin d
5306142|NCT02147327|cord blood|cord blood
5306143|NCT02147327|neonatal sepsis|neonatal sepsis
5306144|NCT02147327|neonatal morbidity|neonatal morbidity
5293135|NCT02209857|Adjuvant chemotherapy|adjuvant chemotherapy
5293140|NCT02209818|Placebo|placebo
5306145|NCT02147314|diabetes|diabetes
5306146|NCT02147314|glucometer|glucometer
5306147|NCT02147314|Yofimeter|yofimeter
5306148|NCT02147314|diabetes monitoring|diabetes monitoring
5306149|NCT02147275|hypertension|hypertension
5306150|NCT02147275|cerebral oxygen saturation|cerebral oxygen saturation
5306151|NCT02147275|near-infrared spectroscopy|near-infrared spectroscopy
5306152|NCT02147275|cognitive function|cognitive function
5306153|NCT02147262|chronic atrophic acrodermatitis|chronic atrophic acrodermatitis
5306154|NCT02147262|Lyme borreliosis|lyme borreliosis
5306155|NCT02147262|molecular characteristics|molecular characteristics
5306156|NCT02147262|outcome|outcome
5306157|NCT02147249|erythema migrans|erythema migrans
5306158|NCT02147249|Lyme borreliosis|lyme borreliosis
5306159|NCT02147249|inflammation|inflammation
5306160|NCT02147249|outcome|outcome
5306161|NCT02147236|autism|autism
5306162|NCT02147236|pervasive developmental disorders|pervasive developmental disorders
5306163|NCT02147236|social skills intervention|social skills intervention
5306164|NCT02147223|flavanols|flavanols
5306165|NCT02147223|sex-related cardiovascular effects|sex-related cardiovascular effects
5306166|NCT02147210|Chronic transplant glomerulopathy|chronic transplant glomerulopathy
5306167|NCT02147210|antibody mediated rejection|antibody mediated rejection
5306168|NCT02147210|Ephrin-B1|ephrin-b1
5306169|NCT02147184|SSRI|ssri
5306170|NCT02147184|serotonin transporter|serotonin transporter
5306172|NCT02147184|pQCT|pqct
5306173|NCT02147184|bone mass|bone mass
5306174|NCT02147184|adolescents|adolescents
5306175|NCT02147171|Retinal ageing, macular pigment, visual function|retinal ageing, macular pigment, visual function
5306176|NCT02147145|GIST|gist
5306177|NCT02147145|endoscopy|endoscopy
5306178|NCT02147145|endoscopic ultrasound|endoscopic ultrasound
5306180|NCT02147132|Methadone|methadone
5306181|NCT02147132|Smoking|smoking
5306182|NCT02147132|Cessation|cessation
5306183|NCT02147132|Varenicline|varenicline
5306184|NCT02147132|Nicotine|nicotine
5306185|NCT02147106|Neuroendocrine tumor|neuroendocrine tumor
5306186|NCT02147106|Videoconsultation|videoconsultation
5306187|NCT02147106|Feasibility|feasibility
5343007|NCT01981161|JC virus|jc virus
5306188|NCT02147080|prevention or control|prevention or control
5306189|NCT02147067|microvascular angina|microvascular angina
5306190|NCT02147067|coronary microvascular disease|coronary microvascular disease
5306191|NCT02147067|coronary physiology|coronary physiology
5306192|NCT02147067|ranolazine|ranolazine
5306193|NCT02147054|Organophosphate poisoning|organophosphate poisoning
5306194|NCT02147054|Intermediate syndrome|intermediate syndrome
5306195|NCT02147054|Rocuronium|rocuronium
5306196|NCT02147041|diabetes mellitus|diabetes mellitus
5306197|NCT02147041|hyperlipidemia|hyperlipidemia
5201314|NCT02735876|ACP-196|acp-196
5306198|NCT02147041|green tea|green tea
5306199|NCT02147041|epigallocatechin gallate|epigallocatechin gallate
5306200|NCT02147028|whole brain RT|whole brain rt
5306201|NCT02147028|hippocampal sparing|hippocampal sparing
5306202|NCT02147028|neurocognitive function|neurocognitive function
5306203|NCT02147015|Acute Exacerbations|acute exacerbations
5306204|NCT02147015|Corticosteroids|corticosteroids
5306205|NCT02147015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5306206|NCT02147015|Doses|doses
5306207|NCT02147002|Chronic Kidney Disease|chronic kidney disease
5306208|NCT02147002|Cardiovascular Complications|cardiovascular complications
5306209|NCT02146989|Cerebral Palsy|cerebral palsy
5306210|NCT02146989|child|child
5306211|NCT02146989|upper extremity|upper extremity
5306212|NCT02146989|strength, reproducibility|strength, reproducibility
5306213|NCT02146976|postoperative|postoperative
5306214|NCT02146976|sleep quality|sleep quality
5306215|NCT02146976|propofol|propofol
5306216|NCT02146976|sevoflurane|sevoflurane
5306217|NCT02146950|LCS-12|lcs-12
5306218|NCT02146950|Intrauterine Device (IUD)|intrauterine device (iud)
5306219|NCT02146950|Intrauterine System (IUS)|intrauterine system (ius)
5306220|NCT02146950|Levonorgestrel|levonorgestrel
5306221|NCT02146950|Pearl Index|pearl index
5306222|NCT02146950|Hormonal Contraception|hormonal contraception
5306223|NCT02146937|active surveillance|active surveillance
5306224|NCT02146937|MRI/transrectal ultrasound fusion guided biopsy|mri/transrectal ultrasound fusion guided biopsy
5306225|NCT02146937|biopsy|biopsy
5187267|NCT02819674|target organ damage|target organ damage
5187268|NCT02819661|Elective Caesarean Section|elective caesarean section
5187269|NCT02819661|obese women|obese women
5187270|NCT02819661|BMI≥30|bmi≥30
5187271|NCT02819661|spinal anesthesia combined with intrathecal morphine|spinal anesthesia combined with intrathecal morphine
5306226|NCT02146911|Smoking Cessation Medication|smoking cessation medication
5306233|NCT02146911|Pharmacogenetics of Smoking Treatment|pharmacogenetics of smoking treatment
5306235|NCT02146911|Smoking Personality|smoking personality
5306236|NCT02146911|Dependence|dependence
5306237|NCT02146911|Addiction|addiction
5306238|NCT02146911|Cigarettes|cigarettes
5306239|NCT02146911|Primary Care Physicians|primary care physicians
5306240|NCT02146911|Biochemical Confirmation|biochemical confirmation
5306241|NCT02146898|spinal anesthesia|spinal anesthesia
5306242|NCT02146898|hypotension|hypotension
5306243|NCT02146898|pregnancy|pregnancy
5306244|NCT02146872|Coronary Artery Disease|coronary artery disease
5306245|NCT02146872|Myocardial Infarction|myocardial infarction
5306246|NCT02146872|Atherosclerosis|atherosclerosis
5306247|NCT02146872|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
5306248|NCT02146872|Sequence Analysis, DNA|sequence analysis, dna
5306249|NCT02146872|Genetic Testing|genetic testing
5306250|NCT02146872|Genetic Linkage|genetic linkage
5306251|NCT02146859|residual neuromuscular blockade|residual neuromuscular blockade
5306253|NCT02146833|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5306254|NCT02146833|prostate cancer|prostate cancer
5306255|NCT02146833|Karyopharm|karyopharm
5306257|NCT02146833|selinexor|selinexor
5306258|NCT02146820|Pigmented Lesions, Skin Pigment, Picosecond Laser, Syneron|pigmented lesions, skin pigment, picosecond laser, syneron
5306259|NCT02146807|Tattoos, Picosecond Laser, Syneron|tattoos, picosecond laser, syneron
5306260|NCT02146742|ASP1707|asp1707
5306261|NCT02146742|Japanese subjects|japanese subjects
5306262|NCT02146742|Safety|safety
5306263|NCT02146742|Pharmacokinetics|pharmacokinetics
5306264|NCT02146742|Pharmacodynamics|pharmacodynamics
5306265|NCT02146729|Randomized|randomized
5306266|NCT02146729|Thoracolumbar fractures|thoracolumbar fractures
5306267|NCT02146729|Spine Trauma|spine trauma
5306268|NCT02146729|Percutaneous Pedicle Screw Fixation|percutaneous pedicle screw fixation
5306269|NCT02146729|Functional Outcome|functional outcome
5306270|NCT02146716|RESC, alcohol withdrawal syndrome|resc, alcohol withdrawal syndrome
5306271|NCT02146703|biliary tract neoplasm|biliary tract neoplasm
5306272|NCT02146703|gemcitabine|gemcitabine
5306273|NCT02146703|S-1|s-1
5306274|NCT02146690|pathology|pathology
5306275|NCT02146690|newborn|newborn
5310809|NCT02126007|HIV|hiv
5306276|NCT02146690|osteopathic manipulative treatment|osteopathic manipulative treatment
5306277|NCT02146690|pain|pain
5306278|NCT02146677|prematurity|prematurity
5306279|NCT02146677|newborns|newborns
5306280|NCT02146677|pain|pain
5306281|NCT02146677|cost|cost
5306282|NCT02146664|Acute NSTEMI|acute nstemi
5306283|NCT02146664|DLBS1033|dlbs1033
5306284|NCT02146664|SPECT|spect
5306285|NCT02146664|Infarct size|infarct size
5306286|NCT02146664|Left ventricular function|left ventricular function
5306287|NCT02146638|post operative analgesia, morphine, fentanyl|post operative analgesia, morphine, fentanyl
5306288|NCT02146573|Intensive Care Units, Pediatric|intensive care units, pediatric
5306289|NCT02146573|Communication|communication
5306290|NCT02146573|Health personnel|health personnel
5306291|NCT02146573|Decision making|decision making
5306292|NCT02146573|Critical Care|critical care
5306293|NCT02146573|Length of Stay|length of stay
5306294|NCT02146573|Iatrogenic Disease|iatrogenic disease
5306296|NCT02146560|Non-cardiac|non-cardiac
5306297|NCT02146560|Elective|elective
5306298|NCT02146560|Adult|adult
5306299|NCT02146560|Patients|patients
5306300|NCT02146560|Troponin|troponin
5306301|NCT02146560|Myocardial|myocardial
5306302|NCT02146560|Injury|injury
5306303|NCT02146560|Postoperative|postoperative
5306304|NCT02146560|Recovery|recovery
5306305|NCT02146560|Outcome|outcome
5306306|NCT02146547|depot, oral, antipsychotics, paliperidone, aripiprazole|depot, oral, antipsychotics, paliperidone, aripiprazole
5306307|NCT02146521|z-axis limited CT|z-axis limited ct
5306308|NCT02146521|computed tomography|computed tomography
5306309|NCT02146521|CT|ct
5306310|NCT02146521|abdominal non-traumatic pain and tenderness|abdominal non-traumatic pain and tenderness
5306311|NCT02146521|emergency patients|emergency patients
5306312|NCT02146508|Esophageal cancer|esophageal cancer
5306313|NCT02146508|Radiofrequency, catheter ablation|radiofrequency, catheter ablation
5306314|NCT02146508|Endoscopic mucosal resection|endoscopic mucosal resection
5306315|NCT02146508|Esophageal squamous dysplasia|esophageal squamous dysplasia
5306316|NCT02146508|Cancer prevention|cancer prevention
5306317|NCT02146482|back pain|back pain
5306318|NCT02146482|low back pain|low back pain
5963080|NCT04274205|Brief supportive psychotherapy, acute coronary syndrome, major adverse cardiovascular events, neutrophil-lymphocytes ratio, psychological symptoms|brief supportive psychotherapy, acute coronary syndrome, major adverse cardiovascular events, neutrophil-lymphocytes ratio, psychological symptoms
5963081|NCT04274088|multifocal IOL, optical quality, angle alpha|multifocal iol, optical quality, angle alpha
5963082|NCT04273646|2019 Novel Coronavirus Pneumonia|2019 novel coronavirus pneumonia
5963083|NCT04273646|Safety|safety
5963084|NCT04273646|Efficiency|efficiency
5187382|NCT02818881|aerobic|aerobic
5306319|NCT02146482|sit-stand workstation|sit-stand workstation
5306320|NCT02146482|standing desk|standing desk
5306321|NCT02146469|varicella vaccination|varicella vaccination
5306322|NCT02146443|Manual dexterity|manual dexterity
5306323|NCT02146443|hand to eye coordination|hand to eye coordination
5306324|NCT02146443|stress|stress
5306325|NCT02146443|fatigue|fatigue
5306326|NCT02146430|pain|pain
5306327|NCT02146430|fibromyalgia|fibromyalgia
5306328|NCT02146417|Low pressure pneumoperitoneum|low pressure pneumoperitoneum
5306329|NCT02146417|Deep neuromuscular block|deep neuromuscular block
5306330|NCT02146404|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5306331|NCT02146404|Hypoglycemia unawareness|hypoglycemia unawareness
5306332|NCT02146404|1H MRS|1h mrs
5306333|NCT02146404|Lactate|lactate
5306334|NCT02146352|Pancreatic pseudocyst|pancreatic pseudocyst
5306335|NCT02146339|nutrition|nutrition
5306336|NCT02146339|milk|milk
5306337|NCT02146339|polar lipids|polar lipids
5306338|NCT02146339|cardiometabolic risk|cardiometabolic risk
5306339|NCT02146300|birch pollen|birch pollen
5306340|NCT02146300|allergy|allergy
5306341|NCT02146300|breathing|breathing
5306342|NCT02146300|pattern|pattern
5306349|NCT02146274|Stroke|stroke
5306350|NCT02146274|Ischemic Stroke|ischemic stroke
5306351|NCT02146261|Volunteers|volunteers
5306352|NCT02146261|Japanese|japanese
5306353|NCT02146261|Males|males
5306354|NCT02146248|hysterosalpingography, DMPA, combined oral contraceptive, tubal patency|hysterosalpingography, dmpa, combined oral contraceptive, tubal patency
5306355|NCT02146235|Music Therapy|music therapy
5306356|NCT02146235|Pulmonary Disease|pulmonary disease
5306357|NCT02146235|COPD|copd
5306358|NCT02146235|Music Visualization|music visualization
5306359|NCT02146235|Therapeutic Singing|therapeutic singing
5306360|NCT02146235|Wind-playing|wind-playing
5306361|NCT02146235|Lung Condition|lung condition
5306362|NCT02146196|Heart failure|heart failure
5306363|NCT02146196|robotic assisted gait therapy|robotic assisted gait therapy
5306364|NCT02146183|Stevio glycosides|stevio glycosides
5306365|NCT02146183|sport|sport
5306366|NCT02146183|glycogen|glycogen
5306372|NCT02146144|Idiopathic epimacular membrane|idiopathic epimacular membrane
5306373|NCT02146144|internal limiting membrane peeling|internal limiting membrane peeling
5306374|NCT02146144|microscotomas|microscotomas
5306375|NCT02146131|Peripheral pulmonary lesions|peripheral pulmonary lesions
5306376|NCT02146131|Solitary pulmonary lesions|solitary pulmonary lesions
5306377|NCT02146131|Multiple pulmonary lesions|multiple pulmonary lesions
5306378|NCT02146118|Erlotinib|erlotinib
5306379|NCT02146118|Silybin-phytosome|silybin-phytosome
5306380|NCT02146118|EGFR mutant lung adenocarcinoma|egfr mutant lung adenocarcinoma
5306381|NCT02146092|lung resection|lung resection
5306382|NCT02146092|incentive spirometry|incentive spirometry
5306383|NCT02146092|physiotherapy|physiotherapy
5306384|NCT02146092|quality improvement|quality improvement
5306385|NCT02146092|outcomes|outcomes
5306386|NCT02146092|post operative complications|post operative complications
5306387|NCT02146066|GBM|gbm
5306388|NCT02146066|Brain tumor|brain tumor
5306389|NCT02146066|glioblastoma|glioblastoma
5306390|NCT02146066|Brain tumor WHO grade IV|brain tumor who grade iv
5306391|NCT02146053|healthy participants|healthy participants
5306392|NCT02146053|gastrointestinal side-effects associated with oral iron|gastrointestinal side-effects associated with oral iron
5306393|NCT02146040|anticoagulation|anticoagulation
5306394|NCT02146040|atrial fibrillation|atrial fibrillation
5306395|NCT02146040|cardioversion|cardioversion
5306396|NCT02146040|complications|complications
5306397|NCT02146040|hemorrhage|hemorrhage
5306398|NCT02146040|medications|medications
5306399|NCT02146040|thromboembolism|thromboembolism
5306400|NCT02146040|TIA|tia
5306401|NCT02146040|stroke|stroke
5306402|NCT02146040|treatment|treatment
5306403|NCT02146027|HIV|hiv
5306404|NCT02146027|Lactobacillus casei Shirota|lactobacillus casei shirota
5306405|NCT02146027|NK cell|nk cell
5306406|NCT02146027|CD4|cd4
5306407|NCT02146027|Lymphocyte|lymphocyte
5306408|NCT02146027|Cell activation|cell activation
5306409|NCT02146027|Antiretroviral therapy|antiretroviral therapy
5306410|NCT02146027|Immune discordants|immune discordants
5306411|NCT02146014|cigarette smoking, smoking|cigarette smoking, smoking
5306412|NCT02146001|sedentary behavior|sedentary behavior
5306413|NCT02146001|physical activity|physical activity
5306414|NCT02146001|older adults|older adults
5306415|NCT02145988|DLBS1033|dlbs1033
5306416|NCT02145988|Peripheral arterial disease|peripheral arterial disease
5306417|NCT02145988|Ankle-brachial index|ankle-brachial index
5306418|NCT02145975|Severe postoperative pain|severe postoperative pain
5306419|NCT02145975|Morphine|morphine
5306420|NCT02145975|Fentanyl|fentanyl
5306421|NCT02145975|Time to titration of pain|time to titration of pain
5306422|NCT02145975|Pain and PACU|pain and pacu
5306423|NCT02145975|Anesthesiology|anesthesiology
5306424|NCT02145962|diabetic foot ulcer healing|diabetic foot ulcer healing
5306425|NCT02145962|magnetic therapy|magnetic therapy
5306426|NCT02145962|safety and efficacy|safety and efficacy
5963085|NCT04273646|Cell Therapy|cell therapy
5187494|NCT02818296|Anxiety|anxiety
5306427|NCT02145962|wound care|wound care
5306428|NCT02145949|aging|aging
5306429|NCT02145949|clinical|clinical
5306430|NCT02145949|translational|translational
5306431|NCT02145949|functional mobility|functional mobility
5306432|NCT02145949|total knee arthroplasty|total knee arthroplasty
5306433|NCT02145936|fatty acid|fatty acid
5306434|NCT02145923|Hodgkin Lymphoma|hodgkin lymphoma
5306435|NCT02145923|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
5306436|NCT02145923|Allogeneic Mesenchymal Stem Cell Transplantation|allogeneic mesenchymal stem cell transplantation
5306437|NCT02145923|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
5306438|NCT02145923|Neutropenic Enterocolitis|neutropenic enterocolitis
5306439|NCT02145923|Myeloablative Chemotherapy|myeloablative chemotherapy
5306440|NCT02145923|Bone Marrow Aplasia|bone marrow aplasia
5306442|NCT02145884|hemangioma|hemangioma
5306443|NCT02145884|birthmark|birthmark
5306444|NCT02145884|strawberry hemangioma|strawberry hemangioma
5306445|NCT02145884|timolol|timolol
5306446|NCT02145871|Radical Cystectomy|radical cystectomy
5306447|NCT02145871|Perioperative Fluid Management|perioperative fluid management
5306448|NCT02145871|EV1000|ev1000
5306449|NCT02145871|14-069|14-069
5306450|NCT02145858|atrial fibrillation, pericardial effusion, pleural effusion|atrial fibrillation, pericardial effusion, pleural effusion
5306451|NCT02145845|critical limb ischemia|critical limb ischemia
5306452|NCT02145845|wound healing|wound healing
5306453|NCT02145845|amputation|amputation
5306454|NCT02145832|TINN|tinn
5306455|NCT02145832|Pharmacokinetic|pharmacokinetic
5306456|NCT02145832|Neonates|neonates
5306457|NCT02145832|Antifungal|antifungal
5306458|NCT02145832|Fluconazole|fluconazole
5306459|NCT02145832|Micafungin|micafungin
5306460|NCT02145806|Urinary incontinence|urinary incontinence
5306461|NCT02145806|Validation study|validation study
5306462|NCT02145806|Pregnant women|pregnant women
5306463|NCT02145806|Postpartum period|postpartum period
5306464|NCT02145793|primary care|primary care
5306465|NCT02145793|pediatrics|pediatrics
5306466|NCT02145793|parenting|parenting
5306467|NCT02145793|education|education
5306468|NCT02145780|Overfeeding|overfeeding
5306469|NCT02145780|Fat distribution|fat distribution
5306470|NCT02145780|Subcutaneous and visceral adipose tissue|subcutaneous and visceral adipose tissue
5306471|NCT02145780|Insulin sensitivity|insulin sensitivity
5306472|NCT02145780|Insulin resistance|insulin resistance
5306473|NCT02145780|Peripheral and hepatic insulin sensitivity|peripheral and hepatic insulin sensitivity
5306474|NCT02145780|Stable isotopes|stable isotopes
5306475|NCT02145780|Lipid oxidation|lipid oxidation
5306476|NCT02145780|Energy expenditure|energy expenditure
5306477|NCT02145780|Muscle and subcutaneous adipose tissue gene expression|muscle and subcutaneous adipose tissue gene expression
5306478|NCT02145754|erythema migrans|erythema migrans
5306479|NCT02145754|Lyme borreliosis|lyme borreliosis
5306480|NCT02145754|Borrelia burgdorferi|borrelia burgdorferi
5306481|NCT02145754|skin culture|skin culture
5306482|NCT02145754|culture media|culture media
5306483|NCT02145728|Non-specific chronic low back pain|non-specific chronic low back pain
5306484|NCT02145728|Cognitive functional therapy|cognitive functional therapy
5306485|NCT02145728|Exercise classes|exercise classes
5306486|NCT02145702|ESRD|esrd
5306487|NCT02145702|Kidney Failure|kidney failure
5306488|NCT02145702|Exercise|exercise
5306489|NCT02145702|Cognitive impairment|cognitive impairment
5201655|NCT02733848|Creon|creon
5306490|NCT02145637|Cancer, Lung cancer, Head and neck squamous cell carcinoma, Afatinib, Ruxolitinib, EGFR, JAK, STAT|cancer, lung cancer, head and neck squamous cell carcinoma, afatinib, ruxolitinib, egfr, jak, stat
5306492|NCT02145624|maternal vaccination|maternal vaccination
5306493|NCT02145624|maternal immunisation|maternal immunisation
5306494|NCT02145624|immune response|immune response
5306495|NCT02145611|hypertension, diabetes, endothelial function|hypertension, diabetes, endothelial function
5306496|NCT02145598|Multiple Myeloma|multiple myeloma
5306497|NCT02145598|Revlimid|revlimid
5306498|NCT02145598|Lenalidomide maintenance|lenalidomide maintenance
5306499|NCT02145585|Cardiac surgery|cardiac surgery
5306500|NCT02145585|Robotic pharmacological anesthesia|robotic pharmacological anesthesia
5306501|NCT02145585|Anesthesia|anesthesia
5306502|NCT02145546|Pacing dependent|pacing dependent
5306503|NCT02145546|Atrial Fibrillation|atrial fibrillation
5306504|NCT02145546|Amiodarone|amiodarone
5306505|NCT02145546|Propafenone|propafenone
5306506|NCT02145546|Sotalol|sotalol
5306507|NCT02145546|AF burden|af burden
5306509|NCT02145533|NGAL|ngal
5306510|NCT02145533|Arterial Aneurysms|arterial aneurysms
5306511|NCT02145520|bronchiolitis|bronchiolitis
5306512|NCT02145507|Leukoreduction|leukoreduction
5306513|NCT02145507|Red Blood Cell post-leukoreduction recovery|red blood cell post-leukoreduction recovery
5306514|NCT02145507|Packed red blood cell post storage hemolysis|packed red blood cell post storage hemolysis
5306515|NCT02145507|Red blood cell recovery|red blood cell recovery
5306516|NCT02145507|Plasma clotting factors|plasma clotting factors
5306517|NCT02145507|2,3-DPG rejuvenation|2,3-dpg rejuvenation
5306518|NCT02145494|SBRT (stereotactic body radiotherapy)|sbrt (stereotactic body radiotherapy)
5963086|NCT04273646|UC-MSCs|uc-mscs
5963087|NCT04273516|ESUS|esus
5306519|NCT02145494|Focal boost|focal boost
5306520|NCT02145494|Prostate|prostate
5306521|NCT02145481|coronary artery disease|coronary artery disease
5306522|NCT02145481|decision quality|decision quality
5306523|NCT02145481|decision making|decision making
5306524|NCT02145481|survey|survey
5306525|NCT02145481|measure development|measure development
5306541|NCT02145455|Outcome Assessment (Health Care)|outcome assessment (health care)
5306542|NCT02145455|Female|female
5306543|NCT02145455|Male|male
5306544|NCT02145455|Adult|adult
5306545|NCT02145442|Impaired fasting glucose|impaired fasting glucose
5306546|NCT02145442|Prediabetes|prediabetes
5306547|NCT02145442|Obesity|obesity
5306548|NCT02145442|Overweight|overweight
5306549|NCT02145442|Insulin sensitivity|insulin sensitivity
5306550|NCT02145442|Weight loss|weight loss
5306551|NCT02145442|Nutritional supplement|nutritional supplement
5306552|NCT02145442|Waist|waist
5306553|NCT02145442|Body composition|body composition
5306554|NCT02145429|Prevention of depression and anxiety disorder|prevention of depression and anxiety disorder
5306555|NCT02145429|Depression Prevention|depression prevention
5306556|NCT02145416|Imaging|imaging
5306557|NCT02145416|Chemoradiotherapy|chemoradiotherapy
5306558|NCT02145403|Allogeneic Transplantation|allogeneic transplantation
5306559|NCT02145403|Carfilzomib|carfilzomib
5306561|NCT02145403|Graft-Versus-Host Disease|graft-versus-host disease
5306562|NCT02145403|Multiple Myeloma|multiple myeloma
5306563|NCT02145403|Lymphoma|lymphoma
5306564|NCT02145403|Leukemia|leukemia
5306565|NCT02145390|Bladder Cancer|bladder cancer
5306566|NCT02145390|Bladder Carcinoma|bladder carcinoma
5306567|NCT02145390|Transition Cell Cancer|transition cell cancer
5306569|NCT02145390|Muscle Invasive Bladder Carcinoma|muscle invasive bladder carcinoma
5306570|NCT02145377|Cholera|cholera
5306571|NCT02145377|Vaccine|vaccine
5306572|NCT02145377|Mali|mali
5306573|NCT02145364|Ulthera System®|ulthera system®
5306574|NCT02145364|Ultherapy®|ultherapy®
5306575|NCT02145364|Ulthera, Inc.|ulthera, inc.
5306576|NCT02145351|HFpEF|hfpef
5306577|NCT02145351|Heart failure|heart failure
5306578|NCT02145351|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5306579|NCT02145351|Chronotropic incompetence|chronotropic incompetence
5306580|NCT02145338|Urinary tract infection|urinary tract infection
5306581|NCT02145338|Clean intermittent self-catheterisation|clean intermittent self-catheterisation
5306582|NCT02145338|Antibiotic prophylaxis|antibiotic prophylaxis
5306583|NCT02145325|Kidney transplant|kidney transplant
5306584|NCT02145325|Regulatory T cells|regulatory t cells
5306585|NCT02145325|Leukopheresis|leukopheresis
5306586|NCT02145325|Immune cells|immune cells
5306587|NCT02145325|Stem Cells|stem cells
5306588|NCT02145325|Tolerance|tolerance
5306589|NCT02145273|Maternal Depression|maternal depression
5306590|NCT02145273|Interpersonal Psychotherapy|interpersonal psychotherapy
5306591|NCT02145273|School Readiness|school readiness
5306592|NCT02145260|Hemodialysis|hemodialysis
5306593|NCT02145260|Hypotension|hypotension
5306594|NCT02145260|Hospitalization|hospitalization
5306595|NCT02145208|BPH|bph
5306596|NCT02145195|Vitamin D|vitamin d
5306597|NCT02145195|Children|children
5306598|NCT02145195|Supplements|supplements
5306599|NCT02145195|Cardiometabolic markers|cardiometabolic markers
5306600|NCT02145195|Immune defense|immune defense
5306601|NCT02145195|Bone turnover|bone turnover
5306602|NCT02145195|Muscle strength|muscle strength
5306603|NCT02145182|DGF|dgf
5306604|NCT02145182|Dialysis|dialysis
5306605|NCT02145182|Kidney|kidney
5306606|NCT02145182|Kidney Transplantation|kidney transplantation
5306607|NCT02145182|eGFR|egfr
5306608|NCT02145182|Complement|complement
5306609|NCT02145182|Eculizumab|eculizumab
5306610|NCT02145169|procedural sedation|procedural sedation
5306611|NCT02145169|emergence reaction|emergence reaction
5306612|NCT02145169|nitrous oxide|nitrous oxide
5306613|NCT02145169|ketamine|ketamine
5306614|NCT02145156|HPV vaccination|hpv vaccination
5306615|NCT02145156|Tailored health messaging|tailored health messaging
5306619|NCT02145130|Skin|skin
5306620|NCT02145130|Tissue-engineering|tissue-engineering
5306621|NCT02145130|Autologous|autologous
5306622|NCT02145130|Dermis|dermis
5306623|NCT02145130|Epidermis|epidermis
5306624|NCT02145117|MBSR|mbsr
5306625|NCT02145117|fMRI|fmri
5306626|NCT02145117|PTH|pth
5306627|NCT02145091|Psilocybin|psilocybin
5306628|NCT02145091|Hallucinogens|hallucinogens
5306629|NCT02145091|Pharmacologic Actions|pharmacologic actions
5306630|NCT02145091|Central Nervous System Agents|central nervous system agents
5306631|NCT02145091|Therapeutic Uses|therapeutic uses
5963088|NCT04273516|DOACS|doacs
5306632|NCT02145091|Psychotropic Drugs|psychotropic drugs
5306633|NCT02145065|paclitaxel coated balloon|paclitaxel coated balloon
5306634|NCT02145065|restenosis|restenosis
5306635|NCT02145065|Femoropopliteal artery disease|femoropopliteal artery disease
5306636|NCT02145052|Fascial closure|fascial closure
5306637|NCT02145052|Interrupted suture|interrupted suture
5306638|NCT02145052|Running suture|running suture
5306639|NCT02145052|Continuous suture|continuous suture
5306640|NCT02145039|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5306641|NCT02145039|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5306642|NCT02145039|Burkitt's lymphoma|burkitt's lymphoma
5306643|NCT02145039|Natural killer cell malignancies|natural killer cell malignancies
5306644|NCT02145039|Chronic myelogenous leukemia|chronic myelogenous leukemia
5306645|NCT02145039|Myelodysplastic syndrome|myelodysplastic syndrome
5306646|NCT02145039|Large-cell lymphoma|large-cell lymphoma
5306647|NCT02145039|Hodgkin lymphoma|hodgkin lymphoma
5306648|NCT02145039|Multiple myeloma|multiple myeloma
5306649|NCT02145039|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5306650|NCT02145039|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
5306651|NCT02145039|Marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5306652|NCT02145039|Follicular lymphoma|follicular lymphoma
5306653|NCT02145039|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5306654|NCT02145039|Mantle-cell lymphoma|mantle-cell lymphoma
5306655|NCT02145039|Prolymphocytic leukemia|prolymphocytic leukemia
5306656|NCT02145039|Refractory leukemia|refractory leukemia
5306657|NCT02145039|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5306658|NCT02145039|Bone marrow failure syndromes|bone marrow failure syndromes
5306659|NCT02145039|Myeloproliferative syndromes|myeloproliferative syndromes
5306660|NCT02145013|portal hypertension, hepatocellular carcinoma, resection|portal hypertension, hepatocellular carcinoma, resection
5306661|NCT02145000|Rotavirus|rotavirus
5306662|NCT02145000|Gastroenteritis|gastroenteritis
5306663|NCT02145000|Diarrhea|diarrhea
5306664|NCT02145000|Vaccine|vaccine
5306665|NCT02145000|Niger|niger
5306666|NCT02144974|Total pelvic exenteration.|total pelvic exenteration.
5306667|NCT02144961|breast reconstruction|breast reconstruction
5306668|NCT02144961|Deep Inferior Epigastric Artery Perforator (DIEP)|deep inferior epigastric artery perforator (diep)
5306669|NCT02144961|Indocyanine Green Angiography (IGA)|indocyanine green angiography (iga)
5306670|NCT02144961|autologous tissue transfer|autologous tissue transfer
5306671|NCT02144948|diabetes|diabetes
5306672|NCT02144935|pediatrics|pediatrics
5306673|NCT02144922|Hypertension|hypertension
5306674|NCT02144922|Statin|statin
5306675|NCT02144909|Diabetes self management|diabetes self management
5306676|NCT02144909|support group|support group
5306677|NCT02144909|semi structured support group|semi structured support group
5306678|NCT02144883|telephone counseling|telephone counseling
5306679|NCT02144870|Tic-Disorder, Tourette-Disorder, Habit Reversal Training, Resources activation|tic-disorder, tourette-disorder, habit reversal training, resources activation
5306680|NCT02144844|Antepartum depressive symptoms|antepartum depressive symptoms
5306681|NCT02144844|Antepartum depression|antepartum depression
5423278|NCT01616355|sodium hypochlorite;|sodium hypochlorite;
5306682|NCT02144844|Cognitive behavioral intervention|cognitive behavioral intervention
5306683|NCT02144844|Feasibility|feasibility
5306684|NCT02144844|randomized clinical trial|randomized clinical trial
5306686|NCT02144831|stroke prevention|stroke prevention
5306687|NCT02144831|ASA|asa
5306688|NCT02144831|clopidogrel|clopidogrel
5306689|NCT02144831|dual antiplatelet treatment|dual antiplatelet treatment
5306690|NCT02144753|IBS-C|ibs-c
5306691|NCT02144753|Constipation|constipation
5306692|NCT02144753|IBS|ibs
5306693|NCT02144740|Flow-mediated dilation|flow-mediated dilation
5201845|NCT02732782|tendinopathy|tendinopathy
5306694|NCT02144688|Human Immunodeficiency Virus|human immunodeficiency virus
5306695|NCT02144688|HIV|hiv
5306696|NCT02144688|Cognitive symptoms|cognitive symptoms
5306697|NCT02144688|Cognitive evaluation|cognitive evaluation
5306698|NCT02144688|Neuropsychological testing|neuropsychological testing
5306699|NCT02144688|Quality of life|quality of life
5306700|NCT02144688|Anxiety|anxiety
5306701|NCT02144688|Viral load|viral load
5306702|NCT02144688|Antiretroviral|antiretroviral
5306703|NCT02144688|Cerebrospinal fluid|cerebrospinal fluid
5306704|NCT02144688|Lumbar puncture|lumbar puncture
5306705|NCT02144688|Magnetic resonance imaging|magnetic resonance imaging
5306706|NCT02144688|MRI|mri
5306707|NCT02144649|Prostate Cancer|prostate cancer
5306708|NCT02144649|Tangerine Juice|tangerine juice
5306709|NCT02144649|Tomato Juice|tomato juice
5306710|NCT02144623|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5306711|NCT02144623|Valproate|valproate
5306712|NCT02144623|Cluster of differentiation antigen 20|cluster of differentiation antigen 20
5306713|NCT02144623|Lymphomas|lymphomas
5306714|NCT02144623|B-cell lymphomas|b-cell lymphomas
5306715|NCT02144623|Translational research|translational research
5306716|NCT02144623|Monoclonal antibodies|monoclonal antibodies
5306717|NCT02144610|CLI|cli
5306718|NCT02144597|morbid obesity|morbid obesity
5306719|NCT02144597|gastric bypass|gastric bypass
5306720|NCT02144597|bariatrics|bariatrics
5306721|NCT02144597|diet|diet
5306722|NCT02144597|caloric restriction|caloric restriction
5306723|NCT02144597|liver fat|liver fat
5306724|NCT02144597|appetite|appetite
5306725|NCT02144584|ischemic stroke|ischemic stroke
5306726|NCT02144584|memantine|memantine
5306727|NCT02144584|upper extremity weakness|upper extremity weakness
5306728|NCT02144584|motor recovery|motor recovery
5306729|NCT02144558|Sperm parameters|sperm parameters
5306730|NCT02144558|Spinal cord injuries|spinal cord injuries
5306731|NCT02144558|Oxidative stress|oxidative stress
5306732|NCT02144558|Inflammatory syndrome|inflammatory syndrome
5306733|NCT02144545|Surgery|surgery
5306734|NCT02144545|Morbid Obesity|morbid obesity
5306735|NCT02144545|Bariatric surgery|bariatric surgery
5306736|NCT02144545|Sleeve gastrectomy|sleeve gastrectomy
5306737|NCT02144545|Bougie Size|bougie size
5293727|NCT02207036|Internet|internet
5306738|NCT02144545|Distance from pylorus|distance from pylorus
5306739|NCT02144545|Hormones|hormones
5306740|NCT02144545|Gastric remanent|gastric remanent
5306741|NCT02144532|Ehlers-Danlos syndrome|ehlers-danlos syndrome
5306742|NCT02144532|hypermobility|hypermobility
5306743|NCT02144532|Compression garment|compression garment
5306744|NCT02144532|pain|pain
5306745|NCT02144532|isokinetic evaluation|isokinetic evaluation
5306746|NCT02144506|Elderly, home-based exercises programm|elderly, home-based exercises programm
5306747|NCT02144493|common bile duct stones|common bile duct stones
5306748|NCT02144493|diverticulum|diverticulum
5306749|NCT02144480|coronary bypass surgery|coronary bypass surgery
5306750|NCT02144480|rehabilitation|rehabilitation
5306751|NCT02144480|exercise training|exercise training
5306752|NCT02144480|platelet activation|platelet activation
5306753|NCT02144480|cardiopulmonary fitness|cardiopulmonary fitness
5306754|NCT02144467|Multiple-MRI, Gene, Cognition|multiple-mri, gene, cognition
5306755|NCT02144454|Cardiovascular disease|cardiovascular disease
5306756|NCT02144454|Fatty acids|fatty acids
5306757|NCT02144454|Vascular function|vascular function
5306758|NCT02144454|Blood pressure|blood pressure
5306759|NCT02144454|Plasma lipids|plasma lipids
5306760|NCT02144454|Insulin resistance|insulin resistance
5306761|NCT02144454|Endothelial activation|endothelial activation
5306762|NCT02144441|Diabetes Mellitus|diabetes mellitus
5306763|NCT02144441|Insulin|insulin
5306764|NCT02144441|Self Administration|self administration
5306765|NCT02144441|Patient Satisfaction|patient satisfaction
5306766|NCT02144441|Glucose|glucose
5306767|NCT02144441|Hypoglycemia|hypoglycemia
5306768|NCT02144441|Hyperglycemia|hyperglycemia
5306769|NCT02144415|abuse liability|abuse liability
5306770|NCT02144415|recreational drug user|recreational drug user
5306771|NCT02144415|stimulant|stimulant
5306772|NCT02144415|d-amphetamine|d-amphetamine
5306773|NCT02144415|ADHD|adhd
5306774|NCT02144389|Arachidonic acid|arachidonic acid
5306775|NCT02144389|Bilharzia|bilharzia
5306776|NCT02144389|Mansoni|mansoni
5306777|NCT02144389|Schistosomiasis|schistosomiasis
5306778|NCT02144389|Polyunsaturated fatty acid|polyunsaturated fatty acid
5306779|NCT02144376|Constipation|constipation
5306780|NCT02144376|psyllium|psyllium
5306781|NCT02144376|ispaghula|ispaghula
5306782|NCT02144376|Magnetic Resonance Imaging|magnetic resonance imaging
5306783|NCT02144376|MRI|mri
5306784|NCT02144376|microbiota|microbiota
5306785|NCT02144363|Preterm|preterm
5306787|NCT02144363|Mechanical Ventilation|mechanical ventilation
5306788|NCT02144363|Extubation failure|extubation failure
5306789|NCT02144350|hyperbaric oxygen|hyperbaric oxygen
5306790|NCT02144337|Physical activity|physical activity
5306791|NCT02144337|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5306792|NCT02144337|Children|children
5306793|NCT02144337|Intervention|intervention
5306794|NCT02144324|Maxillary protraction|maxillary protraction
5306795|NCT02144324|Modified Tandem Appliance|modified tandem appliance
5306796|NCT02144324|Face mask therapy|face mask therapy
5306797|NCT02144324|Class III malocclusion|class iii malocclusion
5306798|NCT02144324|Maxillary deficiency|maxillary deficiency
5306799|NCT02144311|MRI|mri
5306800|NCT02144311|FDG PET/CT|fdg pet/ct
5306801|NCT02144311|histologic heterogeneity|histologic heterogeneity
5306802|NCT02144311|14-061|14-061
5306803|NCT02144298|microcirculation|microcirculation
5306804|NCT02144298|coronary artery bypass grafting|coronary artery bypass grafting
5306805|NCT02144298|cold blood cardioplegia|cold blood cardioplegia
5306806|NCT02144298|cristalloid cardioplegia|cristalloid cardioplegia
5306807|NCT02144285|Renal dialysis|renal dialysis
5306808|NCT02144272|Antibody|antibody
5306809|NCT02144272|Tumor Necrosis Factor alpha|tumor necrosis factor alpha
5306810|NCT02144272|Interleukin-17|interleukin-17
5306811|NCT02144233|Pain|pain
5306812|NCT02144233|Temporomandibular joint disorders|temporomandibular joint disorders
5306815|NCT02144233|Randomized clinical trial|randomized clinical trial
5306816|NCT02144233|Mastication|mastication
5306817|NCT02144233|Habitual chewing side|habitual chewing side
5306818|NCT02144233|Handedness preference|handedness preference
5306819|NCT02144233|Hemimandibular retrognathia|hemimandibular retrognathia
5306820|NCT02144220|Telemedicine|telemedicine
5306821|NCT02144220|Virtual care visit|virtual care visit
5306822|NCT02144220|Remote visit|remote visit
5306823|NCT02144220|Video-conferencing|video-conferencing
5306824|NCT02144194|Oral Vinorelbine|oral vinorelbine
5306825|NCT02144194|Oral Chemotherapy|oral chemotherapy
5306826|NCT02144194|Metastatic Breast Cancer|metastatic breast cancer
5306827|NCT02144194|Advanced Breast Cancer|advanced breast cancer
5306828|NCT02144194|Maintenance treatment|maintenance treatment
5306829|NCT02144181|Ulthera® System|ulthera® system
5306830|NCT02144181|Ultherapy® Treatment|ultherapy® treatment
5306831|NCT02144181|Ulthera, Inc.|ulthera, inc.
5306832|NCT02144168|Prebiotics|prebiotics
5306833|NCT02144168|diarrhoea|diarrhoea
5306834|NCT02144168|Enteral nutrition|enteral nutrition
5306835|NCT02144168|Fibre|fibre
5306836|NCT02144168|Bifidobacteria|bifidobacteria
5306837|NCT02144168|SCFA|scfa
5306838|NCT02144155|Oxytocin|oxytocin
5306839|NCT02144142|Microbiome|microbiome
5306840|NCT02144142|Atopic dermatitis|atopic dermatitis
5306841|NCT02144142|Eczema|eczema
5306842|NCT02144142|Bacteriotherapy|bacteriotherapy
5306843|NCT02144129|Whole Body Electromyostimulation|whole body electromyostimulation
5306844|NCT02144129|Inflammatory Bowel Disease|inflammatory bowel disease
5306845|NCT02144129|Lean Body Mass|lean body mass
5306846|NCT02144129|Muscle Strength|muscle strength
5306847|NCT02144116|dance-movement therapy|dance-movement therapy
5306848|NCT02144116|balance|balance
5306849|NCT02144116|Fibromyalgia|fibromyalgia
5306850|NCT02144103|Glaucomatous Neurodegeneration|glaucomatous neurodegeneration
5306851|NCT02144103|Retinal Degeneration|retinal degeneration
5306852|NCT02144103|Primary Open-Angle Glaucoma|primary open-angle glaucoma
5306853|NCT02144103|Optic Neuropathy|optic neuropathy
5306854|NCT02144103|Intraocular pressure|intraocular pressure
5306855|NCT02144103|Retinal ganglion cell degeneration|retinal ganglion cell degeneration
5306856|NCT02144103|Optic nerve atrophy|optic nerve atrophy
5306857|NCT02144103|Subtenon injection|subtenon injection
5306858|NCT02144103|Glaucomatous damage|glaucomatous damage
5306859|NCT02144103|ADRC|adrc
5306860|NCT02144103|Adipose-derived regenerative cells|adipose-derived regenerative cells
5306861|NCT02144103|Fat tissue|fat tissue
5306862|NCT02144103|Stem cells|stem cells
5306863|NCT02144090|Angiography|angiography
5306864|NCT02144090|Angioplasty|angioplasty
5306865|NCT02144090|Coronary artery disease|coronary artery disease
5306866|NCT02144090|Diagnostic|diagnostic
5306867|NCT02144090|Fractional flow reserve|fractional flow reserve
5306868|NCT02144077|Photodynamic Therapy|photodynamic therapy
5306870|NCT02144077|non-aggressive BCC|non-aggressive bcc
5306871|NCT02144064|Aspirin, heparin, pregnancy, recurrent pregnancy loss|aspirin, heparin, pregnancy, recurrent pregnancy loss
5306872|NCT02144051|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer|solid tumor, prostate cancer, breast cancer, bladder cancer, ovarian cancer, gastric cancer, salivary duct cancer
5306873|NCT02144038|multiple myeloma,|multiple myeloma,
5306874|NCT02144038|relapsed and refractory,|relapsed and refractory,
5306875|NCT02144038|LGH447,|lgh447,
5306876|NCT02144038|pan-PIM inhibitor,|pan-pim inhibitor,
5306877|NCT02144038|PIM Kinase,|pim kinase,
5306878|NCT02144038|BYL719,|byl719,
5306879|NCT02144038|PI3K inhibitor|pi3k inhibitor
5306880|NCT02144025|Ocular Graft-Versus-Host-Disease|ocular graft-versus-host-disease
5306881|NCT02144025|Topical Cyclosporine|topical cyclosporine
5306883|NCT02143986|Macrophagic activation syndrome|macrophagic activation syndrome
5306884|NCT02143986|Ferritin|ferritin
5306885|NCT02143986|Still's disease|still's disease
5306886|NCT02143973|Uremic|uremic
5306887|NCT02143973|Pruritus|pruritus
5306888|NCT02143973|Itch|itch
5306889|NCT02143973|Chronic Itch|chronic itch
5306890|NCT02143973|Nalbuphine|nalbuphine
5306891|NCT02143960|Syneron|syneron
5306892|NCT02143960|Velashape|velashape
5306893|NCT02143960|ELOS|elos
5306894|NCT02143960|Zeltiq|zeltiq
5306895|NCT02143960|Cryolipolysis|cryolipolysis
5306896|NCT02143947|Orthoses|orthoses
5306897|NCT02143947|Foot|foot
5306898|NCT02143947|Kinematics|kinematics
5306899|NCT02143947|EMG|emg
5306900|NCT02143947|Biomechanics|biomechanics
5306901|NCT02143934|Plasmodium vivax|plasmodium vivax
5306902|NCT02143934|Hypnozoites|hypnozoites
5306903|NCT02143934|Primaquine|primaquine
5306904|NCT02143934|Liver-stage|liver-stage
5306905|NCT02143934|Blood-stage|blood-stage
5306906|NCT02143934|Plasmodium falciparum|plasmodium falciparum
5306907|NCT02143921|NGO zinc scale|ngo zinc scale
5306908|NCT02143921|compliance with WHO zinc treatment recommendations|compliance with who zinc treatment recommendations
5306909|NCT02143908|Diarrhea|diarrhea
5306910|NCT02143908|L-lysine supplementation|l-lysine supplementation
5306916|NCT02143882|Live attenuated influenza vaccine|live attenuated influenza vaccine
5306917|NCT02143882|fluenz|fluenz
5306918|NCT02143882|pandemrix|pandemrix
5306919|NCT02143882|pandemic influenza vaccine|pandemic influenza vaccine
5306920|NCT02143882|immunogenicity|immunogenicity
5306921|NCT02143869|Gastrointestinal cancer|gastrointestinal cancer
5306922|NCT02143869|Lung cancer|lung cancer
5306923|NCT02143869|Bioelectrical Impedance analysis|bioelectrical impedance analysis
5306924|NCT02143869|Body composition|body composition
5306925|NCT02143869|Perioperative|perioperative
5306926|NCT02143830|marrow aplasia|marrow aplasia
5306927|NCT02143830|cytopenia|cytopenia
5306928|NCT02143830|myelodysplasia|myelodysplasia
5306930|NCT02143830|bone marrow transplant|bone marrow transplant
5306931|NCT02143830|cytoreductive regimen|cytoreductive regimen
5306932|NCT02143830|T-cell reduction|t-cell reduction
5306948|NCT02143791|Burst stimulation|burst stimulation
5306949|NCT02143778|MBT|mbt
5306950|NCT02143778|CSPH|csph
5306951|NCT02143778|HVPG|hvpg
5306952|NCT02143765|Mitiglinide|mitiglinide
5306953|NCT02143765|Acarbose|acarbose
5306954|NCT02143765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5306955|NCT02143752|Smoking|smoking
5306956|NCT02143752|Tobacco|tobacco
5306957|NCT02143752|Addiction|addiction
5306958|NCT02143752|Mindfulness|mindfulness
5306959|NCT02143752|Meditation|meditation
5306960|NCT02143739|asthma|asthma
5306961|NCT02143713|Endometriosis-associated pain|endometriosis-associated pain
5306962|NCT02143713|Elagolix|elagolix
5306963|NCT02143713|Gonadotropin-releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
5306964|NCT02143713|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5306965|NCT02143713|Non-menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
5306966|NCT02143713|Dyspareunia|dyspareunia
5306967|NCT02143700|exacerbation|exacerbation
5306968|NCT02143700|cognitive|cognitive
5306969|NCT02143700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5306970|NCT02143687|Pulmonary hypertension|pulmonary hypertension
5306971|NCT02143687|Interstitial lung disease|interstitial lung disease
5306972|NCT02143687|Pulmonary fibrosis|pulmonary fibrosis
5306973|NCT02143674|Stretching exercise muscle|stretching exercise muscle
5306974|NCT02143674|Elderly|elderly
5306975|NCT02143674|Techniques and exercise|techniques and exercise
5306976|NCT02143674|Physiotherapy|physiotherapy
5306977|NCT02143648|uremic|uremic
5306978|NCT02143648|pruritus|pruritus
5306979|NCT02143648|itch|itch
5306980|NCT02143648|chronic itch|chronic itch
5306981|NCT02143648|nalbuphine|nalbuphine
5306982|NCT02143635|HDM201,TP53wt, p53, MDM2, HDM2, advanced tumors, BLRM (Bayesian logistic regression model)|hdm201,tp53wt, p53, mdm2, hdm2, advanced tumors, blrm (bayesian logistic regression model)
5306983|NCT02143622|Head and neck cancer|head and neck cancer
5306984|NCT02143609|airway disease|airway disease
5306985|NCT02143609|bronchitis|bronchitis
5306986|NCT02143609|emphysema|emphysema
5306987|NCT02143609|lung|lung
5306988|NCT02143596|stroke|stroke
5306989|NCT02143596|dehydration|dehydration
5306990|NCT02143596|prognosis|prognosis
5306991|NCT02143583|rhinoconjunctivitis|rhinoconjunctivitis
5306992|NCT02143583|birch pollen|birch pollen
5306993|NCT02143583|desensitization|desensitization
5306994|NCT02143583|allergen immunotherapy|allergen immunotherapy
5306995|NCT02143570|Urinary Bladder, Overactive|urinary bladder, overactive
5306996|NCT02143570|Darifenacin|darifenacin
5306997|NCT02143570|Physiotherapy|physiotherapy
5306998|NCT02143570|Quality of Life|quality of life
5306999|NCT02143557|breast milk|breast milk
5307000|NCT02143557|infants|infants
5307001|NCT02143557|chylothorax|chylothorax
5307002|NCT02143557|cardiac surgery|cardiac surgery
5307003|NCT02143557|modified breast milk|modified breast milk
5307004|NCT02143544|Intra-aortic balloon counterpulsation|intra-aortic balloon counterpulsation
5307005|NCT02143544|Cardiac surgery|cardiac surgery
5307006|NCT02143544|High-risk patients|high-risk patients
5307007|NCT02143518|Human Hookworm|human hookworm
5307008|NCT02143518|Necator americanus|necator americanus
5307009|NCT02143518|Hookworm|hookworm
5307010|NCT02143518|Hookworm Disease|hookworm disease
5307011|NCT02143518|Iron-deficiency anemia|iron-deficiency anemia
5307012|NCT02143518|Soil-transmitted helminth infection|soil-transmitted helminth infection
5307013|NCT02143518|Neglected Tropical Disease|neglected tropical disease
5307014|NCT02143518|Na-GST-1|na-gst-1
5307015|NCT02143518|CpG|cpg
5307016|NCT02143479|France|france
5307017|NCT02143479|Prograf|prograf
5307018|NCT02143479|Pharmaco-epidemiology|pharmaco-epidemiology
5307019|NCT02143479|Tacrolimus|tacrolimus
5307020|NCT02143479|Observational|observational
5307336|NCT02141932|Hand-held|hand-held
5307039|NCT02143453|overweight|overweight
5307040|NCT02143453|children|children
5307041|NCT02143427|social skills training,|social skills training,
5307042|NCT02143427|computer based,|computer based,
5307043|NCT02143427|social competence training,|social competence training,
5307044|NCT02143427|Oppositional Defiant Disorder|oppositional defiant disorder
5307045|NCT02143427|peer related aggressive behavior|peer related aggressive behavior
5307046|NCT02143427|randomized controlled trial|randomized controlled trial
5307047|NCT02143388|Local advanced|local advanced
5307048|NCT02143388|high risk|high risk
5307049|NCT02143388|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5307050|NCT02143362|Intraoperative wake up|intraoperative wake up
5307051|NCT02143362|Closed loop of target controlled infusion|closed loop of target controlled infusion
5307052|NCT02143362|Dexmedetomidine|dexmedetomidine
5307053|NCT02143362|Propofol|propofol
5307055|NCT02143349|herbal remedies|herbal remedies
5307056|NCT02143349|metabolic disorders|metabolic disorders
5307057|NCT02143336|Surgical site infections|surgical site infections
5307058|NCT02143336|Skin closure techniques|skin closure techniques
5307059|NCT02143336|Colorectal surgery|colorectal surgery
5307060|NCT02143323|GST, DILI, biomarker|gst, dili, biomarker
5307061|NCT02143297|Sleep Apnea/Hypopnea Syndrome|sleep apnea/hypopnea syndrome
5307062|NCT02143297|Pulse Oximetry|pulse oximetry
5307063|NCT02143297|Nonlinear Dynamics|nonlinear dynamics
5307064|NCT02143297|Fourier Analysis|fourier analysis
5307065|NCT02143297|Neural Networks (Computer)|neural networks (computer)
5307066|NCT02143271|Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis|secondary hyperparathyroidism in patients receiving peritoneal dialysis
5307067|NCT02143258|stenting venous sinus|stenting venous sinus
5307068|NCT02143258|intracranial hypertension|intracranial hypertension
5307069|NCT02143258|quality of life|quality of life
5307070|NCT02143258|headache|headache
5307071|NCT02143258|visual impairment|visual impairment
5307072|NCT02143232|knee replacement|knee replacement
5307073|NCT02143232|hip replacement|hip replacement
5307074|NCT02143232|patient monitor|patient monitor
5307075|NCT02143219|Pancreatic metastatic cancer|pancreatic metastatic cancer
5307076|NCT02143219|FOLFIRINOX|folfirinox
5307077|NCT02143219|toxicity|toxicity
5307078|NCT02143219|efficacy|efficacy
5307079|NCT02143206|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5307080|NCT02143206|Pain|pain
5307081|NCT02143206|Arthritis|arthritis
5307082|NCT02143206|Dyspnea|dyspnea
5307083|NCT02143206|Exercise|exercise
5307084|NCT02143206|Aerobic|aerobic
5307085|NCT02143193|Breastfeeding|breastfeeding
5307086|NCT02143193|Newborn|newborn
5307087|NCT02143193|Formula|formula
5307088|NCT02143193|Temperature|temperature
5307089|NCT02143193|Initial Bath|initial bath
5307090|NCT02143180|real-time tissue elastography|real-time tissue elastography
5307091|NCT02143180|hepatic fibrosis|hepatic fibrosis
5307092|NCT02143154|vancomycin, GBS|vancomycin, gbs
5307093|NCT02143141|postoperative pain|postoperative pain
5307094|NCT02143141|narcotic side effects|narcotic side effects
5307095|NCT02143128|score|score
5307096|NCT02143128|postoperative|postoperative
5307097|NCT02143128|pain|pain
5307098|NCT02143128|nausea|nausea
5307099|NCT02143128|mental status|mental status
5307100|NCT02143128|tool|tool
5307101|NCT02143115|Colorectal cancer surveillance|colorectal cancer surveillance
5307102|NCT02143089|CCSWI|ccswi
5307103|NCT02143076|Medication Adherence|medication adherence
5307104|NCT02143076|Hydroxyurea|hydroxyurea
5307105|NCT02143050|Unresectable melanoma Stage IIIC and Stage IV BRAF V600E+|unresectable melanoma stage iiic and stage iv braf v600e+
5307106|NCT02143024|depression|depression
5307107|NCT02143024|family|family
5307108|NCT02143024|primary health care|primary health care
5307109|NCT02143011|sugar|sugar
5307110|NCT02143011|sucrose|sucrose
5307111|NCT02143011|fruit juice|fruit juice
5307112|NCT02143011|orange juice|orange juice
5307113|NCT02143011|metabolism|metabolism
5307114|NCT02143011|immune cell aging|immune cell aging
5307115|NCT02143011|lipids|lipids
5307116|NCT02142998|GERD|gerd
5307117|NCT02142998|Laparoscopic|laparoscopic
5307118|NCT02142998|sleeve|sleeve
5307119|NCT02142998|gastrectomy|gastrectomy
5307120|NCT02142972|Low back pain|low back pain
5307121|NCT02142972|Oswestry questionnaire|oswestry questionnaire
5307122|NCT02142972|Post-partum Depression|post-partum depression
5307123|NCT02142972|Pelvic pain|pelvic pain
5307124|NCT02142959|RTA 408|rta 408
5307125|NCT02142959|RTA 408 Lotion|rta 408 lotion
5307126|NCT02142959|Breast cancer|breast cancer
5307127|NCT02142959|Radiation therapy|radiation therapy
5307128|NCT02142959|Radiation dermatitis|radiation dermatitis
5307129|NCT02142959|Oxidative stress|oxidative stress
5307130|NCT02142959|Inflammation|inflammation
5307131|NCT02142959|omaveloxolone|omaveloxolone
5307132|NCT02142933|colonization|colonization
5307133|NCT02142933|screening|screening
5307134|NCT02142933|group B streptococci|group b streptococci
5307135|NCT02142933|extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
5307136|NCT02142933|enterobacteriaceae|enterobacteriaceae
5307137|NCT02142920|Healthy Volunteers|healthy volunteers
5307138|NCT02142907|Breast conservative surgery|breast conservative surgery
5307139|NCT02142907|boost radiation|boost radiation
5307140|NCT02142907|acute toxicity|acute toxicity
5307141|NCT02142907|cosmesis|cosmesis
5307142|NCT02142907|local control|local control
5307143|NCT02142894|Tuberculosis|tuberculosis
5307145|NCT02142868|Expanded Access|expanded access
5307146|NCT02142868|Advanced Breast Cancer|advanced breast cancer
5307147|NCT02142855|volunteers|volunteers
5307148|NCT02142855|young (18-30 y)|young (18-30 y)
5307149|NCT02142855|older (65-75 y)|older (65-75 y)
5307150|NCT02142855|age groups|age groups
5307151|NCT02142842|Adipose stem cell|adipose stem cell
5307152|NCT02142842|Platelet rich plasma|platelet rich plasma
5307153|NCT02142842|Knee Osteoarthritis|knee osteoarthritis
5307154|NCT02142842|Injured cartilage|injured cartilage
5307155|NCT02142829|bariatric surgery, postoperative pain|bariatric surgery, postoperative pain
5307156|NCT02142777|S-equol|s-equol
5307157|NCT02142777|COX activity|cox activity
5307158|NCT02142764|Multiple Sclerosis|multiple sclerosis
5307159|NCT02142764|CD8+ T-cells|cd8+ t-cells
5307160|NCT02142764|Class I Major Histocompatibility Complex (MHC)|class i major histocompatibility complex (mhc)
5307161|NCT02142764|pentamers|pentamers
5307162|NCT02142751|Escherichia coli|escherichia coli
5307163|NCT02142751|Extended-spectrum β-lactamases (ESBLs)|extended-spectrum β-lactamases (esbls)
5307164|NCT02142751|Bacteremia|bacteremia
5307165|NCT02142751|Urinary tract infection|urinary tract infection
5307166|NCT02142751|Bloodstream infection|bloodstream infection
5307167|NCT02142751|Fosfomycin|fosfomycin
5307168|NCT02142751|Meropenem|meropenem
5307169|NCT02142751|Pharmacokinetics|pharmacokinetics
5307170|NCT02142751|intestinal colonization|intestinal colonization
5307171|NCT02142751|Recurrence|recurrence
5307172|NCT02142751|multidrug resistance E.coli|multidrug resistance e.coli
5307173|NCT02142751|Ceftriaxone|ceftriaxone
5307174|NCT02142738|PD-1|pd-1
5307175|NCT02142738|PD1|pd1
5307176|NCT02142738|PD-L1|pd-l1
5307177|NCT02142738|PDL1|pdl1
5307178|NCT02142712|Ischemic Stroke|ischemic stroke
5307179|NCT02142712|Brain Edema|brain edema
5307180|NCT02142712|Diphenhydramine|diphenhydramine
5307181|NCT02142712|Dextromethorphan|dextromethorphan
5307182|NCT02142712|Famotidine|famotidine
5307183|NCT02142699|Acute kidney injury|acute kidney injury
5307184|NCT02142699|Cardiac surgery|cardiac surgery
5307185|NCT02142699|Ischaemia reperfusion injury|ischaemia reperfusion injury
5307186|NCT02142699|hemearginate|hemearginate
5307187|NCT02142686|Hysteroscopy|hysteroscopy
5307188|NCT02142686|Filling pressures|filling pressures
5307189|NCT02142673|Operative hysteroscopy|operative hysteroscopy
5307190|NCT02142673|Filling pressure|filling pressure
5307191|NCT02142660|Adhesion barrier system|adhesion barrier system
5307192|NCT02142660|Bariatric surgery|bariatric surgery
5307193|NCT02142647|infant growth|infant growth
5307194|NCT02142647|dietary protein|dietary protein
5307195|NCT02142647|body composition|body composition
5307196|NCT02142647|gut microbiome|gut microbiome
5307197|NCT02142608|Prostate cancer|prostate cancer
5307198|NCT02142608|Ultrasound Imaging|ultrasound imaging
5307199|NCT02142595|dexmedetomidine|dexmedetomidine
5307200|NCT02142595|midazolam|midazolam
5307201|NCT02142595|sleep quality|sleep quality
5307202|NCT02142595|delirium|delirium
5307203|NCT02142582|Home Parenteral Nutrition|home parenteral nutrition
5307204|NCT02142582|Compliance|compliance
5307205|NCT02142582|Short Bowel Syndrome|short bowel syndrome
5307206|NCT02142582|Oral Rehydration Solution|oral rehydration solution
5307207|NCT02142569|Monacolin K|monacolin k
5307208|NCT02142569|Cholesterol|cholesterol
5307209|NCT02142569|Tocotrienol-enriched fraction of palm oil (TRF)|tocotrienol-enriched fraction of palm oil (trf)
5307210|NCT02142569|Chinese Red Yeast Rice (CRYR|chinese red yeast rice (cryr
5307211|NCT02142530|NHL|nhl
5307212|NCT02142530|DLBCL|dlbcl
5307213|NCT02142530|PTCL|ptcl
5307214|NCT02142530|Marginal zone lymphoma|marginal zone lymphoma
5307215|NCT02142530|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5307216|NCT02142530|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5307217|NCT02142517|pancreaticoduodenectomy, pancreatic fistula|pancreaticoduodenectomy, pancreatic fistula
5307218|NCT02142504|Drug therapy|drug therapy
5307219|NCT02142491|Egg allergy|egg allergy
5307220|NCT02142491|live attenuated influenza vaccine|live attenuated influenza vaccine
5307221|NCT02142478|physical activity|physical activity
5307222|NCT02142478|behaviour change|behaviour change
5307223|NCT02142478|exercise referral|exercise referral
5307224|NCT02142478|self-determination theory|self-determination theory
5307225|NCT02142478|mixed-method|mixed-method
5307226|NCT02142478|evaluation|evaluation
5307227|NCT02142478|qualitative|qualitative
5307228|NCT02142452|Pregnancy|pregnancy
5202341|NCT02729545|LH/FSH|lh/fsh
5307229|NCT02142452|Obesity/Overweight|obesity/overweight
5307230|NCT02142452|postpartum|postpartum
5307231|NCT02142452|mobile health|mobile health
5307232|NCT02142452|cardiovascular disease|cardiovascular disease
5307233|NCT02142439|Anorexia|anorexia
5307234|NCT02142439|Bulimia|bulimia
5307235|NCT02142439|Physical activity|physical activity
5307236|NCT02142439|Treatment|treatment
5307237|NCT02142426|wound chronic|wound chronic
5307238|NCT02142413|Stroke|stroke
5307239|NCT02142413|Atrial fibrillation|atrial fibrillation
5307240|NCT02142413|Holter ECG|holter ecg
5307241|NCT02142413|cardiac MRI|cardiac mri
5307242|NCT02142335|B-Raf, inoperable stage III melanoma, metastatic stage IV melanoma,|b-raf, inoperable stage iii melanoma, metastatic stage iv melanoma,
5307243|NCT02142296|Pigment Epithelial Detachment|pigment epithelial detachment
5307244|NCT02142296|Age-related Macular degeneration|age-related macular degeneration
5307245|NCT02142283|Mechanical thrombectomy|mechanical thrombectomy
5307246|NCT02142283|Acute ischemic stroke|acute ischemic stroke
5307247|NCT02142283|Wake up stroke|wake up stroke
5307248|NCT02142283|Late presenting stroke|late presenting stroke
5307249|NCT02142257|Obesity|obesity
5307250|NCT02142257|Gastric Bypass|gastric bypass
5307251|NCT02142257|Aspiration Therapy|aspiration therapy
5307252|NCT02142257|AspireAssist|aspireassist
5307253|NCT02142244|Sentinel node biopsy|sentinel node biopsy
5307254|NCT02142244|Near infra red light|near infra red light
5307255|NCT02142244|Indocyanine green|indocyanine green
5307256|NCT02142244|micrometastasis|micrometastasis
5307257|NCT02142231|acupuncture|acupuncture
5307258|NCT02142231|test anxiety|test anxiety
5307259|NCT02142231|neuroenhancer|neuroenhancer
5307260|NCT02142231|placebo|placebo
5307261|NCT02142179|Asthma|asthma
5307262|NCT02142179|Knowledge|knowledge
5307263|NCT02142179|School-Based Service|school-based service
5307264|NCT02142179|Adolescents|adolescents
5307265|NCT02142166|aneurysmal subarachnoid hemorrhage (ASH)|aneurysmal subarachnoid hemorrhage (ash)
5307266|NCT02142166|biomarker|biomarker
5307267|NCT02142153|First in man|first in man
5307268|NCT02142153|Antifungal|antifungal
5307269|NCT02142153|Intravenous infusion|intravenous infusion
5307270|NCT02142153|Healthy volunteers|healthy volunteers
5307271|NCT02142140|Treatment of ADHD|treatment of adhd
5307272|NCT02142140|Long-term treatment follow-up|long-term treatment follow-up
5307273|NCT02142127|GFT505|gft505
5307274|NCT02142127|Mass balance|mass balance
5307275|NCT02142127|Pharmacokinetics|pharmacokinetics
5307276|NCT02142127|Metabolites|metabolites
5307277|NCT02142127|Healthy subjects|healthy subjects
5307278|NCT02142127|Healthy male volunteers|healthy male volunteers
5307279|NCT02142114|Intravitreal injection|intravitreal injection
5307280|NCT02142114|Needle size|needle size
5307281|NCT02142114|Pain|pain
5307282|NCT02142114|Intraocular pressure|intraocular pressure
5307283|NCT02142114|Pain following an Intravitreal injection|pain following an intravitreal injection
5307284|NCT02142101|Gut Microbiota|gut microbiota
5307285|NCT02142101|Polycystic kidney disease|polycystic kidney disease
5307286|NCT02142101|Chronic kidney disease|chronic kidney disease
5307287|NCT02142101|Uremic metabolites|uremic metabolites
5307288|NCT02142088|Glycaemic Control|glycaemic control
5307289|NCT02142088|Glucose Monitoring|glucose monitoring
5307290|NCT02142088|Intravascular Glucose Monitoring|intravascular glucose monitoring
5307291|NCT02142075|Pharmacokinetics|pharmacokinetics
5307292|NCT02142062|Venous outflow obstruction|venous outflow obstruction
5307293|NCT02142062|Iliac Vein|iliac vein
5307294|NCT02142062|Common Femoral Vein|common femoral vein
5307295|NCT02142062|Iliac Compression|iliac compression
5307296|NCT02142049|DLBCL|dlbcl
5307297|NCT02142049|ABC|abc
5307298|NCT02142049|GCB|gcb
5307299|NCT02142049|Primary Mediastinal B-cell lymphoma|primary mediastinal b-cell lymphoma
5307300|NCT02142049|Pharmacyclics|pharmacyclics
5307301|NCT02142049|Lenalidomide|lenalidomide
5307302|NCT02142049|lymphoma|lymphoma
5307303|NCT02142049|Rituximab|rituximab
5307304|NCT02142049|EPOCH|epoch
5307305|NCT02142049|Recommended Phase 2 Dose(RP2D)|recommended phase 2 dose(rp2d)
5307306|NCT02142036|Metastatic disease|metastatic disease
5307307|NCT02142036|Metastasis|metastasis
5307308|NCT02142036|Targeted therapy|targeted therapy
5307309|NCT02142036|Solid tumor|solid tumor
5307310|NCT02142036|Personalized medicine|personalized medicine
5307311|NCT02142036|N-of-1 trial|n-of-1 trial
5307312|NCT02141997|efficacy|efficacy
5307313|NCT02141997|Methotrexate|methotrexate
5307315|NCT02141984|Korean regulatory required Postmarketing Surveillance|korean regulatory required postmarketing surveillance
5307316|NCT02141971|Down syndrome|down syndrome
5307317|NCT02141971|Alzheimer's disease|alzheimer's disease
5307318|NCT02141971|biomarkers|biomarkers
5307319|NCT02141971|amyloid|amyloid
5307320|NCT02141971|tau|tau
5307321|NCT02141945|Cancer|cancer
5307322|NCT02141945|Colon Cancer|colon cancer
5307323|NCT02141945|Colorectal Cancer|colorectal cancer
5307324|NCT02141945|Neoplasm|neoplasm
5307325|NCT02141945|Colorectal Neoplasm|colorectal neoplasm
5307326|NCT02141945|Intestinal Neoplasms|intestinal neoplasms
5307327|NCT02141945|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5307328|NCT02141945|Digestive System Neoplasms|digestive system neoplasms
5307329|NCT02141945|Neoplasms by Site|neoplasms by site
5307330|NCT02141945|Neoplasms|neoplasms
5307331|NCT02141945|Colonic Diseases|colonic diseases
5307332|NCT02141945|Digestive System Diseases|digestive system diseases
5307333|NCT02141945|Gastrointestinal Diseases|gastrointestinal diseases
5307334|NCT02141945|Intestinal Diseases|intestinal diseases
5307335|NCT02141945|Rectal Diseases|rectal diseases
5307338|NCT02141932|Diagnosis|diagnosis
5307339|NCT02141932|Cardiovascular|cardiovascular
5307340|NCT02141932|Carotid artery stenosis|carotid artery stenosis
5307341|NCT02141919|renal cancer|renal cancer
5307342|NCT02141880|Obesity|obesity
5307343|NCT02141867|Surgery|surgery
5307344|NCT02141867|Mortality|mortality
5307345|NCT02141841|intrathecal;|intrathecal;
5307346|NCT02141841|bupivacaine;|bupivacaine;
5307347|NCT02141841|concentration;|concentration;
5307348|NCT02141828|Leukemia|leukemia
5307349|NCT02141828|Advanced hematologic malignancies|advanced hematologic malignancies
5307350|NCT02141828|Epizyme|epizyme
5307351|NCT02141828|Phase 1b|phase 1b
5307352|NCT02141828|MLL gene|mll gene
5307353|NCT02141828|11q23|11q23
5307354|NCT02141828|Ambiguous lineage|ambiguous lineage
5307355|NCT02141828|ALL|all
5307356|NCT02141828|AML|aml
5307357|NCT02141828|Acute leukemias|acute leukemias
5307358|NCT02141828|MLL-r|mll-r
5307359|NCT02141763|Psoriatic Arthritis|psoriatic arthritis
5307360|NCT02141724|Neuromuscular|neuromuscular
5307361|NCT02141724|Wheelchair|wheelchair
5307362|NCT02141724|Pain|pain
5307363|NCT02141724|Bedsore|bedsore
5307364|NCT02141724|Trouble postural|trouble postural
5307366|NCT02141698|Drug therapy|drug therapy
5307367|NCT02141685|in vitro fertilization|in vitro fertilization
5307368|NCT02141685|assisted reproduction techniques|assisted reproduction techniques
5307369|NCT02141685|noninvasive imaging of embryos|noninvasive imaging of embryos
5307370|NCT02141685|time lapse imaging of embryos|time lapse imaging of embryos
5253522|NCT02425358|BMC|bmc
5176379|NCT02889315|PAH|pah
5307371|NCT02141685|traditional morphological grading of embryos|traditional morphological grading of embryos
5963089|NCT04273516|Prevention|prevention
5963090|NCT04273438|Perimetry|perimetry
5307372|NCT02141685|prediction of blastocysts|prediction of blastocysts
5307373|NCT02141685|infertility|infertility
5307374|NCT02141685|preimplantation genetic diagnosis|preimplantation genetic diagnosis
5307375|NCT02141685|array-Comparative Genomic Hybridization|array-comparative genomic hybridization
5307376|NCT02141672|lupus nephritis|lupus nephritis
5307377|NCT02141672|calcineurin inhibitors|calcineurin inhibitors
5307378|NCT02141672|voclosporin|voclosporin
5307379|NCT02141646|HIV/AIDS, motivational interviewing, behavioral skills training, MRI|hiv/aids, motivational interviewing, behavioral skills training, mri
5307380|NCT02141633|smokers|smokers
5307381|NCT02141633|airway blood flow|airway blood flow
5307382|NCT02141633|fluticasone|fluticasone
5307383|NCT02141633|echocardiogram|echocardiogram
5307384|NCT02141607|shock|shock
5307385|NCT02141607|heart failure|heart failure
5307386|NCT02141607|inflammation|inflammation
5307387|NCT02141607|biomarkers|biomarkers
5307388|NCT02141607|cardiovascular instability|cardiovascular instability
5307389|NCT02141607|metabolic pathways|metabolic pathways
5307390|NCT02141607|proteolysis|proteolysis
5307391|NCT02141581|Intramuscular inactivated trivalent influenza vaccine|intramuscular inactivated trivalent influenza vaccine
5307392|NCT02141581|Intradermal inactivated trivalent influenza vaccine|intradermal inactivated trivalent influenza vaccine
5307393|NCT02141581|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5307394|NCT02141581|Young adults|young adults
5307395|NCT02141568|Cost-effective|cost-effective
5307396|NCT02141568|Unexplained Medical Symptoms|unexplained medical symptoms
5307397|NCT02141568|Frequent Attenders|frequent attenders
5307398|NCT02141555|misoprostol, early pregnancy loss, missed abortion|misoprostol, early pregnancy loss, missed abortion
5307399|NCT02141542|Metastatic Melanoma|metastatic melanoma
5307400|NCT02141529|Intraarticular|intraarticular
5307401|NCT02141529|pulsed radiofrequency|pulsed radiofrequency
5307402|NCT02141529|osteoarthritis|osteoarthritis
5307403|NCT02141516|Meningitis|meningitis
5307404|NCT02141516|vaccination|vaccination
5307405|NCT02141516|complement deficiency|complement deficiency
5307407|NCT02141516|splenic dysfunction|splenic dysfunction
5307408|NCT02141503|Biomarkers|biomarkers
5307409|NCT02141503|Alpha-Manosidosis|alpha-manosidosis
5307410|NCT02141490|Lymph Node|lymph node
5307411|NCT02141490|Biopsy|biopsy
5307437|NCT02141386|Multiple Sclerosis|multiple sclerosis
5307438|NCT02141386|Cognitive remediation|cognitive remediation
5307439|NCT02141386|Plasticity-based, adaptive, computerized cognitive remediation|plasticity-based, adaptive, computerized cognitive remediation
5307440|NCT02141386|Cognitive impairment|cognitive impairment
5307442|NCT02141373|axillary|axillary
5307443|NCT02141373|dissection|dissection
5307444|NCT02141360|Mild Traumatic Brain Injury|mild traumatic brain injury
5307445|NCT02141321|IUD|iud
5307446|NCT02141321|Misoprostol|misoprostol
5307447|NCT02141321|Rectal administration|rectal administration
5307448|NCT02141308|Retina|retina
5307449|NCT02141308|Optical coherence tomography|optical coherence tomography
5307450|NCT02141308|Imaging|imaging
5307451|NCT02141282|Oncology|oncology
5307452|NCT02141282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5307453|NCT02141282|Cancer of the blood and bone marrow|cancer of the blood and bone marrow
5307454|NCT02141269|Transthoracic echocardiogram|transthoracic echocardiogram
5307455|NCT02141269|Hand-held Echocardiography|hand-held echocardiography
5307456|NCT02141256|elderly|elderly
5307457|NCT02141256|protein enrichment|protein enrichment
5307458|NCT02141256|undernutrition|undernutrition
5307459|NCT02141217|Odontogenic (Dental) Infections|odontogenic (dental) infections
5307460|NCT02141217|Dental infections, periapical abscess|dental infections, periapical abscess
5307461|NCT02141217|Bacterial infection|bacterial infection
5307462|NCT02141204|Rotarix|rotarix
5307463|NCT02141204|HRV|hrv
5307464|NCT02141204|Healthy infants|healthy infants
5307465|NCT02141204|Liquid formulation|liquid formulation
5307467|NCT02141204|Human rotavirus vaccine|human rotavirus vaccine
5307468|NCT02141191|cystic fibrosis|cystic fibrosis
5307469|NCT02141191|hypertonic saline|hypertonic saline
5307470|NCT02141191|nebulizer|nebulizer
5307471|NCT02141191|nasal cannula|nasal cannula
5307472|NCT02141165|sleep apnea|sleep apnea
5307473|NCT02141165|portable monitor|portable monitor
5307474|NCT02141165|primary care|primary care
5307475|NCT02141165|cost-effectiveness|cost-effectiveness
5307476|NCT02141165|OSAS|osas
5307477|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5307478|NCT02141139|Inflammation|inflammation
5307479|NCT02141139|Perioperative Period|perioperative period
5307480|NCT02141126|Older adults|older adults
5307481|NCT02141126|Strength training|strength training
5307482|NCT02141126|Muscle mass|muscle mass
5307483|NCT02141126|Function|function
5307484|NCT02141126|Inpatients|inpatients
5307485|NCT02141100|thioguanine|thioguanine
5307486|NCT02141100|mercaptopurine|mercaptopurine
5307487|NCT02141100|methotrexate|methotrexate
5307488|NCT02141048|Parenting programme|parenting programme
5307489|NCT02141048|Randomised controlled trial|randomised controlled trial
5307490|NCT02141048|South Africa|south africa
5307491|NCT02141048|Positive parenting|positive parenting
5307492|NCT02141048|Child behaviour problems|child behaviour problems
5307493|NCT02141048|Implementation fidelity|implementation fidelity
5307494|NCT02141048|Low- and middle-income country|low- and middle-income country
5307495|NCT02141035|Acetyl-l-carnitine|acetyl-l-carnitine
5307496|NCT02141035|Carpal tunnel syndrome|carpal tunnel syndrome
5307497|NCT02141035|Motor unit number estimation|motor unit number estimation
5307498|NCT02141035|Compression neuropathy|compression neuropathy
5307499|NCT02141022|Multiple Sclerosis|multiple sclerosis
5307500|NCT02141022|Cognition|cognition
5307501|NCT02141022|Cognitive Remediation|cognitive remediation
5307503|NCT02141022|Computerized Cognitive Exercise|computerized cognitive exercise
5307504|NCT02141009|Vaccination, prevnar, PCV13|vaccination, prevnar, pcv13
5418685|NCT01637415|PAWSS|pawss
5307505|NCT02140996|MUC-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation|muc-1 vector vaccine; epithelial cancers; immunotherapy; safety; antigen specific vaccine, dendritic cell activation
5307506|NCT02140983|Insulin Resistance|insulin resistance
5307507|NCT02140983|Family History of Dementia|family history of dementia
5307508|NCT02140983|Cognition|cognition
5307509|NCT02140970|ureteral stent|ureteral stent
5307510|NCT02140970|stent pain|stent pain
5307511|NCT02140970|ureteral spasm|ureteral spasm
5307512|NCT02140970|NSAID|nsaid
5307513|NCT02140970|ibuprofen|ibuprofen
5307514|NCT02140970|placebo|placebo
5307515|NCT02140970|ureteropelvic junction obstruction|ureteropelvic junction obstruction
5307516|NCT02140970|urolithiasis|urolithiasis
5307517|NCT02140957|Toddler Bottle Use|toddler bottle use
5307518|NCT02140957|Educational Intervention|educational intervention
5307519|NCT02140957|Pediatrics|pediatrics
5307520|NCT02140957|Iron Deficiency|iron deficiency
5307521|NCT02140944|Cord blood transplantation|cord blood transplantation
5307522|NCT02140944|CCR5Δ32|ccr5δ32
5307523|NCT02140944|HIV cure|hiv cure
5307524|NCT02140931|Cell therapy|cell therapy
5307525|NCT02140931|Autologous|autologous
5307526|NCT02140918|Fludrocortisone|fludrocortisone
5307527|NCT02140918|Mineralocorticoids|mineralocorticoids
5307528|NCT02140918|Hemodynamics|hemodynamics
5307529|NCT02140918|Pharmacokinetics|pharmacokinetics
5307530|NCT02140905|Hemodialysis|hemodialysis
5307531|NCT02140905|Heart failure|heart failure
5307532|NCT02140905|Impedance|impedance
5307534|NCT02140879|pregnancy|pregnancy
5307535|NCT02140879|inflammation|inflammation
5307536|NCT02140879|infant assessment|infant assessment
5307537|NCT02140853|MDR gram-negative bacilli|mdr gram-negative bacilli
5307538|NCT02140853|Mortality|mortality
5307539|NCT02140853|Therapy|therapy
5307540|NCT02140840|TMTB|tmtb
5307541|NCT02140840|Mekinist|mekinist
5307542|NCT02140840|Trametinib|trametinib
5307543|NCT02140840|relapse|relapse
5307544|NCT02140840|refractory|refractory
5307545|NCT02140840|response rate|response rate
5307546|NCT02140827|bowel preparation|bowel preparation
5307547|NCT02140827|instant messaging program|instant messaging program
5307549|NCT02140814|niacinamide|niacinamide
5307550|NCT02140814|Vitamin B3|vitamin b3
5307551|NCT02140814|Vitamin B|vitamin b
5307552|NCT02140801|Percutaneous coronary intervention|percutaneous coronary intervention
5307553|NCT02140801|Drug-eluting stent|drug-eluting stent
5307554|NCT02140801|Thrombosis|thrombosis
5307555|NCT02140788|schizophrenia|schizophrenia
5307556|NCT02140788|schizo-affective disorder|schizo-affective disorder
5307557|NCT02140775|HIV|hiv
5307558|NCT02140775|AIDS|aids
5307559|NCT02140775|Fatigue|fatigue
5307560|NCT02140775|armodafinil|armodafinil
5307561|NCT02140775|Unemployment|unemployment
5307562|NCT02140762|Meningitis ABCWY|meningitis abcwy
5307563|NCT02140762|Adolescents|adolescents
5307564|NCT02140762|Vaccination|vaccination
5307565|NCT02140762|Meningococcal disease|meningococcal disease
5307572|NCT02140749|Oligofructose|oligofructose
5307573|NCT02140736|Chemotherapy-induced anemia|chemotherapy-induced anemia
5307574|NCT02140736|Epoetin biosimilar|epoetin biosimilar
5307575|NCT02140723|preoperative short course radiotherapy|preoperative short course radiotherapy
5307576|NCT02140723|delay of surgery|delay of surgery
5307577|NCT02140723|rectal cancer|rectal cancer
5307579|NCT02140723|predictive marker|predictive marker
5307580|NCT02140723|MRT imaging|mrt imaging
5307581|NCT02140710|premature infant|premature infant
5307582|NCT02140710|visceral osteopathy|visceral osteopathy
5307583|NCT02140710|alternative medicine|alternative medicine
5307584|NCT02140710|meconium passage|meconium passage
5307585|NCT02140710|enteral feedings|enteral feedings
5307586|NCT02140710|hospital stay|hospital stay
5307587|NCT02140684|Real-world|real-world
5307588|NCT02140684|observational|observational
5307589|NCT02140684|Nitric oxide|nitric oxide
5307590|NCT02140684|Inhaled corticosteroid|inhaled corticosteroid
5307592|NCT02140671|asthma management|asthma management
5307593|NCT02140671|anti-inflammatory therapy|anti-inflammatory therapy
5307598|NCT02140671|guidelines|guidelines
5176499|NCT02888431|arterial blood samples|arterial blood samples
5176500|NCT02888418|vaccine|vaccine
5188613|NCT02811913|transcranial magnetic stimulation|transcranial magnetic stimulation
5188614|NCT02811913|brain stimulation|brain stimulation
5188615|NCT02811913|rehabilitation|rehabilitation
5307599|NCT02140671|exacerbations|exacerbations
5307600|NCT02140671|diagnostic accuracy|diagnostic accuracy
5307601|NCT02140671|symptom control|symptom control
5307602|NCT02140658|ischemic stroke|ischemic stroke
5307603|NCT02140658|Statins Medication Persistence|statins medication persistence
5307605|NCT02140632|Carpal tunnel syndrome|carpal tunnel syndrome
5903814|NCT00297752|randomised clinical trial|randomised clinical trial
5307606|NCT02140632|Local steroid injection|local steroid injection
5307607|NCT02140632|Wrist splinting|wrist splinting
5307608|NCT02140619|ischemic stroke|ischemic stroke
5307609|NCT02140619|Medication Persistence|medication persistence
5307610|NCT02140619|outcome|outcome
5307611|NCT02140606|AML|aml
5307612|NCT02140606|phase1|phase1
5307613|NCT02140606|MTD|mtd
5307614|NCT02140606|Cafusertib|cafusertib
5307615|NCT02140580|Minimally-invasive surfactant therapy|minimally-invasive surfactant therapy
5307616|NCT02140541|Asthma|asthma
5307617|NCT02140541|Blood eosinophils|blood eosinophils
5307618|NCT02140541|Sputum eosinophils|sputum eosinophils
5307619|NCT02140541|Clinical predictor|clinical predictor
5307620|NCT02140541|UK primary care|uk primary care
5307621|NCT02140541|Global Initiative for Asthma (GINA)|global initiative for asthma (gina)
5307622|NCT02140528|Allogenic adipose derived mesenchymal stem cell tibial fracture|allogenic adipose derived mesenchymal stem cell tibial fracture
5307623|NCT02140515|Gonal-F Luveris Assisted Reproductive Technology Hypogonadotropic Hypogonadism|gonal-f luveris assisted reproductive technology hypogonadotropic hypogonadism
5307624|NCT02140502|Enterobacterial Infections|enterobacterial infections
5307625|NCT02140502|Prostate cancer|prostate cancer
5307626|NCT02140502|Biopsy|biopsy
5307627|NCT02140502|Incidence of fluoroquinolone resistant enteric bacteria|incidence of fluoroquinolone resistant enteric bacteria
5307628|NCT02140476|Thyroid goiter|thyroid goiter
5307629|NCT02140476|Papillary thyroid cancer|papillary thyroid cancer
5307630|NCT02140476|Bipolar device|bipolar device
5307631|NCT02140476|Sealing and cutting device|sealing and cutting device
5307632|NCT02140476|Thyroidectomy|thyroidectomy
5307741|NCT02139982|hemodynamics|hemodynamics
5307635|NCT02140437|Anastrozole|anastrozole
5307636|NCT02140437|Luminal A-like|luminal a-like
5307637|NCT02140437|Postmenopausal|postmenopausal
5307638|NCT02140437|Advanced breast cancer|advanced breast cancer
5307639|NCT02140424|type 1 diabetes|type 1 diabetes
5307640|NCT02140424|osteoporosis|osteoporosis
5307641|NCT02140424|children|children
5307642|NCT02140398|infertility|infertility
5307643|NCT02140398|PCOS|pcos
5307644|NCT02140398|scratching|scratching
5307645|NCT02140398|endometrial receptivity|endometrial receptivity
5307646|NCT02140372|colchicine|colchicine
5307647|NCT02140372|platelet activity|platelet activity
5307648|NCT02140372|neutrophil|neutrophil
5307649|NCT02140359|homelessness|homelessness
5307650|NCT02140359|housing first|housing first
5307651|NCT02140359|social networks|social networks
5307652|NCT02140359|drug abuse|drug abuse
5307653|NCT02140359|alcohol use|alcohol use
5307654|NCT02140359|HIV|hiv
5307655|NCT02140333|erlotinib|erlotinib
5307656|NCT02140333|EGFR mutation|egfr mutation
5307657|NCT02140307|Health Promotion|health promotion
5307658|NCT02140307|Prevention|prevention
5307659|NCT02140307|Relaxation Response|relaxation response
5307660|NCT02140307|Meditation|meditation
5307661|NCT02140307|Cortisol|cortisol
5307662|NCT02140281|Phase I, Healthy Volunteers|phase i, healthy volunteers
5307663|NCT02140268|Phase I|phase i
5307664|NCT02140268|Healthy|healthy
5307668|NCT02140242|leukemia|leukemia
5307669|NCT02140242|induction treatment|induction treatment
5307670|NCT02140242|daunorubicin|daunorubicin
5307672|NCT02140229|Rheumatoid Arthritis|rheumatoid arthritis
5307673|NCT02140229|Remission,|remission,
5307674|NCT02140229|DAS28,|das28,
5307675|NCT02140229|ACR/EULAR,|acr/eular,
5307676|NCT02140229|RAPID, Randomized study,|rapid, randomized study,
5307677|NCT02140229|Longitudinal follow-up|longitudinal follow-up
5307678|NCT02140216|Blood transfusion|blood transfusion
5307679|NCT02140216|Immune|immune
5307680|NCT02140216|Surgery|surgery
5307681|NCT02140203|Metabolic Syndrome|metabolic syndrome
5307682|NCT02140203|Waist circumference|waist circumference
5307683|NCT02140203|blood pressure|blood pressure
5307684|NCT02140203|triglyceride|triglyceride
5307685|NCT02140203|HDL|hdl
5307690|NCT02140164|Cystoid Macular Edema|cystoid macular edema
5307691|NCT02140164|Minocycline|minocycline
5307692|NCT02140164|Microglia|microglia
5963091|NCT04273438|Virtual Reality|virtual reality
5963092|NCT04273438|Visual field testing|visual field testing
5963093|NCT04273360|Physical contention|physical contention
5963094|NCT04273360|ICU|icu
5963095|NCT04273360|mechanical ventilation|mechanical ventilation
5307693|NCT02140164|Retinitis Pigmentosa|retinitis pigmentosa
5307694|NCT02140151|amd|amd
5307695|NCT02140151|non-exudative macular degeneration|non-exudative macular degeneration
5963096|NCT04273243|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
5963097|NCT04273243|NCL|ncl
5963098|NCT04273243|Gene Transfer|gene transfer
5307696|NCT02140151|exudative macular degeneration|exudative macular degeneration
5307697|NCT02140151|age-related macular degeneration|age-related macular degeneration
5307698|NCT02140151|ranibizumab|ranibizumab
5307699|NCT02140151|anti-VEGF|anti-vegf
5307700|NCT02140125|ASP2408|asp2408
5307701|NCT02140112|T. suis ova|t. suis ova
5307702|NCT02140112|Trichuris suis ova|trichuris suis ova
5307703|NCT02140112|Autism Spectrum Disorder|autism spectrum disorder
5307704|NCT02140112|ASD|asd
5307705|NCT02140099|Mental health|mental health
5307706|NCT02140099|Violence|violence
5307707|NCT02140099|Substance use|substance use
5307708|NCT02140099|Adolescent|adolescent
5307709|NCT02140099|Prevention|prevention
5307710|NCT02140086|asthma|asthma
5307711|NCT02140086|Buteyko|buteyko
5307712|NCT02140086|remedial breathing|remedial breathing
5307713|NCT02140086|children|children
5307714|NCT02140073|GERD|gerd
5307715|NCT02140073|Omez|omez
5307716|NCT02140073|Omez DSR|omez dsr
5307717|NCT02140073|heartburn|heartburn
5307718|NCT02140073|esophagitis|esophagitis
5307719|NCT02140073|omeprazole|omeprazole
5307720|NCT02140073|omeprazole+domperidone|omeprazole+domperidone
5307721|NCT02140060|Glaucoma|glaucoma
5307722|NCT02140060|Ocular|ocular
5307723|NCT02140060|Hypertension|hypertension
5307724|NCT02140060|OAG|oag
5307725|NCT02140060|POAG|poag
5307726|NCT02140060|OHT|oht
5307727|NCT02140047|Haemophilus influenza type b|haemophilus influenza type b
5307728|NCT02140047|Hib|hib
5307729|NCT02140034|Extensive Peritoneal Lavage|extensive peritoneal lavage
5307730|NCT02140034|Overall Survival|overall survival
5307731|NCT02140034|Disease Free Survival|disease free survival
5307732|NCT02140034|Peritoneal Recurrence Rate|peritoneal recurrence rate
5307733|NCT02140034|T3 and T4 Gastric Cancer|t3 and t4 gastric cancer
5307734|NCT02140008|supraglottic airway devices|supraglottic airway devices
5307735|NCT02140008|the i-gel|the i-gel
5307736|NCT02140008|the self-pressurised air-Q intubating laryngeal airway,|the self-pressurised air-q intubating laryngeal airway,
5307737|NCT02140008|children|children
5307738|NCT02139995|transfusion|transfusion
5307739|NCT02139995|trigger|trigger
5307740|NCT02139995|critically-ill|critically-ill
5307742|NCT02139982|anaesthetics|anaesthetics
5307743|NCT02139982|brachial plexus|brachial plexus
5307744|NCT02139982|peripheral nerves|peripheral nerves
5307745|NCT02139982|skin temperature|skin temperature
5307746|NCT02139982|sympathetic nervous system|sympathetic nervous system
5307747|NCT02139982|dose-response relationship|dose-response relationship
5307748|NCT02139943|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5307749|NCT02139943|Canagliflozin|canagliflozin
5307750|NCT02139943|Continuous Glucose Monitoring|continuous glucose monitoring
5307751|NCT02139930|smoking|smoking
5307752|NCT02139930|nicotine reduction|nicotine reduction
5307753|NCT02139917|transitional palliative care|transitional palliative care
5307754|NCT02139917|end stage renal failure|end stage renal failure
5307755|NCT02139904|Mesothelioma|mesothelioma
5307756|NCT02139904|Vinorelbine|vinorelbine
5307757|NCT02139904|BRCA1|brca1
5307758|NCT02139891|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5307759|NCT02139891|non responders|non responders
5307760|NCT02139891|MultiPoint Pacing (MPP)|multipoint pacing (mpp)
5307761|NCT02139813|Obesity -|obesity -
5307762|NCT02139813|Bariatric surgery|bariatric surgery
5307763|NCT02139813|Gastric bypass|gastric bypass
5307764|NCT02139800|Neonatal resuscitation|neonatal resuscitation
5307765|NCT02139800|Extreme Low Gestational Age Newborn (ELGAN)|extreme low gestational age newborn (elgan)
5307766|NCT02139800|Delivery Room|delivery room
5307767|NCT02139800|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5307768|NCT02139800|Positive pressure ventilation (PPV)|positive pressure ventilation (ppv)
5307773|NCT02139787|Radio story, entertainment health education|radio story, entertainment health education
5307774|NCT02139787|Immigrants|immigrants
5307775|NCT02139787|Somali, Latino, Hmong|somali, latino, hmong
5307776|NCT02139787|Families with 3-18 year old children|families with 3-18 year old children
5307777|NCT02139774|Prostate Cancer|prostate cancer
5307778|NCT02139774|Elderly|elderly
5307779|NCT02139774|Geriatric|geriatric
5307780|NCT02139774|Radiation|radiation
5307781|NCT02139774|Arthritis|arthritis
5307782|NCT02139774|Exercise|exercise
5307783|NCT02139774|Walking|walking
5307784|NCT02139774|Endocrine Therapy|endocrine therapy
5307785|NCT02139774|Androgen Deprivation Therapy|androgen deprivation therapy
5307786|NCT02139774|Active Surveillance|active surveillance
5307788|NCT02139761|Cocaine|cocaine
5307789|NCT02139761|Treatment|treatment
5307790|NCT02139748|Dental Implants|dental implants
5307791|NCT02139748|Alveolar Bone Grafting|alveolar bone grafting
5307792|NCT02139748|Acellular Dermis|acellular dermis
5307793|NCT02139735|Temporomandibular Joint Disorders,|temporomandibular joint disorders,
5307794|NCT02139735|Ultrasonics,|ultrasonics,
5307795|NCT02139735|Electromyography,|electromyography,
5307796|NCT02139735|Pain Measurement,|pain measurement,
5307797|NCT02139735|Muscle Stretching Exercise|muscle stretching exercise
5307798|NCT02139722|hepatitis B|hepatitis b
5307799|NCT02139722|hepatitis C|hepatitis c
5307800|NCT02139722|screening|screening
5307801|NCT02139722|Asian Americans|asian americans
5307802|NCT02139722|mobile technology|mobile technology
5307804|NCT02139657|Rabies virus|rabies virus
5307805|NCT02139657|Rhabdoviridae|rhabdoviridae
5307806|NCT02139657|Rabies immune globulin|rabies immune globulin
5307807|NCT02139657|Rabies antibodies|rabies antibodies
5307808|NCT02139657|Passive rabies immunization|passive rabies immunization
5307809|NCT02139644|fluticasone propionate|fluticasone propionate
5307810|NCT02139644|multidose dry powder inhaler|multidose dry powder inhaler
5307811|NCT02139631|hemodynamic|hemodynamic
5307812|NCT02139631|mechanical ventilation|mechanical ventilation
5307813|NCT02139631|respiration with positive pressure|respiration with positive pressure
5307814|NCT02139618|Randomized-controlled-trial|randomized-controlled-trial
5307815|NCT02139618|Methyl-Aminolevulinate|methyl-aminolevulinate
5307816|NCT02139618|Daylight|daylight
5307817|NCT02139618|Photodynamic-therapy|photodynamic-therapy
5307818|NCT02139605|D2 versus D3 Lymphadenectomy|d2 versus d3 lymphadenectomy
5307819|NCT02139592|Pharmacological therapy|pharmacological therapy
5307820|NCT02139579|chemotherapy|chemotherapy
5307821|NCT02139579|EGFR-TKI resistance|egfr-tki resistance
5307822|NCT02139579|Bevacizumab|bevacizumab
5307823|NCT02139553|Rhythmic versus discrete movements|rhythmic versus discrete movements
5307824|NCT02139553|Rehabilitation|rehabilitation
5307825|NCT02139540|Treatment|treatment
5307826|NCT02139527|arthroplasty|arthroplasty
5307827|NCT02139527|spinal|spinal
5307828|NCT02139527|CHARITE|charite
5307829|NCT02139527|PRODISC-L|prodisc-l
5307830|NCT02139527|PRODISC|prodisc
5307831|NCT02139527|disc|disc
5307832|NCT02139527|replacement|replacement
5307833|NCT02139527|lumbar|lumbar
5307834|NCT02139514|Social Skills|social skills
5307835|NCT02139514|Adults|adults
5307836|NCT02139501|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
5307837|NCT02139501|Dose and frequency|dose and frequency
5307838|NCT02139501|Immune Thrombocytopenia|immune thrombocytopenia
5307839|NCT02139488|Esophageal cancer|esophageal cancer
5307840|NCT02139488|Chemoradiation|chemoradiation
5307841|NCT02139475|bowel cleansing, colorectal cancer surgery|bowel cleansing, colorectal cancer surgery
5307842|NCT02139462|FBT, fidelity, training|fbt, fidelity, training
5307843|NCT02139449|CRT, heart failure, ICD|crt, heart failure, icd
5307844|NCT02139423|Congenital cytomegalovirus infection|congenital cytomegalovirus infection
5307845|NCT02139423|newborn universal hearing screening|newborn universal hearing screening
5307846|NCT02139410|sarcopenia|sarcopenia
5307847|NCT02139410|mortality|mortality
5307848|NCT02139384|procalcitonin|procalcitonin
5307849|NCT02139384|community acquired pneumonia|community acquired pneumonia
5307850|NCT02139384|pneumonia score|pneumonia score
5307851|NCT02139371|Positron Emission Tomography|positron emission tomography
5307852|NCT02139371|Uroplasminogen Plasminogen Activator Receptor|uroplasminogen plasminogen activator receptor
5307853|NCT02139371|Breast cancer|breast cancer
5307854|NCT02139371|Prostate cancer|prostate cancer
5307855|NCT02139371|Urinary bladder cancer|urinary bladder cancer
5307856|NCT02139371|Biodistribution|biodistribution
5307857|NCT02139371|Radiation exposure|radiation exposure
5307858|NCT02139358|Breast - Female|breast - female
5307859|NCT02139358|Metastatic|metastatic
5307860|NCT02139358|HER2+|her2+
5307861|NCT02139345|Osteoarthritis|osteoarthritis
5307866|NCT02139332|Attachment theory|attachment theory
5307867|NCT02139332|Parent- child relationship|parent- child relationship
5307868|NCT02139332|Child mental health|child mental health
5307869|NCT02139332|Behavioral health|behavioral health
5307870|NCT02139293|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
5307871|NCT02139280|Cyclophosphamide|cyclophosphamide
5307872|NCT02139280|Hematopoietic|hematopoietic
5307874|NCT02139280|Mobilization|mobilization
5307875|NCT02139280|Hematologic Malignancy|hematologic malignancy
5307876|NCT02139267|CIN3|cin3
5307877|NCT02139267|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5307878|NCT02139267|High-Risk HPV|high-risk hpv
5307879|NCT02139267|HPV Infection|hpv infection
5307880|NCT02139267|Neoplasm|neoplasm
5307881|NCT02139267|Precancerous Diseases|precancerous diseases
5307882|NCT02139267|Uterine Diseases|uterine diseases
5307883|NCT02139267|Genital Diseases, Female|genital diseases, female
5307884|NCT02139254|Gestational Diabetes|gestational diabetes
5307885|NCT02139254|HbA1c|hba1c
5307886|NCT02139254|Glucose|glucose
5307887|NCT02139254|First Trimenon|first trimenon
5307888|NCT02139228|Haemophilus influenzae type b|haemophilus influenzae type b
5307889|NCT02139228|persistency|persistency
5307890|NCT02139228|children|children
5307891|NCT02139228|CRM197|crm197
5307892|NCT02139228|anti-PRP antibody|anti-prp antibody
5307893|NCT02139202|Acute|acute
5307894|NCT02139202|Myocardial|myocardial
5307895|NCT02139202|Infarction|infarction
5307896|NCT02139202|AMI|ami
5307897|NCT02139176|couple HIV testing and counseling|couple hiv testing and counseling
5307898|NCT02139176|disclosure|disclosure
5307899|NCT02139176|discordant|discordant
5307901|NCT02139176|Malawi|malawi
5307902|NCT02139163|Community acquired pneumonia|community acquired pneumonia
5307903|NCT02139163|CAP|cap
5307904|NCT02139163|CAPNETZ|capnetz
5307905|NCT02139163|age ≥18|age ≥18
5307906|NCT02139163|infiltrate on chest X-ray|infiltrate on chest x-ray
5307907|NCT02139163|cough or production of purulent sputum|cough or production of purulent sputum
5307908|NCT02139163|pathologic lung auscultation|pathologic lung auscultation
5307910|NCT02139150|FLT PET Imaging|flt pet imaging
5307911|NCT02139150|3'deoxy-3' [18F] fluorothymidine ([18F] FLT)|3'deoxy-3' [18f] fluorothymidine ([18f] flt)
5307912|NCT02139150|CT|ct
5307913|NCT02139150|scans|scans
5307914|NCT02139150|14-050|14-050
5307915|NCT02139098|sleep architecture|sleep architecture
5307916|NCT02139098|conditioning of pharmacological responses|conditioning of pharmacological responses
5307917|NCT02139098|insomnia|insomnia
5307918|NCT02139085|varicose veins|varicose veins
5307919|NCT02139085|catheter ablation|catheter ablation
5307920|NCT02139085|Catheter Ablation, Electrical|catheter ablation, electrical
5307921|NCT02139085|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5307922|NCT02139072|Anticoagulation|anticoagulation
5307923|NCT02139072|International normalized ratio|international normalized ratio
5307924|NCT02139072|Warfarin|warfarin
5307925|NCT02139059|anuria|anuria
5307926|NCT02139059|children|children
5307927|NCT02139059|ureteroscopy|ureteroscopy
5307928|NCT02139059|initial urinary drainage|initial urinary drainage
5307929|NCT02139059|ureteric stones|ureteric stones
5307930|NCT02139046|Drug therapy|drug therapy
5307931|NCT02139033|Dry Eye, Dry Eye Syndrome, Retaine, KCS, Keratoconjunctivitis sicca|dry eye, dry eye syndrome, retaine, kcs, keratoconjunctivitis sicca
5307932|NCT02139020|Targeted therapies|targeted therapies
5307933|NCT02139020|Plasma samples|plasma samples
5308622|NCT02135666|Persistence|persistence
5307946|NCT02138929|Advanced adenocarcinoma of the esophagus|advanced adenocarcinoma of the esophagus
5307947|NCT02138929|Advanced adenocarcinoma of the gastroesophageal junction|advanced adenocarcinoma of the gastroesophageal junction
5307949|NCT02138929|Metastatic|metastatic
5307950|NCT02138929|Everolimus|everolimus
5307951|NCT02138929|Afinitor|afinitor
5307952|NCT02138929|Zortress|zortress
5307953|NCT02138929|RAD001|rad001
5307954|NCT02138929|LDE 225|lde 225
5307955|NCT02138916|Obstructive Lung Diseases|obstructive lung diseases
5307956|NCT02138916|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5307957|NCT02138916|Lung Disease|lung disease
5307958|NCT02138916|Bronchial Diseases|bronchial diseases
5307959|NCT02138916|COPD Exacerbation|copd exacerbation
5307960|NCT02138916|Respiratory Tract Diseases|respiratory tract diseases
5307961|NCT02138903|weaning|weaning
5307962|NCT02138903|Cardiac|cardiac
5307963|NCT02138903|Echocardiography|echocardiography
5307964|NCT02138903|Mechanical Ventilation|mechanical ventilation
5307965|NCT02138890|Autologous Protein Solution|autologous protein solution
5307967|NCT02138890|Osteoarthritis|osteoarthritis
5307968|NCT02138890|Intra Articular Injection|intra articular injection
5307969|NCT02138877|Pelviureteric junction obstruction|pelviureteric junction obstruction
5307970|NCT02138877|pyeloplasty|pyeloplasty
5307971|NCT02138877|Neonate affected by hydronephrosis|neonate affected by hydronephrosis
5307972|NCT02138877|obstructive uropathy|obstructive uropathy
5307973|NCT02138877|urinary stent|urinary stent
5307974|NCT02138864|carbon monoxide intoxication|carbon monoxide intoxication
5307975|NCT02138864|Parkinsonism|parkinsonism
5307976|NCT02138864|18F-DTBZ AV-133|18f-dtbz av-133
5307977|NCT02138838|Chronic Kidney Disease, Secondary Hyperparathyroidism, Dialysis, Pediatric|chronic kidney disease, secondary hyperparathyroidism, dialysis, pediatric
5307978|NCT02138812|Phase 1|phase 1
5307979|NCT02138812|Solid tumors|solid tumors
5307980|NCT02138812|Breast cancer|breast cancer
5307981|NCT02138812|Paclitaxel|paclitaxel
5307982|NCT02138812|Mps-1 inhibitor|mps-1 inhibitor
5307983|NCT02138812|Taxanes|taxanes
5307984|NCT02138799|Phase I|phase i
5307985|NCT02138799|Pharmacokinetics|pharmacokinetics
5307986|NCT02138799|Safety|safety
5307987|NCT02138799|Drug-drug interactions|drug-drug interactions
5307988|NCT02138799|Enzalutamide|enzalutamide
5307989|NCT02138799|Rifampin|rifampin
5307990|NCT02138799|CYP3A4|cyp3a4
5307991|NCT02138799|CYP2D8|cyp2d8
5307992|NCT02138799|Enzyme induction|enzyme induction
5307993|NCT02138786|Richter's Transformation|richter's transformation
5307994|NCT02138786|Richter's Syndrome|richter's syndrome
5307996|NCT02138786|selinexor|selinexor
5307997|NCT02138786|KPT-330|kpt-330
5307998|NCT02138786|SIRRT|sirrt
5307999|NCT02138786|CLL|cll
5308000|NCT02138773|prolonged release formulation|prolonged release formulation
5308001|NCT02138773|adrenergic blocker|adrenergic blocker
5308002|NCT02138773|Bioequivalence|bioequivalence
5308003|NCT02138760|prostate cancer|prostate cancer
5308005|NCT02138760|magnetic resonance imaging guidance|magnetic resonance imaging guidance
5308007|NCT02138760|performance|performance
5308024|NCT02138721|Metastatic Prostate Cancer|metastatic prostate cancer
5308025|NCT02138721|Prostatectomy|prostatectomy
5308026|NCT02138708|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
5308027|NCT02138708|congenital heart disease,|congenital heart disease,
5308028|NCT02138708|heart shunt,|heart shunt,
5308029|NCT02138708|acetylcholine|acetylcholine
5308030|NCT02138708|Pharmacological test of pulmonary vascular reactivity (acetylcholine) in|pharmacological test of pulmonary vascular reactivity (acetylcholine) in
5308031|NCT02138695|atrial fibrillation|atrial fibrillation
5308623|NCT02135666|Hepatitis A|hepatitis a
5308032|NCT02138695|catheter ablation|catheter ablation
5308033|NCT02138695|recurrence|recurrence
5308034|NCT02138682|DaT-SPECT scan|dat-spect scan
5308035|NCT02138682|Parkinson's|parkinson's
5308036|NCT02138682|Diagnostic|diagnostic
5308037|NCT02138669|Cornea|cornea
5308038|NCT02138669|Keratoconus|keratoconus
5308039|NCT02138669|Steep cornea|steep cornea
5308040|NCT02138656|Crying|crying
5308041|NCT02138656|Chiropractic|chiropractic
5308042|NCT02138656|Infant|infant
5308043|NCT02138656|pediatric|pediatric
5308044|NCT02138656|Infantile colic|infantile colic
5308045|NCT02138656|Clinical Trial|clinical trial
5308046|NCT02138643|Achalasia|achalasia
5308047|NCT02138643|Megaesophagus|megaesophagus
5308048|NCT02138643|Peropal endoscopic myotomy(POEM)|peropal endoscopic myotomy(poem)
5308049|NCT02138643|Laparoscopic Heller myotomy|laparoscopic heller myotomy
5308050|NCT02138630|Exercise|exercise
5308051|NCT02138617|Colon Cancer|colon cancer
5308052|NCT02138617|Irinotecan|irinotecan
5308053|NCT02138617|FOLFIRI|folfiri
5308054|NCT02138617|Genotyping|genotyping
5308055|NCT02138617|UGT1A1|ugt1a1
5308056|NCT02138604|chest pain|chest pain
5308057|NCT02138604|myocardial ischemia|myocardial ischemia
5308058|NCT02138604|acute myocardial dysfunction|acute myocardial dysfunction
5308059|NCT02138604|plethesmography|plethesmography
5308060|NCT02138604|non invasive dP/dt|non invasive dp/dt
5308061|NCT02138591|vitamin d deficiency|vitamin d deficiency
5308062|NCT02138591|cathelicidin antimicrobial peptide|cathelicidin antimicrobial peptide
5308063|NCT02138591|resistin, human|resistin, human
5308064|NCT02138591|protein, human|protein, human
5308065|NCT02138591|1,25-dihydroxy-16,23-diene vitamin D3|1,25-dihydroxy-16,23-diene vitamin d3
5308066|NCT02138591|Cholecalciferol|cholecalciferol
5308067|NCT02138591|Nutritional Status|nutritional status
5308068|NCT02138591|length of stay|length of stay
5308069|NCT02138539|hyperpigmentation|hyperpigmentation
5308070|NCT02138539|melasma|melasma
5308071|NCT02138539|sun spots|sun spots
5308072|NCT02138539|dark spots|dark spots
5308073|NCT02138526|cancer|cancer
5308074|NCT02138526|pazopanib|pazopanib
5308075|NCT02138526|food|food
5308076|NCT02138526|pharmacokinetics|pharmacokinetics
5308077|NCT02138513|Mindfulness|mindfulness
5308078|NCT02138513|MBCT|mbct
5308079|NCT02138513|Cancer|cancer
5308080|NCT02138513|Oncology|oncology
5308081|NCT02138513|E-health|e-health
5308082|NCT02138513|Cost-effectiveness|cost-effectiveness
5308083|NCT02138500|PF-06372865|pf-06372865
5308084|NCT02138500|phase 1|phase 1
5308085|NCT02138500|open-label|open-label
5308086|NCT02138500|GABA-A receptor occupancy|gaba-a receptor occupancy
5308087|NCT02138500|positron emission tomography|positron emission tomography
5308088|NCT02138500|healthy subjects|healthy subjects
5308089|NCT02138487|pelvic organ prolapse|pelvic organ prolapse
5308090|NCT02138487|reconstructive pelvic surgery|reconstructive pelvic surgery
5308091|NCT02138487|postoperative restrictions|postoperative restrictions
5308092|NCT02138487|patient satisfaction|patient satisfaction
5308093|NCT02138474|Lacticum acidum homaccord|lacticum acidum homaccord
5308094|NCT02138474|homeopathy|homeopathy
5308095|NCT02138474|chronic tension-type headaches|chronic tension-type headaches
5308096|NCT02138461|glaucoma|glaucoma
5308097|NCT02138461|bimatoprost|bimatoprost
5308098|NCT02138461|latanoprost|latanoprost
5308099|NCT02138461|tolerability|tolerability
5308100|NCT02138448|Cancer Screenings|cancer screenings
5308101|NCT02138448|Health Information Technology|health information technology
5308102|NCT02138448|Patient Health Record|patient health record
5308103|NCT02138448|Preventive Services|preventive services
5308104|NCT02138422|colorectal cancer|colorectal cancer
5308105|NCT02138383|advanced pancreatic cancer|advanced pancreatic cancer
5308106|NCT02138383|pancreas|pancreas
5308107|NCT02138383|malignant neoplasm|malignant neoplasm
5308108|NCT02138383|endocrine system|endocrine system
5308109|NCT02138357|Restless Legs Syndrome|restless legs syndrome
5308110|NCT02138357|Willis Ekbom Disease|willis ekbom disease
5308111|NCT02138357|Twitchy Legs|twitchy legs
5308112|NCT02138357|Periodic Limb Movements|periodic limb movements
5308113|NCT02138357|Leg Movements|leg movements
5308114|NCT02138357|Augmentation|augmentation
5308115|NCT02138357|Requip|requip
5308116|NCT02138357|ropinirole|ropinirole
5308117|NCT02138357|Mirapex|mirapex
5308118|NCT02138357|pramipexole|pramipexole
5308119|NCT02138357|gabapentin|gabapentin
5308120|NCT02138357|Horizant|horizant
5308122|NCT02138357|rotigotine|rotigotine
5308123|NCT02138331|Diabetes Mellitus Type 1|diabetes mellitus type 1
5308124|NCT02138331|Microvesicles|microvesicles
5308125|NCT02138331|Exosomes|exosomes
5308126|NCT02138331|Cord Blood|cord blood
5308127|NCT02138331|Mesenchymal Stem Cells|mesenchymal stem cells
5308128|NCT02138305|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5308129|NCT02138305|Instantaneous Wave Free Ratio (iFR)|instantaneous wave free ratio (ifr)
5308130|NCT02138305|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
5308131|NCT02138305|Hyperemic Stenosis Resistance Index (HSR)|hyperemic stenosis resistance index (hsr)
5308132|NCT02138305|Hyperemic microvascular resistance (HMR)|hyperemic microvascular resistance (hmr)
5308624|NCT02135666|Antibody|antibody
5308133|NCT02138305|Wave intensity analysis (WIA)|wave intensity analysis (wia)
5308134|NCT02138305|Myocardial Perfusion|myocardial perfusion
5308135|NCT02138305|SPY NIRF Regional Myocardial Perfusion Analysis|spy nirf regional myocardial perfusion analysis
5308136|NCT02138253|liver transplant|liver transplant
5308137|NCT02138253|hepatitis C|hepatitis c
5308138|NCT02138253|liver fibrosis|liver fibrosis
5308139|NCT02138253|hepatic fibrosis|hepatic fibrosis
5308140|NCT02138253|liver cirrhosis|liver cirrhosis
5308141|NCT02138253|hepatic cirrhosis|hepatic cirrhosis
5308142|NCT02138227|Organ donation request|organ donation request
5308143|NCT02138227|Effective Communication|effective communication
5308144|NCT02138201|diffusion tensor imaging fiber tracking|diffusion tensor imaging fiber tracking
5308145|NCT02138201|magnetic resonance Imaging|magnetic resonance imaging
5308146|NCT02138201|spinal cord injury|spinal cord injury
5308147|NCT02138201|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5308148|NCT02138175|bleeding|bleeding
5308149|NCT02138175|blood loss|blood loss
5308150|NCT02138175|hemoglobin|hemoglobin
5308151|NCT02138175|hemoglobin monitoring|hemoglobin monitoring
5308152|NCT02138175|noninvasive monitoring|noninvasive monitoring
5308154|NCT02138162|Pharmacokinetics|pharmacokinetics
5308155|NCT02138162|Safety|safety
5308156|NCT02138162|Severe hepatic impairment|severe hepatic impairment
5308157|NCT02138162|Enzalutamide|enzalutamide
5308158|NCT02138149|spinal cord injury|spinal cord injury
5308159|NCT02138149|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5308160|NCT02138149|nerve growth factor|nerve growth factor
5308161|NCT02138149|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5308162|NCT02138149|urodynamics|urodynamics
5308163|NCT02138123|dense cataract|dense cataract
5308164|NCT02138123|phacoemulsification|phacoemulsification
5308165|NCT02138123|lens-shell technique|lens-shell technique
5308166|NCT02138123|intraocular lens|intraocular lens
5308167|NCT02138110|Spinal Cord Injury (SCI)|spinal cord injury (sci)
5308168|NCT02138110|Complete (AIS A) Traumatic Acute Spinal Cord Injury|complete (ais a) traumatic acute spinal cord injury
5308169|NCT02138071|low back pain|low back pain
5308170|NCT02138071|lumbar pain|lumbar pain
5308171|NCT02138058|compulsive buying, compulsive shopping, topiramate|compulsive buying, compulsive shopping, topiramate
5308172|NCT02138045|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5308173|NCT02138045|Diabetic Neuropathy|diabetic neuropathy
5308174|NCT02138045|Liraglutide|liraglutide
5308175|NCT02138032|message framing|message framing
5308176|NCT02138032|smoking cessation|smoking cessation
5308177|NCT02138032|peripheral artery disease|peripheral artery disease
5308178|NCT02138019|corneal ulcers|corneal ulcers
5308179|NCT02138019|conjunctival closure in strabismus surgery|conjunctival closure in strabismus surgery
5308180|NCT02138019|surgery for retinal detachment|surgery for retinal detachment
5308181|NCT02138019|cataract surgery|cataract surgery
5308182|NCT02138019|mucous membrane grafting|mucous membrane grafting
5308183|NCT02137954|cancer|cancer
5308184|NCT02137954|pain|pain
5308185|NCT02137941|Stress|stress
5308186|NCT02137941|occupations|occupations
5308187|NCT02137941|biomarkers|biomarkers
5308188|NCT02137941|firefighters|firefighters
5308189|NCT02137928|Retinoblastoma|retinoblastoma
5308190|NCT02137928|carboplatin|carboplatin
5308192|NCT02137902|Tobacco dependence|tobacco dependence
5308193|NCT02137902|Cardiovascular disease|cardiovascular disease
5308194|NCT02137902|Risk behaviors|risk behaviors
5308195|NCT02137902|Smoking|smoking
5308196|NCT02137902|Physical activity|physical activity
5308197|NCT02137902|Alaska Native people|alaska native people
5308199|NCT02137876|B cells|b cells
5308200|NCT02137876|Thymoglubulin|thymoglubulin
5308201|NCT02137876|humoral rejections|humoral rejections
5308202|NCT02137876|transplant|transplant
5308203|NCT02137876|rATG|ratg
5308204|NCT02137863|Contrast induced nephropathy|contrast induced nephropathy
5308205|NCT02137863|Diabetes Mellitus|diabetes mellitus
5308206|NCT02137863|Dexmedetomidine|dexmedetomidine
5308207|NCT02137837|Metastatic breast cancer|metastatic breast cancer
5308208|NCT02137837|Invasive breast carcinoma|invasive breast carcinoma
5308209|NCT02137837|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5308210|NCT02137837|HER2-negative breast cancer|her2-negative breast cancer
5308211|NCT02137837|Stage IV breast cancer|stage iv breast cancer
5308212|NCT02137837|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5308213|NCT02137811|cancer|cancer
5308214|NCT02137811|CorrectChemo|correctchemo
5308215|NCT02137811|assay|assay
5308216|NCT02137811|lab test|lab test
5308217|NCT02137811|MICK assay|mick assay
5254468|NCT02420743|PTD|ptd
5177098|NCT02884193|Dynamometry|dynamometry
5177099|NCT02884180|Dexamethasone|dexamethasone
5189212|NCT02808078|Instrumented treadmill|instrumented treadmill
5189213|NCT02808078|Augmented reality|augmented reality
5189214|NCT02808078|Neurorehabilitation|neurorehabilitation
5189215|NCT02808078|Gait disorders|gait disorders
5189216|NCT02808065|Kidney transplant|kidney transplant
5189230|NCT02807974|Albuminuria|albuminuria
5308218|NCT02137811|apoptosis|apoptosis
5308219|NCT02137811|increase survival|increase survival
5308220|NCT02137811|increase response rates|increase response rates
5308221|NCT02137811|decrease time to progression|decrease time to progression
5308222|NCT02137811|chemotherapy|chemotherapy
5308223|NCT02137811|cancer treatment|cancer treatment
5308224|NCT02137798|fluoroscopy exposure|fluoroscopy exposure
5308225|NCT02137798|paroxysmal atrial fibrillation Ablation|paroxysmal atrial fibrillation ablation
5308226|NCT02137798|fluoroscopy|fluoroscopy
5308227|NCT02137798|Atrial Fibrillation Ablation|atrial fibrillation ablation
5308230|NCT02137746|Prostate Cancer|prostate cancer
5308231|NCT02137746|Radical Prostatectomy|radical prostatectomy
5308232|NCT02137720|Diabetes|diabetes
5308233|NCT02137720|Treatment Adherence|treatment adherence
5308234|NCT02137720|Self-management|self-management
5308235|NCT02137720|Emotional Distress|emotional distress
5308236|NCT02137720|Diabetes-related Distress|diabetes-related distress
5308237|NCT02137707|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5308238|NCT02137707|Gilenya|gilenya
5308239|NCT02137707|Fingolimod|fingolimod
5308240|NCT02137694|Papillomavirus|papillomavirus
5308241|NCT02137694|Vaginal auto-takings|vaginal auto-takings
5308242|NCT02137694|Urinary test|urinary test
5308243|NCT02137681|immune thrombocytopenia|immune thrombocytopenia
5308244|NCT02137681|rituximab|rituximab
5308245|NCT02137681|efficacy|efficacy
5308246|NCT02137681|safety|safety
5308247|NCT02137642|constipation|constipation
5308248|NCT02137629|Myelodysplastic syndromes|myelodysplastic syndromes
5308249|NCT02137629|Vidaza|vidaza
5308250|NCT02137629|Observational study|observational study
5308251|NCT02137629|Korea|korea
5308252|NCT02137616|psychosis|psychosis
5308253|NCT02137616|syndrome|syndrome
5308254|NCT02137616|risk|risk
5308255|NCT02137616|antipsychotic|antipsychotic
5308256|NCT02137603|Suppurative appendicitis, appendicitis, pediatric|suppurative appendicitis, appendicitis, pediatric
5308257|NCT02137590|Spanish Black Radish|spanish black radish
5308258|NCT02137590|Phase I detoxification enzymes|phase i detoxification enzymes
5308259|NCT02137590|Phase II detoxification enzymes|phase ii detoxification enzymes
5308260|NCT02137590|Acetaminophen|acetaminophen
5308261|NCT02137577|drug eluting balloon catheter|drug eluting balloon catheter
5308262|NCT02137551|adherence|adherence
5308263|NCT02137551|healthcare costs|healthcare costs
5308264|NCT02137551|appointment based model|appointment based model
5308265|NCT02137551|accountable care organization|accountable care organization
5308266|NCT02137512|Artificial Pancreas|artificial pancreas
5308267|NCT02137499|Deep venous obstruction|deep venous obstruction
5308268|NCT02137499|Venous insufficiency|venous insufficiency
5308269|NCT02137486|stable angina|stable angina
5308270|NCT02137486|high angulated bifurcation|high angulated bifurcation
5308271|NCT02137486|SYNTAX|syntax
5308273|NCT02137486|BMS|bms
5308274|NCT02137460|Alzheimer's disease|alzheimer's disease
5308275|NCT02137460|Early diagnosis|early diagnosis
5308276|NCT02137460|Prediction|prediction
5308277|NCT02137460|Biomarker|biomarker
5308278|NCT02137460|Imaging|imaging
5308279|NCT02137447|Prevena|prevena
5308280|NCT02137447|faster healing time|faster healing time
5308281|NCT02137447|surgical site infection|surgical site infection
5308282|NCT02137434|Acute calcium|acute calcium
5308283|NCT02137434|Dietary calcium|dietary calcium
5308284|NCT02137434|Supplementary calcium|supplementary calcium
5308285|NCT02137434|Postprandial metabolism|postprandial metabolism
5308286|NCT02137421|Coronary artery disease|coronary artery disease
5308287|NCT02137421|Metabolic syndrome|metabolic syndrome
5308288|NCT02137421|Resveratrol|resveratrol
5308289|NCT02137421|β-catenin|β-catenin
5308290|NCT02137421|Wnt signaling|wnt signaling
5308291|NCT02137421|FOXO|foxo
5308292|NCT02137421|MnSOD|mnsod
5308293|NCT02137408|Chronic hypertension in pregnancy|chronic hypertension in pregnancy
5308294|NCT02137408|Pre-term delivery|pre-term delivery
5308295|NCT02137408|Preeclampsia|preeclampsia
5308296|NCT02137408|Endothelial Health|endothelial health
5308297|NCT02137408|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5308298|NCT02137395|Children, Dexamethasone, Sugammadex,|children, dexamethasone, sugammadex,
5356875|NCT01917604|orthodontic disimpaction|orthodontic disimpaction
5963099|NCT04273178|fungal infection, stem cell transplantation, prophylaxis|fungal infection, stem cell transplantation, prophylaxis
5963100|NCT04273139|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5963101|NCT04273139|ibrutinib|ibrutinib
5963102|NCT04273139|venetoclax|venetoclax
5963103|NCT04273022|Sickle Cell Trait|sickle cell trait
5963104|NCT04272918|caregiver support|caregiver support
5963105|NCT04272918|intensive case management|intensive case management
5963106|NCT04272918|empowerment for caregivers|empowerment for caregivers
5963107|NCT04272775|Drug Therapy|drug therapy
5963108|NCT04272619|prevention|prevention
5963109|NCT04272619|education|education
5308299|NCT02137382|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in Cystic Fibrosis|maldigestion of dietary macronutrients (pancreas not producing enough enzymes for digestion of fat, sugars and proteins) in cystic fibrosis
5308301|NCT02137369|Major Depressive Disorder|major depressive disorder
5308302|NCT02137369|Treatment|treatment
5308303|NCT02137369|Antidepressants|antidepressants
5308304|NCT02137369|Lexapro|lexapro
5308305|NCT02137369|Talk therapy|talk therapy
5308306|NCT02137356|rectal cancer|rectal cancer
5308307|NCT02137356|rectal adenocarcinoma|rectal adenocarcinoma
5308308|NCT02137356|Selinexor|selinexor
5308314|NCT02137356|locally advanced rectal cancer|locally advanced rectal cancer
5308316|NCT02137343|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
5308317|NCT02137343|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
5308318|NCT02137343|GEJ Cancer|gej cancer
5308319|NCT02137330|Obalon swallowable intragastric balloons|obalon swallowable intragastric balloons
5308320|NCT02137330|Severe obesity|severe obesity
5308321|NCT02137330|Children|children
5308322|NCT02137317|Pesticides|pesticides
5308323|NCT02137317|Personal protective equipment|personal protective equipment
5308329|NCT02137304|cough assistance optimization|cough assistance optimization
5308330|NCT02137304|efficient cough flow|efficient cough flow
5308331|NCT02137291|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5308332|NCT02137291|Lung isolation device|lung isolation device
5308333|NCT02137291|One-lung ventilation|one-lung ventilation
5308334|NCT02137291|Double lumen endotracheal tube|double lumen endotracheal tube
5308335|NCT02137291|Bronchial blocker|bronchial blocker
5308336|NCT02137278|Syncope|syncope
5308337|NCT02137278|Presyncope|presyncope
5308338|NCT02137278|Vasoactive drugs|vasoactive drugs
5308339|NCT02137278|Hypotension|hypotension
5308340|NCT02137278|Carotid sinus massage|carotid sinus massage
5308341|NCT02137278|Tilt table test|tilt table test
5308342|NCT02137265|Azoospermia|azoospermia
5308343|NCT02137265|Hypogonadism|hypogonadism
5308344|NCT02137265|Clomiphene|clomiphene
5308345|NCT02137252|Invasive Breast Cancer (Stage I-III)|invasive breast cancer (stage i-iii)
5308346|NCT02137252|Ductal Carcinoma in Situ|ductal carcinoma in situ
5308347|NCT02137252|Lobular Carcinoma in Situ|lobular carcinoma in situ
5308348|NCT02137252|Lobular Carcinoma|lobular carcinoma
5308349|NCT02137252|Fatigue Related to Cancer Treatment|fatigue related to cancer treatment
5308350|NCT02137213|Opioid-induced constipation|opioid-induced constipation
5308351|NCT02137213|Methadone|methadone
5308352|NCT02137213|Naloxone|naloxone
5308353|NCT02137187|Atrial fibrillation|atrial fibrillation
5308354|NCT02137187|Heart failure|heart failure
5308355|NCT02137187|Catheter ablation|catheter ablation
5308356|NCT02137187|Cardiac resynchronization therapy|cardiac resynchronization therapy
5308357|NCT02137187|Implantable defibrillator|implantable defibrillator
5308358|NCT02137148|Vascular Access|vascular access
5308359|NCT02137148|Sonic Window|sonic window
5308360|NCT02137148|Ultrasound|ultrasound
5308361|NCT02137135|chronic postoperative pain|chronic postoperative pain
5308362|NCT02137135|menstrual cycle|menstrual cycle
5308363|NCT02137122|Volunteers|volunteers
5308364|NCT02137109|Pediatric|pediatric
5308365|NCT02137096|Recurrent nasopharynx carcinoma|recurrent nasopharynx carcinoma
5308366|NCT02137083|Chemotherapy|chemotherapy
5308367|NCT02137083|Endocrine therapy|endocrine therapy
5308368|NCT02137083|Docetaxel|docetaxel
5308369|NCT02137083|Fulvestrant|fulvestrant
5308373|NCT02137057|Heart Rate Variability|heart rate variability
5308374|NCT02137057|spinal anesthesia|spinal anesthesia
5308375|NCT02137057|DM|dm
5308376|NCT02137057|cardiac autonomic dysfunction|cardiac autonomic dysfunction
5308377|NCT02137044|multiple sclerosis|multiple sclerosis
5308378|NCT02137044|pain|pain
5308379|NCT02137044|depression|depression
5308380|NCT02137018|hernia|hernia
5308381|NCT02137018|incisional hernia|incisional hernia
5308382|NCT02137018|device|device
5308383|NCT02137018|pig|pig
5308384|NCT02137005|walking|walking
5308385|NCT02137005|gait disorders, neurologic|gait disorders, neurologic
5308386|NCT02137005|health status|health status
5308387|NCT02137005|cognition|cognition
5308388|NCT02137005|quality of life|quality of life
5308389|NCT02137005|Transition to Adult Care|transition to adult care
5308390|NCT02136953|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5308391|NCT02136953|Exercise|exercise
5308392|NCT02136953|Cognitive Behavior Therapy|cognitive behavior therapy
5308393|NCT02136953|Cognitive Behavioral Therapy|cognitive behavioral therapy
5308394|NCT02136953|Treatment Efficacy|treatment efficacy
5308395|NCT02136953|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5308396|NCT02136914|Levodopa Induced Dyskinesia|levodopa induced dyskinesia
5308397|NCT02136914|LID|lid
5308398|NCT02136914|Parkinsonism|parkinsonism
5308399|NCT02136901|NuSurface|nusurface
5308400|NCT02136901|Meniscus|meniscus
5308401|NCT02136901|Prosthesis|prosthesis
5308402|NCT02136901|KOOS|koos
5308403|NCT02136888|Ponesimod|ponesimod
5308404|NCT02136888|Safety|safety
5308405|NCT02136875|COPD|copd
5308406|NCT02136875|COPD exacerbation|copd exacerbation
5308407|NCT02136862|Alport syndrome|alport syndrome
5308408|NCT02136862|kidney disease|kidney disease
5308409|NCT02136849|severe intellectual disability, genetic, de novo exome|severe intellectual disability, genetic, de novo exome
5308410|NCT02136836|Genes, erbB-2|genes, erbb-2
5308411|NCT02136836|Prognosis|prognosis
5308412|NCT02136823|Spinal Cord Injury|spinal cord injury
5308413|NCT02136810|Hypertension|hypertension
5308414|NCT02136810|Perioperative Care|perioperative care
5308415|NCT02136797|CMVpp65 Specific T-cells|cmvpp65 specific t-cells
5308416|NCT02136797|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5308417|NCT02136797|14-070|14-070
5308418|NCT02136784|pain|pain
5308419|NCT02136784|cold presser test|cold presser test
5308420|NCT02136784|buprenorphine|buprenorphine
5308422|NCT02136758|lifestyle modification|lifestyle modification
5308423|NCT02136758|diet|diet
5308424|NCT02136758|exercise|exercise
5308425|NCT02136758|cardiovascular disease|cardiovascular disease
5308426|NCT02136758|gene expression|gene expression
5308427|NCT02136758|obesity|obesity
5308428|NCT02136745|Irritable Bowel Syndrome|irritable bowel syndrome
5308429|NCT02136745|Inflammatory Bowel Disease|inflammatory bowel disease
5308430|NCT02136745|mind body|mind body
5308431|NCT02136745|intervention|intervention
5308432|NCT02136745|group|group
5308433|NCT02136745|Relaxation Response|relaxation response
5308434|NCT02136745|genomic effects|genomic effects
5308435|NCT02136732|chronic conditions|chronic conditions
5308436|NCT02136732|multimorbid|multimorbid
5308437|NCT02136719|Uterine massage|uterine massage
5308438|NCT02136719|vaginal birth|vaginal birth
5308439|NCT02136719|postpartum haemorrhage|postpartum haemorrhage
5308440|NCT02136706|Stable coronary artery disease|stable coronary artery disease
5308441|NCT02136693|obstructed defecation|obstructed defecation
5308442|NCT02136693|STARR|starr
5308443|NCT02136693|constipation|constipation
5308444|NCT02136693|incontinence|incontinence
5308445|NCT02136693|psyllium|psyllium
5308446|NCT02136680|HIV disease|hiv disease
5308447|NCT02136680|palliative care|palliative care
5308448|NCT02136680|educational intervention|educational intervention
5308449|NCT02136667|Preeclampsia|preeclampsia
5308450|NCT02136667|Cardiovascular disease (CVD) risk|cardiovascular disease (cvd) risk
5308451|NCT02136654|diabetes|diabetes
5308452|NCT02136654|ethnicity|ethnicity
5308453|NCT02136654|South Asian|south asian
5308454|NCT02136654|diabetes management|diabetes management
5308455|NCT02136641|Anesthesia|anesthesia
5308456|NCT02136641|Spinal Anesthesia|spinal anesthesia
5308457|NCT02136641|Conscious Sedation|conscious sedation
5308458|NCT02136641|Operating Rooms.|operating rooms.
5308459|NCT02136628|RTL Technique|rtl technique
5308460|NCT02136615|hyperbaric oxygenation|hyperbaric oxygenation
5308461|NCT02136615|insulin sensitivity|insulin sensitivity
5308462|NCT02136615|human|human
5308463|NCT02136615|inflammation|inflammation
5308464|NCT02136615|adipose tissue|adipose tissue
5308465|NCT02136563|Chronic kidney disease|chronic kidney disease
5308466|NCT02136563|Erythropoiesis stimulating agent response index|erythropoiesis stimulating agent response index
5308467|NCT02136563|Hyporesponsive anemia to erythropoiesis stimulating agent|hyporesponsive anemia to erythropoiesis stimulating agent
5308468|NCT02136563|Observational study|observational study
5308469|NCT02136550|smoking|smoking
5308470|NCT02136550|smoking cessation|smoking cessation
5308471|NCT02136550|mucociliary clearance|mucociliary clearance
5308472|NCT02136550|proteomics|proteomics
5308473|NCT02136550|miRNA|mirna
5308474|NCT02136498|smoking cessation|smoking cessation
5308475|NCT02136498|varenicline|varenicline
5308476|NCT02136498|adherence|adherence
5308477|NCT02136472|Subfertility|subfertility
5308478|NCT02136472|Metabolic syndrome|metabolic syndrome
5308479|NCT02136472|Plasma volume|plasma volume
5308480|NCT02136472|Intima media thickness|intima media thickness
5308481|NCT02136472|Flow mediated dilatation|flow mediated dilatation
5308482|NCT02136459|Thyroidectomy|thyroidectomy
5308483|NCT02136459|Endotracheal tube|endotracheal tube
5308484|NCT02136459|Voice|voice
5308485|NCT02136459|Complications|complications
5308486|NCT02136459|Patients undergoing elective thyroidectomy|patients undergoing elective thyroidectomy
5308487|NCT02136446|Paravertebral block|paravertebral block
5308488|NCT02136446|Mastectomy|mastectomy
5308489|NCT02136446|Post-operative pain|post-operative pain
5308490|NCT02136446|Echogenic|echogenic
5308491|NCT02136446|Peripheral nerve block catheter|peripheral nerve block catheter
5308492|NCT02136433|Hand|hand
5308493|NCT02136433|Rehabilitation|rehabilitation
5308494|NCT02136433|Stroke|stroke
5308495|NCT02136433|Brain-injury|brain-injury
5308496|NCT02136433|Tablet|tablet
5308497|NCT02136407|Vitamin D|vitamin d
5308498|NCT02136407|vitamin D deficiency|vitamin d deficiency
5308499|NCT02136407|parathyroid hormone|parathyroid hormone
5308500|NCT02136381|Lifestyle, interventions, retirement|lifestyle, interventions, retirement
5308501|NCT02136368|older adults|older adults
5308502|NCT02136368|multiple-modality exercise|multiple-modality exercise
5356876|NCT01917591|Bandages|bandages
5308503|NCT02136368|mind-motor exercise|mind-motor exercise
5308504|NCT02136368|self-reported cognitive complaints|self-reported cognitive complaints
5308505|NCT02136368|global cognitive functioning|global cognitive functioning
5308506|NCT02136368|mobility|mobility
5308507|NCT02136368|vascular function|vascular function
5308508|NCT02136368|sensorimotor function|sensorimotor function
5308509|NCT02136368|brain imaging|brain imaging
5308510|NCT02136368|community-based research|community-based research
5308511|NCT02136368|subjective cognitive complaints|subjective cognitive complaints
5308512|NCT02136342|no available effective treatment|no available effective treatment
5308513|NCT02136316|Healthy volunteers|healthy volunteers
5308514|NCT02136316|ASP7962|asp7962
5308515|NCT02136316|pharmacokinetics|pharmacokinetics
5308516|NCT02136290|Weight loss|weight loss
5308517|NCT02136277|colorectal surgery|colorectal surgery
5308518|NCT02136277|cardiac output|cardiac output
5308519|NCT02136264|hypertension|hypertension
5308520|NCT02136264|dietary intervention|dietary intervention
5308521|NCT02136264|personalized nutrition|personalized nutrition
5308522|NCT02136264|randomized controlled trial|randomized controlled trial
5308523|NCT02136251|Total Shoulder Arthroplasty|total shoulder arthroplasty
5308524|NCT02136251|Glenoid anchor peg component fixation|glenoid anchor peg component fixation
5308525|NCT02136251|Autologous bone grafting|autologous bone grafting
5308526|NCT02136238|amputation|amputation
5308527|NCT02136238|transradial|transradial
5308528|NCT02136238|prosthesis|prosthesis
5308529|NCT02136238|terminal device|terminal device
5308530|NCT02136225|youth|youth
5308532|NCT02136225|access|access
5308533|NCT02136225|home|home
5308534|NCT02136186|home telemonitoring|home telemonitoring
5308535|NCT02136186|readmission|readmission
5308536|NCT02136186|high risk|high risk
5308537|NCT02136160|elementary school|elementary school
5308538|NCT02136160|children|children
5308539|NCT02136160|health promotion|health promotion
5308540|NCT02136160|teachers|teachers
5308541|NCT02136160|prevention|prevention
5308542|NCT02136147|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5308543|NCT02136147|Neuropsychiatry|neuropsychiatry
5308544|NCT02136147|Drug therapy|drug therapy
5308545|NCT02136147|Pharmacogenetics|pharmacogenetics
5308546|NCT02136147|Child Psychiatry|child psychiatry
5308547|NCT02136134|Multiple Myeloma|multiple myeloma
5308548|NCT02136134|Plasmacytoma|plasmacytoma
5308549|NCT02136134|Refractory Multiple Myeloma|refractory multiple myeloma
5308550|NCT02136134|Relapsed Multiple Myeloma|relapsed multiple myeloma
5308551|NCT02136134|Daratumumab|daratumumab
5308552|NCT02136134|VELCADE|velcade
5308553|NCT02136108|Chronic pain|chronic pain
5308554|NCT02136108|Complementary and alternative therapies|complementary and alternative therapies
5308555|NCT02136108|Mobile health|mobile health
5308556|NCT02136108|Medicaid|medicaid
5308557|NCT02136108|Patient navigation|patient navigation
5308558|NCT02136095|Fluorescent cholangiography|fluorescent cholangiography
5308559|NCT02136095|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5308560|NCT02136082|HIV|hiv
5308561|NCT02136082|Women|women
5308562|NCT02136082|Children|children
5308563|NCT02136082|Nutrition|nutrition
5308564|NCT02136056|Sick-leave|sick-leave
5308565|NCT02136056|Return to work|return to work
5308566|NCT02136056|Self-management|self-management
5308567|NCT02136056|Self-efficacy|self-efficacy
5308568|NCT02136056|Quality of Life and Well-being|quality of life and well-being
5308569|NCT02136056|Motivation|motivation
5308570|NCT02136030|Cryptococcal meningitis|cryptococcal meningitis
5308571|NCT02136017|AEFI|aefi
5308572|NCT02136017|influenza vaccine|influenza vaccine
5308573|NCT02136004|arteriotomy|arteriotomy
5308574|NCT02136004|vessel closure|vessel closure
5308575|NCT02136004|femoral access site|femoral access site
5308576|NCT02135978|Spinal Cord Injury|spinal cord injury
5308577|NCT02135978|Shoulder Pain|shoulder pain
5308578|NCT02135978|Exercise|exercise
5308579|NCT02135952|Periodontitis|periodontitis
5308580|NCT02135952|Diabetes|diabetes
5308581|NCT02135926|Cerebral Stroke, Stroke, Acute, Brain Infarction|cerebral stroke, stroke, acute, brain infarction
5308582|NCT02135913|Obese|obese
5308583|NCT02135913|Children|children
5308584|NCT02135913|Vitamin D deficiency|vitamin d deficiency
5308585|NCT02135913|Low HDL|low hdl
5308586|NCT02135900|Heliox|heliox
5308587|NCT02135900|Obstructive Sleep Apnea|obstructive sleep apnea
5308588|NCT02135887|Stage III Colorectal Cancer|stage iii colorectal cancer
5308589|NCT02135887|Grade 4 Neutropenia|grade 4 neutropenia
5308590|NCT02135887|MB-6|mb-6
5308591|NCT02135861|Acute decompensated heart failure|acute decompensated heart failure
5308592|NCT02135861|heart failure|heart failure
5308594|NCT02135861|trpV4 channel inhibitors|trpv4 channel inhibitors
5308595|NCT02135861|pulmonary oedema|pulmonary oedema
5308596|NCT02135822|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
5308597|NCT02135822|gemcitabine|gemcitabine
5308598|NCT02135822|advanced pancreatic cancer|advanced pancreatic cancer
5308599|NCT02135796|Septic Shock|septic shock
5308600|NCT02135796|Severe Sepsis|severe sepsis
5308601|NCT02135796|ICU|icu
5295548|NCT02198664|Peanut Allergen|peanut allergen
5308602|NCT02135770|heparin|heparin
5308603|NCT02135770|sepsis|sepsis
5308604|NCT02135770|inflammation|inflammation
5308605|NCT02135744|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5308606|NCT02135744|COPD|copd
5308607|NCT02135744|Readmissions|readmissions
5308608|NCT02135718|ELLIPTA|ellipta
5308609|NCT02135718|Asthma|asthma
5308610|NCT02135718|Inhaler preference|inhaler preference
5308611|NCT02135718|Fluticasone furoate|fluticasone furoate
5308612|NCT02135718|ELLIPTA inhaler|ellipta inhaler
5308613|NCT02135718|Dry Powder Inhaler|dry powder inhaler
5308614|NCT02135692|Severe eosinophilic asthma|severe eosinophilic asthma
5308615|NCT02135692|Extension study|extension study
5308616|NCT02135692|Expanded access|expanded access
5308618|NCT02135692|Mepolizumab|mepolizumab
5308619|NCT02135692|Eosinophils|eosinophils
5308621|NCT02135666|Long-term follow-up|long-term follow-up
5308625|NCT02135666|Immunity|immunity
5308626|NCT02135666|Hepatitis B|hepatitis b
5308627|NCT02135666|Combination vaccine|combination vaccine
5308628|NCT02135666|Adult|adult
5308629|NCT02135601|colonoscopy|colonoscopy
5308630|NCT02135601|water|water
5308631|NCT02135601|adenoma|adenoma
5308632|NCT02135601|pain|pain
5308633|NCT02135575|premenopausal|premenopausal
5308634|NCT02135575|postmenopausal|postmenopausal
5308635|NCT02135575|cardiovascular|cardiovascular
5308636|NCT02135575|exercise training|exercise training
5308637|NCT02135575|vascular function|vascular function
5308638|NCT02135575|cardiac function|cardiac function
5308639|NCT02135575|cardiac morphology|cardiac morphology
5308640|NCT02135575|health|health
5308641|NCT02135562|endometrial cancer|endometrial cancer
5308642|NCT02135562|survivor|survivor
5308643|NCT02135562|obesity|obesity
5308644|NCT02135562|diet|diet
5308645|NCT02135562|high protein|high protein
5308646|NCT02135562|protein-sparing modified fast intervention|protein-sparing modified fast intervention
5308647|NCT02135562|PSMF|psmf
5308648|NCT02135523|ovarian cancer|ovarian cancer
5308649|NCT02135523|involved-field radiation therapy|involved-field radiation therapy
5308650|NCT02135523|progression free survival|progression free survival
5308651|NCT02135484|Prostate Cancer|prostate cancer
5308652|NCT02135484|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5308653|NCT02135484|Castrate resistant prostate cancer|castrate resistant prostate cancer
5308654|NCT02135484|CRPC|crpc
5308655|NCT02135484|Skeletal metastases|skeletal metastases
5308656|NCT02135484|Alpharadin|alpharadin
5308657|NCT02135484|Xofigo|xofigo
5308658|NCT02135484|Radium-223 chloride|radium-223 chloride
5308659|NCT02135484|Radium-223 dichloride|radium-223 dichloride
5308660|NCT02135471|gingival recession|gingival recession
5308661|NCT02135471|dental enamel proteins|dental enamel proteins
5308662|NCT02135471|acellular dermal matrix graft|acellular dermal matrix graft
5308663|NCT02135471|tobacco|tobacco
5308664|NCT02135458|Heart failure|heart failure
5308665|NCT02135458|Telemonitoring|telemonitoring
5308666|NCT02135458|therapeutic education|therapeutic education
5308667|NCT02135458|care network|care network
5308668|NCT02135458|hospitalization|hospitalization
5308669|NCT02135445|Drug therapy|drug therapy
5308670|NCT02135432|Chronic Obstructive pulmonary disease, Ivacaftor|chronic obstructive pulmonary disease, ivacaftor
5308671|NCT02135406|Adult|adult
5308672|NCT02135406|18 years or older|18 years or older
5308673|NCT02135406|multiple myeloma|multiple myeloma
5308674|NCT02135406|poor prognosis|poor prognosis
5308675|NCT02135406|relapsed/progressive disease|relapsed/progressive disease
5308676|NCT02135406|within one year of first autologous stem cell transplantation|within one year of first autologous stem cell transplantation
5308677|NCT02135367|PRP|prp
5308678|NCT02135367|growth factors|growth factors
5308679|NCT02135367|Viscosupplementation|viscosupplementation
5308680|NCT02135367|injections|injections
5308681|NCT02135367|chondropathy|chondropathy
5308682|NCT02135367|randomized controlled trial|randomized controlled trial
5308683|NCT02135354|AECOPD|aecopd
5308684|NCT02135354|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5308685|NCT02135354|Acute exacerbation|acute exacerbation
5308686|NCT02135354|Hospitalization|hospitalization
5308687|NCT02135354|Azithromycin|azithromycin
5308688|NCT02135354|Macrolides|macrolides
5308689|NCT02135354|Randomized Controlled Trial|randomized controlled trial
5308690|NCT02135354|Placebo|placebo
5308691|NCT02135341|Detrusor Overactivity|detrusor overactivity
5308692|NCT02135341|Impaired Contractility|impaired contractility
5308693|NCT02135341|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
5308694|NCT02135328|Type 2 diabetes|type 2 diabetes
5308695|NCT02135328|Dietary behaviors|dietary behaviors
5308696|NCT02135328|Physical activity behaviors|physical activity behaviors
5308697|NCT02135328|Radio story, entertainment health education|radio story, entertainment health education
5308698|NCT02135328|Immigrants|immigrants
5308699|NCT02135328|Somali, Latino, Hmong|somali, latino, hmong
5308700|NCT02135328|Families with 3-18 year old children|families with 3-18 year old children
5308701|NCT02135315|Acute Coronary Syndrome, arterial pressure|acute coronary syndrome, arterial pressure
5308703|NCT02135250|Traditional Chinese Medicine|traditional chinese medicine
5308704|NCT02135211|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5308705|NCT02135211|multiple risk factor|multiple risk factor
5308706|NCT02135211|lifestyle intervention|lifestyle intervention
5308707|NCT02135211|health behavior|health behavior
5308708|NCT02135211|lifestyle risk reduction|lifestyle risk reduction
5308709|NCT02135211|health related quality of life|health related quality of life
5308710|NCT02135198|GABA modulator|gaba modulator
5308712|NCT02135198|Short interval intracortical inhibition|short interval intracortical inhibition
5308713|NCT02135198|volunteers|volunteers
5308714|NCT02135146|Hypotension|hypotension
5308715|NCT02135146|Kidney injury|kidney injury
5308716|NCT02135133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5308717|NCT02135133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5308718|NCT02135107|Gastroesophageal reflux disease|gastroesophageal reflux disease
5308719|NCT02135094|trapezius|trapezius
5308720|NCT02135094|upper back|upper back
5308721|NCT02135094|muscle pain|muscle pain
5308722|NCT02135094|pain relief|pain relief
5308723|NCT02135094|ultrasound|ultrasound
5308724|NCT02135094|double blind|double blind
5308725|NCT02135094|Sam|sam
5308726|NCT02135094|ZetrOZ|zetroz
5308727|NCT02135094|muscle|muscle
5308728|NCT02135094|LITUS|litus
5308729|NCT02135094|low intensity therapeutic ultrasound|low intensity therapeutic ultrasound
5308730|NCT02135081|Single ventricle|single ventricle
5308731|NCT02135081|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5308732|NCT02135081|Congenital heart lesion|congenital heart lesion
5308733|NCT02135081|Right or left ventricle|right or left ventricle
5308734|NCT02135081|Cerebral blood flow|cerebral blood flow
5308735|NCT02135081|Pulmonary blood flow|pulmonary blood flow
5308736|NCT02135081|Staged Fontan reconstruction|staged fontan reconstruction
5308737|NCT02135081|hemi Fontan/bidirectional Glenn stages|hemi fontan/bidirectional glenn stages
5308738|NCT02135068|type 1 diabetes|type 1 diabetes
5308739|NCT02135068|closed loop insulin delivery systems|closed loop insulin delivery systems
5308740|NCT02135068|exercise|exercise
5308741|NCT02135068|hypoglycemia|hypoglycemia
5308742|NCT02135055|organ function|organ function
5308743|NCT02135055|sedation|sedation
5308744|NCT02135029|Hyperlipidemia|hyperlipidemia
5308745|NCT02135029|statin intolerance|statin intolerance
5308746|NCT02135016|effect-site concentration|effect-site concentration
5308747|NCT02135016|propofol|propofol
5308748|NCT02135016|thoracic epidural anesthesia|thoracic epidural anesthesia
5308749|NCT02134990|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5308750|NCT02134990|Docetaxel|docetaxel
5308751|NCT02134977|Pharmacological therapy|pharmacological therapy
5308752|NCT02134964|Safety|safety
5308753|NCT02134964|Tolerability|tolerability
5308754|NCT02134964|Pharmacokinetics|pharmacokinetics
5308755|NCT02134964|Dose escalation|dose escalation
5308756|NCT02134964|Randomized|randomized
5308757|NCT02134964|Healthy volunteers|healthy volunteers
5308758|NCT02134964|OLT1177|olt1177
5308759|NCT02134964|Olatec|olatec
5308760|NCT02134899|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5308761|NCT02134899|cyst|cyst
5308762|NCT02134899|kidney|kidney
5308763|NCT02134899|liver|liver
5308764|NCT02134899|kidney transplantation|kidney transplantation
5308765|NCT02134899|IF/TA|if/ta
5308766|NCT02134899|fibrosis|fibrosis
5308767|NCT02134899|DSA|dsa
5308768|NCT02134899|mTOR inhibitors|mtor inhibitors
5308769|NCT02134899|calcineurin inhibitors|calcineurin inhibitors
5308770|NCT02134873|Pain|pain
5308771|NCT02134873|Pain management|pain management
5308772|NCT02134873|Hospitalized|hospitalized
5308773|NCT02134873|Infants|infants
5308774|NCT02134873|Sucrose|sucrose
5308775|NCT02134847|Resident|resident
5308776|NCT02134847|Fatigue|fatigue
5308777|NCT02134847|Sleep deprivation|sleep deprivation
5308778|NCT02134847|medical errors|medical errors
5308779|NCT02134808|Major Depressive Disorder|major depressive disorder
5308780|NCT02134808|Creatine|creatine
5308781|NCT02134808|Brain Chemistry|brain chemistry
5308782|NCT02134808|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5308783|NCT02134808|Treatment Resistance|treatment resistance
5308784|NCT02134808|Selective Serotonin Reuptake Inhibitor (SSRI) Resistance|selective serotonin reuptake inhibitor (ssri) resistance
5308785|NCT02134795|Parkinson's disease|parkinson's disease
5862771|NCT00001516|Treatment Efficacy|treatment efficacy
5862861|NCT00001480|Normal Volunteer|normal volunteer
5308786|NCT02134782|Randomized Controlled Trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life|randomized controlled trial, yoga, children, chemotherapy, haematopoietic stem cell transplantation, fatigue, quality of life
5308790|NCT02134756|Fatigue|fatigue
5308791|NCT02134743|dental implant|dental implant
5308792|NCT02134743|Surface energy|surface energy
5308793|NCT02134743|Hydrophilicity|hydrophilicity
5308794|NCT02134743|Contact angle|contact angle
5308795|NCT02134743|Titanium implant roughness|titanium implant roughness
5308796|NCT02134743|Surface conditioning|surface conditioning
5308797|NCT02134730|FRIENDS for life|friends for life
5308798|NCT02134730|universal prevention|universal prevention
5308800|NCT02134730|anxiety|anxiety
5308801|NCT02134717|sarcoidosis|sarcoidosis
5308802|NCT02134717|CCR5 inhibition|ccr5 inhibition
5308803|NCT02134717|maraviroc|maraviroc
5308804|NCT02134691|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5308805|NCT02134691|Prolonged Exposure (PE)|prolonged exposure (pe)
5308806|NCT02134678|self-system therapy|self-system therapy
5308811|NCT02134665|Vancomycin|vancomycin
5308812|NCT02134665|severe acute pancreatitis|severe acute pancreatitis
5308813|NCT02134665|Creatinine clearance|creatinine clearance
5308814|NCT02134652|Ultrasonography|ultrasonography
5308815|NCT02134652|World Health|world health
5308816|NCT02134626|Portal Hypertension|portal hypertension
5308817|NCT02134626|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5308818|NCT02134626|Esophageal Varices|esophageal varices
5308819|NCT02134626|Liver Cirrhosis|liver cirrhosis
5308820|NCT02134626|Simvastatin|simvastatin
5308821|NCT02134626|Nitric oxide|nitric oxide
5308822|NCT02134626|HVPG|hvpg
5308823|NCT02134613|99mTc-anti-TNF|99mtc-anti-tnf
5308824|NCT02134613|Inflammation|inflammation
5308825|NCT02134613|Psoriatic arthritis|psoriatic arthritis
5308826|NCT02134613|Rheumatoid arthritis|rheumatoid arthritis
5308827|NCT02134600|Omega-3 fatty acids|omega-3 fatty acids
5308829|NCT02134600|EPA|epa
5308830|NCT02134600|Docosahexaenoic acid|docosahexaenoic acid
5308831|NCT02134600|Eicosapentaenoic acid|eicosapentaenoic acid
5308832|NCT02134600|Childhood cancer|childhood cancer
5308833|NCT02134600|Body composition|body composition
5308834|NCT02134600|Inflammation|inflammation
5308835|NCT02134600|Neuropsychiatric symptoms|neuropsychiatric symptoms
5308836|NCT02134587|Health knowledge, attitudes, practices.|health knowledge, attitudes, practices.
5308837|NCT02134587|Adverse drug reaction reporting systems.|adverse drug reaction reporting systems.
5308838|NCT02134587|Pharmacovigilance. Product Surveillance, Postmarketing.|pharmacovigilance. product surveillance, postmarketing.
5308839|NCT02134587|Drug-related side effects and adverse reactions.|drug-related side effects and adverse reactions.
5308840|NCT02134574|Lymphoma,|lymphoma,
5308841|NCT02134574|leukemia,|leukemia,
5308842|NCT02134574|multiple myeloma,|multiple myeloma,
5308843|NCT02134574|hodgkin disease|hodgkin disease
5308844|NCT02134522|non alcoholic fatty liver|non alcoholic fatty liver
5308845|NCT02134522|childhood obesity|childhood obesity
5308846|NCT02134522|Sleep Apnea|sleep apnea
5308847|NCT02134509|Cigarette smoking|cigarette smoking
5308848|NCT02134496|hip|hip
5308849|NCT02134496|knee|knee
5308850|NCT02134496|arthroplasty|arthroplasty
5308851|NCT02134496|spinal|spinal
5308852|NCT02134496|anesthesia|anesthesia
5308853|NCT02134483|Parathyroid|parathyroid
5308854|NCT02134483|Permanent hypocalcemia|permanent hypocalcemia
5308855|NCT02134483|Transplantation|transplantation
5308856|NCT02134470|saliva|saliva
5308857|NCT02134470|blood|blood
5308858|NCT02134470|urine|urine
5308859|NCT02134444|Dizziness|dizziness
5308860|NCT02134444|Vertigo|vertigo
5308861|NCT02134444|Vestibular Diseases|vestibular diseases
5308862|NCT02134444|Vestibular Neuritis|vestibular neuritis
5308863|NCT02134444|Labyrinth Diseases|labyrinth diseases
5308864|NCT02134444|Ear Diseases|ear diseases
5308865|NCT02134444|Vestibular rehabilitation|vestibular rehabilitation
5308866|NCT02134444|Telerehabilitation|telerehabilitation
5308867|NCT02134444|Gaze control|gaze control
5308868|NCT02134444|Balance|balance
5308869|NCT02134431|HIV|hiv
5308870|NCT02134431|tenofovir|tenofovir
5308871|NCT02134431|miocrobicide|miocrobicide
5308872|NCT02134431|endoscopy (colonoscopy, sigmoidoscopy)|endoscopy (colonoscopy, sigmoidoscopy)
5308873|NCT02134431|adolescents|adolescents
5308874|NCT02134431|pediatrics|pediatrics
5308875|NCT02134418|Schizophrenia|schizophrenia
5308876|NCT02134418|Irony|irony
5308877|NCT02134418|Hemispheric processing|hemispheric processing
5308878|NCT02134418|Theory of mind|theory of mind
5308879|NCT02134405|functional dyspepsia|functional dyspepsia
5308880|NCT02134405|symptoms|symptoms
5308881|NCT02134405|proton pump inhibitor|proton pump inhibitor
5308882|NCT02134405|gastritis|gastritis
5308883|NCT02134392|C-diff|c-diff
5308884|NCT02134392|Clostridium difficile|clostridium difficile
5308885|NCT02134392|Fecal Transplant|fecal transplant
5308887|NCT02134392|Fecal Microbiota Transplant|fecal microbiota transplant
5308888|NCT02134379|Thoracic Impedance|thoracic impedance
5308889|NCT02134379|Diagnostic Marker|diagnostic marker
5308890|NCT02134379|Bed Rest Test|bed rest test
5308891|NCT02134379|Transthoracic Impedance|transthoracic impedance
5308892|NCT02134379|Heart Failure|heart failure
5308893|NCT02134379|HF|hf
5308894|NCT02134366|Epilepsia Partialis Continua|epilepsia partialis continua
5308895|NCT02134366|Kojewnikov's Epilepsy|kojewnikov's epilepsy
5308896|NCT02134366|Epilepsy|epilepsy
5308897|NCT02134366|Clobazam|clobazam
5308898|NCT02134366|Focal Motor Epilepsy|focal motor epilepsy
5308899|NCT02134366|Partial Motor Seizure|partial motor seizure
5308900|NCT02134340|IGF1R|igf1r
5308901|NCT02134314|ESRD (End Stage Renal Disease)|esrd (end stage renal disease)
5308902|NCT02134314|CKD (Chronic Kidney Disease)|ckd (chronic kidney disease)
5313359|NCT02114593|Children|children
5308903|NCT02134314|Kidney Transplant|kidney transplant
5308905|NCT02134314|delayed graft function|delayed graft function
5308906|NCT02134314|chronic kidney disease|chronic kidney disease
5308907|NCT02134314|expanded-criteria donor|expanded-criteria donor
5308908|NCT02134314|end stage renal disease|end stage renal disease
5308909|NCT02134301|oritavancin|oritavancin
5308910|NCT02134301|pediatrics|pediatrics
5308911|NCT02134301|gram positive|gram positive
5308912|NCT02134301|bacterial infection|bacterial infection
5308913|NCT02134301|Confirmed|confirmed
5308914|NCT02134301|Suspected|suspected
5308915|NCT02134288|Dialysis|dialysis
5308916|NCT02134288|Kidney Transplant|kidney transplant
5308917|NCT02134288|immunosuppressive therapy|immunosuppressive therapy
5308918|NCT02134288|Delayed Graft Function|delayed graft function
5308925|NCT02134262|Anti-CD19 CAR Expressing T cells Therapy|anti-cd19 car expressing t cells therapy
5308926|NCT02134262|CD19 CAR Gene-Transduced Lymphocyte|cd19 car gene-transduced lymphocyte
5308927|NCT02134262|Adoptive Immunotherapy|adoptive immunotherapy
5308928|NCT02134262|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
5308929|NCT02134262|Retroviral Vector|retroviral vector
5308930|NCT02134262|Burkitt Lymphoma|burkitt lymphoma
5308932|NCT02134262|Lymphoma, Follicular|lymphoma, follicular
5308933|NCT02134262|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5308934|NCT02134262|Lymphomatoid Granulomatosis|lymphomatoid granulomatosis
5308935|NCT02134262|Lymphoma, B-Cell|lymphoma, b-cell
5308936|NCT02134262|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5308937|NCT02134262|Lymphoma, Large-Cell, Immunoblastic|lymphoma, large-cell, immunoblastic
5308938|NCT02134262|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5308939|NCT02134262|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
5308940|NCT02134262|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5308941|NCT02134262|Neoplasms by Histologic Type|neoplasms by histologic type
5308942|NCT02134262|Neoplasms|neoplasms
5308943|NCT02134262|Neoplasms, Experimental|neoplasms, experimental
5308944|NCT02134262|Immune System Diseases|immune system diseases
5308945|NCT02134249|infertility|infertility
5308946|NCT02134249|ICSI|icsi
5308947|NCT02134249|OHSS|ohss
5308948|NCT02134249|Diosmin|diosmin
5308949|NCT02134249|Cabergoline|cabergoline
5308951|NCT02134197|Oncology|oncology
5308952|NCT02134197|Solid tumors|solid tumors
5308953|NCT02134197|Antibody drug conjugate|antibody drug conjugate
5308954|NCT02134197|Maximum tolerated dose|maximum tolerated dose
5308955|NCT02134171|Thrombotic microangiopathy,|thrombotic microangiopathy,
5308956|NCT02134171|haemolytic uremic syndrome,|haemolytic uremic syndrome,
5308957|NCT02134171|thrombotic thrombocytopenic purpura,|thrombotic thrombocytopenic purpura,
5308958|NCT02134171|ADAMTS13,|adamts13,
5308959|NCT02134171|troponin,|troponin,
5308960|NCT02134171|plasma exchange.|plasma exchange.
5308961|NCT02134158|tDCS, gait disorders, equilibrium, hemiplegic, stroke|tdcs, gait disorders, equilibrium, hemiplegic, stroke
5308962|NCT02134145|Mobile Health|mobile health
5308963|NCT02134145|mHealth|mhealth
5308964|NCT02134145|Technology|technology
5308965|NCT02134132|Platelet gel|platelet gel
5308966|NCT02134132|diabetic foot ulcer|diabetic foot ulcer
5308967|NCT02134132|umbilical cord blood|umbilical cord blood
5308968|NCT02134119|dietary supplement|dietary supplement
5308969|NCT02134119|endurance athletes|endurance athletes
5308970|NCT02134119|VO2max|vo2max
5308971|NCT02134119|red blood cells|red blood cells
5308972|NCT02134106|Multicenter|multicenter
5308973|NCT02134106|Open-label|open-label
5308974|NCT02134106|Randomized|randomized
5308975|NCT02134106|Controlled|controlled
5308976|NCT02134106|RCT|rct
5308977|NCT02134106|antibiotic|antibiotic
5308978|NCT02134106|drug-resistant|drug-resistant
5308979|NCT02134106|Gram-negative|gram-negative
5308980|NCT02134106|bacteria|bacteria
5308981|NCT02134080|Tourette Syndrome|tourette syndrome
5308982|NCT02134080|FAAH-Inhibitor|faah-inhibitor
5308983|NCT02134080|Tics|tics
5308984|NCT02134080|Tic Disorders|tic disorders
5308993|NCT02134054|Therapeutic drug monitoring|therapeutic drug monitoring
5308994|NCT02134054|Biological treatment|biological treatment
5308995|NCT02134054|IBD|ibd
5308996|NCT02134041|traumatic brain injury|traumatic brain injury
5309000|NCT02134015|Lung Neoplasms|lung neoplasms
5309001|NCT02134015|Bronchogenic|bronchogenic
5309002|NCT02134015|Bronchial Neoplasms|bronchial neoplasms
5309003|NCT02134015|Respiratory Tract Neoplasms|respiratory tract neoplasms
5309004|NCT02134015|Thoracic Neoplasms|thoracic neoplasms
5309005|NCT02134015|Neoplasms by Site|neoplasms by site
5309007|NCT02134015|Lung Diseases|lung diseases
5309008|NCT02134015|Respiratory Tract Diseases|respiratory tract diseases
5309009|NCT02134015|Erlotinib|erlotinib
5309010|NCT02134015|Therapeutic Uses|therapeutic uses
5309011|NCT02134015|Pharmacologic Actions|pharmacologic actions
5309012|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5309013|NCT02134002|cocaine|cocaine
5309014|NCT02134002|disulfiram|disulfiram
5309015|NCT02134002|beta-dopamine hydroxylase|beta-dopamine hydroxylase
5309016|NCT02133989|Carotid stenosis|carotid stenosis
5309017|NCT02133989|Stenting|stenting
5309020|NCT02133976|chronic low back pain|chronic low back pain
5309021|NCT02133976|psychosocial interventions|psychosocial interventions
5309022|NCT02133976|mechanisms|mechanisms
5309023|NCT02133963|depression|depression
5309024|NCT02133963|postpartum depression|postpartum depression
5309025|NCT02133963|pregnancy|pregnancy
5309026|NCT02133963|perinatal depression|perinatal depression
5309028|NCT02133963|life stress|life stress
5309029|NCT02133950|preimplantation genetic diagnosis|preimplantation genetic diagnosis
5309030|NCT02133950|cryopreservation|cryopreservation
5309031|NCT02133950|pregnancy|pregnancy
5309032|NCT02133924|Graft vs Host Disease|graft vs host disease
5309033|NCT02133924|Graft vs Host Reaction|graft vs host reaction
5309034|NCT02133924|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5309035|NCT02133924|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5309036|NCT02133924|adverse effects|adverse effects
5309037|NCT02133898|Depression|depression
5309038|NCT02133898|MTHFR|mthfr
5309039|NCT02133898|L-methylfolate|l-methylfolate
5309040|NCT02133885|Resistent Hypertension|resistent hypertension
5309041|NCT02133885|Systolic Blood Pressure|systolic blood pressure
5309042|NCT02133872|Resistent Hypertension|resistent hypertension
5309043|NCT02133846|4RT, CBS, PSP, CBD, TPI-287|4rt, cbs, psp, cbd, tpi-287
5309044|NCT02133820|Healthy Volunteer|healthy volunteer
5309045|NCT02133820|Pharmacokinetics|pharmacokinetics
5309046|NCT02133807|Lipoprotein(a);|lipoprotein(a);
5309047|NCT02133807|Lp(a) immunoadsorption;|lp(a) immunoadsorption;
5309048|NCT02133807|Apheresis;|apheresis;
5309049|NCT02133807|Coronary atherosclerosis;|coronary atherosclerosis;
5309050|NCT02133807|Carotid Atherosclerosis;|carotid atherosclerosis;
5309051|NCT02133807|Intima-media thickness;|intima-media thickness;
5309052|NCT02133807|Regression;|regression;
5309053|NCT02133807|Quantitative Coronary Angiography;|quantitative coronary angiography;
5309054|NCT02133807|Intravascular Ultrasound;|intravascular ultrasound;
5309055|NCT02133807|Virtual Histology;|virtual histology;
5309056|NCT02133807|Plaque;|plaque;
5309057|NCT02133807|Atorvastatin;|atorvastatin;
5309058|NCT02133794|Hip fracture|hip fracture
5309059|NCT02133794|Tomosynthesis|tomosynthesis
5309060|NCT02133794|X-ray|x-ray
5309061|NCT02133794|Emergency room|emergency room
5309062|NCT02133781|Inactivated influenza vaccine|inactivated influenza vaccine
5309063|NCT02133781|Live, attenuated influenza vaccine|live, attenuated influenza vaccine
5309064|NCT02133781|Child identical twins|child identical twins
5309065|NCT02133781|Young and elderly adults|young and elderly adults
5309068|NCT02133716|pain|pain
5309069|NCT02133716|premature infant|premature infant
5309070|NCT02133716|sucrose|sucrose
5309071|NCT02133716|breastfeeding|breastfeeding
5309072|NCT02133716|expressed breast milk|expressed breast milk
5309073|NCT02133716|PIPP|pipp
5309074|NCT02133703|Genetic counseling|genetic counseling
5309075|NCT02133703|genetic testing|genetic testing
5309076|NCT02133703|BRCA1|brca1
5309077|NCT02133703|BRCA2|brca2
5309078|NCT02133703|Hereditary breast cancer|hereditary breast cancer
5309079|NCT02133703|Hereditary ovarian cancer|hereditary ovarian cancer
5309080|NCT02133690|rotavirus|rotavirus
5309081|NCT02133690|rotavirus vaccine|rotavirus vaccine
5309082|NCT02133690|BRV-PV|brv-pv
5309083|NCT02133677|lung cancer and breast cancer patients with brain metastases|lung cancer and breast cancer patients with brain metastases
5309084|NCT02133664|multiple sclerosis|multiple sclerosis
5309085|NCT02133664|cognition|cognition
5309086|NCT02133664|clinical trial|clinical trial
5309087|NCT02133664|thiotic acid|thiotic acid
5309088|NCT02133664|Omega-3 fatty acids|omega-3 fatty acids
5309089|NCT02133651|Clostridium difficile|clostridium difficile
5309090|NCT02133651|Intestinal Microbiota Transplantation|intestinal microbiota transplantation
5309091|NCT02133651|Diarrhea|diarrhea
5309092|NCT02133651|Fecal Microbiota Transplant|fecal microbiota transplant
5309093|NCT02133638|Delirium|delirium
5309097|NCT02133638|Sevoflurane|sevoflurane
5309098|NCT02133625|Advanced solid tumor|advanced solid tumor
5309099|NCT02133625|Metastatic solid tumor|metastatic solid tumor
5309100|NCT02133612|esophageal cancer|esophageal cancer
5309101|NCT02133612|adjuvant chemotherapy|adjuvant chemotherapy
5309102|NCT02133612|esophageal surgery|esophageal surgery
5309103|NCT02133612|paclitaxel|paclitaxel
5309104|NCT02133612|cisplatin|cisplatin
5309105|NCT02133586|Air pollution|air pollution
5309107|NCT02133586|Nitrogen dioxide|nitrogen dioxide
5309108|NCT02133586|Lung function|lung function
5309109|NCT02133586|Cytokines|cytokines
5309110|NCT02133573|progesterone|progesterone
5309111|NCT02133573|congenital heart disease|congenital heart disease
5309112|NCT02133573|periventricular leucomalacia|periventricular leucomalacia
5309113|NCT02133573|brain development|brain development
5309118|NCT02133560|Sickle cell|sickle cell
5309119|NCT02133560|Thalassemia|thalassemia
5309120|NCT02133560|Adherence|adherence
5309121|NCT02133547|Nitric Oxide|nitric oxide
5309123|NCT02133547|Healthy Volunteers|healthy volunteers
5309124|NCT02133547|Kartagener Syndrome|kartagener syndrome
5189943|NCT02803502|thrombin generation test|thrombin generation test
5189945|NCT02803502|hemophilia|hemophilia
5189946|NCT02803489|chronic heart failure|chronic heart failure
5189947|NCT02803489|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5309125|NCT02133547|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5309126|NCT02133534|Chronic kidney disease|chronic kidney disease
5309127|NCT02133534|High cholesterol|high cholesterol
5309128|NCT02133521|DLBS1033|dlbs1033
5309129|NCT02133521|Acute ischemic stroke|acute ischemic stroke
5309131|NCT02133521|Barthel Index|barthel index
5309132|NCT02133495|lower eyelid|lower eyelid
5309133|NCT02133495|retraction|retraction
5309134|NCT02133469|Effectiveness|effectiveness
5309135|NCT02133469|Prevenar|prevenar
5309136|NCT02133469|nasopharyngeal carriage|nasopharyngeal carriage
5309137|NCT02133469|vaccine serotype|vaccine serotype
5309138|NCT02133456|safety|safety
5309139|NCT02133456|influenza vaccine|influenza vaccine
5309140|NCT02133456|post-marketing|post-marketing
5309141|NCT02133443|Mechanical ventilation|mechanical ventilation
5309142|NCT02133443|Acute respiratory failure|acute respiratory failure
5309143|NCT02133443|Weaning|weaning
5309144|NCT02133443|Pressure support ventilation|pressure support ventilation
5309145|NCT02133443|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5309146|NCT02133430|Postoperative delirium|postoperative delirium
5309147|NCT02133417|Quantitative Transmission Ultrasound|quantitative transmission ultrasound
5309148|NCT02133417|QTUS|qtus
5309149|NCT02133404|Mineral bone disease(MBD)|mineral bone disease(mbd)
5309150|NCT02133404|Chronic kidney disease(CKD)|chronic kidney disease(ckd)
5309151|NCT02133404|secondary hyperparathyroidism(SHPT)|secondary hyperparathyroidism(shpt)
5309152|NCT02133391|Accountable Care Organization|accountable care organization
5309153|NCT02133391|Comparative Effectiveness Research|comparative effectiveness research
5309154|NCT02133391|Immunization/statistics & numerical data|immunization/statistics & numerical data
5309155|NCT02133391|Medicaid|medicaid
5309156|NCT02133391|Reminder Systems/economics|reminder systems/economics
5309157|NCT02133391|Reminder Systems/statistics & numerical data|reminder systems/statistics & numerical data
5309158|NCT02133378|Bleeding|bleeding
5309159|NCT02133378|Hemostatic|hemostatic
5309160|NCT02133352|pulmonary hypertension|pulmonary hypertension
5309161|NCT02133352|diastolic dyfunction|diastolic dyfunction
5309162|NCT02133326|Analgesia|analgesia
5309163|NCT02133326|Third Molar Extraction|third molar extraction
5309164|NCT02133326|Ibuprofen|ibuprofen
5309165|NCT02133326|Acetaminophen|acetaminophen
5309166|NCT02133326|Pain Medicine|pain medicine
5309167|NCT02133326|Nonsteroidal|nonsteroidal
5309168|NCT02133326|Anti-inflammatory|anti-inflammatory
5309169|NCT02133313|Peritoneal Dialysis|peritoneal dialysis
5309170|NCT02133313|Peritoneal Fibrosis|peritoneal fibrosis
5309171|NCT02133313|Glucose Transporters|glucose transporters
5309172|NCT02133274|Neoplasms|neoplasms
5309173|NCT02133274|Early Palliative Care|early palliative care
5309174|NCT02133274|Psychosocial Intervention|psychosocial intervention
5309175|NCT02133274|Symptoms|symptoms
5309176|NCT02133274|Quality of life|quality of life
5309177|NCT02133274|Depression|depression
5309178|NCT02133248|donor specific antibodies|donor specific antibodies
5309179|NCT02133248|B cells|b cells
5309180|NCT02133248|antibody mediated rejection|antibody mediated rejection
5309181|NCT02133248|kidney transplant|kidney transplant
5309182|NCT02133248|desensitization|desensitization
5309183|NCT02133235|endobronchial blocker|endobronchial blocker
5309184|NCT02133235|lung separation|lung separation
5309185|NCT02133235|vedio-assisted thoracic operation|vedio-assisted thoracic operation
5309186|NCT02133209|migraine|migraine
5309187|NCT02133209|headache|headache
5309188|NCT02133209|meditation|meditation
5309189|NCT02133209|mindfulness based stress reduction|mindfulness based stress reduction
5309190|NCT02133209|MBSR|mbsr
5309195|NCT02133170|BIPOLAR DISORDER|bipolar disorder
5305772|NCT02148835|Omega-3 Index|omega-3 index
5309196|NCT02133170|DEPRESSIVE SYMPTOMS|depressive symptoms
5309197|NCT02133170|MINDFULNESS|mindfulness
5309198|NCT02133170|PSYCHOEDUCATION|psychoeducation
5309199|NCT02133170|BIPOLAR PATIENTS WITH DEPRESSIVE SYMPTOMS|bipolar patients with depressive symptoms
5309200|NCT02133157|tumor|tumor
5309201|NCT02133144|NAFLD|nafld
5309202|NCT02133144|insulin resistance|insulin resistance
5309203|NCT02133144|metabolic syndrome|metabolic syndrome
5309204|NCT02133144|de novo lipogenesis|de novo lipogenesis
5309205|NCT02133144|overfeeding|overfeeding
5309206|NCT02133118|Type 2 diabetes|type 2 diabetes
5309207|NCT02133118|New-user design|new-user design
5309208|NCT02133118|Weight trajectory|weight trajectory
5309209|NCT02133118|Add-on therapy|add-on therapy
5309210|NCT02133118|Sulphonylureas.|sulphonylureas.
5309220|NCT02133092|Acute respiratory infection|acute respiratory infection
5309221|NCT02133092|Belgian children|belgian children
5309222|NCT02133066|Ultrasound|ultrasound
5309223|NCT02133066|Lumbar Puncture|lumbar puncture
5963110|NCT04272307|Inflammatory Bowel Disease|inflammatory bowel disease
5963111|NCT04272307|Acute severe ulcerative colitis|acute severe ulcerative colitis
5963112|NCT04272307|Microbiome|microbiome
5963113|NCT04272307|Prognostic factors|prognostic factors
5963114|NCT04272281|primary health care|primary health care
5309224|NCT02133066|Spinal Tap|spinal tap
5309225|NCT02133066|Pediatric|pediatric
5309226|NCT02133066|Infant|infant
5309227|NCT02133066|Bedside Ultrasonography|bedside ultrasonography
5309228|NCT02133053|Allergic Rhinitis|allergic rhinitis
5309229|NCT02133053|Ectoine|ectoine
5309230|NCT02133053|bitop|bitop
5309231|NCT02133053|Ectoin|ectoin
5309232|NCT02133040|Brown Adipose Tissue|brown adipose tissue
5309233|NCT02133027|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5309235|NCT02133014|laparoscopic|laparoscopic
5309236|NCT02133014|drainage|drainage
5309237|NCT02133014|surgery|surgery
5309238|NCT02133001|Major Depressive Disorder|major depressive disorder
5309240|NCT02133001|Intranasal esketamine|intranasal esketamine
5309241|NCT02133001|Placebo|placebo
5309242|NCT02132975|prostate|prostate
5309243|NCT02132975|cancer|cancer
5309244|NCT02132923|Respiratory syncytial virus|respiratory syncytial virus
5309245|NCT02132923|RSV|rsv
5309246|NCT02132923|Lower respiratory tract infection|lower respiratory tract infection
5309247|NCT02132923|LRTI|lrti
5309248|NCT02132923|Acute respiratory infection|acute respiratory infection
5309249|NCT02132923|Japanese children|japanese children
5309250|NCT02132897|Antiepileptic|antiepileptic
5309251|NCT02132897|Carbamazepine|carbamazepine
5309252|NCT02132897|Bio-equivalence|bio-equivalence
5309253|NCT02132897|Fed|fed
5309254|NCT02132897|Crossover|crossover
5309255|NCT02132832|marijuana|marijuana
5309256|NCT02132832|attentional bias|attentional bias
5309257|NCT02132832|stress|stress
5309258|NCT02132832|buspirone|buspirone
5309259|NCT02132819|transfusion|transfusion
5309260|NCT02132819|feeding|feeding
5309261|NCT02132819|TRAGI|tragi
5309262|NCT02132819|NEC|nec
5309263|NCT02132806|class II furcation involvement|class ii furcation involvement
5309264|NCT02132806|piezoelectric surgery|piezoelectric surgery
5309265|NCT02132806|regeneration|regeneration
5309266|NCT02132806|biomaterial|biomaterial
5309267|NCT02132793|technology|technology
5309268|NCT02132793|mobile|mobile
5309269|NCT02132793|anger management|anger management
5309270|NCT02132793|anger|anger
5309271|NCT02132793|PTSD|ptsd
5309272|NCT02132793|veterans|veterans
5309273|NCT02132767|Heart surgery|heart surgery
5309274|NCT02132767|Cardiac surgery|cardiac surgery
5309275|NCT02132767|Coronary artery bypass|coronary artery bypass
5309276|NCT02132767|Mitral valve surgery|mitral valve surgery
5309277|NCT02132767|Aortic valve surgery|aortic valve surgery
5309278|NCT02132767|Atrial fibrillation|atrial fibrillation
5309279|NCT02132767|Atrial flutter|atrial flutter
5309280|NCT02132767|Cardiac arrhythmia|cardiac arrhythmia
5309281|NCT02132767|Valve surgery|valve surgery
5309282|NCT02132741|OCT; hypertension; CKD|oct; hypertension; ckd
5309283|NCT02132728|flaxseed|flaxseed
5309284|NCT02132728|lignans|lignans
5309285|NCT02132728|inflammation|inflammation
5309286|NCT02132728|Nutrition|nutrition
5309287|NCT02132728|enterolactone|enterolactone
5309288|NCT02132728|enterodiol|enterodiol
5309289|NCT02132689|Moderate Risk Acute Pulmonary Embolism|moderate risk acute pulmonary embolism
5309290|NCT02132676|Self-Management|self-management
5309291|NCT02132676|Patient Care Management|patient care management
5309292|NCT02132676|Peer Group|peer group
5309293|NCT02132676|Disease Management|disease management
5309294|NCT02132676|Health Plan Implementation|health plan implementation
5309295|NCT02132676|Diabetes Mellitus|diabetes mellitus
5309296|NCT02132650|Rehabilitation|rehabilitation
5309297|NCT02132650|Walking|walking
5309298|NCT02132650|Motor skills disorders|motor skills disorders
5309299|NCT02132650|Electromyography|electromyography
5309300|NCT02132598|Lung Cancer|lung cancer
5309301|NCT02132598|Non Small Cell|non small cell
5309302|NCT02132598|Brain metastases|brain metastases
5309303|NCT02132598|c-MET|c-met
5309304|NCT02132520|Hemiparesis|hemiparesis
5309305|NCT02132520|Stroke|stroke
5309306|NCT02132520|Rehabilitation|rehabilitation
5309307|NCT02132520|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5309308|NCT02132520|Electroencephalography|electroencephalography
5309309|NCT02132520|Functional Neuroimaging|functional neuroimaging
5309434|NCT02131961|diabetic foot|diabetic foot
5309310|NCT02132520|Brain-Computer Interface|brain-computer interface
5309312|NCT02132507|fMRI|fmri
5309313|NCT02132507|EEG|eeg
5309314|NCT02132507|ICA|ica
5309315|NCT02132481|Smartphones|smartphones
5309316|NCT02132481|Mobile phones|mobile phones
5309317|NCT02132481|Substance use disorder|substance use disorder
5309318|NCT02132481|Recovery Support Services|recovery support services
5309319|NCT02132481|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
5309320|NCT02132481|Ecological Momentary Intervention (EMI)|ecological momentary intervention (emi)
5309321|NCT02132481|Randomized field experiment|randomized field experiment
5309322|NCT02132481|Effectiveness|effectiveness
5309323|NCT02132481|Post-Discharge|post-discharge
5309324|NCT02132468|PNET|pnet
5309325|NCT02132468|GI-NET|gi-net
5309326|NCT02132468|neuroendocrine|neuroendocrine
5309327|NCT02132468|carcinoid|carcinoid
5309328|NCT02132455|Screening colonoscopy|screening colonoscopy
5963115|NCT04272281|share decision making|share decision making
5178187|NCT02877056|Genes|genes
5309329|NCT02132455|Surveillance colonoscopy|surveillance colonoscopy
5309330|NCT02132442|Children|children
5309331|NCT02132442|Adolescents|adolescents
5309332|NCT02132442|Adults|adults
5309333|NCT02132442|Type 2 diabetes|type 2 diabetes
5309334|NCT02132442|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5309336|NCT02132429|Migraine|migraine
5309337|NCT02132416|Prospective study|prospective study
5309338|NCT02132416|Surgical management|surgical management
5309339|NCT02132416|Unstable thoracic cage injuries|unstable thoracic cage injuries
5309340|NCT02132416|Trauma|trauma
5309341|NCT02132416|Ventilator support|ventilator support
5309342|NCT02132403|pancreatic cancer|pancreatic cancer
5309343|NCT02132403|adenocarcinoma of the pancreas (PDAC)|adenocarcinoma of the pancreas (pdac)
5309344|NCT02132403|mixed adenocarcinoma of the pancreas|mixed adenocarcinoma of the pancreas
5309345|NCT02132403|locally advanced|locally advanced
5309346|NCT02132403|recurrent|recurrent
5309347|NCT02132403|metastatic|metastatic
5309348|NCT02132390|Breast cancer|breast cancer
5309349|NCT02132390|Chemotherapy induced amenorrhea|chemotherapy induced amenorrhea
5309350|NCT02132390|Goserelin|goserelin
5309351|NCT02132364|stroke|stroke
5309352|NCT02132364|hypertension|hypertension
5309353|NCT02132364|secondary prevention|secondary prevention
5309354|NCT02132364|educational program|educational program
5309355|NCT02132338|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5309356|NCT02132338|Prevention|prevention
5309357|NCT02132338|Health Education|health education
5309358|NCT02132325|Pancreatic Cancer|pancreatic cancer
5309359|NCT02132325|Dignity Therapy|dignity therapy
5309360|NCT02132325|Palliative Care|palliative care
5309361|NCT02132325|Advanced Lung Cancer|advanced lung cancer
5309362|NCT02132325|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5309363|NCT02132312|Cataract|cataract
5309364|NCT02132312|Lens replacement|lens replacement
5309365|NCT02132312|pediatric|pediatric
5309366|NCT02132299|Malaria|malaria
5309367|NCT02132299|Plasmodium falciparum malaria|plasmodium falciparum malaria
5309368|NCT02132299|PfSPZ Vaccine|pfspz vaccine
5309369|NCT02132299|PfSPZ Challenge|pfspz challenge
5309370|NCT02132299|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
5309371|NCT02132286|Functional magnetic resonance neuroimaging|functional magnetic resonance neuroimaging
5309372|NCT02132286|Serotonin transporter gene polymorphism|serotonin transporter gene polymorphism
5309373|NCT02132286|Amygdala|amygdala
5309374|NCT02132286|Antidepressant|antidepressant
5309375|NCT02132286|Quetiapine|quetiapine
5309376|NCT02132286|Citalopram|citalopram
5309377|NCT02132286|imaging biomarker|imaging biomarker
5309378|NCT02132260|Naftifine|naftifine
5309379|NCT02132260|Naftin®|naftin®
5309380|NCT02132260|Tinea pedis|tinea pedis
5309381|NCT02132247|Minor athletic injuries|minor athletic injuries
5309382|NCT02132247|Pain|pain
5309383|NCT02132247|Diclofenac|diclofenac
5309384|NCT02132247|Topical|topical
5309385|NCT02132221|Chronic non cancer pain|chronic non cancer pain
5309386|NCT02132221|Long term opioid therapy|long term opioid therapy
5309387|NCT02132221|Side effects|side effects
5309388|NCT02132221|risks|risks
5309389|NCT02132221|function|function
5309390|NCT02132221|negative benefit/risk ratio|negative benefit/risk ratio
5309391|NCT02132143|Lung adenocarcinoma|lung adenocarcinoma
5309392|NCT02132143|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5309393|NCT02132143|Sequential chemoradiotherapy|sequential chemoradiotherapy
5309394|NCT02132143|Progression-free survival|progression-free survival
5309395|NCT02132130|gene therapy|gene therapy
5309396|NCT02132130|unilateral hearing loss|unilateral hearing loss
5309397|NCT02132130|bilateral hearing loss|bilateral hearing loss
5309398|NCT02132130|balance|balance
5309399|NCT02132130|vestibular|vestibular
5309400|NCT02132130|cochlear implant|cochlear implant
5309401|NCT02132130|hearing restoration|hearing restoration
5309402|NCT02132104|Intrauterine adhesions|intrauterine adhesions
5309403|NCT02132104|Asherman Syndrome|asherman syndrome
5309404|NCT02132104|Amnion graft|amnion graft
5309405|NCT02132091|Sirtuins|sirtuins
5309406|NCT02132091|Calorie Restriction|calorie restriction
5309407|NCT02132091|Intermittent Fasting|intermittent fasting
5309408|NCT02132091|Antioxidant|antioxidant
5309409|NCT02132091|Aging|aging
5309410|NCT02132091|Metabolism|metabolism
5309411|NCT02132091|Mitochondria|mitochondria
5309412|NCT02132091|Oxidative Stress|oxidative stress
5309413|NCT02132078|Lung transplant recipients|lung transplant recipients
5309414|NCT02132078|diverticulitis|diverticulitis
5309415|NCT02132078|immunosuppression|immunosuppression
5309416|NCT02132052|Essential Tremor|essential tremor
5309417|NCT02132052|Multiple System Atrophy|multiple system atrophy
5309418|NCT02132052|Corticobasal Degeneration|corticobasal degeneration
5309419|NCT02132052|Supranuclear Palsy, Progressive|supranuclear palsy, progressive
5309420|NCT02132052|Parkinson's Disease|parkinson's disease
5309422|NCT02132039|Tai Chi, dementia, caregivers|tai chi, dementia, caregivers
5309423|NCT02132026|Aortic Stenosis|aortic stenosis
5309424|NCT02132026|Denosumab|denosumab
5963116|NCT04272281|antibiotics|antibiotics
5178267|NCT02876510|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5178268|NCT02876510|non-small cell lung cancer|non-small cell lung cancer
5178269|NCT02876510|Gastric Cancer|gastric cancer
5190239|NCT02801864|transcranial direct current stimulation|transcranial direct current stimulation
5190240|NCT02801864|intensive speech therapy|intensive speech therapy
5190242|NCT02801864|post stroke|post stroke
5309425|NCT02132026|Alendronic Acid|alendronic acid
5309426|NCT02132026|Osteoporosis|osteoporosis
5309427|NCT02131987|Dislocation|dislocation
5309428|NCT02131987|Hemiarthroplasty|hemiarthroplasty
5309429|NCT02131987|Femoral neck fracture|femoral neck fracture
5309430|NCT02131987|Femoral offset|femoral offset
5309431|NCT02131987|Leg length difference|leg length difference
5309432|NCT02131987|Wiberg angle|wiberg angle
5309433|NCT02131974|intubation, pediatric, endotracheal, cuffed ETT|intubation, pediatric, endotracheal, cuffed ett
5309435|NCT02131961|foot ulcer|foot ulcer
5309437|NCT02131961|plantar ulcer|plantar ulcer
5309438|NCT02131961|plantar wound|plantar wound
5309439|NCT02131961|contact cast|contact cast
5309440|NCT02131961|collagenase|collagenase
5309441|NCT02131948|Insulin resistance|insulin resistance
5309442|NCT02131948|Brain insulin action|brain insulin action
5309443|NCT02131948|Type 2 Diabetes|type 2 diabetes
5309444|NCT02131909|unilateral cerebral palsy|unilateral cerebral palsy
5309445|NCT02131909|children|children
5309446|NCT02131909|upper-limb|upper-limb
5309447|NCT02131909|mirror therapy|mirror therapy
5309448|NCT02131909|bimanual coordination|bimanual coordination
5309449|NCT02131909|kinematics analysis|kinematics analysis
5309450|NCT02131896|Type 1 Diabetes|type 1 diabetes
5309451|NCT02131896|Newly diagnosed|newly diagnosed
5204582|NCT02716012|RNA|rna
5309452|NCT02131896|Lipid profile|lipid profile
5309453|NCT02131896|Mediterranean diet|mediterranean diet
5309454|NCT02131883|Health Anxiety|health anxiety
5309455|NCT02131883|Hypochondriasis|hypochondriasis
5309456|NCT02131883|Illness Anxiety Disorder|illness anxiety disorder
5309457|NCT02131883|Somatic Symptom Disorder|somatic symptom disorder
5309458|NCT02131883|Personality Disorders|personality disorders
5309459|NCT02131883|Cognitive Behavioral Therapy|cognitive behavioral therapy
5309460|NCT02131883|Group-CBT|group-cbt
5309461|NCT02131883|Illness Perception|illness perception
5309462|NCT02131883|Cost-effectiveness|cost-effectiveness
5309463|NCT02131870|iron absorption|iron absorption
5309464|NCT02131870|healthy females|healthy females
5309465|NCT02131870|child bearing age|child bearing age
5309466|NCT02131857|Mindfulness|mindfulness
5309467|NCT02131857|stress reduction|stress reduction
5309468|NCT02131844|colorectal surgery|colorectal surgery
5309469|NCT02131844|postoperative recovery|postoperative recovery
5309470|NCT02131844|early mobilization|early mobilization
5309471|NCT02131831|telomere|telomere
5309472|NCT02131831|telomerase|telomerase
5309473|NCT02131831|cirrhosis|cirrhosis
5309474|NCT02131818|amoxicillin|amoxicillin
5309475|NCT02131818|postpartum infections|postpartum infections
5309476|NCT02131818|puerperal infection|puerperal infection
5309478|NCT02131805|Brachytherapy|brachytherapy
5309479|NCT02131805|14-001|14-001
5309480|NCT02131779|prostate cancer disparities|prostate cancer disparities
5309481|NCT02131779|African American|african american
5309482|NCT02131779|Spiritually based intervention|spiritually based intervention
5309483|NCT02131779|Men's Health|men's health
5309484|NCT02131779|Informed Decision Making|informed decision making
5309485|NCT02131779|Community Based Participatory Research|community based participatory research
5309486|NCT02131779|Health Communication|health communication
5309487|NCT02131779|Health Information Technology|health information technology
5309488|NCT02131779|Community Health Advisors|community health advisors
5309489|NCT02131766|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5309490|NCT02131766|Artificial Pancreas Project (APP)|artificial pancreas project (app)
5309491|NCT02131766|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5309492|NCT02131766|Closed-Loop Control (CLC)|closed-loop control (clc)
5309493|NCT02131753|hairy cell leukemia|hairy cell leukemia
5309494|NCT02131753|untreated|untreated
5309495|NCT02131753|cladribine subcutaneous|cladribine subcutaneous
5309496|NCT02131740|corneal|corneal
5309497|NCT02131740|eye rubbing|eye rubbing
5309498|NCT02131727|hand hygiene|hand hygiene
5309499|NCT02131727|communicable diseases|communicable diseases
5309500|NCT02131727|respiratory tract infections|respiratory tract infections
5309501|NCT02131727|primary prevention|primary prevention
5309502|NCT02131727|employees|employees
5309503|NCT02131714|pressure pain threshold|pressure pain threshold
5309504|NCT02131714|temporomandibular disorder syndrome|temporomandibular disorder syndrome
5309505|NCT02131714|therapeutic exercise|therapeutic exercise
5309506|NCT02131714|conservative treatment|conservative treatment
5963117|NCT04272281|daily activities|daily activities
5963118|NCT04272242|LTBI|ltbi
5963119|NCT04272242|HIV and LTBI Co-Infection|hiv and ltbi co-infection
5963120|NCT04272242|Rifapentine|rifapentine
5963121|NCT04272242|Dolutegravir Interaction|dolutegravir interaction
5963122|NCT04272099|Adolescent|adolescent
5963123|NCT04272099|Child|child
5963124|NCT04272099|Quality of Life|quality of life
5963125|NCT04272099|Self Efficacy|self efficacy
5963126|NCT04272099|Haiti|haiti
5309507|NCT02131714|facial pain|facial pain
5309508|NCT02131701|Physical fitness|physical fitness
5309509|NCT02131701|Family history of type 2 diabetes|family history of type 2 diabetes
5309510|NCT02131701|Prescription of exercise|prescription of exercise
5309511|NCT02131688|safety;malignant lymphoma;|safety;malignant lymphoma;
5309513|NCT02131675|type 1 diabetes|type 1 diabetes
5309514|NCT02131662|Uterine fibroids|uterine fibroids
5309515|NCT02131649|Prostate Cancer|prostate cancer
5309516|NCT02131649|PET|pet
5309517|NCT02131649|MRI|mri
5309518|NCT02131649|Fluorocholine|fluorocholine
5309519|NCT02131649|Radiotherapy|radiotherapy
5309520|NCT02131649|Prostatectomy|prostatectomy
5309521|NCT02131610|Sleep apnea|sleep apnea
5309522|NCT02131610|Obstructive sleep apnea|obstructive sleep apnea
5309523|NCT02131610|Subclinical atherosclerosis|subclinical atherosclerosis
5309524|NCT02131610|Epigenetics|epigenetics
5309525|NCT02131610|T cells|t cells
5309527|NCT02131571|bone|bone
5309528|NCT02131571|fractures|fractures
5309529|NCT02131571|vitamin D|vitamin d
5309530|NCT02131571|biomarkers|biomarkers
5309531|NCT02131558|Endometrial cancer|endometrial cancer
5309536|NCT02131545|pharmacokinetics|pharmacokinetics
5309537|NCT02131545|dementia|dementia
5309538|NCT02131545|delirium|delirium
5309539|NCT02131545|palliative care|palliative care
5309540|NCT02131532|Post-stroke fatigue|post-stroke fatigue
5309541|NCT02131532|Psychological intervention|psychological intervention
5309542|NCT02131532|Feasibility|feasibility
5309543|NCT02131506|Advanced HER2 positive Breast Cancer|advanced her2 positive breast cancer
5309544|NCT02131506|pretreated breast cancer|pretreated breast cancer
5309545|NCT02131506|advanced disease|advanced disease
5309546|NCT02131454|asthma and COPD treatment|asthma and copd treatment
5309547|NCT02131454|inhalation techniques|inhalation techniques
5309548|NCT02131454|training of inhalation|training of inhalation
5309549|NCT02131428|Heart Failure|heart failure
5309550|NCT02131428|Depression|depression
5309551|NCT02131428|BNP|bnp
5309552|NCT02131415|schizophrenia|schizophrenia
5309553|NCT02131415|real-life|real-life
5309554|NCT02131415|long-acting injectable|long-acting injectable
5309555|NCT02131415|Reliam|reliam
5309556|NCT02131389|Hip|hip
5309557|NCT02131389|Arthroplasty|arthroplasty
5309558|NCT02131389|Arthroplasties|arthroplasties
5309559|NCT02131389|Prosthesis|prosthesis
5309560|NCT02131389|Iconacy|iconacy
5309561|NCT02131389|Osteoarthritis|osteoarthritis
5309562|NCT02131389|Arthritis|arthritis
5309563|NCT02131389|THA|tha
5309564|NCT02131389|THR|thr
5309565|NCT02131389|DJD|djd
5309566|NCT02131376|carcinoma, renal cell|carcinoma, renal cell
5309567|NCT02131376|partial nephrectomy|partial nephrectomy
5309568|NCT02131376|kidney function test|kidney function test
5309569|NCT02131376|robotics|robotics
5309570|NCT02131324|Psoriasis|psoriasis
5309571|NCT02131311|single use|single use
5309572|NCT02131311|disposable|disposable
5309573|NCT02131311|pessary|pessary
5309574|NCT02131311|stress urinary incontinence|stress urinary incontinence
5309575|NCT02131311|sui|sui
5309576|NCT02131298|Palbociclib|palbociclib
5309577|NCT02131298|Itraconazole|itraconazole
5309578|NCT02131298|Pharmacokinetics|pharmacokinetics
5309579|NCT02131298|Drug-Drug Interaction Study|drug-drug interaction study
5309580|NCT02131298|Healthy Volunteers|healthy volunteers
5309581|NCT02131285|Rehabilitation,|rehabilitation,
5309582|NCT02131285|Balance,|balance,
5309583|NCT02131285|Sensory strategies,|sensory strategies,
5309584|NCT02131285|Multiple Sclerosis,|multiple sclerosis,
5309585|NCT02131285|Postural control|postural control
5309586|NCT02131220|No-Reflow Phenomenon|no-reflow phenomenon
5309587|NCT02131194|Cataract|cataract
5309588|NCT02131194|Nutritional Supplement|nutritional supplement
5309589|NCT02131181|Delirium, postoperative delirium, elderly|delirium, postoperative delirium, elderly
5309590|NCT02131142|ischemic heart disease|ischemic heart disease
5309591|NCT02131142|CAD|cad
5309592|NCT02131129|schizophrenia|schizophrenia
5309593|NCT02131129|schizophreniform disorder|schizophreniform disorder
5309594|NCT02131129|schizoaffective disorder|schizoaffective disorder
5309595|NCT02131129|first episode|first episode
5309596|NCT02131129|psychosis|psychosis
5309597|NCT02131129|cognition|cognition
5309598|NCT02131116|schizophrenia|schizophrenia
5309599|NCT02131116|schizophreniform disorder|schizophreniform disorder
5309600|NCT02131116|schizoaffective disorder|schizoaffective disorder
5309601|NCT02131116|cognition|cognition
5309602|NCT02131116|metacognition|metacognition
5309603|NCT02131116|insight|insight
5309604|NCT02131116|first episode psychosis|first episode psychosis
5309605|NCT02131116|psychosis|psychosis
5309606|NCT02131103|Pharmacoinvasive strategy|pharmacoinvasive strategy
5309607|NCT02131090|Epidural|epidural
5309608|NCT02131090|Catheter|catheter
5309609|NCT02131090|Fixation|fixation
5309610|NCT02131090|Device|device
5309611|NCT02131090|Intrapartum|intrapartum
5309612|NCT02131077|Lateral Epicondylitis|lateral epicondylitis
5309613|NCT02131051|ectoine|ectoine
5309614|NCT02131051|allergic rhinitis|allergic rhinitis
5309615|NCT02131051|bitop|bitop
5309616|NCT02131038|Ectoine|ectoine
5309617|NCT02131038|bitop|bitop
5306179|NCT02147132|Cigarette|cigarette
5309618|NCT02131038|Allergic Rhinitis|allergic rhinitis
5309619|NCT02131012|Macular edema|macular edema
5309620|NCT02130999|Non-24|non-24
5309621|NCT02130999|absolute bioavailability|absolute bioavailability
5309622|NCT02130999|tasimelteon|tasimelteon
5309623|NCT02130999|Hetlioz™|hetlioz™
5309624|NCT02130986|procalcitonin (PCT)|procalcitonin (pct)
5309625|NCT02130986|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
5309626|NCT02130986|antibiotic exposure|antibiotic exposure
5309627|NCT02130986|antibiotic decision making|antibiotic decision making
5309628|NCT02130986|community acquired pneumonia (CAP)|community acquired pneumonia (cap)
5309629|NCT02130986|chronic obstructive pulmonary disease (COPD) exacerbation|chronic obstructive pulmonary disease (copd) exacerbation
5309630|NCT02130986|acute asthma exacerbation|acute asthma exacerbation
5309632|NCT02130986|procalcitonin guideline|procalcitonin guideline
5309633|NCT02130973|teriparatide|teriparatide
5309634|NCT02130973|Forteo|forteo
5309635|NCT02130973|Denosumab|denosumab
5309636|NCT02130973|Prolia|prolia
5309637|NCT02130973|bone density|bone density
5309638|NCT02130973|treatment|treatment
5309639|NCT02130960|RMR|rmr
5309640|NCT02130960|Reliability|reliability
5309641|NCT02130960|Obese|obese
5309642|NCT02130960|Energy Expenditure|energy expenditure
5309643|NCT02130960|Resting Energy Expenditure|resting energy expenditure
5309644|NCT02130960|Resting Metabolic Rate|resting metabolic rate
5309645|NCT02130947|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5309646|NCT02130947|Prostate Cancer|prostate cancer
5309647|NCT02130947|mCRPC|mcrpc
5309648|NCT02130947|Pilot Study|pilot study
5309649|NCT02130947|UNC Lineberger|unc lineberger
5309650|NCT02130947|Exercise|exercise
5309651|NCT02130934|Childhood cancer|childhood cancer
5309652|NCT02130934|anthracyclines|anthracyclines
5309653|NCT02130934|cardiotoxicity|cardiotoxicity
5309654|NCT02130934|cardiac MRI|cardiac mri
5309655|NCT02130934|cumulative does of at least 150 mg/m2 of anthracyclines|cumulative does of at least 150 mg/m2 of anthracyclines
5309656|NCT02130934|Ventricular function|ventricular function
5309657|NCT02130921|Stigma|stigma
5309658|NCT02130921|HIV|hiv
5309659|NCT02130921|CHWs|chws
5309660|NCT02130921|PLH|plh
5309661|NCT02130921|Injecting Drug Users|injecting drug users
5309662|NCT02130921|FM|fm
5309663|NCT02130895|prescribing|prescribing
5309664|NCT02130895|STOPP Criteria|stopp criteria
5309665|NCT02130895|potentially inappropriate prescribing|potentially inappropriate prescribing
5309666|NCT02130895|clinical decision support|clinical decision support
5309667|NCT02130895|Electronic Medical Records|electronic medical records
5309668|NCT02130895|primary care|primary care
5309669|NCT02130882|Benralizumab|benralizumab
5309670|NCT02130882|Pathologic Processes|pathologic processes
5309671|NCT02130882|Syndrome|syndrome
5309672|NCT02130882|Eosinophils|eosinophils
5309673|NCT02130882|EGID|egid
5309674|NCT02130869|Autologous stem cell transplantation|autologous stem cell transplantation
5309675|NCT02130869|Natural killer cells|natural killer cells
5309676|NCT02130856|Neonatal mortality|neonatal mortality
5309677|NCT02130856|Neonatal kit|neonatal kit
5309678|NCT02130856|Pakistan|pakistan
5309679|NCT02130856|Randomized Control Trial|randomized control trial
5309680|NCT02130856|Chlorhexidine|chlorhexidine
5309681|NCT02130856|ThermoSpot|thermospot
5309682|NCT02130856|Birth|birth
5309683|NCT02130843|URINARY INCONTINENCE|urinary incontinence
5309684|NCT02130843|URODYNAMICS|urodynamics
5309685|NCT02130843|URINARY RETENTION|urinary retention
5309686|NCT02130843|URINARY CATHETERIZATION|urinary catheterization
5309687|NCT02130830|hemorrhoids|hemorrhoids
5309688|NCT02130830|Rubber band ligation|rubber band ligation
5309689|NCT02130830|pain|pain
5309690|NCT02130817|Renal Transplant|renal transplant
5309691|NCT02130817|Kidney Transplant|kidney transplant
5309692|NCT02130817|Mean flourescent Intensity|mean flourescent intensity
5309693|NCT02130817|Delayed Graft Function|delayed graft function
5309694|NCT02130817|Antagonist of Thymocyte Cell Activation|antagonist of thymocyte cell activation
5309695|NCT02130804|Obesity|obesity
5309696|NCT02130804|Adipose tissue inflammation|adipose tissue inflammation
5309697|NCT02130804|Salsalate|salsalate
5309698|NCT02130804|Hispanics|hispanics
5309699|NCT02130765|Monomorphic Ventricular Tachycardia|monomorphic ventricular tachycardia
5309700|NCT02130765|Ischemic|ischemic
5309701|NCT02130765|Non-ischemic|non-ischemic
5309702|NCT02130765|Catheter Ablation|catheter ablation
5309703|NCT02130752|Stomach Neoplasms|stomach neoplasms
5309704|NCT02130752|Operative Time|operative time
5309705|NCT02130752|Gastrectomy|gastrectomy
5309706|NCT02130752|Surgical Hemorrhage|surgical hemorrhage
5309707|NCT02130752|Mortality|mortality
5309708|NCT02130752|Morbidity|morbidity
5309709|NCT02130739|Anesthesia|anesthesia
5309710|NCT02130739|Epidural|epidural
5309711|NCT02130739|Thoracic Nerves|thoracic nerves
5309712|NCT02130739|Horner syndrome|horner syndrome
5309713|NCT02130726|Gastric cancer|gastric cancer
5309714|NCT02130726|Minimally-invasive|minimally-invasive
5369159|NCT01861028|total knee replacement|total knee replacement
5309715|NCT02130726|Oncological quality of resection|oncological quality of resection
5309716|NCT02130700|mCRPC|mcrpc
5309717|NCT02130700|metastatic|metastatic
5309911|NCT02129946|Satiety|satiety
5309718|NCT02130700|castration-resistant prostate cancer|castration-resistant prostate cancer
5309719|NCT02130687|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5309721|NCT02130687|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
5309722|NCT02130687|Dipeptidyl Peptidase IV Inhibitors|dipeptidyl peptidase iv inhibitors
5309723|NCT02130687|Sitagliptin|sitagliptin
5309724|NCT02130687|Aprepitant|aprepitant
5309725|NCT02130687|Ramipril|ramipril
5309726|NCT02130674|traumatic brain injury|traumatic brain injury
5309727|NCT02130674|glutamine|glutamine
5309728|NCT02130674|microdialysis|microdialysis
5309730|NCT02130661|drug interaction|drug interaction
5309731|NCT02130661|healthy volunteer|healthy volunteer
5309732|NCT02130661|rilapladib|rilapladib
5309733|NCT02130661|SB-659032|sb-659032
5309734|NCT02130661|Alzheimer's disease|alzheimer's disease
5309735|NCT02130661|itraconazole|itraconazole
5309736|NCT02130648|Non-invasive Prenatal Diagnosis (NIPD)|non-invasive prenatal diagnosis (nipd)
5309737|NCT02130648|Cystic Fibrosis|cystic fibrosis
5309738|NCT02130648|Quantitative real time MEMO-PCR|quantitative real time memo-pcr
5309739|NCT02130635|PI3Kd|pi3kd
5309740|NCT02130635|Pharmacodynamics|pharmacodynamics
5309741|NCT02130635|dry powder inhaler|dry powder inhaler
5309742|NCT02130635|GSK2269557|gsk2269557
5309743|NCT02130635|safety|safety
5309744|NCT02130635|COPD subjects|copd subjects
5309745|NCT02130622|Diabetic Gastroparesis|diabetic gastroparesis
5309746|NCT02130622|Promethazine|promethazine
5309747|NCT02130570|Adverse events|adverse events
5309748|NCT02130570|Readmissions|readmissions
5309749|NCT02130570|Patient Centered Medical Home (PCMH)|patient centered medical home (pcmh)
5309750|NCT02130570|Accountable Care Organizations (ACO)|accountable care organizations (aco)
5309751|NCT02130570|Medication reconciliation|medication reconciliation
5309752|NCT02130570|Discharge Advocate|discharge advocate
5309753|NCT02130570|Patient engagement|patient engagement
5309754|NCT02130570|Transitions of care|transitions of care
5309755|NCT02130570|Transitions coach|transitions coach
5309756|NCT02130570|Pharmacist intervention|pharmacist intervention
5309757|NCT02130557|Leukemia|leukemia
5309758|NCT02130557|Myelogenous|myelogenous
5309759|NCT02130557|Chronic|chronic
5309760|NCT02130557|BCR-ABL Positive|bcr-abl positive
5309761|NCT02130557|Bosutinib|bosutinib
5309762|NCT02130557|Leukemia, Myeloid|leukemia, myeloid
5309763|NCT02130557|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5309764|NCT02130557|Philadelphia Chromosome|philadelphia chromosome
5309765|NCT02130557|Neoplasms by Histologic Type|neoplasms by histologic type
5309766|NCT02130557|Bone Marrow Diseases|bone marrow diseases
5309767|NCT02130557|Hematologic Diseases|hematologic diseases
5309768|NCT02130557|Translocation, Genetic|translocation, genetic
5309769|NCT02130557|Pathologic Processes|pathologic processes
5309770|NCT02130557|Imatinib|imatinib
5309771|NCT02130557|Therapeutic Uses|therapeutic uses
5309772|NCT02130557|Pharmacologic Actions|pharmacologic actions
5309773|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5309775|NCT02130466|PD-1|pd-1
5309776|NCT02130466|PDL1|pdl1
5309777|NCT02130466|PD-L1|pd-l1
5309778|NCT02130453|Ischemia|ischemia
5309779|NCT02130453|Coronary artery disease|coronary artery disease
5309780|NCT02130453|Nuclear stress test|nuclear stress test
5309781|NCT02130453|Stress Echocardiogram|stress echocardiogram
5309782|NCT02130453|Echocardiography strain measurement|echocardiography strain measurement
5309783|NCT02130453|Ultrasound cardiac imaging|ultrasound cardiac imaging
5309784|NCT02130453|ReSTE|reste
5309785|NCT02130453|SPECT|spect
5309786|NCT02130453|Regadenoson|regadenoson
5309787|NCT02130440|nasal obstruction|nasal obstruction
5309788|NCT02130440|sneezing|sneezing
5309789|NCT02130440|itching|itching
5309790|NCT02130440|rhinorrhea|rhinorrhea
5309791|NCT02130440|respiratory infections|respiratory infections
5309792|NCT02130440|wheezing|wheezing
5309793|NCT02130427|Adult subjects|adult subjects
5309794|NCT02130427|NSCLC|nsclc
5309795|NCT02130414|Cyclosporine|cyclosporine
5309796|NCT02130414|Healthy Volunteers|healthy volunteers
5309797|NCT02130414|Immunosuppressive Agents|immunosuppressive agents
5309798|NCT02130414|CyCol|cycol
5309799|NCT02130414|Pharmacokinetics|pharmacokinetics
5309800|NCT02130401|neuromodulation|neuromodulation
5309801|NCT02130401|caloric vestibular stimulation|caloric vestibular stimulation
5309802|NCT02130401|Type 2 Diabetes|type 2 diabetes
5309803|NCT02130362|Crohn's Disease|crohn's disease
5309804|NCT02130362|Registry|registry
5309805|NCT02130362|Adalimumab|adalimumab
5309806|NCT02130362|Crohn's|crohn's
5309807|NCT02130362|Inflammatory Bowel Diseases|inflammatory bowel diseases
5309808|NCT02130362|Gastrointestinal Diseases|gastrointestinal diseases
5309809|NCT02130349|IBD|ibd
5309810|NCT02130349|Crohns Disease|crohns disease
5309811|NCT02130349|Ulcerative Colitis|ulcerative colitis
5309812|NCT02130349|Cohort|cohort
5309813|NCT02130349|Biobank|biobank
5309814|NCT02130349|Population based|population based
5309815|NCT02130349|IBDSL|ibdsl
5309816|NCT02130336|Metabolic syndrome|metabolic syndrome
5309817|NCT02130336|Metabolic risk factors|metabolic risk factors
5309818|NCT02130336|High-intensity interval training|high-intensity interval training
5309819|NCT02130336|Moderate-intensity exercise|moderate-intensity exercise
5309820|NCT02130323|Cervical intraepithelial neoplasia, Imiquimod|cervical intraepithelial neoplasia, imiquimod
5309821|NCT02130310|Chronic ulcers|chronic ulcers
5309822|NCT02130310|Venous ulcers|venous ulcers
5309823|NCT02130297|Mohs|mohs
5309824|NCT02130297|scar|scar
5309825|NCT02130297|post excision|post excision
5309826|NCT02130297|CO2 laser|co2 laser
5309827|NCT02130297|laser|laser
5309828|NCT02130297|skin cancer|skin cancer
5309829|NCT02130297|resurfacing|resurfacing
5309830|NCT02130271|Sciatica|sciatica
5309831|NCT02130271|PET scan|pet scan
5309833|NCT02130271|Inflammation|inflammation
5309834|NCT02130271|Epidural Steroid Injection (ESI)|epidural steroid injection (esi)
5309835|NCT02130258|Radicular|radicular
5309836|NCT02130258|Pain|pain
5309837|NCT02130258|Epidural Steroid Injection|epidural steroid injection
5309838|NCT02130245|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5309839|NCT02130245|Acute cholecystitis|acute cholecystitis
5309840|NCT02130245|Early|early
5309841|NCT02130245|Delayed|delayed
5309842|NCT02130232|Gestational weight gain|gestational weight gain
5309843|NCT02130232|Lifestyle|lifestyle
5309844|NCT02130232|Intervention|intervention
5309845|NCT02130219|ICP, intracranial hypertension, Vittamed 205|icp, intracranial hypertension, vittamed 205
5309846|NCT02130206|Plaque, Saliva, Cavities|plaque, saliva, cavities
5309847|NCT02130193|Efficacy|efficacy
5309848|NCT02130193|Danirixin|danirixin
5309849|NCT02130193|EXACT-PRO|exact-pro
5309850|NCT02130193|COPD|copd
5309851|NCT02130193|Safety|safety
5309852|NCT02130193|RD|rd
5309853|NCT02130193|CXCR2 inhibitor|cxcr2 inhibitor
5309854|NCT02130193|EXACT-RS|exact-rs
5309855|NCT02130193|PK|pk
5309856|NCT02130193|HCRU exacerbations|hcru exacerbations
5309857|NCT02130193|PD|pd
5309858|NCT02130167|Myopia progression|myopia progression
5309859|NCT02130167|Low concentration atropine|low concentration atropine
5309860|NCT02130154|Brown adipose Tissue|brown adipose tissue
5309861|NCT02130154|Ageing|ageing
5309862|NCT02130154|Sympathetic Nervous Stimulation|sympathetic nervous stimulation
5309863|NCT02130154|Obesity|obesity
5309864|NCT02130141|cocoa|cocoa
5309865|NCT02130141|dark chocolate|dark chocolate
5309866|NCT02130141|hypertension|hypertension
5309867|NCT02130141|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
5309868|NCT02130141|flavanols|flavanols
5309869|NCT02130102|technology acceptance|technology acceptance
5309870|NCT02130102|ambient assisted living|ambient assisted living
5309871|NCT02130102|independent living|independent living
5309872|NCT02130102|quality of life|quality of life
5309873|NCT02130102|socioeconomic impact|socioeconomic impact
5309874|NCT02130102|usability of information and communication technologies|usability of information and communication technologies
5309875|NCT02130063|IDA|ida
5309876|NCT02130063|Iron deficiency|iron deficiency
5309877|NCT02130063|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy|iron deficiency anaemia and who are intolerant or unresponsive to oral iron therapy
5309878|NCT02130050|Obstructive Sleep Apnea|obstructive sleep apnea
5309879|NCT02130050|Continuous Positive Airway Pressure|continuous positive airway pressure
5309880|NCT02130050|Cardiovascular disease|cardiovascular disease
5309881|NCT02130050|Polysomnography|polysomnography
5309882|NCT02130050|Metabolomic|metabolomic
5309883|NCT02130037|APPLICATION|application
5309884|NCT02130037|SMARTPHONE|smartphone
5309885|NCT02130037|BULIMIA|bulimia
5309886|NCT02130037|B.E.D|b.e.d
5309887|NCT02130037|BINGE EATING DISORDER|binge eating disorder
5309888|NCT02130024|Age-related macular degeneration|age-related macular degeneration
5309889|NCT02130024|AMD|amd
5309890|NCT02130024|wet AMD|wet amd
5309891|NCT02130024|ranibizumab|ranibizumab
5309892|NCT02130024|aflibercept|aflibercept
5309893|NCT02130024|geographic atrophy|geographic atrophy
5309894|NCT02130024|inject and extend|inject and extend
5309895|NCT02129998|Infertility|infertility
5309896|NCT02129998|IVF/ICSI|ivf/icsi
5309897|NCT02129998|Progesterone|progesterone
5309898|NCT02129998|Preimplantation Factor (PIF)|preimplantation factor (pif)
5309899|NCT02129985|the newly onset type 2 diabetes|the newly onset type 2 diabetes
5309900|NCT02129985|short-term insulin treatment|short-term insulin treatment
5309901|NCT02129985|exenatide sequential therapy|exenatide sequential therapy
5309902|NCT02129985|beta cell function|beta cell function
5309903|NCT02129985|glycaemic remission|glycaemic remission
5309904|NCT02129972|Inflammatory Bowel Disease, colon lesions, colon capsule endoscopy|inflammatory bowel disease, colon lesions, colon capsule endoscopy
5309905|NCT02129959|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic|laparoscopic cholecystectomy, laparoscopic gastrectomy, laparoscopic colectomy, laparoscopic appendectomy, laparoscopic
5369160|NCT01861028|total knee arthroplasty|total knee arthroplasty
5369161|NCT01861028|patient-specific|patient-specific
5309906|NCT02129959|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy|assisted vaginal hysterectomy, robot-assisted laparoscopic radical prostatectomy
5309907|NCT02129946|Type 2 Diabetes|type 2 diabetes
5309908|NCT02129946|Resistant Starch|resistant starch
5309909|NCT02129946|Postprandial Glucose|postprandial glucose
5309910|NCT02129946|Postprandial Insulin|postprandial insulin
5309913|NCT02129933|HGD|hgd
5309914|NCT02129933|Esophagus|esophagus
5309915|NCT02129920|Stroke|stroke
5309916|NCT02129920|Cerebral Infarction|cerebral infarction
5309917|NCT02129920|Atrial Fibrillation|atrial fibrillation
5309918|NCT02129920|Arrhythmias, Cardiac|arrhythmias, cardiac
5309919|NCT02129920|Heart Diseases|heart diseases
5309920|NCT02129920|Cardiovascular Diseases|cardiovascular diseases
5296815|NCT02192853|sitagliptin|sitagliptin
5309921|NCT02129920|Cerebrovascular Disorders|cerebrovascular disorders
5309922|NCT02129920|Brain Diseases|brain diseases
5309923|NCT02129920|Central Nervous System Diseases|central nervous system diseases
5309924|NCT02129920|Nervous System Diseases|nervous system diseases
5309925|NCT02129920|Vascular Diseases|vascular diseases
5309926|NCT02129920|Brain Infarction|brain infarction
5309928|NCT02129920|Anticoagulants|anticoagulants
5309929|NCT02129920|Hematologic Agents|hematologic agents
5309930|NCT02129920|Therapeutic Uses|therapeutic uses
5309932|NCT02129907|Iron-Deficiency|iron-deficiency
5309933|NCT02129907|thrombin|thrombin
5309934|NCT02129894|cesarean section|cesarean section
5309935|NCT02129894|postoperative pain|postoperative pain
5309936|NCT02129894|pregnancy|pregnancy
5309937|NCT02129894|abdominal binder|abdominal binder
5309938|NCT02129868|Type 1 diabetes|type 1 diabetes
5309939|NCT02129868|Closed-loop glucose control|closed-loop glucose control
5309940|NCT02129868|Artificial Pancreas|artificial pancreas
5309941|NCT02129868|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5309942|NCT02129868|Continuous glucose monitoring|continuous glucose monitoring
5309944|NCT02129842|AF|af
5309945|NCT02129842|ablation|ablation
5309946|NCT02129842|EndoPAT|endopat
5309947|NCT02129842|Endothelial dysfunction|endothelial dysfunction
5309948|NCT02129842|PAT|pat
5309949|NCT02129829|Cirrhosis|cirrhosis
5309950|NCT02129829|HBV|hbv
5309951|NCT02129829|HIV|hiv
5309952|NCT02129829|HCV|hcv
5309953|NCT02129816|Female|female
5309954|NCT02129816|Postmenopause|postmenopause
5309955|NCT02129803|Cystic Fibrosis, high flow 20 liters per minute (LPM) humidification therapy|cystic fibrosis, high flow 20 liters per minute (lpm) humidification therapy
5309956|NCT02129790|Bipolar Disorder|bipolar disorder
5309957|NCT02129790|Suicidal|suicidal
5309958|NCT02129790|Depression|depression
5309959|NCT02129790|Self-harm|self-harm
5309960|NCT02129790|Psychosocial intervention|psychosocial intervention
5309961|NCT02129777|Drug therapy|drug therapy
5309962|NCT02129751|able to swallow medications without difficulty|able to swallow medications without difficulty
5309963|NCT02129751|bupropion hydrobromide|bupropion hydrobromide
5309964|NCT02129699|NSCLC|nsclc
5309965|NCT02129699|stage IV|stage iv
5309966|NCT02129686|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
5309967|NCT02129686|Acupuncture|acupuncture
5309968|NCT02129686|Early-Stage Breast Carcinoma|early-stage breast carcinoma
5309969|NCT02129686|Stage I Breast Cancer|stage i breast cancer
5309970|NCT02129686|Stage II Breast Cancer|stage ii breast cancer
5309971|NCT02129686|Stage III Breast Cancer|stage iii breast cancer
5309972|NCT02129673|Glaucoma|glaucoma
5309973|NCT02129673|Intra-ocular pressure|intra-ocular pressure
5309974|NCT02129673|Slow Release|slow release
5309975|NCT02129673|Controlled release|controlled release
5309976|NCT02129647|Neurofibromatosis Type 2|neurofibromatosis type 2
5309977|NCT02129647|Vestibular Schwannomas|vestibular schwannomas
5309978|NCT02129647|Axitinib|axitinib
5309979|NCT02129634|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5309980|NCT02129634|Limb-salvage|limb-salvage
5309981|NCT02129634|Randomized Controlled Trial|randomized controlled trial
5309982|NCT02129634|Paclitaxel|paclitaxel
5309983|NCT02129621|Lipocalin|lipocalin
5309984|NCT02129621|mineralocorticoid receptor|mineralocorticoid receptor
5309985|NCT02129608|overweight|overweight
5309986|NCT02129608|obese|obese
5309987|NCT02129608|central adiposity|central adiposity
5309988|NCT02129608|Laser|laser
5309989|NCT02129608|lorcaserin|lorcaserin
5309990|NCT02129608|low level laser therapy|low level laser therapy
5309991|NCT02129608|belviq|belviq
5309992|NCT02129595|Resveratrol|resveratrol
5309993|NCT02129595|Diabetes Mellitus|diabetes mellitus
5309994|NCT02129595|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5309995|NCT02129595|Insulin Resistance|insulin resistance
5309996|NCT02129595|Glucose Metabolism Disorders|glucose metabolism disorders
5309997|NCT02129595|Metabolic Diseases|metabolic diseases
5309998|NCT02129595|Endocrine System Diseases|endocrine system diseases
5309999|NCT02129595|Hyperinsulinism|hyperinsulinism
5310000|NCT02129595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5310001|NCT02129595|Analgesics, Non-Narcotic|analgesics, non-narcotic
5310002|NCT02129595|Analgesics|analgesics
5310003|NCT02129595|Sensory System Agents|sensory system agents
5310004|NCT02129595|Peripheral Nervous System Agents|peripheral nervous system agents
5310005|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs
5310006|NCT02129595|Pharmacologic Actions|pharmacologic actions
5310007|NCT02129595|Anti-Inflammatory Agents|anti-inflammatory agents
5310008|NCT02129595|Therapeutic Uses|therapeutic uses
5310009|NCT02129595|Antirheumatic Agents|antirheumatic agents
5310010|NCT02129595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5310012|NCT02129595|Antioxidants|antioxidants
5310013|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5310014|NCT02129595|Protective Agents|protective agents
5310015|NCT02129595|Enzyme Inhibitors|enzyme inhibitors
5310016|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5310017|NCT02129595|Hematologic Agents|hematologic agents
5310018|NCT02129595|Antimutagenic Agents|antimutagenic agents
5310019|NCT02129595|Anticarcinogenic Agents|anticarcinogenic agents
5310020|NCT02129595|Central Nervous System Agents|central nervous system agents
5310021|NCT02129595|Brown Adipose Tissue|brown adipose tissue
5310024|NCT02129556|trastuzumab-resistant|trastuzumab-resistant
5310025|NCT02129556|PD-L1 expressing|pd-l1 expressing
5310026|NCT02129556|HER2-positive|her2-positive
5310028|NCT02129543|Stem Cell Transplantation|stem cell transplantation
5310029|NCT02129543|Stem Cell Transplant|stem cell transplant
5310030|NCT02129530|Community Mobilization|community mobilization
5310031|NCT02129530|HIV|hiv
5310032|NCT02129530|Intimate Partner Violence|intimate partner violence
5310033|NCT02129530|Gender Norms|gender norms
5310034|NCT02129504|root coverage|root coverage
5310035|NCT02129504|gingival recession|gingival recession
5310036|NCT02129504|periodontal surgery|periodontal surgery
5310037|NCT02129491|stroke|stroke
5310038|NCT02129491|Congenital stroke|congenital stroke
5310039|NCT02129491|neonatal|neonatal
5310040|NCT02129491|hemiplegia|hemiplegia
5310041|NCT02129478|olanzapine|olanzapine
5310042|NCT02129478|pediatrics|pediatrics
5310043|NCT02129478|chemotherapy-induced nausea|chemotherapy-induced nausea
5310044|NCT02129478|chemotherapy-induced vomiting|chemotherapy-induced vomiting
5310045|NCT02129465|Cytomegalovirus|cytomegalovirus
5310046|NCT02129465|CMV|cmv
5310047|NCT02129465|pregnancy|pregnancy
5310048|NCT02129465|transmission|transmission
5310049|NCT02129452|Alzheimer disease|alzheimer disease
5310050|NCT02129452|Dementia|dementia
5310051|NCT02129452|Neurodegenerative Diseases|neurodegenerative diseases
5310052|NCT02129452|Tauopathies|tauopathies
5310053|NCT02129452|Amyloid beta Peptides|amyloid beta peptides
5310054|NCT02129452|Amyloid Plaque|amyloid plaque
5310055|NCT02129452|MicroRNAs|micrornas
5310056|NCT02129452|Early Diagnosis|early diagnosis
5310184|NCT02128906|hypopharynx|hypopharynx
5310057|NCT02129439|Antisense oligonucleotide|antisense oligonucleotide
5310058|NCT02129439|Colitis Ulcerosa|colitis ulcerosa
5310059|NCT02129439|Ulcerative colitis|ulcerative colitis
5310060|NCT02129439|Phase II|phase ii
5310061|NCT02129439|Transcription factor GATA-3|transcription factor gata-3
5310062|NCT02129439|intrarectal application|intrarectal application
5310063|NCT02129439|proof-of-concept|proof-of-concept
5310064|NCT02129426|Sedation|sedation
5310066|NCT02129413|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5310067|NCT02129413|Subarachnoid hemorrhage|subarachnoid hemorrhage
5310068|NCT02129413|Cerebral vasospasm|cerebral vasospasm
5310069|NCT02129413|Ruptured aneurysm|ruptured aneurysm
5310070|NCT02129413|Delayed Cerebral Ischemia|delayed cerebral ischemia
5310071|NCT02129413|Delayed Ischemic Deficit|delayed ischemic deficit
5310072|NCT02129413|Delayed ischemic neurological deficit|delayed ischemic neurological deficit
5310073|NCT02129413|Neurostimulation|neurostimulation
5310074|NCT02129413|Carotid body|carotid body
5310075|NCT02129400|Xenon-inhalation|xenon-inhalation
5310076|NCT02129400|Erythropoetin|erythropoetin
5310077|NCT02129400|Pharmakokinetic|pharmakokinetic
5310078|NCT02129400|Pharmacodynamic|pharmacodynamic
5310079|NCT02129400|Hemodynamic parameters|hemodynamic parameters
5310080|NCT02129400|Inflammatory parameters|inflammatory parameters
5310081|NCT02129400|Growth factors|growth factors
5310082|NCT02129400|Oxidative stress parameters|oxidative stress parameters
5310083|NCT02129387|Nicotine|nicotine
5310084|NCT02129387|Smoking Progression|smoking progression
5310085|NCT02129387|EEG|eeg
5310086|NCT02129387|Young adults|young adults
5310087|NCT02129387|Light smokers|light smokers
5310088|NCT02129387|rs1051730 genotype|rs1051730 genotype
5310089|NCT02129374|Spondylolysis|spondylolysis
5310090|NCT02129374|Lumbar spine|lumbar spine
5310091|NCT02129374|Young population|young population
5310092|NCT02129374|Direct repair|direct repair
5310093|NCT02129374|Union rate|union rate
5310094|NCT02129374|Functional outcome|functional outcome
5310095|NCT02129361|traumatic brain injury|traumatic brain injury
5310096|NCT02129348|Alzheimer's disease|alzheimer's disease
5310097|NCT02129348|psychosis|psychosis
5310098|NCT02129348|agitation|agitation
5310099|NCT02129348|aggression|aggression
5310100|NCT02129348|Lithium|lithium
5310101|NCT02129348|delusions|delusions
5310102|NCT02129348|hallucinations|hallucinations
5310103|NCT02129335|glioblastoma|glioblastoma
5310104|NCT02129335|partner|partner
5310105|NCT02129335|stress|stress
5310106|NCT02129335|exercise|exercise
5310107|NCT02129335|outcome|outcome
5310108|NCT02129309|COPD|copd
5310113|NCT02129296|Gastric balloon|gastric balloon
5310114|NCT02129296|Weight loss|weight loss
5310115|NCT02129296|Tolerance|tolerance
5310116|NCT02129296|Safety|safety
5310117|NCT02129283|physicians, nurses, ICU, end-of-life, simulation training|physicians, nurses, icu, end-of-life, simulation training
5310122|NCT02129244|HIV|hiv
5297026|NCT02191956|Early Onset|early onset
5310123|NCT02129244|Nurse Case Management (NCM)|nurse case management (ncm)
5310124|NCT02129231|ezetimibe/simvastatin|ezetimibe/simvastatin
5310125|NCT02129231|rosuvastatin|rosuvastatin
5310126|NCT02129231|diabetic polyneuropathy|diabetic polyneuropathy
5310127|NCT02129231|oxidative stress|oxidative stress
5310128|NCT02129231|mitochondrial dysfunction|mitochondrial dysfunction
5310129|NCT02129205|solid tumors|solid tumors
5310130|NCT02129205|triple negative breast cancer|triple negative breast cancer
5310131|NCT02129205|PF-06650808|pf-06650808
5310133|NCT02129153|Randomized controlled trial|randomized controlled trial
5310134|NCT02129153|Population, School Age|population, school age
5310135|NCT02129140|hernia repair|hernia repair
5310136|NCT02129140|ventral incisional hernia|ventral incisional hernia
5310137|NCT02129140|biologic mesh|biologic mesh
5310138|NCT02129140|hernia graft|hernia graft
5310139|NCT02129088|Healthy|healthy
5310140|NCT02129088|Esketamine|esketamine
5310141|NCT02129088|Phase 1|phase 1
5310142|NCT02129088|Placebo|placebo
5310143|NCT02129088|Elderly|elderly
5310144|NCT02129088|Adult|adult
5310145|NCT02129036|Ovarian cancer|ovarian cancer
5310146|NCT02129036|Clear cell carcinoma|clear cell carcinoma
5310147|NCT02129036|Paclitaxel-platinum|paclitaxel-platinum
5310148|NCT02129036|Chemotherapy|chemotherapy
5310149|NCT02129036|response to chemotherapy|response to chemotherapy
5310150|NCT02129036|survival of clear cell ovarian carcinoma|survival of clear cell ovarian carcinoma
5310151|NCT02129036|Prognostic factors|prognostic factors
5310152|NCT02129023|Exergame|exergame
5310153|NCT02129023|user health|user health
5310154|NCT02129023|exercise|exercise
5310155|NCT02129010|subarachnoid hemorrhage|subarachnoid hemorrhage
5310156|NCT02129010|terson syndrome|terson syndrome
5310157|NCT02129010|CSF-proteines|csf-proteines
5310158|NCT02129010|phospho-tau|phospho-tau
5310159|NCT02129010|beta-amyloid|beta-amyloid
5310160|NCT02128997|obesity, cesarean section, wound complication|obesity, cesarean section, wound complication
5310161|NCT02128984|Malnutrition|malnutrition
5310162|NCT02128984|Dietary supplement|dietary supplement
5310163|NCT02128984|Nutritional supplement|nutritional supplement
5310164|NCT02128984|Symbiotic formula|symbiotic formula
5310165|NCT02128984|DHA|dha
5310166|NCT02128984|Cystic Fibrosis|cystic fibrosis
5310167|NCT02128984|Failure to Thrive|failure to thrive
5310168|NCT02128971|Iron supplement study|iron supplement study
5310169|NCT02128958|Hepatocellular Carcinoma|hepatocellular carcinoma
5310170|NCT02128958|Child-Pugh Class B Cirrhosis|child-pugh class b cirrhosis
5310171|NCT02128945|PET|pet
5310172|NCT02128945|Chronic lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5310173|NCT02128945|Diffuse Large B Cells Lymphoma (DLBCL)|diffuse large b cells lymphoma (dlbcl)
5310174|NCT02128945|Fludarabine|fludarabine
5310175|NCT02128919|Schizophrenia|schizophrenia
5310176|NCT02128919|Cigarette smoking|cigarette smoking
5310177|NCT02128919|Cognition|cognition
5310178|NCT02128919|Craving|craving
5310179|NCT02128919|MATRICS|matrics
5310180|NCT02128906|ERCC1|ercc1
5310181|NCT02128906|squamous cell carcinoma|squamous cell carcinoma
5310182|NCT02128906|oropharynx|oropharynx
5310183|NCT02128906|larynx|larynx
5310185|NCT02128906|p16|p16
5310186|NCT02128906|radiotherapy|radiotherapy
5310187|NCT02128906|docetaxel|docetaxel
5310188|NCT02128906|cetuximab|cetuximab
5310189|NCT02128906|cisplatin|cisplatin
5310190|NCT02128906|EGFR|egfr
5310191|NCT02128906|Biomarker|biomarker
5310192|NCT02128906|efficacy|efficacy
5310193|NCT02128906|head and neck|head and neck
5310194|NCT02128906|tongue|tongue
5310195|NCT02128906|throat|throat
5310196|NCT02128893|Isavuconazole|isavuconazole
5310197|NCT02128893|Esomeprazole|esomeprazole
5310198|NCT02128893|BAL4815|bal4815
5310199|NCT02128893|BAL8728|bal8728
5310200|NCT02128893|Healthy Subjects|healthy subjects
5310201|NCT02128880|AEP, drinking, contraception, FASD, Internet interventions|aep, drinking, contraception, fasd, internet interventions
5310202|NCT02128867|gastro-esophageal reflux|gastro-esophageal reflux
5310203|NCT02128867|GOR|gor
5310204|NCT02128867|GER|ger
5310205|NCT02128867|airway clearance techniques|airway clearance techniques
5310206|NCT02128854|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5310207|NCT02128854|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5205287|NCT02712034|Methadone|methadone
5310208|NCT02128854|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5310209|NCT02128854|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
5369162|NCT01861002|Relapse|relapse
5310210|NCT02128854|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5310211|NCT02128854|African Americans|african americans
5310212|NCT02128854|Blacks|blacks
5310213|NCT02128854|Non-Hispanic Blacks|non-hispanic blacks
5310214|NCT02128854|Randomized Control Trial|randomized control trial
5310215|NCT02128854|Controlled Clinical Trial|controlled clinical trial
5310216|NCT02128854|Behavioral Research|behavioral research
5310217|NCT02128854|Behavioral Medicine|behavioral medicine
5310218|NCT02128841|rivaroxaban|rivaroxaban
5306786|NCT02144363|RDS|rds
5310221|NCT02128841|Factor Xa/antagonists & inhibitors|factor xa/antagonists & inhibitors
5310222|NCT02128828|AIDS Dementia Complex|aids dementia complex
5674503|NCT00603330|Poor graft function|poor graft function
5310223|NCT02128828|HIV-1-Associated Cognitive Motor Complex|hiv-1-associated cognitive motor complex
5310224|NCT02128828|Human Immunodeficiency Virus|human immunodeficiency virus
5310225|NCT02128815|adults|adults
5310226|NCT02128815|coaching|coaching
5310227|NCT02128815|type 2 diabetes|type 2 diabetes
5310228|NCT02128802|Obesity|obesity
5310229|NCT02128802|Renal failure|renal failure
5310230|NCT02128802|Gastric bypass|gastric bypass
5310231|NCT02128789|Older Adults|older adults
5310232|NCT02128789|Caregivers|caregivers
5310233|NCT02128789|Aging|aging
5310234|NCT02128789|Support|support
5310235|NCT02128776|Children|children
5310236|NCT02128776|Chronic illnesses|chronic illnesses
5310237|NCT02128724|Lung cancer|lung cancer
5310238|NCT02128724|BKM120|bkm120
5310239|NCT02128724|Hypoxia|hypoxia
5310240|NCT02128724|Misonidazole|misonidazole
5310241|NCT02128724|Radiotherapy|radiotherapy
5310242|NCT02128724|Buparlisib|buparlisib
5310243|NCT02128711|lung|lung
5310244|NCT02128711|cystic fibrosis|cystic fibrosis
5310245|NCT02128711|bacteria|bacteria
5310246|NCT02128711|positive diagnosis of CF,|positive diagnosis of cf,
5310247|NCT02128698|Bariatric surgery|bariatric surgery
5310248|NCT02128698|Protein supplementation|protein supplementation
5310249|NCT02128698|Physical activity|physical activity
5310250|NCT02128698|Muscle mass|muscle mass
5310251|NCT02128698|Weight loss|weight loss
5310252|NCT02128698|Physical fitness|physical fitness
5310253|NCT02128698|Muscle strength|muscle strength
5310254|NCT02128685|Threatened miscarriage|threatened miscarriage
5310255|NCT02128685|Dydrogesterone|dydrogesterone
5310256|NCT02128685|Randomized controlled trial|randomized controlled trial
5310257|NCT02128646|Pain Management|pain management
5310258|NCT02128646|Exparel|exparel
5310259|NCT02128646|Abdominal Hernia Repair|abdominal hernia repair
5310260|NCT02128646|Laparoscopic Surgery|laparoscopic surgery
5310261|NCT02128633|Dentin hypersensitivity|dentin hypersensitivity
5310262|NCT02128633|Dentin Sensitivities|dentin sensitivities
5310263|NCT02128620|Sexually transmitted diseases|sexually transmitted diseases
5310264|NCT02128620|Internet|internet
5310265|NCT02128620|Education|education
5310266|NCT02128620|Appointments and Schedules|appointments and schedules
5310267|NCT02128607|low back pain|low back pain
5310268|NCT02128607|manual therapy|manual therapy
5310269|NCT02128607|Mulligan|mulligan
5310270|NCT02128607|sustained natural apophyseal glide (SNAG)|sustained natural apophyseal glide (snag)
5310271|NCT02128607|Kinematic spine model|kinematic spine model
5310272|NCT02128568|Depression/therapy;|depression/therapy;
5310273|NCT02128568|Developing Countries;|developing countries;
5310274|NCT02128568|Interpersonal Relations;|interpersonal relations;
5310275|NCT02128568|Life Change Events;|life change events;
5310276|NCT02128568|Psychotherapy, Group;|psychotherapy, group;
5310277|NCT02128568|Resilience, Psychological;|resilience, psychological;
5310278|NCT02128568|Sierra Leone;|sierra leone;
5310279|NCT02128568|Survivors/psychology;|survivors/psychology;
5310280|NCT02128568|Social Adjustment;|social adjustment;
5310281|NCT02128568|Social Behavior;|social behavior;
5310283|NCT02128555|ankle arthritis|ankle arthritis
5310284|NCT02128555|osteoarthritis|osteoarthritis
5212233|NCT02668055|TB4|tb4
5310285|NCT02128555|total ankle replacement|total ankle replacement
5310286|NCT02128555|arthrodesis|arthrodesis
5310287|NCT02128555|quality of life|quality of life
5310288|NCT02128555|musculoskeletal|musculoskeletal
5310289|NCT02128542|Veterans HCV|veterans hcv
5310290|NCT02128529|COPD|copd
5310291|NCT02128490|Drug therapy|drug therapy
5310292|NCT02128477|Myocardial infarction|myocardial infarction
5310293|NCT02128477|Repolarization instability|repolarization instability
5310294|NCT02128477|Ventricular fibrillation|ventricular fibrillation
5310295|NCT02128464|Knee Osteoarthritis|knee osteoarthritis
5310296|NCT02128464|Total Knee Arthroplasty|total knee arthroplasty
5310297|NCT02128464|Customized Cutting Block|customized cutting block
5310298|NCT02128464|Conventional Intramedullary Cutting Guide|conventional intramedullary cutting guide
5310299|NCT02128451|meperdine ,fentanyl, clonidine, orthopedic surgery .|meperdine ,fentanyl, clonidine, orthopedic surgery .
5310300|NCT02128425|Colorectal cancer|colorectal cancer
5310301|NCT02128425|Metastatic colorectal cancer|metastatic colorectal cancer
5310302|NCT02128425|FOLFOXIRI|folfoxiri
5310303|NCT02128425|FOLFOX|folfox
5310304|NCT02128425|Oxaliplatin|oxaliplatin
5310305|NCT02128425|irinotecan|irinotecan
5310306|NCT02128425|Leucovorin|leucovorin
5310307|NCT02128425|5-FU|5-fu
5191163|NCT02797015|MS|ms
5310431|NCT02127879|Intensive|intensive
5310554|NCT02127255|vomiting|vomiting
5310308|NCT02128412|Patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses|patients scheduled to undergo coronary angioplasty and stenting because of symptoms related to a single de novo coronary artery stenoses
5310311|NCT02128360|Poor responder|poor responder
5310313|NCT02128347|Hemodialysis, Home|hemodialysis, home
5310314|NCT02128347|Peritoneal Dialysis|peritoneal dialysis
5310315|NCT02128347|Telemedicine|telemedicine
5310316|NCT02128334|Uro-Oncologists|uro-oncologists
5310317|NCT02128334|PSA|psa
5310318|NCT02128334|Eligard|eligard
5310319|NCT02128334|prostate carcinoma|prostate carcinoma
5310320|NCT02128321|Isavuconazole|isavuconazole
5310321|NCT02128321|Repaglinide|repaglinide
5310322|NCT02128321|Caffeine|caffeine
5310323|NCT02128321|BAL4815|bal4815
5310324|NCT02128321|BAL8728|bal8728
5310325|NCT02128321|Healthy Subjects|healthy subjects
5314751|NCT02108951|CML|cml
5310326|NCT02128308|Antituberculosis agents|antituberculosis agents
5310327|NCT02128308|Pharmacokinetics|pharmacokinetics
5310328|NCT02128295|Breast pumps, breast milk, expression, term infants|breast pumps, breast milk, expression, term infants
5310332|NCT02128269|Antiphospholipid (aPL)-positive|antiphospholipid (apl)-positive
5310333|NCT02128269|Antiphospholid syndrome (APS)|antiphospholid syndrome (aps)
5310334|NCT02128256|Osteomyelitis|osteomyelitis
5310335|NCT02128256|Bone substitute|bone substitute
5310336|NCT02128256|Ceramic|ceramic
5310337|NCT02128256|Gentamicin|gentamicin
5310338|NCT02128230|High risk|high risk
5310339|NCT02128230|Carfilzomib|carfilzomib
5310340|NCT02128191|Patent ductus arteriosus|patent ductus arteriosus
5310341|NCT02128191|Ibuprofen|ibuprofen
5310342|NCT02128191|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5310343|NCT02128178|Morbid obesity|morbid obesity
5310344|NCT02128178|Laparoscopic surgery|laparoscopic surgery
5310345|NCT02128178|Compression ultrasonography|compression ultrasonography
5310346|NCT02128178|Pulmonary embolism|pulmonary embolism
5310347|NCT02128178|Bleeding|bleeding
5310348|NCT02128165|gastric balloon|gastric balloon
5310349|NCT02128165|morbid obesity|morbid obesity
5310350|NCT02128152|stroke|stroke
5310351|NCT02128152|exoskeleton|exoskeleton
5310352|NCT02128152|Ekso|ekso
5310353|NCT02128152|ambulation|ambulation
5310354|NCT02128152|robotics|robotics
5310355|NCT02128139|Infective endocarditis|infective endocarditis
5310356|NCT02128139|Developing country|developing country
5310357|NCT02128139|Global health|global health
5310358|NCT02128139|Cardiac surgery|cardiac surgery
5310359|NCT02128139|Heart valve disease|heart valve disease
5310360|NCT02128139|Bacteremia|bacteremia
5310361|NCT02128126|Advanced or recurrent cervical cancer|advanced or recurrent cervical cancer
5310362|NCT02128126|HPV16 positive|hpv16 positive
5310363|NCT02128126|No curative treatment options|no curative treatment options
5310364|NCT02128113|RTA 408|rta 408
5310365|NCT02128113|Cataract surgery|cataract surgery
5310366|NCT02128113|Corneal Endothelial Cells|corneal endothelial cells
5310367|NCT02128113|omaveloxolone|omaveloxolone
5310368|NCT02128100|Pancreatic Cancer|pancreatic cancer
5310370|NCT02128087|Antiretroviral (ARV)|antiretroviral (arv)
5310371|NCT02128087|co-trimoxazole|co-trimoxazole
5310372|NCT02128087|SMS|sms
5310373|NCT02128087|mobile Health (mHealth)|mobile health (mhealth)
5310374|NCT02128087|Adolescents|adolescents
5310375|NCT02128087|Uganda|uganda
5310376|NCT02128087|Adherence|adherence
5310377|NCT02128035|radiation protection|radiation protection
5310378|NCT02128035|interventional cardiologist|interventional cardiologist
5310379|NCT02128035|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5310380|NCT02128035|angiography|angiography
5310381|NCT02128035|lead shield|lead shield
5310382|NCT02128022|Glucagon-Like Peptide 1|glucagon-like peptide 1
5310383|NCT02128022|Angina Pectoris|angina pectoris
5205497|NCT02710643|Follicular|follicular
5310384|NCT02128022|Percutaneous Coronary Intervention|percutaneous coronary intervention
5310385|NCT02128022|Ischemic Preconditioning|ischemic preconditioning
5310386|NCT02128022|Myocardial Reperfusion Injury|myocardial reperfusion injury
5310387|NCT02127996|Angina Pectoris|angina pectoris
5310388|NCT02127996|Percutaneous Coronary Intervention|percutaneous coronary intervention
5310389|NCT02127996|Myocardial Infarction|myocardial infarction
5310390|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1
5310391|NCT02127996|Reperfusion Injury|reperfusion injury
5310392|NCT02127983|TB, HIV, case finding, access, informal providers|tb, hiv, case finding, access, informal providers
5310393|NCT02127957|cystic fibrosis|cystic fibrosis
5310394|NCT02127957|exercise|exercise
5310395|NCT02127957|Cystic fibrosis related diabetes|cystic fibrosis related diabetes
5310396|NCT02127918|Electrical status epilepticus in sleep|electrical status epilepticus in sleep
5310397|NCT02127918|Continuous spikes and waves during sleep|continuous spikes and waves during sleep
5310398|NCT02127918|Children|children
5310399|NCT02127918|Electroencephalogram|electroencephalogram
5310400|NCT02127918|Neuropsychology|neuropsychology
5310401|NCT02127918|Development|development
5310501|NCT02127515|invasive|invasive
5310405|NCT02127905|Fanconi Anemia|fanconi anemia
5963127|NCT04272099|Emigrants and Immigrants|emigrants and immigrants
5310406|NCT02127905|compassionate treatment|compassionate treatment
5310408|NCT02127905|HSCT|hsct
5310409|NCT02127905|unrelated|unrelated
5310410|NCT02127905|bone marrow transplantation|bone marrow transplantation
5310411|NCT02127905|PBSC|pbsc
5310412|NCT02127905|peripheral blood|peripheral blood
5310413|NCT02127905|CD34+|cd34+
5310414|NCT02127892|Severe Combined Immune Deficiency|severe combined immune deficiency
5310415|NCT02127892|SCID|scid
5310416|NCT02127892|HLA-matched unrelated donor|hla-matched unrelated donor
5310417|NCT02127892|unrelated|unrelated
5310419|NCT02127892|bone marrow|bone marrow
5310420|NCT02127892|cord blood|cord blood
5310421|NCT02127892|haplo-identical|haplo-identical
5310422|NCT02127892|peripheral blood|peripheral blood
5310423|NCT02127892|CD34+ selection|cd34+ selection
5310424|NCT02127892|T cell depletion|t cell depletion
5310425|NCT02127892|HSCT|hsct
5310426|NCT02127892|BMT|bmt
5310427|NCT02127892|CliniMACS|clinimacs
5310428|NCT02127879|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5310432|NCT02127879|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5310433|NCT02127866|Asthma, anticholinergics|asthma, anticholinergics
5310435|NCT02127853|hyperalgesia|hyperalgesia
5310436|NCT02127853|gabapentin|gabapentin
5310437|NCT02127853|central sensitization|central sensitization
5310438|NCT02127840|primary aldosteronism|primary aldosteronism
5310439|NCT02127840|adrenal adenoma|adrenal adenoma
5310440|NCT02127840|arterial hypertension|arterial hypertension
5310441|NCT02127814|induced diarrhea|induced diarrhea
5310442|NCT02127814|Clostridium difficile toxicity|clostridium difficile toxicity
5310443|NCT02127788|Haematology|haematology
5310444|NCT02127788|Micafungin|micafungin
5310445|NCT02127788|Observational study|observational study
5310446|NCT02127788|Prophylaxis|prophylaxis
5310447|NCT02127788|Invasive Fungal Infection|invasive fungal infection
5310448|NCT02127788|France|france
5310449|NCT02127762|Pain|pain
5310450|NCT02127762|Quality of Life|quality of life
5310451|NCT02127762|Glycemic Control|glycemic control
5310452|NCT02127762|diabetic neuropathy|diabetic neuropathy
5310453|NCT02127762|mindfulness|mindfulness
5310454|NCT02127762|stress reduction|stress reduction
5310455|NCT02127762|adult|adult
5310456|NCT02127762|chronic pain|chronic pain
5310457|NCT02127762|depression|depression
5310458|NCT02127762|cortisol|cortisol
5310459|NCT02127749|antibiotics|antibiotics
5310460|NCT02127749|gut microbiota|gut microbiota
5310461|NCT02127749|endotoxemia|endotoxemia
5310462|NCT02127749|innate immunity|innate immunity
5310463|NCT02127723|cellulite|cellulite
5310467|NCT02127697|Asthma, poorly controlled asthma, LAMA, Long-Acting Muscarinic Antagonist, Glycopyrronium, Glycopyrronium bromide, Anticholinergic|asthma, poorly controlled asthma, lama, long-acting muscarinic antagonist, glycopyrronium, glycopyrronium bromide, anticholinergic
5310468|NCT02127684|diabetic macular edema|diabetic macular edema
5310469|NCT02127645|RADIOTHERAPY|radiotherapy
5310470|NCT02127645|TRANSANAL ENDOSCOPIC MICROSURGERY|transanal endoscopic microsurgery
5310471|NCT02127645|LOCAL EXCISION|local excision
5310472|NCT02127632|laryngeal mask Supreme|laryngeal mask supreme
5310473|NCT02127632|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5310474|NCT02127632|Laryngeal mask during surgery|laryngeal mask during surgery
5310475|NCT02127619|knee prosthesis|knee prosthesis
5310476|NCT02127619|total knee replacement|total knee replacement
5310477|NCT02127619|total knee arthroplasty|total knee arthroplasty
5310478|NCT02127619|prospective study|prospective study
5310479|NCT02127619|Therapeutic level IV|therapeutic level iv
5310480|NCT02127593|Norgestimate|norgestimate
5310481|NCT02127593|Ethinyl estradiol|ethinyl estradiol
5310482|NCT02127593|Norgestrel|norgestrel
5310483|NCT02127593|Norelgestromin|norelgestromin
5310484|NCT02127593|Ortho cyclen|ortho cyclen
5310485|NCT02127593|Phase 1|phase 1
5310486|NCT02127593|Healthy Women|healthy women
5310487|NCT02127580|THV|thv
5310488|NCT02127580|BAV|bav
5310489|NCT02127580|pre-dilation|pre-dilation
5310490|NCT02127580|Aortic valve stenosis|aortic valve stenosis
5310491|NCT02127567|medical writing, reporting, randomized controlled trial|medical writing, reporting, randomized controlled trial
5310492|NCT02127541|Localisation of Insulinoma|localisation of insulinoma
5310493|NCT02127541|beta-cell imaging|beta-cell imaging
5310494|NCT02127541|exendin-4|exendin-4
5310495|NCT02127541|68Ga-DOTA-exendin-4 PET/CT|68ga-dota-exendin-4 pet/ct
5310496|NCT02127541|111In-DOTA-exendin-4 SPECT/CT|111in-dota-exendin-4 spect/ct
5310497|NCT02127515|Down, trisomy 21|down, trisomy 21
5310498|NCT02127515|NIPT|nipt
5310499|NCT02127515|Amniocentesis|amniocentesis
5310500|NCT02127515|miscarriage|miscarriage
5310502|NCT02127515|prenatal|prenatal
5310503|NCT02127515|screening.|screening.
5310504|NCT02127489|Bupivacaine, caudal, rectal midazolam, children|bupivacaine, caudal, rectal midazolam, children
5310505|NCT02127463|AMD|amd
5310506|NCT02127463|Dry AMD|dry amd
5310507|NCT02127463|Non-Exudative AMD|non-exudative amd
5310508|NCT02127463|MC-1101|mc-1101
5310509|NCT02127450|Enterobacteriaceae|enterobacteriaceae
5310510|NCT02127450|non-susceptible to carbapenem|non-susceptible to carbapenem
5310511|NCT02127450|carbapenemases|carbapenemases
5310512|NCT02127450|prevalence|prevalence
5310513|NCT02127450|screening algorithm|screening algorithm
5310514|NCT02127437|Autosomal dominant polycystic kidney disease,|autosomal dominant polycystic kidney disease,
5310515|NCT02127437|Glomerular filtration rate,|glomerular filtration rate,
5310516|NCT02127437|Somatostatin,|somatostatin,
5310517|NCT02127437|lanreotide|lanreotide
5310518|NCT02127424|Nurse|nurse
5310519|NCT02127424|Nursing|nursing
5310520|NCT02127424|Screening|screening
5310521|NCT02127424|HIV|hiv
5310522|NCT02127424|Emergency Service Hospital|emergency service hospital
5310524|NCT02127411|Benzodiazepines|benzodiazepines
5310525|NCT02127411|Sleep|sleep
5310526|NCT02127411|Dependence|dependence
5310527|NCT02127411|Relapse Prevention|relapse prevention
5310528|NCT02127398|C. difficile colitis|c. difficile colitis
5310529|NCT02127398|fecal microbiota transplantation|fecal microbiota transplantation
5310530|NCT02127372|non-small cell|non-small cell
5310531|NCT02127372|lung cancer|lung cancer
5310532|NCT02127359|Metastatic|metastatic
5310533|NCT02127346|Chronic Periodontitis|chronic periodontitis
5310534|NCT02127346|Vitamin D concentration|vitamin d concentration
5310535|NCT02127346|Calcium concentration|calcium concentration
5310536|NCT02127333|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5310537|NCT02127333|Coronary artery disease|coronary artery disease
5310538|NCT02127333|Endothelial function|endothelial function
5310539|NCT02127307|Myocardial sympathetic innervation|myocardial sympathetic innervation
5310540|NCT02127307|Heart failure (HF)|heart failure (hf)
5310541|NCT02127307|Nuclear imaging|nuclear imaging
5310542|NCT02127307|Radiopharmaceutical|radiopharmaceutical
5310543|NCT02127294|Foramen Ovale, Patent|foramen ovale, patent
5310544|NCT02127294|migraine|migraine
5310545|NCT02127294|transcatheter patent foramen ovale closure|transcatheter patent foramen ovale closure
5310546|NCT02127294|contrast-enhanced transcranial Doppler|contrast-enhanced transcranial doppler
5310547|NCT02127294|Transthoracic Echocardiography|transthoracic echocardiography
5310548|NCT02127281|Revision total knee arthroplasty|revision total knee arthroplasty
5310549|NCT02127281|Revision total hip arthroplasty|revision total hip arthroplasty
5310550|NCT02127281|Negative pressure wound therapy system (NPWT)|negative pressure wound therapy system (npwt)
5310551|NCT02127281|Drainage|drainage
5310552|NCT02127255|chemotherapy|chemotherapy
5310553|NCT02127255|nausea|nausea
5310555|NCT02127255|cancer|cancer
5310556|NCT02127242|hepatolithiasis|hepatolithiasis
5310557|NCT02127242|ureteroscope|ureteroscope
5310558|NCT02127242|air-pressure ballistic lithotripsy|air-pressure ballistic lithotripsy
5310559|NCT02127242|hepatectomy|hepatectomy
5310560|NCT02127229|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5310561|NCT02127229|disposable accessory cost|disposable accessory cost
5310562|NCT02127229|endoscopy cost analysis|endoscopy cost analysis
5310563|NCT02127216|Mobile Health|mobile health
5310564|NCT02127216|Diabetes|diabetes
5310565|NCT02127216|Self-Care of Diabetes|self-care of diabetes
5310566|NCT02127203|oxidative stress|oxidative stress
5310567|NCT02127203|periodontal disease|periodontal disease
5310568|NCT02127203|nitric oxide|nitric oxide
5310569|NCT02127190|nitro-fatty acids|nitro-fatty acids
5310570|NCT02127190|anti-inflammatory|anti-inflammatory
5310571|NCT02127190|Nrf2 activation|nrf2 activation
5310572|NCT02127190|contrast induced AKI|contrast induced aki
5310573|NCT02127177|obstructive sleep apnea|obstructive sleep apnea
5310574|NCT02127177|coronary heart disease|coronary heart disease
5310575|NCT02127177|continuous positive airway pressure|continuous positive airway pressure
5310576|NCT02127177|lipid profiles|lipid profiles
5310577|NCT02127177|high-sensitivity C-reactive protein|high-sensitivity c-reactive protein
5310578|NCT02127138|unprotected distal left main bifurcation lesion|unprotected distal left main bifurcation lesion
5310579|NCT02127138|Percutaneous coronary intervention|percutaneous coronary intervention
5310580|NCT02127138|clinical study|clinical study
5310581|NCT02127138|Active Transfer of Plaque （ATP）|active transfer of plaque （atp）
5310582|NCT02127138|Provisional T Stenting|provisional t stenting
5310583|NCT02127112|Ridge Augmentation|ridge augmentation
5310584|NCT02127112|Bone regeneration|bone regeneration
5310585|NCT02127112|Guided Bone Regeneration|guided bone regeneration
5310586|NCT02127112|Partially Edentulous|partially edentulous
5310587|NCT02127099|OSA|osa
5310588|NCT02127099|obstructive|obstructive
5310589|NCT02127099|sleep|sleep
5310590|NCT02127099|apnea|apnea
5310591|NCT02127099|operation|operation
5310592|NCT02127086|Acute pain severity|acute pain severity
5310593|NCT02127086|Non-communicative patients|non-communicative patients
5310594|NCT02127086|PAIN algorithm|pain algorithm
5310595|NCT02127086|Multi-dimensional Pain Assessment Tool (MOPAT)|multi-dimensional pain assessment tool (mopat)
5310596|NCT02127073|Breast cancer|breast cancer
5310597|NCT02127073|Ductal carcinoma in situ (DCIS)|ductal carcinoma in situ (dcis)
5310598|NCT02127073|Oxytocin|oxytocin
5310599|NCT02127060|vitamin C|vitamin c
5310600|NCT02127060|effectiveness|effectiveness
5310601|NCT02127060|pain management|pain management
5310602|NCT02127060|posterior lumbar interbody fusion|posterior lumbar interbody fusion
5310603|NCT02127034|Healthy subjects|healthy subjects
5310604|NCT02127034|Mirabegron|mirabegron
5310605|NCT02127034|Solifenacin|solifenacin
5310607|NCT02127021|Pancreaticoduodenectomy|pancreaticoduodenectomy
5310608|NCT02127021|Nutritional Status|nutritional status
5310609|NCT02127021|Quality of Life|quality of life
5310610|NCT02127021|Biochemical Marker|biochemical marker
5310611|NCT02127008|epidural fat|epidural fat
5310612|NCT02127008|resection|resection
5310613|NCT02127008|spinal stenosis|spinal stenosis
5310614|NCT02127008|lumbar spine|lumbar spine
5310615|NCT02126995|Fragile X Syndrome, Fra(X) Syndrome, FRAXA Syndrome|fragile x syndrome, fra(x) syndrome, fraxa syndrome
5310617|NCT02126982|clopidogrel hydrogen sulfate|clopidogrel hydrogen sulfate
5310618|NCT02126982|Generic clopidogrel|generic clopidogrel
5310619|NCT02126982|Coronary Artery Disease|coronary artery disease
5310620|NCT02126969|Cancer|cancer
5310621|NCT02126969|Low dose radiation|low dose radiation
5310622|NCT02126956|ACT-128800|act-128800
5310623|NCT02126943|PAH|pah
5310624|NCT02126943|pulmonary arterial hypertension|pulmonary arterial hypertension
5310625|NCT02126930|anti-infectious treatment|anti-infectious treatment
5310626|NCT02126930|observance|observance
5310627|NCT02126930|pharmaceutical consultation|pharmaceutical consultation
5310628|NCT02126917|Phase 1|phase 1
5310629|NCT02126917|Alcohol|alcohol
5310630|NCT02126917|Hydrocodone Bitartrate|hydrocodone bitartrate
5310631|NCT02126917|Pharmacokinetics|pharmacokinetics
5310632|NCT02126891|Cardiac functions|cardiac functions
5310633|NCT02126891|Endurance training|endurance training
5310634|NCT02126891|Senior athletes|senior athletes
5310635|NCT02126852|residual paralysis,neuromuscular blockade,acceleromyography,electromyography|residual paralysis,neuromuscular blockade,acceleromyography,electromyography
5310636|NCT02126813|Postoperative urinary retention|postoperative urinary retention
5310637|NCT02126813|Fast-track total hip (THA) and knee arthroplasty (TKA)|fast-track total hip (tha) and knee arthroplasty (tka)
5310638|NCT02126813|Urinary bladder volume|urinary bladder volume
5310639|NCT02126800|breast cancer|breast cancer
5310640|NCT02126787|Anxiety disorders|anxiety disorders
5310641|NCT02126787|Depressive disorders|depressive disorders
5310642|NCT02126787|Personality disorders|personality disorders
5310643|NCT02126787|Psychodynamic psychotherapy|psychodynamic psychotherapy
5310644|NCT02126787|Cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
5310645|NCT02126787|Group psychotherapy|group psychotherapy
5310646|NCT02126787|Day treatment|day treatment
5310647|NCT02126774|epilepsy|epilepsy
5310648|NCT02126774|focal epilepsy|focal epilepsy
5310649|NCT02126761|Influenza|influenza
5310650|NCT02126761|elderly|elderly
5310651|NCT02126761|adjuvant|adjuvant
5310652|NCT02126748|bronchiolitis|bronchiolitis
5310653|NCT02126748|Wang score|wang score
5310654|NCT02126748|Sa02|sa02
5310655|NCT02126748|airway clearance techniques|airway clearance techniques
5310656|NCT02126748|intrapulmonary percussive ventilation|intrapulmonary percussive ventilation
5205783|NCT02708797|VBM|vbm
5310657|NCT02126748|assisted autogenic drainage|assisted autogenic drainage
5310658|NCT02126722|Helicobacter pylori|helicobacter pylori
5310659|NCT02126722|Gastritis|gastritis
5310660|NCT02126709|Povidone Iodine|povidone iodine
5310661|NCT02126709|Safety|safety
5310662|NCT02126709|Efficacy|efficacy
5310663|NCT02126709|Acne treatment|acne treatment
5310664|NCT02126696|Anti-retroviral Therapy|anti-retroviral therapy
5310665|NCT02126696|Lesotho|lesotho
5310666|NCT02126696|Southern Africa|southern africa
5310667|NCT02126696|Comorbidity|comorbidity
5310668|NCT02126696|Virologic failure|virologic failure
5310669|NCT02126683|Hashimoto's thyroiditis|hashimoto's thyroiditis
5310670|NCT02126683|Plaquenil|plaquenil
5310671|NCT02126657|Acne scars|acne scars
5310672|NCT02126657|70% Glycolic acid peel|70% glycolic acid peel
5310673|NCT02126644|Photoaging|photoaging
5310674|NCT02126644|70% glycolic acid peel|70% glycolic acid peel
5310675|NCT02126618|Lower urinary tract symptoms|lower urinary tract symptoms
5310676|NCT02126618|urodynamic studies|urodynamic studies
5310677|NCT02126618|diuresis|diuresis
5310678|NCT02126605|diabetes alert dogs|diabetes alert dogs
5310679|NCT02126605|hypoglycemia|hypoglycemia
5310680|NCT02126579|melanoma|melanoma
5310681|NCT02126579|neoplasms|neoplasms
5310682|NCT02126579|Poly ICLC|poly iclc
5310683|NCT02126579|Freund's Adjuvant|freund's adjuvant
5310684|NCT02126579|Metastatic melanoma|metastatic melanoma
5310685|NCT02126579|resiquimod|resiquimod
5310686|NCT02126579|adjuvants|adjuvants
5310687|NCT02126579|peptide vaccine|peptide vaccine
5310688|NCT02126566|striae distensiae|striae distensiae
5310689|NCT02126540|Peripheral Arterial Disease|peripheral arterial disease
5310690|NCT02126540|Atherectomy|atherectomy
5310691|NCT02126540|Optical Coherence Tomography|optical coherence tomography
5310692|NCT02126514|Beta secretase inhibitor|beta secretase inhibitor
5310693|NCT02126514|Alzheimer disease|alzheimer disease
5310694|NCT02126501|weaning|weaning
5310695|NCT02126501|NCPAP|ncpap
5310696|NCT02126501|Preterm|preterm
5310697|NCT02126501|sudden wean|sudden wean
5310698|NCT02126501|gradual pressure off wean|gradual pressure off wean
5310699|NCT02126488|treadmill training|treadmill training
5310700|NCT02126488|generalization|generalization
5310701|NCT02126488|retention|retention
5310702|NCT02126475|"parkinson patients ON"|"parkinson patients on"
5963128|NCT04272099|Canada|canada
5310703|NCT02126475|"parkinson patients OFF"|"parkinson patients off"
5310704|NCT02126475|time estimation|time estimation
5310705|NCT02126475|anticipation|anticipation
5310706|NCT02126462|Human Hookworm|human hookworm
5310707|NCT02126462|Necator americanus|necator americanus
5310708|NCT02126462|Hookworm|hookworm
5297710|NCT02189161|RFA|rfa
5310709|NCT02126462|Hookworm Disease|hookworm disease
5310710|NCT02126462|Iron-deficiency anemia|iron-deficiency anemia
5310711|NCT02126462|Soil-transmitted helminth infection|soil-transmitted helminth infection
5310731|NCT02126384|B-lymphocytes subsets|b-lymphocytes subsets
5310732|NCT02126384|Antibody-Producing Cells|antibody-producing cells
5310733|NCT02126384|23 valent pneumococcal capsular polysaccharide vaccine|23 valent pneumococcal capsular polysaccharide vaccine
5310734|NCT02126332|Severe acute pancreatitis|severe acute pancreatitis
5310735|NCT02126332|Epidural analgesia|epidural analgesia
5310736|NCT02126332|Acute respiratory failure|acute respiratory failure
5310737|NCT02126332|Mechanical ventilation|mechanical ventilation
5310738|NCT02126332|Intensive Care Unit (ICU)|intensive care unit (icu)
5310739|NCT02126319|Cognitive-affective preparation|cognitive-affective preparation
5310740|NCT02126319|prostate cancer counseling|prostate cancer counseling
5310741|NCT02126280|proinflammatory cytokines|proinflammatory cytokines
5310742|NCT02126280|anti-inflammatory cytokines|anti-inflammatory cytokines
5310743|NCT02126280|human monocytes|human monocytes
5310744|NCT02126280|activation|activation
5310745|NCT02126280|biomarkers|biomarkers
5310746|NCT02126280|asymptomatic atherosclerosis|asymptomatic atherosclerosis
5310747|NCT02126267|periodontal disease|periodontal disease
5310748|NCT02126267|therapy|therapy
5310749|NCT02126267|anti-bacterial agents|anti-bacterial agents
5310750|NCT02126267|Randomized Controlled Trials|randomized controlled trials
5310751|NCT02126241|Heart Failure|heart failure
5310752|NCT02126241|Cardiac Resyncronization Therapy|cardiac resyncronization therapy
5310753|NCT02126241|Optimization|optimization
5310754|NCT02126241|Non-invasive cardiac system|non-invasive cardiac system
5310755|NCT02126241|Impedance measured cardiac output|impedance measured cardiac output
5310756|NCT02126228|antibiotics, cesarean|antibiotics, cesarean
5310757|NCT02126215|magnetic resonance imaging|magnetic resonance imaging
5310758|NCT02126215|carbon dioxide|carbon dioxide
5310759|NCT02126215|abdominal aortic aneurysm|abdominal aortic aneurysm
5310760|NCT02126215|post-op delirium|post-op delirium
5310761|NCT02126202|Elderly|elderly
5310762|NCT02126202|Octogenarians|octogenarians
5310764|NCT02126202|Myocardial infarction|myocardial infarction
5310765|NCT02126202|NSTEMI|nstemi
5310766|NCT02126202|Unstable angina pectoris|unstable angina pectoris
5310767|NCT02126189|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5310768|NCT02126189|Human Papillomavirus|human papillomavirus
5310769|NCT02126189|Aetiology|aetiology
5310770|NCT02126189|prevalence|prevalence
5310771|NCT02126189|risk factors|risk factors
5310772|NCT02126189|clinical outcome|clinical outcome
5310773|NCT02126163|Excessive Drinking|excessive drinking
5310774|NCT02126163|Hazardous Drinking|hazardous drinking
5310775|NCT02126137|HCV|hcv
5310776|NCT02126137|Ezetimibe|ezetimibe
5310777|NCT02126137|Cholesterol|cholesterol
5310778|NCT02126137|Host|host
5310779|NCT02126124|Brainsway, dTMS, Deep Transcranial Magnetic Stimulation, Smoking Cessation|brainsway, dtms, deep transcranial magnetic stimulation, smoking cessation
5310780|NCT02126098|ANCA-associated vasculitis|anca-associated vasculitis
5310781|NCT02126098|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5310782|NCT02126098|Microscopic polyangiitis|microscopic polyangiitis
5310783|NCT02126098|Wegner's granulomatosis|wegner's granulomatosis
5307412|NCT02141490|Metastatic Nodes|metastatic nodes
5310784|NCT02126098|Eosinphilic granulomatosis with polyangiitis|eosinphilic granulomatosis with polyangiitis
5310785|NCT02126085|ischemic stroke|ischemic stroke
5310888|NCT02125565|Arterial|arterial
5310786|NCT02126085|recanalisation|recanalisation
5310787|NCT02126085|sedation|sedation
5310789|NCT02126072|Alcohol|alcohol
5310790|NCT02126072|Consumption|consumption
5310791|NCT02126072|Gut wall integrity|gut wall integrity
5310792|NCT02126072|Endotoxemia|endotoxemia
5310793|NCT02126059|dementia|dementia
5310794|NCT02126059|behavioral and psychological symptoms|behavioral and psychological symptoms
5310795|NCT02126059|quality of life|quality of life
5310796|NCT02126046|Cord Blood Transplant|cord blood transplant
5310797|NCT02126046|Haploidentical HSCT|haploidentical hsct
5310798|NCT02126046|Thalassemia major|thalassemia major
5310800|NCT02126033|telomere|telomere
5310801|NCT02126033|telomerase|telomerase
5310802|NCT02126020|Keratoprosthesis|keratoprosthesis
5310803|NCT02126020|corneal melt|corneal melt
5310804|NCT02126020|keratolysis|keratolysis
5310805|NCT02126020|Tumor necrosis factor alpha|tumor necrosis factor alpha
5310806|NCT02126020|infliximab|infliximab
5310807|NCT02126020|matrix metalloproteinase|matrix metalloproteinase
5310810|NCT02126007|behavioral intervention|behavioral intervention
5310811|NCT02126007|sleep|sleep
5310825|NCT02125942|Borderline Personality Disorder|borderline personality disorder
5310826|NCT02125877|Iron overload|iron overload
5310827|NCT02125877|Chelation|chelation
5310828|NCT02125877|Thalassemia|thalassemia
5310829|NCT02125877|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5310830|NCT02125877|Transfusional hemisiderosis|transfusional hemisiderosis
5310831|NCT02125877|Deferasirox|deferasirox
5310832|NCT02125877|ICL670|icl670
5310833|NCT02125877|Dispersible tablet|dispersible tablet
5310834|NCT02125877|Film-coated tablet|film-coated tablet
5310835|NCT02125864|AMD|amd
5310836|NCT02125864|VEGF|vegf
5310837|NCT02125864|Aflibercept|aflibercept
5310838|NCT02125851|slurry|slurry
5310839|NCT02125851|splenda|splenda
5310840|NCT02125851|sucralose|sucralose
5310841|NCT02125851|budesonide|budesonide
5310842|NCT02125851|mucosal contact time|mucosal contact time
5310843|NCT02125838|laryngeal mask Supreme|laryngeal mask supreme
5310844|NCT02125838|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5310845|NCT02125838|Laryngeal mask during surgery|laryngeal mask during surgery
5310846|NCT02125812|Aggressive Periodontitis|aggressive periodontitis
5310847|NCT02125812|antimicrobial(s)|antimicrobial(s)
5310848|NCT02125812|microbiology|microbiology
5310849|NCT02125773|PrEP|prep
5310850|NCT02125773|Risk score|risk score
5310851|NCT02125773|Self-perception|self-perception
5310852|NCT02125760|Respiratory muscle training|respiratory muscle training
5310853|NCT02125760|stroke|stroke
5310854|NCT02125760|rehabilitation|rehabilitation
5310855|NCT02125747|Respiratory muscle training; high-intensity training|respiratory muscle training; high-intensity training
5310856|NCT02125721|cystinuria|cystinuria
5310857|NCT02125721|D-penicillamine (Cuprimine®)|d-penicillamine (cuprimine®)
5310858|NCT02125721|tiopronin (Thiola®)|tiopronin (thiola®)
5310859|NCT02125708|preterm prelabor rupture of membranes|preterm prelabor rupture of membranes
5310860|NCT02125708|Ovula Ring|ovula ring
5310861|NCT02125708|body-core-temperature|body-core-temperature
5310862|NCT02125708|biomarkers|biomarkers
5310863|NCT02125708|Single pregnancies|single pregnancies
5310864|NCT02125708|PPROM|pprom
5310865|NCT02125708|gestation week 22 and 27|gestation week 22 and 27
5310866|NCT02125682|HDL|hdl
5310867|NCT02125682|Hyperlipidemia|hyperlipidemia
5310868|NCT02125682|Diabetes|diabetes
5310869|NCT02125682|Inflammation|inflammation
5310870|NCT02125669|basal cell carcinoma|basal cell carcinoma
5310871|NCT02125669|laser surgery|laser surgery
5310872|NCT02125669|pulsed dye laser|pulsed dye laser
5310873|NCT02125669|randomized controlled trial|randomized controlled trial
5310874|NCT02125643|Exercise-induced muscle damage|exercise-induced muscle damage
5310875|NCT02125643|Caffeine|caffeine
5310876|NCT02125643|Maximal voluntary strength|maximal voluntary strength
5310877|NCT02125630|Metastatic breast carcer|metastatic breast carcer
5310878|NCT02125630|Bone metastasis|bone metastasis
5310879|NCT02125630|surgery|surgery
5310880|NCT02125617|Castration-resistant prostate cancer|castration-resistant prostate cancer
5310881|NCT02125617|Abiraterone|abiraterone
5310882|NCT02125617|Biomarker|biomarker
5310883|NCT02125617|Urokinase Plasminogen Activator Receptor|urokinase plasminogen activator receptor
5310884|NCT02125617|Plasma|plasma
5310885|NCT02125617|Predictive markers|predictive markers
5310886|NCT02125604|Gastrointestinal event|gastrointestinal event
5310887|NCT02125591|Mild Traumatic Brain Injury|mild traumatic brain injury
5310889|NCT02125565|Blood|blood
5310890|NCT02125565|Gas|gas
5310891|NCT02125565|Needle|needle
5310892|NCT02125565|Pain|pain
5310893|NCT02125565|Local|local
5310894|NCT02125565|Anaesthesia|anaesthesia
5310895|NCT02125565|Anaesthetic|anaesthetic
5310896|NCT02125552|vascular access device|vascular access device
5310897|NCT02125552|ultrasonography|ultrasonography
5310898|NCT02125539|Online adolescent substance abuse relapse prevention program|online adolescent substance abuse relapse prevention program
5310906|NCT02125513|fallopian tube carcinoma|fallopian tube carcinoma
5310908|NCT02125513|randomized study|randomized study
5310909|NCT02125500|HCV/HIV coinfection|hcv/hiv coinfection
5310910|NCT02125500|HCV genotype 1|hcv genotype 1
5310911|NCT02125487|Clinical Breast Examination|clinical breast examination
5310912|NCT02125487|Breast Cancer detection|breast cancer detection
5310913|NCT02125487|Breast Simulator|breast simulator
5310914|NCT02125487|Hybrid Simulation|hybrid simulation
5310915|NCT02125487|Patient Simulation|patient simulation
5310916|NCT02125487|Standardized Patient|standardized patient
5310917|NCT02125487|Medical student education|medical student education
5310918|NCT02125487|Health Communication|health communication
5310919|NCT02125487|Communication Barriers|communication barriers
5310920|NCT02125487|Cultural competency|cultural competency
5310922|NCT02125487|Middle East|middle east
5310923|NCT02125487|Lebanon|lebanon
5310924|NCT02125474|Neuroendocrine Tumors|neuroendocrine tumors
5310925|NCT02125474|Lutetium|lutetium
5310926|NCT02125474|Treatment Outcome|treatment outcome
5310927|NCT02125461|Locally advanced|locally advanced
5310928|NCT02125461|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
5310929|NCT02125461|MEDI4736|medi4736
5310930|NCT02125461|PD-L1|pd-l1
5310931|NCT02125461|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
5310932|NCT02125461|Chemoradiation|chemoradiation
5310933|NCT02125461|Immune-mediated cancer therapy|immune-mediated cancer therapy
5310934|NCT02125448|Esophageal cancer|esophageal cancer
5310935|NCT02125448|MRI|mri
5310936|NCT02125448|PET-CT|pet-ct
5310937|NCT02125448|Response assessment|response assessment
5310938|NCT02125435|Healthy subjects|healthy subjects
5310939|NCT02125435|ASP2408|asp2408
5310940|NCT02125435|pharmacokinetics|pharmacokinetics
5310941|NCT02125396|hepatocellular carcinoma|hepatocellular carcinoma
5310942|NCT02125396|liver cancer|liver cancer
5310943|NCT02125396|transarterial chemoembolization|transarterial chemoembolization
5310944|NCT02125396|radiotherapy|radiotherapy
5310945|NCT02125396|adjuvant therapy|adjuvant therapy
5310946|NCT02125383|Parkinson's disease|parkinson's disease
5310947|NCT02125383|Transcranial direct current stimulation|transcranial direct current stimulation
5310948|NCT02125357|sequencing|sequencing
5310949|NCT02125357|abiraterone|abiraterone
5310950|NCT02125357|enzalutamide|enzalutamide
5310951|NCT02125357|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5310952|NCT02125357|randomized|randomized
5310953|NCT02125331|Blood Pressure|blood pressure
5310954|NCT02125318|myeloproliferative neoplasm|myeloproliferative neoplasm
5310955|NCT02125318|chronic myelogenous leukemia|chronic myelogenous leukemia
5310956|NCT02125318|polycythemia vera|polycythemia vera
5310957|NCT02125318|primary myelofibrosis|primary myelofibrosis
5310958|NCT02125318|essential thrombocythemia|essential thrombocythemia
5310959|NCT02125318|anagrelide|anagrelide
5310960|NCT02125318|thrombocytosis|thrombocytosis
5310961|NCT02125318|GALE-401|gale-401
5310962|NCT02125305|Metformin|metformin
5310963|NCT02125305|Pharmacokinetics/ Pharmacodynamics|pharmacokinetics/ pharmacodynamics
5310964|NCT02125214|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency|consciousness, anesthesia, electroencephalogram, microstate, long-range dependency
5310965|NCT02125201|intranasal fentanyl|intranasal fentanyl
5310966|NCT02125201|newborn|newborn
5310967|NCT02125162|BCX4161|bcx4161
5310968|NCT02125162|BioCryst|biocryst
5310969|NCT02125162|hereditary angioedema|hereditary angioedema
5310970|NCT02125162|relative bioavailability|relative bioavailability
5310971|NCT02125162|kallikrein inhibitor|kallikrein inhibitor
5310972|NCT02125149|pregnancy|pregnancy
5310973|NCT02125149|obese|obese
5310974|NCT02125136|unresectable|unresectable
5310975|NCT02125136|borderline resectable|borderline resectable
5310976|NCT02125110|neurotoxicants|neurotoxicants
5310977|NCT02125110|MRI|mri
5310978|NCT02125110|developing brain|developing brain
5310979|NCT02125097|Intracranial Aneurysm Treatment|intracranial aneurysm treatment
5310980|NCT02125097|Endovascular Therapy|endovascular therapy
5310981|NCT02125084|Metastatic Prostate Cancer|metastatic prostate cancer
5310982|NCT02125084|Castrate-resistant|castrate-resistant
5310983|NCT02125084|Enzalutamide|enzalutamide
5310984|NCT02125084|Everolimus|everolimus
5206109|NCT02706678|cyclosporin|cyclosporin
5310985|NCT02125058|intracutaneous sutures|intracutaneous sutures
5310986|NCT02125058|transcutaneous sutures|transcutaneous sutures
5310987|NCT02125058|dermatological surgery|dermatological surgery
5310988|NCT02125058|facial area|facial area
5310989|NCT02125045|GSH|gsh
5310990|NCT02125045|cardiovascular risk factors|cardiovascular risk factors
5310991|NCT02125045|endothelial dysfunction|endothelial dysfunction
5310992|NCT02125045|oxidative stress|oxidative stress
5310993|NCT02125019|Breast Cancer|breast cancer
5310994|NCT02125019|Taxane|taxane
5310995|NCT02125019|Gait|gait
5310996|NCT02125019|Men|men
5310997|NCT02125019|Women|women
5310998|NCT02125006|Mindfulness|mindfulness
5310999|NCT02125006|Breast Cancer|breast cancer
5311000|NCT02125006|Painful Neuropathy|painful neuropathy
5311001|NCT02125006|Chronic Pain|chronic pain
5311002|NCT02125006|fMRI|fmri
5311003|NCT02125006|Disability|disability
5311004|NCT02125006|Quality of Life|quality of life
5311005|NCT02125006|Cytokines|cytokines
5311006|NCT02125006|Cortisol|cortisol
5311007|NCT02124993|Gastrectomy|gastrectomy
5311008|NCT02124980|Opioid Substitution Treatment|opioid substitution treatment
5311009|NCT02124980|Cognitive Behavioral Therapy|cognitive behavioral therapy
5311010|NCT02124980|Mobile Health|mobile health
5311011|NCT02124928|stroke|stroke
5311012|NCT02124928|biomarkers|biomarkers
5311013|NCT02124928|vulnerable plaque|vulnerable plaque
5311014|NCT02124928|carotid endarterectomy|carotid endarterectomy
5311015|NCT02124928|carotid artery disease|carotid artery disease
5311016|NCT02124915|prosthetic socket|prosthetic socket
5311017|NCT02124915|amputee|amputee
5311018|NCT02124889|bariatric surgery|bariatric surgery
5311019|NCT02124889|multivitamin|multivitamin
5311020|NCT02124889|weight loss|weight loss
5311021|NCT02124889|adherence|adherence
5311022|NCT02124876|amputee|amputee
5311023|NCT02124876|prosthetics|prosthetics
5311024|NCT02124837|lunch breaks, recovery, nature, park walking, relaxation|lunch breaks, recovery, nature, park walking, relaxation
5311025|NCT02124811|Schizophrenia|schizophrenia
5311026|NCT02124811|Clozapine|clozapine
5311027|NCT02124811|Minocycline|minocycline
5311028|NCT02124798|Subcutaneous|subcutaneous
5311029|NCT02124798|Autoinjector|autoinjector
5311030|NCT02124798|Belimumab|belimumab
5311031|NCT02124798|Real-Life Use Study|real-life use study
5311032|NCT02124798|Reliability|reliability
5311033|NCT02124785|Long-term persistence|long-term persistence
5311034|NCT02124785|Havrix|havrix
5311035|NCT02124785|Hepatitis A|hepatitis a
5311036|NCT02124772|v600-mutation|v600-mutation
5311037|NCT02124772|neuroblastoma|neuroblastoma
5311038|NCT02124772|Trametinib|trametinib
5311039|NCT02124772|pediatrics|pediatrics
5311040|NCT02124772|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
5311041|NCT02124772|low grade glioma plexiform neurofibromas|low grade glioma plexiform neurofibromas
5311042|NCT02124746|Primary Myelofibrosis|primary myelofibrosis
5311043|NCT02124746|Post Polycythemia Vera Myelofibrosis|post polycythemia vera myelofibrosis
5311044|NCT02124746|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
5311045|NCT02124746|Polycythemia Vera|polycythemia vera
5311046|NCT02124746|Essential Thrombocythemia|essential thrombocythemia
5311047|NCT02124746|blood disorders|blood disorders
5311048|NCT02124733|Actinic Keratosis|actinic keratosis
5311049|NCT02124733|Actinic Keratoses|actinic keratoses
5311051|NCT02124733|PDT|pdt
5311052|NCT02124733|Photodynamic Therapy|photodynamic therapy
5311053|NCT02124733|Blue Light Therapy|blue light therapy
5311054|NCT02124733|ALA|ala
5311055|NCT02124733|aminolevulinic acid|aminolevulinic acid
5311056|NCT02124733|Levulan|levulan
5311057|NCT02124720|Autism spectrum disorders|autism spectrum disorders
5311058|NCT02124720|Stereotypy|stereotypy
5311059|NCT02124720|Repetitive behavior|repetitive behavior
5311060|NCT02124707|Head and neck cancer|head and neck cancer
5311061|NCT02124707|Squamous cell carcinoma|squamous cell carcinoma
5311062|NCT02124707|Metastatic|metastatic
5311063|NCT02124707|Recurrent|recurrent
5311064|NCT02124707|Phase II|phase ii
5311065|NCT02124707|Carboplatin|carboplatin
5311066|NCT02124707|Paclitaxel|paclitaxel
5311067|NCT02124707|Cetuximab|cetuximab
5311068|NCT02124694|historical trauma and unresolved grief|historical trauma and unresolved grief
5311069|NCT02124694|complicated grief|complicated grief
5311070|NCT02124694|prolonged grief|prolonged grief
5311071|NCT02124694|interpersonal conflicts|interpersonal conflicts
5311072|NCT02124694|depression|depression
5311073|NCT02124694|American Indians|american indians
5311074|NCT02124694|interpersonal psychotherapy|interpersonal psychotherapy
5311075|NCT02124694|traumatic grief|traumatic grief
5311076|NCT02124694|posttraumatic stress disorder|posttraumatic stress disorder
5311077|NCT02124668|Xtandi|xtandi
5311078|NCT02124668|MDV3100|mdv3100
5311079|NCT02124668|Progressive Castration-Resistant Prostate Cancer|progressive castration-resistant prostate cancer
5311080|NCT02124668|Enzalutamide|enzalutamide
5311081|NCT02124655|Biofilms|biofilms
5311082|NCT02124655|Chlorhexidine|chlorhexidine
5311083|NCT02124655|Microscopy, confocal|microscopy, confocal
5311084|NCT02124655|Dental plaque|dental plaque
5311085|NCT02124655|Mouthwashes|mouthwashes
5206217|NCT02705807|safety|safety
5311086|NCT02124642|Folate requirements|folate requirements
5311087|NCT02124642|Pregnancy|pregnancy
5311088|NCT02124642|Folic acid|folic acid
5311089|NCT02124642|DNA methylation|dna methylation
5311090|NCT02124642|Folate biomarkers|folate biomarkers
5311091|NCT02124616|spinal muscular atrophy|spinal muscular atrophy
5311092|NCT02124616|Muscular dystrophy|muscular dystrophy
5311094|NCT02124616|myasthenic syndromes|myasthenic syndromes
5311095|NCT02124616|Polyneuropathies|polyneuropathies
5311096|NCT02124616|Myopathies|myopathies
5311097|NCT02124603|cataract|cataract
5311098|NCT02124603|prophylaxis|prophylaxis
5311099|NCT02124603|susceptibility|susceptibility
5311100|NCT02124590|Carnitine|carnitine
5311101|NCT02124590|Acylcarnitine|acylcarnitine
5311102|NCT02124590|Exercise|exercise
5311103|NCT02124590|Exercise Intensity|exercise intensity
5311104|NCT02124590|Insulin Sensitivity|insulin sensitivity
5311105|NCT02124564|Lacosamide|lacosamide
5311106|NCT02124564|Epilepsy|epilepsy
5311107|NCT02124564|Focal, Partial-Onset Seizures with or without secondary generalization|focal, partial-onset seizures with or without secondary generalization
5311108|NCT02124564|Monotherapy|monotherapy
5311109|NCT02124551|Goal-directed fluid therapy|goal-directed fluid therapy
5311110|NCT02124512|obese|obese
5311111|NCT02124512|insulin resistance|insulin resistance
5298063|NCT02187783|CDK4|cdk4
5311112|NCT02124512|metabolic syndrome|metabolic syndrome
5311113|NCT02124499|anesthesia recovery period|anesthesia recovery period
5311114|NCT02124499|postoperative complications|postoperative complications
5311115|NCT02124499|pain|pain
5311116|NCT02124499|pain measurement|pain measurement
5311117|NCT02124499|postoperative nausea and vomiting|postoperative nausea and vomiting
5311118|NCT02124499|quality of life|quality of life
5311119|NCT02124499|genetic association study|genetic association study
5311120|NCT02124486|IIH|iih
5311121|NCT02124486|Weight loss|weight loss
5311122|NCT02124486|Bariatric surgery|bariatric surgery
5311123|NCT02124473|Resistant hypertension|resistant hypertension
5311124|NCT02124473|Homeopathy|homeopathy
5311125|NCT02124473|Blood pressure|blood pressure
5311126|NCT02124473|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5311127|NCT02124460|Pediatric|pediatric
5311128|NCT02124460|Obesity|obesity
5311129|NCT02124460|Overweight|overweight
5311130|NCT02124460|Intervention|intervention
5311131|NCT02124434|Laparoscopic Sleeve Gastrectomy surgery|laparoscopic sleeve gastrectomy surgery
5311132|NCT02124421|Ovarian cancer|ovarian cancer
5311133|NCT02124421|Cytoreductive surgery|cytoreductive surgery
5311134|NCT02124421|Hyperthermic Intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5311135|NCT02124421|Systemic chemotherapy|systemic chemotherapy
5311136|NCT02124421|Primary peritoneal carcinoma|primary peritoneal carcinoma
5311137|NCT02124421|Fallopian Tube cancer|fallopian tube cancer
5311138|NCT02124421|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5311139|NCT02124421|IV/IP chemotherapy|iv/ip chemotherapy
5311140|NCT02124421|IV chemotherapy|iv chemotherapy
5311141|NCT02124382|liver failure|liver failure
5311142|NCT02124382|liver malignancy|liver malignancy
5311143|NCT02124382|metabolic diseases|metabolic diseases
5311144|NCT02124382|Pediatric liver transplanted recipients and their healthy donors|pediatric liver transplanted recipients and their healthy donors
5311145|NCT02124369|Pancreatic cancer|pancreatic cancer
5311146|NCT02124369|locally advanced|locally advanced
5311147|NCT02124369|unresectable|unresectable
5311148|NCT02124343|Neutrophil|neutrophil
5311149|NCT02124343|Exercise|exercise
5311150|NCT02124343|COPD|copd
5311151|NCT02124343|Pulmonary Rehabilitation|pulmonary rehabilitation
5311152|NCT02124330|Montmorillonite, proteic diet, in vitro and in vivo models|montmorillonite, proteic diet, in vitro and in vivo models
5311153|NCT02124317|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
5311154|NCT02124317|S-1|s-1
5311155|NCT02124317|advanced pancreatic cancer|advanced pancreatic cancer
5311156|NCT02124317|objective response rate|objective response rate
5311157|NCT02124304|Sternocleidomastoid|sternocleidomastoid
5311158|NCT02124304|Neck pain|neck pain
5311159|NCT02124304|EMG|emg
5311160|NCT02124304|Perceived Exertion|perceived exertion
5311161|NCT02124304|Thera-Band|thera-band
5311162|NCT02124304|Cervical Paraspinals|cervical paraspinals
5311163|NCT02124291|In Vitro Fertilization|in vitro fertilization
5311164|NCT02124291|Vitrification|vitrification
5311165|NCT02124291|Frozen Embryo|frozen embryo
5311166|NCT02124291|Assisted Hatching|assisted hatching
5311167|NCT02124291|Pregnancy Rate|pregnancy rate
5311168|NCT02124278|Single ascending dose|single ascending dose
5311169|NCT02124278|Safety and tolerability in healthy subjects|safety and tolerability in healthy subjects
5311292|NCT02123576|Liver transplantation|liver transplantation
5311170|NCT02124265|Oral Rehydration Therapy|oral rehydration therapy
5311171|NCT02124252|cervical cancer screening|cervical cancer screening
5311172|NCT02124252|human papillomavirus testing|human papillomavirus testing
5311173|NCT02124252|Kenya|kenya
5311174|NCT02124252|implementation science|implementation science
5311175|NCT02124226|Chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab|chronic severe asthma, immunomodulation, methotrexate, steroids, omalizumab
5311176|NCT02124213|Receptor Occupancy|receptor occupancy
5311178|NCT02124213|D1 Receptor Agonist|d1 receptor agonist
5311179|NCT02124174|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5311180|NCT02124174|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5311181|NCT02124161|Pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5311182|NCT02124161|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5311183|NCT02124161|invasive pneumococcal disease|invasive pneumococcal disease
5311185|NCT02124148|cancer|cancer
5311186|NCT02124135|Nutrition|nutrition
5311187|NCT02124122|Focus|focus
5311188|NCT02124122|safety|safety
5311189|NCT02124109|Rheumatic Heart Disease|rheumatic heart disease
5311191|NCT02124096|Influenza|influenza
5311192|NCT02124096|Infections|infections
5311193|NCT02124096|Ohio|ohio
5311194|NCT02124096|Fairs|fairs
5311195|NCT02124083|Niemann Pick Disease, Type C1|niemann pick disease, type c1
5311196|NCT02124083|Phase I, Phase 2|phase i, phase 2
5311197|NCT02124083|Vorinostat|vorinostat
5311198|NCT02124070|Cystinosis|cystinosis
5311199|NCT02124070|Myopathy|myopathy
5311200|NCT02124070|Recombiant Growth Hormone|recombiant growth hormone
5311201|NCT02124057|Liver|liver
5311202|NCT02124057|Motor Neuron Disease|motor neuron disease
5311203|NCT02124044|Coinfection|coinfection
5311204|NCT02124044|HCV Genotype 1b|hcv genotype 1b
5311205|NCT02124044|Interferon Free therapy|interferon free therapy
5311206|NCT02124044|Liver Biopsy|liver biopsy
5311207|NCT02124044|Virological Response|virological response
5311208|NCT02124031|Osteoarthritis|osteoarthritis
5311209|NCT02124031|Rheumatoid Arthritis|rheumatoid arthritis
5311210|NCT02124031|Disability|disability
5311211|NCT02124031|Joint function|joint function
5311212|NCT02124018|Myocardial infarction|myocardial infarction
5311213|NCT02124018|Risk stratification|risk stratification
5311214|NCT02124018|Sudden cardiac death|sudden cardiac death
5311215|NCT02124018|Preserved ejection fraction|preserved ejection fraction
5311216|NCT02124018|Programmed ventricular stimulation|programmed ventricular stimulation
5311217|NCT02124005|Knee surgery|knee surgery
5311218|NCT02124005|Femoral block|femoral block
5311219|NCT02124005|Bupivacaine|bupivacaine
5311220|NCT02124005|Ultrasound|ultrasound
5311221|NCT02123966|Chronic Graft-versus-Host-Disease|chronic graft-versus-host-disease
5311222|NCT02123966|Oral mucosal disease|oral mucosal disease
5311223|NCT02123953|Drug therapy|drug therapy
5963129|NCT04272034|Advanced solid tumors|advanced solid tumors
5180031|NCT02864940|Memory|memory
5180032|NCT02864940|aneurysm|aneurysm
5180033|NCT02864940|deficits|deficits
5180034|NCT02864940|trouble|trouble
5180035|NCT02864940|forgetful|forgetful
5180036|NCT02864940|ruptured|ruptured
5180037|NCT02864940|subarachnoid|subarachnoid
5180038|NCT02864940|hemorrhage|hemorrhage
5180039|NCT02864927|Meningitis|meningitis
5311224|NCT02123940|Weaning from mechanical ventilation|weaning from mechanical ventilation
5311225|NCT02123940|Lung ultrasound|lung ultrasound
5311226|NCT02123940|Nasal humidified high flow therapy|nasal humidified high flow therapy
5311227|NCT02123940|Weaning failure|weaning failure
5311228|NCT02123940|Postextubation distress|postextubation distress
5311229|NCT02123927|Drug therapy|drug therapy
5311230|NCT02123914|Exercise training|exercise training
5311231|NCT02123914|Allergic rhinitis|allergic rhinitis
5311232|NCT02123914|Vitamin C|vitamin c
5311233|NCT02123914|Cytokine|cytokine
5311234|NCT02123914|Rhinitis symptoms|rhinitis symptoms
5311235|NCT02123901|Mind and body Exercise|mind and body exercise
5311236|NCT02123901|Flow mediated dilation|flow mediated dilation
5311237|NCT02123901|Diabetes|diabetes
5311238|NCT02123888|Prostate|prostate
5311239|NCT02123888|Lung|lung
5311240|NCT02123862|Prostate Cancer|prostate cancer
5311241|NCT02123862|Breast Cancer|breast cancer
5311242|NCT02123862|Colorectal Cancer|colorectal cancer
5311243|NCT02123862|Colon Cancer|colon cancer
5311244|NCT02123862|Rectal Cancer|rectal cancer
5311245|NCT02123862|Cancer|cancer
5311246|NCT02123862|Solid Tumor|solid tumor
5311247|NCT02123862|Metastatic|metastatic
5311248|NCT02123862|Circulating Tumor Cells|circulating tumor cells
5311249|NCT02123810|fatigue|fatigue
5311250|NCT02123810|motor skills|motor skills
5311251|NCT02123810|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5311252|NCT02123784|Rotator Cuff Tear|rotator cuff tear
5311253|NCT02123784|Rotator Cuff Repair|rotator cuff repair
5311254|NCT02123784|Biomarker|biomarker
5311255|NCT02123784|Predictive factors|predictive factors
5311256|NCT02123784|Skeletal Muscle|skeletal muscle
5311257|NCT02123784|Tendon|tendon
5311258|NCT02123784|Subacromial Bursa|subacromial bursa
5311259|NCT02123771|Focus of Study : HELICOBACTER PYLORI INFECTIONS|focus of study : helicobacter pylori infections
5311260|NCT02123758|Prostatic Neoplasms|prostatic neoplasms
5311261|NCT02123758|Metastatic Castration-Resistant Prostate Cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5311262|NCT02123758|Prostate cancer|prostate cancer
5311263|NCT02123758|Abiraterone Acetate (ZYTIGA)|abiraterone acetate (zytiga)
5311264|NCT02123758|Prednisone|prednisone
5311265|NCT02123758|JNJ-56021927|jnj-56021927
5311266|NCT02123745|infiltration|infiltration
5311267|NCT02123745|extravasation|extravasation
5311268|NCT02123745|peripheral intravenous therapy|peripheral intravenous therapy
5311269|NCT02123732|Diabetes|diabetes
5311270|NCT02123732|Diabetes Mellitus|diabetes mellitus
5311271|NCT02123732|Herbal|herbal
5311272|NCT02123732|food supplement|food supplement
5311273|NCT02123693|Osteopathic manipulative treatment|osteopathic manipulative treatment
5311274|NCT02123693|Low back pain|low back pain
5311275|NCT02123693|Dynamic MRI|dynamic mri
5311276|NCT02123680|expectation|expectation
5311277|NCT02123680|chronic illness|chronic illness
5311278|NCT02123680|trajectory|trajectory
5311279|NCT02123628|diabetic foot osteomyelitis, antibiotic treatment duration|diabetic foot osteomyelitis, antibiotic treatment duration
5311280|NCT02123615|Primary Immunodeficiency|primary immunodeficiency
5311284|NCT02123615|Injectable electromyography needle|injectable electromyography needle
5311285|NCT02123615|Electrical stimulation|electrical stimulation
5311286|NCT02123615|MRI with Gadolinium|mri with gadolinium
5311287|NCT02123602|patellofemoral pain syndrome|patellofemoral pain syndrome
5311288|NCT02123602|abdominal muscles|abdominal muscles
5311289|NCT02123576|Hepatorenal syndrome|hepatorenal syndrome
5311293|NCT02123576|Cirrhosis|cirrhosis
5311294|NCT02123550|deep|deep
5311295|NCT02123550|venous|venous
5311296|NCT02123550|thrombosis|thrombosis
5311297|NCT02123550|Doppler|doppler
5311298|NCT02123550|ultrasound|ultrasound
5311299|NCT02123550|plastic|plastic
5311300|NCT02123550|surgery|surgery
5311301|NCT02123550|thromboembolism|thromboembolism
5298274|NCT02186834|Myeloma|myeloma
5311302|NCT02123550|prevention|prevention
5311303|NCT02123537|Bioness L300 Foot Drop System|bioness l300 foot drop system
5311304|NCT02123537|Functional electrical stimulation|functional electrical stimulation
5311305|NCT02123524|Superficial Vein Thrombosis|superficial vein thrombosis
5311306|NCT02123498|ear pressure|ear pressure
5311307|NCT02123498|ear fullness|ear fullness
5311308|NCT02123498|ear pain|ear pain
5311310|NCT02123498|laryngopharyngeal reflux|laryngopharyngeal reflux
5963130|NCT04271761|cochlear implantation|cochlear implantation
5963131|NCT04271735|Chronic Inflammatory Skin Disease|chronic inflammatory skin disease
5963132|NCT04271735|Systemic Inflammation-Induced Atherosclerosis|systemic inflammation-induced atherosclerosis
5963133|NCT04271735|TH17 Cell Cytokine IL-17 Secretion in Response to T-cell Differentiation|th17 cell cytokine il-17 secretion in response to t-cell differentiation
5963134|NCT04271735|Effect of NR on Neutrophils|effect of nr on neutrophils
5963135|NCT04271735|Effect of NR on HDL|effect of nr on hdl
5963136|NCT04271449|prismatic adaptation|prismatic adaptation
5963137|NCT04271449|tDCS|tdcs
5192085|NCT02791841|Rhythm|rhythm
5311312|NCT02123498|gastroesophageal reflux disease|gastroesophageal reflux disease
5311313|NCT02123498|GERD|gerd
5311314|NCT02123498|nasopharyngeal reflux|nasopharyngeal reflux
5311315|NCT02123498|acid reflux|acid reflux
5311316|NCT02123485|Depression,|depression,
5311317|NCT02123485|ECT,|ect,
5311318|NCT02123485|rTMS,|rtms,
5311319|NCT02123485|Right prefrontal,|right prefrontal,
5311320|NCT02123485|antidepressive efficacy|antidepressive efficacy
5311321|NCT02123485|Inflammation markers|inflammation markers
5311322|NCT02123433|HIV|hiv
5311323|NCT02123433|Streptococcus pneumoniae|streptococcus pneumoniae
5311324|NCT02123433|13-valent conjugate pneumococcal vaccine|13-valent conjugate pneumococcal vaccine
5311325|NCT02123433|Vaccine|vaccine
5311326|NCT02123433|Immunological Response|immunological response
5311327|NCT02123433|Pneumococcal Carriage|pneumococcal carriage
5311328|NCT02123420|Platform Switching vs Regular Platform|platform switching vs regular platform
5311329|NCT02123407|Advanced Gastric Cancer|advanced gastric cancer
5311330|NCT02123407|Carbon Nanoparticles|carbon nanoparticles
5311331|NCT02123407|Lymph Nodes|lymph nodes
5311332|NCT02123394|Low Back Pain|low back pain
5311333|NCT02123394|Mechanical Low Back Pain|mechanical low back pain
5311334|NCT02123394|Low Back Ache|low back ache
5311335|NCT02123394|Low Backache|low backache
5311336|NCT02123394|Lower Back Pain|lower back pain
5311337|NCT02123394|Lumbago|lumbago
5311338|NCT02123381|tumor tissue and serum biomarkers|tumor tissue and serum biomarkers
5311339|NCT02123381|cetuximab|cetuximab
5311340|NCT02123381|preoperative radiotherapy|preoperative radiotherapy
5311341|NCT02123381|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5311342|NCT02123368|Osteoarthritis|osteoarthritis
5311343|NCT02123368|Mesenchimal stem cell|mesenchimal stem cell
5311344|NCT02123368|Knee|knee
5311345|NCT02123342|health|health
5311346|NCT02123342|older adults|older adults
5311347|NCT02123342|mobile phone|mobile phone
5311348|NCT02123329|Qatar|qatar
5311349|NCT02123329|Pharmacy|pharmacy
5311350|NCT02123329|Pharmacist|pharmacist
5311351|NCT02123329|Smoking cessation|smoking cessation
5311352|NCT02123316|local allergic rhinitis|local allergic rhinitis
5311353|NCT02123316|subcutaneous immunotherapy|subcutaneous immunotherapy
5311354|NCT02123316|house dust mite allergy|house dust mite allergy
5311355|NCT02123316|Dermatophagoides pteronyssinus allergy|dermatophagoides pteronyssinus allergy
5311356|NCT02123303|Hypotension, Orthostatic Hypotension|hypotension, orthostatic hypotension
5311357|NCT02123290|Plasmodium|plasmodium
5311358|NCT02123290|falciparum|falciparum
5311359|NCT02123290|malaria|malaria
5311360|NCT02123290|vivax|vivax
5311361|NCT02123290|DSM265|dsm265
5311362|NCT02123290|pharmacokinetics|pharmacokinetics
5311363|NCT02123290|adult|adult
5311364|NCT02123251|Incentives,|incentives,
5311365|NCT02123251|Diabetes,|diabetes,
5311366|NCT02123251|Medicaid,|medicaid,
5311367|NCT02123251|Health behavior,|health behavior,
5311368|NCT02123251|Cost effectiveness|cost effectiveness
5311369|NCT02123225|STOP-BANG|stop-bang
5311370|NCT02123225|Obstructive sleep apnea (OSA)|obstructive sleep apnea (osa)
5311371|NCT02123225|total knee arthroplasty (TKA)|total knee arthroplasty (tka)
5311372|NCT02123225|portable monitoring|portable monitoring
5311373|NCT02123225|sleep medicine|sleep medicine
5311374|NCT02123225|unattended sleep study|unattended sleep study
5311375|NCT02123225|postoperative sleep study|postoperative sleep study
5311376|NCT02123212|Hepatitis C|hepatitis c
5311377|NCT02123212|Chronic Hepatitis C|chronic hepatitis c
5315857|NCT02104466|pain|pain
5311379|NCT02123199|COPD|copd
5311380|NCT02123186|Newborn Screening , spinal muscular atrophy|newborn screening , spinal muscular atrophy
5311381|NCT02123173|one lung ventilation,|one lung ventilation,
5311382|NCT02123173|cardiac output|cardiac output
5311383|NCT02123173|fluid responsiveness|fluid responsiveness
5311384|NCT02123160|Depression|depression
5311385|NCT02123160|Dyadic therapy|dyadic therapy
5311386|NCT02123160|Behavioral Problems|behavioral problems
5311387|NCT02123160|Child parent therapy|child parent therapy
5311388|NCT02123160|Affect regulation|affect regulation
5311389|NCT02123160|Immune markers|immune markers
5311391|NCT02123121|Aging|aging
5311392|NCT02123121|Biogenesis|biogenesis
5311393|NCT02123121|Cell Respiration|cell respiration
5311394|NCT02123121|Elderly|elderly
5311395|NCT02123121|Enzymes|enzymes
5311396|NCT02123121|Mitochondria|mitochondria
5311397|NCT02123121|Mitochondrial DNA|mitochondrial dna
5311398|NCT02123121|Muscle Fatigue|muscle fatigue
5311399|NCT02123121|Physical Function|physical function
5311400|NCT02123121|Resveratrol|resveratrol
5311401|NCT02123108|Simulect, Myfortic, OLT, Renal Dysfunction, Liver Transplant, Orthotopic Liver Transplantation|simulect, myfortic, olt, renal dysfunction, liver transplant, orthotopic liver transplantation
5311402|NCT02123082|Urolithiasis|urolithiasis
5311403|NCT02123082|Kidney stones|kidney stones
5311404|NCT02123082|Ureteral Obstruction|ureteral obstruction
5311405|NCT02123082|Ureteroscopes|ureteroscopes
5311406|NCT02123082|Ureteroscopies|ureteroscopies
5311407|NCT02123069|Autonomic nervous system|autonomic nervous system
5963138|NCT04271280|High-risk dyslipidemic|high-risk dyslipidemic
5311408|NCT02123069|Blood pressure|blood pressure
5311409|NCT02123069|Blood vessels|blood vessels
5311410|NCT02123069|Physiological effects of drugs|physiological effects of drugs
5311411|NCT02123069|Vascular stiffness|vascular stiffness
5311412|NCT02123056|reflex fainting|reflex fainting
5311413|NCT02123056|vasovagal syncope|vasovagal syncope
5311414|NCT02123056|metoprolol|metoprolol
5311415|NCT02123056|randomized clinical trial|randomized clinical trial
5311416|NCT02123056|quality of life|quality of life
5311417|NCT02123043|rehabilitation|rehabilitation
5311418|NCT02123043|wheelchair|wheelchair
5311419|NCT02123043|older adults|older adults
5311420|NCT02123043|manual wheelchair|manual wheelchair
5311421|NCT02123043|motor learning|motor learning
5311422|NCT02123043|biomechanics|biomechanics
5311423|NCT02123043|gross mechanical efficiency|gross mechanical efficiency
5311424|NCT02123030|Lung cancer|lung cancer
5311425|NCT02123030|pulmonary disease|pulmonary disease
5311426|NCT02123017|Bowel Evacuation|bowel evacuation
5311427|NCT02123017|Colonoscopy Preparation|colonoscopy preparation
5311428|NCT02123004|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5311429|NCT02123004|Percutaneous Coronary Intervention|percutaneous coronary intervention
5311430|NCT02122991|spinal cord injury|spinal cord injury
5311431|NCT02122991|autonomic dysreflexia|autonomic dysreflexia
5311432|NCT02122991|baroreceptor integrity|baroreceptor integrity
5311433|NCT02122991|sympathetic integrity|sympathetic integrity
5311434|NCT02122991|vagal integrity|vagal integrity
5311435|NCT02122991|autonomic integrity|autonomic integrity
5311436|NCT02122991|arterial stiffness|arterial stiffness
5311437|NCT02122991|cognitive function|cognitive function
5311438|NCT02122991|traumatic brain injury|traumatic brain injury
5311439|NCT02122991|cerebral blood flow|cerebral blood flow
5311440|NCT02122978|psoriasis|psoriasis
5311441|NCT02122978|dermatology|dermatology
5311442|NCT02122978|mindfulness|mindfulness
5311443|NCT02122978|self-compassion|self-compassion
5311444|NCT02122952|Gene Transfer|gene transfer
5311445|NCT02122952|Gene Therapy|gene therapy
5311446|NCT02122952|Adeno-associated virus|adeno-associated virus
5311447|NCT02122952|Survival Motor Neuron|survival motor neuron
5311449|NCT02122952|AAV9|aav9
5311450|NCT02122926|Transitions in care|transitions in care
5311451|NCT02122926|discharge intervention|discharge intervention
5311453|NCT02122926|readmission rates|readmission rates
5311454|NCT02122926|medication adherence|medication adherence
5311455|NCT02122926|glycemic control|glycemic control
5311456|NCT02122926|ED visits|ed visits
5311457|NCT02122926|medication reconciliation|medication reconciliation
5311458|NCT02122926|Coleman Transitions Coach|coleman transitions coach
5311459|NCT02122926|telemonitoring; hypoglycemic events|telemonitoring; hypoglycemic events
5311460|NCT02122913|Advanced solid tumors|advanced solid tumors
5311461|NCT02122913|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5311462|NCT02122913|NTRK1|ntrk1
5311463|NCT02122913|NTRK2|ntrk2
5311464|NCT02122913|NTRK3|ntrk3
5311465|NCT02122913|Fusion Positive|fusion positive
5311466|NCT02122913|TRK fusion|trk fusion
5311467|NCT02122913|TRKA|trka
5311468|NCT02122913|TRKB|trkb
5311469|NCT02122913|TRKC|trkc
5311470|NCT02122913|ETV6|etv6
5311471|NCT02122887|jewish, arab, israel, teenagers|jewish, arab, israel, teenagers
5311472|NCT02122874|Percutaneous neurostimulation; dermatome T7, type 2 diabetes|percutaneous neurostimulation; dermatome t7, type 2 diabetes
5311473|NCT02122861|Melanoma|melanoma
5311474|NCT02122848|Heart failure|heart failure
5311475|NCT02122848|Exercise tolerance|exercise tolerance
5311476|NCT02122848|Noninvasive ventilation|noninvasive ventilation
5311479|NCT02122822|supratentoria glioma|supratentoria glioma
5311480|NCT02122809|Chiauranib, advanced solid tumors, phase 1 study|chiauranib, advanced solid tumors, phase 1 study
5311481|NCT02122796|Breast Cancer|breast cancer
5311482|NCT02122796|Mastectomy|mastectomy
5311483|NCT02122796|Acupuncture|acupuncture
5311484|NCT02122770|Drug Therapy|drug therapy
5311485|NCT02122731|antihypertensive therapy|antihypertensive therapy
5311486|NCT02122731|amiloride|amiloride
5311487|NCT02122731|add-on|add-on
5311488|NCT02122731|resistant hypertension|resistant hypertension
5311489|NCT02122731|blood pressure control|blood pressure control
5311490|NCT02122731|type 2 diabetes mellitus,|type 2 diabetes mellitus,
5311491|NCT02122731|microalbuminuria.|microalbuminuria.
5311492|NCT02122705|Remifentanil|remifentanil
5311493|NCT02122705|Labour analgesia|labour analgesia
5311494|NCT02122666|Metabolic Syndrome|metabolic syndrome
5311495|NCT02122666|Pre-diabetes|pre-diabetes
5311496|NCT02122666|impaired glucose tolerance|impaired glucose tolerance
5311497|NCT02122666|Phospholipids|phospholipids
5311498|NCT02122653|Fatigue|fatigue
5311499|NCT02122653|aging|aging
5311500|NCT02122653|transcranial magnetic stimulation|transcranial magnetic stimulation
5311501|NCT02122653|interpolated|interpolated
5311502|NCT02122653|twitch technique|twitch technique
5311503|NCT02122627|Vitamin D, COPD, immunomodulation, pulmonary function|vitamin d, copd, immunomodulation, pulmonary function
5311504|NCT02122614|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5311505|NCT02122614|COPD|copd
5311506|NCT02122614|Pulmonary rehabilitation|pulmonary rehabilitation
5311507|NCT02122614|Physical activity|physical activity
5311508|NCT02122614|Exercise|exercise
5311509|NCT02122588|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, BRCA (breast cancer gene) mutation, genetic testing|serous and endometrioid ovarian, peritoneal, fallopian tube cancer, hereditary ovarian cancer, brca (breast cancer gene) mutation, genetic testing
5311513|NCT02122562|Ketamine|ketamine
5311514|NCT02122562|Major Depression|major depression
5311515|NCT02122562|Alcohol|alcohol
5311516|NCT02122562|Alcohol Clamp|alcohol clamp
5311517|NCT02122562|NMDA Antagonist|nmda antagonist
5311518|NCT02122549|In-Hospital Cardiac Arrest|in-hospital cardiac arrest
5311519|NCT02122549|Telemetry|telemetry
5311520|NCT02122523|Image guided surgery|image guided surgery
5311521|NCT02122510|Analgesia, casarean section, TAP block|analgesia, casarean section, tap block
5311522|NCT02122497|abdominal aortic aneurysm|abdominal aortic aneurysm
5311523|NCT02122497|aortic occlusive disease|aortic occlusive disease
5311524|NCT02122497|cardiovascular biomarkers|cardiovascular biomarkers
5311525|NCT02122497|open surgical repair|open surgical repair
5311526|NCT02122497|endovascular aortic repair|endovascular aortic repair
5311527|NCT02122484|reperfusion damage|reperfusion damage
5311528|NCT02122471|CIC|cic
5311529|NCT02122471|Constipation|constipation
5311530|NCT02122471|Chronic Constipation|chronic constipation
5311531|NCT02122471|Synergy|synergy
5311532|NCT02122471|Plecanatide|plecanatide
5311533|NCT02122458|hearing impairment|hearing impairment
5311534|NCT02122458|post-traumatic stress disorder|post-traumatic stress disorder
5311535|NCT02122458|traumatic brain injury|traumatic brain injury
5311536|NCT02122458|auditory processing disorder|auditory processing disorder
5311537|NCT02122445|Gluteus Maximum|gluteus maximum
5311538|NCT02122445|Gluteus Medius|gluteus medius
5311539|NCT02122445|TFL|tfl
5311540|NCT02122445|EMG|emg
5311541|NCT02122445|Flexion-Response Phenomenon|flexion-response phenomenon
5311542|NCT02122445|Thera-Band|thera-band
5311543|NCT02122445|kinesiology tape|kinesiology tape
5311544|NCT02122432|teledermatology|teledermatology
5311545|NCT02122432|dermatology|dermatology
5311546|NCT02122432|general practice|general practice
5311547|NCT02122432|organization of care|organization of care
5311548|NCT02122406|Rheumatoid Arthritis|rheumatoid arthritis
5311549|NCT02122406|Depression|depression
5311550|NCT02122406|Anxiety|anxiety
5311551|NCT02122406|DAS28|das28
5311552|NCT02122406|HADS|hads
5311553|NCT02122380|Growth Hormone|growth hormone
5311554|NCT02122380|Dipeptidyl Peptidase 4|dipeptidyl peptidase 4
5311555|NCT02122380|Polycystic Ovary Syndrome|polycystic ovary syndrome
5311556|NCT02122328|Twin twin transfusion syndrome|twin twin transfusion syndrome
5311557|NCT02122328|Sequential laser photocoagulation of communicating vessels|sequential laser photocoagulation of communicating vessels
5311558|NCT02122302|Altered gastrointestinal anatomy|altered gastrointestinal anatomy
5311559|NCT02122302|Chronic pancreatic disease|chronic pancreatic disease
5311560|NCT02122302|Chronic pancreatic pain|chronic pancreatic pain
5311561|NCT02122302|Patient self-assessment|patient self-assessment
5311562|NCT02122302|Online assessment|online assessment
5311563|NCT02122289|Exacerbation, QoL|exacerbation, qol
5311564|NCT02122276|Spinal cord injury|spinal cord injury
5311565|NCT02122276|Passive motion|passive motion
5311566|NCT02122276|Fatigue index|fatigue index
5311567|NCT02122276|Hypertonia|hypertonia
5311568|NCT02122250|Diabetes|diabetes
5311569|NCT02122250|Health literacy|health literacy
5311672|NCT02121769|cholestasis|cholestasis
5311570|NCT02122250|web intervention|web intervention
5311571|NCT02122224|satiety|satiety
5311572|NCT02122224|satiation|satiation
5311573|NCT02122224|diet quality|diet quality
5311574|NCT02122224|memory|memory
5311575|NCT02122224|obesity|obesity
5311576|NCT02122224|protein|protein
5311577|NCT02122224|fiber|fiber
5311578|NCT02122211|Sperm motility|sperm motility
5311579|NCT02122198|Cognitive impairment|cognitive impairment
5311580|NCT02122198|Executive function|executive function
5311581|NCT02122198|Arterial stiffness|arterial stiffness
5311582|NCT02122198|Endothelial function|endothelial function
5311583|NCT02122198|Menopause|menopause
5311584|NCT02122198|Women's health|women's health
5311591|NCT02122146|ADC|adc
5311592|NCT02122146|PF-06664178|pf-06664178
5311593|NCT02122146|solid tumors|solid tumors
5311594|NCT02122146|tumors|tumors
5311595|NCT02122146|neoplasm metastasis|neoplasm metastasis
5311596|NCT02122146|NSCLC|nsclc
5311597|NCT02122146|non small cell lung cancer|non small cell lung cancer
5311598|NCT02122146|OVCA|ovca
5311599|NCT02122146|ovarian cancer|ovarian cancer
5311600|NCT02122146|Phase 1|phase 1
5311601|NCT02122146|breast cancer|breast cancer
5311602|NCT02122133|IC aneurysms, coil embolization, PC 400, radiation exposure,|ic aneurysms, coil embolization, pc 400, radiation exposure,
5311603|NCT02122120|enteral nutrition, tube feeding, nutritional support|enteral nutrition, tube feeding, nutritional support
5311604|NCT02122107|Treatment Exposure|treatment exposure
5311605|NCT02122107|Smoking History|smoking history
5192415|NCT02789722|Mate|mate
5311606|NCT02122107|14-071|14-071
5311607|NCT02122068|Meditation|meditation
5311608|NCT02122068|Mindfulness|mindfulness
5311609|NCT02122068|Caregiver|caregiver
5311610|NCT02122068|Dementia|dementia
5311611|NCT02122068|Depression|depression
5311612|NCT02122055|combined sedation|combined sedation
5311613|NCT02122029|Lifestyle intervention|lifestyle intervention
5311614|NCT02122029|Bariatric surgery|bariatric surgery
5311615|NCT02122029|Weight management|weight management
5311616|NCT02122029|Physical activity|physical activity
5311617|NCT02122016|Ventilator weaning|ventilator weaning
5311618|NCT02122016|Protocols|protocols
5311619|NCT02122016|Computer driven weaning|computer driven weaning
5311620|NCT02122016|Decision Making, Computer-Assisted|decision making, computer-assisted
5311621|NCT02122016|Therapy, Computer-Assisted|therapy, computer-assisted
5311622|NCT02122016|Respiration, Artificial|respiration, artificial
5311623|NCT02122003|sorafenib|sorafenib
5311624|NCT02122003|pazopanib|pazopanib
5311625|NCT02122003|cross-resistance|cross-resistance
5311626|NCT02122003|TKI|tki
5311627|NCT02122003|mRCC|mrcc
5311628|NCT02121990|(IP) Cisplatin|(ip) cisplatin
5311629|NCT02121990|IV/IP Paclitaxel|iv/ip paclitaxel
5311630|NCT02121990|IV Bevacizumab|iv bevacizumab
5311631|NCT02121990|Oral Olaparib (AZD2281)|oral olaparib (azd2281)
5311632|NCT02121990|Optimally Debulked|optimally debulked
5311633|NCT02121990|Stage II/III|stage ii/iii
5311634|NCT02121990|Ovary|ovary
5311635|NCT02121990|Pertoneum|pertoneum
5311636|NCT02121990|10-220|10-220
5311637|NCT02121964|unilateral primary total hip arthroplasty|unilateral primary total hip arthroplasty
5311638|NCT02121964|bilateral primary total hip arthroplasty|bilateral primary total hip arthroplasty
5311639|NCT02121964|Arthritis|arthritis
5311640|NCT02121964|Orthopedic Disorders|orthopedic disorders
5311641|NCT02121964|Orthopedics|orthopedics
5311642|NCT02121964|Surgery,|surgery,
5311643|NCT02121964|Orthopedic|orthopedic
5311644|NCT02121964|arthroplasty|arthroplasty
5311645|NCT02121964|hip|hip
5311646|NCT02121964|osteoarthritis|osteoarthritis
5311647|NCT02121964|capsulectomy|capsulectomy
5311648|NCT02121964|capsulotomy|capsulotomy
5311649|NCT02121951|Percutaneous Nephrostomy|percutaneous nephrostomy
5311650|NCT02121951|Quadtatus Lumborum Block|quadtatus lumborum block
5311651|NCT02121951|Cancer|cancer
5311652|NCT02121951|Monitored Anaesthesia Care|monitored anaesthesia care
5311653|NCT02121938|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5311654|NCT02121938|Microbiome|microbiome
5311655|NCT02121925|Registry|registry
5311656|NCT02121899|Registry|registry
5311657|NCT02121873|breast cancer, nipple aspirate, ductal lavage, hyperplasia|breast cancer, nipple aspirate, ductal lavage, hyperplasia
5311658|NCT02121860|Hepatic Impairment|hepatic impairment
5311659|NCT02121860|Pharmacokinetics|pharmacokinetics
5311660|NCT02121860|Pharmacodynamics|pharmacodynamics
5311661|NCT02121808|Morbid Obesity|morbid obesity
5311662|NCT02121808|Bariatric Surgery Candidate|bariatric surgery candidate
5311663|NCT02121808|Pre-Oxygenation|pre-oxygenation
5311664|NCT02121808|Functional Residual Capacity|functional residual capacity
5311665|NCT02121795|HIV|hiv
5311666|NCT02121795|HIV-1 Positive|hiv-1 positive
5311667|NCT02121795|Virologically-suppressed|virologically-suppressed
5311668|NCT02121782|QIV|qiv
5311669|NCT02121782|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
5311670|NCT02121782|Influenza vaccine|influenza vaccine
5311671|NCT02121782|Vaccination|vaccination
5316160|NCT02102997|PCI|pci
5311673|NCT02121769|short bowel syndrome|short bowel syndrome
5311675|NCT02121756|HIV|hiv
5311676|NCT02121756|Immune Markers|immune markers
5311677|NCT02121756|Immune Activation|immune activation
5311678|NCT02121756|Inflammation|inflammation
5311679|NCT02121743|strattice|strattice
5311680|NCT02121743|colostomy|colostomy
5311681|NCT02121743|parastomal hernia|parastomal hernia
5311682|NCT02121730|grafting kidney|grafting kidney
5311683|NCT02121730|Cancer|cancer
5311684|NCT02121717|Chiglitazar,diabetes,type 2 diabetes|chiglitazar,diabetes,type 2 diabetes
5311685|NCT02121704|Sedation|sedation
5311686|NCT02121704|Colonoscopy|colonoscopy
5311687|NCT02121704|Propofol|propofol
5311688|NCT02121704|Scope guide|scope guide
5311689|NCT02121691|Cancer|cancer
5311690|NCT02121691|Obesity|obesity
5311691|NCT02121691|Body Mass Index|body mass index
5311692|NCT02121678|Resistance training|resistance training
5311693|NCT02121678|Aerobic exercise|aerobic exercise
5311694|NCT02121678|Isokinetic muscle strength|isokinetic muscle strength
5311695|NCT02121678|Bicycle ergometry test|bicycle ergometry test
5311696|NCT02121678|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
5311697|NCT02121652|lung cancer survivors|lung cancer survivors
5311698|NCT02121652|insomnia treatment|insomnia treatment
5311699|NCT02121652|cognitive behavioral therapy|cognitive behavioral therapy
5311700|NCT02121639|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5311701|NCT02121639|AZD5363|azd5363
5963139|NCT04271280|Low-density lipoprotein cholesterol|low-density lipoprotein cholesterol
5311702|NCT02121639|Docetaxel|docetaxel
5311703|NCT02121639|Prednisolone|prednisolone
5311704|NCT02121626|Cancer|cancer
5311705|NCT02121626|Chemotheraphy|chemotheraphy
5311706|NCT02121626|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
5311707|NCT02121626|Bile Acid Malabsorption|bile acid malabsorption
5311708|NCT02121626|Pancreatic Insufficiency|pancreatic insufficiency
5311709|NCT02121626|Carbohydrate Malabsorption|carbohydrate malabsorption
5311710|NCT02121626|Anorexia|anorexia
5311711|NCT02121626|Borborygmi|borborygmi
5311712|NCT02121626|Bloating|bloating
5311713|NCT02121626|Constipation|constipation
5311714|NCT02121626|Diarrhoea|diarrhoea
5311715|NCT02121626|Mucositis|mucositis
5311716|NCT02121626|Dysphagia|dysphagia
5311717|NCT02121626|Early satiety|early satiety
5311718|NCT02121626|Frequency of defaecation|frequency of defaecation
5311719|NCT02121626|Incontinence|incontinence
5311720|NCT02121626|Mucus discharge|mucus discharge
5311721|NCT02121626|Nausea|nausea
5311722|NCT02121626|Nocturnal defaecation|nocturnal defaecation
5311723|NCT02121626|Pain|pain
5311724|NCT02121626|Reflux|reflux
5311725|NCT02121626|Regurgitation|regurgitation
5311726|NCT02121626|Steatorrhoea|steatorrhoea
5311727|NCT02121626|Tenesmus|tenesmus
5311728|NCT02121626|Urgency of defaecation|urgency of defaecation
5311729|NCT02121626|Vomiting|vomiting
5311730|NCT02121626|Weight loss|weight loss
5311731|NCT02121626|Wind.|wind.
5311732|NCT02121600|Fluorocholine (FCH)|fluorocholine (fch)
5311733|NCT02121600|Positron Emission Tomography (PET)|positron emission tomography (pet)
5311734|NCT02121600|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5311735|NCT02121587|Musculoskeletal Pain, Osteopathy, Mindfulness|musculoskeletal pain, osteopathy, mindfulness
5311736|NCT02121574|Surgery|surgery
5311737|NCT02121574|thermometers|thermometers
5311738|NCT02121574|Hypothermia|hypothermia
5311739|NCT02121574|anesthesia|anesthesia
5311740|NCT02121574|temperature|temperature
5311741|NCT02121561|Shame|shame
5311742|NCT02121548|Screen|screen
5311743|NCT02121548|cervical, cancer|cervical, cancer
5311744|NCT02121548|HPV|hpv
5311745|NCT02121548|women|women
5311746|NCT02121548|community health workers|community health workers
5311747|NCT02121548|Hispanic/ Latinas|hispanic/ latinas
5311748|NCT02121548|Haitian|haitian
5311749|NCT02121496|Depression|depression
5311750|NCT02121496|Development|development
5311751|NCT02121496|Infant sleep|infant sleep
5311752|NCT02121470|AKI|aki
5311753|NCT02121470|Acute Kidney Injury|acute kidney injury
5311754|NCT02121470|Renal failure|renal failure
5311755|NCT02121470|NGAL|ngal
5311756|NCT02121470|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5311757|NCT02121470|lipocalin-2|lipocalin-2
5311758|NCT02121470|siderocalin|siderocalin
5311759|NCT02121470|Intensive care|intensive care
5311760|NCT02121470|ICU|icu
5311761|NCT02121470|Critical care|critical care
5311762|NCT02121457|cognitive performance|cognitive performance
5311763|NCT02121457|selenium|selenium
5311764|NCT02121457|brazil nuts|brazil nuts
5311765|NCT02121457|oxidative stress|oxidative stress
5311766|NCT02121444|RRMS|rrms
5311767|NCT02121444|CIS|cis
5311768|NCT02121366|Endoscopic Ultrasound-Guided Fine Needle Aspiration|endoscopic ultrasound-guided fine needle aspiration
5311769|NCT02121366|Insulinoma|insulinoma
5311770|NCT02121366|Ethanol|ethanol
5311771|NCT02121366|Ablation Techniques|ablation techniques
5311772|NCT02121353|Age related macular degeneration|age related macular degeneration
5311773|NCT02121353|AMD|amd
5311774|NCT02121353|Wet AMD|wet amd
5311775|NCT02121353|Eye conditions|eye conditions
5311776|NCT02121353|CFT|cft
5311777|NCT02121353|OCT|oct
5311778|NCT02121353|CNV|cnv
5311779|NCT02121353|FA|fa
5311780|NCT02121353|Ocular|ocular
5311781|NCT02121353|Eye|eye
5311782|NCT02121353|Disorder of the eye|disorder of the eye
5311783|NCT02121340|Depression|depression
5311784|NCT02121340|Health disparities|health disparities
5311785|NCT02121340|African American|african american
5311786|NCT02121340|Geriatric|geriatric
5862862|NCT00001476|CD34+ Progenitor|cd34+ progenitor
5311787|NCT02121327|stroke, disease management programs, self-management|stroke, disease management programs, self-management
5311788|NCT02121314|TB|tb
5311789|NCT02121314|bioavailability|bioavailability
5311790|NCT02121314|HRZE|hrze
5311791|NCT02121314|fasting|fasting
5311792|NCT02121314|fed|fed
5311793|NCT02121301|Dry Eye|dry eye
5311794|NCT02121301|Dry Eye Syndrome|dry eye syndrome
5311795|NCT02121301|SkQ1|skq1
5311796|NCT02121301|KCS|kcs
5311797|NCT02121301|Keratoconjunctivitis|keratoconjunctivitis
5311798|NCT02121288|Peripheral Artery Disease|peripheral artery disease
5298782|NCT02184819|mechanical ventilation duration|mechanical ventilation duration
5298783|NCT02184819|ICU stay|icu stay
5298784|NCT02184806|Ovarian tissue transplantation|ovarian tissue transplantation
5298785|NCT02184806|Cryopreserved ovarian tissue|cryopreserved ovarian tissue
5298786|NCT02184793|mechanical ventilation|mechanical ventilation
5311799|NCT02121288|Myocardial Blood Flow|myocardial blood flow
5311800|NCT02121288|Cardiac Blood Flow|cardiac blood flow
5311801|NCT02121236|CBCT|cbct
5311802|NCT02121236|Ultrasonic diagnosis|ultrasonic diagnosis
5311803|NCT02121236|Benign radiolucent lesions|benign radiolucent lesions
5311804|NCT02121236|Histopathology|histopathology
5311805|NCT02121223|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
5311806|NCT02121223|primary percutaneous intervention|primary percutaneous intervention
5311807|NCT02121223|Stent Incomplete Apposition|stent incomplete apposition
5311808|NCT02121197|Macular Diabetic Edema|macular diabetic edema
5311810|NCT02121197|Retrospective|retrospective
5311811|NCT02121197|European|european
5311812|NCT02121197|Intra-vitreal injections|intra-vitreal injections
5311813|NCT02121184|Oxytocin|oxytocin
5311814|NCT02121184|Labor, Obstetric|labor, obstetric
5311815|NCT02121184|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
5311816|NCT02121184|Epidural|epidural
5311817|NCT02121158|CSP 592|csp 592
5311818|NCT02121158|ICD|icd
5311819|NCT02121158|cardiovascular|cardiovascular
5311820|NCT02121158|heart|heart
5311821|NCT02121158|aging|aging
5311822|NCT02121158|chronic diseases|chronic diseases
5311823|NCT02121158|multi-site trial|multi-site trial
5311824|NCT02121158|investigational device|investigational device
5311825|NCT02121158|cardiomyopathy|cardiomyopathy
5311826|NCT02121158|coronary artery disease|coronary artery disease
5311827|NCT02121158|congestive heart failure|congestive heart failure
5311828|NCT02121158|myocardial infarction|myocardial infarction
5311829|NCT02121158|I-70|i-70
5311830|NCT02121158|I70|i70
5311831|NCT02121158|elderly|elderly
5311832|NCT02121158|defibrillator|defibrillator
5311833|NCT02121145|Vivotif|vivotif
5311834|NCT02121145|Typherix|typherix
5311835|NCT02121145|Salmonella Typhi|salmonella typhi
5311836|NCT02121145|non-typhoid Salmonella|non-typhoid salmonella
5311837|NCT02121145|Salmonella Paratyphi|salmonella paratyphi
5207021|NCT02701244|Brachytherapy|brachytherapy
5311838|NCT02121145|enzyme-linked immunospot assay|enzyme-linked immunospot assay
5311839|NCT02121145|Plasmablast|plasmablast
5311840|NCT02121132|Overweight|overweight
5311841|NCT02121132|Obesity|obesity
5311842|NCT02121119|Peripheral nerve block|peripheral nerve block
5311843|NCT02121119|Lidocaine|lidocaine
5311844|NCT02121119|Bupivacaine|bupivacaine
5311845|NCT02121093|vibration|vibration
5311846|NCT02121093|physiotherapy|physiotherapy
5311847|NCT02121093|cortex|cortex
5311848|NCT02121093|muscles|muscles
5311849|NCT02121067|postpartum|postpartum
5311850|NCT02121067|contraception|contraception
5311851|NCT02121067|intrauterine device|intrauterine device
5311852|NCT02121067|intrauterine system|intrauterine system
5311853|NCT02121067|mirena|mirena
5311854|NCT02121067|uterine involution|uterine involution
5311855|NCT02121054|Antiplatelet Agents|antiplatelet agents
5311856|NCT02121054|Drug Resistance|drug resistance
5311857|NCT02121041|Hypertension|hypertension
5311858|NCT02121041|Blood Pressure|blood pressure
5311859|NCT02121041|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5311860|NCT02121028|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
5311861|NCT02121028|Stroke|stroke
5311862|NCT02121028|Transient Ischemic Attack|transient ischemic attack
5311863|NCT02121028|Imaging|imaging
5311864|NCT02121015|Postpartum Depression|postpartum depression
5311865|NCT02121015|Depression Prevention|depression prevention
5311866|NCT02121015|Supportive Accountability|supportive accountability
5311867|NCT02121015|Individual Internet Interventions (IIIs)|individual internet interventions (iiis)
5311868|NCT02121015|Internet Support Groups (ISGs)|internet support groups (isgs)
5311869|NCT02121002|Knee|knee
5311870|NCT02120989|insomnia|insomnia
5311871|NCT02120989|cognitive behavioral therapy for insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
5311872|NCT02120989|partner-assisted|partner-assisted
5311873|NCT02120976|Safety|safety
5311874|NCT02120976|Tolerability|tolerability
5311875|NCT02120976|Pharmacokinetics|pharmacokinetics
5311876|NCT02120976|Food-effect|food-effect
5311877|NCT02120976|Diabetes|diabetes
5311878|NCT02120963|Fatigue|fatigue
5311879|NCT02120963|Rheumatoid Arthritis|rheumatoid arthritis
5312274|NCT02119377|androgynous|androgynous
5311880|NCT02120963|Physical Therapy|physical therapy
5311881|NCT02120963|Person-Centred Care|person-centred care
5311883|NCT02120937|amygdala|amygdala
5311884|NCT02120937|mindfulness|mindfulness
5311885|NCT02120937|mood|mood
5298879|NCT02184468|Defibrillators|defibrillators
5311886|NCT02120937|emotion|emotion
5311887|NCT02120937|bipolar disorder|bipolar disorder
5311888|NCT02120937|parental bipolar disorder|parental bipolar disorder
5311889|NCT02120937|adolescence|adolescence
5311890|NCT02120924|Moderate facial rosacea|moderate facial rosacea
5311891|NCT02120924|Azelaic acid|azelaic acid
5311892|NCT02120924|Rosacea|rosacea
5311893|NCT02120911|Her2+|her2+
5311894|NCT02120911|Resectable esophageal carcinoma|resectable esophageal carcinoma
5311895|NCT02120911|Pertuzumab|pertuzumab
5311896|NCT02120911|Trastuzumab|trastuzumab
5311897|NCT02120898|Actinic Keratosis|actinic keratosis
5311898|NCT02120898|Imiquimod|imiquimod
5311899|NCT02120898|Zyclara|zyclara
5311900|NCT02120885|Gastric cancer|gastric cancer
5311901|NCT02120885|minimally invasive gastrectomy|minimally invasive gastrectomy
5311902|NCT02120885|Physical activity intervention|physical activity intervention
5311904|NCT02120859|Drug-eluting balloon (DEB)|drug-eluting balloon (deb)
5311905|NCT02120859|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
5311906|NCT02120846|Stroke|stroke
5311907|NCT02120846|Flywheel resistance exercise|flywheel resistance exercise
5311908|NCT02120846|Muscle function|muscle function
5311909|NCT02120846|Cognitive function|cognitive function
5311910|NCT02120833|Atopic Dermatitis|atopic dermatitis
5311911|NCT02120820|massage|massage
5311912|NCT02120820|multisensory environment|multisensory environment
5311913|NCT02120820|challenging behaviours|challenging behaviours
5311914|NCT02120820|relaxation|relaxation
5311915|NCT02120807|Certolizumab|certolizumab
5311916|NCT02120807|Cisplatin|cisplatin
5311917|NCT02120807|Pemetrexed|pemetrexed
5311918|NCT02120807|thoracic|thoracic
5311919|NCT02120807|13-063|13-063
5311920|NCT02120794|Type 1 diabetes|type 1 diabetes
5311921|NCT02120794|Pediatric|pediatric
5311922|NCT02120794|Threshold Suspend|threshold suspend
5311923|NCT02120794|Sensor augmented pump|sensor augmented pump
5311924|NCT02120768|Barrier resection|barrier resection
5311925|NCT02120768|Local recurrence|local recurrence
5311926|NCT02120768|Complication|complication
5311927|NCT02120742|Road traffic injury prevention|road traffic injury prevention
5311928|NCT02120742|Helmet use|helmet use
5311929|NCT02120742|mHealth intervention|mhealth intervention
5311930|NCT02120729|Pharmacogenetics|pharmacogenetics
5311931|NCT02120729|CYP2D6 Mutations|cyp2d6 mutations
5311932|NCT02120729|Major Depressive Disorder|major depressive disorder
5311933|NCT02120729|Psychiatric Inpatients|psychiatric inpatients
5311934|NCT02120729|Length of Stay|length of stay
5311935|NCT02120729|30 Day Readmission Rate|30 day readmission rate
5311936|NCT02120729|Psychiatric hospital inpatients|psychiatric hospital inpatients
5311937|NCT02120716|HIV|hiv
5311938|NCT02120716|STIs|stis
5311939|NCT02120716|Health Check Up|health check up
5311940|NCT02120716|Intervention|intervention
5311941|NCT02120703|Pregabalin|pregabalin
5311942|NCT02120703|gabapentin|gabapentin
5311943|NCT02120703|microdiscectomy|microdiscectomy
5311944|NCT02120703|pain|pain
5311945|NCT02120690|pain|pain
5311946|NCT02120690|fibromyagia|fibromyagia
5311947|NCT02120690|TNS|tns
5311948|NCT02120677|skin cancer|skin cancer
5311949|NCT02120677|basal cell carcinoma|basal cell carcinoma
5311950|NCT02120651|Fibrin monomer|fibrin monomer
5311951|NCT02120651|Tympanoplasty|tympanoplasty
5311952|NCT02120651|Hemostatic sponge|hemostatic sponge
5311953|NCT02120638|Multidrug Resistant Tuberculosis|multidrug resistant tuberculosis
5311954|NCT02120638|Pyrazinamide|pyrazinamide
5311955|NCT02120625|radiofrequency ablation|radiofrequency ablation
5311956|NCT02120625|neurotomy|neurotomy
5311957|NCT02120625|facet joint|facet joint
5311958|NCT02120625|medial branch|medial branch
5311959|NCT02120625|low back pain|low back pain
5311960|NCT02120612|Opioid Dependence|opioid dependence
5311961|NCT02120612|Addiction|addiction
5311962|NCT02120612|Naloxone|naloxone
5311963|NCT02120612|Naloxone Education|naloxone education
5311964|NCT02120612|Opiate Overdose Knowledge Scale|opiate overdose knowledge scale
5311965|NCT02120612|OOKS|ooks
5311966|NCT02120586|Elderly|elderly
5311967|NCT02120586|Institutionalization|institutionalization
5311968|NCT02120586|Sarcopenia|sarcopenia
5311969|NCT02120586|Strength training|strength training
5311970|NCT02120586|Muscle mass|muscle mass
5311971|NCT02120586|Muscle strength|muscle strength
5311972|NCT02120586|Physical performance|physical performance
5311973|NCT02120573|Cardiac Arrest|cardiac arrest
5311974|NCT02120573|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5311975|NCT02120573|Training|training
5311976|NCT02120560|Atrial Fibrillation Ablation|atrial fibrillation ablation
5311977|NCT02120560|Cerebrothromboemboli|cerebrothromboemboli
5311978|NCT02120560|Neurocognitive Function|neurocognitive function
5311979|NCT02120547|Liver Insufficiency|liver insufficiency
5311980|NCT02120547|Hepatic impairment|hepatic impairment
5311981|NCT02120534|soluble CD14 ,serum CD88,sepsis , SIRS.|soluble cd14 ,serum cd88,sepsis , sirs.
5312275|NCT02119377|genderqueer|genderqueer
5312001|NCT02120430|Parent-child interaction|parent-child interaction
5312002|NCT02120430|Parenting programs|parenting programs
5298976|NCT02183883|NSCLC|nsclc
5312004|NCT02120417|Breast Cancer|breast cancer
5312005|NCT02120404|septic shock, hemodynamic tolerance, esmolol|septic shock, hemodynamic tolerance, esmolol
5312006|NCT02120378|miscarriage|miscarriage
5312007|NCT02120378|fetal viability|fetal viability
5312008|NCT02120378|prematurity|prematurity
5312009|NCT02120365|Alcoholism|alcoholism
5312010|NCT02120365|Heavy Drinking|heavy drinking
5312011|NCT02120365|Perampanel|perampanel
5312035|NCT02120339|Hypertension|hypertension
5312037|NCT02120326|Chronic migraine, tDCS, Transcranial direct current stimulation|chronic migraine, tdcs, transcranial direct current stimulation
5312038|NCT02120313|rehabilitation|rehabilitation
5312039|NCT02120313|total knee arthroplasty|total knee arthroplasty
5312040|NCT02120287|Border Zone Stereotactic Radiosurgery|border zone stereotactic radiosurgery
5312041|NCT02120287|Bevacizumab|bevacizumab
5312042|NCT02120287|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5963140|NCT04271280|Cardiovascular disease|cardiovascular disease
5312043|NCT02120287|Progressive Glioblastoma Multiforme|progressive glioblastoma multiforme
5312044|NCT02120287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5312045|NCT02120287|Glioblastoma|glioblastoma
5312046|NCT02120287|Brain Cancer|brain cancer
5312048|NCT02120287|Radiosurgery|radiosurgery
5312049|NCT02120274|RNA Virus Infections|rna virus infections
5312050|NCT02120274|Flaviviridae Infections|flaviviridae infections
5312051|NCT02120274|Hepatitis C|hepatitis c
5312052|NCT02120274|Hepatitis C, Chronic|hepatitis c, chronic
5312053|NCT02120274|Vitamin D|vitamin d
5312054|NCT02120274|Cholecalciferol|cholecalciferol
5312055|NCT02120274|Vitamin B 12|vitamin b 12
5312056|NCT02120261|Myofascial Pain Syndrome|myofascial pain syndrome
5312057|NCT02120261|trigger point injection|trigger point injection
5312058|NCT02120248|WIC|wic
5312059|NCT02120248|Oregon|oregon
5312060|NCT02120248|Breastfeeding|breastfeeding
5312061|NCT02120248|Peer Counseling|peer counseling
5312062|NCT02120248|Exclusive Breastfeeding|exclusive breastfeeding
5312063|NCT02120235|Lysosomal storage disorders|lysosomal storage disorders
5312064|NCT02120235|LSD|lsd
5312065|NCT02120235|Gaucher disease|gaucher disease
5312066|NCT02120235|Fabry disease|fabry disease
5312067|NCT02120235|Pompe disease|pompe disease
5312068|NCT02120235|Niemann-Pick disease|niemann-pick disease
5312069|NCT02120222|melanoma|melanoma
5312070|NCT02120209|assessment; falls; older adults; prediction scale; standardized declaration|assessment; falls; older adults; prediction scale; standardized declaration
5312071|NCT02120183|Caregivers|caregivers
5312072|NCT02120183|Quality of life|quality of life
5312073|NCT02120183|Neoplasms|neoplasms
5312074|NCT02120183|Psychotherapy, group|psychotherapy, group
5312075|NCT02120183|Family|family
5312076|NCT02120183|Adaptation, psychological|adaptation, psychological
5312077|NCT02120183|Psycho-educational support group therapy|psycho-educational support group therapy
5312078|NCT02120183|Cancer patients|cancer patients
5312079|NCT02120170|Hemoclip, Heparin bridging therapy, colon polypectomy, warfarin|hemoclip, heparin bridging therapy, colon polypectomy, warfarin
5312374|NCT02118961|Tetanus|tetanus
5312080|NCT02120157|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5312081|NCT02120157|Acute myeloid leukemia|acute myeloid leukemia
5312082|NCT02120157|Juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5312083|NCT02120157|Treatment related leukemia|treatment related leukemia
5312084|NCT02120157|Biphenotypic leukemia|biphenotypic leukemia
5312085|NCT02120131|third molar surgery, periodontal probing depth , flap design|third molar surgery, periodontal probing depth , flap design
5312086|NCT02120118|Treatment failure|treatment failure
5312087|NCT02120105|Renal aminoaciduria|renal aminoaciduria
5312088|NCT02120105|cystinuria|cystinuria
5312089|NCT02120105|D-penicillamine|d-penicillamine
5312090|NCT02120105|renal tubular transport|renal tubular transport
5312091|NCT02120105|inborn errors|inborn errors
5312092|NCT02120105|tiopronin|tiopronin
5312093|NCT02120105|urolithiasis|urolithiasis
5312094|NCT02120092|ACS, Acute coronary syndrome|acs, acute coronary syndrome
5312095|NCT02120079|Dry Eye|dry eye
5312096|NCT02120066|Submacular hemorrhage|submacular hemorrhage
5312097|NCT02120066|Vitrectomy|vitrectomy
5312098|NCT02120066|tissue- plasminogen activator|tissue- plasminogen activator
5312099|NCT02120053|Immediate complete denture|immediate complete denture
5312100|NCT02120053|Alveolar ridge resorption|alveolar ridge resorption
5312101|NCT02120053|Alveolar bone loss|alveolar bone loss
5312102|NCT02120053|Bone substitute material|bone substitute material
5312103|NCT02120053|Edentulism|edentulism
5312104|NCT02120027|Irritable Bowel Syndrome|irritable bowel syndrome
5312105|NCT02120027|Colon, irritable|colon, irritable
5312106|NCT02120027|Bowel disease|bowel disease
5312107|NCT02120027|Diarrhea|diarrhea
5312108|NCT02120014|Heart Failure|heart failure
5312109|NCT02120014|Heart Failure Reduced Ejection Fraction|heart failure reduced ejection fraction
5312110|NCT02120014|Heart Failure Preserved Ejection Fraction|heart failure preserved ejection fraction
5312111|NCT02120014|Venous Plethysmography|venous plethysmography
5312112|NCT02120014|Blood Volume Study|blood volume study
5312113|NCT02120001|Medical Devices|medical devices
5423279|NCT01616355|disinfection;|disinfection;
5862863|NCT00001476|Retrovirus|retrovirus
5312116|NCT02120001|Endotracheal Tube|endotracheal tube
5312117|NCT02120001|Microbial Diversity|microbial diversity
5312119|NCT02120001|biofilms|biofilms
5312120|NCT02120001|endotracheal intubation|endotracheal intubation
5312121|NCT02120001|mechanical ventilation|mechanical ventilation
5312123|NCT02119988|Embolization|embolization
5312124|NCT02119988|Variceal rebleeding|variceal rebleeding
5312125|NCT02119975|Rumination|rumination
5312126|NCT02119975|Working memory|working memory
5312127|NCT02119975|Depression|depression
5312128|NCT02119975|Anxiety|anxiety
5312129|NCT02119975|Working memory training|working memory training
5312130|NCT02119975|Overgeneral memories|overgeneral memories
5312131|NCT02119962|burnout|burnout
5312132|NCT02119962|working memory|working memory
5312133|NCT02119962|working memory training|working memory training
5312134|NCT02119962|cognitive behavioral therapy|cognitive behavioral therapy
5312135|NCT02119962|executive control|executive control
5312136|NCT02119949|Substance abuse|substance abuse
5312137|NCT02119949|Addiction|addiction
5312138|NCT02119949|Working memory|working memory
5312139|NCT02119949|Craving|craving
5312140|NCT02119949|Impulsivity|impulsivity
5312141|NCT02119949|Attention control|attention control
5312142|NCT02119936|Stress|stress
5312143|NCT02119936|Anxiety|anxiety
5312144|NCT02119936|Mental Health|mental health
5312145|NCT02119936|Mental Health Services|mental health services
5312146|NCT02119936|Maternal Mental Health|maternal mental health
5312147|NCT02119923|Depression|depression
5312148|NCT02119923|Anxiety|anxiety
5312149|NCT02119923|Working memory|working memory
5312150|NCT02119923|Rumination|rumination
5312151|NCT02119923|Cognitive training|cognitive training
5312152|NCT02119923|Executive functioning|executive functioning
5312153|NCT02119910|pediatric feeding disorders|pediatric feeding disorders
5312154|NCT02119910|behavioral intervention|behavioral intervention
5312155|NCT02119910|treatment manual|treatment manual
5312156|NCT02119910|feeding|feeding
5312157|NCT02119910|food refusal|food refusal
5312158|NCT02119910|diet|diet
5312159|NCT02119897|Oropharyngeal Mucositis|oropharyngeal mucositis
5312160|NCT02119897|Myeloablative Hematopoietic Cell Transplantation|myeloablative hematopoietic cell transplantation
5312161|NCT02119897|Low Level Light Therapy|low level light therapy
5312162|NCT02119884|Gastric and Esophageal Varices|gastric and esophageal varices
5312163|NCT02119884|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5312164|NCT02119884|Terlipressin|terlipressin
5312165|NCT02119884|Octreotide|octreotide
5312166|NCT02119871|Cerebral air emboli, heart surgery|cerebral air emboli, heart surgery
5312167|NCT02119845|Chronic kidney disease|chronic kidney disease
5312168|NCT02119845|Arteriovenous fistula (AVF)|arteriovenous fistula (avf)
5312169|NCT02119845|Hemodialysis|hemodialysis
5312170|NCT02119845|Vascular access|vascular access
5312171|NCT02119845|Endovascular AVF (EndoAVF)|endovascular avf (endoavf)
5312172|NCT02119832|Chronic kidney disease|chronic kidney disease
5312173|NCT02119832|Arteriovenous fistula|arteriovenous fistula
5312178|NCT02119767|Atherosclerosis|atherosclerosis
5312179|NCT02119754|Wound|wound
5312180|NCT02119754|Ulcer|ulcer
5312181|NCT02119754|Infected|infected
5312182|NCT02119754|Infection|infection
5312183|NCT02119741|Interdental papilla|interdental papilla
5312184|NCT02119741|hyaluronic acid|hyaluronic acid
5312185|NCT02119741|esthetic zone|esthetic zone
5312186|NCT02119741|black triangles|black triangles
5312187|NCT02119715|Breast Cancer|breast cancer
5312188|NCT02119715|Neutropenia|neutropenia
5312189|NCT02119715|Febrile Neutropenia|febrile neutropenia
5312190|NCT02119702|HIV/AIDS, perinatal HIV infection|hiv/aids, perinatal hiv infection
5312191|NCT02119689|Diabetes|diabetes
5312192|NCT02119689|Retinopathy|retinopathy
5312193|NCT02119676|Metastatic Colorectal Cancer|metastatic colorectal cancer
5312194|NCT02119676|Colon Cancer|colon cancer
5312195|NCT02119676|Ruxolitinib|ruxolitinib
5312196|NCT02119676|adenocarcinoma|adenocarcinoma
5312197|NCT02119676|regorafenib|regorafenib
5312198|NCT02119676|Jakavi ®|jakavi ®
5312199|NCT02119676|Jakafi ®|jakafi ®
5312200|NCT02119676|Stivarga ®|stivarga ®
5312201|NCT02119663|Metastatic pancreatic cancer|metastatic pancreatic cancer
5312202|NCT02119650|Non small cell lung cancer|non small cell lung cancer
5312203|NCT02119637|Emotion|emotion
5312204|NCT02119637|Tactile Discrimination|tactile discrimination
5312205|NCT02119637|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5312206|NCT02119637|Somatosensory|somatosensory
5312207|NCT02119637|Somatosensory Cortex|somatosensory cortex
5312208|NCT02119624|Neural Networks|neural networks
5312209|NCT02119624|Alcoholism|alcoholism
5312210|NCT02119624|fMRI|fmri
5312211|NCT02119624|Reward|reward
5312212|NCT02119624|Addiction|addiction
5312217|NCT02119598|Prehospital care|prehospital care
5308808|NCT02134678|depression|depression
5312219|NCT02119598|Ambulance-based telemedicine|ambulance-based telemedicine
5312220|NCT02119585|orthotopic liver transplantation|orthotopic liver transplantation
5312221|NCT02119585|ischemia reperfusion syndrome|ischemia reperfusion syndrome
5312222|NCT02119585|cytokines|cytokines
5312223|NCT02119585|respiratory system elastance|respiratory system elastance
5312224|NCT02119585|lung elastance|lung elastance
5312225|NCT02119585|chest wall elastance|chest wall elastance
5312226|NCT02119585|shunt|shunt
5312227|NCT02119585|dead space|dead space
5312228|NCT02119585|acute respiratory failure|acute respiratory failure
5312229|NCT02119585|atelectasis|atelectasis
5312230|NCT02119585|pleural effusion|pleural effusion
5312231|NCT02119572|diabetes,peer support|diabetes,peer support
5312232|NCT02119559|Circulating Tumor Cells|circulating tumor cells
5312233|NCT02119559|Treatment Efficiency|treatment efficiency
5312234|NCT02119559|Biomarker|biomarker
5312235|NCT02119546|Mild CognitIve impairment|mild cognitive impairment
5312236|NCT02119546|Alzheimer's disease|alzheimer's disease
5312237|NCT02119546|Cognitive function|cognitive function
5312238|NCT02119546|Exercise training|exercise training
5312239|NCT02119533|brain injury|brain injury
5312240|NCT02119533|concussion|concussion
5312241|NCT02119533|post traumatic stress|post traumatic stress
5312242|NCT02119520|Periodontitis|periodontitis
5312243|NCT02119520|Surgery|surgery
5312244|NCT02119520|Growth Factors|growth factors
5312245|NCT02119520|Statins|statins
5312246|NCT02119507|Dental caries|dental caries
5312247|NCT02119507|Curodont Repair|curodont repair
5312248|NCT02119507|P11-4|p11-4
5312249|NCT02119494|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5312250|NCT02119494|phenotypes|phenotypes
5312251|NCT02119494|categories|categories
5312252|NCT02119494|stage|stage
5312253|NCT02119494|GOLD|gold
5312254|NCT02119494|treatment|treatment
5312255|NCT02119481|Mindfulness stress reduction training|mindfulness stress reduction training
5312256|NCT02119481|Expressive writing condition|expressive writing condition
5312257|NCT02119481|Waiting list control condition|waiting list control condition
5312258|NCT02119442|Eisenmenger Syndrome, Pulmonary Arterial Hyptertension|eisenmenger syndrome, pulmonary arterial hyptertension
5312259|NCT02119429|Blood pressure|blood pressure
5312260|NCT02119429|Pre-menopausal|pre-menopausal
5312261|NCT02119429|Supplementation|supplementation
5312262|NCT02119416|Cardiovascular influences|cardiovascular influences
5312263|NCT02119416|caffeine|caffeine
5312264|NCT02119416|healthy children|healthy children
5312265|NCT02119403|Minimal Sedation nitrous oxide|minimal sedation nitrous oxide
5312266|NCT02119390|adolescents|adolescents
5312267|NCT02119390|young adults|young adults
5312268|NCT02119390|medication adherence|medication adherence
5312269|NCT02119377|trans|trans
5312270|NCT02119377|transsexual|transsexual
5312271|NCT02119377|transgender|transgender
5312272|NCT02119377|sistergirl|sistergirl
5312273|NCT02119377|brotherboy|brotherboy
5312276|NCT02119364|cerebral palsy|cerebral palsy
5312277|NCT02119364|working memory|working memory
5312278|NCT02119364|cognitive training|cognitive training
5312279|NCT02119351|peripheral intravenous catheters|peripheral intravenous catheters
5312280|NCT02119351|blood exposure|blood exposure
5312281|NCT02119351|blood control|blood control
5312282|NCT02119351|IV catheter insertion|iv catheter insertion
5312283|NCT02119338|5-ala|5-ala
5312284|NCT02119338|5-aminolevulinic acid|5-aminolevulinic acid
5312285|NCT02119338|fluorescence-guided surgery|fluorescence-guided surgery
5312286|NCT02119338|glioma|glioma
5312287|NCT02119338|astrocytoma|astrocytoma
5312288|NCT02119338|glioblastoma|glioblastoma
5312289|NCT02119338|oligodendroglioma|oligodendroglioma
5312290|NCT02119338|recurrence of glioma|recurrence of glioma
5312291|NCT02119325|fibre|fibre
5312292|NCT02119325|overweight|overweight
5312293|NCT02119325|impaired fasting glucose|impaired fasting glucose
5312294|NCT02119312|Malaria|malaria
5312295|NCT02119312|Plasmodium|plasmodium
5312296|NCT02119312|Plasmodium falciparum|plasmodium falciparum
5312297|NCT02119312|Clinical Trials|clinical trials
5312298|NCT02119312|Vaccine Study|vaccine study
5312299|NCT02119312|Drug Study|drug study
5312300|NCT02119312|Malaria Clinical Trials Center|malaria clinical trials center
5312301|NCT02119312|Seattle BioMed|seattle biomed
5312302|NCT02119312|Center for Infectious Disease Research|center for infectious disease research
5312303|NCT02119286|long acting beta2- receptor agonist|long acting beta2- receptor agonist
5312304|NCT02119286|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
5312305|NCT02119286|dry powder inhaler|dry powder inhaler
5312306|NCT02119286|safety|safety
5312307|NCT02119286|COPD|copd
5312308|NCT02119286|inhaled corticosteroid|inhaled corticosteroid
5312309|NCT02119286|efficacy|efficacy
5312310|NCT02119286|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
5312311|NCT02119286|umeclidinium bromide|umeclidinium bromide
5312312|NCT02119273|CRSsNP|crssnp
5312313|NCT02119273|Steroids|steroids
5312314|NCT02119273|Corticosteroids|corticosteroids
5312315|NCT02119273|Endoscopic|endoscopic
5312316|NCT02119273|Surgery|surgery
5312317|NCT02119273|Perioperative|perioperative
5312318|NCT02119260|First Time in Human|first time in human
5312319|NCT02119260|TRPV4 inhibitor|trpv4 inhibitor
5312320|NCT02119260|Heart failure|heart failure
5312321|NCT02119247|systemic availability , pharmacokinetics, COPD|systemic availability , pharmacokinetics, copd
5312323|NCT02119195|sealant|sealant
5312324|NCT02119195|longevity|longevity
5312325|NCT02119182|Traumatic Brain Injury|traumatic brain injury
5312326|NCT02119182|Biomarkers|biomarkers
5312327|NCT02119182|Neuroimaging|neuroimaging
5312328|NCT02119182|Psychological Health|psychological health
5312329|NCT02119182|Comparative Effectiveness Research|comparative effectiveness research
5312330|NCT02119156|treatment holiday|treatment holiday
5312331|NCT02119156|PGA|pga
5312332|NCT02119156|belimumab|belimumab
5312333|NCT02119156|Lymphostat-B|lymphostat-b
5312334|NCT02119156|rebound|rebound
5312335|NCT02119156|SELENA SLEDAI|selena sledai
5312336|NCT02119156|Systemic Lupus Erythematosus|systemic lupus erythematosus
5312337|NCT02119156|immunogenicity|immunogenicity
5312338|NCT02119143|common cold, immunity, oxidative stress|common cold, immunity, oxidative stress
5312339|NCT02119130|cluster randomized trial|cluster randomized trial
5312340|NCT02119130|interferon-gamma|interferon-gamma
5312341|NCT02119130|tuberculin test|tuberculin test
5312342|NCT02119130|operational comparison|operational comparison
5312343|NCT02119130|cost effectiveness|cost effectiveness
5312344|NCT02119130|qualitative evaluation|qualitative evaluation
5312346|NCT02119117|aneuploidy|aneuploidy
5312347|NCT02119117|IVF|ivf
5312348|NCT02119117|blastocyst|blastocyst
5312349|NCT02119117|COQ10|coq10
5312350|NCT02119091|QT prolongation|qt prolongation
5312351|NCT02119091|Chinese|chinese
5312352|NCT02119091|Caucasian|caucasian
5312353|NCT02119091|Moxifloxacin|moxifloxacin
5312354|NCT02119078|Geriatrics|geriatrics
5312355|NCT02119078|Acute Care for Elders|acute care for elders
5312356|NCT02119078|Geriatric syndromes|geriatric syndromes
5312357|NCT02119078|Delirium|delirium
5312358|NCT02119078|Falls|falls
5312359|NCT02119078|Polypharmacy|polypharmacy
5312360|NCT02119065|Yttrium-90 Radioembolization|yttrium-90 radioembolization
5312361|NCT02119065|hepatic malignancy|hepatic malignancy
5312362|NCT02119065|hepatic metastatic disease|hepatic metastatic disease
5312363|NCT02119039|Cross-linking|cross-linking
5312364|NCT02119039|RGTA OTR4120 (CACICOL20)|rgta otr4120 (cacicol20)
5312365|NCT02119026|metastatic colorectal cancer|metastatic colorectal cancer
5312366|NCT02119026|Patients with metastatic colorectal cancer who did not receive|patients with metastatic colorectal cancer who did not receive
5312367|NCT02119026|systemic treatment for their metastatic disease|systemic treatment for their metastatic disease
5312368|NCT02118987|Drug Desensitization|drug desensitization
5312369|NCT02118987|Hypersensitivity reactions to chemotherapeutic agents|hypersensitivity reactions to chemotherapeutic agents
5312370|NCT02118974|Hysterectomy|hysterectomy
5312371|NCT02118974|Robot-assisted|robot-assisted
5312372|NCT02118974|Laparoscopy|laparoscopy
5312373|NCT02118961|Diphtheria|diphtheria
5312375|NCT02118961|Pertussis|pertussis
5312376|NCT02118961|DTaP vaccine|dtap vaccine
5312377|NCT02118961|Adolescents|adolescents
5312378|NCT02118948|abuse|abuse
5312379|NCT02118948|sexual behavior|sexual behavior
5312380|NCT02118948|sexual risk reduction|sexual risk reduction
5312381|NCT02118948|behavioral intervention|behavioral intervention
5312382|NCT02118922|LASIK|lasik
5312383|NCT02118896|FK506E|fk506e
5312384|NCT02118896|Heart Transplantation|heart transplantation
5312385|NCT02118896|MR4|mr4
5312386|NCT02118896|Tacrolimus|tacrolimus
5312387|NCT02118896|Advagraf|advagraf
5312388|NCT02118896|Kidney Transplantation|kidney transplantation
5312389|NCT02118896|Renal Transplantation|renal transplantation
5312390|NCT02118883|exercise|exercise
5312391|NCT02118883|hydration|hydration
5312392|NCT02118883|dehydration|dehydration
5312393|NCT02118883|rehydration|rehydration
5312394|NCT02118883|alkaline water|alkaline water
5312395|NCT02118883|blood viscosity|blood viscosity
5312396|NCT02118883|plasma osmolality|plasma osmolality
5312397|NCT02118883|bioimpedance|bioimpedance
5312398|NCT02118870|ACS patients|acs patients
5312399|NCT02118870|Older than 18 years|older than 18 years
5312400|NCT02118870|PCI|pci
5312401|NCT02118870|Combo stent|combo stent
5312402|NCT02118857|Microorganisms and foods|microorganisms and foods
5312403|NCT02118857|Fecal microbiota|fecal microbiota
5312404|NCT02118857|Salivary microbiota|salivary microbiota
5312405|NCT02118844|bariatric surgery|bariatric surgery
5312406|NCT02118844|surgical conditions|surgical conditions
5312407|NCT02118844|deep neuromuscular blockade|deep neuromuscular blockade
5312408|NCT02118831|macular degeneration|macular degeneration
5312409|NCT02118831|diabetic macular edema|diabetic macular edema
5312410|NCT02118831|vein occlusion|vein occlusion
5312411|NCT02118831|vascular endothelial growth factor|vascular endothelial growth factor
5312412|NCT02118805|ALS|als
5312413|NCT02118805|Myasthenia Gravis|myasthenia gravis
5312414|NCT02118805|Myopathy|myopathy
5312415|NCT02118805|Stroke|stroke
5312416|NCT02118805|Parkinson's Disease|parkinson's disease
5312417|NCT02118805|Bulbar|bulbar
5312418|NCT02118805|Orofacial|orofacial
5312419|NCT02118805|Ultrasound|ultrasound
5312420|NCT02118805|Electrical Impedance Myography|electrical impedance myography
5312421|NCT02118792|atopic dermatitis|atopic dermatitis
5312422|NCT02118779|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
5312424|NCT02118779|Physical Exercise|physical exercise
5312425|NCT02118779|Cognitive Behavioural Therapy|cognitive behavioural therapy
5312426|NCT02118779|Biomarkers|biomarkers
5312427|NCT02118766|atopic dermatitis|atopic dermatitis
5312428|NCT02118753|ischemia-reperfusion injury|ischemia-reperfusion injury
5312429|NCT02118740|Autologous Stem Cells|autologous stem cells
5312430|NCT02118740|Spinal Cord Injury|spinal cord injury
5312431|NCT02118740|Preclinical|preclinical
5312432|NCT02118727|ALS|als
5312433|NCT02118727|FTD|ftd
5312434|NCT02118727|Tau|tau
5312435|NCT02118727|pNF-H/C3|pnf-h/c3
5312436|NCT02118714|Diabetic Nephropathies|diabetic nephropathies
5312437|NCT02118714|Kidney Diseases|kidney diseases
5312438|NCT02118714|Urologic Diseases|urologic diseases
5312439|NCT02118714|Diabetes Complications|diabetes complications
5312440|NCT02118714|Diabetes Mellitus|diabetes mellitus
5312441|NCT02118714|Endocrine System Diseases|endocrine system diseases
5312442|NCT02118701|Shared decision making|shared decision making
5312443|NCT02118701|Dementia|dementia
5312444|NCT02118701|Long-term care|long-term care
5312445|NCT02118701|Nursing home|nursing home
5312446|NCT02118701|Care plan|care plan
5312447|NCT02118636|Joint pain|joint pain
5312448|NCT02118636|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5312449|NCT02118636|Estrogen|estrogen
5312450|NCT02118636|Androgen|androgen
5312451|NCT02118623|Bipolar Disorder|bipolar disorder
5312452|NCT02118623|Bipolar|bipolar
5312453|NCT02118623|Online intervention|online intervention
5312454|NCT02118623|Internet intervention|internet intervention
5312455|NCT02118623|Self help|self help
5312456|NCT02118545|vWF|vwf
5312457|NCT02118545|Liver Resection|liver resection
5312458|NCT02118545|Liver Dysfunction|liver dysfunction
5312459|NCT02118545|Liver Regeneration|liver regeneration
5312460|NCT02118545|Postoperative Outcome|postoperative outcome
5312461|NCT02118532|Atherosclerosis|atherosclerosis
5312462|NCT02118532|Superficial Femoral Artery|superficial femoral artery
5312463|NCT02118532|Proximal Popliteal Artery|proximal popliteal artery
5312464|NCT02118519|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
5312465|NCT02118519|Knee articular cartilage injury|knee articular cartilage injury
5312466|NCT02118519|Chondrogenesis|chondrogenesis
5312467|NCT02118519|orthopedics|orthopedics
5312468|NCT02118506|Primary Parkinsonism.|primary parkinsonism.
5312469|NCT02118506|Rehabilitation.|rehabilitation.
5312470|NCT02118506|Biomechanics.|biomechanics.
5312471|NCT02118506|Neurological gait disorders.|neurological gait disorders.
5312472|NCT02118493|Benign Biliary Stenosis|benign biliary stenosis
5312473|NCT02118493|Laser Excision|laser excision
5312474|NCT02118480|Parkinson disease, cognitive rehabilitation, REHACOP|parkinson disease, cognitive rehabilitation, rehacop
5312475|NCT02118467|Shock|shock
5312770|NCT02117180|FGID|fgid
5312476|NCT02118467|Vasopressor agents|vasopressor agents
5312477|NCT02118467|Norepinephrine|norepinephrine
5312478|NCT02118467|Epinephrine|epinephrine
5312479|NCT02118467|Phenylephrine|phenylephrine
5312480|NCT02118467|Vasopressin|vasopressin
5312481|NCT02118467|Atrial fibrillation|atrial fibrillation
5312482|NCT02118467|Tachyarrhythmia|tachyarrhythmia
5312483|NCT02118454|Medication adherence|medication adherence
5312484|NCT02118454|Self-management|self-management
5312485|NCT02118454|Depression|depression
5312486|NCT02118454|Coping|coping
5312487|NCT02118454|Social support|social support
5312488|NCT02118454|Mobile health|mobile health
5312489|NCT02118454|Antiretroviral treatment|antiretroviral treatment
5312490|NCT02118428|whole blood|whole blood
5312491|NCT02118428|transfusion|transfusion
5312492|NCT02118428|Plasmodium|plasmodium
5312493|NCT02118428|Malaria|malaria
5312494|NCT02118428|Pathogen Reduction Technology|pathogen reduction technology
5312495|NCT02118428|Whole blood transfusion|whole blood transfusion
5312496|NCT02118415|not eligible for surgery|not eligible for surgery
5312497|NCT02118415|efficacy of immunotherapy following RCTx|efficacy of immunotherapy following rctx
5312498|NCT02118376|obesity; fat distribution; inflammation|obesity; fat distribution; inflammation
5312499|NCT02118363|upper limb|upper limb
5312500|NCT02118363|lower limb|lower limb
5312501|NCT02118363|monitoring|monitoring
5312502|NCT02118363|assessment|assessment
5312503|NCT02118363|sensor|sensor
5312504|NCT02118337|select advanced malignancies,|select advanced malignancies,
5312505|NCT02118337|kidney cancer,|kidney cancer,
5312506|NCT02118337|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5312507|NCT02118324|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5312508|NCT02118324|ALL|all
5312509|NCT02118324|fitness intervention|fitness intervention
5312510|NCT02118311|Acute Leukemias|acute leukemias
5312511|NCT02118311|Burkitt's Lymphoma|burkitt's lymphoma
5312512|NCT02118311|Natural Killer Cell Malignancies|natural killer cell malignancies
5312513|NCT02118311|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5312514|NCT02118311|Myelodysplastic Syndrome|myelodysplastic syndrome
5312515|NCT02118311|Large-Cell Lymphoma|large-cell lymphoma
5312516|NCT02118311|Hodgkin Lymphoma|hodgkin lymphoma
5312517|NCT02118311|Multiple Myeloma|multiple myeloma
5312518|NCT02118311|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5312519|NCT02118311|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5312520|NCT02118311|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
5312521|NCT02118311|Follicular Lymphoma:|follicular lymphoma:
5312522|NCT02118311|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5312523|NCT02118311|Mantle-Cell Lymphoma|mantle-cell lymphoma
5312524|NCT02118311|Prolymphocytic Leukemia|prolymphocytic leukemia
5312526|NCT02118285|Fallopian cancer|fallopian cancer
5312527|NCT02118285|Primary peritoneal cancer|primary peritoneal cancer
5312528|NCT02118259|Multidisciplinary review of drug prescriptions|multidisciplinary review of drug prescriptions
5312529|NCT02118259|Adverse drug events geriatric risk score|adverse drug events geriatric risk score
5312530|NCT02118259|Residence for dependent elderly|residence for dependent elderly
5312531|NCT02118246|Knee pain,Dry Needling, kinesioTape,Trigger point|knee pain,dry needling, kinesiotape,trigger point
5312532|NCT02118233|carotid|carotid
5312533|NCT02118233|stenosis|stenosis
5312534|NCT02118233|surgery|surgery
5312535|NCT02118233|cognitive|cognitive
5312536|NCT02118233|unilateral|unilateral
5312537|NCT02118207|SCUBA diving|scuba diving
5312538|NCT02118207|Exercise|exercise
5312539|NCT02118207|Microparticles|microparticles
5312540|NCT02118207|Repetitive diving|repetitive diving
5312541|NCT02118207|Endothelial function|endothelial function
5312542|NCT02118194|paraplegia|paraplegia
5312543|NCT02118194|paralysis|paralysis
5312544|NCT02118194|robotics|robotics
5312545|NCT02118194|walking|walking
5312546|NCT02118194|immobilization|immobilization
5312548|NCT02118168|HAART|haart
5312549|NCT02118168|Tat Protein|tat protein
5312550|NCT02118129|Vitamin D|vitamin d
5312551|NCT02118129|Intervention|intervention
5312552|NCT02118129|Behaviour|behaviour
5312553|NCT02118129|Mobile app|mobile app
5312554|NCT02118116|ASIST, gatekeeper, suicide, intervention, First Nations, Aboriginal, educational, prevention, safety|asist, gatekeeper, suicide, intervention, first nations, aboriginal, educational, prevention, safety
5312555|NCT02118103|Lumbosacral Region|lumbosacral region
5312556|NCT02118103|Psychomotor Performance|psychomotor performance
5312557|NCT02118103|Manipulation, Spinal|manipulation, spinal
5312558|NCT02118090|malaria|malaria
5312559|NCT02118090|Plasmodium vivax|plasmodium vivax
5312560|NCT02118090|drug resistance|drug resistance
5312561|NCT02118090|chloroquine|chloroquine
5312562|NCT02118090|Cambodia|cambodia
5312563|NCT02118064|G17DT|g17dt
5312564|NCT02118064|irinotecan|irinotecan
5312565|NCT02118064|Colorectal Cancer|colorectal cancer
5312566|NCT02118051|Infertility|infertility
5312567|NCT02118051|IVF|ivf
5312568|NCT02118051|Corifollitropin Alfa treatment|corifollitropin alfa treatment
5312569|NCT02118051|Ovarian stimulation|ovarian stimulation
5312570|NCT02118038|Postpartum haemorrhage|postpartum haemorrhage
5312571|NCT02118038|Sulprostone|sulprostone
5312572|NCT02118038|Cardiac impact|cardiac impact
5312574|NCT02118038|Cardiac magnetic imaging resonance|cardiac magnetic imaging resonance
5312575|NCT02118025|Off-pump bypass graft surgery|off-pump bypass graft surgery
5312576|NCT02118025|Mini extracorporeal circulation bypass surgery|mini extracorporeal circulation bypass surgery
5312578|NCT02118012|Direct Acting Antivirals|direct acting antivirals
5312579|NCT02118012|Ribavirin|ribavirin
5312580|NCT02118012|Chronic Hepatitis C|chronic hepatitis c
5312581|NCT02117999|corneal cross-linking|corneal cross-linking
5312582|NCT02117999|transepithelial corneal cross-linking|transepithelial corneal cross-linking
5312583|NCT02117999|iontophoresis|iontophoresis
5312584|NCT02117999|progressive keratoconus|progressive keratoconus
5312585|NCT02117986|critically ill patients|critically ill patients
5312586|NCT02117986|colistin dosing|colistin dosing
5312587|NCT02117986|multidrug resistant bacteria|multidrug resistant bacteria
5312588|NCT02117960|atherosclerotic|atherosclerotic
5312589|NCT02117960|BMP-4|bmp-4
5312590|NCT02117960|YKL40|ykl40
5312591|NCT02117960|HSP70|hsp70
5312592|NCT02117960|HSP27|hsp27
5312593|NCT02117947|child secondhand smoke|child secondhand smoke
5312594|NCT02117947|maternal smoking|maternal smoking
5312595|NCT02117947|tobacco|tobacco
5312596|NCT02117947|nicotine|nicotine
5312597|NCT02117947|behavioral counseling|behavioral counseling
5312598|NCT02117947|low-income|low-income
5312599|NCT02117947|underserved|underserved
5312600|NCT02117934|HBV vaccine|hbv vaccine
5312601|NCT02117934|HEPLISAV-B|heplisav-b
5312602|NCT02117934|Hepatitis B vaccine|hepatitis b vaccine
5312603|NCT02117934|Hepatitis B|hepatitis b
5312604|NCT02117934|Hepatitis|hepatitis
5312605|NCT02117934|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
5312606|NCT02117934|Prevention and Control|prevention and control
5312607|NCT02117934|Healthy|healthy
5312608|NCT02117934|Healthy volunteers|healthy volunteers
5312609|NCT02117921|Mind Body Syndrome|mind body syndrome
5312610|NCT02117921|MBS|mbs
5312611|NCT02117921|Chronic Pain|chronic pain
5312612|NCT02117908|prevention|prevention
5299595|NCT02179905|Fatty acid|fatty acid
5299596|NCT02179892|anesthesia|anesthesia
5299600|NCT02179853|Kawasaki disease|kawasaki disease
5312613|NCT02117908|radiofrequency treatment|radiofrequency treatment
5312614|NCT02117908|lung cancer ablation|lung cancer ablation
5312615|NCT02117895|Distal Pancreatectomy|distal pancreatectomy
5312616|NCT02117895|Celiac Plexus|celiac plexus
5312617|NCT02117895|Resection|resection
5312618|NCT02117895|Pancreatic Cancer|pancreatic cancer
5312619|NCT02117895|Body and Tail|body and tail
5312620|NCT02117882|lateral approach, bone augmentation , sinus floor elevation|lateral approach, bone augmentation , sinus floor elevation
5312621|NCT02117869|Grapefruit juice|grapefruit juice
5312622|NCT02117856|Implant-Supported Denture|implant-supported denture
5312623|NCT02117856|Single-Implant Denture|single-implant denture
5312624|NCT02117856|Patient Satisfaction|patient satisfaction
5312625|NCT02117856|Edentulous Mandible|edentulous mandible
5312626|NCT02117856|Dental Implants|dental implants
5312627|NCT02117856|Standard of Care|standard of care
5312628|NCT02117856|Randomized Clinical Trial|randomized clinical trial
5312629|NCT02117830|To determine|to determine
5312630|NCT02117830|effects|effects
5312631|NCT02117830|once|once
5312632|NCT02117830|daily|daily
5312633|NCT02117830|oral doses|oral doses
5312634|NCT02117830|Androxal|androxal
5312635|NCT02117804|Discharge Planning|discharge planning
5312636|NCT02117804|Decision Support|decision support
5312639|NCT02117765|ustekinumab|ustekinumab
5312640|NCT02117765|new-onset|new-onset
5312641|NCT02117765|diabetes|diabetes
5312642|NCT02117726|Sedation;|sedation;
5312643|NCT02117726|ARDS;|ards;
5312644|NCT02117726|Mechanical ventilation|mechanical ventilation
5312645|NCT02117726|Hypnotics|hypnotics
5312646|NCT02117726|Antianxiety Drugs|antianxiety drugs
5312647|NCT02117726|Causing|causing
5312648|NCT02117726|Adverse Effects|adverse effects
5312649|NCT02117726|Therapeutic Use|therapeutic use
5312650|NCT02117700|fatty liver|fatty liver
5312651|NCT02117700|obesity|obesity
5312652|NCT02117700|children|children
5312653|NCT02117700|oxidative stress|oxidative stress
5312654|NCT02117700|antioxidants|antioxidants
5312655|NCT02117674|colonoscopy|colonoscopy
5312656|NCT02117674|adenoma detection rate|adenoma detection rate
5312657|NCT02117674|full spectrum colonoscopy|full spectrum colonoscopy
5312658|NCT02117674|right colon retroflexion|right colon retroflexion
5312659|NCT02117674|feasibility|feasibility
5312660|NCT02117661|L-carnitine|l-carnitine
5312661|NCT02117661|Metabolic syndrome|metabolic syndrome
5312662|NCT02117661|Atherosclerosis|atherosclerosis
5312663|NCT02117661|Coronary artery disease|coronary artery disease
5312664|NCT02117661|Carotid|carotid
5312665|NCT02117661|Plaque|plaque
5312666|NCT02117661|Cardiovascular disease|cardiovascular disease
5312667|NCT02117661|Heart disease|heart disease
5312668|NCT02117661|Vascular disease|vascular disease
5312669|NCT02117648|advanced cancer|advanced cancer
5312670|NCT02117648|metastatic cancer|metastatic cancer
5312671|NCT02117635|Efficacy|efficacy
5312672|NCT02117635|Non comparative|non comparative
5312673|NCT02117635|Neural stem cells|neural stem cells
5312674|NCT02117635|Intracranial administration|intracranial administration
5312675|NCT02117609|Elderly|elderly
5312676|NCT02117609|Nursing home|nursing home
5312677|NCT02117609|Functional impairment|functional impairment
5312678|NCT02117609|High-protein oral supplement|high-protein oral supplement
5312679|NCT02117596|Pediatric|pediatric
5312680|NCT02117596|Renal|renal
5312681|NCT02117596|Transplant|transplant
5312682|NCT02117583|pharmacokinetics|pharmacokinetics
5312683|NCT02117583|relative bioavailability|relative bioavailability
5312684|NCT02117583|food effects|food effects
5312685|NCT02117583|oxycodone|oxycodone
5312686|NCT02117570|Clostridium difficile|clostridium difficile
5312687|NCT02117570|vaccine|vaccine
5312688|NCT02117557|Single-incision|single-incision
5312689|NCT02117557|Laparoscopy|laparoscopy
5312690|NCT02117557|Colorectal Cancer|colorectal cancer
5312691|NCT02117544|Contact lens|contact lens
5312692|NCT02117544|Presbyopia|presbyopia
5312693|NCT02117544|Multifocal|multifocal
5312694|NCT02117518|type 1 diabetes|type 1 diabetes
5312695|NCT02117518|autoreactive T cells|autoreactive t cells
5312696|NCT02117518|beta cell peptides|beta cell peptides
5312697|NCT02117518|genetically modified T cells|genetically modified t cells
5312698|NCT02117518|mRNA electroporation|mrna electroporation
5312699|NCT02117505|Biological Availability|biological availability
5312700|NCT02117505|JNJ-39220675|jnj-39220675
5312701|NCT02117505|Healthy|healthy
5312702|NCT02117505|Phase 1|phase 1
5312703|NCT02117492|hysterectomy|hysterectomy
5312704|NCT02117492|vaginal cuff|vaginal cuff
5312705|NCT02117479|Metastatic pancreatic cancer|metastatic pancreatic cancer
5356877|NCT01917591|Biological Dressings|biological dressings
5312706|NCT02117479|Metastatic pancreatic adenocarcinoma that is recurrent|metastatic pancreatic adenocarcinoma that is recurrent
5312707|NCT02117466|cetuximab|cetuximab
5312708|NCT02117466|PET-imaging|pet-imaging
5312709|NCT02117453|ANCA vasculitis|anca vasculitis
5312710|NCT02117453|Statin|statin
5309335|NCT02132442|Vitamin D deficiency|vitamin d deficiency
5312711|NCT02117453|Subclinical markers of atherosclerosis|subclinical markers of atherosclerosis
5312712|NCT02117453|Cardiovascular events|cardiovascular events
5312713|NCT02117453|Myocardial infarction|myocardial infarction
5312715|NCT02117453|Arterial revascularization|arterial revascularization
5312716|NCT02117453|Unstable angina|unstable angina
5312717|NCT02117453|Death|death
5312718|NCT02117440|Lung Cancer|lung cancer
5312719|NCT02117440|Lung Neoplasms|lung neoplasms
5312720|NCT02117414|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5312721|NCT02117388|Older adults|older adults
5312722|NCT02117388|insomnia|insomnia
5312723|NCT02117388|CBT-I (cognitive behavioral therapy-insomnia)|cbt-i (cognitive behavioral therapy-insomnia)
5312724|NCT02117388|Behavioral Therapy|behavioral therapy
5312725|NCT02117388|SRT (sleep restriction therapy)|srt (sleep restriction therapy)
5312726|NCT02117388|Cognitive Therapy|cognitive therapy
5312727|NCT02117375|multiple sclerosis|multiple sclerosis
5312728|NCT02117375|spinal cord|spinal cord
5312729|NCT02117375|MRI|mri
5312730|NCT02117375|longitudinal study|longitudinal study
5312731|NCT02117375|disability|disability
5312732|NCT02117362|Melanoma|melanoma
5312733|NCT02117362|Ipilimumab|ipilimumab
5312734|NCT02117362|Yervoy|yervoy
5312735|NCT02117362|Galectin|galectin
5312736|NCT02117362|GR-MD-02|gr-md-02
5312737|NCT02117362|galactoarabino-rhamnogalacturonate|galactoarabino-rhamnogalacturonate
5312738|NCT02117362|galectin-3 inhibitor|galectin-3 inhibitor
5312739|NCT02117362|Providence Health & Services|providence health & services
5312740|NCT02117362|Earle A. Chiles Research Institute|earle a. chiles research institute
5312741|NCT02117362|Robert W. Franz Cancer Center|robert w. franz cancer center
5312742|NCT02117362|Immunotherapy|immunotherapy
5312743|NCT02117349|surgical hemostasis|surgical hemostasis
5312744|NCT02117349|bleeding|bleeding
5312745|NCT02117349|fibrin sealant|fibrin sealant
5312746|NCT02117349|fibrinogen|fibrinogen
5312747|NCT02117349|thrombin|thrombin
5312748|NCT02117349|spray dried|spray dried
5207888|NCT02695953|PTSD|ptsd
5312749|NCT02117323|corneal opacities|corneal opacities
5312750|NCT02117323|Optical coherence tomography|optical coherence tomography
5312751|NCT02117284|positron emission tomography (PET)|positron emission tomography (pet)
5312752|NCT02117284|Rubidium-82|rubidium-82
5312753|NCT02117284|myocardial perfusion imaging|myocardial perfusion imaging
5312754|NCT02117284|automated elution system|automated elution system
5312755|NCT02117284|controlled radioactivity delivery|controlled radioactivity delivery
5312756|NCT02117271|obstructive sleep apnea|obstructive sleep apnea
5312757|NCT02117271|treatment|treatment
5312758|NCT02117271|placebo|placebo
5312759|NCT02117271|appearance|appearance
5312760|NCT02117271|skin quality|skin quality
5312761|NCT02117258|Z-360, Pancreatic cancer, Pancreatic Adenocarcinoma|z-360, pancreatic cancer, pancreatic adenocarcinoma
5312762|NCT02117245|Food effect on MGCD265 bioavailability in healthy volunteers|food effect on mgcd265 bioavailability in healthy volunteers
5312763|NCT02117232|colonoscopy|colonoscopy
5312764|NCT02117232|cecal intubation|cecal intubation
5312765|NCT02117232|carbon dioxide insufflation|carbon dioxide insufflation
5312766|NCT02117219|Myelodysplastic syndrome|myelodysplastic syndrome
5312767|NCT02117219|MDS|mds
5312768|NCT02117206|L-arginine|l-arginine
5312769|NCT02117180|functional gastrointestinal disorders|functional gastrointestinal disorders
5312771|NCT02117180|children|children
5312772|NCT02117180|FODMAP|fodmap
5312773|NCT02117154|Continuous Glucose Monitoring System|continuous glucose monitoring system
5312774|NCT02117154|HbA1c|hba1c
5312775|NCT02117154|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5312776|NCT02117141|Food Effect|food effect
5312777|NCT02117141|Pharmacokinetics|pharmacokinetics
5312778|NCT02117128|Tranexamic Acid|tranexamic acid
5312779|NCT02117128|Antifibrinolytic|antifibrinolytic
5312780|NCT02117128|Blood transfusion|blood transfusion
5312781|NCT02117128|Total knee arthroplasty|total knee arthroplasty
5312782|NCT02117076|Restless leg syndrome|restless leg syndrome
5312783|NCT02117076|RLS|rls
5312784|NCT02117076|gabapentin|gabapentin
5312785|NCT02117076|gabapentin enacarbil|gabapentin enacarbil
5312786|NCT02117076|Neurontin|neurontin
5312787|NCT02117076|Horizant|horizant
5312788|NCT02117050|Multiple Sclerosis|multiple sclerosis
5312789|NCT02117050|Rebif ®|rebif ®
5312790|NCT02117050|Tecfidera ™|tecfidera ™
5312791|NCT02117050|treatment change|treatment change
5312792|NCT02117024|lung|lung
5312793|NCT02117024|cancer|cancer
5312794|NCT02117024|gp96|gp96
5312795|NCT02117024|vaccine|vaccine
5312796|NCT02117024|immunotherapy|immunotherapy
5312797|NCT02117024|Heat Biologics|heat biologics
5312798|NCT02117024|cyclophosphamide|cyclophosphamide
5312799|NCT02117024|vinorelbine|vinorelbine
5312800|NCT02117024|erlotinib|erlotinib
5312801|NCT02117024|gemcitabine|gemcitabine
5312802|NCT02117024|paclitaxel|paclitaxel
5312803|NCT02117024|docetaxel|docetaxel
5312804|NCT02117024|pemetrexed|pemetrexed
5312805|NCT02116998|GEN-004|gen-004
5312806|NCT02116998|Aluminum hydroxide|aluminum hydroxide
5312807|NCT02116998|Vaccine|vaccine
5312808|NCT02116998|Streptococcus pneumoniae|streptococcus pneumoniae
5312809|NCT02116998|Pneumococcal Infections|pneumococcal infections
5312815|NCT02116972|osteoarthritis|osteoarthritis
5312816|NCT02116972|knee|knee
5312817|NCT02116972|pain|pain
5312818|NCT02116972|corticosteroid|corticosteroid
5312819|NCT02116972|intra-articular|intra-articular
5312820|NCT02116972|injection|injection
5312821|NCT02116959|Systemic|systemic
5312822|NCT02116959|Chemotherapy|chemotherapy
5312823|NCT02116959|Melphalan|melphalan
5312824|NCT02116933|Autologous Fat Grafting|autologous fat grafting
5312825|NCT02116933|Breast Augmentation|breast augmentation
5312826|NCT02116933|Stromal Vascular Fraction|stromal vascular fraction
5312827|NCT02116933|Adipose Derived Stem Cell|adipose derived stem cell
5312829|NCT02116920|HPV DNA|hpv dna
5312830|NCT02116920|mRNA E6/E7|mrna e6/e7
5312831|NCT02116920|CIN triage|cin triage
5312832|NCT02116920|Cervix Biopsy|cervix biopsy
5312833|NCT02116920|VIA|via
5312834|NCT02116920|Cervix Cancer|cervix cancer
5312835|NCT02116907|Healthy|healthy
5312836|NCT02116907|Male Subjects|male subjects
5312837|NCT02116894|Colorectal cancer|colorectal cancer
5312838|NCT02116894|PF-03446962|pf-03446962
5312839|NCT02116894|regorafenib|regorafenib
5312840|NCT02116881|Incisional hernia|incisional hernia
5312841|NCT02116881|colorectal surgery|colorectal surgery
5312842|NCT02116881|bowel obstruction|bowel obstruction
5312843|NCT02116868|Pupillometry|pupillometry
5312844|NCT02116868|Pupillary reflex|pupillary reflex
5312845|NCT02116868|Analgesia|analgesia
5312846|NCT02116868|Laparoscopic surgery|laparoscopic surgery
5312847|NCT02116868|Total intravenous anesthesia|total intravenous anesthesia
5312848|NCT02116868|Target controlled infusion|target controlled infusion
5312849|NCT02116803|solid tumors|solid tumors
5312850|NCT02116803|TKI258|tki258
5312851|NCT02116803|Dovitinib|dovitinib
5312852|NCT02116803|fulvestrant|fulvestrant
5312853|NCT02116803|cancers with a mass|cancers with a mass
5312854|NCT02116803|bulky tumor|bulky tumor
5312855|NCT02116803|nodule|nodule
5312856|NCT02116803|lump|lump
5312857|NCT02116803|cancer|cancer
5312858|NCT02116803|solid malignancies|solid malignancies
5312859|NCT02116790|acute|acute
5312860|NCT02116790|pain|pain
5312861|NCT02116764|Rare Diseases|rare diseases
5312862|NCT02116764|Primary Immune Deficiency Consortium|primary immune deficiency consortium
5312863|NCT02116764|Retrospective|retrospective
5312864|NCT02116751|HIV, antiretroviral, toxicity, eGFR, tubular disease, BMD|hiv, antiretroviral, toxicity, egfr, tubular disease, bmd
5312865|NCT02116738|flap|flap
5312866|NCT02116738|pilonidal sinus|pilonidal sinus
5312867|NCT02116738|vas|vas
5312868|NCT02116738|recurrence|recurrence
5312869|NCT02116712|LAM|lam
5312870|NCT02116712|saracatinib|saracatinib
5312871|NCT02116712|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5312872|NCT02116699|oropharyngeal|oropharyngeal
5312873|NCT02116699|colostrum|colostrum
5312874|NCT02116699|mother's milk|mother's milk
5312875|NCT02116699|premature|premature
5312876|NCT02116699|neonate|neonate
5312877|NCT02116699|infection|infection
5312878|NCT02116699|necrotizing enterocolitis|necrotizing enterocolitis
5313168|NCT02115516|Malaria|malaria
5312885|NCT02116699|enteral feeds|enteral feeds
5312886|NCT02116686|chronic heart failure|chronic heart failure
5312887|NCT02116686|Polysomnography|polysomnography
5312888|NCT02116686|Sleep Apnea Syndromes|sleep apnea syndromes
5312889|NCT02116686|Electrocardiogram|electrocardiogram
5312890|NCT02116673|Head injury|head injury
5312891|NCT02116673|Concussion|concussion
5312892|NCT02116673|Cognitive rest|cognitive rest
5312893|NCT02116673|Emergency department|emergency department
5312894|NCT02116647|Gender discrimination|gender discrimination
5312895|NCT02116647|Psychoanalysis|psychoanalysis
5312896|NCT02116647|Randomized controlled trial|randomized controlled trial
5312897|NCT02116621|Musculoskeletal pain|musculoskeletal pain
5312898|NCT02116621|Chronic pain|chronic pain
5312899|NCT02116621|Patient centered outcomes research|patient centered outcomes research
5312900|NCT02116621|Physician patient relationship|physician patient relationship
5312901|NCT02116621|Mobile applications|mobile applications
5312902|NCT02116595|volunteers|volunteers
5312903|NCT02116582|MDV3100|mdv3100
5312904|NCT02116582|Xtandi|xtandi
5312905|NCT02116582|Abiraterone|abiraterone
5312906|NCT02116582|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5312907|NCT02116582|Enzalutamide|enzalutamide
5312908|NCT02116569|Multiple Myeloma|multiple myeloma
5312909|NCT02116569|Daratumumab|daratumumab
5312910|NCT02116569|JNJ-54767414|jnj-54767414
5312911|NCT02116569|Phase 1|phase 1
5312912|NCT02116569|Relapse|relapse
5312913|NCT02116569|Refractory|refractory
5312914|NCT02116556|Alcoholic Hepatitis|alcoholic hepatitis
5312915|NCT02116556|Bacterial Infections|bacterial infections
5312916|NCT02116556|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
5312918|NCT02116543|HCV|hcv
5312919|NCT02116517|obese women|obese women
5312920|NCT02116517|high LDL-C|high ldl-c
5312921|NCT02116504|Rheumatoid arthritis|rheumatoid arthritis
5312922|NCT02116504|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5312923|NCT02116504|Biopharmaceutical|biopharmaceutical
5312924|NCT02116504|Immunogenicity|immunogenicity
5312925|NCT02116504|Anti-Drug Antibody|anti-drug antibody
5312926|NCT02116504|Prediction|prediction
5312927|NCT02116478|plantar fasciitis|plantar fasciitis
5312928|NCT02116478|gastrocnemius recession|gastrocnemius recession
5312929|NCT02116439|Violence|violence
5312930|NCT02116426|copeptin|copeptin
5312931|NCT02116426|troponin HS|troponin hs
5312932|NCT02116413|fluid challenge|fluid challenge
5312933|NCT02116413|fluid resuscitation|fluid resuscitation
5312934|NCT02116400|Suicidal ideation|suicidal ideation
5312935|NCT02116387|Proprioception|proprioception
5312936|NCT02116348|Cerebral palsy children|cerebral palsy children
5312937|NCT02116348|Cerebrolysin|cerebrolysin
5312938|NCT02116348|Sleep questionnaire|sleep questionnaire
5312939|NCT02116348|Quality of life|quality of life
5312940|NCT02116348|Bayley III scale|bayley iii scale
5312941|NCT02116335|arterial stiffness|arterial stiffness
5312942|NCT02116335|flow-mediated dilation|flow-mediated dilation
5312943|NCT02116335|endothelial function|endothelial function
5312944|NCT02116335|pulse wave velocity|pulse wave velocity
5312945|NCT02116335|inflammation|inflammation
5312946|NCT02116335|oxidative stress|oxidative stress
5312947|NCT02116335|Nitric Oxide|nitric oxide
5312948|NCT02116335|Cold Pressor Test|cold pressor test
5312949|NCT02116335|physio flow|physio flow
5312950|NCT02116335|Bosentan|bosentan
5312951|NCT02116335|Endothelin Receptor|endothelin receptor
5312952|NCT02116335|Endothelin-1|endothelin-1
5312954|NCT02116335|stress|stress
5312955|NCT02116335|blood pressure|blood pressure
5312956|NCT02116283|smoking|smoking
5312957|NCT02116283|healthy|healthy
5312958|NCT02116283|smartphone|smartphone
5312959|NCT02116270|Renal Failure|renal failure
5312960|NCT02116270|Dialysis|dialysis
5312961|NCT02116270|Biological Aging|biological aging
5312962|NCT02116257|Nausea|nausea
5312963|NCT02116257|Vomiting|vomiting
5312964|NCT02116244|Dry Eye|dry eye
5312965|NCT02116244|Civamide|civamide
5312966|NCT02116244|Zucapsaicin|zucapsaicin
5312967|NCT02116244|Neuropeptides|neuropeptides
5312968|NCT02116244|TRPV-1|trpv-1
5312969|NCT02116231|Nasopharyngeal neoplasm;IMRT; Concurrent chemotherapy|nasopharyngeal neoplasm;imrt; concurrent chemotherapy
5312975|NCT02116205|Hantaan virus|hantaan virus
5312976|NCT02116205|Puumala virus|puumala virus
5312977|NCT02116205|HFRS|hfrs
5312978|NCT02116192|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5312979|NCT02116192|Adolescent|adolescent
5312980|NCT02116179|Human Immunodeficiency Virus|human immunodeficiency virus
5312981|NCT02116179|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5312982|NCT02116179|Hepatitis C|hepatitis c
5312983|NCT02116179|Hispanic|hispanic
5312984|NCT02116179|Criminal Justice|criminal justice
5312985|NCT02116166|aging|aging
5312986|NCT02116166|sarcopenia|sarcopenia
5312987|NCT02116166|mitochondria|mitochondria
5312988|NCT02116166|skeletal muscle|skeletal muscle
5312989|NCT02116166|inflammation|inflammation
5312990|NCT02116153|Cardiac Troponin T|cardiac troponin t
5312991|NCT02116153|Micro-RNA|micro-rna
5312992|NCT02116153|Sensitivity|sensitivity
5312993|NCT02116153|Specificity|specificity
5312994|NCT02116140|positron emission tomography|positron emission tomography
5312995|NCT02116140|[11C]hydroxyephedrine (HED)|[11c]hydroxyephedrine (hed)
5312996|NCT02116140|[11C]acetate|[11c]acetate
5312997|NCT02116140|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
5312998|NCT02116140|Myocardial Energetics|myocardial energetics
5312999|NCT02116140|work-metabolic index (WMI)|work-metabolic index (wmi)
5313000|NCT02116140|Myocardial sympathetic neuron (SN) presynaptic function continuous positive airway pressure|myocardial sympathetic neuron (sn) presynaptic function continuous positive airway pressure
5313001|NCT02116140|heart rate variability|heart rate variability
5313002|NCT02116140|overnight polysomnogram|overnight polysomnogram
5313003|NCT02116140|Plasma Norepinephrine|plasma norepinephrine
5313004|NCT02116140|Urine Normetanephrine|urine normetanephrine
5313005|NCT02116140|Quality of Life|quality of life
5313006|NCT02116127|Depression|depression
5313007|NCT02116127|Pregnancy|pregnancy
5313008|NCT02116127|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5313009|NCT02116114|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5313010|NCT02116101|Intestinal Health|intestinal health
5313011|NCT02116101|Prebiotics|prebiotics
5313012|NCT02116101|Blood Lipid|blood lipid
5356878|NCT01917591|Chronic Disease|chronic disease
5356879|NCT01917591|Collagen|collagen
5356880|NCT01917591|Epithelium|epithelium
5356881|NCT01917591|Extracellular Matrix|extracellular matrix
5299999|NCT02177760|aGVHD prophylaxis|agvhd prophylaxis
5300000|NCT02177760|sirolimus|sirolimus
5300001|NCT02177734|Adjuvant|adjuvant
5300002|NCT02177734|Safety|safety
5313013|NCT02116088|Externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training|externalizing problem behavior, teacher training, teacher coaching, primary school, elementary school, continuing professional development, advanced training
5313014|NCT02116049|Disclosure, intervention|disclosure, intervention
5313016|NCT02116049|prevention|prevention
5313017|NCT02116049|Disclosure Intervention|disclosure intervention
5313018|NCT02116049|Attention Control Case Management|attention control case management
5313019|NCT02116036|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
5313020|NCT02116036|Rivaroxaban|rivaroxaban
5313021|NCT02116036|Thromboembolism|thromboembolism
5313022|NCT02116036|Bleeding|bleeding
5313023|NCT02116036|Feasibility|feasibility
5313024|NCT02116023|Satiety, beverage, crossover|satiety, beverage, crossover
5313025|NCT02116010|Wound Infection in burned patient|wound infection in burned patient
5313026|NCT02115971|chronic|chronic
5313027|NCT02115971|functional|functional
5313028|NCT02115971|instability|instability
5313029|NCT02115971|ankle|ankle
5313030|NCT02115945|chronic postoperative pain|chronic postoperative pain
5313031|NCT02115945|total knee arthroplasty|total knee arthroplasty
5313032|NCT02115945|femoral block|femoral block
5313033|NCT02115945|We aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.|we aimed to compare the effects of epidural and femoral block on acute and chronic postoperative pain.
5313034|NCT02115932|Diabetes Mellitus|diabetes mellitus
5313035|NCT02115932|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5313036|NCT02115932|Diabetes Complications|diabetes complications
5313037|NCT02115932|Diabetic Foot|diabetic foot
5313038|NCT02115932|Diabetic Neuropathies|diabetic neuropathies
5313040|NCT02115932|Balance, Postural|balance, postural
5313041|NCT02115932|Muscle Strength|muscle strength
5313042|NCT02115932|Exercise Therapy|exercise therapy
5313043|NCT02115932|Physical Therapy Modalities|physical therapy modalities
5313044|NCT02115932|Endocrine System Diseases|endocrine system diseases
5313045|NCT02115932|Peripheral Nervous System Diseases|peripheral nervous system diseases
5313046|NCT02115932|Metabolic Diseases|metabolic diseases
5313047|NCT02115932|Glucose Metabolism Diseases|glucose metabolism diseases
5313048|NCT02115932|Quality of Life|quality of life
5313049|NCT02115932|Training|training
5313050|NCT02115919|condyloma|condyloma
5313051|NCT02115919|HIV|hiv
5313052|NCT02115893|Nitrate|nitrate
5313053|NCT02115893|Performance|performance
5313054|NCT02115893|Sports|sports
5313055|NCT02115880|Depression|depression
5313056|NCT02115880|Prevention|prevention
5313057|NCT02115880|Adolescent|adolescent
5313058|NCT02115880|Child|child
5313059|NCT02115880|Randomised Controlled Trial|randomised controlled trial
5313060|NCT02115880|Risk|risk
5313061|NCT02115880|Cognitive behavioural therapy|cognitive behavioural therapy
5313062|NCT02115880|Group-based therapy|group-based therapy
5313063|NCT02115867|diverticular disease|diverticular disease
5313064|NCT02115867|diverticulitis|diverticulitis
5313065|NCT02115867|diverticulosis|diverticulosis
5313066|NCT02115854|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis|usefullness of labial biopsy to distinguish between tuberculosis and sarcoidosis
5313067|NCT02115841|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
5313068|NCT02115841|serial reaction time task|serial reaction time task
5313069|NCT02115841|functional near infrared spectroscopy|functional near infrared spectroscopy
5313070|NCT02115841|transcranial magnetic stimulation|transcranial magnetic stimulation
5313071|NCT02115828|Vismodegib|vismodegib
5313072|NCT02115828|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5313073|NCT02115828|Accessible Metastatic Lesions for Tumor Biopsy|accessible metastatic lesions for tumor biopsy
5313074|NCT02115815|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5313075|NCT02115815|MEDI7510|medi7510
5313076|NCT02115789|cicatrix|cicatrix
5313077|NCT02115789|Demonstrate|demonstrate
5313078|NCT02115789|that there|that there
5313079|NCT02115789|is no perception of superiority|is no perception of superiority
5313080|NCT02115776|bacteremia|bacteremia
5313081|NCT02115776|prophylaxis|prophylaxis
5313082|NCT02115776|antibiotics|antibiotics
5313083|NCT02115776|dentistry|dentistry
5313084|NCT02115763|physically active,|physically active,
5313085|NCT02115763|18-35 year old men|18-35 year old men
5313086|NCT02115750|CHS-0214|chs-0214
5313087|NCT02115750|Enbrel|enbrel
5313088|NCT02115750|RA|ra
5313089|NCT02115750|Biosimilar|biosimilar
5313090|NCT02115750|Etanercept|etanercept
5313091|NCT02115724|Low childhood SES|low childhood ses
5313092|NCT02115724|Early Life Stress|early life stress
5313093|NCT02115724|Endothelial function|endothelial function
5313094|NCT02115724|Flow mediated dilation|flow mediated dilation
5313095|NCT02115724|Cardiovascular disease|cardiovascular disease
5313096|NCT02115724|Subcutaneous adipose arterioles|subcutaneous adipose arterioles
5313097|NCT02115711|India|india
5313098|NCT02115711|Cardiovascular risk factors|cardiovascular risk factors
5313099|NCT02115711|Community health workers|community health workers
5313100|NCT02115711|Hypertension|hypertension
5313101|NCT02115711|Diabetes|diabetes
5313103|NCT02115698|Sarcopenia|sarcopenia
5313104|NCT02115698|Frailty|frailty
5313105|NCT02115698|Ageing|ageing
5313106|NCT02115698|Protein supplementation|protein supplementation
5313107|NCT02115698|Protein quality|protein quality
5313108|NCT02115698|Exercise training|exercise training
5313109|NCT02115698|Muscle protein turnover|muscle protein turnover
5313110|NCT02115685|spinal cord injury|spinal cord injury
5313111|NCT02115685|sympathetic nervous system|sympathetic nervous system
5313112|NCT02115685|locomotor training|locomotor training
5313113|NCT02115685|exercise|exercise
5313114|NCT02115672|Chronic myeloid leukemia|chronic myeloid leukemia
5313115|NCT02115672|imatinib|imatinib
5313116|NCT02115672|CXCR4 antagonist|cxcr4 antagonist
5313117|NCT02115672|BL-8040|bl-8040
5313118|NCT02115659|ADPKD|adpkd
5313119|NCT02115659|triptolide|triptolide
5313120|NCT02115646|burn|burn
5313121|NCT02115646|scar|scar
5313122|NCT02115620|Heart failure|heart failure
5313123|NCT02115620|Cardiac failure|cardiac failure
5313124|NCT02115620|Congestive Heart Failure|congestive heart failure
5313125|NCT02115620|Cardiomyopathy|cardiomyopathy
5313126|NCT02115620|Myocardial Failure|myocardial failure
5313127|NCT02115620|Telemedicine|telemedicine
5313128|NCT02115620|Telehealth|telehealth
5313130|NCT02115607|Breast cancer|breast cancer
5313131|NCT02115607|Interstitial fluid pressure|interstitial fluid pressure
5313132|NCT02115607|Angiogenesis|angiogenesis
5313133|NCT02115607|Contrast enhanced ultrasound imaging|contrast enhanced ultrasound imaging
5313134|NCT02115607|Subharmonic imaging|subharmonic imaging
5313135|NCT02115607|Subharmonic pressure estimation|subharmonic pressure estimation
5313136|NCT02115594|metastatic breast cancer|metastatic breast cancer
5313137|NCT02115594|estrogen receptor|estrogen receptor
5193907|NCT02781363|efficacy|efficacy
5193908|NCT02781363|emergency service|emergency service
5313138|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5313139|NCT02115594|Histone Deacetylases|histone deacetylases
5313140|NCT02115594|HDAC inhibitors|hdac inhibitors
5313141|NCT02115594|selective estrogen receptor modulator|selective estrogen receptor modulator
5313142|NCT02115594|estrogen receptor modulator, selective|estrogen receptor modulator, selective
5313143|NCT02115594|Estrogen receptor modulators, selective|estrogen receptor modulators, selective
5313144|NCT02115581|Coenzyme O10|coenzyme o10
5313145|NCT02115581|Children|children
5313146|NCT02115581|Idiopathic Dilated Cardiomyopathy|idiopathic dilated cardiomyopathy
5313147|NCT02115555|type 1|type 1
5313148|NCT02115555|diabetes|diabetes
5313149|NCT02115555|adolescents|adolescents
5313150|NCT02115555|heath information technology|heath information technology
5313151|NCT02115542|biliary|biliary
5313152|NCT02115542|liver|liver
5313153|NCT02115542|Refractory Advanced Biliary Cancers|refractory advanced biliary cancers
5313154|NCT02115542|gallbladder cancer|gallbladder cancer
5313155|NCT02115542|carcinoma|carcinoma
5313156|NCT02115542|intra-hepatic biliary system|intra-hepatic biliary system
5313157|NCT02115542|extra-hepatic biliary system|extra-hepatic biliary system
5313158|NCT02115542|gall bladder|gall bladder
5313159|NCT02115542|unresectable|unresectable
5313160|NCT02115542|locally advanced|locally advanced
5313161|NCT02115542|metastatic disease|metastatic disease
5313162|NCT02115542|Bile Duct Diseases|bile duct diseases
5313163|NCT02115542|Gallbladder Diseases|gallbladder diseases
5313164|NCT02115542|regorafenib|regorafenib
5313165|NCT02115542|stivarga|stivarga
5313166|NCT02115542|Bay 73-4506|bay 73-4506
5313167|NCT02115542|multikinase inhibitor|multikinase inhibitor
5313169|NCT02115516|Plasmodium falciparum malaria|plasmodium falciparum malaria
5313170|NCT02115516|Antimalarial chemoprophylaxis|antimalarial chemoprophylaxis
5313171|NCT02115516|PfSPZ Challenge|pfspz challenge
5313172|NCT02115516|Cryopreserved Plasmodium Falciparum Sporozoites|cryopreserved plasmodium falciparum sporozoites
5313173|NCT02115516|PfSPZ-CVac|pfspz-cvac
5313174|NCT02115490|Alveolar bone|alveolar bone
5313175|NCT02115490|Bisphosphonates|bisphosphonates
5313176|NCT02115490|Cone-beam CT|cone-beam ct
5313177|NCT02115490|Osteoporosis|osteoporosis
5313178|NCT02115477|Uterus cancer|uterus cancer
5313179|NCT02115477|Hysterectomy|hysterectomy
5313180|NCT02115477|Lymphadenectomy|lymphadenectomy
5313181|NCT02115477|Lymphedema|lymphedema
5313182|NCT02115464|Metformin|metformin
5313183|NCT02115464|Non-small cell lung cancer|non-small cell lung cancer
5313184|NCT02115464|Locally advanced|locally advanced
5313185|NCT02115464|Chemo-radiotherapy|chemo-radiotherapy
5313186|NCT02115464|Lung cancer treatment|lung cancer treatment
5313187|NCT02115399|Dermatitis|dermatitis
5313188|NCT02115399|Staphylococcus|staphylococcus
5313189|NCT02115399|Staphylococcus aureus|staphylococcus aureus
5313190|NCT02115399|Dermatitis, Atopic|dermatitis, atopic
5313191|NCT02115399|Non-atopic controls|non-atopic controls
5313192|NCT02115386|Ph+ CML, chronic myeloid leukemia|ph+ cml, chronic myeloid leukemia
5313193|NCT02115373|Hepatocellular Carcinoma|hepatocellular carcinoma
5313194|NCT02115373|c-Met inhibitor|c-met inhibitor
5313195|NCT02115373|Phase 1b|phase 1b
5313196|NCT02115373|Sorafenib|sorafenib
5313197|NCT02115373|MSC2156119J|msc2156119j
5313198|NCT02115360|epidural calcitonin|epidural calcitonin
5313199|NCT02115360|amputation|amputation
5313200|NCT02115360|postoperative pain|postoperative pain
5313202|NCT02115334|Developmental delay|developmental delay
5313203|NCT02115334|Early Intervention|early intervention
5313204|NCT02115334|Home programs|home programs
5313205|NCT02115334|Preschool activities|preschool activities
5313206|NCT02115269|Indoprocaf|indoprocaf
5313207|NCT02115269|Indomethacin|indomethacin
5313208|NCT02115269|Caffeine|caffeine
5313209|NCT02115269|Prochlorperazine|prochlorperazine
5313210|NCT02115269|Migraine with Aura|migraine with aura
5313211|NCT02115269|Migraine without Aura|migraine without aura
5313212|NCT02115269|Tension-Type Headache|tension-type headache
5313213|NCT02115256|External Cephalic Version|external cephalic version
5313215|NCT02115230|Heart Failure|heart failure
5313216|NCT02115230|Heart Failure, Diastolic|heart failure, diastolic
5313217|NCT02115230|Hypertension|hypertension
5313219|NCT02115230|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
5313220|NCT02115217|Kinestiotaping|kinestiotaping
5313221|NCT02115217|Basketball players|basketball players
5313222|NCT02115217|Effect of kinesiotaping|effect of kinesiotaping
5313223|NCT02115217|on postural stability|on postural stability
5313224|NCT02115191|2-octylcyanoacrylate|2-octylcyanoacrylate
5313225|NCT02115191|Urethrocutaneous fistulas.|urethrocutaneous fistulas.
5313226|NCT02115191|Closure.|closure.
5313227|NCT02115191|Recurrence.|recurrence.
5313228|NCT02115178|Hemodynamic changes|hemodynamic changes
5313229|NCT02115178|Spinal anesthesia|spinal anesthesia
5313230|NCT02115178|Patient position|patient position
5963141|NCT04271280|Lipid modifying therapies|lipid modifying therapies
5963142|NCT04271280|Dyslipidemic|dyslipidemic
5963143|NCT04271280|Hypercholesterolemia|hypercholesterolemia
5313231|NCT02115178|Impedance cardiography|impedance cardiography
5313232|NCT02115152|Capecitabine|capecitabine
5313233|NCT02115152|Neoadjuvant therapy|neoadjuvant therapy
5313234|NCT02115152|Early Breast Cancer|early breast cancer
5313235|NCT02115139|melanoma|melanoma
5313236|NCT02115139|brain|brain
5313237|NCT02115139|metastases|metastases
5313238|NCT02115139|Patients with melanoma and brain metastases|patients with melanoma and brain metastases
5313239|NCT02115113|Liver transplantation, everolimus, CNI-minimization, CNI-elimination, renal function|liver transplantation, everolimus, cni-minimization, cni-elimination, renal function
5313240|NCT02115100|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5313241|NCT02115100|Persistent atrial fibrillation|persistent atrial fibrillation
5313242|NCT02115100|Out of range hypertension|out of range hypertension
5313243|NCT02115100|Signs of sympathetic overdrive|signs of sympathetic overdrive
5313244|NCT02115087|laparotomy|laparotomy
5313245|NCT02115087|levobupivacaine|levobupivacaine
5313246|NCT02115087|patient controlled analgesia|patient controlled analgesia
5313247|NCT02115074|Low-grade gliomas|low-grade gliomas
5313248|NCT02115074|high-grade gliomas|high-grade gliomas
5313249|NCT02115074|optico-chiasmatic|optico-chiasmatic
5313250|NCT02115074|relapsed|relapsed
5313251|NCT02115074|refractory|refractory
5313252|NCT02115061|Gastric varices,coil,cyanoacrylate,treating gastric varices.|gastric varices,coil,cyanoacrylate,treating gastric varices.
5313253|NCT02115035|Multiple Myeloma|multiple myeloma
5313254|NCT02115022|pancreatic cancer|pancreatic cancer
5313255|NCT02115022|resectability|resectability
5313256|NCT02115022|endosonography (EUS)|endosonography (eus)
5313257|NCT02115022|multidetection computer tomography (MDCT)|multidetection computer tomography (mdct)
5313258|NCT02115022|staging|staging
5313259|NCT02115009|sacroiliac joint lumbopelvic ,chronic low back pain|sacroiliac joint lumbopelvic ,chronic low back pain
5313260|NCT02114996|mechanical ventilation|mechanical ventilation
5313261|NCT02114996|ischemic stroke|ischemic stroke
5313262|NCT02114983|deep vein thrombosis|deep vein thrombosis
5313263|NCT02114983|diagnostic accuracy|diagnostic accuracy
5313264|NCT02114983|general practitioner|general practitioner
5313265|NCT02114983|test|test
5313266|NCT02114983|compression ultrasonography|compression ultrasonography
5313267|NCT02114983|ultrasound|ultrasound
5313268|NCT02114970|Older Adults|older adults
5313269|NCT02114970|Informed Consent|informed consent
5313270|NCT02114970|Technology|technology
5313271|NCT02114970|Tablet-delivered|tablet-delivered
5313272|NCT02114957|bio-availability|bio-availability
5313273|NCT02114957|decursin|decursin
5313274|NCT02114957|decursinol angelate|decursinol angelate
5313275|NCT02114957|decursinol|decursinol
5313276|NCT02114957|subjects|subjects
5313277|NCT02114944|Do-not-intubate|do-not-intubate
5313279|NCT02114944|Palliative treatment|palliative treatment
5313280|NCT02114944|Acute respiratory failure|acute respiratory failure
5313281|NCT02114944|Acute on chronic respiratory failure|acute on chronic respiratory failure
5313282|NCT02114944|Hypoxia|hypoxia
5313283|NCT02114944|Respiratory acidosis|respiratory acidosis
5313284|NCT02114944|Hypercarbia|hypercarbia
5313285|NCT02114944|Non invasive ventilation|non invasive ventilation
5313286|NCT02114944|NIV|niv
5313287|NCT02114944|CPAP|cpap
5313288|NCT02114944|Oxygen-therapy|oxygen-therapy
5313289|NCT02114944|High-flow oxygen therapy|high-flow oxygen therapy
5313290|NCT02114931|arthritis|arthritis
5313291|NCT02114931|rheumatoid|rheumatoid
5313292|NCT02114918|obsessive compulsive disorder|obsessive compulsive disorder
5313293|NCT02114918|children|children
5313294|NCT02114918|adolescents|adolescents
5313295|NCT02114918|attention bias modification|attention bias modification
5313296|NCT02114905|Tourette's|tourette's
5313298|NCT02114905|CBIT|cbit
5313299|NCT02114905|Dissemination|dissemination
5313300|NCT02114905|Occupational Therapist|occupational therapist
5313301|NCT02114892|metabolic syndrome|metabolic syndrome
5313302|NCT02114892|central obesity|central obesity
5313303|NCT02114892|resveratrol|resveratrol
5313304|NCT02114892|insulin secretion|insulin secretion
5313305|NCT02114892|insulin sensitivity|insulin sensitivity
5313306|NCT02114879|Physical Therapy|physical therapy
5313307|NCT02114879|Occupational Therapy|occupational therapy
5313308|NCT02114879|Rehabilitation|rehabilitation
5313309|NCT02114879|Older adults|older adults
5313310|NCT02114879|Depression|depression
5313311|NCT02114879|Physical Functioning|physical functioning
5313312|NCT02114827|Multiple Myeloma|multiple myeloma
5313313|NCT02114814|Diabetes|diabetes
5313314|NCT02114814|Hispanic|hispanic
5313315|NCT02114814|Adult|adult
5313316|NCT02114814|Family Member|family member
5313317|NCT02114801|Cerebral Palsy;|cerebral palsy;
5313318|NCT02114801|Toothbrushing;|toothbrushing;
5313319|NCT02114801|Dental Plaque|dental plaque
5313320|NCT02114775|mild traumatic brain injury|mild traumatic brain injury
5313321|NCT02114775|growth hormone|growth hormone
5313322|NCT02114775|fatigue|fatigue
5313323|NCT02114775|sildenafil|sildenafil
5313324|NCT02114775|neurology|neurology
5313325|NCT02114762|otitis media|otitis media
5313326|NCT02114762|eustachian tube|eustachian tube
5313327|NCT02114762|eustachian tube dysfunction|eustachian tube dysfunction
5313328|NCT02114762|eustachian tube function testing|eustachian tube function testing
5313329|NCT02114749|Healthy volunteers|healthy volunteers
5313330|NCT02114749|Physiological variables : respiration and circulation|physiological variables : respiration and circulation
5313331|NCT02114736|Stroke|stroke
5313332|NCT02114736|Muscle spasticity|muscle spasticity
5313333|NCT02114736|Stiff knee gait|stiff knee gait
5313334|NCT02114736|Botulinum toxin|botulinum toxin
5313335|NCT02114736|Tenotomy|tenotomy
5313336|NCT02114723|Mediacal Taping concept|mediacal taping concept
5313337|NCT02114723|Neuromuscular bandage|neuromuscular bandage
5313338|NCT02114723|Physiotherapy techniques|physiotherapy techniques
5313339|NCT02114723|Kinesio Tape|kinesio tape
5313340|NCT02114710|coagulopathy|coagulopathy
5313341|NCT02114710|hydrocortisone|hydrocortisone
5313342|NCT02114710|organ failure|organ failure
5313343|NCT02114697|Cancer survivorship|cancer survivorship
5313344|NCT02114697|Cardiovascular disease|cardiovascular disease
5313345|NCT02114697|Stroke|stroke
5313346|NCT02114697|Transient ischemic attack (TIA)|transient ischemic attack (tia)
5313347|NCT02114658|Anaplastic and medullary thyroid carcinoma|anaplastic and medullary thyroid carcinoma
5313348|NCT02114658|Thyroid Neoplasms|thyroid neoplasms
5313349|NCT02114645|Luteal phase support,GnRH agonist,ART cycles|luteal phase support,gnrh agonist,art cycles
5313350|NCT02114632|ADHD, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, PUFA|adhd, attention deficit/hyperactivity disorder, attention deficit disorder, inattention, cognitive skills, children, polyunsaturated fatty acids, pufa
5313351|NCT02114619|radioiodine therapy|radioiodine therapy
5313352|NCT02114619|Graves' disease|graves' disease
5313353|NCT02114619|Hyperthyroidism|hyperthyroidism
5313354|NCT02114619|calculated dose|calculated dose
5313355|NCT02114606|Eosinophilic Esophagitis|eosinophilic esophagitis
5313356|NCT02114606|EoE|eoe
5313357|NCT02114606|Cytosponge|cytosponge
5313358|NCT02114593|Mental Health|mental health
5313363|NCT02114580|mild cognitive impairment|mild cognitive impairment
5313364|NCT02114580|exercise|exercise
5313365|NCT02114580|brain plasticity|brain plasticity
5313366|NCT02114580|FMRI|fmri
5313367|NCT02114567|AECOPD|aecopd
5313368|NCT02114567|work of breathing|work of breathing
5313369|NCT02114567|patient-ventilator synchrony|patient-ventilator synchrony
5313370|NCT02114554|MELAS|melas
5313371|NCT02114554|MIDD|midd
5313372|NCT02114554|Heteroplasmy|heteroplasmy
5313373|NCT02114528|Ventricular Tachycardia|ventricular tachycardia
5313374|NCT02114528|Ventricular Arrhythmia|ventricular arrhythmia
5313375|NCT02114528|Anti-arrhythmic drugs|anti-arrhythmic drugs
5313376|NCT02114528|Catheter Ablation|catheter ablation
5313377|NCT02114528|ICD Shocks|icd shocks
5313378|NCT02114515|Patient Navigators|patient navigators
5313379|NCT02114515|Readmissions|readmissions
5313380|NCT02114515|Peer Coaching|peer coaching
5313381|NCT02114502|Myeloma|myeloma
5313382|NCT02114502|Multiple myeloma|multiple myeloma
5313384|NCT02114502|Refractory|refractory
5313385|NCT02114502|Relapsed|relapsed
5313386|NCT02114502|Stem Cell Transplant|stem cell transplant
5313387|NCT02114502|SCT|sct
5313388|NCT02114502|Carfilzomib|carfilzomib
5313389|NCT02114502|SAHA|saha
5313390|NCT02114502|Vorinostat|vorinostat
5313391|NCT02114502|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5313392|NCT02114502|MSK-390|msk-390
5313393|NCT02114502|Zolinza|zolinza
5313394|NCT02114502|Gemcitabine|gemcitabine
5313395|NCT02114502|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5313396|NCT02114502|Gemzar|gemzar
5313397|NCT02114502|Busulfan|busulfan
5313398|NCT02114502|Busulfex|busulfex
5313399|NCT02114502|Myleran|myleran
5313400|NCT02114502|Palifermin|palifermin
5313401|NCT02114502|Kepivance|kepivance
5313402|NCT02114502|Dexamethasone|dexamethasone
5313403|NCT02114502|Decadron|decadron
5313404|NCT02114502|Melphalan|melphalan
5313405|NCT02114502|Alkeran|alkeran
5313406|NCT02114502|Caphosol|caphosol
5313407|NCT02114502|Glutamine|glutamine
5313408|NCT02114502|Enterex|enterex
5313409|NCT02114502|Glutapak-10|glutapak-10
5313410|NCT02114502|NutreStore|nutrestore
5313411|NCT02114502|Resource|resource
5313412|NCT02114502|GlutaSolve|glutasolve
5313413|NCT02114502|Sympt-X G.I.|sympt-x g.i.
5313414|NCT02114502|Sympt-X|sympt-x
5313415|NCT02114502|Pyridoxine|pyridoxine
5313416|NCT02114489|AOH|aoh
5313417|NCT02114489|ibandronate|ibandronate
5313418|NCT02114476|GDM|gdm
5313419|NCT02114476|implant|implant
5313420|NCT02114476|diabetes mellitus|diabetes mellitus
5313421|NCT02114476|metabolic syndrome|metabolic syndrome
5313422|NCT02114463|Local analgesia system|local analgesia system
5313423|NCT02114463|Ropivacaine|ropivacaine
5313424|NCT02114463|Analgesic efficacy after operation|analgesic efficacy after operation
5313425|NCT02114463|Postoperative|postoperative
5313426|NCT02114450|Stroke|stroke
5313427|NCT02114450|Paresis|paresis
5313428|NCT02114450|Gait rehabilitation|gait rehabilitation
5313429|NCT02114450|Human-Machine Interaction|human-machine interaction
5313430|NCT02114450|Wearable Robotic Devices|wearable robotic devices
5194209|NCT02780102|ADHD|adhd
5313432|NCT02114437|NI|ni
5313433|NCT02114437|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5313434|NCT02114424|Positional Obstructive sleep apnea syndrome (POSAS)|positional obstructive sleep apnea syndrome (posas)
5313435|NCT02114424|Obstructive sleep apnea syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
5313436|NCT02114424|Apnea-Hypnea Index (AHI)|apnea-hypnea index (ahi)
5313437|NCT02114424|Sleep questionnaire|sleep questionnaire
5313438|NCT02114424|Positional sleep apnea belt|positional sleep apnea belt
5313439|NCT02114424|Adverse events|adverse events
5313440|NCT02114424|Compliance|compliance
5313441|NCT02114385|Prevention|prevention
5313445|NCT02114359|gastric cancer, elderly, chemotherapy|gastric cancer, elderly, chemotherapy
5313446|NCT02114346|Computed Tomography Angiogram|computed tomography angiogram
5313447|NCT02114346|Side Effects|side effects
5313448|NCT02114346|Contrast-Induced Nephropathy|contrast-induced nephropathy
5313449|NCT02114346|Prevention|prevention
5313450|NCT02114333|Shingles vaccine|shingles vaccine
5313451|NCT02114333|Immune response|immune response
5313452|NCT02114333|Zoster vaccine|zoster vaccine
5313453|NCT02114320|Endoscopic ultrasonography|endoscopic ultrasonography
5313454|NCT02114320|Biliary drainage|biliary drainage
5313455|NCT02114320|Metal stent|metal stent
5313456|NCT02114307|electrical stimulation|electrical stimulation
5313457|NCT02114307|venous insufficiency|venous insufficiency
5313458|NCT02114307|post thrombotic syndrome|post thrombotic syndrome
5313459|NCT02114307|varicose veins|varicose veins
5313460|NCT02114294|Patellofemoral pain syndrome|patellofemoral pain syndrome
5313461|NCT02114294|Anterior knee pain|anterior knee pain
5313462|NCT02114294|Randomised controlled trial|randomised controlled trial
5313463|NCT02114294|Exercise intervention|exercise intervention
5313464|NCT02114294|Hip strengthening|hip strengthening
5313465|NCT02114294|Quadriceps based training|quadriceps based training
5313466|NCT02114294|Anterior knee pain score|anterior knee pain score
5313467|NCT02114281|Oral Health|oral health
5313468|NCT02114281|Periodontitis|periodontitis
5313469|NCT02114281|Tooth cavities|tooth cavities
5313471|NCT02114281|Halitosis|halitosis
5313472|NCT02114281|Mucosa|mucosa
5313473|NCT02114281|Chronic kidney disease|chronic kidney disease
5313474|NCT02114281|Inflammation|inflammation
5313475|NCT02114281|Nutrition|nutrition
5313476|NCT02114268|Respiratory Syncytial Virus, RSV|respiratory syncytial virus, rsv
5313477|NCT02114255|Influenza|influenza
5313478|NCT02114255|Trained immunity|trained immunity
5313479|NCT02114255|BCG|bcg
5313480|NCT02114242|Parkinson's disease|parkinson's disease
5313481|NCT02114242|multiple system atrophy|multiple system atrophy
5313482|NCT02114242|progressive supranuclear palsy|progressive supranuclear palsy
5313483|NCT02114242|alpha-synuclein|alpha-synuclein
5313484|NCT02114229|Alisertib|alisertib
5313485|NCT02114229|MLN8237|mln8237
5313486|NCT02114229|AT/RT|at/rt
5313487|NCT02114229|MRT|mrt
5313488|NCT02114190|Overweight Adolescents|overweight adolescents
5313489|NCT02114190|Mindful Eating and Living|mindful eating and living
5313490|NCT02114190|Family Systems|family systems
5313491|NCT02114190|Body-Mass Index|body-mass index
5313492|NCT02114190|Mindfulness|mindfulness
5313493|NCT02114177|Hepatitis C Virus Infection|hepatitis c virus infection
5313494|NCT02114177|Simeprevir|simeprevir
5313495|NCT02114177|Sofosbuvir|sofosbuvir
5313496|NCT02114177|HCV|hcv
5313497|NCT02114177|Cirrhosis|cirrhosis
5313498|NCT02114164|AirSeal|airseal
5313499|NCT02114164|Trocar|trocar
5313500|NCT02114164|Carbon Dioxide Exchange and Absorption|carbon dioxide exchange and absorption
5313501|NCT02114151|Hepatitis C Virus Infection|hepatitis c virus infection
5313502|NCT02114151|Simeprevir|simeprevir
5313503|NCT02114151|Sofosbuvir|sofosbuvir
5313504|NCT02114151|HCV|hcv
5313505|NCT02114151|Cirrhosis|cirrhosis
5313506|NCT02114138|postoperative acute kidney injury|postoperative acute kidney injury
5313508|NCT02114138|stress injury on the kidney|stress injury on the kidney
5313509|NCT02114138|chronic kidney disease|chronic kidney disease
5313510|NCT02114138|CKD|ckd
5313511|NCT02114125|Physical activity|physical activity
5313512|NCT02114125|Cognitive training|cognitive training
5313513|NCT02114112|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5313514|NCT02114112|Continuous positive airway pressure pressure|continuous positive airway pressure pressure
5313515|NCT02114112|Preterms|preterms
5313516|NCT02114099|Kawasaki Disease|kawasaki disease
5313517|NCT02114099|Aneurysm, Coronary|aneurysm, coronary
5313518|NCT02114086|Observational Study|observational study
5313519|NCT02114086|intraoperative Radiation of Breast Cancer|intraoperative radiation of breast cancer
5313520|NCT02114086|early and late effects of radiation|early and late effects of radiation
5313521|NCT02114086|cosmesis and quality of life|cosmesis and quality of life
5313522|NCT02114073|glaucoma|glaucoma
5313523|NCT02114073|trabeculectomy|trabeculectomy
5313524|NCT02114073|cyclosporine|cyclosporine
5313525|NCT02114073|betamethasone|betamethasone
5313526|NCT02114060|HSV|hsv
5313527|NCT02114060|Herpes|herpes
5313528|NCT02114060|genital infection|genital infection
5963144|NCT04271280|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
5313529|NCT02114060|vaccine|vaccine
5313530|NCT02114034|Severe asthma,|severe asthma,
5182276|NCT02850250|Observational|observational
5313531|NCT02114034|child,|child,
5313532|NCT02114034|outcome,|outcome,
5313533|NCT02114021|Syndrome incidence after intubation|syndrome incidence after intubation
5313534|NCT02114021|Betamethasone gel|betamethasone gel
5313535|NCT02114021|lidocaine jelly|lidocaine jelly
5313536|NCT02114021|sore throat|sore throat
5313537|NCT02114021|cough|cough
5313538|NCT02114021|hoarseness of voice|hoarseness of voice
5313539|NCT02114008|Gastric emptying.|gastric emptying.
5313540|NCT02114008|Residual gastric volume.|residual gastric volume.
5313541|NCT02114008|Preoperative fasting.|preoperative fasting.
5313542|NCT02114008|Morbid Obesity.|morbid obesity.
5313543|NCT02114008|Diabetes.|diabetes.
5313544|NCT02113995|Obesity, Morbid|obesity, morbid
5313545|NCT02113995|Insulin Resistance|insulin resistance
5313546|NCT02113995|Acute-Phase Reaction|acute-phase reaction
5313547|NCT02113995|Gastroplasty|gastroplasty
5313548|NCT02113995|Length of Stay|length of stay
5313549|NCT02113995|Protocols|protocols
5313550|NCT02113995|Randomized Controlled Trial.|randomized controlled trial.
5313551|NCT02113969|Pelvic Organ Prolapse|pelvic organ prolapse
5313552|NCT02113969|Quality of Life|quality of life
5313553|NCT02113969|Symptoms|symptoms
5313554|NCT02113969|Pessary|pessary
5313555|NCT02113969|Treatment|treatment
5313556|NCT02113956|HIV Prevention|hiv prevention
5313557|NCT02113956|Adolescent Men who Have Sex with Men (AMSM)|adolescent men who have sex with men (amsm)
5313558|NCT02113956|Text-Messaging|text-messaging
5313559|NCT02113956|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
5313560|NCT02113917|infant, adolescent and adult Hemophagocytic Syndrome|infant, adolescent and adult hemophagocytic syndrome
5313561|NCT02113917|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5313562|NCT02113904|Netherton syndrome|netherton syndrome
5313563|NCT02113904|Adalimumab|adalimumab
5313564|NCT02113904|TNF-alpha|tnf-alpha
5313565|NCT02113904|Orphan genetic syndrome|orphan genetic syndrome
5313566|NCT02113891|Antibody-mediated rejection|antibody-mediated rejection
5313567|NCT02113891|Complement blockade|complement blockade
5313568|NCT02113891|Eculizumab|eculizumab
5313569|NCT02113891|Kidney transplantation|kidney transplantation
5313570|NCT02113878|Carcinoma, Squamous Cell of Head and Neck|carcinoma, squamous cell of head and neck
5313571|NCT02113878|Human Papillomavirus Positive Oropharyngeal Carcinoma|human papillomavirus positive oropharyngeal carcinoma
5313572|NCT02113878|Hypopharyngeal Cancer|hypopharyngeal cancer
5313573|NCT02113878|Early Invasive Cervical Squamous Cell Carcinoma|early invasive cervical squamous cell carcinoma
5313574|NCT02113878|Carcinoma of Larynx|carcinoma of larynx
5313575|NCT02113878|Cancer of Nasopharynx|cancer of nasopharynx
5313576|NCT02113852|Non small cell Lung Cancer|non small cell lung cancer
5313577|NCT02113852|Heavy smokers|heavy smokers
5313578|NCT02113852|Treatment naive patients|treatment naive patients
5313579|NCT02113839|Dyspnea perception|dyspnea perception
5313580|NCT02113839|COPD|copd
5313581|NCT02113839|Exacerbations|exacerbations
5313582|NCT02113839|CO2 rebreathing test|co2 rebreathing test
5313583|NCT02113826|Pazopanib|pazopanib
5313584|NCT02113826|Alveolar soft part sarcoma|alveolar soft part sarcoma
5313585|NCT02113813|irreversible EGFR inhibitor|irreversible egfr inhibitor
5313586|NCT02113813|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5313587|NCT02113813|Midazolam|midazolam
5313588|NCT02113813|T790M resistance mutation|t790m resistance mutation
5313589|NCT02113813|EGFR|egfr
5313590|NCT02113813|NSCLC|nsclc
5313591|NCT02113813|naquotinib|naquotinib
5313592|NCT02113813|Epidermal Growth Factor Receptor mutations|epidermal growth factor receptor mutations
5313593|NCT02113813|ASP8273|asp8273
5313594|NCT02113787|epilepsy|epilepsy
5313595|NCT02113787|anticonvulsants|anticonvulsants
5313596|NCT02113787|generic drugs|generic drugs
5313597|NCT02113748|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5313598|NCT02113748|Downhill walking|downhill walking
5313599|NCT02113748|exercise|exercise
5313600|NCT02113735|ARDS|ards
5313601|NCT02113735|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5313602|NCT02113735|Acthar|acthar
5313603|NCT02113735|ACTH|acth
5313604|NCT02113735|H.P. Acthar Gel|h.p. acthar gel
5313605|NCT02113722|Sudden cardiac death|sudden cardiac death
5313606|NCT02113722|Ganglionectomy|ganglionectomy
5313607|NCT02113722|Ventricular arrhythmia|ventricular arrhythmia
5313608|NCT02113722|Cardiac surgery|cardiac surgery
5313609|NCT02113722|Implanted cardiac defibrillator|implanted cardiac defibrillator
5313610|NCT02113709|Amblyopia|amblyopia
5313611|NCT02113709|Strabismus|strabismus
5313612|NCT02113709|Occlusion therapy|occlusion therapy
5313613|NCT02113709|Visual improvement|visual improvement
5313614|NCT02113696|morbid obesity|morbid obesity
5313615|NCT02113696|BMI at or above 4O kg/m2|bmi at or above 4o kg/m2
5313616|NCT02113696|ingestion of omega 3|ingestion of omega 3
5313617|NCT02113696|inflammatory cytokines|inflammatory cytokines
5313618|NCT02113696|biochemical factors|biochemical factors
5313619|NCT02113696|anthropometric factors|anthropometric factors
5313620|NCT02113683|colo-rectal cancer|colo-rectal cancer
5313621|NCT02113683|stomach cancer|stomach cancer
5963145|NCT04271098|open-heart surgery|open-heart surgery
5313622|NCT02113683|melanoma|melanoma
5313623|NCT02113683|MMS test|mms test
5313624|NCT02113683|therapy monitoring|therapy monitoring
5313625|NCT02113683|Sarcoma|sarcoma
5313626|NCT02113670|stress urinary incontinence|stress urinary incontinence
5313627|NCT02113670|abdominal leak point pressure|abdominal leak point pressure
5313628|NCT02113670|urodynamic study|urodynamic study
5313629|NCT02113657|Prostate cancer|prostate cancer
5313630|NCT02113657|Castration-resistant prostate cancer|castration-resistant prostate cancer
5313631|NCT02113657|CRPC|crpc
5313632|NCT02113657|Metastatic|metastatic
5313633|NCT02113657|Hormone therapy treatment|hormone therapy treatment
5313634|NCT02113657|Androgen deprivation therapy|androgen deprivation therapy
5313635|NCT02113657|gonadotropin-releasing hormone|gonadotropin-releasing hormone
5313636|NCT02113657|GnRH|gnrh
5313637|NCT02113657|Ipilimumab|ipilimumab
5313638|NCT02113657|Yervoy|yervoy
5313639|NCT02113657|BMS-734016|bms-734016
5313640|NCT02113657|MDX010|mdx010
5313641|NCT02113631|Hepatitis C treatment,|hepatitis c treatment,
5313642|NCT02113631|Boceprevir,|boceprevir,
5313643|NCT02113631|Telaprevir,|telaprevir,
5313644|NCT02113631|Safety|safety
5313645|NCT02113631|Effectiveness|effectiveness
5313646|NCT02113631|Head-to-head trial|head-to-head trial
5313647|NCT02113618|Cognitive function, alcohol dependence, working memory|cognitive function, alcohol dependence, working memory
5313648|NCT02113605|Functional gastrointestinal disorders|functional gastrointestinal disorders
5313649|NCT02113605|FGID|fgid
5313650|NCT02113605|Recurrent abdominal pain|recurrent abdominal pain
5313651|NCT02113605|Abdominal pain|abdominal pain
5313652|NCT02113605|pain-predominant functional gastrointestinal disorders|pain-predominant functional gastrointestinal disorders
5313653|NCT02113605|Pediatric pain|pediatric pain
5313654|NCT02113592|Pain management|pain management
5313655|NCT02113592|Opioid use|opioid use
5313656|NCT02113592|Pragmatic|pragmatic
5313657|NCT02113592|Collaborative care|collaborative care
5313658|NCT02113592|Primary care|primary care
5313659|NCT02113579|Tooth Sensitivity|tooth sensitivity
5313660|NCT02113566|Delayed onset muscle soreness|delayed onset muscle soreness
5313661|NCT02113566|DOMS|doms
5313662|NCT02113540|coronary angiography|coronary angiography
5313663|NCT02113540|chronic stable angina|chronic stable angina
5313665|NCT02113527|Electrogastrography|electrogastrography
5313666|NCT02113527|Functional dyspepsia|functional dyspepsia
5313667|NCT02113527|Gastric emptying|gastric emptying
5313668|NCT02113527|Gastrointestinal peptides|gastrointestinal peptides
5313669|NCT02113527|Rome III criteria|rome iii criteria
5313670|NCT02113514|Appalachian|appalachian
5313671|NCT02113514|abnormal pap test|abnormal pap test
5313672|NCT02113501|HGT1|hgt1
5313673|NCT02113501|high risk bladder cancer|high risk bladder cancer
5313674|NCT02113501|substaging|substaging
5313675|NCT02113501|repeat transurethral resection (reTUR)|repeat transurethral resection (retur)
5313676|NCT02113501|lamina propria|lamina propria
5313678|NCT02113475|PCDT|pcdt
5313679|NCT02113475|DVT|dvt
5313680|NCT02113475|PTS|pts
5313681|NCT02113475|Quality of Life|quality of life
5313682|NCT02113462|Chronic kidney disease|chronic kidney disease
5313683|NCT02113462|Endothelial dysfunction|endothelial dysfunction
5313684|NCT02113462|Inflammation|inflammation
5313685|NCT02113462|Insulin resistance|insulin resistance
5313686|NCT02113462|Tg/hdl ratio|tg/hdl ratio
5313687|NCT02113449|Carbon Dioxide, Allergy symptoms|carbon dioxide, allergy symptoms
5313688|NCT02113436|FP/SLM|fp/slm
5313689|NCT02113436|Asthma|asthma
5313690|NCT02113436|Infant|infant
5313691|NCT02113436|Efficacy|efficacy
5313692|NCT02113436|Safety|safety
5313693|NCT02113423|superiority, re-irradiation, IMRT, recurrent T1-2 NPC|superiority, re-irradiation, imrt, recurrent t1-2 npc
5313694|NCT02113410|osteoarthritis|osteoarthritis
5313695|NCT02113410|Older adults|older adults
5313696|NCT02113410|Sit 'N' Chair Yoga|sit 'n' chair yoga
5313697|NCT02113410|Pain|pain
5313698|NCT02113410|Physical Function|physical function
5310369|NCT02128087|HIV|hiv
5313703|NCT02113397|Cystic fibrosis|cystic fibrosis
5313704|NCT02113397|Microbiome|microbiome
5313705|NCT02113397|Sputum|sputum
5313706|NCT02113397|Tobramycin|tobramycin
5313707|NCT02113397|Colistimethate|colistimethate
5313708|NCT02113384|Rectal cancer|rectal cancer
5313709|NCT02113384|Locally advanced rectal cancer|locally advanced rectal cancer
5313710|NCT02113384|Peritoneal carcinomatosis|peritoneal carcinomatosis
5313711|NCT02113384|Exfoliated peritoneal cells|exfoliated peritoneal cells
5313712|NCT02113384|Peritoneal lavage|peritoneal lavage
5313713|NCT02113371|Injury Prevention|injury prevention
5313714|NCT02113371|Health Promotion|health promotion
5313715|NCT02113371|Well being|well being
5313717|NCT02113371|Nutrition|nutrition
5313718|NCT02113371|Physical Activity|physical activity
5313719|NCT02113371|Sleep|sleep
5313720|NCT02113371|Stress|stress
5313721|NCT02113358|fluid therapy|fluid therapy
5313722|NCT02113358|neurosurgery|neurosurgery
5313723|NCT02113345|metamemory|metamemory
5313724|NCT02113345|memory|memory
5313725|NCT02113345|mild cognitive impairment|mild cognitive impairment
5313726|NCT02113332|Insulin injections|insulin injections
5313727|NCT02113332|Overweight|overweight
5313728|NCT02113332|Inadequate glycaemic control|inadequate glycaemic control
5313729|NCT02113319|Core Binding Factors|core binding factors
5313730|NCT02113319|Acute Myelogenous Leukemia refractory to conventional chemotherapy|acute myelogenous leukemia refractory to conventional chemotherapy
5313731|NCT02113319|molecular relapse|molecular relapse
5313732|NCT02113293|phase I study|phase i study
5313733|NCT02113293|tolerability|tolerability
5313735|NCT02113293|CyclASol®|cyclasol®
5313736|NCT02113293|eye drops|eye drops
5313737|NCT02113267|esophagitis|esophagitis
5313738|NCT02113267|eosinophils|eosinophils
5313739|NCT02113267|allergy|allergy
5313740|NCT02113267|inflammation|inflammation
5313741|NCT02113267|corticosteroids|corticosteroids
5313742|NCT02113254|corn|corn
5313743|NCT02113254|macular pigment|macular pigment
5313744|NCT02113254|lutein|lutein
5313745|NCT02113254|zeaxanthin|zeaxanthin
5313746|NCT02113254|Age Macular Degeneration|age macular degeneration
5313747|NCT02113254|AMD|amd
5313748|NCT02113241|metabolic syndrome|metabolic syndrome
5313749|NCT02113241|forxiga|forxiga
5313750|NCT02113241|dapagliflozin|dapagliflozin
5313751|NCT02113241|insulin secretion|insulin secretion
5313752|NCT02113241|insulin sensitivity|insulin sensitivity
5313753|NCT02113228|Energy metabolism|energy metabolism
5313754|NCT02113228|Stable isotopes|stable isotopes
5313755|NCT02113228|Short bowel syndrome|short bowel syndrome
5313756|NCT02113228|Doubly labeled water|doubly labeled water
5313757|NCT02113215|aging|aging
5313758|NCT02113215|lipid metabolism|lipid metabolism
5313759|NCT02113215|very low density lipoproteins|very low density lipoproteins
5313760|NCT02113202|Optical imaging|optical imaging
5313761|NCT02113202|Fluorescence endoscopy|fluorescence endoscopy
5313762|NCT02113202|Near infrared fluorescence|near infrared fluorescence
5313763|NCT02113202|Familial Adenomatous Polyposis|familial adenomatous polyposis
5313764|NCT02113202|IRDye800CW|irdye800cw
5313765|NCT02113202|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5313766|NCT02113202|Gastrointestinal endoscopy|gastrointestinal endoscopy
5313767|NCT02113189|gait|gait
5313768|NCT02113189|Parkinson's disease|parkinson's disease
5313769|NCT02113176|SAH|sah
5313770|NCT02113163|Type 2 diabetes|type 2 diabetes
5313771|NCT02113163|T2DM|t2dm
5313772|NCT02113163|hypertriglyceridemia|hypertriglyceridemia
5313773|NCT02113163|severe hypertriglyceridemia|severe hypertriglyceridemia
5313774|NCT02113163|dyslipidemia|dyslipidemia
5313775|NCT02113163|triglycerides|triglycerides
5313776|NCT02113163|lipids|lipids
5313777|NCT02113163|omega-3 fatty acids|omega-3 fatty acids
5313778|NCT02113163|EPA|epa
5313779|NCT02113163|ethyl-EPA|ethyl-epa
5313780|NCT02113163|Metformin|metformin
5313781|NCT02113163|Glucophage|glucophage
5313782|NCT02113163|Lovaza|lovaza
5313783|NCT02113163|Vascepa|vascepa
5313784|NCT02113163|Epanova|epanova
5313785|NCT02113163|Astra Zeneca|astra zeneca
5313786|NCT02113163|Amarin|amarin
5313787|NCT02113163|GSK|gsk
5313788|NCT02113150|troponin t,cystatin-c,ketamine,remifentanil|troponin t,cystatin-c,ketamine,remifentanil
5313789|NCT02113137|halitosis|halitosis
5313790|NCT02113137|chlorine dioxide|chlorine dioxide
5313791|NCT02113137|tongue cleaning|tongue cleaning
5313792|NCT02113124|Chronic Brain Injury|chronic brain injury
5313793|NCT02113124|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
5313794|NCT02113124|Amino Acids|amino acids
5313795|NCT02113124|Microbiome|microbiome
5313796|NCT02113098|Stroke|stroke
5313797|NCT02113098|Gait|gait
5313798|NCT02113098|Rehabilitation|rehabilitation
5313799|NCT02113085|Adolescents, foster care, self-determination|adolescents, foster care, self-determination
5313800|NCT02113072|wheezing, immune system, cytokines, probiotics, infants.|wheezing, immune system, cytokines, probiotics, infants.
5313801|NCT02113059|Liver regeneration|liver regeneration
5313802|NCT02113059|liver dysfunction|liver dysfunction
5313803|NCT02113059|platelets|platelets
5313804|NCT02113059|plasma|plasma
5313805|NCT02113059|serum|serum
5313806|NCT02113059|platelet activation|platelet activation
5313807|NCT02113059|morbidity|morbidity
5208965|NCT02689622|Elderly|elderly
5313808|NCT02113059|mortality|mortality
5313809|NCT02113059|Growth factors|growth factors
5313810|NCT02113059|Postoperative clinical outcome|postoperative clinical outcome
5313811|NCT02113046|pancreas|pancreas
5313812|NCT02113046|pancreatico-jejunal anastomosis|pancreatico-jejunal anastomosis
5313813|NCT02113046|postoperative pancreatic fistulae|postoperative pancreatic fistulae
5313814|NCT02113007|Lymphoma; CNS; rituximab; temozolomide|lymphoma; cns; rituximab; temozolomide
5313815|NCT02112994|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
5313816|NCT02112994|Lysosomal Storage Disease|lysosomal storage disease
5313817|NCT02112994|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
5313818|NCT02112994|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5313819|NCT02112994|Acid lipase disease|acid lipase disease
5313820|NCT02112994|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5313821|NCT02112994|LAL Deficiency|lal deficiency
5313822|NCT02112994|LIPA Deficiency|lipa deficiency
5313823|NCT02112994|Wolman disease|wolman disease
5313824|NCT02112994|Additional relevant MeSH terms:|additional relevant mesh terms:
5313825|NCT02112994|Cholesterol Ester Storage Disease|cholesterol ester storage disease
5313826|NCT02112994|Metabolic Diseases|metabolic diseases
5313827|NCT02112994|Lipidoses|lipidoses
5313828|NCT02112994|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5313829|NCT02112994|Metabolism, Inborn Errors|metabolism, inborn errors
5313830|NCT02112994|Genetic Diseases, Inborn|genetic diseases, inborn
5313831|NCT02112994|Lysosomal Storage Diseases|lysosomal storage diseases
5313832|NCT02112994|Lipid Metabolism Disorders|lipid metabolism disorders
5313833|NCT02112994|Infant, Newborn, Diseases|infant, newborn, diseases
5313834|NCT02112981|Coronary Arteriosclerosis|coronary arteriosclerosis
5313835|NCT02112968|Myopia|myopia
5313836|NCT02112968|Hyperopia|hyperopia
5313837|NCT02112968|Presbyopia|presbyopia
5313838|NCT02112968|Supracor|supracor
5313839|NCT02112968|Zyoptix|zyoptix
5313840|NCT02112968|Proscan|proscan
5313841|NCT02112968|LASIK|lasik
5313842|NCT02112955|Stroke|stroke
5313843|NCT02112955|Disease management|disease management
5313844|NCT02112955|Self efficacy|self efficacy
5313845|NCT02112955|Quality of life|quality of life
5313846|NCT02112955|Community integration|community integration
5313847|NCT02112942|Hepatitis C virus|hepatitis c virus
5313848|NCT02112942|HCV|hcv
5313849|NCT02112929|Magnetic Resonance Imaging|magnetic resonance imaging
5313850|NCT02112929|Lung Diseases|lung diseases
5313851|NCT02112890|Mexico|mexico
5313852|NCT02112890|Adolescents|adolescents
5313853|NCT02112890|Hepatitis|hepatitis
5313854|NCT02112890|Seroprevalence|seroprevalence
5313855|NCT02112890|Pertussis|pertussis
5313856|NCT02112890|Young adults|young adults
5313857|NCT02112877|iliofemoral vein|iliofemoral vein
5313859|NCT02112877|venous obstruction|venous obstruction
5313860|NCT02112838|IGA Glomerulonephritis|iga glomerulonephritis
5313861|NCT02112838|Nephritis, IGA Type|nephritis, iga type
5313862|NCT02112825|Exercise|exercise
5313863|NCT02112825|blood pressure|blood pressure
5313864|NCT02112825|chronic kidney disease|chronic kidney disease
5313865|NCT02112812|Parkinsons disease|parkinsons disease
5313866|NCT02112812|Helicobacter pylori|helicobacter pylori
5313867|NCT02112812|Eradication|eradication
5313868|NCT02112812|Levodopa response|levodopa response
5313869|NCT02112812|Motor outcomes|motor outcomes
5313870|NCT02112812|Quality of Life|quality of life
5313871|NCT02112812|Open label|open label
5313872|NCT02112799|Hepatitis B|hepatitis b
5313873|NCT02112786|Overactive Bladder|overactive bladder
5313874|NCT02112773|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
5313875|NCT02112760|specific stabilization exercise|specific stabilization exercise
5313876|NCT02112760|ultrasound|ultrasound
5313877|NCT02112760|low back pain|low back pain
5313878|NCT02112747|Colorectal Cancer Prevention|colorectal cancer prevention
5313879|NCT02112747|Colorectal Cancer Screening|colorectal cancer screening
5313880|NCT02112747|ACCS|accs
5313881|NCT02112747|Lynch Syndrome|lynch syndrome
5313883|NCT02112734|vitamin D|vitamin d
5313884|NCT02112734|food allergy|food allergy
5313885|NCT02112734|eczema|eczema
5313886|NCT02112708|Psychotherapy, Rational-Emotive|psychotherapy, rational-emotive
5313887|NCT02112708|Depression|depression
5313888|NCT02112708|Social Work|social work
5313889|NCT02112708|Primary Health Care|primary health care
5313890|NCT02112695|endurance sportswomen|endurance sportswomen
5313891|NCT02112695|addiction|addiction
5313892|NCT02112695|undernutrition|undernutrition
5313893|NCT02112695|[11C]diprenorphine Pet|[11c]diprenorphine pet
5313894|NCT02112695|pituitary region|pituitary region
5313895|NCT02112682|Sentinel lymph node metastasis|sentinel lymph node metastasis
5313897|NCT02112682|Axillary radiotherapy|axillary radiotherapy
5313898|NCT02112656|Carcinoma|carcinoma
5313899|NCT02112656|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5313900|NCT02112656|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5313901|NCT02112656|Neoplasms by Histologic Type|neoplasms by histologic type
5313902|NCT02112656|Neoplasms|neoplasms
5313903|NCT02112656|Adenocarcinoma|adenocarcinoma
5313904|NCT02112656|Liver Neoplasms|liver neoplasms
5313905|NCT02112656|Digestive System Neoplasms|digestive system neoplasms
5313906|NCT02112656|Neoplasms by Site|neoplasms by site
5313907|NCT02112656|Digestive System Diseases|digestive system diseases
5313908|NCT02112656|Liver Diseases|liver diseases
5313909|NCT02112656|Doxorubicin|doxorubicin
5313910|NCT02112656|Antibiotics, Antineoplastic|antibiotics, antineoplastic
5313911|NCT02112656|Antineoplastic Agents|antineoplastic agents
5313912|NCT02112656|Therapeutic Uses|therapeutic uses
5313913|NCT02112656|Pharmacologic Actions|pharmacologic actions
5313914|NCT02112643|Thyroid eye disease|thyroid eye disease
5313915|NCT02112643|Thyroid orbitopathy|thyroid orbitopathy
5313916|NCT02112643|Graves' orbitopathy|graves' orbitopathy
5313917|NCT02112643|Graves' ophthalmopathy|graves' ophthalmopathy
5313918|NCT02112630|Hepatitis C Infection|hepatitis c infection
5313919|NCT02112630|HCV, genotype 1|hcv, genotype 1
5313926|NCT02112617|Childhood neuroblastoma|childhood neuroblastoma
5313927|NCT02112617|Ganglioneuroblastoma|ganglioneuroblastoma
5313928|NCT02112617|Pediatric neuroblastoma|pediatric neuroblastoma
5313929|NCT02112604|critically ill, OSA, mechanical ventilation|critically ill, osa, mechanical ventilation
5313930|NCT02112591|Stress urinary incontinence|stress urinary incontinence
5313931|NCT02112591|mesh|mesh
5313932|NCT02112591|tape|tape
5313933|NCT02112591|micturition dysfunction|micturition dysfunction
5313934|NCT02112591|urinary obstruction|urinary obstruction
5313935|NCT02112591|TOT|tot
5313936|NCT02112578|Vertigo, Meclizine, dimenhydrinate, Peripheral Origin|vertigo, meclizine, dimenhydrinate, peripheral origin
5313937|NCT02112526|de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma|de novo activated b-cell (abc) subtype of diffuse large b-cell lymphoma
5313938|NCT02112526|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5313939|NCT02112526|de Novo Activated B-cell (ABC)|de novo activated b-cell (abc)
5313940|NCT02112526|de Novo Activated B-cell|de novo activated b-cell
5313941|NCT02112526|ABC DLBCL|abc dlbcl
5313942|NCT02112526|DLBCL|dlbcl
5313943|NCT02112526|Lymphoma|lymphoma
5313944|NCT02112526|B-Cell|b-cell
5313945|NCT02112526|Immunoproliferative Disorders|immunoproliferative disorders
5313946|NCT02112526|Immune System Diseases|immune system diseases
5313947|NCT02112526|Bruton's tyrosine kinase|bruton's tyrosine kinase
5313948|NCT02112487|pulmonary arterial hypertension|pulmonary arterial hypertension
5313949|NCT02112487|PAH-SYMPACT|pah-sympact
5313950|NCT02112487|PAH|pah
5313951|NCT02112487|psychometric instrument|psychometric instrument
5313952|NCT02112474|Failed Back Surgery Syndrome|failed back surgery syndrome
5313953|NCT02112474|Neuropathic pain|neuropathic pain
5313954|NCT02112474|Leg Pain|leg pain
5313955|NCT02112474|Chronic Pain|chronic pain
5313956|NCT02112474|Spinal Cord Stimulation|spinal cord stimulation
5313957|NCT02112474|Neurostimulation|neurostimulation
5313958|NCT02112461|end of life care|end of life care
5313959|NCT02112448|congenital heart disease, pediatric cardiothoracic surgery|congenital heart disease, pediatric cardiothoracic surgery
5313960|NCT02112435|obstructive sleep apnea|obstructive sleep apnea
5313961|NCT02112435|mandibular advancement splint|mandibular advancement splint
5313962|NCT02112435|active mandibular advancement splint|active mandibular advancement splint
5313963|NCT02112435|oral appliance|oral appliance
5313964|NCT02112422|Parturients|parturients
5313965|NCT02112409|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5313966|NCT02112409|scoliosis corrective surgery|scoliosis corrective surgery
5313967|NCT02112409|autologous blood transfusion|autologous blood transfusion
5313968|NCT02112409|cell salvage|cell salvage
5313969|NCT02112409|acute normovolemic hemodilution|acute normovolemic hemodilution
5313970|NCT02112409|hemoglobin level|hemoglobin level
5313971|NCT02112396|CRAFT|craft
5313972|NCT02112396|Concerned Significant Others|concerned significant others
5313973|NCT02112396|Contingency management|contingency management
5313974|NCT02112396|Reinforcement|reinforcement
5313975|NCT02112396|Family Intervention|family intervention
5313976|NCT02112383|Procrastination|procrastination
5313977|NCT02112383|Cognitive behavior therapy|cognitive behavior therapy
5313978|NCT02112383|Internet interventions|internet interventions
5313979|NCT02112383|Group intervention|group intervention
5313981|NCT02112383|Randomized controlled trial|randomized controlled trial
5313982|NCT02112370|Ropivacaine|ropivacaine
5313983|NCT02112370|Epinephrine|epinephrine
5313984|NCT02112370|Endoscopy|endoscopy
5313985|NCT02112370|Robotics|robotics
5313986|NCT02112370|Thyroidectomy|thyroidectomy
5313987|NCT02112357|molecular profiling|molecular profiling
5313988|NCT02112357|genetic sequencing|genetic sequencing
5313989|NCT02112357|personalised medicine|personalised medicine
5313990|NCT02112357|gastrointestinal cancer|gastrointestinal cancer
5313992|NCT02112331|Gastric lipolysis|gastric lipolysis
5313993|NCT02112331|Physical treatments|physical treatments
5313994|NCT02112331|Human milk|human milk
5313995|NCT02112305|Magnesium sulphate nebulized|magnesium sulphate nebulized
5313996|NCT02112279|Microbiota|microbiota
5313997|NCT02112279|c-difficile|c-difficile
5313998|NCT02112279|colonoscopy|colonoscopy
5313999|NCT02112279|stool transplant|stool transplant
5314000|NCT02112266|depression|depression
5314001|NCT02112266|online therapy|online therapy
5314002|NCT02112266|cognitive behavioural therapy|cognitive behavioural therapy
5314003|NCT02112266|quality of life|quality of life
5314004|NCT02112266|alexithymia|alexithymia
5314005|NCT02112266|therapy expectation and satisfaction|therapy expectation and satisfaction
5314006|NCT02112253|Tourette's syndrome|tourette's syndrome
5314011|NCT02112240|sentinel lymph node|sentinel lymph node
5314012|NCT02112240|lymphatic mapping|lymphatic mapping
5314013|NCT02112240|rectal tumor|rectal tumor
5314014|NCT02112227|Heart Failure|heart failure
5314015|NCT02112227|Transitional Care|transitional care
5314016|NCT02112227|Knowledge Translation|knowledge translation
5314017|NCT02112227|Outcomes|outcomes
5314018|NCT02112214|Helicobacter pylori treatment|helicobacter pylori treatment
5314019|NCT02112214|Gastric cancer|gastric cancer
5314020|NCT02112214|Screening|screening
5314021|NCT02112175|Multiple Myeloma|multiple myeloma
5314022|NCT02112175|Lenalidomide|lenalidomide
5314023|NCT02112175|Revlimid|revlimid
5314025|NCT02112175|Melphalan|melphalan
5314026|NCT02112175|Prednisone|prednisone
5194834|NCT02776189|MRI|mri
5314027|NCT02112175|Velcade|velcade
5314028|NCT02112175|Placebo|placebo
5314029|NCT02112149|Body Composition|body composition
5314030|NCT02112149|Exercise|exercise
5314031|NCT02112149|Survivorship|survivorship
5314032|NCT02112136|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
5314033|NCT02112136|Renal cysts|renal cysts
5314034|NCT02112136|Chronic Kidney Diseases|chronic kidney diseases
5314035|NCT02112136|Genetic|genetic
5314036|NCT02112123|icariin|icariin
5314037|NCT02112123|pharmacokinetics|pharmacokinetics
5314038|NCT02112123|healthy participants|healthy participants
5314039|NCT02112097|Plaque Psoriasis.|plaque psoriasis.
5314040|NCT02112097|Subdermal bloodless space|subdermal bloodless space
5314041|NCT02112097|Subdermal injection|subdermal injection
5314042|NCT02112097|Subcutaneous injection|subcutaneous injection
5314043|NCT02112097|Injectable electromyography needle|injectable electromyography needle
5314044|NCT02112097|Electrical stimulation|electrical stimulation
5314045|NCT02112097|MRI with Gadolinium|mri with gadolinium
5314046|NCT02112071|Exercise|exercise
5314047|NCT02112071|Diabetic kidney disease|diabetic kidney disease
5314052|NCT02112019|Sjögren's Syndrome|sjögren's syndrome
5314053|NCT02112019|Sialoendoscopy|sialoendoscopy
5314054|NCT02112019|Saliva|saliva
5314055|NCT02112019|Dry Mouth|dry mouth
5314056|NCT02112006|hand surgery|hand surgery
5314057|NCT02112006|wrist surgery|wrist surgery
5314058|NCT02112006|finger surgery|finger surgery
5314059|NCT02112006|anesthesia|anesthesia
5314060|NCT02112006|regional anesthesia|regional anesthesia
5314061|NCT02112006|postoperative pain|postoperative pain
5314062|NCT02111993|Defibrillation testing|defibrillation testing
5314063|NCT02111993|Upper Limit of Vulnerability|upper limit of vulnerability
5314064|NCT02111993|ULV|ulv
5314065|NCT02111993|DFT|dft
5314066|NCT02111993|ICD|icd
5314067|NCT02111993|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5314068|NCT02111993|cardiomyopathy|cardiomyopathy
5314069|NCT02111993|cardiac arrhythmia|cardiac arrhythmia
5314070|NCT02111993|cardiac device testing|cardiac device testing
5314071|NCT02111980|CIED|cied
5314072|NCT02111980|pacemaker|pacemaker
5314073|NCT02111980|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5314074|NCT02111980|ICD|icd
5314075|NCT02111980|radiofrequency|radiofrequency
5314076|NCT02111980|cardiac device programming|cardiac device programming
5314077|NCT02111980|RF sponge detection|rf sponge detection
5314078|NCT02111980|RF assure|rf assure
5314079|NCT02111980|cardiac internal electronic devices|cardiac internal electronic devices
5314080|NCT02111980|temporary pacing|temporary pacing
5314081|NCT02111980|pulmonary thromboendarterectomy|pulmonary thromboendarterectomy
5314082|NCT02111980|pacing interference|pacing interference
5314083|NCT02111980|Arrhythmia|arrhythmia
5314084|NCT02111954|prostate cancer|prostate cancer
5314085|NCT02111954|primary|primary
5314086|NCT02111954|recurrence|recurrence
5314087|NCT02111954|F-18-FCH PET/CT|f-18-fch pet/ct
5314088|NCT02111954|Ga-68-NODAGA-MJ9 PET/CT|ga-68-nodaga-mj9 pet/ct
5314089|NCT02111915|Maternal depression|maternal depression
5314090|NCT02111902|Cardiovascular Disease|cardiovascular disease
5314091|NCT02111902|Obesity|obesity
5314092|NCT02111902|Physical Activity|physical activity
5314093|NCT02111902|Vitamin D deficiency|vitamin d deficiency
5314094|NCT02111902|African Americans|african americans
5314095|NCT02111876|ICU, COPD, OHS, OSA, heart failure|icu, copd, ohs, osa, heart failure
5314096|NCT02111863|Skin Cancer|skin cancer
5314097|NCT02111863|Metastatic Melanoma|metastatic melanoma
5314098|NCT02111863|Adoptive Cell Therapy|adoptive cell therapy
5314115|NCT02111811|Delivery of Healthcare, Integrated|delivery of healthcare, integrated
5314116|NCT02111811|Employment|employment
5314117|NCT02111811|Rehabilitation|rehabilitation
5314118|NCT02111798|substance abuse treatment|substance abuse treatment
5314119|NCT02111798|cocaine dependence|cocaine dependence
5314120|NCT02111798|contingency management; abstinence incentives|contingency management; abstinence incentives
5314121|NCT02111798|medication-enhanced behavioral therapy|medication-enhanced behavioral therapy
5314122|NCT02111785|Dexamethasone|dexamethasone
5314123|NCT02111785|Burr hole craniostomy|burr hole craniostomy
5314124|NCT02111785|Chronic subdural hematoma|chronic subdural hematoma
5314125|NCT02111772|mild asthma, rhinovirus, young adults|mild asthma, rhinovirus, young adults
5314126|NCT02111746|Postoperative pain|postoperative pain
5314127|NCT02111746|sternotomy|sternotomy
5314128|NCT02111746|laparotomy|laparotomy
5314129|NCT02111746|thoracotomy|thoracotomy
5314130|NCT02111746|mini-thoracotomy|mini-thoracotomy
5314131|NCT02111746|truncal surgical incisions|truncal surgical incisions
5314132|NCT02111746|local anaesthetics|local anaesthetics
5314133|NCT02111746|bupivacaine|bupivacaine
5314135|NCT02111720|Disclosure|disclosure
5314136|NCT02111720|Family|family
5963146|NCT04271098|postoperative|postoperative
5314137|NCT02111720|Intervention|intervention
5314138|NCT02111694|infant|infant
5314139|NCT02111694|intake|intake
5314140|NCT02111694|satiation|satiation
5314141|NCT02111694|mother|mother
5314142|NCT02111694|feeding practices|feeding practices
5314143|NCT02111694|bottle feeding|bottle feeding
5314144|NCT02111694|formula feeding|formula feeding
5314145|NCT02111694|maternal responsiveness|maternal responsiveness
5314146|NCT02111694|infant cues|infant cues
5314147|NCT02111681|Calypso-based Deep Inspiration Breath Hold (DIBH)|calypso-based deep inspiration breath hold (dibh)
5314148|NCT02111681|radiation treatments|radiation treatments
5314149|NCT02111681|13-174|13-174
5314150|NCT02111668|Aorta|aorta
5314151|NCT02111668|Dilatation|dilatation
5314152|NCT02111668|Marfan syndrome|marfan syndrome
5314153|NCT02111668|Genetic|genetic
5314154|NCT02111668|Fbn1|fbn1
5314155|NCT02111655|Thrombosis|thrombosis
5314156|NCT02111655|Arteriovenous fistulae|arteriovenous fistulae
5314157|NCT02111655|Hemodialysis|hemodialysis
5314158|NCT02111655|Doppler ultrasound|doppler ultrasound
5314159|NCT02111655|Vascular access blood flow|vascular access blood flow
5314160|NCT02111655|Surveillance|surveillance
5314161|NCT02111642|Pelvic organ prolapse|pelvic organ prolapse
5314162|NCT02111642|Stress urinary incontinence|stress urinary incontinence
5314163|NCT02111642|Midurethral sling|midurethral sling
5314164|NCT02111642|Patient satisfaction|patient satisfaction
5314165|NCT02111629|Vaginosis, bacterial; Candidiasis, vulvovaginal|vaginosis, bacterial; candidiasis, vulvovaginal
5314166|NCT02111616|cancer survivorship care|cancer survivorship care
5314167|NCT02111616|provider communication|provider communication
5314168|NCT02111616|provider care coordination|provider care coordination
5314169|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5314170|NCT02111590|Immunoglobulins, Subcutaneous|immunoglobulins, subcutaneous
5314171|NCT02111577|Immunotherapy|immunotherapy
5314172|NCT02111577|Metastatic|metastatic
5314173|NCT02111577|Castrate Resistant|castrate resistant
5314174|NCT02111577|Prostate Cancer|prostate cancer
5314175|NCT02111577|Biological|biological
5314176|NCT02111577|Vaccine|vaccine
5314177|NCT02111564|Heart Failure|heart failure
5314178|NCT02111564|Respiratory Insufficiency|respiratory insufficiency
5314179|NCT02111564|Stroke Acute|stroke acute
5314180|NCT02111564|Infectious Diseases|infectious diseases
5314181|NCT02111564|Rheumatic Diseases|rheumatic diseases
5314182|NCT02111564|Medically ill Patient|medically ill patient
5314183|NCT02111564|Rivaroxaban|rivaroxaban
5314184|NCT02111564|Thromboembolism|thromboembolism
5314185|NCT02111564|Prophylactic Anti-Coagulation|prophylactic anti-coagulation
5314186|NCT02111551|Autism|autism
5314187|NCT02111551|Nicotinic agonist|nicotinic agonist
5314188|NCT02111551|Cognition|cognition
5314190|NCT02111551|Alpha 7|alpha 7
5314197|NCT02111486|Glucose|glucose
5314198|NCT02111486|Gastric emptying|gastric emptying
5314199|NCT02111473|endothelial dysfunction|endothelial dysfunction
5314200|NCT02111473|bone mineral metabolism|bone mineral metabolism
5314201|NCT02111473|testosteron replacement treatment|testosteron replacement treatment
5314203|NCT02111460|Untreated|untreated
5314204|NCT02111460|Distant metastatic|distant metastatic
5314205|NCT02111447|children|children
5314206|NCT02111447|sevoflurane|sevoflurane
5314207|NCT02111447|isoflurane|isoflurane
5314208|NCT02111447|propofol|propofol
5314209|NCT02111447|anesthesia|anesthesia
5314210|NCT02111447|MRI|mri
5314211|NCT02111447|delirium|delirium
5314212|NCT02111434|visceral adiposity index|visceral adiposity index
5314213|NCT02111434|triglycerides / hdl cholesterol ratio|triglycerides / hdl cholesterol ratio
5314214|NCT02111434|testosterone|testosterone
5314215|NCT02111421|dexmedetomidine|dexmedetomidine
5314216|NCT02111421|parturient|parturient
5314217|NCT02111421|nonpregnant women|nonpregnant women
5314218|NCT02111421|sedation|sedation
5314219|NCT02111408|Sleep apnea syndromes|sleep apnea syndromes
5314220|NCT02111408|Autonomic nervous system +/- disease|autonomic nervous system +/- disease
5314221|NCT02111408|Depression|depression
5314222|NCT02111408|Peripheral arterial disease|peripheral arterial disease
5314223|NCT02111382|Low back pain|low back pain
5314224|NCT02111382|osteopathic manipulations|osteopathic manipulations
5314225|NCT02111382|electroencephalography|electroencephalography
5314226|NCT02111369|Essential Tremor|essential tremor
5314227|NCT02111369|Essential Vocal Tremor|essential vocal tremor
5314228|NCT02111369|Essential Voice Tremor|essential voice tremor
5314229|NCT02111343|auditory processing disorder|auditory processing disorder
5314230|NCT02111343|central auditory processing disorder|central auditory processing disorder
5314231|NCT02111343|auditory processing|auditory processing
5314232|NCT02111343|auditory training|auditory training
5314233|NCT02111330|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
5314234|NCT02111330|adenosine receptor modulator|adenosine receptor modulator
5314236|NCT02111317|ASP015K|asp015k
5314237|NCT02111317|Pharmacokinetics|pharmacokinetics
5314238|NCT02111317|Healthy Subjects|healthy subjects
5314239|NCT02111304|cholera|cholera
5314240|NCT02111304|diarrhea|diarrhea
5314241|NCT02111304|secretory diarrhea|secretory diarrhea
5314242|NCT02111304|ORS|ors
5314243|NCT02111304|V. cholerae O1|v. cholerae o1
5314244|NCT02111304|iOWH032|iowh032
5314245|NCT02111304|children|children
5314246|NCT02111304|pharmacokinetic|pharmacokinetic
5314247|NCT02111304|Bangladesh|bangladesh
5314248|NCT02111291|Diabetic Foot Ulcers|diabetic foot ulcers
5963147|NCT04271098|complications|complications
5194987|NCT02775500|Otezla|otezla
5314249|NCT02111278|Manipulation|manipulation
5314251|NCT02111278|Low Back Pain|low back pain
5314252|NCT02111278|Manual Therapy|manual therapy
5314253|NCT02111278|Adolescents|adolescents
5314254|NCT02111252|Drug Therapy|drug therapy
5314255|NCT02111239|DIEP|diep
5314256|NCT02111239|DIEP flap|diep flap
5314257|NCT02111239|Breast reconstruction|breast reconstruction
5314258|NCT02111239|Breast Cancer|breast cancer
5314259|NCT02111239|CTA|cta
5314260|NCT02111239|MRA|mra
5314261|NCT02111226|hypertension|hypertension
5314262|NCT02111226|cardiovascular disease|cardiovascular disease
5314263|NCT02111226|diabetes|diabetes
5314264|NCT02111226|chronic disease management|chronic disease management
5314265|NCT02111213|physical activity|physical activity
5314266|NCT02111213|Intervention|intervention
5314267|NCT02111213|Attitude to Computers|attitude to computers
5314268|NCT02111200|urea cycle disorders|urea cycle disorders
5314269|NCT02111187|LDE225|lde225
5314270|NCT02111187|High risk localized prostate cancer|high risk localized prostate cancer
5314271|NCT02111187|Pre-surgical|pre-surgical
5314272|NCT02111174|Neuropathy|neuropathy
5314273|NCT02111174|Peripheral neuropathy|peripheral neuropathy
5314274|NCT02111174|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5314275|NCT02111161|Randomised controlled trial (RCT)|randomised controlled trial (rct)
5314276|NCT02111161|Immunoglobulin|immunoglobulin
5314277|NCT02111161|Patient Reported Outcome|patient reported outcome
5314278|NCT02111161|Health-Related Quality of Life|health-related quality of life
5314279|NCT02111161|Short Form-36 (SF-36)|short form-36 (sf-36)
5314280|NCT02111148|rupture of membranes, nitrazine, urea, creatinine|rupture of membranes, nitrazine, urea, creatinine
5314281|NCT02111122|excessive daytime sleepiness|excessive daytime sleepiness
5314282|NCT02111122|Parkinson`s Disease|parkinson`s disease
5314283|NCT02111122|sleep-wake disturbances|sleep-wake disturbances
5314284|NCT02111122|Sodium Oxybate|sodium oxybate
5314285|NCT02111109|Microcirculation|microcirculation
5314286|NCT02111109|Trauma|trauma
5314287|NCT02111109|Haemorrhage|haemorrhage
5314288|NCT02111109|Shock|shock
5314289|NCT02111070|Influenza|influenza
5314290|NCT02111070|Influenza vaccine|influenza vaccine
5314291|NCT02111070|Split influenza vaccine|split influenza vaccine
5314292|NCT02111057|Rheumatoid Arthritis|rheumatoid arthritis
5314293|NCT02111057|Total Hip Replacement|total hip replacement
5314294|NCT02111057|Flare|flare
5314295|NCT02111057|Perioperative Outcomes|perioperative outcomes
5314296|NCT02111044|de novo or partial responder to somatostatin analogues|de novo or partial responder to somatostatin analogues
5314298|NCT02111031|CTC|ctc
5314299|NCT02111031|metastatic breast cancer|metastatic breast cancer
5314300|NCT02111031|Registry|registry
5314301|NCT02111031|mBC|mbc
5314302|NCT02111005|apoptosis|apoptosis
5314303|NCT02111005|periodontal disease|periodontal disease
5314304|NCT02111005|smoking|smoking
5314305|NCT02110979|Patient Decision Aid|patient decision aid
5314306|NCT02110979|Shared Decision Making|shared decision making
5314307|NCT02110966|Anaesthetic effect|anaesthetic effect
5314308|NCT02110966|Inferior alveolar nerve block|inferior alveolar nerve block
5314309|NCT02110966|Local tramadol|local tramadol
5314310|NCT02110966|Mepivacaine|mepivacaine
5318754|NCT02091154|Fruit|fruit
5314312|NCT02110927|Abdominal fat|abdominal fat
5314313|NCT02110927|Metabolic syndrome|metabolic syndrome
5314314|NCT02110927|Microcurrent|microcurrent
5314315|NCT02110927|Aerobic exercise|aerobic exercise
5314316|NCT02110927|Lipolysis|lipolysis
5314317|NCT02110914|Feasibility study|feasibility study
5314318|NCT02110914|Coaching|coaching
5314319|NCT02110914|Health related quality of life|health related quality of life
5314320|NCT02110914|Adherence|adherence
5314321|NCT02110901|radiocephalic|radiocephalic
5314322|NCT02110901|arteriovenous fistula|arteriovenous fistula
5314323|NCT02110901|AVF|avf
5314324|NCT02110901|hemodialysis|hemodialysis
5314325|NCT02110901|PRT-201|prt-201
5314326|NCT02110901|vascular access|vascular access
5314327|NCT02110901|kidney|kidney
5314328|NCT02110901|renal|renal
5314329|NCT02110901|vonapanitase|vonapanitase
5314330|NCT02110901|PATENCY-1|patency-1
5314331|NCT02110875|Healthy Volunteers|healthy volunteers
5314332|NCT02110849|Prostate|prostate
5314333|NCT02110849|Proton Therapy|proton therapy
5314334|NCT02110849|Cancer|cancer
5314335|NCT02110810|post-ERCP Acute Pancreatitis|post-ercp acute pancreatitis
5314336|NCT02110810|Indomethacin|indomethacin
5314337|NCT02110810|NSAIDs|nsaids
5314338|NCT02110797|RETT syndrome|rett syndrome
5314339|NCT02110797|MECP2|mecp2
5314340|NCT02110797|Osteoporosis|osteoporosis
5314341|NCT02110797|RANK-ligand|rank-ligand
5314342|NCT02110797|osteoprotegerin|osteoprotegerin
5314343|NCT02110784|Artemisinin based Combination Therapies|artemisinin based combination therapies
5314344|NCT02110784|eurartesim|eurartesim
5314345|NCT02110784|Dihydroartemisinin/Piperaquine|dihydroartemisinin/piperaquine
5314346|NCT02110771|schizophrenia|schizophrenia
5314347|NCT02110771|social cognition|social cognition
5314348|NCT02110771|facial affects recognition|facial affects recognition
5963148|NCT04271098|hyperbilirubinemia|hyperbilirubinemia
5314349|NCT02110771|cognitive remediation|cognitive remediation
5314350|NCT02110758|Patient Care Management|patient care management
5314351|NCT02110758|Patient Care Planning|patient care planning
5314352|NCT02110758|Patient-Centered Care|patient-centered care
5314353|NCT02110758|Patient Care Team|patient care team
5314354|NCT02110758|Advance Care Planning|advance care planning
5314355|NCT02110758|Delivery of Health Care|delivery of health care
5314356|NCT02110758|Evidence-based Practice|evidence-based practice
5314357|NCT02110758|Health Care Costs|health care costs
5314358|NCT02110758|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5314359|NCT02110758|Quality of Health Care|quality of health care
5314360|NCT02110758|Neoplasms|neoplasms
5314361|NCT02110758|Medical Oncology|medical oncology
5314362|NCT02110719|narcotic use|narcotic use
5314363|NCT02110719|pain|pain
5314364|NCT02110719|constipation|constipation
5314365|NCT02110719|nausea|nausea
5314366|NCT02110706|Myasthenia Gravis|myasthenia gravis
5314367|NCT02110706|Rituximab|rituximab
5314368|NCT02110706|SNOMED code 31839002|snomed code 31839002
5314369|NCT02110693|Substance Use|substance use
5314370|NCT02110693|Substance Use Disorder|substance use disorder
5314371|NCT02110693|Screening|screening
5314372|NCT02110693|Brief Assessment|brief assessment
5314373|NCT02110680|overactive bladder|overactive bladder
5314374|NCT02110680|transcutaneous electric stimulation|transcutaneous electric stimulation
5314375|NCT02110680|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5314376|NCT02110667|Prostate cancer|prostate cancer
5314377|NCT02110667|Prostatectomy|prostatectomy
5314378|NCT02110667|Ultrasound|ultrasound
5314379|NCT02110667|TPUS|tpus
5314380|NCT02110654|chronic rhinosinusitis|chronic rhinosinusitis
5314381|NCT02110654|asthma|asthma
5314382|NCT02110654|montelukast|montelukast
5314383|NCT02110654|surgery|surgery
5314384|NCT02110654|treatment outcomes|treatment outcomes
5314385|NCT02110641|Breast Cancer|breast cancer
5314386|NCT02110641|Survivorship|survivorship
5314387|NCT02110641|Weight Loss|weight loss
5314388|NCT02110628|total gastrectomy|total gastrectomy
5314389|NCT02110628|pouch|pouch
5314391|NCT02110628|quality of life|quality of life
5314392|NCT02110602|Nutrition|nutrition
5314393|NCT02110589|seizures|seizures
5314394|NCT02110550|endocrown|endocrown
5314395|NCT02110550|marginal adaptation|marginal adaptation
5314396|NCT02110550|anatomic form|anatomic form
5314397|NCT02110550|retention loss|retention loss
5314398|NCT02110550|IPS.emmax crowns|ips.emmax crowns
5314399|NCT02110537|Atrial fibrillation|atrial fibrillation
5314400|NCT02110537|Acupuncture|acupuncture
5314401|NCT02110537|Recurrence|recurrence
5314402|NCT02110537|Electrical cardioversion|electrical cardioversion
5314403|NCT02110524|Peripheral Arterial Disease|peripheral arterial disease
5314404|NCT02110498|Pancreatic cyst|pancreatic cyst
5314405|NCT02110498|IPMN|ipmn
5314406|NCT02110498|SCA|sca
5314407|NCT02110498|SPN|spn
5314408|NCT02110498|MCN|mcn
5314409|NCT02110498|pancreatic cystic neoplasm|pancreatic cystic neoplasm
5314410|NCT02110485|Appendicitis|appendicitis
5314411|NCT02110485|Pediatric|pediatric
5318844|NCT02090634|HIV|hiv
5314412|NCT02110485|Children|children
5314413|NCT02110485|Non-operative|non-operative
5314414|NCT02110485|Antibiotics alone|antibiotics alone
5314415|NCT02110472|Emmetropic presbyopes|emmetropic presbyopes
5314416|NCT02110472|Presbyopic|presbyopic
5314417|NCT02110459|POL7080|pol7080
5314418|NCT02110459|Pharmacokinetics|pharmacokinetics
5314419|NCT02110446|Sjögren's syndrome|sjögren's syndrome
5314420|NCT02110446|SS-1|ss-1
5314421|NCT02110446|Gan-Lu-Yin|gan-lu-yin
5314422|NCT02110446|Sang-Ju-Yin|sang-ju-yin
5314423|NCT02110446|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
5314424|NCT02110433|chronic heart failure|chronic heart failure
5314425|NCT02110433|BNP|bnp
5314426|NCT02110433|telemedicine|telemedicine
5314427|NCT02110433|telemonitoring|telemonitoring
5314428|NCT02110433|weight|weight
5314429|NCT02110433|education|education
5314430|NCT02110433|self management|self management
5314431|NCT02110433|cost effectiveness|cost effectiveness
5314432|NCT02110420|Safety|safety
5314433|NCT02110420|Pharmacokinetics|pharmacokinetics
5314434|NCT02110420|Healthy Subjects|healthy subjects
5314435|NCT02110420|First-in-Human|first-in-human
5314436|NCT02110407|healthy young adults|healthy young adults
5314437|NCT02110407|tDCS|tdcs
5314438|NCT02110407|LOCATO task|locato task
5314439|NCT02110407|visual-spatial learning|visual-spatial learning
5314440|NCT02110394|observational|observational
5314441|NCT02110394|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5314442|NCT02110394|bendamustine|bendamustine
5314443|NCT02110381|High blood pressure|high blood pressure
5314444|NCT02110355|Metastatic melanoma|metastatic melanoma
5314445|NCT02110342|PF-04449913|pf-04449913
5314446|NCT02110342|[14C]PF-04449913|[14c]pf-04449913
5314447|NCT02110342|Human ADME|human adme
5314448|NCT02110342|Radiolabel|radiolabel
5314449|NCT02110342|Mass Balance|mass balance
5314450|NCT02110342|Pharmacokinetics|pharmacokinetics
5314451|NCT02110329|colorectal cancer|colorectal cancer
5963149|NCT04271098|hepatic impairment|hepatic impairment
5314452|NCT02110329|stage II and III|stage ii and iii
5314453|NCT02110329|somatic quantitative molecular alterations|somatic quantitative molecular alterations
5314454|NCT02110329|Qantitative Multiplex Pcr of Short fluorescent Fragments method (QMPSF)|qantitative multiplex pcr of short fluorescent fragments method (qmpsf)
5314455|NCT02110290|quality of life|quality of life
5314456|NCT02110290|adaptive sports|adaptive sports
5314457|NCT02110290|therapeutic recreation|therapeutic recreation
5314458|NCT02110290|mental health|mental health
5314459|NCT02110277|Ovarian Cancer|ovarian cancer
5314460|NCT02110277|Epithelial ovarian cancer|epithelial ovarian cancer
5314461|NCT02110264|Opioid Use|opioid use
5314462|NCT02110264|Incarceration|incarceration
5314463|NCT02110264|Vivitrol|vivitrol
5314464|NCT02110264|Patient Navigator|patient navigator
5314465|NCT02110264|Drug Education|drug education
5314466|NCT02110238|osteoarthritis|osteoarthritis
5314467|NCT02110238|knee pain|knee pain
5314469|NCT02110238|Euflexxa|euflexxa
5314470|NCT02110238|HA|ha
5314471|NCT02110238|hyaluronic acid|hyaluronic acid
5314472|NCT02110225|Cone-Rod Degenerations|cone-rod degenerations
5314473|NCT02110225|Cone-Rod Dystrophy|cone-rod dystrophy
5314474|NCT02110225|Cone-Rod Dystrophy 2|cone-rod dystrophy 2
5314475|NCT02110225|Cone-Rod Retinal Dystrophy|cone-rod retinal dystrophy
5314476|NCT02110225|Pigmentary Retinopathy|pigmentary retinopathy
5314477|NCT02110225|Retinal Cone-Rod Dystrophy|retinal cone-rod dystrophy
5314478|NCT02110225|Rod Cone Dystrophies|rod cone dystrophies
5314479|NCT02110225|Rod-Cone Dystrophy|rod-cone dystrophy
5314480|NCT02110225|Tapetoretinal Degeneration|tapetoretinal degeneration
5314481|NCT02110212|Cataract|cataract
5314482|NCT02110212|Surgery, cataract extraction|surgery, cataract extraction
5314483|NCT02110212|Optical devices, laser|optical devices, laser
5314484|NCT02110186|lumbar disc herniation|lumbar disc herniation
5314485|NCT02110186|dynamic stabilization|dynamic stabilization
5314486|NCT02110186|discectomy with posterior dynamic stabilization|discectomy with posterior dynamic stabilization
5314487|NCT02110186|discectomy alone|discectomy alone
5314488|NCT02110186|discectomy with internal fixation and fusion|discectomy with internal fixation and fusion
5314490|NCT02110069|Vascular anomaly|vascular anomaly
5314491|NCT02110069|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
5314493|NCT02110069|hemangioendothelioma|hemangioendothelioma
5314494|NCT02110056|healthy older adults|healthy older adults
5314495|NCT02110056|tDCS|tdcs
5314496|NCT02110056|LOCATO task|locato task
5314497|NCT02110056|visual-spatial learning|visual-spatial learning
5314498|NCT02110043|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
5314499|NCT02110043|tDCS|tdcs
5314500|NCT02110043|LOCATO task|locato task
5314501|NCT02110043|visual-spatial learning|visual-spatial learning
5314502|NCT02110030|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5314503|NCT02110030|Ultrasound|ultrasound
5314504|NCT02110030|Interferential current therapy|interferential current therapy
5314505|NCT02110030|Rehabilitation|rehabilitation
5314506|NCT02110030|Shoulder pain|shoulder pain
5314507|NCT02110017|Ecological task|ecological task
5314508|NCT02110017|fMRI|fmri
5314509|NCT02110017|Schizophrenia|schizophrenia
5314510|NCT02110017|Social Cognition|social cognition
5314511|NCT02109978|Diabetes|diabetes
5314512|NCT02109978|Type 2 diabetes|type 2 diabetes
5314513|NCT02109978|Diabetes therapy response|diabetes therapy response
5314514|NCT02109978|Diabetes progression|diabetes progression
5314515|NCT02109939|MDD|mdd
5314516|NCT02109939|Pharmacogenomic|pharmacogenomic
5314517|NCT02109939|Pharmacogenomic Testing|pharmacogenomic testing
5314518|NCT02109939|Pharmacogenomics|pharmacogenomics
5314519|NCT02109939|Genetic Testing|genetic testing
5314520|NCT02109939|Genetics|genetics
5314521|NCT02109939|Major Depressive Disorder|major depressive disorder
5314522|NCT02109939|GeneSight|genesight
5314523|NCT02109939|Assurex|assurex
5314524|NCT02109939|AssureRx|assurerx
5314525|NCT02109939|Psychotropic|psychotropic
5314526|NCT02109939|Randomized|randomized
5314527|NCT02109939|Double Blind|double blind
5314528|NCT02109939|Placebo Controlled|placebo controlled
5314529|NCT02109913|Breast Cancer|breast cancer
5314530|NCT02109913|metastatic|metastatic
5314531|NCT02109913|hormone receptor positive|hormone receptor positive
5314532|NCT02109913|everolimus|everolimus
5314533|NCT02109913|biomarker|biomarker
5314534|NCT02109887|Pneumocystis jiroveci, cytomegalovirus, co-infection|pneumocystis jiroveci, cytomegalovirus, co-infection
5314535|NCT02109861|Multiple Myeloma|multiple myeloma
5314536|NCT02109861|Phase 0 study|phase 0 study
5314537|NCT02109861|Microdose study|microdose study
5314538|NCT02109861|Micro array|micro array
5314539|NCT02109861|Gene expression profiling|gene expression profiling
5314540|NCT02109848|keratoconus|keratoconus
5314541|NCT02109848|post-keratoplasty|post-keratoplasty
5314542|NCT02109835|Diabetes|diabetes
5314543|NCT02109835|coronary artery disease|coronary artery disease
5314544|NCT02109835|Cardiac computed tomography|cardiac computed tomography
5314545|NCT02109835|Computed tomographics coronary angiography|computed tomographics coronary angiography
5314546|NCT02109835|Plaque progression|plaque progression
5314547|NCT02109822|Cystic Fibrosis|cystic fibrosis
5314548|NCT02109822|Pulmonary Exacerbation|pulmonary exacerbation
5314549|NCT02109822|Lung Infection|lung infection
5314550|NCT02109822|Cystic Fibrosis Foundation|cystic fibrosis foundation
5314551|NCT02109822|Cystic Fibrosis Foundation National Patient Registry|cystic fibrosis foundation national patient registry
5314552|NCT02109796|tDCS|tdcs
5314553|NCT02109796|Stroke|stroke
5314554|NCT02109796|Force|force
5314555|NCT02109796|Spasticity|spasticity
5314556|NCT02109796|Gait|gait
5314557|NCT02109796|EMG|emg
5314558|NCT02109796|Isokinetic|isokinetic
5314559|NCT02109783|Athletes|athletes
5314560|NCT02109783|Ergogenic aids|ergogenic aids
5314561|NCT02109783|Caffeine|caffeine
5314562|NCT02109783|Nutrigenomics|nutrigenomics
5314563|NCT02109783|Genotype|genotype
5314564|NCT02109770|22q|22q
5314565|NCT02109770|DiGeorge|digeorge
5314566|NCT02109770|Angelman|angelman
5314567|NCT02109770|Cri du chat|cri du chat
5314568|NCT02109770|Miller Dieker|miller dieker
5314569|NCT02109770|1p36|1p36
5314570|NCT02109770|Phelan McDermid|phelan mcdermid
5314571|NCT02109770|Prader Willi|prader willi
5314572|NCT02109770|Wolf Hirschorn|wolf hirschorn
5314573|NCT02109770|Smith Magenis|smith magenis
5314574|NCT02109770|Trisomy 21|trisomy 21
5314575|NCT02109770|Down syndrome|down syndrome
5314576|NCT02109770|Trisomy 18|trisomy 18
5314577|NCT02109770|Edwards syndrome|edwards syndrome
5314578|NCT02109770|Trisomy 13|trisomy 13
5314579|NCT02109770|Patau syndrome|patau syndrome
5314580|NCT02109770|Monosomy X|monosomy x
5314581|NCT02109770|Turner syndrome|turner syndrome
5314583|NCT02109770|Klinefelter syndrome|klinefelter syndrome
5314584|NCT02109770|XXX|xxx
5314585|NCT02109770|XYY|xyy
5314586|NCT02109757|Hearing conservation|hearing conservation
5314587|NCT02109757|Personal attenuation rating|personal attenuation rating
5314588|NCT02109757|earplug|earplug
5314589|NCT02109731|Obstructive Sleep Apnea Syndrome (OSAS)|obstructive sleep apnea syndrome (osas)
5314590|NCT02109731|Sleep Apnea|sleep apnea
5314591|NCT02109718|Burns|burns
5314595|NCT02109718|Superficial Partial Thickness Burns|superficial partial thickness burns
5674864|NCT00601627|stage III pancreatic cancer|stage iii pancreatic cancer
5314596|NCT02109718|Less than or equal to 10% Total Body Surface Area|less than or equal to 10% total body surface area
5314598|NCT02109692|dystromirs|dystromirs
5314599|NCT02109692|longitudinal study|longitudinal study
5314600|NCT02109692|miRNA|mirna
5314601|NCT02109653|NSCLC,|nsclc,
5314602|NCT02109653|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
5314603|NCT02109653|BRAF V600,|braf v600,
5314604|NCT02109653|LGX818|lgx818
5314605|NCT02109640|Colorectal|colorectal
5314606|NCT02109640|Surgery|surgery
5314607|NCT02109640|Laparoscopic|laparoscopic
5314608|NCT02109640|Analgesia|analgesia
5314609|NCT02109640|Enhanced Recovery|enhanced recovery
5314610|NCT02109640|Targinact|targinact
5314611|NCT02109627|Acute Myeloid Leukemia|acute myeloid leukemia
5314612|NCT02109627|Ficlatuzumab|ficlatuzumab
5314613|NCT02109627|High Dose Cytarabine|high dose cytarabine
5314615|NCT02109614|lipoprotein(a)|lipoprotein(a)
5314616|NCT02109614|aortic stenosis|aortic stenosis
5314617|NCT02109601|Patient Portals|patient portals
5314618|NCT02109601|Personal Health Records|personal health records
5314619|NCT02109601|Patient Engagement|patient engagement
5314620|NCT02109601|Mobile Health|mobile health
5209804|NCT02684370|ABBV-066|abbv-066
5314621|NCT02109601|Tablet Computers|tablet computers
5314622|NCT02109575|Acute Rejection|acute rejection
5314623|NCT02109575|Cardiac Biomarkers|cardiac biomarkers
5314624|NCT02109575|Cardiac Catheterization|cardiac catheterization
5314625|NCT02109575|Cardiomyopathy|cardiomyopathy
5314626|NCT02109575|Cell-Free DNA|cell-free dna
5314627|NCT02109575|Congenital Heart Defect|congenital heart defect
5314628|NCT02109575|Congenital Heart Disease|congenital heart disease
5314629|NCT02109575|Coronary Angiogram|coronary angiogram
5314630|NCT02109575|Donor Specific DNA|donor specific dna
5314631|NCT02109575|Donor Specific Cell-Free DNA|donor specific cell-free dna
5314632|NCT02109575|Endomyocardial Biopsy|endomyocardial biopsy
5314633|NCT02109575|Heart Failure|heart failure
5314634|NCT02109575|Heart Transplant Failure|heart transplant failure
5314635|NCT02109575|Heart Transplant|heart transplant
5314636|NCT02109575|Heart Transplant Rejection|heart transplant rejection
5314637|NCT02109562|Schizophrenia|schizophrenia
5314638|NCT02109562|Schizophrenic|schizophrenic
5314639|NCT02109562|Schizophrenias|schizophrenias
5314640|NCT02109562|Risperidone|risperidone
5314641|NCT02109536|Colonoscopy|colonoscopy
5314642|NCT02109536|Looping|looping
5314643|NCT02109536|Loop recognition|loop recognition
5314644|NCT02109536|magnetic endoscopic imager|magnetic endoscopic imager
5314645|NCT02109471|corneal opacities|corneal opacities
5314646|NCT02109471|Optical coherence tomography|optical coherence tomography
5314647|NCT02109458|Lung nodule biopsy|lung nodule biopsy
5314648|NCT02109432|Pedal Desk|pedal desk
5314649|NCT02109432|Physical Activity|physical activity
5314650|NCT02109432|Workplace|workplace
5314651|NCT02109432|Energy Expenditure|energy expenditure
5314652|NCT02109419|computerized assessments|computerized assessments
5314653|NCT02109419|mood|mood
5314654|NCT02109419|cognition|cognition
5314655|NCT02109393|Rehabilitation|rehabilitation
5314656|NCT02109393|Robot-assisted walking training|robot-assisted walking training
5314657|NCT02109393|Treadmill|treadmill
5314658|NCT02109393|Lokomat|lokomat
5314659|NCT02109367|ovarian cancer|ovarian cancer
5314660|NCT02109367|ovarian mass|ovarian mass
5314661|NCT02109367|CA-125|ca-125
5314663|NCT02109367|culdocentesis|culdocentesis
5314664|NCT02109367|biomarker(s)|biomarker(s)
5314665|NCT02109354|HIV infection|hiv infection
5314666|NCT02109354|Vaccine|vaccine
5314667|NCT02109341|mPC|mpc
5314668|NCT02109328|Bladder cancer|bladder cancer
5314669|NCT02109328|Urothelial cancer|urothelial cancer
5314670|NCT02109328|Alisertib|alisertib
5314671|NCT02109328|Phase 2|phase 2
5314672|NCT02109328|Advanced disease|advanced disease
5314673|NCT02109289|Anti-Tumor necrosis factor alpha|anti-tumor necrosis factor alpha
5314674|NCT02109289|18-FluoroDeoxyGlucose Positron Emission Tomography|18-fluorodeoxyglucose positron emission tomography
5314675|NCT02109289|High-sensitivity C- Reactive protein|high-sensitivity c- reactive protein
5314676|NCT02109276|Fuch's endothelial dystrophy|fuch's endothelial dystrophy
5314677|NCT02109276|Aspheric intraocular lens|aspheric intraocular lens
5314678|NCT02109276|Higher Order Aberrations|higher order aberrations
5314679|NCT02109276|Contrast Sensitivity|contrast sensitivity
5314680|NCT02109263|Breast-feeding|breast-feeding
5314682|NCT02109263|Breast-feeding newborn|breast-feeding newborn
5314683|NCT02109263|cortical pain responses|cortical pain responses
5314684|NCT02109263|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
5314685|NCT02109263|Salivary rate cortisol|salivary rate cortisol
5314686|NCT02109263|heel lance|heel lance
5314687|NCT02109250|Medullary Thyroid Cancer (MTC) vandetanib caprelsa|medullary thyroid cancer (mtc) vandetanib caprelsa
5314688|NCT02109237|Lung transplantation|lung transplantation
5314689|NCT02109237|Bronchiolitis obliterans|bronchiolitis obliterans
5314690|NCT02109198|Mild Traumatic Brain Injury|mild traumatic brain injury
5314691|NCT02109185|seasonal allergic rhinitis|seasonal allergic rhinitis
5314692|NCT02109185|grass/tree/ragweed allergies|grass/tree/ragweed allergies
5314693|NCT02109185|nasal congestion/stuffiness|nasal congestion/stuffiness
5314695|NCT02109185|nasal itching|nasal itching
5314696|NCT02109185|sneezing|sneezing
5314697|NCT02109172|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5314698|NCT02109172|COPD|copd
5314699|NCT02109146|TACE|tace
5314700|NCT02109146|Postoperation|postoperation
5314701|NCT02109133|deep neuromuscular blockade|deep neuromuscular blockade
5314702|NCT02109133|intraocular pressure|intraocular pressure
5314703|NCT02109107|body contouring|body contouring
5314704|NCT02109107|body shaping|body shaping
5314705|NCT02109107|circumference reduction|circumference reduction
5314706|NCT02109094|insulin|insulin
5314707|NCT02109094|metabolomics|metabolomics
5314708|NCT02109081|dexamethasone|dexamethasone
5314713|NCT02109068|Breast Cancer|breast cancer
5314714|NCT02109068|Survivorship|survivorship
5314715|NCT02109068|Weight Loss|weight loss
5314716|NCT02109055|Cardiovascular Diseases|cardiovascular diseases
5314717|NCT02109055|Thoracic Surgery|thoracic surgery
5314718|NCT02109055|Exercise Therapy|exercise therapy
5314719|NCT02109016|FGFR1 amplification|fgfr1 amplification
5314720|NCT02109016|FGF alteration|fgf alteration
5314721|NCT02109016|VEGF alteration|vegf alteration
5314722|NCT02109016|PDGF alteration|pdgf alteration
5314723|NCT02109016|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5314724|NCT02109016|VEGFR inhibitor|vegfr inhibitor
5314725|NCT02109016|FGFR inhibitor|fgfr inhibitor
5314726|NCT02109016|PDGFR inhibitor|pdgfr inhibitor
5314727|NCT02109016|VEGFR-FGFR inhibitor|vegfr-fgfr inhibitor
5314728|NCT02109003|tracheal cuff|tracheal cuff
5314729|NCT02109003|cuff overinflation|cuff overinflation
5314730|NCT02109003|cuff underinflation|cuff underinflation
5314731|NCT02108990|borderline personality disorder|borderline personality disorder
5314732|NCT02108990|rejection|rejection
5314733|NCT02108990|social pain|social pain
5314734|NCT02108977|Remote Consultation|remote consultation
5314735|NCT02108977|Teleconsultation|teleconsultation
5314736|NCT02108977|Videoconferencing|videoconferencing
5314737|NCT02108977|Genetic Counseling|genetic counseling
5314738|NCT02108977|Costs and Cost Analysis|costs and cost analysis
5314739|NCT02108977|Comparative Effectiveness Research|comparative effectiveness research
5314740|NCT02108977|Telehealth|telehealth
5314741|NCT02108964|NSCLC|nsclc
5314742|NCT02108964|Non-small Cell Lung Cancer EGFRmut|non-small cell lung cancer egfrmut
5314743|NCT02108964|EGFR TKIs (EGF816)|egfr tkis (egf816)
5314744|NCT02108964|acquired T790M mutation|acquired t790m mutation
5314745|NCT02108964|de novo T790M mutation|de novo t790m mutation
5314746|NCT02108964|EGFR TKI activating mutation (i.e. L858R or ex19del)|egfr tki activating mutation (i.e. l858r or ex19del)
5314842|NCT02108613|Quality of life|quality of life
5314747|NCT02108964|Treatment naive advanced NSCLC with EGFR activating mutations|treatment naive advanced nsclc with egfr activating mutations
5314748|NCT02108964|Locally advanced NSCLC (Stage IIIB NSCLC not amenable to definitive multi-modality therapy including surgery)|locally advanced nsclc (stage iiib nsclc not amenable to definitive multi-modality therapy including surgery)
5314749|NCT02108964|Metastatic NSCLC refers to Stage IV NSCLC|metastatic nsclc refers to stage iv nsclc
5314750|NCT02108964|1st line|1st line
5314752|NCT02108951|Ph-CML|ph-cml
5314753|NCT02108951|leukaemia|leukaemia
5314754|NCT02108951|leukemia|leukemia
5314755|NCT02108951|chronic myeloid leukemia|chronic myeloid leukemia
5314756|NCT02108951|chronic myeloid leukaemia|chronic myeloid leukaemia
5314757|NCT02108951|TKI intolerance|tki intolerance
5314758|NCT02108951|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5314759|NCT02108951|tyrosine kinase inhibitor intolerance|tyrosine kinase inhibitor intolerance
5314760|NCT02108912|stroke|stroke
5314761|NCT02108912|gait|gait
5314762|NCT02108912|cardiovascular|cardiovascular
5314763|NCT02108899|Schizophrenia|schizophrenia
5314764|NCT02108899|Episodic memory deficits|episodic memory deficits
5314765|NCT02108886|preterm labor|preterm labor
5314766|NCT02108886|montelukast|montelukast
5314767|NCT02108886|uterine contractions|uterine contractions
5314768|NCT02108873|Appointments and Schedules|appointments and schedules
5314769|NCT02108873|Outpatient Clinics, Hospital/economics|outpatient clinics, hospital/economics
5314770|NCT02108860|Granulomatosis with polyangiitis (Wegener's)|granulomatosis with polyangiitis (wegener's)
5314771|NCT02108860|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5314772|NCT02108860|GPA|gpa
5314773|NCT02108860|Wegener's granulomatosis|wegener's granulomatosis
5314774|NCT02108860|Wegener granulomatosis|wegener granulomatosis
5314775|NCT02108860|Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis|anti neutrophil cytoplasmic antibody associated vasculitis
5314776|NCT02108860|ANCA Associated Vasculitis|anca associated vasculitis
5314777|NCT02108860|AAV|aav
5314778|NCT02108860|Vasculitis|vasculitis
5314779|NCT02108860|Systemic vasculitis|systemic vasculitis
5314780|NCT02108860|Systemic inflammatory disease|systemic inflammatory disease
5314781|NCT02108860|Lung Diseases|lung diseases
5314782|NCT02108860|Respiratory Tract Diseases|respiratory tract diseases
5314783|NCT02108860|Vascular Diseases|vascular diseases
5314784|NCT02108860|Abatacept|abatacept
5314785|NCT02108860|CTLA4-Ig|ctla4-ig
5314786|NCT02108860|Immunosuppressive agent|immunosuppressive agent
5314787|NCT02108860|Prednisone|prednisone
5314788|NCT02108860|Glucocorticoids|glucocorticoids
5314789|NCT02108860|Glucocorticoid|glucocorticoid
5314790|NCT02108860|Corticosteroid|corticosteroid
5314791|NCT02108860|Corticosteroids|corticosteroids
5314792|NCT02108860|Treatment|treatment
5314793|NCT02108860|Pharmacologic Actions|pharmacologic actions
5314794|NCT02108860|Therapeutic Uses|therapeutic uses
5314795|NCT02108860|Anti Inflammatory Agents|anti inflammatory agents
5314799|NCT02108847|Anesthesia, Regional|anesthesia, regional
5314800|NCT02108847|Fascia Iliaca Block|fascia iliaca block
5314801|NCT02108847|Ultrasound Guided|ultrasound guided
5314802|NCT02108834|chronic postsurgery pain|chronic postsurgery pain
5314804|NCT02108821|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
5314805|NCT02108821|Crohn's Disease (CD)|crohn's disease (cd)
5314806|NCT02108821|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5314808|NCT02108808|adenosine|adenosine
5314809|NCT02108808|Ticagrelor|ticagrelor
5314810|NCT02108769|Yoga|yoga
5314811|NCT02108769|Yogic breathing|yogic breathing
5314812|NCT02108769|Saliva|saliva
5314813|NCT02108769|Proteomics|proteomics
5314814|NCT02108769|Lipdomics|lipdomics
5314815|NCT02108769|Nerve growth factor|nerve growth factor
5314816|NCT02108769|Thirumanthiram|thirumanthiram
5314817|NCT02108717|Telemedicine|telemedicine
5314818|NCT02108717|appendicitis|appendicitis
5314819|NCT02108717|remote consultation|remote consultation
5314820|NCT02108704|Parkinson's Disease|parkinson's disease
5314821|NCT02108704|Helicobacter pylori infection|helicobacter pylori infection
5314822|NCT02108678|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5314823|NCT02108678|Depression|depression
5314824|NCT02108678|Illness Management|illness management
5314825|NCT02108678|Behavioral Treatment|behavioral treatment
5314826|NCT02108678|Impairment|impairment
5314827|NCT02108652|anti-PD-L1|anti-pd-l1
5314828|NCT02108652|PD-L1|pd-l1
5314829|NCT02108652|MPDL3280A|mpdl3280a
5314830|NCT02108652|PD-1|pd-1
5314831|NCT02108652|bladder cancer|bladder cancer
5314832|NCT02108652|atezolizumab|atezolizumab
5314833|NCT02108652|Tecentriq|tecentriq
5314834|NCT02108626|Electronic Cigarettes|electronic cigarettes
5314835|NCT02108626|Lozenge|lozenge
5314836|NCT02108626|Nicotine|nicotine
5314837|NCT02108626|Tobacco|tobacco
5314838|NCT02108626|Dependence|dependence
5314839|NCT02108626|Withdrawal|withdrawal
5314840|NCT02108613|Androgen deprivation therapy|androgen deprivation therapy
5314841|NCT02108613|Supportive care|supportive care
5314843|NCT02108600|Kidney transplantation|kidney transplantation
5314844|NCT02108600|Inflammation|inflammation
5314845|NCT02108561|Breast Cancer Heterogeneity Her2|breast cancer heterogeneity her2
5314846|NCT02108548|ASP7657|asp7657
5314847|NCT02108548|Pharmacokinetics|pharmacokinetics
5314848|NCT02108548|Pharmacodynamics|pharmacodynamics
5314849|NCT02108548|Healthy Subjects|healthy subjects
5314850|NCT02108548|First in man|first in man
5314851|NCT02108548|Safety|safety
5314852|NCT02108535|burns|burns
5314853|NCT02108535|dressings|dressings
5314854|NCT02108535|silver sulfadiazine|silver sulfadiazine
5314855|NCT02108535|silver compounds|silver compounds
5314856|NCT02108535|cost|cost
5314857|NCT02108522|CMV infection|cmv infection
5314858|NCT02108522|EBV infection|ebv infection
5314859|NCT02108522|HHV6 virus infection|hhv6 virus infection
5314860|NCT02108522|BK virus infection|bk virus infection
5314861|NCT02108522|Adenovirus infection|adenovirus infection
5314862|NCT02108522|JC virus infection|jc virus infection
5314863|NCT02108522|allogeneic stem cell transplant|allogeneic stem cell transplant
5314864|NCT02108522|Virus Specific T cells|virus specific t cells
5314865|NCT02108509|Chronic Pancreatitis|chronic pancreatitis
5314866|NCT02108509|Osteopenia|osteopenia
5314867|NCT02108509|Osteoporosis|osteoporosis
5314868|NCT02108509|Hypogonadism|hypogonadism
5314869|NCT02108509|Opioid medications|opioid medications
5314870|NCT02108496|meniscectomy|meniscectomy
5314871|NCT02108496|meniscus|meniscus
5314872|NCT02108496|implant|implant
5314873|NCT02108496|koos|koos
5314874|NCT02108496|nusurface|nusurface
5356882|NCT01917591|Extra Cellular Matrix|extra cellular matrix
5314875|NCT02108470|Oral Health Related Quality of Life (OHRQoL)|oral health related quality of life (ohrqol)
5314876|NCT02108470|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
5314877|NCT02108470|Dentist-Patient Relations|dentist-patient relations
5314878|NCT02108470|patients' participation.|patients' participation.
5314879|NCT02108470|patients' satisfaction with the consultation.|patients' satisfaction with the consultation.
5314880|NCT02108457|concurrent chemotherapy|concurrent chemotherapy
5314881|NCT02108444|hepatitis|hepatitis
5314882|NCT02108444|hepatitis B|hepatitis b
5314883|NCT02108444|lymphoma|lymphoma
5314884|NCT02108444|Hematologic Diseases|hematologic diseases
5314885|NCT02108431|urinary diversion|urinary diversion
5314886|NCT02108431|urethral catheter|urethral catheter
5314887|NCT02108431|suprapubic tube|suprapubic tube
5314888|NCT02108431|radical prostatectomy|radical prostatectomy
5314889|NCT02108431|robotic surgery|robotic surgery
5314890|NCT02108431|discomfort|discomfort
5314891|NCT02108431|pain|pain
5314892|NCT02108405|critically ill patient.|critically ill patient.
5314894|NCT02108392|phenotype|phenotype
5314903|NCT02108353|Circadian Rhythm|circadian rhythm
5314904|NCT02108353|Melatonin|melatonin
5314905|NCT02108353|Biomarker|biomarker
5314906|NCT02108353|Clock Gene|clock gene
5314907|NCT02108353|PBMC|pbmc
5314908|NCT02108353|Cardiovascular function|cardiovascular function
5314909|NCT02108353|Epigenetic modification|epigenetic modification
5314910|NCT02108353|Lifestyle Intervention|lifestyle intervention
5314911|NCT02108340|Appendicitis|appendicitis
5314912|NCT02108340|Diagnosis|diagnosis
5314913|NCT02108340|Microwave radiometry|microwave radiometry
5314914|NCT02108340|Ultrasonography|ultrasonography
5314915|NCT02108327|Blood loss|blood loss
5314916|NCT02108327|total knee arthroplasty|total knee arthroplasty
5314917|NCT02108327|hot knife|hot knife
5314918|NCT02108327|cold knife|cold knife
5314919|NCT02108327|unipolar electrocautery|unipolar electrocautery
5314920|NCT02108327|surgical blade|surgical blade
5314921|NCT02108301|chronic hepatitis C-virus infection|chronic hepatitis c-virus infection
5314922|NCT02108301|renal transplantation|renal transplantation
5314923|NCT02108301|glucose tolerance|glucose tolerance
5314924|NCT02108301|immunosuppression|immunosuppression
5314925|NCT02108236|acupuncture|acupuncture
5314926|NCT02108236|chinese traditional medicine|chinese traditional medicine
5314927|NCT02108223|ICSI|icsi
5314928|NCT02108223|Suboptimal Ovarian Response|suboptimal ovarian response
5314930|NCT02108210|Chronic fatigue syndrome|chronic fatigue syndrome
5314931|NCT02108210|Cytokines|cytokines
5314932|NCT02108210|Interleukin-1|interleukin-1
5314933|NCT02108210|Fatigue|fatigue
5314934|NCT02108210|Anakinra|anakinra
5314935|NCT02108184|helicobacter eradication rates|helicobacter eradication rates
5314936|NCT02108171|intranasal|intranasal
5314937|NCT02108171|dexmedetomidine|dexmedetomidine
5314938|NCT02108171|early recovery|early recovery
5314939|NCT02108171|suspension laryngoscopy|suspension laryngoscopy
5314940|NCT02108145|cholangiocarcinoma|cholangiocarcinoma
5314941|NCT02108145|jaundice|jaundice
5314942|NCT02108145|metal stent|metal stent
5314943|NCT02108145|PTBS|ptbs
5314944|NCT02108132|hemophilia|hemophilia
5314947|NCT02108106|safety and tolerability|safety and tolerability
5314948|NCT02108106|pharmacokinetic study|pharmacokinetic study
5314954|NCT02108054|fMRI|fmri
5314955|NCT02108054|Alcoholism|alcoholism
5314956|NCT02108054|Phenotype|phenotype
5314957|NCT02108054|Imaging|imaging
5314958|NCT02108041|Physicians|physicians
5314959|NCT02108041|Genomics|genomics
5314960|NCT02108041|Internal Medicine|internal medicine
5314961|NCT02108041|WARFARIN|warfarin
5314962|NCT02108028|Advance Care Planning Guide|advance care planning guide
5314963|NCT02108028|End-of-Life|end-of-life
5314964|NCT02108015|Transmembrane AMPA Receptor Regulatory Protein|transmembrane ampa receptor regulatory protein
5314965|NCT02108015|Glutamate Receptors|glutamate receptors
5314966|NCT02108015|Healthy Volunteers|healthy volunteers
5314967|NCT02108002|Missense Mutations|missense mutations
5314968|NCT02108002|Hemangioblastoma|hemangioblastoma
5314969|NCT02108002|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
5314970|NCT02108002|Von Hippel-Lindau Disease|von hippel-lindau disease
5314975|NCT02107976|Diabetes|diabetes
5314976|NCT02107976|Red Blood Cells|red blood cells
5314977|NCT02107976|Vitamin C|vitamin c
5314978|NCT02107976|Plasma Vitamin C Levels|plasma vitamin c levels
5314979|NCT02107963|GD2-Expressing Tumors|gd2-expressing tumors
5314980|NCT02107963|Anti-GD2 Chimeric Antigen Receptor|anti-gd2 chimeric antigen receptor
5314981|NCT02107963|Osteosarcoma|osteosarcoma
5314982|NCT02107963|Adoptive Immunotherapy|adoptive immunotherapy
5314983|NCT02107963|Sarcomas|sarcomas
5314984|NCT02107950|Ovarian|ovarian
5314985|NCT02107950|Platinum Sensitive|platinum sensitive
5314986|NCT02107950|Epithelial|epithelial
5314987|NCT02107937|serous|serous
5314988|NCT02107937|endometrioid|endometrioid
5314989|NCT02107937|mucinous|mucinous
5314990|NCT02107937|epithelial ovarian cancer|epithelial ovarian cancer
5314991|NCT02107924|Total|total
5314992|NCT02107924|Knee|knee
5314993|NCT02107924|Replacment|replacment
5314994|NCT02107924|Infection|infection
5314995|NCT02107924|Stimulan|stimulan
5314996|NCT02107911|men who have sex with men|men who have sex with men
5314997|NCT02107911|non-occupational post exposure prophylaxis|non-occupational post exposure prophylaxis
5314998|NCT02107911|HIV infection|hiv infection
5314999|NCT02107859|Cystic fibrosis|cystic fibrosis
5315000|NCT02107859|Nonsense mutation|nonsense mutation
5319435|NCT02087618|Cognition|cognition
5315001|NCT02107859|Premature stop codon|premature stop codon
5315003|NCT02107859|Ataluren|ataluren
5315004|NCT02107820|Bladder training|bladder training
5862864|NCT00001476|Leukapheresis|leukapheresis
5315006|NCT02107820|Overactive bladder|overactive bladder
5315007|NCT02107820|Randomised controlled study|randomised controlled study
5315008|NCT02107807|Influenza,|influenza,
5315009|NCT02107807|H5N1|h5n1
5315010|NCT02107807|aH5N1|ah5n1
5315011|NCT02107807|H5N1 vaccine|h5n1 vaccine
5315012|NCT02107807|Pandemic Influenza vaccine|pandemic influenza vaccine
5315013|NCT02107807|MF59|mf59
5315014|NCT02107807|Adjuvant|adjuvant
5315015|NCT02107807|Avian flu|avian flu
5315016|NCT02107807|Underlying Immunosuppressive|underlying immunosuppressive
5315017|NCT02107807|immunosuppressive conditions|immunosuppressive conditions
5315018|NCT02107807|Pandemic vaccine|pandemic vaccine
5315019|NCT02107807|Adjuvanted vaccine|adjuvanted vaccine
5315020|NCT02107794|Grave's|grave's
5315021|NCT02107794|Disease|disease
5315022|NCT02107794|Thyroid|thyroid
5315023|NCT02107794|Hyperthyroidism|hyperthyroidism
5315024|NCT02107794|Thyroidectomy|thyroidectomy
5315025|NCT02107794|Radioactive|radioactive
5315026|NCT02107794|Iodine|iodine
5315027|NCT02107794|Antithyroid|antithyroid
5315028|NCT02107794|Shared|shared
5315029|NCT02107794|Decision|decision
5315030|NCT02107794|Making|making
5315032|NCT02107794|Evidence|evidence
5315033|NCT02107794|Based|based
5315034|NCT02107794|Endocrinology|endocrinology
5315035|NCT02107794|Mayo|mayo
5315036|NCT02107794|Clinic|clinic
5315037|NCT02107781|Open abdomen|open abdomen
5315038|NCT02107781|abdominal compartment pressure|abdominal compartment pressure
5315039|NCT02107768|Stroke|stroke
5315040|NCT02107768|Exercise|exercise
5315041|NCT02107768|Randomized trial|randomized trial
5315042|NCT02107768|Quality of Life|quality of life
5315043|NCT02107755|oligometastatic melanoma|oligometastatic melanoma
5315044|NCT02107755|melanoma|melanoma
5315045|NCT02107742|Injections|injections
5315046|NCT02107742|Time factors|time factors
5315047|NCT02107742|Pain|pain
5315048|NCT02107742|Healthy volunteers|healthy volunteers
5315049|NCT02107742|Lidocaine|lidocaine
5315050|NCT02107729|Injections|injections
5315051|NCT02107729|Pain|pain
5315052|NCT02107729|Healthy volunteers|healthy volunteers
5315053|NCT02107729|Lidocaine|lidocaine
5315054|NCT02107716|Pain|pain
5315055|NCT02107716|Injections|injections
5315056|NCT02107716|Lidocaine|lidocaine
5315057|NCT02107716|Healthy volunteers|healthy volunteers
5315058|NCT02107703|MONARCH 2|monarch 2
5315059|NCT02107690|Injections|injections
5315060|NCT02107690|Temperature|temperature
5315061|NCT02107690|Pain|pain
5315062|NCT02107690|Healthy volunteers|healthy volunteers
5315063|NCT02107690|Lidocaine|lidocaine
5315064|NCT02107664|Radiotherapy|radiotherapy
5315065|NCT02107664|Cachexia|cachexia
5315066|NCT02107664|Inflammation|inflammation
5315067|NCT02107664|Depression|depression
5315068|NCT02107651|Bleeding|bleeding
5315069|NCT02107651|Anticoagulation|anticoagulation
5315070|NCT02107638|Parkinson's Disease|parkinson's disease
5315071|NCT02107638|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5315072|NCT02107638|Falls|falls
5315073|NCT02107638|Balance|balance
5315074|NCT02107638|Motor function|motor function
5315075|NCT02107625|Defecation|defecation
5315076|NCT02107625|Abdominal pain|abdominal pain
5315077|NCT02107612|Mini-Dental Implant|mini-dental implant
5963150|NCT04270474|deprescribing|deprescribing
5315078|NCT02107612|Implant-Supported Dental Prosthesis|implant-supported dental prosthesis
5315079|NCT02107612|Minimally Invasive Surgical procedures|minimally invasive surgical procedures
5315080|NCT02107612|Overdentures|overdentures
5315081|NCT02107612|Aged|aged
5315082|NCT02107586|biceps tenodesis|biceps tenodesis
5315083|NCT02107586|biceps tenotomy|biceps tenotomy
5315084|NCT02107586|biceps tendonitis|biceps tendonitis
5315085|NCT02107586|biceps inflammation|biceps inflammation
5315086|NCT02107586|shoulder surgery|shoulder surgery
5315087|NCT02107573|Randomized Controlled Trial|randomized controlled trial
5315088|NCT02107573|Rotator Cuff Tear|rotator cuff tear
5315089|NCT02107573|Suprascapular Nerve|suprascapular nerve
5315090|NCT02107573|Decompression|decompression
5315091|NCT02107573|Shoulder Surgery|shoulder surgery
5315092|NCT02107560|Cholangitis|cholangitis
5315093|NCT02107560|Bacteremia|bacteremia
5315094|NCT02107560|Endotoxemia|endotoxemia
5315095|NCT02107560|Blood|blood
5315096|NCT02107560|Bile|bile
5315097|NCT02107547|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5315098|NCT02107547|Type 2 SLAP lesions|type 2 slap lesions
5315099|NCT02107547|labral tear|labral tear
5315100|NCT02107547|biceps tenodesis|biceps tenodesis
5315101|NCT02107547|shoulder surgery|shoulder surgery
5315102|NCT02107547|RCT|rct
5315103|NCT02107547|Comparison between two alternative surgical procedures|comparison between two alternative surgical procedures
5315104|NCT02107534|parent training|parent training
5315105|NCT02107534|homework|homework
5315106|NCT02107534|parenting stress|parenting stress
5315107|NCT02107521|sperm morphology|sperm morphology
5315109|NCT02107521|IMSI|imsi
5315110|NCT02107521|implantation|implantation
5315111|NCT02107521|pregnancy|pregnancy
5315112|NCT02107508|activity energy expenditure|activity energy expenditure
5315113|NCT02107508|body composition|body composition
5315114|NCT02107495|CHF|chf
5315115|NCT02107469|Diabetic Polyneuropathy|diabetic polyneuropathy
5315116|NCT02107469|Diabetic|diabetic
5315117|NCT02107469|Polyneuropathy|polyneuropathy
5315118|NCT02107469|Ayurvedic|ayurvedic
5315119|NCT02107469|Ayurveda|ayurveda
5315120|NCT02107469|Neuralgia|neuralgia
5315121|NCT02107469|Diabetic Neuralgia|diabetic neuralgia
5315122|NCT02107469|Sida cordifolia|sida cordifolia
5315123|NCT02107469|Phyllanthus Niruri|phyllanthus niruri
5315124|NCT02107469|Phyllanthus Amarus|phyllanthus amarus
5315125|NCT02107469|Extracts|extracts
5315126|NCT02107469|Extract|extract
5315127|NCT02107469|Crude Herb|crude herb
5315128|NCT02107469|Crude|crude
5315129|NCT02107469|Herb|herb
5315130|NCT02107469|Herbal|herbal
5315131|NCT02107469|Herbal Extract|herbal extract
5315132|NCT02107469|Decoction|decoction
5315133|NCT02107469|Churna|churna
5315134|NCT02107469|Powder|powder
5315135|NCT02107469|Bala|bala
5315136|NCT02107469|Bhumyamalaki|bhumyamalaki
5315137|NCT02107469|Tamalaki|tamalaki
5315138|NCT02107456|Dry Needling, Myofascial trigger point, Upper trapezius|dry needling, myofascial trigger point, upper trapezius
5315139|NCT02107430|Immunotherapy|immunotherapy
5315140|NCT02107430|Prostate Cancer|prostate cancer
5315141|NCT02107430|Biological, Vaccine|biological, vaccine
5315142|NCT02107417|chemotherapy|chemotherapy
5315143|NCT02107417|pain|pain
5315144|NCT02107417|paresthesia|paresthesia
5315145|NCT02107417|Physiotherapy|physiotherapy
5315146|NCT02107417|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5315147|NCT02107404|Immunotherapy|immunotherapy
5315148|NCT02107404|Prostate Cancer|prostate cancer
5315149|NCT02107404|Biological|biological
5315150|NCT02107404|Vaccine|vaccine
5315151|NCT02107391|Immunotherapy|immunotherapy
5315152|NCT02107391|Prostate Cancer|prostate cancer
5315153|NCT02107391|Biological|biological
5315154|NCT02107391|Vaccine|vaccine
5315155|NCT02107391|Androgen Deprivation Therapy|androgen deprivation therapy
5315156|NCT02107378|Immunotherapy|immunotherapy
5315157|NCT02107378|Serous|serous
5315158|NCT02107378|Relapsed|relapsed
5315159|NCT02107378|Platinum resistant (pt)|platinum resistant (pt)
5315160|NCT02107378|Ovarian Cancer (OvCa)|ovarian cancer (ovca)
5315161|NCT02107378|Biological|biological
5315162|NCT02107378|Vaccine|vaccine
5315163|NCT02107365|Hepatitis C|hepatitis c
5315164|NCT02107365|HCV infection|hcv infection
5315165|NCT02107365|HCV genotype 4|hcv genotype 4
5315166|NCT02107365|Non-responders HCV infected patients|non-responders hcv infected patients
5315167|NCT02107365|Asunaprevir|asunaprevir
5315168|NCT02107365|Daclatasvir|daclatasvir
5315169|NCT02107365|Pegylated Interferon|pegylated interferon
5315170|NCT02107365|Ribavirin|ribavirin
5315171|NCT02107352|Anti-craving medication|anti-craving medication
5315172|NCT02107352|Inhibition|inhibition
5315173|NCT02107352|Attentional Bias|attentional bias
5315174|NCT02107352|Event-Related Potentials|event-related potentials
5315175|NCT02107352|Relapse|relapse
5315176|NCT02107339|methadone|methadone
5315177|NCT02107339|hydromorphone|hydromorphone
5315178|NCT02107339|acute postoperative pain|acute postoperative pain
5315179|NCT02107339|chronic persistent surgical pain|chronic persistent surgical pain
5315180|NCT02107326|Type 1 diabetes|type 1 diabetes
5315181|NCT02107326|HbA1C|hba1c
5315182|NCT02107326|Quality of Life|quality of life
5315183|NCT02107326|Hypoglycaemia|hypoglycaemia
5315184|NCT02107326|Self-management|self-management
5315185|NCT02107326|Telemedicine|telemedicine
5315186|NCT02107300|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5315187|NCT02107274|Azithromycin|azithromycin
5315188|NCT02107274|Bronchiectasis|bronchiectasis
5315189|NCT02107274|Macrolide|macrolide
5315190|NCT02107274|Inflammation|inflammation
5315191|NCT02107274|Pulmonary|pulmonary
5315192|NCT02107261|Musician's Dystonia|musician's dystonia
5315193|NCT02107248|Arthroplasty|arthroplasty
5315194|NCT02107248|Replacement|replacement
5315195|NCT02107248|Hip|hip
5315196|NCT02107248|Posterolateral surgery|posterolateral surgery
5315197|NCT02107248|Precautions|precautions
5315198|NCT02107235|Chemoradiotherapy|chemoradiotherapy
5315199|NCT02107235|cisplatin|cisplatin
5315200|NCT02107222|COPD|copd
5315201|NCT02107222|Exacerbation|exacerbation
5315202|NCT02107222|invasive ventilation|invasive ventilation
5315203|NCT02107222|CO2-Removal|co2-removal
5356883|NCT01917591|Fibroblasts|fibroblasts
5315204|NCT02107196|Irritable Bowel Syndrome|irritable bowel syndrome
5315205|NCT02107196|Colon, irritable|colon, irritable
5315206|NCT02107196|Bowel disease|bowel disease
5315207|NCT02107196|Diarrhea|diarrhea
5315208|NCT02107183|Oxygen therapy|oxygen therapy
5315209|NCT02107183|Extubation|extubation
5315210|NCT02107183|Weaning|weaning
5315211|NCT02107183|Reintubation|reintubation
5315212|NCT02107183|Acute respiratory failure|acute respiratory failure
5315213|NCT02107144|trimetazidine|trimetazidine
5315214|NCT02107144|microcirculation|microcirculation
5315215|NCT02107144|stenting|stenting
5315216|NCT02107144|pressure wire|pressure wire
5315217|NCT02107118|Stem cells|stem cells
5315218|NCT02107118|cardiovascular disease|cardiovascular disease
5315219|NCT02107118|erectile dysfunction|erectile dysfunction
5315220|NCT02107105|Rectal cancer|rectal cancer
5315221|NCT02107105|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
5315222|NCT02107105|Quality of Life|quality of life
5315223|NCT02107105|QOL|qol
5315224|NCT02107105|Post surgery|post surgery
5315225|NCT02107105|Pre-surgery|pre-surgery
5315226|NCT02107105|Questionnaires|questionnaires
5315227|NCT02107105|Surveys|surveys
5315228|NCT02107079|melatonin|melatonin
5315229|NCT02107079|bioavailability|bioavailability
5315230|NCT02107079|pharmacokinetics|pharmacokinetics
5315231|NCT02107066|exercise|exercise
5315232|NCT02107066|physical activity|physical activity
5315233|NCT02107066|ovarian cancer|ovarian cancer
5315234|NCT02107066|quality of life|quality of life
5315235|NCT02107066|fatigue|fatigue
5315236|NCT02107066|weight|weight
5315237|NCT02107053|Oxidative stress,|oxidative stress,
5315238|NCT02107053|hemodialysis,|hemodialysis,
5315239|NCT02107053|pomegranate juice,|pomegranate juice,
5315240|NCT02107053|dietary supplement|dietary supplement
5315241|NCT02107053|patients|patients
5315242|NCT02107001|Lung ultrasound|lung ultrasound
5315243|NCT02107001|Community acquired p neumonia (CAP)|community acquired p neumonia (cap)
5315244|NCT02107001|Pleuritis|pleuritis
5315245|NCT02107001|Pulmonary embolism|pulmonary embolism
5315246|NCT02107001|Lung Cancer|lung cancer
5315247|NCT02106988|Lymphoma|lymphoma
5315248|NCT02106988|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
5315249|NCT02106988|Radiation therapy|radiation therapy
5315250|NCT02106988|XRT|xrt
5315251|NCT02106988|Dexamethasone|dexamethasone
5315252|NCT02106988|Decadron|decadron
5315253|NCT02106988|Etoposide|etoposide
5315254|NCT02106988|VePesid|vepesid
5315255|NCT02106988|Ifosfamide|ifosfamide
5315256|NCT02106988|Ifex|ifex
5315257|NCT02106988|Mesna|mesna
5315258|NCT02106988|Mesnex|mesnex
5315259|NCT02106988|Carboplatin|carboplatin
5315260|NCT02106988|Paraplatin|paraplatin
5315261|NCT02106962|hemodialysis|hemodialysis
5315262|NCT02106962|fistula|fistula
5315263|NCT02106962|clotting|clotting
5315264|NCT02106962|tranexamic acid|tranexamic acid
5315265|NCT02106962|bacitracin|bacitracin
5315266|NCT02106949|suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare|suicide attempt, sms monitoring, recurrence, phone, prevention control, tertiary healthcare
5315267|NCT02106936|Focal Hand Dystonia|focal hand dystonia
5315268|NCT02106936|Depotentiation|depotentiation
5315269|NCT02106936|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5315270|NCT02106936|Rapid Paired Associative Stimulation|rapid paired associative stimulation
5315271|NCT02106936|Healthy Volunteer|healthy volunteer
5315272|NCT02106910|Barrett's Esophagus|barrett's esophagus
5315273|NCT02106910|Radiofrequency Ablation|radiofrequency ablation
5315274|NCT02106884|Pancreatic cancer|pancreatic cancer
5315275|NCT02106884|Locally advanced|locally advanced
5315276|NCT02106884|Metastatic|metastatic
5315277|NCT02106871|cancer|cancer
5315278|NCT02106871|pancreas|pancreas
5315279|NCT02106871|cholangiocarcinoma|cholangiocarcinoma
5315280|NCT02106871|fatigue|fatigue
5315281|NCT02106871|sildenafil|sildenafil
5315282|NCT02106871|lean mass|lean mass
5315283|NCT02106871|muscle|muscle
5369163|NCT01861002|Lymphoblastic|lymphoblastic
5315284|NCT02106858|Stivarga / Regorafenib / Metastatic Colorectal Cancer / Metastatic or unresectable locally advanced GIST (Gastrointestinal stromal tumors)|stivarga / regorafenib / metastatic colorectal cancer / metastatic or unresectable locally advanced gist (gastrointestinal stromal tumors)
5315285|NCT02106845|Regorafenib|regorafenib
5315286|NCT02106845|Probe substrates|probe substrates
5315287|NCT02106845|Pharmacokinetics|pharmacokinetics
5315288|NCT02106845|Cancer|cancer
5315289|NCT02106845|Safety|safety
5315290|NCT02106845|Advanced solid malignant tumors|advanced solid malignant tumors
5315291|NCT02106832|Ciprofloxacin|ciprofloxacin
5315292|NCT02106832|Dry Powder for Inhalation|dry powder for inhalation
5315293|NCT02106832|Exacerbation|exacerbation
5315294|NCT02106832|Bronchiectasis|bronchiectasis
5315295|NCT02106819|Cerebellar Ataxia|cerebellar ataxia
5315296|NCT02106819|Emotions|emotions
5315297|NCT02106819|Affective Prosody|affective prosody
5315298|NCT02106819|Facial Expression|facial expression
5315299|NCT02106819|Magnetic Resonance Imaging|magnetic resonance imaging
5315300|NCT02106806|Oxidative stress|oxidative stress
5315301|NCT02106806|Zinc|zinc
5315302|NCT02106806|Chemotherapy|chemotherapy
5315303|NCT02106806|Colorectal cancer|colorectal cancer
5315304|NCT02106793|Chronic Rhinosinusitis|chronic rhinosinusitis
5315305|NCT02106793|Mitomicin C|mitomicin c
5315306|NCT02106793|Postoperative nasal synerchia|postoperative nasal synerchia
5315307|NCT02106780|Phase 1|phase 1
5315308|NCT02106780|Healthy subjects|healthy subjects
5315309|NCT02106780|Excretion|excretion
5315310|NCT02106780|14C-labeled ASP1707|14c-labeled asp1707
5315311|NCT02106767|rosuvastatin|rosuvastatin
5315312|NCT02106767|rifampin|rifampin
5315313|NCT02106767|pharmacokinetics|pharmacokinetics
5315314|NCT02106767|drug interaction|drug interaction
5315315|NCT02106767|healthy volunteer|healthy volunteer
5315316|NCT02106767|drug transporter|drug transporter
5315318|NCT02106767|White|white
5315319|NCT02106741|Pain|pain
5315320|NCT02106741|Acupressure|acupressure
5315321|NCT02106741|Symptoms|symptoms
5315322|NCT02106741|Fatigue|fatigue
5315323|NCT02106741|Self-administered|self-administered
5315324|NCT02106728|Eating Disorders|eating disorders
5315325|NCT02106728|Family Therapy|family therapy
5315326|NCT02106728|Multi-Family Therapy|multi-family therapy
5315327|NCT02106728|Bulimia Nervosa|bulimia nervosa
5315328|NCT02106728|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5315330|NCT02106702|detention|detention
5315331|NCT02106702|substance abuse|substance abuse
5315332|NCT02106689|infertility, superovulation, gonadotropins, needle free injection system|infertility, superovulation, gonadotropins, needle free injection system
5315333|NCT02106676|polycystic ovary Syndrome|polycystic ovary syndrome
5315334|NCT02106676|hyperandrogenism|hyperandrogenism
5315335|NCT02106676|cordblood|cordblood
5315336|NCT02106676|androgens|androgens
5315337|NCT02106663|atrial fibrillation|atrial fibrillation
5315338|NCT02106663|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5315339|NCT02106663|PAF|paf
5315340|NCT02106663|arrhythmia|arrhythmia
5315341|NCT02106663|atrial fibrillation ablation|atrial fibrillation ablation
5315342|NCT02106663|circumferential ablation|circumferential ablation
5315343|NCT02106663|CPVA|cpva
5315344|NCT02106663|segmental ablation|segmental ablation
5315345|NCT02106663|PVI|pvi
5315346|NCT02106663|pulmonary vein isolation|pulmonary vein isolation
5315347|NCT02106650|Relapsed PTCL|relapsed ptcl
5315348|NCT02106650|Refractory PTCL|refractory ptcl
5315349|NCT02106637|ACS|acs
5315350|NCT02106637|Cessation|cessation
5315351|NCT02106624|mechanical ventilation|mechanical ventilation
5315352|NCT02106611|MRI|mri
5315353|NCT02106611|stress echo|stress echo
5315354|NCT02106611|Clinical Assessment|clinical assessment
5315355|NCT02106611|14-017|14-017
5315356|NCT02106598|Sentinel Lymph Node Mapping|sentinel lymph node mapping
5315357|NCT02106598|Intraoperative Sentinel|intraoperative sentinel
5315358|NCT02106598|Head and Neck Melanoma|head and neck melanoma
5315359|NCT02106598|Targeted Silica Nanoparticles|targeted silica nanoparticles
5315360|NCT02106598|cRGDY-PEG-Cy5.5-C dots|crgdy-peg-cy5.5-c dots
5315373|NCT02106559|Pleural Malignancy|pleural malignancy
5315374|NCT02106559|PDT|pdt
5315387|NCT02106533|Coronary artery disease|coronary artery disease
5315388|NCT02106533|Exercise|exercise
5315389|NCT02106533|Ventilatory efficiency|ventilatory efficiency
5315390|NCT02106520|Epistaxis|epistaxis
5315391|NCT02106520|Bevacizumab|bevacizumab
5315392|NCT02106507|Apalutamide|apalutamide
5315393|NCT02106507|RAD001|rad001
5315394|NCT02106507|Everolimus|everolimus
5315395|NCT02106507|Castration-resistant|castration-resistant
5315396|NCT02106507|13-025|13-025
5315397|NCT02106507|ARN-509|arn-509
5315398|NCT02106494|Highly emetogenic chemotherapy (HEC)|highly emetogenic chemotherapy (hec)
5315399|NCT02106494|Chemotherapy-Induced Nausea and Vomiting (CINV)|chemotherapy-induced nausea and vomiting (cinv)
5315400|NCT02106481|TKA|tka
5315401|NCT02106481|TKR|tkr
5315402|NCT02106481|Knee OA|knee oa
5315403|NCT02106481|pain management|pain management
5315404|NCT02106481|Femoral Nerve Catheter|femoral nerve catheter
5315405|NCT02106481|Single Shot Femoral Nerve Blocks|single shot femoral nerve blocks
5369164|NCT01861002|Leukemia|leukemia
5315406|NCT02106468|Oral Lichen Planus|oral lichen planus
5315407|NCT02106468|Corticosteroid|corticosteroid
5315408|NCT02106468|Omega -3|omega -3
5315409|NCT02106455|Pharmacological theapy|pharmacological theapy
5315410|NCT02106442|Pharmacological therapy|pharmacological therapy
5315411|NCT02106429|Vascular Surgery|vascular surgery
5315412|NCT02106416|prostate cancer|prostate cancer
5315413|NCT02106416|bladder cancer|bladder cancer
5315414|NCT02106416|MRI|mri
5315415|NCT02106416|PET|pet
5315416|NCT02106416|perfusion|perfusion
5315417|NCT02106390|Central Nervous System Diseases|central nervous system diseases
5315418|NCT02106390|Nervous System Diseases|nervous system diseases
5315419|NCT02106390|Meningitis|meningitis
5315420|NCT02106338|follow-up to 10-0008, Clostridium difficile, dose-escalating, CRS3123|follow-up to 10-0008, clostridium difficile, dose-escalating, crs3123
5315421|NCT02106325|Ketamine|ketamine
5315422|NCT02106325|Ketlar|ketlar
5315423|NCT02106325|Depression|depression
5315424|NCT02106325|Antidepressants|antidepressants
5315425|NCT02106325|Treatment|treatment
5315426|NCT02106325|Acute|acute
5315427|NCT02106312|Radiotherapy|radiotherapy
5315428|NCT02106312|Myxoid liposarcoma|myxoid liposarcoma
5315429|NCT02106312|Soft tissue sarcoma|soft tissue sarcoma
5315430|NCT02106286|Cardiopulmonary exercise test|cardiopulmonary exercise test
5315431|NCT02106286|surgery|surgery
5315432|NCT02106286|abdominal aortic aneurysm|abdominal aortic aneurysm
5315433|NCT02106286|anaerobic threshold|anaerobic threshold
5315434|NCT02106286|fitness|fitness
5315435|NCT02106286|beta-blockers|beta-blockers
5315436|NCT02106273|LMA|lma
5315437|NCT02106273|Bronchial blocker|bronchial blocker
5315438|NCT02106260|safety|safety
5315439|NCT02106260|pharmacokinetics (PK)|pharmacokinetics (pk)
5315440|NCT02106260|pharmacodynamics (PD)|pharmacodynamics (pd)
5315442|NCT02106234|contrast induced nephropathy|contrast induced nephropathy
5315443|NCT02106234|prophylactic intravenous hydration|prophylactic intravenous hydration
5315444|NCT02106234|intravenous normal saline|intravenous normal saline
5315445|NCT02106234|acute kidney injury|acute kidney injury
5315446|NCT02106221|Care coordination|care coordination
5315447|NCT02106221|nurse care management|nurse care management
5315448|NCT02106221|practice facilitation|practice facilitation
5315449|NCT02106221|health information technology|health information technology
5315450|NCT02106182|Benign prostatic hyperplasia|benign prostatic hyperplasia
5315451|NCT02106182|Nocturia|nocturia
5315452|NCT02106182|Silodosin|silodosin
5315454|NCT02106169|Food allergy|food allergy
5315455|NCT02106169|Children and families|children and families
5315456|NCT02106169|Therapeutic education|therapeutic education
5315457|NCT02106169|Quality of life|quality of life
5315458|NCT02106130|Mosapride citrate|mosapride citrate
5315459|NCT02106130|Rebamipide|rebamipide
5315460|NCT02106130|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
5315465|NCT02106104|Diabetic nephropathy|diabetic nephropathy
5315466|NCT02106104|Renoprotection|renoprotection
5315467|NCT02106104|DPP-4 inhibitors|dpp-4 inhibitors
5315468|NCT02106104|Linagliptin|linagliptin
5315469|NCT02106104|SU derivatives|su derivatives
5315470|NCT02106104|Glimepiride|glimepiride
5315471|NCT02106078|Bipolar Disorder|bipolar disorder
5315472|NCT02106078|Bipolar|bipolar
5315473|NCT02106078|Online Intervention|online intervention
5315474|NCT02106078|Internet intervention|internet intervention
5315475|NCT02106078|Self-Help|self-help
5315476|NCT02106065|Dementia|dementia
5315477|NCT02106065|Caregivers|caregivers
5315478|NCT02106065|Neurodegenerative Diseases|neurodegenerative diseases
5315479|NCT02106065|Brain Diseases|brain diseases
5315480|NCT02106065|Cost of Illness|cost of illness
5315481|NCT02106065|Stress, Psychological|stress, psychological
5315482|NCT02106065|Depression|depression
5315483|NCT02106065|Vital Statistics|vital statistics
5315484|NCT02106065|Mortality|mortality
5315485|NCT02106065|Behavioral Symptoms|behavioral symptoms
5315486|NCT02106065|Residential Facilities|residential facilities
5315487|NCT02106065|Emergency Medical Services|emergency medical services
5315488|NCT02106065|Long-Term Care|long-term care
5315489|NCT02106052|cognitive function|cognitive function
5315490|NCT02106052|cognitive impairment|cognitive impairment
5315491|NCT02106052|cognitive intervention|cognitive intervention
5315492|NCT02106052|cognitive improvement|cognitive improvement
5315493|NCT02106052|information processing speed|information processing speed
5315494|NCT02106052|exercise training program|exercise training program
5315495|NCT02106052|aerobic exercise|aerobic exercise
5315496|NCT02106052|stretching and toning|stretching and toning
5315497|NCT02106052|Multiple sclerosis|multiple sclerosis
5315498|NCT02106052|executive function|executive function
5315499|NCT02106039|diabetes mellitus|diabetes mellitus
5315500|NCT02106039|tuberculosis|tuberculosis
5315501|NCT02106039|management|management
5315502|NCT02106039|randomized controlled trial|randomized controlled trial
5315503|NCT02106026|Breastfeeding|breastfeeding
5315504|NCT02106026|Nursing|nursing
5315505|NCT02106026|Patient Education as Topic|patient education as topic
5315506|NCT02106026|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5315507|NCT02106026|Hispanic Americans.|hispanic americans.
5315508|NCT02106013|HDL|hdl
5315509|NCT02106013|Carotid artery intima-media thickness|carotid artery intima-media thickness
5315510|NCT02106013|Cholesterol efflux capacity|cholesterol efflux capacity
5315511|NCT02106013|Antioxidant effect of HDL|antioxidant effect of hdl
5315512|NCT02106013|Susceptibility to oxidation of HDL|susceptibility to oxidation of hdl
5315513|NCT02106013|Anti-inflammatory effect of HDL|anti-inflammatory effect of hdl
5315514|NCT02106013|Platelet aggregation inhibition by HDL|platelet aggregation inhibition by hdl
5315515|NCT02106000|Post Partum|post partum
5315516|NCT02106000|Inhaled Oxytocin|inhaled oxytocin
5315517|NCT02106000|Inhalation Profiles|inhalation profiles
5315518|NCT02105987|Abacavir/dolutegravir/lamivudine|abacavir/dolutegravir/lamivudine
5315519|NCT02105987|Fixed-dose combination|fixed-dose combination
5315520|NCT02105987|Once daily|once daily
5315521|NCT02105987|Trii|trii
5315522|NCT02105987|Single-tablet regimen|single-tablet regimen
5315523|NCT02105974|COPD|copd
5315524|NCT02105974|Fluticasone Furoate (FF)|fluticasone furoate (ff)
5315525|NCT02105974|Vilanterol (VI)|vilanterol (vi)
5315526|NCT02105974|Dry Powder Inhaler|dry powder inhaler
5315527|NCT02105961|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5315528|NCT02105961|exacerbations|exacerbations
5315529|NCT02105961|SB240563|sb240563
5315530|NCT02105961|mepolizumab|mepolizumab
5315531|NCT02105961|eosinophils|eosinophils
5315532|NCT02105948|eosinophils|eosinophils
5315533|NCT02105948|SB240563|sb240563
5315534|NCT02105948|exacerbations|exacerbations
5315535|NCT02105948|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5315536|NCT02105948|mepolizumab|mepolizumab
5315537|NCT02105922|Frailty|frailty
5315538|NCT02105922|Ageing|ageing
5315540|NCT02105922|Protein quality|protein quality
5315541|NCT02105922|Exercise training|exercise training
5315542|NCT02105922|Sarcopenia|sarcopenia
5315543|NCT02105896|dental bonding|dental bonding
5315544|NCT02105857|knee mobilazation|knee mobilazation
5315545|NCT02105857|TKA|tka
5315546|NCT02105857|joint replacement|joint replacement
5315547|NCT02105857|rehabilitation|rehabilitation
5315553|NCT02105831|left ventricular assist device|left ventricular assist device
5315554|NCT02105831|contrast ultrasound|contrast ultrasound
5315555|NCT02105831|perfusion imaging|perfusion imaging
5315556|NCT02105818|Self-reported questionnaire|self-reported questionnaire
5315557|NCT02105818|Swallowing disorders|swallowing disorders
5315558|NCT02105818|Systemic sclerosis|systemic sclerosis
5315559|NCT02105818|Drug therapy|drug therapy
5315560|NCT02105818|Adherence to medication regime|adherence to medication regime
5315561|NCT02105818|Coping strategy|coping strategy
5315562|NCT02105818|Pharmaceutical care|pharmaceutical care
5315563|NCT02105818|Patient safety|patient safety
5315564|NCT02105818|Patient oriented care|patient oriented care
5315565|NCT02105805|intention weight loss|intention weight loss
5315566|NCT02105805|heart failure|heart failure
5315567|NCT02105805|6-minute walk test|6-minute walk test
5315568|NCT02105792|Diabetes|diabetes
5315569|NCT02105792|Type 2 diabetes|type 2 diabetes
5315570|NCT02105792|Diabetes therapy response|diabetes therapy response
5315571|NCT02105792|Diabetes progression|diabetes progression
5315572|NCT02105766|Sickle Cell Disease|sickle cell disease
5315573|NCT02105766|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5315574|NCT02105766|Pentostatin (Nipent)|pentostatin (nipent)
5315575|NCT02105766|Cyclophosphamide|cyclophosphamide
5315576|NCT02105766|Alemtuzumab (Campath)|alemtuzumab (campath)
5315577|NCT02105740|BEHAVIORAL|behavioral
5315578|NCT02105740|HYPNOSIS|hypnosis
5315579|NCT02105740|ANXIETY|anxiety
5315580|NCT02105740|DEPRESSION|depression
5315581|NCT02105727|Dietary sodium|dietary sodium
5315582|NCT02105727|Urinary sodium excretion|urinary sodium excretion
5315583|NCT02105727|Urinary iodine excretion|urinary iodine excretion
5315584|NCT02105714|Diarrhoea|diarrhoea
5315585|NCT02105714|Abdominal pain|abdominal pain
5315586|NCT02105714|Bacterial|bacterial
5315587|NCT02105714|Protozoal|protozoal
5315588|NCT02105714|Helminth|helminth
5315589|NCT02105675|Immunotherapy|immunotherapy
5315590|NCT02105675|Metastatic|metastatic
5315591|NCT02105675|Castrate Resistant|castrate resistant
5315592|NCT02105675|Prostate Cancer|prostate cancer
5315593|NCT02105675|Biological|biological
5315594|NCT02105675|Vaccine|vaccine
5315595|NCT02105649|cerebral palsy|cerebral palsy
5315596|NCT02105649|standing|standing
5315597|NCT02105649|strengthening|strengthening
5315598|NCT02105623|Coronary Arteriosclerosis|coronary arteriosclerosis
5315599|NCT02105623|rosuvastatin|rosuvastatin
5315600|NCT02105610|volatile anesthetics|volatile anesthetics
5315601|NCT02105610|desflurane|desflurane
5315602|NCT02105610|isoflurane|isoflurane
5315603|NCT02105610|sevoflurane|sevoflurane
5315604|NCT02105610|TIVA|tiva
5315605|NCT02105610|cardiac surgery|cardiac surgery
5315606|NCT02105610|mortality|mortality
5315607|NCT02105610|anesthesia|anesthesia
5315608|NCT02105610|intensive care|intensive care
5315609|NCT02105597|Diabetes mellitus|diabetes mellitus
5315610|NCT02105597|Medication adherence|medication adherence
5315611|NCT02105597|Compliance|compliance
5369165|NCT01861002|Azacytidine|azacytidine
5315612|NCT02105597|Mobile health|mobile health
5315613|NCT02105571|Body Weight|body weight
5315614|NCT02105571|Nutrition|nutrition
5315615|NCT02105571|Physical Activity|physical activity
5315616|NCT02105571|Sleep|sleep
5315617|NCT02105571|Health Promotion|health promotion
5315618|NCT02105571|Stress|stress
5315619|NCT02105571|Safety|safety
5315620|NCT02105558|trial of labor after cesarean|trial of labor after cesarean
5315621|NCT02105558|vaginal birth after cesarean|vaginal birth after cesarean
5315622|NCT02105558|epidural vs combined spinal epidural|epidural vs combined spinal epidural
5315623|NCT02105545|cancer|cancer
5315624|NCT02105545|oncology|oncology
5315625|NCT02105545|malignant|malignant
5315626|NCT02105545|malignancy|malignancy
5315627|NCT02105545|genetics|genetics
5315628|NCT02105545|genomics|genomics
5315629|NCT02105545|exome|exome
5315630|NCT02105545|DNA|dna
5315631|NCT02105545|RNA|rna
5315632|NCT02105545|sequencing|sequencing
5315633|NCT02105545|epigenetic|epigenetic
5315634|NCT02105545|clinically actionable findings|clinically actionable findings
5315636|NCT02105545|secondary findings|secondary findings
5315637|NCT02105545|SF|sf
5315638|NCT02105545|single nucleotide variants|single nucleotide variants
5315639|NCT02105545|SNV|snv
5315640|NCT02105545|bioinformatics|bioinformatics
5315641|NCT02105545|genotype|genotype
5315642|NCT02105545|The American College of Medical Genetics and Genomics|the american college of medical genetics and genomics
5315643|NCT02105545|ACMG|acmg
5315644|NCT02105532|Transfusion in gastrointestinal bleeding|transfusion in gastrointestinal bleeding
5423280|NCT01616355|surface roughness;|surface roughness;
5315645|NCT02105519|trivalent influenza vaccine, chronic kidney disease|trivalent influenza vaccine, chronic kidney disease
5315647|NCT02105506|Stomach|stomach
5315648|NCT02105506|Resection|resection
5315649|NCT02105506|Esophageal disease requiring surgery|esophageal disease requiring surgery
5315650|NCT02105506|Gastric disease requiring surgery|gastric disease requiring surgery
5315651|NCT02105493|Nitroglycerin|nitroglycerin
5315652|NCT02105493|Radial Artery Occlusion|radial artery occlusion
5315653|NCT02105493|Transradial Catheterization|transradial catheterization
5315654|NCT02105480|Computer aided auscultation (CAA)|computer aided auscultation (caa)
5315655|NCT02105480|Phonocardiogram analysis|phonocardiogram analysis
5315656|NCT02105480|Murmur detection|murmur detection
5315657|NCT02105480|Heart auscultation|heart auscultation
5315658|NCT02105441|cochlear implant|cochlear implant
5315659|NCT02105428|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5315660|NCT02105428|Insulin Resistance|insulin resistance
5315661|NCT02105428|Overweight, Obese Women|overweight, obese women
5315662|NCT02105428|Protein Metabolism|protein metabolism
5315663|NCT02105428|Post Translational Modifications|post translational modifications
5315664|NCT02105415|Critical care|critical care
5315665|NCT02105415|Emergent|emergent
5315666|NCT02105415|Etomidate|etomidate
5315667|NCT02105415|Hemodynamics|hemodynamics
5315668|NCT02105415|Intensive care unit|intensive care unit
5315669|NCT02105415|Intubation|intubation
5315670|NCT02105415|Ketamine-Propofol admixture|ketamine-propofol admixture
5315671|NCT02105402|Speech sound disorders|speech sound disorders
5315672|NCT02105402|Randomized Controlled Trial|randomized controlled trial
5315673|NCT02105402|Speech intelligibility|speech intelligibility
5315674|NCT02105402|PROMPT treatment|prompt treatment
5315675|NCT02105402|Developmental motor speech disorders|developmental motor speech disorders
5315676|NCT02105402|Children|children
5315677|NCT02105402|Functional outcomes|functional outcomes
5315678|NCT02105402|Treatment efficacy|treatment efficacy
5315679|NCT02105389|fatigue|fatigue
5315680|NCT02105389|quality of life|quality of life
5315681|NCT02105389|chemotherapy|chemotherapy
5315682|NCT02105389|haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
5315683|NCT02105389|children|children
5315684|NCT02105389|pilot|pilot
5315685|NCT02105389|yoga|yoga
5315686|NCT02105376|depression|depression
5315687|NCT02105376|cranial nerve stimulation|cranial nerve stimulation
5315688|NCT02105376|trigeminal stimulation|trigeminal stimulation
5315689|NCT02105350|MEK162|mek162
5315690|NCT02105350|Gemcitabine|gemcitabine
5315691|NCT02105350|Oxaliplatin|oxaliplatin
5315692|NCT02105350|Non-resectable|non-resectable
5315693|NCT02105350|Recurrent or metastatic|recurrent or metastatic
5315694|NCT02105324|bionic pancreas|bionic pancreas
5315695|NCT02105324|artificial pancreas|artificial pancreas
5315696|NCT02105324|insulin|insulin
5315697|NCT02105324|glucagon|glucagon
5315698|NCT02105324|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5315699|NCT02105324|outpatient|outpatient
5315700|NCT02105324|insulin pump|insulin pump
5315701|NCT02105324|pediatrics|pediatrics
5315702|NCT02105324|children|children
5315703|NCT02105324|camp|camp
5315704|NCT02105324|summer camp|summer camp
5315705|NCT02105311|Intraocular pressure|intraocular pressure
5315706|NCT02105311|Selective laser trabeculoplasty|selective laser trabeculoplasty
5315707|NCT02105311|Travoprost|travoprost
5315708|NCT02105311|Ocular surface disease|ocular surface disease
5315709|NCT02105311|Glaucoma symptom scale|glaucoma symptom scale
5315710|NCT02105298|Fluids|fluids
5315711|NCT02105298|Intraoperative|intraoperative
5315712|NCT02105298|Respiratory|respiratory
5315713|NCT02105298|Outcomes|outcomes
5315714|NCT02105298|Surgery|surgery
5315715|NCT02105298|Anesthesia|anesthesia
5315716|NCT02105259|Test|test
5315717|NCT02105259|psychodynamic|psychodynamic
5315718|NCT02105259|Internet-delivered psychodynamic treatment|internet-delivered psychodynamic treatment
5315719|NCT02105259|patients with social anxiety disorder|patients with social anxiety disorder
5315720|NCT02105246|cardiovascular disease|cardiovascular disease
5315721|NCT02105246|cardiac rehabilitation|cardiac rehabilitation
5315722|NCT02105246|secondary prevention|secondary prevention
5315723|NCT02105246|comparative effectiveness|comparative effectiveness
5315724|NCT02105246|6 minute walk test|6 minute walk test
5315725|NCT02105233|ultrasonography|ultrasonography
5315726|NCT02105233|ultrasonics|ultrasonics
5315727|NCT02105233|brain|brain
5315728|NCT02105233|surgery|surgery
5315729|NCT02105220|Respiratory mechanics|respiratory mechanics
5315730|NCT02105220|Esophageal pressure|esophageal pressure
5315731|NCT02105220|Functional residual capacity|functional residual capacity
5315732|NCT02105220|positive end-expiratory pressure|positive end-expiratory pressure
5315733|NCT02105194|cerebral decompression illness|cerebral decompression illness
5315734|NCT02105181|benign biliary stricture|benign biliary stricture
5315735|NCT02105181|anastomotic biliary stricture after liver transplantation|anastomotic biliary stricture after liver transplantation
5315736|NCT02105181|chronic pancreatitis|chronic pancreatitis
5315737|NCT02105181|biliary surgical procedure|biliary surgical procedure
5315738|NCT02105181|fully covered metal stent|fully covered metal stent
5315744|NCT02105155|GFR|gfr
5315745|NCT02105142|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5315746|NCT02105142|Interventions|interventions
5315747|NCT02105142|Primary care|primary care
5315748|NCT02105142|Pediatric|pediatric
5315749|NCT02105090|Upper gastrointestinal tract|upper gastrointestinal tract
5315750|NCT02105090|Endoscopy|endoscopy
5315751|NCT02105090|Lozenge|lozenge
5315752|NCT02105090|Articaine|articaine
5315754|NCT02105090|Hematemesis|hematemesis
5315755|NCT02105090|Abdominal pain|abdominal pain
5315756|NCT02105090|Heartburn|heartburn
5315757|NCT02105077|xenon|xenon
5315758|NCT02105077|doping|doping
5315759|NCT02105077|anesthesia|anesthesia
5315760|NCT02105077|mass spectrometry|mass spectrometry
5315761|NCT02105077|surgery|surgery
5315762|NCT02105038|distal radius fracture|distal radius fracture
5315763|NCT02105038|steering|steering
5315764|NCT02105038|steering wheel spinner knob|steering wheel spinner knob
5315765|NCT02105025|insertion time|insertion time
5315766|NCT02105012|Mild|mild
5315767|NCT02105012|moderate persistent|moderate persistent
5315768|NCT02105012|Adult|adult
5315769|NCT02104986|non seminomateous malignant germ cell tumour (NSMGCT)|non seminomateous malignant germ cell tumour (nsmgct)
5315770|NCT02104986|Dose De-escalation|dose de-escalation
5315771|NCT02104986|Chemotherapy|chemotherapy
5315772|NCT02104960|Skin Surface Microscopy|skin surface microscopy
5315773|NCT02104960|Skin Aging|skin aging
5315774|NCT02104960|PROOF|proof
5315775|NCT02104895|Breast cancer|breast cancer
5315776|NCT02104895|Early breast cancer|early breast cancer
5315777|NCT02104895|Adjuvant breast cancer|adjuvant breast cancer
5315778|NCT02104895|Accelerated partial breast irradiation|accelerated partial breast irradiation
5315779|NCT02104895|Intensity modulated radiotherapy|intensity modulated radiotherapy
5315780|NCT02104882|Glioblastoma Multiforme|glioblastoma multiforme
5315781|NCT02104882|High-Grade Glioma|high-grade glioma
5315782|NCT02104882|Malignant Glioma|malignant glioma
5315783|NCT02104882|IORT|iort
5315784|NCT02104869|Influenza vaccine|influenza vaccine
5315785|NCT02104856|Asthma|asthma
5315786|NCT02104856|Bronchial Thermoplasty|bronchial thermoplasty
5315787|NCT02104856|Registry|registry
5315788|NCT02104856|Device|device
5315789|NCT02104856|Alair|alair
5315790|NCT02104830|empegfilgrastim|empegfilgrastim
5315791|NCT02104830|pegylated filgrastim|pegylated filgrastim
5315792|NCT02104830|neutropenia|neutropenia
5315793|NCT02104830|febrile neutropenia|febrile neutropenia
5315794|NCT02104830|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
5315795|NCT02104830|breast cancer|breast cancer
5315796|NCT02104830|docetaxel|docetaxel
5315797|NCT02104830|doxorubicin|doxorubicin
5315798|NCT02104817|omega-3 carboxylic acid|omega-3 carboxylic acid
5315799|NCT02104804|Type 2 Diabetes Mellitus, Insulin, Dipeptidyl-Peptidase 4 Inhibitors, Metformin,saxagliptin,Endocrine System Diseases|type 2 diabetes mellitus, insulin, dipeptidyl-peptidase 4 inhibitors, metformin,saxagliptin,endocrine system diseases
5315800|NCT02104791|Procalcitonin|procalcitonin
5315801|NCT02104791|intra-amniotic subclinical infection.|intra-amniotic subclinical infection.
5315802|NCT02104752|Curcumin|curcumin
5315803|NCT02104752|Turmeric|turmeric
5315804|NCT02104752|Schizophrenia|schizophrenia
5315805|NCT02104752|Cognition|cognition
5315806|NCT02104752|Psychosis|psychosis
5315807|NCT02104739|prediabetes|prediabetes
5315808|NCT02104739|diabetes mellitus type 2|diabetes mellitus type 2
5315809|NCT02104739|exenatide|exenatide
5315810|NCT02104739|saxagliptin|saxagliptin
5315811|NCT02104739|exenatide ER|exenatide er
5315812|NCT02104713|Skin Burn Degree Second|skin burn degree second
5315813|NCT02104713|Second degree Burn|second degree burn
5315814|NCT02104713|Burn wound|burn wound
5315816|NCT02104687|GTD, goal-directed haemodynamic therapy|gtd, goal-directed haemodynamic therapy
5315817|NCT02104687|CI, cardiac index|ci, cardiac index
5315818|NCT02104687|MAP, mean arterial pressure|map, mean arterial pressure
5315819|NCT02104687|CVP, central venous pressure|cvp, central venous pressure
5315820|NCT02104622|spinal cord injury|spinal cord injury
5315821|NCT02104622|exoskeleton|exoskeleton
5315822|NCT02104622|ambulation|ambulation
5315823|NCT02104622|walking|walking
5315824|NCT02104622|robotics|robotics
5315825|NCT02104609|Obesity|obesity
5315826|NCT02104609|Emergency contraception|emergency contraception
5356884|NCT01917591|Granulation Tissue|granulation tissue
5315827|NCT02104609|Levonorgestrel emergency contraception|levonorgestrel emergency contraception
5315828|NCT02104583|VT|vt
5315829|NCT02104583|VF|vf
5315830|NCT02104583|Ventricular Tachycardia|ventricular tachycardia
5315831|NCT02104583|Ventricular Fibrillation|ventricular fibrillation
5315832|NCT02104583|shock|shock
5315833|NCT02104583|ATP|atp
5315834|NCT02104570|Fatigue|fatigue
5315845|NCT02104544|Erythrocyte;|erythrocyte;
5315846|NCT02104544|Breast milk.|breast milk.
5315847|NCT02104518|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase
5315848|NCT02104518|point-of-care diagnostic testing|point-of-care diagnostic testing
5315849|NCT02104492|multiple sclerosis|multiple sclerosis
5315850|NCT02104492|respiratory muscle strength|respiratory muscle strength
5315851|NCT02104492|maximal inspiratory pressure (MIP)|maximal inspiratory pressure (mip)
5315852|NCT02104492|maximal expiratory pressure (MEP)|maximal expiratory pressure (mep)
5315853|NCT02104492|respiratory muscle endurance|respiratory muscle endurance
5315858|NCT02104466|neuropathy|neuropathy
5315859|NCT02104453|airway maneuver|airway maneuver
5315860|NCT02104440|Cytopenia|cytopenia
5315861|NCT02104414|Liposomal Bupivacaine|liposomal bupivacaine
5315863|NCT02104375|wave reflection|wave reflection
5315864|NCT02104375|augmentation Index|augmentation index
5315865|NCT02104375|heart rate variability|heart rate variability
5315867|NCT02104349|spine surgery|spine surgery
5315868|NCT02104349|post op pain management|post op pain management
5315869|NCT02104336|Pearson|pearson
5315870|NCT02104336|EPI743|epi743
5315871|NCT02104336|EPI-743|epi-743
5315872|NCT02104336|Vincerinone|vincerinone
5315873|NCT02104336|Mitochondrial disorder|mitochondrial disorder
5315874|NCT02104336|Mitochondrial disease|mitochondrial disease
5315875|NCT02104323|Neurofibromatosis Type 2|neurofibromatosis type 2
5315876|NCT02104323|Vestibular Schwannoma|vestibular schwannoma
5315877|NCT02104323|Other NF2-related tumors|other nf2-related tumors
5315878|NCT02104310|malignant glioma|malignant glioma
5315879|NCT02104310|FDOPA|fdopa
5315880|NCT02104310|PET CT|pet ct
5315881|NCT02104310|radiation therapy|radiation therapy
5315882|NCT02104297|Nasal septum operation|nasal septum operation
5315883|NCT02104297|agitation|agitation
5315884|NCT02104284|Bronchial provocation test|bronchial provocation test
5315885|NCT02104284|Mannitol|mannitol
5315886|NCT02104284|Methacholine|methacholine
5315887|NCT02104284|Bronchial hyperreactivity|bronchial hyperreactivity
5315888|NCT02104284|Sensitivity and specificity|sensitivity and specificity
5315889|NCT02104271|chronic radiation proctitis|chronic radiation proctitis
5315890|NCT02104271|argon plasma coagulation|argon plasma coagulation
5315891|NCT02104271|rectal bleeding|rectal bleeding
5315897|NCT02104245|Non Cystic Fibrosis Bronchiectasis, Pulmaquin, Ciprofloxacin, Pseudomonas aeruginosa|non cystic fibrosis bronchiectasis, pulmaquin, ciprofloxacin, pseudomonas aeruginosa
5315898|NCT02104232|Maternal depression|maternal depression
5315899|NCT02104219|Hypophosphatasia|hypophosphatasia
5315900|NCT02104219|HPP|hpp
5315901|NCT02104219|bone disease|bone disease
5315902|NCT02104219|Soft Bones|soft bones
5315903|NCT02104219|low Alkaline Phosphatase|low alkaline phosphatase
5315904|NCT02104219|genetic metabolic disorder|genetic metabolic disorder
5315905|NCT02104219|alkaline phosphatase|alkaline phosphatase
5315906|NCT02104219|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5315907|NCT02104219|rickets|rickets
5315908|NCT02104219|osteomalacia|osteomalacia
5315909|NCT02104193|brain metastases|brain metastases
5315910|NCT02104193|simvastatin|simvastatin
5315911|NCT02104193|radiation therapy|radiation therapy
5315912|NCT02104180|non-inferiority|non-inferiority
5315913|NCT02104180|randomized|randomized
5315914|NCT02104180|TulleGras|tullegras
5315915|NCT02104180|Urgotul|urgotul
5315916|NCT02104180|pain|pain
5315917|NCT02104180|venous leg ulcer|venous leg ulcer
5315918|NCT02104180|healing|healing
5315919|NCT02104167|DDD|ddd
5315920|NCT02104167|degenerative disc disease|degenerative disc disease
5315921|NCT02104167|cervical spine|cervical spine
5315922|NCT02104167|fusion rate|fusion rate
5315923|NCT02104141|DDD|ddd
5315924|NCT02104141|lumbar spine|lumbar spine
5315925|NCT02104141|fusion rate|fusion rate
5315926|NCT02104141|degenerative disc disease|degenerative disc disease
5315927|NCT02104128|Anhedonia|anhedonia
5315928|NCT02104128|Dopamine|dopamine
5315929|NCT02104128|Bupropion|bupropion
5315930|NCT02104128|fMRI|fmri
5315931|NCT02104128|emotional processing|emotional processing
5315932|NCT02104128|reward|reward
5315933|NCT02104115|Stomach|stomach
5315935|NCT02104115|Colon|colon
5315936|NCT02104115|MRI|mri
5315937|NCT02104115|Function|function
5315938|NCT02104115|Gastrointestinal volumes|gastrointestinal volumes
5315939|NCT02104102|Elderly|elderly
5315940|NCT02104102|mirror therapy|mirror therapy
5315941|NCT02104102|hands|hands
5315942|NCT02104089|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
5315943|NCT02104089|Endovascular|endovascular
5315944|NCT02104089|Fenestration|fenestration
5315945|NCT02104089|Branch|branch
5315946|NCT02104089|Off-the-shelf|off-the-shelf
5315947|NCT02104076|Bile Duct Obstructions|bile duct obstructions
5315948|NCT02104076|Biliary Stases|biliary stases
5315949|NCT02104076|Biliary Tract|biliary tract
5315950|NCT02104076|Stents|stents
5315951|NCT02104024|Kidney|kidney
5315952|NCT02104024|Pancreas|pancreas
5315953|NCT02104024|Transplant|transplant
5315954|NCT02104024|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
5315955|NCT02104011|Angiomyolipomas in tuberous sclerosis|angiomyolipomas in tuberous sclerosis
5315956|NCT02104011|Beta-blockers|beta-blockers
5315957|NCT02104011|Anti-angiogenic therapies|anti-angiogenic therapies
5315958|NCT02103998|extremely low gestational age neonate|extremely low gestational age neonate
5315959|NCT02103998|hypothyroxinemia of prematurity|hypothyroxinemia of prematurity
5315960|NCT02103998|brain development|brain development
5315961|NCT02103998|cerebral palsy|cerebral palsy
5315962|NCT02103998|cognitive dealy|cognitive dealy
5315963|NCT02103985|Healthy|healthy
5315964|NCT02103985|JNJ-39823277|jnj-39823277
5315965|NCT02103985|JNJ-40917006|jnj-40917006
5315966|NCT02103985|Pharmacokinetics|pharmacokinetics
5445401|NCT01521988|Catheter ablation|catheter ablation
5445402|NCT01521975|HBV DNA|hbv dna
5445403|NCT01521975|LdT|ldt
5445404|NCT01521975|ADV|adv
5315967|NCT02103972|All subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a SCORAD equal or above 20|all subjects of any ethnicity aged from 4 to 30 months with atopic dermatitis skin symptoms with a scorad equal or above 20
5315968|NCT02103946|serratus|serratus
5315969|NCT02103946|paravertebral|paravertebral
5315970|NCT02103946|breast|breast
5315971|NCT02103946|cancer|cancer
5315972|NCT02103946|axilla|axilla
5315973|NCT02103907|balance|balance
5315974|NCT02103907|knee|knee
5315975|NCT02103907|osteoarthritis|osteoarthritis
5315976|NCT02103907|physical function|physical function
5315977|NCT02103894|Alzheimer's disease (AD)|alzheimer's disease (ad)
5315978|NCT02103894|Parkinson's disease (PD)|parkinson's disease (pd)
5315979|NCT02103894|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
5315980|NCT02103894|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
5315981|NCT02103894|Frontal temporal dementia (FTD)|frontal temporal dementia (ftd)
5315982|NCT02103894|Pick's disease|pick's disease
5315983|NCT02103894|tauopathies|tauopathies
5315984|NCT02103881|Agitation|agitation
5315985|NCT02103881|Ketamine|ketamine
5315986|NCT02103881|Haloperidol|haloperidol
5315987|NCT02103881|Emergency Medical Services|emergency medical services
5315988|NCT02103881|Feeling of restlessness|feeling of restlessness
5315989|NCT02103881|Increased motor activity|increased motor activity
5315990|NCT02103868|Tobacco cessation|tobacco cessation
5315991|NCT02103868|Zari worker|zari worker
5315992|NCT02103868|Behavior therapy|behavior therapy
5315993|NCT02103868|Qualitative Research|qualitative research
5315994|NCT02103868|Mumbai|mumbai
5315995|NCT02103855|pancreas transplantation|pancreas transplantation
5315996|NCT02103855|immunosuppression|immunosuppression
5315997|NCT02103855|belatacept|belatacept
5315998|NCT02103829|Cigarette smoking|cigarette smoking
5315999|NCT02103829|Tobacco smoking|tobacco smoking
5316000|NCT02103829|Smoking, Tobacco|smoking, tobacco
5316001|NCT02103803|concussion|concussion
5316002|NCT02103803|sports-related concussion|sports-related concussion
5316003|NCT02103803|mild traumatic brain injury (mTBI)|mild traumatic brain injury (mtbi)
5316004|NCT02103803|eye tracking|eye tracking
5316005|NCT02103803|oculometrics|oculometrics
5316006|NCT02103777|high dose of caffeine|high dose of caffeine
5316007|NCT02103777|low dose of caffeine|low dose of caffeine
5316008|NCT02103777|prevention|prevention
5316009|NCT02103764|Anovulatory Dysfunctional Uterine Bleeding|anovulatory dysfunctional uterine bleeding
5316010|NCT02103764|cyclic desogestrel|cyclic desogestrel
5316011|NCT02103764|cyclic medroxyprogesterone acetate|cyclic medroxyprogesterone acetate
5316012|NCT02103764|lipid metabolism|lipid metabolism
5316013|NCT02103764|glucose metabolism|glucose metabolism
5316014|NCT02103764|endometrial histology changing|endometrial histology changing
5316015|NCT02103751|biomarkers|biomarkers
5316016|NCT02103751|HPHCs|hphcs
5316018|NCT02103751|smoking|smoking
5316019|NCT02103751|Smokers|smokers
5316020|NCT02103751|non-smokers|non-smokers
5316021|NCT02103738|Lucentis|lucentis
5316022|NCT02103738|Ranibizumab|ranibizumab
5316023|NCT02103738|Treat and Extend|treat and extend
5316024|NCT02103738|wetAMD|wetamd
5316025|NCT02103738|Age related macular degeneration|age related macular degeneration
5316026|NCT02103699|Hepatitis C virus|hepatitis c virus
5316027|NCT02103699|Simeprevir|simeprevir
5316028|NCT02103699|Ribonucleic acid|ribonucleic acid
5316029|NCT02103699|Sustained virologic response|sustained virologic response
5316030|NCT02103686|Neuropathic pain|neuropathic pain
5316036|NCT02103647|Neuropathic pain|neuropathic pain
5316037|NCT02103647|pregabalin|pregabalin
5316038|NCT02103634|breast cancer|breast cancer
5316039|NCT02103634|FDG PET/CT|fdg pet/ct
5316041|NCT02103634|NaF PET/MRI|naf pet/mri
5316042|NCT02103634|NaF PET/CT|naf pet/ct
5316043|NCT02103608|at Home Photo depilation device, Silk'n.|at home photo depilation device, silk'n.
5316044|NCT02103556|Constipation|constipation
5316045|NCT02103556|Rome III criteria|rome iii criteria
5316046|NCT02103556|Hemodialysis|hemodialysis
5316047|NCT02103491|Half-ironman|half-ironman
5316048|NCT02103491|Triathlon|triathlon
5316049|NCT02103491|Salt|salt
5316050|NCT02103491|Exercise|exercise
5316051|NCT02103491|Performance|performance
5316052|NCT02103478|Myelodysplastic Syndrome|myelodysplastic syndrome
5316053|NCT02103478|MDS|mds
5316054|NCT02103465|Parkinson's Disease|parkinson's disease
5316055|NCT02103465|treatment|treatment
5316056|NCT02103465|old patients|old patients
5316057|NCT02103465|Rotigotine|rotigotine
5316058|NCT02103439|Hepatitis C|hepatitis c
5316059|NCT02103439|Cepeginterferon alfa|cepeginterferon alfa
5316060|NCT02103439|Peginterferon|peginterferon
5316061|NCT02103439|Treatment|treatment
5316062|NCT02103426|Cytomegalovirus|cytomegalovirus
5316063|NCT02103426|ASP0113|asp0113
5316064|NCT02103426|CMV-seropositive|cmv-seropositive
5316065|NCT02103426|Healthy subjects|healthy subjects
5316066|NCT02103426|CMV-seronegative|cmv-seronegative
5316067|NCT02103426|Dialysis|dialysis
5316068|NCT02103374|weaned tobacco|weaned tobacco
5316069|NCT02103374|Has not submitted an exacerbation in the past 3 months|has not submitted an exacerbation in the past 3 months
5316070|NCT02103361|autoimmune disease|autoimmune disease
5316071|NCT02103361|pregnancy|pregnancy
5316072|NCT02103361|psoriasis|psoriasis
5316073|NCT02103361|Stelara|stelara
5316074|NCT02103361|ustekinumab|ustekinumab
5316075|NCT02103361|birth outcome|birth outcome
5316076|NCT02103361|malformation|malformation
5316077|NCT02103361|birth defect|birth defect
5316078|NCT02103361|psoriatic arthritis|psoriatic arthritis
5316079|NCT02103361|Crohn's Disease|crohn's disease
5316081|NCT02103361|guselkumab|guselkumab
5316082|NCT02103348|Severe asthma|severe asthma
5316083|NCT02103348|Sputum|sputum
5316084|NCT02103348|Mucolysis|mucolysis
5316085|NCT02103335|Myeloma|myeloma
5316086|NCT02103335|Multiple Myeloma|multiple myeloma
5316087|NCT02103335|Pomalidomide|pomalidomide
5316088|NCT02103335|Marizomib|marizomib
5316089|NCT02103335|Low dose Dexamethasone|low dose dexamethasone
5316090|NCT02103335|Relapsed|relapsed
5316091|NCT02103335|Refractory|refractory
5316092|NCT02103309|Soft contact lenses|soft contact lenses
5316093|NCT02103309|DACP|dacp
5316094|NCT02103283|Diabetic Macular Edema|diabetic macular edema
5316095|NCT02103244|pharmacokinetics|pharmacokinetics
5316096|NCT02103244|safety|safety
5316097|NCT02103231|Preterm birth|preterm birth
5316098|NCT02103231|Hypertension|hypertension
5316099|NCT02103231|Exercise capacity|exercise capacity
5316100|NCT02103231|Cardiovascular risk|cardiovascular risk
5316101|NCT02103218|HIV|hiv
5316102|NCT02103218|risky sex prevention|risky sex prevention
5316103|NCT02103218|intervention|intervention
5316104|NCT02103205|Lactoferrin|lactoferrin
5316105|NCT02103205|Infant formula|infant formula
5316106|NCT02103205|Iron|iron
5316107|NCT02103179|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
5316108|NCT02103179|ECC|ecc
5316109|NCT02103179|VEGF signaling|vegf signaling
5316110|NCT02103140|Breast Cancer|breast cancer
5316111|NCT02103140|Obesity|obesity
5316112|NCT02103140|African American female|african american female
5316113|NCT02103140|exergaming|exergaming
5316114|NCT02103101|polymorphism|polymorphism
5316115|NCT02103101|ABCB1|abcb1
5316116|NCT02103101|P-glycoprotein|p-glycoprotein
5316117|NCT02103101|oral anticoagulant|oral anticoagulant
5316118|NCT02103101|dabigatran|dabigatran
5316119|NCT02103101|apixaban|apixaban
5316120|NCT02103101|rivaroxaban|rivaroxaban
5316121|NCT02103101|hemorrhagic complication|hemorrhagic complication
5316122|NCT02103101|thrombo-embolism|thrombo-embolism
5316123|NCT02103101|serious adverse event|serious adverse event
5316124|NCT02103088|Prostate cancer|prostate cancer
5316125|NCT02103088|Intervention|intervention
5316126|NCT02103088|Rehabilitation|rehabilitation
5316127|NCT02103088|Couple|couple
5316128|NCT02103088|Sexology|sexology
5316129|NCT02103088|Urology|urology
5316130|NCT02103088|Late effects|late effects
5316131|NCT02103075|spinocerebellar ataxia (SCA)|spinocerebellar ataxia (sca)
5316132|NCT02103075|motor evoked potential (MEP)|motor evoked potential (mep)
5316136|NCT02103062|Metastatic Colorectal Cancer|metastatic colorectal cancer
5316137|NCT02103062|nab®Paclitaxel|nab®paclitaxel
5316138|NCT02103062|Response Evaluation in Solid Tumors|response evaluation in solid tumors
5316139|NCT02103062|Progression Free Survival|progression free survival
5316140|NCT02103062|Overall Survival|overall survival
5369166|NCT01861002|Refractory|refractory
5196820|NCT02763995|HIV|hiv
5316141|NCT02103062|Duration of Response|duration of response
5316143|NCT02103036|Low Back Pain|low back pain
5316144|NCT02103036|Core stability exercise|core stability exercise
5316145|NCT02103036|Back school|back school
5316146|NCT02103036|TENS|tens
5316147|NCT02103036|Infra- red light|infra- red light
5316148|NCT02102997|DTS|dts
5316149|NCT02102997|Stents|stents
5316150|NCT02102997|Stent|stent
5316151|NCT02102997|DES|des
5316152|NCT02102997|Drug eluting|drug eluting
5316153|NCT02102997|Drug Eluting Stent (DES)|drug eluting stent (des)
5316154|NCT02102997|Drug eluting stents|drug eluting stents
5316155|NCT02102997|Endothelial Progenitor Cell (EPC)|endothelial progenitor cell (epc)
5316156|NCT02102997|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
5316157|NCT02102997|Sirolimus|sirolimus
5316158|NCT02102997|Sirolimus eluting|sirolimus eluting
5316159|NCT02102997|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5316161|NCT02102997|Registry|registry
5316162|NCT02102997|Registries|registries
5316163|NCT02102997|Multi center|multi center
5316164|NCT02102997|Multi centre|multi centre
5316165|NCT02102984|distal malignancy of the extra-hepatic biliary tract|distal malignancy of the extra-hepatic biliary tract
5316166|NCT02102984|metallic biliary stents|metallic biliary stents
5316167|NCT02102984|covered biliary stents|covered biliary stents
5316168|NCT02102984|uncovered biliary stents|uncovered biliary stents
5316169|NCT02102971|liver|liver
5316170|NCT02102971|ischemia|ischemia
5316171|NCT02102971|reperfusion|reperfusion
5316172|NCT02102958|diabetes|diabetes
5316173|NCT02102958|visual impairment|visual impairment
5316174|NCT02102958|foot care|foot care
5316175|NCT02102958|diabetes self-management education|diabetes self-management education
5316176|NCT02102945|Computed tomography|computed tomography
5316177|NCT02102945|Perfusion imaging|perfusion imaging
5316178|NCT02102945|Coma|coma
5316179|NCT02102945|Heart arrest|heart arrest
5316180|NCT02102945|Brain death|brain death
5316181|NCT02102906|Adult|adult
5316182|NCT02102906|Humans|humans
5316183|NCT02102906|Conversion disorder|conversion disorder
5316184|NCT02102906|Somatoform Disorders/therapy|somatoform disorders/therapy
5316185|NCT02102906|Nervous System Disorders/therapy|nervous system disorders/therapy
5316186|NCT02102893|for Gastroentero-Pancreatic Neuroendocrine Tumors in Taiwan|for gastroentero-pancreatic neuroendocrine tumors in taiwan
5316187|NCT02102880|Genetic Association Studies|genetic association studies
5316189|NCT02102867|STI|sti
5316190|NCT02102867|Primary Prevention|primary prevention
5316191|NCT02102867|Topical Microbicides|topical microbicides
5316192|NCT02102867|User Experience|user experience
5316193|NCT02102867|Drug Delivery Systems|drug delivery systems
5316194|NCT02102854|kidney transplantation|kidney transplantation
5316195|NCT02102854|acute rejection|acute rejection
5316196|NCT02102854|rabbit antithymocyte globulin|rabbit antithymocyte globulin
5316197|NCT02102828|DVT|dvt
5316198|NCT02102828|Total Knee Arthroplasty|total knee arthroplasty
5316199|NCT02102815|total knee arthroplasty|total knee arthroplasty
5316200|NCT02102815|pain control|pain control
5316201|NCT02102815|dexamethasone|dexamethasone
5316202|NCT02102815|steroids|steroids
5316203|NCT02102802|PTSD|ptsd
5316204|NCT02102802|MDMA|mdma
5316205|NCT02102802|Brain activity|brain activity
5316206|NCT02102802|fMRI|fmri
5316207|NCT02102802|Heart rate variability|heart rate variability
5316208|NCT02102802|Physiological correlate|physiological correlate
5316209|NCT02102776|Primary Pterygium|primary pterygium
5316210|NCT02102776|Mitomycin C|mitomycin c
5316211|NCT02102776|Amniotic membrane transplantation|amniotic membrane transplantation
5316212|NCT02102776|Conjunctival autograft|conjunctival autograft
5316213|NCT02102776|Multi-center randomized clinical trial|multi-center randomized clinical trial
5316214|NCT02102763|Overweight|overweight
5316215|NCT02102763|Obesity|obesity
5316216|NCT02102763|Dietary intake|dietary intake
5316217|NCT02102763|Physical activity levels|physical activity levels
5316218|NCT02102763|Blood pressure levels|blood pressure levels
5316219|NCT02102763|Family perceptions|family perceptions
5316220|NCT02102737|insulin resistance|insulin resistance
5316221|NCT02102737|Scintigraphy|scintigraphy
5316222|NCT02102737|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5316223|NCT02102724|African Americans|african americans
5316224|NCT02102724|Older Adults|older adults
5316225|NCT02102711|VITAMIN A|vitamin a
5316226|NCT02102711|BLOOD CONCENTRATION|blood concentration
5320608|NCT02082171|older adults|older adults
5316227|NCT02102711|retinopathy of prematurity|retinopathy of prematurity
5316228|NCT02102698|Tourette's Syndrome|tourette's syndrome
5316229|NCT02102698|Ecopipam|ecopipam
5316230|NCT02102698|D1 Receptor|d1 receptor
5316231|NCT02102698|Phase 2|phase 2
5316232|NCT02102685|VAC Therapy|vac therapy
5316233|NCT02102685|Neck Abscess|neck abscess
5316234|NCT02102685|Traditional Therapy|traditional therapy
5963151|NCT04270474|anticholinergics|anticholinergics
5316235|NCT02102685|Wound Healing|wound healing
5316236|NCT02102659|Nutritional Assessment|nutritional assessment
5316237|NCT02102659|Oral Epithelial Cell|oral epithelial cell
5316238|NCT02102659|Apoptosis|apoptosis
5316239|NCT02102633|bosutinib|bosutinib
5316240|NCT02102633|dabigatran|dabigatran
5316241|NCT02102633|drug interaction|drug interaction
5316242|NCT02102633|p-glycoprotein|p-glycoprotein
5316243|NCT02102633|pharmacokinetics|pharmacokinetics
5316244|NCT02102620|intra-articular injection|intra-articular injection
5316245|NCT02102620|corticosteroid|corticosteroid
5316246|NCT02102620|osteoarthritis|osteoarthritis
5316247|NCT02102620|Interphalangeal joint|interphalangeal joint
5316248|NCT02102607|intrathecal; ropivacaine; motor blockade; local anesthetics|intrathecal; ropivacaine; motor blockade; local anesthetics
5316249|NCT02102594|Myasthenia Gravis|myasthenia gravis
5356885|NCT01917591|Leg Ulcer|leg ulcer
5316250|NCT02102594|Systemic Lupus Erythematosus|systemic lupus erythematosus
5316251|NCT02102594|Rheumatoid Arthritis|rheumatoid arthritis
5316252|NCT02102594|proteasome inhibitor|proteasome inhibitor
5316253|NCT02102594|Bortezomib|bortezomib
5316254|NCT02102594|Velcade|velcade
5316255|NCT02102594|antibody-mediated autoimmune disease|antibody-mediated autoimmune disease
5316256|NCT02102581|Tourniquet|tourniquet
5316257|NCT02102581|Total knee arthroplasty|total knee arthroplasty
5316258|NCT02102581|Blood loss|blood loss
5316259|NCT02102581|Limb swelling|limb swelling
5316260|NCT02102581|Limb circumference|limb circumference
5316261|NCT02102568|breast cancer|breast cancer
5316262|NCT02102568|Chemotherapy-induced menopause|chemotherapy-induced menopause
5316263|NCT02102568|quality of life|quality of life
5211475|NCT02673255|Td|td
5316264|NCT02102542|glycopyrrolate|glycopyrrolate
5316265|NCT02102542|efficacy|efficacy
5316266|NCT02102542|antisialagogue|antisialagogue
5316268|NCT02102529|quality of life|quality of life
5316269|NCT02102516|Post operative pain management|post operative pain management
5316270|NCT02102490|Endocrine Therapy, Taxane, MONARCH 1|endocrine therapy, taxane, monarch 1
5316271|NCT02102477|Prostatic neoplasms|prostatic neoplasms
5316272|NCT02102477|Locally advanced|locally advanced
5316273|NCT02102477|Radiotherapy|radiotherapy
5316274|NCT02102477|Surgery|surgery
5316275|NCT02102477|Mortality|mortality
5316276|NCT02102451|Interferon-free|interferon-free
5316277|NCT02102451|Direct acting antiviral (DAA)|direct acting antiviral (daa)
5316278|NCT02102451|Treatment as prevention|treatment as prevention
5316279|NCT02102451|Surveillance|surveillance
5316280|NCT02102451|Feasibility|feasibility
5316281|NCT02102438|Elderly patients|elderly patients
5316282|NCT02102438|Localized HER2+ Breast Cancer|localized her2+ breast cancer
5316283|NCT02102438|Omission of anthracyclines|omission of anthracyclines
5316284|NCT02102438|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5316285|NCT02102438|Adjuvant chemotherapy|adjuvant chemotherapy
5316286|NCT02102438|Safety information|safety information
5316287|NCT02102425|Peritoneal Dialysis|peritoneal dialysis
5316288|NCT02102425|Exit site infection|exit site infection
5316289|NCT02102425|Exit site care|exit site care
5316290|NCT02102425|Bandage|bandage
5316291|NCT02102425|Prevention|prevention
5316292|NCT02102425|Guidelines|guidelines
5316294|NCT02102412|colonoscopy|colonoscopy
5316295|NCT02102412|colon cancer|colon cancer
5316296|NCT02102399|Voice training|voice training
5316297|NCT02102399|Education|education
5316298|NCT02102399|Voice|voice
5316299|NCT02102399|Faculty|faculty
5316300|NCT02102386|elective|elective
5316301|NCT02102386|carotid endarterectomy surgery|carotid endarterectomy surgery
5316302|NCT02102373|colonoscopy, pediatric, preparation, diet|colonoscopy, pediatric, preparation, diet
5316303|NCT02102360|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes|microsurgery, furcation defects, periodontal disease, enamel matrix proteins, bone substitutes
5316304|NCT02102347|Physical Therapy Modalities|physical therapy modalities
5316305|NCT02102347|osteoarthritis|osteoarthritis
5316306|NCT02102334|Osteoarthritis, hip,|osteoarthritis, hip,
5316307|NCT02102334|radiograpghic measurements|radiograpghic measurements
5316308|NCT02102334|femoral offset|femoral offset
5316309|NCT02102334|leg length discrepancy|leg length discrepancy
5316310|NCT02102334|cup anteversion|cup anteversion
5316311|NCT02102334|cup inclination|cup inclination
5316312|NCT02102321|hookworm|hookworm
5316313|NCT02102321|albendazole|albendazole
5316314|NCT02102321|iron supplementation|iron supplementation
5316315|NCT02102321|democratic republic of congo|democratic republic of congo
5316316|NCT02102321|subsistence farmers|subsistence farmers
5316317|NCT02102321|randomized control trial|randomized control trial
5316318|NCT02102321|neglected tropical disease|neglected tropical disease
5316319|NCT02102321|helminths|helminths
5316320|NCT02102295|Gingivitis|gingivitis
5316321|NCT02102295|antioxidant|antioxidant
5316322|NCT02102295|dentifrice|dentifrice
5316323|NCT02102295|Ascorbic Acid Derivative|ascorbic acid derivative
5316324|NCT02102295|L ascorbic acid 2 phosphate magnesium salt|l ascorbic acid 2 phosphate magnesium salt
5316325|NCT02102282|Pregnancy|pregnancy
5316326|NCT02102282|Breast Cancer|breast cancer
5316327|NCT02102282|Chemotherapy|chemotherapy
5316329|NCT02102282|Obstetric managment|obstetric managment
5316330|NCT02102256|deafness|deafness
5316331|NCT02102256|congenital|congenital
5316332|NCT02102256|pediatric|pediatric
5316333|NCT02102256|device|device
5316334|NCT02102243|hypertension|hypertension
5316335|NCT02102243|blood pressure|blood pressure
5316336|NCT02102243|sympathetic nerve activity|sympathetic nerve activity
5316337|NCT02102243|vascular oxidative stress|vascular oxidative stress
5316338|NCT02102243|nitric oxide|nitric oxide
5316339|NCT02102243|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
5316340|NCT02102243|endothelium|endothelium
5316341|NCT02102243|endothelial dysfunction|endothelial dysfunction
5316342|NCT02102243|endothelial cell protein expression|endothelial cell protein expression
5316343|NCT02102243|microvascular blood flow|microvascular blood flow
5316344|NCT02102243|flow mediated dilation|flow mediated dilation
5316345|NCT02102243|endothelial cell collection|endothelial cell collection
5316346|NCT02102243|microbubbles|microbubbles
5316347|NCT02102243|Definity|definity
5316348|NCT02102230|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5316349|NCT02102230|marijuana abuse|marijuana abuse
5316350|NCT02102230|Veterans|veterans
5316351|NCT02102217|Major Abdominal Surgery|major abdominal surgery
5316352|NCT02102217|C-reactive protein|c-reactive protein
5316353|NCT02102217|Computed Tomography|computed tomography
5316354|NCT02102217|Quality Control|quality control
5316355|NCT02102217|Postoperative complications|postoperative complications
5316356|NCT02102204|Secondary Hyperparathyroidism (SHPT), chrominc kidney disease (CKD), hemodialysis|secondary hyperparathyroidism (shpt), chrominc kidney disease (ckd), hemodialysis
5316357|NCT02102178|oncological pain|oncological pain
5316358|NCT02102178|therapeutic activities|therapeutic activities
5316359|NCT02102178|occupational therapy.|occupational therapy.
5316360|NCT02102165|Aurora|aurora
5316361|NCT02102165|breast cancer|breast cancer
5316362|NCT02102165|metastatic|metastatic
5316363|NCT02102165|molecular screening|molecular screening
5316364|NCT02102165|targeted gene sequencing|targeted gene sequencing
5316365|NCT02102165|molecular aberrations|molecular aberrations
5316366|NCT02102165|exploratory|exploratory
5316367|NCT02102165|biomarker|biomarker
5316368|NCT02102152|Tobramycin Podhaler|tobramycin podhaler
5316369|NCT02102152|bronchiectasis|bronchiectasis
5316370|NCT02102152|chronic infection|chronic infection
5316371|NCT02102152|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5316372|NCT02102126|Renal denervation therapy|renal denervation therapy
5316373|NCT02102126|Aortic blood pressure|aortic blood pressure
5316375|NCT02102126|Arterial stiffness|arterial stiffness
5316376|NCT02102126|Target organ damage|target organ damage
5316377|NCT02102126|Biomarker|biomarker
5316378|NCT02102100|menthol, electronic cigarette, nicotine, smoking, tobacco|menthol, electronic cigarette, nicotine, smoking, tobacco
5316379|NCT02102074|colon and rectal tumors|colon and rectal tumors
5316380|NCT02102074|colon cancer markers|colon cancer markers
5316381|NCT02102061|overweight|overweight
5316382|NCT02102061|exercise|exercise
5316383|NCT02102061|nutrition|nutrition
5316384|NCT02102061|philosophy|philosophy
5316385|NCT02102048|HIV|hiv
5316386|NCT02102048|diabetes|diabetes
5316387|NCT02102048|glucose metabolism|glucose metabolism
5316388|NCT02102048|antiretroviral therapy|antiretroviral therapy
5316389|NCT02102048|ritonavir|ritonavir
5316390|NCT02102048|atazanavir|atazanavir
5316391|NCT02102035|defect|defect
5316392|NCT02102035|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5316393|NCT02102035|dorsal digital island flap|dorsal digital island flap
5316394|NCT02102035|sensory reconstruction.|sensory reconstruction.
5316395|NCT02102022|argininosuccinate synthetase|argininosuccinate synthetase
5316396|NCT02102022|arginine|arginine
5316397|NCT02102022|arginine deiminase|arginine deiminase
5316398|NCT02102009|Malnutrition|malnutrition
5316399|NCT02102009|Dietary supplement|dietary supplement
5316400|NCT02102009|Nutritional supplement|nutritional supplement
5316401|NCT02102009|Complete enteral formula|complete enteral formula
5316402|NCT02102009|COPD|copd
5316403|NCT02101996|stable isotopes|stable isotopes
5316404|NCT02101996|triacylglycerol|triacylglycerol
5316405|NCT02101983|Acute myeloid leukemia|acute myeloid leukemia
5316406|NCT02101983|outpatient consolidation treatment|outpatient consolidation treatment
5316407|NCT02101970|Breast cancer risk|breast cancer risk
5316408|NCT02101970|DHA|dha
5316409|NCT02101970|Omega-3 Fatty Acids|omega-3 fatty acids
5316410|NCT02101970|EPA|epa
5316411|NCT02101970|Weight Loss|weight loss
5316412|NCT02101931|Bladder Cancer|bladder cancer
5316413|NCT02101931|Laser Diagnosis|laser diagnosis
5316414|NCT02101931|Amino levulinic Acid|amino levulinic acid
5316415|NCT02101931|Photodynamic Detection|photodynamic detection
5316416|NCT02101931|spectra of urine|spectra of urine
5316417|NCT02101892|migraine|migraine
5316418|NCT02101892|Amitriptyline|amitriptyline
5316419|NCT02101892|pain modulation|pain modulation
5316420|NCT02101892|pain psychophysics|pain psychophysics
5316421|NCT02101892|pain neurophysiology|pain neurophysiology
5316422|NCT02101892|preventive treatment|preventive treatment
5316423|NCT02101866|Bioavailability Study|bioavailability study
5316424|NCT02101866|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5316425|NCT02101866|Aviragen Therapeutics|aviragen therapeutics
5316426|NCT02101866|Aviragen|aviragen
5316427|NCT02101840|Substance-Related Disorders|substance-related disorders
5316428|NCT02101840|Prescription Drug Misuse|prescription drug misuse
5185030|NCT02833259|Pneumonia|pneumonia
5185031|NCT02833259|Patient readmission|patient readmission
5185032|NCT02833259|Community-acquired infections|community-acquired infections
5197125|NCT02762149|Labour|labour
5316429|NCT02101840|Analgesics, Opioid|analgesics, opioid
5316430|NCT02101840|Oxycodone|oxycodone
5316431|NCT02101840|Randomized Controlled Trial|randomized controlled trial
5316432|NCT02101840|Cross-Over Studies|cross-over studies
5316434|NCT02101840|Healthy Volunteers|healthy volunteers
5316435|NCT02101801|environment, recycled wastewater, carbamazepine|environment, recycled wastewater, carbamazepine
5316436|NCT02101762|Foley|foley
5316437|NCT02101762|Catheters|catheters
5316438|NCT02101762|CAUTI|cauti
5316439|NCT02101762|ERASE CAUTI|erase cauti
5316440|NCT02101749|trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
5316441|NCT02101736|Ages 3 - 15 years|ages 3 - 15 years
5211586|NCT02672501|CAR-T|car-t
5316442|NCT02101736|Cabozantinib|cabozantinib
5316443|NCT02101736|XL184|xl184
5316444|NCT02101736|Plexiform Neurofibromas|plexiform neurofibromas
5316445|NCT02101736|Neurofibromatosis|neurofibromatosis
5316446|NCT02101736|Pathogenetic NF1 Mutations|pathogenetic nf1 mutations
5316447|NCT02101736|Cometriq|cometriq
5316448|NCT02101736|NF1|nf1
5316449|NCT02101723|Zinc absorption|zinc absorption
5316450|NCT02101723|Micronutrient supplement|micronutrient supplement
5316451|NCT02101723|Microbiome|microbiome
5316452|NCT02101723|Kenya|kenya
5316453|NCT02101723|Complementary foods|complementary foods
5316454|NCT02101723|Home fortification|home fortification
5316455|NCT02101710|Bioequivalence|bioequivalence
5316456|NCT02101710|Isosorbide 5-mononitrate|isosorbide 5-mononitrate
5316457|NCT02101710|Elantan|elantan
5316458|NCT02101710|Imdur|imdur
5316459|NCT02101710|Korean|korean
5316460|NCT02101710|Healthy|healthy
5316461|NCT02101697|reduce|reduce
5316462|NCT02101697|Indian health providers|indian health providers
5316463|NCT02101684|Orteronel, Granulosa Cell Tumour|orteronel, granulosa cell tumour
5316464|NCT02101671|agitation|agitation
5316465|NCT02101671|anaesthesia|anaesthesia
5316466|NCT02101671|laparoscopy|laparoscopy
5316467|NCT02101671|surgery|surgery
5316468|NCT02101671|delirium|delirium
5316469|NCT02101671|sedation|sedation
5316470|NCT02101671|emergence|emergence
5316471|NCT02101671|steep|steep
5316472|NCT02101671|trendelemburg|trendelemburg
5316473|NCT02101671|position|position
5316474|NCT02101671|delayed|delayed
5316477|NCT02101645|Bioimpedance|bioimpedance
5316478|NCT02101645|Venous ulcer|venous ulcer
5316479|NCT02101645|Edema|edema
5316480|NCT02101645|LIDC|lidc
5316481|NCT02101645|Electrical stimulation|electrical stimulation
5316482|NCT02101632|TMD|tmd
5316483|NCT02101632|bee venom|bee venom
5316484|NCT02101632|muscle tension|muscle tension
5316485|NCT02101632|muscle pain|muscle pain
5316486|NCT02101619|aortic stenosis|aortic stenosis
5316487|NCT02101619|myocardial tissue|myocardial tissue
5316488|NCT02101619|echocardiography|echocardiography
5316489|NCT02101619|MRI|mri
5316490|NCT02101606|Acute Stroke|acute stroke
5316491|NCT02101606|Cerebral Stroke|cerebral stroke
5316492|NCT02101606|Brain Ischemia|brain ischemia
5316493|NCT02101606|Perfusion Imaging|perfusion imaging
5316494|NCT02101606|MRI, Diffusion Weighted|mri, diffusion weighted
5316495|NCT02101606|MRI, Perfusion Weighted|mri, perfusion weighted
5316496|NCT02101593|argininosuccinate synthetase|argininosuccinate synthetase
5316497|NCT02101593|arginine|arginine
5316498|NCT02101593|arginine deiminase|arginine deiminase
5316499|NCT02101580|argininosuccinate synthetase|argininosuccinate synthetase
5316500|NCT02101580|arginine|arginine
5316501|NCT02101580|arginine deiminase|arginine deiminase
5316502|NCT02101567|Postpartum hemorrhage, Cesarean section, Uterotonics|postpartum hemorrhage, cesarean section, uterotonics
5316503|NCT02101554|Pediatric|pediatric
5316504|NCT02101554|pain indication|pain indication
5316505|NCT02101554|controlled release morphine|controlled release morphine
5316506|NCT02101541|Atrial fibrillation|atrial fibrillation
5316507|NCT02101541|Arrhythmias, Cardiac|arrhythmias, cardiac
5316508|NCT02101541|Heart diseases|heart diseases
5316509|NCT02101541|Cardiovascular diseases|cardiovascular diseases
5316510|NCT02101541|Pathological processes|pathological processes
5316511|NCT02101528|Strength in PD patients|strength in pd patients
5316512|NCT02101528|Isokinetic muscle strength|isokinetic muscle strength
5316513|NCT02101515|randomized controlled trial|randomized controlled trial
5316514|NCT02101515|labor complications|labor complications
5316515|NCT02101515|cesarean section|cesarean section
5316516|NCT02101515|second stage|second stage
5316517|NCT02101502|Healthcare,educational effectiveness, institutional capacity|healthcare,educational effectiveness, institutional capacity
5316518|NCT02101489|TVT|tvt
5316519|NCT02101489|Stress urinary incontinence|stress urinary incontinence
5316520|NCT02101476|Pain|pain
5316521|NCT02101463|aortic|aortic
5316522|NCT02101463|sm-FBSG|sm-fbsg
5316531|NCT02101450|cesarean section|cesarean section
5316532|NCT02101450|bleeding|bleeding
5963152|NCT04270474|dementia|dementia
5963153|NCT04270474|cognition|cognition
5963154|NCT04270331|pain|pain
5963155|NCT04270331|agitation|agitation
5963156|NCT04270331|sedation|sedation
5316533|NCT02101424|Overdose|overdose
5316534|NCT02101424|Emergency Department|emergency department
5316535|NCT02101424|Supplemental Oxygen|supplemental oxygen
5316536|NCT02101424|Pulse Oximeter|pulse oximeter
5316537|NCT02101424|Capnography|capnography
5316539|NCT02101398|Stroke|stroke
5316540|NCT02101398|Aphasia|aphasia
5316541|NCT02101398|Naming|naming
5316542|NCT02101385|Genomically-Directed Therapy|genomically-directed therapy
5316543|NCT02101385|DNA Sequencing|dna sequencing
5316544|NCT02101385|RNA Sequencing|rna sequencing
5316545|NCT02101372|first episode psychosis|first episode psychosis
5316546|NCT02101372|psychoeducation|psychoeducation
5316547|NCT02101372|group therapy|group therapy
5316548|NCT02101333|TAKAYASU ARTERITIS|takayasu arteritis
5316549|NCT02101333|STEROID SPARING|steroid sparing
5316550|NCT02101333|TOCILIZUMAB|tocilizumab
5316551|NCT02101333|EFFICACY|efficacy
5316552|NCT02101333|SAFETY|safety
5316553|NCT02101320|surgery|surgery
5316554|NCT02101320|nuclear medicine|nuclear medicine
5316555|NCT02101320|Lymphoscintigraphy|lymphoscintigraphy
5316556|NCT02101320|Gamma Camera|gamma camera
5316557|NCT02101320|SNOLL|snoll
5316558|NCT02101320|breast cancer|breast cancer
5316559|NCT02101294|carpal tunnel syndrome|carpal tunnel syndrome
5316560|NCT02101294|repetitive stress disorder|repetitive stress disorder
5316561|NCT02101281|Dry Eye|dry eye
5316562|NCT02101255|Dental caries|dental caries
5316563|NCT02101255|Curodont Repair|curodont repair
5316564|NCT02101255|P11-4|p11-4
5316565|NCT02101242|Near-infrared-Spectroscopy|near-infrared-spectroscopy
5316566|NCT02101229|Glycemic control algorithm|glycemic control algorithm
5316567|NCT02101229|closed loop|closed loop
5316568|NCT02101229|artificial pancreas|artificial pancreas
5316569|NCT02101216|bioequivalence|bioequivalence
5316570|NCT02101216|pharmacokinetics|pharmacokinetics
5316571|NCT02101216|psoriasis|psoriasis
5316572|NCT02101203|HSDD|hsdd
5316573|NCT02101190|BIA 9-1067|bia 9-1067
5316574|NCT02101190|Opicapone|opicapone
5316575|NCT02101190|catechol-O-methyltransferase (COMT)|catechol-o-methyltransferase (comt)
5316576|NCT02101177|Viral Hepatitis C|viral hepatitis c
5316577|NCT02101177|Genotype 4|genotype 4
5316578|NCT02101177|SVR|svr
5316579|NCT02101177|Egyptian National Program|egyptian national program
5316580|NCT02101151|Type 2 diabetes mellitus|type 2 diabetes mellitus
5316581|NCT02101151|vitamin D|vitamin d
5316582|NCT02101151|cholecalciferol|cholecalciferol
5316583|NCT02101151|obesity|obesity
5316584|NCT02101138|Corticosteroids|corticosteroids
5316585|NCT02101138|Eosinophilia|eosinophilia
5316587|NCT02101099|Force|force
5316588|NCT02101099|Monitor|monitor
5316589|NCT02101099|Endoscopist|endoscopist
5316590|NCT02101099|Conscious|conscious
5316591|NCT02101099|Sedation|sedation
5316592|NCT02101099|Propofol|propofol
5316593|NCT02101086|umbilical cord blood|umbilical cord blood
5316594|NCT02101086|premature|premature
5316595|NCT02101086|autologous transfusion|autologous transfusion
5316596|NCT02101086|allogeneic transfusion|allogeneic transfusion
5316597|NCT02101060|exercise|exercise
5316598|NCT02101060|aging|aging
5316599|NCT02101060|aerobic capacity|aerobic capacity
5316600|NCT02101060|cardiac function|cardiac function
5316601|NCT02101060|inflammation|inflammation
5316602|NCT02101047|cesarean section|cesarean section
5316603|NCT02101047|hypotension|hypotension
5316604|NCT02101047|phenylephrine|phenylephrine
5316605|NCT02100982|Multimorbidity|multimorbidity
5316606|NCT02100982|Communication|communication
5316607|NCT02100982|Primary Care|primary care
5316608|NCT02100982|Mental Health|mental health
5316609|NCT02100969|MG|mg
5316610|NCT02100969|Hizentra|hizentra
5316611|NCT02100969|autoimmune neuromuscular disorder|autoimmune neuromuscular disorder
5316612|NCT02100956|chronic pain|chronic pain
5316613|NCT02100956|neuropathic pain|neuropathic pain
5316614|NCT02100943|Obstructive Sleep Apnea|obstructive sleep apnea
5316620|NCT02100917|Bioequivalence|bioequivalence
5316621|NCT02100917|Biosimilarity|biosimilarity
5316622|NCT02100917|Similarity|similarity
5316623|NCT02100917|Pharmacokinetics|pharmacokinetics
5316624|NCT02100917|Phase I|phase i
5316625|NCT02100917|Trastuzumab|trastuzumab
5316626|NCT02100917|Healthy Male Volunteers|healthy male volunteers
5316627|NCT02100917|Single-dose|single-dose
5316629|NCT02100917|Oncology|oncology
5316630|NCT02100904|Fibroids|fibroids
5316631|NCT02100904|Radiofrequency ablation|radiofrequency ablation
5316632|NCT02100904|Myomectomy|myomectomy
5316633|NCT02100891|Ewing Sarcoma|ewing sarcoma
5316634|NCT02100891|Neuroblastoma|neuroblastoma
5316635|NCT02100891|Rhabdomyosarcoma|rhabdomyosarcoma
5316636|NCT02100891|Osteosarcoma|osteosarcoma
5316637|NCT02100891|CNS tumors|cns tumors
5316638|NCT02100891|Brain Tumors|brain tumors
5316639|NCT02100839|hypercholesterolemia|hypercholesterolemia
5316640|NCT02100839|apolipoprotein E|apolipoprotein e
5316641|NCT02100839|First in Human|first in human
5316642|NCT02100839|Apolipoprotein E (ApoE)|apolipoprotein e (apoe)
5316643|NCT02100839|Apolipoprotein E Mimetic (AEM)|apolipoprotein e mimetic (aem)
5316644|NCT02100800|COPD|copd
5316645|NCT02100800|Emphysema|emphysema
5316646|NCT02100800|MRI|mri
5316647|NCT02100800|UTE|ute
5316648|NCT02100800|Quantification|quantification
5316649|NCT02100800|CT|ct
5316650|NCT02100787|tear osmolarity|tear osmolarity
5316651|NCT02100787|keratitis sicca|keratitis sicca
5316652|NCT02100787|ocular surface disease|ocular surface disease
5316653|NCT02100787|TheraTears|theratears
5316654|NCT02100774|bioavailability|bioavailability
5316655|NCT02100774|postprandial period|postprandial period
5316656|NCT02100774|genetic variants|genetic variants
5316657|NCT02100774|single nucleotide polymorphisms|single nucleotide polymorphisms
5316658|NCT02100774|vitamin|vitamin
5316659|NCT02100774|carotenoid|carotenoid
5316660|NCT02100774|lutein|lutein
5316661|NCT02100774|lycopene|lycopene
5316662|NCT02100774|tocopherol|tocopherol
5316663|NCT02100774|cholecalciferol|cholecalciferol
5316664|NCT02100761|Voriconazole|voriconazole
5316665|NCT02100761|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5316666|NCT02100761|Therapeutic drug monitoring|therapeutic drug monitoring
5316667|NCT02100761|CYP genetic polymorphism|cyp genetic polymorphism
5316668|NCT02100761|Efficacy|efficacy
5316669|NCT02100761|Safety|safety
5316670|NCT02100748|moderate to severe acute pain|moderate to severe acute pain
5316671|NCT02100748|bunionectomy|bunionectomy
5316672|NCT02100735|sedatives|sedatives
5316673|NCT02100735|analgesics|analgesics
5316674|NCT02100735|protocol|protocol
5316675|NCT02100735|mechanical ventilation|mechanical ventilation
5316676|NCT02100735|analgosedation|analgosedation
5316677|NCT02100683|Occluder|occluder
5316678|NCT02100657|multiple myeloma|multiple myeloma
5316679|NCT02100657|plitidepsin|plitidepsin
5316680|NCT02100657|APLIDIN|aplidin
5316681|NCT02100618|Adolescents|adolescents
5316682|NCT02100618|Adults|adults
5316683|NCT02100618|Immunogenicity|immunogenicity
5316684|NCT02100618|6.5 years|6.5 years
5316685|NCT02100618|Safety|safety
5316686|NCT02100618|Antibody persistence|antibody persistence
5316687|NCT02100618|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5316688|NCT02100605|Nasal|nasal
5316689|NCT02100605|Congestion|congestion
5316690|NCT02100605|Decongestion|decongestion
5316691|NCT02100605|Hypertonic|hypertonic
5316692|NCT02100605|Saline solution|saline solution
5316693|NCT02100592|brain injury|brain injury
5316694|NCT02100592|coma|coma
5316695|NCT02100592|intensive care|intensive care
5316696|NCT02100592|early rehabilitation|early rehabilitation
5313278|NCT02114944|DNI|dni
5316697|NCT02100566|Advance Directive|advance directive
5316698|NCT02100553|Postmenopausal Women|postmenopausal women
5316699|NCT02100553|Obese|obese
5316700|NCT02100553|Non-obese|non-obese
5316701|NCT02100553|Drug Interaction with Itraconazole|drug interaction with itraconazole
5316702|NCT02100553|Pharmacokinetic|pharmacokinetic
5316703|NCT02100540|PMS|pms
5316704|NCT02100540|hot flashes|hot flashes
5316705|NCT02100527|safety|safety
5316706|NCT02100527|tolerability|tolerability
5316707|NCT02100527|pharmacokinetics|pharmacokinetics
5316708|NCT02100527|oral dosing|oral dosing
5316709|NCT02100527|moderate to severe acne vulgaris|moderate to severe acne vulgaris
5316710|NCT02100514|Primary hyperlipidemia or mixed dyslipidemia|primary hyperlipidemia or mixed dyslipidemia
5316711|NCT02100514|high risk of cardiovascular events|high risk of cardiovascular events
5316712|NCT02100514|multiple cardiovascular disease risk factors.|multiple cardiovascular disease risk factors.
5316713|NCT02100501|Seizure control through dietary therapy in pediatric intractable epilepsy patients.|seizure control through dietary therapy in pediatric intractable epilepsy patients.
5316714|NCT02100488|Closed-loop insulin infusion|closed-loop insulin infusion
5316715|NCT02100488|Postprandial glucose control|postprandial glucose control
5316716|NCT02100488|Glucose variability|glucose variability
5316717|NCT02100462|Hypertension|hypertension
5316718|NCT02100462|Platelet activation|platelet activation
5316719|NCT02100462|Platelet aggregation|platelet aggregation
5316720|NCT02100462|Chlorthalidone|chlorthalidone
5316721|NCT02100449|Atelectasis|atelectasis
5316722|NCT02100449|Pneumonia|pneumonia
5316723|NCT02100449|Lung ultrasound|lung ultrasound
5316724|NCT02100449|Doppler|doppler
5316725|NCT02100436|children|children
5316726|NCT02100436|H3N2|h3n2
5316727|NCT02100436|H3N2v|h3n2v
5316728|NCT02100436|influenza|influenza
5316729|NCT02100436|pediatric|pediatric
5316731|NCT02100436|vaccine|vaccine
5316732|NCT02100410|Contact Lens|contact lens
5316733|NCT02100410|Toric|toric
5316734|NCT02100397|Enteric fever|enteric fever
5316735|NCT02100397|Paratyphoid|paratyphoid
5316736|NCT02100397|Salmonella Paratyphi|salmonella paratyphi
5316737|NCT02100397|Challenge study|challenge study
5316738|NCT02100397|Human model of infection|human model of infection
5316739|NCT02100384|peri implant|peri implant
5316740|NCT02100384|Maintenance|maintenance
5316741|NCT02100384|Ultrasonic|ultrasonic
5316742|NCT02100384|Scalers|scalers
5316743|NCT02100371|BMS-833923|bms-833923
5316744|NCT02100371|CA194002|ca194002
5316745|NCT02100358|acute cholecystitis|acute cholecystitis
5316746|NCT02100332|Drug Therapy|drug therapy
5316747|NCT02100319|Pharmacological therapy|pharmacological therapy
5369167|NCT01861002|Myelogenous|myelogenous
5316748|NCT02100293|magnesium sulfate, rocuronium|magnesium sulfate, rocuronium
5316749|NCT02100280|Neuromuscular blockade|neuromuscular blockade
5316750|NCT02100280|Sugammadex|sugammadex
5316751|NCT02100280|Laparoscopic surgery|laparoscopic surgery
5316752|NCT02100280|IL-6|il-6
5316753|NCT02100241|Young adult|young adult
5316754|NCT02100241|Muscle Stretching Exercises|muscle stretching exercises
5316755|NCT02100241|Range of Motion, Articular|range of motion, articular
5316756|NCT02100228|apixaban|apixaban
5316757|NCT02100228|oral anticoagulant|oral anticoagulant
5316758|NCT02100228|non-valvular atrial fibrillation|non-valvular atrial fibrillation
5316759|NCT02100228|cardioversion|cardioversion
5316760|NCT02100215|simulation|simulation
5316761|NCT02100215|competence|competence
5316762|NCT02100215|self-efficacy|self-efficacy
5316763|NCT02100215|novice nurses|novice nurses
5316764|NCT02100202|Dietary supplements|dietary supplements
5316765|NCT02100202|Cotinine level|cotinine level
5316766|NCT02100202|Malondialdehyde|malondialdehyde
5316767|NCT02100202|Chronic smokers|chronic smokers
5316768|NCT02100202|Hyperlipidemia|hyperlipidemia
5316769|NCT02100176|Rehabilitation treatment|rehabilitation treatment
5316770|NCT02100163|Ortho trauma. Virtual Reality. Pain. Anxiety|ortho trauma. virtual reality. pain. anxiety
5316771|NCT02100150|Concussion|concussion
5316772|NCT02100124|reproductive life planning|reproductive life planning
5316773|NCT02100124|action planning|action planning
5316774|NCT02100124|contraceptive use|contraceptive use
5316775|NCT02100124|unintended pregnancy|unintended pregnancy
5316776|NCT02100098|Ankle fracture|ankle fracture
5316777|NCT02100098|Nerve block|nerve block
5316778|NCT02100098|Postoperative pain|postoperative pain
5316779|NCT02100098|Pain profile|pain profile
5316780|NCT02100098|Rebound pain|rebound pain
5316781|NCT02100085|Phase 1 follow up|phase 1 follow up
5316782|NCT02100085|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5316783|NCT02100085|Adult|adult
5316784|NCT02100085|Safety|safety
5316785|NCT02100085|Efficacy|efficacy
5316786|NCT02100059|meniscectomy|meniscectomy
5316787|NCT02100059|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
5316788|NCT02100059|meniscus|meniscus
5316789|NCT02100046|Ethosuximide|ethosuximide
5316790|NCT02100046|Neuropathic pain|neuropathic pain
5316791|NCT02100046|Pain|pain
5316792|NCT02100046|Quality of life|quality of life
5316793|NCT02100046|Neuropathic Pain diagnostic questionnaire ≥ 4|neuropathic pain diagnostic questionnaire ≥ 4
5316794|NCT02100046|Analgesic treatment failure for at least 3 months|analgesic treatment failure for at least 3 months
5316796|NCT02100020|exercise guidelines|exercise guidelines
5316797|NCT02100020|multiple sclerosis|multiple sclerosis
5316798|NCT02100007|solid tumors|solid tumors
5316799|NCT02100007|relapsed|relapsed
5316800|NCT02100007|advanced|advanced
5316801|NCT02100007|metastatic|metastatic
5316802|NCT02100007|small cell lung cancer|small cell lung cancer
5316803|NCT02100007|ovarian cancer|ovarian cancer
5316804|NCT02100007|refractory|refractory
5316806|NCT02099994|vaccine|vaccine
5316807|NCT02099981|Diabetes|diabetes
5316808|NCT02099981|Diabetic|diabetic
5316809|NCT02099981|Retinopathy|retinopathy
5316810|NCT02099981|Ophthalmology|ophthalmology
5316811|NCT02099981|Eye|eye
5316812|NCT02099981|Eyes|eyes
5316813|NCT02099955|spinal cord injury|spinal cord injury
5316814|NCT02099955|vitamin D deficiency|vitamin d deficiency
5316815|NCT02099955|pulmonary function|pulmonary function
5316816|NCT02099955|metabolic diseases|metabolic diseases
5316817|NCT02099942|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
5316818|NCT02099942|Valvuloplasty|valvuloplasty
5316819|NCT02099942|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5316820|NCT02099942|Surgical Aortic Valve Replacement|surgical aortic valve replacement
5316821|NCT02099929|Coffee|coffee
5316822|NCT02099929|Glucose|glucose
5316823|NCT02099929|Insulin|insulin
5316824|NCT02099929|Diabetes|diabetes
5316825|NCT02099929|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5316826|NCT02099916|DHEA, pregnancy, ovarian reserve, AMH|dhea, pregnancy, ovarian reserve, amh
5316827|NCT02099903|Heart Failure|heart failure
5316828|NCT02099903|Heart Failure, Systolic|heart failure, systolic
5316829|NCT02099903|Chagas Disease|chagas disease
5316834|NCT02099890|Spinal Cord Injury|spinal cord injury
5316835|NCT02099890|Anti-inflammatory Diet|anti-inflammatory diet
5316836|NCT02099890|Neuropathic Pain|neuropathic pain
5316838|NCT02099890|Cognitive Impairment|cognitive impairment
5316839|NCT02099890|Somatic Nerve Function|somatic nerve function
5316840|NCT02099890|Autonomic Nerve Function|autonomic nerve function
5316841|NCT02099877|µ-opioid receptor polymorphism|µ-opioid receptor polymorphism
5316842|NCT02099877|Opioids|opioids
5316843|NCT02099877|Opioid analgesia|opioid analgesia
5316844|NCT02099877|Labor analgesia|labor analgesia
5316845|NCT02099838|Pioglitazone|pioglitazone
5316846|NCT02099838|Metformin|metformin
5316847|NCT02099838|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5316848|NCT02099825|adult male|adult male
5316849|NCT02099825|anxiety|anxiety
5316850|NCT02099825|public speaking|public speaking
5316851|NCT02099825|healthy controls|healthy controls
5185426|NCT02830867|recessive|recessive
5185427|NCT02830841|RIPC|ripc
5185428|NCT02830841|hepatic ischemic and reperfusion injury|hepatic ischemic and reperfusion injury
5185431|NCT02830815|General Anesthesia|general anesthesia
5197513|NCT02760082|Multiple Sclerosis|multiple sclerosis
5316852|NCT02099825|exposure therapy|exposure therapy
5316853|NCT02099825|social anxiety|social anxiety
5316854|NCT02099825|mifepristone|mifepristone
5316855|NCT02099825|d-cycloserine|d-cycloserine
5316856|NCT02099799|Physical Activity|physical activity
5316857|NCT02099799|COPD Self-Management|copd self-management
5316858|NCT02099799|Internet|internet
5316859|NCT02099799|6-Minute Walk Test|6-minute walk test
5316860|NCT02099799|COPD Exacerbation|copd exacerbation
5316861|NCT02099799|Health-related Quality of Life|health-related quality of life
5316862|NCT02099786|hearing|hearing
5316863|NCT02099786|cisplatin|cisplatin
5316864|NCT02099786|Ototoxicity|ototoxicity
5316865|NCT02099786|Veterans|veterans
5316866|NCT02099773|AAC|aac
5316867|NCT02099773|support worker|support worker
5316868|NCT02099773|direct care staff|direct care staff
5316869|NCT02099773|intellectual disability|intellectual disability
5316870|NCT02099773|learning disability|learning disability
5316871|NCT02099773|communication|communication
5316872|NCT02099773|adults|adults
5316873|NCT02099760|gonorrhea|gonorrhea
5316874|NCT02099760|chlamydia|chlamydia
5316875|NCT02099760|trichomonas|trichomonas
5316876|NCT02099747|Aplastic Anaemia|aplastic anaemia
5316877|NCT02099747|Eltrombopag|eltrombopag
5316878|NCT02099747|HATG|hatg
5316879|NCT02099747|ATGAM|atgam
5316881|NCT02099721|Sudden Cardiac Arrest (SCA)|sudden cardiac arrest (sca)
5316882|NCT02099721|Syncope|syncope
5316883|NCT02099721|Non Sustained Ventricular Tachycardia (NSVT)|non sustained ventricular tachycardia (nsvt)
5316884|NCT02099721|Premature Ventricular Contractions (PVC)|premature ventricular contractions (pvc)
5316885|NCT02099721|Left Ventricular Ejection Fraction (LVEF)|left ventricular ejection fraction (lvef)
5316886|NCT02099721|Primary Prevention|primary prevention
5316887|NCT02099721|Secondary Prevention|secondary prevention
5316888|NCT02099721|Antitachycardia pacing (ATP)|antitachycardia pacing (atp)
5316889|NCT02099721|shock|shock
5316890|NCT02099721|appropriate therapy|appropriate therapy
5316891|NCT02099708|Pharmacological therapy|pharmacological therapy
5316892|NCT02099695|Hyperhidrosis|hyperhidrosis
5316893|NCT02099695|Oxybutynin|oxybutynin
5316894|NCT02099682|Pharmacological therapy|pharmacological therapy
5316895|NCT02099604|Hepatitis C - Genotype 4|hepatitis c - genotype 4
5316896|NCT02099604|SVR (Sustained Virological Response)|svr (sustained virological response)
5316897|NCT02099604|Vitamin D|vitamin d
5316898|NCT02099604|Treatment Naïve|treatment naïve
5316899|NCT02099591|Constipation|constipation
5316901|NCT02099591|Dyschezia|dyschezia
5316902|NCT02099591|Pharmacokinetics|pharmacokinetics
5316903|NCT02099591|Naloxegol|naloxegol
5316904|NCT02099591|Paediatric|paediatric
5316905|NCT02099591|Opioids|opioids
5316906|NCT02099591|Opioid induced constipation|opioid induced constipation
5316907|NCT02099591|OIC|oic
5316908|NCT02099591|Phase 1|phase 1
5316909|NCT02099578|Blood pressure|blood pressure
5316910|NCT02099578|Arterial stiffness|arterial stiffness
5316911|NCT02099578|Pulse wave velocity|pulse wave velocity
5316912|NCT02099578|Strawberries|strawberries
5316913|NCT02099578|Endothelial function|endothelial function
5316914|NCT02099578|Oxidative stress|oxidative stress
5316915|NCT02099578|Postmenopausal women|postmenopausal women
5316916|NCT02099565|Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)|major adverse cardiovascular and cerebrovascular events (macce)
5316917|NCT02099565|Statins|statins
5316918|NCT02099565|LDL-cholesterol|ldl-cholesterol
5316919|NCT02099565|Inflammatory markers|inflammatory markers
5316920|NCT02099565|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5316921|NCT02099552|X-Linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
5316922|NCT02099552|XLHED|xlhed
5316923|NCT02099552|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5316924|NCT02099552|HED|hed
5316925|NCT02099552|Christ-Siemens-Touraine syndrome|christ-siemens-touraine syndrome
5316926|NCT02099539|absolute lymphocyte count|absolute lymphocyte count
5316927|NCT02099539|antitumor|antitumor
5316928|NCT02099539|cancer|cancer
5316929|NCT02099539|immunotherapy|immunotherapy
5316930|NCT02099539|immunochemotherapy|immunochemotherapy
5316931|NCT02099539|interleukin-15|interleukin-15
5316932|NCT02099539|multiple myeloma|multiple myeloma
5316933|NCT02099539|NK cell|nk cell
5316934|NCT02099539|refractory|refractory
5316935|NCT02099539|relapsed|relapsed
5316936|NCT02099539|T cell|t cell
5316937|NCT02099539|white blood cell count|white blood cell count
5316938|NCT02099526|cancer|cancer
5316939|NCT02099526|caregiver|caregiver
5316940|NCT02099526|caregiving|caregiving
5316941|NCT02099526|care give|care give
5963157|NCT04270331|delirium|delirium
5963158|NCT04270331|protocol|protocol
5963159|NCT04270214|botulinum toxin type A|botulinum toxin type a
5963160|NCT04269889|Ribosomopathy|ribosomopathy
5963161|NCT04269889|Erythroid Aplasia|erythroid aplasia
5963162|NCT04269889|Iron Homeostasis|iron homeostasis
5963163|NCT04269889|Chelation|chelation
5316942|NCT02099526|elderly|elderly
5316943|NCT02099526|older adults|older adults
5316944|NCT02099526|unmet needs|unmet needs
5316945|NCT02099526|post-discharge|post-discharge
5316946|NCT02099526|cancer symptoms|cancer symptoms
5316947|NCT02099513|Mobile Technology|mobile technology
5316948|NCT02099513|Chronic illness|chronic illness
5316949|NCT02099513|Wireless blood pressure device|wireless blood pressure device
5316950|NCT02099513|Wireless scale|wireless scale
5316951|NCT02099513|Pedometer|pedometer
5316952|NCT02099500|Critical Limb Ischemia|critical limb ischemia
5316953|NCT02099500|Peripheral Vascular Disease|peripheral vascular disease
5316954|NCT02099500|Lower Limb Ulcer|lower limb ulcer
5316955|NCT02099500|Gangrene|gangrene
5316956|NCT02099500|Amputation|amputation
5316957|NCT02099500|Lower Limb Wound|lower limb wound
5316959|NCT02099474|HIV-1|hiv-1
5316960|NCT02099474|HIV mother to child prevention|hiv mother to child prevention
5316961|NCT02099474|Raltegravir|raltegravir
5316962|NCT02099474|Pharmacokinetic|pharmacokinetic
5316963|NCT02099435|Gastriointestinal|gastriointestinal
5317162|NCT02098525|Prognosis|prognosis
5316964|NCT02099435|Lower gastriointestinal|lower gastriointestinal
5316965|NCT02099435|Digestive|digestive
5316966|NCT02099435|Hemostasis|hemostasis
5316967|NCT02099435|Recurrent bleeding|recurrent bleeding
5316968|NCT02099435|Hemospray|hemospray
5316969|NCT02099409|Type 1 diabetes mellitus|type 1 diabetes mellitus
5316970|NCT02099409|children|children
5316971|NCT02099409|closed loop|closed loop
5316972|NCT02099409|cross over|cross over
5316973|NCT02099409|overnight|overnight
5316974|NCT02099409|FLORENCED2|florenced2
5316975|NCT02099409|DANA Diabecare R pump|dana diabecare r pump
5316976|NCT02099409|FreeStyle Navigator II|freestyle navigator ii
5316977|NCT02099409|Dexcom G4|dexcom g4
5316978|NCT02099396|PFS,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma|pfs,efficacy and safety,lobaplatin and gemcitabine in combination, second-line treatments on advanced osteosarcoma
5316979|NCT02099383|Stroke|stroke
5316980|NCT02099383|Dehydration|dehydration
5316981|NCT02099383|Fluid Therapy|fluid therapy
5316982|NCT02099370|Multiple Sclerosis|multiple sclerosis
5316983|NCT02099370|Tecfidera(R)|tecfidera(r)
5316984|NCT02099370|Oral medication|oral medication
5316985|NCT02099370|Adherence|adherence
5316986|NCT02099331|Atrial Fibrillation|atrial fibrillation
5316987|NCT02099331|Reactive Oxygen Species|reactive oxygen species
5316988|NCT02099331|Cardiac Surgery|cardiac surgery
5316989|NCT02099318|Rehearsal Platform|rehearsal platform
5316990|NCT02099305|Adolescent; Depression|adolescent; depression
5316991|NCT02099305|Early intervention (education)|early intervention (education)
5316992|NCT02099305|Randomized Controlled Trial|randomized controlled trial
5316993|NCT02099305|Primary Prevention|primary prevention
5316994|NCT02099305|schools|schools
5316995|NCT02099305|Health Literacy|health literacy
5316996|NCT02099305|Discrimination (Psychology)|discrimination (psychology)
5316997|NCT02099305|Mental Health Services|mental health services
5316998|NCT02099292|lymphoma|lymphoma
5316999|NCT02099292|high dose therapy|high dose therapy
5317000|NCT02099292|DexaBEAM|dexabeam
5317001|NCT02099292|Rituximab|rituximab
5317002|NCT02099292|role of alternative salvage treatment - dexaBEAM|role of alternative salvage treatment - dexabeam
5317003|NCT02099266|Umbilical Cord Blood (UCB) Stem Cell Transplant|umbilical cord blood (ucb) stem cell transplant
5317004|NCT02099266|Hyperbaric oxygen|hyperbaric oxygen
5317005|NCT02099266|Leukemia|leukemia
5317006|NCT02099266|Lymphoma|lymphoma
5317007|NCT02099266|MDS|mds
5317008|NCT02099253|Age|age
5317009|NCT02099253|Pharmacodynamics|pharmacodynamics
5317010|NCT02099253|dexmedetomidine|dexmedetomidine
5317011|NCT02099240|Osteomyelitis|osteomyelitis
5317012|NCT02099240|IV Antibiotics|iv antibiotics
5317013|NCT02099240|Oral Antibiotics|oral antibiotics
5317014|NCT02099227|pediatric|pediatric
5317015|NCT02099227|soft tissue infections|soft tissue infections
5317016|NCT02099227|ultrasonography|ultrasonography
5317017|NCT02099227|effectiveness|effectiveness
5317018|NCT02099214|myocardial iron overload|myocardial iron overload
5317019|NCT02099214|HFE-Associated Hereditary Hemochromatosis|hfe-associated hereditary hemochromatosis
5317020|NCT02099214|3 Tesla MRI|3 tesla mri
5317021|NCT02099214|cardiological strategy in haemochromatosis|cardiological strategy in haemochromatosis
5430594|NCT01585025|FXR|fxr
5317023|NCT02099201|ACT-389949|act-389949
5317024|NCT02099162|OCT|oct
5317025|NCT02099162|Coronary|coronary
5317026|NCT02099162|Stenting|stenting
5317027|NCT02099149|Group B Streptococcus|group b streptococcus
5317028|NCT02099149|early onset disease|early onset disease
5317029|NCT02099149|late onset disease|late onset disease
5317030|NCT02099149|anticapsular antibodies|anticapsular antibodies
5317031|NCT02099149|serotype specific|serotype specific
5317032|NCT02099123|Survival|survival
5317033|NCT02099123|Functional Disability|functional disability
5317034|NCT02099123|Cardiovascular Disease|cardiovascular disease
5317035|NCT02099123|Diabetes|diabetes
5317036|NCT02099123|Dementia|dementia
5317037|NCT02099123|Cancer|cancer
5317038|NCT02099097|3D Coping Skills Game|3d coping skills game
5317039|NCT02099097|Quit smoking|quit smoking
5317040|NCT02099097|14-062|14-062
5317041|NCT02099071|ACT-389949|act-389949
5317045|NCT02099032|nutrition|nutrition
5317046|NCT02099032|milk|milk
5317047|NCT02099032|polar lipids|polar lipids
5317048|NCT02099032|cardiometabolic risk|cardiometabolic risk
5317049|NCT02099019|Coronary CT angiography; Revascularization; Decision-making|coronary ct angiography; revascularization; decision-making
5317050|NCT02098993|Sickle cell disease|sickle cell disease
5317051|NCT02098993|Acute chest syndrome|acute chest syndrome
5317052|NCT02098993|Hemoglobinopathy|hemoglobinopathy
5317053|NCT02098993|Hemolytic anemia|hemolytic anemia
5317054|NCT02098993|Heparin|heparin
5317055|NCT02098993|Anticoagulant|anticoagulant
5317057|NCT02098954|resistance|resistance
5317058|NCT02098954|erlotinib|erlotinib
5317059|NCT02098954|combined chemotherapy|combined chemotherapy
5317060|NCT02098941|topiramate|topiramate
5317061|NCT02098941|oxcarbazepine|oxcarbazepine
5317062|NCT02098941|levetiracetam|levetiracetam
5317063|NCT02098941|retention rate|retention rate
5317064|NCT02098928|Acupuncture|acupuncture
5317065|NCT02098928|Electro acupuncture|electro acupuncture
5317066|NCT02098928|Menopause|menopause
5317067|NCT02098915|gastroschisis|gastroschisis
5317068|NCT02098915|intestinal motility|intestinal motility
5317069|NCT02098915|prokinetic agents|prokinetic agents
5317070|NCT02098915|intravenous metoclopramide|intravenous metoclopramide
5317071|NCT02098915|time to full enteral feeding|time to full enteral feeding
5317072|NCT02098902|Overweight|overweight
5317073|NCT02098902|Obesity|obesity
5317074|NCT02098902|Overnutrition|overnutrition
5317075|NCT02098902|Weight Loss|weight loss
5317076|NCT02098902|Body Weight|body weight
5317077|NCT02098902|Nutrition Disorders|nutrition disorders
5317078|NCT02098889|Cervix, active phase of labor, Hyoscine-N-Butylbromide (HBB)|cervix, active phase of labor, hyoscine-n-butylbromide (hbb)
5317079|NCT02098876|neointimal tissue area|neointimal tissue area
5317080|NCT02098876|angulated coronary vessels|angulated coronary vessels
5317081|NCT02098876|wall shear stress|wall shear stress
5317082|NCT02098876|zotarolimus eluting stent|zotarolimus eluting stent
5317083|NCT02098876|everolimus eluting stent|everolimus eluting stent
5317084|NCT02098863|Sickle Cell Anemia|sickle cell anemia
5317085|NCT02098863|Sickle Cell Disease|sickle cell disease
5317086|NCT02098863|Survival|survival
5317087|NCT02098863|Mortality|mortality
5317088|NCT02098863|End-Order Dysfunction|end-order dysfunction
5317089|NCT02098850|Staphylococcus aureus|staphylococcus aureus
5317090|NCT02098850|bloodstream infection|bloodstream infection
5317091|NCT02098850|bacteremia|bacteremia
5317093|NCT02098824|vascular cognitive impairment|vascular cognitive impairment
5317094|NCT02098824|treatment|treatment
5317095|NCT02098824|cerebrovascular lesions|cerebrovascular lesions
5317096|NCT02098824|memory impairment|memory impairment
5317097|NCT02098824|executive dysfunction|executive dysfunction
5317098|NCT02098824|neuronal networks|neuronal networks
5317099|NCT02098824|white matter tracts|white matter tracts
5317100|NCT02098824|monoaminergic systems|monoaminergic systems
5317101|NCT02098824|cholinergic systems|cholinergic systems
5317103|NCT02098824|rs-fMRI|rs-fmri
5317104|NCT02098798|Dysplasia, Inflammatory Bowel Disease|dysplasia, inflammatory bowel disease
5317105|NCT02098785|VAP|vap
5317106|NCT02098785|liver|liver
5317107|NCT02098785|hepatology|hepatology
5317108|NCT02098785|caffeine|caffeine
5317109|NCT02098772|aortic valve disease|aortic valve disease
5317110|NCT02098772|coronary bypass surgery|coronary bypass surgery
5317111|NCT02098772|cardioplegic solutions|cardioplegic solutions
5317112|NCT02098759|TSC|tsc
5317113|NCT02098759|tuberous sclerosis complex|tuberous sclerosis complex
5317114|NCT02098759|epilepsy|epilepsy
5317115|NCT02098746|Pharmacological therapy|pharmacological therapy
5317116|NCT02098733|Pharmacological therapy|pharmacological therapy
5317117|NCT02098707|Stabilometric Platform|stabilometric platform
5317118|NCT02098707|Rehabilitation|rehabilitation
5317119|NCT02098707|Balance Disorders|balance disorders
5317120|NCT02098707|Falls|falls
5317121|NCT02098694|Physiotherapy|physiotherapy
5317122|NCT02098694|Outpatient clinic|outpatient clinic
5317123|NCT02098681|Pectus Excavatum|pectus excavatum
5317124|NCT02098668|menstrual cycle dynamics|menstrual cycle dynamics
5317125|NCT02098668|PCOS|pcos
5317126|NCT02098668|hyperprolactinemia|hyperprolactinemia
5317127|NCT02098668|endometriosis|endometriosis
5317128|NCT02098668|infertility|infertility
5317129|NCT02098655|Stabilometric Platform|stabilometric platform
5317130|NCT02098655|Postural instability|postural instability
5317131|NCT02098642|Gait Disturbances|gait disturbances
5317132|NCT02098642|Metatarsophalangeal joint|metatarsophalangeal joint
5317133|NCT02098629|Myocardial infarction|myocardial infarction
5317134|NCT02098629|myocardial ischemia|myocardial ischemia
5317135|NCT02098629|reperfusion injury|reperfusion injury
5317136|NCT02098616|Hepatitis|hepatitis
5317137|NCT02098616|Hepatitis, Chronic|hepatitis, chronic
5317138|NCT02098616|Hepatitis C|hepatitis c
5317139|NCT02098616|Hepatitis C, Chronic|hepatitis c, chronic
5317140|NCT02098616|Liver Diseases|liver diseases
5317141|NCT02098616|Digestive System Diseases|digestive system diseases
5197802|NCT02758353|Scale up|scale up
5197803|NCT02758353|Primary Health Care|primary health care
5197804|NCT02758340|induction of labor|induction of labor
5197805|NCT02758340|misoprostol|misoprostol
5317142|NCT02098616|Hepatitis, Viral, Human|hepatitis, viral, human
5317143|NCT02098616|RNA Virus Infections|rna virus infections
5317144|NCT02098616|Antiviral Agents|antiviral agents
5317145|NCT02098616|Drug Resistance, Viral|drug resistance, viral
5317146|NCT02098590|Malaria|malaria
5317147|NCT02098590|Plasmodium falciparum|plasmodium falciparum
5317148|NCT02098577|Balance|balance
5317149|NCT02098564|hand therapy|hand therapy
5317150|NCT02098564|activity-based training|activity-based training
5317151|NCT02098564|hand related injuries|hand related injuries
5317152|NCT02098564|sense of coherence|sense of coherence
5317153|NCT02098551|atopic dermatitis|atopic dermatitis
5317154|NCT02098551|bet v 1|bet v 1
5317155|NCT02098551|bet v 1 fragments|bet v 1 fragments
5317156|NCT02098551|allergy|allergy
5317157|NCT02098538|Regorafenib|regorafenib
5317158|NCT02098538|13-244|13-244
5317159|NCT02098525|Cryptococcal meningitis|cryptococcal meningitis
5317160|NCT02098525|HIV/AIDS|hiv/aids
5317161|NCT02098525|Antiretroviral therapy|antiretroviral therapy
5317163|NCT02098525|Thailand|thailand
5317164|NCT02098512|Brentuximab Vedotin|brentuximab vedotin
5317165|NCT02098512|Immunotherapy|immunotherapy
5317166|NCT02098512|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
5317167|NCT02098512|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
5317168|NCT02098512|Reduced Intensity Conditioning|reduced intensity conditioning
5317169|NCT02098512|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5317170|NCT02098486|Bile duct obstruction|bile duct obstruction
5317171|NCT02098486|Cholangitis|cholangitis
5317172|NCT02098486|Moxifloxacin|moxifloxacin
5317173|NCT02098486|Ceftriaxone|ceftriaxone
5317174|NCT02098486|Sepsis|sepsis
5317175|NCT02098460|the Achilles tendon|the achilles tendon
5317176|NCT02098460|intima-media thickness|intima-media thickness
5317177|NCT02098447|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion|vagus nerve stimulation effects on heart rate variability and peripheral blood perfusion
5317178|NCT02098421|Induction of Labor|induction of labor
5317179|NCT02098421|Pitocin|pitocin
5317180|NCT02098421|Oxytocin|oxytocin
5317181|NCT02098421|Foley bulb|foley bulb
5317182|NCT02098408|Ultra-high risk psychosis|ultra-high risk psychosis
5317183|NCT02098408|Schizophrenia prodrome|schizophrenia prodrome
5317184|NCT02098408|Cognitive remediation|cognitive remediation
5317185|NCT02098382|Cervical ripening|cervical ripening
5317186|NCT02098369|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5317187|NCT02098369|Supplemental oxygen|supplemental oxygen
5317188|NCT02098369|Adherence|adherence
5317189|NCT02098369|Telephonic education|telephonic education
5317190|NCT02098369|Peer coaching|peer coaching
5317191|NCT02098356|hemodialysis|hemodialysis
5317192|NCT02098356|dialysis|dialysis
5317193|NCT02098356|acidosis|acidosis
5317194|NCT02098356|bicarbonate|bicarbonate
5317195|NCT02098343|Ovarian cancer|ovarian cancer
5317196|NCT02098343|Ovarian carcinoma|ovarian carcinoma
5317197|NCT02098343|High Grade Serous Ovarian Cancer|high grade serous ovarian cancer
5317198|NCT02098343|Recurrent Cancer|recurrent cancer
5317199|NCT02098343|Resistant Cancer|resistant cancer
5317200|NCT02098330|Vestibular neuritis|vestibular neuritis
5317201|NCT02098330|Vertigo|vertigo
5317202|NCT02098330|Head impulse test|head impulse test
5317203|NCT02098330|Steroid|steroid
5317204|NCT02098317|NAFLD|nafld
5317205|NCT02098317|NASH|nash
5317206|NCT02098317|DHA|dha
5317207|NCT02098317|VITAMIN D|vitamin d
5317208|NCT02098317|OBESITY|obesity
5317209|NCT02098317|CHILDREN|children
5317210|NCT02098304|Caries|caries
5317211|NCT02098304|ICDAS|icdas
5317212|NCT02098304|Lesion activity|lesion activity
5317213|NCT02098304|Demineralisation|demineralisation
5317214|NCT02098304|Imaging|imaging
5317215|NCT02098265|aneurysm|aneurysm
5317216|NCT02098265|transient ischemic attack|transient ischemic attack
5317217|NCT02098252|brain arteriovenous malformation|brain arteriovenous malformation
5317218|NCT02098252|Arteriovenous Malformations|arteriovenous malformations
5317219|NCT02098252|AVM|avm
5317220|NCT02098252|BAVM|bavm
5317221|NCT02098252|Stroke|stroke
5317222|NCT02098252|Intracranial Hemorrhage|intracranial hemorrhage
5317223|NCT02098252|Congenital Abnormalities|congenital abnormalities
5317225|NCT02098252|Vascular Malformations|vascular malformations
5317226|NCT02098252|Cardiovascular Abnormalities|cardiovascular abnormalities
5212376|NCT02667145|hand osteoarthritis|hand osteoarthritis
5317227|NCT02098252|Cardiovascular Diseases|cardiovascular diseases
5317228|NCT02098252|Vascular Diseases|vascular diseases
5317229|NCT02098213|plaque psoriasis|plaque psoriasis
5317230|NCT02098213|DLQI|dlqi
5963164|NCT04269889|Hemoglobin Synthesis|hemoglobin synthesis
5963165|NCT04269889|Heme Synthesis|heme synthesis
5963166|NCT04269512|prostatectomy|prostatectomy
5963167|NCT04269512|lymphadenectomy|lymphadenectomy
5317231|NCT02098213|VQ Dermato|vq dermato
5317232|NCT02098213|PASI|pasi
5317233|NCT02098213|PASI change|pasi change
5317234|NCT02098213|phototherapy|phototherapy
5369168|NCT01861002|Acute|acute
5963168|NCT04268420|Plasmodium falciparum|plasmodium falciparum
5317235|NCT02098213|balneotherapy|balneotherapy
5317236|NCT02098213|hydrotherapy|hydrotherapy
5317237|NCT02098213|Euroquol EQ 5d scale|euroquol eq 5d scale
5317238|NCT02098213|Visual analogic scale|visual analogic scale
5317239|NCT02098213|SPA treatment Scale|spa treatment scale
5317240|NCT02098213|PSS|pss
5317241|NCT02098200|tricuspid|tricuspid
5317242|NCT02098200|regurgitation|regurgitation
5317243|NCT02098200|repair|repair
5317244|NCT02098200|outcomes|outcomes
5317245|NCT02098187|Glomerular Filtration Rate|glomerular filtration rate
5317246|NCT02098187|Acute Kidney Injury|acute kidney injury
5317247|NCT02098174|Glomerular Filtration Rate|glomerular filtration rate
5317248|NCT02098174|Acute kidney injury|acute kidney injury
5317249|NCT02098096|knee|knee
5317250|NCT02098096|arthritis|arthritis
5317251|NCT02098096|Veterans|veterans
5317252|NCT02098096|strength|strength
5317253|NCT02098096|exercise|exercise
5317254|NCT02098096|muscle|muscle
5317255|NCT02098083|acute|acute
5317256|NCT02098083|stroke|stroke
5317257|NCT02098083|gait|gait
5317258|NCT02098070|Knee Pain|knee pain
5317259|NCT02098070|Community Study|community study
5317260|NCT02098070|Knee Osteoarthritis|knee osteoarthritis
5317261|NCT02098070|Risk Factors|risk factors
5317262|NCT02098057|IBS-diarrhea|ibs-diarrhea
5317263|NCT02098044|knee osteoarthritis|knee osteoarthritis
5317264|NCT02098044|epidemiology|epidemiology
5317265|NCT02098044|risk factors|risk factors
5317266|NCT02098044|prevalence|prevalence
5317267|NCT02098044|professional football|professional football
5317268|NCT02098031|Child Nutrition Sciences|child nutrition sciences
5317269|NCT02098031|Growth and Development|growth and development
5317270|NCT02098031|Developing Countries|developing countries
5317271|NCT02097992|COPD|copd
5317272|NCT02097992|airway blood flow|airway blood flow
5317273|NCT02097979|glaucoma|glaucoma
5317274|NCT02097979|adherence|adherence
5317275|NCT02097979|medication possession ratio|medication possession ratio
5317276|NCT02097979|intervention|intervention
5317277|NCT02097953|Daptomycin|daptomycin
5317278|NCT02097953|Rifampin|rifampin
5317279|NCT02097953|P-glycoprotein|p-glycoprotein
5317280|NCT02097953|Pharmacokinetic|pharmacokinetic
5317281|NCT02097940|Postural balance|postural balance
5317282|NCT02097940|Athletes|athletes
5317283|NCT02097940|Sports|sports
5317284|NCT02097940|Soccer|soccer
5317285|NCT02097940|Physiotherapy|physiotherapy
5317286|NCT02097927|Appetite|appetite
5317287|NCT02097927|Satiety|satiety
5317288|NCT02097927|Energy intake|energy intake
5317289|NCT02097927|Saliva|saliva
5317290|NCT02097927|Biomarkers|biomarkers
5317291|NCT02097914|Secondhand smoke exposure|secondhand smoke exposure
5317292|NCT02097914|Secondhand smoke|secondhand smoke
5317293|NCT02097914|Environmental Tobacco Smoke|environmental tobacco smoke
5317294|NCT02097914|Smoke-free homes|smoke-free homes
5317295|NCT02097914|Smoke-free homes ban|smoke-free homes ban
5317296|NCT02097901|Rotator Cuff|rotator cuff
5317297|NCT02097901|Injury|injury
5317298|NCT02097901|Repair|repair
5317299|NCT02097901|Microfracture|microfracture
5317300|NCT02097901|Healing|healing
5317301|NCT02097875|Skin cancer|skin cancer
5317302|NCT02097875|Basal cell carcinoma|basal cell carcinoma
5317303|NCT02097875|Squamous cell carcinoma|squamous cell carcinoma
5317304|NCT02097875|Melanoma|melanoma
5317305|NCT02097862|Degenerative Disc Disease|degenerative disc disease
5317306|NCT02097862|Disc Disease|disc disease
5317307|NCT02097862|Back pain|back pain
5317308|NCT02097862|stem cells|stem cells
5317316|NCT02097836|postural control|postural control
5317317|NCT02097836|Targeted Training|targeted training
5317318|NCT02097836|cerebral palsy|cerebral palsy
5317319|NCT02097836|trunk segments|trunk segments
5317320|NCT02097823|olanzapine|olanzapine
5317321|NCT02097823|Nausea and vomiting|nausea and vomiting
5317322|NCT02097823|aprepitant|aprepitant
5317323|NCT02097823|pediatrics|pediatrics
5317324|NCT02097797|Inflammatory bowel disease|inflammatory bowel disease
5317325|NCT02097797|Crohn's disease|crohn's disease
5317326|NCT02097797|microbiota|microbiota
5317331|NCT02097784|diastolic function|diastolic function
5317332|NCT02097771|laryngeal mask airway ventilation|laryngeal mask airway ventilation
5317333|NCT02097732|Metastatic melanoma|metastatic melanoma
5317334|NCT02097732|Brain metastases|brain metastases
5317335|NCT02097732|Radiation therapy|radiation therapy
5317337|NCT02097706|Boderline Personality Disorder|boderline personality disorder
5317338|NCT02097706|Mental Illness|mental illness
5317339|NCT02097706|Cognition|cognition
5317341|NCT02097693|quality of life|quality of life
5317342|NCT02097693|dystonia|dystonia
5317343|NCT02097693|dyskinetic cerebral palsy|dyskinetic cerebral palsy
5317344|NCT02097680|with disturbed glucose metabolism|with disturbed glucose metabolism
5317345|NCT02097680|without disturbed glucose metabolism|without disturbed glucose metabolism
5317346|NCT02097667|Severe early onset Fetal Growth Restrictions|severe early onset fetal growth restrictions
5317347|NCT02097654|Hospital acquired|hospital acquired
5317348|NCT02097654|Elderly|elderly
5369169|NCT01861002|Childhood|childhood
5369170|NCT01861002|Pediatric|pediatric
5317349|NCT02097641|Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells|allogeneic bone marrow-derived human mesenchymal stromal cells
5317350|NCT02097641|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5317351|NCT02097628|volume controlled ventilation|volume controlled ventilation
5317352|NCT02097628|pressure controlled ventilation|pressure controlled ventilation
5317353|NCT02097615|soft|soft
5317354|NCT02097615|tissue|tissue
5317355|NCT02097615|infections|infections
5317356|NCT02097602|Reticulated platelets|reticulated platelets
5317357|NCT02097602|noncardiac surgery|noncardiac surgery
5317358|NCT02097602|MACCEs|macces
5317359|NCT02097602|major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
5317360|NCT02097602|outcome|outcome
5317361|NCT02097602|High-risk or intermediate-risk noncardiac surgery|high-risk or intermediate-risk noncardiac surgery
5317362|NCT02097589|Health Controls|health controls
5317363|NCT02097576|Chronic Rhinosinusitis|chronic rhinosinusitis
5317364|NCT02097563|Mood Disorders|mood disorders
5317365|NCT02097563|Psychosis|psychosis
5317366|NCT02097563|Subthreshold|subthreshold
5317367|NCT02097563|Bipolar Disorder|bipolar disorder
5317368|NCT02097550|Renal Insufficiency, Chronic|renal insufficiency, chronic
5317369|NCT02097550|Kidney Failure, Chronic|kidney failure, chronic
5317370|NCT02097550|Self Care|self care
5317371|NCT02097550|Consumer Participation|consumer participation
5356886|NCT01917591|Middle Aged|middle aged
5317372|NCT02097550|Patient Participation|patient participation
5317373|NCT02097550|Marketing|marketing
5317374|NCT02097550|Consumer Health Information|consumer health information
5317375|NCT02097511|Drug-drug interaction|drug-drug interaction
5317376|NCT02097511|Pharmacokinetics|pharmacokinetics
5317377|NCT02097511|Pharmacodynamics|pharmacodynamics
5317378|NCT02097498|Simulation|simulation
5317379|NCT02097498|Enhance|enhance
5317380|NCT02097498|Safety|safety
5317381|NCT02097498|Proficiency|proficiency
5317382|NCT02097498|Paramedics.|paramedics.
5317383|NCT02097498|Airway Management|airway management
5317384|NCT02097498|Intubation|intubation
5317385|NCT02097459|Breast cancer|breast cancer
5317386|NCT02097459|Endocrine therapy|endocrine therapy
5317387|NCT02097459|Perimenopausal and recently postmenopausal patients|perimenopausal and recently postmenopausal patients
5317388|NCT02097459|Early-stage hormone receptor-positive|early-stage hormone receptor-positive
5317389|NCT02097446|cystectomy|cystectomy
5317390|NCT02097433|Dacomitinib|dacomitinib
5317391|NCT02097433|PF299804|pf299804
5317392|NCT02097433|pharmacokinetics|pharmacokinetics
5317393|NCT02097433|healthy|healthy
5317394|NCT02097433|Chinese|chinese
5317395|NCT02097420|Mitral valve|mitral valve
5317396|NCT02097381|HIV infection|hiv infection
5317398|NCT02097381|microbial translocation|microbial translocation
5317399|NCT02097381|chronic inflammation|chronic inflammation
5317400|NCT02097381|antiretroviral therapy|antiretroviral therapy
5317401|NCT02097381|cART|cart
5317402|NCT02097381|HAART|haart
5317403|NCT02097381|Th17|th17
5317404|NCT02097381|Th1|th1
5317410|NCT02097355|patient portal|patient portal
5317411|NCT02097355|health information technology|health information technology
5317412|NCT02097355|patient provider communication|patient provider communication
5317413|NCT02097355|quality improvement|quality improvement
5317414|NCT02097342|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5317415|NCT02097342|Insulin sensitivity- hyperinsulinemic euglycemic clamp|insulin sensitivity- hyperinsulinemic euglycemic clamp
5317416|NCT02097342|Pancreatic beta cell function|pancreatic beta cell function
5317417|NCT02097342|Linagliptin|linagliptin
5317418|NCT02097342|Voglibose|voglibose
5317419|NCT02097342|Mixed meal test|mixed meal test
5317420|NCT02097342|GLP-1 response|glp-1 response
5317421|NCT02097329|bioavailability|bioavailability
5317423|NCT02097329|rabeprazole|rabeprazole
5317424|NCT02097329|famotidine|famotidine
5317425|NCT02097329|palbociclib|palbociclib
5317426|NCT02097316|Glycemic control|glycemic control
5317427|NCT02097316|JewelPump accuracy|jewelpump accuracy
5317428|NCT02097303|Prostate Cancer|prostate cancer
5317429|NCT02097303|Bone Metastasis|bone metastasis
5317430|NCT02097303|Symptomatic|symptomatic
5317431|NCT02097303|Androgen Independent|androgen independent
5317432|NCT02097303|Hormone Refractory|hormone refractory
5317433|NCT02097303|Castrate Resistant|castrate resistant
5317434|NCT02097303|AIPC|aipc
5317435|NCT02097303|pre-chemotherapy|pre-chemotherapy
5317436|NCT02097303|Post-chemotherapy|post-chemotherapy
5317437|NCT02097290|Threshold algorithms|threshold algorithms
5317438|NCT02097290|CRT-D|crt-d
5317439|NCT02097251|Mucopolysaccharidosis Type 7|mucopolysaccharidosis type 7
5317440|NCT02097251|Sly syndrome|sly syndrome
5317441|NCT02097251|UX003|ux003
5317442|NCT02097251|Enzyme Replacement Therapy|enzyme replacement therapy
5317443|NCT02097251|rare disease|rare disease
5317444|NCT02097251|Lysosomal Storage Disease|lysosomal storage disease
5317445|NCT02097251|metabolic disorder|metabolic disorder
5317446|NCT02097212|Tracheobronchomalacia|tracheobronchomalacia
5317447|NCT02097212|TBM|tbm
5317448|NCT02097212|HyperDynamic Airway Collapse|hyperdynamic airway collapse
5317449|NCT02097212|HDAC|hdac
5317450|NCT02097212|Obstructive Sleep Apnea|obstructive sleep apnea
5198166|NCT02756091|IAD|iad
5317451|NCT02097212|OSA|osa
5317452|NCT02097199|activity, osteoprotegerin, endocan, atherosclerosis, biomarker|activity, osteoprotegerin, endocan, atherosclerosis, biomarker
5317453|NCT02097186|Vascular disease|vascular disease
5317454|NCT02097186|Open aortic aneurysm repair|open aortic aneurysm repair
5317455|NCT02097186|Endovascular aneurysm repair|endovascular aneurysm repair
5317456|NCT02097186|Carotid endartrectomy|carotid endartrectomy
5317457|NCT02097186|Lower limb surgical revascularisation|lower limb surgical revascularisation
5317458|NCT02097186|Major lower limb amputation|major lower limb amputation
5317459|NCT02097160|childhood|childhood
5317460|NCT02097160|healthy|healthy
5317461|NCT02097160|vitamin D|vitamin d
5317462|NCT02097160|bone|bone
5317463|NCT02097160|dairy products|dairy products
5317464|NCT02097147|Viibryd|viibryd
5317465|NCT02097108|HIV infection|hiv infection
5317466|NCT02097108|Raltegravir|raltegravir
5317467|NCT02097108|Switch|switch
5317468|NCT02097108|Hyperlipidemia|hyperlipidemia
5317469|NCT02097108|Women|women
5317470|NCT02097095|Correlates of risk|correlates of risk
5317472|NCT02097095|Tuberculosis|tuberculosis
5317473|NCT02097095|Sub-study|sub-study
5317475|NCT02097082|Peripheral Arterial Disease|peripheral arterial disease
5317476|NCT02097082|Intermittent Claudication|intermittent claudication
5317477|NCT02097082|Vascular Diseases|vascular diseases
5317478|NCT02097082|Cardiovascular Diseases|cardiovascular diseases
5317479|NCT02097082|Superficial Femoral Artery|superficial femoral artery
5317480|NCT02097069|Gestational diabetes mellitus|gestational diabetes mellitus
5317481|NCT02097069|Myo-inositol|myo-inositol
5317482|NCT02097069|D-chiro-inositol|d-chiro-inositol
5317483|NCT02097069|Insulin resistance|insulin resistance
5317484|NCT02097056|Alzheimer's disease|alzheimer's disease
5317485|NCT02097017|lidocaine|lidocaine
5317486|NCT02097017|laminaria|laminaria
5317487|NCT02097017|dilatation and evacuation|dilatation and evacuation
5317488|NCT02097017|pain|pain
5317489|NCT02097004|chronic hepatitis B|chronic hepatitis b
5317490|NCT02097004|Pegasys|pegasys
5317491|NCT02097004|Euvax B|euvax b
5317492|NCT02097004|Baracrude|baracrude
5317493|NCT02096978|Implant|implant
5317494|NCT02096978|Stability|stability
5317495|NCT02096978|placement|placement
5317496|NCT02096978|Osteotome|osteotome
5317497|NCT02096965|Calcium oxalate|calcium oxalate
5317498|NCT02096965|Calcium phosphate|calcium phosphate
5317499|NCT02096965|Kidney stone|kidney stone
5317500|NCT02096952|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5317501|NCT02096952|ADHD|adhd
5314007|NCT02112253|Deep brain stimulation|deep brain stimulation
5317502|NCT02096952|Autism spectrum disorder|autism spectrum disorder
5317504|NCT02096952|High-functioning ASD|high-functioning asd
5317505|NCT02096952|Asperger's disorder|asperger's disorder
5317506|NCT02096952|Asperger's|asperger's
5317507|NCT02096926|Third Molar Extraction|third molar extraction
5317508|NCT02096913|Rho-Inhibition|rho-inhibition
5317509|NCT02096913|Plasticity|plasticity
5317510|NCT02096913|Neurological Function|neurological function
5317511|NCT02096913|RhoA|rhoa
5317512|NCT02096913|Ibuprofen|ibuprofen
5317513|NCT02096913|NSAIDs|nsaids
5317514|NCT02096900|Pre-medication|pre-medication
5317515|NCT02096900|Pre-operative anxiety|pre-operative anxiety
5317516|NCT02096887|education|education
5317517|NCT02096887|compliance|compliance
5317518|NCT02096887|risk factors|risk factors
5317519|NCT02096874|Peripheral retinal ischemia|peripheral retinal ischemia
5423281|NCT01616355|color stability.|color stability.
5317520|NCT02096874|ultra wide field fluorescein angiography|ultra wide field fluorescein angiography
5317522|NCT02096848|otitis media|otitis media
5317523|NCT02096848|microbiology|microbiology
5317524|NCT02096848|vaccines|vaccines
5317525|NCT02096835|Postoperative nausea and vomiting|postoperative nausea and vomiting
5317526|NCT02096835|Transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5317527|NCT02096835|Gynecological laparoscopic surgery|gynecological laparoscopic surgery
5317528|NCT02096835|Tropisetron|tropisetron
5317529|NCT02096835|Dexamethasone|dexamethasone
5317530|NCT02096822|Facilitated tucking|facilitated tucking
5317531|NCT02096822|Non nutritive sucking|non nutritive sucking
5317532|NCT02096822|Preterm|preterm
5317533|NCT02096822|Pain relief|pain relief
5317534|NCT02096809|Bone Conduction|bone conduction
5317535|NCT02096809|Hearing loss - conductive|hearing loss - conductive
5317536|NCT02096809|Osseointegration|osseointegration
5317537|NCT02096809|Prostheses and Implants|prostheses and implants
5317538|NCT02096757|Claudication|claudication
5317539|NCT02096757|Critical Limb Ischemia|critical limb ischemia
5317540|NCT02096757|Endovascular procedure|endovascular procedure
5317541|NCT02096757|Atherosclerosis|atherosclerosis
5317542|NCT02096679|Phase I, healthy, pharmacokinetics, Mass balance|phase i, healthy, pharmacokinetics, mass balance
5317543|NCT02096666|MET Amplified Gastric/ Gastroesophageal Junction/ Esophageal Adenocarcinomas, or other solid tumors|met amplified gastric/ gastroesophageal junction/ esophageal adenocarcinomas, or other solid tumors
5317544|NCT02096653|sacroiliac joint|sacroiliac joint
5317545|NCT02096653|low back pain|low back pain
5963169|NCT04268316|virtual reality|virtual reality
5317546|NCT02096653|steroid injection|steroid injection
5317547|NCT02096627|Cataract, femtosecond laser, FLACS|cataract, femtosecond laser, flacs
5317548|NCT02096614|Adoptive cell transfer|adoptive cell transfer
5317549|NCT02096614|Cell therapy|cell therapy
5317550|NCT02096614|Immunotherapy|immunotherapy
5317551|NCT02096614|MAGE-A4|mage-a4
5317552|NCT02096614|Esophageal cancer|esophageal cancer
5317553|NCT02096614|Melanoma|melanoma
5317554|NCT02096614|Head and neck cancer|head and neck cancer
5317555|NCT02096614|Ovarian cancer|ovarian cancer
5317556|NCT02096614|TCR gene therapy|tcr gene therapy
5317557|NCT02096601|Motor fluctuations|motor fluctuations
5317558|NCT02096601|levodopa pharmacokinetics|levodopa pharmacokinetics
5317559|NCT02096601|levodopa and carbidopa solution|levodopa and carbidopa solution
5317560|NCT02096601|continuous subcutaneous delivery|continuous subcutaneous delivery
5317561|NCT02096588|Breast cancer|breast cancer
5317562|NCT02096588|Adriamycin|adriamycin
5317563|NCT02096588|Simvastatin|simvastatin
5317565|NCT02096588|Echocardiogram|echocardiogram
5317566|NCT02096575|nitrous oxide|nitrous oxide
5317567|NCT02096575|pain|pain
5317568|NCT02096562|knee welling outpatient compression stockings|knee welling outpatient compression stockings
5317569|NCT02096549|cerebral palsy|cerebral palsy
5317570|NCT02096549|Botulinum toxin|botulinum toxin
5317571|NCT02096549|Propofol|propofol
5317572|NCT02096549|Deep sedation|deep sedation
5317573|NCT02096549|Bispectral index monitor|bispectral index monitor
5317574|NCT02096536|Neonate|neonate
5317575|NCT02096536|Vancomycin|vancomycin
5317576|NCT02096536|LC/MS-MS|lc/ms-ms
5317577|NCT02096536|protein binding|protein binding
5317578|NCT02096523|inherited platelet disorders|inherited platelet disorders
5317579|NCT02096523|proteome|proteome
5317580|NCT02096510|Addison Disease|addison disease
5317581|NCT02096510|Adrenal Hyperplasia Congenital|adrenal hyperplasia congenital
5317582|NCT02096484|Metacognitive therapy|metacognitive therapy
5317583|NCT02096484|mindfulness meditation therapy|mindfulness meditation therapy
5317584|NCT02096484|group therapy|group therapy
5317585|NCT02096484|generalized anxiety disorder|generalized anxiety disorder
5317586|NCT02096484|Group Based Metacognitive Therapy|group based metacognitive therapy
5317587|NCT02096484|Group Based Mindfulness Meditation Therapy|group based mindfulness meditation therapy
5317588|NCT02096471|Neurofibromatosis Type 1 (Neurofibromas)|neurofibromatosis type 1 (neurofibromas)
5317589|NCT02096471|PD-0325901|pd-0325901
5317590|NCT02096471|Radiographic Response|radiographic response
5317591|NCT02096471|Inoperable Plexiform Neurofibromas|inoperable plexiform neurofibromas
5317592|NCT02096458|Drug therapy|drug therapy
5317593|NCT02096445|stroke|stroke
5317594|NCT02096445|acute|acute
5317596|NCT02096445|robot therapy|robot therapy
5317597|NCT02096445|hand function|hand function
5317598|NCT02096445|fine motor skills|fine motor skills
5317599|NCT02096445|neurocognitive|neurocognitive
5317600|NCT02096445|sensory|sensory
5317601|NCT02096445|Perfetti|perfetti
5317602|NCT02096445|haptics|haptics
5317603|NCT02096419|clopidogrel|clopidogrel
5317604|NCT02096419|platelet reactivity|platelet reactivity
5317605|NCT02096419|acute coronary syndrome|acute coronary syndrome
5317606|NCT02096419|tailoring therapy|tailoring therapy
5317607|NCT02096419|outcome|outcome
5317608|NCT02096406|Coronary artery disease|coronary artery disease
5317609|NCT02096406|Coronary artery bypass grafting|coronary artery bypass grafting
5317610|NCT02096406|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5317611|NCT02096406|angiotensin receptor blocker|angiotensin receptor blocker
5317616|NCT02096380|induction chemotherapy|induction chemotherapy
5317618|NCT02096367|vibrations|vibrations
5317619|NCT02096367|stroke|stroke
5317620|NCT02096367|posture|posture
5317621|NCT02096367|gait|gait
5317622|NCT02096367|readaptation|readaptation
5317623|NCT02096328|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
5317624|NCT02096328|Lower respiratory infection|lower respiratory infection
5317625|NCT02096328|POL7080|pol7080
5317626|NCT02096328|Pseudomonas aeruginosa|pseudomonas aeruginosa
5317627|NCT02096328|Nosocomial pneumonia|nosocomial pneumonia
5317628|NCT02096315|POL7080|pol7080
5317629|NCT02096315|Pseudomonas aeruginosa|pseudomonas aeruginosa
5317630|NCT02096315|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5317631|NCT02096315|Exacerbation|exacerbation
5317632|NCT02096302|Probiotics|probiotics
5317633|NCT02096302|Infant Formula|infant formula
5317634|NCT02096302|Microbiota|microbiota
5317635|NCT02096302|Bifidobacterium longum biovar infantis CECT7210|bifidobacterium longum biovar infantis cect7210
5317636|NCT02096302|Growth|growth
5317637|NCT02096289|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5317638|NCT02096289|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5317639|NCT02096289|Thioridazine|thioridazine
5317640|NCT02096289|Phase I|phase i
5317641|NCT02096289|Clinical Trial|clinical trial
5317642|NCT02096276|Pregnancy Registry|pregnancy registry
5317643|NCT02096276|Boostrix|boostrix
5317644|NCT02096276|Women|women
5317645|NCT02096276|Cohort|cohort
5317646|NCT02096276|Prospective|prospective
5317647|NCT02096276|Pregnancy outcome|pregnancy outcome
5317648|NCT02096276|Exploratory|exploratory
5198335|NCT02754960|Gastrointestinal bleeding|gastrointestinal bleeding
5198338|NCT02754960|Thalidomide|thalidomide
5317649|NCT02096263|Infants|infants
5317650|NCT02096263|Safety|safety
5317651|NCT02096263|Healthy|healthy
5317652|NCT02096263|Infanrix Hexa|infanrix hexa
5317653|NCT02096263|Immunogenicity|immunogenicity
5317654|NCT02096237|asthma, bronchial|asthma, bronchial
5317655|NCT02096237|immunoadsorbents|immunoadsorbents
5317656|NCT02096237|apheresis|apheresis
5317657|NCT02096237|immunoglobulin E|immunoglobulin e
5317658|NCT02096211|Total hip replacement|total hip replacement
5317659|NCT02096211|Total hip arthroplasty|total hip arthroplasty
5317660|NCT02096211|Hip joint replacement|hip joint replacement
5317661|NCT02096211|Hip prosthesis replacement|hip prosthesis replacement
5317662|NCT02096198|Total Hip Replacement|total hip replacement
5317663|NCT02096198|Total Hip Arthroplasty|total hip arthroplasty
5317664|NCT02096198|Hip Joint Replacement|hip joint replacement
5317665|NCT02096198|Hip Prosthesis Replacement|hip prosthesis replacement
5317666|NCT02096185|Breast cancer|breast cancer
5317667|NCT02096185|Surgery|surgery
5317668|NCT02096185|Specimen imaging|specimen imaging
5317669|NCT02096159|Hypospadias|hypospadias
5317670|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents
5317671|NCT02096146|Plate|plate
5317672|NCT02096146|Hallux valgus|hallux valgus
5317673|NCT02096146|Foot deformity|foot deformity
5317674|NCT02096146|Screw|screw
5317675|NCT02096146|Tarsometatarsal angle|tarsometatarsal angle
5317676|NCT02096146|Cost effectiveness|cost effectiveness
5317677|NCT02096133|Multiple sclerosis, vitamin D, HPA-axis, cortisol|multiple sclerosis, vitamin d, hpa-axis, cortisol
5317678|NCT02096120|Periodontitis|periodontitis
5317679|NCT02096107|Everolimus|everolimus
5317680|NCT02096107|Graft dysfunction|graft dysfunction
5317681|NCT02096107|Interstitial fibrosis|interstitial fibrosis
5317682|NCT02096094|Antiseptics|antiseptics
5317683|NCT02096094|Administration cutaneously|administration cutaneously
5317684|NCT02096094|Chlorine compounds|chlorine compounds
5317685|NCT02096094|Infection control|infection control
5317686|NCT02096094|Anti-infecting agents, local|anti-infecting agents, local
5317687|NCT02096081|Glabellar Frown Lines|glabellar frown lines
5317688|NCT02096081|Frown Lines|frown lines
5317689|NCT02096081|Facial Wrinkles|facial wrinkles
5317690|NCT02096068|Neuroprotection|neuroprotection
5317691|NCT02096042|Leukemia|leukemia
5317692|NCT02096042|Acute Myeloid Leukemia|acute myeloid leukemia
5317693|NCT02096042|AML|aml
5317694|NCT02096042|CD30-Positive|cd30-positive
5317695|NCT02096042|Relapsed|relapsed
5317696|NCT02096042|Refractory|refractory
5317697|NCT02096042|Brentuximab Vedotin|brentuximab vedotin
5317699|NCT02096042|Adcetris|adcetris
5317700|NCT02096042|5-Azacytidine|5-azacytidine
5317705|NCT02096042|5-AZC|5-azc
5317706|NCT02096042|AZA-CR|aza-cr
5317707|NCT02096042|Ladakamycin|ladakamycin
5317708|NCT02096042|NSC-102816|nsc-102816
5317709|NCT02096029|smoking|smoking
5317710|NCT02096029|smoking cessation|smoking cessation
5317714|NCT02096016|Surveillance|surveillance
5317715|NCT02096016|Follow up|follow up
5317716|NCT02096003|Intrathecal hydromorphone|intrathecal hydromorphone
5317717|NCT02096003|Intrathecal morphine|intrathecal morphine
5317718|NCT02096003|Primary cesarean section|primary cesarean section
5317719|NCT02096003|Analgesia|analgesia
5317720|NCT02095990|Facial Melasma|facial melasma
5317721|NCT02095977|St. Jude Riata lead failure|st. jude riata lead failure
5317722|NCT02095977|implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
5317723|NCT02095977|externalized conductors|externalized conductors
5317724|NCT02095977|ventricular tachyarrythmia|ventricular tachyarrythmia
5317725|NCT02095977|electrophysiology|electrophysiology
5317726|NCT02095964|cardiac syndrome X|cardiac syndrome x
5317727|NCT02095964|inflammation|inflammation
5317728|NCT02095964|dyslipidemia|dyslipidemia
5317729|NCT02095938|schizophrenia|schizophrenia
5317730|NCT02095938|brain structure|brain structure
5317731|NCT02095938|treatment response|treatment response
5317732|NCT02095938|solian|solian
5317733|NCT02095938|gene|gene
5317734|NCT02095938|mri|mri
5317735|NCT02095912|Squamous Cell Carcinoma|squamous cell carcinoma
5317736|NCT02095899|Thoracic Surgical Procedures|thoracic surgical procedures
5317737|NCT02095873|Oral glucose tolerance test|oral glucose tolerance test
5317738|NCT02095873|Flow mediated dilatation|flow mediated dilatation
5317739|NCT02095873|Aortal pulse wave velocity|aortal pulse wave velocity
5317740|NCT02095873|Finger-fold capillary density by capillaroscopy|finger-fold capillary density by capillaroscopy
5317741|NCT02095847|Uterine Cancer|uterine cancer
5317742|NCT02095847|Endometrial cancer|endometrial cancer
5317743|NCT02095847|Hysterectomy|hysterectomy
5317744|NCT02095847|Hysteroscopy|hysteroscopy
5317745|NCT02095847|High-resolution microendoscopy|high-resolution microendoscopy
5317746|NCT02095847|HRME|hrme
5963170|NCT04268316|behavioral activation|behavioral activation
5963171|NCT04268316|depression|depression
5317747|NCT02095847|Hysteroscopic-guided resection|hysteroscopic-guided resection
5317748|NCT02095847|Proflavine|proflavine
5317749|NCT02095795|Exercise Therapy|exercise therapy
5369173|NCT01861002|Methylation|methylation
5963172|NCT04267991|adenoviral|adenoviral
5198489|NCT02753790|QOL|qol
5317750|NCT02095782|non-small cell lung cancer|non-small cell lung cancer
5317751|NCT02095782|erlotinib|erlotinib
5317752|NCT02095782|chemotherapy|chemotherapy
5317753|NCT02095769|Pharmacogenomics|pharmacogenomics
5317754|NCT02095769|Adverse Drug Reactions|adverse drug reactions
5317755|NCT02095743|Early breast cancer|early breast cancer
5317756|NCT02095743|Chemotherapy|chemotherapy
5317757|NCT02095743|PICC line|picc line
5317758|NCT02095743|Implanted port|implanted port
5317759|NCT02095730|crosslinking|crosslinking
5317760|NCT02095730|cornea|cornea
5317761|NCT02095730|keratoconus|keratoconus
5317762|NCT02095730|ectasia|ectasia
5317763|NCT02095730|irradiance|irradiance
5317764|NCT02095730|riboflavin|riboflavin
5317765|NCT02095691|Renal Sympathetic Denervation|renal sympathetic denervation
5317766|NCT02095678|Hepatocellular Carcinoma|hepatocellular carcinoma
5317767|NCT02095678|Hepatoma|hepatoma
5317768|NCT02095678|Liver Cancer, Adult|liver cancer, adult
5317769|NCT02095678|Liver Cell Carcinoma|liver cell carcinoma
5317770|NCT02095678|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
5317771|NCT02095678|HCC|hcc
5317772|NCT02095665|ureteric stents|ureteric stents
5317773|NCT02095665|LUTS|luts
5317774|NCT02095665|lower urinary tract symptoms|lower urinary tract symptoms
5317775|NCT02095626|Peptide|peptide
5317776|NCT02095587|Phase 1|phase 1
5317777|NCT02095587|hepatic impairment|hepatic impairment
5317778|NCT02095574|GDC-0199|gdc-0199
5317779|NCT02095574|ADME|adme
5317780|NCT02095574|Relapsed|relapsed
5317781|NCT02095574|Refractory|refractory
5317782|NCT02095574|ABT-199|abt-199
5317783|NCT02095574|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5317784|NCT02095561|HPV self testing|hpv self testing
5317785|NCT02095561|screening uptake|screening uptake
5317786|NCT02095561|cervical cáncer|cervical cáncer
5317787|NCT02095561|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5317788|NCT02095535|obstetric patients|obstetric patients
5317789|NCT02095535|chloraprep|chloraprep
5317790|NCT02095535|chlorhexidine|chlorhexidine
5317791|NCT02095535|drying time|drying time
5317792|NCT02095522|colchicine NSTEMI endothelial function inflammation|colchicine nstemi endothelial function inflammation
5317793|NCT02095496|sleep|sleep
5317794|NCT02095496|intensive care|intensive care
5317795|NCT02095496|mechanical ventilation|mechanical ventilation
5317796|NCT02095470|Laryngoscopy|laryngoscopy
5317797|NCT02095470|Equipment|equipment
5317798|NCT02095470|Video Laryngoscope|video laryngoscope
5317799|NCT02095457|Routine Outcome Monitoring|routine outcome monitoring
5317800|NCT02095457|Psychotherapy|psychotherapy
5317801|NCT02095457|Alliance|alliance
5317802|NCT02095457|Feedback Informed Treatment|feedback informed treatment
5317803|NCT02095457|Mental Health Outpatients|mental health outpatients
5322198|NCT02075060|NMIBC|nmibc
5317808|NCT02095405|Supraventricular Tachycardia|supraventricular tachycardia
5317809|NCT02095405|Atrial Fibrillation|atrial fibrillation
5317810|NCT02095405|Electrophysiology Study|electrophysiology study
5317811|NCT02095405|Programmed Electrical Stimulation|programmed electrical stimulation
5317812|NCT02095392|soluble phosphate|soluble phosphate
5317813|NCT02095392|phosphorus metabolism|phosphorus metabolism
5317814|NCT02095392|calcium metabolism|calcium metabolism
5317815|NCT02095392|bone metabolism|bone metabolism
5317816|NCT02095392|human study|human study
5317817|NCT02095379|oligosecretary multiple myeloma|oligosecretary multiple myeloma
5317818|NCT02095366|Acute Pain|acute pain
5317819|NCT02095366|Traumatic Pain|traumatic pain
5317820|NCT02095366|Emergency setting|emergency setting
5317821|NCT02095366|Prehospital setting|prehospital setting
5317822|NCT02095366|Analgesia|analgesia
5317823|NCT02095366|Intranasal device|intranasal device
5317824|NCT02095366|Intra veinous injection|intra veinous injection
5317825|NCT02095366|Sufentanil citrate|sufentanil citrate
5317826|NCT02095366|Morphine Sulfate|morphine sulfate
5317827|NCT02095353|Brain tumor|brain tumor
5317828|NCT02095353|extraaxial|extraaxial
5317829|NCT02095353|metastasis|metastasis
5317830|NCT02095353|glioma|glioma
5317831|NCT02095353|primary brain tumor|primary brain tumor
5317832|NCT02095353|secondary brain tumor|secondary brain tumor
5317834|NCT02095353|perfusion|perfusion
5317835|NCT02095353|dynamic contrast enhancement|dynamic contrast enhancement
5317836|NCT02095353|CBV|cbv
5317837|NCT02095353|CBF|cbf
5317838|NCT02095353|ktrans|ktrans
5317839|NCT02095314|DTP-HB-Hib|dtp-hb-hib
5317840|NCT02095314|Pentavalen|pentavalen
5317841|NCT02095314|Pentabio|pentabio
5317842|NCT02095314|Booster|booster
5317843|NCT02095288|lipidomics|lipidomics
5317844|NCT02095288|in vitro human whole blood assay|in vitro human whole blood assay
5317845|NCT02095288|anti-inflammatory drugs|anti-inflammatory drugs
5317846|NCT02095288|Lipidomics screening of anti-inflammatory drugs|lipidomics screening of anti-inflammatory drugs
5317847|NCT02095275|BNP, acute kidney injury, fluid status|bnp, acute kidney injury, fluid status
5317848|NCT02095249|prostate cancer|prostate cancer
5317849|NCT02095249|radical prostatectomy|radical prostatectomy
5317850|NCT02095223|Knee injury|knee injury
5317851|NCT02095223|Meniscus injury|meniscus injury
5963173|NCT04267991|infiltrates|infiltrates
5963174|NCT04267991|PTK|ptk
5317852|NCT02095223|Anterior cruciate ligament injury|anterior cruciate ligament injury
5317853|NCT02095223|Knee ligament injury|knee ligament injury
5317854|NCT02095210|PET scan|pet scan
5317855|NCT02095210|HER2|her2
5317856|NCT02095210|breast cancer|breast cancer
5317857|NCT02095184|Breast Cancer|breast cancer
5317858|NCT02095184|Postmenopausal|postmenopausal
5317859|NCT02095184|Hormone-Receptor Positive|hormone-receptor positive
5318648|NCT02091583|β-glucan|β-glucan
5317860|NCT02095119|Uterine cervical cancer|uterine cervical cancer
5317861|NCT02095119|Palliative|palliative
5317862|NCT02095119|Treatment|treatment
5317863|NCT02095119|Monoclonal antibody|monoclonal antibody
5317864|NCT02095119|Nimotuzumab|nimotuzumab
5317865|NCT02095106|forearm fractures|forearm fractures
5317866|NCT02095106|pediatric fractures|pediatric fractures
5317867|NCT02095106|distal radius|distal radius
5317868|NCT02095093|Total Hip Arthroplasty|total hip arthroplasty
5317869|NCT02095093|Navigation|navigation
5317870|NCT02095093|Imageless|imageless
5317871|NCT02095093|THA|tha
5317872|NCT02095093|Computer navigated|computer navigated
5317873|NCT02095080|Leucine|leucine
5317874|NCT02095080|Upper Intake Level (UL)|upper intake level (ul)
5317875|NCT02095080|Elderly|elderly
5317876|NCT02095080|Amino acids|amino acids
5317877|NCT02095080|Protein|protein
5317878|NCT02095067|Telemedicine|telemedicine
5317879|NCT02095067|Emergency medical dispatch|emergency medical dispatch
5317880|NCT02095067|Prehospital care|prehospital care
5317881|NCT02095067|Video conference|video conference
5317882|NCT02095054|Advanced Cancers|advanced cancers
5317883|NCT02095054|Advanced malignancy|advanced malignancy
5317884|NCT02095054|Metastatic cancer|metastatic cancer
5317885|NCT02095054|Advanced solid tumor|advanced solid tumor
5317886|NCT02095054|Regorafenib|regorafenib
5317887|NCT02095054|Stivarga|stivarga
5317888|NCT02095054|Cetuximab|cetuximab
5317889|NCT02095054|C225|c225
5317890|NCT02095054|Erbitux|erbitux
5317891|NCT02095054|IMC-C225|imc-c225
5317892|NCT02095054|MOAB C225|moab c225
5317893|NCT02095054|Questionnaire|questionnaire
5317894|NCT02095054|Survey|survey
5317895|NCT02095041|Oxygen saturation.|oxygen saturation.
5317896|NCT02095041|Term infants.|term infants.
5317897|NCT02095041|Saturation trend.|saturation trend.
5317898|NCT02095041|Histogram.|histogram.
5317899|NCT02095041|Public health nurse.|public health nurse.
5317900|NCT02095041|congenital heart disease screening.|congenital heart disease screening.
5317901|NCT02095015|MPS II|mps ii
5317902|NCT02095015|iduronate-2-sulfatase|iduronate-2-sulfatase
5317903|NCT02095015|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
5317905|NCT02095015|MPS VI|mps vi
5317906|NCT02095015|ear, nose and throat|ear, nose and throat
5317907|NCT02095015|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5317908|NCT02095015|Hunter syndrome|hunter syndrome
5317910|NCT02095015|Mucopolysaccharidosis I|mucopolysaccharidosis i
5317911|NCT02095015|Hurler, Hurler-Scheie, or Scheie syndrome|hurler, hurler-scheie, or scheie syndrome
5317912|NCT02095015|Mucopolysaccharidosis|mucopolysaccharidosis
5317914|NCT02095015|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
5317915|NCT02095002|modified valsalva maneuver, internal jugular vein|modified valsalva maneuver, internal jugular vein
5317916|NCT02094989|electrocardiogram|electrocardiogram
5317917|NCT02094989|vectorcardiogram|vectorcardiogram
5317918|NCT02094989|telecardiology|telecardiology
5317919|NCT02094989|linear regression|linear regression
5317920|NCT02094989|individual transformation matrix|individual transformation matrix
5317921|NCT02094989|posture|posture
5317922|NCT02094976|Prone position|prone position
5317923|NCT02094976|Intra-abdominal pressure|intra-abdominal pressure
5317924|NCT02094976|Respiratory system compliance|respiratory system compliance
5317925|NCT02094976|Jackson table|jackson table
5317926|NCT02094976|Wilson frame|wilson frame
5317927|NCT02094976|Chest roll|chest roll
5317928|NCT02094963|acute coronary syndrome|acute coronary syndrome
5317929|NCT02094963|coronary disease|coronary disease
5317930|NCT02094963|coronary artery disease|coronary artery disease
5317931|NCT02094950|concurrent chemotherapy|concurrent chemotherapy
5317932|NCT02094950|concurrent radiation|concurrent radiation
5317933|NCT02094937|fluticasone propionate|fluticasone propionate
5317934|NCT02094937|step-down regimen|step-down regimen
5317935|NCT02094937|well-controlled subjects|well-controlled subjects
5317936|NCT02094937|adults|adults
5317937|NCT02094937|switching regimen|switching regimen
5317938|NCT02094937|asthma|asthma
5317939|NCT02094937|fluticasone furoate|fluticasone furoate
5317940|NCT02094937|fluticasone furoate/Vilanterol|fluticasone furoate/vilanterol
5317941|NCT02094924|Candesartan cilexetil|candesartan cilexetil
5317942|NCT02094924|Hypertension|hypertension
5317943|NCT02094924|Hydrochlorothiazide|hydrochlorothiazide
5317944|NCT02094924|Healthy adult human subjects|healthy adult human subjects
5317945|NCT02094924|Bioequivalence|bioequivalence
5317946|NCT02094911|Prevention|prevention
5317947|NCT02094911|Combined lifestyle intervention|combined lifestyle intervention
5317948|NCT02094911|Primary health care|primary health care
5317949|NCT02094898|Depression|depression
5317950|NCT02094898|Unipolar|unipolar
5317951|NCT02094898|Bipolar|bipolar
5317952|NCT02094898|Suicidal|suicidal
5317953|NCT02094859|Glucose Monitoring|glucose monitoring
5317954|NCT02094846|Cellular phones|cellular phones
5317955|NCT02094846|Type 2 diabetes|type 2 diabetes
5317956|NCT02094846|Glycated hemoglobin|glycated hemoglobin
5317957|NCT02094846|glycemic control|glycemic control
5317958|NCT02094833|Diphtheria|diphtheria
5317959|NCT02094833|Tetanus|tetanus
5317960|NCT02094833|Pertussis|pertussis
5317961|NCT02094833|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
5317962|NCT02094833|Hepatitis B|hepatitis b
5317963|NCT02094833|DTaP-IPV-Hep - PRP-T vaccine|dtap-ipv-hep - prp-t vaccine
5317964|NCT02094807|prospective study|prospective study
5317965|NCT02094807|surgical management|surgical management
5317966|NCT02094807|rib fractures|rib fractures
5317967|NCT02094807|trauma|trauma
5317968|NCT02094755|ASA-PLAVIX Reactivity in CLI|asa-plavix reactivity in cli
5317969|NCT02094742|screening program|screening program
5317970|NCT02094742|metastatic breast cancer|metastatic breast cancer
5317971|NCT02094742|molecular profile|molecular profile
5317972|NCT02094742|gene sequencing|gene sequencing
5317973|NCT02094729|mild cognitive impairment|mild cognitive impairment
5317974|NCT02094729|Alzheimer's disease|alzheimer's disease
5317975|NCT02094716|Sarcoptes|sarcoptes
5317976|NCT02094716|Scabiei|scabiei
5317977|NCT02094716|Scabies|scabies
5317978|NCT02094716|ectoparasite|ectoparasite
5317979|NCT02094716|parasite|parasite
5317980|NCT02094716|infestation|infestation
5317981|NCT02094716|Renaissance|renaissance
5317982|NCT02094703|female|female
5317983|NCT02094703|age 18-65 years|age 18-65 years
5317984|NCT02094703|storage symptoms|storage symptoms
5317985|NCT02094703|clinical urinary tract infection|clinical urinary tract infection
5317986|NCT02094703|non complicated|non complicated
5317987|NCT02094690|head and neck neoplasms|head and neck neoplasms
5317988|NCT02094690|radiotherapy|radiotherapy
5317989|NCT02094690|physical therapy|physical therapy
5317990|NCT02094690|trismus|trismus
5317991|NCT02094664|Heat|heat
5317992|NCT02094664|Humidification|humidification
5317993|NCT02094664|Oxygen|oxygen
5317994|NCT02094651|Abnormal EEGs|abnormal eegs
5317995|NCT02094638|Traditional Chinese Medicine Injection|traditional chinese medicine injection
5317996|NCT02094625|Cisplatin|cisplatin
5317997|NCT02094625|N-acetylcysteine|n-acetylcysteine
5317998|NCT02094625|Hearing Loss|hearing loss
5317999|NCT02094625|Otoprotection|otoprotection
5318000|NCT02094612|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5318001|NCT02094612|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5318002|NCT02094612|Pediatrics|pediatrics
5318003|NCT02094612|Patient Outcome Assessment|patient outcome assessment
5318005|NCT02094560|therapy refractory|therapy refractory
5318006|NCT02094560|endstage|endstage
5318007|NCT02094560|solid tumours|solid tumours
5318008|NCT02094547|Infant Formula|infant formula
5318009|NCT02094547|Cognition|cognition
5318010|NCT02094547|Neurodevelopment|neurodevelopment
5318011|NCT02094547|Immunity|immunity
5318012|NCT02094547|Microbiota|microbiota
5318013|NCT02094534|Diabetes type 1|diabetes type 1
5318014|NCT02094534|Oral Insulin|oral insulin
5318016|NCT02094534|Tolerability|tolerability
5318017|NCT02094534|Phase 2a|phase 2a
5318018|NCT02094534|Randomized|randomized
5318019|NCT02094534|Blinded|blinded
5318020|NCT02094534|Parallel|parallel
5318021|NCT02094508|Parasitemia|parasitemia
5318022|NCT02094508|HIV-Exposed|hiv-exposed
5318023|NCT02094508|HIV-Unexposed|hiv-unexposed
5318024|NCT02094508|Liver Stage|liver stage
5318025|NCT02094508|Randomized|randomized
5318026|NCT02094495|Tamoxifen|tamoxifen
5318027|NCT02094495|Breast cancer|breast cancer
5318028|NCT02094495|Knowkedge|knowkedge
5318029|NCT02094469|Treatment for vasospastic angina|treatment for vasospastic angina
5318030|NCT02094456|diverticular disease|diverticular disease
5318031|NCT02094456|diverticular bleeding|diverticular bleeding
5318032|NCT02094456|endoscopic clipping|endoscopic clipping
5318033|NCT02094456|endoscopy|endoscopy
5318034|NCT02094456|lower gastrointestinal bleeding|lower gastrointestinal bleeding
5318035|NCT02094443|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
5318036|NCT02094443|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
5318037|NCT02094443|Cyclophilin inhibitor|cyclophilin inhibitor
5213206|NCT02662504|PDT|pdt
5318038|NCT02094443|Interferon intolerant|interferon intolerant
5318039|NCT02094417|Anemia, Aplastic|anemia, aplastic
5318040|NCT02094417|Thrombopoietin|thrombopoietin
5318041|NCT02094417|Thrombocytopenia|thrombocytopenia
5318042|NCT02094404|Emergency Department|emergency department
5318043|NCT02094404|Pediatric Early Warning Score|pediatric early warning score
5318044|NCT02094404|Manchester Triage System|manchester triage system
5318045|NCT02094378|Healthy|healthy
5318046|NCT02094378|Esketamine|esketamine
5318047|NCT02094378|Cognitive functioning|cognitive functioning
5318048|NCT02094352|Complex Regional Pain Syndrome|complex regional pain syndrome
5318049|NCT02094352|Pain management|pain management
5318050|NCT02094352|Ketamine infusion|ketamine infusion
5318051|NCT02094339|Local analgesia system|local analgesia system
5318052|NCT02094339|Ropivacaine|ropivacaine
5318053|NCT02094339|Analgesic efficacy after operation|analgesic efficacy after operation
5318054|NCT02094339|Postoperative|postoperative
5318055|NCT02094313|Atorvastatin|atorvastatin
5318056|NCT02094313|Human Spermatozoa|human spermatozoa
5318057|NCT02094313|Seminal fluid|seminal fluid
5318058|NCT02094313|Accessory Glands|accessory glands
5318059|NCT02094313|Cholesterol|cholesterol
5318649|NCT02091583|Barley|barley
5318060|NCT02094313|Gonadotropins,|gonadotropins,
5318061|NCT02094313|Testosterone|testosterone
5318062|NCT02094300|Aorta|aorta
5318063|NCT02094300|Thoracic|thoracic
5318064|NCT02094300|Aortic dissection|aortic dissection
5318065|NCT02094300|Rupture|rupture
5318066|NCT02094300|Type B|type b
5318067|NCT02094300|DeBakey type III|debakey type iii
5318068|NCT02094300|Endovascular|endovascular
5318069|NCT02094261|Phase II, open label study; safety and efficacy of AZD9291; diagnosis of Epidermal Growth Factor Receptor mutation positive and T790M mutation positive NSCLC|phase ii, open label study; safety and efficacy of azd9291; diagnosis of epidermal growth factor receptor mutation positive and t790m mutation positive nsclc
5318071|NCT02094235|Atopic|atopic
5318072|NCT02094235|Pediatric|pediatric
5318073|NCT02094235|Adolescent|adolescent
5318074|NCT02094235|Child|child
5318075|NCT02094209|External Fixation|external fixation
5318076|NCT02094209|Tibial fracture|tibial fracture
5318077|NCT02094209|Fracture healing|fracture healing
5318078|NCT02094196|Reward- based learning|reward- based learning
5318079|NCT02094196|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
5318080|NCT02094196|Relapse Risk|relapse risk
5318081|NCT02094196|Positron emission tomography (PET)|positron emission tomography (pet)
5318082|NCT02094196|Magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5318083|NCT02094196|Dopamine receptor availability|dopamine receptor availability
5318084|NCT02094196|Glutamate|glutamate
5318085|NCT02094157|Atrial fibrillation|atrial fibrillation
5318086|NCT02094157|Mechanical heart valve|mechanical heart valve
5318087|NCT02094157|Stroke|stroke
5318088|NCT02094157|Venous thromboembolism|venous thromboembolism
5318089|NCT02094157|Hemorrhage|hemorrhage
5318090|NCT02094144|Sedentary|sedentary
5318091|NCT02094144|Physical activity|physical activity
5318092|NCT02094144|Brisk walking|brisk walking
5318093|NCT02094144|Postmenopausal women|postmenopausal women
5318094|NCT02094144|Body composition|body composition
5318095|NCT02094144|Balance|balance
5318096|NCT02094144|Muscle strength|muscle strength
5318097|NCT02094144|Depression, bone density|depression, bone density
5318098|NCT02094144|Nutrition|nutrition
5318099|NCT02094144|Biological effects|biological effects
5318100|NCT02094131|incentive spirometry|incentive spirometry
5314614|NCT02109627|antibody|antibody
5318104|NCT02094131|respiratory muscle training|respiratory muscle training
5318105|NCT02094118|Transfusion|transfusion
5318107|NCT02094118|cardiac|cardiac
5318108|NCT02094118|surgery|surgery
5318109|NCT02094118|transfusion related acute lung injury (TRALI)|transfusion related acute lung injury (trali)
5318110|NCT02094118|transfusion associated circulatory overload (TACO)|transfusion associated circulatory overload (taco)
5318111|NCT02094105|esophageal cancer|esophageal cancer
5318112|NCT02094105|screening|screening
5318113|NCT02094105|endoscopy|endoscopy
5318114|NCT02094105|prevention|prevention
5318115|NCT02094092|L.reuteri ProTectis DSM 17938|l.reuteri protectis dsm 17938
5318116|NCT02094092|Infantile colic|infantile colic
5318117|NCT02094092|Maternal mental health.|maternal mental health.
5318118|NCT02094092|Infant crying/fussing|infant crying/fussing
5318119|NCT02094092|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
5318120|NCT02094079|hypothyroidism|hypothyroidism
5318121|NCT02094079|pregnancy|pregnancy
5318122|NCT02094066|tranexamic acid|tranexamic acid
5318123|NCT02094066|total hip arthroplasty|total hip arthroplasty
5318124|NCT02094053|Down syndrome|down syndrome
5318125|NCT02094053|regression symptoms|regression symptoms
5318126|NCT02094053|disabled activities of daily living|disabled activities of daily living
5318127|NCT02094040|frailty|frailty
5318128|NCT02094040|readmission|readmission
5318129|NCT02094040|transition|transition
5318130|NCT02094040|discharge|discharge
5318131|NCT02094040|primary care|primary care
5318132|NCT02094027|Obesity|obesity
5318133|NCT02094027|Bariatric surgery|bariatric surgery
5318134|NCT02094027|Binge eating|binge eating
5318135|NCT02094027|Self help|self help
5318136|NCT02094014|Perceptual masking|perceptual masking
5318137|NCT02094014|Auditory stimulation|auditory stimulation
5318138|NCT02094014|Speech|speech
5318139|NCT02094014|Language|language
5318140|NCT02094014|Verbal Fluency Disorders|verbal fluency disorders
5318141|NCT02093962|TH-302|th-302
5318142|NCT02093962|TH-CR-415|th-cr-415
5318143|NCT02093962|Pemetrexed|pemetrexed
5318144|NCT02093962|Non-small cell lung cancer|non-small cell lung cancer
5318145|NCT02093962|Lung cancer|lung cancer
5318146|NCT02093962|Evofosfamide|evofosfamide
5318147|NCT02093936|airway inflammation|airway inflammation
5318148|NCT02093936|induced sputum|induced sputum
5318149|NCT02093936|normal values|normal values
5318150|NCT02093936|lymphocyte|lymphocyte
5266789|NCT02349698|CAR T|car t
5318151|NCT02093936|eosinophil|eosinophil
5318152|NCT02093936|neutrophil|neutrophil
5318153|NCT02093923|HAE|hae
5318154|NCT02093910|multiple myeloma|multiple myeloma
5318155|NCT02093910|peripheral neuropathy|peripheral neuropathy
5318156|NCT02093910|prophylaxis|prophylaxis
5318157|NCT02093884|Pregnancy|pregnancy
5318158|NCT02093884|Pregnancy, unplanned|pregnancy, unplanned
5318159|NCT02093884|Reproductive behavior|reproductive behavior
5318160|NCT02093884|Pregnancy in Adolescence|pregnancy in adolescence
5318161|NCT02093884|Text messaging|text messaging
5318162|NCT02093871|Ovarian cancer|ovarian cancer
5318163|NCT02093871|Therapeutic hyperthermia|therapeutic hyperthermia
5318165|NCT02093871|whole body hyperthermia|whole body hyperthermia
5318166|NCT02093871|hyperthermia|hyperthermia
5318167|NCT02093871|PISH|pish
5318168|NCT02093871|Verthermia|verthermia
5318169|NCT02093871|Phase 1 clinical trial|phase 1 clinical trial
5318170|NCT02093871|stage 3 ovarian cancer|stage 3 ovarian cancer
5318171|NCT02093871|stage 4 ovarian cancer|stage 4 ovarian cancer
5318172|NCT02093871|stage III ovarian cancer|stage iii ovarian cancer
5318173|NCT02093871|stage IV ovarian cancer|stage iv ovarian cancer
5318174|NCT02093871|late stage ovarian cancer|late stage ovarian cancer
5318175|NCT02093871|Core HFC|core hfc
5318176|NCT02093871|Lilja|lilja
5318177|NCT02093871|Vertrees|vertrees
5318178|NCT02093871|Bastidas|bastidas
5318179|NCT02093871|total body hyperthermia|total body hyperthermia
5318180|NCT02093858|Metabolic Syndrome|metabolic syndrome
5318181|NCT02093845|Percutaneous coronary intervention|percutaneous coronary intervention
5318182|NCT02093845|DES|des
5318183|NCT02093845|Angina pectoris|angina pectoris
5318184|NCT02093845|Stent|stent
5318185|NCT02093832|femoral head size|femoral head size
5318186|NCT02093832|cup size|cup size
5318187|NCT02093832|Total hip arthroplasty|total hip arthroplasty
5318188|NCT02093767|prebiotics|prebiotics
5318189|NCT02093767|Synergy1|synergy1
5318190|NCT02093728|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
5318191|NCT02093715|Bronchiolitis|bronchiolitis
5318192|NCT02093715|FeNO|feno
5318193|NCT02093715|Asthma|asthma
5318194|NCT02093715|wheezing, RSV|wheezing, rsv
5318195|NCT02093676|diabetes|diabetes
5318197|NCT02093676|adolescents|adolescents
5318198|NCT02093676|parents counselling|parents counselling
5318199|NCT02093663|Mild|mild
5318200|NCT02093663|Moderate|moderate
5314712|NCT02109081|elderly|elderly
5318204|NCT02093650|cimicifuga racemosa|cimicifuga racemosa
5318206|NCT02093650|Kupperman index|kupperman index
5318207|NCT02093650|KI|ki
5318208|NCT02093650|liver function tests|liver function tests
5318209|NCT02093598|pharmacokinetic|pharmacokinetic
5318210|NCT02093598|pharmacodynamic|pharmacodynamic
5318211|NCT02093598|Carcinoma, Endometrioid|carcinoma, endometrioid
5318212|NCT02093598|mTOR protein|mtor protein
5318213|NCT02093598|temsirolimus|temsirolimus
5318214|NCT02093598|torisel|torisel
5318215|NCT02093598|biological marker|biological marker
5318216|NCT02093598|phase II|phase ii
5318217|NCT02093585|HIV-1|hiv-1
5318218|NCT02093585|Abacavir|abacavir
5318219|NCT02093585|Platelet activation|platelet activation
5318220|NCT02093585|Thromboelastography|thromboelastography
5318221|NCT02093585|Coagulation|coagulation
5318222|NCT02093572|Clock genes|clock genes
5318223|NCT02093572|Metabolism|metabolism
5318224|NCT02093572|Insulin sensitivity|insulin sensitivity
5318225|NCT02093559|Clinical Trial|clinical trial
5318226|NCT02093559|Naloxone|naloxone
5318227|NCT02093559|Motivational Interviewing|motivational interviewing
5318228|NCT02093533|Membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
5318229|NCT02093533|Nephrotic syndrome|nephrotic syndrome
5318230|NCT02093533|Proteinuria|proteinuria
5318231|NCT02093533|Alternative complement pathway|alternative complement pathway
5318232|NCT02093533|Complement inhibition|complement inhibition
5318233|NCT02093533|Eculizumab|eculizumab
5318234|NCT02093520|Lumbar Spinal Stenosis|lumbar spinal stenosis
5318235|NCT02093520|Spinal Stenosis|spinal stenosis
5318236|NCT02093520|Neurogenic Claudication|neurogenic claudication
5318237|NCT02093507|newborn|newborn
5318238|NCT02093507|foot deformity congenital|foot deformity congenital
5318239|NCT02093494|Septicemia|septicemia
5318240|NCT02093494|Blood culture|blood culture
5318241|NCT02093494|Contamination|contamination
5318242|NCT02093468|Acute limb ischemia|acute limb ischemia
5318243|NCT02093468|ALI|ali
5318244|NCT02093468|Acute lower extremity arterial occlusion|acute lower extremity arterial occlusion
5318245|NCT02093455|Endothelial function|endothelial function
5318246|NCT02093416|Obesity|obesity
5318247|NCT02093416|Leptin|leptin
5318248|NCT02093403|AML|aml
5318249|NCT02093403|Acute Myeloid Leukemia|acute myeloid leukemia
5318250|NCT02093403|Adult Acute Myeloid Leukemia with T(8;21)(Q22;Q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5318251|NCT02093403|adult Acute Myeloid Leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5318252|NCT02093403|adult Acute Myeloid Leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5369174|NCT01861002|Epigenetic therapy|epigenetic therapy
5963175|NCT04267991|tacrolimus|tacrolimus
5318253|NCT02093403|adult Acute Myeloid Leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5318254|NCT02093377|acute myocardial infarction|acute myocardial infarction
5318255|NCT02093377|sleep apnea|sleep apnea
5318256|NCT02093377|adaptive servo-ventilation|adaptive servo-ventilation
5318450|NCT02092480|Unintended pregnancy|unintended pregnancy
5356887|NCT01917591|Prospective Studies|prospective studies
5318257|NCT02093351|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,|oncology, cancer, tumour, neoplasm, anticancer drug, pharmacokinetics, olaparib, anastrozole, tamoxifen, letrozole,
5318259|NCT02093338|probiotic|probiotic
5318260|NCT02093338|mastitis|mastitis
5318261|NCT02093338|lactobacillus fermentun|lactobacillus fermentun
5318262|NCT02093338|Staphylococcus|staphylococcus
5318263|NCT02093325|eltrombopag , thrombocytopenia, solid tumor|eltrombopag , thrombocytopenia, solid tumor
5318264|NCT02093312|Cancer|cancer
5318265|NCT02093312|Food-delivery|food-delivery
5318266|NCT02093312|Nutritional Intervention|nutritional intervention
5318267|NCT02093312|Quality of life|quality of life
5318268|NCT02093312|Outpatients|outpatients
5318269|NCT02093286|Pentabio Vaccine|pentabio vaccine
5318270|NCT02093286|Safety|safety
5318271|NCT02093286|Infants|infants
5318272|NCT02093286|Booster Dose|booster dose
5318273|NCT02093286|DTwP/HepB/Hib|dtwp/hepb/hib
5318274|NCT02093273|tOPV|topv
5318275|NCT02093273|Antibody response|antibody response
5318276|NCT02093273|Safety|safety
5318277|NCT02093260|Flubio Vaccine (Influenza HA)|flubio vaccine (influenza ha)
5318278|NCT02093260|Infants|infants
5318279|NCT02093260|Children|children
5318280|NCT02093260|Safety|safety
5318281|NCT02093260|Immunogenicity|immunogenicity
5318282|NCT02093234|self care of diabetes type 2 patients|self care of diabetes type 2 patients
5318283|NCT02093234|mobile health cell phone application impact on health|mobile health cell phone application impact on health
5318284|NCT02093234|community health workers impact on health|community health workers impact on health
5318285|NCT02093221|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5318286|NCT02093221|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
5318287|NCT02093221|Beta Cell|beta cell
5318288|NCT02093221|Alpha1-Antitrypsin|alpha1-antitrypsin
5314798|NCT02108847|Nerve Block|nerve block
5318294|NCT02093143|Remifentanil|remifentanil
5318295|NCT02093143|Propofol|propofol
5318296|NCT02093143|Target controlled infusion|target controlled infusion
5318297|NCT02093143|Direct laryngoscopy|direct laryngoscopy
5318298|NCT02093143|Tracheoscopy|tracheoscopy
5318299|NCT02093143|Oesophagoscopy|oesophagoscopy
5318300|NCT02093143|Ear Nose and Throat (ENT) tumor|ear nose and throat (ent) tumor
5318301|NCT02093143|Ear Nose and Throat (ENT) cancer|ear nose and throat (ent) cancer
5318302|NCT02093130|Double-blind Trial|double-blind trial
5318303|NCT02093130|Placebo-controlled|placebo-controlled
5318304|NCT02093130|Pomegranate|pomegranate
5318306|NCT02093130|Memory Impairment|memory impairment
5318307|NCT02093130|Cognition|cognition
5318308|NCT02093130|Ages 50-75|ages 50-75
5318309|NCT02093117|Supratentorial neurosurgery|supratentorial neurosurgery
5318310|NCT02093117|Recruitment maneuver|recruitment maneuver
5318311|NCT02093117|Subdural pressure|subdural pressure
5318312|NCT02093117|Brain relaxation|brain relaxation
5318313|NCT02093117|Cerebral perfusion pressure|cerebral perfusion pressure
5318314|NCT02093104|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5318315|NCT02093104|(undergoing chemoembolization and radioembolization)|(undergoing chemoembolization and radioembolization)
5318316|NCT02093091|nano-filled resin modified glass ionomer|nano-filled resin modified glass ionomer
5318317|NCT02093091|clinical performance|clinical performance
5318318|NCT02093091|class I|class i
5318319|NCT02093091|primary teeth|primary teeth
5318320|NCT02093091|dentin bond strength|dentin bond strength
5318321|NCT02093091|Filling of class I|filling of class i
5318322|NCT02093065|severe hemophilia A|severe hemophilia a
5318323|NCT02093065|coated platelets|coated platelets
5318324|NCT02093065|bleeding|bleeding
5318325|NCT02093052|Parenting|parenting
5318326|NCT02093052|Parent child relations|parent child relations
5318327|NCT02093052|Middle childhood outcomes|middle childhood outcomes
5318328|NCT02093039|breast cancer screening|breast cancer screening
5318329|NCT02093039|patient decision aids|patient decision aids
5318330|NCT02093039|informed decision|informed decision
5318331|NCT02093039|empowerment|empowerment
5318332|NCT02093039|randomized control trial|randomized control trial
5318333|NCT02093039|From 50 to 74 years old|from 50 to 74 years old
5318334|NCT02093039|invited to national breast cancer screening|invited to national breast cancer screening
5318335|NCT02093013|asthma|asthma
5318336|NCT02093013|intervention|intervention
5318337|NCT02093013|medication adherence|medication adherence
5318338|NCT02093013|inhaled corticosteroids|inhaled corticosteroids
5318339|NCT02093013|asthma control|asthma control
5318340|NCT02093013|integrated care|integrated care
5318341|NCT02092987|Hispanic|hispanic
5318342|NCT02092987|Dementia|dementia
5318343|NCT02092987|Caregivers|caregivers
5318344|NCT02092987|Depressive symptoms|depressive symptoms
5318345|NCT02092987|Burden|burden
5963176|NCT04267822|RV521|rv521
5318346|NCT02092987|Pragmatic randomized trial|pragmatic randomized trial
5318347|NCT02092974|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5318451|NCT02092480|Parents|parents
5318348|NCT02092974|selective serotonin reuptake inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
5318349|NCT02092974|young|young
5318350|NCT02092974|older adults|older adults
5318351|NCT02092961|Rheumatoid Arthritis|rheumatoid arthritis
5318352|NCT02092961|OSKIRA|oskira
5318353|NCT02092961|fostamatinib|fostamatinib
5318354|NCT02092961|CE-MRI|ce-mri
5318355|NCT02092961|DCE-MRI|dce-mri
5318356|NCT02092948|metastatic|metastatic
5318357|NCT02092948|PSCA|psca
5318358|NCT02092948|minibody|minibody
5318359|NCT02092948|PET/CT|pet/ct
5318360|NCT02092935|CDAD|cdad
5318361|NCT02092935|Clostridium Difficile|clostridium difficile
5318362|NCT02092896|Diabetes Mellitus|diabetes mellitus
5318363|NCT02092896|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5318364|NCT02092896|Glucose Metabolism Disorders|glucose metabolism disorders
5318365|NCT02092896|Metabolic Diseases|metabolic diseases
5318366|NCT02092896|Cognitive performance|cognitive performance
5318367|NCT02092896|Hypoglycemia|hypoglycemia
5318368|NCT02092896|Insulin|insulin
5318369|NCT02092896|Glucagon-Like Peptide 1|glucagon-like peptide 1
5318370|NCT02092896|Hypoglycemic Agents|hypoglycemic agents
5318371|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs
5318372|NCT02092896|Pharmacologic Actions|pharmacologic actions
5318373|NCT02092896|Incretins|incretins
5318374|NCT02092896|Hormones|hormones
5318375|NCT02092883|Infantile Spasms|infantile spasms
5318377|NCT02092883|PK11195|pk11195
5318378|NCT02092883|PET|pet
5318379|NCT02092883|ACTH|acth
5318380|NCT02092870|Chronic Wounds|chronic wounds
5318381|NCT02092870|Diabetes|diabetes
5318382|NCT02092870|Adipose Derived Stem Cells|adipose derived stem cells
5318387|NCT02092857|essential fatty acids|essential fatty acids
5318388|NCT02092844|Menopause|menopause
5318389|NCT02092844|Insomnia|insomnia
5318390|NCT02092844|Hot Flashes|hot flashes
5318391|NCT02092805|VAS|vas
5318392|NCT02092805|VDS|vds
5318393|NCT02092805|HAM-D|ham-d
5318394|NCT02092805|Visceral pain|visceral pain
5318395|NCT02092805|Malignancy|malignancy
5318396|NCT02092805|rTMS|rtms
5318397|NCT02092805|Motor cortex|motor cortex
5318398|NCT02092805|Analgesia|analgesia
5318399|NCT02092805|Dynorphin|dynorphin
5318400|NCT02092766|malaria|malaria
5318401|NCT02092766|anaemia|anaemia
5318402|NCT02092766|artesunate|artesunate
5318403|NCT02092753|Ketogenic diet, logi diet, breast cancer, rehabilitation|ketogenic diet, logi diet, breast cancer, rehabilitation
5318404|NCT02092740|Testicular cancer|testicular cancer
5318405|NCT02092727|Dialysis facilities|dialysis facilities
5318406|NCT02092727|African Americans|african americans
5318407|NCT02092727|Racial disparity|racial disparity
5318408|NCT02092727|Kidney Transplantation|kidney transplantation
5318409|NCT02092727|Community-based Participatory Research|community-based participatory research
5318410|NCT02092727|Coalition|coalition
5318411|NCT02092727|Georgia|georgia
5318412|NCT02092688|time to delivery|time to delivery
5318413|NCT02092688|PROM|prom
5318414|NCT02092688|PTL|ptl
5318415|NCT02092688|positive predictive value|positive predictive value
5318416|NCT02092675|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5318417|NCT02092675|frequent exacerbator|frequent exacerbator
5318418|NCT02092675|endothelial dysfunction|endothelial dysfunction
5318419|NCT02092675|Flow mediated dilatation|flow mediated dilatation
5318420|NCT02092675|Systemic inflammation|systemic inflammation
5318421|NCT02092649|Omega-3|omega-3
5318422|NCT02092649|Resting metabolic rate|resting metabolic rate
5318423|NCT02092649|Eicosapentaenoic acid|eicosapentaenoic acid
5318424|NCT02092649|Docosahexaenoic acid|docosahexaenoic acid
5318425|NCT02092636|Hybrid NIR/US imaging technique|hybrid nir/us imaging technique
5318426|NCT02092636|NIR/US imaging|nir/us imaging
5318427|NCT02092636|US imaging|us imaging
5318428|NCT02092636|US imaging technique|us imaging technique
5318429|NCT02092623|Female|female
5318430|NCT02092623|Prolapse surgery with transvaginal mesh|prolapse surgery with transvaginal mesh
5318431|NCT02092623|Subjective outcome|subjective outcome
5318432|NCT02092584|atherosclerotic|atherosclerotic
5318433|NCT02092584|IGF-1|igf-1
5318434|NCT02092584|IGFBP-3|igfbp-3
5318435|NCT02092558|metaplasia, dysfunction, urinary bladder, children|metaplasia, dysfunction, urinary bladder, children
5318436|NCT02092545|Obesity|obesity
5318437|NCT02092519|EUSFNA|eusfna
5318438|NCT02092519|endoscopic ultrasound|endoscopic ultrasound
5318439|NCT02092519|pancreatic masses|pancreatic masses
5318440|NCT02092506|H pylori|h pylori
5318441|NCT02092506|therapy|therapy
5318442|NCT02092493|ScopeGuide|scopeguide
5318443|NCT02092493|Colonoscopy|colonoscopy
5318444|NCT02092493|Mental workload|mental workload
5318445|NCT02092480|Feasibility Trial|feasibility trial
5318446|NCT02092480|Educational Intervention|educational intervention
5318447|NCT02092480|Teenage Pregnancy|teenage pregnancy
5318448|NCT02092480|Boys|boys
5318449|NCT02092480|Gender sensitive interventions|gender sensitive interventions
5318647|NCT02091583|DHA|dha
5318458|NCT02092467|CP690550|cp690550
5318459|NCT02092467|Xeljanz|xeljanz
5318460|NCT02092467|oral treatment|oral treatment
5318461|NCT02092441|Nausea|nausea
5318462|NCT02092441|Vomiting|vomiting
5318463|NCT02092441|Antiemetic|antiemetic
5318464|NCT02092428|Coronary Magnetic Resonance Imaging|coronary magnetic resonance imaging
5318465|NCT02092428|CAD|cad
5318466|NCT02092428|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
5318467|NCT02092428|MRA|mra
5318468|NCT02092428|3 Tesla MRI|3 tesla mri
5318469|NCT02092415|Tourniquet|tourniquet
5318470|NCT02092415|Muscle perfusion|muscle perfusion
5318471|NCT02092415|Contrast ultrasound|contrast ultrasound
5318472|NCT02092402|Fecal transplantation|fecal transplantation
5318473|NCT02092402|microbiota transplantation|microbiota transplantation
5318474|NCT02092402|irritable bowel syndrome|irritable bowel syndrome
5318475|NCT02092402|IBS|ibs
5318476|NCT02092389|Ulcerative Colitis|ulcerative colitis
5318477|NCT02092389|Inflammatory Bowel Syndrome|inflammatory bowel syndrome
5318478|NCT02092389|Adalimumab|adalimumab
5318479|NCT02092389|Tumor necrosis factor (TNF) alpha Antibody|tumor necrosis factor (tnf) alpha antibody
5318480|NCT02092389|Calprotectin|calprotectin
5318481|NCT02092376|Bariatric surgery|bariatric surgery
5318482|NCT02092376|vitamin D|vitamin d
5318483|NCT02092376|supplementation|supplementation
5318484|NCT02092363|Platinum-Sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
5318485|NCT02092337|CAST, Hearing aids, Speech recognition, Cochlear implants|cast, hearing aids, speech recognition, cochlear implants
5322909|NCT02071758|GLA|gla
5318488|NCT02092311|complications of varicocelectomy|complications of varicocelectomy
5318489|NCT02092311|Recurrence of varicocele|recurrence of varicocele
5318490|NCT02092311|Post-varicocelectomy testicular atrophy|post-varicocelectomy testicular atrophy
5318491|NCT02092311|Post-varicocelectomy hydrocele|post-varicocelectomy hydrocele
5318492|NCT02092298|Gastrointestinal cancer|gastrointestinal cancer
5318493|NCT02092298|Hyperthermic Intraperitoneal Chemoperfusion|hyperthermic intraperitoneal chemoperfusion
5318494|NCT02092298|HIPEC|hipec
5318495|NCT02092298|Gastric carcinomatosis|gastric carcinomatosis
5318496|NCT02092298|Gastroesophageal cancer|gastroesophageal cancer
5318497|NCT02092298|Mitomycin C|mitomycin c
5318498|NCT02092298|Mitomycin|mitomycin
5318499|NCT02092298|Cisplatin|cisplatin
5318500|NCT02092298|Platinol-AQ|platinol-aq
5318501|NCT02092298|Platinol|platinol
5318502|NCT02092298|CDDP|cddp
5318503|NCT02092298|Sodium Thiosulfate|sodium thiosulfate
5318504|NCT02092298|Tinver|tinver
5318505|NCT02092233|ARIES HSV 1&2|aries hsv 1&2
5318506|NCT02092220|Bionic Pancreas|bionic pancreas
5318507|NCT02092220|Insulin|insulin
5318508|NCT02092220|Glucagon|glucagon
5318509|NCT02092220|Continuous Glucose Monitor|continuous glucose monitor
5318510|NCT02092194|beta 2-Microglobulin|beta 2-microglobulin
5318511|NCT02092194|Hemodiafiltration|hemodiafiltration
5318512|NCT02092194|convective volume|convective volume
5318513|NCT02092168|Opicapone|opicapone
5318514|NCT02092168|BIAL|bial
5318515|NCT02092142|Q fever|q fever
5318516|NCT02092142|Coxiella burnetii|coxiella burnetii
5318517|NCT02092129|Acromegaly, surgery, histopathology, hyperprolactinaemia,|acromegaly, surgery, histopathology, hyperprolactinaemia,
5318518|NCT02092103|Premature Birth|premature birth
5318519|NCT02092103|Umbilical Cord Clamping|umbilical cord clamping
5318520|NCT02092090|salt substitute|salt substitute
5318521|NCT02092090|sodium reduction|sodium reduction
5318522|NCT02092090|stroke|stroke
5318523|NCT02092090|cluster randomized trial|cluster randomized trial
5318524|NCT02092090|China|china
5318525|NCT02092077|Growth Hormone-Deficient|growth hormone-deficient
5318526|NCT02092077|recombinant human growth hormone|recombinant human growth hormone
5318527|NCT02092064|basal proteinuria|basal proteinuria
5318528|NCT02092064|FMF|fmf
5318529|NCT02092064|pregnancy|pregnancy
5318530|NCT02092051|Continuous glucose monitoring|continuous glucose monitoring
5318531|NCT02092051|Type 1 diabetes|type 1 diabetes
5318532|NCT02092051|Insulin injections|insulin injections
5318533|NCT02092051|Cross-over|cross-over
5318534|NCT02092038|glioblastoma|glioblastoma
5318535|NCT02092038|temozolomide|temozolomide
5318536|NCT02092038|radiation therapy|radiation therapy
5318537|NCT02092038|radiotherapy|radiotherapy
5318538|NCT02092038|surgery|surgery
5318539|NCT02092038|pre-operative|pre-operative
5318540|NCT02092038|neoadjuvant|neoadjuvant
5318541|NCT02092025|Pharmacological therapy|pharmacological therapy
5318542|NCT02092012|postoperative pain|postoperative pain
5318543|NCT02092012|dexketoprofen trometamol|dexketoprofen trometamol
5318544|NCT02092012|dexmedetomidine|dexmedetomidine
5318559|NCT02091973|microRNA|microrna
5318560|NCT02091960|Enzalutamide|enzalutamide
5318561|NCT02091960|Trastuzumab|trastuzumab
5318562|NCT02091960|Breast cancer|breast cancer
5318563|NCT02091960|HER2|her2
5318564|NCT02091960|Androgen receptor positive|androgen receptor positive
5318565|NCT02091960|Xtandi|xtandi
5318566|NCT02091947|FMS|fms
5318567|NCT02091947|Urine incontinence|urine incontinence
5318568|NCT02091934|Alcon|alcon
5318569|NCT02091934|Wavelight|wavelight
5318571|NCT02091934|Wavefront-guided|wavefront-guided
5199171|NCT02749591|randomized controlled trial|randomized controlled trial
5199172|NCT02749565|asthma|asthma
5199173|NCT02749565|fibrocyte|fibrocyte
5318572|NCT02091934|Wavefront-optimized|wavefront-optimized
5318573|NCT02091934|Myopia|myopia
5318574|NCT02091934|Astigmatism|astigmatism
5318575|NCT02091921|Critical Limb Ischemia, ticagrelor, Brilinta|critical limb ischemia, ticagrelor, brilinta
5318576|NCT02091908|Influenza|influenza
5318577|NCT02091908|H5N1|h5n1
5318578|NCT02091908|aH5N1|ah5n1
5318579|NCT02091908|H5N1 vaccine|h5n1 vaccine
5318580|NCT02091908|Pandemic Influenza vaccine|pandemic influenza vaccine
5318581|NCT02091908|MF59, Adjuvant, Avian flu|mf59, adjuvant, avian flu
5318582|NCT02091908|Underlying medical conditions|underlying medical conditions
5318583|NCT02091908|Underlying cardiovascular medical condition|underlying cardiovascular medical condition
5318584|NCT02091908|Pandemic vaccine|pandemic vaccine
5318585|NCT02091908|Charlson Comorbidity Index (CCI)|charlson comorbidity index (cci)
5318586|NCT02091908|Adjuvanted vaccine|adjuvanted vaccine
5318587|NCT02091895|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders|probe-based confocal laser endomicroscopy, lower gastrointestinal disorders
5318588|NCT02091882|OPC-14597 Digital|opc-14597 digital
5318589|NCT02091882|Aripiprazole|aripiprazole
5318590|NCT02091882|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
5318591|NCT02091882|Ingestible Event Marker|ingestible event marker
5318592|NCT02091869|Adolescents|adolescents
5318593|NCT02091869|Asthma|asthma
5318594|NCT02091869|Asthma Symptoms|asthma symptoms
5318595|NCT02091817|oxytocin|oxytocin
5318596|NCT02091817|face|face
5318597|NCT02091817|memory|memory
5318598|NCT02091804|Attachment theory|attachment theory
5318599|NCT02091804|Parent- child relationship|parent- child relationship
5318600|NCT02091804|Child mental health|child mental health
5318601|NCT02091804|Behavioral health|behavioral health
5318602|NCT02091791|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation|acute lumbar sciatica, lumbar traction, traction force, radicular pain, lumbar functional parameters, disc herniation
5318603|NCT02091765|Sexual dysfunction|sexual dysfunction
5318604|NCT02091765|Intimacy problems|intimacy problems
5318605|NCT02091765|Breast cancer survivors|breast cancer survivors
5318607|NCT02091765|Cognitive behavioral therapy|cognitive behavioral therapy
5318608|NCT02091752|Primary Myelofibrosis|primary myelofibrosis
5318609|NCT02091752|Hematologic Diseases|hematologic diseases
5318610|NCT02091752|Myeloproliferative Disorders|myeloproliferative disorders
5318612|NCT02091752|Ruxolitinib|ruxolitinib
5318613|NCT02091726|Circumcision|circumcision
5318614|NCT02091726|HIV prevention|hiv prevention
5318615|NCT02091726|Surgical device|surgical device
5318616|NCT02091726|Cyanoacrylate|cyanoacrylate
5318617|NCT02091726|Tissue Adhesive|tissue adhesive
5318618|NCT02091726|voluntary|voluntary
5318619|NCT02091713|FMS|fms
5318620|NCT02091713|functional movement screen|functional movement screen
5318621|NCT02091700|Normal|normal
5318622|NCT02091700|Healthy|healthy
5318623|NCT02091700|Normal healthy patient|normal healthy patient
5318624|NCT02091674|ankle sprain|ankle sprain
5318625|NCT02091674|hyaluronic acid|hyaluronic acid
5318626|NCT02091661|Clinically localized prostate cancer|clinically localized prostate cancer
5318627|NCT02091661|Radical retropubic prostatectomy|radical retropubic prostatectomy
5318628|NCT02091661|External beam radiotherapy|external beam radiotherapy
5318629|NCT02091661|Efficacy|efficacy
5318630|NCT02091661|Quality of life|quality of life
5318631|NCT02091661|adverse events|adverse events
5318632|NCT02091648|Asthma|asthma
5318633|NCT02091648|Stress|stress
5318634|NCT02091648|Children|children
5318635|NCT02091648|Psychosocial Factors|psychosocial factors
5318636|NCT02091648|Relaxation|relaxation
5318637|NCT02091648|Stress management|stress management
5318638|NCT02091635|accommodation, emptying, motilitone|accommodation, emptying, motilitone
5318639|NCT02091609|plaque removal around dental implants|plaque removal around dental implants
5318640|NCT02091596|Wound|wound
5318641|NCT02091596|Ulcer|ulcer
5318642|NCT02091596|Infected|infected
5318643|NCT02091596|Infection|infection
5318644|NCT02091583|Metabolic syndrome|metabolic syndrome
5318645|NCT02091583|Cardiovascular disease|cardiovascular disease
5318646|NCT02091583|High Oleic Canola Oil|high oleic canola oil
5318650|NCT02091583|Cholesterol|cholesterol
5318651|NCT02091583|Lipoproteins|lipoproteins
5318652|NCT02091583|Lipids|lipids
5318653|NCT02091583|Inflammation|inflammation
5318654|NCT02091583|Glucose|glucose
5318655|NCT02091583|Insulin|insulin
5318656|NCT02091583|Satiety|satiety
5318657|NCT02091583|Body composition|body composition
5318658|NCT02091583|Blood pressure|blood pressure
5318659|NCT02091570|Hunger|hunger
5318660|NCT02091570|Fullness|fullness
5318661|NCT02091570|Satiety|satiety
5318662|NCT02091570|Nutrition bar|nutrition bar
5318663|NCT02091570|Crossover|crossover
5318664|NCT02091557|GnRH-a|gnrh-a
5318665|NCT02091557|endometriosis|endometriosis
5318666|NCT02091557|chronic pelvic pain|chronic pelvic pain
5963177|NCT04267822|lower respiratory tract complication|lower respiratory tract complication
5963178|NCT04267822|HCT|hct
5963179|NCT04267822|hematopoietic cell transplantation|hematopoietic cell transplantation
5318667|NCT02091557|VAS score|vas score
5318668|NCT02091557|diagnostic accuracy|diagnostic accuracy
5318669|NCT02091544|overweight|overweight
5318670|NCT02091544|obesity|obesity
5318671|NCT02091544|children|children
5318672|NCT02091544|lifestyle intervention|lifestyle intervention
5318673|NCT02091531|mTOR Inhibitor MLN0128|mtor inhibitor mln0128
5318674|NCT02091531|PSA|psa
5318675|NCT02091531|13-143|13-143
5318676|NCT02091518|MRI|mri
5318677|NCT02091518|13-239|13-239
5318678|NCT02091518|volunteers|volunteers
5318679|NCT02091518|patients|patients
5318680|NCT02091492|Proximal humerus fracture, teriparatide|proximal humerus fracture, teriparatide
5318681|NCT02091479|hæmorrhage, thrombosis|hæmorrhage, thrombosis
5318682|NCT02091466|Hypothermia|hypothermia
5318683|NCT02091466|Perioperative Care|perioperative care
5318684|NCT02091466|Anesthesia|anesthesia
5318685|NCT02091466|Spinal|spinal
5318686|NCT02091466|Rewarming|rewarming
5318687|NCT02091453|Brain injury|brain injury
5318688|NCT02091453|stroke|stroke
5318689|NCT02091453|cognitive rehabilitation|cognitive rehabilitation
5318690|NCT02091440|Medical Device|medical device
5318691|NCT02091440|Thoracic Surgical Procedure|thoracic surgical procedure
5318692|NCT02091440|Pumps Heart Assist|pumps heart assist
5318693|NCT02091440|Ventricular Assist Device|ventricular assist device
5318694|NCT02091401|magnesium sulfate|magnesium sulfate
5318695|NCT02091375|Cannabidiol|cannabidiol
5318696|NCT02091375|CBD|cbd
5318697|NCT02091375|Epidiolex|epidiolex
5318698|NCT02091375|GWP42003-P|gwp42003-p
5318699|NCT02091336|gestational diabetes|gestational diabetes
5318700|NCT02091336|metformin|metformin
5318701|NCT02091336|glyburide|glyburide
5318702|NCT02091336|fetal growth|fetal growth
5318705|NCT02091310|GFT505|gft505
5318706|NCT02091310|TQT|tqt
5318707|NCT02091310|QT/QTc|qt/qtc
5318709|NCT02091310|Healthy subjects|healthy subjects
5318710|NCT02091310|Moxifloxacin|moxifloxacin
5318711|NCT02091297|Buprenorphine|buprenorphine
5318712|NCT02091297|Suboxone|suboxone
5318713|NCT02091297|Subutex|subutex
5318714|NCT02091297|Buprenex|buprenex
5318715|NCT02091297|Caesarean Delivery|caesarean delivery
5318716|NCT02091284|alcoholism|alcoholism
5318717|NCT02091284|tDCS|tdcs
5318718|NCT02091284|dlPFC|dlpfc
5318719|NCT02091284|craving|craving
5318720|NCT02091284|cognition|cognition
5318721|NCT02091271|Evaluation|evaluation
5318722|NCT02091271|Research|research
5318723|NCT02091271|Healthy Volunteers|healthy volunteers
5318724|NCT02091245|Relapsed acute lymphoblastic leukemia (ALL)|relapsed acute lymphoblastic leukemia (all)
5318725|NCT02091245|Refractory acute lymphoblastic leukemia (ALL)|refractory acute lymphoblastic leukemia (all)
5318726|NCT02091245|Relapsed acute myelogenous leukemia (AML)|relapsed acute myelogenous leukemia (aml)
5318727|NCT02091245|Refractory acute myelogenous leukemia (AML)|refractory acute myelogenous leukemia (aml)
5318728|NCT02091245|Relapsed childhood leukemia|relapsed childhood leukemia
5318729|NCT02091245|Relapsed mixed lineage leukemia|relapsed mixed lineage leukemia
5318730|NCT02091245|Refractory mixed lineage leukemia|refractory mixed lineage leukemia
5318731|NCT02091245|Relapsed biphenotypic leukemia|relapsed biphenotypic leukemia
5318732|NCT02091245|Refractory biphenotypic leukemia|refractory biphenotypic leukemia
5318733|NCT02091245|Chronic myelogenous leukemia (CML) in blast crisis|chronic myelogenous leukemia (cml) in blast crisis
5318734|NCT02091219|Hypovitaminosis D|hypovitaminosis d
5318735|NCT02091219|Free 25-hydroxyvitamin D|free 25-hydroxyvitamin d
5318736|NCT02091219|Total 25-hydroxyvitamin D|total 25-hydroxyvitamin d
5318737|NCT02091206|Cannabidiol|cannabidiol
5318738|NCT02091206|CBD|cbd
5318739|NCT02091206|Epidiolex|epidiolex
5318740|NCT02091206|GWP42003-P|gwp42003-p
5318741|NCT02091193|Krill Oil|krill oil
5318742|NCT02091193|Endothelial Function|endothelial function
5318743|NCT02091193|Type II Diabetes Mellitus|type ii diabetes mellitus
5318744|NCT02091180|Anesthesia|anesthesia
5318745|NCT02091180|Recovery|recovery
5318746|NCT02091180|laparoscopy|laparoscopy
5318747|NCT02091180|cholecystectomy|cholecystectomy
5318748|NCT02091167|crack-cocaine addiction|crack-cocaine addiction
5318749|NCT02091167|tDCS|tdcs
5318750|NCT02091167|dlPFC|dlpfc
5318751|NCT02091167|craving|craving
5318752|NCT02091167|cognition|cognition
5318753|NCT02091154|Food Intake Regulation|food intake regulation
5318755|NCT02091154|Vegetable|vegetable
5318756|NCT02091115|Constipation|constipation
5318757|NCT02091115|ROMA III criteria|roma iii criteria
5318758|NCT02091115|Scale Bristol|scale bristol
5318759|NCT02091076|Silk fibroin with bioactive coating layer dressing|silk fibroin with bioactive coating layer dressing
5318760|NCT02091076|Wound healing|wound healing
5318761|NCT02091076|Skin graft donor|skin graft donor
5318762|NCT02091063|hematologic malignancies|hematologic malignancies
5318763|NCT02091063|hodgkin|hodgkin
5318764|NCT02091063|hodgkins|hodgkins
5318765|NCT02091063|non-hodgkin|non-hodgkin
5318766|NCT02091063|non-hodgkins|non-hodgkins
5318767|NCT02091063|mantle cell lymphoma|mantle cell lymphoma
5318768|NCT02091063|follicular|follicular
5318769|NCT02091063|lymphoma|lymphoma
5318770|NCT02091063|lymphoid malignancies|lymphoid malignancies
5318771|NCT02091050|3D Brachytherapy|3d brachytherapy
5318772|NCT02091050|cervical cancer|cervical cancer
5318773|NCT02091050|endometrial cancer|endometrial cancer
5318774|NCT02091050|vaginal vault brachytherapy|vaginal vault brachytherapy
5318775|NCT02091037|Atopic dermatitis|atopic dermatitis
5318776|NCT02091037|Bacterial colonization|bacterial colonization
5318777|NCT02091011|This study is designed to efficiently provide device and battery longevity data on market released|this study is designed to efficiently provide device and battery longevity data on market released
5318778|NCT02091011|Boston Scientific ICD and CRT-D (Cardiac Resynchronization Therapy Defibrillator) devices. In addition, the data collected will allow for|boston scientific icd and crt-d (cardiac resynchronization therapy defibrillator) devices. in addition, the data collected will allow for
5318779|NCT02091011|comparisons of device survival probability estimated in the Product Performance Report versus|comparisons of device survival probability estimated in the product performance report versus
5318780|NCT02091011|those collected in the study. The data collected will also provide a better understanding on the|those collected in the study. the data collected will also provide a better understanding on the
5318781|NCT02091011|potential predictors of pulse generator battery longevity.|potential predictors of pulse generator battery longevity.
5318782|NCT02090998|Migraine Headache|migraine headache
5318783|NCT02090998|Menstrual Migraine|menstrual migraine
5318784|NCT02090998|Vascular Headache|vascular headache
5318785|NCT02090998|Temporal Lobe Seizure|temporal lobe seizure
5318787|NCT02090985|Peri-stomal|peri-stomal
5318788|NCT02090985|Lipomodelling|lipomodelling
5318792|NCT02090959|Premature stop codon|premature stop codon
5318793|NCT02090959|Becker muscular dystrophy|becker muscular dystrophy
5318794|NCT02090959|DMD/BMD|dmd/bmd
5318795|NCT02090959|PTC124|ptc124
5318796|NCT02090959|Ataluren|ataluren
5318797|NCT02090946|children with physical disabilities|children with physical disabilities
5315317|NCT02106767|Asian|asian
5318799|NCT02090946|home programmes|home programmes
5318800|NCT02090946|learning|learning
5318801|NCT02090946|therapeutic relationship|therapeutic relationship
5318802|NCT02090946|phenomenology|phenomenology
5318803|NCT02090946|physiotherapy|physiotherapy
5318804|NCT02090946|clinicians who teach|clinicians who teach
5318805|NCT02090946|parent perspective|parent perspective
5318806|NCT02090946|parent-professional relationships|parent-professional relationships
5318807|NCT02090946|Parents/carers|parents/carers
5318808|NCT02090946|long term physiotherapy needs|long term physiotherapy needs
5318809|NCT02090907|Subclinical hypothyroidism|subclinical hypothyroidism
5318810|NCT02090907|Atherosclerosis|atherosclerosis
5318811|NCT02090907|Cardiovascular disease|cardiovascular disease
5318812|NCT02090907|Endothelial function|endothelial function
5318813|NCT02090907|Prevention|prevention
5318814|NCT02090868|Non-Invasive Ventilation|non-invasive ventilation
5318815|NCT02090868|Bi-Level Positive Airway Pressure|bi-level positive airway pressure
5318816|NCT02090868|Continuous Positive Airway Pressure|continuous positive airway pressure
5318817|NCT02090868|Critical Care|critical care
5318818|NCT02090868|Nutrition|nutrition
5318819|NCT02090868|Malnutrition|malnutrition
5318820|NCT02090868|Staff attitudes, knowledge and beliefs|staff attitudes, knowledge and beliefs
5318821|NCT02090842|Milk proteins|milk proteins
5318822|NCT02090842|Blood pressure|blood pressure
5318823|NCT02090842|Vascular function|vascular function
5318824|NCT02090829|Autism|autism
5318825|NCT02090829|Oxytocin|oxytocin
5318826|NCT02090829|Syntocinon|syntocinon
5318827|NCT02090790|dexamethasone|dexamethasone
5318828|NCT02090790|femoral block|femoral block
5318829|NCT02090790|total knee arthroplasty|total knee arthroplasty
5318830|NCT02090751|Retinal Rod Photoreceptor Cells|retinal rod photoreceptor cells
5318831|NCT02090751|Dark Adaptation|dark adaptation
5318832|NCT02090725|fluctuating muscle weakness|fluctuating muscle weakness
5213960|NCT02658409|Vaccination|vaccination
5318833|NCT02090725|hyporeflexia|hyporeflexia
5318834|NCT02090725|autonomic Dysfunction|autonomic dysfunction
5318838|NCT02090699|thalassemia major|thalassemia major
5318839|NCT02090699|chronic blood transfusion related iron overload|chronic blood transfusion related iron overload
5318841|NCT02090699|myocardium|myocardium
5318842|NCT02090699|fibrosis|fibrosis
5318843|NCT02090647|dental implant, aesthetic, implant abutment|dental implant, aesthetic, implant abutment
5318845|NCT02090634|Bipolar Disorder|bipolar disorder
5318846|NCT02090634|Medication Adherence|medication adherence
5318847|NCT02090621|Liver|liver
5318848|NCT02090621|transplantation|transplantation
5318849|NCT02090621|Immunosuppression|immunosuppression
5318850|NCT02090621|photopheresis|photopheresis
5318851|NCT02090621|extracorporeal|extracorporeal
5318852|NCT02090595|bipolar disorder|bipolar disorder
5318853|NCT02090595|anxiety|anxiety
5318854|NCT02090595|mindfulness|mindfulness
5318855|NCT02090595|high risk|high risk
5318856|NCT02090595|cognitive behavioral|cognitive behavioral
5318857|NCT02090569|Functional micro-Doppler Sonography, fmDS, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics|functional micro-doppler sonography, fmds, dysplasia, epilepsy, neurosurgery, cerebral blood volume, echography, hemodynamics
5318860|NCT02090517|Nasal telangiectasis|nasal telangiectasis
5318861|NCT02090504|alcohol withdrawal syndrome|alcohol withdrawal syndrome
5318862|NCT02090504|treatment|treatment
5318863|NCT02090504|sodium oxybate|sodium oxybate
5318864|NCT02090504|oxazepam|oxazepam
5318865|NCT02090491|autism|autism
5318866|NCT02090465|Actinic Keratosis|actinic keratosis
5318867|NCT02090452|Telemedicine|telemedicine
5318868|NCT02090452|Mobile|mobile
5318869|NCT02090452|Vital signs|vital signs
5318870|NCT02090452|Prehospital care|prehospital care
5318871|NCT02090452|Emergency medicine|emergency medicine
5318872|NCT02090413|multiple sclerosis|multiple sclerosis
5318873|NCT02090413|flushing|flushing
5318874|NCT02090413|aspirin|aspirin
5318875|NCT02090400|Women|women
5318876|NCT02090400|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5318877|NCT02090400|Bazedoxifene|bazedoxifene
5318878|NCT02090400|BMD|bmd
5318879|NCT02090374|Allergy|allergy
5318880|NCT02090374|Asthma|asthma
5318881|NCT02090374|Biomarkers|biomarkers
5318882|NCT02090374|Chemokines|chemokines
5318883|NCT02090374|Cytokines|cytokines
5318884|NCT02090374|Eosinophil|eosinophil
5318885|NCT02090374|Gene Expression|gene expression
5318886|NCT02090374|Grass pollen|grass pollen
5318887|NCT02090374|Hay Fever|hay fever
5318888|NCT02090374|Human Challenge Study|human challenge study
5318889|NCT02090374|Inflammation|inflammation
5318890|NCT02090374|Innate Immune Response|innate immune response
5318891|NCT02090374|Lipopolysaccharide|lipopolysaccharide
5318892|NCT02090374|Mucosal Lining Fluid|mucosal lining fluid
5318893|NCT02090374|Nasal|nasal
5318894|NCT02090374|Nasorption|nasorption
5318895|NCT02090374|Respiratory|respiratory
5318896|NCT02090374|Respiratory Tract Infection|respiratory tract infection
5318897|NCT02090374|T cells|t cells
5318898|NCT02090374|Tuberculosis|tuberculosis
5318899|NCT02090374|Virus|virus
5318900|NCT02090361|collagen -elastin matrix|collagen -elastin matrix
5318901|NCT02090361|skin graft|skin graft
5318903|NCT02090335|community mental health|community mental health
5318904|NCT02090335|health coach|health coach
5318905|NCT02090335|weight loss|weight loss
5318906|NCT02090335|fitness|fitness
5318907|NCT02090335|serious mental illness|serious mental illness
5318908|NCT02090335|health promotion|health promotion
5318909|NCT02090322|ROP|rop
5318910|NCT02090322|Bevacizumab|bevacizumab
5318911|NCT02090322|No inferiority|no inferiority
5318912|NCT02090283|Amicus Therapeutics|amicus therapeutics
5318913|NCT02090283|Scioderm, Inc.|scioderm, inc.
5318914|NCT02090283|Recessive Dystrophic|recessive dystrophic
5318915|NCT02090283|Junctional non-Herlitz|junctional non-herlitz
5318916|NCT02090283|Epidermolysis Bullosa|epidermolysis bullosa
5318917|NCT02090283|Simplex|simplex
5318918|NCT02090283|SD-101 6%|sd-101 6%
5318919|NCT02090283|SD-101-6.0|sd-101-6.0
5318920|NCT02090283|Allantoin 6%|allantoin 6%
5318921|NCT02090283|Zorblisa|zorblisa
5318922|NCT02090270|hair cortisol|hair cortisol
5318923|NCT02090270|stroke|stroke
5318924|NCT02090257|Heart transplant recipients who are entering into adult care.|heart transplant recipients who are entering into adult care.
5318925|NCT02090244|PTH|pth
5318926|NCT02090244|Spinal stenosis|spinal stenosis
5318927|NCT02090244|Teriparatide|teriparatide
5318928|NCT02090231|stroke|stroke
5318929|NCT02090231|dysphagia|dysphagia
5318930|NCT02090231|rTMS|rtms
5318931|NCT02090205|cardio-pulmonary bypass|cardio-pulmonary bypass
5318932|NCT02090205|cardiac surgery|cardiac surgery
5318933|NCT02090205|lung injury prevention|lung injury prevention
5318934|NCT02090205|mechanical ventilation|mechanical ventilation
5318935|NCT02090205|pulmonary insufficiency|pulmonary insufficiency
5318936|NCT02090192|Whole-body vibration;|whole-body vibration;
5318937|NCT02090192|Frail Elderly;|frail elderly;
5318938|NCT02090192|Blood flow;|blood flow;
5318939|NCT02090192|Bone density|bone density
5318940|NCT02090192|Mobility;|mobility;
5318941|NCT02090192|Balance;|balance;
5318942|NCT02090192|Muscle strength;|muscle strength;
5318943|NCT02090192|Lower Extremity;|lower extremity;
5318944|NCT02090192|Musculoskeletal System;|musculoskeletal system;
5318945|NCT02090192|Health Status;|health status;
5318946|NCT02090192|Exercise;|exercise;
5318947|NCT02090192|Mechanical Oscillation|mechanical oscillation
5318948|NCT02090179|MPS IIIB|mps iiib
5318949|NCT02090179|Mucopolysaccharidosis|mucopolysaccharidosis
5318950|NCT02090179|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
5318951|NCT02090179|Sanfilippo Syndrome|sanfilippo syndrome
5318952|NCT02090179|Metabolism, Inborn Errors|metabolism, inborn errors
5318953|NCT02090179|Metabolic Diseases|metabolic diseases
5318954|NCT02090179|Genetic Diseases, Inborn|genetic diseases, inborn
5318955|NCT02090153|Advance Gastric Cancer,|advance gastric cancer,
5318956|NCT02090153|S-1 plus leucovorin,|s-1 plus leucovorin,
5318957|NCT02090153|ORR,|orr,
5318958|NCT02090153|OS,|os,
5318959|NCT02090153|TTP,|ttp,
5318960|NCT02090153|TTF,|ttf,
5318961|NCT02090153|Adverse events,|adverse events,
5318962|NCT02090153|Pharmacokinetics|pharmacokinetics
5318963|NCT02090140|cartilage/transplantation|cartilage/transplantation
5318964|NCT02090140|cartilage, articular/injuries|cartilage, articular/injuries
5318965|NCT02090140|cartilage, articular/surgery|cartilage, articular/surgery
5318966|NCT02090140|chondrocytes/cytology|chondrocytes/cytology
5318967|NCT02090140|knee injuries/surgery|knee injuries/surgery
5318968|NCT02090140|knee joint/surgery|knee joint/surgery
5318969|NCT02090140|orthopedic procedures/methods|orthopedic procedures/methods
5318970|NCT02090140|tissue engineering|tissue engineering
5318971|NCT02090140|tissue scaffolds|tissue scaffolds
5318972|NCT02090140|arthroscopy/methods|arthroscopy/methods
5318973|NCT02090140|chondrocytes/transplantation|chondrocytes/transplantation
5318974|NCT02090140|adipose tissue/cytology|adipose tissue/cytology
5318975|NCT02090140|cartilage, articular/cytology|cartilage, articular/cytology
5318976|NCT02090140|chondrogenesis/physiology|chondrogenesis/physiology
5318977|NCT02090140|osteogenesis/physiology|osteogenesis/physiology
5318978|NCT02090140|stem cell transplantation/methods|stem cell transplantation/methods
5318979|NCT02090140|stem cells|stem cells
5318980|NCT02090140|tissue engineering/methods|tissue engineering/methods
5318981|NCT02090140|cartilage, articular/pathology|cartilage, articular/pathology
5318982|NCT02090140|chondrocytes/pathology|chondrocytes/pathology
5318983|NCT02090140|knee joint/pathology|knee joint/pathology
5318984|NCT02090140|platelet-rich plasma|platelet-rich plasma
5318985|NCT02090114|Bipolar Androgen Therapy|bipolar androgen therapy
5318986|NCT02090114|Testosterone|testosterone
5318987|NCT02090114|Enzalutamide|enzalutamide
5318988|NCT02090114|Abiraterone|abiraterone
5318989|NCT02090114|Androgen Ablative Therapies|androgen ablative therapies
5318990|NCT02090075|cardiac Computed tomography|cardiac computed tomography
5318991|NCT02090075|coronary calcification|coronary calcification
5318992|NCT02090075|intervention|intervention
5318993|NCT02090075|warfarin|warfarin
5318994|NCT02090075|apixaban|apixaban
5318995|NCT02090062|endoscopic resection|endoscopic resection
5318996|NCT02090062|H. pylori infection|h. pylori infection
5318997|NCT02090049|Appetite|appetite
5319000|NCT02090049|Dietary fiber|dietary fiber
5319001|NCT02090049|Gastrointestinal hormones|gastrointestinal hormones
5319002|NCT02090049|Glycemia|glycemia
5319003|NCT02090049|Insulinemia|insulinemia
5319004|NCT02090036|Efficacy|efficacy
5319005|NCT02090036|Safety|safety
5319006|NCT02090036|Primaquine|primaquine
5319007|NCT02090036|Artemether-lumefantrine|artemether-lumefantrine
5319008|NCT02090036|Gametocytes|gametocytes
5319009|NCT02090023|Obstructive sleep apnea|obstructive sleep apnea
5319010|NCT02090023|National Health Insurance Research Database in Taiwan|national health insurance research database in taiwan
5319011|NCT02090023|Survival Analysis|survival analysis
5319012|NCT02090023|Validation Studies|validation studies
5319013|NCT02090023|Cohort Studies|cohort studies
5319014|NCT02089997|Pharmacological therapy|pharmacological therapy
5319015|NCT02089984|Cognitive Behavior Therapy|cognitive behavior therapy
5319016|NCT02089984|On-line training|on-line training
5319017|NCT02089958|Lapraoscopy, incisional hernia repair, mesh|lapraoscopy, incisional hernia repair, mesh
5319018|NCT02089945|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5319019|NCT02089945|severe aortic stenosis|severe aortic stenosis
5319020|NCT02089945|cognition|cognition
5319021|NCT02089945|functional capacity|functional capacity
5319022|NCT02089945|quality of life|quality of life
5319023|NCT02089932|femoral nerve block|femoral nerve block
5319024|NCT02089932|peri-neural dexmedetomidine|peri-neural dexmedetomidine
5319025|NCT02089867|Ezetimibe|ezetimibe
5319026|NCT02089867|Plant sterol|plant sterol
5319027|NCT02089867|Hydroxymethylglutaryl coenzyme A Reductase Inhibitors|hydroxymethylglutaryl coenzyme a reductase inhibitors
5319028|NCT02089867|Coronary artery disease|coronary artery disease
5319029|NCT02089867|LDL-cholesterol|ldl-cholesterol
5319030|NCT02089854|triple negative breast cancer|triple negative breast cancer
5319031|NCT02089854|estrogen receptor-beta|estrogen receptor-beta
5319032|NCT02089854|endocrine therapy|endocrine therapy
5319033|NCT02089841|Efficacy|efficacy
5319034|NCT02089841|Artemether/lumefantrine|artemether/lumefantrine
5319035|NCT02089841|Malaria|malaria
5319036|NCT02089841|Children|children
5319038|NCT02089789|Thrombosis|thrombosis
5319039|NCT02089789|Intellectual Disability|intellectual disability
5319040|NCT02089789|Hypotonia|hypotonia
5319041|NCT02089789|Hypoglycemia|hypoglycemia
5319042|NCT02089789|Hypothyroidism|hypothyroidism
5319043|NCT02089776|Stroke|stroke
5319044|NCT02089776|fMRI|fmri
5319045|NCT02089776|Real Time fMRI Feedback|real time fmri feedback
5319046|NCT02089763|Hepatocellular carcinoma|hepatocellular carcinoma
5319047|NCT02089763|HCC|hcc
5319048|NCT02089763|Pegylated recombinant human arginase|pegylated recombinant human arginase
5319049|NCT02089763|PEG-BCT-100|peg-bct-100
5319050|NCT02089763|ASS|ass
5319051|NCT02089763|OTC|otc
5319052|NCT02089750|Low Back Pain|low back pain
5319053|NCT02089750|Chiropractic|chiropractic
5319054|NCT02089750|Shoe Orthotics|shoe orthotics
5319055|NCT02089711|Normal subjects|normal subjects
5319056|NCT02089698|Kelman tip|kelman tip
5319057|NCT02089698|Mini-flared|mini-flared
5319058|NCT02089698|phacoemulsification|phacoemulsification
5319059|NCT02089698|cataract|cataract
5319060|NCT02089633|hepatocellular carcinoma|hepatocellular carcinoma
5319061|NCT02089633|HCC|hcc
5356888|NCT01917591|Soft Tissue Injuries|soft tissue injuries
5319062|NCT02089633|pegylated recombinant human arginase|pegylated recombinant human arginase
5319063|NCT02089633|PEG-BCT-100|peg-bct-100
5319064|NCT02089633|oxaliplatin|oxaliplatin
5199633|NCT02746445|ASD|asd
5319065|NCT02089633|capecitabine|capecitabine
5319066|NCT02089620|Premenstrual syndrome|premenstrual syndrome
5319067|NCT02089620|Oral contraceptive pills|oral contraceptive pills
5319068|NCT02089620|Calcium Supplements|calcium supplements
5319069|NCT02089594|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
5319070|NCT02089594|Mild Traumatic Brain Injury|mild traumatic brain injury
5319071|NCT02089594|Persistent Post-Concussion Syndrome|persistent post-concussion syndrome
5319072|NCT02089581|Healthy Volunteer|healthy volunteer
5319073|NCT02089581|Pharmacokinetics|pharmacokinetics
5319074|NCT02089581|Bioequivalence|bioequivalence
5319075|NCT02089568|Living donation|living donation
5319076|NCT02089568|Antibiotics|antibiotics
5319077|NCT02089568|Laparoscopic surgery|laparoscopic surgery
5319078|NCT02089542|thyroidectomy|thyroidectomy
5319079|NCT02089542|parathyroid surgery|parathyroid surgery
5319080|NCT02089542|parathyroid identification|parathyroid identification
5319081|NCT02089542|methylene blue|methylene blue
5319082|NCT02089542|near infrared fluorescence|near infrared fluorescence
5319083|NCT02089542|intraoperative imaging|intraoperative imaging
5319084|NCT02089529|Axial Spondyloarthritis|axial spondyloarthritis
5319085|NCT02089529|Pain|pain
5319086|NCT02089529|NSAIDs|nsaids
5319087|NCT02089529|Placebo|placebo
5319088|NCT02089529|Placebo intervention|placebo intervention
5319089|NCT02089529|Stress|stress
5319090|NCT02089529|Conditioning|conditioning
5319091|NCT02089516|Frailty|frailty
5319092|NCT02089516|Accelerometry|accelerometry
5319093|NCT02089516|Physical activity|physical activity
5319094|NCT02089516|validity|validity
5315646|NCT02105506|Esophagus|esophagus
5319099|NCT02089360|Advanced glycation end product|advanced glycation end product
5319100|NCT02089360|coronary|coronary
5319101|NCT02089360|atherosclerosis|atherosclerosis
5319102|NCT02089360|inflammation|inflammation
5319103|NCT02089360|outcome|outcome
5319104|NCT02089347|Tetanus|tetanus
5319105|NCT02089347|Diphtheria|diphtheria
5319106|NCT02089347|Pertussis|pertussis
5319107|NCT02089347|TdaP vaccine|tdap vaccine
5319108|NCT02089347|DT vaccine|dt vaccine
5319109|NCT02089334|renal cell carcinoma|renal cell carcinoma
5319110|NCT02089334|clear cell|clear cell
5319111|NCT02089334|renal cancer|renal cancer
5319112|NCT02089334|metastatic renal cancer|metastatic renal cancer
5319113|NCT02089334|Carcinoma, Renal Cell*/therapy|carcinoma, renal cell*/therapy
5319114|NCT02089334|Humans|humans
5319115|NCT02089334|Kidney Neoplasms*/therapy|kidney neoplasms*/therapy
5319116|NCT02089321|low back pain|low back pain
5319117|NCT02089321|lumbopelvic assessment|lumbopelvic assessment
5319118|NCT02089321|active straight leg raise|active straight leg raise
5319119|NCT02089321|active hip abduction|active hip abduction
5319120|NCT02089308|Smoking cessation|smoking cessation
5319121|NCT02089308|Nicotine|nicotine
5319122|NCT02089308|Tobacco Use Disorder|tobacco use disorder
5319123|NCT02089308|Central Nervous System Agents|central nervous system agents
5319124|NCT02089295|dose proportionality|dose proportionality
5319125|NCT02089295|oxycodone|oxycodone
5319126|NCT02089269|pancreatic neoplasms|pancreatic neoplasms
5319127|NCT02089269|neoplasms|neoplasms
5319128|NCT02089269|registry|registry
5319129|NCT02089269|advanced pancreatic cancer|advanced pancreatic cancer
5319130|NCT02089269|health services research|health services research
5319131|NCT02089269|epidemiology|epidemiology
5319132|NCT02089269|Germany|germany
5319133|NCT02089269|palliative treatment|palliative treatment
5319134|NCT02089269|palliative care|palliative care
5319135|NCT02089269|localized, resectable pancreatic cancer|localized, resectable pancreatic cancer
5319136|NCT02089269|adjuvant treatment|adjuvant treatment
5319433|NCT02087618|Tablet|tablet
5319137|NCT02089243|Epilepsy,Temporal Lobe|epilepsy,temporal lobe
5319138|NCT02089243|Brain Diseases|brain diseases
5319139|NCT02089230|Leukemia|leukemia
5319140|NCT02089230|Acute Myeloid Leukemia|acute myeloid leukemia
5319142|NCT02089230|Advanced leukemias|advanced leukemias
5319143|NCT02089230|Myelodysplastic syndrome|myelodysplastic syndrome
5319144|NCT02089230|MDS|mds
5319145|NCT02089230|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5319146|NCT02089230|ALL|all
5319147|NCT02089230|Relapsed|relapsed
5319148|NCT02089230|Refractory|refractory
5319149|NCT02089230|MEK 162|mek 162
5319150|NCT02089217|asymptomatic|asymptomatic
5319151|NCT02089217|carotid|carotid
5319152|NCT02089217|stent|stent
5319153|NCT02089217|endarterectomy|endarterectomy
5319154|NCT02089217|embolic protection|embolic protection
5319155|NCT02089217|medical management|medical management
5319156|NCT02089217|hypertension|hypertension
5319157|NCT02089217|hyperlipidemia|hyperlipidemia
5319158|NCT02089217|cognition|cognition
5319159|NCT02089217|risk factor control|risk factor control
5319160|NCT02089204|Hypoxia Imaging -Guided Radiotherapy|hypoxia imaging -guided radiotherapy
5319161|NCT02089204|PET/CT|pet/ct
5319162|NCT02089204|simultaneous modulated accelerated radiation therapy (SMART)|simultaneous modulated accelerated radiation therapy (smart)
5319163|NCT02089191|DACP|dacp
5963180|NCT04267822|LRTI|lrti
5319164|NCT02089191|DAILIES® AquaComfort Plus|dailies® aquacomfort plus
5319165|NCT02089191|Tear film stability|tear film stability
5319166|NCT02089191|NIK-BUT|nik-but
5319167|NCT02089178|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor|total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor
5319168|NCT02089152|Diabetes|diabetes
5319169|NCT02089152|Melioidosis|melioidosis
5319170|NCT02089152|stepped wedge trial|stepped wedge trial
5319171|NCT02089152|behaviour change|behaviour change
5319172|NCT02089152|Education program|education program
5319173|NCT02089139|Back pain|back pain
5319174|NCT02089139|Discogel|discogel
5319175|NCT02089087|Rheumatoid arthritis, RA, first-in-human, single ascending dose, safety, tolerability|rheumatoid arthritis, ra, first-in-human, single ascending dose, safety, tolerability
5319176|NCT02089074|Secondary Prevention|secondary prevention
5319177|NCT02089074|Pharmacists|pharmacists
5319178|NCT02089074|Directive Counseling|directive counseling
5319179|NCT02089074|Medication Adherence|medication adherence
5319180|NCT02089074|Patient Compliance|patient compliance
5319181|NCT02089048|Amebiasis|amebiasis
5319182|NCT02089048|auranofin|auranofin
5319183|NCT02089048|pharmacodynamics|pharmacodynamics
5319184|NCT02089048|pharmokinetics|pharmokinetics
5319185|NCT02089035|Milk fatty acids|milk fatty acids
5319196|NCT02088970|Corneal cross linking|corneal cross linking
5319197|NCT02088970|Topical antibiotics|topical antibiotics
5319198|NCT02088957|Brivaracetam|brivaracetam
5319199|NCT02088957|Phenytoin|phenytoin
5319200|NCT02088957|Nonconvulsive electrographic seizures|nonconvulsive electrographic seizures
5319201|NCT02088931|Tregs|tregs
5319202|NCT02088931|Kidney transplantation|kidney transplantation
5319203|NCT02088905|PCIT, autism, parent training, noncompliance|pcit, autism, parent training, noncompliance
5319204|NCT02088892|BCG challenge study|bcg challenge study
5319205|NCT02088866|Tinnitus|tinnitus
5319206|NCT02088866|Otolaryngology|otolaryngology
5319207|NCT02088853|intestinal|intestinal
5319208|NCT02088853|metabolic control|metabolic control
5319209|NCT02088853|mucosa|mucosa
5319210|NCT02088853|human|human
5319211|NCT02088853|diet|diet
5319212|NCT02088840|SIGNB|signb
5319213|NCT02088840|severe infections gram negative bacteria|severe infections gram negative bacteria
5319214|NCT02088840|stem cell transplant|stem cell transplant
5319215|NCT02088827|Exercise|exercise
5319216|NCT02088827|Sedentary Behaviour|sedentary behaviour
5319217|NCT02088827|Type 2 Diabetes|type 2 diabetes
5319218|NCT02088827|Older Adults|older adults
5319219|NCT02088814|posttraumatic stress|posttraumatic stress
5319220|NCT02088814|burns|burns
5319221|NCT02088814|injuries|injuries
5319222|NCT02088814|children|children
5319223|NCT02088801|Intubation; Difficult|intubation; difficult
5319224|NCT02088788|radiation|radiation
5319225|NCT02088788|radiation injury|radiation injury
5319226|NCT02088788|occupational risk|occupational risk
5319227|NCT02088762|margin of safety|margin of safety
5319228|NCT02088749|obesity|obesity
5319229|NCT02088749|weight loss|weight loss
5319230|NCT02088749|treatment|treatment
5319231|NCT02088749|lifestyle|lifestyle
5319232|NCT02088723|Sleep Apnea, Obstructive|sleep apnea, obstructive
5319233|NCT02088723|Sleep Apnea Syndromes|sleep apnea syndromes
5319234|NCT02088723|Polysomnography|polysomnography
5319235|NCT02088723|Sleep|sleep
5319239|NCT02088710|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
5319241|NCT02088710|Psycho-oncology|psycho-oncology
5319242|NCT02088710|Satisfaction with information|satisfaction with information
5319243|NCT02088684|Hormone receptor positive, HER2 negative|hormone receptor positive, her2 negative
5319249|NCT02088658|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5319250|NCT02088658|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5319251|NCT02088658|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5319252|NCT02088658|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
5319253|NCT02088658|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5319254|NCT02088658|African Americans|african americans
5319255|NCT02088658|Blacks|blacks
5319256|NCT02088658|non-Hispanic Blacks|non-hispanic blacks
5319257|NCT02088658|Randomized Control Trial|randomized control trial
5319258|NCT02088658|Controlled Clinical Trial|controlled clinical trial
5319259|NCT02088658|Behavioral Research|behavioral research
5319260|NCT02088658|Behavioral Medicine|behavioral medicine
5319261|NCT02088645|Calcitonin|calcitonin
5319262|NCT02088645|Medullary thyroid carcinoma|medullary thyroid carcinoma
5319263|NCT02088645|Peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
5319264|NCT02088645|Gastrin|gastrin
5319265|NCT02088645|Cholecystokinin-2 receptor|cholecystokinin-2 receptor
5319266|NCT02088619|psychological wellbeing|psychological wellbeing
5319267|NCT02088619|anxiety|anxiety
5319268|NCT02088619|depression|depression
5319269|NCT02088619|autonomic functioning|autonomic functioning
5319270|NCT02088593|Medical Students|medical students
5319271|NCT02088541|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
5319272|NCT02088541|Acute Myeloid Leukemia|acute myeloid leukemia
5319274|NCT02088541|Karyopharm|karyopharm
5319275|NCT02088541|Selinexor|selinexor
5319276|NCT02088541|KPT-330|kpt-330
5319277|NCT02088515|Nedaplatin|nedaplatin
5319278|NCT02088515|lung squamous cell carcinoma|lung squamous cell carcinoma
5319279|NCT02088502|Coronary Angiography|coronary angiography
5319280|NCT02088502|Side Effects|side effects
5319281|NCT02088502|Contrast-Induced Nephropathy|contrast-induced nephropathy
5315837|NCT02104557|Sayana|sayana
5319283|NCT02088489|Atrial flutter|atrial flutter
5319284|NCT02088489|Thermocool catheter|thermocool catheter
5319285|NCT02088489|Thermocool SF catheter|thermocool sf catheter
5319286|NCT02088476|candidemia|candidemia
5319287|NCT02088476|children|children
5319288|NCT02088476|mortality|mortality
5319289|NCT02088476|risk factors|risk factors
5319290|NCT02088463|Mechanical LBP|mechanical lbp
5319291|NCT02088463|Mobilization|mobilization
5319292|NCT02088463|Postpartum|postpartum
5319293|NCT02088450|Cardiovascular complications|cardiovascular complications
5319294|NCT02088450|Clinical trial|clinical trial
5319295|NCT02088450|Elderly|elderly
5319296|NCT02088450|Isolated systolic hypertension|isolated systolic hypertension
5319297|NCT02088450|Stroke|stroke
5319298|NCT02088398|relative bioavailability|relative bioavailability
5319299|NCT02088398|food-effect|food-effect
5319300|NCT02088359|cycled light, near darkness, growth|cycled light, near darkness, growth
5319301|NCT02088346|Stroke|stroke
5319302|NCT02088346|Thrombolysis|thrombolysis
5319303|NCT02088346|Tissue plasminogen activator|tissue plasminogen activator
5319304|NCT02088346|Urokinase|urokinase
5319305|NCT02088346|Telemedicine|telemedicine
5319306|NCT02088333|colorectal cancer screening|colorectal cancer screening
5319307|NCT02088333|computer-assisted instruction|computer-assisted instruction
5319308|NCT02088333|mHealth|mhealth
5319309|NCT02088333|text message|text message
5319310|NCT02088307|cardiovascular supplement|cardiovascular supplement
5319311|NCT02088307|cardiovascular disease|cardiovascular disease
5319312|NCT02088307|coronary artery disease|coronary artery disease
5319313|NCT02088294|obesity|obesity
5319314|NCT02088294|stress|stress
5319315|NCT02088294|intuitive eating|intuitive eating
5319316|NCT02088294|guided imagery|guided imagery
5319317|NCT02088294|adolescents|adolescents
5319318|NCT02088294|insulin resistance|insulin resistance
5319319|NCT02088294|latinos|latinos
5319320|NCT02088294|minorities|minorities
5319321|NCT02088281|Indigo naturalis, indirubin, Th1 cells, Th17 cells|indigo naturalis, indirubin, th1 cells, th17 cells
5319322|NCT02088255|Rehabilitation|rehabilitation
5319323|NCT02088255|Gait|gait
5319324|NCT02088255|Stroke|stroke
5319325|NCT02088255|Biomechanics|biomechanics
5319326|NCT02088229|Diabetic Macular Edema|diabetic macular edema
5319327|NCT02088216|N-acetylcysteine；|n-acetylcysteine；
5319328|NCT02088216|Bronchiectasis；|bronchiectasis；
5319329|NCT02088216|Acute exacerbations；|acute exacerbations；
5319330|NCT02088216|Antioxidant；|antioxidant；
5319331|NCT02088216|Anti-inflammatory|anti-inflammatory
5319332|NCT02088177|Cannabis|cannabis
5319621|NCT02086578|14-028|14-028
5319337|NCT02088177|Long Acting Injectable Naltrexone|long acting injectable naltrexone
5319338|NCT02088177|Treatment|treatment
5319339|NCT02088164|PSA,|psa,
5319340|NCT02088164|asian men,|asian men,
5319341|NCT02088164|survival|survival
5319342|NCT02088151|selective laser therapy|selective laser therapy
5319343|NCT02088151|retinal pigment epithelium|retinal pigment epithelium
5319344|NCT02088151|macular edema|macular edema
5319345|NCT02088151|diabetic retinopathy|diabetic retinopathy
5319346|NCT02088151|central serous chorioretinopathy|central serous chorioretinopathy
5319347|NCT02088151|age-related macular degeneration|age-related macular degeneration
5319348|NCT02088151|retinal vein occlusion|retinal vein occlusion
5319349|NCT02088138|Thoracic Surgery|thoracic surgery
5319350|NCT02088138|Electrical Stimulation|electrical stimulation
5319351|NCT02088138|Rehabilitation|rehabilitation
5319352|NCT02088138|Quality of Life|quality of life
5319353|NCT02088125|Stroke|stroke
5319354|NCT02088125|Incentive Spirometry|incentive spirometry
5319355|NCT02088125|Breath Stacking|breath stacking
5319356|NCT02088125|Optoelectronic Plethysmography|optoelectronic plethysmography
5319357|NCT02088112|NSCLC|nsclc
5319358|NCT02088099|Traumatic brain injury|traumatic brain injury
5319359|NCT02088099|Telehealth|telehealth
5319360|NCT02088099|ehealth|ehealth
5319361|NCT02088099|Mobile Health|mobile health
5319362|NCT02088099|social participation|social participation
5319363|NCT02088099|patient participation|patient participation
5319364|NCT02088099|consumer participation|consumer participation
5319365|NCT02088099|Patient Outcome Assessment|patient outcome assessment
5319366|NCT02088086|Pediatric obesity|pediatric obesity
5319367|NCT02088086|Overweight|overweight
5319368|NCT02088086|Body mass index|body mass index
5319369|NCT02088086|Primary schools|primary schools
5319370|NCT02088086|Secondary schools|secondary schools
5319371|NCT02088047|Autism|autism
5319372|NCT02088047|Self-Stimulating behaviors|self-stimulating behaviors
5319373|NCT02088047|Autism Spectrum Disorders|autism spectrum disorders
5319374|NCT02087995|Diabetes Mellitus|diabetes mellitus
5319375|NCT02087956|Women|women
5319376|NCT02087956|Depression|depression
5369176|NCT01860963|ASIL|asil
5319377|NCT02087956|Socioeconomically Disadvantaged|socioeconomically disadvantaged
5319379|NCT02087943|Atopic Dermatitis|atopic dermatitis
5319380|NCT02087943|Atopic Eczema|atopic eczema
5319381|NCT02087917|hypercholesterolemia|hypercholesterolemia
5319382|NCT02087917|cholesterol absorption inhibitor|cholesterol absorption inhibitor
5315934|NCT02104115|Small bowel|small bowel
5319394|NCT02087813|neuromyelitis optica|neuromyelitis optica
5319395|NCT02087813|optic neuritis|optic neuritis
5319396|NCT02087813|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
5319397|NCT02087800|smoking cessation|smoking cessation
5319398|NCT02087800|smoking abstinence|smoking abstinence
5319399|NCT02087800|allopregnanolone|allopregnanolone
5319400|NCT02087787|bone marrow transplant|bone marrow transplant
5319401|NCT02087787|hematologic malignancies|hematologic malignancies
5319402|NCT02087761|ARIES Flu|aries flu
5319404|NCT02087735|Cranberry|cranberry
5319405|NCT02087735|Proanthocyanidins|proanthocyanidins
5319406|NCT02087735|Urinary catabolites|urinary catabolites
5319407|NCT02087722|Primary Insomnia|primary insomnia
5319408|NCT02087696|Arthritis, Rheumatoid|arthritis, rheumatoid
5319409|NCT02087696|methotrexate|methotrexate
5319410|NCT02087696|intolerance|intolerance
5319411|NCT02087696|poor compliance|poor compliance
5319412|NCT02087696|contraindication|contraindication
5319413|NCT02087696|Tocilizumab|tocilizumab
5319414|NCT02087696|monotherapy|monotherapy
5319415|NCT02087683|heart failure|heart failure
5319416|NCT02087683|vitamin D deficiency|vitamin d deficiency
5319417|NCT02087683|ventricular function|ventricular function
5319418|NCT02087683|cytokines|cytokines
5319419|NCT02087670|chronic heart failure|chronic heart failure
5319420|NCT02087670|cardiac rehabilitation|cardiac rehabilitation
5319421|NCT02087670|exercise|exercise
5319422|NCT02087670|Natriuretic Brain Pro-peptid|natriuretic brain pro-peptid
5319423|NCT02087657|Peripheral Blood Stem Cell (PBSC) Transplant|peripheral blood stem cell (pbsc) transplant
5319424|NCT02087657|Hyperbaric oxygen|hyperbaric oxygen
5319425|NCT02087657|Lymphoma|lymphoma
5319426|NCT02087657|Myeloma|myeloma
5319427|NCT02087631|multiple sclerosis|multiple sclerosis
5319428|NCT02087631|quetiapine|quetiapine
5319429|NCT02087631|remyelination|remyelination
5319430|NCT02087618|MCI|mci
5319431|NCT02087618|Alzheimer's|alzheimer's
5319432|NCT02087618|Dementia|dementia
5319436|NCT02087605|Vascular stiffness, retinal vessels, target organ damage|vascular stiffness, retinal vessels, target organ damage
5319437|NCT02087592|hereditary breast and ovarian cancer (HBOC)|hereditary breast and ovarian cancer (hboc)
5319438|NCT02087592|BRCA1/2 mutation carriers|brca1/2 mutation carriers
5319439|NCT02087592|Mediterranean diet|mediterranean diet
5319440|NCT02087592|Structured exercise training|structured exercise training
5319441|NCT02087592|prevention|prevention
5319442|NCT02087579|Psychotic Disorders|psychotic disorders
5319443|NCT02087579|Schizophrenia|schizophrenia
5319444|NCT02087579|Bipolar Disorder|bipolar disorder
5319445|NCT02087579|Depressive Disorder|depressive disorder
5319446|NCT02087579|Antipsychotics|antipsychotics
5319447|NCT02087579|Aripiprazole|aripiprazole
5319448|NCT02087579|Olanzapine|olanzapine
5319449|NCT02087579|Paliperidone|paliperidone
5319450|NCT02087579|Quetiapine|quetiapine
5319451|NCT02087579|Risperidone|risperidone
5319452|NCT02087579|Capillary Concentration|capillary concentration
5319453|NCT02087566|Linezolid|linezolid
5319454|NCT02087566|Pharmacokinetics|pharmacokinetics
5319455|NCT02087566|Haemodialysis|haemodialysis
5319456|NCT02087566|Dosing adjustment|dosing adjustment
5319457|NCT02087566|Eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (CLcr) values or HD status.|eligible subjects were classified into three groups depending on their 24-h urinary creatinine clearance (clcr) values or hd status.
5319458|NCT02087566|Group 1, included 6 healthy subjects with normal renal function (CLcr ˃80 ml/min);|group 1, included 6 healthy subjects with normal renal function (clcr ˃80 ml/min);
5319459|NCT02087566|Group 2, included 6 patients with acute renal failure (RF) (30˂CLcr˂80 ml/mine);|group 2, included 6 patients with acute renal failure (rf) (30˂clcr˂80 ml/mine);
5319460|NCT02087566|Group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)|group 3, included 6 patients on long term haemodialysis (minimum period of dialysis was 40 month while maximum period were 130 month)
5319461|NCT02087553|Blood Transfusion|blood transfusion
5319463|NCT02087553|Packed Red Blood Cells|packed red blood cells
5319464|NCT02087553|PRBC|prbc
5319465|NCT02087553|NTBI|ntbi
5319466|NCT02087527|Cellulitis|cellulitis
5319467|NCT02087527|Soft Tissue Infections|soft tissue infections
5319468|NCT02087527|Skin Diseases, Infectious|skin diseases, infectious
5319469|NCT02087527|Corticosteroids|corticosteroids
5319470|NCT02087527|Glucocorticoids|glucocorticoids
5319471|NCT02087527|Dexamethasone|dexamethasone
5319472|NCT02087514|Blood Transfusion|blood transfusion
5319473|NCT02087514|Iron|iron
5319474|NCT02087514|Red Blood Cells|red blood cells
5319475|NCT02087501|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5319483|NCT02087462|Electroacupuncture|electroacupuncture
5319484|NCT02087462|Intervertebral disc displacement|intervertebral disc displacement
5319485|NCT02087423|Locally advanced, metastatic, Non-Small Cell Lung Cancer, MEDI4736, Durvalumab, PD-L1|locally advanced, metastatic, non-small cell lung cancer, medi4736, durvalumab, pd-l1
5319486|NCT02087397|Stem Cell|stem cell
5319487|NCT02087397|Erectile Dysfunction|erectile dysfunction
5319490|NCT02087384|HPV|hpv
5319491|NCT02087384|Vaccination|vaccination
5319492|NCT02087384|Gardasil|gardasil
5319493|NCT02087384|Prophylactic|prophylactic
5319494|NCT02087358|alcohol dependence|alcohol dependence
5319495|NCT02087358|Stress- correlation|stress- correlation
5319497|NCT02087358|CRHR1|crhr1
5319498|NCT02087332|Kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring|kidney damage hypertension cardiovascular diseases, congestive heart failure renal function natriuresis natriuresis monitoring
5319500|NCT02087241|Stage IV Lung Cancer|stage iv lung cancer
5319501|NCT02087228|Endometrial ablation, menorrhagia|endometrial ablation, menorrhagia
5319502|NCT02087215|diabetes mellitus|diabetes mellitus
5319503|NCT02087215|foot ulcer|foot ulcer
5319504|NCT02087215|boron|boron
5319505|NCT02087215|wound care|wound care
5319506|NCT02087202|pain|pain
5319507|NCT02087189|ICD, CRT-D, lead|icd, crt-d, lead
5319508|NCT02087176|NSCLC|nsclc
5319509|NCT02087137|aging|aging
5319510|NCT02087137|memory|memory
5319511|NCT02087137|memory training|memory training
5319512|NCT02087124|Whey protein|whey protein
5319513|NCT02087124|Postprandial lipaemia|postprandial lipaemia
5319514|NCT02087124|Pre-meal|pre-meal
5319515|NCT02087124|Metabolic syndrome|metabolic syndrome
5319516|NCT02087111|Telaprevir|telaprevir
5319517|NCT02087111|Genotype 3 HCV|genotype 3 hcv
5319518|NCT02087098|overactive bladder|overactive bladder
5319519|NCT02087098|solifenacin|solifenacin
5319520|NCT02087098|quality of life|quality of life
5319521|NCT02087072|home visits|home visits
5319522|NCT02087072|transitions of care|transitions of care
5319523|NCT02087072|pharmacist|pharmacist
5319524|NCT02087059|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
5319525|NCT02087059|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
5319526|NCT02087033|supraventricular ectopic beats|supraventricular ectopic beats
5319527|NCT02087020|Joint Prosthesis|joint prosthesis
5319528|NCT02087020|Prosthesis-Related Infections|prosthesis-related infections
5319529|NCT02087020|Joint Diseases|joint diseases
5319530|NCT02087020|Therapeutic Irrigation|therapeutic irrigation
5319531|NCT02087020|Prostheses and Implants|prostheses and implants
5319532|NCT02087020|Arthroplasty Replacement|arthroplasty replacement
5319533|NCT02087007|Treatment for vasospastic angina|treatment for vasospastic angina
5319534|NCT02086994|carbetocin, misoprostol, pre-eclampsia, pph|carbetocin, misoprostol, pre-eclampsia, pph
5319535|NCT02086955|Diabetes|diabetes
5319536|NCT02086955|Nursing counseling|nursing counseling
5319537|NCT02086955|Foot ulceration|foot ulceration
5319538|NCT02086955|Outpatient|outpatient
5319539|NCT02086955|Advanced Practice Nurse|advanced practice nurse
5319540|NCT02086929|Trazodone|trazodone
5319541|NCT02086929|Venlafaxine|venlafaxine
5319542|NCT02086929|Major depressive disorder|major depressive disorder
5319543|NCT02086916|Clostridium difficile|clostridium difficile
5319544|NCT02086916|Prediction|prediction
5319545|NCT02086916|Treatment|treatment
5319546|NCT02086916|Failure|failure
5319547|NCT02086903|Ticagrelor|ticagrelor
5319548|NCT02086903|Clopidogrel|clopidogrel
5319549|NCT02086903|Platelet function test|platelet function test
5319550|NCT02086890|retinitis pigmentosa|retinitis pigmentosa
5319551|NCT02086890|acupuncture|acupuncture
5319552|NCT02086890|electroacupuncture|electroacupuncture
5319553|NCT02086890|transcorneal electrical stimulation|transcorneal electrical stimulation
5319555|NCT02086864|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5319556|NCT02086864|ADHD|adhd
5319557|NCT02086864|Homeopathy|homeopathy
5319558|NCT02086851|pediatric obesity|pediatric obesity
5319559|NCT02086851|motivational interviewing|motivational interviewing
5319560|NCT02086851|lifestyle intervention|lifestyle intervention
5319561|NCT02086838|Iron deficiency anemia|iron deficiency anemia
5319562|NCT02086838|Pregnancy|pregnancy
5319563|NCT02086838|Iron therapy|iron therapy
5319564|NCT02086799|asthma|asthma
5319565|NCT02086799|thyroid hormones|thyroid hormones
5319566|NCT02086799|treatment|treatment
5319567|NCT02086799|asthma exacerbation|asthma exacerbation
5319568|NCT02086773|Acute Leukemia|acute leukemia
5319569|NCT02086773|Red Cell Transfusion|red cell transfusion
5319570|NCT02086760|hydronephrosis|hydronephrosis
5319571|NCT02086747|Abdominal Hysterectomy, Acetaminophen, chronic pain|abdominal hysterectomy, acetaminophen, chronic pain
5319572|NCT02086734|Perfusion-CT|perfusion-ct
5319573|NCT02086734|mRCC|mrcc
5319574|NCT02086734|antiangiogenic therapy|antiangiogenic therapy
5319575|NCT02086734|response assessment|response assessment
5319576|NCT02086708|Sonoelastography,|sonoelastography,
5319577|NCT02086708|Diffuse liver disease,|diffuse liver disease,
5319578|NCT02086708|chronic liver disease,|chronic liver disease,
5319579|NCT02086708|NASH,|nash,
5319580|NCT02086708|NAFLD,|nafld,
5319581|NCT02086708|Elevated Transaminases,|elevated transaminases,
5319582|NCT02086708|Liver Biopsy,|liver biopsy,
5319583|NCT02086708|Fibrosis,|fibrosis,
5319584|NCT02086708|METAVIR|metavir
5319585|NCT02086695|Chemotherapy|chemotherapy
5319586|NCT02086695|Cardiotoxicity|cardiotoxicity
5319587|NCT02086682|hemodialysis|hemodialysis
5319588|NCT02086682|dialysis|dialysis
5319589|NCT02086682|renal dialysis|renal dialysis
5319590|NCT02086682|clotting|clotting
5319591|NCT02086682|coagulation|coagulation
5319592|NCT02086682|blood lines|blood lines
5319593|NCT02086656|liver metastases|liver metastases
5319594|NCT02086656|colorectal cancer|colorectal cancer
5319595|NCT02086656|perioperative treatment|perioperative treatment
5319596|NCT02086643|Infraclavicular block|infraclavicular block
5319597|NCT02086643|Brachial Plexus|brachial plexus
5319598|NCT02086643|Retroclavicular Approach|retroclavicular approach
5319599|NCT02086643|Complications of retroclavicular approach|complications of retroclavicular approach
5319600|NCT02086643|Success of retroclavicular approach|success of retroclavicular approach
5319601|NCT02086643|Obese Patients|obese patients
5319602|NCT02086643|Obesity and Anesthesia|obesity and anesthesia
5319603|NCT02086630|disparities|disparities
5319604|NCT02086630|antiretroviral|antiretroviral
5319606|NCT02086630|barriers|barriers
5319607|NCT02086630|access|access
5319608|NCT02086630|delay|delay
5319609|NCT02086630|decline|decline
5319610|NCT02086630|discontinue|discontinue
5319611|NCT02086630|African American|african american
5319612|NCT02086630|Black|black
5319613|NCT02086630|Latino|latino
5319614|NCT02086630|Hispanic|hispanic
5319615|NCT02086630|care continuum|care continuum
5319616|NCT02086630|Heart to Heart Behavioral intervention|heart to heart behavioral intervention
5319617|NCT02086630|Treatment as Usual|treatment as usual
5319618|NCT02086591|Non Hodgkin Lymphoma|non hodgkin lymphoma
5319619|NCT02086591|Doxycycline|doxycycline
5319620|NCT02086578|multi-beam Intensity-Modulated Radiation Therapy (IMRT)|multi-beam intensity-modulated radiation therapy (imrt)
5319622|NCT02086565|asthma,|asthma,
5319623|NCT02086565|asthma control,|asthma control,
5319624|NCT02086565|asthma-related quality of life|asthma-related quality of life
5319625|NCT02086565|electronic health record,|electronic health record,
5319626|NCT02086565|portal,|portal,
5319627|NCT02086565|health literacy|health literacy
5319628|NCT02086513|Graft versus Host Disease|graft versus host disease
5319629|NCT02086513|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5319630|NCT02086500|Tranexamic acid|tranexamic acid
5319631|NCT02086500|randomized|randomized
5319632|NCT02086500|hemorrhage|hemorrhage
5319633|NCT02086500|blinded|blinded
5319634|NCT02086487|NIlotinib , Suboptimal Response , Imatinib|nilotinib , suboptimal response , imatinib
5319635|NCT02086435|Myomectomy|myomectomy
5319636|NCT02086435|Laparoscopic myomectomy|laparoscopic myomectomy
5319637|NCT02086435|Morcellation|morcellation
5319638|NCT02086435|Risk of dissemination|risk of dissemination
5319639|NCT02086435|Uterine Sarcoma|uterine sarcoma
5319640|NCT02086435|Parasitic myoma|parasitic myoma
5319641|NCT02086396|obesity|obesity
5319642|NCT02086396|cardiovascular risk factors|cardiovascular risk factors
5319643|NCT02086396|pumpkin seed|pumpkin seed
5319644|NCT02086396|diet quality|diet quality
5319645|NCT02086383|Pulmonary Rehabilitation|pulmonary rehabilitation
5319646|NCT02086383|Self-Efficacy|self-efficacy
5319647|NCT02086383|Physical Activity|physical activity
5319649|NCT02086370|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
5319650|NCT02086370|Ovarian cancer prevention|ovarian cancer prevention
5319651|NCT02086370|Ovarian reserve|ovarian reserve
5319652|NCT02086370|Permanent contraception|permanent contraception
5319653|NCT02086370|Surgical sterilization|surgical sterilization
5319654|NCT02086344|Total Laparoscopic Hysterectomy|total laparoscopic hysterectomy
5319655|NCT02086344|TLH|tlh
5319656|NCT02086344|Ovarian reserve|ovarian reserve
5319657|NCT02086344|Prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
5319658|NCT02086344|Ovarian cancer prevention|ovarian cancer prevention
5319659|NCT02086344|Ovarian cancer|ovarian cancer
5319660|NCT02086344|Fallopian Tubes|fallopian tubes
5319661|NCT02086318|Ovarian reserve|ovarian reserve
5319662|NCT02086318|Ovarian age|ovarian age
5319663|NCT02086318|Fertility|fertility
5319664|NCT02086318|Reproductive prognosis|reproductive prognosis
5319665|NCT02086318|Distance to menopause|distance to menopause
5319666|NCT02086305|Transitional care|transitional care
5319667|NCT02086305|Supportive and palliative care|supportive and palliative care
5319668|NCT02086292|Injections|injections
5319669|NCT02086292|Lidocaine|lidocaine
5319670|NCT02086292|Pain|pain
5319671|NCT02086292|Healthy volunteers|healthy volunteers
5319672|NCT02086279|AMH levels|amh levels
5319673|NCT02086279|Ovarian reserve|ovarian reserve
5319674|NCT02086279|GnRH analogue|gnrh analogue
5319675|NCT02086279|Ovarian reserve after GnRH analogue|ovarian reserve after gnrh analogue
5319676|NCT02086279|Ovarian reserve modification|ovarian reserve modification
5319677|NCT02086279|Antral follicle count|antral follicle count
5319678|NCT02086279|Antral follicle count after GnRH analogue|antral follicle count after gnrh analogue
5319679|NCT02086266|Prostatectomy|prostatectomy
5319680|NCT02086266|Urinary Continence|urinary continence
5319681|NCT02086266|Physical Therapy Modalities|physical therapy modalities
5319682|NCT02086266|Pelvic Floor|pelvic floor
5319683|NCT02086266|Randomized Trial.|randomized trial.
5319684|NCT02086253|Endothelin, endothelium, flow-mediated dilatation|endothelin, endothelium, flow-mediated dilatation
5319687|NCT02086214|Proprioceptive pressure therapy|proprioceptive pressure therapy
5319688|NCT02086214|Children|children
5319689|NCT02086214|Assisting Hand Assessment performance|assisting hand assessment performance
5319690|NCT02086201|major depression|major depression
5319691|NCT02086201|depression|depression
5319692|NCT02086201|depressive disorder|depressive disorder
5319693|NCT02086201|mental health|mental health
5319694|NCT02086201|mental disorder|mental disorder
5319695|NCT02086188|Multiple Sclerosis|multiple sclerosis
5319696|NCT02086188|Overactive Bladder|overactive bladder
5319697|NCT02086188|Incontinence|incontinence
5319699|NCT02086188|Bladder Urgency|bladder urgency
5319700|NCT02086188|Pelvic Floor Exercises|pelvic floor exercises
5319701|NCT02086175|relapsed/refractory indolent B cell non-Hodgkin lymphomas|relapsed/refractory indolent b cell non-hodgkin lymphomas
5319702|NCT02086162|Schizophrenia|schizophrenia
5319704|NCT02086162|Tobacco|tobacco
5319705|NCT02086162|Motivation|motivation
5319706|NCT02086162|Cessation Treatment|cessation treatment
5319707|NCT02086149|Quit smoking|quit smoking
5319708|NCT02086149|Exercise|exercise
5319709|NCT02086149|Tobacco|tobacco
5319710|NCT02086149|Smoking|smoking
5319711|NCT02086136|aortic dissection|aortic dissection
5319712|NCT02086136|diagnosis|diagnosis
5319713|NCT02086136|emergency medicine|emergency medicine
5319714|NCT02086136|d-dimer|d-dimer
5319715|NCT02086123|Analgesia|analgesia
5319716|NCT02086123|Epidural Analgesia|epidural analgesia
5319717|NCT02086123|Narcotic Analgesia|narcotic analgesia
5319718|NCT02086123|Patient Controlled Analgesia|patient controlled analgesia
5319719|NCT02086123|Anesthesia and Analgesia|anesthesia and analgesia
5319720|NCT02086123|Anti inflammatory Analgesics|anti inflammatory analgesics
5319721|NCT02086123|NSAIDS|nsaids
5319722|NCT02086110|probiotic|probiotic
5319723|NCT02086110|prebiotic|prebiotic
5319724|NCT02086110|autism|autism
5319725|NCT02086110|oligosaccharides|oligosaccharides
5319726|NCT02086110|Bifidobacterium infantis|bifidobacterium infantis
5319727|NCT02086097|pain|pain
5319728|NCT02086097|symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
5319729|NCT02086097|postoperative dental pain|postoperative dental pain
5319730|NCT02086084|Acute Exacerbation Chronic Obstructive Pulmonary Disease|acute exacerbation chronic obstructive pulmonary disease
5319731|NCT02086084|AECOPD|aecopd
5319732|NCT02086084|Non invasive ventilation|non invasive ventilation
5319733|NCT02086084|NIV|niv
5319734|NCT02086084|Extracorporeal carbon dioxide removal|extracorporeal carbon dioxide removal
5319735|NCT02086084|ECCO2R|ecco2r
5319736|NCT02086071|REBIOP re-biopsies advanced or metastatic NSCLC|rebiop re-biopsies advanced or metastatic nsclc
5319737|NCT02086058|overactive bladder|overactive bladder
5319738|NCT02086058|daytime urinary incontinence|daytime urinary incontinence
5319739|NCT02086058|children|children
5319740|NCT02086058|gene expression|gene expression
5319741|NCT02086045|Coronary artery disease|coronary artery disease
5319742|NCT02086032|Sleeping quality|sleeping quality
5319743|NCT02086032|menopause|menopause
5319744|NCT02086032|climacteric|climacteric
5319745|NCT02086032|progestin|progestin
5319746|NCT02086032|dydrogesterone|dydrogesterone
5319747|NCT02086032|micronized progesterone|micronized progesterone
5319748|NCT02086019|Revascularisation, octogenarian,acute coronary syndromes|revascularisation, octogenarian,acute coronary syndromes
5319749|NCT02086006|Coronary artery disease|coronary artery disease
5319750|NCT02085993|romiplostim,|romiplostim,
5319751|NCT02085993|Nplate,|nplate,
5319752|NCT02085993|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5319754|NCT02085967|Metabolism|metabolism
5319755|NCT02085967|Drug-Drug Interactions|drug-drug interactions
5319756|NCT02085941|Head and Neck Neoplasms|head and neck neoplasms
5319757|NCT02085941|Malignant Neoplasm of Vertebral Column|malignant neoplasm of vertebral column
5319758|NCT02085928|Tennis elbow|tennis elbow
5319759|NCT02085928|Lateral epicondylitis|lateral epicondylitis
5319760|NCT02085928|Intratissue percutaneous electrolysis|intratissue percutaneous electrolysis
5319761|NCT02085928|Eccentric exercise|eccentric exercise
5319762|NCT02085928|Ultrasonography|ultrasonography
5319763|NCT02085876|patients|patients
5319764|NCT02085876|present|present
5319765|NCT02085876|undergo bariatric surgery|undergo bariatric surgery
5319766|NCT02085811|Kyphoplasty|kyphoplasty
5319767|NCT02085811|at a single level|at a single level
5319768|NCT02085811|(between T11 and L5)|(between t11 and l5)
5319769|NCT02085811|associated surgery|associated surgery
5862772|NCT00001516|Occupational Therapy Process|occupational therapy process
5862773|NCT00001516|Reflection|reflection
5319770|NCT02085798|Leukemia, Myelomonocytic, Chronic, myelodysplastic syndrome, Prospective, Treatment strategy, epidemiologic data|leukemia, myelomonocytic, chronic, myelodysplastic syndrome, prospective, treatment strategy, epidemiologic data
5319771|NCT02085785|weight loss|weight loss
5319772|NCT02085785|exercise|exercise
5319773|NCT02085785|home-based|home-based
5319774|NCT02085785|lower extremity amputation|lower extremity amputation
5319775|NCT02085785|pilot study|pilot study
5319777|NCT02085733|Arthritis, Septic|arthritis, septic
5324177|NCT02065674|FBS|fbs
5319778|NCT02085681|Diabetic Retinopathy|diabetic retinopathy
5319779|NCT02085681|Screening|screening
5319780|NCT02085681|Tele-medicine|tele-medicine
5319781|NCT02085681|Retinal Imaging|retinal imaging
5319782|NCT02085681|Remote diagnosis|remote diagnosis
5319783|NCT02085668|Chronic Heart Failure|chronic heart failure
5319784|NCT02085668|Cardio-Renal Syndrome|cardio-renal syndrome
5319785|NCT02085668|Renal Denervation|renal denervation
5319786|NCT02085668|Symplicity|symplicity
5319787|NCT02085668|Sympathetic activation|sympathetic activation
5319788|NCT02085655|Extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
5319789|NCT02085655|PA-Gemox regimen|pa-gemox regimen
5319790|NCT02085655|thalidomide|thalidomide
5319791|NCT02085642|Stroke|stroke
5319792|NCT02085642|Acupuncture|acupuncture
5319793|NCT02085642|Gait|gait
5319794|NCT02085642|Spasticity|spasticity
5319795|NCT02085629|renal failure, end stage|renal failure, end stage
5319796|NCT02085629|renal transplantation|renal transplantation
5319797|NCT02085629|cell therapy|cell therapy
5319798|NCT02085629|macrophages, monocyte derived|macrophages, monocyte derived
5319799|NCT02085629|immune tolerance|immune tolerance
5319800|NCT02085629|ONE Study|one study
5319801|NCT02085629|immunotherapy|immunotherapy
5319802|NCT02085616|Smoking cessation|smoking cessation
5319803|NCT02085616|Tobacco cessation|tobacco cessation
5319804|NCT02085616|Quitline|quitline
5319805|NCT02085616|Telephone counselling|telephone counselling
5319806|NCT02085616|Intensity|intensity
5319807|NCT02085603|advanced solid malignancies|advanced solid malignancies
5319808|NCT02085590|BCG vaccine|bcg vaccine
5319809|NCT02085590|Sepsis|sepsis
5319810|NCT02085590|Immunity|immunity
5319811|NCT02085577|Morphine consumption|morphine consumption
5319812|NCT02085577|Postoperative pain|postoperative pain
5319813|NCT02085577|Ketamine|ketamine
5319814|NCT02085577|Side effects|side effects
5319815|NCT02085577|Spine surgery|spine surgery
5319816|NCT02085577|Chronic pain|chronic pain
5319817|NCT02085564|Gastroesophageal-junction cancer|gastroesophageal-junction cancer
5319818|NCT02085564|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5319819|NCT02085551|peripheral arterial occlusion|peripheral arterial occlusion
5319820|NCT02085551|visceral emboli|visceral emboli
5319821|NCT02085551|limb ischemia|limb ischemia
5319822|NCT02085551|adverse events|adverse events
5319823|NCT02085551|Indigo System|indigo system
5319824|NCT02085551|aspiration|aspiration
5319825|NCT02085551|mechanical thrombectomy|mechanical thrombectomy
5319826|NCT02085538|renal impairment|renal impairment
5319828|NCT02085538|Cmax|cmax
5319829|NCT02085538|palbociclib|palbociclib
5319830|NCT02085538|normal matched subjects|normal matched subjects
5319831|NCT02085512|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5319832|NCT02085512|Major Depression|major depression
5319833|NCT02085512|Secondary Prevention|secondary prevention
5319834|NCT02085512|Neurocognitive Retraining|neurocognitive retraining
5319835|NCT02085512|Randomized Controlled Trial|randomized controlled trial
5319836|NCT02085499|nasal ventilation|nasal ventilation
5319837|NCT02085499|premature infants|premature infants
5319838|NCT02085499|synchronized ventilation|synchronized ventilation
5319839|NCT02085486|dialysis|dialysis
5319840|NCT02085486|av shunt|av shunt
5319841|NCT02085486|cannulation|cannulation
5319842|NCT02085486|ultrasound|ultrasound
5319843|NCT02085486|outcome|outcome
5319844|NCT02085473|Asthma|asthma
5319845|NCT02085473|Healthy Subjects or Volunteers|healthy subjects or volunteers
5319846|NCT02085473|Tralokinumab|tralokinumab
5319847|NCT02085473|CAT-354|cat-354
5319848|NCT02085447|Homelessness|homelessness
5319849|NCT02085447|Antipsychotic Drugs|antipsychotic drugs
5319850|NCT02085447|Antipsychotics|antipsychotics
5319851|NCT02085447|Injectables|injectables
5319852|NCT02085447|Long Acting Injectable Antipsychotic|long acting injectable antipsychotic
5319853|NCT02085447|Psychotic Disorders|psychotic disorders
5319854|NCT02085447|Schizophrenia|schizophrenia
5319855|NCT02085447|Schizoaffective Disorder|schizoaffective disorder
5319856|NCT02085447|Medication Adherence|medication adherence
5319857|NCT02085447|Medication Non-Adherence|medication non-adherence
5319858|NCT02085447|Community Mental Health Centers|community mental health centers
5319859|NCT02085421|tdcs, neuromodulation, CRT, psychosis, schizophrenia|tdcs, neuromodulation, crt, psychosis, schizophrenia
5319860|NCT02085395|Actinic Keratosis, AK, Bowen's Disease, Bowen|actinic keratosis, ak, bowen's disease, bowen
5319861|NCT02085382|Kangaroo Mother Care(KMC), Low-birth weight, neonates|kangaroo mother care(kmc), low-birth weight, neonates
5319862|NCT02085369|bariatric surgery|bariatric surgery
5319863|NCT02085369|cognitive function|cognitive function
5319872|NCT02085343|Fear of heights|fear of heights
5319873|NCT02085343|Acrophobia|acrophobia
5319874|NCT02085343|Safety behavior fading|safety behavior fading
5319875|NCT02085343|Anti-phobic Actions|anti-phobic actions
5319877|NCT02085317|Leprosy|leprosy
5319878|NCT02085317|Nervous system|nervous system
5319879|NCT02085317|Orthogonal polarization spectral (OPS) imaging|orthogonal polarization spectral (ops) imaging
5319880|NCT02085317|Laser Doppler flowmetry|laser doppler flowmetry
5319881|NCT02085317|Iontophoresis.|iontophoresis.
5319882|NCT02085304|Glioblastoma|glioblastoma
5319884|NCT02085304|Radiation|radiation
5319885|NCT02085304|GammaKnife(R)|gammaknife(r)
5319886|NCT02085304|Radiosurgery|radiosurgery
5319887|NCT02085304|Gliadel(R)|gliadel(r)
5319888|NCT02085304|Temozolomide|temozolomide
5319889|NCT02085304|Temodar(R)|temodar(r)
5319890|NCT02085291|septic shock; microcirculation; norepinephrine|septic shock; microcirculation; norepinephrine
5319891|NCT02085278|arteriovenous malformation|arteriovenous malformation
5319892|NCT02085278|Brain|brain
5319893|NCT02085278|AVM|avm
5319894|NCT02085278|Onyx|onyx
5319895|NCT02085278|Micro catheter|micro catheter
5319896|NCT02085278|catheter entrapment,|catheter entrapment,
5319897|NCT02085278|Embolization|embolization
5319898|NCT02085278|Vein Of Galen|vein of galen
5319899|NCT02085265|Alzheimer's Disease|alzheimer's disease
5319900|NCT02085265|Hypertension|hypertension
5319901|NCT02085265|Perindopril|perindopril
5319902|NCT02085265|Telmisartan|telmisartan
5319903|NCT02085265|Brain atrophy|brain atrophy
5319904|NCT02085252|Drug Therapy|drug therapy
5319905|NCT02085239|Breast Biopsy|breast biopsy
5319906|NCT02085239|Ultrasound|ultrasound
5319907|NCT02085239|Lidocaine|lidocaine
5319908|NCT02085239|Ropivacaine|ropivacaine
5319909|NCT02085239|Breast Lesion|breast lesion
5319910|NCT02085226|Stroke|stroke
5319911|NCT02085226|Rehabilitation|rehabilitation
5319912|NCT02085226|Creative Engagement|creative engagement
5319913|NCT02085226|Psychosocial|psychosocial
5319914|NCT02085226|Art|art
5319915|NCT02085213|Retained placenta|retained placenta
5319916|NCT02085213|Manual Removal of Placenta|manual removal of placenta
5319917|NCT02085213|Glyceryl Trinitrate|glyceryl trinitrate
5319918|NCT02085200|glenohumeral internal rotation deficit|glenohumeral internal rotation deficit
5319919|NCT02085200|overhead athlete|overhead athlete
5319920|NCT02085200|shoulder exercise|shoulder exercise
5319921|NCT02085200|posterior glenohumeral capsule|posterior glenohumeral capsule
5319922|NCT02085200|posteroinferior glenohumeral ligament|posteroinferior glenohumeral ligament
5319923|NCT02085200|posterior rotator cuff|posterior rotator cuff
5319924|NCT02085187|Pulmonary rehabilitation|pulmonary rehabilitation
5319925|NCT02085187|Training|training
5319926|NCT02085187|Counselling|counselling
5319927|NCT02085187|Telemedicine|telemedicine
5319928|NCT02085187|Videoconference|videoconference
5319929|NCT02085187|COPD|copd
5319930|NCT02085187|Chronic disease|chronic disease
5319931|NCT02085187|Internet.|internet.
5319932|NCT02085148|Pediatric cancer|pediatric cancer
5319933|NCT02085148|Rhabdomyosarcoma,|rhabdomyosarcoma,
5319934|NCT02085148|Ewing sarcoma|ewing sarcoma
5319935|NCT02085148|Hepatoblastoma|hepatoblastoma
5319936|NCT02085148|Neuroblastoma|neuroblastoma
5319937|NCT02085148|Wilm's tumor|wilm's tumor
5319938|NCT02085135|depression|depression
5319939|NCT02085135|major depressive disorder|major depressive disorder
5319940|NCT02085135|Alkermes|alkermes
5319941|NCT02085135|ALKS 5461|alks 5461
5319942|NCT02085135|samidorphan|samidorphan
5319943|NCT02085135|buprenorphine|buprenorphine
5319944|NCT02085109|Cardiovascular Diseases|cardiovascular diseases
5319945|NCT02085109|HDL metabolism|hdl metabolism
5319946|NCT02085109|ApoA-I|apoa-i
5319947|NCT02085109|High fat|high fat
5319948|NCT02085109|Theobromine|theobromine
5319949|NCT02085096|Caregivers|caregivers
5319950|NCT02085096|Coping Skills|coping skills
5319951|NCT02085083|Inflammatory Bowel Disease|inflammatory bowel disease
5319952|NCT02085083|Transition|transition
5319953|NCT02085083|Adolescent|adolescent
5319954|NCT02085083|Chronic Disease|chronic disease
5319955|NCT02085083|Colitis, Ulcerative|colitis, ulcerative
5319956|NCT02085044|malnutrition|malnutrition
5319957|NCT02085044|children's health|children's health
5319958|NCT02085044|prevention|prevention
5319959|NCT02085044|ready-to-use supplementary food|ready-to-use supplementary food
5319960|NCT02085044|lipid based nutrient supplement|lipid based nutrient supplement
5319961|NCT02085044|chad|chad
5319964|NCT02085031|laparoscopic surgery|laparoscopic surgery
5319965|NCT02085031|minilaparotomy|minilaparotomy
5319966|NCT02085031|stomach neoplasms|stomach neoplasms
5319967|NCT02085018|omeprazole, idiopathic pulmonary fibrosis|omeprazole, idiopathic pulmonary fibrosis
5319968|NCT02084992|Congestive Heart Failure|congestive heart failure
5319969|NCT02084992|Disease management|disease management
5319970|NCT02084992|Hospitalization|hospitalization
5319971|NCT02084979|Primary care mental health consultation|primary care mental health consultation
5319972|NCT02084979|Telepsychiatry|telepsychiatry
5319973|NCT02084979|Asynchronous telepsychiatry|asynchronous telepsychiatry
5319974|NCT02084966|Kidney|kidney
5319975|NCT02084966|Transplantation|transplantation
5319976|NCT02084966|Imaging|imaging
5319977|NCT02084966|Renal function|renal function
5319978|NCT02084966|Optical Coherence Tomography|optical coherence tomography
5269062|NCT02336685|Hip|hip
5200509|NCT02741193|Transcranial magnet stimulation (nTMS)|transcranial magnet stimulation (ntms)
5200510|NCT02741193|Brainsight Neuronavigation|brainsight neuronavigation
5200511|NCT02741193|Electromyography|electromyography
5200512|NCT02741193|EMG|emg
5319979|NCT02084940|PCOS|pcos
5319980|NCT02084940|OHSS|ohss
5319981|NCT02084940|GnRH antagonist|gnrh antagonist
5319983|NCT02084940|COH|coh
5319984|NCT02084914|endometrial scratching|endometrial scratching
5319985|NCT02084914|pipelle|pipelle
5319986|NCT02084914|pregnancy rate|pregnancy rate
5319987|NCT02084914|unexplained infertility|unexplained infertility
5319988|NCT02084901|Biodegradable stents|biodegradable stents
5319989|NCT02084901|converage|converage
5319990|NCT02084901|OCT|oct
5319991|NCT02084875|Food effect|food effect
5319992|NCT02084875|pharmacokinetic|pharmacokinetic
5319993|NCT02084875|healthy volunteer|healthy volunteer
5319994|NCT02084862|Tracheostomy|tracheostomy
5319995|NCT02084862|Ultrasound|ultrasound
5319996|NCT02084836|fMRI obesity adolescents|fmri obesity adolescents
5319997|NCT02084797|arginine vasopressin|arginine vasopressin
5319998|NCT02084797|sweat sodium|sweat sodium
5319999|NCT02084797|V2 antagonist|v2 antagonist
5320000|NCT02084797|running|running
5320001|NCT02084784|Near-infrared fluorescence|near-infrared fluorescence
5320002|NCT02084784|Image guided surgery|image guided surgery
5320003|NCT02084784|Breast cancer;|breast cancer;
5320004|NCT02084784|Sentinel lymph node biopsy|sentinel lymph node biopsy
5320005|NCT02084784|Indocyanine green|indocyanine green
5320006|NCT02084784|Methylene blue|methylene blue
5320007|NCT02084771|contrast nephropathy|contrast nephropathy
5320008|NCT02084771|contrast induced acute kidney injury|contrast induced acute kidney injury
5320009|NCT02084771|acute kidney injury|acute kidney injury
5320010|NCT02084771|prophylaxis|prophylaxis
5320011|NCT02084771|randomized trial|randomized trial
5320012|NCT02084758|COPD|copd
5320013|NCT02084758|nitrate supplementation|nitrate supplementation
5320014|NCT02084758|metabolic efficiency|metabolic efficiency
5320015|NCT02084745|Boston keratoprosthesis|boston keratoprosthesis
5320016|NCT02084745|Glaucoma drainage device|glaucoma drainage device
5320017|NCT02084745|Ahmed tube shunt|ahmed tube shunt
5320018|NCT02084732|Sorafenib, thyroid neoplasms, salicylic acid|sorafenib, thyroid neoplasms, salicylic acid
5320019|NCT02084680|Prenatal|prenatal
5320020|NCT02084680|Newborn care|newborn care
5320021|NCT02084680|mobile phones|mobile phones
5320022|NCT02084654|prediabetes|prediabetes
5320023|NCT02084654|exenatide|exenatide
5320024|NCT02084654|weight loss|weight loss
5320025|NCT02084654|insulin resistance|insulin resistance
5320026|NCT02084654|acute insulin response|acute insulin response
5320027|NCT02084654|insulin secretion|insulin secretion
5320028|NCT02084641|ectopic fat|ectopic fat
5320029|NCT02084641|obesity|obesity
5320030|NCT02084641|triglyceride storage|triglyceride storage
5320031|NCT02084641|adipocyte|adipocyte
5320032|NCT02084641|overfeeding|overfeeding
5320033|NCT02084641|intrahepatic fat|intrahepatic fat
5320034|NCT02084641|adipocyte proliferation|adipocyte proliferation
5320035|NCT02084641|inflammation|inflammation
5320036|NCT02084641|macrophage|macrophage
5320037|NCT02084615|Aspirin|aspirin
5320038|NCT02084615|Postoperative hemorrhage|postoperative hemorrhage
5320039|NCT02084615|Inguinal hernia|inguinal hernia
5320040|NCT02084602|artesunate|artesunate
5320041|NCT02084602|mefloquine|mefloquine
5320042|NCT02084602|falciparum|falciparum
5320043|NCT02084602|peruvian amazon|peruvian amazon
5320044|NCT02084589|PCEA, labor analgesia, background infusion, ropivacaine|pcea, labor analgesia, background infusion, ropivacaine
5320045|NCT02084576|Cystoid macular edema|cystoid macular edema
5356889|NCT01917591|Treatment Outcome|treatment outcome
5320046|NCT02084576|nonsteroidal anti-inflammatory drug|nonsteroidal anti-inflammatory drug
5320048|NCT02084576|phacoemulsification.|phacoemulsification.
5320049|NCT02084563|Acute Myeloid Leukemia|acute myeloid leukemia
5320050|NCT02084563|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5320051|NCT02084563|Myelodysplastic Syndromes|myelodysplastic syndromes
5320052|NCT02084563|Myeloproliferative/Myelodysplastic Neoplasm|myeloproliferative/myelodysplastic neoplasm
5320053|NCT02084563|Leukemia|leukemia
5320055|NCT02084563|MPN|mpn
5320056|NCT02084563|AML|aml
5320057|NCT02084563|Chronic myelomonocytic leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5320058|NCT02084563|Polycythemia Vera (PV)|polycythemia vera (pv)
5316628|NCT02100917|HER-2|her-2
5320060|NCT02084563|Myelofibrosis (MF)|myelofibrosis (mf)
5320061|NCT02084537|symptomatic|symptomatic
5320062|NCT02084537|infected|infected
5320063|NCT02084537|necrotic collection|necrotic collection
5320064|NCT02084524|vulnerable|vulnerable
5320065|NCT02084524|nutrition|nutrition
5320066|NCT02084524|cancer|cancer
5320067|NCT02084524|colorectal|colorectal
5320068|NCT02084524|tumor|tumor
5320069|NCT02084498|Automated bolus calculator (ABC)|automated bolus calculator (abc)
5963181|NCT04267822|Respiratory tract infection|respiratory tract infection
5963182|NCT04267822|immunocompromise|immunocompromise
5963183|NCT04267536|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5963184|NCT04267536|Upadacitinib|upadacitinib
5963185|NCT04267536|RINVOQ|rinvoq
5963186|NCT04267536|Methotrexate (MTX)|methotrexate (mtx)
5320070|NCT02084498|Advanced carbohydrate counting (ACC)|advanced carbohydrate counting (acc)
5320071|NCT02084498|Patient empowerment|patient empowerment
5320072|NCT02084485|COPD|copd
5320073|NCT02084485|LPS|lps
5320074|NCT02084472|atopic eczema|atopic eczema
5320075|NCT02084472|moisturisers|moisturisers
5320076|NCT02084472|alternatives|alternatives
5320077|NCT02084472|affordable|affordable
5434506|NCT01568749|otc|otc
5320078|NCT02084459|Chronic pain|chronic pain
5320079|NCT02084459|Supportive care|supportive care
5320080|NCT02084459|Psychosocial Circumstances|psychosocial circumstances
5320081|NCT02084459|Autonomy support|autonomy support
5320082|NCT02084459|Nursing intervention|nursing intervention
5320083|NCT02084446|Everolimus|everolimus
5320084|NCT02084446|Tacrolimus|tacrolimus
5320085|NCT02084446|Sodium Mycophenolate|sodium mycophenolate
5320086|NCT02084446|CMV|cmv
5320087|NCT02084446|Graft function|graft function
5320088|NCT02084446|Acute rejection|acute rejection
5320089|NCT02084433|MIH of the first permanent molar|mih of the first permanent molar
5320090|NCT02084407|DM1|dm1
5320091|NCT02084407|Cardiopathy|cardiopathy
5320092|NCT02084407|Adult|adult
5320093|NCT02084394|CBF autoregulation, rSO2,doppler, TCD, delirium,|cbf autoregulation, rso2,doppler, tcd, delirium,
5320094|NCT02084381|CKD5, dialysis, high porous membranes|ckd5, dialysis, high porous membranes
5320095|NCT02084368|combined lumbar plexus and sciatic nerve block，|combined lumbar plexus and sciatic nerve block，
5320096|NCT02084368|combined spinal and epidural anesthesia|combined spinal and epidural anesthesia
5320097|NCT02084355|Significant cancer pain|significant cancer pain
5320098|NCT02084355|at least numeric rating scale 4|at least numeric rating scale 4
5320099|NCT02084342|desmopressin|desmopressin
5320100|NCT02084342|tranexamic acid|tranexamic acid
5320101|NCT02084342|blood loss|blood loss
5320102|NCT02084342|transfusion need|transfusion need
5320103|NCT02084342|posterior scoliosis orthopedics|posterior scoliosis orthopedics
5320104|NCT02084329|Physiotherapy|physiotherapy
5320105|NCT02084329|Physical therapy|physical therapy
5320106|NCT02084329|neurotrauma rehabilitation|neurotrauma rehabilitation
5320107|NCT02084329|Rehabilitation|rehabilitation
5320108|NCT02084329|Balance|balance
5320109|NCT02084329|Balance Confidence|balance confidence
5320110|NCT02084329|concussion|concussion
5320111|NCT02084329|Post-Concussion|post-concussion
5320112|NCT02084329|Mild Traumatic Brain Injury|mild traumatic brain injury
5320113|NCT02084316|China CDC|china cdc
5320114|NCT02084316|One4All testing algorithm|one4all testing algorithm
5320115|NCT02084316|Guangxi Autonomous Region|guangxi autonomous region
5320116|NCT02084316|Testing and Linkage to HIV Care in China|testing and linkage to hiv care in china
5320117|NCT02084290|Crohn's disease|crohn's disease
5320118|NCT02084290|Shared Decision Making|shared decision making
5320119|NCT02084290|Decision Aid|decision aid
5320120|NCT02084277|Oral health-related quality of life (OHRQoL)|oral health-related quality of life (ohrqol)
5320121|NCT02084277|Self-ligating brackets (SLB)|self-ligating brackets (slb)
5320122|NCT02084277|Conventional brackets (CB)|conventional brackets (cb)
5320123|NCT02084277|Oral Health Impact Profile-14 (OHIP-14)|oral health impact profile-14 (ohip-14)
5320124|NCT02084277|Short Form-36 (SF-36)|short form-36 (sf-36)
5320125|NCT02084264|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5320126|NCT02084264|Pediatric Scoliosis|pediatric scoliosis
5320127|NCT02084251|safety,|safety,
5320128|NCT02084251|pharmacokinetics,|pharmacokinetics,
5320129|NCT02084251|Long acting GLP-1 analogue|long acting glp-1 analogue
5320130|NCT02084238|SLE, IL-2|sle, il-2
5320131|NCT02084225|low resource|low resource
5320132|NCT02084225|conflict setting|conflict setting
5320133|NCT02084225|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
5320134|NCT02084225|acute injuries|acute injuries
5320135|NCT02084225|pain management|pain management
5320136|NCT02084225|education|education
5320137|NCT02084225|ultrasound|ultrasound
5320138|NCT02084225|trauma|trauma
5320139|NCT02084225|emergency department|emergency department
5320140|NCT02084173|alcohol|alcohol
5320141|NCT02084173|60+ years|60+ years
5320142|NCT02084173|treatment|treatment
5320143|NCT02084173|met|met
5320144|NCT02084173|cra|cra
5320145|NCT02084173|multi site|multi site
5320146|NCT02084173|multi country|multi country
5320147|NCT02084173|questionnaire|questionnaire
5320148|NCT02084173|random|random
5320149|NCT02084134|pituitary adenoma|pituitary adenoma
5320150|NCT02084134|Pituitary Tumor|pituitary tumor
5320151|NCT02084134|transsphenoidal resection|transsphenoidal resection
5320152|NCT02084134|pituitary cyst|pituitary cyst
5320153|NCT02084121|metachromatic leukodystrophy|metachromatic leukodystrophy
5320159|NCT02084108|Palliative care.|palliative care.
5320160|NCT02084043|aerosol delivery|aerosol delivery
5320161|NCT02084043|vibrating mesh nebulizer|vibrating mesh nebulizer
5320162|NCT02084043|breath-actuated nebulizer|breath-actuated nebulizer
5320163|NCT02084043|non invasive ventilation|non invasive ventilation
5320164|NCT02084043|bilevel ventilator|bilevel ventilator
5320165|NCT02084043|single limb circuit ventilator|single limb circuit ventilator
5320166|NCT02084043|Amikacin|amikacin
5320167|NCT02084030|cardiac surgery|cardiac surgery
5320168|NCT02084030|POCD|pocd
5200712|NCT02740010|MIOL|miol
5320173|NCT02084017|Negative Pressure Wound Therapy|negative pressure wound therapy
5320174|NCT02084004|Type 2 diabetes mellitus|type 2 diabetes mellitus
5320175|NCT02084004|Berberine Hydrochloride|berberine hydrochloride
5320176|NCT02084004|Bifidobacterium|bifidobacterium
5320177|NCT02083991|NODAT|nodat
5320178|NCT02083991|Renal transplantation|renal transplantation
5320179|NCT02083991|Corticosteroids avoidance|corticosteroids avoidance
5320180|NCT02083991|CNI minimization|cni minimization
5320181|NCT02083978|Bipolar Disorder|bipolar disorder
5320182|NCT02083978|Magnetic Resonance Imaging (MRI) scanning|magnetic resonance imaging (mri) scanning
5320183|NCT02083939|Inguinal hernia|inguinal hernia
5320184|NCT02083939|Mesh repair|mesh repair
5320185|NCT02083939|Prophylactic Antibiotics|prophylactic antibiotics
5320186|NCT02083939|Herniorrhaphy|herniorrhaphy
5320187|NCT02083939|Laparoscopic Inguinal Hernia Repair|laparoscopic inguinal hernia repair
5320188|NCT02083926|Social Anxiety Disorder|social anxiety disorder
5320189|NCT02083926|SAD|sad
5320190|NCT02083926|Ketamine|ketamine
5320191|NCT02083913|Severely obese|severely obese
5320192|NCT02083913|Bariatric surgery|bariatric surgery
5320193|NCT02083913|Physical activity|physical activity
5320194|NCT02083913|Physical fitness|physical fitness
5320195|NCT02083913|Telehealth|telehealth
5320196|NCT02083913|Quality of life|quality of life
5320197|NCT02083887|Immune response|immune response
5320198|NCT02083887|Vaccine|vaccine
5320199|NCT02083887|Malaria|malaria
5320200|NCT02083874|cannabidiol|cannabidiol
5320201|NCT02083874|CBD|cbd
5320202|NCT02083874|marijuana|marijuana
5320203|NCT02083874|withdrawal|withdrawal
5320204|NCT02083874|treatment|treatment
5320205|NCT02083861|osteoarthritis|osteoarthritis
5320206|NCT02083861|arthritis|arthritis
5320207|NCT02083861|musculoskeletal|musculoskeletal
5320208|NCT02083861|connective tissue disease|connective tissue disease
5320215|NCT02083861|LITUS|litus
5320216|NCT02083861|Sam|sam
5320217|NCT02083861|grade 1|grade 1
5320218|NCT02083861|grade 2|grade 2
5320219|NCT02083848|Locoregional invasion|locoregional invasion
5320220|NCT02083848|Stage IB1, IB2, IIA or IIB|stage ib1, ib2, iia or iib
5320221|NCT02083835|post-operative pain|post-operative pain
5320222|NCT02083835|paitent reported outcomes|paitent reported outcomes
5320223|NCT02083835|quality improvement|quality improvement
5320224|NCT02083822|premature baby|premature baby
5320225|NCT02083822|MRI : conventional and advanced images|mri : conventional and advanced images
5320226|NCT02083822|Executive function testing at 5 years of age|executive function testing at 5 years of age
5320227|NCT02083796|manual therapy|manual therapy
5320228|NCT02083796|rehabilitation|rehabilitation
5320229|NCT02083796|shoulder|shoulder
5320230|NCT02083796|spine|spine
5320231|NCT02083770|Hispanics|hispanics
5320232|NCT02083770|Patient Participation|patient participation
5320233|NCT02083770|Refusal to Participate|refusal to participate
5320234|NCT02083770|Education|education
5320235|NCT02083770|Clinical Trials|clinical trials
5320236|NCT02083757|Fluid responsiveness; Passive leg raising|fluid responsiveness; passive leg raising
5320240|NCT02083731|CMV infection|cmv infection
5320241|NCT02083731|Mesenchymal Stem Cells|mesenchymal stem cells
5320242|NCT02083731|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5320243|NCT02083718|Poor Graft Function|poor graft function
5320244|NCT02083718|Peripheral Blood Stem Cell|peripheral blood stem cell
5320245|NCT02083718|Mesenchymal Stem Cells|mesenchymal stem cells
5320246|NCT02083718|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5320247|NCT02083705|Chest compression, Delivery Room, NICU,|chest compression, delivery room, nicu,
5320248|NCT02083679|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5320250|NCT02083666|Phase I|phase i
5320251|NCT02083666|Dose cohorts|dose cohorts
5320252|NCT02083666|Escalating dose|escalating dose
5320253|NCT02083666|Single dose|single dose
5320254|NCT02083666|Multiple dose|multiple dose
5320255|NCT02083666|Safety|safety
5320256|NCT02083666|Tolerability|tolerability
5320257|NCT02083666|Pharmacokinetics|pharmacokinetics
5320258|NCT02083666|Pharmacodynamics|pharmacodynamics
5320259|NCT02083666|volunteers|volunteers
5320260|NCT02083653|Metastatic Colorectal Cancer|metastatic colorectal cancer
5320261|NCT02083653|Best Supportive Care|best supportive care
5320262|NCT02083653|Capecitabine|capecitabine
5320263|NCT02083653|Fluorouracil (5-FU)|fluorouracil (5-fu)
5320264|NCT02083653|Sym004|sym004
5320265|NCT02083640|healthy volunteer|healthy volunteer
5320266|NCT02083640|bioavailability|bioavailability
5320267|NCT02083640|palbociclib|palbociclib
5320268|NCT02083640|formulation|formulation
5320269|NCT02083627|Pharmacokinetics|pharmacokinetics
5320270|NCT02083627|Drug-Drug Interaction|drug-drug interaction
5320271|NCT02083627|Intestinal Absorption|intestinal absorption
5320276|NCT02083601|Caregivers|caregivers
5320277|NCT02083601|Spinal Cord Injuries|spinal cord injuries
5320278|NCT02083601|Psychology, Educational|psychology, educational
5320279|NCT02083601|Counseling|counseling
5320280|NCT02083601|Outcome Assessment (Health Care)|outcome assessment (health care)
5320281|NCT02083588|Fibromyalgia|fibromyalgia
5963187|NCT04267536|ABT-494|abt-494
5320282|NCT02083588|dTMS|dtms
5320283|NCT02083588|pain|pain
5320284|NCT02083588|PFC|pfc
5320285|NCT02083588|Subjects with Fibromyalgia|subjects with fibromyalgia
5320286|NCT02083575|vitamin c|vitamin c
5320287|NCT02083575|thalassemia major|thalassemia major
5320288|NCT02083575|iron chelation|iron chelation
5320289|NCT02083562|Bronchopulmonary dysplasia, preterm infant|bronchopulmonary dysplasia, preterm infant
5320291|NCT02083536|Low Dose Fractionated Whole Abdominal Radiation Therapy|low dose fractionated whole abdominal radiation therapy
5320292|NCT02083536|LDFWART|ldfwart
5320293|NCT02083536|Docetaxel|docetaxel
5320294|NCT02083536|Ovarian Cancer|ovarian cancer
5320295|NCT02083536|Ovarian Carcinoma|ovarian carcinoma
5320296|NCT02083536|Platinum-Resistant|platinum-resistant
5320297|NCT02083523|Motivational Interview, normative feedback, adolescents|motivational interview, normative feedback, adolescents
5320298|NCT02083510|Colchicine|colchicine
5320299|NCT02083510|Hypertriglyceridemia|hypertriglyceridemia
5320300|NCT02083510|Apolipoprotein CIII|apolipoprotein ciii
5320301|NCT02083497|kick|kick
5320302|NCT02083497|taping|taping
5320303|NCT02083497|dynamic equilibrium|dynamic equilibrium
5320304|NCT02083458|critical care|critical care
5320305|NCT02083458|catheterization|catheterization
5320306|NCT02083458|axillary vein|axillary vein
5320317|NCT02083419|Left Ventricular Assist Devices (LVAD)|left ventricular assist devices (lvad)
5320318|NCT02083419|Cardiac Resynchronization Devices (CRT)|cardiac resynchronization devices (crt)
5320319|NCT02083406|Malaria|malaria
5320320|NCT02083406|Bio-availability|bio-availability
5320321|NCT02083393|dendritic cell|dendritic cell
5320322|NCT02083380|Plasmodium falciparum malaria|plasmodium falciparum malaria
5320323|NCT02083380|malaria|malaria
5320324|NCT02083380|OZ439|oz439
5320325|NCT02083380|piperaquine|piperaquine
5320326|NCT02083380|PQP|pqp
5320327|NCT02083354|melanoma|melanoma
5320328|NCT02083354|dabrafenib|dabrafenib
5320329|NCT02083354|trametinib|trametinib
5320330|NCT02083328|heart rate variability|heart rate variability
5320331|NCT02083328|exercise performance|exercise performance
5320332|NCT02083315|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry|acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry
5320333|NCT02083302|campus sexual assault|campus sexual assault
5320334|NCT02083302|bystander intervention|bystander intervention
5320335|NCT02083289|ONO-9054|ono-9054
5320336|NCT02083289|ocular hypertension (OHT)|ocular hypertension (oht)
5320337|NCT02083289|Open angle-glaucoma (OAG)|open angle-glaucoma (oag)
5320338|NCT02083289|Glaucoma|glaucoma
5320339|NCT02083289|Eye Diseases|eye diseases
5320340|NCT02083289|Mild to moderate|mild to moderate
5320341|NCT02083276|Chlamydia trachomatis|chlamydia trachomatis
5320342|NCT02083276|Urethritis|urethritis
5320343|NCT02083276|Genital Diseases, Male|genital diseases, male
5320344|NCT02083263|Lung function|lung function
5320345|NCT02083237|mild cognitive impairment|mild cognitive impairment
5320346|NCT02083237|memory training|memory training
5320347|NCT02083237|healthy lifestyle|healthy lifestyle
5320348|NCT02083237|psychosocial support|psychosocial support
5320349|NCT02083211|Cervical cancer|cervical cancer
5320350|NCT02083211|Recurrent or persistent tumor|recurrent or persistent tumor
5320351|NCT02083211|Monoclonal antibody|monoclonal antibody
5320352|NCT02083198|hyperchloremic acidosis|hyperchloremic acidosis
5320353|NCT02083198|balanced fluids|balanced fluids
5320354|NCT02083198|plasmalyte|plasmalyte
5320355|NCT02083185|Drug therapy|drug therapy
5320356|NCT02083172|USCOM (UltraSound Cardiac Output Monitor)|uscom (ultrasound cardiac output monitor)
5320357|NCT02083172|2D echocardiography|2d echocardiography
5320358|NCT02083172|agreement|agreement
5320359|NCT02083172|pediatrics|pediatrics
5320360|NCT02083133|Diabetes|diabetes
5320361|NCT02083133|Renal Failure|renal failure
5320362|NCT02083133|Dialysis|dialysis
5320363|NCT02083133|End Stage Renal Disease|end stage renal disease
5320364|NCT02083133|Hypoglycemia|hypoglycemia
5320365|NCT02083120|high flow|high flow
5320366|NCT02083120|COPD|copd
5320367|NCT02083120|AIRVO|airvo
5320368|NCT02083107|Postpartum hemorrhage|postpartum hemorrhage
5320371|NCT02083081|tobacco|tobacco
5320372|NCT02083081|smoking|smoking
5320373|NCT02083068|Malaria, vaccine, P. vivax|malaria, vaccine, p. vivax
5320374|NCT02083055|dexmedetomidine|dexmedetomidine
5320375|NCT02083055|controlled hypotensive anesthesia|controlled hypotensive anesthesia
5320377|NCT02083042|T-Track CMV|t-track cmv
5320378|NCT02083042|kidney transplantation|kidney transplantation
5320379|NCT02083029|Asthma|asthma
5320380|NCT02083029|Death|death
5320381|NCT02083029|Mechanism|mechanism
5320382|NCT02083029|Syncope|syncope
5320383|NCT02083029|Dive reflex|dive reflex
5320384|NCT02083003|Pain|pain
5320385|NCT02083003|Polyamine|polyamine
5320386|NCT02083003|Cholecystectomy|cholecystectomy
5320387|NCT02082990|Alcohol-related disorders|alcohol-related disorders
5320388|NCT02082990|Alcohol Drinking|alcohol drinking
5320389|NCT02082990|e-health|e-health
5320390|NCT02082990|Alcohol Use Disorder Test|alcohol use disorder test
5320391|NCT02082990|Quality of Life|quality of life
5320401|NCT02082938|stroke,|stroke,
5320402|NCT02082938|rehabilitation,|rehabilitation,
5320403|NCT02082938|hemiparesis,|hemiparesis,
5320404|NCT02082938|gait training|gait training
5320405|NCT02082925|Exercise training|exercise training
5320406|NCT02082925|Dyspnea threshold|dyspnea threshold
5320407|NCT02082925|6MWT|6mwt
5320408|NCT02082899|Allergic Conjunctivitis|allergic conjunctivitis
5320409|NCT02082899|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
5320410|NCT02082899|Environmental Exposure Chamber|environmental exposure chamber
5320411|NCT02082899|Conjunctival Allergen Provocation Test|conjunctival allergen provocation test
5320412|NCT02082886|Metastasis|metastasis
5320413|NCT02082886|Carcinomatosis|carcinomatosis
5320414|NCT02082886|Carcinosis|carcinosis
5320415|NCT02082886|Sarcomatosis|sarcomatosis
5320416|NCT02082886|CRS|crs
5320417|NCT02082886|Cytoreductive surgery|cytoreductive surgery
5320418|NCT02082886|HIPEC|hipec
5320419|NCT02082886|Heated Intraperitoneal Chemotherapy|heated intraperitoneal chemotherapy
5320420|NCT02082886|Intra-abdominal|intra-abdominal
5320421|NCT02082886|Sugarbaker technique|sugarbaker technique
5320422|NCT02082886|Mitomycin C|mitomycin c
5320423|NCT02082886|Cisplatin|cisplatin
5320424|NCT02082886|Doxorubicin|doxorubicin
5320425|NCT02082886|Oxaliplatin|oxaliplatin
5320426|NCT02082886|Melphalan|melphalan
5320427|NCT02082873|Quantitative EEG|quantitative eeg
5320428|NCT02082873|Nonconvulsive seizures|nonconvulsive seizures
5320429|NCT02082873|ICU EEG monitoring|icu eeg monitoring
5320430|NCT02082860|Porphyria|porphyria
5320431|NCT02082860|Gene therapy|gene therapy
5320432|NCT02082860|AAV|aav
5320433|NCT02082860|Liver gene transfer|liver gene transfer
5320434|NCT02082834|Endovascular aneurysm repair EVAR|endovascular aneurysm repair evar
5320435|NCT02082834|Endoleak/diagnosis|endoleak/diagnosis
5320436|NCT02082834|VEOTM|veotm
5320437|NCT02082834|Model-based iterative reconstruction (MBIR)|model-based iterative reconstruction (mbir)
5320438|NCT02082834|Adaptive statistical iterative reconstruction (ASIR)|adaptive statistical iterative reconstruction (asir)
5320439|NCT02082834|Aortic Aneurysm|aortic aneurysm
5320440|NCT02082834|Low dose|low dose
5320441|NCT02082834|Prospective|prospective
5320442|NCT02082834|CTA|cta
5320443|NCT02082808|Dolutegravir|dolutegravir
5320444|NCT02082808|healthy volunteer|healthy volunteer
5320445|NCT02082808|pharmacokinetics|pharmacokinetics
5320446|NCT02082808|daclatasvir|daclatasvir
5320447|NCT02082808|drug interaction|drug interaction
5320448|NCT02082795|Breech presentation|breech presentation
5320449|NCT02082795|External cephalic version|external cephalic version
5320450|NCT02082795|Anaesthesia|anaesthesia
5320451|NCT02082795|Qualitative|qualitative
5320452|NCT02082795|Pregnancy|pregnancy
5320453|NCT02082782|Colorectal liver metastases (CRLM)|colorectal liver metastases (crlm)
5320454|NCT02082782|Tumor ablation|tumor ablation
5320455|NCT02082782|Irreversible electroporation (IRE)|irreversible electroporation (ire)
5320456|NCT02082782|Interventional oncology|interventional oncology
5320457|NCT02082782|NanoKnife|nanoknife
5320458|NCT02082782|Colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts|colorectal liver metastasis, unresectable and not-thermally ablative due to location near vulnerable structures like vessels or bile ducts
5320459|NCT02082769|Gout|gout
5320460|NCT02082769|Uric Acid|uric acid
5320461|NCT02082769|Xanthine oxidase|xanthine oxidase
5320462|NCT02082769|Febuxostat|febuxostat
5320463|NCT02082756|Prediabetes|prediabetes
5320464|NCT02082756|Berberine Hydrochloride|berberine hydrochloride
5320465|NCT02082756|Bifidobacterium|bifidobacterium
5320466|NCT02082743|Myopia|myopia
5320467|NCT02082743|Outdoor activity|outdoor activity
5320468|NCT02082743|Recess outside classroom|recess outside classroom
5320469|NCT02082730|CFS/ME, Chronic fatigue syndrome, Pediatric, remote mobile technology|cfs/me, chronic fatigue syndrome, pediatric, remote mobile technology
5320470|NCT02082704|Diabetes|diabetes
5320471|NCT02082704|Education, Patient|education, patient
5320472|NCT02082704|Educational Technology|educational technology
5320473|NCT02082691|G-202|g-202
5320474|NCT02082691|Hepatocellular|hepatocellular
5320475|NCT02082678|Bipolar Disorder|bipolar disorder
5320476|NCT02082678|BPD|bpd
5320477|NCT02082678|Alcohol Use Disorder|alcohol use disorder
5320478|NCT02082678|Alcohol Abuse|alcohol abuse
5320479|NCT02082678|Alcohol Dependence|alcohol dependence
5320480|NCT02082678|Ondansetron|ondansetron
5320481|NCT02082678|Cognition|cognition
5320482|NCT02082678|Mood|mood
5320483|NCT02082665|rosuvastatin|rosuvastatin
5320484|NCT02082665|BRAF V600|braf v600
5320485|NCT02082665|Melanoma|melanoma
5320486|NCT02082665|dabrafenib|dabrafenib
5320487|NCT02082665|midazolam|midazolam
5320488|NCT02082652|Etonogestrel|etonogestrel
5320489|NCT02082652|Efavirenz|efavirenz
5320490|NCT02082652|Nevirapine|nevirapine
5320491|NCT02082652|Pharmacokinetics|pharmacokinetics
5320492|NCT02082639|Adolescents|adolescents
5320493|NCT02082639|Havrix|havrix
5320494|NCT02082639|Immunogenicity|immunogenicity
5320495|NCT02082639|Cervarix|cervarix
5320496|NCT02082639|Safety|safety
5320497|NCT02082626|Phase I|phase i
5320498|NCT02082626|Pediatric|pediatric
5188991|NCT02809443|DNA|dna
5200997|NCT02737930|Fluoxetine|fluoxetine
5320499|NCT02082626|Cancer|cancer
5320500|NCT02082626|Lymphoma|lymphoma
5320501|NCT02082626|Eribulin|eribulin
5320502|NCT02082613|Testicular hydrocele|testicular hydrocele
5320503|NCT02082613|Hydrocele|hydrocele
5320504|NCT02082613|Sclerotherapy|sclerotherapy
5320505|NCT02082613|Surgery|surgery
5320506|NCT02082613|Complications|complications
5320512|NCT02082561|anxiety|anxiety
5320513|NCT02082561|panic disorder|panic disorder
5320514|NCT02082561|generalized anxiety disorder|generalized anxiety disorder
5320515|NCT02082561|social anxiety disorder|social anxiety disorder
5320516|NCT02082548|atrial fibrillation|atrial fibrillation
5320517|NCT02082548|anticoagulation|anticoagulation
5320518|NCT02082548|education|education
5320519|NCT02082548|educational intervention|educational intervention
5320520|NCT02082535|Premature Birth|premature birth
5320521|NCT02082535|Brain Injuries|brain injuries
5320522|NCT02082535|Leukomalacia Periventricular|leukomalacia periventricular
5320523|NCT02082535|S100B protein human|s100b protein human
5320524|NCT02082535|Glial Fibrillary Acidic Protein|glial fibrillary acidic protein
5320525|NCT02082535|Magnetic Resonance Imaging|magnetic resonance imaging
5320526|NCT02082535|Developmental Disabilities|developmental disabilities
5320527|NCT02082522|Cholangiocarcinoma|cholangiocarcinoma
5320528|NCT02082522|Unresectable perihilar cholangiocarcinoma|unresectable perihilar cholangiocarcinoma
5320529|NCT02082522|Klatskin tumor|klatskin tumor
5320530|NCT02082522|Photodynamic therapy|photodynamic therapy
5320531|NCT02082522|Porfimer sodium|porfimer sodium
5320532|NCT02082522|Photofrin|photofrin
5320533|NCT02082522|Gemcitabine|gemcitabine
5320534|NCT02082522|Cisplatin|cisplatin
5320535|NCT02082522|Stents|stents
5320536|NCT02082522|CCA|cca
5320537|NCT02082522|PDT|pdt
5320538|NCT02082522|Bile duct cancer|bile duct cancer
5320539|NCT02082522|Bile duct tumor|bile duct tumor
5320540|NCT02082522|Bile duct adenocarcinoma|bile duct adenocarcinoma
5320541|NCT02082522|Chemotherapy|chemotherapy
5320542|NCT02082509|Traumatic Brain Injury|traumatic brain injury
5320543|NCT02082509|Post-Concussive Symptoms|post-concussive symptoms
5320544|NCT02082509|Brain Imaging|brain imaging
5320545|NCT02082509|Cognition|cognition
5320546|NCT02082496|Obesity|obesity
5320547|NCT02082496|Obesity Genetics|obesity genetics
5320548|NCT02082496|GLP-1|glp-1
5320549|NCT02082496|GLP-1 Receptor Agonists|glp-1 receptor agonists
5320550|NCT02082483|Kidney Transplant|kidney transplant
5320551|NCT02082483|Screening|screening
5320552|NCT02082457|Irritable Bowel Syndrome|irritable bowel syndrome
5320553|NCT02082457|Constipation|constipation
5320554|NCT02082457|C-IBS|c-ibs
5320555|NCT02082431|Sensorineural hearing loss|sensorineural hearing loss
5320556|NCT02082431|Long QT Syndrome|long qt syndrome
5320557|NCT02082418|Mild cognitive impairment|mild cognitive impairment
5320558|NCT02082418|Protein digestion|protein digestion
5320559|NCT02082418|Tryptophan digestion|tryptophan digestion
5320560|NCT02082418|Cognitive function|cognitive function
5320561|NCT02082418|Mood|mood
5320562|NCT02082418|Muscle function|muscle function
5320563|NCT02082418|Alpha-lactalbumin|alpha-lactalbumin
5320564|NCT02082379|Interface, aerosol, child, acceptance|interface, aerosol, child, acceptance
5320565|NCT02082366|Atrial fibrillation|atrial fibrillation
5320566|NCT02082366|CPVI|cpvi
5320567|NCT02082366|TCD|tcd
5320568|NCT02082366|nMARQ|nmarq
5320569|NCT02082366|MES|mes
5320570|NCT02082366|microembolic signals|microembolic signals
5320571|NCT02082353|Granulomatous Disease, Chronic|granulomatous disease, chronic
5320572|NCT02082353|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5320573|NCT02082353|bone marrow transplant (BMT)|bone marrow transplant (bmt)
5320574|NCT02082353|non-transplant|non-transplant
5320575|NCT02082353|factors associated with best outcomes of transplant in CGD|factors associated with best outcomes of transplant in cgd
5320581|NCT02082327|Fabry Disease|fabry disease
5320582|NCT02082327|Fabry|fabry
5320583|NCT02082327|Lysosomal storage disorders|lysosomal storage disorders
5320584|NCT02082327|LSD|lsd
5320585|NCT02082327|Amicus|amicus
5320588|NCT02082327|AT1001|at1001
5320589|NCT02082314|radiofrequency ablation|radiofrequency ablation
5320590|NCT02082314|bone metastases|bone metastases
5320591|NCT02082288|ICSI outcome|icsi outcome
5320592|NCT02082275|Prenatal Care|prenatal care
5320593|NCT02082275|Obstetrics|obstetrics
5320594|NCT02082249|Safety|safety
5320595|NCT02082249|Tolerability|tolerability
5320596|NCT02082249|Efficacy|efficacy
5320602|NCT02082223|Quality of life|quality of life
5320603|NCT02082223|Deficits|deficits
5320604|NCT02082223|Complex gastrointestinal surgery|complex gastrointestinal surgery
5320605|NCT02082197|low testosterone|low testosterone
5320610|NCT02082171|multidomain intervention|multidomain intervention
5320611|NCT02082171|prevention|prevention
5320612|NCT02082171|pilot study|pilot study
5320613|NCT02082171|frailty|frailty
5320614|NCT02082171|mobility|mobility
5320615|NCT02082171|comprehensive geriatric assessment|comprehensive geriatric assessment
5963188|NCT04267536|C-reactive protein (CRP)|c-reactive protein (crp)
5963189|NCT04267471|Tai Chi|tai chi
5269818|NCT02331966|FGF-23|fgf-23
5189075|NCT02808910|food intake|food intake
5320616|NCT02082145|NMES|nmes
5320617|NCT02082145|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5320618|NCT02082106|alpine skiing|alpine skiing
5320619|NCT02082106|cross country skiing|cross country skiing
5320620|NCT02082106|indoor cycling|indoor cycling
5320621|NCT02082106|physical fitness|physical fitness
5320622|NCT02082106|training status|training status
5320623|NCT02082106|metabolic equivalent|metabolic equivalent
5320624|NCT02082093|Chronic Kidney Disease|chronic kidney disease
5320625|NCT02082093|telemedicine|telemedicine
5320626|NCT02082054|rhinitis|rhinitis
5320627|NCT02082054|seasonal|seasonal
5320628|NCT02082054|allergic|allergic
5320629|NCT02082015|Neuronal plasticity|neuronal plasticity
5320630|NCT02082015|Transcranial magnetic stimulation|transcranial magnetic stimulation
5320631|NCT02082015|Stroke|stroke
5320632|NCT02082015|Upper extremity|upper extremity
5320633|NCT02082015|Function|function
5320634|NCT02082015|Recovery|recovery
5320635|NCT02082002|Multiple scerlosis|multiple scerlosis
5320636|NCT02082002|Fatigue|fatigue
5320637|NCT02082002|Sleep|sleep
5320638|NCT02082002|Somnolence|somnolence
5320639|NCT02082002|Depression|depression
5320640|NCT02082002|Cognitive disorders|cognitive disorders
5320641|NCT02081989|Diabetes|diabetes
5320642|NCT02081989|Renal denervation|renal denervation
5320643|NCT02081963|Nebulized amikacin;|nebulized amikacin;
5320644|NCT02081963|Non-Cystic Fibrosis Bronchiectasis;|non-cystic fibrosis bronchiectasis;
5320645|NCT02081963|Bacterial clearance rate of sputum；|bacterial clearance rate of sputum；
5320646|NCT02081963|Acute exacerbation.|acute exacerbation.
5320647|NCT02081937|chimeric antigen receptor|chimeric antigen receptor
5320648|NCT02081937|immunotherapy|immunotherapy
5320649|NCT02081937|T lymphocyte|t lymphocyte
5320650|NCT02081937|mantle cell lymphoma|mantle cell lymphoma
5320651|NCT02081924|Infertility|infertility
5320652|NCT02081924|Kisspeptin|kisspeptin
5320653|NCT02081924|Reproductive hormones|reproductive hormones
5320654|NCT02081911|adductor canal|adductor canal
5320655|NCT02081911|femoral|femoral
5320656|NCT02081911|quadriceps|quadriceps
5320657|NCT02081898|low calorie diet|low calorie diet
5320658|NCT02081898|BMI|bmi
5320659|NCT02081898|sphingomyelin|sphingomyelin
5320660|NCT02081898|L-leucine|l-leucine
5320661|NCT02081898|L-phenylalanine|l-phenylalanine
5320662|NCT02081885|Tricalcium phosphate|tricalcium phosphate
5320663|NCT02081885|Chitosan|chitosan
5320664|NCT02081885|Grafting, Bone|grafting, bone
5320665|NCT02081885|Mandibular Fractures|mandibular fractures
5320666|NCT02081872|Pharmacogenomics|pharmacogenomics
5320667|NCT02081872|Target Drug Related Adverse Events (TDAE)|target drug related adverse events (tdae)
5320668|NCT02081846|transitions of care|transitions of care
5320669|NCT02081846|reutilization|reutilization
5320670|NCT02081846|home nurse visit|home nurse visit
5320671|NCT02081846|focus groups|focus groups
5320672|NCT02081846|quality improvement|quality improvement
5320673|NCT02081833|acute respiratory infections|acute respiratory infections
5320674|NCT02081833|acute gastrointestinal infections|acute gastrointestinal infections
5320675|NCT02081833|children|children
5320676|NCT02081833|child|child
5320677|NCT02081833|symptom diary|symptom diary
5320678|NCT02081833|nasal swabs|nasal swabs
5320679|NCT02081833|stool samples|stool samples
5320680|NCT02081820|hyperglycemia|hyperglycemia
5320681|NCT02081820|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5320682|NCT02081820|glycated hemoglobin|glycated hemoglobin
5320683|NCT02081820|outcome|outcome
5320685|NCT02081768|Rathke's cleft cyst|rathke's cleft cyst
5320686|NCT02081768|cystic craniopharyngiomas|cystic craniopharyngiomas
5320687|NCT02081755|Immunosuppressive Agents|immunosuppressive agents
5320688|NCT02081755|Liver Transplantation|liver transplantation
5320689|NCT02081742|Colonoscopy, CT colonography, Colon capsule|colonoscopy, ct colonography, colon capsule
5320690|NCT02081703|Postsurgical pain|postsurgical pain
5320691|NCT02081703|Total knee arthroplasty|total knee arthroplasty
5320692|NCT02081703|Total knee replacement|total knee replacement
5320700|NCT02081638|Immune Activation|immune activation
5320711|NCT02081586|Self-management|self-management
5320712|NCT02081573|Brief CBT|brief cbt
5320713|NCT02081573|smartphone app|smartphone app
5320714|NCT02081573|mHealth|mhealth
5320715|NCT02081573|diabetes distress|diabetes distress
5320716|NCT02081573|adherence|adherence
5320717|NCT02081573|cognitive behavioral therapy|cognitive behavioral therapy
5320718|NCT02081560|pharmacokinetics|pharmacokinetics
5320719|NCT02081560|antibiotic|antibiotic
5320720|NCT02081560|Gram negative|gram negative
5320721|NCT02081560|continuous renal replacement therapy|continuous renal replacement therapy
5320722|NCT02081547|rectal carcinoma|rectal carcinoma
5320723|NCT02081547|recurrence|recurrence
5320724|NCT02081547|pathology|pathology
5320725|NCT02081547|cytology|cytology
5320726|NCT02081547|free cancer cells|free cancer cells
5320727|NCT02081547|survival|survival
5369177|NCT01860963|Anal dysplasia|anal dysplasia
5369178|NCT01860963|IBD|ibd
5963190|NCT04267471|Hypertension|hypertension
5963191|NCT04267471|Randomized Controlled Trial|randomized controlled trial
5320728|NCT02081534|S-phosphate, hyperphosphatemia, hemodialysis, ESRD|s-phosphate, hyperphosphatemia, hemodialysis, esrd
5320729|NCT02081521|behaviour change|behaviour change
5320730|NCT02081521|diarrhoeal disease|diarrhoeal disease
5320731|NCT02081521|handwashing|handwashing
5320732|NCT02081521|breastfeeding|breastfeeding
5320733|NCT02081521|diarrhoea management|diarrhoea management
5320734|NCT02081508|Memory|memory
5320735|NCT02081495|Neoplasms|neoplasms
5320736|NCT02081495|Neoplasms, Ovarian|neoplasms, ovarian
5320737|NCT02081495|Ovarian Cancer|ovarian cancer
5320738|NCT02081495|Advanced or Refractory Solid Malignancies|advanced or refractory solid malignancies
5320739|NCT02081495|Doxorubicin|doxorubicin
5320740|NCT02081495|DOXIL|doxil
5320741|NCT02081495|CAELYX|caelyx
5320742|NCT02081469|Chronic hepatitis B|chronic hepatitis b
5320743|NCT02081469|HBV|hbv
5320744|NCT02081469|Chemotherapy|chemotherapy
5320745|NCT02081469|Reactivation|reactivation
5320746|NCT02081469|Prophylaxis|prophylaxis
5320747|NCT02081443|coronary artery disease|coronary artery disease
5320748|NCT02081443|platelet function|platelet function
5320749|NCT02081443|ticagrelor|ticagrelor
5320750|NCT02081443|cangrelor|cangrelor
5320751|NCT02081417|Trauma|trauma
5320752|NCT02081417|Post traumatic stress disorder|post traumatic stress disorder
5320753|NCT02081417|substance use disorders|substance use disorders
5320754|NCT02081417|peer-delivered trauma treatment|peer-delivered trauma treatment
5320755|NCT02081404|Non-erosive Reflux Disease|non-erosive reflux disease
5320756|NCT02081391|Acute Pain|acute pain
5320757|NCT02081391|Post-operative|post-operative
5320758|NCT02081391|Tapentadol|tapentadol
5320759|NCT02081391|Opioid Treatment|opioid treatment
5320760|NCT02081391|Pediatric Participants|pediatric participants
5320761|NCT02081378|CML|cml
5320762|NCT02081378|Ph+ ALL|ph+ all
5320763|NCT02081352|Dermis|dermis
5320764|NCT02081352|Diabetic foot ulcers|diabetic foot ulcers
5320765|NCT02081352|Skin substitutes|skin substitutes
5320766|NCT02081352|Decellularized|decellularized
5320767|NCT02081326|Diabetes Mellitus, Type One|diabetes mellitus, type one
5320768|NCT02081326|Diabetes Mellitus, Type I|diabetes mellitus, type i
5320769|NCT02081326|Autoimmune Diabetes|autoimmune diabetes
5445405|NCT01521975|HBeAg negative hepatitis|hbeag negative hepatitis
5320770|NCT02081326|Insulin Dependent Diabetes Mellitus 1|insulin dependent diabetes mellitus 1
5320771|NCT02081326|IDDM|iddm
5320772|NCT02081313|Netherton syndrome|netherton syndrome
5320773|NCT02081313|Immune system|immune system
5320774|NCT02081313|Skin barrier|skin barrier
5320775|NCT02081300|Testosterone|testosterone
5320776|NCT02081300|Male hypogonadism|male hypogonadism
5320777|NCT02081300|Low testosterone|low testosterone
5320778|NCT02081300|LPCN 1021|lpcn 1021
5320779|NCT02081300|Androgel|androgel
5320780|NCT02081300|Testim|testim
5320781|NCT02081300|Testopel|testopel
5320782|NCT02081300|Fortesta|fortesta
5320783|NCT02081300|Axiron.|axiron.
5320784|NCT02081300|Hypogonadism|hypogonadism
5320785|NCT02081300|Eunuchism|eunuchism
5320786|NCT02081300|Gonadal Disorders|gonadal disorders
5320787|NCT02081300|Endocrine System Diseases|endocrine system diseases
5320788|NCT02081300|Testosterone enanthate|testosterone enanthate
5320802|NCT02081287|Inositol|inositol
5320803|NCT02081287|Inositol Hexaphosphate|inositol hexaphosphate
5435325|NCT01565265|FSH|fsh
5320804|NCT02081287|Phytic Acid|phytic acid
5320805|NCT02081287|IP6|ip6
5320806|NCT02081287|Lithium|lithium
5320807|NCT02081287|Lamotrigine|lamotrigine
5320808|NCT02081274|tidal volume|tidal volume
5320809|NCT02081274|congenital heart disease|congenital heart disease
5320810|NCT02081274|mortality|mortality
5320811|NCT02081261|coronary artery bypass surgery|coronary artery bypass surgery
5320812|NCT02081261|acute kidney injury|acute kidney injury
5320813|NCT02081261|creatinine|creatinine
5320814|NCT02081261|mortality|mortality
5320816|NCT02081235|acute kidney injury|acute kidney injury
5320817|NCT02081235|risk factor|risk factor
5320818|NCT02081235|anesthesia|anesthesia
5320819|NCT02081222|congenital heart disease|congenital heart disease
5320820|NCT02081222|rotational thromboelastometry|rotational thromboelastometry
5320821|NCT02081222|blood loss|blood loss
5320822|NCT02081222|transfusion requirements|transfusion requirements
5320823|NCT02081209|Lipolysis|lipolysis
5320824|NCT02081209|Cryolipolysis|cryolipolysis
5320825|NCT02081209|Fat Reduction|fat reduction
5320826|NCT02081196|Lipolysis|lipolysis
5320827|NCT02081196|Cryolipolysis|cryolipolysis
5320828|NCT02081196|Fat Reduction|fat reduction
5320829|NCT02081144|Standard Care Condition|standard care condition
5320830|NCT02081144|Texting + NRT Condition|texting + nrt condition
5320831|NCT02081131|periampullary cancer|periampullary cancer
5320832|NCT02081131|pancreatic cancer|pancreatic cancer
5320833|NCT02081131|randomized controlled trial|randomized controlled trial
5320834|NCT02081131|Whipple's operation|whipple's operation
5320835|NCT02081131|laparoscopy|laparoscopy
5320836|NCT02081105|ARDS,|ards,
5320837|NCT02081105|PEEP,|peep,
5320838|NCT02081105|lung recruitment,|lung recruitment,
5320839|NCT02081105|lung recruitability,|lung recruitability,
5320840|NCT02081105|Chest-X-Ray,|chest-x-ray,
5320841|NCT02081105|lung imaging,|lung imaging,
5369179|NCT01860963|HPV DNA|hpv dna
5320842|NCT02081105|Pressure/Volume (PV) curve,|pressure/volume (pv) curve,
5320844|NCT02081105|respiratory mechanics|respiratory mechanics
5320846|NCT02081092|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
5320847|NCT02081092|Pulmonary|pulmonary
5320848|NCT02081092|Patients|patients
5320849|NCT02081079|HCV GT 4|hcv gt 4
5320850|NCT02081079|HCV GT 5|hcv gt 5
5320851|NCT02081053|metastatic lesions|metastatic lesions
5320852|NCT02081053|vertebral body|vertebral body
5320853|NCT02081053|ablation|ablation
5320854|NCT02081053|targeted radio-frequency ablation|targeted radio-frequency ablation
5320855|NCT02081053|radio-frequency targeted vertebral augmentation|radio-frequency targeted vertebral augmentation
5320856|NCT02081053|radiofrequency kyphoplasty|radiofrequency kyphoplasty
5320857|NCT02081053|spine|spine
5320858|NCT02081053|vertebral augmentation|vertebral augmentation
5320859|NCT02081053|kyphoplasty|kyphoplasty
5320860|NCT02081053|spinal ablation|spinal ablation
5320861|NCT02081053|pain|pain
5320862|NCT02081053|quality of life|quality of life
5320863|NCT02081040|brainstem|brainstem
5320864|NCT02081040|diaphragm|diaphragm
5320865|NCT02081040|deglutition disorder|deglutition disorder
5320866|NCT02081040|sonography|sonography
5320867|NCT02081014|Hypoglycemia|hypoglycemia
5320868|NCT02081014|Glucagon|glucagon
5320869|NCT02081014|Diabetes|diabetes
5320870|NCT02081001|Hypoglycemia|hypoglycemia
5320871|NCT02081001|Glucagon|glucagon
5325284|NCT02060799|Dyspnea|dyspnea
5320872|NCT02081001|Artificial Pancreas|artificial pancreas
5320873|NCT02080988|stroke|stroke
5320874|NCT02080988|deglutition disorders|deglutition disorders
5320875|NCT02080988|cough|cough
5320876|NCT02080988|aspiration pneumonia|aspiration pneumonia
5320877|NCT02080988|diaphragm|diaphragm
5320878|NCT02080988|respiratory function|respiratory function
5320879|NCT02080962|non-melanoma skin cancer, radiotherapy, orthovoltage|non-melanoma skin cancer, radiotherapy, orthovoltage
5320880|NCT02080949|brain metastases, hypofractionated stereotactic radiotherapy|brain metastases, hypofractionated stereotactic radiotherapy
5320881|NCT02080936|Experimental approaches|experimental approaches
5320882|NCT02080936|Peripheral muscle Keyword|peripheral muscle keyword
5320883|NCT02080936|Rehabilitation|rehabilitation
5320884|NCT02080923|Adolescent|adolescent
5320885|NCT02080923|Adolescent Behavior|adolescent behavior
5320886|NCT02080923|Age Factors|age factors
5320887|NCT02080923|Courtship|courtship
5320888|NCT02080923|Randomized Control Trial|randomized control trial
5320889|NCT02080923|Female|female
5320890|NCT02080923|Male|male
5320891|NCT02080923|Minority Groups/statistics & numerical data|minority groups/statistics & numerical data
5320892|NCT02080923|Risk-Taking|risk-taking
5320893|NCT02080923|Sex Factors|sex factors
5320894|NCT02080923|Sexual Behavior/statistics & numerical data|sexual behavior/statistics & numerical data
5320895|NCT02080923|Substance-Related Disorders/epidemiology|substance-related disorders/epidemiology
5320896|NCT02080923|Urban Population/statistics & numerical data|urban population/statistics & numerical data
5320897|NCT02080923|Violence/statistics & numerical data|violence/statistics & numerical data
5320898|NCT02080923|Dating Violence|dating violence
5320899|NCT02080923|Dating Aggression|dating aggression
5320900|NCT02080923|Perpetration|perpetration
5320901|NCT02080910|Caregiver|caregiver
5320903|NCT02080910|psychoeducation|psychoeducation
5320904|NCT02080910|problem-solving|problem-solving
5320905|NCT02080897|non-surgical|non-surgical
5320906|NCT02080897|palliative surgery|palliative surgery
5320907|NCT02080871|PAD|pad
5320908|NCT02080871|Stent|stent
5320909|NCT02080871|Claudication|claudication
5320910|NCT02080871|Viabahn|viabahn
5320911|NCT02080871|Gore|gore
5320912|NCT02080871|Endoprosthesis|endoprosthesis
5320913|NCT02080871|Vascular Diseases|vascular diseases
5320914|NCT02080871|Cardiovascular Diseases|cardiovascular diseases
5320915|NCT02080871|Iliac Occlusive Disease|iliac occlusive disease
5320916|NCT02080871|Balloon Expandable|balloon expandable
5320917|NCT02080871|Stent-graft|stent-graft
5320919|NCT02080858|Apixaban|apixaban
5320920|NCT02080858|Ticagrelor|ticagrelor
5320921|NCT02080858|ASA|asa
5320922|NCT02080858|shed blood|shed blood
5320923|NCT02080858|perfusion chamber|perfusion chamber
5320924|NCT02080845|Caffeine|caffeine
5320925|NCT02080845|MRI|mri
5320926|NCT02080845|Brain blood flow|brain blood flow
5320927|NCT02080845|Cognition|cognition
5320928|NCT02080845|Perfusion|perfusion
5320929|NCT02080845|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
5320930|NCT02080832|substance abuse|substance abuse
5320931|NCT02080832|cocaine|cocaine
5320932|NCT02080832|impulsivity|impulsivity
5320933|NCT02080832|serotonin|serotonin
5320934|NCT02080832|MRI|mri
5320935|NCT02080819|drug abuse|drug abuse
5320936|NCT02080819|cocaine|cocaine
5320937|NCT02080819|impulsivity|impulsivity
5320938|NCT02080819|dopamine|dopamine
5320939|NCT02080806|stroke, dysphagia, cough, mechanical insufflation exsufflation|stroke, dysphagia, cough, mechanical insufflation exsufflation
5320940|NCT02080754|Crush induction|crush induction
5320941|NCT02080754|Cricoid pressure|cricoid pressure
5320942|NCT02080754|Sellick maneuver|sellick maneuver
5320943|NCT02080754|Lung aspiration|lung aspiration
5320944|NCT02080754|Aspiration pneumonia|aspiration pneumonia
5320946|NCT02080715|regulation|regulation
5320947|NCT02080715|volunteers|volunteers
5320948|NCT02080702|GIT, Monosyn, anastomoses leakage|git, monosyn, anastomoses leakage
5320949|NCT02080676|Cannabis|cannabis
5320950|NCT02080676|Intra ocular pressure|intra ocular pressure
5320951|NCT02080676|Ocular perfusion|ocular perfusion
5320952|NCT02080676|Blood pressure|blood pressure
5320953|NCT02080663|carpectomy, proximal row, long-term, wrist, arthritis|carpectomy, proximal row, long-term, wrist, arthritis
5320954|NCT02080637|Single ventricle|single ventricle
5320955|NCT02080585|Inactivity|inactivity
5320956|NCT02080546|Vaginal cuff dehiscence|vaginal cuff dehiscence
5320957|NCT02080546|Thermal Injury|thermal injury
5320958|NCT02080546|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
5320959|NCT02080533|pulmonary arterial hypertension|pulmonary arterial hypertension
5320960|NCT02080533|symptoms|symptoms
5320961|NCT02080533|dyspnea|dyspnea
5320962|NCT02080533|fatigue|fatigue
5320963|NCT02080533|sleep|sleep
5320964|NCT02080520|Prevention|prevention
5320965|NCT02080520|Soy|soy
5320966|NCT02080520|Fermented soy|fermented soy
5320967|NCT02080520|Nattokinase|nattokinase
5320968|NCT02080520|Randomized controlled trial|randomized controlled trial
5320969|NCT02080520|Carotid artery|carotid artery
5320970|NCT02080520|Cognition|cognition
5320971|NCT02080520|Atherothrombosis|atherothrombosis
5320972|NCT02080507|rTMS|rtms
5320973|NCT02080507|depression|depression
5320974|NCT02080507|ECT|ect
5320975|NCT02080494|tranexamic acid|tranexamic acid
5320976|NCT02080494|orthopaedic trauma|orthopaedic trauma
5320977|NCT02080494|pelvic fracture|pelvic fracture
5320978|NCT02080494|hip fracture|hip fracture
5320979|NCT02080494|femur fracture|femur fracture
5320980|NCT02080494|blood loss|blood loss
5320981|NCT02080468|Effect|effect
5320982|NCT02080468|Ethinyl Estradiol/Norgestimate|ethinyl estradiol/norgestimate
5445406|NCT01521975|CHB|chb
5320983|NCT02080468|Pharmacokinetics|pharmacokinetics
5320984|NCT02080468|Lomitapide.|lomitapide.
5320985|NCT02080442|COPD|copd
5320986|NCT02080442|Balance|balance
5320987|NCT02080442|Pulmonary Rehabilitation|pulmonary rehabilitation
5320988|NCT02080416|EBV|ebv
5320989|NCT02080416|KSHV|kshv
5320990|NCT02080416|malignancy|malignancy
5320991|NCT02080416|lymphoma|lymphoma
5320992|NCT02080416|sarcoma|sarcoma
5320993|NCT02080416|virus-associated|virus-associated
5320994|NCT02080403|Peri-Implantitis|peri-implantitis
5320995|NCT02080403|Periodontal Diseases|periodontal diseases
5320996|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate
5320997|NCT02080403|PerioChip|periochip
5320998|NCT02080403|Anti-Infective Agents|anti-infective agents
5320999|NCT02080403|Mouth Diseases|mouth diseases
5321000|NCT02080403|Antiseptics|antiseptics
5321001|NCT02080390|Her 2 Positive Breast Cancer|her 2 positive breast cancer
5321002|NCT02080390|Trastuzumab|trastuzumab
5321003|NCT02080390|Herceptin|herceptin
5321004|NCT02080390|Heart Failure|heart failure
5321005|NCT02080390|Echocardiography|echocardiography
5321006|NCT02080377|Pregnancy|pregnancy
5321007|NCT02080377|Gestational diabetes|gestational diabetes
5321008|NCT02080377|Glycaemic control|glycaemic control
5321009|NCT02080377|Metformin|metformin
5321013|NCT02080364|CDR-sb|cdr-sb
5321014|NCT02080338|Orthodontic, Bracket slot, Effective, Randomized, Duration|orthodontic, bracket slot, effective, randomized, duration
5321015|NCT02080325|weight loss|weight loss
5321016|NCT02080325|high protein diet|high protein diet
5321017|NCT02080325|plant protein|plant protein
5321018|NCT02080325|satiety|satiety
5321024|NCT02080286|brain stimulation|brain stimulation
5321025|NCT02080286|tDCS|tdcs
5321026|NCT02080286|prism adaptation|prism adaptation
5321027|NCT02080234|Lymphoma, Extranodal NK-T-Cell|lymphoma, extranodal nk-t-cell
5321028|NCT02080234|asparaginase|asparaginase
5321029|NCT02080234|GELOX|gelox
5321030|NCT02080234|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5321031|NCT02080234|sIL-2R|sil-2r
5321035|NCT02080208|hypoxemia|hypoxemia
5321036|NCT02080208|high flow oxygen therapy|high flow oxygen therapy
5321037|NCT02080208|respiratory failure|respiratory failure
5321038|NCT02080182|Acute Pyelonephritis|acute pyelonephritis
5321039|NCT02080182|Acetylcysteine|acetylcysteine
5321040|NCT02080182|Pediatric|pediatric
5321041|NCT02080169|Intensive care unit|intensive care unit
5321042|NCT02080169|Mechanical ventilation|mechanical ventilation
5321043|NCT02080169|Combined sedation|combined sedation
5321044|NCT02080156|Obstructive Sleep Apnea|obstructive sleep apnea
5321045|NCT02080156|Percutaneous Coronary Intervention|percutaneous coronary intervention
5321046|NCT02080156|Coronary Artery Bypass Graft|coronary artery bypass graft
5321047|NCT02080156|Mortality|mortality
5321048|NCT02080156|Questionnaire|questionnaire
5321049|NCT02080156|Biomarker|biomarker
5321050|NCT02080143|Skin temperature measurements|skin temperature measurements
5321051|NCT02080143|Heat patch adhesion|heat patch adhesion
5321052|NCT02080143|Dermal irritation|dermal irritation
5201473|NCT02734875|machine learning algorithm|machine learning algorithm
5201474|NCT02734875|primary care|primary care
5201475|NCT02734862|mycoses|mycoses
5201476|NCT02734810|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5201477|NCT02734810|Cystic Fibrosis|cystic fibrosis
5201478|NCT02734810|Liprotamase|liprotamase
5201479|NCT02734810|Pancreatic Enzyme Replacement Therapy (PERT)|pancreatic enzyme replacement therapy (pert)
5201480|NCT02734771|DLBCL|dlbcl
5201481|NCT02734745|diabetes type 1|diabetes type 1
5201482|NCT02734745|flash glucose monitoring|flash glucose monitoring
5201483|NCT02734732|Prostate|prostate
5201484|NCT02734732|Biopsy|biopsy
5201485|NCT02734732|Infection|infection
5201486|NCT02734732|Prophylaxis|prophylaxis
5201487|NCT02734732|Antibiotic|antibiotic
5201493|NCT02734654|lung lobectomy|lung lobectomy
5201532|NCT02734524|NCT|nct
5321053|NCT02080130|Gastroenteritis|gastroenteritis
5321054|NCT02080130|diarrhea|diarrhea
5321055|NCT02080117|kidney transplantation|kidney transplantation
5321056|NCT02080117|delayed graft function|delayed graft function
5321057|NCT02080117|creatinine|creatinine
5321058|NCT02080117|graft survival|graft survival
5321059|NCT02080104|postpartum hemorrhage|postpartum hemorrhage
5321060|NCT02080104|oxytocin|oxytocin
5321061|NCT02080104|vaginal delivery|vaginal delivery
5321062|NCT02080104|prophylactic|prophylactic
5321063|NCT02080078|Erlotinib|erlotinib
5321064|NCT02080078|Theophylline|theophylline
5321065|NCT02080078|Diarrhea|diarrhea
5321066|NCT02080065|risk factor|risk factor
5321067|NCT02080065|acute kidney injury|acute kidney injury
5321068|NCT02080065|liver transplantation|liver transplantation
5321069|NCT02080065|postoperative renal function|postoperative renal function
5321070|NCT02080039|Spinal Cord Injury|spinal cord injury
5321071|NCT02080039|Denervation|denervation
5321072|NCT02080039|Electrical Stimulation|electrical stimulation
5321073|NCT02080026|malaria|malaria
5321074|NCT02080026|Plasmodium falciparum|plasmodium falciparum
5321075|NCT02080000|Heart Failure|heart failure
5321076|NCT02080000|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5321077|NCT02080000|Biventricular Pacemaker|biventricular pacemaker
5321078|NCT02080000|Optimisation|optimisation
5321082|NCT02079987|Access to Care|access to care
5321083|NCT02079974|endometriosis|endometriosis
5321085|NCT02079974|fertility|fertility
5321086|NCT02079961|anemia|anemia
5321087|NCT02079961|children|children
5321088|NCT02079961|iron-fortified product|iron-fortified product
5321089|NCT02079961|value chain|value chain
5321090|NCT02079948|Aging|aging
5321091|NCT02079948|Cognitive Function|cognitive function
5321092|NCT02079948|Physical Function|physical function
5321093|NCT02079948|Systematic Inflammation|systematic inflammation
5321094|NCT02079948|Methotrexate|methotrexate
5321095|NCT02079948|Pain Symptoms|pain symptoms
5321097|NCT02079935|Binge|binge
5321098|NCT02079935|overconsumption of food|overconsumption of food
5321099|NCT02079935|purging|purging
5321100|NCT02079935|purge|purge
5321101|NCT02079922|Multiple Ascending Dose|multiple ascending dose
5321102|NCT02079922|healthy subjects|healthy subjects
5321103|NCT02079922|Hypercholesterolemia|hypercholesterolemia
5321104|NCT02079922|Hyperlipidemias|hyperlipidemias
5321105|NCT02079922|Dyslipidemias|dyslipidemias
5321106|NCT02079922|Lipid Metabolism Disorders|lipid metabolism disorders
5321107|NCT02079922|Metabolic Diseases|metabolic diseases
5321108|NCT02079909|Alzheimer's Disease|alzheimer's disease
5321109|NCT02079909|Alzheimer's|alzheimer's
5321110|NCT02079896|Dialysis|dialysis
5321111|NCT02079844|Drug therapy|drug therapy
5321112|NCT02079831|Adolescent obesity|adolescent obesity
5321113|NCT02079831|childhood obesity|childhood obesity
5321114|NCT02079831|anthropometry|anthropometry
5321115|NCT02079831|body weights and measures|body weights and measures
5321116|NCT02079818|visceral artery aneurysms|visceral artery aneurysms
5321117|NCT02079818|arteriovenous malformations|arteriovenous malformations
5321118|NCT02079818|Penumbra Ruby Coil System|penumbra ruby coil system
5321119|NCT02079792|Budesonide|budesonide
5321120|NCT02079792|Mucosal Atomization Device|mucosal atomization device
5321124|NCT02079779|International Classification of Functioning, Disability and Health|international classification of functioning, disability and health
5963192|NCT04267393|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5963193|NCT04267393|Liver Disease|liver disease
5963194|NCT04267393|NASH|nash
5963195|NCT04267393|compensated cirrihosis|compensated cirrihosis
5963196|NCT04266795|Drug Therapy|drug therapy
5963197|NCT04266730|lung cancer|lung cancer
5963198|NCT04266730|head and neck cancer|head and neck cancer
5963199|NCT04266730|neoantigen|neoantigen
5963200|NCT04266730|vaccine|vaccine
5963201|NCT04266730|pembrolizumab|pembrolizumab
5963202|NCT04266470|Monitoring blood flow|monitoring blood flow
5963203|NCT04266470|Metabolic activity in malignant tissue - head/ neck|metabolic activity in malignant tissue - head/ neck
5963204|NCT04266470|Tumor response to therapy|tumor response to therapy
5963205|NCT04266366|Low back pain|low back pain
5963206|NCT04266366|Electroanalgesia|electroanalgesia
5963207|NCT04266366|McKenzie Method|mckenzie method
5963208|NCT04266366|Telemedicine|telemedicine
5321125|NCT02079753|COPD, portable concentrator, oxygen sources|copd, portable concentrator, oxygen sources
5963209|NCT04266366|Study protocol for a Randomized clinical trial|study protocol for a randomized clinical trial
5963210|NCT04266210|non-caries cervical lesions|non-caries cervical lesions
5963211|NCT04266210|glass ionomer|glass ionomer
5321127|NCT02079727|Chondroitin sulfate|chondroitin sulfate
5321128|NCT02079727|Celebrex|celebrex
5321130|NCT02079727|Knee osteoarthritis|knee osteoarthritis
5321131|NCT02079714|Orthopaedic Trauma|orthopaedic trauma
5321132|NCT02079714|Injury|injury
5321133|NCT02079701|pneumonia|pneumonia
5321134|NCT02079701|pneumococcus|pneumococcus
5321135|NCT02079701|vaccine|vaccine
5321136|NCT02079701|23-valent pneumococcal vaccine|23-valent pneumococcal vaccine
5321137|NCT02079701|military recruits|military recruits
5321138|NCT02079688|Antisense oligonucleotide|antisense oligonucleotide
5321139|NCT02079688|atopic eczema|atopic eczema
5321140|NCT02079688|atopic dermatitis|atopic dermatitis
5321141|NCT02079688|Phase II|phase ii
5321142|NCT02079688|Transcription factor GATA-3|transcription factor gata-3
5321143|NCT02079688|dermal application|dermal application
5321144|NCT02079688|Proof-of-Concept|proof-of-concept
5321145|NCT02079649|Allergic conjunctivitis|allergic conjunctivitis
5321146|NCT02079649|Red eyes|red eyes
5321147|NCT02079649|Eyelid swelling|eyelid swelling
5321148|NCT02079649|Ragweed|ragweed
5321149|NCT02079649|Allergies|allergies
5321150|NCT02079649|Itchy eyes|itchy eyes
5321151|NCT02079649|Ocular redness|ocular redness
5321152|NCT02079649|Chemosis|chemosis
5321153|NCT02079649|Tearing|tearing
5321154|NCT02079649|Watery eyes|watery eyes
5321155|NCT02079623|Pancreatic cancer|pancreatic cancer
5321156|NCT02079623|Electroporation|electroporation
5321157|NCT02079623|Nano knife treatment|nano knife treatment
5321158|NCT02079610|Depression|depression
5321159|NCT02079610|Neurofeedback|neurofeedback
5321160|NCT02079610|Amygdala|amygdala
5321161|NCT02079597|SIRS|sirs
5321162|NCT02079597|Ninj1|ninj1
5321163|NCT02079597|Sepsis|sepsis
5321164|NCT02079597|Healthy|healthy
5321165|NCT02079584|Patient Compliance|patient compliance
5321166|NCT02079584|Target Specific Anticoagulant|target specific anticoagulant
5321167|NCT02079584|Quality of Life|quality of life
5321168|NCT02079558|prevention|prevention
5321169|NCT02079558|cesarean section|cesarean section
5321170|NCT02079545|Healthy|healthy
5321171|NCT02079545|Bioavailability|bioavailability
5321172|NCT02079545|Pharmacokinetics|pharmacokinetics
5321173|NCT02079545|Sirukumab|sirukumab
5321174|NCT02079545|Subcutaneous|subcutaneous
5321175|NCT02079545|Male|male
5321176|NCT02079493|osteoarthritis|osteoarthritis
5321177|NCT02079493|knee replacement|knee replacement
5321178|NCT02079493|functional testing|functional testing
5321179|NCT02079467|Arthroplasty, Hip|arthroplasty, hip
5321180|NCT02079467|Replacement, Hip|replacement, hip
5321181|NCT02079467|Postoperative Care|postoperative care
5321182|NCT02079467|Rehabilitation|rehabilitation
5321183|NCT02079441|Anti- TNF|anti- tnf
5321184|NCT02079441|inflammatory bowel disease|inflammatory bowel disease
5321185|NCT02079441|pregnancy|pregnancy
5321186|NCT02079441|infant|infant
5321187|NCT02079441|immunity|immunity
5321188|NCT02079441|Immune function|immune function
5321189|NCT02079428|Heart Failure|heart failure
5321190|NCT02079428|Registry|registry
5321191|NCT02079428|China|china
5321192|NCT02079415|NICU|nicu
5321193|NCT02079402|sepsis|sepsis
5321194|NCT02079402|septic|septic
5321195|NCT02079402|shock|shock
5321197|NCT02079402|intensive|intensive
5321198|NCT02079402|critical|critical
5321199|NCT02079402|resuscitation|resuscitation
5321200|NCT02079402|fluid|fluid
5321201|NCT02079402|IV|iv
5321202|NCT02079402|crystalloid|crystalloid
5321203|NCT02079402|balance|balance
5321204|NCT02079389|colon cancer|colon cancer
5321205|NCT02079389|rectum cancer|rectum cancer
5321206|NCT02079389|laparoscopic ultrasound|laparoscopic ultrasound
5321207|NCT02079389|LUS|lus
5321208|NCT02079389|Contrast enhanced ultrasound|contrast enhanced ultrasound
5321209|NCT02079389|CEUS|ceus
5321210|NCT02079389|Peroperative TNM staging|peroperative tnm staging
5321211|NCT02079389|screening for liver metastases|screening for liver metastases
5321212|NCT02079376|diabetes|diabetes
5321213|NCT02079363|Pancreatic Diseases|pancreatic diseases
5321214|NCT02079363|Pancreatic Neoplasms|pancreatic neoplasms
5321215|NCT02079363|Pancreatitis|pancreatitis
5321216|NCT02079363|DNA promoter hypermethylation|dna promoter hypermethylation
5321217|NCT02079363|DNA methylation|dna methylation
5321218|NCT02079363|Cell-free DNA|cell-free dna
5321219|NCT02079363|Plasma|plasma
5321220|NCT02079324|head and neck cancer|head and neck cancer
5321221|NCT02079324|gene therapy|gene therapy
5321222|NCT02079324|stem cell therapy|stem cell therapy
5321223|NCT02079324|immunotherappy|immunotherappy
5321230|NCT02079272|Heart|heart
5321231|NCT02079272|Subclinical cardiac lesions|subclinical cardiac lesions
5321232|NCT02079272|Myocardial lesions|myocardial lesions
5321233|NCT02079272|Coronary lesions|coronary lesions
5321234|NCT02079272|Circulating biomarkers|circulating biomarkers
5321235|NCT02079272|Ionizing radiation|ionizing radiation
5321236|NCT02079272|Heart absorbed doses|heart absorbed doses
5321237|NCT02079233|Basic Science|basic science
5321238|NCT02079233|Safety|safety
5321239|NCT02079233|Tolerability|tolerability
5321240|NCT02079233|Efficacy of CLP|efficacy of clp
5321241|NCT02079220|Colorectal Cancer|colorectal cancer
5321242|NCT02079220|Metastatic Colorectal Cancer|metastatic colorectal cancer
5321243|NCT02079194|Drug-eluting stents|drug-eluting stents
5321244|NCT02079194|aspirin|aspirin
5321245|NCT02079194|P2Y12 antagonist monotherapy|p2y12 antagonist monotherapy
5321246|NCT02079168|Keloid|keloid
5321247|NCT02079168|Cicatrix|cicatrix
5321248|NCT02079168|Keloid prevention|keloid prevention
5321249|NCT02079168|Keloid revision/excision|keloid revision/excision
5321250|NCT02079168|Keloidectomy|keloidectomy
5321251|NCT02079129|agreement between cMRI PVL grading and TTE PVL grading|agreement between cmri pvl grading and tte pvl grading
5321252|NCT02079129|Edwards Sapien TAVR|edwards sapien tavr
5321253|NCT02079116|Obesity|obesity
5321254|NCT02079116|Lipids|lipids
5321255|NCT02079116|Single Photon Emission Computed Tomography|single photon emission computed tomography
5321256|NCT02079116|Functional Neuroimaging|functional neuroimaging
5321257|NCT02079103|Virtual reality|virtual reality
5321258|NCT02079103|Stroke|stroke
5321259|NCT02079103|Arm motor function|arm motor function
5321260|NCT02079103|Neurorehabilitation|neurorehabilitation
5321261|NCT02079090|Propofol|propofol
5321262|NCT02079090|Ketamine|ketamine
5321263|NCT02079090|Fentanyl|fentanyl
5321264|NCT02079090|Procedural sedation|procedural sedation
5321265|NCT02079090|children|children
5321266|NCT02079090|Emergency Department|emergency department
5321267|NCT02079077|HIV, Immune quiescence, ASA, Hydroxychloroquin|hiv, immune quiescence, asa, hydroxychloroquin
5321268|NCT02079064|Splenectomy|splenectomy
5321269|NCT02079064|Desflurane|desflurane
5321270|NCT02079064|Propofol|propofol
5321272|NCT02079064|ROTEM|rotem
5321273|NCT02079051|Obesity Physical Performance Weight loss Optifast|obesity physical performance weight loss optifast
5321274|NCT02079025|Prostate Biopsy|prostate biopsy
5321275|NCT02079025|Ultrasound guided biopsy of the prostate|ultrasound guided biopsy of the prostate
5321276|NCT02079025|High-resolution ultrasound|high-resolution ultrasound
5321277|NCT02079012|Walking Program|walking program
5321278|NCT02079012|Mental Disorders|mental disorders
5321279|NCT02079012|Physical Activity|physical activity
5321280|NCT02079012|Physical Fitness|physical fitness
5321282|NCT02079012|Depression|depression
5321283|NCT02079012|Self Determination|self determination
5321284|NCT02078999|Mechanical ventilation, procalcitonin, c-reactive protein|mechanical ventilation, procalcitonin, c-reactive protein
5321285|NCT02078986|Whole-Body-Electromyostimulation|whole-body-electromyostimulation
5321286|NCT02078986|High Intensity Resistance Exercise Training (HIT)|high intensity resistance exercise training (hit)
5321287|NCT02078986|Lean Body Mass|lean body mass
5321288|NCT02078986|Muscle Strength|muscle strength
5321289|NCT02078973|Tolvaptan|tolvaptan
5321290|NCT02078973|L-NMMA|l-nmma
5321291|NCT02078973|Healthy subjects|healthy subjects
5321292|NCT02078973|Nephrology|nephrology
5321293|NCT02078960|Chronic Phase|chronic phase
5321294|NCT02078960|Accelerated Phase|accelerated phase
5321296|NCT02078960|Chronic Myeloid Leukemia|chronic myeloid leukemia
5321297|NCT02078947|Diastolic heart failure, Heart failure with preserved ejection fraction, exercise|diastolic heart failure, heart failure with preserved ejection fraction, exercise
5321298|NCT02078934|Surgical Endoscopy|surgical endoscopy
5321299|NCT02078934|Morbid Obesity|morbid obesity
5321300|NCT02078934|Weight Loss|weight loss
5321301|NCT02078934|Bariatrics|bariatrics
5321302|NCT02078934|Complex incisional hernia with mesh|complex incisional hernia with mesh
5321303|NCT02078908|Central blood pressure|central blood pressure
5321304|NCT02078908|Peripheral (brachial) blood pressure|peripheral (brachial) blood pressure
5321305|NCT02078908|Renal variables|renal variables
5321306|NCT02078908|Vasoactive hormones|vasoactive hormones
5321307|NCT02078908|Pharmacology|pharmacology
5321308|NCT02078908|Pharmacokinetics|pharmacokinetics
5321309|NCT02078895|Lower Urinary tract discomfort , ureteral stent pain|lower urinary tract discomfort , ureteral stent pain
5321411|NCT02078466|readmission|readmission
5321315|NCT02078843|Gallium-68-DOTATATE|gallium-68-dotatate
5321316|NCT02078843|PET/CT|pet/ct
5321317|NCT02078843|Indium-111-pentetreotide scintigraphy|indium-111-pentetreotide scintigraphy
5321318|NCT02078843|octreoscan|octreoscan
5321320|NCT02078843|gastroenteropancreatic neuroendocrine tumors|gastroenteropancreatic neuroendocrine tumors
5321321|NCT02078830|Wound Contamination|wound contamination
5321322|NCT02078817|Treatment-resistant|treatment-resistant
5321328|NCT02078791|Fibromyalgia|fibromyalgia
5321329|NCT02078791|Group Problem Solving Technique|group problem solving technique
5321330|NCT02078791|infiltration|infiltration
5321331|NCT02078778|Continuous airway pressure|continuous airway pressure
5321332|NCT02078778|Hypertension|hypertension
5321333|NCT02078778|Obstructive sleep apnea|obstructive sleep apnea
5321334|NCT02078765|hypertension|hypertension
5321335|NCT02078765|chronic kidneys disease|chronic kidneys disease
5321336|NCT02078765|obstructive sleep apnea|obstructive sleep apnea
5321337|NCT02078765|24-h blood pressure|24-h blood pressure
5321338|NCT02078765|central blood pressure|central blood pressure
5321339|NCT02078765|peripheral blood pressure|peripheral blood pressure
5321341|NCT02078752|PF-06647263|pf-06647263
5321342|NCT02078752|solid tumors|solid tumors
5321343|NCT02078752|tumors|tumors
5321344|NCT02078752|neoplasm metastasis|neoplasm metastasis
5321345|NCT02078752|TNBC|tnbc
5321346|NCT02078752|Triple negative breast cancer|triple negative breast cancer
5321347|NCT02078739|Yoga|yoga
5321348|NCT02078739|COPD|copd
5321349|NCT02078739|Congestive Heart Failure|congestive heart failure
5321350|NCT02078726|glucagon, screening colonoscopy|glucagon, screening colonoscopy
5321351|NCT02078713|contraception|contraception
5321352|NCT02078713|patient decision support|patient decision support
5321353|NCT02078713|patient decision aid|patient decision aid
5321354|NCT02078713|shared decision making|shared decision making
5321355|NCT02078713|Decision Making, Shared|decision making, shared
5321356|NCT02078713|Patient-Centered Outcomes Research|patient-centered outcomes research
5321357|NCT02078700|cancer|cancer
5321358|NCT02078700|early palliative care|early palliative care
5321359|NCT02078700|feasibility|feasibility
5321360|NCT02078687|very preterm|very preterm
5321361|NCT02078687|nutrition|nutrition
5321362|NCT02078687|6 year follow-up|6 year follow-up
5321363|NCT02078687|growth|growth
5321364|NCT02078687|metabolic syndrome|metabolic syndrome
5321365|NCT02078687|allergy|allergy
5321366|NCT02078687|dexa|dexa
5321367|NCT02078674|H7N9|h7n9
5321368|NCT02078661|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
5321369|NCT02078661|Dry eye|dry eye
5321370|NCT02078648|Glioma Associated Antigen|glioma associated antigen
5321371|NCT02078648|Vaccine|vaccine
5321372|NCT02078648|Adult|adult
5321373|NCT02078648|Recurrent Glioblastoma|recurrent glioblastoma
5321374|NCT02078648|Immunotherapy|immunotherapy
5321375|NCT02078635|Arterial plaque|arterial plaque
5321376|NCT02078635|portfolio diet|portfolio diet
5321377|NCT02078635|dietary modification|dietary modification
5321378|NCT02078635|dietary trials|dietary trials
5321379|NCT02078635|Canadian Network|canadian network
5321380|NCT02078635|knowledge synthesis and translation|knowledge synthesis and translation
5321381|NCT02078635|Magnetic resonance imaging|magnetic resonance imaging
5321382|NCT02078622|COPD|copd
5321383|NCT02078622|Respiratory Therapist|respiratory therapist
5321384|NCT02078622|Case Management|case management
5321386|NCT02078609|AML,|aml,
5321387|NCT02078609|MDS,|mds,
5321388|NCT02078609|PIM,|pim,
5321389|NCT02078609|LGH447,|lgh447,
5321390|NCT02078609|acute myelod leukemia,|acute myelod leukemia,
5321391|NCT02078609|myelodysplastic syndrome,|myelodysplastic syndrome,
5321392|NCT02078609|midostaurin,|midostaurin,
5321393|NCT02078609|PKC412|pkc412
5321394|NCT02078596|temper outbursts|temper outbursts
5321395|NCT02078596|pediatric aggression|pediatric aggression
5321396|NCT02078596|irritability|irritability
5321397|NCT02078544|Cancer in Gynaecologic Oncology|cancer in gynaecologic oncology
5321398|NCT02078505|Change in gut microbial population|change in gut microbial population
5321399|NCT02078505|polycystic ovary syndrome|polycystic ovary syndrome
5321400|NCT02078505|gut microbiome|gut microbiome
5321401|NCT02078505|diet|diet
5321402|NCT02078479|Malignancy|malignancy
5321403|NCT02078479|VAS|vas
5321404|NCT02078479|LANSS|lanss
5321405|NCT02078479|VDS|vds
5321406|NCT02078479|Neuropathic pain|neuropathic pain
5321407|NCT02078479|rTMS|rtms
5321408|NCT02078479|motor cortex|motor cortex
5321409|NCT02078479|analgesia|analgesia
5321410|NCT02078466|Functional assessment|functional assessment
5321412|NCT02078466|acute care|acute care
5321413|NCT02078466|older medical patients|older medical patients
5321414|NCT02078453|Dental caries|dental caries
5321415|NCT02078453|Diagnosis|diagnosis
5321416|NCT02078453|Visual inspection|visual inspection
5321417|NCT02078453|Radiographic examination|radiographic examination
5321418|NCT02078440|Type 2 Diabetes|type 2 diabetes
5321419|NCT02078440|Children|children
5321420|NCT02078440|Adolescents|adolescents
5321421|NCT02078440|Bioavailability|bioavailability
5321423|NCT02078440|Bromocriptine Mesylate|bromocriptine mesylate
5321424|NCT02078401|Optic pathway glioma|optic pathway glioma
5321425|NCT02078401|Ophthalmological screening|ophthalmological screening
5321426|NCT02078375|Rheumatoid Arthritis|rheumatoid arthritis
5321427|NCT02078323|Irritable Bowel Syndrome with Constipation (IBS-C)|irritable bowel syndrome with constipation (ibs-c)
5321428|NCT02078323|Linaclotide|linaclotide
5321429|NCT02078310|Dementia,|dementia,
5321431|NCT02078310|geriatric|geriatric
5321432|NCT02078310|volunteers|volunteers
5321433|NCT02078310|patients|patients
5321435|NCT02078297|IL-17A|il-17a
5321436|NCT02078297|Skin biopsies|skin biopsies
5321437|NCT02078284|platelet transfusion|platelet transfusion
5321438|NCT02078258|depression，adolescent，attention bias，modification|depression，adolescent，attention bias，modification
5321439|NCT02078245|Familial pancreatic cancer|familial pancreatic cancer
5321440|NCT02078245|Surveillance|surveillance
5321441|NCT02078245|Screening|screening
5321442|NCT02078232|fine needle aspiration under ultrasound endoscopy|fine needle aspiration under ultrasound endoscopy
5321443|NCT02078232|solid pancreatic tumors|solid pancreatic tumors
5321444|NCT02078232|head of pancreas|head of pancreas
5321445|NCT02078232|19G Flex needle|19g flex needle
5321446|NCT02078232|22G standard needle|22g standard needle
5321447|NCT02078206|Critical illness|critical illness
5321448|NCT02078206|Neurocognition|neurocognition
5321449|NCT02078206|Neurocognitive stimulation|neurocognitive stimulation
5321450|NCT02078206|Delirium|delirium
5321451|NCT02078206|Virtual Reality|virtual reality
5321452|NCT02078206|cognitive|cognitive
5321453|NCT02078206|rehabilitation|rehabilitation
5321454|NCT02078206|ICU|icu
5321455|NCT02078167|ipercholesterolemia not familiarity|ipercholesterolemia not familiarity
5321456|NCT02078154|D-Dimer|d-dimer
5321457|NCT02078154|DVT|dvt
5321458|NCT02078154|Wells score|wells score
5321459|NCT02078141|18F-deoxyglucose (FDG) PET, idiopathic Dilated Cardiomyopathy|18f-deoxyglucose (fdg) pet, idiopathic dilated cardiomyopathy
5321460|NCT02078128|burn, wound healing, skin graft|burn, wound healing, skin graft
5321461|NCT02078089|Refractory cancer pain|refractory cancer pain
5321462|NCT02078076|MRI|mri
5321463|NCT02078076|free-breathing acquisitions|free-breathing acquisitions
5321464|NCT02078076|myopathy|myopathy
5321465|NCT02078076|fibrosis assessment|fibrosis assessment
5321466|NCT02078076|function|function
5321467|NCT02078037|Intracerebral hemorrhage|intracerebral hemorrhage
5321468|NCT02078037|Perihematomal edema|perihematomal edema
5321469|NCT02078037|hemorrhage|hemorrhage
5321470|NCT02078037|normothermia|normothermia
5321471|NCT02078024|Onchocerciasis|onchocerciasis
5321472|NCT02077985|autism|autism
5321473|NCT02077985|electrodermal activity|electrodermal activity
5321474|NCT02077985|cooperation|cooperation
5321475|NCT02077985|anxiety|anxiety
5321476|NCT02077985|distress|distress
5321477|NCT02077985|stress|stress
5321478|NCT02077985|oral care|oral care
5321479|NCT02077985|sensory processing|sensory processing
5321480|NCT02077985|behavior|behavior
5321481|NCT02077985|occupational therapy|occupational therapy
5321482|NCT02077972|PTSD|ptsd
5321483|NCT02077972|Military service|military service
5321484|NCT02077972|depression|depression
5321485|NCT02077972|Whole Body Hyperthermia (WBH)|whole body hyperthermia (wbh)
5321486|NCT02077959|Relapsed Multiple Myeloma|relapsed multiple myeloma
5321487|NCT02077959|Refractory Multiple Myeloma|refractory multiple myeloma
5321488|NCT02077933|Solid tumors|solid tumors
5321489|NCT02077933|renal cell carcinoma|renal cell carcinoma
5321490|NCT02077933|pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
5321491|NCT02077933|breast cancer|breast cancer
5321492|NCT02077933|PI3K inhibitor|pi3k inhibitor
5321493|NCT02077933|BYL719|byl719
5321494|NCT02077933|alpelisib|alpelisib
5321495|NCT02077933|everolimus|everolimus
5321496|NCT02077933|exemestane|exemestane
5321497|NCT02077920|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
5321498|NCT02077920|Chlorhexidine|chlorhexidine
5321499|NCT02077920|Oropharyngeal decontamination|oropharyngeal decontamination
5321500|NCT02077920|Subglottic secretion drainage|subglottic secretion drainage
5321501|NCT02077894|Whole Genome Sequencing|whole genome sequencing
5321502|NCT02077894|Genetic Eye Disease|genetic eye disease
5321503|NCT02077881|metastatic|metastatic
5321504|NCT02077881|metastasis|metastasis
5321505|NCT02077881|Pancreatic|pancreatic
5321506|NCT02077881|Pancreas|pancreas
5321507|NCT02077881|Cancer|cancer
5321508|NCT02077881|adenocarcinoma|adenocarcinoma
5321509|NCT02077868|CRC|crc
5321510|NCT02077868|mCRC|mcrc
5321511|NCT02077868|maintenance treatment|maintenance treatment
5321512|NCT02077868|immune modulation|immune modulation
5321513|NCT02077868|colorectal cancer|colorectal cancer
5321514|NCT02077868|immunotherapy|immunotherapy
5321515|NCT02077868|metastatic|metastatic
5321516|NCT02077855|Sensitivity and Sensitivity|sensitivity and sensitivity
5321517|NCT02077829|Implementation process|implementation process
5321518|NCT02077829|implementation strategy|implementation strategy
5321519|NCT02077829|Implementation research|implementation research
5321520|NCT02077829|evidence based practice|evidence based practice
5321521|NCT02077829|recovery|recovery
5321522|NCT02077829|Illness management and recovery|illness management and recovery
5321523|NCT02077816|body temperature|body temperature
5321524|NCT02077816|Thermometry|thermometry
5318015|NCT02094534|Safety|safety
5321525|NCT02077816|Infrared Rays|infrared rays
5321526|NCT02077816|catheter related infection|catheter related infection
5321527|NCT02077803|Healthy|healthy
5321528|NCT02077803|Canagliflozin|canagliflozin
5321529|NCT02077803|Metformin|metformin
5321530|NCT02077803|Type 2 diabetes mellitus|type 2 diabetes mellitus
5321531|NCT02077803|Bioequivalence|bioequivalence
5321532|NCT02077803|GLUMETZA®|glumetza®
5321533|NCT02077777|mesalazine|mesalazine
5321534|NCT02077777|colon|colon
5321535|NCT02077777|cancer|cancer
5321536|NCT02077764|heart transplantation,|heart transplantation,
5321537|NCT02077764|rejection|rejection
5321538|NCT02077764|cardiac vasculopathy|cardiac vasculopathy
5321539|NCT02077764|optical coherence tomography|optical coherence tomography
5321540|NCT02077764|speckle tracking|speckle tracking
5321541|NCT02077764|Positron Emission Tomography .|positron emission tomography .
5321542|NCT02077764|exercise capacity|exercise capacity
5321543|NCT02077738|effectiveness|effectiveness
5321544|NCT02077738|elderly|elderly
5321545|NCT02077738|high frequency chest wall oscillation|high frequency chest wall oscillation
5321546|NCT02077738|mechanical ventilation|mechanical ventilation
5321547|NCT02077738|pneumonia|pneumonia
5321548|NCT02077738|randomized controlled trial|randomized controlled trial
5321549|NCT02077725|drug related problems|drug related problems
5321550|NCT02077725|comprehensive medication review|comprehensive medication review
5321551|NCT02077725|quality of life|quality of life
5321552|NCT02077699|Lactobacillus casei DG|lactobacillus casei dg
5321553|NCT02077699|Irritable Bowel Syndrome|irritable bowel syndrome
5321554|NCT02077686|diabetes|diabetes
5321555|NCT02077686|education|education
5321556|NCT02077686|randomized|randomized
5321557|NCT02077686|prospective|prospective
5321558|NCT02077673|GEJ-cancer|gej-cancer
5321559|NCT02077673|surgery|surgery
5321560|NCT02077673|gastroesophageal resection|gastroesophageal resection
5321561|NCT02077673|gastroesophageal anastomosis|gastroesophageal anastomosis
5321562|NCT02077673|anastomotic leakage|anastomotic leakage
5321563|NCT02077660|Green tea, aging, oxidation, anthropometrics.|green tea, aging, oxidation, anthropometrics.
5321564|NCT02077647|Knee osteoarthritis|knee osteoarthritis
5321565|NCT02077647|knee osteonecrosis|knee osteonecrosis
5321566|NCT02077647|osteotomy|osteotomy
5321567|NCT02077621|cancer-related fatigue|cancer-related fatigue
5321568|NCT02077621|Palliative Abdominal Surgery|palliative abdominal surgery
5321569|NCT02077621|HRQL|hrql
5321570|NCT02077608|In vitro fertilization|in vitro fertilization
5321571|NCT02077608|Embryotransfer|embryotransfer
5321572|NCT02077608|Hyaluronan|hyaluronan
5321573|NCT02077608|Pregnancy rate|pregnancy rate
5321574|NCT02077608|Implantation rate|implantation rate
5321575|NCT02077595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5321576|NCT02077595|transcranial magnetic stimulation|transcranial magnetic stimulation
5321577|NCT02077582|acute ischemic stroke|acute ischemic stroke
5321578|NCT02077569|AKT inhibitor|akt inhibitor
5321579|NCT02077569|AZD5363|azd5363
5321580|NCT02077569|Anti-tumour activity|anti-tumour activity
5321581|NCT02077569|Breast cancer|breast cancer
5321582|NCT02077569|ER positive|er positive
5321583|NCT02077569|Oestrogen positive|oestrogen positive
5321584|NCT02077569|post menopausal|post menopausal
5321585|NCT02077569|chemotherapy required|chemotherapy required
5321586|NCT02077569|no prior cancer treatment|no prior cancer treatment
5321587|NCT02077556|tacrolimus, everolimus, pharmacokinetics, drug interaction|tacrolimus, everolimus, pharmacokinetics, drug interaction
5321588|NCT02077530|Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL|patients with metabolic syndrome age between 30 to 64: central obesity (men ≥ 90 cm women ≥ 85 cm), plasma triglycerides ≥ 150 mg/dl
5321589|NCT02077530|HDL cholesterol Men < 40 mg/dL, Women < 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),|hdl cholesterol men < 40 mg/dl, women < 50 mg/dl, blood pressure ≥130/85 mm hg (or treatment for hypertension),
5321590|NCT02077530|Fasting plasma glucose ≥ 100 mg/dL|fasting plasma glucose ≥ 100 mg/dl
5321591|NCT02077517|Roux en Y Gastric Bypass|roux en y gastric bypass
5321592|NCT02077517|Postoperative complications|postoperative complications
5321593|NCT02077517|Hand sewn anastomosis|hand sewn anastomosis
5321594|NCT02077517|Stapled anastomosis|stapled anastomosis
5321596|NCT02077491|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5321597|NCT02077491|Body Composition|body composition
5321598|NCT02077491|Dietary Protein|dietary protein
5321599|NCT02077465|COPD, chronic obstructive pulmonary disease; Phase 1b, Safety, Pharmacokinetics|copd, chronic obstructive pulmonary disease; phase 1b, safety, pharmacokinetics
5321600|NCT02077452|Glucokinase activator|glucokinase activator
5321601|NCT02077452|Phase I|phase i
5321602|NCT02077452|Type 2 diabetes mellitus|type 2 diabetes mellitus
5321603|NCT02077439|Stroke|stroke
5321604|NCT02077439|Hand|hand
5321605|NCT02077439|Upper Extremity|upper extremity
5321606|NCT02077439|Robotics|robotics
5321607|NCT02077426|Functional Capacity|functional capacity
5321608|NCT02077426|Exercise Independence|exercise independence
5321609|NCT02077426|Peripheral|peripheral
5321610|NCT02077426|Strength|strength
5321611|NCT02077413|muscle|muscle
5321612|NCT02077413|eccentric exercise|eccentric exercise
5321613|NCT02077413|T2 MRI|t2 mri
5321614|NCT02077387|Inhibitory control|inhibitory control
5321616|NCT02077387|childhood obesity|childhood obesity
5321617|NCT02077387|preschool|preschool
5321618|NCT02077387|snack foods|snack foods
5321619|NCT02077387|caloric intake|caloric intake
5321620|NCT02077374|NAFLD|nafld
5321621|NCT02077374|NASH|nash
5321622|NCT02077361|choroideremia|choroideremia
5321623|NCT02077361|gene therapy|gene therapy
5321624|NCT02077361|gene transfer|gene transfer
5321625|NCT02077348|Diabetes Mellitus type I|diabetes mellitus type i
5321626|NCT02077348|Ketoacidosis|ketoacidosis
5321627|NCT02077348|Insulin withdrawal|insulin withdrawal
5321628|NCT02077348|Growth hormone injection|growth hormone injection
5321629|NCT02077348|Lipolysis and ATGL|lipolysis and atgl
5321630|NCT02077335|Brachytherapy|brachytherapy
5321631|NCT02077335|Monotherapy|monotherapy
5321632|NCT02077335|HDR|hdr
5321633|NCT02077322|Merocel Middle Meatus Spacers|merocel middle meatus spacers
5321634|NCT02077322|Silastic Middle Meatus Spacers|silastic middle meatus spacers
5321635|NCT02077322|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5321636|NCT02077309|T2DM,|t2dm,
5321637|NCT02077309|vascular inflammation,|vascular inflammation,
5321638|NCT02077309|18-FDG-PET,|18-fdg-pet,
5321639|NCT02077309|plaque morphology,|plaque morphology,
5321640|NCT02077309|MRI,|mri,
5321641|NCT02077309|DPP-4 Inhibition|dpp-4 inhibition
5321642|NCT02077296|cytokines|cytokines
5321643|NCT02077296|predictive value|predictive value
5321644|NCT02077296|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5321645|NCT02077296|rectal cancer|rectal cancer
5321646|NCT02077283|NAFLD (non-alcoholic fatty liver disease, NAFLD)|nafld (non-alcoholic fatty liver disease, nafld)
5321647|NCT02077283|urinary metabonomics|urinary metabonomics
5321648|NCT02077283|TCM pattern|tcm pattern
5321649|NCT02077283|"liver depression and spleen deficiency pattern,"|"liver depression and spleen deficiency pattern,"
5321650|NCT02077283|"damp-heat in the interior pattern"|"damp-heat in the interior pattern"
5321651|NCT02077270|colonoscopy|colonoscopy
5321652|NCT02077270|acupuncture|acupuncture
5321653|NCT02077270|pain|pain
5321654|NCT02077244|patient|patient
5321655|NCT02077244|intensive care|intensive care
5321656|NCT02077244|follow up|follow up
5321657|NCT02077244|post traumatic stress symptoms|post traumatic stress symptoms
5321658|NCT02077244|randomized controlled trial|randomized controlled trial
5321659|NCT02077205|Diagnostic and Statistical Manual of Mental Disorders-IV/-5: Anxiety Disorders in children|diagnostic and statistical manual of mental disorders-iv/-5: anxiety disorders in children
5321660|NCT02077179|Postpartum|postpartum
5321661|NCT02077179|Preeclampsia|preeclampsia
5321662|NCT02077179|Gestational Hypertension|gestational hypertension
5321663|NCT02077179|Gestational Diabetes|gestational diabetes
5321664|NCT02077179|Exercise Intervention|exercise intervention
5321665|NCT02077179|Dietary Intervention|dietary intervention
5321666|NCT02077179|Behavioral Intervention|behavioral intervention
5321667|NCT02077179|Mobile Website|mobile website
5321668|NCT02077179|Mobile Application|mobile application
5321669|NCT02077166|DLBCL|dlbcl
5321670|NCT02077101|HIV|hiv
5321671|NCT02077101|Therapeutic vaccine|therapeutic vaccine
5321672|NCT02077101|acceptability|acceptability
5321673|NCT02077101|representations|representations
5321674|NCT02077088|interventional|interventional
5321675|NCT02077088|doubleblind|doubleblind
5321676|NCT02077088|randomised|randomised
5321677|NCT02077088|pediatric|pediatric
5321678|NCT02077088|prebiotic|prebiotic
5321680|NCT02077088|dermatitis|dermatitis
5321681|NCT02077088|infant|infant
5321682|NCT02077075|weight loss|weight loss
5321683|NCT02077075|healthy weight|healthy weight
5321684|NCT02077075|overweight|overweight
5321685|NCT02077075|body mass index greater that 25 kg/m2|body mass index greater that 25 kg/m2
5321686|NCT02077062|hepatectomy,|hepatectomy,
5321687|NCT02077062|liver regeneration|liver regeneration
5321688|NCT02077062|mediators|mediators
5321689|NCT02077049|elderly|elderly
5321690|NCT02077049|exercise program|exercise program
5321691|NCT02077049|self-training|self-training
5321692|NCT02077049|mobility|mobility
5321693|NCT02077049|computer-based learning games|computer-based learning games
5321694|NCT02077049|serious game|serious game
5321695|NCT02077049|balance|balance
5321696|NCT02077049|training adherence|training adherence
5321697|NCT02077049|training compliance|training compliance
5321698|NCT02077049|Kinect ®|kinect ®
5321699|NCT02077049|Fit Bit ®|fit bit ®
5321700|NCT02077023|Stroke|stroke
5321701|NCT02077023|Heart Attack|heart attack
5321702|NCT02077023|Asymptomatic Carotid Artery Disease|asymptomatic carotid artery disease
5321703|NCT02077023|Atrial Fibrillation|atrial fibrillation
5321704|NCT02077010|milrinone|milrinone
5321705|NCT02077010|heart failure|heart failure
5321706|NCT02077010|cardiomyopathy|cardiomyopathy
5321708|NCT02076997|Cancer|cancer
5321709|NCT02076997|High Dose Methotrexate|high dose methotrexate
5321710|NCT02076984|Ventral hernia|ventral hernia
5321711|NCT02076984|Incisional hernia|incisional hernia
5321712|NCT02076984|Patient affected by ventral or incisional hernias|patient affected by ventral or incisional hernias
5321713|NCT02076971|Lung transplant|lung transplant
5321714|NCT02076971|Quantiferon|quantiferon
5321715|NCT02076971|Immuknow|immuknow
5321716|NCT02076958|Implementation|implementation
5321717|NCT02076958|Cancer|cancer
5321718|NCT02076958|Early detection|early detection
5321719|NCT02076958|Faith-based|faith-based
5321720|NCT02076958|Community health advisor|community health advisor
5321721|NCT02076945|Regional anesthesia|regional anesthesia
5321722|NCT02076945|Diabetic neuropathy|diabetic neuropathy
5321723|NCT02076945|Ultrasound|ultrasound
5321724|NCT02076919|LHA510|lha510
5321725|NCT02076919|First in human|first in human
5321726|NCT02076919|Safety|safety
5321727|NCT02076919|Tolerability|tolerability
5321728|NCT02076919|Pharmacokinetics|pharmacokinetics
5321729|NCT02076919|Elderly|elderly
5321730|NCT02076919|Age-Related Macular Degeneration|age-related macular degeneration
5321731|NCT02076919|AMD|amd
5321732|NCT02076919|Ocular|ocular
5321733|NCT02076919|Eye drop|eye drop
5321734|NCT02076906|relapsed pediatric solid tumors|relapsed pediatric solid tumors
5321735|NCT02076906|refractory pediatric solid tumors|refractory pediatric solid tumors
5963212|NCT04266210|composite resin|composite resin
5321736|NCT02076906|high intensity focused ultrasound|high intensity focused ultrasound
5321737|NCT02076906|rhabdomyosarcoma|rhabdomyosarcoma
5321738|NCT02076906|Ewing's sarcoma|ewing's sarcoma
5321739|NCT02076906|osteosarcoma|osteosarcoma
5321740|NCT02076906|neuroblastoma|neuroblastoma
5321741|NCT02076906|Wilms' tumor|wilms' tumor
5321742|NCT02076906|hepatic tumors|hepatic tumors
5321743|NCT02076906|germ cell tumors|germ cell tumors
5321744|NCT02076906|desmoid tumor|desmoid tumor
5321745|NCT02076893|Tonsillectomy|tonsillectomy
5321746|NCT02076893|Pain management|pain management
5321747|NCT02076893|Pediatrics|pediatrics
5321748|NCT02076880|Type 2 diabetes|type 2 diabetes
5321749|NCT02076880|Obesity|obesity
5321750|NCT02076880|Sleeve gastrectomy|sleeve gastrectomy
5321751|NCT02076880|Insulin|insulin
5321752|NCT02076880|GLP-1|glp-1
5321753|NCT02076867|somatic symptoms and related disorders|somatic symptoms and related disorders
5321754|NCT02076867|somatic symptoms|somatic symptoms
5321755|NCT02076867|psychodynamic psychotherapy|psychodynamic psychotherapy
5321756|NCT02076854|eating disorders|eating disorders
5321757|NCT02076854|anorexia nervosa|anorexia nervosa
5321758|NCT02076854|treatment|treatment
5321759|NCT02076854|technology|technology
5321760|NCT02076828|anemia|anemia
5321761|NCT02076828|iron polymaltose complexes|iron polymaltose complexes
5321762|NCT02076828|iron zinc|iron zinc
5321763|NCT02076815|myeloproliferative neoplasm|myeloproliferative neoplasm
5321764|NCT02076815|essential thrombocythemia|essential thrombocythemia
5321765|NCT02076815|high risk patients|high risk patients
5321766|NCT02076815|anagrelide|anagrelide
5321767|NCT02076802|prehypertension|prehypertension
5321768|NCT02076802|coronary atherosclerosis|coronary atherosclerosis
5321769|NCT02076802|cardiovascular disease|cardiovascular disease
5321770|NCT02076789|Device Replacement|device replacement
5321771|NCT02076789|Device Upgrade|device upgrade
5321772|NCT02076789|Long-term Postoperative Complications|long-term postoperative complications
5321773|NCT02076789|Resource consumption and associated costs after device replacement/upgrade|resource consumption and associated costs after device replacement/upgrade
5321774|NCT02076776|Stroke|stroke
5321775|NCT02076776|Exercise|exercise
5321776|NCT02076776|Rehabilitation|rehabilitation
5321777|NCT02076776|Neuroplasticity|neuroplasticity
5321778|NCT02076776|Task Practice|task practice
5321779|NCT02076763|Observational|observational
5321780|NCT02076763|Porphyria|porphyria
5321781|NCT02076750|Inflammatory Bowel Diseases|inflammatory bowel diseases
5321782|NCT02076750|Vitamin D|vitamin d
5321783|NCT02076750|Cholecalciferol|cholecalciferol
5321784|NCT02076750|Skin Pigmentation|skin pigmentation
5321785|NCT02076737|Model-based iterative reconstruction MB-IR|model-based iterative reconstruction mb-ir
5321786|NCT02076737|VEOTM|veotm
5321787|NCT02076737|Ultra low-dose|ultra low-dose
5321788|NCT02076737|Abdominal CT|abdominal ct
5321789|NCT02076737|Dose reduction|dose reduction
5321790|NCT02076737|Adaptative statistical iterative reconstruction ASIR|adaptative statistical iterative reconstruction asir
5321791|NCT02076737|Acute renal colic|acute renal colic
5321792|NCT02076724|Abdominal donor-site|abdominal donor-site
5321793|NCT02076724|Breast reconstruction|breast reconstruction
5321794|NCT02076724|Synthetic mesh|synthetic mesh
5321795|NCT02076724|Biological mesh|biological mesh
5321796|NCT02076711|Aortic Stenosis|aortic stenosis
5321797|NCT02076711|Myocardial efficiency|myocardial efficiency
5321798|NCT02076698|Deep Brain Stimulation|deep brain stimulation
5321802|NCT02076698|vagus nerve stimulation therapy|vagus nerve stimulation therapy
5321803|NCT02076685|pharmacogenetics|pharmacogenetics
5321804|NCT02076685|anti-tuberculosis drug|anti-tuberculosis drug
5321805|NCT02076685|genetic polymorphism|genetic polymorphism
5321806|NCT02076685|isoniazid|isoniazid
5321812|NCT02076659|IL10|il10
5321813|NCT02076659|Interleukin|interleukin
5321814|NCT02076659|monoclonal|monoclonal
5321815|NCT02076659|antibody|antibody
5321816|NCT02076659|Rheumatoid Arthritis|rheumatoid arthritis
5321817|NCT02076646|Interleukin|interleukin
5321818|NCT02076646|IL2|il2
5321819|NCT02076646|monoclonal|monoclonal
5321820|NCT02076646|antibody|antibody
5321821|NCT02076646|cytokine|cytokine
5321822|NCT02076646|Dacarbazine|dacarbazine
5321827|NCT02076646|L19|l19
5321828|NCT02076633|L19|l19
5321829|NCT02076633|monoclonal|monoclonal
5321830|NCT02076633|antibody|antibody
5321831|NCT02076633|IL-2|il-2
5321832|NCT02076633|TNFα|tnfα
5321833|NCT02076633|Interleukin|interleukin
5321834|NCT02076633|Phase II|phase ii
5321835|NCT02076633|metastatic melanoma|metastatic melanoma
5321836|NCT02076633|clinical stage III|clinical stage iii
5321837|NCT02076633|Clinical stage IV M1a|clinical stage iv m1a
5321838|NCT02076620|L19|l19
5321839|NCT02076620|monoclonal|monoclonal
5321840|NCT02076620|antibody|antibody
5321841|NCT02076620|doxorubicin|doxorubicin
5321842|NCT02076620|TNFα|tnfα
5321843|NCT02076620|solid tumour|solid tumour
5321844|NCT02076620|sarcoma, breast cancer, lung carcinomas, gynecological cancer|sarcoma, breast cancer, lung carcinomas, gynecological cancer
5321845|NCT02076620|anthracycline|anthracycline
5321846|NCT02076607|vertebra|vertebra
5321847|NCT02076607|column|column
5321848|NCT02076607|lumbar|lumbar
5321849|NCT02076607|toracica|toracica
5321850|NCT02076607|fracture|fracture
5321851|NCT02076607|burst|burst
5321852|NCT02076568|diabetes|diabetes
5321853|NCT02076568|education|education
5321854|NCT02076568|randomized|randomized
5321855|NCT02076568|prospective|prospective
5321856|NCT02076555|diabetes|diabetes
5321857|NCT02076555|education|education
5321858|NCT02076555|randomized|randomized
5321859|NCT02076555|prospective|prospective
5321860|NCT02076542|diabetes|diabetes
5321861|NCT02076542|education|education
5321862|NCT02076542|randomized|randomized
5321863|NCT02076542|prospective|prospective
5321864|NCT02076529|chemotherapy induced nausea vomiting|chemotherapy induced nausea vomiting
5321865|NCT02076516|Drug-eluting Stent,Coronary Artery Disease|drug-eluting stent,coronary artery disease
5321866|NCT02076503|Neoplasm Staging|neoplasm staging
5321867|NCT02076503|Positron-Emission Tomography|positron-emission tomography
5321868|NCT02076503|Magnetic Resonance Imaging|magnetic resonance imaging
5321869|NCT02076503|1-amino-3-fluorocyclobutane-1-carboxylic acid|1-amino-3-fluorocyclobutane-1-carboxylic acid
5321870|NCT02076490|Telerehabilitation, mirror therapy, phantom limb pain|telerehabilitation, mirror therapy, phantom limb pain
5321871|NCT02076477|intervention time|intervention time
5321872|NCT02076477|radiotherapy|radiotherapy
5321873|NCT02076477|oligometastatic|oligometastatic
5321874|NCT02076477|non-small cell lung cancer|non-small cell lung cancer
5321875|NCT02076438|antibiotics|antibiotics
5321876|NCT02076438|diarrhea|diarrhea
5321877|NCT02076438|c diff|c diff
5321878|NCT02076438|Hospitalized patients|hospitalized patients
5321879|NCT02076425|Depressive Disorder, Major|depressive disorder, major
5321880|NCT02076425|Child Psychiatry|child psychiatry
5321881|NCT02076425|Parent-Child Relationship|parent-child relationship
5321882|NCT02076425|Therapy|therapy
5321883|NCT02076399|Persistent Immune Thrombocytopenic Purpura|persistent immune thrombocytopenic purpura
5321884|NCT02076399|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
5321885|NCT02076360|Preoperative counseling|preoperative counseling
5321886|NCT02076360|Patient satisfaction|patient satisfaction
5321887|NCT02076360|Prolapse|prolapse
5321888|NCT02076360|Sacrocolpopexy|sacrocolpopexy
5321889|NCT02076347|Metformin|metformin
5321890|NCT02076347|Vitamin B12 Deficiency|vitamin b12 deficiency
5321891|NCT02076347|Population Management|population management
5321892|NCT02076347|Pharmacist|pharmacist
5321893|NCT02076334|compression, isokinetic, far-infrared|compression, isokinetic, far-infrared
5321894|NCT02076308|Acupuncture, ultrasound|acupuncture, ultrasound
5321895|NCT02076295|Cognition|cognition
5321896|NCT02076295|Cholinergic nicotinic receptors|cholinergic nicotinic receptors
5321897|NCT02076295|Positron Emission Tomography|positron emission tomography
5321898|NCT02076282|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5321899|NCT02076282|Optimization|optimization
5321901|NCT02076282|Radiotherapy|radiotherapy
5321902|NCT02076269|HRCT|hrct
5321903|NCT02076269|Dry Powder Inhaler|dry powder inhaler
5321904|NCT02076269|COPD|copd
5321905|NCT02076269|Pharyngometry|pharyngometry
5321906|NCT02076269|Inhalation Profiles|inhalation profiles
5321907|NCT02076256|helping relationships, healthy lifestyle, quality of life|helping relationships, healthy lifestyle, quality of life
5321908|NCT02076243|cutaneous squamous cell carcinoma|cutaneous squamous cell carcinoma
5321909|NCT02076243|SCC|scc
5321910|NCT02076243|abraxane|abraxane
5321911|NCT02076243|nab-paclitaxel|nab-paclitaxel
5321912|NCT02076243|unresectable|unresectable
5321913|NCT02076243|metastatic|metastatic
5321914|NCT02076230|14C-TH-302|14c-th-302
5321915|NCT02076230|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
5321916|NCT02076230|Evofosfamide|evofosfamide
5321917|NCT02076217|Highly Effective Contraception|highly effective contraception
5321918|NCT02076217|Emergency Contraception|emergency contraception
5321919|NCT02076217|Birth Control|birth control
5321920|NCT02076217|LARC (Long Acting Reversible Contraception)|larc (long acting reversible contraception)
5321921|NCT02076217|HERC (Highly Effective Contraception)|herc (highly effective contraception)
5321923|NCT02076204|Postpartum programs|postpartum programs
5321924|NCT02076204|Infant health services|infant health services
5321925|NCT02076191|Ruxolitinib|ruxolitinib
5321926|NCT02076191|Decitabine|decitabine
5321927|NCT02076191|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5321928|NCT02076191|Combination Therapy|combination therapy
5321929|NCT02076178|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5321930|NCT02076178|HIV integrase|hiv integrase
5321931|NCT02076178|Intramuscular Injection|intramuscular injection
5321932|NCT02076178|GSK1265744|gsk1265744
5321933|NCT02076165|insomnia|insomnia
5321934|NCT02076165|women|women
5321935|NCT02076152|Recurrent Glioblastoma|recurrent glioblastoma
5321936|NCT02076139|tuberculosis|tuberculosis
5321937|NCT02076139|treg|treg
5321938|NCT02076139|tolerance|tolerance
5321939|NCT02076139|probiotic|probiotic
5321940|NCT02076139|mycobacteria|mycobacteria
5321941|NCT02076126|Lung maturity|lung maturity
5321942|NCT02076126|RDS|rds
5321943|NCT02076126|Prematurity|prematurity
5369180|NCT01860950|Healthy Adults|healthy adults
5202364|NCT02729415|Hair Diseases|hair diseases
5321944|NCT02076126|Lecithin-sphingomyelin ratio|lecithin-sphingomyelin ratio
5321945|NCT02076126|Spectroscopy|spectroscopy
5321946|NCT02076126|Chemometrics|chemometrics
5321947|NCT02076113|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5321948|NCT02076113|degenerative cervical spondylosis|degenerative cervical spondylosis
5321949|NCT02076113|spinal fusion|spinal fusion
5321950|NCT02076087|Subcutaneous adipose tissue|subcutaneous adipose tissue
5321951|NCT02076087|Lipectomy|lipectomy
5321952|NCT02076061|COPD|copd
5321953|NCT02076061|Primary Care|primary care
5321954|NCT02076061|Smoking|smoking
5321955|NCT02076061|Smokers|smokers
5321956|NCT02076061|ex-Smokers|ex-smokers
5321957|NCT02076061|Lung Cancer|lung cancer
5321958|NCT02076061|Cardiovascular Disease|cardiovascular disease
5321959|NCT02076061|Proteomics|proteomics
5321960|NCT02076061|Biomarkers|biomarkers
5321961|NCT02076061|Biobank|biobank
5321962|NCT02076061|Disease Staging|disease staging
5321963|NCT02076061|Gold Stage|gold stage
5321964|NCT02076048|LCPUFA supplementation|lcpufa supplementation
5321965|NCT02076048|Brain Imaging|brain imaging
5321966|NCT02076048|MRI|mri
5321967|NCT02076048|MEG|meg
5321968|NCT02076035|low back pain|low back pain
5321969|NCT02076035|periduroscopy|periduroscopy
5321970|NCT02076035|genetic|genetic
5321971|NCT02076035|genomic|genomic
5321972|NCT02076035|inflammation|inflammation
5321973|NCT02076022|Fat Grafting|fat grafting
5321974|NCT02076022|Pain at amputation site|pain at amputation site
5321975|NCT02076022|prosthetic|prosthetic
5321976|NCT02076009|Multiple Myeloma|multiple myeloma
5321977|NCT02076009|Relapsed Multiple Myeloma|relapsed multiple myeloma
5321978|NCT02076009|Refractory Multiple Myeloma|refractory multiple myeloma
5321979|NCT02076009|Daratumumab|daratumumab
5321980|NCT02076009|Lenalidomide|lenalidomide
5321981|NCT02076009|Dexamethasone|dexamethasone
5321982|NCT02075996|pomalidomide, Imnovid, dexamethasone, Poseidon, multiple myeloma, daily routine, secondary malignancies, Germany, non-interventional study, safety,|pomalidomide, imnovid, dexamethasone, poseidon, multiple myeloma, daily routine, secondary malignancies, germany, non-interventional study, safety,
5321989|NCT02075983|Transcutaneous|transcutaneous
5321990|NCT02075983|GTU MultiHIV B Clade|gtu multihiv b clade
5321991|NCT02075983|Antibody|antibody
5321992|NCT02075983|Intramuscular|intramuscular
5321993|NCT02075983|Immunogenicity|immunogenicity
5321994|NCT02075970|Neonatal|neonatal
5321995|NCT02075970|Anemia|anemia
5321996|NCT02075970|Transfusion|transfusion
5321997|NCT02075970|Erythropoetin|erythropoetin
5321998|NCT02075970|Epoetin Alpha|epoetin alpha
5321999|NCT02075970|Red Blood Cell|red blood cell
5322000|NCT02075970|Survival|survival
5322001|NCT02075970|Pharmacodynamics|pharmacodynamics
5322002|NCT02075970|Model|model
5322003|NCT02075957|Non-small cell lung cancer, adjuvant chemo-therapy, DNA chip|non-small cell lung cancer, adjuvant chemo-therapy, dna chip
5322004|NCT02075944|Aerobic exercise|aerobic exercise
5322005|NCT02075944|Cognitive function|cognitive function
5322006|NCT02075944|Executive function|executive function
5322007|NCT02075944|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5322008|NCT02075905|Barrett's Esophagus|barrett's esophagus
5322009|NCT02075905|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5322010|NCT02075892|cordyceps, aerobic capacity, exercise performance, fatigue|cordyceps, aerobic capacity, exercise performance, fatigue
5322011|NCT02075853|Cerebral palsy|cerebral palsy
5322012|NCT02075853|Pes planus|pes planus
5322013|NCT02075853|Calcaneal lengthening|calcaneal lengthening
5322014|NCT02075827|Appetite, metabolism, sedentary behaviour, stress response|appetite, metabolism, sedentary behaviour, stress response
5322015|NCT02075801|Sealant, Margins Defect, Amalgam|sealant, margins defect, amalgam
5322017|NCT02075749|irradiation|irradiation
5322018|NCT02075749|mucositis|mucositis
5322019|NCT02075749|triamcinolone acetonide|triamcinolone acetonide
5322020|NCT02075749|licorice|licorice
5322021|NCT02075749|mucoadhesive film|mucoadhesive film
5322024|NCT02075710|Cardiovascular|cardiovascular
5322025|NCT02075710|Lipid|lipid
5322026|NCT02075697|psoriasis|psoriasis
5322027|NCT02075697|biologic therapy|biologic therapy
5322028|NCT02075697|infliximab|infliximab
5322029|NCT02075697|etanercept|etanercept
5322030|NCT02075697|efalizumab|efalizumab
5322031|NCT02075697|adalimumab|adalimumab
5322032|NCT02075697|ustekinumab|ustekinumab
5322033|NCT02075697|methotrexate|methotrexate
5322034|NCT02075697|cyclosporine|cyclosporine
5322035|NCT02075697|acitretin|acitretin
5322036|NCT02075671|Rosacea|rosacea
5322037|NCT02075671|Photodynamic Therapy|photodynamic therapy
5322038|NCT02075671|Aminolevulinic Acid|aminolevulinic acid
5322039|NCT02075671|Papulopustular Rosacea|papulopustular rosacea
5322040|NCT02075671|Blue Light|blue light
5322041|NCT02075658|renal cell carcinoma|renal cell carcinoma
5322042|NCT02075658|minimally invasive procedures|minimally invasive procedures
5963213|NCT04266093|Gene Transfer|gene transfer
5322043|NCT02075658|robotic nephrectomy|robotic nephrectomy
5322044|NCT02075658|laparoscopic nephrectomy|laparoscopic nephrectomy
5322045|NCT02075658|pneumoperitoneum|pneumoperitoneum
5322046|NCT02075658|trocars|trocars
5963214|NCT04266093|Recombinant DNA Product|recombinant dna product
5322048|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate
5322049|NCT02075632|Eczema|eczema
5322050|NCT02075632|Psoriasis|psoriasis
5322051|NCT02075632|Itch|itch
5322052|NCT02075619|Amlodipine|amlodipine
5322053|NCT02075619|Healthy volunteers|healthy volunteers
5322054|NCT02075619|Rosuvastatin|rosuvastatin
5322055|NCT02075619|Dyslipidaemia|dyslipidaemia
5322056|NCT02075619|Pharmacokinetics|pharmacokinetics
5322057|NCT02075619|Hypertension|hypertension
5322058|NCT02075606|NET|net
5322059|NCT02075606|Symptomatic response|symptomatic response
5322060|NCT02075606|Functioning NeuroEndocrine Tumours|functioning neuroendocrine tumours
5322061|NCT02075606|midgut region|midgut region
5322062|NCT02075593|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
5322063|NCT02075593|pregnant women|pregnant women
5322064|NCT02075593|once daily|once daily
5322065|NCT02075593|antiretroviral therapy-naive|antiretroviral therapy-naive
5322066|NCT02075593|HIV-1 Infection|hiv-1 infection
5322067|NCT02075593|integrase inhibitor|integrase inhibitor
5322068|NCT02075580|cancer, quality of life, body-image, subcutaneous-implant|cancer, quality of life, body-image, subcutaneous-implant
5322069|NCT02075567|Diabetes Mellitus Type 1|diabetes mellitus type 1
5322070|NCT02075567|Exercise|exercise
5322071|NCT02075567|Insulin Reduction|insulin reduction
5322072|NCT02075567|Glucose|glucose
5322073|NCT02075567|Hypoglycemia|hypoglycemia
5322074|NCT02075567|Continuous Glucose Monitoring System|continuous glucose monitoring system
5322075|NCT02075541|Immunogenicity|immunogenicity
5322076|NCT02075541|Observer-blind|observer-blind
5322078|NCT02075541|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5322080|NCT02075528|Paliperidone|paliperidone
5322081|NCT02075528|Treatment response|treatment response
5322082|NCT02075528|Schizophrenia|schizophrenia
5322083|NCT02075528|Early prediction|early prediction
5322084|NCT02075528|Pharmacokinetics|pharmacokinetics
5322085|NCT02075515|Safety|safety
5322086|NCT02075515|Zoster|zoster
5322087|NCT02075515|Immunogenicity|immunogenicity
5322088|NCT02075515|Adults|adults
5322089|NCT02075515|Consistency|consistency
5322090|NCT02075502|claudication|claudication
5322091|NCT02075502|community walking exercise|community walking exercise
5322092|NCT02075502|community-based participatory research|community-based participatory research
5322093|NCT02075502|exercise adherence|exercise adherence
5322094|NCT02075502|endovascular therapy|endovascular therapy
5322095|NCT02075489|Acupressure|acupressure
5322096|NCT02075489|Reiki|reiki
5322102|NCT02075476|humeral proximal extremity|humeral proximal extremity
5322104|NCT02075476|reverse Arthroplasty|reverse arthroplasty
5322105|NCT02075463|recombinant human erythropoietin|recombinant human erythropoietin
5322106|NCT02075463|GSK1278863|gsk1278863
5322107|NCT02075463|hemodialysis|hemodialysis
5322108|NCT02075463|anemia|anemia
5322109|NCT02075463|Hemoglobin|hemoglobin
5322110|NCT02075463|chronic rhEPO hyporesponsiveness|chronic rhepo hyporesponsiveness
5322111|NCT02075463|chronic kidney disease|chronic kidney disease
5322112|NCT02075463|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5322113|NCT02075463|pharmacokinetics|pharmacokinetics
5322114|NCT02075450|Cardiac|cardiac
5322115|NCT02075450|Arrest|arrest
5322116|NCT02075450|Simulation|simulation
5322117|NCT02075450|Feedback|feedback
5322118|NCT02075437|Functional Abdominal Pain, Children|functional abdominal pain, children
5322119|NCT02075437|Finding a treatment or intervention for children|finding a treatment or intervention for children
5322120|NCT02075424|stress|stress
5322121|NCT02075424|cortisol|cortisol
5322122|NCT02075424|emergency call center|emergency call center
5322123|NCT02075424|hospital staff|hospital staff
5322124|NCT02075411|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5322125|NCT02075411|transplantation allografts|transplantation allografts
5322126|NCT02075411|adolescent|adolescent
5322130|NCT02075385|Dysphagia|dysphagia
5322131|NCT02075385|speech language therapy|speech language therapy
5322132|NCT02075385|quality of life|quality of life
5322133|NCT02075385|induction chemotherapy|induction chemotherapy
5322134|NCT02075385|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5322135|NCT02075372|Chronic Total Occlusion of Coronary Artery|chronic total occlusion of coronary artery
5322136|NCT02075372|Percutaneous Coronary Intervention|percutaneous coronary intervention
5322138|NCT02075372|Angioplasty|angioplasty
5322143|NCT02075346|Patient safety monitors|patient safety monitors
5322144|NCT02075320|CT|ct
5322145|NCT02075320|Chest|chest
5322146|NCT02075320|Lung|lung
5322147|NCT02075307|insulin|insulin
5322148|NCT02075307|diabetes|diabetes
5322149|NCT02075307|obesity|obesity
5322150|NCT02075307|DNA damage|dna damage
5322151|NCT02075307|metabolic syndrome|metabolic syndrome
5322152|NCT02075294|Aged|aged
5322153|NCT02075294|Hepatitis B, Chronic|hepatitis b, chronic
5322154|NCT02075294|Antiviral Agents|antiviral agents
5322155|NCT02075268|Korean|korean
5322156|NCT02075268|Healthy|healthy
5322157|NCT02075268|Male|male
5369181|NCT01860950|Pain Perception|pain perception
5202574|NCT02727972|PET|pet
5322158|NCT02075255|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases, OCS, Oral Corticosteroids|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases, ocs, oral corticosteroids
5322159|NCT02075242|HBV|hbv
5322160|NCT02075229|Cochlear Implant|cochlear implant
5322161|NCT02075229|Post-lingual onset hearing loss|post-lingual onset hearing loss
5322162|NCT02075229|Profound hearing loss|profound hearing loss
5322163|NCT02075229|Low Frequency hearing loss|low frequency hearing loss
5322164|NCT02075229|Profound sensorineural hearing loss|profound sensorineural hearing loss
5322165|NCT02075229|High frequency hearing loss|high frequency hearing loss
5322166|NCT02075229|CMS-eligible patients|cms-eligible patients
5322167|NCT02075216|Urinary Incontinence|urinary incontinence
5322168|NCT02075216|Children|children
5322169|NCT02075216|Bladder Exstrophy|bladder exstrophy
5322170|NCT02075216|Extrophy -Epispadias complex,|extrophy -epispadias complex,
5322171|NCT02075216|Modern staged repair,|modern staged repair,
5322172|NCT02075216|Bladder neck reconstruction|bladder neck reconstruction
5322173|NCT02075203|BCG Vaccinated|bcg vaccinated
5322174|NCT02075177|neuroblastoma|neuroblastoma
5322175|NCT02075164|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5322176|NCT02075164|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5322177|NCT02075164|NAFLD|nafld
5322178|NCT02075164|NASH|nash
5322179|NCT02075151|Bronchial Thermoplasty|bronchial thermoplasty
5322181|NCT02075125|Platelet inhibition|platelet inhibition
5322182|NCT02075125|Prasugrel|prasugrel
5322183|NCT02075125|Ticagrelor|ticagrelor
5322184|NCT02075125|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5322186|NCT02075112|Isoflavone|isoflavone
5322187|NCT02075112|Radiation Therapy|radiation therapy
5322188|NCT02075112|Cisplatin|cisplatin
5322189|NCT02075099|whole blood donation|whole blood donation
5322190|NCT02075099|donation water drink|donation water drink
5322191|NCT02075099|isotonic drink|isotonic drink
5322192|NCT02075099|presyncopal and syncopal reactions|presyncopal and syncopal reactions
5322193|NCT02075086|angiogenic switch|angiogenic switch
5322197|NCT02075060|low-grade|low-grade
5322200|NCT02075034|Myelodysplastic syndrome|myelodysplastic syndrome
5322201|NCT02075034|MDS|mds
5322202|NCT02075034|Low risk|low risk
5322203|NCT02075034|Intermediate-1 risk|intermediate-1 risk
5322204|NCT02075034|Intermediate-2 risk|intermediate-2 risk
5322205|NCT02075034|International Prognostic Scoring System|international prognostic scoring system
5322206|NCT02075034|IPSS|ipss
5322207|NCT02075021|relapsed|relapsed
5322208|NCT02075021|refractory|refractory
5322209|NCT02075021|multiple myeloma|multiple myeloma
5322210|NCT02075021|revlimid|revlimid
5322211|NCT02075021|lenalidomide|lenalidomide
5322212|NCT02075021|abraxane|abraxane
5322213|NCT02075021|n-paclitaxel|n-paclitaxel
5322214|NCT02075008|asthma|asthma
5322215|NCT02075008|allergic asthma|allergic asthma
5322216|NCT02075008|QGE031|qge031
5322217|NCT02075008|open-label|open-label
5322218|NCT02075008|IgE|ige
5322219|NCT02075008|long-term safety|long-term safety
5322220|NCT02074995|Burn, Severe burn, Lean body mass, Cachexia, Hypermetabolism, Catabolism, Wound healing|burn, severe burn, lean body mass, cachexia, hypermetabolism, catabolism, wound healing
5356890|NCT01917591|Varicose Ulcer|varicose ulcer
5356891|NCT01917591|Wound Healing|wound healing
5322221|NCT02074982|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling|chronic plaque type psoriasis, secukinumab, ustekinumab, inflammatory skin disease, scaling
5322222|NCT02074969|re-operation rate|re-operation rate
5322223|NCT02074969|pertrochanteric fractures|pertrochanteric fractures
5322224|NCT02074969|GammaNail|gammanail
5322225|NCT02074969|PFNA|pfna
5322226|NCT02074969|Tip-Apex-Distance|tip-apex-distance
5322227|NCT02074969|Parkers-Ratio|parkers-ratio
5322231|NCT02074917|anterior cruciate ligament|anterior cruciate ligament
5322233|NCT02074917|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5322234|NCT02074917|outcome assessment|outcome assessment
5322235|NCT02074917|outcome assessment, patient|outcome assessment, patient
5322236|NCT02074917|treatment outcome|treatment outcome
5322237|NCT02074917|exercise test|exercise test
5322238|NCT02074917|anatomic|anatomic
5322239|NCT02074917|anatomical|anatomical
5322240|NCT02074917|single-bundle|single-bundle
5322241|NCT02074917|force platform|force platform
5322242|NCT02074917|postural balance|postural balance
5322243|NCT02074917|biomechanics|biomechanics
5322244|NCT02074917|CT scan|ct scan
5322245|NCT02074917|X-ray computed tomography|x-ray computed tomography
5322246|NCT02074917|tomography|tomography
5322247|NCT02074917|diagnostic imaging|diagnostic imaging
5322248|NCT02074917|knee|knee
5322249|NCT02074917|knee injuries|knee injuries
5322250|NCT02074917|joint instability|joint instability
5322251|NCT02074917|reconstructive surgical procedures|reconstructive surgical procedures
5322252|NCT02074917|knee surgery|knee surgery
5322253|NCT02074917|arthroscopy|arthroscopy
5322254|NCT02074917|athletes|athletes
5322255|NCT02074917|sports medicine|sports medicine
5322256|NCT02074917|humans|humans
5963215|NCT04266093|Gamma-Retroviral Vectors|gamma-retroviral vectors
5322257|NCT02074917|prospective studies|prospective studies
5322258|NCT02074917|Randomized Controlled Trial|randomized controlled trial
5322259|NCT02074891|preexposure prophylaxis|preexposure prophylaxis
5322260|NCT02074891|PrEP|prep
5322261|NCT02074891|HIV|hiv
5322262|NCT02074878|Breast Cancer|breast cancer
5322263|NCT02074878|Metastatic|metastatic
5322264|NCT02074878|Crizotinib|crizotinib
5322265|NCT02074878|Sunitinib|sunitinib
5322266|NCT02074878|Xalcori|xalcori
5322267|NCT02074878|Sutent|sutent
5322268|NCT02074839|acute myeloid leukemia|acute myeloid leukemia
5322269|NCT02074839|AML|aml
5322270|NCT02074839|myelodysplastic syndrome|myelodysplastic syndrome
5322271|NCT02074839|MDS|mds
5322272|NCT02074839|hematologic malignancies|hematologic malignancies
5322273|NCT02074839|IDH|idh
5322274|NCT02074839|Untreated AML|untreated aml
5322275|NCT02074839|IDH1|idh1
5322276|NCT02074839|relapsed AML|relapsed aml
5322277|NCT02074839|refractory AML|refractory aml
5322278|NCT02074813|Inspiratory muscle training|inspiratory muscle training
5322279|NCT02074813|COPD|copd
5322280|NCT02074813|dyspnea|dyspnea
5322281|NCT02074813|Multidimensional Dyspnea Profile questionnaire (MDP).|multidimensional dyspnea profile questionnaire (mdp).
5322282|NCT02074813|pulmonary rehabilitation|pulmonary rehabilitation
5322283|NCT02074800|Healthy|healthy
5322284|NCT02074800|CNTO 328|cnto 328
5322285|NCT02074800|Sp2/0-derived CNTO 328|sp2/0-derived cnto 328
5322286|NCT02074800|CHO-derived CNTO 328|cho-derived cnto 328
5322288|NCT02074800|Pharmacokinetics|pharmacokinetics
5322289|NCT02074774|nasal cannula, high flow oxygen therapy, pulse oximetry|nasal cannula, high flow oxygen therapy, pulse oximetry
5322290|NCT02074761|sacroiliac joint fusion|sacroiliac joint fusion
5322291|NCT02074761|SIJ fusion|sij fusion
5322299|NCT02074709|Pain, Liposomal bupivacaine, Wound infiltration|pain, liposomal bupivacaine, wound infiltration
5322300|NCT02074696|brain derived neurotrophic factor|brain derived neurotrophic factor
5322301|NCT02074657|Immunotherapy|immunotherapy
5322302|NCT02074657|NKAEs|nkaes
5322303|NCT02074657|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
5322304|NCT02074657|Activated natural killer cells|activated natural killer cells
5322311|NCT02074631|bone mineral content|bone mineral content
5322312|NCT02074631|bone mineral density|bone mineral density
5322313|NCT02074631|bone formation|bone formation
5322314|NCT02074631|bone resorption|bone resorption
5322315|NCT02074631|pamidronate|pamidronate
5322316|NCT02074631|children|children
5322317|NCT02074631|DXA|dxa
5322318|NCT02074631|bone marrow transplant|bone marrow transplant
5322319|NCT02074618|Physical Therapy.|physical therapy.
5322320|NCT02074618|Exercise.|exercise.
5322321|NCT02074618|Rehabilitation.|rehabilitation.
5322322|NCT02074618|Renal Insufficiency.|renal insufficiency.
5322323|NCT02074618|Quality of life.|quality of life.
5322324|NCT02074605|Melanoma|melanoma
5322325|NCT02074605|Interferon|interferon
5322326|NCT02074605|Cognition|cognition
5322327|NCT02074592|Self assessment|self assessment
5322328|NCT02074592|Audit|audit
5322329|NCT02074592|Feedback|feedback
5322330|NCT02074592|Quality|quality
5322331|NCT02074592|Ultrasound|ultrasound
5322332|NCT02074592|Fetal|fetal
5322333|NCT02074592|Biometry|biometry
5322334|NCT02074579|Irritable Bowel Syndrome|irritable bowel syndrome
5322335|NCT02074579|Rome III criteria|rome iii criteria
5322336|NCT02074579|abdominal bloating|abdominal bloating
5322337|NCT02074579|natural|natural
5322338|NCT02074579|herbal|herbal
5322339|NCT02074579|Kampo|kampo
5322340|NCT02074579|Adult ages 18 to 65|adult ages 18 to 65
5322341|NCT02074579|Female subjects|female subjects
5322342|NCT02074566|Pulmonary Vein Isolation|pulmonary vein isolation
5322343|NCT02074566|Atrial fibrillation|atrial fibrillation
5322344|NCT02074566|Cryoballoon therapy|cryoballoon therapy
5322345|NCT02074566|Duration|duration
5322346|NCT02074527|congenital heart disease|congenital heart disease
5322347|NCT02074527|cardiac catheterization|cardiac catheterization
5322348|NCT02074527|brazilian electronic registration|brazilian electronic registration
5322349|NCT02074501|stroke|stroke
5322350|NCT02074501|elderly|elderly
5322351|NCT02074501|caregivers|caregivers
5322352|NCT02074501|empowerment|empowerment
5322353|NCT02074501|self-care|self-care
5322354|NCT02074501|pilot study|pilot study
5322355|NCT02074488|balance|balance
5322356|NCT02074488|gait|gait
5322357|NCT02074462|Voriconazole|voriconazole
5322358|NCT02074462|CRP|crp
5322359|NCT02074462|Inflammation|inflammation
5322360|NCT02074462|Pharmacokinetics|pharmacokinetics
5322361|NCT02074449|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5322362|NCT02074449|Right Ventricular Performance|right ventricular performance
5322363|NCT02074449|Treprostinil|treprostinil
5322364|NCT02074449|Remodulin|remodulin
5322365|NCT02074436|hematological malignancies|hematological malignancies
5322366|NCT02074436|thrombocytopenia|thrombocytopenia
5322367|NCT02074436|aminocaproic acid|aminocaproic acid
5322368|NCT02074423|Cinnamon extract|cinnamon extract
5322369|NCT02074423|Postprandial glycemia|postprandial glycemia
5322370|NCT02074423|Glycemic index|glycemic index
5322371|NCT02074423|Pre-diabetes|pre-diabetes
5202767|NCT02726750|MGUS|mgus
5322372|NCT02074423|Metabolic syndrome|metabolic syndrome
5322373|NCT02074371|coronary artery bypass surgery|coronary artery bypass surgery
5322374|NCT02074371|cardiopulmonary bypass|cardiopulmonary bypass
5322375|NCT02074371|ICU|icu
5322376|NCT02074371|postoperative respiratory depression|postoperative respiratory depression
5322377|NCT02074345|Drug therapy|drug therapy
5322378|NCT02074345|Safety and immunogenicity of Hib vaccine|safety and immunogenicity of hib vaccine
5322379|NCT02074332|Obesity|obesity
5322380|NCT02074332|Physical activity|physical activity
5322381|NCT02074332|Schoolchildren|schoolchildren
5322382|NCT02074332|Intervention Studies|intervention studies
5322383|NCT02074319|Schizophrenia|schizophrenia
5322384|NCT02074319|Anti-Inflammatory|anti-inflammatory
5322385|NCT02074319|Methotrexate|methotrexate
5322386|NCT02074319|Psychosis Not Otherwise Specified|psychosis not otherwise specified
5322387|NCT02074306|endotracheal intubation|endotracheal intubation
5322388|NCT02074306|low energy ultrasound|low energy ultrasound
5322389|NCT02074306|sputum culture|sputum culture
5322390|NCT02074293|Subdermal bloodless space|subdermal bloodless space
5322391|NCT02074293|Subdermal injection|subdermal injection
5322584|NCT02073383|Bupivacaine|bupivacaine
5322392|NCT02074293|injectable EMG needle|injectable emg needle
5322393|NCT02074293|electrical stimulation|electrical stimulation
5322394|NCT02074293|MRI with Gadolinium|mri with gadolinium
5322395|NCT02074293|Cervical Dystonia|cervical dystonia
5322396|NCT02074293|intramuscular injection|intramuscular injection
5322397|NCT02074293|cervical dystonia,|cervical dystonia,
5322398|NCT02074280|rifaximin|rifaximin
5322399|NCT02074280|endotoxemia|endotoxemia
5322400|NCT02074280|cirrhosis|cirrhosis
5322401|NCT02074280|advanced cirrhosis|advanced cirrhosis
5322402|NCT02074228|Attention-deficit/hyperactivity disorder,|attention-deficit/hyperactivity disorder,
5322403|NCT02074228|symptomatology,|symptomatology,
5322404|NCT02074228|neurocognitive endophenotype,|neurocognitive endophenotype,
5322405|NCT02074228|medication response|medication response
5322406|NCT02074215|Mild Cognitive Impairment|mild cognitive impairment
5322407|NCT02074215|Alzheimer's disease|alzheimer's disease
5322408|NCT02074215|Aerobic exercise|aerobic exercise
5322409|NCT02074202|18F fluorocholine|18f fluorocholine
5322410|NCT02074202|18F fluorodeoxyglucose|18f fluorodeoxyglucose
5322411|NCT02074202|hepatocellular carcinoma|hepatocellular carcinoma
5322412|NCT02074202|PET CT scan|pet ct scan
5322413|NCT02074176|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5322414|NCT02074176|orexin A|orexin a
5322416|NCT02074163|Subdermal bloodless space|subdermal bloodless space
5322417|NCT02074163|Subdermal injection|subdermal injection
5322418|NCT02074163|injectable EMG needle|injectable emg needle
5322419|NCT02074163|electrical stimulation|electrical stimulation
5322420|NCT02074163|MRI with Gadolinium|mri with gadolinium
5322421|NCT02074163|Chronic Migraine|chronic migraine
5322422|NCT02074163|intramuscular injection|intramuscular injection
5322423|NCT02074150|Subdermal bloodless space|subdermal bloodless space
5322424|NCT02074150|Subdermal injection|subdermal injection
5322425|NCT02074150|injectable EMG needle|injectable emg needle
5322426|NCT02074150|electrical stimulation|electrical stimulation
5322427|NCT02074150|MRI with Gadolinium|mri with gadolinium
5322428|NCT02074150|Upper Limb Spasticity|upper limb spasticity
5322429|NCT02074150|intramuscular injection|intramuscular injection
5322430|NCT02074111|Moyamoya disease|moyamoya disease
5322431|NCT02074111|Intracranial atherosclerotic stroke|intracranial atherosclerotic stroke
5322432|NCT02074111|Intracranial steno-occlusive disease|intracranial steno-occlusive disease
5322433|NCT02074111|ring finger 213 (RNF213) gene mutation|ring finger 213 (rnf213) gene mutation
5322435|NCT02074098|intubation|intubation
5322436|NCT02074098|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5322437|NCT02074098|Manikin study|manikin study
5322438|NCT02074072|Endotracheal intubation|endotracheal intubation
5322439|NCT02074072|Left lateral tilt wedge|left lateral tilt wedge
5322440|NCT02074072|Maternal Cardiopulmonary Resuscitation|maternal cardiopulmonary resuscitation
5322441|NCT02074072|Manikin Study|manikin study
5322442|NCT02074020|SLE|sle
5322443|NCT02074020|Lupus|lupus
5322444|NCT02074020|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5322445|NCT02074020|Autoimmune Diseases|autoimmune diseases
5322446|NCT02074020|A-623|a-623
5322447|NCT02074020|Blisibimod|blisibimod
5322448|NCT02074020|Nephritis|nephritis
5322449|NCT02074007|Acute Otitis Media|acute otitis media
5322450|NCT02074007|Pain|pain
5322451|NCT02074007|Ear Pain|ear pain
5322452|NCT02074007|Ear Ache|ear ache
5322453|NCT02074007|Ear infection|ear infection
5322454|NCT02074007|middle ear infection|middle ear infection
5322455|NCT02073994|chondrosarcoma|chondrosarcoma
5322456|NCT02073994|cholangiocarcinoma|cholangiocarcinoma
5322457|NCT02073994|glioma|glioma
5322458|NCT02073994|advanced solid tumors|advanced solid tumors
5322459|NCT02073994|IDH1|idh1
5322460|NCT02073994|AG-120|ag-120
5322461|NCT02073981|Parkinson Disease|parkinson disease
5322462|NCT02073955|Stroke|stroke
5322463|NCT02073955|Validation|validation
5963216|NCT04266093|Laboratory Evaluation|laboratory evaluation
5963217|NCT04264585|anxiety|anxiety
5322464|NCT02073955|Community Health workers|community health workers
5322465|NCT02073955|stroke symptom questionnaire|stroke symptom questionnaire
5322466|NCT02073916|Breast Cancer|breast cancer
5322467|NCT02073916|HER2 positive Breast Cancer|her2 positive breast cancer
5322468|NCT02073903|dual handset interpreter phones|dual handset interpreter phones
5322469|NCT02073903|communication|communication
5322470|NCT02073903|14-042|14-042
5322471|NCT02073890|traumatic Subarachnoid Haemorrhage|traumatic subarachnoid haemorrhage
5322472|NCT02073890|Head Trauma|head trauma
5322473|NCT02073890|Computed Tomography|computed tomography
5322474|NCT02073877|Peri-implant dermatitis|peri-implant dermatitis
5322475|NCT02073864|Aortic valve stenosis, stenosis, intervention|aortic valve stenosis, stenosis, intervention
5322476|NCT02073851|TAVR|tavr
5322477|NCT02073825|Computer-assisted interventions|computer-assisted interventions
5322478|NCT02073825|Alcohol use disorders|alcohol use disorders
5322479|NCT02073825|At-risk drinking|at-risk drinking
5322480|NCT02073825|Spouses|spouses
5322481|NCT02073825|Military|military
5322482|NCT02073825|Brief Intervention|brief intervention
5322483|NCT02073773|stroke, virtual reality based therapy|stroke, virtual reality based therapy
5322484|NCT02073760|Healthcare acquired infections|healthcare acquired infections
5322485|NCT02073760|Cardiac Surgery|cardiac surgery
5322486|NCT02073760|Sternal Superficial Wound Infection|sternal superficial wound infection
5322487|NCT02073760|Deep Sternal Infection|deep sternal infection
5322488|NCT02073760|Mediastinitis|mediastinitis
5322489|NCT02073760|Thoracotomy|thoracotomy
5423282|NCT01616329|alloimmunization|alloimmunization
5322490|NCT02073760|Conduit harvest or cannulation site|conduit harvest or cannulation site
5322492|NCT02073760|Pneumonia|pneumonia
5322493|NCT02073747|Albuterol|albuterol
5322494|NCT02073747|Serum Lactate|serum lactate
5322495|NCT02073747|Lactic Acidosis|lactic acidosis
5322496|NCT02073747|Asthma|asthma
5322497|NCT02073734|pelvic organ prolapse surgery|pelvic organ prolapse surgery
5322498|NCT02073734|dexamethasone|dexamethasone
5322499|NCT02073734|postoperative nausea and vomiting|postoperative nausea and vomiting
5322500|NCT02073734|peroperative administration|peroperative administration
5322501|NCT02073695|Proximal humeral fracture|proximal humeral fracture
5322502|NCT02073695|Shoulder|shoulder
5322503|NCT02073695|Orthopaedics|orthopaedics
5322504|NCT02073695|Neutral rotation brace|neutral rotation brace
5322505|NCT02073695|Polysling|polysling
5322506|NCT02073682|Active Cancer with Metastasis|active cancer with metastasis
5322507|NCT02073669|latent tuberculosis|latent tuberculosis
5322508|NCT02073669|tuberculin skin test|tuberculin skin test
5322509|NCT02073669|Interferon gamma release assay|interferon gamma release assay
5322510|NCT02073669|immigration|immigration
5322511|NCT02073656|genotype 1|genotype 1
5322512|NCT02073656|genotype 4|genotype 4
5322513|NCT02073656|HIV|hiv
5322514|NCT02073630|magnetoencephalography|magnetoencephalography
5322515|NCT02073630|non invasive brain stimulation|non invasive brain stimulation
5322516|NCT02073630|cerebellum|cerebellum
5322517|NCT02073630|gamma rhythms|gamma rhythms
5322518|NCT02073617|DynaCT|dynact
5322519|NCT02073617|Aortic valve and root measurements|aortic valve and root measurements
5322520|NCT02073617|TAVR|tavr
5322521|NCT02073604|Congenital mirror movements|congenital mirror movements
5322523|NCT02073604|Movement preparation|movement preparation
5322524|NCT02073604|Movement lateralization|movement lateralization
5322525|NCT02073604|MRI|mri
5322526|NCT02073604|Transcranial magnetic stimulation|transcranial magnetic stimulation
5322527|NCT02073591|Children|children
5322528|NCT02073591|Atopic Dermatitis|atopic dermatitis
5322529|NCT02073591|Ceradan|ceradan
5322530|NCT02073591|PEST|pest
5322531|NCT02073591|SCORAD|scorad
5322534|NCT02073578|peroral endoscopic myotomy|peroral endoscopic myotomy
5322535|NCT02073578|myotomy|myotomy
5322536|NCT02073578|Heller myotomy|heller myotomy
5322537|NCT02073565|intracoronary stent|intracoronary stent
5322538|NCT02073565|drug eluting stent|drug eluting stent
5322539|NCT02073565|sirolimus|sirolimus
5322540|NCT02073565|endothelial progenitor cells|endothelial progenitor cells
5322541|NCT02073552|colon cleansing, bowel preparations; polyethyleneglycol|colon cleansing, bowel preparations; polyethyleneglycol
5322542|NCT02073539|Chest compression|chest compression
5322543|NCT02073539|One accelerometer|one accelerometer
5322544|NCT02073539|Manikin Study|manikin study
5322545|NCT02073526|Antibodies, Monoclonal|antibodies, monoclonal
5322546|NCT02073526|Anti-TNF|anti-tnf
5322547|NCT02073526|TNF-alpha|tnf-alpha
5322548|NCT02073526|Trough level|trough level
5322549|NCT02073526|Drug concentration|drug concentration
5322550|NCT02073526|ELISA|elisa
5322551|NCT02073513|Spasticity, Hand Function, Cerebral Palsy, Kinesiotape|spasticity, hand function, cerebral palsy, kinesiotape
5322552|NCT02073500|Peritoneal carcinomatosis|peritoneal carcinomatosis
5322553|NCT02073500|Peritoneal surface malignancy|peritoneal surface malignancy
5322554|NCT02073500|Cytoreductive surgery|cytoreductive surgery
5322555|NCT02073500|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5322556|NCT02073500|CRS|crs
5322557|NCT02073500|HIPEC|hipec
5322558|NCT02073500|Prognostic biomarker|prognostic biomarker
5190929|NCT02798081|augmentative and alternative communication|augmentative and alternative communication
5190930|NCT02798081|social inclusion|social inclusion
5190931|NCT02798081|serious games|serious games
5190932|NCT02798081|Information and communication technologies|information and communication technologies
5190933|NCT02798068|Steroids|steroids
5190934|NCT02798068|Cardiac surgery|cardiac surgery
5190935|NCT02798068|Endothelial dysfunction|endothelial dysfunction
5190936|NCT02798068|Glycocalyx|glycocalyx
5190937|NCT02798068|Flow mediated vasodilation|flow mediated vasodilation
5190938|NCT02798003|Cachexia|cachexia
5190958|NCT02797977|MYC|myc
5202959|NCT02725632|splicing variant|splicing variant
5322559|NCT02073500|Predictive biomarker|predictive biomarker
5322560|NCT02073487|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
5322561|NCT02073487|HER2 positive Breast Cancer|her2 positive breast cancer
5322562|NCT02073474|cannabinoids|cannabinoids
5322563|NCT02073474|Sativex|sativex
5322564|NCT02073474|THC|thc
5322565|NCT02073474|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
5322566|NCT02073474|cannabidiol|cannabidiol
5322567|NCT02073474|CBD|cbd
5322568|NCT02073474|Registry|registry
5322569|NCT02073474|Safety|safety
5322570|NCT02073474|MS|ms
5322571|NCT02073461|Acne Vulgaris|acne vulgaris
5322572|NCT02073448|Acne Vulgaris|acne vulgaris
5322573|NCT02073435|liver transplantation|liver transplantation
5322574|NCT02073435|living donor|living donor
5322575|NCT02073435|Safety|safety
5322576|NCT02073422|Magnetic resonance imaging|magnetic resonance imaging
5322577|NCT02073422|Myocardial stress perfusion magnetic resonance imaging|myocardial stress perfusion magnetic resonance imaging
5322578|NCT02073422|Fractional flow reserve|fractional flow reserve
5322579|NCT02073422|Relaxometry|relaxometry
5322580|NCT02073422|Coronary artery disease|coronary artery disease
5322581|NCT02073409|Nontuberculous Mycobacteria|nontuberculous mycobacteria
5322582|NCT02073383|Axillary brachial plexus block|axillary brachial plexus block
5322583|NCT02073383|Ultrasound|ultrasound
5322585|NCT02073344|obstructive sleep apnea|obstructive sleep apnea
5322586|NCT02073344|overhydration|overhydration
5322587|NCT02073344|end stage renal disease|end stage renal disease
5322588|NCT02073344|renal transplantation|renal transplantation
5322589|NCT02073344|polysomnography|polysomnography
5322590|NCT02073344|bioimpedance|bioimpedance
5322591|NCT02073344|leg fluid shift|leg fluid shift
5322592|NCT02073344|neck circumference|neck circumference
5322593|NCT02073331|Open heart surgery, cardiac repair|open heart surgery, cardiac repair
5322594|NCT02073305|obstructive sleep apnea|obstructive sleep apnea
5322595|NCT02073305|end stage renal disease|end stage renal disease
5322596|NCT02073305|cardiovascular events|cardiovascular events
5322597|NCT02073240|Tuberculosis|tuberculosis
5322598|NCT02073240|Infection Control|infection control
5322599|NCT02073227|Healthy Volunteers|healthy volunteers
5322600|NCT02073227|Canagliflozin|canagliflozin
5322601|NCT02073227|Metformin|metformin
5322602|NCT02073227|Type 2 diabetes mellitus|type 2 diabetes mellitus
5322603|NCT02073175|Postpartum|postpartum
5322604|NCT02073175|Dietary Supplements|dietary supplements
5322605|NCT02073175|Mood Symptoms|mood symptoms
5322606|NCT02073149|Iron|iron
5322607|NCT02073149|Anemia|anemia
5322608|NCT02073149|Sodium Fe(III)-ethylenediaminetetraacetic acid (NaFeEDTA)|sodium fe(iii)-ethylenediaminetetraacetic acid (nafeedta)
5322609|NCT02073149|Ferrous compounds|ferrous compounds
5322610|NCT02073149|Child, preschool|child, preschool
5322611|NCT02073149|Kenya|kenya
5322612|NCT02073123|Metastatic melanoma|metastatic melanoma
5322613|NCT02073123|Stage III melanoma|stage iii melanoma
5322614|NCT02073123|Stage IV melanoma|stage iv melanoma
5322615|NCT02073123|unresectable|unresectable
5322616|NCT02073110|Kidney cancer|kidney cancer
5322617|NCT02073110|Renal mass|renal mass
5322618|NCT02073110|Small renal mass|small renal mass
5322619|NCT02073110|Optical Coherence Tomography|optical coherence tomography
5322621|NCT02073110|Diffuse Reflectance Spectroscopy|diffuse reflectance spectroscopy
5322622|NCT02073110|DRS|drs
5322623|NCT02073110|Optical Biopsy|optical biopsy
5322624|NCT02073110|OB|ob
5322625|NCT02073058|Subjects with Type 1 or Type 2 Diabetes Requiring Multiple daily Insulin Injection (MDI) or Continuous Subcutaneous Insulin Infusion (CSII)|subjects with type 1 or type 2 diabetes requiring multiple daily insulin injection (mdi) or continuous subcutaneous insulin infusion (csii)
5322626|NCT02073032|Refeeding syndrome, risk factors, head and neck cancer|refeeding syndrome, risk factors, head and neck cancer
5322627|NCT02073006|Chronic|chronic
5322628|NCT02073006|Functional|functional
5963218|NCT04264585|depression|depression
5963219|NCT04264585|post-secondary students|post-secondary students
5963220|NCT04264585|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5963221|NCT04264585|randomized controlled trial|randomized controlled trial
5963222|NCT04264585|patient-centred|patient-centred
5963223|NCT04264585|therapist-assistance|therapist-assistance
5963224|NCT04264143|Blood brain barrier|blood brain barrier
5963225|NCT04264143|Diffuse Midline Gliomas|diffuse midline gliomas
5963226|NCT04264143|Convection-Enhanced Delivery (CED)|convection-enhanced delivery (ced)
5963227|NCT04264143|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5963228|NCT04264143|Thalamic Gliomas|thalamic gliomas
5963229|NCT04263766|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5963230|NCT04263766|Metacognition|metacognition
5963231|NCT04263766|Prefrontal Cortex|prefrontal cortex
5963232|NCT04263727|IPF|ipf
5322629|NCT02073006|Constipation|constipation
5322630|NCT02073006|less than 3 bowel movements per week|less than 3 bowel movements per week
5322631|NCT02072993|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
5322633|NCT02072980|DAILIES TOTAL1®|dailies total1®
5322634|NCT02072980|Lubricity|lubricity
5322635|NCT02072967|Relapsed|relapsed
5322636|NCT02072967|Refractory|refractory
5322637|NCT02072967|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5322638|NCT02072967|Bendamustine|bendamustine
5322639|NCT02072941|Advance care planning|advance care planning
5322640|NCT02072941|Latino Health|latino health
5322641|NCT02072941|Medical decision making|medical decision making
5322642|NCT02072941|Health Literacy|health literacy
5322643|NCT02072941|Limited English proficiency|limited english proficiency
5322644|NCT02072941|Aging|aging
5322645|NCT02072902|Cohort|cohort
5322646|NCT02072902|Historical|historical
5322647|NCT02072902|Prospective|prospective
5322648|NCT02072902|Medications|medications
5322649|NCT02072902|Observational|observational
5322650|NCT02072902|Glucose|glucose
5322651|NCT02072902|Control|control
5322652|NCT02072889|Cardiac Surgery|cardiac surgery
5322653|NCT02072889|Internal Jugular Cannulation|internal jugular cannulation
5322654|NCT02072889|Optimal Neck Angle|optimal neck angle
5322655|NCT02072876|Stroke|stroke
5322656|NCT02072876|Asymptomatic Intracranial Atherosclerotic Disease|asymptomatic intracranial atherosclerotic disease
5322657|NCT02072876|Lifestyle and socio-economic risk factors|lifestyle and socio-economic risk factors
5322658|NCT02072876|Clinical predictors|clinical predictors
5322659|NCT02072850|Myocardial infarction|myocardial infarction
5322660|NCT02072850|Primary percutaneous coronary intervention (PCI)|primary percutaneous coronary intervention (pci)
5322661|NCT02072850|Thrombolysis|thrombolysis
5322662|NCT02072850|Rescue PCI|rescue pci
5322663|NCT02072850|Electrocardiogram|electrocardiogram
5322664|NCT02072850|Magnetic resonance imaging|magnetic resonance imaging
5322665|NCT02072850|Area-at-risk|area-at-risk
5322666|NCT02072850|Myocardial salvage|myocardial salvage
5322667|NCT02072850|Infarct size|infarct size
5322668|NCT02072850|Pressure wire|pressure wire
5322669|NCT02072850|Coronary thermodilution|coronary thermodilution
5322670|NCT02072850|Coronary microvascular function|coronary microvascular function
5322671|NCT02072850|Index of microvascular resistance|index of microvascular resistance
5322672|NCT02072850|Heart failure|heart failure
5322673|NCT02072850|Prognosis|prognosis
5322674|NCT02072837|hemodialysis, dyslipidemia, cardiovascular disease|hemodialysis, dyslipidemia, cardiovascular disease
5322675|NCT02072824|Partial Onset Seizures|partial onset seizures
5322676|NCT02072824|Epilepsy|epilepsy
5322677|NCT02072824|Safety|safety
5322678|NCT02072824|Efficacy|efficacy
5322679|NCT02072824|Tolerability|tolerability
5322681|NCT02072824|Lyrica|lyrica
5322682|NCT02072824|Adjunctive treatment|adjunctive treatment
5322683|NCT02072824|Placebo controlled|placebo controlled
5322684|NCT02072824|blinded|blinded
5322685|NCT02072824|Eligibility Criteria|eligibility criteria
5322686|NCT02072811|AML|aml
5322687|NCT02072798|Randomized Controlled Trial|randomized controlled trial
5322688|NCT02072798|Caesarean Section|caesarean section
5322689|NCT02072798|Surgical Site Infections|surgical site infections
5322690|NCT02072798|Wound Infections|wound infections
5322691|NCT02072798|Infectious Morbidity|infectious morbidity
5322692|NCT02072785|Adult Acute Lymphoblastic Leukemia|adult acute lymphoblastic leukemia
5322693|NCT02072785|Vincristine Sulfate Liposome|vincristine sulfate liposome
5322694|NCT02072785|Vincristine Sulfate|vincristine sulfate
5322695|NCT02072759|Insulin sensitivity|insulin sensitivity
5322696|NCT02072759|Metabolic flexibility|metabolic flexibility
5322697|NCT02072746|cirrhosis|cirrhosis
5322698|NCT02072746|alcohol|alcohol
5322699|NCT02072733|frailty|frailty
5322700|NCT02072733|oncogeriatrics|oncogeriatrics
5322701|NCT02072733|Multidisciplinary intervention|multidisciplinary intervention
5322702|NCT02072733|multimorbidity|multimorbidity
5322703|NCT02072733|Comprehensive geriatric assessment|comprehensive geriatric assessment
5322704|NCT02072733|patients|patients
5322705|NCT02072720|Radiotherapy|radiotherapy
5322706|NCT02072720|VEGF|vegf
5322707|NCT02072720|esophagus carcinoma|esophagus carcinoma
5322708|NCT02072720|bevacizumab|bevacizumab
5322709|NCT02072707|Ventricular Tachycardia|ventricular tachycardia
5322710|NCT02072707|RF ablation|rf ablation
5322711|NCT02072707|Epicardial Access|epicardial access
5322712|NCT02072707|Contact Sensor Irrigated tip catheter|contact sensor irrigated tip catheter
5322713|NCT02072694|Obesity|obesity
5322714|NCT02072694|Single Photon Emission Computed Tomography|single photon emission computed tomography
5322715|NCT02072694|Functional Neuroimaging|functional neuroimaging
5322716|NCT02072668|sickle cell anemia|sickle cell anemia
5322717|NCT02072668|sickle cell disease|sickle cell disease
5322718|NCT02072668|rivaroxaban|rivaroxaban
5322719|NCT02072668|direct Xa inhibition|direct xa inhibition
5322720|NCT02072668|coagulation|coagulation
5322721|NCT02072668|anticoagulation|anticoagulation
5322722|NCT02072629|Antimalarials|antimalarials
5322724|NCT02072629|ORS Zn|ors zn
5322725|NCT02072629|Village Health Volunteers|village health volunteers
5322726|NCT02072629|Integrated Community Case Management|integrated community case management
5322727|NCT02072616|Circulating Tumor Cells|circulating tumor cells
5322728|NCT02072616|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5322729|NCT02072616|circulating tumor DNA (KRAS)|circulating tumor dna (kras)
5322730|NCT02072616|CA 19.9|ca 19.9
5322731|NCT02072603|Infant HIV|infant hiv
5322732|NCT02072603|Kenya|kenya
5322733|NCT02072603|HITSystem|hitsystem
5322734|NCT02072603|EID care|eid care
5322735|NCT02072603|Early Infant Diagnosis|early infant diagnosis
5322736|NCT02072590|Celiac disease|celiac disease
5322737|NCT02072590|Eosinophilic esophagitis|eosinophilic esophagitis
5322738|NCT02072590|Endomysial antibodies|endomysial antibodies
5322739|NCT02072590|Transglutaminase antibodies|transglutaminase antibodies
5322740|NCT02072590|Small-bowel|small-bowel
5322741|NCT02072577|Nursing care, oral health, educational video, oral hygiene.|nursing care, oral health, educational video, oral hygiene.
5322742|NCT02072538|Stress testing|stress testing
5322743|NCT02072538|Troponin T|troponin t
5322744|NCT02072538|GRACE score|grace score
5322745|NCT02072538|Outcome|outcome
5322746|NCT02072525|Pertussis|pertussis
5322747|NCT02072525|Healthy adults|healthy adults
5322748|NCT02072525|Tetanus|tetanus
5322749|NCT02072525|Human serum samples|human serum samples
5322750|NCT02072525|Streptococcus|streptococcus
5322751|NCT02072525|Diphtheria|diphtheria
5322752|NCT02072525|Plasma|plasma
5322753|NCT02072525|Meningococcus|meningococcus
5322754|NCT02072512|pre- and perimenopausal HR+ advanced breast cancer|pre- and perimenopausal hr+ advanced breast cancer
5322755|NCT02072473|Re-entrant Atrioventricular Node Tachycardia|re-entrant atrioventricular node tachycardia
5322756|NCT02072473|Unsuccessful right-sided slow pathway ablation|unsuccessful right-sided slow pathway ablation
5322757|NCT02072473|Coronary sinus / left-sided slow pathway ablation|coronary sinus / left-sided slow pathway ablation
5322758|NCT02072447|absolute bioavailability,|absolute bioavailability,
5322759|NCT02072447|microdose,|microdose,
5322760|NCT02072447|AMS|ams
5322761|NCT02072434|Nonvalvular atrial fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
5322762|NCT02072434|anti-coagulant|anti-coagulant
5322763|NCT02072434|warfarin|warfarin
5322764|NCT02072434|edoxaban|edoxaban
5322765|NCT02072434|electrical cardioversion|electrical cardioversion
5322766|NCT02072395|morbid obesity|morbid obesity
5322767|NCT02072395|bariatric surgery|bariatric surgery
5322768|NCT02072395|gastric banding|gastric banding
5322769|NCT02072395|gastric plication|gastric plication
5322770|NCT02072382|Hypertension|hypertension
5322771|NCT02072382|Metformin|metformin
5322772|NCT02072382|Ambulatory blood pressure monitor|ambulatory blood pressure monitor
5322773|NCT02072369|stroke|stroke
5322774|NCT02072369|hand|hand
5322775|NCT02072369|fingers|fingers
5322776|NCT02072369|rehabilitation|rehabilitation
5322777|NCT02072369|training|training
5322778|NCT02072356|Humanitarian Device|humanitarian device
5322779|NCT02072356|Carcinoma|carcinoma
5322780|NCT02072356|Hepatocellular Carcinoma|hepatocellular carcinoma
5322781|NCT02072356|TheraSphere®|therasphere®
5322782|NCT02072356|HUD|hud
5322783|NCT02072343|Capnography|capnography
5322784|NCT02072343|Catheters|catheters
5322785|NCT02072343|Intubation|intubation
5322786|NCT02072330|Hypertension, Drug therapy|hypertension, drug therapy
5322787|NCT02072317|PFS|pfs
5322788|NCT02072304|mood disorder|mood disorder
5322789|NCT02072304|depressive disorder|depressive disorder
5322790|NCT02072304|mental disorders|mental disorders
5322791|NCT02072304|program acceptability|program acceptability
5322792|NCT02072304|behavioral symptoms|behavioral symptoms
5322793|NCT02072304|suicidal ideation|suicidal ideation
5322794|NCT02072304|patient adherence|patient adherence
5322795|NCT02072265|infrared thermal image|infrared thermal image
5322796|NCT02072265|wound healing|wound healing
5322797|NCT02072265|wound infection|wound infection
5322798|NCT02072252|Depression|depression
5322799|NCT02072252|Anxiety|anxiety
5322800|NCT02072252|Mobile Phone|mobile phone
5322801|NCT02072252|Cellular Phone|cellular phone
5322802|NCT02072252|Mobile Application|mobile application
5322803|NCT02072252|Mobile Intervention|mobile intervention
5322804|NCT02072252|App|app
5322805|NCT02072252|mHealth|mhealth
5322806|NCT02072252|eHealth|ehealth
5322807|NCT02072252|Technology Assisted|technology assisted
5322808|NCT02072252|Internet|internet
5322809|NCT02072252|Cognitive Behavioral Therapy|cognitive behavioral therapy
5322810|NCT02072252|LGBT|lgbt
5322811|NCT02072252|Sexual Minorities|sexual minorities
5322812|NCT02072252|Gay|gay
5322813|NCT02072252|Bisexual|bisexual
5322814|NCT02072252|Same Sex Attraction|same sex attraction
5322815|NCT02072252|Males|males
5322816|NCT02072252|Men|men
5322817|NCT02072252|Youth|youth
5322818|NCT02072252|Adolescents|adolescents
5322819|NCT02072252|Young Adults|young adults
5322820|NCT02072239|CABG|cabg
5322821|NCT02072239|Intimal Hyperplasia|intimal hyperplasia
5322822|NCT02072239|Atherosclerosis|atherosclerosis
5322823|NCT02072239|Myocardial Infarction|myocardial infarction
5322824|NCT02072213|Tamsulosin,controlled release formulation|tamsulosin,controlled release formulation
5963233|NCT04263727|COPD|copd
5322825|NCT02072200|RA, MS, Safety, Efficacy, MR prednisone|ra, ms, safety, efficacy, mr prednisone
5322826|NCT02072187|Depression|depression
5322827|NCT02072187|Vitamin D|vitamin d
5322828|NCT02072187|Complementary and Alternative Medicine|complementary and alternative medicine
5322829|NCT02072187|Supplements|supplements
5322830|NCT02072187|Non Remitted Depression|non remitted depression
5322832|NCT02072161|LDL|ldl
5322833|NCT02072161|Cholesterol|cholesterol
5322834|NCT02072148|Human Papilloma Virus|human papilloma virus
5322835|NCT02072148|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5322836|NCT02072148|Transoral Robotic Surgery|transoral robotic surgery
5322837|NCT02072122|dry eye|dry eye
5322838|NCT02072122|fertility treatment|fertility treatment
5322839|NCT02072122|Meibomian gland dysfunction|meibomian gland dysfunction
5322840|NCT02072122|supra physiologic estrogen level|supra physiologic estrogen level
5322841|NCT02072109|Near infrared spectroscopy|near infrared spectroscopy
5322842|NCT02072109|Bolus nutrition|bolus nutrition
5322843|NCT02072109|Continuous nutrition|continuous nutrition
5322844|NCT02072109|Mesenteric circulation|mesenteric circulation
5322845|NCT02072083|dexmedetomidine|dexmedetomidine
5322846|NCT02072083|intranasal|intranasal
5322847|NCT02072083|strabismus surgery|strabismus surgery
5322848|NCT02072083|premedication|premedication
5322849|NCT02072083|oculocardiac reflex|oculocardiac reflex
5322850|NCT02072070|chondrocyte cells, Osteoarthritis, gene therapy|chondrocyte cells, osteoarthritis, gene therapy
5322851|NCT02072044|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
5322852|NCT02072044|Anlotinib|anlotinib
5322853|NCT02072031|Anlotinib|anlotinib
5322854|NCT02072031|Sunitinib|sunitinib
5322855|NCT02072031|Renal Cell Carcinoma（RCC）|renal cell carcinoma（rcc）
5322856|NCT02072018|Peyronie's|peyronie's
5322857|NCT02072018|Peyronie's disease|peyronie's disease
5322858|NCT02072018|Treatment|treatment
5322859|NCT02072018|Clinical Study|clinical study
5322860|NCT02071979|Chronic|chronic
5322861|NCT02071979|Non-healing|non-healing
5322862|NCT02071979|Wounds|wounds
5322863|NCT02071966|Micro-RNA, Microparticles, Ticagrelor, NSTE-ACS|micro-rna, microparticles, ticagrelor, nste-acs
5322864|NCT02071940|Acral Melanoma subtypes|acral melanoma subtypes
5322865|NCT02071940|Mucosal Melanoma subtypes|mucosal melanoma subtypes
5322866|NCT02071927|leukemia|leukemia
5322867|NCT02071927|glutaminase|glutaminase
5322868|NCT02071927|glutamine|glutamine
5322869|NCT02071888|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5322870|NCT02071888|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5322871|NCT02071888|Multiple myeloma|multiple myeloma
5322872|NCT02071888|glutaminase|glutaminase
5322873|NCT02071888|glutamine|glutamine
5322874|NCT02071875|Vasospasm|vasospasm
5322875|NCT02071875|Aneurysm|aneurysm
5322876|NCT02071875|SAH|sah
5322877|NCT02071875|Nautilus NeuroWave|nautilus neurowave
5322890|NCT02071823|Parkinson,|parkinson,
5322891|NCT02071823|Bial,|bial,
5322892|NCT02071823|BIA 9-1067|bia 9-1067
5218000|NCT02634489|Vesicare®|vesicare®
5322893|NCT02071810|Parkinson's disease (PD)|parkinson's disease (pd)
5322894|NCT02071810|Opicapone|opicapone
5322895|NCT02071810|Bial|bial
5322896|NCT02071810|BIA 9-1067|bia 9-1067
5322897|NCT02071797|Therapeutic Hypothermia|therapeutic hypothermia
5322898|NCT02071797|Cardiac Arrest|cardiac arrest
5322899|NCT02071797|Randomised Controlled trial|randomised controlled trial
5322900|NCT02071797|Pilot study|pilot study
5322901|NCT02071771|DACP Toric|dacp toric
5322902|NCT02071771|DAILIES® AquaComfort Plus®|dailies® aquacomfort plus®
5322903|NCT02071771|Astigmatism|astigmatism
5322904|NCT02071771|Toric|toric
5322905|NCT02071758|Leishmaniasis|leishmaniasis
5322906|NCT02071758|Visceral leishmaniasis|visceral leishmaniasis
5322907|NCT02071758|Vaccine|vaccine
5322908|NCT02071758|Adjuvant|adjuvant
5322910|NCT02071758|SLA|sla
5322911|NCT02071693|subthalamic nucleus|subthalamic nucleus
5322912|NCT02071693|deep brain stimulation|deep brain stimulation
5322913|NCT02071693|cognition|cognition
5322914|NCT02071693|white matter hyperintensities|white matter hyperintensities
5322915|NCT02071680|atrial fibrillation|atrial fibrillation
5322916|NCT02071680|atrial cardiac innervation|atrial cardiac innervation
5322917|NCT02071680|catheter ablation of atrial fibrillation|catheter ablation of atrial fibrillation
5322918|NCT02071680|High Frequency Stimulation|high frequency stimulation
5322919|NCT02071680|ganglionated plexuses|ganglionated plexuses
5322920|NCT02071680|123I-mIBG|123i-mibg
5322921|NCT02071680|nuclear imaging|nuclear imaging
5322922|NCT02071667|Chronic sinusitis|chronic sinusitis
5322923|NCT02071667|Nasal Polyps|nasal polyps
5322924|NCT02071654|Venus P-valve|venus p-valve
5322925|NCT02071615|Brain Activity|brain activity
5322926|NCT02071602|Heart attack|heart attack
5322927|NCT02071602|Myocardial Infarction|myocardial infarction
5322928|NCT02071602|STEMI|stemi
5322929|NCT02071576|Myopia|myopia
5322930|NCT02071576|Hyperopia|hyperopia
5322931|NCT02071576|Proscan|proscan
5322932|NCT02071576|LASIK|lasik
5322933|NCT02071576|TENEO|teneo
5322934|NCT02071576|Excimer|excimer
5319403|NCT02087748|DOMS|doms
5862774|NCT00001516|Occupational Therapy|occupational therapy
5369182|NCT01860937|T cell Immunotherapy|t cell immunotherapy
5963234|NCT04263727|Respiratory Disease|respiratory disease
5322935|NCT02071550|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure|laparoscopic cholecystectomy, near infrared spectroscopy, positive end expiratory pressure
5322938|NCT02071498|Applications|applications
5322939|NCT02071498|Patient safety|patient safety
5322940|NCT02071498|Elderly|elderly
5322941|NCT02071459|L-threo DOPS (DroxiDopa)|l-threo dops (droxidopa)
5322942|NCT02071459|Orthostatic Hypotension|orthostatic hypotension
5322943|NCT02071459|Multiple system atrophy|multiple system atrophy
5322944|NCT02071446|Deep Brain Stimulation|deep brain stimulation
5322945|NCT02071446|Local Field Potential|local field potential
5322946|NCT02071446|Subthalamic Nucleus|subthalamic nucleus
5322947|NCT02071433|Saphenous nerve block|saphenous nerve block
5322948|NCT02071433|Adductor canal block|adductor canal block
5322949|NCT02071433|Anterior cruciate ligament|anterior cruciate ligament
5322950|NCT02071433|Pain management|pain management
5322951|NCT02071433|Day care|day care
5322952|NCT02071407|traumatic brain injury|traumatic brain injury
5322953|NCT02071407|sedation|sedation
5322954|NCT02071407|midazolam|midazolam
5322955|NCT02071394|Xenon|xenon
5322956|NCT02071394|Hypothermia|hypothermia
5322957|NCT02071394|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5322958|NCT02071394|Newborn|newborn
5322959|NCT02071394|Neonate|neonate
5322960|NCT02071394|Term|term
5322961|NCT02071394|Neuroprotection|neuroprotection
5322962|NCT02071394|Cooling|cooling
5322963|NCT02071394|HIE|hie
5322964|NCT02071368|Healthy|healthy
5322965|NCT02071368|Canagliflozin|canagliflozin
5322966|NCT02071368|Metformin|metformin
5322967|NCT02071368|JNJ-28431754|jnj-28431754
5322968|NCT02071368|GLUMETZA®|glumetza®
5322969|NCT02071368|Bioequivalence|bioequivalence
5322970|NCT02071368|Fixed Dose Combination|fixed dose combination
5322971|NCT02071355|Healthy|healthy
5322972|NCT02071355|Chinese participants|chinese participants
5322973|NCT02071355|TMC435|tmc435
5322974|NCT02071355|Multiple oral doses|multiple oral doses
5322975|NCT02071355|Pharmacokinetics|pharmacokinetics
5322976|NCT02071355|Safety|safety
5322977|NCT02071355|Tolerability|tolerability
5322978|NCT02071342|acute myocardial infarction|acute myocardial infarction
5218076|NCT02634203|Riociguat|riociguat
5322979|NCT02071342|bioresorbable vascular scaffold|bioresorbable vascular scaffold
5423283|NCT01616329|RBC|rbc
5322985|NCT02071329|Virus|virus
5322986|NCT02071329|H1N1|h1n1
5322987|NCT02071329|Challenge|challenge
5322988|NCT02071316|upper gastrointestinal bleeding|upper gastrointestinal bleeding
5322989|NCT02071316|Hexacapron|hexacapron
5322990|NCT02071316|hemostasis|hemostasis
5322991|NCT02071303|Pain|pain
5322992|NCT02071303|Hysteroscopy|hysteroscopy
5322993|NCT02071303|Tramadol|tramadol
5322994|NCT02071303|Celecoxib|celecoxib
5322995|NCT02071290|Hemorrhagic Shock|hemorrhagic shock
5322996|NCT02071290|Remote Ischemic Conditioning|remote ischemic conditioning
5322997|NCT02071277|Mechanical ventilation|mechanical ventilation
5322998|NCT02071277|Airway pressure release ventilation|airway pressure release ventilation
5322999|NCT02071277|Biphasic intermittent positive airway pressure|biphasic intermittent positive airway pressure
5323000|NCT02071277|Pressure-controlled ventilation|pressure-controlled ventilation
5323001|NCT02071277|Lung protective ventilation|lung protective ventilation
5323002|NCT02071277|Spontaneous breathing|spontaneous breathing
5323003|NCT02071264|HIV/AIDS|hiv/aids
5323004|NCT02071264|sex work|sex work
5323005|NCT02071264|reproductive health|reproductive health
5323006|NCT02071264|human rights|human rights
5323007|NCT02071264|ethics|ethics
5323008|NCT02071251|Wound complications|wound complications
5323009|NCT02071251|Wound infection|wound infection
5323010|NCT02071251|Wound separation|wound separation
5323011|NCT02071238|Carpal tunnel|carpal tunnel
5323012|NCT02071238|Carpal tunnel release|carpal tunnel release
5323013|NCT02071238|Risk Recall|risk recall
5323014|NCT02071238|Patient satisfaction|patient satisfaction
5323015|NCT02071238|Pamphlet|pamphlet
5323016|NCT02071238|Brochure|brochure
5323017|NCT02071199|Gingivitis|gingivitis
5323018|NCT02071199|Periodontitis|periodontitis
5323019|NCT02071199|ACCS|accs
5323020|NCT02071160|HIE|hie
5323021|NCT02071160|hypothermia|hypothermia
5323022|NCT02071160|encephalopathy|encephalopathy
5323023|NCT02071160|anti oxidants|anti oxidants
5323024|NCT02071160|MRI|mri
5323025|NCT02071147|Follow-up|follow-up
5323026|NCT02071147|No follow-up|no follow-up
5323027|NCT02071147|removal|removal
5323028|NCT02071147|Randomised Controlled Trial|randomised controlled trial
5323029|NCT02071147|6 Weeks|6 weeks
5323030|NCT02071134|Deep brain stimulation|deep brain stimulation
5323031|NCT02071134|Parkinson's disease|parkinson's disease
5323032|NCT02071134|Vercise|vercise
5323033|NCT02071121|BIIB061|biib061
5323034|NCT02071121|Healthy|healthy
5323035|NCT02071095|Human immunodeficiency virus 1|human immunodeficiency virus 1
5323036|NCT02071095|Combined Antiretroviral Therapy|combined antiretroviral therapy
5323037|NCT02071095|Poly-ICLC|poly-iclc
5323038|NCT02071095|Adjuvant|adjuvant
5323039|NCT02071082|HIV|hiv
5323040|NCT02071082|HBV|hbv
5323041|NCT02071082|Coinfection|coinfection
5323042|NCT02071069|Incurable colorectal cancer|incurable colorectal cancer
5323043|NCT02071069|maintenance therapy|maintenance therapy
5323044|NCT02071069|Cetuximab|cetuximab
5323045|NCT02071043|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5323046|NCT02071043|advanced gastric cancer patients|advanced gastric cancer patients
5323047|NCT02071043|para-aortic lymph node metastasis|para-aortic lymph node metastasis
5323048|NCT02071030|CBCT|cbct
5323049|NCT02071030|Third molar removal|third molar removal
5323050|NCT02071030|Inferior alveolar nerve injury|inferior alveolar nerve injury
5323051|NCT02071004|acute ischemic stroke|acute ischemic stroke
5323052|NCT02070991|pre- and post-capillary pulmonary hypertension|pre- and post-capillary pulmonary hypertension
5323053|NCT02070991|CpcPH|cpcph
5323054|NCT02070978|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5323055|NCT02070978|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
5323057|NCT02070952|CyberKnife|cyberknife
5323058|NCT02070952|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5323059|NCT02070952|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
5323060|NCT02070939|Phase 1|phase 1
5323061|NCT02070939|Randomized|randomized
5323062|NCT02070939|Double Blind|double blind
5323063|NCT02070939|Placebo-Controlled|placebo-controlled
5323064|NCT02070939|Single and Multiple Dose Escalation|single and multiple dose escalation
5323065|NCT02070939|Safety Tolerability|safety tolerability
5323066|NCT02070939|PK|pk
5323067|NCT02070939|PD|pd
5323068|NCT02070939|PF-06460414|pf-06460414
5323069|NCT02070913|Hypothermia|hypothermia
5323070|NCT02070913|Acute Myocardial Infarction|acute myocardial infarction
5323071|NCT02070913|Percutaneous Coronary Intervention|percutaneous coronary intervention
5323072|NCT02070913|AMI|ami
5323073|NCT02070913|PCI|pci
5323074|NCT02070913|Therapeutic Hypothermia|therapeutic hypothermia
5323075|NCT02070900|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5323076|NCT02070900|PMTCT|pmtct
5323077|NCT02070900|Option B+|option b+
5323078|NCT02070900|ART|art
5323079|NCT02070900|Retention|retention
5323080|NCT02070900|Loss to Follow Up|loss to follow up
5323081|NCT02070900|Time to initiation|time to initiation
5323082|NCT02070900|POC CD4|poc cd4
5323083|NCT02070900|Clinical mentoring|clinical mentoring
5323084|NCT02070900|Costing|costing
5323085|NCT02070900|HIV|hiv
5323086|NCT02070900|AIDS|aids
5323087|NCT02070900|Zimbabwe|zimbabwe
5323088|NCT02070874|pain and symptom management|pain and symptom management
5323089|NCT02070861|Cardiac output|cardiac output
5323090|NCT02070861|Exhaled CO2|exhaled co2
5323091|NCT02070861|Nexfin|nexfin
5323092|NCT02070861|Esophageal Doppler|esophageal doppler
5323093|NCT02070848|red blood cell|red blood cell
5323094|NCT02070848|knee extension exercise|knee extension exercise
5323095|NCT02070835|Diabetic Foot Ulcer|diabetic foot ulcer
5323096|NCT02070835|ReCell|recell
5323097|NCT02070822|Hepatocellular carcinoma|hepatocellular carcinoma
5323098|NCT02070822|Transarterial chemoembolization|transarterial chemoembolization
5323099|NCT02070822|Magnetic resonance imaging|magnetic resonance imaging
5323100|NCT02070809|wound|wound
5323101|NCT02070809|tissue-engineered skin|tissue-engineered skin
5323102|NCT02070796|Rotigotine|rotigotine
5323103|NCT02070796|Transdermal Patch|transdermal patch
5323104|NCT02070796|Bioequivalence|bioequivalence
5323105|NCT02070783|depression|depression
5323106|NCT02070783|cognition|cognition
5323107|NCT02070783|emotion perception|emotion perception
5323108|NCT02070783|information processing|information processing
5323110|NCT02070731|TAVR|tavr
5323111|NCT02070731|TAVI|tavi
5323112|NCT02070731|Aortic Valve Stenosis|aortic valve stenosis
5323113|NCT02070718|hot flashes|hot flashes
5323114|NCT02070718|menopause|menopause
5323115|NCT02070718|kappa agonist|kappa agonist
5323116|NCT02070692|Contraceptive implant|contraceptive implant
5323117|NCT02070692|Irregular vaginal bleeding|irregular vaginal bleeding
5323118|NCT02070692|Etonogestrel implant|etonogestrel implant
5323119|NCT02070679|Alpha-tocopherol|alpha-tocopherol
5323120|NCT02070679|Vitamin E|vitamin e
5323121|NCT02070679|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
5323122|NCT02070679|Coronary angiography|coronary angiography
5323123|NCT02070666|ARDS|ards
5323124|NCT02070666|Prevention|prevention
5310022|NCT02129556|Metastatic|metastatic
5323125|NCT02070666|Protective mechanical ventilation|protective mechanical ventilation
5323126|NCT02070666|low tidal volumes|low tidal volumes
5323127|NCT02070653|Aorta|aorta
5323128|NCT02070653|Aneurysm|aneurysm
5323129|NCT02070653|Antiplatelet|antiplatelet
5323130|NCT02070640|cholecystectomy|cholecystectomy
5323131|NCT02070640|cholecystitis|cholecystitis
5323132|NCT02070627|acute cholecystitis|acute cholecystitis
5323133|NCT02070627|acute cholangitis|acute cholangitis
5323134|NCT02070627|cholecystectomy|cholecystectomy
5323135|NCT02070614|sufentanil|sufentanil
5323136|NCT02070614|metabolism|metabolism
5323137|NCT02070614|cytochrome P450 3A4|cytochrome p450 3a4
5323138|NCT02070614|gene polymorphism|gene polymorphism
5323139|NCT02070588|TBI|tbi
5323140|NCT02070588|mTBI|mtbi
5323141|NCT02070588|MR|mr
5323142|NCT02070588|MRI|mri
5323143|NCT02070588|Pulse Sequences|pulse sequences
5323146|NCT02070575|Human Kallikrein 2|human kallikrein 2
5323147|NCT02070575|locally resected prostate cancer|locally resected prostate cancer
5323148|NCT02070575|biochemical recurrence|biochemical recurrence
5323149|NCT02070575|14-041|14-041
5323150|NCT02070562|breast milk, dietary survey|breast milk, dietary survey
5323151|NCT02070536|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5323152|NCT02070536|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5323153|NCT02070536|Soluble RAGE (sRAGE)|soluble rage (srage)
5323154|NCT02070536|Gene polymorphisms|gene polymorphisms
5323155|NCT02070536|Biomarker|biomarker
5323156|NCT02070484|NuCel|nucel
5323157|NCT02070484|Lumbar Spine|lumbar spine
5323158|NCT02070484|Degenerative Disease|degenerative disease
5323159|NCT02070484|Efficacy|efficacy
5323160|NCT02070484|Fusion|fusion
5323161|NCT02070445|CABG|cabg
5323162|NCT02070445|pilot|pilot
5323163|NCT02070445|ultrasound|ultrasound
5323164|NCT02070445|perioperative|perioperative
5323165|NCT02070445|low tidal volume ventilation|low tidal volume ventilation
5323166|NCT02070432|LUZ11|luz11
5323167|NCT02070432|head and neck cancer|head and neck cancer
5323168|NCT02070432|photodynamic therapy|photodynamic therapy
5323169|NCT02070432|Redaporfin|redaporfin
5323170|NCT02070393|Hodgkins Disease in Young Females|hodgkins disease in young females
5323171|NCT02070393|Breast Sparing Radiation Treatments|breast sparing radiation treatments
5323172|NCT02070380|confirmed brain disease|confirmed brain disease
5323173|NCT02070380|highly suspected brain disease|highly suspected brain disease
5323174|NCT02070367|allodynia|allodynia
5323175|NCT02070367|complex regional pain syndrome|complex regional pain syndrome
5323176|NCT02070367|peripheral nerve injuries|peripheral nerve injuries
5323177|NCT02070367|clinical measurement properties|clinical measurement properties
5323178|NCT02070354|Obesity|obesity
5218260|NCT02633137|15-196|15-196
5323179|NCT02070354|Bariatric surgery|bariatric surgery
5323180|NCT02070354|Physical Activity|physical activity
5323181|NCT02070354|Nutrition|nutrition
5323182|NCT02070354|Weight Loss|weight loss
5323183|NCT02070341|patient tolerability|patient tolerability
5323184|NCT02070341|quality|quality
5323191|NCT02070289|safety|safety
5323192|NCT02070289|tolerability|tolerability
5323194|NCT02070276|Fluid therapy|fluid therapy
5323195|NCT02070276|Hypotension|hypotension
5323196|NCT02070276|Inferior veina cava|inferior veina cava
5323197|NCT02070276|Spinal anesthesia|spinal anesthesia
5323198|NCT02070276|Ultrasonography|ultrasonography
5323199|NCT02070263|Food allergy|food allergy
5323200|NCT02070263|Tree nuts|tree nuts
5323201|NCT02070250|Stress management|stress management
5323202|NCT02070250|Coping skills|coping skills
5323203|NCT02070250|Recently diagnosed cancer patients|recently diagnosed cancer patients
5323204|NCT02070250|Intervention, Psychological|intervention, psychological
5323205|NCT02070237|Obesity|obesity
5323206|NCT02070237|Obesity, Morbid|obesity, morbid
5323207|NCT02070237|Pregnancy|pregnancy
5323208|NCT02070237|Cesarean|cesarean
5323209|NCT02070237|Venous thromboembolism|venous thromboembolism
5323210|NCT02070237|Deep venous thrombosis|deep venous thrombosis
5323211|NCT02070237|Pulmonary embolism|pulmonary embolism
5438385|NCT01552174|MGD|mgd
5323212|NCT02070211|Psychotic Disorder|psychotic disorder
5323213|NCT02070211|22q11 Deletion Syndrome|22q11 deletion syndrome
5323214|NCT02070211|Fatty Acids, Omega-3|fatty acids, omega-3
5323215|NCT02070198|Poor responders, IVF, GnRH agonist, GnRH antagonist, recombinant FSH|poor responders, ivf, gnrh agonist, gnrh antagonist, recombinant fsh
5323216|NCT02070185|caloric adjustment,liking, flavour nutrient learning, children|caloric adjustment,liking, flavour nutrient learning, children
5323217|NCT02070172|headache diagnosis|headache diagnosis
5323218|NCT02070172|flexion rotation test|flexion rotation test
5323219|NCT02070172|range of motion|range of motion
5323220|NCT02070172|upper cervical|upper cervical
5323221|NCT02070159|coronary artery disease|coronary artery disease
5323222|NCT02070159|prasugrel|prasugrel
5323223|NCT02070159|platelet function tests|platelet function tests
5323224|NCT02070133|Chronic Bronchitis|chronic bronchitis
5323225|NCT02070133|Statins|statins
5323226|NCT02070133|Endothelial dysfunction|endothelial dysfunction
5323227|NCT02070133|Systemic inflammation|systemic inflammation
5323228|NCT02070133|BODE index|bode index
5323229|NCT02070133|Uric acid|uric acid
5323230|NCT02070133|Vascular growth factors|vascular growth factors
5323231|NCT02070120|Nonmuscle invasive bladder cancer (NMIBC)|nonmuscle invasive bladder cancer (nmibc)
5323232|NCT02070120|Mitomycin C|mitomycin c
5323233|NCT02070120|Chemoresection|chemoresection
5323234|NCT02070081|Obesity|obesity
5323235|NCT02070081|Bariatric surgery|bariatric surgery
5323236|NCT02070055|Maximal Rate of Fat Oxidation|maximal rate of fat oxidation
5323237|NCT02070055|Substrate Oxidation|substrate oxidation
5323238|NCT02070055|Fat oxidation|fat oxidation
5323239|NCT02070055|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
5323240|NCT02070055|Exercise|exercise
5323241|NCT02070055|indirect calorimetry|indirect calorimetry
5323242|NCT02070055|substrate crossover|substrate crossover
5323243|NCT02070042|Overactive Bladder|overactive bladder
5323245|NCT02070042|Omega -3 Fatty Acid|omega -3 fatty acid
5323246|NCT02070029|Female Sexual Dysfunction (FSD)|female sexual dysfunction (fsd)
5323247|NCT02070029|Hypoactive Sexual Desire Disorder (HSDD)|hypoactive sexual desire disorder (hsdd)
5323248|NCT02070029|Low libido|low libido
5323249|NCT02070029|Acupuncture|acupuncture
5323251|NCT02069977|Aripiprazole|aripiprazole
5323252|NCT02069977|Abilify|abilify
5323253|NCT02069951|Laparoscopy|laparoscopy
5323254|NCT02069951|Training|training
5323255|NCT02069951|Simulator|simulator
5323256|NCT02069938|Subjects|subjects
5323257|NCT02069912|Major Depression|major depression
5323258|NCT02069912|Heart Disease|heart disease
5323259|NCT02069912|Hispanics|hispanics
5323260|NCT02069912|Collaborative Depression Care Management|collaborative depression care management
5323261|NCT02069899|Hemophagocytic lymphohistiocytosis (HLH) previously treated with NI-0501|hemophagocytic lymphohistiocytosis (hlh) previously treated with ni-0501
5323262|NCT02069899|Emapalumab|emapalumab
5323263|NCT02069886|Endocrine complications|endocrine complications
5323264|NCT02069886|transfusion dependent thalassemia|transfusion dependent thalassemia
5323265|NCT02069873|Post Traumatic Stress Disorder|post traumatic stress disorder
5323266|NCT02069873|Group|group
5323267|NCT02069873|Treatment|treatment
5323268|NCT02069873|Cognitive, Exposure, Skills|cognitive, exposure, skills
5323269|NCT02069873|Women|women
5323270|NCT02069873|Veterans|veterans
5323271|NCT02069860|Bone Anchored Port|bone anchored port
5323272|NCT02069860|Haemodialysis|haemodialysis
5323273|NCT02069860|Mastoid bone|mastoid bone
5323274|NCT02069860|Nephrology|nephrology
5323275|NCT02069860|Retroauricular anchored devices|retroauricular anchored devices
5323276|NCT02069860|Permanent central venous vascular access|permanent central venous vascular access
5323277|NCT02069860|Hemodialysis|hemodialysis
5323278|NCT02069860|Vascular Access for Haemodialysis|vascular access for haemodialysis
5323279|NCT02069847|Esophageal stricture formation|esophageal stricture formation
5323485|NCT02068950|Feasibility|feasibility
5323280|NCT02069847|Endoscopic mucosal resection|endoscopic mucosal resection
5323284|NCT02069847|EMR|emr
5323285|NCT02069847|ESD|esd
5323286|NCT02069834|Dolutegravir|dolutegravir
5323287|NCT02069834|Rilpivirine|rilpivirine
5323288|NCT02069834|PI- and NRTI- sparing ART regimen|pi- and nrti- sparing art regimen
5323289|NCT02069834|switch study|switch study
5323290|NCT02069795|concussion, athlete, speech analysis|concussion, athlete, speech analysis
5323291|NCT02069782|Pregnancy|pregnancy
5323292|NCT02069782|postpartum programs|postpartum programs
5323293|NCT02069782|infant health services|infant health services
5323294|NCT02069769|Hospice Care|hospice care
5323295|NCT02069769|Head and Neck cancer|head and neck cancer
5323296|NCT02069769|Gynecological Oncology|gynecological oncology
5323297|NCT02069769|Sarcoma|sarcoma
5323298|NCT02069769|Melanoma|melanoma
5323299|NCT02069756|Duchenne|duchenne
5323300|NCT02069756|Becker|becker
5323301|NCT02069756|Muscular Dystrophy|muscular dystrophy
5323302|NCT02069743|cancer pain|cancer pain
5323303|NCT02069730|molecular profiling|molecular profiling
5323304|NCT02069730|selinexor|selinexor
5323305|NCT02069730|tumor tissue|tumor tissue
5323306|NCT02069704|colorectal cancer|colorectal cancer
5323307|NCT02069704|metastatic|metastatic
5323308|NCT02069704|first-line treatment|first-line treatment
5323309|NCT02069704|comparability|comparability
5323310|NCT02069691|stroke,|stroke,
5323311|NCT02069691|rehabilitation,|rehabilitation,
5323312|NCT02069691|leg cycling,|leg cycling,
5323313|NCT02069691|feedback,|feedback,
5323314|NCT02069691|virtual reality|virtual reality
5323315|NCT02069665|pneumonia|pneumonia
5323316|NCT02069665|pediatrics|pediatrics
5323317|NCT02069665|viral|viral
5323318|NCT02069613|Mild traumatic injury to extremity (for controls)|mild traumatic injury to extremity (for controls)
5323319|NCT02069613|mTBI|mtbi
5323320|NCT02069613|concussion|concussion
5323321|NCT02069613|MEG|meg
5323322|NCT02069613|EEG|eeg
5323323|NCT02069613|Blood|blood
5323324|NCT02069613|MRI|mri
5323325|NCT02069613|DTI|dti
5323326|NCT02069613|biomarkers|biomarkers
5323327|NCT02069600|Elderly|elderly
5323328|NCT02069600|CPAP|cpap
5323329|NCT02069600|clinical trial|clinical trial
5323330|NCT02069600|obstructive sleep apnea|obstructive sleep apnea
5323331|NCT02069587|PPROM|pprom
5323332|NCT02069587|PREGNANCY|pregnancy
5323333|NCT02069587|POMEGRANATE|pomegranate
5323334|NCT02069587|OXIDATIVE STRESS|oxidative stress
5323335|NCT02069535|Cupressus arizonica|cupressus arizonica
5323336|NCT02069509|Friedreich's Ataxia|friedreich's ataxia
5323337|NCT02069509|EFACTS|efacts
5323338|NCT02069509|FRDA|frda
5323339|NCT02069483|smoking|smoking
5323340|NCT02069483|smoker|smoker
5323341|NCT02069483|text|text
5323342|NCT02069483|smartphone|smartphone
5323343|NCT02069483|motivation|motivation
5323344|NCT02069483|quitting|quitting
5323345|NCT02069483|cessation|cessation
5323346|NCT02069483|feedback|feedback
5323347|NCT02069483|messages|messages
5323348|NCT02069470|Stepped wedged design|stepped wedged design
5323350|NCT02069470|Continuing medical education|continuing medical education
5323351|NCT02069431|inflammation|inflammation
5323352|NCT02069431|physical function|physical function
5203758|NCT02721043|Cancer|cancer
5323353|NCT02069431|cognitive function|cognitive function
5323354|NCT02069392|schizophrenia|schizophrenia
5323356|NCT02069392|cognitive remediation|cognitive remediation
5323357|NCT02069392|nicotine|nicotine
5323358|NCT02069379|Metabolic syndrome|metabolic syndrome
5323359|NCT02069379|Insulin resistance|insulin resistance
5323360|NCT02069379|Mu-opioid system|mu-opioid system
5323361|NCT02069379|Depression|depression
5323362|NCT02069379|Emotion regulation|emotion regulation
5323363|NCT02069366|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5323364|NCT02069366|Dronabinol|dronabinol
5323365|NCT02069366|Extinction|extinction
5323366|NCT02069366|fMRI|fmri
5323367|NCT02069353|Cardiac arrest|cardiac arrest
5323368|NCT02069353|Neurological injury|neurological injury
5323369|NCT02069353|Seizures|seizures
5323370|NCT02069353|Spreading depolarizations|spreading depolarizations
5323371|NCT02069353|Cerebral hypoperfusion|cerebral hypoperfusion
5323372|NCT02069353|Brain tissue hypoxia|brain tissue hypoxia
5323373|NCT02069327|Femur|femur
5323374|NCT02069327|Fat|fat
5323375|NCT02069327|Emboli|emboli
5323376|NCT02069327|Bone|bone
5323377|NCT02069327|Marrow|marrow
5323378|NCT02069327|proteomic|proteomic
5323379|NCT02069327|proteomics|proteomics
5323380|NCT02069327|metabolomics|metabolomics
5323381|NCT02069327|metabolomic|metabolomic
5323382|NCT02069327|inflammatory|inflammatory
5323383|NCT02069327|cytokine|cytokine
5323384|NCT02069327|chemokine|chemokine
5323385|NCT02069327|anaphlylatoxin|anaphlylatoxin
5323386|NCT02069327|Thromboelastography|thromboelastography
5323387|NCT02069327|Medical Center of the Rockies|medical center of the rockies
5323388|NCT02069327|Fat Embolism Syndrome|fat embolism syndrome
5323389|NCT02069327|Injury|injury
5323390|NCT02069327|Fracture|fracture
5323391|NCT02069327|Metabolite|metabolite
5323393|NCT02069327|TEG|teg
5323394|NCT02069327|FES|fes
5323395|NCT02069301|Behavior Activation|behavior activation
5323396|NCT02069301|Problem solving therapy|problem solving therapy
5323397|NCT02069301|Depression Treatment|depression treatment
5323398|NCT02069301|depression care integration|depression care integration
5323399|NCT02069301|microfinance|microfinance
5323400|NCT02069301|livelihood|livelihood
5323401|NCT02069288|fludrocortisone|fludrocortisone
5323402|NCT02069288|pharmacology|pharmacology
5323403|NCT02069288|septic shock|septic shock
5323404|NCT02069275|Immediate mobilization|immediate mobilization
5323405|NCT02069275|Bedrest|bedrest
5323406|NCT02069275|Coronary angiography|coronary angiography
5323407|NCT02069275|Coronary percutaneous intervention|coronary percutaneous intervention
5323408|NCT02069275|Vascular access complications|vascular access complications
5323409|NCT02069275|Patients comfort|patients comfort
5323410|NCT02069262|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
5323411|NCT02069262|laparoscopy|laparoscopy
5323412|NCT02069262|angiography|angiography
5323413|NCT02069249|Preschool children|preschool children
5323414|NCT02069249|Sleep problems|sleep problems
5323415|NCT02069249|Nutrition problems|nutrition problems
5323416|NCT02069249|Online intervention|online intervention
5323417|NCT02069249|Psychological functioning|psychological functioning
5323418|NCT02069236|Glucose-6 phosphate dehydrogenase deficiency|glucose-6 phosphate dehydrogenase deficiency
5323419|NCT02069236|capillary|capillary
5323420|NCT02069236|venous|venous
5323421|NCT02069236|genotype phenotype correlation|genotype phenotype correlation
5323422|NCT02069223|Biliopancreatic Diversion with Duodenal Switch|biliopancreatic diversion with duodenal switch
5323423|NCT02069223|Gastrectomy|gastrectomy
5323424|NCT02069197|ketogenic diet|ketogenic diet
5323425|NCT02069197|obesity|obesity
5323426|NCT02069197|diabetes|diabetes
5323427|NCT02069197|obstructive sleep apnea|obstructive sleep apnea
5323428|NCT02069184|opioid usage requirements|opioid usage requirements
5323429|NCT02069184|pain|pain
5323430|NCT02069184|IV acetaminophen|iv acetaminophen
5323431|NCT02069184|opioid usage|opioid usage
5323432|NCT02069184|c-section|c-section
5323433|NCT02069171|Lower extremity edema|lower extremity edema
5323434|NCT02069171|Lower leg lymphedema|lower leg lymphedema
5323435|NCT02069171|Lower leg edema|lower leg edema
5323436|NCT02069171|Lymphedema|lymphedema
5323437|NCT02069171|Pelvic lymph node dissection|pelvic lymph node dissection
5323438|NCT02069171|Gynecologic Cancer Lymphedema Questionnaire|gynecologic cancer lymphedema questionnaire
5323439|NCT02069158|Advanced solid tumor|advanced solid tumor
5323440|NCT02069145|Hepatocellular Cancer|hepatocellular cancer
5323441|NCT02069145|Liver Cancer|liver cancer
5323442|NCT02069132|Warfarin|warfarin
5323443|NCT02069132|International Warfarin Pharmacogenetics Consortium algorithm|international warfarin pharmacogenetics consortium algorithm
5323444|NCT02069132|Atrial Fibrillation|atrial fibrillation
5323445|NCT02069132|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5323446|NCT02069132|elderly|elderly
5323447|NCT02069132|comorbidity|comorbidity
5323448|NCT02069106|low density lipoprotein cholesterol|low density lipoprotein cholesterol
5323449|NCT02069106|triglycerides|triglycerides
5323450|NCT02069106|mixed hyperlipoproteinemia|mixed hyperlipoproteinemia
5963235|NCT04263727|Asthma|asthma
5323451|NCT02069106|Dehydroascorbic Acid|dehydroascorbic acid
5323452|NCT02069106|Eicosapentaenoic Acid|eicosapentaenoic acid
5323453|NCT02069106|Fish oil|fish oil
5323454|NCT02069080|Positron Emission Tomograhy|positron emission tomograhy
5323455|NCT02069080|Metastasis|metastasis
5323456|NCT02069067|breakthrough cancer pain|breakthrough cancer pain
5323457|NCT02069067|pain|pain
5323458|NCT02069067|neuropathic pain|neuropathic pain
5323459|NCT02069067|intractable pain|intractable pain
5323460|NCT02069067|cancer|cancer
5323461|NCT02069054|asthma|asthma
5323462|NCT02069054|COPD|copd
5323463|NCT02069054|airway inflammation|airway inflammation
5323464|NCT02069054|remodeling|remodeling
5323465|NCT02069054|cytokines|cytokines
5323466|NCT02069054|airway wall thickness|airway wall thickness
5323467|NCT02069028|surviving sepsis campaign|surviving sepsis campaign
5323468|NCT02069028|sepsis|sepsis
5323469|NCT02069028|septic|septic
5323470|NCT02069028|septicemia|septicemia
5323471|NCT02069028|mortality|mortality
5323472|NCT02069028|compliance|compliance
5323473|NCT02069015|Patient education|patient education
5218528|NCT02631876|ADC|adc
5323474|NCT02069015|Hypertension|hypertension
5323475|NCT02069015|Patient activation|patient activation
5323476|NCT02069002|Indoor Air|indoor air
5323477|NCT02069002|Medically unexplained symptoms|medically unexplained symptoms
5323478|NCT02069002|Randomized controlled trial|randomized controlled trial
5323479|NCT02069002|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5323480|NCT02069002|Applied relaxation|applied relaxation
5323481|NCT02068950|Head and neck cancer|head and neck cancer
5323482|NCT02068950|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5323483|NCT02068950|Progressive resistance training|progressive resistance training
5323484|NCT02068950|Exercise|exercise
5323486|NCT02068950|Weight loss|weight loss
5323488|NCT02068950|Body composition|body composition
5323489|NCT02068937|Heart Failure|heart failure
5323491|NCT02068937|Diuretics|diuretics
5323492|NCT02068937|Algorithms|algorithms
5323493|NCT02068924|Slow freezing|slow freezing
5323494|NCT02068924|Vitrification|vitrification
5323495|NCT02068924|Single embryo transfer|single embryo transfer
5323496|NCT02068911|Neuromuscular disease|neuromuscular disease
5323497|NCT02068911|Home ventilation|home ventilation
5323498|NCT02068911|End tidal CO2|end tidal co2
5323499|NCT02068911|Transcutaneous CO2|transcutaneous co2
5323500|NCT02068911|Monitoring|monitoring
5323501|NCT02068885|Low carbohydrate diet|low carbohydrate diet
5323502|NCT02068885|Low fat diet|low fat diet
5323503|NCT02068885|Glycemic index|glycemic index
5323504|NCT02068885|Weight loss maintenance|weight loss maintenance
5323505|NCT02068872|Obesity|obesity
5323506|NCT02068872|Transplant|transplant
5323507|NCT02068872|Sleeve Gastrectomy|sleeve gastrectomy
5323508|NCT02068872|Liver Transplantation|liver transplantation
5323509|NCT02068872|Weight Loss|weight loss
5323511|NCT02068846|Salivary Gland Disease|salivary gland disease
5323512|NCT02068846|Benign Lymphoepithelial Lesion|benign lymphoepithelial lesion
5323513|NCT02068846|BK Polyomavirus|bk polyomavirus
5323514|NCT02068833|Microalbuminuria|microalbuminuria
5323515|NCT02068833|Gastrectomy|gastrectomy
5323516|NCT02068833|Biliopancreatic Diversion With Duodenal Switch|biliopancreatic diversion with duodenal switch
5323517|NCT02068820|Sentinel lymph nodes|sentinel lymph nodes
5323518|NCT02068820|da Vinci|da vinci
5323519|NCT02068820|Firefly|firefly
5323520|NCT02068820|Sentinel lymph node mapping|sentinel lymph node mapping
5323521|NCT02068820|Fluorescence Imaging|fluorescence imaging
5323523|NCT02068820|SLN mapping|sln mapping
5323524|NCT02068768|fusion|fusion
5323525|NCT02068768|lateral interbody fusion system|lateral interbody fusion system
5323526|NCT02068768|lumbar spine|lumbar spine
5323527|NCT02068768|degenerative disc disease|degenerative disc disease
5323528|NCT02068755|anemia|anemia
5323529|NCT02068755|renal impairment|renal impairment
5323530|NCT02068755|thrombocytopenia|thrombocytopenia
5323531|NCT02068755|anticoagulation|anticoagulation
5323532|NCT02068755|Coronary bypass|coronary bypass
5323533|NCT02068755|Aortic valve surgery|aortic valve surgery
5323534|NCT02068755|Mitral valve surgery|mitral valve surgery
5323535|NCT02068755|red blood cell|red blood cell
5323536|NCT02068755|platelet|platelet
5323537|NCT02068755|fresh frozen plasma|fresh frozen plasma
5323538|NCT02068755|octaplas|octaplas
5323539|NCT02068742|post-operative cognitive dysfunction|post-operative cognitive dysfunction
5323540|NCT02068742|elderly|elderly
5323541|NCT02068742|Mini Mental State Examination|mini mental state examination
5323542|NCT02068742|Geriatric Index of Comorbidity|geriatric index of comorbidity
5323543|NCT02068742|Geriatric Depression Scale|geriatric depression scale
5323544|NCT02068742|Trail Making Test B-A|trail making test b-a
5323545|NCT02068742|Digit Span|digit span
5323546|NCT02068742|Digit Symbol Substitution Test|digit symbol substitution test
5323547|NCT02068729|degenerative disc disease|degenerative disc disease
5323549|NCT02068729|Grade 1 spondylolisthesis|grade 1 spondylolisthesis
5323550|NCT02068729|spondylolisthesis|spondylolisthesis
5323552|NCT02068716|Healthcare acquired infections|healthcare acquired infections
5323553|NCT02068716|Cardiovascular Surgery|cardiovascular surgery
5323554|NCT02068716|Mediastinitis|mediastinitis
5323555|NCT02068716|Thoracotomy|thoracotomy
5323556|NCT02068716|Conduit harvest or cannulation site|conduit harvest or cannulation site
5323557|NCT02068703|survey|survey
5323558|NCT02068664|spatial neglect|spatial neglect
5323559|NCT02068664|aphasia|aphasia
5323560|NCT02068651|End-of-life care|end-of-life care
5323561|NCT02068651|Treatment decision making|treatment decision making
5323562|NCT02068651|Advance care planning|advance care planning
5323563|NCT02068638|exercise|exercise
5323564|NCT02068638|isotope labeling, stable|isotope labeling, stable
5323565|NCT02068638|spectroscopy, magnetic resonance|spectroscopy, magnetic resonance
5323566|NCT02068638|monitoring, home blood glucose|monitoring, home blood glucose
5323567|NCT02068638|hormones|hormones
5323568|NCT02068625|retinal detachment|retinal detachment
5323569|NCT02068625|rasagiline|rasagiline
5323570|NCT02068625|optical coherence tomography|optical coherence tomography
5323571|NCT02068625|visual acuity|visual acuity
5323572|NCT02068625|neuroprotection|neuroprotection
5323573|NCT02068625|azilect|azilect
5323574|NCT02068612|Executive function,|executive function,
5323575|NCT02068612|cardiovascular fitness,|cardiovascular fitness,
5323576|NCT02068612|cognitive function|cognitive function
5323577|NCT02068599|Osteoarthritis|osteoarthritis
5323578|NCT02068599|OA|oa
5323579|NCT02068599|Arthritis pain|arthritis pain
5323580|NCT02068573|Childhood Asthma|childhood asthma
5323581|NCT02068573|Allergy|allergy
5323582|NCT02068573|House dust mites|house dust mites
5323583|NCT02068573|Indoor air quality|indoor air quality
5323584|NCT02068547|posterior cervical fusion|posterior cervical fusion
5323585|NCT02068547|posterior cervical decompression|posterior cervical decompression
5323586|NCT02068534|in-depth individual interview|in-depth individual interview
5323587|NCT02068534|charcoal-burning suicide|charcoal-burning suicide
5323588|NCT02068521|Growth Hormone Deficiency|growth hormone deficiency
5323589|NCT02068521|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
5323591|NCT02068521|PGHD|pghd
5323592|NCT02068521|VRS-317|vrs-317
5323593|NCT02068521|Versartis|versartis
5323594|NCT02068521|Growth disorder|growth disorder
5323595|NCT02068521|Long acting growth hormone|long acting growth hormone
5323596|NCT02068521|Growth hormone|growth hormone
5323597|NCT02068521|Weekly growth hormone dosing|weekly growth hormone dosing
5323598|NCT02068521|Semi-monthly growth hormone dosing|semi-monthly growth hormone dosing
5323599|NCT02068521|Monthly growth hormone dosing|monthly growth hormone dosing
5323600|NCT02068521|IGF-I|igf-i
5323601|NCT02068521|Short stature|short stature
5323602|NCT02068521|Height velocity|height velocity
5323603|NCT02068521|Annual height velocity|annual height velocity
5323604|NCT02068521|Growth rate|growth rate
5323605|NCT02068521|Somavaratan|somavaratan
5323606|NCT02068508|Drug therapy|drug therapy
5323607|NCT02068495|Drug therapy|drug therapy
5323608|NCT02068482|Uncomplicated|uncomplicated
5323609|NCT02068482|Symptomatic|symptomatic
5323610|NCT02068456|Drug therapy|drug therapy
5323611|NCT02068443|Drug therapy|drug therapy
5323612|NCT02068430|Corneal Ulcers|corneal ulcers
5323613|NCT02068430|cross-linking|cross-linking
5323614|NCT02068430|UVA|uva
5323615|NCT02068430|Riboflavin|riboflavin
5323616|NCT02068417|IIEF score|iief score
5323617|NCT02068417|ED|ed
5323618|NCT02068404|Tocolysis|tocolysis
5323619|NCT02068404|Preterm labor|preterm labor
5323620|NCT02068404|Nifedipine|nifedipine
5323621|NCT02068404|Pharmacokinetics|pharmacokinetics
5323622|NCT02068391|covert stroke|covert stroke
5323623|NCT02068391|cerebral blood flow|cerebral blood flow
5323624|NCT02068391|grey matter|grey matter
5323625|NCT02068391|attention|attention
5323626|NCT02068391|executive function|executive function
5323627|NCT02068391|aerobic exercise|aerobic exercise
5323628|NCT02068352|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
5323629|NCT02068326|Mentalization-based Treatment|mentalization-based treatment
5323631|NCT02068326|Borderline Personality Disorder|borderline personality disorder
5323632|NCT02068300|1,5-anhydro-D-glucitol, hypoglycemia, surrogate marker|1,5-anhydro-d-glucitol, hypoglycemia, surrogate marker
5323633|NCT02068287|Septic Shock|septic shock
5323634|NCT02068287|Hemodynamic|hemodynamic
5323635|NCT02068287|Inflammatory status|inflammatory status
5323636|NCT02068287|Beta adrenergic modulation|beta adrenergic modulation
5323637|NCT02068287|Esmolol|esmolol
5323638|NCT02068235|Ponesimod|ponesimod
5323639|NCT02068235|Bioavailability|bioavailability
5323640|NCT02068235|Pharmacokinetics|pharmacokinetics
5323641|NCT02068235|Safety|safety
5323642|NCT02068222|Hepatitis C|hepatitis c
5323643|NCT02068222|HCV|hcv
5323644|NCT02068222|Interferon Free|interferon free
5323645|NCT02068222|Chronic Hepatitis C|chronic hepatitis c
5323646|NCT02068222|Hepatitis C virus|hepatitis c virus
5323647|NCT02068222|Hepatitis C Genotype 3|hepatitis c genotype 3
5323648|NCT02068209|Outpatient hysteroscopy|outpatient hysteroscopy
5323649|NCT02068209|Tramadol|tramadol
5323650|NCT02068196|Cancer|cancer
5323654|NCT02068183|cardiovascular risk|cardiovascular risk
5323655|NCT02068183|insulin resistance|insulin resistance
5323656|NCT02068183|post-traumatic stress|post-traumatic stress
5323657|NCT02068183|pulmonary disease|pulmonary disease
5323658|NCT02068170|QT-prolongation|qt-prolongation
5323659|NCT02068170|Torsade de Pointes|torsade de pointes
5323660|NCT02068170|QT-prolonging drugs|qt-prolonging drugs
5323661|NCT02068144|Cranberry Extract|cranberry extract
5323662|NCT02068131|Metastatic Colorectal Cancer|metastatic colorectal cancer
5323664|NCT02068131|Recombinant anti-tumor and anti-virus protein for injection|recombinant anti-tumor and anti-virus protein for injection
5323665|NCT02068131|xeloda|xeloda
5323666|NCT02068118|E health|e health
5323667|NCT02068118|Telemonitoring|telemonitoring
5323668|NCT02068118|Prevention|prevention
5323669|NCT02068118|Heart Failure|heart failure
5323670|NCT02068118|Cordiva|cordiva
5323671|NCT02068118|Telecardiology Program|telecardiology program
5323672|NCT02068118|Remote Patient Management|remote patient management
5323673|NCT02068118|Education|education
5323674|NCT02068105|ALKS 5461|alks 5461
5323675|NCT02068105|samidorphan|samidorphan
5323676|NCT02068066|Physical work requirements|physical work requirements
5323677|NCT02068066|Energy expenditure|energy expenditure
5323678|NCT02068066|Physical activity|physical activity
5323679|NCT02068066|Different occupational categories|different occupational categories
5323680|NCT02068066|Aerobic capacity|aerobic capacity
5323703|NCT02067923|type 1 diabetes mellitus|type 1 diabetes mellitus
5323704|NCT02067923|juvenile diabetes|juvenile diabetes
5323705|NCT02067923|autoimmune diabetes|autoimmune diabetes
5323706|NCT02067923|autoimmune|autoimmune
5323707|NCT02067923|anti-CD3 mAb|anti-cd3 mab
5323708|NCT02067923|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
5323709|NCT02067923|teplizumab|teplizumab
5323710|NCT02067910|Abatacept|abatacept
5323711|NCT02067910|Subcutaneous|subcutaneous
5323712|NCT02067910|Sjögren's syndrome|sjögren's syndrome
5323713|NCT02067910|Treatment|treatment
5323714|NCT02067910|Safety|safety
5323715|NCT02067910|Efficacy|efficacy
5323716|NCT02067897|Nails, Ingrown|nails, ingrown
5323717|NCT02067897|Children|children
5323718|NCT02067897|Ambulatory Surgical Procedures|ambulatory surgical procedures
5323719|NCT02067871|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5323720|NCT02067871|low-level laser therapy|low-level laser therapy
5323721|NCT02067871|knee osteoarthritis|knee osteoarthritis
5323722|NCT02067871|muscle architecture|muscle architecture
5323723|NCT02067871|functionality|functionality
5323724|NCT02067871|neuromuscular parameters|neuromuscular parameters
5323725|NCT02067845|Lesbian, queer, bisexual women|lesbian, queer, bisexual women
5323726|NCT02067845|HIV and STI prevention|hiv and sti prevention
5323727|NCT02067845|Resilient coping|resilient coping
5323728|NCT02067845|Sexual stigma|sexual stigma
5323729|NCT02067845|Depression|depression
5323730|NCT02067845|Safer-sex practices|safer-sex practices
5323731|NCT02067845|Safer sex self-efficacy|safer sex self-efficacy
5323732|NCT02067845|HIV/STI knowledge and testing|hiv/sti knowledge and testing
5323733|NCT02067845|Pilot-testing|pilot-testing
5323739|NCT02067806|PASS|pass
5323741|NCT02067806|CES|ces
5323742|NCT02067806|CHLOROPROCAINE|chloroprocaine
5323743|NCT02067793|NRX-1074|nrx-1074
5323744|NCT02067793|NMDA Receptor Modulator|nmda receptor modulator
5323745|NCT02067793|Major Depressive Disorder|major depressive disorder
5323746|NCT02067793|Glycine site modulator|glycine site modulator
5323747|NCT02067767|HIV-1 infection|hiv-1 infection
5323748|NCT02067767|Nevirapine|nevirapine
5323749|NCT02067767|Dolutegravir|dolutegravir
5323750|NCT02067767|Anti-retroviral agents|anti-retroviral agents
5323751|NCT02067754|The mutation profiling of circulating free DNA|the mutation profiling of circulating free dna
5323752|NCT02067741|Post-menopausal women|post-menopausal women
5323754|NCT02067741|endocrine responsive-HER2neg breast cancer|endocrine responsive-her2neg breast cancer
5323755|NCT02067741|triple negative-androgen receptor positive breast cancer|triple negative-androgen receptor positive breast cancer
5323758|NCT02067715|Bleaching Agents|bleaching agents
5323759|NCT02067715|Tooth Bleaching|tooth bleaching
5323760|NCT02067689|Normal cognition in healthy adults|normal cognition in healthy adults
5323761|NCT02067689|Cognitive function|cognitive function
5323762|NCT02067689|Transcranial direct current stimulation|transcranial direct current stimulation
5323763|NCT02067689|Structural Magnetic Resonance Imaging|structural magnetic resonance imaging
5323764|NCT02067689|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5323765|NCT02067676|Campylobacter jejuni|campylobacter jejuni
5323766|NCT02067663|Postplacental IUD placement|postplacental iud placement
5323767|NCT02067663|LNG-IUS|lng-ius
5323768|NCT02067637|cancer therapy, cancer treatment|cancer therapy, cancer treatment
5323769|NCT02067611|Phase 2, Efficacy, Safety, Osteoarthritis|phase 2, efficacy, safety, osteoarthritis
5320169|NCT02084030|GWAS|gwas
5323774|NCT02067572|hospice|hospice
5323775|NCT02067572|xerostomia|xerostomia
5323776|NCT02067572|mouth sores|mouth sores
5323777|NCT02067559|Post Traumatic Stress Disorder|post traumatic stress disorder
5323778|NCT02067559|PTSD|ptsd
5323779|NCT02067559|Intensive Care Unit|intensive care unit
5323781|NCT02067546|constipation|constipation
5323782|NCT02067520|Post C/S pain relief|post c/s pain relief
5323783|NCT02067507|Human Papillomavirus|human papillomavirus
5323784|NCT02067507|Immunization|immunization
5323785|NCT02067507|Oncogenic viruses|oncogenic viruses
5323786|NCT02067507|Cervical Cancer|cervical cancer
5323787|NCT02067507|Health Disparities|health disparities
5323788|NCT02067494|Low Back Pain|low back pain
5323789|NCT02067494|Chronic Pain|chronic pain
5323790|NCT02067494|Manual Therapy|manual therapy
5323791|NCT02067494|Randomized Clinical Trial|randomized clinical trial
5323793|NCT02067481|Breast cancer|breast cancer
5323794|NCT02067481|Survivors|survivors
5323795|NCT02067481|Weight loss|weight loss
5323797|NCT02067481|Physical activity|physical activity
5323798|NCT02067468|Human Papillomavirus|human papillomavirus
5323799|NCT02067468|cervical cancer|cervical cancer
5323800|NCT02067468|health services research|health services research
5323801|NCT02067468|Colombia|colombia
5323802|NCT02067468|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5323803|NCT02067455|Right ventricular function|right ventricular function
5323804|NCT02067455|echocardiography|echocardiography
5323805|NCT02067455|left ventricular assist device|left ventricular assist device
5323806|NCT02067455|exercise|exercise
5323807|NCT02067442|acetaminophen intravenous oral pain scores opioids|acetaminophen intravenous oral pain scores opioids
5323808|NCT02067416|neoadjuvant|neoadjuvant
5323809|NCT02067416|mammostrat|mammostrat
5323810|NCT02067416|TLE3|tle3
5323811|NCT02067416|DDR|ddr
5323812|NCT02067416|breast cancer|breast cancer
5323813|NCT02067403|Pressure-support|pressure-support
5323814|NCT02067403|Asynchrony|asynchrony
5323815|NCT02067377|GOLD, COPD, cachexia, BMI|gold, copd, cachexia, bmi
5323816|NCT02067364|hydrocephalus|hydrocephalus
5323817|NCT02067364|CSF shunt|csf shunt
5323818|NCT02067299|Depressive Disorder, Major|depressive disorder, major
5323819|NCT02067299|Major Depressive Disorder|major depressive disorder
5323820|NCT02067299|Insomnia|insomnia
5323821|NCT02067299|JNJ-42847922|jnj-42847922
5323822|NCT02067299|Placebo|placebo
5323823|NCT02067221|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5323824|NCT02067221|renal calculi|renal calculi
5323825|NCT02067221|ureteroscopy|ureteroscopy
5323826|NCT02067208|Osteoarthritis|osteoarthritis
5323827|NCT02067208|Cartilage|cartilage
5323828|NCT02067208|Musculoskeletal|musculoskeletal
5323829|NCT02067208|Biomechanics|biomechanics
5323830|NCT02067208|Subtype|subtype
5323831|NCT02067208|Footwear|footwear
5323832|NCT02067208|Orthotics|orthotics
5323833|NCT02067208|Joint Loading|joint loading
5323834|NCT02067195|acute myocardial infarction,contrast,coronary intervention|acute myocardial infarction,contrast,coronary intervention
5323835|NCT02067169|Transplantation|transplantation
5323836|NCT02067169|CMV infection|cmv infection
5323837|NCT02067169|antiviral resistance|antiviral resistance
5323838|NCT02067156|glioblastoma|glioblastoma
5323839|NCT02067143|Untreated philadelphia positive acute lymphoblastic leukemia|untreated philadelphia positive acute lymphoblastic leukemia
5323840|NCT02067143|De novo|de novo
5323841|NCT02067143|Secondary|secondary
5323842|NCT02067143|Low-dose corticosteroids pretreatment|low-dose corticosteroids pretreatment
5323843|NCT02067143|Pegylated asparaginase|pegylated asparaginase
5323844|NCT02067143|Lineage-targeted risk and minimal residual disease|lineage-targeted risk and minimal residual disease
5323845|NCT02067130|Beta Thalassemia Major|beta thalassemia major
5323854|NCT02067078|total knee arthroplasty|total knee arthroplasty
5323855|NCT02067078|saphenous nerve block|saphenous nerve block
5323856|NCT02067078|obturator nerve block|obturator nerve block
5323858|NCT02067078|opioid consumption|opioid consumption
5323859|NCT02067065|Colonoscopy|colonoscopy
5323860|NCT02067065|Sedation|sedation
5323861|NCT02067065|Propofol|propofol
5323862|NCT02067065|Non-anesthesiologist propofol administration|non-anesthesiologist propofol administration
5323863|NCT02067052|Vulvar neoplasm|vulvar neoplasm
5323864|NCT02067052|sentinel nodes|sentinel nodes
5323865|NCT02067052|chemotherapy|chemotherapy
5323866|NCT02067052|radiotherapy|radiotherapy
5323867|NCT02067039|HIV testing|hiv testing
5323868|NCT02067039|Rapid HIV test|rapid hiv test
5323869|NCT02067039|HIV self-testing|hiv self-testing
5323870|NCT02067039|Men who have sex with men (MSM)|men who have sex with men (msm)
5323871|NCT02067039|HIV diagnosis|hiv diagnosis
5323872|NCT02067039|Sexual behavior|sexual behavior
5323873|NCT02067026|overweight|overweight
5323874|NCT02067013|Tractional retinal detachment|tractional retinal detachment
5323875|NCT02067013|Exudative retinal detachment|exudative retinal detachment
5323876|NCT02067013|Macular hole|macular hole
5323877|NCT02067013|Neovascular glaucoma|neovascular glaucoma
5323878|NCT02066987|Action planning, Implementation intention|action planning, implementation intention
5323879|NCT02066974|hepatocellular carcinoma|hepatocellular carcinoma
5323880|NCT02066974|genomic expression|genomic expression
5323881|NCT02066974|radiotherapy|radiotherapy
5323882|NCT02066961|metastatic prostate cancer|metastatic prostate cancer
5323883|NCT02066961|castration-resistant prostate cancer|castration-resistant prostate cancer
5323884|NCT02066961|prostate cancer|prostate cancer
5323886|NCT02066948|MRI|mri
5323887|NCT02066948|Fitness assessment|fitness assessment
5323888|NCT02066948|Meal tolerance test|meal tolerance test
5323889|NCT02066935|immunosuppression|immunosuppression
5323890|NCT02066935|medication nonadherence|medication nonadherence
5204221|NCT02718144|safety|safety
5323891|NCT02066935|kidney transplantation|kidney transplantation
5323892|NCT02066922|Contact lenses|contact lenses
5323893|NCT02066922|Nearsightedness|nearsightedness
5323894|NCT02066922|Corneal curvature|corneal curvature
5323895|NCT02066922|K-reading|k-reading
5323896|NCT02066922|High minus|high minus
5323897|NCT02066922|Spectacle refraction|spectacle refraction
5323898|NCT02066909|pharmacokinetics|pharmacokinetics
5323899|NCT02066909|safety|safety
5323900|NCT02066909|tolerability|tolerability
5323901|NCT02066909|healthy volunteers|healthy volunteers
5323902|NCT02066909|steady state|steady state
5323903|NCT02066909|multiple doses|multiple doses
5323904|NCT02066909|Japanese subjects|japanese subjects
5323905|NCT02066896|Sjogrens Syndrome|sjogrens syndrome
5323906|NCT02066896|Syndrome, Sjogren's|syndrome, sjogren's
5323907|NCT02066896|Sjogren Syndrome|sjogren syndrome
5323908|NCT02066896|Sicca Syndrome|sicca syndrome
5323909|NCT02066896|Syndrome, Sicca|syndrome, sicca
5323910|NCT02066870|Icotinib|icotinib
5323911|NCT02066870|Arsenic Trioxide|arsenic trioxide
5323912|NCT02066870|Resistance|resistance
5323913|NCT02066870|Non-small cell lung cancer|non-small cell lung cancer
5323914|NCT02066857|Wrist fracture|wrist fracture
5323915|NCT02066857|Radius fracture|radius fracture
5323916|NCT02066857|Elderly|elderly
5323917|NCT02066857|Splint|splint
5323918|NCT02066857|Cast|cast
5323919|NCT02066844|Hip Pain|hip pain
5323920|NCT02066844|Hip Injection|hip injection
5323921|NCT02066844|Hip Fracture|hip fracture
5323922|NCT02066844|Hip Bursitis|hip bursitis
5323923|NCT02066844|Hip Arthritis|hip arthritis
5323924|NCT02066844|Hip Sciatica|hip sciatica
5323925|NCT02066818|local anesthetic|local anesthetic
5323926|NCT02066818|incision and drainage|incision and drainage
5323927|NCT02066818|pain|pain
5323928|NCT02066818|cutaneous abscess|cutaneous abscess
5323929|NCT02066792|Social Phobia|social phobia
5323930|NCT02066753|Cardiac arrest|cardiac arrest
5323931|NCT02066753|Therapeutic Hypothermia|therapeutic hypothermia
5323932|NCT02066753|Cardioprotectiveness|cardioprotectiveness
5323933|NCT02066753|Hemodynamics|hemodynamics
5323934|NCT02066740|Superficial Femoral Artery|superficial femoral artery
5323935|NCT02066740|Proximal Popliteal Artery|proximal popliteal artery
5323936|NCT02066740|Everflex|everflex
5323937|NCT02066740|Entrust|entrust
5323938|NCT02066740|stent|stent
5323939|NCT02066727|Dexmedetomidine|dexmedetomidine
5323940|NCT02066727|obturator nerve block|obturator nerve block
5323941|NCT02066727|lidocaine|lidocaine
5323942|NCT02066727|EC50|ec50
5323943|NCT02066714|Enterovirus Infections|enterovirus infections
5323944|NCT02066714|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5323945|NCT02066714|Coxsackievirus Infections|coxsackievirus infections
5323946|NCT02066714|Herpangina|herpangina
5323947|NCT02066714|Cognition|cognition
5323948|NCT02066714|Neurocognitive|neurocognitive
5323949|NCT02066714|Sequelae|sequelae
5323950|NCT02066714|Outcomes|outcomes
5323951|NCT02066701|Barrett's esophagus|barrett's esophagus
5323952|NCT02066675|Metastatic|metastatic
5323953|NCT02066675|Locally advanced|locally advanced
5323954|NCT02066675|Soft tissue tumors|soft tissue tumors
5323955|NCT02066662|Coronary or Valvular Calcification|coronary or valvular calcification
5323956|NCT02066662|Agatston Score|agatston score
5323957|NCT02066662|Rivaroxaban|rivaroxaban
5323958|NCT02066662|Coumarin|coumarin
5323959|NCT02066662|Oral Anticoagulation Therapy (OAT)|oral anticoagulation therapy (oat)
5323960|NCT02066662|Atrial Fibrillation|atrial fibrillation
5323961|NCT02066662|Pulmonary Embolism|pulmonary embolism
5323962|NCT02066649|portal hypertension|portal hypertension
5323963|NCT02066649|esophageal varices|esophageal varices
5323964|NCT02066649|variceal bleed|variceal bleed
5323965|NCT02066649|carvedilol|carvedilol
5323966|NCT02066649|variceal band ligation|variceal band ligation
5323967|NCT02066623|coronary artery stenosis, vascular scaffold, ABSORB|coronary artery stenosis, vascular scaffold, absorb
5323968|NCT02066597|Deep vein thrombosis|deep vein thrombosis
5323969|NCT02066597|thrombectomy|thrombectomy
5323970|NCT02066597|percutaneuos|percutaneuos
5323971|NCT02066584|sibling oocytes|sibling oocytes
5323973|NCT02066584|culture media|culture media
5323974|NCT02066571|Parkinson's disease|parkinson's disease
5323975|NCT02066571|Freezing of gait|freezing of gait
5323976|NCT02066571|Gait|gait
5323977|NCT02066558|Carbon monoxide|carbon monoxide
5323980|NCT02066532|Breast Neoplasms|breast neoplasms
5323981|NCT02066532|Breast Cancer|breast cancer
5323982|NCT02066532|Breast Carcinoma|breast carcinoma
5323983|NCT02066532|Breast tumors|breast tumors
5323984|NCT02066532|Cancer of the Breast|cancer of the breast
5323985|NCT02066532|Malignant tumor of the breast|malignant tumor of the breast
5323986|NCT02066532|HER2 positive|her2 positive
5323987|NCT02066532|erythroblastosis virus oncogene B-2 (erbB-2)|erythroblastosis virus oncogene b-2 (erbb-2)
5323988|NCT02066532|Metastatic Breast Cancer|metastatic breast cancer
5323989|NCT02066532|Secondary Breast Cancer|secondary breast cancer
5323990|NCT02066519|Myasthenia gravis|myasthenia gravis
5963236|NCT04263012|left ventricular assist device (LVAD)|left ventricular assist device (lvad)
5963237|NCT04263012|heart|heart
5192315|NCT02790398|Transdiagnostic treatment protocol + PA component|transdiagnostic treatment protocol + pa component
5192316|NCT02790372|Nursing homes|nursing homes
5204324|NCT02717663|Financial incentive|financial incentive
5204325|NCT02717663|Walkability|walkability
5323991|NCT02066519|physical exercise|physical exercise
5323992|NCT02066519|quality of life|quality of life
5323993|NCT02066519|muscular performance|muscular performance
5323994|NCT02066519|fatigability|fatigability
5323995|NCT02066506|systemic right ventricle|systemic right ventricle
5323996|NCT02066506|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5323997|NCT02066506|congenital heart disease|congenital heart disease
5323998|NCT02066493|giant intracranial aneurysm|giant intracranial aneurysm
5323999|NCT02066467|Phrenic Nerve Stimulation|phrenic nerve stimulation
5324000|NCT02066467|Heartfailure treatment|heartfailure treatment
5219038|NCT02629068|Shame|shame
5324001|NCT02066467|CRT-D therapy|crt-d therapy
5324002|NCT02066467|Quadripolar lead|quadripolar lead
5324003|NCT02066467|Lead related complication free rate|lead related complication free rate
5324004|NCT02066454|myeloma|myeloma
5324005|NCT02066454|antiXa anticoagulant|antixa anticoagulant
5324006|NCT02066454|venous thromboembolic disease|venous thromboembolic disease
5324007|NCT02066454|iMiDs|imids
5324008|NCT02066441|Vitamin D|vitamin d
5324009|NCT02066441|bone formation|bone formation
5324010|NCT02066441|resorption|resorption
5324011|NCT02066441|mineral density|mineral density
5324012|NCT02066441|inflammation|inflammation
5324013|NCT02066441|flexibility|flexibility
5324014|NCT02066441|balance|balance
5324015|NCT02066441|elderly|elderly
5324016|NCT02066428|BCG Vaccinated|bcg vaccinated
5324017|NCT02066428|HIV Negative|hiv negative
5324018|NCT02066415|Chronic Migraine|chronic migraine
5324019|NCT02066389|Musculoskeletal Disease|musculoskeletal disease
5324020|NCT02066389|Arthritis|arthritis
5324021|NCT02066389|Joint Diseases|joint diseases
5324022|NCT02066389|anti-inflammatory agents|anti-inflammatory agents
5324023|NCT02066389|antirheumatic agents|antirheumatic agents
5324024|NCT02066363|Bioelectrical impedance|bioelectrical impedance
5324025|NCT02066363|Parenteral nutrition|parenteral nutrition
5324026|NCT02066363|Malnutrition|malnutrition
5324027|NCT02066363|Quality of life.|quality of life.
5324028|NCT02066363|Cancer cachexia|cancer cachexia
5324029|NCT02066363|Body composition|body composition
5324030|NCT02066350|Diabetes type 1|diabetes type 1
5324031|NCT02066350|Endothelial dysfunction|endothelial dysfunction
5324032|NCT02066350|Pancreas transplantation|pancreas transplantation
5324033|NCT02066337|Ozone gel|ozone gel
5324034|NCT02066337|Antioxidants|antioxidants
5324035|NCT02066337|Chronic periodontitis|chronic periodontitis
5324043|NCT02066285|Extraskeletal myxoid chondrosarcoma|extraskeletal myxoid chondrosarcoma
5324044|NCT02066285|Unresectable|unresectable
5324045|NCT02066285|Locally advanced|locally advanced
5324046|NCT02066285|Metastatic disease|metastatic disease
5324048|NCT02066272|anti-TNF|anti-tnf
5324049|NCT02066272|biosimilars|biosimilars
5324050|NCT02066272|safety|safety
5324051|NCT02066259|colon cancer|colon cancer
5324052|NCT02066259|cancer associated auto antibodies|cancer associated auto antibodies
5324053|NCT02066259|colon cancer blood test|colon cancer blood test
5324054|NCT02066246|laparoscopic robot-assisted surgery|laparoscopic robot-assisted surgery
5324055|NCT02066246|in steep trendelenburg position|in steep trendelenburg position
5324056|NCT02066233|Barrett's|barrett's
5324057|NCT02066233|esophagus|esophagus
5324058|NCT02066233|reflux|reflux
5324059|NCT02066233|heartburn|heartburn
5324060|NCT02066233|screening|screening
5324061|NCT02066220|pediatric brain tumor|pediatric brain tumor
5324062|NCT02066220|medulloblastoma|medulloblastoma
5324063|NCT02066220|event-free survival (EFS)|event-free survival (efs)
5324064|NCT02066220|progression-free survival (PFS)|progression-free survival (pfs)
5324065|NCT02066220|overall survival (OS)|overall survival (os)
5324067|NCT02066220|posterior fossa|posterior fossa
5324068|NCT02066220|chemotherapy|chemotherapy
5324069|NCT02066220|radiotherapy|radiotherapy
5324070|NCT02066220|biological profile|biological profile
5324071|NCT02066220|ß-catenin|ß-catenin
5324072|NCT02066155|diabetes self-management support|diabetes self-management support
5324073|NCT02066155|diabetes-related distress|diabetes-related distress
5324074|NCT02066155|parish nurses|parish nurses
5324075|NCT02066155|peer support|peer support
5324076|NCT02066129|Asthma|asthma
5324077|NCT02066129|Fluticasone|fluticasone
5324078|NCT02066090|acupuncture|acupuncture
5324079|NCT02066090|obesity|obesity
5324080|NCT02066090|metabolomics|metabolomics
5324081|NCT02066077|Major Depressive Disorder|major depressive disorder
5324082|NCT02066077|Modified Electroconvulsive Therapy|modified electroconvulsive therapy
5324083|NCT02066077|Cognition|cognition
5324084|NCT02066077|Memory|memory
5324091|NCT02066038|erlotinib|erlotinib
5324092|NCT02066025|breast cancer|breast cancer
5369183|NCT01860937|CD19 Targeted Therapy|cd19 targeted therapy
5963238|NCT04263012|implant|implant
5963239|NCT04263012|artificial|artificial
5963240|NCT04262570|Muscular Diseases|muscular diseases
5963241|NCT04262570|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5963242|NCT04262570|Multispectral Optoacoustic Tomography (MSOT)|multispectral optoacoustic tomography (msot)
5204418|NCT02717013|Bone|bone
5204419|NCT02717013|Fat|fat
5324093|NCT02066025|cancer associated auto antibodies|cancer associated auto antibodies
5324094|NCT02066025|breast cancer blood test|breast cancer blood test
5324095|NCT02066012|Dysmetabolic Iron Overload Syndrome|dysmetabolic iron overload syndrome
5324096|NCT02066012|Metabolic Syndrome X|metabolic syndrome x
5324097|NCT02066012|Iron|iron
5324098|NCT02066012|Monocyte|monocyte
5324099|NCT02066012|Macrophage|macrophage
5324100|NCT02066012|Polarization|polarization
5324101|NCT02065999|Hepatitis C, chronic|hepatitis c, chronic
5324103|NCT02065986|Prevention|prevention
5324104|NCT02065986|Truvada|truvada
5324105|NCT02065960|Feasibility study|feasibility study
5324106|NCT02065960|Early breast cancer|early breast cancer
5324107|NCT02065960|Stereotactic body radiotherapy|stereotactic body radiotherapy
5324108|NCT02065960|Cyberknife|cyberknife
5324109|NCT02065960|Pre-operative radiotherapy|pre-operative radiotherapy
5324110|NCT02065947|paravertebral block, mastectomy, efficiency|paravertebral block, mastectomy, efficiency
5324111|NCT02065934|in hospital cardiac arrest|in hospital cardiac arrest
5324112|NCT02065934|in situ simulation|in situ simulation
5324113|NCT02065934|clinical audit|clinical audit
5324114|NCT02065934|education|education
5324115|NCT02065921|COPD cohort|copd cohort
5324116|NCT02065921|COPD management|copd management
5324117|NCT02065921|exacerbation|exacerbation
5324118|NCT02065908|breast cancer|breast cancer
5324119|NCT02065908|anthracyclines|anthracyclines
5324120|NCT02065908|cardiotoxicity|cardiotoxicity
5324121|NCT02065908|circulating microRNA|circulating microrna
5324122|NCT02065908|biomarker|biomarker
5324123|NCT02065908|serum|serum
5324124|NCT02065908|anthracyclines based chemotherapy|anthracyclines based chemotherapy
5324125|NCT02065895|Physiologic Insulin Delivery (PID)|physiologic insulin delivery (pid)
5324126|NCT02065895|Closed Loop|closed loop
5324127|NCT02065895|Sensor|sensor
5324128|NCT02065895|Insulin sensitivity|insulin sensitivity
5324129|NCT02065882|fibrinogen, bleeding,|fibrinogen, bleeding,
5324130|NCT02065869|ALL|all
5324131|NCT02065869|AML|aml
5324132|NCT02065869|hematologic neoplasms|hematologic neoplasms
5324133|NCT02065869|hematologic malignancies|hematologic malignancies
5324134|NCT02065869|primary immune deficiences|primary immune deficiences
5324135|NCT02065869|hemoglobinopathy|hemoglobinopathy
5324136|NCT02065869|congenital cytopenia|congenital cytopenia
5324137|NCT02065869|anemia|anemia
5324138|NCT02065843|Anxiety|anxiety
5324139|NCT02065843|Third molar surgery|third molar surgery
5324140|NCT02065843|Blood pressure|blood pressure
5324141|NCT02065843|Heart rate|heart rate
5324142|NCT02065843|Oxygen saturation|oxygen saturation
5324143|NCT02065830|Robot|robot
5324144|NCT02065830|Spinal Cord Injury|spinal cord injury
5324145|NCT02065830|Gait|gait
5324146|NCT02065830|Quality of life|quality of life
5324147|NCT02065830|Rehabilitation|rehabilitation
5324148|NCT02065830|Lower Limb|lower limb
5324149|NCT02065817|Lipid|lipid
5324150|NCT02065817|Apolipoproteins|apolipoproteins
5324151|NCT02065817|Cardiovascular disease risks|cardiovascular disease risks
5324152|NCT02065804|Herniorrhaphy|herniorrhaphy
5324153|NCT02065804|Surgical Equipment|surgical equipment
5324154|NCT02065804|Chronic Pain|chronic pain
5324155|NCT02065804|Inguinal Herniorrhaphy|inguinal herniorrhaphy
5324156|NCT02065804|Laparoscopy|laparoscopy
5324157|NCT02065804|Surgical Outcome|surgical outcome
5324158|NCT02065791|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5324159|NCT02065791|Diabetic Nephropathies|diabetic nephropathies
5324160|NCT02065791|Canagliflozin|canagliflozin
5324161|NCT02065791|JNJ-28431754|jnj-28431754
5324162|NCT02065791|End-Stage Kidney Disease|end-stage kidney disease
5324163|NCT02065791|Chronic Kidney Disease|chronic kidney disease
5324164|NCT02065791|Macroalbuminuria|macroalbuminuria
5324165|NCT02065752|Healthy Volunteers|healthy volunteers
5324166|NCT02065752|Canagliflozin|canagliflozin
5324167|NCT02065752|Metformin|metformin
5324168|NCT02065752|Type 2 diabetes mellitus|type 2 diabetes mellitus
5324169|NCT02065739|Healthy|healthy
5324170|NCT02065739|JNJ-42165279|jnj-42165279
5324171|NCT02065739|Itraconazole|itraconazole
5324172|NCT02065739|Pharmacokinetics|pharmacokinetics
5324173|NCT02065713|Psoriatic arthritis, dactylitis, enthesitis|psoriatic arthritis, dactylitis, enthesitis
5324174|NCT02065700|Methotrexate|methotrexate
5324175|NCT02065700|insufficient responders|insufficient responders
5324384|NCT02064842|TMC647055|tmc647055
5324178|NCT02065674|PPBS|ppbs
5324179|NCT02065674|HbA1c%|hba1c%
5324189|NCT02065596|fludarabine|fludarabine
5324190|NCT02065583|Ileus|ileus
5324191|NCT02065583|Equipment and Supplies|equipment and supplies
5324192|NCT02065583|Technology|technology
5324193|NCT02065583|Acoustics|acoustics
5324194|NCT02065570|Crohn's Disease|crohn's disease
5324197|NCT02065544|Type 2 diabetes mellitus|type 2 diabetes mellitus
5324198|NCT02065544|behavioral weight loss|behavioral weight loss
5324199|NCT02065544|exercise training|exercise training
5324200|NCT02065544|hemoglobin A1c|hemoglobin a1c
5324201|NCT02065531|Low Back Pain|low back pain
5963243|NCT04262570|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5963244|NCT04262206|statin|statin
5192504|NCT02789254|AML|aml
5324202|NCT02065531|Chronic Pain|chronic pain
5324203|NCT02065531|Manipulation|manipulation
5324204|NCT02065531|Manual Therapy|manual therapy
5324205|NCT02065531|Randomized Controlled Trial|randomized controlled trial
5324206|NCT02065518|Muscle strength|muscle strength
5324207|NCT02065518|Electrical muscle stimulation|electrical muscle stimulation
5324208|NCT02065518|Strength training|strength training
5324209|NCT02065505|Spastic hemiparesis|spastic hemiparesis
5324210|NCT02065505|Posture|posture
5324211|NCT02065505|Pilates|pilates
5324212|NCT02065505|Respiratory Capacity|respiratory capacity
5324213|NCT02065492|Thalassemia|thalassemia
5324214|NCT02065492|Amlodipine|amlodipine
5324215|NCT02065492|Chelation|chelation
5324217|NCT02065492|MRI|mri
5324218|NCT02065492|Myocardial Iron|myocardial iron
5324219|NCT02065479|Coronary Artery Disease|coronary artery disease
5324220|NCT02065479|Percutaneous Coronary Intervention|percutaneous coronary intervention
5324221|NCT02065479|Genetic Polymorphism|genetic polymorphism
5324222|NCT02065479|Pharmacodynamic|pharmacodynamic
5324223|NCT02065453|lap hysterectomy|lap hysterectomy
5324224|NCT02065453|Women in need of a lap hysterectomy for benign disease.|women in need of a lap hysterectomy for benign disease.
5324225|NCT02065440|Ebastine/Pseudoephedrine|ebastine/pseudoephedrine
5324226|NCT02065440|subacute cough|subacute cough
5324227|NCT02065440|upper airway cough syndrome|upper airway cough syndrome
5324228|NCT02065427|Caregiver|caregiver
5324229|NCT02065427|Burden|burden
5324230|NCT02065427|Social support|social support
5324231|NCT02065427|Primary health Care|primary health care
5324232|NCT02065427|Home Care|home care
5324233|NCT02065427|Intervention|intervention
5324234|NCT02065414|Gums|gums
5324235|NCT02065414|Gingiva|gingiva
5324236|NCT02065414|Gingival Inflammation|gingival inflammation
5324237|NCT02065414|Gingival Bleeding|gingival bleeding
5324238|NCT02065375|RTA 408|rta 408
5324239|NCT02065375|Ocular surgery|ocular surgery
5324240|NCT02065375|Cataract surgery|cataract surgery
5324241|NCT02065375|Ocular inflammation|ocular inflammation
5324242|NCT02065375|Ocular pain|ocular pain
5324243|NCT02065375|Eye inflammation|eye inflammation
5324244|NCT02065362|EBV positive|ebv positive
5324245|NCT02065362|TGFbeta|tgfbeta
5324246|NCT02065362|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5324247|NCT02065362|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5324248|NCT02065349|peripheral neuropathy|peripheral neuropathy
5324249|NCT02065349|PHN|phn
5324250|NCT02065349|pain|pain
5324251|NCT02065349|PDPN|pdpn
5324252|NCT02065336|HBV|hbv
5324253|NCT02065336|Hepatitis|hepatitis
5324254|NCT02065323|Prostate Cancer|prostate cancer
5324255|NCT02065323|Metastatic|metastatic
5324256|NCT02065323|Hormone-sensitive|hormone-sensitive
5324257|NCT02065323|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
5324258|NCT02065323|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
5324259|NCT02065323|Dovitinib|dovitinib
5324260|NCT02065323|TKI258|tki258
5324261|NCT02065323|Circulating Tumor Cells|circulating tumor cells
5324262|NCT02065310|AGE|age
5324263|NCT02065310|Diabetes Biomarkers|diabetes biomarkers
5324264|NCT02065310|CEdG|cedg
5324265|NCT02065284|MS|ms
5324266|NCT02065284|Ambulation|ambulation
5324267|NCT02065258|Asthma, Clinical control, Exercise|asthma, clinical control, exercise
5324268|NCT02065245|Aging Frailty, Frailty, Cardiovascular, stem cells|aging frailty, frailty, cardiovascular, stem cells
5324269|NCT02065219|Chronic Pain|chronic pain
5324270|NCT02065219|Inguinal Hernia|inguinal hernia
5324271|NCT02065219|Outcome|outcome
5324272|NCT02065219|Surgical Procedure, Operative|surgical procedure, operative
5324273|NCT02065206|Focus groups|focus groups
5324274|NCT02065206|Underrepresented Minorities|underrepresented minorities
5324275|NCT02065206|Social Media|social media
5324290|NCT02065154|Hodgkin lymphoma|hodgkin lymphoma
5324292|NCT02065154|myelodysplastic syndrome|myelodysplastic syndrome
5324293|NCT02065154|MDS|mds
5324294|NCT02065154|myelofibrosis|myelofibrosis
5324295|NCT02065154|severe aplastic anemia|severe aplastic anemia
5324296|NCT02065141|digestion|digestion
5324297|NCT02065141|absorption|absorption
5324298|NCT02065141|protein|protein
5324299|NCT02065141|amino acids|amino acids
5324300|NCT02065141|heart failure|heart failure
5324301|NCT02065141|COPD|copd
5324302|NCT02065115|ice|ice
5324303|NCT02065115|cryotherapy|cryotherapy
5324304|NCT02065115|puncture|puncture
5324305|NCT02065115|pain|pain
5324306|NCT02065102|Rotational atherectomy|rotational atherectomy
5324307|NCT02065102|Angina|angina
5324308|NCT02065102|Optical coherence tomography|optical coherence tomography
5324309|NCT02065102|Intravascular ultrasound|intravascular ultrasound
5324310|NCT02065102|Coronary stent|coronary stent
5963245|NCT04262206|older adults|older adults
5324311|NCT02065076|Sodium Polystyrene Sulfonate|sodium polystyrene sulfonate
5324312|NCT02065076|Kayexalate|kayexalate
5324313|NCT02065076|Pre-dialysis|pre-dialysis
5324314|NCT02065076|Outpatients|outpatients
5324315|NCT02065076|Hyperkalemia|hyperkalemia
5324316|NCT02065076|Chronic kidney failure|chronic kidney failure
5324317|NCT02065076|Potassium|potassium
5204702|NCT02715336|ART|art
5324318|NCT02065063|MEK inhibitor|mek inhibitor
5324319|NCT02065063|PD-0332991|pd-0332991
5324320|NCT02065063|CDK4/6 inhibitor|cdk4/6 inhibitor
5324321|NCT02065063|palbociclib|palbociclib
5324322|NCT02065063|NRAS wild type|nras wild type
5324323|NCT02065063|cutaneous melanoma|cutaneous melanoma
5324324|NCT02065063|GSK1120212|gsk1120212
5324325|NCT02065063|trametinib|trametinib
5324326|NCT02065063|NRAS mutant|nras mutant
5324327|NCT02065063|BRAFV600 wild type|brafv600 wild type
5324328|NCT02065050|Diabetes mellitus|diabetes mellitus
5324329|NCT02065050|Team approach|team approach
5324330|NCT02065037|Insufflation|insufflation
5324331|NCT02065037|Carbon Dioxide|carbon dioxide
5324332|NCT02065037|Colonic Polyps|colonic polyps
5324333|NCT02065037|Colonoscopy|colonoscopy
5324334|NCT02065037|Randomized Controlled Trial|randomized controlled trial
5324335|NCT02065024|b-cryptoxanthin|b-cryptoxanthin
5324336|NCT02065024|plant sterols|plant sterols
5324337|NCT02065024|serum Cholesterol|serum cholesterol
5324338|NCT02065024|bone turnover markers|bone turnover markers
5324339|NCT02064998|Randomized Controlled Trial|randomized controlled trial
5324340|NCT02064998|Alcohol|alcohol
5324341|NCT02064998|Internet|internet
5324342|NCT02064998|Mobile phone|mobile phone
5324348|NCT02064972|Circulating Endothelial Cells|circulating endothelial cells
5324349|NCT02064972|Endothelial Dysfunction|endothelial dysfunction
5324350|NCT02064959|Subdural Hematoma|subdural hematoma
5324351|NCT02064959|Traumatic Brain Injury|traumatic brain injury
5324352|NCT02064959|Hypothermia|hypothermia
5324353|NCT02064946|prostate cancer|prostate cancer
5324354|NCT02064946|bone density|bone density
5324355|NCT02064946|vitamin D|vitamin d
5324356|NCT02064946|micronutrients|micronutrients
5324357|NCT02064946|pharmacologic actions|pharmacologic actions
5324358|NCT02064933|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5324359|NCT02064933|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5324360|NCT02064933|Genetic Therapy|genetic therapy
5324361|NCT02064907|Drug therapy|drug therapy
5324362|NCT02064894|children|children
5324363|NCT02064894|analgesia|analgesia
5324364|NCT02064894|musculoskeletal injury|musculoskeletal injury
5324365|NCT02064894|emergency|emergency
5324366|NCT02064894|opioids|opioids
5324367|NCT02064881|Postprandial lipemia|postprandial lipemia
5324368|NCT02064881|Diabetes|diabetes
5324369|NCT02064881|Metformin glycinate|metformin glycinate
5324370|NCT02064881|oxidized LDL|oxidized ldl
5324371|NCT02064868|AHF,|ahf,
5324372|NCT02064868|RLX030,|rlx030,
5324373|NCT02064868|SOC,|soc,
5324374|NCT02064868|WHF,|whf,
5324375|NCT02064868|RELAX-AHF-EU|relax-ahf-eu
5324376|NCT02064868|Renal Impairment|renal impairment
5324377|NCT02064855|Spinal stenosis|spinal stenosis
5324378|NCT02064855|Spondylolisthesis|spondylolisthesis
5324379|NCT02064855|Degenerative disc disease|degenerative disc disease
5324380|NCT02064855|Spinal fusion|spinal fusion
5324381|NCT02064855|Allograft|allograft
5324382|NCT02064855|Interbody fusion|interbody fusion
5324383|NCT02064842|Healthy|healthy
5324387|NCT02064842|Sovriad|sovriad
5324388|NCT02064842|Ritonavir (RTV)|ritonavir (rtv)
5324389|NCT02064829|Metastatic breast cancer|metastatic breast cancer
5324390|NCT02064829|Locally recurrent breast cancer|locally recurrent breast cancer
5324391|NCT02064829|Bioequivalence|bioequivalence
5324392|NCT02064829|IG-001|ig-001
5324393|NCT02064829|nab-paclitaxel|nab-paclitaxel
5324394|NCT02064829|Paclitaxel|paclitaxel
5324395|NCT02064829|Pharmacokinetics|pharmacokinetics
5324396|NCT02064816|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5324397|NCT02064816|Interferon beta 1a|interferon beta 1a
5324398|NCT02064816|Rebif®|rebif®
5324400|NCT02064790|Pregabalin|pregabalin
5324401|NCT02064790|Lyrica|lyrica
5324402|NCT02064790|Neurontin|neurontin
5324403|NCT02064790|lumbar|lumbar
5324404|NCT02064790|cervical|cervical
5324405|NCT02064738|Omega-3 fatty acids|omega-3 fatty acids
5324406|NCT02064738|Omega-6 fatty acids|omega-6 fatty acids
5324407|NCT02064738|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
5324408|NCT02064738|AERD|aerd
5324409|NCT02064738|Samter's Triad|samter's triad
5324410|NCT02064738|nasal polyp|nasal polyp
5324411|NCT02064738|aspirin|aspirin
5324412|NCT02064738|diet|diet
5324413|NCT02064738|leukotriene|leukotriene
5324414|NCT02064725|Endometrial cancer|endometrial cancer
5324415|NCT02064725|Recurrent or persistent endometrial carcinoma|recurrent or persistent endometrial carcinoma
5324416|NCT02064725|Progesterone Receptor Negative|progesterone receptor negative
5324417|NCT02064725|Sodium cridanimod|sodium cridanimod
5324418|NCT02064725|Virexxa|virexxa
5324419|NCT02064712|Continuous Positive Airway Pressure|continuous positive airway pressure
5324420|NCT02064699|Renal transplant|renal transplant
5324422|NCT02064699|Test QuantiFERON-CMV|test quantiferon-cmv
5324425|NCT02064660|Myopia|myopia
5324426|NCT02064660|Children|children
5324427|NCT02064660|Acupressure|acupressure
5324428|NCT02064660|Refractive error|refractive error
5324429|NCT02064660|Axial length|axial length
5324430|NCT02064660|Korean medicine|korean medicine
5963246|NCT04262089|Uterine cancer|uterine cancer
5192693|NCT02788097|blastocysts|blastocysts
5324431|NCT02064647|Insulin Infusion Systems|insulin infusion systems
5324432|NCT02064647|Blood Glucose|blood glucose
5324433|NCT02064634|Shinbaro Capsule|shinbaro capsule
5324434|NCT02064634|Celecoxib|celecoxib
5324435|NCT02064634|Osteoarthritis|osteoarthritis
5324436|NCT02064634|GCSB-5|gcsb-5
5324437|NCT02064634|Discontinuation rate|discontinuation rate
5324438|NCT02064634|Gastrointestinal adverse event|gastrointestinal adverse event
5324439|NCT02064634|NSAIDs|nsaids
5324440|NCT02064634|OASIS|oasis
5324441|NCT02064608|Prostate|prostate
5324442|NCT02064608|Cancer|cancer
5324443|NCT02064608|Prostate Cancer|prostate cancer
5324444|NCT02064608|High Risk|high risk
5324445|NCT02064608|Intermediate Risk|intermediate risk
5324446|NCT02064608|Early disease|early disease
5324448|NCT02064608|Radical Prostatectomy|radical prostatectomy
5324449|NCT02064595|Tibial fractures.|tibial fractures.
5324450|NCT02064595|Fracture fixation.|fracture fixation.
5324451|NCT02064595|External fixators.|external fixators.
5324452|NCT02064595|Intramedullary.|intramedullary.
5324453|NCT02064595|Quality of life.|quality of life.
5324454|NCT02064582|prostate cancer, enzalutamide, radiation, hormone therapy|prostate cancer, enzalutamide, radiation, hormone therapy
5324455|NCT02064543|Parkinson's disease|parkinson's disease
5324456|NCT02064543|gait|gait
5324457|NCT02064530|TAP block|tap block
5324458|NCT02064530|dexmedetomidine|dexmedetomidine
5324459|NCT02064530|bupivacaine|bupivacaine
5324460|NCT02064530|postoperative analgesia|postoperative analgesia
5324461|NCT02064517|Necrosed Immature monoradicular Teeth , Revascularisation pulpar, MTA apical barrier, Clinical and radiographic success|necrosed immature monoradicular teeth , revascularisation pulpar, mta apical barrier, clinical and radiographic success
5324462|NCT02064504|Respiratory|respiratory
5324463|NCT02064504|GSK961081 (MABA)|gsk961081 (maba)
5324464|NCT02064504|healthy subjects|healthy subjects
5324465|NCT02064504|pharmacokinetics|pharmacokinetics
5324466|NCT02064504|GW685698 (fluticasone furoate)|gw685698 (fluticasone furoate)
5324467|NCT02064491|Non-small cell lung cancer|non-small cell lung cancer
5324468|NCT02064491|EGFR mutant|egfr mutant
5324469|NCT02064491|Erlotinib|erlotinib
5324470|NCT02064491|Treatment Beyond Progression|treatment beyond progression
5324471|NCT02064478|Bone anchored hearing implant|bone anchored hearing implant
5324472|NCT02064478|Bone anchored hearing device|bone anchored hearing device
5324473|NCT02064452|behavior problems|behavior problems
5324474|NCT02064452|children|children
5324475|NCT02064452|prevention|prevention
5324476|NCT02064452|parenting|parenting
5324478|NCT02064452|pediatric|pediatric
5324479|NCT02064439|deep vein thrombosis|deep vein thrombosis
5324480|NCT02064439|pulmonary embolism|pulmonary embolism
5324481|NCT02064439|long-term prevention of recurrent symptomatic VTE|long-term prevention of recurrent symptomatic vte
5324482|NCT02064426|Anemia of CKD on dialysis|anemia of ckd on dialysis
5324483|NCT02064413|Birth control|birth control
5324484|NCT02064400|Rheumatoid arthritis|rheumatoid arthritis
5324485|NCT02064400|Ultrasound|ultrasound
5324486|NCT02064400|Remission|remission
5324487|NCT02064400|Qualitative|qualitative
5324488|NCT02064387|Multiple Myeloma|multiple myeloma
5324489|NCT02064387|BCMA expressing Lymphomas|bcma expressing lymphomas
5324490|NCT02064374|Dolutegravir|dolutegravir
5324491|NCT02064374|drug interaction|drug interaction
5324492|NCT02064374|metformin|metformin
5324493|NCT02064374|pharmacokinetics|pharmacokinetics
5324494|NCT02064374|healthy volunteers|healthy volunteers
5324495|NCT02064361|SCUBA diving|scuba diving
5324496|NCT02064361|exercise,|exercise,
5324497|NCT02064361|microparticles|microparticles
5324498|NCT02064361|neutrophil activation,|neutrophil activation,
5324499|NCT02064361|high intensity exercise|high intensity exercise
5324500|NCT02064335|physical activity coach, diabetic persons, health, behaviour|physical activity coach, diabetic persons, health, behaviour
5324501|NCT02064322|sacroiliac joint fusion|sacroiliac joint fusion
5324502|NCT02064322|SIJ fusion|sij fusion
5324503|NCT02064322|SI joint|si joint
5324504|NCT02064296|Fibromyalgia Chronic Pain|fibromyalgia chronic pain
5324505|NCT02064270|incision care|incision care
5324506|NCT02064270|Total Hip Arthroplasty|total hip arthroplasty
5324507|NCT02064270|Total Knee Arthroplasty|total knee arthroplasty
5324508|NCT02064270|Knee surgery|knee surgery
5324509|NCT02064270|Hip surgery|hip surgery
5324510|NCT02064257|autonomic nervous system|autonomic nervous system
5324511|NCT02064257|auditory processing disorder|auditory processing disorder
5324512|NCT02064257|social behavior|social behavior
5324513|NCT02064244|renal|renal
5324514|NCT02064244|kidney|kidney
5324515|NCT02064244|creatinine|creatinine
5324516|NCT02064244|Inferior Vena Cava (IVC)|inferior vena cava (ivc)
5324517|NCT02064244|Acute Renal Failure (ARF)|acute renal failure (arf)
5324518|NCT02064244|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5324519|NCT02064205|pre-load|pre-load
5324520|NCT02064205|satiety|satiety
5324521|NCT02064205|energy intake|energy intake
5324522|NCT02064205|appetite|appetite
5324523|NCT02064192|defibrillator, implantable cardioverter|defibrillator, implantable cardioverter
5324524|NCT02064192|sudden cardiac death|sudden cardiac death
5963247|NCT04262089|dMMR|dmmr
5324525|NCT02064192|primary prophylaxis|primary prophylaxis
5324526|NCT02064192|risk stratification|risk stratification
5324527|NCT02064179|Congenital heart disease|congenital heart disease
5324528|NCT02064179|Antiplatelet therapy|antiplatelet therapy
5324529|NCT02064179|Aspirin|aspirin
5324530|NCT02064166|Parkinson disease|parkinson disease
5324531|NCT02064166|Multiple system atrophy|multiple system atrophy
5324532|NCT02064166|Intranasal|intranasal
5324533|NCT02064166|Insulin|insulin
5324534|NCT02064153|Dialysate temperature|dialysate temperature
5324535|NCT02064153|Spent dialysate|spent dialysate
5324536|NCT02064153|Toxin removal|toxin removal
5324537|NCT02064153|Intra-dialytic hypotension|intra-dialytic hypotension
5324538|NCT02064153|Inter-compartmental resistance|inter-compartmental resistance
5324539|NCT02064140|ARDS|ards
5324540|NCT02064140|Mechanical Ventilation|mechanical ventilation
5324541|NCT02064140|Tidal volume|tidal volume
5324542|NCT02064140|NMBA|nmba
5324543|NCT02064114|BMI >40|bmi >40
5324544|NCT02064101|Scoliosis|scoliosis
5324545|NCT02064101|EMG|emg
5324546|NCT02064101|Pedicle screw|pedicle screw
5324547|NCT02064101|Neuromonitoring|neuromonitoring
5324548|NCT02064088|Regional anesthesia|regional anesthesia
5324549|NCT02064088|TAP block|tap block
5324550|NCT02064088|Pediatric anesthesia|pediatric anesthesia
5324551|NCT02064088|analgesic effects|analgesic effects
5324552|NCT02064088|pharmacokinetics|pharmacokinetics
5324553|NCT02064075|Subarachnoid hemorrhage|subarachnoid hemorrhage
5324554|NCT02064075|vasospasm|vasospasm
5324555|NCT02064075|Lactated Ringer's solution|lactated ringer's solution
5324556|NCT02064075|Hydroxyethyl starch solution|hydroxyethyl starch solution
5324557|NCT02064062|Achilles Tendinopathy|achilles tendinopathy
5324558|NCT02064062|Autologous Stem Cells|autologous stem cells
5324559|NCT02064062|Musculoskeletal|musculoskeletal
5324560|NCT02064049|Hepatitis C virus|hepatitis c virus
5324561|NCT02064049|People who inject drugs|people who inject drugs
5324562|NCT02064049|Drug users|drug users
5324563|NCT02064049|Direct acting antiviral (DAA)|direct acting antiviral (daa)
5324564|NCT02064049|Infectious diseases|infectious diseases
5324565|NCT02064049|Prisoners|prisoners
5324566|NCT02064036|Prostate Cancer|prostate cancer
5324567|NCT02064036|Radiotherapy|radiotherapy
5324568|NCT02064036|Androgen Deprivation|androgen deprivation
5324569|NCT02064023|insulin pump|insulin pump
5324570|NCT02064023|CSII|csii
5324571|NCT02064023|multiple daily injections|multiple daily injections
5324572|NCT02064023|MDI|mdi
5324573|NCT02064023|type 1 diabetes|type 1 diabetes
5324579|NCT02063958|Neuroendocrine tumor|neuroendocrine tumor
5324580|NCT02063958|Hsp90|hsp90
5324581|NCT02063945|ADHA|adha
5324582|NCT02063945|ODD|odd
5324583|NCT02063945|Conduct disorder|conduct disorder
5324584|NCT02063945|Aggression|aggression
5324585|NCT02063945|Treatment|treatment
5324586|NCT02063945|Methylphenidate|methylphenidate
5324587|NCT02063945|Risperidone|risperidone
5324588|NCT02063932|mucosal microbiome|mucosal microbiome
5324589|NCT02063932|H.pylori|h.pylori
5324590|NCT02063932|intestinal metaplasia|intestinal metaplasia
5324591|NCT02063932|gastric neoplasia|gastric neoplasia
5324592|NCT02063932|endomicroscopy|endomicroscopy
5324593|NCT02063880|HIV-1|hiv-1
5324594|NCT02063880|IRIS|iris
5324595|NCT02063867|HAI|hai
5324596|NCT02063867|MRSA|mrsa
5324597|NCT02063867|VRE|vre
5324598|NCT02063854|Drug Therapy|drug therapy
5324599|NCT02063828|anxiety|anxiety
5324600|NCT02063828|Dyspnea|dyspnea
5324601|NCT02063828|respiratory functioning|respiratory functioning
5324602|NCT02063802|pediatric obesity|pediatric obesity
5324603|NCT02063802|conjugated linoleic acid|conjugated linoleic acid
5324604|NCT02063802|CLA|cla
5324605|NCT02063802|metformin|metformin
5324606|NCT02063789|Immune Thrombocytopenia|immune thrombocytopenia
5324607|NCT02063789|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5324608|NCT02063789|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5324609|NCT02063789|Human Immunoglobulin|human immunoglobulin
5324610|NCT02063789|ITP|itp
5324611|NCT02063789|IVIg|ivig
5324612|NCT02063789|IgIV|igiv
5324613|NCT02063789|IV-Globulin SN Inj.|iv-globulin sn inj.
5324614|NCT02063776|Haemodiafiltration (HDF)|haemodiafiltration (hdf)
5324615|NCT02063776|Haemodialysis (HD)|haemodialysis (hd)
5324616|NCT02063776|Children|children
5324617|NCT02063776|Carotid intima media thickness|carotid intima media thickness
5324618|NCT02063776|Pulse wave velocity|pulse wave velocity
5324619|NCT02063776|Height standard deviation score|height standard deviation score
5324620|NCT02063763|Adult patients|adult patients
5324621|NCT02063763|Immune primary thrombocytopenia|immune primary thrombocytopenia
5324622|NCT02063763|Splenectomy|splenectomy
5324623|NCT02063763|TPO-mimetics|tpo-mimetics
5324624|NCT02063763|Eltrombopag|eltrombopag
5324625|NCT02063763|Romiplostim|romiplostim
5324626|NCT02063750|Fibromyalgia|fibromyalgia
5324627|NCT02063750|Muscle strength exercises|muscle strength exercises
5324628|NCT02063750|Pain|pain
5324629|NCT02063750|Quality of life|quality of life
5324630|NCT02063737|Shift work|shift work
5324631|NCT02063737|Fatigue|fatigue
5324632|NCT02063737|Sleepiness|sleepiness
5324633|NCT02063737|Injury|injury
5324634|NCT02063724|Invasive Breast Cancer|invasive breast cancer
5324635|NCT02063724|Breast Cancer|breast cancer
5324636|NCT02063724|Immunotherapy|immunotherapy
5324637|NCT02063724|Vaccine|vaccine
5324638|NCT02063724|Dendritic Cell|dendritic cell
5324639|NCT02063711|Prenatal Yoga|prenatal yoga
5324640|NCT02063711|Yoga, Pregnancy|yoga, pregnancy
5324641|NCT02063711|Yoga, Fetal Response|yoga, fetal response
5324642|NCT02063646|polyphenols|polyphenols
5324643|NCT02063646|memory|memory
5324644|NCT02063646|elderly|elderly
5324645|NCT02063633|Thoracic malignancy, irradiation, respiratory gating system PET|thoracic malignancy, irradiation, respiratory gating system pet
5324646|NCT02063620|IVRA, ketamine, lidocaine, ECG|ivra, ketamine, lidocaine, ecg
5324647|NCT02063607|Hepatitis C naive|hepatitis c naive
5324648|NCT02063594|Iodixanol|iodixanol
5324649|NCT02063594|Iodinated Contrast|iodinated contrast
5324650|NCT02063594|Liposome|liposome
5324651|NCT02063594|Computed Tomography|computed tomography
5324652|NCT02063594|X-ray Imaging|x-ray imaging
5324653|NCT02063594|Blood pool agent|blood pool agent
5324654|NCT02063594|Biomarker|biomarker
5324655|NCT02063555|Tuberculosis|tuberculosis
5324656|NCT02063555|BCG|bcg
5324657|NCT02063555|HIV|hiv
5324658|NCT02063555|TB Vaccines|tb vaccines
5324659|NCT02063542|Postoperative cognitive changes|postoperative cognitive changes
5324660|NCT02063542|Acetylcholine in CSF|acetylcholine in csf
5324661|NCT02063542|Surgery|surgery
5324662|NCT02063529|Colorectal cancer|colorectal cancer
5324663|NCT02063529|Metastatic colorectal cancer|metastatic colorectal cancer
5324664|NCT02063529|Liver metastases|liver metastases
5324665|NCT02063529|Liver resection|liver resection
5324666|NCT02063529|Liver ablation|liver ablation
5324667|NCT02063529|Conversion therapy|conversion therapy
5324668|NCT02063529|FOLFOXIRI|folfoxiri
5324669|NCT02063529|Cetuximab|cetuximab
5324670|NCT02063529|Oxaliplatin|oxaliplatin
5324671|NCT02063529|Irinotecan|irinotecan
5324672|NCT02063529|Leucovorin|leucovorin
5324673|NCT02063516|Airway Cuff|airway cuff
5324674|NCT02063516|Guardian|guardian
5324675|NCT02063516|Proseal|proseal
5324676|NCT02063516|Cuff Pressure|cuff pressure
5324677|NCT02063516|laryngeal Mask Airway|laryngeal mask airway
5324678|NCT02063503|prognostic indicator|prognostic indicator
5324679|NCT02063503|nonspecific|nonspecific
5324681|NCT02063503|low back pain|low back pain
5324682|NCT02063503|Non specific chronic low back pain|non specific chronic low back pain
5324683|NCT02063490|Adherence|adherence
5324684|NCT02063490|dialysis|dialysis
5324685|NCT02063490|intervention|intervention
5324686|NCT02063490|nurse-led|nurse-led
5324687|NCT02063490|phosphate binders|phosphate binders
5324688|NCT02063490|trial|trial
5324689|NCT02063464|Tumorcidal|tumorcidal
5324693|NCT02063451|Receptor, Opioid, mu [D12.776.543.750.100.620.550]|receptor, opioid, mu [d12.776.543.750.100.620.550]
5324694|NCT02063451|Brain [A08.186.211]|brain [a08.186.211]
5324695|NCT02063451|Affect [F01.470.047]|affect [f01.470.047]
5324696|NCT02063438|Thoracotomy|thoracotomy
5324697|NCT02063438|Pain|pain
5324698|NCT02063438|Intracostal Suture|intracostal suture
5324699|NCT02063438|Pericostal Suture|pericostal suture
5324700|NCT02063425|Motor recovery|motor recovery
5324701|NCT02063425|Fluoxetine|fluoxetine
5324702|NCT02063425|Transcranial magnetic stimulation|transcranial magnetic stimulation
5324703|NCT02063425|stroke|stroke
5324707|NCT02063347|innate collateral supply|innate collateral supply
5324708|NCT02063347|collateral|collateral
5324709|NCT02063347|coronary collateral|coronary collateral
5324710|NCT02063347|renal collateral|renal collateral
5324711|NCT02063347|peripheral collateral|peripheral collateral
5324712|NCT02063347|coronary artery disease|coronary artery disease
5324713|NCT02063334|vitamin D3|vitamin d3
5324714|NCT02063334|cholecalciferol|cholecalciferol
5324715|NCT02063334|calcidiol|calcidiol
5324716|NCT02063334|25-hydroxyvitamin D|25-hydroxyvitamin d
5324717|NCT02063334|gene expression|gene expression
5324718|NCT02063334|vitamin D receptor|vitamin d receptor
5324719|NCT02063334|randomized controlled trial|randomized controlled trial
5324721|NCT02063334|adults|adults
5324722|NCT02063321|DME, diabetic retinopathy, diabetes mellitus, epidemiology|dme, diabetic retinopathy, diabetes mellitus, epidemiology
5324723|NCT02063308|Oxaloacetate|oxaloacetate
5324724|NCT02063308|OAA|oaa
5324725|NCT02063308|AD|ad
5324726|NCT02063308|Alzheimer's Disease|alzheimer's disease
5324727|NCT02063295|Beloranib|beloranib
5324728|NCT02063295|ZGN-440|zgn-440
5324729|NCT02063295|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
5324730|NCT02063295|ZGN-433|zgn-433
5324731|NCT02063282|Asymptomatic|asymptomatic
5324732|NCT02063282|Carriage|carriage
5324733|NCT02063282|Colonization|colonization
5324734|NCT02063282|Clostridium difficile|clostridium difficile
5324735|NCT02063282|Colitis|colitis
5324736|NCT02063282|Rectal swab|rectal swab
5324737|NCT02063269|rivastigmine, butyrylcholinesterase, MRI, PET|rivastigmine, butyrylcholinesterase, mri, pet
5324738|NCT02063256|sperm count|sperm count
5324739|NCT02063256|sperm concentration|sperm concentration
5324740|NCT02063256|mobility|mobility
5324741|NCT02063256|diet|diet
5324742|NCT02063256|PUFA (polyunsaturated fatty acids)|pufa (polyunsaturated fatty acids)
5324743|NCT02063243|Keloid, hypertrophic scar|keloid, hypertrophic scar
5324744|NCT02063230|Phase I, healthy, pharmacokinetic, hepatic impairment|phase i, healthy, pharmacokinetic, hepatic impairment
5445407|NCT01521949|Prostate Cancer|prostate cancer
5445408|NCT01521949|Nutraceutical|nutraceutical
5324745|NCT02063204|Phase I, healthy, pharmacokinetics, renal impairment|phase i, healthy, pharmacokinetics, renal impairment
5324746|NCT02063191|Atrial Fibrillation|atrial fibrillation
5324747|NCT02063191|Bundle Branch Block|bundle branch block
5324748|NCT02063165|Safflower Oil|safflower oil
5324749|NCT02063165|Linoleic Acid|linoleic acid
5324750|NCT02063165|Dyslipidemia|dyslipidemia
5324751|NCT02063165|Hypertension|hypertension
5324752|NCT02063139|Knemometry|knemometry
5324753|NCT02063126|Coenzyme Q10 plus NADH|coenzyme q10 plus nadh
5324754|NCT02063126|maximum Heart Rate|maximum heart rate
5324756|NCT02063126|Pain|pain
5324757|NCT02063126|Sleep|sleep
5324758|NCT02063113|Multiple myeloma,|multiple myeloma,
5324759|NCT02063113|Older patient,|older patient,
5324760|NCT02063113|Treatment,|treatment,
5324761|NCT02063113|Geriatric assessment|geriatric assessment
5324762|NCT02063100|Glomerulonephritis|glomerulonephritis
5324763|NCT02063100|proteinuria|proteinuria
5324764|NCT02063100|shenyankangfu tablets|shenyankangfu tablets
5324765|NCT02063100|Losartan Potassium|losartan potassium
5324766|NCT02063100|efficacy|efficacy
5324767|NCT02063100|safety|safety
5324768|NCT02063087|Head CT|head ct
5324769|NCT02063087|Head Injury|head injury
5324770|NCT02063087|Pediatric|pediatric
5324771|NCT02063087|Emergency Department|emergency department
5324772|NCT02063087|Decision Aids|decision aids
5324773|NCT02063087|Shared Decision Making|shared decision making
5324774|NCT02063061|extracorporeal shock wave therapy ESWT|extracorporeal shock wave therapy eswt
5324775|NCT02063061|erectile dysfunction|erectile dysfunction
5324776|NCT02063048|weight loss|weight loss
5324777|NCT02063048|Text Messaging|text messaging
5324778|NCT02063048|Short Message Service|short message service
5324779|NCT02063048|Text Messages|text messages
5324780|NCT02063035|lumbar spine surgery|lumbar spine surgery
5324781|NCT02063035|thoracic spine surgery|thoracic spine surgery
5324783|NCT02062944|Liver Transplant|liver transplant
5324784|NCT02062944|Sirolimus|sirolimus
5324785|NCT02062944|Rapamune|rapamune
5324786|NCT02062944|Immunosuppressant Therapy|immunosuppressant therapy
5324787|NCT02062944|Withdrawal|withdrawal
5324788|NCT02062931|Primary Infertility|primary infertility
5324792|NCT02062918|Abdominal belt|abdominal belt
5324793|NCT02062918|Chronic low back pain|chronic low back pain
5324794|NCT02062918|Pain|pain
5324795|NCT02062918|Functional capacity|functional capacity
5324796|NCT02062892|everolimus|everolimus
5324797|NCT02062892|sirolimus|sirolimus
5324798|NCT02062892|tacrolimus|tacrolimus
5324799|NCT02062892|vascular endothelial function|vascular endothelial function
5324800|NCT02062892|kidney|kidney
5324801|NCT02062892|Transplantation|transplantation
5324802|NCT02062892|biomarkers|biomarkers
5324803|NCT02062879|pain|pain
5324804|NCT02062879|trauma|trauma
5324805|NCT02062840|Whole Body Hyperthermia|whole body hyperthermia
5324806|NCT02062840|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5324808|NCT02062827|Glioma|glioma
5324809|NCT02062827|Virus|virus
5324810|NCT02062827|Oncolytic virus|oncolytic virus
5324811|NCT02062827|Gene therapy|gene therapy
5324812|NCT02062827|Immunotherapy|immunotherapy
5324813|NCT02062801|Combined spinal epidural analgesia, labor, fetal bradycardia|combined spinal epidural analgesia, labor, fetal bradycardia
5324814|NCT02062788|Early Recovery After Surgery|early recovery after surgery
5324815|NCT02062788|Oral rehydration solution|oral rehydration solution
5324816|NCT02062788|Insulin resistance|insulin resistance
5324817|NCT02062788|Postoperative complication|postoperative complication
5324818|NCT02062749|Colorectal cancer|colorectal cancer
5324819|NCT02062749|Colon Cancer|colon cancer
5324820|NCT02062749|Pediatric|pediatric
5324821|NCT02062749|Adolescent|adolescent
5324822|NCT02062749|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5324823|NCT02062749|HIPEC|hipec
5324824|NCT02062749|Oxaliplatin|oxaliplatin
5324825|NCT02062749|Eloxatin|eloxatin
5324826|NCT02062736|methadone|methadone
5324827|NCT02062736|heroin addiction|heroin addiction
5324828|NCT02062736|methadone maintenance treatment|methadone maintenance treatment
5324829|NCT02062736|adequate dosage of methadone|adequate dosage of methadone
5324830|NCT02062723|methadone|methadone
5324831|NCT02062723|heroin addiction|heroin addiction
5324832|NCT02062723|methadone maintenance treatment|methadone maintenance treatment
5324833|NCT02062723|adequate dosage of methadone|adequate dosage of methadone
5324834|NCT02062710|cough|cough
5324835|NCT02062710|cough reflex|cough reflex
5324836|NCT02062710|capsaicin|capsaicin
5324837|NCT02062710|diphenhydramine|diphenhydramine
5324838|NCT02062710|phenylephrine|phenylephrine
5324839|NCT02062710|dextromethorphan|dextromethorphan
5324840|NCT02062710|placebo|placebo
5324845|NCT02062684|IgAN|igan
5324846|NCT02062684|IgA Nephropathy|iga nephropathy
5324847|NCT02062684|A-623|a-623
5324848|NCT02062684|Blisibimod|blisibimod
5205066|NCT02713425|Separation Anxiety|separation anxiety
5205067|NCT02713425|Generalized Anxiety|generalized anxiety
5205068|NCT02713425|GAD|gad
5324849|NCT02062684|Kidney Disease|kidney disease
5324850|NCT02062684|Persistent proteinuria|persistent proteinuria
5324851|NCT02062671|ADPKD|adpkd
5324852|NCT02062671|denervation|denervation
5324853|NCT02062671|renal denervation|renal denervation
5324855|NCT02062645|essential hypertension|essential hypertension
5324856|NCT02062619|Stroke|stroke
5324857|NCT02062619|Aphasia|aphasia
5324858|NCT02062619|Acquired reading disorders|acquired reading disorders
5324859|NCT02062619|Central alexia|central alexia
5324860|NCT02062619|Computer based rehabilitation|computer based rehabilitation
5324861|NCT02062619|Transcranial direct current stimulation|transcranial direct current stimulation
5324863|NCT02062619|Magnetoencephalography|magnetoencephalography
5324864|NCT02062619|MEG|meg
5324865|NCT02062619|Magnetic Resonance Imaging|magnetic resonance imaging
5324866|NCT02062619|MRI|mri
5324867|NCT02062606|Scoliosis|scoliosis
5324868|NCT02062606|Spinal Curvatures|spinal curvatures
5324869|NCT02062606|Spinal Diseases|spinal diseases
5324870|NCT02062606|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5324871|NCT02062606|Spinal Deformity|spinal deformity
5324872|NCT02062593|Stable angina|stable angina
5324873|NCT02062593|Percutaneous coronary intervention|percutaneous coronary intervention
5324874|NCT02062593|Optimal medical therapy|optimal medical therapy
5324875|NCT02062593|Sham-control|sham-control
5324876|NCT02062580|Vaccine immunogenicity|vaccine immunogenicity
5324877|NCT02062580|Immune activation|immune activation
5324878|NCT02062554|Myocardial infarction|myocardial infarction
5324879|NCT02062554|Clinical outcome|clinical outcome
5324880|NCT02062554|Flow-mediated dilation|flow-mediated dilation
5324881|NCT02062554|Inflammation|inflammation
5324882|NCT02062541|functional assessment|functional assessment
5324883|NCT02062541|rehabilitation|rehabilitation
5324884|NCT02062541|cross-sectorial cooperation|cross-sectorial cooperation
5324885|NCT02062528|EPA|epa
5324886|NCT02062489|breast cancer,|breast cancer,
5324887|NCT02062489|tamoxifen,|tamoxifen,
5324888|NCT02062489|ER/PR negative, ER-beta positive|er/pr negative, er-beta positive
5324889|NCT02062463|Asthma|asthma
5324890|NCT02062450|Arthroplasty|arthroplasty
5324891|NCT02062450|Hip Replacement|hip replacement
5324892|NCT02062450|Acetabular cup|acetabular cup
5324893|NCT02062450|Dual mobility|dual mobility
5324894|NCT02062450|Hip revision surgery|hip revision surgery
5324895|NCT02062437|Arthroplasty|arthroplasty
5324896|NCT02062437|Hip Replacement|hip replacement
5324898|NCT02062437|Acetabular cup|acetabular cup
5324899|NCT02062437|Femoral stem|femoral stem
5324900|NCT02062424|ischemic heart disease, dietary guidelines|ischemic heart disease, dietary guidelines
5324901|NCT02062411|attention deficit disorder (ADHD)|attention deficit disorder (adhd)
5324902|NCT02062411|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5324903|NCT02062411|adult|adult
5324904|NCT02062398|PNP|pnp
5324905|NCT02062398|Stimulation|stimulation
5324906|NCT02062398|Peripheral neurostimulation|peripheral neurostimulation
5324907|NCT02062372|7 T MRI|7 t mri
5324908|NCT02062372|Radiotherapy|radiotherapy
5324909|NCT02062372|Glioblastoma|glioblastoma
5324910|NCT02062372|Biopsy|biopsy
5324911|NCT02062359|Malignant Melanoma|malignant melanoma
5324912|NCT02062359|Metastatic Cancer|metastatic cancer
5324914|NCT02062359|Immunotherapy|immunotherapy
5324915|NCT02062359|Tumor Regression|tumor regression
5324916|NCT02062346|endothelin;|endothelin;
5324917|NCT02062346|blood pressure;|blood pressure;
5324918|NCT02062346|vasculitis|vasculitis
5324919|NCT02062333|dexmedetomidine|dexmedetomidine
5324920|NCT02062333|esmolol|esmolol
5324921|NCT02062333|stapes reflex|stapes reflex
5324922|NCT02062320|Acute Pain Service|acute pain service
5324923|NCT02062320|postoperative analgesia|postoperative analgesia
5324924|NCT02062320|Caesarean Section|caesarean section
5324925|NCT02062320|non-opioid analgesia|non-opioid analgesia
5324926|NCT02062320|opioid analgesia|opioid analgesia
5324927|NCT02062320|epidural analgesia|epidural analgesia
5324928|NCT02062307|Hypogonadism|hypogonadism
5324929|NCT02062307|Asymmetric Dimethyl Arginine|asymmetric dimethyl arginine
5324930|NCT02062307|Osteoprotegerin|osteoprotegerin
5324931|NCT02062307|Fibroblast Growth Factor|fibroblast growth factor
5324932|NCT02062307|Vitamin D|vitamin d
5324933|NCT02062281|Safety|safety
5324934|NCT02062281|Immunogenicity|immunogenicity
5324935|NCT02062281|vaccine|vaccine
5324936|NCT02062281|pneumococcal|pneumococcal
5324937|NCT02062281|influenza|influenza
5324938|NCT02062268|KAP|kap
5324939|NCT02062268|drink driving|drink driving
5324940|NCT02062268|public|public
5324941|NCT02062268|Jiangsu province|jiangsu province
5324942|NCT02062268|China|china
5963248|NCT04262089|POLE-EDM|pole-edm
5963249|NCT04262089|neo-adjuvant|neo-adjuvant
5963250|NCT04262089|pembrolizumab|pembrolizumab
5324943|NCT02062255|Asprin|asprin
5324944|NCT02062255|Omega-3 Free Fatty Acids|omega-3 free fatty acids
5324945|NCT02062255|Obesity|obesity
5324946|NCT02062255|COX-2 inhibitor|cox-2 inhibitor
5324947|NCT02062242|Pelvic Floor|pelvic floor
5963251|NCT04262011|chronic kidney disease|chronic kidney disease
5275069|NCT02302781|IVF|ivf
5324948|NCT02062242|Physical Therapy Specialty|physical therapy specialty
5324949|NCT02062242|Awareness|awareness
5324950|NCT02062242|Electric Stimulation|electric stimulation
5324951|NCT02062242|Palpation|palpation
5324952|NCT02062229|oxidative stress|oxidative stress
5324953|NCT02062229|oxysterols|oxysterols
5324954|NCT02062229|fatty acids|fatty acids
5324955|NCT02062229|seminal fluid|seminal fluid
5324956|NCT02062216|Coronary artery disease|coronary artery disease
5324957|NCT02062216|Percutaneous coronary intervention|percutaneous coronary intervention
5324958|NCT02062216|Inflammatory receptors|inflammatory receptors
5324959|NCT02062203|Akebia|akebia
5324960|NCT02062203|QT interval|qt interval
5324962|NCT02062203|pharmacokinetic|pharmacokinetic
5324963|NCT02062203|anemia|anemia
5329371|NCT02043080|HIV|hiv
5324971|NCT02062138|rehabilitation|rehabilitation
5324972|NCT02062138|total knee arthroplasty|total knee arthroplasty
5324973|NCT02062138|range of motion|range of motion
5324974|NCT02062138|continuous passive motion|continuous passive motion
5324975|NCT02062138|controlled active motion|controlled active motion
5324976|NCT02062138|postoperative physical therapy|postoperative physical therapy
5324977|NCT02062125|scleroderma|scleroderma
5324978|NCT02062125|calcinosis|calcinosis
5324979|NCT02062112|Bowel preparation solutions|bowel preparation solutions
5324980|NCT02062112|Colonoscopy|colonoscopy
5324981|NCT02062112|Polyethylene glycol|polyethylene glycol
5324982|NCT02062086|Sarcopenia|sarcopenia
5324983|NCT02062086|Mass muscle|mass muscle
5324984|NCT02062086|Quality of life|quality of life
5324985|NCT02062073|head lice|head lice
5324986|NCT02062073|Hatchtech|hatchtech
5324987|NCT02062060|Head Lice|head lice
5324988|NCT02062060|Hatchtech|hatchtech
5324989|NCT02062047|Diabetes Mellitus|diabetes mellitus
5324990|NCT02062047|Chronic Periodontitis|chronic periodontitis
5324991|NCT02062047|Root Planing|root planing
5324992|NCT02062047|Cytokines|cytokines
5324993|NCT02062047|microbiology|microbiology
5324994|NCT02062047|Glycated hemoglobin|glycated hemoglobin
5324995|NCT02062047|diabetic subjects|diabetic subjects
5324996|NCT02062034|Oxidative stress|oxidative stress
5324997|NCT02062034|Mitochondrial dysfunction|mitochondrial dysfunction
5324998|NCT02062034|Ubiquinone|ubiquinone
5324999|NCT02062034|Antioxidant combined therapy|antioxidant combined therapy
5325000|NCT02062034|Diabetic retinopathy|diabetic retinopathy
5325001|NCT02062008|Positron Emission Tomography-Magnetic Resonance Imaging|positron emission tomography-magnetic resonance imaging
5321385|NCT02078622|Education|education
5325002|NCT02062008|Cardiac Disease|cardiac disease
5325003|NCT02061995|Bone Diseases|bone diseases
5325004|NCT02061995|Metabolic Bone Diseases|metabolic bone diseases
5325005|NCT02061995|Osteoporosis|osteoporosis
5325006|NCT02061995|Bone Fractures|bone fractures
5325007|NCT02061995|Osteoporotic Fractures|osteoporotic fractures
5325008|NCT02061995|Musculoskeletal Diseases|musculoskeletal diseases
5325009|NCT02061982|Do It Yourself (DIY)|do it yourself (diy)
5325010|NCT02061982|Caffeine|caffeine
5325011|NCT02061982|Cognition|cognition
5325012|NCT02061969|nursing home facility|nursing home facility
5325013|NCT02061969|long-term care facility|long-term care facility
5325014|NCT02061969|older patients|older patients
5325015|NCT02061969|elderly patients|elderly patients
5325016|NCT02061969|hyperglycemia|hyperglycemia
5325017|NCT02061969|type 2 diabetes|type 2 diabetes
5325018|NCT02061943|Spasmodic dysphonia|spasmodic dysphonia
5325019|NCT02061943|Laryngeal dystonia|laryngeal dystonia
5325020|NCT02061943|Dystonia|dystonia
5325021|NCT02061943|Severity|severity
5325022|NCT02061930|single tooth|single tooth
5325023|NCT02061930|dental implant|dental implant
5325024|NCT02061930|aesthetics outcome|aesthetics outcome
5325025|NCT02061930|long term|long term
5325026|NCT02061930|soft tissue recession|soft tissue recession
5325027|NCT02061930|pink esthetic score|pink esthetic score
5325028|NCT02061930|white esthetic score|white esthetic score
5325029|NCT02061917|Biomarkers|biomarkers
5325031|NCT02061917|Tobacco-heating|tobacco-heating
5325032|NCT02061917|Smokeless Tobacco|smokeless tobacco
5325033|NCT02061917|Snus|snus
5325034|NCT02061917|Smoking|smoking
5325035|NCT02061917|Exposure|exposure
5325036|NCT02061917|Quality of Life|quality of life
5325037|NCT02061891|Coronary Stenosis|coronary stenosis
5325038|NCT02061891|Coronary Artery Disease|coronary artery disease
5325039|NCT02061891|Acute coronary syndrome|acute coronary syndrome
5325040|NCT02061891|Percutaneous Coronary Intervention|percutaneous coronary intervention
5325041|NCT02061891|Multidetector Computed Tomography|multidetector computed tomography
5325042|NCT02061878|ApoE|apoe
5325043|NCT02061878|beta-amyloid|beta-amyloid
5325044|NCT02061813|Hatchtech|hatchtech
5325045|NCT02061800|Unrelated donor transplant|unrelated donor transplant
5325046|NCT02061800|Allogenic Stem Cell Transplant|allogenic stem cell transplant
5325047|NCT02061800|Adult Bone Marrow Transplant|adult bone marrow transplant
5325048|NCT02061800|Pediatric Bone Marrow Transplant|pediatric bone marrow transplant
5445409|NCT01521949|Acai Juice|acai juice
5325049|NCT02061800|Related donor transplant|related donor transplant
5325050|NCT02061800|Haploidentical donor transplant|haploidentical donor transplant
5963252|NCT04262011|hemodialysis|hemodialysis
5325051|NCT02061800|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5325052|NCT02061800|Non-malignant disease|non-malignant disease
5325053|NCT02061800|Malignant disease|malignant disease
5325054|NCT02061800|Bone marrow failure syndrome|bone marrow failure syndrome
5325055|NCT02061800|Severe Aplastic Anemia|severe aplastic anemia
5325056|NCT02061800|Severe Congenital Neutropenia|severe congenital neutropenia
5325057|NCT02061800|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
5325058|NCT02061800|Diamond-Blackfan Anemia|diamond-blackfan anemia
5325059|NCT02061800|Schwachman Diamond Syndrome|schwachman diamond syndrome
5325060|NCT02061800|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
5325061|NCT02061800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5325062|NCT02061800|Histiocytic Syndrome|histiocytic syndrome
5325063|NCT02061800|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
5325064|NCT02061800|Lymphohistiocytosis|lymphohistiocytosis
5325065|NCT02061800|Macrophage Activation Syndrome|macrophage activation syndrome
5325066|NCT02061800|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
5325067|NCT02061800|Hemoglobinopathies|hemoglobinopathies
5325068|NCT02061800|Reduced-Intensity Conditioning|reduced-intensity conditioning
5325069|NCT02061800|Sickle Cell Disease|sickle cell disease
5325070|NCT02061800|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
5325071|NCT02061774|acetaminophen in transforaminal lumbar interbody fusion|acetaminophen in transforaminal lumbar interbody fusion
5325072|NCT02061735|skin imaging|skin imaging
5325073|NCT02061735|image analysis|image analysis
5325074|NCT02061735|infrared thermography|infrared thermography
5325075|NCT02061735|infantile hemangioma|infantile hemangioma
5325076|NCT02061735|three dimensional imaging|three dimensional imaging
5325077|NCT02061735|color imaging and analysis|color imaging and analysis
5325078|NCT02061735|propranolol|propranolol
5325079|NCT02061735|timolol|timolol
5325080|NCT02061735|ontogeny|ontogeny
5325081|NCT02061709|Rhinoconjunctivitis|rhinoconjunctivitis
5325082|NCT02061709|Rhinitis|rhinitis
5325083|NCT02061709|Seasonal|seasonal
5325084|NCT02061709|Ragweed|ragweed
5325091|NCT02061696|Atherosclerosis|atherosclerosis
5325092|NCT02061696|Manual Compression|manual compression
5325093|NCT02061670|Ragweed|ragweed
5325094|NCT02061670|Allergy|allergy
5325095|NCT02061670|rhinoconjunctivitis|rhinoconjunctivitis
5325096|NCT02061670|rhinitis|rhinitis
5325097|NCT02061670|asthma|asthma
5325098|NCT02061618|South Asian|south asian
5325099|NCT02061605|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
5325100|NCT02061605|Surgical hemostasis|surgical hemostasis
5325101|NCT02061605|Laser tissue welding|laser tissue welding
5325102|NCT02061605|Tissue sealant|tissue sealant
5325103|NCT02061579|Physical Activity|physical activity
5325104|NCT02061566|Acute kidney injury|acute kidney injury
5325105|NCT02061553|traumatic brain injury|traumatic brain injury
5325107|NCT02061553|head injury|head injury
5325108|NCT02061553|brain injury|brain injury
5325109|NCT02061553|depression|depression
5325110|NCT02061553|anxiety|anxiety
5325111|NCT02061527|ADM|adm
5325113|NCT02061527|Breast reconstruction|breast reconstruction
5325114|NCT02061527|Immediate breast reconstruction|immediate breast reconstruction
5325115|NCT02061527|IBR|ibr
5325116|NCT02061527|Acellular dermal matrix|acellular dermal matrix
5325117|NCT02061527|Biological mesh|biological mesh
5325118|NCT02061527|Randomized controlled trial|randomized controlled trial
5325119|NCT02061527|RCT|rct
5325120|NCT02061527|Breast cancer|breast cancer
5325121|NCT02061527|Implants|implants
5325122|NCT02061527|Mastectomy|mastectomy
5325123|NCT02061527|Direct-to-implant|direct-to-implant
5325124|NCT02061501|visual cognitive deficits|visual cognitive deficits
5325125|NCT02061488|Artificial pancreas, closed loop glucose control, model predictive control|artificial pancreas, closed loop glucose control, model predictive control
5325126|NCT02061475|Lidocaine patches|lidocaine patches
5325127|NCT02061475|Pain|pain
5325128|NCT02061475|Intravenous cannulation|intravenous cannulation
5325129|NCT02061449|Toll-like receptor agonist|toll-like receptor agonist
5325130|NCT02061449|immunostimulation|immunostimulation
5325131|NCT02061436|chronic total occlusion, percutaneous coronary intervention|chronic total occlusion, percutaneous coronary intervention
5325132|NCT02061423|Invasive Breast Cancer|invasive breast cancer
5325133|NCT02061423|Breast Cancer|breast cancer
5325134|NCT02061423|Immunotherapy|immunotherapy
5325135|NCT02061423|Vaccine|vaccine
5325136|NCT02061423|Dendritic Cell|dendritic cell
5325137|NCT02061423|Neoadjuvant|neoadjuvant
5325138|NCT02061410|Elderly|elderly
5325139|NCT02061397|lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5325140|NCT02061397|tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
5325141|NCT02061397|simvastatin|simvastatin
5325142|NCT02061397|sirolimus|sirolimus
5325143|NCT02061397|everolimus|everolimus
5325144|NCT02061384|Infertility|infertility
5325145|NCT02061371|stroke|stroke
5325146|NCT02061371|spasticity|spasticity
5325147|NCT02061371|physiotherapy|physiotherapy
5325148|NCT02061371|virtual reality|virtual reality
5325149|NCT02061358|Dengue|dengue
5325150|NCT02061358|Arbovirus Infections|arbovirus infections
5325151|NCT02061358|Flaviviridae Infections|flaviviridae infections
5325152|NCT02061358|Flavivirus Infections|flavivirus infections
5325153|NCT02061358|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
5325154|NCT02061358|RNA Virus Infections|rna virus infections
5325155|NCT02061358|Virus Diseases|virus diseases
5325156|NCT02061358|Pharmaceutical Solutions|pharmaceutical solutions
5325157|NCT02061358|Pharmacologic Actions|pharmacologic actions
5325158|NCT02061358|Therapeutic Uses|therapeutic uses
5325159|NCT02061345|Prostate cancer|prostate cancer
5325160|NCT02061345|Androgen Deprivation Therapy|androgen deprivation therapy
5325161|NCT02061345|Mild Cognitive Impairment|mild cognitive impairment
5325162|NCT02061332|Breast Cancer|breast cancer
5325164|NCT02061332|Immunotherapy|immunotherapy
5325165|NCT02061332|Vaccine|vaccine
5325166|NCT02061332|Dendritic Cell|dendritic cell
5325174|NCT02061280|Asthma|asthma
5325175|NCT02061280|Clinical Trial Design|clinical trial design
5325176|NCT02061280|Electronic Data Entry|electronic data entry
5325177|NCT02061280|Mobile Devices|mobile devices
5325178|NCT02061280|Home Spirometry|home spirometry
5325179|NCT02061267|Metabolic Syndrome|metabolic syndrome
5325180|NCT02061267|Olive Oil|olive oil
5325181|NCT02061267|Niacin|niacin
5325182|NCT02061254|Venous insufficiency|venous insufficiency
5325183|NCT02061254|Lymphedema|lymphedema
5325184|NCT02061254|Elastograph|elastograph
5325185|NCT02061254|Ultrasonography|ultrasonography
5325186|NCT02061254|Fibrosis|fibrosis
5325197|NCT02061202|Pain Crisis|pain crisis
5325198|NCT02061202|Painful Crisis|painful crisis
5325199|NCT02061202|Sickle Pain|sickle pain
5325203|NCT02061176|Hemorrhoids|hemorrhoids
5325204|NCT02061176|Haemorrhoids|haemorrhoids
5325205|NCT02061176|Transanal Haemorrhoidal Dearterialization|transanal haemorrhoidal dearterialization
5325206|NCT02061176|Transanal Hemorrhoidal Dearterialisation|transanal hemorrhoidal dearterialisation
5325207|NCT02061176|Open Haemorrhoidectomy|open haemorrhoidectomy
5325208|NCT02061176|Open Hemorrhoidectomy|open hemorrhoidectomy
5325209|NCT02061150|Early onset GBS sepsis|early onset gbs sepsis
5325210|NCT02061150|Prevention|prevention
5325211|NCT02061150|Maternal risk factors|maternal risk factors
5325212|NCT02061137|Rett Syndrome (Mecp2 positive)|rett syndrome (mecp2 positive)
5325213|NCT02061137|Fingolimod (FTY 720)|fingolimod (fty 720)
5325214|NCT02061137|BDNF|bdnf
5325215|NCT02061137|Brain Atrophy|brain atrophy
5325216|NCT02061111|Mitochondria Function|mitochondria function
5325217|NCT02061111|TPO-antibodies|tpo-antibodies
5325218|NCT02061111|Subclinical Thyroid Disease|subclinical thyroid disease
5325219|NCT02061111|Thyroid Disease In Pregnancy|thyroid disease in pregnancy
5325220|NCT02061111|Children´s Development|children´s development
5325221|NCT02061098|Pomegranate|pomegranate
5325223|NCT02061098|Urolithins|urolithins
5325224|NCT02061098|Microbiota|microbiota
5325225|NCT02061098|Polyphenols|polyphenols
5325226|NCT02061098|Nutraceutical|nutraceutical
5325227|NCT02061098|Dietary supplement|dietary supplement
5325228|NCT02061085|Breast Neoplasm Metastasis|breast neoplasm metastasis
5325229|NCT02061085|Receptor,HER-2|receptor,her-2
5325230|NCT02061085|Eribulin|eribulin
5325231|NCT02061085|Furans, quetones|furans, quetones
5325232|NCT02061085|Antimitotic agent|antimitotic agent
5325233|NCT02061072|pharmacokinetics|pharmacokinetics
5325234|NCT02061072|population pharmacokinetics|population pharmacokinetics
5325235|NCT02061072|hemophilia|hemophilia
5325236|NCT02061072|factor VIII|factor viii
5325237|NCT02061072|factor IX|factor ix
5325238|NCT02061046|Gait|gait
5325239|NCT02061046|Dual task|dual task
5325240|NCT02061033|Hemophilia A|hemophilia a
5325241|NCT02061033|Hemophilia B|hemophilia b
5325242|NCT02061033|Von Willebrand's Disease|von willebrand's disease
5325243|NCT02061033|Endogen thrombin potential|endogen thrombin potential
5325244|NCT02061033|Overall hemostatic potential|overall hemostatic potential
5325245|NCT02061033|Microparticles|microparticles
5325246|NCT02061033|Fibrin clot|fibrin clot
5325247|NCT02061020|delta-9-tetrahydrocannabinol, volunteers, cannabis users|delta-9-tetrahydrocannabinol, volunteers, cannabis users
5325248|NCT02061007|skin cancer|skin cancer
5325249|NCT02060981|Randomized controlled trial|randomized controlled trial
5325250|NCT02060981|Primary medication adherence|primary medication adherence
5325251|NCT02060981|Decision-support tool|decision-support tool
5325252|NCT02060981|Patient-centered outcomes research|patient-centered outcomes research
5325253|NCT02060981|Antihypertensive medications|antihypertensive medications
5325254|NCT02060981|One-on-one patient interviews|one-on-one patient interviews
5325255|NCT02060968|Promus PREMIER|promus premier
5325256|NCT02060968|Routine Clinical Practice|routine clinical practice
5325257|NCT02060955|Glioblastoma multiforme|glioblastoma multiforme
5325258|NCT02060955|Immunotherapy|immunotherapy
5325259|NCT02060955|Bevacizumab/Irinotecan|bevacizumab/irinotecan
5325260|NCT02060955|ALECSAT|alecsat
5325261|NCT02060955|recurrent|recurrent
5325262|NCT02060942|Volume responsiveness mean systemic filling pressure|volume responsiveness mean systemic filling pressure
5325263|NCT02060929|Healthy|healthy
5325264|NCT02060929|Esketamine|esketamine
5325265|NCT02060929|Intranasal|intranasal
5325266|NCT02060929|Nasal Guide|nasal guide
5325267|NCT02060929|Pharmacokinetics|pharmacokinetics
5325268|NCT02060903|Head Lice|head lice
5325269|NCT02060903|Hatchtech|hatchtech
5325270|NCT02060890|Glioblastoma|glioblastoma
5325295|NCT02060760|Prospective cohort study|prospective cohort study
5325296|NCT02060760|Diagnostic accuracy|diagnostic accuracy
5325297|NCT02060760|High sensitivity versus contemporary troponin I assay|high sensitivity versus contemporary troponin i assay
5325298|NCT02060760|Gender|gender
5325299|NCT02060760|Renal Function|renal function
5325300|NCT02060734|Whiplash,|whiplash,
5325301|NCT02060734|injection,|injection,
5325302|NCT02060734|lidocaine,|lidocaine,
5325303|NCT02060734|sham needling|sham needling
5325305|NCT02060695|Parkinson disease|parkinson disease
5325306|NCT02060682|Fractional Flow Reserve|fractional flow reserve
5325307|NCT02060682|Rapid Exchange|rapid exchange
5325308|NCT02060682|Catheter|catheter
5325309|NCT02060656|Relapsed or refractory Diffuse Large B-Cell Lymphoma after R-CHOP chemotherapy|relapsed or refractory diffuse large b-cell lymphoma after r-chop chemotherapy
5325319|NCT02060617|low back pain|low back pain
5325320|NCT02060617|physical therapy|physical therapy
5325321|NCT02060617|manual therapy|manual therapy
5325322|NCT02060617|manipulation|manipulation
5325323|NCT02060617|exercise|exercise
5325324|NCT02060617|motor control|motor control
5325325|NCT02060617|regional interdependence|regional interdependence
5325326|NCT02060604|ketorolac|ketorolac
5325327|NCT02060604|NSAIDs|nsaids
5325328|NCT02060604|wet macular degeneration|wet macular degeneration
5325329|NCT02060604|choroidal neovascularization|choroidal neovascularization
5325330|NCT02060578|Cancer palliative care|cancer palliative care
5325331|NCT02060578|Dead child|dead child
5325332|NCT02060565|diagnosis|diagnosis
5325333|NCT02060565|survival|survival
5325334|NCT02060565|non-invasive method|non-invasive method
5325335|NCT02060565|cirrhosis|cirrhosis
5325336|NCT02060565|FibroScan|fibroscan
5325337|NCT02060526|sulfoglucosamine sulfohydrolase (SGSH)|sulfoglucosamine sulfohydrolase (sgsh)
5325338|NCT02060526|recombinant human heparan N-sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
5325339|NCT02060526|Hunter's Syndrome|hunter's syndrome
5325340|NCT02060526|Shire HGT|shire hgt
5325341|NCT02060526|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
5325342|NCT02060526|Sanfilippo Syndrome Type A (Sanfilippo A)|sanfilippo syndrome type a (sanfilippo a)
5325343|NCT02060526|enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
5325344|NCT02060513|Wounded warriors|wounded warriors
5325345|NCT02060513|Battlefield infection|battlefield infection
5325346|NCT02060513|Acinetobacter|acinetobacter
5325348|NCT02060513|MRSA|mrsa
5325350|NCT02060500|GERD|gerd
5325351|NCT02060500|fundoplication|fundoplication
5325352|NCT02060500|cardiaplication|cardiaplication
5325353|NCT02060500|reflux|reflux
5325359|NCT02060474|Allan-Herndon-Dudley Syndrome|allan-herndon-dudley syndrome
5325360|NCT02060474|MCT8|mct8
5325361|NCT02060474|Triac|triac
5325362|NCT02060474|Therapeutic Trial|therapeutic trial
5325363|NCT02060448|Non-suicidal self-injury|non-suicidal self-injury
5325364|NCT02060448|Self-injurious behavior|self-injurious behavior
5325365|NCT02060448|NSSI|nssi
5325366|NCT02060448|Anxiety|anxiety
5325367|NCT02060448|Depression|depression
5325368|NCT02060448|Transdiagnostic|transdiagnostic
5325370|NCT02060448|Unified Protocol|unified protocol
5325371|NCT02060435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5325372|NCT02060435|Ebstein-Barr Virus|ebstein-barr virus
5325373|NCT02060422|Epilepsy|epilepsy
5325374|NCT02060422|Drug-resistant epilepsy|drug-resistant epilepsy
5325375|NCT02060422|Seizure|seizure
5325376|NCT02060422|Mindfulness|mindfulness
5325377|NCT02060422|Stress|stress
5325378|NCT02060422|Psychotherapy|psychotherapy
5325380|NCT02060409|decitabine|decitabine
5325381|NCT02060409|spliceosome mutation|spliceosome mutation
5325382|NCT02060383|Cushing's disease|cushing's disease
5325383|NCT02060383|acromegaly|acromegaly
5325384|NCT02060383|pasireotide|pasireotide
5325385|NCT02060383|hyperglycemia|hyperglycemia
5325396|NCT02060357|Diabetes Mellitus|diabetes mellitus
5325397|NCT02060357|PCI|pci
5325398|NCT02060357|Drug eluting stent|drug eluting stent
5325399|NCT02060357|OCT|oct
5325400|NCT02060344|Cardiovascular Disease|cardiovascular disease
5325401|NCT02060344|Hispanic|hispanic
5325402|NCT02060344|Latinos|latinos
5325403|NCT02060331|Nocturia|nocturia
5325404|NCT02060331|Pelvic Organ Prolapse|pelvic organ prolapse
5325405|NCT02060331|Nocturnal Polyuria|nocturnal polyuria
5325406|NCT02060331|Post-obstructive Diuresis|post-obstructive diuresis
5325407|NCT02060318|Crohn Disease|crohn disease
5325408|NCT02060318|Regulatory T-cells|regulatory t-cells
5325409|NCT02060318|Infliximab|infliximab
5325410|NCT02060292|COPD|copd
5325411|NCT02060292|Cognitive Function|cognitive function
5325412|NCT02060292|MRI Brain|mri brain
5325413|NCT02060292|Aortic Stiffness|aortic stiffness
5325414|NCT02060292|Cerebrovascular disease|cerebrovascular disease
5325415|NCT02060279|Obesity|obesity
5325416|NCT02060279|Diabetes Mellitus|diabetes mellitus
5325417|NCT02060279|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5325418|NCT02060279|Prevention|prevention
5325419|NCT02060279|Behavioral research|behavioral research
5325420|NCT02060279|Metabolic Syndrome|metabolic syndrome
5325421|NCT02060279|Metabolic Disease|metabolic disease
5325422|NCT02060279|Overnutrition|overnutrition
5325423|NCT02060279|Nutrition Disorders|nutrition disorders
5325424|NCT02060279|Overweight|overweight
5325425|NCT02060279|Body weight|body weight
5325426|NCT02060279|Insulin resistance|insulin resistance
5325427|NCT02060279|Carotenoids|carotenoids
5325428|NCT02060279|Dietary Supplement|dietary supplement
5325429|NCT02060279|Physical fitness|physical fitness
5325430|NCT02060279|Sedentary lifestyle|sedentary lifestyle
5325431|NCT02060240|Obesity|obesity
5325432|NCT02060240|Prediabetic State|prediabetic state
5325433|NCT02060240|Sedentary Lifestyle|sedentary lifestyle
5325434|NCT02060240|Insulin Resistance|insulin resistance
5325435|NCT02060240|Endothelium|endothelium
5325436|NCT02060240|Eicosanoids|eicosanoids
5325437|NCT02060240|Nitric Oxide|nitric oxide
5325438|NCT02060240|Regional Blood Flow|regional blood flow
5325439|NCT02060175|Optical coherence tomography, Drug-eluting stent, Strut coverage|optical coherence tomography, drug-eluting stent, strut coverage
5325440|NCT02060162|antiretroviral therapy|antiretroviral therapy
5325441|NCT02060162|Hepatitis C virus|hepatitis c virus
5325442|NCT02060149|Extensively Drug Resistant A. Baumannii|extensively drug resistant a. baumannii
5325443|NCT02060136|Electronic micturition chart, validation|electronic micturition chart, validation
5325444|NCT02060123|Qigong|qigong
5325445|NCT02060123|Telomerase|telomerase
5325446|NCT02060123|Perceived stress|perceived stress
5325448|NCT02060123|Chinese|chinese
5325449|NCT02060123|Abused women|abused women
5325450|NCT02060123|intervention|intervention
5325451|NCT02060123|Depression|depression
5325452|NCT02060110|CRT|crt
5325453|NCT02060110|HEART FAILURE|heart failure
5325454|NCT02060097|Anti-aging|anti-aging
5325455|NCT02060097|High-flavanol cocoa|high-flavanol cocoa
5325456|NCT02060084|preterm;|preterm;
5325457|NCT02060084|Intestinal flora;|intestinal flora;
5325458|NCT02060084|early Micro-feeding|early micro-feeding
5325459|NCT02060084|Feeding intolerance|feeding intolerance
5325460|NCT02060071|aortic stenosis|aortic stenosis
5325461|NCT02060058|hepatitis C virus|hepatitis c virus
5325462|NCT02060058|hepatitis B virus|hepatitis b virus
5325463|NCT02060058|boceprevir|boceprevir
5325464|NCT02060058|null responder|null responder
5325465|NCT02060058|partial responder|partial responder
5325466|NCT02060058|relapser|relapser
5325467|NCT02060045|bundle|bundle
5325468|NCT02060045|prevention|prevention
5325469|NCT02060045|Disturbance; Heart, Functional, Postoperative, Cardiac Surgery|disturbance; heart, functional, postoperative, cardiac surgery
5325470|NCT02060032|Chronic periodontitis, Local drug delivery,|chronic periodontitis, local drug delivery,
5325471|NCT02060019|Pharmacokinetics|pharmacokinetics
5325472|NCT02060019|Pharmacodynamics|pharmacodynamics
5325473|NCT02060019|Safety|safety
5325474|NCT02060019|Tolerability|tolerability
5325476|NCT02060006|IRIS|iris
5325477|NCT02059993|continuous positive airway pressure|continuous positive airway pressure
5325478|NCT02059993|hypertension|hypertension
5325479|NCT02059993|coronary heart disease|coronary heart disease
5325480|NCT02059993|metabolic disorder|metabolic disorder
5325481|NCT02059993|obstructive sleep apnea|obstructive sleep apnea
5325483|NCT02059980|Trichotillomania|trichotillomania
5325484|NCT02059980|Response inhibition|response inhibition
5325485|NCT02059980|Cognitive training|cognitive training
5325486|NCT02059967|Lung|lung
5325487|NCT02059954|Hysterectomy|hysterectomy
5325488|NCT02059941|Severe traumatic brain injury, ICP, Latin America, outcomes|severe traumatic brain injury, icp, latin america, outcomes
5325489|NCT02059928|fluid resuscitation|fluid resuscitation
5325490|NCT02059928|invasive pressure monitoring|invasive pressure monitoring
5325491|NCT02059915|pharmacokinetics|pharmacokinetics
5325492|NCT02059915|bioequivalence|bioequivalence
5325493|NCT02059915|bioavailability|bioavailability
5325494|NCT02059915|oxycodone|oxycodone
5325495|NCT02059902|Pain management|pain management
5325496|NCT02059902|Narcotic consumption|narcotic consumption
5325497|NCT02059902|Skin graft|skin graft
5325498|NCT02059889|Lung|lung
5325499|NCT02059876|breast cancer|breast cancer
5325500|NCT02059876|dose dense|dose dense
5325501|NCT02059876|neoadjuvant treatment|neoadjuvant treatment
5325502|NCT02059876|pathologic complete response|pathologic complete response
5325503|NCT02059863|cluster randomised trial|cluster randomised trial
5325504|NCT02059863|low and middle income countries|low and middle income countries
5325505|NCT02059863|community based intervention|community based intervention
5325506|NCT02059863|complex intervention|complex intervention
5325507|NCT02059824|Eyelid sensation, aesthesiometer|eyelid sensation, aesthesiometer
5325508|NCT02059811|Kidney Diseases|kidney diseases
5325509|NCT02059811|Renal Insufficiency, Chronic|renal insufficiency, chronic
5325510|NCT02059811|Diet|diet
5325511|NCT02059811|DASH diet|dash diet
5325512|NCT02059811|Hypertension|hypertension
5325513|NCT02059811|Vascular diseases|vascular diseases
5325514|NCT02059811|Cardiovascular Diseases|cardiovascular diseases
5325515|NCT02059811|Blood pressure|blood pressure
5325516|NCT02059798|Myelopathy|myelopathy
5325517|NCT02059785|Pinocembrin for Injection|pinocembrin for injection
5325518|NCT02059785|Placebo|placebo
5325519|NCT02059785|mRS|mrs
5205651|NCT02709720|Lung Cancer|lung cancer
5325520|NCT02059759|low-dose interleukin 2|low-dose interleukin 2
5325521|NCT02059746|cesarean section|cesarean section
5325522|NCT02059746|vaginal birth|vaginal birth
5325523|NCT02059746|twins|twins
5325524|NCT02059746|urinary incontinence|urinary incontinence
5325525|NCT02059746|sexuality|sexuality
5325526|NCT02059746|quality of life|quality of life
5325527|NCT02059733|18F-DTBZ|18f-dtbz
5325528|NCT02059720|acute myeloid leukemia|acute myeloid leukemia
5325529|NCT02059720|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5325530|NCT02059720|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5325531|NCT02059720|maintenance treatment|maintenance treatment
5325532|NCT02059720|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5325533|NCT02059694|Eyelid surgery|eyelid surgery
5325534|NCT02059694|local block/anesthesia|local block/anesthesia
5325535|NCT02059694|hyaluronidase|hyaluronidase
5325536|NCT02059694|Bilateral upper eyelid surgery|bilateral upper eyelid surgery
5325537|NCT02059694|Duke Eye Centre|duke eye centre
5325538|NCT02059694|Duke Aesthetic Center|duke aesthetic center
5325539|NCT02059668|locally advanced head and neck cancer|locally advanced head and neck cancer
5325540|NCT02059668|biomarkers|biomarkers
5325541|NCT02059668|definitive treatment|definitive treatment
5325542|NCT02059668|adjuvant treatment|adjuvant treatment
5325543|NCT02059668|radiochemotherapy|radiochemotherapy
5325544|NCT02059655|Graves' disease|graves' disease
5325545|NCT02059629|Heart failure|heart failure
5325546|NCT02059629|Eluna pacemaker family|eluna pacemaker family
5325547|NCT02059629|Sentus OTW BP L left ventricular lead|sentus otw bp l left ventricular lead
5325548|NCT02059629|Bradycardia|bradycardia
5441195|NCT01540318|Trauma|trauma
5325549|NCT02059629|SADE-free rate|sade-free rate
5325550|NCT02059603|Electroacupuncture|electroacupuncture
5325551|NCT02059603|Fast track program|fast track program
5325552|NCT02059603|Postoperative ileus|postoperative ileus
5325553|NCT02059603|Laparoscopic surgery|laparoscopic surgery
5325554|NCT02059603|Colorectal surgery|colorectal surgery
5325555|NCT02059603|Randomized controlled trial|randomized controlled trial
5325556|NCT02059603|Hospital stay|hospital stay
5325557|NCT02059590|14C-labeled isavuconazonium sulfate|14c-labeled isavuconazonium sulfate
5325558|NCT02059590|Pyridinylmethyl-14C-labeled isavuconazonium sulfate|pyridinylmethyl-14c-labeled isavuconazonium sulfate
5325559|NCT02059590|Healthy Subjects|healthy subjects
5325561|NCT02059590|BAL4815|bal4815
5325562|NCT02059577|vitamins|vitamins
5325563|NCT02059577|minerals|minerals
5325564|NCT02059577|essential fatty acids|essential fatty acids
5325565|NCT02059577|Epsom salts|epsom salts
5325571|NCT02059564|Glucose Metabolism Disorders|glucose metabolism disorders
5325572|NCT02059564|Metabolic Diseases|metabolic diseases
5325573|NCT02059564|Endocrine System Diseases|endocrine system diseases
5325574|NCT02059564|Exendin-4|exendin-4
5325575|NCT02059551|pulmonary embolism|pulmonary embolism
5325580|NCT02059538|Type 2 diabetes|type 2 diabetes
5325581|NCT02059538|Coronary artery diseases|coronary artery diseases
5325582|NCT02059538|Microbiota|microbiota
5325583|NCT02059538|Omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)|omics (ie transcriptomics, metabolomics, metagenomics, lipidomics)
5325584|NCT02059525|observational|observational
5325585|NCT02059525|Belgium|belgium
5325586|NCT02059512|ischemic heart disease,|ischemic heart disease,
5325587|NCT02059512|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
5325588|NCT02059512|coronary artery bypass grafting|coronary artery bypass grafting
5325589|NCT02059460|Terlipressin|terlipressin
5325590|NCT02059460|Acute kidney injury|acute kidney injury
5325591|NCT02059460|Liver transplantation|liver transplantation
5325592|NCT02059460|NGAL|ngal
5325593|NCT02059447|Controlled trial|controlled trial
5325594|NCT02059447|Active control|active control
5325595|NCT02059447|Waiting, non treatment, period|waiting, non treatment, period
5325596|NCT02059447|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5325597|NCT02059447|Relaxation Therapy|relaxation therapy
5325598|NCT02059421|Johrei therapy|johrei therapy
5325599|NCT02059421|Sleep|sleep
5325600|NCT02059421|CBT-I|cbt-i
5325601|NCT02059421|Critical illness|critical illness
5325602|NCT02059382|daily physical activity|daily physical activity
5325603|NCT02059382|exercise|exercise
5325604|NCT02059382|social support|social support
5325605|NCT02059382|online social network|online social network
5325606|NCT02059369|Atrial fibrillation|atrial fibrillation
5325607|NCT02059369|Recurrence|recurrence
5325608|NCT02059369|CFAE|cfae
5325609|NCT02059369|linear ablation|linear ablation
5325610|NCT02059356|Dementia|dementia
5325611|NCT02059356|Alzheimer's|alzheimer's
5325612|NCT02059356|Alzheimers|alzheimers
5325613|NCT02059356|Cognitive decline|cognitive decline
5325614|NCT02059356|Cognitive impairment|cognitive impairment
5325615|NCT02059356|Memory loss|memory loss
5325616|NCT02059356|Memory disorder|memory disorder
5325617|NCT02059356|Forgetfulness|forgetfulness
5325618|NCT02059356|Confusion|confusion
5325619|NCT02059356|Senile|senile
5325620|NCT02059356|Demented|demented
5963253|NCT04262011|periodontal diseases|periodontal diseases
5205782|NCT02708797|MRI|mri
5325621|NCT02059356|Developmental delay|developmental delay
5325622|NCT02059356|Portal systemic shunting|portal systemic shunting
5325623|NCT02059356|High ammonia level|high ammonia level
5325624|NCT02059356|Elevated ammonia level|elevated ammonia level
5325625|NCT02059343|pharmacokinetics|pharmacokinetics
5325626|NCT02059343|pharmacodynamics|pharmacodynamics
5325627|NCT02059343|safety|safety
5325628|NCT02059343|dexmedetomidine|dexmedetomidine
5325629|NCT02059343|cardiopulmonary bypass|cardiopulmonary bypass
5325630|NCT02059343|children|children
5325631|NCT02059330|Japanese PK-Bridging Study|japanese pk-bridging study
5325632|NCT02059330|dose-proportionality study|dose-proportionality study
5325633|NCT02059330|Palbociclib|palbociclib
5325634|NCT02059330|PD-0332991|pd-0332991
5325635|NCT02059330|healthy volunteers|healthy volunteers
5325636|NCT02059304|cervical length|cervical length
5325637|NCT02059304|prediction of preterm delivery|prediction of preterm delivery
5325638|NCT02059291|Canakinumab, interleukin-1, Hereditary Periodic Fevers, auto-inflammatory diseases|canakinumab, interleukin-1, hereditary periodic fevers, auto-inflammatory diseases
5325639|NCT02059278|Primary open angle glaucoma|primary open angle glaucoma
5325640|NCT02059278|Ocular hypertension|ocular hypertension
5325645|NCT02059200|Randomised controlled trial|randomised controlled trial
5325646|NCT02059200|Recurrent depression|recurrent depression
5325647|NCT02059200|Mindfulness training|mindfulness training
5325648|NCT02059200|Compassion training (MBCL)|compassion training (mbcl)
5325649|NCT02059200|Fear of Compassion|fear of compassion
5325650|NCT02059200|Added value Compassion|added value compassion
5325651|NCT02059135|Preeclampsia|preeclampsia
5325652|NCT02059135|Preterm preeclampsia|preterm preeclampsia
5325653|NCT02059135|Pregnancy|pregnancy
5325654|NCT02059109|Belmont|belmont
5325655|NCT02059109|Rapid|rapid
5325656|NCT02059109|Infuser|infuser
5325657|NCT02059109|proficiency|proficiency
5325658|NCT02059109|proficient|proficient
5325659|NCT02059109|training|training
5325660|NCT02059096|Multiple Sclerosis|multiple sclerosis
5325661|NCT02059096|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5321983|NCT02075983|HIV|hiv
5325665|NCT02059083|cannabis|cannabis
5325666|NCT02059083|biofeedback|biofeedback
5325667|NCT02059070|Nerve Block/adverse effects|nerve block/adverse effects
5325668|NCT02059070|Phrenic Nerve|phrenic nerve
5325669|NCT02059070|Respiratory function|respiratory function
5325670|NCT02059070|Pain measurement|pain measurement
5325671|NCT02059044|patient safety|patient safety
5325672|NCT02059044|pharmacoepidemiology|pharmacoepidemiology
5325673|NCT02059044|health services research|health services research
5325674|NCT02059044|adherence|adherence
5325675|NCT02059044|information technology|information technology
5325676|NCT02059031|integrase inhibitor|integrase inhibitor
5325677|NCT02059031|pharmacokinetics|pharmacokinetics
5325678|NCT02059031|HIV|hiv
5325679|NCT02059031|relative bioavailability|relative bioavailability
5325680|NCT02059031|food|food
5325681|NCT02059031|GSK1265744|gsk1265744
5325682|NCT02059005|Addiction|addiction
5325683|NCT02059005|Substance Use Disorder|substance use disorder
5325684|NCT02059005|Rehospitalization|rehospitalization
5325685|NCT02059005|Community Disease Management|community disease management
5325686|NCT02059005|Behavioral Health|behavioral health
5325687|NCT02059005|Community Health Worker|community health worker
5325688|NCT02058992|Drug therapy|drug therapy
5325689|NCT02058966|Entacapone|entacapone
5325690|NCT02058966|COMT val158met|comt val158met
5325691|NCT02058966|Methamphetamine|methamphetamine
5325692|NCT02058953|Melanoma|melanoma
5325693|NCT02058953|skin cancer|skin cancer
5325694|NCT02058953|brain metastases|brain metastases
5325695|NCT02058953|craniotomy|craniotomy
5325696|NCT02058927|HIV|hiv
5325697|NCT02058927|ART|art
5325698|NCT02058927|children|children
5325699|NCT02058914|Sugar sweetened beverages|sugar sweetened beverages
5325700|NCT02058914|metabolism|metabolism
5325714|NCT02058836|Botulinum toxin|botulinum toxin
5325715|NCT02058836|Botox|botox
5325716|NCT02058836|Urology|urology
5325717|NCT02058823|Hypoxia|hypoxia
5325718|NCT02058823|Sleep apnea|sleep apnea
5325719|NCT02058823|Valsartan|valsartan
5325720|NCT02058823|Amlodipine|amlodipine
5325721|NCT02058823|Healthy subjects|healthy subjects
5325722|NCT02058823|Randomized|randomized
5325723|NCT02058823|Cross-over|cross-over
5325724|NCT02058823|International|international
5325725|NCT02058823|Sympathetic nervous system|sympathetic nervous system
5325726|NCT02058810|nasal high flow oxygen|nasal high flow oxygen
5325727|NCT02058810|cardio-renal syndrom|cardio-renal syndrom
5325728|NCT02058810|heartfailure|heartfailure
5325729|NCT02058797|Procrastination|procrastination
5325730|NCT02058797|Coherence Therapy|coherence therapy
5325731|NCT02058797|Cognitive Behavioral Therapy|cognitive behavioral therapy
5325732|NCT02058797|Repertory Grid Technique|repertory grid technique
5325733|NCT02058797|Cognitive Conflicts|cognitive conflicts
5325734|NCT02058797|Personal Dilemmas|personal dilemmas
5325735|NCT02058771|Action potential duration restitution|action potential duration restitution
5963254|NCT04262011|periodontitis|periodontitis
5963255|NCT04261088|Ethics|ethics
5205916|NCT02707861|HIV|hiv
5325736|NCT02058771|Ventricular arrhythmia|ventricular arrhythmia
5325737|NCT02058771|Sudden cardiac death|sudden cardiac death
5325738|NCT02058771|Body-surface potential mapping|body-surface potential mapping
5325739|NCT02058771|Electrocardiogram|electrocardiogram
5325740|NCT02058758|Breast cancer|breast cancer
5325741|NCT02058758|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5325742|NCT02058758|Diffusion weighted imaging|diffusion weighted imaging
5325743|NCT02058745|Neuro-oncology|neuro-oncology
5325744|NCT02058745|Caregivers|caregivers
5325745|NCT02058745|Intervention Research|intervention research
5325746|NCT02058745|Representational Approach|representational approach
5325747|NCT02058745|Cognitive Behavioral Therapy|cognitive behavioral therapy
5325748|NCT02058745|Family|family
5325749|NCT02058745|Internet|internet
5325750|NCT02058680|prostate specific antigen (PSA)|prostate specific antigen (psa)
5325751|NCT02058667|Breast Cancer|breast cancer
5325752|NCT02058667|Paclitaxel|paclitaxel
5325753|NCT02058667|Helical Tomotherapy|helical tomotherapy
5325754|NCT02058667|Chest wall|chest wall
5325755|NCT02058654|Creatine|creatine
5325756|NCT02058654|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5325757|NCT02058654|Phosphorus-31 magnetic resonance spectroscopy (31P-MRS)|phosphorus-31 magnetic resonance spectroscopy (31p-mrs)
5325758|NCT02058641|cellular accumulation|cellular accumulation
5325759|NCT02058641|macrophage phenotype|macrophage phenotype
5325760|NCT02058641|cantharidin blister|cantharidin blister
5325761|NCT02058641|M1/M2|m1/m2
5325762|NCT02058641|inflammatory mediators|inflammatory mediators
5325763|NCT02058641|Type 2 diabetes mellitus|type 2 diabetes mellitus
5325764|NCT02058641|darapladib|darapladib
5325765|NCT02058641|cytokines|cytokines
5325766|NCT02058628|azelaic acid|azelaic acid
5325767|NCT02058628|Clindamycin|clindamycin
5325768|NCT02058628|Benzoyl peroxide|benzoyl peroxide
5325769|NCT02058628|Acne vulgaris|acne vulgaris
5322079|NCT02075541|Safety|safety
5325770|NCT02058615|Male caregivers|male caregivers
5325771|NCT02058615|Breast cancer|breast cancer
5325772|NCT02058615|Intervention|intervention
5325773|NCT02058615|Online toolkit|online toolkit
5325775|NCT02058602|Airway morphometry|airway morphometry
5325776|NCT02058602|Resistivity|resistivity
5325777|NCT02058602|Inhalation Profiles|inhalation profiles
5325778|NCT02058602|Inhaler|inhaler
5325779|NCT02058602|Pharyngometry|pharyngometry
5325780|NCT02058602|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5325781|NCT02058589|Immunocompromised|immunocompromised
5325782|NCT02058589|Safety|safety
5325783|NCT02058589|≥ 18 years of age|≥ 18 years of age
5325784|NCT02058589|Renal transplant|renal transplant
5325785|NCT02058589|Adults|adults
5325786|NCT02058589|Immunosuppressed|immunosuppressed
5325787|NCT02058589|Immunogenicity|immunogenicity
5325788|NCT02058589|Herpes zoster|herpes zoster
5325789|NCT02058576|combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
5325790|NCT02058576|Tamsulosin|tamsulosin
5325791|NCT02058576|healthy subject|healthy subject
5325792|NCT02058576|bioequivalence|bioequivalence
5325793|NCT02058576|GI198745|gi198745
5325794|NCT02058576|dutasteride|dutasteride
5325795|NCT02058576|tamsulosin hydrochloride|tamsulosin hydrochloride
5325796|NCT02058563|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
5325798|NCT02058563|Immunogenicity|immunogenicity
5325799|NCT02058524|Ulcerative Colitis|ulcerative colitis
5325800|NCT02058524|Fecal Microbiota Transplantation|fecal microbiota transplantation
5325801|NCT02058498|Liver transplant|liver transplant
5325802|NCT02058498|Physical Activity|physical activity
5325803|NCT02058498|Quality of Life|quality of life
5325804|NCT02058485|hypertension|hypertension
5325805|NCT02058485|dexmedetomidine|dexmedetomidine
5325806|NCT02058485|midazolam|midazolam
5325807|NCT02058485|premedication|premedication
5326054|NCT02057263|Vaccine|vaccine
5325808|NCT02058459|Chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, Holaira|chronic obstructive pulmonary disease, targeted lung denervation, intervention, device, safety, lung function, holaira
5325809|NCT02058433|Chemotherapy|chemotherapy
5325810|NCT02058433|Individual Paclitaxel dose|individual paclitaxel dose
5325811|NCT02058433|pharmacokinetics|pharmacokinetics
5325812|NCT02058420|bone health|bone health
5325813|NCT02058407|food effect|food effect
5325814|NCT02058407|pharmacokinetics|pharmacokinetics
5325815|NCT02058407|GSK2793660|gsk2793660
5325816|NCT02058407|FTIH|ftih
5325817|NCT02058407|pharmacodynamics|pharmacodynamics
5325818|NCT02058407|safety|safety
5325819|NCT02058394|Retained nuclear lens fragments|retained nuclear lens fragments
5325820|NCT02058394|Phacoemulsification|phacoemulsification
5325821|NCT02058394|Cataract Surgery|cataract surgery
5325822|NCT02058368|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5325823|NCT02058368|Quality of Life|quality of life
5325824|NCT02058342|Prader Willi syndrome|prader willi syndrome
5325825|NCT02058342|Obesity|obesity
5963256|NCT04261088|Switzerland|switzerland
5325826|NCT02058342|Childhood|childhood
5325827|NCT02058342|Family|family
5325828|NCT02058342|Interactive games|interactive games
5325829|NCT02058342|Playground games|playground games
5325830|NCT02058342|Exercise routine|exercise routine
5325831|NCT02058329|Hip fracture|hip fracture
5325832|NCT02058329|postoperative complications|postoperative complications
5325833|NCT02058329|Depression|depression
5325834|NCT02058329|Environmental Hazards|environmental hazards
5325835|NCT02058329|FIM scores|fim scores
5325836|NCT02058329|Falls|falls
5325837|NCT02058303|hand surgery|hand surgery
5325838|NCT02058303|wrist surgery|wrist surgery
5325839|NCT02058303|finger surgery|finger surgery
5325840|NCT02058303|anesthesia|anesthesia
5325841|NCT02058303|regional anesthesia|regional anesthesia
5325842|NCT02058303|postoperative pain|postoperative pain
5325843|NCT02058290|laparoscopic colectomy|laparoscopic colectomy
5325844|NCT02058277|bosutinib|bosutinib
5325845|NCT02058277|aprepitant|aprepitant
5325846|NCT02058277|drug interaction|drug interaction
5325847|NCT02058277|healthy volunteers|healthy volunteers
5325848|NCT02058277|pharmacokinetics|pharmacokinetics
5325849|NCT02058277|chronic myelogenous leukemia|chronic myelogenous leukemia
5325850|NCT02058251|Alcohol|alcohol
5325851|NCT02058251|Oxytocin|oxytocin
5325852|NCT02058251|Stress reactivity|stress reactivity
5325853|NCT02058238|Robotic-guided spinal fusions|robotic-guided spinal fusions
5325854|NCT02058238|Scoliosis|scoliosis
5325855|NCT02058238|Kyphoscoliosis|kyphoscoliosis
5325856|NCT02058238|Spinal deformity|spinal deformity
5325857|NCT02058238|Spondylosis|spondylosis
5325858|NCT02058225|Infant Nutrition|infant nutrition
5325859|NCT02058225|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5325860|NCT02058225|Infant Brain Development|infant brain development
5325861|NCT02058225|Diffusion weighted Imaging|diffusion weighted imaging
5325862|NCT02058225|Diffusion tensor tractography|diffusion tensor tractography
5325863|NCT02058212|ICSI|icsi
5325864|NCT02058212|antioxidants|antioxidants
5325866|NCT02058212|endometriosis|endometriosis
5325867|NCT02058199|gastric bypass|gastric bypass
5325868|NCT02058199|rivaroxaban|rivaroxaban
5325870|NCT02058186|Atopic dermatitis, vitamin D supplementation, cathelicidin, Staphylococcus aureus colonization, SCORAD score|atopic dermatitis, vitamin d supplementation, cathelicidin, staphylococcus aureus colonization, scorad score
5325871|NCT02058121|Eating disorders|eating disorders
5325872|NCT02058121|Acceptance and Commitment Therapy|acceptance and commitment therapy
5325873|NCT02058121|Body image|body image
5325874|NCT02058108|Chronic hepatitis B, pediatrics, antiviral treatment, telbivudine|chronic hepatitis b, pediatrics, antiviral treatment, telbivudine
5325875|NCT02058082|Failure to Conceive Due to Infertility of Male Partner|failure to conceive due to infertility of male partner
5325876|NCT02058082|DNA Damage|dna damage
5330259|NCT02039180|phase I|phase i
5325878|NCT02058056|cranial irradiation|cranial irradiation
5325879|NCT02058056|hippocampal avoidance|hippocampal avoidance
5325880|NCT02058056|limited disease small-cell lung cancer|limited disease small-cell lung cancer
5325881|NCT02058030|ProSeal laryngeal mask airway|proseal laryngeal mask airway
5325882|NCT02058030|Insertion success|insertion success
5325883|NCT02058030|complication|complication
5325884|NCT02058004|Microaspiration|microaspiration
5325885|NCT02058004|ARDS|ards
5325886|NCT02058004|Hospital acquired pneumonia|hospital acquired pneumonia
5325887|NCT02058004|Cricoid pressure|cricoid pressure
5325888|NCT02057978|Late Lumen Loss|late lumen loss
5325889|NCT02057978|MACE|mace
5325890|NCT02057978|Death|death
5325891|NCT02057978|TLF|tlf
5325892|NCT02057978|Thrombosis(definite or probable )|thrombosis(definite or probable )
5325893|NCT02057965|Mesenchymal Stromal Cells|mesenchymal stromal cells
5325894|NCT02057965|Allograft rejection|allograft rejection
5325895|NCT02057965|Fibrosis|fibrosis
5325896|NCT02057952|Weight Management|weight management
5325897|NCT02057952|Diabetes|diabetes
5325898|NCT02057952|Exercise|exercise
5325899|NCT02057952|Portion Control|portion control
5325900|NCT02057952|Multiple Chronic Conditions|multiple chronic conditions
5325901|NCT02057939|Prostate cancer|prostate cancer
5325902|NCT02057939|enzalutamide|enzalutamide
5325903|NCT02057939|ADT|adt
5325904|NCT02057939|radiation|radiation
5325905|NCT02057926|Membrane degradation|membrane degradation
5325906|NCT02057926|Collagen membrane bio-durability|collagen membrane bio-durability
5325907|NCT02057913|Penile neoplasms|penile neoplasms
5325908|NCT02057913|Chemotherapy|chemotherapy
5325909|NCT02057913|Vinflunine|vinflunine
5325910|NCT02057913|Phase II|phase ii
5325911|NCT02057900|Postinfarction heart failure|postinfarction heart failure
5325912|NCT02057900|Transplantation of human embryonic stem cell-derived cardiac progenitors|transplantation of human embryonic stem cell-derived cardiac progenitors
5325913|NCT02057900|Tissue-engineered cellular graft|tissue-engineered cellular graft
5325914|NCT02057900|Fibrin hydrogel|fibrin hydrogel
5325915|NCT02057861|diabetes mellitus|diabetes mellitus
5325916|NCT02057861|neuromuscular blockade|neuromuscular blockade
5325917|NCT02057861|sugammadex|sugammadex
5325918|NCT02057848|carbohydrate, hypoglycemia|carbohydrate, hypoglycemia
5325919|NCT02057822|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5325920|NCT02057822|Cytokines|cytokines
5325921|NCT02057822|Mediators|mediators
5325922|NCT02057822|Tears|tears
5963257|NCT04261088|End of life|end of life
5325923|NCT02057809|Developmental Disabilities|developmental disabilities
5325924|NCT02057809|Family-centered services|family-centered services
5325925|NCT02057809|Pediatric rehabilitation|pediatric rehabilitation
5325926|NCT02057796|HIV-1|hiv-1
5325927|NCT02057796|Tuberculosis|tuberculosis
5325928|NCT02057796|Systematic empiric TB treatment|systematic empiric tb treatment
5325929|NCT02057796|ART|art
5325930|NCT02057796|TB diagnosis|tb diagnosis
5325931|NCT02057796|Xpert MTB/RIF®|xpert mtb/rif®
5325932|NCT02057796|Urine LAM|urine lam
5325933|NCT02057744|Robotic-guided surgery|robotic-guided surgery
5325934|NCT02057744|Minimally invasive spinal surgery|minimally invasive spinal surgery
5325935|NCT02057744|Spinal fusion|spinal fusion
5325936|NCT02057744|Pedicle screws|pedicle screws
5325937|NCT02057718|Bile duct diseases|bile duct diseases
5325938|NCT02057718|Intrahepatic Cholestasis|intrahepatic cholestasis
5325939|NCT02057718|Cholestasis|cholestasis
5325940|NCT02057718|PFIC|pfic
5325941|NCT02057718|Pruritus|pruritus
5325942|NCT02057718|Cholestatic Liver Disease|cholestatic liver disease
5325943|NCT02057705|MTM|mtm
5325944|NCT02057705|myotubular myopathy|myotubular myopathy
5325945|NCT02057705|X-linked centronuclear myopathy|x-linked centronuclear myopathy
5325946|NCT02057705|inherited myopathies|inherited myopathies
5325947|NCT02057705|neuromuscular diseases|neuromuscular diseases
5325948|NCT02057705|hypotonia|hypotonia
5325949|NCT02057705|genetic mutation|genetic mutation
5325950|NCT02057679|Acute cholecystitis.|acute cholecystitis.
5325951|NCT02057679|Amoxicillin clavulanic|amoxicillin clavulanic
5325952|NCT02057653|Goal-directed fluid management|goal-directed fluid management
5325953|NCT02057601|Local anaesthetic infiltration|local anaesthetic infiltration
5325954|NCT02057601|Fractured neck of femur|fractured neck of femur
5325955|NCT02057601|Postoperative pain|postoperative pain
5325956|NCT02057588|ablation|ablation
5325957|NCT02057575|Open Angle Glaucoma|open angle glaucoma
5325958|NCT02057575|Ocular Hypertension|ocular hypertension
5325959|NCT02057575|Intraocular Pressure|intraocular pressure
5325960|NCT02057575|AR13324|ar13324
5325961|NCT02057575|PG324|pg324
5325962|NCT02057562|Adenoma|adenoma
5325963|NCT02057562|Diverticular disease|diverticular disease
5325964|NCT02057562|Diverticulosis|diverticulosis
5325965|NCT02057562|Colorectal carcinoma|colorectal carcinoma
5325966|NCT02057562|Polyp|polyp
5325967|NCT02057536|estrogen receptor positive, aromatase inhibitors, exercise,|estrogen receptor positive, aromatase inhibitors, exercise,
5325968|NCT02057510|Head and Neck Cancer|head and neck cancer
5325969|NCT02057510|Radiation Therapy|radiation therapy
5325970|NCT02057484|long-term follow-up|long-term follow-up
5325971|NCT02057484|liver transplant|liver transplant
5325981|NCT02057471|Postoperative care|postoperative care
5325982|NCT02057471|Iron|iron
5325983|NCT02057471|Hematinics|hematinics
5325984|NCT02057471|Hepcidin|hepcidin
5325985|NCT02057471|Quality of life|quality of life
5325986|NCT02057471|Postoperative complications|postoperative complications
5325987|NCT02057458|arterial stiffness|arterial stiffness
5325988|NCT02057458|flow-mediated dilation|flow-mediated dilation
5325989|NCT02057458|endothelial function|endothelial function
5325990|NCT02057458|pulse wave velocity|pulse wave velocity
5325991|NCT02057458|inflammation|inflammation
5325992|NCT02057458|oxidative stress|oxidative stress
5325993|NCT02057458|pulmonary function test|pulmonary function test
5325994|NCT02057458|Cystic Fibrosis|cystic fibrosis
5325995|NCT02057458|Lung Disease|lung disease
5325996|NCT02057458|Nitric Oxide|nitric oxide
5325997|NCT02057458|Exercise Capacity|exercise capacity
5325999|NCT02057458|Muscle Function|muscle function
5326000|NCT02057458|Sildenafil|sildenafil
5326001|NCT02057458|Viagra|viagra
5326002|NCT02057458|Revatio|revatio
5326003|NCT02057445|cellular therapy|cellular therapy
5326004|NCT02057445|lymphoma|lymphoma
5326005|NCT02057445|lymphoproliferative disorder|lymphoproliferative disorder
5326006|NCT02057432|I-II Breast Cancer|i-ii breast cancer
5326007|NCT02057419|contraception|contraception
5326008|NCT02057419|contraceptive methods|contraceptive methods
5326009|NCT02057419|sexual lubricant|sexual lubricant
5326010|NCT02057419|user experience|user experience
5326011|NCT02057419|adherence|adherence
5326012|NCT02057419|User experience: impact on use of contraceptive methods|user experience: impact on use of contraceptive methods
5326013|NCT02057419|User experience: impact on use of sexual lubricants|user experience: impact on use of sexual lubricants
5326014|NCT02057393|Melanoma|melanoma
5326015|NCT02057393|Sentinel node biopsy|sentinel node biopsy
5326016|NCT02057393|Indocyanine green|indocyanine green
5326017|NCT02057393|Real time lymphangiography|real time lymphangiography
5326018|NCT02057380|Paclitaxel|paclitaxel
5326019|NCT02057380|Linsitinib|linsitinib
5326020|NCT02057380|OSI-774|osi-774
5326021|NCT02057380|Advanced Solid Tumor|advanced solid tumor
5326022|NCT02057380|Tarceva|tarceva
5326023|NCT02057380|Erlotinib|erlotinib
5326024|NCT02057380|OSI-906|osi-906
5326025|NCT02057367|supratentorial brain tumour|supratentorial brain tumour
5326026|NCT02057367|craniotomy|craniotomy
5326027|NCT02057354|Brain|brain
5326028|NCT02057354|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5326029|NCT02057354|Brain Mapping|brain mapping
5326030|NCT02057354|Cognition|cognition
5326031|NCT02057354|Exercise|exercise
5326032|NCT02057354|Hippocampus|hippocampus
5326033|NCT02057354|Hydrocortisone|hydrocortisone
5326034|NCT02057354|Learning|learning
5326035|NCT02057354|Memory|memory
5326036|NCT02057354|Magnetic Resonance Imaging|magnetic resonance imaging
5326037|NCT02057354|Nerve Growth Factors|nerve growth factors
5326038|NCT02057354|Neuroimaging|neuroimaging
5326039|NCT02057354|Physical Endurance|physical endurance
5326040|NCT02057354|Physical Fitness|physical fitness
5326041|NCT02057354|Resistance Training|resistance training
5326042|NCT02057354|Walking|walking
5326043|NCT02057341|laminopathy|laminopathy
5326044|NCT02057315|Migraine headache|migraine headache
5326045|NCT02057315|Photophobia|photophobia
5326046|NCT02057315|Phonophobia|phonophobia
5326047|NCT02057315|Aura|aura
5326048|NCT02057315|Topical treatment|topical treatment
5326049|NCT02057302|Xuezhikang Dyslipidemia chinese medicine RCT|xuezhikang dyslipidemia chinese medicine rct
5326050|NCT02057289|pediatric|pediatric
5326051|NCT02057289|antifungal|antifungal
5326052|NCT02057289|bone marrow|bone marrow
5326053|NCT02057289|AML or relapsed ALL|aml or relapsed all
5326055|NCT02057263|Adjuvant|adjuvant
5326056|NCT02057263|Bisphosphonates|bisphosphonates
5326057|NCT02057263|Alendronate|alendronate
5326058|NCT02057263|Hepatitis B vaccine|hepatitis b vaccine
5326059|NCT02057224|Renal denervation|renal denervation
5326060|NCT02057224|Hypertension|hypertension
5326061|NCT02057224|Insulin resistance|insulin resistance
5326062|NCT02057224|Adipose tissue function|adipose tissue function
5326063|NCT02057185|Chronic Hematological Diseases|chronic hematological diseases
5326064|NCT02057185|work|work
5326066|NCT02057172|glycaemic control|glycaemic control
5326067|NCT02057172|HM11260C|hm11260c
5326068|NCT02057172|placebo|placebo
5326069|NCT02057172|safety|safety
5326070|NCT02057172|tolerability|tolerability
5326071|NCT02057172|type 2 diabetes mellitus|type 2 diabetes mellitus
5326072|NCT02057172|efficacy|efficacy
5326073|NCT02057172|T2DM|t2dm
5326074|NCT02057172|glycated haemoglobin (HbA1c)|glycated haemoglobin (hba1c)
5326075|NCT02057172|glycosylated haemoglobin (HbA1c)|glycosylated haemoglobin (hba1c)
5326076|NCT02057172|Glucagon-Like Peptide-1 (GLP-1) agonists|glucagon-like peptide-1 (glp-1) agonists
5326078|NCT02057172|fasting plasma glucose (FPG)|fasting plasma glucose (fpg)
5326079|NCT02057159|Secondary Progress Multiple Sclerosis|secondary progress multiple sclerosis
5326080|NCT02057159|SPMS|spms
5326081|NCT02057159|Multiple Sclerosis|multiple sclerosis
5326082|NCT02057159|NeuroVax|neurovax
5326083|NCT02057146|PSC|psc
5326084|NCT02057146|mother-baby endoscopy|mother-baby endoscopy
5326085|NCT02057146|ERCP|ercp
5326086|NCT02057146|IPMN|ipmn
5326087|NCT02057120|Kinesio Taping, Soccer, Hop Test, Electromyography, Athletic Performance, Muscle Strength Dynamometer|kinesio taping, soccer, hop test, electromyography, athletic performance, muscle strength dynamometer
5326088|NCT02057081|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5326089|NCT02057081|Mild Traumatic Brain Injury|mild traumatic brain injury
5326090|NCT02057081|Veterans Health|veterans health
5326091|NCT02057081|Veterans|veterans
5326092|NCT02057081|Spouses|spouses
5326093|NCT02057081|Couples|couples
5326094|NCT02057081|Psychotherapy, Group|psychotherapy, group
5326095|NCT02057081|Depression|depression
5326096|NCT02057081|Couples Therapy|couples therapy
5326097|NCT02057081|Family Therapy|family therapy
5326098|NCT02057081|PTSD|ptsd
5326099|NCT02057081|posttraumatic stress disorder|posttraumatic stress disorder
5326100|NCT02057068|Caregivers|caregivers
5326101|NCT02057068|Telemedicine|telemedicine
5326102|NCT02057068|Sleep Disorders|sleep disorders
5326103|NCT02057068|Meditation|meditation
5326104|NCT02057068|Cognitive Behavioral Therapy|cognitive behavioral therapy
5326105|NCT02057068|Activity Enhancement|activity enhancement
5326106|NCT02057068|Technology|technology
5326107|NCT02057068|Non-pharmacological sleep intervention|non-pharmacological sleep intervention
5326108|NCT02057055|Antibacterial soaps|antibacterial soaps
5326109|NCT02057055|Microbiome|microbiome
5326110|NCT02057055|Commensal bacteria|commensal bacteria
5326111|NCT02057055|Pyrosequencing|pyrosequencing
5326112|NCT02057055|Innate immunity|innate immunity
5326113|NCT02057042|Peer Support|peer support
5326114|NCT02057042|cCBT|ccbt
5326115|NCT02057042|primary care|primary care
5326116|NCT02057029|Estrogen Receptor (ER) Positive|estrogen receptor (er) positive
5326117|NCT02057029|Early Stage Breast Cancer|early stage breast cancer
5326118|NCT02057029|Breast Cancer Index|breast cancer index
5326119|NCT02057003|HIV|hiv
5326120|NCT02057003|hepatitis C virus|hepatitis c virus
5326121|NCT02057003|sustained virologic response|sustained virologic response
5326122|NCT02057003|telaprevir|telaprevir
5326123|NCT02057003|boceprevir|boceprevir
5326124|NCT02057003|simeprevir|simeprevir
5326125|NCT02057003|sofosbuvir|sofosbuvir
5326126|NCT02057003|daclatasvir|daclatasvir
5326127|NCT02057003|paritaprevir|paritaprevir
5326128|NCT02057003|pegylated interferon|pegylated interferon
5326129|NCT02057003|ribavirin|ribavirin
5326130|NCT02057003|direct-acting antivirals|direct-acting antivirals
5326131|NCT02057003|dasabuvir|dasabuvir
5326132|NCT02057003|ombitasvir|ombitasvir
5326133|NCT02057003|ledipasvir|ledipasvir
5326134|NCT02057003|velpatasvir|velpatasvir
5326135|NCT02057003|grazoprevir|grazoprevir
5326136|NCT02057003|elbasvir|elbasvir
5326137|NCT02056990|Athletes|athletes
5326138|NCT02056977|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5326139|NCT02056977|Cardiac Surgical Procedure|cardiac surgical procedure
5326140|NCT02056977|Mechanical Ventilation|mechanical ventilation
5326141|NCT02056977|Postoperative Complications|postoperative complications
5326142|NCT02056977|Positive End-Expiratory Pressure|positive end-expiratory pressure
5326143|NCT02056977|Lung Collapse|lung collapse
5326144|NCT02056977|Respiratory Failure|respiratory failure
5326145|NCT02056977|Electrical Impedance Tomography|electrical impedance tomography
5326146|NCT02056964|Acute Coronary Syndrome|acute coronary syndrome
5326147|NCT02056964|Chest Pain|chest pain
5326148|NCT02056964|Risk Stratification|risk stratification
5326149|NCT02056964|Clinical Decision Aid|clinical decision aid
5326150|NCT02056964|Emergency Department|emergency department
5326151|NCT02056964|Low Risk Chest Pain|low risk chest pain
5326152|NCT02056964|Non Cardiac Chest Pain|non cardiac chest pain
5326153|NCT02056951|Rehabilitation|rehabilitation
5326154|NCT02056951|Treatment Outcome|treatment outcome
5326155|NCT02056951|Interprofessional Relations|interprofessional relations
5326156|NCT02056951|Interdisciplinary Communication|interdisciplinary communication
5326157|NCT02056951|Behavioural Exercise Therapy|behavioural exercise therapy
5326158|NCT02056951|Cognitive Therapy|cognitive therapy
5326159|NCT02056951|Health Education|health education
5326160|NCT02056951|Workplace related information|workplace related information
5326161|NCT02056951|Multicenter Study|multicenter study
5326162|NCT02056938|Transplantation|transplantation
5326165|NCT02056938|induction therapy|induction therapy
5326166|NCT02056938|personalized medicine|personalized medicine
5326167|NCT02056938|First kidney transplantation|first kidney transplantation
5326168|NCT02056938|No anti HLA immunization prior transplantation|no anti hla immunization prior transplantation
5326169|NCT02056938|Risk of DGF higher than 40% calculated byt he score DGFS|risk of dgf higher than 40% calculated byt he score dgfs
5326172|NCT02056912|inborn error of metabolism|inborn error of metabolism
5326173|NCT02056899|Preterm labor, premature birth, gabapentin|preterm labor, premature birth, gabapentin
5326174|NCT02056886|breast cancer, sentinel lymph node, extemporaneous, OSNA|breast cancer, sentinel lymph node, extemporaneous, osna
5326175|NCT02056873|deep brain stimulation|deep brain stimulation
5326178|NCT02056873|tourette's|tourette's
5326179|NCT02056873|tourette syndrome|tourette syndrome
5326180|NCT02056873|TS|ts
5326181|NCT02056860|cystic fibrosis|cystic fibrosis
5326182|NCT02056847|Livalo, pitavastatin, hyperlipidemia, IFG|livalo, pitavastatin, hyperlipidemia, ifg
5326183|NCT02056821|stroke|stroke
5326184|NCT02056821|transcranial doppler|transcranial doppler
5326185|NCT02056821|cerebral blood flow|cerebral blood flow
5326186|NCT02056821|cardiac output|cardiac output
5326187|NCT02056821|non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
5326188|NCT02056782|Acute Myeloid Leukemia|acute myeloid leukemia
5326189|NCT02056782|AML|aml
5326190|NCT02056782|ODSH|odsh
5326191|NCT02056782|ODSH-AML|odsh-aml
5326192|NCT02056782|Cantex|cantex
5326193|NCT02056756|REFRACTORY OR RELAPSED|refractory or relapsed
5326194|NCT02056756|CBD|cbd
5326195|NCT02056730|chronic hemodialysis patients|chronic hemodialysis patients
5326196|NCT02056730|Hyperparathyroidism|hyperparathyroidism
5326197|NCT02056730|Regpara|regpara
5326198|NCT02056730|FGF 23|fgf 23
5326199|NCT02056704|Dialysis Fistula|dialysis fistula
5326200|NCT02056704|Dialysis Graft|dialysis graft
5326201|NCT02056704|Stenosis|stenosis
5326202|NCT02056704|Intravascular Ultrasound|intravascular ultrasound
5326203|NCT02056704|Angiography|angiography
5326204|NCT02056691|Resectable|resectable
5326205|NCT02056691|non-metastatic|non-metastatic
5326206|NCT02056691|colorectal|colorectal
5326207|NCT02056691|carcinoma|carcinoma
5326208|NCT02056691|cancer|cancer
5326209|NCT02056691|neoplasm|neoplasm
5326210|NCT02056691|exercise|exercise
5326211|NCT02056691|effects|effects
5326212|NCT02056691|program|program
5326213|NCT02056691|pre-operative|pre-operative
5326214|NCT02056691|proliferation|proliferation
5326215|NCT02056691|diagnosed|diagnosed
5326216|NCT02056691|surgery|surgery
5326217|NCT02056691|biopsy|biopsy
5326218|NCT02056691|muscle|muscle
5326219|NCT02056691|signalling|signalling
5326220|NCT02056691|IGF1|igf1
5326221|NCT02056691|ki67|ki67
5326222|NCT02056691|p53|p53
5326223|NCT02056691|response|response
5326224|NCT02056691|training|training
5326225|NCT02056691|biochemical|biochemical
5326226|NCT02056691|pathways|pathways
5326227|NCT02056691|glucose|glucose
5326228|NCT02056678|cholecystitis|cholecystitis
5326229|NCT02056678|cholelithiasis|cholelithiasis
5326230|NCT02056678|obstructive sleep apnea|obstructive sleep apnea
5326231|NCT02056678|acetaminophen|acetaminophen
5326232|NCT02056665|Angelman Syndrome|angelman syndrome
5326233|NCT02056665|EFFICACY|efficacy
5326234|NCT02056665|SAFETY|safety
5326235|NCT02056665|MINOCYCLINE|minocycline
5963258|NCT04261088|Assisted Death|assisted death
5326236|NCT02056665|Pediatrics population|pediatrics population
5326237|NCT02056665|Rare diseases|rare diseases
5326238|NCT02056652|Preterm birth|preterm birth
5326239|NCT02056652|Preterm delivery|preterm delivery
5326240|NCT02056652|short cervix|short cervix
5326241|NCT02056652|pessary|pessary
5326242|NCT02056639|Premature birth|premature birth
5326243|NCT02056639|Premature delivery|premature delivery
5326244|NCT02056639|Short cervix|short cervix
5326245|NCT02056639|Pessary|pessary
5326246|NCT02056626|hypertension|hypertension
5326247|NCT02056613|Blood Donation|blood donation
5326248|NCT02056613|Tissue Procurement|tissue procurement
5326249|NCT02056613|Cellular Therapies|cellular therapies
5326250|NCT02056587|renal cell carcinoma|renal cell carcinoma
5326251|NCT02056587|kidney cancer|kidney cancer
5326252|NCT02056587|bevacizumab failure|bevacizumab failure
5326253|NCT02056587|everolimus|everolimus
5326254|NCT02056574|Endovascular repair|endovascular repair
5326255|NCT02056574|Subarachnoid hemorrhage|subarachnoid hemorrhage
5326256|NCT02056574|Ruptured intracranial aneurysm|ruptured intracranial aneurysm
5326257|NCT02056574|Stroke|stroke
5326258|NCT02056574|Coiling|coiling
5326259|NCT02056574|NA-1|na-1
5326260|NCT02056561|Anesthesia|anesthesia
5326261|NCT02056561|Oxidants|oxidants
5326262|NCT02056561|Antioxidants|antioxidants
5326263|NCT02056548|preemptive antiviral treatment|preemptive antiviral treatment
5326264|NCT02056548|lymphoma|lymphoma
5327451|NCT02051140|Cognition|cognition
5326265|NCT02056548|chronic hepatitis B|chronic hepatitis b
5326266|NCT02056535|Alcohol|alcohol
5326267|NCT02056535|SBIRT (Screening, Brief Intervention, Referral to Treatment)|sbirt (screening, brief intervention, referral to treatment)
5326268|NCT02056522|Melanoma|melanoma
5326269|NCT02056522|Skin Cancer|skin cancer
5326270|NCT02056509|cardiopulmonary resuscitation,Ventilation|cardiopulmonary resuscitation,ventilation
5326271|NCT02056496|Pomegranate|pomegranate
5322620|NCT02073110|OCT|oct
5326273|NCT02056496|Pharmacokinetics|pharmacokinetics
5326274|NCT02056496|Urolithins|urolithins
5326275|NCT02056496|Bioavailability|bioavailability
5326276|NCT02056483|neoplasms|neoplasms
5326277|NCT02056483|rehabilitation|rehabilitation
5326278|NCT02056483|anxiety|anxiety
5326279|NCT02056483|depression|depression
5326280|NCT02056483|adverse effects|adverse effects
5326281|NCT02056483|health behavior|health behavior
5326282|NCT02056457|Responsible fatherhood|responsible fatherhood
5326283|NCT02056457|Healthy marriage|healthy marriage
5326284|NCT02056457|Healthy relationships|healthy relationships
5326285|NCT02056457|Parenting|parenting
5326286|NCT02056457|Economic self-sufficiency|economic self-sufficiency
5326287|NCT02056444|Blood conservation|blood conservation
5326288|NCT02056444|Tranexamic acid|tranexamic acid
5326289|NCT02056444|Total hip arthroplasty|total hip arthroplasty
5326290|NCT02056431|Diabetes|diabetes
5326291|NCT02056431|Neuropathy|neuropathy
5326292|NCT02056431|Patient-Reported Outcomes|patient-reported outcomes
5326293|NCT02056405|Postoperative Ileus|postoperative ileus
5326294|NCT02056405|Mosapride|mosapride
5326295|NCT02056405|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
5326296|NCT02056405|Prolonged postoperative ileus|prolonged postoperative ileus
5326297|NCT02056392|Phase I, healthy, pharmacokinetics|phase i, healthy, pharmacokinetics
5326298|NCT02056379|stridor|stridor
5326299|NCT02056379|laryngitis|laryngitis
5326300|NCT02056379|budesonide|budesonide
5326301|NCT02056379|dexamethasone|dexamethasone
5326302|NCT02056379|children|children
5326303|NCT02056366|Cardiac Autonomic Neuropathy|cardiac autonomic neuropathy
5326304|NCT02056353|Software|software
5326305|NCT02056353|Algorithm|algorithm
5326306|NCT02056353|Cardiac surgery|cardiac surgery
5326307|NCT02056327|Oral Appliance|oral appliance
5326308|NCT02056262|Bacteria|bacteria
5326309|NCT02056262|microbial community|microbial community
5326310|NCT02056262|hygiene|hygiene
5326311|NCT02056249|hypoglycemia|hypoglycemia
5326312|NCT02056249|Positron Emission Tomography|positron emission tomography
5326313|NCT02056249|norepinephrine transporter|norepinephrine transporter
5326314|NCT02056236|Cardiac arrest|cardiac arrest
5326315|NCT02056236|Postanoxic encephalopathy|postanoxic encephalopathy
5326316|NCT02056236|Electroencephalographic status epilepticus|electroencephalographic status epilepticus
5326317|NCT02056236|EEG monitoring|eeg monitoring
5326318|NCT02056236|Anti-epileptic drugs|anti-epileptic drugs
5326319|NCT02056223|Patent ductus arteriosus|patent ductus arteriosus
5326320|NCT02056223|Preterm infant|preterm infant
5326321|NCT02056223|Paracetamol|paracetamol
5326322|NCT02056223|Ibuprofen|ibuprofen
5326323|NCT02056210|Stem cells|stem cells
5326324|NCT02056210|Bone marrow|bone marrow
5326325|NCT02056171|delirium|delirium
5326326|NCT02056171|pediatrics|pediatrics
5326327|NCT02056171|critical care|critical care
5326328|NCT02056171|quetiapine|quetiapine
5326329|NCT02056158|HIV|hiv
5326330|NCT02056158|COPD|copd
5326331|NCT02056158|Emphysema|emphysema
5326332|NCT02056158|Smoking|smoking
5326333|NCT02056119|Ventilators, mechanical|ventilators, mechanical
5326334|NCT02056119|Aerosol Drug Therapy|aerosol drug therapy
5326335|NCT02056119|Nebulizers|nebulizers
5206499|NCT02704130|MWA|mwa
5326336|NCT02056119|Equipment Contamination|equipment contamination
5326337|NCT02056119|vibrating mesh nebulizer|vibrating mesh nebulizer
5326338|NCT02056119|jet nebulizer|jet nebulizer
5326339|NCT02056119|mechanical ventilation|mechanical ventilation
5326340|NCT02056119|ventilator associated event|ventilator associated event
5326341|NCT02056119|ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
5326342|NCT02056106|depression, Uganda, HIV, task-shifting, condom use, adherence|depression, uganda, hiv, task-shifting, condom use, adherence
5326343|NCT02056093|NAVA - PAV- Breathing Variability - Asynchrony|nava - pav- breathing variability - asynchrony
5326344|NCT02056080|Breast Neoplasm|breast neoplasm
5326345|NCT02056080|Receptor,HER2|receptor,her2
5326346|NCT02056080|Antineoplastic agent|antineoplastic agent
5326347|NCT02056080|Antibodies, monoclonal|antibodies, monoclonal
5326348|NCT02056080|Trastuzumab, Lapatinib|trastuzumab, lapatinib
5326349|NCT02056080|Protein kinase inhibitors|protein kinase inhibitors
5326350|NCT02056080|quinazolines|quinazolines
5326351|NCT02056054|Autoimmune hepatitis|autoimmune hepatitis
5326352|NCT02056054|Liver transplantation|liver transplantation
5326353|NCT02056054|Hepatitis C|hepatitis c
5326354|NCT02056002|Peer-driven intervention|peer-driven intervention
5326355|NCT02056002|Interactive voice response system|interactive voice response system
5326356|NCT02056002|Continuous Positive Airway Pressure therapy and adherence|continuous positive airway pressure therapy and adherence
5326357|NCT02055976|PF-04950615|pf-04950615
5326358|NCT02055976|Japan|japan
5326359|NCT02055963|Head And Neck Cancer|head and neck cancer
5326463|NCT02055573|Abusive Head Trauma|abusive head trauma
5326360|NCT02055963|Postsurgical symptom reduction|postsurgical symptom reduction
5326361|NCT02055963|Minocycline|minocycline
5326362|NCT02055963|Dynacin|dynacin
5326363|NCT02055963|Minocin|minocin
5326364|NCT02055963|Minocin PAC|minocin pac
5326365|NCT02055963|Myrac|myrac
5326366|NCT02055963|Solodyn|solodyn
5326367|NCT02055963|Placebo|placebo
5326368|NCT02055963|Sugar pill|sugar pill
5326369|NCT02055963|Questionnaires|questionnaires
5326371|NCT02055950|Kidney transplant|kidney transplant
5326372|NCT02055950|Marginal donors|marginal donors
5326373|NCT02055950|Pulse perfusion|pulse perfusion
5326374|NCT02055950|Graft function|graft function
5326375|NCT02055937|mastectomy, reconstruction|mastectomy, reconstruction
5326376|NCT02055924|Bruton's tyrosine kinase (BTK) Inhibition in B-cell Lymphomas|bruton's tyrosine kinase (btk) inhibition in b-cell lymphomas
5326377|NCT02055911|diabetic macular edema|diabetic macular edema
5326378|NCT02055911|intravitreal ranibizumab|intravitreal ranibizumab
5326379|NCT02055911|f retinal ganglion cell|f retinal ganglion cell
5326380|NCT02055872|Edema|edema
5326381|NCT02055872|Hypoproteinemia|hypoproteinemia
5326382|NCT02055872|Albumin|albumin
5326383|NCT02055872|Diuresis|diuresis
5326384|NCT02055872|Critical illness|critical illness
5326385|NCT02055859|acoustic neuromas|acoustic neuromas
5326386|NCT02055859|radiosurgery|radiosurgery
5326387|NCT02055859|hearing preservation|hearing preservation
5326388|NCT02055846|Androgen-independent prostate cancer|androgen-independent prostate cancer
5326389|NCT02055807|Atelectasis|atelectasis
5326390|NCT02055807|Ultrasound|ultrasound
5326391|NCT02055807|Recruitment maneuver|recruitment maneuver
5326392|NCT02055807|Positive end-expiratory pressure|positive end-expiratory pressure
5326393|NCT02055794|perineal wound|perineal wound
5326394|NCT02055794|perineal tear|perineal tear
5326395|NCT02055794|perineum|perineum
5326396|NCT02055794|pain|pain
5326397|NCT02055794|childbirth|childbirth
5326398|NCT02055781|Myelofibrosis|myelofibrosis
5326399|NCT02055781|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5326400|NCT02055781|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5326401|NCT02055781|Primary Myelofibrosis|primary myelofibrosis
5326402|NCT02055781|Polycythemia|polycythemia
5326403|NCT02055781|Polycythemia Vera|polycythemia vera
5326404|NCT02055781|Thrombocythemia, Essential|thrombocythemia, essential
5326405|NCT02055781|Thrombocythemia|thrombocythemia
5326406|NCT02055781|Myeloproliferative Disorders|myeloproliferative disorders
5326407|NCT02055781|Bone Marrow Disease|bone marrow disease
5326408|NCT02055781|Hematologic Diseases|hematologic diseases
5326409|NCT02055781|Blood Platelet Disorders|blood platelet disorders
5326410|NCT02055781|Hemorrhagic Disorders|hemorrhagic disorders
5326411|NCT02055781|Splenomegaly|splenomegaly
5326412|NCT02055781|Pacritinib|pacritinib
5326413|NCT02055781|MPN-SAF|mpn-saf
5326414|NCT02055781|MPN-SAF TSS|mpn-saf tss
5326415|NCT02055781|Anemia|anemia
5326416|NCT02055781|Myeloproliferative|myeloproliferative
5326417|NCT02055781|Myeloproliferative Neoplasm|myeloproliferative neoplasm
5326418|NCT02055781|Spleen|spleen
5326419|NCT02055781|Spleen volume|spleen volume
5326420|NCT02055781|Thrombocytopenia|thrombocytopenia
5326421|NCT02055781|SB1518|sb1518
5326422|NCT02055755|Diabetes|diabetes
5326423|NCT02055755|Wounds|wounds
5326424|NCT02055755|Wound Healing|wound healing
5326425|NCT02055755|Diabetic Foot Ulcer|diabetic foot ulcer
5326426|NCT02055755|DFU|dfu
5326427|NCT02055755|Clinical Decision Support|clinical decision support
5963259|NCT04260971|Essential Tremor|essential tremor
5326428|NCT02055729|bedsore|bedsore
5326429|NCT02055729|bacteria|bacteria
5326430|NCT02055729|colonization|colonization
5326431|NCT02055729|ecology|ecology
5326432|NCT02055703|Healthy Subjects|healthy subjects
5326433|NCT02055690|Advanced Recurrent Ovarian Cancer|advanced recurrent ovarian cancer
5326434|NCT02055690|Pazopanib|pazopanib
5326435|NCT02055690|Votrient|votrient
5326436|NCT02055690|Fosbretabulin|fosbretabulin
5326437|NCT02055677|personality profiles|personality profiles
5326438|NCT02055677|values|values
5326439|NCT02055677|empathy|empathy
5326440|NCT02055677|quality of life|quality of life
5326441|NCT02055677|vegetarians|vegetarians
5326442|NCT02055677|vegans|vegans
5326443|NCT02055651|Worksite|worksite
5326444|NCT02055651|Cardiovascular|cardiovascular
5326445|NCT02055651|Epidemiology|epidemiology
5326446|NCT02055651|Risk factors|risk factors
5326447|NCT02055638|Intermittent Explosive Disorder|intermittent explosive disorder
5326448|NCT02055638|IED|ied
5326449|NCT02055638|Aggression|aggression
5326450|NCT02055638|SRX246|srx246
5326451|NCT02055638|Vasopressin 1a Receptor Antagonist|vasopressin 1a receptor antagonist
5326452|NCT02055638|V1a|v1a
5326453|NCT02055625|Graft-versus-host-disease|graft-versus-host-disease
5326454|NCT02055625|Immune system diseases|immune system diseases
5326455|NCT02055625|Oral|oral
5326456|NCT02055612|wet AMD|wet amd
5326457|NCT02055612|epidemiology|epidemiology
5326458|NCT02055599|Wound|wound
5326459|NCT02055599|Wound Healing|wound healing
5326460|NCT02055599|Pressure Ulcers|pressure ulcers
5326471|NCT02055560|pharmacokinetics|pharmacokinetics
5326472|NCT02055560|exposure|exposure
5326473|NCT02055560|optimization|optimization
5326474|NCT02055560|dose adjustment|dose adjustment
5326475|NCT02055521|Composite tissue allograft|composite tissue allograft
5326476|NCT02055521|operational tolerance|operational tolerance
5326477|NCT02055521|skin rejection|skin rejection
5326478|NCT02055521|Hand and Face allotransplantation|hand and face allotransplantation
5326486|NCT02055495|Subtalar arthroeresis|subtalar arthroeresis
5326487|NCT02055495|Lateral column lengthening|lateral column lengthening
5326488|NCT02055495|Kinematic motion analysis|kinematic motion analysis
5326489|NCT02055482|Anemia on CKD|anemia on ckd
5326490|NCT02055469|Achalasia|achalasia
5326491|NCT02055456|Hormones|hormones
5326492|NCT02055456|Androgens|androgens
5326493|NCT02055456|Aplastic Anemia|aplastic anemia
5326494|NCT02055456|Bone Marrow Failure Syndromes|bone marrow failure syndromes
5326495|NCT02055456|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5326496|NCT02055456|Telomere|telomere
5326497|NCT02055456|Telomere Shortening|telomere shortening
5326498|NCT02055443|nuclear cardiology|nuclear cardiology
5326499|NCT02055443|chest pain|chest pain
5326500|NCT02055443|cardiac ischemia|cardiac ischemia
5326501|NCT02055443|shortness of breath|shortness of breath
5326502|NCT02055443|ECG|ecg
5326503|NCT02055443|EKG|ekg
5326504|NCT02055443|electrocardiogram|electrocardiogram
5326505|NCT02055430|anuria|anuria
5326506|NCT02055430|children|children
5326507|NCT02055430|nephrostomy|nephrostomy
5326508|NCT02055430|stents|stents
5326509|NCT02055430|urinary calculi|urinary calculi
5326510|NCT02055404|astigmatism|astigmatism
5326511|NCT02055404|toric|toric
5326512|NCT02055404|contact lenses|contact lenses
5326513|NCT02055404|daily disposable contact lenses|daily disposable contact lenses
5326514|NCT02055404|molded mark|molded mark
5326515|NCT02055404|rotation mark|rotation mark
5326516|NCT02055378|myopia|myopia
5326517|NCT02055378|atropine|atropine
5326518|NCT02055378|anterior chamber depth|anterior chamber depth
5326519|NCT02055378|auricular acupoint|auricular acupoint
5326520|NCT02055378|axial length|axial length
5326521|NCT02055365|Hepatitis B vaccine|hepatitis b vaccine
5326522|NCT02055326|Smoking|smoking
5326523|NCT02055326|yoga|yoga
5326524|NCT02055326|men|men
5326525|NCT02055326|intervention|intervention
5326526|NCT02055313|Exceptional patient|exceptional patient
5326527|NCT02055313|Cancer care|cancer care
5326528|NCT02055313|Lung cancer|lung cancer
5326529|NCT02055313|Pancreatic cancer|pancreatic cancer
5326530|NCT02055313|Stomach cancer|stomach cancer
5326531|NCT02055313|Unexplained survival|unexplained survival
5326532|NCT02055313|still alive from 2001-2008|still alive from 2001-2008
5326533|NCT02055287|schizophrenia|schizophrenia
5326534|NCT02055287|schizoaffective disorder|schizoaffective disorder
5326535|NCT02055274|Parkinsons|parkinsons
5326541|NCT02055235|Brain|brain
5326542|NCT02055235|Pain|pain
5326543|NCT02055235|Yoga|yoga
5326548|NCT02055183|Registry|registry
5326549|NCT02055183|Botulinum toxin|botulinum toxin
5326550|NCT02055183|Botulism Antitoxin Heptavalent- (Equine)|botulism antitoxin heptavalent- (equine)
5326551|NCT02055183|BAT®|bat®
5326552|NCT02055157|Achondroplasia|achondroplasia
5326553|NCT02055157|Dwarfism|dwarfism
5326554|NCT02055157|Bone Diseases, Developmental|bone diseases, developmental
5326555|NCT02055157|Bone Diseases|bone diseases
5326556|NCT02055144|NSCLC|nsclc
5326557|NCT02055144|VeriStrat|veristrat
5326558|NCT02055144|chemotherapy|chemotherapy
5963260|NCT04260971|Deep Brain Stimulation|deep brain stimulation
5326559|NCT02055144|circulating tumor cells|circulating tumor cells
5326560|NCT02055131|vascular access|vascular access
5326561|NCT02055131|hemodialysis|hemodialysis
5326562|NCT02055131|aspirin resistance|aspirin resistance
5326564|NCT02055118|hunters disease|hunters disease
5326565|NCT02055118|MPS II|mps ii
5326566|NCT02055118|lysosomal storage disorder|lysosomal storage disorder
5326567|NCT02055118|hunters syndrome|hunters syndrome
5326568|NCT02055118|ert treatment|ert treatment
5326569|NCT02055118|hunter's disease|hunter's disease
5326572|NCT02055118|mps 2|mps 2
5326573|NCT02055118|enlarged adenoids|enlarged adenoids
5326574|NCT02055118|hunter's syndrome|hunter's syndrome
5326575|NCT02055118|iduronate 2 sulfatase|iduronate 2 sulfatase
5326576|NCT02055118|chronic ear infection|chronic ear infection
5326577|NCT02055118|mucopolysaccharides|mucopolysaccharides
5326578|NCT02055118|hunter syndrome therapy|hunter syndrome therapy
5326579|NCT02055118|hunter's syndrome treatment|hunter's syndrome treatment
5326580|NCT02055118|enzyme replacement therapy|enzyme replacement therapy
5326581|NCT02055118|hunter syndrome treatment|hunter syndrome treatment
5326582|NCT02055118|elaprase|elaprase
5326584|NCT02055118|lysosomal storage disease|lysosomal storage disease
5326585|NCT02055118|mps diagnosis|mps diagnosis
5326586|NCT02055118|mps symptoms|mps symptoms
5326587|NCT02055118|idursulfase|idursulfase
5326588|NCT02055118|hunter disease|hunter disease
5326594|NCT02055092|Specific needs|specific needs
5326595|NCT02055092|Healthcare resources in dementia|healthcare resources in dementia
5326596|NCT02055092|Frontotemporal dementia|frontotemporal dementia
5326597|NCT02055092|Alzheimer's disease|alzheimer's disease
5326598|NCT02055092|Healthcare services|healthcare services
5326599|NCT02055079|ADPKD|adpkd
5326601|NCT02055079|Polycystic kidney disease|polycystic kidney disease
5326602|NCT02055079|Mammalian target of rapamycin|mammalian target of rapamycin
5326603|NCT02055079|mTOR-I|mtor-i
5326604|NCT02055079|Sirolimus|sirolimus
5326605|NCT02055066|cancer|cancer
5326606|NCT02055066|c-MET|c-met
5326609|NCT02055027|Sleep Apnea, Obstructive|sleep apnea, obstructive
5326610|NCT02055027|Continuous Positive Airway Pressure|continuous positive airway pressure
5326611|NCT02055027|Perioperative Period|perioperative period
5326612|NCT02055014|Endobarrier|endobarrier
5326613|NCT02055014|Duodenal-jejunal bypass liner|duodenal-jejunal bypass liner
5326614|NCT02055014|Glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
5326615|NCT02055014|Liraglutide|liraglutide
5326616|NCT02055014|Diabesity|diabesity
5326617|NCT02055014|Type 2 diabetes|type 2 diabetes
5326618|NCT02055014|Obesity|obesity
5326619|NCT02055001|gender medicine|gender medicine
5326620|NCT02055001|platelet function|platelet function
5326621|NCT02055001|sex hormones|sex hormones
5326622|NCT02055001|antiplatelet drugs|antiplatelet drugs
5326623|NCT02055001|haemostasis|haemostasis
5326624|NCT02054975|asthma, children, vitamin D deficiency, clinical trial|asthma, children, vitamin d deficiency, clinical trial
5326625|NCT02054962|Pain|pain
5326626|NCT02054949|N-acetyl cysteine|n-acetyl cysteine
5326627|NCT02054949|Refractory Seizures|refractory seizures
5326628|NCT02054923|colonoscopy|colonoscopy
5326629|NCT02054923|videorecording|videorecording
5326630|NCT02054923|quality indicators|quality indicators
5326631|NCT02054923|screening|screening
5326632|NCT02054923|colorectal cancer|colorectal cancer
5326633|NCT02054884|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, Merkel cell carcinoma|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, merkel cell carcinoma
5326634|NCT02054871|Peripheral Angioplasty|peripheral angioplasty
5326635|NCT02054871|Remote Ischaemic Preconditioning|remote ischaemic preconditioning
5326636|NCT02054871|Contrast Induced Nephropathy|contrast induced nephropathy
5326637|NCT02054858|Computerized Tomography|computerized tomography
5326638|NCT02054858|Contrast enhanced|contrast enhanced
5326639|NCT02054858|Acute Kidney Injury|acute kidney injury
5326640|NCT02054858|Remote ischaemic preconditioning|remote ischaemic preconditioning
5326641|NCT02054858|RIPC|ripc
5326642|NCT02054845|Body awareness therapy|body awareness therapy
5326643|NCT02054845|Physical therapy|physical therapy
5326644|NCT02054819|lung cancer|lung cancer
5326645|NCT02054819|NSCLC|nsclc
5326646|NCT02054806|PD1|pd1
5326647|NCT02054806|PD-1|pd-1
5326648|NCT02054806|PDL1|pdl1
5326649|NCT02054806|PD-L1|pd-l1
5326650|NCT02054793|metastatic disease|metastatic disease
5326651|NCT02054793|non-metastatic disease|non-metastatic disease
5326652|NCT02054793|prostate cancer|prostate cancer
5326653|NCT02054793|castration-resistant prostate cancer|castration-resistant prostate cancer
5326654|NCT02054767|articaine|articaine
5326655|NCT02054767|lidocaine|lidocaine
5326656|NCT02054767|mepivacaine|mepivacaine
5326657|NCT02054767|inferior alveolar nerve block|inferior alveolar nerve block
5326658|NCT02054767|irreversible pulpitis|irreversible pulpitis
5326659|NCT02054754|Dexanabinol|dexanabinol
5326660|NCT02054754|Oral|oral
5326661|NCT02054754|Safety|safety
5326662|NCT02054754|Tolerability|tolerability
5326663|NCT02054754|Pharmacokinetics|pharmacokinetics
5326664|NCT02054728|right-heart catheterization|right-heart catheterization
5326665|NCT02054728|respiratory muscle training|respiratory muscle training
5326666|NCT02054728|inspiratory resistance|inspiratory resistance
5326667|NCT02054728|hemodynamics|hemodynamics
5326668|NCT02054702|Schizophrenia|schizophrenia
5326669|NCT02054702|Mental Disorders|mental disorders
5326670|NCT02054702|Psychotic Disorders|psychotic disorders
5326671|NCT02054702|Antipsychotic|antipsychotic
5326672|NCT02054702|Cognitive testing|cognitive testing
5326673|NCT02054676|mandible|mandible
5326674|NCT02054676|alveolar nerve inferior|alveolar nerve inferior
5326675|NCT02054676|anatomy|anatomy
5326676|NCT02054676|cross-sectional|cross-sectional
5326677|NCT02054676|dental implants|dental implants
5326678|NCT02054676|classification|classification
5326683|NCT02054663|Antiplatelet therapy|antiplatelet therapy
5326684|NCT02054663|Ticagrelor|ticagrelor
5326685|NCT02054663|Clopidogrel|clopidogrel
5326686|NCT02054650|Chronic low back pain|chronic low back pain
5326687|NCT02054650|Type 2 diabetes mellitus|type 2 diabetes mellitus
5326688|NCT02054650|Back pain|back pain
5326689|NCT02054650|Diabetes|diabetes
5326690|NCT02054650|Osteopathic manual treatment|osteopathic manual treatment
5326691|NCT02054650|Osteopathic manipulative treatment|osteopathic manipulative treatment
5326692|NCT02054650|OMT|omt
5326693|NCT02054650|Biomarkers|biomarkers
5326694|NCT02054650|Glycemic control|glycemic control
5326695|NCT02054650|Kidney function|kidney function
5326696|NCT02054637|Bile reflux|bile reflux
5326697|NCT02054637|Reflux esophagitis|reflux esophagitis
5326698|NCT02054637|Lanreotide autogel|lanreotide autogel
5326699|NCT02054637|Somatuline|somatuline
5326700|NCT02054637|Endoscopy|endoscopy
5326701|NCT02054637|Impedancemetry|impedancemetry
5326702|NCT02054624|Obesity|obesity
5326703|NCT02054624|Rural Health|rural health
5326704|NCT02054624|Exercise|exercise
5326705|NCT02054624|Weight loss|weight loss
5326706|NCT02054624|Behavior change|behavior change
5326707|NCT02054611|ARDS|ards
5326708|NCT02054611|Chest radiographs|chest radiographs
5326709|NCT02054611|Vignettes|vignettes
5326710|NCT02054611|Online educational video|online educational video
5326711|NCT02054585|dehydration|dehydration
5326712|NCT02054585|pediatric|pediatric
5326713|NCT02054585|glucose|glucose
5326714|NCT02054585|IV fluid|iv fluid
5326715|NCT02054572|AMG 416, ESRD, hemodialysis|amg 416, esrd, hemodialysis
5326716|NCT02054559|localized|localized
5326717|NCT02054559|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5326718|NCT02054559|R-CHOP chemotherapy|r-chop chemotherapy
5326719|NCT02054559|radiotherapy|radiotherapy
5326720|NCT02054533|Crohn's disease|crohn's disease
5326721|NCT02054533|Ulcerative colitis|ulcerative colitis
5326722|NCT02054533|Inflammatory bowel disease|inflammatory bowel disease
5326723|NCT02054533|Surgery|surgery
5326724|NCT02054533|Anti-Tumor Necrosis Factor|anti-tumor necrosis factor
5326725|NCT02054533|Infection|infection
5326726|NCT02054520|Stage IV|stage iv
5326727|NCT02054520|metastatic melanoma|metastatic melanoma
5326728|NCT02054507|Children|children
5326729|NCT02054507|Cognitive outcome|cognitive outcome
5326730|NCT02054507|Prematurity|prematurity
5326731|NCT02054507|Care Network|care network
5326732|NCT02054507|Outpatient follow-up of cognitive development|outpatient follow-up of cognitive development
5326733|NCT02054507|Care resources|care resources
5326734|NCT02054468|Muscle relaxant, Rocuronium, TIVA, Propofol|muscle relaxant, rocuronium, tiva, propofol
5326735|NCT02054455|PPI|ppi
5326736|NCT02054455|SIBO|sibo
5326737|NCT02054455|LP-F19|lp-f19
5326738|NCT02054442|cetuximab|cetuximab
5326739|NCT02054442|methotrexate|methotrexate
5326740|NCT02054442|squamous cell carcinoma head neck|squamous cell carcinoma head neck
5326741|NCT02054442|palliative chemotherapy|palliative chemotherapy
5326742|NCT02054416|non-traumatic lower limb amputation|non-traumatic lower limb amputation
5326744|NCT02054416|BKA|bka
5326745|NCT02054390|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5326746|NCT02054390|inflammation|inflammation
5326747|NCT02054390|metabolic syndrome|metabolic syndrome
5326748|NCT02054390|myonecrosis|myonecrosis
5326749|NCT02054390|percutaneous coronary intervention|percutaneous coronary intervention
5326750|NCT02054390|periprocedural myocardial injury|periprocedural myocardial injury
5326751|NCT02054377|cystic fibrosis|cystic fibrosis
5326752|NCT02054377|tai chi|tai chi
5326753|NCT02054364|Eating Disorder|eating disorder
5326754|NCT02054364|Anorexia Nervosa|anorexia nervosa
5326755|NCT02054364|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5326756|NCT02054364|Maudsley|maudsley
5326757|NCT02054364|Family-Based Therapy|family-based therapy
5326758|NCT02054364|FBT|fbt
5326759|NCT02054364|Family Therapy|family therapy
5326760|NCT02054364|Cognitive Remediation Therapy|cognitive remediation therapy
5326761|NCT02054364|CRT|crt
5326762|NCT02054351|Advanced ovarian cancer|advanced ovarian cancer
5326763|NCT02054351|CLDN6 positive|cldn6 positive
5326764|NCT02054325|Sclerotherapy|sclerotherapy
5326765|NCT02054325|varicose veins|varicose veins
5326766|NCT02054325|veins|veins
5326767|NCT02054273|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
5963261|NCT04259996|Progesterone in luteal phase|progesterone in luteal phase
5206894|NCT02701959|Nitric oxide|nitric oxide
5206895|NCT02701959|Dietary intervention trail|dietary intervention trail
5206896|NCT02701946|Blood loss|blood loss
5445410|NCT01521923|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
5326768|NCT02054247|Carpal tunnel syndrome,ultrasound,pulsed ultrasound|carpal tunnel syndrome,ultrasound,pulsed ultrasound
5326769|NCT02054234|Adenoviral conjunctivitis diagnosed with AdenoPlus™ Test|adenoviral conjunctivitis diagnosed with adenoplus™ test
5326770|NCT02054221|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5326771|NCT02054221|mitral valve|mitral valve
5423284|NCT01616329|clinicalfactors|clinicalfactors
5423285|NCT01616329|Risk|risk
5326772|NCT02054208|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
5326773|NCT02054208|stem cells|stem cells
5326774|NCT02054208|alzheimer's disease|alzheimer's disease
5326775|NCT02054208|cognitive ability|cognitive ability
5326776|NCT02054208|mesenchymal stem cells|mesenchymal stem cells
5326777|NCT02054208|cord blood|cord blood
5326778|NCT02054182|vitamin D supplementation, pneumonia, bronchiolitis|vitamin d supplementation, pneumonia, bronchiolitis
5326779|NCT02054156|Cystic fibrosis (CF)|cystic fibrosis (cf)
5326780|NCT02054156|Azithromycin|azithromycin
5326781|NCT02054156|Tobramycin solution for inhalation (TIS)|tobramycin solution for inhalation (tis)
5326782|NCT02054156|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
5862775|NCT00001515|Wegener's Granulomatosis|wegener's granulomatosis
5326783|NCT02054156|Early Pseudomonas aeruginosa infection|early pseudomonas aeruginosa infection
5326784|NCT02054156|Pulmonary exacerbation|pulmonary exacerbation
5326785|NCT02054156|Standardized anti-pseudomonal therapy|standardized anti-pseudomonal therapy
5326786|NCT02054143|sevoflurane|sevoflurane
5326787|NCT02054143|cerebral vasoreactivity|cerebral vasoreactivity
5326788|NCT02054143|arterial stiffness|arterial stiffness
5326789|NCT02054143|Transcranial Doppler|transcranial doppler
5326790|NCT02054143|SphygmoCor|sphygmocor
5326792|NCT02054117|Hemorrhage|hemorrhage
5326793|NCT02054117|Intracerebral hemorrhage (ICH)|intracerebral hemorrhage (ich)
5326794|NCT02054104|Minimal Residual Disease|minimal residual disease
5326795|NCT02054104|Cancer Vaccine|cancer vaccine
5326796|NCT02054104|Immunotherapy|immunotherapy
5326797|NCT02054104|No Clinical Evidence of Active Disease|no clinical evidence of active disease
5326798|NCT02054091|Preterm infants|preterm infants
5326799|NCT02054091|Bovine colostrum|bovine colostrum
5326800|NCT02054091|Feeding intolerance|feeding intolerance
5326801|NCT02054091|Postnatal growth|postnatal growth
5326802|NCT02054091|Intestinal maturation|intestinal maturation
5326803|NCT02054091|Necrotizing enterocolitis|necrotizing enterocolitis
5326804|NCT02054065|Urinary Catheter|urinary catheter
5326805|NCT02054065|urinary tract infection|urinary tract infection
5326806|NCT02054052|non-small cell lung cancer|non-small cell lung cancer
5326807|NCT02054052|malignant pleural effusion|malignant pleural effusion
5326808|NCT02054052|bevacizumab|bevacizumab
5326809|NCT02054052|intrapleural injection|intrapleural injection
5326810|NCT02054052|pericardial effusion|pericardial effusion
5326811|NCT02054039|Cardiac surgery|cardiac surgery
5326812|NCT02054039|Spirometry|spirometry
5326813|NCT02054039|Physical Therapy Modalities|physical therapy modalities
5326814|NCT02054039|Postoperative Complications|postoperative complications
5326815|NCT02054000|No-reflow phenomenon, tirofiban, intracoronary|no-reflow phenomenon, tirofiban, intracoronary
5326816|NCT02053974|Anthracycline|anthracycline
5326817|NCT02053974|spironolactone|spironolactone
5326818|NCT02053974|cardiotoxicity|cardiotoxicity
5326819|NCT02053948|Reversal|reversal
5326820|NCT02053948|Surgical technique|surgical technique
5326821|NCT02053948|Pursestring Wound Closure|pursestring wound closure
5326822|NCT02053948|Gunsight Skin Incision and Closure Technique|gunsight skin incision and closure technique
5326823|NCT02053935|Dopamine|dopamine
5326824|NCT02053935|hyperglycemic clamp|hyperglycemic clamp
5326825|NCT02053935|sepsis|sepsis
5326826|NCT02053935|hyperglycemia|hyperglycemia
5326827|NCT02053935|insulin secretion|insulin secretion
5675226|NCT00600275|Solid tumors|solid tumors
5326828|NCT02053922|caesarean section, ecbolics, postpartum hemorrhage|caesarean section, ecbolics, postpartum hemorrhage
5326829|NCT02053909|Saphenous vein graft disease|saphenous vein graft disease
5326830|NCT02053909|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5326831|NCT02053909|Antiplatelet therapy|antiplatelet therapy
5326832|NCT02053909|Coronary artery disease|coronary artery disease
5326833|NCT02053909|Secondary prevention|secondary prevention
5326834|NCT02053909|Graft patency|graft patency
5326835|NCT02053896|Type I Gaucher|type i gaucher
5326836|NCT02053896|ISU302|isu302
5326837|NCT02053896|Imiglucerase|imiglucerase
5326839|NCT02053883|spinal cord injury|spinal cord injury
5326840|NCT02053883|biologic drug|biologic drug
5326841|NCT02053883|rho|rho
5326842|NCT02053883|paralysis|paralysis
5326843|NCT02053883|paraplegia|paraplegia
5326844|NCT02053883|tetraplegia|tetraplegia
5326845|NCT02053883|quadriplegia|quadriplegia
5326846|NCT02053883|trauma|trauma
5326847|NCT02053883|central nervous system|central nervous system
5963262|NCT04259996|modified natural cycle|modified natural cycle
5963263|NCT04259996|stimulated cycle|stimulated cycle
5963264|NCT04259996|clinical pregnancy rate|clinical pregnancy rate
5963265|NCT04259996|live birth rate|live birth rate
5326848|NCT02053883|fibrin sealant|fibrin sealant
5326849|NCT02053883|neurosurgery|neurosurgery
5326850|NCT02053883|cervical|cervical
5326851|NCT02053883|regeneration|regeneration
5326852|NCT02053883|neurotrauma|neurotrauma
5326853|NCT02053870|Adventitious lung sounds|adventitious lung sounds
5326854|NCT02053870|Crackles|crackles
5326855|NCT02053870|Wheezes|wheezes
5326856|NCT02053870|Sputum location|sputum location
5326857|NCT02053857|severe acute malnutrition|severe acute malnutrition
5326858|NCT02053857|polyunsaturated fatty acids|polyunsaturated fatty acids
5327449|NCT02051140|Walking|walking
5326859|NCT02053857|ready-to-use therapeutic food|ready-to-use therapeutic food
5326860|NCT02053844|health care costs|health care costs
5326861|NCT02053844|quality of health care|quality of health care
5326862|NCT02053831|plastic surgery|plastic surgery
5326863|NCT02053818|Cognitive dysfunction|cognitive dysfunction
5326864|NCT02053818|Cardioprotection|cardioprotection
5326865|NCT02053818|Recovery|recovery
5326866|NCT02053818|Renal function|renal function
5326867|NCT02053818|ICU discharge|icu discharge
5326868|NCT02053805|prostate cancer|prostate cancer
5326869|NCT02053805|BRCA1 Syndrome|brca1 syndrome
5326870|NCT02053805|BRCA germ-line mutation|brca germ-line mutation
5326871|NCT02053805|Lynch syndrome|lynch syndrome
5326872|NCT02053805|BRCA2 Syndrome|brca2 syndrome
5326873|NCT02053779|GnRH agonist|gnrh agonist
5326874|NCT02053779|GnRH antagonist|gnrh antagonist
5326875|NCT02053779|Luteal phase|luteal phase
5326876|NCT02053766|Mitochondrial Diseases|mitochondrial diseases
5326880|NCT02053753|denosumab, bioequivalence|denosumab, bioequivalence
5326881|NCT02053727|Rheumatoid Arthritis|rheumatoid arthritis
5326883|NCT02053727|Abatacept|abatacept
5326885|NCT02053727|entecavir|entecavir
5326886|NCT02053701|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5326887|NCT02053701|quantification precision|quantification precision
5326888|NCT02053701|brain|brain
5326889|NCT02053701|brain metabolites|brain metabolites
5326890|NCT02053675|septic shock|septic shock
5326891|NCT02053675|vasopressin|vasopressin
5326892|NCT02053675|microcirculation|microcirculation
5326893|NCT02053675|tissue oxygenation|tissue oxygenation
5326894|NCT02053675|vasopressors|vasopressors
5326895|NCT02053675|hemodynamics|hemodynamics
5326896|NCT02053662|Bladder Cancer|bladder cancer
5326897|NCT02053649|depression|depression
5326898|NCT02053649|major depressive disorder|major depressive disorder
5326899|NCT02053649|postpartum depression|postpartum depression
5326900|NCT02053649|antenatal depression|antenatal depression
5326901|NCT02053649|sleep|sleep
5326902|NCT02053649|circadian|circadian
5326903|NCT02053649|bright light|bright light
5326904|NCT02053597|Primary breast cancer|primary breast cancer
5326905|NCT02053597|Young women|young women
5326906|NCT02053597|Ovarian function|ovarian function
5326907|NCT02053597|Sexual function|sexual function
5326908|NCT02053597|Eligible for adjuvant or neoadjuvant chemotherapy|eligible for adjuvant or neoadjuvant chemotherapy
5326909|NCT02053597|Negative hormone-receptor status|negative hormone-receptor status
5326910|NCT02053558|Anesthesiology|anesthesiology
5326911|NCT02053558|Pain|pain
5326912|NCT02053558|TAP block|tap block
5326913|NCT02053558|Gynecology|gynecology
5326914|NCT02053558|Postoperative|postoperative
5326915|NCT02053558|Analgesia|analgesia
5326916|NCT02053532|Trauma|trauma
5326917|NCT02053532|Post-traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5326918|NCT02053532|Imaging|imaging
5326919|NCT02053532|Neuroimaging|neuroimaging
5326920|NCT02053532|F-18-fluorodeoxyglucose (FDG)|f-18-fluorodeoxyglucose (fdg)
5326921|NCT02053493|Heart Failure|heart failure
5326922|NCT02053493|Preserved Ejection Fraction|preserved ejection fraction
5326923|NCT02053480|pyruvate kinase deficiency|pyruvate kinase deficiency
5326924|NCT02053480|hemolytic anemia|hemolytic anemia
5326925|NCT02053480|anemia|anemia
5326926|NCT02053480|enzymopathy|enzymopathy
5326927|NCT02053480|jaundice|jaundice
5326928|NCT02053480|splenectomy|splenectomy
5326929|NCT02053480|health-related quality of life|health-related quality of life
5326930|NCT02053480|Hematologic diseases|hematologic diseases
5326931|NCT02053467|eConsultation|econsultation
5326932|NCT02053467|Specialist care|specialist care
5326933|NCT02053467|Primary health care|primary health care
5327056|NCT02052882|Thrombocytopenia|thrombocytopenia
5326934|NCT02053467|Reducing wait times for specialist care|reducing wait times for specialist care
5326935|NCT02053467|Reducing referral rates|reducing referral rates
5326936|NCT02053454|RNAi therapeutic|rnai therapeutic
5326937|NCT02053441|Muscle Protein Synthesis|muscle protein synthesis
5326938|NCT02053441|Muscle Protein Breakdown|muscle protein breakdown
5326939|NCT02053428|Head and neck cancer|head and neck cancer
5326940|NCT02053428|Percutaneous image-guided gastrostomy|percutaneous image-guided gastrostomy
5326941|NCT02053428|Pain|pain
5326942|NCT02053428|Quality of life|quality of life
5326943|NCT02053428|Complication|complication
5326944|NCT02053415|krill oil|krill oil
5326945|NCT02053415|omega-3 index|omega-3 index
5326946|NCT02053415|plasma lipid profile|plasma lipid profile
5326947|NCT02053415|tolerance|tolerance
5326948|NCT02053415|young adults|young adults
5207070|NCT02700867|cadaver|cadaver
5326949|NCT02053402|vitamin D supplementation, persistent asthma, control|vitamin d supplementation, persistent asthma, control
5326950|NCT02053389|Patient-Physician communication|patient-physician communication
5326951|NCT02053389|Decision Support Techniques|decision support techniques
5326952|NCT02053389|Health Communication|health communication
5326953|NCT02053389|Physician-Patient Relationship|physician-patient relationship
5326954|NCT02053389|Decision Making|decision making
5326955|NCT02053376|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, Biliary Tract Carcinoma|gallbladder cancer, biliary cancer, bile duct cancer, hepatobiliary cancer, biliary tract carcinoma
5326956|NCT02053376|Cholangiocarcinoma|cholangiocarcinoma
5326957|NCT02053363|tranexamic acid, reconstructive spine surgery|tranexamic acid, reconstructive spine surgery
5326958|NCT02053350|Clostridium difficile|clostridium difficile
5326959|NCT02053350|glutamine|glutamine
5326960|NCT02053350|diarrhea|diarrhea
5326961|NCT02053350|alanyl-glutamine|alanyl-glutamine
5326962|NCT02053324|AvidinOX|avidinox
5326963|NCT02053311|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5326964|NCT02053311|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5323282|NCT02069847|Budesonide|budesonide
5326965|NCT02053311|maintenance therapy|maintenance therapy
5326967|NCT02053311|TAK-700|tak-700
5326968|NCT02053298|Glaucoma|glaucoma
5326969|NCT02053272|Diabetes|diabetes
5326970|NCT02053272|Glycaemic control|glycaemic control
5326971|NCT02053272|Delta-9-tetrahydrocannabivarin|delta-9-tetrahydrocannabivarin
5326972|NCT02053272|Cannabinoids|cannabinoids
5326973|NCT02053233|stroke|stroke
5326974|NCT02053233|robot-assisted therapy|robot-assisted therapy
5326975|NCT02053233|conventional therapy|conventional therapy
5326976|NCT02053233|motor function|motor function
5326977|NCT02053207|Cognitive training|cognitive training
5326978|NCT02053207|Brain training|brain training
5326979|NCT02053207|Plasticity-based training|plasticity-based training
5326980|NCT02053207|Cardiac surgery|cardiac surgery
5326981|NCT02053207|Preoperative|preoperative
5326982|NCT02053207|Cognitive function|cognitive function
5326983|NCT02053194|Inappropriate prescribing|inappropriate prescribing
5326984|NCT02053194|Health Education|health education
5326985|NCT02053194|Community Pharmacy Services|community pharmacy services
5326986|NCT02053194|Medication Therapy Management|medication therapy management
5326987|NCT02053194|Preventive Health Services|preventive health services
5326988|NCT02053194|Polypharmacy|polypharmacy
5326989|NCT02053194|Inappropriate prescriptions|inappropriate prescriptions
5326990|NCT02053194|Aged|aged
5326991|NCT02053181|Cadazolid|cadazolid
5326992|NCT02053181|ACT-179811|act-179811
5326993|NCT02053181|Pharmacokinetics|pharmacokinetics
5326994|NCT02053181|Safety|safety
5326995|NCT02053181|Tolerability|tolerability
5326996|NCT02053155|Smoking cessation|smoking cessation
5326997|NCT02053155|perioperative complication|perioperative complication
5326998|NCT02053155|Smokerlyzer|smokerlyzer
5326999|NCT02053155|smokers help line|smokers help line
5327000|NCT02053142|Pharmacokinetics|pharmacokinetics
5327001|NCT02053142|Herpes simplex virus|herpes simplex virus
5327002|NCT02053142|Genital herpes ulcers|genital herpes ulcers
5327003|NCT02053129|tuberculosis|tuberculosis
5327004|NCT02053129|HIV|hiv
5327005|NCT02053129|pregnancy|pregnancy
5327006|NCT02053090|Fibromyalgia|fibromyalgia
5327007|NCT02053090|Group Acupuncture|group acupuncture
5327008|NCT02053090|Group Education with Stretching|group education with stretching
5327009|NCT02053090|Nociceptive Reflex Testing|nociceptive reflex testing
5327010|NCT02053090|Pain|pain
5327011|NCT02053090|Sleep|sleep
5327012|NCT02053090|Fatigue|fatigue
5327013|NCT02053064|Neurodegenerative diseases|neurodegenerative diseases
5327014|NCT02053064|Nervous systems diseases|nervous systems diseases
5327015|NCT02053064|Genetic diseases, Inborn|genetic diseases, inborn
5327016|NCT02053064|Metabolic diseases|metabolic diseases
5327017|NCT02053064|Gene therapy|gene therapy
5327018|NCT02053064|Adeno Associated Virus (AAV)|adeno associated virus (aav)
5327019|NCT02053051|Type 1 Diabetes|type 1 diabetes
5327020|NCT02053051|Advanced Bolus Calculator|advanced bolus calculator
5327021|NCT02053025|appetite|appetite
5327022|NCT02053025|overweight|overweight
5327023|NCT02053025|energy intake|energy intake
5327024|NCT02053025|obesity|obesity
5327025|NCT02053025|gut hormones|gut hormones
5327026|NCT02052986|Fatty Acids, Omega-3|fatty acids, omega-3
5327027|NCT02052986|Omega-3 fatty acids|omega-3 fatty acids
5327028|NCT02052986|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5327029|NCT02052986|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5327030|NCT02052986|Docosapentaenoic acid (DPA)|docosapentaenoic acid (dpa)
5327031|NCT02052986|Omega Index|omega index
5327032|NCT02052986|Omega Score|omega score
5327033|NCT02052986|Cardiac Rehab|cardiac rehab
5327034|NCT02052973|Streptococcus mutans|streptococcus mutans
5327035|NCT02052973|Natural products|natural products
5327036|NCT02052947|Alzheimer's disease|alzheimer's disease
5327037|NCT02052947|cerebrovascular disease|cerebrovascular disease
5327038|NCT02052947|Lewy body disease|lewy body disease
5327039|NCT02052947|MRI|mri
5327040|NCT02052947|SPECT|spect
5963266|NCT04258566|Hepatic Carcinoma|hepatic carcinoma
5207164|NCT02700217|Donor Nephrectomy|donor nephrectomy
5445411|NCT01521923|Rheumatoid Arthritis|rheumatoid arthritis
5207165|NCT02700139|Myopia control, aspheric lenses, children|myopia control, aspheric lenses, children
5207167|NCT02700126|total intravenous anesthesia|total intravenous anesthesia
5207168|NCT02700126|cerebral aneurysm|cerebral aneurysm
5207169|NCT02700126|single nucleotide polymorphism|single nucleotide polymorphism
5207171|NCT02700061|Induced Constraint Therapy|induced constraint therapy
5327042|NCT02052947|biomarkers|biomarkers
5327043|NCT02052947|disability|disability
5327044|NCT02052947|Multicenter and prospective cohort study|multicenter and prospective cohort study
5327045|NCT02052934|Escherichia coli Infections|escherichia coli infections
5327046|NCT02052934|ETEC Candidate Vaccine|etec candidate vaccine
5327047|NCT02052934|Immunogenicity|immunogenicity
5327048|NCT02052921|Observation|observation
5327049|NCT02052921|Rectal Resection|rectal resection
5327050|NCT02052921|complete clinical response|complete clinical response
5327051|NCT02052921|neoadjuvant chemoradiotherapy.|neoadjuvant chemoradiotherapy.
5327052|NCT02052895|Presepsin|presepsin
5327053|NCT02052895|Sepsis|sepsis
5327054|NCT02052895|SIRS|sirs
5327055|NCT02052882|Romiplostim|romiplostim
5327063|NCT02052791|Spinal Muscular Atrophy|spinal muscular atrophy
5327065|NCT02052791|SMN|smn
5327066|NCT02052791|SMNRx|smnrx
5327067|NCT02052791|ISIS-SMNRx|isis-smnrx
5327068|NCT02052791|ISIS 396443|isis 396443
5327069|NCT02052791|IONIS-SMNRx|ionis-smnrx
5327070|NCT02052791|IONIS-SMN Rx|ionis-smn rx
5327071|NCT02052791|Spinraza|spinraza
5327080|NCT02052739|Status Epilepticus|status epilepticus
5323392|NCT02069327|MCR|mcr
5327082|NCT02052739|Super-refractory status epilepticus|super-refractory status epilepticus
5327083|NCT02052739|SAGE-547|sage-547
5327084|NCT02052739|SAGE|sage
5327085|NCT02052739|Sage Therapeutics|sage therapeutics
5327086|NCT02052713|dutasteride|dutasteride
5327087|NCT02052713|tamsulosin|tamsulosin
5327088|NCT02052713|healthy subject|healthy subject
5327089|NCT02052713|dutasteride and tamsulosin combination|dutasteride and tamsulosin combination
5327090|NCT02052713|combination capsule of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg|combination capsule of dutasteride 0.5 mg and tamsulosin hcl 0.4 mg
5327091|NCT02052687|Healthy volunteer|healthy volunteer
5327092|NCT02052674|Precursor to CAUTI|precursor to cauti
5327093|NCT02052661|Infanrix™ hexa|infanrix™ hexa
5327094|NCT02052661|Hepatitis B antibodies|hepatitis b antibodies
5327095|NCT02052661|Immunogenicity|immunogenicity
5327096|NCT02052661|Hepatitis B|hepatitis b
5327097|NCT02052661|Adolescents|adolescents
5327098|NCT02052661|Infancy|infancy
5327099|NCT02052661|Engerix™-B Kinder|engerix™-b kinder
5327100|NCT02052661|Safety|safety
5327101|NCT02052648|glioblastoma multiforme|glioblastoma multiforme
5327102|NCT02052648|glioma|glioma
5327103|NCT02052648|gliosarcoma|gliosarcoma
5327104|NCT02052648|malignant brain tumor|malignant brain tumor
5327105|NCT02052635|Percutaneous Coronary Intervention|percutaneous coronary intervention
5327106|NCT02052596|Boostrix|boostrix
5327107|NCT02052596|Herpes zoster|herpes zoster
5327108|NCT02052596|Immunogenicity|immunogenicity
5327109|NCT02052596|Co-administration|co-administration
5327110|NCT02052596|Adults|adults
5327111|NCT02052596|Safety|safety
5327112|NCT02052583|Cardiac arrest|cardiac arrest
5327113|NCT02052583|Oxymetry|oxymetry
5327114|NCT02052583|Hypothermia|hypothermia
5327115|NCT02052570|School Reentry after pediatric HSCT|school reentry after pediatric hsct
5327116|NCT02052557|Exparel|exparel
5327117|NCT02052557|liposomal bupivicaine|liposomal bupivicaine
5327118|NCT02052557|post operative pain control|post operative pain control
5327119|NCT02052557|local anesthetic after surgery|local anesthetic after surgery
5327120|NCT02052557|colorectal surgery|colorectal surgery
5327121|NCT02052557|marcaine|marcaine
5327122|NCT02052557|long acting local anesthetic|long acting local anesthetic
5327123|NCT02052557|pain medication use after surgery|pain medication use after surgery
5327124|NCT02052544|determination of heparin levels|determination of heparin levels
5327125|NCT02052544|Patients|patients
5327126|NCT02052544|requiring|requiring
5327127|NCT02052544|unfractionated|unfractionated
5327128|NCT02052518|Childhood obesity|childhood obesity
5327129|NCT02052518|Breastfeeding|breastfeeding
5327130|NCT02052518|Introduction of solids|introduction of solids
5327131|NCT02052518|Introduction of juice|introduction of juice
5327132|NCT02052505|inappropriate prescribing|inappropriate prescribing
5327133|NCT02052505|psychiatry|psychiatry
5327134|NCT02052505|medication quality|medication quality
5327135|NCT02052505|patient safety|patient safety
5327136|NCT02052505|medication errors|medication errors
5327137|NCT02052479|Polycystic Ovary Syndrome|polycystic ovary syndrome
5327138|NCT02052479|PCOS|pcos
5327139|NCT02052479|Secondary Amenorrhea|secondary amenorrhea
5963267|NCT04258566|INDOCYANINE GREEN|indocyanine green
5963268|NCT04258566|Optical Imaging|optical imaging
5963269|NCT04258449|Ovarian Cancer|ovarian cancer
5963270|NCT04258449|Endometrial Cancer|endometrial cancer
5963271|NCT04258449|Genomics|genomics
5963272|NCT04258449|DNA tagging|dna tagging
5963273|NCT04258449|Somatic mutations|somatic mutations
5963274|NCT04258449|Endometrial sampling|endometrial sampling
5963275|NCT04258449|Uterine sampling|uterine sampling
5963276|NCT04258449|Medical device|medical device
5327140|NCT02052479|Hirsutism|hirsutism
5327141|NCT02052479|Hyperandrogenism|hyperandrogenism
5327142|NCT02052479|Insulin Resistance|insulin resistance
5327143|NCT02052466|Shoulder Joint|shoulder joint
5327144|NCT02052466|Computed tomography|computed tomography
5327145|NCT02052453|Pacemaker|pacemaker
5327147|NCT02052453|Surgery|surgery
5327148|NCT02052453|Electrocautery|electrocautery
5327149|NCT02052453|Electromagnetic interference|electromagnetic interference
5327150|NCT02052427|Ischemic heart disease|ischemic heart disease
5327151|NCT02052427|Coronary artery disease|coronary artery disease
5327152|NCT02052427|Chronic Heart Failure|chronic heart failure
5327153|NCT02052427|Cardiovascular disease|cardiovascular disease
5327154|NCT02052427|adult stem cells|adult stem cells
5327155|NCT02052427|adipose derived regenerative cells|adipose derived regenerative cells
5331548|NCT02033304|Pain|pain
5327156|NCT02052414|side effects|side effects
5327158|NCT02052414|efficacy|efficacy
5327159|NCT02052414|Gralise|gralise
5327160|NCT02052414|Fibromyalgia|fibromyalgia
5327161|NCT02052414|gabapentin|gabapentin
5327162|NCT02052401|OLD AGE|old age
5327163|NCT02052401|Elderly|elderly
5327164|NCT02052401|Domiciliary Intervention|domiciliary intervention
5327165|NCT02052401|Occupational Therapy|occupational therapy
5327166|NCT02052401|Rehospitalization|rehospitalization
5327167|NCT02052388|Skin Infection|skin infection
5327168|NCT02052388|Staph aureus|staph aureus
5327169|NCT02052388|MRSA|mrsa
5327170|NCT02052388|MSSA|mssa
5327171|NCT02052388|Cellulitis/Erysipelas|cellulitis/erysipelas
5327172|NCT02052388|Wound Infection|wound infection
5327173|NCT02052388|Abscess|abscess
5327174|NCT02052375|Rheumatoid Arthritis|rheumatoid arthritis
5327175|NCT02052375|ASP2408|asp2408
5327176|NCT02052375|methotrexate|methotrexate
5327177|NCT02052362|absolute bioavailability|absolute bioavailability
5327178|NCT02052362|healthy volunteers|healthy volunteers
5327179|NCT02052349|relative bioavailability|relative bioavailability
5327181|NCT02052336|Drug-Drug interaction|drug-drug interaction
5327182|NCT02052336|Pharmacokinetics|pharmacokinetics
5327308|NCT02051868|Cisplatin-5FU|cisplatin-5fu
5327183|NCT02052323|P.f Malaria, Artemisinin resistance, ACT treatment failure|p.f malaria, artemisinin resistance, act treatment failure
5327185|NCT02052310|Chronic Kidney Disease|chronic kidney disease
5327186|NCT02052310|Hemoglobin|hemoglobin
5327187|NCT02052310|End-Stage Renal Disease|end-stage renal disease
5327188|NCT02052310|Incident-Dialysis|incident-dialysis
5327189|NCT02052310|Erythropoieitin|erythropoieitin
5327190|NCT02052310|Erythropoieisis stimulating-agent|erythropoieisis stimulating-agent
5327191|NCT02052310|Roxadustat|roxadustat
5327192|NCT02052310|AZD9941|azd9941
5327193|NCT02052310|ASP1517|asp1517
5327194|NCT02052297|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5327195|NCT02052297|dosimetry|dosimetry
5327196|NCT02052297|Positron Emission Tomograph (PET)|positron emission tomograph (pet)
5327197|NCT02052284|ELBW|elbw
5327198|NCT02052284|premature|premature
5327199|NCT02052284|neonate|neonate
5327200|NCT02052284|skin|skin
5327201|NCT02052284|water loss|water loss
5327202|NCT02052271|essential tremor|essential tremor
5327203|NCT02052271|cerebellum|cerebellum
5327204|NCT02052271|transcranial direct current stimulation|transcranial direct current stimulation
5327205|NCT02052271|electrophysiology|electrophysiology
5327206|NCT02052258|oxytocin|oxytocin
5327207|NCT02052219|Blisibimod|blisibimod
5327208|NCT02052219|IgA nephropathy|iga nephropathy
5327209|NCT02052219|BAFF|baff
5327210|NCT02052219|BLyS|blys
5327211|NCT02052206|osteoarthritis|osteoarthritis
5327212|NCT02052206|complexe proximal humeral fracture|complexe proximal humeral fracture
5327213|NCT02052206|shoulder|shoulder
5327214|NCT02052206|shoulder replacement|shoulder replacement
5327215|NCT02052206|accuracy|accuracy
5327216|NCT02052206|computer-assisted|computer-assisted
5327218|NCT02052180|Carpalmetacarpal arthroplasty|carpalmetacarpal arthroplasty
5327219|NCT02052180|Proximal row carpectomy|proximal row carpectomy
5327220|NCT02052180|Post-operative pain control|post-operative pain control
5327221|NCT02052180|Exparel|exparel
5327222|NCT02052180|Marcaine|marcaine
5327223|NCT02052154|Pneumococcal infection|pneumococcal infection
5327224|NCT02052154|Splenectomized|splenectomized
5327225|NCT02052154|vaccination|vaccination
5327226|NCT02052141|Pediatric|pediatric
5327227|NCT02052141|C1 inhibitor|c1 inhibitor
5327229|NCT02052141|Cinryze|cinryze
5327230|NCT02052141|C1 INH|c1 inh
5327231|NCT02052141|Prevention|prevention
5327232|NCT02052128|endometrial cancer|endometrial cancer
5327233|NCT02052128|ovarian cancer|ovarian cancer
5327234|NCT02052128|breast cancer|breast cancer
5327235|NCT02052128|uterine sarcoma|uterine sarcoma
5327236|NCT02052128|uterine endometrioid adenocarcinoma|uterine endometrioid adenocarcinoma
5327237|NCT02052115|breast cancer|breast cancer
5327238|NCT02052115|exercise|exercise
5327239|NCT02052115|weight loss|weight loss
5327240|NCT02052115|executive function|executive function
5327241|NCT02052115|breast cancer survivor|breast cancer survivor
5327242|NCT02052102|Deep inspiration breath hold|deep inspiration breath hold
5327243|NCT02052102|radiation therapy|radiation therapy
5327244|NCT02052102|Cardiac toxicity|cardiac toxicity
5327245|NCT02052102|Left-sided breast cancer|left-sided breast cancer
5327246|NCT02052089|Tennis Elbow|tennis elbow
5327247|NCT02052089|lateral epicondylosis|lateral epicondylosis
5327248|NCT02052089|lateral epicondylitis|lateral epicondylitis
5327249|NCT02052089|Platelet-Rich Plasma|platelet-rich plasma
5327250|NCT02052089|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5327251|NCT02052089|Prolotherapy|prolotherapy
5327252|NCT02052089|Physiotherapy|physiotherapy
5327253|NCT02052076|Energy balance|energy balance
5327254|NCT02052076|meal pattern|meal pattern
5327255|NCT02052076|metabolic syndrome|metabolic syndrome
5327256|NCT02052063|rectocele|rectocele
5327257|NCT02052063|intussusception|intussusception
5327258|NCT02052063|surgery|surgery
5327259|NCT02052050|colorectal-neoplasms,deep-muscles of the back,rehabilitation|colorectal-neoplasms,deep-muscles of the back,rehabilitation
5327260|NCT02052037|Type 2 Diabetes|type 2 diabetes
5327262|NCT02052037|Glycemic Control|glycemic control
5327263|NCT02052037|Insulin sensitivity|insulin sensitivity
5327264|NCT02052037|Diet quality|diet quality
5327265|NCT02052024|Spasticity|spasticity
5327266|NCT02052024|Modified Ashworth Scale|modified ashworth scale
5327267|NCT02052024|MYOBLOC|myobloc
5327268|NCT02052024|Botox|botox
5327269|NCT02052024|Muscle Atrophy|muscle atrophy
5327270|NCT02052011|Chest Pain|chest pain
5327271|NCT02052011|Microvascular Angina|microvascular angina
5327272|NCT02052011|Ranolazine|ranolazine
5327273|NCT02052011|Emergency department|emergency department
5327274|NCT02052011|PET|pet
5327275|NCT02051998|Geographic atrophy|geographic atrophy
5327276|NCT02051998|Age-related macular degeneration|age-related macular degeneration
5327277|NCT02051998|Retina|retina
5327278|NCT02051998|Retinal pigment epithelium|retinal pigment epithelium
5327279|NCT02051998|Optical coherence tomography|optical coherence tomography
5323590|NCT02068521|GHD|ghd
5327302|NCT02051894|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5327303|NCT02051894|Pleth Variability Index|pleth variability index
5327304|NCT02051868|Squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5327306|NCT02051868|Cancer of the anus|cancer of the anus
5327307|NCT02051868|SCCA|scca
5327309|NCT02051868|Carboplatin-Paclitaxel|carboplatin-paclitaxel
5327310|NCT02051868|inoperable|inoperable
5327311|NCT02051868|locally recurrent|locally recurrent
5327312|NCT02051868|metastatic|metastatic
5327313|NCT02051855|Neonates|neonates
5327314|NCT02051855|Superior Vena Cava Flow|superior vena cava flow
5327315|NCT02051855|Pleth Variability Index|pleth variability index
5327316|NCT02051855|Dobutamine|dobutamine
5327317|NCT02051855|Intensive Care|intensive care
5327318|NCT02051842|NAFLD|nafld
5327319|NCT02051842|oxidative stress|oxidative stress
5327320|NCT02051842|malondialdehyde|malondialdehyde
5327321|NCT02051816|Endotracheal Intubation|endotracheal intubation
5327322|NCT02051816|Apneic Oxygenation|apneic oxygenation
5327323|NCT02051816|Respiratory failure|respiratory failure
5327324|NCT02051803|smoking cessation|smoking cessation
5327325|NCT02051803|women|women
5327326|NCT02051751|Solid tumors, Head and neck non squamous cell carcinoma, breast cancer, PI3K inhibitor, BYL719, paclitaxel|solid tumors, head and neck non squamous cell carcinoma, breast cancer, pi3k inhibitor, byl719, paclitaxel
5327327|NCT02051738|Healthy|healthy
5327328|NCT02051738|Mebendazole|mebendazole
5327329|NCT02051738|Fast-Disintegrating Chewable Formulation|fast-disintegrating chewable formulation
5327330|NCT02051738|Bioavailability|bioavailability
5327331|NCT02051712|chronic heart failure|chronic heart failure
5327332|NCT02051712|exercise training|exercise training
5327333|NCT02051712|preferred training|preferred training
5327334|NCT02051712|prevention|prevention
5327335|NCT02051699|Osteoarthritis of the knee|osteoarthritis of the knee
5327336|NCT02051699|Weight bearing radiograph|weight bearing radiograph
5327337|NCT02051699|Kellgren-Lawrence classification|kellgren-lawrence classification
5327338|NCT02051699|Joint space width|joint space width
5327339|NCT02051699|One-leg standing view|one-leg standing view
5327340|NCT02051686|Acetabulum Fractures|acetabulum fractures
5327341|NCT02051686|Pelvic Ring Injuries|pelvic ring injuries
5327342|NCT02051686|Tranexamic Acid|tranexamic acid
5327343|NCT02051673|Kidney Transplantation|kidney transplantation
5327344|NCT02051647|medical students|medical students
5327345|NCT02051647|Basel University|basel university
5327346|NCT02051634|Aging|aging
5327347|NCT02051634|Papaya|papaya
5327348|NCT02051634|Fermented Papaya|fermented papaya
5327450|NCT02051140|Giat|giat
5323695|NCT02067962|JIA|jia
5327358|NCT02051595|heart lung machine|heart lung machine
5327360|NCT02051595|cardiac surgery|cardiac surgery
5327361|NCT02051595|cardiopulmonary bypass|cardiopulmonary bypass
5327362|NCT02051595|circulation|circulation
5327363|NCT02051556|Parkinson's disease|parkinson's disease
5327364|NCT02051556|Freezing of gait|freezing of gait
5327365|NCT02051556|Asymmetry|asymmetry
5327366|NCT02051556|Rehabilitation|rehabilitation
5327367|NCT02051556|Physical therapy|physical therapy
5327369|NCT02051530|empathy|empathy
5327370|NCT02051530|mimicry|mimicry
5327371|NCT02051530|emotional reactivity|emotional reactivity
5327372|NCT02051530|prosody|prosody
5327373|NCT02051517|Virectomy|virectomy
5327374|NCT02051504|Type 1 diabetes|type 1 diabetes
5327375|NCT02051504|Glycated hemoglobin|glycated hemoglobin
5327376|NCT02051504|Muscle Oxygenation|muscle oxygenation
5327377|NCT02051504|Exercise|exercise
5327378|NCT02051504|Maximal Oxygen uptake|maximal oxygen uptake
5327379|NCT02051504|Mitochondrial respiration|mitochondrial respiration
5327380|NCT02051504|Endocannabinoid system|endocannabinoid system
5327381|NCT02051504|Oxidative stress|oxidative stress
5327382|NCT02051478|manipulation|manipulation
5327383|NCT02051478|mobilization|mobilization
5327384|NCT02051478|spine|spine
5327385|NCT02051478|pressure pain|pressure pain
5327386|NCT02051439|Varicose Veins|varicose veins
5327387|NCT02051439|Venous Insufficiency|venous insufficiency
5327388|NCT02051439|Doppler|doppler
5327389|NCT02051439|Duplex|duplex
5327390|NCT02051439|Valsava|valsava
5327391|NCT02051426|neuropsychiatric effects|neuropsychiatric effects
5327392|NCT02051413|Major depression|major depression
5327393|NCT02051413|Antidepressant drug|antidepressant drug
5327394|NCT02051413|Beta-arrestin|beta-arrestin
5327395|NCT02051413|Biomarker|biomarker
5327396|NCT02051413|Predictive factor|predictive factor
5327397|NCT02051400|Intubation|intubation
5327398|NCT02051400|Laryngoscopes|laryngoscopes
5327399|NCT02051361|DAT = Dual Antiplatelet Treatment|dat = dual antiplatelet treatment
5327400|NCT02051361|Major Cardiac Adverse Events|major cardiac adverse events
5327401|NCT02051348|Helicobacter pylori|helicobacter pylori
5327402|NCT02051348|Mild Indigestion|mild indigestion
5327403|NCT02051335|Drug therapy|drug therapy
5327404|NCT02051309|Smokers|smokers
5327405|NCT02051309|Quit Smoking|quit smoking
5327406|NCT02051309|Treatment|treatment
5327407|NCT02051309|Guanfacine|guanfacine
5327408|NCT02051283|Hepatocellular carcinoma|hepatocellular carcinoma
5327409|NCT02051283|RFA|rfa
5327410|NCT02051283|MRI|mri
5327411|NCT02051270|Elderly|elderly
5327412|NCT02051270|Nursing homes|nursing homes
5327413|NCT02051270|Mild cognitive impairment|mild cognitive impairment
5327414|NCT02051244|Alzheimer's Disease|alzheimer's disease
5327415|NCT02051244|Retinal Nerve Fiber Layer|retinal nerve fiber layer
5327416|NCT02051244|Ocular Computerized Tomography|ocular computerized tomography
5327417|NCT02051244|Minimal Cognitive Impairment|minimal cognitive impairment
5327418|NCT02051244|Subjective Memory Loss|subjective memory loss
5327419|NCT02051244|Asymptomatic Preclinical Alzheimer's Disease|asymptomatic preclinical alzheimer's disease
5327420|NCT02051231|Uterine contraction|uterine contraction
5327421|NCT02051231|Oxytocin receptors|oxytocin receptors
5327422|NCT02051231|Oxytocin desensitization|oxytocin desensitization
5327429|NCT02051205|Parkinson's disease, risk factors, epidemiology|parkinson's disease, risk factors, epidemiology
5327430|NCT02051192|obsessive-compulsive disorder|obsessive-compulsive disorder
5327431|NCT02051192|Social phobia|social phobia
5327432|NCT02051192|Generalized anxiety disorder|generalized anxiety disorder
5327433|NCT02051192|Specific phobia|specific phobia
5327434|NCT02051192|Separation anxiety disorder|separation anxiety disorder
5327435|NCT02051192|Selective Mutism|selective mutism
5327436|NCT02051192|Anxiety Disorder, Not Otherwise Specified|anxiety disorder, not otherwise specified
5327437|NCT02051192|Counseling|counseling
5327438|NCT02051192|Behavioral therapy|behavioral therapy
5327439|NCT02051192|Psychotherapy|psychotherapy
5327440|NCT02051192|Exposure|exposure
5327441|NCT02051192|Young Children|young children
5327442|NCT02051179|Repair|repair
5327443|NCT02051179|Replacement|replacement
5327444|NCT02051179|Dental Amalgam|dental amalgam
5327445|NCT02051153|Modafinil|modafinil
5327446|NCT02051153|Cognitive|cognitive
5327447|NCT02051153|Performance|performance
5327448|NCT02051140|Postural Balance|postural balance
5327457|NCT02051140|Strawberry|strawberry
5327458|NCT02051127|Exercise|exercise
5327459|NCT02051127|Physical Fitness|physical fitness
5327460|NCT02051127|Stress, Psychological|stress, psychological
5327461|NCT02051127|Cognition|cognition
5327462|NCT02051127|Psychophysiology|psychophysiology
5327463|NCT02051127|Ergometry|ergometry
5327464|NCT02051127|Exercise Test|exercise test
5327465|NCT02051127|Sedentary Lifestyle|sedentary lifestyle
5327466|NCT02051114|Rheumatoid arthritis|rheumatoid arthritis
5327467|NCT02051088|Critical limb ischemia|critical limb ischemia
5327479|NCT02051049|CN|cn
5327480|NCT02051049|UCD|ucd
5327481|NCT02051036|moxibustion|moxibustion
5327482|NCT02051023|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5327483|NCT02051023|dry eye|dry eye
5327484|NCT02051023|dry eye syndrome|dry eye syndrome
5327485|NCT02051023|dry eye disease|dry eye disease
5327486|NCT02051023|steroids|steroids
5327487|NCT02050984|Obesity|obesity
5327488|NCT02050984|Hypertension|hypertension
5327489|NCT02050984|Bariatric Surgery|bariatric surgery
5327490|NCT02050984|Diabetes|diabetes
5327491|NCT02050971|Umbilical Cord Blood|umbilical cord blood
5314202|NCT02111460|Initially|initially
5327492|NCT02050971|Autologous Umbilical Cord Blood Transfusion|autologous umbilical cord blood transfusion
5327493|NCT02050971|Prematurity Complications|prematurity complications
5195582|NCT02771782|BCG|bcg
5327494|NCT02050971|Infant, Premature, Diseases|infant, premature, diseases
5327495|NCT02050971|Infant, Newborn, Diseases|infant, newborn, diseases
5327496|NCT02050971|Hematologic Diseases|hematologic diseases
5327497|NCT02050971|Lung Diseases|lung diseases
5327498|NCT02050971|Central Nervous System Diseases|central nervous system diseases
5327499|NCT02050971|Gastrointestinal Tract Diseases|gastrointestinal tract diseases
5327500|NCT02050971|Vascular Diseases|vascular diseases
5327501|NCT02050971|Retinopathies, Neonates|retinopathies, neonates
5327502|NCT02050971|Prevention,Treatment|prevention,treatment
5327503|NCT02050932|hepcidin|hepcidin
5327504|NCT02050932|iron bioavailability|iron bioavailability
5327505|NCT02050932|iron supplementation|iron supplementation
5327506|NCT02050906|IDEA-P|idea-p
5327507|NCT02050906|Androgen Deprivation Therapy|androgen deprivation therapy
5327508|NCT02050893|septic shock|septic shock
5327509|NCT02050893|sepsis|sepsis
5327510|NCT02050893|fluid responsiveness|fluid responsiveness
5327511|NCT02050893|Midazolam|midazolam
5327512|NCT02050893|Propofol|propofol
5327513|NCT02050893|haemodynamics|haemodynamics
5327514|NCT02050880|Normal Eyes|normal eyes
5327515|NCT02050880|Eye; Disorder with Glaucoma|eye; disorder with glaucoma
5327516|NCT02050880|Eye; Disorder with Retinal Disease|eye; disorder with retinal disease
5327517|NCT02050880|Eye; Disorder Corneal Disease incl kerato-refractive group|eye; disorder corneal disease incl kerato-refractive group
5327518|NCT02050867|Youth Suicide|youth suicide
5327519|NCT02050867|Suicide|suicide
5327520|NCT02050854|Aripiprazole|aripiprazole
5327521|NCT02050854|Treatment Adherence|treatment adherence
5327522|NCT02050841|Pediatric|pediatric
5327523|NCT02050841|patients|patients
5327524|NCT02050841|replacement|replacement
5327525|NCT02050841|coagulation factors|coagulation factors
5327526|NCT02050841|plasma|plasma
5327527|NCT02050841|s/d plasma|s/d plasma
5327528|NCT02050841|Octaplas|octaplas
5676416|NCT00595049|tracleer|tracleer
5327529|NCT02050841|plasma replacement|plasma replacement
5327530|NCT02050815|MEK162|mek162
5327531|NCT02050815|Hepatic impairment|hepatic impairment
5327532|NCT02050815|Healthy subjects|healthy subjects
5327533|NCT02050802|Macitentan|macitentan
5327534|NCT02050802|Pharmacokinetics|pharmacokinetics
5327535|NCT02050802|Pharmacodynamics|pharmacodynamics
5327537|NCT02050763|Intimate partner violence|intimate partner violence
5327538|NCT02050763|Community based prevention intervention|community based prevention intervention
5327539|NCT02050763|Uganda|uganda
5327540|NCT02050763|Cluster randomized trial|cluster randomized trial
5327544|NCT02050724|Solitary Pulmonary Nodule|solitary pulmonary nodule
5327545|NCT02050724|Thoracoscopy|thoracoscopy
5327546|NCT02050724|Thoracic Surgery|thoracic surgery
5327547|NCT02050724|Video-Assisted|video-assisted
5327548|NCT02050724|Radioactive Tracers|radioactive tracers
5327549|NCT02050724|Radioguided surgery|radioguided surgery
5327550|NCT02050724|Handheld-SPECT|handheld-spect
5327747|NCT02049892|Metal Ion|metal ion
5327551|NCT02050711|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5327552|NCT02050711|Pulmonary rehabilitation|pulmonary rehabilitation
5327553|NCT02050711|Computerized respiratory sounds|computerized respiratory sounds
5327554|NCT02050698|fift metatarsal avulsion fracture|fift metatarsal avulsion fracture
5327555|NCT02050698|hard-soled shoe|hard-soled shoe
5327556|NCT02050698|short leg walking cast|short leg walking cast
5327557|NCT02050698|protected weightbearing|protected weightbearing
5327558|NCT02050672|Myoinositol|myoinositol
5327560|NCT02050672|EMBRYO QUALITY|embryo quality
5327561|NCT02050646|Autoimmune hepatitis|autoimmune hepatitis
5327562|NCT02050646|Liver dysfunction|liver dysfunction
5327563|NCT02050646|Elevated serum auto antibodies|elevated serum auto antibodies
5327564|NCT02050633|Craniocerebral Trauma|craniocerebral trauma
5327565|NCT02050633|Long term outcome|long term outcome
5327566|NCT02050633|Activities of Daily Living|activities of daily living
5327567|NCT02050633|Cognitive Deficiency|cognitive deficiency
5327568|NCT02050633|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5327569|NCT02050633|Burden of care|burden of care
5327570|NCT02050620|Breast cancer, exercise and quality of life|breast cancer, exercise and quality of life
5327571|NCT02050581|Platelets are a part of the blood hat helps with clotting|platelets are a part of the blood hat helps with clotting
5327572|NCT02050581|ITP idiopathic thrombocytopenia purpura low platelet count|itp idiopathic thrombocytopenia purpura low platelet count
5327573|NCT02050568|Genital prolapse|genital prolapse
5327574|NCT02050568|Genital prolapse surgery|genital prolapse surgery
5327575|NCT02050568|Stress urinary incontinence|stress urinary incontinence
5327576|NCT02050568|Urethral Pressure Reflectometry|urethral pressure reflectometry
5327577|NCT02050542|cancer|cancer
5327578|NCT02050542|prostate|prostate
5327579|NCT02050542|PSA|psa
5327580|NCT02050542|biopsies|biopsies
5327581|NCT02050542|ultrasound|ultrasound
5327582|NCT02050542|MRI|mri
5314297|NCT02111031|CELLSEARCH|cellsearch
5327583|NCT02050542|fusion of images|fusion of images
5327584|NCT02050529|Hypertension, Pregnancy induced|hypertension, pregnancy induced
5327585|NCT02050529|Pre-eclampsia|pre-eclampsia
5963277|NCT04258449|Uterine biofluid|uterine biofluid
5327586|NCT02050529|Eclampsia|eclampsia
5327587|NCT02050529|Labetalol|labetalol
5327588|NCT02050529|Hydralazine|hydralazine
5327589|NCT02050516|Blastocyst, micro-well group culture dish|blastocyst, micro-well group culture dish
5327590|NCT02050503|Mucositis|mucositis
5327591|NCT02050503|Breakthrough pain|breakthrough pain
5327592|NCT02050503|Head Nad neck cancer|head nad neck cancer
5327593|NCT02050503|Intranasal transmucosal fentanyl in pectin|intranasal transmucosal fentanyl in pectin
5327595|NCT02050477|Bariatric|bariatric
5327597|NCT02050477|Sleeve|sleeve
5327598|NCT02050477|Gastroplasty|gastroplasty
5327599|NCT02050477|Laparoscopy|laparoscopy
5327600|NCT02050464|Alzheimer Disease|alzheimer disease
5327601|NCT02050464|Frontotemporal Dementia|frontotemporal dementia
5327602|NCT02050464|Dementia, Vascular|dementia, vascular
5327603|NCT02050464|Mild Cognitive Impairment|mild cognitive impairment
5327604|NCT02050464|Diagnosis|diagnosis
5327605|NCT02050464|Risk factors|risk factors
5327606|NCT02050464|Biomarkers|biomarkers
5327607|NCT02050464|AD|ad
5327608|NCT02050464|FTD|ftd
5327609|NCT02050464|VAD|vad
5327610|NCT02050464|MCI|mci
5327611|NCT02050451|radical cystectomy|radical cystectomy
5327612|NCT02050451|urinary diversion|urinary diversion
5327613|NCT02050451|nutrition|nutrition
5327614|NCT02050451|oral supplementation|oral supplementation
5327615|NCT02050451|enteral nutrition|enteral nutrition
5327616|NCT02050438|Osteoarthritis Knee|osteoarthritis knee
5327617|NCT02050438|Total Knee Arthroplasty|total knee arthroplasty
5327618|NCT02050438|Quality of Life|quality of life
5327619|NCT02050425|OSA|osa
5327620|NCT02050425|CPAP|cpap
5327621|NCT02050425|exhaled breath|exhaled breath
5327622|NCT02050399|Isometric Exercise|isometric exercise
5327623|NCT02050399|Arterial Pressure|arterial pressure
5327624|NCT02050399|Autonomic Nervous System|autonomic nervous system
5327625|NCT02050399|Cardiovascular system|cardiovascular system
5327626|NCT02050399|Posture|posture
5327627|NCT02050386|Brain arousal systems|brain arousal systems
5327628|NCT02050386|Aging|aging
5327630|NCT02050386|fMRI|fmri
5327631|NCT02050386|Cognition|cognition
5327632|NCT02050373|Mucositis|mucositis
5327633|NCT02050373|Stomatitis|stomatitis
5327634|NCT02050373|Chemotherapy|chemotherapy
5327635|NCT02050373|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5327636|NCT02050373|Laser therapy|laser therapy
5327637|NCT02050373|Inflammatory cytokines|inflammatory cytokines
5327638|NCT02050360|Raynaud's phenomenon|raynaud's phenomenon
5327639|NCT02050360|Sildenafil|sildenafil
5327640|NCT02050360|Systemic Sclerosis|systemic sclerosis
5327641|NCT02050360|Local cooling|local cooling
5327642|NCT02050360|Microcirculation|microcirculation
5327643|NCT02050347|CD19.CAR-CD28zeta|cd19.car-cd28zeta
5327644|NCT02050347|chimeric antigen receptor|chimeric antigen receptor
5327645|NCT02050347|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5327646|NCT02050334|Phase 1|phase 1
5327647|NCT02050334|Healthy Volunteer|healthy volunteer
5327648|NCT02050334|Safety|safety
5327649|NCT02050334|Healthy Volunteer Safety Study|healthy volunteer safety study
5327650|NCT02050282|Dyspnea|dyspnea
5327651|NCT02050282|Prehospital|prehospital
5327652|NCT02050282|Biomarker|biomarker
5327653|NCT02050282|Heart failure|heart failure
5327654|NCT02050282|Triage|triage
5327655|NCT02050282|Randomized, controlled study|randomized, controlled study
5327656|NCT02050256|Palliative care|palliative care
5327657|NCT02050256|Continuing medical education|continuing medical education
5327663|NCT02050243|fluorescence|fluorescence
5327664|NCT02050243|5ALA|5ala
5327665|NCT02050230|transfusion|transfusion
5327666|NCT02050230|pulmonary hypertension|pulmonary hypertension
5327667|NCT02050230|intensive care medicine|intensive care medicine
5327668|NCT02050217|Helmet|helmet
5327669|NCT02050217|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5327670|NCT02050217|Children|children
5327671|NCT02050217|Respiratory Failure|respiratory failure
5327672|NCT02050204|work to family conflict|work to family conflict
5327673|NCT02050204|supervisor support|supervisor support
5327674|NCT02050204|long work hours|long work hours
5327675|NCT02050204|cardiometabolic risk|cardiometabolic risk
5327676|NCT02050204|sleep duration|sleep duration
5327677|NCT02050204|insomnia symptoms|insomnia symptoms
5327678|NCT02050178|Pancreatic Cancer|pancreatic cancer
5327679|NCT02050178|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
5327680|NCT02050165|obesity|obesity
5327681|NCT02050165|snacks|snacks
5327682|NCT02050165|satiety|satiety
5327683|NCT02050165|hunger|hunger
5327685|NCT02050152|Memory|memory
5327686|NCT02050152|Implicit|implicit
5327687|NCT02050152|Explicit|explicit
5327688|NCT02050152|Nitrous Oxide|nitrous oxide
5327689|NCT02050139|L-Cysteine|l-cysteine
5327690|NCT02050139|Peritoneal dialysis|peritoneal dialysis
5327691|NCT02050139|Diuresis|diuresis
5327692|NCT02050139|Glomerular filtration rate|glomerular filtration rate
5327693|NCT02050139|Peritoneal function|peritoneal function
5327694|NCT02050139|Inflammation|inflammation
5327695|NCT02050113|Complex Aortic Aneurysms|complex aortic aneurysms
5327696|NCT02050113|Thoracoabdominal Aneurysms|thoracoabdominal aneurysms
5327697|NCT02050113|Pararenal Aortic Aneurysms|pararenal aortic aneurysms
5327698|NCT02050113|Juxtarenal Renal Aneurysms|juxtarenal renal aneurysms
5327699|NCT02050113|Endovascular Branch Graft|endovascular branch graft
5327700|NCT02050113|Fenestrated Stent Graft|fenestrated stent graft
5327701|NCT02050113|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5327702|NCT02050113|Endovascular|endovascular
5327703|NCT02050100|primary lung adenocarcinoma Stages I, II, IIIA, IIIB|primary lung adenocarcinoma stages i, ii, iiia, iiib
5327704|NCT02050100|squamous cell carcinoma Stages I, II, IIIA, IIIB|squamous cell carcinoma stages i, ii, iiia, iiib
5327705|NCT02050100|benign non-calcified pulmonary nodules|benign non-calcified pulmonary nodules
5327706|NCT02050100|early detection|early detection
5327707|NCT02050087|Rotator cuff|rotator cuff
5327708|NCT02050087|Rehabilitation|rehabilitation
5327709|NCT02050048|Pancreatitis|pancreatitis
5327710|NCT02050048|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5327711|NCT02050048|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5327712|NCT02050048|ERCP|ercp
5327713|NCT02050048|High Volume|high volume
5327714|NCT02050048|Lactated Ringer|lactated ringer
5327715|NCT02050048|Intravenous Administration|intravenous administration
5327716|NCT02050048|Sphincterotomy, Endoscopic|sphincterotomy, endoscopic
5327717|NCT02050048|Pancreas|pancreas
5327718|NCT02050035|Exercise Therapy|exercise therapy
5327719|NCT02050035|Endothelium, vascular|endothelium, vascular
5327720|NCT02050035|Blood Vessels|blood vessels
5327721|NCT02050022|Biomarkers|biomarkers
5327722|NCT02050022|Genomics|genomics
5327723|NCT02050022|Proteomics|proteomics
5327724|NCT02050022|Diagnostics|diagnostics
5327725|NCT02050022|Prognostics|prognostics
5327726|NCT02049996|Quality of life|quality of life
5327727|NCT02049996|Robotic surgery|robotic surgery
5327728|NCT02049996|Vaginal surgery|vaginal surgery
5327729|NCT02049996|Prolapse repair|prolapse repair
5327730|NCT02049996|Vaginal hysterectomy|vaginal hysterectomy
5327731|NCT02049970|Supraclavicular block|supraclavicular block
5327732|NCT02049957|Sapanisertib|sapanisertib
5327733|NCT02049957|MLN0128|mln0128
5327734|NCT02049944|Antibiotic Prophylaxis|antibiotic prophylaxis
5327735|NCT02049944|Obesity|obesity
5327736|NCT02049944|Obesity, Morbid|obesity, morbid
5327737|NCT02049944|Pregnancy|pregnancy
5327738|NCT02049944|Infection; Cesarean Section|infection; cesarean section
5327739|NCT02049931|osteoporosis, compression fracture, brace|osteoporosis, compression fracture, brace
5327740|NCT02049918|Respiratory viruses|respiratory viruses
5327741|NCT02049905|soft tissue sarcoma|soft tissue sarcoma
5327742|NCT02049905|unresectable|unresectable
5327743|NCT02049905|metastatic|metastatic
5327744|NCT02049905|locally advanced|locally advanced
5327745|NCT02049905|sarcoma|sarcoma
5327746|NCT02049892|Total Hip Replacement|total hip replacement
5327752|NCT02049866|denosumab|denosumab
5327753|NCT02049866|idiopathic|idiopathic
5327754|NCT02049866|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
5327755|NCT02049853|acute dyspnea|acute dyspnea
5327756|NCT02049853|heart failure|heart failure
5327758|NCT02049853|POCT analysis|poct analysis
5327759|NCT02049853|preclinical area|preclinical area
5327760|NCT02049840|Female sling|female sling
5327761|NCT02049840|Stress Urinary Incontinence|stress urinary incontinence
5327762|NCT02049840|Urination Disorders|urination disorders
5327763|NCT02049840|Urologic Diseases|urologic diseases
5327764|NCT02049827|Renal transplant, BK virus|renal transplant, bk virus
5327765|NCT02049814|Drug therapy|drug therapy
5327766|NCT02049762|novel P2Y12 inhibitors|novel p2y12 inhibitors
5327767|NCT02049762|aspirin|aspirin
5327768|NCT02049762|platelet reactivity|platelet reactivity
5327769|NCT02049762|acute coronary syndrome|acute coronary syndrome
5327770|NCT02049749|Child Behavior Problems|child behavior problems
5327771|NCT02049749|Parent Training Program|parent training program
5327772|NCT02049723|Gastroesophageal reflux disease|gastroesophageal reflux disease
5327773|NCT02049723|Knowledge|knowledge
5327774|NCT02049697|Healthy|healthy
5327775|NCT02049697|Healthy male participants|healthy male participants
5327776|NCT02049697|14C-JNJ -39823277|14c-jnj -39823277
5327778|NCT02049697|Tianeptine|tianeptine
5327779|NCT02049697|Absorption|absorption
5327780|NCT02049697|Metabolism|metabolism
5327781|NCT02049697|Excretion|excretion
5327782|NCT02049697|Pharmacokinetics|pharmacokinetics
5327783|NCT02049658|tumor|tumor
5327784|NCT02049658|cancer|cancer
5327785|NCT02049645|lung cancer|lung cancer
5327786|NCT02049645|breast cancer|breast cancer
5327791|NCT02049619|Pharyngeal pack|pharyngeal pack
5327792|NCT02049619|Nausea|nausea
5327793|NCT02049619|Vomiting|vomiting
5327794|NCT02049619|orthognathic surgery|orthognathic surgery
5327795|NCT02049619|maxillary osteotomy|maxillary osteotomy
5327796|NCT02049606|LAYLA|layla
5327797|NCT02049606|Non-inferiority|non-inferiority
5327798|NCT02049606|100mm pain VAS|100mm pain vas
5327799|NCT02049593|protocol specific|protocol specific
5327800|NCT02049580|lymphoma|lymphoma
5327801|NCT02049567|cataract, presbyopia|cataract, presbyopia
5327802|NCT02049554|preconception care|preconception care
5327803|NCT02049554|women's health|women's health
5327804|NCT02049541|BKM120|bkm120
5327805|NCT02049541|B-Cell Lymphoma|b-cell lymphoma
5327806|NCT02049541|PI3K inhibitor|pi3k inhibitor
5327807|NCT02049528|Food Effect|food effect
5327808|NCT02049528|Pharmacokinetic|pharmacokinetic
5327809|NCT02049528|Healthy|healthy
5327810|NCT02049528|Male|male
5327811|NCT02049515|Phase 3|phase 3
5327812|NCT02049515|CLL/SLL|cll/sll
5327813|NCT02049515|PI3K|pi3k
5327814|NCT02049502|ulcerative colitis|ulcerative colitis
5327815|NCT02049502|fecal microbiota transplantation|fecal microbiota transplantation
5327816|NCT02049489|ICT-121|ict-121
5327817|NCT02049489|glioblastoma|glioblastoma
5327818|NCT02049489|immunotherapy|immunotherapy
5327819|NCT02049489|dendritic cell vaccine|dendritic cell vaccine
5327820|NCT02049489|CD133|cd133
5327821|NCT02049476|Uveitis, Intermediate|uveitis, intermediate
5327822|NCT02049476|Uveitis, Posterior|uveitis, posterior
5327823|NCT02049476|Dexamethasone|dexamethasone
5327824|NCT02049476|Immunosuppressive Agents|immunosuppressive agents
5327825|NCT02049476|Eye Abnormalities|eye abnormalities
5327826|NCT02049476|Eye Diseases|eye diseases
5327827|NCT02049476|Ophthalmology|ophthalmology
5327828|NCT02049476|Ophthalmologic Surgical Procedures|ophthalmologic surgical procedures
5327829|NCT02049476|Vision Disorders|vision disorders
5327830|NCT02049476|Inflammation|inflammation
5327831|NCT02049463|carotid artery|carotid artery
5327832|NCT02049463|sound|sound
5327833|NCT02049463|stenosis|stenosis
5327834|NCT02049463|wall|wall
5327835|NCT02049463|stroke|stroke
5327836|NCT02049450|thalassemia|thalassemia
5327837|NCT02049450|thalassemia major|thalassemia major
5327838|NCT02049450|spleen enlargement|spleen enlargement
5327839|NCT02049450|INC424|inc424
5327840|NCT02049450|ruxolitinib|ruxolitinib
5327841|NCT02049437|HIV|hiv
5327842|NCT02049437|Immune failure|immune failure
5327843|NCT02049437|Tocilizumab|tocilizumab
5327844|NCT02049437|ACTEMRA|actemra
5327845|NCT02049437|Antiretroviral therapy|antiretroviral therapy
5327846|NCT02049437|HAART|haart
5327847|NCT02049411|Ketamine|ketamine
5327848|NCT02049411|acute cognitive dysfunction|acute cognitive dysfunction
5327849|NCT02049411|geriatric patients|geriatric patients
5327850|NCT02049398|Microbiome|microbiome
5327851|NCT02049398|Saliva|saliva
5327852|NCT02049398|Reliability|reliability
5327853|NCT02049398|Oral Cavity|oral cavity
5327854|NCT02049385|Glutamate|glutamate
5327855|NCT02049385|Pathophysiology|pathophysiology
5327856|NCT02049385|Depression|depression
5327857|NCT02049385|Treatment|treatment
5327858|NCT02049372|complications|complications
5327859|NCT02049372|tonsillectomy|tonsillectomy
5327860|NCT02049372|tonsillotomy|tonsillotomy
5327861|NCT02049359|Diabetes|diabetes
5327862|NCT02049346|Anemia|anemia
5327863|NCT02049346|Hemodialysis|hemodialysis
5327864|NCT02049346|Erythropoetin Stimulating Agents|erythropoetin stimulating agents
5327865|NCT02049346|Comparison|comparison
5327866|NCT02049294|Prednisone|prednisone
5327867|NCT02049294|Eosinophils|eosinophils
5327868|NCT02049294|Immunoglobin E (IgE)|immunoglobin e (ige)
5327869|NCT02049294|Asthma|asthma
5327870|NCT02049294|Bronchitis|bronchitis
5327871|NCT02049294|Inflammation|inflammation
5327872|NCT02049294|Allergy|allergy
5327873|NCT02049268|alcohol|alcohol
5327874|NCT02049268|nicotine|nicotine
5327875|NCT02049268|addiction|addiction
5327876|NCT02049268|functional MRI|functional mri
5327877|NCT02049268|functional connectivity|functional connectivity
5327878|NCT02049268|brain circuits|brain circuits
5327879|NCT02049255|All|all
5327880|NCT02049242|Hemorrhage|hemorrhage
5327881|NCT02049242|Leiomyoma|leiomyoma
5327882|NCT02049242|Myofibroma|myofibroma
5327883|NCT02049242|Uterine Myomectomy|uterine myomectomy
5327884|NCT02049242|Tourniquet|tourniquet
5327885|NCT02049229|Stent|stent
5327886|NCT02049229|Titanium|titanium
5327887|NCT02049229|drug eluting stent|drug eluting stent
5327888|NCT02049229|myocardial infarction|myocardial infarction
5327889|NCT02049229|stent thrombosis|stent thrombosis
5327890|NCT02049216|knee|knee
5327893|NCT02049216|exercise|exercise
5327894|NCT02049216|rocktape|rocktape
5327895|NCT02049190|Advanced Prostate Cancer|advanced prostate cancer
5327896|NCT02049190|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5327897|NCT02049190|Prostatic Neoplasms|prostatic neoplasms
5327898|NCT02049190|Genital Neoplasms, Male|genital neoplasms, male
5327899|NCT02049190|Urogenital Neoplasms|urogenital neoplasms
5327900|NCT02049190|Neoplasms by Site|neoplasms by site
5327901|NCT02049190|Neoplasms|neoplasms
5327902|NCT02049190|Genital Diseases, Male|genital diseases, male
5327903|NCT02049190|Prostatic Diseases|prostatic diseases
5327904|NCT02049190|onapristone|onapristone
5327905|NCT02049177|Cancer|cancer
5327906|NCT02049177|Epidemiology|epidemiology
5327907|NCT02049177|Head and Neck|head and neck
5327908|NCT02049177|HPV|hpv
5327909|NCT02049164|AR08, Vasomotor Symptoms|ar08, vasomotor symptoms
5327910|NCT02049151|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5327911|NCT02049151|Tecemotide|tecemotide
5327912|NCT02049151|Placebo|placebo
5327913|NCT02049151|NSCLC|nsclc
5327914|NCT02049151|L-BLP25|l-blp25
5327915|NCT02049138|Musculoskeletal Disease|musculoskeletal disease
5327916|NCT02049138|Arthritis|arthritis
5327917|NCT02049138|Joint Diseases|joint diseases
5327918|NCT02049138|Anti-inflammatory Agents|anti-inflammatory agents
5327919|NCT02049138|Antirheumatic agents|antirheumatic agents
5327920|NCT02049125|NGAL|ngal
5327921|NCT02049125|Acute kidney injury|acute kidney injury
5327922|NCT02049125|Cirrhosis|cirrhosis
5327923|NCT02049125|Hepatorenal syndrome|hepatorenal syndrome
5327924|NCT02049112|Cross-over|cross-over
5327925|NCT02049112|Salivary equivalent|salivary equivalent
5327926|NCT02049112|Dry mouth|dry mouth
5327927|NCT02049112|Medical device|medical device
5327928|NCT02049086|SBIRT|sbirt
5327929|NCT02049086|Screening|screening
5327930|NCT02049086|Brief Intervention|brief intervention
5327931|NCT02049086|Referral to Treatment|referral to treatment
5327932|NCT02049086|Pain-Management|pain-management
5327933|NCT02049086|Veterans|veterans
5327934|NCT02049073|hearing loss|hearing loss
5327935|NCT02049073|noise induced hearing loss|noise induced hearing loss
5327936|NCT02049073|zonisamide|zonisamide
5327937|NCT02049060|MPM|mpm
5327938|NCT02049060|NSCLC|nsclc
5327939|NCT02049047|thymoma thymic carcinoma|thymoma thymic carcinoma
5327940|NCT02049034|GLP-1 agonist|glp-1 agonist
5327941|NCT02049034|Lixisenatide|lixisenatide
5676803|NCT00593216|vertigo|vertigo
5327942|NCT02049034|Postprandial glucose metabolism|postprandial glucose metabolism
5327943|NCT02049034|Postprandial lipid metabolism|postprandial lipid metabolism
5327944|NCT02049034|Gastric emptying|gastric emptying
5327945|NCT02049034|Lipoprotein lipase activity|lipoprotein lipase activity
5327946|NCT02049021|schizophrenia|schizophrenia
5327947|NCT02049021|electroconvulsive therapy|electroconvulsive therapy
5327948|NCT02049021|refractory Schizophrenia|refractory schizophrenia
5327949|NCT02049021|super refractory schizophrenia|super refractory schizophrenia
5327950|NCT02049021|clozapine|clozapine
5327951|NCT02048995|Bipolar Disorder|bipolar disorder
5327952|NCT02048995|Depression|depression
5327953|NCT02048995|Light Therapy|light therapy
5327954|NCT02048995|Contrast Sensitivity|contrast sensitivity
5327955|NCT02048995|Visual Evoked Potential|visual evoked potential
5327956|NCT02048995|Visual or Neural Responses|visual or neural responses
5327957|NCT02048995|Biomarker|biomarker
5328144|NCT02048098|misoprostol|misoprostol
5327958|NCT02048982|physician prescribing|physician prescribing
5327959|NCT02048982|behavioral economics|behavioral economics
5327960|NCT02048982|primary care practice|primary care practice
5327961|NCT02048969|hepatic encephalopathy|hepatic encephalopathy
5327962|NCT02048969|flumazenil|flumazenil
5327963|NCT02048969|liver cirrhosis|liver cirrhosis
5327964|NCT02048956|knee osteoarthritis|knee osteoarthritis
5327965|NCT02048956|hydrotherapy|hydrotherapy
5327966|NCT02048930|GPRD|gprd
5327967|NCT02048930|effectiveness|effectiveness
5327968|NCT02048930|cost-effectiveness|cost-effectiveness
5327969|NCT02048930|Easyhaler|easyhaler
5327970|NCT02048930|Primary care|primary care
5327972|NCT02048917|Smoking|smoking
5327979|NCT02048904|microalbuminuria|microalbuminuria
5327980|NCT02048904|type 2 diabetes|type 2 diabetes
5327981|NCT02048878|Insomnia|insomnia
5327982|NCT02048865|VTE Cancer|vte cancer
5327984|NCT02048852|nicotine|nicotine
5327985|NCT02048826|stroke|stroke
5327986|NCT02048800|Treosulfan pharmacokinetics|treosulfan pharmacokinetics
5327987|NCT02048800|Children|children
5327988|NCT02048800|Any condition that requires an allogeneic HSCT|any condition that requires an allogeneic hsct
5327989|NCT02048787|Renal impairment|renal impairment
5327990|NCT02048787|Healthy volunteers|healthy volunteers
5327991|NCT02048787|Clinical pharmacology study|clinical pharmacology study
5327992|NCT02048748|Home Care Services|home care services
5327993|NCT02048748|Telemedicine|telemedicine
5327994|NCT02048696|Exercise training|exercise training
5327995|NCT02048696|High intensity interval training|high intensity interval training
5327996|NCT02048696|left ventricular systolic function|left ventricular systolic function
5327997|NCT02048696|G-protein related kinase 2|g-protein related kinase 2
5327998|NCT02048696|heart failure|heart failure
5327999|NCT02048696|myocardial infarction|myocardial infarction
5328000|NCT02048696|coronary artery disease|coronary artery disease
5328001|NCT02048696|beta adrenergic receptor|beta adrenergic receptor
5328002|NCT02048683|Pharmacokinetics|pharmacokinetics
5328003|NCT02048683|Sevoflurane|sevoflurane
5328004|NCT02048683|Burn|burn
5328005|NCT02048683|Sedation|sedation
5328006|NCT02048670|Pilot study|pilot study
5328007|NCT02048670|Assessment of sway phase|assessment of sway phase
5328008|NCT02048670|Therapy trial phase|therapy trial phase
5328009|NCT02048657|LMA, Foley Airway Stylet Tool (FAST), introducer-tool (I-Tool)|lma, foley airway stylet tool (fast), introducer-tool (i-tool)
5328010|NCT02048644|Platelets adhesion|platelets adhesion
5328011|NCT02048631|oral cancer,Quality of life,Sensory|oral cancer,quality of life,sensory
5328012|NCT02048618|Active Crohn's Disease|active crohn's disease
5328013|NCT02048618|GLPG0634|glpg0634
5328014|NCT02048592|cystic fibrosis, immunonutrition, oxidative stress|cystic fibrosis, immunonutrition, oxidative stress
5328015|NCT02048566|Echocardiography, Transesophageal|echocardiography, transesophageal
5328016|NCT02048566|Monitoring, Physiologic|monitoring, physiologic
5328017|NCT02048566|Shock|shock
5328018|NCT02048553|ventriculostomy; complications in neurosurgery;catheter accuracy;|ventriculostomy; complications in neurosurgery;catheter accuracy;
5328019|NCT02048514|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5328020|NCT02048514|Endovascular Procedures|endovascular procedures
5328021|NCT02048501|Weight regain|weight regain
5328022|NCT02048501|Sustain weight loss|sustain weight loss
5328023|NCT02048501|Weight loss|weight loss
5328024|NCT02048501|Gut hormones|gut hormones
5328025|NCT02048488|non small cell lung cancer|non small cell lung cancer
5328026|NCT02048488|NSCLC|nsclc
5328027|NCT02048488|Anaplastic lymphoma kinase|anaplastic lymphoma kinase
5328028|NCT02048488|ALK tyrosine kinase receptor|alk tyrosine kinase receptor
5328029|NCT02048488|ALK+|alk+
5328030|NCT02048488|TRK+|trk+
5328031|NCT02048488|ALK inhibitor|alk inhibitor
5328032|NCT02048488|TRK inhibitor|trk inhibitor
5328033|NCT02048488|tropomyosin receptor kinase|tropomyosin receptor kinase
5328034|NCT02048488|TRKA|trka
5328035|NCT02048488|TRKB|trkb
5328036|NCT02048488|TRKC|trkc
5328037|NCT02048488|advanced malignancy|advanced malignancy
5328038|NCT02048475|desflurane|desflurane
5328039|NCT02048475|electroencephalogram|electroencephalogram
5328040|NCT02048449|Reflux finding score, interrater reliability|reflux finding score, interrater reliability
5328041|NCT02048436|Respiratory Rate|respiratory rate
5328042|NCT02048423|suicidal|suicidal
5328043|NCT02048397|Bronchiectasis.|bronchiectasis.
5328044|NCT02048384|rapamycin|rapamycin
5328045|NCT02048384|metformin|metformin
5328046|NCT02048384|pancreatic cancer|pancreatic cancer
5328047|NCT02048384|adenocarcinoma|adenocarcinoma
5328048|NCT02048384|metastatic|metastatic
5328049|NCT02048358|Healthy volunteers|healthy volunteers
5328050|NCT02048358|first in human|first in human
5328051|NCT02048358|2B3-201|2b3-201
5328052|NCT02048358|methylprednisolone|methylprednisolone
5328053|NCT02048358|CNS-targeting|cns-targeting
5328054|NCT02048358|liposomal|liposomal
5328055|NCT02048358|crossover|crossover
5328056|NCT02048358|placebo controlled|placebo controlled
5328057|NCT02048358|active controlled|active controlled
5328058|NCT02048358|multiple sclerosis|multiple sclerosis
5328059|NCT02048358|multiple sclerosis relapse|multiple sclerosis relapse
5328060|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fasted state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fasted state
5324343|NCT02064998|Screening|screening
5328061|NCT02048345|ten mL suspension of posaconazol (Noxafil) together with 240mL water will be taken by the volunteer in a fed state|ten ml suspension of posaconazol (noxafil) together with 240ml water will be taken by the volunteer in a fed state
5328062|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fasted state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fasted state
5328063|NCT02048345|two point six mL of suspension that is dissolved in 247mL water will be administered to the volunteer by the stomach catheter in a fed state|two point six ml of suspension that is dissolved in 247ml water will be administered to the volunteer by the stomach catheter in a fed state
5328065|NCT02048332|Adenovirus (ADV)|adenovirus (adv)
5328066|NCT02048332|t-cells|t-cells
5328067|NCT02048332|donor|donor
5328068|NCT02048332|transplant|transplant
5328069|NCT02048332|children|children
5328070|NCT02048332|cytomegalovirus (CMV)|cytomegalovirus (cmv)
5328071|NCT02048332|BK virus (BKV)|bk virus (bkv)
5328072|NCT02048319|Liver cyst|liver cyst
5328073|NCT02048319|Hepatic cyst|hepatic cyst
5328074|NCT02048319|Symptomatic|symptomatic
5328075|NCT02048319|Aspiration sclerotherapy|aspiration sclerotherapy
5328076|NCT02048306|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5328077|NCT02048306|Pulmonary rehabilitation|pulmonary rehabilitation
5328079|NCT02048306|Integrated care|integrated care
5328080|NCT02048306|Mixed methods|mixed methods
5328081|NCT02048293|remifentanil|remifentanil
5328082|NCT02048293|propofol|propofol
5328083|NCT02048293|pharmacodynamic|pharmacodynamic
5328084|NCT02048293|total intravenous anesthesia|total intravenous anesthesia
5328085|NCT02048293|orotracheal intubation|orotracheal intubation
5328086|NCT02048293|heart rate|heart rate
5328087|NCT02048293|mean arterial pressure|mean arterial pressure
5328088|NCT02048293|Cooper intubation condition score|cooper intubation condition score
5328089|NCT02048267|Alcoholic|alcoholic
5328090|NCT02048267|Non alcoholic|non alcoholic
5328091|NCT02048267|Idiopathic|idiopathic
5328092|NCT02048267|Tropical|tropical
5328093|NCT02048267|Exocrine dysfunction|exocrine dysfunction
5328094|NCT02048267|Endocrine dysfunction|endocrine dysfunction
5328095|NCT02048267|Pain control|pain control
5328096|NCT02048267|Frey's procedure|frey's procedure
5328097|NCT02048267|Duodenum preserving pancreatic head resection|duodenum preserving pancreatic head resection
5328098|NCT02048254|inoperable salivary gland cancer|inoperable salivary gland cancer
5328099|NCT02048254|brachytherapy|brachytherapy
5328100|NCT02048254|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5328101|NCT02048241|childhood|childhood
5328102|NCT02048241|temper|temper
5328103|NCT02048241|explosive|explosive
5328104|NCT02048241|aggression|aggression
5328105|NCT02048241|tantrums|tantrums
5328106|NCT02048241|oppositional|oppositional
5328107|NCT02048241|defiant|defiant
5328108|NCT02048241|conduct|conduct
5328109|NCT02048241|disruptive|disruptive
5328110|NCT02048241|emotional dysregulation|emotional dysregulation
5328111|NCT02048241|special education|special education
5328112|NCT02048228|Clopidogrel,|clopidogrel,
5328113|NCT02048228|Pharmacogenetics,|pharmacogenetics,
5328114|NCT02048228|Platelet reactivity,|platelet reactivity,
5328115|NCT02048228|CYP2C19,|cyp2c19,
5328116|NCT02048228|point-of-care|point-of-care
5328117|NCT02048215|thermogenesis|thermogenesis
5328118|NCT02048215|low-calorie diet|low-calorie diet
5328119|NCT02048215|uncoupling-protein 3|uncoupling-protein 3
5328120|NCT02048215|beta-3 adrenoceptors|beta-3 adrenoceptors
5328121|NCT02048215|thermogenic drugs|thermogenic drugs
5328122|NCT02048202|clown|clown
5328123|NCT02048202|neonate|neonate
5328124|NCT02048202|premature|premature
5328125|NCT02048176|Mutism|mutism
5328126|NCT02048163|Meropenem|meropenem
5328127|NCT02048163|Nausea|nausea
5328128|NCT02048163|Pharmacokinetics|pharmacokinetics
5328129|NCT02048124|25d ProCor needle|25d procor needle
5328130|NCT02048124|22 gauge|22 gauge
5328131|NCT02048124|endoscopic ultrasonography|endoscopic ultrasonography
5328132|NCT02048124|fine needle biopsies|fine needle biopsies
5328133|NCT02048124|Patients|patients
5328134|NCT02048124|presenting|presenting
5328135|NCT02048111|Hemophilia B|hemophilia b
5328136|NCT02048111|Hemophilia A|hemophilia a
5328137|NCT02048111|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5328138|NCT02048111|Blood Coagulation Disorders|blood coagulation disorders
5328139|NCT02048111|Hematologic Diseases|hematologic diseases
5328140|NCT02048111|Coagulation Protein Disorders|coagulation protein disorders
5328141|NCT02048111|Hemorrhagic Disorders|hemorrhagic disorders
5328142|NCT02048111|Genetic Diseases, Inborn|genetic diseases, inborn
5328143|NCT02048111|Genetic Diseases, X-Linked|genetic diseases, x-linked
5328189|NCT02048007|Infection|infection
5328190|NCT02048007|Bacterial infections|bacterial infections
5328191|NCT02048007|Trachoma|trachoma
5328192|NCT02048007|Chlamydia infections|chlamydia infections
5328193|NCT02048007|Malaria|malaria
5328194|NCT02048007|Diarrhea|diarrhea
5328195|NCT02048007|Respiratory Infections|respiratory infections
5328196|NCT02048007|Antibiotic resistance|antibiotic resistance
5328197|NCT02048007|Verbal Autopsy|verbal autopsy
5328198|NCT02048007|Microbiome|microbiome
5328205|NCT02047981|Childhood mortality|childhood mortality
5328206|NCT02047981|Azithromycin|azithromycin
5328207|NCT02047981|Mass treatment|mass treatment
5328208|NCT02047981|Infection|infection
5328209|NCT02047981|Verbal Autopsy|verbal autopsy
5328210|NCT02047968|Wake therapy|wake therapy
5328211|NCT02047968|Sleep deprivation|sleep deprivation
5328212|NCT02047968|Light therapy|light therapy
5328213|NCT02047968|Bipolar depression|bipolar depression
5328214|NCT02047968|Sleep-wake cycle|sleep-wake cycle
5328215|NCT02047968|Major depression|major depression
5328216|NCT02047968|Depression|depression
5328217|NCT02047968|Depressive Disorder|depressive disorder
5328218|NCT02047968|Major Behavioural Symptoms|major behavioural symptoms
5328219|NCT02047968|Mood Disorders|mood disorders
5328220|NCT02047968|Mental Disorders|mental disorders
5328221|NCT02047968|Dyssomnias|dyssomnias
5328222|NCT02047968|Sleep Disorders|sleep disorders
5328223|NCT02047968|Affective Disorders|affective disorders
5328224|NCT02047929|Asthma|asthma
5328225|NCT02047929|Shared decision making|shared decision making
5328226|NCT02047929|Participatory methods|participatory methods
5328227|NCT02047929|Practice facilitator|practice facilitator
5328228|NCT02047929|Health coach|health coach
5328229|NCT02047916|Neonates|neonates
5328230|NCT02047916|Superior Vena Cava Flow|superior vena cava flow
5328231|NCT02047916|Pleth variabilty index|pleth variabilty index
5328232|NCT02047890|CDK inhibitor|cdk inhibitor
5328233|NCT02047890|BAY1000394|bay1000394
5328234|NCT02047890|Advanced malignancies|advanced malignancies
5328235|NCT02047890|Japanese|japanese
5328236|NCT02047877|Respiratory Secretions|respiratory secretions
5328237|NCT02047877|Tracheal Secretions|tracheal secretions
5328238|NCT02047877|Bronchial Secretions|bronchial secretions
5328239|NCT02047877|NonBronchoscopic BAL|nonbronchoscopic bal
5328240|NCT02047877|Interleukin 10|interleukin 10
5328241|NCT02047877|Interleukin 12p70|interleukin 12p70
5328242|NCT02047864|Osteoporosis|osteoporosis
5328243|NCT02047864|Sarcopenia|sarcopenia
5328244|NCT02047864|Strength|strength
5328245|NCT02047864|Bone|bone
5328246|NCT02047864|Muscle|muscle
5328249|NCT02047825|Dexterity|dexterity
5328250|NCT02047825|Upper limbs|upper limbs
5328251|NCT02047812|Laparotomy|laparotomy
5328252|NCT02047812|General Surgery|general surgery
5328253|NCT02047812|Hospitals,General|hospitals,general
5328254|NCT02047812|Hospitals,High-Volume|hospitals,high-volume
5328255|NCT02047812|Hospitals,Low-Volume|hospitals,low-volume
5196261|NCT02767284|Diagnostic Techniques, Ophthalmological|diagnostic techniques, ophthalmological
5196264|NCT02767245|Thiamine|thiamine
5208192|NCT02693964|Bone Density|bone density
5294261|NCT02204683|AMD|amd
5328256|NCT02047812|Outcome Assessment (Health Care)|outcome assessment (health care)
5328257|NCT02047799|elderly people, high blood pressure, vitamin D.|elderly people, high blood pressure, vitamin d.
5328258|NCT02047786|Outcome Assessment (Health Care)|outcome assessment (health care)
5328259|NCT02047786|Appendectomy|appendectomy
5328260|NCT02047786|Child|child
5328261|NCT02047786|Hospitals, Pediatric|hospitals, pediatric
5328262|NCT02047786|Hospitals, General|hospitals, general
5328263|NCT02047773|bronchiectasis|bronchiectasis
5328264|NCT02047773|intravenous antibiotics|intravenous antibiotics
5328265|NCT02047773|duration of antibiotic course|duration of antibiotic course
5328266|NCT02047773|side effects|side effects
5328267|NCT02047773|bacterial load|bacterial load
5328268|NCT02047747|Brain|brain
5328269|NCT02047747|Metastasis|metastasis
5328270|NCT02047747|human epidermal receptor (HER)|human epidermal receptor (her)
5328271|NCT02047695|migraine with aura|migraine with aura
5328272|NCT02047695|migraine|migraine
5328273|NCT02047695|case-control study|case-control study
5328274|NCT02047695|magnetic resonance imaging|magnetic resonance imaging
5328275|NCT02047695|brain diseases|brain diseases
5328276|NCT02047656|Healthy volunteers, hypertension|healthy volunteers, hypertension
5328277|NCT02047643|Type 1 diabetes|type 1 diabetes
5328278|NCT02047643|Hypoglycemia|hypoglycemia
5328279|NCT02047643|Accelerometer|accelerometer
5328280|NCT02047630|Primary open angle glaucoma|primary open angle glaucoma
5328281|NCT02047630|Ocular hypertension|ocular hypertension
5328282|NCT02047630|latanoprost|latanoprost
5328283|NCT02047630|generic|generic
5328284|NCT02047630|intraocular pressure|intraocular pressure
5328285|NCT02047617|Muscle Weakness|muscle weakness
5328286|NCT02047617|Exercise therapy|exercise therapy
5328287|NCT02047617|Physiotherapy|physiotherapy
5328288|NCT02047617|Critical illness|critical illness
5328289|NCT02047617|Intensive care|intensive care
5328290|NCT02047617|Mechanical ventilation|mechanical ventilation
5328291|NCT02047617|Rehabilitation|rehabilitation
5328292|NCT02047604|Phase 2a multiple ascending dose, Anti-Very Late Antigen-1|phase 2a multiple ascending dose, anti-very late antigen-1
5328293|NCT02047578|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5328294|NCT02047565|punch biopsy|punch biopsy
5328295|NCT02047552|trauma|trauma
5328296|NCT02047552|iron|iron
5328297|NCT02047552|anemia|anemia
5328298|NCT02047552|red blood cell transfusion|red blood cell transfusion
5328299|NCT02047526|Heart Failure|heart failure
5328300|NCT02047526|Cardiovascular disease|cardiovascular disease
5328301|NCT02047526|Congestive Heart Failure|congestive heart failure
5328302|NCT02047500|TH-302|th-302
5328303|NCT02047500|Nab-paclitaxel|nab-paclitaxel
5328304|NCT02047500|Gemcitabine|gemcitabine
5328305|NCT02047500|Evofosfamide|evofosfamide
5328306|NCT02047461|Molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
5328307|NCT02047461|molybdenum cofactor (MoCo) biosynthesis|molybdenum cofactor (moco) biosynthesis
5328308|NCT02047461|sulfite oxidase (SO)|sulfite oxidase (so)
5328309|NCT02047461|xanthine dehydrogenase|xanthine dehydrogenase
5328310|NCT02047461|aldehyde oxidase|aldehyde oxidase
5328311|NCT02047461|S sulfocysteine (SSC)|s sulfocysteine (ssc)
5328312|NCT02047448|transition of care|transition of care
5328313|NCT02047448|care transitions|care transitions
5328314|NCT02047448|readmission|readmission
5328315|NCT02047448|medication|medication
5328316|NCT02047448|adherence|adherence
5328317|NCT02047448|medication management|medication management
5328318|NCT02047448|medication reconciliation|medication reconciliation
5328319|NCT02047448|patient counseling|patient counseling
5328320|NCT02047448|pharmacist|pharmacist
5328321|NCT02047435|Social participation|social participation
5328322|NCT02047435|Loneliness|loneliness
5328323|NCT02047435|General practice|general practice
5328324|NCT02047435|Cultural institutions|cultural institutions
5328325|NCT02047422|Heart failure, diuretics, kidney, glomerular filtration rate|heart failure, diuretics, kidney, glomerular filtration rate
5328326|NCT02047383|respiratory infection|respiratory infection
5328327|NCT02047383|physical variables|physical variables
5328328|NCT02047370|stretching, diaphragm, asthma, manual therapy|stretching, diaphragm, asthma, manual therapy
5328329|NCT02047357|Maternal depression|maternal depression
5328332|NCT02047357|LTP|ltp
5328333|NCT02047357|Learning Through Play|learning through play
5328334|NCT02047357|Healthy thinking|healthy thinking
5328336|NCT02047331|periarticular drug injection|periarticular drug injection
5328337|NCT02047331|fascia iliaca block|fascia iliaca block
5328338|NCT02047331|knee arthroplasty|knee arthroplasty
5328339|NCT02047305|ESCN|escn
5328340|NCT02047305|RFA|rfa
5328655|NCT02046044|Ivabradine|ivabradine
5963278|NCT04258124|Physiotherapy|physiotherapy
5963279|NCT04258124|Motor Control|motor control
5963280|NCT04258124|Cervical|cervical
5963281|NCT04258124|Stabilizer|stabilizer
5963282|NCT04258124|Esports|esports
5963283|NCT04258059|groundwater|groundwater
5963284|NCT04258059|private wells|private wells
5208293|NCT02693548|Familial Hypercholesterolaemia|familial hypercholesterolaemia
5208294|NCT02693548|Prognosis|prognosis
5208295|NCT02693548|Cardiovascular disease|cardiovascular disease
5208300|NCT02693496|ResearchKit|researchkit
5208301|NCT02693496|CT screening|ct screening
5208302|NCT02693496|Early Diagnosis|early diagnosis
5208303|NCT02693496|Lung Cancer|lung cancer
5208304|NCT02693392|Fenugreek seed extract|fenugreek seed extract
5208305|NCT02693392|HbA1c|hba1c
5445412|NCT01521910|survival|survival
5328360|NCT02047240|glomerular filtration|glomerular filtration
5328361|NCT02047240|cystatin C|cystatin c
5328362|NCT02047227|ESPART|espart
5328363|NCT02047227|Reproductive Techniques, Assisted|reproductive techniques, assisted
5328364|NCT02047227|Infertility|infertility
5328365|NCT02047227|Pergoveris®|pergoveris®
5328366|NCT02047227|GONAL-f®|gonal-f®
5328367|NCT02047214|Glioblastoma multiforme|glioblastoma multiforme
5328368|NCT02047214|Glioblastoma|glioblastoma
5328369|NCT02047214|Radiotherapy|radiotherapy
5328370|NCT02047214|Temozolomide|temozolomide
5328371|NCT02047214|TPI 287|tpi 287
5328372|NCT02047214|Taxoid|taxoid
5328373|NCT02047214|Avastin|avastin
5328374|NCT02047214|Bevacizumab|bevacizumab
5328375|NCT02047201|Head and neck cancer|head and neck cancer
5328376|NCT02047201|PET/CT|pet/ct
5328377|NCT02047201|induction chemotherapy|induction chemotherapy
5328378|NCT02047201|IMRT|imrt
5328379|NCT02047188|narrow band imaging,microvessels,matrix metalloproteinase-7|narrow band imaging,microvessels,matrix metalloproteinase-7
5328380|NCT02047162|diarrhea|diarrhea
5328381|NCT02047162|gastroenteritis|gastroenteritis
5328382|NCT02047162|antimicrobial drug resistance|antimicrobial drug resistance
5328383|NCT02047162|antimicrobial agents|antimicrobial agents
5328384|NCT02047162|Pakistan|pakistan
5328385|NCT02047162|ambulatory care|ambulatory care
5328386|NCT02047162|bismuth|bismuth
5328387|NCT02047149|Myelogenous Leukemia|myelogenous leukemia
5328388|NCT02047123|commercial flaxseed|commercial flaxseed
5328389|NCT02047123|cholesterol|cholesterol
5328390|NCT02047123|lipidic profile|lipidic profile
5328391|NCT02047123|yoghurt|yoghurt
5328392|NCT02047123|consumption|consumption
5328393|NCT02047071|Obstructive sleep apnea|obstructive sleep apnea
5328394|NCT02047071|Female gender|female gender
5328395|NCT02047071|Continuous Positive Airway Pressure|continuous positive airway pressure
5328396|NCT02047058|biomarker|biomarker
5328397|NCT02047058|Q cell|q cell
5328398|NCT02047058|Overall survival|overall survival
5328399|NCT02047058|Progression-free survival|progression-free survival
5328400|NCT02047045|severe chronic constipation|severe chronic constipation
5328401|NCT02047045|randomized controlled|randomized controlled
5328402|NCT02047045|electro-acupuncture|electro-acupuncture
5328403|NCT02047045|prucalopride|prucalopride
5328404|NCT02047032|electroacupuncture|electroacupuncture
5328405|NCT02047032|urinary incontinence|urinary incontinence
5328406|NCT02047032|PFMT|pfmt
5328407|NCT02047032|Solifenacin|solifenacin
5328408|NCT02047019|Drug combination|drug combination
5328409|NCT02047019|Nifedipine GITS|nifedipine gits
5328410|NCT02047019|Candesartan Cilexetil|candesartan cilexetil
5328411|NCT02047019|Hypertension|hypertension
5328412|NCT02047019|Combination therapy|combination therapy
5328413|NCT02047006|Hemodialysis|hemodialysis
5328414|NCT02047006|Rivaroxaban|rivaroxaban
5328416|NCT02046993|Hypertension|hypertension
5328417|NCT02046993|self blood pressure monitoring|self blood pressure monitoring
5328418|NCT02046993|smartphone based telemonitoring|smartphone based telemonitoring
5328419|NCT02046993|primary care|primary care
5328420|NCT02046967|endovenous laser ablation|endovenous laser ablation
5328421|NCT02046967|endovenous steam ablation|endovenous steam ablation
5328422|NCT02046967|great saphenous veins|great saphenous veins
5328424|NCT02046954|transesophageal echocardiography|transesophageal echocardiography
5328425|NCT02046954|tee|tee
5328426|NCT02046954|toe|toe
5328427|NCT02046954|cardiac surgery|cardiac surgery
5328428|NCT02046941|aphasia|aphasia
5328429|NCT02046941|stroke|stroke
5328430|NCT02046941|Magnetic Resonance Imaging|magnetic resonance imaging
5328431|NCT02046941|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5328432|NCT02046928|Leukemia|leukemia
5328433|NCT02046928|Lymphoma|lymphoma
5328434|NCT02046902|coronary artery disease|coronary artery disease
5328435|NCT02046902|cardiac stent|cardiac stent
5328436|NCT02046902|PCI procedure|pci procedure
5328437|NCT02046902|Patient preference|patient preference
5328438|NCT02046876|neck pain|neck pain
5328439|NCT02046876|physiotherapy|physiotherapy
5328440|NCT02046876|adapted swimming|adapted swimming
5328441|NCT02046876|therapeutic exercises|therapeutic exercises
5328442|NCT02046876|health education|health education
5963285|NCT04258059|acute gastrointestinal illness|acute gastrointestinal illness
5963286|NCT04258059|respiratory infection|respiratory infection
5963287|NCT04257916|Kinesiotape|kinesiotape
5963288|NCT04257916|Myofascial|myofascial
5963289|NCT04257916|Ankle sprain|ankle sprain
5963290|NCT04257916|Pain|pain
5963291|NCT04257916|Stability|stability
5963292|NCT04257734|optic neuritis|optic neuritis
5963293|NCT04257734|clinical Characteristics|clinical characteristics
5963294|NCT04257734|epidemiology|epidemiology
5963295|NCT04257006|acute kidney injury|acute kidney injury
5328443|NCT02046863|Parkinson's disease|parkinson's disease
5328445|NCT02046863|Bradykinesia|bradykinesia
5328446|NCT02046863|Deep brain stimulation|deep brain stimulation
5328448|NCT02046850|Phase I, healthy, pharmacokinetics,|phase i, healthy, pharmacokinetics,
5328449|NCT02046837|Prostate cancer|prostate cancer
5328450|NCT02046837|Exercise|exercise
5328451|NCT02046837|Elderly|elderly
5328452|NCT02046837|Quality of life|quality of life
5328453|NCT02046837|Fatigue|fatigue
5328454|NCT02046837|Physical fitness|physical fitness
5328455|NCT02046837|Adherence|adherence
5328456|NCT02046837|Cost-effectiveness|cost-effectiveness
5328457|NCT02046811|Skin neoplasms|skin neoplasms
5328458|NCT02046811|Radiation|radiation
5328459|NCT02046811|Screening|screening
5328460|NCT02046811|Self-examination|self-examination
5328461|NCT02046811|Comparative effectiveness research|comparative effectiveness research
5328462|NCT02046811|Dermoscopy|dermoscopy
5328463|NCT02046798|Pharmacokinetics|pharmacokinetics
5328464|NCT02046798|ASP3652|asp3652
5328465|NCT02046798|14C radio-labeled|14c radio-labeled
5328466|NCT02046798|Phase 1|phase 1
5328467|NCT02046785|Fluid administration|fluid administration
5328468|NCT02046785|Cardiac output|cardiac output
5328469|NCT02046785|Right atrial pressure|right atrial pressure
5328470|NCT02046785|Resuscitation|resuscitation
5328471|NCT02046772|hemorrhoidectomy|hemorrhoidectomy
5328472|NCT02046772|analgesia|analgesia
5328473|NCT02046772|anaesthetic|anaesthetic
5328474|NCT02046772|bupivacaine|bupivacaine
5328475|NCT02046772|morphine chloride|morphine chloride
5328476|NCT02046733|SCLC|sclc
5328477|NCT02046733|CTLA-4|ctla-4
5328478|NCT02046694|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5328479|NCT02046694|ALL|all
5328480|NCT02046694|pediatric|pediatric
5328481|NCT02046694|maintenance|maintenance
5328482|NCT02046694|allopurinol|allopurinol
5328483|NCT02046694|6-MP|6-mp
5328484|NCT02046694|6-mercaptopurine|6-mercaptopurine
5328485|NCT02046681|Medication Adherence|medication adherence
5328486|NCT02046681|Medication Compliance|medication compliance
5328487|NCT02046681|Medication Therapy Management|medication therapy management
5328488|NCT02046681|Side effects|side effects
5328489|NCT02046681|Analgesics|analgesics
5676804|NCT00593216|vestibular|vestibular
5328490|NCT02046681|Emergency Medicine|emergency medicine
5328491|NCT02046681|Home care|home care
5328492|NCT02046681|Aged|aged
5328493|NCT02046681|Acetaminophen|acetaminophen
5328494|NCT02046681|codeine|codeine
5328495|NCT02046681|ibuprofen|ibuprofen
5328496|NCT02046681|Oxycodone|oxycodone
5328497|NCT02046668|Osteoarthritis of knee|osteoarthritis of knee
5328498|NCT02046642|Amniotic fluid index;|amniotic fluid index;
5328499|NCT02046642|amniotic fluid volume;|amniotic fluid volume;
5328500|NCT02046642|intervention studies;|intervention studies;
5328501|NCT02046642|maternal care patterns;|maternal care patterns;
5328502|NCT02046642|mother-fetus relationships;|mother-fetus relationships;
5328503|NCT02046642|rest;|rest;
5328504|NCT02046642|sonography;|sonography;
5328505|NCT02046642|transplacental exposure|transplacental exposure
5328506|NCT02046590|Propofol|propofol
5328507|NCT02046590|remifentanil|remifentanil
5328508|NCT02046590|safety|safety
5328509|NCT02046590|gastro-intestinal|gastro-intestinal
5328510|NCT02046590|ERCP|ercp
5328511|NCT02046590|minimally invasive|minimally invasive
5328512|NCT02046590|intubation|intubation
5328513|NCT02046590|ventilation|ventilation
5328514|NCT02046577|Acute respiratory tract infections|acute respiratory tract infections
5328515|NCT02046577|vitamin D|vitamin d
5328516|NCT02046577|cholecalciferol|cholecalciferol
5328517|NCT02046577|children|children
5328518|NCT02046577|bronchiolitis|bronchiolitis
5328519|NCT02046577|pneumonia|pneumonia
5328520|NCT02046577|prevention|prevention
5328521|NCT02046551|nicotine|nicotine
5328522|NCT02046551|smoking|smoking
5328523|NCT02046551|atomoxetine|atomoxetine
5328524|NCT02046551|stress|stress
5324755|NCT02063126|Fatigue|fatigue
5328525|NCT02046525|Fecal microbiota therapy|fecal microbiota therapy
5328527|NCT02046499|Prevention, post partum haemorrhage|prevention, post partum haemorrhage
5328528|NCT02046486|ticagrelor|ticagrelor
5328529|NCT02046486|ST elevation myocardial infarction|st elevation myocardial infarction
5328530|NCT02046486|liquid formulation|liquid formulation
5328531|NCT02046447|dystonia|dystonia
5328532|NCT02046447|cervical dystonia|cervical dystonia
5328533|NCT02046447|DYT1|dyt1
5328534|NCT02046447|DYT 1|dyt 1
5328535|NCT02046447|DYT-1|dyt-1
5328536|NCT02046447|Dystonia 1|dystonia 1
5328537|NCT02046447|fMRI|fmri
5328538|NCT02046447|healthy|healthy
5328539|NCT02046447|trihexyphenidyl|trihexyphenidyl
5328540|NCT02046447|Artane|artane
5328541|NCT02046447|Apo-Trihex|apo-trihex
5328542|NCT02046447|Parkin|parkin
5328543|NCT02046447|Pacitane|pacitane
5328544|NCT02046447|Benzhexol|benzhexol
5328545|NCT02046447|Trihex|trihex
5328546|NCT02046408|Smoking|smoking
5328547|NCT02046408|5A's for smoking cessation|5a's for smoking cessation
5328548|NCT02046408|tailored health messages|tailored health messages
5328571|NCT02046330|Depression|depression
5328572|NCT02046330|ECT|ect
5328573|NCT02046330|TNS|tns
5328574|NCT02046304|Sarcoma|sarcoma
5328575|NCT02046304|Soft Tissue Sarcomas|soft tissue sarcomas
5328576|NCT02046304|STS|sts
5328577|NCT02046304|Extremity and Trunk|extremity and trunk
5328578|NCT02046304|Gemcitabine|gemcitabine
5328579|NCT02046304|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5328580|NCT02046304|Gemzar|gemzar
5328581|NCT02046304|External beam radiation therapy|external beam radiation therapy
5328582|NCT02046304|EBRT|ebrt
5328583|NCT02046304|Radiotherapy|radiotherapy
5328585|NCT02046291|umbilical cord transplant|umbilical cord transplant
5328586|NCT02046291|acute leukemia|acute leukemia
5328587|NCT02046291|UCBT|ucbt
5328588|NCT02046291|Hodgkin's Lymphoma|hodgkin's lymphoma
5328589|NCT02046291|Lymphoid Leukemia|lymphoid leukemia
5328590|NCT02046291|Multiple Myeloma|multiple myeloma
5328591|NCT02046291|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5328592|NCT02046291|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5328593|NCT02046291|Hematopoietic malignancies|hematopoietic malignancies
5328594|NCT02046265|Cervical cancer prevention|cervical cancer prevention
5328595|NCT02046226|Critical Limb Ischemia|critical limb ischemia
5328596|NCT02046226|Non Healing Wounds|non healing wounds
5328597|NCT02046226|Diabetic Wounds|diabetic wounds
5328598|NCT02046226|Foot Ulcers|foot ulcers
5328599|NCT02046213|Metabolism and Excretion|metabolism and excretion
5328600|NCT02046200|ivermectin, alcoholism, alcohol use disorder, treatment|ivermectin, alcoholism, alcohol use disorder, treatment
5328601|NCT02046187|Ketogenic Diet|ketogenic diet
5328602|NCT02046187|Brain tumor|brain tumor
5328603|NCT02046187|Glioma|glioma
5328604|NCT02046187|Glioblastoma|glioblastoma
5328605|NCT02046187|Radiation|radiation
5328606|NCT02046187|Chemotherapy|chemotherapy
5328607|NCT02046187|temozolomide|temozolomide
5328608|NCT02046174|colon|colon
5328609|NCT02046174|colorectal|colorectal
5328610|NCT02046174|rectal|rectal
5328611|NCT02046174|cancer|cancer
5328612|NCT02046174|macrobead|macrobead
5328613|NCT02046174|stage IV|stage iv
5328614|NCT02046174|metastatic|metastatic
5328615|NCT02046174|biological|biological
5328616|NCT02046174|mouse cells|mouse cells
5328617|NCT02046174|new york|new york
5328618|NCT02046174|new jersey|new jersey
5328619|NCT02046174|clinical research|clinical research
5328620|NCT02046161|colon preparation|colon preparation
5328621|NCT02046148|Maternal vaccine|maternal vaccine
5328622|NCT02046148|IgG|igg
5328623|NCT02046148|IgA|iga
5328624|NCT02046148|GBS|gbs
5328625|NCT02046148|pregnant women|pregnant women
5328626|NCT02046135|Pediatric|pediatric
5328627|NCT02046135|Sodium bicarbonate|sodium bicarbonate
5328628|NCT02046135|Acute kidney injury|acute kidney injury
5328629|NCT02046135|Cardiac surgery|cardiac surgery
5328630|NCT02046109|Repair|repair
5328631|NCT02046109|Replace|replace
5328632|NCT02046109|Composite|composite
5328633|NCT02046109|restoration|restoration
5328634|NCT02046109|failing dental restoration|failing dental restoration
5328635|NCT02046109|filling|filling
5328636|NCT02046109|dental|dental
5328637|NCT02046109|dentistry|dentistry
5328643|NCT02046083|Teenager|teenager
5328644|NCT02046083|Peanut|peanut
5328645|NCT02046083|OIT (Oral Induction Tolerance)|oit (oral induction tolerance)
5328646|NCT02046070|MLN9708|mln9708
5328647|NCT02046070|Newly diagnosed|newly diagnosed
5328648|NCT02046070|NDMM|ndmm
5328649|NCT02046070|IXAZOMIB|ixazomib
5328650|NCT02046070|RRMM|rrmm
5328651|NCT02046057|Sentinel Lymph Node|sentinel lymph node
5328652|NCT02046057|Ultrasound Guided Needle Core Biopsy|ultrasound guided needle core biopsy
5328653|NCT02046044|Heart failure|heart failure
5328654|NCT02046044|Digoxin|digoxin
5328656|NCT02046031|Ischemic stroke|ischemic stroke
5328657|NCT02046031|safety|safety
5328658|NCT02046031|Pharmacokinetics|pharmacokinetics
5328659|NCT02046031|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
5328660|NCT02046018|Maternal and Child Health|maternal and child health
5328669|NCT02045953|Healthy Subjects|healthy subjects
5328670|NCT02045953|SERETIDE|seretide
5328671|NCT02045953|Pharmocokinetics|pharmocokinetics
5328672|NCT02045953|FLIXOTIDE|flixotide
5328673|NCT02045953|VENTOLIN Mini-Spacer|ventolin mini-spacer
5328675|NCT02045940|pharmacokinetics|pharmacokinetics
5328676|NCT02045940|SARM|sarm
5328677|NCT02045940|safety|safety
5328678|NCT02045927|sedation|sedation
5328679|NCT02045927|BIS|bis
5328680|NCT02045927|monitoring|monitoring
5328681|NCT02045914|calcium ionophore|calcium ionophore
5328682|NCT02045914|fertilization rate|fertilization rate
5328683|NCT02045914|poor ovarian reserve|poor ovarian reserve
5328684|NCT02045901|Nausea|nausea
5328685|NCT02045901|Vomiting|vomiting
5328686|NCT02045901|Pregnancy|pregnancy
5328687|NCT02045901|Adolescent|adolescent
5328688|NCT02045901|Diclegis|diclegis
5328689|NCT02045901|Morning|morning
5328690|NCT02045901|Sickness|sickness
5328691|NCT02045888|Hamstring|hamstring
5328692|NCT02045888|Tear|tear
5328693|NCT02045888|Muscle|muscle
5328695|NCT02045888|adipose|adipose
5328696|NCT02045888|cells|cells
5328697|NCT02045888|regenerative|regenerative
5328698|NCT02045888|Celution|celution
5328699|NCT02045888|stem|stem
5328700|NCT02045888|cell|cell
5328701|NCT02045888|liposuction|liposuction
5328703|NCT02045875|Adherence monitoring|adherence monitoring
5328704|NCT02045875|Motivational Interviewing Adherence strategies|motivational interviewing adherence strategies
5328705|NCT02045862|Solifenacin Succinate|solifenacin succinate
5328706|NCT02045862|Mirabegron|mirabegron
5328707|NCT02045862|Urinary Incontinence|urinary incontinence
5328708|NCT02045862|Combination Therapy|combination therapy
5328709|NCT02045862|Urgency|urgency
5328710|NCT02045862|Nocturia|nocturia
5328711|NCT02045862|Overactive Bladder|overactive bladder
5328712|NCT02045849|pharmacokinetics|pharmacokinetics
5328713|NCT02045849|GSK2140944|gsk2140944
5328714|NCT02045849|tolerability|tolerability
5328715|NCT02045849|drug interaction|drug interaction
5328716|NCT02045849|safety|safety
5328717|NCT02045849|itraconazole|itraconazole
5328718|NCT02045849|elderly healthy subjects|elderly healthy subjects
5328719|NCT02045849|food effect|food effect
5328720|NCT02045849|relative bioavailability|relative bioavailability
5328721|NCT02045836|Pneumovax 23|pneumovax 23
5328722|NCT02045836|Co-administration|co-administration
5328723|NCT02045836|Herpes zoster|herpes zoster
5328724|NCT02045836|Immunogenicity|immunogenicity
5328725|NCT02045836|Safety|safety
5328726|NCT02045836|Adults|adults
5328727|NCT02045810|Measurement|measurement
5328728|NCT02045810|nosiseption|nosiseption
5328729|NCT02045797|Dose ranging|dose ranging
5328730|NCT02045797|Intravenous|intravenous
5328731|NCT02045797|Adaptive design|adaptive design
5328732|NCT02045797|suspected or confirmed gram-positive acute bacterial skin and skin structure infection|suspected or confirmed gram-positive acute bacterial skin and skin structure infection
5328733|NCT02045797|Subjects|subjects
5328734|NCT02045797|infection|infection
5328735|NCT02045797|Oral|oral
5328736|NCT02045797|GSK2140944|gsk2140944
5328737|NCT02045771|Depression|depression
5328738|NCT02045771|Behavioral Activation|behavioral activation
5328739|NCT02045745|Postoperative air leaks in risk patients.|postoperative air leaks in risk patients.
5328740|NCT02045732|Multiple Sclerosis|multiple sclerosis
5328741|NCT02045732|MRI|mri
5328742|NCT02045719|cat´s claw|cat´s claw
5328743|NCT02045719|uncaria tomentosa|uncaria tomentosa
5328744|NCT02045719|quality of life|quality of life
5328745|NCT02045719|no further therapeutic options|no further therapeutic options
5328746|NCT02045706|Community Health Workers|community health workers
5328747|NCT02045706|Service|service
5328748|NCT02045706|Volunteerism|volunteerism
5328749|NCT02045706|Health Behaviors|health behaviors
5328750|NCT02045680|colorectal cancer|colorectal cancer
5328751|NCT02045680|laparoscopy|laparoscopy
5328752|NCT02045680|neuromuscular block|neuromuscular block
5328753|NCT02045680|oxygen delivery|oxygen delivery
5328754|NCT02045667|Becker's myotonia congenita (BMC)|becker's myotonia congenita (bmc)
5328755|NCT02045667|Thomson's myotonia congenita (TMC)|thomson's myotonia congenita (tmc)
5328756|NCT02045667|Paramyotonia Congenita (PMC)|paramyotonia congenita (pmc)
5328757|NCT02045667|Sodium Channel Myotonia (SCM)|sodium channel myotonia (scm)
5328758|NCT02045641|cardiac surgery|cardiac surgery
5328759|NCT02045641|postoperative treatment|postoperative treatment
5328760|NCT02045641|pleural effusion|pleural effusion
5328761|NCT02045641|physical performance|physical performance
5328762|NCT02045628|Bariatric Surgery|bariatric surgery
5328763|NCT02045628|Health Psychology|health psychology
5328764|NCT02045602|Cancer|cancer
5328765|NCT02045602|Solid Tumors|solid tumors
5328766|NCT02045602|Gemcitabine|gemcitabine
5328767|NCT02045602|Oncolytic virus|oncolytic virus
5328768|NCT02045602|Metastatic|metastatic
5328769|NCT02045602|Pancreatic cancer|pancreatic cancer
5328770|NCT02045589|Cancer|cancer
5328771|NCT02045589|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5328772|NCT02045589|Locally advanced|locally advanced
5328773|NCT02045589|Metastatic|metastatic
5328774|NCT02045589|Gemcitabine|gemcitabine
5328775|NCT02045589|Oncolytic virus|oncolytic virus
5328776|NCT02045589|Abraxane®|abraxane®
5328777|NCT02045576|Obstructive Sleep Apnea|obstructive sleep apnea
5328778|NCT02045576|sleep position trainer|sleep position trainer
5328779|NCT02045576|oral appliance therapy|oral appliance therapy
5328780|NCT02045576|mandibular advancement device or splint|mandibular advancement device or splint
5328781|NCT02045537|HIV|hiv
5328782|NCT02045498|cpr|cpr
5328783|NCT02045498|feedback|feedback
5328784|NCT02045498|capnography|capnography
5328785|NCT02045498|outcome|outcome
5328786|NCT02045498|quality|quality
5328787|NCT02045498|resuscitation|resuscitation
5328788|NCT02045472|Influenza|influenza
5328789|NCT02045472|Monoclonal antibody|monoclonal antibody
5328790|NCT02045459|Microvascular Disease|microvascular disease
5328791|NCT02045459|Exercise|exercise
5328792|NCT02045459|Angina|angina
5328793|NCT02045459|Chest pain|chest pain
5328794|NCT02045420|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5328795|NCT02045420|Magnetic Resonance Imaging|magnetic resonance imaging
5328796|NCT02045420|MR Venography|mr venography
5328797|NCT02045420|Flow Quantification|flow quantification
5328798|NCT02045420|Susceptibility Weighted Imaging|susceptibility weighted imaging
5328799|NCT02045407|Brain Death|brain death
5328800|NCT02045407|Neurological Death|neurological death
5328801|NCT02045407|Cerebral circulatory arrest|cerebral circulatory arrest
5328802|NCT02045407|Computed Tomography Angiography|computed tomography angiography
5328803|NCT02045394|haemoptysis|haemoptysis
5328804|NCT02045394|hemoptysis|hemoptysis
5328805|NCT02045394|airway bleeding|airway bleeding
5328806|NCT02045381|Cancer|cancer
5328808|NCT02045368|refractory|refractory
5328809|NCT02045368|intolerant|intolerant
5328810|NCT02045368|solid tumors|solid tumors
5328811|NCT02045329|Staphylococcus aureus, mupirocin, decolonization|staphylococcus aureus, mupirocin, decolonization
5328812|NCT02045316|Preeclampsia|preeclampsia
5328813|NCT02045316|Aquaporins|aquaporins
5328814|NCT02045316|Placenta|placenta
5328815|NCT02045303|Sub-acute wound|sub-acute wound
5328816|NCT02045303|Chronic wound|chronic wound
5328817|NCT02045303|wound|wound
5328818|NCT02045303|MIST|mist
5328819|NCT02045303|Soring|soring
5328820|NCT02045303|Contact Ultrasound|contact ultrasound
5328821|NCT02045303|Noncontact ultrasound|noncontact ultrasound
5328822|NCT02045303|Wound Care|wound care
5328823|NCT02045303|VIP Ultrasound Protocol|vip ultrasound protocol
5328824|NCT02045303|Ultrasound|ultrasound
5328825|NCT02045264|Firazyr|firazyr
5328826|NCT02045264|Angioedema|angioedema
5328827|NCT02045264|Angioedemas, Hereditary|angioedemas, hereditary
5328828|NCT02045264|Vascular Diseases|vascular diseases
5328829|NCT02045264|Cardiovascular Diseases|cardiovascular diseases
5328830|NCT02045264|Urticaria|urticaria
5328831|NCT02045264|Skin Diseases, Vascular|skin diseases, vascular
5328832|NCT02045264|Skin Diseases|skin diseases
5328833|NCT02045264|Hypersensitivity, Immediate|hypersensitivity, immediate
5328834|NCT02045264|Hypersensitivity|hypersensitivity
5328835|NCT02045264|Immune System Diseases|immune system diseases
5328836|NCT02045264|Genetic Diseases, Inborn|genetic diseases, inborn
5328837|NCT02045264|Icatibant|icatibant
5328838|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5328839|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic
5328840|NCT02045264|Analgesics|analgesics
5328841|NCT02045264|Sensory System Agents|sensory system agents
5328842|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents
5328843|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs
5328844|NCT02045264|Pharmacologic Actions|pharmacologic actions
5328845|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents
5328846|NCT02045264|Therapeutic Uses|therapeutic uses
5328847|NCT02045264|Antirheumatic Agents|antirheumatic agents
5328848|NCT02045264|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5328849|NCT02045264|Adrenergic Antagonists|adrenergic antagonists
5328851|NCT02045264|Neurotransmitter Agents|neurotransmitter agents
5328852|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5328853|NCT02045264|Central Nervous System Agents|central nervous system agents
5328854|NCT02045251|Helicobacter pylori|helicobacter pylori
5328855|NCT02045251|H. pylori|h. pylori
5328856|NCT02045251|Pylera|pylera
5328857|NCT02045238|Bronchiolitis|bronchiolitis
5328858|NCT02045238|Therapeutics|therapeutics
5328859|NCT02045238|Saline Solution, Hypertonic|saline solution, hypertonic
5328863|NCT02045212|Non Arteritic Ischemic Neuropathy (NAION)|non arteritic ischemic neuropathy (naion)
5328865|NCT02045199|Diabetes Mellitus|diabetes mellitus
5328866|NCT02045199|Diabetic Foot|diabetic foot
5328867|NCT02045199|Diabetes Complications|diabetes complications
5328868|NCT02045186|Human Papilloma Virus|human papilloma virus
5328869|NCT02045186|Oropharynx|oropharynx
5328870|NCT02045186|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5328871|NCT02045186|Squamous Cell Carcinoma|squamous cell carcinoma
5328872|NCT02045186|Radiation Therapy|radiation therapy
5328873|NCT02045186|Chemotherapy|chemotherapy
5328874|NCT02045173|Sleep apnea, Arrhythmias, Heart Failure, ICD, CRT-D, Apneascan|sleep apnea, arrhythmias, heart failure, icd, crt-d, apneascan
5328875|NCT02045147|Home Bound Care Transitions|home bound care transitions
5328876|NCT02045134|Post Operative Atrial Fibrillation after a cardiac surgery|post operative atrial fibrillation after a cardiac surgery
5328877|NCT02045095|Drug therapy|drug therapy
5328878|NCT02045082|Flocked swab|flocked swab
5328879|NCT02045082|Traditional fiber swab|traditional fiber swab
5328880|NCT02045082|Herpes simplex epithelial keratitis|herpes simplex epithelial keratitis
5328881|NCT02045082|Quantitative PCR|quantitative pcr
5328882|NCT02045056|Alzheimer disease|alzheimer disease
5328883|NCT02045056|mild cognitive impairment|mild cognitive impairment
5328884|NCT02045056|normal cognition|normal cognition
5328885|NCT02045043|Sudden Cardiac Death|sudden cardiac death
5328886|NCT02045043|Arrhythmias|arrhythmias
5328887|NCT02045043|Congestive Heart Failure|congestive heart failure
5328888|NCT02045043|Cardiomyopathy|cardiomyopathy
5328889|NCT02045043|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5328890|NCT02045043|Genomics|genomics
5328891|NCT02045030|metastatic|metastatic
5328892|NCT02045030|colorectal|colorectal
5328893|NCT02045030|cancer|cancer
5328894|NCT02045030|aflibercept|aflibercept
5328895|NCT02045030|FOLFIRI|folfiri
5328896|NCT02045017|Multiple Myeloma|multiple myeloma
5328897|NCT02045017|Relapsed Multiple Myeloma|relapsed multiple myeloma
5328898|NCT02045017|Refactory Multiple Myeloma|refactory multiple myeloma
5328899|NCT02045017|Renal Insufficiency|renal insufficiency
5328900|NCT02045017|Pomalidomide|pomalidomide
5328901|NCT02045017|Dexamethasone|dexamethasone
5328902|NCT02045004|Anesthesia|anesthesia
5328903|NCT02045004|Surgery|surgery
5328904|NCT02045004|Geriatrics|geriatrics
5328905|NCT02045004|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5328906|NCT02045004|Postoperative delirium|postoperative delirium
5328907|NCT02045004|Dementia|dementia
5328908|NCT02045004|Postoperative complications|postoperative complications
5328909|NCT02045004|Neurological complications|neurological complications
5328910|NCT02045004|Psychological complications|psychological complications
5328911|NCT02044991|Sciatica|sciatica
5328912|NCT02044991|Pelvic girdle pain|pelvic girdle pain
5328913|NCT02044965|urinary tract infection|urinary tract infection
5328914|NCT02044965|antibiotic prophylaxis|antibiotic prophylaxis
5328915|NCT02044965|probiotics|probiotics
5328916|NCT02044965|neurogenic bladder|neurogenic bladder
5328917|NCT02044965|clean intermittent catheterization|clean intermittent catheterization
5328918|NCT02044952|Crohn's Disease|crohn's disease
5328919|NCT02044952|mesalazine|mesalazine
5328920|NCT02044952|Tripterygium Glycosides|tripterygium glycosides
5328921|NCT02044952|induction remission|induction remission
5328922|NCT02044939|Sarcoidosis, pulmonary rehabilitation|sarcoidosis, pulmonary rehabilitation
5328923|NCT02044900|obstructive sleep apnea|obstructive sleep apnea
5328924|NCT02044900|polysomnography|polysomnography
5328925|NCT02044900|heart rate variability|heart rate variability
5328926|NCT02044900|mathematical biomarker|mathematical biomarker
5328932|NCT02044848|type 1 diabetes mellitus|type 1 diabetes mellitus
5328933|NCT02044835|atherosclerotic renal artery stenosis, herbal medicine|atherosclerotic renal artery stenosis, herbal medicine
5328934|NCT02044822|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5328936|NCT02044783|Adults|adults
5328937|NCT02044783|Elderly|elderly
5328938|NCT02044770|laparoscopic|laparoscopic
5328939|NCT02044770|colectomy|colectomy
5328940|NCT02044770|ENSEAL|enseal
5328941|NCT02044757|Caffeine|caffeine
5328942|NCT02044757|Addiction|addiction
5328943|NCT02044757|Withdrawal symptoms|withdrawal symptoms
5328944|NCT02044757|Pediatric|pediatric
5328945|NCT02044757|Adolescent|adolescent
5328946|NCT02044757|Overweight|overweight
5328947|NCT02044744|Obesity|obesity
5328948|NCT02044744|Pediatric Obesity|pediatric obesity
5328949|NCT02044744|Physical Activity|physical activity
5328950|NCT02044744|Physical Fitness|physical fitness
5328951|NCT02044744|Primary Health Care|primary health care
5328952|NCT02044744|Referral and Consultation|referral and consultation
5328953|NCT02044731|Schools|schools
5328954|NCT02044731|Pediatrics|pediatrics
5328956|NCT02044731|Overweight|overweight
5328957|NCT02044731|Intervention Studies|intervention studies
5328958|NCT02044731|African Americans|african americans
5328960|NCT02044731|Body mass index|body mass index
5328961|NCT02044718|adverse events|adverse events
5328962|NCT02044718|unplanned admission intensive care|unplanned admission intensive care
5328963|NCT02044718|chart review|chart review
5328973|NCT02044692|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5328975|NCT02044666|Critical Limb Ischemia|critical limb ischemia
5328976|NCT02044666|Amputation|amputation
5328977|NCT02044653|Phase 2|phase 2
5328978|NCT02044614|Hemodialysis/Peritoneal Dialysis|hemodialysis/peritoneal dialysis
5328979|NCT02044614|functionally anuric|functionally anuric
5328980|NCT02044614|Icodextrin|icodextrin
5328981|NCT02044614|Kidney Disease Quality of Life|kidney disease quality of life
5328982|NCT02044601|Lung Cancer|lung cancer
5328983|NCT02044601|Non-small cell lung cancer|non-small cell lung cancer
5328984|NCT02044601|NSCLC|nsclc
5328985|NCT02044601|Squamous cell carcinoma of the lung|squamous cell carcinoma of the lung
5328986|NCT02044601|Adenocarcinoma of the lung|adenocarcinoma of the lung
5328987|NCT02044601|Radiation therapy|radiation therapy
5328988|NCT02044601|Proton therapy|proton therapy
5328990|NCT02044601|Carboplatin|carboplatin
5328991|NCT02044601|Paraplatin|paraplatin
5328992|NCT02044601|Paclitaxel|paclitaxel
5328993|NCT02044601|Taxol|taxol
5328994|NCT02044601|Onartuzumab|onartuzumab
5328995|NCT02044601|Erlotinib|erlotinib
5328996|NCT02044601|Erlotinib hydrochloride|erlotinib hydrochloride
5328997|NCT02044601|OSI-774|osi-774
5328998|NCT02044601|CP358774|cp358774
5328999|NCT02044601|Tarceva|tarceva
5329000|NCT02044588|HBsAg(+) donor|hbsag(+) donor
5329001|NCT02044588|HBsAg(-) donor|hbsag(-) donor
5329002|NCT02044588|Anti-hepatitis B antibody|anti-hepatitis b antibody
5329003|NCT02044588|Kidney allograft|kidney allograft
5329004|NCT02044575|Clock genes, circadian regulation|clock genes, circadian regulation
5329005|NCT02044562|dietary nitrate|dietary nitrate
5329006|NCT02044562|radiotherapy|radiotherapy
5329007|NCT02044562|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5329008|NCT02044549|Carbetocin|carbetocin
5329009|NCT02044549|syntometrine|syntometrine
5329010|NCT02044549|postpartum hemorrhage|postpartum hemorrhage
5329011|NCT02044549|cesarean section|cesarean section
5329012|NCT02044536|biopsy|biopsy
5329013|NCT02044536|endoscopy|endoscopy
5329014|NCT02044536|neoplasms|neoplasms
5329015|NCT02044523|Chronic liver disease|chronic liver disease
5329016|NCT02044523|Fibrosis|fibrosis
5329017|NCT02044523|Elastography|elastography
5329018|NCT02044523|Ultrasound|ultrasound
5329019|NCT02044523|Magnetic resonance elastography|magnetic resonance elastography
5329020|NCT02044523|Diagnostic performance|diagnostic performance
5223951|NCT02599246|O2|o2
5329021|NCT02044523|Sensitivity and specificity|sensitivity and specificity
5329022|NCT02044510|Multiple Sclerosis|multiple sclerosis
5329023|NCT02044510|Spinal Cord Injuries|spinal cord injuries
5329024|NCT02044510|mirabegron|mirabegron
5329025|NCT02044510|Urodynamics|urodynamics
5329026|NCT02044497|pharmacokinetics|pharmacokinetics
5329027|NCT02044497|pharmacogenomics|pharmacogenomics
5329028|NCT02044497|oral oxycodone|oral oxycodone
5329029|NCT02044497|pediatric surgical patients|pediatric surgical patients
5329030|NCT02044484|HIV|hiv
5329031|NCT02044484|AIDS|aids
5329032|NCT02044484|Viral load|viral load
5329033|NCT02044484|Primary care|primary care
5329034|NCT02044471|left ventricular assist device|left ventricular assist device
5329035|NCT02044471|continuous flow|continuous flow
5329036|NCT02044471|remote ischemic conditioning|remote ischemic conditioning
5329037|NCT02044471|hypertension|hypertension
5329038|NCT02044471|sympathetic tone|sympathetic tone
5329039|NCT02044471|endothelial dysfunction|endothelial dysfunction
5329040|NCT02044458|Foley Catheterization|foley catheterization
5329041|NCT02044458|Induction of Labor|induction of labor
5329042|NCT02044458|5 French Stylette|5 french stylette
5329043|NCT02044445|IVF, hCG, oocyte retrieval, time interval|ivf, hcg, oocyte retrieval, time interval
5329044|NCT02044419|Comparative|comparative
5329045|NCT02044419|Bioavailability|bioavailability
5329046|NCT02044419|lomitapide|lomitapide
5329047|NCT02044341|Acute Otitis Media|acute otitis media
5329048|NCT02044341|Pain|pain
5329049|NCT02044341|Ear Pain|ear pain
5329050|NCT02044341|Ear Ache|ear ache
5329051|NCT02044341|Ear infection|ear infection
5329052|NCT02044341|middle ear infection|middle ear infection
5329053|NCT02044302|pain|pain
5329054|NCT02044302|breast cancer|breast cancer
5329055|NCT02044302|breast implant|breast implant
5329070|NCT02044250|Clopidogrel|clopidogrel
5329071|NCT02044250|Antiplatelet monotherapy|antiplatelet monotherapy
5329072|NCT02044250|Drug-eluting stent|drug-eluting stent
5329073|NCT02044237|trichotillomania|trichotillomania
5329075|NCT02044211|Heart Failure, Systolic|heart failure, systolic
5329076|NCT02044211|Depressive Disorder|depressive disorder
5329077|NCT02044211|Depressive Disorder, Major|depressive disorder, major
5329078|NCT02044211|Mood Disorder|mood disorder
5329079|NCT02044198|Plasmodium Falciparum|plasmodium falciparum
5329080|NCT02044198|Malaria|malaria
5329081|NCT02044198|Vaccine|vaccine
5329082|NCT02044198|Plasmodium|plasmodium
5329083|NCT02044198|Falciparum|falciparum
5329084|NCT02044185|HMGB1 Protein|hmgb1 protein
5329085|NCT02044185|Graft versus Host Disease|graft versus host disease
5329086|NCT02044185|Immunosuppressive Agents|immunosuppressive agents
5329087|NCT02044185|oral mucositis|oral mucositis
5329088|NCT02044172|Prostate cancer|prostate cancer
5329089|NCT02044172|Treatment|treatment
5329090|NCT02044172|Screening|screening
5329091|NCT02044172|Surgery|surgery
5329092|NCT02044172|Radiotherapy|radiotherapy
5329093|NCT02044172|Active monitoring|active monitoring
5329094|NCT02044159|Hydrocortisone|hydrocortisone
5329095|NCT02044159|Pediatrics|pediatrics
5329096|NCT02044159|Adrenal Insufficiency|adrenal insufficiency
5329097|NCT02044107|Diarrhea,|diarrhea,
5329098|NCT02044107|Pneumonia,|pneumonia,
5329099|NCT02044107|Zinc treatment,|zinc treatment,
5329100|NCT02044107|Patient Compliance.|patient compliance.
5329101|NCT02044094|Opioid dependent|opioid dependent
5329102|NCT02044094|Buprenorphine|buprenorphine
5329103|NCT02044094|Suboxone Film|suboxone film
5329104|NCT02044094|Opioid blockade|opioid blockade
5329105|NCT02044094|Hydromorphone challenge|hydromorphone challenge
5329106|NCT02044016|Achilles tendon rupture, lengthening, validity, goniometer.|achilles tendon rupture, lengthening, validity, goniometer.
5329107|NCT02044003|angioplasty|angioplasty
5329108|NCT02044003|dissections|dissections
5329109|NCT02043990|NAVA|nava
5329110|NCT02043990|noninvasive ventilation|noninvasive ventilation
5329111|NCT02043990|infants|infants
5329112|NCT02043977|Propofol|propofol
5329113|NCT02043977|Insomnia|insomnia
5329114|NCT02043977|Sleep disorder|sleep disorder
5315741|NCT02105155|Prograf® ,|prograf® ,
5329115|NCT02043977|Sleep deprivation|sleep deprivation
5329116|NCT02043977|Chronic insomnia|chronic insomnia
5329117|NCT02043977|Refractory insomnia|refractory insomnia
5329118|NCT02043977|Primary insomnia|primary insomnia
5329119|NCT02043964|Multiple Sclerosis|multiple sclerosis
5329120|NCT02043964|Clinically Isolated Syndrome|clinically isolated syndrome
5329121|NCT02043964|Tears|tears
5329122|NCT02043964|Isoelectric focusing|isoelectric focusing
5197107|NCT02762227|CT|ct
5329123|NCT02043964|Oligoclonal profile|oligoclonal profile
5329124|NCT02043938|Electroencephalography|electroencephalography
5329125|NCT02043938|pharmacological|pharmacological
5329126|NCT02043925|QT-prolongation|qt-prolongation
5329127|NCT02043925|Torsade de Pointes|torsade de pointes
5329128|NCT02043925|drug interactions|drug interactions
5329129|NCT02043925|psychiatry|psychiatry
5329130|NCT02043912|QT-prolongation|qt-prolongation
5329131|NCT02043912|Torsade de Pointes|torsade de pointes
5329132|NCT02043912|Haloperidol|haloperidol
5329133|NCT02043912|Drug interactions|drug interactions
5329134|NCT02043899|Neuroblastoma|neuroblastoma
5329135|NCT02043899|Positron emission tomography|positron emission tomography
5329136|NCT02043899|124-iodine|124-iodine
5329137|NCT02043899|Meta-Iodobenzylguanidine|meta-iodobenzylguanidine
5329138|NCT02043886|Type 2 Diabetes, Postprandial Hypotension, Acarbose|type 2 diabetes, postprandial hypotension, acarbose
5329139|NCT02043873|Clinical Trial|clinical trial
5329140|NCT02043873|Composite Restorations|composite restorations
5329142|NCT02043873|Replacement Restorations|replacement restorations
5329143|NCT02043873|Operative Dentistry.|operative dentistry.
5329144|NCT02043860|Multiple Myeloma|multiple myeloma
5329145|NCT02043860|High Risk|high risk
5329146|NCT02043860|Intermediate Risk|intermediate risk
5329147|NCT02043860|Symptomatic|symptomatic
5329148|NCT02043847|Multiple Myeloma|multiple myeloma
5329149|NCT02043847|Relapsed|relapsed
5329150|NCT02043847|Refractory|refractory
5329151|NCT02043847|Progressive Disease|progressive disease
5329152|NCT02043847|Symptomatic|symptomatic
5329153|NCT02043795|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
5329154|NCT02043795|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5329155|NCT02043795|Stent|stent
5329156|NCT02043769|South Africa|south africa
5329157|NCT02043769|Eastern Cape|eastern cape
5329158|NCT02043769|Child ARV|child arv
5329159|NCT02043769|CLWHIV|clwhiv
5329160|NCT02043756|Mitoxantrone Hydrochloride Liposome Injection|mitoxantrone hydrochloride liposome injection
5329161|NCT02043730|pancreatic cancer|pancreatic cancer
5329162|NCT02043730|locally advanced|locally advanced
5329163|NCT02043730|unresectable cancer|unresectable cancer
5329164|NCT02043717|Cystic Fibrosis|cystic fibrosis
5329165|NCT02043717|Vitamin D|vitamin d
5329166|NCT02043717|Lung function|lung function
5329167|NCT02043704|IV Acetaminophen|iv acetaminophen
5329168|NCT02043704|Vaginal Reconstruction|vaginal reconstruction
5329169|NCT02043704|Pain, Postoperative|pain, postoperative
5329170|NCT02043691|Endovascular|endovascular
5329172|NCT02043691|Aneurysm|aneurysm
5329173|NCT02043691|Thoracoabdominal|thoracoabdominal
5329174|NCT02043691|Juxtarenal|juxtarenal
5329175|NCT02043691|Suprarenal|suprarenal
5329176|NCT02043691|Endograft|endograft
5329177|NCT02043691|Fenestrated|fenestrated
5329178|NCT02043691|Branched|branched
5329179|NCT02043691|Complex|complex
5329180|NCT02043691|Abdominal|abdominal
5329181|NCT02043691|Thoracic|thoracic
5329182|NCT02043691|Stent|stent
5329183|NCT02043691|Stentgraft|stentgraft
5329184|NCT02043678|Phase III|phase iii
5329185|NCT02043678|Radium-223 dichloride|radium-223 dichloride
5329186|NCT02043678|Abiraterone acetate|abiraterone acetate
5329187|NCT02043678|Combination therapy|combination therapy
5329188|NCT02043678|Chemotherapy-naive|chemotherapy-naive
5329189|NCT02043678|Bone metastasis|bone metastasis
5329190|NCT02043678|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
5329191|NCT02043665|CAVATAK|cavatak
5329192|NCT02043665|KEYNOTE-200|keynote-200
5329193|NCT02043665|pembrolizumab|pembrolizumab
5329194|NCT02043665|lung cancer|lung cancer
5329195|NCT02043665|bladder cancer|bladder cancer
5329196|NCT02043639|rotation|rotation
5329197|NCT02043639|shoulder|shoulder
5329199|NCT02043639|ROM|rom
5329200|NCT02043639|abduction,|abduction,
5329201|NCT02043639|internal rotation,|internal rotation,
5329202|NCT02043639|external rotation,|external rotation,
5329203|NCT02043639|flexion|flexion
5329204|NCT02043639|normal|normal
5329205|NCT02043639|joint movement|joint movement
5329206|NCT02043639|physical examination|physical examination
5329207|NCT02043626|childhood nutrition|childhood nutrition
5329208|NCT02043626|physical activity|physical activity
5329209|NCT02043626|school wellness|school wellness
5329210|NCT02043626|school health|school health
5329211|NCT02043626|nutritional policies|nutritional policies
5329212|NCT02043626|childhood obesity|childhood obesity
5329213|NCT02043613|Joint pain|joint pain
5329214|NCT02043613|Context effects|context effects
5329215|NCT02043613|Placebo effect|placebo effect
5329216|NCT02043613|Exercise treatment|exercise treatment
5329217|NCT02043600|Colitis, ulcerative|colitis, ulcerative
5329218|NCT02043600|Yoga|yoga
5963296|NCT04256681|OUTCOME MEASURE, HEREDITARY SPASTIC PARAPLEGIA|outcome measure, hereditary spastic paraplegia
5329219|NCT02043587|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5329220|NCT02043587|Lymphoblastic leukemia|lymphoblastic leukemia
5329221|NCT02043587|Lymphoblastic lymphoma|lymphoblastic lymphoma
5329222|NCT02043574|Aerobic Exercise|aerobic exercise
5329223|NCT02043574|Treadmill Test|treadmill test
5329224|NCT02043574|Sedentary Lifestyle|sedentary lifestyle
5329225|NCT02043548|dermatomyositis|dermatomyositis
5329226|NCT02043548|polymyositis|polymyositis
5329227|NCT02043548|tocilizumab|tocilizumab
5329228|NCT02043548|Actemra|actemra
5329229|NCT02043535|myocardial perfusion imaging|myocardial perfusion imaging
5329230|NCT02043535|myocardial blood flow|myocardial blood flow
5329231|NCT02043535|pharmacologic stress agents|pharmacologic stress agents
5329232|NCT02043535|carbon dioxide|carbon dioxide
5329233|NCT02043535|rubidium 82 radioisotope|rubidium 82 radioisotope
5329234|NCT02043535|positron emission tomography|positron emission tomography
5329235|NCT02043522|123I-mIBG|123i-mibg
5329236|NCT02043522|SPECT Imaging|spect imaging
5329237|NCT02043522|Phantom imaging|phantom imaging
5329238|NCT02043522|Heart failure|heart failure
5329239|NCT02043522|Coronary artery disease|coronary artery disease
5329240|NCT02043522|Heart to mediastinum ratios|heart to mediastinum ratios
5329241|NCT02043522|heart to calibration ratios|heart to calibration ratios
5329242|NCT02043522|Myocardial blood flow|myocardial blood flow
5329243|NCT02043522|Myocardial blood flow researve|myocardial blood flow researve
5329244|NCT02043509|smoking cessation|smoking cessation
5329245|NCT02043509|pregnancy|pregnancy
5329246|NCT02043509|cessation support|cessation support
5329247|NCT02043509|tailored text messages|tailored text messages
5329248|NCT02043509|self-help|self-help
5329249|NCT02043509|MiQuit|miquit
5329250|NCT02043496|Binge Eating Disorder|binge eating disorder
5329251|NCT02043496|Binge Eating|binge eating
5329252|NCT02043496|Eating Disorders|eating disorders
5329253|NCT02043496|Obesity|obesity
5329254|NCT02043496|Psychotherapy|psychotherapy
5329255|NCT02043496|Cognitive Behavioral Therapy|cognitive behavioral therapy
5329256|NCT02043483|CPAP|cpap
5329257|NCT02043483|OSAS|osas
5329258|NCT02043483|CEDOC (Centro de Estudos de Doenças Crónicas)|cedoc (centro de estudos de doenças crónicas)
5329259|NCT02043483|FCM (Faculdade de Ciências Médicas)|fcm (faculdade de ciências médicas)
5329657|NCT02041936|Nanoknife|nanoknife
5329260|NCT02043483|UNL (Universidade Nova de Lisboa|unl (universidade nova de lisboa
5329261|NCT02043483|NOVA MEDICAL SCHOOL|nova medical school
5329262|NCT02043483|FCT (Fundação para a Ciência e Tecnologia)|fct (fundação para a ciência e tecnologia)
5329263|NCT02043470|Sinus/nasal cancer|sinus/nasal cancer
5329264|NCT02043431|Heart failure|heart failure
5329265|NCT02043431|Electronic medical records|electronic medical records
5329266|NCT02043431|Genomics|genomics
5329268|NCT02043418|HIV|hiv
5329269|NCT02043418|ARV|arv
5329270|NCT02043418|Pediatric|pediatric
5329271|NCT02043418|Cameroon|cameroon
5329272|NCT02043392|intestinal anastomosis|intestinal anastomosis
5329273|NCT02043392|non-emergent|non-emergent
5329274|NCT02043392|intestinal revision|intestinal revision
5329275|NCT02043392|magnetic compression|magnetic compression
5329276|NCT02043392|anastomotic leak|anastomotic leak
5329277|NCT02043379|congenital heart disease|congenital heart disease
5329278|NCT02043379|Cardiopulmonary Bypass|cardiopulmonary bypass
5329279|NCT02043379|Hypogammaglobulinemia|hypogammaglobulinemia
5329280|NCT02043366|Remifentanil|remifentanil
5329281|NCT02043366|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
5329282|NCT02043366|Postoperative pain|postoperative pain
5329283|NCT02043366|Pain Intensity|pain intensity
5329284|NCT02043340|Periodontitis|periodontitis
5329285|NCT02043340|Bacterial viability|bacterial viability
5329286|NCT02043340|Lactate dehydrogenase levels|lactate dehydrogenase levels
5329287|NCT02043340|Indocyanine green|indocyanine green
5329288|NCT02043340|Scaling and root planing|scaling and root planing
5329289|NCT02043340|Antimicrobial photodynamic therapy.|antimicrobial photodynamic therapy.
5329290|NCT02043327|Colonoscopy|colonoscopy
5329291|NCT02043327|assessment|assessment
5329292|NCT02043327|certification,|certification,
5329293|NCT02043327|simulation,|simulation,
5329294|NCT02043327|standard setting|standard setting
5329295|NCT02043301|pharmacokinetics|pharmacokinetics
5329296|NCT02043301|bioavailability|bioavailability
5329297|NCT02043301|PF-04950615|pf-04950615
5329298|NCT02043288|Pancreatic cancer|pancreatic cancer
5329299|NCT02043288|Platinum|platinum
5329300|NCT02043288|Micelle|micelle
5329301|NCT02043275|resistance training|resistance training
5329302|NCT02043262|Elderly|elderly
5329303|NCT02043262|Home-based rehabilitation|home-based rehabilitation
5329304|NCT02043262|Activities of daily living|activities of daily living
5329305|NCT02043262|Restorative care|restorative care
5329306|NCT02043262|Reablement|reablement
5329307|NCT02043262|Everyday rehabilitation|everyday rehabilitation
5329308|NCT02043249|DELAYED CORD CLAMPING|delayed cord clamping
5329309|NCT02043249|MILKING OF CORD|milking of cord
5329310|NCT02043249|PREMATURE INFANTS|premature infants
5329311|NCT02043249|LEVEL OF IgG IN NEONATES|level of igg in neonates
5329312|NCT02043236|Prostate cancer|prostate cancer
5329313|NCT02043236|Androgen deprivation therapy|androgen deprivation therapy
5329314|NCT02043236|Bone health|bone health
5329315|NCT02043236|Bone mineral density|bone mineral density
5329316|NCT02043223|Vitamin A|vitamin a
5329317|NCT02043223|Breast milk|breast milk
5329318|NCT02043223|Postpartum vitamin A supplementation|postpartum vitamin a supplementation
5329319|NCT02043223|Infant vaccine response|infant vaccine response
5209211|NCT02688205|Resisted test|resisted test
5209212|NCT02688153|Aortic Valve Replacement|aortic valve replacement
5209213|NCT02688153|Aortic Stenosis|aortic stenosis
5209214|NCT02688153|EDWARDS INTUITY|edwards intuity
5209221|NCT02688127|obstetric bleeding placenta previa|obstetric bleeding placenta previa
5209222|NCT02688075|Diabetes Mellitus Type 2|diabetes mellitus type 2
5209223|NCT02688075|Canagliflozin|canagliflozin
5329320|NCT02043210|substance use, Spanish speaking, CBT4CBT|substance use, spanish speaking, cbt4cbt
5329321|NCT02043197|Depression,|depression,
5329322|NCT02043197|depressive symptoms,|depressive symptoms,
5329323|NCT02043197|major depressive disorder,|major depressive disorder,
5329324|NCT02043197|Fevarine,|fevarine,
5329325|NCT02043197|fluvoxamine,|fluvoxamine,
5329326|NCT02043197|cognitive function,|cognitive function,
5329327|NCT02043197|neurological disorders,|neurological disorders,
5329328|NCT02043197|sleep state|sleep state
5329329|NCT02043184|Neoplasms|neoplasms
5329330|NCT02043184|Medication Adherence|medication adherence
5329331|NCT02043184|Administration, Oral|administration, oral
5329332|NCT02043184|Symptom Assessment|symptom assessment
5329333|NCT02043184|Neurobehavioral Manifestations|neurobehavioral manifestations
5329334|NCT02043184|Depression|depression
5329335|NCT02043184|Behavioral Symptoms|behavioral symptoms
5329336|NCT02043184|Utilization|utilization
5329337|NCT02043158|Ovarian Cancer|ovarian cancer
5329338|NCT02043158|Short term survivors|short term survivors
5329340|NCT02043158|Biobehavioral characteristics|biobehavioral characteristics
5329341|NCT02043158|Sociodemographic characteristics|sociodemographic characteristics
5329343|NCT02043158|Survey|survey
5329344|NCT02043158|Interview|interview
5329345|NCT02043132|reverse shoulder arthroplasty|reverse shoulder arthroplasty
5329346|NCT02043132|Rotator cuff|rotator cuff
5329347|NCT02043132|Orthopedic joint surgery|orthopedic joint surgery
5329348|NCT02043132|Total shoulder|total shoulder
5329349|NCT02043132|Perioperative bleeding|perioperative bleeding
5329350|NCT02043132|Tranexamic acid|tranexamic acid
5329351|NCT02043132|Orthopedic complications|orthopedic complications
5329352|NCT02043132|Hemorrhage|hemorrhage
5329353|NCT02043132|Postoperative Hemorrhage|postoperative hemorrhage
5329354|NCT02043132|Pathologic Processes|pathologic processes
5329355|NCT02043132|Arthritis|arthritis
5329356|NCT02043132|Joint Diseases|joint diseases
5329357|NCT02043132|Musculoskeletal Diseases|musculoskeletal diseases
5329358|NCT02043132|Postoperative Complications|postoperative complications
5329359|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents
5329360|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents
5329361|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5329362|NCT02043132|Pharmacologic Actions|pharmacologic actions
5329363|NCT02043132|Hemostatics|hemostatics
5329364|NCT02043132|Coagulants|coagulants
5329365|NCT02043132|Hematologic Agents|hematologic agents
5329366|NCT02043132|Therapeutic Uses|therapeutic uses
5329367|NCT02043093|Adolescent suicide prevention|adolescent suicide prevention
5329368|NCT02043093|Peer Leader prevention model|peer leader prevention model
5329381|NCT02043067|Extra pulmonary TB|extra pulmonary tb
5329382|NCT02043054|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5329383|NCT02043054|Young Adults|young adults
5329384|NCT02043054|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5329385|NCT02043054|GLP1 Analogue|glp1 analogue
5329386|NCT02043054|DPP IV Inhibitor|dpp iv inhibitor
5329388|NCT02043054|Cardiometabolic Effects|cardiometabolic effects
5329389|NCT02043054|Cardiac MRI|cardiac mri
5329390|NCT02043028|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5329391|NCT02043028|Chest compression|chest compression
5329392|NCT02043028|Advanced cardiac life support|advanced cardiac life support
5329393|NCT02043028|Posture|posture
5329394|NCT02043015|voluntary counseling and testing (VCT)|voluntary counseling and testing (vct)
5329395|NCT02043015|couples voluntary counseling and testing (CVCT)|couples voluntary counseling and testing (cvct)
5329396|NCT02043015|pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5329397|NCT02043015|homosexuality|homosexuality
5329398|NCT02043015|male|male
5329399|NCT02043015|South Africa|south africa
5329400|NCT02042989|Advanced Cancers|advanced cancers
5329401|NCT02042989|Advanced solid tumor|advanced solid tumor
5329402|NCT02042989|Advanced p53 Mutant Malignancies|advanced p53 mutant malignancies
5329403|NCT02042989|MLN9708|mln9708
5329404|NCT02042989|Vorinostat|vorinostat
5316031|NCT02103686|pregabalin|pregabalin
5329405|NCT02042989|SAHA|saha
5329406|NCT02042989|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5329407|NCT02042989|MSK-390|msk-390
5329408|NCT02042989|Zolinza|zolinza
5329409|NCT02042976|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5963297|NCT04256395|registry study|registry study
5963298|NCT04256395|novel coronavirus（COVID-19）|novel coronavirus（covid-19）
5963299|NCT04256395|mobile internet survey|mobile internet survey
5963300|NCT04256161|Steroids' concentrations|steroids' concentrations
5963301|NCT04256161|Biopsy needle|biopsy needle
5963302|NCT04256161|Cystoprostatectomy|cystoprostatectomy
5963303|NCT04255732|retinal imaging|retinal imaging
5963304|NCT04255732|wide field|wide field
5963305|NCT04255706|ss-OCT|ss-oct
5963306|NCT04255706|OLCR|olcr
5963307|NCT04255706|biometry|biometry
5329410|NCT02042976|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
5329411|NCT02042976|Behavioural intervention|behavioural intervention
5329412|NCT02042976|Quality-of-life|quality-of-life
5329414|NCT02042976|Depression|depression
5329415|NCT02042976|Physical health status|physical health status
5329416|NCT02042963|The cohort of Asian kidney transplant recipients|the cohort of asian kidney transplant recipients
5329417|NCT02042963|The cohort of metabolic complication after kidney transplant|the cohort of metabolic complication after kidney transplant
5329418|NCT02042963|The biorepository of Asian kidney transplant recipients|the biorepository of asian kidney transplant recipients
5329419|NCT02042950|Lymphoma|lymphoma
5329420|NCT02042950|Mantle Cell Lymphoma|mantle cell lymphoma
5329422|NCT02042950|Relapsed|relapsed
5329423|NCT02042950|Refractory|refractory
5329424|NCT02042950|Carfilzomib|carfilzomib
5329425|NCT02042937|Knee|knee
5329426|NCT02042937|Hip|hip
5329427|NCT02042937|Muscle Strength|muscle strength
5329428|NCT02042937|Electromyography|electromyography
5329429|NCT02042937|Biomechanical Phenomena|biomechanical phenomena
5329430|NCT02042924|Leukemia|leukemia
5329431|NCT02042924|Lymphoma|lymphoma
5329432|NCT02042924|Myeloma|myeloma
5329433|NCT02042924|Myelodysplastic Syndrome|myelodysplastic syndrome
5329434|NCT02042898|Cardiac Surgery|cardiac surgery
5329435|NCT02042898|Transfusion|transfusion
5329436|NCT02042885|Prostate cancer|prostate cancer
5329437|NCT02042872|Spinal Cord Injury|spinal cord injury
5329438|NCT02042872|Disuse Osteoporosis|disuse osteoporosis
5329439|NCT02042872|Zoledronic acid|zoledronic acid
5329440|NCT02042872|Bisphosphonates|bisphosphonates
5329441|NCT02042872|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
5329442|NCT02042859|EndoHPB|endohpb
5329443|NCT02042820|Dry Eye|dry eye
5329444|NCT02042781|PG545|pg545
5329445|NCT02042781|Phase I|phase i
5329446|NCT02042781|Progen|progen
5329447|NCT02042781|antimetastatic|antimetastatic
5329448|NCT02042781|antiangiogenic|antiangiogenic
5329449|NCT02042781|advanced cancer patients|advanced cancer patients
5329450|NCT02042781|solid tumors|solid tumors
5329464|NCT02042742|Hydroxytyrosol|hydroxytyrosol
5329466|NCT02042742|Treatment outcome|treatment outcome
5325702|NCT02058914|lipids|lipids
5329467|NCT02042742|Inflammatory markers|inflammatory markers
5329468|NCT02042742|Endothelial function|endothelial function
5329470|NCT02042742|Adults|adults
5329471|NCT02042742|volunteers|volunteers
5329472|NCT02042729|volunteer|volunteer
5329473|NCT02042716|preterm and term newborns|preterm and term newborns
5329474|NCT02042716|diagnosis of cerebral white matter damage|diagnosis of cerebral white matter damage
5329475|NCT02042716|quantitative brain elasticity|quantitative brain elasticity
5329476|NCT02042716|Transfontanel ultrafast doppler|transfontanel ultrafast doppler
5329477|NCT02042690|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5329478|NCT02042690|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5329479|NCT02042690|chemotherapy|chemotherapy
5329480|NCT02042677|ileostomy|ileostomy
5329481|NCT02042677|1-piece|1-piece
5329482|NCT02042677|assessment|assessment
5329483|NCT02042677|Nova|nova
5329484|NCT02042677|NovaLife|novalife
5329485|NCT02042677|Dansac|dansac
5329486|NCT02042651|ESWT|eswt
5329487|NCT02042651|Chronic pelvic pain|chronic pelvic pain
5329488|NCT02042651|randomized|randomized
5329489|NCT02042651|sham controlled|sham controlled
5329490|NCT02042612|Pharmacokinetics|pharmacokinetics
5329491|NCT02042612|Sevoflurane|sevoflurane
5329492|NCT02042612|Obesity|obesity
5329493|NCT02042612|Sedation|sedation
5329494|NCT02042612|ICU patients|icu patients
5329495|NCT02042599|Pharmacokinetics|pharmacokinetics
5329496|NCT02042599|Sevoflurane|sevoflurane
5329497|NCT02042599|Acute kidney injury|acute kidney injury
5329498|NCT02042599|Sedation|sedation
5329499|NCT02042599|ICU patients|icu patients
5329500|NCT02042534|stroke|stroke
5329501|NCT02042534|TIA|tia
5329502|NCT02042521|Cigarette|cigarette
5329503|NCT02042521|Withdrawal|withdrawal
5329504|NCT02042521|Nicotine|nicotine
5329505|NCT02042482|Ultra coenzyme Q10|ultra coenzyme q10
5329506|NCT02042482|L-carnitine|l-carnitine
5329507|NCT02042469|awareness, clinical research, Saudi arabia|awareness, clinical research, saudi arabia
5329508|NCT02042456|breast cancer|breast cancer
5329509|NCT02042456|dense breasts|dense breasts
5329510|NCT02042456|mammography screening|mammography screening
5329511|NCT02042456|Screening techniques|screening techniques
5329512|NCT02042456|women|women
5329513|NCT02042404|Hearing impairment|hearing impairment
5329514|NCT02042404|Hearing loss|hearing loss
5329515|NCT02042391|PTLD|ptld
5329516|NCT02042391|CD20-positive|cd20-positive
5329517|NCT02042391|solid organ transplantation|solid organ transplantation
5329518|NCT02042378|BRCA|brca
5329519|NCT02042378|BRCA mutation|brca mutation
5329520|NCT02042378|germline BRCA|germline brca
5329521|NCT02042378|somatic BRCA|somatic brca
5329522|NCT02042378|PARP inhibitor|parp inhibitor
5329523|NCT02042378|rucaparib|rucaparib
5329524|NCT02042378|CO-338|co-338
5329525|NCT02042378|PF 01367338|pf 01367338
5329526|NCT02042378|AG 14699|ag 14699
5329527|NCT02042378|Clovis|clovis
5329528|NCT02042378|Clovis Oncology|clovis oncology
5329529|NCT02042378|RucaPanc|rucapanc
5329530|NCT02042365|Enhanced recovery,|enhanced recovery,
5329531|NCT02042365|sleeve gastrectomy,|sleeve gastrectomy,
5329532|NCT02042339|Hyperbaric Oxygen|hyperbaric oxygen
5329533|NCT02042339|Diabetic ulcer|diabetic ulcer
5329534|NCT02042339|Wound healing|wound healing
5329535|NCT02042339|3-D life-viz- system|3-d life-viz- system
5329536|NCT02042339|Indocyanine green video angiography|indocyanine green video angiography
5329537|NCT02042339|Transcutaneous oxygen pressure|transcutaneous oxygen pressure
5224457|NCT02596152|strength|strength
5329538|NCT02042339|Endothelial progenitor cells|endothelial progenitor cells
5329539|NCT02042326|Arteriovenous Malformations|arteriovenous malformations
5329540|NCT02042326|Sirolimus|sirolimus
5329541|NCT02042326|Maxillofacial Surgery|maxillofacial surgery
5329542|NCT02042300|XIENCE Xpedition|xience xpedition
5329543|NCT02042300|Routine Clinical Practice|routine clinical practice
5329544|NCT02042300|Alpine|alpine
5329545|NCT02042300|Sierra|sierra
5329549|NCT02042274|Fish oil|fish oil
5329551|NCT02042274|DHA|dha
5329552|NCT02042274|fatty acids|fatty acids
5329561|NCT02042248|ART|art
5329562|NCT02042248|UNC|unc
5329563|NCT02042248|Argos Therapeutics|argos therapeutics
5329564|NCT02042248|The CARE Collaboratory of AIDS|the care collaboratory of aids
5329565|NCT02042248|Immunization|immunization
5329566|NCT02042248|vaccination|vaccination
5329567|NCT02042235|prematurity|prematurity
5329568|NCT02042235|language|language
5329569|NCT02042235|parent-implemented intervention|parent-implemented intervention
5329570|NCT02042235|speech therapy|speech therapy
5329571|NCT02042235|neurodevelopment|neurodevelopment
5329572|NCT02042222|Sickle cell|sickle cell
5329573|NCT02042222|Hydroxyurea|hydroxyurea
5329574|NCT02042222|Dose prediction|dose prediction
5329575|NCT02042222|Maximum tolerated dose|maximum tolerated dose
5329576|NCT02042209|acute coronary syndrome|acute coronary syndrome
5329577|NCT02042209|thoracic pain|thoracic pain
5329578|NCT02042209|prehospital|prehospital
5329579|NCT02042209|diagnostic score|diagnostic score
5329580|NCT02042196|endothelial function|endothelial function
5329581|NCT02042196|women|women
5329583|NCT02042196|sex hormones|sex hormones
5329584|NCT02042196|adiposity|adiposity
5329585|NCT02042196|oxidative stress|oxidative stress
5329586|NCT02042196|antioxidants|antioxidants
5329587|NCT02042157|Quality of Life|quality of life
5329588|NCT02042157|Caregivers|caregivers
5329589|NCT02042157|Caregiver burden|caregiver burden
5329590|NCT02042157|Urinary Tract Infections|urinary tract infections
5329591|NCT02042157|Bidet|bidet
5329592|NCT02042157|Women's health|women's health
5329593|NCT02042157|Toileting|toileting
5329594|NCT02042157|Hygiene|hygiene
5329595|NCT02042157|Activities of Daily Living|activities of daily living
5329596|NCT02042157|Functional impairment|functional impairment
5329597|NCT02042157|Geriatrics|geriatrics
5329598|NCT02042144|Neoplasms, Colorectal|neoplasms, colorectal
5329599|NCT02042131|suicide|suicide
5329600|NCT02042131|suicidal ideation|suicidal ideation
5329601|NCT02042131|ambivalence|ambivalence
5329602|NCT02042131|suicide ambivalence|suicide ambivalence
5329603|NCT02042131|reasons for living|reasons for living
5329604|NCT02042131|reasons for dying|reasons for dying
5329605|NCT02042131|military|military
5329606|NCT02042131|veteran|veteran
5329607|NCT02042131|clinical trial|clinical trial
5329608|NCT02042131|cognitive behavioral therapy|cognitive behavioral therapy
5329609|NCT02042131|psychotherapy|psychotherapy
5329610|NCT02042131|crisis|crisis
5329611|NCT02042131|Treatment As Usual (TAU)|treatment as usual (tau)
5329612|NCT02042131|Crisis Response Plan (CRP)|crisis response plan (crp)
5329613|NCT02042131|Enhanced Crisis Response Plan (E-CRP)|enhanced crisis response plan (e-crp)
5329614|NCT02042118|Neonatal resuscitation|neonatal resuscitation
5329615|NCT02042118|Laryngeal Mask Airway (LMA)|laryngeal mask airway (lma)
5329616|NCT02042118|Face mask ventilation (FMV)|face mask ventilation (fmv)
5329617|NCT02042118|Uganda|uganda
5329618|NCT02042118|Africa|africa
5329619|NCT02042105|non-small-cell lung cancer|non-small-cell lung cancer
5329620|NCT02042105|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5677009|NCT00592111|Pediatric|pediatric
5446270|NCT01518374|AD|ad
5329621|NCT02042105|immunohistochemistry|immunohistochemistry
5329622|NCT02042092|Ultrasound|ultrasound
5329623|NCT02042092|MRA|mra
5329624|NCT02042092|Large Vessel Vasculitis|large vessel vasculitis
5329625|NCT02042092|Giant Cell Arteritis|giant cell arteritis
5329626|NCT02042092|Takayasu Arteritis|takayasu arteritis
5329627|NCT02042092|Immunological abnormalities|immunological abnormalities
5329628|NCT02042079|Endoscopic full-thickness resection|endoscopic full-thickness resection
5329629|NCT02042079|gastric subepithelial tumor|gastric subepithelial tumor
5329630|NCT02042079|hybrid-NOTES|hybrid-notes
5329631|NCT02042066|Resistant Hypertension|resistant hypertension
5329632|NCT02042066|RH|rh
5329633|NCT02042066|RHT|rht
5329634|NCT02042066|Blood Pressure|blood pressure
5329635|NCT02042066|Kidney|kidney
5329636|NCT02042066|Shockwave|shockwave
5329637|NCT02042053|imaging|imaging
5329638|NCT02042053|diagnostic|diagnostic
5329639|NCT02042053|castration resistant|castration resistant
5329640|NCT02042053|metastatic prostate cancer|metastatic prostate cancer
5329641|NCT02042053|immunotherapy|immunotherapy
5329642|NCT02042027|corneal neovascularization|corneal neovascularization
5329643|NCT02042027|Gamunex-C|gamunex-c
5329644|NCT02042027|IVI-g|ivi-g
5329645|NCT02042027|anterior segment inflammation|anterior segment inflammation
5329646|NCT02042014|Pulmonary arterial hypertension, QTI571, open label study|pulmonary arterial hypertension, qti571, open label study
5329647|NCT02041988|premedication|premedication
5329648|NCT02041988|oral morphine|oral morphine
5329649|NCT02041988|preemptive analgesia|preemptive analgesia
5329650|NCT02041975|Prebiotics|prebiotics
5329651|NCT02041975|Gut health|gut health
5329652|NCT02041975|Satisfaction|satisfaction
5329653|NCT02041962|Care Management|care management
5329654|NCT02041962|Chronic Care Model|chronic care model
5329655|NCT02041962|Mood Disorders|mood disorders
5329656|NCT02041936|irreversible electroporation|irreversible electroporation
5329658|NCT02041936|pancreatic cancer|pancreatic cancer
5329659|NCT02041923|preterm infant|preterm infant
5329660|NCT02041923|stable infant|stable infant
5329661|NCT02041923|mother-infant interaction|mother-infant interaction
5329662|NCT02041923|health care cost|health care cost
5329663|NCT02041923|H-HOPE intervention|h-hope intervention
5329664|NCT02041923|mother outcomes|mother outcomes
5329665|NCT02041923|infant behavioral organization|infant behavioral organization
5329666|NCT02041923|infant growth|infant growth
5329667|NCT02041897|EUS-FNA|eus-fna
5329668|NCT02041897|Pancreatic cystic lesion|pancreatic cystic lesion
5329669|NCT02041897|Diagnosis|diagnosis
5329670|NCT02041884|Cognitive Behavioral Therapy|cognitive behavioral therapy
5329671|NCT02041884|Dialectical Behavioral Therapy|dialectical behavioral therapy
5329672|NCT02041884|Applied Relaxation|applied relaxation
5329673|NCT02041884|Stress-reduction|stress-reduction
5329674|NCT02041884|Smartphone application|smartphone application
5329675|NCT02041884|ADHD|adhd
5329676|NCT02041884|Randomized controlled trial|randomized controlled trial
5329677|NCT02041884|Psychological treatment|psychological treatment
5329678|NCT02041884|Efficacy|efficacy
5329689|NCT02041858|Adverse Events|adverse events
5329690|NCT02041845|Radiotherapy|radiotherapy
5329691|NCT02041845|Radiotherapy dosage|radiotherapy dosage
5329692|NCT02041845|Dose fractionation|dose fractionation
5329693|NCT02041845|Radiotherapy, image-guided|radiotherapy, image-guided
5329695|NCT02041819|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5329696|NCT02041819|Nimotuzumab|nimotuzumab
5329697|NCT02041819|Nab-Paclitaxel|nab-paclitaxel
5329698|NCT02041819|Carcinoma of Esophagus|carcinoma of esophagus
5329699|NCT02041793|Acute pancreatitis|acute pancreatitis
5329700|NCT02041793|Pseudocyst|pseudocyst
5329701|NCT02041780|Diagnostic|diagnostic
5329702|NCT02041780|Liver fibrosis|liver fibrosis
5329703|NCT02041780|Ishak score|ishak score
5329704|NCT02041780|Fibrotest|fibrotest
5329705|NCT02041780|ShearWave elastography|shearwave elastography
5329706|NCT02041780|Liver biopsies|liver biopsies
5329707|NCT02041767|Ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia|ertapenem; prostatic diffusion; antibioprophylaxy; pharmacokinetics; benign prostatic hyperplasia
5329708|NCT02041741|happiness|happiness
5329709|NCT02041741|well-being|well-being
5329710|NCT02041741|distress|distress
5329711|NCT02041741|positive psychology|positive psychology
5329712|NCT02041715|Virus Diseases|virus diseases
5329713|NCT02041715|Hemorrhagic Fever, Ebola|hemorrhagic fever, ebola
5329714|NCT02041715|Hemorrhagic Fevers, Viral|hemorrhagic fevers, viral
5329715|NCT02041715|RNA Virus Infections|rna virus infections
5329716|NCT02041715|Filoviridae Infections|filoviridae infections
5329717|NCT02041715|Mononegavirales Infections|mononegavirales infections
5329718|NCT02041702|Bradycardia|bradycardia
5329719|NCT02041702|MRI Conditional Pacemaker|mri conditional pacemaker
5329720|NCT02041702|St Jude Medical|st jude medical
5329721|NCT02041702|Accent MRI Pacemaker|accent mri pacemaker
5329722|NCT02041702|Tendril MRI Lead|tendril mri lead
5329723|NCT02041689|Children|children
5329724|NCT02041689|Cancer|cancer
5329725|NCT02041689|Learning|learning
5329726|NCT02041689|Education|education
5329727|NCT02041689|Qualitative|qualitative
5329728|NCT02041676|Chest|chest
5329729|NCT02041676|Physiotherapy|physiotherapy
5329730|NCT02041676|Increased Inspiratory Flow Technique|increased inspiratory flow technique
5329731|NCT02041676|Prematurity|prematurity
5329732|NCT02041676|Non Invasive Ventilation|non invasive ventilation
5329733|NCT02041663|brain natriuretic peptide|brain natriuretic peptide
5329734|NCT02041663|cardiac function|cardiac function
5329735|NCT02041663|meningococcal infections|meningococcal infections
5329736|NCT02041663|septic shock|septic shock
5329737|NCT02041663|severe sepsis|severe sepsis
5329738|NCT02041637|liver failure|liver failure
5329739|NCT02041637|etiology|etiology
5329740|NCT02041637|liver transplantation|liver transplantation
5329741|NCT02041624|allergic|allergic
5329742|NCT02041624|rhinitis|rhinitis
5329743|NCT02041624|conjunctivitis|conjunctivitis
5329744|NCT02041624|grass pollen|grass pollen
5329745|NCT02041624|Allergen ImmunoTherapy (AIT)|allergen immunotherapy (ait)
5329747|NCT02041611|WHO grade III and IV|who grade iii and iv
5329748|NCT02041585|Hospital Readmission|hospital readmission
5329749|NCT02041585|Social Isolation and Hospital Readmission|social isolation and hospital readmission
5329750|NCT02041585|Age and Hospital Readmission|age and hospital readmission
5329751|NCT02041585|Functional Status and Hospital Readmission|functional status and hospital readmission
5329752|NCT02041585|Charlson Score and Hospital Readmission|charlson score and hospital readmission
5329753|NCT02041585|Length of Stay and Hospital Readmission|length of stay and hospital readmission
5329754|NCT02041546|Lung lavage,|lung lavage,
5329755|NCT02041546|Surfactant,|surfactant,
5329756|NCT02041546|Duration of mechanical|duration of mechanical
5329757|NCT02041546|ventilation|ventilation
5329758|NCT02041520|Seropositive HIV|seropositive hiv
5329759|NCT02041520|Omega 3 fatty acids|omega 3 fatty acids
5329760|NCT02041520|Oxidative stress|oxidative stress
5329761|NCT02041507|Water-aided colonoscopy|water-aided colonoscopy
5329762|NCT02041507|Water Immersion|water immersion
5329763|NCT02041507|Water Exchange|water exchange
5329764|NCT02041507|On-demand sedation|on-demand sedation
5329765|NCT02041507|Unsedated colonoscopy|unsedated colonoscopy
5329766|NCT02041507|Adenoma detection rate|adenoma detection rate
5329767|NCT02041507|Mean adenomas per procedure|mean adenomas per procedure
5329768|NCT02041494|Hernia|hernia
5329769|NCT02041494|Ventral|ventral
5329770|NCT02041494|Incisional|incisional
5329771|NCT02041494|Abdominal|abdominal
5329772|NCT02041494|Herniorrhaphy|herniorrhaphy
5329773|NCT02041494|Recurrence|recurrence
5329774|NCT02041494|Infection|infection
5329775|NCT02041494|Mesh|mesh
5329776|NCT02041494|Biologic|biologic
5329777|NCT02041494|Synthetic|synthetic
5329778|NCT02041468|ALK-positive|alk-positive
5329779|NCT02041455|Fibromyalgia|fibromyalgia
5329780|NCT02041455|Melatonin|melatonin
5329781|NCT02041455|Amitriptylin|amitriptylin
5329782|NCT02041455|Imune-pineal axis|imune-pineal axis
5329783|NCT02041442|overactive bladder|overactive bladder
5329784|NCT02041442|cystoscopy|cystoscopy
5329785|NCT02041429|Recurrent Breast Cancer|recurrent breast cancer
5329786|NCT02041429|Advanced Breast Cancer|advanced breast cancer
5329787|NCT02041429|Metastatic Breast Cancer|metastatic breast cancer
5329788|NCT02041416|Geriatric assessment|geriatric assessment
5329789|NCT02041416|REDCap|redcap
5329790|NCT02041416|touchscreen|touchscreen
5329791|NCT02041416|age 65|age 65
5329792|NCT02041364|Fatigue|fatigue
5329793|NCT02041364|Biomarkers|biomarkers
5329794|NCT02041364|Breast Cancer|breast cancer
5329795|NCT02041351|metastatic breast cancer|metastatic breast cancer
5329796|NCT02041351|taxanes|taxanes
5329797|NCT02041351|heavily pretreated|heavily pretreated
5329798|NCT02041312|Cholesterol|cholesterol
5329799|NCT02041312|Gastric cancer|gastric cancer
5329800|NCT02041312|Stage|stage
5329801|NCT02041299|sickle cell disease|sickle cell disease
5329802|NCT02041299|Iron overload|iron overload
5329803|NCT02041299|Deferiprone|deferiprone
5329804|NCT02041299|Ferriprox|ferriprox
5329805|NCT02041299|deferoxamine|deferoxamine
5329806|NCT02041299|Chelation|chelation
5329807|NCT02041273|bioavailability|bioavailability
5329808|NCT02041273|bioequivalence|bioequivalence
5329809|NCT02041273|AUC|auc
5329810|NCT02041273|Cmax|cmax
5329811|NCT02041260|Adult|adult
5329812|NCT02041260|differentiated thyroid cancer (DTC),|differentiated thyroid cancer (dtc),
5329813|NCT02041260|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
5329814|NCT02041260|not anaplastic thyroid cancer|not anaplastic thyroid cancer
5329815|NCT02041234|Diabetes|diabetes
5329816|NCT02041234|surgical treatment|surgical treatment
5329817|NCT02041234|medical treatment|medical treatment
5329818|NCT02041221|pharmacokinetics, pharmacodynamics, asthma|pharmacokinetics, pharmacodynamics, asthma
5329819|NCT02041208|Chronic renal anemia|chronic renal anemia
5329820|NCT02041208|Hemoglobin|hemoglobin
5329821|NCT02041208|Kidney transplant|kidney transplant
5329822|NCT02041195|Overweight|overweight
5329823|NCT02041182|youth violence|youth violence
5329824|NCT02041182|doctor-patient communication|doctor-patient communication
5329825|NCT02041182|health risk behaviors|health risk behaviors
5329826|NCT02041182|pre-visit questionnaires|pre-visit questionnaires
5329827|NCT02041130|Heart Failure|heart failure
5329828|NCT02041130|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5329829|NCT02041104|Metabolic syndrome|metabolic syndrome
5329830|NCT02041104|4 -week intervention|4 -week intervention
5329831|NCT02041104|Randomised placebo controlled parallel study|randomised placebo controlled parallel study
5329832|NCT02041104|Beta-glucans|beta-glucans
5329833|NCT02041104|Abdominal fat|abdominal fat
5329834|NCT02041104|Dyslipidemia|dyslipidemia
5329835|NCT02041104|Insulin resistance|insulin resistance
5329836|NCT02041104|Hypertension|hypertension
5329837|NCT02041104|Gut Microbiota Composition|gut microbiota composition
5329838|NCT02041104|Oral Glucose Tolerance Test|oral glucose tolerance test
5963308|NCT04255433|Diabetes Mellitus|diabetes mellitus
5329839|NCT02041104|Lipid Profile|lipid profile
5329845|NCT02041078|Hepatic transection|hepatic transection
5329846|NCT02041065|Liver transection|liver transection
5329847|NCT02041065|Bloodloss|bloodloss
5329848|NCT02041065|Operation time|operation time
5329850|NCT02041065|feasibility|feasibility
5329851|NCT02041026|probiotic|probiotic
5329852|NCT02041026|Yoghurt|yoghurt
5329853|NCT02041026|NN20|nn20
5329854|NCT02041013|Asthma|asthma
5329855|NCT02041013|Health Literacy|health literacy
5329856|NCT02041000|COPD|copd
5329857|NCT02041000|pulmonary|pulmonary
5329858|NCT02041000|stem cells|stem cells
5329859|NCT02041000|emphysema|emphysema
5329860|NCT02041000|lungs|lungs
5329861|NCT02040987|Thorough QT study|thorough qt study
5329862|NCT02040974|immunotherapy, house dust mites, pollens, allergic rhinitis|immunotherapy, house dust mites, pollens, allergic rhinitis
5329863|NCT02040961|Patients|patients
5329864|NCT02040961|Undergoing|undergoing
5329865|NCT02040961|Elective|elective
5329866|NCT02040961|Thoracic|thoracic
5329867|NCT02040961|Surgery|surgery
5329868|NCT02040922|Antibiotics|antibiotics
5329869|NCT02040922|Campylobacter|campylobacter
5329870|NCT02040922|Diarrhoea|diarrhoea
5329871|NCT02040922|Enteritis|enteritis
5329872|NCT02040922|Microbiota|microbiota
5329873|NCT02040922|Calprotectin|calprotectin
5329874|NCT02040909|sedation|sedation
5329878|NCT02040909|pharmacokinetics|pharmacokinetics
5329879|NCT02040896|computed tomography|computed tomography
5329880|NCT02040896|emergency|emergency
5329881|NCT02040896|CT scan|ct scan
5329882|NCT02040896|ordering behavior|ordering behavior
5329883|NCT02040896|diagnosis|diagnosis
5329884|NCT02040896|radiation|radiation
5329885|NCT02040883|Schizophrenia|schizophrenia
5329886|NCT02040883|Tandospirone|tandospirone
5329887|NCT02040883|Cognitive Therapy|cognitive therapy
5329888|NCT02040870|Non-Small Cell lung Cancer|non-small cell lung cancer
5329889|NCT02040870|NSCLC|nsclc
5329890|NCT02040870|ALK|alk
5329891|NCT02040870|LDK378|ldk378
5329892|NCT02040870|ALK-rearranged|alk-rearranged
5329893|NCT02040870|ALK-positive|alk-positive
5329894|NCT02040870|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5329895|NCT02040857|Breast Cancer|breast cancer
5329896|NCT02040805|compulsive hoarding|compulsive hoarding
5329897|NCT02040805|clutter|clutter
5329898|NCT02040805|hoarding disorder|hoarding disorder
5329899|NCT02040792|COPD|copd
5329900|NCT02040792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5329901|NCT02040779|asthma|asthma
5329902|NCT02040779|breath-actuated inhaler|breath-actuated inhaler
5329903|NCT02040779|beclomethasone|beclomethasone
5329904|NCT02040766|asthma|asthma
5329905|NCT02040766|breath-actuated inhaler|breath-actuated inhaler
5329906|NCT02040766|metered dose inhaler|metered dose inhaler
5329907|NCT02040753|Lifestyle intervention|lifestyle intervention
5329908|NCT02040753|Change of body composition|change of body composition
5329909|NCT02040753|Physical activity|physical activity
5329910|NCT02040753|Weight loss maintenance|weight loss maintenance
5329911|NCT02040727|Myokines|myokines
5329912|NCT02040727|Osteokines|osteokines
5329913|NCT02040727|Glucose homeostasis|glucose homeostasis
5329914|NCT02040727|Puberty|puberty
5329915|NCT02040714|femur head necrosis|femur head necrosis
5329916|NCT02040714|hip|hip
5329917|NCT02040714|pediatric orthopedics|pediatric orthopedics
5329918|NCT02040714|MRI|mri
5329919|NCT02040714|Osteonecrosis|osteonecrosis
5329920|NCT02040714|Bone diseases|bone diseases
5329921|NCT02040714|Legg Calve Perthes Syndrome|legg calve perthes syndrome
5329922|NCT02040662|paravertebral block|paravertebral block
5329923|NCT02040662|thoracic epidural analgesia|thoracic epidural analgesia
5329924|NCT02040662|videothoracoscopic surgery|videothoracoscopic surgery
5329925|NCT02040662|lung lobectomy|lung lobectomy
5329926|NCT02040649|Critical care|critical care
5329927|NCT02040649|Respiration, artificial|respiration, artificial
5329928|NCT02040636|Pertussis|pertussis
5329929|NCT02040636|Tetanus|tetanus
5329930|NCT02040636|Diphtheria|diphtheria
5329931|NCT02040636|Poliomyelitis|poliomyelitis
5329932|NCT02040636|Hepatitis B|hepatitis b
5329933|NCT02040636|Acellular Pertussis Vaccines|acellular pertussis vaccines
5329934|NCT02040623|Chronic Graft versus Host Disease|chronic graft versus host disease
5329935|NCT02040623|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5329936|NCT02040610|Low Risk Prostate Cancer|low risk prostate cancer
5329937|NCT02040610|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
5329938|NCT02040610|Hypofractionated|hypofractionated
5329941|NCT02040545|Infertility|infertility
5329942|NCT02040545|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5329943|NCT02040545|Venopuncture-free treatment|venopuncture-free treatment
5329944|NCT02040545|Needle-free treatment|needle-free treatment
5329945|NCT02040519|Overactive bladder|overactive bladder
5329946|NCT02040519|Non obstructive urinary retention|non obstructive urinary retention
5329947|NCT02040519|Sacral neuromodulation|sacral neuromodulation
5329948|NCT02040506|Acute Myelogenous Leukemia|acute myelogenous leukemia
5329949|NCT02040506|Acute Myeloid Leukemia|acute myeloid leukemia
5329950|NCT02040506|Drug therapy|drug therapy
5329951|NCT02040506|CD98|cd98
5329952|NCT02040506|Relapsed|relapsed
5329953|NCT02040506|Refractory|refractory
5329954|NCT02040506|Monoclonal antibody|monoclonal antibody
5329955|NCT02040493|breast cancer|breast cancer
5329956|NCT02040493|IORT|iort
5329957|NCT02040493|brachytherapy|brachytherapy
5329958|NCT02040480|bioavailability|bioavailability
5329959|NCT02040480|food effect|food effect
5329960|NCT02040480|formulation|formulation
5329961|NCT02040480|GSK2110183|gsk2110183
5329962|NCT02040480|afuresertib|afuresertib
5329963|NCT02040480|AKT inhibitor|akt inhibitor
5329964|NCT02040441|Proteomics|proteomics
5329965|NCT02040441|Diabetes|diabetes
5329966|NCT02040441|Chronic kidney disease|chronic kidney disease
5329967|NCT02040441|Diabetic nephropathy|diabetic nephropathy
5329968|NCT02040441|Diabetic retinopathy|diabetic retinopathy
5224860|NCT02593929|operable|operable
5329969|NCT02040441|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
5329970|NCT02040441|Spironolactone|spironolactone
5329971|NCT02040441|Microalbuminuria|microalbuminuria
5329972|NCT02040428|Cardiovascular Diseases|cardiovascular diseases
5329973|NCT02040428|Fibrin Sealant|fibrin sealant
5329974|NCT02040428|Hemostatics|hemostatics
5329975|NCT02040428|Coagulants|coagulants
5329976|NCT02040402|Comparison of pneumococcal conjugated vaccine regimes|comparison of pneumococcal conjugated vaccine regimes
5329977|NCT02040389|children|children
5329978|NCT02040389|penile|penile
5329979|NCT02040389|inguinal|inguinal
5329980|NCT02040389|kidney parents|kidney parents
5329981|NCT02040389|anxiety|anxiety
5329982|NCT02040376|Paediatrics|paediatrics
5329983|NCT02040376|Medulloblastoma|medulloblastoma
5329984|NCT02040376|Metformin|metformin
5329985|NCT02040363|COPD|copd
5329986|NCT02040363|skeletal muscle|skeletal muscle
5329987|NCT02040363|angiogenesis|angiogenesis
5329988|NCT02040363|exercise training|exercise training
5329989|NCT02040363|intensity|intensity
5329990|NCT02040350|Pralidoxime, atropine, organophosphorous poisoning.|pralidoxime, atropine, organophosphorous poisoning.
5329991|NCT02040285|CT colonography|ct colonography
5329992|NCT02040259|ischemic stroke|ischemic stroke
5329993|NCT02040259|mechanical thrombectomy device|mechanical thrombectomy device
5329994|NCT02040259|Retriever|retriever
5329995|NCT02040220|CRVO, Macular edema, Aflibercept, anti-VEGF|crvo, macular edema, aflibercept, anti-vegf
5329996|NCT02040181|renal function, creatinine clearance|renal function, creatinine clearance
5329997|NCT02040168|Ventilation|ventilation
5329998|NCT02040168|PTSD|ptsd
5329999|NCT02040168|sedation|sedation
5330000|NCT02040142|Hyperthermic Intraperitoneal Mitomycin c|hyperthermic intraperitoneal mitomycin c
5330001|NCT02040142|HIPEC|hipec
5330002|NCT02040142|Cytoreduction|cytoreduction
5330003|NCT02040116|Rapid Infusion Rituximab|rapid infusion rituximab
5330004|NCT02040103|Deep Vein Thrombosis|deep vein thrombosis
5330005|NCT02040103|Pulmonary Embolism|pulmonary embolism
5330006|NCT02040103|Intermittent Pneumatic Compression|intermittent pneumatic compression
5330007|NCT02040103|Pharmacologic DVT|pharmacologic dvt
5330008|NCT02040103|Prophylaxis|prophylaxis
5330009|NCT02040103|Critically Ill Patients.|critically ill patients.
5330010|NCT02040077|opioid|opioid
5330011|NCT02040077|overdose|overdose
5330012|NCT02040077|OD|od
5330013|NCT02040077|opiate|opiate
5330014|NCT02040077|prescription opioids|prescription opioids
5330015|NCT02040077|prescription pain medication|prescription pain medication
5330016|NCT02040077|heroin|heroin
5330017|NCT02040077|detoxification|detoxification
5330018|NCT02040077|prevention|prevention
5330019|NCT02040051|intensive care units|intensive care units
5330020|NCT02040051|mechanical ventilation|mechanical ventilation
5330021|NCT02040051|music therapy|music therapy
5330022|NCT02040038|Diabetes|diabetes
5330023|NCT02040038|Virtual Environment|virtual environment
5330024|NCT02040038|Self-Management|self-management
5330025|NCT02040025|hypertension|hypertension
5330026|NCT02040025|diabetes mellitus|diabetes mellitus
5330027|NCT02040025|hemoglobin A1C|hemoglobin a1c
5330040|NCT02039999|ATP|atp
5330041|NCT02039999|hypersensitivity|hypersensitivity
5330042|NCT02039999|TRPA1|trpa1
5330043|NCT02039986|cystic fibrosis|cystic fibrosis
5330044|NCT02039986|CF|cf
5330045|NCT02039986|cystic fibrosis related diabetes|cystic fibrosis related diabetes
5330046|NCT02039986|CFRD|cfrd
5330047|NCT02039986|kalydeco|kalydeco
5330048|NCT02039986|ivacaftor|ivacaftor
5330049|NCT02039973|HIV|hiv
5330050|NCT02039973|AIDS|aids
5330051|NCT02039973|Tanzania|tanzania
5330052|NCT02039973|depression|depression
5330053|NCT02039973|perinatal|perinatal
5330054|NCT02039973|psychotherapy|psychotherapy
5330055|NCT02039973|task-sharing|task-sharing
5330056|NCT02039973|problem-solving|problem-solving
5330057|NCT02039960|Epidemiology|epidemiology
5330058|NCT02039960|Drug Abuse Warning Network (DAWN)|drug abuse warning network (dawn)
5330059|NCT02039960|bupropion|bupropion
5330060|NCT02039960|abuse|abuse
5330061|NCT02039947|BRAF V600K mutation|braf v600k mutation
5330062|NCT02039947|Metastatic Melanoma|metastatic melanoma
5330063|NCT02039947|BRAF V600R mutation|braf v600r mutation
5330064|NCT02039947|BRAF V600D mutation|braf v600d mutation
5330065|NCT02039947|BRAF V600E mutation|braf v600e mutation
5330066|NCT02039947|Brain metastases BRAF inhibitor|brain metastases braf inhibitor
5330067|NCT02039947|Intracranial|intracranial
5330068|NCT02039934|type 2 diabetes|type 2 diabetes
5330069|NCT02039934|exercise intervention|exercise intervention
5330070|NCT02039934|high intensity interval training|high intensity interval training
5330071|NCT02039908|Tolerance to stimulant medication|tolerance to stimulant medication
5330072|NCT02039895|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5330073|NCT02039895|Helical irradiation of the total skin|helical irradiation of the total skin
5330074|NCT02039895|Refractory|refractory
5330075|NCT02039895|Total skin electron beam therapy|total skin electron beam therapy
5330076|NCT02039882|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5330077|NCT02039882|Percutaneous Coronary Intervention PCI|percutaneous coronary intervention pci
5330078|NCT02039882|Normals|normals
5330079|NCT02039882|Myocardial Infarction MI|myocardial infarction mi
5330080|NCT02039882|Point of Care POC|point of care poc
5330081|NCT02039882|Hypoxanthine|hypoxanthine
5330082|NCT02039882|Inosine|inosine
5330083|NCT02039882|HPLC High Pressure Liquid Chromatography|hplc high pressure liquid chromatography
5330084|NCT02039869|NERD|nerd
5330085|NCT02039869|Non erosive reflux disease|non erosive reflux disease
5330086|NCT02039869|functional dyspepsia|functional dyspepsia
5330087|NCT02039869|erosive esophagitis|erosive esophagitis
5330088|NCT02039869|confocal endomicroscopy|confocal endomicroscopy
5330089|NCT02039869|cell visio|cell visio
5330090|NCT02039869|proton pump inhibitor|proton pump inhibitor
5330091|NCT02039869|sucralfate|sucralfate
5330092|NCT02039856|Patient-centered medical homes|patient-centered medical homes
5330093|NCT02039856|Primary care|primary care
5330094|NCT02039856|Women's health|women's health
5330095|NCT02039856|Veterans|veterans
5330097|NCT02039830|aging|aging
5330098|NCT02039830|physiotherapy|physiotherapy
5330099|NCT02039830|pelvic floor|pelvic floor
5330100|NCT02039830|rehabilitation|rehabilitation
5330101|NCT02039817|pharmacokinetics|pharmacokinetics
5330102|NCT02039817|pharmacodynamics|pharmacodynamics
5330103|NCT02039817|renal impairment|renal impairment
5330104|NCT02039778|Glioblastoma|glioblastoma
5330105|NCT02039778|High-grade Glioma|high-grade glioma
5330106|NCT02039778|Brain Tums|brain tums
5330107|NCT02039778|Temozolomide|temozolomide
5677310|NCT00591006|Mood|mood
5330108|NCT02039778|Stem cell radiation therapy|stem cell radiation therapy
5330109|NCT02039778|IMRT|imrt
5330110|NCT02039778|Proton beam radiotherapy|proton beam radiotherapy
5330111|NCT02039778|Conventional external beam radiotherapy|conventional external beam radiotherapy
5330112|NCT02039778|Quality of Life|quality of life
5330113|NCT02039778|Neurocognition|neurocognition
5330114|NCT02039765|Ocular Redness|ocular redness
5330115|NCT02039752|Multivessel|multivessel
5330116|NCT02039739|Orsiro|orsiro
5330117|NCT02039739|Drug Eluting Stent|drug eluting stent
5330118|NCT02039739|Routine Clinical Practice|routine clinical practice
5330119|NCT02039739|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5330120|NCT02039739|Coronary Artery Disease|coronary artery disease
5330121|NCT02039726|Acute Myeloid Leukemia|acute myeloid leukemia
5330123|NCT02039726|FMS-like tyrosine kinase 3|fms-like tyrosine kinase 3
5330124|NCT02039726|FLT3-ITD|flt3-itd
5330125|NCT02039726|Quizartinib|quizartinib
5330126|NCT02039726|Leukemia|leukemia
5330127|NCT02039726|Tablets|tablets
5330128|NCT02039713|DeSyne|desyne
5330129|NCT02039713|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5330130|NCT02039713|Coronary Artery Disease|coronary artery disease
5330131|NCT02039687|neuropathy|neuropathy
5330132|NCT02039687|sarcoidosis|sarcoidosis
5330133|NCT02039674|PD-1|pd-1
5330134|NCT02039674|PD1|pd1
5330135|NCT02039674|Programmed Cell Death-1|programmed cell death-1
5330136|NCT02039674|Programmed Cell Death 1|programmed cell death 1
5330137|NCT02039674|Chemotherapy|chemotherapy
5330138|NCT02039674|Pemetrexed|pemetrexed
5330140|NCT02039674|Bevacizumab|bevacizumab
5330141|NCT02039674|Erlotinib|erlotinib
5330142|NCT02039674|Gefitinib|gefitinib
5330143|NCT02039674|Ipilimumab|ipilimumab
5330144|NCT02039674|Carboplatin|carboplatin
5330145|NCT02039661|Curettage;|curettage;
5330146|NCT02039661|Pain Score|pain score
5330147|NCT02039648|Periodontitis|periodontitis
5330148|NCT02039648|Porphyromonas gingivalis|porphyromonas gingivalis
5330149|NCT02039648|Rumex acetosa L.|rumex acetosa l.
5330150|NCT02039648|Proanthocyanidins|proanthocyanidins
5330151|NCT02039635|cancer|cancer
5330152|NCT02039635|cancer related fatigue|cancer related fatigue
5330153|NCT02039635|Korean red ginseng|korean red ginseng
5330154|NCT02039635|chemotherapy|chemotherapy
5330155|NCT02039609|vegetarian|vegetarian
5330170|NCT02039531|plasma rich in growth factors|plasma rich in growth factors
5330171|NCT02039531|platelet rich plasma|platelet rich plasma
5330172|NCT02039531|hyaluronic acid|hyaluronic acid
5330173|NCT02039518|Progression free Survival|progression free survival
5330174|NCT02039505|Drug therapy|drug therapy
5330175|NCT02039479|anti-suicide|anti-suicide
5330176|NCT02039479|Lithium|lithium
5330177|NCT02039479|Depression|depression
5330178|NCT02039479|suicidal Ideation/behavior|suicidal ideation/behavior
5330179|NCT02039453|Colonoscopy|colonoscopy
5330180|NCT02039453|sedation|sedation
5330181|NCT02039453|propofol|propofol
5330182|NCT02039453|fentanyl|fentanyl
5330183|NCT02039453|pethidine|pethidine
5330184|NCT02039427|Sore throat|sore throat
5330185|NCT02039427|Hoarseness|hoarseness
5330186|NCT02039427|Intubation|intubation
5330187|NCT02039427|Thyroidectomy|thyroidectomy
5330188|NCT02039427|Ketorolac|ketorolac
5330189|NCT02039427|Dexamethasone|dexamethasone
5330190|NCT02039414|Obesity|obesity
5330191|NCT02039414|Physical Inactivity|physical inactivity
5330192|NCT02039414|Lipid Oxidation|lipid oxidation
5330193|NCT02039414|Oxidative stress|oxidative stress
5330194|NCT02039414|pregnancy|pregnancy
5330195|NCT02039414|neonatal adiposity|neonatal adiposity
5330196|NCT02039414|neonatal insulin sensitivity|neonatal insulin sensitivity
5330197|NCT02039401|ALS|als
5330198|NCT02039401|Lou Gehrig's disease|lou gehrig's disease
5330199|NCT02039401|neurodegenerative disease|neurodegenerative disease
5330212|NCT02039375|IV tPA|iv tpa
5330213|NCT02039375|Thrombolysis|thrombolysis
5330214|NCT02039375|Stroke|stroke
5330219|NCT02039349|Ghrelin Antagonism|ghrelin antagonism
5330220|NCT02039323|Tenofovir|tenofovir
5330221|NCT02039323|Tenofovir disoproxil|tenofovir disoproxil
5330222|NCT02039323|Maraviroc|maraviroc
5330223|NCT02039323|Pharmacologic Actions|pharmacologic actions
5330224|NCT02039323|Anti-HIV agents|anti-hiv agents
5330225|NCT02039323|Pharmacodynamics|pharmacodynamics
5330226|NCT02039297|AWARE, Checklist, ICU, Outcome, Adults|aware, checklist, icu, outcome, adults
5330227|NCT02039284|Cerebral palsy|cerebral palsy
5330228|NCT02039284|novel intervention|novel intervention
5330229|NCT02039284|sensory electrical stimulation|sensory electrical stimulation
5330230|NCT02039284|virtual reality|virtual reality
5330231|NCT02039284|cycling training|cycling training
5330232|NCT02039284|constraint-induced therapy|constraint-induced therapy
5330233|NCT02039284|biomechanical|biomechanical
5330234|NCT02039284|physiology|physiology
5330235|NCT02039284|outcome|outcome
5330236|NCT02039271|music|music
5330237|NCT02039271|total knee replacement|total knee replacement
5330238|NCT02039271|Pain management|pain management
5330239|NCT02039258|Healthy Volunteers|healthy volunteers
5330240|NCT02039258|Canagliflozin|canagliflozin
5330241|NCT02039258|Metformin|metformin
5330242|NCT02039258|INVOKANA®|invokana®
5330243|NCT02039258|Type 2 diabetes mellitus|type 2 diabetes mellitus
5330244|NCT02039245|Healthy Volunteers|healthy volunteers
5330245|NCT02039245|Canagliflozin|canagliflozin
5330246|NCT02039245|Metformin|metformin
5330247|NCT02039245|INVOKANA®|invokana®
5330248|NCT02039245|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5330249|NCT02039206|Machado Joseph disease|machado joseph disease
5330250|NCT02039206|Deep TMS|deep tms
5330251|NCT02039206|TMS|tms
5330252|NCT02039206|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5330253|NCT02039206|SCA3|sca3
5330254|NCT02039206|Magnetic Stimulation|magnetic stimulation
5330255|NCT02039206|Brainsway|brainsway
5330256|NCT02039193|Generalized anxiety disorder|generalized anxiety disorder
5330257|NCT02039193|cognitive behavior therapy|cognitive behavior therapy
5330258|NCT02039193|adherence|adherence
5330260|NCT02039180|healthy volunteers|healthy volunteers
5330261|NCT02039180|AZD3293|azd3293
5330262|NCT02039180|bioavailability|bioavailability
5330263|NCT02039180|Pharmacokinetics|pharmacokinetics
5330264|NCT02039154|Exercise|exercise
5330265|NCT02039154|Exercise tolerance|exercise tolerance
5330266|NCT02039154|Aging|aging
5330267|NCT02039154|Physical activity|physical activity
5330268|NCT02039141|diabetes prevention program|diabetes prevention program
5330269|NCT02039141|community based interventions|community based interventions
5330270|NCT02039141|childhood obesity|childhood obesity
5330271|NCT02039141|insulin resistance|insulin resistance
5330272|NCT02039141|glucose tolerance|glucose tolerance
5330273|NCT02039141|quality of life|quality of life
5330274|NCT02039141|Latino youth|latino youth
5330275|NCT02039141|physical activity|physical activity
5330276|NCT02039141|nutrition|nutrition
5330277|NCT02039102|hormonal contraceptives|hormonal contraceptives
5330278|NCT02039102|combined pills|combined pills
5330279|NCT02039102|progesterone-only contraceptives|progesterone-only contraceptives
5330280|NCT02039102|body mass index|body mass index
5330281|NCT02039102|asthma|asthma
5330282|NCT02039102|Scotland|scotland
5330283|NCT02039102|women|women
5330284|NCT02039076|Healthy|healthy
5330285|NCT02039063|Crohn's Disease|crohn's disease
5330286|NCT02039050|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5330287|NCT02039050|Long-acting muscarinic antagonists|long-acting muscarinic antagonists
5330288|NCT02039050|Impulse oscillometry|impulse oscillometry
5330289|NCT02039024|18F-DTBZ|18f-dtbz
5330290|NCT02039011|Asthma|asthma
5330291|NCT02039011|Long acting beta-agonists|long acting beta-agonists
5330292|NCT02039011|Long acting muscarinic antagonists|long acting muscarinic antagonists
5330293|NCT02039011|Mannitol challenge|mannitol challenge
5330294|NCT02038998|stroke|stroke
5330295|NCT02038998|periodic acceleration|periodic acceleration
5330296|NCT02038998|endothelium release|endothelium release
5330297|NCT02038998|ischemic penumbra|ischemic penumbra
5330298|NCT02038998|shear stress|shear stress
5330299|NCT02038998|adrenomedullin|adrenomedullin
5330300|NCT02038985|Endometriosis|endometriosis
5330301|NCT02038985|Robotic Surgery|robotic surgery
5330302|NCT02038985|Diagnostic Imaging|diagnostic imaging
5330303|NCT02038959|Parkinson disease|parkinson disease
5330304|NCT02038959|Parkinson's|parkinson's
5330305|NCT02038959|Parkinson's disease|parkinson's disease
5330306|NCT02038959|telemedicine|telemedicine
5330307|NCT02038959|virtual visits|virtual visits
5330308|NCT02038959|video calls|video calls
5330309|NCT02038959|video conferencing|video conferencing
5330310|NCT02038959|virtual house calls|virtual house calls
5330311|NCT02038920|Drug Therapy|drug therapy
5330312|NCT02038907|Norovirus, vaccination|norovirus, vaccination
5330314|NCT02038894|Pediatric|pediatric
5330315|NCT02038894|Esophagogastroduodenoscopies|esophagogastroduodenoscopies
5330316|NCT02038894|Eosinophilic esophagitis|eosinophilic esophagitis
5330317|NCT02038894|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5330318|NCT02038894|Abdominal Pain|abdominal pain
5330319|NCT02038894|Vomiting|vomiting
5330320|NCT02038894|Sevofluorane|sevofluorane
5330321|NCT02038894|Propofol|propofol
5330322|NCT02038894|Nasal cannula|nasal cannula
5330323|NCT02038894|Intubation|intubation
5330324|NCT02038894|Endotracheal tube|endotracheal tube
5330325|NCT02038868|ASP4901|asp4901
5330326|NCT02038868|BPH|bph
5330327|NCT02038855|Dual-diagnosis|dual-diagnosis
5330328|NCT02038855|Latino|latino
5330329|NCT02038855|Mental health|mental health
5330330|NCT02038855|Substance use|substance use
5330331|NCT02038855|HIV risk|hiv risk
5330332|NCT02038829|COPD|copd
5330333|NCT02038803|Cystic Fibrosis Medication Adherence|cystic fibrosis medication adherence
5330334|NCT02038790|opioid dependence|opioid dependence
5330335|NCT02038790|buprenorphine/naloxone|buprenorphine/naloxone
5677311|NCT00591006|Memory|memory
5330336|NCT02038790|Opioid-Related Disorders|opioid-related disorders
5330337|NCT02038777|Hematologic Malignancies|hematologic malignancies
5330338|NCT02038764|Phase 1|phase 1
5330339|NCT02038764|RN168|rn168
5330340|NCT02038764|Adults|adults
5330341|NCT02038764|Type 1 Diabetes|type 1 diabetes
5330342|NCT02038764|T1D|t1d
5330343|NCT02038751|Genotyping|genotyping
5330344|NCT02038751|Phenotyping|phenotyping
5330345|NCT02038751|Sleep Apnea|sleep apnea
5330346|NCT02038751|Genetic Association Studies|genetic association studies
5330347|NCT02038751|Phenotype|phenotype
5330348|NCT02038738|gallium|gallium
5330349|NCT02038738|Ga|ga
5330350|NCT02038738|PET Scan|pet scan
5330351|NCT02038725|Risks|risks
5330352|NCT02038725|Risk Factors|risk factors
5330353|NCT02038725|ABCD2 score|abcd2 score
5330354|NCT02038725|Predictive Value of Tests|predictive value of tests
5330355|NCT02038725|Risk Assessment|risk assessment
5330356|NCT02038725|Severity of Illness Index|severity of illness index
5330357|NCT02038725|Decision Support Techniques|decision support techniques
5330358|NCT02038712|Obesity|obesity
5330359|NCT02038712|Binge eating disorder|binge eating disorder
5330360|NCT02038712|fMRI|fmri
5330361|NCT02038712|gut hormones|gut hormones
5330363|NCT02038686|Unstable (31A2 and 31A3)|unstable (31a2 and 31a3)
5330364|NCT02038686|Proximal femoral nail|proximal femoral nail
5330365|NCT02038673|ASP5878|asp5878
5330366|NCT02038673|FGFR 1,2,3 and 4 inhibitor|fgfr 1,2,3 and 4 inhibitor
5330367|NCT02038660|Coronary Artery Disease|coronary artery disease
5330368|NCT02038660|Angioplasty, Balloon|angioplasty, balloon
5330369|NCT02038647|Drug therapy|drug therapy
5330370|NCT02038634|wrist|wrist
5330371|NCT02038634|tendonitis|tendonitis
5330372|NCT02038634|dequervain's|dequervain's
5330373|NCT02038634|tenosynovitis|tenosynovitis
5330374|NCT02038608|Parkinson|parkinson
5330375|NCT02038608|serotonin|serotonin
5330376|NCT02038608|dopamine|dopamine
5330377|NCT02038608|non motor|non motor
5330378|NCT02038608|progression|progression
5330379|NCT02038608|PET|pet
5330380|NCT02038595|brown adipose tissue|brown adipose tissue
5330381|NCT02038582|HIV|hiv
5330382|NCT02038582|HIV Counseling and Testing|hiv counseling and testing
5330383|NCT02038582|Linkages to Care|linkages to care
5330384|NCT02038582|Point of Care CD4|point of care cd4
5330385|NCT02038582|Point of Care Viral Load|point of care viral load
5330386|NCT02038543|Hyperoxaluria|hyperoxaluria
5330387|NCT02038543|Oxalate|oxalate
5330388|NCT02038543|Primary Hyperoxaluria|primary hyperoxaluria
5330389|NCT02038530|Deep Vein Thrombosis|deep vein thrombosis
5330390|NCT02038517|Insulin secretion|insulin secretion
5330391|NCT02038517|Insulin sensitivity|insulin sensitivity
5330392|NCT02038517|Orthotopic liver transplantation|orthotopic liver transplantation
5330393|NCT02038517|Type 2 diabetes|type 2 diabetes
5330394|NCT02038517|Metabolic syndrome|metabolic syndrome
5330395|NCT02038517|Cardiovascular disease|cardiovascular disease
5330396|NCT02038504|gastrointestinal fistula|gastrointestinal fistula
5330397|NCT02038504|enteral nutrition|enteral nutrition
5330398|NCT02038504|thyroid function|thyroid function
5330399|NCT02038491|Epidural anesthesia|epidural anesthesia
5330400|NCT02038491|Spinal anesthesia|spinal anesthesia
5330401|NCT02038491|nerve blocks|nerve blocks
5330402|NCT02038491|complications|complications
5330403|NCT02038478|Sickle Cell Disease|sickle cell disease
5330404|NCT02038478|Thalassemia|thalassemia
5330405|NCT02038452|hand|hand
5330406|NCT02038452|wrist|wrist
5330407|NCT02038452|carpal|carpal
5330408|NCT02038452|tunnel|tunnel
5330409|NCT02038452|syndrome|syndrome
5330410|NCT02038452|pragmatic|pragmatic
5330411|NCT02038452|randomised|randomised
5330412|NCT02038452|steroid|steroid
5330413|NCT02038452|splint|splint
5330414|NCT02038439|Evidence-Based Medicine|evidence-based medicine
5330415|NCT02038439|Evidence Retrieval|evidence retrieval
5330416|NCT02038439|Knowledge Translation|knowledge translation
5326583|NCT02055118|MPSII|mpsii
5330421|NCT02038413|MAASTRO|maastro
5330422|NCT02038413|age >18 years|age >18 years
5330423|NCT02038335|immune cells|immune cells
5330424|NCT02038335|contraception|contraception
5330425|NCT02038335|intrauterine device|intrauterine device
5330426|NCT02038335|IUD|iud
5330427|NCT02038335|copper|copper
5330428|NCT02038335|microbiota|microbiota
5330429|NCT02038335|DMPA|dmpa
5330430|NCT02038335|etonogestrel|etonogestrel
5330431|NCT02038335|subdermal implant|subdermal implant
5330432|NCT02038335|NET-EN|net-en
5330433|NCT02038335|Jadelle|jadelle
5330434|NCT02038335|Implanon|implanon
5330435|NCT02038335|Cyclofem|cyclofem
5330436|NCT02038322|OTC Home Use Conception Aid Cervical Cap Insemination|otc home use conception aid cervical cap insemination
5330437|NCT02038309|Acute coronary syndrome|acute coronary syndrome
5330438|NCT02038309|persistent platelet reactivity|persistent platelet reactivity
5330439|NCT02038296|Hepatocellular carcinoma|hepatocellular carcinoma
5330440|NCT02038296|Transarterial chemoembolization|transarterial chemoembolization
5330441|NCT02038296|Gemcitabine|gemcitabine
5330442|NCT02038283|Colorectal Neoplasms|colorectal neoplasms
5330443|NCT02038283|Early Detection of Cancer|early detection of cancer
5330444|NCT02038283|Quality of Life|quality of life
5330445|NCT02038283|Quality-Adjusted Life Years|quality-adjusted life years
5330446|NCT02038283|Direct Service Costs|direct service costs
5330447|NCT02038283|Cost-Benefit Analysis|cost-benefit analysis
5330448|NCT02038231|Adolescence|adolescence
5330449|NCT02038231|Substance abuse|substance abuse
5330450|NCT02038231|Mindfulness|mindfulness
5330451|NCT02038218|DM-CHOC-PEN|dm-choc-pen
5330452|NCT02038218|CNS|cns
5330453|NCT02038218|brain|brain
5330454|NCT02038218|melanoma|melanoma
5330455|NCT02038218|lung cancer|lung cancer
5330456|NCT02038218|breast cancer|breast cancer
5330457|NCT02038218|glioblastoma multiforme|glioblastoma multiforme
5330458|NCT02038218|primary brain tumors|primary brain tumors
5330459|NCT02038192|Caregiver|caregiver
5330460|NCT02038192|Dementia|dementia
5330461|NCT02038192|Long Term Care|long term care
5330462|NCT02038192|Hope|hope
5330463|NCT02038192|Quality of Life|quality of life
5330464|NCT02038192|Intervention|intervention
5330473|NCT02038114|Ontario|ontario
5330474|NCT02038088|Need general anesthesia|need general anesthesia
5330475|NCT02038075|suicide|suicide
5330476|NCT02038075|suicidal ideation|suicidal ideation
5330477|NCT02038075|military|military
5330478|NCT02038075|veteran|veteran
5330479|NCT02038075|cognitive behavioral therapy|cognitive behavioral therapy
5330480|NCT02038075|behavioral therapy|behavioral therapy
5330481|NCT02038075|psychotherapy|psychotherapy
5330482|NCT02038075|Brief Cognitive Behavioral Therapy (BCBT)|brief cognitive behavioral therapy (bcbt)
5330483|NCT02038075|Treatement As Usual (TAU)|treatement as usual (tau)
5330485|NCT02038049|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5330486|NCT02038049|Magnetic Resonance Imaging|magnetic resonance imaging
5330487|NCT02038049|VAY736|vay736
5330488|NCT02038049|Lanalumab|lanalumab
5330489|NCT02038049|monoclonal antibody|monoclonal antibody
5330490|NCT02038049|gadolinium [Gd]-enhancing lesions|gadolinium [gd]-enhancing lesions
5330491|NCT02038049|B-Cell|b-cell
5330499|NCT02038023|Iv iron in pregnant women|iv iron in pregnant women
5330500|NCT02038023|second and third trimester|second and third trimester
5330502|NCT02037971|Systemic Lupus Erythematosus|systemic lupus erythematosus
5330503|NCT02037971|Lupus|lupus
5330504|NCT02037971|Sleep disorders|sleep disorders
5330505|NCT02037971|Sleep disturbed|sleep disturbed
5330506|NCT02037971|Physical exercise|physical exercise
5330507|NCT02037971|Aerobic exercise|aerobic exercise
5330508|NCT02037945|18F-Fluorocholine (18F-FCho)|18f-fluorocholine (18f-fcho)
5330509|NCT02037945|Pet Scan|pet scan
5330510|NCT02037945|MRI|mri
5330511|NCT02037945|13-199|13-199
5330512|NCT02037932|Aneurysm|aneurysm
5330513|NCT02037932|Brain Aneurysm|brain aneurysm
5330514|NCT02037906|Renal stones|renal stones
5330515|NCT02037906|SWL|swl
5330516|NCT02037880|Mucopolysaccharidosis|mucopolysaccharidosis
5330517|NCT02037880|MPS|mps
5330518|NCT02037880|Sanfilippo|sanfilippo
5330519|NCT02037867|alcohol|alcohol
5330520|NCT02037867|type 2 diabetes|type 2 diabetes
5330521|NCT02037867|ALT|alt
5330522|NCT02037867|abnormal liver enzymes|abnormal liver enzymes
5330523|NCT02037867|hepatic fibrosis|hepatic fibrosis
5330524|NCT02037867|cirrhosis|cirrhosis
5330525|NCT02037841|Asthma|asthma
5330526|NCT02037841|Nursing|nursing
5330527|NCT02037841|Protocol|protocol
5330528|NCT02037841|PRAM|pram
5330529|NCT02037841|Length of Stay|length of stay
5330530|NCT02037841|Weaning|weaning
5330531|NCT02037841|Clinical pathway|clinical pathway
5330532|NCT02037841|Asthma exacerbation|asthma exacerbation
5330533|NCT02037828|COPD|copd
5330534|NCT02037828|biomarker|biomarker
5330536|NCT02037828|FEV1|fev1
5330537|NCT02037815|hyperosmolar drugs|hyperosmolar drugs
5330538|NCT02037815|mannitol|mannitol
5330539|NCT02037815|hypertonic saline|hypertonic saline
5330540|NCT02037815|serum osmolality|serum osmolality
5330541|NCT02037815|correlation|correlation
5330542|NCT02037802|caudal|caudal
5330543|NCT02037802|epidural|epidural
5330544|NCT02037802|pediatric|pediatric
5330545|NCT02037802|renal|renal
5330546|NCT02037802|transplant|transplant
5330547|NCT02037802|hemodynamics|hemodynamics
5330548|NCT02037789|pain|pain
5330549|NCT02037789|low back pain|low back pain
5330550|NCT02037789|GWAS|gwas
5330551|NCT02037789|glycomics|glycomics
5330552|NCT02037789|activomics|activomics
5330553|NCT02037776|Rikkunshito|rikkunshito
5330554|NCT02037776|Double blind|double blind
5330555|NCT02037776|Functional dyspepsia (FD)|functional dyspepsia (fd)
5330556|NCT02037763|Low back pain|low back pain
5330557|NCT02037763|GWAS|gwas
5330558|NCT02037763|Glycomics|glycomics
5330559|NCT02037763|Activomics|activomics
5330560|NCT02037763|Epigenetics|epigenetics
5330561|NCT02037750|foster care|foster care
5330562|NCT02037750|school adjustment|school adjustment
5330563|NCT02037711|Laparoscopic|laparoscopic
5330564|NCT02037711|Levobupivacaine|levobupivacaine
5330565|NCT02037711|Pediatric|pediatric
5330566|NCT02037711|Anesthesia|anesthesia
5330567|NCT02037711|Instillation|instillation
5330568|NCT02037711|surgeries|surgeries
5330569|NCT02037698|CTO|cto
5330570|NCT02037698|CT|ct
5330571|NCT02037698|Revascularization|revascularization
5330572|NCT02037685|Statins|statins
5330573|NCT02037685|Cholesterol lowering medications|cholesterol lowering medications
5330574|NCT02037685|Adherence|adherence
5330575|NCT02037685|Motivational interviewing|motivational interviewing
5330576|NCT02037685|Minority populations|minority populations
5330577|NCT02037672|PCOS|pcos
5330592|NCT02037607|Anti-coagulant|anti-coagulant
5330593|NCT02037607|Neurosurgical procedures|neurosurgical procedures
5330594|NCT02037607|Blood Clot|blood clot
5330595|NCT02037594|HIV|hiv
5330596|NCT02037594|Pre-exposure prophylaxis|pre-exposure prophylaxis
5330597|NCT02037594|PrEP|prep
5330598|NCT02037594|MSM|msm
5330599|NCT02037594|Demonstration Project|demonstration project
5330600|NCT02037581|integrated care|integrated care
5330601|NCT02037581|hometreatment|hometreatment
5330602|NCT02037581|assertive community treatment (ACT)|assertive community treatment (act)
5330603|NCT02037581|psychosis|psychosis
5330604|NCT02037581|schizophrenia|schizophrenia
5330605|NCT02037581|bipolar disorder|bipolar disorder
5330606|NCT02037581|first episode|first episode
5330607|NCT02037568|depression|depression
5330608|NCT02037568|stress|stress
5330609|NCT02037568|caregiving|caregiving
5330610|NCT02037568|anxiety|anxiety
5330611|NCT02037568|psychoeducation intervention|psychoeducation intervention
5330612|NCT02037568|psycho-oncology|psycho-oncology
5330613|NCT02037568|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5330614|NCT02037555|Antithrombin|antithrombin
5330615|NCT02037555|Cardiopulmonary bypass|cardiopulmonary bypass
5330616|NCT02037542|BMI, Lipid profile|bmi, lipid profile
5330617|NCT02037516|residual muscle weakness, respiratory events|residual muscle weakness, respiratory events
5330619|NCT02037490|Mothers|mothers
5330620|NCT02037490|Social media|social media
5330621|NCT02037490|Obesity prevention|obesity prevention
5330622|NCT02037464|Prostate Cancer|prostate cancer
5330623|NCT02037464|Active Surveillance|active surveillance
5330624|NCT02037464|Radical Prostatectomy|radical prostatectomy
5330625|NCT02037451|Parkinson's disease|parkinson's disease
5330626|NCT02037451|Auditory Cueing|auditory cueing
5330627|NCT02037438|Clinical sleep medicine|clinical sleep medicine
5330628|NCT02037438|New methodology for healthcare delivery|new methodology for healthcare delivery
5330629|NCT02037438|Diagnosis and treatment of sleep disorders|diagnosis and treatment of sleep disorders
5330630|NCT02037438|Electronic health records|electronic health records
5330631|NCT02037438|Clinical informatics|clinical informatics
5330632|NCT02037438|Evidence-based comparative effectiveness research|evidence-based comparative effectiveness research
5330633|NCT02037438|Sleep specialists|sleep specialists
5330634|NCT02037438|Primary care providers|primary care providers
5330635|NCT02037438|Allied health professionals|allied health professionals
5330636|NCT02037438|Patient-centered care|patient-centered care
5330637|NCT02037425|Chronic Migraine|chronic migraine
5330638|NCT02037425|onabotulinumtoxinA|onabotulinumtoxina
5330639|NCT02037425|Headache|headache
5330640|NCT02037425|Migraine|migraine
5330641|NCT02037425|Neuronal regrowth|neuronal regrowth
5330643|NCT02037412|Ticagrelor|ticagrelor
5330644|NCT02037412|strut coverage|strut coverage
5330645|NCT02037412|DES|des
5330646|NCT02037412|ACS|acs
5330647|NCT02037412|OCT|oct
5330648|NCT02037399|Endoscopic submucosal dissection|endoscopic submucosal dissection
5330649|NCT02037399|early gastric cancer|early gastric cancer
5330650|NCT02037399|pain relief|pain relief
5330651|NCT02037399|intravenous dexamethasone|intravenous dexamethasone
5330652|NCT02037399|present pain intensity|present pain intensity
5330654|NCT02037386|Coronary bifurcation lesion|coronary bifurcation lesion
5330655|NCT02037373|intra and post-op coagulopathy in patients undergoing OLT|intra and post-op coagulopathy in patients undergoing olt
5330656|NCT02037360|Smoking|smoking
5330657|NCT02037360|Cessation|cessation
5330658|NCT02037334|Preterm delivery|preterm delivery
5330659|NCT02037334|Diagnostics|diagnostics
5330660|NCT02037334|Biomechanics|biomechanics
5445413|NCT01521910|protein restriction|protein restriction
5330661|NCT02037321|Systematic review and meta-analysis|systematic review and meta-analysis
5330662|NCT02037308|Glu298Asp polymorphism|glu298asp polymorphism
5330663|NCT02037308|Blood pressure|blood pressure
5330664|NCT02037308|Plasma NOx|plasma nox
5330665|NCT02037308|Beetroot|beetroot
5330666|NCT02037295|Gut Microbiota|gut microbiota
5330667|NCT02037295|Obesity|obesity
5330668|NCT02037295|Absorption|absorption
5330669|NCT02037295|Overfeeding|overfeeding
5330670|NCT02037282|HAI Titer|hai titer
5330673|NCT02037282|Serum Antibody Response|serum antibody response
5330674|NCT02037269|Cerenkov Luminescence Imaging, CLI, margin status|cerenkov luminescence imaging, cli, margin status
5330675|NCT02037243|behavior change|behavior change
5330676|NCT02037243|handwashing|handwashing
5330677|NCT02037243|water treatment|water treatment
5330678|NCT02037243|disgust|disgust
5330679|NCT02037243|shame|shame
5330680|NCT02037243|neighbour|neighbour
5330681|NCT02037243|willingness to pay|willingness to pay
5330682|NCT02037204|IMPACT|impact
5330683|NCT02037204|Chondrons|chondrons
5330684|NCT02037204|Mesenchymal stem cells|mesenchymal stem cells
5330685|NCT02037204|Allogeneic MSCs|allogeneic mscs
5330686|NCT02037204|single-stage|single-stage
5330687|NCT02037204|Cartilage repair|cartilage repair
5330688|NCT02037204|Safety|safety
5330689|NCT02037204|Efficacy|efficacy
5330690|NCT02037191|ALOPECIA AREATA|alopecia areata
5330691|NCT02037191|TREATMENT METHOTREXATE|treatment methotrexate
5330692|NCT02037178|Peripheral Obliterative Arteriopathy of the legs|peripheral obliterative arteriopathy of the legs
5330693|NCT02037178|Screening by generalists|screening by generalists
5330694|NCT02037178|Ultrasound|ultrasound
5330695|NCT02037152|Chronic pain|chronic pain
5330696|NCT02037152|Mobile applications|mobile applications
5330697|NCT02037152|Mindfulness|mindfulness
5330698|NCT02037152|Meditation|meditation
5330699|NCT02037152|Telemedicine|telemedicine
5330700|NCT02037152|Cellular phone|cellular phone
5330701|NCT02037152|Pain Management|pain management
5330702|NCT02037152|Therapy, computer-assisted|therapy, computer-assisted
5330703|NCT02037139|Hearing loss|hearing loss
5330704|NCT02037139|Screening|screening
5330705|NCT02037139|Primary Care|primary care
5330706|NCT02037113|IVUS|ivus
5330707|NCT02037113|PAD|pad
5330708|NCT02037113|Femoro-popliteal disease|femoro-popliteal disease
5330709|NCT02037113|Intravascular ultrasound|intravascular ultrasound
5330710|NCT02037087|Short Message Service|short message service
5330711|NCT02037087|newborn health|newborn health
5330712|NCT02037087|maternal behavior|maternal behavior
5330713|NCT02037087|good household pregnancy practice|good household pregnancy practice
5330714|NCT02037087|care seeking|care seeking
5330715|NCT02037074|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
5330718|NCT02036983|Ultrasound guided|ultrasound guided
5330719|NCT02036983|Bilateral Transversus abdominis Plane Block|bilateral transversus abdominis plane block
5330720|NCT02036983|Dexamethasone|dexamethasone
5330721|NCT02036983|Preperitoneal Instillation|preperitoneal instillation
5330722|NCT02036983|Local Analgesic|local analgesic
5330723|NCT02036983|Efficacy|efficacy
5330724|NCT02036983|Total Extraperitoneal Bilateral Inguinal hernia repair|total extraperitoneal bilateral inguinal hernia repair
5330725|NCT02036970|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5330727|NCT02036970|Bardoxolone methyl|bardoxolone methyl
5330728|NCT02036970|6-minute walk distance|6-minute walk distance
5330729|NCT02036970|CDDO-me|cddo-me
5330730|NCT02036970|RTA 402|rta 402
5330731|NCT02036970|Pulmonary Hypertension|pulmonary hypertension
5330732|NCT02036970|Interstitial Lung Disease|interstitial lung disease
5330733|NCT02036970|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
5330734|NCT02036970|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5330735|NCT02036970|Sarcoidosis|sarcoidosis
5330736|NCT02036970|Respiratory Bronchiolitis Associated ILD|respiratory bronchiolitis associated ild
5330737|NCT02036970|Desquamative Interstitial Pneumonia|desquamative interstitial pneumonia
5330738|NCT02036970|Cryptogenic Organizing Pneumonia|cryptogenic organizing pneumonia
5330739|NCT02036970|Acute Interstitial Pneumonitis|acute interstitial pneumonitis
5330740|NCT02036970|Idiopathic Lymphoid Interstitial Pneumonia|idiopathic lymphoid interstitial pneumonia
5210502|NCT02679846|adverse event|adverse event
5330741|NCT02036970|Idiopathic Pleuroparenchymal Fibroelastosis|idiopathic pleuroparenchymal fibroelastosis
5330742|NCT02036957|capecitabine|capecitabine
5330743|NCT02036957|dermatologic toxicity|dermatologic toxicity
5330744|NCT02036944|Celiac Disease|celiac disease
5330745|NCT02036944|Celiac Sprue|celiac sprue
5330746|NCT02036944|Iron-Deficiency Anemia|iron-deficiency anemia
5330748|NCT02036931|Osteoarthritis|osteoarthritis
5330749|NCT02036931|Avascular Necrosis|avascular necrosis
5326884|NCT02053727|Orencia|orencia
5330750|NCT02036918|castrate resistant prostate cancer|castrate resistant prostate cancer
5330751|NCT02036918|metastatic|metastatic
5330752|NCT02036918|sipuleucel-T|sipuleucel-t
5330753|NCT02036918|lymphadenectomy|lymphadenectomy
5330754|NCT02036918|Excisional lymph node biopsy|excisional lymph node biopsy
5330755|NCT02036905|neck pain, orthopedic manual therapy|neck pain, orthopedic manual therapy
5330756|NCT02036892|Diabetes|diabetes
5330757|NCT02036879|Cystic Fibrosis|cystic fibrosis
5330758|NCT02036879|Loestrin|loestrin
5330759|NCT02036879|Hormone|hormone
5330760|NCT02036866|knee osteoarthritis|knee osteoarthritis
5330761|NCT02036866|grade I and II knee osteoarthritis|grade i and ii knee osteoarthritis
5330762|NCT02036866|arthritis|arthritis
5330763|NCT02036853|Triheptanoin|triheptanoin
5330764|NCT02036853|Glut1 DS|glut1 ds
5330765|NCT02036853|Epilepsy|epilepsy
5330766|NCT02036853|Seizures|seizures
5330767|NCT02036827|Pain, Postoperative|pain, postoperative
5330768|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents
5330769|NCT02036827|Laparoscopy|laparoscopy
5330770|NCT02036814|Hypertension|hypertension
5330771|NCT02036814|Nursing|nursing
5330772|NCT02036814|Therapeutic compliance|therapeutic compliance
5330773|NCT02036814|Quality of life|quality of life
5330774|NCT02036814|Health education|health education
5330775|NCT02036801|ARDS|ards
5330776|NCT02036801|Lung|lung
5330777|NCT02036801|Specific Elastance|specific elastance
5330778|NCT02036801|Pediatric patients|pediatric patients
5330779|NCT02036788|Esophageal pressure, Mechanical ventilation|esophageal pressure, mechanical ventilation
5330780|NCT02036762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5330781|NCT02036762|Thoracoabdominal Mechanics|thoracoabdominal mechanics
5330782|NCT02036762|Functional capacity|functional capacity
5330783|NCT02036762|Quality of life|quality of life
5330784|NCT02036736|Orthopedic Surgery|orthopedic surgery
5330785|NCT02036736|Total hip prosthesis|total hip prosthesis
5330786|NCT02036736|Total knee replacement|total knee replacement
5330787|NCT02036736|Intraoperative anesthetic strategy|intraoperative anesthetic strategy
5330788|NCT02036736|Propofol|propofol
5330789|NCT02036736|Desflurane|desflurane
5330790|NCT02036723|Macular Degeneration|macular degeneration
5330791|NCT02036723|Eye Diseases|eye diseases
5330792|NCT02036723|Neovascular Macular Degeneration|neovascular macular degeneration
5330793|NCT02036723|Choroidal Neovascularization|choroidal neovascularization
5330794|NCT02036723|Geographic Atrophy|geographic atrophy
5330795|NCT02036710|GLP-1|glp-1
5330796|NCT02036710|PYY|pyy
5330797|NCT02036710|Leptin|leptin
5330798|NCT02036710|Duodenal Switch|duodenal switch
5330799|NCT02036697|Cesarean section|cesarean section
5330800|NCT02036697|spinal anesthesia|spinal anesthesia
5330801|NCT02036697|low dose spinal|low dose spinal
5330802|NCT02036697|bupivacaine|bupivacaine
5330803|NCT02036697|hemodynamics|hemodynamics
5330804|NCT02036697|blood pressure|blood pressure
5330805|NCT02036697|cardiac output|cardiac output
5330806|NCT02036684|Prostate cancer|prostate cancer
5330807|NCT02036684|Radical prostatectomy|radical prostatectomy
5330808|NCT02036684|Prehabilitation|prehabilitation
5330809|NCT02036684|Pelvic floor muscle exercises|pelvic floor muscle exercises
5330810|NCT02036671|Arteriovenous fistula|arteriovenous fistula
5330811|NCT02036671|Fistula|fistula
5330812|NCT02036671|Chronic kidney disease|chronic kidney disease
5330813|NCT02036671|Percutaneous|percutaneous
5330814|NCT02036671|Kidney Disease|kidney disease
5330815|NCT02036671|Kidney Failure, Chronic|kidney failure, chronic
5330816|NCT02036671|Urologic Diseases|urologic diseases
5330817|NCT02036671|Renal Insufficiency, Chronic|renal insufficiency, chronic
5330818|NCT02036671|Renal Insufficiency|renal insufficiency
5330819|NCT02036671|CKD|ckd
5330820|NCT02036671|hemodialysis|hemodialysis
5330821|NCT02036658|social anxiety|social anxiety
5330822|NCT02036658|treatment|treatment
5330823|NCT02036658|cognitive-behavioral therapy|cognitive-behavioral therapy
5330824|NCT02036658|mindfulness-based stress reduction|mindfulness-based stress reduction
5330825|NCT02036658|emotion regulation|emotion regulation
5330826|NCT02036658|randomized controlled trial|randomized controlled trial
5330827|NCT02036658|neuroimaging|neuroimaging
5330828|NCT02036658|functional magnetic resonance imaging|functional magnetic resonance imaging
5330829|NCT02036658|mediators|mediators
5330830|NCT02036658|mechanisms|mechanisms
5330831|NCT02036619|gestational diabetes|gestational diabetes
5330832|NCT02036619|pregestational diabetes|pregestational diabetes
5330833|NCT02036619|screening|screening
5963309|NCT04255433|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5330834|NCT02036619|diagnostic criteria|diagnostic criteria
5330836|NCT02036593|Cardiovascular Risk Factors|cardiovascular risk factors
5330837|NCT02036580|Japan|japan
5330838|NCT02036580|Phase2|phase2
5330839|NCT02036580|Safety|safety
5330840|NCT02036580|Tolerability|tolerability
5330841|NCT02036580|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5330842|NCT02036580|IPF|ipf
5330843|NCT02036580|CAT-354|cat-354
5330844|NCT02036580|Tralokinumab|tralokinumab
5330845|NCT02036541|Glaucoma Implant|glaucoma implant
5330846|NCT02036541|Trabeculectomy|trabeculectomy
5330847|NCT02036541|POAG|poag
5330848|NCT02036541|Primary Open Angle Glaucoma|primary open angle glaucoma
5330857|NCT02036502|PDL1|pdl1
5330858|NCT02036502|PD-L1|pd-l1
5330859|NCT02036476|Merkel Cell Carcinoma|merkel cell carcinoma
5330860|NCT02036476|Skin Cancer|skin cancer
5330861|NCT02036463|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5330862|NCT02036463|Corticosteroids|corticosteroids
5330867|NCT02036450|bleeding|bleeding
5330868|NCT02036450|anticoagulation|anticoagulation
5330869|NCT02036450|hypertension|hypertension
5330870|NCT02036450|diabetes|diabetes
5330871|NCT02036450|heart failure|heart failure
5330872|NCT02036450|mortality|mortality
5330873|NCT02036437|Induction of Labor|induction of labor
5330874|NCT02036437|Misoprostol|misoprostol
5330875|NCT02036411|clomiphene citrate|clomiphene citrate
5330877|NCT02036411|inhibin b|inhibin b
5330878|NCT02036398|Percutaneous Nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
5330879|NCT02036398|Nephrostomy|nephrostomy
5330880|NCT02036398|Double J stent|double j stent
5330881|NCT02036398|PleuraL Effusion|pleural effusion
5330882|NCT02036372|glucose|glucose
5330883|NCT02036372|diabetes mellitus|diabetes mellitus
5330884|NCT02036372|perioperative|perioperative
5330885|NCT02036359|Non-small Cell Lung Cancer(NSCLC)|non-small cell lung cancer(nsclc)
5330886|NCT02036346|ileostomy|ileostomy
5330887|NCT02036346|colorectal resection|colorectal resection
5330888|NCT02036346|dehydration|dehydration
5330889|NCT02036346|nutritional status|nutritional status
5330890|NCT02036333|near infrared spectroscopy|near infrared spectroscopy
5330891|NCT02036333|pediatrics|pediatrics
5330892|NCT02036307|Fish oils|fish oils
5330893|NCT02036307|Triglycerides|triglycerides
5330894|NCT02036307|Blood pressure|blood pressure
5330895|NCT02036294|Patient self-care behaviors|patient self-care behaviors
5330896|NCT02036294|Patient activation|patient activation
5330897|NCT02036294|Family caregiver support|family caregiver support
5330898|NCT02036294|Patient-centered care|patient-centered care
5330899|NCT02036281|Terminally ill , histologically-confirmed advanced cancer|terminally ill , histologically-confirmed advanced cancer
5330900|NCT02036281|Pain unrelieved by opioids|pain unrelieved by opioids
5330901|NCT02036268|Ostomy education|ostomy education
5330902|NCT02036268|Education|education
5330903|NCT02036268|care of ostomy site|care of ostomy site
5330904|NCT02036255|Prevention, Thrombosis, Hemodialysis, Vascular access device|prevention, thrombosis, hemodialysis, vascular access device
5330905|NCT02036242|Opioid|opioid
5330906|NCT02036242|Local anesthetic|local anesthetic
5330907|NCT02036242|Labor delivery|labor delivery
5330908|NCT02036242|Safety|safety
5330909|NCT02036229|demodex|demodex
5330910|NCT02036229|demodicidosis|demodicidosis
5330911|NCT02036229|rosacea|rosacea
5330912|NCT02036229|ivermectin|ivermectin
5330913|NCT02036216|Hepatocellular Carcinoma；cell free tumor DNA; Mutation;|hepatocellular carcinoma；cell free tumor dna; mutation;
5330914|NCT02036190|COPD, chronic obstructive pulmonary disease, emphysema|copd, chronic obstructive pulmonary disease, emphysema
5330915|NCT02036177|IUB|iub
5330916|NCT02036164|Locally advanced cervical cancer|locally advanced cervical cancer
5330917|NCT02036164|Concurrent chemoradiation|concurrent chemoradiation
5330918|NCT02036164|Adjuvant chemotherapy|adjuvant chemotherapy
5330919|NCT02036151|Xylitol|xylitol
5330920|NCT02036151|prevention|prevention
5330921|NCT02036151|Mutans streptococci|mutans streptococci
5330922|NCT02036151|caries|caries
5330923|NCT02036151|plaque|plaque
5330924|NCT02036151|children|children
5330925|NCT02036125|Corticosteroid|corticosteroid
5330926|NCT02036125|Ultrasound|ultrasound
5330927|NCT02036125|Guided injection|guided injection
5330928|NCT02036112|Advanced Lower rectal cancer|advanced lower rectal cancer
5330929|NCT02036112|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
5330930|NCT02036112|Circumferential resection margin|circumferential resection margin
5330931|NCT02036112|Morbidity|morbidity
5330932|NCT02036112|Survival|survival
5330933|NCT02036099|Dementia|dementia
5330934|NCT02036099|Automobile driving|automobile driving
5330935|NCT02036099|Accidents, traffic|accidents, traffic
5330936|NCT02036086|Melanoma stage IIIB or C with BRAF mutation|melanoma stage iiib or c with braf mutation
5330937|NCT02036086|Recurrent regional lymphadenopathy not suitable for surgery|recurrent regional lymphadenopathy not suitable for surgery
5330938|NCT02036086|Eligible for neoadjuvant vemurafenib and cobimetinib|eligible for neoadjuvant vemurafenib and cobimetinib
5330939|NCT02036073|erythropoietin|erythropoietin
5330940|NCT02036073|preterm|preterm
5330941|NCT02036073|brain injury|brain injury
5210695|NCT02678455|Dengue Virus|dengue virus
5210696|NCT02678416|comparison|comparison
5210697|NCT02678403|peripheral artery disease|peripheral artery disease
5330942|NCT02036073|cerebral palsy|cerebral palsy
5330943|NCT02036073|PVL|pvl
5330944|NCT02036060|Metastatic prostate cancer|metastatic prostate cancer
5330945|NCT02036060|Abiraterone acetate|abiraterone acetate
5330946|NCT02036021|pediatric anesthesia|pediatric anesthesia
5330947|NCT02036021|perioperative respiratory events|perioperative respiratory events
5330948|NCT02036021|days of hospitalization|days of hospitalization
5330949|NCT02036021|cost of hospitalization|cost of hospitalization
5330950|NCT02036008|Liver metastases|liver metastases
5330951|NCT02036008|MRI|mri
5330952|NCT02036008|Contrast Agents|contrast agents
5335230|NCT02016105|equivalent efficacy|equivalent efficacy
5343009|NCT01981135|Controlled Human exposure study|controlled human exposure study
5330953|NCT02035995|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.|gestational diabetes mellitus; optical coherence tomography; pregnancy; retinal nerve fiber layer.
5330954|NCT02035956|IVAC MUTANOME|ivac mutanome
5330955|NCT02035956|IVAC|ivac
5330956|NCT02035956|personalized therapy|personalized therapy
5330957|NCT02035956|personalized immuno therapy|personalized immuno therapy
5330958|NCT02035956|RB_0004-01|rb_0004-01
5330959|NCT02035956|Ribological|ribological
5330960|NCT02035956|Melanoma|melanoma
5330961|NCT02035956|cancer vaccine|cancer vaccine
5330962|NCT02035930|Bispectral Index Monitor, Menstrual Cycle, Dexmedetomidine|bispectral index monitor, menstrual cycle, dexmedetomidine
5330963|NCT02035891|colchicine|colchicine
5330964|NCT02035891|urinary albumin-to-creatinine ratio|urinary albumin-to-creatinine ratio
5330965|NCT02035891|carotid Intima-Media Thickness|carotid intima-media thickness
5330966|NCT02035891|overt nephropathy|overt nephropathy
5330967|NCT02035891|Type 2 diabetes|type 2 diabetes
5330968|NCT02035878|anxiety|anxiety
5330969|NCT02035878|depression|depression
5330970|NCT02035878|probiotics|probiotics
5330971|NCT02035878|adult|adult
5330972|NCT02035878|human|human
5330973|NCT02035878|depression anxiety stress scale|depression anxiety stress scale
5330974|NCT02035878|anxiety sensitivity index|anxiety sensitivity index
5330975|NCT02035865|Psychiatric morbidity|psychiatric morbidity
5330976|NCT02035865|Cognitive function|cognitive function
5330977|NCT02035865|Heart transplantation|heart transplantation
5330978|NCT02035865|Mortality|mortality
5330979|NCT02035865|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
5330980|NCT02035839|Target Temperature Management|target temperature management
5330981|NCT02035839|Cooling comatose survivors from OHCA|cooling comatose survivors from ohca
5330982|NCT02035839|Good neurological outcome at modified Rankin Score (mRS) ≤ 3|good neurological outcome at modified rankin score (mrs) ≤ 3
5330983|NCT02035813|metastatic breast cancer|metastatic breast cancer
5330984|NCT02035813|circulating tumor cells|circulating tumor cells
5330985|NCT02035813|eribulin|eribulin
5330986|NCT02035813|ribociclib|ribociclib
5330987|NCT02035800|Rheumatoid Arthritis|rheumatoid arthritis
5330988|NCT02035800|Adalimumab|adalimumab
5330989|NCT02035800|Humira|humira
5330990|NCT02035787|metformin|metformin
5330991|NCT02035787|endometrial cancer|endometrial cancer
5330992|NCT02035787|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5330993|NCT02035787|complex atypical hyperplasia|complex atypical hyperplasia
5330994|NCT02035774|Brachial plexus block|brachial plexus block
5330995|NCT02035774|Suprascapular nerve block|suprascapular nerve block
5330997|NCT02035761|Shy-Dragers Syndrome|shy-dragers syndrome
5330998|NCT02035761|Possible or Probable|possible or probable
5330999|NCT02035748|Vitreomacular traction|vitreomacular traction
5331000|NCT02035748|Symptomatic vitreomacular adhesion|symptomatic vitreomacular adhesion
5331001|NCT02035748|Ocriplasmin|ocriplasmin
5331002|NCT02035748|JETREA|jetrea
5331003|NCT02035735|NBI,|nbi,
5331004|NCT02035735|squamous cell carcinoma,|squamous cell carcinoma,
5331005|NCT02035735|pharynx, larynx, surgical margins.|pharynx, larynx, surgical margins.
5331006|NCT02035709|Therapy|therapy
5331007|NCT02035696|influenza|influenza
5331008|NCT02035696|children|children
5331009|NCT02035696|safety|safety
5331010|NCT02035696|tolerability|tolerability
5331011|NCT02035696|immunogenicity|immunogenicity
5331012|NCT02035683|metabolic response|metabolic response
5331013|NCT02035683|chemotherapy|chemotherapy
5331014|NCT02035670|diagnostic strategy|diagnostic strategy
5331015|NCT02035670|effectiveness|effectiveness
5331016|NCT02035670|fever of unknown origin|fever of unknown origin
5331017|NCT02035657|Merkel cell carcinoma|merkel cell carcinoma
5331018|NCT02035657|MCC|mcc
5331019|NCT02035631|Breast Neoplasms|breast neoplasms
5331020|NCT02035631|Recurrence|recurrence
5331021|NCT02035631|Motor Activity|motor activity
5331022|NCT02035631|Diet|diet
5331023|NCT02035631|Quality of Life|quality of life
5331024|NCT02035579|concussion|concussion
5331025|NCT02035579|mild traumatic brain injury|mild traumatic brain injury
5331026|NCT02035579|post-concussion syndrome|post-concussion syndrome
5331027|NCT02035579|adolescents|adolescents
5963310|NCT04255433|Glucose Metabolism Disorders|glucose metabolism disorders
5963311|NCT04255433|Metabolic Diseases|metabolic diseases
5963312|NCT04255433|Endocrine System Diseases|endocrine system diseases
5331028|NCT02035579|sports injury|sports injury
5331029|NCT02035579|aerobic training|aerobic training
5331030|NCT02035579|stretching training|stretching training
5331031|NCT02035566|Minority Health|minority health
5331032|NCT02035566|Health Status Disparities|health status disparities
5331033|NCT02035566|Health Care Disparities|health care disparities
5331034|NCT02035566|Rural Health|rural health
5331035|NCT02035566|Telemedicine|telemedicine
5331036|NCT02035566|Health Services Research|health services research
5331037|NCT02035566|Social Determinants of Health|social determinants of health
5331038|NCT02035566|Ecological Theory of Health|ecological theory of health
5331039|NCT02035527|squamous cell carcinoma|squamous cell carcinoma
5331041|NCT02035514|multiple sclerosis|multiple sclerosis
5331042|NCT02035514|mesenchymal stem cells|mesenchymal stem cells
5331043|NCT02035514|autologous transplantation|autologous transplantation
5331044|NCT02035514|MRI efficacy|mri efficacy
5331045|NCT02035514|clinical safety|clinical safety
5331046|NCT02035488|Dry powder inhalation|dry powder inhalation
5331047|NCT02035488|Bronchiectasis|bronchiectasis
5331048|NCT02035488|Tobramycin|tobramycin
5331049|NCT02035475|Prevention|prevention
5331050|NCT02035475|Pelvic Lymph Node Dissection|pelvic lymph node dissection
5331051|NCT02035475|Lymphoceles|lymphoceles
5331052|NCT02035475|Prostate Malignancies|prostate malignancies
5331053|NCT02035475|daVinci|davinci
5331054|NCT02035475|Vessel Sealer|vessel sealer
5331055|NCT02035475|EndoWrist One|endowrist one
5331056|NCT02035449|Video laryngoscope|video laryngoscope
5331057|NCT02035449|Pre-hospital|pre-hospital
5331058|NCT02035449|Endotracheal intubation|endotracheal intubation
5331059|NCT02035449|Difficult endotracheal intubation|difficult endotracheal intubation
5331060|NCT02035449|Pre hospital Critical care|pre hospital critical care
5331061|NCT02035449|McGrath MAC|mcgrath mac
5331062|NCT02035449|Airway device|airway device
5331063|NCT02035436|Respiration, artificial|respiration, artificial
5331064|NCT02035436|Critcal care|critcal care
5331065|NCT02035423|Vitamin D Deficiency|vitamin d deficiency
5331066|NCT02035423|Compliance|compliance
5331067|NCT02035423|Milk|milk
5331068|NCT02035410|cardiac devices|cardiac devices
5331069|NCT02035410|prevention|prevention
5331070|NCT02035410|infection|infection
5331071|NCT02035397|botulinum toxin|botulinum toxin
5331072|NCT02035397|Endoscopy|endoscopy
5331073|NCT02035397|Satiation|satiation
5331074|NCT02035397|Diet|diet
5331075|NCT02035397|Weight Loss|weight loss
5331076|NCT02035358|Metastatic|metastatic
5331077|NCT02035358|Recurrent|recurrent
5331078|NCT02035358|Refractory|refractory
5331079|NCT02035358|Renal Cell Carcinoma|renal cell carcinoma
5331080|NCT02035358|Kidney|kidney
5331081|NCT02035358|clear-cell renal cancer|clear-cell renal cancer
5331082|NCT02035358|Cancer|cancer
5331083|NCT02035345|Recurrent Ovarian Cancer|recurrent ovarian cancer
5331084|NCT02035345|Platinum Sensitive Ovarian Cancer|platinum sensitive ovarian cancer
5331085|NCT02035332|Excessive Uterine Bleeding|excessive uterine bleeding
5331086|NCT02035332|Menorrhagia|menorrhagia
5331087|NCT02035332|Endometrial Ablation|endometrial ablation
5331088|NCT02035293|COPD Exacerbation|copd exacerbation
5331089|NCT02035293|Pulmonary embolism|pulmonary embolism
5331090|NCT02035293|Standardized and consensus diagnostic strategy|standardized and consensus diagnostic strategy
5331091|NCT02035280|Spine|spine
5331092|NCT02035280|Deformity|deformity
5331093|NCT02035280|Fusion|fusion
5331094|NCT02035280|Elderly|elderly
5331095|NCT02035280|SRS-22r|srs-22r
5331096|NCT02035241|Spices|spices
5331097|NCT02035241|Herbs|herbs
5331098|NCT02035241|Functional food|functional food
5331099|NCT02035241|Cardiometabolic risk|cardiometabolic risk
5331100|NCT02035241|Metabolic syndrome|metabolic syndrome
5331101|NCT02035241|Inflammation|inflammation
5331102|NCT02035241|Appetite|appetite
5331103|NCT02035241|Gut hormone|gut hormone
5331104|NCT02035228|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5331105|NCT02035228|Lung Hyperinflation|lung hyperinflation
5331106|NCT02035228|Abdominal Muscle|abdominal muscle
5331107|NCT02035228|Functional Electrical Stimulation|functional electrical stimulation
5331108|NCT02035215|Hyperlipidemia, Familial Combined|hyperlipidemia, familial combined
5331109|NCT02035215|Omega 3 acids ethylesters 90|omega 3 acids ethylesters 90
5331110|NCT02035215|Atorvastatin|atorvastatin
5331111|NCT02035176|autism|autism
5331112|NCT02035176|ADHD|adhd
5331113|NCT02035176|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5331114|NCT02035176|behavioral assessment|behavioral assessment
5331115|NCT02035176|behavior|behavior
5331116|NCT02035163|Atrial fibrillation|atrial fibrillation
5331117|NCT02035163|coronary artery bypass graft|coronary artery bypass graft
5331118|NCT02035163|cryoablation|cryoablation
5331119|NCT02035163|ganglionic plexi|ganglionic plexi
5331120|NCT02035150|breakfast|breakfast
5331121|NCT02035150|oatmeal|oatmeal
5331122|NCT02035150|appetite|appetite
5331123|NCT02035150|cholesterol|cholesterol
5331124|NCT02035124|Prostate|prostate
5331125|NCT02035124|Metastatic|metastatic
5331126|NCT02035124|Refractory|refractory
5331127|NCT02035124|mCRPC|mcrpc
5210923|NCT02676843|FTD|ftd
5331128|NCT02035111|Migraine|migraine
5331129|NCT02035111|Tianshu capsule|tianshu capsule
5331130|NCT02035098|cancer, pain, cluster trial, quality improvement|cancer, pain, cluster trial, quality improvement
5331131|NCT02035085|19F MRI|19f mri
5331132|NCT02035059|Oral Glucose Tolerance Test|oral glucose tolerance test
5331133|NCT02035059|Fibronectin|fibronectin
5331134|NCT02035059|Adiponectin|adiponectin
5331135|NCT02035059|Copeptin|copeptin
5331137|NCT02035046|Gitelman|gitelman
5331138|NCT02035046|Heterozygous SLC12A3 mutation|heterozygous slc12a3 mutation
5331139|NCT02035046|Blood pressure|blood pressure
5331140|NCT02035046|Hypokalemia|hypokalemia
5331141|NCT02035020|frataxin, gamma interferon, Friedreich ataxia|frataxin, gamma interferon, friedreich ataxia
5331142|NCT02034994|school-based intervention|school-based intervention
5331143|NCT02034994|after school physical activity|after school physical activity
5677620|NCT00589732|stents|stents
5331144|NCT02034994|sugar sweetened beverages|sugar sweetened beverages
5331145|NCT02034994|sedentary behavior|sedentary behavior
5331146|NCT02034994|schoolchildren|schoolchildren
5331147|NCT02034981|metastatic or unresectable locally advanced malignancies.|metastatic or unresectable locally advanced malignancies.
5331148|NCT02034981|genomic alterations.|genomic alterations.
5331149|NCT02034981|biological crizotinib targets (ALK, MET, ROS1, RON, AXL).|biological crizotinib targets (alk, met, ros1, ron, axl).
5331150|NCT02034968|Nimotuzumab|nimotuzumab
5331151|NCT02034968|Nab-Paclitaxel|nab-paclitaxel
5331152|NCT02034968|Carcinoma of Esophagus|carcinoma of esophagus
5331153|NCT02034955|Prostate Cancer|prostate cancer
5331154|NCT02034955|Adaptive Radiotherapy|adaptive radiotherapy
5331159|NCT02034929|adenoma|adenoma
5331160|NCT02034929|colon polyps|colon polyps
5331161|NCT02034916|Breast cancer|breast cancer
5331162|NCT02034916|BRCA mutation|brca mutation
5331163|NCT02034916|PARP inhibitor|parp inhibitor
5331164|NCT02034916|BRCA 1|brca 1
5331165|NCT02034916|BRCA 2|brca 2
5331166|NCT02034903|Enteral Feeding|enteral feeding
5331167|NCT02034903|Infant, Premature|infant, premature
5331168|NCT02034890|orthotopic neobladder|orthotopic neobladder
5331169|NCT02034890|urinary tract infection|urinary tract infection
5331170|NCT02034890|intravesical instillation|intravesical instillation
5331171|NCT02034890|hyaluronic acid|hyaluronic acid
5331172|NCT02034877|13-valent pneunococcal conjugate vaccine|13-valent pneunococcal conjugate vaccine
5331173|NCT02034877|pneumococcal disease prevention; safety and immunogenicity study|pneumococcal disease prevention; safety and immunogenicity study
5331174|NCT02034864|low back pain|low back pain
5331175|NCT02034864|manual therapy|manual therapy
5331176|NCT02034864|randomized controlled trial|randomized controlled trial
5331177|NCT02034851|Acute pyelonephritis|acute pyelonephritis
5331178|NCT02034851|Renal scarring|renal scarring
5331179|NCT02034851|Dexamethasone|dexamethasone
5331180|NCT02034851|Children|children
5331181|NCT02034851|Corticoids|corticoids
5331182|NCT02034851|Complementary treatment|complementary treatment
5331183|NCT02034851|Prevention strategy|prevention strategy
5331184|NCT02034838|PK|pk
5331185|NCT02034838|pharmacokinetic|pharmacokinetic
5331186|NCT02034838|HIV-infected|hiv-infected
5331187|NCT02034838|atazanavir|atazanavir
5331188|NCT02034838|ritonavir|ritonavir
5331189|NCT02034786|Mesenchymal stem cell|mesenchymal stem cell
5331190|NCT02034786|Hyaluronic acid|hyaluronic acid
5331191|NCT02034786|Adipose Tissue|adipose tissue
5331192|NCT02034786|Filler Agent|filler agent
5331193|NCT02034773|Safety, Pharmacokinetics, Pharmacodynamics, Healthy Subjects|safety, pharmacokinetics, pharmacodynamics, healthy subjects
5331195|NCT02034760|Ageing|ageing
5331196|NCT02034760|Protein supplementation|protein supplementation
5331197|NCT02034760|Protein quality|protein quality
5331198|NCT02034760|Gut microbiota|gut microbiota
5331199|NCT02034760|Metabolome|metabolome
5331200|NCT02034760|Exercise training|exercise training
5331201|NCT02034760|Sarcopenia|sarcopenia
5331202|NCT02034747|Immunosuppressive regimen|immunosuppressive regimen
5331203|NCT02034747|Advagraf|advagraf
5331204|NCT02034747|kidney transplant|kidney transplant
5331205|NCT02034747|Corticosteroid|corticosteroid
5331206|NCT02034734|Phase 1|phase 1
5331207|NCT02034734|ASP3652|asp3652
5331208|NCT02034734|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5331209|NCT02034734|Multiple doses|multiple doses
5331210|NCT02034721|Muscle damage|muscle damage
5331211|NCT02034721|Muscle soreness|muscle soreness
5331212|NCT02034721|Muscle function|muscle function
5331213|NCT02034721|Innate immune function|innate immune function
5331214|NCT02034721|Inflammation|inflammation
5331215|NCT02034708|Primary brain tumor|primary brain tumor
5331216|NCT02034695|Diabetes mellitus|diabetes mellitus
5331217|NCT02034669|Acute Spinal cord Injury, Adipose derived stem cells|acute spinal cord injury, adipose derived stem cells
5331218|NCT02034656|imatinib resistance|imatinib resistance
5331219|NCT02034656|mutation|mutation
5331220|NCT02034630|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5331221|NCT02034617|Cognition|cognition
5331222|NCT02034617|Family nursing|family nursing
5331223|NCT02034617|Infant, premature|infant, premature
5331224|NCT02034617|Object attachment|object attachment
5963313|NCT04255433|Hypoglycemic Agents|hypoglycemic agents
5331225|NCT02034617|Stress, physiological|stress, physiological
5331226|NCT02034617|Stress, psychological|stress, psychological
5331227|NCT02034604|Naftopidil|naftopidil
5331228|NCT02034604|safety|safety
5331229|NCT02034539|peripheral artery disease|peripheral artery disease
5331230|NCT02034539|critical limb ischemia|critical limb ischemia
5331231|NCT02034539|VADOplex|vadoplex
5331232|NCT02034539|intermittent foot compression|intermittent foot compression
5331233|NCT02034526|Sinus node disease|sinus node disease
5331234|NCT02034526|Atrial fibrillation|atrial fibrillation
5331235|NCT02034526|Pacing|pacing
5331236|NCT02034500|prevention|prevention
5331237|NCT02034500|Shigella sonnei|shigella sonnei
5331238|NCT02034487|Delayed Puberty|delayed puberty
5331239|NCT02034487|Boys|boys
5331240|NCT02034487|Hormones|hormones
5331241|NCT02034487|Polymorphism, Genetic|polymorphism, genetic
5331246|NCT02034448|CRRT|crrt
5331247|NCT02034448|Renal|renal
5331248|NCT02034448|Kidney|kidney
5331249|NCT02034448|adults|adults
5331250|NCT02034448|registry|registry
5331252|NCT02034422|Exercise|exercise
5331253|NCT02034409|Knee Osteoarthritis|knee osteoarthritis
5331254|NCT02034409|Pulsed Low Intensity Ultrasound|pulsed low intensity ultrasound
5331255|NCT02034396|Ulcers, venous, unna's boot|ulcers, venous, unna's boot
5331256|NCT02034370|Interscalene nerve block|interscalene nerve block
5331257|NCT02034370|Shoulder surgery|shoulder surgery
5331258|NCT02034370|Obstructive Sleep Apnea|obstructive sleep apnea
5331259|NCT02034370|Sleep Disordered Breathing|sleep disordered breathing
5331260|NCT02034357|Parkinson Disease|parkinson disease
5331261|NCT02034357|Sleep Disordered Breathing|sleep disordered breathing
5331262|NCT02034357|Sleep Obstructive Apnea|sleep obstructive apnea
5331263|NCT02034357|Polysomnography|polysomnography
5331264|NCT02034357|CPAP (continuous positive airway pressure) titration|cpap (continuous positive airway pressure) titration
5331265|NCT02034357|CPAP (continuous positive airway pressure) treatment|cpap (continuous positive airway pressure) treatment
5331266|NCT02034344|Lupus Erythematosus, Cutaneous|lupus erythematosus, cutaneous
5331267|NCT02034344|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5331268|NCT02034344|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
5331269|NCT02034344|Healthy|healthy
5331270|NCT02034344|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
5331271|NCT02034344|Longitudinal Study|longitudinal study
5331272|NCT02034344|Biomarkers|biomarkers
5331273|NCT02034344|Subacute Cutaneous Lupus Erythematosus|subacute cutaneous lupus erythematosus
5331274|NCT02034344|Skin Biopsy|skin biopsy
5331275|NCT02034331|Insulin Sensitivity|insulin sensitivity
5331276|NCT02034331|Microvascular permeability|microvascular permeability
5331277|NCT02034331|Sympathetic nervous system|sympathetic nervous system
5331278|NCT02034318|Fatigue|fatigue
5331279|NCT02034318|Cardiac Sympathetic Denervation|cardiac sympathetic denervation
5331280|NCT02034318|Parkinson Disease|parkinson disease
5331281|NCT02034305|Airway Clearance|airway clearance
5331282|NCT02034305|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5331283|NCT02034305|Peak Cough Flow|peak cough flow
5331284|NCT02034279|cirrhosis|cirrhosis
5331285|NCT02034266|Type one diabetes|type one diabetes
5331286|NCT02034266|nerve damage|nerve damage
5331287|NCT02034266|neuropathy|neuropathy
5331288|NCT02034266|omega-3 fatty acid|omega-3 fatty acid
5331290|NCT02034266|nutrition|nutrition
5331291|NCT02034253|duration of untreated psychosis|duration of untreated psychosis
5331292|NCT02034253|glutamate|glutamate
5331293|NCT02034253|functional connectivity|functional connectivity
5331294|NCT02034253|structural connectivity|structural connectivity
5331295|NCT02034253|schizophrenia|schizophrenia
5331296|NCT02034253|psychosis|psychosis
5331297|NCT02034227|leukemia|leukemia
5331298|NCT02034214|HIV|hiv
5331299|NCT02034214|adolescents|adolescents
5331300|NCT02034188|multiple sclerosis|multiple sclerosis
5331301|NCT02034188|umbilical cord|umbilical cord
5331302|NCT02034188|mesenchymal|mesenchymal
5331303|NCT02034188|stem cells|stem cells
5331304|NCT02034175|apnea|apnea
5331305|NCT02034175|hypopnea|hypopnea
5331306|NCT02034175|polysomnography|polysomnography
5331307|NCT02034175|respiratory|respiratory
5331308|NCT02034175|cheyne|cheyne
5331309|NCT02034162|Helminth infections|helminth infections
5331310|NCT02034162|Helminths|helminths
5331311|NCT02034162|Pediatric|pediatric
5331312|NCT02034162|Preschool aged|preschool aged
5331313|NCT02034162|School aged|school aged
5331314|NCT02034162|Mebendazole|mebendazole
5331315|NCT02034162|Vermox|vermox
5331316|NCT02034162|Placebo|placebo
5331317|NCT02034149|chronic kidney disease|chronic kidney disease
5331318|NCT02034149|high risk|high risk
5331319|NCT02034149|intervention|intervention
5331320|NCT02034149|hypertension|hypertension
5331321|NCT02034149|hyperglycemia|hyperglycemia
5331322|NCT02034149|hyperlipidemia|hyperlipidemia
5331323|NCT02034123|First time in humans|first time in humans
5331324|NCT02034123|Small cell lung carcinoma|small cell lung carcinoma
5331325|NCT02034123|Oncology|oncology
5331326|NCT02034123|GSK2879552|gsk2879552
5331327|NCT02034123|LSD1 inhibitor|lsd1 inhibitor
5331328|NCT02034110|solid tumors|solid tumors
5331329|NCT02034110|efficacy|efficacy
5331330|NCT02034110|BRAF V600E mutation|braf v600e mutation
5331331|NCT02034110|trametinib|trametinib
5331332|NCT02034110|safety|safety
5331333|NCT02034110|Dabrafenib|dabrafenib
5331334|NCT02034097|ROS1|ros1
5331335|NCT02034097|erlotinib|erlotinib
5331336|NCT02034097|EGFR|egfr
5331337|NCT02034097|non-small cell lung cancer|non-small cell lung cancer
5331338|NCT02034097|foretinib|foretinib
5331339|NCT02034084|Transradial approach,|transradial approach,
5327477|NCT02051062|BAT|bat
5331340|NCT02034084|Coronary angiography|coronary angiography
5331341|NCT02034071|Prader-Willi syndrome|prader-willi syndrome
5331342|NCT02034058|Wingspan Stent System|wingspan stent system
5331343|NCT02034058|Wingspan Stent|wingspan stent
5331344|NCT02034058|Intracranial Stent|intracranial stent
5331345|NCT02034058|Ischemic Stroke|ischemic stroke
5331346|NCT02034058|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
5331347|NCT02034058|Intracranial Stenosis|intracranial stenosis
5331348|NCT02034032|Osteoarthritis|osteoarthritis
5331349|NCT02034032|Knee|knee
5331350|NCT02034032|Arthritis|arthritis
5226149|NCT02586519|Orpyx|orpyx
5331352|NCT02034032|Total Knee Arthroplasty|total knee arthroplasty
5331353|NCT02034006|pathological myopia|pathological myopia
5331544|NCT02033330|phenolics|phenolics
5331354|NCT02034006|choroidal neovascularization|choroidal neovascularization
5331355|NCT02034006|ranibizumab|ranibizumab
5331356|NCT02034006|mono-bilateral|mono-bilateral
5331357|NCT02034006|poor visual acuity|poor visual acuity
5331358|NCT02034006|retinal disease|retinal disease
5331359|NCT02034006|eye disease|eye disease
5331360|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors
5331361|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents
5331362|NCT02033980|narrow band imaging(NBI)|narrow band imaging(nbi)
5331363|NCT02033980|NICE classification|nice classification
5331364|NCT02033980|colorectal lesions|colorectal lesions
5331365|NCT02033980|predicting histology|predicting histology
5331366|NCT02033967|liver donor|liver donor
5331367|NCT02033967|hepatectomy|hepatectomy
5331368|NCT02033967|vasodilator|vasodilator
5331369|NCT02033967|central venous pressure|central venous pressure
5331370|NCT02033967|stroke volume variation|stroke volume variation
5331371|NCT02033954|Embolization|embolization
5331372|NCT02033954|Hemorrhage|hemorrhage
5331373|NCT02033954|TIPS|tips
5331374|NCT02033954|GI Bleeding|gi bleeding
5331375|NCT02033954|AV Fistula|av fistula
5331376|NCT02033954|AV Malformation|av malformation
5331377|NCT02033954|Traumatic Vascular Injury|traumatic vascular injury
5331378|NCT02033941|Alzheimer's Disease|alzheimer's disease
5331379|NCT02033941|Grapeseed Extract|grapeseed extract
5331380|NCT02033941|Clinical Trial|clinical trial
5331381|NCT02033941|Meganatural-AZ|meganatural-az
5331382|NCT02033941|anti-oligomerization|anti-oligomerization
5331383|NCT02033941|Phase 2|phase 2
5331384|NCT02033941|Dietary Supplement|dietary supplement
5331385|NCT02033941|Nutraceutical|nutraceutical
5331386|NCT02033928|Myeloma|myeloma
5331387|NCT02033928|MGUS (monoclonal gammopathy of undetermined significance)|mgus (monoclonal gammopathy of undetermined significance)
5331388|NCT02033928|amyloidosis|amyloidosis
5331389|NCT02033928|stem cell transplant|stem cell transplant
5331390|NCT02033915|Suicide risk assessment|suicide risk assessment
5331391|NCT02033915|interactive discussion group|interactive discussion group
5331392|NCT02033915|suicide attempt|suicide attempt
5331393|NCT02033915|self-harm|self-harm
5331394|NCT02033915|randomized control study|randomized control study
5331395|NCT02033915|identifying high risk group for suicide|identifying high risk group for suicide
5331396|NCT02033902|Epilepsy|epilepsy
5331397|NCT02033863|Varicocele|varicocele
5331398|NCT02033863|Pelvic Congestion Syndrome|pelvic congestion syndrome
5331399|NCT02033863|Pelvic Venous Incompetence|pelvic venous incompetence
5331400|NCT02033863|Ovarian Varices|ovarian varices
5331401|NCT02033850|small vessel disease|small vessel disease
5331402|NCT02033850|cognition|cognition
5331403|NCT02033850|treatment|treatment
5331404|NCT02033850|rehabilitation|rehabilitation
5331405|NCT02033850|attention|attention
5331406|NCT02033850|fMRI|fmri
5331407|NCT02033850|vascular dementia|vascular dementia
5331408|NCT02033837|Coronary artery disease|coronary artery disease
5331409|NCT02033837|Cardiac CT|cardiac ct
5331410|NCT02033837|Appropriate Use Criteria (AUC)|appropriate use criteria (auc)
5331411|NCT02033811|mitral regurgitation|mitral regurgitation
5331412|NCT02033811|MitraClip system|mitraclip system
5331413|NCT02033811|percutaneous mitral valve repair|percutaneous mitral valve repair
5331414|NCT02033798|Urodynamics|urodynamics
5331415|NCT02033798|Glomerular Filtration Rate|glomerular filtration rate
5331416|NCT02033785|Prostatic hyperplasia|prostatic hyperplasia
5331417|NCT02033759|Lymphedema|lymphedema
5331418|NCT02033733|Post cardiac arrest|post cardiac arrest
5331419|NCT02033733|Postcardiac arrest therapeutic hypothermia|postcardiac arrest therapeutic hypothermia
5331420|NCT02033733|Therapeutic hypothermia protocol|therapeutic hypothermia protocol
5331421|NCT02033733|Neuromuscular blocking agents|neuromuscular blocking agents
5331422|NCT02033733|Muscle relaxants|muscle relaxants
5331423|NCT02033733|Hypothermia-induced increased muscle tone|hypothermia-induced increased muscle tone
5331424|NCT02033733|Microshivering|microshivering
5331425|NCT02033720|postcardiac arrest|postcardiac arrest
5331426|NCT02033720|post cardiac arrest syndrome|post cardiac arrest syndrome
5331427|NCT02033720|post cardiac arrest hypothermia|post cardiac arrest hypothermia
5331428|NCT02033720|pulseless electrical activity|pulseless electrical activity
5331429|NCT02033720|asystole|asystole
5331430|NCT02033720|therapeutic hypothermia|therapeutic hypothermia
5331431|NCT02033720|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
5331432|NCT02033720|therapeutic hypothermia neurologic outcome|therapeutic hypothermia neurologic outcome
5331433|NCT02033707|Hallucinogen|hallucinogen
5331434|NCT02033707|Cognitive effects|cognitive effects
5331435|NCT02033707|Subjective effects|subjective effects
5331436|NCT02033694|Lipid|lipid
5677911|NCT00589225|PH type I|ph type i
5331437|NCT02033694|Vulnerable Plaque|vulnerable plaque
5331438|NCT02033694|Plaque|plaque
5331439|NCT02033694|Cholesterol|cholesterol
5331440|NCT02033694|Near Infrared Spectroscopy|near infrared spectroscopy
5331441|NCT02033694|NIRS-IVUS|nirs-ivus
5331442|NCT02033694|Intravascular Ultrasound|intravascular ultrasound
5331443|NCT02033694|Angiography|angiography
5331444|NCT02033694|Coronary Imaging|coronary imaging
5331445|NCT02033681|epinephrine|epinephrine
5331447|NCT02033681|ischemia|ischemia
5331448|NCT02033681|lidocaine|lidocaine
5331449|NCT02033681|upper extremity|upper extremity
5331450|NCT02033668|bioavailability|bioavailability
5331451|NCT02033668|Pharmacokinetics|pharmacokinetics
5331452|NCT02033668|intravenous|intravenous
5331453|NCT02033668|subcutaneous and intramuscular administration|subcutaneous and intramuscular administration
5331454|NCT02033668|amyloid beta|amyloid beta
5331455|NCT02033668|monoclonal antibody|monoclonal antibody
5331456|NCT02033655|weight loss|weight loss
5331457|NCT02033655|older adults|older adults
5331458|NCT02033655|obesity|obesity
5331459|NCT02033642|weight loss, nutrition, physical activity, lifestyle, intellectual disability, adolescence, families|weight loss, nutrition, physical activity, lifestyle, intellectual disability, adolescence, families
5331460|NCT02033629|Anesthesia|anesthesia
5331461|NCT02033629|remifentanil|remifentanil
5331462|NCT02033629|propofol|propofol
5331463|NCT02033629|target-controlled infusion|target-controlled infusion
5331464|NCT02033629|cardiac surgery|cardiac surgery
5331465|NCT02033603|Total knee arthroplasty|total knee arthroplasty
5331466|NCT02033603|Total knee replacement|total knee replacement
5331467|NCT02033603|Femoral Nerve Block|femoral nerve block
5331468|NCT02033603|Adductor Canal Block|adductor canal block
5331469|NCT02033564|Sore Throat|sore throat
5331470|NCT02033564|Intubation|intubation
5331471|NCT02033564|Laryngoscopy|laryngoscopy
5331472|NCT02033564|Anesthesiology|anesthesiology
5331473|NCT02033564|Perioperative|perioperative
5331474|NCT02033564|Airway Management|airway management
5331475|NCT02033551|Gastric Cancer|gastric cancer
5331476|NCT02033551|Lung Cancer|lung cancer
5331477|NCT02033551|PARP Inhibitor|parp inhibitor
5331478|NCT02033551|Ovarian Cancer|ovarian cancer
5331479|NCT02033551|Solid Tumors|solid tumors
5331480|NCT02033551|Breast Cancer|breast cancer
5331481|NCT02033551|Colon Cancer|colon cancer
5331482|NCT02033538|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5331483|NCT02033538|Nab-Paclitaxel|nab-paclitaxel
5331484|NCT02033538|Carcinoma of Esophagus|carcinoma of esophagus
5331485|NCT02033525|Chronic Meniscal Injury|chronic meniscal injury
5331486|NCT02033525|Degenerative meniscus|degenerative meniscus
5331487|NCT02033525|Meniscus injury|meniscus injury
5331488|NCT02033525|Meniscal injury|meniscal injury
5331489|NCT02033525|Mesenchymal stromal cells|mesenchymal stromal cells
5331490|NCT02033525|Mesenchymal stem cells|mesenchymal stem cells
5331491|NCT02033525|Advanced Therapy|advanced therapy
5331492|NCT02033525|Bone marrow|bone marrow
5331493|NCT02033512|Post-menopause|post-menopause
5331494|NCT02033512|Hormone Replacement Therapy|hormone replacement therapy
5331495|NCT02033512|Nanotechnology|nanotechnology
5331496|NCT02033512|Biolipid B2|biolipid b2
5331497|NCT02033499|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5331498|NCT02033499|Self-Monitoring, Blood Glucose|self-monitoring, blood glucose
5331499|NCT02033499|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5331500|NCT02033499|Quality of Life|quality of life
5331501|NCT02033486|diffuse optical tomography|diffuse optical tomography
5331502|NCT02033486|digital breast tomosynthesis|digital breast tomosynthesis
5331503|NCT02033486|breast cancer|breast cancer
5331504|NCT02033486|solid benign lesions|solid benign lesions
5331505|NCT02033486|cysts|cysts
5331506|NCT02033486|malignant lesions|malignant lesions
5331507|NCT02033473|Apelin|apelin
5331508|NCT02033473|insulin|insulin
5331509|NCT02033473|volunteers|volunteers
5331510|NCT02033460|Manual therapy|manual therapy
5331511|NCT02033460|Exercise|exercise
5331512|NCT02033460|Education|education
5331513|NCT02033447|Prostate Cancer|prostate cancer
5331514|NCT02033434|intranasal|intranasal
5331515|NCT02033434|ketamine|ketamine
5331516|NCT02033434|analgesia|analgesia
5331517|NCT02033434|mountain medicine|mountain medicine
5331518|NCT02033434|pre-hospital care|pre-hospital care
5331519|NCT02033434|patient transport|patient transport
5331520|NCT02033434|pilot study|pilot study
5331521|NCT02033434|mountain environment|mountain environment
5331522|NCT02033421|Infective endocarditis|infective endocarditis
5331523|NCT02033421|Therapeutic drug monitoring|therapeutic drug monitoring
5331524|NCT02033408|IBD: Inflammatory Bowel Diseases|ibd: inflammatory bowel diseases
5331525|NCT02033408|CD: Crohn's Disease|cd: crohn's disease
5331526|NCT02033408|UC: Ulcerative Colitis|uc: ulcerative colitis
5331527|NCT02033408|ASC: Acute Severe Colitis|asc: acute severe colitis
5331528|NCT02033408|FMT: Fecal Microbiota Transplantation|fmt: fecal microbiota transplantation
5331529|NCT02033408|PUCAI: Pediatric Ulcerative Colitis Activity Index|pucai: pediatric ulcerative colitis activity index
5343011|NCT01981135|Temperature|temperature
5343013|NCT01981135|Cardiovascular|cardiovascular
5331530|NCT02033408|Ciprofloxacin, Doxycycline, Gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin|ciprofloxacin, doxycycline, gentamycin, amoxicillin, vancomycin, metronidazole,ciprofloxacin
5331531|NCT02033369|Major depressive disorder|major depressive disorder
5331533|NCT02033369|depression|depression
5335852|NCT02013583|G1D|g1d
5331534|NCT02033369|pramipexole|pramipexole
5331535|NCT02033356|adductor canal block|adductor canal block
5331536|NCT02033356|volunteers|volunteers
5331537|NCT02033356|US-guided peripheral nerve block|us-guided peripheral nerve block
5331538|NCT02033356|lower limb|lower limb
5331540|NCT02033343|Prostate Cancer|prostate cancer
5331541|NCT02033343|Real-time tracking|real-time tracking
5331542|NCT02033343|Radiotherapy|radiotherapy
5331543|NCT02033343|Dynamic Multileaf Collimator|dynamic multileaf collimator
5331545|NCT02033330|orange peel|orange peel
5331546|NCT02033330|bioavailability|bioavailability
5331547|NCT02033304|Cesarean section|cesarean section
5331549|NCT02033304|Wound hyperalgesia|wound hyperalgesia
5331550|NCT02033291|Cerebral Small Vessel Disease|cerebral small vessel disease
5331551|NCT02033291|Blood-Brain Barrier permeability|blood-brain barrier permeability
5331552|NCT02033291|Dynamic contrast enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
5331553|NCT02033291|Pharmacokinetic modeling|pharmacokinetic modeling
5331554|NCT02033291|Reproducibility|reproducibility
5331555|NCT02033265|Ultrasound-guided Axillary Brachial Plexus Block|ultrasound-guided axillary brachial plexus block
5331556|NCT02033265|Obesity|obesity
5331557|NCT02033265|Performance time|performance time
5331558|NCT02033265|Failure rate|failure rate
5331559|NCT02033265|Acute complications|acute complications
5331560|NCT02033226|Periodontitis|periodontitis
5331561|NCT02033226|Periodontal Regeneration|periodontal regeneration
5331562|NCT02033226|Amniotic membrane|amniotic membrane
5331563|NCT02033226|Guided tissue regeneration|guided tissue regeneration
5331564|NCT02033226|Anti-inflammatory|anti-inflammatory
5331565|NCT02033226|Periodontal Therapy.|periodontal therapy.
5331566|NCT02033213|intraoperative|intraoperative
5331567|NCT02033213|fluid management|fluid management
5331568|NCT02033213|esophageal carcinoma|esophageal carcinoma
5331569|NCT02033213|surgery|surgery
5331570|NCT02033213|gas exchange|gas exchange
5331571|NCT02033213|tissue perfusion|tissue perfusion
5331572|NCT02033200|vision|vision
5331573|NCT02033200|Stendra|stendra
5331574|NCT02033200|avanafil|avanafil
5331575|NCT02033200|PDE5 inhibitor|pde5 inhibitor
5331576|NCT02033200|visual acuity|visual acuity
5331577|NCT02033200|intraocular pressure|intraocular pressure
5331578|NCT02033200|pupillometry|pupillometry
5331579|NCT02033200|color vision discrimination|color vision discrimination
5331580|NCT02033200|healthy males|healthy males
5331581|NCT02033174|alcohol, inflammation, oxidation.|alcohol, inflammation, oxidation.
5331582|NCT02033161|Functional gastrointestinal disorders|functional gastrointestinal disorders
5331583|NCT02033161|FGID|fgid
5331584|NCT02033161|Recurrent abdominal pain|recurrent abdominal pain
5331585|NCT02033161|Abdominal pain|abdominal pain
5331586|NCT02033161|pain-related functional gastrointestinal disorders|pain-related functional gastrointestinal disorders
5331587|NCT02033135|Atherosclerosis|atherosclerosis
5331588|NCT02033135|Intermittent claudication|intermittent claudication
5331589|NCT02033135|Angioplasty|angioplasty
5331590|NCT02033122|exercise, bronchial hyperresponsiveness, inflammation|exercise, bronchial hyperresponsiveness, inflammation
5331591|NCT02033096|stannsoporfin|stannsoporfin
5331592|NCT02033096|hyperbilirubinemia|hyperbilirubinemia
5331593|NCT02033096|heme oxygenase|heme oxygenase
5331594|NCT02033083|abortion|abortion
5331595|NCT02033083|cervical dilation|cervical dilation
5331596|NCT02033070|RFA|rfa
5331597|NCT02033057|Muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.|muscular electrostimulation, mechanically ventilated, critically ill patients, muscular weakness.
5331598|NCT02033044|borderline personality disorder|borderline personality disorder
5331599|NCT02033044|cognitive rehabilitation|cognitive rehabilitation
5331600|NCT02033044|psychoeducation|psychoeducation
5331601|NCT02033044|psychosocial functioning|psychosocial functioning
5331602|NCT02033031|branch retinal vein occlusion|branch retinal vein occlusion
5331603|NCT02033031|central retinal thickness|central retinal thickness
5331604|NCT02033031|visual acuity|visual acuity
5331605|NCT02033031|central reintal sensitivity|central reintal sensitivity
5331606|NCT02033018|Aflibercept|aflibercept
5331607|NCT02033018|Myopia|myopia
5331608|NCT02033018|Complications|complications
5331609|NCT02033018|Neovascularization|neovascularization
5331610|NCT02033018|OCT|oct
5331611|NCT02033005|Body Composition|body composition
5331612|NCT02033005|Adipose Tissue|adipose tissue
5331613|NCT02033005|Intrahepatocellular Lipid|intrahepatocellular lipid
5331614|NCT02033005|Infant|infant
5331615|NCT02033005|Magnetic Resonance Imaging|magnetic resonance imaging
5331616|NCT02033005|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5331617|NCT02032966|outcomes|outcomes
5331618|NCT02032966|surgical|surgical
5331619|NCT02032966|non-surgical|non-surgical
5331622|NCT02032966|fracture|fracture
5331623|NCT02032966|tibia|tibia
5331624|NCT02032966|fibula|fibula
5331625|NCT02032966|bimalleolar|bimalleolar
5331626|NCT02032966|trimalleolar|trimalleolar
5331627|NCT02032953|colorectal cancer|colorectal cancer
5331628|NCT02032953|protein recovery|protein recovery
5331629|NCT02032953|perioperative nutrition|perioperative nutrition
5331630|NCT02032953|hyperinsulinemia|hyperinsulinemia
5331631|NCT02032953|normoglycemia|normoglycemia
5331632|NCT02032953|hyperinsulinemic-normoglycemic clamp|hyperinsulinemic-normoglycemic clamp
5331634|NCT02032940|MRI, Angiography, Pulse Sequence|mri, angiography, pulse sequence
5331635|NCT02032927|osteoarthritis|osteoarthritis
5331636|NCT02032927|pain|pain
5331637|NCT02032927|opioids|opioids
5331638|NCT02032914|pyogenic liver abscess|pyogenic liver abscess
5331639|NCT02032914|colon cancer|colon cancer
5331640|NCT02032862|menopause, hot flushes, hot flashes, salvia, sage, sweating|menopause, hot flushes, hot flashes, salvia, sage, sweating
5331641|NCT02032849|ventilator associated pneumonia|ventilator associated pneumonia
5331642|NCT02032849|subglottic secretion drainage|subglottic secretion drainage
5331643|NCT02032849|manual air-impingement operation|manual air-impingement operation
5331644|NCT02032849|prolonged intubation|prolonged intubation
5331645|NCT02032823|Breast Cancer|breast cancer
5331646|NCT02032823|Adjuvant|adjuvant
5331647|NCT02032823|Olaparib|olaparib
5331648|NCT02032823|BRCA 1/2|brca 1/2
5331649|NCT02032823|HER2|her2
5331650|NCT02032810|Stage III Melanoma|stage iii melanoma
5331651|NCT02032810|Stage IV Melanoma|stage iv melanoma
5331652|NCT02032810|HDAC Inhibitor|hdac inhibitor
5331653|NCT02032758|Occupational; Cramp(s)|occupational; cramp(s)
5331654|NCT02032719|Hypertension, Systolic, Uncontrolled|hypertension, systolic, uncontrolled
5331655|NCT02032706|obstructive sleep apnea|obstructive sleep apnea
5331656|NCT02032706|position therapy|position therapy
5331657|NCT02032706|snoring|snoring
5331658|NCT02032706|positional|positional
5331659|NCT02032693|Everycell|everycell
5331660|NCT02032693|DNA damage|dna damage
5331661|NCT02032693|DNA inflammation|dna inflammation
5331662|NCT02032693|DNA stress|dna stress
5331663|NCT02032667|physical activity|physical activity
5331664|NCT02032667|exergames|exergames
5331665|NCT02032654|antibiotics|antibiotics
5331666|NCT02032654|flucloxacillin|flucloxacillin
5331667|NCT02032654|therapy duration|therapy duration
5331668|NCT02032654|cellulitis|cellulitis
5331670|NCT02032654|skin infections|skin infections
5331671|NCT02032654|hospital|hospital
5331672|NCT02032641|Non-ablative laser|non-ablative laser
5331673|NCT02032641|Scar revision|scar revision
5331674|NCT02032641|direct brow lift|direct brow lift
5331675|NCT02032628|epigenetics|epigenetics
5331676|NCT02032628|cancer|cancer
5331677|NCT02032628|exercise|exercise
5331678|NCT02032628|intensity|intensity
5331679|NCT02032628|duration|duration
5331680|NCT02032615|anemia|anemia
5331681|NCT02032602|Myofascial Pain Syndromes|myofascial pain syndromes
5331682|NCT02032602|Trigger Point|trigger point
5331683|NCT02032602|Shoulder Pain|shoulder pain
5331684|NCT02032602|Aged|aged
5331685|NCT02032576|major depressive episode, electroconvulsive therapy|major depressive episode, electroconvulsive therapy
5331686|NCT02032563|neoadjuvant therapy|neoadjuvant therapy
5331687|NCT02032550|Localized prostate cancer|localized prostate cancer
5331688|NCT02032550|Patient preference|patient preference
5331689|NCT02032550|Treatment choice|treatment choice
5331690|NCT02032550|Decision making|decision making
5331691|NCT02032550|Patient centered outcomes|patient centered outcomes
5331692|NCT02032537|callmax cream|callmax cream
5331693|NCT02032537|uremic pruritus|uremic pruritus
5331694|NCT02032498|sentinel lymph nodes|sentinel lymph nodes
5331695|NCT02032498|radiocolloids|radiocolloids
5331696|NCT02032498|Indocyanine Green|indocyanine green
5331697|NCT02032498|complementarity|complementarity
5331698|NCT02032498|axillary lymph node dissection|axillary lymph node dissection
5331699|NCT02032485|colorectal cancer|colorectal cancer
5331700|NCT02032485|Indocyanine Green|indocyanine green
5331701|NCT02032485|visualization of peritoneal metastases|visualization of peritoneal metastases
5331702|NCT02032472|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5331703|NCT02032472|Arterial Pressure|arterial pressure
5331704|NCT02032472|Hypertension Controlled|hypertension controlled
5331705|NCT02032472|Pharmacies|pharmacies
5331706|NCT02032459|Pregnancy|pregnancy
5331707|NCT02032459|Minority Women|minority women
5331708|NCT02032459|Preterm delivery|preterm delivery
5331709|NCT02032459|Fetal growth restriction|fetal growth restriction
5331711|NCT02032459|Gestational Diabetes|gestational diabetes
5331712|NCT02032459|Vitamin D|vitamin d
5331713|NCT02032433|extended-release naltrexone (Vivitrol)|extended-release naltrexone (vivitrol)
5331714|NCT02032433|buprenorphine-naloxone (Suboxone)|buprenorphine-naloxone (suboxone)
5331715|NCT02032433|comparative effective|comparative effective
5331716|NCT02032433|relapse prevention|relapse prevention
5331717|NCT02032394|Chlorhexidine|chlorhexidine
5331718|NCT02032394|Povidone-iodine|povidone-iodine
5331719|NCT02032394|bacteriuria|bacteriuria
5331720|NCT02032394|Urinary Catheterization|urinary catheterization
5331721|NCT02032394|Urinary tract infection|urinary tract infection
5331722|NCT02032381|non infectious pulmonary complications after hematopoietic cell transplant|non infectious pulmonary complications after hematopoietic cell transplant
5331723|NCT02032381|functional respiratory test and exercise test|functional respiratory test and exercise test
5331724|NCT02032381|thoracic tomodensitometry|thoracic tomodensitometry
5331725|NCT02032368|circulating tumour cell;|circulating tumour cell;
5331726|NCT02032368|transarterial chemoembolization;|transarterial chemoembolization;
5331727|NCT02032368|hepatocellular carcinoma;|hepatocellular carcinoma;
5331728|NCT02032368|recurrence|recurrence
5331729|NCT02032329|Functional Electrical Stimulation (FES)|functional electrical stimulation (fes)
5331730|NCT02032316|Renal Stone|renal stone
5331731|NCT02032316|Ureteroscopy|ureteroscopy
5331732|NCT02032316|Ureteral Stent|ureteral stent
5331733|NCT02032316|post-uncomplicated ureteroscopy|post-uncomplicated ureteroscopy
5331735|NCT02032277|Oncology|oncology
5331736|NCT02032277|Triple negative breast cancer|triple negative breast cancer
5331737|NCT02032277|German Breast Group - GBG 81|german breast group - gbg 81
5331738|NCT02032277|United States Oncology - 12152|united states oncology - 12152
5331739|NCT02032277|National Surgical Adjuvant Breast and Bowel Project - B-56-I|national surgical adjuvant breast and bowel project - b-56-i
5331740|NCT02032277|Alliance - AFT-04|alliance - aft-04
5331741|NCT02032277|Grupo Español de Investigación en Cáncer de Mama - GEICAM/2014-02|grupo español de investigación en cáncer de mama - geicam/2014-02
5331742|NCT02032264|Next generation sequencing|next generation sequencing
5331743|NCT02032264|Embryonic aneuploidy|embryonic aneuploidy
5331744|NCT02032251|Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine|sperm dna damage ejaculated spermatozoa ginger herbal drug herbal medicine
5331745|NCT02032199|Gastric bypass|gastric bypass
5331746|NCT02032199|Health-related quality of life|health-related quality of life
5331748|NCT02032199|Questionnaire|questionnaire
5331749|NCT02032199|Treatment guidelines|treatment guidelines
5331750|NCT02032186|magnesium|magnesium
5331751|NCT02032186|prematurity|prematurity
5331752|NCT02032173|Ranibizumab|ranibizumab
5331753|NCT02032173|Diabetic Macular Edema|diabetic macular edema
5331754|NCT02032160|ADITEC|aditec
5331755|NCT02032160|Immunology|immunology
5331756|NCT02032160|Vaccines|vaccines
5331757|NCT02032160|Hepatitis B|hepatitis b
5331758|NCT02032160|Investigational study|investigational study
5331759|NCT02032160|innate and adaptive immune responses|innate and adaptive immune responses
5331760|NCT02032160|Hepatitis B vaccinations|hepatitis b vaccinations
5331761|NCT02032134|Cryopreserved platelets, thrombocytopenia, DMSO|cryopreserved platelets, thrombocytopenia, dmso
5331762|NCT02032121|Cancer survivors|cancer survivors
5331763|NCT02032121|Long-term cancer survivor|long-term cancer survivor
5331764|NCT02032108|Diabetes lifestyle intervention Rwanda|diabetes lifestyle intervention rwanda
5331765|NCT02032095|IVIG|ivig
5331766|NCT02032095|Renal transplantation|renal transplantation
5331767|NCT02032095|desensitization|desensitization
5331768|NCT02032056|Infections|infections
5331769|NCT02032056|Allergy|allergy
5331770|NCT02032056|Immune function|immune function
5331771|NCT02032056|Microbiota|microbiota
5331772|NCT02032056|infant|infant
5331773|NCT02032043|Filariasis|filariasis
5331774|NCT02032043|Onchocerciasis|onchocerciasis
5331775|NCT02032043|Albendazole|albendazole
5331776|NCT02032043|Ivermectin|ivermectin
5331777|NCT02032043|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
5331778|NCT02032043|MDA Mass Drug Administration|mda mass drug administration
5331779|NCT02032030|quality of Life|quality of life
5331780|NCT02032030|pain|pain
5331781|NCT02032030|nausea|nausea
5331782|NCT02032030|falls|falls
5331783|NCT02032030|intraoperative awareness|intraoperative awareness
5331784|NCT02032030|anesthesia awareness|anesthesia awareness
5331785|NCT02032030|cognition|cognition
5331786|NCT02032030|activities of daily living|activities of daily living
5331787|NCT02032030|major morbidity|major morbidity
5331788|NCT02032030|all-cause mortality|all-cause mortality
5331789|NCT02032017|Total Hip Arthroplasty|total hip arthroplasty
5331790|NCT02032017|Gluteus medius|gluteus medius
5331791|NCT02032017|Approach|approach
5331792|NCT02032017|Rehabilitation|rehabilitation
5331793|NCT02032017|Functional outcome|functional outcome
5331794|NCT02032004|Chronic Heart Failure|chronic heart failure
5331795|NCT02032004|CHF|chf
5331796|NCT02032004|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
5331797|NCT02032004|Ischemic Heart Failure|ischemic heart failure
5331798|NCT02032004|Nonischemic Heart Failure|nonischemic heart failure
5331800|NCT02032004|Allogeneic Mesenchymal Precursor Cells|allogeneic mesenchymal precursor cells
5331801|NCT02031991|Bioequivalence|bioequivalence
5331802|NCT02031991|Biosimilarity|biosimilarity
5331803|NCT02031991|Similarity|similarity
5331804|NCT02031991|PK|pk
5331805|NCT02031991|Phase 1|phase 1
5331806|NCT02031991|Bevacizumab|bevacizumab
5678409|NCT00586911|NASH|nash
5331807|NCT02031991|Healthy Volunteers|healthy volunteers
5331808|NCT02031991|Single-Dose|single-dose
5331810|NCT02031978|Breast Feeding|breast feeding
5331811|NCT02031978|Infant Nutrition|infant nutrition
5331812|NCT02031978|Childhood Obesity|childhood obesity
5331813|NCT02031978|Infant feeding patterns|infant feeding patterns
5331814|NCT02031978|WIC|wic
5331815|NCT02031952|hepatocellular carcinoma|hepatocellular carcinoma
5331816|NCT02031952|hepatectomy|hepatectomy
5331817|NCT02031952|lymphadenectomy|lymphadenectomy
5331818|NCT02031952|complication|complication
5331819|NCT02031952|prognosis|prognosis
5331820|NCT02031939|Rectal cancer|rectal cancer
5331821|NCT02031939|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5331822|NCT02031939|optimization|optimization
5331823|NCT02031913|Chronic hepatitis B|chronic hepatitis b
5331824|NCT02031913|Hepatic fibrosis|hepatic fibrosis
5331825|NCT02031913|Steatosis|steatosis
5331826|NCT02031887|starter formula|starter formula
5331827|NCT02031887|stool microbiota|stool microbiota
5331828|NCT02031887|infants|infants
5331829|NCT02031887|caesarean section delivery|caesarean section delivery
5331830|NCT02031874|H1N1|h1n1
5331832|NCT02031874|Immunogenecity|immunogenecity
5331833|NCT02031848|weight loss|weight loss
5331834|NCT02031848|diet|diet
5331835|NCT02031822|Primary Headache|primary headache
5331836|NCT02031822|Greater Occipital Nerve|greater occipital nerve
5331837|NCT02031822|Ultrasound|ultrasound
5331838|NCT02031822|Chronic Pain|chronic pain
5331839|NCT02031822|Cervicogenic|cervicogenic
5331840|NCT02031822|Occipital Neuralgia|occipital neuralgia
5331841|NCT02031822|Migraine|migraine
5331842|NCT02031822|Tension type headache|tension type headache
5331843|NCT02031822|Cluster headache|cluster headache
5331844|NCT02031809|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5331845|NCT02031770|vascular endothelial cells|vascular endothelial cells
5331846|NCT02031757|Balance control|balance control
5331847|NCT02031757|Aging|aging
5331848|NCT02031757|Balance reactions|balance reactions
5331849|NCT02031757|Perturbation|perturbation
5331850|NCT02031705|Fibrillation|fibrillation
5331851|NCT02031705|Catheter ablation|catheter ablation
5331852|NCT02031692|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5331853|NCT02031692|Vitamin D|vitamin d
5331854|NCT02031692|Calcium|calcium
5331855|NCT02031692|Prevention|prevention
5331856|NCT02031679|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5331858|NCT02031666|JNJ-56021927|jnj-56021927
5331859|NCT02031666|ARN-509|arn-509
5331860|NCT02031666|Bioavailability|bioavailability
5331861|NCT02031653|Penile Cuff Test|penile cuff test
5331862|NCT02031640|asthma|asthma
5331863|NCT02031640|breath-actuated inhaler|breath-actuated inhaler
5331864|NCT02031640|metered-dose inhaler|metered-dose inhaler
5331865|NCT02031627|lymphedema|lymphedema
5331866|NCT02031627|lymphoedema|lymphoedema
5331867|NCT02031627|leg lymphoedema|leg lymphoedema
5331868|NCT02031627|lower extremity lymphoedema|lower extremity lymphoedema
5331869|NCT02031627|pneumatic compression device|pneumatic compression device
5331870|NCT02031614|anemia|anemia
5331871|NCT02031614|blood withdrawal|blood withdrawal
5331872|NCT02031614|phlebotomy|phlebotomy
5331873|NCT02031614|innate immunity|innate immunity
5331874|NCT02031614|Immune reponse|immune reponse
5331875|NCT02031588|Study of commensal flora|study of commensal flora
5331876|NCT02031588|Fluoroquinolones|fluoroquinolones
5331877|NCT02031575|Reproductive Health|reproductive health
5331878|NCT02031575|Contraception|contraception
5331879|NCT02031575|Public Health|public health
5331880|NCT02031575|Sexual Health|sexual health
5331881|NCT02031575|Adolescents|adolescents
5331882|NCT02031575|Mobile Health|mobile health
5331883|NCT02031562|Balance|balance
5331884|NCT02031562|Falls|falls
5331885|NCT02031562|Low back pain|low back pain
5331886|NCT02031562|Geriatric|geriatric
5331887|NCT02031523|endometriosis|endometriosis
5331888|NCT02031523|dysmenorrhea|dysmenorrhea
5331889|NCT02031523|Sanjie analgesic capsule|sanjie analgesic capsule
5331890|NCT02031523|effect/safety|effect/safety
5331891|NCT02031497|Sweetener, insulin, body mass index, physical activity|sweetener, insulin, body mass index, physical activity
5331892|NCT02031432|cancer-related pain|cancer-related pain
5331893|NCT02031432|cebranopadol|cebranopadol
5331894|NCT02031419|CC-122|cc-122
5331895|NCT02031419|CC-223|cc-223
5331896|NCT02031419|CC-292|cc-292
5331897|NCT02031419|Rituximab|rituximab
5331898|NCT02031419|Lymphoma|lymphoma
5331899|NCT02031419|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5331900|NCT02031419|Lenalidomide naïve Follicular Lymphoma|lenalidomide naïve follicular lymphoma
5211667|NCT02671864|GLP1|glp1
5331901|NCT02031419|Lenalidomide exposed Follicular Lymphoma|lenalidomide exposed follicular lymphoma
5331902|NCT02031380|Glaucoma|glaucoma
5331903|NCT02031380|Open angle glaucoma|open angle glaucoma
5331904|NCT02031380|ocular hypertension|ocular hypertension
5331905|NCT02031380|compliance|compliance
5331906|NCT02031354|Lysine Chloride|lysine chloride
5331907|NCT02031328|prostate|prostate
5331908|NCT02031328|radiation|radiation
5331909|NCT02031328|stereotactic body radiation|stereotactic body radiation
5331910|NCT02031315|sudden death|sudden death
5331911|NCT02031315|sudden cardiac arrest|sudden cardiac arrest
5331913|NCT02031302|Valve|valve
5331914|NCT02031302|Real world|real world
5331915|NCT02031302|Aortic stenosis|aortic stenosis
5331916|NCT02031302|High risk|high risk
5331917|NCT02031289|Anemia|anemia
5331918|NCT02031289|Iron deficiency|iron deficiency
5331919|NCT02031289|Cardiac surgery|cardiac surgery
5331920|NCT02031289|Perioperative Care|perioperative care
5331921|NCT02031276|ABBV-066|abbv-066
5331922|NCT02031276|BI 655066|bi 655066
5331923|NCT02031276|risankizumab|risankizumab
5331924|NCT02031224|Chronic Kidney Disease|chronic kidney disease
5331925|NCT02031224|Restricted protein diets|restricted protein diets
5331926|NCT02031224|Nutritional status|nutritional status
5331927|NCT02031198|Alzheimer's disease|alzheimer's disease
5331929|NCT02031198|dementia|dementia
5331930|NCT02031198|elderly|elderly
5331931|NCT02031198|cognitive|cognitive
5331932|NCT02031198|disease modifying|disease modifying
5331933|NCT02031198|treatment|treatment
5331934|NCT02031198|immunization|immunization
5331935|NCT02031198|vaccine|vaccine
5331936|NCT02031172|Dry Eye Disease|dry eye disease
5331937|NCT02031172|Sjogren's Syndrome|sjogren's syndrome
5331938|NCT02031172|Tear Film|tear film
5331939|NCT02031172|Ocular Surface|ocular surface
5331940|NCT02031172|Aqueous Tear Deficiency|aqueous tear deficiency
5331941|NCT02031159|perioperative hypothermia|perioperative hypothermia
5331942|NCT02031159|zero heat flux|zero heat flux
5331943|NCT02031159|non-invasive measurement of body core temperature|non-invasive measurement of body core temperature
5331944|NCT02031107|stroke|stroke
5331945|NCT02031107|brain stimulation|brain stimulation
5331946|NCT02031107|electroencephalography|electroencephalography
5331947|NCT02031107|functional magnetic resonance imaging|functional magnetic resonance imaging
5331948|NCT02031107|functional connectivity|functional connectivity
5331949|NCT02031068|active rehabilitation|active rehabilitation
5331950|NCT02031068|exercise|exercise
5331951|NCT02031068|concussion|concussion
5331952|NCT02031055|Advanced solid tumors|advanced solid tumors
5331953|NCT02031042|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5331954|NCT02031042|breast cancer|breast cancer
5331955|NCT02031042|sentinel lymph node biopsy|sentinel lymph node biopsy
5331956|NCT02031042|false negative rate|false negative rate
5331957|NCT02031042|identification rate|identification rate
5331958|NCT02031029|personality scores|personality scores
5331959|NCT02031016|Chronic thoracic pain|chronic thoracic pain
5331960|NCT02031016|Remifentanil|remifentanil
5331961|NCT02031016|Fentanyl|fentanyl
5331962|NCT02031016|sternotomy|sternotomy
5331963|NCT02030990|photorefractive keratectomy|photorefractive keratectomy
5331964|NCT02030990|corneal haze|corneal haze
5331965|NCT02030990|mitomycin-C|mitomycin-c
5331966|NCT02030990|postoperative steroids|postoperative steroids
5331967|NCT02030951|preterm infant behavior|preterm infant behavior
5331968|NCT02030951|tube feeding|tube feeding
5331969|NCT02030951|feeding efficiency|feeding efficiency
5331970|NCT02030938|breast implant|breast implant
5331971|NCT02030938|revision augmentation|revision augmentation
5331972|NCT02030938|stretch deformity|stretch deformity
5331973|NCT02030938|fold malposition|fold malposition
5331974|NCT02030938|bottoming out|bottoming out
5331975|NCT02030912|The impact of a number of different types of antibiotics|the impact of a number of different types of antibiotics
5331976|NCT02030912|The emergence and persistence of antibiotic resistance|the emergence and persistence of antibiotic resistance
5331977|NCT02030899|Cervical vertebrae|cervical vertebrae
5331978|NCT02030899|single|single
5331979|NCT02030899|degenerative disease|degenerative disease
5331980|NCT02030899|Fusion|fusion
5331981|NCT02030899|Sagittal angle|sagittal angle
5331982|NCT02030873|virtual simulation|virtual simulation
5331983|NCT02030873|temporal bone|temporal bone
5331984|NCT02030873|surgical training|surgical training
5331985|NCT02030873|medical education|medical education
5331986|NCT02030873|self-directed learning|self-directed learning
5331987|NCT02030873|final product assessment|final product assessment
5331988|NCT02030873|cognitive load|cognitive load
5331989|NCT02030873|reaction time|reaction time
5331990|NCT02030873|skills training|skills training
5331991|NCT02030873|simulator metrics|simulator metrics
5331992|NCT02030808|Thoracic surgery|thoracic surgery
5331993|NCT02030808|non-muscle relaxant|non-muscle relaxant
5331994|NCT02030808|target-controlled infusion|target-controlled infusion
5963314|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs
5331995|NCT02030808|remifentanil|remifentanil
5331996|NCT02030808|surgical conditions|surgical conditions
5331997|NCT02030795|Thoracic surgery|thoracic surgery
5331998|NCT02030795|Arndt® blocker|arndt® blocker
5331999|NCT02030795|lung deflation|lung deflation
5332000|NCT02030795|Disconnection technique|disconnection technique
5332001|NCT02030795|Continuous suction|continuous suction
5332002|NCT02030795|Elective video-assisted thoracoscopic|elective video-assisted thoracoscopic
5332003|NCT02030782|depression|depression
5332004|NCT02030782|quality improvement|quality improvement
5332005|NCT02030782|treatment|treatment
5332006|NCT02030782|adolescents|adolescents
5332007|NCT02030769|Esophageal Neoplasms|esophageal neoplasms
5332008|NCT02030769|Lugol's solution|lugol's solution
5332010|NCT02030769|Endoscopy, Digestive System|endoscopy, digestive system
5332011|NCT02030769|Pretreatment method|pretreatment method
5332013|NCT02030743|Falls|falls
5332014|NCT02030743|Older adults|older adults
5332015|NCT02030743|Balance|balance
5332016|NCT02030743|Mobility|mobility
5332017|NCT02030743|Visual attention|visual attention
5332018|NCT02030730|Brief Parenting Training|brief parenting training
5332019|NCT02030730|Early Intervention|early intervention
5332020|NCT02030730|Child Behavior|child behavior
5332021|NCT02030730|Greece|greece
5332022|NCT02030717|Spinal anesthesia|spinal anesthesia
5332023|NCT02030717|Epidural anesthesia|epidural anesthesia
5332024|NCT02030717|Klonidin|klonidin
5332025|NCT02030717|renal cell carcinoma|renal cell carcinoma
5332026|NCT02030691|Neonatal respiratory distress|neonatal respiratory distress
5332027|NCT02030691|nHFPV|nhfpv
5332028|NCT02030691|nCPAP|ncpap
5332029|NCT02030691|cerebral tissue oxygenation|cerebral tissue oxygenation
5332030|NCT02030691|NIRS|nirs
5332031|NCT02030665|Marijuana Dependence|marijuana dependence
5332032|NCT02030665|Individualized treatment|individualized treatment
5332033|NCT02030665|Motivational Enhancement Treatment|motivational enhancement treatment
5332034|NCT02030665|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
5332035|NCT02030665|Contingency Management|contingency management
5332036|NCT02030652|premature newborn|premature newborn
5332037|NCT02030652|nasal ventilation|nasal ventilation
5332038|NCT02030652|noninvasive ventilation|noninvasive ventilation
5332039|NCT02030652|continuous positive airway pressure|continuous positive airway pressure
5332040|NCT02030626|Neuropathic pain|neuropathic pain
5332041|NCT02030626|lumbar radiculopathy|lumbar radiculopathy
5332042|NCT02030626|rTMS|rtms
5332043|NCT02030626|tDCS|tdcs
5332044|NCT02030626|placebo controlled study|placebo controlled study
5332045|NCT02030613|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5332046|NCT02030613|etanercept|etanercept
5332047|NCT02030587|Hyperaldosteronism|hyperaldosteronism
5332048|NCT02030587|Adrenocortical adenoma|adrenocortical adenoma
5332049|NCT02030587|Adrenalectomy|adrenalectomy
5332050|NCT02030587|Catheter ablation|catheter ablation
5332051|NCT02030561|NK cells|nk cells
5332052|NCT02030561|trastuzumab|trastuzumab
5332053|NCT02030561|immunotherapy|immunotherapy
5332054|NCT02030548|CABG|cabg
5332055|NCT02030548|dual antiplatelet therapy|dual antiplatelet therapy
5332056|NCT02030548|aspirin|aspirin
5332057|NCT02030548|clopidogrel|clopidogrel
5332058|NCT02030548|prasugrel|prasugrel
5332059|NCT02030548|ticagrelor|ticagrelor
5332060|NCT02030522|Post-traumatic stress disorder|post-traumatic stress disorder
5332061|NCT02030522|PTSD|ptsd
5332062|NCT02030522|Accelerated Resolution Therapy|accelerated resolution therapy
5332063|NCT02030522|Military|military
5332064|NCT02030522|Veterans|veterans
5332065|NCT02030522|Exposure therapy|exposure therapy
5332066|NCT02030522|Eye movements|eye movements
5332067|NCT02030509|cancer diagnosis|cancer diagnosis
5332068|NCT02030496|distal radius fractures|distal radius fractures
5332069|NCT02030496|Closed reduction|closed reduction
5332070|NCT02030496|Open reduction internal fixation|open reduction internal fixation
5332071|NCT02030496|Volar plate|volar plate
5332072|NCT02030496|Redislocation|redislocation
5332073|NCT02030496|Unstable fracture|unstable fracture
5332074|NCT02030496|Extra-articular fracture|extra-articular fracture
5332075|NCT02030496|Colles fracture|colles fracture
5332076|NCT02030496|Barton fracture|barton fracture
5332077|NCT02030470|Periodontitis, treatment, photodynamic, mid-term, bacteria|periodontitis, treatment, photodynamic, mid-term, bacteria
5332078|NCT02030444|Neoplasms Staging|neoplasms staging
5332079|NCT02030444|Bronchoscopy|bronchoscopy
5332080|NCT02030444|Nuclear Medicine|nuclear medicine
5332081|NCT02030444|Radiology|radiology
5332082|NCT02030392|Functional abdominal pain|functional abdominal pain
5332083|NCT02030392|psychological intervention|psychological intervention
5332084|NCT02030392|quality of life|quality of life
5332085|NCT02030392|Randomized controlled trial|randomized controlled trial
5332086|NCT02030392|children|children
5332087|NCT02030379|Cancer|cancer
5332088|NCT02030353|Lifestyle intervention|lifestyle intervention
5332089|NCT02030353|Internet intervention|internet intervention
5332090|NCT02030353|Breast neoplasms|breast neoplasms
5332091|NCT02030353|Body weight|body weight
5332092|NCT02030353|Body weight changes|body weight changes
5332093|NCT02030340|urodynamic investigation|urodynamic investigation
5211879|NCT02670356|DHA|dha
5332094|NCT02030340|lower urinary tract dysfunction|lower urinary tract dysfunction
5332095|NCT02030340|catheter|catheter
5332096|NCT02030340|air-charged|air-charged
5332097|NCT02030340|water filled|water filled
5332098|NCT02030327|proteomics|proteomics
5332099|NCT02030327|multiple trauma|multiple trauma
5332100|NCT02030327|organ dysfunction|organ dysfunction
5332101|NCT02030314|Chlorthalidone|chlorthalidone
5678410|NCT00586911|Betaine|betaine
5332102|NCT02030314|Resistant Hypertension|resistant hypertension
5332103|NCT02030314|Kidney Transplant Patients|kidney transplant patients
5332104|NCT02030301|Herpes Simplex Virus, Type 2|herpes simplex virus, type 2
5332106|NCT02030301|HSV-2|hsv-2
5332108|NCT02030288|substance use|substance use
5332109|NCT02030288|eHealth|ehealth
5332110|NCT02030275|Hypertrophic scar|hypertrophic scar
5332111|NCT02030275|Cicatrix|cicatrix
5332112|NCT02030275|Scar prevention|scar prevention
5332113|NCT02030275|Scar revision|scar revision
5332114|NCT02030249|Pre-diabetes|pre-diabetes
5332115|NCT02030249|Obesity|obesity
5332116|NCT02030249|Low calorie diet|low calorie diet
5332125|NCT02030236|hypothermia, induced|hypothermia, induced
5332127|NCT02030236|therapeutic|therapeutic
5332128|NCT02030236|heart arrest|heart arrest
5332129|NCT02030236|asystole|asystole
5332130|NCT02030236|frostbite|frostbite
5332131|NCT02030223|transversus abdominis plane block|transversus abdominis plane block
5332132|NCT02030223|inguinal hernia repair|inguinal hernia repair
5332133|NCT02030223|acute postoperative pain|acute postoperative pain
5332134|NCT02030223|neuropathic pain|neuropathic pain
5332135|NCT02030210|Quality improvement|quality improvement
5332136|NCT02030210|STEMI|stemi
5332137|NCT02030210|Belgium|belgium
5332138|NCT02030184|Lung cancer|lung cancer
5332139|NCT02030184|Small cell lung cancer|small cell lung cancer
5332140|NCT02030184|Neuroendocrine tumor|neuroendocrine tumor
5332141|NCT02030184|Rhenium|rhenium
5332142|NCT02030184|Re 188-P2045|re 188-p2045
5332143|NCT02030171|Chronic low back pain|chronic low back pain
5332144|NCT02030158|Severe sepsis|severe sepsis
5332145|NCT02030158|Septic shock|septic shock
5332146|NCT02030158|Early goal directed therapy|early goal directed therapy
5332147|NCT02030158|Individual patient data meta-analysis|individual patient data meta-analysis
5332148|NCT02030145|COPD|copd
5332149|NCT02030145|Pulmonary|pulmonary
5332150|NCT02030132|Physical activity|physical activity
5332151|NCT02030132|Sedentary lifestyle|sedentary lifestyle
5332152|NCT02030132|Pedometers|pedometers
5332153|NCT02030132|Walking|walking
5332154|NCT02030132|Financial Incentives|financial incentives
5332155|NCT02030132|Behavioral Economics|behavioral economics
5332156|NCT02030119|Sedentary lifestyle|sedentary lifestyle
5332157|NCT02030119|Pedometers|pedometers
5332158|NCT02030119|Obesity|obesity
5332159|NCT02030119|Physical Activity|physical activity
5332160|NCT02030119|Financial Incentives|financial incentives
5332161|NCT02030119|Behavioral Economics|behavioral economics
5332162|NCT02030106|Cervicovaginal microbiome|cervicovaginal microbiome
5332163|NCT02030106|Microbiome|microbiome
5332164|NCT02030106|Preterm Birth|preterm birth
5332165|NCT02030106|Cervical Remodeling|cervical remodeling
5332166|NCT02030106|Preterm delivery|preterm delivery
5332167|NCT02030106|Microbiota|microbiota
5332168|NCT02030093|Alcohol dependence|alcohol dependence
5332169|NCT02030093|Telephone-based continuing care|telephone-based continuing care
5332170|NCT02030093|Outcome monitoring|outcome monitoring
5332171|NCT02030080|Pedometers|pedometers
5332172|NCT02030080|Walking|walking
5332173|NCT02030080|Financial incentives|financial incentives
5332174|NCT02030080|Sedentary lifestyle|sedentary lifestyle
5332175|NCT02030080|Behavioral economics|behavioral economics
5332176|NCT02030067|oncology|oncology
5332177|NCT02030067|tumor|tumor
5332178|NCT02030067|metastatic|metastatic
5332179|NCT02030067|bladder|bladder
5332180|NCT02030041|simvastatin|simvastatin
5332181|NCT02030041|cardiorespiratory fitness|cardiorespiratory fitness
5332182|NCT02030041|vitamin D|vitamin d
5332183|NCT02030041|exercise|exercise
5332184|NCT02030041|mitochondria|mitochondria
5332185|NCT02030028|Rheumatoid Arthritis|rheumatoid arthritis
5332186|NCT02030028|ACTH gel|acth gel
5332187|NCT02030015|infantile Tay-Sachs disease|infantile tay-sachs disease
5332188|NCT02030015|juvenile Tay-Sachs disease|juvenile tay-sachs disease
5332189|NCT02030015|infantile GM1 gangliosidosis|infantile gm1 gangliosidosis
5332190|NCT02030015|juvenile GM1 gangliosidosis|juvenile gm1 gangliosidosis
5332191|NCT02030015|infantile GM2 gangliosidosis|infantile gm2 gangliosidosis
5332192|NCT02030015|juvenile GM2 gangliosidosis|juvenile gm2 gangliosidosis
5332193|NCT02030015|Sandhoff disease|sandhoff disease
5332194|NCT02030015|gangliosidoses|gangliosidoses
5332195|NCT02030015|miglustat|miglustat
5332196|NCT02030015|ketogenic diet|ketogenic diet
5332197|NCT02030015|SYNER-G regimen|syner-g regimen
5963315|NCT04255433|Tirzepatide|tirzepatide
5332198|NCT02030015|Syner-G|syner-g
5332199|NCT02030015|Zavesca|zavesca
5332200|NCT02030015|Tay-Sachs disease|tay-sachs disease
5332201|NCT02030015|Tay Sachs disease|tay sachs disease
5332202|NCT02029989|Metabolic Syndrome|metabolic syndrome
5332203|NCT02029989|Antipsychotics|antipsychotics
5332204|NCT02029989|Schizophrenia|schizophrenia
5332205|NCT02029989|Bipolar Disorder|bipolar disorder
5332206|NCT02029989|Diabetes|diabetes
5332207|NCT02029989|Dyslipidemia|dyslipidemia
5332208|NCT02029989|Hyperlipidemia|hyperlipidemia
5332209|NCT02029989|Hypertension|hypertension
5332210|NCT02029989|Obesity|obesity
5332211|NCT02029989|Medication Therapy Management|medication therapy management
5332213|NCT02029989|Pharmacist|pharmacist
5332214|NCT02029989|Comprehensive Medication Management|comprehensive medication management
5332215|NCT02029989|CMM|cmm
5332216|NCT02029989|Health Disparity|health disparity
5332217|NCT02029989|Monitoring|monitoring
5332237|NCT02029859|preeclampsy|preeclampsy
5332238|NCT02029859|intrauterine growth restriction|intrauterine growth restriction
5332239|NCT02029820|Contrast Nephropathy|contrast nephropathy
5332240|NCT02029820|Prevention|prevention
5332241|NCT02029820|Renalguard|renalguard
5332242|NCT02029794|Cervical Cancer|cervical cancer
5332243|NCT02029794|Cervical Cancer Screening|cervical cancer screening
5332244|NCT02029794|Low Resource setting|low resource setting
5332245|NCT02029794|HPV|hpv
5332246|NCT02029794|Self-Collection|self-collection
5332247|NCT02029794|VIA|via
5332248|NCT02029781|Appendicitis|appendicitis
5332249|NCT02029781|Laparoscopy|laparoscopy
5332250|NCT02029781|Appendectomy|appendectomy
5332251|NCT02029781|Negative appendectomy|negative appendectomy
5332252|NCT02029781|Morbidity|morbidity
5332253|NCT02029768|outcome|outcome
5332254|NCT02029755|transversus abdominis plane block|transversus abdominis plane block
5332255|NCT02029755|local infiltration|local infiltration
5332256|NCT02029755|ropivacaine|ropivacaine
5332257|NCT02029755|heart rate variability|heart rate variability
5332258|NCT02029755|postoperative analgesia|postoperative analgesia
5332259|NCT02029742|Sickle cell disease|sickle cell disease
5332260|NCT02029742|Medication adherence|medication adherence
5332261|NCT02029742|Hydroxyurea|hydroxyurea
5332262|NCT02029742|Community health worker intervention|community health worker intervention
5332263|NCT02029742|Sickle Cell Treatment|sickle cell treatment
5332265|NCT02029729|RTA 408 Capsules|rta 408 capsules
5332266|NCT02029729|Non-small cell lung cancer|non-small cell lung cancer
5332267|NCT02029729|Metastatic non-small cell lung cancer|metastatic non-small cell lung cancer
5332268|NCT02029729|Incurable non-small cell lung cancer|incurable non-small cell lung cancer
5332269|NCT02029729|Refractory melanoma|refractory melanoma
5332270|NCT02029729|Relapsed melanoma|relapsed melanoma
5332271|NCT02029716|RTA 408|rta 408
5332272|NCT02029716|RTA 408 Lotion|rta 408 lotion
5332273|NCT02029716|Oxidative stress|oxidative stress
5332274|NCT02029716|Inflammation|inflammation
5332275|NCT02029716|Volunteers|volunteers
5332276|NCT02029703|Knee Osteoarthritis|knee osteoarthritis
5332277|NCT02029703|Knee Pain|knee pain
5332278|NCT02029703|Synvisc-One|synvisc-one
5332279|NCT02029690|argininosuccinate synthetase|argininosuccinate synthetase
5332280|NCT02029690|arginine|arginine
5332281|NCT02029690|arginine deiminase|arginine deiminase
5332282|NCT02029651|Stroke|stroke
5332283|NCT02029651|Hand|hand
5332284|NCT02029651|Rehabilitation|rehabilitation
5332285|NCT02029651|Game|game
5332286|NCT02029638|renal transplantation|renal transplantation
5332287|NCT02029638|conditioning regimen|conditioning regimen
5332288|NCT02029638|BMT|bmt
5332289|NCT02029638|high dose post-transplant cyclophosphamide (PT/Cy)|high dose post-transplant cyclophosphamide (pt/cy)
5332290|NCT02029638|renal allograft tolerance|renal allograft tolerance
5332291|NCT02029638|immunosuppression withdrawal|immunosuppression withdrawal
5332292|NCT02029612|Tobacco Use Cessation|tobacco use cessation
5332293|NCT02029612|Cancer Prevention|cancer prevention
5332294|NCT02029612|HIV/AIDS|hiv/aids
5332295|NCT02029612|Questionnaires|questionnaires
5332296|NCT02029612|Surveys|surveys
5332297|NCT02029612|Nicotine patch|nicotine patch
5332298|NCT02029612|Breath test|breath test
5332299|NCT02029612|Cell Phone Calls for Smoking Cessation Counseling|cell phone calls for smoking cessation counseling
5332300|NCT02029612|Text Message Smoking Cessation Support|text message smoking cessation support
5332301|NCT02029573|Phase II|phase ii
5332302|NCT02029573|Atorvastatin|atorvastatin
5332303|NCT02029573|Temozolomide|temozolomide
5332304|NCT02029573|Radiotherapy|radiotherapy
5332305|NCT02029573|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5332306|NCT02029534|post-operative atrial fibrillation|post-operative atrial fibrillation
5332307|NCT02029534|POAF|poaf
5332308|NCT02029534|A-Fib|a-fib
5332309|NCT02029521|cystic fibrosis|cystic fibrosis
5332310|NCT02029521|growth Failure|growth failure
5332311|NCT02029521|glutathione|glutathione
5332312|NCT02029508|PSCC(Posterior semicircular canal)|pscc(posterior semicircular canal)
5332313|NCT02029508|BPPV(Bening paroxysmal positional vertigo)|bppv(bening paroxysmal positional vertigo)
5332314|NCT02029508|Vertigo|vertigo
5332315|NCT02029508|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5332316|NCT02029495|Psoriatic Arthritis|psoriatic arthritis
5332317|NCT02029495|Brodalumab|brodalumab
5332318|NCT02029495|AMG 827|amg 827
5332319|NCT02029482|ACT-128800|act-128800
5332320|NCT02029469|Humeral Resurfacing|humeral resurfacing
5332321|NCT02029469|Humeral Resurfacing Arthroplasty|humeral resurfacing arthroplasty
5332322|NCT02029456|Massive Pulmonary embolism|massive pulmonary embolism
5332323|NCT02029456|thrombolytic therapy|thrombolytic therapy
5332324|NCT02029456|high risk|high risk
5332325|NCT02029456|elderly|elderly
5332326|NCT02029443|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5332327|NCT02029430|HIV +|hiv +
5332330|NCT02029430|Kaposi's sarcoma|kaposi's sarcoma
5332331|NCT02029430|Sarcoma|sarcoma
5332332|NCT02029430|tumor|tumor
5332333|NCT02029430|cancer|cancer
5332334|NCT02029391|Myofascial pain syndrome|myofascial pain syndrome
5332335|NCT02029391|taping|taping
5332336|NCT02029391|manual therapies|manual therapies
5332337|NCT02029365|Infertility|infertility
5332338|NCT02029365|desire for children|desire for children
5332339|NCT02029365|eating disorder|eating disorder
5332340|NCT02029365|anorexia nervosa|anorexia nervosa
5332341|NCT02029365|bulimia nervosa|bulimia nervosa
5332342|NCT02029365|eating disorders not otherwise specified|eating disorders not otherwise specified
5332343|NCT02029352|Treatment|treatment
5332344|NCT02029352|Sinecatechins|sinecatechins
5332345|NCT02029339|Negative pressure wound therapy|negative pressure wound therapy
5332346|NCT02029339|Acute wound infection|acute wound infection
5332347|NCT02029339|complicated abdominal infection|complicated abdominal infection
5332348|NCT02029339|Cytokines|cytokines
5332349|NCT02029339|Matrix metalloproteinase|matrix metalloproteinase
5332350|NCT02029326|colorectal cancer, cetuximab, biomarker, prometheus|colorectal cancer, cetuximab, biomarker, prometheus
5332351|NCT02029300|pediatrics|pediatrics
5332352|NCT02029300|fiberoptic intubation|fiberoptic intubation
5227196|NCT02579928|Suicide|suicide
5332353|NCT02029300|oral intubation|oral intubation
5332354|NCT02029300|nasal intubation|nasal intubation
5332355|NCT02029300|children under the age of 2|children under the age of 2
5332356|NCT02029287|Chronic heart failure|chronic heart failure
5332357|NCT02029287|telemedicine|telemedicine
5332358|NCT02029287|health service platform|health service platform
5332359|NCT02029274|Dermatomyositis|dermatomyositis
5332360|NCT02029261|Burn|burn
5332361|NCT02029248|Anorectal malformation|anorectal malformation
5332362|NCT02029248|fecal incontinence|fecal incontinence
5332363|NCT02029248|quality of life|quality of life
5332364|NCT02029248|child|child
5332365|NCT02029235|Adult|adult
5332366|NCT02029235|soft-tissue hand surgery|soft-tissue hand surgery
5332367|NCT02029183|stroke, SAHS, BiPAP|stroke, sahs, bipap
5332368|NCT02029170|ankle fracture|ankle fracture
5332369|NCT02029170|weightbearing|weightbearing
5332370|NCT02029170|cast|cast
5332372|NCT02029105|Mesothelioma,|mesothelioma,
5332373|NCT02029105|Pleural diseases,|pleural diseases,
5332374|NCT02029105|Mesothelin,|mesothelin,
5332375|NCT02029105|Osteopontin,|osteopontin,
5332376|NCT02029105|Hyaluronan,|hyaluronan,
5332377|NCT02029105|Syndecan-1|syndecan-1
5332378|NCT02029092|International|international
5332379|NCT02029092|Multicenter|multicenter
5332380|NCT02029092|Observational registry|observational registry
5332381|NCT02029092|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5332382|NCT02029092|Stenting|stenting
5332383|NCT02029092|Treatment of coronary artery disease|treatment of coronary artery disease
5332384|NCT02029092|Coronary revascularization|coronary revascularization
5332385|NCT02029092|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5332386|NCT02029092|STEMI|stemi
5332387|NCT02029092|NSTEMI|nstemi
5332388|NCT02029092|Ischemia|ischemia
5332389|NCT02029092|Angina|angina
5332390|NCT02029092|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5332391|NCT02029092|Small Vessels|small vessels
5332392|NCT02029092|Chronical Total Occlusion (CTO)|chronical total occlusion (cto)
5332393|NCT02029079|Malnutrition|malnutrition
5332394|NCT02029066|actinic keratosis|actinic keratosis
5332395|NCT02029066|SR-T100|sr-t100
5332396|NCT02029066|pharmacokinetics|pharmacokinetics
5332397|NCT02029053|Vaginal dryness|vaginal dryness
5332398|NCT02029053|Vaginal lubrication|vaginal lubrication
5332399|NCT02029053|Post-menopausal symptoms|post-menopausal symptoms
5332400|NCT02029053|Peri-menopausal symptoms|peri-menopausal symptoms
5332401|NCT02029053|Urogenital atrophy|urogenital atrophy
5332402|NCT02029053|Dyspareunia|dyspareunia
5332403|NCT02029053|Painful intercourse|painful intercourse
5332404|NCT02029040|Bronchiolitis|bronchiolitis
5332405|NCT02029040|Hypertonic saline|hypertonic saline
5332406|NCT02029040|Emergency Department|emergency department
5332407|NCT02029027|Urinary Stress Incontinence|urinary stress incontinence
5332408|NCT02029027|Urinary Mixed Incontinence|urinary mixed incontinence
5332410|NCT02029001|Solid tumor|solid tumor
5332411|NCT02029001|Recurrent/metastatic|recurrent/metastatic
5332412|NCT02029001|Personalized medicine|personalized medicine
5332413|NCT02029001|Genomic alteration|genomic alteration
5332414|NCT02029001|Targeted therapy|targeted therapy
5332415|NCT02029001|Nilotinib|nilotinib
5332416|NCT02029001|Everolimus|everolimus
5332417|NCT02029001|Sorafenib|sorafenib
5332418|NCT02029001|Lapatinib|lapatinib
5332419|NCT02029001|Pazopanib|pazopanib
5332420|NCT02029001|Olaparib|olaparib
5332421|NCT02029001|Immunotherapy|immunotherapy
5332422|NCT02029001|Durvalumab|durvalumab
5332423|NCT02029001|Tremelimumab|tremelimumab
5332424|NCT02028988|Intermediate Risk Prostate Cancer|intermediate risk prostate cancer
5332425|NCT02028962|Smoking cessation|smoking cessation
5332719|NCT02027714|Counseling|counseling
5332426|NCT02028962|Romanian adults|romanian adults
5332427|NCT02028923|topical morphine|topical morphine
5332428|NCT02028910|gastroenteritis|gastroenteritis
5332429|NCT02028910|pediatrics|pediatrics
5332430|NCT02028910|vomiting|vomiting
5332431|NCT02028897|In vitro fertilization|in vitro fertilization
5332432|NCT02028897|IVF|ivf
5332433|NCT02028897|Embryo culture|embryo culture
5332434|NCT02028897|Blastocyst transfer|blastocyst transfer
5332435|NCT02028832|pain|pain
5332436|NCT02028832|nausea/vomiting|nausea/vomiting
5332437|NCT02028832|anxiety|anxiety
5332438|NCT02028832|complementary and alternative medicine|complementary and alternative medicine
5332439|NCT02028832|pediatric|pediatric
5332440|NCT02028832|oncology|oncology
5332441|NCT02028832|cost-effectiveness|cost-effectiveness
5332442|NCT02028793|Pharmaceutical Care, Taiwan, pharmacist, Workload, pressure|pharmaceutical care, taiwan, pharmacist, workload, pressure
5332443|NCT02028741|neck pain|neck pain
5332444|NCT02028741|transverse vertebral pressures|transverse vertebral pressures
5332445|NCT02028741|thoracic mobilization|thoracic mobilization
5332446|NCT02028728|International|international
5332447|NCT02028728|Multicenter|multicenter
5332448|NCT02028728|Observational registry|observational registry
5332449|NCT02028728|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5332450|NCT02028728|Stenting|stenting
5332451|NCT02028728|Treatment of coronary artery disease|treatment of coronary artery disease
5332452|NCT02028728|Coronary revascularization|coronary revascularization
5332453|NCT02028728|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5332454|NCT02028728|STEMI|stemi
5332455|NCT02028728|NSTEMI|nstemi
5332456|NCT02028728|Ischemia|ischemia
5332457|NCT02028728|Angina|angina
5332458|NCT02028728|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5332459|NCT02028728|Small Vessels|small vessels
5332460|NCT02028728|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5332461|NCT02028715|IV Acetaminophen|iv acetaminophen
5332462|NCT02028715|Ofirmev|ofirmev
5332463|NCT02028715|Post-operative pain|post-operative pain
5332464|NCT02028702|red clover|red clover
5332465|NCT02028702|menopause|menopause
5332466|NCT02028702|bioactive compounds|bioactive compounds
5332467|NCT02028702|isoflavones|isoflavones
5332468|NCT02028702|phytoestrogen|phytoestrogen
5332469|NCT02028676|HIV|hiv
5332470|NCT02028676|Africa|africa
5332471|NCT02028676|children|children
5332472|NCT02028676|antiretroviral therapy|antiretroviral therapy
5332473|NCT02028676|laboratory monitoring|laboratory monitoring
5332474|NCT02028676|toxicity|toxicity
5332475|NCT02028676|CD4|cd4
5332476|NCT02028676|induction maintenance|induction maintenance
5332477|NCT02028676|cotrimoxazole|cotrimoxazole
5332478|NCT02028676|prophylaxis|prophylaxis
5332479|NCT02028676|abacavir|abacavir
5332480|NCT02028676|lamivudine|lamivudine
5332481|NCT02028676|once daily|once daily
5332482|NCT02028663|P-CAB|p-cab
5332483|NCT02028663|APA(Acid Pump Antagonist)|apa(acid pump antagonist)
5332484|NCT02028650|relapse leukemia|relapse leukemia
5332485|NCT02028650|DSI|dsi
5332486|NCT02028637|asthma|asthma
5332487|NCT02028637|toll like receptor|toll like receptor
5332488|NCT02028637|innate immunity|innate immunity
5332489|NCT02028624|Rheumatoid arthritis|rheumatoid arthritis
5332490|NCT02028624|Mediterranean diet|mediterranean diet
5332491|NCT02028624|Lifestyle intervention|lifestyle intervention
5332492|NCT02028624|Adiponectin|adiponectin
5332493|NCT02028624|Telephone counseling|telephone counseling
5332494|NCT02028611|Rib fracture|rib fracture
5332495|NCT02028611|Inverted grayscale|inverted grayscale
5332496|NCT02028598|Clomipramine|clomipramine
5332497|NCT02028598|Premature ejaculation|premature ejaculation
5332499|NCT02028585|metabolic syndrome|metabolic syndrome
5332500|NCT02028585|lipid profile|lipid profile
5332501|NCT02028585|inflammation|inflammation
5332502|NCT02028585|oxidative stress|oxidative stress
5332503|NCT02028585|endothelial function|endothelial function
5332504|NCT02028572|Structure function correlation|structure function correlation
5332505|NCT02028572|Optical coherence tomography|optical coherence tomography
5332506|NCT02028572|Retinal Nerve fibre layer thickness|retinal nerve fibre layer thickness
5332507|NCT02028572|Visual fields|visual fields
5332508|NCT02028572|Primary open angle glaucoma|primary open angle glaucoma
5332510|NCT02028559|kidney|kidney
5332511|NCT02028559|stone fragments|stone fragments
5332512|NCT02028559|lithotripsy|lithotripsy
5332513|NCT02028546|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration|atopic dermatitis, skin cleansing, cleanser, moisturizer, skin hydration
5332514|NCT02028533|addiction|addiction
5332515|NCT02028533|oxytocin|oxytocin
5332516|NCT02028533|tolerability|tolerability
5332517|NCT02028507|Palbociclib|palbociclib
5332518|NCT02028507|Capecitabine|capecitabine
5332519|NCT02028507|Hormonal Receptor positive|hormonal receptor positive
5332520|NCT02028507|HER2 negative|her2 negative
5332521|NCT02028507|Metastatic Breast Cancer|metastatic breast cancer
5332522|NCT02028507|Resistance to non-steroidal Aromatase inhibitors|resistance to non-steroidal aromatase inhibitors
5332523|NCT02028507|Fulvestrant|fulvestrant
5332524|NCT02028507|Exemestane|exemestane
5332525|NCT02028507|Aromatase inhibitor|aromatase inhibitor
5332526|NCT02028481|Macular hole|macular hole
5332527|NCT02028481|Vitreoretinal surgery|vitreoretinal surgery
5332528|NCT02028481|Macular surgery|macular surgery
5332529|NCT02028481|Air tamponade|air tamponade
5332530|NCT02028468|Femoral Neck Fracture|femoral neck fracture
5332531|NCT02028468|Anterolateral approach|anterolateral approach
5332532|NCT02028468|Trans-gluteal approach|trans-gluteal approach
5332533|NCT02028468|Watson Jones approach|watson jones approach
5332534|NCT02028468|Hardinge approach|hardinge approach
5332535|NCT02028455|pediatric|pediatric
5332536|NCT02028455|young adult|young adult
5332537|NCT02028455|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5332539|NCT02028455|leukemia|leukemia
5332540|NCT02028455|Chimeric Antigen Receptor|chimeric antigen receptor
5332541|NCT02028455|T cell|t cell
5332542|NCT02028429|Minimal Hepatic Encephalopathy (MHE)|minimal hepatic encephalopathy (mhe)
5332543|NCT02028429|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
5332544|NCT02028429|Sickness Impact Profile (SIP)|sickness impact profile (sip)
5332545|NCT02028429|Model for End-stage Liver Disease (MELD)|model for end-stage liver disease (meld)
5332546|NCT02028429|Child-Turcotte-Pugh score (CTP)|child-turcotte-pugh score (ctp)
5332547|NCT02028416|pancytopenia|pancytopenia
5332548|NCT02028416|aplastic anemia|aplastic anemia
5332549|NCT02028416|ATG|atg
5227418|NCT02578706|Aspirin|aspirin
5332550|NCT02028416|Cyclosporin|cyclosporin
5332551|NCT02028390|wounds|wounds
5332552|NCT02028390|thermal|thermal
5332553|NCT02028390|temperature|temperature
5332554|NCT02028390|periwound|periwound
5332555|NCT02028390|camera|camera
5332556|NCT02028390|imaging|imaging
5332557|NCT02028377|Adenocarcinoma|adenocarcinoma
5332558|NCT02028377|imaging|imaging
5332559|NCT02028377|PET|pet
5332560|NCT02028377|MRI|mri
5332561|NCT02028364|Locally advanced breast cancer|locally advanced breast cancer
5332562|NCT02028364|HER2 negative|her2 negative
5332563|NCT02028364|NSAI refractory|nsai refractory
5332564|NCT02028364|Metastatic breast cancer|metastatic breast cancer
5332565|NCT02028364|Estrogen-receptor positive (ER+)|estrogen-receptor positive (er+)
5332566|NCT02028351|visual acuity|visual acuity
5332567|NCT02028351|contrast sensitivity|contrast sensitivity
5332568|NCT02028351|cataract|cataract
5332569|NCT02028351|maculopathy|maculopathy
5332570|NCT02028312|Dry Eye|dry eye
5332571|NCT02028299|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5332572|NCT02028299|Pulmonary Vascular Resistance|pulmonary vascular resistance
5332573|NCT02028299|Right Heart Catheterization|right heart catheterization
5332574|NCT02028286|Rosacea|rosacea
5332575|NCT02028273|Neurogenesis|neurogenesis
5332576|NCT02028273|Addiction|addiction
5332577|NCT02028273|Cocaine|cocaine
5332578|NCT02028273|MRI|mri
5332579|NCT02028273|MRS|mrs
5332580|NCT02028247|Autism spectrum disorders|autism spectrum disorders
5332581|NCT02028247|Autism|autism
5332582|NCT02028247|Asperger's syndrome|asperger's syndrome
5332583|NCT02028247|Pervasive developmental disability - not otherwise specified|pervasive developmental disability - not otherwise specified
5332584|NCT02028247|obsessive-compulsive disorder|obsessive-compulsive disorder
5332585|NCT02028247|Social phobia|social phobia
5332586|NCT02028247|Generalized anxiety disorder|generalized anxiety disorder
5332587|NCT02028247|Specific phobia|specific phobia
5332588|NCT02028247|Separation anxiety disorder|separation anxiety disorder
5332589|NCT02028247|Counseling|counseling
5332590|NCT02028247|Cognitive-behavioral therapy|cognitive-behavioral therapy
5332591|NCT02028247|Psychotherapy|psychotherapy
5332592|NCT02028221|Breast cancer prevention|breast cancer prevention
5332593|NCT02028221|metformin|metformin
5328850|NCT02045264|Adrenergic Agents|adrenergic agents
5332594|NCT02028221|Breast cancer risk reduction|breast cancer risk reduction
5332596|NCT02028208|Allergy Testing|allergy testing
5332597|NCT02028208|Contact Dermatitis|contact dermatitis
5332598|NCT02028208|Mercury, Aluminum or Palladium skin allergy|mercury, aluminum or palladium skin allergy
5332599|NCT02028195|Health check|health check
5332600|NCT02028195|Health promotion|health promotion
5332601|NCT02028195|prevention diabetes|prevention diabetes
5332602|NCT02028195|prevention cardiovascular disease|prevention cardiovascular disease
5332603|NCT02028195|mental health|mental health
5332604|NCT02028182|Patch Test|patch test
5332605|NCT02028182|Allergy Testing|allergy testing
5332606|NCT02028182|Contact dermatitis|contact dermatitis
5332607|NCT02028182|Lyral allergen|lyral allergen
5332608|NCT02028182|Fragrance Mix allergen|fragrance mix allergen
5332609|NCT02028169|Work Productivity|work productivity
5332610|NCT02028169|Anti-TNFs|anti-tnfs
5332611|NCT02028169|Psoriatic Arthritis|psoriatic arthritis
5332612|NCT02028143|Atrial Fibrillation|atrial fibrillation
5332613|NCT02028130|Atrial fibrillation|atrial fibrillation
5332614|NCT02028130|Ablation|ablation
5332615|NCT02028130|Left atrial appendage occlusion|left atrial appendage occlusion
5332616|NCT02028130|Stroke prevention|stroke prevention
5332617|NCT02028091|Pulse walve arrival time differences|pulse walve arrival time differences
5332618|NCT02028078|Endogenous glucose production|endogenous glucose production
5332619|NCT02028078|Type 1 diabetes mellitus|type 1 diabetes mellitus
5332620|NCT02028078|hypoglycaemic clamp|hypoglycaemic clamp
5332621|NCT02028078|tracer to technique|tracer to technique
5332622|NCT02028078|pharmacodynamics|pharmacodynamics
5332623|NCT02028078|pharmacokinetics|pharmacokinetics
5332624|NCT02028065|reversal of neuromuscular blockade|reversal of neuromuscular blockade
5332625|NCT02028052|enlarged mediastinal nodes|enlarged mediastinal nodes
5332626|NCT02028052|enlarged hilar lymph nodes|enlarged hilar lymph nodes
5332627|NCT02028039|Leukemia|leukemia
5332628|NCT02028039|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
5332630|NCT02028039|Burkitt's lymphoma|burkitt's lymphoma
5332631|NCT02028039|Lymphoblastic lymphoma|lymphoblastic lymphoma
5332633|NCT02028026|Depressive Disorder|depressive disorder
5332634|NCT02028026|Anxiety|anxiety
5332635|NCT02028026|Comorbidity|comorbidity
5332636|NCT02028026|Magnetic Resonance Imaging|magnetic resonance imaging
5332637|NCT02028026|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5332638|NCT02028026|Citalopram|citalopram
5332639|NCT02028026|Vilazodone|vilazodone
5332640|NCT02028026|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5332641|NCT02028026|Receptor, Serotonin, 5-HT1A|receptor, serotonin, 5-ht1a
5332642|NCT02028013|Erectile dysfunction, sexual dysfunction, bioresonance|erectile dysfunction, sexual dysfunction, bioresonance
5332643|NCT02028000|Pregnancy|pregnancy
5332644|NCT02028000|Pregnant|pregnant
5332645|NCT02028000|Cesarean Section Delivery|cesarean section delivery
5332646|NCT02027987|valproate acid|valproate acid
5332647|NCT02027987|traumatic brain injury|traumatic brain injury
5332648|NCT02027987|brain protection|brain protection
5332649|NCT02027987|epilepsy|epilepsy
5332650|NCT02027974|Hip|hip
5332651|NCT02027974|Arthroplasty|arthroplasty
5332652|NCT02027974|Arthroplasties|arthroplasties
5332653|NCT02027974|Prosthesis|prosthesis
5332654|NCT02027974|Iconacy|iconacy
5332655|NCT02027974|Osteoarthritis|osteoarthritis
5332656|NCT02027974|Arthritis|arthritis
5332657|NCT02027974|THA|tha
5332658|NCT02027974|THR|thr
5332659|NCT02027974|DJD|djd
5332660|NCT02027961|Metastatic or Unresectable Melanoma, durvalumab (MEDI4736), dafrafenib, trametinib, BRAF-mutation positive, wild-type BRAF, PD-L1, PD-1|metastatic or unresectable melanoma, durvalumab (medi4736), dafrafenib, trametinib, braf-mutation positive, wild-type braf, pd-l1, pd-1
5332661|NCT02027948|nutritional management algorithm|nutritional management algorithm
5332662|NCT02027948|nutritional and functional assessments|nutritional and functional assessments
5332663|NCT02027948|13-264|13-264
5332664|NCT02027935|Melanoma|melanoma
5332665|NCT02027935|Metastatic|metastatic
5332666|NCT02027935|CD8+ T cells|cd8+ t cells
5332667|NCT02027935|White blood cell|white blood cell
5332668|NCT02027935|Leukapheresis|leukapheresis
5332669|NCT02027935|Cyclophosphamide|cyclophosphamide
5332670|NCT02027935|Cytoxan|cytoxan
5332671|NCT02027935|Neosar|neosar
5332672|NCT02027935|Interleukin-2|interleukin-2
5332673|NCT02027935|Aldesleukin|aldesleukin
5332674|NCT02027935|IL-2|il-2
5332675|NCT02027935|Proleukin|proleukin
5332676|NCT02027935|Ipilimumab|ipilimumab
5332677|NCT02027935|Yervoy|yervoy
5332678|NCT02027935|BMS-734016|bms-734016
5332679|NCT02027935|MDX010|mdx010
5332680|NCT02027922|white spot lesion|white spot lesion
5332681|NCT02027922|caries|caries
5332682|NCT02027909|Sinus Node Dysfunction|sinus node dysfunction
5332683|NCT02027896|Perioperative outcomes|perioperative outcomes
5332684|NCT02027883|Defibrillators|defibrillators
5332685|NCT02027883|Ventricular Fibrillation Induction Testing|ventricular fibrillation induction testing
5332686|NCT02027870|DES|des
5332687|NCT02027870|CAD|cad
5332688|NCT02027870|EXCEL-II|excel-ii
5332689|NCT02027870|JWMS|jwms
5332690|NCT02027870|PCI|pci
5332691|NCT02027857|brain electrical impedance;|brain electrical impedance;
5332704|NCT02027805|Immune System Diseases|immune system diseases
5332705|NCT02027805|Antibodies, monoclonal|antibodies, monoclonal
5332706|NCT02027805|Immunotoxins|immunotoxins
5332707|NCT02027805|Immunosuppressive agents|immunosuppressive agents
5332708|NCT02027779|GreenGene™ F, Previously Treated Patients|greengene™ f, previously treated patients
5332709|NCT02027727|inflammatory bowel disease|inflammatory bowel disease
5332711|NCT02027727|trough level|trough level
5332712|NCT02027727|crohn's disease|crohn's disease
5332713|NCT02027727|ulcerative colitis|ulcerative colitis
5332714|NCT02027714|Discordant|discordant
5332715|NCT02027714|Lesotho|lesotho
5332716|NCT02027714|Couples|couples
5332717|NCT02027714|Enhanced Prevention Package (EPP)|enhanced prevention package (epp)
5332718|NCT02027714|ART|art
5332720|NCT02027714|Male Circumcision|male circumcision
5332721|NCT02027688|Oral feeding|oral feeding
5332722|NCT02027688|Premature|premature
5332723|NCT02027688|Infants|infants
5332724|NCT02027688|Neonatal Intensive Care Unit|neonatal intensive care unit
5332725|NCT02027675|exercise|exercise
5332726|NCT02027675|immune function|immune function
5332727|NCT02027675|inflammation|inflammation
5332728|NCT02027675|immunity|immunity
5332729|NCT02027675|diet|diet
5332730|NCT02027675|obesity|obesity
5332731|NCT02027675|asthma|asthma
5332732|NCT02027649|Bladder cancer|bladder cancer
5332733|NCT02027649|Keratin 14|keratin 14
5332734|NCT02027649|Pronostic marker|pronostic marker
5332735|NCT02027649|Diagnostic marker|diagnostic marker
5332736|NCT02027649|Noninvasive technique|noninvasive technique
5332737|NCT02027636|Depression|depression
5332738|NCT02027636|Latinos|latinos
5332739|NCT02027636|Mental Health|mental health
5332740|NCT02027636|Disparities|disparities
5332741|NCT02027623|Mechanical low back pain|mechanical low back pain
5332742|NCT02027623|Non-specific low back pain|non-specific low back pain
5332743|NCT02027623|Exercise|exercise
5332744|NCT02027623|Motor skill training|motor skill training
5332745|NCT02027610|Infant|infant
5332746|NCT02027610|Bangladesh|bangladesh
5332747|NCT02027610|vitamin A|vitamin a
5332748|NCT02027610|microbiota|microbiota
5332749|NCT02027610|vaccine|vaccine
5332750|NCT02027610|immunity|immunity
5332751|NCT02027597|video games|video games
5332752|NCT02027597|oral health|oral health
5332753|NCT02027597|social cognitive theory|social cognitive theory
5332754|NCT02027597|behavior change|behavior change
5332755|NCT02027597|randomized trial|randomized trial
5332756|NCT02027597|growth modeling|growth modeling
5332757|NCT02027597|minority|minority
5332758|NCT02027597|gender|gender
5332759|NCT02027584|infant, premature|infant, premature
5332760|NCT02027584|infant, newborn|infant, newborn
5332761|NCT02027584|choline|choline
5332762|NCT02027571|Diabetes|diabetes
5332763|NCT02027571|Race/Ethnicity|race/ethnicity
5332764|NCT02027571|Offspring Cohort|offspring cohort
5332765|NCT02027571|African Americans|african americans
5332766|NCT02027571|Prediabetes Reversal|prediabetes reversal
5332767|NCT02027571|Lifestyle Intervention|lifestyle intervention
5332768|NCT02027571|Insulin Sensitivity|insulin sensitivity
5332769|NCT02027571|Beta-cell Function|beta-cell function
5332770|NCT02027571|Diabetes Prevention|diabetes prevention
5332771|NCT02027558|cognitive behavioral therapy|cognitive behavioral therapy
5332772|NCT02027558|insomnia|insomnia
5332773|NCT02027558|apnea|apnea
5332774|NCT02027545|cancer screening|cancer screening
5332775|NCT02027545|decision making|decision making
5332776|NCT02027519|Self-testing|self-testing
5332777|NCT02027519|Home-based testing|home-based testing
5332778|NCT02027519|Lesotho|lesotho
5332779|NCT02027519|Discordant|discordant
5332781|NCT02027506|aVL|avl
5332782|NCT02027506|CHRONIC STABLE ANGINA|chronic stable angina
5332784|NCT02027493|Children|children
5332785|NCT02027493|Chronic hepatitis C|chronic hepatitis c
5332786|NCT02027493|Hansenula polymorpha|hansenula polymorpha
5332787|NCT02027493|Pegylated interferon|pegylated interferon
5332788|NCT02027493|Response rate|response rate
5332789|NCT02027493|Ribavirin|ribavirin
5332790|NCT02027493|Treatment|treatment
5332791|NCT02027480|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
5332792|NCT02027480|Biomarkers|biomarkers
5332793|NCT02027480|Nyanza Province|nyanza province
5332794|NCT02027480|Kenya|kenya
5678411|NCT00586898|Prostate|prostate
5332795|NCT02027467|Hematopoietic stem cells|hematopoietic stem cells
5332796|NCT02027467|Herbal|herbal
5332797|NCT02027467|Dietary|dietary
5332798|NCT02027467|CD cells|cd cells
5332799|NCT02027467|Basic research|basic research
5332800|NCT02027454|GSK1265744|gsk1265744
5332802|NCT02027454|placebo|placebo
5332803|NCT02027454|cardiac repolarization|cardiac repolarization
5332804|NCT02027454|12-lead ECG|12-lead ecg
5332805|NCT02027454|moxifloxacin|moxifloxacin
5332806|NCT02027454|QTc|qtc
5332807|NCT02027441|Serodiscordant|serodiscordant
5332808|NCT02027441|Lesotho|lesotho
5332809|NCT02027441|Home-based testing|home-based testing
5332810|NCT02027428|Nab-paclitaxel|nab-paclitaxel
5332811|NCT02027428|Albumin bound paclitaxel|albumin bound paclitaxel
5332813|NCT02027428|Maintenance trials|maintenance trials
5332814|NCT02027428|Celgene|celgene
5332815|NCT02027428|Abraxane|abraxane
5332816|NCT02027428|ABI-007|abi-007
5332817|NCT02027428|NSCLC|nsclc
5332818|NCT02027428|Non-Small Cell Lung Cancer|non-small cell lung cancer
5332819|NCT02027428|Cancer of the Lung|cancer of the lung
5332820|NCT02027428|Carcinoma, Squamous Cell|carcinoma, squamous cell
5332821|NCT02027428|Lung Neoplasms|lung neoplasms
5332822|NCT02027428|Abound.sqm|abound.sqm
5332823|NCT02027415|air pollution|air pollution
5332824|NCT02027415|food|food
5332825|NCT02027415|nitrites|nitrites
5332826|NCT02027415|nitrates|nitrates
5332827|NCT02027415|breath tests/methods|breath tests/methods
5332828|NCT02027389|MSSA, MRSA|mssa, mrsa
5332829|NCT02027376|Advanced Breast Cancer|advanced breast cancer
5963316|NCT04255433|Incretins|incretins
5332831|NCT02027376|Triple Negative|triple negative
5332832|NCT02027376|Hormonal Receptor negative|hormonal receptor negative
5332833|NCT02027376|Her2 negative|her2 negative
5332834|NCT02027363|Metastasis colorectal cancer|metastasis colorectal cancer
5332835|NCT02027363|Maintenance|maintenance
5332836|NCT02027363|First-line treatment|first-line treatment
5332837|NCT02027363|Capecitabine|capecitabine
5332838|NCT02027337|combined oral contraceptives|combined oral contraceptives
5332839|NCT02027337|drospirenone|drospirenone
5332840|NCT02027337|cyproterone|cyproterone
5332841|NCT02027337|hemostasis|hemostasis
5332842|NCT02027337|antioxidants|antioxidants
5332843|NCT02027324|Surgical site infection|surgical site infection
5332844|NCT02027324|Cesarean delivery|cesarean delivery
5332845|NCT02027324|Antisepsis|antisepsis
5332846|NCT02027324|Povidone iodine|povidone iodine
5332847|NCT02027324|Chlorhexidine alcohol|chlorhexidine alcohol
5332848|NCT02027324|Endometritis|endometritis
5332849|NCT02027311|Endoscopic Retrograde Cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
5332850|NCT02027311|Conscious Sedation|conscious sedation
5332851|NCT02027311|etomidate|etomidate
5332852|NCT02027311|midazolam|midazolam
5332853|NCT02027298|Abatacept|abatacept
5332854|NCT02027298|Sjogren's Syndrome|sjogren's syndrome
5332855|NCT02027298|Rheumatoid Arthritis|rheumatoid arthritis
5332856|NCT02027285|fortified milk, aging, health status|fortified milk, aging, health status
5332857|NCT02027272|Eclampsia|eclampsia
5332858|NCT02027259|Diabetes|diabetes
5332859|NCT02027259|Depression|depression
5332860|NCT02027259|Group|group
5332861|NCT02027246|spinal cord injury|spinal cord injury
5332862|NCT02027246|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
5332863|NCT02027246|stem cell therapy|stem cell therapy
5332864|NCT02027233|Prevention|prevention
5332865|NCT02027233|Influenza|influenza
5332866|NCT02027233|Adults hospitalized|adults hospitalized
5332867|NCT02027233|Vaccines|vaccines
5332868|NCT02027233|Effectiveness|effectiveness
5332869|NCT02027207|Cholera|cholera
5227714|NCT02577120|Epiceram|epiceram
5332870|NCT02027207|Oral cholera vaccine|oral cholera vaccine
5332871|NCT02027207|Shanchol|shanchol
5332872|NCT02027207|Protective efficacy|protective efficacy
5332873|NCT02027207|Bangladesh|bangladesh
5332874|NCT02027194|Allergic Rhinitis|allergic rhinitis
5332875|NCT02027194|Chinese herbal medicine|chinese herbal medicine
5332876|NCT02027194|Adolescents|adolescents
5332877|NCT02027194|Double-blinded|double-blinded
5332878|NCT02027194|Randomized controlled trial|randomized controlled trial
5332879|NCT02027168|infertility|infertility
5332880|NCT02027168|elevated FSH|elevated fsh
5332881|NCT02027168|alternative treatment|alternative treatment
5332882|NCT02027168|Clear Passage Approach|clear passage approach
5332883|NCT02027168|Clear Passage Physical Therapy|clear passage physical therapy
5332884|NCT02027155|healthy volunteers|healthy volunteers
5329141|NCT02043873|Restorations Repair|restorations repair
5332885|NCT02027129|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5332886|NCT02027129|Cor Pulmonale|cor pulmonale
5332887|NCT02027129|High Frequency Ventilaiton|high frequency ventilaiton
5332888|NCT02027116|chronic hepatitis C|chronic hepatitis c
5332889|NCT02027116|DNA Vaccine|dna vaccine
5332890|NCT02027116|Electroporation|electroporation
5332891|NCT02027116|Intramuscular (IM) Injection|intramuscular (im) injection
5332892|NCT02027103|Fetuin-A|fetuin-a
5332893|NCT02027103|OPG|opg
5332894|NCT02027103|Metformin|metformin
5332895|NCT02027103|Pioglitazone|pioglitazone
5332896|NCT02027077|physical activity|physical activity
5332897|NCT02027077|diet|diet
5332898|NCT02027077|small change|small change
5332899|NCT02027077|behavior change|behavior change
5332900|NCT02027051|population genetics|population genetics
5332901|NCT02027025|Spasticity, Multiple sclerosis|spasticity, multiple sclerosis
5332902|NCT02026934|Graft-Versus-Host Disease(GVHD)|graft-versus-host disease(gvhd)
5332903|NCT02026934|Hematopoietic Stem Cell Transplantation.|hematopoietic stem cell transplantation.
5332904|NCT02026934|Graft failure|graft failure
5332905|NCT02026934|Graft exhaustion|graft exhaustion
5332906|NCT02026921|Phase II study,|phase ii study,
5332907|NCT02026921|Recurrent platinum-sensitive ovarian cancer|recurrent platinum-sensitive ovarian cancer
5332908|NCT02026921|docetaxel|docetaxel
5332909|NCT02026921|Carboplatin|carboplatin
5332910|NCT02026921|Toxicity|toxicity
5332911|NCT02026908|Prostate Artery Embolization|prostate artery embolization
5332913|NCT02026908|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5332914|NCT02026908|BPH|bph
5332915|NCT02026908|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5332916|NCT02026908|LUTS|luts
5332917|NCT02026882|Airway, Caesarean|airway, caesarean
5332918|NCT02026869|Vaginal administration, PCOS, Metformin|vaginal administration, pcos, metformin
5332919|NCT02026856|oxidative stress, sepsis, selenium|oxidative stress, sepsis, selenium
5332920|NCT02026830|Diabetic foot infections|diabetic foot infections
5332921|NCT02026830|microorganisms|microorganisms
5332922|NCT02026791|Supraglottic airway device|supraglottic airway device
5332923|NCT02026791|I-gel|i-gel
5332924|NCT02026791|SupremeLMA|supremelma
5332925|NCT02026791|Elderly patient|elderly patient
5332944|NCT02026596|subrachnoid hemorrhage|subrachnoid hemorrhage
5332945|NCT02026596|secondary brain injury|secondary brain injury
5332946|NCT02026570|Prosthesis|prosthesis
5332947|NCT02026570|Falls|falls
5332948|NCT02026570|Training|training
5332949|NCT02026544|low frequency ultrasound|low frequency ultrasound
5332950|NCT02026544|glomerular filtration rate|glomerular filtration rate
5963317|NCT04255433|Glucagon-Like Peptide 1|glucagon-like peptide 1
5332951|NCT02026492|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5332952|NCT02026492|exercise-induced asthma|exercise-induced asthma
5332953|NCT02026492|cold chamber|cold chamber
5332954|NCT02026492|exercise challenge|exercise challenge
5332955|NCT02026492|cold air challenge|cold air challenge
5332956|NCT02026492|combined exercise- and cold-air challenge|combined exercise- and cold-air challenge
5332957|NCT02026492|methacholine challenge|methacholine challenge
5332958|NCT02026479|full-frequency sudden hearing loss|full-frequency sudden hearing loss
5332959|NCT02026479|post auricular injection|post auricular injection
5332960|NCT02026479|glucocorticoid|glucocorticoid
5332961|NCT02026479|multi-center|multi-center
5332962|NCT02026466|Coronary Artery Disease|coronary artery disease
5332963|NCT02026466|Chronic Total Occlusion|chronic total occlusion
5332964|NCT02026453|Adverse drug events|adverse drug events
5332965|NCT02026440|oral fluid collection device cotinine detection|oral fluid collection device cotinine detection
5332966|NCT02026414|PrimaVie|primavie
5332967|NCT02026414|Herbal Supplement|herbal supplement
5332968|NCT02026414|Muscle biopsy|muscle biopsy
5332969|NCT02026414|Energy|energy
5332970|NCT02026414|Exercise|exercise
5332971|NCT02026414|Human skeletal muscle adaptation|human skeletal muscle adaptation
5332972|NCT02026414|Muscle function|muscle function
5332989|NCT02026362|HCC|hcc
5332990|NCT02026362|DC|dc
5332991|NCT02026362|CTL|ctl
5332992|NCT02026349|influenza|influenza
5332993|NCT02026349|flu|flu
5332994|NCT02026349|fever|fever
5332995|NCT02026349|cough|cough
5332996|NCT02026349|body aches|body aches
5332997|NCT02026349|headache|headache
5332998|NCT02026349|nasal congestion|nasal congestion
5332999|NCT02026349|body pains|body pains
5333000|NCT02026349|sore throat|sore throat
5333001|NCT02026349|fatigue|fatigue
5333002|NCT02026349|T-705|t-705
5333003|NCT02026349|favipiravir|favipiravir
5333004|NCT02026349|favor|favor
5333005|NCT02026349|flu symptoms|flu symptoms
5333006|NCT02026336|asthma; inflammation; electronic nose|asthma; inflammation; electronic nose
5333007|NCT02026310|glimepiride|glimepiride
5333008|NCT02026310|metformin|metformin
5333009|NCT02026310|basal insulin|basal insulin
5333010|NCT02026310|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5333011|NCT02026310|glucose fluctuation|glucose fluctuation
5333012|NCT02026310|hypoglycemia|hypoglycemia
5333018|NCT02026284|Caesarean section|caesarean section
5333019|NCT02026284|Anaesthesia|anaesthesia
5333020|NCT02026284|Questionnaires|questionnaires
5333021|NCT02026245|Arthritis|arthritis
5333022|NCT02026245|rheumatoid|rheumatoid
5333023|NCT02026245|joints|joints
5333026|NCT02026245|movement|movement
5333027|NCT02026245|electronic|electronic
5333028|NCT02026245|data|data
5333029|NCT02026245|glove|glove
5333030|NCT02026245|goniometry|goniometry
5333031|NCT02026245|outcome|outcome
5333032|NCT02026245|stiffness|stiffness
5333033|NCT02026232|Type 2 Diabetes|type 2 diabetes
5333034|NCT02026232|Overweight|overweight
5333035|NCT02026206|Primary Dysmenorrhea|primary dysmenorrhea
5333036|NCT02026206|Pain|pain
5333037|NCT02026167|Chronic Pain|chronic pain
5333038|NCT02026167|Mood|mood
5333039|NCT02026167|Physical Activity|physical activity
5333040|NCT02026154|hypertension, biomarkers, echocardiography, heart failure|hypertension, biomarkers, echocardiography, heart failure
5333041|NCT02026128|Uveitis|uveitis
5333042|NCT02026128|Inflammation|inflammation
5333043|NCT02026128|OCT|oct
5333044|NCT02026128|Grading|grading
5333045|NCT02026115|cancer|cancer
5333046|NCT02026115|hospice|hospice
5333047|NCT02026115|pain|pain
5333048|NCT02026102|decision aid|decision aid
5333049|NCT02026102|patient decision making|patient decision making
5333050|NCT02026102|heart failure|heart failure
5333051|NCT02026102|ejection fraction|ejection fraction
5333052|NCT02026102|primary prevention|primary prevention
5333053|NCT02026102|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5333054|NCT02026102|ICD|icd
5333055|NCT02026102|pilot trial|pilot trial
5333056|NCT02026102|patient centered health care|patient centered health care
5333057|NCT02026076|low back pain|low back pain
5333058|NCT02026076|traction|traction
5333059|NCT02026076|unloading|unloading
5333060|NCT02026050|dexamethasone|dexamethasone
5333061|NCT02026050|intraarticular injection|intraarticular injection
5333062|NCT02026050|interscalene brachial plexus block|interscalene brachial plexus block
5333063|NCT02026037|Stress Disorders|stress disorders
5333064|NCT02026037|Post-Traumatic|post-traumatic
5333065|NCT02026037|Burns|burns
5333066|NCT02026037|Brief Psychotherapy|brief psychotherapy
5333067|NCT02026037|Cognitive Behavior Therapy|cognitive behavior therapy
5333068|NCT02026011|alcohol use disorder|alcohol use disorder
5333069|NCT02026011|naltrexone|naltrexone
5333070|NCT02026011|Asian American|asian american
5333071|NCT02026011|pharmacogenetics|pharmacogenetics
5333072|NCT02026011|OPRM1 gene|oprm1 gene
5333073|NCT02025998|ibudilast, alcoholism|ibudilast, alcoholism
5333074|NCT02025985|Karyopharm|karyopharm
5333075|NCT02025985|KPT-330|kpt-330
5333076|NCT02025985|Selinexor|selinexor
5333077|NCT02025985|SIGN|sign
5333078|NCT02025985|ovarian cancer|ovarian cancer
5333079|NCT02025985|endometrial cancer|endometrial cancer
5333080|NCT02025985|cervical cancer|cervical cancer
5333081|NCT02025985|SINE™|sine™
5333082|NCT02025985|breast cancer|breast cancer
5333083|NCT02025985|HER2 negative|her2 negative
5333084|NCT02025972|Cerebral palsy|cerebral palsy
5333085|NCT02025972|Umbilical cord blood|umbilical cord blood
5333086|NCT02025972|Rehabilitation|rehabilitation
5333087|NCT02025972|Cytokine|cytokine
5333088|NCT02025972|Outcome|outcome
5333089|NCT02025959|staff empowerment|staff empowerment
5333090|NCT02025959|Sleep Apnea|sleep apnea
5333091|NCT02025959|educational intervention|educational intervention
5333092|NCT02025933|Children|children
5333093|NCT02025933|Age 9-12 years|age 9-12 years
5333094|NCT02025933|Overweight (iso-BMI > 25)|overweight (iso-bmi > 25)
5333095|NCT02025907|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5333096|NCT02025907|Canagliflozin|canagliflozin
5333097|NCT02025907|Hemoglobin A1c|hemoglobin a1c
5333098|NCT02025907|Metformin|metformin
5333099|NCT02025907|Sitagliptin|sitagliptin
5333100|NCT02025907|T2DM|t2dm
5333101|NCT02025907|JNJ-28431754|jnj-28431754
5333102|NCT02025894|neoplastic solid tumour|neoplastic solid tumour
5333103|NCT02025894|PCVC|pcvc
5333104|NCT02025894|thromboembolic complications|thromboembolic complications
5333105|NCT02025894|infectious complications|infectious complications
5333106|NCT02025894|risk factors|risk factors
5333107|NCT02025868|Africa|africa
5333108|NCT02025868|Antiretroviral Treatment|antiretroviral treatment
5333109|NCT02025868|Adherence reinforcement|adherence reinforcement
5333110|NCT02025868|Third line ART|third line art
5333111|NCT02025868|Second line ART|second line art
5333112|NCT02025868|Virologic failure|virologic failure
5333113|NCT02025868|Adults|adults
5333114|NCT02025855|Iatrogenic opioid abstinence syndrome|iatrogenic opioid abstinence syndrome
5333115|NCT02025855|Methadone|methadone
5333116|NCT02025855|Mechanical ventilation|mechanical ventilation
5333117|NCT02025855|ICU delirium|icu delirium
5333118|NCT02025855|Continuous sedation|continuous sedation
5333119|NCT02025842|Hepatocellular carcinoma|hepatocellular carcinoma
5333120|NCT02025842|Hepatitis B|hepatitis b
5333121|NCT02025829|cystic fibrosis|cystic fibrosis
5333122|NCT02025829|IL-17 neutrophils|il-17 neutrophils
5333123|NCT02025803|Advanced solid tumors|advanced solid tumors
5333124|NCT02025790|Achalasia|achalasia
5333125|NCT02025790|POEM|poem
5329342|NCT02043158|Questionnaire|questionnaire
5333126|NCT02025790|Pneumatic dilatation|pneumatic dilatation
5333127|NCT02025790|Eckardt score|eckardt score
5333128|NCT02025777|Ulcerative Colitis|ulcerative colitis
5333129|NCT02025777|PillCam|pillcam
5333131|NCT02025751|Diabetes|diabetes
5333132|NCT02025751|Gastroparesis|gastroparesis
5333133|NCT02025751|Delayed gastric emptying|delayed gastric emptying
5333134|NCT02025751|Nausea|nausea
5333135|NCT02025751|Vomiting|vomiting
5333136|NCT02025751|Bloating|bloating
5333137|NCT02025751|Abdominal pain|abdominal pain
5333138|NCT02025751|Early Satiety|early satiety
5333139|NCT02025751|Gastric stasis|gastric stasis
5333140|NCT02025751|Gastropathy|gastropathy
5333141|NCT02025725|Gastroparesis|gastroparesis
5333142|NCT02025725|Diabetic|diabetic
5333143|NCT02025725|Delayed gastric emptying|delayed gastric emptying
5333144|NCT02025725|Gastric stasis|gastric stasis
5333145|NCT02025725|Nausea|nausea
5333146|NCT02025725|Vomiting|vomiting
5333147|NCT02025725|Bloating|bloating
5333148|NCT02025725|Abdominal pain|abdominal pain
5333149|NCT02025725|Early satiety|early satiety
5333150|NCT02025725|Gastropathy|gastropathy
5333151|NCT02025686|Pain|pain
5333152|NCT02025686|Inflammation|inflammation
5333153|NCT02025686|Hyperalgesia|hyperalgesia
5333154|NCT02025686|burn injury|burn injury
5333155|NCT02025686|Hyperbaric Oxygen|hyperbaric oxygen
5333157|NCT02025660|Mycobacterium indicum prannii|mycobacterium indicum prannii
5333159|NCT02025660|Severe sepsis|severe sepsis
5333160|NCT02025660|Septic shock|septic shock
5333161|NCT02025647|Mood disorders|mood disorders
5333162|NCT02025647|Anxiety disorders|anxiety disorders
5333163|NCT02025647|Eating concerns|eating concerns
5333164|NCT02025647|Pain concerns|pain concerns
5333165|NCT02025647|Alcohol abuse|alcohol abuse
5333166|NCT02025647|Self harm|self harm
5333167|NCT02025647|Mental health|mental health
5333168|NCT02025647|Clinical Decision Support|clinical decision support
5333169|NCT02025634|Pain, Postoperative|pain, postoperative
5333170|NCT02025634|Ofirmev|ofirmev
5333171|NCT02025634|Acetaminophen|acetaminophen
5333172|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic
5333173|NCT02025634|Arthroscopy|arthroscopy
5333174|NCT02025621|coronary artery bypass grafting|coronary artery bypass grafting
5333175|NCT02025621|CABG|cabg
5333176|NCT02025621|mitral valve|mitral valve
5333177|NCT02025621|LCOS|lcos
5333178|NCT02025621|low cardiac output syndrome|low cardiac output syndrome
5333179|NCT02025621|levosimendan|levosimendan
5333180|NCT02025608|Restless legs syndrome|restless legs syndrome
5333181|NCT02025595|Brain|brain
5333182|NCT02025595|Genes|genes
5333183|NCT02025595|Environment|environment
5333184|NCT02025595|Etiology|etiology
5333185|NCT02025595|Reward|reward
5333186|NCT02025595|Satiety Response|satiety response
5333187|NCT02025595|Central Nervous System|central nervous system
5333188|NCT02025595|Magnetic Resonance Imaging|magnetic resonance imaging
5333189|NCT02025595|Twins, Monozygotic|twins, monozygotic
5333190|NCT02025595|Overweight|overweight
5333191|NCT02025595|Obesity|obesity
5333192|NCT02025582|idiopathic toe walking|idiopathic toe walking
5333193|NCT02025582|gait disorder|gait disorder
5333194|NCT02025582|gait analysis|gait analysis
5333195|NCT02025582|kinesio taping|kinesio taping
5333196|NCT02025582|ultrasound elastography|ultrasound elastography
5333197|NCT02025582|pediatric|pediatric
5333198|NCT02025582|children|children
5333199|NCT02025582|muscle stiffness|muscle stiffness
5333200|NCT02025582|muscle elasticity|muscle elasticity
5333201|NCT02025569|chronic ankle instability|chronic ankle instability
5333202|NCT02025569|lateral ankle sprain|lateral ankle sprain
5333203|NCT02025569|manual therapy|manual therapy
5333204|NCT02025569|star excursion balance test|star excursion balance test
5333205|NCT02025569|strain and counterstrain|strain and counterstrain
5333206|NCT02025556|High Frequency Episodic Migraine Headache|high frequency episodic migraine headache
5333207|NCT02025556|Episodic Migraine Headache|episodic migraine headache
5333208|NCT02025556|Migraine Headache|migraine headache
5333210|NCT02025543|Iron overload|iron overload
5333211|NCT02025530|Stillbirth|stillbirth
5333212|NCT02025530|Modifiable risk factors|modifiable risk factors
5333213|NCT02025517|Parkinson's disease|parkinson's disease
5333214|NCT02025517|rehabilitation|rehabilitation
5333215|NCT02025517|kinematics|kinematics
5333216|NCT02025517|cognition|cognition
5333217|NCT02025504|Colonoscopy, Looping, Sigmoid Looping, ColoWrap, Binder, Patient Satisfaction|colonoscopy, looping, sigmoid looping, colowrap, binder, patient satisfaction
5333218|NCT02025491|Disseminated leishmaniasis|disseminated leishmaniasis
5333219|NCT02025491|Liposomal Amphotericin B|liposomal amphotericin b
5333220|NCT02025491|Leishmania braziliensis|leishmania braziliensis
5333221|NCT02025478|children|children
5333222|NCT02025478|bone marrow transplant|bone marrow transplant
5333223|NCT02025478|autologous|autologous
5333224|NCT02025478|allogeneic|allogeneic
5333225|NCT02025478|breastmilk|breastmilk
5333226|NCT02025478|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5333227|NCT02025465|Atrial Fibrillation|atrial fibrillation
5333228|NCT02025465|Atrial Flutter|atrial flutter
5333229|NCT02025465|Metoprolol|metoprolol
5333230|NCT02025465|Diltiazem|diltiazem
5333237|NCT02025439|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5333239|NCT02025439|Vegetative State|vegetative state
5333240|NCT02025439|Minimally Conscious State|minimally conscious state
5333241|NCT02025426|Cesarean delivery|cesarean delivery
5333242|NCT02025426|Spinal Anesthesia|spinal anesthesia
5333243|NCT02025400|Rehabilitation|rehabilitation
5333245|NCT02025400|Physical Therapy|physical therapy
5333246|NCT02025400|e-Health|e-health
5333247|NCT02025400|Telemedicine|telemedicine
5333248|NCT02025400|Telerehabilitation|telerehabilitation
5333249|NCT02025400|Patient-Centered|patient-centered
5333250|NCT02025374|spinal anesthesia|spinal anesthesia
5333251|NCT02025374|cesarean section|cesarean section
5333252|NCT02025374|hyperbaric levobupivacaine|hyperbaric levobupivacaine
5333253|NCT02025361|prostate biopsy, local anesthesia, cancer detection rate.|prostate biopsy, local anesthesia, cancer detection rate.
5333254|NCT02025322|HIV/AIDS|hiv/aids
5333255|NCT02025322|Peer Mentoring|peer mentoring
5333256|NCT02025322|Medication Adherence|medication adherence
5333257|NCT02025322|Medication Non-adherent|medication non-adherent
5333258|NCT02025322|Newly diagnosed|newly diagnosed
5333259|NCT02025322|HIV-positive individuals|hiv-positive individuals
5333260|NCT02025322|HIV viral load|hiv viral load
5333261|NCT02025322|CD4 lymphocyte cell counts|cd4 lymphocyte cell counts
5333262|NCT02025322|Treatment adherence|treatment adherence
5333263|NCT02025322|Health literacy|health literacy
5333264|NCT02025322|Self-efficacy|self-efficacy
5333265|NCT02025309|train of four|train of four
5333266|NCT02025309|neuromuscular recovery|neuromuscular recovery
5333267|NCT02025309|sugammadex|sugammadex
5333268|NCT02025296|Telemedicine|telemedicine
5333269|NCT02025296|Clinical decision support system|clinical decision support system
5333270|NCT02025296|Ubiquitous healthcare|ubiquitous healthcare
5333271|NCT02025296|Diabetes Care|diabetes care
5333272|NCT02025296|Multifactorial Intervention|multifactorial intervention
5333273|NCT02025283|Intervertebral disc disease|intervertebral disc disease
5333274|NCT02025283|Radiculopathy|radiculopathy
5333275|NCT02025283|Chronic pain|chronic pain
5333276|NCT02025283|Thermocoagulation|thermocoagulation
5333277|NCT02025270|Azoospermia, Spermatogonial Arrest, Maturation Arrest.|azoospermia, spermatogonial arrest, maturation arrest.
5333278|NCT02025257|coronary artery disease|coronary artery disease
5333279|NCT02025257|elderly|elderly
5333280|NCT02025257|exercise|exercise
5333281|NCT02025257|exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
5333282|NCT02025244|Key hole biopsy|key hole biopsy
5333283|NCT02025244|Upper Gastrointestinal Submucosal Tumors|upper gastrointestinal submucosal tumors
5333284|NCT02025244|EUS-FNA|eus-fna
5333285|NCT02025244|Mitototic Activity|mitototic activity
5333286|NCT02025244|GIST|gist
5333287|NCT02025231|reirradiation|reirradiation
5333288|NCT02025231|recurrent glioma|recurrent glioma
5333289|NCT02025231|positron emission tomography|positron emission tomography
5333290|NCT02025231|amino acid tracer|amino acid tracer
5333291|NCT02025218|NSCLC|nsclc
5333292|NCT02025218|EGFR|egfr
5333293|NCT02025218|TKI|tki
5333294|NCT02025218|Re-challenge|re-challenge
5333295|NCT02025218|Lung Cancer|lung cancer
5333296|NCT02025218|Resistance|resistance
5333297|NCT02025192|ONT-380|ont-380
5333298|NCT02025192|Capecitabine|capecitabine
5333299|NCT02025192|Trastuzumab|trastuzumab
5333300|NCT02025192|Xeloda|xeloda
5333301|NCT02025192|Herceptin|herceptin
5333302|NCT02025192|HER2 positive breast cancer|her2 positive breast cancer
5333303|NCT02025192|Breast cancer|breast cancer
5333304|NCT02025192|ARRY-380|arry-380
5333305|NCT02025192|Tucatinib|tucatinib
5333306|NCT02025179|Teriparatide|teriparatide
5333307|NCT02025179|Osteoporosis|osteoporosis
5333308|NCT02025179|Spinal Cord Injury|spinal cord injury
5333309|NCT02025179|Bone Diseases|bone diseases
5333310|NCT02025179|Metabolic Bone Diseases|metabolic bone diseases
5333311|NCT02025179|Musculoskeletal Diseases|musculoskeletal diseases
5333312|NCT02025179|Spinal Cord Diseases|spinal cord diseases
5333313|NCT02025179|Central Nervous System Diseases|central nervous system diseases
5333314|NCT02025179|Nervous System Diseases|nervous system diseases
5333315|NCT02025179|Nervous System|nervous system
5333316|NCT02025179|Wounds and Injuries|wounds and injuries
5333317|NCT02025179|Bone Density Conservation Agents|bone density conservation agents
5333318|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs
5333319|NCT02025179|Pharmacologic Actions|pharmacologic actions
5333320|NCT02025179|Vibration|vibration
5333321|NCT02025166|Pain|pain
5333322|NCT02025166|abortion|abortion
5333323|NCT02025166|paracetamol|paracetamol
5333324|NCT02025166|lornoxicam|lornoxicam
5333325|NCT02025140|Computer controlled anesthesia (CCLAD)|computer controlled anesthesia (cclad)
5333326|NCT02025140|pain perception|pain perception
5333327|NCT02025140|Effectiveness|effectiveness
5333328|NCT02025140|primary molars|primary molars
5333329|NCT02025140|Behavior|behavior
5333330|NCT02025127|septic shock|septic shock
5333331|NCT02025127|mechanical ventilation|mechanical ventilation
5333332|NCT02025127|enteral nutrition|enteral nutrition
5333333|NCT02025127|trophic feeding|trophic feeding
5333334|NCT02025114|NSCLC, EGFR mutation|nsclc, egfr mutation
5333335|NCT02025101|Slow Coronary Flow|slow coronary flow
5333336|NCT02025075|Tomography|tomography
5333337|NCT02025075|Oximetry|oximetry
5333338|NCT02025075|Echocardiography|echocardiography
5333339|NCT02025062|head and neck squamous cell carcinomas (HNSCCs)|head and neck squamous cell carcinomas (hnsccs)
5333340|NCT02025062|elderly|elderly
5333341|NCT02025062|cancer|cancer
5333342|NCT02025062|comprehensive geriatric assessment|comprehensive geriatric assessment
5333343|NCT02025062|functional status|functional status
5333344|NCT02025062|malnutrition|malnutrition
5333345|NCT02025062|survival|survival
5333346|NCT02025049|pancreatitis|pancreatitis
5333347|NCT02025036|Chemoradiotherapy， Esophageal Squamous Cancer|chemoradiotherapy， esophageal squamous cancer
5333348|NCT02025023|Size|size
5333349|NCT02025023|Pain|pain
5333350|NCT02025023|Resolution|resolution
5333351|NCT02025023|Complications|complications
5333352|NCT02025023|Swelling|swelling
5333353|NCT02025010|castration-resistant prostate cancer|castration-resistant prostate cancer
5333354|NCT02024997|Pancreatic malignancy|pancreatic malignancy
5333355|NCT02024997|Radiation Therapy|radiation therapy
5333356|NCT02024984|LPFPCCPCOS|lpfpccpcos
5333357|NCT02024971|Drug therapy|drug therapy
5333358|NCT02024958|Adult ICU patients|adult icu patients
5333359|NCT02024958|spontaneous breathing|spontaneous breathing
5333360|NCT02024958|invasive ventilation|invasive ventilation
5333361|NCT02024958|non-invasive ventilation|non-invasive ventilation
5333362|NCT02024945|Drug therapy|drug therapy
5333363|NCT02024906|isoflavone|isoflavone
5333364|NCT02024906|CVD|cvd
5333365|NCT02024906|soy intake|soy intake
5333366|NCT02024906|subclinical hypothyroid|subclinical hypothyroid
5333367|NCT02024893|Humeral retroversion|humeral retroversion
5333368|NCT02024893|dynamic control ratio|dynamic control ratio
5333369|NCT02024893|GIRD|gird
5333370|NCT02024880|in vitro fertilization|in vitro fertilization
5333371|NCT02024880|embryo transfer|embryo transfer
5333372|NCT02024880|transfer catheter|transfer catheter
5333373|NCT02024867|Methicillin resistent Staphylococcus aureus|methicillin resistent staphylococcus aureus
5333374|NCT02024867|Staphylococcus aureus|staphylococcus aureus
5333375|NCT02024854|Kangaroo-Mother Care Method|kangaroo-mother care method
5333376|NCT02024854|Stress, Physiological|stress, physiological
5333377|NCT02024841|Gastric cancer|gastric cancer
5333378|NCT02024841|Peritoneal carcinomatosis|peritoneal carcinomatosis
5333379|NCT02024841|Intraperitoneal docetaxel|intraperitoneal docetaxel
5333380|NCT02024841|Cisplatin|cisplatin
5333381|NCT02024841|TS-ONE|ts-one
5333382|NCT02024828|Infant feeding|infant feeding
5333383|NCT02024802|Pain|pain
5333384|NCT02024802|Pain Cream|pain cream
5333385|NCT02024802|Nociceptive pain|nociceptive pain
5333386|NCT02024802|neurologic pain|neurologic pain
5333387|NCT02024802|transdermal|transdermal
5333388|NCT02024802|compounding|compounding
5333389|NCT02024802|compound|compound
5333390|NCT02024776|Training|training
5333391|NCT02024776|Wellness|wellness
5333392|NCT02024776|Aerobic capacity|aerobic capacity
5333393|NCT02024776|Information and communication technology, surgical risk|information and communication technology, surgical risk
5333394|NCT02024776|Abdominal surgery|abdominal surgery
5333395|NCT02024763|Energy Expenditure|energy expenditure
5333396|NCT02024763|Physical Education|physical education
5333397|NCT02024763|Children|children
5333398|NCT02024763|Randomized Controlled Trial|randomized controlled trial
5333399|NCT02024750|Family centered care|family centered care
5333400|NCT02024750|Patient centered care|patient centered care
5333401|NCT02024750|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5333402|NCT02024750|Problem Recognition in Illness Self-Management (PRISM)|problem recognition in illness self-management (prism)
5333403|NCT02024711|Cataract|cataract
5333404|NCT02024711|Intraocular Lens|intraocular lens
5333406|NCT02024711|Aphakia|aphakia
5333407|NCT02024685|Prostate|prostate
5333408|NCT02024685|Localized Prostate Cancer|localized prostate cancer
5333409|NCT02024685|Decision making|decision making
5333410|NCT02024672|Intrauterine devices|intrauterine devices
5333411|NCT02024672|IUDs|iuds
5333412|NCT02024672|postpartum|postpartum
5333413|NCT02024672|contraception|contraception
5333414|NCT02024659|nasal polyps|nasal polyps
5333415|NCT02024659|remodeling|remodeling
5333416|NCT02024659|inflammatory cells|inflammatory cells
5333417|NCT02024659|budesonide|budesonide
5333418|NCT02024646|Psoriatic Arthritis|psoriatic arthritis
5333419|NCT02024646|Brodalumab|brodalumab
5333421|NCT02024620|depression|depression
5333422|NCT02024620|technology|technology
5333423|NCT02024620|psychotherapy|psychotherapy
5333424|NCT02024620|behavioral activation|behavioral activation
5333425|NCT02024594|Nitrous Oxide-Oxygen conscious sedation|nitrous oxide-oxygen conscious sedation
5333426|NCT02024594|Cognitive Behavioral Therapy|cognitive behavioral therapy
5333427|NCT02024594|Children, Preschool|children, preschool
5333428|NCT02024594|dental anxiety|dental anxiety
5333429|NCT02024594|Patient Cooperation|patient cooperation
5333430|NCT02024581|pediatric|pediatric
5333431|NCT02024581|dermatology|dermatology
5333447|NCT02024503|stroke|stroke
5333448|NCT02024503|fMRI|fmri
5333449|NCT02024503|DTI|dti
5333450|NCT02024490|vitamin D, prematurity, RDS, BPD, maternal, neonatal|vitamin d, prematurity, rds, bpd, maternal, neonatal
5333451|NCT02024477|endothelial cells|endothelial cells
5333452|NCT02024477|cellular biomarker|cellular biomarker
5333453|NCT02024477|endothelial dysfunction|endothelial dysfunction
5333454|NCT02024464|Primary open angle glaucoma|primary open angle glaucoma
5333455|NCT02024464|POAG|poag
5333456|NCT02024464|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5333457|NCT02024464|PXG|pxg
5333458|NCT02024464|Pigmentary dispersion glaucoma|pigmentary dispersion glaucoma
5333459|NCT02024464|PDG|pdg
5333460|NCT02024464|Hydrus|hydrus
5333461|NCT02024451|Radial shock wave|radial shock wave
5333462|NCT02024451|Acupuncture|acupuncture
5333463|NCT02024438|metastatic gastric cancer|metastatic gastric cancer
5333464|NCT02024438|neurotoxicity|neurotoxicity
5333465|NCT02024438|mFOLFOX6|mfolfox6
5333466|NCT02024438|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
5333467|NCT02024425|Clinical trials|clinical trials
5333468|NCT02024425|Adult|adult
5333469|NCT02024425|Women|women
5333470|NCT02024425|Functional food|functional food
5333471|NCT02024425|Dietary Supplements|dietary supplements
5333472|NCT02024425|Overweight|overweight
5333473|NCT02024425|Obese|obese
5333474|NCT02024425|Absorptiometry, Dual X-Ray|absorptiometry, dual x-ray
5333475|NCT02024425|Rosmarinus|rosmarinus
5333476|NCT02024425|Oligosaccharides|oligosaccharides
5333477|NCT02024425|Lactulose|lactulose
5333478|NCT02024425|Bioactive peptide|bioactive peptide
5333479|NCT02024412|metastatic colorectal cancer|metastatic colorectal cancer
5333480|NCT02024412|neurotoxicity|neurotoxicity
5333481|NCT02024412|mFOLFOX6|mfolfox6
5333482|NCT02024412|monosialotetrahexosylganglioside Sodium Injection|monosialotetrahexosylganglioside sodium injection
5333483|NCT02024399|Pediatric Overweight/Obesity, DEXA, Fitness|pediatric overweight/obesity, dexa, fitness
5333484|NCT02024386|Guanylate Cyclase|guanylate cyclase
5333485|NCT02024386|Pulmonary Edema of Mountaineers|pulmonary edema of mountaineers
5333486|NCT02024386|Mountaineering|mountaineering
5333487|NCT02024386|Performance-Enhancing Substances|performance-enhancing substances
5333488|NCT02024386|Athletic Performance|athletic performance
5333489|NCT02024373|chronic subdural hematoma|chronic subdural hematoma
5333490|NCT02024373|Atorvastatin|atorvastatin
5333491|NCT02024373|oral administration therapy|oral administration therapy
5333496|NCT02024334|JIA|jia
5333497|NCT02024334|LEFLUNOMIDE|leflunomide
5333498|NCT02024334|EFFICACY|efficacy
5333499|NCT02024321|abdominal surgery|abdominal surgery
5333500|NCT02024321|TPN|tpn
5333501|NCT02024321|blood glucose|blood glucose
5333502|NCT02024308|acute myeloid leukemia,|acute myeloid leukemia,
5333503|NCT02024308|AML1-ETO fusion protein,|aml1-eto fusion protein,
5333504|NCT02024308|Fludarabine,|fludarabine,
5333505|NCT02024308|recurrence|recurrence
5333506|NCT02024269|macular degeneration|macular degeneration
5333508|NCT02024269|adipose stem cells|adipose stem cells
5333509|NCT02024256|Vaginal delivery|vaginal delivery
5333510|NCT02024256|Perineal swelling|perineal swelling
5333511|NCT02024256|Perineal pain|perineal pain
5333512|NCT02024256|MgSo4|mgso4
5333513|NCT02024256|Magnesium sulfate|magnesium sulfate
5333514|NCT02024256|Cold water|cold water
5333515|NCT02024243|Micro RNA|micro rna
5333516|NCT02024243|Wound|wound
5333517|NCT02024243|Chronic Venous Leg Ulcer|chronic venous leg ulcer
5333518|NCT02024243|VLU|vlu
5333519|NCT02024243|miR210|mir210
5333520|NCT02024243|Indiana University Health Comprehensive Wound Center (CWC)|indiana university health comprehensive wound center (cwc)
5333534|NCT02024191|oxaliplatin|oxaliplatin
5333535|NCT02024191|peripheral neuropathy|peripheral neuropathy
5333536|NCT02024178|Prostate Cancer|prostate cancer
5333537|NCT02024178|Radical Prostatectomy|radical prostatectomy
5333538|NCT02024178|Ultrasound Imaging|ultrasound imaging
5333539|NCT02024165|Ultrasound|ultrasound
5333541|NCT02024165|IUPC|iupc
5333542|NCT02024139|Orthodontic pain|orthodontic pain
5333543|NCT02024139|Chewing gum|chewing gum
5333544|NCT02024126|Knee osteoarthritis|knee osteoarthritis
5333545|NCT02024126|Exercise therapy|exercise therapy
5333546|NCT02024126|RCT|rct
5333547|NCT02024126|Intervention|intervention
5333548|NCT02024126|Knee pain|knee pain
5333549|NCT02024126|Muticenter|muticenter
5333550|NCT02024126|Knee function|knee function
5333551|NCT02024113|validation|validation
5333552|NCT02024113|model|model
5333553|NCT02024113|metabolic profile|metabolic profile
5333558|NCT02024061|Sedentary behavior|sedentary behavior
5333559|NCT02024061|Psychosocial health|psychosocial health
5333561|NCT02024048|OCT|oct
5333562|NCT02024048|Enhanced depth imaging|enhanced depth imaging
5333563|NCT02024048|Choroid|choroid
5333564|NCT02024035|Tomotherapy|tomotherapy
5333565|NCT02024035|Head and neck squamous celle carcinoma|head and neck squamous celle carcinoma
5333566|NCT02024035|Health economic evaluation|health economic evaluation
5333567|NCT02024022|colonoscopy|colonoscopy
5333568|NCT02024022|bowel cleansing|bowel cleansing
5333569|NCT02024022|polyethylene glycol|polyethylene glycol
5333570|NCT02024022|sodium picosulphate / magnesium citrate|sodium picosulphate / magnesium citrate
5333571|NCT02024009|chemoradiotherapy|chemoradiotherapy
5333572|NCT02024009|nelfinavir|nelfinavir
5333573|NCT02024009|abraxane|abraxane
5333574|NCT02024009|gemcitabine|gemcitabine
5333575|NCT02024009|radiotherapy|radiotherapy
5333576|NCT02024009|capecitabine|capecitabine
5333577|NCT02023996|HER2 positive|her2 positive
5333578|NCT02023996|PET Imaging|pet imaging
5333579|NCT02023996|89Zr-DFO-trastuzumab|89zr-dfo-trastuzumab
5333580|NCT02023996|13-165|13-165
5333581|NCT02023983|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5333582|NCT02023983|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5333583|NCT02023983|Low risk|low risk
5333584|NCT02023983|Early discharge|early discharge
5423291|NCT01616290|peripheral artery disease|peripheral artery disease
5423292|NCT01616290|PAD|pad
5333585|NCT02023970|Bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.|bioprosthetic heart valves, immune response, structural valve deterioration, valvular disease.
5333586|NCT02023957|Interactive Health-risk assessment|interactive health-risk assessment
5333587|NCT02023957|Primary Care|primary care
5333588|NCT02023957|Randomized|randomized
5333589|NCT02023957|Open Label|open label
5333590|NCT02023957|Efficacy Study|efficacy study
5333591|NCT02023944|Memory|memory
5333592|NCT02023944|Aging|aging
5333593|NCT02023944|Healthy People|healthy people
5333594|NCT02023944|Intervention|intervention
5333595|NCT02023931|Oral mucosa|oral mucosa
5333596|NCT02023931|Nrf2 pathway|nrf2 pathway
5333597|NCT02023931|Broccoli Sprout Extract|broccoli sprout extract
5333598|NCT02023931|Head and Neck Cancer|head and neck cancer
5333599|NCT02023918|Growth hormone antagonism|growth hormone antagonism
5333600|NCT02023866|Leigh Syndrome|leigh syndrome
5333601|NCT02023866|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
5333602|NCT02023866|myoclonic epilepsy|myoclonic epilepsy
5333603|NCT02023866|mitochondrial encephalomyopathy|mitochondrial encephalomyopathy
5333604|NCT02023866|Kearn-Sayre syndrome|kearn-sayre syndrome
5333605|NCT02023866|POLG-related disorders|polg-related disorders
5333606|NCT02023866|Neurogastrointestinal encephalopathy|neurogastrointestinal encephalopathy
5333607|NCT02023840|periodontitis|periodontitis
5333608|NCT02023840|pockets|pockets
5333609|NCT02023827|Transtheoretical Model|transtheoretical model
5333610|NCT02023827|Stages of change|stages of change
5333611|NCT02023827|Computer-tailored intervention|computer-tailored intervention
5333612|NCT02023827|Delinquency|delinquency
5333613|NCT02023827|Substance abuse|substance abuse
5333614|NCT02023827|Juvenile offender|juvenile offender
5333615|NCT02023827|Juvenile justice|juvenile justice
5333616|NCT02023827|Rise Above Your Situation (RAYS) program|rise above your situation (rays) program
5333617|NCT02023801|Menorrhagia|menorrhagia
5333618|NCT02023801|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
5333619|NCT02023801|Endometrial Ablation|endometrial ablation
5333620|NCT02023788|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
5333621|NCT02023788|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5333622|NCT02023788|respiratory tract infection|respiratory tract infection
5333623|NCT02023788|Premature infants|premature infants
5333624|NCT02023762|mitral regurgitation|mitral regurgitation
5333625|NCT02023762|local anaesthesia|local anaesthesia
5333626|NCT02023762|percutaneous repair|percutaneous repair
5333627|NCT02023749|nuts|nuts
5333628|NCT02023749|metabolic syndrome|metabolic syndrome
5333629|NCT02023749|lipid profile|lipid profile
5333630|NCT02023749|inflammation|inflammation
5333631|NCT02023749|oxidative stress|oxidative stress
5333632|NCT02023749|endothelial function|endothelial function
5333633|NCT02023723|Energy Drink|energy drink
5333634|NCT02023723|Electrocardiograph|electrocardiograph
5333635|NCT02023723|Hemodynamic|hemodynamic
5333636|NCT02023710|mucosal melanoma|mucosal melanoma
5333637|NCT02023710|Bevacizumab|bevacizumab
5333638|NCT02023710|Carboplatin|carboplatin
5333639|NCT02023710|Paclitaxel|paclitaxel
5333640|NCT02023684|Sleeve Gastrectomy|sleeve gastrectomy
5333641|NCT02023684|Lidocaine|lidocaine
5333650|NCT02023632|physical activity|physical activity
5333651|NCT02023632|self-categorization|self-categorization
5333652|NCT02023632|group dynamics|group dynamics
5333653|NCT02023632|self-identity|self-identity
5333654|NCT02023619|Keratoconus|keratoconus
5333655|NCT02023619|Astigmatism|astigmatism
5333656|NCT02023619|Cornea|cornea
5333657|NCT02023619|SD-OCT|sd-oct
5678412|NCT00586898|Cancer|cancer
5333658|NCT02023606|Impulsive Aggression|impulsive aggression
5333659|NCT02023606|ADHD|adhd
5333660|NCT02023580|Viral suppression|viral suppression
5333661|NCT02023580|Sexual risk|sexual risk
5333662|NCT02023554|azithromycin|azithromycin
5333663|NCT02023554|theophylline|theophylline
5333664|NCT02023554|CYP3A4|cyp3a4
5333665|NCT02023515|weight loss|weight loss
5333666|NCT02023515|metabolic syndrome|metabolic syndrome
5333667|NCT02023515|stress|stress
5333668|NCT02023515|obesity|obesity
5333669|NCT02023502|female stress urinary incontinence|female stress urinary incontinence
5333670|NCT02023502|proteomics|proteomics
5333671|NCT02023502|biomarker|biomarker
5333672|NCT02023424|BDNF|bdnf
5333673|NCT02023424|GLATIRAMER ACETATE|glatiramer acetate
5333674|NCT02023424|RETT SYNDROME|rett syndrome
5333675|NCT02023424|COPAXONE|copaxone
5333676|NCT02023424|Bruria Ben-Zeev|bruria ben-zeev
5333677|NCT02023411|Teriparatide|teriparatide
5333678|NCT02023411|Inactive Charcot's neuroarthropathy|inactive charcot's neuroarthropathy
5333679|NCT02023398|High Frequency|high frequency
5333680|NCT02023398|Waist circumferential reduction|waist circumferential reduction
5333681|NCT02023385|Low Level Laser Therapy|low level laser therapy
5333682|NCT02023385|LLLT|lllt
5333683|NCT02023385|Waist circumferential reduction|waist circumferential reduction
5333685|NCT02023372|Lumbar Spine|lumbar spine
5333686|NCT02023372|Degenerative Disease|degenerative disease
5333687|NCT02023372|Efficacy|efficacy
5333688|NCT02023372|Fusion|fusion
5333689|NCT02023359|Advanced breast cancer|advanced breast cancer
5333690|NCT02023359|Everolimus|everolimus
5333691|NCT02023346|Patient-Physician Communication|patient-physician communication
5333692|NCT02023346|Brain cancer|brain cancer
5333693|NCT02023346|13-253|13-253
5333694|NCT02023333|Regorafenib|regorafenib
5333695|NCT02023333|Performance Status|performance status
5333696|NCT02023333|13-211|13-211
5333697|NCT02023281|Depression|depression
5333698|NCT02023281|Exercise|exercise
5333699|NCT02023281|Neurotransmitters|neurotransmitters
5333700|NCT02023281|Catecholimines|catecholimines
5333701|NCT02023281|EEG|eeg
5333702|NCT02023255|Healthy|healthy
5333703|NCT02023255|JNJ-39393406|jnj-39393406
5333704|NCT02023255|Safety|safety
5333705|NCT02023255|Tolerability|tolerability
5333706|NCT02023255|Pharmacokinetics|pharmacokinetics
5333707|NCT02023242|Primary open angle glaucoma|primary open angle glaucoma
5333708|NCT02023242|POAG|poag
5333709|NCT02023242|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5333711|NCT02023242|Pigmentary glaucoma|pigmentary glaucoma
5333712|NCT02023242|PG|pg
5333713|NCT02023242|Hydrus|hydrus
5333714|NCT02023229|Branched chain aminoacids|branched chain aminoacids
5333715|NCT02023229|Nutritional status|nutritional status
5333716|NCT02023229|Hepatic encephalopathy|hepatic encephalopathy
5333717|NCT02023216|Preterm infants|preterm infants
5333718|NCT02023216|Non-nutritive sucking|non-nutritive sucking
5333719|NCT02023216|Pacifier|pacifier
5333720|NCT02023216|Gastro-esophageal reflux|gastro-esophageal reflux
5333721|NCT02023216|pH-multiple intraluminal impedance|ph-multiple intraluminal impedance
5333722|NCT02023216|Apneas|apneas
5333723|NCT02023216|Bradycardias|bradycardias
5333724|NCT02023216|Hypoxic episodes|hypoxic episodes
5333725|NCT02023216|Polysomnographic monitoring|polysomnographic monitoring
5333726|NCT02023190|liver cirrhosis|liver cirrhosis
5333727|NCT02023190|liver transplant|liver transplant
5333728|NCT02023190|nutritional status|nutritional status
5333729|NCT02023190|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
5333730|NCT02023177|phase angle|phase angle
5333731|NCT02023177|liver cirrhosis|liver cirrhosis
5333732|NCT02023177|mortality|mortality
5333733|NCT02023177|malnutrition|malnutrition
5333734|NCT02023138|Clinical practice guideline|clinical practice guideline
5333735|NCT02023138|Brain injury|brain injury
5333736|NCT02023138|Acceptability|acceptability
5333739|NCT02023112|Japanese|japanese
5333740|NCT02023112|Hepatitis C|hepatitis c
5333741|NCT02023112|Treatment naive|treatment naive
5333742|NCT02023112|Treatment experienced|treatment experienced
5333743|NCT02023112|Genotype 2|genotype 2
5333756|NCT02023099|paritaprevir|paritaprevir
5333757|NCT02023099|ritonavir|ritonavir
5333758|NCT02023099|VIEKIRAX Combination Tablets|viekirax combination tablets
5333759|NCT02023086|Visual field defect|visual field defect
5333760|NCT02023086|Blood oxygenation|blood oxygenation
5333761|NCT02023086|Optic nerve Head|optic nerve head
5333762|NCT02023047|Anal Fissure|anal fissure
5333763|NCT02023047|Nifedipine|nifedipine
5333764|NCT02023034|Parkinson disease, Physical Therapy, Fatigue, Quality of Life|parkinson disease, physical therapy, fatigue, quality of life
5333765|NCT02023021|Pancreatic Cancer; Pancreatic Adenocarcinoma; Nab-paclitaxel; Gemcitabine; Adjuvant Therapy|pancreatic cancer; pancreatic adenocarcinoma; nab-paclitaxel; gemcitabine; adjuvant therapy
5333767|NCT02022995|cetuximab|cetuximab
5333768|NCT02022995|colon cancer|colon cancer
5333769|NCT02022982|KRAS mutant Non-Small Cell Lung Cancer|kras mutant non-small cell lung cancer
5333770|NCT02022982|Solid Tumors|solid tumors
5333773|NCT02022943|Alzheimer's|alzheimer's
5333774|NCT02022943|prevention|prevention
5333775|NCT02022930|Osteoarthritis|osteoarthritis
5333776|NCT02022930|Knee|knee
5333777|NCT02022917|ovarian cancer.|ovarian cancer.
5333778|NCT02022917|tubal cancer|tubal cancer
5333779|NCT02022917|peritoneal cancer|peritoneal cancer
5333780|NCT02022904|prostate cancer|prostate cancer
5333781|NCT02022904|metastatic|metastatic
5333782|NCT02022904|castrate resistant|castrate resistant
5333783|NCT02022891|Sickle cell disease|sickle cell disease
5333784|NCT02022891|psychological support|psychological support
5333785|NCT02022891|quality of life|quality of life
5333786|NCT02022878|Chronic total occlusion|chronic total occlusion
5423293|NCT01616290|claudication|claudication
5333787|NCT02022878|Percutaneous coronary intervention|percutaneous coronary intervention
5333788|NCT02022878|Coronary computed tomography angiography|coronary computed tomography angiography
5333789|NCT02022878|Coronary angiography|coronary angiography
5333790|NCT02022865|periodontitis|periodontitis
5333791|NCT02022865|cytokines|cytokines
5333792|NCT02022865|adverse pregnancy outcome|adverse pregnancy outcome
5333793|NCT02022852|Rectal Cancer|rectal cancer
5333794|NCT02022852|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5333795|NCT02022852|Sequential Therapy|sequential therapy
5333796|NCT02022839|mechanical ventilation, weaning|mechanical ventilation, weaning
5333797|NCT02022839|ultrasonography|ultrasonography
5333798|NCT02022826|Gastroparesis|gastroparesis
5333799|NCT02022826|SmartPill Monitoring System (SPM)|smartpill monitoring system (spm)
5333800|NCT02022826|Gastric Emptying Scintigraphy (GES)|gastric emptying scintigraphy (ges)
5333801|NCT02022813|Energy requirements, Glucose turnover, Protein turnover|energy requirements, glucose turnover, protein turnover
5333803|NCT02022787|Chemokines|chemokines
5333804|NCT02022787|nephrectomy|nephrectomy
5333805|NCT02022787|partial nephrectomy|partial nephrectomy
5333806|NCT02022761|Mild or moderate asthmatics|mild or moderate asthmatics
5333807|NCT02022761|Adults|adults
5333808|NCT02022761|Laninamivir|laninamivir
5333809|NCT02022735|Deep Brain Stimulation|deep brain stimulation
5333810|NCT02022722|Pelvic Floor Myalgia|pelvic floor myalgia
5333811|NCT02022722|Trigger Point Injections|trigger point injections
5333812|NCT02022722|Pelvic Rehabilitation|pelvic rehabilitation
5333813|NCT02022722|Dyspareunia|dyspareunia
5333814|NCT02022709|Cognitive Behavior Therapy|cognitive behavior therapy
5333815|NCT02022709|Exposure and Response/Ritual Prevention|exposure and response/ritual prevention
5333816|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5333817|NCT02022709|Psychotherapy|psychotherapy
5333818|NCT02022709|Pharmacotherapy|pharmacotherapy
5333819|NCT02022709|Citalopram|citalopram
5333820|NCT02022709|Fluoxetine|fluoxetine
5333821|NCT02022709|Paroxetine|paroxetine
5333822|NCT02022709|Sertraline|sertraline
5333823|NCT02022709|Fluvoxamine|fluvoxamine
5333824|NCT02022709|fMRI|fmri
5333825|NCT02022709|Stop Signal Task|stop signal task
5333826|NCT02022696|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5333827|NCT02022696|Gene Therapy|gene therapy
5333828|NCT02022696|Lentiviral Vectors|lentiviral vectors
5333829|NCT02022683|Endoscopic lung volume reduction|endoscopic lung volume reduction
5333830|NCT02022683|Endobronchial valves|endobronchial valves
5333831|NCT02022670|endothelial function|endothelial function
5334130|NCT02021253|Probiotic|probiotic
5333832|NCT02022670|arterial stiffness|arterial stiffness
5333833|NCT02022670|flow-mediated dilation|flow-mediated dilation
5333834|NCT02022670|pulse wave velocity|pulse wave velocity
5333835|NCT02022670|sodium nitrite|sodium nitrite
5333836|NCT02022670|aging|aging
5333837|NCT02022670|vascular diseases|vascular diseases
5333838|NCT02022657|Pre exposure prophylaxis|pre exposure prophylaxis
5333839|NCT02022657|Dried blood spots|dried blood spots
5333840|NCT02022618|Hypertension|hypertension
5333841|NCT02022618|Target organ damage|target organ damage
5333842|NCT02022618|polymorphism|polymorphism
5333843|NCT02022618|Hypertensive patients|hypertensive patients
5333844|NCT02022605|ERCP, trainning, trainees, EMS|ercp, trainning, trainees, ems
5333845|NCT02022579|Breast Cancer|breast cancer
5333846|NCT02022579|Diagnosis|diagnosis
5333847|NCT02022579|Malignant|malignant
5333848|NCT02022579|Benign|benign
5333849|NCT02022579|Biopsy|biopsy
5333850|NCT02022566|Osteoarthritis knee|osteoarthritis knee
5333851|NCT02022566|Osteoarthritis hip|osteoarthritis hip
5333852|NCT02022566|Physical activity|physical activity
5333853|NCT02022566|accelerometer|accelerometer
5333854|NCT02022553|rectal cancer|rectal cancer
5333855|NCT02022553|RACHEL|rachel
5333856|NCT02022553|oil chemoembolization|oil chemoembolization
5343014|NCT01981096|juvenile fibromyalgia|juvenile fibromyalgia
5333857|NCT02022540|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5333858|NCT02022540|AMD|amd
5333859|NCT02022540|Macular Degeneration|macular degeneration
5333860|NCT02022540|Age-Related Macular Degeneration|age-related macular degeneration
5333861|NCT02022540|wet AMD|wet amd
5333862|NCT02022540|neovascular AMD|neovascular amd
5333863|NCT02022540|exudative AMD|exudative amd
5333864|NCT02022527|Cost-Effectiveness,|cost-effectiveness,
5333865|NCT02022527|Heart valve prosthesis|heart valve prosthesis
5333866|NCT02022527|Warfarin,|warfarin,
5333867|NCT02022527|Aspirin,|aspirin,
5333868|NCT02022527|Egypt|egypt
5333869|NCT02022501|Macular Degeneration|macular degeneration
5333870|NCT02022488|Child|child
5333871|NCT02022488|Sevoflurane|sevoflurane
5333872|NCT02022488|Emergence delirium|emergence delirium
5333873|NCT02022488|General anesthesia|general anesthesia
5333874|NCT02022488|Premedication.|premedication.
5333875|NCT02022475|vitamin D|vitamin d
5333876|NCT02022475|fatigue|fatigue
5333877|NCT02022462|Serious mental illnesses|serious mental illnesses
5333878|NCT02022462|peer navigator|peer navigator
5333879|NCT02022462|integrated health care|integrated health care
5333880|NCT02022449|Maternal depression|maternal depression
5423294|NCT01616290|angioplasty|angioplasty
5333887|NCT02022410|Rehabilitation localisation|rehabilitation localisation
5333889|NCT02022397|tracheal intubation|tracheal intubation
5333890|NCT02022397|predicting difficult intubation|predicting difficult intubation
5333891|NCT02022397|general anesthesia|general anesthesia
5333892|NCT02022397|difficult ventilation|difficult ventilation
5333893|NCT02022384|Malignant glioma|malignant glioma
5333894|NCT02022384|Anaplastic astrocytoma|anaplastic astrocytoma
5333895|NCT02022384|Glioblastoma multiforme|glioblastoma multiforme
5333896|NCT02022384|Immune|immune
5333897|NCT02022384|Immunophenotyping|immunophenotyping
5333898|NCT02022384|Immune cells|immune cells
5333899|NCT02022384|activation state|activation state
5333900|NCT02022384|Quality of live|quality of live
5333901|NCT02022384|translational research|translational research
5333902|NCT02022358|Osteosarcoma|osteosarcoma
5333903|NCT02022358|Methotrexate|methotrexate
5333904|NCT02022358|Glucarpidase|glucarpidase
5333905|NCT02022358|Mucositis|mucositis
5333906|NCT02022345|Percutaneous Coronary Intervention|percutaneous coronary intervention
5333907|NCT02022345|Coronary Artery Disease|coronary artery disease
5333908|NCT02022345|Angioplasty|angioplasty
5333909|NCT02022345|Offsite cardiac surgery|offsite cardiac surgery
5333910|NCT02022345|Heart disease|heart disease
5333911|NCT02022345|Ischemic Heart Disease|ischemic heart disease
5333912|NCT02022306|Hepatitis C|hepatitis c
5333913|NCT02022293|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5333914|NCT02022293|Radiotherapy|radiotherapy
5333915|NCT02022293|Carotid Stenosis|carotid stenosis
5333916|NCT02022293|Atorvastatin|atorvastatin
5333917|NCT02022267|clubfoot|clubfoot
5333918|NCT02022267|gait analysis|gait analysis
5333919|NCT02022267|outcome questionaire|outcome questionaire
5333920|NCT02022267|Ponseti method|ponseti method
5333921|NCT02022241|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5333922|NCT02022241|Luteinizing Hormone|luteinizing hormone
5333923|NCT02022241|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5333924|NCT02022241|Ovarian Yield|ovarian yield
5333925|NCT02022241|Ovarian Maturity|ovarian maturity
5333926|NCT02022228|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5333927|NCT02022228|Luteinizing Hormone|luteinizing hormone
5333928|NCT02022228|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5333929|NCT02022228|Ovarian Yield|ovarian yield
5333930|NCT02022228|Ovarian Maturity|ovarian maturity
5333938|NCT02022189|Clinical Biopsy|clinical biopsy
5333941|NCT02022176|Nitric oxide|nitric oxide
5333942|NCT02022176|Resting metabolic rate|resting metabolic rate
5201587|NCT02734251|Relora|relora
5213546|NCT02660476|Diet|diet
5213547|NCT02660476|Middle East and North Africa country|middle east and north africa country
5213548|NCT02660476|Health|health
5333943|NCT02022176|Glucose uptake|glucose uptake
5333944|NCT02022176|Insulin sensitivity|insulin sensitivity
5333945|NCT02022176|Reactive oxygen species production|reactive oxygen species production
5333946|NCT02022176|inorganic nitrate|inorganic nitrate
5333947|NCT02022176|Sodium nitrite infusion|sodium nitrite infusion
5333948|NCT02022163|Influenza, Human|influenza, human
5333949|NCT02022163|RNA Virus Infections|rna virus infections
5333950|NCT02022163|Respiratory Tract Diseases|respiratory tract diseases
5333951|NCT02022163|Respiratory Tract Infections|respiratory tract infections
5333952|NCT02022163|Aluminum Hydroxide|aluminum hydroxide
5333953|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic
5333954|NCT02022163|Immunogenic Factors|immunogenic factors
5334082|NCT02021539|Predicting delivery|predicting delivery
5333955|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs
5333956|NCT02022163|Virus Diseases|virus diseases
5333957|NCT02022163|Orthomyxoviridae Infections|orthomyxoviridae infections
5333958|NCT02022163|Infection|infection
5333959|NCT02022150|Paracentesis|paracentesis
5333960|NCT02022150|Liver Cirrhosis|liver cirrhosis
5333961|NCT02022150|ascites|ascites
5333962|NCT02022150|body composition|body composition
5333963|NCT02022137|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5333964|NCT02022137|Hepatic encephalopathy|hepatic encephalopathy
5333965|NCT02022124|chronic low back pain|chronic low back pain
5333966|NCT02022124|open-label placebo|open-label placebo
5333967|NCT02022046|chronic kidney disease|chronic kidney disease
5333968|NCT02022046|cardiovascular disease|cardiovascular disease
5333969|NCT02022046|nitric oxide|nitric oxide
5333970|NCT02022046|homocysteine|homocysteine
5333971|NCT02022046|asymmetric dimethylarginine|asymmetric dimethylarginine
5333972|NCT02022046|methylation|methylation
5333980|NCT02022007|PCOS|pcos
5333981|NCT02022007|IGT|igt
5338223|NCT02002780|stress|stress
5333982|NCT02022007|DPP-4 inhibitor|dpp-4 inhibitor
5333983|NCT02021981|Quality Improvement|quality improvement
5333984|NCT02021981|Primary Care|primary care
5333985|NCT02021981|Blood Pressure, High|blood pressure, high
5333986|NCT02021981|Feedback|feedback
5333987|NCT02021981|Knowledge|knowledge
5333988|NCT02021955|randomized controlled trial|randomized controlled trial
5333989|NCT02021955|quality of life|quality of life
5333990|NCT02021955|patient readmission|patient readmission
5333991|NCT02021955|mortality|mortality
5333992|NCT02021955|patient satisfaction|patient satisfaction
5333993|NCT02021955|intervention studies|intervention studies
5333994|NCT02021955|multicenter study|multicenter study
5333995|NCT02021942|primary inoperable thymoma|primary inoperable thymoma
5333996|NCT02021942|local recurrent thymoma|local recurrent thymoma
5333997|NCT02021942|reduction of tumor size|reduction of tumor size
5333998|NCT02021942|SOM230 LAR|som230 lar
5333999|NCT02021929|Randomized Controlled Trial|randomized controlled trial
5334000|NCT02021929|Clinical Trial|clinical trial
5334001|NCT02021929|sorafenib|sorafenib
5334002|NCT02021929|Hepatopulmonary Syndrome|hepatopulmonary syndrome
5334003|NCT02021903|arterial hypotension|arterial hypotension
5334004|NCT02021903|postprandial sleepiness|postprandial sleepiness
5334005|NCT02021903|orthostatic hypotension|orthostatic hypotension
5334006|NCT02021903|synucleinopathies|synucleinopathies
5334007|NCT02021903|hyperglycemia|hyperglycemia
5334008|NCT02021890|Dance|dance
5334009|NCT02021890|Physical activity|physical activity
5334010|NCT02021890|Physical fitness|physical fitness
5334011|NCT02021890|Weight loss|weight loss
5334012|NCT02021877|Brain trauma|brain trauma
5334013|NCT02021877|ICP measurement|icp measurement
5334014|NCT02021877|cranial CT / MRI|cranial ct / mri
5334015|NCT02021877|Glasgow Coma Score|glasgow coma score
5334016|NCT02021877|acute TBI|acute tbi
5334017|NCT02021877|EEG|eeg
5334018|NCT02021877|metabolic, proteomic, and genetic biomarkers of TBIs|metabolic, proteomic, and genetic biomarkers of tbis
5334019|NCT02021877|injury mechanism|injury mechanism
5334020|NCT02021864|hypocalcemia, pregnancy, vitamin D|hypocalcemia, pregnancy, vitamin d
5334021|NCT02021851|Dexamethasone,|dexamethasone,
5334022|NCT02021851|Ondansetron|ondansetron
5334023|NCT02021851|Aprepitant|aprepitant
5334024|NCT02021851|PONV|ponv
5334025|NCT02021851|Laparoscopic surgery|laparoscopic surgery
5334026|NCT02021838|domestic violence homicide prevention|domestic violence homicide prevention
5334027|NCT02021825|mitoxantrone|mitoxantrone
5334028|NCT02021825|neuromyelitis optica|neuromyelitis optica
5334029|NCT02021825|relapse|relapse
5334030|NCT02021799|Gut microbiome|gut microbiome
5334031|NCT02021799|Vaginal microbiome|vaginal microbiome
5334032|NCT02021799|Oral microbiome|oral microbiome
5334033|NCT02021799|Human milk microbiome|human milk microbiome
5334034|NCT02021799|Nutritional Status|nutritional status
5334035|NCT02021773|Headache|headache
5334036|NCT02021773|Migraine|migraine
5963318|NCT04255433|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5963319|NCT04255433|Hormones|hormones
5963320|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5963321|NCT04255420|sphenopalatine ganglion block|sphenopalatine ganglion block
5213657|NCT02659930|HIV|hiv
5334037|NCT02021773|Chronic Migraine|chronic migraine
5334038|NCT02021682|Aβ|aβ
5334039|NCT02021682|ABeta|abeta
5334040|NCT02021682|ABeta kinetics|abeta kinetics
5334041|NCT02021682|Alzheimer's Disease|alzheimer's disease
5334042|NCT02021682|Alzheimer's|alzheimer's
5334043|NCT02021682|amyloid beta|amyloid beta
5334044|NCT02021682|biomarker|biomarker
5334045|NCT02021682|dementia|dementia
5334046|NCT02021682|PET/PIB|pet/pib
5334047|NCT02021669|Antidepressive agents|antidepressive agents
5334048|NCT02021669|Coronary disease|coronary disease
5334049|NCT02021669|Depression|depression
5334050|NCT02021669|Depressive disorder|depressive disorder
5334051|NCT02021669|Fatty Acids, Omega-3|fatty acids, omega-3
5334052|NCT02021630|Obesity|obesity
5334053|NCT02021630|Bariatric Surgery|bariatric surgery
5334054|NCT02021630|Weight Loss|weight loss
5334055|NCT02021630|Physical Activity|physical activity
5334056|NCT02021630|Body Composition|body composition
5334057|NCT02021617|Intraosseous Access|intraosseous access
5334058|NCT02021617|EZ-IO|ez-io
5334059|NCT02021604|Congenital Hyperinsulinism|congenital hyperinsulinism
5334061|NCT02021604|Hypoglycemia|hypoglycemia
5334062|NCT02021604|FDOPA|fdopa
5334063|NCT02021604|18F-DOPA|18f-dopa
5334064|NCT02021604|Hyperinsulinism|hyperinsulinism
5334065|NCT02021604|Insulinoma|insulinoma
5334066|NCT02021591|Diabetes|diabetes
5334067|NCT02021591|Chronic disease|chronic disease
5334068|NCT02021591|problem solving|problem solving
5334069|NCT02021591|self management|self management
5334070|NCT02021578|Depression|depression
5334071|NCT02021578|Mood disorder|mood disorder
5334072|NCT02021565|Caregivers|caregivers
5334073|NCT02021565|Activities of Daily Living|activities of daily living
5334074|NCT02021565|Dementia|dementia
5334075|NCT02021565|Veterans|veterans
5334076|NCT02021565|Self-Help Devices|self-help devices
5334077|NCT02021565|Telemedicine|telemedicine
5334078|NCT02021552|Trauma|trauma
5334079|NCT02021552|Sepsis|sepsis
5334080|NCT02021539|Elastography of the cervix|elastography of the cervix
5334081|NCT02021539|Cervical elastography|cervical elastography
5334083|NCT02021526|G1D|g1d
5334084|NCT02021526|Glut1 Deficiency|glut1 deficiency
5334085|NCT02021526|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
5334089|NCT02021513|Omega-3|omega-3
5334091|NCT02021422|metastatic pancreatic ductal adenocarcinoma (PDAC)|metastatic pancreatic ductal adenocarcinoma (pdac)
5334092|NCT02021422|pancreatic cancer|pancreatic cancer
5334093|NCT02021422|pancreas cancer|pancreas cancer
5334094|NCT02021422|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5334095|NCT02021422|metastatic pancreas cancer|metastatic pancreas cancer
5334096|NCT02021422|metastatic pancreatic cancer|metastatic pancreatic cancer
5334097|NCT02021409|Anemia on CKD|anemia on ckd
5334098|NCT02021396|splenic rescue; splenectomy|splenic rescue; splenectomy
5334099|NCT02021383|Weight loss|weight loss
5334100|NCT02021383|Weight maintenance|weight maintenance
5334101|NCT02021383|Contingency Management|contingency management
5334102|NCT02021383|College students|college students
5334103|NCT02021383|Financial incentives|financial incentives
5334104|NCT02021370|Anemia of CKD|anemia of ckd
5334105|NCT02021357|Facial Pain|facial pain
5334106|NCT02021357|Physical Therapy Modalities|physical therapy modalities
5334107|NCT02021357|Temporomandibular Joint Disorders|temporomandibular joint disorders
5334108|NCT02021357|Exercise Therapy|exercise therapy
5334109|NCT02021331|jaw, edentulous, partially|jaw, edentulous, partially
5334110|NCT02021318|Non-dialysis|non-dialysis
5334111|NCT02021318|Roxadustat|roxadustat
5334112|NCT02021318|ASP1517|asp1517
5334113|NCT02021318|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5334114|NCT02021318|Anemia|anemia
5334115|NCT02021318|Hemoglobin|hemoglobin
5334116|NCT02021305|Toll like Receptors|toll like receptors
5334117|NCT02021305|TLR 4|tlr 4
5334118|NCT02021305|Urinary track infections in children|urinary track infections in children
5334119|NCT02021305|TLR 4 polymorphisms|tlr 4 polymorphisms
5334120|NCT02021305|Innate immunity|innate immunity
5334121|NCT02021305|Defence mechanisms|defence mechanisms
5334122|NCT02021305|Immune responses|immune responses
5334123|NCT02021292|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5334124|NCT02021279|pelvic organ prolapse|pelvic organ prolapse
5334125|NCT02021279|MatriStem|matristem
5334126|NCT02021279|pelvic floor matrix|pelvic floor matrix
5334127|NCT02021279|ACell|acell
5334128|NCT02021279|native tissue repair|native tissue repair
5334129|NCT02021253|Endotoxemia|endotoxemia
5334131|NCT02021253|Leaky gut|leaky gut
5334132|NCT02021253|Gut permeability|gut permeability
5334133|NCT02021253|Liver cirrhosis|liver cirrhosis
5334134|NCT02021253|Liver fibrosis|liver fibrosis
5334135|NCT02021253|Hepatocellular carcinoma|hepatocellular carcinoma
5334136|NCT02021227|Acute respiratory failure|acute respiratory failure
5963322|NCT04255290|Isquiotibial|isquiotibial
5334137|NCT02021227|Mechanical ventilation|mechanical ventilation
5334138|NCT02021227|Rehabilitation|rehabilitation
5334139|NCT02021227|Exercise chair sitting|exercise chair sitting
5334140|NCT02021227|Weaning|weaning
5963323|NCT04255290|Plyometrics|plyometrics
5334141|NCT02021227|Chronic respiratory failure|chronic respiratory failure
5334146|NCT02021188|Vascular inflammation|vascular inflammation
5334147|NCT02021188|Atherosclerosis|atherosclerosis
5334148|NCT02021188|Positron Emission Tomography|positron emission tomography
5334149|NCT02021188|Molecular Imaging|molecular imaging
5334150|NCT02021188|68Ga-DOTATATE|68ga-dotatate
5334151|NCT02021175|Smoking Cessation|smoking cessation
5334152|NCT02021175|Korean|korean
5334153|NCT02021175|Youth|youth
5334154|NCT02021175|Adolescent|adolescent
5334155|NCT02021175|Dependence|dependence
5334156|NCT02021175|Teen Smoking|teen smoking
5334157|NCT02021175|Smoking and Youth|smoking and youth
5334158|NCT02021175|Youth and Tobacco|youth and tobacco
5334159|NCT02021175|Cognitive-Behavioral Motivational Enhancement|cognitive-behavioral motivational enhancement
5334160|NCT02021175|Technology|technology
5334161|NCT02021175|Nicotine Dependence|nicotine dependence
5334162|NCT02021175|Cell Phone|cell phone
5334163|NCT02021175|Smart Phone|smart phone
5334164|NCT02021175|Internet|internet
5334165|NCT02021175|Web|web
5334166|NCT02021162|Multiple sclerosis|multiple sclerosis
5334167|NCT02021162|Gilenya|gilenya
5334168|NCT02021162|Healthy controls|healthy controls
5334169|NCT02021162|Thalamic atrophy|thalamic atrophy
5334170|NCT02021162|MRI|mri
5334171|NCT02021149|Major Depressive Disorder|major depressive disorder
5334172|NCT02021149|Whole Body Hyperthermia|whole body hyperthermia
5334173|NCT02021149|Psychotherapy|psychotherapy
5334174|NCT02021149|Therapist and patient alliance|therapist and patient alliance
5334175|NCT02021123|Anidulafungin|anidulafungin
5334176|NCT02021123|Gastric bypass|gastric bypass
5334177|NCT02021123|Morbidly obese|morbidly obese
5334178|NCT02021123|Pharmacokinetics|pharmacokinetics
5334179|NCT02021123|Prophylaxis|prophylaxis
5334180|NCT02021123|Yeast infection|yeast infection
5334181|NCT02021097|Levonorgestrel；|levonorgestrel；
5334182|NCT02021097|Ethinyl Estradiol；|ethinyl estradiol；
5334183|NCT02021097|Oral Contraceptive|oral contraceptive
5334184|NCT02021084|Familial Mediterranean Fever (FMF), probiotics|familial mediterranean fever (fmf), probiotics
5334185|NCT02021032|BPH|bph
5334186|NCT02021006|antibiotic prophylaxis|antibiotic prophylaxis
5334187|NCT02021006|vesicoureteral reflux|vesicoureteral reflux
5334188|NCT02021006|congenital abnormalities of kidney|congenital abnormalities of kidney
5334189|NCT02021006|renal hypodysplasia|renal hypodysplasia
5334190|NCT02021006|chronic kidney disease|chronic kidney disease
5334191|NCT02020993|Nt-proBNP, newborn, preterm|nt-probnp, newborn, preterm
5334192|NCT02020928|Oral Mucositis|oral mucositis
5334193|NCT02020928|chemotherapy|chemotherapy
5334194|NCT02020928|Bone Marrow Transplantation|bone marrow transplantation
5334195|NCT02020889|eosinophils|eosinophils
5334196|NCT02020889|SB 240563|sb 240563
5334197|NCT02020889|Churg-Strauss Syndrome|churg-strauss syndrome
5334198|NCT02020889|quality of life|quality of life
5334199|NCT02020889|mepolizumab|mepolizumab
5334200|NCT02020889|safety|safety
5334201|NCT02020889|biomarkers|biomarkers
5334202|NCT02020889|efficacy|efficacy
5334203|NCT02020889|corticosteroids|corticosteroids
5334204|NCT02020889|Eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis
5334205|NCT02020850|Toe-Brachial Index|toe-brachial index
5334206|NCT02020850|Ankle-Brachial Index|ankle-brachial index
5334207|NCT02020850|Systolic blood pressure|systolic blood pressure
5334208|NCT02020824|Acrophobia|acrophobia
5334209|NCT02020785|proteinuria|proteinuria
5334210|NCT02020772|primary health care|primary health care
5334211|NCT02020772|Physical Therapy Specialty|physical therapy specialty
5334212|NCT02020772|General Practitioners|general practitioners
5334213|NCT02020772|General Practice|general practice
5334214|NCT02020733|Hysterosalpingography|hysterosalpingography
5334215|NCT02020733|balloon catheter|balloon catheter
5334216|NCT02020733|metal cannula|metal cannula
5334217|NCT02020733|pain assessment|pain assessment
5334218|NCT02020694|Obesity|obesity
5334219|NCT02020694|Insulin resistance|insulin resistance
5334220|NCT02020694|Vitamin D|vitamin d
5334221|NCT02020694|Cardiovascular risk factors|cardiovascular risk factors
5334222|NCT02020681|Dental caries|dental caries
5334223|NCT02020681|Curodont Repair|curodont repair
5334224|NCT02020681|P11-4|p11-4
5334225|NCT02020668|Pain|pain
5334226|NCT02020668|Functional capacity|functional capacity
5334227|NCT02020668|Quality of Life|quality of life
5334228|NCT02020655|IL-1 alpha, Sebutape, shear- force|il-1 alpha, sebutape, shear- force
5334229|NCT02020642|polysomnography|polysomnography
5334230|NCT02020642|bioimpedance|bioimpedance
5334235|NCT02020642|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5334237|NCT02020642|Apnea|apnea
5334238|NCT02020642|Kidney Diseases|kidney diseases
5334239|NCT02020642|Kidney Failure, Chronic|kidney failure, chronic
5334240|NCT02020642|Renal Insufficiency, Chronic|renal insufficiency, chronic
5334241|NCT02020642|Renal Insufficiency|renal insufficiency
5334242|NCT02020642|Dyssomnias|dyssomnias
5334243|NCT02020629|Glucagon|glucagon
5334244|NCT02020629|Hypoglycemia|hypoglycemia
5334245|NCT02020629|Counterregulation|counterregulation
5334246|NCT02020603|peptic ulcer bleeding|peptic ulcer bleeding
5334247|NCT02020603|hemostatic forceps|hemostatic forceps
5334248|NCT02020603|soft coagulation|soft coagulation
5334249|NCT02020603|argon plasma coagulation|argon plasma coagulation
5334256|NCT02020564|Processing Speed|processing speed
5334257|NCT02020564|Cognition|cognition
5334258|NCT02020564|Intervention|intervention
5334259|NCT02020564|Traumatic Brain Injury|traumatic brain injury
5334260|NCT02020564|Mild Cognitive Impairment|mild cognitive impairment
5334273|NCT02020460|refractory chronic neuropathic pain,|refractory chronic neuropathic pain,
5334274|NCT02020460|failed back surgery syndrome.|failed back surgery syndrome.
5334275|NCT02020421|ischemic stroke|ischemic stroke
5334276|NCT02020421|rehabilitation|rehabilitation
5334277|NCT02020421|aphasia|aphasia
5334278|NCT02020421|non-invasive brain stimulation|non-invasive brain stimulation
5334279|NCT02020382|microRNAs|micrornas
5334280|NCT02020382|IBD|ibd
5334281|NCT02020382|Crohn's disease|crohn's disease
5334282|NCT02020382|Ulcerative colitis|ulcerative colitis
5334283|NCT02020382|colonic polyps screening|colonic polyps screening
5334284|NCT02020382|controls|controls
5334285|NCT02020356|Alzheimer's disease|alzheimer's disease
5334286|NCT02020356|Neuroleptics|neuroleptics
5334287|NCT02020356|Music therapy|music therapy
5334288|NCT02020330|falciparum, malaria|falciparum, malaria
5334289|NCT02020317|drug interactions|drug interactions
5334290|NCT02020317|Drug Monitoring|drug monitoring
5334291|NCT02020317|Potassium|potassium
5334292|NCT02020317|Hyperkalemia|hyperkalemia
5334293|NCT02020304|Combined spinal epidural duration|combined spinal epidural duration
5334295|NCT02020291|Foxy-5|foxy-5
5334296|NCT02020291|Wnt-5A|wnt-5a
5334297|NCT02020278|Hyponatremia|hyponatremia
5334298|NCT02020278|Euvolemic|euvolemic
5334299|NCT02020278|Hypervolemic|hypervolemic
5334300|NCT02020278|Serum sodium|serum sodium
5334301|NCT02020278|Dilutional hyponatremia|dilutional hyponatremia
5334302|NCT02020278|Electrolyte abnormality|electrolyte abnormality
5334303|NCT02020278|Electrolyte imbalance|electrolyte imbalance
5334304|NCT02020278|Metabolic disease|metabolic disease
5334305|NCT02020278|Water-Electrolyte Imbalance|water-electrolyte imbalance
5334306|NCT02020265|stress and depression related symptoms|stress and depression related symptoms
5334307|NCT02020239|physical activity|physical activity
5334308|NCT02020239|females|females
5334309|NCT02020239|body composition|body composition
5334310|NCT02020226|TH-302|th-302
5334311|NCT02020226|Solid Tumors|solid tumors
5334312|NCT02020226|QTc|qtc
5334313|NCT02020226|Cardiac|cardiac
5334314|NCT02020226|Evofosfamide|evofosfamide
5334315|NCT02020213|successful percentage|successful percentage
5334316|NCT02020200|Bipolar Disorder|bipolar disorder
5334317|NCT02020200|Methylphenidate|methylphenidate
5334318|NCT02020200|Cognitive Function|cognitive function
5334319|NCT02020187|Congenital myopathy|congenital myopathy
5334320|NCT02020187|Exercise|exercise
5334321|NCT02020174|Preeclampsia|preeclampsia
5334322|NCT02020174|Eclampsia|eclampsia
5334323|NCT02020174|HELLP|hellp
5334324|NCT02020174|HELLP Syndrome|hellp syndrome
5334325|NCT02020174|Toxemia|toxemia
5334326|NCT02020174|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
5334327|NCT02020174|Registry|registry
5334328|NCT02020174|Pregnancy Complication|pregnancy complication
5334329|NCT02020174|Pregnancy|pregnancy
5334330|NCT02020174|Maternal Death|maternal death
5334338|NCT02020148|pregnant women|pregnant women
5334340|NCT02020148|anxiety|anxiety
5334341|NCT02020148|hormones|hormones
5334342|NCT02020148|women's health|women's health
5334343|NCT02020148|mental health|mental health
5334344|NCT02020148|baby blues|baby blues
5334345|NCT02020148|mood disorders|mood disorders
5334346|NCT02020122|endogenous pain modulation|endogenous pain modulation
5334347|NCT02020122|coronary artery bypass grafting|coronary artery bypass grafting
5334348|NCT02020122|quantitative sensory testings|quantitative sensory testings
5334349|NCT02020122|duloxetine|duloxetine
5334350|NCT02020122|pregabalin|pregabalin
5334351|NCT02020122|preemptive treatment|preemptive treatment
5334352|NCT02020096|Lumbar plexus block|lumbar plexus block
5334353|NCT02020096|Ultrasound guidance|ultrasound guidance
5334354|NCT02020096|Nerve stimulator|nerve stimulator
5330578|NCT02037672|PDE-4 inhibitor|pde-4 inhibitor
5330581|NCT02037672|obesity|obesity
5334355|NCT02020083|VIH ; Placental transfer ; Tenofovir ; Emtricitabine ; Membrane transporter|vih ; placental transfer ; tenofovir ; emtricitabine ; membrane transporter
5334356|NCT02020070|Ipilimumab|ipilimumab
5334357|NCT02020070|Degarelix|degarelix
5334358|NCT02020070|Radical Prostatectomy|radical prostatectomy
5334359|NCT02020070|13-134|13-134
5334360|NCT02020031|Revision knee joint|revision knee joint
5334361|NCT02020005|menthol cigarettes|menthol cigarettes
5334362|NCT02020005|smoking cessation|smoking cessation
5334363|NCT02019992|sepsis|sepsis
5334364|NCT02019992|mitochondrial DNA|mitochondrial dna
5334365|NCT02019992|systemic inflammation|systemic inflammation
5334366|NCT02019992|outcome|outcome
5334367|NCT02019979|non squamous|non squamous
5334368|NCT02019979|non small cell|non small cell
5334369|NCT02019979|lung cancer|lung cancer
5334370|NCT02019979|metformin|metformin
5334371|NCT02019927|NAION|naion
5334372|NCT02019927|Decreased vision|decreased vision
5214022|NCT02658097|RT|rt
5334373|NCT02019927|Eye trauma|eye trauma
5334374|NCT02019927|TES|tes
5334375|NCT02019927|Electrical stimulation|electrical stimulation
5334376|NCT02019927|Multiple Sclerosis|multiple sclerosis
5334377|NCT02019927|Optic Neuritis|optic neuritis
5334378|NCT02019914|PTSD|ptsd
5334379|NCT02019914|CPAP|cpap
5334380|NCT02019914|OSA|osa
5334381|NCT02019901|Rheumatoid arthritis|rheumatoid arthritis
5678413|NCT00586898|Hormones|hormones
5334382|NCT02019901|Person-centered care|person-centered care
5334383|NCT02019901|Tight control|tight control
5334388|NCT02019875|Vitamin D|vitamin d
5334389|NCT02019875|CYP3A4|cyp3a4
5334390|NCT02019875|Calcium|calcium
5334391|NCT02019862|Total hip arthroplasty|total hip arthroplasty
5334392|NCT02019862|TRJ|trj
5334393|NCT02019862|PMCF|pmcf
5334394|NCT02019862|Hip stem|hip stem
5334395|NCT02019849|THA, Plasmafit®|tha, plasmafit®
5334396|NCT02019836|vit D; sepsis; newborn; maternal; neonatal|vit d; sepsis; newborn; maternal; neonatal
5334397|NCT02019823|SMS-text|sms-text
5334398|NCT02019823|mobile health|mobile health
5334399|NCT02019823|mHealth|mhealth
5334400|NCT02019823|treatment|treatment
5334401|NCT02019823|adherence|adherence
5334402|NCT02019797|aortic valve replacement|aortic valve replacement
5334403|NCT02019784|Cirrhosis|cirrhosis
5334404|NCT02019784|Hepatic encephalopathy|hepatic encephalopathy
5334405|NCT02019771|HIV Infection|hiv infection
5334406|NCT02019771|Men who have sex with men|men who have sex with men
5334407|NCT02019771|Chlamydia|chlamydia
5334408|NCT02019771|Gonorrhea|gonorrhea
5334415|NCT02019732|Database|database
5334416|NCT02019732|Influenza-attributable|influenza-attributable
5334417|NCT02019732|Retrospective|retrospective
5334418|NCT02019732|Influenza|influenza
5334419|NCT02019732|United States of America (USA)|united states of america (usa)
5334420|NCT02019719|Hemodialysis|hemodialysis
5334421|NCT02019719|GSK1278863|gsk1278863
5334422|NCT02019719|Pharmacokinetics|pharmacokinetics
5334423|NCT02019719|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
5334424|NCT02019719|Chronic Kidney Disease|chronic kidney disease
5334425|NCT02019719|Hemoglobin|hemoglobin
5334426|NCT02019719|Recombinant Erythropoietin|recombinant erythropoietin
5334427|NCT02019719|Prolyl Hydroxylase Inhibitor|prolyl hydroxylase inhibitor
5334428|NCT02019719|Anemia|anemia
5334429|NCT02019706|DOTATATE|dotatate
5334430|NCT02019706|Cushing's Syndrome|cushing's syndrome
5334431|NCT02019706|Hypercortisolism|hypercortisolism
5334456|NCT02019615|transcranial direct current stimulation|transcranial direct current stimulation
5334458|NCT02019602|CZP|czp
5334459|NCT02019602|Placental transfer|placental transfer
5334460|NCT02019602|Autoimmune diseases and pregnancy|autoimmune diseases and pregnancy
5334461|NCT02019589|Secondary Amenorrhea|secondary amenorrhea
5334462|NCT02019589|SPRY Trial|spry trial
5334463|NCT02019576|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5334465|NCT02019576|Clear cell|clear cell
5334466|NCT02019563|pediatrics|pediatrics
5334467|NCT02019563|dental caries|dental caries
5334468|NCT02019563|dental pulp exposure|dental pulp exposure
5334469|NCT02019563|incisor|incisor
5334470|NCT02019550|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5334471|NCT02019550|Rebif®Rebidose®|rebif®rebidose®
5334472|NCT02019550|Rebiject II®|rebiject ii®
5334473|NCT02019524|Stage I breast cancer|stage i breast cancer
5334474|NCT02019524|Stage II breast cancer|stage ii breast cancer
5334475|NCT02019524|Stage IIIA, IIIB, and IIIC breast cancer|stage iiia, iiib, and iiic breast cancer
5334476|NCT02019524|Male breast cancer|male breast cancer
5334477|NCT02019524|Ovarian cancer|ovarian cancer
5334478|NCT02019511|Orthopedic surgery|orthopedic surgery
5334479|NCT02019511|Infections|infections
5334480|NCT02019511|Steroid|steroid
5334481|NCT02019511|Fast-track|fast-track
5334482|NCT02019511|Total knee arthroplasty|total knee arthroplasty
5334483|NCT02019511|Safety|safety
5334484|NCT02019498|low back pain|low back pain
5334485|NCT02019498|relaxation|relaxation
5334486|NCT02019485|Healthy|healthy
5334487|NCT02019485|Tapentadol|tapentadol
5334488|NCT02019485|Tapentadol extended-release tamper-resistant formulation|tapentadol extended-release tamper-resistant formulation
5334489|NCT02019485|Tapentadol extended-release prolonged-release formulation|tapentadol extended-release prolonged-release formulation
5334490|NCT02019485|Bioequivalence|bioequivalence
5334491|NCT02019485|Fasted Conditions|fasted conditions
5334492|NCT02019472|Rheumatoid arthritis|rheumatoid arthritis
5334493|NCT02019472|CNTO 136|cnto 136
5334494|NCT02019472|Sirukumab|sirukumab
5334495|NCT02019472|Adalimumab|adalimumab
5334496|NCT02019472|HUMIRA®|humira®
5334497|NCT02019446|type 2 diabetes mellitus|type 2 diabetes mellitus
5334498|NCT02019446|onychomycosis|onychomycosis
5334499|NCT02019446|laser treatment|laser treatment
5334500|NCT02019446|antifungal|antifungal
5334501|NCT02019433|THA, augment, revision, pelvis|tha, augment, revision, pelvis
5334502|NCT02019407|atrial fibrillation|atrial fibrillation
5334503|NCT02019407|atrial flutter|atrial flutter
5334504|NCT02019407|catheter ablation|catheter ablation
5963324|NCT04255290|Eccentric|eccentric
5963325|NCT04255290|Soccer|soccer
5334505|NCT02019407|cavo-tricuspid isthmus block|cavo-tricuspid isthmus block
5334506|NCT02019342|blood pressure|blood pressure
5678414|NCT00586898|01-085|01-085
5334507|NCT02019342|mean arterial pressure|mean arterial pressure
5334508|NCT02019342|MAP|map
5334509|NCT02019342|intraoperative|intraoperative
5334510|NCT02019342|postoperative|postoperative
5334511|NCT02019342|anesthesia|anesthesia
5334512|NCT02019316|Supplementation|supplementation
5334513|NCT02019316|Performance|performance
5334514|NCT02019316|Cognitive Function|cognitive function
5334515|NCT02019316|Muscular Endurance|muscular endurance
5334516|NCT02019316|BioSteel|biosteel
5334517|NCT02019316|BCAA|bcaa
5334518|NCT02019316|Branched Chain Amino Acids|branched chain amino acids
5334519|NCT02019316|Sprint Interval Exercise|sprint interval exercise
5334520|NCT02019264|Diabetes|diabetes
5334521|NCT02019264|Cardiovascular Disease|cardiovascular disease
5334522|NCT02019264|Multiple Cardiovascular Risk Factors|multiple cardiovascular risk factors
5334523|NCT02019264|Obesity|obesity
5334524|NCT02019264|Overweight|overweight
5334525|NCT02019264|MACE|mace
5334526|NCT02019264|Conversion to Diabetes|conversion to diabetes
5334528|NCT02019225|hemodialysis|hemodialysis
5334529|NCT02019225|pragmatic trial|pragmatic trial
5334530|NCT02019225|end stage renal disease|end stage renal disease
5334531|NCT02019225|randomized clinical trial|randomized clinical trial
5334926|NCT02017457|Relapse|relapse
5334532|NCT02019212|99mTc-tetrofosmin|99mtc-tetrofosmin
5334533|NCT02019212|myocardial perfusion imaging|myocardial perfusion imaging
5334534|NCT02019212|SPECT|spect
5334535|NCT02019212|radiation|radiation
5334536|NCT02019186|type 1 diabetes|type 1 diabetes
5334537|NCT02019186|endothelial function|endothelial function
5334538|NCT02019186|adolescents|adolescents
5334539|NCT02019186|vitamin C|vitamin c
5334540|NCT02019186|vitamin E|vitamin e
5334541|NCT02019173|exercise therapy|exercise therapy
5334542|NCT02019173|brain injury|brain injury
5334543|NCT02019173|postural balance|postural balance
5334544|NCT02019160|silver nitrate|silver nitrate
5334545|NCT02019160|sodium fluoride|sodium fluoride
5334546|NCT02019160|silver diamine fluoride|silver diamine fluoride
5334547|NCT02019160|caries|caries
5334548|NCT02019160|non-inferiority trial|non-inferiority trial
5334549|NCT02019147|HIE|hie
5334550|NCT02019147|Biomarker|biomarker
5334551|NCT02019134|chronic neck pain|chronic neck pain
5334552|NCT02019134|relaxation technique|relaxation technique
5334553|NCT02019134|comparative effectiveness research|comparative effectiveness research
5334554|NCT02019108|osteoarthritis|osteoarthritis
5334555|NCT02019108|knee|knee
5334556|NCT02019108|walking|walking
5334557|NCT02019108|toeout|toeout
5334558|NCT02019108|gait modification|gait modification
5334559|NCT02019095|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5334560|NCT02019095|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5334561|NCT02019095|Pulmonary Surfactant-Associated Proteins|pulmonary surfactant-associated proteins
5334562|NCT02019095|activin A|activin a
5334563|NCT02019030|benign prostatic hyperplasia|benign prostatic hyperplasia
5334564|NCT02019030|Transurethral vaporization of prostate|transurethral vaporization of prostate
5334565|NCT02019017|Cluster Headache|cluster headache
5334566|NCT02019017|Botulinum Toxin Type A|botulinum toxin type a
5334567|NCT02019017|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5334568|NCT02019017|Autonomic Nerve Block|autonomic nerve block
5334569|NCT02018978|HIV prevention|hiv prevention
5334570|NCT02018978|Behavioral intervention|behavioral intervention
5334571|NCT02018978|Community-randomized trial|community-randomized trial
5334572|NCT02018965|HIV|hiv
5334573|NCT02018965|Extended-release Niacin|extended-release niacin
5334574|NCT02018965|Immune activation|immune activation
5334575|NCT02018952|Septic arthritis|septic arthritis
5334576|NCT02018952|Ultrasonography|ultrasonography
5334577|NCT02018952|Prognosis parameters|prognosis parameters
5334578|NCT02018939|pharmacokinetics, doripenem, renal replacement therapy, MARS, organ replacement therapy|pharmacokinetics, doripenem, renal replacement therapy, mars, organ replacement therapy
5334579|NCT02018926|Mocetinostat|mocetinostat
5334581|NCT02018926|Vidaza|vidaza
5334582|NCT02018926|Myelodysplastic syndrome|myelodysplastic syndrome
5334583|NCT02018926|HDAC|hdac
5334584|NCT02018926|HMA|hma
5334585|NCT02018926|MDS|mds
5334586|NCT02018900|Synbiotics|synbiotics
5334587|NCT02018900|Intestinal permeability|intestinal permeability
5334588|NCT02018900|Microbiota|microbiota
5334593|NCT02018848|Dot-Probe Task|dot-probe task
5334594|NCT02018848|Randomized Controlled Trial|randomized controlled trial
5334595|NCT02018848|Online Treatment|online treatment
5334596|NCT02018848|Washing|washing
5334597|NCT02018848|Checking|checking
5334598|NCT02018822|restorative material|restorative material
5334599|NCT02018809|Medication Adherence|medication adherence
5334600|NCT02018809|High Blood Pressure|high blood pressure
5334601|NCT02018809|Diabetes|diabetes
5334602|NCT02018809|Statins|statins
5678515|NCT00586469|Influenza|influenza
5334603|NCT02018770|Temporomandibular Disorders, Electromyogram,|temporomandibular disorders, electromyogram,
5963326|NCT04255290|Prevention|prevention
5334604|NCT02018770|Modalities of physiotherapy,|modalities of physiotherapy,
5334605|NCT02018770|Temporomandibular dysfunction syndrome,|temporomandibular dysfunction syndrome,
5334606|NCT02018770|Lasers.|lasers.
5334607|NCT02018757|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5334608|NCT02018757|primary liver cancer|primary liver cancer
5334609|NCT02018757|primary hepatocellular carcinoma|primary hepatocellular carcinoma
5334610|NCT02018757|transarterial chemoembolization|transarterial chemoembolization
5334611|NCT02018757|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5334612|NCT02018757|arsenic trioxide|arsenic trioxide
5334613|NCT02018757|arsenous anhydride|arsenous anhydride
5334614|NCT02018757|diarsenic trioxide|diarsenic trioxide
5334615|NCT02018757|randomized controlled trial|randomized controlled trial
5334616|NCT02018757|multicenter study|multicenter study
5334617|NCT02018757|HCC|hcc
5334618|NCT02018757|TACE|tace
5334619|NCT02018731|Becker's Muscular dystrophy|becker's muscular dystrophy
5334620|NCT02018731|BMD|bmd
5334621|NCT02018731|Metformin|metformin
5334622|NCT02018731|L-citrulline|l-citrulline
5334623|NCT02018718|Skeletal muscle|skeletal muscle
5334624|NCT02018718|Marathon|marathon
5334625|NCT02018718|MRI|mri
5334626|NCT02018705|POEM|poem
5334627|NCT02018705|LHM|lhm
5334628|NCT02018705|Achalasia treatment|achalasia treatment
5334629|NCT02018705|LES sphincter myotomy|les sphincter myotomy
5334630|NCT02018679|Nodular basal cell carcinoma|nodular basal cell carcinoma
5334631|NCT02018679|Er:YAG|er:yag
5334632|NCT02018679|AFL-assisted|afl-assisted
5334633|NCT02018679|MAL-PDT|mal-pdt
5334634|NCT02018653|Cancer|cancer
5334635|NCT02018653|Diarrhea|diarrhea
5334636|NCT02018653|Calcium Alumina-Silicate|calcium alumina-silicate
5334637|NCT02018653|CASAD|casad
5334638|NCT02018653|Calcium Aluminosilicate anti-diarrheal|calcium aluminosilicate anti-diarrheal
5334639|NCT02018653|Placebo|placebo
5334640|NCT02018653|Sugar pill|sugar pill
5334641|NCT02018653|Questionnaire|questionnaire
5334642|NCT02018653|Survey|survey
5334643|NCT02018640|cancer|cancer
5334644|NCT02018640|tobacco use|tobacco use
5334645|NCT02018640|pregnancy|pregnancy
5334646|NCT02018627|bionic pancreas|bionic pancreas
5334647|NCT02018627|artificial pancreas|artificial pancreas
5334648|NCT02018627|insulin|insulin
5334649|NCT02018627|glucagon|glucagon
5334650|NCT02018627|clamp|clamp
5334651|NCT02018614|Pain|pain
5334652|NCT02018614|elderly|elderly
5334653|NCT02018614|aged 65 or above 65|aged 65 or above 65
5334654|NCT02018614|communication disorders|communication disorders
5334655|NCT02018614|Algoplus® scale|algoplus® scale
5334656|NCT02018588|requirements|requirements
5334657|NCT02018588|amino acid|amino acid
5334658|NCT02018588|tryptophan|tryptophan
5334659|NCT02018575|lysine|lysine
5334660|NCT02018575|bioavailability|bioavailability
5334661|NCT02018575|amino acids|amino acids
5334662|NCT02018575|corn|corn
5334663|NCT02018562|Quality of Life|quality of life
5334664|NCT02018562|Talking Tracheostomy Tube|talking tracheostomy tube
5334665|NCT02018562|Speech|speech
5334666|NCT02018562|Mechanically ventilated patients|mechanically ventilated patients
5334667|NCT02018549|COPD|copd
5334668|NCT02018549|placebo|placebo
5334669|NCT02018549|inhalatory profile|inhalatory profile
5334670|NCT02018536|Healthy|healthy
5334671|NCT02018536|TMC435|tmc435
5334672|NCT02018536|GSK2336805|gsk2336805
5334673|NCT02018536|Pharmacokinetic|pharmacokinetic
5334674|NCT02018536|Safety|safety
5334675|NCT02018536|Tolerability|tolerability
5334676|NCT02018523|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5334677|NCT02018523|Stage 3B/4|stage 3b/4
5334678|NCT02018523|Maintenance Therapy|maintenance therapy
5334679|NCT02018523|Lenalidomide|lenalidomide
5334680|NCT02018510|Healthy Volunteers|healthy volunteers
5334681|NCT02018510|HIV|hiv
5334682|NCT02018497|Essential arterial hypotension|essential arterial hypotension
5334683|NCT02018497|Arterial hypotension|arterial hypotension
5334684|NCT02018497|Low blood pressure|low blood pressure
5334686|NCT02018497|Essential arterial hypertension|essential arterial hypertension
5334687|NCT02018497|Syncope|syncope
5334688|NCT02018497|Dysautonomia|dysautonomia
5334690|NCT02018497|Adaptability|adaptability
5334691|NCT02018497|Reactivity|reactivity
5334692|NCT02018497|Homeostasis|homeostasis
5334693|NCT02018497|Allostasis|allostasis
5334694|NCT02018497|Allostatic load|allostatic load
5334695|NCT02018497|Distress|distress
5334696|NCT02018497|Epigenetic|epigenetic
5334697|NCT02018497|Plasticity|plasticity
5334698|NCT02018484|Surgery / Knee / Replacement / MRI / Specific cutting guides|surgery / knee / replacement / mri / specific cutting guides
5334699|NCT02018471|anxiety|anxiety
5334700|NCT02018471|psychoeducational training|psychoeducational training
5334701|NCT02018471|coping|coping
5334702|NCT02018471|relaxation|relaxation
5334703|NCT02018458|Dendritic cell vaccine|dendritic cell vaccine
5334704|NCT02018458|Breast Cancer|breast cancer
5334705|NCT02018458|Doxorubicin|doxorubicin
5334706|NCT02018458|Paclitaxel|paclitaxel
5334707|NCT02018458|Cyclophosphamide|cyclophosphamide
5334708|NCT02018458|Carboplatin|carboplatin
5334709|NCT02018406|Hematopoietic Growth Factors (EPO, G-CSF),|hematopoietic growth factors (epo, g-csf),
5334710|NCT02018406|Neurological Diseases,|neurological diseases,
5334711|NCT02018406|Neurorehabilitation,|neurorehabilitation,
5334712|NCT02018406|Neurotrophic and Neuroprotective Effects|neurotrophic and neuroprotective effects
5334714|NCT02018367|Barrett's esophagus|barrett's esophagus
5334715|NCT02018367|proflavine|proflavine
5334716|NCT02018367|Microscopic imaging|microscopic imaging
5334717|NCT02018354|Orthopaedics|orthopaedics
5334718|NCT02018354|Anterior cruciate ligament (ACL) reconstruction|anterior cruciate ligament (acl) reconstruction
5334719|NCT02018354|Anterolateral ligament|anterolateral ligament
5334720|NCT02018354|Lateral Extra-articular Tenodesis (LET)|lateral extra-articular tenodesis (let)
5334721|NCT02018341|Assessment of biologic activity of a homeopathic remedy|assessment of biologic activity of a homeopathic remedy
5334722|NCT02018315|G1D|g1d
5334723|NCT02018315|Glut1 Disorder|glut1 disorder
5334724|NCT02018315|Glucose Transporter Type 1 Disorder|glucose transporter type 1 disorder
5334725|NCT02018315|Glucose Transporter Type I Disorder|glucose transporter type i disorder
5334727|NCT02018302|Glut1 Deficiency|glut1 deficiency
5334728|NCT02018302|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
5334729|NCT02018302|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
5334730|NCT02018289|Triclosan coated suture|triclosan coated suture
5334731|NCT02018289|Surgical site infection|surgical site infection
5334732|NCT02018289|Fecal peritonitis|fecal peritonitis
5334733|NCT02018289|Superficial|superficial
5334734|NCT02018289|incisional|incisional
5334735|NCT02018276|Lidocaine|lidocaine
5334736|NCT02018276|Magnesium|magnesium
5334737|NCT02018276|Functional recovery|functional recovery
5334738|NCT02018237|Obesity|obesity
5334739|NCT02018237|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5334740|NCT02018237|High fructose corn syrup|high fructose corn syrup
5445414|NCT01521910|diabetic nephropathy|diabetic nephropathy
5445415|NCT01521910|type 1 diabetes|type 1 diabetes
5334741|NCT02018224|Achilles tendon rupture, operative treatment, elongation, long-term follow up.|achilles tendon rupture, operative treatment, elongation, long-term follow up.
5334742|NCT02018211|delayed onset muscle soreness|delayed onset muscle soreness
5334743|NCT02018211|muscle damage|muscle damage
5334744|NCT02018211|muscle function|muscle function
5334745|NCT02018211|inflammation|inflammation
5334746|NCT02018198|Host Immune Response|host immune response
5334747|NCT02018198|Biomarker|biomarker
5334748|NCT02018198|Point-of-Care|point-of-care
5334749|NCT02018198|Myxovirus Resistance Protein A (MxA)|myxovirus resistance protein a (mxa)
5334750|NCT02018198|C-reactive Protein (CRP)|c-reactive protein (crp)
5334751|NCT02018146|Laryngeal Masks|laryngeal masks
5334752|NCT02018146|Airway Management|airway management
5334753|NCT02018133|CKD|ckd
5334754|NCT02018133|chronic|chronic
5334755|NCT02018133|kidney|kidney
5334756|NCT02018133|vitamin D|vitamin d
5334757|NCT02018120|multiple gingival recession|multiple gingival recession
5334758|NCT02018120|platelet rich fibrin|platelet rich fibrin
5334759|NCT02018120|connective tissue graft|connective tissue graft
5334760|NCT02018120|microsurgery|microsurgery
5334761|NCT02018120|periodontal diseases|periodontal diseases
5334762|NCT02018120|gingival recession|gingival recession
5334763|NCT02018107|Liver Tumor Ablation|liver tumor ablation
5334764|NCT02018107|Liver Neoplasms|liver neoplasms
5334765|NCT02018107|Positron Emission Tomography|positron emission tomography
5334766|NCT02018107|Computed Tomography|computed tomography
5334767|NCT02018094|Amputation|amputation
5334768|NCT02018094|Infection|infection
5334769|NCT02018094|Skin Preparation|skin preparation
5334770|NCT02018094|SSI|ssi
5334771|NCT02018094|Stump|stump
5334772|NCT02018094|Wound|wound
5334773|NCT02018081|pharmacokinetic study : open, prospective, monocentric|pharmacokinetic study : open, prospective, monocentric
5334774|NCT02018068|Patient-controlled Perineural analgesia|patient-controlled perineural analgesia
5334775|NCT02018068|Postoperative|postoperative
5334776|NCT02018068|Orthopedic surgery|orthopedic surgery
5334777|NCT02018068|"Remote Control versus at bedside care"|"remote control versus at bedside care"
5334778|NCT02018068|Comparative medico-economic evaluation|comparative medico-economic evaluation
5334779|NCT02018042|Alopecia Areata|alopecia areata
5334781|NCT02018029|Heart failure|heart failure
5330996|NCT02035761|MSA|msa
5334782|NCT02018029|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5334783|NCT02018029|collagen peptides|collagen peptides
5334784|NCT02018029|MIBG scintigraphy|mibg scintigraphy
5334785|NCT02018016|Appendectomy|appendectomy
5334786|NCT02018016|Hospitals,General|hospitals,general
5334787|NCT02018016|Hospitals,High-Volume|hospitals,high-volume
5334788|NCT02018016|Hospitals,Low-Volume|hospitals,low-volume
5334789|NCT02018016|Outcome Assessment (Health Care)|outcome assessment (health care)
5334790|NCT02017990|Renal transplantation|renal transplantation
5334791|NCT02017990|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5334793|NCT02017990|Graft loss|graft loss
5334794|NCT02017990|Rejection|rejection
5334795|NCT02017977|Laparotomy|laparotomy
5334796|NCT02017977|General Surgery|general surgery
5334797|NCT02017977|Hospitals,General|hospitals,general
5334798|NCT02017977|Hospitals,Rural|hospitals,rural
5334799|NCT02017977|Hospitals,Urban|hospitals,urban
5334800|NCT02017977|Rural Health Services|rural health services
5334801|NCT02017977|Geography, Medical|geography, medical
5963327|NCT04254783|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5334802|NCT02017977|Outcome Assessment (Health Care)|outcome assessment (health care)
5334803|NCT02017951|Appendectomy|appendectomy
5334804|NCT02017951|Hospitals,General|hospitals,general
5334805|NCT02017951|Hospitals,Rural|hospitals,rural
5334806|NCT02017951|Hospitals,Urban|hospitals,urban
5334807|NCT02017951|Rural Health Services|rural health services
5334808|NCT02017951|Geography, Medical|geography, medical
5334809|NCT02017951|Outcome Assessment (Health Care)|outcome assessment (health care)
5334811|NCT02017938|electromyography (EMG)|electromyography (emg)
5334812|NCT02017938|central fatigue|central fatigue
5334813|NCT02017938|cycling training|cycling training
5334814|NCT02017925|Pulmonary Rehabilitation|pulmonary rehabilitation
5334815|NCT02017925|Non-Small Cell Lung Cancer|non-small cell lung cancer
5334816|NCT02017925|NSCLC|nsclc
5334817|NCT02017912|Mesenchymal Stromal cells|mesenchymal stromal cells
5334818|NCT02017912|MSC-NTF|msc-ntf
5334819|NCT02017912|Cell therapy|cell therapy
5334820|NCT02017912|ALS|als
5334821|NCT02017899|prevention|prevention
5334822|NCT02017899|Shigella sonnei|shigella sonnei
5334823|NCT02017886|Probiotics|probiotics
5334824|NCT02017886|Oral health|oral health
5334825|NCT02017886|Innate immunity|innate immunity
5334826|NCT02017873|bleaching|bleaching
5334827|NCT02017873|smokers|smokers
5334828|NCT02017873|effectiveness|effectiveness
5334829|NCT02017873|pain|pain
5334830|NCT02017860|RAD001, everolimus, roll-over|rad001, everolimus, roll-over
5334831|NCT02017847|oxygen consumption|oxygen consumption
5334832|NCT02017847|activity monitors|activity monitors
5334833|NCT02017847|METs|mets
5334834|NCT02017847|intensity|intensity
5334835|NCT02017834|oral cavity squamous cell carcinoma|oral cavity squamous cell carcinoma
5334836|NCT02017834|head and neck cancer|head and neck cancer
5334837|NCT02017834|oral cancer|oral cancer
5334838|NCT02017821|Exercise|exercise
5334839|NCT02017821|Oxygen Consumption|oxygen consumption
5334840|NCT02017821|mental health|mental health
5334842|NCT02017808|Copaxone|copaxone
5334843|NCT02017808|Multiple sclerosis|multiple sclerosis
5334844|NCT02017808|relapsing-remitting|relapsing-remitting
5334845|NCT02017795|asthma, mixed asthma, telehealth, action plan, exacerbation|asthma, mixed asthma, telehealth, action plan, exacerbation
5334846|NCT02017782|Dust|dust
5334847|NCT02017782|Ozone|ozone
5334848|NCT02017782|Indoor air quality|indoor air quality
5334849|NCT02017782|Indoor environment|indoor environment
5334850|NCT02017782|Indoor climate|indoor climate
5334851|NCT02017782|Cardiovascular diseases|cardiovascular diseases
5334852|NCT02017782|Full body exposure|full body exposure
5334853|NCT02017782|Exposure experiment with dust and ozone|exposure experiment with dust and ozone
5334854|NCT02017782|Acute exposure to ozone and dust|acute exposure to ozone and dust
5334855|NCT02017782|Respiratory outcomes|respiratory outcomes
5334856|NCT02017782|Cardiovascular outcomes|cardiovascular outcomes
5334857|NCT02017782|Acoustic rhinometry|acoustic rhinometry
5334858|NCT02017782|Body inflammatory markers|body inflammatory markers
5334859|NCT02017782|Cytokines|cytokines
5334860|NCT02017782|Exhaled FeNO|exhaled feno
5334861|NCT02017782|Nasal Lavage|nasal lavage
5334862|NCT02017782|Heart rate variability|heart rate variability
5334863|NCT02017782|Blood biomarkers|blood biomarkers
5334864|NCT02017782|Subjective discomfort|subjective discomfort
5334865|NCT02017782|General mucosal irritation|general mucosal irritation
5334866|NCT02017769|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
5334867|NCT02017769|Magnetic resonance imaging|magnetic resonance imaging
5334868|NCT02017756|Carotid artery|carotid artery
5334869|NCT02017756|Atherosclerosis|atherosclerosis
5334870|NCT02017756|Vulnerable plaque|vulnerable plaque
5334871|NCT02017756|Magnetic resonance imaging|magnetic resonance imaging
5334872|NCT02017756|Arterial wall|arterial wall
5334873|NCT02017704|Endorectal Brachytherapy Radiation Therapy|endorectal brachytherapy radiation therapy
5334874|NCT02017704|Intensity Modulated Radiation Therapy and Capecitabine|intensity modulated radiation therapy and capecitabine
5334875|NCT02017678|JX-594|jx-594
5334876|NCT02017678|Ovarian cancer|ovarian cancer
5334877|NCT02017678|Peritoneal|peritoneal
5677619|NCT00589745|Diagnosis|diagnosis
5334878|NCT02017678|Carcinomatosis|carcinomatosis
5334879|NCT02017678|Vaccinia virus|vaccinia virus
5334880|NCT02017678|Oncolytic virus|oncolytic virus
5334881|NCT02017665|encephalitis|encephalitis
5334882|NCT02017665|viral infections|viral infections
5334883|NCT02017665|central nervous system|central nervous system
5334884|NCT02017652|bowel motility|bowel motility
5334885|NCT02017652|cerebral perfusion|cerebral perfusion
5334886|NCT02017652|intestinal perfusion|intestinal perfusion
5334887|NCT02017626|Fish allergy|fish allergy
5334888|NCT02017626|immunotherapy|immunotherapy
5334889|NCT02017626|hypoallergen|hypoallergen
5334890|NCT02017613|CLL, SLL, NHL, SLL, PTCL, CTCL, MM, AML|cll, sll, nhl, sll, ptcl, ctcl, mm, aml
5334892|NCT02017574|Cerebral Infarction|cerebral infarction
5334893|NCT02017561|Diastolic dysfunction|diastolic dysfunction
5334894|NCT02017561|Metabolic syndrome|metabolic syndrome
5334895|NCT02017561|Metformin|metformin
5334896|NCT02017548|advance directives, advance care planning|advance directives, advance care planning
5334898|NCT02017522|Cardiac sarcoidosis|cardiac sarcoidosis
5334899|NCT02017522|FDG|fdg
5334900|NCT02017522|Cardiac MRI|cardiac mri
5334901|NCT02017509|Immunophenotype|immunophenotype
5334902|NCT02017509|Immunoscore|immunoscore
5334903|NCT02017509|MRI|mri
5334904|NCT02017509|RNA Later|rna later
5334905|NCT02017496|Breast cancer|breast cancer
5334906|NCT02017496|locally advanced|locally advanced
5334907|NCT02017496|neoadjuvant treatment|neoadjuvant treatment
5334908|NCT02017496|breast conserving surgery|breast conserving surgery
5334909|NCT02017483|ADHD,|adhd,
5334910|NCT02017483|emotion recognition|emotion recognition
5334911|NCT02017483|attention|attention
5334912|NCT02017470|Women Heart Health|women heart health
5334913|NCT02017470|Cardiovascular Disease|cardiovascular disease
5334914|NCT02017470|focus group|focus group
5334915|NCT02017470|advisory board|advisory board
5334916|NCT02017470|one-on-one interview|one-on-one interview
5334917|NCT02017457|Hematology|hematology
5334918|NCT02017457|Acute Myelogenous Leukemia|acute myelogenous leukemia
5334919|NCT02017457|Myelodysplasic syndrome|myelodysplasic syndrome
5334920|NCT02017457|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5334921|NCT02017457|Donor lymphocyte infusion|donor lymphocyte infusion
5334922|NCT02017457|DLI|dli
5334923|NCT02017457|Azacytidine|azacytidine
5334924|NCT02017457|Vidaza|vidaza
5334925|NCT02017457|Overall response rate|overall response rate
5334939|NCT02017431|Particle depleted diesel exhaust|particle depleted diesel exhaust
5334941|NCT02017431|Airway responsiveness|airway responsiveness
5334942|NCT02017431|Allergies|allergies
5334943|NCT02017418|zeaxanthin|zeaxanthin
5334944|NCT02017418|visual function|visual function
5334945|NCT02017418|reaction time|reaction time
5334946|NCT02017418|processing speed|processing speed
5334947|NCT02017405|Digestibility|digestibility
5334948|NCT02017405|Healthy volunteers|healthy volunteers
5334949|NCT02017405|serum-derived bovine immunoglobulin protein isolate|serum-derived bovine immunoglobulin protein isolate
5334950|NCT02017405|bovine IgG|bovine igg
5334951|NCT02017405|adults|adults
5334952|NCT02017392|postoperative agitation|postoperative agitation
5334953|NCT02017392|endotracheal intubation|endotracheal intubation
5334954|NCT02017392|general anesthesia|general anesthesia
5334955|NCT02017379|upper gastrointestinal bleeding|upper gastrointestinal bleeding
5334956|NCT02017379|melena|melena
5334957|NCT02017379|hematemesis|hematemesis
5334958|NCT02017366|Surgery|surgery
5334959|NCT02017366|Malnutrition|malnutrition
5334960|NCT02017366|Nutrition, Enteral|nutrition, enteral
5334961|NCT02017340|Alzheimer's Disease|alzheimer's disease
5334962|NCT02017340|Investigator-driven clinical trial|investigator-driven clinical trial
5334963|NCT02017340|Nilvadipine|nilvadipine
5334964|NCT02017340|Calcium Channel blocker|calcium channel blocker
5334965|NCT02017340|Elderly|elderly
5334966|NCT02017340|Therapeutic Intervention|therapeutic intervention
5334967|NCT02017314|morbid obesity|morbid obesity
5334968|NCT02017314|postoperative pain|postoperative pain
5334969|NCT02017301|Liver Cirrhosis,Infection, Impedance, Body Composition|liver cirrhosis,infection, impedance, body composition
5334970|NCT02017288|Head and Neck Cancers|head and neck cancers
5334971|NCT02017288|Larynx|larynx
5334972|NCT02017288|Oropharynx|oropharynx
5334973|NCT02017288|Oral Cavity|oral cavity
5334974|NCT02017262|Self-care|self-care
5334975|NCT02017262|Patient education|patient education
5334976|NCT02017236|Food Effect|food effect
5334977|NCT02017236|Health subjects|health subjects
5334978|NCT02017223|Physical activity|physical activity
5334984|NCT02017197|Therapeutic Equivalency|therapeutic equivalency
5334985|NCT02017197|Warfarin|warfarin
5334986|NCT02017197|Drugs, Generic|drugs, generic
5334987|NCT02017197|Anticoagulants|anticoagulants
5334988|NCT02017197|Anticoagulants [Pharmacological Action]|anticoagulants [pharmacological action]
5334989|NCT02017197|Coumarins|coumarins
5334990|NCT02017184|Body Temperature Regulation Sensor Noninvasive|body temperature regulation sensor noninvasive
5334999|NCT02017158|Obesity|obesity
5335000|NCT02017158|Nutrition|nutrition
5335001|NCT02017158|Children|children
5335002|NCT02017145|infection|infection
5335003|NCT02017145|chloraprep|chloraprep
5335004|NCT02017145|chlorhexidine|chlorhexidine
5335005|NCT02017145|lower extremity surgery|lower extremity surgery
5335006|NCT02017145|antiseptic|antiseptic
5335007|NCT02017145|bacterial colonization|bacterial colonization
5335008|NCT02017132|Pomegranate|pomegranate
5335009|NCT02017132|Blood pressure|blood pressure
5335010|NCT02017132|Body composition|body composition
5335011|NCT02017132|Weight-loss|weight-loss
5335012|NCT02017132|Fat mass|fat mass
5335013|NCT02017132|Polyphenols|polyphenols
5335014|NCT02017132|Quality of Life|quality of life
5335015|NCT02017106|Varicose Veins|varicose veins
5335016|NCT02017093|CVA, rehabilitation|cva, rehabilitation
5335017|NCT02017080|fetal thyroid ultrasound|fetal thyroid ultrasound
5335018|NCT02017080|fetal fT4|fetal ft4
5335019|NCT02017080|antithyroid antibodies|antithyroid antibodies
5335020|NCT02017080|pregnancy|pregnancy
5335021|NCT02017080|autoimmune thyroid disease|autoimmune thyroid disease
5335022|NCT02017067|Resistance training|resistance training
5335023|NCT02017067|musculoskeletal conditions|musculoskeletal conditions
5335024|NCT02017067|RFD|rfd
5335126|NCT02016612|Recurrent|recurrent
5335025|NCT02017041|opioid dependence, buprenorphine, smartphone, suboxone|opioid dependence, buprenorphine, smartphone, suboxone
5335026|NCT02017015|Pancreatic cancer|pancreatic cancer
5335027|NCT02017015|Metastatic pancreatic cancer|metastatic pancreatic cancer
5335028|NCT02017015|treatment for pancreatic cancer|treatment for pancreatic cancer
5335029|NCT02017015|Abraxane clinical research trials|abraxane clinical research trials
5335030|NCT02017015|Celgene clinical research trials|celgene clinical research trials
5335031|NCT02017002|Esophageal cancer|esophageal cancer
5335032|NCT02017002|minimally invasive|minimally invasive
5335033|NCT02017002|Surgical Procedures|surgical procedures
5335034|NCT02017002|Esophagectomy|esophagectomy
5335035|NCT02016989|Bacterial keratitis|bacterial keratitis
5335036|NCT02016989|OTR4120|otr4120
5335037|NCT02016989|Matrix therapy|matrix therapy
5335038|NCT02016963|Monoclonal Antibody|monoclonal antibody
5335039|NCT02016963|Safety|safety
5335040|NCT02016963|Raxibacumab|raxibacumab
5335051|NCT02016898|mitomycin-C|mitomycin-c
5335052|NCT02016898|express mini-shunt|express mini-shunt
5335053|NCT02016872|PET/CT|pet/ct
5335054|NCT02016872|18F-FMISO|18f-fmiso
5335055|NCT02016872|tumor hypoxia|tumor hypoxia
5335056|NCT02016872|13-186|13-186
5335057|NCT02016859|IPF Immature platelet fraction|ipf immature platelet fraction
5335058|NCT02016859|ICU neutropenic fever|icu neutropenic fever
5335059|NCT02016859|hip fracture|hip fracture
5335060|NCT02016859|critically ill|critically ill
5335061|NCT02016833|Ovarian Cancer|ovarian cancer
5335062|NCT02016833|Cervical Cancer|cervical cancer
5335063|NCT02016833|Leukemia|leukemia
5335064|NCT02016833|Immunity|immunity
5335065|NCT02016833|WT-1|wt-1
5335066|NCT02016833|Survivin|survivin
5335067|NCT02016833|HPV|hpv
5335068|NCT02016820|Clostridium Difficile Infection|clostridium difficile infection
5335069|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors
5335070|NCT02016820|Histamine-2 Receptor Antagonists|histamine-2 receptor antagonists
5335071|NCT02016820|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5335072|NCT02016807|Mucositis|mucositis
5335073|NCT02016807|Sucralfate|sucralfate
5335074|NCT02016807|Prothelial|prothelial
5335075|NCT02016807|High potency sucralfate|high potency sucralfate
5335076|NCT02016807|Ulcerations|ulcerations
5335077|NCT02016807|Chemotherapy induced diarrhea|chemotherapy induced diarrhea
5335078|NCT02016807|Radiation induced mucositis|radiation induced mucositis
5335079|NCT02016807|Chemotherapy colitis|chemotherapy colitis
5335080|NCT02016807|Radiation colitis|radiation colitis
5335081|NCT02016807|Mucosal erosions|mucosal erosions
5335082|NCT02016794|cervical|cervical
5335083|NCT02016794|interbody|interbody
5335084|NCT02016794|spacer|spacer
5335085|NCT02016794|degenerative|degenerative
5335086|NCT02016794|pain|pain
5335087|NCT02016794|neck|neck
5335088|NCT02016794|decompression|decompression
5335089|NCT02016794|fusion|fusion
5335090|NCT02016794|implant|implant
5335091|NCT02016781|Myelodysplastic Syndrome|myelodysplastic syndrome
5335092|NCT02016755|Peripheral Arterial Disease|peripheral arterial disease
5335093|NCT02016755|Vascular Disease|vascular disease
5335094|NCT02016755|CLI|cli
5335095|NCT02016755|Critical Limb Ischemia|critical limb ischemia
5335096|NCT02016755|PAD|pad
5335097|NCT02016755|AnGes|anges
5335098|NCT02016755|HGF Plasmid|hgf plasmid
5335099|NCT02016755|HGF|hgf
5335100|NCT02016755|Hepatocyte Growth Factor Plasmid|hepatocyte growth factor plasmid
5335101|NCT02016755|gene therapy|gene therapy
5335102|NCT02016742|Pharmacokinetics|pharmacokinetics
5335103|NCT02016729|AML|aml
5335104|NCT02016716|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5335105|NCT02016703|erythritol|erythritol
5335106|NCT02016703|polyol|polyol
5335107|NCT02016703|laxation|laxation
5335108|NCT02016703|gastrointestinal|gastrointestinal
5335109|NCT02016703|tolerance|tolerance
5335110|NCT02016703|soft drinks|soft drinks
5335111|NCT02016703|child|child
5335112|NCT02016703|diarrhoea|diarrhoea
5335113|NCT02016690|Prevention of severe RSV infection|prevention of severe rsv infection
5335114|NCT02016690|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
5335115|NCT02016690|Down Syndrome|down syndrome
5335116|NCT02016690|Immunocompromised|immunocompromised
5335117|NCT02016690|Effectiveness of palivizumab|effectiveness of palivizumab
5335118|NCT02016677|Breast reduction|breast reduction
5335119|NCT02016677|Mastopexy|mastopexy
5335120|NCT02016677|Sagging|sagging
5335121|NCT02016664|Chronic Pain, Ketamine, Safety|chronic pain, ketamine, safety
5335122|NCT02016638|Obstructive Sleep Apnea in pregnancy|obstructive sleep apnea in pregnancy
5335123|NCT02016638|Pregnancy induced hypertension|pregnancy induced hypertension
5335124|NCT02016638|Restless leg syndrome|restless leg syndrome
5335125|NCT02016638|Sleep|sleep
5335127|NCT02016612|Ptosis|ptosis
5335128|NCT02016612|Reduction|reduction
5335129|NCT02016612|Mammoplasty|mammoplasty
5335130|NCT02016612|Mastopexy|mastopexy
5335131|NCT02016599|Hypotension|hypotension
5335132|NCT02016599|Low blood pressure|low blood pressure
5335133|NCT02016599|Neonate|neonate
5335134|NCT02016599|Extremely Low Birth Weight Infant|extremely low birth weight infant
5335135|NCT02016573|renal denervation|renal denervation
5335136|NCT02016573|blood pressure|blood pressure
5335137|NCT02016573|cardiovascular risk|cardiovascular risk
5335138|NCT02016573|target organ damage|target organ damage
5335139|NCT02016573|sympathetic activity|sympathetic activity
5335140|NCT02016547|Stroke|stroke
5335141|NCT02016547|Middle Cerebral Artery|middle cerebral artery
5335142|NCT02016547|Thrombectomy|thrombectomy
5335143|NCT02016547|Mechanical Thrombolysis|mechanical thrombolysis
5335144|NCT02016547|Abciximab|abciximab
5335145|NCT02016534|MET Amplified Gastric / Gastroesophageal Junction / Esophageal Adenocarcinoma, or other solid tumors.|met amplified gastric / gastroesophageal junction / esophageal adenocarcinoma, or other solid tumors.
5335146|NCT02016521|Exercise|exercise
5335147|NCT02016521|Clothing|clothing
5335148|NCT02016521|Core body temperature|core body temperature
5335149|NCT02016521|Skin Temperature|skin temperature
5335150|NCT02016521|Performance|performance
5335151|NCT02016508|Adult bone marrow stem cells|adult bone marrow stem cells
5335152|NCT02016508|AMD|amd
5335153|NCT02016482|Nail Psoriasis|nail psoriasis
5335154|NCT02016482|Plaque Psoriasis|plaque psoriasis
5335155|NCT02016456|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5335156|NCT02016456|Neuronavigation|neuronavigation
5335157|NCT02016456|Magnetic Resonance Imaging|magnetic resonance imaging
5335158|NCT02016443|inguinal hernia|inguinal hernia
5335159|NCT02016430|TMAO|tmao
5335160|NCT02016430|Gut Flora|gut flora
5335161|NCT02016430|Dietary Intervention|dietary intervention
5335162|NCT02016430|Choline|choline
5335163|NCT02016430|Carnitine|carnitine
5335164|NCT02016417|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5335165|NCT02016417|Induction chemotherapy|induction chemotherapy
5335166|NCT02016417|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5229904|NCT02565108|CBD|cbd
5335167|NCT02016417|Gemcitabine|gemcitabine
5335168|NCT02016417|Docetaxel|docetaxel
5335169|NCT02016404|blood pressure|blood pressure
5335170|NCT02016404|sodium|sodium
5335171|NCT02016404|salt|salt
5335172|NCT02016404|low sodium high potassium salt|low sodium high potassium salt
5335173|NCT02016404|potassium|potassium
5335174|NCT02016404|Vietnam|vietnam
5335175|NCT02016404|randomized controlled trial|randomized controlled trial
5335176|NCT02016365|Transthyretin amyloidosis|transthyretin amyloidosis
5335177|NCT02016365|Cardiomyopathy|cardiomyopathy
5335178|NCT02016365|ATTR|attr
5335179|NCT02016365|neuropathy|neuropathy
5335180|NCT02016352|hydrocephalus|hydrocephalus
5335181|NCT02016352|proteomic|proteomic
5335182|NCT02016352|cerebrospinal fluid|cerebrospinal fluid
5335183|NCT02016326|Colonoscopy|colonoscopy
5335184|NCT02016326|High Definition White Light|high definition white light
5335185|NCT02016326|I-Scan|i-scan
5335186|NCT02016326|Adenomas|adenomas
5335187|NCT02016300|cartilage|cartilage
5335188|NCT02016300|microfracture|microfracture
5335189|NCT02016300|knee|knee
5335190|NCT02016300|bracing|bracing
5335191|NCT02016261|Cognitive function|cognitive function
5335192|NCT02016248|CyberKnife|cyberknife
5335193|NCT02016248|Prostate Cancer|prostate cancer
5335194|NCT02016248|Stereotactic Body Radiation|stereotactic body radiation
5335195|NCT02016248|SBRT|sbrt
5335196|NCT02016248|Radiosurgery|radiosurgery
5335197|NCT02016248|SABR|sabr
5335198|NCT02016248|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
5335199|NCT02016248|Boost|boost
5335200|NCT02016235|Dent|dent
5335201|NCT02016235|Dents|dents
5335202|NCT02016235|Dent Disease|dent disease
5335203|NCT02016235|Phosphorus Supplements|phosphorus supplements
5335204|NCT02016235|FGF 23|fgf 23
5335205|NCT02016222|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5335206|NCT02016222|diagnosis|diagnosis
5335207|NCT02016222|tears|tears
5335208|NCT02016222|isoelectric focusing|isoelectric focusing
5335209|NCT02016222|oligoclonal bands|oligoclonal bands
5335210|NCT02016196|TIPS|tips
5335211|NCT02016196|portal pressure|portal pressure
5335212|NCT02016196|rifaximin|rifaximin
5335213|NCT02016196|overt hepatic encephalopathy|overt hepatic encephalopathy
5335214|NCT02016196|microbiota|microbiota
5335215|NCT02016183|Drug Therapy|drug therapy
5331351|NCT02034032|TKA|tka
5335217|NCT02016170|ticagrelor|ticagrelor
5335218|NCT02016170|prasugrel|prasugrel
5335219|NCT02016157|Moxifloxacin|moxifloxacin
5335220|NCT02016157|Chlorhexidine|chlorhexidine
5335221|NCT02016157|In situ gel|in situ gel
5335222|NCT02016157|Chronic periodontitis|chronic periodontitis
5335223|NCT02016144|Airway management; Fiber optic technology; Intubation|airway management; fiber optic technology; intubation
5335224|NCT02016131|endoleak|endoleak
5335225|NCT02016131|EVAR|evar
5335227|NCT02016131|CQDSA|cqdsa
5335228|NCT02016118|RUTI|ruti
5335229|NCT02016105|plaque type psoriasis|plaque type psoriasis
5335234|NCT02016092|Parkinson's disease|parkinson's disease
5335235|NCT02016092|biomarkers|biomarkers
5335236|NCT02016092|blood|blood
5335237|NCT02016092|urine,|urine,
5335238|NCT02016092|proteomics|proteomics
5335239|NCT02016092|lipidomics|lipidomics
5335240|NCT02016092|metabolomics|metabolomics
5335241|NCT02016079|randomized controlled trial|randomized controlled trial
5335242|NCT02016079|omega-3|omega-3
5335248|NCT02016079|aggressive|aggressive
5335249|NCT02016066|Healthy|healthy
5335250|NCT02016066|CR6261|cr6261
5335251|NCT02016066|Japanese|japanese
5335252|NCT02016066|Safety|safety
5335253|NCT02016066|Pharmacokinetics|pharmacokinetics
5335254|NCT02016066|Immunogenicity|immunogenicity
5335255|NCT02016040|Prostate cancer|prostate cancer
5335256|NCT02016040|HIFU Hemi-ablation|hifu hemi-ablation
5335257|NCT02016040|Prostate biopsies|prostate biopsies
5335262|NCT02016001|fluoride|fluoride
5335263|NCT02016001|dental caries|dental caries
5335264|NCT02016001|prevention|prevention
5335265|NCT02015988|Acute coronary syndrome|acute coronary syndrome
5335266|NCT02015988|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5335267|NCT02015988|Hypertriglyceridemia|hypertriglyceridemia
5335268|NCT02015988|Simvastatin|simvastatin
5335269|NCT02015988|Fenofibrate|fenofibrate
5335270|NCT02015975|patellar fracture|patellar fracture
5335271|NCT02015975|fracture of patella|fracture of patella
5335272|NCT02015975|patella|patella
5335273|NCT02015975|locking plate osteosynthesis|locking plate osteosynthesis
5335274|NCT02015975|osteosynthesis|osteosynthesis
5335275|NCT02015975|star-plate|star-plate
5335276|NCT02015975|arrow-plate|arrow-plate
5335277|NCT02015962|Hypokalemia|hypokalemia
5335278|NCT02015962|Intravenous|intravenous
5335279|NCT02015962|Enteral|enteral
5335280|NCT02015962|post-cardiac surgery|post-cardiac surgery
5335281|NCT02015936|stage III cancer|stage iii cancer
5335282|NCT02015936|stage IV cancer|stage iv cancer
5335283|NCT02015936|cancer|cancer
5335284|NCT02015936|advanced stage cancer|advanced stage cancer
5335285|NCT02015936|Nintendo Wii training|nintendo wii training
5335286|NCT02015936|exercise|exercise
5335287|NCT02015936|physical training|physical training
5335288|NCT02015936|physical function|physical function
5335289|NCT02015936|physical fitness test|physical fitness test
5335290|NCT02015923|Colonic cancer|colonic cancer
5335291|NCT02015923|Metastasis|metastasis
5335292|NCT02015884|Incivility|incivility
5335293|NCT02015884|Rudeness|rudeness
5335294|NCT02015884|Aggression|aggression
5335295|NCT02015884|Violent act|violent act
5335296|NCT02015884|Healthcare workers|healthcare workers
5335297|NCT02015884|Emergency unit|emergency unit
5335298|NCT02015832|SYNTAX II Score|syntax ii score
5335299|NCT02015832|Pressure wires|pressure wires
5335300|NCT02015832|instantaneous wave-free ratio|instantaneous wave-free ratio
5335301|NCT02015832|fractional flow reserve|fractional flow reserve
5335302|NCT02015832|intravascular ultrasound|intravascular ultrasound
5335303|NCT02015832|Drug eluting stents|drug eluting stents
5335304|NCT02015832|Stents|stents
5335305|NCT02015832|Angioplasty|angioplasty
5335306|NCT02015832|multi slice computed tomography|multi slice computed tomography
5335307|NCT02015806|Quality improvement|quality improvement
5335308|NCT02015806|Randomized controlled trial|randomized controlled trial
5335309|NCT02015806|Medication adherence|medication adherence
5335310|NCT02015806|RxTimer Cap|rxtimer cap
5335311|NCT02015806|PillMinder|pillminder
5335312|NCT02015806|Take-N-Slide|take-n-slide
5335313|NCT02015806|Low-touch devices|low-touch devices
5335314|NCT02015806|Medication management|medication management
5335315|NCT02015793|Crohn's Disease|crohn's disease
5335316|NCT02015793|Pharmacokinetics|pharmacokinetics
5335317|NCT02015780|Drug therapy|drug therapy
5335318|NCT02015767|Drug therapy|drug therapy
5335319|NCT02015728|Refractory|refractory
5335320|NCT02015728|Recurrent|recurrent
5335321|NCT02015728|Brain|brain
5335322|NCT02015728|Tumor|tumor
5335323|NCT02015728|Pediatric|pediatric
5335324|NCT02015728|Biologically Targeted Therapy|biologically targeted therapy
5335325|NCT02015728|Sorafenib|sorafenib
5335326|NCT02015728|Everolimus|everolimus
5335327|NCT02015728|Erlotinib|erlotinib
5335328|NCT02015728|Dasatinib|dasatinib
5335329|NCT02015728|Temozolomide|temozolomide
5335330|NCT02015728|Etoposide|etoposide
5335331|NCT02015702|Physicians|physicians
5335332|NCT02015702|Electronic Health Record|electronic health record
5335333|NCT02015702|Education|education
5335334|NCT02015663|Cystic Fibrosis|cystic fibrosis
5335336|NCT02015650|Locally advanced squamous cell carcinomas of head and neck|locally advanced squamous cell carcinomas of head and neck
5335337|NCT02015637|Gonorrhea|gonorrhea
5335338|NCT02015637|N. gonorrhoeae|n. gonorrhoeae
5335339|NCT02015637|bacterial infection|bacterial infection
5335340|NCT02015637|Anti-Infective Agents|anti-infective agents
5335341|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents
5335342|NCT02015624|Acute coronary syndromes|acute coronary syndromes
5335343|NCT02015624|Intensive Care Unit|intensive care unit
5335344|NCT02015611|Vitamin D|vitamin d
5335345|NCT02015611|Muscle power|muscle power
5335346|NCT02015611|Muscle fiber|muscle fiber
5335348|NCT02015611|Aging|aging
5335349|NCT02015598|Obstructive sleep apnoea|obstructive sleep apnoea
5335350|NCT02015598|Antioxidant|antioxidant
5335351|NCT02015598|drug treatment|drug treatment
5335352|NCT02015598|oxidative stress|oxidative stress
5335353|NCT02015598|Continuous Positive Airway Pressure|continuous positive airway pressure
5335354|NCT02015572|Low back pain|low back pain
5335355|NCT02015572|Return to work|return to work
5335356|NCT02015572|Sickness absence|sickness absence
5335357|NCT02015572|Rehabilitation|rehabilitation
5335358|NCT02015572|Occupational intervention|occupational intervention
5335359|NCT02015546|Major Depressive Disorder|major depressive disorder
5335360|NCT02015546|Vilazodone|vilazodone
5335361|NCT02015533|Healthy|healthy
5335362|NCT02015533|CR8020|cr8020
5335363|NCT02015533|Japanese|japanese
5335364|NCT02015533|Safety|safety
5335365|NCT02015533|Pharmacokinetics|pharmacokinetics
5335366|NCT02015533|Immunogenicity|immunogenicity
5335367|NCT02015494|Safety|safety
5335368|NCT02015494|Immunogenicity|immunogenicity
5335369|NCT02015481|Case control, safety, tolerability, efficacy.|case control, safety, tolerability, efficacy.
5335370|NCT02015468|Distal radius fracture|distal radius fracture
5335371|NCT02015468|Wrist fracture|wrist fracture
5335372|NCT02015468|Physiotherapy|physiotherapy
5335373|NCT02015468|Immobilization|immobilization
5335374|NCT02015468|Volar locking plates|volar locking plates
5335375|NCT02015468|Mobilization|mobilization
5335376|NCT02015455|pragmatic trial|pragmatic trial
5335377|NCT02015455|stepped-wedge design|stepped-wedge design
5335378|NCT02015455|cluster-randomized trial|cluster-randomized trial
5335379|NCT02015442|Sucrose in diet|sucrose in diet
5335380|NCT02015429|Food intake|food intake
5335381|NCT02015429|satiety|satiety
5335382|NCT02015429|glycemia|glycemia
5335383|NCT02015429|appetite|appetite
5335384|NCT02015429|blood glucose|blood glucose
5335385|NCT02015429|yellow peas|yellow peas
5335386|NCT02015429|fibre|fibre
5335387|NCT02015429|protein|protein
5335388|NCT02015429|mixed meal|mixed meal
5335389|NCT02015416|Melanoma|melanoma
5335390|NCT02015416|Ovarian cancer|ovarian cancer
5335391|NCT02015416|Sarcoma|sarcoma
5335392|NCT02015416|Non-small cell lung cancer|non-small cell lung cancer
5335393|NCT02015416|NSCLC|nsclc
5335394|NCT02015416|Breast cancer|breast cancer
5335395|NCT02015390|bone defects|bone defects
5335396|NCT02015390|iatrogenic resection|iatrogenic resection
5335397|NCT02015390|titanium mesh cage|titanium mesh cage
5335398|NCT02015390|biomembrane|biomembrane
5335399|NCT02015390|Masquelet technique|masquelet technique
5335400|NCT02015364|Achilles tendon|achilles tendon
5335401|NCT02015364|Rupture|rupture
5335402|NCT02015364|Rehabilitation|rehabilitation
5335403|NCT02015364|Dynamic rehabilitation|dynamic rehabilitation
5335404|NCT02015351|Choroidal neovascularization|choroidal neovascularization
5335405|NCT02015351|Vogt Koyanagi Harada Disease|vogt koyanagi harada disease
5335406|NCT02015351|Inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
5335407|NCT02015351|Anti-VEGF|anti-vegf
5335408|NCT02015338|Hemiparesis|hemiparesis
5335409|NCT02015338|Cerebral Palsy|cerebral palsy
5335410|NCT02015338|Congenital Stroke|congenital stroke
5335411|NCT02015338|Congenital Infarct|congenital infarct
5335412|NCT02015325|Water|water
5335413|NCT02015325|Sanitation|sanitation
5335414|NCT02015325|Hygiene|hygiene
5335415|NCT02015325|Education|education
5335416|NCT02015325|Evaluation|evaluation
5335417|NCT02015312|Amyloidosis|amyloidosis
5335418|NCT02015299|Diabetes|diabetes
5335419|NCT02015299|Pulse Wave Velocity|pulse wave velocity
5335420|NCT02015299|Dipeptidyl peptidase (DPP)-4 inhibitors|dipeptidyl peptidase (dpp)-4 inhibitors
5335421|NCT02015299|Linagliptin|linagliptin
5335422|NCT02015299|Arterial Stiffness|arterial stiffness
5335423|NCT02015299|Subclinical arterial inflammation|subclinical arterial inflammation
5335424|NCT02015286|Growth disorders|growth disorders
5335425|NCT02015286|Saizen|saizen
5335426|NCT02015286|Easypod|easypod
5335427|NCT02015286|Growth hormone|growth hormone
5335428|NCT02015286|Pediatric subject|pediatric subject
5335429|NCT02015273|easypod™|easypod™
5335430|NCT02015273|SAIZEN®|saizen®
5335431|NCT02015260|human papilloma virus infection|human papilloma virus infection
5335432|NCT02015260|Anogenital warts|anogenital warts
5335433|NCT02015260|condylomata acuminata|condylomata acuminata
5335434|NCT02015234|TNX-102 SL|tnx-102 sl
5335435|NCT02015234|bedtime|bedtime
5335436|NCT02015234|sublingual|sublingual
5335437|NCT02015234|12-month|12-month
5335543|NCT02014870|Influenza|influenza
5335439|NCT02015234|long term efficacy|long term efficacy
5335440|NCT02015234|Fibromyalgia|fibromyalgia
5335441|NCT02015221|chronic venous insufficiency|chronic venous insufficiency
5335442|NCT02015221|venous leg ulcers|venous leg ulcers
5335443|NCT02015221|pneumatic compression|pneumatic compression
5335445|NCT02015208|cytokine signaling|cytokine signaling
5335446|NCT02015208|signal transduction inhibitors|signal transduction inhibitors
5335448|NCT02015208|p53|p53
5335449|NCT02015195|Jellyfish stings|jellyfish stings
5339601|NCT01996813|obesity|obesity
5335450|NCT02015195|Treatment|treatment
5335452|NCT02015195|Topical Treatments|topical treatments
5335453|NCT02015195|Pain|pain
5335454|NCT02015195|Erythema|erythema
5335455|NCT02015182|Bupivacaine|bupivacaine
5335456|NCT02015182|Sensorcaine|sensorcaine
5335457|NCT02015182|Population pharmacokinetics|population pharmacokinetics
5335458|NCT02015182|Children|children
5335459|NCT02015182|Pediatrics|pediatrics
5963328|NCT04254783|Crohn's Disease|crohn's disease
5963329|NCT04254783|Risankizumab|risankizumab
5335460|NCT02015182|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
5335461|NCT02015182|Regional Anesthesia|regional anesthesia
5335462|NCT02015169|gastric cancer|gastric cancer
5335463|NCT02015169|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5335464|NCT02015169|capecitabine|capecitabine
5335465|NCT02015169|oxaliplatin|oxaliplatin
5335466|NCT02015169|lapatinib|lapatinib
5335467|NCT02015156|Trastuzumab|trastuzumab
5335468|NCT02015156|Healthy Male Volunteers|healthy male volunteers
5335469|NCT02015156|Single-Dose|single-dose
5335471|NCT02015156|Biosimilarity|biosimilarity
5335472|NCT02015130|Type 2 diabetes|type 2 diabetes
5335473|NCT02015130|hypertension|hypertension
5335474|NCT02015130|individual|individual
5335475|NCT02015104|Urothelial Carcinoma|urothelial carcinoma
5335476|NCT02015104|Vaccines|vaccines
5335477|NCT02015104|Immunotherapy|immunotherapy
5335478|NCT02015104|TICE BCG|tice bcg
5335479|NCT02015104|Intravesical Treatment|intravesical treatment
5335480|NCT02015091|Healthy Subjects|healthy subjects
5335481|NCT02015091|Vaccine-Mediated Protection|vaccine-mediated protection
5335482|NCT02015091|Immunogenicity|immunogenicity
5335483|NCT02015091|Sporozoites|sporozoites
5335484|NCT02015091|Parasitemia|parasitemia
5335485|NCT02015078|African American|african american
5335486|NCT02015078|Eating Behavior Phenotypes|eating behavior phenotypes
5335487|NCT02015078|Obesity|obesity
5335488|NCT02015065|GIST|gist
5335489|NCT02015065|Small Molecule|small molecule
5335490|NCT02015065|Mesenchymal Tumor|mesenchymal tumor
5335491|NCT02015065|Receptor Tyrosine Kinase|receptor tyrosine kinase
5335492|NCT02015065|Survival|survival
5335493|NCT02015039|Occupational Therapy|occupational therapy
5335494|NCT02015039|Botulinum Toxin|botulinum toxin
5335495|NCT02015039|Writer's Cramp|writer's cramp
5335496|NCT02015026|Biospecimen Repository|biospecimen repository
5335497|NCT02015026|Disease Progression Pattern|disease progression pattern
5335498|NCT02015026|Specimen Analysis|specimen analysis
5335499|NCT02015026|Genetic Analysis|genetic analysis
5335500|NCT02015013|Leukapheresis|leukapheresis
5335501|NCT02015013|Progenitor Cells|progenitor cells
5335502|NCT02015000|Pterygium|pterygium
5335503|NCT02015000|Recurrence|recurrence
5335504|NCT02014987|Running related injury|running related injury
5335505|NCT02014987|Overuse injury|overuse injury
5335506|NCT02014987|Running pattern|running pattern
5335507|NCT02014974|Fractures|fractures
5335508|NCT02014974|burden of fractures|burden of fractures
5335509|NCT02014974|orthopaedic fractures|orthopaedic fractures
5335510|NCT02014974|orthopaedic injuries|orthopaedic injuries
5335511|NCT02014974|orthopaedic trauma|orthopaedic trauma
5335512|NCT02014974|fractures India|fractures india
5335513|NCT02014974|observational study|observational study
5335514|NCT02014974|outcomes of fracture care|outcomes of fracture care
5335515|NCT02014974|wait times India|wait times india
5335516|NCT02014974|epidemiology|epidemiology
5335517|NCT02014948|Low Back Pain|low back pain
5335518|NCT02014948|Physiotherapy|physiotherapy
5335519|NCT02014935|Low-intensity Laser|low-intensity laser
5335520|NCT02014935|Spasticity|spasticity
5335521|NCT02014935|pain,|pain,
5335522|NCT02014935|Fatigue|fatigue
5335523|NCT02014909|KTN3379|ktn3379
5335524|NCT02014909|Advanced cancer|advanced cancer
5335525|NCT02014909|Phase 1|phase 1
5335526|NCT02014909|Monoclonal antibody|monoclonal antibody
5335527|NCT02014909|Safety and pharmacokinetics|safety and pharmacokinetics
5335528|NCT02014909|CDX3379|cdx3379
5335529|NCT02014896|Ischemic Stroke|ischemic stroke
5335530|NCT02014896|Transient Ischemic Attack|transient ischemic attack
5335531|NCT02014896|Transient Neurological Event|transient neurological event
5335532|NCT02014896|Atrial Fibrillation|atrial fibrillation
5335533|NCT02014896|Cryptogenic Stroke|cryptogenic stroke
5335534|NCT02014896|Gene Expression|gene expression
5335536|NCT02014896|Anticoagulant|anticoagulant
5335537|NCT02014896|NOAC|noac
5335538|NCT02014896|Antiplatelet|antiplatelet
5335539|NCT02014896|Cardiac monitoring|cardiac monitoring
5335540|NCT02014896|Point of Care|point of care
5335542|NCT02014896|Atheroembolic|atheroembolic
5335544|NCT02014870|Vaccine|vaccine
5335546|NCT02014870|H1N1|h1n1
5335547|NCT02014870|Challenge|challenge
5335548|NCT02014870|Vismederi|vismederi
5335549|NCT02014857|Smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers|smoking, gingival crevicular fluid, matrix metalloproteinases, intercellular signaling peptides and proteins, healthy volunteers
5335550|NCT02014844|glioblastoma|glioblastoma
5335551|NCT02014844|aldoxorubicin|aldoxorubicin
5335552|NCT02014844|temozolomide|temozolomide
5339707|NCT01996384|TCM|tcm
5335553|NCT02014844|brain cancer|brain cancer
5335554|NCT02014844|brain tumor|brain tumor
5335555|NCT02014831|Squamous Cell Carcinoma of the penis|squamous cell carcinoma of the penis
5335556|NCT02014831|Stage N3|stage n3
5335557|NCT02014831|Metastasis|metastasis
5335559|NCT02014831|Cetuximab|cetuximab
5335560|NCT02014831|Objective Response Rate|objective response rate
5335561|NCT02014831|Safety profile|safety profile
5335562|NCT02014831|Overall Survival|overall survival
5335563|NCT02014831|Progression Free Survival|progression free survival
5335564|NCT02014831|Quality of Life|quality of life
5335565|NCT02014805|postoperative|postoperative
5335566|NCT02014805|conformal|conformal
5335567|NCT02014805|radiotherapy|radiotherapy
5335568|NCT02014805|thymoma|thymoma
5335569|NCT02014792|Haemodialysis|haemodialysis
5335570|NCT02014792|Heart rate variability|heart rate variability
5335571|NCT02014792|n-3 PUFA|n-3 pufa
5335572|NCT02014779|Randomized Controlled Trial|randomized controlled trial
5335573|NCT02014779|Alcohol|alcohol
5335574|NCT02014779|Internet|internet
5335575|NCT02014779|Internet based therapy|internet based therapy
5335576|NCT02014779|Cognitive behavioral therapy|cognitive behavioral therapy
5335577|NCT02014753|AMI|ami
5335578|NCT02014753|STEMI|stemi
5335579|NCT02014753|ACS|acs
5335580|NCT02014740|Epicardial fat|epicardial fat
5335581|NCT02014740|Type 2 diabetes|type 2 diabetes
5335582|NCT02014740|Obesity|obesity
5335583|NCT02014740|GLP-1 analogs|glp-1 analogs
5335584|NCT02014727|Malaria vaccine|malaria vaccine
5335585|NCT02014727|phase 1,|phase 1,
5335586|NCT02014727|AMA1-DiCO|ama1-dico
5335587|NCT02014701|echocardiogram|echocardiogram
5335588|NCT02014701|regional wall motion abnormalities|regional wall motion abnormalities
5335589|NCT02014701|myocardial contrast|myocardial contrast
5335590|NCT02014688|Normal subjects|normal subjects
5335591|NCT02014675|ICD|icd
5335592|NCT02014675|CRT-D|crt-d
5335593|NCT02014675|Lead|lead
5335594|NCT02014662|Muscle function, Muscle damage and recovery, Eccentric exercise, Muscle soreness, Protein synthesis|muscle function, muscle damage and recovery, eccentric exercise, muscle soreness, protein synthesis
5335595|NCT02014649|Influenza treatment|influenza treatment
5335596|NCT02014649|pediatric|pediatric
5335597|NCT02014649|laninamivir|laninamivir
5335598|NCT02014636|Pazopanib (GW786034)|pazopanib (gw786034)
5335599|NCT02014636|MK 3475|mk 3475
5335600|NCT02014636|Renal cell carcinoma|renal cell carcinoma
5335601|NCT02014623|Allergic rhinitis|allergic rhinitis
5335602|NCT02014623|Asthma|asthma
5335603|NCT02014623|Regulatory T cells|regulatory t cells
5335604|NCT02014623|IgE|ige
5335605|NCT02014623|IgG4|igg4
5335606|NCT02014610|Neutrophil|neutrophil
5335607|NCT02014610|Lymphocyte|lymphocyte
5335608|NCT02014610|Eosinophil|eosinophil
5335609|NCT02014610|Leukocyte count|leukocyte count
5335610|NCT02014610|Cardiovascular disease|cardiovascular disease
5335611|NCT02014610|Atherosclerosis|atherosclerosis
5335612|NCT02014610|Monocyte|monocyte
5335613|NCT02014610|Basophil|basophil
5335614|NCT02014597|Glaucoma|glaucoma
5335615|NCT02014584|quality of life|quality of life
5335616|NCT02014584|safety|safety
5335617|NCT02014584|sexual function|sexual function
5335618|NCT02014584|male pattern hair loss (MPHL)|male pattern hair loss (mphl)
5335619|NCT02014584|Androgenic alopecia (AGA)|androgenic alopecia (aga)
5335620|NCT02014584|dutasteride|dutasteride
5335621|NCT02014584|satisfaction with hair growth|satisfaction with hair growth
5335622|NCT02014571|NS5B|ns5b
5335623|NCT02014571|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
5335624|NCT02014571|antiviral activity|antiviral activity
5335625|NCT02014571|pharmacokinetics (PK)|pharmacokinetics (pk)
5335626|NCT02014571|Safety|safety
5335627|NCT02014571|hepatitis C virus (HCV)|hepatitis c virus (hcv)
5335628|NCT02014571|GSK2878175|gsk2878175
5335629|NCT02014558|Acute Myeloid Leukemia|acute myeloid leukemia
5335630|NCT02014558|Gilteritinib|gilteritinib
5335631|NCT02014558|ASP2215|asp2215
5335632|NCT02014545|brain metastases|brain metastases
5335633|NCT02014545|non-small cell lung cancer|non-small cell lung cancer
5335634|NCT02014545|whole brain radiation therapy|whole brain radiation therapy
5335635|NCT02014545|lucanthone|lucanthone
5335636|NCT02014532|Leukotriene receptor antagonist|leukotriene receptor antagonist
5335637|NCT02014532|Chronic periodontitis|chronic periodontitis
5678920|NCT00584298|irritable|irritable
5335638|NCT02014532|Scaling and root planing|scaling and root planing
5335639|NCT02014532|C- reactive protein|c- reactive protein
5335640|NCT02014519|Adults|adults
5335641|NCT02014519|Hungary|hungary
5335642|NCT02014519|Bordetella pertussis|bordetella pertussis
5335643|NCT02014519|Seroprevalence|seroprevalence
5335644|NCT02014519|Pertussis antibodies|pertussis antibodies
5335645|NCT02014506|Children and adolescents|children and adolescents
5335647|NCT02014506|Non-malignant disease|non-malignant disease
5335648|NCT02014506|TCRαβ depletion|tcrαβ depletion
5335649|NCT02014506|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5335650|NCT02014493|Respiration|respiration
5335651|NCT02014493|Noninvasive Ventilation|noninvasive ventilation
5335652|NCT02014493|Work of breathing|work of breathing
5335657|NCT02014480|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5335658|NCT02014480|Umeclidinium|umeclidinium
5335659|NCT02014480|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5335660|NCT02014480|Vilanterol|vilanterol
5335661|NCT02014454|Retinopathy of prematurity|retinopathy of prematurity
5335662|NCT02014454|Propranolol|propranolol
5335663|NCT02014454|Eye drops|eye drops
5335664|NCT02014454|Newborns|newborns
5335665|NCT02014454|Retinal angiogenesis|retinal angiogenesis
5335666|NCT02014454|Retinal neovascularization|retinal neovascularization
5335667|NCT02014415|Alpha-1|alpha-1
5335668|NCT02014415|AAT Deficiency|aat deficiency
5335669|NCT02014415|AATD|aatd
5335670|NCT02014415|Liver|liver
5335671|NCT02014415|Fibrosis|fibrosis
5335672|NCT02014415|Liver Transplant|liver transplant
5335673|NCT02014415|Cirrhosis|cirrhosis
5335674|NCT02014402|Vascular surgery|vascular surgery
5335675|NCT02014402|Hepatic surgery|hepatic surgery
5335676|NCT02014402|Soft tissue surgery|soft tissue surgery
5335677|NCT02014402|Spinal surgery|spinal surgery
5335678|NCT02014389|Retinal Dystrophies|retinal dystrophies
5335679|NCT02014389|Retinitis Pigmentosa|retinitis pigmentosa
5335680|NCT02014389|Glaucoma|glaucoma
5335681|NCT02014389|Visual Field|visual field
5335682|NCT02014376|Epidermolysis Bullosa|epidermolysis bullosa
5335683|NCT02014376|Simplex|simplex
5335684|NCT02014376|Recessive Dystrophic|recessive dystrophic
5335685|NCT02014376|Junctional non-Herlitz|junctional non-herlitz
5335686|NCT02014376|Amicus Therapeutics|amicus therapeutics
5335687|NCT02014376|Scioderm, Inc.|scioderm, inc.
5335688|NCT02014376|SD-101 6%|sd-101 6%
5335689|NCT02014376|SD-101-6.0|sd-101-6.0
5335690|NCT02014376|Allantoin 6%|allantoin 6%
5335691|NCT02014376|SD-101 3%|sd-101 3%
5335692|NCT02014376|SD-101-3.0|sd-101-3.0
5335693|NCT02014376|Allantoin 3%|allantoin 3%
5335694|NCT02014376|Zorblisa|zorblisa
5335695|NCT02014337|Mifepristone|mifepristone
5335696|NCT02014337|Eribulin Mesylate|eribulin mesylate
5335697|NCT02014337|Breast Cancer|breast cancer
5335698|NCT02014337|Ovarian Cancer|ovarian cancer
5335699|NCT02014337|Sarcoma|sarcoma
5335700|NCT02014337|Non-small cell lung cancer|non-small cell lung cancer
5335701|NCT02014337|Carcinoma, transitional cell|carcinoma, transitional cell
5335702|NCT02014337|Prostate cancer|prostate cancer
5445416|NCT01521910|GFR|gfr
5335703|NCT02014337|Prostatic neoplasms|prostatic neoplasms
5335704|NCT02014311|Multidetector Computed Tomography|multidetector computed tomography
5335705|NCT02014311|Myocardial Perfusion Imaging|myocardial perfusion imaging
5335706|NCT02014311|Coronary Stenosis|coronary stenosis
5335707|NCT02014311|Coronary Artery Disease|coronary artery disease
5335708|NCT02014311|Angina Pectoris|angina pectoris
5335709|NCT02014298|Burns|burns
5335710|NCT02014298|Non-ablative fractional laser|non-ablative fractional laser
5335711|NCT02014298|scar texture|scar texture
5335712|NCT02014298|histology|histology
5335713|NCT02014298|laser treatment|laser treatment
5335714|NCT02014298|erbium:glass laser|erbium:glass laser
5335715|NCT02014298|meshed skin-grafts|meshed skin-grafts
5335716|NCT02014298|photothermolysis|photothermolysis
5335717|NCT02014298|skin|skin
5335718|NCT02014285|Acute Respiratory Failure|acute respiratory failure
5335719|NCT02014285|Critical Illness|critical illness
5335720|NCT02014285|Mechanical Ventilation|mechanical ventilation
5335721|NCT02014285|Muscle Architecture|muscle architecture
5335722|NCT02014285|Muscle Ultrasound|muscle ultrasound
5335723|NCT02014272|Bioequivalence|bioequivalence
5335724|NCT02014272|RIN 150|rin 150
5335725|NCT02014272|Healthy volunteers|healthy volunteers
5335730|NCT02014233|Randomized clinical trial|randomized clinical trial
5335731|NCT02014233|Humans|humans
5335732|NCT02014233|Omega-3 fatty acids|omega-3 fatty acids
5335733|NCT02014233|Essential fatty acid|essential fatty acid
5335734|NCT02014233|Neuromuscular function|neuromuscular function
5335735|NCT02014233|Wingate|wingate
5335736|NCT02014233|Maximum voluntary contraction|maximum voluntary contraction
5335737|NCT02014233|Electromyography|electromyography
5335738|NCT02014233|Seal oil|seal oil
5335739|NCT02014233|Cycling time trial|cycling time trial
5335740|NCT02014233|Placebo controlled|placebo controlled
5335741|NCT02014194|Attentional Bias|attentional bias
5335742|NCT02014194|Attentional Bias modification treatment|attentional bias modification treatment
5335743|NCT02014181|cystic fibrosis|cystic fibrosis
5335744|NCT02014181|isoprostanes|isoprostanes
5335745|NCT02014181|8-oxo-dGuo|8-oxo-dguo
5335746|NCT02014181|oxidative stress|oxidative stress
5335747|NCT02014181|inflammation|inflammation
5335748|NCT02014181|flaxseed|flaxseed
5335749|NCT02014181|enterodiol|enterodiol
5335751|NCT02014155|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
5335752|NCT02014103|bioequivalence|bioequivalence
5335754|NCT02014103|transplant|transplant
5335755|NCT02014103|CYP3A5 expressors/non expressors|cyp3a5 expressors/non expressors
5335756|NCT02014090|ECP|ecp
5335757|NCT02014090|Endurance exercise|endurance exercise
5335758|NCT02014090|myocardial perfusion|myocardial perfusion
5335759|NCT02014077|VATS( Video-Assisted Thoracoscopy )|vats( video-assisted thoracoscopy )
5335760|NCT02014077|Thoracostomy Tube|thoracostomy tube
5335761|NCT02014077|Empyema|empyema
5335762|NCT02014077|Thoracotomy|thoracotomy
5335763|NCT02014064|Methamphetamine, Atomoxetine, Clinical Pharmacology|methamphetamine, atomoxetine, clinical pharmacology
5335764|NCT02014038|Ultrarunners|ultrarunners
5335765|NCT02014038|ultramarathon runners|ultramarathon runners
5335766|NCT02014038|ULTRA|ultra
5335767|NCT02014038|Physical activity|physical activity
5335768|NCT02014038|Health Risks|health risks
5335769|NCT02014038|sedentary|sedentary
5335770|NCT02014038|moderately active|moderately active
5203281|NCT02724007|Trauma|trauma
5215191|NCT02651064|price incentive|price incentive
5215192|NCT02651051|Postprandial glycemia|postprandial glycemia
5215193|NCT02651051|Metabolic health measures|metabolic health measures
5335771|NCT02014025|Laparoscope hepatectomy|laparoscope hepatectomy
5335772|NCT02014025|Open hepatectomy|open hepatectomy
5335773|NCT02014025|large PHC|large phc
5335774|NCT02014025|safety and sensibility|safety and sensibility
5335775|NCT02013986|salivary cortisol|salivary cortisol
5335776|NCT02013986|circadian rhythm|circadian rhythm
5335777|NCT02013986|children|children
5335778|NCT02013986|etomidate|etomidate
5335779|NCT02013973|Anti mullerian hormone|anti mullerian hormone
5335780|NCT02013973|In vitro fertilization|in vitro fertilization
5335781|NCT02013973|Optimal treatment|optimal treatment
5335782|NCT02013973|Randomized controlled trial|randomized controlled trial
5335783|NCT02013947|Exercise, moderate altitude, hypoxia, metabolic syndrome|exercise, moderate altitude, hypoxia, metabolic syndrome
5335784|NCT02013921|Physical activity|physical activity
5335785|NCT02013921|Cancer|cancer
5335786|NCT02013908|acupuncture|acupuncture
5335787|NCT02013908|emergency department|emergency department
5335788|NCT02013908|acute pain|acute pain
5335789|NCT02013908|ankle sprain|ankle sprain
5335790|NCT02013908|neck pain|neck pain
5335791|NCT02013908|primary headache|primary headache
5335792|NCT02013895|liver|liver
5335793|NCT02013895|surgery|surgery
5335794|NCT02013895|liver function|liver function
5335795|NCT02013895|GSA|gsa
5335796|NCT02013895|ICG|icg
5335797|NCT02013882|low flow anesthesia|low flow anesthesia
5335798|NCT02013882|wash-in|wash-in
5335799|NCT02013882|desflurane|desflurane
5335800|NCT02013869|fresh gas flow|fresh gas flow
5335801|NCT02013869|quality of anaesthesia|quality of anaesthesia
5445417|NCT01521910|ESRD|esrd
5335802|NCT02013869|minimal alveolar concentration|minimal alveolar concentration
5335803|NCT02013856|Blood pressure|blood pressure
5335804|NCT02013856|Flavanols|flavanols
5335805|NCT02013856|Cardiovascular disease|cardiovascular disease
5335806|NCT02013843|Pediatric obesity|pediatric obesity
5335807|NCT02013843|Community-based treatment|community-based treatment
5335808|NCT02013843|dyslipidemia|dyslipidemia
5335809|NCT02013843|hypertension|hypertension
5335810|NCT02013843|diabetes|diabetes
5335811|NCT02013778|outside of transplant criteria|outside of transplant criteria
5335812|NCT02013752|Delivery tears|delivery tears
5335813|NCT02013752|Birth injuries|birth injuries
5335814|NCT02013752|Perineal protection device|perineal protection device
5335815|NCT02013713|Cardiology|cardiology
5335816|NCT02013713|Family Hypercholesterolemia|family hypercholesterolemia
5335817|NCT02013700|IPF|ipf
5335818|NCT02013700|Pulmonary fibrosis|pulmonary fibrosis
5335819|NCT02013674|Cardiovascular|cardiovascular
5335820|NCT02013674|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
5335821|NCT02013661|periodontal debridement|periodontal debridement
5335822|NCT02013661|sutures|sutures
5335823|NCT02013661|tissue reaction|tissue reaction
5335824|NCT02013648|AML|aml
5335825|NCT02013648|Dasatinib|dasatinib
5335826|NCT02013648|Core Binding Factor (CBF)|core binding factor (cbf)
5335827|NCT02013635|cerebral venous thrombosis|cerebral venous thrombosis
5335828|NCT02013635|thrombin generation|thrombin generation
5335829|NCT02013635|d-dimers|d-dimers
5335831|NCT02013622|schizophrenia|schizophrenia
5335832|NCT02013622|Mental Disorders|mental disorders
5335833|NCT02013622|Psychotic Disorders|psychotic disorders
5335834|NCT02013622|social avoidance|social avoidance
5335835|NCT02013622|emotional withdrawal|emotional withdrawal
5335836|NCT02013622|passive/apathetic|passive/apathetic
5335837|NCT02013622|social withdrawal|social withdrawal
5335838|NCT02013622|antipsychotic|antipsychotic
5335839|NCT02013609|schizophrenia|schizophrenia
5335840|NCT02013609|Major depressive disorder|major depressive disorder
5335841|NCT02013609|Anxiety Symptoms|anxiety symptoms
5335842|NCT02013609|School, Work environment|school, work environment
5336225|NCT02011815|distress|distress
5335843|NCT02013609|Mental Disorders|mental disorders
5335844|NCT02013609|Psychotic Disorders|psychotic disorders
5335845|NCT02013609|antipsychotic|antipsychotic
5335846|NCT02013596|hepatic dysfunction|hepatic dysfunction
5335847|NCT02013596|renal dysfunction|renal dysfunction
5335848|NCT02013596|pneumoperitoneum|pneumoperitoneum
5335849|NCT02013596|Transcutaneous electric stimulation|transcutaneous electric stimulation
5335850|NCT02013583|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
5335851|NCT02013583|Glucose Transporter Type 1 Deficiency|glucose transporter type 1 deficiency
5335853|NCT02013583|Glut1 Deficiency|glut1 deficiency
5335854|NCT02013570|postoperative pain; dexmedetomidine; adenotonsillectomy|postoperative pain; dexmedetomidine; adenotonsillectomy
5335855|NCT02013557|Gestational Diabetes|gestational diabetes
5335856|NCT02013557|Postpartum screening|postpartum screening
5335857|NCT02013557|Text-messages|text-messages
5335858|NCT02013557|75-g oral glucose tolerance test|75-g oral glucose tolerance test
5963330|NCT04254783|SKYRIZI|skyrizi
5963331|NCT04254783|ABBV-066|abbv-066
5963332|NCT04254783|Cytochrome P450|cytochrome p450
5963333|NCT04254302|Tele-intervention|tele-intervention
5963334|NCT04254302|Motor delay|motor delay
5963335|NCT04254302|Child|child
5335859|NCT02013544|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
5335860|NCT02013544|Vaginal atrophy|vaginal atrophy
5335861|NCT02013544|Atrophic vaginitis|atrophic vaginitis
5335862|NCT02013544|prasterone|prasterone
5335864|NCT02013544|Intrarosa|intrarosa
5335865|NCT02013531|schizophrenia|schizophrenia
5335866|NCT02013531|Major depressive disorder|major depressive disorder
5335867|NCT02013531|Anxiety Symptoms|anxiety symptoms
5335868|NCT02013531|Mental Disorders|mental disorders
5335869|NCT02013531|Psychotic Disorders|psychotic disorders
5335870|NCT02013531|emotional withdrawal|emotional withdrawal
5335871|NCT02013531|antipsychotic|antipsychotic
5335872|NCT02013518|Alzheimers' disease|alzheimers' disease
5335873|NCT02013518|Cognitive behavioral therapy|cognitive behavioral therapy
5335874|NCT02013518|Depression|depression
5335875|NCT02013518|Self-efficacy|self-efficacy
5335876|NCT02013518|Quality of Life|quality of life
5335877|NCT02013505|Colonoscopy|colonoscopy
5335878|NCT02013492|Beta-Blocker|beta-blocker
5335879|NCT02013492|metastatic melanoma|metastatic melanoma
5335880|NCT02013492|hepatocellular carcinoma|hepatocellular carcinoma
5335881|NCT02013466|Bioavailability|bioavailability
5335882|NCT02013466|Amino Acids|amino acids
5335884|NCT02013466|Supplement|supplement
5335885|NCT02013427|chronic|chronic
5335886|NCT02013427|back|back
5335887|NCT02013427|pain|pain
5335888|NCT02013427|brain|brain
5335889|NCT02013427|MRI|mri
5335890|NCT02013401|mother-infant dyadic regulation|mother-infant dyadic regulation
5335891|NCT02013401|stress|stress
5335892|NCT02013401|psychophysiology|psychophysiology
5335893|NCT02013401|emotion regulation|emotion regulation
5335894|NCT02013388|N91115|n91115
5335895|NCT02013388|GSNORi|gsnori
5335896|NCT02013388|SNO|sno
5335897|NCT02013388|Cavosonstat|cavosonstat
5335898|NCT02013336|pediatric|pediatric
5335899|NCT02013336|MM-398|mm-398
5335900|NCT02013336|cyclophosphamide|cyclophosphamide
5335901|NCT02013336|irinotecan|irinotecan
5335902|NCT02013323|Septiline, chronic periodontitis, Immunomodulator, microbiology|septiline, chronic periodontitis, immunomodulator, microbiology
5335903|NCT02013297|Pediatrics|pediatrics
5335904|NCT02013297|SBRT|sbrt
5335905|NCT02013297|Brain metastasis|brain metastasis
5335906|NCT02013297|Pulmonary metastasis|pulmonary metastasis
5335907|NCT02013297|Spinal metastasis|spinal metastasis
5335908|NCT02013297|Pulmonary primary tumor|pulmonary primary tumor
5335909|NCT02013297|Spinal primary tumor|spinal primary tumor
5335910|NCT02013297|Relapsed ependymoma|relapsed ependymoma
5335911|NCT02013297|Relapsed irradiated tumors|relapsed irradiated tumors
5335912|NCT02013297|Local control rate|local control rate
5335913|NCT02013297|Safety|safety
5335914|NCT02013297|Overall survival|overall survival
5335915|NCT02013297|Progression Free Survival|progression free survival
5335916|NCT02013258|Prader Willi syndrome|prader willi syndrome
5335917|NCT02013258|Oxytocin|oxytocin
5335918|NCT02013232|Risperidone;|risperidone;
5335919|NCT02013232|Aripiprazole;|aripiprazole;
5335920|NCT02013232|Hyperprolactinemia;|hyperprolactinemia;
5335921|NCT02013232|dose effects|dose effects
5335922|NCT02013193|drug-coated balloon|drug-coated balloon
5335923|NCT02013193|drug-eluting balloon|drug-eluting balloon
5335924|NCT02013193|peripheral artery disease|peripheral artery disease
5335925|NCT02013193|claudication|claudication
5335926|NCT02013180|Prostate cancer, PSA, zinc, zinc/PSA|prostate cancer, psa, zinc, zinc/psa
5335927|NCT02013167|Relapsed; Refractory; B-precursor; Acute Lymphoblastic Leukemia; Philadelphia Negative; ALL; Blinatumomab; Leukemia; Standard of Care; SOC|relapsed; refractory; b-precursor; acute lymphoblastic leukemia; philadelphia negative; all; blinatumomab; leukemia; standard of care; soc
5335928|NCT02013141|Gram positive bacteria|gram positive bacteria
5335929|NCT02013141|Telavancin|telavancin
5335930|NCT02013141|VIBATIV|vibativ
5335931|NCT02013141|Pediatric|pediatric
5335932|NCT02013141|Pharmacokinetics|pharmacokinetics
5335933|NCT02013115|infant|infant
5335934|NCT02013115|respiratory distress syndrome|respiratory distress syndrome
5335935|NCT02013089|genomic sequencing, Integrated genomic network analysis|genomic sequencing, integrated genomic network analysis
5335936|NCT02013076|Asthma; Children; Cohort study; Corticosteroids|asthma; children; cohort study; corticosteroids
5335937|NCT02013063|Single Pulmonary Nodule|single pulmonary nodule
5335939|NCT02013063|Lung cancer|lung cancer
5335940|NCT02013063|Diagnostic|diagnostic
5335941|NCT02013063|Computed Tomography|computed tomography
5335942|NCT02013063|CT scan|ct scan
5335943|NCT02013063|FDG-PET scan|fdg-pet scan
5335944|NCT02013063|Dynamic CT scan|dynamic ct scan
5335945|NCT02013063|DCE-CT scan|dce-ct scan
5862865|NCT00001476|Transduction|transduction
5335953|NCT02013037|sensitization|sensitization
5335954|NCT02013037|antibody production in cardiac patients|antibody production in cardiac patients
5335955|NCT02013037|panel reactive antibodies|panel reactive antibodies
5335956|NCT02013037|desensitization strategies in heart transplant patients|desensitization strategies in heart transplant patients
5335957|NCT02013037|complement activation|complement activation
5335958|NCT02013037|complement c3d and c4d deposition|complement c3d and c4d deposition
5335959|NCT02013037|terminal complement inhibition|terminal complement inhibition
5335960|NCT02013037|complement C5 binding|complement c5 binding
5335961|NCT02013037|Eculizumab|eculizumab
5335962|NCT02013037|monoclonal antibody|monoclonal antibody
5335963|NCT02013037|donor specific antibodies|donor specific antibodies
5335964|NCT02012985|hyperoxaluria|hyperoxaluria
5335966|NCT02012985|PH|ph
5335967|NCT02012972|Antiretroviral therapy|antiretroviral therapy
5335968|NCT02012972|HIV/AIDS|hiv/aids
5335969|NCT02012972|Non-communicable diseases|non-communicable diseases
5335970|NCT02012972|South Africa|south africa
5335971|NCT02012959|Hyponatremia|hyponatremia
5335972|NCT02012959|Euvolemic|euvolemic
5335973|NCT02012959|Hypervolemic|hypervolemic
5335974|NCT02012959|Serum sodium|serum sodium
5335975|NCT02012959|Dilutional hyponatremia|dilutional hyponatremia
5335976|NCT02012959|Electrolyte abnormality|electrolyte abnormality
5335977|NCT02012959|Electrolyte imbalance|electrolyte imbalance
5335978|NCT02012959|Metabolic disease|metabolic disease
5335979|NCT02012933|3,4DAP, LEMS, CM|3,4dap, lems, cm
5335980|NCT02012920|castration-resistant prostate cancer|castration-resistant prostate cancer
5335981|NCT02012920|CYP17|cyp17
5335982|NCT02012920|P450c17a|p450c17a
5335983|NCT02012920|lyase|lyase
5335984|NCT02012920|Prostate Cancer|prostate cancer
5335985|NCT02012894|Obesity|obesity
5335986|NCT02012894|Gastroesophageal reflux|gastroesophageal reflux
5335987|NCT02012894|sleeve gastrectomy|sleeve gastrectomy
5335988|NCT02012894|pH-monitoring|ph-monitoring
5335989|NCT02012894|manometry|manometry
5335990|NCT02012868|obstructive sleep apnoea|obstructive sleep apnoea
5335991|NCT02012868|weight loss|weight loss
5335992|NCT02012868|bariatric surgery|bariatric surgery
5335993|NCT02012842|Metabolic Syndrome|metabolic syndrome
5335994|NCT02012842|Periodontal Disease|periodontal disease
5335995|NCT02012842|Periodontal therapy|periodontal therapy
5335996|NCT02012842|inflammatory markers|inflammatory markers
5335997|NCT02012842|C reactive protein|c reactive protein
5335998|NCT02012842|serum fibrinogen|serum fibrinogen
5335999|NCT02012842|glycated hemoglobin|glycated hemoglobin
5336000|NCT02012829|cancer, CRC screening, communication|cancer, crc screening, communication
5336001|NCT02012816|Uncircumcised men|uncircumcised men
5336002|NCT02012816|Voluntary Medical Male circumcision|voluntary medical male circumcision
5336003|NCT02012816|Peer-referral incentive|peer-referral incentive
5336004|NCT02012803|Achilles tendon rupture|achilles tendon rupture
5336005|NCT02012803|treatment, elongation|treatment, elongation
5336006|NCT02012803|operative treatment of achilles tendon rupture|operative treatment of achilles tendon rupture
5336007|NCT02012803|conservative treatment of achilles tendon rupture|conservative treatment of achilles tendon rupture
5336008|NCT02012790|Migraine disorders|migraine disorders
5336009|NCT02012777|sickle cell disease|sickle cell disease
5336010|NCT02012777|propanolol|propanolol
5336011|NCT02012777|red blood cell adhesion|red blood cell adhesion
5336012|NCT02012764|Anti-CCP antibody|anti-ccp antibody
5336013|NCT02012764|Inflammatory arthritis|inflammatory arthritis
5336014|NCT02012764|Rheumatoid arthritis|rheumatoid arthritis
5336015|NCT02012764|Musculoskeletal symptom|musculoskeletal symptom
5336016|NCT02012751|Computer-assisted diagnosis|computer-assisted diagnosis
5336017|NCT02012751|General practice|general practice
5336018|NCT02012751|Dermatoscopy|dermatoscopy
5336019|NCT02012751|Melanoma|melanoma
5336020|NCT02012751|Nevus|nevus
5336021|NCT02012725|Healthy|healthy
5336022|NCT02012725|Myocardial fibrosis|myocardial fibrosis
5336023|NCT02012725|Chronic kidney disease|chronic kidney disease
5336024|NCT02012712|Personal health record|personal health record
5336025|NCT02012712|medication management|medication management
5336026|NCT02012712|patient safety|patient safety
5336027|NCT02012699|Pancreatic Cancer|pancreatic cancer
5336028|NCT02012699|Thyroid Cancer|thyroid cancer
5336029|NCT02012699|Esophageal cancer|esophageal cancer
5336030|NCT02012699|Thymus cancer|thymus cancer
5336032|NCT02012699|Esophageal tumor|esophageal tumor
5336033|NCT02012699|Thymus tumor|thymus tumor
5336034|NCT02012699|Thyroid Tumor|thyroid tumor
5336035|NCT02012699|Thyroid Nodule|thyroid nodule
5336036|NCT02012699|Lung Tumor|lung tumor
5336037|NCT02012699|Breast Cancer|breast cancer
5336038|NCT02012699|Neuroendocrine tumor|neuroendocrine tumor
5336039|NCT02012699|Plasma Cell Dyscrasia|plasma cell dyscrasia
5336041|NCT02012686|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5336042|NCT02012686|thyroidectomy|thyroidectomy
5336043|NCT02012686|neck pain|neck pain
5336044|NCT02012686|pain management|pain management
5336045|NCT02012673|COPD|copd
5336046|NCT02012673|Emphysema|emphysema
5336047|NCT02012673|Bronchoscopy|bronchoscopy
5336048|NCT02012673|Lung Volume Reduction|lung volume reduction
5336049|NCT02012647|parkinson|parkinson
5336050|NCT02012647|PD|pd
5336051|NCT02012647|parkinson disease|parkinson disease
5336052|NCT02012647|parkinson's|parkinson's
5336053|NCT02012647|parkinson's disease|parkinson's disease
5336054|NCT02012647|parkinsons|parkinsons
5336055|NCT02012647|parkinsons disease|parkinsons disease
5336056|NCT02012647|TMS|tms
5336057|NCT02012647|DBS|dbs
5336058|NCT02012647|transcranial magnetic stimulation|transcranial magnetic stimulation
5336059|NCT02012647|deep brain stimulation|deep brain stimulation
5336060|NCT02012634|Breast Cancer|breast cancer
5336061|NCT02012634|Capecitabine|capecitabine
5336062|NCT02012634|Triple Negative Breast CancerTNBC（TNBC）|triple negative breast cancertnbc（tnbc）
5336063|NCT02012621|HIV/AIDS|hiv/aids
5336064|NCT02012621|Adherence|adherence
5336065|NCT02012621|Tenofovir|tenofovir
5336066|NCT02012621|Dried Blood Spots|dried blood spots
5336067|NCT02012608|breast|breast
5336068|NCT02012569|skin grafting|skin grafting
5336069|NCT02012569|elective treatment|elective treatment
5336070|NCT02012543|constipation, agar|constipation, agar
5336071|NCT02012530|Articular cartilage|articular cartilage
5336072|NCT02012530|Hyaluronic Acid (HA)|hyaluronic acid (ha)
5336073|NCT02012530|Platelet rich plasma (PRP)|platelet rich plasma (prp)
5336074|NCT02012517|surgical site infection|surgical site infection
5336075|NCT02012517|breast reconstruction|breast reconstruction
5336076|NCT02012517|drains|drains
5336077|NCT02012517|prophylaxis|prophylaxis
5336078|NCT02012491|Spontaneous abortion|spontaneous abortion
5336079|NCT02012491|Early Pregnancy Failure|early pregnancy failure
5336080|NCT02012491|Mifepristone|mifepristone
5336081|NCT02012491|Misoprostol|misoprostol
5336082|NCT02012465|Steroid induced hyperglycemia|steroid induced hyperglycemia
5336083|NCT02012465|Glucocorticoid induced hyperglycemia|glucocorticoid induced hyperglycemia
5336084|NCT02012452|posttraumatic stress disorder|posttraumatic stress disorder
5336085|NCT02012452|tobacco dependence|tobacco dependence
5336086|NCT02012452|cognitive behavioral therapy|cognitive behavioral therapy
5336087|NCT02012439|multiple sclerosis|multiple sclerosis
5336088|NCT02012439|chronic pain|chronic pain
5336089|NCT02012439|treatment|treatment
5336090|NCT02012439|nonpharmacological|nonpharmacological
5336091|NCT02012439|mindfulness|mindfulness
5336092|NCT02012439|cognitive therapy|cognitive therapy
5336093|NCT02012413|knee|knee
5336094|NCT02012413|chondromalacia|chondromalacia
5336095|NCT02012413|patella|patella
5230975|NCT02558790|ADD|add
5336096|NCT02012413|pulsed signal therapy|pulsed signal therapy
5336097|NCT02012413|PST|pst
5336098|NCT02012400|Asthma|asthma
5336099|NCT02012400|Exercise|exercise
5336100|NCT02012400|Asthma control|asthma control
5336101|NCT02012400|Physical fitness|physical fitness
5336102|NCT02012400|Quality of life|quality of life
5336103|NCT02012387|Cholinergic urticaria|cholinergic urticaria
5336104|NCT02012387|Omalizumab|omalizumab
5336105|NCT02012374|aphasia|aphasia
5336106|NCT02012374|anomia|anomia
5336107|NCT02012374|speech therapy|speech therapy
5336108|NCT02012374|rehabilitation|rehabilitation
5336109|NCT02012374|neuroplasticity|neuroplasticity
5336110|NCT02012374|fMRI|fmri
5336111|NCT02012374|quality of life|quality of life
5336112|NCT02012361|Ischemic preconditioning|ischemic preconditioning
5336113|NCT02012361|Human limb ischemia|human limb ischemia
5336114|NCT02012361|Total knee arthroplasty|total knee arthroplasty
5336115|NCT02012361|Supplemental inspired helium|supplemental inspired helium
5336116|NCT02012348|bacteria survival, surfactants|bacteria survival, surfactants
5336117|NCT02012322|Aging|aging
5336118|NCT02012322|Coenzyme Q10|coenzyme q10
5336119|NCT02012322|Q10|q10
5336120|NCT02012322|Quality of Life|quality of life
5336121|NCT02012322|Oxidative Stress|oxidative stress
5336122|NCT02012322|Mitochondrial Function|mitochondrial function
5336123|NCT02012322|Cell Energetics|cell energetics
5336124|NCT02012322|Fatigue|fatigue
5336125|NCT02012322|Ubiquinone|ubiquinone
5336126|NCT02012309|HIV|hiv
5336127|NCT02012309|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
5336128|NCT02012309|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
5336129|NCT02012309|Pneumococcal vaccines|pneumococcal vaccines
5336130|NCT02012309|Prevnar|prevnar
5336131|NCT02012309|Pneumovax|pneumovax
5336132|NCT02012309|Nasopharyngeal microbiome|nasopharyngeal microbiome
5336133|NCT02012283|spices and vegetables|spices and vegetables
5336134|NCT02012270|Aortic Aneurysm|aortic aneurysm
5336135|NCT02012270|Hernia|hernia
5336136|NCT02012270|Abdominal Wound Closure Techniques|abdominal wound closure techniques
5336137|NCT02012257|anterior middle superior alveolar nerve|anterior middle superior alveolar nerve
5336138|NCT02012257|electric pulp tester|electric pulp tester
5336139|NCT02012257|local anesthesia|local anesthesia
5336140|NCT02012244|analgesia; colorectal surgery; immunity; local anesthetics; opioids|analgesia; colorectal surgery; immunity; local anesthetics; opioids
5336141|NCT02012231|melanoma|melanoma
5336142|NCT02012231|anaplastic thyroid cancer|anaplastic thyroid cancer
5336143|NCT02012231|advanced papillary thyroid cancer|advanced papillary thyroid cancer
5336144|NCT02012231|colorectal cancer|colorectal cancer
5336145|NCT02012231|non-small cell lung cancer|non-small cell lung cancer
5336146|NCT02012231|cholangiocarcinoma|cholangiocarcinoma
5336147|NCT02012231|histiocytosis|histiocytosis
5336148|NCT02012231|hairy cell leukemia|hairy cell leukemia
5336149|NCT02012218|Major Depressive Disorder, Depression|major depressive disorder, depression
5336150|NCT02012205|wet cupping - back pain - NSLBP - Saudi|wet cupping - back pain - nslbp - saudi
5336151|NCT02012192|High-grade serous|high-grade serous
5336152|NCT02012192|high-grade endometrioid|high-grade endometrioid
5336153|NCT02012192|undifferentiated|undifferentiated
5336154|NCT02012179|Diet|diet
5336155|NCT02012179|Dietary sodium reduction|dietary sodium reduction
5336156|NCT02012179|Salt restriction|salt restriction
5336157|NCT02012179|Nutrition|nutrition
5336158|NCT02012166|Diabetes Mellitus|diabetes mellitus
5336159|NCT02012166|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5336160|NCT02012166|Glucose Metabolism Disorders|glucose metabolism disorders
5336161|NCT02012166|Metabolic Diseases|metabolic diseases
5336162|NCT02012166|Endocrine System Diseases|endocrine system diseases
5336163|NCT02012166|Therapeutic Uses|therapeutic uses
5336164|NCT02012166|Pharmacologic Actions|pharmacologic actions
5336165|NCT02012166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5336166|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs
5336167|NCT02012153|Mesenchymal stromal cells|mesenchymal stromal cells
5336168|NCT02012153|Kidney transplantation|kidney transplantation
5336169|NCT02012153|Tolerance|tolerance
5336170|NCT02012114|Cystinosis, compliance, cysteamine, neurological assessments|cystinosis, compliance, cysteamine, neurological assessments
5336171|NCT02012101|COPD|copd
5336172|NCT02012101|dyspnea|dyspnea
5336173|NCT02012101|exercise|exercise
5336174|NCT02012101|Noninvasive Ventilation|noninvasive ventilation
5336175|NCT02012088|Follicular lymphoma, large B-cell lymphoma|follicular lymphoma, large b-cell lymphoma
5336176|NCT02012062|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5336177|NCT02012062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5336178|NCT02012062|Concurrent chemotherapy|concurrent chemotherapy
5336179|NCT02012062|Nimotuzumab|nimotuzumab
5336180|NCT02012049|Healthy|healthy
5336181|NCT02012049|Risperdal OD|risperdal od
5336182|NCT02012049|Risperdal Quicklet|risperdal quicklet
5336183|NCT02012049|Korea|korea
5336184|NCT02012023|Low anterior resection|low anterior resection
5336185|NCT02012023|Anastomotic leakage|anastomotic leakage
5336186|NCT02012023|Defunctioning stoma|defunctioning stoma
5336187|NCT02012023|Controllable tube ileostomy|controllable tube ileostomy
5336188|NCT02012023|Loop ileostomy|loop ileostomy
5336189|NCT02012010|hysteroscopy, water intoxication, hyponatremia|hysteroscopy, water intoxication, hyponatremia
5336190|NCT02011971|epilepsy|epilepsy
5336191|NCT02011971|cognition|cognition
5336192|NCT02011971|memory|memory
5336193|NCT02011958|Visceral Leishmaniasis|visceral leishmaniasis
5336194|NCT02011958|HIV positive patients|hiv positive patients
5336195|NCT02011958|Phase III trial|phase iii trial
5336196|NCT02011958|Randomised|randomised
5336197|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b
5336198|NCT02011958|Ambisome|ambisome
5336199|NCT02011958|Miltefosine|miltefosine
5336200|NCT02011958|Pentamidine|pentamidine
5336201|NCT02011958|Efficacy|efficacy
5336202|NCT02011958|Safety|safety
5336203|NCT02011906|antioxidant enzymes|antioxidant enzymes
5336204|NCT02011906|omega 3|omega 3
5336205|NCT02011906|vitamin E|vitamin e
5336207|NCT02011906|Sirtuins|sirtuins
5336208|NCT02011906|FOXOs|foxos
5336209|NCT02011880|breast cancer|breast cancer
5336210|NCT02011880|bone metastasis|bone metastasis
5336338|NCT02011230|pain control|pain control
5678921|NCT00584298|bowel|bowel
5336211|NCT02011880|traditional Chinese medicine(TCM)|traditional chinese medicine(tcm)
5336212|NCT02011867|Inner Ear Malformations|inner ear malformations
5336213|NCT02011867|Gusher|gusher
5336214|NCT02011867|Cochlear Implantation|cochlear implantation
5336215|NCT02011854|acupuncture，rehabilitation,Shoulder-hand Syndrome|acupuncture，rehabilitation,shoulder-hand syndrome
5336216|NCT02011841|liver cirrhosis|liver cirrhosis
5336217|NCT02011841|ascites|ascites
5336218|NCT02011841|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5336219|NCT02011841|recurrence|recurrence
5336220|NCT02011828|Hemodialysis, paricalcitol|hemodialysis, paricalcitol
5336221|NCT02011815|Breast neoplasms|breast neoplasms
5336222|NCT02011815|Circadian rhythm|circadian rhythm
5336223|NCT02011815|sleep|sleep
5336224|NCT02011815|survival|survival
5336226|NCT02011815|anxiety|anxiety
5336227|NCT02011815|depression|depression
5336228|NCT02011815|quality of life|quality of life
5336229|NCT02011815|actigraph|actigraph
5336230|NCT02011815|fatigue|fatigue
5336231|NCT02011802|Sorbact TM|sorbact tm
5336232|NCT02011802|Alginates|alginates
5336233|NCT02011802|Dressing|dressing
5336234|NCT02011802|Wound healing|wound healing
5336235|NCT02011789|hypercholesterolemia|hypercholesterolemia
5336236|NCT02011789|inflammation|inflammation
5336237|NCT02011789|citrus limonoids|citrus limonoids
5336238|NCT02011776|Corticosteroids Dry Eye Sjögren syndrome inflammation treatment|corticosteroids dry eye sjögren syndrome inflammation treatment
5336239|NCT02011763|Hepatitis A|hepatitis a
5336240|NCT02011763|hepatitis A virus|hepatitis a virus
5336241|NCT02011763|Avaxim® 80U Pediatric|avaxim® 80u pediatric
5336242|NCT02011750|schizophrenia|schizophrenia
5336243|NCT02011750|toxoplasmosis|toxoplasmosis
5336244|NCT02011737|Medical Expulsive therapy|medical expulsive therapy
5336245|NCT02011698|Groin hernia|groin hernia
5336246|NCT02011698|lichtenstein herniorrhaphy|lichtenstein herniorrhaphy
5336247|NCT02011672|dairy|dairy
5336248|NCT02011672|glucose|glucose
5336249|NCT02011672|inflammation|inflammation
5336250|NCT02011659|Ramosetron, postoperative nausea and vomiting, laparoscopy|ramosetron, postoperative nausea and vomiting, laparoscopy
5336251|NCT02011646|diet|diet
5215757|NCT02647866|UC|uc
5336252|NCT02011646|body weight|body weight
5336253|NCT02011646|eating|eating
5336254|NCT02011646|eating disorder|eating disorder
5336255|NCT02011646|exercise|exercise
5336256|NCT02011581|Overweight|overweight
5336257|NCT02011568|Therapeutic Hypothermia|therapeutic hypothermia
5336258|NCT02011568|Out of hospital cardiac arrest|out of hospital cardiac arrest
5336259|NCT02011568|Mild hypothermia|mild hypothermia
5336260|NCT02011568|Moderate hypothermia|moderate hypothermia
5336261|NCT02011542|Irritable Bowel Syndrome|irritable bowel syndrome
5336262|NCT02011542|Gulf War Illness|gulf war illness
5336263|NCT02011516|Marijuana|marijuana
5336264|NCT02011516|Addiction|addiction
5336265|NCT02011516|fMRI|fmri
5336266|NCT02011516|Baclofen|baclofen
5336267|NCT02011516|Treatment|treatment
5336268|NCT02011477|Neural mobilization|neural mobilization
5336269|NCT02011477|Physical therapy|physical therapy
5336270|NCT02011477|Asymptomatic subjects|asymptomatic subjects
5336271|NCT02011451|Multiple Sclerosis|multiple sclerosis
5336272|NCT02011451|Green Tea|green tea
5336273|NCT02011451|ECGC|ecgc
5336274|NCT02011451|Theaphenon|theaphenon
5336275|NCT02011451|Randomized placebo controlled trial|randomized placebo controlled trial
5336276|NCT02011451|NAA|naa
5336277|NCT02011451|Spectroscopy|spectroscopy
5336278|NCT02011451|Brain Atrophy|brain atrophy
5336279|NCT02011451|SIENA|siena
5336280|NCT02011438|Social Anxiety|social anxiety
5336281|NCT02011438|Prevention|prevention
5336282|NCT02011438|Peer Relations|peer relations
5336283|NCT02011438|Depression|depression
5336284|NCT02011438|Adolescent|adolescent
5336285|NCT02011438|High School|high school
5336286|NCT02011438|Interpersonal|interpersonal
5336287|NCT02011438|Peer Victimization|peer victimization
5336288|NCT02011425|obstructive sleep apnea|obstructive sleep apnea
5336289|NCT02011425|oral appliance|oral appliance
5336290|NCT02011425|therapy|therapy
5336291|NCT02011425|masseter muscle activity|masseter muscle activity
5336292|NCT02011425|randomized controlled trial|randomized controlled trial
5336293|NCT02011425|mandibular advancement device|mandibular advancement device
5336294|NCT02011425|mandibular advancement appliance|mandibular advancement appliance
5336295|NCT02011425|arousals|arousals
5336296|NCT02011412|Trauma|trauma
5336297|NCT02011412|Scoring Systems|scoring systems
5336298|NCT02011412|Intermountain Risk Score|intermountain risk score
5336299|NCT02011399|brain|brain
5336300|NCT02011399|computer|computer
5336301|NCT02011399|interfaces|interfaces
5336302|NCT02011399|mobility impairments|mobility impairments
5336303|NCT02011373|prolapse, laparoscopic sacrocolpopexy, IFABONDTM glue|prolapse, laparoscopic sacrocolpopexy, ifabondtm glue
5336304|NCT02011360|Prader Willi syndrome|prader willi syndrome
5336305|NCT02011360|childhood obesity|childhood obesity
5336306|NCT02011360|ghrelin|ghrelin
5336307|NCT02011360|appetite regulation|appetite regulation
5336308|NCT02011321|subarachnoid hemorrhage|subarachnoid hemorrhage
5336309|NCT02011321|aneurysm|aneurysm
5336310|NCT02011321|vasospasm|vasospasm
5336311|NCT02011321|clevidipine|clevidipine
5336312|NCT02011321|transcranial dopplers|transcranial dopplers
5336314|NCT02011295|Surgical Intervention|surgical intervention
5336315|NCT02011295|BMAC|bmac
5336316|NCT02011282|ICU,|icu,
5336317|NCT02011282|MYOPATHY,|myopathy,
5336318|NCT02011282|NEUROPATHY,|neuropathy,
5336319|NCT02011282|PNEUMONIA|pneumonia
5336320|NCT02011269|TSO|tso
5336321|NCT02011269|Ova|ova
5336322|NCT02011269|Psoriasis|psoriasis
5336323|NCT02011269|plaque psoriasis|plaque psoriasis
5336324|NCT02011269|plaque-type|plaque-type
5336325|NCT02011269|Coronado|coronado
5336326|NCT02011269|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5336327|NCT02011256|Transient Ischemic Attack|transient ischemic attack
5336328|NCT02011256|Atrial Fibrillation|atrial fibrillation
5336329|NCT02011256|NOTICE|notice
5336330|NCT02011256|Implantable loop-recorder|implantable loop-recorder
5336331|NCT02011256|Holter-monitoring|holter-monitoring
5336332|NCT02011243|deficit|deficit
5336333|NCT02011243|internal rotation|internal rotation
5336334|NCT02011243|gleno humeral articulation|gleno humeral articulation
5336335|NCT02011243|hand ball|hand ball
5336336|NCT02011230|Dehydration|dehydration
5336337|NCT02011230|Hoist|hoist
5336339|NCT02011230|The intervention is to provide a commercially available isotonic hydration solution (Hoist®) to the patients.|the intervention is to provide a commercially available isotonic hydration solution (hoist®) to the patients.
5336340|NCT02011230|Patients will drink this solution post procedure as needed.|patients will drink this solution post procedure as needed.
5336341|NCT02011230|Patients in the control group will use their discretion to drink any solution they feel suitable|patients in the control group will use their discretion to drink any solution they feel suitable
5336343|NCT02011217|Dietary Fibre|dietary fibre
5336345|NCT02011217|Crisp bread|crisp bread
5336346|NCT02011217|Appetite|appetite
5336347|NCT02011217|Satiety|satiety
5336348|NCT02011217|Hunger|hunger
5336349|NCT02011217|Desire to eat|desire to eat
5336350|NCT02011217|Metabolism|metabolism
5336351|NCT02011217|Glucose|glucose
5336352|NCT02011217|Insulin|insulin
5963336|NCT04254302|Parental support|parental support
5203833|NCT02720510|farydak|farydak
5215813|NCT02647619|MCP joint|mcp joint
5336353|NCT02011217|Gut hormones|gut hormones
5336354|NCT02011217|Gastric emptying rate|gastric emptying rate
5336355|NCT02011191|Biotin|biotin
5336356|NCT02011191|Restless|restless
5336357|NCT02011191|Kidney|kidney
5336358|NCT02011191|Dialysis|dialysis
5336359|NCT02011191|Renal|renal
5336360|NCT02011165|Macular hole|macular hole
5336361|NCT02011165|Vitrectomy|vitrectomy
5336362|NCT02011165|Gas tamponade|gas tamponade
5336363|NCT02011165|Vitreomacular traction in danger of macular hole formation|vitreomacular traction in danger of macular hole formation
5336364|NCT02011165|Epiretinal membrane in danger of macular hole formation|epiretinal membrane in danger of macular hole formation
5336365|NCT02011113|Pomalidomide,|pomalidomide,
5336366|NCT02011113|CC-4047,|cc-4047,
5336367|NCT02011113|Dexamethasone,|dexamethasone,
5336368|NCT02011113|Relapsed and refractory multiple myeloma,|relapsed and refractory multiple myeloma,
5336369|NCT02011113|phase 2|phase 2
5336370|NCT02011061|Multidetector Computed Tomography|multidetector computed tomography
5336371|NCT02011061|Coronary Stenosis|coronary stenosis
5336372|NCT02011061|Coronary Artery Disease|coronary artery disease
5336373|NCT02011061|Angina Pectoris|angina pectoris
5336374|NCT02011035|Oral health|oral health
5336375|NCT02011035|Mouth health|mouth health
5336376|NCT02011035|Halitosis|halitosis
5336377|NCT02011035|Oral bacteria|oral bacteria
5336378|NCT02011035|Sore throat|sore throat
5336379|NCT02011035|Colds|colds
5336380|NCT02011022|Methotrexate,|methotrexate,
5336381|NCT02011022|Pharmacokinetic|pharmacokinetic
5336382|NCT02011022|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5336383|NCT02011022|Model|model
5336384|NCT02010970|phase I|phase i
5336385|NCT02010970|healthy volunteers|healthy volunteers
5336386|NCT02010970|AZD3293|azd3293
5231180|NCT02557373|infants|infants
5336387|NCT02010970|itraconazole|itraconazole
5336388|NCT02010970|diltiazem|diltiazem
5336389|NCT02010970|medazolam|medazolam
5336390|NCT02010970|drug interactions|drug interactions
5336391|NCT02010970|Pharmacokinetics|pharmacokinetics
5336392|NCT02010957|123I Iodometomidate imaging|123i iodometomidate imaging
5336393|NCT02010957|18F FDG positron emission tomography|18f fdg positron emission tomography
5336394|NCT02010957|Adrenal tumour|adrenal tumour
5336395|NCT02010944|Solifenacin|solifenacin
5336396|NCT02010944|Mirabegron|mirabegron
5336397|NCT02010944|Fixed-dose combination (FDC)|fixed-dose combination (fdc)
5336398|NCT02010944|Single Entity Tablet (SET)|single entity tablet (set)
5336399|NCT02010944|Pharmacokinetics|pharmacokinetics
5336400|NCT02010944|Bioavailability|bioavailability
5336401|NCT02010918|Knee Osteoarthritis;|knee osteoarthritis;
5336402|NCT02010918|Glucosamine;|glucosamine;
5336403|NCT02010918|Chondroitin.|chondroitin.
5336404|NCT02010905|Losartan|losartan
5336405|NCT02010879|patent ductus arterioses|patent ductus arterioses
5336406|NCT02010879|ductal closure|ductal closure
5336407|NCT02010879|thrombocyte|thrombocyte
5336408|NCT02010866|internship and residency|internship and residency
5336409|NCT02010866|physicians|physicians
5336410|NCT02010866|prevention|prevention
5336411|NCT02010866|counseling|counseling
5336412|NCT02010866|suicide|suicide
5336413|NCT02010866|depression|depression
5336414|NCT02010866|burnout|burnout
5336415|NCT02010853|Transient Global amnesia|transient global amnesia
5336416|NCT02010853|fMRI|fmri
5336417|NCT02010853|resting state|resting state
5336418|NCT02010840|Depressive symptoms, marital relationship, quality of life|depressive symptoms, marital relationship, quality of life
5336419|NCT02010827|Diabetes mellitus|diabetes mellitus
5336420|NCT02010827|Glucagon|glucagon
5336421|NCT02010827|Endogenous glucose production|endogenous glucose production
5336422|NCT02010827|Incretin hormones|incretin hormones
5336423|NCT02010814|PCOS|pcos
5336424|NCT02010814|Inflammation|inflammation
5336425|NCT02010814|Body Composition|body composition
5336426|NCT02010801|hepatocellular carcinoma|hepatocellular carcinoma
5336427|NCT02010801|irreversible electroporation|irreversible electroporation
5336428|NCT02010801|liver cancer|liver cancer
5336431|NCT02010762|Postoperative|postoperative
5336432|NCT02010762|Recurrence|recurrence
5336433|NCT02010762|Inflammatory bowel disease|inflammatory bowel disease
5336434|NCT02010762|Gastroenteritis|gastroenteritis
5336435|NCT02010762|Gastrointestinal Diseases|gastrointestinal diseases
5336436|NCT02010762|Digestive System Diseases|digestive system diseases
5336437|NCT02010762|Colonic Diseases|colonic diseases
5336438|NCT02010762|Intestinal Diseases|intestinal diseases
5336439|NCT02010762|Pathologic Processes|pathologic processes
5336440|NCT02010736|Cerebral palsy|cerebral palsy
5336441|NCT02010736|Gait|gait
5336442|NCT02010736|Weight Bearing|weight bearing
5336443|NCT02010736|Rehabilitation|rehabilitation
5336444|NCT02010723|varicosis|varicosis
5336445|NCT02010723|foam sclerotherapy|foam sclerotherapy
5336446|NCT02010723|surgery|surgery
5336447|NCT02010710|continuous electronic fetal monitoring|continuous electronic fetal monitoring
5336448|NCT02010710|labour|labour
5336449|NCT02010710|pregnancy|pregnancy
5963337|NCT04254185|Decompression|decompression
5963338|NCT04254185|Anterior Subcutaneous Transposition|anterior subcutaneous transposition
5336450|NCT02010710|fetal distress|fetal distress
5336451|NCT02010697|smoking cessation|smoking cessation
5336452|NCT02010697|nonsmokers|nonsmokers
5336453|NCT02010697|proxy|proxy
5336454|NCT02010697|mail intervention|mail intervention
5336455|NCT02010697|self-help|self-help
5336456|NCT02010697|behavioral intervention|behavioral intervention
5336457|NCT02010684|Diabetes|diabetes
5336458|NCT02010684|Depression|depression
5336459|NCT02010684|Self care|self care
5336460|NCT02010684|Empowerment|empowerment
5336461|NCT02010684|Behavioral intervention|behavioral intervention
5336462|NCT02010684|Cognitive behavioral therapy|cognitive behavioral therapy
5336463|NCT02010684|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5336464|NCT02010671|Pregnancy|pregnancy
5336465|NCT02010671|Cesarean Section|cesarean section
5336467|NCT02010671|Delivery|delivery
5336468|NCT02010645|Leukemia|leukemia
5336469|NCT02010645|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
5336470|NCT02010645|MDS|mds
5336471|NCT02010645|Intermediate-2 Myelodysplastic Syndrome|intermediate-2 myelodysplastic syndrome
5336472|NCT02010645|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5336473|NCT02010645|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5336474|NCT02010645|CMML|cmml
5336475|NCT02010645|Eltrombopag|eltrombopag
5336476|NCT02010645|Promacta|promacta
5336477|NCT02010645|Decitabine|decitabine
5336478|NCT02010645|Dacogen|dacogen
5336479|NCT02010632|Clopidogrel|clopidogrel
5336480|NCT02010632|Platelet inhibition|platelet inhibition
5336481|NCT02010632|Platelet aggregation|platelet aggregation
5336482|NCT02010606|Newly diagnosed glioblastoma|newly diagnosed glioblastoma
5336483|NCT02010606|Recurrent glioblastoma|recurrent glioblastoma
5336484|NCT02010606|Dendritic cell vaccine|dendritic cell vaccine
5336485|NCT02010606|Immunotherapy|immunotherapy
5336486|NCT02010606|Cancer stem cells|cancer stem cells
5336487|NCT02010606|Glioma stem cells|glioma stem cells
5336488|NCT02010606|Glioma stem-like cells|glioma stem-like cells
5336489|NCT02010606|Cancer stem-like cells|cancer stem-like cells
5336490|NCT02010606|Neurosphere|neurosphere
5336491|NCT02010606|Therapeutic Uses|therapeutic uses
5336492|NCT02010606|Antineoplastic Agents|antineoplastic agents
5336493|NCT02010606|Neoplasms|neoplasms
5336494|NCT02010606|Immunologic Factors|immunologic factors
5336495|NCT02010606|Interferon Inducers|interferon inducers
5336496|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs
5336497|NCT02010606|Pharmacologic Actions|pharmacologic actions
5336498|NCT02010567|rectal cancer|rectal cancer
5336499|NCT02010567|colorectal cancer|colorectal cancer
5336500|NCT02010567|locally advanced rectal cancer|locally advanced rectal cancer
5336501|NCT02010567|locally advanced rectal cancer (resectable)|locally advanced rectal cancer (resectable)
5336502|NCT02010567|locally advanced rectal cancer (non-resectable)|locally advanced rectal cancer (non-resectable)
5336503|NCT02010567|chemoradiotherapy|chemoradiotherapy
5336504|NCT02010567|nanopharmaceutical|nanopharmaceutical
5336505|NCT02010567|CLRX101|clrx101
5336506|NCT02010567|camptothecin|camptothecin
5336507|NCT02010567|capecitabine|capecitabine
5336508|NCT02010554|Multiple Sclerosis|multiple sclerosis
5336509|NCT02010554|Disease modifying medication|disease modifying medication
5336510|NCT02010554|Relapsing-Remitting MS|relapsing-remitting ms
5336511|NCT02010554|Motivational Interviewing|motivational interviewing
5336512|NCT02010554|Telephone Counseling|telephone counseling
5336513|NCT02010541|type 1 diabetes among young children, sensor, insulin pump, education, psychological support|type 1 diabetes among young children, sensor, insulin pump, education, psychological support
5336514|NCT02010528|Diabetes related distress, children, T1D, family hardiness, psychological well-being|diabetes related distress, children, t1d, family hardiness, psychological well-being
5336515|NCT02010515|sudden cardiac death|sudden cardiac death
5336516|NCT02010515|risk stratification|risk stratification
5336517|NCT02010515|t-wave alternans|t-wave alternans
5336518|NCT02010515|Holter electrocardiography|holter electrocardiography
5336519|NCT02010515|heart rate turbulence|heart rate turbulence
5336520|NCT02010502|Beet root|beet root
5332632|NCT02028039|IPI-145|ipi-145
5336521|NCT02010502|exercise performance|exercise performance
5336530|NCT02010463|clinically obese|clinically obese
5336531|NCT02010450|Sudden Infant Death Syndrome|sudden infant death syndrome
5336532|NCT02010450|SIDS|sids
5336533|NCT02010450|safe sleep|safe sleep
5336534|NCT02010450|safe sleep message|safe sleep message
5336536|NCT02010424|reduced fertility|reduced fertility
5336537|NCT02010398|Resistance training/methods|resistance training/methods
5336538|NCT02010398|contralateral strength training|contralateral strength training
5336539|NCT02010398|ipsilateral strength training|ipsilateral strength training
5336540|NCT02010398|Isokinetic contraction|isokinetic contraction
5336541|NCT02010398|Adaptation, Physiological/physiology|adaptation, physiological/physiology
5336542|NCT02010398|Electromyography/methods|electromyography/methods
5336543|NCT02010398|Transcranial Magnetic Stimulation/methods|transcranial magnetic stimulation/methods
5336544|NCT02010398|Evoked Potentials, Motor|evoked potentials, motor
5336545|NCT02010385|RYGB|rygb
5336546|NCT02010385|Bariatric surgery|bariatric surgery
5336547|NCT02010385|Taste|taste
5336548|NCT02010385|Reward|reward
5336549|NCT02010385|Food behaviour|food behaviour
5336550|NCT02010385|Gut hormones|gut hormones
5336551|NCT02010372|Immunization Registry|immunization registry
5336552|NCT02010372|Human Papillomavirus|human papillomavirus
5336553|NCT02010346|Early orthodontic treatment|early orthodontic treatment
5336554|NCT02010346|Class II treatment|class ii treatment
5336555|NCT02010346|Orthodontic treatment outcome|orthodontic treatment outcome
5336556|NCT02010320|population model|population model
5336557|NCT02010320|pharmacokinetic|pharmacokinetic
5336558|NCT02010320|tacrolimus|tacrolimus
5336559|NCT02010320|therapeutic drug monitoring|therapeutic drug monitoring
5336560|NCT02010320|individualized dosing|individualized dosing
5336561|NCT02010294|Invasive GAS infection|invasive gas infection
5336562|NCT02010294|emm genotypes|emm genotypes
5336563|NCT02010294|Bacterial virulence factors|bacterial virulence factors
5336564|NCT02010294|Mendelian susceptibility to infections|mendelian susceptibility to infections
5336565|NCT02010281|rTMS|rtms
5336566|NCT02010281|peripheral neuropathic pain|peripheral neuropathic pain
5336567|NCT02010281|randomized controlled trial|randomized controlled trial
5336568|NCT02010268|Faecal calprotectin|faecal calprotectin
5336569|NCT02010268|Feces|feces
5336570|NCT02010268|Preterm neonates|preterm neonates
5336571|NCT02010268|Enterocolitis|enterocolitis
5336572|NCT02010268|Enteropathy|enteropathy
5336573|NCT02010268|Necrotizing|necrotizing
5336574|NCT02010242|Type 2 diabetes|type 2 diabetes
5336575|NCT02010242|Proteinuria|proteinuria
5336576|NCT02010242|Albuminuria|albuminuria
5336577|NCT02010229|Placenta accreta|placenta accreta
5336578|NCT02010229|previous caesarean|previous caesarean
5336579|NCT02010229|placenta praevia|placenta praevia
5336580|NCT02010229|severe obstetric haemorrhage|severe obstetric haemorrhage
5336581|NCT02010229|population-based study|population-based study
5336592|NCT02010190|Pediatric malignancies|pediatric malignancies
5336593|NCT02010190|Cancer survivors|cancer survivors
5336594|NCT02010190|Coronary artery risk|coronary artery risk
5336595|NCT02010190|Vascular function|vascular function
5336596|NCT02010190|Cardiovascular risk in survivors of pediatric cancer|cardiovascular risk in survivors of pediatric cancer
5336597|NCT02010164|Reproductive aging|reproductive aging
5336598|NCT02010164|Mitochondria|mitochondria
5336599|NCT02010151|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
5336600|NCT02010151|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5336601|NCT02010151|dispatch|dispatch
5336602|NCT02010151|emergency medicine|emergency medicine
5336603|NCT02010138|Internal Limiting Membrane|internal limiting membrane
5336604|NCT02010138|Metamorphopsia|metamorphopsia
5336605|NCT02010125|Anterior Cruciate Ligament (ACL)|anterior cruciate ligament (acl)
5336606|NCT02010125|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5336607|NCT02010125|Osteoarthritis (OA)|osteoarthritis (oa)
5336608|NCT02010125|Bio-specimens|bio-specimens
5336609|NCT02010125|Acute ACL Injury|acute acl injury
5336610|NCT02010125|Arthritis Foundation (AF)|arthritis foundation (af)
5336611|NCT02010112|H.Pylori|h.pylori
5336612|NCT02010086|Intervention|intervention
5336613|NCT02010086|Autism|autism
5336614|NCT02010086|Treatment sensitivity|treatment sensitivity
5336615|NCT02010086|School aged|school aged
5336616|NCT02010086|Cognitive behavioral therapy|cognitive behavioral therapy
5336617|NCT02010086|Social Skills Intervention|social skills intervention
5336618|NCT02010073|Lung|lung
5336619|NCT02010073|ARDS|ards
5336620|NCT02010073|acute|acute
5336621|NCT02010073|respiratory|respiratory
5336622|NCT02010073|syndrome|syndrome
5336623|NCT02010073|prognosis|prognosis
5336624|NCT02010073|outcome research|outcome research
5336625|NCT02010073|respiratory infection|respiratory infection
5336626|NCT02010073|sepsis|sepsis
5336627|NCT02010073|organ failure|organ failure
5336628|NCT02010073|hypoxaemia|hypoxaemia
5336629|NCT02010060|Exercise training|exercise training
5336630|NCT02010060|Non-exercise physical activity|non-exercise physical activity
5336631|NCT02010060|pedometers|pedometers
5332710|NCT02027727|infliximab|infliximab
5336632|NCT02010047|Anaplastic lymphoma kinase gene|anaplastic lymphoma kinase gene
5336633|NCT02010047|Polymerase chain reaction|polymerase chain reaction
5336634|NCT02010047|Immunohistochemistry|immunohistochemistry
5336635|NCT02010047|Fluorescence in situ hybridization|fluorescence in situ hybridization
5336638|NCT02010034|parenteral nutritional fat emulsions|parenteral nutritional fat emulsions
5336639|NCT02010021|breast cancer|breast cancer
5336640|NCT02010021|postmenopausal|postmenopausal
5336641|NCT02010021|letrozole|letrozole
5336643|NCT02010021|Everolimus|everolimus
5336644|NCT02010008|breast cancer|breast cancer
5336645|NCT02010008|cancer disparities|cancer disparities
5336646|NCT02010008|Latino women|latino women
5336647|NCT02010008|Hispanic women|hispanic women
5336648|NCT02010008|mammography|mammography
5336649|NCT02010008|multi-level intervention|multi-level intervention
5336650|NCT02009995|Diabetes Mellitus|diabetes mellitus
5336651|NCT02009995|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5336652|NCT02009995|Resistance Training|resistance training
5336653|NCT02009995|Resistance Exercise|resistance exercise
5336654|NCT02009995|Resistance Band|resistance band
5336655|NCT02009995|Thera-band|thera-band
5336656|NCT02009995|elastic band|elastic band
5336657|NCT02009995|exercise band|exercise band
5336658|NCT02009982|Fainting|fainting
5336659|NCT02009982|Ablation|ablation
5336660|NCT02009982|Cardiology|cardiology
5336661|NCT02009982|Cardiac Electrophysiology|cardiac electrophysiology
5336662|NCT02009969|Psychosis|psychosis
5336663|NCT02009969|Adverse effects|adverse effects
5336664|NCT02009969|Symptom Severity|symptom severity
5336665|NCT02009969|Magnetic Resonance Imaging|magnetic resonance imaging
5336666|NCT02009943|critical illness|critical illness
5336667|NCT02009943|iron supplementation|iron supplementation
5336668|NCT02009943|functional iron deficiency|functional iron deficiency
5336669|NCT02009943|ICU anemia|icu anemia
5336670|NCT02009943|red blood cell transfusion|red blood cell transfusion
5336671|NCT02009930|Enlisted military members|enlisted military members
5336672|NCT02009930|CAC|cac
5336673|NCT02009930|Coronary Artery Calcium|coronary artery calcium
5336674|NCT02009930|Cardiovascular|cardiovascular
5336675|NCT02009917|Indicator Amino Acid Oxidation|indicator amino acid oxidation
5336676|NCT02009917|Non essential Amino acids|non essential amino acids
5336677|NCT02009917|Protein|protein
5336678|NCT02009917|Amino acid|amino acid
5336679|NCT02009904|PKU|pku
5336680|NCT02009904|Phenylketonuria|phenylketonuria
5336681|NCT02009904|Phenylalanine|phenylalanine
5336682|NCT02009904|Children|children
5336683|NCT02009904|Stable isotopes|stable isotopes
5336684|NCT02009904|Sapropterin dihydrochloride responsiveness|sapropterin dihydrochloride responsiveness
5336685|NCT02009891|predictive model|predictive model
5336686|NCT02009891|in vitro fertilization|in vitro fertilization
5336687|NCT02009891|elective single embryo transfer|elective single embryo transfer
5336688|NCT02009878|SIADH|siadh
5336689|NCT02009865|Hypertriglyceridemia|hypertriglyceridemia
5336690|NCT02009865|Dyslipidemia|dyslipidemia
5336691|NCT02009865|Eicosapentaenoic acid|eicosapentaenoic acid
5336692|NCT02009865|EPA|epa
5336693|NCT02009865|Docosahexaenoic acid|docosahexaenoic acid
5336694|NCT02009865|DHA|dha
5336695|NCT02009852|microRNA-29b|microrna-29b
5336696|NCT02009852|Oral squamous cell carcinoma|oral squamous cell carcinoma
5336697|NCT02009852|migration|migration
5336698|NCT02009852|prognosis|prognosis
5336699|NCT02009839|anxiety|anxiety
5336700|NCT02009839|frequency of speech|frequency of speech
5336701|NCT02009839|selective mutism|selective mutism
5336702|NCT02009826|Schizophrenia|schizophrenia
5336703|NCT02009826|Psychosis|psychosis
5336704|NCT02009826|Neuroinflammation|neuroinflammation
5336705|NCT02009826|Microglial activation|microglial activation
5336706|NCT02009813|Insulin resistance|insulin resistance
5336707|NCT02009813|Inflammation|inflammation
5336708|NCT02009813|Hypoxia|hypoxia
5336709|NCT02009787|hypercholesterolemia; vitamin D; adjuvant therapy|hypercholesterolemia; vitamin d; adjuvant therapy
5336710|NCT02009774|Colonoscopy|colonoscopy
5336711|NCT02009774|Adenoma detection rate|adenoma detection rate
5336712|NCT02009774|Narrow band imaging|narrow band imaging
5336713|NCT02009774|Optical biopsy|optical biopsy
5336714|NCT02009774|Accuracy|accuracy
5336715|NCT02009735|Enterovirus 71 and Influenza Virus|enterovirus 71 and influenza virus
5336716|NCT02009722|Cesarean Delivery|cesarean delivery
5336717|NCT02009722|Intrathecal Morphine|intrathecal morphine
5336914|NCT02008773|HSV1|hsv1
5336718|NCT02009722|Intrathecal Hydromorphone|intrathecal hydromorphone
5336719|NCT02009722|Obstetrical Analgesia|obstetrical analgesia
5336720|NCT02009722|Spinal Anesthesia|spinal anesthesia
5336721|NCT02009709|keratoconus|keratoconus
5336722|NCT02009709|collagen crosslinking|collagen crosslinking
5336723|NCT02009709|crosslinking|crosslinking
5336724|NCT02009709|ectasia|ectasia
5336725|NCT02009644|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5336727|NCT02009644|Aneurysm|aneurysm
5336728|NCT02009631|Solid Tumors|solid tumors
5336729|NCT02009631|Ovarian Cancer|ovarian cancer
5336730|NCT02009631|Colon Cancer|colon cancer
5336731|NCT02009631|Lung Cancer|lung cancer
5332812|NCT02027428|Taxanes|taxanes
5336732|NCT02009631|Breast Cancer|breast cancer
5336733|NCT02009631|Gastric Cancer|gastric cancer
5336735|NCT02009618|Rifaximin|rifaximin
5336736|NCT02009605|icotinib, SCC|icotinib, scc
5336737|NCT02009592|Hepatosteatosis|hepatosteatosis
5336738|NCT02009592|Steatohepatitis|steatohepatitis
5336739|NCT02009592|Rifaximin|rifaximin
5336740|NCT02009592|Inflammatory cytokines|inflammatory cytokines
5336741|NCT02009579|Uterine Cervical Cancer|uterine cervical cancer
5336742|NCT02009579|Paclitaxel|paclitaxel
5336743|NCT02009579|Carboplatin|carboplatin
5336744|NCT02009579|Nintedanib|nintedanib
5336746|NCT02009553|Urodynamics|urodynamics
5336747|NCT02009514|Hemodialysis|hemodialysis
5336748|NCT02009514|Continuous glucose monitoring|continuous glucose monitoring
5336749|NCT02009514|Hypoglycemia|hypoglycemia
5336750|NCT02009514|Hyperglycemia|hyperglycemia
5336751|NCT02009501|Infected wounds|infected wounds
5336752|NCT02009501|NPWTi|npwti
5336753|NCT02009501|VAC Instill|vac instill
5336754|NCT02009501|Biofilm|biofilm
5336755|NCT02009488|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5336756|NCT02009488|Metformin|metformin
5336757|NCT02009488|Canagliflozin|canagliflozin
5336758|NCT02009488|INVOKANA®|invokana®
5336759|NCT02009488|Insulin sensitivity|insulin sensitivity
5336760|NCT02009488|DPP-4 inhibitor|dpp-4 inhibitor
5336761|NCT02009488|dipeptidyl peptidase-4|dipeptidyl peptidase-4
5336762|NCT02009475|Rehabilitation|rehabilitation
5336763|NCT02009475|Exercise Training|exercise training
5336764|NCT02009475|Interval training|interval training
5336766|NCT02009462|Facial lipoatrophy|facial lipoatrophy
5336767|NCT02009449|Phase 1/Phase 1b|phase 1/phase 1b
5336768|NCT02009449|Oncology|oncology
5336769|NCT02009449|Cancer|cancer
5336770|NCT02009449|Solid Tumors|solid tumors
5336771|NCT02009423|Gastro-Intestinal Stromal Tumour|gastro-intestinal stromal tumour
5336772|NCT02009423|GIST|gist
5336773|NCT02009423|Localized primary tumor|localized primary tumor
5336774|NCT02009423|Adjuvant therapy.|adjuvant therapy.
5336775|NCT02009410|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5336776|NCT02009358|mental health promotion|mental health promotion
5336777|NCT02009358|depression|depression
5336778|NCT02009358|migrant workers|migrant workers
5336779|NCT02009358|China|china
5336780|NCT02009345|Familial hypercholesterolemia,|familial hypercholesterolemia,
5336781|NCT02009345|High LDL-cholesterol|high ldl-cholesterol
5336782|NCT02009345|Registry|registry
5336783|NCT02009345|Coronary artery disease|coronary artery disease
5336784|NCT02009319|endobronchial ultrasound|endobronchial ultrasound
5336785|NCT02009319|EBUS - TBNA|ebus - tbna
5336786|NCT02009319|elastography|elastography
5336787|NCT02009319|strain ratio|strain ratio
5336788|NCT02009319|lung cancer staging|lung cancer staging
5336789|NCT02009306|Palliative|palliative
5336790|NCT02009306|Symptom control|symptom control
5336791|NCT02009306|Hospice|hospice
5336792|NCT02009306|Opioid|opioid
5336793|NCT02009306|Benzodiazepine|benzodiazepine
5336794|NCT02009293|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5336795|NCT02009293|cough|cough
5336796|NCT02009293|quality of life|quality of life
5336797|NCT02009280|Propofol|propofol
5336798|NCT02009280|Lung transplantation|lung transplantation
5336799|NCT02009280|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5336800|NCT02009280|Acute kidney injury|acute kidney injury
5336801|NCT02009241|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5336802|NCT02009241|Rehabilitation|rehabilitation
5336803|NCT02009241|Exercise|exercise
5336804|NCT02009228|Single-port laparoscopy|single-port laparoscopy
5336805|NCT02009228|Abdominal pain|abdominal pain
5336806|NCT02009228|Ovarian spillage|ovarian spillage
5336807|NCT02009228|Endobag rupture|endobag rupture
5336808|NCT02009228|Ovarian reserve|ovarian reserve
5336809|NCT02009215|Uganda|uganda
5336810|NCT02009215|intermittent preventive treatment|intermittent preventive treatment
5336811|NCT02009215|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5336812|NCT02009215|schoolchildren|schoolchildren
5336813|NCT02009215|malaria|malaria
5336814|NCT02009202|Colon preparation|colon preparation
5336815|NCT02009202|Child|child
5336816|NCT02009189|home parenteral nutrition|home parenteral nutrition
5336817|NCT02009189|central venous catheter|central venous catheter
5336818|NCT02009176|Hepatocellular Carcinoma|hepatocellular carcinoma
5336819|NCT02009176|Laparoscopic|laparoscopic
5336820|NCT02009176|Aon-anatomical hepatectomy|aon-anatomical hepatectomy
5336821|NCT02009176|Anatomical hepatectomy|anatomical hepatectomy
5336822|NCT02009176|Micrometastases|micrometastases
5336823|NCT02009137|small breast|small breast
5336824|NCT02009137|augmentation|augmentation
5336825|NCT02009137|breast volume|breast volume
5336826|NCT02009137|External Soft Tissue Expansion System(ESTES)|external soft tissue expansion system(estes)
5336827|NCT02009124|spinal cord injury|spinal cord injury
5336828|NCT02009124|stem cell therapy|stem cell therapy
5336829|NCT02009124|bone marrow|bone marrow
5336830|NCT02009124|mononuclear cells|mononuclear cells
5336831|NCT02009124|autologous|autologous
5336832|NCT02009111|Transition to parenthood|transition to parenthood
5332912|NCT02026908|PAE|pae
5336833|NCT02009111|Relationship intervention|relationship intervention
5336834|NCT02009098|Randomized Controlled Trial|randomized controlled trial
5336835|NCT02009098|Caesarean Section|caesarean section
5336836|NCT02009098|preoperative|preoperative
5336837|NCT02009098|intraoperative|intraoperative
5336838|NCT02009098|prophylactic antibiotics|prophylactic antibiotics
5336839|NCT02009098|antibiotics|antibiotics
5336840|NCT02009098|timing|timing
5336841|NCT02009098|surgical site infections|surgical site infections
5336842|NCT02009098|endometritis|endometritis
5336843|NCT02009098|wound infections|wound infections
5336844|NCT02009098|urinary tract infections|urinary tract infections
5336845|NCT02009098|infectious morbidity|infectious morbidity
5336846|NCT02009098|neonatal antibiotics exposure|neonatal antibiotics exposure
5336847|NCT02009098|Antibiotic Prophylaxis|antibiotic prophylaxis
5336848|NCT02009072|Pterygium surgery|pterygium surgery
5336849|NCT02009072|Sutureless glue free conjunctival autograft|sutureless glue free conjunctival autograft
5336850|NCT02009072|Amniotic membrane graft.|amniotic membrane graft.
5336851|NCT02009059|hypothermia|hypothermia
5336852|NCT02009059|Temperature|temperature
5336853|NCT02009059|epitympanic|epitympanic
5336854|NCT02009059|pre-hospital|pre-hospital
5336855|NCT02009046|Adolescent|adolescent
5336856|NCT02009046|Sex education|sex education
5336857|NCT02009046|Sexuality education|sexuality education
5336858|NCT02009046|Sexually transmitted diseases|sexually transmitted diseases
5336859|NCT02009046|Pregnancy|pregnancy
5336860|NCT02009046|Sexual behavior|sexual behavior
5336861|NCT02009046|Sexuality|sexuality
5336862|NCT02009046|Relationship rights|relationship rights
5336863|NCT02009046|Gender norms|gender norms
5336864|NCT02009046|Human rights|human rights
5336865|NCT02009046|Intervention studies|intervention studies
5336866|NCT02009046|Parent intervention|parent intervention
5336867|NCT02009046|Peer intervention|peer intervention
5336868|NCT02009007|cerebral oximeter|cerebral oximeter
5336869|NCT02009007|one lung ventilation|one lung ventilation
5336870|NCT02009007|dopamine|dopamine
5336871|NCT02009007|phenylephrine|phenylephrine
5336872|NCT02008994|metastatic breast cancer|metastatic breast cancer
5336873|NCT02008994|breast cancer|breast cancer
5336874|NCT02008994|genomics|genomics
5336875|NCT02008994|personalized medicine|personalized medicine
5336876|NCT02008994|precision oncology|precision oncology
5336877|NCT02008994|breast cancer treatment|breast cancer treatment
5336878|NCT02008994|metastatic breast cancer treatment|metastatic breast cancer treatment
5336879|NCT02008994|genetic testing and breast cancer treatment|genetic testing and breast cancer treatment
5336880|NCT02008994|breast cancer trial|breast cancer trial
5336881|NCT02008994|metastatic breast cancer trial|metastatic breast cancer trial
5336882|NCT02008955|lysine, elderly, amino acid requirement, diet|lysine, elderly, amino acid requirement, diet
5336883|NCT02008929|NKCELL|nkcell
5336884|NCT02008916|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, secukinumab, self-injection
5336885|NCT02008890|palmoplantar, pustular, psoriasis|palmoplantar, pustular, psoriasis
5445418|NCT01521910|progressive renal disease|progressive renal disease
5336886|NCT02008877|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
5336887|NCT02008877|MPNST|mpnst
5336888|NCT02008877|Sarcoma|sarcoma
5336889|NCT02008877|Ganetespib|ganetespib
5336890|NCT02008877|Sirolimus|sirolimus
5336891|NCT02008877|mTOR inhibitor|mtor inhibitor
5336892|NCT02008877|Heat shock protein|heat shock protein
5336893|NCT02008877|Hsp90|hsp90
5336894|NCT02008864|End stage renal diseases|end stage renal diseases
5336895|NCT02008864|Hemodialysis|hemodialysis
5336896|NCT02008864|Uremic pruritus|uremic pruritus
5336897|NCT02008864|Iranian traditional medicine|iranian traditional medicine
5336898|NCT02008864|Cassia angustifolia|cassia angustifolia
5336899|NCT02008851|Chronic kidney disease|chronic kidney disease
5336900|NCT02008851|Type 2 Diabetes|type 2 diabetes
5336901|NCT02008851|Neo-kidney augment|neo-kidney augment
5336902|NCT02008851|Regenerative medicine|regenerative medicine
5336904|NCT02008825|Calibration tube|calibration tube
5336905|NCT02008825|Sleeve gastrectomy|sleeve gastrectomy
5336906|NCT02008812|Adenovirus|adenovirus
5336907|NCT02008799|Stem cell, infertility, Azoospermia|stem cell, infertility, azoospermia
5336908|NCT02008786|Coronary Artery Dissection, Spontaneous|coronary artery dissection, spontaneous
5336909|NCT02008786|Angina|angina
5336910|NCT02008773|schizophrenia|schizophrenia
5336911|NCT02008773|schizoaffective|schizoaffective
5336912|NCT02008773|schizophreniform|schizophreniform
5336913|NCT02008773|inflammatory markers|inflammatory markers
5336915|NCT02008773|cognition|cognition
5336916|NCT02008773|early psychosis|early psychosis
5336917|NCT02008773|valacyclovir|valacyclovir
5336918|NCT02008760|pain|pain
5336919|NCT02008760|quality of life|quality of life
5336920|NCT02008760|ADL|adl
5336921|NCT02008760|DOLO test|dolo test
5336922|NCT02008760|compliance|compliance
5336923|NCT02008760|D3|d3
5336924|NCT02008747|Atrial fibrillation|atrial fibrillation
5336925|NCT02008747|Neuropathic pain|neuropathic pain
5336926|NCT02008747|Posterolateral thoracotomy|posterolateral thoracotomy
5336927|NCT02008747|Lung resection|lung resection
5336928|NCT02008721|Multiple System Atrophy|multiple system atrophy
5336930|NCT02008708|Health|health
5336931|NCT02008708|Microfinance|microfinance
5336932|NCT02008695|Health|health
5336933|NCT02008695|Youth|youth
5336934|NCT02008695|Microfinance|microfinance
5336935|NCT02008669|Multiple Sclerosis, Fatigue, Nutritional Status, Disability.|multiple sclerosis, fatigue, nutritional status, disability.
5336936|NCT02008656|CAPECITABINE (ORAL)|capecitabine (oral)
5336937|NCT02008656|FLUOROURACIL|fluorouracil
5336938|NCT02008656|LEUCOVORIN|leucovorin
5336939|NCT02008656|OXALIPLATIN|oxaliplatin
5336940|NCT02008656|Total mesorectal excision|total mesorectal excision
5336941|NCT02008656|Chemoradiation therapy|chemoradiation therapy
5336942|NCT02008656|Total neoadjuvant therapy|total neoadjuvant therapy
5336943|NCT02008656|13-213|13-213
5336944|NCT02008643|Health related quality of life, food allergy, children, chronic diseases|health related quality of life, food allergy, children, chronic diseases
5336945|NCT02008617|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5336946|NCT02008604|ischemia|ischemia
5336947|NCT02008604|stroke|stroke
5336948|NCT02008604|transient ischemic attack (TIA)|transient ischemic attack (tia)
5336949|NCT02008604|microbiome|microbiome
5336950|NCT02008604|microbiota|microbiota
5336951|NCT02008604|gut|gut
5336952|NCT02008591|Neuraxial Technique|neuraxial technique
5336953|NCT02008591|Epidural Technique|epidural technique
5336954|NCT02008591|Dural Puncture Epidural Technique|dural puncture epidural technique
5336955|NCT02008591|Combined Spinal Epidural Technique|combined spinal epidural technique
5336956|NCT02008591|Labor Analgesia|labor analgesia
5336957|NCT02008591|Obstetric|obstetric
5336958|NCT02008578|Antiviral|antiviral
5336959|NCT02008578|Adjunctive Therapy|adjunctive therapy
5336960|NCT02008578|Antibody|antibody
5336961|NCT02008565|Fecal incontinence|fecal incontinence
5336962|NCT02008565|Loperamide|loperamide
5336963|NCT02008565|anal exercises|anal exercises
5336964|NCT02008565|biofeedback|biofeedback
5336965|NCT02008552|Genetic factor|genetic factor
5336966|NCT02008552|Valvulopathy|valvulopathy
5336967|NCT02008552|Mediator|mediator
5336968|NCT02008526|Text Messaging|text messaging
5336969|NCT02008526|mHealth|mhealth
5336970|NCT02008526|Methamphetamine|methamphetamine
5336971|NCT02008526|HIV|hiv
5336972|NCT02008526|AIDS|aids
5336973|NCT02008513|AFFITOPE® AD02|affitope® ad02
5336974|NCT02008513|Alzheimer Disease|alzheimer disease
5336975|NCT02008513|Dementia|dementia
5336976|NCT02008513|Brain Disease|brain disease
5336977|NCT02008513|Nervous System Diseases|nervous system diseases
5336978|NCT02008513|Tauopathies|tauopathies
5336979|NCT02008513|Neurodegenerative Diseases|neurodegenerative diseases
5336980|NCT02008513|Mental Disorders|mental disorders
5336981|NCT02008500|Dentinal Hypersensitivity|dentinal hypersensitivity
5336982|NCT02008500|Gingival Recession|gingival recession
5336983|NCT02008500|Visual Analogue Score|visual analogue score
5336984|NCT02008487|wound|wound
5336985|NCT02008487|palliative care|palliative care
5336986|NCT02008487|hospice|hospice
5336987|NCT02008487|pressure ulcers|pressure ulcers
5336988|NCT02008435|Group-delivered Diabetes Prevention Program|group-delivered diabetes prevention program
5336989|NCT02008435|Obesity|obesity
5336990|NCT02008435|Overweight|overweight
5336991|NCT02008435|Lifestyle change|lifestyle change
5336992|NCT02008435|Healthy eating|healthy eating
5336993|NCT02008435|Weight loss|weight loss
5336994|NCT02008435|Exercise|exercise
5336995|NCT02008435|Cognitive-behavioral intervention|cognitive-behavioral intervention
5336996|NCT02008435|Implementation intentions|implementation intentions
5336997|NCT02008435|Mental imagery|mental imagery
5336998|NCT02008435|Mental practice|mental practice
5336999|NCT02008435|If-then plans|if-then plans
5337000|NCT02008409|Minimally Invasive Surgery|minimally invasive surgery
5337001|NCT02008409|EndoLift Liver Retractor|endolift liver retractor
5337002|NCT02008396|MDMA|mdma
5337003|NCT02008396|autism|autism
5337004|NCT02008396|social anxiety|social anxiety
5337005|NCT02008383|Colorectal cancer|colorectal cancer
5337006|NCT02008383|Panitumumab|panitumumab
5337007|NCT02008383|Cabozantinib|cabozantinib
5337008|NCT02008370|minimally invasive cardiac surgery|minimally invasive cardiac surgery
5337009|NCT02008370|Exparel|exparel
5337010|NCT02008357|Cognition|cognition
5337011|NCT02008357|Prevention|prevention
5337012|NCT02008344|influenza|influenza
5337013|NCT02008344|flu|flu
5337014|NCT02008344|fever|fever
5337015|NCT02008344|cough|cough
5337016|NCT02008344|body aches|body aches
5337017|NCT02008344|headache|headache
5337018|NCT02008344|nasal congestion|nasal congestion
5337019|NCT02008344|body pains|body pains
5337020|NCT02008344|sore throat|sore throat
5337021|NCT02008344|fatigue|fatigue
5337022|NCT02008344|T-705|t-705
5337023|NCT02008344|favipiravir|favipiravir
5337024|NCT02008344|favor|favor
5337025|NCT02008344|flu symptoms|flu symptoms
5337026|NCT02008331|chronic kidney disease|chronic kidney disease
5337027|NCT02008331|p-cresol|p-cresol
5337028|NCT02008331|synbiotic|synbiotic
5337029|NCT02008292|smoking|smoking
5337030|NCT02008292|schizophrenia|schizophrenia
5337031|NCT02008292|acetylcholine|acetylcholine
5337032|NCT02008279|Healthy|healthy
5337033|NCT02008279|CNTO 3157|cnto 3157
5337034|NCT02008279|Pharmacokinetics|pharmacokinetics
5337035|NCT02008253|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
5337036|NCT02008253|ASTIGMATISM|astigmatism
5337039|NCT02008240|IVF-ET|ivf-et
5337040|NCT02008240|Salpingectomy|salpingectomy
5337041|NCT02008214|Pentoxifylline|pentoxifylline
5337042|NCT02008214|Sustained virologic response|sustained virologic response
5337043|NCT02008214|Hepatic fibrosis|hepatic fibrosis
5337044|NCT02008201|dose-response study|dose-response study
5337045|NCT02008188|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5337046|NCT02008188|Artificial Pancreas|artificial pancreas
5337047|NCT02008188|Closed Loop Control|closed loop control
5337048|NCT02008188|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5337049|NCT02008188|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5337050|NCT02008188|Insulin Pump|insulin pump
5337051|NCT02008188|Metabolic Diseases|metabolic diseases
5337052|NCT02008188|Endocrine System Diseases|endocrine system diseases
5963339|NCT04254185|Elbow|elbow
5337053|NCT02008188|Autoimmune Diseases|autoimmune diseases
5337054|NCT02008175|paediatric, keratoconus, collagen cross linking|paediatric, keratoconus, collagen cross linking
5337055|NCT02008162|Emphysema, COPD, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, LVRS|emphysema, copd, bronchoreversibility, ventilatory obstruction, lung volume reduction surgery, lvrs
5337056|NCT02008149|Osteoporosis|osteoporosis
5337057|NCT02008136|myofascial pain|myofascial pain
5337058|NCT02008136|muscle spasm|muscle spasm
5337059|NCT02008136|botulinum toxin|botulinum toxin
5337060|NCT02008136|cervicalgia|cervicalgia
5337061|NCT02008136|lumbago|lumbago
5337062|NCT02008136|low back pain|low back pain
5337063|NCT02008123|Clopidogrel|clopidogrel
5337064|NCT02008123|Clopidogrel Resistance|clopidogrel resistance
5337065|NCT02008123|Primidone|primidone
5337066|NCT02008123|Secondary Stroke Prevention|secondary stroke prevention
5337067|NCT02008110|Heart failure|heart failure
5337068|NCT02008110|Biomarker guided-therapy|biomarker guided-therapy
5337069|NCT02008110|Carbohydrate antigen 125|carbohydrate antigen 125
5337070|NCT02008110|Clinical outcomes.|clinical outcomes.
5337071|NCT02008097|Ultrasound|ultrasound
5337072|NCT02008097|Ultrasonography|ultrasonography
5337073|NCT02008097|Liver transplantation|liver transplantation
5337074|NCT02008097|Arterial Occlusive Diseases|arterial occlusive diseases
5337075|NCT02008097|Hypertension|hypertension
5337076|NCT02008097|Pregnancy, High Risk|pregnancy, high risk
5337077|NCT02008097|Pregnancy|pregnancy
5337078|NCT02008084|hypertriglyceridemia|hypertriglyceridemia
5337079|NCT02008084|mixed hyperlipidemia|mixed hyperlipidemia
5337206|NCT02007694|Yohimbine|yohimbine
5337080|NCT02008058|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
5337081|NCT02008058|LCCC 1231|lccc 1231
5337082|NCT02008058|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5337083|NCT02008058|UNC Lineberger|unc lineberger
5337084|NCT02008058|Prostate Cancer|prostate cancer
5337085|NCT02008058|Pain|pain
5337087|NCT02008045|Imaging|imaging
5337088|NCT02008045|Neurocognitive|neurocognitive
5337089|NCT02008045|White matter injury|white matter injury
5337090|NCT02008032|Mammography|mammography
5337091|NCT02008032|Breast|breast
5337092|NCT02008032|Implants|implants
5337093|NCT02008019|Chondrosarcoma|chondrosarcoma
5337094|NCT02008019|Neoadjuvant therapy|neoadjuvant therapy
5337095|NCT02008019|Phase II|phase ii
5337096|NCT02008019|Everolimus|everolimus
5337097|NCT02008019|Success Rate|success rate
5337098|NCT02008019|Progression Free Survival|progression free survival
5337099|NCT02008019|Overall Survival|overall survival
5337100|NCT02008019|Safety|safety
5337101|NCT02008019|Quality of Life|quality of life
5337102|NCT02008019|Molecular study (ancillary study)|molecular study (ancillary study)
5337103|NCT02008006|Follicular Lymphoma|follicular lymphoma
5337104|NCT02008006|Chemosensitive relapse|chemosensitive relapse
5337105|NCT02008006|High Dose Chemotherapy|high dose chemotherapy
5337106|NCT02008006|Bendamustine|bendamustine
5337107|NCT02008006|BeEAM|beeam
5337108|NCT02008006|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5337109|NCT02008006|Safety|safety
5337110|NCT02008006|Event Free Survival|event free survival
5337111|NCT02008006|Overall Response Rate|overall response rate
5337112|NCT02008006|Progression Free Survival|progression free survival
5337113|NCT02008006|Overall Survival|overall survival
5337114|NCT02008006|Phase II|phase ii
5337115|NCT02008006|World Health Organization (WHO) 1 grade|world health organization (who) 1 grade
5337116|NCT02008006|WHO 2 grade|who 2 grade
5337117|NCT02008006|WHO 3a grade|who 3a grade
5337118|NCT02007993|Halitosis,|halitosis,
5337119|NCT02007993|Photodynamic Therapy,|photodynamic therapy,
5337120|NCT02007993|Adolescent|adolescent
5337121|NCT02007980|urological problems|urological problems
5337122|NCT02007980|indwelling urologic stent|indwelling urologic stent
5337123|NCT02007980|kidney stone disease|kidney stone disease
5337124|NCT02007980|urinary system obstruction|urinary system obstruction
5337125|NCT02007980|hydronephrosis|hydronephrosis
5337126|NCT02007980|ureteral damage|ureteral damage
5337128|NCT02007915|Adolescent|adolescent
5337129|NCT02007915|Avascular Necrosis|avascular necrosis
5337130|NCT02007915|Bisphosphonates|bisphosphonates
5337132|NCT02007902|Preterm baby|preterm baby
5337133|NCT02007902|Total plasma protein|total plasma protein
5337134|NCT02007902|Albumin|albumin
5337135|NCT02007902|Hemodynamic disturbances|hemodynamic disturbances
5337136|NCT02007902|Perfusion|perfusion
5337137|NCT02007902|Near Infra Red Spectroscopy (NIRS)|near infra red spectroscopy (nirs)
5337138|NCT02007902|Ultrasound|ultrasound
5337139|NCT02007876|Mobility|mobility
5337140|NCT02007876|Activity|activity
5337141|NCT02007876|Training|training
5337142|NCT02007876|Abdominal|abdominal
5337143|NCT02007876|Surgery|surgery
5337144|NCT02007876|Adult|adult
5337145|NCT02007863|Leukemia|leukemia
5337146|NCT02007863|Myelodysplasia|myelodysplasia
5337147|NCT02007863|Acute lymphocytic leukemia|acute lymphocytic leukemia
5337149|NCT02007863|Acute myelogenous leukemia|acute myelogenous leukemia
5337150|NCT02007863|AML|aml
5337151|NCT02007863|Pediatric|pediatric
5963340|NCT04254185|Ulnar Nerve|ulnar nerve
5216611|NCT02642393|PD|pd
5337152|NCT02007850|continuous femoral nerve block|continuous femoral nerve block
5337153|NCT02007850|knee arthroplasty|knee arthroplasty
5337154|NCT02007850|quadriceps muscle strength|quadriceps muscle strength
5337155|NCT02007837|pregnancy induced hypertension|pregnancy induced hypertension
5337156|NCT02007837|gestational hypertension|gestational hypertension
5337157|NCT02007837|pre-eclampsia|pre-eclampsia
5337158|NCT02007837|preeclampsia|preeclampsia
5337159|NCT02007837|hypertensive disorders in pregnancy|hypertensive disorders in pregnancy
5337160|NCT02007824|pressure ulcer|pressure ulcer
5337161|NCT02007824|chronic wound|chronic wound
5337162|NCT02007824|tissue necrosis|tissue necrosis
5337163|NCT02007824|slough|slough
5337164|NCT02007824|ultra sound|ultra sound
5337165|NCT02007798|dexmedetomidine|dexmedetomidine
5337166|NCT02007798|supratentorial tumors|supratentorial tumors
5337167|NCT02007785|Cognitive Orientation to daily Occupational Performance|cognitive orientation to daily occupational performance
5337168|NCT02007785|CO-OP|co-op
5337169|NCT02007772|COPD, nHF, BiPAP|copd, nhf, bipap
5337170|NCT02007759|Dysphagia|dysphagia
5337171|NCT02007759|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5337172|NCT02007759|NMES|nmes
5337173|NCT02007759|Neonates|neonates
5337174|NCT02007759|Vitalstim|vitalstim
5337175|NCT02007746|sickle cell disease|sickle cell disease
5337176|NCT02007746|hemochromatosis|hemochromatosis
5337177|NCT02007746|liver fibrosis|liver fibrosis
5337178|NCT02007746|liver cirrhosis|liver cirrhosis
5337179|NCT02007746|FibroScan|fibroscan
5337180|NCT02007746|Ferriscan|ferriscan
5337181|NCT02007746|liver iron|liver iron
5337182|NCT02007733|Diarrhea|diarrhea
5337183|NCT02007733|Dehydration|dehydration
5337184|NCT02007733|Children|children
5337185|NCT02007733|Resuscitation|resuscitation
5337186|NCT02007733|Clinical Prediction Rule|clinical prediction rule
5337187|NCT02007733|Low Income Country|low income country
5337188|NCT02007733|Bangladesh|bangladesh
5337189|NCT02007720|Serelaxin,|serelaxin,
5337190|NCT02007720|WHF,|whf,
5337191|NCT02007720|Likert Scale,|likert scale,
5231976|NCT02552602|HIV|hiv
5337192|NCT02007720|RELAX-AHF-ASIA,|relax-ahf-asia,
5337193|NCT02007720|RLX030,|rlx030,
5337194|NCT02007720|AHF,|ahf,
5337195|NCT02007720|acute heart failure|acute heart failure
5337196|NCT02007707|Asian American|asian american
5337197|NCT02007707|Vietnamese American|vietnamese american
5337198|NCT02007707|Smoking cessation|smoking cessation
5337199|NCT02007707|Community Health Worker|community health worker
5678922|NCT00584298|syndrome|syndrome
5337200|NCT02007707|Lay Health Worker Outreach|lay health worker outreach
5337201|NCT02007707|Family Intervention|family intervention
5337202|NCT02007694|Phobic Disorders (Fear of Flying and acrophobia)|phobic disorders (fear of flying and acrophobia)
5438860|NCT01550120|fat|fat
5337203|NCT02007694|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5337204|NCT02007694|Fear extinction|fear extinction
5337205|NCT02007694|propranolol|propranolol
5337207|NCT02007681|Sedentary Behavior; Breaks; Workplace; Energy Expenditure; Physical activity; doubly labeled water|sedentary behavior; breaks; workplace; energy expenditure; physical activity; doubly labeled water
5337208|NCT02007668|low back pain|low back pain
5337209|NCT02007668|kinesio taping|kinesio taping
5337210|NCT02007655|Cardiovascular|cardiovascular
5337211|NCT02007616|Cognitive aging|cognitive aging
5337212|NCT02007616|Video games training|video games training
5337213|NCT02007616|Attention|attention
5337214|NCT02007616|Memory|memory
5337215|NCT02007616|Wellbeing|wellbeing
5337216|NCT02007616|Speed of processing|speed of processing
5338414|NCT02001961|MRI|mri
5337217|NCT02007616|Executive functions|executive functions
5337218|NCT02007603|chronic hemodialysis|chronic hemodialysis
5337219|NCT02007603|ampicillin|ampicillin
5337220|NCT02007603|sulbactam|sulbactam
5337221|NCT02007603|amoxicillin|amoxicillin
5337222|NCT02007603|clavulanic acid|clavulanic acid
5337223|NCT02007603|pharmacokinetics|pharmacokinetics
5337224|NCT02007577|insulin resistant|insulin resistant
5337225|NCT02007564|Palliative care dyads|palliative care dyads
5337226|NCT02007564|Volunteers|volunteers
5337227|NCT02007564|Community-based|community-based
5337228|NCT02007564|Mixed methods|mixed methods
5337229|NCT02007551|Social Isolation|social isolation
5337230|NCT02007551|Nutrition Assessments|nutrition assessments
5337231|NCT02007551|Food Habits|food habits
5337232|NCT02007551|Meals|meals
5337233|NCT02007551|Self Efficacy|self efficacy
5337234|NCT02007551|Quality of Life|quality of life
5337235|NCT02007551|Peer Group|peer group
5337236|NCT02007538|Lung Cancer|lung cancer
5337237|NCT02007538|Bronchoscopy|bronchoscopy
5337238|NCT02007538|Fine Need Aspiration|fine need aspiration
5337239|NCT02007538|Cytochemical Assays|cytochemical assays
5337240|NCT02007512|advanced breast cancer|advanced breast cancer
5337241|NCT02007512|enzalutamide|enzalutamide
5337242|NCT02007512|MDV3100|mdv3100
5337243|NCT02007512|Estrogen receptor positive (ER +)|estrogen receptor positive (er +)
5337244|NCT02007512|Progesterone receptor positive (PgR +)|progesterone receptor positive (pgr +)
5337245|NCT02007512|HER-2 normal|her-2 normal
5963341|NCT04254055|Shoulder|shoulder
5963342|NCT04254055|Strength|strength
5337246|NCT02007499|Prehospital emergency care|prehospital emergency care
5337247|NCT02007499|Out of hospital cardiac arrest|out of hospital cardiac arrest
5337248|NCT02007499|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5337249|NCT02007499|CPR|cpr
5337250|NCT02007499|Heart arrest|heart arrest
5337251|NCT02007499|Outcome|outcome
5337252|NCT02007499|Bystander|bystander
5337253|NCT02007486|Heart Failure|heart failure
5337254|NCT02007486|Exercise|exercise
5337255|NCT02007486|Dyspnea|dyspnea
5337256|NCT02007486|Diaphragm electromyogram|diaphragm electromyogram
5337257|NCT02007486|Respiratory mechanics|respiratory mechanics
5337258|NCT02007473|Haemovigilance|haemovigilance
5337259|NCT02007473|Plasma|plasma
5337260|NCT02007473|Pathogen reduction|pathogen reduction
5337261|NCT02007473|Methylene Blue|methylene blue
5337262|NCT02007447|autism, oxytocin, autism spectrum disorder, social skills.|autism, oxytocin, autism spectrum disorder, social skills.
5337263|NCT02007421|Human Papillomavirus,|human papillomavirus,
5337264|NCT02007421|Anal High Grade Squamous intraepithelial lesions,|anal high grade squamous intraepithelial lesions,
5337265|NCT02007421|Homosexual Men|homosexual men
5337266|NCT02007421|High resolution anoscopy,|high resolution anoscopy,
5337267|NCT02007421|Cancer Screening|cancer screening
5337268|NCT02007421|HIV|hiv
5337269|NCT02007408|abortion|abortion
5337270|NCT02007408|analgesia|analgesia
5337271|NCT02007408|paracervical block|paracervical block
5337272|NCT02007408|lidocaine spray|lidocaine spray
5337273|NCT02007343|Enterobacteriaceae|enterobacteriaceae
5337274|NCT02007343|Pseudomonas|pseudomonas
5337275|NCT02007343|Acinetobacter|acinetobacter
5337276|NCT02007343|Stenotrophomonas|stenotrophomonas
5337277|NCT02007343|Mortality|mortality
5337278|NCT02007343|Morbidity|morbidity
5337279|NCT02007343|Cost of Illness|cost of illness
5337280|NCT02007343|Causality|causality
5337281|NCT02007343|Multicenter Study|multicenter study
5337282|NCT02007343|Cohort Studies|cohort studies
5337283|NCT02007343|Case-Control Studies|case-control studies
5337284|NCT02007343|Prospective Studies|prospective studies
5337285|NCT02007343|Follow-up Studies|follow-up studies
5337286|NCT02007330|systemic lidocaine|systemic lidocaine
5337287|NCT02007330|postoperative pain|postoperative pain
5337288|NCT02007330|recovery, pediatric|recovery, pediatric
5337289|NCT02007330|inguinal hernia|inguinal hernia
5337290|NCT02007330|laparoscopy|laparoscopy
5337291|NCT02007317|BCC|bcc
5337292|NCT02007291|Alzheimer, MMSE, response, colinesterase inhibitors (ChEI)|alzheimer, mmse, response, colinesterase inhibitors (chei)
5337293|NCT02007278|diabetes|diabetes
5337294|NCT02007278|hypoglycemia|hypoglycemia
5337295|NCT02007278|glycemic variability|glycemic variability
5337296|NCT02007278|vildagliptin|vildagliptin
5337297|NCT02007278|glimepiride|glimepiride
5337298|NCT02007252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5337299|NCT02007252|AAA|aaa
5337300|NCT02007252|IL-1b|il-1b
5337301|NCT02007252|Abdominal ultrasound|abdominal ultrasound
5337302|NCT02007239|tocilizumab|tocilizumab
5337303|NCT02007239|hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5337304|NCT02007239|cytokine|cytokine
5337305|NCT02007239|cytokine release syndrome|cytokine release syndrome
5337306|NCT02007226|Coronary Heart Disease|coronary heart disease
5337307|NCT02007226|spinal cord injury|spinal cord injury
5337308|NCT02007226|risk factor|risk factor
5337309|NCT02007226|postprandial lipemia|postprandial lipemia
5337310|NCT02007213|Neuromuscular Disease|neuromuscular disease
5337311|NCT02007213|Motor Function|motor function
5337312|NCT02007213|Proxy Reported Outcome|proxy reported outcome
5337313|NCT02007213|Young Children|young children
5337314|NCT02007187|Unstable Angina Pectoris|unstable angina pectoris
5337315|NCT02007187|Randomized Controlled Trial|randomized controlled trial
5337316|NCT02007187|Traditional Chinese Medicine|traditional chinese medicine
5337317|NCT02007174|recurrent pterygium|recurrent pterygium
5337318|NCT02007174|bevacizumab|bevacizumab
5337319|NCT02007174|triple dose|triple dose
5337320|NCT02007148|gastric adenocarcinoma,|gastric adenocarcinoma,
5337321|NCT02007148|capecitabine,|capecitabine,
5337322|NCT02007148|second line treatment,|second line treatment,
5337323|NCT02007148|recurrent or metastatic disease,|recurrent or metastatic disease,
5337324|NCT02007148|overall survival,|overall survival,
5337325|NCT02007148|tumor response,|tumor response,
5337326|NCT02007148|quality of life|quality of life
5337328|NCT02007122|CVVH|cvvh
5337329|NCT02007122|renal replacement therapy|renal replacement therapy
5337330|NCT02007122|ceftaroline|ceftaroline
5337331|NCT02007122|pharmacokinetics|pharmacokinetics
5337332|NCT02007096|Transabdominal plane block|transabdominal plane block
5337333|NCT02007096|ventral hernia|ventral hernia
5337334|NCT02007096|umbilical hernia|umbilical hernia
5337335|NCT02007096|incisional hernia|incisional hernia
5337336|NCT02007096|hernia repair|hernia repair
5337337|NCT02007083|Lumbar Spinal stenosis|lumbar spinal stenosis
5337338|NCT02007083|Surgical treatment of LSS.|surgical treatment of lss.
5337340|NCT02007070|PD-1|pd-1
5337341|NCT02007070|PDL1|pdl1
5337342|NCT02007070|PD-L1|pd-l1
5337343|NCT02007057|Suprascapular nerve block|suprascapular nerve block
5963343|NCT04254055|Stability|stability
5337344|NCT02007057|Interscalene nerve block|interscalene nerve block
5337345|NCT02007031|Hypertension|hypertension
5337346|NCT02007031|Cold temperature|cold temperature
5337347|NCT02007031|Blood pressure|blood pressure
5337348|NCT02007031|Electrocardiography|electrocardiography
5337349|NCT02007018|Surgical Site Infections|surgical site infections
5337350|NCT02007018|Colorectal Resection|colorectal resection
5337351|NCT02007018|Negative Pressure Wound Therapy|negative pressure wound therapy
5337352|NCT02007005|superficial bladder cancer|superficial bladder cancer
5337353|NCT02007005|mistletoe extract|mistletoe extract
5337354|NCT02007005|maximum tolerated dose|maximum tolerated dose
5337355|NCT02007005|marker tumor|marker tumor
5337356|NCT02007005|remission|remission
5337357|NCT02007005|recurrence rate|recurrence rate
5337358|NCT02006979|cardiotoxicity|cardiotoxicity
5337359|NCT02006979|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5337360|NCT02006979|Breast Neoplasms|breast neoplasms
5337361|NCT02006979|Exercise|exercise
5337362|NCT02006979|Cardiotoxins|cardiotoxins
5337363|NCT02006979|Echocardiography|echocardiography
5337364|NCT02006979|Speckle tracking|speckle tracking
5337365|NCT02006979|Biological Markers|biological markers
5337366|NCT02006979|Electrocardiography|electrocardiography
5337367|NCT02006966|Systemic lidocaine|systemic lidocaine
5337368|NCT02006966|postoperative pain|postoperative pain
5337369|NCT02006966|Video-assisted thoracic surgery|video-assisted thoracic surgery
5337370|NCT02006966|VATS|vats
5337371|NCT02006953|gastrostomy|gastrostomy
5337372|NCT02006953|enteral|enteral
5337373|NCT02006940|alveoflex|alveoflex
5337374|NCT02006940|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5337375|NCT02006940|pCLE|pcle
5337376|NCT02006940|alveoscopy|alveoscopy
5337377|NCT02006940|morphology|morphology
5337378|NCT02006940|high resolution computed tomography|high resolution computed tomography
5337379|NCT02006927|Prostate Cancer|prostate cancer
5337380|NCT02006914|Insulin resistance|insulin resistance
5337381|NCT02006914|HIV disease|hiv disease
5337382|NCT02006914|chromium picolinate|chromium picolinate
5337383|NCT02006901|surgical procedures, operative|surgical procedures, operative
5337384|NCT02006901|lumbar vertebrae|lumbar vertebrae
5337385|NCT02006901|decompression, surgical|decompression, surgical
5337386|NCT02006901|microdecompression|microdecompression
5337387|NCT02006901|laminectomy|laminectomy
5337388|NCT02006901|registries|registries
5337389|NCT02006888|Inflammation|inflammation
5337390|NCT02006888|cataract surgery|cataract surgery
5337391|NCT02006875|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5337392|NCT02006875|postural|postural
5337393|NCT02006875|balance|balance
5337394|NCT02006875|mobility|mobility
5337396|NCT02006875|stroke|stroke
5337397|NCT02006862|olanzapine|olanzapine
5337398|NCT02006862|olanzapine treatment efficacy|olanzapine treatment efficacy
5337399|NCT02006849|AfricanAmericans|africanamericans
5337400|NCT02006849|Hypertension|hypertension
5337401|NCT02006849|Proteinuria|proteinuria
5337402|NCT02006849|ApoL1 gene|apol1 gene
5337403|NCT02006836|glycemic index|glycemic index
5337404|NCT02006836|glycemic response|glycemic response
5337405|NCT02006836|diabetes|diabetes
5337406|NCT02006836|pomelo|pomelo
5337407|NCT02006823|Chronic Hepatitis C|chronic hepatitis c
5337408|NCT02006810|Endothelium biomarkers|endothelium biomarkers
5337409|NCT02006810|Atherosclerotic disease|atherosclerotic disease
5337410|NCT02006810|Endothelial function|endothelial function
5337411|NCT02006810|Nutritional stimuli|nutritional stimuli
5337412|NCT02006797|reconciliation|reconciliation
5337413|NCT02006797|discharge|discharge
5337414|NCT02006797|pharmacist|pharmacist
5337415|NCT02006797|drug related problems|drug related problems
5337416|NCT02006771|Meal|meal
5337417|NCT02006771|Postprandial oxidative stress|postprandial oxidative stress
5337418|NCT02006719|Adhesive Capsulitis|adhesive capsulitis
5337419|NCT02006719|Frozen Shoulder|frozen shoulder
5337420|NCT02006719|Shoulder Range of Motion limitation|shoulder range of motion limitation
5337421|NCT02006719|Shoulder Pain|shoulder pain
5337422|NCT02006693|XEN|xen
5337423|NCT02006693|Primary Open Angle Glaucoma|primary open angle glaucoma
5337424|NCT02006693|Filtration Device|filtration device
5337425|NCT02006693|Ab interno|ab interno
5337426|NCT02006680|Central Precocious Puberty|central precocious puberty
5337427|NCT02006680|Suppression|suppression
5337428|NCT02006680|Alpha Subunit|alpha subunit
5337429|NCT02006680|Leuprolide Stimulation Test|leuprolide stimulation test
5337430|NCT02006628|GWP42003|gwp42003
5337432|NCT02006628|Schizophrenia|schizophrenia
5337433|NCT02006628|CBD|cbd
5337434|NCT02006628|Cannabidiol|cannabidiol
5337435|NCT02006602|Candesartan cilexetil|candesartan cilexetil
5337436|NCT02006602|Healthy adult human subjects|healthy adult human subjects
5337437|NCT02006602|Bioequivalence|bioequivalence
5337438|NCT02006589|Bioequivalence|bioequivalence
5337439|NCT02006589|Candesartan cilexetil|candesartan cilexetil
5337440|NCT02006589|Healthy adult human subjects|healthy adult human subjects
5337441|NCT02006576|Emphysema|emphysema
5337442|NCT02006576|Prostaglandin E|prostaglandin e
5337443|NCT02006576|Bronchoalveolar lavage|bronchoalveolar lavage
5337444|NCT02006563|Brain Tumor|brain tumor
5337445|NCT02006563|Glioblastoma multiforme|glioblastoma multiforme
5337446|NCT02006563|GBM|gbm
5337447|NCT02006563|Metabolic Tumor Volume|metabolic tumor volume
5337448|NCT02006563|MTV|mtv
5337449|NCT02006563|Clinical Tumor Volume|clinical tumor volume
5337450|NCT02006563|CTV|ctv
5337451|NCT02006550|Wnt|wnt
5337452|NCT02006550|Notch|notch
5337453|NCT02006550|Hedgehog|hedgehog
5337454|NCT02006550|Tumor Sample|tumor sample
5337455|NCT02006537|soluble epoxide hydrolase inhibitor|soluble epoxide hydrolase inhibitor
5337456|NCT02006537|Entero-Test|entero-test
5337457|NCT02006537|pharmacokinetics|pharmacokinetics
5337458|NCT02006537|COPD|copd
5337459|NCT02006537|safety|safety
5337460|NCT02006524|Silent atrial fibrillation|silent atrial fibrillation
5337461|NCT02006524|primary care|primary care
5337462|NCT02006524|screening|screening
5337463|NCT02006524|influenza vaccination|influenza vaccination
5337464|NCT02006511|incisional negative pressure wound therapy|incisional negative pressure wound therapy
5337465|NCT02006511|groin incision|groin incision
5337466|NCT02006511|incisional VAC|incisional vac
5337467|NCT02006511|Prevena|prevena
5337468|NCT02006511|groin wound|groin wound
5337469|NCT02006498|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5337470|NCT02006498|sillymarin|sillymarin
5337471|NCT02006498|randomised trial|randomised trial
5337472|NCT02006498|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5337473|NCT02006472|Huntington's Disease|huntington's disease
5337474|NCT02006472|Pridopidine|pridopidine
5337475|NCT02006472|Pride-HD|pride-hd
5337476|NCT02006459|Gastrointestinal-mediated glucose disposal|gastrointestinal-mediated glucose disposal
5337477|NCT02006459|Total pancreatectomy|total pancreatectomy
5337478|NCT02006459|Incretin hormones|incretin hormones
5337479|NCT02006459|Glucagon|glucagon
5337480|NCT02006446|Male infertility|male infertility
5337481|NCT02006446|sperm head vacuoles|sperm head vacuoles
5337482|NCT02006446|sperm morphology|sperm morphology
5337483|NCT02006446|aneuploidy|aneuploidy
5337484|NCT02006446|DNA fragmentation|dna fragmentation
5337485|NCT02006446|abnormal chromatin condensation|abnormal chromatin condensation
5337486|NCT02006446|telomere abnormalities|telomere abnormalities
5337487|NCT02006394|Inflammation|inflammation
5337488|NCT02006394|Monocytes|monocytes
5337489|NCT02006381|healthy boys|healthy boys
5337490|NCT02006381|plasma oxytocin|plasma oxytocin
5337491|NCT02006381|pediatric|pediatric
5337492|NCT02006368|Volunteers|volunteers
5337493|NCT02006368|Blood Platelets|blood platelets
5337494|NCT02006368|Platelet Transfusion|platelet transfusion
5337495|NCT02006342|Diabetes Mellitus|diabetes mellitus
5337496|NCT02006342|Diabetic Ketoacidosis|diabetic ketoacidosis
5337497|NCT02006342|Insulin Glargine|insulin glargine
5337498|NCT02006342|Anion gap|anion gap
5337499|NCT02006342|Metabolic acidosis|metabolic acidosis
5337500|NCT02006303|Benign Prostate Hyperplasia|benign prostate hyperplasia
5337501|NCT02006303|Green light|green light
5337502|NCT02006303|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
5337503|NCT02006303|Prostatic artery embolization|prostatic artery embolization
5337504|NCT02006303|Outcome|outcome
5337505|NCT02006277|healthy volunteers|healthy volunteers
5337506|NCT02006277|taste|taste
5337507|NCT02006277|bioavailability|bioavailability
5337508|NCT02006238|Hot flash|hot flash
5337509|NCT02006238|Farabloc|farabloc
5337510|NCT02006238|menopausal women|menopausal women
5337511|NCT02006225|autologous|autologous
5337512|NCT02006225|stem cell|stem cell
5337513|NCT02006225|transplantation|transplantation
5337514|NCT02006199|obsessive-compulsive disorder|obsessive-compulsive disorder
5337515|NCT02006199|mindfulness|mindfulness
5337516|NCT02006199|meditation|meditation
5337517|NCT02006186|Bicycling|bicycling
5337518|NCT02006173|Hya-Dermis mixed with lidocaine on reducing pain|hya-dermis mixed with lidocaine on reducing pain
5337519|NCT02006147|Macular Edema|macular edema
5337520|NCT02006147|RVO|rvo
5337521|NCT02006134|Vasculitis|vasculitis
5337522|NCT02006134|Primary CNS Vasculitis|primary cns vasculitis
5337523|NCT02006134|Systemic vasculitis|systemic vasculitis
5337524|NCT02006134|Churg-Strauss Syndrome|churg-strauss syndrome
5337525|NCT02006134|Polyarteritis Nodosa|polyarteritis nodosa
5337526|NCT02006134|Wegener Granulomatosis|wegener granulomatosis
5337527|NCT02006134|Pediatric vasculitis|pediatric vasculitis
5337528|NCT02006134|Childhood vasculitis|childhood vasculitis
5337529|NCT02006134|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5337530|NCT02006134|Microscopic Polyangiitis|microscopic polyangiitis
5337531|NCT02006134|Takayasu Arteritis|takayasu arteritis
5337532|NCT02006134|Autoimmune|autoimmune
5337533|NCT02006134|ANCA-associated vasculitis|anca-associated vasculitis
5337534|NCT02006121|Parkinson's disease|parkinson's disease
5337535|NCT02006121|motor fluctuations|motor fluctuations
5337536|NCT02006121|not well controlled|not well controlled
5337537|NCT02006121|medical treatment|medical treatment
5337538|NCT02006121|apomorphine|apomorphine
5337539|NCT02006108|kidney|kidney
5337540|NCT02006108|transplant|transplant
5337541|NCT02006108|rejection|rejection
5337542|NCT02006108|Feraheme|feraheme
5337543|NCT02006108|ferumoxytol|ferumoxytol
5337544|NCT02006095|carotid artery stenting|carotid artery stenting
5337545|NCT02006095|carotid endarterectomy|carotid endarterectomy
5337546|NCT02006095|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5337547|NCT02006095|neuropsychological testing|neuropsychological testing
5337548|NCT02006095|microemboli|microemboli
5337549|NCT02006082|Telemedicine video-consultation (TVC)|telemedicine video-consultation (tvc)
5337550|NCT02006082|Re-admission to hospital|re-admission to hospital
5337551|NCT02006082|Time to re-admission|time to re-admission
5337552|NCT02006082|Length if hospital stay|length if hospital stay
5337553|NCT02006082|Patient satisfaction|patient satisfaction
5337554|NCT02006082|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5337555|NCT02006069|CRT, non responders, MultiPoint Pacing (MPP)|crt, non responders, multipoint pacing (mpp)
5337556|NCT02006030|Unresectable Hepatocellular Carcinoma|unresectable hepatocellular carcinoma
5337557|NCT02006030|Liver Cancer|liver cancer
5337558|NCT02006030|ADI|adi
5337559|NCT02006030|ADI-PEG 20|adi-peg 20
5337560|NCT02006004|AML|aml
5337561|NCT02005991|PF-05212377|pf-05212377
5337562|NCT02005991|phase 1|phase 1
5337563|NCT02005991|open-label|open-label
5337564|NCT02005991|5-HT2a receptor occupancy|5-ht2a receptor occupancy
5337565|NCT02005991|positron emission tomography|positron emission tomography
5337566|NCT02005991|healthy subjects|healthy subjects
5337567|NCT02005991|brain|brain
5337568|NCT02005991|cortex|cortex
5337569|NCT02005991|alzheimers disease|alzheimers disease
5337570|NCT02005965|Rectal Cancer|rectal cancer
5337571|NCT02005965|Low Rectal Cancer|low rectal cancer
5337572|NCT02005965|MERCURY|mercury
5337573|NCT02005965|Cancer|cancer
5337574|NCT02005965|CRM|crm
5337575|NCT02005965|Circumferential Margin|circumferential margin
5337576|NCT02005965|Quality of Life|quality of life
5337577|NCT02005965|MRI|mri
5337578|NCT02005965|Radiology|radiology
5337579|NCT02005965|Abdominoperineal Excision|abdominoperineal excision
5337580|NCT02005965|Anterior Resection|anterior resection
5337581|NCT02005965|Surgery|surgery
5337582|NCT02005965|Pathology|pathology
5337583|NCT02005939|Pomegranate|pomegranate
5232365|NCT02550171|Biobank|biobank
5337584|NCT02005939|Blood pressure|blood pressure
5337585|NCT02005939|Insulin sensitivity|insulin sensitivity
5337586|NCT02005939|Cortisol|cortisol
5337587|NCT02005939|Quality of life|quality of life
5337588|NCT02005939|Body composition|body composition
5337589|NCT02005926|Breast cancer|breast cancer
5337590|NCT02005926|Sentinel lymph node biopsy|sentinel lymph node biopsy
5337591|NCT02005926|Ultrasonography|ultrasonography
5678923|NCT00584298|colorectal|colorectal
5337592|NCT02005926|Fine needle aspiration|fine needle aspiration
5337594|NCT02005900|Omega 3|omega 3
5337595|NCT02005900|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5337596|NCT02005900|Dyslipidemia induced by HAART|dyslipidemia induced by haart
5337597|NCT02005900|Lipid metabolic alterations|lipid metabolic alterations
5337598|NCT02005900|HIV|hiv
5337599|NCT02005887|Premenopausal patients|premenopausal patients
5337600|NCT02005887|ER-positive|er-positive
5337601|NCT02005887|PgR+ (>50%)|pgr+ (>50%)
5337602|NCT02005887|HER2-negative or not amplified|her2-negative or not amplified
5337603|NCT02005861|osteochondral lesion|osteochondral lesion
5337604|NCT02005861|talus|talus
5337605|NCT02005861|ankle|ankle
5337606|NCT02005861|cartilage repair|cartilage repair
5337607|NCT02005848|Type-1 Diabetes|type-1 diabetes
5337608|NCT02005848|T1D|t1d
5337609|NCT02005848|Diabetes Mellitus|diabetes mellitus
5337610|NCT02005835|HIV|hiv
5337611|NCT02005835|Option B+|option b+
5337612|NCT02005835|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5337613|NCT02005822|Cytomegalovirus|cytomegalovirus
5337614|NCT02005822|Congenital infection|congenital infection
5337615|NCT02005822|Sensorineural hearing loss|sensorineural hearing loss
5337616|NCT02005822|Valganciclovir|valganciclovir
5337617|NCT02005809|Endoscopic submucosal dissection|endoscopic submucosal dissection
5337618|NCT02005809|gastric neoplasm|gastric neoplasm
5337619|NCT02005809|second look endoscopy|second look endoscopy
5337620|NCT02005783|incidence of grade 3/4 neutropenia|incidence of grade 3/4 neutropenia
5337621|NCT02005783|incidence of febrile neutropenia|incidence of febrile neutropenia
5337622|NCT02005783|time to neutropenia recovery|time to neutropenia recovery
5337623|NCT02005783|safety|safety
5337624|NCT02005757|rheumatoid arthritis|rheumatoid arthritis
5337625|NCT02005757|RA|ra
5337626|NCT02005757|Mizoribine|mizoribine
5337627|NCT02005757|DAS28|das28
5423356|NCT01616017|thermodilution|thermodilution
5337629|NCT02005744|CKD-501|ckd-501
5337636|NCT02005692|patient movement|patient movement
5337637|NCT02005692|patient monitoring|patient monitoring
5337638|NCT02005679|Prelingual Deafness|prelingual deafness
5337639|NCT02005679|Retention Disorders, Cognitive|retention disorders, cognitive
5337640|NCT02005679|Sign language|sign language
5337641|NCT02005679|Mini-Mental State|mini-mental state
5337642|NCT02005666|Acne Vulgaris|acne vulgaris
5337643|NCT02005666|DUAC|duac
5337644|NCT02005666|CADILA|cadila
5337645|NCT02005666|CLIANTHA|cliantha
5963344|NCT04254055|Functionality|functionality
5217131|NCT02639312|Mandibular|mandibular
5217132|NCT02639312|Facial Defects|facial defects
5217133|NCT02639312|Hasburg Jaw|hasburg jaw
5217139|NCT02639286|Lipodystrophy|lipodystrophy
5337646|NCT02005653|Lymphatic filariasis|lymphatic filariasis
5337647|NCT02005653|W. bancrofti|w. bancrofti
5337649|NCT02005653|Albendazole|albendazole
5337650|NCT02005653|Doxycycline|doxycycline
5337651|NCT02005627|grass pollen allergy|grass pollen allergy
5337652|NCT02005627|hayfever|hayfever
5337653|NCT02005627|atopy|atopy
5337654|NCT02005627|allergic rhinitis|allergic rhinitis
5337655|NCT02005627|sublingual immunotherapy tablets|sublingual immunotherapy tablets
5337656|NCT02005614|Rational dose selection|rational dose selection
5337657|NCT02005614|gamma knife radiosurgery|gamma knife radiosurgery
5337658|NCT02005588|amino acid chelated iron|amino acid chelated iron
5337659|NCT02005588|iron salt|iron salt
5337660|NCT02005588|iron deficiency anemia|iron deficiency anemia
5337661|NCT02005536|Poliomyelitis|poliomyelitis
5337662|NCT02005536|Poliovirus|poliovirus
5337663|NCT02005536|Polio|polio
5337664|NCT02005536|IMOVAX POLIO®|imovax polio®
5337665|NCT02005536|Inactivated polio vaccine|inactivated polio vaccine
5337666|NCT02005510|cervical cancer|cervical cancer
5337667|NCT02005510|screening|screening
5337668|NCT02005510|human papillomavirus|human papillomavirus
5337669|NCT02005510|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5337670|NCT02005497|Cancer prevention and control|cancer prevention and control
5337671|NCT02005497|Health promotion|health promotion
5337672|NCT02005497|Workplace|workplace
5337673|NCT02005497|Dissemination|dissemination
5337674|NCT02005497|Implementation|implementation
5337675|NCT02005458|Neutropenia|neutropenia
5337676|NCT02005458|Febrile neutropenia|febrile neutropenia
5337677|NCT02005458|PEG-rhG-CSF|peg-rhg-csf
5337678|NCT02005458|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
5337679|NCT02005445|Obstructive sleep apnea|obstructive sleep apnea
5337680|NCT02005445|Coronary heart disease|coronary heart disease
5337681|NCT02005445|Cardiac rehabilitation|cardiac rehabilitation
5337682|NCT02005445|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5337683|NCT02005432|Diabetis|diabetis
5337684|NCT02005432|Retinal Neovascularization|retinal neovascularization
5337685|NCT02005432|laser treatment|laser treatment
5337686|NCT02005419|Pancreatic Cancer|pancreatic cancer
5337687|NCT02005419|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5337688|NCT02005419|Metformin|metformin
5337689|NCT02005419|Gemcitabine|gemcitabine
5337690|NCT02005419|Adjuvant Therapy|adjuvant therapy
5337691|NCT02005406|Wei JET|wei jet
5337692|NCT02005393|FICE|fice
5337693|NCT02005393|NBI|nbi
5337694|NCT02005380|Alzheimer's Disease Rehabilitation|alzheimer's disease rehabilitation
5337695|NCT02005367|substance use treatment|substance use treatment
5337696|NCT02005367|person-centered treatment|person-centered treatment
5337697|NCT02005367|residential treatment outcomes|residential treatment outcomes
5337698|NCT02005367|dual diagnosis|dual diagnosis
5337699|NCT02005367|recovery model|recovery model
5337700|NCT02005367|psychosocial treatment|psychosocial treatment
5337701|NCT02005354|Pain|pain
5337702|NCT02005354|Bone marrow aspiration|bone marrow aspiration
5337703|NCT02005354|trephine biopsy|trephine biopsy
5337704|NCT02005341|Lumbar|lumbar
5337705|NCT02005341|fusion|fusion
5337706|NCT02005328|Xerostomia|xerostomia
5337707|NCT02005328|hyposialia|hyposialia
5337708|NCT02005328|hyposalivation|hyposalivation
5337709|NCT02005328|saliva substitute|saliva substitute
5337710|NCT02005328|Salivary Gland|salivary gland
5337711|NCT02005328|Mouth Diseases|mouth diseases
5337712|NCT02005328|Dry mouth|dry mouth
5337713|NCT02005315|Pancreatic Cancer|pancreatic cancer
5337714|NCT02005315|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
5339995|NCT01995084|HX4|hx4
5337715|NCT02005302|chronic kidney disease|chronic kidney disease
5337716|NCT02005302|mineral and bone disease|mineral and bone disease
5337717|NCT02005302|Malnutrition|malnutrition
5337718|NCT02005302|Vitamin D|vitamin d
5337719|NCT02005302|low protein diet|low protein diet
5337721|NCT02005289|SLL|sll
5337722|NCT02005289|PLL|pll
5333883|NCT02022449|Social support|social support
5337723|NCT02005289|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5337724|NCT02005289|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5341897|NCT01985724|HER-2 negative|her-2 negative
5337729|NCT02005276|Behavioral Economic Intervention|behavioral economic intervention
5337731|NCT02005276|Financial Incentives|financial incentives
5337732|NCT02005276|Workplace Wellness|workplace wellness
5337733|NCT02005276|Team Incentives|team incentives
5337734|NCT02005263|Hysteroscopy|hysteroscopy
5337735|NCT02005250|osteoporosis|osteoporosis
5337736|NCT02005250|hyperthyroidism|hyperthyroidism
5337737|NCT02005250|hypothyroidism|hypothyroidism
5337738|NCT02005237|Exercise|exercise
5337739|NCT02005237|Cognition|cognition
5963345|NCT04254055|Rugby.|rugby.
5963346|NCT04252300|P2X3 receptor antagonist|p2x3 receptor antagonist
5963347|NCT04252300|Rosuvastatin|rosuvastatin
5963348|NCT04252300|Organic Anion Transporting Polypeptide 1B1 (OATP1B1)|organic anion transporting polypeptide 1b1 (oatp1b1)
5337741|NCT02005237|Rehabilitation|rehabilitation
5337742|NCT02005237|Connectivity|connectivity
5337743|NCT02005224|Insulin sensitivity|insulin sensitivity
5337744|NCT02005224|Lipid profile|lipid profile
5337745|NCT02005224|Body composition|body composition
5337746|NCT02005224|Weight|weight
5337747|NCT02005211|AZD3293|azd3293
5337748|NCT02005211|Healthy volunteers|healthy volunteers
5337749|NCT02005211|Young volunteers|young volunteers
5337750|NCT02005211|Elderly volunteers|elderly volunteers
5337751|NCT02005211|Japanese volunteers|japanese volunteers
5337752|NCT02005211|Phase 1|phase 1
5337753|NCT02005211|Single and multiple ascending dose study|single and multiple ascending dose study
5337754|NCT02005172|arrhythmia, palpitations, lightheadedness|arrhythmia, palpitations, lightheadedness
5337755|NCT02005159|Enterobacteria|enterobacteria
5337756|NCT02005159|Bacteremia|bacteremia
5337757|NCT02005159|Minimum inhibitory concentration|minimum inhibitory concentration
5337758|NCT02005159|Susceptible|susceptible
5337759|NCT02005159|Prognosis|prognosis
5337760|NCT02005146|Hepatitis B|hepatitis b
5337761|NCT02005146|Nucleoside/nucleotide|nucleoside/nucleotide
5337762|NCT02005146|HBsAg loss|hbsag loss
5337763|NCT02005133|Wet age-related macular degeneration|wet age-related macular degeneration
5337764|NCT02005068|Osteoarticular infections|osteoarticular infections
5337765|NCT02005068|Osteomyelitis|osteomyelitis
5337766|NCT02005068|Joint infections|joint infections
5337767|NCT02005068|MRSA (Methicillin- Resistant Staphylococcus Aureus)|mrsa (methicillin- resistant staphylococcus aureus)
5337768|NCT02005068|MSSA (Methicillin- Susceptible Staphylococcus Aureus)|mssa (methicillin- susceptible staphylococcus aureus)
5337769|NCT02005055|Brachytherapy|brachytherapy
5337770|NCT02005055|Radiotherapy|radiotherapy
5337771|NCT02005055|Scar treatment|scar treatment
5337772|NCT02005042|Physical activity|physical activity
5337773|NCT02005042|Ecological Momentary Assessment|ecological momentary assessment
5337774|NCT02005042|Ecological Momentary Intervention|ecological momentary intervention
5337775|NCT02005042|Accelerometer|accelerometer
5337776|NCT02005042|Smartphone|smartphone
5337777|NCT02005029|Parkinson's Disease|parkinson's disease
5337778|NCT02005029|Levodopa|levodopa
5337779|NCT02005029|motor fluctuations|motor fluctuations
5337780|NCT02005029|gastroparesis|gastroparesis
5337781|NCT02005016|Aphasia|aphasia
5337782|NCT02005016|Language Therapy|language therapy
5337783|NCT02005016|Acquired Language Disorders|acquired language disorders
5337784|NCT02005016|Semantics|semantics
5337785|NCT02005016|Stroke|stroke
5678924|NCT00584298|sensation|sensation
5337786|NCT02004990|Children, Plaque|children, plaque
5337787|NCT02004951|Superficial femoral artery|superficial femoral artery
5337788|NCT02004951|paclitaxel|paclitaxel
5337789|NCT02004951|stent|stent
5337790|NCT02004951|self expandable|self expandable
5337792|NCT02004951|endovascular|endovascular
5337793|NCT02004951|above-the-knee intermediate length|above-the-knee intermediate length
5337794|NCT02004938|measurements|measurements
5337795|NCT02004938|jugular|jugular
5337796|NCT02004938|ultrasound|ultrasound
5337797|NCT02004938|pediatric|pediatric
5337798|NCT02004938|respiratory|respiratory
5337799|NCT02004938|diameter|diameter
5337800|NCT02004925|pneumoperitoneum|pneumoperitoneum
5337801|NCT02004925|free peritoneal air|free peritoneal air
5337802|NCT02004925|ultrasonography|ultrasonography
5337803|NCT02004912|maternal|maternal
5337804|NCT02004912|neonatal|neonatal
5337805|NCT02004912|child|child
5337806|NCT02004912|health services|health services
5337807|NCT02004912|health care|health care
5337808|NCT02004912|Karnataka|karnataka
5337809|NCT02004912|India|india
5337810|NCT02004899|Labor epidural analgesia|labor epidural analgesia
5337811|NCT02004899|Fentanyl|fentanyl
5337812|NCT02004899|Bupivacaine|bupivacaine
5337813|NCT02004899|Onset|onset
5337814|NCT02004886|Diabetes Mellitus|diabetes mellitus
5337815|NCT02004886|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5339996|NCT01995084|PET|pet
5337816|NCT02004886|Glucose Metabolism Disorders|glucose metabolism disorders
5337817|NCT02004886|Metabolic Diseases|metabolic diseases
5337818|NCT02004886|Endocrine System Diseases|endocrine system diseases
5337819|NCT02004886|Therapeutic Uses|therapeutic uses
5337820|NCT02004886|Pharmacologic Actions|pharmacologic actions
5337821|NCT02004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5337822|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs
5337823|NCT02004886|Metformin|metformin
5337828|NCT02004860|Maintenance therapy|maintenance therapy
5337829|NCT02004795|Boron Neutron Capture Therapy|boron neutron capture therapy
5337830|NCT02004795|Image-guided intensity modulation radiotherapy|image-guided intensity modulation radiotherapy
5337831|NCT02004769|Metastatic gastric or gastro-esophageal junction cancer|metastatic gastric or gastro-esophageal junction cancer
5337832|NCT02004769|Trastuzumab|trastuzumab
5337833|NCT02004769|HER2-positive|her2-positive
5337834|NCT02004769|Capecitabine|capecitabine
5337835|NCT02004769|Docetaxel|docetaxel
5337836|NCT02004769|First-line therapy|first-line therapy
5337837|NCT02004756|pediatric|pediatric
5337839|NCT02004756|congenital heart disease|congenital heart disease
5337840|NCT02004756|cardiac and musculoskeletal funion|cardiac and musculoskeletal funion
5337841|NCT02004756|cardiac and/or musculoskeletal metabolism|cardiac and/or musculoskeletal metabolism
5337842|NCT02004756|exercise training intervention|exercise training intervention
5337843|NCT02004743|Early Intervention|early intervention
5337844|NCT02004743|Prevention|prevention
5337845|NCT02004743|Risk Factors|risk factors
5337846|NCT02004743|Exposure Therapy|exposure therapy
5337847|NCT02004743|Psychoeducation|psychoeducation
5337848|NCT02004717|advanced solid tumor|advanced solid tumor
5337849|NCT02004717|Phase 1|phase 1
5337850|NCT02004717|Oncology|oncology
5337851|NCT02004652|Prucalopride|prucalopride
5337852|NCT02004652|Gastrointestinal Diseases|gastrointestinal diseases
5337853|NCT02004652|Postoperative ileus|postoperative ileus
5337854|NCT02004652|Randomised trial|randomised trial
5337855|NCT02004639|IMRT or HT with chemotherapy|imrt or ht with chemotherapy
5337856|NCT02004626|Collagenase|collagenase
5337857|NCT02004626|Phase III|phase iii
5337858|NCT02004626|National|national
5337859|NCT02004626|Noninferiority|noninferiority
5337860|NCT02004626|Double-blind|double-blind
5337861|NCT02004626|Multicenter|multicenter
5337862|NCT02004626|Prospective.|prospective.
5337863|NCT02004587|Hepatic impairment|hepatic impairment
5337864|NCT02004587|Pharmacokinetics|pharmacokinetics
5337865|NCT02004587|Pharmacodynamics|pharmacodynamics
5337866|NCT02004587|Gemigliptin|gemigliptin
5337867|NCT02004561|bariatric_surgery|bariatric_surgery
5337868|NCT02004561|pediatric obesity|pediatric obesity
5337869|NCT02004561|diabetes|diabetes
5337870|NCT02004535|Hearing loss|hearing loss
5337871|NCT02004535|Asymmetric hearing loss|asymmetric hearing loss
5337872|NCT02004535|Cochlear implantation|cochlear implantation
5337873|NCT02004522|Phase 3|phase 3
5337874|NCT02004522|CLL/SLL|cll/sll
5337875|NCT02004522|Pi3K|pi3k
5337876|NCT02004509|atrial fibrillation|atrial fibrillation
5337877|NCT02004509|stroke|stroke
5337878|NCT02004509|pacemaker|pacemaker
5337879|NCT02004509|anticoagulant|anticoagulant
5337880|NCT02004483|percutaneous coronary intervention|percutaneous coronary intervention
5337881|NCT02004483|ischemia|ischemia
5337882|NCT02004483|strain|strain
5337883|NCT02004483|coronary stenosis|coronary stenosis
5343015|NCT01981096|pain in children|pain in children
5337884|NCT02004470|post laparoscopic shoulder pain|post laparoscopic shoulder pain
5337885|NCT02004470|active suction|active suction
5337886|NCT02004470|lavage and suction|lavage and suction
5337888|NCT02004470|post operative shoulder pain|post operative shoulder pain
5337890|NCT02004457|Primary care|primary care
5337891|NCT02004457|Engagement|engagement
5337892|NCT02004457|Acceptance|acceptance
5337893|NCT02004457|Disclosure|disclosure
5337894|NCT02004457|Stigma|stigma
5337895|NCT02004444|JC Virus|jc virus
5337896|NCT02004444|Natalizumab|natalizumab
5337897|NCT02004431|Chronic post surgical pain|chronic post surgical pain
5337898|NCT02004431|Orthopaedic|orthopaedic
5337899|NCT02004431|Anxiety|anxiety
5337900|NCT02004431|depression|depression
5337901|NCT02004418|C-Choline PET scans|c-choline pet scans
5337902|NCT02004418|external beam radiotherapy|external beam radiotherapy
5337903|NCT02004405|autonomic nervous system|autonomic nervous system
5337904|NCT02004405|fibromyalgia|fibromyalgia
5337905|NCT02004405|autonomic dysfunction|autonomic dysfunction
5337906|NCT02004405|strengthening|strengthening
5337907|NCT02004405|flexibility|flexibility
5337908|NCT02004405|exercise|exercise
5337909|NCT02004405|heart rate variability|heart rate variability
5337910|NCT02004392|Alzheimer's disease|alzheimer's disease
5337911|NCT02004392|Cognition|cognition
5337912|NCT02004392|Alpha-7 nAChR|alpha-7 nachr
5337913|NCT02004379|HCV|hcv
5337914|NCT02004379|Hepatitis C|hepatitis c
5337915|NCT02004379|telaprevir|telaprevir
5337916|NCT02004379|boceprevir|boceprevir
5337917|NCT02004379|clinical practice|clinical practice
5337918|NCT02004366|Diabetes|diabetes
5337919|NCT02004366|Linagliptin|linagliptin
5337920|NCT02004366|hospital hyperglycemia|hospital hyperglycemia
5337921|NCT02004366|inpatient diabetes|inpatient diabetes
5337922|NCT02004353|Cochlear® Hearing Implants|cochlear® hearing implants
5337923|NCT02004340|pediatric epilepsy|pediatric epilepsy
5337924|NCT02004340|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
5337925|NCT02004314|Chloroquine|chloroquine
5337926|NCT02004314|T cell immune activation|t cell immune activation
5337927|NCT02004314|CD4 recovery|cd4 recovery
5337928|NCT02004314|HIV|hiv
5337929|NCT02004301|Formulation behaviour|formulation behaviour
5337930|NCT02004301|Drug absorption profile|drug absorption profile
5337931|NCT02004288|Probiotics|probiotics
5337932|NCT02004288|Anorexia nervosa|anorexia nervosa
5337933|NCT02004288|Constipation|constipation
5337934|NCT02004288|Body weight|body weight
5337935|NCT02004262|cancer|cancer
5337936|NCT02004262|cancer vaccine|cancer vaccine
5337937|NCT02004262|Listeria monocytogenes|listeria monocytogenes
5337938|NCT02004262|Listeria-based vaccine|listeria-based vaccine
5337939|NCT02004262|GVAX|gvax
5337940|NCT02004262|cyclophosphamide|cyclophosphamide
5337941|NCT02004262|Cytoxan|cytoxan
5337942|NCT02004262|immunotherapy|immunotherapy
5337943|NCT02004262|mesothelin|mesothelin
5337944|NCT02004236|tRNS|trns
5337945|NCT02004236|QEEG|qeeg
5337946|NCT02004236|ERP|erp
5337947|NCT02004236|ASD|asd
5337948|NCT02004236|Autism|autism
5337949|NCT02004236|verbal fluency|verbal fluency
5337950|NCT02004236|empathy|empathy
5337951|NCT02004236|noninvasive brain stimulation|noninvasive brain stimulation
5337952|NCT02004236|tDCS|tdcs
5337953|NCT02004223|Prostate Cancer|prostate cancer
5337954|NCT02004223|Dose escalation|dose escalation
5337955|NCT02004223|Stereotactic|stereotactic
5337956|NCT02004223|SBRT|sbrt
5337957|NCT02004223|Hypofractionation|hypofractionation
5337958|NCT02004210|transarterial chemoembolization|transarterial chemoembolization
5337959|NCT02004210|transarterial radioembolization|transarterial radioembolization
5337960|NCT02004210|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5337961|NCT02004184|Pemetrexed|pemetrexed
5337962|NCT02004184|drug therapy|drug therapy
5337963|NCT02004171|electronic cigarette|electronic cigarette
5337964|NCT02004171|nicotine inhaler|nicotine inhaler
5337965|NCT02004171|smoking cessation|smoking cessation
5337966|NCT02004158|Acute coronary syndrome|acute coronary syndrome
5337967|NCT02004158|Health behavior|health behavior
5337968|NCT02004158|Mental health|mental health
5337969|NCT02004145|MDD|mdd
5337970|NCT02004145|Positive Psychology|positive psychology
5337971|NCT02004145|Suicidality|suicidality
5337972|NCT02004080|TBI|tbi
5337973|NCT02004080|ICU|icu
5337974|NCT02004080|Comparative Effectiveness Research|comparative effectiveness research
5337975|NCT02004067|Evaporative|evaporative
5337976|NCT02004067|Aqueous deficient|aqueous deficient
5337977|NCT02004067|Dry eye disease|dry eye disease
5337978|NCT02004054|multiple sclerosis|multiple sclerosis
5337979|NCT02004054|diameter pupil|diameter pupil
5337980|NCT02004041|pruritus|pruritus
5337981|NCT02004041|atopic dermatitis|atopic dermatitis
5337982|NCT02004041|VLY-686|vly-686
5337983|NCT02004028|Mesothelioma|mesothelioma
5337984|NCT02004028|adenoma|adenoma
5337985|NCT02004028|Neoplasms, Mesothelial|neoplasms, mesothelial
5337986|NCT02004028|Focal Adhesion Kinase Inhibitor|focal adhesion kinase inhibitor
5337987|NCT02004015|Analytical|analytical
5337988|NCT02004015|Diagnostic|diagnostic
5337989|NCT02004015|Anesthesia|anesthesia
5337990|NCT02004015|Analgesia|analgesia
5337991|NCT02003976|knee osteoarthritis|knee osteoarthritis
5324399|NCT02064790|Gabapentin|gabapentin
5337992|NCT02003976|high tibial osteotomy|high tibial osteotomy
5337993|NCT02003976|gait analysis|gait analysis
5337994|NCT02003976|muscular strength|muscular strength
5337995|NCT02003976|body composition|body composition
5337996|NCT02003976|magnetic resonance imaging|magnetic resonance imaging
5337997|NCT02003976|biological markers|biological markers
5337998|NCT02003963|Physical Activity|physical activity
5337999|NCT02003963|Sedentary Behavior|sedentary behavior
5338000|NCT02003963|Video Games|video games
5338001|NCT02003963|Exergames|exergames
5338002|NCT02003911|Asthma|asthma
5338003|NCT02003911|Acute asthma exacerbation|acute asthma exacerbation
5338004|NCT02003911|Pediatric|pediatric
5338005|NCT02003911|Azithromycin|azithromycin
5338006|NCT02003911|Macrolide|macrolide
5338007|NCT02003911|Length of Stay|length of stay
5338008|NCT02003911|Hospital Medicine|hospital medicine
5338009|NCT02003898|Diabetes|diabetes
5338010|NCT02003898|Insulin pump|insulin pump
5338011|NCT02003898|Threshold Suspend|threshold suspend
5338012|NCT02003885|Desflurane, mitral annular velocity, tissue Doppler imaging|desflurane, mitral annular velocity, tissue doppler imaging
5338014|NCT02003859|Pediatrics|pediatrics
5338015|NCT02003859|pCLE|pcle
5338016|NCT02003833|Poly-L-lactic acid|poly-l-lactic acid
5338017|NCT02003833|Sculptra Aesthetic|sculptra aesthetic
5338018|NCT02003833|Skin Quality|skin quality
5338019|NCT02003833|Wrinkles|wrinkles
5338020|NCT02003833|Filler|filler
5338021|NCT02003820|Autism|autism
5338022|NCT02003820|Dental Caries|dental caries
5338023|NCT02003820|Prevention|prevention
5338024|NCT02003820|Oral Hygiene|oral hygiene
5338025|NCT02003794|acute ischemic stroke|acute ischemic stroke
5338026|NCT02003794|intravenous fluid|intravenous fluid
5338027|NCT02003794|้hydration|้hydration
5338029|NCT02003781|metabolic disease|metabolic disease
5338030|NCT02003781|high risk|high risk
5338031|NCT02003781|prospective cohort|prospective cohort
5338032|NCT02003768|pneumoperitoneum|pneumoperitoneum
5338033|NCT02003768|optic nerve sheath diameter|optic nerve sheath diameter
5338034|NCT02003768|laparoscopy|laparoscopy
5338035|NCT02003768|Patients|patients
5338036|NCT02003768|general anesthesia|general anesthesia
5338037|NCT02003768|diameter|diameter
5338038|NCT02003755|Cerebral palsy|cerebral palsy
5338039|NCT02003755|Continuous passive motion|continuous passive motion
5338040|NCT02003755|Hypertonia|hypertonia
5338042|NCT02003742|BPH|bph
5338043|NCT02003729|obstructive sleep apnea|obstructive sleep apnea
5338044|NCT02003729|Portable Monitor|portable monitor
5338045|NCT02003729|AHI|ahi
5338047|NCT02003729|Cost effectiveness|cost effectiveness
5338048|NCT02003703|Vaccine|vaccine
5338049|NCT02003703|Primary Prevention|primary prevention
5338050|NCT02003703|Immunogenicity|immunogenicity
5338051|NCT02003690|Bipolar disorder|bipolar disorder
5338052|NCT02003690|Adolescent suicidal behavior|adolescent suicidal behavior
5338053|NCT02003690|Psychotherapy|psychotherapy
5338054|NCT02003664|Cocaine|cocaine
5338055|NCT02003664|Treatment|treatment
5338056|NCT02003664|fMRI|fmri
5338057|NCT02003664|Outcomes|outcomes
5338058|NCT02003651|Common cold|common cold
5338059|NCT02003625|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5338060|NCT02003625|Hodgkin's lymphoma|hodgkin's lymphoma
5338061|NCT02003625|Multiple myeloma|multiple myeloma
5338062|NCT02003625|Hematopoietic stem cells|hematopoietic stem cells
5338063|NCT02003599|Radiodermatitis|radiodermatitis
5338064|NCT02003599|Breast neoplasms|breast neoplasms
5338065|NCT02003599|Laser Therapy, Low- Level|laser therapy, low- level
5338066|NCT02003586|subjects|subjects
5338067|NCT02003560|breast cancer|breast cancer
5338068|NCT02003560|breast conserving therapy|breast conserving therapy
5338069|NCT02003560|accelerated partial breast irradiation|accelerated partial breast irradiation
5338070|NCT02003560|3D conformal radiotherapy|3d conformal radiotherapy
5338071|NCT02003560|intensity modulated radiotherapy|intensity modulated radiotherapy
5338072|NCT02003521|Lung Flute|lung flute
5338073|NCT02003508|Prevalence|prevalence
5338074|NCT02003508|HPV|hpv
5338075|NCT02003508|Human papillomavirus|human papillomavirus
5338076|NCT02003508|Vaccination|vaccination
5338077|NCT02003495|Immunogenicity, Safety, Meningococcal Conjugate Vaccine|immunogenicity, safety, meningococcal conjugate vaccine
5338078|NCT02003482|Head and Neck Cancer|head and neck cancer
5338079|NCT02003482|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5338080|NCT02003482|Intensity modulated radiation therapy|intensity modulated radiation therapy
5338081|NCT02003482|IMRT|imrt
5338082|NCT02003482|Anatomic Changes|anatomic changes
5338083|NCT02003482|Postoperative|postoperative
5338084|NCT02003482|Unresectable|unresectable
5338085|NCT02003469|hypertension|hypertension
5338086|NCT02003469|kidney disease|kidney disease
5338087|NCT02003469|cardiovascular disease|cardiovascular disease
5343016|NCT01981096|musculoskeletal pain|musculoskeletal pain
5338088|NCT02003456|positron emission tomography|positron emission tomography
5338089|NCT02003456|rubidium|rubidium
5439952|NCT01545674|Trisomy|trisomy
5338090|NCT02003456|myocardial perfusion imaging|myocardial perfusion imaging
5338091|NCT02003456|viability|viability
5338092|NCT02003456|FDG|fdg
5338093|NCT02003443|Acupressure|acupressure
5338094|NCT02003443|Older Adults|older adults
5338095|NCT02003443|Knee pain|knee pain
5338096|NCT02003443|Pain Treatment|pain treatment
5338097|NCT02003430|gynecologic malignancy|gynecologic malignancy
5338098|NCT02003430|non-ovarian gynecological cancer|non-ovarian gynecological cancer
5338099|NCT02003430|cervical cancer|cervical cancer
5338100|NCT02003430|vaginal cancer|vaginal cancer
5338101|NCT02003430|vulvar cancer|vulvar cancer
5338102|NCT02003430|endometrial cancer|endometrial cancer
5338103|NCT02003417|Prostate cancer|prostate cancer
5338104|NCT02003417|External beam radiation treatment|external beam radiation treatment
5338105|NCT02003417|Androgen deprivation therapy|androgen deprivation therapy
5338106|NCT02003417|Definitive treatment|definitive treatment
5338107|NCT02003417|Cardiovascular risk factors|cardiovascular risk factors
5338108|NCT02003417|Quality of life|quality of life
5338109|NCT02003404|ostomy appliance|ostomy appliance
5338110|NCT02003391|Open Angle Glaucoma|open angle glaucoma
5338111|NCT02003391|Ocular Hypertension|ocular hypertension
5338112|NCT02003391|Intraocular Pressure|intraocular pressure
5338113|NCT02003378|Chronotropic incompetence|chronotropic incompetence
5338114|NCT02003365|osteoarthritis|osteoarthritis
5338115|NCT02003365|knee|knee
5338116|NCT02003365|corticosteroids|corticosteroids
5338117|NCT02003365|triamcinolone acetonide|triamcinolone acetonide
5338118|NCT02003365|synovial fluid|synovial fluid
5338119|NCT02003352|TBI|tbi
5338120|NCT02003352|PTSD|ptsd
5338121|NCT02003352|Functional Neurology|functional neurology
5338122|NCT02003352|Vestibular Rehabilitation|vestibular rehabilitation
5338123|NCT02003352|Dynamic Computerized Posturography|dynamic computerized posturography
5338129|NCT02003287|Intensive Care Units, Neonatal|intensive care units, neonatal
5338130|NCT02003274|Mixed Meal Test|mixed meal test
5338131|NCT02003274|Insulin Pump|insulin pump
5338132|NCT02003274|Continuous Glucose Monitoring|continuous glucose monitoring
5338133|NCT02003274|Metabolic Control Analysis|metabolic control analysis
5338134|NCT02003274|Closed Loop Control|closed loop control
5338135|NCT02003274|Artificial Pancreas|artificial pancreas
5338136|NCT02003248|Parkinson's disease|parkinson's disease
5338137|NCT02003248|ultrasound|ultrasound
5338138|NCT02003248|dyskinesia|dyskinesia
5338139|NCT02003248|magnetic resonance|magnetic resonance
5338140|NCT02003235|Amblyopia|amblyopia
5338141|NCT02003196|Brain injury|brain injury
5338142|NCT02003196|virus|virus
5338143|NCT02003196|immunosuppression|immunosuppression
5338144|NCT02003196|mechanical ventilation|mechanical ventilation
5338145|NCT02003183|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
5338146|NCT02003183|Traumatic Brain Injury|traumatic brain injury
5338147|NCT02003183|Cognitive Impairment|cognitive impairment
5338148|NCT02003183|Positron Emission Tomography|positron emission tomography
5338149|NCT02003183|[F-18]FDDNP|[f-18]fddnp
5338150|NCT02003170|Autism|autism
5338151|NCT02003170|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5338152|NCT02003170|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
5338153|NCT02003170|Developmental delays|developmental delays
5338154|NCT02003170|Genetic disorder|genetic disorder
5338155|NCT02003170|Mitochondrial disorder|mitochondrial disorder
5338156|NCT02003157|hypnosis embryo transfer IVF ICSI|hypnosis embryo transfer ivf icsi
5338157|NCT02003144|Long-term safety study|long-term safety study
5338158|NCT02003144|Extension trial|extension trial
5338159|NCT02003144|Eculizumab|eculizumab
5338160|NCT02003144|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5338161|NCT02003144|Devic's disease|devic's disease
5338162|NCT02003144|Transverse Myelitis|transverse myelitis
5338163|NCT02003144|Optic Neuritis|optic neuritis
5338164|NCT02003144|Relapse|relapse
5338165|NCT02003144|NMO-IgG|nmo-igg
5338166|NCT02003144|CNS Autoimmune Disorders|cns autoimmune disorders
5338167|NCT02003144|Demyelinating Disorders|demyelinating disorders
5338168|NCT02003131|osteoarthritis|osteoarthritis
5338169|NCT02003131|umbilical cord|umbilical cord
5338170|NCT02003131|mesenchymal|mesenchymal
5338171|NCT02003131|stem cells|stem cells
5338172|NCT02003131|trophic factors|trophic factors
5338173|NCT02003092|Metastatic|metastatic
5338174|NCT02003092|Rexahn|rexahn
5338175|NCT02003092|Phase 1|phase 1
5338176|NCT02003092|Triple Negative Breast Cancer|triple negative breast cancer
5338177|NCT02003092|Phase 2|phase 2
5338178|NCT02003092|Relapsed|relapsed
5338179|NCT02003066|Fluid Therapy|fluid therapy
5338180|NCT02003066|Head and Neck Neoplasms|head and neck neoplasms
5338181|NCT02003066|Surgical Flaps|surgical flaps
5338182|NCT02003053|Critically ill|critically ill
5338184|NCT02003053|safety|safety
5338185|NCT02003053|feasibility|feasibility
5338186|NCT02003053|inspiratory muscle training|inspiratory muscle training
5338187|NCT02003014|Drug Therapy|drug therapy
5338188|NCT02002975|Drug Therapy|drug therapy
5338189|NCT02002949|Hemodialysis|hemodialysis
5338191|NCT02002910|FFR|ffr
5338192|NCT02002910|Medical Economy|medical economy
5338193|NCT02002910|physiological assessment|physiological assessment
5338194|NCT02002910|SYNTAX score|syntax score
5445419|NCT01521897|Pneumococcal Vaccine|pneumococcal vaccine
5338195|NCT02002897|Localized scleroderma UVA1 fractional carbon dioxide laser|localized scleroderma uva1 fractional carbon dioxide laser
5338196|NCT02002884|Upper limb spasticity|upper limb spasticity
5338197|NCT02002884|lower limb spasticity|lower limb spasticity
5338198|NCT02002884|combined upper and lower limb spasticity|combined upper and lower limb spasticity
5338199|NCT02002858|smoking|smoking
5338200|NCT02002858|cessation|cessation
5338201|NCT02002858|anxiety|anxiety
5338202|NCT02002858|anxious|anxious
5338203|NCT02002858|depression|depression
5338204|NCT02002858|depressed|depressed
5338205|NCT02002858|smoker|smoker
5338206|NCT02002858|stress|stress
5338207|NCT02002845|Tongue base resection, partial glossectomy|tongue base resection, partial glossectomy
5338208|NCT02002832|schizophrenia|schizophrenia
5338209|NCT02002832|Lurasidone|lurasidone
5338210|NCT02002832|LATUDA|latuda
5338211|NCT02002819|Alzheimer's disease|alzheimer's disease
5338212|NCT02002819|AD|ad
5338213|NCT02002819|Early-onset AD|early-onset ad
5338214|NCT02002819|EOAD|eoad
5338215|NCT02002819|Early-onset Alzheimer's|early-onset alzheimer's
5338216|NCT02002819|Early-onset Alzheimer's disease|early-onset alzheimer's disease
5338218|NCT02002806|Pain|pain
5338226|NCT02002754|cough variant asthma|cough variant asthma
5338242|NCT02002702|Safety and tolerability, Pharmacokinetics,|safety and tolerability, pharmacokinetics,
5338243|NCT02002702|Renal Impairment|renal impairment
5338244|NCT02002689|Solid tumor malignancy,|solid tumor malignancy,
5338245|NCT02002689|hematologic malignancy,|hematologic malignancy,
5338246|NCT02002689|mutation, translocations,|mutation, translocations,
5338247|NCT02002689|signature,|signature,
5338249|NCT02002689|SMO,|smo,
5338250|NCT02002689|LDE225,|lde225,
5338251|NCT02002689|endometrial cancer,|endometrial cancer,
5338252|NCT02002689|colon cancer,|colon cancer,
5338253|NCT02002689|bladder,|bladder,
5338254|NCT02002689|NSCLC|nsclc
5338255|NCT02002676|rest energy expenditure,critical ill, outcome|rest energy expenditure,critical ill, outcome
5338256|NCT02002650|Indomethacin, pancreatitis, ERCP|indomethacin, pancreatitis, ercp
5338257|NCT02002611|Lobeglitazone|lobeglitazone
5338258|NCT02002611|Warfarin|warfarin
5338259|NCT02002611|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5338260|NCT02002611|Drug-Drug interaction|drug-drug interaction
5338261|NCT02002611|Phase 1|phase 1
5338262|NCT02002598|Newly diagnosed|newly diagnosed
5338263|NCT02002598|multiple myeloma|multiple myeloma
5338264|NCT02002598|myeloma|myeloma
5338265|NCT02002598|bendamustine|bendamustine
5338266|NCT02002598|Treanda|treanda
5338267|NCT02002598|carfilzomib|carfilzomib
5338268|NCT02002598|dexamethasone|dexamethasone
5338269|NCT02002598|phase I|phase i
5338270|NCT02002598|phase II|phase ii
5338271|NCT02002598|dose escalation|dose escalation
5338272|NCT02002598|transplant|transplant
5338273|NCT02002598|non-transplant|non-transplant
5338274|NCT02002598|plasma cell|plasma cell
5338275|NCT02002598|Kyprolis|kyprolis
5338276|NCT02002585|Renal protection|renal protection
5338277|NCT02002585|Renal sympathetic denervation|renal sympathetic denervation
5338278|NCT02002572|Facial Mimic Muscle|facial mimic muscle
5338279|NCT02002572|MRI|mri
5338280|NCT02002572|Segmentation|segmentation
5338281|NCT02002572|Three dimensional assessment|three dimensional assessment
5338282|NCT02002572|Motion capture|motion capture
5338283|NCT02002572|Movement analysis|movement analysis
5338284|NCT02002572|Digital Image Correlation|digital image correlation
5338285|NCT02002546|Heart Attack|heart attack
5338286|NCT02002546|Myocardial Infarction|myocardial infarction
5338287|NCT02002546|Angina|angina
5338288|NCT02002546|Chest Pain|chest pain
5338289|NCT02002520|Acute pain|acute pain
5338290|NCT02002520|Epigenetic|epigenetic
5338291|NCT02002520|Dental pain|dental pain
5338292|NCT02002468|Risk Communication|risk communication
5338293|NCT02002468|Follow-up|follow-up
5338294|NCT02002468|Organisation of screening|organisation of screening
5338295|NCT02002455|FACBC|facbc
5338296|NCT02002455|PET/CT|pet/ct
5338297|NCT02002455|PET/MRI|pet/mri
5338298|NCT02002455|Radical prostatectomy|radical prostatectomy
5338299|NCT02002455|Radiotherapy|radiotherapy
5338300|NCT02002442|Mouthwash|mouthwash
5338301|NCT02002442|Chlorhexidine|chlorhexidine
5338302|NCT02002442|cetylpyridinium chloride|cetylpyridinium chloride
5338303|NCT02002442|Saline|saline
5338304|NCT02002442|Implants|implants
5338305|NCT02002442|Saliva Collection|saliva collection
5338306|NCT02002429|Facet joint|facet joint
5338307|NCT02002429|Medial branch block|medial branch block
5338308|NCT02002429|Radiofrequency denervation|radiofrequency denervation
5338309|NCT02002429|Zygapophysial joint|zygapophysial joint
5338311|NCT02002416|C-met expression, gastric cancer, overall survival|c-met expression, gastric cancer, overall survival
5338312|NCT02002403|Edema|edema
5338313|NCT02002403|Macular Edema|macular edema
5338314|NCT02002403|Retinal Diseases|retinal diseases
5338315|NCT02002403|Eye Diseases|eye diseases
5338316|NCT02002403|Danazol|danazol
5338317|NCT02002403|Estrogen Antagonists|estrogen antagonists
5338318|NCT02002403|Estrogen Receptor Modulators|estrogen receptor modulators
5338319|NCT02002403|Hormone Antagonists|hormone antagonists
5445420|NCT01521897|Prevenar|prevenar
5338320|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5338321|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs
5338322|NCT02002403|Pharmacologic Actions|pharmacologic actions
5338323|NCT02002390|Stroke,Fingolimod(FTY 720), treatment|stroke,fingolimod(fty 720), treatment
5338324|NCT02002377|Age Related Macular Degeneration, wet|age related macular degeneration, wet
5338325|NCT02002377|aflibercept|aflibercept
5338326|NCT02002364|tracheal intubation|tracheal intubation
5338327|NCT02002338|pterygium surgery|pterygium surgery
5338328|NCT02002338|refractive changes|refractive changes
5338329|NCT02002338|surgical technique|surgical technique
5338330|NCT02002312|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5338331|NCT02002312|Clear Cell Renal Cell Carcinoma (ccRCC)|clear cell renal cell carcinoma (ccrcc)
5338332|NCT02002312|Lutetium-177|lutetium-177
5338333|NCT02002312|Lu-177|lu-177
5338334|NCT02002312|girentuximab|girentuximab
5338335|NCT02002312|cG250|cg250
5338336|NCT02002312|Monoclonal Antibody|monoclonal antibody
5338337|NCT02002299|colorectal cancer|colorectal cancer
5338338|NCT02002299|surface|surface
5338339|NCT02002299|invasive front|invasive front
5338340|NCT02002299|tumor budding|tumor budding
5338341|NCT02002286|HIV-infected immunological non-responders|hiv-infected immunological non-responders
5338342|NCT02002286|Tripterygium Wilfordii Hook F|tripterygium wilfordii hook f
5338343|NCT02002286|Immune activation|immune activation
5338344|NCT02002247|antioxidants|antioxidants
5338345|NCT02002247|selenium|selenium
5338346|NCT02002247|heart disease|heart disease
5338347|NCT02002247|cardiac surgery|cardiac surgery
5338348|NCT02002247|perioperative|perioperative
5338349|NCT02002234|Hemicraniectomy, stroke, decompressive surgery, HeMMI|hemicraniectomy, stroke, decompressive surgery, hemmi
5338350|NCT02002221|Diabetes Mellitus (DM) ,|diabetes mellitus (dm) ,
5338351|NCT02002221|diabetes,|diabetes,
5338352|NCT02002221|noninsulin-dependent diabetes mellitus (NIDDM),|noninsulin-dependent diabetes mellitus (niddm),
5338353|NCT02002221|adult-onset diabetes,|adult-onset diabetes,
5338354|NCT02002221|high blood sugar,|high blood sugar,
5338355|NCT02002221|T2DM|t2dm
5338356|NCT02002195|metastatic gastric cancer,|metastatic gastric cancer,
5338357|NCT02002195|elderly,|elderly,
5338358|NCT02002195|folinic acid,|folinic acid,
5338359|NCT02002195|fluorouracil,|fluorouracil,
5338360|NCT02002195|oxaliplatin,|oxaliplatin,
5338361|NCT02002195|capecitabine,|capecitabine,
5338362|NCT02002195|overall survival,|overall survival,
5338363|NCT02002195|progression free survival|progression free survival
5338364|NCT02002182|HPV|hpv
5338365|NCT02002182|oropharynx|oropharynx
5338366|NCT02002182|squamous cell carcinoma|squamous cell carcinoma
5338367|NCT02002182|head and neck cancer|head and neck cancer
5338368|NCT02002182|transoral robotic surgery|transoral robotic surgery
5338369|NCT02002169|Catheter Related Bacteremia|catheter related bacteremia
5338370|NCT02002143|Diabetes|diabetes
5338371|NCT02002143|Older People|older people
5338372|NCT02002143|Seniors|seniors
5338373|NCT02002143|Group Appointments|group appointments
5338374|NCT02002143|Group Medical Visits|group medical visits
5338375|NCT02002143|Shared Appointments|shared appointments
5338376|NCT02002143|Quality of Life|quality of life
5338377|NCT02002143|Physical Activity|physical activity
5338378|NCT02002143|Health care Utilization|health care utilization
5338379|NCT02002143|Depression|depression
5338380|NCT02002143|Anxiety|anxiety
5338381|NCT02002130|Diabetes|diabetes
5338382|NCT02002104|Expanded polytetrafluoroethylene( ePTFE)|expanded polytetrafluoroethylene( eptfe)
5338383|NCT02002091|Type2 diabetes mellitus|type2 diabetes mellitus
5338384|NCT02002091|Microangiopathy|microangiopathy
5338385|NCT02002091|Chronic Kidney disease|chronic kidney disease
5338386|NCT02002091|Cardiovascular disease|cardiovascular disease
5338387|NCT02002078|caustic|caustic
5338388|NCT02002078|corticosteroid therapy|corticosteroid therapy
5338389|NCT02002078|stricture|stricture
5338390|NCT02002078|children|children
5338391|NCT02002065|hepatitis A|hepatitis a
5338392|NCT02002065|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
5338393|NCT02002065|attenuated alive hepatitis A vaccine|attenuated alive hepatitis a vaccine
5338394|NCT02002065|immune persistence|immune persistence
5338395|NCT02002052|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance|non-small cell lung cancer, radiotherapy, chemotherapy, pneumonitis, functional lung avoidance
5338396|NCT02002039|Perinatal asphyxia|perinatal asphyxia
5338397|NCT02002039|erythropoietin|erythropoietin
5338398|NCT02002026|placenta previa, uterine artery ligation|placenta previa, uterine artery ligation
5338399|NCT02002013|Adult|adult
5338400|NCT02002013|ICU patient|icu patient
5338401|NCT02002013|Fluid resuscitation|fluid resuscitation
5338402|NCT02002013|observational study|observational study
5338403|NCT02002000|Vitamin D deficiency|vitamin d deficiency
5338404|NCT02002000|Musculoskeletal pain|musculoskeletal pain
5338405|NCT02002000|Vitamin D supplementation|vitamin d supplementation
5338406|NCT02001974|HER 2 negative|her 2 negative
5338407|NCT02001974|metastatic breast cancer|metastatic breast cancer
5338408|NCT02001974|Cancer Stem Cells|cancer stem cells
5338409|NCT02001961|Fibrosis|fibrosis
5338410|NCT02001961|collagen metabolism|collagen metabolism
5445421|NCT01521897|7-valent|7-valent
5338411|NCT02001961|paediatric, dilated cardiomyopathy|paediatric, dilated cardiomyopathy
5338412|NCT02001961|biomarkers|biomarkers
5338413|NCT02001961|T1 mapping|t1 mapping
5338415|NCT02001948|Spinal anaesthesia|spinal anaesthesia
5338416|NCT02001948|morphine|morphine
5338417|NCT02001948|postoperative analgesia|postoperative analgesia
5338418|NCT02001948|vomiting|vomiting
5338419|NCT02001935|COPD|copd
5338420|NCT02001935|theophylline|theophylline
5338421|NCT02001935|CYP1A2|cyp1a2
5338422|NCT02001935|CYP2E1|cyp2e1
5338423|NCT02001922|COPD|copd
5338424|NCT02001922|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5338425|NCT02001922|Integrated care|integrated care
5338426|NCT02001922|Outcome and process assessment|outcome and process assessment
5338427|NCT02001922|Quality indicators, Health care|quality indicators, health care
5338428|NCT02001922|Self-management,|self-management,
5338429|NCT02001922|Patient empowerment|patient empowerment
5338430|NCT02001922|Quantitative and qualitative methods|quantitative and qualitative methods
5338431|NCT02001909|Regorafenib|regorafenib
5338432|NCT02001909|Neomycin|neomycin
5338433|NCT02001909|Cancer|cancer
5338434|NCT02001909|Pharmacokinetics|pharmacokinetics
5338436|NCT02001896|NSCLC|nsclc
5338437|NCT02001896|EGFR-TKI|egfr-tki
5338438|NCT02001883|Coronary artery disease, nutraceuticals, statins|coronary artery disease, nutraceuticals, statins
5338439|NCT02001870|Infertility|infertility
5338440|NCT02001870|female age|female age
5338441|NCT02001870|intra-uterine insemination|intra-uterine insemination
5338442|NCT02001870|in vitro fecundation|in vitro fecundation
5338443|NCT02001870|assisted reproductive technology center|assisted reproductive technology center
5338444|NCT02001857|patients,|patients,
5338445|NCT02001857|undergoing|undergoing
5338446|NCT02001857|pelvic|pelvic
5338447|NCT02001857|lymph|lymph
5338448|NCT02001857|node|node
5338449|NCT02001857|dissection.|dissection.
5338450|NCT02001831|Sarcopenia|sarcopenia
5338451|NCT02001831|Frailty|frailty
5338452|NCT02001831|Aging|aging
5338453|NCT02001831|Skeletal muscle|skeletal muscle
5338454|NCT02001831|Nutrition|nutrition
5338455|NCT02001792|sedation|sedation
5338456|NCT02001792|endoscopy|endoscopy
5338457|NCT02001792|patient positioning|patient positioning
5338458|NCT02001792|hypoxemia|hypoxemia
5338459|NCT02001779|Malignant biliary obstruction|malignant biliary obstruction
5338460|NCT02001779|Obstruction/stricture|obstruction/stricture
5338461|NCT02001779|Stent|stent
5338462|NCT02001779|Brachytherapy|brachytherapy
5217846|NCT02635230|Cardiovascular Diseases|cardiovascular diseases
5217847|NCT02635230|Embolism and Thrombosis|embolism and thrombosis
5217848|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5338463|NCT02001779|Bile duct|bile duct
5338464|NCT02001766|High intensity exercise|high intensity exercise
5338465|NCT02001766|Glycemic control|glycemic control
5338466|NCT02001766|Exercise|exercise
5338467|NCT02001740|shoulder|shoulder
5338468|NCT02001701|vitreomacular adhesion|vitreomacular adhesion
5338469|NCT02001701|vitreomacular traction|vitreomacular traction
5338470|NCT02001701|macular hole|macular hole
5338471|NCT02001701|epiretinal membrane|epiretinal membrane
5338472|NCT02001701|intravitreal gas|intravitreal gas
5338473|NCT02001701|sulfahexafluoride gas|sulfahexafluoride gas
5338474|NCT02001701|perfluoropropane gas|perfluoropropane gas
5338475|NCT02001701|ocriplasmin|ocriplasmin
5338476|NCT02001701|vitrectomy|vitrectomy
5338477|NCT02001675|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5338478|NCT02001662|Minor arthroscopic knee surgery including ACL-reconstruction (hamstrins graft)|minor arthroscopic knee surgery including acl-reconstruction (hamstrins graft)
5338479|NCT02001662|High pain responders|high pain responders
5338480|NCT02001662|Adductore Canal Block|adductore canal block
5338481|NCT02001662|Analgesics|analgesics
5338482|NCT02001662|Ultrasound guided nerve block|ultrasound guided nerve block
5338483|NCT02001649|suicide|suicide
5338484|NCT02001649|adolescent|adolescent
5338485|NCT02001649|genetic|genetic
5338487|NCT02001636|Bariatric surgery|bariatric surgery
5338488|NCT02001636|Protein malnutrition|protein malnutrition
5338489|NCT02001636|Protein supplementation|protein supplementation
5338490|NCT02001636|Body composition|body composition
5338491|NCT02001636|Body fat mass|body fat mass
5338492|NCT02001636|Protein intake|protein intake
5338493|NCT02001623|ovary cancer|ovary cancer
5338494|NCT02001623|cervix cancer|cervix cancer
5338495|NCT02001623|endometrium cancer|endometrium cancer
5338496|NCT02001623|bladder cancer|bladder cancer
5338497|NCT02001623|prostate cancer (CRPC)|prostate cancer (crpc)
5338498|NCT02001623|esophagus cancer|esophagus cancer
5338499|NCT02001623|lung cancer(NSCLC)|lung cancer(nsclc)
5338500|NCT02001623|Squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5338501|NCT02001610|microbiota|microbiota
5338502|NCT02001610|probiotics|probiotics
5338503|NCT02001610|fecal markers|fecal markers
5338505|NCT02001597|robotic|robotic
5338506|NCT02001597|ultrasound|ultrasound
5338507|NCT02001597|guidance|guidance
5338508|NCT02001597|endorectal|endorectal
5338509|NCT02001571|Prostate Cancer|prostate cancer
5338510|NCT02001571|Abiraterone acetate|abiraterone acetate
5338511|NCT02001571|Pharmacokinetics|pharmacokinetics
5338512|NCT02001558|Spinal cord injuries|spinal cord injuries
5338513|NCT02001558|Pressure ulcer|pressure ulcer
5338610|NCT02001090|Heart-Lung Machine|heart-lung machine
5338611|NCT02001090|Coronary Artery Bypass|coronary artery bypass
5338514|NCT02001545|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies|acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies
5338515|NCT02001532|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5338516|NCT02001532|Diabetes Complications|diabetes complications
5338517|NCT02001532|Diabetic Angiopathies|diabetic angiopathies
5338518|NCT02001532|Diabetic Nephropathies|diabetic nephropathies
5338519|NCT02001532|Myocardial Infarction|myocardial infarction
5338521|NCT02001532|Vascular Stiffness|vascular stiffness
5338522|NCT02001532|Pulse Wave Analysis|pulse wave analysis
5338523|NCT02001506|breast cancer|breast cancer
5338524|NCT02001506|neoadjuvant|neoadjuvant
5338525|NCT02001506|different number of chemotherapy cycles|different number of chemotherapy cycles
5338526|NCT02001441|Physical Activity, Aging, Memory, Cognitive Impairment, MRI, Neuroscience|physical activity, aging, memory, cognitive impairment, mri, neuroscience
5338527|NCT02001428|malaria|malaria
5338528|NCT02001428|vivax|vivax
5338529|NCT02001428|falciparum|falciparum
5338530|NCT02001428|infants|infants
5338531|NCT02001415|Progressive Myopia|progressive myopia
5338532|NCT02001415|Contact Lenses|contact lenses
5338533|NCT02001415|Spectacles|spectacles
5338534|NCT02001402|climacteric symptoms ; nurse ;|climacteric symptoms ; nurse ;
5338535|NCT02001402|intervention;follow-up|intervention;follow-up
5338536|NCT02001389|Enzyme occupancy|enzyme occupancy
5338537|NCT02001389|Positron emission tomography (PET)|positron emission tomography (pet)
5338538|NCT02001389|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
5338539|NCT02001363|Reperfusion injury|reperfusion injury
5338540|NCT02001363|Liraglutide|liraglutide
5338541|NCT02001337|pancreatic cancer|pancreatic cancer
5338542|NCT02001337|new-onset diabetic|new-onset diabetic
5338543|NCT02001337|diabetes|diabetes
5338544|NCT02001324|quality of life, heavy menstrual bleeding, electronic data collection|quality of life, heavy menstrual bleeding, electronic data collection
5963349|NCT04252300|Organic Anion Transporting Polypeptide 1B3 (OATP1B3)|organic anion transporting polypeptide 1b3 (oatp1b3)
5963350|NCT04252300|Breast Cancer Resistance Protein (BCRP)|breast cancer resistance protein (bcrp)
5963351|NCT04252300|Pain|pain
5963352|NCT04252300|Chronic cough|chronic cough
5963353|NCT04252300|Cholesterol|cholesterol
5205983|NCT02707497|28-day mortality|28-day mortality
5205984|NCT02707484|Gastrointestinal vascular malformation|gastrointestinal vascular malformation
5205985|NCT02707484|thalidomide|thalidomide
5205986|NCT02707484|Small intestinal bleeding|small intestinal bleeding
5205987|NCT02707458|apolipoprotein E|apolipoprotein e
5205988|NCT02707458|Alzheimer|alzheimer
5205989|NCT02707458|pre-clinical|pre-clinical
5205990|NCT02707458|pre-symptomatic|pre-symptomatic
5205991|NCT02707458|dose-finding|dose-finding
5338545|NCT02001311|chlorhexidine gel|chlorhexidine gel
5338546|NCT02001311|orthodontic brackets|orthodontic brackets
5338547|NCT02001311|orthodontic patients|orthodontic patients
5338548|NCT02001311|bacterial count|bacterial count
5338549|NCT02001311|friction|friction
5338550|NCT02001298|remifentanil|remifentanil
5338551|NCT02001298|nitroprusside|nitroprusside
5338552|NCT02001298|hypotension|hypotension
5338553|NCT02001285|remifentanil|remifentanil
5338554|NCT02001272|Elderly|elderly
5338555|NCT02001272|Vulnerable|vulnerable
5338556|NCT02001272|Ovarian cancer|ovarian cancer
5338557|NCT02001272|Chemotherapy|chemotherapy
5338558|NCT02001259|post-operative pain control|post-operative pain control
5338559|NCT02001259|total knee arthroplasty|total knee arthroplasty
5338560|NCT02001259|epidural steroid injection|epidural steroid injection
5338561|NCT02001246|mindfulness|mindfulness
5338562|NCT02001246|cognitive behavior therapy|cognitive behavior therapy
5338563|NCT02001246|awareness|awareness
5338564|NCT02001246|anger|anger
5338565|NCT02001246|aggression|aggression
5338566|NCT02001233|EV71 vaccine|ev71 vaccine
5338567|NCT02001233|EV71-associated HFMD|ev71-associated hfmd
5338568|NCT02001233|efficacy|efficacy
5338569|NCT02001233|safety|safety
5338570|NCT02001233|immune persistence|immune persistence
5338571|NCT02001220|screening|screening
5338572|NCT02001220|invasive ventilation|invasive ventilation
5338573|NCT02001220|mechanical ventilation|mechanical ventilation
5338574|NCT02001220|weaning|weaning
5338575|NCT02001220|spontaneous breathing trials|spontaneous breathing trials
5338576|NCT02001194|Sedentary|sedentary
5338577|NCT02001194|Behavioral Economic Intervention|behavioral economic intervention
5338578|NCT02001194|Team Studies|team studies
5338579|NCT02001194|Financial Incentives|financial incentives
5338580|NCT02001194|Workplace Wellness|workplace wellness
5338581|NCT02001194|Team Incentives|team incentives
5338582|NCT02001181|Atopic Dermatitis|atopic dermatitis
5338583|NCT02001181|Atopic Eczema|atopic eczema
5338584|NCT02001181|Eczema|eczema
5338585|NCT02001181|topical treatment|topical treatment
5233427|NCT02543879|FT-1101|ft-1101
5338586|NCT02001181|skin diseases|skin diseases
5338587|NCT02001181|tofacitinib|tofacitinib
5338588|NCT02001181|CP-690|cp-690
5338589|NCT02001181|550|550
5338590|NCT02001181|Janus Kinase inhibitor|janus kinase inhibitor
5338591|NCT02001155|Water drinking test|water drinking test
5338592|NCT02001155|trabeculectomy|trabeculectomy
5338593|NCT02001155|tube shunt|tube shunt
5338594|NCT02001142|Insulin Sensitivity|insulin sensitivity
5338595|NCT02001142|Exercise|exercise
5338596|NCT02001142|Metabolism|metabolism
5338597|NCT02001129|Eye care adherence|eye care adherence
5338598|NCT02001129|health care utilization|health care utilization
5338599|NCT02001116|Quality of care|quality of care
5338600|NCT02001116|Hospital|hospital
5338601|NCT02001116|Children|children
5338602|NCT02001116|WHO guideline|who guideline
5338603|NCT02001103|adjuvant therapy|adjuvant therapy
5338604|NCT02001103|cognitive deficits|cognitive deficits
5338605|NCT02001103|first episode schizophrenia|first episode schizophrenia
5338606|NCT02001103|glutamate hypothesis|glutamate hypothesis
5338607|NCT02001103|memantine|memantine
5338608|NCT02001103|negative symptoms|negative symptoms
5338609|NCT02001090|Cardiac Surgical Procedures|cardiac surgical procedures
5338612|NCT02001090|Brachial Artery|brachial artery
5338613|NCT02001090|Vasodilation|vasodilation
5338614|NCT02001090|Regional Blood Flow|regional blood flow
5338615|NCT02001090|Ultrasonography|ultrasonography
5338616|NCT02001064|interventions|interventions
5338617|NCT02001064|technology|technology
5338618|NCT02001064|adherence|adherence
5338619|NCT02001064|ARV|arv
5423295|NCT01616290|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5338622|NCT02001051|Adrenal Incidentalomas|adrenal incidentalomas
5338623|NCT02001051|Excess of Cortisol|excess of cortisol
5338624|NCT02001025|coronary vessels|coronary vessels
5338625|NCT02001025|coronary stenosis|coronary stenosis
5338626|NCT02001025|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5338627|NCT02001025|stents|stents
5338628|NCT02001025|drug-eluting stents|drug-eluting stents
5338629|NCT02001025|bioresorbable scaffolds|bioresorbable scaffolds
5963354|NCT04252118|2019 Novel Coronavirus Pneumonia|2019 novel coronavirus pneumonia
5963355|NCT04252118|Safety|safety
5963356|NCT04252118|Efficiency|efficiency
5963357|NCT04252118|Cell Therapy|cell therapy
5963358|NCT04252118|Mesenchymal stem cell|mesenchymal stem cell
5963359|NCT04251182|mild-to-moderate Alzheimer Disease|mild-to-moderate alzheimer disease
5963360|NCT04251026|MPS II|mps ii
5963361|NCT04251026|Hunter Syndrome|hunter syndrome
5963362|NCT04251026|nMPS II|nmps ii
5963363|NCT04250571|imaginary pills|imaginary pills
5963364|NCT04250571|open label placebo (OLP) treatment|open label placebo (olp) treatment
5963365|NCT04250571|placebo|placebo
5338630|NCT02001025|optical coherence tomography|optical coherence tomography
5338631|NCT02001012|uncomplicated|uncomplicated
5338632|NCT02001012|plasmodium|plasmodium
5338633|NCT02001012|knowlesi|knowlesi
5338634|NCT02001012|malaria|malaria
5338635|NCT02001012|infection|infection
5338636|NCT02000999|Bile duct stricture|bile duct stricture
5338637|NCT02000999|Cholangiocarcinoma|cholangiocarcinoma
5338638|NCT02000999|Pancreatic cancer|pancreatic cancer
5338639|NCT02000999|Chronic pancreatitis|chronic pancreatitis
5338640|NCT02000986|Hodgkin's Lymphoma|hodgkin's lymphoma
5338641|NCT02000986|Brain and Nervous System|brain and nervous system
5338642|NCT02000986|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5338643|NCT02000986|Leukemia, not otherwise specified|leukemia, not otherwise specified
5338644|NCT02000960|Glut1 DS|glut1 ds
5338645|NCT02000947|anti-CTLA-4|anti-ctla-4
5338646|NCT02000947|anti-PD-L1|anti-pd-l1
5338647|NCT02000947|immunotherapy|immunotherapy
5338648|NCT02000947|IMTC|imtc
5338649|NCT02000934|TAK-659|tak-659
5338650|NCT02000934|Solid Tumors|solid tumors
5338652|NCT02000934|DLBCL|dlbcl
5338653|NCT02000921|Cigarette Smoking|cigarette smoking
5338654|NCT02000921|Very Low Nicotine Content cigarettes (VLNC)|very low nicotine content cigarettes (vlnc)
5338655|NCT02000921|Dual Tobacco Use|dual tobacco use
5338656|NCT02000908|gynecological cancer|gynecological cancer
5338657|NCT02000908|ovarian cancer|ovarian cancer
5338658|NCT02000908|primary peritoneal cancer|primary peritoneal cancer
5338659|NCT02000908|cervical caner|cervical caner
5338660|NCT02000908|peripheral neuropathy|peripheral neuropathy
5338661|NCT02000882|Breast Cancer|breast cancer
5338662|NCT02000882|Triple Negative Breast Cancer|triple negative breast cancer
5338663|NCT02000882|Brain Metastases|brain metastases
5338664|NCT02000882|Capecitabine|capecitabine
5338665|NCT02000882|Metastatic Breast Cancer|metastatic breast cancer
5338666|NCT02000843|perforation|perforation
5338667|NCT02000843|tympanoplasty|tympanoplasty
5338668|NCT02000843|conchal cavum approach|conchal cavum approach
5338669|NCT02000843|perichondrium/ cartilage|perichondrium/ cartilage
5338670|NCT02000843|scar|scar
5338671|NCT02000830|stannsoporfin|stannsoporfin
5338672|NCT02000817|Beta Cell|beta cell
5338673|NCT02000817|Monoclonal Antibody|monoclonal antibody
5338674|NCT02000817|Otelixizumab|otelixizumab
5338675|NCT02000817|Cytokine Release Syndrome|cytokine release syndrome
5338676|NCT02000817|Epstein-Barr Virus|epstein-barr virus
5338677|NCT02000817|Diabetes Mellitus|diabetes mellitus
5338678|NCT02000804|Darapladib, Safety, Pharmacokinetics, Pharmacodynamics, Healthy Chinese Subjects|darapladib, safety, pharmacokinetics, pharmacodynamics, healthy chinese subjects
5338679|NCT02000791|cLMA|clma
5338680|NCT02000791|laryngoscopy|laryngoscopy
5338681|NCT02000791|fiberoptic|fiberoptic
5338682|NCT02000778|Occult Ovarian Carcinoma|occult ovarian carcinoma
5338683|NCT02000765|oral|oral
5338684|NCT02000765|ADME|adme
5338685|NCT02000765|IV|iv
5338686|NCT02000765|antibiotic|antibiotic
5338687|NCT02000765|healthy volunteer|healthy volunteer
5338688|NCT02000765|[14C]-GSK2140944|[14c]-gsk2140944
5338689|NCT02000765|mass balance|mass balance
5338690|NCT02000765|radiolabel|radiolabel
5338691|NCT02000752|Labor|labor
5338692|NCT02000752|Acupuncture|acupuncture
5338693|NCT02000752|Placental expulsion time|placental expulsion time
5338694|NCT02000752|Postpartum hemorrhage|postpartum hemorrhage
5338695|NCT02000739|Breast cancer|breast cancer
5338696|NCT02000739|melanoma|melanoma
5338697|NCT02000739|GI cancer|gi cancer
5338698|NCT02000739|ovarian cancer|ovarian cancer
5338699|NCT02000739|lung cancer|lung cancer
5338700|NCT02000739|metastatic cancer|metastatic cancer
5338701|NCT02000739|brain cancer|brain cancer
5338702|NCT02000739|head and neck cancer|head and neck cancer
5338703|NCT02000700|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5338704|NCT02000700|Canagliflozin|canagliflozin
5338705|NCT02000700|JNJ-28431754|jnj-28431754
5338706|NCT02000700|Pharmacokinetics|pharmacokinetics
5338707|NCT02000700|Pharmacodynamics|pharmacodynamics
5338708|NCT02000700|Children|children
5338709|NCT02000700|Adolescents|adolescents
5338710|NCT02000674|tracheal intubation|tracheal intubation
5338715|NCT02000648|Allergic Rhinitis|allergic rhinitis
5338716|NCT02000648|Non-allergic Rhinitis|non-allergic rhinitis
5338725|NCT02000609|pharmacodynamics COPD|pharmacodynamics copd
5338726|NCT02000596|HER2 overexpressed|her2 overexpressed
5338727|NCT02000596|Metastatic Breast Cancer|metastatic breast cancer
5338728|NCT02000596|Elderly|elderly
5338729|NCT02000583|Alzheimer's Disease|alzheimer's disease
5338730|NCT02000583|AD|ad
5338731|NCT02000583|Aerobic Exercise|aerobic exercise
5338732|NCT02000583|Exercise|exercise
5338733|NCT02000570|sitting position|sitting position
5338734|NCT02000570|PPV|ppv
5338735|NCT02000570|SVV|svv
5338736|NCT02000570|PVI|pvi
5338737|NCT02000570|fluid challenge|fluid challenge
5338738|NCT02000570|preload indicators|preload indicators
5338739|NCT02000557|Photographic analysis|photographic analysis
5338740|NCT02000557|Cephalometric analysis|cephalometric analysis
5338741|NCT02000557|Standardized photographs|standardized photographs
5963366|NCT04250558|Trauma|trauma
5338742|NCT02000557|Angular measurements|angular measurements
5338743|NCT02000557|Linear measurements|linear measurements
5338744|NCT02000557|Malocclusion|malocclusion
5338745|NCT02000557|Facial Profile|facial profile
5338755|NCT02000466|Pregnancy exposure|pregnancy exposure
5338756|NCT02000466|FluLaval Quadrivalent|flulaval quadrivalent
5338757|NCT02000466|Pregnancy outcome|pregnancy outcome
5338758|NCT02000466|Pregnancy Registry|pregnancy registry
5338759|NCT02000453|Quality of Life|quality of life
5338760|NCT02000453|Infection|infection
5338761|NCT02000453|GSK2586184|gsk2586184
5338762|NCT02000453|ulcerative colitis|ulcerative colitis
5338763|NCT02000440|GW856553|gw856553
5338764|NCT02000440|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
5338765|NCT02000440|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
5338766|NCT02000440|losmapimod|losmapimod
5338767|NCT02000440|nephrotic syndrome|nephrotic syndrome
5338768|NCT02000427|Relapsed; Refractory; Philadelphia Positive; B-precursor; Acute Lymphoblastic Leukemia; ALL; Blinatumomab; Leukemia;|relapsed; refractory; philadelphia positive; b-precursor; acute lymphoblastic leukemia; all; blinatumomab; leukemia;
5338769|NCT02000414|intraperitoneal|intraperitoneal
5338770|NCT02000414|peritoneal dialysis|peritoneal dialysis
5338771|NCT02000414|daptomycin|daptomycin
5338772|NCT02000414|pharmacokinetics|pharmacokinetics
5338773|NCT02000414|peritonitis|peritonitis
5338774|NCT02000375|metastatic breastcancer|metastatic breastcancer
5338775|NCT02000375|ER/PgR-negative/AR-positive|er/pgr-negative/ar-positive
5338776|NCT02000375|ER and/or PgR-positive/AR-positive|er and/or pgr-positive/ar-positive
5338777|NCT02000375|Androgen Receptor positve|androgen receptor positve
5338778|NCT02000362|Crohn's Disease|crohn's disease
5338779|NCT02000362|Stem cell|stem cell
5338780|NCT02000362|Cell therapy|cell therapy
5338781|NCT02000362|Auto-immune disease|auto-immune disease
5338782|NCT02000362|furestem|furestem
5338783|NCT02000362|CD|cd
5338784|NCT02000362|inflammatory bowel disease|inflammatory bowel disease
5338785|NCT02000362|MSCs|mscs
5338786|NCT02000362|Mesenchymal Stem Cells|mesenchymal stem cells
5338787|NCT02000362|hUCB-MSC|hucb-msc
5338788|NCT02000362|UCB-MSC|ucb-msc
5338789|NCT02000362|Umbilical cord Blood|umbilical cord blood
5338790|NCT02000349|infertility|infertility
5338791|NCT02000349|next generation sequencing|next generation sequencing
5338792|NCT02000336|radiographic damage|radiographic damage
5338793|NCT02000336|rheumatoid arthritis|rheumatoid arthritis
5338794|NCT02000323|pancreatitis|pancreatitis
5338795|NCT02000323|enteral nutrition|enteral nutrition
5338796|NCT02000310|Gaucher disease|gaucher disease
5338797|NCT02000310|Fabry disease|fabry disease
5338798|NCT02000310|Pompe disease|pompe disease
5338799|NCT02000310|Niemann-Pick disease|niemann-pick disease
5338800|NCT02000297|Osteoarthritis|osteoarthritis
5338801|NCT02000297|Knee|knee
5338802|NCT02000297|High tibial osteotomy|high tibial osteotomy
5338803|NCT02000297|Calcium phosphate|calcium phosphate
5338804|NCT02000297|Calcium sulfate|calcium sulfate
5338805|NCT02000284|Autism Spectrum Disorder|autism spectrum disorder
5338806|NCT02000284|ASD|asd
5338807|NCT02000284|Autism|autism
5339997|NCT01995084|cancer|cancer
5338808|NCT02000284|Pervasive developmental disorder - Not Otherwise Specified|pervasive developmental disorder - not otherwise specified
5338809|NCT02000284|PDD-NOS|pdd-nos
5338810|NCT02000284|Asperger's Syndrome|asperger's syndrome
5338811|NCT02000284|Mitochondrial Disease|mitochondrial disease
5338812|NCT02000284|Developmental Delay|developmental delay
5338813|NCT02000284|Typical Development|typical development
5338814|NCT02000258|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5338815|NCT02000258|Double-bundle|double-bundle
5338816|NCT02000258|MRI|mri
5338817|NCT02000258|Graft location|graft location
5338818|NCT02000245|bronchoscopy|bronchoscopy
5338819|NCT02000245|anxiety|anxiety
5338820|NCT02000245|touch|touch
5338821|NCT02000245|sympathy|sympathy
5338822|NCT02000232|gout|gout
5338823|NCT02000232|colchicine|colchicine
5338824|NCT02000219|hyperoxaluria|hyperoxaluria
5338825|NCT02000219|oxalate|oxalate
5338827|NCT02000219|dialysis|dialysis
5338828|NCT02000206|Ketamine|ketamine
5338829|NCT02000206|Alfentanil|alfentanil
5338830|NCT02000206|Propofol|propofol
5338831|NCT02000206|Oxygen saturation|oxygen saturation
5338832|NCT02000206|Percutaneous carbon dioxide|percutaneous carbon dioxide
5338833|NCT02000206|Bronchoscopy|bronchoscopy
5338834|NCT02000167|Electron Transport Chain|electron transport chain
5338835|NCT02000167|Mitochondrial Disease|mitochondrial disease
5338836|NCT02000167|Chromosomal Deletion|chromosomal deletion
5338837|NCT02000128|Peritoneal Dialysis|peritoneal dialysis
5338838|NCT02000128|fluid overload|fluid overload
5338839|NCT02000128|bioimpedance analysis|bioimpedance analysis
5338840|NCT02000128|Randomized Controlled Trial|randomized controlled trial
5338841|NCT02000089|familial pancreas cancer|familial pancreas cancer
5338842|NCT02000089|(Peutz-Jeghers Syndrome) PJS|(peutz-jeghers syndrome) pjs
5338843|NCT02000089|Breast cancer (BRCA) 2|breast cancer (brca) 2
5338844|NCT02000089|Partner and Locator of BRCA2 (PALB2)|partner and locator of brca2 (palb2)
5963367|NCT04250558|Amputation|amputation
5291707|NCT02216734|Infants|infants
5206282|NCT02705482|immuno-oncology|immuno-oncology
5206283|NCT02705482|Cancer|cancer
5206285|NCT02705469|Phase 1|phase 1
5218185|NCT02633475|interleukin-10|interleukin-10
5338845|NCT02000089|Familial Atypical Multiple Mole- Melanoma (FAMMM)|familial atypical multiple mole- melanoma (fammm)
5338846|NCT02000089|p16|p16
5338847|NCT02000089|Breast Cancer (BRCA)1|breast cancer (brca)1
5338848|NCT02000089|(hereditary non-polyposis colorectal cancer or Lynch syndrome) HNPCC|(hereditary non-polyposis colorectal cancer or lynch syndrome) hnpcc
5338849|NCT02000089|Lynch Syndrome|lynch syndrome
5338850|NCT02000089|hereditary pancreatitis|hereditary pancreatitis
5338851|NCT02000089|Protease Serine (PRSS)|protease serine (prss)
5338852|NCT02000089|Chymotrypsin C (CTRC)|chymotrypsin c (ctrc)
5338853|NCT02000089|Ataxia Telangiectasia Mutated(ATM)|ataxia telangiectasia mutated(atm)
5338854|NCT02000076|Sleep|sleep
5338855|NCT02000076|resting state|resting state
5338856|NCT02000076|functional connectivity|functional connectivity
5338857|NCT02000076|emotional contagion|emotional contagion
5338858|NCT02000076|empathy|empathy
5338859|NCT02000076|emotional regulation|emotional regulation
5338860|NCT02000063|Hepatitis C|hepatitis c
5338861|NCT02000063|acute|acute
5338862|NCT02000063|early chronic|early chronic
5338863|NCT02000050|resectable rectal cancer|resectable rectal cancer
5338864|NCT02000050|up-front chemotherapy|up-front chemotherapy
5338865|NCT02000050|neo-adjuvant short course radiotherapy|neo-adjuvant short course radiotherapy
5338866|NCT02000050|short course radiotherapy|short course radiotherapy
5338867|NCT02000011|patients|patients
5338868|NCT02000011|aged 70 years old|aged 70 years old
5338869|NCT02000011|thoracic,|thoracic,
5338870|NCT02000011|digestive or|digestive or
5338871|NCT02000011|urological|urological
5338872|NCT02000011|resectable|resectable
5338873|NCT01999985|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5338874|NCT01999985|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5338875|NCT01999985|Neoplasms|neoplasms
5338876|NCT01999985|Lung Diseases|lung diseases
5338877|NCT01999985|Respiratory Tract Diseases|respiratory tract diseases
5338878|NCT01999985|Pleural Diseases|pleural diseases
5338879|NCT01999985|Pleural Neoplasms|pleural neoplasms
5338880|NCT01999985|Lung Neoplasms|lung neoplasms
5338881|NCT01999985|Pleural Effusion|pleural effusion
5338882|NCT01999985|Pleural Effusion, Malignant|pleural effusion, malignant
5338883|NCT01999985|Respiratory Tract Neoplasms|respiratory tract neoplasms
5338884|NCT01999985|Thoracic Neoplasms|thoracic neoplasms
5233690|NCT02542137|ZADAXIN|zadaxin
5338885|NCT01999985|Neoplasms by Site|neoplasms by site
5338886|NCT01999985|EGFR mutation|egfr mutation
5338887|NCT01999985|Afatinib|afatinib
5338888|NCT01999985|Dasatinib|dasatinib
5338889|NCT01999985|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5338890|NCT01999985|Gene Mutation|gene mutation
5325347|NCT02060513|ESBL|esbl
5338891|NCT01999985|T790M mutation.|t790m mutation.
5338892|NCT01999985|Non-small cell lung cancer|non-small cell lung cancer
5338893|NCT01999972|Carcinoma|carcinoma
5338894|NCT01999972|Renal Cell|renal cell
5338895|NCT01999959|Unexplained Infertility, Pertubation, Gonadotrophin, Ovulation Induction, Intrauterine Insemination|unexplained infertility, pertubation, gonadotrophin, ovulation induction, intrauterine insemination
5338896|NCT01999946|Heroin Dependence|heroin dependence
5338897|NCT01999946|Opioid-Related Disorders|opioid-related disorders
5338898|NCT01999933|Cervical cancer|cervical cancer
5338899|NCT01999933|postoperative risk factor|postoperative risk factor
5338900|NCT01999933|treatment|treatment
5339105|NCT01998828|Polycythemia Vera|polycythemia vera
5338901|NCT01999920|Adult separation anxiety disorder|adult separation anxiety disorder
5338902|NCT01999920|ASAD|asad
5338903|NCT01999907|asthma|asthma
5338904|NCT01999907|virus diseases|virus diseases
5338905|NCT01999907|pediatric|pediatric
5338906|NCT01999907|RCT|rct
5338907|NCT01999907|steroid|steroid
5338908|NCT01999894|Namenda|namenda
5338909|NCT01999894|Autism|autism
5338910|NCT01999894|Memantine|memantine
5338911|NCT01999894|Pediatric|pediatric
5338912|NCT01999894|Forest Laboratories|forest laboratories
5338913|NCT01999868|psoriasis vulgaris|psoriasis vulgaris
5338915|NCT01999868|abatacept|abatacept
5338916|NCT01999842|H7N9|h7n9
5338917|NCT01999842|Influenza|influenza
5338918|NCT01999842|Safety|safety
5338919|NCT01999842|Adults|adults
5338920|NCT01999842|Adjuvant|adjuvant
5338921|NCT01999842|Immunogenicity|immunogenicity
5338922|NCT01999816|pressure ulcer|pressure ulcer
5338923|NCT01999816|lifestyle redesign|lifestyle redesign
5338924|NCT01999816|spinal cord injury|spinal cord injury
5338925|NCT01999790|upper lid|upper lid
5338926|NCT01999790|exophthalmos|exophthalmos
5338927|NCT01999790|grave's orbitopathy|grave's orbitopathy
5338928|NCT01999777|Epilepsy|epilepsy
5338933|NCT01999751|Pacemaker, Artificial|pacemaker, artificial
5338934|NCT01999751|Defibrillators, Implantable|defibrillators, implantable
5338935|NCT01999725|Normal Volunteers, Safety, Pharmacokinetics|normal volunteers, safety, pharmacokinetics
5963368|NCT04250558|Orthopaedic|orthopaedic
5963369|NCT04250558|Lower Extremity|lower extremity
5963370|NCT04249882|Alcohol Use Disorder|alcohol use disorder
5963371|NCT04249882|Medications Development|medications development
5963372|NCT04249843|BGB3245|bgb3245
5338936|NCT01999712|heart failure|heart failure
5338937|NCT01999712|left ventricular assist device|left ventricular assist device
5338938|NCT01999712|right ventricular failure|right ventricular failure
5338939|NCT01999699|Heplisav|heplisav
5338940|NCT01999686|Polycystic ovarium syndrome|polycystic ovarium syndrome
5338941|NCT01999686|DLBS3233|dlbs3233
5338942|NCT01999686|metformin|metformin
5338943|NCT01999686|insulin resistance|insulin resistance
5338944|NCT01999686|Female|female
5338945|NCT01999673|SUNRISE|sunrise
5338946|NCT01999673|PPHM 1202|pphm 1202
5338947|NCT01999673|Bavituximab|bavituximab
5338948|NCT01999673|Peregrine|peregrine
5338949|NCT01999660|Prostatic Neoplasms|prostatic neoplasms
5338950|NCT01999660|Radiotherapy|radiotherapy
5338951|NCT01999660|rectal toxicity|rectal toxicity
5338952|NCT01999647|Lower Extremity|lower extremity
5338953|NCT01999647|Sciatic Nerve|sciatic nerve
5338954|NCT01999647|Anesthetics, Local|anesthetics, local
5338955|NCT01999647|Ropivacaine|ropivacaine
5338956|NCT01999647|Ultrasonography|ultrasonography
5338957|NCT01999634|rectum|rectum
5338958|NCT01999634|microdialysis|microdialysis
5338959|NCT01999634|anastomotic leaks|anastomotic leaks
5338960|NCT01999621|organ failure|organ failure
5338961|NCT01999621|intensive care|intensive care
5338962|NCT01999621|palliative care|palliative care
5338963|NCT01999621|patient's wishes|patient's wishes
5338964|NCT01999608|Infertility|infertility
5338965|NCT01999595|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5338966|NCT01999595|pad size|pad size
5338967|NCT01999595|pulse frequency|pulse frequency
5338968|NCT01999595|blunt pressure pain|blunt pressure pain
5338969|NCT01999595|healthy humans.|healthy humans.
5338970|NCT01999582|Anemia|anemia
5338971|NCT01999582|End Stage Kidney Disease|end stage kidney disease
5338972|NCT01999582|Chronic Kidney Disease|chronic kidney disease
5338973|NCT01999582|Dialysis|dialysis
5338974|NCT01999582|Erythrpoietin Stimulating Agent (ESA)|erythrpoietin stimulating agent (esa)
5338975|NCT01999543|Blood glucose|blood glucose
5338976|NCT01999530|prazosin|prazosin
5338977|NCT01999530|dopamine|dopamine
5338978|NCT01999530|healthy|healthy
5338979|NCT01999530|Positron Emission Tomography|positron emission tomography
5338980|NCT01999530|PHNO|phno
5338981|NCT01999530|scan|scan
5338982|NCT01999530|effect|effect
5338983|NCT01999504|Glucagon-like peptide-1|glucagon-like peptide-1
5338984|NCT01999504|Glucose-dependent Insulinotropic Peptide|glucose-dependent insulinotropic peptide
5338985|NCT01999504|Peptide YY|peptide yy
5338986|NCT01999504|Glucagon|glucagon
5338987|NCT01999504|Satiety|satiety
5338988|NCT01999504|Meal|meal
5338989|NCT01999504|palaeolithic|palaeolithic
5338990|NCT01999465|Brachial plexus injury|brachial plexus injury
5338991|NCT01999465|Brachial plexus palsy|brachial plexus palsy
5338992|NCT01999465|Neonate|neonate
5338993|NCT01999452|Paleolithic diet|paleolithic diet
5338994|NCT01999426|Physical Therapy Modalities|physical therapy modalities
5338995|NCT01999426|Pediatrics|pediatrics
5338996|NCT01999426|Critical Care|critical care
5338997|NCT01999426|Respiration, Artificial|respiration, artificial
5338998|NCT01999413|AML|aml
5338999|NCT01999413|high-risk cytogenetics|high-risk cytogenetics
5339000|NCT01999413|younger patients|younger patients
5339001|NCT01999413|Induction treatment|induction treatment
5339002|NCT01999413|OMEGAVEN|omegaven
5339003|NCT01999387|food|food
5339004|NCT01999387|consumption|consumption
5339106|NCT01998828|Essential Thrombocythemia|essential thrombocythemia
5339005|NCT01999309|Schizophrenia spectrum disorders|schizophrenia spectrum disorders
5339006|NCT01999283|Cervical pain|cervical pain
5339007|NCT01999283|yoga|yoga
5339008|NCT01999283|pilates|pilates
5339009|NCT01999283|exercise|exercise
5339010|NCT01999257|Genetic Counseling|genetic counseling
5339011|NCT01999257|Technology|technology
5339012|NCT01999257|Ashkenazi Jewish|ashkenazi jewish
5339013|NCT01999257|Carrier screening|carrier screening
5339014|NCT01999244|Overweight|overweight
5339015|NCT01999244|Obesity|obesity
5339018|NCT01999244|Food Records|food records
5339019|NCT01999244|Self-weighing|self-weighing
5339020|NCT01999244|Technology|technology
5339021|NCT01999231|Safety|safety
5339022|NCT01999231|Tolerability|tolerability
5339023|NCT01999231|ESAT6|esat6
5339024|NCT01999231|CFP10|cfp10
5339025|NCT01999231|skin test|skin test
5339026|NCT01999231|diagnostic test|diagnostic test
5339027|NCT01999205|workplace|workplace
5339028|NCT01999205|intervention|intervention
5339030|NCT01999205|sedentary behavior|sedentary behavior
5339031|NCT01999205|evaluation|evaluation
5339032|NCT01999192|inadequate response to MTX|inadequate response to mtx
5339033|NCT01999192|Methotrexate|methotrexate
5339034|NCT01999192|rheumatoid Arthritis|rheumatoid arthritis
5339035|NCT01999192|Phase 2b|phase 2b
5339036|NCT01999179|catheter related thrombosis|catheter related thrombosis
5339037|NCT01999179|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
5339038|NCT01999179|central venous catheters|central venous catheters
5339039|NCT01999179|cancer|cancer
5339040|NCT01999179|Catheters|catheters
5339041|NCT01999153|skin graft|skin graft
5339042|NCT01999153|donor site|donor site
5339043|NCT01999114|Healthy subjects|healthy subjects
5339044|NCT01999114|Opioid|opioid
5339045|NCT01999114|Transdermal|transdermal
5339047|NCT01999088|Fatty Acids, Omega-3|fatty acids, omega-3
5339048|NCT01999088|Rosemary extract|rosemary extract
5339049|NCT01999088|Functional meat|functional meat
5339050|NCT01999088|Cardiovascular disease|cardiovascular disease
5339051|NCT01999075|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5339052|NCT01999075|Pulmonary complications|pulmonary complications
5339053|NCT01999075|Lung volume recruitment,|lung volume recruitment,
5339054|NCT01999075|Breath-stacking,|breath-stacking,
5339055|NCT01999075|Cough efficacy,|cough efficacy,
5339056|NCT01999075|Maximal insufflation capacity|maximal insufflation capacity
5339057|NCT01999062|Breast RT|breast rt
5339058|NCT01999062|Breast radiation therapy|breast radiation therapy
5339059|NCT01999036|cardiac arrest, CPR, resuscitation|cardiac arrest, cpr, resuscitation
5339060|NCT01999010|psychiatry|psychiatry
5339061|NCT01999010|mental health|mental health
5339062|NCT01999010|major depressive disorder|major depressive disorder
5339063|NCT01999010|self-management|self-management
5339064|NCT01999010|data visualization|data visualization
5339065|NCT01999010|mood diaries|mood diaries
5339066|NCT01999010|electronic diaries|electronic diaries
5339067|NCT01999010|cell phones|cell phones
5339068|NCT01999010|software|software
5339069|NCT01999010|mental health telemetry|mental health telemetry
5339070|NCT01999010|ecological momentary assessment|ecological momentary assessment
5339071|NCT01998997|Delirium|delirium
5339072|NCT01998997|Hospitalized elderly|hospitalized elderly
5339073|NCT01998971|Multiple myeloma|multiple myeloma
5339074|NCT01998971|Daratumumab|daratumumab
5339075|NCT01998971|JNJ-54767414|jnj-54767414
5339076|NCT01998971|Velcade-dexamethasone|velcade-dexamethasone
5339077|NCT01998971|Velcade-melphalan-prednisone|velcade-melphalan-prednisone
5339078|NCT01998971|Velcade-thalidomide-dexamethasone|velcade-thalidomide-dexamethasone
5339079|NCT01998971|Pomalidomide-dexamethasone|pomalidomide-dexamethasone
5339080|NCT01998971|Carfilzomib-dexamethasone|carfilzomib-dexamethasone
5339081|NCT01998971|Carfilzomib-lenalidomide-dexamethasone|carfilzomib-lenalidomide-dexamethasone
5672663|NCT00611299|Intestinal microflora|intestinal microflora
5339082|NCT01998971|Anti-CD38 Monoclonal Antibody|anti-cd38 monoclonal antibody
5339083|NCT01998971|Immunomodulatory drug|immunomodulatory drug
5339084|NCT01998971|IMiD|imid
5339085|NCT01998958|Treatment resistant depressive disorder|treatment resistant depressive disorder
5339086|NCT01998958|Intranasal esketamine|intranasal esketamine
5339087|NCT01998958|Efficacy|efficacy
5339088|NCT01998958|SYNAPSE|synapse
5339089|NCT01998958|JNJ-54135419|jnj-54135419
5339090|NCT01998945|Exposure therapy|exposure therapy
5339091|NCT01998945|Cognitive behavioral therapy|cognitive behavioral therapy
5339092|NCT01998945|Relaxation Training|relaxation training
5339093|NCT01998945|Older Adults|older adults
5339094|NCT01998945|Fall Injury|fall injury
5339095|NCT01998945|Anxiety|anxiety
5339096|NCT01998945|Posttraumatic Stress|posttraumatic stress
5339097|NCT01998932|Venous Ulcer|venous ulcer
5339098|NCT01998932|Leg Ulcer|leg ulcer
5339099|NCT01998932|Metabonomics|metabonomics
5339100|NCT01998932|Ulcer Fluid|ulcer fluid
5339101|NCT01998854|Menorrhagia|menorrhagia
5339102|NCT01998854|Leiomyoma|leiomyoma
5339103|NCT01998854|Uterine Fibroids|uterine fibroids
5339104|NCT01998828|Polycythemia|polycythemia
5339107|NCT01998828|Thrombocytosis|thrombocytosis
5339108|NCT01998828|Myeloproliferative Disorders|myeloproliferative disorders
5339109|NCT01998828|Bone Marrow Diseases|bone marrow diseases
5339110|NCT01998828|Hematologic Diseases|hematologic diseases
5339111|NCT01998828|Blood Coagulation Disorders|blood coagulation disorders
5339112|NCT01998828|Blood Platelet Disorders|blood platelet disorders
5339113|NCT01998828|Hemorrhagic Disorders|hemorrhagic disorders
5339116|NCT01998789|Immunosuppression|immunosuppression
5339118|NCT01998763|Vitamin D3 supplementation|vitamin d3 supplementation
5339119|NCT01998763|metabolite profile|metabolite profile
5339120|NCT01998763|SNPs|snps
5339121|NCT01998763|bone-turnover marker|bone-turnover marker
5339122|NCT01998750|obesity|obesity
5339123|NCT01998750|genetics|genetics
5339124|NCT01998750|early-onset|early-onset
5339125|NCT01998750|childhood|childhood
5339126|NCT01998737|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
5339127|NCT01998724|Chronic bronchitis|chronic bronchitis
5339128|NCT01998724|Emphysema|emphysema
5339130|NCT01998724|COPD|copd
5339131|NCT01998711|Alzheimer's disease|alzheimer's disease
5339132|NCT01998711|Mild cognitive impairment|mild cognitive impairment
5339133|NCT01998711|Memory intervention|memory intervention
5339134|NCT01998711|Strategy use|strategy use
5339135|NCT01998711|Memory group|memory group
5339136|NCT01998698|cataract|cataract
5339137|NCT01998698|phacoemulsification|phacoemulsification
5339138|NCT01998698|monovision|monovision
5339139|NCT01998698|multifocal lens|multifocal lens
5339140|NCT01998685|Prostatectomy|prostatectomy
5339141|NCT01998685|Coagulation Factor|coagulation factor
5339142|NCT01998685|Balanced Anesthesia|balanced anesthesia
5339143|NCT01998685|Intravenous Anesthesia,|intravenous anesthesia,
5339144|NCT01998646|ASP4058|asp4058
5339145|NCT01998646|healthy subjects|healthy subjects
5339146|NCT01998633|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5339147|NCT01998633|Chronic Active EBV|chronic active ebv
5339148|NCT01998633|Chronic Granulomatous Disease|chronic granulomatous disease
5339149|NCT01998633|Hyperimmunoglobulin M Syndrome (Hyper IGM)|hyperimmunoglobulin m syndrome (hyper igm)
5339150|NCT01998633|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
5339151|NCT01998633|IPEX|ipex
5339152|NCT01998633|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5339153|NCT01998633|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
5339154|NCT01998633|Reduced-Intensity Conditioning (RIC)|reduced-intensity conditioning (ric)
5339155|NCT01998620|Hepatitis B|hepatitis b
5339156|NCT01998620|Cholestasis|cholestasis
5339157|NCT01998607|Solid tumours|solid tumours
5339158|NCT01998607|Bone Metastasis|bone metastasis
5339159|NCT01998594|Thumb arthritis|thumb arthritis
5339160|NCT01998594|CMC arthritis|cmc arthritis
5339161|NCT01998594|Arthroplasty|arthroplasty
5339162|NCT01998568|Intraocular pressure|intraocular pressure
5339163|NCT01998568|Corneal edema|corneal edema
5339164|NCT01998568|Tonometer|tonometer
5339165|NCT01998568|Dynamic contour tonometer|dynamic contour tonometer
5339166|NCT01998568|Tonopen|tonopen
5339167|NCT01998568|iCare|icare
5339168|NCT01998568|Goldmann applanation|goldmann applanation
5339169|NCT01998542|Head and neck cancers|head and neck cancers
5339170|NCT01998542|tumor vaccine|tumor vaccine
5339171|NCT01998542|immunotherapy|immunotherapy
5339172|NCT01998542|personalized anti-cancer vaccine|personalized anti-cancer vaccine
5339173|NCT01998529|Lung Cancer|lung cancer
5339174|NCT01998529|Unilateral Pleural Malignancy|unilateral pleural malignancy
5339175|NCT01998529|Metastatic active pleural malignancy|metastatic active pleural malignancy
5339176|NCT01998529|Lung tumors|lung tumors
5339177|NCT01998529|Sarcomas|sarcomas
5339178|NCT01998529|Cytoreductive Surgery|cytoreductive surgery
5672664|NCT00611299|Tolerance|tolerance
5339179|NCT01998529|Hyperthermic Intrathoracic Pleural Chemotherapy|hyperthermic intrathoracic pleural chemotherapy
5339180|NCT01998529|HITC|hitc
5339181|NCT01998529|Cisplatin|cisplatin
5339182|NCT01998529|Platinol-AQ|platinol-aq
5339183|NCT01998529|Platinol|platinol
5339184|NCT01998529|CDDP|cddp
5234072|NCT02539680|CKD|ckd
5339185|NCT01998529|Amifostine|amifostine
5339186|NCT01998529|Ethyol|ethyol
5339187|NCT01998529|Ethiofos|ethiofos
5339188|NCT01998529|Gammaphos|gammaphos
5441328|NCT01539629|Pacing|pacing
5339189|NCT01998516|Emotional Intelligence|emotional intelligence
5339190|NCT01998503|AL amyloidosis|al amyloidosis
5339191|NCT01998503|bortezomib|bortezomib
5339192|NCT01998503|autologous stem cell transplantation|autologous stem cell transplantation
5339193|NCT01998477|Influenza|influenza
5339194|NCT01998477|Vaccine|vaccine
5339196|NCT01998477|Children|children
5339197|NCT01998477|Adolescents|adolescents
5339198|NCT01998464|Retinal Vasculitis|retinal vasculitis
5339199|NCT01998464|Optical coherence tomography|optical coherence tomography
5339200|NCT01998464|OCT|oct
5339201|NCT01998464|Imaging|imaging
5339202|NCT01998451|double sphincter in gallbladder|double sphincter in gallbladder
5339203|NCT01998451|recurrence rate of gallstones|recurrence rate of gallstones
5339204|NCT01998438|tranexamic acid|tranexamic acid
5339205|NCT01998438|cardiac surgery|cardiac surgery
5339206|NCT01998438|cardiopulmonary bypass|cardiopulmonary bypass
5339207|NCT01998425|circulating fibrocytes|circulating fibrocytes
5339208|NCT01998425|fibrocyte|fibrocyte
5339209|NCT01998425|NSCLC|nsclc
5339210|NCT01998425|treatment response|treatment response
5339211|NCT01998425|survival|survival
5339212|NCT01998425|stage|stage
5339213|NCT01998399|CAP|cap
5339214|NCT01998399|Pneumonia|pneumonia
5339215|NCT01998399|Intensive Care Unit|intensive care unit
5339216|NCT01998399|Mechanical Ventilation|mechanical ventilation
5339217|NCT01998386|Tooth Whitening|tooth whitening
5339218|NCT01998386|Adolescent|adolescent
5339219|NCT01998386|Clinical Trial|clinical trial
5339220|NCT01998373|Patient training|patient training
5339221|NCT01998373|Rheumatoid arthritis|rheumatoid arthritis
5339222|NCT01998373|Quality of life|quality of life
5339223|NCT01998360|Circumcision|circumcision
5339224|NCT01998360|Voluntary medical male circumcision|voluntary medical male circumcision
5339225|NCT01998360|Minimally-invasive|minimally-invasive
5339226|NCT01998360|HIV prevention|hiv prevention
5339227|NCT01998334|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5339228|NCT01998334|Continuous Blood Purification|continuous blood purification
5339229|NCT01998321|PSI: Patient Specific Instrument|psi: patient specific instrument
5339230|NCT01998321|TKA: Total Knee Arthroplasty|tka: total knee arthroplasty
5339231|NCT01998321|Articular Deformity|articular deformity
5339232|NCT01998321|Varus|varus
5339233|NCT01998295|Clearance time|clearance time
5339234|NCT01998295|Recurrence time|recurrence time
5339235|NCT01998295|Artemether/lumefantrine|artemether/lumefantrine
5339236|NCT01998295|P. falciparum|p. falciparum
5339237|NCT01998295|Uncomplicated malaria|uncomplicated malaria
5339238|NCT01998295|Children|children
5963373|NCT04249843|B-RAF inhibitor|b-raf inhibitor
5339239|NCT01998282|Focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.|focus of study is to assess filter/stove use and efficacy in reducing exposure to waterborne and airborne pathogens.
5339240|NCT01998256|AV optimization|av optimization
5339241|NCT01998256|Interatrial conduction delay|interatrial conduction delay
5339242|NCT01998243|morbid obesity|morbid obesity
5339243|NCT01998243|bioenterics intragastric balloon|bioenterics intragastric balloon
5339244|NCT01998243|bariatric surgery|bariatric surgery
5339245|NCT01998230|esophageal cancer|esophageal cancer
5339246|NCT01998230|esophagectomy|esophagectomy
5339247|NCT01998230|oral feeding|oral feeding
5339248|NCT01998217|extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
5339249|NCT01998217|remifentanil|remifentanil
5339250|NCT01998217|flurbiprofen|flurbiprofen
5339251|NCT01998217|pancreatic stone|pancreatic stone
5339252|NCT01998204|Parkinson's disease|parkinson's disease
5339253|NCT01998204|propofol|propofol
5339254|NCT01998204|deep brain stimulator|deep brain stimulator
5339255|NCT01998191|mortality|mortality
5339256|NCT01998191|adverse events|adverse events
5339257|NCT01998165|Anesthesia|anesthesia
5339258|NCT01998165|Remifentanil|remifentanil
5339259|NCT01998165|Ultiva|ultiva
5339260|NCT01998113|gestational diabetes mellitus|gestational diabetes mellitus
5339261|NCT01998113|glyburide|glyburide
5339262|NCT01998113|metformin|metformin
5339263|NCT01998113|oral agents|oral agents
5339264|NCT01998113|insulin|insulin
5339265|NCT01998113|outcomes|outcomes
5339266|NCT01998100|PTSD|ptsd
5339267|NCT01998100|Anxiety|anxiety
5339268|NCT01998100|Behavior Therapy|behavior therapy
5339269|NCT01998100|Prolonged Exposure|prolonged exposure
5339270|NCT01998100|Exercise|exercise
5339271|NCT01998100|Wellness|wellness
5339272|NCT01998100|Post-traumatic|post-traumatic
5339273|NCT01998100|Stress|stress
5339274|NCT01998087|Exclusive breastfeeding|exclusive breastfeeding
5339275|NCT01998087|Breastfeeding|breastfeeding
5339276|NCT01998087|Proactive breastfeeding support|proactive breastfeeding support
5678925|NCT00584298|modulation|modulation
5339277|NCT01998087|Telephone breastfeeding support|telephone breastfeeding support
5339278|NCT01998087|Infant feeding attitudes|infant feeding attitudes
5339279|NCT01998087|Breastfeeding self-efficacy|breastfeeding self-efficacy
5339280|NCT01998087|Breastfeeding difficulties|breastfeeding difficulties
5339281|NCT01998074|Cow's Milk protein Allergy|cow's milk protein allergy
5339282|NCT01998048|surgical treatment|surgical treatment
5339284|NCT01998048|Latarjet|latarjet
5339285|NCT01998048|redislocation|redislocation
5339286|NCT01998035|Lymphoid Malignancies|lymphoid malignancies
5339287|NCT01998035|Lymphoma|lymphoma
5339288|NCT01998035|Hodgkin Lymphoma|hodgkin lymphoma
5339289|NCT01998035|Non-hodgkin Lymphoma|non-hodgkin lymphoma
5339290|NCT01998035|Follicular Lymphoma|follicular lymphoma
5339291|NCT01998035|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5339292|NCT01998035|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5339293|NCT01998035|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5339294|NCT01998035|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5339295|NCT01998035|Mantle Cell Lymphoma|mantle cell lymphoma
5339296|NCT01998035|Marginal Zone Lymphoma|marginal zone lymphoma
5339297|NCT01998035|Burkitt Lymphoma|burkitt lymphoma
5339298|NCT01998035|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5339299|NCT01998035|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5339300|NCT01998035|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5339310|NCT01997983|interstitial cystitis|interstitial cystitis
5339313|NCT01997983|Botox|botox
5339314|NCT01997983|Botulinum toxin|botulinum toxin
5339315|NCT01997983|TC-3 Gel|tc-3 gel
5339316|NCT01997983|TCGel|tcgel
5339317|NCT01997983|TheraCoat|theracoat
5339318|NCT01997970|NEAT|neat
5339319|NCT01997970|Treadmill desk|treadmill desk
5339320|NCT01997957|Hepatocellular Carcinoma|hepatocellular carcinoma
5339321|NCT01997957|Transarterial Chemoembolization|transarterial chemoembolization
5339322|NCT01997957|Hepatic Arterial Infusion Chemotherapy|hepatic arterial infusion chemotherapy
5339323|NCT01997957|Efficacy|efficacy
5339324|NCT01997931|bispectral index|bispectral index
5339325|NCT01997931|sedation|sedation
5339326|NCT01997931|intensive care|intensive care
5339327|NCT01997931|mechanical ventilation|mechanical ventilation
5339328|NCT01997918|Secondary allogeneic HSCT|secondary allogeneic hsct
5339329|NCT01997918|Haploidentical HSCT|haploidentical hsct
5335558|NCT02014831|TIP|tip
5339335|NCT01997905|IRB approved|irb approved
5339336|NCT01997905|clinical|clinical
5339337|NCT01997905|Stroke|stroke
5339338|NCT01997905|TIA|tia
5339339|NCT01997905|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
5339340|NCT01997905|Arrhythmias, Cardiac|arrhythmias, cardiac
5339341|NCT01997905|OAC|oac
5339342|NCT01997905|trial|trial
5339343|NCT01997905|study|study
5339344|NCT01997905|LAA occlusion|laa occlusion
5339345|NCT01997905|occluded|occluded
5339346|NCT01997905|prevent|prevent
5339347|NCT01997892|CKD|ckd
5339348|NCT01997892|Darbepoetin Alfa|darbepoetin alfa
5339349|NCT01997892|Dialysis|dialysis
5339350|NCT01997892|Hemodialysis|hemodialysis
5339351|NCT01997892|Anemia|anemia
5339352|NCT01997892|Peg epoetin beta|peg epoetin beta
5339353|NCT01997866|Obstructive Sleep Apnea|obstructive sleep apnea
5339354|NCT01997866|Sleep Apnea|sleep apnea
5339355|NCT01997866|Congestive Heart Failure|congestive heart failure
5339356|NCT01997866|Heart Failure|heart failure
5339357|NCT01997853|Omega 3 fatty acids|omega 3 fatty acids
5339358|NCT01997853|C Reactive Protein|c reactive protein
5339359|NCT01997853|Host Modulation|host modulation
5339360|NCT01997853|Chronic Periodontitis|chronic periodontitis
5339370|NCT01997814|Herbal medicine,|herbal medicine,
5339371|NCT01997814|Host modulation therapy,|host modulation therapy,
5339372|NCT01997814|Periodontitis,|periodontitis,
5339373|NCT01997814|Meta-analysis,|meta-analysis,
5339374|NCT01997814|Scaling and root planing.|scaling and root planing.
5339375|NCT01997801|Thyroidectomy|thyroidectomy
5339376|NCT01997801|Endoscopy|endoscopy
5339377|NCT01997801|Ketamine|ketamine
5339378|NCT01997801|Acute Pain|acute pain
5339379|NCT01997801|Chronic Pain|chronic pain
5339380|NCT01997801|Postoperative period|postoperative period
5339381|NCT01997788|Injection, Spinal|injection, spinal
5339382|NCT01997788|Morphine|morphine
5339383|NCT01997788|Analgesia|analgesia
5339384|NCT01997788|Patient-Controlled|patient-controlled
5339385|NCT01997788|Pain|pain
5339386|NCT01997788|Postoperative|postoperative
5339387|NCT01997788|Combined Modality Therapy|combined modality therapy
5339388|NCT01997788|Nephrectomy|nephrectomy
5339389|NCT01997775|IL-6|il-6
5339390|NCT01997775|Metformin|metformin
5339391|NCT01997775|Non-small cell lung cancer|non-small cell lung cancer
5339392|NCT01997775|Lung adenocarcinoma|lung adenocarcinoma
5339393|NCT01997762|resveratrol,|resveratrol,
5339394|NCT01997762|gestational diabetes,|gestational diabetes,
5339395|NCT01997762|beta cell function|beta cell function
5339396|NCT01997762|history|history
5339397|NCT01997749|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection|stroke, ketogenic diet, ketosis, ischemia, brain, ketones, hyperglycemia, neuroprotection
5339398|NCT01997736|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5339399|NCT01997736|Catheter Ablation|catheter ablation
5339400|NCT01997736|Ablation Techniques|ablation techniques
5339401|NCT01997723|OSA, portable monitoring, home diagnosis|osa, portable monitoring, home diagnosis
5339402|NCT01997684|Colorectal Cancer|colorectal cancer
5339403|NCT01997684|Colonic Obstruction|colonic obstruction
5339404|NCT01997671|Primary Care|primary care
5339405|NCT01997671|Lipid-lowering therapy|lipid-lowering therapy
5339406|NCT01997671|Prescription|prescription
5339407|NCT01997671|Adequacy|adequacy
5339408|NCT01997671|Primary prevention|primary prevention
5339409|NCT01997671|Cardiovascular diseases|cardiovascular diseases
5339410|NCT01997671|Electronic Medical records|electronic medical records
5339411|NCT01997671|Clinical Practice Guideline|clinical practice guideline
5339412|NCT01997658|Glucocorticoids|glucocorticoids
5339413|NCT01997658|Total complication rate|total complication rate
5339414|NCT01997658|Hepatectomy.|hepatectomy.
5339415|NCT01997645|Anal fistula|anal fistula
5339416|NCT01997645|Rectal fistula|rectal fistula
5339417|NCT01997645|Intersphincteric fistula|intersphincteric fistula
5339418|NCT01997645|Perianal fistula|perianal fistula
5339419|NCT01997632|Poliomyelitis|poliomyelitis
5339420|NCT01997632|Vaccine|vaccine
5339421|NCT01997619|biological mesh|biological mesh
5339422|NCT01997619|contaminated hernia|contaminated hernia
5339423|NCT01997619|abdominal wall reconstruction|abdominal wall reconstruction
5339424|NCT01997593|analgesia|analgesia
5339425|NCT01997593|pediatric|pediatric
5339426|NCT01997593|pain|pain
5339427|NCT01997593|laparoscopy|laparoscopy
5339428|NCT01997593|ropivacaine|ropivacaine
5339429|NCT01997580|depression|depression
5339430|NCT01997580|treatment|treatment
5339431|NCT01997580|electrophysiology|electrophysiology
5339432|NCT01997580|biomarker|biomarker
5339433|NCT01997567|Hip Arthroscopy|hip arthroscopy
5339434|NCT01997567|Regional Anesthesia|regional anesthesia
5339435|NCT01997567|Peripheral Nerve block|peripheral nerve block
5339437|NCT01997554|sub-clinical hypothyroidism|sub-clinical hypothyroidism
5339438|NCT01997515|Quality of Recovery 40 Questionaire|quality of recovery 40 questionaire
5339440|NCT01997515|Hypoxia|hypoxia
5339441|NCT01997515|Gastric Surgery|gastric surgery
5339442|NCT01997515|Obesity|obesity
5339443|NCT01997515|Ketamine|ketamine
5339444|NCT01997502|Hemoglobin|hemoglobin
5339445|NCT01997502|Non-invasive|non-invasive
5339446|NCT01997489|Eye|eye
5339447|NCT01997489|Fabry|fabry
5339448|NCT01997489|vessels|vessels
5339449|NCT01997476|Combined Endoscopic Ultrasound Morphologic Evaluation.|combined endoscopic ultrasound morphologic evaluation.
5339450|NCT01997450|Q/LAIV/FluMist® Quadrivalent Vaccine|q/laiv/flumist® quadrivalent vaccine
5339451|NCT01997450|Inactivated Influenza Vaccine (IIV)|inactivated influenza vaccine (iiv)
5339452|NCT01997450|Effectiveness|effectiveness
5339453|NCT01997450|Influenza|influenza
5339454|NCT01997437|Tissue-engineered tracheal transplantation|tissue-engineered tracheal transplantation
5339455|NCT01997398|Deep brain stimulation surgery under general anesthesia|deep brain stimulation surgery under general anesthesia
5963374|NCT04249843|B-RAF|b-raf
5218749|NCT02630732|Brain School|brain school
5218750|NCT02630732|Lumbar surgery|lumbar surgery
5218751|NCT02630732|Education|education
5218752|NCT02630719|headache|headache
5339456|NCT01997398|Deep brain stimulation target accuracy|deep brain stimulation target accuracy
5339457|NCT01997398|Deep brain stimulation for Parkinsons's disease|deep brain stimulation for parkinsons's disease
5339458|NCT01997398|Deep brain stimulation functional outcomes|deep brain stimulation functional outcomes
5339459|NCT01997398|Deep brain stimulation quality of life outcomes|deep brain stimulation quality of life outcomes
5339460|NCT01997385|adapted APD|adapted apd
5339461|NCT01997385|dwell time|dwell time
5339462|NCT01997385|fill volume|fill volume
5339465|NCT01997372|immunosuppressive treatment|immunosuppressive treatment
5339466|NCT01997372|cyclosporine|cyclosporine
5339467|NCT01997359|ART initiation|art initiation
5339468|NCT01997359|HIV|hiv
5339469|NCT01997359|AIDS|aids
5339470|NCT01997359|Ethiopia|ethiopia
5339471|NCT01997346|ART initiation|art initiation
5339472|NCT01997346|Ethiopia|ethiopia
5339473|NCT01997346|Clinic observation|clinic observation
5339474|NCT01997346|VCT observation|vct observation
5339475|NCT01997333|Metastatic Breast Cancer|metastatic breast cancer
5339476|NCT01997333|Locally advanced breast cancer|locally advanced breast cancer
5339477|NCT01997333|Breast cancer|breast cancer
5339478|NCT01997333|Triple negative|triple negative
5339479|NCT01997333|Estrogen|estrogen
5339480|NCT01997333|Progesterone|progesterone
5339481|NCT01997333|HER2 receptors|her2 receptors
5339482|NCT01997333|Targeted treatment for breast cancer|targeted treatment for breast cancer
5339483|NCT01997333|Antibody-drug-conjugate|antibody-drug-conjugate
5339484|NCT01997333|Breast Neoplasms|breast neoplasms
5339485|NCT01997333|CDX-011|cdx-011
5339486|NCT01997333|gpNMB|gpnmb
5339487|NCT01997333|METRIC|metric
5339488|NCT01997333|Glembatumumab vedotin|glembatumumab vedotin
5339489|NCT01997333|Triple Negative Breast Cancer|triple negative breast cancer
5339490|NCT01997333|TNBC|tnbc
5339491|NCT01997320|Sarcopenia|sarcopenia
5339492|NCT01997320|Frailty|frailty
5339493|NCT01997320|Strength|strength
5339494|NCT01997320|Protein supplementation|protein supplementation
5339495|NCT01997320|Ageing|ageing
5339496|NCT01997307|acute coronary syndrome, coronary arteriography, menopause|acute coronary syndrome, coronary arteriography, menopause
5339497|NCT01997294|sequential therapy|sequential therapy
5339498|NCT01997294|atorvastatin|atorvastatin
5339499|NCT01997294|acute myocardial infarction|acute myocardial infarction
5339500|NCT01997281|dietary fiber|dietary fiber
5339505|NCT01997268|Omega-3 Fatty Acids|omega-3 fatty acids
5339506|NCT01997268|Metabolic Diseases|metabolic diseases
5339507|NCT01997268|TG ≥500 mg/dL and ≤ 2,000 mg/dL|tg ≥500 mg/dl and ≤ 2,000 mg/dl
5339508|NCT01997255|Everolimus|everolimus
5339509|NCT01997255|Epilepsy|epilepsy
5339510|NCT01997255|Sturge Weber Syndrome|sturge weber syndrome
5339511|NCT01997255|Port wine stain|port wine stain
5339512|NCT01997255|Glaucoma|glaucoma
5339513|NCT01997242|CORONARY STENT|coronary stent
5339514|NCT01997242|CARDIAC SURGERY|cardiac surgery
5339515|NCT01997242|NON CARDIAC SURGEY|non cardiac surgey
5339516|NCT01997229|Myasthenia Gravis|myasthenia gravis
5339517|NCT01997229|Eculizumab|eculizumab
5339518|NCT01997229|safety|safety
5339519|NCT01997229|efficacy|efficacy
5339520|NCT01997216|contact lenses|contact lenses
5339521|NCT01997216|multifocal|multifocal
5339522|NCT01997203|hepatitis C infection|hepatitis c infection
5339523|NCT01997203|vitamin D|vitamin d
5339524|NCT01997190|Immunotherapy|immunotherapy
5339525|NCT01997190|Gene therapy|gene therapy
5339526|NCT01997190|Tumor vaccine|tumor vaccine
5339527|NCT01997177|simulation|simulation
5339528|NCT01997177|training|training
5339529|NCT01997177|colonoscopy|colonoscopy
5339530|NCT01997177|standard setting|standard setting
5339531|NCT01997138|pain, inflammation, surgery|pain, inflammation, surgery
5339532|NCT01997112|Blood pressure|blood pressure
5339533|NCT01997112|Hypertension|hypertension
5339534|NCT01997112|Paracetamol|paracetamol
5339535|NCT01997112|Acetaminophen|acetaminophen
5339536|NCT01997099|Drug Library|drug library
5339537|NCT01997099|Ambulatory Infusion Pump|ambulatory infusion pump
5339538|NCT01997099|Medication Safety Software|medication safety software
5339539|NCT01997099|CADD®-Solis VIP|cadd®-solis vip
5339540|NCT01997099|Pump Programming|pump programming
5339541|NCT01997099|Home Infusion Workflow|home infusion workflow
5339542|NCT01997073|Respiratory enthalpy|respiratory enthalpy
5339543|NCT01997073|One Lung Ventilation|one lung ventilation
5339544|NCT01997060|Lifestyle intervention|lifestyle intervention
5339546|NCT01997060|Body composition|body composition
5339547|NCT01997060|Weight loss maintenance|weight loss maintenance
5339548|NCT01997060|Physical activity|physical activity
5339549|NCT01997047|Pneumonia|pneumonia
5339550|NCT01997047|bronchiolitis|bronchiolitis
5339551|NCT01997047|asthma|asthma
5963375|NCT04249843|K-RAS|k-ras
5963376|NCT04249843|N-RAS|n-ras
5963377|NCT04249843|Mitogen Activated Protein Kinase (MAPK) Pathway|mitogen activated protein kinase (mapk) pathway
5963378|NCT04248634|Rectal neoplasmdelayed coloanal anastomosis|rectal neoplasmdelayed coloanal anastomosis
5339552|NCT01997047|children|children
5218879|NCT02629978|RFA|rfa
5339553|NCT01997047|tachypnea|tachypnea
5339554|NCT01997047|developing countries|developing countries
5339555|NCT01997047|diagnostic criteria|diagnostic criteria
5339556|NCT01997034|Weight loss maintenance|weight loss maintenance
5339557|NCT01997034|Body composition|body composition
5339558|NCT01997034|Physical activity|physical activity
5339559|NCT01997034|Lifestyle intervention|lifestyle intervention
5339560|NCT01997021|Sedentary behavior|sedentary behavior
5339561|NCT01997021|physical activity|physical activity
5339562|NCT01997021|older adults|older adults
5339563|NCT01996982|Induced therapeutic hypothermia|induced therapeutic hypothermia
5339564|NCT01996969|metastatic colorectal cancer|metastatic colorectal cancer
5339565|NCT01996969|refractory|refractory
5339566|NCT01996969|regorafenib|regorafenib
5339567|NCT01996969|biomarker|biomarker
5339568|NCT01996969|gene sequencing|gene sequencing
5339569|NCT01996956|stroke volume variation,|stroke volume variation,
5339570|NCT01996956|cardiac output,|cardiac output,
5339571|NCT01996956|fluid responsiveness,|fluid responsiveness,
5339572|NCT01996956|noninvasive cardiac output monitor|noninvasive cardiac output monitor
5339573|NCT01996943|Atrial Fibrillation|atrial fibrillation
5339574|NCT01996943|Alcohol|alcohol
5339575|NCT01996943|Electrophysiologic properties of the atria|electrophysiologic properties of the atria
5339576|NCT01996943|Randomized Clinical Study|randomized clinical study
5339577|NCT01996917|wound closure|wound closure
5339578|NCT01996917|prineo|prineo
5339579|NCT01996917|scar|scar
5339580|NCT01996904|subscapularis tear|subscapularis tear
5339581|NCT01996904|arthroscopic tendon repair|arthroscopic tendon repair
5339582|NCT01996904|arthroscopic tendon debridement|arthroscopic tendon debridement
5339583|NCT01996904|ASES|ases
5339584|NCT01996891|Asthma|asthma
5339585|NCT01996891|Nutrition|nutrition
5339586|NCT01996891|Anti-inflammatory diet|anti-inflammatory diet
5339587|NCT01996878|Parkinson's disease|parkinson's disease
5339588|NCT01996878|Genetic Polymorphism|genetic polymorphism
5339590|NCT01996852|Erectile dysfunction|erectile dysfunction
5339592|NCT01996852|Prostate|prostate
5339593|NCT01996852|Prostatectomy|prostatectomy
5458634|NCT01466907|outcome|outcome
5339594|NCT01996826|Corneal Neovascularization|corneal neovascularization
5339595|NCT01996826|Cornea Blood Vessels|cornea blood vessels
5234385|NCT02537769|Mild|mild
5339596|NCT01996826|Corneal Graft Failure|corneal graft failure
5339792|NCT01996085|impedance cardiography|impedance cardiography
5339597|NCT01996826|High-Risk Penetrating Keratoplasty|high-risk penetrating keratoplasty
5339598|NCT01996826|Corneal Transplant|corneal transplant
5339599|NCT01996813|arthroscopy|arthroscopy
5339600|NCT01996813|shoulder|shoulder
5339602|NCT01996813|beach chair|beach chair
5339603|NCT01996813|compression hose|compression hose
5339604|NCT01996787|visibility tinted silicone hydrogel contact lenses for daily wear|visibility tinted silicone hydrogel contact lenses for daily wear
5339605|NCT01996735|Endothelial function|endothelial function
5339606|NCT01996735|Adenosine receptor stimulation|adenosine receptor stimulation
5339607|NCT01996709|Silicone hydrogel contact lenses|silicone hydrogel contact lenses
5339608|NCT01996709|Multi-purpose solution|multi-purpose solution
5339609|NCT01996709|Lid Papillae|lid papillae
5339610|NCT01996709|Palpebral Roughness|palpebral roughness
5339611|NCT01996696|metformin|metformin
5339612|NCT01996696|metabolic syndrome|metabolic syndrome
5339613|NCT01996696|weight gain|weight gain
5339614|NCT01996683|B-thalassemia|b-thalassemia
5339615|NCT01996683|ferritin|ferritin
5339616|NCT01996657|mechanical valves replacement|mechanical valves replacement
5339617|NCT01996657|INR|inr
5339618|NCT01996657|D-dimer|d-dimer
5339619|NCT01996657|thromboembolic events|thromboembolic events
5339620|NCT01996644|Anorexia, Bulimia, Anxiety, Exposure|anorexia, bulimia, anxiety, exposure
5339621|NCT01996618|Premature Ventricular Beats|premature ventricular beats
5339622|NCT01996618|Premature Heart Beats|premature heart beats
5339623|NCT01996618|Ranolazine|ranolazine
5339624|NCT01996592|chronic pain|chronic pain
5339625|NCT01996592|cesarean section pain|cesarean section pain
5339628|NCT01996579|Nasogastric tube|nasogastric tube
5339630|NCT01996579|mechanically ventilated|mechanically ventilated
5339631|NCT01996579|nosocomially acquired infections|nosocomially acquired infections
5339632|NCT01996579|length of stay|length of stay
5339633|NCT01996579|lactoferrin|lactoferrin
5339634|NCT01996579|placebo controlled|placebo controlled
5339635|NCT01996579|antibiotic free days|antibiotic free days
5339636|NCT01996566|taste|taste
5339639|NCT01996566|sensitivity|sensitivity
5339640|NCT01996566|human|human
5339641|NCT01996553|blood flow, regional|blood flow, regional
5339642|NCT01996553|complications|complications
5339643|NCT01996553|disease, arterial obstructive|disease, arterial obstructive
5339644|NCT01996553|cardiac catheterization|cardiac catheterization
5339645|NCT01996553|radial artery|radial artery
5339646|NCT01996540|gastric neoplasm|gastric neoplasm
5339647|NCT01996540|pancreatic neoplasm|pancreatic neoplasm
5339648|NCT01996540|advanced|advanced
5339649|NCT01996540|palliative care|palliative care
5339650|NCT01996514|Children|children
5339651|NCT01996514|Food advertisement|food advertisement
5963379|NCT04248634|Ileostomy|ileostomy
5339652|NCT01996514|Obesity|obesity
5339653|NCT01996514|Television viewing|television viewing
5339654|NCT01996514|Food intake|food intake
5339655|NCT01996449|Hypertension|hypertension
5339656|NCT01996449|blood pressure|blood pressure
5339657|NCT01996449|Aldosterone|aldosterone
5339658|NCT01996449|Eplerenone|eplerenone
5339659|NCT01996449|Amlodipine|amlodipine
5339660|NCT01996449|Primary aldosteronism|primary aldosteronism
5339661|NCT01996449|Exercise pressor reflex|exercise pressor reflex
5339662|NCT01996449|handgrip exercise|handgrip exercise
5339663|NCT01996449|passive arm cycling|passive arm cycling
5339664|NCT01996449|active arm cycling|active arm cycling
5339665|NCT01996436|cerebral vasospasm|cerebral vasospasm
5339666|NCT01996436|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5339667|NCT01996436|intra arterial drug treatment for cerebral vasospasm|intra arterial drug treatment for cerebral vasospasm
5339668|NCT01996436|nicardipine milrinone nitroglycerin verapamil|nicardipine milrinone nitroglycerin verapamil
5339669|NCT01996423|Atopic dermatitis|atopic dermatitis
5339670|NCT01996423|vitamin D|vitamin d
5339671|NCT01996410|Breast Cancer|breast cancer
5339672|NCT01996410|Acupuncture|acupuncture
5339673|NCT01996410|Taxol|taxol
5339674|NCT01996410|Cytoxan|cytoxan
5339675|NCT01996410|Adriamycin|adriamycin
5339676|NCT01996410|Taxotere|taxotere
5339677|NCT01996410|Carboplatin|carboplatin
5339678|NCT01996410|Perjeta|perjeta
5339679|NCT01996410|Chemotherapy|chemotherapy
5339680|NCT01996410|Chemotherapy-induced nausea, vomiting|chemotherapy-induced nausea, vomiting
5339681|NCT01996410|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5339682|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (175 mg/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (175 mg/m2)
5339683|NCT01996410|Adriamycin (60 mg/m2), Cytoxan (600 mg/m2), Taxol (80 g/m2)|adriamycin (60 mg/m2), cytoxan (600 mg/m2), taxol (80 g/m2)
5672665|NCT00611286|Drug-eluting stent|drug-eluting stent
5339684|NCT01996410|Taxotere (75mg/m2), Cytoxan (600 mg/m2)|taxotere (75mg/m2), cytoxan (600 mg/m2)
5339685|NCT01996410|Taxotere (75 mg/m2), Carboplatin (AUC 6), Perjeta (840 mg loading fixed dose)|taxotere (75 mg/m2), carboplatin (auc 6), perjeta (840 mg loading fixed dose)
5339686|NCT01996397|Heart failure|heart failure
5339687|NCT01996397|Bundle branch block|bundle branch block
5339688|NCT01996397|CRT response|crt response
5339689|NCT01996384|Vulvodynia|vulvodynia
5339690|NCT01996384|Provoked, localized vulvodynia|provoked, localized vulvodynia
5339691|NCT01996384|vulvar vestibulitis|vulvar vestibulitis
5339692|NCT01996384|provoked vestibulodynia|provoked vestibulodynia
5339693|NCT01996384|vulvovaginal pain|vulvovaginal pain
5339694|NCT01996384|vulvar pain|vulvar pain
5339695|NCT01996384|vaginal pain|vaginal pain
5339696|NCT01996384|chronic pain|chronic pain
5339697|NCT01996384|lidocaine|lidocaine
5339698|NCT01996384|numbing agent|numbing agent
5339699|NCT01996384|anesthetic cream|anesthetic cream
5339700|NCT01996384|acupuncture|acupuncture
5339701|NCT01996384|electroacupuncture|electroacupuncture
5339702|NCT01996384|electrical stimulated acupuncture|electrical stimulated acupuncture
5339703|NCT01996384|manual acupuncture|manual acupuncture
5339704|NCT01996384|classical acupuncture|classical acupuncture
5339705|NCT01996384|non-classical acupuncture|non-classical acupuncture
5339706|NCT01996384|Traditional Chinese Medicine|traditional chinese medicine
5339708|NCT01996384|Chinese medicine|chinese medicine
5339709|NCT01996384|Acupuncture and Oriental Medicine|acupuncture and oriental medicine
5339710|NCT01996384|AOM|aom
5339711|NCT01996384|treatment|treatment
5339712|NCT01996384|feasibility|feasibility
5339713|NCT01996384|pilot study|pilot study
5339714|NCT01996384|Patient Reported Outcomes Measure Information System|patient reported outcomes measure information system
5339715|NCT01996384|Tampon Test|tampon test
5339716|NCT01996384|cotton swab test|cotton swab test
5339717|NCT01996384|pain diary|pain diary
5339718|NCT01996384|Research Electronic Data Capture|research electronic data capture
5339719|NCT01996384|REDCap|redcap
5339720|NCT01996358|Succinylcholine|succinylcholine
5339721|NCT01996358|Rocuronium|rocuronium
5339722|NCT01996358|Rigid Bronchoscopy|rigid bronchoscopy
5339723|NCT01996345|Placenta Previa|placenta previa
5339724|NCT01996345|Vaginal Pessary|vaginal pessary
5339725|NCT01996345|Premature Birth|premature birth
5339726|NCT01996319|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5339727|NCT01996319|COPD|copd
5339728|NCT01996306|AXEPT|axept
5339730|NCT01996306|CPT-11|cpt-11
5339731|NCT01996306|XELIRI|xeliri
5339732|NCT01996306|Bevacizumab|bevacizumab
5339733|NCT01996306|FOLFIRI|folfiri
5339734|NCT01996306|Capecitabine|capecitabine
5339735|NCT01996306|2nd-line metastatic colorectal cancer|2nd-line metastatic colorectal cancer
5339736|NCT01996293|pregnant|pregnant
5339737|NCT01996293|bipolar|bipolar
5339738|NCT01996293|lamotrigine|lamotrigine
5339739|NCT01996293|lamictal|lamictal
5339740|NCT01996293|women|women
5339741|NCT01996293|female|female
5339742|NCT01996267|neoadjuvant|neoadjuvant
5339743|NCT01996267|breast cancer|breast cancer
5339744|NCT01996267|HER2 positive|her2 positive
5339745|NCT01996254|electrical stimulation|electrical stimulation
5339746|NCT01996254|neurostimulation|neurostimulation
5339747|NCT01996254|neuromodulation|neuromodulation
5339748|NCT01996254|post-amputation pain|post-amputation pain
5339749|NCT01996254|phantom limb pain|phantom limb pain
5339750|NCT01996254|residual limb pain|residual limb pain
5339751|NCT01996254|neuropathic pain|neuropathic pain
5339752|NCT01996254|amputee pain|amputee pain
5339753|NCT01996241|adolescent girls|adolescent girls
5339754|NCT01996241|female sex work|female sex work
5339755|NCT01996241|age at marriage|age at marriage
5339756|NCT01996241|retention in school|retention in school
5339757|NCT01996241|sexual debut|sexual debut
5339758|NCT01996241|India|india
5339759|NCT01996241|Karnataka|karnataka
5339760|NCT01996228|Type 1 diabetes|type 1 diabetes
5339761|NCT01996228|autoimmune|autoimmune
5339762|NCT01996228|cord blood stem cell|cord blood stem cell
5339763|NCT01996228|stem cell educator|stem cell educator
5339764|NCT01996228|immune modulation|immune modulation
5339765|NCT01996228|children|children
5339766|NCT01996228|Control autoimmunity|control autoimmunity
5339767|NCT01996228|stimulate the regeneration of islet beta cells|stimulate the regeneration of islet beta cells
5339768|NCT01996202|Melanoma|melanoma
5339769|NCT01996176|Sedentary Lifestyle|sedentary lifestyle
5339770|NCT01996176|Sedentary work|sedentary work
5339771|NCT01996176|Office workers|office workers
5339772|NCT01996176|Work|work
5339773|NCT01996176|Workplace intervention|workplace intervention
5339774|NCT01996176|Sitting time|sitting time
5339775|NCT01996150|atopic dermatitis|atopic dermatitis
5339776|NCT01996150|eczema|eczema
5339777|NCT01996150|bleach bath|bleach bath
5339778|NCT01996150|itch|itch
5339779|NCT01996150|skin barrier|skin barrier
5339780|NCT01996150|staphylococcus aureus|staphylococcus aureus
5339781|NCT01996137|Stroke|stroke
5339782|NCT01996137|Treadmill|treadmill
5339783|NCT01996137|Gait Speed|gait speed
5339784|NCT01996124|COPD|copd
5339785|NCT01996124|Pulmonary Hyperinflation|pulmonary hyperinflation
5339786|NCT01996124|Ultra Long Acting Beta 2 Agonists|ultra long acting beta 2 agonists
5339787|NCT01996124|Cor Pulmonale|cor pulmonale
5339788|NCT01996124|Cardiac performance|cardiac performance
5339789|NCT01996111|plantar fasciitis|plantar fasciitis
5339790|NCT01996085|arterial hypertension|arterial hypertension
5339791|NCT01996085|hemodynamics|hemodynamics
5339793|NCT01996085|hypotensive therapy|hypotensive therapy
5339794|NCT01996072|Primary hyperparathyroidism|primary hyperparathyroidism
5234671|NCT02535884|DBS|dbs
5339795|NCT01996072|Parathyroid|parathyroid
5339796|NCT01996059|nutritional status|nutritional status
5339797|NCT01996059|functional jejunal interposition|functional jejunal interposition
5339798|NCT01996059|Roux-en-Y|roux-en-y
5339799|NCT01996059|gastrectomy|gastrectomy
5339800|NCT01996033|uncontrolled hypertension|uncontrolled hypertension
5339801|NCT01996033|Renal Denervation|renal denervation
5339802|NCT01996007|Pneumococcus|pneumococcus
5339803|NCT01996007|Carriage|carriage
5339804|NCT01996007|Children|children
5339805|NCT01996007|Parents|parents
5339806|NCT01996007|Immunogenicity|immunogenicity
5339807|NCT01996007|PCV13|pcv13
5339808|NCT01995981|Sarcoma, Soft Tissue|sarcoma, soft tissue
5339809|NCT01995981|Pazopanib|pazopanib
5339810|NCT01995981|Positron-Emission Tomography|positron-emission tomography
5339811|NCT01995981|Pharmacokinetics|pharmacokinetics
5339812|NCT01995981|Biomarker|biomarker
5339813|NCT01995968|Stillbirth|stillbirth
5339814|NCT01995968|Fetal growth restriction|fetal growth restriction
5339815|NCT01995968|Small for gestational age|small for gestational age
5339816|NCT01995968|Antenatal detection|antenatal detection
5339817|NCT01995968|Prenatal Care|prenatal care
5339818|NCT01995968|Mass Screening|mass screening
5339819|NCT01995955|Coronary Microvascular Dysfunction|coronary microvascular dysfunction
5339820|NCT01995955|coronary artery disease|coronary artery disease
5339821|NCT01995955|index of myocardial resistance|index of myocardial resistance
5339822|NCT01995942|Rectal Cancer|rectal cancer
5339824|NCT01995942|Extramural Venous Invasion|extramural venous invasion
5339825|NCT01995942|Microarray|microarray
5339826|NCT01995942|Biomarker|biomarker
5339827|NCT01995942|mrEMVI|mremvi
5339828|NCT01995942|Tumour Regression Grade|tumour regression grade
5339829|NCT01995942|Cancer|cancer
5339830|NCT01995942|Circumferential Resection Margin|circumferential resection margin
5339832|NCT01995942|MRI|mri
5339833|NCT01995942|Radiology|radiology
5339834|NCT01995942|Surgery|surgery
5339835|NCT01995942|Pathology|pathology
5339836|NCT01995929|neurogenic dysphagia|neurogenic dysphagia
5339837|NCT01995929|transnasal endoscopy|transnasal endoscopy
5339838|NCT01995929|functional endoscopy|functional endoscopy
5339839|NCT01995890|nepafenac eye drops|nepafenac eye drops
5339840|NCT01995890|intraocular pressure|intraocular pressure
5339841|NCT01995864|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5339842|NCT01995864|Community Psychiatry|community psychiatry
5339843|NCT01995851|Influenza|influenza
5339844|NCT01995851|Vaccine|vaccine
5339845|NCT01995838|Chronic Insomnia|chronic insomnia
5339846|NCT01995838|Adults|adults
5339847|NCT01995838|Elderly|elderly
5339848|NCT01995825|bioequivalence|bioequivalence
5339849|NCT01995825|lamotrigine|lamotrigine
5339850|NCT01995825|epilepsy|epilepsy
5339851|NCT01995799|Myocardial Infarction (and related inflammation)|myocardial infarction (and related inflammation)
5339852|NCT01995786|Fluid Therapy|fluid therapy
5339853|NCT01995786|Cost-Benefit Analysis|cost-benefit analysis
5339854|NCT01995786|Hemodynamics|hemodynamics
5339855|NCT01995786|Cost Control|cost control
5339856|NCT01995773|Healthy women|healthy women
5339857|NCT01995773|Quality of life|quality of life
5339858|NCT01995773|Glucose metabolism|glucose metabolism
5339859|NCT01995773|Adrenal reactivity|adrenal reactivity
5339860|NCT01995773|Physical activity|physical activity
5339861|NCT01995773|Body Composition|body composition
5339862|NCT01995760|vancomycin|vancomycin
5339863|NCT01995760|therapeutic response monitoring|therapeutic response monitoring
5339864|NCT01995760|AUC/MIC|auc/mic
5339866|NCT01995747|Atopic Dermatitis|atopic dermatitis
5339867|NCT01995747|antibody|antibody
5339868|NCT01995747|allergy|allergy
5339869|NCT01995734|Acromegaly, Pituitary diseases|acromegaly, pituitary diseases
5339870|NCT01995721|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5339871|NCT01995721|human papillomavirus|human papillomavirus
5339872|NCT01995721|vaccine|vaccine
5339873|NCT01995721|treatment|treatment
5339874|NCT01995721|immunology|immunology
5339875|NCT01995721|relapse|relapse
5339876|NCT01995708|CT7|ct7
5339877|NCT01995708|MAGE-A3|mage-a3
5339878|NCT01995708|WT1 mRNA-electroporated Autologous Langerhans|wt1 mrna-electroporated autologous langerhans
5339879|NCT01995708|vaccine|vaccine
5339880|NCT01995708|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5339881|NCT01995708|13-009|13-009
5339882|NCT01995682|Independent living|independent living
5339883|NCT01995682|walk with or without walking aids|walk with or without walking aids
5339884|NCT01995643|Grape seed extract|grape seed extract
5339885|NCT01995643|Polyphenols|polyphenols
5339887|NCT01995643|Oxidative stress Marker|oxidative stress marker
5339888|NCT01995643|Inflammatory marker|inflammatory marker
5339889|NCT01995643|Healthy human|healthy human
5339890|NCT01995617|vaccine|vaccine
5339891|NCT01995617|Streptococcus pneumoniae|streptococcus pneumoniae
5339892|NCT01995617|Strep pneumo|strep pneumo
5339893|NCT01995591|colon cancer|colon cancer
5339894|NCT01995591|sentinel lymph node|sentinel lymph node
5339895|NCT01995591|Indocyanine Green|indocyanine green
5339896|NCT01995578|5'-Azacitidine|5'-azacitidine
5339897|NCT01995578|Stem cell transplant|stem cell transplant
5339898|NCT01995578|13-192|13-192
5339899|NCT01995552|Post myocardial infarction patients with low EF.|post myocardial infarction patients with low ef.
5339900|NCT01995539|Type 2|type 2
5339901|NCT01995500|CAD|cad
5339902|NCT01995500|PCI|pci
5339903|NCT01995500|ACS|acs
5339904|NCT01995500|non ACS|non acs
5339905|NCT01995500|BioNIR|bionir
5339906|NCT01995500|DES|des
5339907|NCT01995487|more comers|more comers
5339908|NCT01995487|DES|des
5339909|NCT01995487|BioNIR|bionir
5339910|NCT01995487|ACS|acs
5339911|NCT01995487|non ACS|non acs
5339912|NCT01995487|complex lesions|complex lesions
5339913|NCT01995474|EUS|eus
5339914|NCT01995474|pancreatic cancer|pancreatic cancer
5339915|NCT01995474|cytology|cytology
5339916|NCT01995474|fine needle aspiration|fine needle aspiration
5339917|NCT01995448|The acute phase of Sepsis|the acute phase of sepsis
5339918|NCT01995448|multiparameter 8-color flow cytometry|multiparameter 8-color flow cytometry
5339919|NCT01995422|Major depressive disorder|major depressive disorder
5339920|NCT01995422|Follow-up study|follow-up study
5339921|NCT01995422|Ecological momentary assessment|ecological momentary assessment
5339922|NCT01995422|Physical activity|physical activity
5339923|NCT01995422|Depression|depression
5339926|NCT01995422|Rumination|rumination
5339927|NCT01995422|Quality of life|quality of life
5339928|NCT01995396|rectal cancer,|rectal cancer,
5339929|NCT01995396|fecal incontinence,|fecal incontinence,
5339930|NCT01995396|severe co-morbidity,|severe co-morbidity,
5339931|NCT01995396|Hartmann´s procedure,|hartmann´s procedure,
5339932|NCT01995396|abdominoperineal excision with intersphincteric dissection,|abdominoperineal excision with intersphincteric dissection,
5339933|NCT01995396|postoperative complications,|postoperative complications,
5339934|NCT01995396|pelvic abscess,|pelvic abscess,
5339935|NCT01995396|perineal infections|perineal infections
5339936|NCT01995370|Noncardioembolic cerebral infarction|noncardioembolic cerebral infarction
5339937|NCT01995370|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
5339938|NCT01995370|Cilostazol|cilostazol
5339940|NCT01995370|Clopidogrel|clopidogrel
5339941|NCT01995331|aplastic anemia;|aplastic anemia;
5339942|NCT01995331|cyclophosphamide;|cyclophosphamide;
5339943|NCT01995331|immunosuppressive therapy;|immunosuppressive therapy;
5339944|NCT01995331|cyclosporine A|cyclosporine a
5339945|NCT01995318|Kinesiotaping|kinesiotaping
5339946|NCT01995305|fanconi anemia|fanconi anemia
5339947|NCT01995305|hematopoiesis maintainance|hematopoiesis maintainance
5339948|NCT01995292|awake fiberoptic intubation|awake fiberoptic intubation
5339949|NCT01995292|spray as you go technique|spray as you go technique
5339950|NCT01995292|anesthesia|anesthesia
5339951|NCT01995292|Enk Fiberoptic Atomizer Set|enk fiberoptic atomizer set
5339953|NCT01995279|French Auriculotherapy|french auriculotherapy
5339954|NCT01995279|postural control|postural control
5339955|NCT01995279|balance|balance
5339956|NCT01995279|posture|posture
5339957|NCT01995240|pancreatic cancer|pancreatic cancer
5339958|NCT01995240|MRI|mri
5339959|NCT01995240|reproducibility|reproducibility
5339960|NCT01995240|optimalization|optimalization
5339961|NCT01995227|liver cancer|liver cancer
5339962|NCT01995227|HCC|hcc
5339963|NCT01995227|tumor vaccine|tumor vaccine
5339964|NCT01995227|immunotherapy|immunotherapy
5339965|NCT01995227|personalized anti-cancer vaccine|personalized anti-cancer vaccine
5339966|NCT01995214|Postoperative delirium|postoperative delirium
5339967|NCT01995214|Geriatric|geriatric
5339968|NCT01995214|General anesthesia|general anesthesia
5339969|NCT01995214|Propofol|propofol
5339970|NCT01995214|Sevoflurane|sevoflurane
5339971|NCT01995175|Asthma|asthma
5339972|NCT01995175|Respiratory Syncytial virus|respiratory syncytial virus
5339973|NCT01995175|Cohort study|cohort study
5339974|NCT01995175|Quarterly phone contacts|quarterly phone contacts
5339975|NCT01995175|Wheeze|wheeze
5339976|NCT01995175|New born|new born
5339977|NCT01995175|Lower Respiratory Tract Infection|lower respiratory tract infection
5339978|NCT01995149|Familial Hypercholesterolemia|familial hypercholesterolemia
5339979|NCT01995149|Familial Combined Hypercholesterolemia|familial combined hypercholesterolemia
5339980|NCT01995149|Weight loss; Lipids; Phytosterols|weight loss; lipids; phytosterols
5339981|NCT01995149|Obesity|obesity
5339982|NCT01995149|Overweight.|overweight.
5339983|NCT01995149|Lipids|lipids
5339984|NCT01995136|Glaucoma|glaucoma
5339985|NCT01995136|Ocular hypertension|ocular hypertension
5339986|NCT01995123|Tobacco dependence|tobacco dependence
5339987|NCT01995123|PTSD|ptsd
5339988|NCT01995123|Behavioral Activation Therapy|behavioral activation therapy
5339989|NCT01995097|smoking cessation|smoking cessation
5339990|NCT01995097|smoking reduction|smoking reduction
5339991|NCT01995097|scheduled gradual reduction|scheduled gradual reduction
5339992|NCT01995097|pregnancy|pregnancy
5339993|NCT01995097|text message intervention|text message intervention
5339994|NCT01995084|hypoxia|hypoxia
5339998|NCT01995071|Chronic Hepatitis C|chronic hepatitis c
5339999|NCT01995071|Cirrhosis|cirrhosis
5340000|NCT01995071|Child Pugh A|child pugh a
5340001|NCT01995071|Hepatitis C virus|hepatitis c virus
5442361|NCT01535235|HIV|hiv
5340002|NCT01995071|Compensated Cirrhosis|compensated cirrhosis
5234781|NCT02534870|Volunteer|volunteer
5340003|NCT01995071|Hepatitis C Genotype 1|hepatitis c genotype 1
5340004|NCT01995071|Hepatitis C|hepatitis c
5340005|NCT01995071|Interferon-Free|interferon-free
5340006|NCT01995071|Cirrhotic|cirrhotic
5340007|NCT01995058|CRPC|crpc
5340008|NCT01995058|castration resistant prostate cancer|castration resistant prostate cancer
5340009|NCT01995058|prostate cancer|prostate cancer
5340010|NCT01995045|Retina|retina
5340011|NCT01995045|Vitreoretinal|vitreoretinal
5340012|NCT01995045|Surgery|surgery
5340013|NCT01995032|Duchenne's muscular dystrophy|duchenne's muscular dystrophy
5340015|NCT01995019|Arthralgia|arthralgia
5340016|NCT01995019|Temporomandibular joint|temporomandibular joint
5340017|NCT01995019|corticosteroids|corticosteroids
5340018|NCT01995019|injection|injection
5340019|NCT01995019|intra-articular|intra-articular
5340020|NCT01995006|Effect|effect
5340021|NCT01995006|metamizole|metamizole
5340022|NCT01995006|salt-depleted|salt-depleted
5340023|NCT01995006|subjects|subjects
5340024|NCT01994993|Antibiotics|antibiotics
5340025|NCT01994993|ampicillin|ampicillin
5340026|NCT01994993|metronidazole|metronidazole
5340027|NCT01994993|clindamycin|clindamycin
5340028|NCT01994993|piperacillin-tazobactam|piperacillin-tazobactam
5340029|NCT01994993|Safety|safety
5340030|NCT01994993|Infants|infants
5340031|NCT01994993|Intra abdominal infections|intra abdominal infections
5340032|NCT01994967|Phase III|phase iii
5340033|NCT01994967|Noninferiority|noninferiority
5340034|NCT01994967|Controlled|controlled
5340035|NCT01994967|Double-blind|double-blind
5340036|NCT01994967|Randomized|randomized
5340037|NCT01994967|Spinal|spinal
5340038|NCT01994967|Anesthetic|anesthetic
5340039|NCT01994967|Lower limb|lower limb
5340040|NCT01994954|newborn intensive care unit|newborn intensive care unit
5340041|NCT01994954|NICU|nicu
5340042|NCT01994954|supplemental oxygen|supplemental oxygen
5340043|NCT01994941|Acute Coronary Syndrome|acute coronary syndrome
5340045|NCT01994941|P2Y12 Receptor Blocker|p2y12 receptor blocker
5340046|NCT01994941|CYP2C19 Genotyping|cyp2c19 genotyping
5340047|NCT01994915|exacerbation|exacerbation
5340048|NCT01994915|functionality|functionality
5340049|NCT01994915|occupational therapy|occupational therapy
5340050|NCT01994915|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5340051|NCT01994889|amyloidosis|amyloidosis
5340052|NCT01994889|amyloid|amyloid
5340053|NCT01994889|transthyretin|transthyretin
5340054|NCT01994889|TTR|ttr
5340055|NCT01994837|GDC-0199|gdc-0199
5340056|NCT01994837|Acute Myelogenous Leukemia|acute myelogenous leukemia
5340057|NCT01994837|AML|aml
5340058|NCT01994837|ABT-199|abt-199
5340059|NCT01994837|Acute Myeloid Leukemia|acute myeloid leukemia
5340060|NCT01994837|Myeloid Leukemia|myeloid leukemia
5340061|NCT01994811|cancer|cancer
5340062|NCT01994811|cardiovascular disease|cardiovascular disease
5340063|NCT01994811|diabetes|diabetes
5340064|NCT01994785|Sedation|sedation
5340065|NCT01994785|Endoscopy|endoscopy
5340066|NCT01994785|Capnography|capnography
5340067|NCT01994772|Therapeutic hypothermia|therapeutic hypothermia
5340068|NCT01994772|Targeted controlled temperature|targeted controlled temperature
5340069|NCT01994772|Cardiac arrest|cardiac arrest
5340070|NCT01994772|Non shockable rhythm|non shockable rhythm
5340071|NCT01994772|successful resuscitation|successful resuscitation
5340072|NCT01994759|Plantar fasciitis|plantar fasciitis
5340073|NCT01994759|Treatment|treatment
5340074|NCT01994759|Training|training
5340075|NCT01994759|Glucocorticosteroid injection|glucocorticosteroid injection
5340076|NCT01994733|end-stage renal disease|end-stage renal disease
5340077|NCT01994733|hemodialysis|hemodialysis
5340078|NCT01994733|mineral metabolism|mineral metabolism
5340079|NCT01994733|serum phosphate|serum phosphate
5340080|NCT01994733|phosphate binders|phosphate binders
5340081|NCT01994720|Acute ischaemic stroke.|acute ischaemic stroke.
5340082|NCT01994720|Transient ischaemic attack.|transient ischaemic attack.
5340083|NCT01994707|Remote ischemic preconditioning|remote ischemic preconditioning
5340209|NCT01994148|Laparoscopy|laparoscopy
5340084|NCT01994707|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5340085|NCT01994707|Troponin T|troponin t
5340086|NCT01994707|Apoptosis|apoptosis
5340087|NCT01994707|Experimental|experimental
5340088|NCT01994707|Cardioprotection|cardioprotection
5340089|NCT01994668|lorazepam|lorazepam
5340090|NCT01994668|intravenous|intravenous
5340091|NCT01994668|pharmacolinetics|pharmacolinetics
5340092|NCT01994668|healthy|healthy
5340093|NCT01994668|Japanese|japanese
5340094|NCT01994655|climacteric symptoms|climacteric symptoms
5340095|NCT01994655|menopause|menopause
5340096|NCT01994655|nurses|nurses
5340097|NCT01994629|meningococcal disease|meningococcal disease
5340098|NCT01994629|children|children
5340099|NCT01994629|vaccination|vaccination
5340100|NCT01994616|Keloid, hypertrophic scar|keloid, hypertrophic scar
5340101|NCT01994603|Prevention|prevention
5340102|NCT01994603|HIV|hiv
5340103|NCT01994603|AIDS|aids
5326600|NCT02055079|PKD|pkd
5340104|NCT01994603|Fetal Alcohol Syndrome (FAS)|fetal alcohol syndrome (fas)
5340105|NCT01994603|Alcohol Related Neurodevelopmental Disorder (ARND)|alcohol related neurodevelopmental disorder (arnd)
5340106|NCT01994590|Prostate Cancer|prostate cancer
5340107|NCT01994590|Metastatic Castrate-Resistant Prostate Cancer|metastatic castrate-resistant prostate cancer
5340108|NCT01994590|mCRPC|mcrpc
5340109|NCT01994590|Dovitinib|dovitinib
5340110|NCT01994590|TKI258|tki258
5340111|NCT01994590|Abiraterone Acetate|abiraterone acetate
5340112|NCT01994590|Zytiga|zytiga
5340113|NCT01994590|Prednisone|prednisone
5340114|NCT01994577|Emergency Department|emergency department
5340115|NCT01994577|Cardiac troponin|cardiac troponin
5340116|NCT01994577|Myocardial infarction|myocardial infarction
5340117|NCT01994564|OAG|oag
5340118|NCT01994538|Urinary Tract Infections|urinary tract infections
5340119|NCT01994538|Urinary antiinfective agents|urinary antiinfective agents
5340120|NCT01994512|Spinal stenosis|spinal stenosis
5340121|NCT01994512|Decompression|decompression
5340122|NCT01994512|Fusion|fusion
5340123|NCT01994512|Olisthesis|olisthesis
5340124|NCT01994486|HCV Genotype 1|hcv genotype 1
5340125|NCT01994486|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
5340126|NCT01994486|HCV|hcv
5340127|NCT01994486|TVR|tvr
5340128|NCT01994473|Schizophrenia|schizophrenia
5340129|NCT01994460|Tuberculosis|tuberculosis
5340130|NCT01994447|Informed Consent|informed consent
5340131|NCT01994447|Instructional Films and Video|instructional films and video
5340132|NCT01994447|Consent Comprehension|consent comprehension
5340133|NCT01994447|Multimedia Consent|multimedia consent
5340134|NCT01994447|Parent|parent
5340135|NCT01994434|Deep branch of the ulnar nerve|deep branch of the ulnar nerve
5340136|NCT01994434|Distal ulnar nerve compression|distal ulnar nerve compression
5340137|NCT01994421|Facilitating kinesiotape|facilitating kinesiotape
5340138|NCT01994421|Inhibiting kinesiotape|inhibiting kinesiotape
5340139|NCT01994421|Classical tape|classical tape
5340140|NCT01994421|No tape|no tape
5340141|NCT01994408|physician inertia|physician inertia
5340142|NCT01994408|hypertension|hypertension
5340143|NCT01994408|telemedicine|telemedicine
5340144|NCT01994408|mobile technology|mobile technology
5340145|NCT01994395|Stroke|stroke
5340146|NCT01994395|Gait|gait
5340147|NCT01994395|Stride Management Assist|stride management assist
5340148|NCT01994395|Mild-moderate Stroke, post 30 days or longer|mild-moderate stroke, post 30 days or longer
5340149|NCT01994382|Leukemia|leukemia
5340150|NCT01994382|Lymphocytic|lymphocytic
5340151|NCT01994382|Chronic|chronic
5340152|NCT01994382|B Cell|b cell
5340153|NCT01994369|Breast Cancer|breast cancer
5340154|NCT01994356|Contraceptive counseling|contraceptive counseling
5340155|NCT01994356|Physician self disclosure|physician self disclosure
5340156|NCT01994356|Satisfaction|satisfaction
5340157|NCT01994356|Intrauterine contraceptive use|intrauterine contraceptive use
5340158|NCT01994343|Chronic pelvic pain, women, pain, posture.|chronic pelvic pain, women, pain, posture.
5340159|NCT01994330|acquired von Willebrand disease|acquired von willebrand disease
5340160|NCT01994330|severe aortic stenosis|severe aortic stenosis
5340161|NCT01994330|Heye´s syndrome|heye´s syndrome
5340162|NCT01994330|desmopressin|desmopressin
5340163|NCT01994330|von Willebrand multimers|von willebrand multimers
5340164|NCT01994304|Safe Childbirth Checklist|safe childbirth checklist
5340165|NCT01994304|Intrapartum mortality, Quality of Institutional delivery care|intrapartum mortality, quality of institutional delivery care
5340166|NCT01994304|Maternal & newborn care practices|maternal & newborn care practices
5340167|NCT01994291|Chemokine Antagonist|chemokine antagonist
5340168|NCT01994291|Diabetic Macular Edema|diabetic macular edema
5340169|NCT01994291|Diabetes|diabetes
5340170|NCT01994291|Diabetes Mellitus|diabetes mellitus
5340171|NCT01994291|Macular Edema|macular edema
5340172|NCT01994291|Diabetic Retinopathy|diabetic retinopathy
5340173|NCT01994291|Anti-VEGF|anti-vegf
5340174|NCT01994265|Atrial fibrillation|atrial fibrillation
5340175|NCT01994265|Cognition|cognition
5340176|NCT01994265|Cognitive impairment|cognitive impairment
5340177|NCT01994265|Anticoagulation|anticoagulation
5340178|NCT01994265|Dabigatran|dabigatran
5340179|NCT01994265|Warfarin|warfarin
5340180|NCT01994265|Efficacy|efficacy
5340181|NCT01994252|defibrillator|defibrillator
5340182|NCT01994252|cardiac resynchronization|cardiac resynchronization
5340183|NCT01994239|Prostate-Specific Antigen|prostate-specific antigen
5340184|NCT01994239|LHRH antagonist|lhrh antagonist
5340185|NCT01994239|Radiotherapy|radiotherapy
5340186|NCT01994213|Famitinib|famitinib
5340187|NCT01994213|Gastroenteropancreatic Neuroendocrine Tumor|gastroenteropancreatic neuroendocrine tumor
5340188|NCT01994213|GEPNET|gepnet
5340189|NCT01994200|Thyroid cancer|thyroid cancer
5340190|NCT01994200|New diagnosis|new diagnosis
5340191|NCT01994200|Dedicated Nurse|dedicated nurse
5340192|NCT01994200|Interdisciplinary team|interdisciplinary team
5340193|NCT01994200|Randomized Controlled Trial|randomized controlled trial
5340194|NCT01994200|Intervention|intervention
5340195|NCT01994200|Supportive care|supportive care
5340196|NCT01994187|Carotid stenosis|carotid stenosis
5340197|NCT01994187|Angioplasty|angioplasty
5340198|NCT01994187|Carotid endarterectomy|carotid endarterectomy
5340199|NCT01994187|Stroke|stroke
5340200|NCT01994174|vascular|vascular
5340201|NCT01994174|retina|retina
5340202|NCT01994174|Anti-VEGF|anti-vegf
5340203|NCT01994174|Aqueous humor dynamics|aqueous humor dynamics
5340204|NCT01994161|ischemic stroke|ischemic stroke
5340205|NCT01994161|intracranial stenting|intracranial stenting
5340206|NCT01994161|vascular risk factor management|vascular risk factor management
5340207|NCT01994148|Trauma|trauma
5340208|NCT01994148|Gastrointestinal injury|gastrointestinal injury
5340210|NCT01994109|Sialorrhea|sialorrhea
5340211|NCT01994109|Parkinson's disease|parkinson's disease
5340212|NCT01994109|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5340213|NCT01994109|stroke|stroke
5340214|NCT01994109|neuroleptics|neuroleptics
5340215|NCT01994057|Non-small cell lung cancer (NSCLC);|non-small cell lung cancer (nsclc);
5340216|NCT01994057|EGFR-TKI;|egfr-tki;
5340217|NCT01994057|Pharmacogenetics;|pharmacogenetics;
5340218|NCT01994057|Precision medicine|precision medicine
5340219|NCT01994057|somatic mutations ,germline mutations;|somatic mutations ,germline mutations;
5340220|NCT01994044|Whiplash, surgery, multimodal rehabilitation, independent examiners|whiplash, surgery, multimodal rehabilitation, independent examiners
5340221|NCT01994031|paclitaxel liposome injection|paclitaxel liposome injection
5340222|NCT01994031|paclitaxel|paclitaxel
5340223|NCT01994018|Vitamin D|vitamin d
5340224|NCT01994018|Interferon Beta|interferon beta
5340225|NCT01994018|Glatiramer Acetate|glatiramer acetate
5340226|NCT01994018|Relapse rates|relapse rates
5340227|NCT01993992|Anesthesia|anesthesia
5340228|NCT01993979|Adjuvant chemotherapy|adjuvant chemotherapy
5340229|NCT01993979|Surveillance|surveillance
5340230|NCT01993979|Nephro-ureterectomy|nephro-ureterectomy
5340231|NCT01993966|Urothelial carcinoma (UC),|urothelial carcinoma (uc),
5340232|NCT01993966|(-)-epigallocatechin-3-gallate(EGCG),|(-)-epigallocatechin-3-gallate(egcg),
5340233|NCT01993966|chemotherapy,|chemotherapy,
5340234|NCT01993966|cytotoxicity,|cytotoxicity,
5340235|NCT01993966|drug resistance,|drug resistance,
5340236|NCT01993966|xenograft.|xenograft.
5340237|NCT01993953|Muscle strength|muscle strength
5340239|NCT01993953|Body weight|body weight
5340240|NCT01993953|Resistance training|resistance training
5340241|NCT01993953|Personal training|personal training
5340242|NCT01993953|BodyPump|bodypump
5340243|NCT01993940|Opioid-induced Constipation|opioid-induced constipation
5340244|NCT01993927|Drug Therapy|drug therapy
5340245|NCT01993901|lung SBRT, ESAS, anxiety|lung sbrt, esas, anxiety
5340246|NCT01993888|Hepatobiliary Surgery|hepatobiliary surgery
5340248|NCT01993849|Impulse control|impulse control
5340249|NCT01993849|Depression|depression
5340251|NCT01993849|Fingernail Biting|fingernail biting
5340252|NCT01993849|N-Acetylcysteine|n-acetylcysteine
5340253|NCT01993849|NAC|nac
5340254|NCT01993836|isoflurane|isoflurane
5340255|NCT01993836|propofol|propofol
5340256|NCT01993836|total intravenous anesthesia|total intravenous anesthesia
5340257|NCT01993836|inhaled anesthetic|inhaled anesthetic
5340258|NCT01993836|volatile anesthetic|volatile anesthetic
5340259|NCT01993836|anesthesia|anesthesia
5340260|NCT01993836|delirium|delirium
5340261|NCT01993836|Post Operative Cognitive Dysfunction|post operative cognitive dysfunction
5340262|NCT01993836|Alzheimer's Disease|alzheimer's disease
5340263|NCT01993836|Mild Cognitive Impairment|mild cognitive impairment
5340264|NCT01993797|Bronchiolitis|bronchiolitis
5340265|NCT01993758|tourniquet pressure|tourniquet pressure
5340266|NCT01993758|total knee arthroplasty|total knee arthroplasty
5340267|NCT01993745|ECMO|ecmo
5340268|NCT01993745|APACH II score|apach ii score
5340269|NCT01993732|Cancer|cancer
5340270|NCT01993732|Cryopreservation|cryopreservation
5340271|NCT01993732|Ovarian Function|ovarian function
5340272|NCT01993732|In Vitro|in vitro
5340273|NCT01993719|Melanoma|melanoma
5340274|NCT01993719|Adoptive Cell Therapy|adoptive cell therapy
5340275|NCT01993706|Broadly HIV-1 Neutralizing Activity|broadly hiv-1 neutralizing activity
5340276|NCT01993706|Healthy Adults|healthy adults
5340277|NCT01993706|Placebo|placebo
5340278|NCT01993706|HIV Prevention|hiv prevention
5340279|NCT01993706|Monoclonal Antibodies|monoclonal antibodies
5340280|NCT01993706|Antibodies|antibodies
5340281|NCT01993693|knee|knee
5340282|NCT01993693|pain|pain
5340283|NCT01993693|osteoarthritis|osteoarthritis
5340284|NCT01993693|ultrasound|ultrasound
5459486|NCT01463475|MSC|msc
5340285|NCT01993654|Pigmented Lesions|pigmented lesions
5340286|NCT01993654|PAM|pam
5340287|NCT01993654|Ocular lesion|ocular lesion
5340288|NCT01993641|Myelodysplastic Syndrome|myelodysplastic syndrome
5340289|NCT01993641|MDS|mds
5340290|NCT01993641|pracinostat|pracinostat
5340291|NCT01993641|Hypomethylating Agent|hypomethylating agent
5340292|NCT01993641|HMA|hma
5340293|NCT01993641|azacitadine|azacitadine
5340294|NCT01993641|Vidaza|vidaza
5340295|NCT01993641|decitabine|decitabine
5340296|NCT01993641|dacogen|dacogen
5340297|NCT01993615|FAI|fai
5326743|NCT02054416|AKA|aka
5340298|NCT01993615|femoroacetabular impingement|femoroacetabular impingement
5340299|NCT01993615|hip pain|hip pain
5340300|NCT01993615|hip arthroscopy|hip arthroscopy
5340301|NCT01993615|physical therapy|physical therapy
5340302|NCT01993602|general surgery|general surgery
5340303|NCT01993602|postoperative care|postoperative care
5340304|NCT01993602|breathing exercises|breathing exercises
5340305|NCT01993602|respiratory muscle|respiratory muscle
5235118|NCT02532764|CFTR|cftr
5340306|NCT01993602|postoperative complications|postoperative complications
5340307|NCT01993602|lung volume measurements|lung volume measurements
5340308|NCT01993602|pulmonary ventilations|pulmonary ventilations
5340309|NCT01993602|thoracic wall|thoracic wall
5340310|NCT01993589|Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.|curettage; analgesia; paracetamol; lidocaine; dexketoprofen trometamol; pethidine; diclofenac.
5340311|NCT01993563|Stroke|stroke
5340312|NCT01993563|Rehabilitation|rehabilitation
5340313|NCT01993563|Motor Imagery|motor imagery
5340314|NCT01993563|Upper Extremity|upper extremity
5340315|NCT01993563|Mirror Therapy|mirror therapy
5340316|NCT01993550|lung cancer|lung cancer
5340317|NCT01993550|family caregiving|family caregiving
5340318|NCT01993550|behavioral intervention|behavioral intervention
5340319|NCT01993550|counseling|counseling
5340320|NCT01993550|symptom management|symptom management
5340321|NCT01993498|cancer toxicities|cancer toxicities
5340322|NCT01993498|cohort|cohort
5340323|NCT01993498|breast cancer|breast cancer
5340324|NCT01993485|transaortic valve replacement (TAVI)|transaortic valve replacement (tavi)
5340325|NCT01993485|endothelial function|endothelial function
5340326|NCT01993485|circulating microparticles|circulating microparticles
5340327|NCT01993459|Quality of Recovery|quality of recovery
5340328|NCT01993394|human centrifuge, oxygen, imaging, stroke volume, lung|human centrifuge, oxygen, imaging, stroke volume, lung
5340329|NCT01993381|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5340330|NCT01993368|wisdom teeth extraction|wisdom teeth extraction
5340331|NCT01993355|non-specific chronic low back pain,|non-specific chronic low back pain,
5340332|NCT01993355|health-related quality of life,|health-related quality of life,
5340333|NCT01993355|physioterapy,|physioterapy,
5340334|NCT01993355|sophrology,|sophrology,
5340336|NCT01993355|motivational interviewing|motivational interviewing
5340337|NCT01993342|adipocytokines|adipocytokines
5340338|NCT01993342|osteoarthritis|osteoarthritis
5340339|NCT01993342|inflammation|inflammation
5340340|NCT01993342|ultrasonography|ultrasonography
5340341|NCT01993316|neurofeedback|neurofeedback
5340343|NCT01993316|transcranial magnetic stimulation|transcranial magnetic stimulation
5340344|NCT01993303|Myocardial Perfusion Imaging|myocardial perfusion imaging
5340345|NCT01993303|PET|pet
5340346|NCT01993303|Rb-82|rb-82
5340347|NCT01993264|Heart disease|heart disease
5340348|NCT01993264|Echocardiogram|echocardiogram
5340349|NCT01993264|Ultrasound|ultrasound
5340350|NCT01993264|Heart defect|heart defect
5340351|NCT01993264|Heart Dysfunction|heart dysfunction
5340352|NCT01993264|Pediatric Cardiologists|pediatric cardiologists
5340353|NCT01993264|Prenatal|prenatal
5340354|NCT01993251|sleep,melatonin,autism,children|sleep,melatonin,autism,children
5340355|NCT01993225|Low Testosterone|low testosterone
5340356|NCT01993212|Low Testosterone|low testosterone
5340357|NCT01993186|Glucose Transporter Type 1 Deficiency Syndrome Glut1|glucose transporter type 1 deficiency syndrome glut1
5340358|NCT01993173|Diphtheria|diphtheria
5340359|NCT01993173|Tetanus|tetanus
5340360|NCT01993173|Pertussis|pertussis
5340361|NCT01993173|ADACEL®|adacel®
5340362|NCT01993173|Tdap vaccine|tdap vaccine
5340363|NCT01993160|Fluorocholine (FCH)|fluorocholine (fch)
5340364|NCT01993160|Positron emission tomography (PET)|positron emission tomography (pet)
5340365|NCT01993160|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5340366|NCT01993147|Methylphenidate|methylphenidate
5340367|NCT01993147|Placebo|placebo
5340368|NCT01993147|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5340369|NCT01993147|Attention Control|attention control
5340370|NCT01993134|Postoperative infection|postoperative infection
5340371|NCT01993134|Antibiotic prophylaxis|antibiotic prophylaxis
5340372|NCT01993134|Cefazolin|cefazolin
5340373|NCT01993121|diabetes|diabetes
5340374|NCT01993121|exercise|exercise
5340375|NCT01993121|heart|heart
5340376|NCT01993121|cardiovascular|cardiovascular
5340377|NCT01993108|Methylphenidate|methylphenidate
5340378|NCT01993108|Naltrexone|naltrexone
5340379|NCT01993108|Placebo|placebo
5340380|NCT01993108|Neuroimaging|neuroimaging
5340381|NCT01993108|Prefrontal Control Circuits|prefrontal control circuits
5340382|NCT01993108|Attention Control|attention control
5340383|NCT01993108|Motor Control|motor control
5340384|NCT01993108|Appetitive Control|appetitive control
5340385|NCT01993095|Multiple Sclerosis|multiple sclerosis
5340386|NCT01993095|Quality of Life|quality of life
5340387|NCT01993095|Functional Fitness|functional fitness
5340388|NCT01993082|Caregivers|caregivers
5340389|NCT01993082|Telomerase|telomerase
5340390|NCT01993082|Telomere Length|telomere length
5340391|NCT01993082|Psychological Stress|psychological stress
5340392|NCT01993082|Cardiovascular Risk|cardiovascular risk
5340393|NCT01993082|Exercise|exercise
5340394|NCT01993056|injury incidence, male veteran soccer, 11+, Functional Movement Screen, FMS, warm-up|injury incidence, male veteran soccer, 11+, functional movement screen, fms, warm-up
5340395|NCT01993043|ROP|rop
5340396|NCT01993043|Bevacizumab|bevacizumab
5340397|NCT01993043|Laser|laser
5340398|NCT01993043|Development|development
5340399|NCT01993017|Acute Coronary Syndrome|acute coronary syndrome
5340400|NCT01993017|Depressive Symptoms|depressive symptoms
5340401|NCT01992991|transcranial stimulation|transcranial stimulation
5340402|NCT01992991|Intracranial hemorrhage|intracranial hemorrhage
5340403|NCT01992991|Home training|home training
5340404|NCT01992991|Occupational Therapy|occupational therapy
5340405|NCT01992991|Jebsen Taylor Hand Function Test|jebsen taylor hand function test
5340406|NCT01992978|radiofrequency-assisted（RF）|radiofrequency-assisted（rf）
5340407|NCT01992978|hepatectomy|hepatectomy
5340408|NCT01992978|postoperative liver injury|postoperative liver injury
5340409|NCT01992965|continuous glucose monitoring；|continuous glucose monitoring；
5340410|NCT01992965|critically ill;|critically ill;
5340411|NCT01992939|pulse|pulse
5340412|NCT01992939|heat|heat
5340413|NCT01992939|blood circulation|blood circulation
5340414|NCT01992926|health literacy|health literacy
5340415|NCT01992926|health numeracy|health numeracy
5340416|NCT01992913|Schizophrenia|schizophrenia
5340417|NCT01992913|Cognitive Behavioral Therapy|cognitive behavioral therapy
5340418|NCT01992913|Cognition|cognition
5340419|NCT01992913|Vocational Rehabilitation|vocational rehabilitation
5340420|NCT01992913|Supported Employment|supported employment
5340421|NCT01992913|Schizoaffective Disorder|schizoaffective disorder
5340422|NCT01992900|Plasmodium falciparum Malaria|plasmodium falciparum malaria
5340423|NCT01992900|Eurartesim|eurartesim
5340424|NCT01992900|ACT|act
5340425|NCT01992887|HIV/AIDS|hiv/aids
5340426|NCT01992887|Retention|retention
5340427|NCT01992887|ART (anti-retroviral therapy) ineligible|art (anti-retroviral therapy) ineligible
5340428|NCT01992874|Neoplasms|neoplasms
5340429|NCT01992874|Pimasertib|pimasertib
5340430|NCT01992874|Cancer|cancer
5340431|NCT01992822|rTMS|rtms
5340432|NCT01992822|fibromyalgia|fibromyalgia
5340433|NCT01992822|experimental pain|experimental pain
5340434|NCT01992809|Nonalcoholic fatty liver|nonalcoholic fatty liver
5340436|NCT01992796|irbesartan, angiotensin, sepsis|irbesartan, angiotensin, sepsis
5340437|NCT01992783|Resistant Starch|resistant starch
5340438|NCT01992783|Antioxidant Status|antioxidant status
5340439|NCT01992783|Insulin Resistance|insulin resistance
5340440|NCT01992783|Overweight|overweight
5340441|NCT01992783|Obesity|obesity
5340442|NCT01992770|behavioural medicine|behavioural medicine
5340443|NCT01992770|pain|pain
5340444|NCT01992770|physical therapy|physical therapy
5340445|NCT01992770|physical exercise|physical exercise
5340446|NCT01992770|primary care|primary care
5340447|NCT01992757|functional fibrinogen assay|functional fibrinogen assay
5340448|NCT01992757|cardiac surgery|cardiac surgery
5340450|NCT01992744|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5340451|NCT01992744|birth outcomes|birth outcomes
5340452|NCT01992731|Age (38-42 years)|age (38-42 years)
5340453|NCT01992731|pregnancy rates|pregnancy rates
5340454|NCT01992731|3 IUI cycles|3 iui cycles
5340455|NCT01992731|1 IVF/ICSI cycle|1 ivf/icsi cycle
5340456|NCT01992705|pancreatic cancer|pancreatic cancer
5340457|NCT01992692|Parkinson's disease|parkinson's disease
5340458|NCT01992692|remifentanil|remifentanil
5340459|NCT01992692|deep brain stimulator|deep brain stimulator
5340460|NCT01992692|cardiovascular response|cardiovascular response
5340461|NCT01992666|Systemic lupus erythematosus|systemic lupus erythematosus
5340462|NCT01992666|genetic|genetic
5340463|NCT01992666|immunological|immunological
5340464|NCT01992666|pediatric|pediatric
5340465|NCT01992666|mutation|mutation
5340466|NCT01992666|lupus|lupus
5340467|NCT01992627|High Intensity Laser Therapy|high intensity laser therapy
5340468|NCT01992627|elbow epicondylosis|elbow epicondylosis
5340469|NCT01992614|Single Ascending Dose|single ascending dose
5340470|NCT01992614|healthy subjects|healthy subjects
5340471|NCT01992614|Hypercholesterolemia|hypercholesterolemia
5340472|NCT01992614|Hyperlipidemias|hyperlipidemias
5340473|NCT01992614|Dyslipidemias|dyslipidemias
5340474|NCT01992614|Lipid Metabolism Disorders|lipid metabolism disorders
5340475|NCT01992614|Metabolic Diseases|metabolic diseases
5672666|NCT00611286|clopidogrel|clopidogrel
5340476|NCT01992601|Drug interaction|drug interaction
5340477|NCT01992601|Rosuvastatin|rosuvastatin
5340478|NCT01992601|Telmisartan|telmisartan
5340479|NCT01992601|Pharmacokinetic|pharmacokinetic
5340480|NCT01992601|(Pharmacokinetics and Drug Interaction)|(pharmacokinetics and drug interaction)
5340481|NCT01992575|Retinal vein occlusion|retinal vein occlusion
5340483|NCT01992575|Optical coherence tomography|optical coherence tomography
5340484|NCT01992575|Imaging|imaging
5340485|NCT01992536|Meningococcal|meningococcal
5340486|NCT01992536|Booster|booster
5340487|NCT01992536|MenABCWY|menabcwy
5340488|NCT01992536|Menveo|menveo
5340489|NCT01992536|Vaccine Adolescents|vaccine adolescents
5340490|NCT01992536|Immune Response|immune response
5340491|NCT01992536|N. Meningitidis|n. meningitidis
5340492|NCT01992523|Ticagrelor|ticagrelor
5340493|NCT01992523|antiplatelet|antiplatelet
5340494|NCT01992523|Acute Coronary Syndrome|acute coronary syndrome
5340591|NCT01992029|ALS|als
5340495|NCT01992497|Cesarean section, probiotic, formula fed, gut microbiota|cesarean section, probiotic, formula fed, gut microbiota
5445422|NCT01521897|Special Use-result surveillance|special use-result surveillance
5445423|NCT01521871|Tissue glue|tissue glue
5340496|NCT01992484|platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin|platelets, acute coronary syndrome (acs), prasugrel, ticagrelor, aspirin
5340497|NCT01992471|BRCA1 testing|brca1 testing
5340498|NCT01992471|BRCA2 testing|brca2 testing
5340499|NCT01992471|13-215|13-215
5340500|NCT01992458|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5340501|NCT01992458|death|death
5340502|NCT01992458|shock|shock
5340503|NCT01992458|mortality|mortality
5340504|NCT01992458|complication|complication
5340505|NCT01992458|sudden death|sudden death
5340506|NCT01992445|suicide|suicide
5340507|NCT01992445|suicidal intent|suicidal intent
5340508|NCT01992445|thought markers|thought markers
5340509|NCT01992432|Brain magnetic resonance imaging|brain magnetic resonance imaging
5340510|NCT01992432|chemotherapy toxicity|chemotherapy toxicity
5340511|NCT01992432|older woman|older woman
5340512|NCT01992432|breast cancer|breast cancer
5340513|NCT01992419|Out-of-hospital Cardiac arrest|out-of-hospital cardiac arrest
5340514|NCT01992419|telephone dispatch assisted resuscitation|telephone dispatch assisted resuscitation
5340518|NCT01992393|Schizoaffective Disorder|schizoaffective disorder
5340519|NCT01992393|Bipolar Disorder|bipolar disorder
5340520|NCT01992393|Depression|depression
5340521|NCT01992393|Intervention|intervention
5340522|NCT01992393|Treatment|treatment
5340523|NCT01992393|Adherence|adherence
5340524|NCT01992341|sarcomas|sarcomas
5340525|NCT01992341|carcinomas|carcinomas
5340526|NCT01992328|Immunoglobulin G Deficiency|immunoglobulin g deficiency
5340527|NCT01992315|Scar|scar
5340528|NCT01992315|Soft tissue defect|soft tissue defect
5340529|NCT01992302|Rapid cycling|rapid cycling
5340530|NCT01992289|XLHED|xlhed
5340531|NCT01992289|HED|hed
5336745|NCT02009553|Anxiety|anxiety
5340532|NCT01992289|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5340533|NCT01992289|Christ-Siemens-Touraine Syndrome|christ-siemens-touraine syndrome
5340534|NCT01992276|Influenza|influenza
5340535|NCT01992276|Virus|virus
5340536|NCT01992276|Monoclonal Antibody|monoclonal antibody
5340537|NCT01992276|Immunization|immunization
5340538|NCT01992276|Treatment|treatment
5340539|NCT01992263|tuberculosis|tuberculosis
5340540|NCT01992263|vitamin D|vitamin d
5340541|NCT01992263|immunity|immunity
5340542|NCT01992250|Cryoablation|cryoablation
5340543|NCT01992237|ALI,|ali,
5340544|NCT01992237|ARDS,|ards,
5340545|NCT01992237|ECMO,|ecmo,
5340546|NCT01992237|energy expenditure,|energy expenditure,
5340547|NCT01992237|mechanical ventilation,|mechanical ventilation,
5207935|NCT02695641|Avastin|avastin
5340548|NCT01992237|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5340549|NCT01992237|Nutrition Assessment|nutrition assessment
5340550|NCT01992237|Pulmonary Ventilation|pulmonary ventilation
5340551|NCT01992224|severe acute pancreatitis|severe acute pancreatitis
5340552|NCT01992224|mechanical ventilation|mechanical ventilation
5340553|NCT01992198|antibiothearpy strategy|antibiothearpy strategy
5340554|NCT01992198|cefoperazone|cefoperazone
5340555|NCT01992198|metronidazole|metronidazole
5340556|NCT01992198|meropenem|meropenem
5340557|NCT01992159|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
5340558|NCT01992146|central sensitization|central sensitization
5340559|NCT01992146|endogenous opioids|endogenous opioids
5340560|NCT01992146|humans|humans
5340561|NCT01992146|latent sensitization|latent sensitization
5340562|NCT01992146|naloxone|naloxone
5340563|NCT01992146|open groin hernia repair|open groin hernia repair
5340564|NCT01992146|pain|pain
5340565|NCT01992146|randomized controlled trial|randomized controlled trial
5340566|NCT01992146|secondary hyperalgesia|secondary hyperalgesia
5340567|NCT01992146|target-controlled infusion|target-controlled infusion
5340568|NCT01992133|Former gestational Diabetes|former gestational diabetes
5340569|NCT01992133|Vitamin D deficiency|vitamin d deficiency
5340570|NCT01992133|insulin resistance|insulin resistance
5340571|NCT01992133|beta cell function|beta cell function
5340572|NCT01992120|Simulation|simulation
5340573|NCT01992120|Sepsis|sepsis
5340574|NCT01992120|High-fidelity|high-fidelity
5340575|NCT01992120|Severe Sepsis|severe sepsis
5340576|NCT01992120|Septic Shock|septic shock
5340577|NCT01992120|Education|education
5340578|NCT01992107|Influenza|influenza
5340579|NCT01992107|Influenza vaccine|influenza vaccine
5340580|NCT01992107|Novartis|novartis
5340581|NCT01992107|children|children
5340582|NCT01992094|Influenza|influenza
5340583|NCT01992094|Influenza vaccine|influenza vaccine
5340584|NCT01992094|Novartis|novartis
5340586|NCT01992081|COPD, Physical Activity, Telecoaching, PROactive|copd, physical activity, telecoaching, proactive
5340587|NCT01992068|lung cancer|lung cancer
5340588|NCT01992055|Executive dysfunction|executive dysfunction
5340589|NCT01992055|Neuropsychological rehabilitation|neuropsychological rehabilitation
5340590|NCT01992055|Goal Management Training|goal management training
5340592|NCT01992029|miRNA|mirna
5340593|NCT01992029|biomarker|biomarker
5340594|NCT01992029|monocentric observational study|monocentric observational study
5235448|NCT02530827|HIV|hiv
5340595|NCT01992016|Prostate cancer|prostate cancer
5340596|NCT01992016|F18 FDG-PET|f18 fdg-pet
5340597|NCT01992016|Imaging|imaging
5340598|NCT01992016|Ranolazine|ranolazine
5340599|NCT01992016|Bone metastases|bone metastases
5340600|NCT01992016|Soft tissue metastases|soft tissue metastases
5340601|NCT01991964|stridor|stridor
5340602|NCT01991964|laryngomalacia|laryngomalacia
5340603|NCT01991964|ultrasound|ultrasound
5340604|NCT01991938|PI3K Inhibitor|pi3k inhibitor
5340605|NCT01991938|mTOR Inhibitor|mtor inhibitor
5340606|NCT01991938|Dual PI3K/mTOR Inhibitor|dual pi3k/mtor inhibitor
5340607|NCT01991938|CSC|csc
5340608|NCT01991938|Cancer Stem Cells|cancer stem cells
5340609|NCT01991912|irrigation endoscopic decompression|irrigation endoscopic decompression
5340610|NCT01991912|minimally invasive surgery|minimally invasive surgery
5340611|NCT01991912|spinal stenosis|spinal stenosis
5340612|NCT01991899|Measles, mumps and rubella vaccine|measles, mumps and rubella vaccine
5340613|NCT01991899|Tetraviral vaccine|tetraviral vaccine
5340614|NCT01991899|Immunogenicity, Reactogenicity and Safety|immunogenicity, reactogenicity and safety
5340615|NCT01991899|Consistency of production|consistency of production
5340616|NCT01991886|nasal High Flow|nasal high flow
5340617|NCT01991886|premature baby|premature baby
5340618|NCT01991886|CPAP (Continuous positive airways pressure)|cpap (continuous positive airways pressure)
5340619|NCT01991873|metastatic colorectal cancer|metastatic colorectal cancer
5340620|NCT01991873|maintenance therapy|maintenance therapy
5340621|NCT01991873|Panitumumab|panitumumab
5340622|NCT01991873|Vectibix®|vectibix®
5340623|NCT01991847|colon|colon
5340624|NCT01991847|cancer|cancer
5340625|NCT01991847|prevention|prevention
5340626|NCT01991847|exercise|exercise
5340627|NCT01991847|physical activity|physical activity
5340628|NCT01991847|rectal|rectal
5340629|NCT01991834|laparoscopy|laparoscopy
5340630|NCT01991834|surgical wound infection|surgical wound infection
5340631|NCT01991834|antibiotic prophylaxis|antibiotic prophylaxis
5340632|NCT01991834|gynecologic surgical procedures|gynecologic surgical procedures
5340633|NCT01991795|Diabetes|diabetes
5340634|NCT01991795|Coronary artery disease|coronary artery disease
5340636|NCT01991795|Prevention|prevention
5340637|NCT01991795|Antiplatelet|antiplatelet
5340638|NCT01991782|Telemedicine|telemedicine
5340639|NCT01991782|Fracture|fracture
5340640|NCT01991782|Orthopaedics|orthopaedics
5340641|NCT01991769|exercise|exercise
5340642|NCT01991769|endothelium|endothelium
5340643|NCT01991769|postprandial period|postprandial period
5963380|NCT04248634|Delayed coloanal anastomosis|delayed coloanal anastomosis
5963381|NCT04248413|Shoulder injury|shoulder injury
5220033|NCT02623764|Alzheimer´s disease|alzheimer´s disease
5220034|NCT02623764|Lewy body dementia|lewy body dementia
5220035|NCT02623764|Parkinson dementia|parkinson dementia
5220036|NCT02623764|EEG|eeg
5340644|NCT01991756|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5340645|NCT01991756|AAA|aaa
5340646|NCT01991743|Version|version
5340647|NCT01991743|Pregnancy|pregnancy
5340648|NCT01991743|Vaginal Delivery|vaginal delivery
5340649|NCT01991743|Pain Control|pain control
5340650|NCT01991743|Combined Spinal Epidural|combined spinal epidural
5340651|NCT01991717|Victus|victus
5340652|NCT01991717|lensfragmentation|lensfragmentation
5340653|NCT01991717|femtosecond laser assisted|femtosecond laser assisted
5340654|NCT01991717|capsulotomy,|capsulotomy,
5340655|NCT01991717|manual, continuous curvilinear capsulorhexis (CCC)|manual, continuous curvilinear capsulorhexis (ccc)
5340656|NCT01991717|effective phaco time, phaco|effective phaco time, phaco
5340657|NCT01991704|incubation|incubation
5340658|NCT01991704|Craving|craving
5340659|NCT01991704|alcohol dependence|alcohol dependence
5340660|NCT01991691|Antineoplastic Agents|antineoplastic agents
5340661|NCT01991665|Intrapartum Ultrasound|intrapartum ultrasound
5340662|NCT01991665|Vacuum|vacuum
5340663|NCT01991665|Occiput position|occiput position
5340664|NCT01991652|Wilms tumour|wilms tumour
5340665|NCT01991652|Childhood cancer|childhood cancer
5340666|NCT01991652|Africa|africa
5340667|NCT01991639|frailty|frailty
5340668|NCT01991639|community-dwelling|community-dwelling
5340669|NCT01991639|malnutrition|malnutrition
5340670|NCT01991639|physical activity|physical activity
5340671|NCT01991639|nutritional intervention|nutritional intervention
5340672|NCT01991600|iron absorption|iron absorption
5340673|NCT01991600|bioavailability|bioavailability
5340674|NCT01991600|anaemia|anaemia
5340675|NCT01991600|iron deficiency|iron deficiency
5340676|NCT01991600|ferrous sulphate|ferrous sulphate
5340677|NCT01991587|Influenza|influenza
5340678|NCT01991587|Human|human
5340679|NCT01991587|RNA Virus Infections|rna virus infections
5340680|NCT01991587|Immunologic|immunologic
5340681|NCT01991587|Immunogenic Factors|immunogenic factors
5340682|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs
5340683|NCT01991587|Virus diseases|virus diseases
5340684|NCT01991587|Orthomyxoviridae Infections|orthomyxoviridae infections
5340685|NCT01991587|Infection|infection
5340686|NCT01991574|urinary phosphate|urinary phosphate
5340687|NCT01991574|iron hydroxide|iron hydroxide
5340688|NCT01991574|hypophosphatemia|hypophosphatemia
5340689|NCT01991574|phosphate binder|phosphate binder
5340690|NCT01991574|ferric hydroxide adipate|ferric hydroxide adipate
5340691|NCT01991561|Influenza, Human|influenza, human
5340692|NCT01991561|RNA Virus Infections|rna virus infections
5340693|NCT01991561|Respiratory Tract Diseases|respiratory tract diseases
5340694|NCT01991561|Respiratory Tract Infections|respiratory tract infections
5340695|NCT01991561|Aluminum Hydroxide|aluminum hydroxide
5340696|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic
5340697|NCT01991561|Immunogenic Factors|immunogenic factors
5340698|NCT01991561|GLA-SE|gla-se
5340699|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs
5340700|NCT01991561|Virus Diseases|virus diseases
5340701|NCT01991561|Orthomyxoviridae Infections|orthomyxoviridae infections
5340702|NCT01991561|Infection|infection
5340703|NCT01991548|Insulin pump|insulin pump
5340704|NCT01991470|Insulin requiring diabetes|insulin requiring diabetes
5340705|NCT01991470|Children|children
5340706|NCT01991470|Sensor|sensor
5340707|NCT01991470|Accuracy|accuracy
5340708|NCT01991457|ALL|all
5340709|NCT01991418|non-small cell lung cancer|non-small cell lung cancer
5340710|NCT01991418|thioredoxin reductase|thioredoxin reductase
5423296|NCT01616290|PTA|pta
5340711|NCT01991418|carcina embryonic antigen|carcina embryonic antigen
5340712|NCT01991405|Mild Cognitive Impairment|mild cognitive impairment
5340713|NCT01991405|Working Memory Training|working memory training
5340714|NCT01991405|Neuropsychological function in MCI|neuropsychological function in mci
5340715|NCT01991392|Pancreaticoduodenectomy|pancreaticoduodenectomy
5340716|NCT01991392|nasogastric tube|nasogastric tube
5340717|NCT01991379|MEK162|mek162
5340718|NCT01991379|Imatinib|imatinib
5340719|NCT01991379|13-162|13-162
5340720|NCT01991366|Major adverse microvascular integrity|major adverse microvascular integrity
5340721|NCT01991366|all cause mortality|all cause mortality
5340722|NCT01991366|Q Wave MI|q wave mi
5340723|NCT01991353|Knee|knee
5340724|NCT01991353|meniscus|meniscus
5340725|NCT01991353|platelet rich plasma|platelet rich plasma
5340726|NCT01991301|graft-versus-host disease|graft-versus-host disease
5340727|NCT01991301|stem cell transplantation|stem cell transplantation
5340728|NCT01991301|matched unrelated donors|matched unrelated donors
5340731|NCT01991288|Total Knee Replacement|total knee replacement
5340732|NCT01991288|Bupivacaine|bupivacaine
5340733|NCT01991288|Levobupivacaine|levobupivacaine
5963382|NCT04248413|Baseball injury|baseball injury
5963383|NCT04248413|Muscle strength|muscle strength
5963384|NCT04247789|fatigue|fatigue
5963385|NCT04247789|physical function|physical function
5963386|NCT04247789|strength|strength
5963387|NCT04247789|older adults|older adults
5340734|NCT01991288|Saphenous Nerve Block|saphenous nerve block
5340735|NCT01991288|Local Infiltration Analgesia|local infiltration analgesia
5340736|NCT01991275|Prostatic Neoplasms|prostatic neoplasms
5340737|NCT01991275|Laparoscopy|laparoscopy
5340738|NCT01991275|Injections, Spinal|injections, spinal
5340739|NCT01991275|Morphine|morphine
5340740|NCT01991249|pediatric acute leukemia|pediatric acute leukemia
5340741|NCT01991249|Targeted high throughput sequencing|targeted high throughput sequencing
5340742|NCT01991249|messenger RNA|messenger rna
5340743|NCT01991197|Psoriasis|psoriasis
5340744|NCT01991197|Type 2 Diabetes|type 2 diabetes
5340745|NCT01991197|Dipeptidyl peptidase-4 inhibition|dipeptidyl peptidase-4 inhibition
5340746|NCT01991197|Sitagliptin|sitagliptin
5340747|NCT01991197|Gliclazide|gliclazide
5340748|NCT01991197|Psoriasis area and severity index|psoriasis area and severity index
5340749|NCT01991171|kinesio taping|kinesio taping
5340750|NCT01991171|Muscle activation|muscle activation
5340751|NCT01991171|Muscle inhibition|muscle inhibition
5340752|NCT01991158|GAD-M regimen|gad-m regimen
5340753|NCT01991158|first line chemotherapy|first line chemotherapy
5340754|NCT01991158|NK/T-cell Lymphoma|nk/t-cell lymphoma
5340755|NCT01991145|Cerebral Palsy|cerebral palsy
5340756|NCT01991145|Umbilical Cord Blood|umbilical cord blood
5340757|NCT01991145|Erythropoietin|erythropoietin
5340758|NCT01991145|Rehabilitation|rehabilitation
5340759|NCT01991132|Dry Eyes|dry eyes
5340760|NCT01991132|Meibomian glands|meibomian glands
5340761|NCT01991132|Algorithm|algorithm
5340762|NCT01991132|MediView software|mediview software
5340763|NCT01991119|Atrial fibrillation|atrial fibrillation
5340764|NCT01991119|Propafenone|propafenone
5340765|NCT01991119|Dronedarone|dronedarone
5340766|NCT01991106|Exercise|exercise
5340767|NCT01991106|Myocardial function|myocardial function
5340768|NCT01991106|Vascular function|vascular function
5340769|NCT01991106|Cardiovascular disease/prevention & control|cardiovascular disease/prevention & control
5340770|NCT01991106|Paediatric obesity|paediatric obesity
5340771|NCT01991106|Visceral adipose tissue|visceral adipose tissue
5340772|NCT01991093|light transmittance aggregometry (LTA),multiple electrode aggregometry, clopidogrel-resistance|light transmittance aggregometry (lta),multiple electrode aggregometry, clopidogrel-resistance
5340773|NCT01991080|biofeedback|biofeedback
5340774|NCT01991080|relaxation|relaxation
5340775|NCT01991080|Wheat germ juice|wheat germ juice
5340776|NCT01991067|Marrow transplant recipients|marrow transplant recipients
5340777|NCT01991054|Diabetes mellitus|diabetes mellitus
5340778|NCT01991054|HgA1C|hga1c
5340779|NCT01991054|25(OH) vitamin D|25(oh) vitamin d
5340780|NCT01991054|HgA1C levels above 7.5%|hga1c levels above 7.5%
5340781|NCT01991041|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5340782|NCT01991002|14/21 diet|14/21 diet
5340783|NCT01991002|BMI|bmi
5340784|NCT01991002|biochemical blood markers|biochemical blood markers
5340785|NCT01991002|quality of life|quality of life
5340786|NCT01990989|clopidogrel|clopidogrel
5340787|NCT01990989|pharmacogenomics|pharmacogenomics
5340788|NCT01990989|CYP2C19|cyp2c19
5340790|NCT01990989|score system|score system
5340791|NCT01990989|ischemic cardiovascular outcomes|ischemic cardiovascular outcomes
5340792|NCT01990989|hemorrhage complications|hemorrhage complications
5340793|NCT01990976|Muscular Dystrophy|muscular dystrophy
5340794|NCT01990976|Facioscapulohumeral|facioscapulohumeral
5340795|NCT01990976|Physical training|physical training
5340796|NCT01990976|Magnetic Resonance Imaging|magnetic resonance imaging
5340797|NCT01990976|Muscle Biopsy|muscle biopsy
5340798|NCT01990963|Brain trauma;|brain trauma;
5340799|NCT01990963|MALUNA;|maluna;
5340800|NCT01990963|densitometric data|densitometric data
5340801|NCT01990963|CT|ct
5340802|NCT01990950|Aneurysm|aneurysm
5340803|NCT01990950|Aortic Aneurysm|aortic aneurysm
5340804|NCT01990950|Iliac Aneurysm|iliac aneurysm
5340805|NCT01990950|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5340806|NCT01990950|Vascular Diseases|vascular diseases
5340807|NCT01990950|Cardiovascular Diseases|cardiovascular diseases
5340808|NCT01990950|Aortic Diseases|aortic diseases
5340809|NCT01990937|oral midazolam|oral midazolam
5340810|NCT01990937|sedation|sedation
5340811|NCT01990937|premedication|premedication
5340812|NCT01990937|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5340813|NCT01990937|EGD|egd
5340814|NCT01990924|fluoroscopy|fluoroscopy
5340815|NCT01990924|radiation|radiation
5340816|NCT01990924|transradial|transradial
5340817|NCT01990924|diagnostic|diagnostic
5340818|NCT01990924|angiography|angiography
5340819|NCT01990924|cardiac|cardiac
5340820|NCT01990924|coronary|coronary
5340821|NCT01990924|angioplasty|angioplasty
5340822|NCT01990911|hypertension|hypertension
5340823|NCT01990911|hypertensive heart disease|hypertensive heart disease
5340824|NCT01990911|atrial fibrillation|atrial fibrillation
5340825|NCT01990911|autonomic imbalance|autonomic imbalance
5963388|NCT04247789|nursing homes|nursing homes
5963389|NCT04247542|Clostridioides difficile|clostridioides difficile
5963390|NCT04247542|CDAD (Clostridioides difficile-associated diarrhea)|cdad (clostridioides difficile-associated diarrhea)
5963391|NCT04247542|DNA polymerase IIIC|dna polymerase iiic
5963392|NCT04247282|Immuno-oncology|immuno-oncology
5963393|NCT04247282|Neoadjuvant Treatments|neoadjuvant treatments
5963394|NCT04247282|Vaccine|vaccine
5337127|NCT02007954|HCC|hcc
5340826|NCT01990872|Vitamin D status|vitamin d status
5340827|NCT01990872|25-hydroxyvitamin D|25-hydroxyvitamin d
5340829|NCT01990872|RCT|rct
5340830|NCT01990872|Calcium intake|calcium intake
5340831|NCT01990872|Dietary requirement|dietary requirement
5340832|NCT01990846|antiviral, influenza|antiviral, influenza
5340834|NCT01990807|high risk|high risk
5340835|NCT01990807|Philadelphia Chromosome absent|philadelphia chromosome absent
5340836|NCT01990807|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5340837|NCT01990794|Cobalt|cobalt
5340838|NCT01990794|Dietary Supplements|dietary supplements
5340839|NCT01990794|Hematological|hematological
5340840|NCT01990794|Thyroid|thyroid
5340841|NCT01990781|Lidocaine, Dexamethasone, Postoperative sore throat|lidocaine, dexamethasone, postoperative sore throat
5340842|NCT01990768|tranexamic acid|tranexamic acid
5340843|NCT01990768|traumatic brain injury|traumatic brain injury
5340844|NCT01990768|intracranial hemorrhage|intracranial hemorrhage
5340845|NCT01990768|prehospital|prehospital
5340846|NCT01990768|neurologic outcome|neurologic outcome
5340847|NCT01990768|glasgow outcome scale extended|glasgow outcome scale extended
5340848|NCT01990768|disability rating scale|disability rating scale
5340849|NCT01990716|Adult|adult
5340850|NCT01990716|Colonoscopy|colonoscopy
5340851|NCT01990703|Contraception|contraception
5340852|NCT01990703|Birth Control|birth control
5340853|NCT01990703|Levonorgestrel IUD|levonorgestrel iud
5340854|NCT01990703|Mirena IUD|mirena iud
5340855|NCT01990690|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes|oligohydramnios,antioxidant,oxidative stress and pregnancy outcomes
5340856|NCT01990677|Central Serous Chorioretinopathy|central serous chorioretinopathy
5340857|NCT01990677|csr|csr
5340858|NCT01990677|cscr|cscr
5340859|NCT01990677|eplerenone|eplerenone
5340860|NCT01990677|vision|vision
5340861|NCT01990677|choroid|choroid
5340862|NCT01990677|retina|retina
5340863|NCT01990677|acute|acute
5340864|NCT01990677|chronic|chronic
5340865|NCT01990638|coronary artery bypass graft|coronary artery bypass graft
5340866|NCT01990638|Diabetes mellitus, type 2|diabetes mellitus, type 2
5340867|NCT01990625|Maternal Near Miss Morbidity|maternal near miss morbidity
5340868|NCT01990625|Maternal Mortality|maternal mortality
5340869|NCT01990625|Neonatal Mortality|neonatal mortality
5340870|NCT01990625|Gestational Age Dating|gestational age dating
5340871|NCT01990625|Pregnancy Complications|pregnancy complications
5340872|NCT01990625|Ultrasound|ultrasound
5340873|NCT01990625|Stillbirth|stillbirth
5340874|NCT01990612|Induction of labor|induction of labor
5340875|NCT01990612|Expectant management of labor|expectant management of labor
5340877|NCT01990599|nasopharyngeal tube|nasopharyngeal tube
5340878|NCT01990599|airway management|airway management
5340879|NCT01990599|thermal coagulation of the Gasserian ganglion|thermal coagulation of the gasserian ganglion
5340880|NCT01990573|spinal surgery|spinal surgery
5340881|NCT01990573|Methadone|methadone
5340882|NCT01990560|mild hypercortisolism|mild hypercortisolism
5340883|NCT01990560|Subclinical Cushing's Syndrome|subclinical cushing's syndrome
5340884|NCT01990560|Preclinical Cushing's Syndrome|preclinical cushing's syndrome
5340885|NCT01990547|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5341379|NCT01988233|Aging|aging
5340886|NCT01990547|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5340888|NCT01990547|Trauma Survivor|trauma survivor
5340889|NCT01990547|Combat-related PTSD|combat-related ptsd
5340890|NCT01990547|mTBI|mtbi
5340891|NCT01990547|mild TBI|mild tbi
5340892|NCT01990547|PTSD|ptsd
5340893|NCT01990547|Veteran|veteran
5340894|NCT01990534|Lymphoma|lymphoma
5340895|NCT01990534|Hodgkin|hodgkin
5340896|NCT01990534|Relapsed|relapsed
5340897|NCT01990534|Refractory|refractory
5340898|NCT01990534|Antigens, CD30|antigens, cd30
5340899|NCT01990534|Antibody-Drug Conjugate|antibody-drug conjugate
5340900|NCT01990534|Antibodies, Monoclonal|antibodies, monoclonal
5340901|NCT01990534|Monomethyl auristatin E|monomethyl auristatin e
5340902|NCT01990534|Drug Therapy|drug therapy
5340903|NCT01990534|Immunotherapy|immunotherapy
5340904|NCT01990534|Hematologic Diseases|hematologic diseases
5340905|NCT01990534|Additional Relevant MeSH terms:|additional relevant mesh terms:
5340906|NCT01990534|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5340907|NCT01990534|Lymphoma, Hodgkin|lymphoma, hodgkin
5340908|NCT01990534|Neoplasms by Histologic Type|neoplasms by histologic type
5340910|NCT01990534|Lymphoproliferative Disorders|lymphoproliferative disorders
5340911|NCT01990534|Lymphatic Diseases|lymphatic diseases
5340912|NCT01990534|Immunoproliferative Disorders|immunoproliferative disorders
5340913|NCT01990534|Immune System Diseases|immune system diseases
5340914|NCT01990534|Lymphoma, B-Cell|lymphoma, b-cell
5340915|NCT01990534|Lymphoma, T-Cell|lymphoma, t-cell
5340916|NCT01990534|Immunologic Factors|immunologic factors
5340917|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs
5340918|NCT01990534|Pharmacologic Actions|pharmacologic actions
5340919|NCT01990508|sugar-sweetened beverages|sugar-sweetened beverages
5340920|NCT01990508|traffic-light labels|traffic-light labels
5340921|NCT01990508|financial incentives|financial incentives
5340922|NCT01990508|low-income community|low-income community
5340923|NCT01990508|obesity prevention|obesity prevention
5340924|NCT01990495|Renal failure|renal failure
5340925|NCT01990495|Exercise testing|exercise testing
5340926|NCT01990495|Exercise training|exercise training
5340927|NCT01990495|Protein signaling|protein signaling
5340928|NCT01990495|Skeletal muscle|skeletal muscle
5340929|NCT01990469|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5340930|NCT01990456|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5340931|NCT01990456|Ventilator-Induced Lung Injury|ventilator-induced lung injury
5340932|NCT01990456|Ventilators, Mechanical|ventilators, mechanical
5340933|NCT01990456|Pulmonary Heart Disease|pulmonary heart disease
5340934|NCT01990456|Ultrasonography|ultrasonography
5340935|NCT01990443|Reslizumab|reslizumab
5340936|NCT01990443|monoclonal antibody|monoclonal antibody
5340937|NCT01990417|Muscle Stretching Exercises|muscle stretching exercises
5340938|NCT01990417|Joint range of motion|joint range of motion
5340939|NCT01990417|Resistance Training|resistance training
5340940|NCT01990417|Physical Therapy|physical therapy
5340941|NCT01990404|Premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
5340942|NCT01990404|Severe acute pain|severe acute pain
5340943|NCT01990404|Prehospital setting|prehospital setting
5340944|NCT01990365|Vertebral fracture, low back pain, gips, mobility|vertebral fracture, low back pain, gips, mobility
5340945|NCT01990313|Parkinson's Disease|parkinson's disease
5340947|NCT01990313|Deep Brain Stimulation|deep brain stimulation
5340948|NCT01990313|Subthalamic Nucleus|subthalamic nucleus
5340949|NCT01990300|Drug Therapy|drug therapy
5340950|NCT01990287|Low Back Pain|low back pain
5340951|NCT01990287|Failed Back surgery Syndrome|failed back surgery syndrome
5340952|NCT01990287|Post-Laminectomy Syndrome|post-laminectomy syndrome
5340953|NCT01990287|Spinal Cord Stimulation|spinal cord stimulation
5340954|NCT01990287|Peripheral Nerve field Stimulation|peripheral nerve field stimulation
5340955|NCT01990287|Pain|pain
5340956|NCT01990274|Tuberculosis|tuberculosis
5340957|NCT01990274|Diagnosis|diagnosis
5340958|NCT01990274|GeneXpert MTB/RIF|genexpert mtb/rif
5679028|NCT00583830|Lung Cancer|lung cancer
5340959|NCT01990274|Point-of-treatment|point-of-treatment
5340960|NCT01990274|Mobile unit|mobile unit
5340961|NCT01990235|Advance care planning|advance care planning
5340962|NCT01990235|Aging|aging
5340963|NCT01990235|Health communication|health communication
5340964|NCT01990235|Health literacy|health literacy
5340965|NCT01990235|Medical decision making|medical decision making
5340966|NCT01990235|primary care|primary care
5340968|NCT01990235|chronic illness|chronic illness
5340970|NCT01990209|triple-negative breast cancer|triple-negative breast cancer
5340971|NCT01990209|orteronel|orteronel
5340972|NCT01990209|TAK-700|tak-700
5340973|NCT01990209|metastatic breast cancer|metastatic breast cancer
5340974|NCT01990196|prostate cancer|prostate cancer
5340975|NCT01990196|hormone therapy|hormone therapy
5340976|NCT01990196|radical prostatectomy|radical prostatectomy
5340977|NCT01990183|preterm infants|preterm infants
5340978|NCT01990183|early intervention|early intervention
5340979|NCT01990183|enrichment|enrichment
5340980|NCT01990183|cognitive, motor, visual development|cognitive, motor, visual development
5340981|NCT01990183|tele-rehabilitation|tele-rehabilitation
5340982|NCT01990131|computerized intervention|computerized intervention
5340983|NCT01990131|cognitive bias modification|cognitive bias modification
5340984|NCT01990131|anxiety|anxiety
5340985|NCT01990131|suicide|suicide
5340986|NCT01990118|Renal transplant|renal transplant
5340987|NCT01990118|Renal allograft rejection|renal allograft rejection
5340988|NCT01990118|Cyclosporine|cyclosporine
5340989|NCT01990118|Gengraf|gengraf
5340990|NCT01990105|atrial fibrillation|atrial fibrillation
5340991|NCT01990105|anticoagulation|anticoagulation
5340992|NCT01990105|antiarrhythmic medication|antiarrhythmic medication
5340993|NCT01990105|CHA2DS2VASc score|cha2ds2vasc score
5340994|NCT01990105|HAS-BLED score|has-bled score
5340995|NCT01990105|CHADS2 score|chads2 score
5340996|NCT01990092|Metanx|metanx
5340997|NCT01990092|B vitamins|b vitamins
5340998|NCT01990092|neuropathy|neuropathy
5340999|NCT01990092|nutrition|nutrition
5341000|NCT01990079|PTSD|ptsd
5341001|NCT01990079|smoking|smoking
5341002|NCT01990066|Quality of Life|quality of life
5341004|NCT01990040|Short Bowel Syndrome|short bowel syndrome
5341006|NCT01990040|teduglutide|teduglutide
5341007|NCT01990040|Gattex|gattex
5341008|NCT01990027|kidney stone|kidney stone
5341009|NCT01990001|contraception, adherence, medication reminder|contraception, adherence, medication reminder
5341010|NCT01989988|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5341011|NCT01989988|Obesity|obesity
5341012|NCT01989988|Laparoscopic gastric bypass|laparoscopic gastric bypass
5341013|NCT01989988|Duodenum exclusion|duodenum exclusion
5341014|NCT01989975|Sensor-Augmented Pump Therapy|sensor-augmented pump therapy
5341015|NCT01989975|Connected Care|connected care
5341016|NCT01989962|Aboriginal Health|aboriginal health
5341017|NCT01989962|Diabetes Mellitus Type 2|diabetes mellitus type 2
5963395|NCT04247282|Immunotherapy|immunotherapy
5963396|NCT04247282|Head and Neck Cancer|head and neck cancer
5963397|NCT04247061|Dental cleaning|dental cleaning
5963398|NCT04247061|Video|video
5963399|NCT04247061|Text messages|text messages
5963400|NCT04245826|body weight|body weight
5341018|NCT01989962|Cultural Competency|cultural competency
5341019|NCT01989962|Continuing Medical Education|continuing medical education
5341020|NCT01989923|Smoking cessation|smoking cessation
5862866|NCT00001476|Granulocytes|granulocytes
5341021|NCT01989923|Traditional nicotine replacement therapy|traditional nicotine replacement therapy
5341022|NCT01989923|Electronic nicotine delivery devices|electronic nicotine delivery devices
5341023|NCT01989923|electronic cigarettes|electronic cigarettes
5341024|NCT01989923|cervical dysplasia|cervical dysplasia
5341025|NCT01989910|Efavirenz|efavirenz
5341026|NCT01989910|Raltegravir|raltegravir
5341027|NCT01989910|Combination antiretroviral therapy|combination antiretroviral therapy
5341028|NCT01989897|diluent|diluent
5341029|NCT01989897|rhinitis|rhinitis
5341030|NCT01989897|allergic|allergic
5341031|NCT01989871|preterm|preterm
5341032|NCT01989871|oral feeding|oral feeding
5341033|NCT01989871|outcome|outcome
5341034|NCT01989858|localized gastric adenocarcinoma, operable considered.|localized gastric adenocarcinoma, operable considered.
5341035|NCT01989832|cohort|cohort
5341036|NCT01989832|pharmaco-economic|pharmaco-economic
5341037|NCT01989832|kidney|kidney
5341038|NCT01989832|transplantation|transplantation
5341039|NCT01989832|quality of life|quality of life
5341040|NCT01989806|Spinal cord injury|spinal cord injury
5341041|NCT01989806|robotic|robotic
5341042|NCT01989806|locomotion|locomotion
5341043|NCT01989793|sarcopenia|sarcopenia
5341044|NCT01989793|frailty|frailty
5341045|NCT01989793|losartan|losartan
5341046|NCT01989767|sickness absence|sickness absence
5341047|NCT01989767|rehabilitation|rehabilitation
5341048|NCT01989767|mental disorders|mental disorders
5341049|NCT01989767|screening|screening
5341050|NCT01989754|Albuminuria|albuminuria
5341051|NCT01989754|Canagliflozin|canagliflozin
5341052|NCT01989754|Cardiovascular outcomes|cardiovascular outcomes
5341053|NCT01989754|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5341054|NCT01989754|T2DM|t2dm
5341055|NCT01989754|JNJ-28431754|jnj-28431754
5341056|NCT01989754|Antihyperglycemic Agent|antihyperglycemic agent
5341057|NCT01989741|sleep restriction, decision making, wakefullness|sleep restriction, decision making, wakefullness
5445424|NCT01521871|Cyanoacrylate|cyanoacrylate
5445425|NCT01521871|Wound closure|wound closure
5341058|NCT01989728|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation|sickness absence, return to work, psychiatric examination, feedback, psychological distress, quality of life, attrition analysis, multiple imputation
5341059|NCT01989689|PSORIASIS|psoriasis
5341060|NCT01989676|Phase 3|phase 3
5341061|NCT01989676|trastuzumab|trastuzumab
5341062|NCT01989676|Breast Neoplasms|breast neoplasms
5341063|NCT01989663|Healthy Women|healthy women
5341064|NCT01989624|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5341066|NCT01989624|treatment|treatment
5341067|NCT01989546|DNA Damage|dna damage
5341068|NCT01989546|Advanced Solid Tumors|advanced solid tumors
5341069|NCT01989546|BRCA Mutations|brca mutations
5341070|NCT01989546|PARP Inhibitor|parp inhibitor
5341071|NCT01989546|Pharmacodynamics|pharmacodynamics
5341072|NCT01989533|HIV Vaccine|hiv vaccine
5341073|NCT01989533|Healthy Volunteer|healthy volunteer
5341201|NCT01989052|CeeNU|ceenu
5341074|NCT01989520|Relative bioavailability, Healthy volunteers, Neutrophils|relative bioavailability, healthy volunteers, neutrophils
5341075|NCT01989507|tobacco smoking|tobacco smoking
5341076|NCT01989507|smoking cessation|smoking cessation
5341077|NCT01989507|nicotine dependence|nicotine dependence
5341078|NCT01989507|tobacco use disorder|tobacco use disorder
5341079|NCT01989494|anesthesiologists|anesthesiologists
5341080|NCT01989494|physical activity|physical activity
5341081|NCT01989494|pedometer|pedometer
5341082|NCT01989494|wellness|wellness
5341083|NCT01989494|exercise|exercise
5341084|NCT01989468|Psoriatic arthritis|psoriatic arthritis
5341085|NCT01989468|AIN457|ain457
5341087|NCT01989468|ACR|acr
5341088|NCT01989468|CASPAR|caspar
5341089|NCT01989468|PASDAS|pasdas
5341090|NCT01989468|secukinumab|secukinumab
5341091|NCT01989468|autoinjector|autoinjector
5341092|NCT01989455|Healthy|healthy
5341093|NCT01989455|Deferiprone|deferiprone
5341094|NCT01989455|DFP|dfp
5341095|NCT01989455|L1|l1
5341096|NCT01989442|cpap failure|cpap failure
5341097|NCT01989442|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5341098|NCT01989442|nasal trauma|nasal trauma
5341099|NCT01989442|ventilation duration|ventilation duration
5341100|NCT01989442|non-invasive ventilation|non-invasive ventilation
5341101|NCT01989429|psoriasis|psoriasis
5341102|NCT01989429|Vitamin D3|vitamin d3
5341103|NCT01989429|topical|topical
5341104|NCT01989429|ointments|ointments
5341105|NCT01989416|colonization|colonization
5341106|NCT01989338|hallux valgus|hallux valgus
5341107|NCT01989338|pain|pain
5341108|NCT01989338|functional status|functional status
5341109|NCT01989338|quality of life|quality of life
5341110|NCT01989312|ultrasound|ultrasound
5341111|NCT01989312|peripheral nerves|peripheral nerves
5341112|NCT01989312|anesthetics|anesthetics
5341113|NCT01989312|local|local
5341114|NCT01989299|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5341115|NCT01989299|ILR|ilr
5963401|NCT04245826|BMI|bmi
5341116|NCT01989299|ventricular tachyarrhythmias|ventricular tachyarrhythmias
5341117|NCT01989299|Safety|safety
5341118|NCT01989286|Plagiocephaly|plagiocephaly
5341119|NCT01989286|Posture|posture
5341120|NCT01989286|Spine|spine
5341121|NCT01989273|Trauma|trauma
5341122|NCT01989273|Ultrasound|ultrasound
5341124|NCT01989273|Resuscitation|resuscitation
5341125|NCT01989260|Endometriosis|endometriosis
5341126|NCT01989247|Depression|depression
5341127|NCT01989247|Anxiety|anxiety
5341128|NCT01989247|Randomized Controlled Trial|randomized controlled trial
5341129|NCT01989247|Self Care|self care
5341130|NCT01989247|Intervention Studies|intervention studies
5341131|NCT01989247|Health Education|health education
5341132|NCT01989208|Heart Failure|heart failure
5341133|NCT01989208|Congestive Heart Failure|congestive heart failure
5341134|NCT01989208|Oxidative Stress|oxidative stress
5341135|NCT01989208|Hydrogen Sulfide|hydrogen sulfide
5341136|NCT01989195|ISCHEMIC OR CORONARY HEART DISEASE|ischemic or coronary heart disease
5341137|NCT01989195|MYOCARDIAL INFARCTION|myocardial infarction
5341138|NCT01989195|MAGNETIC RESONANCE IMAGING|magnetic resonance imaging
5341139|NCT01989195|DELAYED GADOLINIUM ENHANCEMENT MRI|delayed gadolinium enhancement mri
5341140|NCT01989195|MANGANESE-ENHANCED MRI|manganese-enhanced mri
5341141|NCT01989195|INFARCT VOLUME/SIZE|infarct volume/size
5341142|NCT01989195|ALL CAUSE MORTALITY|all cause mortality
5341143|NCT01989195|VENTRICULAR ARRHYTHMIAS|ventricular arrhythmias
5341144|NCT01989182|Endobronchial Valves|endobronchial valves
5341145|NCT01989182|Intrabronchial Valves|intrabronchial valves
5341146|NCT01989182|Bronchial Valve|bronchial valve
5341147|NCT01989182|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5341148|NCT01989182|COPD|copd
5341149|NCT01989182|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5341150|NCT01989182|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5341151|NCT01989182|BLVR|blvr
5341152|NCT01989182|TLVR|tlvr
5341153|NCT01989182|Emphysema|emphysema
5341154|NCT01989182|Pulmonary Emphysema|pulmonary emphysema
5341155|NCT01989182|Pathologic Process|pathologic process
5341156|NCT01989182|Lung Diseases|lung diseases
5341157|NCT01989182|Respiratory Tract Disease|respiratory tract disease
5341158|NCT01989182|China|china
5341159|NCT01989182|Spiration Valve System (SVS)|spiration valve system (svs)
5341160|NCT01989156|Smoking|smoking
5341161|NCT01989156|Candidate modified risk tobacco product|candidate modified risk tobacco product
5341162|NCT01989156|Menthol conventional cigarettes|menthol conventional cigarettes
5341163|NCT01989156|Reduced exposure|reduced exposure
5341164|NCT01989156|HPHCs|hphcs
5341165|NCT01989156|Ambulatory|ambulatory
5341166|NCT01989143|Phase 1|phase 1
5341167|NCT01989143|Randomized|randomized
5341168|NCT01989143|Double-blind|double-blind
5341169|NCT01989143|Placebo-controlled|placebo-controlled
5341170|NCT01989143|Dose escalating|dose escalating
5341171|NCT01989143|Single and Multiple doses|single and multiple doses
5341172|NCT01989143|Safety|safety
5341173|NCT01989143|Tolerability|tolerability
5341174|NCT01989143|PK/PD|pk/pd
5341175|NCT01989143|PF-06480605|pf-06480605
5341176|NCT01989130|antimicrobial stewardship|antimicrobial stewardship
5341177|NCT01989130|Cepheid Xpert CT/NG|cepheid xpert ct/ng
5341178|NCT01989130|chlamydia|chlamydia
5341179|NCT01989130|gonorrhea|gonorrhea
5341485|NCT01987856|live birth|live birth
5341180|NCT01989130|emergency department|emergency department
5341181|NCT01989130|Diagnostic Techniques, Obstetrical and Gynecological|diagnostic techniques, obstetrical and gynecological
5341182|NCT01989130|Diagnostic Techniques, Urological|diagnostic techniques, urological
5341183|NCT01989104|Indirect calorimetry|indirect calorimetry
5341184|NCT01989091|kidney dialysis|kidney dialysis
5341185|NCT01989091|hemodialysis|hemodialysis
5341186|NCT01989091|locking solution|locking solution
5341187|NCT01989091|antimicrobial|antimicrobial
5341188|NCT01989091|thrombolytic|thrombolytic
5341189|NCT01989078|Kidney disorder|kidney disorder
5341190|NCT01989078|Blood disorder|blood disorder
5341191|NCT01989078|Pediatrics|pediatrics
5341192|NCT01989065|Child obesity|child obesity
5341193|NCT01989065|childhood obesity|childhood obesity
5341194|NCT01989065|obesity treatment|obesity treatment
5341195|NCT01989065|text messaging|text messaging
5341196|NCT01989065|Lifestyle|lifestyle
5341197|NCT01989052|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
5341199|NCT01989052|Lomustine|lomustine
5341200|NCT01989052|N-(2-chloroethyl)-N'-cyclo-hexyl-N-nitrosourea (CCNU)|n-(2-chloroethyl)-n'-cyclo-hexyl-n-nitrosourea (ccnu)
5341202|NCT01989052|Malignant Glioma|malignant glioma
5341203|NCT01989052|Pro00047969|pro00047969
5341204|NCT01989052|Desjardins|desjardins
5341205|NCT01989052|Duke|duke
5341206|NCT01989052|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
5341208|NCT01989026|non-specific effects|non-specific effects
5341209|NCT01989026|neonatal mortality|neonatal mortality
5341210|NCT01989026|vaccines|vaccines
5341211|NCT01989013|Parkinson's disease|parkinson's disease
5341212|NCT01989013|Craniosacral therapy|craniosacral therapy
5341213|NCT01989013|cranial osteopathy|cranial osteopathy
5341214|NCT01989000|Pancreatic cancer|pancreatic cancer
5341215|NCT01989000|Hypoxia|hypoxia
5341216|NCT01989000|Vasculature|vasculature
5341217|NCT01989000|Stroma|stroma
5341218|NCT01988987|Gestational diabetes|gestational diabetes
5341219|NCT01988987|Postpartum glucose testing|postpartum glucose testing
5341220|NCT01988987|Impaired glucose metabolism|impaired glucose metabolism
5341221|NCT01988987|Diabetes mellitus|diabetes mellitus
5341222|NCT01988961|Colitis, Ulcerative|colitis, ulcerative
5341223|NCT01988961|Golimumab|golimumab
5341224|NCT01988961|CNTO148|cnto148
5341225|NCT01988961|SIMPONI|simponi
5341226|NCT01988961|Length-109 Probe Set Panel|length-109 probe set panel
5341227|NCT01988948|Human papilloma virus|human papilloma virus
5341228|NCT01988948|Young women|young women
5341229|NCT01988948|I-Share|i-share
5341230|NCT01988922|ketamine polymorphisms|ketamine polymorphisms
5341231|NCT01988909|Cutaneous leishmaniasis|cutaneous leishmaniasis
5341232|NCT01988909|Paromomycin + Gentamicin Topical Cream|paromomycin + gentamicin topical cream
5341233|NCT01988909|Safety|safety
5341234|NCT01988909|Efficacy|efficacy
5341235|NCT01988883|Postural Tachycardia Syndrome|postural tachycardia syndrome
5341236|NCT01988883|Tachycardia|tachycardia
5341237|NCT01988883|Orthostatic Intolerance|orthostatic intolerance
5341238|NCT01988883|Autonomic Nervous System Diseases|autonomic nervous system diseases
5341239|NCT01988883|Primary Dysautonomias|primary dysautonomias
5341240|NCT01988883|Nervous System Diseases|nervous system diseases
5341241|NCT01988883|Cardiovascular Diseases|cardiovascular diseases
5341242|NCT01988883|Modafinil|modafinil
5341243|NCT01988883|Propranolol|propranolol
5341244|NCT01988883|Neurobehavioral Manifestations|neurobehavioral manifestations
5341245|NCT01988883|Neurologic Manifestations|neurologic manifestations
5341246|NCT01988883|Cognitive Symptoms|cognitive symptoms
5341247|NCT01988883|Neuropsychological Tests|neuropsychological tests
5341248|NCT01988857|Vietnam|vietnam
5341249|NCT01988857|Children|children
5341250|NCT01988857|Reactogenicity|reactogenicity
5341251|NCT01988857|BoostrixTM|boostrixtm
5341252|NCT01988857|Safety|safety
5341253|NCT01988857|dTpa|dtpa
5341254|NCT01988857|Booster|booster
5341255|NCT01988857|Healthy|healthy
5341256|NCT01988844|functionality|functionality
5341257|NCT01988844|Cerebral palsy|cerebral palsy
5341258|NCT01988844|Handwriting|handwriting
5341259|NCT01988831|Malignant melanoma|malignant melanoma
5341261|NCT01988831|propranolol|propranolol
5341262|NCT01988831|interventional|interventional
5341263|NCT01988831|prospective|prospective
5341264|NCT01988831|adjuvant|adjuvant
5341265|NCT01988831|recurrence|recurrence
5341266|NCT01988818|wound dressing|wound dressing
5341267|NCT01988818|silicone|silicone
5341268|NCT01988818|standard wound dressing|standard wound dressing
5341269|NCT01988766|Thrombosis|thrombosis
5341270|NCT01988766|Central Venosis Catheter|central venosis catheter
5341271|NCT01988766|Renal Disease|renal disease
5341272|NCT01988766|Vascular Access|vascular access
5341273|NCT01988753|Serum Biomarkers|serum biomarkers
5341274|NCT01988753|Sheer-wave Elastography|sheer-wave elastography
5341275|NCT01988753|Ultrasound imaging|ultrasound imaging
5341276|NCT01988753|Viral hepatitis|viral hepatitis
5341277|NCT01988753|Liver Fibrosis|liver fibrosis
5341278|NCT01988753|Liver disease|liver disease
5341279|NCT01988753|Hepatitis B|hepatitis b
5341280|NCT01988753|Hepatitis C|hepatitis c
5341486|NCT01987843|Psoriasis|psoriasis
5341282|NCT01988740|Recurrent pregnancy loss|recurrent pregnancy loss
5341284|NCT01988714|Targeted cognitive training (TCT) plus evidence-based SE|targeted cognitive training (tct) plus evidence-based se
5341285|NCT01988714|Computer games (CG) plus evidence-based SE|computer games (cg) plus evidence-based se
5341286|NCT01988701|GVHD|gvhd
5341287|NCT01988701|chronic Graft versus Host Disease|chronic graft versus host disease
5341288|NCT01988688|deep brain stimulation|deep brain stimulation
5341289|NCT01988662|nAMD, VEGF, VEGF agent, BCVA, CRT, Ranibizumab, Lucentis, Aflibercept, Eylea|namd, vegf, vegf agent, bcva, crt, ranibizumab, lucentis, aflibercept, eylea
5341290|NCT01988649|Pain|pain
5341291|NCT01988649|Oxytocin|oxytocin
5341292|NCT01988636|Randomized|randomized
5341293|NCT01988636|Double Blinded|double blinded
5341294|NCT01988636|Mali|mali
5341295|NCT01988636|Malaria|malaria
5341296|NCT01988636|Transmission|transmission
5341297|NCT01988623|Intellectual Disabilities|intellectual disabilities
5341298|NCT01988623|Speech Delay|speech delay
5341299|NCT01988623|Language Disorder|language disorder
5341311|NCT01988584|Umbilical Cord Blood|umbilical cord blood
5341312|NCT01988571|Stage I breast cancer|stage i breast cancer
5341313|NCT01988571|Stage II breast cancer|stage ii breast cancer
5341314|NCT01988571|Stage III breast cancer|stage iii breast cancer
5341315|NCT01988558|Recurrent Tonsillitis|recurrent tonsillitis
5341316|NCT01988558|Streptococcus A|streptococcus a
5341317|NCT01988545|GLP-1|glp-1
5341318|NCT01988545|blood flow|blood flow
5341319|NCT01988545|cardiac out put|cardiac out put
5341320|NCT01988545|stroke volume|stroke volume
5341321|NCT01988545|beat to beat|beat to beat
5341322|NCT01988545|effect of GLP-1 on cardiac parameters and blood flow|effect of glp-1 on cardiac parameters and blood flow
5341334|NCT01988493|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5341335|NCT01988493|MSC2156119J|msc2156119j
5341336|NCT01988493|Sorafenib|sorafenib
5341337|NCT01988493|Recommended Phase 2 dose|recommended phase 2 dose
5341338|NCT01988480|Guided surgery|guided surgery
5341339|NCT01988480|Sinus graft|sinus graft
5341340|NCT01988467|nasal breathing, oral breathing, secondhand smoking,|nasal breathing, oral breathing, secondhand smoking,
5341343|NCT01988441|polymorphism|polymorphism
5341345|NCT01988428|severe sepsis|severe sepsis
5341346|NCT01988428|septic shock|septic shock
5341348|NCT01988402|allopurinol|allopurinol
5341349|NCT01988363|greater occipital nerve|greater occipital nerve
5341350|NCT01988363|occipital neuralgia|occipital neuralgia
5341351|NCT01988363|cervicogenic headache|cervicogenic headache
5341352|NCT01988350|pancreatic insufficiency|pancreatic insufficiency
5341353|NCT01988350|pancreatic elastase|pancreatic elastase
5341354|NCT01988350|fecal elastase|fecal elastase
5341355|NCT01988350|smoking|smoking
5341356|NCT01988350|tobacco|tobacco
5341357|NCT01988337|Icon|icon
5341358|NCT01988311|Psilocybin|psilocybin
5341359|NCT01988311|Hallucinogens|hallucinogens
5341360|NCT01988311|Pharmacologic Actions|pharmacologic actions
5341361|NCT01988311|Central Nervous System Agents|central nervous system agents
5341362|NCT01988311|Therapeutic Uses|therapeutic uses
5341363|NCT01988311|Psychotropic Drugs|psychotropic drugs
5341364|NCT01988285|Esophagitis|esophagitis
5341365|NCT01988285|Eosinophilic Esophagitis|eosinophilic esophagitis
5341366|NCT01988285|Esophageal Diseases|esophageal diseases
5341367|NCT01988285|Gastrointestinal Diseases|gastrointestinal diseases
5341368|NCT01988285|Digestive System Diseases|digestive system diseases
5341369|NCT01988272|SPECT/CT|spect/ct
5341370|NCT01988272|Dosimetry|dosimetry
5341371|NCT01988272|Radiation absorbed dose|radiation absorbed dose
5341372|NCT01988272|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5341373|NCT01988272|I-131 tositumomab radioimmunotherapy|i-131 tositumomab radioimmunotherapy
5341376|NCT01988233|Physical activity|physical activity
5341377|NCT01988233|Dance|dance
5341378|NCT01988233|Latinos|latinos
5341380|NCT01988233|Older adults|older adults
5341381|NCT01988233|Health disparities|health disparities
5341383|NCT01988220|sensory deficit|sensory deficit
5341384|NCT01988220|sensory retraining|sensory retraining
5341385|NCT01988220|perceptual learning|perceptual learning
5341386|NCT01988220|lower extremity|lower extremity
5341387|NCT01988207|Muscle Tension Dysphonia|muscle tension dysphonia
5341388|NCT01988207|Voice|voice
5341389|NCT01988207|Hyperfunction|hyperfunction
5341390|NCT01988194|acupuncture|acupuncture
5341391|NCT01988194|postoperative pain|postoperative pain
5341392|NCT01988194|nausea|nausea
5341393|NCT01988194|vomiting|vomiting
5341394|NCT01988194|anxiety|anxiety
5341395|NCT01988194|depression|depression
5341396|NCT01988194|hospitalization|hospitalization
5341397|NCT01988194|inpatient|inpatient
5341398|NCT01988181|Intradialytic Hypotension|intradialytic hypotension
5341399|NCT01988181|Renal Dialysis|renal dialysis
5341400|NCT01988181|Blood Volume Determination|blood volume determination
5341401|NCT01988181|Clinical Trials, Randomized|clinical trials, randomized
5341402|NCT01988181|Crossover Studies|crossover studies
5341403|NCT01988168|Suture Techniques|suture techniques
5341404|NCT01988168|Sutures|sutures
5341405|NCT01988168|Surgical Staplers|surgical staplers
5341406|NCT01988142|Spinal Cord Injury|spinal cord injury
5341407|NCT01988142|Passive motion|passive motion
5341408|NCT01988142|Fatigue index|fatigue index
5341409|NCT01988142|Hypertonia|hypertonia
5341410|NCT01988129|sleep|sleep
5341411|NCT01988129|firefighter|firefighter
5341412|NCT01988129|fire|fire
5341413|NCT01988129|apnea|apnea
5341414|NCT01988129|insomnia|insomnia
5341415|NCT01988129|shift|shift
5341416|NCT01988129|narcolepsy|narcolepsy
5341417|NCT01988129|restless leg|restless leg
5341419|NCT01988129|fatigue|fatigue
5341420|NCT01988129|actigraph|actigraph
5341421|NCT01988129|actigraphy|actigraphy
5341422|NCT01988129|actiwatch|actiwatch
5341423|NCT01988129|safety|safety
5341424|NCT01988129|sleepiness|sleepiness
5341425|NCT01988129|sleepy|sleepy
5341426|NCT01988129|work|work
5341427|NCT01988129|hours|hours
5341428|NCT01988129|Federal Emergency Management Agency|federal emergency management agency
5341429|NCT01988129|drowsy|drowsy
5341430|NCT01988116|Chronic kidney disease|chronic kidney disease
5341431|NCT01988116|Anemia of chronic disease|anemia of chronic disease
5341432|NCT01988116|Iron Metabolism|iron metabolism
5341433|NCT01988116|Iron Homeostasis|iron homeostasis
5341434|NCT01988116|Vitamin D|vitamin d
5341435|NCT01988116|Calcitriol|calcitriol
5341436|NCT01988116|hemojuvelin|hemojuvelin
5341437|NCT01988116|hepcidin|hepcidin
5341438|NCT01988116|anemia|anemia
5341439|NCT01988116|ferroportin|ferroportin
5341440|NCT01988103|Psoriasis; Psoriatic Arthritis|psoriasis; psoriatic arthritis
5341441|NCT01988090|Breast Cancer|breast cancer
5341442|NCT01988090|Hormone Receptor Positive|hormone receptor positive
5341443|NCT01988090|Vitamin D|vitamin d
5341444|NCT01988064|pulse rate|pulse rate
5341445|NCT01988064|patient education|patient education
5341446|NCT01988064|training|training
5341447|NCT01988038|Polycystic Kidney Disease|polycystic kidney disease
5341448|NCT01988038|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5341454|NCT01987986|mattress texture|mattress texture
5341455|NCT01987947|MEMP1972A|memp1972a
5341456|NCT01987934|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5341457|NCT01987934|Methyl Green Pyronin Staining|methyl green pyronin staining
5341458|NCT01987934|AgNORs|agnors
5341459|NCT01987934|Morphometry|morphometry
5341460|NCT01987921|Acute kidney injury|acute kidney injury
5341461|NCT01987921|Pediatrics|pediatrics
5341462|NCT01987921|Critical Care|critical care
5341463|NCT01987908|Pain|pain
5341464|NCT01987908|Biomarkers|biomarkers
5341465|NCT01987908|6 minute walk test|6 minute walk test
5341466|NCT01987908|5-HMF|5-hmf
5341467|NCT01987908|Pharmacokinetics|pharmacokinetics
5341468|NCT01987908|Analgesic use|analgesic use
5341469|NCT01987908|Sickle cell disease|sickle cell disease
5341470|NCT01987908|Aes-103|aes-103
5341471|NCT01987908|SpO2|spo2
5341472|NCT01987908|Anemia|anemia
5341473|NCT01987908|Hemoglobin|hemoglobin
5341474|NCT01987895|Post-antibiotic diarrhea|post-antibiotic diarrhea
5341475|NCT01987895|Clostridium difficile infection|clostridium difficile infection
5341476|NCT01987882|Outcomes research, treatment effectiveness, quality of life|outcomes research, treatment effectiveness, quality of life
5341477|NCT01987869|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria|hiperemesis gravidarum,vomiting,serotonin levels,ketonuria
5341478|NCT01987856|aCGH|acgh
5341479|NCT01987856|chromosome|chromosome
5341480|NCT01987856|blastocyst|blastocyst
5341481|NCT01987856|trophectoderm|trophectoderm
5341482|NCT01987856|vitrification|vitrification
5341483|NCT01987856|natural cycle|natural cycle
5341484|NCT01987856|pregnancy|pregnancy
5341487|NCT01987843|Plaque Psoriasis|plaque psoriasis
5341488|NCT01987830|Recurrent glioblastoma|recurrent glioblastoma
5341489|NCT01987817|Characterized Peanut Allergen|characterized peanut allergen
5341490|NCT01987817|Peanut|peanut
5341492|NCT01987817|Oral Desensitization|oral desensitization
5341493|NCT01987817|Peanut Allergen|peanut allergen
5341494|NCT01987817|Allergy|allergy
5341495|NCT01987817|Peanut Allergy|peanut allergy
5341496|NCT01987817|Peanut-Allergic Children|peanut-allergic children
5341497|NCT01987817|Children|children
5341498|NCT01987817|Peanut-Allergic Adults|peanut-allergic adults
5341499|NCT01987778|Hot flashes|hot flashes
5341500|NCT01987778|Menopause|menopause
5341501|NCT01987778|HRQoL|hrqol
5341502|NCT01987778|Resistance training|resistance training
5341503|NCT01987778|Physical activity|physical activity
5341504|NCT01987778|Adipose tissue|adipose tissue
5341505|NCT01987739|Almorexant|almorexant
5341506|NCT01987739|Zolpidem|zolpidem
5341507|NCT01987726|Solid Tumor Malignancies|solid tumor malignancies
5341508|NCT01987700|Abdominal Hernia Repair|abdominal hernia repair
5341509|NCT01987700|Dermal Allograft|dermal allograft
5341510|NCT01987700|Mesh|mesh
5341511|NCT01987700|Component Separation|component separation
5341512|NCT01987661|COPD|copd
5341513|NCT01987661|NIV|niv
5341530|NCT01987622|randomized controlled trial|randomized controlled trial
5341531|NCT01987609|Psoriasis|psoriasis
5341532|NCT01987609|Dendritic cells|dendritic cells
5341533|NCT01987609|Hyaluronidase|hyaluronidase
5341534|NCT01987609|Hylenex|hylenex
5341535|NCT01987570|Xanthine oxidase|xanthine oxidase
5341536|NCT01987570|Magnetic resonance|magnetic resonance
5341537|NCT01987570|Oxidative stress|oxidative stress
5341538|NCT01987570|Inflammation|inflammation
5341539|NCT01987557|treadmill|treadmill
5341540|NCT01987557|parkinson's|parkinson's
5341541|NCT01987557|proprioception|proprioception
5341542|NCT01987557|cadence|cadence
5341543|NCT01987557|step length|step length
5341544|NCT01987557|intrinsic feedback|intrinsic feedback
5341545|NCT01987544|COPD|copd
5341546|NCT01987544|telemonitoring|telemonitoring
5341547|NCT01987544|training|training
5341548|NCT01987544|ergometer|ergometer
5341549|NCT01987544|telemedicine|telemedicine
5341550|NCT01987531|after open cardiac chamber cardiac surgery|after open cardiac chamber cardiac surgery
5341551|NCT01987466|Neutrophil Gelatinase-associated Lipocalin(NGAL)|neutrophil gelatinase-associated lipocalin(ngal)
5341552|NCT01987466|Acute renal failure|acute renal failure
5341553|NCT01987466|Cardiac arrest|cardiac arrest
5341554|NCT01987466|Hypothermia|hypothermia
5341555|NCT01987453|genotype 1|genotype 1
5341556|NCT01987427|Overweight|overweight
5341557|NCT01987427|Obese|obese
5341558|NCT01987427|Weight Management|weight management
5341559|NCT01987414|Stroke|stroke
5680073|NCT00579280|GAD|gad
5341560|NCT01987414|Cardiovascular Accident|cardiovascular accident
5341561|NCT01987414|Task-oriented approach|task-oriented approach
5341562|NCT01987414|Orthosis|orthosis
5341563|NCT01987414|occupational therapy|occupational therapy
5341564|NCT01987401|pulmonary|pulmonary
5341565|NCT01987401|lung|lung
5341566|NCT01987401|military and environmental exposures|military and environmental exposures
5220909|NCT02618499|umbilical cord clamping|umbilical cord clamping
5220910|NCT02618473|Coronary computed tomography angiography|coronary computed tomography angiography
5220911|NCT02618473|motion artifacts|motion artifacts
5220912|NCT02618473|motion correction algorithm|motion correction algorithm
5222113|NCT02610270|omega 3|omega 3
5341567|NCT01987401|epidemiologic|epidemiologic
5341568|NCT01987401|observational|observational
5341569|NCT01987401|interview or questionnaire|interview or questionnaire
5341570|NCT01987401|deployment related|deployment related
5341571|NCT01987401|Enduring Freedom|enduring freedom
5341572|NCT01987401|Iraqi Freedom|iraqi freedom
5341573|NCT01987375|HNSCC|hnscc
5341574|NCT01987375|Imaging|imaging
5341575|NCT01987349|Influenza vaccines|influenza vaccines
5341576|NCT01987349|healthy participants|healthy participants
5341577|NCT01987349|immunity to influenza|immunity to influenza
5341578|NCT01987349|identical twins|identical twins
5341579|NCT01987349|fraternal twins|fraternal twins
5341580|NCT01987349|non-twins|non-twins
5341581|NCT01987336|Standard Foley Catheter|standard foley catheter
5341582|NCT01987323|glaucoma|glaucoma
5341583|NCT01987323|raised intraocular pressure|raised intraocular pressure
5341709|NCT01986634|Laser Resurfacing|laser resurfacing
5341584|NCT01987310|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5341585|NCT01987310|endothelial function|endothelial function
5341586|NCT01987310|liver steatosis|liver steatosis
5341788|NCT01986348|selinexor|selinexor
5341587|NCT01987310|liver fibrosis|liver fibrosis
5341588|NCT01987310|statin treatment|statin treatment
5341589|NCT01987297|acute promyelocytic leukemia|acute promyelocytic leukemia
5341590|NCT01987297|ATRA|atra
5341591|NCT01987297|arsenic|arsenic
5341592|NCT01987271|exercise tolerance|exercise tolerance
5341593|NCT01987271|exercise test|exercise test
5341597|NCT01987219|familial dysautonomia|familial dysautonomia
5341598|NCT01987206|artificial pancreas|artificial pancreas
5341599|NCT01987193|Proton radiation|proton radiation
5341600|NCT01987193|tumor blood flow|tumor blood flow
5341601|NCT01987180|self-efficacy|self-efficacy
5341602|NCT01987167|acute optic neuritis|acute optic neuritis
5341603|NCT01987115|Trigger Finger|trigger finger
5341604|NCT01987115|Physiotherapy|physiotherapy
5341605|NCT01987115|Fascial Manipulation|fascial manipulation
5341607|NCT01987102|Rescue treatment|rescue treatment
5341608|NCT01987089|Insomnia|insomnia
5341609|NCT01987089|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
5341610|NCT01987089|Alcoholism|alcoholism
5341611|NCT01987089|Cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5341612|NCT01987076|DRESS|dress
5341613|NCT01987076|Systemic steroid|systemic steroid
5341614|NCT01987076|Topical steroid|topical steroid
5341615|NCT01987076|Treatment|treatment
5341616|NCT01987063|Twin delivery|twin delivery
5341617|NCT01987063|Planned vaginal delivery|planned vaginal delivery
5341618|NCT01987063|Planned cesarean delivery|planned cesarean delivery
5341619|NCT01987063|Total breech extraction|total breech extraction
5341620|NCT01987063|Internal cephalic version|internal cephalic version
5341621|NCT01987063|External cephalic version|external cephalic version
5341622|NCT01987037|autism spectrum disorder|autism spectrum disorder
5341623|NCT01987037|neuropsychomotor assessment|neuropsychomotor assessment
5341624|NCT01987037|NP-MOT|np-mot
5341625|NCT01987037|motor skills|motor skills
5341626|NCT01987037|gross motor|gross motor
5341627|NCT01987011|Avian influenza|avian influenza
5341628|NCT01986998|Multiple sclerosis relapse|multiple sclerosis relapse
5341629|NCT01986998|oral methylprednisolone|oral methylprednisolone
5341630|NCT01986998|EDSS|edss
5341631|NCT01986998|gadolinium|gadolinium
5341632|NCT01986972|Toothbrushing|toothbrushing
5341633|NCT01986972|Dental plaque|dental plaque
5341634|NCT01986972|Dentifrice|dentifrice
5341635|NCT01986972|Oral hygiene|oral hygiene
5341636|NCT01986959|Periodontal Dressings|periodontal dressings
5341637|NCT01986959|Surgical crown lengthening|surgical crown lengthening
5341638|NCT01986959|Periodontal surgery|periodontal surgery
5341640|NCT01986920|Seborrheic Keratosis|seborrheic keratosis
5341641|NCT01986907|wet AMD|wet amd
5341642|NCT01986907|macular degeneration|macular degeneration
5341643|NCT01986907|ranibizumab|ranibizumab
5341644|NCT01986907|mono-bilateral|mono-bilateral
5341645|NCT01986907|poor visual acuity|poor visual acuity
5341646|NCT01986907|retinal disease|retinal disease
5341647|NCT01986907|eye disease|eye disease
5341648|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors
5341649|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents
5341651|NCT01986894|Pharmacokinetic|pharmacokinetic
5341652|NCT01986894|Healthy|healthy
5341653|NCT01986868|Coronary Magnetic Resonance Angiography|coronary magnetic resonance angiography
5341654|NCT01986868|CMRA|cmra
5680074|NCT00579267|MINI-KID|mini-kid
5341655|NCT01986868|MRI with contrast|mri with contrast
5963402|NCT04245826|waist circumference|waist circumference
5963403|NCT04245826|diabetes|diabetes
5963404|NCT04245826|cardiovascular disease|cardiovascular disease
5963405|NCT04245826|metabolic syndrome|metabolic syndrome
5963406|NCT04245826|mortality|mortality
5963407|NCT04245826|overweight incidence|overweight incidence
5963408|NCT04245826|obesity incdience|obesity incdience
5341656|NCT01986868|MultiHance|multihance
5341657|NCT01986868|Optimark|optimark
5341658|NCT01986868|Gadolinium-based contrast|gadolinium-based contrast
5341659|NCT01986868|MRA|mra
5341660|NCT01986868|MR angiography|mr angiography
5341661|NCT01986842|Muscle protein synthesis|muscle protein synthesis
5341662|NCT01986842|Digestion and absorption kinetics|digestion and absorption kinetics
5341663|NCT01986842|Leucine|leucine
5341664|NCT01986842|Whey protein|whey protein
5341665|NCT01986816|Obesity|obesity
5337889|NCT02004457|HIV|hiv
5341666|NCT01986816|Bariatric surgery|bariatric surgery
5341667|NCT01986816|Laparoscopic gastric bypass|laparoscopic gastric bypass
5341668|NCT01986816|Quality of life|quality of life
5341669|NCT01986816|QALY|qaly
5341670|NCT01986803|ST-elevation Myocardial Infarction (STEMI)|st-elevation myocardial infarction (stemi)
5341671|NCT01986803|Primary Percutaneous Coronary Intervention within 24 hrs|primary percutaneous coronary intervention within 24 hrs
5341672|NCT01986803|Healing score|healing score
5341673|NCT01986803|OFDI|ofdi
5341674|NCT01986790|Health insurance|health insurance
5341675|NCT01986790|Health services accessibility|health services accessibility
5341676|NCT01986790|Decision making|decision making
5341677|NCT01986790|Health literacy|health literacy
5341678|NCT01986777|cognitive complains|cognitive complains
5341679|NCT01986777|RRSO|rrso
5341680|NCT01986777|oophorectomy|oophorectomy
5341681|NCT01986777|memory|memory
5341682|NCT01986777|cognition|cognition
5341683|NCT01986777|early menopause|early menopause
5341684|NCT01986764|oophorectomy|oophorectomy
5341685|NCT01986764|RRSO|rrso
5341686|NCT01986764|menopause|menopause
5341687|NCT01986764|early menopause|early menopause
5341688|NCT01986764|cognition|cognition
5341689|NCT01986764|memory|memory
5341690|NCT01986764|brain-imaging|brain-imaging
5341691|NCT01986751|nerve|nerve
5341692|NCT01986751|block|block
5341693|NCT01986751|motor blockade|motor blockade
5341694|NCT01986751|lower extremity pain|lower extremity pain
5341695|NCT01986751|nerve block|nerve block
5341696|NCT01986725|vulvar neoplasia|vulvar neoplasia
5341697|NCT01986725|vulvar cancer|vulvar cancer
5341698|NCT01986725|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
5341699|NCT01986725|self management|self management
5341700|NCT01986725|symptom management|symptom management
5341701|NCT01986712|Melanoma, Stage III, adjuvant, Quality of Life|melanoma, stage iii, adjuvant, quality of life
5341702|NCT01986699|polypectomy|polypectomy
5341703|NCT01986699|laparoscopic|laparoscopic
5341704|NCT01986673|Pharmacokinetic Characterization|pharmacokinetic characterization
5236649|NCT02523326|PCR|pcr
5341705|NCT01986660|Pharmacokinetic Study|pharmacokinetic study
5341706|NCT01986647|exercise|exercise
5341707|NCT01986647|older adults|older adults
5341708|NCT01986647|mobility disability|mobility disability
5341710|NCT01986634|Rhytids|rhytids
5341711|NCT01986634|Perioral|perioral
5341712|NCT01986621|Percutaneous Coronary Intervention|percutaneous coronary intervention
5341713|NCT01986621|Cardiac troponin|cardiac troponin
5341714|NCT01986621|Antiplatelet therapy|antiplatelet therapy
5341715|NCT01986608|Lacosamide|lacosamide
5341716|NCT01986608|Vimpat|vimpat
5341717|NCT01986608|Bioequivalence|bioequivalence
5341718|NCT01986608|Bioavailability|bioavailability
5341719|NCT01986608|Japanese|japanese
5341720|NCT01986595|Neuroblastoma|neuroblastoma
5341721|NCT01986595|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5341722|NCT01986595|cancer genetics|cancer genetics
5341723|NCT01986595|target therapy|target therapy
5341724|NCT01986595|RNA and genomic DNA extraction|rna and genomic dna extraction
5341725|NCT01986595|complementary DNA(cDNA) preparation|complementary dna(cdna) preparation
5341726|NCT01986595|Array-comparative genomic hybridization|array-comparative genomic hybridization
5341727|NCT01986595|Multiplex ligation-dependent probe amplification (MLPA)|multiplex ligation-dependent probe amplification (mlpa)
5341728|NCT01986595|Sequencing of cDNA prepared from NB|sequencing of cdna prepared from nb
5341729|NCT01986595|Pyrosequencing|pyrosequencing
5341730|NCT01986595|Quantitative real-time polymerase chain reaction(RT-PCR)|quantitative real-time polymerase chain reaction(rt-pcr)
5341731|NCT01986595|Immunohistochemistry|immunohistochemistry
5341732|NCT01986582|Allergic Rhinitis|allergic rhinitis
5341733|NCT01986582|Congestion|congestion
5341734|NCT01986582|Mucoadhesive Treatment|mucoadhesive treatment
5341735|NCT01986582|Nasal Decongestant|nasal decongestant
5341736|NCT01986569|Fluoroestradiol (FES)|fluoroestradiol (fes)
5341737|NCT01986569|PET/CT scan|pet/ct scan
5963409|NCT04245306|pragmatic inferences|pragmatic inferences
5963410|NCT04245306|non-literal language|non-literal language
5963411|NCT04245306|autism|autism
5963412|NCT04245215|dose escalation|dose escalation
5963413|NCT04245215|ustekinumab|ustekinumab
5963414|NCT04244890|Continuous Positive Airway Pressure|continuous positive airway pressure
5963415|NCT04244890|Resuscitation|resuscitation
5963416|NCT04244656|CAR T|car t
5963417|NCT04244656|Allogeneic|allogeneic
5963418|NCT04244656|Multiple myeloma|multiple myeloma
5963419|NCT04244656|CRISPR-Cas9|crispr-cas9
5963420|NCT04244292|Intubation|intubation
5963421|NCT04244292|Laryngeal view|laryngeal view
5963422|NCT04244292|Scoring systems|scoring systems
5963423|NCT04244292|Larynx|larynx
5963424|NCT04244175|CVL-865|cvl-865
5963425|NCT04244175|Anti-epileptic drugs (AEDs)|anti-epileptic drugs (aeds)
5963426|NCT04244175|Focal epilepsy|focal epilepsy
5963427|NCT04244175|γ-aminobutyric acid (GABA)|γ-aminobutyric acid (gaba)
5341738|NCT01986569|Estrogen Receptor|estrogen receptor
5341739|NCT01986569|Recurrent breast cancer|recurrent breast cancer
5341740|NCT01986569|Stage IV breast cancer|stage iv breast cancer
5341741|NCT01986543|Pharmacokinetic|pharmacokinetic
5341742|NCT01986530|irisin|irisin
5341743|NCT01986530|adiponectin|adiponectin
5341744|NCT01986530|leptin|leptin
5341745|NCT01986530|lean body mass|lean body mass
5341746|NCT01986530|fat mass|fat mass
5341747|NCT01986517|Feedback|feedback
5341748|NCT01986517|Therapeutic competencies|therapeutic competencies
5341749|NCT01986517|Training|training
5341750|NCT01986504|Infection|infection
5341751|NCT01986504|Cohort|cohort
5341752|NCT01986504|Prospective|prospective
5341753|NCT01986504|Epidemiology|epidemiology
5341754|NCT01986504|Outcome|outcome
5341755|NCT01986491|Healthy|healthy
5341756|NCT01986491|JNJ-39393406|jnj-39393406
5341757|NCT01986491|Relative Bioavailability|relative bioavailability
5341758|NCT01986491|Solid Formulation|solid formulation
5341759|NCT01986465|lateral epicondylitis|lateral epicondylitis
5341760|NCT01986465|treatment|treatment
5341761|NCT01986465|steroid|steroid
5341762|NCT01986465|immobilization|immobilization
5341764|NCT01986452|Apoplexy|apoplexy
5341765|NCT01986452|CPAP|cpap
5341766|NCT01986452|adherence|adherence
5341767|NCT01986452|telemonitoring|telemonitoring
5341768|NCT01986426|Transdermal accessible tumours|transdermal accessible tumours
5341770|NCT01986413|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
5341771|NCT01986413|NIV|niv
5341772|NCT01986413|respiratory events|respiratory events
5341773|NCT01986413|IVAPS|ivaps
5341774|NCT01986400|Adolescent|adolescent
5341775|NCT01986400|Skype|skype
5341776|NCT01986400|Peer Mentorship|peer mentorship
5341777|NCT01986400|Internet Self-Management|internet self-management
5341778|NCT01986387|adolescent|adolescent
5341779|NCT01986387|Skype|skype
5341780|NCT01986387|peer mentorship|peer mentorship
5341781|NCT01986387|internet self-management|internet self-management
5341782|NCT01986374|IVF , embryo implantation, HCG|ivf , embryo implantation, hcg
5341783|NCT01986361|Pharyngitis|pharyngitis
5341784|NCT01986361|Sore Throat|sore throat
5341785|NCT01986361|acute upper respiratory tract infection (URTI)|acute upper respiratory tract infection (urti)
5341786|NCT01986348|GBM|gbm
5341787|NCT01986348|Glioblastoma|glioblastoma
5341789|NCT01986348|KPT-330|kpt-330
5341790|NCT01986348|Karyopharm|karyopharm
5341791|NCT01986348|brain tumor|brain tumor
5341792|NCT01986348|brain cancer|brain cancer
5341793|NCT01986348|Glioma|glioma
5341794|NCT01986348|Astrocytoma|astrocytoma
5341795|NCT01986348|Oligodendrogliomas|oligodendrogliomas
5341796|NCT01986348|Oligo-astrocytomas|oligo-astrocytomas
5341797|NCT01986335|Combined pentavalent DTP/HB/Hib vaccine|combined pentavalent dtp/hb/hib vaccine
5341798|NCT01986335|Infants|infants
5341799|NCT01986335|Primary vaccination|primary vaccination
5341800|NCT01986322|DTP/HB/Hib vaccine|dtp/hb/hib vaccine
5341801|NCT01986322|Immunogenicity|immunogenicity
5341802|NCT01986322|Infants|infants
5341803|NCT01986322|Safety|safety
5341804|NCT01986309|Postoperative|postoperative
5341805|NCT01986309|Nausea|nausea
5341806|NCT01986309|Vomiting|vomiting
5341807|NCT01986309|Pain|pain
5341808|NCT01986309|Surgery|surgery
5341809|NCT01986283|Abuse potential|abuse potential
5341810|NCT01986283|PF-00345439|pf-00345439
5341811|NCT01986283|drug abuse|drug abuse
5341812|NCT01986244|Osteoarthritis|osteoarthritis
5341813|NCT01986244|Arthritis|arthritis
5341814|NCT01986244|Joint Diseases|joint diseases
5341815|NCT01986231|diabetes|diabetes
5341816|NCT01986231|insulin|insulin
5341817|NCT01986231|glucagon|glucagon
5341818|NCT01986231|glycogen|glycogen
5341819|NCT01986231|MRS|mrs
5341820|NCT01986205|Concussion|concussion
5341821|NCT01986205|Traumatic brain injury|traumatic brain injury
5341822|NCT01986205|Hyperbaric oxygenation|hyperbaric oxygenation
5341823|NCT01986205|Post-concussion symptoms|post-concussion symptoms
5341824|NCT01986205|Headache|headache
5341825|NCT01986205|Carbon monoxide|carbon monoxide
5341826|NCT01986192|anticoagulation|anticoagulation
5341827|NCT01986192|pharmacomechanical thrombolysis|pharmacomechanical thrombolysis
5341828|NCT01986192|aspiration thrombectomy|aspiration thrombectomy
5341829|NCT01986153|Fatty acid, essential|fatty acid, essential
5341830|NCT01986153|Immune system|immune system
5341831|NCT01986153|Home parenteral nutrition|home parenteral nutrition
5341832|NCT01986140|Breast Cancer|breast cancer
5341833|NCT01986140|Alopecia|alopecia
5341834|NCT01986140|Scalp|scalp
5341835|NCT01986140|Cooling|cooling
5341836|NCT01986127|Crohn disease|crohn disease
5963428|NCT04244175|Partial seizure|partial seizure
5963429|NCT04244175|PF-06372865|pf-06372865
5341837|NCT01986075|Cocaine Dependence Treatment|cocaine dependence treatment
5963430|NCT04244110|diabetes|diabetes
5963431|NCT04244110|self-management|self-management
5341838|NCT01986075|Computer-assisted therapy|computer-assisted therapy
5341839|NCT01986075|Pharmacotherapy|pharmacotherapy
5341840|NCT01986062|ADHD|adhd
5341841|NCT01986062|AR11|ar11
5341842|NCT01986062|classroom design|classroom design
5341843|NCT01986062|amphetamine sulfate|amphetamine sulfate
5341844|NCT01986023|Stroke|stroke
5341845|NCT01986023|Medication Adherence|medication adherence
5341846|NCT01986023|SMS|sms
5341847|NCT01986023|Randomised|randomised
5341848|NCT01985997|FluMist, Quadrivalent, Vaccine|flumist, quadrivalent, vaccine
5341849|NCT01985984|Head and neck cancer|head and neck cancer
5341850|NCT01985906|Aorta|aorta
5341851|NCT01985906|Aneurysm|aneurysm
5341852|NCT01985906|Stents|stents
5341853|NCT01985906|Collateral Circulation|collateral circulation
5341854|NCT01985893|Metastatic|metastatic
5341855|NCT01985893|breast|breast
5341856|NCT01985893|cancer|cancer
5341857|NCT01985880|Biomarkers|biomarkers
5341858|NCT01985854|Desflurane|desflurane
5341859|NCT01985854|Propofol|propofol
5341860|NCT01985854|Total intravenous anesthesia|total intravenous anesthesia
5341861|NCT01985854|Neurosurgery|neurosurgery
5341862|NCT01985841|Early breast cancer|early breast cancer
5341863|NCT01985841|Primary operable breast cancer|primary operable breast cancer
5341864|NCT01985841|HER2- negative|her2- negative
5341865|NCT01985841|bevacizumab|bevacizumab
5341866|NCT01985828|Prostate neoplasm|prostate neoplasm
5341867|NCT01985828|Prostate Cancer|prostate cancer
5341868|NCT01985815|obsessive-compulsive disorder|obsessive-compulsive disorder
5341869|NCT01985815|Deep Brain Stimulation|deep brain stimulation
5341870|NCT01985815|Psychosurgery|psychosurgery
5341871|NCT01985789|airway hyperresponsiveness|airway hyperresponsiveness
5341872|NCT01985776|Exercise|exercise
5341873|NCT01985776|Electric Stimulation|electric stimulation
5341874|NCT01985763|Genistein|genistein
5341875|NCT01985763|soy supplements|soy supplements
5341876|NCT01985763|phytoestrogens|phytoestrogens
5341877|NCT01985763|colon cancer|colon cancer
5341878|NCT01985763|rectal cancer|rectal cancer
5341879|NCT01985763|colorectal cancer|colorectal cancer
5341880|NCT01985763|metastatic|metastatic
5341881|NCT01985763|stage IV|stage iv
5341883|NCT01985763|FOLFOX-Avastin|folfox-avastin
5341884|NCT01985763|Chemotherapy|chemotherapy
5341885|NCT01985750|dyspnea|dyspnea
5341886|NCT01985750|fmri|fmri
5341887|NCT01985750|d-cycloserine|d-cycloserine
5341888|NCT01985737|Neonatal Intensive Care Units (NICUs)|neonatal intensive care units (nicus)
5341889|NCT01985737|NICUs|nicus
5341890|NCT01985737|Neonates|neonates
5341891|NCT01985737|CLABSI|clabsi
5341892|NCT01985737|Microbiome|microbiome
5341893|NCT01985737|DNA signature|dna signature
5341894|NCT01985737|Catheter infections|catheter infections
5341895|NCT01985724|Early breast cancer|early breast cancer
5341898|NCT01985724|Adjuvant chemotherapy|adjuvant chemotherapy
5341899|NCT01985724|Dose dense|dose dense
5341900|NCT01985724|Docetaxel|docetaxel
5341901|NCT01985724|FEC|fec
5341902|NCT01985711|Motivational Interviewing|motivational interviewing
5341903|NCT01985711|Cognitive Behavioral Therapy|cognitive behavioral therapy
5341904|NCT01985711|Transtheoretical Model of behavior change|transtheoretical model of behavior change
5341905|NCT01985711|Questionnaires|questionnaires
5341906|NCT01985711|Telemedicine/*methods|telemedicine/*methods
5341907|NCT01985711|Comorbidity|comorbidity
5341908|NCT01985711|Diabetes|diabetes
5341909|NCT01985711|Glucose/metabolism|glucose/metabolism
5341910|NCT01985711|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5341911|NCT01985711|Blood Pressure|blood pressure
5341912|NCT01985711|Cholesterol, LDL/blood|cholesterol, ldl/blood
5341913|NCT01985711|Quality of life|quality of life
5341914|NCT01985711|Depressive Disorder/psychology/*therapy|depressive disorder/psychology/*therapy
5341915|NCT01985711|Randomized Controlled Trials|randomized controlled trials
5341916|NCT01985698|Low rectal cancer|low rectal cancer
5341917|NCT01985698|Robotic|robotic
5341918|NCT01985698|Laparoscopic|laparoscopic
5341919|NCT01985698|Abdominoperineal resection|abdominoperineal resection
5341920|NCT01985685|VO2, critically ill, oxygen consumption|vo2, critically ill, oxygen consumption
5341921|NCT01985672|Infertility|infertility
5341922|NCT01985659|Lymph Node Excision|lymph node excision
5341923|NCT01985659|Thoracic Surgical Procedures|thoracic surgical procedures
5341924|NCT01985659|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5341925|NCT01985659|Thoracotomy|thoracotomy
5341926|NCT01985646|Hirschsprung disease|hirschsprung disease
5341927|NCT01985646|conservative treatment|conservative treatment
5341928|NCT01985646|surgery treatment|surgery treatment
5341929|NCT01985646|infants|infants
5341930|NCT01985633|Osteoarthritis|osteoarthritis
5341931|NCT01985633|stem cells|stem cells
5341932|NCT01985633|Platelet gel|platelet gel
5341933|NCT01985633|Functional outcome|functional outcome
5341934|NCT01985620|Vaccination|vaccination
5341935|NCT01985620|RSV|rsv
5341936|NCT01985620|Influenza|influenza
5341937|NCT01985620|Prematurity|prematurity
5963432|NCT04244110|mHealth|mhealth
5963433|NCT04243798|transcranial magnetic stimulation|transcranial magnetic stimulation
5963434|NCT04243798|theta burst|theta burst
5963435|NCT04243447|Femoracetabular Impingement (FAI)|femoracetabular impingement (fai)
5963436|NCT04243447|Low-dose computed tomography (CT)|low-dose computed tomography (ct)
5963437|NCT04243447|Patient Reported Outcomes (PROs)|patient reported outcomes (pros)
5963438|NCT04243447|Academic Network for Conservational Hip Outcomes Research (ANCHOR)|academic network for conservational hip outcomes research (anchor)
5963439|NCT04243447|Hip Arthroscopy|hip arthroscopy
5963440|NCT04243447|Osteoarthritis (OA)|osteoarthritis (oa)
5963441|NCT04243343|Plantar fasciosis|plantar fasciosis
5341938|NCT01985594|preterm labor|preterm labor
5341939|NCT01985581|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5341940|NCT01985581|Intuniv extended release|intuniv extended release
5341941|NCT01985581|Executive Function|executive function
5341942|NCT01985581|Quality of Life|quality of life
5341946|NCT01985555|Phase I|phase i
5341947|NCT01985555|Safety|safety
5341948|NCT01985555|Pharmacokinetics|pharmacokinetics
5341949|NCT01985516|Pain|pain
5341950|NCT01985516|Urethra|urethra
5341951|NCT01985516|Catheter|catheter
5341952|NCT01985503|positron emission tomography|positron emission tomography
5341953|NCT01985503|magnetic resonance imaging|magnetic resonance imaging
5341954|NCT01985503|brown adipose tissue|brown adipose tissue
5341955|NCT01985503|obesity|obesity
5341956|NCT01985503|cardiovascular disease|cardiovascular disease
5341957|NCT01985503|subclinical atherosclerosis|subclinical atherosclerosis
5341958|NCT01985490|epiretinal membrane|epiretinal membrane
5341959|NCT01985490|foveal avascular zone|foveal avascular zone
5341960|NCT01985490|internal limiting membrane|internal limiting membrane
5341961|NCT01985477|Myeloma|myeloma
5341962|NCT01985477|Multiple myeloma|multiple myeloma
5341963|NCT01985477|MM|mm
5341964|NCT01985477|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5341965|NCT01985477|RR MM|rr mm
5341966|NCT01985477|Lenalidomide|lenalidomide
5341967|NCT01985477|CC-5013|cc-5013
5341968|NCT01985477|Revlimid|revlimid
5341969|NCT01985477|Dexamethasone|dexamethasone
5341970|NCT01985477|Decadron|decadron
5341971|NCT01985477|All-Trans Retinoic Acid|all-trans retinoic acid
5341972|NCT01985477|ATRA|atra
5341973|NCT01985477|Tretinoin (Oral)|tretinoin (oral)
5341974|NCT01985477|Vesanoid|vesanoid
5341975|NCT01985464|rheumatoid arthritis|rheumatoid arthritis
5341976|NCT01985464|umbilical cord|umbilical cord
5341977|NCT01985464|mesenchymal|mesenchymal
5341983|NCT01985438|Percutaneous Endoscopic Gastrostomy tube|percutaneous endoscopic gastrostomy tube
5341985|NCT01985438|Radiation Effects|radiation effects
5341986|NCT01985438|Pakistan|pakistan
5341987|NCT01985412|Rejection|rejection
5341988|NCT01985412|Transplant|transplant
5341989|NCT01985412|Cardiac|cardiac
5341990|NCT01985412|Pulmonary|pulmonary
5341991|NCT01985412|Heart|heart
5341992|NCT01985412|Lung|lung
5341993|NCT01985412|Cell-Free DNA|cell-free dna
5341994|NCT01985412|cfDNA|cfdna
5341995|NCT01985412|Cell|cell
5341996|NCT01985412|Free|free
5341997|NCT01985412|DNA|dna
5342004|NCT01985386|Slow release iron|slow release iron
5342005|NCT01985386|Gastric delivery system|gastric delivery system
5342006|NCT01985386|Iron deficiency|iron deficiency
5342007|NCT01985373|intravenous immunoglobulin|intravenous immunoglobulin
5342008|NCT01985373|pharmacokinetics|pharmacokinetics
5342009|NCT01985373|10% IVIG|10% ivig
5342010|NCT01985334|Moderate COPD, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide FDC, NVA237, QVA149|moderate copd, glycopyrronium bromide, indacaterol maleate and glycopyrronium bromide fdc, nva237, qva149
5342011|NCT01985321|herpes labialis|herpes labialis
5342012|NCT01985321|cold sore|cold sore
5342013|NCT01985269|High risk|high risk
5342014|NCT01985269|ART naive|art naive
5342015|NCT01985256|glioma|glioma
5342016|NCT01985256|glioblastoma|glioblastoma
5342017|NCT01985256|glioblastoma multiforme|glioblastoma multiforme
5342018|NCT01985256|Grade IV astrocytoma|grade iv astrocytoma
5342019|NCT01985256|brain cancer|brain cancer
5342021|NCT01985256|GBM|gbm
5342022|NCT01985256|AA|aa
5342023|NCT01985256|AOD|aod
5342024|NCT01985256|anaplastic astrocytoma|anaplastic astrocytoma
5342025|NCT01985256|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5342026|NCT01985256|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5342027|NCT01985256|malignant glioma|malignant glioma
5342028|NCT01985256|high grade glioma|high grade glioma
5342029|NCT01985243|Dietary diversity|dietary diversity
5342030|NCT01985243|Infant and young child|infant and young child
5342031|NCT01985243|Adolescents|adolescents
5342032|NCT01985243|Anemia|anemia
5342033|NCT01985243|Rural health|rural health
5342034|NCT01985204|iodine|iodine
5342035|NCT01985204|thyroid hormones|thyroid hormones
5342036|NCT01985204|obesity|obesity
5342037|NCT01985204|TSH|tsh
5342038|NCT01985204|dyslipidemia|dyslipidemia
5342039|NCT01985204|insulin resistance|insulin resistance
5342040|NCT01985139|Obesity, food pleasure, behavioral tasks, endocannabinoids|obesity, food pleasure, behavioral tasks, endocannabinoids
5342041|NCT01985126|Multiple myeloma|multiple myeloma
5342042|NCT01985126|Daratumumab|daratumumab
5342043|NCT01985126|Proteasome inhibitor|proteasome inhibitor
5342044|NCT01985126|Immunomodulatory drug|immunomodulatory drug
5342045|NCT01985126|IMiD|imid
5342046|NCT01985113|thioredoxin reductase|thioredoxin reductase
5342047|NCT01985113|non-small cell lung cancer|non-small cell lung cancer
5342048|NCT01985074|case management, disease management, emergency|case management, disease management, emergency
5342049|NCT01985074|department|department
5963442|NCT04243343|acupuncture|acupuncture
5963443|NCT04243343|electrostimulation|electrostimulation
5963444|NCT04243343|primary care|primary care
5963445|NCT04242264|Adults|adults
5963446|NCT04242264|Challenge|challenge
5342050|NCT01985061|Myelodysplasic syndrome|myelodysplasic syndrome
5342051|NCT01985061|Acute Myeloid leukemia|acute myeloid leukemia
5342052|NCT01985035|Obstructive sleep apnea|obstructive sleep apnea
5342053|NCT01985035|obesity|obesity
5342054|NCT01985035|diet|diet
5342055|NCT01985035|energy expenditure|energy expenditure
5342061|NCT01984983|Venezuelan equine encephalitis virus|venezuelan equine encephalitis virus
5342062|NCT01984983|DNA vaccine|dna vaccine
5342063|NCT01984983|electroporation|electroporation
5342064|NCT01984983|intradermal|intradermal
5342065|NCT01984983|intramuscular|intramuscular
5342066|NCT01984970|McGrath Videolaryngoscope|mcgrath videolaryngoscope
5342067|NCT01984970|double-lumen tube intubation|double-lumen tube intubation
5342068|NCT01984970|Thoracic surgery|thoracic surgery
5342069|NCT01984957|ALS|als
5342070|NCT01984957|Motor neuron diseases|motor neuron diseases
5342071|NCT01984957|Transcriptome|transcriptome
5342072|NCT01984944|circadian rhythm|circadian rhythm
5680271|NCT00578422|Plaque|plaque
5342073|NCT01984931|post operative nausea and vomiting|post operative nausea and vomiting
5342074|NCT01984931|Trimebutine Maleate|trimebutine maleate
5342075|NCT01984905|18 FDG PET-scan|18 fdg pet-scan
5342076|NCT01984905|angioscan|angioscan
5342077|NCT01984905|aortic dissection|aortic dissection
5342078|NCT01984892|Autologous Vaccination|autologous vaccination
5342079|NCT01984892|Intratumoral Injections|intratumoral injections
5342080|NCT01984892|Intramuscular Injections|intramuscular injections
5338241|NCT02002702|Japanese,|japanese,
5342081|NCT01984892|Advanced Accessible Solid Tumors|advanced accessible solid tumors
5342082|NCT01984892|Poly-ICLC|poly-iclc
5342083|NCT01984892|Phase II Clinical Trial|phase ii clinical trial
5342084|NCT01984892|Safety|safety
5342085|NCT01984892|Efficacy|efficacy
5342086|NCT01984892|Autovaccination|autovaccination
5342087|NCT01984892|In Situ|in situ
5342088|NCT01984892|Host Targeted Strategy|host targeted strategy
5342089|NCT01984892|Overall Survival|overall survival
5342090|NCT01984892|Immunotherapy|immunotherapy
5342091|NCT01984892|Adjuvant|adjuvant
5237003|NCT02520947|BIS|bis
5342092|NCT01984866|CPR: Complete Pathological Response|cpr: complete pathological response
5342093|NCT01984853|ACS|acs
5342094|NCT01984853|repository|repository
5342095|NCT01984853|Observational|observational
5342096|NCT01984827|Hyperglycaemia|hyperglycaemia
5342097|NCT01984827|Moxifloxacin|moxifloxacin
5342098|NCT01984827|QTc prolongation|qtc prolongation
5342099|NCT01984827|C-peptide|c-peptide
5342100|NCT01984827|Dead in bed syndrome|dead in bed syndrome
5342101|NCT01984801|SCD1|scd1
5342102|NCT01984801|Gel|gel
5342103|NCT01984801|Topical Administration|topical administration
5342104|NCT01984801|Acne|acne
5342105|NCT01984788|Oral Prophylaxis|oral prophylaxis
5342106|NCT01984775|safety|safety
5342107|NCT01984775|dermal|dermal
5342108|NCT01984775|GSK2894512|gsk2894512
5342109|NCT01984775|Cumulative irritation|cumulative irritation
5342110|NCT01984736|Pharmacokinetic|pharmacokinetic
5342111|NCT01984736|Safety|safety
5342112|NCT01984723|Pharmacokinetic|pharmacokinetic
5342113|NCT01984723|Safety|safety
5342114|NCT01984710|Treatment Resistant Depression|treatment resistant depression
5342115|NCT01984710|Deep Brain Stimulation|deep brain stimulation
5342116|NCT01984710|Psychiatry|psychiatry
5342117|NCT01984710|Neuro Surgery|neuro surgery
5342118|NCT01984684|Bacterial skin infection|bacterial skin infection
5342119|NCT01984684|infection|infection
5342120|NCT01984684|skin|skin
5342121|NCT01984684|delafloxacin|delafloxacin
5342122|NCT01984684|vancomycin|vancomycin
5342123|NCT01984684|aztreonam|aztreonam
5342124|NCT01984684|methicillin-resistant Staphylococcus aureus (MRSA) bacteria|methicillin-resistant staphylococcus aureus (mrsa) bacteria
5342125|NCT01984684|bacterial infection|bacterial infection
5342126|NCT01984684|Anti-Infective Agents|anti-infective agents
5342127|NCT01984658|pancreatic cancer|pancreatic cancer
5342128|NCT01984645|Emergency Visit|emergency visit
5342129|NCT01984645|Secure Health messaging|secure health messaging
5342130|NCT01984645|Inpatient|inpatient
5342131|NCT01984593|Yoga|yoga
5342132|NCT01984593|Hypertension|hypertension
5342133|NCT01984593|Quality of Life|quality of life
5342134|NCT01984593|Primary Health Care|primary health care
5342135|NCT01984593|Stress|stress
5342136|NCT01984593|Anxiety|anxiety
5342137|NCT01984593|Depression|depression
5342138|NCT01984580|Barrett's esophagus|barrett's esophagus
5342139|NCT01984580|Esophagus|esophagus
5342140|NCT01984580|Adenocarcinoma|adenocarcinoma
5342141|NCT01984567|Oxyphytosterols|oxyphytosterols
5342142|NCT01984567|Oxidative stress|oxidative stress
5342143|NCT01984567|Vitamin E|vitamin e
5342144|NCT01984567|Lipoic acid|lipoic acid
5342145|NCT01984541|Pollen|pollen
5342146|NCT01984528|Immunotherapy|immunotherapy
5342147|NCT01984528|Skin prick test|skin prick test
5342148|NCT01984528|Standardization|standardization
5342149|NCT01984528|Alternaria alternata|alternaria alternata
5342150|NCT01984515|Post-traumatic Stress Disorder|post-traumatic stress disorder
5342151|NCT01984515|Evidence-Based Psychotherapy|evidence-based psychotherapy
5342152|NCT01984515|Treatment Engagement|treatment engagement
5342153|NCT01984515|Cognitive Behavioral Therapy|cognitive behavioral therapy
5342154|NCT01984515|Implementation Science|implementation science
5342155|NCT01984502|Larynx Cancer|larynx cancer
5342156|NCT01984489|SHR117887, Metformin,combination,PhaseII|shr117887, metformin,combination,phaseii
5342157|NCT01984476|spinal cord injury|spinal cord injury
5342158|NCT01984476|autonomic dysreflexia|autonomic dysreflexia
5342159|NCT01984476|baroreceptor integrity|baroreceptor integrity
5342160|NCT01984476|sympathetic integrity|sympathetic integrity
5342161|NCT01984476|vagal integrity|vagal integrity
5342162|NCT01984476|autonomic integrity|autonomic integrity
5342163|NCT01984476|arterial stiffness|arterial stiffness
5342164|NCT01984476|cognitive function|cognitive function
5342165|NCT01984476|traumatic brain injury|traumatic brain injury
5342166|NCT01984476|cerebral blood flow|cerebral blood flow
5342167|NCT01984476|white matter hyperintensities|white matter hyperintensities
5342168|NCT01984476|cerebral vascular resistance index|cerebral vascular resistance index
5342169|NCT01984463|Postoperative pain|postoperative pain
5342170|NCT01984463|Shoulder pain|shoulder pain
5342171|NCT01984463|Thoracotomy|thoracotomy
5342172|NCT01984450|Articular cartilage|articular cartilage
5342173|NCT01984450|Autologous collagen|autologous collagen
5342174|NCT01984450|BMAC|bmac
5342175|NCT01984437|Vascular disease|vascular disease
5342176|NCT01984437|Minimally invasive treatment|minimally invasive treatment
5342177|NCT01984437|Endovascular treatment|endovascular treatment
5342178|NCT01984437|Magellan|magellan
5342179|NCT01984437|Robotic|robotic
5862776|NCT00001515|Computer Assisted Visualization|computer assisted visualization
5862777|NCT00001515|Lung Cavities|lung cavities
5342180|NCT01984424|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
5342181|NCT01984346|Atrial Fibrillation|atrial fibrillation
5342182|NCT01984346|Convergent Procedure|convergent procedure
5342183|NCT01984346|Combined Epicardial/ Endocardial Ablation|combined epicardial/ endocardial ablation
5342184|NCT01984346|Hybrid Procedure|hybrid procedure
5342185|NCT01984346|Radiofrequency Ablation|radiofrequency ablation
5342186|NCT01984346|Arrhythmia|arrhythmia
5342187|NCT01984346|RF Ablation|rf ablation
5342188|NCT01984333|trichotillomania|trichotillomania
5342189|NCT01984333|response inhibition|response inhibition
5342190|NCT01984333|cognitive retraining|cognitive retraining
5342191|NCT01984320|OHSS|ohss
5342192|NCT01984320|ICSI|icsi
5342193|NCT01984320|Coasting|coasting
5342194|NCT01984320|Cabergoline|cabergoline
5342195|NCT01984307|Acute coronary syndrome|acute coronary syndrome
5342196|NCT01984307|Myocardial infarction|myocardial infarction
5342197|NCT01984307|retrospective|retrospective
5342198|NCT01984307|cohort study|cohort study
5342199|NCT01984307|Healthcare resources utilization|healthcare resources utilization
5342200|NCT01984294|HCV genotype 1|hcv genotype 1
5342202|NCT01984294|Sustained Virologic Response|sustained virologic response
5342203|NCT01984294|Direct-Acting Antiviral|direct-acting antiviral
5342204|NCT01984294|Combination Therapy|combination therapy
5342205|NCT01984294|GS-7977|gs-7977
5342206|NCT01984294|GS-5885|gs-5885
5342207|NCT01984294|Ribavirin|ribavirin
5342208|NCT01984294|Open Label|open label
5342209|NCT01984294|Sofosbuvir|sofosbuvir
5342210|NCT01984294|Treatment-Naive|treatment-naive
5342211|NCT01984294|Protease Inhibitors|protease inhibitors
5342213|NCT01984294|Treatment experienced|treatment experienced
5342214|NCT01984294|Cirrhotic|cirrhotic
5342215|NCT01984281|Physical Activity|physical activity
5342216|NCT01984281|Pedometers|pedometers
5342217|NCT01984281|Quality of Life|quality of life
5342218|NCT01984268|Rheumatoid arthritis|rheumatoid arthritis
5342219|NCT01984268|ACTHAR|acthar
5342220|NCT01984268|Methotrexate|methotrexate
5342221|NCT01984268|Inadequate response|inadequate response
5342222|NCT01984203|Shoulder|shoulder
5342223|NCT01984203|Impingement|impingement
5342224|NCT01984203|Rotator Cuff Syndrome|rotator cuff syndrome
5342225|NCT01984203|Subacromial Impingement Syndrome|subacromial impingement syndrome
5342226|NCT01984203|Exercise|exercise
5342227|NCT01984203|Physiotherapy|physiotherapy
5342228|NCT01984190|venous thromboembolism|venous thromboembolism
5342229|NCT01984190|deep vein thrombosis|deep vein thrombosis
5342230|NCT01984190|pulmonary emboli|pulmonary emboli
5342231|NCT01984190|hip arthroplasty|hip arthroplasty
5342232|NCT01984190|knee arthroplasty|knee arthroplasty
5342233|NCT01984190|efficacy|efficacy
5342234|NCT01984190|mobile compression device|mobile compression device
5342235|NCT01984190|mechanical device|mechanical device
5342236|NCT01984190|prophylaxis.|prophylaxis.
5342237|NCT01984177|Cocaine|cocaine
5342238|NCT01984177|Substance-Related Disorders|substance-related disorders
5342239|NCT01984177|Drug Addiction|drug addiction
5342240|NCT01984177|Substance Addiction|substance addiction
5342241|NCT01984177|Dopamine|dopamine
5342242|NCT01984177|Receptors, Dopamine D2|receptors, dopamine d2
5342243|NCT01984177|Receptors, Dopamine D3|receptors, dopamine d3
5342244|NCT01984177|Stress, Psychological|stress, psychological
5342245|NCT01984177|Corticorelin|corticorelin
5342246|NCT01984177|Neuroendocrine System|neuroendocrine system
5342247|NCT01984177|Cortisol|cortisol
5221615|NCT02613728|Surveys|surveys
5342248|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5342249|NCT01984177|Positron-Emission Tomography|positron-emission tomography
5342250|NCT01984177|11C-PHNO|11c-phno
5342251|NCT01984164|Cerebrovascular function|cerebrovascular function
5342252|NCT01984138|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
5342253|NCT01984138|breast cancer|breast cancer
5342254|NCT01984125|Adolescent Immunization Rates|adolescent immunization rates
5342255|NCT01984125|Provider prompts|provider prompts
5342256|NCT01984112|Humerus|humerus
5342257|NCT01984112|fracture|fracture
5342258|NCT01984112|nail|nail
5342259|NCT01984112|plate|plate
5342260|NCT01984112|tuberosity|tuberosity
5342261|NCT01984099|Postmolar Gestational Trophoblastic Disease, Hydatidiform Mole|postmolar gestational trophoblastic disease, hydatidiform mole
5342262|NCT01984086|COPD|copd
5342263|NCT01984086|Asthma|asthma
5342264|NCT01984086|Respiratory|respiratory
5342265|NCT01984073|Atherogenic dyslipidemia phenotype|atherogenic dyslipidemia phenotype
5342266|NCT01984060|Aging|aging
5342267|NCT01984060|Physical Activity|physical activity
5342268|NCT01984060|Physical Function|physical function
5342269|NCT01984060|HIV|hiv
5342270|NCT01984060|Frailty|frailty
5342271|NCT01984060|Autonomous Motivation|autonomous motivation
5342272|NCT01984060|Depression|depression
5342273|NCT01984047|safety|safety
5342274|NCT01984047|GSK3050002|gsk3050002
5342275|NCT01984047|CCR6 receptor|ccr6 receptor
5342276|NCT01984047|single dose escalation|single dose escalation
5342277|NCT01984047|Phase 1|phase 1
5342278|NCT01984047|CCL20|ccl20
5342279|NCT01984034|Educational outreach|educational outreach
5342281|NCT01984034|Guideline adherence|guideline adherence
5342282|NCT01984034|Family Practice|family practice
5342283|NCT01984034|Drug utilization|drug utilization
5342284|NCT01984034|Program evaluation|program evaluation
5342285|NCT01984034|Cost effectiveness|cost effectiveness
5342286|NCT01984021|Physical Therapy Modalities|physical therapy modalities
5342287|NCT01984021|Neck pain|neck pain
5342288|NCT01984021|Acupuncture|acupuncture
5342289|NCT01983995|Breast Cancer|breast cancer
5342290|NCT01983995|Aromatase Inhibitors|aromatase inhibitors
5342291|NCT01983995|Actigraphy|actigraphy
5342292|NCT01983995|Pain|pain
5342293|NCT01983995|Fatigue|fatigue
5342294|NCT01983995|Sleep quality|sleep quality
5342295|NCT01983982|Breast Cancer|breast cancer
5342296|NCT01983982|Chemotherapy|chemotherapy
5342297|NCT01983982|Chronic Pain|chronic pain
5342298|NCT01983982|Survivorship|survivorship
5342299|NCT01983969|Advanced Cancers|advanced cancers
5342300|NCT01983969|Lymphoma|lymphoma
5342301|NCT01983969|Recurrent Hodgkin's|recurrent hodgkin's
5342302|NCT01983969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5342303|NCT01983969|Stem cell transplant|stem cell transplant
5342304|NCT01983969|Azacitidine|azacitidine
5342305|NCT01983969|5-azacytidine|5-azacytidine
5342306|NCT01983969|5-aza|5-aza
5342307|NCT01983969|Vidaza|vidaza
5342308|NCT01983969|5-AZC|5-azc
5342309|NCT01983969|AZA-CR|aza-cr
5342310|NCT01983969|Ladakamycin|ladakamycin
5342311|NCT01983969|NSC-102816|nsc-102816
5346505|NCT01965535|HCV|hcv
5342312|NCT01983969|Azacytidine|azacytidine
5342313|NCT01983969|Vorinostat|vorinostat
5342314|NCT01983969|SAHA|saha
5342315|NCT01983969|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5342316|NCT01983969|MSK-390|msk-390
5342317|NCT01983969|Zolinza|zolinza
5342318|NCT01983969|Gemcitabine|gemcitabine
5342319|NCT01983969|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5342320|NCT01983969|Gemzar|gemzar
5342321|NCT01983969|Busulfan|busulfan
5342323|NCT01983969|Myleran|myleran
5342324|NCT01983969|Melphalan|melphalan
5342325|NCT01983969|Alkeran|alkeran
5342326|NCT01983969|Dexamethasone|dexamethasone
5342327|NCT01983969|Decadron|decadron
5342328|NCT01983969|Caphosol|caphosol
5342329|NCT01983969|Glutamine|glutamine
5342330|NCT01983969|Enterex|enterex
5342331|NCT01983969|Glutapak-10|glutapak-10
5342332|NCT01983969|NutreStore|nutrestore
5342333|NCT01983969|Resource|resource
5342334|NCT01983969|GlutaSolve|glutasolve
5342335|NCT01983969|Sympt-X G.I.|sympt-x g.i.
5342336|NCT01983969|Sympt-X|sympt-x
5342337|NCT01983969|Pyridoxine|pyridoxine
5342338|NCT01983969|Rituximab|rituximab
5342339|NCT01983969|Rituxan|rituxan
5342340|NCT01983956|early palliative care|early palliative care
5342341|NCT01983956|patient empowerment|patient empowerment
5963447|NCT04242264|Double-blind|double-blind
5342342|NCT01983956|cancer|cancer
5342343|NCT01983956|assessment|assessment
5342344|NCT01983956|end of life|end of life
5342345|NCT01983930|Memory impairment|memory impairment
5342346|NCT01983930|Meditation|meditation
5342347|NCT01983930|Yoga|yoga
5342348|NCT01983930|memory training|memory training
5342349|NCT01983930|Mild cognitive impairment|mild cognitive impairment
5342350|NCT01983930|MCI|mci
5342351|NCT01983930|geriatric|geriatric
5342352|NCT01983930|fMRI|fmri
5342353|NCT01983917|diabetes|diabetes
5342354|NCT01983917|mobile application|mobile application
5963448|NCT04242264|Efficacy|efficacy
5209751|NCT02684734|UC|uc
5342355|NCT01983917|diabetic retinopathy|diabetic retinopathy
5342356|NCT01983904|Major depressive disorder (MDD)|major depressive disorder (mdd)
5342357|NCT01983904|Bi-polar disorder (BP)|bi-polar disorder (bp)
5342358|NCT01983891|food shelf|food shelf
5342359|NCT01983891|nutrition education|nutrition education
5342360|NCT01983891|cooking course|cooking course
5342361|NCT01983852|End of Life Care|end of life care
5342362|NCT01983852|Paediatric|paediatric
5342363|NCT01983852|Experiences|experiences
5342364|NCT01983852|Needs|needs
5342365|NCT01983852|Current Practices|current practices
5342366|NCT01983839|Moxifloxacin|moxifloxacin
5342367|NCT01983839|Pneumonia|pneumonia
5342368|NCT01983839|Pharmacokinetics|pharmacokinetics
5342369|NCT01983826|nitrates|nitrates
5342370|NCT01983826|blood flow|blood flow
5342371|NCT01983826|vascular function|vascular function
5342372|NCT01983826|exercise|exercise
5342373|NCT01983813|Diabetes|diabetes
5342374|NCT01983813|High Blood Pressure|high blood pressure
5342375|NCT01983813|High Cholesterol|high cholesterol
5342376|NCT01983813|Heart Irregularity|heart irregularity
5342377|NCT01983813|Stroke|stroke
5342378|NCT01983800|Mechanical Ventilation|mechanical ventilation
5342379|NCT01983800|Volatile Sedation|volatile sedation
5342380|NCT01983800|Intravenous Sedation|intravenous sedation
5342381|NCT01983800|Delirium|delirium
5342382|NCT01983787|Cystic Fibrosis|cystic fibrosis
5342383|NCT01983787|Continuous infusion|continuous infusion
5342384|NCT01983787|Pharmacokinetics|pharmacokinetics
5342385|NCT01983774|CF|cf
5342386|NCT01983748|Uveal Melanoma, Monosomy 3|uveal melanoma, monosomy 3
5342387|NCT01983735|TELMINUVO Tab.|telminuvo tab.
5342388|NCT01983735|CKD-828|ckd-828
5342393|NCT01983696|low oxygen tension|low oxygen tension
5342395|NCT01983683|Clostridium difficile infection|clostridium difficile infection
5342396|NCT01983683|Post-antibiotic diarrhea|post-antibiotic diarrhea
5342397|NCT01983670|Pre-movement facilitation|pre-movement facilitation
5342398|NCT01983670|Fast goal directed movement|fast goal directed movement
5342399|NCT01983670|Triphasic EMG pattern|triphasic emg pattern
5342400|NCT01983670|Temporal electrical stimulation,|temporal electrical stimulation,
5342401|NCT01983670|Spinocerebellar Ataxia|spinocerebellar ataxia
5342402|NCT01983657|Pulmonary|pulmonary
5342403|NCT01983657|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
5342404|NCT01983657|PAP|pap
5342405|NCT01983644|acute ischemic stroke,endovascular recanalization|acute ischemic stroke,endovascular recanalization
5342406|NCT01983644|mechanical thrombectomy|mechanical thrombectomy
5342407|NCT01983631|Whole body vibration|whole body vibration
5342408|NCT01983631|Reciprocal inhibition|reciprocal inhibition
5342409|NCT01983631|Spinocerebellar ataxia|spinocerebellar ataxia
5342410|NCT01983631|voluntary activation level|voluntary activation level
5342411|NCT01983618|Cerebral ischemia|cerebral ischemia
5342412|NCT01983618|Beachchair position|beachchair position
5342413|NCT01983618|Interscalene nerve block|interscalene nerve block
5342414|NCT01983592|Homeopathy|homeopathy
5342415|NCT01983592|Fatigue|fatigue
5342416|NCT01983592|Chemotherapy|chemotherapy
5342423|NCT01983540|Tetanus|tetanus
5342424|NCT01983540|Whooping Cough|whooping cough
5342425|NCT01983540|Hepatitis B|hepatitis b
5342426|NCT01983540|Poliomyelitis|poliomyelitis
5342427|NCT01983540|Pediatric combined vaccine|pediatric combined vaccine
5342428|NCT01983527|Arthrographic distention|arthrographic distention
5342429|NCT01983527|Hydrodilatation|hydrodilatation
5342430|NCT01983527|Intra-articular corticosteroid injection|intra-articular corticosteroid injection
5342431|NCT01983514|oxytocin|oxytocin
5342432|NCT01983514|fMRI|fmri
5342433|NCT01983514|social cognition|social cognition
5342434|NCT01983514|heart rate variability|heart rate variability
5342435|NCT01983514|pupillometry|pupillometry
5342436|NCT01983514|eye tracking|eye tracking
5342437|NCT01983501|ONT-380|ont-380
5342438|NCT01983501|T-DM1|t-dm1
5342439|NCT01983501|Kadcyla|kadcyla
5342440|NCT01983501|Breast cancer|breast cancer
5342441|NCT01983501|ARRY-380|arry-380
5342442|NCT01983501|Tucatinib|tucatinib
5342443|NCT01983488|Uveitis|uveitis
5342444|NCT01983488|Vision Loss|vision loss
5342445|NCT01983475|Spinal Cord Injury|spinal cord injury
5342446|NCT01983475|Denosumab|denosumab
5342447|NCT01983475|Osteoporosis|osteoporosis
5342448|NCT01983475|Dual Energy X-ray Absorptiometry|dual energy x-ray absorptiometry
5342449|NCT01983462|Prehypertension|prehypertension
5342450|NCT01983462|Hypertension|hypertension
5342451|NCT01983462|Obese|obese
5342452|NCT01983462|Sympathetic Nervous System|sympathetic nervous system
5342453|NCT01983462|renin-angiotensin system|renin-angiotensin system
5342454|NCT01983462|Endothelial function|endothelial function
5342455|NCT01983449|Adventitia|adventitia
5342456|NCT01983449|Peripheral Artery Disease|peripheral artery disease
5342457|NCT01983449|Restenosis|restenosis
5342458|NCT01983449|Inflammation|inflammation
5342459|NCT01983449|Anti-Inflammatory|anti-inflammatory
5342460|NCT01983449|Dexamethasone|dexamethasone
5342461|NCT01983436|Maxillofacial Orthognathic Surgery|maxillofacial orthognathic surgery
5963449|NCT04242264|Healthy|healthy
5963450|NCT04242264|Immunogenicity|immunogenicity
5342462|NCT01983436|Manual lymphatic drainage|manual lymphatic drainage
5342463|NCT01983423|Endometrial Biopsy|endometrial biopsy
5342464|NCT01983423|Endometrial Sampling|endometrial sampling
5342465|NCT01983423|In Vitro Fertilization|in vitro fertilization
5342466|NCT01983423|Pregnancy|pregnancy
5342467|NCT01983423|Implantation|implantation
5342468|NCT01983410|BRCA Mutation Carriers|brca mutation carriers
5342469|NCT01983410|PDAC carriers|pdac carriers
5342470|NCT01983410|BRCAmut carriers|brcamut carriers
5342471|NCT01983410|Registry|registry
5342472|NCT01983410|13-217|13-217
5342473|NCT01983397|aged, 80 and over|aged, 80 and over
5342474|NCT01983397|Exercise|exercise
5342475|NCT01983397|Cognition|cognition
5342476|NCT01983397|Balance|balance
5342477|NCT01983397|Randomized controlled trial|randomized controlled trial
5342478|NCT01983384|Delirium|delirium
5342479|NCT01983384|Cognition|cognition
5342480|NCT01983384|Surgery|surgery
5342481|NCT01983384|Anesthesia|anesthesia
5342482|NCT01983384|Aging|aging
5342483|NCT01983384|Electroencephalography|electroencephalography
5342484|NCT01983358|PARP-1 inhibitor|parp-1 inhibitor
5342485|NCT01983345|Myelomeningocele|myelomeningocele
5342486|NCT01983345|Arnold Chiari malformation|arnold chiari malformation
5342487|NCT01983345|Spina bifida|spina bifida
5342488|NCT01983332|MDACC|mdacc
5342489|NCT01983332|MOHO|moho
5342492|NCT01983306|GC C Agonist|gc c agonist
5342493|NCT01983306|Pain|pain
5342494|NCT01983293|Non-left bundle branch block|non-left bundle branch block
5342496|NCT01983293|LV lead pacing location|lv lead pacing location
5342497|NCT01983293|CRT-D|crt-d
5342498|NCT01983280|polysomnography|polysomnography
5342499|NCT01983280|sleep|sleep
5342500|NCT01983280|healing touch|healing touch
5342501|NCT01983280|pediatric burn|pediatric burn
5342502|NCT01983254|coping|coping
5342503|NCT01983254|acute respiratory failure|acute respiratory failure
5342504|NCT01983254|critical illness|critical illness
5342505|NCT01983254|depression|depression
5342506|NCT01983254|anxiety|anxiety
5342507|NCT01983254|post-traumatic stress|post-traumatic stress
5342608|NCT01982838|pain|pain
5342514|NCT01983228|Musculoskeletal Pain|musculoskeletal pain
5342515|NCT01983228|Walking|walking
5342516|NCT01983228|African American|african american
5342517|NCT01983228|Telephone Coaching|telephone coaching
5342518|NCT01983228|Pedometer|pedometer
5342519|NCT01983215|groin incisions|groin incisions
5342520|NCT01983202|PCOS|pcos
5342521|NCT01983202|Pregnancy|pregnancy
5342522|NCT01983202|Obstetric|obstetric
5342523|NCT01983189|TMS|tms
5342524|NCT01983189|transcranial magnetic stimulation|transcranial magnetic stimulation
5342525|NCT01983189|rTMS|rtms
5342526|NCT01983189|recurrent transcranial magnetic stimulation|recurrent transcranial magnetic stimulation
5342527|NCT01983189|fMRI|fmri
5342528|NCT01983189|functional magnetic resonance imaging.|functional magnetic resonance imaging.
5342529|NCT01983176|Parotid tumor|parotid tumor
5342530|NCT01983176|Partial superficial parotidectomy|partial superficial parotidectomy
5342531|NCT01983176|Facial palsy|facial palsy
5342532|NCT01983150|Population Health|population health
5342533|NCT01983150|Smoking cessation|smoking cessation
5342534|NCT01983150|Young adults|young adults
5342535|NCT01983150|Cancer prevention|cancer prevention
5342536|NCT01983150|Tobacco control strategies|tobacco control strategies
5342537|NCT01983150|Behaviour modification|behaviour modification
5342538|NCT01983150|Social Media|social media
5342539|NCT01983150|Smartphone technology|smartphone technology
5342540|NCT01983137|Chronic pain|chronic pain
5342541|NCT01983137|Severe pain|severe pain
5342542|NCT01983137|oxycodon|oxycodon
5342543|NCT01983137|naloxon|naloxon
5342544|NCT01983137|opioid-induced constipation|opioid-induced constipation
5342545|NCT01983137|opioid|opioid
5342546|NCT01983137|quality of life|quality of life
5342547|NCT01983137|laxative|laxative
5342548|NCT01983137|analgesic rescue medication|analgesic rescue medication
5342549|NCT01983124|Advanced Melanoma|advanced melanoma
5342550|NCT01983098|Colorectal cancer|colorectal cancer
5342551|NCT01983098|Metastatic|metastatic
5342552|NCT01983098|Circulating tumor DNA|circulating tumor dna
5342553|NCT01983098|Biomaker|biomaker
5342554|NCT01983085|Nitric Oxide Dressing|nitric oxide dressing
5342555|NCT01983085|Nitric oxide|nitric oxide
5342556|NCT01983085|Superficial partial thickness wound|superficial partial thickness wound
5342557|NCT01983085|Burns|burns
5342558|NCT01983085|Skin graft donor sites|skin graft donor sites
5342559|NCT01983085|Improved healing|improved healing
5342560|NCT01983085|Vasodilation|vasodilation
5342561|NCT01983085|Angiogenesis|angiogenesis
5342562|NCT01983085|Anti-microbial|anti-microbial
5963451|NCT04242264|Live-attenuated Shigella sonnei Vaccine|live-attenuated shigella sonnei vaccine
5963452|NCT04242264|Phase 2 Trial|phase 2 trial
5963453|NCT04242264|Placebo-controlled|placebo-controlled
5963454|NCT04242264|Protective efficacy|protective efficacy
5963455|NCT04242264|Reactogenicity|reactogenicity
5963456|NCT04242264|Safety|safety
5963457|NCT04242264|Shigella sonnei 53G Challenge|shigella sonnei 53g challenge
5963458|NCT04242264|WRSs2|wrss2
5963459|NCT04242212|Medication abortion|medication abortion
5963460|NCT04242212|Misoprostol|misoprostol
5963461|NCT04242043|Artificial Intelligence|artificial intelligence
5221932|NCT02611518|Healthy|healthy
5342563|NCT01983072|colonization of the gastrointestinal tract with bacteria|colonization of the gastrointestinal tract with bacteria
5342564|NCT01983007|Diabetes Mellitus.|diabetes mellitus.
5342565|NCT01982994|Physical Activity Education|physical activity education
5342566|NCT01982994|Caregivers|caregivers
5342567|NCT01982981|perception|perception
5342568|NCT01982981|wellbeing|wellbeing
5342569|NCT01982981|plain water|plain water
5342570|NCT01982968|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5342571|NCT01982968|IPF|ipf
5342572|NCT01982968|Gastroesophageal reflux|gastroesophageal reflux
5342573|NCT01982968|GER|ger
5342574|NCT01982968|GERD|gerd
5342583|NCT01982916|Allergic Rhinitis|allergic rhinitis
5342584|NCT01982916|Perennial Allergic Rhinitis|perennial allergic rhinitis
5342585|NCT01982916|Non-seasonal Allergic Rhinitis|non-seasonal allergic rhinitis
5342586|NCT01982916|PAR|par
5342587|NCT01982903|kidney transplantation|kidney transplantation
5342588|NCT01982903|connective tissue growth factor|connective tissue growth factor
5342589|NCT01982903|fibrosis|fibrosis
5342590|NCT01982890|Telomere length|telomere length
5342591|NCT01982890|Longitudinal observation|longitudinal observation
5342592|NCT01982877|decision making|decision making
5342593|NCT01982877|values elicitation|values elicitation
5342594|NCT01982877|patient centered care|patient centered care
5342595|NCT01982877|Four Supports|four supports
5342596|NCT01982877|Family Support|family support
5342597|NCT01982864|Aminoglycosides|aminoglycosides
5342598|NCT01982864|hemodialysis|hemodialysis
5342599|NCT01982864|clinical pharmacokinetics|clinical pharmacokinetics
5342600|NCT01982864|pharmacokinetic modelling|pharmacokinetic modelling
5342601|NCT01982864|Bayesian estimation|bayesian estimation
5342602|NCT01982864|Necessity|necessity
5342603|NCT01982864|of the treatment|of the treatment
5342604|NCT01982864|gentamicin|gentamicin
5342606|NCT01982851|epidural|epidural
5342607|NCT01982851|combined spinal epidural|combined spinal epidural
5342609|NCT01982838|epidural|epidural
5342610|NCT01982838|combined spinal epidural|combined spinal epidural
5342611|NCT01982825|Tobacco use cessation|tobacco use cessation
5342612|NCT01982825|Cigarette smoking|cigarette smoking
5342613|NCT01982799|Endodontic treatment, analgesics, anesthesia, post-operative pain|endodontic treatment, analgesics, anesthesia, post-operative pain
5342614|NCT01982773|Virtual Hope Box|virtual hope box
5342615|NCT01982760|Rhinoplasty|rhinoplasty
5342616|NCT01982760|Ecchymosis|ecchymosis
5342618|NCT01982747|Cardiac Safety|cardiac safety
5342619|NCT01982747|General Safety|general safety
5342620|NCT01982747|Pharmacokinetics|pharmacokinetics
5342621|NCT01982734|bioavailability|bioavailability
5342622|NCT01982734|curcumin|curcumin
5342623|NCT01982734|pharmacokinetic|pharmacokinetic
5342624|NCT01982734|curcuma longa|curcuma longa
5342625|NCT01982734|age differences|age differences
5342626|NCT01982734|sex differences|sex differences
5342627|NCT01982708|Evaluation|evaluation
5342628|NCT01982695|Duchenne muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
5342629|NCT01982695|Cardiomyopathy|cardiomyopathy
5342630|NCT01982695|Losartan|losartan
5342631|NCT01982695|Lisinopril|lisinopril
5342632|NCT01982669|Salty taste|salty taste
5342633|NCT01982669|Urinary sodium excretion|urinary sodium excretion
5342634|NCT01982669|Spicy hedonic|spicy hedonic
5342635|NCT01982669|Blood pressure|blood pressure
5342636|NCT01982617|Transtheoretical Model|transtheoretical model
5342637|NCT01982617|Stages of Change|stages of change
5342638|NCT01982617|Nicotine Dependence|nicotine dependence
5342639|NCT01982617|Severe Mental Illness|severe mental illness
5342640|NCT01982578|Treatment|treatment
5342641|NCT01982578|Genistein|genistein
5342642|NCT01982578|Alzheimer's disease|alzheimer's disease
5342643|NCT01982578|Cerebrospinal fluid|cerebrospinal fluid
5342644|NCT01982578|Amyloid beta|amyloid beta
5342645|NCT01982565|Nitric oxide|nitric oxide
5342646|NCT01982565|Nitric oxide dressing|nitric oxide dressing
5342647|NCT01982565|NOx|nox
5342648|NCT01982565|NOx dressing|nox dressing
5342649|NCT01982565|Diabetic|diabetic
5342650|NCT01982565|Foot|foot
5342651|NCT01982565|Ulcers|ulcers
5342652|NCT01982565|Chronic|chronic
5342653|NCT01982552|Plaque psoriasis|plaque psoriasis
5342654|NCT01982552|calcipotriene|calcipotriene
5342655|NCT01982552|betamethasone dipropionate|betamethasone dipropionate
5342656|NCT01982552|topical|topical
5342657|NCT01982539|pain|pain
5342658|NCT01982539|NSAID|nsaid
5342659|NCT01982539|moderate pain|moderate pain
5342660|NCT01982539|mild pain|mild pain
5342661|NCT01982539|acute pain|acute pain
5342662|NCT01982539|mild acute pain|mild acute pain
5342663|NCT01982539|moderate acute pain|moderate acute pain
5342664|NCT01982539|mild or moderate acute pain|mild or moderate acute pain
5342665|NCT01982526|Ovarian reserve|ovarian reserve
5342666|NCT01982526|Antimullerian hormone|antimullerian hormone
5342667|NCT01982513|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5342668|NCT01982513|Pregnancy|pregnancy
5342669|NCT01982513|Ultrasound|ultrasound
5342670|NCT01982513|Inferior Vena Cava|inferior vena cava
5963462|NCT04242043|Geriatrics|geriatrics
5342671|NCT01982500|Ovarian Cancer|ovarian cancer
5222032|NCT02610868|ALS|als
5342672|NCT01982500|Chemotherapy|chemotherapy
5342673|NCT01982500|Anti-angiogenic agent|anti-angiogenic agent
5342674|NCT01982500|Bevacizumab|bevacizumab
5342675|NCT01982500|Front Line|front line
5342676|NCT01982474|allergic rhinitis|allergic rhinitis
5342677|NCT01982448|TRIPLE NEGATIVE BREAST CANCER WITHOUT GERMLINE BRCA MUTATIONS|triple negative breast cancer without germline brca mutations
5342678|NCT01982448|CISPLATIN|cisplatin
5342679|NCT01982448|PACLITAXEL|paclitaxel
5342680|NCT01982435|Diabetes|diabetes
5342681|NCT01982435|Macular Edema|macular edema
5342682|NCT01982422|Attention Deficit and Hyperactivity Disorder|attention deficit and hyperactivity disorder
5342683|NCT01982422|Nutrition|nutrition
5342684|NCT01982422|Diet|diet
5342685|NCT01982422|Developmental Origins of Disease|developmental origins of disease
5342686|NCT01982396|HIV|hiv
5342687|NCT01982396|paediatric|paediatric
5342688|NCT01982396|Abacavir|abacavir
5342689|NCT01982396|lamivudine|lamivudine
5342690|NCT01982383|CSC|csc
5342691|NCT01982383|Edema|edema
5342692|NCT01982383|Retinopathy|retinopathy
5342693|NCT01982344|mini-exchange-room|mini-exchange-room
5342694|NCT01982344|physical activity|physical activity
5342695|NCT01982344|quality of life|quality of life
5342696|NCT01982344|peritoneal dialysis|peritoneal dialysis
5342697|NCT01982331|H2N2|h2n2
5342698|NCT01982331|vaccine|vaccine
5342699|NCT01982318|Venous Leg Ulcer|venous leg ulcer
5342700|NCT01982318|Leg Ulcer|leg ulcer
5342701|NCT01982318|Venous Hypertension|venous hypertension
5342702|NCT01982318|Venous Reflux|venous reflux
5342703|NCT01982318|Deep Venous System|deep venous system
5342704|NCT01982318|Chronic leg ulceration|chronic leg ulceration
5342705|NCT01982318|Calf perforator|calf perforator
5338826|NCT02000219|PH|ph
5862778|NCT00001515|Endobronchial Lesions|endobronchial lesions
5445426|NCT01521871|Living donor nephrectomy|living donor nephrectomy
5342706|NCT01982292|Chronic Heart Failure, CHF, Heart Failure, HF, Immunogenicity, Anti-bodies, Hypersensitivity, Serelaxin, RELAX-REPEAT|chronic heart failure, chf, heart failure, hf, immunogenicity, anti-bodies, hypersensitivity, serelaxin, relax-repeat
5342707|NCT01982279|Caloric compensation|caloric compensation
5342708|NCT01982279|Eating in the absence of hunger|eating in the absence of hunger
5342710|NCT01982279|Maternal feeding practices|maternal feeding practices
5342711|NCT01982279|Maternal eating behavior|maternal eating behavior
5342712|NCT01982279|one year|one year
5342713|NCT01982279|children|children
5342714|NCT01982253|Drug therapy|drug therapy
5342715|NCT01982240|CIC|cic
5342716|NCT01982240|Constipation|constipation
5342717|NCT01982240|Chronic Constipation|chronic constipation
5342718|NCT01982240|Synergy|synergy
5342719|NCT01982240|Plecanatide|plecanatide
5342720|NCT01982227|colorectal cancer metastatic|colorectal cancer metastatic
5342721|NCT01982227|indocyanine green|indocyanine green
5342722|NCT01982214|osteopenia|osteopenia
5342723|NCT01982214|whole body vibration|whole body vibration
5342724|NCT01982214|women|women
5342725|NCT01982214|bone microarchitecture|bone microarchitecture
5342726|NCT01982214|bone density|bone density
5342727|NCT01982188|single incision sling|single incision sling
5342728|NCT01982188|cough stress test|cough stress test
5342729|NCT01982188|MiniArc|miniarc
5342730|NCT01982188|UDI-6|udi-6
5342731|NCT01982188|UIQ-7|uiq-7
5342732|NCT01982188|Sandvick Severity Index (SSI)|sandvick severity index (ssi)
5342733|NCT01982175|Alemtuzumab|alemtuzumab
5342734|NCT01982175|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5342735|NCT01982175|CD52|cd52
5342736|NCT01982162|Sputum|sputum
5342737|NCT01982162|Clinical cohorts|clinical cohorts
5342738|NCT01982162|Smokers|smokers
5342739|NCT01982162|Asthma|asthma
5342740|NCT01982162|Biopsies|biopsies
5342741|NCT01982162|Severe asthma|severe asthma
5342742|NCT01982162|Collaborative research|collaborative research
5342743|NCT01982162|Phenotyping|phenotyping
5342744|NCT01982162|Lipidomics|lipidomics
5342745|NCT01982162|Transcriptomics|transcriptomics
5342746|NCT01982162|Proteomics|proteomics
5342747|NCT01982162|Paediatric cohort|paediatric cohort
5342748|NCT01982162|Systems Biology|systems biology
5342749|NCT01982149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5342750|NCT01982149|COPD|copd
5342751|NCT01982149|Smokers|smokers
5342752|NCT01982149|Nonsmokers|nonsmokers
5342753|NCT01982110|smoking cessation|smoking cessation
5342754|NCT01982110|mindfulness|mindfulness
5342755|NCT01982110|behavioral intervention|behavioral intervention
5342756|NCT01982097|Non-interventional|non-interventional
5342757|NCT01982097|Nexavar|nexavar
5342758|NCT01982097|Sorafenib|sorafenib
5342759|NCT01982097|Carcinoma, renal cell|carcinoma, renal cell
5342760|NCT01982097|Neoadjuvant|neoadjuvant
5342761|NCT01982097|Nephrectomy|nephrectomy
5342762|NCT01982097|Russian Federation|russian federation
5342763|NCT01982084|Group B streptococcus|group b streptococcus
5342764|NCT01982084|Immunisation|immunisation
5342765|NCT01982084|Pregnancy|pregnancy
5342766|NCT01982084|Attitudes|attitudes
5963463|NCT04242043|diagnostic proposals elderly|diagnostic proposals elderly
5342767|NCT01982071|Micafungin|micafungin
5342768|NCT01982071|candidiasis|candidiasis
5342769|NCT01982071|candidemia|candidemia
5342770|NCT01982071|Open-label design|open-label design
5342771|NCT01982045|Bone graft|bone graft
5342772|NCT01982045|Ceramic|ceramic
5342773|NCT01982045|Spinal fusion|spinal fusion
5342775|NCT01982045|Thoracolumbar region|thoracolumbar region
5342776|NCT01982032|Periprosthetic aortic valve regurgitation|periprosthetic aortic valve regurgitation
5342777|NCT01982032|3D transesophageal echocardiography|3d transesophageal echocardiography
5342778|NCT01982032|Cardiac MRI|cardiac mri
5342779|NCT01982019|26RFa|26rfa
5342780|NCT01982019|sleeve gastrectomy|sleeve gastrectomy
5342781|NCT01982019|diabetes|diabetes
5342782|NCT01982019|obesity|obesity
5342783|NCT01982006|cataract surgery|cataract surgery
5342784|NCT01982006|femtosecond laser cataract surgery|femtosecond laser cataract surgery
5342785|NCT01982006|phacoemulsification|phacoemulsification
5342786|NCT01982006|Cost-Benefit Analysis|cost-benefit analysis
5342787|NCT01982006|Cost Effectiveness|cost effectiveness
5342788|NCT01982006|Hospital Costs|hospital costs
5342789|NCT01981980|Carbon dioxide|carbon dioxide
5342790|NCT01981980|Carboxytherapy|carboxytherapy
5342791|NCT01981980|Radiofrequency|radiofrequency
5342792|NCT01981967|Japanese encephalitis|japanese encephalitis
5343017|NCT01981096|cognitive behavioral therapy|cognitive behavioral therapy
5343018|NCT01981096|coping skills training|coping skills training
5343019|NCT01981083|Protein-Energy Malnutrition|protein-energy malnutrition
5343020|NCT01981083|Chronic Kidney Disease|chronic kidney disease
5343021|NCT01981083|Malnutrition-Inflammation Score|malnutrition-inflammation score
5343022|NCT01981083|Subjective Global Assessment|subjective global assessment
5343023|NCT01981083|Hemodialysis|hemodialysis
5343024|NCT01981083|Egg albumin|egg albumin
5343025|NCT01981070|parent support|parent support
5343026|NCT01981070|mindfulness|mindfulness
5343027|NCT01981070|intellectual disability|intellectual disability
5343028|NCT01981070|developmental disability|developmental disability
5343030|NCT01981070|psychological acceptance|psychological acceptance
5343032|NCT01981070|parental depression|parental depression
5343033|NCT01981057|parenteral nutrition|parenteral nutrition
5343034|NCT01981057|Numeta|numeta
5343035|NCT01981057|prescription software Cato Pan|prescription software cato pan
5343036|NCT01981018|Mental imagery, CBT, anxiety, mood instability|mental imagery, cbt, anxiety, mood instability
5343037|NCT01980992|Food Allergy|food allergy
5343038|NCT01980992|Wheat Allergy|wheat allergy
5343039|NCT01980992|Oral Immunotherapy|oral immunotherapy
5343040|NCT01980979|congenital heart disease,pulmonary hypertension,prostacyclin|congenital heart disease,pulmonary hypertension,prostacyclin
5343041|NCT01980927|Migraine|migraine
5343042|NCT01980927|National Upper Cervical Chiropractic Association atlas correction|national upper cervical chiropractic association atlas correction
5343043|NCT01980914|hypoglycemia|hypoglycemia
5343044|NCT01980914|type 2 diabetes|type 2 diabetes
5343045|NCT01980914|insulin glargine|insulin glargine
5343046|NCT01980914|cardiac function|cardiac function
5343047|NCT01980914|myocardial ischemia|myocardial ischemia
5343048|NCT01980914|cardiac rhythm|cardiac rhythm
5343049|NCT01980914|autonomic cardiovascular function|autonomic cardiovascular function
5343051|NCT01980849|Nadroparin|nadroparin
5343052|NCT01980849|venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5343053|NCT01980836|Rheumatoid arthritis|rheumatoid arthritis
5343055|NCT01980836|Seasonal influenza vaccine|seasonal influenza vaccine
5343056|NCT01980823|Breast Cancer|breast cancer
5343057|NCT01980823|Metformin|metformin
5343058|NCT01980823|Atorvastatin|atorvastatin
5343059|NCT01980823|Ki-67|ki-67
5343060|NCT01980797|Bicuspid aortic valve disease|bicuspid aortic valve disease
5343061|NCT01980797|Thoracic aortic disease|thoracic aortic disease
5343062|NCT01980797|Genetics|genetics
5343063|NCT01980797|Echocardiography|echocardiography
5343064|NCT01980797|Cardiac CT|cardiac ct
5343065|NCT01980797|Cardiac MRI|cardiac mri
5343066|NCT01980784|Spinal Cord Injury|spinal cord injury
5343067|NCT01980771|HIV|hiv
5343069|NCT01980771|men|men
5343070|NCT01980771|African American|african american
5343071|NCT01980758|obesity, pediatric obesity, bariatric, bariatric surgery|obesity, pediatric obesity, bariatric, bariatric surgery
5343072|NCT01980745|autoimmune hepatitis|autoimmune hepatitis
5963464|NCT04241419|ESRD|esrd
5963465|NCT04241419|Thoracic Disease|thoracic disease
5963466|NCT04241419|Kidney Transplant|kidney transplant
5963467|NCT04241146|enteral nutrition|enteral nutrition
5963468|NCT04241146|radiation exposure|radiation exposure
5963469|NCT04241146|nursing care|nursing care
5963470|NCT04241146|pediatrics|pediatrics
5963471|NCT04241146|radiation, non-ionizing|radiation, non-ionizing
5963472|NCT04240301|medication safety|medication safety
5963473|NCT04240301|anesthesiology|anesthesiology
5963474|NCT04240301|perioperative|perioperative
5963475|NCT04238793|Lumbosacral Radiculopathy|lumbosacral radiculopathy
5963476|NCT04238793|LSR|lsr
5963477|NCT04238689|malaria|malaria
5963478|NCT04238689|monoclonal antibody|monoclonal antibody
5963479|NCT04238689|falciparum|falciparum
5963480|NCT04238689|TB31F|tb31f
5963481|NCT04238689|transmission blocking|transmission blocking
5963482|NCT04238689|gametocyte|gametocyte
5963483|NCT04238221|COPD|copd
5963484|NCT04238221|Bronchodilator|bronchodilator
5963485|NCT04238221|Pulmonary Function Test|pulmonary function test
5963486|NCT04238221|Doxofylline|doxofylline
5963487|NCT04238221|Methylxanthines|methylxanthines
5963488|NCT04238221|6-minute walk test|6-minute walk test
5963489|NCT04238221|FEV1|fev1
5210230|NCT02681653|Statins|statins
5343073|NCT01980745|recurrence|recurrence
5343074|NCT01980745|treatment withdrawal|treatment withdrawal
5343075|NCT01980745|chloroquine|chloroquine
5343076|NCT01980745|maintenance of remission|maintenance of remission
5343077|NCT01980706|Baclofen|baclofen
5343078|NCT01980706|Alcohol Dependence|alcohol dependence
5343079|NCT01980667|lurbinectedin|lurbinectedin
5343080|NCT01980667|PM01183|pm01183
5343081|NCT01980667|tumors|tumors
5343082|NCT01980667|cancer|cancer
5343083|NCT01980667|Pharma Mar|pharma mar
5343084|NCT01980654|Pharmacyclics (PCYC)|pharmacyclics (pcyc)
5343085|NCT01980654|PCYC|pcyc
5343086|NCT01980654|Lymphoma|lymphoma
5343087|NCT01980654|Follicular Lymphoma|follicular lymphoma
5343088|NCT01980654|FL|fl
5343089|NCT01980654|Rituximab|rituximab
5343090|NCT01980654|Ibrutinib|ibrutinib
5343091|NCT01980654|Rituxan|rituxan
5343092|NCT01980654|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5343093|NCT01980654|NHL|nhl
5343094|NCT01980654|B-cell Lymphoma|b-cell lymphoma
5343095|NCT01980641|Stroke|stroke
5343096|NCT01980641|ADL|adl
5343097|NCT01980641|mHealth|mhealth
5343098|NCT01980641|App|app
5343099|NCT01980641|Adherence|adherence
5343100|NCT01980641|Home|home
5343101|NCT01980641|Environment|environment
5343102|NCT01980641|Tool|tool
5343103|NCT01980641|Advice|advice
5343104|NCT01980641|Smartphone|smartphone
5343105|NCT01980628|MZL|mzl
5343106|NCT01980628|NHL|nhl
5343107|NCT01980628|SMZL|smzl
5343108|NCT01980628|NMZL|nmzl
5237915|NCT02515175|HSV|hsv
5343109|NCT01980628|MALT|malt
5343110|NCT01980602|Intermittent claudication|intermittent claudication
5343111|NCT01980602|endothelial function|endothelial function
5343112|NCT01980602|cardiopulmonary testing|cardiopulmonary testing
5343113|NCT01980602|inflammation|inflammation
5343114|NCT01980602|muscle architecture|muscle architecture
5343115|NCT01980589|multiple myeloma|multiple myeloma
5343116|NCT01980576|Pain|pain
5343117|NCT01980576|Sensitization|sensitization
5343118|NCT01980576|Spondylitis|spondylitis
5343119|NCT01980485|smoker|smoker
5343120|NCT01980459|Hypomagnesemia, Cellular Mg, Inflammation, Diabetes Mellitus|hypomagnesemia, cellular mg, inflammation, diabetes mellitus
5343121|NCT01980446|Coma|coma
5343122|NCT01980446|Cardiac arrest|cardiac arrest
5343123|NCT01980446|Neurophysiology|neurophysiology
5343124|NCT01980446|Auditory evoked potential|auditory evoked potential
5343125|NCT01980433|Wilson disease|wilson disease
5343126|NCT01980433|Dystonia|dystonia
5343127|NCT01980433|Movement Disorders|movement disorders
5343128|NCT01980433|Handwriting|handwriting
5343129|NCT01980433|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5343130|NCT01980420|Sleeve gastrectomy|sleeve gastrectomy
5339016|NCT01999244|Weight Loss|weight loss
5343133|NCT01980407|S-1|s-1
5343134|NCT01980407|Oxaliplatin|oxaliplatin
5343135|NCT01980407|Leucovorin|leucovorin
5343136|NCT01980407|Gastric Cancer|gastric cancer
5343137|NCT01980394|esophagus|esophagus
5343138|NCT01980394|gastro-esophegeal junction|gastro-esophegeal junction
5343139|NCT01980394|cancer|cancer
5343140|NCT01980394|tumor seeding|tumor seeding
5343141|NCT01980394|free viable tumor cells|free viable tumor cells
5343142|NCT01980394|surgery|surgery
5343143|NCT01980394|intraluminal tumor cells|intraluminal tumor cells
5343144|NCT01980394|stump washout|stump washout
5343145|NCT01980355|cancer|cancer
5343146|NCT01980355|surgery|surgery
5343147|NCT01980355|oncology|oncology
5343148|NCT01980355|major|major
5343149|NCT01980355|surgical oncology|surgical oncology
5343150|NCT01980355|tranexamic acid|tranexamic acid
5343151|NCT01980342|Long acting reversible contraception|long acting reversible contraception
5343152|NCT01980342|HIV|hiv
5343153|NCT01980329|CYP3A5|cyp3a5
5343154|NCT01980329|maraviroc|maraviroc
5343155|NCT01980329|polymorphism|polymorphism
5343156|NCT01980316|Argatroban|argatroban
5343157|NCT01980316|Extracranial vertebral Artery Stenting|extracranial vertebral artery stenting
5343158|NCT01980316|restenosis|restenosis
5343159|NCT01980303|Healthy|healthy
5343160|NCT01980303|Japanese|japanese
5343161|NCT01980303|Caucasian|caucasian
5343162|NCT01980303|Anesthetics|anesthetics
5343163|NCT01980303|Intranasal|intranasal
5343164|NCT01980303|Esketamine|esketamine
5343165|NCT01980303|Pharmacokinetics|pharmacokinetics
5343166|NCT01980290|HCV genotype 1|hcv genotype 1
5343167|NCT01980290|Liver Fibrosis|liver fibrosis
5963490|NCT04238091|Hair Loss|hair loss
5343168|NCT01980290|ex-People who INject Drugs (ex-PWIDs)|ex-people who inject drugs (ex-pwids)
5343169|NCT01980264|Melanoma|melanoma
5343170|NCT01980264|Basal Cell Carcinoma|basal cell carcinoma
5343171|NCT01980264|Squamous Cell Carcinoma|squamous cell carcinoma
5343172|NCT01980264|BD, AK|bd, ak
5343173|NCT01980264|melanin|melanin
5343174|NCT01980251|Delirium, electroencephalography, CSD|delirium, electroencephalography, csd
5343176|NCT01980238|anastomotic leakage|anastomotic leakage
5343177|NCT01980238|Cannula ileostomy|cannula ileostomy
5343178|NCT01980238|loop ileostomy|loop ileostomy
5343179|NCT01980225|vitrification, blastocyst, artificial shrinkage, collapse|vitrification, blastocyst, artificial shrinkage, collapse
5343180|NCT01980212|non-small cell lung cancer|non-small cell lung cancer
5343181|NCT01980212|thioredoxin reductase|thioredoxin reductase
5343182|NCT01980199|visceral leishmaniasis|visceral leishmaniasis
5343183|NCT01980199|fexinidazole|fexinidazole
5343184|NCT01980199|adults|adults
5343185|NCT01980199|proof of concept|proof of concept
5343186|NCT01980199|efficacy|efficacy
5343187|NCT01980199|safety|safety
5343188|NCT01980199|pharmacokinetic|pharmacokinetic
5343189|NCT01980199|pharmacodynamic|pharmacodynamic
5343190|NCT01980186|transcranial ultrasound|transcranial ultrasound
5343191|NCT01980186|autism|autism
5343192|NCT01980186|cortical dysplasia|cortical dysplasia
5343193|NCT01980186|extra-axial fluid|extra-axial fluid
5343194|NCT01980173|Bakri balloon|bakri balloon
5343195|NCT01980147|Severe Mental Illness|severe mental illness
5343196|NCT01980134|adenomatous colorectal lesions|adenomatous colorectal lesions
5343197|NCT01980134|colorectal polyps|colorectal polyps
5343198|NCT01980134|polyps|polyps
5343199|NCT01980121|Respiratory Aspiration|respiratory aspiration
5343200|NCT01980121|Pregnancy|pregnancy
5343201|NCT01980121|Ultrasound|ultrasound
5343202|NCT01980121|Gastric Contents|gastric contents
5343203|NCT01980108|Pregnancy|pregnancy
5343204|NCT01980108|Respiratory Aspiration|respiratory aspiration
5343205|NCT01980108|Gastric Contents|gastric contents
5343206|NCT01980108|Ultrasound|ultrasound
5343207|NCT01980095|Helicobacter pylori|helicobacter pylori
5343208|NCT01980095|H. pylori|h. pylori
5343209|NCT01980095|Dyspepsia|dyspepsia
5343210|NCT01980082|head and neck surgery|head and neck surgery
5343211|NCT01980082|surgical wound infection|surgical wound infection
5343212|NCT01980082|antibiotic prophylaxis|antibiotic prophylaxis
5343213|NCT01980069|Sugammadex|sugammadex
5343214|NCT01980069|Neostigmine|neostigmine
5343215|NCT01980069|Surgery|surgery
5343216|NCT01980056|INT-2 or high-risk MDS|int-2 or high-risk mds
5343217|NCT01980017|Diabetes Type 2 Mellitus|diabetes type 2 mellitus
5343218|NCT01980017|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
5343219|NCT01980017|Diabetes Education Programs|diabetes education programs
5343220|NCT01979965|Mitral Regurgitation|mitral regurgitation
5343221|NCT01979965|cardiac resynchronization therapy|cardiac resynchronization therapy
5343222|NCT01979965|ranolazine|ranolazine
5343223|NCT01979965|maximal medical therapy|maximal medical therapy
5343224|NCT01979965|ischemic cardiomyopathy|ischemic cardiomyopathy
5343225|NCT01979913|Primary Open Angle Glaucoma|primary open angle glaucoma
5343226|NCT01979913|Ocular Hypertension|ocular hypertension
5343227|NCT01979913|Tafluprost|tafluprost
5343228|NCT01979913|Saflutan|saflutan
5343229|NCT01979913|Intraocular pressure|intraocular pressure
5343230|NCT01979913|Preservative free|preservative free
5343231|NCT01979913|Single dose unit|single dose unit
5343232|NCT01979900|TB Infection|tb infection
5343233|NCT01979900|Lesion Degree|lesion degree
5343234|NCT01979900|Bacteriology Indicators|bacteriology indicators
5343236|NCT01979900|Humoral Immunity|humoral immunity
5343237|NCT01979900|Cellular Immunologic Response|cellular immunologic response
5343238|NCT01979861|Endometrial ablation with vapor|endometrial ablation with vapor
5343239|NCT01979848|continence outcomes|continence outcomes
5343240|NCT01979848|sexual function|sexual function
5343241|NCT01979848|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
5343242|NCT01979848|thermal imaging|thermal imaging
5343243|NCT01979848|localized hypothermia|localized hypothermia
5343244|NCT01979835|intrauterine device, contraception|intrauterine device, contraception
5343245|NCT01979822|medication pump, complications, safety observation|medication pump, complications, safety observation
5343246|NCT01979809|Dietary change|dietary change
5343247|NCT01979809|Young adult|young adult
5343248|NCT01979809|Prevention|prevention
5343249|NCT01979809|Web-based intervention|web-based intervention
5343250|NCT01979809|eCoaching|ecoaching
5343251|NCT01979796|Addiction, Schizophrenia, Electronic cigarettes|addiction, schizophrenia, electronic cigarettes
5343252|NCT01979770|Adolescent|adolescent
5343253|NCT01979770|Nutritional status|nutritional status
5343254|NCT01979770|Body composition|body composition
5343255|NCT01979770|Biochemical status|biochemical status
5343256|NCT01979744|Intravenous ultrasound,|intravenous ultrasound,
5423297|NCT01616290|superficial femoral artery|superficial femoral artery
5343257|NCT01979744|third generation drug-eluting stent|third generation drug-eluting stent
5343258|NCT01979731|Occupational health|occupational health
5343259|NCT01979731|Ergonomics|ergonomics
5343260|NCT01979731|Environments|environments
5343261|NCT01979731|Prevention and Control|prevention and control
5343263|NCT01979692|The study will|the study will
5343264|NCT01979692|focus on using|focus on using
5343265|NCT01979692|CLM to|clm to
5963491|NCT04238091|Alopecia|alopecia
5963492|NCT04237792|procedural sedation|procedural sedation
5963493|NCT04237792|dexmedetomidine|dexmedetomidine
5963494|NCT04237792|propofol|propofol
5963495|NCT04237792|MRI|mri
5963496|NCT04237584|mCRPC|mcrpc
5963497|NCT04237584|ARB|arb
5963498|NCT04237584|Radiopharmaceutical|radiopharmaceutical
5963499|NCT04237155|Sorce-monitoring|sorce-monitoring
5963500|NCT04236583|Video Visits|video visits
5963501|NCT04236583|Virtual Visits|virtual visits
5963502|NCT04236583|Telehealth|telehealth
5222502|NCT02608086|RCT|rct
5343266|NCT01979692|distinguish between|distinguish between
5343267|NCT01979692|viable and|viable and
5343268|NCT01979692|necrotic tissue|necrotic tissue
5343269|NCT01979692|at TTNB in real time|at ttnb in real time
5343270|NCT01979666|Knee AVN, Nitrates|knee avn, nitrates
5343271|NCT01979640|bronchial cuff|bronchial cuff
5343272|NCT01979640|double lumen tube|double lumen tube
5343273|NCT01979640|blood tight seal|blood tight seal
5343274|NCT01979627|transulnar approach|transulnar approach
5343275|NCT01979627|transradial approach|transradial approach
5343276|NCT01979627|angiography|angiography
5343277|NCT01979627|angioplasty|angioplasty
5343278|NCT01979614|coronary artery disease|coronary artery disease
5343279|NCT01979601|hypercholesterolemia,|hypercholesterolemia,
5343280|NCT01979601|LGT209,|lgt209,
5343281|NCT01979601|PCSK9,|pcsk9,
5343282|NCT01979601|LDL-C|ldl-c
5343283|NCT01979575|Nexfin|nexfin
5343284|NCT01979575|Flotrac|flotrac
5343285|NCT01979575|Esophageal|esophageal
5343286|NCT01979575|Cardiac output|cardiac output
5343287|NCT01979562|Overuse injury|overuse injury
5343288|NCT01979562|Femur|femur
5343289|NCT01979562|Tibia|tibia
5343290|NCT01979562|Running|running
5343291|NCT01979562|Prevention|prevention
5343292|NCT01979549|Adverse events|adverse events
5343293|NCT01979549|Upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5343294|NCT01979549|Sedation|sedation
5343295|NCT01979484|bioavailability|bioavailability
5343296|NCT01979471|Cardiovascular risk reduction|cardiovascular risk reduction
5343297|NCT01979471|Diabetes|diabetes
5343298|NCT01979471|Chronic Kidney Disease|chronic kidney disease
5343299|NCT01979471|Atherosclerotic vascular disease|atherosclerotic vascular disease
5343300|NCT01979471|Community Pharmacist|community pharmacist
5343301|NCT01979471|Randomized controlled trial|randomized controlled trial
5343302|NCT01979471|[eGFR <60 ml/min/1.73m2 and/or (ACR >= 30 mg/mmol or two consecutive ACR tests which are >= 3 mg/mmol)]|[egfr <60 ml/min/1.73m2 and/or (acr >= 30 mg/mmol or two consecutive acr tests which are >= 3 mg/mmol)]
5343303|NCT01979458|Colonoscopy|colonoscopy
5343305|NCT01979432|Alzheimer, cognitive diseases, Ankle-to-brachial index|alzheimer, cognitive diseases, ankle-to-brachial index
5343306|NCT01979419|mild cognitive impairment|mild cognitive impairment
5343307|NCT01979419|Alzheimer's disease|alzheimer's disease
5343308|NCT01979419|subcortical Vascular Dementia|subcortical vascular dementia
5343309|NCT01979419|amyloid|amyloid
5343310|NCT01979419|plaques|plaques
5343312|NCT01979419|biomarkers|biomarkers
5343313|NCT01979419|cognition disorder|cognition disorder
5343315|NCT01979419|pre-dementia|pre-dementia
5343316|NCT01979419|dementia|dementia
5343317|NCT01979419|vascular MCI|vascular mci
5343318|NCT01979406|Anthrax vaccine|anthrax vaccine
5343319|NCT01979393|Locally advanced|locally advanced
5343320|NCT01979393|stage III|stage iii
5343321|NCT01979393|stage IV|stage iv
5343322|NCT01979393|residual disease after primary surgery|residual disease after primary surgery
5343323|NCT01979393|newly diagnosed HGUS|newly diagnosed hgus
5343324|NCT01979393|Metastatic|metastatic
5343326|NCT01979380|Anti-obesity Agents|anti-obesity agents
5343327|NCT01979354|spinal morphine|spinal morphine
5343328|NCT01979354|VATs lobectomy|vats lobectomy
5343329|NCT01979341|dual trigger|dual trigger
5343331|NCT01979341|GnRH agonist|gnrh agonist
5343332|NCT01979341|ICSI|icsi
5343333|NCT01979341|pregnancy|pregnancy
5343334|NCT01979341|OHSS|ohss
5343335|NCT01979328|Deep Vein Thrombosis|deep vein thrombosis
5343336|NCT01979302|Geriatric Depression|geriatric depression
5343337|NCT01979302|Depression Care Management|depression care management
5343338|NCT01979302|home healthcare|home healthcare
5343339|NCT01979302|nurse training intervention|nurse training intervention
5343340|NCT01979289|Executive Dysfunction|executive dysfunction
5343341|NCT01979289|Cognitive Remediation|cognitive remediation
5343342|NCT01979289|Geriatric|geriatric
5343343|NCT01979289|Depression|depression
5343344|NCT01979250|endothelial keratoplasty|endothelial keratoplasty
5343345|NCT01979250|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
5343346|NCT01979250|lamellar keratoplasty|lamellar keratoplasty
5343347|NCT01979224|educational intervention, Asthma control, asthma knowledge|educational intervention, asthma control, asthma knowledge
5343349|NCT01979198|burst fracture, kyphotic angle, surgical outcome|burst fracture, kyphotic angle, surgical outcome
5343350|NCT01979172|LASIK|lasik
5343351|NCT01979172|Intraocular lens|intraocular lens
5343352|NCT01979172|Biometry|biometry
5343353|NCT01979172|IOL master|iol master
5343354|NCT01979159|aphasia|aphasia
5343355|NCT01979159|apraxia of speech|apraxia of speech
5343356|NCT01979159|outcomes|outcomes
5343357|NCT01979146|Cancer|cancer
5343358|NCT01979120|Sleep-disordered breathing|sleep-disordered breathing
5423298|NCT01616290|SFA|sfa
5343359|NCT01979120|Chronic heart failure|chronic heart failure
5343360|NCT01979120|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5343361|NCT01979120|Apnea-Hypopnea-Index|apnea-hypopnea-index
5343362|NCT01979120|Portable Polygraphy Monitoring|portable polygraphy monitoring
5343363|NCT01979120|Polysomnography|polysomnography
5963503|NCT04236154|Exercise, Falls|exercise, falls
5343364|NCT01979107|Health behavior|health behavior
5343365|NCT01979107|Chronic disease|chronic disease
5343366|NCT01979107|Proactive action|proactive action
5343367|NCT01979107|General practitioner|general practitioner
5343368|NCT01979107|Preventive health check|preventive health check
5343369|NCT01979107|Social inequality in health|social inequality in health
5343370|NCT01979107|Randomised controlled trial|randomised controlled trial
5343372|NCT01979055|older adults|older adults
5343373|NCT01979055|elderly|elderly
5343374|NCT01979055|behavior|behavior
5343375|NCT01979042|renal colic|renal colic
5343376|NCT01979042|acute renal failure|acute renal failure
5343377|NCT01979042|Neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
5343378|NCT01978977|mBC|mbc
5343379|NCT01978977|HER2 negative|her2 negative
5343380|NCT01978977|Chemotherapy|chemotherapy
5343381|NCT01978977|Anti-angiogenic agent|anti-angiogenic agent
5343382|NCT01978977|Bevacizumab|bevacizumab
5343383|NCT01978977|1st Line|1st line
5343384|NCT01978964|ONT-10|ont-10
5343385|NCT01978964|MUC1|muc1
5343386|NCT01978964|Vaccine|vaccine
5343387|NCT01978964|Phase 1b|phase 1b
5343388|NCT01978964|Solid tumors|solid tumors
5343389|NCT01978964|Maintenance therapy|maintenance therapy
5343390|NCT01978951|Chronic Kidney Disease|chronic kidney disease
5343391|NCT01978951|Integrated Chronic Kidney Disease Care|integrated chronic kidney disease care
5343392|NCT01978951|Village Health Volunteers|village health volunteers
5343393|NCT01978925|Pharmaceutical care|pharmaceutical care
5343394|NCT01978925|Medication Adherence|medication adherence
5343395|NCT01978925|Blood Pressure|blood pressure
5343396|NCT01978925|Diabetes|diabetes
5343397|NCT01978925|Emergency|emergency
5343398|NCT01978886|Diabetes Mellitus|diabetes mellitus
5343399|NCT01978886|frozen shoulder|frozen shoulder
5343400|NCT01978886|adhesive capsulitis|adhesive capsulitis
5343401|NCT01978860|CABG Coronary artery bypass grafting|cabg coronary artery bypass grafting
5343402|NCT01978860|CTO Chronic Total Occlusion|cto chronic total occlusion
5343403|NCT01978860|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
5343404|NCT01978860|MACE Major adverse cardiovascular event(s)|mace major adverse cardiovascular event(s)
5343405|NCT01978860|MI Myocardial infarction|mi myocardial infarction
5343406|NCT01978834|Osteoporosis, diagnosis, ultrasound|osteoporosis, diagnosis, ultrasound
5343409|NCT01978821|stem cell therapy|stem cell therapy
5343410|NCT01978795|concussion|concussion
5343411|NCT01978795|high school|high school
5343412|NCT01978795|web-based training|web-based training
5343413|NCT01978795|school-based health care|school-based health care
5343414|NCT01978782|raltegravir|raltegravir
5343415|NCT01978782|citalopram|citalopram
5343416|NCT01978782|pharmacokinetics|pharmacokinetics
5343417|NCT01978782|drug-drug interaction|drug-drug interaction
5343418|NCT01978756|Outpatient clinic|outpatient clinic
5343419|NCT01978756|Breast cancer|breast cancer
5343420|NCT01978756|Late toxicity|late toxicity
5343422|NCT01978743|HIV-associated neurocognitive disorder|hiv-associated neurocognitive disorder
5343423|NCT01978743|neurotoxicity|neurotoxicity
5343424|NCT01978730|vascular dementia|vascular dementia
5343425|NCT01978730|cognition|cognition
5343426|NCT01978730|stroke|stroke
5343427|NCT01978717|Anesthesia|anesthesia
5343428|NCT01978717|T-helper|t-helper
5343429|NCT01978717|MDSCs|mdscs
5343430|NCT01978717|Colorectal cancer|colorectal cancer
5343431|NCT01978717|Fast track|fast track
5343432|NCT01978691|Obesity|obesity
5343433|NCT01978691|Blood glucose|blood glucose
5343434|NCT01978691|Waist circumference|waist circumference
5343435|NCT01978691|Lipid metabolism|lipid metabolism
5343436|NCT01978691|Probiotics|probiotics
5343437|NCT01978691|Prebiotics|prebiotics
5343438|NCT01978691|Dietary supplements|dietary supplements
5343439|NCT01978691|Endotoxemia|endotoxemia
5343440|NCT01978665|COPD exercise inflammation prednisone|copd exercise inflammation prednisone
5343441|NCT01978626|Insomnia|insomnia
5343442|NCT01978626|Comorbid insomnia|comorbid insomnia
5343443|NCT01978626|Cognitive Behavioral Therapy|cognitive behavioral therapy
5343444|NCT01978600|Open-Angle Glaucoma|open-angle glaucoma
5343445|NCT01978600|Ocular Hypertension|ocular hypertension
5343446|NCT01978600|Simbrinza™|simbrinza™
5343447|NCT01978600|Intraocular Pressure|intraocular pressure
5343448|NCT01978587|End-stage Renal Disease|end-stage renal disease
5343449|NCT01978587|Hemodialysis|hemodialysis
5343450|NCT01978587|Pharmacokinetics|pharmacokinetics
5343453|NCT01978548|Alzheimer Disease|alzheimer disease
5343454|NCT01978548|Prodromal Alzheimer Disease|prodromal alzheimer disease
5343455|NCT01978548|Safety|safety
5343456|NCT01978548|Tolerability|tolerability
5343457|NCT01978548|Pharmacokinetic|pharmacokinetic
5343458|NCT01978548|Proof of Mechanism|proof of mechanism
5343459|NCT01978548|JNJ-54861911|jnj-54861911
5343460|NCT01978535|POTS|pots
5343461|NCT01978522|Randomised trial|randomised trial
5343473|NCT01978483|denosumab|denosumab
5343474|NCT01978483|diphenylcyclopropenone|diphenylcyclopropenone
5343475|NCT01978483|diphencyprone|diphencyprone
5343476|NCT01978483|immunology|immunology
5963504|NCT04235777|Immunocytokine|immunocytokine
5343477|NCT01978483|immunosuppression|immunosuppression
5343478|NCT01978483|Antibodies, Monoclonal|antibodies, monoclonal
5343479|NCT01978483|Dermatitis, Allergic Contact|dermatitis, allergic contact
5343480|NCT01978483|Hypersensitivity, Delayed|hypersensitivity, delayed
5343481|NCT01978470|epilepsy|epilepsy
5343482|NCT01978470|drug resistent epilepsy|drug resistent epilepsy
5343483|NCT01978470|partial onset seizures|partial onset seizures
5343484|NCT01978470|trigeminal nerve stimulation|trigeminal nerve stimulation
5343485|NCT01978470|neuromodulation|neuromodulation
5343486|NCT01978444|D2 lymphadenectomy|d2 lymphadenectomy
5343487|NCT01978444|Complete Mesogastrium Excision|complete mesogastrium excision
5343488|NCT01978418|Lung fluid|lung fluid
5343489|NCT01978418|Postnatal adaptation|postnatal adaptation
5343490|NCT01978418|Salbutamol|salbutamol
5343491|NCT01978418|Albuterol|albuterol
5343492|NCT01978418|Epithelial Sodium Channel|epithelial sodium channel
5343493|NCT01978405|Type 2 diabetes|type 2 diabetes
5343494|NCT01978405|Nephropathy|nephropathy
5343495|NCT01978405|Contrast medium|contrast medium
5343496|NCT01978405|Alpha lipoic acid|alpha lipoic acid
5343497|NCT01978392|disability|disability
5343498|NCT01978392|self-management|self-management
5343499|NCT01978392|chronic illness|chronic illness
5343500|NCT01978392|chronic pain|chronic pain
5343501|NCT01978392|occupation|occupation
5343502|NCT01978392|> 6 months|> 6 months
5343503|NCT01978379|General Anesthesia|general anesthesia
5343504|NCT01978379|Nociception Level|nociception level
5343505|NCT01978366|Duchenne muscular dystrophy|duchenne muscular dystrophy
5343506|NCT01978366|halofuginone hydrobromide|halofuginone hydrobromide
5343507|NCT01978366|anti-fibrotic|anti-fibrotic
5238279|NCT02513017|insomnia|insomnia
5343508|NCT01978366|anti-inflammatory|anti-inflammatory
5343509|NCT01978366|muscle regeneration|muscle regeneration
5343510|NCT01978366|protein synthesis inhibitor|protein synthesis inhibitor
5343511|NCT01978353|Mild cognitive impairment|mild cognitive impairment
5343512|NCT01978353|Dementia|dementia
5343513|NCT01978353|Alzheimer's disease|alzheimer's disease
5343514|NCT01978353|Memory Training|memory training
5343515|NCT01978353|Cognitive Training|cognitive training
5343516|NCT01978353|Cognitive Rehabilitation|cognitive rehabilitation
5343517|NCT01978353|Neuropsychological Rehabilitation|neuropsychological rehabilitation
5343518|NCT01978327|Alzheimer's disease|alzheimer's disease
5343519|NCT01978327|GSK2647544|gsk2647544
5343520|NCT01978327|drug-drug interaction|drug-drug interaction
5343521|NCT01978327|healthy subjects|healthy subjects
5343523|NCT01978327|simvastatin|simvastatin
5343524|NCT01978314|Chronic Kidney Disease|chronic kidney disease
5343525|NCT01978314|Acute Kidney Injury|acute kidney injury
5343527|NCT01978314|CKD|ckd
5343528|NCT01978314|Plasma Volume|plasma volume
5343529|NCT01978314|GFR|gfr
5343530|NCT01978314|Glomerular Filtration Rate|glomerular filtration rate
5343531|NCT01978314|Blood volume|blood volume
5343532|NCT01978314|mGFR|mgfr
5343533|NCT01978314|measured GFR|measured gfr
5343534|NCT01978314|kidney biomarker|kidney biomarker
5343535|NCT01978314|renal disease|renal disease
5343536|NCT01978314|renal biomarker|renal biomarker
5343537|NCT01978314|Renal function|renal function
5343538|NCT01978314|kidney function|kidney function
5343539|NCT01978314|organ function|organ function
5343540|NCT01978314|kidney monitor|kidney monitor
5343541|NCT01978314|kidney device|kidney device
5343542|NCT01978301|triamcinolone acetonide (TAC)|triamcinolone acetonide (tac)
5343543|NCT01978301|heavy water|heavy water
5343544|NCT01978301|fibrosis|fibrosis
5343545|NCT01978301|deuterium|deuterium
5343546|NCT01978301|collagen degradation|collagen degradation
5343547|NCT01978301|collagen synthesis|collagen synthesis
5343548|NCT01978301|Keloid|keloid
5343549|NCT01978301|patient|patient
5343550|NCT01978275|total knee arthroplasty|total knee arthroplasty
5343551|NCT01978275|lumbar plexus block|lumbar plexus block
5343552|NCT01978275|stimulating catheters|stimulating catheters
5343553|NCT01978275|peripheral nerve blocks|peripheral nerve blocks
5343554|NCT01978262|influenza vaccine|influenza vaccine
5343563|NCT01978236|BRAF V600E mutation|braf v600e mutation
5343564|NCT01978236|brain metastases|brain metastases
5343565|NCT01978236|BRAF V600K mutation|braf v600k mutation
5343566|NCT01978236|Metastatic melanoma|metastatic melanoma
5343568|NCT01978236|brain neoplasms|brain neoplasms
5343569|NCT01978236|GSK2118436|gsk2118436
5343570|NCT01978223|Rotarix™|rotarix™
5343571|NCT01978223|Case-control|case-control
5343572|NCT01978223|Venezuela|venezuela
5343573|NCT01978223|Vaccine effectiveness|vaccine effectiveness
5343574|NCT01978223|Rotavirus Severe Gastroenteritis|rotavirus severe gastroenteritis
5343575|NCT01978223|Children|children
5343576|NCT01978223|Hospitalised|hospitalised
5343577|NCT01978210|autism|autism
5343578|NCT01978210|enuresis|enuresis
5343579|NCT01978210|toilet-training|toilet-training
5343580|NCT01978184|Pancreatic Cancer, resectable adenocarcinoma of the pancreas|pancreatic cancer, resectable adenocarcinoma of the pancreas
5343581|NCT01978171|breast neoplasms|breast neoplasms
5343582|NCT01978171|everolimus|everolimus
5343583|NCT01978171|interstitial lung disease|interstitial lung disease
5343584|NCT01978171|pneumonitis|pneumonitis
5210707|NCT02678286|Abdominoplasty|abdominoplasty
5343585|NCT01978158|Oxygen|oxygen
5343586|NCT01978158|Hypoxia|hypoxia
5343587|NCT01978158|Hyperoxia|hyperoxia
5963505|NCT04235777|Renal Cell Carcinoma|renal cell carcinoma
5343588|NCT01978158|Inflammation|inflammation
5343589|NCT01978158|Innate immunity|innate immunity
5343590|NCT01978145|efficacy|efficacy
5343591|NCT01978145|tolerability|tolerability
5343592|NCT01978145|capsule-based inhaler|capsule-based inhaler
5343593|NCT01978145|quality of life|quality of life
5343594|NCT01978145|safety|safety
5343595|NCT01978145|multi-dose inhaler|multi-dose inhaler
5343596|NCT01978145|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
5343597|NCT01978145|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5343598|NCT01978132|primary hyperaldosteronism|primary hyperaldosteronism
5343599|NCT01978132|primary hypertension|primary hypertension
5343600|NCT01978132|forearm ischemia-reperfusion|forearm ischemia-reperfusion
5343601|NCT01978132|(reduction) in brachial artery FMD|(reduction) in brachial artery fmd
5343602|NCT01978132|endothelial ischemia-reperfusion injury|endothelial ischemia-reperfusion injury
5343603|NCT01978119|Multi-Dose Inhaler|multi-dose inhaler
5343604|NCT01978119|safety|safety
5343605|NCT01978119|Asthma|asthma
5343606|NCT01978119|efficacy|efficacy
5343607|NCT01978119|pharmacodynamics|pharmacodynamics
5343706|NCT01977716|Peritonitis|peritonitis
5343608|NCT01978119|fluticasone propionate/salmeterol (FSC) 250/50 mcg|fluticasone propionate/salmeterol (fsc) 250/50 mcg
5343609|NCT01978119|tolerability|tolerability
5343610|NCT01978119|Capsule-Based Inhaler|capsule-based inhaler
5343611|NCT01978106|toric calculator|toric calculator
5343612|NCT01978106|toric intraocular lens power|toric intraocular lens power
5343613|NCT01978106|Acrysof|acrysof
5343614|NCT01978106|Tecnis|tecnis
5343615|NCT01978106|iTrace|itrace
5343616|NCT01978093|Conjugate|conjugate
5343617|NCT01978093|Immunogenicity|immunogenicity
5343618|NCT01978093|Hib-MenCY-TT vaccine|hib-mency-tt vaccine
5343619|NCT01978093|Haemophilus type b|haemophilus type b
5343620|NCT01978093|Safety|safety
5343621|NCT01978093|Reactogenicity|reactogenicity
5343622|NCT01978067|Uterine Scar From Previous Cesarean Delivery|uterine scar from previous cesarean delivery
5343623|NCT01978067|previous caesarean scar deficiency|previous caesarean scar deficiency
5343624|NCT01978067|transvaginal resection|transvaginal resection
5343625|NCT01978067|quality of life|quality of life
5343626|NCT01978067|sexual activity|sexual activity
5343627|NCT01978054|Information Dissemination|information dissemination
5343628|NCT01978054|Information Sharing|information sharing
5343629|NCT01978054|Innovation Diffusion|innovation diffusion
5343630|NCT01978054|Public Health Practice|public health practice
5343631|NCT01978054|Evidence-Based Public Health|evidence-based public health
5343632|NCT01978054|Chronic Disease Prevention|chronic disease prevention
5343633|NCT01978054|Cancer Prevention and Control|cancer prevention and control
5343634|NCT01978041|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries|pharmacokinetics, saliva, plasma, fluoride, dental fluorosis, dental caries
5343635|NCT01978028|heart failure|heart failure
5343636|NCT01978015|primary open angle glaucoma|primary open angle glaucoma
5343637|NCT01978015|timolol|timolol
5343638|NCT01978015|prostaglandin analogues|prostaglandin analogues
5343639|NCT01977976|Endometrial injury|endometrial injury
5343640|NCT01977976|Pipelle|pipelle
5343641|NCT01977976|Implantation|implantation
5343642|NCT01977976|Ongoing pregnancy rate|ongoing pregnancy rate
5343644|NCT01977950|Undernutrition, Nutritional risk, NRS2002, nutritional care practices, hospital, elderly patients, nursing students|undernutrition, nutritional risk, nrs2002, nutritional care practices, hospital, elderly patients, nursing students
5343645|NCT01977937|gabapentin|gabapentin
5343646|NCT01977937|Analgesic Drugs|analgesic drugs
5343650|NCT01977924|endothelial function|endothelial function
5343651|NCT01977911|Airway reconstruction|airway reconstruction
5343652|NCT01977911|Regenerative medicine|regenerative medicine
5343653|NCT01977898|Postdural puncture headache|postdural puncture headache
5343654|NCT01977898|Intrathecal morphine|intrathecal morphine
5343655|NCT01977898|Intrathecal catheter|intrathecal catheter
5343656|NCT01977898|Headache|headache
5343657|NCT01977898|Labor and delivery|labor and delivery
5343658|NCT01977898|Unintentional dural puncture|unintentional dural puncture
5343659|NCT01977885|epigenetics|epigenetics
5343660|NCT01977885|obesity|obesity
5343661|NCT01977885|overweight|overweight
5343662|NCT01977885|high protein diet|high protein diet
5343663|NCT01977885|exercise|exercise
5343664|NCT01977885|post menopausal women|post menopausal women
5343665|NCT01977872|Arthritis|arthritis
5343666|NCT01977872|Physical Activity|physical activity
5343667|NCT01977872|Diet|diet
5343668|NCT01977859|B-type Natriuretic Peptide|b-type natriuretic peptide
5343669|NCT01977859|Metabolism|metabolism
5963506|NCT04235777|Urothelial Cancinoma|urothelial cancinoma
5963507|NCT04235777|Immune Therapy|immune therapy
5963508|NCT04235764|TURBT|turbt
5963509|NCT04235764|Transurethral Resection of Bladder Tumors|transurethral resection of bladder tumors
5963510|NCT04235764|Cystectomy|cystectomy
5963511|NCT04235764|Modified Resectoscope|modified resectoscope
5963512|NCT04234672|Drug Therapy|drug therapy
5963513|NCT04234477|beta-blocker|beta-blocker
5963514|NCT04234477|calcium channel blocker|calcium channel blocker
5343670|NCT01977859|Insulin infusion|insulin infusion
5343671|NCT01977846|genetic testing|genetic testing
5343672|NCT01977846|ABCA4|abca4
5343673|NCT01977846|Stargardt|stargardt
5343674|NCT01977846|retina|retina
5343675|NCT01977846|retinal degeneration|retinal degeneration
5343676|NCT01977833|BTdiet|btdiet
5343677|NCT01977833|Dtdiet|dtdiet
5343678|NCT01977833|High Calorie Breakfast diet (BTdiet)|high calorie breakfast diet (btdiet)
5343679|NCT01977833|High Calorie Dinner diet (DTdiet)|high calorie dinner diet (dtdiet)
5343680|NCT01977820|Phenylketonuria|phenylketonuria
5343681|NCT01977820|Sapropterin|sapropterin
5343682|NCT01977820|Placebo|placebo
5343683|NCT01977820|Cognitive Abilities|cognitive abilities
5343684|NCT01977820|Kuvan®|kuvan®
5343685|NCT01977807|Myopia|myopia
5343686|NCT01977807|Hyperopia|hyperopia
5343687|NCT01977807|Presbyopia|presbyopia
5343688|NCT01977807|Supracor|supracor
5343689|NCT01977807|Zyoptix|zyoptix
5343690|NCT01977807|Proscan|proscan
5343691|NCT01977807|LASIK|lasik
5343692|NCT01977794|Bisoprolol|bisoprolol
5343693|NCT01977794|Amlodipine|amlodipine
5343694|NCT01977794|Fixed dose combination (FDC)|fixed dose combination (fdc)
5343695|NCT01977794|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
5343696|NCT01977794|Diastolic Blood Pressure (DBP)|diastolic blood pressure (dbp)
5343697|NCT01977781|GVHD|gvhd
5343698|NCT01977781|Ocular GVHD|ocular gvhd
5343699|NCT01977781|Tacrolimus|tacrolimus
5343700|NCT01977781|Methylprednisolone|methylprednisolone
5343701|NCT01977768|M. vaccae|m. vaccae
5343702|NCT01977768|TB|tb
5343703|NCT01977768|MDR-TB|mdr-tb
5343704|NCT01977768|V7-immunitor|v7-immunitor
5343705|NCT01977729|anxiety|anxiety
5343707|NCT01977716|loss of residual renal function|loss of residual renal function
5343708|NCT01977716|technique survival|technique survival
5343709|NCT01977703|Heart Failure|heart failure
5343710|NCT01977703|Advanced Heart Failure|advanced heart failure
5343711|NCT01977703|LVAD|lvad
5343712|NCT01977703|Left Ventricular Assist Device|left ventricular assist device
5343713|NCT01977703|Heart-Assist Devices|heart-assist devices
5343714|NCT01977664|oocyte maturation failure|oocyte maturation failure
5343715|NCT01977664|Maturation induction in vitro|maturation induction in vitro
5343716|NCT01977651|enzalutamide|enzalutamide
5343717|NCT01977651|Xtandi|xtandi
5343718|NCT01977651|seizure|seizure
5343719|NCT01977651|Central Nervous System|central nervous system
5343720|NCT01977651|MDV3100|mdv3100
5343721|NCT01977651|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5343722|NCT01977638|Advanced solid tumours|advanced solid tumours
5343723|NCT01977638|Lymphoma|lymphoma
5343724|NCT01977638|Myeloma|myeloma
5343725|NCT01977625|Menopause|menopause
5343726|NCT01977625|fMRI|fmri
5343727|NCT01977625|Vyvanse|vyvanse
5343728|NCT01977612|Wound infection|wound infection
5343729|NCT01977612|Wound separation|wound separation
5343730|NCT01977612|Skin staples|skin staples
5343731|NCT01977612|Subcuticular suture|subcuticular suture
5343732|NCT01977599|Text message reminders|text message reminders
5343733|NCT01977599|Short Message Service (SMS) Reminders|short message service (sms) reminders
5343734|NCT01977599|Social Health Inequalities|social health inequalities
5343735|NCT01977599|Breast Screening|breast screening
5343736|NCT01977599|Screening|screening
5343737|NCT01977599|Public Health Intervention|public health intervention
5343738|NCT01977599|Missed Appointments|missed appointments
5343739|NCT01977599|Non-attendance|non-attendance
5343740|NCT01977586|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
5343741|NCT01977586|Stage IV renal cell carcinoma|stage iv renal cell carcinoma
5343742|NCT01977586|Anti-angiogenic therapy|anti-angiogenic therapy
5343743|NCT01977586|Response assessment|response assessment
5343744|NCT01977586|Magnetic resonance imaging|magnetic resonance imaging
5343745|NCT01977573|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5343746|NCT01977573|pharmacokinetics|pharmacokinetics
5343748|NCT01977573|Anemia|anemia
5343749|NCT01977573|hemoglobin|hemoglobin
5343750|NCT01977573|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5343751|NCT01977573|Chronic kidney disease|chronic kidney disease
5343752|NCT01977560|Type 2 diabetes|type 2 diabetes
5343753|NCT01977560|Exercise|exercise
5343754|NCT01977560|High protein|high protein
5343755|NCT01977547|Red blood cell transfusions|red blood cell transfusions
5343756|NCT01977547|Red blood cell storage age|red blood cell storage age
5343757|NCT01977547|Pediatrics|pediatrics
5343758|NCT01977547|Critical Care|critical care
5343759|NCT01977534|Bioabsorbable|bioabsorbable
5343760|NCT01977534|Coronary Stent|coronary stent
5343761|NCT01977534|Everolimus|everolimus
5963515|NCT04234477|rapid ventricular rate (RVR)|rapid ventricular rate (rvr)
5963516|NCT04234204|ESN364|esn364
5963517|NCT04234204|menopause|menopause
5963518|NCT04234204|fezolinetant|fezolinetant
5963519|NCT04234204|vasomotor symptoms|vasomotor symptoms
5963520|NCT04233164|Immunosuppressive Drugs|immunosuppressive drugs
5963521|NCT04233164|Methylprednisolone|methylprednisolone
5963522|NCT04233164|PREDNISONE|prednisone
5963523|NCT04233164|Steroids|steroids
5963524|NCT04233164|Autoimmunity|autoimmunity
5963525|NCT04232696|UUI|uui
5963526|NCT04232527|Dynamic balance|dynamic balance
5963527|NCT04232527|Stretching|stretching
5343762|NCT01977534|drug eluting stents|drug eluting stents
5343763|NCT01977534|stents|stents
5343764|NCT01977534|angioplasty|angioplasty
5343765|NCT01977534|coronary artery disease|coronary artery disease
5343766|NCT01977534|total coronary occlusion|total coronary occlusion
5343767|NCT01977534|coronary artery restenosis|coronary artery restenosis
5343768|NCT01977534|stent thrombosis|stent thrombosis
5343769|NCT01977534|vascular disease|vascular disease
5343770|NCT01977534|myocardial ischemia|myocardial ischemia
5343771|NCT01977534|coronary artery stenosis|coronary artery stenosis
5343772|NCT01977534|CAD|cad
5343773|NCT01977534|CAOD|caod
5343774|NCT01977508|Vascular access grafts|vascular access grafts
5343775|NCT01977508|Haemodialysis|haemodialysis
5343776|NCT01977495|Diabetes|diabetes
5343777|NCT01977495|Enrollment methods|enrollment methods
5343778|NCT01977495|Behavioral Economic Intervention|behavioral economic intervention
5343779|NCT01977495|Opt-in Enrollment|opt-in enrollment
5343780|NCT01977495|Opt-out Enrollment|opt-out enrollment
5343781|NCT01977495|lottery|lottery
5343782|NCT01977495|financial incentives|financial incentives
5343783|NCT01977482|hemoglobin|hemoglobin
5343784|NCT01977482|recombinant human erythropoietin|recombinant human erythropoietin
5343785|NCT01977482|Chronic kidney disease|chronic kidney disease
5343786|NCT01977482|hemodialysis|hemodialysis
5343787|NCT01977482|pharmacokinetics|pharmacokinetics
5343788|NCT01977482|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5343789|NCT01977482|Anemia|anemia
5343790|NCT01977482|GSK1278863|gsk1278863
5445427|NCT01521871|Surgical wound closure|surgical wound closure
5343791|NCT01977469|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5343792|NCT01977469|Activities of Daily Living|activities of daily living
5343793|NCT01977469|Mortality|mortality
5343794|NCT01977469|Strength Training|strength training
5343795|NCT01977456|acute ischemic stroke|acute ischemic stroke
5343796|NCT01977456|stroke|stroke
5343797|NCT01977456|rt-PA, thrombolytic|rt-pa, thrombolytic
5343798|NCT01977456|t-PA|t-pa
5343799|NCT01977456|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5343800|NCT01977456|Activase|activase
5343801|NCT01977456|eptifibatide|eptifibatide
5343802|NCT01977456|Integrilin|integrilin
5343803|NCT01977456|fibrinolytic agents|fibrinolytic agents
5343804|NCT01977456|clot dissolving|clot dissolving
5343805|NCT01977456|blood clot|blood clot
5343806|NCT01977430|Residual renal function|residual renal function
5343807|NCT01977430|Combined thiazide-furosemide therapy|combined thiazide-furosemide therapy
5343808|NCT01977430|Haemodialysis|haemodialysis
5343809|NCT01977417|Endothelial Function|endothelial function
5343810|NCT01977417|Arterial Stiffness|arterial stiffness
5343811|NCT01977417|Inflammation|inflammation
5343812|NCT01977417|Muscle Sympathetic Nervous System|muscle sympathetic nervous system
5343813|NCT01977417|Prediabetes|prediabetes
5343814|NCT01977417|Autonomic function|autonomic function
5343815|NCT01977404|Congestive heart failure|congestive heart failure
5343816|NCT01977404|Energy expenditure|energy expenditure
5343817|NCT01977404|Body composition|body composition
5343818|NCT01977404|Caloric intake|caloric intake
5343819|NCT01977365|Cluster Randomized Trial,|cluster randomized trial,
5343820|NCT01977365|Nutrition counseling,|nutrition counseling,
5343821|NCT01977365|Caretaker's knowledge|caretaker's knowledge
5343822|NCT01977365|Child growth,|child growth,
5343823|NCT01977365|Prevention,|prevention,
5343824|NCT01977365|Acute malnutrition|acute malnutrition
5343825|NCT01977352|Exparel|exparel
5343826|NCT01977352|Liposomal Bupivacaine|liposomal bupivacaine
5343827|NCT01977352|Arthroscopic Shoulder Surgery|arthroscopic shoulder surgery
5343828|NCT01977339|Femoral Nerve Block|femoral nerve block
5343829|NCT01977339|Liposomal Bupivacaine|liposomal bupivacaine
5343830|NCT01977326|task sharing|task sharing
5343831|NCT01977326|task shifting|task shifting
5343832|NCT01977326|prenatal depression|prenatal depression
5343833|NCT01977326|counselling|counselling
5343834|NCT01977326|lay health workers|lay health workers
5343835|NCT01977287|Multiple Sclerosis|multiple sclerosis
5343836|NCT01977287|Functional Electrical Stimulation|functional electrical stimulation
5343837|NCT01977287|Ankle Foot Orthosis|ankle foot orthosis
5343838|NCT01977287|Walking performance|walking performance
5343839|NCT01977287|gait analysis|gait analysis
5343841|NCT01977287|activity monitoring|activity monitoring
5343842|NCT01977274|ovarian, endometrium, cervix cancer|ovarian, endometrium, cervix cancer
5343843|NCT01977235|Irinotecan; Cisplatin; Small-cell lung cancer; UGT1A1|irinotecan; cisplatin; small-cell lung cancer; ugt1a1
5343844|NCT01977209|NSCLC; Gossypol; APE1; Chemotherapy|nsclc; gossypol; ape1; chemotherapy
5343845|NCT01977196|DTB/HB/Hib vaccine|dtb/hb/hib vaccine
5343847|NCT01977196|Phase I|phase i
5343848|NCT01977183|gastrointestinal|gastrointestinal
5343849|NCT01977183|microbiome|microbiome
5343850|NCT01977183|prebiotic|prebiotic
5343851|NCT01977183|starch|starch
5343852|NCT01977170|Adults|adults
5343853|NCT01977170|Hib vaccines|hib vaccines
5343854|NCT01977170|Immunogenicity|immunogenicity
5343855|NCT01977170|Safety|safety
5343856|NCT01977157|Impedance cardiography|impedance cardiography
5343857|NCT01977157|bioimpedance|bioimpedance
5343858|NCT01977157|spectroscopy|spectroscopy
5343859|NCT01977157|extracellular resistance|extracellular resistance
5343860|NCT01977157|body composition|body composition
5343861|NCT01977157|hemodynamics|hemodynamics
5343863|NCT01977144|Single Embryo Transfer|single embryo transfer
5343864|NCT01977144|Double Embryo Transfer|double embryo transfer
5343865|NCT01977144|CCS (Comprehensive Chromosome Screening)|ccs (comprehensive chromosome screening)
5343866|NCT01977144|Aneuploidy|aneuploidy
5343867|NCT01977144|Low Responders|low responders
5343868|NCT01977118|Streptokinase|streptokinase
5343869|NCT01977118|Percutaneous catheter drainage|percutaneous catheter drainage
5343870|NCT01977118|Pancreatic necrosis|pancreatic necrosis
5343871|NCT01977118|peripancreatic necrosis|peripancreatic necrosis
5343872|NCT01977105|Infants|infants
5343873|NCT01977105|Mothers|mothers
5343874|NCT01977105|Social media|social media
5343875|NCT01977105|Obesity prevention|obesity prevention
5343876|NCT01977092|sober living houses|sober living houses
5343877|NCT01977092|HIV|hiv
5343878|NCT01977092|alcohol and drugs|alcohol and drugs
5343879|NCT01977079|pregnancy|pregnancy
5343880|NCT01977079|premature birth|premature birth
5343881|NCT01977079|procalcitonin|procalcitonin
5343882|NCT01977066|pancreatic cancer|pancreatic cancer
5343883|NCT01977066|exercise training|exercise training
5343884|NCT01977066|quality of life|quality of life
5343885|NCT01977066|physical functioning|physical functioning
5343886|NCT01977053|breast cancer|breast cancer
5343887|NCT01977053|colon cancer|colon cancer
5343888|NCT01977053|rectal cancer|rectal cancer
5343889|NCT01977053|adjuvant chemotherapy|adjuvant chemotherapy
5343890|NCT01977053|phone calls|phone calls
5343891|NCT01977053|emotional states|emotional states
5343892|NCT01977053|quality of life|quality of life
5343893|NCT01977040|Vasa Previa|vasa previa
5343894|NCT01977027|Rehabilitation|rehabilitation
5343895|NCT01977027|Fingers|fingers
5343896|NCT01977027|Grasp|grasp
5343897|NCT01977027|Strength|strength
5343898|NCT01977027|Hand Function|hand function
5343899|NCT01977027|Motor Function|motor function
5343900|NCT01977027|Post Stroke|post stroke
5343901|NCT01977027|Brain Infraction|brain infraction
5343902|NCT01977027|Biomechanis|biomechanis
5343903|NCT01977027|Neuronal Plasticity|neuronal plasticity
5343904|NCT01977027|Weight-Bearing|weight-bearing
5343908|NCT01976975|Depression|depression
5343909|NCT01976975|Major Depressive Disorder|major depressive disorder
5343910|NCT01976975|Bipolar Disorder|bipolar disorder
5343911|NCT01976975|Mania|mania
5343912|NCT01976975|Hypomania|hypomania
5343913|NCT01976975|EEG|eeg
5343914|NCT01976975|MRI|mri
5343915|NCT01976975|Reward|reward
5343916|NCT01976962|Prostatic neoplasms|prostatic neoplasms
5343917|NCT01976962|Radiotherapy|radiotherapy
5343918|NCT01976962|Dose fractionation|dose fractionation
5343919|NCT01976962|Magnetic resonance imaging|magnetic resonance imaging
5343920|NCT01976949|Cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery|cancer, social-networking intervention, cancer-related distress, internet health services, intervention delivery
5343921|NCT01976936|Stroke|stroke
5343922|NCT01976936|Rhabdomyolysis|rhabdomyolysis
5343923|NCT01976936|Jaundice|jaundice
5343924|NCT01976923|Intravitreal Bevacizumab|intravitreal bevacizumab
5343925|NCT01976923|Tractional Retinal Detachment|tractional retinal detachment
5343926|NCT01976923|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5343927|NCT01976923|Small gauge pars plana vitrectomy|small gauge pars plana vitrectomy
5343928|NCT01976923|Intraoperative bleeding|intraoperative bleeding
5343929|NCT01976923|Post-operative vitreous hemorrhage|post-operative vitreous hemorrhage
5343930|NCT01976923|Visual acuity|visual acuity
5343931|NCT01976910|Glioblastoma multiforme|glioblastoma multiforme
5343932|NCT01976910|Advanced cancers|advanced cancers
5343933|NCT01976910|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
5343934|NCT01976910|Brain Tumor, Recurrent|brain tumor, recurrent
5343935|NCT01976910|Advanced cancer|advanced cancer
5343936|NCT01976897|heel - mattress pressure interface|heel - mattress pressure interface
5343937|NCT01976897|flexion|flexion
5343938|NCT01976897|knee angular position|knee angular position
5343939|NCT01976884|sepsis|sepsis
5347873|NCT01959503|Aorta|aorta
5343940|NCT01976884|immunosuppression|immunosuppression
5343941|NCT01976884|PD-L1|pd-l1
5343942|NCT01976871|Restless Legs Syndrome|restless legs syndrome
5343943|NCT01976871|Ekbom Syndrome|ekbom syndrome
5343946|NCT01976871|Neupro|neupro
5343947|NCT01976871|Dopamine Agonist|dopamine agonist
5343948|NCT01976858|PEX168, diabetes, phase I|pex168, diabetes, phase i
5343949|NCT01976845|propofol|propofol
5343950|NCT01976845|midazolam|midazolam
5343951|NCT01976845|sedative|sedative
5343952|NCT01976845|anxiolytic|anxiolytic
5343953|NCT01976845|amnesic|amnesic
5343954|NCT01976845|recall|recall
5343955|NCT01976845|Memory|memory
5343956|NCT01976845|Perioperative outcomes|perioperative outcomes
5343957|NCT01976819|Tracheotomy|tracheotomy
5343958|NCT01976819|Tracheostomy|tracheostomy
5343959|NCT01976819|Speaking valve|speaking valve
5343961|NCT01976819|patients|patients
5343962|NCT01976806|Docosahexaenoic acid|docosahexaenoic acid
5211102|NCT02675608|aging|aging
5343963|NCT01976806|DHA|dha
5343964|NCT01976806|Periodontitis|periodontitis
5343965|NCT01976806|Gingivitis|gingivitis
5343966|NCT01976806|Omega-3 fatty acid|omega-3 fatty acid
5343967|NCT01976806|Fish oil|fish oil
5343968|NCT01976793|Recurrent depressive disorder|recurrent depressive disorder
5343969|NCT01976793|Depression|depression
5343970|NCT01976793|Depressive episode|depressive episode
5343971|NCT01976793|Atypical antipsychotics|atypical antipsychotics
5343972|NCT01976780|Malaria|malaria
5343973|NCT01976780|P. falciparum mono infection|p. falciparum mono infection
5343974|NCT01976780|Early Treatment Failure|early treatment failure
5343975|NCT01976780|Late Treatment Failure|late treatment failure
5343976|NCT01976767|Sputum|sputum
5343977|NCT01976767|Clinical cohorts|clinical cohorts
5343978|NCT01976767|Smokers|smokers
5343979|NCT01976767|Asthma|asthma
5343980|NCT01976767|Biopsies|biopsies
5343981|NCT01976767|Severe asthma|severe asthma
5343982|NCT01976767|Collaborative research|collaborative research
5343983|NCT01976767|Phenotyping|phenotyping
5343984|NCT01976767|Lipidomics|lipidomics
5343985|NCT01976767|Transcriptomics|transcriptomics
5343986|NCT01976767|Proteomics|proteomics
5343987|NCT01976767|Paediatric cohort|paediatric cohort
5343988|NCT01976767|Systems Biology|systems biology
5343989|NCT01976741|Phase I|phase i
5343990|NCT01976741|Dose escalation|dose escalation
5343991|NCT01976741|refractory, locally advanced or metastatic solid tumor|refractory, locally advanced or metastatic solid tumor
5343992|NCT01976741|Bladder cancer|bladder cancer
5343993|NCT01976741|squamous non-small cell lung cancer|squamous non-small cell lung cancer
5343994|NCT01976741|pan-FGFR inhibitor|pan-fgfr inhibitor
5343995|NCT01976741|lung adenocarcinoma|lung adenocarcinoma
5343996|NCT01976741|head and neck cancer|head and neck cancer
5344000|NCT01976702|HIV risk behaviors|hiv risk behaviors
5344001|NCT01976702|Pregnant drug abusers|pregnant drug abusers
5344002|NCT01976689|Glucose Regulation|glucose regulation
5344003|NCT01976689|Left Ventricular Hypertrophy|left ventricular hypertrophy
5344004|NCT01976689|New-onset Diabetes|new-onset diabetes
5344005|NCT01976689|Renal Transplantation|renal transplantation
5344006|NCT01976598|chronic|chronic
5344007|NCT01976598|back|back
5344008|NCT01976598|leg|leg
5344009|NCT01976598|pain|pain
5344010|NCT01976598|sub-sensory|sub-sensory
5344011|NCT01976598|stimulation|stimulation
5344012|NCT01976598|Neuromodulation|neuromodulation
5344013|NCT01976598|Yearwood|yearwood
5344014|NCT01976585|Intratumoral injections|intratumoral injections
5344015|NCT01976585|rhuFlt3L|rhuflt3l
5344016|NCT01976585|Flt3L|flt3l
5344017|NCT01976585|CDX-301|cdx-301
5344018|NCT01976585|Vaccine|vaccine
5344019|NCT01976585|Poly-ICLC|poly-iclc
5344020|NCT01976585|iNHL|inhl
5344021|NCT01976585|TLR3|tlr3
5344022|NCT01976585|Low-Grade B-cell Lymphoma|low-grade b-cell lymphoma
5344023|NCT01976585|Follicular|follicular
5344024|NCT01976585|Marginal Zone|marginal zone
5344025|NCT01976585|SLL|sll
5344026|NCT01976585|Small lymphocytic|small lymphocytic
5344027|NCT01976572|CKD Stage V|ckd stage v
5344028|NCT01976572|dialysis|dialysis
5344029|NCT01976559|ICP|icp
5344030|NCT01976559|Intracranial pressure|intracranial pressure
5344031|NCT01976559|Hydrocephalus|hydrocephalus
5344032|NCT01976559|Idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
5344033|NCT01976559|CSF|csf
5344034|NCT01976559|Cerebrospinal fluid|cerebrospinal fluid
5344035|NCT01976559|Noninvasive ICP|noninvasive icp
5344036|NCT01976520|Cancer vaccine|cancer vaccine
5344037|NCT01976520|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5344038|NCT01976520|CLL|cll
5344039|NCT01976520|Autologous vaccine|autologous vaccine
5344040|NCT01976520|B cell leukemia|b cell leukemia
5344041|NCT01976494|Patient controlled analgesia equipment|patient controlled analgesia equipment
5344042|NCT01976494|efficacy|efficacy
5344043|NCT01976494|safety|safety
5344044|NCT01976494|Accufuser Omnibus®|accufuser omnibus®
5344045|NCT01976494|Upper abdominal surgery|upper abdominal surgery
5344046|NCT01976494|laparotomy|laparotomy
5344047|NCT01976455|obesity|obesity
5344048|NCT01976455|carbon13|carbon13
5344049|NCT01976455|over-eating|over-eating
5344050|NCT01976455|metabolic chamber|metabolic chamber
5339924|NCT01995422|Self-esteem|self-esteem
5344051|NCT01976455|room calorimeter|room calorimeter
5344052|NCT01976442|Leukemia|leukemia
5344053|NCT01976442|Transfusion|transfusion
5344054|NCT01976429|barotrauma|barotrauma
5344055|NCT01976429|barotitis|barotitis
5344056|NCT01976429|middle ear|middle ear
5344057|NCT01976429|flying|flying
5344058|NCT01976429|diving|diving
5344059|NCT01976429|Eustachian tube|eustachian tube
5344060|NCT01976416|Hydroxyurea|hydroxyurea
5963528|NCT04232527|Flexibility|flexibility
5963529|NCT04232527|Agility|agility
5963530|NCT04231435|Healthy Adult Subjects|healthy adult subjects
5963531|NCT04231435|Fedratinib|fedratinib
5963532|NCT04231435|Drug Interactions|drug interactions
5963533|NCT04231435|Transporters|transporters
5344061|NCT01976390|Kidney|kidney
5344062|NCT01976390|Kidney transplant|kidney transplant
5963534|NCT04231201|Ballistocariodgraphy|ballistocariodgraphy
5963535|NCT04231201|Seismocardiography|seismocardiography
5963536|NCT04231201|LV mechanics|lv mechanics
5223247|NCT02603328|MRI|mri
5344063|NCT01976390|Renal failure|renal failure
5344064|NCT01976390|End Stage Renal Disease|end stage renal disease
5344065|NCT01976390|kidney transplant recipient|kidney transplant recipient
5344066|NCT01976364|Tofacitinib|tofacitinib
5344067|NCT01976364|Psoriatic Arthritis|psoriatic arthritis
5344068|NCT01976364|Xeljanz|xeljanz
5344069|NCT01976364|CP-690550|cp-690550
5344070|NCT01976364|Jak-inhibitor|jak-inhibitor
5344071|NCT01976364|oral treatment|oral treatment
5344072|NCT01976364|psoriasis|psoriasis
5344073|NCT01976364|OPAL BALANCE|opal balance
5344074|NCT01976364|methotrexate|methotrexate
5344075|NCT01976364|pruritus|pruritus
5344076|NCT01976364|itch|itch
5344077|NCT01976364|DLQI|dlqi
5344078|NCT01976351|Barrett's esophagus|barrett's esophagus
5344079|NCT01976351|image-enhanced endoscopy|image-enhanced endoscopy
5344080|NCT01976338|BRVO|brvo
5344081|NCT01976338|macular edema|macular edema
5344082|NCT01976338|vision impairment|vision impairment
5344083|NCT01976338|retinal vein occlusion|retinal vein occlusion
5344084|NCT01976338|ranibizumab|ranibizumab
5344085|NCT01976338|branch retinal vein occlusion|branch retinal vein occlusion
5344086|NCT01976338|anti-VEGF therapy|anti-vegf therapy
5344087|NCT01976338|RFB002|rfb002
5344088|NCT01976325|decision aid|decision aid
5344089|NCT01976325|imported malaria|imported malaria
5344090|NCT01976325|malaria prevention and control|malaria prevention and control
5344091|NCT01976325|malaria chemoprophylaxis|malaria chemoprophylaxis
5344092|NCT01976325|mefloquine|mefloquine
5344093|NCT01976325|lariam|lariam
5344094|NCT01976325|atovaquone-proguanil|atovaquone-proguanil
5344095|NCT01976325|malarone|malarone
5344096|NCT01976325|doxycycline|doxycycline
5344097|NCT01976325|vibramycin|vibramycin
5344098|NCT01976312|CRVO, macular edema, vision impairment, retinal vein occlusion, ranibizumab|crvo, macular edema, vision impairment, retinal vein occlusion, ranibizumab
5344099|NCT01976221|Comprehensive referrals|comprehensive referrals
5344100|NCT01976221|Appropriate referring|appropriate referring
5344101|NCT01976221|Priority setting|priority setting
5344102|NCT01976221|Waiting time in hospital|waiting time in hospital
5344103|NCT01976208|Omalizumab|omalizumab
5344105|NCT01976208|Asthma|asthma
5344106|NCT01976195|Thalidomide|thalidomide
5344107|NCT01976195|Dexamethasone|dexamethasone
5344108|NCT01976195|ITP|itp
5344109|NCT01976182|large granular lymphocytes leukemia|large granular lymphocytes leukemia
5344110|NCT01976182|immunosuppressive drugs|immunosuppressive drugs
5344111|NCT01976182|methotrexate|methotrexate
5344112|NCT01976182|cyclophosphamide|cyclophosphamide
5344113|NCT01976182|efficiency|efficiency
5344114|NCT01976182|phase II randomized controlled trial|phase ii randomized controlled trial
5344115|NCT01976169|Breast Cancer|breast cancer
5344116|NCT01976169|Advanced Breast Cancer|advanced breast cancer
5344117|NCT01976104|Thrombocytopenia|thrombocytopenia
5344118|NCT01976104|Chronic Liver Disease|chronic liver disease
5344119|NCT01976091|limb girdle muscular dystrophy|limb girdle muscular dystrophy
5344121|NCT01976091|alpha-sarcoglycan|alpha-sarcoglycan
5344122|NCT01976091|gene transfer|gene transfer
5344123|NCT01976091|adeno-associated virus|adeno-associated virus
5344124|NCT01976078|Voriconazole|voriconazole
5344125|NCT01976078|Pharmacokinetics|pharmacokinetics
5344126|NCT01976078|Ontogeny|ontogeny
5344127|NCT01976078|Modeling|modeling
5344128|NCT01976078|Bayesian|bayesian
5344129|NCT01976065|Necrotic tooth pulp|necrotic tooth pulp
5344130|NCT01976065|Immature permanent teeth|immature permanent teeth
5344131|NCT01976065|Regeneration|regeneration
5344132|NCT01976052|Biomarkers|biomarkers
5344133|NCT01976052|Genomics|genomics
5344134|NCT01976039|motorcyclist|motorcyclist
5344135|NCT01976039|nasal mucociliary clearance|nasal mucociliary clearance
5344136|NCT01976039|physical therapy|physical therapy
5344137|NCT01976026|Flow Diversion|flow diversion
5344138|NCT01976026|Aneurysm|aneurysm
5344139|NCT01976026|Intracranial|intracranial
5344140|NCT01976026|Cerebral|cerebral
5344141|NCT01976026|Vertebral|vertebral
5344142|NCT01976026|blood blister-like|blood blister-like
5344143|NCT01976026|ruptured aneurysm|ruptured aneurysm
5344144|NCT01976026|Pipeline Flow Diversion|pipeline flow diversion
5344145|NCT01976026|Pipeline Flow Diverter|pipeline flow diverter
5344146|NCT01976026|Best-Standard Treatment|best-standard treatment
5344148|NCT01976013|INR|inr
5344149|NCT01976013|intraventricular haemorrhage|intraventricular haemorrhage
5344150|NCT01976013|pulmonary haemorrhage|pulmonary haemorrhage
5344151|NCT01976013|ELBW infants|elbw infants
5344152|NCT01975987|Intubation|intubation
5344153|NCT01975987|Bonfils fiberscope|bonfils fiberscope
5344154|NCT01975974|vascular|vascular
5344155|NCT01975974|access|access
5344156|NCT01975974|ultrasound|ultrasound
5344157|NCT01975948|Mental Health|mental health
5344158|NCT01975948|Education and Practice Support Program|education and practice support program
5344159|NCT01975948|Depression|depression
5344160|NCT01975948|Primary Care|primary care
5344161|NCT01975948|Skill-based training|skill-based training
5344162|NCT01975948|Patient centered outcomes|patient centered outcomes
5963537|NCT04230720|biometry measurement|biometry measurement
5864003|NCT00001144|Engraftment|engraftment
5223281|NCT02603133|healthcare|healthcare
5223282|NCT02603133|burnout|burnout
5223283|NCT02603133|resilience|resilience
5344163|NCT01975935|diabetes mellitus type 2|diabetes mellitus type 2
5344164|NCT01975935|non-alcoholic fatt liver disease|non-alcoholic fatt liver disease
5344165|NCT01975935|obesity|obesity
5344166|NCT01975922|language impairment|language impairment
5344167|NCT01975922|language disorder|language disorder
5344168|NCT01975922|language delay|language delay
5344169|NCT01975922|late talkers|late talkers
5344170|NCT01975922|late talking|late talking
5344171|NCT01975909|Spinocerebellar Ataxia|spinocerebellar ataxia
5344172|NCT01975909|SCA|sca
5344173|NCT01975909|Ataxia|ataxia
5344174|NCT01975909|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5344175|NCT01975909|TMS|tms
5344176|NCT01975883|Blood Glucose|blood glucose
5344177|NCT01975883|Postoperative Complications|postoperative complications
5344178|NCT01975883|Spine|spine
5344179|NCT01975883|Orthopedic surgery|orthopedic surgery
5344180|NCT01975870|Sedentary behavior, smartphone, application|sedentary behavior, smartphone, application
5344181|NCT01975857|mild traumatic brain injury|mild traumatic brain injury
5344182|NCT01975857|sleep|sleep
5344183|NCT01975857|mind body intervention|mind body intervention
5344184|NCT01975857|mind body bridging|mind body bridging
5344185|NCT01975844|Anemia|anemia
5344186|NCT01975844|End Stage Renal Disease|end stage renal disease
5344187|NCT01975831|Non Triple Negative Breast Cancer|non triple negative breast cancer
5344188|NCT01975818|Anemia of CKD on dialysis|anemia of ckd on dialysis
5344189|NCT01975805|cesarean delivery|cesarean delivery
5344190|NCT01975805|chlorhexidine|chlorhexidine
5344191|NCT01975805|iodine|iodine
5344192|NCT01975805|skin disinfectant|skin disinfectant
5344193|NCT01975792|PPROM|pprom
5344194|NCT01975792|Pregnant|pregnant
5344195|NCT01975792|Preterm|preterm
5344196|NCT01975792|Premature, labor|premature, labor
5344197|NCT01975766|Carcinoma, squamous cell of head and neck|carcinoma, squamous cell of head and neck
5344198|NCT01975766|Head and neck cancer|head and neck cancer
5344199|NCT01975766|ketogenic diet|ketogenic diet
5344200|NCT01975766|radiotherapy|radiotherapy
5344201|NCT01975766|cisplatin|cisplatin
5344202|NCT01975753|pain|pain
5344203|NCT01975727|PONV|ponv
5344204|NCT01975727|Dexamethasone|dexamethasone
5344205|NCT01975727|Treatment|treatment
5344206|NCT01975714|Glaucoma|glaucoma
5344207|NCT01975714|Ocular hypertension|ocular hypertension
5344208|NCT01975714|Preservative-free prostaglandins|preservative-free prostaglandins
5344209|NCT01975701|BGJ398,|bgj398,
5344210|NCT01975701|recurrent glioblastoma'|recurrent glioblastoma'
5344213|NCT01975662|MRSA|mrsa
5344214|NCT01975662|bacteremia|bacteremia
5344215|NCT01975662|vancomycin|vancomycin
5344216|NCT01975662|daptomycin|daptomycin
5344217|NCT01975649|postmenopausal|postmenopausal
5344218|NCT01975649|hypoactive|hypoactive
5344219|NCT01975649|sexual disorder|sexual disorder
5344220|NCT01975649|androgen|androgen
5344221|NCT01975636|Metabolism and Elimination|metabolism and elimination
5344222|NCT01975350|Colistimethate sodium inhalation|colistimethate sodium inhalation
5344223|NCT01975272|postoperative|postoperative
5344224|NCT01975272|anemia|anemia
5344225|NCT01975272|gynaecologic|gynaecologic
5344226|NCT01975272|surgery|surgery
5344227|NCT01974908|Ventricular Tachycardia|ventricular tachycardia
5344228|NCT01974882|abdominal surgery|abdominal surgery
5344229|NCT01974882|cryotherapy|cryotherapy
5344230|NCT01974882|pain score|pain score
5344231|NCT01974882|narcotic utilization|narcotic utilization
5344232|NCT01975623|Video assisted thoracoscopic surgery (VATS)|video assisted thoracoscopic surgery (vats)
5344233|NCT01975610|Arthritis, Rheumatoid, Autoimmune, Inflammatory, Synovial, Bruton's tyrosine kinase (Btk), CC-292, Joint Disease|arthritis, rheumatoid, autoimmune, inflammatory, synovial, bruton's tyrosine kinase (btk), cc-292, joint disease
5344234|NCT01975571|residual hearing|residual hearing
5344235|NCT01975571|hybrid|hybrid
5344236|NCT01975571|hearing preservation|hearing preservation
5344237|NCT01975545|Down syndrome|down syndrome
5344238|NCT01975545|Caries|caries
5344239|NCT01975545|Dental varnish|dental varnish
5344240|NCT01975519|TRC105|trc105
5344241|NCT01975519|CD105|cd105
5344242|NCT01975519|Endoglin|endoglin
5344243|NCT01975519|Angiogenesis Inhibitor|angiogenesis inhibitor
5344245|NCT01975519|Soft Tissue Sarcoma|soft tissue sarcoma
5344246|NCT01975519|TKI|tki
5344247|NCT01975519|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5344248|NCT01975519|Pazopanib|pazopanib
5344249|NCT01975519|Votrient|votrient
5344250|NCT01975519|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
5344251|NCT01975519|Angiosarcoma|angiosarcoma
5344252|NCT01975506|Head Start|head start
5344253|NCT01975506|Occupational Therapy|occupational therapy
5344254|NCT01975493|Infectious Diseases|infectious diseases
5344255|NCT01975493|Paediatrics|paediatrics
5344262|NCT01975454|Metastatic colorectal cancer|metastatic colorectal cancer
5963538|NCT04230720|artificial tear|artificial tear
5963539|NCT04230720|cataract surgery|cataract surgery
5963540|NCT04230382|Type 2 Diabetes|type 2 diabetes
5963541|NCT04230382|Untreated diabetes|untreated diabetes
5963542|NCT04230382|Epidemiology|epidemiology
5344263|NCT01975454|Chemotherapy|chemotherapy
5344264|NCT01975454|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
5344266|NCT01975441|Diethycarbamazine|diethycarbamazine
5344267|NCT01975441|Albendazole|albendazole
5344268|NCT01975441|Ivermectin|ivermectin
5344269|NCT01975441|Lymphatic filariasis|lymphatic filariasis
5344270|NCT01975415|Meditation|meditation
5344271|NCT01975415|Sensors|sensors
5344272|NCT01975415|Digital medicine|digital medicine
5344273|NCT01975402|Congestive Heart Failure|congestive heart failure
5344274|NCT01975389|myocardial infarction|myocardial infarction
5344275|NCT01975389|stroke|stroke
5344276|NCT01975389|hyperlipidemia|hyperlipidemia
5344277|NCT01975376|myocardial infarction|myocardial infarction
5344278|NCT01975376|stroke|stroke
5344279|NCT01975376|hyperlipidemia|hyperlipidemia
5344280|NCT01975363|Breast Cancer|breast cancer
5344281|NCT01975324|Ampyra|ampyra
5344282|NCT01975324|NAION|naion
5344283|NCT01975324|Dalfampridine|dalfampridine
5344284|NCT01975298|RRMS|rrms
5344285|NCT01975285|Pain management|pain management
5344286|NCT01975285|Postoperative opioid requirements|postoperative opioid requirements
5344287|NCT01975285|Perioperative outcomes|perioperative outcomes
5344288|NCT01975285|Dexamethasone|dexamethasone
5344289|NCT01975285|Anesthetic adjuvant|anesthetic adjuvant
5344290|NCT01975285|Analgesic adjuvant|analgesic adjuvant
5344291|NCT01975233|Endovascular|endovascular
5344292|NCT01975233|Brain Aneurysm|brain aneurysm
5344293|NCT01975181|cardiovascular health|cardiovascular health
5344294|NCT01975181|lifestyle modification|lifestyle modification
5344295|NCT01975181|patient reported outcomes|patient reported outcomes
5344296|NCT01975181|risk assessment|risk assessment
5344297|NCT01975168|laser acupuncture|laser acupuncture
5344298|NCT01975168|obesity|obesity
5344299|NCT01975155|Celiac disease|celiac disease
5344300|NCT01975155|Gluten free diet nutrient content|gluten free diet nutrient content
5344301|NCT01975155|mycotoxins|mycotoxins
5344302|NCT01975155|Gluten free diet|gluten free diet
5344303|NCT01975142|Metastatic breast cancer|metastatic breast cancer
5344304|NCT01975142|HER2 negative primary tumor|her2 negative primary tumor
5344305|NCT01975142|CTC HER2 positive|ctc her2 positive
5344307|NCT01975064|Breast neoplasms|breast neoplasms
5344308|NCT01975064|Colonic neoplasms|colonic neoplasms
5344309|NCT01975064|Rectal neoplasms|rectal neoplasms
5344310|NCT01975051|Kala- azar|kala- azar
5344311|NCT01975051|PKDL|pkdl
5344312|NCT01975051|Treatment|treatment
5344313|NCT01975051|Pathogenesis|pathogenesis
5344314|NCT01975051|Bangladesh|bangladesh
5344315|NCT01975038|Melanin Index|melanin index
5344316|NCT01975038|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
5344317|NCT01975038|Spectrophotometry|spectrophotometry
5344318|NCT01975038|Skin Diseases|skin diseases
5344319|NCT01975025|Renal Dialysis|renal dialysis
5344320|NCT01974999|Kidney|kidney
5344321|NCT01974999|Transplant|transplant
5344322|NCT01974999|Rejection|rejection
5344323|NCT01974986|dehydration|dehydration
5344324|NCT01974986|exercise|exercise
5344325|NCT01974986|rehydration|rehydration
5344326|NCT01974986|sodium|sodium
5344327|NCT01974986|water|water
5344328|NCT01974986|carbohydrate|carbohydrate
5344329|NCT01974973|autism spectrum disorders|autism spectrum disorders
5344330|NCT01974973|stem cells|stem cells
5344331|NCT01974947|Metabolic syndrome|metabolic syndrome
5344332|NCT01974947|Epigenetic|epigenetic
5344333|NCT01974947|Male infertility|male infertility
5344334|NCT01974947|Sperm parameters|sperm parameters
5344335|NCT01974947|Biomarkers|biomarkers
5344336|NCT01974921|Asthma|asthma
5344337|NCT01974921|Bronchial Thermoplasty|bronchial thermoplasty
5344338|NCT01974921|Bronchial smooth muscle|bronchial smooth muscle
5344339|NCT01974895|Children|children
5344340|NCT01974895|Immunogenicity|immunogenicity
5344341|NCT01974895|Fluzone®|fluzone®
5344342|NCT01974895|6 to 35 months of age|6 to 35 months of age
5344343|NCT01974895|Seasonal influenza|seasonal influenza
5344344|NCT01974895|Safety|safety
5344345|NCT01974869|Surgery,Crohn's disease,Ulcerative colitis|surgery,crohn's disease,ulcerative colitis
5344346|NCT01974830|alpha-1|alpha-1
5344347|NCT01974830|anti-trypsin|anti-trypsin
5344348|NCT01974830|pulmonary function|pulmonary function
5344349|NCT01974830|augmentation therayp|augmentation therayp
5344350|NCT01974830|home care|home care
5344351|NCT01974817|pneumococcal vaccine|pneumococcal vaccine
5344352|NCT01974817|end stage renal disease|end stage renal disease
5344353|NCT01974817|dialysis|dialysis
5344355|NCT01974804|Brain metastases|brain metastases
5344356|NCT01974804|13-094|13-094
5344357|NCT01974765|Enzalutamide|enzalutamide
5344358|NCT01974765|Androgen Receptor Positive (AR+)|androgen receptor positive (ar+)
5344359|NCT01974765|13-119|13-119
5344360|NCT01974752|uveal melanoma|uveal melanoma
5344361|NCT01974739|intensive care|intensive care
5344362|NCT01974739|diuretics|diuretics
5344363|NCT01974726|ear|ear
5344364|NCT01974726|middle ear|middle ear
5344365|NCT01974726|Eustachian tube|eustachian tube
5344366|NCT01974726|Eustachian tube dysfunction|eustachian tube dysfunction
5223485|NCT02602106|Pregnancy|pregnancy
5344367|NCT01974726|Eustachian tube function|eustachian tube function
5344368|NCT01974713|CKD progression|ckd progression
5344369|NCT01974713|Inflammation|inflammation
5344370|NCT01974713|FGF23|fgf23
5344371|NCT01974713|Genetic biomarkers|genetic biomarkers
5344372|NCT01974687|Hepatitis C virus|hepatitis c virus
5344373|NCT01974687|HCV|hcv
5344374|NCT01974674|diabetes|diabetes
5344375|NCT01974674|transplantation|transplantation
5344376|NCT01974648|Laryngeal Mask Airway Supreme|laryngeal mask airway supreme
5344377|NCT01974648|propofol|propofol
5344378|NCT01974648|remifentanil|remifentanil
5344379|NCT01974648|effective dose of intravenous propofol|effective dose of intravenous propofol
5344380|NCT01974648|ED50|ed50
5344381|NCT01974635|Spinal Cord Injury|spinal cord injury
5344382|NCT01974635|Robotic therapy|robotic therapy
5344383|NCT01974635|Rehabilitation|rehabilitation
5344384|NCT01974635|Sensation|sensation
5344385|NCT01974635|Movement|movement
5344386|NCT01974635|Proprioception|proprioception
5344387|NCT01974635|Stroke|stroke
5344388|NCT01974635|Acquired Brain Injury|acquired brain injury
5344389|NCT01974609|pain relief|pain relief
5344390|NCT01974609|narcotic pain relief|narcotic pain relief
5344391|NCT01974609|non-narcotic pain relief|non-narcotic pain relief
5344392|NCT01974609|post-operative pain relief|post-operative pain relief
5344393|NCT01974609|carpal tunnel|carpal tunnel
5344395|NCT01974596|Probiotics|probiotics
5344396|NCT01974596|Lactobacillus reuteri|lactobacillus reuteri
5344397|NCT01974596|Periimplant mucositis|periimplant mucositis
5344398|NCT01974596|Cytokines|cytokines
5344399|NCT01974596|Bacterial load|bacterial load
5344400|NCT01974583|the split-thickness skin graft （STSG） donor site|the split-thickness skin graft （stsg） donor site
5344401|NCT01974583|regraft|regraft
5344402|NCT01974583|wound healing|wound healing
5344403|NCT01974570|Prehypertension|prehypertension
5344404|NCT01974570|Hypertension|hypertension
5344405|NCT01974570|Shrimp protein hydrolysate|shrimp protein hydrolysate
5344406|NCT01974570|Marine protein hydrolysate|marine protein hydrolysate
5344407|NCT01974570|Ambulatory blood pressure|ambulatory blood pressure
5344408|NCT01974570|Blood pressure|blood pressure
5344409|NCT01974557|Cardiac physiology|cardiac physiology
5344410|NCT01974557|ageing|ageing
5344411|NCT01974557|gender differences|gender differences
5344412|NCT01974557|diastole|diastole
5344413|NCT01974557|fluid challenge|fluid challenge
5344414|NCT01974544|diabetes complications|diabetes complications
5344415|NCT01974544|metabolic surgery|metabolic surgery
5344416|NCT01974544|Intensive medicines|intensive medicines
5344417|NCT01974518|Pemphigus|pemphigus
5344419|NCT01974518|Rituximab and IV cyclophosphamide combination|rituximab and iv cyclophosphamide combination
5344420|NCT01974518|B cell re-population characteristics following Rituximab|b cell re-population characteristics following rituximab
5344421|NCT01974492|saphenous vein graft|saphenous vein graft
5344422|NCT01974492|composite graft|composite graft
5344423|NCT01974492|coronary artery bypass grafting|coronary artery bypass grafting
5344424|NCT01974492|graft remodeling|graft remodeling
5344425|NCT01974479|Redirected Natural Killer Cells|redirected natural killer cells
5344426|NCT01974479|Haploidentical Cell Therapy|haploidentical cell therapy
5344427|NCT01974466|pancreatitis|pancreatitis
5344428|NCT01974466|resuscitation goal|resuscitation goal
5344429|NCT01974453|Radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography|radiation dose, transradial approach, percutaneous coronary interventions, coronary angiography
5344430|NCT01974440|Lymphoma|lymphoma
5344431|NCT01974440|Follicular lymphoma|follicular lymphoma
5344432|NCT01974440|Marginal zone lymphoma|marginal zone lymphoma
5344433|NCT01974440|Indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
5344434|NCT01974440|PCI-32765|pci-32765
5344435|NCT01974440|Ibrutinib|ibrutinib
5344436|NCT01974440|Bendamustine|bendamustine
5344437|NCT01974440|Rituximab|rituximab
5344438|NCT01974440|Cyclophosphamide|cyclophosphamide
5344439|NCT01974440|Doxorubicin|doxorubicin
5344440|NCT01974440|Vincristine|vincristine
5344441|NCT01974440|Prednisone|prednisone
5344442|NCT01974440|R-CHOP|r-chop
5344443|NCT01974427|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5344444|NCT01974427|Functional Imaging|functional imaging
5344445|NCT01974427|BOLD Effect|bold effect
5344446|NCT01974427|EEG|eeg
5344447|NCT01974427|MEG|meg
5344448|NCT01974414|oral lichen planus|oral lichen planus
5344449|NCT01974414|cedar honey|cedar honey
5344450|NCT01974414|atrophic|atrophic
5344451|NCT01974414|erosive|erosive
5344452|NCT01974414|pain|pain
5344453|NCT01974414|treatment|treatment
5344454|NCT01974414|clinical trial|clinical trial
5344455|NCT01974401|oral irrigator|oral irrigator
5344456|NCT01974401|leukemia|leukemia
5344457|NCT01974401|blood dyscrasia|blood dyscrasia
5344458|NCT01974401|Oral Health Index Simplified (OHI-S)|oral health index simplified (ohi-s)
5344459|NCT01974401|supra gingival irrigator|supra gingival irrigator
5344460|NCT01974388|Bariatric surgery, sleeve gastrectomy, gastric leak|bariatric surgery, sleeve gastrectomy, gastric leak
5344461|NCT01974375|Living donor|living donor
5963543|NCT04230382|OGTT|ogtt
5963544|NCT04230382|oral glucose tolerance test|oral glucose tolerance test
5223580|NCT02601534|sedentary behaviour|sedentary behaviour
5223581|NCT02601534|physical activity|physical activity
5223582|NCT02601508|deep NM block|deep nm block
5223583|NCT02601508|Surgeon's satisfaction|surgeon's satisfaction
5223584|NCT02601508|bridion|bridion
5223585|NCT02601482|Glycemic control|glycemic control
5223586|NCT02601482|exercise|exercise
5344462|NCT01974375|Liver transplant|liver transplant
5344463|NCT01974375|antifungal prevention|antifungal prevention
5344464|NCT01974362|Monolithic Zirconia|monolithic zirconia
5344465|NCT01974362|Zirconia-Feldspathic zirconia|zirconia-feldspathic zirconia
5344466|NCT01974362|Dental Implants|dental implants
5344467|NCT01974362|Fracture|fracture
5344468|NCT01974362|Chipping|chipping
5344469|NCT01974349|Phase I, healthy, pharmacokinetics, food effect.|phase i, healthy, pharmacokinetics, food effect.
5344470|NCT01974310|Macular Holes|macular holes
5344471|NCT01974310|Non face down positioning|non face down positioning
5344472|NCT01974310|Face down positioning|face down positioning
5344473|NCT01974297|Hyperlipidemia|hyperlipidemia
5344474|NCT01974297|Atorvastatin|atorvastatin
5344475|NCT01974297|Fenofibric acid|fenofibric acid
5344476|NCT01974297|combination|combination
5344477|NCT01974297|monotherapy|monotherapy
5344478|NCT01974245|Cholecalciferol|cholecalciferol
5344479|NCT01974245|Kidney diseases|kidney diseases
5344480|NCT01974232|Immune Thrombocytopenia (ITP), Thrombopoietin (TPO) agents, children, romiplostim and eltrombopag|immune thrombocytopenia (itp), thrombopoietin (tpo) agents, children, romiplostim and eltrombopag
5344482|NCT01974219|COPD|copd
5344483|NCT01974219|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5344484|NCT01974219|Smoking|smoking
5344485|NCT01974206|ASP0113|asp0113
5344486|NCT01974206|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5344487|NCT01974206|Kidney Transplantation|kidney transplantation
5344488|NCT01974180|Smoking|smoking
5344489|NCT01974180|COPD|copd
5344490|NCT01974180|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5344491|NCT01974180|Healthy Smoker|healthy smoker
5344492|NCT01974180|Non-smoker|non-smoker
5344493|NCT01974167|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
5344494|NCT01974154|COPD|copd
5344495|NCT01974154|Smoking|smoking
5344496|NCT01974154|Non-smoker|non-smoker
5344497|NCT01974128|MI|mi
5344498|NCT01974115|Cellulite|cellulite
5344499|NCT01974115|Extracorporeal shock wave therapy|extracorporeal shock wave therapy
5344500|NCT01974115|ESWT|eswt
5344501|NCT01974115|Radial shock wave therapy|radial shock wave therapy
5344502|NCT01974115|RSWT|rswt
5344503|NCT01974089|Dysphagia|dysphagia
5344504|NCT01974089|Community acquired pneumonia|community acquired pneumonia
5344505|NCT01974089|Mortality|mortality
5344506|NCT01974089|Rehospitalization|rehospitalization
5344507|NCT01974063|Smoking|smoking
5344508|NCT01974063|Smoking Cessation|smoking cessation
5344509|NCT01974063|Healthy Smoker|healthy smoker
5344510|NCT01974063|Shisha Smoker|shisha smoker
5344511|NCT01974063|Non-smoker|non-smoker
5344512|NCT01974050|Influenza vaccination|influenza vaccination
5344513|NCT01974024|Dexamethasone|dexamethasone
5344514|NCT01974024|Hiccup|hiccup
5344515|NCT01974024|Chemotherapy|chemotherapy
5344516|NCT01974024|Methylprednisolone|methylprednisolone
5344517|NCT01973998|COPD|copd
5344518|NCT01973998|Emphysema|emphysema
5344519|NCT01973998|Roflumilast|roflumilast
5344520|NCT01973998|readmission|readmission
5344521|NCT01973985|Pleural Effusion|pleural effusion
5344522|NCT01973972|Diabetes|diabetes
5344523|NCT01973972|Obesity|obesity
5344524|NCT01973972|Complex Care|complex care
5344525|NCT01973972|Primary Care|primary care
5344526|NCT01973972|Chronic Disease|chronic disease
5344527|NCT01973946|Cancer|cancer
5344528|NCT01973933|Metformin|metformin
5344529|NCT01973933|Pyrimethamine|pyrimethamine
5344530|NCT01973933|Drug interaction|drug interaction
5344531|NCT01973920|Diabetes Mellitus|diabetes mellitus
5344532|NCT01973920|Oral Insulin|oral insulin
5344533|NCT01973907|Sepsis|sepsis
5344534|NCT01973907|Septic Shock|septic shock
5344535|NCT01973907|Fluid Therapy|fluid therapy
5344536|NCT01973907|Pediatrics|pediatrics
5344537|NCT01973907|Resuscitation|resuscitation
5344538|NCT01973907|Emergency Medicine|emergency medicine
5344539|NCT01973907|Critical Care|critical care
5344540|NCT01973894|PBPK|pbpk
5344541|NCT01973894|Midazolam|midazolam
5344542|NCT01973894|Pharmacokinetics|pharmacokinetics
5344543|NCT01973894|Critically ill patients|critically ill patients
5344544|NCT01973868|Regorafenib|regorafenib
5344545|NCT01973868|Cetuximab|cetuximab
5344546|NCT01973868|Solid tumors|solid tumors
5344547|NCT01973868|Cancer|cancer
5344548|NCT01973868|Safety|safety
5344549|NCT01973868|Tolerability|tolerability
5344550|NCT01973868|Pharmacokinetics|pharmacokinetics
5963545|NCT04230382|HbA1c|hba1c
5963546|NCT04230382|Serum magnesium|serum magnesium
5963547|NCT04229225|Osteoarthritis|osteoarthritis
5963548|NCT04229225|Painful Osteoarthritis|painful osteoarthritis
5963549|NCT04229225|Osteoarthritis, Knee|osteoarthritis, knee
5963550|NCT04229225|Senescence|senescence
5963551|NCT04227821|Hemodynamic instability|hemodynamic instability
5963552|NCT04227821|vasopressor therapy|vasopressor therapy
5223749|NCT02600429|NK|nk
5344551|NCT01973842|GnRH agonist|gnrh agonist
5344552|NCT01973842|OHSS|ohss
5344553|NCT01973842|Triggering final oocyte maturation|triggering final oocyte maturation
5423299|NCT01616290|popliteal artery|popliteal artery
5344554|NCT01973829|CERTAIN, Checklist, ICU, Outcome, Adults|certain, checklist, icu, outcome, adults
5344556|NCT01973816|rectal endometriosis;|rectal endometriosis;
5344557|NCT01973816|rectal shaving;|rectal shaving;
5344558|NCT01973816|colorectal resection;|colorectal resection;
5344559|NCT01973816|bowel endometriosis|bowel endometriosis
5344560|NCT01973803|Carpometacarpal joint|carpometacarpal joint
5344561|NCT01973803|Osteoarthritis of CMC-1 joint|osteoarthritis of cmc-1 joint
5344562|NCT01973790|Z-338|z-338
5344563|NCT01973790|Functional Dyspepsia|functional dyspepsia
5344564|NCT01973790|Postprandial Distress Syndrome|postprandial distress syndrome
5344565|NCT01973777|intrauterine device, contraception|intrauterine device, contraception
5344566|NCT01973764|Intraoperative ultrasound|intraoperative ultrasound
5344570|NCT01973764|Ventriculostomy|ventriculostomy
5344571|NCT01973764|Hydrocephalus|hydrocephalus
5344572|NCT01973764|Excessive accumulation of cerebrospinal fluids within the cranium. Often associated with dilatation of cerebral ventricles|excessive accumulation of cerebrospinal fluids within the cranium. often associated with dilatation of cerebral ventricles
5344573|NCT01973764|Intracranial Hypertension|intracranial hypertension
5344574|NCT01973764|increased pressure within the cranial vault. This may result from several conditions, including hydrocephalus, brain edema.|increased pressure within the cranial vault. this may result from several conditions, including hydrocephalus, brain edema.
5344575|NCT01973738|raloxifene|raloxifene
5344576|NCT01973738|bazedoxifene|bazedoxifene
5344577|NCT01973738|bone mineral density|bone mineral density
5344578|NCT01973738|bone turnover markers|bone turnover markers
5344579|NCT01973738|bone quality|bone quality
5344580|NCT01973699|shoulder arthroscopy, epinephrine, visualization|shoulder arthroscopy, epinephrine, visualization
5344581|NCT01973673|prostate cancer|prostate cancer
5344582|NCT01973673|ADT|adt
5344583|NCT01973673|bone health|bone health
5344584|NCT01973660|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
5344585|NCT01973660|HER2|her2
5344586|NCT01973660|HER2 positive|her2 positive
5344587|NCT01973660|PAM50|pam50
5344588|NCT01973660|lapatinib|lapatinib
5344589|NCT01973660|trastuzumab|trastuzumab
5344590|NCT01973660|dual HER2 blockade|dual her2 blockade
5344591|NCT01973660|neoadjuvant|neoadjuvant
5344592|NCT01973647|insomnia|insomnia
5344593|NCT01973647|cognitive behavioral therapy|cognitive behavioral therapy
5344594|NCT01973647|COPD|copd
5344595|NCT01973647|fatigue|fatigue
5344596|NCT01973634|Radiotherapy|radiotherapy
5344597|NCT01973608|Melanoma|melanoma
5344598|NCT01973608|MSB0010445|msb0010445
5344599|NCT01973608|Dose limiting toxicity|dose limiting toxicity
5344600|NCT01973608|Stereotactic body radiation therapy|stereotactic body radiation therapy
5344601|NCT01973595|almonds|almonds
5344602|NCT01973595|inflammation|inflammation
5344603|NCT01973595|immunity|immunity
5344604|NCT01973595|gut microbiota|gut microbiota
5344605|NCT01973595|stress|stress
5344606|NCT01973595|diet quality|diet quality
5344607|NCT01973582|Hepatitis B|hepatitis b
5344608|NCT01973582|epidemiology|epidemiology
5344609|NCT01973582|youth|youth
5344610|NCT01973582|vaccine|vaccine
5344611|NCT01973569|Rheumatoid Arthritis|rheumatoid arthritis
5344612|NCT01973569|Denosumab|denosumab
5344613|NCT01973569|RANKL|rankl
5344614|NCT01973569|RANK|rank
5344615|NCT01973569|AMG 162|amg 162
5344616|NCT01973569|joint damage|joint damage
5344617|NCT01973569|Developmental Phase III|developmental phase iii
5344619|NCT01973543|Parkinson's disease|parkinson's disease
5344620|NCT01973543|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
5344622|NCT01973543|AAV2-AADC|aav2-aadc
5344623|NCT01973543|AAV2|aav2
5344624|NCT01973543|Viral Vector|viral vector
5344625|NCT01973543|Gene Therapy|gene therapy
5344626|NCT01973543|Gene Transfer|gene transfer
5344627|NCT01973543|MRI|mri
5344628|NCT01973543|PET|pet
5344629|NCT01973543|VY-AADC01|vy-aadc01
5344630|NCT01973530|femoral nerve block|femoral nerve block
5344631|NCT01973530|adductor canal block|adductor canal block
5344632|NCT01973530|steroid|steroid
5344633|NCT01973530|total knee replacement|total knee replacement
5344634|NCT01973517|Multiple sclerosis|multiple sclerosis
5344635|NCT01973517|MRI|mri
5344636|NCT01973517|USPIO|uspio
5344637|NCT01973517|Ferumoxytol|ferumoxytol
5344638|NCT01973517|Feraheme|feraheme
5344639|NCT01973504|Trauma|trauma
5344640|NCT01973504|Hemorrhagic shock|hemorrhagic shock
5344641|NCT01973504|Hemorrhage|hemorrhage
5344642|NCT01973504|Lactic acidosis|lactic acidosis
5344643|NCT01973504|Oxygen therapeutics|oxygen therapeutics
5344644|NCT01973504|Oxygen carriers|oxygen carriers
5344645|NCT01973504|Ischemic rescue therapy|ischemic rescue therapy
5963553|NCT04227821|Pediatric patient|pediatric patient
5963554|NCT04227821|Norepinephrine|norepinephrine
5963555|NCT04227821|Epinephrine|epinephrine
5963556|NCT04227821|Dobutamine|dobutamine
5963557|NCT04226378|Diabetes|diabetes
5963558|NCT04226378|Observational study|observational study
5963559|NCT04226378|Glycemic control|glycemic control
5344646|NCT01973504|Hemoglobin solutions|hemoglobin solutions
5344647|NCT01973504|PEGylated hemoglobin|pegylated hemoglobin
5344648|NCT01973491|ATX-MS-1467 (MSC2358825A)|atx-ms-1467 (msc2358825a)
5344649|NCT01973491|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5344650|NCT01973491|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5344651|NCT01973491|M2736|m2736
5344652|NCT01973478|Major depressive disorder|major depressive disorder
5344653|NCT01973478|Recurrent depressive disorder|recurrent depressive disorder
5344654|NCT01973478|Bipolar disorder|bipolar disorder
5344655|NCT01973478|Deep brain stimulation|deep brain stimulation
5344656|NCT01973478|Accumbens|accumbens
5344657|NCT01973465|C-Diff|c-diff
5344658|NCT01973465|Diarrhea|diarrhea
5344659|NCT01973452|Dexmedetomidine|dexmedetomidine
5344660|NCT01973452|Opioid|opioid
5344661|NCT01973452|Thoracic Surgery|thoracic surgery
5344662|NCT01973439|HIV|hiv
5344663|NCT01973439|Abacavir|abacavir
5344664|NCT01973439|Lamivudine|lamivudine
5340516|NCT01992393|Epilepsy|epilepsy
5344665|NCT01973439|Pharmacokinetics|pharmacokinetics
5344666|NCT01973426|Robot|robot
5344667|NCT01973426|Thumb|thumb
5344668|NCT01973426|Orthosis|orthosis
5344669|NCT01973426|Hemiplegia|hemiplegia
5344670|NCT01973426|Hemiplegic Stroke|hemiplegic stroke
5344671|NCT01973426|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
5344672|NCT01973426|Stroke|stroke
5344673|NCT01973426|Cerebral Palsy|cerebral palsy
5344674|NCT01973426|Grasp assistance|grasp assistance
5344675|NCT01973413|Artificial Pancreas Project|artificial pancreas project
5344676|NCT01973413|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5344677|NCT01973413|Insulin pump therapy|insulin pump therapy
5344678|NCT01973413|Continuous Glucose Monitors (CGM)|continuous glucose monitors (cgm)
5344679|NCT01973413|Juvenile-Onset Diabetes|juvenile-onset diabetes
5344680|NCT01973413|Autoimmune Diabetes|autoimmune diabetes
5344681|NCT01973413|Closed-to-Range|closed-to-range
5344682|NCT01973413|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5344683|NCT01973387|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5344684|NCT01973387|Small lymphocytic lymphoma|small lymphocytic lymphoma
5356892|NCT01917591|Wounds and Injuries|wounds and injuries
5344685|NCT01973387|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
5344686|NCT01973387|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
5344687|NCT01973387|Ibrutinib|ibrutinib
5344688|NCT01973387|PCI-32765|pci-32765
5344689|NCT01973387|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5344690|NCT01973387|Rituximab|rituximab
5344691|NCT01973387|Asia Pacific region participants|asia pacific region participants
5344692|NCT01973361|Wounds|wounds
5344693|NCT01973361|Lower extremity|lower extremity
5344694|NCT01973361|Diabetes|diabetes
5344695|NCT01973361|Arterial Insufficiency|arterial insufficiency
5344696|NCT01973361|Debridement|debridement
5344697|NCT01973361|Low frequency ultrasound|low frequency ultrasound
5344698|NCT01973361|Contact ultrasound|contact ultrasound
5344699|NCT01973361|Wound clinic|wound clinic
5344700|NCT01973361|Wound bed preparation|wound bed preparation
5344701|NCT01973361|Wound infection|wound infection
5344702|NCT01973361|Chronic wound inflammation|chronic wound inflammation
5344703|NCT01973348|amblyopia|amblyopia
5344704|NCT01973335|acetazolamide|acetazolamide
5344705|NCT01973335|bumetanide|bumetanide
5344706|NCT01973335|cardio-renal syndrome|cardio-renal syndrome
5344707|NCT01973335|diuretics|diuretics
5344708|NCT01973335|heart failure|heart failure
5344709|NCT01973335|natriuresis|natriuresis
5344710|NCT01973335|spironolactone|spironolactone
5344711|NCT01973322|Malignant melanoma stage III or IV|malignant melanoma stage iii or iv
5344712|NCT01973322|pretreated melanoma|pretreated melanoma
5344713|NCT01973322|vaccination|vaccination
5344714|NCT01973322|autologous dendritic cells|autologous dendritic cells
5344715|NCT01973322|autologous tumor lysate or homogenate|autologous tumor lysate or homogenate
5344716|NCT01973322|immunomodulating radiotherapy|immunomodulating radiotherapy
5344717|NCT01973309|Locally Recurrent|locally recurrent
5344718|NCT01973309|Metastatic Breast Cancer|metastatic breast cancer
5344719|NCT01973296|Health Literacy|health literacy
5344720|NCT01973296|Care Transition Intervention|care transition intervention
5344721|NCT01973296|Emergency Department Population|emergency department population
5344722|NCT01973296|Access to Care|access to care
5344723|NCT01973218|Meningitis, adolescents, Meningococcal B|meningitis, adolescents, meningococcal b
5344724|NCT01973205|Migraine|migraine
5344725|NCT01973205|acetaminophen|acetaminophen
5344726|NCT01973205|aspirin|aspirin
5344727|NCT01973166|Tattoo Removal|tattoo removal
5344728|NCT01973166|Q-switched laser|q-switched laser
5344729|NCT01973166|Nd:YAG laser|nd:yag laser
5344730|NCT01973166|Nanosecond laser|nanosecond laser
5344731|NCT01973166|Picosecond laser|picosecond laser
5344732|NCT01973166|Laser therapy|laser therapy
5344733|NCT01973166|Tattoo|tattoo
5344734|NCT01973166|pulsed-laser|pulsed-laser
5963560|NCT04226378|Insulin pumps|insulin pumps
5963561|NCT04226131|Skeletal Muscle|skeletal muscle
5963562|NCT04225767|Calcium|calcium
5963563|NCT04225767|Electroporation|electroporation
5963564|NCT04225767|Cancer|cancer
5344735|NCT01973166|laser treatment|laser treatment
5344736|NCT01973166|remove tattoo|remove tattoo
5344737|NCT01973166|tattoo clearing|tattoo clearing
5344738|NCT01973166|tattoo lightening|tattoo lightening
5344739|NCT01973166|tattoo lighten|tattoo lighten
5344740|NCT01973153|Obesity prevention|obesity prevention
5344741|NCT01973153|Weight management|weight management
5344742|NCT01973153|Motivational Interviewing|motivational interviewing
5344744|NCT01973140|Aquaretic Efficacy|aquaretic efficacy
5344745|NCT01973127|alcohol|alcohol
5344746|NCT01973127|addiction|addiction
5344747|NCT01973127|TMS|tms
5344748|NCT01973127|craving|craving
5344749|NCT01973127|use|use
5344750|NCT01973127|rTMS|rtms
5344751|NCT01973127|EEG|eeg
5344752|NCT01973127|LPP|lpp
5344753|NCT01973127|p300|p300
5344754|NCT01973127|ERN|ern
5344755|NCT01973127|SST|sst
5344756|NCT01973127|CCT|cct
5344757|NCT01973127|AAAT|aaat
5344758|NCT01973114|Menière's disease|menière's disease
5344759|NCT01973114|Vertigo|vertigo
5344760|NCT01973114|Hearing loss|hearing loss
5344761|NCT01973114|Tinnitus|tinnitus
5344762|NCT01973101|Advanced carcinomas of uterine cervix|advanced carcinomas of uterine cervix
5344763|NCT01973101|Chemoradiation|chemoradiation
5344765|NCT01973101|Cisplatin|cisplatin
5344766|NCT01973101|Gemcitabine|gemcitabine
5344767|NCT01973075|Premature Ovarian Insufficiency (POI)|premature ovarian insufficiency (poi)
5344768|NCT01973036|foley catheter|foley catheter
5344769|NCT01973036|foley bulb|foley bulb
5344770|NCT01973036|oxytocin|oxytocin
5344771|NCT01973023|botulinum toxin injection|botulinum toxin injection
5344772|NCT01973023|stroke|stroke
5344773|NCT01973023|3D motion analysis|3d motion analysis
5344774|NCT01973023|gait pattern|gait pattern
5344775|NCT01973010|massage|massage
5344776|NCT01973010|low back pain|low back pain
5344777|NCT01972984|Estrogen receptor positive|estrogen receptor positive
5344778|NCT01972971|warfarin|warfarin
5344779|NCT01972971|pharmacist|pharmacist
5344780|NCT01972971|anticoagulation|anticoagulation
5344781|NCT01972945|vaginoscopy|vaginoscopy
5344782|NCT01972945|hysteroscopy|hysteroscopy
5344783|NCT01972945|office hysteroscopy|office hysteroscopy
5344784|NCT01972945|outpatient hysteroscopy|outpatient hysteroscopy
5344785|NCT01972932|Bio-K+®|bio-k+®
5344786|NCT01972932|Placebo|placebo
5344787|NCT01972932|AAD|aad
5344788|NCT01972932|CDI|cdi
5344789|NCT01972932|hospitalized subjects|hospitalized subjects
5344790|NCT01972906|moxibustion|moxibustion
5344791|NCT01972906|primary dysmenorrhea|primary dysmenorrhea
5344792|NCT01972893|Selective GLP-1 agonist|selective glp-1 agonist
5344793|NCT01972880|Open-label design|open-label design
5344794|NCT01972880|Bioequivalence|bioequivalence
5344795|NCT01972880|ASP1941|asp1941
5344796|NCT01972867|Focal|focal
5344797|NCT01972867|Prostate|prostate
5344798|NCT01972867|Cancer|cancer
5344799|NCT01972867|Irreversible|irreversible
5344800|NCT01972867|Electroporation|electroporation
5344801|NCT01972867|NanoKnife|nanoknife
5344802|NCT01972854|keratoconus|keratoconus
5344803|NCT01972854|cross-linking|cross-linking
5344804|NCT01972854|KXL|kxl
5344805|NCT01972841|Combination Therapy|combination therapy
5344806|NCT01972841|Mirabegron|mirabegron
5344807|NCT01972841|Overactive Bladder|overactive bladder
5344808|NCT01972841|Urgency|urgency
5344809|NCT01972841|Urinary Incontinence|urinary incontinence
5344810|NCT01972841|Nocturia|nocturia
5344811|NCT01972841|Solifenacin Succinate|solifenacin succinate
5344812|NCT01972828|Septic shock|septic shock
5344813|NCT01972828|Randomized controlled trial|randomized controlled trial
5344814|NCT01972828|Preload dependence|preload dependence
5344815|NCT01972828|Pulmonary thermodilution|pulmonary thermodilution
5344819|NCT01972789|inject and extend|inject and extend
5344820|NCT01972789|retinal fluid|retinal fluid
5344821|NCT01972776|COPD, inflammation, small airways, LCI, PFTs, lung heterogeneity|copd, inflammation, small airways, lci, pfts, lung heterogeneity
5344822|NCT01972750|glioblastoma|glioblastoma
5344823|NCT01972750|recurrence|recurrence
5344824|NCT01972737|Vaccine|vaccine
5344825|NCT01972737|Colon cancer|colon cancer
5344826|NCT01972737|safety|safety
5344827|NCT01972737|tolerability|tolerability
5344828|NCT01972737|antibody responses|antibody responses
5344829|NCT01972737|T cell responses|t cell responses
5344830|NCT01972724|Drug therapy|drug therapy
5344831|NCT01972711|Schizophrenia|schizophrenia
5344832|NCT01972698|Focused Cardiac Ultrasound|focused cardiac ultrasound
5344833|NCT01972698|Lung Ultrasound|lung ultrasound
5344834|NCT01972698|Simulation|simulation
5344835|NCT01972698|Education|education
5344836|NCT01972698|Web-based learning|web-based learning
5963565|NCT04225767|Skin|skin
5344837|NCT01972685|ILD, transbronchial, cryoprobe, VATS|ild, transbronchial, cryoprobe, vats
5344838|NCT01972659|sugammadex|sugammadex
5344839|NCT01972659|rocuronium|rocuronium
5344840|NCT01972659|magnesium|magnesium
5344841|NCT01972659|female|female
5344842|NCT01972646|Cellulitis, treatment failure, skin and soft tissue infections, risk factors.|cellulitis, treatment failure, skin and soft tissue infections, risk factors.
5223979|NCT02599090|XRT|xrt
5344843|NCT01972633|endovenous treatment|endovenous treatment
5344844|NCT01972633|Laser, Vnus Closure Fast|laser, vnus closure fast
5344845|NCT01972633|Varicosis|varicosis
5344846|NCT01972633|great saphenous vein|great saphenous vein
5344847|NCT01972633|small saphenous vein|small saphenous vein
5344848|NCT01972633|Venous Insufficiency|venous insufficiency
5344849|NCT01972620|gallstones|gallstones
5344850|NCT01972620|cholelithiasis|cholelithiasis
5344851|NCT01972620|cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
5344852|NCT01972620|pain|pain
5344853|NCT01972607|Migraine, aerobic exercise, prevention|migraine, aerobic exercise, prevention
5344854|NCT01972581|neurocognitive visual reaction training|neurocognitive visual reaction training
5344855|NCT01972581|baseball|baseball
5344856|NCT01972568|Atacicept|atacicept
5344857|NCT01972568|Placebo|placebo
5344858|NCT01972542|Postprandial period|postprandial period
5344859|NCT01972542|triglyceride|triglyceride
5344860|NCT01972542|Diabetes mellitus, type 2|diabetes mellitus, type 2
5344861|NCT01972542|Prediabetic state|prediabetic state
5344862|NCT01972529|Thrombocytopenia|thrombocytopenia
5344863|NCT01972529|Chronic Liver Disease|chronic liver disease
5344864|NCT01972516|Platinum-Sensitive|platinum-sensitive
5344865|NCT01972516|Ovarian Cancer|ovarian cancer
5344866|NCT01972516|Fallopian Tube Cancer|fallopian tube cancer
5344867|NCT01972516|Primary Peritoneal Cancer|primary peritoneal cancer
5344868|NCT01972516|High-grade Serous|high-grade serous
5344869|NCT01972503|Colorectal Neoplasms|colorectal neoplasms
5344871|NCT01972503|Neoplasm Metastasis|neoplasm metastasis
5344872|NCT01972503|Tegafur|tegafur
5344873|NCT01972503|oxaliplatin|oxaliplatin
5344874|NCT01972490|colorectal neoplasms|colorectal neoplasms
5344875|NCT01972490|liver metastasis|liver metastasis
5344876|NCT01972490|chemotherapy|chemotherapy
5344877|NCT01972490|avastin|avastin
5344878|NCT01972477|DLBS1449|dlbs1449
5344879|NCT01972477|diabetes mellitus|diabetes mellitus
5344880|NCT01972477|HDL-cholesterol|hdl-cholesterol
5344881|NCT01972464|Progesterone|progesterone
5344882|NCT01972464|Placebo|placebo
5344883|NCT01972464|Postpartum|postpartum
5344884|NCT01972464|Tobacco|tobacco
5344885|NCT01972464|Pregnancy|pregnancy
5344886|NCT01972438|Graft Versus Host Disease|graft versus host disease
5344887|NCT01972438|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5356893|NCT01917591|biopsy|biopsy
5344888|NCT01972412|nursing care|nursing care
5344889|NCT01972412|diabetes mellitus|diabetes mellitus
5344890|NCT01972412|phone support|phone support
5344891|NCT01972412|chronic care model|chronic care model
5344892|NCT01972373|VEGF|vegf
5344893|NCT01972373|Fluorescence|fluorescence
5344894|NCT01972373|Endoscopy|endoscopy
5344895|NCT01972373|Rectal cancer|rectal cancer
5344899|NCT01972347|Melanoma|melanoma
5344900|NCT01972347|Cutaneous melanoma|cutaneous melanoma
5344901|NCT01972347|Malignant melanoma|malignant melanoma
5344902|NCT01972347|Stage III B / C melanoma|stage iii b / c melanoma
5344903|NCT01972347|Neoadjuvant treatment|neoadjuvant treatment
5344904|NCT01972347|Pyrexia|pyrexia
5344905|NCT01972347|Biomarkers|biomarkers
5344906|NCT01972347|Dabrafenib|dabrafenib
5344907|NCT01972347|Trametinib|trametinib
5344908|NCT01972334|clostridium difficile|clostridium difficile
5344909|NCT01972334|children|children
5344910|NCT01972334|fecal transplant|fecal transplant
5344911|NCT01972321|Community health worker|community health worker
5344912|NCT01972321|Motivation|motivation
5344913|NCT01972321|Performance|performance
5344914|NCT01972321|Quality of care|quality of care
5344915|NCT01972321|Africa|africa
5344916|NCT01972308|asthma|asthma
5344917|NCT01972308|patient advocate|patient advocate
5344918|NCT01972308|health disparity|health disparity
5344919|NCT01972308|patient-provider communication|patient-provider communication
5344920|NCT01972282|Atrial fibrillation|atrial fibrillation
5344921|NCT01972282|Stroke|stroke
5344922|NCT01972282|Thrombus|thrombus
5344923|NCT01972282|Thromboembolism|thromboembolism
5344924|NCT01972282|Left atrial appendage|left atrial appendage
5344925|NCT01972269|Epidural|epidural
5344926|NCT01972269|Labor Analgesia|labor analgesia
5344927|NCT01972269|Bupivacaine|bupivacaine
5344928|NCT01972269|Minimum effective volume|minimum effective volume
5344929|NCT01972243|risk of recurrent|risk of recurrent
5344930|NCT01972217|Olaparib|olaparib
5344931|NCT01972217|castration-resistant, metastatic prostate cancer|castration-resistant, metastatic prostate cancer
5344932|NCT01972217|Prior Docetaxel Chemotherapy|prior docetaxel chemotherapy
5344933|NCT01972191|Toric marking, Corneal horizontal marking|toric marking, corneal horizontal marking
5344934|NCT01972165|Carpal tunnel syndrome|carpal tunnel syndrome
5963566|NCT04225663|SUB-CONCUSSIVE HEAD IMPACTS|sub-concussive head impacts
5963567|NCT04225663|MEDITATION|meditation
5963568|NCT04225663|adolescent athletes|adolescent athletes
5963569|NCT04225221|bulimia nervosa|bulimia nervosa
5963570|NCT04225221|binge eating|binge eating
5963571|NCT04225221|eating disorder|eating disorder
5963572|NCT04225221|estrogen|estrogen
5963573|NCT04224870|Epidermal|epidermal
5963574|NCT04224870|Transcriptomics|transcriptomics
5963575|NCT04224870|Dermal|dermal
5963576|NCT04224870|Surgery|surgery
5963577|NCT04224870|Incision|incision
5224080|NCT02598583|PNH|pnh
5344935|NCT01972152|Hypoglycemia|hypoglycemia
5344936|NCT01972152|Glucagon|glucagon
5344937|NCT01972139|Uncontrolled hypertension|uncontrolled hypertension
5344938|NCT01972139|blood pressure|blood pressure
5344939|NCT01972139|renal denervation|renal denervation
5344940|NCT01972139|HTN-4|htn-4
5344941|NCT01972139|SYMPLICITY|symplicity
5344942|NCT01972113|Vitamin K|vitamin k
5344943|NCT01972113|Vitamin K2|vitamin k2
5344944|NCT01972113|Menaquinone-7|menaquinone-7
5344945|NCT01972113|Osteocalcin|osteocalcin
5344946|NCT01972113|Children|children
5344947|NCT01972113|Obesity|obesity
5344948|NCT01972113|Insulin resistance|insulin resistance
5344949|NCT01972113|Insulin sensitivity|insulin sensitivity
5344950|NCT01972113|Beta-cell function|beta-cell function
5344951|NCT01972113|Prediabetes|prediabetes
5344952|NCT01972113|Matrix Gla protein|matrix gla protein
5344953|NCT01972113|Arterial stiffness|arterial stiffness
5344954|NCT01972113|Endothelial function|endothelial function
5344955|NCT01972100|Low-level laser therapy|low-level laser therapy
5344956|NCT01972100|Muscle fatigue resistance|muscle fatigue resistance
5344957|NCT01972074|Autism spectrum disorder|autism spectrum disorder
5344958|NCT01972074|Treatment|treatment
5344959|NCT01972074|Adolescents|adolescents
5344960|NCT01972074|Memantine|memantine
5344961|NCT01972074|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5344962|NCT01972074|MRS|mrs
5344963|NCT01972074|Neuroimaging|neuroimaging
5344964|NCT01972048|breast cancer|breast cancer
5344965|NCT01972048|breast cancer screening|breast cancer screening
5344966|NCT01972048|mammogram|mammogram
5344967|NCT01972035|EBV|ebv
5344968|NCT01972035|CMV|cmv
5344969|NCT01972035|Kidney transplant|kidney transplant
5344970|NCT01972035|valganciclovir|valganciclovir
5344971|NCT01972035|valacyclovir|valacyclovir
5344973|NCT01972022|Bioabsorbale Polymer Coating|bioabsorbale polymer coating
5344974|NCT01972022|Neoatherosclerosis|neoatherosclerosis
5344975|NCT01972022|Stent Coverage|stent coverage
5344976|NCT01972022|Stent Failure|stent failure
5344977|NCT01971996|Near infrared Spectroscopy|near infrared spectroscopy
5344978|NCT01971983|Low back pain|low back pain
5344979|NCT01971983|Spinal manipulation|spinal manipulation
5344980|NCT01971983|Osteopathy|osteopathy
5344981|NCT01971983|Muscle energy technique|muscle energy technique
5344982|NCT01971983|Muscle thickness|muscle thickness
5344983|NCT01971970|Inflammatory bowel disease|inflammatory bowel disease
5344984|NCT01971970|Pediatric|pediatric
5344985|NCT01971970|Adult|adult
5344986|NCT01971970|Biomarker|biomarker
5344987|NCT01971970|Anti-TNF response|anti-tnf response
5344988|NCT01971970|Infliximab|infliximab
5344989|NCT01971970|Adalimumab|adalimumab
5344990|NCT01971957|ichthyosis|ichthyosis
5344991|NCT01971957|spasticity|spasticity
5344992|NCT01971957|spastic diplegia|spastic diplegia
5344993|NCT01971957|intellectual disability|intellectual disability
5344994|NCT01971944|Beta Blocker|beta blocker
5344995|NCT01971944|Inotrope|inotrope
5344996|NCT01971918|spondyloarthritis|spondyloarthritis
5344997|NCT01971918|monoclonal antibodies anti-TNF|monoclonal antibodies anti-tnf
5344998|NCT01971918|secondary treatment failure|secondary treatment failure
5344999|NCT01971892|Abdominal surgery;|abdominal surgery;
5345000|NCT01971892|Postoperative complication;|postoperative complication;
5345001|NCT01971892|Acute respiratory failure;|acute respiratory failure;
5345002|NCT01971892|Hypoxemia;|hypoxemia;
5345003|NCT01971892|Intubation;|intubation;
5345004|NCT01971892|Non-invasive ventilation|non-invasive ventilation
5345005|NCT01971879|Remote ischemic preconditioning|remote ischemic preconditioning
5345006|NCT01971879|Obliterating Arteriopathy of the Lower Limbs|obliterating arteriopathy of the lower limbs
5345007|NCT01971866|Proton radiation|proton radiation
5345008|NCT01971866|AlignRT|alignrt
5345009|NCT01971853|Analgesia|analgesia
5345010|NCT01971840|Physical activity|physical activity
5345011|NCT01971840|Physical fitness|physical fitness
5345012|NCT01971840|Obesity|obesity
5345013|NCT01971840|Adiposity|adiposity
5345014|NCT01971840|Adiposity rebound period|adiposity rebound period
5345015|NCT01971840|Children|children
5345016|NCT01971840|Blood pressure|blood pressure
5345017|NCT01971840|Randomized controlled trials|randomized controlled trials
5345018|NCT01971840|Barriers and facilitators of the environment|barriers and facilitators of the environment
5345019|NCT01971827|Physical activity|physical activity
5345020|NCT01971827|Obesity|obesity
5345021|NCT01971827|Adiposity rebound period|adiposity rebound period
5345022|NCT01971827|Children with ADHD|children with adhd
5963578|NCT04223882|Stress, Psychological;|stress, psychological;
5963579|NCT04223882|Coronary Artery Disease;|coronary artery disease;
5963580|NCT04223882|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
5963581|NCT04223882|Endothelium;|endothelium;
5963582|NCT04223037|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5963583|NCT04223037|Phase III Clinical Trial|phase iii clinical trial
5963584|NCT04222998|Home-based growth charts|home-based growth charts
5963585|NCT04222998|Child nutrition|child nutrition
5963586|NCT04222998|Growth faltering|growth faltering
5963587|NCT04222998|Stunting|stunting
5963588|NCT04222998|Indonesia|indonesia
5963589|NCT04222660|diabetes|diabetes
5963590|NCT04222660|neuropathy|neuropathy
5963591|NCT04222660|fish oil|fish oil
5224149|NCT02598219|Sentinel node|sentinel node
5224150|NCT02598206|food effect|food effect
5345023|NCT01971827|Children without ADHD|children without adhd
5345024|NCT01971827|Academic performance|academic performance
5345025|NCT01971827|Motor skills|motor skills
5345026|NCT01971827|Health related-quality of life|health related-quality of life
5345027|NCT01971827|Sleep|sleep
5345028|NCT01971801|urinary incontinence|urinary incontinence
5345029|NCT01971801|bowel incontinence|bowel incontinence
5345030|NCT01971801|vitamin D|vitamin d
5345031|NCT01971801|overactive bladder|overactive bladder
5345032|NCT01971801|lower urinary tract symptoms|lower urinary tract symptoms
5345033|NCT01971801|quality of life|quality of life
5345034|NCT01971775|Ultrasonically Activated Shear|ultrasonically activated shear
5345035|NCT01971775|Conventional Monopolar Electrocautery|conventional monopolar electrocautery
5345036|NCT01971775|Gastric Cancer|gastric cancer
5345037|NCT01971762|multiresistant bacteremia|multiresistant bacteremia
5345038|NCT01971762|bacteremia management|bacteremia management
5345039|NCT01971762|blood culture|blood culture
5345040|NCT01971749|Coronary stent procedure (CSP|coronary stent procedure (csp
5345041|NCT01971749|Coronary-artery bypass grafting (CABG)|coronary-artery bypass grafting (cabg)
5345042|NCT01971736|1064nm YAG laser|1064nm yag laser
5345043|NCT01971736|laxity|laxity
5345044|NCT01971736|rhytides|rhytides
5345045|NCT01971736|asian|asian
5345046|NCT01971723|Testosterone|testosterone
5345047|NCT01971723|Estrogen|estrogen
5345048|NCT01971723|Insulin|insulin
5345049|NCT01971723|Blood Lipid|blood lipid
5345050|NCT01971723|Glucose|glucose
5345051|NCT01971723|Creatine Kinase|creatine kinase
5345052|NCT01971723|Strength|strength
5345053|NCT01971723|Power Athlete|power athlete
5345055|NCT01971710|AIDS|aids
5345056|NCT01971710|PMTCT|pmtct
5345057|NCT01971684|ITP|itp
5345058|NCT01971684|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5345059|NCT01971684|bleeding score|bleeding score
5345073|NCT01971684|Hemorrhagic Disorders|hemorrhagic disorders
5345074|NCT01971684|Autoimmune Diseases|autoimmune diseases
5345075|NCT01971684|Therapeutic Uses|therapeutic uses
5345076|NCT01971658|Multiple myeloma|multiple myeloma
5345077|NCT01971658|Newly Diagnosed|newly diagnosed
5345078|NCT01971645|Dexamethasone|dexamethasone
5345079|NCT01971645|Ropivacaine|ropivacaine
5345080|NCT01971645|Knee arthroscopy|knee arthroscopy
5345081|NCT01971645|Femoral nerve blocks|femoral nerve blocks
5345082|NCT01971645|Peripheral nerve blocks|peripheral nerve blocks
5345084|NCT01971645|Pediatrics|pediatrics
5345085|NCT01971606|Statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome|statin, coronary artery bypass grafting, off-pump surgery, acute coronary syndrome
5345086|NCT01971567|Insomnia|insomnia
5345087|NCT01971567|Electroencephalic|electroencephalic
5345088|NCT01971567|Biofeedback|biofeedback
5345089|NCT01971567|Neural oscillations|neural oscillations
5345090|NCT01971567|Auto calibration|auto calibration
5345091|NCT01971567|Relaxation|relaxation
5345092|NCT01971541|mindfulness|mindfulness
5345093|NCT01971541|behavior therapies, cognitive|behavior therapies, cognitive
5345094|NCT01971541|posttraumatic stress disorder|posttraumatic stress disorder
5345095|NCT01971541|group therapy|group therapy
5345096|NCT01971528|Muscle strength, fatigue, electromyography (EMG), central fatigue, strength straining|muscle strength, fatigue, electromyography (emg), central fatigue, strength straining
5345097|NCT01971515|MSC2363318A|msc2363318a
5345098|NCT01971515|Maximum tolerated dose|maximum tolerated dose
5345099|NCT01971515|Dose limiting toxicities|dose limiting toxicities
5345100|NCT01971515|Recommended phase 2 dose|recommended phase 2 dose
5345101|NCT01971515|M2698|m2698
5345102|NCT01971515|Metastatic Breast Cancer|metastatic breast cancer
5345103|NCT01971515|HER2+ Metastatic Breast Cancer|her2+ metastatic breast cancer
5345104|NCT01971515|Hormone refractory ER/PR+ breast cancer|hormone refractory er/pr+ breast cancer
5345105|NCT01971515|Tamoxifen|tamoxifen
5345106|NCT01971515|PAM Pathway Alteration(s)|pam pathway alteration(s)
5345107|NCT01971515|PAM Pathway|pam pathway
5345108|NCT01971515|Targeted Therapy|targeted therapy
5345109|NCT01971515|P70S6K|p70s6k
5345110|NCT01971515|AKT Inhibition|akt inhibition
5345111|NCT01971515|PI3K Pathway|pi3k pathway
5345112|NCT01971515|HER2+ Trastuzumab Resistance|her2+ trastuzumab resistance
5345113|NCT01971450|Non-interventional|non-interventional
5345114|NCT01971450|Ventavis|ventavis
5345115|NCT01971450|Iloprost|iloprost
5345116|NCT01971450|Pulmonary hypertension|pulmonary hypertension
5345117|NCT01971450|Compliance|compliance
5345118|NCT01971450|Russian Federation|russian federation
5345119|NCT01971437|Overactive Bladder|overactive bladder
5345121|NCT01971437|Cystoscopy|cystoscopy
5345122|NCT01971437|Cystodistension|cystodistension
5345123|NCT01971437|UTI|uti
5345124|NCT01971437|Cytokines|cytokines
5345125|NCT01971424|magnesium|magnesium
5345126|NCT01971424|SPPB|sppb
5345127|NCT01971424|strength|strength
5345128|NCT01971424|physical performance|physical performance
5345129|NCT01971424|24 hour magnesuria|24 hour magnesuria
5963592|NCT04222660|cornea|cornea
5963593|NCT04222660|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
5345130|NCT01971411|Hyperparathyroidism|hyperparathyroidism
5345131|NCT01971411|Hypoparathyroidism|hypoparathyroidism
5345132|NCT01971411|Calcium|calcium
5345133|NCT01971411|Vitamin D|vitamin d
5345134|NCT01971411|Bone mineral density|bone mineral density
5345135|NCT01971411|African American|african american
5345136|NCT01971411|Female|female
5345137|NCT01971411|Elderly|elderly
5345138|NCT01971398|Fetal Alcohol Spectrum Disorders (FASD)|fetal alcohol spectrum disorders (fasd)
5345139|NCT01971398|Prevention|prevention
5345140|NCT01971398|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
5349041|NCT01953809|oral|oral
5345160|NCT01971281|Treatment|treatment
5345161|NCT01971281|Minimal toxicity|minimal toxicity
5345162|NCT01971281|TTFields|ttfields
5345163|NCT01971281|Tumor Treating Fields|tumor treating fields
5345164|NCT01971281|Novocure|novocure
5345165|NCT01971268|T3 dental implants|t3 dental implants
5345166|NCT01971268|Marginal bone loss|marginal bone loss
5345167|NCT01971268|Survival rate|survival rate
5345168|NCT01971255|Influenza A|influenza a
5345169|NCT01971255|HAI|hai
5345170|NCT01971255|H1N1|h1n1
5345171|NCT01971255|Challenge Study|challenge study
5345172|NCT01971255|Correlates of Protection|correlates of protection
5345173|NCT01971242|Parkinson's|parkinson's
5345174|NCT01971242|Parkinson's Disease|parkinson's disease
5345175|NCT01971242|Exenatide|exenatide
5345176|NCT01971242|Bydureon|bydureon
5345177|NCT01971216|Breastfeeding, relaxation, anxiety, infant growth|breastfeeding, relaxation, anxiety, infant growth
5345178|NCT01971203|seroquel XR|seroquel xr
5345179|NCT01971203|quetiapine XR|quetiapine xr
5345180|NCT01971203|major depression|major depression
5345181|NCT01971203|generalized anxiety disorder|generalized anxiety disorder
5345182|NCT01971203|CBT|cbt
5345183|NCT01971203|co-morbid MDD|co-morbid mdd
5345184|NCT01971164|anemia|anemia
5345185|NCT01971164|chronic kidney disease|chronic kidney disease
5345186|NCT01971164|hemodialysis|hemodialysis
5345187|NCT01971151|Chronic|chronic
5345188|NCT01971151|Back pain|back pain
5345189|NCT01971151|Low back|low back
5345190|NCT01971125|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5345191|NCT01971125|Heart Diseases|heart diseases
5345192|NCT01971125|Left Ventricular Dysfunction|left ventricular dysfunction
5345193|NCT01971112|Multi-vitamins|multi-vitamins
5345194|NCT01971112|Minerals|minerals
5345195|NCT01971112|Respiratory infections|respiratory infections
5345196|NCT01971112|DTH|dth
5345197|NCT01971112|CRP|crp
5345198|NCT01971112|Cathelicidin|cathelicidin
5345199|NCT01971099|sexual function|sexual function
5345200|NCT01971099|hypoactive|hypoactive
5345201|NCT01971099|desire|desire
5345202|NCT01971099|androgens|androgens
5345203|NCT01971073|schizophrenic patients|schizophrenic patients
5345204|NCT01971073|tDCS|tdcs
5345205|NCT01971073|Executive functions|executive functions
5345206|NCT01971073|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5345207|NCT01971060|uterine fibroids|uterine fibroids
5345208|NCT01971060|barbed suture|barbed suture
5345209|NCT01971060|infertility|infertility
5345210|NCT01971060|adhesions|adhesions
5345211|NCT01971047|Diabetes|diabetes
5345212|NCT01971047|Surgery|surgery
5345213|NCT01971047|anesthesiology|anesthesiology
5345214|NCT01971047|endocrinology|endocrinology
5345215|NCT01970995|Candidate modified risk tobacco product|candidate modified risk tobacco product
5345216|NCT01970995|Conventional cigarettes|conventional cigarettes
5345217|NCT01970995|Reduced exposure|reduced exposure
5345219|NCT01970995|Ambulatory|ambulatory
5345220|NCT01970982|Candidate modified risk tobacco product|candidate modified risk tobacco product
5345221|NCT01970982|Conventional cigarette|conventional cigarette
5423300|NCT01616290|PA|pa
5345222|NCT01970982|Reduced exposure|reduced exposure
5345223|NCT01970982|HPHCs|hphcs
5345224|NCT01970982|Confinement|confinement
5345225|NCT01970969|Atrial Fibrillation|atrial fibrillation
5345226|NCT01970969|Cardiac monitoring|cardiac monitoring
5345227|NCT01970969|Genomics|genomics
5345228|NCT01970943|migraine, headache, episodic, chronic, pain|migraine, headache, episodic, chronic, pain
5345229|NCT01970930|Tissue banking|tissue banking
5345230|NCT01970917|tear film thickness|tear film thickness
5345231|NCT01970917|optical coherence tomography|optical coherence tomography
5345232|NCT01970917|topical lubricants|topical lubricants
5345233|NCT01970917|tear film thickness in healthy subjects|tear film thickness in healthy subjects
5345234|NCT01970904|Chronic hepatitis C|chronic hepatitis c
5345235|NCT01970904|DEB025|deb025
5345236|NCT01970904|Alisporivir|alisporivir
5345237|NCT01970904|ribavirin therapy|ribavirin therapy
5345238|NCT01970904|genotype 2/3 treatment naive patients|genotype 2/3 treatment naive patients
5345239|NCT01970891|Freezing of Gait|freezing of gait
5345240|NCT01970891|Gait|gait
5345241|NCT01970891|Comfort|comfort
5963594|NCT04222413|First-In-Class Investigational Agent|first-in-class investigational agent
5963595|NCT04222413|Peri-Nuclear Compartment (PNC)|peri-nuclear compartment (pnc)
5963596|NCT04222413|Effective Therpaies Against Metastasis|effective therpaies against metastasis
5963597|NCT04222413|Oral Administration|oral administration
5963598|NCT04222413|Maximum Recommended Starting Dose|maximum recommended starting dose
5963599|NCT04221945|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
5963600|NCT04221945|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
5345242|NCT01970891|Pain tolerance|pain tolerance
5345243|NCT01970891|Pain|pain
5345244|NCT01970891|Sensory threshold|sensory threshold
5345245|NCT01970891|Motor threshold|motor threshold
5345246|NCT01970891|Pain threshold|pain threshold
5345247|NCT01970865|Phase 1|phase 1
5345248|NCT01970865|Phase 2|phase 2
5345249|NCT01970865|safety|safety
5345250|NCT01970865|pharmacokinetic|pharmacokinetic
5345251|NCT01970865|pharmacodynamic|pharmacodynamic
5345252|NCT01970865|efficacy|efficacy
5345253|NCT01970852|Inpatient|inpatient
5345254|NCT01970852|PHR Portal|phr portal
5345255|NCT01970852|Information Technology|information technology
5345256|NCT01970839|Tourniquet|tourniquet
5345257|NCT01970839|Endoneural|endoneural
5345258|NCT01970839|Ischemia|ischemia
5345259|NCT01970826|aseptic sterilized field|aseptic sterilized field
5345260|NCT01970826|clean sterilized field|clean sterilized field
5345261|NCT01970826|dental implants|dental implants
5345262|NCT01970826|Surgery|surgery
5345263|NCT01970813|Parkinson's disease|parkinson's disease
5345264|NCT01970813|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5345265|NCT01970813|acupuncture|acupuncture
5345266|NCT01970813|bee venom acupuncture|bee venom acupuncture
5345267|NCT01970800|IGF-1|igf-1
5345268|NCT01970800|Short Stature|short stature
5345269|NCT01970800|GH|gh
5345270|NCT01970748|Variceal bleeding|variceal bleeding
5345271|NCT01970748|Portal hypertension|portal hypertension
5345272|NCT01970748|Hepatocellular carcinoma|hepatocellular carcinoma
5345273|NCT01970748|Endoscopic variceal ligation|endoscopic variceal ligation
5345274|NCT01970748|Non-selective beta-blocker|non-selective beta-blocker
5345275|NCT01970709|Adverse Drug Reactions|adverse drug reactions
5345276|NCT01970709|Emergency Department Visits|emergency department visits
5345277|NCT01970709|Hospitalizations|hospitalizations
5345278|NCT01970709|Pharmacogenomic|pharmacogenomic
5345279|NCT01970696|ovarian|ovarian
5345280|NCT01970696|testicular|testicular
5345281|NCT01970696|stromal|stromal
5345282|NCT01970696|Sertoli|sertoli
5345283|NCT01970696|Leydig|leydig
5345284|NCT01970696|gynandroblastoma|gynandroblastoma
5345285|NCT01970696|juvenile granulosa cell tumor|juvenile granulosa cell tumor
5345286|NCT01970696|DICER1|dicer1
5345287|NCT01970657|Venous Stasis Ulcer|venous stasis ulcer
5345288|NCT01970657|VLU|vlu
5345289|NCT01970644|Neoplasm metastasis|neoplasm metastasis
5345290|NCT01970644|Brain neoplasms|brain neoplasms
5345291|NCT01970644|Radiosurgery|radiosurgery
5345292|NCT01970644|Cognition disorders|cognition disorders
5345293|NCT01970644|Cranial irradiation|cranial irradiation
5345294|NCT01970631|Osteoarthritis|osteoarthritis
5345295|NCT01970631|Total Knee Replacement|total knee replacement
5345296|NCT01970631|total Knee Arthroplasty|total knee arthroplasty
5345297|NCT01970631|Post-operative recovery TKR|post-operative recovery tkr
5345298|NCT01970631|Physical Activity|physical activity
5345299|NCT01970631|Motivational Interviewing|motivational interviewing
5345300|NCT01970631|Financial Incentives|financial incentives
5345301|NCT01970592|exercise|exercise
5345303|NCT01970592|walking|walking
5345304|NCT01970566|Intense Exercise/Moderate Calorie Restriction|intense exercise/moderate calorie restriction
5345305|NCT01970566|Topiramate-Phentermine|topiramate-phentermine
5345306|NCT01970553|lurbinectedin|lurbinectedin
5345307|NCT01970553|PM01183|pm01183
5345309|NCT01970553|cancer|cancer
5345310|NCT01970553|Pharma Mar|pharma mar
5345311|NCT01970540|lurbinectedin|lurbinectedin
5345312|NCT01970540|PM01183|pm01183
5345313|NCT01970540|tumors|tumors
5345314|NCT01970540|cancer|cancer
5345315|NCT01970540|Pharma Mar|pharma mar
5345316|NCT01970501|atrial fibrillation|atrial fibrillation
5345317|NCT01970501|atrial flutter|atrial flutter
5345318|NCT01970501|heart failure|heart failure
5345319|NCT01970501|reduced left ventricle ejection fraction|reduced left ventricle ejection fraction
5345320|NCT01970501|electrical cardioversion|electrical cardioversion
5345321|NCT01970501|GENETIC-AF|genetic-af
5345322|NCT01970501|Medtronic|medtronic
5345323|NCT01970501|bucindolol|bucindolol
5345324|NCT01970501|pharmacogenetic|pharmacogenetic
5345326|NCT01970501|Toprol|toprol
5345330|NCT01970488|Plaque Psoriasis|plaque psoriasis
5345331|NCT01970475|Arthritis|arthritis
5345332|NCT01970475|Rheumatoid|rheumatoid
5345333|NCT01970436|Prenatal care|prenatal care
5345334|NCT01970436|Pregnancy|pregnancy
5345335|NCT01970436|Obstetrics|obstetrics
5345336|NCT01970436|Telemedicine|telemedicine
5345337|NCT01970423|Patients with pacemaker or ICD therapy|patients with pacemaker or icd therapy
5345338|NCT01970410|teriflunomide|teriflunomide
5345339|NCT01970410|natalizumab|natalizumab
5345340|NCT01970410|relapsing multiple sclerosis|relapsing multiple sclerosis
5345341|NCT01970384|transcranial direct current stimulation|transcranial direct current stimulation
5345342|NCT01970384|stroke-related dysphagia|stroke-related dysphagia
5345343|NCT01970384|cortical plasticity|cortical plasticity
5345344|NCT01970371|Gram-negative|gram-negative
5345345|NCT01970371|bacterial infection|bacterial infection
5345346|NCT01970371|antibacterial|antibacterial
5345347|NCT01970371|antimicrobial|antimicrobial
5345348|NCT01970371|CRE|cre
5345349|NCT01970371|CPE|cpe
5345350|NCT01970371|BSI|bsi
5345351|NCT01970371|pneumonia|pneumonia
5345352|NCT01970371|HABP|habp
5345353|NCT01970371|VABP|vabp
5345354|NCT01970371|AP|ap
5345355|NCT01970371|cUTI|cuti
5345356|NCT01970371|UTI|uti
5345357|NCT01970358|melanoma|melanoma
5345358|NCT01970358|melanoma vaccine|melanoma vaccine
5345359|NCT01970358|adjuvant therapy|adjuvant therapy
5345360|NCT01970345|Autism Spectrum Disorder|autism spectrum disorder
5345361|NCT01970345|IGF-1|igf-1
5345362|NCT01970332|Peripheral Arterial Disease|peripheral arterial disease
5345363|NCT01970332|Peripheral Vascular Disease|peripheral vascular disease
5345364|NCT01970332|Claudication|claudication
5345365|NCT01970332|Myopathy|myopathy
5345366|NCT01970332|Oxidative stress|oxidative stress
5345367|NCT01970332|Mitochondrial dysfunction|mitochondrial dysfunction
5345368|NCT01970332|Biomechanics|biomechanics
5345369|NCT01970332|Inflammation|inflammation
5345370|NCT01970306|Esophageal Reinforcement|esophageal reinforcement
5345371|NCT01970306|ACell MatriStem|acell matristem
5345372|NCT01970306|13-178|13-178
5345373|NCT01970293|Alcohol use|alcohol use
5345374|NCT01970293|STI|sti
5345375|NCT01970293|Incarcerated women|incarcerated women
5345376|NCT01970293|AA|aa
5345377|NCT01970254|hepatitis B virus infection|hepatitis b virus infection
5345378|NCT01970254|HBV|hbv
5345379|NCT01970254|Cancer Patients|cancer patients
5345380|NCT01970254|chemotherapy|chemotherapy
5345381|NCT01970254|HBV screening strategy|hbv screening strategy
5345382|NCT01970254|HBV care|hbv care
5345383|NCT01970254|chronic HBV|chronic hbv
5345384|NCT01970254|concomitant HBV infection|concomitant hbv infection
5345385|NCT01970254|viral infections|viral infections
5345386|NCT01970241|corticosteroid|corticosteroid
5345387|NCT01970241|diabetes|diabetes
5345388|NCT01970241|insulin|insulin
5345389|NCT01970202|obesity|obesity
5345390|NCT01970202|overweight|overweight
5345391|NCT01970202|sleeve gastrectomy|sleeve gastrectomy
5345392|NCT01970189|Immune Thrombocytopenia|immune thrombocytopenia
5345393|NCT01970189|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
5345394|NCT01970189|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5345395|NCT01970189|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
5345396|NCT01970189|Thrombocytopenia|thrombocytopenia
5345397|NCT01970163|Diabetic foot ulcer|diabetic foot ulcer
5345398|NCT01970163|Venous stasis ulcer|venous stasis ulcer
5345399|NCT01970163|Wound of the lower extremity|wound of the lower extremity
5345400|NCT01970163|Skin substitute|skin substitute
5345401|NCT01970163|Acellular Dermal Matrix|acellular dermal matrix
5345402|NCT01970150|rTMS|rtms
5345403|NCT01970150|Alzheimer Disease|alzheimer disease
5345404|NCT01970150|Memory|memory
5345405|NCT01970150|attention|attention
5345406|NCT01970150|EEG|eeg
5345407|NCT01970137|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5345408|NCT01970137|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5345409|NCT01970137|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
5345417|NCT01970098|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5345418|NCT01970098|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5345419|NCT01970098|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
5345420|NCT01970098|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
5423301|NCT01616290|PRT-201|prt-201
5345422|NCT01970072|Phase Ⅰ study|phase ⅰ study
5345423|NCT01970072|Health|health
5345424|NCT01970059|Hypertension|hypertension
5345425|NCT01970046|SP2086|sp2086
5345426|NCT01970046|Phase III|phase iii
5345427|NCT01970046|combination therapy|combination therapy
5345428|NCT01970033|SP2086|sp2086
5345429|NCT01970033|Phase III|phase iii
5345430|NCT01970033|Monotherapy|monotherapy
5345431|NCT01970020|Healthy|healthy
5345432|NCT01970020|JNJ-38518168|jnj-38518168
5345433|NCT01970020|14C-JNJ-38518168|14c-jnj-38518168
5345434|NCT01970020|Absorption|absorption
5345435|NCT01970020|Metabolism|metabolism
5345436|NCT01970020|Excretion|excretion
5345437|NCT01970007|venous|venous
5345438|NCT01970007|outflow obstruction|outflow obstruction
5345439|NCT01970007|iliofemoral vein|iliofemoral vein
5345440|NCT01969994|Epicatechin|epicatechin
5345441|NCT01969994|Flavanols|flavanols
5345442|NCT01969994|Procyanidins|procyanidins
5345443|NCT01969994|Polyphenols|polyphenols
5345444|NCT01969994|Phytonutrients|phytonutrients
5345445|NCT01969994|AMDE|amde
5345446|NCT01969994|Antioxidants|antioxidants
5345447|NCT01969981|Peripheral Inserted Central Catheter|peripheral inserted central catheter
5345448|NCT01969955|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
5345449|NCT01969955|Squamous Cell Carcinoma of Lung|squamous cell carcinoma of lung
5345450|NCT01969942|Ewings sarcoma|ewings sarcoma
5345451|NCT01969916|Cardiac CT imaging|cardiac ct imaging
5963601|NCT04221945|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
5345452|NCT01969916|Myocardial ischemia|myocardial ischemia
5345453|NCT01969916|Myocardial perfusion|myocardial perfusion
5345454|NCT01969916|Vasodilator stress testing|vasodilator stress testing
5345455|NCT01969916|Regadenoson|regadenoson
5345456|NCT01969903|brachial plexus block|brachial plexus block
5345457|NCT01969903|lidocaine|lidocaine
5345459|NCT01969903|bradycardia|bradycardia
5345460|NCT01969903|hypotension|hypotension
5345461|NCT01969877|Head and neck cancer|head and neck cancer
5345462|NCT01969877|Cetuximab|cetuximab
5345463|NCT01969877|Cisplatin|cisplatin
5345464|NCT01969877|Radiotherapy|radiotherapy
5345465|NCT01969877|Quality of life|quality of life
5345466|NCT01969877|Human papilloma virus|human papilloma virus
5345467|NCT01969877|Health economy|health economy
5345468|NCT01969877|Biomarker investigations|biomarker investigations
5345469|NCT01969864|Randomized Controlled Trial|randomized controlled trial
5345470|NCT01969864|Healthcare Disparities|healthcare disparities
5345471|NCT01969851|Lacosamide|lacosamide
5345472|NCT01969851|Vimpat|vimpat
5345473|NCT01969851|Epilepsy|epilepsy
5345474|NCT01969851|Children|children
5345475|NCT01969825|Infertility|infertility
5345476|NCT01969825|Intrauterine insemination|intrauterine insemination
5345477|NCT01969825|Male factor infertility|male factor infertility
5345478|NCT01969825|Massage|massage
5345479|NCT01969825|Total motile sperm count|total motile sperm count
5345480|NCT01969812|Infertility|infertility
5345481|NCT01969812|Intrauterine Insemination|intrauterine insemination
5345482|NCT01969812|Slow-release Insemination|slow-release insemination
5345483|NCT01969812|Evie|evie
5345484|NCT01969799|Gram-negative pneumonia|gram-negative pneumonia
5345485|NCT01969799|Aerosol antibiotics|aerosol antibiotics
5345486|NCT01969799|Mechanical ventilation|mechanical ventilation
5345487|NCT01969799|Amikacin|amikacin
5345488|NCT01969799|Fosfomycin|fosfomycin
5345489|NCT01969799|Pneumonia, Bacterial|pneumonia, bacterial
5345490|NCT01969799|Pneumonia|pneumonia
5345491|NCT01969799|Bacterial Infections|bacterial infections
5345492|NCT01969799|Lung Diseases|lung diseases
5345493|NCT01969799|Respiratory Tract Diseases|respiratory tract diseases
5345494|NCT01969799|Respiratory Tract Infections|respiratory tract infections
5345495|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents
5345496|NCT01969799|Anti-Infective Agents|anti-infective agents
5345497|NCT01969799|Therapeutic Uses|therapeutic uses
5345498|NCT01969799|Pharmacologic Actions|pharmacologic actions
5345499|NCT01969773|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
5345500|NCT01969773|Interstitial Cystitis|interstitial cystitis
5345501|NCT01969734|Emphysema|emphysema
5345502|NCT01969734|Moderate COPD|moderate copd
5345503|NCT01969734|Hyperinflation|hyperinflation
5345504|NCT01969734|Endobronchial valves|endobronchial valves
5345506|NCT01969695|Cancer|cancer
5345507|NCT01969695|GDC-0199|gdc-0199
5345508|NCT01969695|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5345509|NCT01969695|Relapsed|relapsed
5345510|NCT01969695|Refractory|refractory
5345511|NCT01969695|Safety|safety
5345512|NCT01969682|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5345513|NCT01969682|GDC-0199|gdc-0199
5345514|NCT01969682|Safety|safety
5345515|NCT01969682|Relapsed|relapsed
5345516|NCT01969682|Refractory|refractory
5345517|NCT01969682|ABT-199|abt-199
5345518|NCT01969682|Pharmacokinetics|pharmacokinetics
5345519|NCT01969682|Cancer|cancer
5345520|NCT01969669|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5345521|NCT01969669|GDC-0199|gdc-0199
5345522|NCT01969669|Safety|safety
5345523|NCT01969669|Relapsed|relapsed
5345542|NCT01969604|Short Text Message Service|short text message service
5345543|NCT01969604|Fatigue|fatigue
5345544|NCT01969604|Pain|pain
5345545|NCT01969604|Self-efficacy|self-efficacy
5345546|NCT01969604|ActivPAL|activpal
5345547|NCT01969591|Fast track surgery, Laparoscopic surgery, colorectal cancer|fast track surgery, laparoscopic surgery, colorectal cancer
5345548|NCT01969578|salivary duct cancer|salivary duct cancer
5345549|NCT01969578|adenocarcinoma, NOS|adenocarcinoma, nos
5345550|NCT01969578|androgen deprivation|androgen deprivation
5345551|NCT01969578|androgen receptor|androgen receptor
5345552|NCT01969552|TSH, thyroid hormones, thyroid tresting, levothyroxine|tsh, thyroid hormones, thyroid tresting, levothyroxine
5345553|NCT01969526|Frail elderly|frail elderly
5345554|NCT01969513|Vestibular Diseases|vestibular diseases
5345555|NCT01969513|Vertigo|vertigo
5345556|NCT01969513|Primary care|primary care
5345557|NCT01969513|Epley maneuver|epley maneuver
5345558|NCT01969500|Schizophrenia|schizophrenia
5345559|NCT01969500|Schizoaffective Disorder|schizoaffective disorder
5345560|NCT01969500|Self Management of Schizophrenia|self management of schizophrenia
5345561|NCT01969500|SOS|sos
5345562|NCT01969500|Serious Mental Illness|serious mental illness
5345563|NCT01969500|Psychosis|psychosis
5345564|NCT01969500|Social Dysfunction|social dysfunction
5345565|NCT01969500|Medication Adherence|medication adherence
5345566|NCT01969500|Mobile Application|mobile application
5345567|NCT01969500|EHealth|ehealth
5345568|NCT01969500|E-Health|e-health
5345569|NCT01969500|Health Technology|health technology
5345570|NCT01969500|mobile health|mobile health
5345571|NCT01969500|m-Health|m-health
5345572|NCT01969500|electronic health|electronic health
5345573|NCT01969474|Tinnitus Cannabis|tinnitus cannabis
5345574|NCT01969461|HIV positive|hiv positive
5345575|NCT01969461|Adolescents|adolescents
5345576|NCT01969461|Adolescent Trials Network|adolescent trials network
5345577|NCT01969461|Comparative Effectiveness Trial|comparative effectiveness trial
5345578|NCT01969461|Implementation|implementation
5345579|NCT01969461|Adherence Intervention|adherence intervention
5345580|NCT01969461|Alcohol Intervention|alcohol intervention
5345581|NCT01969448|Nipple-areola skin sparing mastectomy|nipple-areola skin sparing mastectomy
5345582|NCT01969448|Immediate reconstruction|immediate reconstruction
5345583|NCT01969448|Prophylactic Mastectomy|prophylactic mastectomy
5345584|NCT01969448|Breast-Q|breast-q
5345585|NCT01969448|Breast Cancer|breast cancer
5345586|NCT01969448|Ductal Carcinoma in Situ - Category|ductal carcinoma in situ - category
5345587|NCT01969409|Lung|lung
5345588|NCT01969409|Fibrosis|fibrosis
5345589|NCT01969396|Biopsy|biopsy
5345590|NCT01969396|Endometrial biopsy|endometrial biopsy
5345591|NCT01969396|Endometrial sampling|endometrial sampling
5345592|NCT01969396|sonohysterography|sonohysterography
5345593|NCT01969383|healthy|healthy
5345594|NCT01969370|Cancer|cancer
5345595|NCT01969370|Cardiovascular disease|cardiovascular disease
5345596|NCT01969370|Neurodegenerative disease|neurodegenerative disease
5345597|NCT01969370|Neurodevelopmental disease|neurodevelopmental disease
5345598|NCT01969370|Dysmorphology|dysmorphology
5345599|NCT01969370|Hearing loss|hearing loss
5345600|NCT01969370|Other conditions, including ophthalmic conditions|other conditions, including ophthalmic conditions
5345601|NCT01969357|Sp2086|sp2086
5345602|NCT01969357|Phase II|phase ii
5345603|NCT01969357|monotherapy|monotherapy
5345604|NCT01969331|Gastritis|gastritis
5345605|NCT01969331|Helicobacter pylori|helicobacter pylori
5345606|NCT01969318|SP2086|sp2086
5345607|NCT01969318|Phase II|phase ii
5345608|NCT01969318|combination therapy|combination therapy
5345609|NCT01969305|Kazakhstan|kazakhstan
5345610|NCT01969305|Central Asia|central asia
5345611|NCT01969305|HIV prevention|hiv prevention
5345612|NCT01969305|Adolescents|adolescents
5345613|NCT01969305|Sexual risk behaviors|sexual risk behaviors
5345614|NCT01969305|Drug abuse prevention|drug abuse prevention
5345636|NCT01969240|Patient Centered Outcomes|patient centered outcomes
5345637|NCT01969240|Shared Decision Making|shared decision making
5345638|NCT01969240|Unnecessary hospital admissions|unnecessary hospital admissions
5345639|NCT01969227|Subanesthetic ketamine|subanesthetic ketamine
5345640|NCT01969227|Mechanical ventilation|mechanical ventilation
5345641|NCT01969227|Transpulmonary pressure|transpulmonary pressure
5345642|NCT01969227|Spontaneous breathing trial|spontaneous breathing trial
5345644|NCT01969201|In vitro fertilization (IVF)|in vitro fertilization (ivf)
5345645|NCT01969201|Assisted reproduction technologies (ART)|assisted reproduction technologies (art)
5345646|NCT01969201|GnRH-antagonist|gnrh-antagonist
5345647|NCT01969201|Follicle stimulating hormone (FSH)|follicle stimulating hormone (fsh)
5345648|NCT01969188|spondyloarthritis|spondyloarthritis
5345649|NCT01969188|ankylosing spondylitis|ankylosing spondylitis
5345650|NCT01969188|psoriatic arthritis|psoriatic arthritis
5345651|NCT01969149|Stress Hyperglycemia|stress hyperglycemia
5345652|NCT01969149|Perioperative glycemic control|perioperative glycemic control
5345653|NCT01969149|Cardiac surgery|cardiac surgery
5345654|NCT01969149|Coronary artery bypass surgery|coronary artery bypass surgery
5345655|NCT01969136|Alzheimer's disease|alzheimer's disease
5345656|NCT01969136|Cognition|cognition
5345657|NCT01969136|Alpha-7 nAChR|alpha-7 nachr
5345658|NCT01969123|Alzheimer's disease|alzheimer's disease
5345659|NCT01969123|Cognition|cognition
5345660|NCT01969123|Alpha-7 nAChR|alpha-7 nachr
5345661|NCT01969110|Immunonutrition|immunonutrition
5345662|NCT01969097|Stroke|stroke
5345663|NCT01969097|Hemiparesis|hemiparesis
5345664|NCT01969097|tDCS|tdcs
5345665|NCT01969097|Motor cortex|motor cortex
5345666|NCT01969084|Type II Diabetes Mellitus|type ii diabetes mellitus
5345667|NCT01969084|Diabetes|diabetes
5345668|NCT01969084|Metabolism|metabolism
5345669|NCT01969084|Linagliptin|linagliptin
5345670|NCT01969084|Tradjenta|tradjenta
5345671|NCT01969084|Glucose|glucose
5345672|NCT01969071|levosimendan|levosimendan
5345673|NCT01969071|mitral valve surgery|mitral valve surgery
5345674|NCT01969071|cardiopulmonary bypass|cardiopulmonary bypass
5345675|NCT01969071|serum creatinine|serum creatinine
5345676|NCT01969071|estimated glomerular filtration rate|estimated glomerular filtration rate
5345677|NCT01969071|ejection fraction|ejection fraction
5345678|NCT01969058|Isotretinoin|isotretinoin
5345679|NCT01969058|HIV-1|hiv-1
5345680|NCT01969058|immunology markers|immunology markers
5345681|NCT01969058|immune activation|immune activation
5345682|NCT01969058|viral suppression|viral suppression
5345683|NCT01969045|felxible bronchoscopy|felxible bronchoscopy
5345684|NCT01969045|anaesthetics|anaesthetics
5963602|NCT04221802|Severe asthma, benralizumab, real-world, observational|severe asthma, benralizumab, real-world, observational
5345685|NCT01969045|transcutaneous pCO2|transcutaneous pco2
5345686|NCT01969045|capillary pCO2|capillary pco2
5345687|NCT01969006|inguinal hernia, postoperative pain, localanesthesia, nerve blockage|inguinal hernia, postoperative pain, localanesthesia, nerve blockage
5345688|NCT01968993|Degenerative Disc Disease|degenerative disc disease
5345689|NCT01968980|High Risk of cardiovascular events|high risk of cardiovascular events
5963603|NCT04220216|Cancer|cancer
5230763|NCT02560129|ICU|icu
5345690|NCT01968980|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5345691|NCT01968967|mixed dyslipidemia|mixed dyslipidemia
5345692|NCT01968967|high risk of cardiovascular events|high risk of cardiovascular events
5345693|NCT01968967|multiple cardiovascular disease risk factors|multiple cardiovascular disease risk factors
5345694|NCT01968954|mixed dyslipidemia|mixed dyslipidemia
5341514|NCT01987661|Airtrapping|airtrapping
5345697|NCT01968941|conventional radiotherapy|conventional radiotherapy
5345698|NCT01968941|inoperable patients|inoperable patients
5345700|NCT01968941|cancer recurrence|cancer recurrence
5345701|NCT01968941|toxicity|toxicity
5345702|NCT01968941|survival|survival
5345703|NCT01968928|Bladder urothelial carcinoma (UC)|bladder urothelial carcinoma (uc)
5345704|NCT01968928|pyruvate kinase|pyruvate kinase
5345705|NCT01968928|drug resistance|drug resistance
5345706|NCT01968928|shikonin|shikonin
5345707|NCT01968915|LCL161, Paclitaxel, Japanese patient, Neoplasms|lcl161, paclitaxel, japanese patient, neoplasms
5345708|NCT01968902|spasticity|spasticity
5345709|NCT01968902|lower limb|lower limb
5345710|NCT01968902|multiple sclerosis|multiple sclerosis
5345711|NCT01968902|toxin|toxin
5345712|NCT01968889|Critical illness neuromyopathy|critical illness neuromyopathy
5345713|NCT01968889|Diaphragm dysfunction|diaphragm dysfunction
5345714|NCT01968889|Mechanical ventilation|mechanical ventilation
5345715|NCT01968889|Weaning|weaning
5345716|NCT01968889|Ultrasound|ultrasound
5345717|NCT01968850|osteoporosis|osteoporosis
5345718|NCT01968850|HIV|hiv
5345719|NCT01968850|bone Mineral Density|bone mineral density
5345720|NCT01968850|alendronate|alendronate
5345721|NCT01968850|vitamin D|vitamin d
5345722|NCT01968824|pain|pain
5345723|NCT01968798|ACES|aces
5345724|NCT01968798|ASPREE Cancer Endpoints Study|aspree cancer endpoints study
5345725|NCT01968798|Cancer|cancer
5345726|NCT01968798|Aspirin|aspirin
5345727|NCT01968798|Tumor|tumor
5345728|NCT01968772|Fibromyalgia|fibromyalgia
5345729|NCT01968772|Fibromyalgia Syndrome|fibromyalgia syndrome
5345730|NCT01968772|Magnesium Chloride|magnesium chloride
5345731|NCT01968772|Transdermal Magnesium Chloride|transdermal magnesium chloride
5345732|NCT01968759|Chronic kidney disease|chronic kidney disease
5345734|NCT01968759|Proteinuria|proteinuria
5345735|NCT01968759|Phosphate binders|phosphate binders
5345736|NCT01968746|Sepsis|sepsis
5345737|NCT01968746|Shock|shock
5345738|NCT01968733|Pneumonia|pneumonia
5345739|NCT01968733|CABP|cabp
5345740|NCT01968733|CAP|cap
5345741|NCT01968733|Macrolide|macrolide
5345742|NCT01968707|surgical prep|surgical prep
5345743|NCT01968707|CHG|chg
5345744|NCT01968707|IPA|ipa
5345745|NCT01968694|endometriosis|endometriosis
5345746|NCT01968694|chronic pain|chronic pain
5345747|NCT01968694|intravenous lidocaine|intravenous lidocaine
5345748|NCT01968668|BAY94-8862|bay94-8862
5345749|NCT01968668|MR antagonist|mr antagonist
5345750|NCT01968668|Diabetic nephropathy|diabetic nephropathy
5345752|NCT01968655|Factor VIII Inhibitory Auto-antibodies|factor viii inhibitory auto-antibodies
5345753|NCT01968642|Transthoracic echocardiograms|transthoracic echocardiograms
5345754|NCT01968642|Appropriate Use Criteria|appropriate use criteria
5345755|NCT01968642|Medical Education|medical education
5345756|NCT01968629|Hepatocellular Carcinoma|hepatocellular carcinoma
5345757|NCT01968590|Vitamin D|vitamin d
5345758|NCT01968590|Cholecalciferol|cholecalciferol
5345759|NCT01968590|Bone density|bone density
5345760|NCT01968577|Coronary angioplasty|coronary angioplasty
5345761|NCT01968577|Myocardial infarction|myocardial infarction
5345762|NCT01968551|HIV-1|hiv-1
5345763|NCT01968551|HIV|hiv
5345764|NCT01968551|Treatment-Experienced|treatment-experienced
5345765|NCT01968525|anemia|anemia
5345766|NCT01968525|non-hypoxic apnoea|non-hypoxic apnoea
5345767|NCT01968525|tracheal intubation|tracheal intubation
5345768|NCT01968525|anesthesia|anesthesia
5345769|NCT01968512|Attention Deficit Hyperactivity Disorder (ADHD);|attention deficit hyperactivity disorder (adhd);
5345770|NCT01968512|Transcranial Direct Current Stimulation (tDCS);|transcranial direct current stimulation (tdcs);
5345771|NCT01968512|Control Inhibitory;|control inhibitory;
5345772|NCT01968512|Quantitative electroencephalography;|quantitative electroencephalography;
5345773|NCT01968512|Functional Brain Network;|functional brain network;
5345774|NCT01968512|Go/No Go test.|go/no go test.
5345775|NCT01968499|coronary stent implantation; clopidogrel low response|coronary stent implantation; clopidogrel low response
5345776|NCT01968473|Parkinson's disease|parkinson's disease
5345777|NCT01968473|Freezing of Gait|freezing of gait
5345778|NCT01968473|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5345779|NCT01968473|Comfort|comfort
5345780|NCT01968473|Pain tolerance|pain tolerance
5345781|NCT01968473|Pain|pain
5345782|NCT01968473|Sensory threshold|sensory threshold
5345783|NCT01968473|Motor threshold|motor threshold
5345784|NCT01968473|Pain threshold|pain threshold
5345785|NCT01968460|Parkinson's Disease, Rasagiline, Pramipexole|parkinson's disease, rasagiline, pramipexole
5345786|NCT01968434|cough|cough
5345787|NCT01968434|common cold|common cold
5345788|NCT01968434|antitussive agents|antitussive agents
5963604|NCT04220216|Exercise Test|exercise test
5212900|NCT02664038|AUD|aud
5224830|NCT02594124|ISIS-SMNRx|isis-smnrx
5224831|NCT02594124|ISIS 396443|isis 396443
5224832|NCT02594124|SHINE|shine
5224833|NCT02594124|IONIS-SMNRx|ionis-smnrx
5224834|NCT02594124|IONIS-SMN Rx|ionis-smn rx
5345789|NCT01968434|mucosal protection|mucosal protection
5345790|NCT01968434|medical device|medical device
5341595|NCT01987258|Glycemic control|glycemic control
5345791|NCT01968421|OM-85, bronchiectasis, placebo, acute exacerbation|om-85, bronchiectasis, placebo, acute exacerbation
5345792|NCT01968408|nosocomial diarrhea|nosocomial diarrhea
5345793|NCT01968408|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
5345794|NCT01968408|rotavirus diarrhea|rotavirus diarrhea
5345795|NCT01968408|probiotics|probiotics
5345796|NCT01968382|IMM 124-E|imm 124-e
5345797|NCT01968382|Bovine Colostrum|bovine colostrum
5345798|NCT01968382|Alcoholic|alcoholic
5345799|NCT01968382|Hepatitis|hepatitis
5345800|NCT01968382|LPS|lps
5345801|NCT01968382|Hyper-immune|hyper-immune
5345802|NCT01968369|flow mediated vasodilatation|flow mediated vasodilatation
5345803|NCT01968369|tomato|tomato
5345804|NCT01968369|arterial stiffness|arterial stiffness
5345805|NCT01968369|lycopene|lycopene
5345806|NCT01968356|surgical skin prep|surgical skin prep
5345807|NCT01968356|CHG|chg
5345808|NCT01968356|IPA|ipa
5346216|NCT01966809|gbm tumor|gbm tumor
5345825|NCT01968226|carotid artery disease|carotid artery disease
5345826|NCT01968226|carotid stenosis|carotid stenosis
5345827|NCT01968226|carotid endarterectomy|carotid endarterectomy
5345829|NCT01968226|PET imaging|pet imaging
5345847|NCT01968200|cancer|cancer
5345848|NCT01968200|chemotherapy|chemotherapy
5345849|NCT01968200|anthracyclines|anthracyclines
5345850|NCT01968174|astigmatism|astigmatism
5345851|NCT01968174|lid surgery|lid surgery
5345852|NCT01968174|older than 40 years|older than 40 years
5345853|NCT01968174|can sign an acceptance form|can sign an acceptance form
5345854|NCT01968174|uper lid surgery|uper lid surgery
5345855|NCT01968148|glucose|glucose
5345856|NCT01968148|cardiac arrest|cardiac arrest
5345857|NCT01968148|resuscitation|resuscitation
5345858|NCT01968148|insulin|insulin
5345859|NCT01968148|GLP-1|glp-1
5345860|NCT01968122|symptomatic Intracranial artery stenosis|symptomatic intracranial artery stenosis
5345861|NCT01968122|conventional treatment|conventional treatment
5345862|NCT01968122|stenting|stenting
5345863|NCT01968122|stroke prevention|stroke prevention
5345864|NCT01968122|medical treatment|medical treatment
5345865|NCT01968122|endovascular treatment|endovascular treatment
5345866|NCT01968096|Reflex|reflex
5345867|NCT01968096|Post activation|post activation
5345868|NCT01968096|Spinal cord injury|spinal cord injury
5345869|NCT01968096|Pre-synaptic inhibition|pre-synaptic inhibition
5345870|NCT01968096|Machine driven passive strech|machine driven passive strech
5345871|NCT01968044|renal impairment|renal impairment
5345872|NCT01968031|Parkinson's disease|parkinson's disease
5345873|NCT01968031|Moderate to Severe Parkinson's Disease|moderate to severe parkinson's disease
5345874|NCT01968018|Cancer|cancer
5345875|NCT01968018|Chronic Cancer Pain|chronic cancer pain
5345876|NCT01968018|Tramadol HCI|tramadol hci
5345877|NCT01968018|Acetaminophen|acetaminophen
5345878|NCT01968018|Analgesics|analgesics
5345879|NCT01968018|Pain assessment|pain assessment
5345880|NCT01967992|diabetes|diabetes
5345881|NCT01967992|obesity|obesity
5345882|NCT01967992|mindful eating|mindful eating
5345883|NCT01967992|positive affect|positive affect
5345884|NCT01967992|low carbohydrate|low carbohydrate
5345885|NCT01967992|ketogenic|ketogenic
5345886|NCT01967992|diet|diet
5345887|NCT01967940|HIV-1|hiv-1
5345889|NCT01967940|Treatment-Experienced|treatment-experienced
5345890|NCT01967927|carcinoma|carcinoma
5345891|NCT01967927|cancer|cancer
5345892|NCT01967927|head|head
5345893|NCT01967927|neck|neck
5345894|NCT01967927|otolaryngology|otolaryngology
5345895|NCT01967901|Diabetic nephropathies|diabetic nephropathies
5345896|NCT01967901|Nursing|nursing
5345897|NCT01967901|Multidisciplinary|multidisciplinary
5345898|NCT01967901|Self-care|self-care
5345899|NCT01967901|Quality of Life|quality of life
5345900|NCT01967888|Pancreatic islet auto-transplantation|pancreatic islet auto-transplantation
5345901|NCT01967875|Gastric Cancer|gastric cancer
5345902|NCT01967875|ERCC1|ercc1
5345903|NCT01967875|Platinum|platinum
5345904|NCT01967875|Chemotherapy|chemotherapy
5345905|NCT01967849|obesity|obesity
5345906|NCT01967849|type 2 diabetes|type 2 diabetes
5345907|NCT01967836|Invasive Line|invasive line
5963605|NCT04220216|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5345908|NCT01967836|IV Dressing protection|iv dressing protection
5963606|NCT04220216|Fatigue|fatigue
5963607|NCT04220216|Mood|mood
5963608|NCT04220216|Quality of Life|quality of life
5963609|NCT04220216|Biomarkers|biomarkers
5963610|NCT04220216|Analysis, Survival|analysis, survival
5345909|NCT01967836|Hygiene|hygiene
5345910|NCT01967836|Oncology|oncology
5345915|NCT01967823|Tumor Regression|tumor regression
5345916|NCT01967823|Melanoma|melanoma
5345922|NCT01967797|Obesity|obesity
5345923|NCT01967784|Influenza|influenza
5963611|NCT04217473|oncolytic virus|oncolytic virus
5963612|NCT04217473|T-cell therapy|t-cell therapy
5224926|NCT02593383|safety|safety
5345924|NCT01967784|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5345925|NCT01967771|healthy volunteers|healthy volunteers
5345926|NCT01967771|drug interaction|drug interaction
5345927|NCT01967771|carbamazepine|carbamazepine
5345928|NCT01967771|Dolutegravir|dolutegravir
5345929|NCT01967771|pharmacokinetics|pharmacokinetics
5345930|NCT01967758|Astrocytic Tumors|astrocytic tumors
5345931|NCT01967758|Glioblastoma Multiforme|glioblastoma multiforme
5345932|NCT01967758|Anaplastic Astrocytoma|anaplastic astrocytoma
5345933|NCT01967758|Brain Tumor|brain tumor
5345934|NCT01967758|Brain Cancer|brain cancer
5345935|NCT01967758|Immunotherapy|immunotherapy
5345936|NCT01967745|open appendectomy|open appendectomy
5345937|NCT01967745|laparoscopic appendectomy|laparoscopic appendectomy
5345938|NCT01967745|appendicitis|appendicitis
5345939|NCT01967732|Smoking|smoking
5345940|NCT01967732|Nicotine absorption|nicotine absorption
5671193|NCT00616824|tissue expander|tissue expander
5345941|NCT01967732|Modified risk tobacco product|modified risk tobacco product
5345942|NCT01967732|Conventional cigarette|conventional cigarette
5240738|NCT02499107|food intake|food intake
5345943|NCT01967732|Nicotine replacement therapy|nicotine replacement therapy
5345944|NCT01967732|Nicotine nasal spray|nicotine nasal spray
5345945|NCT01967719|Smoking|smoking
5345946|NCT01967719|Nicotine absorption|nicotine absorption
5345947|NCT01967719|Candidate modified risk tobacco product|candidate modified risk tobacco product
5345948|NCT01967719|Conventional cigarette|conventional cigarette
5345949|NCT01967719|Nicotine replacement therapy: nasal spray|nicotine replacement therapy: nasal spray
5345950|NCT01967706|Smoking|smoking
5345951|NCT01967706|Nicotine absorption|nicotine absorption
5345952|NCT01967706|Candidate modified risk tobacco product|candidate modified risk tobacco product
5345953|NCT01967706|Cigarette|cigarette
5345954|NCT01967706|Nicotine replacement therapy|nicotine replacement therapy
5345955|NCT01967706|Nicotine gum|nicotine gum
5345956|NCT01967693|Laryngeal contact granuloma|laryngeal contact granuloma
5345957|NCT01967693|Treatment type|treatment type
5345958|NCT01967693|Outcome|outcome
5345959|NCT01967641|opioid dependence|opioid dependence
5345960|NCT01967641|opioid abuse|opioid abuse
5345961|NCT01967641|suboxone|suboxone
5345962|NCT01967641|prescription pain medications|prescription pain medications
5345963|NCT01967628|Vitamin D|vitamin d
5345964|NCT01967628|Respiratory infection|respiratory infection
5345965|NCT01967628|Innate immunity|innate immunity
5345966|NCT01967615|PCI,|pci,
5345967|NCT01967615|CTO,|cto,
5345968|NCT01967615|bifurcation,|bifurcation,
5345969|NCT01967615|clopidogrel,|clopidogrel,
5345970|NCT01967615|prasugrel,|prasugrel,
5345971|NCT01967615|ticagrelor|ticagrelor
5345972|NCT01967602|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5345973|NCT01967602|Extracorporeal membrane oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
5345974|NCT01967602|biomarker|biomarker
5345975|NCT01967576|Mutation in SDHB gene|mutation in sdhb gene
5345976|NCT01967576|Mutation in SDHV gene|mutation in sdhv gene
5345977|NCT01967576|Mutation in VHL gene|mutation in vhl gene
5345978|NCT01967576|Pharmacogenomics analyses|pharmacogenomics analyses
5345979|NCT01967576|Germline DNA examination|germline dna examination
5345980|NCT01967563|Energy Expenditure|energy expenditure
5345981|NCT01967563|Obesity|obesity
5345982|NCT01967563|Carbohydrate|carbohydrate
5345984|NCT01967563|Ketones|ketones
5345985|NCT01967550|Symptomatic knee OA Kellgren-Lawrence grade 1-3|symptomatic knee oa kellgren-lawrence grade 1-3
5345986|NCT01967537|NET|net
5345987|NCT01967537|MEN1|men1
5345988|NCT01967537|Von Hippel Lindau (VHL)|von hippel lindau (vhl)
5345989|NCT01967537|Surgical Resection|surgical resection
5345990|NCT01967537|Somatostatin Receptor Status|somatostatin receptor status
5345991|NCT01967524|Myofascial pain|myofascial pain
5345992|NCT01967524|Perineal pain|perineal pain
5345993|NCT01967524|Chronic pelvic pain|chronic pelvic pain
5345994|NCT01967524|Botulinum toxin type A|botulinum toxin type a
5345995|NCT01967524|Ropivacaïne|ropivacaïne
5345996|NCT01967511|Cross-sectional study|cross-sectional study
5345997|NCT01967511|Fibromuscular dysplasia|fibromuscular dysplasia
5345998|NCT01967511|Fibroblast|fibroblast
5345999|NCT01967511|Spontaneous Coronary Artery Dissection|spontaneous coronary artery dissection
5346000|NCT01967511|Cervical Artery Dissection|cervical artery dissection
5346129|NCT01966978|Elevated A1c|elevated a1c
5346001|NCT01967498|chronic otitis media with effusion|chronic otitis media with effusion
5346002|NCT01967498|conductive hearing loss|conductive hearing loss
5346003|NCT01967485|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5346004|NCT01967485|Medication adherence|medication adherence
5346005|NCT01967485|Disease management|disease management
5346006|NCT01967485|Text message|text message
5346007|NCT01967485|ADHD|adhd
5346008|NCT01967485|Children|children
5346009|NCT01967485|Reminder systems|reminder systems
5346010|NCT01967485|Text Messaging|text messaging
5346011|NCT01967485|Telemedicine|telemedicine
5346012|NCT01967433|Fentanyl|fentanyl
5346013|NCT01967433|Midazolam|midazolam
5346014|NCT01967433|Sedation|sedation
5963613|NCT04217473|immunotherapy|immunotherapy
5213067|NCT02663219|PAF|paf
5346015|NCT01967433|Patient tolerance|patient tolerance
5346016|NCT01967433|Duration of colonoscopy|duration of colonoscopy
5346017|NCT01967420|Cognitive remediation|cognitive remediation
5346018|NCT01967420|Social cognition training|social cognition training
5346019|NCT01967420|First episode psychosis|first episode psychosis
5346020|NCT01967420|Schizophrenia|schizophrenia
5346021|NCT01967407|kidney tumor|kidney tumor
5346022|NCT01967407|renal cell cancer|renal cell cancer
5346023|NCT01967407|RCC|rcc
5346024|NCT01967407|irreversible electroporation|irreversible electroporation
5346025|NCT01967407|IRE|ire
5346026|NCT01967407|partial kidney resection|partial kidney resection
5346027|NCT01967407|percutaneous|percutaneous
5346028|NCT01967407|ablation|ablation
5346029|NCT01967407|IRENE|irene
5346030|NCT01967394|Health Care Quality|health care quality
5346031|NCT01967394|Access|access
5346032|NCT01967394|Evaluation|evaluation
5346033|NCT01967368|Influenza vaccine|influenza vaccine
5346034|NCT01967368|intradermal|intradermal
5346035|NCT01967368|intramuscular|intramuscular
5346036|NCT01967368|efficacy|efficacy
5346037|NCT01967368|safety|safety
5346038|NCT01967355|preeclampsia|preeclampsia
5346039|NCT01967355|lipid apheresis|lipid apheresis
5346040|NCT01967355|apheresis|apheresis
5346041|NCT01967342|chronic pain|chronic pain
5346042|NCT01967342|pain|pain
5346043|NCT01967342|chronic pain syndrome|chronic pain syndrome
5346044|NCT01967342|widespread chronic pain|widespread chronic pain
5346045|NCT01967342|back pain|back pain
5346046|NCT01967342|literacy|literacy
5346047|NCT01967342|health literacy|health literacy
5346048|NCT01967342|group therapy|group therapy
5346049|NCT01967342|psychosocial treatment|psychosocial treatment
5423302|NCT01616290|restenosis|restenosis
5346050|NCT01967342|cognitive-behavioral therapy|cognitive-behavioral therapy
5346051|NCT01967342|pain education|pain education
5346052|NCT01967342|health disparities|health disparities
5346053|NCT01967342|patient-centered outcomes|patient-centered outcomes
5346054|NCT01967303|Restless legs syndrome|restless legs syndrome
5346056|NCT01967303|Transient ischemic attack|transient ischemic attack
5346057|NCT01967303|Cerebrovascular risk factors|cerebrovascular risk factors
5346058|NCT01967290|stroke|stroke
5346059|NCT01967290|motor deficits|motor deficits
5346060|NCT01967290|motor rehabilitation|motor rehabilitation
5346061|NCT01967290|neurorehabilitation|neurorehabilitation
5346062|NCT01967290|medical devices|medical devices
5346063|NCT01967290|wearable devices|wearable devices
5346064|NCT01967290|e-health systems|e-health systems
5346065|NCT01967264|Drug therapy|drug therapy
5346066|NCT01967251|Prostatic Hyperplasia|prostatic hyperplasia
5346067|NCT01967251|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
5346068|NCT01967251|Erectile DysfunctionDrug Therapy|erectile dysfunctiondrug therapy
5346069|NCT01967238|immune response|immune response
5346070|NCT01967225|Methicillin Resistant Staphylococcus Aureus,|methicillin resistant staphylococcus aureus,
5346071|NCT01967225|Skin and soft tissue infection,|skin and soft tissue infection,
5346073|NCT01967225|Tedizolid|tedizolid
5346074|NCT01967212|stroke|stroke
5346075|NCT01967212|swallowing training|swallowing training
5346076|NCT01967212|game-based|game-based
5346077|NCT01967212|biofeedback|biofeedback
5346078|NCT01967199|drug-eluting stent|drug-eluting stent
5346079|NCT01967199|drug-coated Balloon|drug-coated balloon
5346080|NCT01967199|recurrent In-Stent restenosis|recurrent in-stent restenosis
5346081|NCT01967186|Type 1 diabetes|type 1 diabetes
5346082|NCT01967186|islets|islets
5346083|NCT01967186|transplantation|transplantation
5346084|NCT01967186|nephropathy|nephropathy
5346085|NCT01967186|intramuscular|intramuscular
5346086|NCT01967173|Asthma|asthma
5346087|NCT01967173|Fluticasone|fluticasone
5346088|NCT01967173|Salmeterol|salmeterol
5346089|NCT01967147|Dry eye|dry eye
5346090|NCT01967147|Lipid deficiency|lipid deficiency
5346091|NCT01967147|Tear film break-up time|tear film break-up time
5346092|NCT01967134|HIV Negative|hiv negative
5346093|NCT01967121|Compex, ice|compex, ice
5346094|NCT01967095|Erlotinib|erlotinib
5346095|NCT01967095|12-278|12-278
5346096|NCT01967095|CNS involvement|cns involvement
5346097|NCT01967056|Muscle strength|muscle strength
5346098|NCT01967056|respiratory failure|respiratory failure
5346099|NCT01967056|extubation failure|extubation failure
5346100|NCT01967056|intensive care unit|intensive care unit
5346101|NCT01967056|outcome prediction|outcome prediction
5346102|NCT01967030|gestational diabetes mellitus|gestational diabetes mellitus
5346103|NCT01967030|breastfeeding|breastfeeding
5346104|NCT01967030|obesity|obesity
5346105|NCT01967030|type 2 diabetes|type 2 diabetes
5346106|NCT01967030|lactation|lactation
5346107|NCT01967030|prospective|prospective
5963614|NCT04216342|Pharmacology|pharmacology
5346108|NCT01967030|women|women
5346109|NCT01967030|postpartum|postpartum
5346110|NCT01967030|incident diabetes|incident diabetes
5346111|NCT01967030|epidemiology|epidemiology
5346112|NCT01967030|metabolomics|metabolomics
5346113|NCT01967017|Intrauterine device|intrauterine device
5346114|NCT01967017|Paracervical block|paracervical block
5346115|NCT01966991|Down syndrome|down syndrome
5213168|NCT02662673|HIFU|hifu
5346116|NCT01966991|prenatal screening|prenatal screening
5346117|NCT01966991|trisomy 21|trisomy 21
5346118|NCT01966991|patient satisfaction|patient satisfaction
5346119|NCT01966978|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5346120|NCT01966978|Insulin|insulin
5346121|NCT01966978|Insulin, Long-Acting|insulin, long-acting
5346122|NCT01966978|Insulin, Short Acting|insulin, short acting
5346123|NCT01966978|Detemir|detemir
5346124|NCT01966978|Liraglutide|liraglutide
5346125|NCT01966978|GLP-1|glp-1
5346126|NCT01966978|Glucagon Like Peptide|glucagon like peptide
5346127|NCT01966978|Metformin|metformin
5346128|NCT01966978|Uncontrolled Diabetes|uncontrolled diabetes
5346130|NCT01966978|Incretins|incretins
5346131|NCT01966965|PIOLIN®, PEDICULOSIS, EFFICACY, SAFETY, PHYTOMEDICINE,|piolin®, pediculosis, efficacy, safety, phytomedicine,
5346132|NCT01966965|ARRUDA, RUTA|arruda, ruta
5346133|NCT01966952|Hypertension|hypertension
5346134|NCT01966939|craniotomy|craniotomy
5346135|NCT01966939|craniectomy|craniectomy
5346136|NCT01966939|temporalis|temporalis
5346138|NCT01966939|mastication|mastication
5346139|NCT01966939|QoL|qol
5346140|NCT01966926|self monitoring|self monitoring
5346141|NCT01966926|self weighing|self weighing
5346142|NCT01966926|weight tracking|weight tracking
5346143|NCT01966926|psychosocial outcomes|psychosocial outcomes
5346144|NCT01966926|feasibility|feasibility
5346145|NCT01966913|Germ Cell Tumors|germ cell tumors
5346146|NCT01966913|Bevacizumab|bevacizumab
5346147|NCT01966913|salvage therapy|salvage therapy
5346148|NCT01966900|Human immunodeficiency disease|human immunodeficiency disease
5346149|NCT01966900|HIV|hiv
5346150|NCT01966900|Vaccine|vaccine
5346151|NCT01966900|CN54gp140|cn54gp140
5346152|NCT01966900|Glucopyranosyl lipid adjuvant|glucopyranosyl lipid adjuvant
5346153|NCT01966900|GLA|gla
5346154|NCT01966900|GLA-AF|gla-af
5346155|NCT01966887|Heart failure|heart failure
5346156|NCT01966887|Gene therapy|gene therapy
5346157|NCT01966887|Serca2a|serca2a
5346158|NCT01966887|Cardiomyopathy|cardiomyopathy
5346159|NCT01966874|Medical abortion|medical abortion
5346160|NCT01966874|Mifepristone|mifepristone
5346161|NCT01966874|Misoprostol|misoprostol
5346162|NCT01966874|Zacafemyl|zacafemyl
5346163|NCT01966874|Mexico|mexico
5346164|NCT01966861|mechanical ventilation|mechanical ventilation
5346165|NCT01966861|weaning|weaning
5346166|NCT01966861|acute respiratory failure|acute respiratory failure
5346167|NCT01966861|weaning failure|weaning failure
5346168|NCT01966861|lung ultrasound|lung ultrasound
5346169|NCT01966848|Knee|knee
5346170|NCT01966848|osteoarthritis|osteoarthritis
5346171|NCT01966848|arthroplasty|arthroplasty
5346172|NCT01966848|tka|tka
5346173|NCT01966848|rsa|rsa
5346174|NCT01966835|sleep quality|sleep quality
5346175|NCT01966835|sleep disturbances|sleep disturbances
5346176|NCT01966835|high intensity aerobic interval training|high intensity aerobic interval training
5346177|NCT01966835|rheumatoid arthritis|rheumatoid arthritis
5346178|NCT01966835|fatigue|fatigue
5346179|NCT01966835|pain|pain
5346180|NCT01966835|polysomnography|polysomnography
5346181|NCT01966835|watt max|watt max
5346182|NCT01966822|Osteoporosis|osteoporosis
5346183|NCT01966822|Bone mineral density|bone mineral density
5346184|NCT01966822|Dual-energy X-ray absorptiometry|dual-energy x-ray absorptiometry
5346185|NCT01966822|HIV infection|hiv infection
5346186|NCT01966822|Dolutegravir|dolutegravir
5346187|NCT01966822|Integrase inhibitor|integrase inhibitor
5346188|NCT01966809|Brain Tumor|brain tumor
5346189|NCT01966809|Photodynamic Therapy|photodynamic therapy
5346190|NCT01966809|Photochemotherapy|photochemotherapy
5346191|NCT01966809|Astrocytoma|astrocytoma
5346192|NCT01966809|Pilocytic Astrocytoma|pilocytic astrocytoma
5346193|NCT01966809|Low grade Astrocytoma|low grade astrocytoma
5346194|NCT01966809|Anaplastic Astrocytoma|anaplastic astrocytoma
5346195|NCT01966809|Glioblastoma|glioblastoma
5346196|NCT01966809|GBM|gbm
5346197|NCT01966809|Chordoma|chordoma
5346198|NCT01966809|Germinoma|germinoma
5346199|NCT01966809|Germ Cell Tumor|germ cell tumor
5346200|NCT01966809|Non-germinoma|non-germinoma
5346201|NCT01966809|CNS Lymphoma|cns lymphoma
5346202|NCT01966809|Craniopharyngioma|craniopharyngioma
5346203|NCT01966809|Mixed Glioma|mixed glioma
5346204|NCT01966809|Optic Nerve Glioma|optic nerve glioma
5963615|NCT04216342|PEPTIDE|peptide
5963616|NCT04216342|ApoA-I|apoa-i
5963617|NCT04216342|Fx-5A|fx-5a
5963618|NCT04216329|Radiotherapy|radiotherapy
5346205|NCT01966809|Meningioma|meningioma
5346206|NCT01966809|Oligodendroglioma|oligodendroglioma
5346207|NCT01966809|Pituitary Tumors|pituitary tumors
5346208|NCT01966809|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
5346209|NCT01966809|DNET|dnet
5346210|NCT01966809|glioblastoma multiforme|glioblastoma multiforme
5346211|NCT01966809|glioma|glioma
5346212|NCT01966809|glioblastoma survivors|glioblastoma survivors
5346213|NCT01966809|what is glioblastoma|what is glioblastoma
5346214|NCT01966809|gbm cancer|gbm cancer
5346215|NCT01966809|oligoastrocytoma|oligoastrocytoma
5963619|NCT04216329|GBM|gbm
5963620|NCT04216329|Gliosarcoma|gliosarcoma
5963621|NCT04216251|Colorectal Adenoma|colorectal adenoma
5346217|NCT01966809|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5346218|NCT01966809|High-Grade Glioma|high-grade glioma
5346219|NCT01966809|high grade glioma|high grade glioma
5346220|NCT01966809|glioblastomas|glioblastomas
5346221|NCT01966809|glioblastoma cancer|glioblastoma cancer
5346222|NCT01966809|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5346223|NCT01966809|astrocytoma glioma|astrocytoma glioma
5346224|NCT01966809|glioblastoma clinical trials|glioblastoma clinical trials
5346225|NCT01966809|photodynamic therapy for cancer|photodynamic therapy for cancer
5346226|NCT01966809|glioblastoma multiforme clinical trials|glioblastoma multiforme clinical trials
5346227|NCT01966809|astrocytoma glioblastoma|astrocytoma glioblastoma
5346228|NCT01966809|gbm grade 4|gbm grade 4
5346229|NCT01966809|clinical trials for glioblastoma|clinical trials for glioblastoma
5346230|NCT01966809|photodynamic therapy cancer|photodynamic therapy cancer
5346231|NCT01966809|clinical trials glioblastoma|clinical trials glioblastoma
5346232|NCT01966809|glioblastoma clinical trials 2015|glioblastoma clinical trials 2015
5346233|NCT01966809|glioblastoma clinical trials 2014 not open in 2014|glioblastoma clinical trials 2014 not open in 2014
5346234|NCT01966809|glioblastoma trials|glioblastoma trials
5346235|NCT01966809|gbm clinical trials|gbm clinical trials
5346236|NCT01966809|glioblastoma immunotherapy|glioblastoma immunotherapy
5346238|NCT01966809|anaplastic astrocytomas|anaplastic astrocytomas
5346239|NCT01966809|immunotherapy for glioblastoma|immunotherapy for glioblastoma
5346240|NCT01966809|immunotherapy glioblastoma|immunotherapy glioblastoma
5346241|NCT01966809|High Grade Glioblastoma Multiforme|high grade glioblastoma multiforme
5346242|NCT01966809|clinical trial glioblastoma|clinical trial glioblastoma
5346243|NCT01966809|glioblastoma clinical trial|glioblastoma clinical trial
5346244|NCT01966809|glioblastoma trial|glioblastoma trial
5346245|NCT01966809|brain tumors|brain tumors
5346246|NCT01966809|recurrent brain tumors|recurrent brain tumors
5346247|NCT01966809|glioma grade 3|glioma grade 3
5346248|NCT01966809|grade 3 brain tumor|grade 3 brain tumor
5346249|NCT01966809|grade 4 brain tumor|grade 4 brain tumor
5346250|NCT01966796|healthcare associated pneumonia|healthcare associated pneumonia
5346252|NCT01966796|pneumonia severity index|pneumonia severity index
5346253|NCT01966757|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
5346255|NCT01966757|Batten's Disease|batten's disease
5346256|NCT01966757|Children's Sleep Habits Questionnaire|children's sleep habits questionnaire
5346257|NCT01966757|Restless Leg Syndrome|restless leg syndrome
5346258|NCT01966731|Africa|africa
5346259|NCT01966718|Rheumatoid arthritis|rheumatoid arthritis
5346260|NCT01966718|Joint pain|joint pain
5346261|NCT01966718|Repository corticotropin injection|repository corticotropin injection
5346262|NCT01966705|severe health anxiety|severe health anxiety
5346263|NCT01966705|somatic symptom disorder|somatic symptom disorder
5346264|NCT01966705|illness anxiety disorder|illness anxiety disorder
5346265|NCT01966705|cognitive behavior therapy|cognitive behavior therapy
5346266|NCT01966705|bibliotherapy|bibliotherapy
5346267|NCT01966705|internet|internet
5346268|NCT01966705|exposure|exposure
5346269|NCT01966692|Bioequivalence|bioequivalence
5346270|NCT01966692|Fluticasone Propionate|fluticasone propionate
5346271|NCT01966666|Alzheimer's disease|alzheimer's disease
5346272|NCT01966666|mild to moderate|mild to moderate
5346273|NCT01966653|nitrofurantoin|nitrofurantoin
5346274|NCT01966653|fosfomycin|fosfomycin
5346275|NCT01966653|urinary tract infection|urinary tract infection
5346276|NCT01966653|clinical efficacy|clinical efficacy
5346277|NCT01966653|bacteriologic response|bacteriologic response
5346278|NCT01966640|diagnosis of allergy|diagnosis of allergy
5346279|NCT01966640|Basophil Activation Test|basophil activation test
5346280|NCT01966627|non alcoholic fatty liver|non alcoholic fatty liver
5346281|NCT01966627|childhood obesity|childhood obesity
5346282|NCT01966627|genetic variants|genetic variants
5346283|NCT01966614|Benign prostatic hyperplasia|benign prostatic hyperplasia
5346284|NCT01966614|BPH|bph
5346285|NCT01966614|Enlarged prostate|enlarged prostate
5346286|NCT01966614|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5346287|NCT01966588|Antipsychotic agents|antipsychotic agents
5346288|NCT01966588|Adverse effects|adverse effects
5346289|NCT01966588|Genomics|genomics
5346290|NCT01966588|Transcriptome|transcriptome
5346291|NCT01966575|Polycystic ovary syndrome|polycystic ovary syndrome
5346292|NCT01966575|Progestin|progestin
5346293|NCT01966575|Endometrial shedding|endometrial shedding
5346294|NCT01966575|Ovulation induction cycles|ovulation induction cycles
5346295|NCT01966575|Clomiphene citrate|clomiphene citrate
5346296|NCT01966575|Clinical pregnancy rate|clinical pregnancy rate
5346297|NCT01966549|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5346298|NCT01966549|Moderate to Severe Chronic Obstructive Pulmonary Disease|moderate to severe chronic obstructive pulmonary disease
5346299|NCT01966549|CNTO 6785|cnto 6785
5346300|NCT01966549|Placebo|placebo
5346301|NCT01966510|cord blood transplant|cord blood transplant
5346302|NCT01966510|advanced lymphoid malignancies|advanced lymphoid malignancies
5346303|NCT01966497|AML|aml
5346304|NCT01966484|Succinylcholine|succinylcholine
5346305|NCT01966484|Mivacurium|mivacurium
5346306|NCT01966484|Rigid Bronchoscopy|rigid bronchoscopy
5963622|NCT04216251|Colorectal Cancer|colorectal cancer
5346307|NCT01966484|Intubating conditions|intubating conditions
5346308|NCT01966484|Short Procedure|short procedure
5346309|NCT01966445|GSK2849330|gsk2849330
5346310|NCT01966445|Oncology|oncology
5346311|NCT01966445|First Time in Human|first time in human
5346313|NCT01966432|Substance abuse|substance abuse
5346314|NCT01966432|Alcohol use|alcohol use
5346315|NCT01966432|Tobacco use|tobacco use
5346316|NCT01966432|Brief intervention|brief intervention
5346317|NCT01966432|Referral to treatment|referral to treatment
5346318|NCT01966419|hepatic encephalopathy|hepatic encephalopathy
5346319|NCT01966419|hyperammonemia|hyperammonemia
5346320|NCT01966419|cirrhosis|cirrhosis
5346321|NCT01966419|ornithine phenylacetate|ornithine phenylacetate
5346322|NCT01966419|OCR-002|ocr-002
5346323|NCT01966406|Pancreaticoduodenectomy|pancreaticoduodenectomy
5346324|NCT01966406|nasogastric tube|nasogastric tube
5346325|NCT01966393|Type 1 diabetes|type 1 diabetes
5346326|NCT01966393|Hypoglycemia|hypoglycemia
5346327|NCT01966393|Insulin|insulin
5346328|NCT01966393|Glucagon|glucagon
5346329|NCT01966393|Closed-loop strategy|closed-loop strategy
5346330|NCT01966393|Artificial pancreas|artificial pancreas
5346331|NCT01966367|Unrelated donor transplant|unrelated donor transplant
5342201|NCT01984294|HCV|hcv
5346332|NCT01966367|Haploidentical donor transplant|haploidentical donor transplant
5346333|NCT01966367|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5346335|NCT01966367|Non-malignant disease|non-malignant disease
5346336|NCT01966367|Bone marrow failure syndrome|bone marrow failure syndrome
5346337|NCT01966367|Severe Aplastic Anemia|severe aplastic anemia
5346338|NCT01966367|Severe Congenital Neutropenia|severe congenital neutropenia
5346339|NCT01966367|Amegakaryocytic Thrombocytopenia|amegakaryocytic thrombocytopenia
5346340|NCT01966367|Diamond-Blackfan Anemia|diamond-blackfan anemia
5346341|NCT01966367|Schwachman Diamond Syndrome|schwachman diamond syndrome
5346342|NCT01966367|Primary Immunodeficiency Syndrome|primary immunodeficiency syndrome
5423303|NCT01616290|vonapanitase|vonapanitase
5346343|NCT01966367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5346345|NCT01966367|Familial Hemophagocytic Lymphocytosis|familial hemophagocytic lymphocytosis
5346346|NCT01966367|Lymphohistiocytosis|lymphohistiocytosis
5346347|NCT01966367|Macrophage Activation Syndrome|macrophage activation syndrome
5346348|NCT01966367|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
5346349|NCT01966367|Hemoglobinopathies|hemoglobinopathies
5346350|NCT01966367|Sickle Cell Disease|sickle cell disease
5346351|NCT01966367|Sickle Cell-beta-thalassemia|sickle cell-beta-thalassemia
5346352|NCT01966354|adult|adult
5346353|NCT01966354|catheterization, central venous|catheterization, central venous
5346354|NCT01966354|ultrasonography, interventional|ultrasonography, interventional
5346355|NCT01966354|evidence-based medicine|evidence-based medicine
5346356|NCT01966354|cost-benefit analysis|cost-benefit analysis
5346357|NCT01966302|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5346358|NCT01966302|prostacyclin|prostacyclin
5346359|NCT01966302|oral|oral
5346360|NCT01966289|Colorectal Neoplasms|colorectal neoplasms
5346361|NCT01966289|Intestinal Neoplasms|intestinal neoplasms
5346362|NCT01966289|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5346363|NCT01966289|Digestive System Neoplasms|digestive system neoplasms
5346364|NCT01966289|Neoplasms by Site|neoplasms by site
5346365|NCT01966289|Neoplasms|neoplasms
5346366|NCT01966289|Digestive System Diseases|digestive system diseases
5346367|NCT01966289|Gastrointestinal Diseases|gastrointestinal diseases
5346368|NCT01966289|Colonic Diseases|colonic diseases
5346369|NCT01966289|Intestinal Diseases|intestinal diseases
5346370|NCT01966289|Rectal Diseases|rectal diseases
5346371|NCT01966276|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
5346372|NCT01966276|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
5346373|NCT01966276|central nervous system (CNS)|central nervous system (cns)
5346374|NCT01966276|fatigue|fatigue
5346375|NCT01966276|alertness|alertness
5346376|NCT01966276|brain fog|brain fog
5346377|NCT01966276|mitochondria|mitochondria
5346378|NCT01966276|methylphenidate|methylphenidate
5346379|NCT01966276|Ritalin|ritalin
5346380|NCT01966276|stimulant|stimulant
5346381|NCT01966276|multivitamin|multivitamin
5346382|NCT01966276|multimineral|multimineral
5346383|NCT01966276|micronutrients|micronutrients
5346384|NCT01966276|supplements|supplements
5346385|NCT01966263|total knee arthroplasty|total knee arthroplasty
5346386|NCT01966263|femoral nerve block|femoral nerve block
5346387|NCT01966263|local infiltration analgesia|local infiltration analgesia
5346388|NCT01966263|fast track|fast track
5346389|NCT01966198|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex|pulse plethysmography, autonomic nervous system, heart rate variability, baro-reflex
5346390|NCT01966185|virtual simulation|virtual simulation
5346391|NCT01966185|temporal bone|temporal bone
5346392|NCT01966185|surgical training|surgical training
5346393|NCT01966185|medical education|medical education
5346394|NCT01966185|self-directed learning|self-directed learning
5346395|NCT01966185|final product assessment|final product assessment
5346396|NCT01966185|cognitive load|cognitive load
5346397|NCT01966185|reaction time|reaction time
5225424|NCT02590744|eye patch|eye patch
5346398|NCT01966185|skills training|skills training
5346399|NCT01966185|simulator metrics|simulator metrics
5346400|NCT01966172|NSAID, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.|nsaid, gabapentin, multimodal, morphine, dexamethasone, cardiac surgery, postoperative pain, analgesia.
5346402|NCT01966133|Randomised controlled trial|randomised controlled trial
5346403|NCT01966133|TACE|tace
5346404|NCT01966133|Resection|resection
5346405|NCT01966120|Photodynamic Therapy|photodynamic therapy
5346406|NCT01966120|Field-directed Treatment|field-directed treatment
5346407|NCT01966068|Asthma|asthma
5346408|NCT01966068|Pediatrics|pediatrics
5346409|NCT01966068|Health Technology|health technology
5346410|NCT01966068|Meaningful Use Stage-3|meaningful use stage-3
5346411|NCT01966068|Web Portal|web portal
5346412|NCT01966042|Refractory angina|refractory angina
5346413|NCT01966042|Cell Therapy|cell therapy
5346414|NCT01966042|Bone Marrow|bone marrow
5346415|NCT01966042|Mononuclear Cells|mononuclear cells
5346416|NCT01966016|LV- Left Ventricular|lv- left ventricular
5346417|NCT01966016|CRT- Cardiac resynchronization therapy|crt- cardiac resynchronization therapy
5342212|NCT01984294|PI|pi
5241263|NCT02496247|Z-score|z-score
5862779|NCT00001515|Computed Tomography (CT)|computed tomography (ct)
5346418|NCT01966016|MSCRT- Multisite Cardiac resynchronization therapy (P-pacemaker; D-defibrillator)|mscrt- multisite cardiac resynchronization therapy (p-pacemaker; d-defibrillator)
5346419|NCT01966016|BBB -bundle branch block|bbb -bundle branch block
5346420|NCT01965990|Enteral nutrition|enteral nutrition
5346421|NCT01965990|very low-calorie diet|very low-calorie diet
5346422|NCT01965990|severe obesity|severe obesity
5346424|NCT01965990|ketosis|ketosis
5346425|NCT01965964|Dysphagia, Swallowing functions, Questionnaire in German|dysphagia, swallowing functions, questionnaire in german
5346426|NCT01965925|Cognition|cognition
5346427|NCT01965925|Sleep problems|sleep problems
5346428|NCT01965925|Bipolar Disorder|bipolar disorder
5346429|NCT01965912|Phenylketonuria|phenylketonuria
5346430|NCT01965912|Kuvan|kuvan
5346431|NCT01965912|Sapropterin dihydrochloride|sapropterin dihydrochloride
5346432|NCT01965886|osteoarthritis|osteoarthritis
5346433|NCT01965886|knee|knee
5346434|NCT01965886|arthroplasty|arthroplasty
5346435|NCT01965886|replacement|replacement
5346436|NCT01965873|Pancreatitis, Acute necrotizing|pancreatitis, acute necrotizing
5346437|NCT01965873|Enteral nutrition|enteral nutrition
5346438|NCT01965873|Fasting|fasting
5346439|NCT01965873|Complications|complications
5346440|NCT01965873|Mortality|mortality
5346441|NCT01965834|Multiple Myeloma|multiple myeloma
5346442|NCT01965834|Fenofibrate|fenofibrate
5346443|NCT01965821|tracheal cuff pressure|tracheal cuff pressure
5346444|NCT01965821|continuous control|continuous control
5346445|NCT01965821|microaspiration|microaspiration
5346446|NCT01965795|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5346447|NCT01965795|Cognitive function|cognitive function
5346448|NCT01965795|Dietary supplement|dietary supplement
5346449|NCT01965795|Coffee plant extract|coffee plant extract
5346450|NCT01965769|Very low birth weight infants|very low birth weight infants
5346451|NCT01965769|premature|premature
5346452|NCT01965769|nutrition|nutrition
5346453|NCT01965769|gastric residual|gastric residual
5346454|NCT01965756|Alzheimer's Disease|alzheimer's disease
5346455|NCT01965756|Vascular Dementia|vascular dementia
5346456|NCT01965756|Dementia|dementia
5346457|NCT01965756|Memory Impairment|memory impairment
5346458|NCT01965743|intrauterine contraception (IUC)|intrauterine contraception (iuc)
5346459|NCT01965743|social networks|social networks
5346460|NCT01965743|social influence|social influence
5346461|NCT01965743|diffusion of innovation|diffusion of innovation
5346462|NCT01965743|intrauterine device (IUD)|intrauterine device (iud)
5346463|NCT01965743|LARC|larc
5346464|NCT01965730|dilated ascending aorta|dilated ascending aorta
5346465|NCT01965717|endoleak|endoleak
5346466|NCT01965717|MMP- 9|mmp- 9
5346467|NCT01965717|biomarker|biomarker
5346468|NCT01965704|Narcotic addiction during pregnancy|narcotic addiction during pregnancy
5346469|NCT01965704|Neonatal abstinence syndrome|neonatal abstinence syndrome
5346471|NCT01965691|Phenylketonuria|phenylketonuria
5346472|NCT01965691|PKU|pku
5346473|NCT01965691|Phenylalanine metabolism|phenylalanine metabolism
5346474|NCT01965691|Protein requirements|protein requirements
5346475|NCT01965691|Indicator Amino acid Oxidation|indicator amino acid oxidation
5346476|NCT01965691|Stable isotopes|stable isotopes
5346477|NCT01965678|Osteopathic manipulative treatment|osteopathic manipulative treatment
5346478|NCT01965678|muscle-skeletal disorder|muscle-skeletal disorder
5346479|NCT01965678|quality of life|quality of life
5346480|NCT01965665|Diabetes|diabetes
5346481|NCT01965665|Surgical Intervention|surgical intervention
5346482|NCT01965665|Honey|honey
5346483|NCT01965652|Opioid Induced Constipation|opioid induced constipation
5346484|NCT01965639|Diabetes Mellitus Type 2|diabetes mellitus type 2
5346485|NCT01965639|Standard of care|standard of care
5346486|NCT01965639|Quality of life|quality of life
5346487|NCT01965639|Disease management|disease management
5346488|NCT01965626|Oseltamivir|oseltamivir
5963623|NCT04216251|colonoscopic Surgery|colonoscopic surgery
5225516|NCT02590263|Glioblastoma|glioblastoma
5346489|NCT01965626|Dexamethasone|dexamethasone
5346490|NCT01965626|ITP|itp
5346491|NCT01965613|Pyoderma Gangrenosum|pyoderma gangrenosum
5346492|NCT01965600|Endotoxin challenge|endotoxin challenge
5346493|NCT01965587|novasure|novasure
5346494|NCT01965587|Mirena IUS|mirena ius
5346495|NCT01965587|menorrhagia|menorrhagia
5346496|NCT01965587|pelvic pain|pelvic pain
5346497|NCT01965587|ashermanns|ashermanns
5346498|NCT01965574|ARDS - FLUID LOADING - PRELOAD DEPENDENCE|ards - fluid loading - preload dependence
5346499|NCT01965548|spleen|spleen
5346500|NCT01965548|injury|injury
5346501|NCT01965548|patient transfer|patient transfer
5346502|NCT01965548|splenectomy|splenectomy
5346503|NCT01965548|embolization, theurapeutic|embolization, theurapeutic
5346504|NCT01965535|Hepatitis C|hepatitis c
5346506|NCT01965535|Cirrhosis|cirrhosis
5346507|NCT01965522|Breast cancer|breast cancer
5346508|NCT01965522|melatonin|melatonin
5346509|NCT01965522|vitamin d|vitamin d
5346510|NCT01965522|ki67|ki67
5346511|NCT01965509|PEX168|pex168
5346512|NCT01965509|Phase I/II|phase i/ii
5346513|NCT01965509|add on to metformin|add on to metformin
5346514|NCT01965496|PEX168|pex168
5346515|NCT01965496|Phase I|phase i
5346516|NCT01965496|titration|titration
5346517|NCT01965483|radiotherapy|radiotherapy
5346518|NCT01965483|adjuvant|adjuvant
5346519|NCT01965483|weekly hypofractionation|weekly hypofractionation
5346527|NCT01965405|Nicotine Dependence|nicotine dependence
5346528|NCT01965405|Smoking|smoking
5346529|NCT01965405|Smoking cessation|smoking cessation
5346530|NCT01965405|Contingency Management|contingency management
5346531|NCT01965379|Dialysis|dialysis
5346532|NCT01965379|Phosphorus|phosphorus
5346533|NCT01965379|Diet|diet
5346534|NCT01965366|Dexamethasone|dexamethasone
5346535|NCT01965366|Virtual Reality|virtual reality
5346536|NCT01965366|Military|military
5346537|NCT01965366|PTSD|ptsd
5346538|NCT01965353|Relapsed Multiple Myeloma|relapsed multiple myeloma
5346539|NCT01965353|Relapse-Refractory Multiple Myeloma|relapse-refractory multiple myeloma
5346540|NCT01965340|patients|patients
5346541|NCT01965327|Friedreich ataxia|friedreich ataxia
5346542|NCT01965327|Interferon gamma-1b|interferon gamma-1b
5346543|NCT01965327|FRDA|frda
5346544|NCT01965314|ultrasound guided regional anaesthesia|ultrasound guided regional anaesthesia
5346545|NCT01965314|upper limb surgery|upper limb surgery
5346546|NCT01965314|ultrasound guided axillary brachial plexus blockade|ultrasound guided axillary brachial plexus blockade
5346547|NCT01965275|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5346548|NCT01965275|High-dose|high-dose
5346549|NCT01965275|Pulsatile|pulsatile
5346550|NCT01965275|EGFR-TKIs|egfr-tkis
5346551|NCT01965249|Laparotomy|laparotomy
5346552|NCT01965249|short stitch|short stitch
5346553|NCT01965249|long stitch|long stitch
5346554|NCT01965249|MonoMax|monomax
5346555|NCT01965236|hypertension, sodium intake, left ventricular function|hypertension, sodium intake, left ventricular function
5346556|NCT01965223|Oligometastatic|oligometastatic
5346557|NCT01965223|Neoplasia|neoplasia
5346558|NCT01965223|Radiosurgery|radiosurgery
5346559|NCT01965223|Stereotactic Ablative Body Radiotherapy|stereotactic ablative body radiotherapy
5346560|NCT01965223|SABR|sabr
5346561|NCT01965223|Metastases to the Lung|metastases to the lung
5346562|NCT01965223|Non Haematological|non haematological
5346563|NCT01965210|Rye|rye
5346564|NCT01965210|Fermentable dietary fibre|fermentable dietary fibre
5346565|NCT01965210|Inulin|inulin
5346566|NCT01965210|Plant protein|plant protein
5346567|NCT01965210|Gluten|gluten
5346568|NCT01965210|Porridge|porridge
5346569|NCT01965210|Bread|bread
5346570|NCT01965210|Appetite|appetite
5346571|NCT01965210|Satiety|satiety
5346572|NCT01965210|Hunger|hunger
5346573|NCT01965210|Desire to eat|desire to eat
5346574|NCT01965210|Metabolism|metabolism
5346575|NCT01965210|Glucose|glucose
5346576|NCT01965210|Insulin|insulin
5346577|NCT01965210|Gut hormones|gut hormones
5346578|NCT01965210|Metabolomics|metabolomics
5346579|NCT01965210|Gastric emptying rate|gastric emptying rate
5346580|NCT01965210|Breath hydrogen and methane excretion|breath hydrogen and methane excretion
5346581|NCT01965184|child|child
5346582|NCT01965184|cognitive behavioral therapy|cognitive behavioral therapy
5346583|NCT01965184|CBT|cbt
5346584|NCT01965184|aggression|aggression
5346585|NCT01965184|disruptive behavior|disruptive behavior
5346586|NCT01965184|treatment|treatment
5346587|NCT01965184|frustrative non-reward|frustrative non-reward
5346588|NCT01965184|irritability|irritability
5346589|NCT01965171|hematologic malignancy|hematologic malignancy
5346590|NCT01965171|iron overload|iron overload
5963624|NCT04216251|Endoscopic Surgery|endoscopic surgery
5346591|NCT01965171|magnetic resonance imaging|magnetic resonance imaging
5346592|NCT01965171|childhood cancer survivors|childhood cancer survivors
5346593|NCT01965158|Opioid-induced Constipation|opioid-induced constipation
5346594|NCT01965132|Rheumatiod Arhthritis|rheumatiod arhthritis
5346595|NCT01965132|Ankylosing spondylitis|ankylosing spondylitis
5346596|NCT01965132|Psoriatic arthritis|psoriatic arthritis
5346597|NCT01965132|Biologic agents|biologic agents
5213668|NCT02659852|stent in stent|stent in stent
5346598|NCT01965132|Cohort studies|cohort studies
5346599|NCT01965106|Glaucoma, Angle-Closure|glaucoma, angle-closure
5346600|NCT01965106|Glaucoma, Closed-Angle|glaucoma, closed-angle
5346601|NCT01965106|Primary angle closure|primary angle closure
5346602|NCT01965106|Acute angle closure|acute angle closure
5346603|NCT01965106|Acute angle-closure glaucoma|acute angle-closure glaucoma
5346604|NCT01965093|perioperative|perioperative
5346605|NCT01965093|desaturation|desaturation
5346606|NCT01965093|growth development|growth development
5346607|NCT01965093|intelligence outcome|intelligence outcome
5346608|NCT01965080|Endometrial cancer|endometrial cancer
5346609|NCT01965054|Intrahepatic cholestasis of pregnancy|intrahepatic cholestasis of pregnancy
5346610|NCT01965054|fish oil|fish oil
5346611|NCT01965054|omega-3|omega-3
5346612|NCT01965054|Docosahexaenoic acid,|docosahexaenoic acid,
5346613|NCT01965054|eicosapentaenoic acid|eicosapentaenoic acid
5346614|NCT01965041|AVA Study|ava study
5346615|NCT01965028|tinnitus|tinnitus
5346616|NCT01965028|transcranial random noise stimulation|transcranial random noise stimulation
5346618|NCT01965028|auditory cortex|auditory cortex
5346619|NCT01965028|non-invasive brain stimulation|non-invasive brain stimulation
5241461|NCT02495103|Safety|safety
5346620|NCT01965015|Heart Failure (HF)|heart failure (hf)
5346621|NCT01965015|Left Atrial Pressure|left atrial pressure
5346622|NCT01964989|Influenza|influenza
5346623|NCT01964989|children|children
5346624|NCT01964950|drug therapy|drug therapy
5346625|NCT01964911|Martorell ulcer|martorell ulcer
5346626|NCT01964911|Hypertensive leg ulcer|hypertensive leg ulcer
5346627|NCT01964911|Pain|pain
5346628|NCT01964911|Continuous nerve block|continuous nerve block
5346629|NCT01964911|Ropivacaïne|ropivacaïne
5346630|NCT01964911|Local anesthesic|local anesthesic
5346631|NCT01964898|Smoking|smoking
5346632|NCT01964898|Mood Management|mood management
5346633|NCT01964898|Depression|depression
5346634|NCT01964898|Behavioral Activation|behavioral activation
5346635|NCT01964898|Acute Coronary Syndrome|acute coronary syndrome
5346636|NCT01964898|Myocardial Infarction|myocardial infarction
5346637|NCT01964872|Healthy volunteers|healthy volunteers
5346638|NCT01964872|JNJ-38877618|jnj-38877618
5346639|NCT01964872|Pharmacokinetic|pharmacokinetic
5346640|NCT01964872|Safety|safety
5346641|NCT01964872|Single-ascending dose|single-ascending dose
5346642|NCT01964872|Multiple-ascending dose|multiple-ascending dose
5346643|NCT01964859|healthy skin|healthy skin
5346644|NCT01964859|wounds and injuries|wounds and injuries
5346645|NCT01964859|prosthetics|prosthetics
5346646|NCT01964859|amputations|amputations
5346647|NCT01964859|dermal fibroblasts|dermal fibroblasts
5346648|NCT01964846|inflammation|inflammation
5346649|NCT01964846|high fat meal|high fat meal
5346650|NCT01964846|resveratrol|resveratrol
5346651|NCT01964846|curcumin|curcumin
5346653|NCT01964833|clinical trial|clinical trial
5346654|NCT01964833|DMT2|dmt2
5346655|NCT01964833|periodontitis|periodontitis
5346657|NCT01964807|Cardiovascular|cardiovascular
5346658|NCT01964807|tobacco|tobacco
5346659|NCT01964807|cigarettes|cigarettes
5346660|NCT01964807|secondhand cigarette smoke|secondhand cigarette smoke
5346661|NCT01964807|SHS|shs
5346662|NCT01964807|smokeless tobacco|smokeless tobacco
5346663|NCT01964807|chewing tobacco|chewing tobacco
5346664|NCT01964807|snus|snus
5346665|NCT01964807|electronic cigarettes|electronic cigarettes
5346666|NCT01964807|vapor|vapor
5346667|NCT01964807|particles|particles
5346668|NCT01964807|oxidative stress|oxidative stress
5346669|NCT01964807|flow-mediated dilation|flow-mediated dilation
5346670|NCT01964807|FMD|fmd
5346671|NCT01964794|Warfarin|warfarin
5346672|NCT01964781|Administration, topical|administration, topical
5346673|NCT01964781|tranexamic acid|tranexamic acid
5346674|NCT01964781|adrenaline|adrenaline
5346675|NCT01964781|bupivacaine|bupivacaine
5346676|NCT01964781|surgery|surgery
5346677|NCT01964755|EBV+|ebv+
5346678|NCT01964755|NHL|nhl
5346679|NCT01964755|HL|hl
5346680|NCT01964755|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5346681|NCT01964755|Hodgkin's Lymphoma|hodgkin's lymphoma
5346682|NCT01964755|Epstein Barr Virus|epstein barr virus
5346683|NCT01964755|Epstein Barr Virus Associated Non Hodgkin's Lymphoma|epstein barr virus associated non hodgkin's lymphoma
5346684|NCT01964755|Epstein Barr Virus Associated Hodgkin's Lymphoma|epstein barr virus associated hodgkin's lymphoma
5346685|NCT01964755|Post-Transplant Lymphoproliferative Disease|post-transplant lymphoproliferative disease
5346686|NCT01964729|rTMS|rtms
5346687|NCT01964729|Pain threshold|pain threshold
5346688|NCT01964729|Neuromodulation|neuromodulation
5346689|NCT01964729|Myofascial|myofascial
5346690|NCT01964716|Prevenar 13|prevenar 13
5346691|NCT01964716|13vPnC|13vpnc
5346692|NCT01964716|Healthy Subjects|healthy subjects
5346693|NCT01964690|Lactate|lactate
5346694|NCT01964690|Sepsis|sepsis
5963625|NCT04216251|Eicosapentaenoic acid|eicosapentaenoic acid
5963626|NCT04216251|Gastrointestinal Microbiome|gastrointestinal microbiome
5963627|NCT04216251|Mucosal Tissue|mucosal tissue
5346695|NCT01964690|Capillary lactate|capillary lactate
5963628|NCT04215276|valsalva maneuver|valsalva maneuver
5963629|NCT04215276|control|control
5963630|NCT04215276|pain|pain
5963631|NCT04215276|spinal injection|spinal injection
5346696|NCT01964690|Venous lactate|venous lactate
5346697|NCT01964690|Quick test|quick test
5346698|NCT01964677|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5346699|NCT01964677|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
5346705|NCT01964664|Locked-in Syndrome|locked-in syndrome
5346707|NCT01964651|JNJ-42165279|jnj-42165279
5346708|NCT01964651|Pharmacokinetics|pharmacokinetics
5346709|NCT01964651|Elderly|elderly
5346710|NCT01964651|Young|young
5346711|NCT01964638|Prostate Cancer|prostate cancer
5346712|NCT01964638|Prostate Biopsy|prostate biopsy
5346713|NCT01964638|Targeted Biopsy|targeted biopsy
5346714|NCT01964625|Chronic GvHD|chronic gvhd
5346715|NCT01964599|Fiber|fiber
5346716|NCT01964599|Gastrointestinal|gastrointestinal
5346717|NCT01964586|Septoplasty, Dexmedetomidine, Surgical Conditions|septoplasty, dexmedetomidine, surgical conditions
5346718|NCT01964573|Parkinson's Disease|parkinson's disease
5346719|NCT01964573|Rotigotine|rotigotine
5346720|NCT01964573|Pharmacokinetics|pharmacokinetics
5346721|NCT01964573|Healthy subjects|healthy subjects
5346722|NCT01964560|Lacosamide|lacosamide
5346724|NCT01964560|UCB|ucb
5346725|NCT01964560|Epilepsy|epilepsy
5346726|NCT01964560|Partial Onset Seizures|partial onset seizures
5346727|NCT01964560|Pediatric|pediatric
5346728|NCT01964547|Cognition|cognition
5346729|NCT01964547|Mood|mood
5346730|NCT01964534|Metastatic|metastatic
5346731|NCT01964534|Pancreatic|pancreatic
5346732|NCT01964534|Cancer|cancer
5346733|NCT01964534|Pancreas|pancreas
5346734|NCT01964534|GERCOR|gercor
5346735|NCT01964534|Gemcitabine|gemcitabine
5346736|NCT01964534|LV5FU2|lv5fu2
5346737|NCT01964534|ABI-007|abi-007
5346738|NCT01964534|PACLITAXEL ALBUMIN-BOUND PARTICLES|paclitaxel albumin-bound particles
5346739|NCT01964482|Hospitalization|hospitalization
5346740|NCT01964482|Older|older
5346741|NCT01964482|Medical patient|medical patient
5346742|NCT01964482|Strength training|strength training
5346743|NCT01964456|Bodily self-consciousness|bodily self-consciousness
5346744|NCT01964456|intersubjective body|intersubjective body
5346745|NCT01964456|Anorexia Nervosa|anorexia nervosa
5346746|NCT01964456|Joint perception task|joint perception task
5346747|NCT01964456|Interoceptive awareness|interoceptive awareness
5346748|NCT01964443|Plaque Psoriasis|plaque psoriasis
5346750|NCT01964443|Quality of life|quality of life
5346751|NCT01964430|Resectable pancreatic cancer|resectable pancreatic cancer
5346752|NCT01964430|resected|resected
5346753|NCT01964430|resectable PDA|resectable pda
5346754|NCT01964430|adenocarcinoma|adenocarcinoma
5346755|NCT01964430|surgically resected|surgically resected
5346756|NCT01964430|adjuvant|adjuvant
5346757|NCT01964430|Abraxane|abraxane
5346758|NCT01964430|nab-paclitaxel|nab-paclitaxel
5346759|NCT01964430|ABI-007|abi-007
5346760|NCT01964430|gemcitabine|gemcitabine
5346761|NCT01964430|Gemzar|gemzar
5346762|NCT01964430|Phase 3|phase 3
5346763|NCT01964417|BOWEL PREPARATION|bowel preparation
5346764|NCT01964417|PEG|peg
5346765|NCT01964417|Low-volume PEG Plus Ascorbic Acid|low-volume peg plus ascorbic acid
5346766|NCT01964404|Dronabinol|dronabinol
5346767|NCT01964404|Schizophrenia|schizophrenia
5346768|NCT01964404|Dual Diagnosis|dual diagnosis
5346769|NCT01964404|Substance Abuse|substance abuse
5346770|NCT01964404|Cannabis Use Disorder|cannabis use disorder
5346776|NCT01964326|atorvastatin|atorvastatin
5346777|NCT01964326|Hypercholesterolemia|hypercholesterolemia
5346778|NCT01964313|Acute coronary syndrome|acute coronary syndrome
5346779|NCT01964313|treatment strategy|treatment strategy
5346780|NCT01964313|genetics|genetics
5346781|NCT01964274|Nursing Delirium Screening Scale,|nursing delirium screening scale,
5346782|NCT01964274|Acetylcholinesterase Activity|acetylcholinesterase activity
5346783|NCT01964261|Neural|neural
5346784|NCT01964261|Prosthetic|prosthetic
5346785|NCT01964261|Brain machine interface|brain machine interface
5346786|NCT01964261|brain computer interface|brain computer interface
5346787|NCT01964261|brain control|brain control
5346788|NCT01964261|paralysis|paralysis
5346789|NCT01964261|tetraplegia|tetraplegia
5346790|NCT01964261|quadriplegia|quadriplegia
5346791|NCT01964261|spinal cord injury|spinal cord injury
5346792|NCT01964261|stimulation|stimulation
5346793|NCT01964261|sensory feedback|sensory feedback
5346794|NCT01964248|Blood gas analysis|blood gas analysis
5346795|NCT01964248|Arterial puncture|arterial puncture
5346796|NCT01964248|Local anesthesia|local anesthesia
5346797|NCT01964248|Eutectic mixture|eutectic mixture
5346798|NCT01964248|Lidocaïne/prilocaïne cream (5%)|lidocaïne/prilocaïne cream (5%)
5346799|NCT01964248|Placebo|placebo
5346800|NCT01964248|Pain Intensity Scale|pain intensity scale
5346801|NCT01964248|Numerical Rating Scale|numerical rating scale
5346901|NCT01963832|eCIMT|ecimt
5346902|NCT01963832|Central Nervous System|central nervous system
5346802|NCT01964235|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation.|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation.
5346803|NCT01964222|Cancer|cancer
5346804|NCT01964222|Clinical trials|clinical trials
5346805|NCT01964222|Informed consent|informed consent
5346806|NCT01964222|Health literacy|health literacy
5346807|NCT01964209|ADHD|adhd
5346808|NCT01964209|Validation|validation
5346809|NCT01964209|Quality Improvement|quality improvement
5346810|NCT01964209|Vanderbilt|vanderbilt
5346811|NCT01964209|Conners 3rd Edition|conners 3rd edition
5346812|NCT01964209|ADHD Measures|adhd measures
5346813|NCT01964209|ADHD Adolescent|adhd adolescent
5346814|NCT01964209|ADHD Questionnaire|adhd questionnaire
5346816|NCT01964209|Integrated Clinical Information Sharing System|integrated clinical information sharing system
5346817|NCT01964196|Chronic Renal Failure|chronic renal failure
5346818|NCT01964196|Renal anemia|renal anemia
5346819|NCT01964196|ASP1517|asp1517
5346820|NCT01964183|Open-label design|open-label design
5346821|NCT01964183|Pharmacokinetics|pharmacokinetics
5346822|NCT01964183|Drug-Drug Interaction|drug-drug interaction
5346823|NCT01964183|Mirabegron|mirabegron
5346824|NCT01964170|ASP3550|asp3550
5346825|NCT01964170|Prostate cancer|prostate cancer
5241660|NCT02494089|clinical audit|clinical audit
5346826|NCT01964157|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5346827|NCT01964144|thyroid cancer, dovitinib|thyroid cancer, dovitinib
5346828|NCT01964131|Bioequivalence|bioequivalence
5346829|NCT01964131|pharmacodynamics|pharmacodynamics
5346830|NCT01964131|pharmacokinetics|pharmacokinetics
5346832|NCT01964131|tolerability|tolerability
5346833|NCT01964131|D961H|d961h
5346835|NCT01964118|intermittent fasting|intermittent fasting
5346836|NCT01964118|obesity|obesity
5346837|NCT01964118|calorie restriction|calorie restriction
5346838|NCT01964105|Hypomastia|hypomastia
5346839|NCT01964105|Augmentation|augmentation
5346840|NCT01964105|Breast|breast
5346841|NCT01964105|3D|3d
5346842|NCT01964105|Breast Q|breast q
5346843|NCT01964092|Disability|disability
5346844|NCT01964092|Individual placement and support|individual placement and support
5346845|NCT01964092|Mental health|mental health
5346846|NCT01964092|Quality of life|quality of life
5346847|NCT01964092|Randomized controlled trial|randomized controlled trial
5346848|NCT01964092|Rehabilitation|rehabilitation
5346849|NCT01964092|Return to work|return to work
5346850|NCT01964092|Supported employment|supported employment
5346851|NCT01964066|therapeutic ERCP|therapeutic ercp
5346852|NCT01964066|prevention of post-ERCP pancreatitis|prevention of post-ercp pancreatitis
5346853|NCT01964066|thoracic epidural analgesia|thoracic epidural analgesia
5346854|NCT01964053|Self-management adherence|self-management adherence
5346855|NCT01964053|post acute care|post acute care
5346856|NCT01964053|critical access hospitals|critical access hospitals
5346857|NCT01964053|patient activation|patient activation
5346858|NCT01964053|hospital readmission|hospital readmission
5346859|NCT01964040|femoral nerve block|femoral nerve block
5346860|NCT01964040|peri-neural dexmedetomidine|peri-neural dexmedetomidine
5346861|NCT01964027|second line chemoregime|second line chemoregime
5346862|NCT01964027|gastric cancer|gastric cancer
5346864|NCT01963988|Bladder Pain Syndrome|bladder pain syndrome
5346865|NCT01963988|Transurethral Resection of Ulcer|transurethral resection of ulcer
5346866|NCT01963988|Transurethral Coagulation of Ulcer|transurethral coagulation of ulcer
5346867|NCT01963962|Emergency contraception|emergency contraception
5346868|NCT01963962|Levonorgestrel IUD|levonorgestrel iud
5346869|NCT01963962|Copper IUD|copper iud
5346870|NCT01963962|Oral Levonorgestrel|oral levonorgestrel
5346871|NCT01963936|Infant newborn|infant newborn
5346872|NCT01963936|Laryngeal mask airway|laryngeal mask airway
5346873|NCT01963936|Positive pressure ventilation|positive pressure ventilation
5346874|NCT01963936|Resuscitation|resuscitation
5346875|NCT01963923|Pulmonary Rehabilitation|pulmonary rehabilitation
5346876|NCT01963923|Lung Cancer Resection|lung cancer resection
5346877|NCT01963923|Video-assisted thoracic surgery|video-assisted thoracic surgery
5346878|NCT01963923|Exercise tolerance|exercise tolerance
5346879|NCT01963923|Quality of life|quality of life
5346880|NCT01963910|Mannitol|mannitol
5346881|NCT01963910|TRPV1 receptor|trpv1 receptor
5346882|NCT01963910|Pain|pain
5346883|NCT01963910|Burning pain|burning pain
5346884|NCT01963910|neuropathy|neuropathy
5346885|NCT01963910|neuropathic pain|neuropathic pain
5346886|NCT01963897|Genotype/phenotype correlations|genotype/phenotype correlations
5346887|NCT01963897|Growth|growth
5346888|NCT01963897|Bone health|bone health
5346889|NCT01963897|Puberty|puberty
5346890|NCT01963897|Quality of life|quality of life
5346891|NCT01963884|Extraction Sockets|extraction sockets
5346892|NCT01963884|Ridge dimensions|ridge dimensions
5346893|NCT01963884|Dental Alveolar Anatomy|dental alveolar anatomy
5346894|NCT01963884|Dental Implants|dental implants
5346895|NCT01963884|Bone Physiology|bone physiology
5346896|NCT01963871|chronic low back pain|chronic low back pain
5346897|NCT01963871|low back pain|low back pain
5346898|NCT01963871|yoga|yoga
5346899|NCT01963832|stroke|stroke
5346900|NCT01963832|Fluoxetine (FLX)|fluoxetine (flx)
5346903|NCT01963793|Pruritus|pruritus
5346904|NCT01963780|lung transplantation|lung transplantation
5346905|NCT01963780|lung preservation|lung preservation
5346906|NCT01963780|breathing lung transplant|breathing lung transplant
5346907|NCT01963767|memory|memory
5346908|NCT01963767|cognition|cognition
5346909|NCT01963767|dietary supplements|dietary supplements
5225895|NCT02587858|NBIA|nbia
5346910|NCT01963754|Articaine 1:100.000|articaine 1:100.000
5346911|NCT01963754|Dental Implants|dental implants
5346912|NCT01963754|Posterior mandible|posterior mandible
5346913|NCT01963754|Loco-regional Anesthesia|loco-regional anesthesia
5346914|NCT01963754|Subperiosteal Anesthesia|subperiosteal anesthesia
5346915|NCT01963741|Leukotriene D4|leukotriene d4
5346916|NCT01963741|allergic rhinitis|allergic rhinitis
5346917|NCT01963741|nasal airway resistance|nasal airway resistance
5346918|NCT01963741|nasal provocation test|nasal provocation test
5346919|NCT01963741|nasal hyperreactivity|nasal hyperreactivity
5346920|NCT01963741|airway inflammation|airway inflammation
5346921|NCT01963741|asthma|asthma
5346922|NCT01963728|post-transplant|post-transplant
5346923|NCT01963728|diabetes mellitus|diabetes mellitus
5346924|NCT01963728|renal transplant|renal transplant
5346925|NCT01963728|kidney transplant|kidney transplant
5346926|NCT01963728|lung transplant|lung transplant
5346927|NCT01963728|heart transplant|heart transplant
5346928|NCT01963728|insulin|insulin
5346929|NCT01963715|IMGN289|imgn289
5346930|NCT01963715|Antibody Drug Conjugate|antibody drug conjugate
5346931|NCT01963715|antibody|antibody
5346932|NCT01963715|EGFR|egfr
5346933|NCT01963715|NSCLC|nsclc
5346934|NCT01963715|SCCHN|scchn
5346935|NCT01963715|Head and neck|head and neck
5346937|NCT01963715|Solid tumor|solid tumor
5346938|NCT01963715|Immunogen|immunogen
5346939|NCT01963715|Lung|lung
5346940|NCT01963715|Phase 1|phase 1
5346941|NCT01963702|predictive factor|predictive factor
5346942|NCT01963702|response|response
5346943|NCT01963702|gastric neoplasm|gastric neoplasm
5346944|NCT01963702|oxaliplatin|oxaliplatin
5346945|NCT01963702|docetaxol|docetaxol
5346946|NCT01963702|capecitabine|capecitabine
5346947|NCT01963689|Anxiety|anxiety
5346948|NCT01963689|Self-Esteem|self-esteem
5346949|NCT01963676|schizophrenia|schizophrenia
5346950|NCT01963676|auditory hallucinations|auditory hallucinations
5346951|NCT01963676|transcranial stimulation|transcranial stimulation
5346952|NCT01963676|tDCS|tdcs
5346953|NCT01963676|tACS|tacs
5346954|NCT01963663|YKL-40|ykl-40
5346955|NCT01963663|Chronic low grade inflammation|chronic low grade inflammation
5346956|NCT01963663|type 2 diabetes mellitus|type 2 diabetes mellitus
5346957|NCT01963663|metformin|metformin
5346958|NCT01963663|pioglitazone|pioglitazone
5346959|NCT01963637|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain|obesity, sleeve gastrectomy, gastric bypass, gastric tomodensitometry, gastric pouch size, weight regain
5346960|NCT01963624|Breast|breast
5346961|NCT01963624|Screening|screening
5346962|NCT01963624|Ultrasound|ultrasound
5346963|NCT01963624|Elastography|elastography
5346964|NCT01963624|Doppler ultrasonography|doppler ultrasonography
5346965|NCT01963611|Multiple Sclerosis|multiple sclerosis
5346966|NCT01963611|Relapsing Remitting|relapsing remitting
5346967|NCT01963611|Plovamer acetate|plovamer acetate
5346969|NCT01963585|C reactive protein|c reactive protein
5346970|NCT01963585|Airway hyperreactivity|airway hyperreactivity
5346971|NCT01963585|Body mass index|body mass index
5346972|NCT01963572|Breast cancer|breast cancer
5346973|NCT01963572|Care model|care model
5346974|NCT01963572|Physical Therapy|physical therapy
5346975|NCT01963546|diabetic|diabetic
5346976|NCT01963546|laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
5346977|NCT01963546|stress response|stress response
5346978|NCT01963546|anesthesia|anesthesia
5346979|NCT01963546|dexmedetomidine|dexmedetomidine
5346980|NCT01963533|lung cancer|lung cancer
5346981|NCT01963533|telomere length|telomere length
5346982|NCT01963533|comorbidity|comorbidity
5346983|NCT01963533|Eastern Cooperation Oncology Group (ECOG)|eastern cooperation oncology group (ecog)
5346984|NCT01963533|chemotherapy|chemotherapy
5346985|NCT01963520|Hip prosthesis infection|hip prosthesis infection
5346986|NCT01963520|Reinfection|reinfection
5346987|NCT01963520|Excision-synovectomy|excision-synovectomy
5346988|NCT01963520|One stage/two stage revision|one stage/two stage revision
5346989|NCT01963520|Antibiotherapy|antibiotherapy
5346990|NCT01963494|Physical activity|physical activity
5346991|NCT01963494|Health-behavior-change|health-behavior-change
5346992|NCT01963494|Dyadic Planning|dyadic planning
5346993|NCT01963494|Individual Planning|individual planning
5346994|NCT01963481|hormonal therapy|hormonal therapy
5346995|NCT01963481|immunotherapy|immunotherapy
5346996|NCT01963468|Hearing Loss|hearing loss
5346997|NCT01963468|Cochlear Implant|cochlear implant
5346998|NCT01963468|Deaf|deaf
5346999|NCT01963468|Hearing Impairment|hearing impairment
5347000|NCT01963468|Hard of Hearing|hard of hearing
5347001|NCT01963455|transplantation autologous stress urinary incontinence|transplantation autologous stress urinary incontinence
5347002|NCT01963455|muscle derived cells|muscle derived cells
5347003|NCT01963429|hepatocellular|hepatocellular
5963632|NCT04215263|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5347004|NCT01963429|Proton|proton
5347006|NCT01963403|etonogestrel implant|etonogestrel implant
5347007|NCT01963403|birth control|birth control
5347008|NCT01963403|irregular bleeding|irregular bleeding
5347009|NCT01963403|heavy bleeding|heavy bleeding
5347010|NCT01963390|Hypogonadism|hypogonadism
5347011|NCT01963390|Testosterone Deficiency|testosterone deficiency
5347012|NCT01963377|bronchoscopy|bronchoscopy
5347013|NCT01963377|O2-supplementation|o2-supplementation
5347014|NCT01963364|fructans|fructans
5347015|NCT01963364|inulin|inulin
5347016|NCT01963364|oligofructose|oligofructose
5347017|NCT01963364|colonic fermentation|colonic fermentation
5347018|NCT01963364|microbiota|microbiota
5347019|NCT01963364|whoe gut transit|whoe gut transit
5347020|NCT01963351|NSCLC|nsclc
5347021|NCT01963351|Non-squamous|non-squamous
5347022|NCT01963286|ICD|icd
5347023|NCT01963286|CRT-D|crt-d
5347024|NCT01963286|Sudden cardiac death|sudden cardiac death
5347025|NCT01963286|Device settings|device settings
5347026|NCT01963286|Optimized programming strategy|optimized programming strategy
5347027|NCT01963221|elderly|elderly
5347028|NCT01963221|aorta|aorta
5347029|NCT01963221|inflammation|inflammation
5347030|NCT01963221|arterial stiffness|arterial stiffness
5347031|NCT01963221|PET/CT Imaging|pet/ct imaging
5347032|NCT01963221|hypertension|hypertension
5347033|NCT01963221|MRI|mri
5347034|NCT01963208|partial onset seizures|partial onset seizures
5347035|NCT01963208|complex partial seizures|complex partial seizures
5347036|NCT01963208|simple partial seizures|simple partial seizures
5347037|NCT01963208|anticonvulsant|anticonvulsant
5347038|NCT01963208|ganaxolone|ganaxolone
5347039|NCT01963208|neurosteroid|neurosteroid
5347040|NCT01963208|Marinus|marinus
5347041|NCT01963208|epilepsy|epilepsy
5347042|NCT01963195|Adverse Reaction to Drug|adverse reaction to drug
5347043|NCT01963195|Self Efficacy|self efficacy
5347044|NCT01963169|Bone Health|bone health
5347045|NCT01963169|Online intervention|online intervention
5347046|NCT01963169|Dissemination|dissemination
5347047|NCT01963169|Theory-based intervention|theory-based intervention
5347048|NCT01963156|Prescription synchronization|prescription synchronization
5347049|NCT01963156|Cardiovascular disease|cardiovascular disease
5347050|NCT01963156|Medication adherence|medication adherence
5347051|NCT01963156|Randomized controlled trial|randomized controlled trial
5347052|NCT01963156|Chronic disease|chronic disease
5347053|NCT01963156|Pharmacy benefit design|pharmacy benefit design
5347058|NCT01963104|hearing test, audiology, healthcare utilization,|hearing test, audiology, healthcare utilization,
5347059|NCT01963104|patient education, hearing screening|patient education, hearing screening
5347060|NCT01963065|Children's environmental health|children's environmental health
5347061|NCT01963065|Preterm birth|preterm birth
5347062|NCT01963065|Newborns|newborns
5347063|NCT01963065|Bisphenol A|bisphenol a
5347064|NCT01963065|BPA|bpa
5347065|NCT01963065|Phthalates|phthalates
5347066|NCT01963065|Metals exposure|metals exposure
5347067|NCT01963065|Very low birth weight|very low birth weight
5347069|NCT01963065|Stress|stress
5347070|NCT01963052|Metastatic Urothelial Cancer|metastatic urothelial cancer
5347071|NCT01963052|AGS15E|ags15e
5347072|NCT01963052|AGS15E-13-1|ags15e-13-1
5347073|NCT01963052|ASG-15ME|asg-15me
5347074|NCT01963052|Pharmacokinetics of AGS15E|pharmacokinetics of ags15e
5347075|NCT01963026|spinal cord injury|spinal cord injury
5347076|NCT01963026|upper extremity|upper extremity
5347077|NCT01963026|skill performance|skill performance
5347078|NCT01963026|motor learning|motor learning
5347079|NCT01963013|Non-returning catheter valve|non-returning catheter valve
5347080|NCT01963013|Catheter associated urinary tract infection|catheter associated urinary tract infection
5347081|NCT01963013|Critically ill patients|critically ill patients
5347082|NCT01963013|Prevention|prevention
5347083|NCT01963000|Community Acquired Pneumonia|community acquired pneumonia
5347084|NCT01963000|Emergency Department|emergency department
5347085|NCT01963000|Standardized Care|standardized care
5347086|NCT01963000|Reduced Mortality|reduced mortality
5347087|NCT01963000|CRB-65 Risk Classes|crb-65 risk classes
5347088|NCT01963000|Antibiotic Therapy|antibiotic therapy
5347089|NCT01962974|Arthritis, Rheumatoid|arthritis, rheumatoid
5347090|NCT01962961|HIV|hiv
5347091|NCT01962961|Endothelial function|endothelial function
5347092|NCT01962961|Oxidative stress|oxidative stress
5347093|NCT01962961|Cardiovascular disease|cardiovascular disease
5347094|NCT01962961|N-acetylcysteine|n-acetylcysteine
5347095|NCT01962935|Healthy volunteer|healthy volunteer
5347096|NCT01962935|Multiple ascending dose|multiple ascending dose
5347097|NCT01962909|Pancreatic Resection|pancreatic resection
5347098|NCT01962883|Post Concussion Syndrome|post concussion syndrome
5347099|NCT01962883|Vestibular disturbance|vestibular disturbance
5347100|NCT01962883|Balance|balance
5347101|NCT01962883|Dizziness|dizziness
5347284|NCT01962415|Inflammatory Bowel Disease|inflammatory bowel disease
5347102|NCT01962883|Dizziness handicap inventory|dizziness handicap inventory
5347103|NCT01962883|Balance Error Scoring System|balance error scoring system
5347104|NCT01962857|Physical activity|physical activity
5347105|NCT01962857|Exercise|exercise
5347106|NCT01962857|Insulin resistance|insulin resistance
5347107|NCT01962857|High intensity interval training|high intensity interval training
5347108|NCT01962857|Fat oxidation|fat oxidation
5963633|NCT04215263|geriatrics|geriatrics
5963634|NCT04215263|general anaesthesia|general anaesthesia
5347110|NCT01962857|Lipids|lipids
5347111|NCT01962857|Blood pressure|blood pressure
5347112|NCT01962844|chronic coronary artery disease|chronic coronary artery disease
5347113|NCT01962844|coconut oil extra virgin|coconut oil extra virgin
5347114|NCT01962844|index of diet quality|index of diet quality
5347115|NCT01962844|nutritional treatment|nutritional treatment
5347116|NCT01962831|obesity|obesity
5347117|NCT01962831|labor, induced|labor, induced
5347118|NCT01962831|pregnancy|pregnancy
5347119|NCT01962831|cervical ripening|cervical ripening
5347120|NCT01962831|dinoprostone|dinoprostone
5347121|NCT01962818|Respiratory Distress Syndrome In Premature Infants|respiratory distress syndrome in premature infants
5347122|NCT01962818|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5347123|NCT01962818|Ventilator-Induced Lung Injury|ventilator-induced lung injury
5347124|NCT01962818|Functional Residual Capacity|functional residual capacity
5347125|NCT01962818|Electric impedance tomography|electric impedance tomography
5347126|NCT01962792|PCI-32765|pci-32765
5347127|NCT01962792|Multiple Myeloma|multiple myeloma
5347128|NCT01962792|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5347129|NCT01962792|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5347130|NCT01962792|Carfilzomib|carfilzomib
5347131|NCT01962792|Dexamethasone|dexamethasone
5347132|NCT01962792|Ibrutinib|ibrutinib
5347133|NCT01962779|Sleep Disordered Breathing|sleep disordered breathing
5347134|NCT01962779|Cognitively normal elderly|cognitively normal elderly
5347135|NCT01962779|Alzheimer's disease|alzheimer's disease
5347136|NCT01962779|Prevention|prevention
5347137|NCT01962779|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5347138|NCT01962753|Affective symptoms as prodromal stage of Alzheimer|affective symptoms as prodromal stage of alzheimer
5347139|NCT01962727|scapular dyskinesis, kinematics, muscular activities|scapular dyskinesis, kinematics, muscular activities
5347144|NCT01962701|C-section|c-section
5347145|NCT01962688|Heart Failure|heart failure
5347146|NCT01962688|Handheld ultrasound|handheld ultrasound
5347147|NCT01962688|Inferior Vena Cava|inferior vena cava
5347149|NCT01962675|motor training|motor training
5347151|NCT01962662|stroke|stroke
5347152|NCT01962662|transcranial magnetic stimulation|transcranial magnetic stimulation
5347153|NCT01962662|EMG biofeedback|emg biofeedback
5347154|NCT01962662|motor function|motor function
5347155|NCT01962662|neural plasticity|neural plasticity
5347156|NCT01962662|force|force
5347157|NCT01962649|Hepatocellular carcinoma|hepatocellular carcinoma
5347158|NCT01962636|Umbilical Cord Transplant|umbilical cord transplant
5347159|NCT01962636|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5347160|NCT01962636|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5347161|NCT01962636|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5347162|NCT01962636|Plasma Cell Leukemia|plasma cell leukemia
5347163|NCT01962636|Myelofibrosis|myelofibrosis
5347164|NCT01962636|Myelodysplasia|myelodysplasia
5347165|NCT01962636|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5347166|NCT01962636|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5347167|NCT01962636|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
5347168|NCT01962636|Follicular Lymphoma|follicular lymphoma
5347169|NCT01962636|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5347170|NCT01962636|Mantle-Cell Lymphoma|mantle-cell lymphoma
5347171|NCT01962636|Prolymphocytic Leukemia|prolymphocytic leukemia
5347172|NCT01962636|Large Cell Non-Hodgkin Lymphoma|large cell non-hodgkin lymphoma
5347173|NCT01962636|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5347174|NCT01962636|Burkitt's Lymphoma|burkitt's lymphoma
5347175|NCT01962636|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5347176|NCT01962636|Multiple Myeloma|multiple myeloma
5347177|NCT01962623|Severe Mood Dysregulation|severe mood dysregulation
5347178|NCT01962623|Mood Disorders|mood disorders
5347179|NCT01962623|Irritability|irritability
5347180|NCT01962623|Disruptive Mood Dysregulation Disorder|disruptive mood dysregulation disorder
5347181|NCT01962623|Interpersonal Psychotherapy|interpersonal psychotherapy
5347182|NCT01962610|Pain care|pain care
5347183|NCT01962610|emergency|emergency
5347184|NCT01962610|clinical decision support|clinical decision support
5347185|NCT01962610|abdominal pain|abdominal pain
5347186|NCT01962597|hemodialysis|hemodialysis
5347187|NCT01962597|aerobic exercise|aerobic exercise
5347188|NCT01962597|resistance training|resistance training
5347189|NCT01962597|walking speed|walking speed
5347190|NCT01962597|randomized controlled trial|randomized controlled trial
5347191|NCT01962571|Optic neuritis|optic neuritis
5347192|NCT01962571|Multiple Sclerosis|multiple sclerosis
5347193|NCT01962571|Clinically isolated syndrome|clinically isolated syndrome
5347194|NCT01962571|Erythropoietin|erythropoietin
5347195|NCT01962558|Tinnitus|tinnitus
5347196|NCT01962558|Medical Device|medical device
5347197|NCT01962558|Randomized|randomized
5347198|NCT01962558|Vagus Nerve Stimulation|vagus nerve stimulation
5347199|NCT01962545|Atrial Fibrillation|atrial fibrillation
5347200|NCT01962545|Percutaneous coronary intervention|percutaneous coronary intervention
5347201|NCT01962545|Stent|stent
5347202|NCT01962545|Anticoagulant therapy|anticoagulant therapy
5347203|NCT01962545|Antiplatelet therapy|antiplatelet therapy
5347204|NCT01962545|Warfarin|warfarin
5347205|NCT01962545|NOAC|noac
5347206|NCT01962545|Aspirin|aspirin
5347207|NCT01962545|Clopidogrel|clopidogrel
5347208|NCT01962532|Neoplasms|neoplasms
5347209|NCT01962532|Lymphoma|lymphoma
5347210|NCT01962532|Advanced or refractory solid tumors|advanced or refractory solid tumors
5347211|NCT01962532|Advanced or refractory lymphoma|advanced or refractory lymphoma
5347212|NCT01962532|Gastric adenocarcinoma|gastric adenocarcinoma
5347213|NCT01962532|Gastroesophageal junctions|gastroesophageal junctions
5347214|NCT01962532|JNJ-42756493|jnj-42756493
5347215|NCT01962532|Pharmacokinetics|pharmacokinetics
5347216|NCT01962532|Japanese|japanese
5347217|NCT01962532|Asian|asian
5347218|NCT01962532|Pharmacodynamics|pharmacodynamics
5347219|NCT01962519|gastrectomy|gastrectomy
5229948|NCT02564926|DM|dm
5347220|NCT01962519|gastric cancer|gastric cancer
5347221|NCT01962519|oral feeding|oral feeding
5347222|NCT01962519|complications|complications
5347223|NCT01962506|Chest pain|chest pain
5347224|NCT01962506|Copeptin|copeptin
5347225|NCT01962506|High-sensitivity cardiac troponin|high-sensitivity cardiac troponin
5347226|NCT01962506|Non-ST-Elevation (NSTE) - ACS|non-st-elevation (nste) - acs
5347227|NCT01962467|Allergic rhinitis|allergic rhinitis
5347228|NCT01962467|healthy volunteers|healthy volunteers
5347229|NCT01962467|fluticasone furoate|fluticasone furoate
5347230|NCT01962467|levocabastine|levocabastine
5347231|NCT01962467|fixed dose combination|fixed dose combination
5347232|NCT01962467|pharmacokinetics|pharmacokinetics
5347233|NCT01962454|muscle mass|muscle mass
5347234|NCT01962454|dynamic proteomics|dynamic proteomics
5347235|NCT01962454|Duke University|duke university
5347236|NCT01962454|Microbiopsy|microbiopsy
5347238|NCT01962454|testosterone|testosterone
5347239|NCT01962454|skeletal muscle|skeletal muscle
5347240|NCT01962441|7977|7977
5347241|NCT01962441|GS-7977|gs-7977
5347242|NCT01962441|PSI-7977|psi-7977
5347243|NCT01962441|Sofosbuvir (SOF)|sofosbuvir (sof)
5347244|NCT01962441|Pegylated Interferon (Peg-IFN)|pegylated interferon (peg-ifn)
5347245|NCT01962441|Ribavirin (RBV)|ribavirin (rbv)
5347246|NCT01962428|ticagrelor|ticagrelor
5347247|NCT01962428|loading dose|loading dose
5347248|NCT01962428|non-ST-segment elevation acute coronary syndromes|non-st-segment elevation acute coronary syndromes
5347249|NCT01962428|percutaneous coronary intervention|percutaneous coronary intervention
5347250|NCT01962428|the antiplatelet effects|the antiplatelet effects
5347251|NCT01962428|bleeding events|bleeding events
5347252|NCT01962428|major adverse cardiac events|major adverse cardiac events
5347253|NCT01962415|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
5347254|NCT01962415|Omenn Syndrome|omenn syndrome
5347255|NCT01962415|Bare Lymphocyte Syndrome (BLS)|bare lymphocyte syndrome (bls)
5347256|NCT01962415|Combined Immune Deficiency (CID) syndromes|combined immune deficiency (cid) syndromes
5347257|NCT01962415|Combined Variable Immune Deficiency (CVID) syndrome|combined variable immune deficiency (cvid) syndrome
5347258|NCT01962415|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5347259|NCT01962415|Leukocyte adhesion deficiency|leukocyte adhesion deficiency
5347260|NCT01962415|Chronic granulomatous disease (CGD)|chronic granulomatous disease (cgd)
5347261|NCT01962415|X-linked Hyper IgM (XHIM) syndrome|x-linked hyper igm (xhim) syndrome
5347262|NCT01962415|IPEX syndrome|ipex syndrome
5347263|NCT01962415|Chediak - Higashi Syndrome|chediak - higashi syndrome
5347264|NCT01962415|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
5347265|NCT01962415|Hemophagocytic Lymphohistiocytosis (HLH) syndromes|hemophagocytic lymphohistiocytosis (hlh) syndromes
5347266|NCT01962415|Lymphocyte Signaling defects|lymphocyte signaling defects
5347267|NCT01962415|Dyskeratosis Congenita (DC)|dyskeratosis congenita (dc)
5347268|NCT01962415|Congenital Amegakaryocytic Thrombocytopenia (CAMT)|congenital amegakaryocytic thrombocytopenia (camt)
5347269|NCT01962415|Osteopetrosis|osteopetrosis
5347270|NCT01962415|Mucopolysaccharidoses|mucopolysaccharidoses
5347271|NCT01962415|Hurler syndrome (MPS I)|hurler syndrome (mps i)
5347272|NCT01962415|Hunter syndrome (MPS II)|hunter syndrome (mps ii)
5347273|NCT01962415|Sanfilippo syndrome (MPS II)|sanfilippo syndrome (mps ii)
5347274|NCT01962415|Leukodystrophies|leukodystrophies
5347275|NCT01962415|Krabbe Disease|krabbe disease
5347276|NCT01962415|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5347277|NCT01962415|X-linked adrenoleukodystrophy (ALD)|x-linked adrenoleukodystrophy (ald)
5347278|NCT01962415|Alpha mannosidosis|alpha mannosidosis
5347279|NCT01962415|Gaucher Disease|gaucher disease
5347280|NCT01962415|Thalassemia major|thalassemia major
5347281|NCT01962415|Sickle cell disease (SCD)|sickle cell disease (scd)
5347282|NCT01962415|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
5347283|NCT01962415|Crohn's Disease|crohn's disease
5347285|NCT01962415|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5347286|NCT01962415|Congenital transfusion dependent anemias|congenital transfusion dependent anemias
5347287|NCT01962415|Globoid cell leukodystrophy|globoid cell leukodystrophy
5347288|NCT01962415|Hereditary diffuse leukoencephalopathy with spheroids (HDLS)|hereditary diffuse leukoencephalopathy with spheroids (hdls)
5347289|NCT01962389|ISR, Laser, SFA, PAD|isr, laser, sfa, pad
5963635|NCT04214509|genetic Parkinson's disease|genetic parkinson's disease
5963636|NCT04214509|LRRK2|lrrk2
5963637|NCT04213495|Anesthesia|anesthesia
5226284|NCT02585362|palliative|palliative
5347290|NCT01962376|Capecitabine|capecitabine
5347291|NCT01962376|Oxaliplatin|oxaliplatin
5347292|NCT01962376|Bevacizumab|bevacizumab
5347293|NCT01962376|Potentially Resectable Gastric Cancer Liver Metastasis|potentially resectable gastric cancer liver metastasis
5347294|NCT01962363|Friedreich's ataxia point mutation|friedreich's ataxia point mutation
5347295|NCT01962350|Deep Brain Transcranial Magnetic Stimulation;|deep brain transcranial magnetic stimulation;
5347296|NCT01962350|H1-Coil deep brain rTMS;|h1-coil deep brain rtms;
5347298|NCT01962350|Bipolar Depression;|bipolar depression;
5347299|NCT01962350|Cognition.|cognition.
5347300|NCT01962324|Quality of Life|quality of life
5347301|NCT01962324|Radiotherapy|radiotherapy
5347302|NCT01962324|Radiotherapy, dose-escalation|radiotherapy, dose-escalation
5347303|NCT01962311|ALS|als
5347304|NCT01962311|Spinal Cerebrospinal Fluid|spinal cerebrospinal fluid
5347305|NCT01962311|Urine|urine
5347306|NCT01962311|SERUM|serum
5347307|NCT01962311|Diagnosis|diagnosis
5347308|NCT01962285|neuronal inertia|neuronal inertia
5347309|NCT01962285|loss of consciousness|loss of consciousness
5347310|NCT01962285|propofol pharmacodynamics|propofol pharmacodynamics
5347311|NCT01962285|Bispectral index|bispectral index
5347312|NCT01962285|anesthesia, general/pharmacology|anesthesia, general/pharmacology
5347313|NCT01962272|cancer|cancer
5347314|NCT01962272|radiotherapy|radiotherapy
5347315|NCT01962272|chemotherapy|chemotherapy
5347316|NCT01962272|nutrition|nutrition
5347317|NCT01962272|dietary counseling|dietary counseling
5347318|NCT01962272|quality of life|quality of life
5347319|NCT01962246|Capecitabine|capecitabine
5347320|NCT01962246|Oxaliplatin|oxaliplatin
5347331|NCT01962207|Adolescents|adolescents
5347332|NCT01962207|Adults|adults
5347333|NCT01962207|Immunogenicity|immunogenicity
5347334|NCT01962207|Mencevax ACWY|mencevax acwy
5347335|NCT01962181|EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning|eeg attention deficit / hyperactivity disorder (adhd) ritalin machine learning
5347336|NCT01962168|Biliary Tract Neoplasms|biliary tract neoplasms
5347337|NCT01962168|Neoplasms|neoplasms
5347338|NCT01962168|Gastrointestinal Diseases|gastrointestinal diseases
5347339|NCT01962168|Digestive System Diseases|digestive system diseases
5347340|NCT01962168|Biliary Tract|biliary tract
5347341|NCT01962168|Stents|stents
5347343|NCT01962155|Liver Cirrhosis|liver cirrhosis
5347344|NCT01962155|non-invasive|non-invasive
5347345|NCT01962155|biopsy|biopsy
5347346|NCT01962155|hepatitis B virus|hepatitis b virus
5347347|NCT01962103|Neuroblastoma|neuroblastoma
5347348|NCT01962103|Rhabdomyosarcoma|rhabdomyosarcoma
5347349|NCT01962103|Soft Tissue|soft tissue
5347350|NCT01962103|Pediatric Oncology|pediatric oncology
5347351|NCT01962103|Abraxane|abraxane
5347352|NCT01962103|albumin-bound paclitaxel|albumin-bound paclitaxel
5347353|NCT01962103|nab-paclitaxel|nab-paclitaxel
5347354|NCT01962103|ABI-007|abi-007
5347355|NCT01962103|taxane|taxane
5347356|NCT01962103|solid tumors|solid tumors
5347357|NCT01962090|Neck Pain|neck pain
5347358|NCT01962090|Thoracic spine thrust manipulation|thoracic spine thrust manipulation
5347359|NCT01962090|Osteopathic Manipulation|osteopathic manipulation
5347360|NCT01962090|Dentistry|dentistry
5347361|NCT01962090|Range of Motion|range of motion
5347362|NCT01962077|pulpotomy|pulpotomy
5347363|NCT01962077|MTA|mta
5347364|NCT01962077|primary teeth|primary teeth
5347365|NCT01962077|formocresol|formocresol
5347366|NCT01962038|Mild Cognitive Impairment|mild cognitive impairment
5347367|NCT01962038|Aging|aging
5347368|NCT01962025|Renal failure|renal failure
5347369|NCT01962025|Hemodialysis|hemodialysis
5347370|NCT01962025|Canulation technique|canulation technique
5347371|NCT01962025|Training time|training time
5347372|NCT01962025|Cost|cost
5347373|NCT01962025|Patient discomfort with cannulation technique|patient discomfort with cannulation technique
5347374|NCT01962012|Orthodontic|orthodontic
5347375|NCT01962012|Orthodontic Treatment|orthodontic treatment
5347376|NCT01962012|Accelerated Tooth Movement|accelerated tooth movement
5347377|NCT01962012|Malocclusion|malocclusion
5347378|NCT01962012|Device|device
5347379|NCT01962012|AcceleDent Aura|acceledent aura
5347380|NCT01962012|Clear Aligners|clear aligners
5347381|NCT01961999|Acute kidney injury|acute kidney injury
5347382|NCT01961999|Cardiac surgery|cardiac surgery
5347383|NCT01961999|Renal replacement therapy|renal replacement therapy
5347384|NCT01961986|Rotator Cuff|rotator cuff
5347385|NCT01961986|Rotator Cuff Sparing|rotator cuff sparing
5347386|NCT01961986|Shoulder Replacement|shoulder replacement
5347387|NCT01961986|Total Shoulder Replacement|total shoulder replacement
5347388|NCT01961986|Total Shoulder Arthroplasty|total shoulder arthroplasty
5347389|NCT01961986|Arthritis|arthritis
5347390|NCT01961973|Articular cartilage|articular cartilage
5347391|NCT01961973|Chondrocytes|chondrocytes
5347392|NCT01961973|BMAC|bmac
5347393|NCT01961960|ASP7374|asp7374
5347394|NCT01961960|Prevention of seasonal influenza|prevention of seasonal influenza
5347395|NCT01961947|ASP7374|asp7374
5347396|NCT01961947|Approved egg-derived vaccine|approved egg-derived vaccine
5963638|NCT04213495|Practice|practice
5963639|NCT04213495|Czech Republic|czech republic
5302082|NCT02166047|HBV|hbv
5347397|NCT01961947|Prevention of seasonal influenza|prevention of seasonal influenza
5347398|NCT01961934|glioblastoma|glioblastoma
5347399|NCT01961934|high grade brain tumors|high grade brain tumors
5347400|NCT01961934|recurrent|recurrent
5347401|NCT01961934|pseudo-progression|pseudo-progression
5347402|NCT01961934|radionecrosis|radionecrosis
5347403|NCT01961934|carbon acetate|carbon acetate
5347404|NCT01961934|C11 aceate|c11 aceate
5347405|NCT01961934|PET|pet
5347406|NCT01961934|positron emission tomography|positron emission tomography
5347407|NCT01961921|RNAi therapeutic|rnai therapeutic
5347408|NCT01961895|Continuous lumbar plexus (LP) block analgesia|continuous lumbar plexus (lp) block analgesia
5347409|NCT01961882|OCV-501|ocv-501
5347410|NCT01961882|Acute Myeloid Leukemia|acute myeloid leukemia
5343465|NCT01978483|Humans|humans
5347418|NCT01961843|Castration Resistant|castration resistant
5347419|NCT01961817|Retromolar|retromolar
5347420|NCT01961817|Difficult Intubation|difficult intubation
5347421|NCT01961791|gastric cancer, staging system, prognosis|gastric cancer, staging system, prognosis
5347422|NCT01961765|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5347423|NCT01961765|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
5347424|NCT01961752|bupivacaine,|bupivacaine,
5347425|NCT01961752|triamcinolone acetonide,|triamcinolone acetonide,
5347426|NCT01961752|endoscopic|endoscopic
5347427|NCT01961752|submucosal|submucosal
5347428|NCT01961752|dissection|dissection
5347429|NCT01961752|Patients|patients
5347430|NCT01961739|Hemorrhoids|hemorrhoids
5347431|NCT01961739|Lidocaine|lidocaine
5347432|NCT01961713|circulating tumor cells|circulating tumor cells
5347433|NCT01961713|CTC-Chip|ctc-chip
5347434|NCT01961661|intestinal inflammation|intestinal inflammation
5347435|NCT01961661|intestinal microflora|intestinal microflora
5347436|NCT01961661|children|children
5347438|NCT01961648|Sleep Apnea Disorder|sleep apnea disorder
5347439|NCT01961648|Respiratory chemical drive|respiratory chemical drive
5347440|NCT01961648|CO2|co2
5347441|NCT01961635|Dental Implants|dental implants
5347442|NCT01961635|Zirconia Abutments|zirconia abutments
5347443|NCT01961635|Titanium abutments|titanium abutments
5347444|NCT01961635|Acrylic abutments|acrylic abutments
5347445|NCT01961635|Gingival Healing|gingival healing
5347446|NCT01961635|Inflammation|inflammation
5347447|NCT01961635|Bone loss|bone loss
5347448|NCT01961622|Type 1 diabetes|type 1 diabetes
5347449|NCT01961622|Closed loop insulin delivery|closed loop insulin delivery
5347450|NCT01961622|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
5347451|NCT01961622|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5347452|NCT01961609|Chronic plaque psoriasis|chronic plaque psoriasis
5347453|NCT01961596|Cooling ice spray|cooling ice spray
5347454|NCT01961596|Time to stability|time to stability
5347455|NCT01961596|Jump|jump
5347456|NCT01961570|Early stage hand osteoarthritis|early stage hand osteoarthritis
5347457|NCT01961570|Carpometacarpal osteoarthritis|carpometacarpal osteoarthritis
5347458|NCT01961557|incomplete spinal cord injury|incomplete spinal cord injury
5347459|NCT01961557|EEG|eeg
5347460|NCT01961557|Cerebral Palsy|cerebral palsy
5347461|NCT01961557|Knee|knee
5347462|NCT01961557|Muscular Dystrophies|muscular dystrophies
5347463|NCT01961544|Breast Cancer|breast cancer
5347464|NCT01961544|Metastatic|metastatic
5347465|NCT01961531|DCIS|dcis
5347466|NCT01961531|IDC|idc
5347467|NCT01961531|Invasive breast carcinoma|invasive breast carcinoma
5347468|NCT01961479|Premenstrual syndrome (PMS)|premenstrual syndrome (pms)
5347469|NCT01961479|Premenstrual Dysphoric Disorder (PMDD)|premenstrual dysphoric disorder (pmdd)
5347470|NCT01961479|Internet-based Therapy|internet-based therapy
5347471|NCT01961479|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
5347472|NCT01961453|Hypertension|hypertension
5347473|NCT01961453|Isosorbide Mononitrate|isosorbide mononitrate
5347474|NCT01961453|Myocardial fibrosis|myocardial fibrosis
5347475|NCT01961427|dietary nitrate|dietary nitrate
5347476|NCT01961427|beetroot juice|beetroot juice
5347487|NCT01961401|exercise therapy|exercise therapy
5347488|NCT01961401|insulin resistance|insulin resistance
5347489|NCT01961388|Type 2 Diabetes|type 2 diabetes
5347497|NCT01961349|sedation, propofol, gastrointestinal endoscopy|sedation, propofol, gastrointestinal endoscopy
5347498|NCT01961336|IVF, poor responder, testosterone|ivf, poor responder, testosterone
5347499|NCT01961323|Hypertension|hypertension
5347500|NCT01961323|high blood pressure|high blood pressure
5347501|NCT01961323|stress echocardiogram|stress echocardiogram
5347502|NCT01961323|nebivolol|nebivolol
5347503|NCT01961323|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5347504|NCT01961310|bacterial translocation|bacterial translocation
5347505|NCT01961310|intestinal microbiota|intestinal microbiota
5347506|NCT01961297|dystonia|dystonia
5347507|NCT01961297|tremor|tremor
5963640|NCT04213261|RDEB|rdeb
5963641|NCT04213248|Dry eye|dry eye
5963642|NCT04213248|UMSC|umsc
5963643|NCT04213248|Exosome|exosome
5963644|NCT04213248|cGVHD|cgvhd
5963645|NCT04212689|Rehabilitation|rehabilitation
5963646|NCT04212689|Physiotherapy and Rehabilitation|physiotherapy and rehabilitation
5963647|NCT04212689|Virtual Reality|virtual reality
5347508|NCT01961297|treatment|treatment
5347509|NCT01961297|sodium oxybate|sodium oxybate
5347510|NCT01961297|brain activity|brain activity
5347511|NCT01961271|Norspan|norspan
5347512|NCT01961271|buprenorphine|buprenorphine
5347513|NCT01961271|transdermal|transdermal
5347514|NCT01961271|patch|patch
5347516|NCT01961271|non-malignant|non-malignant
5347517|NCT01961271|osteoarthritis|osteoarthritis
5347518|NCT01961271|rheumatoid arthritis|rheumatoid arthritis
5347519|NCT01961271|lower back pain|lower back pain
5347520|NCT01961271|joint pain|joint pain
5347521|NCT01961271|muscle pain|muscle pain
5347522|NCT01961271|opioid|opioid
5347523|NCT01961271|analgesic|analgesic
5347524|NCT01961271|painkiller|painkiller
5347525|NCT01961271|Mundipharma|mundipharma
5347526|NCT01961258|Severe Asthma, Community, comorbidities, patient compliance,PFT, anti-IgE therapy|severe asthma, community, comorbidities, patient compliance,pft, anti-ige therapy
5347527|NCT01961232|Pulmonary Hypertension|pulmonary hypertension
5347528|NCT01961232|biomarker|biomarker
5347529|NCT01961232|cardiac|cardiac
5347530|NCT01961232|circulation|circulation
5347531|NCT01961232|heart disease|heart disease
5347532|NCT01961232|lung disease|lung disease
5347533|NCT01961193|critically ill patients|critically ill patients
5347534|NCT01961193|punctal plug|punctal plug
5347535|NCT01961193|corneal injuries|corneal injuries
5347536|NCT01961180|Quality of Life|quality of life
5347537|NCT01961180|Adrenal hyper activity|adrenal hyper activity
5347538|NCT01961180|Glucose metabolism|glucose metabolism
5347540|NCT01961167|Stent|stent
5347541|NCT01961167|Claudication|claudication
5347542|NCT01961167|VIABAHN|viabahn
5347543|NCT01961167|Gore|gore
5347544|NCT01961167|Endoprosthesis|endoprosthesis
5347545|NCT01961167|Vascular Diseases|vascular diseases
5347546|NCT01961167|Cardiovascular Diseases|cardiovascular diseases
5347547|NCT01961167|Iliac Occlusive Disease|iliac occlusive disease
5347548|NCT01961167|Balloon Expandable|balloon expandable
5347549|NCT01961167|Stent Graft|stent graft
5347550|NCT01961167|VBX|vbx
5347551|NCT01961154|Asthma|asthma
5347552|NCT01961154|medication reduction|medication reduction
5347553|NCT01961154|asthma exacerbation|asthma exacerbation
5347554|NCT01961141|Ultrasound Doppler|ultrasound doppler
5347555|NCT01961141|Pulmonary diseases|pulmonary diseases
5347556|NCT01961141|Cardiopulmonary conditions|cardiopulmonary conditions
5347557|NCT01961128|High risk|high risk
5347558|NCT01961102|postmenopausal bleeding|postmenopausal bleeding
5347559|NCT01961102|postmenopausal hyperplasia|postmenopausal hyperplasia
5347560|NCT01961102|endometrial cancer|endometrial cancer
5347561|NCT01961102|atypical hyperplasia|atypical hyperplasia
5347562|NCT01961102|curettage|curettage
5347563|NCT01961102|intraoperative rapid section|intraoperative rapid section
5347564|NCT01961050|alcohol|alcohol
5347565|NCT01961050|pregnancy|pregnancy
5347566|NCT01961050|fetal exposure|fetal exposure
5347567|NCT01961050|prevention|prevention
5347568|NCT01961050|FAS|fas
5347569|NCT01961050|Alcohol-Related Neurodevelopmental Disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
5347570|NCT01961037|Accidental Falls|accidental falls
5347571|NCT01961037|Tai Chi|tai chi
5347572|NCT01961037|Older Adults|older adults
5347573|NCT01961037|Balance|balance
5347574|NCT01961037|Moving for Better Balance|moving for better balance
5347575|NCT01961037|Church|church
5347576|NCT01961037|Congregational Intervention|congregational intervention
5347584|NCT01960998|urinary incontinence|urinary incontinence
5347586|NCT01960998|telehealth|telehealth
5347587|NCT01960998|pelvic floor muscle training|pelvic floor muscle training
5347588|NCT01960985|Balance, Postural|balance, postural
5347589|NCT01960985|Parkinson´s Disease|parkinson´s disease
5347590|NCT01960985|H&Y 1-3|h&y 1-3
5347591|NCT01960985|Exrecice|exrecice
5347592|NCT01960985|Postural adjustments|postural adjustments
5347593|NCT01960985|antecipatory postural|antecipatory postural
5347594|NCT01960985|compensatory postural adjustments|compensatory postural adjustments
5347595|NCT01960972|Blood pressure|blood pressure
5347596|NCT01960972|Hypertension|hypertension
5347597|NCT01960972|Stepped wedge trial design|stepped wedge trial design
5347603|NCT01960933|STEMI|stemi
5347604|NCT01960933|MVD|mvd
5347605|NCT01960933|Full revascularization|full revascularization
5347606|NCT01960933|Culprit lesion revascularization only|culprit lesion revascularization only
5347607|NCT01960933|Primary PCI|primary pci
5347608|NCT01960920|Air Pollution|air pollution
5347609|NCT01960920|Heart Failure|heart failure
5347610|NCT01960920|Endothelium|endothelium
5347611|NCT01960920|Autonomic Dysfunction|autonomic dysfunction
5347612|NCT01960920|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5347613|NCT01960907|COPD|copd
5347614|NCT01960907|CHF|chf
5347615|NCT01960907|SDB|sdb
5347616|NCT01960894|Heart Failure|heart failure
5347617|NCT01960881|Prostate cancer|prostate cancer
5347618|NCT01960855|anti-inflammatory agents|anti-inflammatory agents
5347619|NCT01960855|Joint Diseases|joint diseases
5347620|NCT01960855|Arthritis|arthritis
5347621|NCT01960855|Musculoskeletal Disease|musculoskeletal disease
5347622|NCT01960855|antirheumatic agents|antirheumatic agents
5347623|NCT01960842|levodopa|levodopa
5347624|NCT01960842|Advanced Parkinson's Disease|advanced parkinson's disease
5347625|NCT01960842|carbidopa|carbidopa
5347626|NCT01960842|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5347627|NCT01960842|Safety and Efficacy|safety and efficacy
5347628|NCT01960829|melanoma|melanoma
5242387|NCT02489175|prevention|prevention
5347629|NCT01960829|TOR Serine-Threonine Kinases|tor serine-threonine kinases
5347630|NCT01960816|nasal obstruction|nasal obstruction
5347631|NCT01960803|Stage I Breast Carcinoma|stage i breast carcinoma
5347632|NCT01960790|Humira®|humira®
5347633|NCT01960790|Behcet's Disease|behcet's disease
5347634|NCT01960790|Adalimumab|adalimumab
5347635|NCT01960777|Hernia, Inguinal|hernia, inguinal
5347636|NCT01960777|Laparoscopy|laparoscopy
5347637|NCT01960777|Onstep|onstep
5347638|NCT01960764|Autologous microbiome transplant|autologous microbiome transplant
5347639|NCT01960764|Bacteria transplant|bacteria transplant
5347640|NCT01960764|Treatment for atopic dermatitis|treatment for atopic dermatitis
5347641|NCT01960738|Diving|diving
5347642|NCT01960738|Water|water
5347643|NCT01960738|Recreation|recreation
5347644|NCT01960738|Precursor|precursor
5347645|NCT01960725|Gastroenteritis|gastroenteritis
5347646|NCT01960725|Diarrhea|diarrhea
5347647|NCT01960725|Rotavirus|rotavirus
5347648|NCT01960725|Vaccine|vaccine
5347649|NCT01960725|Dehydration|dehydration
5347654|NCT01960673|supraglottic airway,igel-LMA, ambu-LMA, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation|supraglottic airway,igel-lma, ambu-lma, changing position, head and neck position, oropharyngeal leak pressure,degree of rotation
5347655|NCT01960660|Fish Oil|fish oil
5347656|NCT01960660|EPA|epa
5347657|NCT01960660|DHA|dha
5347658|NCT01960660|Omega-Score|omega-score
5347659|NCT01960660|Lipemic Index|lipemic index
5347660|NCT01960660|ethyl esters|ethyl esters
5347661|NCT01960660|triglycerides|triglycerides
5347662|NCT01960660|phospholipids|phospholipids
5347663|NCT01960595|PCA,Nerve block,Hullax Valgus|pca,nerve block,hullax valgus
5347664|NCT01960582|Housing adaptation|housing adaptation
5347665|NCT01960582|Independence|independence
5347666|NCT01960582|Costs|costs
5347667|NCT01960569|Thrombexx|thrombexx
5347668|NCT01960569|Topical r-Hirudin|topical r-hirudin
5347669|NCT01960569|Efficacy|efficacy
5347670|NCT01960569|haematoma|haematoma
5347671|NCT01960556|simulation|simulation
5347672|NCT01960543|Intrathecal anesthesia|intrathecal anesthesia
5347673|NCT01960543|Levobupivacaine|levobupivacaine
5347674|NCT01960543|Bupivacaine|bupivacaine
5347675|NCT01960543|Hip fracture|hip fracture
5347677|NCT01960517|Incontinence|incontinence
5347678|NCT01960517|Catheter|catheter
5347679|NCT01960504|DREAMS|dreams
5347680|NCT01960504|Drug Eluting Absorbable Metal Scaffold|drug eluting absorbable metal scaffold
5347681|NCT01960504|Scaffold|scaffold
5347682|NCT01960504|Coronary Artery Disease|coronary artery disease
5347683|NCT01960504|Myocardial Ischemia|myocardial ischemia
5347684|NCT01960504|Atherosclerosis|atherosclerosis
5347685|NCT01960465|CPAP treatment|cpap treatment
5347686|NCT01960465|hypertension|hypertension
5347687|NCT01960452|Insomnia|insomnia
5347688|NCT01960452|Primary insomnia|primary insomnia
5347689|NCT01960452|High density EEG|high density eeg
5347690|NCT01960452|Polysomnography|polysomnography
5347691|NCT01960452|Healthy sleeping controls|healthy sleeping controls
5347692|NCT01960439|disease activity|disease activity
5347693|NCT01960439|central reader|central reader
5347694|NCT01960439|endoscopic indices|endoscopic indices
5347695|NCT01960426|Harvey Bradshaw score|harvey bradshaw score
5347696|NCT01960426|Partial Mayo Clinical Score|partial mayo clinical score
5347697|NCT01960426|Infliximab|infliximab
5347698|NCT01960426|Adalimumab|adalimumab
5347699|NCT01960400|Complex regional pain syndrome type 1 (CRPS)|complex regional pain syndrome type 1 (crps)
5347700|NCT01960400|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5347701|NCT01960400|Graded motor imagery (GMI)|graded motor imagery (gmi)
5347702|NCT01960400|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5347703|NCT01960400|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5347704|NCT01960387|AML|aml
5347705|NCT01960387|clofarabine|clofarabine
5347706|NCT01960387|cytarabine|cytarabine
5347707|NCT01960387|persistent AML|persistent aml
5347708|NCT01960387|induction therapy|induction therapy
5347709|NCT01960374|RAS or RAF oncogenes, Inhibition of MEK pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.|ras or raf oncogenes, inhibition of mek pathway, inhibition cancer cell proliferation promising anti-cancer therapeutic strategy.
5347710|NCT01960348|RNAi therapeutic|rnai therapeutic
5347711|NCT01960348|FAP|fap
5347712|NCT01960348|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5347713|NCT01960348|TTR|ttr
5347714|NCT01960348|Transthyretin|transthyretin
5347715|NCT01960348|Amyloidosis|amyloidosis
5347716|NCT01960335|whey protein intake|whey protein intake
5347717|NCT01960335|obesity|obesity
5347718|NCT01960335|visceral fat|visceral fat
5347719|NCT01960335|resistance exercise training|resistance exercise training
5347720|NCT01960335|sprint interval training|sprint interval training
5963648|NCT04212689|Multiple Sclerosis|multiple sclerosis
5226768|NCT02582346|MRI|mri
5347721|NCT01960335|endurance exercise training|endurance exercise training
5347722|NCT01960335|yoga training|yoga training
5347723|NCT01960335|healthy eating|healthy eating
5347724|NCT01960335|healthy lifestyle strategies|healthy lifestyle strategies
5347725|NCT01960335|leptin|leptin
5347726|NCT01960335|hunger|hunger
5347727|NCT01960322|adherence|adherence
5347728|NCT01960322|nonadherence|nonadherence
5347729|NCT01960322|compliance|compliance
5347730|NCT01960322|noncompliance|noncompliance
5347731|NCT01960322|liver transplantation|liver transplantation
5347732|NCT01960296|clopidogrel|clopidogrel
5347733|NCT01960296|general surgery|general surgery
5347734|NCT01960270|relapse after an initial clinical response|relapse after an initial clinical response
5347735|NCT01960257|tuberculosis|tuberculosis
5347736|NCT01960257|tuberculosis treatment|tuberculosis treatment
5347737|NCT01960257|wirelessly observed therapy|wirelessly observed therapy
5347738|NCT01960257|proteus digital health|proteus digital health
5347739|NCT01960257|digital health feedback system|digital health feedback system
5347740|NCT01960244|familial|familial
5347741|NCT01960244|hypercholesterolemia|hypercholesterolemia
5347743|NCT01960218|acute decompensated heart failure|acute decompensated heart failure
5347744|NCT01960218|gas exchange|gas exchange
5347745|NCT01960218|cardiopulmonary|cardiopulmonary
5347746|NCT01960218|dyspnea|dyspnea
5347747|NCT01960218|cardiopulmonary analyzer|cardiopulmonary analyzer
5347748|NCT01960218|heart disease|heart disease
5347749|NCT01960218|cardiovascular disease|cardiovascular disease
5347750|NCT01960218|cardiopulmonary exercise|cardiopulmonary exercise
5347751|NCT01960205|Saxagliptin, prediabetes, glucose intolerance,obesity|saxagliptin, prediabetes, glucose intolerance,obesity
5347755|NCT01960153|Pulmonary hypertension|pulmonary hypertension
5347756|NCT01960153|tadalafil|tadalafil
5347757|NCT01960153|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
5347758|NCT01960114|Acetaminophen|acetaminophen
5347759|NCT01960114|Paracetamol Analgesics|paracetamol analgesics
5347760|NCT01960114|Analgesics|analgesics
5347761|NCT01960114|Non-Narcotic Pain|non-narcotic pain
5347762|NCT01960114|Postoperative Pain|postoperative pain
5347763|NCT01960114|Antipyretics Dental Surgery|antipyretics dental surgery
5347764|NCT01960114|Third molar extraction|third molar extraction
5347765|NCT01960101|xerostomia|xerostomia
5347766|NCT01960101|Saliva|saliva
5347767|NCT01960101|iatrogenic oral dryness|iatrogenic oral dryness
5347768|NCT01960101|antidepressants|antidepressants
5347769|NCT01960101|mouth dryness|mouth dryness
5347770|NCT01960101|milk product|milk product
5347771|NCT01960088|Adolescent vaccines|adolescent vaccines
5347772|NCT01960088|HPV vaccine|hpv vaccine
5347773|NCT01960088|Pharmacies|pharmacies
5347775|NCT01960062|diabetes|diabetes
5347776|NCT01960062|web-based|web-based
5347777|NCT01960062|software|software
5347778|NCT01960062|device|device
5347779|NCT01960049|Postoperative pain|postoperative pain
5347780|NCT01960049|Liver resection|liver resection
5347781|NCT01960049|Medial Open Transversus Abdominis Plane catheter|medial open transversus abdominis plane catheter
5347782|NCT01960036|Substance Use Disorders|substance use disorders
5347783|NCT01960036|Complementary Therapies|complementary therapies
5347784|NCT01960036|Women|women
5347785|NCT01960036|Mind-Body Therapies|mind-body therapies
5347786|NCT01960036|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
5347787|NCT01960023|Colorectal cancer|colorectal cancer
5347788|NCT01960023|KRAS|kras
5347789|NCT01960023|BRAF|braf
5347790|NCT01960023|NRAS|nras
5347791|NCT01960023|PIK3CA|pik3ca
5347792|NCT01960023|NSABP|nsabp
5347793|NCT01959958|Nocturnal enuresis|nocturnal enuresis
5347794|NCT01959958|Barriers to treatment|barriers to treatment
5347795|NCT01959945|Prevention|prevention
5347796|NCT01959932|Smoking|smoking
5347797|NCT01959932|Candidate Modified Risk Tobacco Product|candidate modified risk tobacco product
5347798|NCT01959932|Conventional cigarettes|conventional cigarettes
5347799|NCT01959932|Reduced exposure|reduced exposure
5347800|NCT01959932|Confinement|confinement
5347801|NCT01959906|Esophagectomy|esophagectomy
5347802|NCT01959880|Breast Augmentation|breast augmentation
5347803|NCT01959880|Breast Reconstruction|breast reconstruction
5347804|NCT01959880|Breast Revision|breast revision
5347805|NCT01959880|Silicone Gel|silicone gel
5347806|NCT01959880|Contour Profile Gel|contour profile gel
5347807|NCT01959880|Siltex|siltex
5347808|NCT01959880|CPG Styles|cpg styles
5347809|NCT01959867|mastectomy|mastectomy
5347810|NCT01959867|breast reconstruction|breast reconstruction
5347811|NCT01959867|bovine|bovine
5347812|NCT01959867|ADM|adm
5347813|NCT01959867|breast cancer|breast cancer
5347814|NCT01959867|breast implants|breast implants
5347815|NCT01959867|breast expanders|breast expanders
5347816|NCT01959867|radiation therapy|radiation therapy
5347817|NCT01959828|pulmonary hypertension|pulmonary hypertension
5347818|NCT01959828|cardiac surgery|cardiac surgery
5347819|NCT01959828|Glenn surgery|glenn surgery
5963649|NCT04212689|Upper extremity|upper extremity
5963650|NCT04212403|TURP|turp
5347820|NCT01959828|fontan surgery|fontan surgery
5963651|NCT04212403|TURB|turb
5963652|NCT04212065|Sublocade|sublocade
5347821|NCT01959828|left ventricular assist device|left ventricular assist device
5347822|NCT01959828|LVAD|lvad
5347823|NCT01959802|Macular pseudohole|macular pseudohole
5347824|NCT01959802|Cone outer segment tips line|cone outer segment tips line
5242610|NCT02487966|tDCS|tdcs
5347825|NCT01959789|Randomized Controlled Clinical Trial|randomized controlled clinical trial
5347826|NCT01959789|Tooth Bleaching|tooth bleaching
5347827|NCT01959776|cone outer segment tips line, foveal displacement|cone outer segment tips line, foveal displacement
5347828|NCT01959763|Metabolic syndrome|metabolic syndrome
5347829|NCT01959763|obesity|obesity
5347830|NCT01959763|overweight|overweight
5343840|NCT01977287|fatigue|fatigue
5347831|NCT01959763|weight loss intervention|weight loss intervention
5347832|NCT01959763|cognitive behavioral therapy|cognitive behavioral therapy
5347834|NCT01959763|cardiovascular disease|cardiovascular disease
5347835|NCT01959763|persuasive systems design|persuasive systems design
5347836|NCT01959737|reactivity of HPA axis|reactivity of hpa axis
5347837|NCT01959724|Macular detachment|macular detachment
5347838|NCT01959724|Macular retinoschisis|macular retinoschisis
5347839|NCT01959724|Vitrectomy|vitrectomy
5347840|NCT01959711|Lateral transperitoneal laparoscopic adrenalectomy|lateral transperitoneal laparoscopic adrenalectomy
5347841|NCT01959711|Posterior retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
5347842|NCT01959646|Immune Function|immune function
5347843|NCT01959646|Aged Garlic Extract|aged garlic extract
5347844|NCT01959646|Supplementation|supplementation
5347845|NCT01959646|Inflammation|inflammation
5347846|NCT01959620|PTSD|ptsd
5347847|NCT01959607|Smoking|smoking
5347848|NCT01959607|Nicotine absorption|nicotine absorption
5347849|NCT01959607|Candidate modified risk tobacco product|candidate modified risk tobacco product
5347850|NCT01959607|Cigarettes|cigarettes
5347851|NCT01959607|Nicotine Replacement Therapy gum (NRT gum)|nicotine replacement therapy gum (nrt gum)
5347852|NCT01959594|multiple doses|multiple doses
5347853|NCT01959594|pharmacokinetics|pharmacokinetics
5347854|NCT01959594|safety|safety
5347855|NCT01959594|tolerability|tolerability
5347856|NCT01959594|healthy volunteers|healthy volunteers
5347857|NCT01959594|steady state|steady state
5347858|NCT01959594|cognitive impairment associated with schizophrenia|cognitive impairment associated with schizophrenia
5347859|NCT01959581|Wilmington Robotic Exoskeleton|wilmington robotic exoskeleton
5347860|NCT01959581|Reaching|reaching
5347861|NCT01959581|Upper extremity function|upper extremity function
5347862|NCT01959581|Preterm Infants|preterm infants
5347863|NCT01959581|Brain injury|brain injury
5347864|NCT01959581|Pediatrics|pediatrics
5348155|NCT01958021|LEE011|lee011
5347865|NCT01959581|Early Intervention|early intervention
5347866|NCT01959581|Arthrogryposis|arthrogryposis
5347867|NCT01959568|Retinal Detachment|retinal detachment
5347868|NCT01959568|Double Tamponade|double tamponade
5347869|NCT01959568|Perfluorocarbon liquids|perfluorocarbon liquids
5347870|NCT01959568|Vitrectomy|vitrectomy
5347871|NCT01959542|Prostate Cancer|prostate cancer
5347872|NCT01959516|COPD, early morning symptoms|copd, early morning symptoms
5347874|NCT01959503|Aortic|aortic
5347875|NCT01959503|Reconstruction|reconstruction
5347876|NCT01959503|CABG|cabg
5347877|NCT01959503|Bypass|bypass
5347878|NCT01959464|Assisted reproductive technology|assisted reproductive technology
5347879|NCT01959464|Infertility|infertility
5347880|NCT01959464|Progesterone|progesterone
5347881|NCT01959464|Vaginal gel|vaginal gel
5347882|NCT01959464|Luteal-phase support|luteal-phase support
5347883|NCT01959451|Prasugrel|prasugrel
5347884|NCT01959451|Clopidogrel|clopidogrel
5347885|NCT01959438|Phase I study for safety|phase i study for safety
5347886|NCT01959438|Later Phase II study for responses|later phase ii study for responses
5347887|NCT01959425|Anticoagulation|anticoagulation
5347888|NCT01959425|Oral|oral
5347889|NCT01959425|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5347890|NCT01959425|Patients post successful cardiac ablation|patients post successful cardiac ablation
5347891|NCT01959425|Symptomatic high-burden paroxysmal AF|symptomatic high-burden paroxysmal af
5347892|NCT01959425|3 months post procedure|3 months post procedure
5347893|NCT01959425|Remain free from AF recurrence|remain free from af recurrence
5347894|NCT01959412|wheezing, short of breath, laba, inhaler|wheezing, short of breath, laba, inhaler
5347895|NCT01959399|ASP015K|asp015k
5347896|NCT01959399|healthy subjects|healthy subjects
5347897|NCT01959360|Arthroplasty, Total Hip Replacement, Hip|arthroplasty, total hip replacement, hip
5347898|NCT01959360|Surgical Procedures, Operative|surgical procedures, operative
5347899|NCT01959360|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5347900|NCT01959347|urinary incontinence|urinary incontinence
5347901|NCT01959347|midurethral sling|midurethral sling
5347902|NCT01959347|pelvic floor therapy|pelvic floor therapy
5347903|NCT01959334|Diabetes Mellitus|diabetes mellitus
5347904|NCT01959334|Hypoglycemia|hypoglycemia
5347905|NCT01959334|Glucagon|glucagon
5347906|NCT01959334|Anti-glucagon Antibody|anti-glucagon antibody
5347907|NCT01959334|Immunogenicity|immunogenicity
5347908|NCT01959308|Adherence|adherence
5347909|NCT01959308|Compliance|compliance
5347910|NCT01959308|Immunosuppressive Therapy|immunosuppressive therapy
5963653|NCT04212065|Suboxone|suboxone
5226890|NCT02581436|Prediction test|prediction test
5226891|NCT02581436|genetic transcription profile|genetic transcription profile
5242740|NCT02487238|FMT|fmt
5226898|NCT02581410|Shingles|shingles
5226899|NCT02581410|Immunogenicity|immunogenicity
5347911|NCT01959308|Liver Transplant|liver transplant
5347912|NCT01959308|Liver Recipients|liver recipients
5347914|NCT01959308|Adolescent|adolescent
5347915|NCT01959282|Colitis, Ulcerative|colitis, ulcerative
5347916|NCT01959282|JNJ-54781532|jnj-54781532
5347917|NCT01959282|Moderate|moderate
5347918|NCT01959282|Severe|severe
5347919|NCT01959282|Active|active
5347920|NCT01959256|Stroke|stroke
5347921|NCT01959256|Visual Field Defect|visual field defect
5347922|NCT01959256|Visual perceptual learning|visual perceptual learning
5347923|NCT01959256|Brain connectivity|brain connectivity
5347924|NCT01959243|Ocular redness|ocular redness
5347925|NCT01959230|Ocular redness|ocular redness
5347926|NCT01959217|HIV|hiv
5347927|NCT01959217|Substance Abuse|substance abuse
5347928|NCT01959217|Prospective Memory|prospective memory
5347929|NCT01959204|pharmacokinetics|pharmacokinetics
5347930|NCT01959204|safety|safety
5347931|NCT01959191|Platelet activity, CABG, off-pump surgery|platelet activity, cabg, off-pump surgery
5347932|NCT01959165|Ulcerative Colitis, Japanese, subcutaneously|ulcerative colitis, japanese, subcutaneously
5347933|NCT01959152|Cochlear Implant|cochlear implant
5347934|NCT01959152|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
5347935|NCT01959152|Cochlear Implantation|cochlear implantation
5347936|NCT01959152|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
5347937|NCT01959152|Listening Benefits|listening benefits
5347938|NCT01959152|Adults|adults
5347939|NCT01959152|Cochlear Implant Benefit|cochlear implant benefit
5347940|NCT01959152|HiRes Fidelity 120™|hires fidelity 120™
5347941|NCT01959152|Electrical Stimulation|electrical stimulation
5347942|NCT01959126|Telomerase|telomerase
5347957|NCT01959048|Clostridium difficile associated disease|clostridium difficile associated disease
5347958|NCT01959048|fecal microbiota transplantation|fecal microbiota transplantation
5347959|NCT01959022|Posttramatic Stress Disorder|posttramatic stress disorder
5347960|NCT01959022|Post-traumatic Stress Disorder|post-traumatic stress disorder
5347962|NCT01959022|Doxazosin|doxazosin
5347963|NCT01959022|Nightmares|nightmares
5347964|NCT01959022|Sleep Disturbance|sleep disturbance
5347965|NCT01959009|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation|newborn, lung disease, mechanical ventilation, lung recruitment, high frequency ventilation
5347966|NCT01958983|dementia|dementia
5347967|NCT01958983|drumming|drumming
5347968|NCT01958983|emotion|emotion
5347969|NCT01958983|cognition|cognition
5347970|NCT01958983|functional MRI|functional mri
5347971|NCT01958970|End Stage Renal Disease|end stage renal disease
5347972|NCT01958970|ESRD|esrd
5347973|NCT01958970|Maintenance Hemodialysis|maintenance hemodialysis
5347974|NCT01958970|Hemodialysis|hemodialysis
5347975|NCT01958970|Dialysis|dialysis
5347976|NCT01958970|MHD|mhd
5347977|NCT01958970|Protein Energy Wasting|protein energy wasting
5347978|NCT01958970|PEW|pew
5347979|NCT01958957|ischemic stroke|ischemic stroke
5347980|NCT01958957|safety|safety
5347981|NCT01958957|Ginkgolides Meglumine Injection|ginkgolides meglumine injection
5347982|NCT01958944|CF|cf
5347983|NCT01958944|Cystic Fibrosis|cystic fibrosis
5347984|NCT01958944|NO|no
5347985|NCT01958944|nitric oxide|nitric oxide
5347986|NCT01958944|inhalation|inhalation
5347987|NCT01958918|wet age-related macular degeneration (AMD)|wet age-related macular degeneration (amd)
5347988|NCT01958918|ranibizumab|ranibizumab
5347989|NCT01958918|aflibercept|aflibercept
5347990|NCT01958918|Best Corrected Visual Acuity (BCVA)|best corrected visual acuity (bcva)
5347991|NCT01958918|Spectral Domain Optical Coherence Tomography (SD-OCT)|spectral domain optical coherence tomography (sd-oct)
5347992|NCT01958892|BPH|bph
5347993|NCT01958879|internal derangement,arthrocentesis,corticosteroid|internal derangement,arthrocentesis,corticosteroid
5347994|NCT01958866|Fever|fever
5347995|NCT01958866|Body temperature|body temperature
5347996|NCT01958853|Pain|pain
5347997|NCT01958840|Behavioral|behavioral
5347998|NCT01958840|Activation|activation
5347999|NCT01958840|Treatment|treatment
5348000|NCT01958827|Dose Escalation|dose escalation
5348001|NCT01958827|Crohn's Disease|crohn's disease
5348002|NCT01958801|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
5348003|NCT01958801|Interscalene brachial plexus block|interscalene brachial plexus block
5348004|NCT01958801|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
5348005|NCT01958788|Cognitive-behavioral treatment|cognitive-behavioral treatment
5348006|NCT01958788|Generalized anxiety disorder|generalized anxiety disorder
5348007|NCT01958788|Worry|worry
5348008|NCT01958788|Behavioral experiments|behavioral experiments
5348009|NCT01958788|Safety behaviors|safety behaviors
5348010|NCT01958788|Anxiety|anxiety
5348011|NCT01958775|Lipoproteins, apoB, GLP-2|lipoproteins, apob, glp-2
5963654|NCT04211571|End-stage renal disease|end-stage renal disease
5963655|NCT04211571|Medium cut-off dialyzer|medium cut-off dialyzer
5963656|NCT04211571|High-flux dialyzer|high-flux dialyzer
5963657|NCT04211571|Residual renal function|residual renal function
5963658|NCT04211116|Central line|central line
5348012|NCT01958762|Screening|screening
5348013|NCT01958762|Cancer|cancer
5348014|NCT01958762|Tobacco|tobacco
5242850|NCT02486666|RCT|rct
5348015|NCT01958762|General Practitioner|general practitioner
5348016|NCT01958762|Precancerous Lesion|precancerous lesion
5348017|NCT01958762|Dysplasia|dysplasia
5348018|NCT01958762|Tobacco vendor|tobacco vendor
5348019|NCT01958723|Problem Specific Template|problem specific template
5348020|NCT01958723|Physician Documentation|physician documentation
5348021|NCT01958723|Electronic Medical Record Documentation|electronic medical record documentation
5348022|NCT01958710|Catheterization, Bronchial|catheterization, bronchial
5348023|NCT01958710|Pneumonectomy|pneumonectomy
5348024|NCT01958710|Lobectomy|lobectomy
5348025|NCT01958710|Thoracoplasty|thoracoplasty
5348026|NCT01958697|Nutritional Disorders|nutritional disorders
5348027|NCT01958697|Feeding Behavior|feeding behavior
5348028|NCT01958684|Bleeding pattern|bleeding pattern
5348029|NCT01958684|LNG-IUS|lng-ius
5348030|NCT01958684|Cu-IUD|cu-iud
5348031|NCT01958684|postabortion|postabortion
5862780|NCT00001515|Bronchogenic Carcinoma|bronchogenic carcinoma
5862781|NCT00001512|ProMace Chemotherapy|promace chemotherapy
5348032|NCT01958645|Phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic|phase 1, healthy male subjects, safety and tolerability, pharmacodynamic, pharmacokinetic
5348033|NCT01958619|open label|open label
5348034|NCT01958619|healthy volunteers|healthy volunteers
5348035|NCT01958619|pharmacokinetic|pharmacokinetic
5348036|NCT01958619|parallel group|parallel group
5348037|NCT01958606|Stroke|stroke
5348038|NCT01958606|Rehabilitation|rehabilitation
5348039|NCT01958606|Exercise|exercise
5348040|NCT01958606|Intensity|intensity
5348041|NCT01958606|Gait|gait
5348042|NCT01958593|PTSD|ptsd
5348043|NCT01958593|Posttraumatic stress disorder|posttraumatic stress disorder
5348044|NCT01958593|MDMA|mdma
5348045|NCT01958593|psychotherapy|psychotherapy
5348046|NCT01958567|Scleritis|scleritis
5348047|NCT01958567|Episcleritis|episcleritis
5348048|NCT01958567|Optical coherence Tomography|optical coherence tomography
5348049|NCT01958541|Sleep|sleep
5348050|NCT01958541|Insomnia|insomnia
5348051|NCT01958541|Suicidal Symptoms|suicidal symptoms
5348052|NCT01958541|Suicidal Ideation|suicidal ideation
5348053|NCT01958541|Military Veteran|military veteran
5348054|NCT01958541|Service Member|service member
5348055|NCT01958541|Depression|depression
5348056|NCT01958515|Radiation Therapy|radiation therapy
5348057|NCT01958515|Chemotherapy|chemotherapy
5348058|NCT01958515|Chemoradiation Therapy|chemoradiation therapy
5348059|NCT01958502|nonunion|nonunion
5348060|NCT01958502|mesenchymal stem cell|mesenchymal stem cell
5348061|NCT01958502|scaffold|scaffold
5348062|NCT01958502|BMP2|bmp2
5348063|NCT01958502|long bone|long bone
5348064|NCT01958476|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5348065|NCT01958476|Opioids|opioids
5348066|NCT01958463|Clostridium Difficile Infection|clostridium difficile infection
5348067|NCT01958463|Fecal Microbiota Transplantation|fecal microbiota transplantation
5348068|NCT01958450|acne scar|acne scar
5348069|NCT01958450|Laser therapy|laser therapy
5348070|NCT01958450|wound healing|wound healing
5348071|NCT01958437|Aging|aging
5348072|NCT01958437|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
5348073|NCT01958437|Cognitive Disorders|cognitive disorders
5348074|NCT01958437|Imaging|imaging
5348075|NCT01958437|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5348076|NCT01958437|Neurology|neurology
5348077|NCT01958437|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
5348078|NCT01958437|transcranial direct current stimulation|transcranial direct current stimulation
5348079|NCT01958424|metabolic syndrome|metabolic syndrome
5348080|NCT01958424|in vitro fertilization|in vitro fertilization
5348081|NCT01958424|c reactive protein|c reactive protein
5348082|NCT01958424|over-weight women|over-weight women
5348083|NCT01958424|ovarian stimulation|ovarian stimulation
5348084|NCT01958398|Randomized Controlled Trial|randomized controlled trial
5348085|NCT01958398|Alcohol|alcohol
5348086|NCT01958398|Internet|internet
5348087|NCT01958398|Mobile phone|mobile phone
5348088|NCT01958398|Screening|screening
5348089|NCT01958398|Brief intervention|brief intervention
5348090|NCT01958385|Total Body Weight Loss|total body weight loss
5348091|NCT01958359|Randomized Controlled Trial|randomized controlled trial
5348092|NCT01958359|Alcohol|alcohol
5348093|NCT01958359|Telephone|telephone
5348094|NCT01958359|Mobile phone|mobile phone
5348095|NCT01958359|Screening|screening
5348096|NCT01958359|Brief intervention|brief intervention
5348097|NCT01958359|IVR-based conversation menu with exercises and vignettes|ivr-based conversation menu with exercises and vignettes
5348098|NCT01958333|Health-Related Physical Fitness|health-related physical fitness
5348099|NCT01958333|Aerobic Endurance|aerobic endurance
5242918|NCT02486341|elderly|elderly
5963659|NCT04211116|Pediatric patient|pediatric patient
5963660|NCT04211116|Insertion|insertion
5963661|NCT04211116|Cannulation|cannulation
5963662|NCT04210388|Relative Bioavailability|relative bioavailability
5963663|NCT04210388|Crossover Study|crossover study
5963664|NCT04210388|Safety|safety
5963665|NCT04209894|enthesitis|enthesitis
5963666|NCT04209894|psoriasis|psoriasis
5963667|NCT04209894|ultrasound|ultrasound
5302946|NCT02162238|zinc|zinc
5348100|NCT01958333|Muscular Endurance|muscular endurance
5348102|NCT01958320|patent ductus arteriosus|patent ductus arteriosus
5348103|NCT01958320|patent ductus arteriosus ligation|patent ductus arteriosus ligation
5348104|NCT01958320|necrotizing enterocolitis|necrotizing enterocolitis
5348105|NCT01958320|spontaneous intestinal perforation|spontaneous intestinal perforation
5348106|NCT01958255|tobacco quit rates|tobacco quit rates
5348107|NCT01958242|Cardiopulmonary bypass|cardiopulmonary bypass
5348108|NCT01958242|pediatric|pediatric
5348109|NCT01958242|blood products|blood products
5348110|NCT01958242|conservation|conservation
5348111|NCT01958216|TICE-human-stable isotopes|tice-human-stable isotopes
5348112|NCT01958190|Liver transplantation long term renal function|liver transplantation long term renal function
5348113|NCT01958190|tacrolimus sirolimus|tacrolimus sirolimus
5348114|NCT01958177|stem cell|stem cell
5348115|NCT01958177|cerebellar ataxia|cerebellar ataxia
5348116|NCT01958177|BMMNC|bmmnc
5348117|NCT01958151|colonoscopy|colonoscopy
5348118|NCT01958151|deep sedation|deep sedation
5348119|NCT01958151|anxiety|anxiety
5348120|NCT01958138|Laryngeal Mask Airway|laryngeal mask airway
5348121|NCT01958138|Propofol|propofol
5348122|NCT01958138|Isoflurane|isoflurane
5348123|NCT01958138|Pediatric patients|pediatric patients
5348124|NCT01958138|Emergence|emergence
5348125|NCT01958125|vagus nerve stimulation|vagus nerve stimulation
5348126|NCT01958125|vagal nerve stimulation|vagal nerve stimulation
5348127|NCT01958125|nVNS|nvns
5348129|NCT01958125|cluster headache|cluster headache
5348136|NCT01958086|Neural|neural
5348137|NCT01958086|Prosthetic|prosthetic
5348138|NCT01958086|brain machine interface|brain machine interface
5348139|NCT01958086|brain computer interface|brain computer interface
5348140|NCT01958086|brain control|brain control
5348141|NCT01958086|paralysis|paralysis
5348142|NCT01958086|tetraplegia|tetraplegia
5348143|NCT01958086|quadriplegia|quadriplegia
5348144|NCT01958086|spinal cord injury|spinal cord injury
5348145|NCT01958073|Recurrent Urinary Tract Infection|recurrent urinary tract infection
5348146|NCT01958073|Postmenopausal|postmenopausal
5348147|NCT01958073|Vaginal Estrogen|vaginal estrogen
5348148|NCT01958047|Phase I|phase i
5348149|NCT01958047|ASP3652|asp3652
5348150|NCT01958047|Single dose|single dose
5348151|NCT01958047|Dietary intake|dietary intake
5348152|NCT01958021|HR-positive|hr-positive
5348153|NCT01958021|HER2-negative|her2-negative
5348154|NCT01958021|Advanced breast cancer|advanced breast cancer
5348156|NCT01958021|Letrozole|letrozole
5348157|NCT01958021|CDK|cdk
5348158|NCT01958021|CDK4|cdk4
5348159|NCT01958021|CDK6|cdk6
5348160|NCT01958021|CDK4/6|cdk4/6
5348161|NCT01958021|Phase III|phase iii
5348162|NCT01958021|ER-positive|er-positive
5348163|NCT01958021|PR-positive|pr-positive
5348164|NCT01958021|Postmenopausal|postmenopausal
5348165|NCT01957943|Omega 3 lipid emulsions|omega 3 lipid emulsions
5348166|NCT01957943|Liver transplantation|liver transplantation
5348167|NCT01957943|Ischemia reperfusion injury|ischemia reperfusion injury
5348168|NCT01957943|graft function|graft function
5348169|NCT01957930|HbA1c|hba1c
5348170|NCT01957930|Iontophoresis|iontophoresis
5348171|NCT01957930|Intensified insulin treatment|intensified insulin treatment
5348172|NCT01957930|Ischemic foot ulcer|ischemic foot ulcer
5348173|NCT01957930|Type 1 diabetes|type 1 diabetes
5348175|NCT01957917|Food Insecurity|food insecurity
5348176|NCT01957917|Antiretroviral Therapy|antiretroviral therapy
5348177|NCT01957904|ArterX, surgical sealant|arterx, surgical sealant
5348178|NCT01957891|Hypoxia|hypoxia
5348179|NCT01957891|Multiple wavelengths|multiple wavelengths
5348180|NCT01957865|HIV/AIDS|hiv/aids
5348181|NCT01957865|adherence|adherence
5348182|NCT01957865|real time monitoring|real time monitoring
5348183|NCT01957865|SMS|sms
5348184|NCT01957865|mHealth|mhealth
5348185|NCT01957865|social support|social support
5348186|NCT01957826|mesenchymal|mesenchymal
5348187|NCT01957826|stem cells|stem cells
5348188|NCT01957826|transendocardial injection|transendocardial injection
5348189|NCT01957826|dilated idiopathic cardiomyopathy|dilated idiopathic cardiomyopathy
5348190|NCT01957826|idiopathic cardiomyopathy|idiopathic cardiomyopathy
5348191|NCT01957813|APHIA AIDS, Population and Health Integrated Assistance|aphia aids, population and health integrated assistance
5348192|NCT01957813|DIC Drop-in center|dic drop-in center
5348193|NCT01957813|DMPA depot medroxyprogesterone acetate|dmpa depot medroxyprogesterone acetate
5348194|NCT01957813|DRH Division of Reproductive Health|drh division of reproductive health
5348195|NCT01957813|FAIR Family AIDS Initiative Response|fair family aids initiative response
5348196|NCT01957813|FHOK Family Health Options Kenya|fhok family health options kenya
5348197|NCT01957813|FP Family planning|fp family planning
5348198|NCT01957813|FGD Focus group discussion|fgd focus group discussion
5348199|NCT01957813|FSW Female sex worker|fsw female sex worker
5348200|NCT01957813|GSKenya Gold Star Kenya|gskenya gold star kenya
5963668|NCT04209660|Lenvatinib|lenvatinib
5963669|NCT04209660|Pembrolizumab|pembrolizumab
5963670|NCT04209660|19-310|19-310
5963671|NCT04209621|P13K Inhibitor|p13k inhibitor
5963672|NCT04209621|PLCG2 Mutations|plcg2 mutations
5963673|NCT04209621|BTK Mutations|btk mutations
5348201|NCT01957813|HTC HIV testing and counseling|htc hiv testing and counseling
5348202|NCT01957813|HIV Human Immunodeficiency Virus|hiv human immunodeficiency virus
5348203|NCT01957813|KNASP Kenya National AIDS Strategic Plan|knasp kenya national aids strategic plan
5348204|NCT01957813|MARPS Most at-risk populations|marps most at-risk populations
5348205|NCT01957813|MoPHS Ministry of Public Health and Sanitation|mophs ministry of public health and sanitation
5348206|NCT01957813|MMS Ministry of Medical Services|mms ministry of medical services
5348207|NCT01957813|NASCOP National AIDS and STI Control Program|nascop national aids and sti control program
5348208|NCT01957813|RH Reproductive health|rh reproductive health
5348209|NCT01957813|SRH Sexual and reproductive health|srh sexual and reproductive health
5348210|NCT01957813|STI Sexually transmitted infection|sti sexually transmitted infection
5348211|NCT01957813|USAID United States Agency for International Development|usaid united states agency for international development
5348212|NCT01957800|weight loss|weight loss
5348213|NCT01957800|healthy diet|healthy diet
5348214|NCT01957800|website|website
5348215|NCT01957800|action planning|action planning
5348216|NCT01957800|phone|phone
5348217|NCT01957800|social|social
5348218|NCT01957787|Metastatic lung tumors|metastatic lung tumors
5348219|NCT01957787|Pulmonary metastatic disease|pulmonary metastatic disease
5348220|NCT01957748|Retention|retention
5348222|NCT01957748|Engagement|engagement
5348223|NCT01957735|metastatic cancer|metastatic cancer
5348224|NCT01957735|solid tumor|solid tumor
5348225|NCT01957735|unresectable tumor|unresectable tumor
5348226|NCT01957735|brain cancer|brain cancer
5348227|NCT01957735|lymphoma|lymphoma
5348228|NCT01957696|Diabetes mellitus|diabetes mellitus
5348229|NCT01957696|Pancreas transplantation|pancreas transplantation
5348230|NCT01957696|Rejection|rejection
5348231|NCT01957696|Surgical complications|surgical complications
5348232|NCT01957696|Allograft biopsies|allograft biopsies
5348233|NCT01957696|Immunological analyses|immunological analyses
5348234|NCT01957696|Pancreas graft survival|pancreas graft survival
5348235|NCT01957683|intracranial aneurysm|intracranial aneurysm
5348236|NCT01957683|bifurcation|bifurcation
5348237|NCT01957683|wide-neck|wide-neck
5348238|NCT01957683|saccular|saccular
5348239|NCT01957683|endovascular treatment|endovascular treatment
5348240|NCT01957683|coil embolization|coil embolization
5348241|NCT01957683|stent|stent
5348242|NCT01957683|bare platinum|bare platinum
5348243|NCT01957670|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5348244|NCT01957670|Dry Eye Syndromes|dry eye syndromes
5348245|NCT01957631|Plantar Fasciitis|plantar fasciitis
5348246|NCT01957631|Steroid|steroid
5348247|NCT01957631|Platelet rich plasma|platelet rich plasma
5348248|NCT01957631|Injection|injection
5348249|NCT01957631|Ultrasound|ultrasound
5348250|NCT01957605|prone position|prone position
5348257|NCT01957579|CD19|cd19
5348258|NCT01957579|Japanese|japanese
5348259|NCT01957566|propofol sedation|propofol sedation
5348260|NCT01957566|children|children
5348261|NCT01957566|procedure sedation|procedure sedation
5348262|NCT01957540|ticagrelor|ticagrelor
5348263|NCT01957540|prasugrel|prasugrel
5348264|NCT01957540|endothelial function|endothelial function
5348265|NCT01957527|ticagrelor|ticagrelor
5348266|NCT01957527|endothelial function|endothelial function
5348267|NCT01957527|peripheral arterial tonometry|peripheral arterial tonometry
5348268|NCT01957501|Major Depressive Disorder|major depressive disorder
5348269|NCT01957501|Bipolar Disorder|bipolar disorder
5348270|NCT01957501|Adolescents|adolescents
5348271|NCT01957501|Biomarker|biomarker
5348272|NCT01957436|prostate|prostate
5348274|NCT01957436|metastatic hormone-naive|metastatic hormone-naive
5348275|NCT01957436|radiotherapy|radiotherapy
5348276|NCT01957436|abiraterone acetate|abiraterone acetate
5348277|NCT01957436|docetaxel|docetaxel
5348278|NCT01957423|Crohn's disease|crohn's disease
5348279|NCT01957423|whey protein|whey protein
5348280|NCT01957423|soy protein|soy protein
5348281|NCT01957423|nutritional status|nutritional status
5348282|NCT01957423|activity of disease|activity of disease
5243110|NCT02485158|THC|thc
5348283|NCT01957410|Major Depressive Disorder|major depressive disorder
5348284|NCT01957410|Ketamine|ketamine
5348285|NCT01957410|Evoked potentials|evoked potentials
5348286|NCT01957410|Somatosensory evoked potentials|somatosensory evoked potentials
5348287|NCT01957410|Motor evoked potentials|motor evoked potentials
5348288|NCT01957410|Cortical plasticity|cortical plasticity
5348289|NCT01957371|PTSD|ptsd
5348290|NCT01957371|Yoga|yoga
5348291|NCT01957371|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
5348292|NCT01957371|Chronic Pain|chronic pain
5348293|NCT01957345|constitutional functional disorders of platelets|constitutional functional disorders of platelets
5348294|NCT01957345|platelet signalling defects|platelet signalling defects
5348295|NCT01957332|molecular imaging|molecular imaging
5348296|NCT01957332|HER2-PET|her2-pet
5348297|NCT01957332|89Zr-trastuzumab|89zr-trastuzumab
5348298|NCT01957332|FES-PET|fes-pet
5348299|NCT01957332|metastatic breast cancer|metastatic breast cancer
5348300|NCT01957332|clinical utility|clinical utility
5348301|NCT01957306|hot flashes, night sweats|hot flashes, night sweats
5348302|NCT01957280|HER3|her3
5348303|NCT01957267|Glaucoma|glaucoma
5348304|NCT01957267|Optical Coherence Tomography|optical coherence tomography
5348305|NCT01957267|Intraocular pressure|intraocular pressure
5348306|NCT01957267|Optic nervehead|optic nervehead
5348307|NCT01957267|Nerve fiber layer|nerve fiber layer
5348308|NCT01957202|levocabastine fixed dose combination, Rhinitis, Allergic, Perennial and Seasonal, Allergic Rhinitis, fluticasone furoate|levocabastine fixed dose combination, rhinitis, allergic, perennial and seasonal, allergic rhinitis, fluticasone furoate
5348309|NCT01957189|pharmacokinetics, Chinese|pharmacokinetics, chinese
5348310|NCT01957189|Avodart, Duodart, dutasteride, tamsulosin, drug-drug interaction,|avodart, duodart, dutasteride, tamsulosin, drug-drug interaction,
5348317|NCT01957163|dry powder inhaler|dry powder inhaler
5348318|NCT01957163|fluticasone furoate/vilanterol|fluticasone furoate/vilanterol
5348319|NCT01957163|umeclidinium bromide|umeclidinium bromide
5348320|NCT01957163|safety|safety
5348321|NCT01957163|long acting beta2- receptor agonist|long acting beta2- receptor agonist
5348322|NCT01957163|long acting muscarininc receptor antagonist|long acting muscarininc receptor antagonist
5348323|NCT01957163|efficacy|efficacy
5348324|NCT01957163|COPD|copd
5348325|NCT01957163|inhaled corticosteroid|inhaled corticosteroid
5348326|NCT01957137|Urinary|urinary
5348327|NCT01957137|Urge|urge
5348328|NCT01957137|Incontinence|incontinence
5348329|NCT01957098|L-arabinose|l-arabinose
5348330|NCT01957098|D-xylose|d-xylose
5348331|NCT01957098|sucrose|sucrose
5348332|NCT01957098|glucose|glucose
5348333|NCT01957098|insulin|insulin
5348334|NCT01957098|C-peptide|c-peptide
5348335|NCT01957098|GLP-1|glp-1
5348336|NCT01957085|Hepatitis C|hepatitis c
5348337|NCT01957072|Cystic fibrosis|cystic fibrosis
5348338|NCT01957072|Nutrition|nutrition
5348339|NCT01957072|Weight|weight
5348341|NCT01957072|Behaviour change|behaviour change
5348342|NCT01957059|DMD|dmd
5348343|NCT01957059|Duchenne muscular dystrophy|duchenne muscular dystrophy
5348344|NCT01957059|Duchenne|duchenne
5348345|NCT01957059|BMN053|bmn053
5348346|NCT01957059|BioMarin|biomarin
5348347|NCT01957046|Opioid induced constipation|opioid induced constipation
5348348|NCT01957046|Laxatives|laxatives
5348349|NCT01957033|whiplash|whiplash
5348350|NCT01957033|neck pain|neck pain
5348351|NCT01957033|manual therapy|manual therapy
5348352|NCT01957033|exercise|exercise
5348353|NCT01957033|dosage|dosage
5348354|NCT01957007|Phase 1|phase 1
5348355|NCT01957007|dose escalation|dose escalation
5348356|NCT01957007|histologically confirmed|histologically confirmed
5348357|NCT01957007|malignancy metastatic|malignancy metastatic
5348358|NCT01956994|Whey Protein|whey protein
5348359|NCT01956994|Arterial Stiffness|arterial stiffness
5348360|NCT01956994|Neurovascular Coupling|neurovascular coupling
5348361|NCT01956994|Cerebrovascular Reactivity|cerebrovascular reactivity
5348362|NCT01956994|Hemodynamics|hemodynamics
5348363|NCT01956994|Blood Flow|blood flow
5348364|NCT01956994|Pulsatility|pulsatility
5348365|NCT01956981|controlled hypotension, dexmedetomidine, magnesium sulfate.|controlled hypotension, dexmedetomidine, magnesium sulfate.
5356894|NCT01917591|autoimmunity|autoimmunity
5348366|NCT01956968|Shoulder pain, Scapular dyskinesia, Physical examination|shoulder pain, scapular dyskinesia, physical examination
5348367|NCT01956942|GLAUCOMA|glaucoma
5348368|NCT01956942|MICROPULSE|micropulse
5348370|NCT01956942|TRABECULOPLASTY|trabeculoplasty
5348371|NCT01956942|OPEN ANGLE|open angle
5348372|NCT01956942|INTRAOCULAR PRESSURE|intraocular pressure
5348373|NCT01956929|Insulin Resistance|insulin resistance
5348374|NCT01956929|Prediabetic State|prediabetic state
5348375|NCT01956929|Metformin|metformin
5348376|NCT01956916|Pulmonary exacerbation|pulmonary exacerbation
5348377|NCT01956916|Inflammation|inflammation
5348378|NCT01956916|Intestinal microbiota|intestinal microbiota
5348379|NCT01956903|mesenchymal stem cell transplantation|mesenchymal stem cell transplantation
5348380|NCT01956890|Breast neoplasms|breast neoplasms
5348381|NCT01956890|PET|pet
5348382|NCT01956890|MRI|mri
5348383|NCT01956864|Vitamin D|vitamin d
5348384|NCT01956851|insulin, kisspeptin, GLP 1|insulin, kisspeptin, glp 1
5348385|NCT01956838|food intake|food intake
5348386|NCT01956838|tastants|tastants
5348387|NCT01956838|obesity|obesity
5348388|NCT01956825|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5348389|NCT01956825|LCARNITINE amino acid|lcarnitine amino acid
5348390|NCT01956825|magnesium|magnesium
5348391|NCT01956825|fat content|fat content
5348392|NCT01956812|clivatuzumab tetraxetan|clivatuzumab tetraxetan
5348393|NCT01956812|90Y-clivatuzumab tetraxetan|90y-clivatuzumab tetraxetan
5348394|NCT01956812|IMMU-107|immu-107
5348395|NCT01956799|MDS|mds
5348396|NCT01956799|PMF|pmf
5348397|NCT01956799|CMML|cmml
5348398|NCT01956799|AA|aa
5348399|NCT01956786|Amlodipine|amlodipine
5348400|NCT01956786|Folic Acid|folic acid
5963674|NCT04209621|Myeloid Cells and Myeloid Derived Suppressor Cells (MDSCs)|myeloid cells and myeloid derived suppressor cells (mdscs)
5963675|NCT04209621|T and Leukemic B Cells Aggregate|t and leukemic b cells aggregate
5963676|NCT04209595|PARP Inhibitor|parp inhibitor
5963677|NCT04209595|Chemotherapy|chemotherapy
5963678|NCT04209595|DDR Inhibitor|ddr inhibitor
5963679|NCT04209114|immunotherapy|immunotherapy
5348401|NCT01956786|Homocysteine|homocysteine
5348402|NCT01956786|Blood Pressure|blood pressure
5348403|NCT01956773|family health history|family health history
5348404|NCT01956773|prevention|prevention
5348405|NCT01956773|genetic risk|genetic risk
5348406|NCT01956773|clinical decision support|clinical decision support
5348407|NCT01956760|Insomnia|insomnia
5348408|NCT01956734|glioblastoma|glioblastoma
5348409|NCT01956734|first recurrence|first recurrence
5348410|NCT01956734|temozolomide|temozolomide
5348411|NCT01956721|Heart Failure , Skeletal muscle,Calcium,Ryanodine Receptor, Mitochondria, Exercise training, Muscle biopsy, Healthy volunteers|heart failure , skeletal muscle,calcium,ryanodine receptor, mitochondria, exercise training, muscle biopsy, healthy volunteers
5348412|NCT01956669|VEGF|vegf
5348413|NCT01956669|Pazopanib|pazopanib
5348414|NCT01956669|Sarcoma|sarcoma
5348415|NCT01956669|GW786034|gw786034
5348416|NCT01956669|Refractory Solid Tumors|refractory solid tumors
5348417|NCT01956656|lotus leaf, mouthwash, gingivitis|lotus leaf, mouthwash, gingivitis
5348418|NCT01956643|sham feeding|sham feeding
5348419|NCT01956643|postoperative ileus|postoperative ileus
5348420|NCT01956643|liver transplantation|liver transplantation
5348421|NCT01956591|Treatment efficacy|treatment efficacy
5348422|NCT01956591|Long-term effects|long-term effects
5348427|NCT01956591|Hyperhidrosis|hyperhidrosis
5348428|NCT01956591|Quality of life|quality of life
5348429|NCT01956565|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5348430|NCT01956565|Rehabilitation|rehabilitation
5348431|NCT01956565|Physiotherapy|physiotherapy
5348432|NCT01956565|Patient Compliance|patient compliance
5348433|NCT01956565|Inspiratory Muscle Training|inspiratory muscle training
5348434|NCT01956565|Respiratory Muscle Training|respiratory muscle training
5348436|NCT01956552|Tumor biopsy|tumor biopsy
5348437|NCT01956552|Phenotype and genotype characterization|phenotype and genotype characterization
5348438|NCT01956526|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5348439|NCT01956526|Diastolic Heart Failure (DHF)|diastolic heart failure (dhf)
5348440|NCT01956526|Diastolic Dysfunction (DD)|diastolic dysfunction (dd)
5348442|NCT01956513|breast cancer|breast cancer
5348443|NCT01956513|complete pathological response|complete pathological response
5348444|NCT01956500|glucosamine|glucosamine
5348445|NCT01956500|inflammation|inflammation
5348446|NCT01956500|quality of life|quality of life
5348447|NCT01956500|physical function|physical function
5348448|NCT01956487|Bioequivalence|bioequivalence
5348449|NCT01956487|RYTHMOL SR®|rythmol sr®
5348450|NCT01956487|Atrial fibrillation|atrial fibrillation
5348451|NCT01956487|Propafenone|propafenone
5348452|NCT01956487|Pharmavokinetics|pharmavokinetics
5348453|NCT01956474|keratoconus|keratoconus
5348454|NCT01956474|cross-linking|cross-linking
5348455|NCT01956474|Post-LASIK ectasia|post-lasik ectasia
5348456|NCT01956474|Pellucid marginal degeneration|pellucid marginal degeneration
5348457|NCT01956474|Forme fruste pellucid marginal degeneration|forme fruste pellucid marginal degeneration
5348458|NCT01956474|FFKC|ffkc
5348459|NCT01956474|Radial Keratotomy|radial keratotomy
5348460|NCT01956474|Terrien's Marginal Degeneration|terrien's marginal degeneration
5348461|NCT01956461|osteoporosis|osteoporosis
5348462|NCT01956461|BMD|bmd
5348463|NCT01956461|teriparatide|teriparatide
5348464|NCT01956461|nursing home|nursing home
5348465|NCT01956448|Percutaneous coronary intervention|percutaneous coronary intervention
5348467|NCT01956448|Angina pectoris|angina pectoris
5348468|NCT01956448|Stent|stent
5348469|NCT01956409|breast neoplasms|breast neoplasms
5348470|NCT01956409|18F-FCH PET|18f-fch pet
5348471|NCT01956409|MRI|mri
5348472|NCT01956396|male circumcision|male circumcision
5348473|NCT01956396|HIV|hiv
5348474|NCT01956396|Zimbabwe|zimbabwe
5348475|NCT01956383|male circumcision|male circumcision
5348476|NCT01956383|HIV|hiv
5348477|NCT01956383|Zimbabwe|zimbabwe
5348478|NCT01956370|Male Circumcision|male circumcision
5348479|NCT01956370|HIV Prevention|hiv prevention
5348480|NCT01956370|Medical Device|medical device
5348481|NCT01956357|aquatic exercises;|aquatic exercises;
5348482|NCT01956357|deep water running;|deep water running;
5348483|NCT01956357|diabetes;|diabetes;
5348484|NCT01956357|blood glucose;|blood glucose;
5348485|NCT01956357|inflammation.|inflammation.
5348486|NCT01956344|Hoarding Disorder|hoarding disorder
5348487|NCT01956344|Clutter|clutter
5348488|NCT01956344|CBT|cbt
5348489|NCT01956344|Cognitive behavior therapy|cognitive behavior therapy
5348490|NCT01956344|fMRI|fmri
5348491|NCT01956344|Obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
5348492|NCT01956344|Healthy control|healthy control
5671194|NCT00616824|postoperative pain|postoperative pain
5348493|NCT01956331|NSC lung Cancer,Elderly patients,post operative,|nsc lung cancer,elderly patients,post operative,
5348494|NCT01956318|Chronic venous insufficiency|chronic venous insufficiency
5348495|NCT01956318|Varicose vein|varicose vein
5348496|NCT01956318|Crenobalneotherapy|crenobalneotherapy
5348497|NCT01956318|Balneotherapy|balneotherapy
5348498|NCT01956318|Spa therapy|spa therapy
5348499|NCT01956279|Pregnenolone|pregnenolone
5348500|NCT01956279|Gulf War Veteran|gulf war veteran
5348501|NCT01956279|Fatigue|fatigue
5215531|NCT02649075|IBD|ibd
5348502|NCT01956279|Musculoskeletal Pain|musculoskeletal pain
5348503|NCT01956279|Cognitive Decline|cognitive decline
5348504|NCT01956279|Placebo Control|placebo control
5348505|NCT01956266|Prosody|prosody
5348506|NCT01956266|Communication|communication
5348507|NCT01956266|Dysarthria|dysarthria
5348508|NCT01956253|Bladder Cancer|bladder cancer
5348509|NCT01956253|Neratinib|neratinib
5348510|NCT01956253|13-2526|13-2526
5348511|NCT01956240|shoulder|shoulder
5348512|NCT01956240|pectoralis minor|pectoralis minor
5348513|NCT01956240|stretching|stretching
5348514|NCT01956240|scapular kinematics|scapular kinematics
5348515|NCT01956214|hemodialysis|hemodialysis
5348516|NCT01956214|exercise|exercise
5348517|NCT01956214|electrical stimulation|electrical stimulation
5348518|NCT01956175|electrical pharyngeal stimulation|electrical pharyngeal stimulation
5348519|NCT01956175|stroke-related dysphagia|stroke-related dysphagia
5348520|NCT01956175|tracheostomy|tracheostomy
5348521|NCT01956175|decannulation|decannulation
5348522|NCT01956149|gastric cancer|gastric cancer
5348523|NCT01956149|second-line treatment|second-line treatment
5348524|NCT01956149|Cabazitaxel|cabazitaxel
5348525|NCT01956149|response|response
5348526|NCT01956045|Intensive Care Units|intensive care units
5348527|NCT01956045|Judgment|judgment
5348528|NCT01956045|Disability Evaluation|disability evaluation
5348529|NCT01956045|Autonomy|autonomy
5348530|NCT01956032|LCIG|lcig
5348531|NCT01956032|Parkinson's disease|parkinson's disease
5348532|NCT01956032|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
5348533|NCT01956032|Telemedicine|telemedicine
5344555|NCT01973816|deep endometriosis;|deep endometriosis;
5348534|NCT01955993|Obesity, adolescence,pharmacokinetics,fentanyl|obesity, adolescence,pharmacokinetics,fentanyl
5348535|NCT01955980|CRS|crs
5348536|NCT01955980|without polyposis|without polyposis
5348537|NCT01955967|Effect|effect
5348538|NCT01955967|Lidocaine|lidocaine
5348539|NCT01955954|carbon dioxide monitoring|carbon dioxide monitoring
5348540|NCT01955954|panic disorder|panic disorder
5348541|NCT01955954|biofeedback|biofeedback
5348542|NCT01955954|breathing training|breathing training
5348543|NCT01955954|Primary diagnosis|primary diagnosis
5348544|NCT01955954|panic attacks|panic attacks
5348545|NCT01955941|Uveal melanoma|uveal melanoma
5348546|NCT01955941|brachytherapy|brachytherapy
5348547|NCT01955941|radiation|radiation
5348548|NCT01955941|ciliary body|ciliary body
5348550|NCT01955941|I-125 plaque brachytherapy|i-125 plaque brachytherapy
5348551|NCT01955915|choroid|choroid
5348552|NCT01955915|tumor|tumor
5348553|NCT01955915|OCT|oct
5348554|NCT01955915|malignant melanoma|malignant melanoma
5348555|NCT01955902|Opioid dependence|opioid dependence
5348556|NCT01955902|Buprenorphine|buprenorphine
5348557|NCT01955902|Adherence|adherence
5348558|NCT01955902|Substance use|substance use
5348559|NCT01955902|Suboxone|suboxone
5348560|NCT01955889|Exercise|exercise
5348561|NCT01955889|Rehabilitation|rehabilitation
5348562|NCT01955889|Telemedicine|telemedicine
5348563|NCT01955876|Fosrenol|fosrenol
5348564|NCT01955876|hyperphosphatemia|hyperphosphatemia
5348565|NCT01955876|chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
5348566|NCT01955863|Prostatic Neoplasms|prostatic neoplasms
5348567|NCT01955863|Prostatectomy, Retropubic|prostatectomy, retropubic
5348568|NCT01955863|Patient Discharge|patient discharge
5348569|NCT01955824|bronchoscopy|bronchoscopy
5348570|NCT01955824|lignocaine|lignocaine
5348571|NCT01955824|cough|cough
5348572|NCT01955811|platelet transfusion|platelet transfusion
5348573|NCT01955811|Fibrinogen|fibrinogen
5348574|NCT01955811|blood coagulation|blood coagulation
5348575|NCT01955811|Thrombocytopenia|thrombocytopenia
5348576|NCT01955811|in-vitro experiments|in-vitro experiments
5348577|NCT01955811|FGTW|fgtw
5348578|NCT01955811|Fit2012|fit2012
5348579|NCT01955811|factor I|factor i
5348580|NCT01955811|Fibrin|fibrin
5348581|NCT01955798|Laparoscopy|laparoscopy
5348582|NCT01955798|Gyneacological|gyneacological
5348583|NCT01955798|Entry techniques|entry techniques
5348584|NCT01955785|Traumatic brain injury|traumatic brain injury
5348585|NCT01955785|Intracranial pressure|intracranial pressure
5348586|NCT01955785|Ventilation|ventilation
5348587|NCT01955785|Respiratory therapy|respiratory therapy
5348588|NCT01955772|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
5348589|NCT01955772|Malignant hemopathy|malignant hemopathy
5348590|NCT01955772|Artificial nutrition|artificial nutrition
5348591|NCT01955694|BAY94-8862|bay94-8862
5348592|NCT01955694|MR antagonist|mr antagonist
5963680|NCT04209114|NKTR-214|nktr-214
5963681|NCT04209114|nivolumab|nivolumab
5963682|NCT04209075|Metformin|metformin
5963683|NCT04209075|Type 2 Diabetes|type 2 diabetes
5963684|NCT04209075|Youth|youth
5963685|NCT04209075|Microbiome|microbiome
5963686|NCT04209075|Gastrointestinal Side Effects|gastrointestinal side effects
5348593|NCT01955694|Heart failure|heart failure
5348594|NCT01955694|Japanese patients|japanese patients
5348595|NCT01955681|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor retrement.|epidermal growth factor receptor tyrosine kinase inhibitor retrement.
5963687|NCT04208490|Survivorship|survivorship
5227656|NCT02577289|PRF|prf
5348596|NCT01955668|11q-deleted relapsed/refractory chronic lymphocytic leukaemia|11q-deleted relapsed/refractory chronic lymphocytic leukaemia
5348597|NCT01955668|Prolymphocytic leukaemia|prolymphocytic leukaemia
5348598|NCT01955668|B cell lymphomas|b cell lymphomas
5348599|NCT01955655|Baclofen|baclofen
5348600|NCT01955655|cerebral palsy|cerebral palsy
5348601|NCT01955655|colic|colic
5348602|NCT01955655|crying infant|crying infant
5348603|NCT01955655|recurrent crying spells|recurrent crying spells
5348604|NCT01955655|spasticity|spasticity
5348605|NCT01955655|therapy|therapy
5348606|NCT01955642|Clopidogrel|clopidogrel
5348607|NCT01955642|Brain Ischemia|brain ischemia
5348608|NCT01955642|Ischemic attack|ischemic attack
5348609|NCT01955642|Biological response to clopidogrel|biological response to clopidogrel
5348610|NCT01955616|Parkinson's disease, chronic constipation|parkinson's disease, chronic constipation
5348611|NCT01955590|Metacognitive therapy|metacognitive therapy
5348612|NCT01955590|Eye Movement Desensitization Reprocessing (EMDR)|eye movement desensitization reprocessing (emdr)
5348613|NCT01955590|Cognitive therapy|cognitive therapy
5348614|NCT01955577|Vitamin D deficiency|vitamin d deficiency
5348615|NCT01955577|Ring fixator|ring fixator
5352525|NCT01937455|HIV|hiv
5348616|NCT01955577|Tibial fracture|tibial fracture
5348617|NCT01955525|Acute coronary syndrome|acute coronary syndrome
5348618|NCT01955525|health related quality of life|health related quality of life
5348620|NCT01955486|flight simulation|flight simulation
5348621|NCT01955486|middle ear|middle ear
5348622|NCT01955486|Eustachian tube function|eustachian tube function
5348623|NCT01955473|Solid tumors|solid tumors
5348624|NCT01955473|Sym004|sym004
5348625|NCT01955473|Phase 1|phase 1
5348626|NCT01955447|Blood glucose|blood glucose
5348627|NCT01955421|NSCLC|nsclc
5348628|NCT01955421|stage IIIB|stage iiib
5348629|NCT01955421|stage IV)|stage iv)
5348630|NCT01955421|confirmed by histology or cytology methods|confirmed by histology or cytology methods
5862782|NCT00001512|Indolent Lymphoma|indolent lymphoma
5862783|NCT00001512|Anti-Idiotype Antibody|anti-idiotype antibody
5862784|NCT00001512|GM-CSF|gm-csf
5348631|NCT01955421|Harboring a PCR-confirmed activating mutation of EGFR, including an exon 19 deletion or an exon 21 L858R point mutation|harboring a pcr-confirmed activating mutation of egfr, including an exon 19 deletion or an exon 21 l858r point mutation
5348632|NCT01955408|overactive bladder|overactive bladder
5348634|NCT01955408|Synergo|synergo
5348635|NCT01955408|urodynamic study|urodynamic study
5348636|NCT01955395|Relaxation Response Resiliency Program (3RP)|relaxation response resiliency program (3rp)
5348637|NCT01955395|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5348638|NCT01955395|smoldering multiple myeloma|smoldering multiple myeloma
5348639|NCT01955382|Parasite Clearance Rate|parasite clearance rate
5348640|NCT01955382|Parasite Half Life|parasite half life
5348641|NCT01955382|Actidose Aqua|actidose aqua
5348642|NCT01955382|Severe Malaria|severe malaria
5348643|NCT01955369|incidence|incidence
5348644|NCT01955369|phenotype|phenotype
5348645|NCT01955369|mortality|mortality
5348646|NCT01955356|Scratching|scratching
5348647|NCT01955356|Endometrial biopsy|endometrial biopsy
5348648|NCT01955356|Ongoing embryo implantation|ongoing embryo implantation
5348649|NCT01955356|Assisted reproductive techniques|assisted reproductive techniques
5348650|NCT01955343|Immune response|immune response
5348651|NCT01955343|Cancer|cancer
5348652|NCT01955330|CABG, Hybrid, Robotic surgery|cabg, hybrid, robotic surgery
5348653|NCT01955317|Neonate|neonate
5348654|NCT01955317|Bangladesh|bangladesh
5348655|NCT01955317|Health behavior|health behavior
5348656|NCT01955317|Handwashing|handwashing
5348657|NCT01955317|Developing countries|developing countries
5348658|NCT01955317|Infectious disease|infectious disease
5348659|NCT01955291|Virtual Reality, Motor Learning, Rehabilitation, Upper Limb|virtual reality, motor learning, rehabilitation, upper limb
5348660|NCT01955278|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5348661|NCT01955278|Parastomal hernia|parastomal hernia
5348662|NCT01955278|Prophylactic|prophylactic
5348663|NCT01955278|Mesh|mesh
5348664|NCT01955265|Positive youth development|positive youth development
5348665|NCT01955265|Sports / physical activity|sports / physical activity
5348666|NCT01955252|Endemic treponematoses|endemic treponematoses
5348667|NCT01955252|Azithromycin|azithromycin
5348668|NCT01955252|Mass drug administration|mass drug administration
5348669|NCT01955252|Eradication|eradication
5348670|NCT01955239|Head and Neck Cancer|head and neck cancer
5348671|NCT01955239|Radiotherapy|radiotherapy
5348672|NCT01955239|IMRT|imrt
5348673|NCT01955239|Stem cell|stem cell
5348674|NCT01955239|Parotid gland|parotid gland
5348675|NCT01955213|constipation, methylnaltrexone, opoid|constipation, methylnaltrexone, opoid
5348676|NCT01955200|Stent implantation|stent implantation
5348677|NCT01955200|Clopidogrel low response|clopidogrel low response
5348678|NCT01955200|Ticagrelor|ticagrelor
5348679|NCT01955200|Cilostazol|cilostazol
5348680|NCT01955200|Clopidogrel|clopidogrel
5348681|NCT01955187|SEQUENTIAL THERAPY|sequential therapy
5348682|NCT01955187|PRIMARY MEMBRANOUS NEPHROPATHY|primary membranous nephropathy
5963688|NCT04208321|Adults|adults
5963689|NCT04208321|Healthy|healthy
5963690|NCT04208321|Pharmacokinetics|pharmacokinetics
5348683|NCT01955187|TACROLIMUS|tacrolimus
5348684|NCT01955187|RITUXIMAB|rituximab
5348685|NCT01955174|Botulinum toxin|botulinum toxin
5348686|NCT01955174|Esophageal motility disorder|esophageal motility disorder
5348687|NCT01955174|Distal esophageal spasm|distal esophageal spasm
5348689|NCT01955148|sPTB|sptb
5348690|NCT01955148|cervical cerclage|cervical cerclage
5348691|NCT01955148|LEEP|leep
5348692|NCT01955148|PROM|prom
5348693|NCT01955148|short cervix|short cervix
5348694|NCT01955135|Prematurity, Retinopathy, propofol, ketamine, sedation|prematurity, retinopathy, propofol, ketamine, sedation
5348695|NCT01955122|polyp/adenoma miss rate|polyp/adenoma miss rate
5348696|NCT01955122|colonoscopy add-on device|colonoscopy add-on device
5348697|NCT01955122|enhanced screening|enhanced screening
5348698|NCT01955109|Food allergy|food allergy
5348699|NCT01955109|Immediate hypersensitivity|immediate hypersensitivity
5348700|NCT01955109|Whole peanut extract|whole peanut extract
5348701|NCT01955109|Allergenic product|allergenic product
5348702|NCT01955109|Specific Immunotherapy|specific immunotherapy
5348703|NCT01955109|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5348704|NCT01955096|fast-track surgery, laparoscopic gastrectomy|fast-track surgery, laparoscopic gastrectomy
5348705|NCT01955083|Obstructive sleep apnea|obstructive sleep apnea
5348706|NCT01955083|snoring|snoring
5348707|NCT01955083|radiofrequency|radiofrequency
5348708|NCT01955083|pillar implant|pillar implant
5348709|NCT01955083|snore sound analysis|snore sound analysis
5348710|NCT01955070|Informed consent|informed consent
5348712|NCT01955044|neonatal prematurity|neonatal prematurity
5348713|NCT01955044|infant, extremely low birth weight|infant, extremely low birth weight
5348714|NCT01955044|fatty acids, polyunsaturated|fatty acids, polyunsaturated
5348715|NCT01955031|Telemedicine|telemedicine
5348716|NCT01955031|Telemonitoring|telemonitoring
5348717|NCT01955031|Education|education
5348718|NCT01955031|Nutrition|nutrition
5348719|NCT01955031|Food behaviour|food behaviour
5348720|NCT01955031|Weight|weight
5348721|NCT01955031|Physical activity|physical activity
5348722|NCT01955031|Glycaemia|glycaemia
5348723|NCT01955031|Self-monitoring blood glucose|self-monitoring blood glucose
5348724|NCT01955018|computed tomography|computed tomography
5348725|NCT01955018|radiation|radiation
5348726|NCT01955018|screening|screening
5348727|NCT01955018|asbestos|asbestos
5348728|NCT01955018|workers|workers
5348729|NCT01955018|cancer|cancer
5348730|NCT01955005|Health Records, Personal|health records, personal
5348731|NCT01955005|Delivery of healthcare|delivery of healthcare
5348732|NCT01955005|Consumer Participation|consumer participation
5348733|NCT01955005|Internet|internet
5348734|NCT01954992|glufosfamide|glufosfamide
5348735|NCT01954992|5-FU|5-fu
5348736|NCT01954992|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5348737|NCT01954979|Graft versus Host Disease|graft versus host disease
5348738|NCT01954979|ABATACEPT|abatacept
5348739|NCT01954966|Nicotine|nicotine
5348740|NCT01954966|Smoking|smoking
5348741|NCT01954953|Retinitis Pigmentosa Syndromic|retinitis pigmentosa syndromic
5348742|NCT01954953|Congenital Deafness|congenital deafness
5348743|NCT01954953|Usher Syndrome Retinitis Pigmentosa and Deafness|usher syndrome retinitis pigmentosa and deafness
5348744|NCT01954953|Progressive Hearing Loss|progressive hearing loss
5348745|NCT01954953|Retinitis Pigmentosa|retinitis pigmentosa
5348746|NCT01954940|Whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.|whole body vibration therapy, muscle strength testing, bone health, ambulatory, endurance.
5348747|NCT01954927|Pain control|pain control
5348748|NCT01954914|Plerixafor|plerixafor
5348749|NCT01954914|donor|donor
5348750|NCT01954914|allogeneic peripheral stam cell donation|allogeneic peripheral stam cell donation
5348751|NCT01954914|PBSC|pbsc
5348753|NCT01954875|neurodegenerative diseases|neurodegenerative diseases
5348754|NCT01954875|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5348755|NCT01954875|multiple sclerosis|multiple sclerosis
5348756|NCT01954875|Parkinson's Disease|parkinson's disease
5348757|NCT01954862|Water-aided colonoscopy|water-aided colonoscopy
5348758|NCT01954862|Water Immersion colonoscopy|water immersion colonoscopy
5348759|NCT01954862|Water Exchange colonoscopy|water exchange colonoscopy
5348760|NCT01954862|Carbon-dioxide colonoscopy|carbon-dioxide colonoscopy
5348761|NCT01954862|Painless unsedated colonoscopy|painless unsedated colonoscopy
5348762|NCT01954862|Adenoma detection rate|adenoma detection rate
5348763|NCT01954862|Mean Adenomas per Procedure|mean adenomas per procedure
5348764|NCT01954849|gingivitis|gingivitis
5348765|NCT01954849|inflammation|inflammation
5348766|NCT01954849|plaque|plaque
5348767|NCT01954849|orthodontics|orthodontics
5348768|NCT01954836|short-term fasting|short-term fasting
5348769|NCT01954836|adjuvant chemotherapy|adjuvant chemotherapy
5348770|NCT01954836|toxicity|toxicity
5348771|NCT01954836|side-effects|side-effects
5963691|NCT04208321|Phase 1|phase 1
5963692|NCT04208321|Safety|safety
5963693|NCT04208321|Single Oral Doses|single oral doses
5963694|NCT04208321|Tolerability|tolerability
5963695|NCT04208321|VT-1598|vt-1598
5963696|NCT04208256|pediatric obesity|pediatric obesity
5963697|NCT04208256|resting-state functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
5963698|NCT04208256|disinhibited eating behavior|disinhibited eating behavior
5227799|NCT02576691|cardiac arrest|cardiac arrest
5227800|NCT02576691|percutaneous coronary intervention|percutaneous coronary intervention
5227801|NCT02576691|cardiogenic shock|cardiogenic shock
5227802|NCT02576691|outcome|outcome
5227812|NCT02576665|Anaplastic Astrocytoma, Glioblastoma|anaplastic astrocytoma, glioblastoma
5227813|NCT02576652|bone biopsy|bone biopsy
5227814|NCT02576652|tetracycline|tetracycline
5227815|NCT02576652|demeclocycline|demeclocycline
5227816|NCT02576652|total hip replacement|total hip replacement
5227817|NCT02576639|Alzheimer's Disease,|alzheimer's disease,
5227818|NCT02576639|Amyloid Beta,|amyloid beta,
5227819|NCT02576639|cerebrospinal fluid,|cerebrospinal fluid,
5227820|NCT02576639|beta secretase|beta secretase
5227821|NCT02576626|Nebulizer|nebulizer
5227823|NCT02576626|COPD|copd
5227824|NCT02576626|indacaterol|indacaterol
5227825|NCT02576626|ipratropium|ipratropium
5348772|NCT01954836|ovarial carinoma|ovarial carinoma
5348773|NCT01954836|breast cancer|breast cancer
5348774|NCT01954823|Multiple sclerosis, Patient-reported outcomes, patient diary|multiple sclerosis, patient-reported outcomes, patient diary
5348775|NCT01954810|JECV|jecv
5348776|NCT01954810|IMOJEV|imojev
5348777|NCT01954810|Booster response|booster response
5348778|NCT01954810|Children|children
5348779|NCT01954810|antibody response|antibody response
5348780|NCT01954810|Duration|duration
5348781|NCT01954797|Physical fitness|physical fitness
5348782|NCT01954797|relaxation|relaxation
5348783|NCT01954797|stroke|stroke
5348784|NCT01954797|cerebral ischemia|cerebral ischemia
5348785|NCT01954797|cerebral perfusion|cerebral perfusion
5348786|NCT01954797|biomarkers|biomarkers
5348788|NCT01954771|Diabetes mellitus|diabetes mellitus
5348789|NCT01954771|Coronary artery disease|coronary artery disease
5348790|NCT01954771|SMBG|smbg
5348791|NCT01954771|Elderly|elderly
5348792|NCT01954758|Window of implantation|window of implantation
5348793|NCT01954758|Personalized embryo transfer|personalized embryo transfer
5348794|NCT01954758|Fresh embryo transfer|fresh embryo transfer
5348795|NCT01954758|Delayed embryo transfer|delayed embryo transfer
5348796|NCT01954758|Elective deferred embryo transfer|elective deferred embryo transfer
5348797|NCT01954758|Endometrial receptivity array|endometrial receptivity array
5348798|NCT01954758|Endometrial receptivity analysis|endometrial receptivity analysis
5348799|NCT01954758|Endometrial receptivity test|endometrial receptivity test
5348800|NCT01954758|Frozen embryo transfer|frozen embryo transfer
5348801|NCT01954745|Bile Duct Cancer|bile duct cancer
5348802|NCT01954745|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5348803|NCT01954745|extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
5348804|NCT01954745|Cabozantinib|cabozantinib
5348805|NCT01954719|Cervix Uteri, Cesarean Section, Infection, Dilatation|cervix uteri, cesarean section, infection, dilatation
5348806|NCT01954693|Tuberous Sclerosis|tuberous sclerosis
5348807|NCT01954693|Everolimus|everolimus
5348808|NCT01954693|Neurocognitive functioning|neurocognitive functioning
5348809|NCT01954680|bipolar disorder|bipolar disorder
5348811|NCT01954680|adolescent|adolescent
5348812|NCT01954667|Gastroesophageal Reflux Disease; Anthropometric Measures; Leptin|gastroesophageal reflux disease; anthropometric measures; leptin
5348813|NCT01954641|breast cancer|breast cancer
5348814|NCT01954641|lung cancer|lung cancer
5348815|NCT01954641|cancer treatments|cancer treatments
5348816|NCT01954641|racial inequity|racial inequity
5348817|NCT01954641|health systems change|health systems change
5348818|NCT01954641|transparency|transparency
5348819|NCT01954641|accountability|accountability
5348820|NCT01954628|Exacerbation of COPD|exacerbation of copd
5348821|NCT01954628|Unstable COPD|unstable copd
5348822|NCT01954615|ACT-281959|act-281959
5348823|NCT01954615|ACT-246475|act-246475
5348824|NCT01954602|Biliary cannulation|biliary cannulation
5348825|NCT01954602|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5348826|NCT01954602|Touch guide-wire techniques|touch guide-wire techniques
5348827|NCT01954602|No touch guide-wire techniques|no touch guide-wire techniques
5348828|NCT01954589|ACT-462206|act-462206
5348829|NCT01954589|Selective dual orexin receptor antagonist|selective dual orexin receptor antagonist
5348830|NCT01954576|bevacizumab-naïve recurrent GBM|bevacizumab-naïve recurrent gbm
5348831|NCT01954576|bevacizumab-refractory GBM|bevacizumab-refractory gbm
5963699|NCT04208074|Exercise|exercise
5963700|NCT04208074|Resistance Exercise|resistance exercise
5963701|NCT04208074|T cells|t cells
5963702|NCT04208074|Immune system|immune system
5963703|NCT04207632|Shear wave elastography|shear wave elastography
5963704|NCT04207632|Portable spasticity assessment device|portable spasticity assessment device
5963705|NCT04207632|Feasibility|feasibility
5963706|NCT04207632|Outcome measure|outcome measure
5963707|NCT04207632|Reliability|reliability
5963708|NCT04207632|Validity|validity
5963709|NCT04207632|Clinimetrics|clinimetrics
5963710|NCT04207437|Neuropathy|neuropathy
5963711|NCT04207437|Vibration|vibration
5963712|NCT04206813|Gardasil|gardasil
5963713|NCT04206813|Immunogenicity|immunogenicity
5963714|NCT04206813|9-valent 2-dose HPV vaccination|9-valent 2-dose hpv vaccination
5963715|NCT04206813|9-valent 3-dose HPV vaccination|9-valent 3-dose hpv vaccination
5963716|NCT04206670|Caregivers|caregivers
5963717|NCT04206670|Dementia|dementia
5963718|NCT04206670|Mild Cognitive Impairment|mild cognitive impairment
5963719|NCT04206670|In-Home Technology|in-home technology
5963720|NCT04206332|Prevention and Control|prevention and control
5227902|NCT02576275|Phase 3|phase 3
5348832|NCT01954563|Tuberculosis|tuberculosis
5348833|NCT01954563|Vaccine|vaccine
5348834|NCT01954563|Immunogenicity|immunogenicity
5348835|NCT01954550|Exercise|exercise
5348836|NCT01954550|Dementia|dementia
5348837|NCT01954550|Cognition|cognition
5348838|NCT01954550|Brain Volume|brain volume
5348839|NCT01954550|Aging|aging
5348840|NCT01954537|Exertional heat illness|exertional heat illness
5348841|NCT01954537|Hydration Status|hydration status
5348842|NCT01954537|Preseason football|preseason football
5348843|NCT01954537|heat stroke|heat stroke
5348844|NCT01954511|Stomatognathic diseases;|stomatognathic diseases;
5348845|NCT01954511|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
5348846|NCT01954498|Randomized controlled trial|randomized controlled trial
5348847|NCT01954498|Spermatozoa|spermatozoa
5348848|NCT01954498|Sperm|sperm
5348849|NCT01954498|Male Infertility|male infertility
5348850|NCT01954498|Walnuts|walnuts
5348851|NCT01954498|Nutrition|nutrition
5348852|NCT01954498|Male Reproduction|male reproduction
5348853|NCT01954485|LaserLok, connective tissue, adhesion|laserlok, connective tissue, adhesion
5348854|NCT01954472|Portfolio diet|portfolio diet
5348855|NCT01954472|dietary modification|dietary modification
5348856|NCT01954472|hypercholesterolemia|hypercholesterolemia
5348857|NCT01954472|diabetes|diabetes
5348858|NCT01954472|Exercise|exercise
5348859|NCT01954472|CVD risk|cvd risk
5348860|NCT01954472|glycemic index|glycemic index
5348861|NCT01954472|inflammatory biomarkers|inflammatory biomarkers
5348862|NCT01954472|monounsaturated fat|monounsaturated fat
5348863|NCT01954472|saturated fat|saturated fat
5348864|NCT01954472|nuts|nuts
5348865|NCT01954472|plant sterols|plant sterols
5348866|NCT01954472|vegetable protein|vegetable protein
5348867|NCT01954472|viscous fiber|viscous fiber
5348868|NCT01954472|soy|soy
5348869|NCT01954459|Type 1 diabetes|type 1 diabetes
5348870|NCT01954459|Continuous glucose sensor|continuous glucose sensor
5348871|NCT01954459|Insupatch|insupatch
5348872|NCT01954433|Cost-effectiveness analyses|cost-effectiveness analyses
5348873|NCT01954433|Cost-utility analyses|cost-utility analyses
5348874|NCT01954433|Upper extremity|upper extremity
5348875|NCT01954433|Orthopedic|orthopedic
5348876|NCT01954433|Shoulder arthroplasty|shoulder arthroplasty
5348877|NCT01954433|Rotator cuff tear repair|rotator cuff tear repair
5348878|NCT01954433|Resection interposition suspension arthroplasty|resection interposition suspension arthroplasty
5348879|NCT01954420|Pain|pain
5348880|NCT01954420|Fatigue|fatigue
5348881|NCT01954420|Sleep|sleep
5348882|NCT01954420|Cancer|cancer
5348883|NCT01954420|Relaxation|relaxation
5348884|NCT01954420|Distraction|distraction
5348885|NCT01954420|Symptoms|symptoms
5348886|NCT01954407|smoking-related messages|smoking-related messages
5348887|NCT01954407|anti-smoking messages|anti-smoking messages
5348888|NCT01954407|smoking-related beliefs|smoking-related beliefs
5348889|NCT01954407|anti-smoking intentions|anti-smoking intentions
5348890|NCT01954355|advanced solid tumor|advanced solid tumor
5348891|NCT01954355|ovarian cancer|ovarian cancer
5348892|NCT01954355|LDE225|lde225
5348893|NCT01954355|Paclitaxel|paclitaxel
5348894|NCT01954355|Hedgehog inhibitor|hedgehog inhibitor
5348895|NCT01954342|Pregnancy|pregnancy
5348896|NCT01954342|Postpartum|postpartum
5348897|NCT01954329|Biomarkers|biomarkers
5348898|NCT01954329|TIA|tia
5348899|NCT01954329|Diagnosis|diagnosis
5348900|NCT01954316|advanced cancer|advanced cancer
5348901|NCT01954316|CFI-400945 fumarate|cfi-400945 fumarate
5348902|NCT01954316|polo-like kinase 4|polo-like kinase 4
5348903|NCT01954316|PLK4|plk4
5348904|NCT01954316|tablet|tablet
5348905|NCT01954316|dose escalation|dose escalation
5348906|NCT01954316|genetic testing|genetic testing
5348907|NCT01954290|Stroke|stroke
5348908|NCT01954290|Brain Edema|brain edema
5348909|NCT01954290|Brain Herniation|brain herniation
5348910|NCT01954290|Conivaptan|conivaptan
5348911|NCT01954277|Chronic Tension-Type Headache|chronic tension-type headache
5348912|NCT01954277|Electroacupuncture|electroacupuncture
5348913|NCT01954277|Headache Impact|headache impact
5348914|NCT01954277|BDNF|bdnf
5348916|NCT01954264|Saharan Western Africa|saharan western africa
5348917|NCT01954264|Epidemiology|epidemiology
5348918|NCT01954264|Post-Approval Programme study|post-approval programme study
5348919|NCT01954264|Malaria|malaria
5348935|NCT01954199|Low back pain|low back pain
5348936|NCT01954186|Oxytocin|oxytocin
5348937|NCT01954186|Active Management of Third Stage of Labour|active management of third stage of labour
5348938|NCT01954134|Tumor Suppressor Protein p53,|tumor suppressor protein p53,
5348939|NCT01954134|Iodine Radioisotopes|iodine radioisotopes
5348940|NCT01954121|Levetiracetam|levetiracetam
5348941|NCT01954121|Keppra|keppra
5348942|NCT01954121|Monotherapy|monotherapy
5348943|NCT01954121|China|china
5348944|NCT01954121|Epilepsy|epilepsy
5348945|NCT01954121|Partial-onset Seizures|partial-onset seizures
5348946|NCT01954108|tendinopathy|tendinopathy
5963721|NCT04206332|Mosquito|mosquito
5348947|NCT01954108|hyaluronan|hyaluronan
5348948|NCT01954108|tendon|tendon
5228004|NCT02575482|safety|safety
5348949|NCT01954108|hyaluronic acid|hyaluronic acid
5348950|NCT01954108|extracorporeal shock wave|extracorporeal shock wave
5348951|NCT01954095|17-OHPC, Prometrium, Cerclage, Pre-term birth, Short cervix|17-ohpc, prometrium, cerclage, pre-term birth, short cervix
5348952|NCT01954082|Retinopathy|retinopathy
5348953|NCT01954082|Prematurity|prematurity
5348954|NCT01954082|Infant, Newborn, Diseases|infant, newborn, diseases
5348955|NCT01954056|NICHD Neonatal Research Network|nichd neonatal research network
5348956|NCT01954056|Mechanical ventilation|mechanical ventilation
5348957|NCT01954056|Intubation|intubation
5348958|NCT01954056|Neurodevelopmental impairment|neurodevelopmental impairment
5348959|NCT01954043|melanoma|melanoma
5348960|NCT01954043|dabrafenib|dabrafenib
5348961|NCT01954043|BRAF V600|braf v600
5348962|NCT01954043|rabeprazole|rabeprazole
5348963|NCT01954043|rifampin|rifampin
5348964|NCT01954030|Carboxyamidotriazole Orotate|carboxyamidotriazole orotate
5348965|NCT01954030|CTO|cto
5348966|NCT01954030|Bevacizumab|bevacizumab
5348967|NCT01954030|Avastin|avastin
5348968|NCT01954030|Malignant Glioma|malignant glioma
5348969|NCT01954030|Pro00044274|pro00044274
5348970|NCT01954030|Desjardins|desjardins
5348971|NCT01954030|Duke|duke
5671195|NCT00616824|complication|complication
5348972|NCT01954030|The Preston Robert Tisch Brain Tumor Center|the preston robert tisch brain tumor center
5348973|NCT01953978|Pain|pain
5348974|NCT01953978|Analgesia|analgesia
5348975|NCT01953978|Postoperative|postoperative
5348976|NCT01953978|Dexamethasone|dexamethasone
5348977|NCT01953978|Spine surgery|spine surgery
5348978|NCT01953926|Neratinib|neratinib
5348979|NCT01953926|Nerlynx|nerlynx
5348980|NCT01953926|Breast|breast
5348981|NCT01953926|Gastroesophageal|gastroesophageal
5348982|NCT01953926|Endometrial|endometrial
5348983|NCT01953926|Ovarian|ovarian
5348984|NCT01953926|Biliary Tract|biliary tract
5348985|NCT01953926|Solid Tumors|solid tumors
5348986|NCT01953926|Cancer|cancer
5348987|NCT01953926|HER2|her2
5348988|NCT01953926|HER4|her4
5348989|NCT01953926|EGFR|egfr
5348990|NCT01953926|Bladder/Urinary Tract|bladder/urinary tract
5348991|NCT01953926|Paclitaxel|paclitaxel
5348992|NCT01953926|Fulvestrant|fulvestrant
5348993|NCT01953926|Trastuzumab|trastuzumab
5348994|NCT01953926|Fibrolamellar Carcinoma|fibrolamellar carcinoma
5348995|NCT01953900|Osteosarcoma|osteosarcoma
5348996|NCT01953900|T-Cells|t-cells
5348997|NCT01953900|varicella zoster virus (VZV)|varicella zoster virus (vzv)
5348998|NCT01953900|GD2|gd2
5348999|NCT01953900|Neuroblastoma|neuroblastoma
5349000|NCT01953887|Phase I|phase i
5349001|NCT01953887|Final formulation EC905|final formulation ec905
5349002|NCT01953887|Solifenacin succinate|solifenacin succinate
5349003|NCT01953887|Tamsulosin HCl|tamsulosin hcl
5349004|NCT01953887|Marketed drugs|marketed drugs
5349005|NCT01953874|heart failure|heart failure
5349006|NCT01953874|congestive heart failure|congestive heart failure
5243911|NCT02480803|Duodopa|duodopa
5349007|NCT01953874|acute decompensated heart failure|acute decompensated heart failure
5345060|NCT01971684|platelet count|platelet count
5349027|NCT01953848|Vesomni|vesomni
5349028|NCT01953848|VesiFlow|vesiflow
5349029|NCT01953848|Urizia|urizia
5349030|NCT01953835|Pharmacokinetics|pharmacokinetics
5349031|NCT01953835|GSK2586184|gsk2586184
5349032|NCT01953835|Simvastatin|simvastatin
5349033|NCT01953835|Rosuvastatin|rosuvastatin
5349034|NCT01953835|Poloxamer|poloxamer
5349035|NCT01953822|Observational|observational
5349036|NCT01953822|Cohort|cohort
5349037|NCT01953822|Autoimmune disease|autoimmune disease
5349038|NCT01953822|Cervarix®|cervarix®
5349039|NCT01953822|Women aged 9 to 25 years|women aged 9 to 25 years
5349334|NCT01952223|relapse|relapse
5349052|NCT01953744|Fluconazole; Meglumine antimoniate;L.Braziliensis;|fluconazole; meglumine antimoniate;l.braziliensis;
5349053|NCT01953744|L.Guyanensis|l.guyanensis
5349054|NCT01953731|palbociclib|palbociclib
5349055|NCT01953731|PD-0332991|pd-0332991
5349056|NCT01953731|rifampin|rifampin
5349057|NCT01953731|drug-drug interaction study|drug-drug interaction study
5349058|NCT01953705|omega 3 fatty acids|omega 3 fatty acids
5349059|NCT01953705|cognitive decline|cognitive decline
5349061|NCT01953705|endothelial function|endothelial function
5349062|NCT01953705|white matter|white matter
5349063|NCT01953705|executive function|executive function
5349064|NCT01953705|prevention|prevention
5349065|NCT01953705|DTI|dti
5349066|NCT01953705|ASL|asl
5349067|NCT01953692|PD1|pd1
5349068|NCT01953692|PD-1|pd-1
5349069|NCT01953692|PDL1|pdl1
5349070|NCT01953692|PD-L1|pd-l1
5349071|NCT01953666|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury|word prediction software, text input speed, copm, occupational therapist, rehabilitation, spinal cord injury
5349072|NCT01953614|quantitative encephalography|quantitative encephalography
5349073|NCT01953614|brain computer interface|brain computer interface
5349074|NCT01953614|chiropractic|chiropractic
5349075|NCT01953614|sacro-occipital technique|sacro-occipital technique
5349076|NCT01953575|Mucosal Impedance|mucosal impedance
5349077|NCT01953575|Eosinophilic Esophagitis|eosinophilic esophagitis
5963722|NCT04206332|Malaria Challenge|malaria challenge
5349079|NCT01953562|infants|infants
5349080|NCT01953562|NICU|nicu
5349081|NCT01953562|intubated|intubated
5349082|NCT01953562|ventilator|ventilator
5671196|NCT00616824|pain|pain
5349083|NCT01953549|physical activity, relaxation, activities of daily living, motor functions, cognitive functions|physical activity, relaxation, activities of daily living, motor functions, cognitive functions
5349084|NCT01953523|erectile dysfunction|erectile dysfunction
5349085|NCT01953523|peyronies|peyronies
5349086|NCT01953523|interstitial cystitis|interstitial cystitis
5349087|NCT01953523|cardiomyopathy|cardiomyopathy
5349088|NCT01953523|emphysema|emphysema
5349089|NCT01953523|copd|copd
5349090|NCT01953523|arthritis|arthritis
5349091|NCT01953523|multiple sclerosis|multiple sclerosis
5349092|NCT01953523|parkinson's|parkinson's
5349093|NCT01953510|Pneumococcal vaccines|pneumococcal vaccines
5349094|NCT01953510|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
5349095|NCT01953510|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
5345141|NCT01971398|Knowledge|knowledge
5349096|NCT01953510|Immunization Schedule|immunization schedule
5349097|NCT01953510|Public Health|public health
5349098|NCT01953458|Hepatitis B and C|hepatitis b and c
5349099|NCT01953458|ANRS HEPATHER French Cohort|anrs hepather french cohort
5349113|NCT01953406|hepatocellular carcinoma|hepatocellular carcinoma
5349114|NCT01953406|lung metastasis|lung metastasis
5349115|NCT01953406|5-fluorouracil/mitomycin|5-fluorouracil/mitomycin
5349116|NCT01953380|Intervention Studies|intervention studies
5349117|NCT01953380|Eczema|eczema
5349118|NCT01953380|Randomized Controlled Trial|randomized controlled trial
5349119|NCT01953380|Knowledge|knowledge
5349120|NCT01953380|Quality of Life|quality of life
5349121|NCT01953367|Bioequivalence|bioequivalence
5349122|NCT01953367|AUC|auc
5349123|NCT01953367|Cmax|cmax
5349124|NCT01953354|Ulcerative colitis (UC)|ulcerative colitis (uc)
5349125|NCT01953354|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5349126|NCT01953354|Trichuris suis ova (TSO)|trichuris suis ova (tso)
5349128|NCT01953328|Japanese, high cholesterol, LDL-C, High Cardiovascular Risk|japanese, high cholesterol, ldl-c, high cardiovascular risk
5349129|NCT01953315|urinary incontinence, muscle progenitor cells, MPCs|urinary incontinence, muscle progenitor cells, mpcs
5349439|NCT01951781|marker CD64|marker cd64
5349149|NCT01953237|antipsychotic medication adherence|antipsychotic medication adherence
5349150|NCT01953237|mobile phones|mobile phones
5349151|NCT01953224|Physical activity|physical activity
5349152|NCT01953224|Video game|video game
5349153|NCT01953224|Mobile|mobile
5349154|NCT01953224|Technology|technology
5349155|NCT01953224|Obesity|obesity
5349156|NCT01953198|hypoxia hypobaric|hypoxia hypobaric
5349157|NCT01953185|elderly|elderly
5349158|NCT01953185|subjects|subjects
5349159|NCT01953146|PCOS|pcos
5349160|NCT01953107|Anemia|anemia
5349161|NCT01953107|Ovarian cancer|ovarian cancer
5349162|NCT01953107|Uterine cancer|uterine cancer
5349163|NCT01953107|Cervical cancer|cervical cancer
5349164|NCT01953107|Oral iron|oral iron
5349165|NCT01953094|Cervical|cervical
5349167|NCT01953068|POCD|pocd
5349168|NCT01953068|Executive Reaction Time Test|executive reaction time test
5349169|NCT01953068|Aortic valve surgery|aortic valve surgery
5349170|NCT01953068|Cognitive functions|cognitive functions
5349171|NCT01953068|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5349172|NCT01953055|stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5349173|NCT01953055|androgen deprivation therapy|androgen deprivation therapy
5349174|NCT01953042|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5349175|NCT01953042|Health Education|health education
5349181|NCT01952990|Pharmacokinetic|pharmacokinetic
5349182|NCT01952964|exit site infection|exit site infection
5349183|NCT01952964|skin allergy|skin allergy
5349184|NCT01952964|physical damage|physical damage
5349185|NCT01952951|rectal neoplasms|rectal neoplasms
5349186|NCT01952951|radiotherapy|radiotherapy
5349187|NCT01952951|Antineoplastic Agents|antineoplastic agents
5349188|NCT01952938|knee revision surgery,|knee revision surgery,
5349189|NCT01952938|rotating hinge prosthesis|rotating hinge prosthesis
5349190|NCT01952899|Intensive Care Unit|intensive care unit
5349191|NCT01952899|Delirium|delirium
5349192|NCT01952899|Implementation|implementation
5349193|NCT01952899|Guideline|guideline
5349194|NCT01952886|malignant glioma|malignant glioma
5349195|NCT01952886|antiemetic|antiemetic
5349196|NCT01952886|ondansetron|ondansetron
5349197|NCT01952886|granisetron|granisetron
5349198|NCT01952886|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
5349199|NCT01952886|Pro00041233|pro00041233
5349200|NCT01952886|Duke|duke
5349201|NCT01952873|stents|stents
5349202|NCT01952873|angioplasty, balloon, coronary|angioplasty, balloon, coronary
5349203|NCT01952873|coronary artery stenosis|coronary artery stenosis
5349204|NCT01952873|optical coherence tomography|optical coherence tomography
5349205|NCT01952860|Lung Cancer|lung cancer
5963723|NCT04206332|Parasitemia|parasitemia
5963724|NCT04206332|Passive Immunization|passive immunization
5963725|NCT04206319|Immune Response|immune response
5963726|NCT04206319|Isotope|isotope
5963727|NCT04206319|PSA|psa
5349206|NCT01952860|Non-small cell lung cancer|non-small cell lung cancer
5349207|NCT01952860|NSCLC|nsclc
5349208|NCT01952860|Caregiving partner|caregiving partner
5349209|NCT01952860|Hatha Yoga|hatha yoga
5349210|NCT01952860|Radiation therapy|radiation therapy
5349211|NCT01952860|XRT|xrt
5349212|NCT01952860|Questionnaires|questionnaires
5349213|NCT01952860|Surveys|surveys
5349231|NCT01952834|coronary artery disease|coronary artery disease
5349232|NCT01952834|probiotic|probiotic
5349233|NCT01952834|endothelial function|endothelial function
5349234|NCT01952834|brachial artery|brachial artery
5349235|NCT01952834|ntric oxide|ntric oxide
5349236|NCT01952821|Head and Neck Cancer|head and neck cancer
5349237|NCT01952821|Physical function|physical function
5349238|NCT01952821|Cancer Related Fatigue|cancer related fatigue
5349239|NCT01952821|Gait Speed|gait speed
5349240|NCT01952821|6MWT|6mwt
5349241|NCT01952821|10-Meter Walk Test|10-meter walk test
5349242|NCT01952821|30-Second Chair Stand|30-second chair stand
5349243|NCT01952821|Linear Analog Scale of Function|linear analog scale of function
5349244|NCT01952821|Modified Brief Fatigue Inventory|modified brief fatigue inventory
5349245|NCT01952769|anti PD1,diffuse pontine glioma|anti pd1,diffuse pontine glioma
5349246|NCT01952756|cilostazol|cilostazol
5349247|NCT01952756|endothelial progenitor cells|endothelial progenitor cells
5349250|NCT01952756|peripheral arterial disease|peripheral arterial disease
5349252|NCT01952743|Atrial Fibrillation|atrial fibrillation
5349253|NCT01952743|Hypertension|hypertension
5349254|NCT01952743|Renal Denervation|renal denervation
5349255|NCT01952730|Stage IV|stage iv
5349256|NCT01952730|Hepatic Lesions|hepatic lesions
5349257|NCT01952691|hallux valgus|hallux valgus
5349258|NCT01952691|pain|pain
5349259|NCT01952691|conservative|conservative
5349260|NCT01952691|treatment|treatment
5349261|NCT01952678|DaTscan|datscan
5349262|NCT01952678|Parkinson's Disease|parkinson's disease
5349263|NCT01952652|Naproxen-codeine|naproxen-codeine
5349264|NCT01952652|preemptive analgesia|preemptive analgesia
5349272|NCT01952613|Functional Electrical Stimulation|functional electrical stimulation
5349273|NCT01952600|Chronic Kidney Disease|chronic kidney disease
5349274|NCT01952600|Hemodialysis|hemodialysis
5349275|NCT01952600|Peritoneal Dialysis|peritoneal dialysis
5349276|NCT01952574|migraine, headache, prevention, prophylaxis|migraine, headache, prevention, prophylaxis
5349277|NCT01952561|pharmacokinetics|pharmacokinetics
5349278|NCT01952561|vaginal ring|vaginal ring
5349279|NCT01952522|Resistance training|resistance training
5349280|NCT01952522|Walking|walking
5349281|NCT01952522|Weight bearing|weight bearing
5349282|NCT01952496|Cerebral Palsy|cerebral palsy
5349283|NCT01952496|Non ambulatory|non ambulatory
5349284|NCT01952496|Neuromuscular disability|neuromuscular disability
5349285|NCT01952496|Children|children
5349286|NCT01952483|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5349287|NCT01952470|Lung transplantation|lung transplantation
5349288|NCT01952470|Respiratory Tract Infections|respiratory tract infections
5349289|NCT01952470|Respiratory Therapy|respiratory therapy
5349290|NCT01952470|Isotonic Solutions|isotonic solutions
5349291|NCT01952470|Sodium Chloride|sodium chloride
5349292|NCT01952470|Postoperative complications|postoperative complications
5349293|NCT01952470|Postoperative care|postoperative care
5349294|NCT01952470|dornase alfa|dornase alfa
5349295|NCT01952444|monoclonal antibody, ETI-204, ciprofloxacin, safety, PK|monoclonal antibody, eti-204, ciprofloxacin, safety, pk
5349296|NCT01952431|Total Lung Capacity|total lung capacity
5349297|NCT01952392|Effectiveness study|effectiveness study
5349298|NCT01952392|Acute coronary Syndrome|acute coronary syndrome
5349299|NCT01952392|Real-life|real-life
5349300|NCT01952392|France|france
5349301|NCT01952379|Melasma|melasma
5349302|NCT01952379|Lymphocytes|lymphocytes
5349303|NCT01952379|Macrophages|macrophages
5349304|NCT01952379|Mast cells|mast cells
5349305|NCT01952379|Interleukin 17|interleukin 17
5349306|NCT01952379|COX-2|cox-2
5349307|NCT01952379|Inflammation|inflammation
5349308|NCT01952366|Aged|aged
5349309|NCT01952366|Depression|depression
5349310|NCT01952366|Cognition|cognition
5349311|NCT01952366|Longitudinal study|longitudinal study
5356895|NCT01917578|Breast Cancer|breast cancer
5349312|NCT01952353|Hepatocellular Carcinoma; Transarterial Chemoembolization; Hepatic Resection; Portal Vein Tumor Thrombosis|hepatocellular carcinoma; transarterial chemoembolization; hepatic resection; portal vein tumor thrombosis
5349313|NCT01952301|Autologous; Collagen Matrix; Keratinized Tissue|autologous; collagen matrix; keratinized tissue
5349314|NCT01952262|ultrasound|ultrasound
5349315|NCT01952262|diaphragm|diaphragm
5349316|NCT01952262|intensive care|intensive care
5349317|NCT01952262|critical care|critical care
5349318|NCT01952249|Ovarian|ovarian
5349319|NCT01952249|Primary Peritoneal|primary peritoneal
5963728|NCT04205019|Traumatic Spinal Cord Injury|traumatic spinal cord injury
5963729|NCT04205019|Stem Cells|stem cells
5963730|NCT04204057|Phosphoinositide 3-kinase|phosphoinositide 3-kinase
5963731|NCT04204057|Pi3k Delta and gamma inhibitor|pi3k delta and gamma inhibitor
5963732|NCT04204057|Tenalisib|tenalisib
5963733|NCT04204057|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5963734|NCT04203992|Student athletes|student athletes
5963735|NCT04203992|Supplements|supplements
5963736|NCT04203992|Videogame|videogame
5963737|NCT04203121|radiotherapy|radiotherapy
5304430|NCT02155309|motion|motion
5349320|NCT01952249|Fallopian Tube Cancer|fallopian tube cancer
5349321|NCT01952236|Smoking|smoking
5349322|NCT01952236|Quit|quit
5349323|NCT01952236|Tobacco|tobacco
5349324|NCT01952236|Abstinence|abstinence
5349325|NCT01952236|Adult|adult
5349326|NCT01952236|Text Messaging|text messaging
5349327|NCT01952236|Web-based|web-based
5349328|NCT01952236|Mobile phone|mobile phone
5349329|NCT01952236|smartphone|smartphone
5349330|NCT01952236|internet|internet
5349332|NCT01952223|adenocarcinome|adenocarcinome
5349333|NCT01952223|prostate|prostate
5349337|NCT01952223|Cabazitaxel|cabazitaxel
5349338|NCT01952197|Passive Leg Raise|passive leg raise
5349339|NCT01952197|Cardiac arrest|cardiac arrest
5349340|NCT01952197|Survival after CPR|survival after cpr
5349341|NCT01952184|vitrification|vitrification
5349342|NCT01952184|oocyte|oocyte
5349343|NCT01952184|donor|donor
5349344|NCT01952184|open|open
5349345|NCT01952184|closed|closed
5349349|NCT01952158|Multidrug-Resistant Organisms|multidrug-resistant organisms
5349350|NCT01952158|Hospital Infection|hospital infection
5349351|NCT01952158|Colonization|colonization
5349352|NCT01952158|Healthcare Personnel|healthcare personnel
5349353|NCT01952132|Schizophrenia|schizophrenia
5349354|NCT01952119|hypertension|hypertension
5349355|NCT01952106|venepuncture|venepuncture
5349356|NCT01952106|distraction|distraction
5349357|NCT01952106|distress|distress
5349358|NCT01952093|Early intervention|early intervention
5345327|NCT01970501|Toprol-XL|toprol-xl
5349361|NCT01952093|Parenting|parenting
5349362|NCT01952093|Prematurity|prematurity
5349363|NCT01952093|School age|school age
5349365|NCT01952080|Pediatric SBS|pediatric sbs
5349366|NCT01952080|Short Bowel Syndrome|short bowel syndrome
5349367|NCT01952067|Hip Prosthesis|hip prosthesis
5349371|NCT01952054|Breast cancer|breast cancer
5349372|NCT01952054|Breast carcinoma|breast carcinoma
5349373|NCT01952054|Bone metastasis|bone metastasis
5349374|NCT01952054|Cancer that has spread to the bone|cancer that has spread to the bone
5349375|NCT01952054|Denosumab|denosumab
5349377|NCT01952054|Prolia|prolia
5349378|NCT01952054|Hormonal agent|hormonal agent
5349379|NCT01952041|Schizophrenia|schizophrenia
5349380|NCT01952041|Schizoaffective Disorder|schizoaffective disorder
5349381|NCT01952041|Mobile Application|mobile application
5349382|NCT01952041|Relapse|relapse
5349383|NCT01952041|SMI|smi
5349384|NCT01952041|EHealth|ehealth
5349385|NCT01952041|E-Health|e-health
5349386|NCT01952041|Health Technology|health technology
5349387|NCT01952041|mHealth|mhealth
5349388|NCT01952041|m-Health|m-health
5349389|NCT01952041|Mobile Health|mobile health
5349390|NCT01952041|Serious Mental Illness|serious mental illness
5349391|NCT01952041|Electronic Health|electronic health
5349392|NCT01952028|MDC1A|mdc1a
5349393|NCT01952028|Congenital Muscular Dystrophy|congenital muscular dystrophy
5349394|NCT01952028|Merosin Deficient|merosin deficient
5349395|NCT01952028|LAMA2|lama2
5349396|NCT01952028|brain white matter abnormalities|brain white matter abnormalities
5349397|NCT01952028|Seizure|seizure
5349398|NCT01952015|generalized pustular psoriasis|generalized pustular psoriasis
5349399|NCT01952015|skin condition|skin condition
5349400|NCT01952015|skin disease,|skin disease,
5349401|NCT01952002|Blood Pressure|blood pressure
5349402|NCT01952002|heart rate|heart rate
5349403|NCT01952002|electrocardiogram|electrocardiogram
5349404|NCT01952002|Cardiac arrhythmias|cardiac arrhythmias
5349405|NCT01952002|respiratory exercise|respiratory exercise
5349406|NCT01951989|Gaucher disease|gaucher disease
5349407|NCT01951989|Imiglucerase|imiglucerase
5349408|NCT01951989|Pharmacokinetics|pharmacokinetics
5349409|NCT01951976|breast|breast
5349410|NCT01951976|carcinoma|carcinoma
5349411|NCT01951976|stage 0-III breast cancer|stage 0-iii breast cancer
5349412|NCT01951976|post-menopausal|post-menopausal
5349413|NCT01951976|aromatase inhibitor (AI)|aromatase inhibitor (ai)
5349414|NCT01951976|joint pain|joint pain
5349415|NCT01951976|AI-associated joint pain|ai-associated joint pain
5349416|NCT01951963|pain management|pain management
5349417|NCT01951963|ketamine|ketamine
5349418|NCT01951963|morphine|morphine
5349419|NCT01951963|pediatrics|pediatrics
5349420|NCT01951963|emergency medicine|emergency medicine
5349421|NCT01951937|Cognitive Test|cognitive test
5349422|NCT01951937|Omega-3 Fatty acids|omega-3 fatty acids
5349423|NCT01951924|Multifocal Motor Neuropathy|multifocal motor neuropathy
5349424|NCT01951911|Pain Management|pain management
5349426|NCT01951911|Palliative care|palliative care
5349427|NCT01951898|asthma|asthma
5349428|NCT01951898|regulatory T cells|regulatory t cells
5349429|NCT01951898|leukotriene antagonist|leukotriene antagonist
5963738|NCT04203082|cesarean|cesarean
5963739|NCT04202471|Chlorhexidine Cloth|chlorhexidine cloth
5963740|NCT04202471|Surgical Site Infection|surgical site infection
5963741|NCT04202471|Non-scheduled cesarean delivery|non-scheduled cesarean delivery
5963742|NCT04201860|Arterial blood gas|arterial blood gas
5349430|NCT01951872|caffeine dependence|caffeine dependence
5349431|NCT01951872|caffeine withdrawal|caffeine withdrawal
5963743|NCT04201860|Coagulation|coagulation
5963744|NCT04201860|Nitrogen compounds|nitrogen compounds
5349432|NCT01951872|caffeine use disorder|caffeine use disorder
5349433|NCT01951833|Lung clearance index (LCI)|lung clearance index (lci)
5349434|NCT01951807|Psychosocial Effects of Cancer and Treatment|psychosocial effects of cancer and treatment
5349436|NCT01951794|HIV infected|hiv infected
5349437|NCT01951794|HIV exposed|hiv exposed
5349438|NCT01951794|HIV-free|hiv-free
5349440|NCT01951781|blood sample|blood sample
5349441|NCT01951781|nosocomial infection|nosocomial infection
5349442|NCT01951781|preterm newborn|preterm newborn
5349443|NCT01951755|Inoperable NSCLC|inoperable nsclc
5349444|NCT01951755|TKIs|tkis
5349445|NCT01951742|wrinkles|wrinkles
5349446|NCT01951729|Blood sugar|blood sugar
5349448|NCT01951729|Xenin-25|xenin-25
5349449|NCT01951729|Cholinergic Signaling|cholinergic signaling
5349450|NCT01951729|Atropine|atropine
5349451|NCT01951729|Insulin|insulin
5349452|NCT01951729|Glucagon|glucagon
5349453|NCT01951729|Pancreatic polypeptide|pancreatic polypeptide
5349454|NCT01951716|Vagotomy|vagotomy
5349455|NCT01951716|Vagus Nerve|vagus nerve
5349456|NCT01951716|Xenin-25|xenin-25
5349457|NCT01951716|GIP|gip
5349458|NCT01951716|Insulin Secretion|insulin secretion
5349459|NCT01951716|Glucagon Secretion|glucagon secretion
5349460|NCT01951716|Gastric Emptying|gastric emptying
5349461|NCT01951690|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
5349462|NCT01951690|FAK inhibitor|fak inhibitor
5349463|NCT01951690|Cancer Stem Cells|cancer stem cells
5349464|NCT01951690|CSC|csc
5349465|NCT01951690|KRAS mutation|kras mutation
5349466|NCT01951677|hepatitis B virus|hepatitis b virus
5349476|NCT01951612|ischemic white matter disease|ischemic white matter disease
5349477|NCT01951612|small vessel disease|small vessel disease
5349478|NCT01951612|transient ischemic attack|transient ischemic attack
5349479|NCT01951612|mild stroke|mild stroke
5349480|NCT01951612|stroke risk|stroke risk
5349611|NCT01951001|Acute Coronary Syndrome, Asians, platelet, prasugrel|acute coronary syndrome, asians, platelet, prasugrel
5349481|NCT01951599|Phase I, healthy, bioavailability, pharmacokinetics, safety, tolerability.|phase i, healthy, bioavailability, pharmacokinetics, safety, tolerability.
5349482|NCT01951573|contact lenses|contact lenses
5349483|NCT01951573|multifocal|multifocal
5349484|NCT01951573|daily disposable|daily disposable
5349485|NCT01951573|silicone hydrogel|silicone hydrogel
5349486|NCT01951573|presbyopia|presbyopia
5349487|NCT01951547|HbA1c|hba1c
5349488|NCT01951547|hs-CRP|hs-crp
5349489|NCT01951547|non-surgical periodontal therapy|non-surgical periodontal therapy
5349490|NCT01951547|oral health education|oral health education
5349491|NCT01951547|probing pocket depth|probing pocket depth
5349492|NCT01951547|plaque index|plaque index
5349493|NCT01951547|gingival bleeding index.|gingival bleeding index.
5244312|NCT02478268|xenon gas|xenon gas
5349494|NCT01951534|breast reconstruction|breast reconstruction
5349495|NCT01951521|Rectal cancer|rectal cancer
5349496|NCT01951521|Locally advanced rectal cancer|locally advanced rectal cancer
5349497|NCT01951521|Radiotherapy|radiotherapy
5349498|NCT01951521|Boost|boost
5349499|NCT01951521|Dose-escalation|dose-escalation
5349500|NCT01951521|Pathological complete response|pathological complete response
5349501|NCT01951521|Response|response
5349502|NCT01951508|Methylphenidate|methylphenidate
5349503|NCT01951508|Modafinil|modafinil
5349504|NCT01951508|MDMA|mdma
5349505|NCT01951508|fMRI|fmri
5349506|NCT01951508|emotion-processing|emotion-processing
5349507|NCT01951508|social cognition|social cognition
5349508|NCT01951456|Smoking cessation|smoking cessation
5349509|NCT01951456|resistance training|resistance training
5349510|NCT01951443|ginseng|ginseng
5349511|NCT01951443|clinical trial|clinical trial
5349512|NCT01951443|vascular|vascular
5349513|NCT01951443|ginsenosides|ginsenosides
5349514|NCT01951443|blood pressure|blood pressure
5349515|NCT01951430|Adult patients|adult patients
5349516|NCT01951430|Infective events|infective events
5349517|NCT01951430|Antibiotic|antibiotic
5349518|NCT01951430|Antifungal|antifungal
5349519|NCT01951430|Myelodysplastic syndrome|myelodysplastic syndrome
5349520|NCT01951404|Left Ventricular Hypertrophy|left ventricular hypertrophy
5349521|NCT01951404|Allopurinol|allopurinol
5349522|NCT01951404|End Stage Renal Disease|end stage renal disease
5349523|NCT01951404|Haemodialysis|haemodialysis
5349524|NCT01951404|Renal Replacement Therapy|renal replacement therapy
5349526|NCT01951391|study|study
5349527|NCT01951391|subjects|subjects
5349528|NCT01951378|Asthma|asthma
5349529|NCT01951378|Asthma exacerbation|asthma exacerbation
5349530|NCT01951365|Schwannoma|schwannoma
5349531|NCT01951365|Growth|growth
5349532|NCT01951365|intradural|intradural
5349533|NCT01951365|natural history|natural history
5349534|NCT01951352|study|study
5349535|NCT01951352|meant|meant
5349536|NCT01951352|individuals|individuals
5349537|NCT01951339|diabetes|diabetes
5349538|NCT01951339|type 2 diabetes|type 2 diabetes
5349539|NCT01951339|exercise|exercise
5349540|NCT01951339|echo|echo
5349541|NCT01951339|heart|heart
5349542|NCT01951339|sitagliptin|sitagliptin
5349543|NCT01951339|glimepiride|glimepiride
5349544|NCT01951339|cardiovascular|cardiovascular
5349545|NCT01951326|Crohn's Disease|crohn's disease
5349546|NCT01951326|moderate to severe|moderate to severe
5349547|NCT01951326|remission|remission
5349548|NCT01951326|MAP|map
5349549|NCT01951326|antibiotic|antibiotic
5349550|NCT01951313|Meal tolerance test focusing on carotenoids absorption|meal tolerance test focusing on carotenoids absorption
5349551|NCT01951261|Telemonitoring|telemonitoring
5349552|NCT01951261|COPD|copd
5349553|NCT01951261|Home care|home care
5349554|NCT01951248|chronic kidney disease|chronic kidney disease
5349555|NCT01951248|obstructive sleep apnea|obstructive sleep apnea
5349556|NCT01951248|24-h blood pressure|24-h blood pressure
5349557|NCT01951248|central blood pressure|central blood pressure
5349558|NCT01951248|peripheral blood pressure|peripheral blood pressure
5349564|NCT01951209|Rifaximin|rifaximin
5349565|NCT01951196|Chronic kidney disease|chronic kidney disease
5349566|NCT01951196|24 hour blood pressure|24 hour blood pressure
5349567|NCT01951196|central blood pressure|central blood pressure
5349568|NCT01951196|peripheral blood pressure|peripheral blood pressure
5349569|NCT01951196|obstructive sleep apnea|obstructive sleep apnea
5349570|NCT01951144|Phase 1|phase 1
5349571|NCT01951144|Single Dose|single dose
5349572|NCT01951144|Pharmacokinetics|pharmacokinetics
5349573|NCT01951144|Safety|safety
5349574|NCT01951144|Toleration|toleration
5349575|NCT01951144|Pharmacodynamics|pharmacodynamics
5349576|NCT01951118|Smell|smell
5349577|NCT01951118|Olfaction Disorders|olfaction disorders
5349578|NCT01951118|Atropine|atropine
5349579|NCT01951118|Donepezil|donepezil
5349580|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors
5349581|NCT01951118|Cognition Disorders|cognition disorders
5349582|NCT01951105|Subacute|subacute
5349583|NCT01951105|Back|back
5349584|NCT01951105|Pain|pain
5349585|NCT01951105|Brain|brain
5349587|NCT01951092|HIV|hiv
5349588|NCT01951092|adherence|adherence
5349589|NCT01951092|retention|retention
5349590|NCT01951092|texting|texting
5349591|NCT01951079|Digoxin|digoxin
5349592|NCT01951079|Intra-amniotic injection|intra-amniotic injection
5349593|NCT01951079|feticide|feticide
5349594|NCT01951079|second trimester abortion|second trimester abortion
5349595|NCT01951053|Healthy|healthy
5349596|NCT01951053|Safety|safety
5349597|NCT01951053|Tolerability|tolerability
5349598|NCT01951053|Pharmacokinetics|pharmacokinetics
5349599|NCT01951053|Pharmacodynamics|pharmacodynamics
5349600|NCT01951053|JNJ-40411813|jnj-40411813
5349601|NCT01951053|Positive allosteric modulator|positive allosteric modulator
5349602|NCT01951040|Oxytocin, breastfeeding|oxytocin, breastfeeding
5349603|NCT01951027|Safety|safety
5349604|NCT01951027|Pharmacokinetics|pharmacokinetics
5349605|NCT01951027|Pharmacodynamics|pharmacodynamics
5349606|NCT01951027|DLT|dlt
5349607|NCT01951027|Immunogenecity|immunogenecity
5349608|NCT01951014|Adolescence|adolescence
5349609|NCT01951014|Pregnancy|pregnancy
5349610|NCT01951014|Telemedicine|telemedicine
5349612|NCT01950936|Infection|infection
5349613|NCT01950936|Antibiotics|antibiotics
5349614|NCT01950936|COLD|cold
5349615|NCT01950910|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5349616|NCT01950910|motor neuron disease|motor neuron disease
5349617|NCT01950910|biological markers|biological markers
5349618|NCT01950910|biomarkers|biomarkers
5349619|NCT01950897|muscular dystrophies|muscular dystrophies
5349620|NCT01950897|muscular dystrophy|muscular dystrophy
5349621|NCT01950884|•Non-alcoholic Steatohepatitis (NASH)|•non-alcoholic steatohepatitis (nash)
5349622|NCT01950871|HistoScanning|histoscanning
5349623|NCT01950871|TRUS|trus
5349624|NCT01950871|Prostate cancer|prostate cancer
5349625|NCT01950871|Biopsy guidance|biopsy guidance
5349626|NCT01950845|anesthesiology, Closed-Loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery|anesthesiology, closed-loop system, automated fluid management, cardiac output optimization, high risk surgical patient, major abdominal surgery
5349627|NCT01950832|Structure of Retina|structure of retina
5349628|NCT01950832|Macular Thickness|macular thickness
5349629|NCT01950832|Retinal Nerve Fiber Layer|retinal nerve fiber layer
5349630|NCT01950832|Choroidal Thickness|choroidal thickness
5349631|NCT01950832|PCOS|pcos
5349632|NCT01950832|Optical Coherence Tomography|optical coherence tomography
5349633|NCT01950819|kidney failure|kidney failure
5349634|NCT01950819|dialysis|dialysis
5349635|NCT01950819|renal failure|renal failure
5349636|NCT01950819|transplantation|transplantation
5349637|NCT01950793|Hyaluronic acid, trigger finger|hyaluronic acid, trigger finger
5349638|NCT01950780|Alopecia Areata|alopecia areata
5349639|NCT01950780|Ruxolitinib|ruxolitinib
5349640|NCT01950728|volunteers|volunteers
5963745|NCT04201496|Artificial Pancreas (AP)|artificial pancreas (ap)
5963746|NCT04201496|Sodium-glucose co-transporter 2 (SGLT2) inhibitor|sodium-glucose co-transporter 2 (sglt2) inhibitor
5963747|NCT04201496|Insulin Pumps|insulin pumps
5963748|NCT04201496|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5963749|NCT04201496|Closed Loop Control|closed loop control
5963750|NCT04201496|Low blood glucose index (LBGI)|low blood glucose index (lbgi)
5349641|NCT01950728|18 to 65 years|18 to 65 years
5963751|NCT04201496|High blood glucose index (HBGI)|high blood glucose index (hbgi)
5470901|NCT01417104|plaque|plaque
5349642|NCT01950728|Males and Females|males and females
5349648|NCT01950663|Validation Studies|validation studies
5349649|NCT01950624|Patient Registry|patient registry
5349650|NCT01950624|Down Syndrome|down syndrome
5349651|NCT01950611|acute promyelocytic leukemia|acute promyelocytic leukemia
5349652|NCT01950611|arsenic trioxide|arsenic trioxide
5349653|NCT01950611|proteasome inhibition|proteasome inhibition
5349654|NCT01950611|bortezomib|bortezomib
5349655|NCT01950598|Boston Keratoprosthesis type I surgery, frozen corneal graft|boston keratoprosthesis type i surgery, frozen corneal graft
5349656|NCT01950585|Hydroxyurea|hydroxyurea
5349657|NCT01950585|Pulmonary Hypertension|pulmonary hypertension
5349658|NCT01950585|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5349659|NCT01950585|Familial Pulmonary Arterial Hypertension|familial pulmonary arterial hypertension
5349665|NCT01950559|soy allergy|soy allergy
5349666|NCT01950559|food allergy|food allergy
5349667|NCT01950559|pediatric|pediatric
5349668|NCT01950559|adult|adult
5349669|NCT01950546|silver nanoparticles|silver nanoparticles
5349670|NCT01950546|antimicrobial activity|antimicrobial activity
5349671|NCT01950546|toxicity|toxicity
5349672|NCT01950546|biofilm|biofilm
5349673|NCT01950546|cariostatic agents|cariostatic agents
5349674|NCT01950533|Peanut allergy|peanut allergy
5349675|NCT01950533|Milk allergy|milk allergy
5349677|NCT01950533|Pediatric|pediatric
5349678|NCT01950533|Adult|adult
5349679|NCT01950533|Food allergy|food allergy
5349680|NCT01950520|Adipose Tissue|adipose tissue
5349681|NCT01950520|Adult|adult
5349682|NCT01950520|Resting Energy Expenditure|resting energy expenditure
5349683|NCT01950520|RESPIRATORY QUOTIENT|respiratory quotient
5349684|NCT01950520|BASAL METABOLIC RATE|basal metabolic rate
5349685|NCT01950507|Fluconazole|fluconazole
5349686|NCT01950507|Graft Versus Host Disease|graft versus host disease
5349687|NCT01950507|Voriconazole|voriconazole
5349688|NCT01950507|Azoles|azoles
5349689|NCT01950494|hand dermatitis|hand dermatitis
5349690|NCT01950494|health care workers|health care workers
5349691|NCT01950494|hand sanitizer|hand sanitizer
5349692|NCT01950481|LDK378|ldk378
5349693|NCT01950481|pharmacokinetics|pharmacokinetics
5349694|NCT01950481|hepatic impairment|hepatic impairment
5349695|NCT01950468|Parkinson's Disease|parkinson's disease
5349696|NCT01950455|Parkinson's Disease|parkinson's disease
5349697|NCT01950442|malignant strictures|malignant strictures
5349698|NCT01950442|esophageal staging|esophageal staging
5349702|NCT01950416|ST elevation myocardial infarction|st elevation myocardial infarction
5349703|NCT01950416|Fibrinolysis|fibrinolysis
5349704|NCT01950416|Ticagrelor|ticagrelor
5349705|NCT01950416|Clopidogrel|clopidogrel
5349706|NCT01950416|Platelet reactivity|platelet reactivity
5349707|NCT01950377|Dopamine Transporter|dopamine transporter
5349708|NCT01950377|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
5349709|NCT01950377|Dopamine|dopamine
5349710|NCT01950377|Dopamine Genes|dopamine genes
5349711|NCT01950377|Dopaminergic Mechanisms|dopaminergic mechanisms
5349712|NCT01950364|Lymphoma|lymphoma
5349713|NCT01950364|Hodgkin|hodgkin
5349714|NCT01950364|Anaplastic Large-cell|anaplastic large-cell
5349715|NCT01950364|Relapsed|relapsed
5349716|NCT01950364|Refractory|refractory
5349717|NCT01950364|Antigens, CD30|antigens, cd30
5349718|NCT01950364|Antibody-Drug Conjugate|antibody-drug conjugate
5349719|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal
5349720|NCT01950364|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5349721|NCT01950364|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5349722|NCT01950364|Monomethyl auristatin E|monomethyl auristatin e
5349723|NCT01950364|Drug Therapy|drug therapy
5349724|NCT01950364|Immunotherapy|immunotherapy
5349725|NCT01950364|Hematologic Diseases|hematologic diseases
5349726|NCT01950325|HIV-1 Viral Load|hiv-1 viral load
5349727|NCT01950325|CD4 Count|cd4 count
5349728|NCT01950325|Antiviral|antiviral
5349729|NCT01950325|HIV-1 Infection|hiv-1 infection
5349730|NCT01950325|Broadly Neutralizing Antibody|broadly neutralizing antibody
5349731|NCT01950312|Autoimmune Inner Ear Disease|autoimmune inner ear disease
5349732|NCT01950312|Inner Ear Disease|inner ear disease
5349733|NCT01950312|Meniere's Disease|meniere's disease
5349734|NCT01950312|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
5349735|NCT01950286|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
5349737|NCT01950286|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5349738|NCT01950260|Graves' disease|graves' disease
5349842|NCT01949831|acute care|acute care
5349739|NCT01950260|Radioactive iodine|radioactive iodine
5349740|NCT01950260|Hypothyroidism|hypothyroidism
5349741|NCT01950221|Double-blind Trial|double-blind trial
5349742|NCT01950221|Placebo-controlled|placebo-controlled
5349743|NCT01950221|Pomegranate|pomegranate
5349744|NCT01950221|Memory|memory
5349745|NCT01950221|Memory Impairment|memory impairment
5349746|NCT01950221|Cognition|cognition
5349747|NCT01950221|Ages 50-75|ages 50-75
5963752|NCT04200664|Superficial siderosis, infratentorial|superficial siderosis, infratentorial
5963753|NCT04200664|Nervous system diseases|nervous system diseases
5471062|NCT01416558|GBG|gbg
5304950|NCT02152761|BYM338|bym338
5349748|NCT01950208|Assessment|assessment
5349749|NCT01950195|Melanoma|melanoma
5349750|NCT01950195|Metastases|metastases
5349751|NCT01950195|Brain|brain
5349752|NCT01950195|Spine|spine
5349753|NCT01950195|SRS(Stereotactic Radiosurgery))|srs(stereotactic radiosurgery))
5349754|NCT01950195|Ipilimumab|ipilimumab
5349755|NCT01950182|Luminal B2 subtype|luminal b2 subtype
5349756|NCT01950182|First line treatment|first line treatment
5349757|NCT01950169|Hip fracture|hip fracture
5349758|NCT01950169|Nutritional supplement|nutritional supplement
5349759|NCT01950169|Bisphosphonates|bisphosphonates
5349760|NCT01950169|Bone mineral density|bone mineral density
5349761|NCT01950169|Body composition|body composition
5349762|NCT01950143|prostate cancer prevention|prostate cancer prevention
5349763|NCT01950143|diet|diet
5349765|NCT01950143|metabolic changes|metabolic changes
5349767|NCT01950130|IABC|iabc
5349768|NCT01950130|coronary artery disease|coronary artery disease
5349769|NCT01950130|prophylactic|prophylactic
5349770|NCT01950130|cardiac assist|cardiac assist
5349771|NCT01950117|nonpedunculated|nonpedunculated
5349772|NCT01950117|neoplastic|neoplastic
5349773|NCT01950117|colorectal|colorectal
5349774|NCT01950117|polyps|polyps
5349784|NCT01950078|gene polymorphism|gene polymorphism
5349785|NCT01950078|pain perception|pain perception
5349786|NCT01950078|postoperative pain|postoperative pain
5349787|NCT01950052|VLCD|vlcd
5349788|NCT01950052|Low calorie diet|low calorie diet
5349789|NCT01950052|very low calorie diet|very low calorie diet
5349790|NCT01950052|pre-operative diet|pre-operative diet
5349791|NCT01950052|liver shrinking diet|liver shrinking diet
5349792|NCT01950052|bariatric surgery|bariatric surgery
5349793|NCT01950052|gastric bypass|gastric bypass
5349794|NCT01950039|Obesity|obesity
5349795|NCT01950039|Glucose Intolerance|glucose intolerance
5349796|NCT01950026|skin temperature|skin temperature
5349797|NCT01950026|ethnic groups|ethnic groups
5349798|NCT01950026|cryotherapy|cryotherapy
5349799|NCT01950013|Presbycusis|presbycusis
5349800|NCT01950013|Aging|aging
5349801|NCT01950013|hearing aids|hearing aids
5349802|NCT01950013|hearing training|hearing training
5349803|NCT01950000|Pain. Analgesia. Prevention|pain. analgesia. prevention
5349804|NCT01949974|Palliative Chemotherapy|palliative chemotherapy
5349805|NCT01949974|Integral Attention Program|integral attention program
5349806|NCT01949974|Advanced cancer|advanced cancer
5349807|NCT01949974|Randomized Clinical Trial|randomized clinical trial
5349808|NCT01949961|intervention|intervention
5349809|NCT01949961|sonothrombolysis|sonothrombolysis
5349810|NCT01949961|Ultrasound treatment|ultrasound treatment
5349811|NCT01949948|treatment, intervention, thrombolysis|treatment, intervention, thrombolysis
5349812|NCT01949935|Mupirocin|mupirocin
5349813|NCT01949935|Surgical Site Infections|surgical site infections
5349814|NCT01949935|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5349815|NCT01949922|regenerative medicine|regenerative medicine
5349816|NCT01949922|fecal incontinence|fecal incontinence
5349817|NCT01949922|muscle fiber injection|muscle fiber injection
5349818|NCT01949909|plasmodium falciparum|plasmodium falciparum
5349819|NCT01949909|long synthetic peptide|long synthetic peptide
5349820|NCT01949909|antibody|antibody
5349821|NCT01949909|T cell|t cell
5349822|NCT01949909|cytokine|cytokine
5349823|NCT01949909|vaccine|vaccine
5349824|NCT01949909|safety|safety
5349825|NCT01949909|phase 1|phase 1
5349826|NCT01949896|Pro inflammatory cytokine|pro inflammatory cytokine
5349827|NCT01949896|Necrotizing enterocolitis|necrotizing enterocolitis
5349828|NCT01949896|Packed red blood cell transfusion|packed red blood cell transfusion
5349829|NCT01949883|Phase 1|phase 1
5349830|NCT01949883|Oncology|oncology
5349831|NCT01949883|BET Inhibitor|bet inhibitor
5349832|NCT01949857|Hepatitis A|hepatitis a
5349833|NCT01949857|Vaccine|vaccine
5349834|NCT01949857|Safety|safety
5349835|NCT01949857|efficacy|efficacy
5349837|NCT01949844|Magnetic Resonance Imaging|magnetic resonance imaging
5349838|NCT01949844|myocardial perfusion|myocardial perfusion
5349839|NCT01949844|myocardial perfusion imaging|myocardial perfusion imaging
5349840|NCT01949844|Novel MRI Techniques|novel mri techniques
5349841|NCT01949831|functional assessment|functional assessment
5349843|NCT01949831|older medical patients|older medical patients
5349844|NCT01949779|Coil embolization|coil embolization
5349845|NCT01949779|TransForm™ Occlusion Balloon Catheter|transform™ occlusion balloon catheter
5349846|NCT01949779|Registry|registry
5349847|NCT01949779|Neurointerventional procedures|neurointerventional procedures
5349848|NCT01949753|Obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
5349849|NCT01949753|Exposure therapy|exposure therapy
5349850|NCT01949753|Extinction learning|extinction learning
5349851|NCT01949753|Pregnenolone|pregnenolone
5963754|NCT04200664|Hearing loss|hearing loss
5963755|NCT04200664|Hearing tests|hearing tests
5963756|NCT04200664|Auditory pathways|auditory pathways
5963757|NCT04200664|Vestibulocochlear nerve|vestibulocochlear nerve
5963758|NCT04200664|Ataxia|ataxia
5963759|NCT04200664|Vestibular function tests|vestibular function tests
5963760|NCT04200664|Biomarkers|biomarkers
5216800|NCT02641184|Heart Diseases|heart diseases
5349852|NCT01949727|AECOPD|aecopd
5349853|NCT01949727|COPD|copd
5349854|NCT01949727|Emphysema|emphysema
5349855|NCT01949727|Chronic bronchitis|chronic bronchitis
5349856|NCT01949675|Cholera|cholera
5349857|NCT01949675|Shanchol™|shanchol™
5349858|NCT01949675|Cholera Vaccine|cholera vaccine
5349859|NCT01949662|Advanced Cancers|advanced cancers
5349860|NCT01949662|Locally advanced cancer|locally advanced cancer
5349861|NCT01949662|Metastatic cancer|metastatic cancer
5349862|NCT01949662|Recurrent cancer|recurrent cancer
5349863|NCT01949662|Incurable cancer|incurable cancer
5349864|NCT01949662|Delirium|delirium
5349865|NCT01949662|Agitation|agitation
5349866|NCT01949662|Lorazepam|lorazepam
5349867|NCT01949662|Haloperidol|haloperidol
5349869|NCT01949662|Questionnaires|questionnaires
5349870|NCT01949662|Surveys|surveys
5349871|NCT01949662|Acute palliative care unit|acute palliative care unit
5349872|NCT01949649|body image|body image
5349873|NCT01949649|body dissatisfaction|body dissatisfaction
5349874|NCT01949623|RP|rp
5349875|NCT01949610|Healthy Participants|healthy participants
5349876|NCT01949610|JNJ26489112|jnj26489112
5349877|NCT01949610|14C-JNJ26489112|14c-jnj26489112
5349878|NCT01949610|Absorption|absorption
5349879|NCT01949610|Metabolism|metabolism
5349880|NCT01949610|Excretion|excretion
5349881|NCT01949571|Mirtazapine.|mirtazapine.
5349882|NCT01949571|Addiction.|addiction.
5349883|NCT01949571|Cocaine.|cocaine.
5349884|NCT01949571|Cocaine-craving.|cocaine-craving.
5349885|NCT01949571|Cocaine-withdrawal|cocaine-withdrawal
5349886|NCT01949558|diet|diet
5349887|NCT01949558|lifestyle|lifestyle
5349888|NCT01949519|prostate cancer|prostate cancer
5349889|NCT01949519|lycopene|lycopene
5349890|NCT01949519|docetaxel|docetaxel
5349891|NCT01949519|metastatic|metastatic
5349892|NCT01949519|castration resistant|castration resistant
5349893|NCT01949506|Lung metastases|lung metastases
5349894|NCT01949506|Radiation Therapy|radiation therapy
5349895|NCT01949506|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5349896|NCT01949493|carpal tunnel syndrome|carpal tunnel syndrome
5349897|NCT01949493|traction|traction
5349898|NCT01949493|mechanical traction|mechanical traction
5349899|NCT01949493|Phystrac|phystrac
5349900|NCT01949480|Peripheral nerve block|peripheral nerve block
5349901|NCT01949480|Ultrasound guidance|ultrasound guidance
5349902|NCT01949480|Postoperative pain management post status thoracotomy|postoperative pain management post status thoracotomy
5349903|NCT01949480|Postoperative pain management post status VATS|postoperative pain management post status vats
5349904|NCT01949467|ferroportin disease|ferroportin disease
5349905|NCT01949467|dysmetabolic hepatosiderosis|dysmetabolic hepatosiderosis
5349906|NCT01949467|genetic hemochromatosis|genetic hemochromatosis
5349907|NCT01949467|hyperferritinemia|hyperferritinemia
5349908|NCT01949467|hepcidin|hepcidin
5349909|NCT01949467|iron fumarate|iron fumarate
5349910|NCT01949467|physiopathological study|physiopathological study
5349911|NCT01949467|diagnosis|diagnosis
5349912|NCT01949467|HFE gene|hfe gene
5349913|NCT01949467|TRF2 gene|trf2 gene
5349914|NCT01949467|iron parameters|iron parameters
5349915|NCT01949467|divalent cations|divalent cations
5349916|NCT01949454|trachoma|trachoma
5349917|NCT01949454|trichiasis|trichiasis
5349918|NCT01949454|trachomatous trichiasis|trachomatous trichiasis
5349919|NCT01949454|bilamellar tarsal rotation|bilamellar tarsal rotation
5349920|NCT01949454|fluorometholone|fluorometholone
5349921|NCT01949454|placebo controlled|placebo controlled
5349922|NCT01949441|HDM Allergy|hdm allergy
5349923|NCT01949441|Rhinoconjunctivitis|rhinoconjunctivitis
5349924|NCT01949441|Immunotherapy|immunotherapy
5349925|NCT01949441|ToleroMune HDM|toleromune hdm
5349926|NCT01949428|HDM Allergy|hdm allergy
5349927|NCT01949428|Rhinoconjunctivitis|rhinoconjunctivitis
5349928|NCT01949415|House Dust Mite|house dust mite
5349929|NCT01949415|Rhinoconjunctivitis|rhinoconjunctivitis
5349930|NCT01949415|ToleroMune|toleromune
5349931|NCT01949376|breast cancer|breast cancer
5349932|NCT01949376|invasive ductal carcinoma|invasive ductal carcinoma
5349933|NCT01949376|cognitive impairment|cognitive impairment
5349934|NCT01949376|adjuvant therapy|adjuvant therapy
5349935|NCT01949376|hormone therapy|hormone therapy
5349936|NCT01949376|hormonal therapy|hormonal therapy
5349937|NCT01949376|chemotherapy|chemotherapy
5349938|NCT01949376|chemo brain|chemo brain
5349939|NCT01949376|MRI|mri
5356896|NCT01917578|shrinkage modes|shrinkage modes
5356897|NCT01917578|three-dimensional reconstruction|three-dimensional reconstruction
5349940|NCT01949363|Gonococcal Infections, Cefixime, Neisseria gonorrhoeae, Azithromycin, antibiotic, cephalosporin|gonococcal infections, cefixime, neisseria gonorrhoeae, azithromycin, antibiotic, cephalosporin
5963761|NCT04200664|Central nervous system|central nervous system
5963762|NCT04200612|Equine-Assisted Psychotherapy|equine-assisted psychotherapy
5963763|NCT04200612|Emotion Regulation|emotion regulation
5963764|NCT04200612|Aggression|aggression
5963765|NCT04200612|Outcomes|outcomes
5963766|NCT04200612|Randomized-Controlled Trials|randomized-controlled trials
5349941|NCT01949324|MacTel|mactel
5349942|NCT01949298|immediate loading of dental implant|immediate loading of dental implant
5963767|NCT04199793|Lavare Cycle|lavare cycle
5963768|NCT04199793|HeartWare LVAD|heartware lvad
5228832|NCT02571309|Asthma|asthma
5349943|NCT01949298|implant supported over denture|implant supported over denture
5349944|NCT01949285|Spinal cord injury|spinal cord injury
5349945|NCT01949285|Paralysis|paralysis
5349946|NCT01949285|Rehabilitation|rehabilitation
5349947|NCT01949285|Assessment|assessment
5349948|NCT01949285|Theranostics|theranostics
5349949|NCT01949272|ARDS|ards
5349950|NCT01949259|Retrospective|retrospective
5349951|NCT01949259|Lung cancer|lung cancer
5349952|NCT01949246|Biomarkers|biomarkers
5349953|NCT01949220|Inherited|inherited
5349954|NCT01949220|Von Willebrand disease|von willebrand disease
5349955|NCT01949220|Von Willebrand factor|von willebrand factor
5349956|NCT01949220|Deficiency|deficiency
5349957|NCT01949220|safety|safety
5349958|NCT01949207|Incompetent perforating veins|incompetent perforating veins
5349959|NCT01949207|EVLA|evla
5349960|NCT01949207|Phlebectomies|phlebectomies
5349961|NCT01949207|TRansluminal Occlusion of Perforators (TRLOP) closure of incompetent perforators.|transluminal occlusion of perforators (trlop) closure of incompetent perforators.
5349962|NCT01949194|liver metastases|liver metastases
5349963|NCT01949181|Metals|metals
5349964|NCT01949181|Metalloids|metalloids
5349965|NCT01949181|Blood|blood
5349966|NCT01949181|Hair|hair
5349969|NCT01949181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5349970|NCT01949155|otitis media|otitis media
5349971|NCT01949155|otorrhea|otorrhea
5244842|NCT02475083|Stroke|stroke
5349972|NCT01949155|middle ear effusion|middle ear effusion
5349973|NCT01949155|tympanostomy tubes|tympanostomy tubes
5349974|NCT01949142|otitis media|otitis media
5349975|NCT01949142|otorrhea|otorrhea
5349976|NCT01949142|middle ear effusion|middle ear effusion
5349977|NCT01949142|tympanostomy tubes|tympanostomy tubes
5349978|NCT01949129|stem cell transplantation|stem cell transplantation
5349979|NCT01949129|children and adolescents|children and adolescents
5349980|NCT01949129|high risk acute lymphoblastic leukaemia|high risk acute lymphoblastic leukaemia
5349981|NCT01949103|Gram-positive|gram-positive
5349983|NCT01949090|AS03 adjuvant|as03 adjuvant
5349984|NCT01949090|Safety|safety
5349985|NCT01949090|Immunogenicity|immunogenicity
5349986|NCT01949090|Influenza|influenza
5349987|NCT01949090|Adults|adults
5349988|NCT01949090|Elderly adults|elderly adults
5349989|NCT01949077|Hepatitis|hepatitis
5349990|NCT01949077|Hepatitis C|hepatitis c
5349991|NCT01949077|Observational study|observational study
5349992|NCT01949077|Biomarkers of treatment response|biomarkers of treatment response
5349993|NCT01949051|Allergic rhinitis|allergic rhinitis
5349994|NCT01949051|levocabastine|levocabastine
5349995|NCT01949051|allergen challenge|allergen challenge
5349996|NCT01949038|Pain|pain
5349997|NCT01949038|Discomfort|discomfort
5349998|NCT01949038|Anxiety|anxiety
5349999|NCT01949038|Satisfaction|satisfaction
5350000|NCT01949038|Compliance|compliance
5350001|NCT01949012|Midazolam|midazolam
5350002|NCT01949012|Endtidal carbon dioxide|endtidal carbon dioxide
5350003|NCT01949012|Desaturation|desaturation
5350004|NCT01948999|electroconvulsive therapy|electroconvulsive therapy
5350005|NCT01948999|treatment-refractory schizophrenia|treatment-refractory schizophrenia
5350006|NCT01948973|Irritable Bowel Syndrome|irritable bowel syndrome
5350007|NCT01948973|Sacral Nerve Stimulation|sacral nerve stimulation
5350008|NCT01948973|Symptoms|symptoms
5350009|NCT01948973|Quality of Life|quality of life
5350010|NCT01948973|Bowel habits|bowel habits
5350011|NCT01948960|Breast Neoplasms|breast neoplasms
5350012|NCT01948960|everolimus|everolimus
5350013|NCT01948960|pharmacokinetics|pharmacokinetics
5350014|NCT01948960|elderly patients|elderly patients
5350015|NCT01948960|obese patients|obese patients
5350016|NCT01948934|Skin|skin
5350017|NCT01948934|Injury|injury
5350018|NCT01948934|Membrane amniotic|membrane amniotic
5350019|NCT01948934|Wound|wound
5350021|NCT01948921|tolerance|tolerance
5350022|NCT01948921|discomfort|discomfort
5350023|NCT01948908|Sedation|sedation
5350024|NCT01948908|Laceration repair|laceration repair
5350025|NCT01948908|Children|children
5350026|NCT01948908|Intranasal|intranasal
5350027|NCT01948908|Midazolam|midazolam
5350028|NCT01948895|Desvenlafaxine|desvenlafaxine
5350029|NCT01948895|Open-label|open-label
5350030|NCT01948895|Flexible-dose|flexible-dose
5350031|NCT01948895|Dysthymic disorder|dysthymic disorder
5350032|NCT01948895|Anxiety disorders|anxiety disorders
5350033|NCT01948895|Generalized anxiety disorder|generalized anxiety disorder
5350034|NCT01948895|Social anxiety disorder|social anxiety disorder
5350035|NCT01948895|Post-traumatic stress disorder|post-traumatic stress disorder
5350036|NCT01948882|Birth control|birth control
5350037|NCT01948869|Phoenix|phoenix
5350038|NCT01948869|Mild atopic dermatitis|mild atopic dermatitis
5350039|NCT01948869|efficacy|efficacy
5963769|NCT04199793|Thromboembolic events|thromboembolic events
5963770|NCT04199780|total knee arthroplasty|total knee arthroplasty
5963771|NCT04199780|pain|pain
5350040|NCT01948869|safety|safety
5350041|NCT01948856|Recurrent common cold|recurrent common cold
5350043|NCT01948856|pharyngitis/tonsillitis|pharyngitis/tonsillitis
5350044|NCT01948856|acute rhinitis|acute rhinitis
5963772|NCT04199780|postsurgical pain|postsurgical pain
5350045|NCT01948856|acute rhinosinusitis|acute rhinosinusitis
5350046|NCT01948856|acute otitis media|acute otitis media
5350047|NCT01948843|HER2 Negative Metastatic Breast Cancer|her2 negative metastatic breast cancer
5671197|NCT00616824|patient satisfaction|patient satisfaction
5350048|NCT01948830|Ranibizumab, Lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen|ranibizumab, lucentis, choroidal neovascularization, age-related macular degeneration, treat and extend regimen
5350050|NCT01948791|Alzheimer's disease|alzheimer's disease
5350051|NCT01948791|ENA713|ena713
5350052|NCT01948791|Chinese patients|chinese patients
5350053|NCT01948791|INSTINCT|instinct
5350054|NCT01948765|xenon anesthesia|xenon anesthesia
5350055|NCT01948765|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
5350056|NCT01948752|Nutrition policy|nutrition policy
5350057|NCT01948752|food labelling|food labelling
5350058|NCT01948752|diet|diet
5350059|NCT01948752|obesity|obesity
5350060|NCT01948752|health behavior|health behavior
5350061|NCT01948739|Brain machine interface|brain machine interface
5350062|NCT01948739|Rehabilitation robotics|rehabilitation robotics
5350063|NCT01948739|Stroke|stroke
5350064|NCT01948739|Hemiparesis|hemiparesis
5350065|NCT01948726|Breast cancer|breast cancer
5350066|NCT01948726|Hypofractionation|hypofractionation
5350067|NCT01948726|Simultaneous integrated boost|simultaneous integrated boost
5350068|NCT01948726|Toxicity|toxicity
5244919|NCT02474667|DGF|dgf
5350069|NCT01948700|Motivational Interviewing|motivational interviewing
5350070|NCT01948700|Problem Drinking|problem drinking
5350071|NCT01948700|Adolescents|adolescents
5346055|NCT01967303|Stroke|stroke
5350072|NCT01948700|Minority Health|minority health
5350073|NCT01948687|real time elastography|real time elastography
5350074|NCT01948687|hepatitis|hepatitis
5350075|NCT01948648|plant sterols|plant sterols
5350076|NCT01948648|cholesterol|cholesterol
5350077|NCT01948648|colesevelam|colesevelam
5350078|NCT01948648|phytosterolemia|phytosterolemia
5350079|NCT01948648|fish oil|fish oil
5350080|NCT01948635|tracheal cuff shape|tracheal cuff shape
5350081|NCT01948635|microaspiration|microaspiration
5350082|NCT01948635|pepsin|pepsin
5350083|NCT01948635|ventilator-associated pneumonia|ventilator-associated pneumonia
5350084|NCT01948622|Anxiety|anxiety
5350085|NCT01948622|Third molar surgery|third molar surgery
5350086|NCT01948622|Blood pressure|blood pressure
5350087|NCT01948622|Heart rate|heart rate
5350088|NCT01948622|Oxygen saturation|oxygen saturation
5350089|NCT01948596|pregnant women|pregnant women
5350090|NCT01948596|depression|depression
5350091|NCT01948596|depressive symptoms|depressive symptoms
5350092|NCT01948596|omega-3 fatty acids|omega-3 fatty acids
5350093|NCT01948583|vaginal dryness|vaginal dryness
5350094|NCT01948583|hyaluronic acid|hyaluronic acid
5350095|NCT01948583|menopause|menopause
5350096|NCT01948570|acne,comedones, oily skin|acne,comedones, oily skin
5350097|NCT01948557|Breastfeeding|breastfeeding
5350098|NCT01948557|Infants|infants
5350099|NCT01948557|Mother to child transmission of HIV|mother to child transmission of hiv
5350100|NCT01948557|Survival|survival
5350101|NCT01948544|COPD|copd
5350102|NCT01948544|LTOT|ltot
5350103|NCT01948544|Long-Term Oxygen Therapy|long-term oxygen therapy
5350104|NCT01948544|Portable Oxygen Concentrator|portable oxygen concentrator
5350105|NCT01948544|Quality of Life|quality of life
5350106|NCT01948544|Six Minute Walk Distance Test|six minute walk distance test
5350107|NCT01948531|Antiage|antiage
5350108|NCT01948518|Pulmonary hypertension|pulmonary hypertension
5350109|NCT01948518|Parenchymal Lung Disease|parenchymal lung disease
5350110|NCT01948518|Diffusion Capacity|diffusion capacity
5350111|NCT01948505|Craniotomy|craniotomy
5350112|NCT01948466|Nutrition|nutrition
5350113|NCT01948466|Commercials|commercials
5350114|NCT01948466|Elementary|elementary
5350115|NCT01948466|Lunchroom|lunchroom
5350116|NCT01948466|Fruits|fruits
5350117|NCT01948466|Vegetables|vegetables
5350119|NCT01948453|CIMT|cimt
5350121|NCT01948440|Substance abuse, early recovery, relapse prevention|substance abuse, early recovery, relapse prevention
5350122|NCT01948427|UCD|ucd
5350123|NCT01948427|BUPHENYL|buphenyl
5350124|NCT01948427|RAVICTI|ravicti
5350125|NCT01948427|Urea|urea
5350126|NCT01948427|Urea cycle disorder|urea cycle disorder
5350127|NCT01948427|Glycerol phenylbutyrate|glycerol phenylbutyrate
5350128|NCT01948427|Benzoate|benzoate
5350129|NCT01948427|Sodium phenylbutyrate|sodium phenylbutyrate
5350130|NCT01948427|Ornithine transcarbamylase (OTC)|ornithine transcarbamylase (otc)
5350131|NCT01948427|Argininosuccinate synthetase (ASS)|argininosuccinate synthetase (ass)
5350132|NCT01948427|Argininosuccinate lyase (ASL)|argininosuccinate lyase (asl)
5350133|NCT01948427|Carbamyl phosphate synthetase (CPS)|carbamyl phosphate synthetase (cps)
5963773|NCT04199780|opioid|opioid
5963774|NCT04199780|transcranial direct current stimulation|transcranial direct current stimulation
5963775|NCT04199780|tDCS|tdcs
5963776|NCT04199780|brain stimulation|brain stimulation
5963777|NCT04199780|total hip arthroplasty|total hip arthroplasty
5963778|NCT04199780|TKA|tka
5963779|NCT04199780|THA|tha
5963780|NCT04199767|Intranasal Delivery of Insulin|intranasal delivery of insulin
5963781|NCT04199767|Cognitive Testing|cognitive testing
5963782|NCT04199767|Nasal Insulin|nasal insulin
5217092|NCT02639624|hemodialysis|hemodialysis
5350134|NCT01948427|Arginine|arginine
5350135|NCT01948427|Citrulline|citrulline
5350136|NCT01948427|Ammonia|ammonia
5350137|NCT01948414|Obesity|obesity
5350138|NCT01948414|Hyperalimentation|hyperalimentation
5350139|NCT01948414|Event-Related Potential|event-related potential
5350140|NCT01948414|P300|p300
5350141|NCT01948388|Rheumatoid arthritis|rheumatoid arthritis
5350142|NCT01948375|subject blinding|subject blinding
5350143|NCT01948375|placebo needle|placebo needle
5350144|NCT01948336|Contrast-induced nephropathy, Dexmedetomidine, Endothelin-1|contrast-induced nephropathy, dexmedetomidine, endothelin-1
5350145|NCT01948323|Pregnancy|pregnancy
5350147|NCT01948323|Newborn health|newborn health
5350148|NCT01948323|Information technology|information technology
5350149|NCT01948323|Health education|health education
5350150|NCT01948323|Cellphone|cellphone
5350151|NCT01948323|Touch screen technology|touch screen technology
5350152|NCT01948323|Pregnancy outcome|pregnancy outcome
5350153|NCT01948323|Low-Middle income|low-middle income
5350154|NCT01948323|Nurse-led|nurse-led
5350155|NCT01948323|Nutrition|nutrition
5350156|NCT01948323|Exercise|exercise
5350157|NCT01948284|cecal intubation time|cecal intubation time
5350158|NCT01948284|water exchange|water exchange
5350159|NCT01948284|pain|pain
5350160|NCT01948271|Psoriasis|psoriasis
5350161|NCT01948271|Trichuris suis ova|trichuris suis ova
5350162|NCT01948271|T-lymphocytes|t-lymphocytes
5350163|NCT01948258|Pregnancy|pregnancy
5350164|NCT01948245|Catheter Related Blood Stream Infection|catheter related blood stream infection
5350165|NCT01948245|Long-term intestinal Failure|long-term intestinal failure
5350166|NCT01948245|Taurolidine|taurolidine
5350167|NCT01948245|Catheter lock solution|catheter lock solution
5350168|NCT01948245|Antimicrobial agent|antimicrobial agent
5350169|NCT01948245|Home Parenteral Nutrition|home parenteral nutrition
5350170|NCT01948245|Anti-infective agents|anti-infective agents
5350171|NCT01948206|Sudden Cardiac Death|sudden cardiac death
5350172|NCT01948206|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5350173|NCT01948206|Cardiomyopathy|cardiomyopathy
5350174|NCT01948206|Prolonged Paced QRS Duration|prolonged paced qrs duration
5350177|NCT01948193|Whooping Cough|whooping cough
5350178|NCT01948193|Hepatitis B|hepatitis b
5350179|NCT01948193|Poliomyelitis|poliomyelitis
5350180|NCT01948193|DTaP IPV-Hep B-PRP~T combined vaccine (Hexaxim™)|dtap ipv-hep b-prp~t combined vaccine (hexaxim™)
5350181|NCT01948180|NKTCL|nktcl
5350182|NCT01948180|T cell|t cell
5350183|NCT01948180|CITADEL|citadel
5350184|NCT01948180|Epstein-Barr Virus|epstein-barr virus
5350185|NCT01948180|Natural Killer|natural killer
5350186|NCT01948167|Depression|depression
5350187|NCT01948167|Prevention|prevention
5350188|NCT01948167|Adolescents|adolescents
5350189|NCT01948154|Cerebral Palsy|cerebral palsy
5350190|NCT01948154|Early Intervention|early intervention
5350191|NCT01948154|Speech Function|speech function
5350192|NCT01948154|Quality of Life|quality of life
5350193|NCT01948128|Breast|breast
5350194|NCT01948115|Breech presentation|breech presentation
5350195|NCT01948115|equimolar mixture of oxygen and nitrous oxide|equimolar mixture of oxygen and nitrous oxide
5350196|NCT01948115|external cephalic version|external cephalic version
5350197|NCT01948102|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5350198|NCT01948102|motor neuron disease|motor neuron disease
5350199|NCT01948102|biological markers|biological markers
5350200|NCT01948102|biomarkers|biomarkers
5350201|NCT01948089|Chronic Stroke|chronic stroke
5350202|NCT01948089|near transfer|near transfer
5350203|NCT01948089|far transfer|far transfer
5350204|NCT01948089|working memory|working memory
5350205|NCT01948089|fluid intelligence|fluid intelligence
5350206|NCT01948089|cognitive training|cognitive training
5350207|NCT01948089|dual n-back|dual n-back
5350208|NCT01948076|splenomegaly|splenomegaly
5350209|NCT01948076|pleural effusion|pleural effusion
5350210|NCT01948037|hydrotherapy|hydrotherapy
5350211|NCT01948037|randomized controlled trial|randomized controlled trial
5350212|NCT01948037|lower extremity arterial disease|lower extremity arterial disease
5350213|NCT01948037|diabetes|diabetes
5350214|NCT01947998|Rivaroxaban|rivaroxaban
5350215|NCT01947998|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
5350216|NCT01947998|Anticoagulants|anticoagulants
5350217|NCT01947998|Hematologic Agents|hematologic agents
5350218|NCT01947998|Therapeutic Uses|therapeutic uses
5350219|NCT01947998|Observational|observational
5350220|NCT01947998|Venous Thromboembolism|venous thromboembolism
5350221|NCT01947998|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
5350222|NCT01947998|Intracranial Hemorrhages|intracranial hemorrhages
5963783|NCT04199104|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5963784|NCT04199104|pembrolizumab|pembrolizumab
5963785|NCT04199104|lenvatinib|lenvatinib
5963786|NCT04199104|PD-L1|pd-l1
5963787|NCT04199091|Craniosacral Therapy|craniosacral therapy
5963788|NCT04199091|Low Back Pain, Chronic|low back pain, chronic
5963789|NCT04199091|Randomized Controlled Trial|randomized controlled trial
5963790|NCT04199091|Self-help|self-help
5963791|NCT04198558|Double-blind|double-blind
5963792|NCT04198558|Placebo-controlled|placebo-controlled
5963793|NCT04198558|Safety and Tolerability Study|safety and tolerability study
5229100|NCT02569762|Microbiota|microbiota
5229101|NCT02569762|Dysbiosis|dysbiosis
5229102|NCT02569671|Dental Implants, Single-Tooth|dental implants, single-tooth
5229103|NCT02569645|Rectal cancer|rectal cancer
5229112|NCT02569619|Promotion|promotion
5350223|NCT01947998|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5350224|NCT01947985|Rivaroxaban|rivaroxaban
5350225|NCT01947985|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
5350226|NCT01947985|Anticoagulants|anticoagulants
5350227|NCT01947985|Hematologic Agents|hematologic agents
5350228|NCT01947985|Therapeutic Uses|therapeutic uses
5350229|NCT01947985|Observational|observational
5350230|NCT01947985|Venous Thromboembolism|venous thromboembolism
5350231|NCT01947985|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
5350232|NCT01947985|Intracranial Hemorrhages|intracranial hemorrhages
5350233|NCT01947985|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5350235|NCT01947972|tailored fortification|tailored fortification
5350236|NCT01947972|nutrition|nutrition
5350237|NCT01947972|maternal breast milk composition|maternal breast milk composition
5350238|NCT01947959|Rivaroxaban|rivaroxaban
5350239|NCT01947959|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
5350240|NCT01947959|Anticoagulants|anticoagulants
5350242|NCT01947959|Therapeutic Uses|therapeutic uses
5350243|NCT01947959|Observational|observational
5350244|NCT01947959|Venous Thromboembolism|venous thromboembolism
5350245|NCT01947959|Secondary Prevention of Acute Coronary Syndrome|secondary prevention of acute coronary syndrome
5350246|NCT01947959|Intracranial Hemorrhages|intracranial hemorrhages
5350247|NCT01947959|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5350248|NCT01947946|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
5350249|NCT01947920|Healthy|healthy
5350250|NCT01947920|Pain|pain
5350251|NCT01947920|Tramadol hydrochloride|tramadol hydrochloride
5350252|NCT01947920|Tramadol HCl|tramadol hcl
5350253|NCT01947920|Analgesic|analgesic
5350254|NCT01947920|QT prolongation|qt prolongation
5350255|NCT01947920|RWJ-26898-002|rwj-26898-002
5350256|NCT01947907|Human Growth Hormone|human growth hormone
5350257|NCT01947907|rhGH|rhgh
5350259|NCT01947907|GHD|ghd
5350260|NCT01947881|Diabetic Macular Edema|diabetic macular edema
5350261|NCT01947881|anti-VEGF|anti-vegf
5350262|NCT01947881|Treatment Response|treatment response
5350263|NCT01947842|Smartphone|smartphone
5350264|NCT01947842|adherence|adherence
5350265|NCT01947842|contraceptives|contraceptives
5350266|NCT01947842|college|college
5350267|NCT01947842|females|females
5350268|NCT01947829|hemodialysis|hemodialysis
5350269|NCT01947829|dialysis dose|dialysis dose
5350270|NCT01947816|Ulcerative Colitis|ulcerative colitis
5350271|NCT01947803|Schizophrenia|schizophrenia
5350272|NCT01947803|Paliperidone|paliperidone
5350274|NCT01947803|Effectiveness|effectiveness
5350275|NCT01947803|Chinese|chinese
5350276|NCT01947790|Type 2 diabetes|type 2 diabetes
5350277|NCT01947790|left ventricular mass|left ventricular mass
5350278|NCT01947790|pioglitazone|pioglitazone
5350279|NCT01947777|Phase 1|phase 1
5350280|NCT01947777|Healthy subjects|healthy subjects
5350281|NCT01947777|DDI|ddi
5350282|NCT01947777|CYP3A|cyp3a
5350283|NCT01947764|HIV|hiv
5350284|NCT01947764|Disclosure|disclosure
5350285|NCT01947764|Pediatrics|pediatrics
5350286|NCT01947751|Catheter related infection|catheter related infection
5350287|NCT01947751|Central venous catheter|central venous catheter
5350288|NCT01947751|CVC infection|cvc infection
5350289|NCT01947738|Healthy|healthy
5350290|NCT01947738|Subjects|subjects
5350291|NCT01947738|Safety|safety
5350292|NCT01947738|Tolerability|tolerability
5350293|NCT01947738|VBY891|vby891
5350294|NCT01947738|Maximum|maximum
5350295|NCT01947738|Pharmacodynamic|pharmacodynamic
5350296|NCT01947738|Pharmacokinetic|pharmacokinetic
5350297|NCT01947712|Peripheral arterial disease|peripheral arterial disease
5350298|NCT01947712|Oxidative stress|oxidative stress
5350299|NCT01947712|Cocoa|cocoa
5350300|NCT01947712|polyphenols|polyphenols
5350301|NCT01947712|NADPH oxidase|nadph oxidase
5350302|NCT01947686|osteoarthritis, patellofemoral|osteoarthritis, patellofemoral
5350303|NCT01947647|behavior therapy|behavior therapy
5350304|NCT01947647|Randomized Controlled Trials|randomized controlled trials
5350305|NCT01947647|Depressive Disorder|depressive disorder
5350306|NCT01947647|Anxiety Disorders|anxiety disorders
5350307|NCT01947647|comorbidity|comorbidity
5350308|NCT01947621|Broken heart syndrome, stress cardiomyopathy|broken heart syndrome, stress cardiomyopathy
5350309|NCT01947595|diabetes mellitus type 2|diabetes mellitus type 2
5350310|NCT01947595|impaired glucose tolerance|impaired glucose tolerance
5350311|NCT01947595|lifestyle intervention|lifestyle intervention
5350312|NCT01947595|body fat distribution|body fat distribution
5350313|NCT01947595|prevention|prevention
5963794|NCT04198558|Healthy Volunteers|healthy volunteers
5963795|NCT04197908|Acute cholecystitis|acute cholecystitis
5963796|NCT04197908|EUS-guided gallbladder drainage|eus-guided gallbladder drainage
5963797|NCT04197908|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5963798|NCT04197908|gallbladder polyp|gallbladder polyp
5963799|NCT04197908|gallstone|gallstone
5350314|NCT01947582|multiple sclerosis|multiple sclerosis
5350315|NCT01947582|gait|gait
5350316|NCT01947582|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
5350317|NCT01947556|diabetes|diabetes
5350318|NCT01947556|insulin administration|insulin administration
5350319|NCT01947556|hyperglycaemia|hyperglycaemia
5350320|NCT01947556|insulin aspart|insulin aspart
5350321|NCT01947478|Drug-Eluting Angioplasty Balloon|drug-eluting angioplasty balloon
5350322|NCT01947478|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5350323|NCT01947478|Peripheral Artery Disease|peripheral artery disease
5350324|NCT01947478|Experimental|experimental
5350325|NCT01947478|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5350326|NCT01947452|Youth violence reduction|youth violence reduction
5350327|NCT01947452|Youth crime reduction|youth crime reduction
5350328|NCT01947452|School engagement|school engagement
5350329|NCT01947452|Employment|employment
5350330|NCT01947452|Social-emotional learning|social-emotional learning
5350332|NCT01947426|DHA, term neonates, mother milk|dha, term neonates, mother milk
5350333|NCT01947413|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5350334|NCT01947413|BoNTA|bonta
5350335|NCT01947413|stroke|stroke
5350336|NCT01947413|optimal treatment protocol|optimal treatment protocol
5350337|NCT01947413|randomized controlled trial|randomized controlled trial
5350338|NCT01947413|motor control|motor control
5350339|NCT01947413|clinical predictors|clinical predictors
5350340|NCT01947400|Physician and Patient Communication|physician and patient communication
5350341|NCT01947400|Acknowledge Introduce Duration Explanation Thank|acknowledge introduce duration explanation thank
5350342|NCT01947400|Hospital Consumer Assessment of Health Plans Survey|hospital consumer assessment of health plans survey
5350344|NCT01947374|Articular|articular
5350345|NCT01947335|Coronary|coronary
5350346|NCT01947335|Angioplasty|angioplasty
5350347|NCT01947335|Percutaneous coronary intervention|percutaneous coronary intervention
5350349|NCT01947335|Contrast|contrast
5350350|NCT01947335|Acute Renal failure|acute renal failure
5350351|NCT01947335|Intravascular ultrasound|intravascular ultrasound
5350352|NCT01947335|Prevention|prevention
5350353|NCT01947322|Natural killer cell|natural killer cell
5350354|NCT01947322|Haploidentical|haploidentical
5350355|NCT01947322|Acute myeloid leukemia|acute myeloid leukemia
5350356|NCT01947322|Chemotherapy|chemotherapy
5350357|NCT01947309|Revlimid, lenalidomide, multiple myeloma, PFS, Response Rates|revlimid, lenalidomide, multiple myeloma, pfs, response rates
5350358|NCT01947296|Oral antineoplastic agent|oral antineoplastic agent
5350359|NCT01947296|Adverse Effects|adverse effects
5350360|NCT01947296|Cancer Networks|cancer networks
5350361|NCT01947296|Continuity of care|continuity of care
5350362|NCT01947296|Coordination of patient's care|coordination of patient's care
5350363|NCT01947283|Patient-Provider Relationship|patient-provider relationship
5350364|NCT01947283|Shared Decision Making|shared decision making
5350365|NCT01947283|Therapeutic Alliance|therapeutic alliance
5350366|NCT01947283|Mental Health|mental health
5350367|NCT01947283|Minority Health|minority health
5350368|NCT01947283|Patient Activation|patient activation
5350369|NCT01947283|Communication|communication
5350370|NCT01947270|Potentially inappropriate medications|potentially inappropriate medications
5350372|NCT01947270|Prevention|prevention
5350373|NCT01947270|Multidisciplinary program|multidisciplinary program
5350374|NCT01947270|Checklist|checklist
5350375|NCT01947270|Stepped wedge design|stepped wedge design
5350376|NCT01947270|AGED, 75 AND OVER|aged, 75 and over
5350377|NCT01947244|Doulas|doulas
5350378|NCT01947244|Parenting|parenting
5350379|NCT01947244|Breast Feeding|breast feeding
5350380|NCT01947244|Pregnancy in Adolescence|pregnancy in adolescence
5350381|NCT01947244|Child Development|child development
5350382|NCT01947231|neck pain|neck pain
5350383|NCT01947231|chronic|chronic
5350384|NCT01947231|Global Postural Re-education|global postural re-education
5350385|NCT01947231|manual therapy|manual therapy
5350386|NCT01947231|physical therapy|physical therapy
5350387|NCT01947205|Curettage|curettage
5350388|NCT01947205|analgesia|analgesia
5350389|NCT01947205|paracervical block|paracervical block
5350390|NCT01947205|paracetamol|paracetamol
5350391|NCT01947205|lidocaine|lidocaine
5350392|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol
5350393|NCT01947192|Chlorhexidine|chlorhexidine
5350394|NCT01947192|Matrix metalloproteinases (MMP) inhibitor|matrix metalloproteinases (mmp) inhibitor
5350395|NCT01947192|Adhesive system|adhesive system
5350396|NCT01947192|Controlled clinical trial|controlled clinical trial
5350397|NCT01947192|Dental restoration|dental restoration
5350398|NCT01947192|Noncarious cervical lesions|noncarious cervical lesions
5350399|NCT01947192|Dental restoration failure|dental restoration failure
5350400|NCT01947166|Whipple|whipple
5350401|NCT01947140|Lymphoid Malignancies|lymphoid malignancies
5350402|NCT01947140|Multiple Myeloma|multiple myeloma
5350403|NCT01947140|Lymphoma|lymphoma
5350404|NCT01947140|Hodgkin Lymphoma|hodgkin lymphoma
5350405|NCT01947140|Non-hodgkin Lymphoma|non-hodgkin lymphoma
5350406|NCT01947140|Follicular Lymphoma|follicular lymphoma
5350407|NCT01947140|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5229304|NCT02568696|graft rejection|graft rejection
5350408|NCT01947140|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5350409|NCT01947140|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5350410|NCT01947140|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5350411|NCT01947140|Mantle Cell Lymphoma|mantle cell lymphoma
5350412|NCT01947140|Marginal Zone Lymphoma|marginal zone lymphoma
5350413|NCT01947140|Burkitt Lymphoma|burkitt lymphoma
5350414|NCT01947140|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5350415|NCT01947140|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5350416|NCT01947140|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5350417|NCT01947127|Lactate|lactate
5350418|NCT01947127|Sepsis|sepsis
5350419|NCT01947127|Septic shock|septic shock
5350420|NCT01947127|Disease progression|disease progression
5350421|NCT01947127|Prognosis|prognosis
5350422|NCT01947114|General anesthesia,|general anesthesia,
5350423|NCT01947114|Children,|children,
5350424|NCT01947114|Rigid Bronchoscopy,|rigid bronchoscopy,
5350425|NCT01947114|Remifentanil,|remifentanil,
5350426|NCT01947114|Propofol,|propofol,
5350427|NCT01947114|Ketamine.|ketamine.
5350428|NCT01947101|Stool transplant|stool transplant
5350429|NCT01947101|Ulcerative Colitis|ulcerative colitis
5350430|NCT01947101|Fecal transplant|fecal transplant
5350431|NCT01947101|Inflammatory Bowel Disease|inflammatory bowel disease
5350432|NCT01947088|Epilepsy, seizure disorder|epilepsy, seizure disorder
5350434|NCT01947075|Tanzania|tanzania
5350435|NCT01947075|Pneumonia|pneumonia
5350437|NCT01947075|Diabetes|diabetes
5350438|NCT01947075|Indoor Air Pollution|indoor air pollution
5350439|NCT01947062|NSCLC|nsclc
5350440|NCT01947062|Metronomic chemotherapy|metronomic chemotherapy
5350441|NCT01947062|Metronomic cyclophosphamide|metronomic cyclophosphamide
5350442|NCT01947049|Influenza|influenza
5350443|NCT01947049|diagnostic testing|diagnostic testing
5350444|NCT01947049|antiviral treatment|antiviral treatment
5350445|NCT01947049|rapid influenza testing|rapid influenza testing
5350446|NCT01947036|autoimmune disease|autoimmune disease
5350447|NCT01947036|immune-mediated disease|immune-mediated disease
5350448|NCT01947036|T and B cells immunophenotype|t and b cells immunophenotype
5350449|NCT01947036|IL23 signaling|il23 signaling
5350450|NCT01947036|genetic risk variants|genetic risk variants
5350451|NCT01947010|antibodies|antibodies
5350452|NCT01946984|diclofenac, ERCP and pancreatitis|diclofenac, ercp and pancreatitis
5350453|NCT01946958|Triple P|triple p
5350454|NCT01946945|infertility|infertility
5350455|NCT01946945|recurrent pregnancy loss|recurrent pregnancy loss
5350456|NCT01946945|miscarriage|miscarriage
5350457|NCT01946945|Next Generation Sequencing|next generation sequencing
5350458|NCT01946932|Induced hypothermia|induced hypothermia
5350459|NCT01946932|Mild induced hypothermia|mild induced hypothermia
5350460|NCT01946932|Resuscitation|resuscitation
5350461|NCT01946932|Therapeutic hypothermia|therapeutic hypothermia
5350462|NCT01946932|Neurological function|neurological function
5350463|NCT01946932|Cardiovascular diseases|cardiovascular diseases
5350464|NCT01946932|Rehabilitation|rehabilitation
5350465|NCT01946932|Quality of life|quality of life
5350466|NCT01946932|Cognition|cognition
5350467|NCT01946919|Cinepazide|cinepazide
5350468|NCT01946919|Adverse Drug Reaction|adverse drug reaction
5350470|NCT01946919|Real World Study|real world study
5350471|NCT01946893|meditation|meditation
5350472|NCT01946893|education|education
5350473|NCT01946893|stress, psychological|stress, psychological
5350474|NCT01946893|aged|aged
5350475|NCT01946880|Systemic Lupus Erythematosus|systemic lupus erythematosus
5350476|NCT01946880|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
5350477|NCT01946867|Oral cavity Cancer|oral cavity cancer
5350478|NCT01946867|Oropharynx Cancer|oropharynx cancer
5350479|NCT01946854|Gastrointestinal|gastrointestinal
5350480|NCT01946854|Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas with Pseudomyxoma Peritonea|metastatic well-differentiated mucinous appendiceal adenocarcinomas with pseudomyxoma peritonea
5350481|NCT01946854|Appendiceal cancer|appendiceal cancer
5350482|NCT01946854|Surgically unresectable|surgically unresectable
5350483|NCT01946854|Chemotherapy|chemotherapy
5350484|NCT01946854|Observation|observation
5350485|NCT01946854|Questionnaires|questionnaires
5350486|NCT01946841|Chronic kidney disease|chronic kidney disease
5350487|NCT01946841|Hemodialysis|hemodialysis
5350488|NCT01946841|Severe malnutrition|severe malnutrition
5350489|NCT01946841|Enteral nutrition|enteral nutrition
5350490|NCT01946828|Field Induced Mydriasis|field induced mydriasis
5350491|NCT01946828|FIM|fim
5350492|NCT01946828|ATI|ati
5350493|NCT01946802|Heart arrest|heart arrest
5350494|NCT01946802|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5350495|NCT01946802|Hypothermia induced|hypothermia induced
5350496|NCT01946802|Seizures|seizures
5350497|NCT01946802|Electroencephalography|electroencephalography
5350498|NCT01946789|cancer|cancer
5350499|NCT01946789|IL-15|il-15
5350500|NCT01946789|melanoma|melanoma
5350501|NCT01946789|metastatic|metastatic
5350502|NCT01946789|unresectable|unresectable
5350503|NCT01946789|solid tumors|solid tumors
5350504|NCT01946789|renal cell|renal cell
5963800|NCT04197466|Pelvic Floor Muscle Exercise|pelvic floor muscle exercise
5350505|NCT01946789|non-small cell lung|non-small cell lung
5350506|NCT01946789|squamous cell head and neck|squamous cell head and neck
5350507|NCT01946737|Coronary|coronary
5350508|NCT01946737|Artery|artery
5350509|NCT01946737|Disease|disease
5350510|NCT01946737|Diagnostic|diagnostic
5350511|NCT01946737|Performance|performance
5350512|NCT01946737|Angiography|angiography
5350513|NCT01946711|CRS|crs
5350514|NCT01946711|polyposis|polyposis
5350515|NCT01946672|gynaecological malignancy|gynaecological malignancy
5350516|NCT01946672|pelvic lymphadenectomy|pelvic lymphadenectomy
5350517|NCT01946672|lymphedema|lymphedema
5350518|NCT01946672|sentinel node|sentinel node
5350519|NCT01946672|reverse mapping|reverse mapping
5350520|NCT01946659|Tailored Telephone Intervention|tailored telephone intervention
5350521|NCT01946620|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5350522|NCT01946620|Exacerbations|exacerbations
5336726|NCT02009644|AAA|aaa
5350523|NCT01946620|FEV1 ≤ 50%|fev1 ≤ 50%
5350524|NCT01946607|Neuroticism|neuroticism
5350525|NCT01946607|Emotion processing|emotion processing
5350526|NCT01946607|Eye gaze movements|eye gaze movements
5350527|NCT01946607|Heart Rate Variability|heart rate variability
5350528|NCT01946594|fever|fever
5350529|NCT01946594|antipyretics|antipyretics
5350530|NCT01946594|acetaminophen|acetaminophen
5350531|NCT01946594|influenza vaccine|influenza vaccine
5350532|NCT01946594|influenza, human|influenza, human
5350533|NCT01946594|body temperature changes|body temperature changes
5350534|NCT01946594|Orthomyxoviridae Infections|orthomyxoviridae infections
5350535|NCT01946594|RNA virus infections|rna virus infections
5350536|NCT01946594|Virus Diseases|virus diseases
5350537|NCT01946594|Respiratory Tract Infections|respiratory tract infections
5350538|NCT01946594|Respiratory Tract Diseases|respiratory tract diseases
5350539|NCT01946555|Breakthrough cancer pain|breakthrough cancer pain
5350540|NCT01946555|Neuropathic pain|neuropathic pain
5350541|NCT01946555|Major opioid|major opioid
5350542|NCT01946555|Analgesics|analgesics
5350543|NCT01946542|exercise|exercise
5350544|NCT01946542|heart failure|heart failure
5350545|NCT01946542|fatigue|fatigue
5350546|NCT01946542|physical endurance|physical endurance
5350547|NCT01946542|functional food|functional food
5350548|NCT01946516|viral screening|viral screening
5350549|NCT01946503|Short Gut|short gut
5350550|NCT01946503|Short Bowel Syndrome|short bowel syndrome
5350551|NCT01946503|Intestinal Failure|intestinal failure
5350552|NCT01946503|Home parenteral nutrition|home parenteral nutrition
5350553|NCT01946503|Feeding Behavior|feeding behavior
5350554|NCT01946503|Enteral Nutrition|enteral nutrition
5350555|NCT01946503|Parent-Child Relations|parent-child relations
5350556|NCT01946503|Parenteral Nutrition|parenteral nutrition
5354371|NCT01928654|Laser|laser
5350557|NCT01946503|Digestive System Diseases|digestive system diseases
5350558|NCT01946477|Multiple Myeloma, MM, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma|multiple myeloma, mm, cancer, oncology, hematology, plasma, neoplasm, plasmacytoma
5350559|NCT01946464|edentulous|edentulous
5350561|NCT01946464|patients|patients
5350562|NCT01946464|requiring|requiring
5350563|NCT01946464|general anesthesia|general anesthesia
5350564|NCT01946464|Mallampati Class II or IV|mallampati class ii or iv
5350565|NCT01946451|idiopathic epiretinal membranes|idiopathic epiretinal membranes
5350566|NCT01946451|secondary epiretinal membranes|secondary epiretinal membranes
5350567|NCT01946438|Influenza|influenza
5350568|NCT01946438|Fluzone® Quadrivalent, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® quadrivalent, influenza virus vaccine (2013-2014 formulation),
5350569|NCT01946438|Fluzone® Intradermal, Influenza Virus Vaccine (2013-2014 formulation),|fluzone® intradermal, influenza virus vaccine (2013-2014 formulation),
5350570|NCT01946438|Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)|fluzone® high-dose, influenza virus vaccine (2013-2014 formulation)
5350571|NCT01946425|Influenza|influenza
5350572|NCT01946425|Influenza virus vaccine|influenza virus vaccine
5350573|NCT01946425|Fluzone® Quadrivalent Influenza Vaccine (No Preservative)|fluzone® quadrivalent influenza vaccine (no preservative)
5350574|NCT01946412|Cystic Fibrosis|cystic fibrosis
5350575|NCT01946373|Melanoma|melanoma
5350576|NCT01946373|Dendritic cell vaccination|dendritic cell vaccination
5350577|NCT01946373|Lymphodepletion|lymphodepletion
5350578|NCT01946373|Adoptive cell transfer|adoptive cell transfer
5350579|NCT01946373|T cells|t cells
5350580|NCT01946373|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
5350581|NCT01946373|Fludarabine|fludarabine
5350582|NCT01946373|IL-2|il-2
5350583|NCT01946373|Interleukin-2|interleukin-2
5350584|NCT01946373|Cyclophosphamide|cyclophosphamide
5350585|NCT01946373|Phase I study|phase i study
5350586|NCT01946373|Monocytes|monocytes
5350587|NCT01946373|Autologous|autologous
5350588|NCT01946373|NY-ESO-1|ny-eso-1
5350589|NCT01946347|Insulin Resistance|insulin resistance
5350590|NCT01946347|Hyperglycemia|hyperglycemia
5350591|NCT01946347|Endothelial function|endothelial function
5350592|NCT01946347|Oxidative stress|oxidative stress
5350593|NCT01946308|sleep|sleep
5350594|NCT01946308|sleep efficiency|sleep efficiency
5350595|NCT01946308|active sleep|active sleep
5350596|NCT01946308|quiet sleep|quiet sleep
5350597|NCT01946308|arousals|arousals
5350598|NCT01946308|premature infant|premature infant
5350599|NCT01946308|conformational positioning|conformational positioning
5350600|NCT01946308|mattress|mattress
5350601|NCT01946308|feeding difficulty|feeding difficulty
5350602|NCT01946308|neonatal intensive care unit|neonatal intensive care unit
5350603|NCT01946308|sleep state|sleep state
5350604|NCT01946308|behavioral observation|behavioral observation
5350605|NCT01946308|stress behavior|stress behavior
5245543|NCT02471560|MS|ms
5350606|NCT01946308|self-regulatory behavior|self-regulatory behavior
5350607|NCT01946308|surgery|surgery
5350608|NCT01946308|gastrointestinal|gastrointestinal
5350609|NCT01946282|neoplasm|neoplasm
5350610|NCT01946282|colorectal|colorectal
5350611|NCT01946282|cancer|cancer
5350612|NCT01946282|uninsured|uninsured
5350614|NCT01946282|Fecal Immunochemical Test|fecal immunochemical test
5350615|NCT01946204|Prostate neoplasms|prostate neoplasms
5350616|NCT01946204|Prostate cancer|prostate cancer
5350617|NCT01946204|Castration-resistant prostate cancer|castration-resistant prostate cancer
5350618|NCT01946204|Non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer
5350619|NCT01946204|ARN-509|arn-509
5350620|NCT01946204|Apalutamide|apalutamide
5350621|NCT01946191|Weight maintenance|weight maintenance
5350622|NCT01946191|Electronic health record|electronic health record
5350623|NCT01946191|Primary care|primary care
5350624|NCT01946178|Uterine Fibroids|uterine fibroids
5350625|NCT01946178|Leiomyomas|leiomyomas
5350626|NCT01946178|High-Intensity Focused Ultrasound Ablation|high-intensity focused ultrasound ablation
5350627|NCT01946178|Ultrasonography|ultrasonography
5350628|NCT01946165|Prostate Cancer|prostate cancer
5350629|NCT01946165|High risk prostate cancer|high risk prostate cancer
5350630|NCT01946165|Abiraterone acetate|abiraterone acetate
5350631|NCT01946165|Zytiga|zytiga
5350632|NCT01946165|Prednisone|prednisone
5350633|NCT01946165|Enzalutamide|enzalutamide
5350634|NCT01946165|MDV3100|mdv3100
5350635|NCT01946165|XTANDI|xtandi
5350636|NCT01946165|Androgen ablation|androgen ablation
5350637|NCT01946165|LHRHa|lhrha
5350638|NCT01946165|Hormonal therapy|hormonal therapy
5350639|NCT01946100|multifocal|multifocal
5350640|NCT01946100|genetic|genetic
5350641|NCT01946100|bronchoalveolar carcinoma|bronchoalveolar carcinoma
5350642|NCT01946100|adenocarcinoma in situ|adenocarcinoma in situ
5350643|NCT01946100|ground glass opacity|ground glass opacity
5350644|NCT01946100|next generation sequencing|next generation sequencing
5350645|NCT01946087|Remote ischemic preconditioning|remote ischemic preconditioning
5350646|NCT01946087|cardiac surgery|cardiac surgery
5350647|NCT01946087|left ventricular hypertrophy|left ventricular hypertrophy
5350648|NCT01946087|reperfusion injury salvage kinase|reperfusion injury salvage kinase
5354473|NCT01928225|CIN|cin
5350650|NCT01946074|ABT-165|abt-165
5350651|NCT01946074|cancer|cancer
5350652|NCT01946074|neoplasm|neoplasm
5350653|NCT01946074|advanced solid tumor|advanced solid tumor
5350654|NCT01946074|colorectal cancer|colorectal cancer
5350655|NCT01946061|Oxaliplatin, S-1, Gastric cancer, Adjuvant chemotherapy|oxaliplatin, s-1, gastric cancer, adjuvant chemotherapy
5350656|NCT01946022|infertility|infertility
5350657|NCT01946022|ovulation induction|ovulation induction
5350658|NCT01946022|luteal phase|luteal phase
5350659|NCT01946022|granulosa cells function|granulosa cells function
5350661|NCT01946022|HMG|hmg
5350662|NCT01946022|FSHr|fshr
5350663|NCT01945996|Hispanic Americans|hispanic americans
5350664|NCT01945996|Cellular Phone|cellular phone
5350665|NCT01945996|Behavior|behavior
5350666|NCT01945983|Septic shock|septic shock
5350667|NCT01945983|Severe sepsis|severe sepsis
5350668|NCT01945983|Norepinephrine|norepinephrine
5350669|NCT01945970|Vascular function|vascular function
5350670|NCT01945970|Flow mediated dilation|flow mediated dilation
5350671|NCT01945970|Tea|tea
5350672|NCT01945957|autism|autism
5350673|NCT01945957|brain|brain
5350674|NCT01945957|functional magnetic resonance imaging|functional magnetic resonance imaging
5350675|NCT01945957|oxytocin|oxytocin
5350676|NCT01945944|pediatric|pediatric
5350677|NCT01945944|mucolytic|mucolytic
5350678|NCT01945944|respiratory failure|respiratory failure
5350679|NCT01945944|atelectasis|atelectasis
5350680|NCT01945944|hypertonic saline|hypertonic saline
5350681|NCT01945931|Maternal health|maternal health
5350682|NCT01945931|perinatal health|perinatal health
5350683|NCT01945931|mHealth|mhealth
5350684|NCT01945931|smartphone|smartphone
5350685|NCT01945931|mobile phone|mobile phone
5350686|NCT01945931|Ethiopia|ethiopia
5350687|NCT01945918|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5350688|NCT01945918|Diabetes Mellitus|diabetes mellitus
5350689|NCT01945918|Primary Health Care|primary health care
5350690|NCT01945918|Self care|self care
5350691|NCT01945905|Tuberculosis|tuberculosis
5350692|NCT01945905|Adherence, medication|adherence, medication
5350693|NCT01945905|Patient compliance|patient compliance
5350694|NCT01945892|macular edema, irvine gass syndrome, ozurdex|macular edema, irvine gass syndrome, ozurdex
5350695|NCT01945879|pancreatic cancer|pancreatic cancer
5350696|NCT01945879|heparin|heparin
5350697|NCT01945879|thromboembolic events|thromboembolic events
5350698|NCT01945879|bleedings|bleedings
5350699|NCT01945866|Diabetic Macular Edema|diabetic macular edema
5350700|NCT01945866|Anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5350701|NCT01945866|Dexamethasone Intravitreal implant|dexamethasone intravitreal implant
5350702|NCT01945866|Ranibizumab intravitreal injection|ranibizumab intravitreal injection
5350703|NCT01945801|Sleep apnea|sleep apnea
5350704|NCT01945801|Treatment|treatment
5350705|NCT01945801|Sodium-Restricted Diet|sodium-restricted diet
5350706|NCT01945801|Diuretic|diuretic
5350707|NCT01945801|Lasilactone|lasilactone
5350708|NCT01945775|Breast cancer|breast cancer
5350709|NCT01945775|BRCA mutation|brca mutation
5350710|NCT01945775|PARP inhibitor|parp inhibitor
5350711|NCT01945775|BRCA 1|brca 1
5336903|NCT02008825|ViSiGi|visigi
5350712|NCT01945775|BRCA 2|brca 2
5350713|NCT01945762|RET Mutation|ret mutation
5350714|NCT01945762|DIagnostics|diagnostics
5350715|NCT01945762|Medullary Thyroid Cancer|medullary thyroid cancer
5350717|NCT01945736|Opiate withdrawal in children|opiate withdrawal in children
5350718|NCT01945723|Endoscopy|endoscopy
5350719|NCT01945723|Gastrointestinal tract|gastrointestinal tract
5350720|NCT01945723|Bacterial markers|bacterial markers
5350721|NCT01945723|volunteers|volunteers
5350722|NCT01945710|Tumors|tumors
5350723|NCT01945697|DNA methylation, biomarkers, oral cancer|dna methylation, biomarkers, oral cancer
5350724|NCT01945645|Prevention|prevention
5350725|NCT01945645|Screening|screening
5350726|NCT01945645|Type 2 diabetes|type 2 diabetes
5350727|NCT01945645|Action Competence|action competence
5350728|NCT01945645|Family practice|family practice
5350729|NCT01945645|Health Services Research|health services research
5350731|NCT01945619|Adenovirus|adenovirus
5350732|NCT01945619|EBV|ebv
5350733|NCT01945619|Stem cell transplant|stem cell transplant
5350734|NCT01945619|cytotoxic T-lymphocytes|cytotoxic t-lymphocytes
5350735|NCT01945580|POP|pop
5350736|NCT01945580|Transvaginal|transvaginal
5350737|NCT01945580|Native Tissue Repair|native tissue repair
5350738|NCT01945580|Repair Augmented with Mesh|repair augmented with mesh
5350739|NCT01945580|Biologic Graft|biologic graft
5350740|NCT01945580|Pelvic Organ Prolapse|pelvic organ prolapse
5350741|NCT01945567|Parkinson's disease|parkinson's disease
5350742|NCT01945567|Essential tremor|essential tremor
5350743|NCT01945567|Tremor|tremor
5350744|NCT01945567|Deep brain stimulation|deep brain stimulation
5350745|NCT01945567|Posterior subthalamic area|posterior subthalamic area
5350746|NCT01945567|Zona incerta|zona incerta
5350747|NCT01945554|infiltrative therapy|infiltrative therapy
5350748|NCT01945554|cervical disc herniation|cervical disc herniation
5350749|NCT01945554|lumbar disc herniation|lumbar disc herniation
5350750|NCT01945541|Intraoperative Fluid Administration|intraoperative fluid administration
5350751|NCT01945541|Body Composition Measurement|body composition measurement
5350752|NCT01945528|Platelet Rich Plasma|platelet rich plasma
5350753|NCT01945528|tendinopathy|tendinopathy
5350754|NCT01945528|epicondylitis|epicondylitis
5350755|NCT01945528|ultrasound|ultrasound
5350756|NCT01945528|injection therapy|injection therapy
5350757|NCT01945528|needle tenotomy|needle tenotomy
5350758|NCT01945515|Stroke|stroke
5350759|NCT01945515|transcranial direct current stimulation|transcranial direct current stimulation
5350761|NCT01945515|gait|gait
5350762|NCT01945476|midazolam|midazolam
5350763|NCT01945476|premedication|premedication
5350764|NCT01945476|functional recovery|functional recovery
5350765|NCT01945476|breast cancer|breast cancer
5350766|NCT01945424|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
5350767|NCT01945424|Pregnancy Registry|pregnancy registry
5350768|NCT01945424|Influenza|influenza
5350769|NCT01945411|Airway Management|airway management
5350770|NCT01945411|Ventilation|ventilation
5350771|NCT01945398|Pulmonary Rehabilitation|pulmonary rehabilitation
5350772|NCT01945398|Inspiratory Muscle Training|inspiratory muscle training
5350773|NCT01945398|Inspiratory Muscle Strength|inspiratory muscle strength
5350774|NCT01945398|Vascular Resistance|vascular resistance
5350775|NCT01945398|Exercise|exercise
5350776|NCT01945398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5350777|NCT01945385|Abortion|abortion
5350778|NCT01945385|LARC|larc
5350779|NCT01945385|Contraception|contraception
5350780|NCT01945385|IUD|iud
5350781|NCT01945385|Contraceptive implant|contraceptive implant
5350782|NCT01945385|behavioral change|behavioral change
5350783|NCT01945385|video intervention|video intervention
5350784|NCT01945359|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5350785|NCT01945359|Dimethyl Fumarate|dimethyl fumarate
5350786|NCT01945359|Natalizumab|natalizumab
5350787|NCT01945346|PRX167700|prx167700
5350788|NCT01945346|Osteoarthritis|osteoarthritis
5350789|NCT01945333|Cognitive remediation|cognitive remediation
5350790|NCT01945333|Schizophrenia|schizophrenia
5350791|NCT01945333|Schizoaffective disorder|schizoaffective disorder
5350792|NCT01945320|hemodialysis|hemodialysis
5350793|NCT01945320|wasting and malnutrition|wasting and malnutrition
5350794|NCT01945320|nutrition status|nutrition status
5963801|NCT04197466|Kinesio taping|kinesio taping
5350795|NCT01945320|bioelectrical impedance analysis|bioelectrical impedance analysis
5350796|NCT01945320|body composition|body composition
5350797|NCT01945307|Complement|complement
5350798|NCT01945307|Serum Bactericidal Assay|serum bactericidal assay
5350799|NCT01945268|vascular, influenza, vaccine, heart failure|vascular, influenza, vaccine, heart failure
5350800|NCT01945255|Calcification|calcification
5350801|NCT01945255|aortic pulse wave velocity|aortic pulse wave velocity
5350802|NCT01945255|peripheral artery occlusion disease|peripheral artery occlusion disease
5350803|NCT01945255|hemodialysis|hemodialysis
5350804|NCT01945255|metabolic syndrome|metabolic syndrome
5350805|NCT01945242|Drug Therapy|drug therapy
5350806|NCT01945216|Drug therapy|drug therapy
5350807|NCT01945203|Calcification|calcification
5350808|NCT01945203|aortic pulse wave velocity|aortic pulse wave velocity
5350809|NCT01945203|peripheral artery occlusion disease|peripheral artery occlusion disease
5350810|NCT01945203|peritoneal dialysis|peritoneal dialysis
5350811|NCT01945203|metabolic syndrome|metabolic syndrome
5350812|NCT01945177|endoscopy|endoscopy
5350813|NCT01945177|gastric intestinal metaplasia|gastric intestinal metaplasia
5350814|NCT01945177|gastric cancer|gastric cancer
5350816|NCT01945164|Advanced Malignancy|advanced malignancy
5350817|NCT01945151|spastic hemiparesis|spastic hemiparesis
5350818|NCT01945138|Total Pancreatectomy|total pancreatectomy
5350819|NCT01945138|Islet Auto-Transplantation|islet auto-transplantation
5350820|NCT01945138|Closed Loop Insulin Pump|closed loop insulin pump
5350821|NCT01945099|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia|diabetes, insulin,post prandial, closed loop, artificial pancreas, hyperglycemia
5350822|NCT01945086|Dermatitis, Atopic|dermatitis, atopic
5350823|NCT01945086|Eczema|eczema
5350824|NCT01945086|Ustekinumab|ustekinumab
5350825|NCT01945086|CNTO1275|cnto1275
5350826|NCT01945086|STELARA|stelara
5350827|NCT01945073|Educational intervention|educational intervention
5350828|NCT01945073|Formal Counselling|formal counselling
5350829|NCT01945073|Knowledge|knowledge
5350830|NCT01945073|Illness Perception|illness perception
5350831|NCT01945060|Artificial Pancreas Project|artificial pancreas project
5350832|NCT01945060|Diabetes Assistant (DiAs) Medical Platform System|diabetes assistant (dias) medical platform system
5350833|NCT01945060|Artificial Pancreas Platform|artificial pancreas platform
5350834|NCT01945060|Insulin Pump|insulin pump
5350835|NCT01945060|Continuous Glucose Monitor|continuous glucose monitor
5350836|NCT01945060|Closed-Loop Control|closed-loop control
5350837|NCT01945060|heart rate Control to Range System (hrCTR)|heart rate control to range system (hrctr)
5350838|NCT01945047|depression|depression
5350839|NCT01945047|treatment|treatment
5350840|NCT01945047|ketamine|ketamine
5350841|NCT01945047|ottawa|ottawa
5350842|NCT01945047|treatment-resistant|treatment-resistant
5350843|NCT01945047|infusion|infusion
5350844|NCT01945034|topical ibuprofen|topical ibuprofen
5350845|NCT01945034|ankle sprain|ankle sprain
5350846|NCT01945021|Non small cell lung cancer|non small cell lung cancer
5350847|NCT01945021|NSCLC|nsclc
5350848|NCT01945021|ROS1|ros1
5350849|NCT01945021|ROS1 positive|ros1 positive
5350850|NCT01945021|ROS1 proto oncogene|ros1 proto oncogene
5350851|NCT01945021|c ros tyrosine kinases|c ros tyrosine kinases
5350852|NCT01945021|ROS1 positive NSCLC|ros1 positive nsclc
5350853|NCT01945021|ROS1 lung cancer|ros1 lung cancer
5350854|NCT01945021|ALK negative|alk negative
5350855|NCT01945021|Lung Carcinoma|lung carcinoma
5350856|NCT01945021|Neoplasm|neoplasm
5350857|NCT01945021|Crizotinib|crizotinib
5350859|NCT01945021|Previously treated or untreated|previously treated or untreated
5350860|NCT01945021|North East Asian|north east asian
5350862|NCT01945008|observational study|observational study
5350863|NCT01945008|HCV direct-acting antiviral agents|hcv direct-acting antiviral agents
5350864|NCT01944982|Immunotherapy|immunotherapy
5350865|NCT01944982|NKAEs|nkaes
5350866|NCT01944982|Expanded haploidentical natural killer cells|expanded haploidentical natural killer cells
5350867|NCT01944982|Activated natural killer cells|activated natural killer cells
5350868|NCT01944956|Maturation|maturation
5350869|NCT01944956|preterm infants|preterm infants
5350870|NCT01944956|sucking and swallowing|sucking and swallowing
5350871|NCT01944943|refractory/relapsed|refractory/relapsed
5350872|NCT01944943|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5350873|NCT01944943|indolent non-hodgkin lymphoma|indolent non-hodgkin lymphoma
5350874|NCT01944943|Primary central nervous system lymphoma|primary central nervous system lymphoma
5350875|NCT01944943|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5350876|NCT01944917|Electromagnetic field|electromagnetic field
5350877|NCT01944917|VAS score|vas score
5350878|NCT01944917|Heart Rate Variability|heart rate variability
5350880|NCT01944904|pre-diabetic|pre-diabetic
5350881|NCT01944904|abnormal glucose levels|abnormal glucose levels
5350882|NCT01944891|Adolescent girls|adolescent girls
5350883|NCT01944891|Mozambique|mozambique
5963802|NCT04197466|Electric Stimulation|electric stimulation
5963803|NCT04197453|Lipids|lipids
5963804|NCT04197453|Lipid-lowering therapy|lipid-lowering therapy
5963805|NCT04197453|Coronary heart disease|coronary heart disease
5963806|NCT04197453|Peripheral arterial disease|peripheral arterial disease
5963807|NCT04197453|Proprotein convertase subtilisin/kexin type 9 inhibition|proprotein convertase subtilisin/kexin type 9 inhibition
5963808|NCT04197453|Effectiveness|effectiveness
5229837|NCT02565563|EMDR|emdr
5350884|NCT01944891|Diet|diet
5350885|NCT01944891|Anthropometrics|anthropometrics
5350886|NCT01944891|Serum biomarkers|serum biomarkers
5350887|NCT01944878|Peptic ulcer|peptic ulcer
5350888|NCT01944878|Liver cirrhosis|liver cirrhosis
5350889|NCT01944878|Portal hypertension|portal hypertension
5350890|NCT01944865|Aerobic Interval Training|aerobic interval training
5350891|NCT01944865|Supramaximal Training|supramaximal training
5350892|NCT01944852|icodextrin|icodextrin
5350893|NCT01944852|double dose|double dose
5350894|NCT01944852|elderly incident CAPD patients|elderly incident capd patients
5350895|NCT01944852|DIDo study|dido study
5350896|NCT01944839|Wet AMD|wet amd
5350897|NCT01944839|choroidal neovascularization|choroidal neovascularization
5350898|NCT01944839|Fovista®|fovista®
5350899|NCT01944839|E10030|e10030
5350900|NCT01944839|Lucentis®|lucentis®
5350901|NCT01944826|Dyspnea|dyspnea
5350902|NCT01944826|Angina pectoris|angina pectoris
5350903|NCT01944813|Advance Care planning|advance care planning
5350904|NCT01944813|End-of-life Discussions|end-of-life discussions
5350905|NCT01944813|Questionaires|questionaires
5350906|NCT01944813|Palliative Care|palliative care
5350907|NCT01944800|Ticagrelor|ticagrelor
5350908|NCT01944800|Prasugrel|prasugrel
5350909|NCT01944800|Acute coronary syndrome|acute coronary syndrome
5350910|NCT01944800|Percutaneous coronary intervention|percutaneous coronary intervention
5350911|NCT01944774|Moxifloxacin|moxifloxacin
5350912|NCT01944761|pediatrics|pediatrics
5350913|NCT01944761|Brain Tumor|brain tumor
5350914|NCT01944761|Neuro-radiation|neuro-radiation
5350915|NCT01944761|Exercise|exercise
5350916|NCT01944709|melanoma|melanoma
5350917|NCT01944709|dendritic cells|dendritic cells
5350918|NCT01944709|peptide|peptide
5350919|NCT01944709|Melan-A|melan-a
5350920|NCT01944696|hyperbilirubinemia|hyperbilirubinemia
5350921|NCT01944696|prematurity|prematurity
5350922|NCT01944696|extremely low birth weight (ELBW)|extremely low birth weight (elbw)
5351019|NCT01944215|Fasting|fasting
5350923|NCT01944696|phototherapy|phototherapy
5350924|NCT01944696|cycled phototherapy|cycled phototherapy
5350925|NCT01944696|intermittent phototherapy|intermittent phototherapy
5350926|NCT01944657|Major Depressive Disorder Clinical Outcomes|major depressive disorder clinical outcomes
5350927|NCT01944657|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5350928|NCT01944657|Standard Medication Monotherapy|standard medication monotherapy
5350929|NCT01944657|Exploratory Field Study|exploratory field study
5350930|NCT01944605|Endotoxin|endotoxin
5350931|NCT01944605|Cytokine|cytokine
5350932|NCT01944605|Metabolism|metabolism
5350933|NCT01944592|Gynaecology Teaching Associate|gynaecology teaching associate
5350934|NCT01944592|Pelvic examination|pelvic examination
5350935|NCT01944592|Students|students
5350936|NCT01944553|Spine|spine
5350937|NCT01944553|Accurancy|accurancy
5350938|NCT01944553|Robotic|robotic
5350939|NCT01944553|Screw placement|screw placement
5350940|NCT01944553|Degenerative|degenerative
5350941|NCT01944514|Action potential duration restitution|action potential duration restitution
5350942|NCT01944514|Ventricular arrhythmia|ventricular arrhythmia
5350943|NCT01944514|Sudden cardiac death|sudden cardiac death
5350944|NCT01944514|Peri-infarct zone|peri-infarct zone
5350945|NCT01944514|Electrocardiogram|electrocardiogram
5350947|NCT01944501|hearing loss|hearing loss
5350948|NCT01944501|Transcranial magnetic stimulation|transcranial magnetic stimulation
5350949|NCT01944501|Transcranial direct current stimulation|transcranial direct current stimulation
5350950|NCT01944488|Precocious puberty|precocious puberty
5350951|NCT01944488|GnRH-test|gnrh-test
5350952|NCT01944475|Precocious puberty|precocious puberty
5350957|NCT01944462|pharmacist vaccination|pharmacist vaccination
5350958|NCT01944462|Pneumovax 23|pneumovax 23
5350959|NCT01944462|pneumococcal vaccine polyvalent|pneumococcal vaccine polyvalent
5350960|NCT01944449|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
5350961|NCT01944449|Whey Protein Concentrate (WPC)|whey protein concentrate (wpc)
5350962|NCT01944436|Pharmacogenomics|pharmacogenomics
5350963|NCT01944436|Dementia with Lewy bodies|dementia with lewy bodies
5350964|NCT01944436|Adverse events|adverse events
5350965|NCT01944436|Polymorphisms|polymorphisms
5350966|NCT01944436|Acetylcholinesterase|acetylcholinesterase
5350967|NCT01944436|Parkinson's Disease Dementia|parkinson's disease dementia
5350968|NCT01944436|Cognitive enhancers|cognitive enhancers
5350969|NCT01944436|Clinical efficacy|clinical efficacy
5350970|NCT01944436|Cytochrome P450|cytochrome p450
5350971|NCT01944436|Butyrylcholinesterase|butyrylcholinesterase
5350973|NCT01944410|TBC|tbc
5350974|NCT01944410|Treatment|treatment
5350975|NCT01944397|Atrial fibrillation|atrial fibrillation
5350976|NCT01944397|Heart failure|heart failure
5350977|NCT01944397|Stroke|stroke
5350978|NCT01944397|Myocardial infarction|myocardial infarction
5350979|NCT01944371|Latent reservoir|latent reservoir
5963809|NCT04197024|virtual reality|virtual reality
5350980|NCT01944358|Syphilis; human immunodeficiency virus; penicillin|syphilis; human immunodeficiency virus; penicillin
5350981|NCT01944332|gamete treatment|gamete treatment
5350982|NCT01944332|ICSI|icsi
5350983|NCT01944332|IVF|ivf
5350984|NCT01944332|infertility|infertility
5350985|NCT01944332|oocyte activation|oocyte activation
5445428|NCT01521845|elective percutaneous coronary intervention|elective percutaneous coronary intervention
5350986|NCT01944319|Infection; Meropenem; Pharmacokinetics; Pharmacodynamics|infection; meropenem; pharmacokinetics; pharmacodynamics
5350987|NCT01944306|Pharmacokinetics|pharmacokinetics
5350988|NCT01944306|Pharmacology, Clinical|pharmacology, clinical
5350989|NCT01944306|Drug Efficacy|drug efficacy
5350990|NCT01944306|Drug Failure|drug failure
5350991|NCT01944306|Contraceptive Agents|contraceptive agents
5350992|NCT01944293|Ketamine|ketamine
5350993|NCT01944293|Midazolam|midazolam
5350994|NCT01944293|Bipolar Disorder|bipolar disorder
5350995|NCT01944293|Major Depressive Episode|major depressive episode
5350996|NCT01944293|Suicidal Ideation|suicidal ideation
5350997|NCT01944293|Suicide|suicide
5350998|NCT01944293|Depression|depression
5350999|NCT01944293|Treatment|treatment
5351000|NCT01944293|Ketamine Treatment|ketamine treatment
5351001|NCT01944254|Cardiac surgical procedures|cardiac surgical procedures
5351002|NCT01944254|Pulmonary Artery Catheterizations|pulmonary artery catheterizations
5351003|NCT01944254|Cardiac output|cardiac output
5351004|NCT01944254|Swan Ganz Catheterization|swan ganz catheterization
5351005|NCT01944241|cervical surgery|cervical surgery
5351006|NCT01944241|LLETZ|lletz
5351007|NCT01944241|LEEP|leep
5351008|NCT01944241|Cone biopsy|cone biopsy
5351009|NCT01944241|Fertility|fertility
5351010|NCT01944228|inflammation|inflammation
5351011|NCT01944228|vagus nerve stimulation|vagus nerve stimulation
5351012|NCT01944228|chronic heart failure|chronic heart failure
5351013|NCT01944228|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5351014|NCT01944228|sepsis|sepsis
5351015|NCT01944228|auto-immune diseases|auto-immune diseases
5351016|NCT01944215|Normal subjects|normal subjects
5351017|NCT01944215|Female|female
5351018|NCT01944215|Molecular Breast Imaging|molecular breast imaging
5351020|NCT01944215|Exercise|exercise
5351021|NCT01944215|Tracer Uptake|tracer uptake
5351022|NCT01944215|Tc-99m Sestamibi|tc-99m sestamibi
5351023|NCT01944215|Prandial status|prandial status
5351024|NCT01944215|metabolic status|metabolic status
5351025|NCT01944215|negative mammogram|negative mammogram
5351026|NCT01944215|Caffeine|caffeine
5351027|NCT01944215|External Warming|external warming
5351028|NCT01944202|Echocardiography|echocardiography
5351029|NCT01944202|Appropriate Use Criteria|appropriate use criteria
5351030|NCT01944202|Educational Intervention|educational intervention
5351031|NCT01944189|lumefantrine pharmacokinetics & bioavailability|lumefantrine pharmacokinetics & bioavailability
5351032|NCT01944176|COPD|copd
5351033|NCT01944176|Statins|statins
5351034|NCT01944176|Cytokines|cytokines
5351035|NCT01944163|Low back pain|low back pain
5351036|NCT01944163|Impact analysis|impact analysis
5351037|NCT01944163|Cluster randomized trial|cluster randomized trial
5351038|NCT01944163|Referral rule|referral rule
5351039|NCT01944163|Axial spondyloarthritis|axial spondyloarthritis
5351047|NCT01944137|Lung neoplasms|lung neoplasms
5351048|NCT01944137|patient-centered nursing|patient-centered nursing
5351049|NCT01944137|breast neoplasms|breast neoplasms
5351050|NCT01944124|Mobile health|mobile health
5351051|NCT01944124|Metabolic syndrome|metabolic syndrome
5351052|NCT01944124|Exercise prescription|exercise prescription
5351053|NCT01944124|Exercise intervention|exercise intervention
5351054|NCT01944124|Disease prevention|disease prevention
5351055|NCT01944124|Rural health|rural health
5351056|NCT01944111|Gastric plication|gastric plication
5351057|NCT01944085|children|children
5351058|NCT01944085|supracondylar fracture|supracondylar fracture
5351059|NCT01944085|pin removal|pin removal
5351060|NCT01944085|analgesia|analgesia
5351061|NCT01944085|pain score|pain score
5351062|NCT01944072|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5351063|NCT01944072|COPD|copd
5351064|NCT01944072|Pulmonary rehabilitation|pulmonary rehabilitation
5351065|NCT01944072|Aerobic exercise|aerobic exercise
5351066|NCT01944072|CEDOC|cedoc
5351068|NCT01944072|UNL|unl
5351069|NCT01944072|NOVA MEDICAL SCHOOL|nova medical school
5351070|NCT01944046|autism, ASD, autistic, Asperger's, PDD-NOS, oxytocin|autism, asd, autistic, asperger's, pdd-nos, oxytocin
5351071|NCT01944033|β2-agonist|β2-agonist
5351072|NCT01944033|Ipratropium Bromide|ipratropium bromide
5351073|NCT01944033|Chronic Obstructive Pulmonary Disease Exacerbation|chronic obstructive pulmonary disease exacerbation
5351074|NCT01944033|Emergency departement|emergency departement
5351075|NCT01944020|Sleep Apnea, Obstructive|sleep apnea, obstructive
5351076|NCT01944020|Energy Balance|energy balance
5351077|NCT01944020|Food Intake|food intake
5351078|NCT01944020|Energy Expenditure|energy expenditure
5351079|NCT01944020|Sleep|sleep
5351080|NCT01944020|Obesity|obesity
5351081|NCT01944007|CLP|clp
5351082|NCT01943994|Psilocybin|psilocybin
5351083|NCT01943994|Smoking cessation|smoking cessation
5351084|NCT01943955|dizziness|dizziness
5351085|NCT01943955|vertigo|vertigo
5351086|NCT01943955|unsteadiness|unsteadiness
5351087|NCT01943955|unbalance|unbalance
5351088|NCT01943955|falls|falls
5351089|NCT01943942|Mexico|mexico
5351090|NCT01943942|Montelukast|montelukast
5230085|NCT02563951|Nausea|nausea
5351091|NCT01943942|Pharmacokinetics|pharmacokinetics
5351092|NCT01943942|Bioequivalence|bioequivalence
5351093|NCT01943929|Nasal septum|nasal septum
5351094|NCT01943929|Headache|headache
5351095|NCT01943929|Mucosa contact point headache|mucosa contact point headache
5351096|NCT01943916|breast imaging diagnosis|breast imaging diagnosis
5351097|NCT01943916|breast ultrasound|breast ultrasound
5351098|NCT01943916|Imagio|imagio
5351099|NCT01943916|Seno Medical Instruments, Inc.|seno medical instruments, inc.
5351100|NCT01943916|Seno|seno
5351101|NCT01943916|opto-acoustics|opto-acoustics
5351102|NCT01943916|OA|oa
5351103|NCT01943916|angiogenesis|angiogenesis
5351104|NCT01943916|blood map|blood map
5351105|NCT01943890|Hypertonic saline|hypertonic saline
5351106|NCT01943890|Lung physiotherapy|lung physiotherapy
5351107|NCT01943864|pharmacokinetics|pharmacokinetics
5351108|NCT01943864|second line monotherapy|second line monotherapy
5351109|NCT01943864|GSK1120212 (trametinib)|gsk1120212 (trametinib)
5351110|NCT01943864|MEK inhibitor|mek inhibitor
5351111|NCT01943864|locally advanced or metastatic biliary tract cancers|locally advanced or metastatic biliary tract cancers
5351120|NCT01943825|Dengue|dengue
5351121|NCT01943825|Dengue fever|dengue fever
5351122|NCT01943825|CYD dengue vaccine|cyd dengue vaccine
5351123|NCT01943825|IXIARO JE vaccine|ixiaro je vaccine
5351124|NCT01943825|Flavivirus|flavivirus
5351125|NCT01943799|Hepatitis B (HBV)|hepatitis b (hbv)
5351126|NCT01943799|Oral antiviral (OAV)|oral antiviral (oav)
5351127|NCT01943799|GS-4774|gs-4774
5351128|NCT01943786|Wild type KRAS|wild type kras
5351129|NCT01943773|delirium|delirium
5351130|NCT01943773|surgery|surgery
5351131|NCT01943773|operation|operation
5351132|NCT01943773|geriatric|geriatric
5351133|NCT01943773|complication|complication
5351134|NCT01943760|Tramadol|tramadol
5351135|NCT01943760|Children|children
5351136|NCT01943760|Hernioplasty|hernioplasty
5351137|NCT01943760|Wound infiltration|wound infiltration
5351138|NCT01943747|sepsis|sepsis
5351139|NCT01943747|severe sepsis|severe sepsis
5351140|NCT01943747|septic shock|septic shock
5351141|NCT01943747|infection|infection
5351142|NCT01943747|organ dysfunction|organ dysfunction
5351143|NCT01943747|quality improvement|quality improvement
5351144|NCT01943734|Information|information
5351145|NCT01943734|Lifestyle|lifestyle
5351146|NCT01943734|Occupational Health|occupational health
5351147|NCT01943695|Breast Cancer|breast cancer
5351148|NCT01943695|Exercise|exercise
5351149|NCT01943695|Chemotherapy|chemotherapy
5351150|NCT01943695|15-178|15-178
5351151|NCT01943682|Relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5351152|NCT01943682|non-therapy related acute myeloid leukemia|non-therapy related acute myeloid leukemia
5351153|NCT01943682|Refractory acute myeloid leukemia|refractory acute myeloid leukemia
5351154|NCT01943682|Untreated acute myeloid leukemia|untreated acute myeloid leukemia
5351155|NCT01943682|Lymphoma|lymphoma
5351156|NCT01943682|Leukemia|leukemia
5351157|NCT01943669|Spinal Cord Injury|spinal cord injury
5351158|NCT01943656|Spinal Cord Injury|spinal cord injury
5351159|NCT01943643|angiography, bifurcation, stenting, CT|angiography, bifurcation, stenting, ct
5351160|NCT01943630|HPV condyloma acuminata|hpv condyloma acuminata
5351161|NCT01943617|Liver Cirrhosis|liver cirrhosis
5351162|NCT01943617|Hepatitis B|hepatitis b
5351163|NCT01943617|Compensation|compensation
5351164|NCT01943617|Efficacy|efficacy
5347237|NCT01962454|D2O|d2o
5351166|NCT01943604|Breakfast eating patters|breakfast eating patters
5351167|NCT01943604|Glucose|glucose
5351168|NCT01943604|Child Psychology|child psychology
5351169|NCT01943591|treatment trial|treatment trial
5351170|NCT01943591|cerebral aneurysm|cerebral aneurysm
5351171|NCT01943591|randomized|randomized
5351172|NCT01943591|coils|coils
5351173|NCT01943591|endovascular|endovascular
5351174|NCT01943591|Aneurysm|aneurysm
5351175|NCT01943591|Intracranial Aneurysm|intracranial aneurysm
5351176|NCT01943591|Vascular Diseases|vascular diseases
5351177|NCT01943591|Cardiovascular Diseases|cardiovascular diseases
5351178|NCT01943591|Intracranial Arterial Diseases|intracranial arterial diseases
5351179|NCT01943591|Cerebrovascular Disorders|cerebrovascular disorders
5351180|NCT01943591|Brain Diseases|brain diseases
5351181|NCT01943591|Central Nervous System Diseases|central nervous system diseases
5351182|NCT01943591|Nervous System Diseases|nervous system diseases
5351183|NCT01943565|Pregnancy|pregnancy
5351184|NCT01943565|Healthy|healthy
5351185|NCT01943565|Intrathecal|intrathecal
5351186|NCT01943565|Opioids|opioids
5351187|NCT01943565|Spinal|spinal
5351188|NCT01943565|Anesthesia|anesthesia
5351189|NCT01943565|Pain|pain
5351190|NCT01943565|Cesarean|cesarean
5351191|NCT01943565|Delivery|delivery
5963810|NCT04197024|COPD|copd
5351192|NCT01943565|Human|human
5351193|NCT01943526|Ireland|ireland
5351194|NCT01943526|Natalizumab|natalizumab
5351195|NCT01943513|Muscle Disuse Atrophy|muscle disuse atrophy
5351196|NCT01943500|Breast cancer|breast cancer
5351197|NCT01943500|Prostate cancer|prostate cancer
5351198|NCT01943500|Colorectal cancer|colorectal cancer
5963811|NCT04197024|exercise capacity|exercise capacity
5351199|NCT01943500|Circulating tumor cell (CTC)|circulating tumor cell (ctc)
5351200|NCT01943487|Phase I|phase i
5246141|NCT02468232|HF-rEF|hf-ref
5351201|NCT01943487|Verapamil|verapamil
5351202|NCT01943487|Tamsulosin OCAS|tamsulosin ocas
5351203|NCT01943487|Solifenacin|solifenacin
5351204|NCT01943487|Pharmacokinetics|pharmacokinetics
5351205|NCT01943487|EC905|ec905
5351206|NCT01943474|IV Catheter comparison|iv catheter comparison
5671837|NCT00614172|Breast cancer|breast cancer
5351207|NCT01943474|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
5351208|NCT01943474|IV Catheter Study|iv catheter study
5351209|NCT01943474|IV Catheter User Preference Comparison|iv catheter user preference comparison
5351210|NCT01943474|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
5351211|NCT01943474|AccuCath Device Performance|accucath device performance
5351212|NCT01943474|Complication Rates for IV Catheters|complication rates for iv catheters
5351213|NCT01943474|Average Dwell Time for IV Catheters|average dwell time for iv catheters
5351214|NCT01943474|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
5351215|NCT01943474|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
5351216|NCT01943461|Solid Tumors|solid tumors
5351217|NCT01943461|MSB0010718C|msb0010718c
5351218|NCT01943461|anti PD-L1|anti pd-l1
5351219|NCT01943461|avelumab|avelumab
5351221|NCT01943448|Macula Lutea Hemorrhage|macula lutea hemorrhage
5351222|NCT01943448|High Myopia|high myopia
5351223|NCT01943448|Optical Coherence Tomography|optical coherence tomography
5351224|NCT01943435|Spinal Stenosis|spinal stenosis
5351225|NCT01943435|Spinal manipulation|spinal manipulation
5351226|NCT01943435|Exercise|exercise
5351227|NCT01943435|Epidural injection|epidural injection
5351228|NCT01943422|advanced|advanced
5351229|NCT01943422|melanoma|melanoma
5351230|NCT01943422|Vemurafenib|vemurafenib
5351231|NCT01943422|High-dose Interferon alfa-2b|high-dose interferon alfa-2b
5351232|NCT01943409|Parenteral nutrition|parenteral nutrition
5351233|NCT01943409|lipid emulsion|lipid emulsion
5351234|NCT01943409|Intralipid|intralipid
5351235|NCT01943409|ClinOleic|clinoleic
5351236|NCT01943409|Inflammation|inflammation
5351237|NCT01943409|Infection|infection
5351238|NCT01943409|Bloodstream Infection|bloodstream infection
5351240|NCT01943409|mortality|mortality
5351241|NCT01943396|age-related macular degeneration|age-related macular degeneration
5351243|NCT01943396|rheohemapheresis|rheohemapheresis
5351244|NCT01943396|plasma filtration|plasma filtration
5351245|NCT01943396|electroretinography|electroretinography
5351246|NCT01943396|ERG|erg
5351247|NCT01943396|multifocal ERG|multifocal erg
5351248|NCT01943396|double plasma filtration|double plasma filtration
5351249|NCT01943383|Hypertension|hypertension
5351250|NCT01943370|endoscopic sinus surgery|endoscopic sinus surgery
5351251|NCT01943370|post-operative irrigation|post-operative irrigation
5351252|NCT01943370|pain|pain
5351253|NCT01943370|debridement|debridement
5351254|NCT01943357|diabetes|diabetes
5351255|NCT01943357|patient education|patient education
5351256|NCT01943357|self management|self management
5351257|NCT01943357|health improvement|health improvement
5351258|NCT01943344|vascular large hole closure|vascular large hole closure
5351259|NCT01943344|arteriotomy closure|arteriotomy closure
5351260|NCT01943344|Large hole vascular closure device|large hole vascular closure device
5351261|NCT01943344|vascular closure device|vascular closure device
5351262|NCT01943344|percutaneous vascular closure device|percutaneous vascular closure device
5351263|NCT01943318|Liver Cirrhosis|liver cirrhosis
5351264|NCT01943318|Hepatocellular carcinoma|hepatocellular carcinoma
5351265|NCT01943305|Yellow Fever|yellow fever
5351267|NCT01943305|Japanese encephalitis|japanese encephalitis
5351268|NCT01943305|antibodies|antibodies
5351269|NCT01943292|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
5351270|NCT01943292|FAK inhibitor|fak inhibitor
5351271|NCT01943292|Cancer Stem Cells|cancer stem cells
5351272|NCT01943292|CSC|csc
5351273|NCT01943279|medical abortion|medical abortion
5351274|NCT01943279|telephone follow-up|telephone follow-up
5351275|NCT01943279|ultrasound|ultrasound
5351276|NCT01943279|serum hCG|serum hcg
5351277|NCT01943279|methotrexate|methotrexate
5351278|NCT01943279|misoprostol|misoprostol
5351279|NCT01943253|Early gastric cancer,|early gastric cancer,
5351280|NCT01943253|endoscopic submucosal dissection (ESD)|endoscopic submucosal dissection (esd)
5351281|NCT01943253|water-jet assisted ESD|water-jet assisted esd
5351282|NCT01943227|humidity|humidity
5351283|NCT01943227|enthalpy|enthalpy
5351284|NCT01943227|mechanical ventilation|mechanical ventilation
5351285|NCT01943214|Diabetes Mellitus|diabetes mellitus
5351286|NCT01943214|Body constitution|body constitution
5351287|NCT01943175|schizophrenia|schizophrenia
5351288|NCT01943175|stem cells|stem cells
5351289|NCT01943175|neurons|neurons
5351290|NCT01943175|genetic hish risk for schizophrenia|genetic hish risk for schizophrenia
5351291|NCT01943136|impetigo|impetigo
5351292|NCT01943136|papaya extract ointment|papaya extract ointment
5351293|NCT01943123|probiotics,|probiotics,
5351294|NCT01943123|streptococcus mutans,|streptococcus mutans,
5351295|NCT01943123|lactobacilli,|lactobacilli,
5351296|NCT01943123|plaque index,|plaque index,
5351297|NCT01943123|gingival index|gingival index
5351298|NCT01943110|Intradermal injections|intradermal injections
5351299|NCT01943110|Vaccine delivery devices|vaccine delivery devices
5351300|NCT01943071|dementia|dementia
5351301|NCT01943071|day care centre programs|day care centre programs
5351302|NCT01943071|patients|patients
5351303|NCT01943071|family carers|family carers
5351304|NCT01943071|cost-consequence analysis|cost-consequence analysis
5351305|NCT01943006|Mucopolysaccaride polysulfate (MPS)|mucopolysaccaride polysulfate (mps)
5351306|NCT01943006|MPS|mps
5351307|NCT01943006|Heparinoide|heparinoide
5351308|NCT01943006|Infusionphlebitis|infusionphlebitis
5351309|NCT01943006|Prevention|prevention
5351310|NCT01943006|Superficial thrombophlebitis|superficial thrombophlebitis
5351311|NCT01943006|Treatment|treatment
5351312|NCT01942993|melanoma|melanoma
5351313|NCT01942993|unresectable|unresectable
5351314|NCT01942993|mutation|mutation
5351315|NCT01942993|BRAF protein|braf protein
5351316|NCT01942980|Breast cancer|breast cancer
5351317|NCT01942980|one brain metastasis|one brain metastasis
5351318|NCT01942967|Neonate|neonate
5351319|NCT01942967|Hemodynamic|hemodynamic
5351320|NCT01942967|Tissue oxygenation|tissue oxygenation
5351321|NCT01942967|Non invasive ventilation|non invasive ventilation
5351322|NCT01942954|Alcohol Dependence|alcohol dependence
5351323|NCT01942954|Cognitive Therapy|cognitive therapy
5351324|NCT01942954|Executive Function|executive function
5351325|NCT01942954|Mobile Health|mobile health
5351326|NCT01942954|Recovery of Function|recovery of function
5351327|NCT01942954|Rehabilitation|rehabilitation
5351329|NCT01942889|exercise training|exercise training
5351330|NCT01942889|pulmonary rehabilitation|pulmonary rehabilitation
5351331|NCT01942889|antioxidant|antioxidant
5351332|NCT01942889|muscle|muscle
5351333|NCT01942876|Drugs|drugs
5351334|NCT01942876|at risk|at risk
5351335|NCT01942876|community health center patients|community health center patients
5351336|NCT01942837|Enzalutamid|enzalutamid
5351337|NCT01942837|Prostate Cancer|prostate cancer
5351338|NCT01942811|DRUG PREVENTION|drug prevention
5351339|NCT01942811|BINATIONAL|binational
5351340|NCT01942811|CASUAL USE OF ILLICIT DRUGS|casual use of illicit drugs
5351341|NCT01942811|BRIEF INTERVENTION|brief intervention
5351342|NCT01942811|SBIRT|sbirt
5351343|NCT01942798|Rehabilitation|rehabilitation
5351344|NCT01942798|Lower Limb Amputation|lower limb amputation
5351345|NCT01942798|Prosthetic|prosthetic
5351346|NCT01942798|Walking|walking
5351347|NCT01942798|unilateral transtibial amputation|unilateral transtibial amputation
5351348|NCT01942798|unilateral transfemoral amputation|unilateral transfemoral amputation
5351349|NCT01942798|older adults|older adults
5351350|NCT01942798|cognitive computer games|cognitive computer games
5351351|NCT01942798|home-based training|home-based training
5351352|NCT01942798|Nintendo Wii|nintendo wii
5351353|NCT01942798|virtual reality|virtual reality
5351354|NCT01942772|powered ankle-foot orthosis|powered ankle-foot orthosis
5351355|NCT01942772|mechanical structure|mechanical structure
5351356|NCT01942772|optimization|optimization
5351357|NCT01942772|dorsiflexion|dorsiflexion
5351358|NCT01942772|plantar flexion|plantar flexion
5351359|NCT01942772|gait|gait
5351360|NCT01942772|servomotor|servomotor
5351361|NCT01942772|ankle rehabilitation|ankle rehabilitation
5351362|NCT01942759|Breast Neoplasms|breast neoplasms
5351363|NCT01942759|Positron-Emission Tomography|positron-emission tomography
5347329|NCT01962207|Safety|safety
5351364|NCT01942759|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5351366|NCT01942746|anthocyanin|anthocyanin
5351367|NCT01942746|dark vision|dark vision
5351368|NCT01942746|photo bleaching|photo bleaching
5351369|NCT01942746|Visual Perception|visual perception
5351370|NCT01942746|Photic Stimulation|photic stimulation
5351371|NCT01942707|Abdominoplasty,Seroma,Bariatric surgery|abdominoplasty,seroma,bariatric surgery
5351372|NCT01942694|Prediabetes|prediabetes
5351373|NCT01942694|Vitamin D|vitamin d
5351374|NCT01942681|female|female
5351375|NCT01942681|mixed urinary incontinence|mixed urinary incontinence
5351376|NCT01942668|Vasomotor symptoms|vasomotor symptoms
5351377|NCT01942668|Hot flashes|hot flashes
5351378|NCT01942668|Endometrial protection|endometrial protection
5351379|NCT01942655|HIV|hiv
5351380|NCT01942655|Chronic inflammatory bowel disease|chronic inflammatory bowel disease
5351381|NCT01942655|Reservoirs|reservoirs
5351382|NCT01942655|IL-17|il-17
5351383|NCT01942655|IL-23|il-23
5351384|NCT01942655|Intestinal biopsies|intestinal biopsies
5351385|NCT01942642|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography|cataract surgery, meibomian gland dysfunction, meibum expressibility, meibography
5351386|NCT01942629|prognostic markers,Pancreatic ductal adenocarcinoma|prognostic markers,pancreatic ductal adenocarcinoma
5351387|NCT01942616|IPV|ipv
5351388|NCT01942603|Minimal (SN) tumor burden|minimal (sn) tumor burden
5351389|NCT01942603|Stage III|stage iii
5351390|NCT01942603|Patients|patients
5963812|NCT04196010|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5445429|NCT01521845|hs-CRP|hs-crp
5963813|NCT04196010|Other Hematopoietic|other hematopoietic
5963814|NCT04195100|Xerostomia|xerostomia
5351391|NCT01942603|Lymphnode Dissections|lymphnode dissections
5351392|NCT01942590|Pompe disease|pompe disease
5351393|NCT01942577|NoSting|nosting
5351394|NCT01942577|Skin protectants|skin protectants
5351395|NCT01942577|Emollients|emollients
5351396|NCT01942577|Skin microbiome|skin microbiome
5351397|NCT01942564|traumatic brain injury|traumatic brain injury
5351398|NCT01942564|photophobia|photophobia
5351399|NCT01942564|photosensitivity|photosensitivity
5351400|NCT01942564|pupil|pupil
5351401|NCT01942538|rTMS|rtms
5351402|NCT01942538|fibromyalgia|fibromyalgia
5351403|NCT01942538|sham|sham
5351404|NCT01942538|maintenance session|maintenance session
5351405|NCT01942538|pain|pain
5351406|NCT01942525|IUGR|iugr
5351407|NCT01942525|aEEG|aeeg
5351408|NCT01942525|preterm infants|preterm infants
5351409|NCT01942525|neurodevelopmental outcome|neurodevelopmental outcome
5351410|NCT01942512|Intracranial Aneurysm - Endovascular treatment -|intracranial aneurysm - endovascular treatment -
5337593|NCT02005900|DHA|dha
5351411|NCT01942512|Coiling - Stenting - Flow diversion - Flow disruption -|coiling - stenting - flow diversion - flow disruption -
5351412|NCT01942512|Recanalization - Risk factors|recanalization - risk factors
5351413|NCT01942499|COPD, exercise, community|copd, exercise, community
5351414|NCT01942486|migraine|migraine
5351415|NCT01942486|photophobia|photophobia
5351416|NCT01942486|light sensitivity|light sensitivity
5351417|NCT01942486|melanopsin cells|melanopsin cells
5351510|NCT01942070|Stent|stent
5351418|NCT01942486|intrinsically photosensitive retinal ganglion cells|intrinsically photosensitive retinal ganglion cells
5351419|NCT01942460|Iron|iron
5351420|NCT01942460|Anemia|anemia
5351421|NCT01942460|Chronic Kidney Disease|chronic kidney disease
5351422|NCT01942460|Peritoneal Dialysis|peritoneal dialysis
5351423|NCT01942460|Inflammation|inflammation
5351424|NCT01942460|Oxidative stress|oxidative stress
5351425|NCT01942447|Fecal microbiota transplantation|fecal microbiota transplantation
5351426|NCT01942447|microbiota|microbiota
5351427|NCT01942447|clostridium difficile|clostridium difficile
5351428|NCT01942447|clostridium difficile infection|clostridium difficile infection
5351429|NCT01942447|Efficacy of FMT|efficacy of fmt
5351430|NCT01942434|Fatty acids|fatty acids
5351431|NCT01942434|Breast milk nutrients|breast milk nutrients
5351432|NCT01942434|Cognitive development|cognitive development
5351433|NCT01942434|Electrophysiology|electrophysiology
5351434|NCT01942434|Long-term assessment|long-term assessment
5351435|NCT01942421|Limbal deficiency|limbal deficiency
5351436|NCT01942421|Cultivated limbal transplantation|cultivated limbal transplantation
5351437|NCT01942421|Ex vivo limbal transplantation|ex vivo limbal transplantation
5351438|NCT01942421|Cultivated autologous mucosal epithelial transplantation|cultivated autologous mucosal epithelial transplantation
5351439|NCT01942408|Atrial fibrillation|atrial fibrillation
5351440|NCT01942408|Pulmonary vein isolation|pulmonary vein isolation
5351441|NCT01942408|Pulmonary vein reconnection|pulmonary vein reconnection
5351443|NCT01942395|Sodium|sodium
5351444|NCT01942395|Hypertension|hypertension
5351445|NCT01942395|Potassium|potassium
5351446|NCT01942395|Antioxidants|antioxidants
5351447|NCT01942395|Congestive Heart Failure|congestive heart failure
5351448|NCT01942395|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5351449|NCT01942395|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5351450|NCT01942382|Schizophrenia|schizophrenia
5351451|NCT01942382|JNS010|jns010
5351452|NCT01942382|Paliperidone Palmitate|paliperidone palmitate
5351453|NCT01942382|Clinical Pharmacology|clinical pharmacology
5351454|NCT01942369|Endometriosis|endometriosis
5351455|NCT01942304|Sinus Floor Augmentation|sinus floor augmentation
5351456|NCT01942304|Maxillary Sinus|maxillary sinus
5351457|NCT01942304|Bone Substitutes|bone substitutes
5351458|NCT01942304|Bone Regeneration|bone regeneration
5351459|NCT01942291|Niacin|niacin
5351460|NCT01942291|Endothelial function|endothelial function
5351461|NCT01942291|Laropiprant|laropiprant
5351462|NCT01942291|HDL|hdl
5351463|NCT01942278|Healthcare|healthcare
5351464|NCT01942278|Patients|patients
5351465|NCT01942265|Influenza, Immunogenicity, Monovalent, A/H7N9, Vaccine, AS03, Adjuvant|influenza, immunogenicity, monovalent, a/h7n9, vaccine, as03, adjuvant
5351466|NCT01942252|Secondhand smoking, pain, postoperative complications|secondhand smoking, pain, postoperative complications
5351467|NCT01942239|hypoglycemia|hypoglycemia
5351468|NCT01942239|very low birth weight neonate|very low birth weight neonate
5351469|NCT01942239|continuous glucose monitoring|continuous glucose monitoring
5351470|NCT01942226|Dry eye syndrome|dry eye syndrome
5351471|NCT01942213|Macular|macular
5351472|NCT01942213|Degeneration|degeneration
5351473|NCT01942213|Age related|age related
5351474|NCT01942213|Neovascular|neovascular
5351475|NCT01942200|carcinoma|carcinoma
5351476|NCT01942200|colon cancer|colon cancer
5351477|NCT01942200|colorectal cancer|colorectal cancer
5351478|NCT01942200|ambulant chemotherapy|ambulant chemotherapy
5351479|NCT01942200|treatment cycles|treatment cycles
5351480|NCT01942200|Oxaliplatin|oxaliplatin
5351481|NCT01942200|Oxaliplatin onkovis|oxaliplatin onkovis
5351482|NCT01942200|Quantity of Oxaliplatin|quantity of oxaliplatin
5351483|NCT01942200|Packaging Sizes|packaging sizes
5351484|NCT01942174|Antipneumococcal vaccination|antipneumococcal vaccination
5351485|NCT01942174|Methotrexate treatment|methotrexate treatment
5351486|NCT01942161|Schyzophrenia, pediatric patients|schyzophrenia, pediatric patients
5351487|NCT01942148|Schizophrenia, Pediatric patients|schizophrenia, pediatric patients
5351488|NCT01942135|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
5351489|NCT01942135|Fulvestrant|fulvestrant
5351490|NCT01942135|Goserelin|goserelin
5351491|NCT01942135|Hormone receptor-+|hormone receptor-+
5351492|NCT01942135|HER2-negative|her2-negative
5351493|NCT01942135|Prior Endocrine treatment|prior endocrine treatment
5351494|NCT01942135|any menopausal status|any menopausal status
5351495|NCT01942135|PALOMA-3|paloma-3
5351496|NCT01942122|DLBS1442|dlbs1442
5351497|NCT01942122|Endometriosis|endometriosis
5351498|NCT01942122|Pain|pain
5351499|NCT01942122|Visual Analogue Scale|visual analogue scale
5351500|NCT01942122|Endometriosis Health Profile (EHP-30TM)|endometriosis health profile (ehp-30tm)
5351501|NCT01942109|heart failure|heart failure
5351502|NCT01942109|diuretics|diuretics
5351503|NCT01942109|furosemide|furosemide
5351504|NCT01942109|torasemide|torasemide
5351505|NCT01942070|Cardiovascular Disease|cardiovascular disease
5351506|NCT01942070|Myocardial Infarction|myocardial infarction
5351507|NCT01942070|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
5351508|NCT01942070|Durable polymer everolimus-eluting stent|durable polymer everolimus-eluting stent
5351509|NCT01942070|Primary angioplasty|primary angioplasty
5351511|NCT01942044|Shear stress|shear stress
5351512|NCT01942044|Optical coherence tomography|optical coherence tomography
5351513|NCT01942044|Drug-eluting stents|drug-eluting stents
5351514|NCT01942031|Ischemic stroke|ischemic stroke
5351515|NCT01942031|Hemorrhagic stroke|hemorrhagic stroke
5351517|NCT01942031|Atrial fibrillation|atrial fibrillation
5351518|NCT01942031|prevention|prevention
5351519|NCT01942031|primary care|primary care
5351520|NCT01942018|esophagogastric junction outflow obstruction|esophagogastric junction outflow obstruction
5351521|NCT01942018|EGOO|egoo
5351522|NCT01942018|Per oral endoscopic myotomy|per oral endoscopic myotomy
5351523|NCT01942018|POEM|poem
5351524|NCT01942018|Gastroesophageal reflux disease|gastroesophageal reflux disease
5351525|NCT01942018|GERD|gerd
5351526|NCT01941992|head and neck|head and neck
5351527|NCT01941992|Squamous Cell Carcinoma|squamous cell carcinoma
5355380|NCT01924286|HIV|hiv
5351528|NCT01941992|oral mucositis|oral mucositis
5351529|NCT01941992|Chemo-radiotherapy|chemo-radiotherapy
5351530|NCT01941966|Anal canal cancer;capecitabine; mitomycin; radiotherapy.|anal canal cancer;capecitabine; mitomycin; radiotherapy.
5351531|NCT01941953|Metformin|metformin
5351532|NCT01941953|Metastatic Colorectal Cancer|metastatic colorectal cancer
5351533|NCT01941953|Fluorouracil|fluorouracil
5351534|NCT01941927|Melanoma|melanoma
5351535|NCT01941927|Wild-type|wild-type
5351536|NCT01941927|BRAF|braf
5351537|NCT01941914|Calcium electroporation|calcium electroporation
5351538|NCT01941914|calcium|calcium
5351539|NCT01941914|electroporation|electroporation
5351540|NCT01941914|electrotransfer|electrotransfer
5351541|NCT01941914|keloid|keloid
5351542|NCT01941901|Cutaneous metastases|cutaneous metastases
5351543|NCT01941875|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5351544|NCT01941875|gonadotropins|gonadotropins
5351545|NCT01941875|intrauterine insemination|intrauterine insemination
5351546|NCT01941875|infertility|infertility
5351547|NCT01941875|luteal progesterone|luteal progesterone
5351548|NCT01941862|computerized intervention|computerized intervention
5351549|NCT01941862|cognitive bias modification|cognitive bias modification
5351550|NCT01941862|anxiety|anxiety
5351551|NCT01941862|mood|mood
5351552|NCT01941862|perceived burdensomeness|perceived burdensomeness
5351553|NCT01941862|thwarted belongingness|thwarted belongingness
5351554|NCT01941862|suicide|suicide
5351555|NCT01941862|post-traumatic stress disorder|post-traumatic stress disorder
5351556|NCT01941849|Phaeochromocytoma|phaeochromocytoma
5351557|NCT01941849|Paraganglioma|paraganglioma
5351558|NCT01941849|Neuroendocrine Tumour|neuroendocrine tumour
5351559|NCT01941849|Vandetanib|vandetanib
5351560|NCT01941849|131I-mIBG|131i-mibg
5351561|NCT01941849|Radionucleotide Therapy|radionucleotide therapy
5351562|NCT01941849|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5351563|NCT01941849|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5351564|NCT01941849|RET|ret
5351565|NCT01941849|Tyrosine Kinase|tyrosine kinase
5351566|NCT01941836|Statin intolerant|statin intolerant
5351567|NCT01941836|Statin tolerant|statin tolerant
5351568|NCT01941836|LDL|ldl
5351569|NCT01941836|Cholesterol|cholesterol
5351570|NCT01941823|acute renal failure|acute renal failure
5351571|NCT01941823|CRRT|crrt
5351572|NCT01941823|continuous dialysis|continuous dialysis
5351573|NCT01941823|carnitine|carnitine
5351574|NCT01941823|cardiac strain|cardiac strain
5351575|NCT01941771|Breast cancer|breast cancer
5351576|NCT01941771|Metronomic chemotherapy|metronomic chemotherapy
5351577|NCT01941771|Vinorelbine|vinorelbine
5351578|NCT01941771|Navelbine|navelbine
5351579|NCT01941771|Capecitabine|capecitabine
5351580|NCT01941771|Xeloda|xeloda
5351581|NCT01941771|Antineoplastic Agents|antineoplastic agents
5351582|NCT01941719|Diabetes Mellitus|diabetes mellitus
5351583|NCT01941719|Diabetic Foot|diabetic foot
5351584|NCT01941719|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5351585|NCT01941719|Diabetic Foot Education|diabetic foot education
5351586|NCT01941706|Epilepsy|epilepsy
5351587|NCT01941706|Seizure|seizure
5351588|NCT01941706|Cognitive Behavioral Therapy|cognitive behavioral therapy
5351589|NCT01941706|Mindfulness|mindfulness
5351590|NCT01941706|Depression|depression
5351591|NCT01941706|Depressive symptoms|depressive symptoms
5351592|NCT01941706|prevention|prevention
5351593|NCT01941706|Coping skills|coping skills
5351594|NCT01941706|Quality of life|quality of life
5351595|NCT01941706|Telehealth|telehealth
5351596|NCT01941706|Phone intervention|phone intervention
5351597|NCT01941706|Internet-based intervention|internet-based intervention
5351600|NCT01941693|depression|depression
5351601|NCT01941693|comorbidity|comorbidity
5351602|NCT01941693|CBT|cbt
5351603|NCT01941667|Congenital Heart Disease|congenital heart disease
5351604|NCT01941667|Neonates and infants|neonates and infants
5351605|NCT01941667|Telehealth|telehealth
5351606|NCT01941667|Virtual Home Visits|virtual home visits
5351607|NCT01941628|Cesarean section|cesarean section
5351608|NCT01941628|General anesthesia|general anesthesia
5351609|NCT01941628|neuromuscular blockade|neuromuscular blockade
5351610|NCT01941628|Surgical conditions|surgical conditions
5351611|NCT01941602|surgery|surgery
5351612|NCT01941602|enoxaparin|enoxaparin
5351613|NCT01941602|venous thromboembolism|venous thromboembolism
5351614|NCT01941602|perioperative care|perioperative care
5351615|NCT01941576|Heart defects, Congenital|heart defects, congenital
5351616|NCT01941576|rhBNP|rhbnp
5351617|NCT01941576|heart failure|heart failure
5351618|NCT01941550|untreated, high risk prostate cancer|untreated, high risk prostate cancer
5351619|NCT01941537|Atopic Dermatitis|atopic dermatitis
5351620|NCT01941524|Brain oxygenation|brain oxygenation
5351621|NCT01941524|NIRS|nirs
5351622|NCT01941524|aEEG|aeeg
5351623|NCT01941524|surfactant|surfactant
5351624|NCT01941511|QTc|qtc
5351625|NCT01941511|African-American|african-american
5351626|NCT01941511|GMI-1070|gmi-1070
5351627|NCT01941511|QT/QTc interval prolongation|qt/qtc interval prolongation
5351628|NCT01941498|nearsighted|nearsighted
5351629|NCT01941498|farsighted|farsighted
5351630|NCT01941498|astigmatism|astigmatism
5351631|NCT01941498|LASIK|lasik
5351632|NCT01941498|refractive surgery|refractive surgery
5351633|NCT01941498|WaveLight|wavelight
5351634|NCT01941485|nearsighted|nearsighted
5351635|NCT01941485|astigmatism|astigmatism
5351636|NCT01941485|LASIK|lasik
5351637|NCT01941485|refractive surgery|refractive surgery
5351638|NCT01941485|WaveLight|wavelight
5351639|NCT01941459|CK-MB|ck-mb
5351640|NCT01941459|troponin-T|troponin-t
5351641|NCT01941433|rheumatoid arthritis|rheumatoid arthritis
5351642|NCT01941433|self-management|self-management
5351643|NCT01941433|online|online
5351644|NCT01941433|patient passport|patient passport
5351645|NCT01941420|CK-MB|ck-mb
5351646|NCT01941420|troponin-T|troponin-t
5351647|NCT01941420|Cytokines under ischemia|cytokines under ischemia
5351648|NCT01941394|GVHD|gvhd
5351649|NCT01941394|Relapse|relapse
5351650|NCT01941394|Overall Survival|overall survival
5351651|NCT01941381|Otitis Media|otitis media
5351652|NCT01941381|Tympanometry|tympanometry
5351653|NCT01941368|Performance|performance
5351654|NCT01941368|Aerobic Exercise|aerobic exercise
5351655|NCT01941342|Obstructive Jaundice|obstructive jaundice
5351656|NCT01941342|Preoperative Biliary Drainage|preoperative biliary drainage
5351657|NCT01941342|Pancreatoduodenectomy|pancreatoduodenectomy
5351661|NCT01941329|Panretinal Photocoagulation|panretinal photocoagulation
5351662|NCT01941316|Carfilzomib|carfilzomib
5351663|NCT01941316|Irinotecan|irinotecan
5351664|NCT01941316|Small Cell Lung Cancer|small cell lung cancer
5351665|NCT01941316|Non Small Cell Lung Cancer|non small cell lung cancer
5351666|NCT01941316|Ovarian Cancer|ovarian cancer
5351667|NCT01941316|Gastric Cancer|gastric cancer
5351668|NCT01941316|Esophageal Cancer|esophageal cancer
5351669|NCT01941316|Cervical Cancer|cervical cancer
5351670|NCT01941303|Non-small cell lung cancer|non-small cell lung cancer
5351671|NCT01941290|International|international
5351672|NCT01941290|Multicenter|multicenter
5351673|NCT01941290|Observational registry|observational registry
5351674|NCT01941290|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
5963815|NCT04195100|Pilocarpine|pilocarpine
5963816|NCT04195100|advanced age (≥ 70 years)|advanced age (≥ 70 years)
5963817|NCT04193410|Nutrition|nutrition
5963818|NCT04193410|Physical activity|physical activity
5963819|NCT04193410|School|school
5351675|NCT01941290|Stenting|stenting
5351676|NCT01941290|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5351677|NCT01941290|Coronary Revascularization|coronary revascularization
5671227|NCT00616590|fatigue|fatigue
5351678|NCT01941290|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5963820|NCT04193410|Children|children
5963821|NCT04193410|Prevention|prevention
5963822|NCT04193410|School Health|school health
5351679|NCT01941290|Diabetes Mellitus Type 1|diabetes mellitus type 1
5351680|NCT01941290|Diabetes Mellitus Type 2|diabetes mellitus type 2
5351682|NCT01941290|NSTEMI|nstemi
5351683|NCT01941290|Ischemia|ischemia
5351684|NCT01941290|Angina|angina
5351685|NCT01941290|Subgroups|subgroups
5351686|NCT01941290|Acute Myocardial Infarction|acute myocardial infarction
5351687|NCT01941290|Small Vessels|small vessels
5351688|NCT01941290|Chronic Total Occlusion|chronic total occlusion
5351689|NCT01941264|malaria|malaria
5351690|NCT01941264|placenta|placenta
5351691|NCT01941264|pregnancy|pregnancy
5351692|NCT01941264|plasmodium falciparum|plasmodium falciparum
5351693|NCT01941264|screening and treatment|screening and treatment
5351694|NCT01941264|rapid diagnostic test|rapid diagnostic test
5351695|NCT01941264|coartem|coartem
5351696|NCT01941264|artemether-lumefantrine|artemether-lumefantrine
5351697|NCT01941264|community health worker|community health worker
5351698|NCT01941251|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5351699|NCT01941251|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5351700|NCT01941251|Schizophrenia|schizophrenia
5351701|NCT01941251|Schizoaffective Disorder|schizoaffective disorder
5351702|NCT01941251|Treatment|treatment
5351703|NCT01941251|Negative Symptoms|negative symptoms
5351704|NCT01941251|Positive Symptoms|positive symptoms
5351705|NCT01941251|TMS|tms
5351706|NCT01941251|rTMS|rtms
5351707|NCT01941238|Ramadan|ramadan
5351708|NCT01941238|Fasting|fasting
5351709|NCT01941238|Diabetes|diabetes
5351710|NCT01941238|Type1|type1
5351711|NCT01941238|Insulin|insulin
5351712|NCT01941238|Pump|pump
5351713|NCT01941225|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5351714|NCT01941225|Pulmonary vasculature|pulmonary vasculature
5351715|NCT01941225|Inhaled iloprost|inhaled iloprost
5351716|NCT01941225|Inhaled prostacyclin|inhaled prostacyclin
5351717|NCT01941225|Dynamic hyperinflation|dynamic hyperinflation
5351718|NCT01941225|Oxidative stress|oxidative stress
5351719|NCT01941225|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5351720|NCT01941225|B-type natriuretic peptide|b-type natriuretic peptide
5351721|NCT01941212|Music therapy|music therapy
5351722|NCT01941212|pain|pain
5351723|NCT01941212|gynecological surgeries|gynecological surgeries
5351724|NCT01941186|Children|children
5351725|NCT01941186|Developmental Delays|developmental delays
5351726|NCT01941186|Early Intervention (EI)|early intervention (ei)
5351727|NCT01941186|Patient Decision Aid (PDA)|patient decision aid (pda)
5351728|NCT01941147|Acute Stroke|acute stroke
5351729|NCT01941147|Brain Ischemia|brain ischemia
5423304|NCT01616264|Tuberculosis|tuberculosis
5351730|NCT01941147|Extremely Low Frequency Magnetic Fields|extremely low frequency magnetic fields
5351731|NCT01941121|HIV Screening|hiv screening
5351732|NCT01941121|Linkage to PrEP|linkage to prep
5351733|NCT01941121|Linkage to Care|linkage to care
5351734|NCT01941121|CCTG|cctg
5351735|NCT01941121|593|593
5351736|NCT01941108|AIDS|aids
5351737|NCT01941108|peer navigation|peer navigation
5351738|NCT01941108|ecological momentary assessment|ecological momentary assessment
5351739|NCT01941108|eMOCHA|emocha
5351740|NCT01941108|Baltimore|baltimore
5351741|NCT01941108|IDU|idu
5351742|NCT01941030|Peripheral Artery Disease|peripheral artery disease
5351743|NCT01941030|Critical Limb Ischemia|critical limb ischemia
5351744|NCT01941030|Orbital Atherectomy|orbital atherectomy
5351745|NCT01941030|Balloon Angioplasty|balloon angioplasty
5351746|NCT01941030|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
5351747|NCT01941030|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5351748|NCT01941004|multiple sclerosis (MS)|multiple sclerosis (ms)
5351749|NCT01941004|relapsing remitting multiple sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5351750|NCT01941004|fingolimod|fingolimod
5351751|NCT01940978|Methamphetamine|methamphetamine
5351752|NCT01940978|Methylphenidate|methylphenidate
5351754|NCT01940939|schizophrenia|schizophrenia
5351755|NCT01940926|rheumatoid arthritis|rheumatoid arthritis
5351756|NCT01940926|angiogenesis|angiogenesis
5351757|NCT01940926|68Ga-PRGD2|68ga-prgd2
5351758|NCT01940926|18F-FDG|18f-fdg
5351759|NCT01940926|positron emission tomography/computed tomography|positron emission tomography/computed tomography
5351760|NCT01940900|Wet AMD|wet amd
5351761|NCT01940900|choroidal neovascularization|choroidal neovascularization
5351762|NCT01940900|Fovista®|fovista®
5351763|NCT01940900|E10030|e10030
5351764|NCT01940900|Lucentis®|lucentis®
5351765|NCT01940887|Wet AMD|wet amd
5351766|NCT01940887|choroidal neovascularization|choroidal neovascularization
5351767|NCT01940887|Fovista®|fovista®
5351768|NCT01940887|E10030|e10030
5351769|NCT01940887|Avastin®|avastin®
5351770|NCT01940887|Eylea®|eylea®
5351771|NCT01940874|Cerebral Oximetry.|cerebral oximetry.
5351772|NCT01940874|Aortic valve stenosis.|aortic valve stenosis.
5351773|NCT01940874|Aortic valve regurgitation.|aortic valve regurgitation.
5246820|NCT02464501|PAD|pad
5351774|NCT01940874|Coronary artery disease.|coronary artery disease.
5351775|NCT01940848|Iberogast|iberogast
5351776|NCT01940848|efficacy|efficacy
5351777|NCT01940848|safety|safety
5351778|NCT01940796|Brentuximab Vedotin|brentuximab vedotin
5230788|NCT02559999|Pain|pain
5351779|NCT01940796|GVHD|gvhd
5351780|NCT01940796|Refractory Chronic Graft vs Host Disease|refractory chronic graft vs host disease
5351781|NCT01940770|Diabetes Mellitus(DM)|diabetes mellitus(dm)
5351782|NCT01940770|Bydureon|bydureon
5351783|NCT01940770|Exenatide|exenatide
5351784|NCT01940757|Necator americanus|necator americanus
5351785|NCT01940757|Hookworm Infection|hookworm infection
5351786|NCT01940757|Experimental challenge infection|experimental challenge infection
5351787|NCT01940744|Low back pain|low back pain
5351788|NCT01940744|Non-specific Low back pain|non-specific low back pain
5351789|NCT01940718|Priapism|priapism
5351790|NCT01940718|Sickle cell disease|sickle cell disease
5351791|NCT01940718|Testosterone|testosterone
5351792|NCT01940718|Androgen deficiency|androgen deficiency
5351793|NCT01940705|hearing aids|hearing aids
5351794|NCT01940705|counseling|counseling
5351795|NCT01940705|outcomes assessment (health care)|outcomes assessment (health care)
5351796|NCT01940705|rehabilitation|rehabilitation
5351797|NCT01940666|Hyperandrogenism/|hyperandrogenism/
5351799|NCT01940666|Metabolic syndrome/|metabolic syndrome/
5351800|NCT01940666|Adipocytokines/|adipocytokines/
5351801|NCT01940666|Insulin resistance.|insulin resistance.
5351802|NCT01940640|neonates, DHA|neonates, dha
5351803|NCT01940627|Ubiquinol, exercise|ubiquinol, exercise
5351804|NCT01940614|Copeptin|copeptin
5351805|NCT01940614|differential diagnosis of polyuria polydipsia syndrome|differential diagnosis of polyuria polydipsia syndrome
5351806|NCT01940614|diabetes insipidus|diabetes insipidus
5351807|NCT01940614|compulsive water drinking|compulsive water drinking
5351808|NCT01940614|water deprivation test|water deprivation test
5351809|NCT01940614|Diabetes insipidus (central and nephrogenic)|diabetes insipidus (central and nephrogenic)
5351810|NCT01940601|solid tumors|solid tumors
5351811|NCT01940601|balugrastim|balugrastim
5351812|NCT01940575|Tissue restorative biomaterial|tissue restorative biomaterial
5351813|NCT01940575|Hyaluronic acid|hyaluronic acid
5351814|NCT01940575|Restylane®|restylane®
5351815|NCT01940575|Wrinkle Severity Rating Scale (WSRS)|wrinkle severity rating scale (wsrs)
5351816|NCT01940575|Global Aesthetic Improvement Scale (GAIS)|global aesthetic improvement scale (gais)
5351817|NCT01940575|Nasolabial fold(NLF)|nasolabial fold(nlf)
5351818|NCT01940562|cord blood transplantation|cord blood transplantation
5351819|NCT01940562|platelets|platelets
5351820|NCT01940562|eltrombopag|eltrombopag
5351821|NCT01940549|PTSD|ptsd
5351822|NCT01940549|tDCS|tdcs
5351823|NCT01940549|Trauma|trauma
5351824|NCT01940536|Hip Fracture|hip fracture
5351825|NCT01940536|Blood Transfusion|blood transfusion
5351826|NCT01940536|Blood Loss|blood loss
5351827|NCT01940536|Tranexamic Acid|tranexamic acid
5351828|NCT01940523|total knee arthroplasty|total knee arthroplasty
5351829|NCT01940523|total knee replacement|total knee replacement
5351831|NCT01940523|osteoarthritis|osteoarthritis
5351832|NCT01940523|degenerative joint disease|degenerative joint disease
5351833|NCT01940471|Hepatitis|hepatitis
5351834|NCT01940471|Tenofovir|tenofovir
5351835|NCT01940471|Viread|viread
5351836|NCT01940432|simple stress urinary incontinence|simple stress urinary incontinence
5351837|NCT01940419|Reduction of blood loss|reduction of blood loss
5351838|NCT01940419|Surgical complication|surgical complication
5351839|NCT01940419|Hysterectomy|hysterectomy
5351840|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents
5351841|NCT01940419|Randomized Controlled Trials|randomized controlled trials
5351842|NCT01940406|Essential Tremor|essential tremor
5351843|NCT01940406|Parkinson Disease|parkinson disease
5351844|NCT01940406|Electrical Stimulation|electrical stimulation
5351845|NCT01940406|Tremor|tremor
5351846|NCT01940393|urticaria|urticaria
5351847|NCT01940393|bilastine|bilastine
5351848|NCT01940393|fexofenadine|fexofenadine
5351849|NCT01940393|cetirizine|cetirizine
5351850|NCT01940393|ebastine|ebastine
5351864|NCT01940354|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
5351866|NCT01940341|Tenofovir|tenofovir
5351868|NCT01940328|Ultrasound Doppler|ultrasound doppler
5351869|NCT01940328|Congestive heart failure|congestive heart failure
5351870|NCT01940328|Pulmonary Edema|pulmonary edema
5351871|NCT01940315|Defender Study|defender study
5351872|NCT01940315|experimental vaccine|experimental vaccine
5351873|NCT01940315|inhalational intoxication|inhalational intoxication
5351874|NCT01940302|Malnutrition; Metabolic disorders|malnutrition; metabolic disorders
5351875|NCT01940289|algometry|algometry
5351876|NCT01940289|pain|pain
5351877|NCT01940289|VAS|vas
5351878|NCT01940276|Prostate cancer|prostate cancer
5351879|NCT01940276|metastatic|metastatic
5671935|NCT00613535|Debridement|debridement
5351880|NCT01940276|castrate resistant|castrate resistant
5351881|NCT01940276|abiraterone acetate|abiraterone acetate
5351883|NCT01940276|metastatic prostate cancer|metastatic prostate cancer
5351884|NCT01940263|oxidative stress|oxidative stress
5351885|NCT01940263|dyslipidemia|dyslipidemia
5351886|NCT01940263|inflammation|inflammation
5351887|NCT01940263|apoptosis|apoptosis
5963823|NCT04193293|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5351888|NCT01940250|Hand, foot and mouth disease|hand, foot and mouth disease
5230931|NCT02558985|Casting|casting
5351889|NCT01940250|Autonomic nervous system dysregulation|autonomic nervous system dysregulation
5351891|NCT01940237|Depression|depression
5351892|NCT01940237|Psychotherapy|psychotherapy
5351893|NCT01940237|Cancer|cancer
5351894|NCT01940237|Pancreatic Cancer|pancreatic cancer
5351895|NCT01940237|Lung Cancer|lung cancer
5351896|NCT01940237|Colon Cancer|colon cancer
5351897|NCT01940237|Prostate Cancer|prostate cancer
5351898|NCT01940224|Pregabalin|pregabalin
5351899|NCT01940224|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5351900|NCT01940224|Postoperative pain|postoperative pain
5351901|NCT01940224|Opioid consumption|opioid consumption
5351902|NCT01940198|Atazanavir|atazanavir
5351903|NCT01940198|long-term|long-term
5351904|NCT01940198|primary care setting|primary care setting
5351905|NCT01940198|sydney|sydney
5351906|NCT01940159|Schizophrenia|schizophrenia
5351907|NCT01940159|Schizoaffective disorders|schizoaffective disorders
5351924|NCT01940120|Heart Attack|heart attack
5351925|NCT01940120|EVEREST|everest
5351926|NCT01940120|EVEREST I|everest i
5351927|NCT01940120|EVEREST II|everest ii
5351928|NCT01940120|REALISM|realism
5351929|NCT01940107|breast cancer,|breast cancer,
5351930|NCT01940107|radiotherapy,|radiotherapy,
5351931|NCT01940107|physical therapy,|physical therapy,
5351932|NCT01940107|upper limb|upper limb
5351933|NCT01940094|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5351934|NCT01940094|Wegener's granulomatosis|wegener's granulomatosis
5351937|NCT01940094|ANCA-Associated Vasculitis|anca-associated vasculitis
5351938|NCT01940094|AAV|aav
5351939|NCT01940094|Vasculitis|vasculitis
5351940|NCT01940094|Prednisone|prednisone
5351941|NCT01940094|Glucocorticoid|glucocorticoid
5351942|NCT01940094|Taper|taper
5351957|NCT01940068|Hypersensitivity|hypersensitivity
5351958|NCT01940068|Milk Hypersensitivity|milk hypersensitivity
5351959|NCT01940068|Immune System Diseases|immune system diseases
5351960|NCT01940068|Food Hypersensitivity|food hypersensitivity
5351962|NCT01940055|Gait|gait
5351963|NCT01940055|Instrumented Treadmill|instrumented treadmill
5351964|NCT01940055|Recumbent cycle|recumbent cycle
5351965|NCT01940055|Cognitive games|cognitive games
5351966|NCT01940029|vancomycin, neurosurgery, critical ill, pharmacokinetics|vancomycin, neurosurgery, critical ill, pharmacokinetics
5351967|NCT01940016|Feasibility study|feasibility study
5351968|NCT01940016|Interactive voice response system (IVR)|interactive voice response system (ivr)
5351969|NCT01940016|health coach|health coach
5351970|NCT01940016|no evidence of disease|no evidence of disease
5351971|NCT01940003|Diabetes, Gestational|diabetes, gestational
5351972|NCT01940003|Pregnancy Outcome|pregnancy outcome
5351973|NCT01940003|Exercise|exercise
5351974|NCT01940003|glycemic control|glycemic control
5351975|NCT01939990|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5351976|NCT01939977|Hyperparathyroidism|hyperparathyroidism
5351977|NCT01939977|Hyperparathyroidism Secondary|hyperparathyroidism secondary
5351978|NCT01939977|Paricalcitol|paricalcitol
5351979|NCT01939977|Calcifediol|calcifediol
5351980|NCT01939977|Parathyroid hormone|parathyroid hormone
5351981|NCT01939977|Renal transplantation|renal transplantation
5351982|NCT01939964|Wrinkles|wrinkles
5351983|NCT01939964|Activation Mist|activation mist
5351984|NCT01939951|Asthma|asthma
5351985|NCT01939951|Persistent|persistent
5351986|NCT01939925|patient education|patient education
5351987|NCT01939925|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5351988|NCT01939925|comprehension|comprehension
5351989|NCT01939925|consumer health information|consumer health information
5351990|NCT01939899|MLN9708|mln9708
5351991|NCT01939899|Lymphoma|lymphoma
5351992|NCT01939899|IXAZOMIB|ixazomib
5351993|NCT01939886|Malaria treatment efficacy|malaria treatment efficacy
5351994|NCT01939886|Malaria transmission|malaria transmission
5351995|NCT01939873|Kristeller maneuver; Second stage of labor;|kristeller maneuver; second stage of labor;
5351996|NCT01939873|Perineal laceration; Obstetrical outcome;|perineal laceration; obstetrical outcome;
5351997|NCT01939873|Neonatal outcome|neonatal outcome
5351998|NCT01939847|Metastatic breast cancer|metastatic breast cancer
5351999|NCT01939847|Breast cancer|breast cancer
5352000|NCT01939847|Molecular profiling|molecular profiling
5352001|NCT01939847|Personalized medicine|personalized medicine
5352002|NCT01939834|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5352003|NCT01939834|Artificial Pancreas|artificial pancreas
5352004|NCT01939834|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5352005|NCT01939834|Continuous Glucose Monitor|continuous glucose monitor
5352006|NCT01939821|Fecal incontinence|fecal incontinence
5352007|NCT01939821|attitudes|attitudes
5352008|NCT01939821|knowledge|knowledge
5352009|NCT01939821|quality of care|quality of care
5352010|NCT01939795|cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5352011|NCT01939782|Metabolic CLock Genes (MCG)|metabolic clock genes (mcg)
5963824|NCT04193293|Head and Neck Cancer|head and neck cancer
5352012|NCT01939782|Type 2 Diabetes (T2D)|type 2 diabetes (t2d)
5352013|NCT01939769|fMRI|fmri
5352014|NCT01939769|Catecholamines|catecholamines
5352015|NCT01939769|Stress|stress
5218948|NCT02629406|HIF|hif
5352016|NCT01939769|Exercise|exercise
5352017|NCT01939769|Memory|memory
5352018|NCT01939756|High risk non-muscle invasive urothelial bladder cancer|high risk non-muscle invasive urothelial bladder cancer
5352019|NCT01939756|Intravesical BCG|intravesical bcg
5352020|NCT01939756|Local toxicity|local toxicity
5352021|NCT01939756|Natural baobab oil|natural baobab oil
5352022|NCT01939730|Lymphoma|lymphoma
5352023|NCT01939730|Follicular B-Cell Lymphoma|follicular b-cell lymphoma
5352024|NCT01939730|Rituximab|rituximab
5352025|NCT01939730|Rituxan|rituxan
5352026|NCT01939730|GM-CSF|gm-csf
5352027|NCT01939730|Sargramostim|sargramostim
5352028|NCT01939730|Leukine|leukine
5352029|NCT01939717|Parkinson's disease|parkinson's disease
5352030|NCT01939717|Irish set dancing|irish set dancing
5352031|NCT01939691|difluprednate|difluprednate
5352032|NCT01939691|prednisolone acetate|prednisolone acetate
5352033|NCT01939691|nepafenac|nepafenac
5352034|NCT01939665|Locally advanced pancreatic carcinoma|locally advanced pancreatic carcinoma
5352035|NCT01939665|LAPC|lapc
5352036|NCT01939665|Irreversible electroporation|irreversible electroporation
5352037|NCT01939665|NanoKnife|nanoknife
5352039|NCT01939665|Safety|safety
5352040|NCT01939665|Efficacy|efficacy
5352041|NCT01939665|Non-thermal ablation|non-thermal ablation
5352042|NCT01939665|Percutaneous ablation|percutaneous ablation
5352043|NCT01939665|Low Energy Direct Current|low energy direct current
5352044|NCT01939652|minilaparotomy|minilaparotomy
5352045|NCT01939652|AAA|aaa
5352046|NCT01939652|fluid regime|fluid regime
5352047|NCT01939639|Oxytocin|oxytocin
5352048|NCT01939639|fMRI|fmri
5352049|NCT01939626|embryo|embryo
5352050|NCT01939626|culture|culture
5352051|NCT01939613|fluid resuscitation|fluid resuscitation
5352052|NCT01939613|burn|burn
5352053|NCT01939613|colloid,|colloid,
5355882|NCT01921777|Muscle|muscle
5352058|NCT01939600|In vivo|in vivo
5352059|NCT01939600|Carbohydrate digestibility|carbohydrate digestibility
5352060|NCT01939587|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
5352061|NCT01939587|Asthma|asthma
5352062|NCT01939587|adenosine receptor modulator|adenosine receptor modulator
5352063|NCT01939587|COPD|copd
5352064|NCT01939574|Glioblastoma|glioblastoma
5352065|NCT01939574|Potential Image Biomarkers|potential image biomarkers
5352067|NCT01939574|Bevacizumab|bevacizumab
5352068|NCT01939574|Conventional Therapy|conventional therapy
5352069|NCT01939561|Myotonia|myotonia
5352070|NCT01939561|Lamotrigine|lamotrigine
5352071|NCT01939561|RCT|rct
5352072|NCT01939561|treatment|treatment
5352073|NCT01939548|PF-02545920|pf-02545920
5352074|NCT01939548|schizophrenia|schizophrenia
5352075|NCT01939548|outpatient|outpatient
5352076|NCT01939548|safety|safety
5352077|NCT01939548|efficacy|efficacy
5352078|NCT01939548|suboptimal response|suboptimal response
5352079|NCT01939535|Endometriosis|endometriosis
5352080|NCT01939535|Magnetic resonance imaging|magnetic resonance imaging
5352081|NCT01939522|diabetes|diabetes
5352082|NCT01939522|pneumococcal|pneumococcal
5352083|NCT01939496|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5352084|NCT01939496|Hypertension|hypertension
5352085|NCT01939496|Canagliflozin|canagliflozin
5352086|NCT01939496|JNJ 28431754|jnj 28431754
5352087|NCT01939496|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
5352088|NCT01939496|Blood Glucose|blood glucose
5352089|NCT01939496|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5352090|NCT01939483|Irinotecan hydrochloride|irinotecan hydrochloride
5352091|NCT01939483|Irinotecan|irinotecan
5352092|NCT01939483|CAMPTOSAR|camptosar
5352093|NCT01939470|osteoporosis|osteoporosis
5352094|NCT01939470|bone|bone
5352095|NCT01939470|inflammation|inflammation
5352096|NCT01939470|diabetes|diabetes
5352097|NCT01939470|vitamin D|vitamin d
5352098|NCT01939444|Antidotes|antidotes
5352099|NCT01939444|naloxone|naloxone
5352100|NCT01939444|administration, intravenous|administration, intravenous
5352101|NCT01939444|administration, intranasal|administration, intranasal
5352102|NCT01939444|pharmacology|pharmacology
5352103|NCT01939431|Podoconiosis|podoconiosis
5352104|NCT01939431|Ethiopian|ethiopian
5352205|NCT01938963|Depression|depression
5352105|NCT01939418|metastatic breast cancer|metastatic breast cancer
5352106|NCT01939418|triple negative breast cancer|triple negative breast cancer
5352107|NCT01939418|gemcitabine|gemcitabine
5352108|NCT01939418|RAD001|rad001
5352109|NCT01939405|Obesity|obesity
5352110|NCT01939405|Overweight|overweight
5963825|NCT04193293|PI3K-δ,γ|pi3k-δ,γ
5963826|NCT04193293|PI3K Inhibitor|pi3k inhibitor
5963827|NCT04193241|Chest tube insertion|chest tube insertion
5963828|NCT04193241|Purse-string suture|purse-string suture
5963829|NCT04193241|occlusive adhesive-absorbent dressing|occlusive adhesive-absorbent dressing
5352111|NCT01939405|Physical Activity|physical activity
5352112|NCT01939405|Built Environment|built environment
5352113|NCT01939405|counseling|counseling
5352114|NCT01939392|Resistant hypertension|resistant hypertension
5352115|NCT01939392|Uncontrolled hypertension|uncontrolled hypertension
5352116|NCT01939392|Renal artery ablation|renal artery ablation
5352117|NCT01939379|Total knee arthroplasty|total knee arthroplasty
5231110|NCT02557867|obesity|obesity
5352118|NCT01939379|nerve block|nerve block
5352119|NCT01939379|Pain control after surgery|pain control after surgery
5352120|NCT01939366|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
5352121|NCT01939353|Adult ADHD|adult adhd
5352122|NCT01939327|diffuse large B cell|diffuse large b cell
5352123|NCT01939327|non-Hodgkin lymphoma|non-hodgkin lymphoma
5352124|NCT01939314|Headache|headache
5352125|NCT01939314|Migraine|migraine
5352126|NCT01939301|Pulmonary embolism clot|pulmonary embolism clot
5352127|NCT01939288|neuromuscular stimulation|neuromuscular stimulation
5352128|NCT01939288|intermittent pneumatic compression|intermittent pneumatic compression
5352129|NCT01939262|Arthritis|arthritis
5352131|NCT01939262|Function|function
5352132|NCT01939262|Diet|diet
5352133|NCT01939262|Vegan|vegan
5352134|NCT01939262|Vegetarian|vegetarian
5352135|NCT01939262|Restriction|restriction
5352136|NCT01939236|chronic heart failure|chronic heart failure
5352137|NCT01939236|traditional Chinese medicine|traditional chinese medicine
5352138|NCT01939236|syndrome differentiation|syndrome differentiation
5352139|NCT01939223|Stage IV colorectal cancer / Liver Metastasis|stage iv colorectal cancer / liver metastasis
5352140|NCT01939197|HCV Genotype 4|hcv genotype 4
5352141|NCT01939197|Interferon-Free|interferon-free
5352142|NCT01939197|Hepatitis C Genotype 1|hepatitis c genotype 1
5352143|NCT01939197|Compensated Cirrhosis|compensated cirrhosis
5352144|NCT01939197|Hepatitis C Genotype 4|hepatitis c genotype 4
5352145|NCT01939197|HCV / HIV coinfection|hcv / hiv coinfection
5352146|NCT01939197|Cirrhotic|cirrhotic
5352147|NCT01939197|Hepatitis C|hepatitis c
5352148|NCT01939197|HIV-1|hiv-1
5352149|NCT01939197|HCV Genotype 1|hcv genotype 1
5352150|NCT01939171|Thymoglobulin|thymoglobulin
5352151|NCT01939171|Cadaver donor|cadaver donor
5352152|NCT01939171|Kidney injury brain death related|kidney injury brain death related
5352153|NCT01939158|Co-administration|co-administration
5352154|NCT01939158|Safety|safety
5352155|NCT01939158|Persistence|persistence
5352156|NCT01939158|Immunogenicity|immunogenicity
5352157|NCT01939158|Prevenar 13|prevenar 13
5352158|NCT01939158|Meningococcal vaccine|meningococcal vaccine
5352159|NCT01939158|Toddlers|toddlers
5352160|NCT01939158|5 years|5 years
5352161|NCT01939145|hospital admission|hospital admission
5352162|NCT01939132|Psoriatic Arthritis|psoriatic arthritis
5352163|NCT01939132|ACTH|acth
5352164|NCT01939132|Acthar|acthar
5352165|NCT01939119|retinal vascular occlusion|retinal vascular occlusion
5352166|NCT01939119|drinking habits|drinking habits
5352167|NCT01939119|body hydration|body hydration
5352168|NCT01939119|body-fluid balance|body-fluid balance
5352170|NCT01939106|Ileostomy|ileostomy
5352171|NCT01939106|pouch|pouch
5352172|NCT01939106|Drainable Pouch for collection of stool|drainable pouch for collection of stool
5352173|NCT01939093|Quetiapine|quetiapine
5352174|NCT01939093|Haloperidol|haloperidol
5352175|NCT01939093|Methamphetamine|methamphetamine
5352176|NCT01939093|Psychosis|psychosis
5352177|NCT01939080|moderate risk|moderate risk
5352178|NCT01939080|high risk|high risk
5352179|NCT01939067|respiratory distress|respiratory distress
5352180|NCT01939067|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
5352181|NCT01939067|HHHFNC|hhhfnc
5352182|NCT01939067|noninvasive nasal continuous positive airway pressure (NCPAP)|noninvasive nasal continuous positive airway pressure (ncpap)
5352183|NCT01939067|NCPAP|ncpap
5352184|NCT01939041|Subacute Stroke|subacute stroke
5352185|NCT01939041|Unilateral Robot-Assisted Training|unilateral robot-assisted training
5352186|NCT01939041|Bilateral Robot-Assisted Training|bilateral robot-assisted training
5352187|NCT01939041|Motor control|motor control
5352188|NCT01939041|Physiological Response|physiological response
5352189|NCT01939015|3D miniplate|3d miniplate
5352190|NCT01939015|angle mandibular fracture|angle mandibular fracture
5352191|NCT01939015|champy technique|champy technique
5352192|NCT01939015|internal rigid fixation|internal rigid fixation
5352193|NCT01939002|flu-like symptoms|flu-like symptoms
5352194|NCT01938989|cataract|cataract
5247170|NCT02462590|Infections|infections
5352195|NCT01938989|intraocular lens|intraocular lens
5352197|NCT01938989|blue light filter|blue light filter
5352198|NCT01938976|Asthma|asthma
5352199|NCT01938976|Tobacco|tobacco
5352200|NCT01938976|Waterpipe|waterpipe
5352201|NCT01938976|Cigarettes|cigarettes
5352202|NCT01938976|Adolescents|adolescents
5352203|NCT01938976|Peer education|peer education
5352204|NCT01938976|Jordan|jordan
5352206|NCT01938963|Hypertension|hypertension
5352208|NCT01938911|Trier social stress test|trier social stress test
5352209|NCT01938911|Oxytocin|oxytocin
5352210|NCT01938911|Hypertension|hypertension
5352211|NCT01938898|Randomized trial|randomized trial
5352212|NCT01938898|Invitation letter|invitation letter
5352213|NCT01938898|Recruitment|recruitment
5352214|NCT01938898|Retention|retention
5963830|NCT04193241|thoracostomy wound closure|thoracostomy wound closure
5963831|NCT04193241|wound complications|wound complications
5963832|NCT04193241|wound outcomes|wound outcomes
5963833|NCT04192513|Atopic Dermatitis|atopic dermatitis
5963834|NCT04192513|S. aureus|s. aureus
5963835|NCT04191616|Multiple Myeloma|multiple myeloma
5963836|NCT04191616|RRMM|rrmm
5352215|NCT01938872|critical limb ischemia|critical limb ischemia
5352216|NCT01938872|drug-eluting balloon|drug-eluting balloon
5352217|NCT01938872|restenosis|restenosis
5352218|NCT01938859|bipolar disorder|bipolar disorder
5352220|NCT01938859|quetiapine|quetiapine
5352221|NCT01938859|Medicine, Chinese Traditional|medicine, chinese traditional
5352222|NCT01938859|efficacy|efficacy
5352223|NCT01938859|safety|safety
5352224|NCT01938859|Recurrence|recurrence
5352225|NCT01938820|Hepatitis B|hepatitis b
5352226|NCT01938820|Liver Cirrhosis|liver cirrhosis
5352227|NCT01938820|Regression|regression
5352228|NCT01938820|Efficacy|efficacy
5352229|NCT01938807|type 1 diabetes|type 1 diabetes
5352230|NCT01938807|parents|parents
5352231|NCT01938807|mobile application|mobile application
5352232|NCT01938807|diabetes management|diabetes management
5352233|NCT01938781|Hepatitis B|hepatitis b
5352234|NCT01938781|Liver fibrosis|liver fibrosis
5352235|NCT01938781|Regression|regression
5352236|NCT01938781|Efficacy|efficacy
5352237|NCT01938768|Multiple trauma|multiple trauma
5352238|NCT01938768|Polytrauma|polytrauma
5352239|NCT01938768|Hyperfibrinolysis|hyperfibrinolysis
5352240|NCT01938768|Tranexamic acid|tranexamic acid
5352241|NCT01938768|Thrombelastometry|thrombelastometry
5352242|NCT01938742|A/H7N9,Adjuvant,Immunogenicity,Influenza,MF59,Monovalent,Vaccine|a/h7n9,adjuvant,immunogenicity,influenza,mf59,monovalent,vaccine
5352243|NCT01938729|HEPATIC ARTERIAL INFUSION|hepatic arterial infusion
5352244|NCT01938729|FLOXURIDINE|floxuridine
5352245|NCT01938729|DEXAMETHASONE|dexamethasone
5352246|NCT01938729|GEMCITABINE|gemcitabine
5352247|NCT01938729|Pump|pump
5352248|NCT01938729|13-148|13-148
5352249|NCT01938716|Pancreatic Cancer|pancreatic cancer
5352250|NCT01938716|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5352251|NCT01938716|Intratumoral gemcitabine levels|intratumoral gemcitabine levels
5352252|NCT01938716|Pancreatic surgery|pancreatic surgery
5352253|NCT01938716|Pharmacokinetic testing|pharmacokinetic testing
5352255|NCT01938716|Gemcitabine|gemcitabine
5352256|NCT01938716|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5352257|NCT01938716|Gemzar|gemzar
5352258|NCT01938690|stroke, transcranial magnetic stimulation, rehabilitation|stroke, transcranial magnetic stimulation, rehabilitation
5352259|NCT01938677|Vestibular schwannoma|vestibular schwannoma
5352260|NCT01938677|Gamma knife radiosurgery|gamma knife radiosurgery
5352261|NCT01938677|Hearing preservation|hearing preservation
5352262|NCT01938664|cocaine|cocaine
5352263|NCT01938664|dependence|dependence
5352264|NCT01938664|pharmacotherapy|pharmacotherapy
5352265|NCT01938638|Advanced malignancies|advanced malignancies
5352266|NCT01938638|TNBC|tnbc
5352267|NCT01938638|DLBCL|dlbcl
5352268|NCT01938638|Gastric cancer|gastric cancer
5352269|NCT01938625|Hepatitis C, Chronic|hepatitis c, chronic
5352270|NCT01938625|Recurrent Chronic Hepatitis C|recurrent chronic hepatitis c
5352271|NCT01938625|Pharmacokinetics|pharmacokinetics
5352272|NCT01938625|Simeprevir|simeprevir
5352273|NCT01938625|Daclatasvir|daclatasvir
5352274|NCT01938625|Ribavirin|ribavirin
5352275|NCT01938625|Orthotopic Liver Transplantation|orthotopic liver transplantation
5352276|NCT01938625|TMC435|tmc435
5352277|NCT01938625|BMS-790052|bms-790052
5352279|NCT01938612|MEDI4736|medi4736
5352280|NCT01938612|Advanced solid tumors|advanced solid tumors
5352281|NCT01938612|squamous cell carcinoma of the head and Neck|squamous cell carcinoma of the head and neck
5352282|NCT01938612|biliary tract cancer|biliary tract cancer
5352283|NCT01938612|squamous cell carcinoma of esophagus cancer|squamous cell carcinoma of esophagus cancer
5352284|NCT01938612|B7-H1|b7-h1
5352285|NCT01938612|PD-L1|pd-l1
5352286|NCT01938599|Plaque Psoriasis|plaque psoriasis
5352287|NCT01938586|Scar|scar
5352288|NCT01938586|Appearance|appearance
5352289|NCT01938547|perioperative|perioperative
5352290|NCT01938547|blood pressure|blood pressure
5352291|NCT01938547|pediatrics|pediatrics
5352292|NCT01938547|pediatric surgery|pediatric surgery
5352293|NCT01938521|Red Grape Cells powder (RGC)|red grape cells powder (rgc)
5352294|NCT01938521|Placebo (PLA)|placebo (pla)
5352295|NCT01938508|dermatitis|dermatitis
5352296|NCT01938508|Minocycline|minocycline
5352297|NCT01938508|bioavailability|bioavailability
5352298|NCT01938495|ALS|als
5352299|NCT01938495|DPS|dps
5352300|NCT01938495|Diaphragm Pacing|diaphragm pacing
5352301|NCT01938482|SCD1|scd1
5963837|NCT04191616|Open-label|open-label
5963838|NCT04191616|First Relapse Multiple Myeloma|first relapse multiple myeloma
5963839|NCT04191616|Second Relapse Multiple Myeloma|second relapse multiple myeloma
5963840|NCT04191616|Refractory to Lenalidomide|refractory to lenalidomide
5963841|NCT04191616|Triplicate Treatment Regimen|triplicate treatment regimen
5963842|NCT04191616|dexamethasone|dexamethasone
5963843|NCT04191616|Carfilzomib|carfilzomib
5963844|NCT04191616|Pomalidomide|pomalidomide
5963845|NCT04191278|Smoking|smoking
5963846|NCT04191278|mHealth|mhealth
5963847|NCT04191278|Chantix|chantix
5963848|NCT04191278|Varenicline|varenicline
5963849|NCT04191278|HIV|hiv
5963850|NCT04191174|lung cancer|lung cancer
5963851|NCT04191174|lung resection|lung resection
5963852|NCT04191174|ventilation heterogeneity|ventilation heterogeneity
5963853|NCT04191174|Technegas V SPECT|technegas v spect
5963854|NCT04191174|hyperpolarized 129Xe MRI|hyperpolarized 129xe mri
5963855|NCT04191174|airway inflammation|airway inflammation
5352302|NCT01938482|Topical Administration|topical administration
5352303|NCT01938482|Acne|acne
5352304|NCT01938482|Gel|gel
5352305|NCT01938469|Bariatric|bariatric
5352306|NCT01938469|Gastric Bypass|gastric bypass
5352307|NCT01938469|Gastric Banding,|gastric banding,
5352308|NCT01938469|Incretins|incretins
5352309|NCT01938469|glucagon-like peptide-1(GLP-1)|glucagon-like peptide-1(glp-1)
5352310|NCT01938469|gastric inhibitory peptide (GIP)|gastric inhibitory peptide (gip)
5352311|NCT01938456|Non-small cell lung cancer|non-small cell lung cancer
5352312|NCT01938456|GSK1120212 (trametinib)|gsk1120212 (trametinib)
5352313|NCT01938456|Japanese|japanese
5352314|NCT01938456|Phase Ib|phase ib
5352315|NCT01938456|combination therapy|combination therapy
5352316|NCT01938456|docetaxel|docetaxel
5352317|NCT01938456|MEK inhibitor|mek inhibitor
5352318|NCT01938443|pharmacodynamics|pharmacodynamics
5352319|NCT01938443|MEK inhibitor|mek inhibitor
5352320|NCT01938443|Focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
5352321|NCT01938443|cancer|cancer
5352322|NCT01938443|pharmacokinetic|pharmacokinetic
5352323|NCT01938443|mesothelioma|mesothelioma
5352324|NCT01938443|Phase 1|phase 1
5352325|NCT01938417|tobramycin|tobramycin
5352326|NCT01938417|bone graft substitute|bone graft substitute
5352327|NCT01938417|pharmacokinetics|pharmacokinetics
5352328|NCT01938417|renal failure|renal failure
5352329|NCT01938404|Plasma exchange|plasma exchange
5352330|NCT01938404|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5352331|NCT01938404|TTP|ttp
5352332|NCT01938391|Peripheral Artery Disease|peripheral artery disease
5352333|NCT01938391|PAD|pad
5352334|NCT01938391|Claudication|claudication
5352335|NCT01938391|Peripheral Vascular Disease|peripheral vascular disease
5352336|NCT01938391|PVD|pvd
5352337|NCT01938391|Orbital Atherectomy|orbital atherectomy
5352338|NCT01938391|Balloon Angioplasty|balloon angioplasty
5352339|NCT01938391|Intravascular Ultrasound (IVUS)|intravascular ultrasound (ivus)
5352340|NCT01938378|Octaplas|octaplas
5352341|NCT01938352|Influenza|influenza
5352342|NCT01938352|Virus|virus
5352343|NCT01938352|Monoclonal Antibody|monoclonal antibody
5352344|NCT01938352|Immunization|immunization
5352345|NCT01938352|Treatment|treatment
5352346|NCT01938339|prostate cancer|prostate cancer
5352347|NCT01938339|MRI|mri
5352348|NCT01938339|PET|pet
5352349|NCT01938326|Stomach neoplasm|stomach neoplasm
5352350|NCT01938326|TLDG|tldg
5352351|NCT01938326|SIDG|sidg
5352352|NCT01938326|single-port|single-port
5352353|NCT01938326|inflammatory response|inflammatory response
5352354|NCT01938313|gastric cancer|gastric cancer
5352355|NCT01938313|ERAS (early recovery after surgery)|eras (early recovery after surgery)
5352356|NCT01938313|fast track|fast track
5352357|NCT01938313|laparoscopic gastrectomy|laparoscopic gastrectomy
5352359|NCT01938274|Knee|knee
5352360|NCT01938274|Osteoarthritis|osteoarthritis
5352361|NCT01938274|Arthroplasty|arthroplasty
5352362|NCT01938274|Physical Activity|physical activity
5352363|NCT01938274|Expectations|expectations
5352364|NCT01938274|Leisure Activity|leisure activity
5352365|NCT01938248|Pacemaker, Artificial|pacemaker, artificial
5352366|NCT01938248|Defibrillators, Implantable|defibrillators, implantable
5352367|NCT01938248|Atrial Fibrillation|atrial fibrillation
5352368|NCT01938248|Stroke Risk|stroke risk
5352369|NCT01938235|Myocardial infarction|myocardial infarction
5352370|NCT01938235|Percutaneous coronary intervention|percutaneous coronary intervention
5352371|NCT01938235|Reperfusion injury|reperfusion injury
5352372|NCT01938235|Exenatide|exenatide
5352373|NCT01938235|Magnetic resonance imaging|magnetic resonance imaging
5352374|NCT01938222|abdominal wall closure|abdominal wall closure
5352375|NCT01938222|short stitch technique|short stitch technique
5352380|NCT01938183|metronidazole|metronidazole
5247350|NCT02461446|Macrocephaly|macrocephaly
5352381|NCT01938157|High Risk of Breast Cancer|high risk of breast cancer
5352382|NCT01938157|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5352383|NCT01938144|Common cold|common cold
5352384|NCT01938144|efficacy|efficacy
5352385|NCT01938144|symptoms|symptoms
5352386|NCT01938144|Wisconsin Upper Respiratory Symptom Survey - 21|wisconsin upper respiratory symptom survey - 21
5352387|NCT01938144|ibuprofen|ibuprofen
5963856|NCT04191135|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
5963857|NCT04191135|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
5963858|NCT04191135|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
5963859|NCT04191096|Programmed Cell Death-1 (PD1, PD-1),|programmed cell death-1 (pd1, pd-1),
5963860|NCT04191096|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5963861|NCT04190680|Nutrition|nutrition
5963862|NCT04190680|Fruit and vegetables|fruit and vegetables
5963863|NCT04190680|School|school
5963864|NCT04190680|Children|children
5963865|NCT04190680|Prevention|prevention
5963866|NCT04190030|Mindfulness|mindfulness
5963867|NCT04189614|Non-small Cell Lung Cancer (NCSLC)|non-small cell lung cancer (ncslc)
5963868|NCT04189614|PTK7-Expressing Tumor|ptk7-expressing tumor
5963869|NCT04189614|Antibody Drug Conjugate|antibody drug conjugate
5963870|NCT04189614|Cofetuzumab Pelidotin|cofetuzumab pelidotin
5963871|NCT04189614|ABBV-647|abbv-647
5963872|NCT04189614|Cancer|cancer
5963873|NCT04189172|duraplasty|duraplasty
5963874|NCT04189172|dural substitute|dural substitute
5963875|NCT04189172|synthetic graft|synthetic graft
5963876|NCT04189172|Neuro-Patch®|neuro-patch®
5963877|NCT04188652|Ultrasound in accordance to IOTA|ultrasound in accordance to iota
5352388|NCT01938144|phenylephrine|phenylephrine
5352389|NCT01938144|pseudoephedrine|pseudoephedrine
5352390|NCT01938131|knee, osteoarthritis, muscle vibration|knee, osteoarthritis, muscle vibration
5352391|NCT01938118|Infant diet|infant diet
5352392|NCT01938118|Family diet|family diet
5352393|NCT01938118|Responsive feeding|responsive feeding
5352394|NCT01938118|Infant temperament|infant temperament
5352395|NCT01938118|Physical activity|physical activity
5352396|NCT01938118|Television|television
5352397|NCT01938105|Cervical cancer|cervical cancer
5352398|NCT01938105|Nimotuzumab|nimotuzumab
5352399|NCT01938105|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5352400|NCT01938105|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5352401|NCT01938092|High-tone pelvic floor dysfunction|high-tone pelvic floor dysfunction
5352402|NCT01938092|Spasm|spasm
5352403|NCT01938092|Pelvic pain|pelvic pain
5352404|NCT01938092|Diazepam|diazepam
5352405|NCT01938092|Female|female
5352406|NCT01938092|Randomized trial|randomized trial
5352407|NCT01938079|ECMO|ecmo
5352408|NCT01938079|Ketamine|ketamine
5352409|NCT01938079|Opiates|opiates
5352414|NCT01938066|procellera|procellera
5352415|NCT01938053|STI, STD|sti, std
5352416|NCT01938040|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5352417|NCT01938027|Rectal Neoplasms|rectal neoplasms
5352418|NCT01938027|Colorectal Neoplasms|colorectal neoplasms
5352419|NCT01938027|transanal surgery|transanal surgery
5352420|NCT01938014|MPS I|mps i
5352421|NCT01938014|MPS II|mps ii
5352422|NCT01938014|MPS III|mps iii
5352423|NCT01938014|MPS VI|mps vi
5352424|NCT01938014|Krabbe disease|krabbe disease
5352425|NCT01938014|globoid cell leukodystrophy|globoid cell leukodystrophy
5352426|NCT01938014|galactosylceramide lipidosis|galactosylceramide lipidosis
5352427|NCT01938014|mucopolysaccharidoses|mucopolysaccharidoses
5352428|NCT01938014|mucopolysaccharidosis|mucopolysaccharidosis
5356898|NCT01917578|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5352429|NCT01938014|Rare Diseases Clinical Research Network|rare diseases clinical research network
5352430|NCT01938014|Lysosomal Disease Network|lysosomal disease network
5352431|NCT01938014|enzyme replacement therapy|enzyme replacement therapy
5352432|NCT01938014|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5352433|NCT01938014|telephone-based surveillance|telephone-based surveillance
5352434|NCT01938014|Hurler syndrome|hurler syndrome
5352435|NCT01938014|Hunter syndrome|hunter syndrome
5352436|NCT01938014|Scheie syndrome|scheie syndrome
5352437|NCT01938014|Hurler-Scheie syndrome|hurler-scheie syndrome
5352438|NCT01938014|Sanfilippo syndrome|sanfilippo syndrome
5352439|NCT01938014|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
5352440|NCT01938001|Non-Hodgkins Follicular lymphoma, Non-Hodgkins Marginal zone lymphoma, treatment for follicular lymphoma, treatment for Marginal zone lymphoma|non-hodgkins follicular lymphoma, non-hodgkins marginal zone lymphoma, treatment for follicular lymphoma, treatment for marginal zone lymphoma
5352441|NCT01937988|Doula|doula
5352442|NCT01937988|Abortion|abortion
5352443|NCT01937988|Pain|pain
5352444|NCT01937988|support|support
5352445|NCT01937949|Aortic aneurysm|aortic aneurysm
5352446|NCT01937936|caregiver stress|caregiver stress
5352447|NCT01937936|depression|depression
5352448|NCT01937936|quality of life|quality of life
5352449|NCT01937936|cognitive behavioral therapy|cognitive behavioral therapy
5352450|NCT01937910|neuroplastic change|neuroplastic change
5352451|NCT01937910|myelin|myelin
5352452|NCT01937897|Unilateral Massage|unilateral massage
5352453|NCT01937897|Depression|depression
5352459|NCT01937819|BOWEL PREPARATION|bowel preparation
5352460|NCT01937819|SMARTPHONE APPLICATION|smartphone application
5352461|NCT01937806|Chronic hepatitis B|chronic hepatitis b
5352462|NCT01937793|radiation|radiation
5352463|NCT01937793|speech-language pathology|speech-language pathology
5352464|NCT01937754|Prehypertension|prehypertension
5352465|NCT01937754|Nitric Oxide|nitric oxide
5352466|NCT01937754|Blood Pressure|blood pressure
5352467|NCT01937754|Functional Capacity|functional capacity
5352468|NCT01937754|Quality of Life|quality of life
5352469|NCT01937728|Hepatitis C|hepatitis c
5352470|NCT01937728|Genotype 1|genotype 1
5352471|NCT01937728|Peg interferon|peg interferon
5352473|NCT01937728|Ribavirin|ribavirin
5352474|NCT01937689|Breast cancer|breast cancer
5352475|NCT01937689|advanced|advanced
5352476|NCT01937689|Pyrotinib|pyrotinib
5352477|NCT01937689|Phase I|phase i
5352478|NCT01937689|HER2 positive advanced breast cancer|her2 positive advanced breast cancer
5352479|NCT01937663|Chronic Constipation|chronic constipation
5352480|NCT01937663|Constipation|constipation
5352481|NCT01937663|Functional gastrointestinal disorders|functional gastrointestinal disorders
5352482|NCT01937650|Radiotherapy, metronidazole, cervical cancer, Mulago|radiotherapy, metronidazole, cervical cancer, mulago
5352483|NCT01937637|Cognitive Behavioral Intervention for Breathlessness|cognitive behavioral intervention for breathlessness
5352484|NCT01937624|Diagnostic ultrasound|diagnostic ultrasound
5352485|NCT01937611|dexmedetomidine|dexmedetomidine
5963878|NCT04188652|Symptoms and healthdata in women with ovarian cysts|symptoms and healthdata in women with ovarian cysts
5963879|NCT04188652|HE4 measured in women with ovarian cysts|he4 measured in women with ovarian cysts
5963880|NCT04188392|Post-traumatic Stress Disorder|post-traumatic stress disorder
5963881|NCT04188392|Insomnia|insomnia
5352486|NCT01937611|intramuscular premedication|intramuscular premedication
5352487|NCT01937611|bradycardiac|bradycardiac
5352488|NCT01937598|Incretin, DPP-4 inhibitor|incretin, dpp-4 inhibitor
5352489|NCT01937585|prostate cancer|prostate cancer
5352490|NCT01937585|partner|partner
5352491|NCT01937585|communication messages|communication messages
5352492|NCT01937585|monitoring style|monitoring style
5352493|NCT01937585|AA men|aa men
5352494|NCT01937572|Total knee arthroplasty (TKA)|total knee arthroplasty (tka)
5352495|NCT01937572|Computer aided systems|computer aided systems
5352496|NCT01937559|tranexaminic acid (TXA)|tranexaminic acid (txa)
5352497|NCT01937546|Anal Canal/injuries|anal canal/injuries
5352498|NCT01937546|Delivery, Obstetric/methods|delivery, obstetric/methods
5352499|NCT01937546|Labour Stage, Second|labour stage, second
5352500|NCT01937546|Lacerations/prevention & control|lacerations/prevention & control
5352501|NCT01937546|Obstetric Labour Complications/prevention & control|obstetric labour complications/prevention & control
5352502|NCT01937546|perineum/injuries|perineum/injuries
5352503|NCT01937533|Magnetic Resonance Imaging|magnetic resonance imaging
5352504|NCT01937520|acupuncture|acupuncture
5352505|NCT01937520|inflammation|inflammation
5352506|NCT01937520|thyroid|thyroid
5352507|NCT01937520|parathyroid|parathyroid
5352508|NCT01937494|asthma|asthma
5352509|NCT01937494|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5352510|NCT01937494|histamine challenge test|histamine challenge test
5352511|NCT01937494|spirometry|spirometry
5352512|NCT01937481|Child, Preschool|child, preschool
5352514|NCT01937481|Family|family
5352515|NCT01937481|Obesity|obesity
5352516|NCT01937481|Overweight|overweight
5352517|NCT01937481|Diet|diet
5352518|NCT01937481|Overnutrition|overnutrition
5352519|NCT01937481|Motor Activity|motor activity
5352520|NCT01937481|Child Care|child care
5352521|NCT01937481|Schools|schools
5352522|NCT01937468|Chronic GVHD|chronic gvhd
5352523|NCT01937468|Chronic graft versus host disease|chronic graft versus host disease
5352524|NCT01937468|Allogeneic stem cell transplant|allogeneic stem cell transplant
5352526|NCT01937455|AIDS|aids
5352527|NCT01937455|HIV vaccine|hiv vaccine
5352528|NCT01937455|HIV prevention|hiv prevention
5352529|NCT01937455|AAV|aav
5352530|NCT01937455|PG9|pg9
5352531|NCT01937442|Multiple myeloma|multiple myeloma
5352532|NCT01937442|Pharmacokinetics|pharmacokinetics
5352533|NCT01937442|Thalidomide|thalidomide
5352534|NCT01937429|Colonoscopy - Chromoendoscopy - Indigo Carmin® - Adenoma detection - Tepid water|colonoscopy - chromoendoscopy - indigo carmin® - adenoma detection - tepid water
5352535|NCT01937403|Physical Therapy|physical therapy
5352536|NCT01937403|Return to sport|return to sport
5352537|NCT01937351|Atherectomy|atherectomy
5352538|NCT01937351|Optical Coherence Tomography|optical coherence tomography
5352539|NCT01937351|Lumivascular|lumivascular
5352540|NCT01937338|Healthy volunteers, Phase 1|healthy volunteers, phase 1
5352541|NCT01937325|Eligible CF patients with G551D gene mutation|eligible cf patients with g551d gene mutation
5352542|NCT01937312|glaucoma|glaucoma
5352543|NCT01937312|prostaglandin analogue|prostaglandin analogue
5352544|NCT01937312|brinzolamide|brinzolamide
5352545|NCT01937312|brimonidine|brimonidine
5352546|NCT01937299|glaucoma|glaucoma
5352547|NCT01937299|prostaglandin analogue|prostaglandin analogue
5352548|NCT01937299|brinzolamide|brinzolamide
5352549|NCT01937299|brimonidine|brimonidine
5247587|NCT02460237|HPV|hpv
5352550|NCT01937286|LDLT,HCC, Microvascular invasion|ldlt,hcc, microvascular invasion
5352551|NCT01937273|Nutritional status, malnutrition, chemo-radiotherapy|nutritional status, malnutrition, chemo-radiotherapy
5352552|NCT01937247|Operative Time|operative time
5352553|NCT01937247|Operating Rooms|operating rooms
5352554|NCT01937247|Efficiency|efficiency
5352555|NCT01937221|mild cognitive impairment|mild cognitive impairment
5352556|NCT01937221|mild to moderate cognitive impairment|mild to moderate cognitive impairment
5352563|NCT01937195|IV Catheter User Preference Comparison|iv catheter user preference comparison
5352564|NCT01937195|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
5352565|NCT01937195|AccuCath Device Performance|accucath device performance
5352566|NCT01937195|Complication Rates for IV Catheters|complication rates for iv catheters
5352567|NCT01937195|Average Dwell Time for IV Catheters|average dwell time for iv catheters
5352568|NCT01937195|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
5352569|NCT01937195|Clinician Satisfaction with AccuCath Device Performance|clinician satisfaction with accucath device performance
5352570|NCT01937182|Stroke|stroke
5352571|NCT01937182|SSRI (Selective Serotonin Reuptake Inhibitors)|ssri (selective serotonin reuptake inhibitors)
5352572|NCT01937182|Serotonin|serotonin
5352573|NCT01937182|5-HT (5-Hydroxytryptamine)|5-ht (5-hydroxytryptamine)
5352574|NCT01937182|Neuroprotection|neuroprotection
5352575|NCT01937182|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5352577|NCT01937182|CT (computerized tomography)|ct (computerized tomography)
5352578|NCT01937182|Post Stroke Depression|post stroke depression
5352579|NCT01937143|parent education|parent education
5352580|NCT01937143|immunization|immunization
5352581|NCT01937143|vaccination|vaccination
5352582|NCT01937143|infant|infant
5352583|NCT01937143|pain management|pain management
5963882|NCT04187937|Image-Guidance|image-guidance
5963883|NCT04187937|Liver Neoplasm|liver neoplasm
5352584|NCT01937130|Liver Failure|liver failure
5352585|NCT01937130|Cirrhosis|cirrhosis
5352586|NCT01937130|Alcoholic Hepatitis|alcoholic hepatitis
5352587|NCT01937117|Breast cancer|breast cancer
5352588|NCT01937117|Preoperative treatment|preoperative treatment
5352589|NCT01937117|Neoadjuvant treatment|neoadjuvant treatment
5352590|NCT01937104|Intracranial pressure|intracranial pressure
5352591|NCT01937104|Laparoscopy|laparoscopy
5352592|NCT01937104|Optic nerve sheath diameter|optic nerve sheath diameter
5352593|NCT01937104|Position|position
5352595|NCT01937091|clinical trials|clinical trials
5352596|NCT01937013|Frontotemporal Dementia|frontotemporal dementia
5352598|NCT01937013|oxytocin|oxytocin
5352599|NCT01937013|fMRI|fmri
5352600|NCT01936961|Cancer|cancer
5352601|NCT01936948|Large colon polyps|large colon polyps
5352602|NCT01936948|Polyp resection|polyp resection
5352603|NCT01936948|Colon cancer screening|colon cancer screening
5352604|NCT01936948|Colonoscopy|colonoscopy
5352605|NCT01936948|Endoscopic mucosal resection|endoscopic mucosal resection
5352606|NCT01936935|Insulin sensitivity|insulin sensitivity
5352607|NCT01936922|Fall accidents|fall accidents
5352608|NCT01936922|Gait|gait
5352609|NCT01936922|Balance|balance
5352610|NCT01936922|Fear of falling|fear of falling
5352611|NCT01936922|Virtual reality|virtual reality
5352612|NCT01936896|Acute myocardial infarction|acute myocardial infarction
5352613|NCT01936896|Heart Failure|heart failure
5352614|NCT01936896|Inflammation|inflammation
5352615|NCT01936883|prostatic neoplasm|prostatic neoplasm
5352616|NCT01936883|brachytherapy|brachytherapy
5352617|NCT01936883|quality of life|quality of life
5352618|NCT01936883|high dose rate|high dose rate
5352619|NCT01936883|low dose rate|low dose rate
5352620|NCT01936870|Toviaz|toviaz
5352621|NCT01936870|Fesoterodine|fesoterodine
5352622|NCT01936870|Post marketing surveillance|post marketing surveillance
5352623|NCT01936870|Japanese|japanese
5352624|NCT01936870|Overactive Bladder|overactive bladder
5352625|NCT01936870|OAB|oab
5352626|NCT01936870|Good post marketing practice|good post marketing practice
5352627|NCT01936870|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5352628|NCT01936792|Concussion|concussion
5352629|NCT01936792|Mild Traumatic Brain Injury|mild traumatic brain injury
5352630|NCT01936792|Traumatic Brain Injury|traumatic brain injury
5352631|NCT01936779|plasma triglycerides|plasma triglycerides
5352632|NCT01936779|dietary fat|dietary fat
5352633|NCT01936779|liver fat metabolism|liver fat metabolism
5352634|NCT01936779|human|human
5352635|NCT01936766|malaria, falciparum|malaria, falciparum
5352636|NCT01936766|sepsis|sepsis
5352637|NCT01936766|fluid therapy|fluid therapy
5352638|NCT01936766|thermodilution|thermodilution
5352639|NCT01936766|extravascular lung water|extravascular lung water
5352640|NCT01936766|acute kidney injury|acute kidney injury
5352641|NCT01936753|PMTCT|pmtct
5352642|NCT01936753|HIV|hiv
5352643|NCT01936753|Mentor Mothers|mentor mothers
5352644|NCT01936753|Nigeria|nigeria
5352645|NCT01936753|Retention|retention
5352646|NCT01936753|Adherence|adherence
5352647|NCT01936740|Efficacy and Safety|efficacy and safety
5352648|NCT01936727|efficiency and safety|efficiency and safety
5352649|NCT01936714|Efficacy and Safety|efficacy and safety
5352650|NCT01936675|Coronary Artery Disease|coronary artery disease
5247671|NCT02459691|latinos|latinos
5352651|NCT01936675|Myocardial Infarction|myocardial infarction
5352652|NCT01936675|Genomic Risk Communication|genomic risk communication
5352653|NCT01936675|Risk Stratification|risk stratification
5352654|NCT01936662|Airway management comparison|airway management comparison
5352655|NCT01936649|Nuclear imaging|nuclear imaging
5352656|NCT01936649|Radiopharmaceutical|radiopharmaceutical
5352657|NCT01936649|Iobenguane|iobenguane
5352658|NCT01936649|I-123|i-123
5352659|NCT01936649|reproducibility|reproducibility
5352660|NCT01936649|Quantitative measurements|quantitative measurements
5352661|NCT01936649|myocardial uptake|myocardial uptake
5352662|NCT01936649|SPECT imaging|spect imaging
5352663|NCT01936649|planar imaging|planar imaging
5352664|NCT01936649|AdreView™|adreview™
5352665|NCT01936636|Breakthrough cancer pain|breakthrough cancer pain
5352666|NCT01936636|diary|diary
5352667|NCT01936636|quality of life|quality of life
5352668|NCT01936636|Abstral|abstral
5352669|NCT01936636|BTcP|btcp
5352670|NCT01936623|brief intervention|brief intervention
5352671|NCT01936623|computerized brief intervention|computerized brief intervention
5352672|NCT01936610|Lecture|lecture
5352673|NCT01936610|Role-playing|role-playing
5352674|NCT01936610|Knowledge|knowledge
5352675|NCT01936610|Attitude|attitude
5352676|NCT01936610|Decision making|decision making
5352677|NCT01936610|Type of delivery|type of delivery
5352678|NCT01936597|external cardiac massage, medical hotline,|external cardiac massage, medical hotline,
5963884|NCT04186845|Recurrent Prostate Cancer|recurrent prostate cancer
5963885|NCT04186845|Diagnostic|diagnostic
5963886|NCT04186845|Prostate Specific Membrane Antigen (PSMA)|prostate specific membrane antigen (psma)
5963887|NCT04186845|Positron Emission Tomography (PET) Scan|positron emission tomography (pet) scan
5352679|NCT01936545|Liver transplantation, reactive oxygen species, antioxidant|liver transplantation, reactive oxygen species, antioxidant
5352681|NCT01936519|Everolimus|everolimus
5352683|NCT01936519|Renal Function|renal function
5352684|NCT01936519|Tacrolimus|tacrolimus
5352685|NCT01936519|Cyclosporine|cyclosporine
5352686|NCT01936519|Myfortic|myfortic
5352687|NCT01936519|Mycophenolic Acid|mycophenolic acid
5352688|NCT01936519|Liver Transplantation|liver transplantation
5352689|NCT01936506|Cognitive training|cognitive training
5352690|NCT01936506|Depression|depression
5352691|NCT01936493|Uterine leiomyomas (fibroids or myomas)|uterine leiomyomas (fibroids or myomas)
5352692|NCT01936493|Uterine fibroids|uterine fibroids
5352693|NCT01936493|Fibroids|fibroids
5352694|NCT01936493|Uterine leiomyomas|uterine leiomyomas
5352695|NCT01936467|Pancreatic solid lesions|pancreatic solid lesions
5352696|NCT01936467|Pancreatic mass|pancreatic mass
5352697|NCT01936467|Pancreatic cancer|pancreatic cancer
5352998|NCT01935063|Vulvodynia|vulvodynia
5352698|NCT01936467|Endoscopic Ultrasound|endoscopic ultrasound
5352700|NCT01936467|Fine needle aspiration|fine needle aspiration
5352702|NCT01936467|EUS-FNA|eus-fna
5352703|NCT01936441|Menopause|menopause
5352704|NCT01936441|Vasomotor|vasomotor
5352705|NCT01936441|Symptoms|symptoms
5352706|NCT01936441|Sleep|sleep
5352707|NCT01936441|Cognitive Behavioral Therapy|cognitive behavioral therapy
5352708|NCT01936415|Knee prosthesis|knee prosthesis
5352709|NCT01936402|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5352710|NCT01936376|kidney safety|kidney safety
5352711|NCT01936376|biomarkers|biomarkers
5352712|NCT01936376|serum creatinine|serum creatinine
5352713|NCT01936376|BUN|bun
5352714|NCT01936376|cystic fibrosis|cystic fibrosis
5352715|NCT01936376|head and neck cancer|head and neck cancer
5352716|NCT01936376|renal injury|renal injury
5352717|NCT01936376|drug induced acute kidney injury|drug induced acute kidney injury
5352718|NCT01936376|aminoglycoside|aminoglycoside
5352719|NCT01936376|cisplatin|cisplatin
5352720|NCT01936376|nephrotoxicity|nephrotoxicity
5352721|NCT01936376|biomarker qualification|biomarker qualification
5352722|NCT01936363|Ovarian Cancer|ovarian cancer
5352723|NCT01936363|Pimasertib|pimasertib
5352724|NCT01936363|Placebo|placebo
5352725|NCT01936363|SAR245409|sar245409
5352726|NCT01936350|Heart failure|heart failure
5352727|NCT01936324|acne vulgaris|acne vulgaris
5352728|NCT01936311|Health Behavior|health behavior
5352729|NCT01936311|Behavior change|behavior change
5352730|NCT01936311|self-management goal|self-management goal
5352731|NCT01936311|health goal|health goal
5352732|NCT01936298|Hand Edema|hand edema
5352733|NCT01936298|Exercise Therapy|exercise therapy
5352734|NCT01936259|Shoulder|shoulder
5352735|NCT01936259|Joint|joint
5352736|NCT01936259|Osteoarthritis|osteoarthritis
5352737|NCT01936233|Hepatocellular Carcinoma|hepatocellular carcinoma
5352738|NCT01936233|Aspirin|aspirin
5352739|NCT01936233|antiviral treatment|antiviral treatment
5352740|NCT01936233|recurrence free survival|recurrence free survival
5352741|NCT01936233|radical therapy|radical therapy
5352742|NCT01936220|Schizophrenia|schizophrenia
5352743|NCT01936220|First-psychotic episode|first-psychotic episode
5352744|NCT01936220|Initial phase|initial phase
5352745|NCT01936220|Relapse prevention|relapse prevention
5352746|NCT01936220|Specialized treatment|specialized treatment
5352747|NCT01936220|Parent groups|parent groups
5352748|NCT01936220|Social functioning|social functioning
5352749|NCT01936207|acute|acute
5352750|NCT01936207|respiratory|respiratory
5352752|NCT01936207|prognosis|prognosis
5352753|NCT01936207|outcome research|outcome research
5352754|NCT01936207|respiratory infection|respiratory infection
5352755|NCT01936207|sepsis|sepsis
5352756|NCT01936207|organ failure|organ failure
5352757|NCT01936181|Rheumatoid Arthritis|rheumatoid arthritis
5352758|NCT01936181|Infliximab|infliximab
5352759|NCT01936181|Biosimilar|biosimilar
5352760|NCT01936168|GSV|gsv
5352761|NCT01936168|Primary Varicose Veins|primary varicose veins
5352762|NCT01936168|Great Saphenous Vein|great saphenous vein
5352763|NCT01936168|Treatment|treatment
5352764|NCT01936155|Joint Mobility|joint mobility
5352765|NCT01936155|Skin Tissue Oxygenation|skin tissue oxygenation
5352766|NCT01936155|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5352767|NCT01936155|Goniometry|goniometry
5352768|NCT01936155|Transcutaneous Oxygen Measurements (tcpO2)|transcutaneous oxygen measurements (tcpo2)
5352769|NCT01936155|Water Displacement|water displacement
5352770|NCT01936142|Resynchroniztion therapy|resynchroniztion therapy
5352771|NCT01936142|Kidney|kidney
5352772|NCT01936142|Contrast media|contrast media
5352773|NCT01936142|Prevention|prevention
5352774|NCT01936116|Sonohysterography|sonohysterography
5352775|NCT01936116|catheter placement|catheter placement
5352776|NCT01936116|pain magnitude|pain magnitude
5352777|NCT01936116|vasovagal reaction|vasovagal reaction
5348711|NCT01955070|Ethics|ethics
5963888|NCT04186819|Primary Prostate Cancer|primary prostate cancer
5963889|NCT04186819|Diagnostic|diagnostic
5963890|NCT04186819|Prostate Specific Membrane Antigen (PSMA)|prostate specific membrane antigen (psma)
5352778|NCT01936103|Acute anterior myocardial infarction|acute anterior myocardial infarction
5352779|NCT01936103|Percutaneous coronary stent implantation|percutaneous coronary stent implantation
5352780|NCT01936103|Intensive statin therapy|intensive statin therapy
5352781|NCT01936103|Left ventricular function|left ventricular function
5352782|NCT01936077|Infertility, IVF, ovarian stimulation, rec LH, GnRH antagonist|infertility, ivf, ovarian stimulation, rec lh, gnrh antagonist
5352784|NCT01936064|Jobelyn|jobelyn
5352785|NCT01936064|Sorghum bicolor|sorghum bicolor
5352786|NCT01936038|CPAP|cpap
5352787|NCT01936038|Upper Airway Toning|upper airway toning
5352788|NCT01936038|Obstructive Sleep Apnoea|obstructive sleep apnoea
5352789|NCT01936025|Diabetes mellitus|diabetes mellitus
5352790|NCT01936012|Lisinopril|lisinopril
5352791|NCT01936012|Bioequivalence|bioequivalence
5352792|NCT01936012|Bioavailability|bioavailability
5352793|NCT01936012|Pharmacokinetic|pharmacokinetic
5352794|NCT01936012|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5352795|NCT01935999|Colostomy|colostomy
5352796|NCT01935999|peristomal skin|peristomal skin
5352797|NCT01935999|stoma|stoma
5352798|NCT01935999|pouch|pouch
5352799|NCT01935908|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5352800|NCT01935908|Seizures|seizures
5352801|NCT01935908|Prophylaxis|prophylaxis
5352802|NCT01935908|Levetiracetam|levetiracetam
5352803|NCT01935895|blood pressure reduction|blood pressure reduction
5352804|NCT01935895|vascular reactivity|vascular reactivity
5352805|NCT01935895|combined exercise session|combined exercise session
5352806|NCT01935856|patients|patients
5352807|NCT01935856|receiving|receiving
5352808|NCT01935856|hemodialysis|hemodialysis
5352809|NCT01935856|Secondary|secondary
5352810|NCT01935843|CART-HER-2|cart-her-2
5352811|NCT01935843|HER-2 positive|her-2 positive
5352812|NCT01935843|Advanced|advanced
5352813|NCT01935843|Refactory|refactory
5352814|NCT01935843|Solid tumors|solid tumors
5352815|NCT01935830|PET Imaging|pet imaging
5352816|NCT01935830|Efavirenz|efavirenz
5352817|NCT01935830|Ritonavior [11C] LAAM|ritonavior [11c] laam
5352818|NCT01935830|Healthy volunteers|healthy volunteers
5352819|NCT01935804|pioglitazone|pioglitazone
5352820|NCT01935804|metformin|metformin
5352821|NCT01935804|hyperglycemic agents|hyperglycemic agents
5352822|NCT01935804|physiological effects of drugs|physiological effects of drugs
5352823|NCT01935804|bone health|bone health
5352824|NCT01935765|Type 1 diabetes, sleep apnea, polysomnography,|type 1 diabetes, sleep apnea, polysomnography,
5352825|NCT01935765|autonomic neuropathy, intima media thickness|autonomic neuropathy, intima media thickness
5352826|NCT01935752|fibromuscular|fibromuscular
5352827|NCT01935752|dysplasia|dysplasia
5352828|NCT01935752|endothelium|endothelium
5352829|NCT01935752|microparticles|microparticles
5352830|NCT01935752|microRNA|microrna
5352831|NCT01935726|Pulmonary fibrosis|pulmonary fibrosis
5352832|NCT01935726|Interstitial lung disease|interstitial lung disease
5352833|NCT01935726|Connective tissue disease|connective tissue disease
5352834|NCT01935726|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
5352835|NCT01935726|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5352836|NCT01935700|hepatocellular carcinoma|hepatocellular carcinoma
5352837|NCT01935700|colchicine|colchicine
5352838|NCT01935687|Instrumented Wheel|instrumented wheel
5352839|NCT01935687|Manual Wheelchair|manual wheelchair
5352840|NCT01935687|Spinal Cord Injury (SCI)|spinal cord injury (sci)
5352841|NCT01935687|Manual wheelchair Users|manual wheelchair users
5352842|NCT01935687|Aged between 18-70 years|aged between 18-70 years
5352843|NCT01935674|Hypercholesterolaemia|hypercholesterolaemia
5352845|NCT01935674|Rosuvastatin|rosuvastatin
5352846|NCT01935674|Protease inhibitor switching|protease inhibitor switching
5352847|NCT01935661|Blood transfusion|blood transfusion
5352848|NCT01935661|Hemosiderosis|hemosiderosis
5352850|NCT01935648|Knee arthroplasty|knee arthroplasty
5352851|NCT01935635|CHB|chb
5352852|NCT01935635|Antiviral|antiviral
5352853|NCT01935635|Dentritic cells|dentritic cells
5352854|NCT01935635|Immune Therapy|immune therapy
5352855|NCT01935622|heart failure|heart failure
5352856|NCT01935622|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
5352857|NCT01935609|traumatic brain injury|traumatic brain injury
5352858|NCT01935609|acquired brain injury|acquired brain injury
5352859|NCT01935596|Anesthesia|anesthesia
5352860|NCT01935596|Randomized study|randomized study
5352861|NCT01935596|Lower limbs surgery|lower limbs surgery
5352862|NCT01935583|traumatic brain injury|traumatic brain injury
5352863|NCT01935570|Bioavailability of magnesium|bioavailability of magnesium
5352864|NCT01935570|Digestive and general tolerance|digestive and general tolerance
5352865|NCT01935557|Continuous heparin infusion|continuous heparin infusion
5352866|NCT01935557|Intermittent heparin infusion|intermittent heparin infusion
5352867|NCT01935557|during catheter ablation|during catheter ablation
5352868|NCT01935544|Botulinum Toxin|botulinum toxin
5352869|NCT01935544|Ultrasound-guidance|ultrasound-guidance
5352870|NCT01935544|Stroke|stroke
5963891|NCT04186819|Positron Emission Tomography (PET) Scan|positron emission tomography (pet) scan
5963892|NCT04186455|baska-mask|baska-mask
5963893|NCT04186455|proseal|proseal
5963894|NCT04186455|urs|urs
5963895|NCT04185532|ACL|acl
5963896|NCT04185532|children and adolescents|children and adolescents
5963897|NCT04185532|rebound ACL brace|rebound acl brace
5352871|NCT01935544|Spasticity|spasticity
5352872|NCT01935544|Ultrasonography|ultrasonography
5352873|NCT01935544|Hemiplegia|hemiplegia
5348810|NCT01954680|child|child
5352874|NCT01935531|actinic keratoses|actinic keratoses
5352875|NCT01935531|tumor metabolism|tumor metabolism
5352876|NCT01935531|glycolysis|glycolysis
5352877|NCT01935531|diclofenac|diclofenac
5352878|NCT01935531|warburg effect|warburg effect
5352879|NCT01935505|smoking cessation|smoking cessation
5352880|NCT01935505|intervention model|intervention model
5352882|NCT01935505|quitting rate|quitting rate
5352883|NCT01935492|metastatic breast cancer|metastatic breast cancer
5352884|NCT01935492|HER2/neu negative|her2/neu negative
5352885|NCT01935492|paclitaxel|paclitaxel
5352886|NCT01935492|bevacizumab|bevacizumab
5352887|NCT01935492|liposomal doxorubicine|liposomal doxorubicine
5352888|NCT01935492|capecitabine|capecitabine
5352889|NCT01935479|AK159, teriparatide acetate|ak159, teriparatide acetate
5352890|NCT01935466|Pioglitazone|pioglitazone
5352891|NCT01935466|Bladder cancer|bladder cancer
5352892|NCT01935466|Type 2 Diabetes|type 2 diabetes
5352893|NCT01935440|HIV, drug use|hiv, drug use
5352894|NCT01935427|Pulse Oximeter|pulse oximeter
5352895|NCT01935427|Stroke Volume|stroke volume
5352896|NCT01935427|Hemorrhagic shock|hemorrhagic shock
5353397|NCT01933334|scleroderma|scleroderma
5352897|NCT01935427|Compensatory Reserve Index|compensatory reserve index
5352898|NCT01935401|Bulimia Nervosa|bulimia nervosa
5352899|NCT01935401|Bulimia|bulimia
5352900|NCT01935401|Response Inhibition|response inhibition
5352901|NCT01935401|fNIR|fnir
5352902|NCT01935401|Neuroimaging|neuroimaging
5352903|NCT01935388|Mechanical ventilation|mechanical ventilation
5352904|NCT01935388|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5352905|NCT01935388|asthma|asthma
5352906|NCT01935388|common canister|common canister
5352907|NCT01935388|MDI|mdi
5352908|NCT01935388|ventilator associated pneumonia|ventilator associated pneumonia
5352909|NCT01935375|Postpartum Depression|postpartum depression
5352910|NCT01935375|Nurse Midwife|nurse midwife
5352911|NCT01935375|Interpersonal Psychotherapy|interpersonal psychotherapy
5352912|NCT01935362|Flavanones|flavanones
5352913|NCT01935362|Bioavailability|bioavailability
5352914|NCT01935362|Blood vessel health|blood vessel health
5352915|NCT01935362|Blood glucose|blood glucose
5352916|NCT01935349|Diabetes mellitus (DM)|diabetes mellitus (dm)
5352917|NCT01935349|hypertension (HT)|hypertension (ht)
5352918|NCT01935349|Hong Kong|hong kong
5352919|NCT01935336|Lung Cancer|lung cancer
5352920|NCT01935336|Malignancy|malignancy
5352921|NCT01935336|Predictive biomarkers|predictive biomarkers
5352922|NCT01935323|high intensity interval training|high intensity interval training
5352923|NCT01935323|aerobic exercise|aerobic exercise
5352924|NCT01935323|insulin sensitivity|insulin sensitivity
5352926|NCT01935323|cardiovascular fitness|cardiovascular fitness
5352927|NCT01935310|Photoaging|photoaging
5352928|NCT01935310|imiquimod|imiquimod
5352929|NCT01935310|wrinkles|wrinkles
5352930|NCT01935310|elastosis|elastosis
5352931|NCT01935271|immunosenescence|immunosenescence
5352932|NCT01935271|sarcopenia|sarcopenia
5352933|NCT01935258|Medically unexplained symptoms|medically unexplained symptoms
5352934|NCT01935258|Somatization|somatization
5352935|NCT01935258|Psychosomatic therapy|psychosomatic therapy
5352936|NCT01935245|Coronary artery bypass grafting|coronary artery bypass grafting
5352937|NCT01935245|Extracorporeal circulation|extracorporeal circulation
5352938|NCT01935245|Minimal extracorporeal circulation|minimal extracorporeal circulation
5352939|NCT01935245|Coagulopathy|coagulopathy
5352940|NCT01935245|Thrombocytopathy|thrombocytopathy
5352941|NCT01935245|Platelet dysfunction|platelet dysfunction
5352942|NCT01935232|Osteoporosis, diagnostics, ultrasound|osteoporosis, diagnostics, ultrasound
5352943|NCT01935219|mild cognitive impairment|mild cognitive impairment
5352944|NCT01935219|seniors|seniors
5352945|NCT01935219|cognitive training|cognitive training
5352946|NCT01935219|driving|driving
5352947|NCT01935219|driving simulation|driving simulation
5352948|NCT01935219|intervention|intervention
5352949|NCT01935219|goal management training|goal management training
5352950|NCT01935219|process speed training|process speed training
5352951|NCT01935206|secondary hyperalgesia|secondary hyperalgesia
5352952|NCT01935206|allodynia|allodynia
5352953|NCT01935206|mechanical pain threshold|mechanical pain threshold
5352954|NCT01935206|naloxone|naloxone
5352955|NCT01935206|endogenous opioids|endogenous opioids
5352956|NCT01935206|pain|pain
5352957|NCT01935193|platelets aggregation|platelets aggregation
5352958|NCT01935193|asa resistance|asa resistance
5352959|NCT01935180|colon polyps|colon polyps
5352960|NCT01935180|adenoma resection|adenoma resection
5352961|NCT01935180|colon cancer screening|colon cancer screening
5352962|NCT01935180|colonoscopy|colonoscopy
5352963|NCT01935180|polyp detection|polyp detection
5352964|NCT01935167|Microalbuminuria|microalbuminuria
5352965|NCT01935154|NSCLC|nsclc
5352966|NCT01935154|Vaccine|vaccine
5352967|NCT01935141|Pulmonary Embolus|pulmonary embolus
5352968|NCT01935141|Radio Contrast Material|radio contrast material
5352969|NCT01935141|Computed Tomography|computed tomography
5352970|NCT01935128|Renal Transplant|renal transplant
5352971|NCT01935128|Immunosuppression|immunosuppression
5352972|NCT01935128|Steroid Avoidance|steroid avoidance
5352973|NCT01935128|Calcineurin Avoidance|calcineurin avoidance
5352974|NCT01935128|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5352976|NCT01935115|Depression|depression
5352977|NCT01935115|MDD|mdd
5352978|NCT01935115|Treatment Resistant Depression|treatment resistant depression
5352979|NCT01935115|Electroconvulsive Therapy|electroconvulsive therapy
5352980|NCT01935115|ECT|ect
5352981|NCT01935115|Ketamine|ketamine
5352982|NCT01935115|Propofol|propofol
5352983|NCT01935115|NMDA|nmda
5352984|NCT01935102|metastatic breast cancer|metastatic breast cancer
5352985|NCT01935102|bevacizumab|bevacizumab
5352986|NCT01935102|single nucleotide polymorphism|single nucleotide polymorphism
5352987|NCT01935102|VEGF-A|vegf-a
5352988|NCT01935102|VEGFR-2|vegfr-2
5352989|NCT01935102|IL-8|il-8
5352990|NCT01935089|HIV-1|hiv-1
5352991|NCT01935089|Interferon alpha|interferon alpha
5352992|NCT01935089|Integrated DNA|integrated dna
5352993|NCT01935089|Latent reservoir|latent reservoir
5352994|NCT01935076|Maternal obesity|maternal obesity
5352995|NCT01935076|Macrosomic|macrosomic
5352996|NCT01935076|miRNA|mirna
5352997|NCT01935076|Fetal overgrowth|fetal overgrowth
5352999|NCT01935063|Provoked vestibulodynia|provoked vestibulodynia
5353000|NCT01935063|Vulvar pain|vulvar pain
5353001|NCT01935063|Dyspareunia|dyspareunia
5353002|NCT01935063|Couples therapy|couples therapy
5353003|NCT01935063|Lidocaine|lidocaine
5353004|NCT01935063|Cognitive behavioral couple therapy|cognitive behavioral couple therapy
5353005|NCT01935063|Cognitive behavioral therapy|cognitive behavioral therapy
5353006|NCT01935063|Pain|pain
5353007|NCT01935063|Pain during sexual intercourse|pain during sexual intercourse
5353008|NCT01935050|Depression|depression
5353009|NCT01935050|Parkinson's disease|parkinson's disease
5353010|NCT01935050|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
5353011|NCT01935024|Alzheimer's disease|alzheimer's disease
5353012|NCT01935024|dementia|dementia
5353013|NCT01935024|aerobic exercise|aerobic exercise
5353014|NCT01934998|SCA6, parkinsonism, Datscan|sca6, parkinsonism, datscan
5353015|NCT01934985|Single-Photon Emission-Computed Tomography|single-photon emission-computed tomography
5353016|NCT01934985|Myocardial Perfusion Imaging|myocardial perfusion imaging
5353017|NCT01934985|Ischemia|ischemia
5353018|NCT01934985|Stress test|stress test
5353019|NCT01934985|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5353020|NCT01934985|Coronary Flow Reserve (CFR)|coronary flow reserve (cfr)
5353021|NCT01934985|Coronary Angiography|coronary angiography
5353022|NCT01934972|Bipolar disorder|bipolar disorder
5353023|NCT01934946|hip fracture|hip fracture
5353024|NCT01934933|inflammation|inflammation
5353025|NCT01934933|etanercept|etanercept
5353026|NCT01934933|celecoxib|celecoxib
5353027|NCT01934933|ankylsoing spondylitis|ankylsoing spondylitis
5353028|NCT01934894|HER2-positive breast cancer|her2-positive breast cancer
5353029|NCT01934894|intracranial metastases|intracranial metastases
5353030|NCT01934894|lapatinib|lapatinib
5353031|NCT01934894|cabazitaxel|cabazitaxel
5353032|NCT01934868|low back pain|low back pain
5353033|NCT01934868|sciatica|sciatica
5353034|NCT01934868|spinal stenosis|spinal stenosis
5353035|NCT01934868|epidural injections|epidural injections
5353036|NCT01934868|prolotherapy|prolotherapy
5353037|NCT01934868|sacroiliac pain or dysfunction.|sacroiliac pain or dysfunction.
5353038|NCT01934855|cancer|cancer
5353039|NCT01934855|radiotherapy|radiotherapy
5353040|NCT01934855|4D-MRI|4d-mri
5353041|NCT01934855|4D-CT|4d-ct
5353042|NCT01934855|MRI|mri
5353043|NCT01934816|Incretins, KATP channels, intradermal injection|incretins, katp channels, intradermal injection
5353044|NCT01934803|Alcohol Use|alcohol use
5353045|NCT01934803|Microbial Translocation|microbial translocation
5353046|NCT01934803|Inflammation|inflammation
5353047|NCT01934803|Altered Coagulation|altered coagulation
5353048|NCT01934803|Russia|russia
5353049|NCT01934803|Zinc|zinc
5353050|NCT01934803|AMI|ami
5353051|NCT01934803|VACS index|vacs index
5353052|NCT01934803|Reynolds risk score|reynolds risk score
5353053|NCT01934777|NAFLD|nafld
5353054|NCT01934777|NASH|nash
5353055|NCT01934777|fibrosis|fibrosis
5353056|NCT01934738|Multiple dose|multiple dose
5353057|NCT01934738|safety|safety
5353058|NCT01934738|tolerability|tolerability
5353059|NCT01934738|PK|pk
5353060|NCT01934725|Ischemic Stroke|ischemic stroke
5353061|NCT01934725|Brain Infarction|brain infarction
5353062|NCT01934725|Patent Foramen Ovale|patent foramen ovale
5963898|NCT04185220|Antibody-Dependent Cell Cytotoxicity (ADCC)|antibody-dependent cell cytotoxicity (adcc)
5963899|NCT04185220|CCR4|ccr4
5963900|NCT04185220|Monoclonal Antibodies|monoclonal antibodies
5963901|NCT04185038|CNS, CAR T cell, B7-H3, pediatric, young adult, brain tumor, DIPG, DMG|cns, car t cell, b7-h3, pediatric, young adult, brain tumor, dipg, dmg
5963902|NCT04184882|tolerability|tolerability
5963903|NCT04184882|ASP0367|asp0367
5963904|NCT04184882|MA-0211|ma-0211
5963905|NCT04184882|safety|safety
5963906|NCT04184804|organic|organic
5963907|NCT04184804|children|children
5963908|NCT04184804|school|school
5963909|NCT04184804|health promotion|health promotion
5353063|NCT01934725|Stroke in the Young|stroke in the young
5353064|NCT01934725|Myocardial Infarction|myocardial infarction
5353065|NCT01934725|Cerebral Venous Thrombosis|cerebral venous thrombosis
5353066|NCT01934725|Pulmonary Embolism|pulmonary embolism
5353067|NCT01934725|Deep Vein Thrombosis|deep vein thrombosis
5353068|NCT01934725|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5353069|NCT01934725|Prognosis|prognosis
5353070|NCT01934725|Databases, Genetic|databases, genetic
5353071|NCT01934699|Coronary stenosis|coronary stenosis
5353072|NCT01934699|Angina pectoris|angina pectoris
5353073|NCT01934699|Left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
5353074|NCT01934699|2D-Strain|2d-strain
5353075|NCT01934660|Cardiovascular Disease|cardiovascular disease
5353076|NCT01934660|Diabetes Mellitus|diabetes mellitus
5353078|NCT01934634|Pancreatic Cancer|pancreatic cancer
5353079|NCT01934634|Stage IV Pancreatic Cancer|stage iv pancreatic cancer
5353080|NCT01934634|Stage IV metastatic pancreatic ductal adenocarcinoma|stage iv metastatic pancreatic ductal adenocarcinoma
5353081|NCT01934621|Stroke|stroke
5353082|NCT01934621|Rehabilitation|rehabilitation
5353083|NCT01934621|Cognition|cognition
5353084|NCT01934621|Disability|disability
5353085|NCT01934595|Critically ill|critically ill
5353086|NCT01934595|Protein|protein
5353087|NCT01934595|Supplement|supplement
5353088|NCT01934595|ICU|icu
5353089|NCT01934595|Protein synthesis|protein synthesis
5353090|NCT01934530|implant complications|implant complications
5353091|NCT01934530|esthetics|esthetics
5353092|NCT01934530|soft tissue grafting|soft tissue grafting
5353093|NCT01934504|clinical tolerance|clinical tolerance
5353094|NCT01934504|biomarker(s) identification|biomarker(s) identification
5353095|NCT01934491|Cognitive training|cognitive training
5353096|NCT01934491|Depression|depression
5353097|NCT01934478|Breast|breast
5353098|NCT01934478|Cancer|cancer
5353776|NCT01931644|Hepatitis B|hepatitis b
5353099|NCT01934478|Human Epidermal Growth Factor 2 (Her2)|human epidermal growth factor 2 (her2)
5353100|NCT01934478|irradiation|irradiation
5353102|NCT01934465|Chemotherapy|chemotherapy
5353103|NCT01934465|Anti-angiogenic agent|anti-angiogenic agent
5353104|NCT01934465|Bevacizumab|bevacizumab
5353105|NCT01934465|1st Line|1st line
5353106|NCT01934452|complete remission|complete remission
5353107|NCT01934439|Stroke|stroke
5353108|NCT01934439|Rehabilitation|rehabilitation
5353109|NCT01934439|Dyssynergia|dyssynergia
5353110|NCT01934439|Robotics|robotics
5353111|NCT01934439|AMES|ames
5353112|NCT01934439|Cerebrovascular Accident|cerebrovascular accident
5353113|NCT01934426|Admission High Risk Elderly|admission high risk elderly
5353114|NCT01934413|Palliative Care|palliative care
5353115|NCT01934413|Technology|technology
5353116|NCT01934413|Rural|rural
5353117|NCT01934413|Transitional Care|transitional care
5353118|NCT01934400|Osteoporosis|osteoporosis
5353119|NCT01934400|fall prevention|fall prevention
5353120|NCT01934400|high risk population|high risk population
5353121|NCT01934387|World Health Organization Fracture Risk Assessment Tool|world health organization fracture risk assessment tool
5353122|NCT01934387|Osteoporosis|osteoporosis
5353123|NCT01934387|Aged|aged
5353125|NCT01934387|Fracture|fracture
5353126|NCT01934387|FRAX|frax
5353127|NCT01934374|task-oriented training, long-term effects, plasticity|task-oriented training, long-term effects, plasticity
5353128|NCT01934361|BKM120|bkm120
5353129|NCT01934361|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5353130|NCT01934361|rGBM|rgbm
5353131|NCT01934361|buparlisib|buparlisib
5353132|NCT01934335|breast cancer, TKI, tyrosine kinase inhibitor, vandetanib, Ki-67|breast cancer, tki, tyrosine kinase inhibitor, vandetanib, ki-67
5353133|NCT01934322|frequent users of the emergency department|frequent users of the emergency department
5353134|NCT01934322|vulnerable populations|vulnerable populations
5353135|NCT01934322|case management|case management
5353136|NCT01934322|cost savings intervention|cost savings intervention
5353137|NCT01934322|quality of life|quality of life
5353138|NCT01934322|number of emergency department visits|number of emergency department visits
5353139|NCT01934309|tuberculosis|tuberculosis
5353140|NCT01934309|isoniazid preventative therapy|isoniazid preventative therapy
5353141|NCT01934309|clinical decision support|clinical decision support
5353142|NCT01934309|HIV|hiv
5353143|NCT01934309|Kenya|kenya
5353144|NCT01934309|eHealth|ehealth
5353145|NCT01934296|deep brain stimulation|deep brain stimulation
5353146|NCT01934296|cortical recording|cortical recording
5353147|NCT01934296|neuroprosthesis|neuroprosthesis
5353148|NCT01934231|Acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
5353149|NCT01934231|Amoxicilin|amoxicilin
5353150|NCT01934231|Infection|infection
5353151|NCT01934231|Potassium clavulanate|potassium clavulanate
5353152|NCT01934218|Knee|knee
5353153|NCT01934218|Osteoarthritis|osteoarthritis
5353154|NCT01934218|Intra-articular injection|intra-articular injection
5353155|NCT01934205|GSK2140944|gsk2140944
5353156|NCT01934205|pharmacokinetics|pharmacokinetics
5353157|NCT01934205|bronchoalveolar lavage|bronchoalveolar lavage
5353158|NCT01934205|pulmonary|pulmonary
5353159|NCT01934205|antimicrobial|antimicrobial
5353160|NCT01934205|healthy volunteer|healthy volunteer
5353161|NCT01934192|tolerability|tolerability
5353162|NCT01934192|camicinal|camicinal
5353163|NCT01934192|single dose|single dose
5353164|NCT01934192|acetaminophen|acetaminophen
5353165|NCT01934192|gastric emptying|gastric emptying
5353166|NCT01934192|critically ill|critically ill
5353167|NCT01934192|GSK962040|gsk962040
5353168|NCT01934192|pharmacokinetics|pharmacokinetics
5353169|NCT01934192|pharmacodynamics|pharmacodynamics
5353170|NCT01934192|gut motility|gut motility
5353171|NCT01934153|hyperhidrosis|hyperhidrosis
5353173|NCT01934153|[14C] radiolabel|[14c] radiolabel
5353174|NCT01934153|palm|palm
5353182|NCT01934140|Booster response|booster response
5353183|NCT01934140|Immunogenicity|immunogenicity
5353185|NCT01934140|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
5353186|NCT01934140|long-term antibody persistence|long-term antibody persistence
5353187|NCT01934127|Immunogenicity|immunogenicity
5353188|NCT01934127|H7N1|h7n1
5353189|NCT01934127|Influenza|influenza
5353190|NCT01934127|Safety|safety
5353191|NCT01934127|AS03 adjuvant|as03 adjuvant
5353192|NCT01934127|Adults|adults
5353193|NCT01934088|Inflammatory Bowel disease|inflammatory bowel disease
5353194|NCT01934088|IBD|ibd
5353195|NCT01934088|Sedation|sedation
5353196|NCT01934088|NAPS|naps
5353198|NCT01934088|Midazolam|midazolam
5353199|NCT01934088|Satisfaction|satisfaction
5353200|NCT01934088|Feasibility|feasibility
5353208|NCT01934036|Skinfolds|skinfolds
5353209|NCT01934023|plasticity, schizophrenia, varenicline, non smokers,|plasticity, schizophrenia, varenicline, non smokers,
5353210|NCT01933997|pharmacokinetics|pharmacokinetics
5353211|NCT01933997|metadoxine|metadoxine
5353218|NCT01933932|Mitogen-Activated Protein Kinase Kinase inhibitor; Non Small Cell Lung Cancer; metastatic; second line treatment for Non Small Cell Lung Cancer; KRAS mutation|mitogen-activated protein kinase kinase inhibitor; non small cell lung cancer; metastatic; second line treatment for non small cell lung cancer; kras mutation
5353219|NCT01933919|Obsessive Compulsive Disorder|obsessive compulsive disorder
5353220|NCT01933919|Adolescent Subjects|adolescent subjects
5353221|NCT01933919|Pediatric Subjects|pediatric subjects
5353222|NCT01933906|CML|cml
5353223|NCT01933906|Chronic myeloid leukemia|chronic myeloid leukemia
5353349|NCT01933516|CD20|cd20
5353224|NCT01933906|Chronic myeloid leukaemia|chronic myeloid leukaemia
5353225|NCT01933906|PEG-Proline-Interferon-alpha 2b|peg-proline-interferon-alpha 2b
5353226|NCT01933906|Interferon|interferon
5353227|NCT01933906|P1101|p1101
5353228|NCT01933906|Imatinib|imatinib
5353229|NCT01933893|Pipelle, luteal, follicular, implantation|pipelle, luteal, follicular, implantation
5353230|NCT01933880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5353231|NCT01933880|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5353232|NCT01933880|CONCERTA|concerta
5353233|NCT01933867|water|water
5353234|NCT01933867|colonoscopy|colonoscopy
5353235|NCT01933867|Crohn´s disease|crohn´s disease
5353236|NCT01933867|ulcerative colitis|ulcerative colitis
5353237|NCT01933854|Urinary incontinence|urinary incontinence
5353238|NCT01933854|riverside|riverside
5353239|NCT01933854|women|women
5353240|NCT01933854|Amapa|amapa
5353241|NCT01933841|Post operative residual curarization|post operative residual curarization
5353242|NCT01933841|Neuromuscular blocking drugs|neuromuscular blocking drugs
5353243|NCT01933828|Lung cancer|lung cancer
5353244|NCT01933828|surgery video-assisted|surgery video-assisted
5353245|NCT01933828|robot|robot
5353246|NCT01933828|surgical treatment|surgical treatment
5353247|NCT01933815|Glioblastoma multiforme|glioblastoma multiforme
5353248|NCT01933815|Glioblastoma|glioblastoma
5353249|NCT01933815|Radiotherapy|radiotherapy
5353250|NCT01933815|Temozolomide|temozolomide
5353251|NCT01933815|TPI 287|tpi 287
5353252|NCT01933815|Taxoid|taxoid
5353253|NCT01933815|Avastin|avastin
5353254|NCT01933815|Bevacizumab|bevacizumab
5353255|NCT01933802|mesenchymal stem cells|mesenchymal stem cells
5353256|NCT01933802|neural progenitors|neural progenitors
5353257|NCT01933802|autologous|autologous
5353258|NCT01933802|bone marrow|bone marrow
5353259|NCT01933802|multiple sclerosis|multiple sclerosis
5353260|NCT01933789|Palliative Care|palliative care
5353261|NCT01933789|End-of-Life Issues|end-of-life issues
5353262|NCT01933789|Patient/Clinician Communication|patient/clinician communication
5353263|NCT01933789|Patient/Family Communication|patient/family communication
5353264|NCT01933789|Concordance|concordance
5353265|NCT01933789|Treatment Preferences|treatment preferences
5353266|NCT01933789|Anxiety|anxiety
5353267|NCT01933789|Depressive Symptoms|depressive symptoms
5353268|NCT01933789|Talking with Your Doctor|talking with your doctor
5353269|NCT01933789|Coping with Serious Illness|coping with serious illness
5353270|NCT01933789|Outpatient Collaboration|outpatient collaboration
5353271|NCT01933776|Diphtheria|diphtheria
5353272|NCT01933776|Tetanus|tetanus
5353273|NCT01933776|Pertussis|pertussis
5353274|NCT01933776|ADACEL®|adacel®
5353275|NCT01933776|Tdap vaccine|tdap vaccine
5353276|NCT01933750|Presbyopia|presbyopia
5353277|NCT01933750|Reading Glasses|reading glasses
5353278|NCT01933750|Near Vision|near vision
5353279|NCT01933737|postural balance;|postural balance;
5353283|NCT01933737|fall|fall
5353284|NCT01933724|granulomatosis with polyangiitis|granulomatosis with polyangiitis
5353285|NCT01933724|GPA|gpa
5353286|NCT01933724|Wegeners'|wegeners'
5353287|NCT01933724|WG|wg
5353288|NCT01933724|vasculitis|vasculitis
5353289|NCT01933724|taper|taper
5353290|NCT01933724|prednisone|prednisone
5353291|NCT01933724|glucocorticoid|glucocorticoid
5353292|NCT01933724|ANCA-associated vasculitis|anca-associated vasculitis
5353293|NCT01933724|AAV|aav
5353294|NCT01933724|Wegener Granulomatosis|wegener granulomatosis
5353295|NCT01933724|Systemic Vasculitis|systemic vasculitis
5353296|NCT01933724|Lung diseases, interstitial|lung diseases, interstitial
5353299|NCT01933724|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
5353300|NCT01933724|Vascular Diseases|vascular diseases
5353301|NCT01933724|Cardiovascular Diseases|cardiovascular diseases
5353302|NCT01933724|Glucocorticoids|glucocorticoids
5353303|NCT01933724|Hormones|hormones
5353304|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5353305|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs
5353306|NCT01933724|Pharmacologic Actions|pharmacologic actions
5353307|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5353308|NCT01933724|Antineoplastic Agents|antineoplastic agents
5353309|NCT01933724|Therapeutic Uses|therapeutic uses
5353310|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents
5353311|NCT01933711|CD20+ aggressive lymphoma|cd20+ aggressive lymphoma
5353312|NCT01933711|mantle cell lymphoma|mantle cell lymphoma
5353313|NCT01933711|rituximab|rituximab
5353314|NCT01933711|maintenance|maintenance
5353315|NCT01933698|Bioequivalence|bioequivalence
5353316|NCT01933698|Amoxicillin|amoxicillin
5353317|NCT01933698|Human|human
5353318|NCT01933672|Phase 1b|phase 1b
5353319|NCT01933672|type 2 diabetes|type 2 diabetes
5353320|NCT01933672|metformin background|metformin background
5353321|NCT01933672|PF-04937319|pf-04937319
5353322|NCT01933659|Helicobacter pylori|helicobacter pylori
5353323|NCT01933659|deep see water|deep see water
5353324|NCT01933646|Group B streptococcus|group b streptococcus
5353325|NCT01933646|Incidence|incidence
5353326|NCT01933646|Case fatality rate|case fatality rate
5353327|NCT01933646|Serotype distribution|serotype distribution
5353328|NCT01933633|Pregnancy|pregnancy
5353329|NCT01933633|Fertility|fertility
5353330|NCT01933633|exercise|exercise
5353331|NCT01933633|Fertilization in vitro|fertilization in vitro
5353334|NCT01933542|Chlorzoxazone|chlorzoxazone
5353335|NCT01933542|Postoperative pain|postoperative pain
5353336|NCT01933542|Spine surgery|spine surgery
5353337|NCT01933542|Opioid consumption|opioid consumption
5353338|NCT01933529|diabetes|diabetes
5353339|NCT01933529|glucose tolerance|glucose tolerance
5353340|NCT01933529|insulin secretion|insulin secretion
5353341|NCT01933529|insulin sensitivity|insulin sensitivity
5248426|NCT02454842|TH-4000|th-4000
5353342|NCT01933529|erythropoietin|erythropoietin
5353343|NCT01933529|inflammation|inflammation
5353344|NCT01933529|cytokines|cytokines
5353345|NCT01933516|GP2013|gp2013
5353346|NCT01933516|Japanese|japanese
5353347|NCT01933516|indolent B-cell non-Hodgkin's lymphoma|indolent b-cell non-hodgkin's lymphoma
5353348|NCT01933516|biosimilar|biosimilar
5353350|NCT01933516|GP13-101|gp13-101
5353352|NCT01933503|SAD|sad
5353353|NCT01933503|Obeticholic Acid (OCA)|obeticholic acid (oca)
5353354|NCT01933490|hyperinsulinemic hypoglycemia|hyperinsulinemic hypoglycemia
5353355|NCT01933477|Maternal Health|maternal health
5353356|NCT01933477|Child Health|child health
5353357|NCT01933477|HIV infection|hiv infection
5353358|NCT01933477|Antenatal care|antenatal care
5353359|NCT01933477|Postpartum care|postpartum care
5353360|NCT01933477|Prevention of mother to child transmission (PMTCT)|prevention of mother to child transmission (pmtct)
5353361|NCT01933477|Breast feeding|breast feeding
5353362|NCT01933477|Antiretrovirals|antiretrovirals
5353363|NCT01933464|Rosacea|rosacea
5353364|NCT01933464|Cromolyn sodium|cromolyn sodium
5353365|NCT01933451|fluid therapy|fluid therapy
5353366|NCT01933451|Intraoperative care|intraoperative care
5353367|NCT01933451|Patient Outcome Assessment|patient outcome assessment
5353368|NCT01933451|pulse pressure variation|pulse pressure variation
5353369|NCT01933451|restrictive fluid therapy|restrictive fluid therapy
5353370|NCT01933451|goal-directed fluid therapy|goal-directed fluid therapy
5353371|NCT01933451|esophagectomy|esophagectomy
5353372|NCT01933438|birth related brachial plexus injury|birth related brachial plexus injury
5353373|NCT01933438|brachial plexus|brachial plexus
5353374|NCT01933438|splint|splint
5353375|NCT01933425|surgical conditions|surgical conditions
5353376|NCT01933425|laparoscopy|laparoscopy
5353377|NCT01933412|Dialysis|dialysis
5963910|NCT04184804|fruits|fruits
5963911|NCT04184804|vegetables|vegetables
5353378|NCT01933412|Hepatitis B|hepatitis b
5353379|NCT01933399|Low back pain|low back pain
5353380|NCT01933399|Back brace|back brace
5353381|NCT01933399|Lumbar orthoses|lumbar orthoses
5349368|NCT01952067|surgery|surgery
5353384|NCT01933386|Single Sided Deafness|single sided deafness
5353385|NCT01933386|SSD|ssd
5353386|NCT01933386|Unilateral hearing loss|unilateral hearing loss
5353387|NCT01933373|Randomized|randomized
5353388|NCT01933373|Toupet|toupet
5353389|NCT01933373|Dor|dor
5353390|NCT01933373|Achalasia|achalasia
5353391|NCT01933360|Misoprostol|misoprostol
5353392|NCT01933360|First trimester pregnancy|first trimester pregnancy
5353393|NCT01933360|Surgical abortion|surgical abortion
5353394|NCT01933360|Cervical priming|cervical priming
5353395|NCT01933334|pirfenidone|pirfenidone
5353396|NCT01933334|SSc-ILD|ssc-ild
5353400|NCT01933321|ALS, stem cells|als, stem cells
5353401|NCT01933308|Pulmonary Rehabilitation|pulmonary rehabilitation
5353402|NCT01933308|Comparison of exercise training protocol|comparison of exercise training protocol
5353403|NCT01933308|Exercise tolerance|exercise tolerance
5353404|NCT01933308|Functional and quality of life status|functional and quality of life status
5353405|NCT01933308|Cognitive and psychological status|cognitive and psychological status
5353406|NCT01933308|Compliance to exercise recommendations|compliance to exercise recommendations
5353407|NCT01933308|Long term adherence to exercise recommendations|long term adherence to exercise recommendations
5353408|NCT01933295|treatment|treatment
5353409|NCT01933282|MESA, chemotherapy,NK/T cell lymphoma|mesa, chemotherapy,nk/t cell lymphoma
5353410|NCT01933256|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5353411|NCT01933256|HIP2B|hip2b
5353412|NCT01933256|Placebo|placebo
5353413|NCT01933256|islet β cell|islet β cell
5353414|NCT01933243|Anxiety|anxiety
5353415|NCT01933243|Anorexia nervosa|anorexia nervosa
5353416|NCT01933243|Adolescents|adolescents
5353417|NCT01933243|Fish oil|fish oil
5353418|NCT01933217|TBI|tbi
5353419|NCT01933217|traumatic brain injury|traumatic brain injury
5353420|NCT01933217|ADHD|adhd
5353421|NCT01933217|methylphenidate|methylphenidate
5353422|NCT01933217|Concerta|concerta
5353423|NCT01933217|attention problems|attention problems
5353427|NCT01933191|Dental Anxiety, Physical Activity, Dental Phobia|dental anxiety, physical activity, dental phobia
5353428|NCT01933191|Cortisol, Amylase|cortisol, amylase
5353429|NCT01933178|Dry eyes|dry eyes
5353430|NCT01933178|Cirrus AS-OCT|cirrus as-oct
5353431|NCT01933178|Excess folds of the conjunctiva|excess folds of the conjunctiva
5353432|NCT01933165|Dry Eyes|dry eyes
5353433|NCT01933165|LipiView|lipiview
5353434|NCT01933165|Lipid thickness|lipid thickness
5353435|NCT01933152|wAMD|wamd
5353436|NCT01933152|anti-VEGF|anti-vegf
5353437|NCT01933139|Informed consent|informed consent
5353438|NCT01933139|preoperative counseling|preoperative counseling
5353439|NCT01933139|hysterectomy|hysterectomy
5353440|NCT01933113|Obesity|obesity
5353441|NCT01933113|Deep Brain Stimulation|deep brain stimulation
5353442|NCT01933113|LHA|lha
5353443|NCT01933100|Functional constipation|functional constipation
5353444|NCT01933100|Brown rice based-meal|brown rice based-meal
5353445|NCT01933100|Polished rice based-meal|polished rice based-meal
5353446|NCT01933100|Wheat based-meal|wheat based-meal
5353447|NCT01933087|Hand hygiene,|hand hygiene,
5353448|NCT01933087|Randonmised Controlled Trials,|randonmised controlled trials,
5353449|NCT01933087|Hospital|hospital
5353450|NCT01933074|Urinary Urgency|urinary urgency
5353451|NCT01933061|Skin cancer, Melanoma|skin cancer, melanoma
5353452|NCT01933048|influenza|influenza
5353453|NCT01933035|ITP|itp
5353454|NCT01933035|Thrombocytopenia|thrombocytopenia
5353455|NCT01933035|mean platelet mass|mean platelet mass
5353456|NCT01933035|mean platelet component|mean platelet component
5353457|NCT01933022|Exploratory|exploratory
5353458|NCT01933022|Biomarkers|biomarkers
5353459|NCT01933022|Eligard|eligard
5353460|NCT01933022|Metastatic prostate cancer|metastatic prostate cancer
5353461|NCT01932996|Smoking Cessation|smoking cessation
5353462|NCT01932996|Smoking Cessation Products|smoking cessation products
5353463|NCT01932996|Tobacco Use Cessation Products|tobacco use cessation products
5353464|NCT01932983|Neuromuscular blockade|neuromuscular blockade
5353465|NCT01932983|TOF test|tof test
5353466|NCT01932983|Quantitative TOF method|quantitative tof method
5353467|NCT01932983|Visual interpretation of TOF|visual interpretation of tof
5423305|NCT01616264|Pleural Effusion|pleural effusion
5423306|NCT01616264|Computed Tomography|computed tomography
5353468|NCT01932970|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
5353472|NCT01932931|Major depression|major depression
5353473|NCT01932931|SSRIs|ssris
5353474|NCT01932931|Osteoporosis|osteoporosis
5353475|NCT01932918|reactive oxygen species|reactive oxygen species
5353476|NCT01932918|ischemia reperfusion injury|ischemia reperfusion injury
5353477|NCT01932905|deep repetitive transcranial magnetic stimulation|deep repetitive transcranial magnetic stimulation
5353478|NCT01932905|chronic pain|chronic pain
5353479|NCT01932905|assessment|assessment
5349470|NCT01951651|Diabetes|diabetes
5353481|NCT01932905|central pain|central pain
5353482|NCT01932905|treatment|treatment
5353483|NCT01932892|transhumeral|transhumeral
5353484|NCT01932866|pre-diabetes|pre-diabetes
5963912|NCT04184622|Metabolism and Nutrition Disorder|metabolism and nutrition disorder
5963913|NCT04184622|Prediabetes|prediabetes
5353485|NCT01932866|diabetes risk score|diabetes risk score
5353486|NCT01932866|motivation|motivation
5353487|NCT01932866|Air Force|air force
5353488|NCT01932866|Military|military
5353489|NCT01932866|Lifestyle change|lifestyle change
5353490|NCT01932840|attitudes and understanding of plant sterol claims|attitudes and understanding of plant sterol claims
5354167|NCT01929681|bipolar|bipolar
5353491|NCT01932840|general Canadian population|general canadian population
5353492|NCT01932827|Attitudes and understanding of oat fibre claims|attitudes and understanding of oat fibre claims
5353493|NCT01932827|Food labels|food labels
5353494|NCT01932827|General Canadian population|general canadian population
5353495|NCT01932814|Aminoglycosides|aminoglycosides
5353496|NCT01932814|Acute kidney injury|acute kidney injury
5353497|NCT01932814|Severe sepsis|severe sepsis
5353498|NCT01932814|Critically ill patient|critically ill patient
5353499|NCT01932801|harm reduction, naltrexone, alcohol dependence, homelessness|harm reduction, naltrexone, alcohol dependence, homelessness
5353500|NCT01932788|pregnancy|pregnancy
5353501|NCT01932788|Vitamin D status|vitamin d status
5353502|NCT01932736|middle ear|middle ear
5353503|NCT01932736|Eustachian tube|eustachian tube
5353504|NCT01932736|fMRI|fmri
5353505|NCT01932723|Stabilization exercises, Pain, Disability, Menstruation|stabilization exercises, pain, disability, menstruation
5353506|NCT01932710|Leukemia|leukemia
5353507|NCT01932710|Acute myelogenous leukemia|acute myelogenous leukemia
5353508|NCT01932710|AML|aml
5353509|NCT01932710|High-risk myelodysplastic leukemia|high-risk myelodysplastic leukemia
5353510|NCT01932710|MDS|mds
5353511|NCT01932710|Infection risk|infection risk
5353512|NCT01932710|White Blood Cell transfusion|white blood cell transfusion
5353513|NCT01932710|Prophylactic therapy|prophylactic therapy
5353514|NCT01932671|Cardiovascular diseases|cardiovascular diseases
5353515|NCT01932671|Atherosclerosis|atherosclerosis
5353516|NCT01932671|Multidetector Computed Tomography|multidetector computed tomography
5353517|NCT01932671|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5353518|NCT01932658|autologous|autologous
5353519|NCT01932658|Lymphoablation|lymphoablation
5353520|NCT01932658|hematopoietic|hematopoietic
5353521|NCT01932658|immune system|immune system
5353522|NCT01932645|prostatitis|prostatitis
5353523|NCT01932645|pelvic pain|pelvic pain
5353524|NCT01932645|urinary symptoms|urinary symptoms
5353525|NCT01932645|sexual dysfunction|sexual dysfunction
5353526|NCT01932632|Polypharmacy|polypharmacy
5353527|NCT01932632|De-prescribing|de-prescribing
5353528|NCT01932632|Frailty|frailty
5353529|NCT01932593|multiple sclerosis|multiple sclerosis
5353530|NCT01932593|bone marrow|bone marrow
5353531|NCT01932593|stem cell therapy|stem cell therapy
5353533|NCT01932580|esophageal|esophageal
5353534|NCT01932580|adenocarcinoma|adenocarcinoma
5353535|NCT01932554|Sickle Cell Pain Crisis|sickle cell pain crisis
5353536|NCT01932554|Abciximab|abciximab
5353537|NCT01932554|Integrins|integrins
5353538|NCT01932554|Cell Adhesion Molecules|cell adhesion molecules
5353539|NCT01932541|Bipolar Disorder|bipolar disorder
5353540|NCT01932541|Mania|mania
5353541|NCT01932541|Bipolar I|bipolar i
5353542|NCT01932541|Bipolar II|bipolar ii
5353543|NCT01932541|Bipolar Spectrum Disorder|bipolar spectrum disorder
5353544|NCT01932541|Pediatric|pediatric
5353545|NCT01932528|Absorption|absorption
5353546|NCT01932528|Metabolism|metabolism
5353547|NCT01932528|Excretion|excretion
5353548|NCT01932502|epilepsy|epilepsy
5353549|NCT01932502|Onfi|onfi
5353550|NCT01932502|clonazepam|clonazepam
5353551|NCT01932463|Tremor|tremor
5353552|NCT01932463|Essential Tremor|essential tremor
5353553|NCT01932463|Medication-refractory Essential Tremor|medication-refractory essential tremor
5353554|NCT01932450|hypertension|hypertension
5353555|NCT01932450|radiofrequency ablation|radiofrequency ablation
5353556|NCT01932450|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5353557|NCT01932437|Monoclonal antibody, ETI-204, IM, safety, PK, immunogenicity|monoclonal antibody, eti-204, im, safety, pk, immunogenicity
5353558|NCT01932424|Children|children
5353559|NCT01932398|Alpha|alpha
5353560|NCT01932398|Lateralization|lateralization
5353561|NCT01932398|Attention|attention
5353562|NCT01932398|ADHD|adhd
5353563|NCT01932398|Oscillation|oscillation
5353564|NCT01932385|Sorafenib|sorafenib
5353565|NCT01932385|Hepatocellular carcinoma|hepatocellular carcinoma
5353566|NCT01932385|Best supportive care|best supportive care
5353567|NCT01932385|Survival|survival
5353568|NCT01932372|Rheumatoid Arthritis|rheumatoid arthritis
5353569|NCT01932372|Good Post Marketing Study Practice|good post marketing study practice
5353570|NCT01932372|Tofacitinib|tofacitinib
5353571|NCT01932372|Xeljanz|xeljanz
5353572|NCT01932372|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5353573|NCT01932359|Scar outcome|scar outcome
5353574|NCT01932359|Mohs surgery|mohs surgery
5353575|NCT01932359|face|face
5349586|NCT01951105|MRI|mri
5862785|NCT00001512|B-Cell Lymphoma|b-cell lymphoma
5353576|NCT01932346|near infra-red spectroscopy, coronary artery bypass grafting|near infra-red spectroscopy, coronary artery bypass grafting
5353579|NCT01932333|Tolerability|tolerability
5353580|NCT01932333|Pharmacokinetics|pharmacokinetics
5353581|NCT01932333|Pharmacodynamics|pharmacodynamics
5353582|NCT01932333|JNJ-40411813|jnj-40411813
5353583|NCT01932333|Positive allosteric modulator|positive allosteric modulator
5353584|NCT01932320|Healthy|healthy
5353585|NCT01932320|Relative Bioavailability|relative bioavailability
5353586|NCT01932320|Food effect|food effect
5353587|NCT01932320|JNJ-40411813|jnj-40411813
5353678|NCT01931956|Mitral Insufficiency|mitral insufficiency
5353588|NCT01932320|Positive allosteric modulator|positive allosteric modulator
5353589|NCT01932320|Solid Dosage Formulation of JNJ-40411813|solid dosage formulation of jnj-40411813
5353590|NCT01932320|Ketoconazole|ketoconazole
5353591|NCT01932307|Surgeon neck health|surgeon neck health
5353592|NCT01932294|Advanced Heart Failure|advanced heart failure
5353593|NCT01932294|Refractory Heart Failure|refractory heart failure
5353594|NCT01932294|Mechanical Circulatory Support Device|mechanical circulatory support device
5353595|NCT01932294|Ventricular Assist Device|ventricular assist device
5353596|NCT01932294|Medamacs|medamacs
5353597|NCT01932281|muscle power|muscle power
5353598|NCT01932281|muscle fatigue|muscle fatigue
5353599|NCT01932281|SierraSil|sierrasil
5353600|NCT01932255|microvascular decompression surgery|microvascular decompression surgery
5353601|NCT01932255|cerebrospinal fluid leakage|cerebrospinal fluid leakage
5353602|NCT01932255|postoperative complications|postoperative complications
5353603|NCT01932242|anthrax, monoclonal antibody, ETI-204, safety, PK|anthrax, monoclonal antibody, eti-204, safety, pk
5353604|NCT01932229|Advanced NSCLC|advanced nsclc
5353605|NCT01932229|EGFR mutation|egfr mutation
5353606|NCT01932229|TKIs|tkis
5353607|NCT01932229|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5353608|NCT01932216|robotic single-site cholecystectomy|robotic single-site cholecystectomy
5353609|NCT01932216|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5353610|NCT01932216|cosmesis|cosmesis
5353611|NCT01932216|quality of life|quality of life
5353612|NCT01932203|Cerebral small vessel disease|cerebral small vessel disease
5353613|NCT01932203|Leukoaraiosis|leukoaraiosis
5353614|NCT01932203|Magnetic Resonance Imaging|magnetic resonance imaging
5353615|NCT01932203|Diffusion Tensor Imaging|diffusion tensor imaging
5353616|NCT01932190|Acute Kidney Injury|acute kidney injury
5353617|NCT01932190|Critical Care|critical care
5353618|NCT01932190|Renal Replacement Therapy|renal replacement therapy
5353619|NCT01932190|Treatment Outcome|treatment outcome
5353620|NCT01932177|Everolimus ; Sorafenib ; Phase 1 trial ; Solid tumor|everolimus ; sorafenib ; phase 1 trial ; solid tumor
5353621|NCT01932164|Cleft lip and palate|cleft lip and palate
5353622|NCT01932164|Deciduous dental pulp stem cells|deciduous dental pulp stem cells
5353623|NCT01932164|mesenchymal stem cells|mesenchymal stem cells
5353624|NCT01932164|tissue engineering|tissue engineering
5353625|NCT01932164|bone tissue engineering|bone tissue engineering
5353626|NCT01932164|bioengineering|bioengineering
5353627|NCT01932151|type-1 HRS|type-1 hrs
5353628|NCT01932151|active bacterial infections|active bacterial infections
5353629|NCT01932151|terlipressin and albumin|terlipressin and albumin
5353630|NCT01932151|kidney function|kidney function
5353631|NCT01932138|Community-based intervention|community-based intervention
5353632|NCT01932138|Community health workers|community health workers
5353633|NCT01932138|Antenatal care|antenatal care
5353635|NCT01932138|PMTCT|pmtct
5353636|NCT01932138|HIV vertical transmission|hiv vertical transmission
5353637|NCT01932138|Public-sector health systems|public-sector health systems
5353638|NCT01932112|Pulmonary Vein Isolation|pulmonary vein isolation
5353639|NCT01932112|Adenosin effect|adenosin effect
5353640|NCT01932112|Atrial fibrillation ablation|atrial fibrillation ablation
5353641|NCT01932099|pathological constriction; restricted outflow, stenosis|pathological constriction; restricted outflow, stenosis
5353642|NCT01932086|male|male
5353643|NCT01932086|Glucose|glucose
5353644|NCT01932086|Triglyceride|triglyceride
5353645|NCT01932086|Glycemic index|glycemic index
5353646|NCT01932086|White rice|white rice
5353647|NCT01932086|Brown rice|brown rice
5353648|NCT01932086|Black rice|black rice
5353650|NCT01932073|Radiation|radiation
5353651|NCT01932073|dermatitis|dermatitis
5353652|NCT01932073|radiodermatitis|radiodermatitis
5353653|NCT01932073|radiotherapy induced|radiotherapy induced
5353654|NCT01932073|skin reactions|skin reactions
5353655|NCT01932073|low level laser therapy|low level laser therapy
5353656|NCT01932073|breast cancer|breast cancer
5353657|NCT01932060|Oxytocin|oxytocin
5353658|NCT01932060|blood loss|blood loss
5353659|NCT01932060|Cesarean delivery|cesarean delivery
5353660|NCT01932034|Vancomycin|vancomycin
5353661|NCT01932034|Pharmacokinetics|pharmacokinetics
5353662|NCT01932034|Pharmacodynamics|pharmacodynamics
5353663|NCT01932034|Decision support|decision support
5353664|NCT01932021|necrotitis angiodermatitis|necrotitis angiodermatitis
5353665|NCT01932021|autologous fat transplantation|autologous fat transplantation
5353666|NCT01932021|mesenchymal stem cells|mesenchymal stem cells
5353673|NCT01931969|Vein catheterization; Ultrasound; Landmark; Complication|vein catheterization; ultrasound; landmark; complication
5353674|NCT01931956|Mitral Valve Insufficiency|mitral valve insufficiency
5353675|NCT01931956|Mitral Valve Regurgitation|mitral valve regurgitation
5963914|NCT04184557|cancer|cancer
5963915|NCT04184557|mindfulness|mindfulness
5353676|NCT01931956|Mitral Valve Incompetence|mitral valve incompetence
5353677|NCT01931956|Mitral Regurgitation|mitral regurgitation
5353687|NCT01931956|Echocardiogram|echocardiogram
5353688|NCT01931956|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5353689|NCT01931956|Heart Failure|heart failure
5353690|NCT01931956|Heart Attack|heart attack
5353692|NCT01931956|EVEREST I|everest i
5353693|NCT01931956|EVEREST II|everest ii
5353695|NCT01931930|Gastrointestinal discomfort|gastrointestinal discomfort
5353696|NCT01931930|Perilla frutescens|perilla frutescens
5353697|NCT01931930|bloating|bloating
5353698|NCT01931930|abdominal discomfort|abdominal discomfort
5353699|NCT01931930|human study|human study
5353700|NCT01931930|healthy subjects|healthy subjects
5353701|NCT01931917|Prevention|prevention
5353702|NCT01931917|Parenting|parenting
5353703|NCT01931917|Infants|infants
5353704|NCT01931917|Family programs|family programs
5353705|NCT01931917|Early intervention|early intervention
5353706|NCT01931904|IOP|iop
5353707|NCT01931904|Glaucoma|glaucoma
5353708|NCT01931904|Trabeculectomy|trabeculectomy
5353709|NCT01931891|preeclampsia, ADAMTS , wharton jelly, extracellüler matrix, placenta|preeclampsia, adamts , wharton jelly, extracellüler matrix, placenta
5353710|NCT01931878|Restless Legs Syndrome|restless legs syndrome
5353711|NCT01931878|Leg pain|leg pain
5353712|NCT01931878|Sleep|sleep
5353713|NCT01931878|Dysesthesias|dysesthesias
5353714|NCT01931878|incobotulinumtoxin|incobotulinumtoxin
5353715|NCT01931865|cancer pain, radiation therapy, surgery, incobotulinum toxin|cancer pain, radiation therapy, surgery, incobotulinum toxin
5353724|NCT01931826|Schistosomiasis|schistosomiasis
5353725|NCT01931826|Surgical treatment|surgical treatment
5353726|NCT01931826|Endoscopic treatment|endoscopic treatment
5353727|NCT01931774|acne vulgaris cognitive functions|acne vulgaris cognitive functions
5353728|NCT01931761|Pharmacokinetics, mass balance, AZD6244|pharmacokinetics, mass balance, azd6244
5353729|NCT01931735|menisci|menisci
5353730|NCT01931735|tibial|tibial
5353731|NCT01931722|branched chain amino acid requirement|branched chain amino acid requirement
5353732|NCT01931722|older men|older men
5353733|NCT01931722|strength training|strength training
5353735|NCT01931696|Efficacy|efficacy
5353736|NCT01931696|Acupuncture|acupuncture
5353737|NCT01931696|Asthma|asthma
5353738|NCT01931683|LMA removal|lma removal
5353739|NCT01931683|remifentanil|remifentanil
5353740|NCT01931683|propofol|propofol
5353741|NCT01931670|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
5353742|NCT01931670|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5353743|NCT01931670|Elagolix|elagolix
5353744|NCT01931670|Endometriosis Associated Pain|endometriosis associated pain
5353745|NCT01931670|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
5353746|NCT01931657|LNG-IUS|lng-ius
5353747|NCT01931657|Mirena|mirena
5353748|NCT01931657|Contraception|contraception
5353749|NCT01931657|Bleeding|bleeding
5353750|NCT01931657|Hormonal effects in the breast|hormonal effects in the breast
5353751|NCT01931644|ADD/ADHD|add/adhd
5353752|NCT01931644|Alopecia Areata|alopecia areata
5353753|NCT01931644|Ankylosing Spondylitis|ankylosing spondylitis
5353754|NCT01931644|Asthma|asthma
5353755|NCT01931644|Atopic Dermatitis Eczema|atopic dermatitis eczema
5353756|NCT01931644|Beta Thalassemia|beta thalassemia
5353757|NCT01931644|Bipolar Disorder|bipolar disorder
5353758|NCT01931644|Breast Cancer|breast cancer
5353759|NCT01931644|Celiac Disease|celiac disease
5353760|NCT01931644|Cervical Cancer|cervical cancer
5353761|NCT01931644|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5353762|NCT01931644|Chronic Kidney Diseases|chronic kidney diseases
5353763|NCT01931644|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5353764|NCT01931644|Colon Cancer|colon cancer
5353765|NCT01931644|Colorectal Cancer|colorectal cancer
5353766|NCT01931644|Crohn's Disease|crohn's disease
5353767|NCT01931644|Cystic Fibrosis|cystic fibrosis
5353768|NCT01931644|Depression|depression
5353769|NCT01931644|Diabete Mellitus|diabete mellitus
5349775|NCT01950104|Embryo biopsy|embryo biopsy
5353770|NCT01931644|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5353771|NCT01931644|Endometriosis|endometriosis
5353772|NCT01931644|Epilepsy|epilepsy
5353773|NCT01931644|Facioscapulohumeral Muscular Dystrophy|facioscapulohumeral muscular dystrophy
5353774|NCT01931644|G6PD Deficiency|g6pd deficiency
5353775|NCT01931644|General Anxiety Disorder|general anxiety disorder
5353777|NCT01931644|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5353778|NCT01931644|HIV/AIDS|hiv/aids
5353779|NCT01931644|Human Papilloma Virus|human papilloma virus
5353780|NCT01931644|Huntington's Disease|huntington's disease
5353781|NCT01931644|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5353782|NCT01931644|Insomnia|insomnia
5353783|NCT01931644|Kidney Cancer|kidney cancer
5353784|NCT01931644|Leukemia|leukemia
5353785|NCT01931644|Lung Cancer|lung cancer
5353786|NCT01931644|Lupus Nephritis|lupus nephritis
5353787|NCT01931644|Lymphoma|lymphoma
5353788|NCT01931644|Melanoma|melanoma
5353789|NCT01931644|Multiple Myeloma|multiple myeloma
5353790|NCT01931644|Multiple Sclerosis|multiple sclerosis
5353791|NCT01931644|Myositis|myositis
5353792|NCT01931644|Myotonic Dystrophy|myotonic dystrophy
5353793|NCT01931644|Ovarian Cancer|ovarian cancer
5353794|NCT01931644|Pancreatic Cancer|pancreatic cancer
5353795|NCT01931644|Parkinson's Disease|parkinson's disease
5353796|NCT01931644|Polycystic Kidney Diseases|polycystic kidney diseases
5353797|NCT01931644|Prostate Cancer|prostate cancer
5353798|NCT01931644|Psoriasis|psoriasis
5353799|NCT01931644|Psoriatic Arthritis|psoriatic arthritis
5353801|NCT01931644|Scleroderma|scleroderma
5353802|NCT01931644|Sickle Cell Anemia|sickle cell anemia
5353803|NCT01931644|Sickle Cell Disease|sickle cell disease
5353804|NCT01931644|Sickle Cell Trait|sickle cell trait
5353805|NCT01931644|Sjogren's Syndrome|sjogren's syndrome
5353806|NCT01931644|Skin Cancer|skin cancer
5353807|NCT01931644|Spinal Muscular Atrophy|spinal muscular atrophy
5353808|NCT01931644|Systemic Lupus Erythematosus|systemic lupus erythematosus
5353809|NCT01931644|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5353810|NCT01931644|Trisomy 21|trisomy 21
5353811|NCT01931644|Ulcerative Colitis|ulcerative colitis
5353812|NCT01931631|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5353813|NCT01931631|Diet, Vegetarian|diet, vegetarian
5353814|NCT01931631|Diet, Fat-Restricted|diet, fat-restricted
5353815|NCT01931631|Glycemic Index|glycemic index
5353817|NCT01931618|online intervention|online intervention
5353818|NCT01931618|hazardous drinking|hazardous drinking
5353819|NCT01931618|harmful drinking|harmful drinking
5353820|NCT01931618|early intervention|early intervention
5353821|NCT01931618|behavior change intervention|behavior change intervention
5353822|NCT01931592|ESBL|esbl
5353823|NCT01931592|neutropenia|neutropenia
5353824|NCT01931592|eradication|eradication
5353825|NCT01931592|bloodstream infection|bloodstream infection
5353826|NCT01931592|immunosuppression|immunosuppression
5353827|NCT01931579|confocal endo-microscopy, lung nodule, respiratory neoplasms|confocal endo-microscopy, lung nodule, respiratory neoplasms
5353828|NCT01931566|Drug therapy|drug therapy
5353829|NCT01931540|Obesity|obesity
5353830|NCT01931540|Epigenesis, Genetic|epigenesis, genetic
5353831|NCT01931540|Exercise Therapy|exercise therapy
5353832|NCT01931527|Obesity|obesity
5353833|NCT01931527|Metabolic syndrome|metabolic syndrome
5353834|NCT01931527|Hyperuricemia|hyperuricemia
5353835|NCT01931462|Cancer of the Kidney|cancer of the kidney
5353836|NCT01931462|Renal Cancer|renal cancer
5353837|NCT01931462|Renal Neoplasms|renal neoplasms
5353838|NCT01931462|Neoplasms, Kidney|neoplasms, kidney
5353839|NCT01931449|Pancreatoduodenectomy|pancreatoduodenectomy
5445430|NCT01521845|CKMB and troponin I|ckmb and troponin i
5353840|NCT01931449|Digestive Tract Reconstruction|digestive tract reconstruction
5353841|NCT01931449|Pancreas|pancreas
5353842|NCT01931436|Menopause, pharmacokinetic|menopause, pharmacokinetic
5353843|NCT01931397|Dried blood spots|dried blood spots
5353844|NCT01931397|kidney transplant|kidney transplant
5353845|NCT01931397|Children|children
5353846|NCT01931384|Luteal phase support|luteal phase support
5353847|NCT01931384|Human chorionic gonadotrophin|human chorionic gonadotrophin
5353848|NCT01931384|frozen-thawed embryo transfer cycle|frozen-thawed embryo transfer cycle
5353849|NCT01931371|fistula in ano|fistula in ano
5353850|NCT01931371|anal fistula|anal fistula
5353851|NCT01931371|recurrence|recurrence
5353852|NCT01931371|costs|costs
5353853|NCT01931345|Rapid HIV testing|rapid hiv testing
5353854|NCT01931345|MSM|msm
5353855|NCT01931345|Motivational Interviewing|motivational interviewing
5353856|NCT01931345|HIV prevention|hiv prevention
5353857|NCT01931345|HIV/AIDS|hiv/aids
5353858|NCT01931345|At-risk anal intercourse|at-risk anal intercourse
5353859|NCT01931345|Randomized trial|randomized trial
5353860|NCT01931332|Arthroplasty|arthroplasty
5353861|NCT01931332|Analgesia|analgesia
5353862|NCT01931319|baclofen withdrawal|baclofen withdrawal
5353863|NCT01931319|interruption|interruption
5353864|NCT01931319|spasticity|spasticity
5353865|NCT01931319|pharmacokinetics|pharmacokinetics
5353866|NCT01931319|tolerability|tolerability
5353867|NCT01931319|intravenous|intravenous
5349868|NCT01949662|Placebo|placebo
5862786|NCT00001507|T-cells|t-cells
5353868|NCT01931293|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, HLA-DR, HLA-DQ|atrophic glossitis, burning mouth syndrome, gastric parietal cell antibody, thyroglobulin antibody, thyroid microsomal antibody, hla-dr, hla-dq
5353870|NCT01931241|atherosclerosis|atherosclerosis
5353871|NCT01931241|atherosclerotic heart disease|atherosclerotic heart disease
5353874|NCT01931241|hyperlipidemia|hyperlipidemia
5353875|NCT01931228|Intensive care unit|intensive care unit
5353876|NCT01931228|acute respiratory insufficiency|acute respiratory insufficiency
5353877|NCT01931228|Respiratory failure|respiratory failure
5353878|NCT01931228|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
5353879|NCT01931150|Topical Dapsone 5% Gel|topical dapsone 5% gel
5353880|NCT01931150|Moisturizer|moisturizer
5353882|NCT01931150|13-012|13-012
5353883|NCT01931124|maximal oxygen uptake, activity levels, elderly|maximal oxygen uptake, activity levels, elderly
5353884|NCT01931111|physical activity|physical activity
5963916|NCT04184557|RCT|rct
5963917|NCT04184557|e-Health|e-health
5220834|NCT02618928|HCV|hcv
5353885|NCT01931111|maximal oxygen uptake|maximal oxygen uptake
5353886|NCT01931098|Brain Tumors|brain tumors
5353887|NCT01931072|Exercise|exercise
5353888|NCT01931072|High-intensity interval training|high-intensity interval training
5353889|NCT01931072|Moderate training|moderate training
5353890|NCT01931072|Healthy elderly|healthy elderly
5353891|NCT01931072|Skeletal muscle|skeletal muscle
5353892|NCT01931072|DNA-methylation|dna-methylation
5353893|NCT01931072|Gene expression|gene expression
5353894|NCT01931072|subjects|subjects
5353895|NCT01931059|Imaging|imaging
5353896|NCT01931059|Risperidone|risperidone
5353897|NCT01931059|Placebo|placebo
5353898|NCT01931059|antipsychotic|antipsychotic
5353901|NCT01931033|Autism Spectrum Disorders|autism spectrum disorders
5353902|NCT01931033|Pervasive Developmental Disorders|pervasive developmental disorders
5353903|NCT01931033|ASD|asd
5353904|NCT01931033|PDD|pdd
5353905|NCT01931033|Oxytocin|oxytocin
5353906|NCT01931033|Syntocinon|syntocinon
5353907|NCT01931033|treatment|treatment
5353908|NCT01931020|Pain|pain
5353909|NCT01931020|Preterm|preterm
5353910|NCT01931020|Neonates|neonates
5353911|NCT01931020|24% Sucrose|24% sucrose
5353912|NCT01931020|25% Dextrose|25% dextrose
5353913|NCT01931007|osteoarthritis|osteoarthritis
5353914|NCT01930994|LNG: Levonorgestrel|lng: levonorgestrel
5353915|NCT01930994|MSI: Marie Stopes International|msi: marie stopes international
5353916|NCT01930994|MSK: Marie Stopes Kenya|msk: marie stopes kenya
5353917|NCT01930994|PK: Pharmacokinetic|pk: pharmacokinetic
5353918|NCT01930981|quality of life|quality of life
5353919|NCT01930981|toxicities|toxicities
5353920|NCT01930981|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5353921|NCT01930968|Uveal melanoma, ocular melanoma|uveal melanoma, ocular melanoma
5353922|NCT01930955|Non-antibiotic prescribing|non-antibiotic prescribing
5353923|NCT01930955|acute upper respiratory tract infection|acute upper respiratory tract infection
5353924|NCT01930955|white cell count|white cell count
5353925|NCT01930955|vomiting|vomiting
5353926|NCT01930942|rectal carcinoma|rectal carcinoma
5353927|NCT01930942|preoperative concurrent chemoradiotherapy|preoperative concurrent chemoradiotherapy
5353928|NCT01930929|Bariatric surgery|bariatric surgery
5445431|NCT01521819|AMD|amd
5353929|NCT01930929|Complications|complications
5353930|NCT01930929|Drugs|drugs
5353931|NCT01930916|Prothrombin Time/instrumentation|prothrombin time/instrumentation
5353932|NCT01930916|Prothrombin Time/utilization|prothrombin time/utilization
5353933|NCT01930916|Blood Coagulation Disorders/blood|blood coagulation disorders/blood
5353934|NCT01930916|Blood Coagulation Disorders/complications|blood coagulation disorders/complications
5353935|NCT01930916|Blood Coagulation Disorders/diagnosis|blood coagulation disorders/diagnosis
5353936|NCT01930916|Prospective Studies|prospective studies
5353937|NCT01930916|Adult|adult
5353938|NCT01930916|Reproducibility of Results|reproducibility of results
5353939|NCT01930916|Point-of-Care Systems/utilization|point-of-care systems/utilization
5353940|NCT01930916|Aged|aged
5353941|NCT01930916|Elderly|elderly
5353942|NCT01930903|PRO-Kinetic Energy BMS + Pantera Lux DEB combination|pro-kinetic energy bms + pantera lux deb combination
5353943|NCT01930877|quality of recovery|quality of recovery
5353944|NCT01930877|spine surgery|spine surgery
5353945|NCT01930877|intravenous lidocaine|intravenous lidocaine
5353946|NCT01930864|metformin|metformin
5353947|NCT01930864|colorectal cancer|colorectal cancer
5353948|NCT01930864|chemotherapy|chemotherapy
5353949|NCT01930851|Bariatric surgery|bariatric surgery
5353950|NCT01930851|Quality of life|quality of life
5353951|NCT01930851|Complications|complications
5353952|NCT01930838|Bariatric surgery|bariatric surgery
5353953|NCT01930838|Complications|complications
5353954|NCT01930838|Osteoporosis|osteoporosis
5357841|NCT01912950|IPL|ipl
5353955|NCT01930838|Neuropathy|neuropathy
5353956|NCT01930838|Vitamine deficiency|vitamine deficiency
5353957|NCT01930812|18F-NaF PET/CT|18f-naf pet/ct
5353958|NCT01930812|Bone imaging|bone imaging
5353959|NCT01930773|clopidogrel|clopidogrel
5353960|NCT01930773|prasugrel|prasugrel
5353961|NCT01930773|platelet function testing|platelet function testing
5353962|NCT01930773|genotyping|genotyping
5349967|NCT01949181|Lung|lung
5353964|NCT01930760|pediatric|pediatric
5353965|NCT01930760|Childhood Obesity|childhood obesity
5353966|NCT01930760|motivational interviewing|motivational interviewing
5353967|NCT01930760|pediatric primary care physicians|pediatric primary care physicians
5353968|NCT01930747|pneumoperitoneum|pneumoperitoneum
5353969|NCT01930747|laparoscopy|laparoscopy
5353970|NCT01930734|Heart Failure|heart failure
5353971|NCT01930734|Dobutamine|dobutamine
5353972|NCT01930708|BG-12|bg-12
5353973|NCT01930695|DX functionality|dx functionality
5353974|NCT01930695|Atrial fibrillation|atrial fibrillation
5353975|NCT01930695|CRT-D indication|crt-d indication
5353976|NCT01930682|Myocardial Infarction|myocardial infarction
5353977|NCT01930682|Catheterization|catheterization
5353978|NCT01930682|Fibrinolysis|fibrinolysis
5353979|NCT01930669|Heart Rate Variability|heart rate variability
5353980|NCT01930669|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
5963918|NCT04184557|En Calma en el Quirófano|en calma en el quirófano
5220916|NCT02618460|renal diffusion|renal diffusion
5353981|NCT01930669|Critically Ill|critically ill
5353982|NCT01930656|osteoporisis|osteoporisis
5353983|NCT01930656|fracture|fracture
5353984|NCT01930656|risk|risk
5353985|NCT01930656|cost effectiveness|cost effectiveness
5353986|NCT01930656|FRAX|frax
5353987|NCT01930656|mobile device|mobile device
5353988|NCT01930643|Electric muscle stimulation|electric muscle stimulation
5353989|NCT01930643|mechanical ventilation|mechanical ventilation
5353990|NCT01930643|chronic respiratory failure|chronic respiratory failure
5353991|NCT01930630|extraesophageal saline injection (ESI);|extraesophageal saline injection (esi);
5353992|NCT01930630|esophageal squamous cell carcinoma (ESCC);|esophageal squamous cell carcinoma (escc);
5353993|NCT01930630|esophageal cancer;|esophageal cancer;
5353994|NCT01930630|endoscopic ultrasonography (EUS)|endoscopic ultrasonography (eus)
5353995|NCT01930617|surgery|surgery
5353996|NCT01930617|trephining|trephining
5353997|NCT01930617|drainage|drainage
5353998|NCT01930617|therapeutic irrigation|therapeutic irrigation
5353999|NCT01930617|subdural space|subdural space
5354000|NCT01930617|postoperative complications|postoperative complications
5354001|NCT01930617|mortality|mortality
5354002|NCT01930604|Palmar hyperhidrosis.|palmar hyperhidrosis.
5354003|NCT01930604|Plantar hyperhidrosis.|plantar hyperhidrosis.
5354004|NCT01930604|Inguinal (groins and buttocks) hyperhidrosis.|inguinal (groins and buttocks) hyperhidrosis.
5354005|NCT01930604|Craniofacial hyperhidrosis.|craniofacial hyperhidrosis.
5354006|NCT01930604|Truncal hyperhidrosis.|truncal hyperhidrosis.
5354007|NCT01930591|fibrinolytic therapy|fibrinolytic therapy
5354008|NCT01930591|stenting|stenting
5354009|NCT01930591|platelet activity|platelet activity
5354010|NCT01930578|bioimpedance analysis|bioimpedance analysis
5354011|NCT01930578|spectroscopy|spectroscopy
5354012|NCT01930578|electrolyte sodium bromide|electrolyte sodium bromide
5354013|NCT01930578|extracellular water|extracellular water
5354014|NCT01930565|acne|acne
5354015|NCT01930565|therapeutics|therapeutics
5354016|NCT01930565|clinical trial|clinical trial
5354017|NCT01930565|natural compound|natural compound
5354018|NCT01930565|Lactobacillus fermented Chamaecypris obtuse|lactobacillus fermented chamaecypris obtuse
5354019|NCT01930565|tea tree oil|tea tree oil
5354020|NCT01930526|COPD|copd
5354021|NCT01930526|Exercise|exercise
5354022|NCT01930526|Cycling|cycling
5354023|NCT01930526|Single leg|single leg
5354024|NCT01930526|Pulmonary Rehabilitation|pulmonary rehabilitation
5354025|NCT01930513|Obesity|obesity
5354026|NCT01930513|Obstructive Sleep Apnea|obstructive sleep apnea
5354027|NCT01930513|Exercise|exercise
5354028|NCT01930513|Walking tests|walking tests
5354029|NCT01930513|Cardiopulmonary exercise tests|cardiopulmonary exercise tests
5354030|NCT01930513|Physical activity|physical activity
5354031|NCT01930487|Primary open angle glaucoma|primary open angle glaucoma
5354032|NCT01930487|intraocular pressure|intraocular pressure
5354033|NCT01930487|ocular perfusion pressure|ocular perfusion pressure
5354034|NCT01930487|retrobulbar blood flow|retrobulbar blood flow
5354035|NCT01930487|retinal capillary blood flow|retinal capillary blood flow
5354036|NCT01930487|choroidal blood flow|choroidal blood flow
5354037|NCT01930474|lung cancer, plasma DNA, free DNA, EGFR, ALK|lung cancer, plasma dna, free dna, egfr, alk
5354038|NCT01930448|Bariatric|bariatric
5354039|NCT01930448|Gastric Bypass|gastric bypass
5354040|NCT01930448|Gastric Banding,|gastric banding,
5354041|NCT01930448|Type 2 Diabetes|type 2 diabetes
5354042|NCT01930448|Incretins|incretins
5354043|NCT01930448|GLP-1|glp-1
5354044|NCT01930448|GIP|gip
5354045|NCT01930448|Insulin secretion|insulin secretion
5354046|NCT01930448|insulin sensitivity|insulin sensitivity
5354047|NCT01930435|Quality of Life|quality of life
5354048|NCT01930422|Direct transcranial electrical stimulation (tDCS)|direct transcranial electrical stimulation (tdcs)
5354049|NCT01930422|Sham procedure|sham procedure
5354050|NCT01930422|Tobacco consumption|tobacco consumption
5354053|NCT01930409|Hip Fractures|hip fractures
5354054|NCT01930409|Frail older adults|frail older adults
5354055|NCT01930409|Quality of Life|quality of life
5354056|NCT01930409|Feasibility Studies|feasibility studies
5354057|NCT01930396|Hemodialysis|hemodialysis
5354058|NCT01930396|Anticoagulation|anticoagulation
5354059|NCT01930396|Tinzaparin|tinzaparin
5354060|NCT01930396|Unfractionated Heparin|unfractionated heparin
5354061|NCT01930396|Randomized Controlled Trial|randomized controlled trial
5354062|NCT01930383|biomarkers|biomarkers
5354063|NCT01930370|pediatrics|pediatrics
5354168|NCT01929681|depression|depression
5354064|NCT01930370|phosphate and postassium revmoval|phosphate and postassium revmoval
5354065|NCT01930370|dialysate bicarbonate modeling|dialysate bicarbonate modeling
5354067|NCT01930357|Purified Vero Rabies Vaccine - Serum Free (VRVg)|purified vero rabies vaccine - serum free (vrvg)
5354068|NCT01930357|Imovax® rabies|imovax® rabies
5354069|NCT01930357|Human Diploid Cell Vaccine|human diploid cell vaccine
5963919|NCT04184557|Staying Calm in the OR|staying calm in the or
5963920|NCT04184284|benralizumab|benralizumab
5963921|NCT04182620|renal denervation|renal denervation
5963922|NCT04182620|atrial fibrillation|atrial fibrillation
5963923|NCT04182620|cardiology|cardiology
5963924|NCT04182620|electrophysiology|electrophysiology
5963925|NCT04182555|Diagnosis|diagnosis
5232994|NCT02546661|AZD2281|azd2281
5354070|NCT01930344|stereopsis|stereopsis
5354071|NCT01930344|3D laparoscopy|3d laparoscopy
5354073|NCT01930331|Uncomplicated Plasmodium falciparum Malaria|uncomplicated plasmodium falciparum malaria
5354074|NCT01930305|Heating transfusion|heating transfusion
5354075|NCT01930279|T cell markers|t cell markers
5354076|NCT01930227|hypotension|hypotension
5354077|NCT01930227|spinal anesthesia|spinal anesthesia
5354078|NCT01930227|cesarean|cesarean
5354079|NCT01930175|Pemphigus vulgaris|pemphigus vulgaris
5354080|NCT01930175|pemphigus|pemphigus
5354081|NCT01930175|blistering disease|blistering disease
5354082|NCT01930162|HSC835|hsc835
5354083|NCT01930162|single umbilical cord blood transplantation|single umbilical cord blood transplantation
5354084|NCT01930162|non-myeloablative conditioning regimen|non-myeloablative conditioning regimen
5354085|NCT01930162|Umbilical cord blood|umbilical cord blood
5354086|NCT01930162|UCB transplantation|ucb transplantation
5354087|NCT01930149|Cholesterol screening|cholesterol screening
5354088|NCT01930149|High cholesterol|high cholesterol
5354089|NCT01930149|Cardiovascular disease|cardiovascular disease
5354090|NCT01930149|Statin treatment|statin treatment
5354091|NCT01930136|Calorie restriction|calorie restriction
5354092|NCT01930136|Type 2 diabetes|type 2 diabetes
5354093|NCT01930136|Obesity|obesity
5354094|NCT01930136|Diabetic nephropathy prevention|diabetic nephropathy prevention
5354095|NCT01930123|Fructose|fructose
5354096|NCT01930123|NASH|nash
5354097|NCT01930123|advanced fibrosis|advanced fibrosis
5354098|NCT01930123|biomarker|biomarker
5354099|NCT01930123|magnetic resonance|magnetic resonance
5354100|NCT01930110|Type 1 diabetes|type 1 diabetes
5354101|NCT01930110|Hypoglycemia|hypoglycemia
5354102|NCT01930110|Insulin|insulin
5354103|NCT01930110|Glucagon|glucagon
5354104|NCT01930110|Closed-loop system|closed-loop system
5354105|NCT01930110|Artificial pancreas|artificial pancreas
5354106|NCT01930097|Type 1 diabetes|type 1 diabetes
5354107|NCT01930097|Hypoglycemia|hypoglycemia
5354108|NCT01930097|Insulin|insulin
5354109|NCT01930097|Glucagon|glucagon
5354110|NCT01930097|Closed-loop system|closed-loop system
5354111|NCT01930097|Artificial pancreas|artificial pancreas
5445432|NCT01521819|V-Ped|v-ped
5354112|NCT01930097|Carbohydrate counting|carbohydrate counting
5354113|NCT01930084|HIV|hiv
5354114|NCT01930084|linkage|linkage
5354115|NCT01930084|retention|retention
5354116|NCT01930032|Clostridium difficile infection|clostridium difficile infection
5354117|NCT01930019|etomidate,|etomidate,
5354118|NCT01930019|thiopental,|thiopental,
5354119|NCT01930019|serum cortisol concentration,|serum cortisol concentration,
5354120|NCT01930006|c-Met|c-met
5354121|NCT01930006|VEGFR|vegfr
5354123|NCT01930006|Cancer|cancer
5354124|NCT01930006|Tumor|tumor
5354125|NCT01930006|Safety|safety
5354126|NCT01930006|Phase 1|phase 1
5354127|NCT01929993|Conization|conization
5354128|NCT01929993|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5354129|NCT01929993|Cervix Dysplasia|cervix dysplasia
5354130|NCT01929993|Therapy|therapy
5354131|NCT01929993|Electrosurgery|electrosurgery
5354132|NCT01929980|HSCT|hsct
5354133|NCT01929980|cytopenia|cytopenia
5354134|NCT01929980|immune suppression|immune suppression
5354135|NCT01929980|proteasome inhibitor|proteasome inhibitor
5354136|NCT01929967|Heterotaxy syndrome|heterotaxy syndrome
5354137|NCT01929967|Asplenia|asplenia
5354138|NCT01929967|Polysplenia|polysplenia
5354139|NCT01929889|schizophrenia|schizophrenia
5354140|NCT01929889|schizoaffective disorder|schizoaffective disorder
5354141|NCT01929889|iloperidone|iloperidone
5354142|NCT01929889|Fanapt|fanapt
5354143|NCT01929889|social cognition|social cognition
5354144|NCT01929889|cognition|cognition
5354145|NCT01929863|Metformin|metformin
5354146|NCT01929863|Diabetes|diabetes
5354147|NCT01929837|Tinnitus|tinnitus
5354148|NCT01929837|Transcranial magnetic stimulation|transcranial magnetic stimulation
5354149|NCT01929824|dysphagia, trouble swallowing, chest pain|dysphagia, trouble swallowing, chest pain
5354150|NCT01929798|artificial pancreas|artificial pancreas
5354151|NCT01929785|post tranplant heart allograft|post tranplant heart allograft
5354153|NCT01929759|neurocognitive symptoms|neurocognitive symptoms
5354154|NCT01929759|efavirenz|efavirenz
5354155|NCT01929759|elvitegravir|elvitegravir
5354156|NCT01929759|neurometabolites|neurometabolites
5354157|NCT01929733|Patent Ductus Arteriosus|patent ductus arteriosus
5354158|NCT01929720|cancer|cancer
5354159|NCT01929720|cancer survivors|cancer survivors
5354160|NCT01929720|worry|worry
5354161|NCT01929720|insomnia|insomnia
5354162|NCT01929720|symptoms|symptoms
5354164|NCT01929720|depression|depression
5354165|NCT01929720|anxiety|anxiety
5354166|NCT01929681|Low Field Magnetic Stimulation|low field magnetic stimulation
5963926|NCT04182555|Cell Phones|cell phones
5963927|NCT04182555|Infant, Newborn|infant, newborn
5354169|NCT01929681|alternative treatment|alternative treatment
5354170|NCT01929668|ulcerative colitis|ulcerative colitis
5354171|NCT01929668|bowel preparation|bowel preparation
5354172|NCT01929655|Phase II|phase ii
5354173|NCT01929655|symptomatic castration-resistant prostate cancer|symptomatic castration-resistant prostate cancer
5963928|NCT04182555|Skin Pigmentation|skin pigmentation
5354174|NCT01929655|bone metastases|bone metastases
5354175|NCT01929642|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5354176|NCT01929642|self-injury|self-injury
5354177|NCT01929642|Autism|autism
5354178|NCT01929629|Phase 1|phase 1
5354179|NCT01929629|Healthy Volunteers|healthy volunteers
5354180|NCT01929629|First Time in Man|first time in man
5354181|NCT01929629|Pharmacokinetics|pharmacokinetics
5354182|NCT01929616|adenocarcinoma, colorectal,regorafenib|adenocarcinoma, colorectal,regorafenib
5354183|NCT01929603|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, CYP P450 inducer|oncology, cancer, tumour, anticancer drug, pharmacokinetics, olaparib, rifampicin, neoplasm, cyp p450 inducer
5354184|NCT01929590|Colonoscopy|colonoscopy
5354185|NCT01929590|Preparation|preparation
5354186|NCT01929590|Polyp|polyp
5354187|NCT01929590|Polyethylene glycol|polyethylene glycol
5354188|NCT01929577|ASP015K|asp015k
5354189|NCT01929577|healthy subjects|healthy subjects
5354190|NCT01929564|cardiovascular disease|cardiovascular disease
5354191|NCT01929564|risk factor|risk factor
5354192|NCT01929564|broccoli|broccoli
5354193|NCT01929564|GST|gst
5354194|NCT01929564|blood pressure|blood pressure
5354195|NCT01929564|Total cholesterol|total cholesterol
5354196|NCT01929551|glycemic index|glycemic index
5354197|NCT01929538|Chronic pancreatitis|chronic pancreatitis
5354198|NCT01929538|Biliary stricture|biliary stricture
5354199|NCT01929538|Endoscopic treatment|endoscopic treatment
5354200|NCT01929538|cSEMS|csems
5354201|NCT01929499|Colon cancer|colon cancer
5354202|NCT01929499|Cytokine-induced killer cells|cytokine-induced killer cells
5354203|NCT01929499|Adjuvant immunotherapy|adjuvant immunotherapy
5354204|NCT01929499|Adjuvant chemotherapy|adjuvant chemotherapy
5354205|NCT01929473|Pertussis infection|pertussis infection
5354206|NCT01929473|Risk factors|risk factors
5354207|NCT01929447|sleep disorders|sleep disorders
5354208|NCT01929447|sleep apnea|sleep apnea
5354209|NCT01929447|ambulatory device|ambulatory device
5354210|NCT01929447|WatchPAT|watchpat
5354211|NCT01929434|cerebral palsy|cerebral palsy
5354212|NCT01929434|cell transplantation|cell transplantation
5354213|NCT01929434|rehabilitation|rehabilitation
5354214|NCT01929421|colorectal cancer|colorectal cancer
5354215|NCT01929421|gemcitabine|gemcitabine
5354216|NCT01929421|S-1|s-1
5354217|NCT01929395|Breast Cancer|breast cancer
5354218|NCT01929395|Breast Conserving Surgery|breast conserving surgery
5354219|NCT01929395|Breast diagnostics|breast diagnostics
5354220|NCT01929395|Breast imaging|breast imaging
5354221|NCT01929382|dose titration|dose titration
5354222|NCT01929382|FLS|fls
5354223|NCT01929382|flu like symptoms|flu like symptoms
5354224|NCT01929382|Actimmune|actimmune
5354225|NCT01929369|ESRD|esrd
5354226|NCT01929369|CKD|ckd
5354227|NCT01929369|AV GRAFTS|av grafts
5354228|NCT01929369|THROMBOSED AV GRAFTS|thrombosed av grafts
5354229|NCT01929356|lung function tests|lung function tests
5354230|NCT01929356|chest physiotherapy|chest physiotherapy
5354231|NCT01929343|cocaine|cocaine
5354232|NCT01929343|addiction|addiction
5354233|NCT01929343|lidocaine|lidocaine
5354234|NCT01929343|memory|memory
5354235|NCT01929343|drug abuse|drug abuse
5354236|NCT01929330|Bioequivalence|bioequivalence
5354237|NCT01929330|Healthy Male Volunteers|healthy male volunteers
5354238|NCT01929330|Androgenetic Alopecia|androgenetic alopecia
5354239|NCT01929330|Dutasteride|dutasteride
5354240|NCT01929330|Safety|safety
5354241|NCT01929330|Tolerability|tolerability
5354242|NCT01929317|Ropinirole|ropinirole
5354243|NCT01929317|Parkinson's disease|parkinson's disease
5354244|NCT01929291|Korea|korea
5354245|NCT01929291|Post-marketing surveillance|post-marketing surveillance
5354246|NCT01929291|Boostrix|boostrix
5354247|NCT01929291|Prescribing information|prescribing information
5354248|NCT01929291|Safety|safety
5354249|NCT01929265|INFL|infl
5354250|NCT01929265|Indolent non-follicular|indolent non-follicular
5354251|NCT01929265|untreated INFL|untreated infl
5354252|NCT01929252|dexmedetomidine|dexmedetomidine
5354253|NCT01929252|wound infiltration|wound infiltration
5354254|NCT01929252|postoperative analgesia|postoperative analgesia
5354255|NCT01929226|anthrax, monoclonal antibody, ETI-204, safety, PK|anthrax, monoclonal antibody, eti-204, safety, pk
5354256|NCT01929187|Onychomycosis, BioEqual carrier system, amorolfine.|onychomycosis, bioequal carrier system, amorolfine.
5354257|NCT01929174|Congenital heart disease|congenital heart disease
5354258|NCT01929174|Myocardial fibrosis|myocardial fibrosis
5354259|NCT01929174|Diastolic dysfunction|diastolic dysfunction
5354260|NCT01929161|positive emotions|positive emotions
5354261|NCT01929161|meditation|meditation
5354262|NCT01929161|oxytocin|oxytocin
5354263|NCT01929148|risk-reducing salpingectomy|risk-reducing salpingectomy
5354264|NCT01929148|prophylactic bilateral salpingectomy|prophylactic bilateral salpingectomy
5354265|NCT01929148|ovarian cancer prevention|ovarian cancer prevention
5354266|NCT01929148|ovarian reserve|ovarian reserve
5354369|NCT01928654|Edema|edema
5354267|NCT01929135|Periodontal Disease|periodontal disease
5963929|NCT04182542|Capacitive Radiofrequency|capacitive radiofrequency
5963930|NCT04182542|Abdominal Adipose Tissue|abdominal adipose tissue
5963931|NCT04182243|Job Satisfaction|job satisfaction
5963932|NCT04182243|Emergency Health Care|emergency health care
5233202|NCT02545374|tablet|tablet
5354268|NCT01929135|Chronic Periodontitis|chronic periodontitis
5354269|NCT01929135|Atorvastatin|atorvastatin
5354270|NCT01929135|Statins|statins
5354271|NCT01929135|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
5354272|NCT01929135|Dentifrice|dentifrice
5354273|NCT01929122|Prevention & control|prevention & control
5354274|NCT01929122|Diet|diet
5354275|NCT01929122|Functional food|functional food
5354276|NCT01929122|Nutrition Assessment|nutrition assessment
5354277|NCT01929122|Oryza sativa|oryza sativa
5354278|NCT01929122|Rice Bran|rice bran
5354279|NCT01929122|Phaseolus vulgaris L.|phaseolus vulgaris l.
5354280|NCT01929122|Legumes|legumes
5354281|NCT01929122|Microbiome|microbiome
5354282|NCT01929122|Metabolomics|metabolomics
5354283|NCT01929122|Prebiotics|prebiotics
5354284|NCT01929083|Torsades de pointes|torsades de pointes
5354285|NCT01929083|Progesterone|progesterone
5354286|NCT01929083|Clinical trial|clinical trial
5354287|NCT01929083|Risk reduction|risk reduction
5354288|NCT01929083|Electrocardiography|electrocardiography
5354289|NCT01929070|HCP1007|hcp1007
5354290|NCT01929070|Rosuvastatin|rosuvastatin
5354291|NCT01929070|Omega-3|omega-3
5354292|NCT01929018|Amputation|amputation
5354293|NCT01929018|Rehabilitation|rehabilitation
5354294|NCT01929018|Exercise|exercise
5354295|NCT01929018|Movement|movement
5354296|NCT01929005|Comprehensive care|comprehensive care
5354297|NCT01929005|Medicare|medicare
5354298|NCT01929005|Cost-sharing|cost-sharing
5354299|NCT01929005|Quality of care|quality of care
5354300|NCT01928992|Mammography|mammography
5354301|NCT01928992|3D|3d
5354302|NCT01928992|Breast Cancer Detection|breast cancer detection
5354303|NCT01928979|LA/LAA Thrombus|la/laa thrombus
5354304|NCT01928979|Atrial Fibrillation|atrial fibrillation
5354305|NCT01928979|Observation|observation
5354306|NCT01928966|dietary fat|dietary fat
5354307|NCT01928966|fat intake|fat intake
5354308|NCT01928966|blood pressure|blood pressure
5354309|NCT01928966|women|women
5354310|NCT01928966|phytoestrogen|phytoestrogen
5354311|NCT01928966|pumpkin seeds|pumpkin seeds
5354312|NCT01928966|cardiovascular disease|cardiovascular disease
5354313|NCT01928966|heart disease|heart disease
5354314|NCT01928966|secoisolariciresinol|secoisolariciresinol
5354315|NCT01928966|monounsaturated fat|monounsaturated fat
5354316|NCT01928966|polyunsaturated fat|polyunsaturated fat
5354317|NCT01928966|feeding study|feeding study
5354318|NCT01928953|opioid induced constipation in patients without cancer and with cancer|opioid induced constipation in patients without cancer and with cancer
5354319|NCT01928940|Advanced solid tumors|advanced solid tumors
5354320|NCT01928940|BRAF|braf
5354321|NCT01928940|Melanoma|melanoma
5354322|NCT01928888|Acute heartburn episodes|acute heartburn episodes
5354323|NCT01928849|Amputation|amputation
5354324|NCT01928849|Post-amputation Pain|post-amputation pain
5354325|NCT01928849|Neuropathic pain|neuropathic pain
5354326|NCT01928849|Valproic Acid|valproic acid
5354327|NCT01928849|Anesthesia, Conduction|anesthesia, conduction
5354328|NCT01928849|Neuralgia, stump|neuralgia, stump
5354329|NCT01928836|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5354330|NCT01928836|Small Cell Lung Carcinoma|small cell lung carcinoma
5354331|NCT01928836|Biological Markers|biological markers
5354332|NCT01928836|ROC Curve|roc curve
5354333|NCT01928836|Delayed Diagnosis|delayed diagnosis
5354334|NCT01928823|agoraphobia|agoraphobia
5354335|NCT01928823|panic disorder|panic disorder
5354336|NCT01928823|D-Cycloserine|d-cycloserine
5354338|NCT01928823|exposure|exposure
5354339|NCT01928823|cognitive behavioral therapy|cognitive behavioral therapy
5354340|NCT01928823|CBT|cbt
5354341|NCT01928823|augmentation|augmentation
5354342|NCT01928810|Panic Disorder|panic disorder
5354343|NCT01928810|Agoraphobia|agoraphobia
5354344|NCT01928810|Physical Activity|physical activity
5354345|NCT01928797|cardiac output pregnancy spinal anesthesia|cardiac output pregnancy spinal anesthesia
5354346|NCT01928784|Low back pain|low back pain
5354347|NCT01928784|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5354348|NCT01928784|Trigger Points|trigger points
5354349|NCT01928771|Asthma,|asthma,
5354350|NCT01928771|Bronchial Diseases,|bronchial diseases,
5354351|NCT01928771|Respiratory Tract Diseases,|respiratory tract diseases,
5354352|NCT01928771|Lung Diseases,|lung diseases,
5354353|NCT01928771|Obstructive Lung Diseases|obstructive lung diseases
5354354|NCT01928758|Smoking|smoking
5354355|NCT01928758|Nicotine|nicotine
5354356|NCT01928745|Stewart approach|stewart approach
5354357|NCT01928745|sepsis|sepsis
5354358|NCT01928745|SIRS|sirs
5354359|NCT01928745|cardiothoracic surgery|cardiothoracic surgery
5354360|NCT01928745|CABG|cabg
5354361|NCT01928719|Smoking|smoking
5354362|NCT01928719|Nicotine|nicotine
5354363|NCT01928706|edentulism|edentulism
5354364|NCT01928706|denture liner|denture liner
5354365|NCT01928706|prosthodontics|prosthodontics
5354367|NCT01928693|infectious corneal ulcers|infectious corneal ulcers
5963933|NCT04182243|Paramedic|paramedic
5354368|NCT01928680|Triple Negative Breast Cancer, Cisplatin, Capecitabine|triple negative breast cancer, cisplatin, capecitabine
5310799|NCT02126033|celiac|celiac
5354370|NCT01928654|Diabetic|diabetic
5354372|NCT01928654|Treatment|treatment
5354373|NCT01928602|Crossover|crossover
5354374|NCT01928602|Chronic stroke|chronic stroke
5354375|NCT01928602|Stroke|stroke
5354376|NCT01928602|Rehabilitation|rehabilitation
5354377|NCT01928602|Language Therapy|language therapy
5354378|NCT01928602|Aphasia|aphasia
5354379|NCT01928602|Aphasia Therapy|aphasia therapy
5354380|NCT01928602|Computerised Therapy|computerised therapy
5354381|NCT01928602|Computerised Rehabilitation|computerised rehabilitation
5354382|NCT01928602|Tablet|tablet
5354383|NCT01928602|Apps|apps
5354384|NCT01928602|Aphasia Rehabilitation|aphasia rehabilitation
5354385|NCT01928602|Rehabilitation on Portable Tablets|rehabilitation on portable tablets
5354386|NCT01928589|Cyclophosphamide|cyclophosphamide
5354387|NCT01928589|Doxorubicin|doxorubicin
5354388|NCT01928589|Docetaxel|docetaxel
5354389|NCT01928589|Carboplatin|carboplatin
5354390|NCT01928589|Herceptin|herceptin
5354391|NCT01928589|Partial Breast Irradiation|partial breast irradiation
5354392|NCT01928589|Concurrent Chemotherapy|concurrent chemotherapy
5354393|NCT01928550|Diabetes|diabetes
5354394|NCT01928550|OCT|oct
5354395|NCT01928550|PDR|pdr
5354396|NCT01928537|International Working Group|international working group
5354397|NCT01928537|azacitidine|azacitidine
5354398|NCT01928537|decitabine|decitabine
5354399|NCT01928524|Gastric cancer|gastric cancer
5354400|NCT01928524|Cancer of the esophagus|cancer of the esophagus
5354401|NCT01928524|Oxaliplatin|oxaliplatin
5354402|NCT01928524|Docetaxel|docetaxel
5354404|NCT01928511|Hepatitis B virus|hepatitis b virus
5354405|NCT01928511|HBeAg positive|hbeag positive
5354406|NCT01928511|HBeAg negative|hbeag negative
5354407|NCT01928511|antiviral therapy|antiviral therapy
5354408|NCT01928511|nucleoside analogues|nucleoside analogues
5354409|NCT01928498|arteriovenous fistulae|arteriovenous fistulae
5354410|NCT01928498|arteriovenous graft|arteriovenous graft
5354411|NCT01928498|restenosis|restenosis
5354412|NCT01928498|angioplasty|angioplasty
5354413|NCT01928498|drug eluting balloon|drug eluting balloon
5354414|NCT01928472|Influenza, H7N9, Vaccine|influenza, h7n9, vaccine
5354415|NCT01928459|BGJ398|bgj398
5354416|NCT01928459|BYL719|byl719
5354417|NCT01928459|advanced solid tumor|advanced solid tumor
5354418|NCT01928459|metastatic breast cancer|metastatic breast cancer
5354419|NCT01928459|PK3CA|pk3ca
5354420|NCT01928459|FGFR|fgfr
5354421|NCT01928459|fibroblast growth factor receptor|fibroblast growth factor receptor
5354422|NCT01928446|Lithium|lithium
5354423|NCT01928446|Placebo|placebo
5354424|NCT01928446|Double-blind methods|double-blind methods
5354425|NCT01928446|Clinical Trials, Randomized|clinical trials, randomized
5354426|NCT01928446|Veterans|veterans
5354427|NCT01928433|Urinary Tract Infection|urinary tract infection
5354428|NCT01928433|Pyelonephritis|pyelonephritis
5354429|NCT01928420|Alzheimer Disease|alzheimer disease
5354430|NCT01928420|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5354431|NCT01928420|Alzheimer's Disease|alzheimer's disease
5354432|NCT01928420|clinical trial|clinical trial
5354433|NCT01928420|dementia|dementia
5354434|NCT01928420|diabetes|diabetes
5354435|NCT01928420|dietary supplements|dietary supplements
5354436|NCT01928420|Senile Dementia, Alzheimer|senile dementia, alzheimer
5354437|NCT01928420|Therapeutics|therapeutics
5354438|NCT01928420|Brain Diseases|brain diseases
5354439|NCT01928420|Central Nervous System Diseases|central nervous system diseases
5354440|NCT01928420|Nervous System Diseases|nervous system diseases
5354441|NCT01928420|Neurodegenerative Diseases|neurodegenerative diseases
5354442|NCT01928420|Delirium, Dementia, Amnestic, Cognitive|delirium, dementia, amnestic, cognitive
5354443|NCT01928420|Disorders|disorders
5354444|NCT01928420|Mental Disorders|mental disorders
5354445|NCT01928407|naives, CD4 < 200 cell/mm3, Atazanavir, Darunavir|naives, cd4 < 200 cell/mm3, atazanavir, darunavir
5354446|NCT01928368|Mild asthma|mild asthma
5354447|NCT01928368|Atopic asthma|atopic asthma
5354448|NCT01928368|Healthy volunteers|healthy volunteers
5354449|NCT01928368|First-in-human|first-in-human
5354450|NCT01928316|Healthy|healthy
5354451|NCT01928316|Bioequivalence|bioequivalence
5354452|NCT01928316|Mizolastine|mizolastine
5354453|NCT01928316|Domestic|domestic
5354454|NCT01928316|Imported|imported
5354455|NCT01928303|opioids|opioids
5354456|NCT01928303|chronic pain|chronic pain
5354457|NCT01928303|oxycodone|oxycodone
5354458|NCT01928303|oxymorphone|oxymorphone
5354459|NCT01928303|patients using opioid pain medication|patients using opioid pain medication
5354460|NCT01928277|Symptom assessment agreement|symptom assessment agreement
5354461|NCT01928277|Work of breathing|work of breathing
5354462|NCT01928264|Mental disorders|mental disorders
5354463|NCT01928264|Physical activity|physical activity
5354464|NCT01928264|Disability pension|disability pension
5354465|NCT01928264|Disability pension due to mental illness|disability pension due to mental illness
5354466|NCT01928264|Ability to work|ability to work
5354467|NCT01928264|Mental toughness|mental toughness
5354470|NCT01928238|noninvasive neurally adjusted ventilatory|noninvasive neurally adjusted ventilatory
5963934|NCT04182243|Emergency Medical Technician|emergency medical technician
5221412|NCT02614989|Tremor|tremor
5354471|NCT01928238|noninvasive pressure support ventilation|noninvasive pressure support ventilation
5354472|NCT01928225|HSIL|hsil
5354474|NCT01928225|HPV|hpv
5354475|NCT01928225|HPV vaccination|hpv vaccination
5354476|NCT01928225|gardasil|gardasil
5354477|NCT01928225|HIV|hiv
5354478|NCT01928225|cervical dysplasia|cervical dysplasia
5354479|NCT01928225|LEEP|leep
5354480|NCT01928225|cervical cancer|cervical cancer
5354481|NCT01928212|retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
5354482|NCT01928212|optical coherence tomography|optical coherence tomography
5354483|NCT01928212|Parkinson disease|parkinson disease
5354484|NCT01928199|diabetes|diabetes
5354485|NCT01928199|transplant|transplant
5354486|NCT01928199|kidney|kidney
5354487|NCT01928173|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5354488|NCT01928173|Cognitive Therapy|cognitive therapy
5354489|NCT01928160|Non-small cell lung cancer, EGFR mutation, erlotinib acquired resistance|non-small cell lung cancer, egfr mutation, erlotinib acquired resistance
5354490|NCT01928147|NS5B polymerase inhibitor|ns5b polymerase inhibitor
5354491|NCT01928147|Phase 1|phase 1
5354492|NCT01928147|Genotype 1|genotype 1
5354494|NCT01928134|Vitamin D3|vitamin d3
5354495|NCT01928134|Bioavailability of calcium|bioavailability of calcium
5354496|NCT01928134|volunteers|volunteers
5354497|NCT01928134|Men|men
5354498|NCT01928134|non-pregnant women|non-pregnant women
5354499|NCT01928134|twenty years of age|twenty years of age
5354500|NCT01928121|nurse|nurse
5354501|NCT01928121|expert program|expert program
5354502|NCT01928121|primary care|primary care
5354503|NCT01928121|implementation|implementation
5354504|NCT01928121|interdisciplinary|interdisciplinary
5354505|NCT01928121|effectiveness|effectiveness
5354506|NCT01928121|disease management system|disease management system
5354507|NCT01928095|atherosclerosis|atherosclerosis
5354508|NCT01928095|carotid endartherectomy|carotid endartherectomy
5354509|NCT01928082|Hypercalciuria, Familial Idiopathic|hypercalciuria, familial idiopathic
5354510|NCT01928082|Hypercalciuria|hypercalciuria
5354511|NCT01928082|Osteopenia|osteopenia
5354512|NCT01928082|Osteoporosis|osteoporosis
5354513|NCT01928082|Postmenopausal women|postmenopausal women
5354514|NCT01928004|edentulous|edentulous
5354515|NCT01928004|complete denture|complete denture
5354516|NCT01927991|tinnitus|tinnitus
5354517|NCT01927991|cognitive behavioural therapy|cognitive behavioural therapy
5354518|NCT01927991|internet treatment|internet treatment
5354519|NCT01927978|Esophageal cancer|esophageal cancer
5354520|NCT01927978|18F-FDG PET|18f-fdg pet
5354521|NCT01927978|staging|staging
5354522|NCT01927978|therapy planning|therapy planning
5354523|NCT01927978|therapy response monitoring|therapy response monitoring
5354524|NCT01927978|prognosis|prognosis
5354525|NCT01927965|gastrointestinal tract|gastrointestinal tract
5354526|NCT01927965|GI tract|gi tract
5354527|NCT01927965|advanced gastrointestinal tumors|advanced gastrointestinal tumors
5354528|NCT01927965|gastrointestinal tumors|gastrointestinal tumors
5354530|NCT01927965|biliary|biliary
5354531|NCT01927965|gallbladder,|gallbladder,
5354532|NCT01927965|colorectal,|colorectal,
5354533|NCT01927965|gastric,|gastric,
5354534|NCT01927965|hepatocellular|hepatocellular
5354535|NCT01927965|esophageal|esophageal
5354536|NCT01927965|pancreatic|pancreatic
5354537|NCT01927952|hammertoe|hammertoe
5354538|NCT01927939|Breast cancer; bone metastases; 18F-FDG PET; 99mTc bone scintigraphy; therapy response monitoring; prognosis|breast cancer; bone metastases; 18f-fdg pet; 99mtc bone scintigraphy; therapy response monitoring; prognosis
5354539|NCT01927926|Energy intake|energy intake
5354540|NCT01927926|appetite|appetite
5354541|NCT01927926|satiety|satiety
5963935|NCT04182243|Nurse|nurse
5963936|NCT04181606|Esmolol hydrochloride|esmolol hydrochloride
5963937|NCT04181606|Coronary blood flow|coronary blood flow
5963938|NCT04181294|Palliative Care|palliative care
5963939|NCT04181294|Medical Futility|medical futility
5963940|NCT04181294|Intensive Care|intensive care
5963941|NCT04179864|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5963942|NCT04179864|tazemetostat|tazemetostat
5963943|NCT04179864|EPZ-6438|epz-6438
5963944|NCT04179864|E7438|e7438
5963945|NCT04179864|enzalutamide|enzalutamide
5963946|NCT04179864|abiraterone|abiraterone
5963947|NCT04179864|Prednisone|prednisone
5963948|NCT04179864|Zytiga|zytiga
5963949|NCT04179864|Xtandi|xtandi
5963950|NCT04179409|DMD|dmd
5963951|NCT04179409|Exon Skipping|exon skipping
5963952|NCT04177823|belantamab mafodotin|belantamab mafodotin
5963953|NCT04177823|DLT|dlt
5963954|NCT04177823|RRMM|rrmm
5963955|NCT04176900|Radiation Therapy|radiation therapy
5963956|NCT04176900|Radiation Dosimetry|radiation dosimetry
5963957|NCT04176900|Patient Reported Outcomes|patient reported outcomes
5963958|NCT04176900|3D-printed bolus|3d-printed bolus
5963959|NCT04176354|Breast cancer|breast cancer
5963960|NCT04176354|Palbociclib|palbociclib
5963961|NCT04176354|Real-world data|real-world data
5963962|NCT04176354|Retrospective study|retrospective study
5963963|NCT04176354|Effectiveness|effectiveness
5963964|NCT04176250|Rifampicin-sensitive pulmonary tuberculosis|rifampicin-sensitive pulmonary tuberculosis
5963965|NCT04176250|TBA-7371|tba-7371
5963966|NCT04176250|Pulmonary tuberculosis|pulmonary tuberculosis
5963967|NCT04176172|Smoking Cessation|smoking cessation
5963968|NCT04176172|Nicotine Dependence|nicotine dependence
5963969|NCT04176172|HIV/AIDS|hiv/aids
5963970|NCT04176172|Varenicline|varenicline
5963971|NCT04176172|Nicotine Patch|nicotine patch
5354542|NCT01927926|gut hormones|gut hormones
5354543|NCT01927900|Human milk oligosaccharides|human milk oligosaccharides
5354544|NCT01927900|Microbiota|microbiota
5354545|NCT01927900|Prebiotics|prebiotics
5354546|NCT01927887|Papillary Carcinoma of Thyroid|papillary carcinoma of thyroid
5354547|NCT01927887|Follicular thyroid cancer lymph node metastasis|follicular thyroid cancer lymph node metastasis
5354548|NCT01927887|Metastatic medullary thyroid cancer|metastatic medullary thyroid cancer
5354549|NCT01927874|infiltration|infiltration
5354550|NCT01927874|hemorrhoidectomy|hemorrhoidectomy
5354551|NCT01927874|Postoperative pain|postoperative pain
5354552|NCT01927822|termination of pregnancy, abortion|termination of pregnancy, abortion
5354553|NCT01927809|Hereditary Diseases|hereditary diseases
5354555|NCT01927783|Cardiovascular Disease|cardiovascular disease
5354556|NCT01927783|Obesity|obesity
5354557|NCT01927770|WES|wes
5354558|NCT01927770|Informed Consent|informed consent
5354559|NCT01927770|WGS|wgs
5354560|NCT01927757|rheumatoid arthritis|rheumatoid arthritis
5354561|NCT01927757|etanercept|etanercept
5354562|NCT01927757|arthritis|arthritis
5354563|NCT01927757|adalimumab failure to respond|adalimumab failure to respond
5354564|NCT01927757|loss of response to adalimumab|loss of response to adalimumab
5354565|NCT01927757|ACR20|acr20
5354566|NCT01927757|methotrexate|methotrexate
5354567|NCT01927757|Swollen joints|swollen joints
5350560|NCT01946464|bearded|bearded
5354568|NCT01927757|tender joints|tender joints
5354569|NCT01927744|Head and Neck Cancer|head and neck cancer
5354570|NCT01927744|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5354572|NCT01927744|Oral cavity squamous cell carcinomas|oral cavity squamous cell carcinomas
5354573|NCT01927744|Docetaxel|docetaxel
5354574|NCT01927744|Taxotere|taxotere
5354575|NCT01927744|Erlotinib|erlotinib
5354576|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride
5354577|NCT01927744|OSI-774|osi-774
5354578|NCT01927744|CP358774|cp358774
5354579|NCT01927744|Tarceva|tarceva
5354580|NCT01927744|Questionnaire|questionnaire
5354581|NCT01927744|Survey|survey
5354582|NCT01927744|Phone call|phone call
5354583|NCT01927718|Blood And Marrow Transplantation|blood and marrow transplantation
5354584|NCT01927718|Myeloma|myeloma
5354585|NCT01927718|Multiple myeloma|multiple myeloma
5354586|NCT01927718|MM|mm
5354587|NCT01927718|Autologous stem cell transplantation|autologous stem cell transplantation
5354588|NCT01927718|ASCT|asct
5354589|NCT01927718|Thalidomide|thalidomide
5354590|NCT01927718|Thalomid|thalomid
5354591|NCT01927718|Lenalidomide|lenalidomide
5354592|NCT01927718|CC-5013|cc-5013
5354593|NCT01927718|Revlimid|revlimid
5354594|NCT01927718|Questionnaires|questionnaires
5354595|NCT01927718|Surveys|surveys
5354596|NCT01927705|Atopic dermatitis|atopic dermatitis
5354597|NCT01927705|Stem cell|stem cell
5354598|NCT01927705|Cell therapy|cell therapy
5354599|NCT01927705|skin disease|skin disease
5354600|NCT01927705|furestem|furestem
5354601|NCT01927705|AD|ad
5354602|NCT01927705|hUCB-MSC|hucb-msc
5354603|NCT01927705|UCB-MSC|ucb-msc
5354604|NCT01927705|Umbilical cord Blood|umbilical cord blood
5354605|NCT01927692|MG|mg
5354606|NCT01927666|glucoraphanin|glucoraphanin
5354607|NCT01927666|broccoli|broccoli
5354608|NCT01927666|gut microbiota|gut microbiota
5354609|NCT01927653|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
5354610|NCT01927653|Dysexecutive mild cognitive impairment|dysexecutive mild cognitive impairment
5354611|NCT01927653|Diffusion MRI|diffusion mri
5354612|NCT01927640|Cocaine|cocaine
5354613|NCT01927640|Dexmedetomidine|dexmedetomidine
5354614|NCT01927640|Myocardial Contrast Echocardiography|myocardial contrast echocardiography
5354615|NCT01927627|Prostate cancer|prostate cancer
5354616|NCT01927627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5354617|NCT01927627|Enzalutamide|enzalutamide
5354618|NCT01927614|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5354619|NCT01927614|Cardiac MRI|cardiac mri
5354620|NCT01927614|Cardiac CT|cardiac ct
5354621|NCT01927614|Observational study|observational study
5354622|NCT01927601|TAVR|tavr
5354623|NCT01927601|aortic disease|aortic disease
5354624|NCT01927588|Certican|certican
5354625|NCT01927588|Renal Transplant|renal transplant
5354626|NCT01927588|Cytomegalovirus Infection|cytomegalovirus infection
5354627|NCT01927575|TOMOSYNTHESIS|tomosynthesis
5354628|NCT01927549|cardiogenic shock|cardiogenic shock
5354629|NCT01927549|infarction|infarction
5354630|NCT01927549|multivessel coronary artery disease|multivessel coronary artery disease
5354631|NCT01927549|angioplasty|angioplasty
5354632|NCT01927523|Youth violence|youth violence
5354633|NCT01927523|Crime|crime
5354634|NCT01927523|Educational achievement|educational achievement
5354635|NCT01927510|Early mobilization, rehabilitation, intensive care|early mobilization, rehabilitation, intensive care
5354636|NCT01927497|Rectal cancer|rectal cancer
5354637|NCT01927497|Extralevator abdominoperineal resection|extralevator abdominoperineal resection
5354638|NCT01927497|Biological Mesh|biological mesh
5354639|NCT01927497|Primary closure|primary closure
5354640|NCT01927484|methotrexate,|methotrexate,
5354641|NCT01927484|osteoarthritis,|osteoarthritis,
5354642|NCT01927484|pain,|pain,
5354643|NCT01927484|function,|function,
5354644|NCT01927484|synovitis|synovitis
5354645|NCT01927471|Menstrual cycles|menstrual cycles
5354646|NCT01927471|Ultrasound|ultrasound
5354647|NCT01927471|Ovary|ovary
5354648|NCT01927471|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5354649|NCT01927471|Physical activity|physical activity
5354650|NCT01927471|Diet|diet
5354651|NCT01927432|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5354652|NCT01927432|Nutrition|nutrition
5354653|NCT01927432|Metabolism|metabolism
5354654|NCT01927432|Antral follicle growth|antral follicle growth
5354655|NCT01927432|Menstrual Cyclicity|menstrual cyclicity
5354656|NCT01927406|Thyroid Eye Disease|thyroid eye disease
5354657|NCT01927406|Graves' Disease|graves' disease
5354658|NCT01927406|Prostaglandin Analogues|prostaglandin analogues
5354659|NCT01927380|autonomic nervous system modulation|autonomic nervous system modulation
5354660|NCT01927380|heart rate variability|heart rate variability
5354661|NCT01927380|prostatectomy|prostatectomy
5354662|NCT01927380|steep trendelenburg|steep trendelenburg
5354663|NCT01927380|pneumoperitoneum|pneumoperitoneum
5354664|NCT01927367|Clinical Decision Support System|clinical decision support system
5354665|NCT01927367|Primary Health Care|primary health care
5354666|NCT01927367|Clinical Practice Guidelines|clinical practice guidelines
5350649|NCT01946074|ABBV-181|abbv-181
5354667|NCT01927354|Head-and-Neck squamous cell carcinoma (HNSCC)|head-and-neck squamous cell carcinoma (hnscc)
5354668|NCT01927354|epithelial-mesenchymal transition (EMT)|epithelial-mesenchymal transition (emt)
5354669|NCT01927354|microRNA29|microrna29
5354670|NCT01927354|Twist1|twist1
5354671|NCT01927341|MEK162,|mek162,
5354672|NCT01927341|panitumumab,|panitumumab,
5354673|NCT01927341|mutant RAS,|mutant ras,
5354674|NCT01927341|wild-type RAS,|wild-type ras,
5354675|NCT01927341|metastatic colorectal cancer,|metastatic colorectal cancer,
5354676|NCT01927341|adult mCRC patient|adult mcrc patient
5354677|NCT01927328|Adenocarcinoma|adenocarcinoma
5354678|NCT01927328|Anemia|anemia
5354679|NCT01927328|Palliative therapy|palliative therapy
5354680|NCT01927328|Palliative care|palliative care
5354681|NCT01927328|Palliative treatments|palliative treatments
5354682|NCT01927328|Chemotherapy|chemotherapy
5354683|NCT01927328|Esophageal Cancer|esophageal cancer
5354684|NCT01927328|Gastric Cancer|gastric cancer
5354685|NCT01927315|Stem cells|stem cells
5354686|NCT01927315|Regeneration|regeneration
5354687|NCT01927315|Angiogenesis|angiogenesis
5354688|NCT01927315|Prevention|prevention
5354690|NCT01927302|Dysgraphia|dysgraphia
5354691|NCT01927302|Anomia|anomia
5354692|NCT01927302|Agrammatism|agrammatism
5354693|NCT01927302|Stroke|stroke
5354694|NCT01927302|Language Recovery|language recovery
5354695|NCT01927302|Treatment|treatment
5354696|NCT01927302|Biomarkers of Recovery|biomarkers of recovery
5354697|NCT01927289|Ultrasound|ultrasound
5354698|NCT01927289|supraclavicular block|supraclavicular block
5354699|NCT01927289|distal forearm block|distal forearm block
5354700|NCT01927289|Grip Strength|grip strength
5354701|NCT01927289|Satisfaction|satisfaction
5354702|NCT01927276|Schizophrenia|schizophrenia
5354703|NCT01927276|Gluten|gluten
5354704|NCT01927250|cohort study|cohort study
5354705|NCT01927250|diet program|diet program
5354706|NCT01927250|art therapy|art therapy
5354707|NCT01927250|laying-on-of-hands|laying-on-of-hands
5354708|NCT01927250|quality of life|quality of life
5354709|NCT01927237|pulmonary artery pressure|pulmonary artery pressure
5354710|NCT01927237|ARDS|ards
5354711|NCT01927237|alveolar hypoventilation|alveolar hypoventilation
5354712|NCT01927237|hypercapnic acidosis|hypercapnic acidosis
5354713|NCT01927237|permissive hypercapnia|permissive hypercapnia
5354714|NCT01927237|myocardial strain|myocardial strain
5354715|NCT01927185|central venous access|central venous access
5354716|NCT01927185|ultrasonography|ultrasonography
5354717|NCT01927185|subclavian vein|subclavian vein
5354718|NCT01927185|pneumothorax|pneumothorax
5354719|NCT01927185|vessel view|vessel view
5354720|NCT01927159|Tuberculosis|tuberculosis
5354722|NCT01927159|Pulmonary|pulmonary
5354723|NCT01927159|Vaccine|vaccine
5354724|NCT01927159|Adjuvant|adjuvant
5354725|NCT01927146|Lauren classification|lauren classification
5354726|NCT01927146|HER2 status|her2 status
5354727|NCT01927146|Resectable gastric cancer|resectable gastric cancer
5354728|NCT01927133|Fibrosis, HBV, HCV, ALD, NAFLD|fibrosis, hbv, hcv, ald, nafld
5354729|NCT01927120|GVHD|gvhd
5354730|NCT01927120|Allogeneic|allogeneic
5354731|NCT01927120|Hematopoietic Cell Transplant|hematopoietic cell transplant
5354732|NCT01927107|probiotics|probiotics
5354733|NCT01927107|obesity|obesity
5354734|NCT01927107|oxidative stress|oxidative stress
5354735|NCT01927094|probiotics, diarrhea|probiotics, diarrhea
5354736|NCT01927055|NOH|noh
5963972|NCT04176172|Cigarette Smoking|cigarette smoking
5963973|NCT04176172|Managed Problem Solving|managed problem solving
5963974|NCT04176159|Developmental Coordination Disorder|developmental coordination disorder
5963975|NCT04176159|Task-Oriented Training|task-oriented training
5354737|NCT01927055|OH|oh
5354738|NCT01927055|PD|pd
5354739|NCT01927055|MSA|msa
5354741|NCT01927055|DBH|dbh
5354742|NCT01927042|Eating Disorders|eating disorders
5354743|NCT01927042|Carers|carers
5354744|NCT01927029|twin pregnancy|twin pregnancy
5354745|NCT01927029|progesterone|progesterone
5354746|NCT01927029|preterm delivery|preterm delivery
5354747|NCT01927029|>14 years|>14 years
5354748|NCT01927029|Abscense of cerclage,|abscense of cerclage,
5354749|NCT01927029|TTTS, hemorrage,|ttts, hemorrage,
5354750|NCT01927029|history of thrombosis.|history of thrombosis.
5354751|NCT01927029|cervix >15mm|cervix >15mm
5354752|NCT01927016|Esophageal Neoplasm|esophageal neoplasm
5354753|NCT01927016|Esophagus|esophagus
5354754|NCT01927016|Surgery|surgery
5354755|NCT01927016|Outcome assessment|outcome assessment
5354756|NCT01927003|defect,|defect,
5354757|NCT01927003|dorsal branch of the digital artery,|dorsal branch of the digital artery,
5354758|NCT01927003|dorsal digital flap,|dorsal digital flap,
5354759|NCT01927003|dorsal metacarpal artery flap.|dorsal metacarpal artery flap.
5358558|NCT01909453|Cancer|cancer
5249920|NCT02445339|Emergency Room|emergency room
5354760|NCT01926964|Adjuvant treatment recommendation|adjuvant treatment recommendation
5354761|NCT01926964|Early breast cancer|early breast cancer
5354762|NCT01926964|Oncotype DX|oncotype dx
5354763|NCT01926964|Genetic profiling|genetic profiling
5354764|NCT01926951|hypertension|hypertension
5354765|NCT01926925|Type 2 diabetes, Endothelium, children/adolescents|type 2 diabetes, endothelium, children/adolescents
5354766|NCT01926912|Schizophrenia|schizophrenia
5354767|NCT01926912|Paliperidone Palmitate|paliperidone palmitate
5354768|NCT01926912|Hospital setting|hospital setting
5354769|NCT01926912|Schizophrenic Disorders|schizophrenic disorders
5354771|NCT01926860|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5354773|NCT01926860|hepatitis A vaccine|hepatitis a vaccine
5354774|NCT01926847|Digital ischemia|digital ischemia
5354775|NCT01926847|Raynaud's phenomenon|raynaud's phenomenon
5354776|NCT01926834|promoting angiogenesis in multiple targets|promoting angiogenesis in multiple targets
5354777|NCT01926834|herbal medicine|herbal medicine
5354778|NCT01926834|traditional chinese medicine|traditional chinese medicine
5354779|NCT01926834|random clinical trial|random clinical trial
5354780|NCT01926795|toddler's fracture|toddler's fracture
5354781|NCT01926795|tibial fracture|tibial fracture
5354782|NCT01926795|children|children
5354783|NCT01926769|Colorectal cancer|colorectal cancer
5354784|NCT01926769|Metformin|metformin
5354785|NCT01926769|FOLFOX6|folfox6
5354786|NCT01926769|FOFIRI|fofiri
5354788|NCT01926769|irinotecan|irinotecan
5354789|NCT01926769|oxaliplatin|oxaliplatin
5354790|NCT01926756|bacteriuria|bacteriuria
5354791|NCT01926756|straight catheterization|straight catheterization
5354792|NCT01926756|urinary tract infections|urinary tract infections
5354793|NCT01926756|iatrogenic|iatrogenic
5354794|NCT01926743|near infrared|near infrared
5354795|NCT01926743|fluorescence imaging|fluorescence imaging
5354796|NCT01926743|indocyanine green|indocyanine green
5354797|NCT01926743|gastrectomy|gastrectomy
5354798|NCT01926717|Single Roux-y of Pancreaticojejunostomy-choledochojejunostomy|single roux-y of pancreaticojejunostomy-choledochojejunostomy
5354799|NCT01926691|dementia|dementia
5354800|NCT01926691|poststroke cognitive impairment|poststroke cognitive impairment
5354801|NCT01926691|inflammation|inflammation
5354803|NCT01926678|swedish massage|swedish massage
5354804|NCT01926678|fatigue|fatigue
5354805|NCT01926678|light touch|light touch
5354806|NCT01926678|inflammation|inflammation
5354807|NCT01926665|Blood And Marrow Transplantation|blood and marrow transplantation
5354808|NCT01926665|Mantle cell lymphoma|mantle cell lymphoma
5354809|NCT01926665|MCL|mcl
5354810|NCT01926665|T-cell lymphoma|t-cell lymphoma
5354811|NCT01926665|TCL|tcl
5354812|NCT01926665|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5354813|NCT01926665|DLBCL|dlbcl
5354814|NCT01926665|Autologous stem cell transplantation|autologous stem cell transplantation
5354815|NCT01926665|ASCT|asct
5354816|NCT01926665|Carfilzomib|carfilzomib
5354817|NCT01926665|CFZ|cfz
5354818|NCT01926665|Dexamethasone|dexamethasone
5354819|NCT01926665|Decadron|decadron
5354820|NCT01926639|Follicular lymphoma|follicular lymphoma
5354821|NCT01926639|Rituximab|rituximab
5354822|NCT01926639|Autologous dendritic cells|autologous dendritic cells
5354823|NCT01926639|Cancer vaccine|cancer vaccine
5354824|NCT01926626|Nicotine addiction|nicotine addiction
5354825|NCT01926626|Smoking Cessation|smoking cessation
5354826|NCT01926626|Quit Smoking|quit smoking
5354827|NCT01926626|moclobemide|moclobemide
5354828|NCT01926626|Nicotine Patch|nicotine patch
5354829|NCT01926613|Schizophrenia|schizophrenia
5354830|NCT01926613|Chronic Mental Disorder|chronic mental disorder
5354831|NCT01926613|Employment|employment
5354832|NCT01926613|Cognitive remediation|cognitive remediation
5354833|NCT01926613|Vocational rehabilitation|vocational rehabilitation
5354834|NCT01926600|gastric ulcer|gastric ulcer
5963976|NCT04176159|Motor Imagery|motor imagery
5963977|NCT04176159|Physical Therapy|physical therapy
5963978|NCT04175873|music therapy|music therapy
5963979|NCT04175873|pain|pain
5354835|NCT01926600|duodenal ulcer|duodenal ulcer
5963980|NCT04175873|oxidative stress|oxidative stress
5963981|NCT04175665|semaglutide|semaglutide
5354836|NCT01926600|re-bleeding rate|re-bleeding rate
5354837|NCT01926600|intragastric pH|intragastric ph
5354838|NCT01926600|proton pump inhibitor|proton pump inhibitor
5354839|NCT01926587|rigosertib|rigosertib
5354840|NCT01926587|ON 01910.Na|on 01910.na
5354841|NCT01926587|azacitidine|azacitidine
5354842|NCT01926587|Vidaza|vidaza
5354843|NCT01926574|absenteeism|absenteeism
5354844|NCT01926574|rehabilitation|rehabilitation
5354845|NCT01926574|return to work|return to work
5354846|NCT01926561|Hypotensive bradycardic event|hypotensive bradycardic event
5354847|NCT01926561|Interscalene brachial plexus block|interscalene brachial plexus block
5354848|NCT01926561|Sitting position|sitting position
5354849|NCT01926561|Shoulder arthroscopic surgery|shoulder arthroscopic surgery
5354850|NCT01926548|Pharmacokinetics|pharmacokinetics
5354851|NCT01926548|Safety|safety
5354852|NCT01926535|amniotic membrane|amniotic membrane
5354853|NCT01926535|contact lens|contact lens
5354854|NCT01926535|bullous keratopathy|bullous keratopathy
5354855|NCT01926522|Exercise Therapy|exercise therapy
5354856|NCT01926483|Stage IIIA-N2 NSCLC|stage iiia-n2 nsclc
5354857|NCT01926470|epidural injections, intravascular injection|epidural injections, intravascular injection
5354858|NCT01926457|First trimester treatment of prediabetes|first trimester treatment of prediabetes
5423307|NCT01616251|Protein sources|protein sources
5354859|NCT01926457|First trimester treatment of gestational diabetes|first trimester treatment of gestational diabetes
5354860|NCT01926457|Umbilical cord C-Peptide|umbilical cord c-peptide
5354861|NCT01926457|Neonatal fat mass|neonatal fat mass
5354862|NCT01926457|Gestational weight gain|gestational weight gain
5354863|NCT01926457|Infant obesity|infant obesity
5354864|NCT01926444|colonoscopy|colonoscopy
5354865|NCT01926444|sedation-free|sedation-free
5354866|NCT01926444|colorectal cancer|colorectal cancer
5354867|NCT01926444|CRC screening|crc screening
5354868|NCT01926444|prevention|prevention
5354870|NCT01926444|colonic|colonic
5354871|NCT01926444|kappa|kappa
5354872|NCT01926444|opioid agonist|opioid agonist
5354873|NCT01926444|pain management|pain management
5354875|NCT01926444|hydrogen sulfide|hydrogen sulfide
5354876|NCT01926444|peripheral|peripheral
5354877|NCT01926418|HIV|hiv
5354878|NCT01926418|Condoms|condoms
5354879|NCT01926418|Men who have sex with men|men who have sex with men
5354880|NCT01926418|implementation intentions|implementation intentions
5354881|NCT01926418|executive function|executive function
5354882|NCT01926405|hypersomnia|hypersomnia
5354883|NCT01926405|narcolepsy|narcolepsy
5354884|NCT01926405|amylase|amylase
5354885|NCT01926405|salivary sampling|salivary sampling
5354886|NCT01926379|Ethiopia|ethiopia
5354887|NCT01926379|TB|tb
5354888|NCT01926379|tuberculosis|tuberculosis
5354889|NCT01926379|HIV|hiv
5354890|NCT01926379|IPT|ipt
5354891|NCT01926379|isoniazid|isoniazid
5354892|NCT01926379|adherence|adherence
5354893|NCT01926379|combination intervention package|combination intervention package
5354894|NCT01926379|retention|retention
5354895|NCT01926353|Vesicoureteral Reflux (VUR)|vesicoureteral reflux (vur)
5354896|NCT01926353|Complicated Urinary Tract Infection|complicated urinary tract infection
5354898|NCT01926353|Polyacrylate Polyalcohol Copolymer|polyacrylate polyalcohol copolymer
5354899|NCT01926327|PRP PRGF Osteoarthritis|prp prgf osteoarthritis
5354900|NCT01926301|sepsis|sepsis
5354901|NCT01926301|cerebrovascular autoregulation|cerebrovascular autoregulation
5354902|NCT01926301|delirium|delirium
5354903|NCT01926275|COPD|copd
5354904|NCT01926275|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5354905|NCT01926275|Respiratory Muscle Training|respiratory muscle training
5354906|NCT01926262|Pain, Neck, Exercise, Pilots, Crewmembers,|pain, neck, exercise, pilots, crewmembers,
5354907|NCT01926249|Alzheimer's disease|alzheimer's disease
5354908|NCT01926249|Mild Cognitive Impairment|mild cognitive impairment
5354909|NCT01926210|Poor ovarian response|poor ovarian response
5354910|NCT01926210|in vitro fertilization|in vitro fertilization
5354911|NCT01926210|mild ovarian stimulation|mild ovarian stimulation
5354912|NCT01926210|controlled ovarian stimulation|controlled ovarian stimulation
5354913|NCT01926184|HIV/AIDS|hiv/aids
5354914|NCT01926184|Treatment as Prevention|treatment as prevention
5354915|NCT01926184|Methamphetamine|methamphetamine
5354916|NCT01926184|Cocaine|cocaine
5354917|NCT01926184|HIV viral Load|hiv viral load
5354918|NCT01926158|Denosumab|denosumab
5354919|NCT01926158|Osteoporosis|osteoporosis
5354920|NCT01926158|Hip replacement|hip replacement
5354921|NCT01926158|Osteoarthritis|osteoarthritis
5354922|NCT01926158|Radiostereometric analysis (RSA)|radiostereometric analysis (rsa)
5354923|NCT01926158|Dual energy X-ray absorptiometry (DXA)|dual energy x-ray absorptiometry (dxa)
5354924|NCT01926132|ascorbic acid|ascorbic acid
5354925|NCT01926132|fatigue|fatigue
5963982|NCT04175665|retrospective study|retrospective study
5963983|NCT04175665|hemoglobin A1c|hemoglobin a1c
5963984|NCT04175665|body weight|body weight
5963985|NCT04175392|Fatty Liver|fatty liver
5963986|NCT04175392|Fibrosis|fibrosis
5963987|NCT04175392|Cirrhosis|cirrhosis
5963988|NCT04175392|Probiotic|probiotic
5963989|NCT04175392|Steatohepatitis|steatohepatitis
5963990|NCT04175392|Elastography|elastography
5963991|NCT04174560|Healthy Adults|healthy adults
5963992|NCT04174560|Norovirus GII.4 CIN-3|norovirus gii.4 cin-3
5354926|NCT01926132|mitochondrial DNA|mitochondrial dna
5354927|NCT01926132|patient for more than 6 months|patient for more than 6 months
5354928|NCT01926106|Nasal Intermittent Positive-Pressure Ventilation|nasal intermittent positive-pressure ventilation
5354929|NCT01926106|Nasal Continuous Positive Airway Pressure|nasal continuous positive airway pressure
5354930|NCT01926106|twin|twin
5354931|NCT01926106|respiratory distress syndrome|respiratory distress syndrome
5354932|NCT01926093|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5354933|NCT01926080|Depression|depression
5354934|NCT01926080|Spirituality|spirituality
5354935|NCT01926080|Neonatal death|neonatal death
5354936|NCT01926080|Bereavement|bereavement
5354937|NCT01926080|Randomized controlled trial|randomized controlled trial
5354938|NCT01926067|Accelerometer|accelerometer
5354939|NCT01926067|Cardiopulmonary by pass|cardiopulmonary by pass
5354940|NCT01926041|community|community
5354941|NCT01926041|preventive medicine|preventive medicine
5354942|NCT01926041|prediabetes|prediabetes
5354943|NCT01926041|smoking cessation|smoking cessation
5354944|NCT01926028|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
5354945|NCT01926028|candida|candida
5354946|NCT01926028|NDV3|ndv3
5354947|NCT01926028|vaginal thrush|vaginal thrush
5354948|NCT01926028|chronic yeast infection|chronic yeast infection
5354949|NCT01925976|obesity|obesity
5354950|NCT01925976|dietetic intervention|dietetic intervention
5354951|NCT01925976|eating behaviors|eating behaviors
5354952|NCT01925976|children|children
5354953|NCT01925976|healthy eating|healthy eating
5354954|NCT01925976|energy dense foods|energy dense foods
5354955|NCT01925963|Normal|normal
5354956|NCT01925963|Traumatic brain injury|traumatic brain injury
5354957|NCT01925963|Neuroimaging|neuroimaging
5423308|NCT01616251|Appetite|appetite
5354958|NCT01925963|Hyperbaric oxygen|hyperbaric oxygen
5354959|NCT01925963|Neurobehavioral symptom inventory|neurobehavioral symptom inventory
5354961|NCT01925950|orBec|orbec
5354962|NCT01925950|GVHD|gvhd
5354963|NCT01925950|beclomethasone dipropionate|beclomethasone dipropionate
5354964|NCT01925950|bone marrow transplant|bone marrow transplant
5354965|NCT01925950|hematopoietic cell transplant|hematopoietic cell transplant
5354966|NCT01925950|HCT|hct
5354967|NCT01925950|stem cell transplant|stem cell transplant
5354975|NCT01925924|Dental cements|dental cements
5354976|NCT01925924|Orthodontic adhesives|orthodontic adhesives
5354977|NCT01925924|Glass ionomer cement|glass ionomer cement
5354978|NCT01925924|Tooth demineralization|tooth demineralization
5354979|NCT01925911|Phase 1|phase 1
5354980|NCT01925911|Healthy subjects|healthy subjects
5354982|NCT01925911|CYP3A|cyp3a
5354983|NCT01925898|Laceration|laceration
5354984|NCT01925898|Sedation|sedation
5354985|NCT01925898|Pediatrics|pediatrics
5354986|NCT01925885|Atrial Arrhythmia|atrial arrhythmia
5354987|NCT01925872|ischemic cerebrovascular disease|ischemic cerebrovascular disease
5354988|NCT01925872|Percutaneous transluminal angioplasty and stenting|percutaneous transluminal angioplasty and stenting
5354989|NCT01925872|Clopidogrel resistance|clopidogrel resistance
5354990|NCT01925859|Pharmacokinetic analysis|pharmacokinetic analysis
5354992|NCT01925846|Pseudomonas aeruginosa|pseudomonas aeruginosa
5354993|NCT01925846|type three secretory system|type three secretory system
5354994|NCT01925846|contact lens associated microbial keratitis|contact lens associated microbial keratitis
5354995|NCT01925820|Hepatitis B,Entecavir,Pegylated IFN|hepatitis b,entecavir,pegylated ifn
5354996|NCT01925807|Adolescent|adolescent
5354997|NCT01925807|Suicidal Ideation|suicidal ideation
5354998|NCT01925807|Emergency Department|emergency department
5354999|NCT01925807|Crisis|crisis
5355000|NCT01925807|Attachment|attachment
5355001|NCT01925807|Coping|coping
5355002|NCT01925794|Stent, Coronary Arteries for Early healing|stent, coronary arteries for early healing
5355003|NCT01925781|Smoking Cessation|smoking cessation
5355004|NCT01925781|Nicotine Addiction|nicotine addiction
5355005|NCT01925781|e-Cigarette|e-cigarette
5355006|NCT01925781|electronic nicotine delivery device|electronic nicotine delivery device
5355007|NCT01925781|electronic cigarette|electronic cigarette
5355008|NCT01925781|nicotine replacement therapy|nicotine replacement therapy
5355009|NCT01925768|Apremilast, Psoriatic Arthritis, PDE4 inhibitor|apremilast, psoriatic arthritis, pde4 inhibitor
5355010|NCT01925755|Non-interventional|non-interventional
5355011|NCT01925755|Rivaroxaban|rivaroxaban
5355012|NCT01925755|Prevention in prior stroke or TIA|prevention in prior stroke or tia
5355013|NCT01925755|Russian Federation|russian federation
5355014|NCT01925742|Fetal aneuploidy|fetal aneuploidy
5355015|NCT01925729|middle ear|middle ear
5355016|NCT01925729|allergy|allergy
5355017|NCT01925729|nose|nose
5355018|NCT01925716|cholesterol,LDL|cholesterol,ldl
5355019|NCT01925716|vegetable oils|vegetable oils
5355020|NCT01925716|heart diseases|heart diseases
5355021|NCT01925690|Multiple Sclerosis|multiple sclerosis
5355022|NCT01925690|Disease modifying medication|disease modifying medication
5355023|NCT01925690|Relapsing-Remitting MS|relapsing-remitting ms
5355024|NCT01925690|Motivational Interviewing|motivational interviewing
5355025|NCT01925690|Telephone Counseling|telephone counseling
5233979|NCT02540395|IFN-γ|ifn-γ
5355026|NCT01925677|Transplant|transplant
5355027|NCT01925677|donor|donor
5355028|NCT01925677|nephrectomy|nephrectomy
5355029|NCT01925677|robotic|robotic
5355030|NCT01925677|laparoscopy|laparoscopy
5355031|NCT01925677|single-port|single-port
5355032|NCT01925664|Doulas|doulas
5355033|NCT01925664|Parenting|parenting
5355034|NCT01925664|Breastfeeding|breastfeeding
5355035|NCT01925664|Pregnancy in Adolescence|pregnancy in adolescence
5355036|NCT01925651|Post Mastectomy Radiotherapy|post mastectomy radiotherapy
5355037|NCT01925651|Breast Cancer|breast cancer
5355038|NCT01925651|Bolus|bolus
5355039|NCT01925651|Radiodermatitis|radiodermatitis
5355040|NCT01925638|Healthy Volunteers|healthy volunteers
5355041|NCT01925638|Refametinib|refametinib
5355042|NCT01925638|Ketoconazole|ketoconazole
5355043|NCT01925638|Pharmacokinetics|pharmacokinetics
5355044|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal
5355045|NCT01925612|Antibody-Drug Conjugate|antibody-drug conjugate
5355046|NCT01925612|Antigens, CD30|antigens, cd30
5355047|NCT01925612|Drug Therapy|drug therapy
5355048|NCT01925612|Hematologic Diseases|hematologic diseases
5355049|NCT01925612|Lymphoma, B-cell|lymphoma, b-cell
5355050|NCT01925612|Lymphoma, Large B-cell, Diffuse|lymphoma, large b-cell, diffuse
5355051|NCT01925612|Monomethyl auristatin E|monomethyl auristatin e
5355052|NCT01925599|Nevus|nevus
5355053|NCT01925599|Choroidal Melanoma|choroidal melanoma
5355054|NCT01925599|BAP1 mutation|bap1 mutation
5358853|NCT01908062|HIV|hiv
5355064|NCT01925495|middle ear|middle ear
5355065|NCT01925495|feedback pathways|feedback pathways
5355273|NCT01924689|Malignancy|malignancy
5355066|NCT01925495|middle-ear pressure|middle-ear pressure
5355067|NCT01925482|middle ear|middle ear
5355068|NCT01925482|otitis|otitis
5355069|NCT01925482|gas exchange|gas exchange
5355070|NCT01925469|Hysterosalpingogram|hysterosalpingogram
5355071|NCT01925469|HSG|hsg
5355072|NCT01925469|Pain relief|pain relief
5355073|NCT01925469|Analgesia|analgesia
5355074|NCT01925469|Benzocaine|benzocaine
5355075|NCT01925456|urge urinary incontinence|urge urinary incontinence
5355076|NCT01925443|diabetes mellitus non-insulin-dependent|diabetes mellitus non-insulin-dependent
5355077|NCT01925443|low level laser therapy|low level laser therapy
5355078|NCT01925430|Observational|observational
5355079|NCT01925430|Sleep|sleep
5355080|NCT01925430|Algorithm|algorithm
5355081|NCT01925417|Clostridium difficile|clostridium difficile
5355083|NCT01925417|Microbiota Restoration Therapy|microbiota restoration therapy
5355084|NCT01925417|MRT|mrt
5355085|NCT01925417|microbiota suspension|microbiota suspension
5355086|NCT01925417|CDI|cdi
5355087|NCT01925417|CDAD|cdad
5355088|NCT01925417|Fecal transplant|fecal transplant
5355089|NCT01925417|Fecal Microbiota Transplant|fecal microbiota transplant
5355090|NCT01925417|FMT|fmt
5355091|NCT01925417|Diarrhea|diarrhea
5355092|NCT01925417|Fecal bacteriotherapy|fecal bacteriotherapy
5355093|NCT01925404|Physical activity|physical activity
5355094|NCT01925404|parks|parks
5355095|NCT01925404|programming|programming
5355096|NCT01925404|public health|public health
5355097|NCT01925391|Pediatric glaucoma|pediatric glaucoma
5355098|NCT01925391|Intraocular pressure|intraocular pressure
5355099|NCT01925391|pediatric glaucoma diagnosis|pediatric glaucoma diagnosis
5355100|NCT01925391|Volatiles and intraocular pressure|volatiles and intraocular pressure
5355101|NCT01925391|nitrous oxide|nitrous oxide
5355102|NCT01925391|Tetracaine|tetracaine
5355103|NCT01925378|Cervical Dysplasia|cervical dysplasia
5355104|NCT01925352|ischemic heart disease|ischemic heart disease
5355105|NCT01925352|adenovirus|adenovirus
5355106|NCT01925352|hepatocyte growth factor|hepatocyte growth factor
5355107|NCT01925313|Safety|safety
5355108|NCT01925313|Pharmacokinetics|pharmacokinetics
5355109|NCT01925300|Pharmacokinetics|pharmacokinetics
5355110|NCT01925300|Pharmacodynamics|pharmacodynamics
5355111|NCT01925300|Safety|safety
5355112|NCT01925300|Tolerability|tolerability
5355113|NCT01925287|bioavailability|bioavailability
5355114|NCT01925287|curcumin|curcumin
5355115|NCT01925287|curcuma longa|curcuma longa
5355116|NCT01925287|healthy humans|healthy humans
5355117|NCT01925287|safety|safety
5355118|NCT01925287|sex differences|sex differences
5355119|NCT01925274|metastatic colorectal cancer|metastatic colorectal cancer
5355120|NCT01925274|colorectal cancer|colorectal cancer
5355121|NCT01925274|KRAS|kras
5355122|NCT01925274|colon cancer|colon cancer
5355123|NCT01925274|mCRC|mcrc
5355124|NCT01925274|CRC|crc
5963993|NCT04174560|Optimal Human Challenge Dose|optimal human challenge dose
5963994|NCT04173572|Walking|walking
5963995|NCT04173572|Exercise|exercise
5963996|NCT04173572|Physical Health|physical health
5963997|NCT04173494|Myelofibrosis|myelofibrosis
5355125|NCT01925274|PF-05212384|pf-05212384
5355126|NCT01925274|KRAS wild type colorectal cancer|kras wild type colorectal cancer
5355127|NCT01925274|irinotecan|irinotecan
5355128|NCT01925274|cetuximab|cetuximab
5355129|NCT01925274|NRAS|nras
5355130|NCT01925261|knee osteoarthritis|knee osteoarthritis
5355131|NCT01925261|bilateral|bilateral
5355132|NCT01925261|osteoarthritis|osteoarthritis
5963998|NCT04173494|JAK inhibitor|jak inhibitor
5355133|NCT01925248|Whey protein|whey protein
5355134|NCT01925248|protein supplement|protein supplement
5355135|NCT01925248|Diabetes|diabetes
5355136|NCT01925248|Type 2 DM|type 2 dm
5355137|NCT01925248|Hyperglycemia|hyperglycemia
5355138|NCT01925248|Insulin secretagogue|insulin secretagogue
5355139|NCT01925235|remote ischemic preconditioning|remote ischemic preconditioning
5355140|NCT01925235|acute kidney injury|acute kidney injury
5355141|NCT01925235|TAVI|tavi
5355142|NCT01925235|RenPRO trial|renpro trial
5355143|NCT01925235|parameters|parameters
5355144|NCT01925209|sporadic inclusion body myositis,|sporadic inclusion body myositis,
5355145|NCT01925209|myositis,|myositis,
5355146|NCT01925209|muscle wasting,|muscle wasting,
5358942|NCT01907607|Orally|orally
5355157|NCT01925196|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5355158|NCT01925196|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5355160|NCT01925183|HIV/HCV-coinfection|hiv/hcv-coinfection
5355161|NCT01925183|HIV/HCV coinfection|hiv/hcv coinfection
5355162|NCT01925183|HIV/HCV|hiv/hcv
5355163|NCT01925183|Response-guided therapy|response-guided therapy
5355164|NCT01925170|Dense breast tissue|dense breast tissue
5355165|NCT01925170|Breast Cancer Screening|breast cancer screening
5355166|NCT01925170|Molecular Breast Imaging|molecular breast imaging
5355167|NCT01925170|Breast Cancer|breast cancer
5355168|NCT01925170|Breast|breast
5355169|NCT01925105|Polypharmacy|polypharmacy
5355170|NCT01925092|Cushing's disease|cushing's disease
5355171|NCT01925092|Mifepristone|mifepristone
5355172|NCT01925092|Cushing's syndrome|cushing's syndrome
5355173|NCT01925092|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
5355174|NCT01925092|Child/pediatric population|child/pediatric population
5355175|NCT01925092|Safety-efficacy|safety-efficacy
5355176|NCT01925079|acute coronary syndrome|acute coronary syndrome
5355177|NCT01925079|statins|statins
5355178|NCT01925079|LDL-C|ldl-c
5355179|NCT01925079|intensive education|intensive education
5355182|NCT01925027|Neointimal hyperplasia|neointimal hyperplasia
5355184|NCT01925027|3 month|3 month
5355185|NCT01925014|Appendectomy|appendectomy
5355186|NCT01925014|Appendicitis|appendicitis
5355187|NCT01925014|False Positive Reactions|false positive reactions
5355188|NCT01925014|Humans|humans
5355189|NCT01925014|Radiation Dosage|radiation dosage
5355190|NCT01925014|Tomography, X-Ray Computed|tomography, x-ray computed
5355191|NCT01925014|Young Adult|young adult
5355192|NCT01925001|Sickle cell anemia|sickle cell anemia
5355193|NCT01925001|Sickle cell disease|sickle cell disease
5355194|NCT01925001|Sickling crisis|sickling crisis
5355195|NCT01925001|Vaso-occlusive crisis|vaso-occlusive crisis
5355196|NCT01925001|Carboxyhemoglobin|carboxyhemoglobin
5355197|NCT01925001|Oxygen therapeutic|oxygen therapeutic
5355198|NCT01925001|Ischemic rescue therapy|ischemic rescue therapy
5355199|NCT01925001|Hemoglobin solution|hemoglobin solution
5355200|NCT01925001|Pegylated hemoglobin|pegylated hemoglobin
5355201|NCT01924988|BPH, benign prostatic hyperplasia|bph, benign prostatic hyperplasia
5355202|NCT01924962|chronic occlusion of coronary artery|chronic occlusion of coronary artery
5355203|NCT01924962|left ventricular function|left ventricular function
5355204|NCT01924962|revascularisation|revascularisation
5355205|NCT01924949|7977|7977
5355206|NCT01924949|5885|5885
5355207|NCT01924949|GS-7977|gs-7977
5355208|NCT01924949|GS-5885|gs-5885
5355209|NCT01924949|SOF|sof
5355210|NCT01924949|LDV|ldv
5355211|NCT01924949|Sofosbuvir|sofosbuvir
5355212|NCT01924949|Ledipasvir|ledipasvir
5355213|NCT01924949|FDC|fdc
5355214|NCT01924923|uveal melanoma|uveal melanoma
5355215|NCT01924923|biopsy|biopsy
5355216|NCT01924923|enucleation|enucleation
5355217|NCT01924923|ocular cancer|ocular cancer
5355218|NCT01924910|Healthy, by self report|healthy, by self report
5355219|NCT01924897|CPET test|cpet test
5355220|NCT01924897|Exercise training|exercise training
5355221|NCT01924897|Prehabilitation|prehabilitation
5355222|NCT01924897|Exercise Test|exercise test
5355223|NCT01924884|Vacuum-Assisted Closure|vacuum-assisted closure
5355224|NCT01924884|Topical Negative-Pressure Therapy|topical negative-pressure therapy
5355225|NCT01924884|Negative-Pressure Dressings|negative-pressure dressings
5355226|NCT01924858|PET, healthy subjects|pet, healthy subjects
5355227|NCT01924858|Lp-PLA2|lp-pla2
5355228|NCT01924858|positron emission tomography|positron emission tomography
5355229|NCT01924858|Alzheimer's disease|alzheimer's disease
5355230|NCT01924858|brain exposure|brain exposure
5355231|NCT01924858|GSK2647544|gsk2647544
5355232|NCT01924819|Gastric cancer|gastric cancer
5355233|NCT01924819|Stomach cancer|stomach cancer
5355234|NCT01924819|Chemoradiotherapy|chemoradiotherapy
5355235|NCT01924819|Surgery|surgery
5355236|NCT01924819|Chemotherapy|chemotherapy
5355237|NCT01924819|Neoadjuvant|neoadjuvant
5355269|NCT01924715|personality disorder|personality disorder
5355270|NCT01924689|Phase 1|phase 1
5355271|NCT01924689|Metastatic Disease|metastatic disease
5355272|NCT01924689|Solid Tumor|solid tumor
5355274|NCT01924689|Metastases|metastases
5963999|NCT04173494|Danazol|danazol
5964000|NCT04173494|Momelotinib|momelotinib
5964001|NCT04173494|Functional Iron deficiency|functional iron deficiency
5964002|NCT04173494|ACVR1|acvr1
5234239|NCT02538822|ATA|ata
5355275|NCT01924689|Clinical Trial|clinical trial
5355276|NCT01924689|Hypoxia|hypoxia
5355277|NCT01924689|Necrosis|necrosis
5355278|NCT01924689|Intratumoral|intratumoral
5355279|NCT01924689|Locally advanced cancer|locally advanced cancer
5355280|NCT01924689|Immunotherapy|immunotherapy
5355281|NCT01924689|Sarcoma|sarcoma
5355282|NCT01924689|Chordoma|chordoma
5355283|NCT01924689|Bacteriolytic|bacteriolytic
5355284|NCT01924676|food effect|food effect
5355285|NCT01924676|pharmacokinetics|pharmacokinetics
5355286|NCT01924676|bioavailability|bioavailability
5355287|NCT01924676|oxycodone|oxycodone
5355288|NCT01924676|management of moderate to severe pain|management of moderate to severe pain
5355289|NCT01924663|Heart Failure|heart failure
5355290|NCT01924663|Acute Kidney Injury|acute kidney injury
5355291|NCT01924663|Myocardial Dysfunction|myocardial dysfunction
5355292|NCT01924663|Pediatric Critical Care|pediatric critical care
5355293|NCT01924663|Pediatric Intensive Care Units|pediatric intensive care units
5355294|NCT01924663|Respiratory Virus|respiratory virus
5355295|NCT01924611|Dental caries|dental caries
5355296|NCT01924611|Atraumatic Restorative Technique|atraumatic restorative technique
5355297|NCT01924598|Anorexia Nervosa|anorexia nervosa
5355298|NCT01924598|Treatment Development|treatment development
5355299|NCT01924598|Capacity|capacity
5355300|NCT01924598|Neuroimaging|neuroimaging
5355301|NCT01924598|Magnetoencephalography|magnetoencephalography
5355302|NCT01924598|functional MRI|functional mri
5355303|NCT01924598|Reward processing|reward processing
5355304|NCT01924598|Habit formation|habit formation
5355305|NCT01924585|Colorectal|colorectal
5355307|NCT01924585|Frailty|frailty
5355308|NCT01924585|Elderly|elderly
5355309|NCT01924585|Quality of Life|quality of life
5355310|NCT01924572|umbilical cord clamping|umbilical cord clamping
5355311|NCT01924572|Placental residual blood volume|placental residual blood volume
5355312|NCT01924572|hematocrit|hematocrit
5355313|NCT01924572|hemoglobin|hemoglobin
5355314|NCT01924572|bilirubin|bilirubin
5355315|NCT01924559|Airway|airway
5355317|NCT01924546|hydration|hydration
5355318|NCT01924546|schoolchildren|schoolchildren
5355319|NCT01924520|Antipsychotic|antipsychotic
5355320|NCT01924520|FK949E|fk949e
5355321|NCT01924520|Quetiapine|quetiapine
5355322|NCT01924507|Sleep medicine|sleep medicine
5355323|NCT01924507|Sleep apnea|sleep apnea
5355324|NCT01924507|Acute myocardial infarction|acute myocardial infarction
5355325|NCT01924507|Heart failure|heart failure
5355326|NCT01924507|CPAP|cpap
5355327|NCT01924494|telemedicine, tele-endoscopy|telemedicine, tele-endoscopy
5355328|NCT01924481|Caffeine|caffeine
5355329|NCT01924481|Flavonoids|flavonoids
5355331|NCT01924481|Brain blood flow|brain blood flow
5355332|NCT01924481|Cognition|cognition
5355333|NCT01924481|Perfusion|perfusion
5355334|NCT01924481|Resting functional magnetic resonance imaging (fMRI)|resting functional magnetic resonance imaging (fmri)
5355335|NCT01924468|Cognitive Control|cognitive control
5355336|NCT01924468|fMRI|fmri
5355337|NCT01924468|Genetics|genetics
5355338|NCT01924468|Dopamine|dopamine
5355339|NCT01924455|HIV|hiv
5355340|NCT01924455|HBV|hbv
5355341|NCT01924442|Coronary Artery Disease|coronary artery disease
5355342|NCT01924442|Off-Pump|off-pump
5355343|NCT01924442|Myocardial Ischemia|myocardial ischemia
5355344|NCT01924442|Heart Disease|heart disease
5355345|NCT01924429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5355346|NCT01924429|ADHD|adhd
5355347|NCT01924429|fMRI|fmri
5355348|NCT01924429|Imaging|imaging
5355349|NCT01924429|Vyvanse|vyvanse
5355350|NCT01924429|Stimulant Medication|stimulant medication
5355351|NCT01924429|Treatment|treatment
5355352|NCT01924429|Clinical Trial|clinical trial
5355353|NCT01924429|Adult|adult
5355354|NCT01924403|TKA|tka
5355355|NCT01924403|Wound Closure|wound closure
5355356|NCT01924403|Wound Perfusion|wound perfusion
5355362|NCT01924364|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5355364|NCT01924351|Breast Cancer with Brain Metastasis|breast cancer with brain metastasis
5355365|NCT01924351|HER2-positive|her2-positive
5355366|NCT01924351|HER-2 therapy|her-2 therapy
5355367|NCT01924338|Patient|patient
5355368|NCT01924338|localisation|localisation
5355369|NCT01924338|in cranial|in cranial
5355370|NCT01924338|radiation|radiation
5355371|NCT01924338|therapy|therapy
5355372|NCT01924338|thickness of|thickness of
5964003|NCT04173494|Anemia|anemia
5355373|NCT01924325|apixaban|apixaban
5355374|NCT01924325|clopidogrel|clopidogrel
5355375|NCT01924325|aspirin|aspirin
5355376|NCT01924325|new oral anticoagulant|new oral anticoagulant
5355377|NCT01924325|TIA|tia
5355378|NCT01924325|acute minor ischemic stroke|acute minor ischemic stroke
5355576|NCT01923376|PSE|pse
5355379|NCT01924312|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity|stroke, dementia, hypertension, diabetes, hyperlipidemia, smoking, obesity
5355381|NCT01924286|Tuberculosis|tuberculosis
5355382|NCT01924286|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5355383|NCT01924286|Highly active antiretroviral therapy|highly active antiretroviral therapy
5964004|NCT04173494|Transfusion|transfusion
5355384|NCT01924286|Glucocorticoids|glucocorticoids
5355386|NCT01924286|Preventive therapy|preventive therapy
5355387|NCT01924273|Port Wine Stain Birthmarks|port wine stain birthmarks
5355388|NCT01924234|Remifentanil|remifentanil
5355389|NCT01924234|Pharyngeal dysfunction|pharyngeal dysfunction
5355390|NCT01924234|Subjective swallowing difficulties|subjective swallowing difficulties
5355391|NCT01924234|Pulmonary aspiration|pulmonary aspiration
5355392|NCT01924208|Timothy|timothy
5355393|NCT01924208|Influenza|influenza
5355394|NCT01924208|Interferon|interferon
5355395|NCT01924208|T cell|t cell
5355396|NCT01924208|Tonsil|tonsil
5355397|NCT01924195|lung|lung
5355398|NCT01924195|Anlotinib|anlotinib
5355399|NCT01924195|AL3818|al3818
5355400|NCT01924195|NSCLC|nsclc
5355401|NCT01924195|Cancer|cancer
5355402|NCT01924182|chronic pain|chronic pain
5355403|NCT01924182|inadequate pain relief|inadequate pain relief
5355404|NCT01924182|intolerable side effects|intolerable side effects
5355405|NCT01924169|Hematologic Disorder|hematologic disorder
5355406|NCT01924169|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5355408|NCT01924169|Hypogammaglobulinemia|hypogammaglobulinemia
5355409|NCT01924169|Impaired Response to Vaccinations|impaired response to vaccinations
5355410|NCT01924169|Immunoglobulins|immunoglobulins
5355411|NCT01924169|Immune system's function|immune system's function
5355412|NCT01924169|Lenalidomide|lenalidomide
5355413|NCT01924169|CC-5013|cc-5013
5355414|NCT01924169|Revlimid|revlimid
5355415|NCT01924169|Flu vaccine|flu vaccine
5355416|NCT01924169|TIV|tiv
5355417|NCT01924169|Pneumonia vaccine|pneumonia vaccine
5355418|NCT01924143|ADHD|adhd
5355419|NCT01924143|Fibromyalgia|fibromyalgia
5355420|NCT01924117|cervical intraepithelial neoplasia, HPV, Cancer|cervical intraepithelial neoplasia, hpv, cancer
5355421|NCT01924104|IVF failure, implantation rate, heparin & aspirin|ivf failure, implantation rate, heparin & aspirin
5355422|NCT01924078|breast cancer|breast cancer
5355423|NCT01924078|metronomic chemotherapy|metronomic chemotherapy
5355424|NCT01924078|aromatase inhibitors|aromatase inhibitors
5355425|NCT01924065|Atrial fibrillation, conversion, stroke|atrial fibrillation, conversion, stroke
5355427|NCT01924039|Substance Use|substance use
5355428|NCT01924039|Motivational Enhancement Therapy|motivational enhancement therapy
5355429|NCT01924026|Phenylketonuria|phenylketonuria
5355430|NCT01924026|Mild Hyperphenylalaninemia|mild hyperphenylalaninemia
5355431|NCT01924026|PKU|pku
5355432|NCT01924026|MHP|mhp
5355433|NCT01924013|Pregnancy|pregnancy
5355434|NCT01924013|Infant Growth|infant growth
5355435|NCT01924013|Vitamin D|vitamin d
5355436|NCT01924013|Bangladesh|bangladesh
5355437|NCT01923987|Short course radiotherapy|short course radiotherapy
5355438|NCT01923987|Modified FOLFOX6|modified folfox6
5355439|NCT01923987|Delayed surgery|delayed surgery
5355440|NCT01923987|Rectal cancer|rectal cancer
5355441|NCT01923987|Synchronous metastasis|synchronous metastasis
5355442|NCT01923987|Liver metastasis|liver metastasis
5355443|NCT01923987|Lung metastasis|lung metastasis
5355444|NCT01923961|Maintenance hemodialysis or hemodiafiltration|maintenance hemodialysis or hemodiafiltration
5355445|NCT01923961|>18 years|>18 years
5355446|NCT01923961|Stable condition|stable condition
5355447|NCT01923948|Hepatocellular carcinoma|hepatocellular carcinoma
5355448|NCT01923948|Hepatectomy|hepatectomy
5355449|NCT01923948|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
5355450|NCT01923948|Postoperative Pain|postoperative pain
5355451|NCT01923935|Multiple myeloma, busulfan, melphalan,transplantation|multiple myeloma, busulfan, melphalan,transplantation
5355452|NCT01923922|glioblastoma multiforme|glioblastoma multiforme
5355453|NCT01923922|CT Perfusion|ct perfusion
5355454|NCT01923922|Survival|survival
5355455|NCT01923909|Knee|knee
5355456|NCT01923909|Osteoarthritis|osteoarthritis
5355457|NCT01923909|Bahrain|bahrain
5355458|NCT01923909|PRP|prp
5355459|NCT01923909|Steroid|steroid
5355460|NCT01923909|WOMAC|womac
5355461|NCT01923909|Oxford Knee Score|oxford knee score
5355462|NCT01923909|Platelet-rich plasma|platelet-rich plasma
5355463|NCT01923896|food refusal|food refusal
5355464|NCT01923896|behavioral intervention|behavioral intervention
5355465|NCT01923896|D-cycloserine|d-cycloserine
5355466|NCT01923844|Newborn|newborn
5355467|NCT01923844|perfusion index|perfusion index
5355468|NCT01923844|pulsatility index|pulsatility index
5355469|NCT01923844|respiratory distress syndrome|respiratory distress syndrome
5355470|NCT01923844|surfactant|surfactant
5355471|NCT01923844|transcutaneous carbon monoxide|transcutaneous carbon monoxide
5355472|NCT01923831|Magnesium, Post operative sore throat, Prone position, Tracheal intubation|magnesium, post operative sore throat, prone position, tracheal intubation
5355473|NCT01923818|rivaroxaban|rivaroxaban
5355474|NCT01923818|aspirin|aspirin
5355475|NCT01923818|new oral anticoagulant|new oral anticoagulant
5355477|NCT01923818|acute minor ischemic stroke|acute minor ischemic stroke
5355478|NCT01923792|House Dust Mite Allergy|house dust mite allergy
5355479|NCT01923792|Rhinoconjunctivitis|rhinoconjunctivitis
5355480|NCT01923792|Environmental Exposure Unit|environmental exposure unit
5355481|NCT01923792|Immunotherapy|immunotherapy
5355482|NCT01923792|ToleroMune HDM|toleromune hdm
5234353|NCT02538016|Cystinuria|cystinuria
5355483|NCT01923779|Grass allergy|grass allergy
5355484|NCT01923779|Rhinoconjunctivitis|rhinoconjunctivitis
5355485|NCT01923779|Environmental Exposure Unit|environmental exposure unit
5355486|NCT01923779|Immunotherapy|immunotherapy
5355487|NCT01923779|ToleroMune Grass|toleromune grass
5355488|NCT01923766|Transplantation|transplantation
5355489|NCT01923753|Cystic Fibrosis|cystic fibrosis
5355490|NCT01923753|Neural respiratory drive|neural respiratory drive
5355491|NCT01923753|Airway clearance technique|airway clearance technique
5355492|NCT01923753|Expectoration|expectoration
5355493|NCT01923753|Positive expiratory pressure device|positive expiratory pressure device
5355494|NCT01923740|Absorb™ BVS|absorb™ bvs
5355496|NCT01923740|Bioabsorbable|bioabsorbable
5355497|NCT01923740|BVS|bvs
5355498|NCT01923740|Bioresorbable|bioresorbable
5355499|NCT01923740|Coronary Artery Disease|coronary artery disease
5355500|NCT01923740|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5355501|NCT01923740|Coronary artery restenosis|coronary artery restenosis
5355502|NCT01923740|Coronary artery stenosis|coronary artery stenosis
5355503|NCT01923740|Coronary scaffold|coronary scaffold
5355504|NCT01923740|Coronary Stent|coronary stent
5355505|NCT01923740|Drug eluting stents|drug eluting stents
5355506|NCT01923740|Everolimus|everolimus
5355507|NCT01923740|Myocardial ischemia|myocardial ischemia
5355508|NCT01923740|Stent thrombosis|stent thrombosis
5355509|NCT01923740|Stents|stents
5355510|NCT01923727|[89Zr]Df-IAB2M|[89zr]df-iab2m
5355511|NCT01923727|Prostate|prostate
5355512|NCT01923727|PET Scan|pet scan
5355513|NCT01923714|Glaucoma|glaucoma
5355514|NCT01923701|At Risk Mental State|at risk mental state
5355515|NCT01923701|Attenuated Psychosis Syndrome|attenuated psychosis syndrome
5355516|NCT01923701|Prodrom|prodrom
5355517|NCT01923701|Paranoia|paranoia
5355518|NCT01923701|Psychosis|psychosis
5355519|NCT01923701|Cognitive Behavioral Therapy|cognitive behavioral therapy
5355520|NCT01923701|Group|group
5355521|NCT01923701|Family|family
5355522|NCT01923701|ARMS|arms
5351442|NCT01942395|Diet|diet
5355523|NCT01923688|Prediction Prevention Severe Hypoglycemia RealTime Alert|prediction prevention severe hypoglycemia realtime alert
5355524|NCT01923675|myopia|myopia
5355525|NCT01923675|nearsightedness|nearsightedness
5355526|NCT01923675|axial elongation of the eye|axial elongation of the eye
5355527|NCT01923675|refractive error|refractive error
5355528|NCT01923662|Paraplegia|paraplegia
5355529|NCT01923662|Tetraplegia|tetraplegia
5355530|NCT01923662|Spinal Cord Injury|spinal cord injury
5355531|NCT01923662|FES|fes
5355532|NCT01923649|postoperative dumping|postoperative dumping
5355533|NCT01923649|somatostatin analogues|somatostatin analogues
5355534|NCT01923649|somatulin|somatulin
5355535|NCT01923649|lanreotide|lanreotide
5355536|NCT01923649|dumping syndrome|dumping syndrome
5355537|NCT01923636|Cytomegalovirus, congenital, handicap|cytomegalovirus, congenital, handicap
5355538|NCT01923610|Low risk HIV infection|low risk hiv infection
5355539|NCT01923610|HIV Seronegativity|hiv seronegativity
5355540|NCT01923610|HIV Preventive Vaccine|hiv preventive vaccine
5355541|NCT01923597|Proteinuria|proteinuria
5355542|NCT01923597|Oxidative stress|oxidative stress
5355543|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate
5355544|NCT01923545|PEG-G-CSF|peg-g-csf
5355545|NCT01923493|neck pain|neck pain
5355546|NCT01923493|tuina|tuina
5355547|NCT01923467|smoking|smoking
5355548|NCT01923467|nicotine replacement|nicotine replacement
5355550|NCT01923454|paracentesis|paracentesis
5355551|NCT01923454|primary acute angle closure|primary acute angle closure
5355552|NCT01923454|iridotomy|iridotomy
5355553|NCT01923454|filtration|filtration
5355554|NCT01923454|glaucoma|glaucoma
5355555|NCT01923415|Lupus Erythematosus, Subacute, Cutaneous|lupus erythematosus, subacute, cutaneous
5355556|NCT01923415|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5355557|NCT01923415|Lupus Erythematosus, Discoid|lupus erythematosus, discoid
5355558|NCT01923415|Active Cutaneous Lupus Erythematosus|active cutaneous lupus erythematosus
5355559|NCT01923415|Systemic Cutaneous Lupus Erythematosus|systemic cutaneous lupus erythematosus
5355560|NCT01923415|Skin Biopsy|skin biopsy
5355561|NCT01923415|Lesions|lesions
5355562|NCT01923402|Biomarkers|biomarkers
5355563|NCT01923402|Metabolic Profiling|metabolic profiling
5355564|NCT01923402|Metabolomics|metabolomics
5355565|NCT01923402|Tobacco|tobacco
5355566|NCT01923402|Smokeless Tobacco|smokeless tobacco
5355567|NCT01923402|Moist Snuff|moist snuff
5355568|NCT01923389|T2DM|t2dm
5355569|NCT01923389|obesity|obesity
5355570|NCT01923389|safety|safety
5355571|NCT01923389|multiple dose|multiple dose
5355572|NCT01923389|intravenous|intravenous
5355573|NCT01923376|hepatic encephalopathy|hepatic encephalopathy
5355574|NCT01923376|hepatic coma|hepatic coma
5355575|NCT01923376|HE|he
5355577|NCT01923376|lactulose|lactulose
5355578|NCT01923376|golytely|golytely
5355579|NCT01923376|cirrhosis|cirrhosis
5964005|NCT04173494|Hepcidin|hepcidin
5964006|NCT04173494|Myeloproliferative Disorders|myeloproliferative disorders
5355580|NCT01923376|Hepatic Insufficiency|hepatic insufficiency
5355581|NCT01923376|Liver Cirrhosis|liver cirrhosis
5250757|NCT02440906|Asthma|asthma
5355582|NCT01923376|Fibrosis|fibrosis
5355583|NCT01923376|Brain Damage, Chronic|brain damage, chronic
5355584|NCT01923376|Delirium|delirium
5355585|NCT01923376|Encephalitis|encephalitis
5355586|NCT01923376|Neurotoxicity Syndromes|neurotoxicity syndromes
5355587|NCT01923376|Liver Failure|liver failure
5355588|NCT01923376|Liver Diseases|liver diseases
5355589|NCT01923376|Digestive System Diseases|digestive system diseases
5355590|NCT01923376|Brain Diseases, Metabolic|brain diseases, metabolic
5355591|NCT01923376|Brain Diseases|brain diseases
5355592|NCT01923376|Central Nervous System Diseases|central nervous system diseases
5355593|NCT01923376|Nervous System Diseases|nervous system diseases
5355594|NCT01923376|Metabolic Diseases|metabolic diseases
5355595|NCT01923376|Pathologic Processes|pathologic processes
5355596|NCT01923376|Confusion|confusion
5355597|NCT01923376|Neurobehavioral Manifestations|neurobehavioral manifestations
5355598|NCT01923376|Neurologic Manifestations|neurologic manifestations
5355599|NCT01923376|Signs and Symptoms|signs and symptoms
5355600|NCT01923376|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5355601|NCT01923376|Mental Disorders|mental disorders
5355602|NCT01923376|Central Nervous System Viral Diseases|central nervous system viral diseases
5355603|NCT01923376|Virus Diseases|virus diseases
5355604|NCT01923376|Central Nervous System Infections|central nervous system infections
5355605|NCT01923376|Poisoning|poisoning
5355606|NCT01923376|Substance-Related Disorders|substance-related disorders
5355607|NCT01923376|Citric Acid|citric acid
5355608|NCT01923363|pharmacokinetics|pharmacokinetics
5355609|NCT01923363|obesity|obesity
5355610|NCT01923363|piperacillin-tazobactam combination product|piperacillin-tazobactam combination product
5355611|NCT01923363|pharmacodynamics|pharmacodynamics
5355612|NCT01923363|piperacillin/tazobactam|piperacillin/tazobactam
5355613|NCT01923350|Weight reduction|weight reduction
5355614|NCT01923350|Behavioral intervention|behavioral intervention
5355615|NCT01923350|Gestational diabetes mellitus|gestational diabetes mellitus
5355616|NCT01923350|Type 2 diabetes|type 2 diabetes
5355617|NCT01923350|Diabetes testing|diabetes testing
5355618|NCT01923337|Colorectal cancer|colorectal cancer
5355619|NCT01923311|Pediatrics|pediatrics
5355620|NCT01923311|Adolescents|adolescents
5355621|NCT01923311|HIV|hiv
5355622|NCT01923311|HIV-1|hiv-1
5355623|NCT01923311|Treatment-experienced|treatment-experienced
5355624|NCT01923246|Alcohol consumption|alcohol consumption
5355625|NCT01923246|Brief intervention|brief intervention
5355626|NCT01923246|Automated techniques|automated techniques
5355627|NCT01923233|liver cancer|liver cancer
5355629|NCT01923233|tumor vaccine|tumor vaccine
5355630|NCT01923233|immunotherapy|immunotherapy
5355631|NCT01923220|Breast Cancer|breast cancer
5355632|NCT01923220|Radiation Therapy|radiation therapy
5355633|NCT01923220|Radiation Dermatitis|radiation dermatitis
5355634|NCT01923168|BYL719|byl719
5355635|NCT01923168|alpelisib|alpelisib
5355636|NCT01923168|Breast Cancer|breast cancer
5355637|NCT01923168|BKM120|bkm120
5355638|NCT01923168|buparlisib|buparlisib
5355639|NCT01923168|Pathological Complete Response|pathological complete response
5355640|NCT01923168|neoadjuvant|neoadjuvant
5355641|NCT01923168|hormone receptor-positive|hormone receptor-positive
5355642|NCT01923168|HER2 negative|her2 negative
5355643|NCT01923168|Objective Response Rate|objective response rate
5355644|NCT01923142|Vitiligo|vitiligo
5355645|NCT01923142|Outer-Root-Sheath|outer-root-sheath
5355646|NCT01923142|Melanocytes|melanocytes
5355647|NCT01923142|Hair Follicles|hair follicles
5355648|NCT01923129|indwelling catheter|indwelling catheter
5355649|NCT01923129|foley|foley
5355650|NCT01923129|duration|duration
5355651|NCT01923116|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
5355652|NCT01923116|HIV|hiv
5355653|NCT01923116|HPV|hpv
5355654|NCT01923116|Vaccination|vaccination
5355655|NCT01923116|Treatment|treatment
5355656|NCT01923077|acute myocardial infarction|acute myocardial infarction
5355657|NCT01923077|Statin|statin
5355658|NCT01923077|speckle tracking echocardiography|speckle tracking echocardiography
5355659|NCT01923077|Strain|strain
5355660|NCT01923077|MSCT|msct
5355661|NCT01923077|plaque|plaque
5355662|NCT01923077|vulnerable plaque|vulnerable plaque
5355663|NCT01923051|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5355664|NCT01923051|COPD|copd
5355665|NCT01923051|national database|national database
5355666|NCT01923051|observational|observational
5355667|NCT01923038|atelectasis|atelectasis
5355668|NCT01923038|laparoscopic surgery|laparoscopic surgery
5355669|NCT01923038|anesthesia|anesthesia
5355670|NCT01923038|mechanical ventilation|mechanical ventilation
5355671|NCT01923038|Prevent|prevent
5355672|NCT01923038|shape of the airway|shape of the airway
5355673|NCT01923038|pressure-time curve|pressure-time curve
5355674|NCT01922986|stroke|stroke
5355675|NCT01922986|rehabilitation|rehabilitation
5355676|NCT01922986|hemiplegia|hemiplegia
5356170|NCT01920503|doxorubicin|doxorubicin
5355677|NCT01922986|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5964007|NCT04173494|Bone Marrow Diseases|bone marrow diseases
5355679|NCT01922973|growth hormone|growth hormone
5355680|NCT01922973|aging|aging
5355681|NCT01922973|normal volunteers|normal volunteers
5355683|NCT01922960|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5355684|NCT01922908|Ischemic|ischemic
5355685|NCT01922908|Stroke|stroke
5355686|NCT01922908|Stem Cells|stem cells
5355687|NCT01922908|MSC|msc
5355688|NCT01922908|Allogeneic|allogeneic
5355689|NCT01922908|Bone Marrow|bone marrow
5355690|NCT01922895|Alcoholic Hepatitis|alcoholic hepatitis
5355691|NCT01922895|MELD < 20|meld < 20
5355692|NCT01922895|Probiotic|probiotic
5355693|NCT01922895|Nutritional Supplement|nutritional supplement
5355694|NCT01922895|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
5355695|NCT01922882|HIV|hiv
5355696|NCT01922882|Maternal disclosure|maternal disclosure
5355697|NCT01922882|Health promotion|health promotion
5355698|NCT01922882|Maternal mental health|maternal mental health
5355699|NCT01922882|Child behavior|child behavior
5355700|NCT01922869|Absorption|absorption
5355701|NCT01922869|Metabolism|metabolism
5355702|NCT01922869|Excretion|excretion
5355703|NCT01922869|Flavonoids|flavonoids
5355704|NCT01922869|Polyphenols|polyphenols
5355705|NCT01922869|Genes|genes
5355706|NCT01922869|Gut-microflora|gut-microflora
5355707|NCT01922843|Hemodialysis|hemodialysis
5355708|NCT01922830|Sleeve Gastrectomy|sleeve gastrectomy
5355709|NCT01922830|NAFLD|nafld
5355710|NCT01922830|gut microbiot|gut microbiot
5355711|NCT01922830|Bariatric surgery|bariatric surgery
5355712|NCT01922791|Nutrition|nutrition
5355713|NCT01922791|Probiotics|probiotics
5355714|NCT01922791|Fish oil|fish oil
5355715|NCT01922765|Helicobacter|helicobacter
5355716|NCT01922765|Eradication|eradication
5355717|NCT01922752|CEP-37440|cep-37440
5355718|NCT01922752|Advanced solid tumors|advanced solid tumors
5355719|NCT01922752|Metastatic solid tumors|metastatic solid tumors
5355720|NCT01922739|low back pain|low back pain
5355721|NCT01922739|hydrocodone bitartrate|hydrocodone bitartrate
5355722|NCT01922739|opioids|opioids
5355723|NCT01922713|biofortification|biofortification
5355724|NCT01922713|vitamin A|vitamin a
5355725|NCT01922713|maize|maize
5355726|NCT01922713|beta-carotene|beta-carotene
5355727|NCT01922713|breastmilk|breastmilk
5355728|NCT01922713|Zambia|zambia
5355729|NCT01922700|Pepper spray|pepper spray
5355730|NCT01922700|bronchospasm|bronchospasm
5355731|NCT01922700|lacrimation|lacrimation
5355733|NCT01922648|Immune response|immune response
5355734|NCT01922648|Paediatric|paediatric
5355735|NCT01922635|Primary lymphedema quality of life, genetic research|primary lymphedema quality of life, genetic research
5355736|NCT01922622|minimum effective dose of local anaesthetic|minimum effective dose of local anaesthetic
5355737|NCT01922622|spinal catheter|spinal catheter
5355738|NCT01922622|fractured neck of femur|fractured neck of femur
5355739|NCT01922622|a step up, step down methodology|a step up, step down methodology
5355740|NCT01922609|Carotid stenting|carotid stenting
5355741|NCT01922609|Proximal protection system|proximal protection system
5355742|NCT01922609|Transcranial Doppler ultrasound|transcranial doppler ultrasound
5355743|NCT01922609|Cerebrovascular reserve|cerebrovascular reserve
5355744|NCT01922596|Total Knee Arthroplasty|total knee arthroplasty
5355745|NCT01922596|Adductor Canal Blockade|adductor canal blockade
5355746|NCT01922596|Us-guided nerve blockade|us-guided nerve blockade
5355747|NCT01922583|NSCLC, EGFR mutation|nsclc, egfr mutation
5355748|NCT01922570|Enteral nutrition|enteral nutrition
5355749|NCT01922570|Supplemental parenteral nutrition|supplemental parenteral nutrition
5355750|NCT01922570|Critical illness|critical illness
5355751|NCT01922570|ICU patients|icu patients
5355752|NCT01922570|diarrhea|diarrhea
5355753|NCT01922544|heart failure|heart failure
5355754|NCT01922544|cardiac resynchronization therapy|cardiac resynchronization therapy
5355755|NCT01922544|coronary sinus lead|coronary sinus lead
5355756|NCT01922531|mTBI|mtbi
5355757|NCT01922531|Mild Traumatic Brain Injury|mild traumatic brain injury
5355758|NCT01922531|Axonal Injury|axonal injury
5355759|NCT01922518|atrioventricular block, cardiomyopathy|atrioventricular block, cardiomyopathy
5355760|NCT01922492|autologous islet transplantation|autologous islet transplantation
5355761|NCT01922492|partial pancreatectomy|partial pancreatectomy
5355762|NCT01922492|pancreatogenic diabetes|pancreatogenic diabetes
5355763|NCT01922479|Heart Failure|heart failure
5355764|NCT01922479|Anemia|anemia
5355765|NCT01922479|Iron Deficiency|iron deficiency
5355766|NCT01922479|Ferric Carboxymaltose|ferric carboxymaltose
5355767|NCT01922479|Asian|asian
5355768|NCT01922466|chronic neck pain|chronic neck pain
5355769|NCT01922466|combined treatment between conventional and complementary alternative medical treatment|combined treatment between conventional and complementary alternative medical treatment
5355770|NCT01922466|bee venom acupuncture|bee venom acupuncture
5355771|NCT01922466|NSAIDs|nsaids
5355772|NCT01922453|breech presentation|breech presentation
5355773|NCT01922453|vertex presentation|vertex presentation
5355774|NCT01922440|Chronic Hypoparathyroidism|chronic hypoparathyroidism
5964008|NCT04173494|Hematologic Diseases|hematologic diseases
5964009|NCT04172870|Ebstein Barr Virus|ebstein barr virus
5964010|NCT04172870|Cytomegalovirus|cytomegalovirus
5964011|NCT04172870|Herpes Simplex Virus|herpes simplex virus
5222712|NCT02606487|CF|cf
5355775|NCT01922440|rhPTH(1-84)|rhpth(1-84)
5356371|NCT01919853|Mindfulness|mindfulness
5355776|NCT01922440|Observational study|observational study
5355777|NCT01922440|parathyroid hormone (PTH)|parathyroid hormone (pth)
5355778|NCT01922440|Drug registry|drug registry
5355779|NCT01922414|Staghorn stones|staghorn stones
5355780|NCT01922414|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5355781|NCT01922414|Laser|laser
5355782|NCT01922414|Randomized trial|randomized trial
5355783|NCT01922414|Lithotripsy|lithotripsy
5355784|NCT01922388|Parkinson disease|parkinson disease
5355785|NCT01922388|deep brain stimulation|deep brain stimulation
5355786|NCT01922388|subthalamic nucleus|subthalamic nucleus
5355787|NCT01922388|motor complication|motor complication
5355788|NCT01922388|quality of life|quality of life
5355789|NCT01922362|STSG|stsg
5355790|NCT01922362|wound healing|wound healing
5355791|NCT01922336|Pharmacokinetics|pharmacokinetics
5355792|NCT01922323|Living liver donor|living liver donor
5355793|NCT01922297|Delinquency|delinquency
5355794|NCT01922297|HIV Associated Risk Behavior|hiv associated risk behavior
5355795|NCT01922297|Juveniles|juveniles
5355796|NCT01922297|Family based treatment|family based treatment
5355797|NCT01922297|Multidimensional Family Therapy|multidimensional family therapy
5355799|NCT01922284|Vaccine|vaccine
5355800|NCT01922284|Immunisation|immunisation
5355801|NCT01922284|DNA|dna
5355802|NCT01922284|Adverse events|adverse events
5355803|NCT01922284|MVA-C|mva-c
5355804|NCT01922284|GLA-AF|gla-af
5355805|NCT01922284|Antibody|antibody
5355806|NCT01922271|COPD|copd
5355807|NCT01922258|OPC-34712|opc-34712
5355808|NCT01922258|brexpiprazole|brexpiprazole
5355809|NCT01922258|Dementia|dementia
5355810|NCT01922258|Alzheimer's Disease|alzheimer's disease
5355811|NCT01922258|Cognitive Disorders|cognitive disorders
5355812|NCT01922258|Memory|memory
5355813|NCT01922258|Agitation|agitation
5355814|NCT01922245|aphasia|aphasia
5355815|NCT01922245|therapy|therapy
5355816|NCT01922245|stroke|stroke
5355817|NCT01922245|language|language
5355818|NCT01922245|naming|naming
5355819|NCT01922245|quality of life|quality of life
5355820|NCT01922245|tDCS|tdcs
5355821|NCT01922245|treatment|treatment
5355822|NCT01922219|depression|depression
5355823|NCT01922219|cognitive therapy|cognitive therapy
5355824|NCT01922219|cognitive behavioral therapy|cognitive behavioral therapy
5355825|NCT01922219|CBT|cbt
5355826|NCT01922219|psychotherapy|psychotherapy
5355827|NCT01922219|MDD|mdd
5355828|NCT01922219|major depressive disorder|major depressive disorder
5355829|NCT01922219|MRI|mri
5355831|NCT01922206|HIV|hiv
5355832|NCT01922206|Maternal Disclosure|maternal disclosure
5355833|NCT01922180|Chest Computed Tomography|chest computed tomography
5355834|NCT01922167|Aging|aging
5355835|NCT01922167|Frailty|frailty
5355836|NCT01922167|Leucine|leucine
5355837|NCT01922167|Resistance Exercise|resistance exercise
5355838|NCT01922154|Angiogenesis inhibitors|angiogenesis inhibitors
5355839|NCT01922154|Neovascular|neovascular
5355840|NCT01922154|Intraocular pressure|intraocular pressure
5355841|NCT01922154|Retinal Vein Occlusion|retinal vein occlusion
5355842|NCT01922154|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5355843|NCT01922141|High blood pressure, stage 1 and 2 hypertension|high blood pressure, stage 1 and 2 hypertension
5355844|NCT01922128|Non-exudative, dry AMD|non-exudative, dry amd
5355845|NCT01922115|COGNITIVE FUNCTION|cognitive function
5355846|NCT01922115|OVERACTIVE BLADDER|overactive bladder
5355847|NCT01922115|[C23.888.942.343.780]|[c23.888.942.343.780]
5355848|NCT01922102|vision loss,PM,CNV,ranibizumab,verteporfinPDT,Brilliance|vision loss,pm,cnv,ranibizumab,verteporfinpdt,brilliance
5355849|NCT01922089|Heart failure, reduced ejection fraction, LCZ696, titration, safety, tolerability|heart failure, reduced ejection fraction, lcz696, titration, safety, tolerability
5355850|NCT01922063|disc herniation surgery|disc herniation surgery
5355851|NCT01922063|physiotherapy, exercise therapy|physiotherapy, exercise therapy
5355853|NCT01922063|long term|long term
5355854|NCT01922063|follow up|follow up
5355855|NCT01921972|AD, Dementia|ad, dementia
5355856|NCT01921946|Fimasartan|fimasartan
5355857|NCT01921933|End-stage renal disease|end-stage renal disease
5355858|NCT01921933|ESRD|esrd
5355859|NCT01921933|AVF|avf
5355860|NCT01921933|Fistulas|fistulas
5355861|NCT01921920|Omeprazole, Prilosec, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|omeprazole, prilosec, phase i, healthy subjects, pharmacokinetics, bioequivalence
5355862|NCT01921907|Actinic keratosis|actinic keratosis
5355863|NCT01921907|topical|topical
5355864|NCT01921907|dermatology|dermatology
5355865|NCT01921907|treatment|treatment
5355866|NCT01921907|clinical study|clinical study
5355867|NCT01921907|double blinded|double blinded
5355868|NCT01921894|asthma|asthma
5964012|NCT04172870|Pentraxins|pentraxins
5355869|NCT01921894|vitamin D|vitamin d
5964013|NCT04172870|Toll Like Receptors|toll like receptors
5355870|NCT01921881|Glucose tolerance|glucose tolerance
5355871|NCT01921829|Cardiorenal failure|cardiorenal failure
5355872|NCT01921829|Cardiorenal syndrome|cardiorenal syndrome
5355873|NCT01921829|Diuretic resistance|diuretic resistance
5355874|NCT01921829|Volume overload|volume overload
5355875|NCT01921829|Edema|edema
5355876|NCT01921829|Health-related quality of life|health-related quality of life
5355877|NCT01921829|Outcomes|outcomes
5355878|NCT01921829|Treatment protocol|treatment protocol
5355880|NCT01921790|first line chemotherapy|first line chemotherapy
5355881|NCT01921790|NK/T-cell Lymphoma|nk/t-cell lymphoma
5355883|NCT01921777|exercise|exercise
5355884|NCT01921777|soreness|soreness
5355885|NCT01921777|Damage|damage
5355886|NCT01921777|Traumeel|traumeel
5355887|NCT01921777|homeopathy|homeopathy
5355888|NCT01921751|SMAD4|smad4
5355889|NCT01921751|IMRT|imrt
5355890|NCT01921751|gemcitabine|gemcitabine
5355891|NCT01921751|high-dose radiotherapy|high-dose radiotherapy
5355892|NCT01921738|Chronic Periodontitis, Azithromycin, SRP|chronic periodontitis, azithromycin, srp
5355893|NCT01921725|wound healing|wound healing
5355894|NCT01921725|carbon|carbon
5355895|NCT01921712|COPD|copd
5355896|NCT01921712|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5355897|NCT01921699|macrophages|macrophages
5355898|NCT01921699|adenocarcinoma|adenocarcinoma
5355899|NCT01921699|chemoresistance|chemoresistance
5355900|NCT01921686|Eosinophil|eosinophil
5355901|NCT01921686|Reflux|reflux
5355902|NCT01921686|Esophagus|esophagus
5355903|NCT01921686|Food allergy|food allergy
5355904|NCT01921686|Trouble Swallowing|trouble swallowing
5355905|NCT01921686|Pediatrics|pediatrics
5355906|NCT01921686|Healthy Volunteers|healthy volunteers
5355907|NCT01921673|Gastric cancer|gastric cancer
5355908|NCT01921673|Phase I/II|phase i/ii
5355909|NCT01921673|Second-line chemotherapy|second-line chemotherapy
5355910|NCT01921673|Dovitinib|dovitinib
5355911|NCT01921673|Docetaxel|docetaxel
5355912|NCT01921673|Refractory to first-line chemotherapy|refractory to first-line chemotherapy
5355913|NCT01921647|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
5355914|NCT01921621|proficiency based progression|proficiency based progression
5355915|NCT01921621|surgical skill|surgical skill
5355916|NCT01921621|metric validation|metric validation
5355917|NCT01921621|formative feedback|formative feedback
5355918|NCT01921621|simulator model|simulator model
5355919|NCT01921608|Male Circumcision|male circumcision
5355920|NCT01921608|HIV Prevention|hiv prevention
5355921|NCT01921608|HIV Infections|hiv infections
5355922|NCT01921595|balanced salt colloid, coagulation profiles, spinal cord tumor|balanced salt colloid, coagulation profiles, spinal cord tumor
5355923|NCT01921543|Deep Brain Stimulation|deep brain stimulation
5355924|NCT01921543|Major Depressive Disorder|major depressive disorder
5355925|NCT01921543|Psychosurgery|psychosurgery
5355926|NCT01921543|Electrical stimulation|electrical stimulation
5351830|NCT01940523|tranexamic acid|tranexamic acid
5355927|NCT01921530|Posterolateral Fusion|posterolateral fusion
5355928|NCT01921530|Interbody Fusion|interbody fusion
5355930|NCT01921530|Spinal Stenosis|spinal stenosis
5355931|NCT01921530|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5355932|NCT01921517|Biomechanics|biomechanics
5355933|NCT01921517|Osteogenesis|osteogenesis
5355934|NCT01921504|Functional Dyspepsia|functional dyspepsia
5355935|NCT01921504|Acupuncture|acupuncture
5355936|NCT01921504|Genotype|genotype
5355937|NCT01921504|Ghrelin|ghrelin
5355938|NCT01921465|outpatient care|outpatient care
5355939|NCT01921465|videoconferencing|videoconferencing
5355940|NCT01921465|elective cesarean section|elective cesarean section
5355941|NCT01921452|Hypothyroidism|hypothyroidism
5355942|NCT01921452|Third generation TSH kit|third generation tsh kit
5355943|NCT01921452|Quantitative POC TSH kit|quantitative poc tsh kit
5355944|NCT01921452|Qualitative POC TSH kit|qualitative poc tsh kit
5355945|NCT01921439|smoking|smoking
5355946|NCT01921439|quit smoking|quit smoking
5355947|NCT01921439|smoking cessation|smoking cessation
5355948|NCT01921439|smoking study|smoking study
5355949|NCT01921439|secondhand smoke|secondhand smoke
5355950|NCT01921439|smokers|smokers
5355951|NCT01921426|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5355952|NCT01921426|Oral Cavity|oral cavity
5355953|NCT01921426|Oropharynx|oropharynx
5355954|NCT01921426|Radiation|radiation
5355955|NCT01921426|Chemotherapy|chemotherapy
5355956|NCT01921426|Cisplatin|cisplatin
5355957|NCT01921426|Oral Mucositis|oral mucositis
5355958|NCT01921426|Superoxide Dismutase|superoxide dismutase
5355959|NCT01921413|Plasmodium falciparum|plasmodium falciparum
5355960|NCT01921413|Clinical Malaria|clinical malaria
5355961|NCT01921413|Fever|fever
5355962|NCT01921413|Schistosoma hematobium|schistosoma hematobium
5355963|NCT01921413|Rheumatoid arthritis|rheumatoid arthritis
5355964|NCT01921400|Hepatitis C (HCV)|hepatitis c (hcv)
5355965|NCT01921400|Infection Transmission, Maternal-Fetal|infection transmission, maternal-fetal
5355966|NCT01921400|Placenta|placenta
5355967|NCT01921400|Trophoblast|trophoblast
5355968|NCT01921374|Duchenne;|duchenne;
5355969|NCT01921374|mothers caregivers;|mothers caregivers;
5355970|NCT01921374|sleep;|sleep;
5355971|NCT01921374|hormonal profile;|hormonal profile;
5355972|NCT01921374|cardiac profile;|cardiac profile;
5964014|NCT04172714|Cancer|cancer
5355973|NCT01921374|biochemical profile;|biochemical profile;
5355974|NCT01921374|inflammatory profile.|inflammatory profile.
5355976|NCT01921361|Dexmedetomidine|dexmedetomidine
5355982|NCT01921348|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5355983|NCT01921335|ARRY-380|arry-380
5355984|NCT01921335|Trastuzumab|trastuzumab
5355985|NCT01921335|Advanced HER2-positive breast cancer|advanced her2-positive breast cancer
5355986|NCT01921309|osteoarthritis|osteoarthritis
5355987|NCT01921309|avascular necrosis|avascular necrosis
5355988|NCT01921309|rheumatoid arthritis|rheumatoid arthritis
5355989|NCT01921309|correction of functional deformity|correction of functional deformity
5355990|NCT01921309|dysplasia of the hip|dysplasia of the hip
5355991|NCT01921296|Breast cancer|breast cancer
5355992|NCT01921296|Aromatase inhibitor|aromatase inhibitor
5355993|NCT01921283|propofol, endoscopy, bispectral index|propofol, endoscopy, bispectral index
5355994|NCT01921270|Oromandibular Dystonia|oromandibular dystonia
5355995|NCT01921270|Oral Dystonia|oral dystonia
5355996|NCT01921270|Tardive Dystonia|tardive dystonia
5355997|NCT01921270|botulinum toxin|botulinum toxin
5355998|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina
5355999|NCT01921257|Cat Allergy|cat allergy
5356000|NCT01921257|Rhinoconjunctivitis|rhinoconjunctivitis
5356001|NCT01921244|Autistic Disorder|autistic disorder
5356002|NCT01921244|Decision Making|decision making
5356003|NCT01921244|Medication Therapy Management|medication therapy management
5356004|NCT01921218|Kidney transplant|kidney transplant
5356005|NCT01921205|Lacosamide|lacosamide
5356008|NCT01921205|Epilepsy|epilepsy
5356009|NCT01921205|Partial Onset Seizures|partial onset seizures
5356010|NCT01921205|Pediatric|pediatric
5356015|NCT01921166|infertility|infertility
5356016|NCT01921166|diminished ovarian reserve|diminished ovarian reserve
5356017|NCT01921166|fertilization in vitro|fertilization in vitro
5356018|NCT01921166|ovulation inducion|ovulation inducion
5356019|NCT01921166|vitrification|vitrification
5356020|NCT01921140|Oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, QT interval effects|oncology, cancer, tumour, neoplasm, anticancer drug, food, area under the curve, pharmacokinetics, olaparib, neoplasm, metabolites, qt interval effects
5356021|NCT01921127|COPD, Comparative effectiveness, Symbicort|copd, comparative effectiveness, symbicort
5356022|NCT01921101|nutrition|nutrition
5356023|NCT01921101|enteral feeding|enteral feeding
5356024|NCT01921101|parenteral feeding|parenteral feeding
5356025|NCT01921101|hospital malnutrition|hospital malnutrition
5356026|NCT01921088|fMRI|fmri
5356027|NCT01921088|Neurofeedback|neurofeedback
5356028|NCT01921088|Blood pressure|blood pressure
5356029|NCT01921088|Psychophysiology|psychophysiology
5356030|NCT01921075|physiology, normal function|physiology, normal function
5356031|NCT01921062|Distal radius fracture|distal radius fracture
5351961|NCT01940055|Balance|balance
5356038|NCT01920971|chronic low back pain|chronic low back pain
5356039|NCT01920971|infrared energy|infrared energy
5356040|NCT01920971|effects|effects
5356041|NCT01920932|Pediatric cancer|pediatric cancer
5356042|NCT01920932|Hodgkin lymphoma|hodgkin lymphoma
5356043|NCT01920932|Targeted therapy|targeted therapy
5356044|NCT01920932|Frontline therapy|frontline therapy
5356045|NCT01920932|Brentuximab vedotin|brentuximab vedotin
5356046|NCT01920932|Quality of Life|quality of life
5356047|NCT01920932|OEPA/COPDac|oepa/copdac
5356048|NCT01920906|Psoriasis|psoriasis
5356049|NCT01920906|Korean|korean
5356050|NCT01920906|Healthy Volunteers|healthy volunteers
5356051|NCT01920880|Anterior cutaneous nerve entrapment syndrome|anterior cutaneous nerve entrapment syndrome
5356052|NCT01920880|ACNES|acnes
5356053|NCT01920880|chronic abdominal wall pain|chronic abdominal wall pain
5356054|NCT01920880|CAWP|cawp
5356055|NCT01920867|Stem Cells|stem cells
5356056|NCT01920867|Bone Marrow Derived Stem Cells|bone marrow derived stem cells
5356057|NCT01920867|BMSC|bmsc
5356058|NCT01920867|BMC (Bone Marrow Cell)|bmc (bone marrow cell)
5356059|NCT01920867|Mesenchymal Stem Cells|mesenchymal stem cells
5356061|NCT01920867|Eye Disease|eye disease
5356062|NCT01920867|Eye Stem Cells|eye stem cells
5356063|NCT01920867|Ophthalmology|ophthalmology
5356064|NCT01920867|Ophthalmic Disease|ophthalmic disease
5356065|NCT01920867|Retina|retina
5356066|NCT01920867|Retinal Disease|retinal disease
5356067|NCT01920867|Macular Degeneration|macular degeneration
5356068|NCT01920867|Age Related Macular Degeneration|age related macular degeneration
5356069|NCT01920867|Myopic Macular Degeneration|myopic macular degeneration
5356070|NCT01920867|Geographic Atrophy|geographic atrophy
5356071|NCT01920867|Dry Macular Degeneration|dry macular degeneration
5356072|NCT01920867|Wet Macular Degeneration|wet macular degeneration
5356073|NCT01920867|Retinal Atrophy|retinal atrophy
5356074|NCT01920867|Retinal Dystrophy|retinal dystrophy
5356075|NCT01920867|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
5356076|NCT01920867|Retinitis Pigmentosa|retinitis pigmentosa
5356077|NCT01920867|Stargardt Disease|stargardt disease
5356078|NCT01920867|Cone Dystrophy|cone dystrophy
5356079|NCT01920867|Cone Rod Dystrophy|cone rod dystrophy
5356080|NCT01920867|Maculopathy|maculopathy
5356081|NCT01920867|Optic Nerve Disease|optic nerve disease
5356082|NCT01920867|Optic Nerve Atrophy|optic nerve atrophy
5356083|NCT01920867|Optic Atrophy|optic atrophy
5356084|NCT01920867|Ischemic Optic Neuropathy|ischemic optic neuropathy
5356085|NCT01920867|Optic Nerve Damage|optic nerve damage
5356086|NCT01920867|Optic Nerve Compression|optic nerve compression
5356087|NCT01920867|Compressive Optic Neuropathy|compressive optic neuropathy
5356088|NCT01920867|Devics Syndrome|devics syndrome
5356089|NCT01920854|Soluble Ferric Pyrophosphate, Pharmacokinetics, Iron, Hemodialysis|soluble ferric pyrophosphate, pharmacokinetics, iron, hemodialysis
5356090|NCT01920841|lipolytic|lipolytic
5356091|NCT01920841|herbal extracts|herbal extracts
5356092|NCT01920841|thigh girth|thigh girth
5356093|NCT01920841|thigh smoothness|thigh smoothness
5356094|NCT01920789|Non-small call lung cancer|non-small call lung cancer
5356095|NCT01920789|Medically inoperable|medically inoperable
5356096|NCT01920789|Stage one|stage one
5356097|NCT01920789|Radiotherapy|radiotherapy
5356098|NCT01920789|SBRT|sbrt
5356099|NCT01920789|Hypofractionation|hypofractionation
5356100|NCT01920789|Conventional fractionation|conventional fractionation
5356101|NCT01920776|critical ultrasound|critical ultrasound
5356102|NCT01920763|Intracerebral hemorrhage|intracerebral hemorrhage
5356103|NCT01920763|Surgical evacuation|surgical evacuation
5356104|NCT01920763|Minimally-invasive surgery|minimally-invasive surgery
5356105|NCT01920750|Leprosy, skin test, MLSA-LAM, MLCwA, diagnosis, Protocol 98-202|leprosy, skin test, mlsa-lam, mlcwa, diagnosis, protocol 98-202
5356106|NCT01920737|ALL|all
5356107|NCT01920737|Bone Marrow|bone marrow
5356108|NCT01920737|Ph Negative|ph negative
5356109|NCT01920737|Daunorubicin|daunorubicin
5356110|NCT01920737|Vincristine|vincristine
5356111|NCT01920737|Prednisone|prednisone
5356112|NCT01920737|PEG-Asparaginase|peg-asparaginase
5356113|NCT01920737|Methotrexate|methotrexate
5356114|NCT01920737|16-MP (6-Mercaptopurine)|16-mp (6-mercaptopurine)
5356115|NCT01920737|Cyclophosphamide|cyclophosphamide
5356116|NCT01920737|Cytarabine|cytarabine
5356117|NCT01920737|Leucovorin|leucovorin
5356118|NCT01920737|Dexamethasone|dexamethasone
5356119|NCT01920737|12-266|12-266
5356120|NCT01920724|Preschool children|preschool children
5356121|NCT01920724|Body composition|body composition
5356122|NCT01920711|Heart failure|heart failure
5352057|NCT01939600|Ileostomy|ileostomy
5356123|NCT01920711|preserved ejection fraction|preserved ejection fraction
5356124|NCT01920711|diastolic heart failure|diastolic heart failure
5356125|NCT01920698|Heart Valve Diseases|heart valve diseases
5356127|NCT01920698|Heart diseases|heart diseases
5356128|NCT01920698|Mitral valve insufficiency|mitral valve insufficiency
5356129|NCT01920685|Paranoia|paranoia
5356130|NCT01920685|CBT|cbt
5356131|NCT01920685|Reasoning|reasoning
5356132|NCT01920685|Anxiety|anxiety
5356133|NCT01920659|High Intensity Training|high intensity training
5356134|NCT01920659|Insulin sensitivity|insulin sensitivity
5356135|NCT01920659|Fitness|fitness
5356136|NCT01920620|obesity, inpatient, intervention, weight loss|obesity, inpatient, intervention, weight loss
5356137|NCT01920607|Fecal Incontinence.|fecal incontinence.
5356138|NCT01920607|Anal Incontinence.|anal incontinence.
5356139|NCT01920607|Functional Bowel Disorders.|functional bowel disorders.
5356140|NCT01920607|SNS.|sns.
5356141|NCT01920607|Artificial Sphincters.|artificial sphincters.
5356142|NCT01920607|Magnetic Anal Sphincter.|magnetic anal sphincter.
5356143|NCT01920594|GSK1278863|gsk1278863
5356144|NCT01920594|Thoracic Aortic Aneurysm Repair|thoracic aortic aneurysm repair
5356145|NCT01920581|CEIP|ceip
5356146|NCT01920581|pharmacodependance|pharmacodependance
5356147|NCT01920581|addictovigilance|addictovigilance
5356148|NCT01920581|benzodiazepines and benzodiazepines related drugs|benzodiazepines and benzodiazepines related drugs
5356149|NCT01920581|elderly|elderly
5356150|NCT01920568|GSK2371746|gsk2371746
5356151|NCT01920568|Denosumab|denosumab
5356153|NCT01920568|skeletal-related events|skeletal-related events
5356154|NCT01920568|bone metastases|bone metastases
5356155|NCT01920568|bridging study|bridging study
5356156|NCT01920568|solid tumors|solid tumors
5356157|NCT01920555|Depression|depression
5356158|NCT01920555|Treatment Resistant Depression|treatment resistant depression
5356159|NCT01920555|Ketamine|ketamine
5356160|NCT01920555|Antidepressant|antidepressant
5356161|NCT01920555|MDD|mdd
5356162|NCT01920555|Major Depression|major depression
5356163|NCT01920529|asthma, aerobic exercise, child, cytokines|asthma, aerobic exercise, child, cytokines
5356164|NCT01920516|Isolated limb infusion|isolated limb infusion
5356165|NCT01920516|Melphalan|melphalan
5356166|NCT01920516|Limb Melanoma|limb melanoma
5356167|NCT01920516|Tumor response|tumor response
5356168|NCT01920503|cholangiocarcinoma|cholangiocarcinoma
5356169|NCT01920503|transarterial chemoembolization|transarterial chemoembolization
5356171|NCT01920503|tumor response|tumor response
5356172|NCT01920477|Pemphigus|pemphigus
5356173|NCT01920477|MAB|mab
5356175|NCT01920477|human CD20 antigen|human cd20 antigen
5356176|NCT01920477|subcutaneous|subcutaneous
5356178|NCT01920477|Phase 3|phase 3
5356179|NCT01920477|monoclonal antibody|monoclonal antibody
5964015|NCT04172714|Radiation therapy|radiation therapy
5356180|NCT01920477|ofatumumab|ofatumumab
5356181|NCT01920477|PV|pv
5356182|NCT01920477|rare disease|rare disease
5356183|NCT01920477|OMB157|omb157
5356184|NCT01920477|adult|adult
5356185|NCT01920451|sleep|sleep
5356186|NCT01920451|insomnia|insomnia
5356187|NCT01920451|posttraumatic stress disorder|posttraumatic stress disorder
5356188|NCT01920451|hypertension|hypertension
5356189|NCT01920451|cardiovascular disease|cardiovascular disease
5356190|NCT01920438|Percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
5356191|NCT01920438|Radiologically inserted gastrostomy,|radiologically inserted gastrostomy,
5356192|NCT01920438|Complications|complications
5356193|NCT01920425|Parkinson's disease|parkinson's disease
5356194|NCT01920425|dyskinesia|dyskinesia
5356195|NCT01920425|fluctuations|fluctuations
5356196|NCT01920425|tremor|tremor
5356197|NCT01920425|bradykinesia|bradykinesia
5356198|NCT01920425|levodopa|levodopa
5356199|NCT01920412|Atrial fibrillation|atrial fibrillation
5356200|NCT01920412|Thrombosis|thrombosis
5356201|NCT01920412|Ischemic stroke|ischemic stroke
5356202|NCT01920412|Left atrial appendage occluder|left atrial appendage occluder
5356203|NCT01920412|Intervention method|intervention method
5356204|NCT01920399|CAZ-AVI China phase I PK study|caz-avi china phase i pk study
5356205|NCT01920386|Acute Toothache|acute toothache
5356206|NCT01920386|Wontran|wontran
5356207|NCT01920386|Wontran SR Tab.|wontran sr tab.
5356208|NCT01920386|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
5356209|NCT01920373|degenerative joint disease|degenerative joint disease
5356210|NCT01920373|temporomandibular joint|temporomandibular joint
5356211|NCT01920360|KNEE OSTEOARTHRITIS|knee osteoarthritis
5356212|NCT01920360|BALNEOTHERAPY|balneotherapy
5356213|NCT01920360|SULPHUROUS WATERS|sulphurous waters
5356214|NCT01920360|WOMAC|womac
5356215|NCT01920360|LEQUESNE|lequesne
5356216|NCT01920360|HEALTH ASSESSMENT QUESTIONNAIRE|health assessment questionnaire
5356217|NCT01920360|SHORT FORM - 36|short form - 36
5356218|NCT01920360|VAS|vas
5356219|NCT01920347|hypoxic encephalopathy|hypoxic encephalopathy
5356220|NCT01920347|cardiac arrest|cardiac arrest
5356221|NCT01920347|outcome|outcome
5356222|NCT01920347|pupillary reflex|pupillary reflex
5356223|NCT01920334|coronary disease|coronary disease
5356224|NCT01920334|heart diseases|heart diseases
5356225|NCT01920334|enzymes|enzymes
5356226|NCT01920334|sleep|sleep
5356227|NCT01920334|troponin|troponin
5356228|NCT01920334|zolpidem|zolpidem
5356229|NCT01920321|COPD|copd
5356230|NCT01920321|Bronchoscopic LVR|bronchoscopic lvr
5356231|NCT01920321|Emphysema|emphysema
5356232|NCT01920321|Hot injury|hot injury
5356233|NCT01920269|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5356234|NCT01920269|intravesical chemotherapy|intravesical chemotherapy
5356235|NCT01920269|mitomycin|mitomycin
5356236|NCT01920269|passive diffusion|passive diffusion
5356237|NCT01920269|electromotive drug administration|electromotive drug administration
5356238|NCT01920256|Insulin therapy|insulin therapy
5356239|NCT01920256|Type 2 diabetes|type 2 diabetes
5356240|NCT01920243|Telemedicine|telemedicine
5356241|NCT01920243|self-management|self-management
5356242|NCT01920243|Medical psychology|medical psychology
5356243|NCT01920243|Health psychology|health psychology
5356244|NCT01920243|Rehabilitation|rehabilitation
5356245|NCT01920243|Education, Health|education, health
5356246|NCT01920230|Burnout|burnout
5356247|NCT01920230|Stress|stress
5356248|NCT01920230|Mindfulness|mindfulness
5356249|NCT01920230|Acceptance-commitment therapy (ACT)|acceptance-commitment therapy (act)
5356250|NCT01920230|Intervention|intervention
5356251|NCT01920230|Effectiveness|effectiveness
5356252|NCT01920230|Working conditions|working conditions
5356253|NCT01920230|Work engagement|work engagement
5356254|NCT01920230|Psychological well-being|psychological well-being
5356255|NCT01920230|Life situation|life situation
5356256|NCT01920217|sepsis|sepsis
5356258|NCT01920217|mortality|mortality
5356259|NCT01920204|Mastocytosis|mastocytosis
5356260|NCT01920204|ISM|ism
5356261|NCT01920204|SSM|ssm
5356262|NCT01920191|Glioblastoma|glioblastoma
5356263|NCT01920165|respiratory tract infections|respiratory tract infections
5356264|NCT01920165|upper respiratory tract infections|upper respiratory tract infections
5356265|NCT01920165|lower respiratory tract infections|lower respiratory tract infections
5356266|NCT01920165|hospitalisation|hospitalisation
5356267|NCT01920165|child|child
5356268|NCT01920165|children|children
5356269|NCT01920165|minors|minors
5356270|NCT01920165|infants|infants
5356271|NCT01920165|second-hand smoke|second-hand smoke
5356272|NCT01920165|tobacco smoke pollution|tobacco smoke pollution
5356273|NCT01920165|smoke-free|smoke-free
5356274|NCT01920165|smoke-free policy|smoke-free policy
5356275|NCT01920165|smoke-free legislation|smoke-free legislation
5356276|NCT01920165|public places|public places
5356277|NCT01920152|Hip, Chondropenia, Osteoarthritis.|hip, chondropenia, osteoarthritis.
5356278|NCT01920126|sodium bicarbonate, renal function, infective endocarditis, open heart surgery|sodium bicarbonate, renal function, infective endocarditis, open heart surgery
5356279|NCT01920113|Endoscopic submucosal dissection|endoscopic submucosal dissection
5356281|NCT01920113|remifentanil|remifentanil
5356282|NCT01920113|dexmedetomidine|dexmedetomidine
5356283|NCT01920113|efficacy|efficacy
5356284|NCT01920113|safeness|safeness
5356285|NCT01920100|Health Care Costs|health care costs
5356286|NCT01920100|Genetic Polymorphism|genetic polymorphism
5356287|NCT01920087|Atypical Facial Pain|atypical facial pain
5356288|NCT01920087|Persistent Idiopathic Facial Pain|persistent idiopathic facial pain
5356289|NCT01920087|Atypical Trigeminal Neuralgia|atypical trigeminal neuralgia
5356290|NCT01920087|Orofacial Pain|orofacial pain
5356291|NCT01920087|Orofacial neuropathic pain|orofacial neuropathic pain
5356292|NCT01920087|Fothergill Disease|fothergill disease
5356293|NCT01920087|Tic Douloureux|tic douloureux
5356294|NCT01920087|Prosopalgia|prosopalgia
5356295|NCT01920074|Anal Fissure|anal fissure
5356296|NCT01920074|Nitroglycerin|nitroglycerin
5356297|NCT01920074|Pediatrics|pediatrics
5356298|NCT01920074|RECTIV®|rectiv®
5356299|NCT01920074|Pediatric Research Equity Act|pediatric research equity act
5356300|NCT01920061|Advanced cancer|advanced cancer
5356301|NCT01920061|solid tumors|solid tumors
5356302|NCT01920061|PI3K|pi3k
5356303|NCT01920061|mTOR|mtor
5356304|NCT01920061|PI3K/mTOR|pi3k/mtor
5356305|NCT01920061|metastatic|metastatic
5356306|NCT01920061|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
5356307|NCT01920048|Heart Failure|heart failure
5356308|NCT01920048|Ventricular Dysfunction|ventricular dysfunction
5356309|NCT01920048|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5356310|NCT01920048|Ischemic Heart Disease|ischemic heart disease
5356311|NCT01920048|Revascularization|revascularization
5356312|NCT01920048|Percutaneous Coronary Intervention|percutaneous coronary intervention
5356313|NCT01920048|Randomized Control Trial|randomized control trial
5356314|NCT01920048|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5356315|NCT01920035|Incontinence post RARP|incontinence post rarp
5356316|NCT01920035|Surgery induced incontinence|surgery induced incontinence
5356317|NCT01920035|Incontinence after prostatectomy|incontinence after prostatectomy
5356318|NCT01920035|Neuropathy-induced incontinence|neuropathy-induced incontinence
5356319|NCT01920022|medical abortion|medical abortion
5356320|NCT01920022|postabortion contraception|postabortion contraception
5356321|NCT01920022|LARC|larc
5356322|NCT01920022|Nexplanon|nexplanon
5356323|NCT01920022|subdermal contraceptive implant|subdermal contraceptive implant
5356324|NCT01920009|pharmacy care|pharmacy care
5356326|NCT01920009|coronary heart disease|coronary heart disease
5356327|NCT01919996|Ocular safety|ocular safety
5356328|NCT01919996|azithromycin|azithromycin
5356329|NCT01919996|pharyngitis|pharyngitis
5356330|NCT01919996|tonsillitis|tonsillitis
5356331|NCT01919983|cardiac|cardiac
5356332|NCT01919983|innervation|innervation
5356333|NCT01919983|inflammation|inflammation
5356334|NCT01919983|sudden|sudden
5356335|NCT01919983|death|death
5356336|NCT01919970|Autism|autism
5356337|NCT01919970|Asperger's Syndrome|asperger's syndrome
5356338|NCT01919970|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
5356339|NCT01919970|Treatment|treatment
5356340|NCT01919970|Cognitive-behavioral therapy|cognitive-behavioral therapy
5356341|NCT01919970|Anxiety|anxiety
5356342|NCT01919970|Children|children
5356343|NCT01919970|Therapy|therapy
5356344|NCT01919970|Generalized Anxiety Disorder|generalized anxiety disorder
5356345|NCT01919970|Social Phobia|social phobia
5356346|NCT01919970|Separation Anxiety Disorder|separation anxiety disorder
5356347|NCT01919970|Obsessive-compulsive Disorder|obsessive-compulsive disorder
5356348|NCT01919970|Specific Phobia|specific phobia
5356349|NCT01919957|epilepsy|epilepsy
5356350|NCT01919957|surgery|surgery
5356351|NCT01919957|functional MRI|functional mri
5356352|NCT01919957|memory outcome|memory outcome
5356354|NCT01919931|Candida albicans|candida albicans
5356355|NCT01919931|Candidiasis|candidiasis
5356356|NCT01919931|Biofilm|biofilm
5356357|NCT01919931|Flow cytometry|flow cytometry
5356358|NCT01919931|Mannose Binding Lectin|mannose binding lectin
5356359|NCT01919905|Mozzarella cheese fortification|mozzarella cheese fortification
5356360|NCT01919905|Bioavailability of Vitamin D|bioavailability of vitamin d
5356361|NCT01919892|predictors of response|predictors of response
5356362|NCT01919892|bipolar disorder|bipolar disorder
5356363|NCT01919892|depression|depression
5356364|NCT01919892|lithium treatment|lithium treatment
5356365|NCT01919892|biomarkers|biomarkers
5356366|NCT01919879|Chemotherapy refractory|chemotherapy refractory
5356367|NCT01919879|wtKRAS metastatic colorectal cancer|wtkras metastatic colorectal cancer
5356368|NCT01919879|cross over|cross over
5356369|NCT01919853|Cancer|cancer
5356370|NCT01919853|Fatigue|fatigue
5356372|NCT01919853|Meditation|meditation
5356373|NCT01919853|Neoplasms|neoplasms
5356374|NCT01919853|Signs and symptoms|signs and symptoms
5356375|NCT01919840|hemostatic disorders|hemostatic disorders
5356376|NCT01919840|ardiac surgery|ardiac surgery
5356377|NCT01919840|cardiopulmonary bypass|cardiopulmonary bypass
5356378|NCT01919827|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5964016|NCT04172714|Liver Diseases|liver diseases
5964017|NCT04172714|Radiology, Interventional|radiology, interventional
5964018|NCT04172714|Radiology|radiology
5964019|NCT04171635|Quantitative Susceptibility Mapping|quantitative susceptibility mapping
5964020|NCT04171635|Iron chelating therapy|iron chelating therapy
5964021|NCT04171635|Iron overload|iron overload
5356379|NCT01919827|Stem cells|stem cells
5356380|NCT01919827|Mesenchymal stem cells|mesenchymal stem cells
5356381|NCT01919801|icatibant|icatibant
5356382|NCT01919801|Firazyr|firazyr
5356383|NCT01919801|ACE-I|ace-i
5356384|NCT01919788|Diabetes Mellitus Type I|diabetes mellitus type i
5356385|NCT01919788|Hypoglycemia|hypoglycemia
5356386|NCT01919788|Counter-regulatory mechanisms|counter-regulatory mechanisms
5356387|NCT01919762|Bacteremia|bacteremia
5356388|NCT01919762|Sepsis|sepsis
5356389|NCT01919762|Acinetobacter baumannii|acinetobacter baumannii
5356390|NCT01919762|Staphylococcus aureus|staphylococcus aureus
5356391|NCT01919762|Klebsiella pneumonia|klebsiella pneumonia
5356392|NCT01919762|Pseudomonas aeruginosa|pseudomonas aeruginosa
5356393|NCT01919762|Enterococcus faecalis|enterococcus faecalis
5356394|NCT01919762|Magnetic Relaxation Detection|magnetic relaxation detection
5356395|NCT01919762|Nuclear Magnetic Resonance Detection|nuclear magnetic resonance detection
5356396|NCT01919762|Blood culture|blood culture
5356397|NCT01919749|breast cancer metastatic|breast cancer metastatic
5356398|NCT01919749|molecular profiling|molecular profiling
5356399|NCT01919749|sequencing|sequencing
5356400|NCT01919749|profiling|profiling
5356401|NCT01919749|breast cancer|breast cancer
5356402|NCT01919736|knee OA|knee oa
5356404|NCT01919723|Ticagrelor|ticagrelor
5356405|NCT01919723|Eptifibatide|eptifibatide
5356406|NCT01919710|Neutropenia|neutropenia
5356407|NCT01919710|chemotherapy|chemotherapy
5356408|NCT01919710|rHSA/GCSF|rhsa/gcsf
5356409|NCT01919697|Plecantaide|plecantaide
5356410|NCT01919697|Chronic Idiopathic Constipation|chronic idiopathic constipation
5356411|NCT01919697|Chronic|chronic
5356412|NCT01919697|Idiopathic|idiopathic
5356413|NCT01919697|Constipation|constipation
5356414|NCT01919697|Synergy|synergy
5356415|NCT01919697|CIC|cic
5356416|NCT01919697|CIC study|cic study
5356417|NCT01919697|CIC OLE|cic ole
5356418|NCT01919697|CIC OLE study|cic ole study
5356419|NCT01919697|OLE|ole
5356420|NCT01919697|OLE CIC|ole cic
5356421|NCT01919697|OLE CIC3|ole cic3
5356422|NCT01919697|Open label|open label
5356423|NCT01919697|Open label study|open label study
5356424|NCT01919697|Long term|long term
5356425|NCT01919697|Long term study|long term study
5356426|NCT01919697|Extension|extension
5356427|NCT01919697|Extension study|extension study
5356428|NCT01919684|Glucagon receptor antagonist|glucagon receptor antagonist
5356429|NCT01919671|Ischemic Stroke|ischemic stroke
5356430|NCT01919671|Tongxinluo capsule|tongxinluo capsule
5356431|NCT01919658|nerve blocks in Anterior cruciate ligament surgery|nerve blocks in anterior cruciate ligament surgery
5356432|NCT01919645|Rheumatoid Arthritis|rheumatoid arthritis
5356434|NCT01919645|Polysomnography|polysomnography
5356435|NCT01919645|Sleep Stages|sleep stages
5356436|NCT01919645|Physical Exercise|physical exercise
5356437|NCT01919632|lifestyle|lifestyle
5356438|NCT01919632|physical activity|physical activity
5356439|NCT01919632|endothelial function|endothelial function
5356440|NCT01919632|cardiovascular|cardiovascular
5356441|NCT01919632|occupational|occupational
5356442|NCT01919632|prevention|prevention
5356443|NCT01919606|hysterectomy|hysterectomy
5356444|NCT01919606|analgesia|analgesia
5356445|NCT01919593|Blood culture|blood culture
5356446|NCT01919593|Contamination|contamination
5356447|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate
5356448|NCT01919593|Povidone iodine|povidone iodine
5356449|NCT01919580|Gα12|gα12
5356450|NCT01919580|Oral cancer|oral cancer
5356451|NCT01919567|SOX-9|sox-9
5356452|NCT01919567|Oral cancer|oral cancer
5356453|NCT01919567|arecoline|arecoline
5356454|NCT01919554|House Dust Mite Allergic Rhinitis|house dust mite allergic rhinitis
5356455|NCT01919554|Phase I|phase i
5251608|NCT02435940|Best|best
5423309|NCT01616251|Dietary fibers|dietary fibers
5356465|NCT01919515|primary molars|primary molars
5356466|NCT01919515|stainless steel crowns|stainless steel crowns
5356467|NCT01919489|Incretins|incretins
5356468|NCT01919489|Liraglutide|liraglutide
5356469|NCT01919489|Glargine|glargine
5356470|NCT01919489|Randomized controlled trial|randomized controlled trial
5356471|NCT01919489|basal insulin|basal insulin
5356472|NCT01919489|hospital discharge|hospital discharge
5356473|NCT01919489|inpatient diabetes|inpatient diabetes
5356474|NCT01919476|Postprandial|postprandial
5356475|NCT01919476|Insulin resistance|insulin resistance
5356484|NCT01919450|Lexiscan|lexiscan
5356485|NCT01919450|Regadenoson|regadenoson
5356486|NCT01919450|Rubidium|rubidium
5356487|NCT01919450|Blood Flow Reserve|blood flow reserve
5356488|NCT01919450|Myocardial Perfusion|myocardial perfusion
5356489|NCT01919450|Quantitated Myocardial Perfusion|quantitated myocardial perfusion
5356493|NCT01919385|Type 1 diabetes|type 1 diabetes
5356494|NCT01919385|Insulin Pump|insulin pump
5356495|NCT01919359|ablative laser|ablative laser
5356496|NCT01919359|soft tissue filler|soft tissue filler
5356497|NCT01919346|Kidney Transplantation|kidney transplantation
5356498|NCT01919346|Delayed Graft Function|delayed graft function
5356499|NCT01919320|SynCardia|syncardia
5356500|NCT01919320|Total Artificial Heart|total artificial heart
5356501|NCT01919320|TAH-t|tah-t
5356502|NCT01919307|Seizures|seizures
5356503|NCT01919307|Convulsions|convulsions
5356504|NCT01919307|Anticonvulsants|anticonvulsants
5356505|NCT01919307|Epilepsy|epilepsy
5356506|NCT01919307|Neurologic|neurologic
5356507|NCT01919294|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5356508|NCT01919294|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5356509|NCT01919294|hypogonadism|hypogonadism
5356510|NCT01919294|testosterone replacement therapy|testosterone replacement therapy
5356511|NCT01919281|exercise|exercise
5356512|NCT01919281|resistance training|resistance training
5356513|NCT01919281|insulin resistance|insulin resistance
5356514|NCT01919281|high intensity interval training|high intensity interval training
5356515|NCT01919268|Pilates-based exercises|pilates-based exercises
5356516|NCT01919268|Electrotherapy|electrotherapy
5356517|NCT01919268|Interferencial current|interferencial current
5356518|NCT01919255|Colonoscopy|colonoscopy
5356519|NCT01919255|Bowel preparation|bowel preparation
5356520|NCT01919255|Picolight|picolight
5356521|NCT01919255|Clicolon|clicolon
5356522|NCT01919255|Coolprep|coolprep
5356523|NCT01919229|HR-positive|hr-positive
5356524|NCT01919229|HER2-negative|her2-negative
5356525|NCT01919229|Breast cancer|breast cancer
5356526|NCT01919229|LEE011|lee011
5356527|NCT01919229|Letrozole|letrozole
5356528|NCT01919229|CDK|cdk
5356529|NCT01919229|CDK4|cdk4
5356530|NCT01919229|CDK6|cdk6
5356531|NCT01919229|CDK4/6|cdk4/6
5356532|NCT01919229|Pharmacodynamics|pharmacodynamics
5356533|NCT01919229|Pre-surgical|pre-surgical
5356534|NCT01919229|Postmenopausal|postmenopausal
5356535|NCT01919177|Heart Failure|heart failure
5356536|NCT01919177|Arterial hemodynamics|arterial hemodynamics
5356537|NCT01919177|Exercise capacity|exercise capacity
5356538|NCT01919177|Mitochondrial oxidative capacity|mitochondrial oxidative capacity
5356539|NCT01919164|Osteoarthritis of knee|osteoarthritis of knee
5356540|NCT01919164|Recombinant Human Fibroblast Growth Factor-18 (rhFGF-18)|recombinant human fibroblast growth factor-18 (rhfgf-18)
5356541|NCT01919164|Sprifermin|sprifermin
5356542|NCT01919164|Placebo|placebo
5356543|NCT01919151|survival|survival
5356544|NCT01919125|Chronic hepatitis C|chronic hepatitis c
5356545|NCT01919125|Hepatitis C virus|hepatitis c virus
5356546|NCT01919125|HCV|hcv
5356547|NCT01919112|Brain stimulation|brain stimulation
5356548|NCT01919099|Post-Transplant Infection|post-transplant infection
5356549|NCT01919099|Post-Transplant Bacteremia|post-transplant bacteremia
5352472|NCT01937728|alfa 1a|alfa 1a
5356558|NCT01919047|occurrence of adverse events|occurrence of adverse events
5356559|NCT01919047|Overactive Bladder Symptom Score|overactive bladder symptom score
5356560|NCT01919034|Interleukin-20, Thrombomodulin, Huntington disease, patient control analgesic|interleukin-20, thrombomodulin, huntington disease, patient control analgesic
5356562|NCT01919008|Pharmacokinetics|pharmacokinetics
5356563|NCT01919008|Major Depressive Disorder|major depressive disorder
5356564|NCT01918995|CVT3146|cvt3146
5356565|NCT01918995|Regadenoson|regadenoson
5356566|NCT01918982|Aortic aneurysm|aortic aneurysm
5356567|NCT01918982|circulating endothelial progenitor cells|circulating endothelial progenitor cells
5356568|NCT01918969|Endothelial progenitor cells|endothelial progenitor cells
5356569|NCT01918969|Healthy blood donors|healthy blood donors
5356570|NCT01918956|immunotherapy|immunotherapy
5356571|NCT01918956|birch pollen|birch pollen
5356572|NCT01918956|seasonal allergy|seasonal allergy
5356573|NCT01918956|up-dosing|up-dosing
5356574|NCT01918943|Spine|spine
5356575|NCT01918943|Aspen device|aspen device
5356576|NCT01918943|PLIF|plif
5356577|NCT01918943|Low back pain|low back pain
5356578|NCT01918930|Melanoma|melanoma
5356579|NCT01918930|Accessible tumors|accessible tumors
5356580|NCT01918930|B7-H3 positive tumors|b7-h3 positive tumors
5356581|NCT01918917|Arthroscopic knee surgery|arthroscopic knee surgery
5356582|NCT01918917|Dexmedetomidine|dexmedetomidine
5356583|NCT01918917|Analgesia|analgesia
5356584|NCT01918904|calcinosis|calcinosis
5356585|NCT01918904|sodium thiosulfate|sodium thiosulfate
5356586|NCT01918904|topical treatment|topical treatment
5356587|NCT01918904|connective tissue disease|connective tissue disease
5356588|NCT01918891|stroke|stroke
5356589|NCT01918891|transient ischemic attack|transient ischemic attack
5356590|NCT01918891|High blood pressure|high blood pressure
5356591|NCT01918891|Hypertension|hypertension
5356592|NCT01918878|age-related macular degeneration|age-related macular degeneration
5356593|NCT01918878|intravitreal injections|intravitreal injections
5356594|NCT01918878|Aflibercept|aflibercept
5356595|NCT01918878|EYLEA|eylea
5356596|NCT01918865|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5356597|NCT01918865|T2DM|t2dm
5356598|NCT01918852|Hand-foot syndrome|hand-foot syndrome
5356599|NCT01918852|Toxicity|toxicity
5356600|NCT01918852|Fluoropyrimidine|fluoropyrimidine
5356601|NCT01918852|Capecitabine|capecitabine
5356602|NCT01918852|Teysuno|teysuno
5356603|NCT01918852|S1|s1
5356604|NCT01918839|Investigational Device (VINCI Plus)|investigational device (vinci plus)
5356605|NCT01918839|Correction of nasolabial fold|correction of nasolabial fold
5356606|NCT01918839|Wrinkle improvement|wrinkle improvement
5235493|NCT02530580|AZD7325|azd7325
5235503|NCT02530476|AML|aml
5356607|NCT01918839|Wrinkle correction|wrinkle correction
5356608|NCT01918800|fatigue|fatigue
5356609|NCT01918800|quality of life|quality of life
5356610|NCT01918800|rehabilitation|rehabilitation
5356611|NCT01918800|self management|self management
5356612|NCT01918800|energy effectiveness|energy effectiveness
5356613|NCT01918774|Unemployment|unemployment
5356614|NCT01918774|Cognitive Behavioral Therapy|cognitive behavioral therapy
5356615|NCT01918774|Mental Disorders|mental disorders
5356616|NCT01918761|NSCLC|nsclc
5356617|NCT01918761|Stage IV|stage iv
5356618|NCT01918761|Pemetrexed|pemetrexed
5356619|NCT01918761|Dacomitinib|dacomitinib
5356620|NCT01918735|Safety|safety
5356621|NCT01918735|Tolerability|tolerability
5356622|NCT01918735|Assessment of potential adverse events|assessment of potential adverse events
5356623|NCT01918735|Assessment of potential laboratory abnormalities|assessment of potential laboratory abnormalities
5356624|NCT01918722|Activating blood stagnation and expelling blood stasis|activating blood stagnation and expelling blood stasis
5356625|NCT01918722|Hematoma enlargement|hematoma enlargement
5356626|NCT01918722|herbal medicine|herbal medicine
5356627|NCT01918722|traditional chinese medicine|traditional chinese medicine
5356628|NCT01918722|random clinical trial|random clinical trial
5356629|NCT01918696|suicide|suicide
5356630|NCT01918696|anger|anger
5356631|NCT01918696|interpretation modification|interpretation modification
5356632|NCT01918696|computerized treatment|computerized treatment
5356633|NCT01918670|atrial fibrillation; catheter ablation; relapse; stroke; death|atrial fibrillation; catheter ablation; relapse; stroke; death
5356634|NCT01918657|Interventional|interventional
5356635|NCT01918657|Randomized|randomized
5356636|NCT01918657|Double blind|double blind
5356637|NCT01918657|Placebo controlled|placebo controlled
5356638|NCT01918657|Pediatric|pediatric
5356639|NCT01918618|levosimendan|levosimendan
5356640|NCT01918618|renal effects|renal effects
5356641|NCT01918618|cardiac surgery|cardiac surgery
5356642|NCT01918618|left heart insufficiency|left heart insufficiency
5356643|NCT01918605|prostate cancer|prostate cancer
5356644|NCT01918605|brachytherapy|brachytherapy
5356646|NCT01918605|side effect|side effect
5356647|NCT01918592|bladder cancer|bladder cancer
5356648|NCT01918592|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5356649|NCT01918592|radical cystectomy|radical cystectomy
5356650|NCT01918592|lymphadenectomy|lymphadenectomy
5356651|NCT01918592|biomarker|biomarker
5356652|NCT01918553|AMD|amd
5356653|NCT01918553|epidemiology|epidemiology
5356659|NCT01918527|Locally advanced colon cancer|locally advanced colon cancer
5356660|NCT01918527|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5356661|NCT01918514|Magnesium sulfate|magnesium sulfate
5356663|NCT01918514|interscalene|interscalene
5356664|NCT01918514|NMDA receptor|nmda receptor
5356665|NCT01918501|multiple sclerosis|multiple sclerosis
5356666|NCT01918501|Remyelination|remyelination
5356667|NCT01918501|Mitochondria|mitochondria
5356668|NCT01918501|fatty acids|fatty acids
5356669|NCT01918488|Diabetic Nephropathies|diabetic nephropathies
5356670|NCT01918488|Hypertension|hypertension
5356671|NCT01918488|Proteinuria|proteinuria
5356672|NCT01918488|Albuminuria|albuminuria
5356673|NCT01918488|Epithelial Sodium Channels|epithelial sodium channels
5356674|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers
5356675|NCT01918488|Amiloride|amiloride
5356676|NCT01918475|randomized controlled trial|randomized controlled trial
5251812|NCT02434705|Eosinophilic|eosinophilic
5356677|NCT01918475|placebo controlled trial|placebo controlled trial
5356678|NCT01918475|cross over trial|cross over trial
5356679|NCT01918462|Alcoholic hepatitis|alcoholic hepatitis
5356680|NCT01918462|IL-22|il-22
5356681|NCT01918462|Kupffer cells|kupffer cells
5356682|NCT01918449|OSA|osa
5356684|NCT01918449|primary care|primary care
5356685|NCT01918449|efficacy|efficacy
5356686|NCT01918436|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5356687|NCT01918436|Neurocognitive training for preschool children with ADHD|neurocognitive training for preschool children with adhd
5356688|NCT01918436|Play intervention for children with ADHD|play intervention for children with adhd
5356689|NCT01918423|Childhood adiposity|childhood adiposity
5356690|NCT01918423|Metabolic risk factors|metabolic risk factors
5356691|NCT01918423|Bone mineralization|bone mineralization
5356692|NCT01918410|contact lens|contact lens
5356693|NCT01918410|alginic|alginic
5356694|NCT01918410|dry eyes|dry eyes
5356695|NCT01918397|Levofloxacin|levofloxacin
5356906|NCT01917552|Gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b|gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, adjuvant, capecitabine, gastric cancer, stage 1b
5356907|NCT01917526|Oxygen|oxygen
5356908|NCT01917526|PACU|pacu
5356909|NCT01917526|Hypoxemia|hypoxemia
5356910|NCT01917513|Adenoma|adenoma
5356911|NCT01917513|Polyps|polyps
5356912|NCT01917513|CRC|crc
5356913|NCT01917513|Colonoscopy|colonoscopy
5356914|NCT01917513|Detection Yield|detection yield
5356915|NCT01917500|Continues non-invasive Blood pressure measurement|continues non-invasive blood pressure measurement
5964022|NCT04171635|Liver iron concentration|liver iron concentration
5964023|NCT04171635|erythrocyte transfusion|erythrocyte transfusion
5235613|NCT02529878|S1|s1
5356916|NCT01917500|Continues non-invasive Cardiac Output measurement|continues non-invasive cardiac output measurement
5356917|NCT01917474|low-lipid diet|low-lipid diet
5356918|NCT01917474|normal lipid intake|normal lipid intake
5356919|NCT01917474|saturated fats reduction|saturated fats reduction
5356920|NCT01917474|headache attacks|headache attacks
5356921|NCT01917448|postoperative pain|postoperative pain
5356922|NCT01917448|spinal morphine|spinal morphine
5356923|NCT01917448|video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5356924|NCT01917435|fiberoptic bronchoscopy,|fiberoptic bronchoscopy,
5356925|NCT01917435|Video-stylet,|video-stylet,
5356926|NCT01917435|Nasotracheal Intubation|nasotracheal intubation
5356927|NCT01917409|Conventional Laryngoscopy ,|conventional laryngoscopy ,
5356928|NCT01917409|Video-stylet ,|video-stylet ,
5356929|NCT01917409|Nasotracheal Intubation|nasotracheal intubation
5356930|NCT01917396|caesarean, bowel, gass|caesarean, bowel, gass
5356931|NCT01917383|glaucoma|glaucoma
5356932|NCT01917383|primary open angle glaucoma|primary open angle glaucoma
5356933|NCT01917383|ocular hypertension|ocular hypertension
5356934|NCT01917383|adenosine agonist|adenosine agonist
5356935|NCT01917383|eye drop|eye drop
5356936|NCT01917383|trabodenoson|trabodenoson
5356937|NCT01917383|trabecular meshwork|trabecular meshwork
5356938|NCT01917370|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5356939|NCT01917370|icc|icc
5356940|NCT01917370|vegf signal pathway|vegf signal pathway
5356941|NCT01917357|Vaccination|vaccination
5356942|NCT01917357|Immunisation|immunisation
5356943|NCT01917357|Virus|virus
5356944|NCT01917357|Diphtheria|diphtheria
5356945|NCT01917357|Pertussis|pertussis
5356946|NCT01917357|Tetanus|tetanus
5356947|NCT01917357|Hepatitis B|hepatitis b
5356948|NCT01917357|Haemophilus Influenzae|haemophilus influenzae
5356949|NCT01917357|Immunity|immunity
5356950|NCT01917344|Phenylketonuria|phenylketonuria
5356951|NCT01917344|MRI|mri
5356952|NCT01917344|Neuropsychological functioning|neuropsychological functioning
5356954|NCT01917344|EEG|eeg
5356955|NCT01917331|spirometry|spirometry
5356956|NCT01917331|severe COPD|severe copd
5356957|NCT01917331|lung disease|lung disease
5356958|NCT01917331|fixed combination|fixed combination
5356959|NCT01917318|Post traumatic stress disorder|post traumatic stress disorder
5356960|NCT01917318|Treatment of post traumatic stress disorder|treatment of post traumatic stress disorder
5356961|NCT01917318|Symptoms of arousal in post traumatic stress disorder|symptoms of arousal in post traumatic stress disorder
5356962|NCT01917318|Iloperidone in post traumatic stress disorder|iloperidone in post traumatic stress disorder
5356963|NCT01917305|Bacteria|bacteria
5356964|NCT01917305|bone level|bone level
5356965|NCT01917305|bone loss|bone loss
5356966|NCT01917305|dental implants|dental implants
5356967|NCT01917305|implant design|implant design
5356968|NCT01917305|platform-shifting|platform-shifting
5356969|NCT01917305|platform-matching|platform-matching
5356970|NCT01917292|Periodontitis|periodontitis
5356971|NCT01917292|Prehypertension|prehypertension
5356972|NCT01917292|Periodontal Intervention|periodontal intervention
5356973|NCT01917279|Metastatic Breast Cancer|metastatic breast cancer
5356974|NCT01917279|Antineoplastic Agents|antineoplastic agents
5356975|NCT01917279|Therapeutic Uses|therapeutic uses
5356976|NCT01917279|Antimetabolites|antimetabolites
5356977|NCT01917279|Tubulin Modulators|tubulin modulators
5356978|NCT01917279|Maintenance chemotherapy|maintenance chemotherapy
5356979|NCT01917279|Metronomic chemotherapy|metronomic chemotherapy
5356980|NCT01917279|Capecitabine|capecitabine
5356981|NCT01917279|Docetaxel|docetaxel
5356982|NCT01917253|infiltration, phlebitis, occlusion, thrombosis|infiltration, phlebitis, occlusion, thrombosis
5356983|NCT01917240|Monophasic|monophasic
5356984|NCT01917240|Sequential|sequential
5356985|NCT01917240|Media|media
5356986|NCT01917201|Coronary Artery Disease|coronary artery disease
5356987|NCT01917201|Drug Eluting Stents|drug eluting stents
5356988|NCT01917201|Intravascular Ultrasound|intravascular ultrasound
5356989|NCT01917201|Optical Coherence Tomography|optical coherence tomography
5356990|NCT01917201|Intravascular Visualization|intravascular visualization
5356991|NCT01917175|HIV|hiv
5356992|NCT01917175|Cohort|cohort
5356993|NCT01917175|Early HIV infection|early hiv infection
5356994|NCT01917175|Côte d'Ivoire|côte d'ivoire
5356995|NCT01917175|Disease progression|disease progression
5356996|NCT01917162|contact lenses|contact lenses
5356997|NCT01917162|daily disposable contact lenses|daily disposable contact lenses
5356998|NCT01917162|silicone hydrogel|silicone hydrogel
5356999|NCT01917162|contact lens comfort|contact lens comfort
5357000|NCT01917162|near-sighted|near-sighted
5357001|NCT01917149|Dilated cardiomyopathy|dilated cardiomyopathy
5357002|NCT01917149|High dose ACEI/ARB|high dose acei/arb
5357003|NCT01917136|pulmonary hypertension|pulmonary hypertension
5357004|NCT01917136|right ventricular function|right ventricular function
5357005|NCT01917136|11C acetate|11c acetate
5357007|NCT01917136|ranolazine|ranolazine
5357008|NCT01917123|L-Citrulline malate,Coronary Heart Disease, Brachial Index|l-citrulline malate,coronary heart disease, brachial index
5357009|NCT01917084|Passive range of motion|passive range of motion
5964024|NCT04171635|liver transplantation|liver transplantation
5223741|NCT02600442|FDG|fdg
5235711|NCT02529514|Sleep|sleep
5357010|NCT01917084|Single ventricle|single ventricle
5357011|NCT01917084|Infants|infants
5357012|NCT01917084|Congenital heart disease|congenital heart disease
5357013|NCT01917058|Alopecia Areata|alopecia areata
5357014|NCT01917058|Abatacept|abatacept
5357015|NCT01917045|sufentanil|sufentanil
5357016|NCT01917045|morphine|morphine
5357017|NCT01917045|postoperative pain control|postoperative pain control
5357018|NCT01917045|body fat percentage|body fat percentage
5357019|NCT01917045|gynecology laparoscopic surgery|gynecology laparoscopic surgery
5357020|NCT01917045|lipid solubility|lipid solubility
5357021|NCT01917032|Trace Elements|trace elements
5357022|NCT01917032|Preschool|preschool
5357023|NCT01917032|Malnutrition|malnutrition
5357024|NCT01917032|Fortified Food|fortified food
5357025|NCT01917019|Japan|japan
5357026|NCT01916980|Dermatitis|dermatitis
5357027|NCT01916980|Dermatitis, Atopic|dermatitis, atopic
5357028|NCT01916980|Skin Diseases|skin diseases
5357029|NCT01916980|Skin Diseases, Genetic|skin diseases, genetic
5357030|NCT01916980|Genetic Diseases, Inborn|genetic diseases, inborn
5357031|NCT01916980|Skin Diseases, Eczematous|skin diseases, eczematous
5357032|NCT01916980|Hypersensitivity, Immediate|hypersensitivity, immediate
5357033|NCT01916980|Hypersensitivity|hypersensitivity
5357034|NCT01916980|Immune System Diseases|immune system diseases
5357035|NCT01916967|Urticaria|urticaria
5357036|NCT01916967|Skin Diseases, Vascular|skin diseases, vascular
5357037|NCT01916967|Skin Diseases|skin diseases
5357038|NCT01916967|Hypersensitivity, Immediate|hypersensitivity, immediate
5357039|NCT01916967|Hypersensitivity|hypersensitivity
5357040|NCT01916967|Immune System Diseases|immune system diseases
5357041|NCT01916967|Cholinergic Antagonists|cholinergic antagonists
5357042|NCT01916967|Cholinergic Agents|cholinergic agents
5357043|NCT01916967|Neurotransmitter Agents|neurotransmitter agents
5357044|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
5357045|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists
5357046|NCT01916967|Histamine Antagonists|histamine antagonists
5357049|NCT01916954|Pregnancy|pregnancy
5357050|NCT01916954|Plasmodium falciparum|plasmodium falciparum
5357051|NCT01916928|Circulating cell free fetal DNA|circulating cell free fetal dna
5357052|NCT01916928|Intrauterine fetal demise|intrauterine fetal demise
5357053|NCT01916928|Miscarriage|miscarriage
5357054|NCT01916902|Optical Coherence Tomography|optical coherence tomography
5357055|NCT01916902|Ticagrelor|ticagrelor
5357056|NCT01916889|Delirium|delirium
5357057|NCT01916876|medical in-patients|medical in-patients
5357058|NCT01916876|follow-up care|follow-up care
5357059|NCT01916876|developing country|developing country
5357060|NCT01916837|Breast cancer|breast cancer
5357061|NCT01916837|Feasibility|feasibility
5357062|NCT01916837|Genomic grade index|genomic grade index
5357063|NCT01916824|depression|depression
5357064|NCT01916824|melancholia|melancholia
5357065|NCT01916824|treatment|treatment
5357066|NCT01916811|Low Back Pain|low back pain
5357067|NCT01916811|Load quantitative MRI|load quantitative mri
5357068|NCT01916798|Infertility|infertility
5357069|NCT01916798|intralipid|intralipid
5357070|NCT01916798|invitro fertilization|invitro fertilization
5357071|NCT01916798|repeated implantation failure|repeated implantation failure
5357072|NCT01916798|repeated miscarriage|repeated miscarriage
5357073|NCT01916772|cherubism|cherubism
5357074|NCT01916772|bone tumors|bone tumors
5357075|NCT01916759|immunization|immunization
5357076|NCT01916746|Caesarean Scar Pregnancy|caesarean scar pregnancy
5357077|NCT01916746|Transvaginal Resection|transvaginal resection
5357078|NCT01916746|treatment|treatment
5357079|NCT01916707|trauma|trauma
5357080|NCT01916707|enoxaparin|enoxaparin
5357081|NCT01916707|weight based|weight based
5357082|NCT01916707|prophylaxis|prophylaxis
5357083|NCT01916694|Gestational diabetes mellitus|gestational diabetes mellitus
5357084|NCT01916694|m Health|m health
5357085|NCT01916694|Smartphone|smartphone
5357086|NCT01916694|Blood glucose monitoring|blood glucose monitoring
5357087|NCT01916681|Induction|induction
5357088|NCT01916681|Labor|labor
5357089|NCT01916681|Cervical foley|cervical foley
5357090|NCT01916681|Misoprostol|misoprostol
5357091|NCT01916681|Pitocin|pitocin
5357092|NCT01916681|Oxytocin|oxytocin
5357093|NCT01916681|Cytotec|cytotec
5357094|NCT01916681|Delivery|delivery
5357095|NCT01916681|IOL|iol
5357096|NCT01916655|Obstructive Sleep Apnea|obstructive sleep apnea
5357097|NCT01916655|Adherence|adherence
5357098|NCT01916655|Chronic Disease|chronic disease
5357099|NCT01916655|Telemedicine|telemedicine
5357100|NCT01916655|Continuous Positive Airway Pressure|continuous positive airway pressure
5357101|NCT01916655|Mobile Health|mobile health
5357102|NCT01916642|iv lidocaine|iv lidocaine
5357103|NCT01916642|inducing dose|inducing dose
5964025|NCT04171635|magnetic resonance imaging|magnetic resonance imaging
5964026|NCT04171635|thalassemia major|thalassemia major
5357104|NCT01916642|etomidate|etomidate
5357105|NCT01916642|dose response|dose response
5357106|NCT01916616|paradoxical vocal fold motion|paradoxical vocal fold motion
5357107|NCT01916616|cognitive-behavioral therapy|cognitive-behavioral therapy
5357108|NCT01916590|Post-operative pain|post-operative pain
5357109|NCT01916590|Anterior Cruciate Ligament repair|anterior cruciate ligament repair
5357110|NCT01916577|Stem Cell Mobilization|stem cell mobilization
5357111|NCT01916577|Stem Cells|stem cells
5357112|NCT01916577|Transplantation|transplantation
5357113|NCT01916577|Autologous|autologous
5357114|NCT01916564|Bowel preparation|bowel preparation
5357115|NCT01916564|Morning colonoscopy|morning colonoscopy
5357116|NCT01916564|Split-dose|split-dose
5357117|NCT01916564|Same-morning whole-dose|same-morning whole-dose
5357118|NCT01916564|Reduced-volume PEG-ELS|reduced-volume peg-els
5357119|NCT01916538|anorexia nervosa|anorexia nervosa
5357120|NCT01916538|genetics|genetics
5357121|NCT01916538|gene|gene
5357122|NCT01916538|eating disorder|eating disorder
5357123|NCT01916525|Acute coronary syndrome|acute coronary syndrome
5357124|NCT01916525|Cost-effectiveness|cost-effectiveness
5357125|NCT01916525|Cardiac rehabilitation|cardiac rehabilitation
5357126|NCT01916525|Exercise|exercise
5357127|NCT01916525|Physical activity|physical activity
5357128|NCT01916525|Home monitoring|home monitoring
5357129|NCT01916512|CETP, HDL, LDL, apoB-100, apoB-48, remnants|cetp, hdl, ldl, apob-100, apob-48, remnants
5357130|NCT01916499|Child, adolescent|child, adolescent
5357131|NCT01916499|Coronary artery disease|coronary artery disease
5357132|NCT01916499|Magnetic resonance imaging|magnetic resonance imaging
5357133|NCT01916473|Epidural analgesia|epidural analgesia
5357134|NCT01916473|continuous wound infusion|continuous wound infusion
5357135|NCT01916473|ropivacaine|ropivacaine
5357136|NCT01916473|total abdominal hysterectomy|total abdominal hysterectomy
5357137|NCT01916460|Gastroparesis|gastroparesis
5357138|NCT01916460|Endoscopic ultrasound|endoscopic ultrasound
5357141|NCT01916447|Monoclonal Antibody|monoclonal antibody
5357142|NCT01916447|Vascular Endothelial Growth Factor A (VEGF-A)|vascular endothelial growth factor a (vegf-a)
5357143|NCT01916434|Farmed fish|farmed fish
5357144|NCT01916434|Dietary intervention|dietary intervention
5357145|NCT01916434|Long-term intervention|long-term intervention
5357146|NCT01916434|Omega-3 index|omega-3 index
5357147|NCT01916434|Cardiovascular risk markers|cardiovascular risk markers
5352849|NCT01935661|ERP|erp
5357148|NCT01916434|Coagulation and endothelial activation|coagulation and endothelial activation
5357149|NCT01916434|Bleeding time|bleeding time
5357150|NCT01916434|Inflammation|inflammation
5357151|NCT01916434|Oxidative stress|oxidative stress
5357152|NCT01916434|Gut health|gut health
5357153|NCT01916434|Micronutrient availability|micronutrient availability
5357154|NCT01916421|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5357155|NCT01916421|lymphadenopathy|lymphadenopathy
5357156|NCT01916421|Endoscopic ultrasound|endoscopic ultrasound
5357157|NCT01916408|Exercise|exercise
5357158|NCT01916408|Inflammation|inflammation
5357159|NCT01916408|Upper Respiratory Tract Illness|upper respiratory tract illness
5357160|NCT01916408|Oral Proteolytic and Hydrolytic Enzymes|oral proteolytic and hydrolytic enzymes
5357161|NCT01916408|Flavinoids|flavinoids
5357162|NCT01916395|Migraine|migraine
5357163|NCT01916382|Alkaptonuria, nitisinone,Ochronosis, Homogentisic acid|alkaptonuria, nitisinone,ochronosis, homogentisic acid
5357164|NCT01916369|Peripheral Arterial Disease|peripheral arterial disease
5357165|NCT01916369|Fontaine Stage II, III or IV|fontaine stage ii, iii or iv
5357166|NCT01916369|Vascular disease|vascular disease
5357167|NCT01916369|Cardiovascular diseases|cardiovascular diseases
5357168|NCT01916369|Neural stem cell|neural stem cell
5357169|NCT01916356|Infertility|infertility
5357170|NCT01916356|Education|education
5357171|NCT01916356|Risk Factors|risk factors
5357172|NCT01916356|Fertility knowledge|fertility knowledge
5357173|NCT01916356|Fertility myths|fertility myths
5357174|NCT01916343|Laparoscopy|laparoscopy
5357175|NCT01916343|Surgical skills|surgical skills
5357176|NCT01916343|Team training|team training
5357177|NCT01916343|Obstetrics and Gynecology|obstetrics and gynecology
5357178|NCT01916343|Curriculum|curriculum
5357179|NCT01916304|Drug Therapy|drug therapy
5357180|NCT01916252|Multiple Myeloma|multiple myeloma
5357181|NCT01916252|MEL200|mel200
5357182|NCT01916252|BUMEL|bumel
5357183|NCT01916239|Pomegranate|pomegranate
5357184|NCT01916239|Urolithins|urolithins
5357185|NCT01916239|Colorectal cancer|colorectal cancer
5357186|NCT01916239|Colon cancer|colon cancer
5357187|NCT01916239|Metabolite|metabolite
5357188|NCT01916239|Gene expression|gene expression
5357189|NCT01916239|microRNA|microrna
5357190|NCT01916239|Nutraceutical|nutraceutical
5357191|NCT01916239|Food supplement|food supplement
5357192|NCT01916239|Polyphenol|polyphenol
5357193|NCT01916239|Gut microbiota|gut microbiota
5357194|NCT01916226|cetirizine|cetirizine
5343314|NCT01979419|early detection|early detection
5357195|NCT01916226|seasonal allergic rhinitis|seasonal allergic rhinitis
5357196|NCT01916226|Quality of Life|quality of life
5357197|NCT01916226|fluticasone propionate nasal spray|fluticasone propionate nasal spray
5357198|NCT01916161|Crohn's disease|crohn's disease
5357199|NCT01916161|ulcerative colitis|ulcerative colitis
5357200|NCT01916161|anxiety|anxiety
5357201|NCT01916161|patient knowledge|patient knowledge
5357202|NCT01916161|information sources|information sources
5223887|NCT02599649|Opdivo|opdivo
5357205|NCT01916135|[18F]-SKI-249380|[18f]-ski-249380
5357206|NCT01916135|PET Imaging|pet imaging
5357207|NCT01916135|CT Imaging|ct imaging
5357208|NCT01916135|12-182|12-182
5357209|NCT01916122|Fluorestradiol (FES)|fluorestradiol (fes)
5357210|NCT01916122|PET/CT scan|pet/ct scan
5357211|NCT01916122|Estrogen Receptor|estrogen receptor
5357212|NCT01916122|13-071|13-071
5357213|NCT01916109|Gemcitabine|gemcitabine
5357214|NCT01916109|Carboplatin|carboplatin
5357215|NCT01916109|Panitumumab|panitumumab
5357216|NCT01916109|(GCaP)|(gcap)
5357217|NCT01916109|radical cystectomy|radical cystectomy
5357218|NCT01916109|10-103|10-103
5357219|NCT01916070|syncope|syncope
5357220|NCT01916070|near syncope|near syncope
5357221|NCT01916070|prognosis|prognosis
5357222|NCT01916070|emergency department|emergency department
5357223|NCT01916057|Positron-Emission Tomography Scan|positron-emission tomography scan
5357224|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5357225|NCT01916057|Magnetic Resonance Imaging|magnetic resonance imaging
5357226|NCT01916057|Enzyme-Linked Immunospot Assay|enzyme-linked immunospot assay
5357227|NCT01916057|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
5357228|NCT01916057|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
5357229|NCT01916057|beta-1,3-D-glucan|beta-1,3-d-glucan
5357230|NCT01916057|Candida spp.|candida spp.
5357231|NCT01916057|Genetic Susceptibility|genetic susceptibility
5357232|NCT01916057|Genotype|genotype
5357233|NCT01916044|caesarean,|caesarean,
5357234|NCT01916044|trial of labor,|trial of labor,
5357235|NCT01916044|ultrasound|ultrasound
5357236|NCT01916018|Congenital hypothyroidism|congenital hypothyroidism
5357237|NCT01916018|Thyroid dysgenesis|thyroid dysgenesis
5357238|NCT01916018|Genetics|genetics
5357239|NCT01916018|Associated malformations|associated malformations
5357240|NCT01916018|Psychomotor delay|psychomotor delay
5357241|NCT01916018|Mental retardation|mental retardation
5357242|NCT01915979|plasma rich in growth factors, tendinopathy, traumatology|plasma rich in growth factors, tendinopathy, traumatology
5357243|NCT01915979|,rotator cuff, effectiveness, plasma rich in platelets|,rotator cuff, effectiveness, plasma rich in platelets
5357244|NCT01915953|Accurte Hb noninvasive measurement|accurte hb noninvasive measurement
5357245|NCT01915940|Glaucoma|glaucoma
5357246|NCT01915940|Primary Open-Angle Glaucoma|primary open-angle glaucoma
5357247|NCT01915940|Ocular Hypertension|ocular hypertension
5357248|NCT01915888|Clinical|clinical
5357249|NCT01915888|Children|children
5357250|NCT01915888|Rotavirus|rotavirus
5357251|NCT01915888|Cost|cost
5357252|NCT01915888|Rotarix vaccination|rotarix vaccination
5357253|NCT01915875|Cystic fibrosis-pain-sophrology|cystic fibrosis-pain-sophrology
5357254|NCT01915862|Acute ischemic stroke|acute ischemic stroke
5357255|NCT01915862|Blood pressure variability|blood pressure variability
5357256|NCT01915862|Ambulatory arterial stiffness index|ambulatory arterial stiffness index
5671936|NCT00613535|Recurrent Knee Pain|recurrent knee pain
5357257|NCT01915862|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5357258|NCT01915862|Outcome|outcome
5357259|NCT01915836|11-043|11-043
5357260|NCT01915836|MSKCC Tobacco Cessation Program|mskcc tobacco cessation program
5357261|NCT01915797|Pediatric patients, tumor, developmental abnormalities|pediatric patients, tumor, developmental abnormalities
5357262|NCT01915745|Osteoporosis|osteoporosis
5357263|NCT01915745|Bone densitometry|bone densitometry
5357264|NCT01915745|Fracture|fracture
5357265|NCT01915745|Anti-osteoporotic treatment|anti-osteoporotic treatment
5357266|NCT01915745|Short message service|short message service
5357267|NCT01915706|Glaucoma drainage device|glaucoma drainage device
5357268|NCT01915706|Baerveldt 350|baerveldt 350
5357269|NCT01915706|Ripcord|ripcord
5357270|NCT01915706|Complications|complications
5357271|NCT01915693|Radiotherapy|radiotherapy
5357272|NCT01915693|stent|stent
5357273|NCT01915693|quality of life|quality of life
5357274|NCT01915654|Cardiac surgery|cardiac surgery
5357275|NCT01915654|Transfusion|transfusion
5357276|NCT01915641|walking capacity|walking capacity
5357277|NCT01915641|COPD|copd
5357279|NCT01915641|CPAP|cpap
5357280|NCT01915628|MACE|mace
5357281|NCT01915628|Safety|safety
5357282|NCT01915628|Efficacy|efficacy
5357283|NCT01915628|On label|on label
5357284|NCT01915628|Myocardial Infarction|myocardial infarction
5357285|NCT01915628|Cardiac death|cardiac death
5357287|NCT01915628|stent thrombosis|stent thrombosis
5357288|NCT01915615|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5357289|NCT01915615|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5357290|NCT01915615|CMR|cmr
5343421|NCT01978743|HIV|hiv
5357291|NCT01915615|Genetics|genetics
5357292|NCT01915615|Biomarkers|biomarkers
5357293|NCT01915615|Late gadolinium enhancement|late gadolinium enhancement
5357294|NCT01915615|T1 mapping|t1 mapping
5357295|NCT01915602|Hepatocellular Carcinoma|hepatocellular carcinoma
5357296|NCT01915602|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
5357297|NCT01915602|Sorafenib|sorafenib
5964027|NCT04171141|Gastric cancer|gastric cancer
5964028|NCT04171141|Esophageal cancer|esophageal cancer
5223982|NCT02599077|dienogest|dienogest
5357298|NCT01915602|Objective tumor response rate (ORR)|objective tumor response rate (orr)
5357299|NCT01915602|modified RECIST criteria|modified recist criteria
5357300|NCT01915589|Hepatocellular Carcinoma|hepatocellular carcinoma
5357301|NCT01915589|Mitogen-activated Extracellular-signal-regulated kinase (MEK) inhibitor|mitogen-activated extracellular-signal-regulated kinase (mek) inhibitor
5357302|NCT01915589|Objective tumor response rate (ORR)|objective tumor response rate (orr)
5357303|NCT01915589|modified RECIST criteria|modified recist criteria
5357304|NCT01915563|Mechanical ventilation|mechanical ventilation
5357305|NCT01915563|Weaning|weaning
5357306|NCT01915563|Extubation failure|extubation failure
5357307|NCT01915550|Diabetes mellitus|diabetes mellitus
5357308|NCT01915550|Pregnancy|pregnancy
5357309|NCT01915550|Insulin|insulin
5357310|NCT01915550|Metformin|metformin
5357311|NCT01915537|poor prognosis|poor prognosis
5357312|NCT01915537|severe RA|severe ra
5357313|NCT01915537|infliximab|infliximab
5357314|NCT01915511|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5357315|NCT01915511|Pulmonary fibrosis|pulmonary fibrosis
5357316|NCT01915511|IPF|ipf
5357317|NCT01915511|Registry|registry
5357318|NCT01915511|1199.174|1199.174
5357319|NCT01915511|Interstitial Lung Disease|interstitial lung disease
5357320|NCT01915511|ILD|ild
5357321|NCT01915511|Interstitial Lung Disease with Progressive Phenotype|interstitial lung disease with progressive phenotype
5357322|NCT01915498|acute myeloid leukemia|acute myeloid leukemia
5357323|NCT01915498|AML|aml
5357324|NCT01915498|myelodysplastic syndrome|myelodysplastic syndrome
5357325|NCT01915498|MDS|mds
5357326|NCT01915498|hematologic malignancies|hematologic malignancies
5357327|NCT01915498|IDH2|idh2
5357328|NCT01915498|Phase I|phase i
5357329|NCT01915498|Phase II|phase ii
5357330|NCT01915498|AG-221|ag-221
5357335|NCT01915472|Rectal Cancer|rectal cancer
5357336|NCT01915472|previously treated|previously treated
5357337|NCT01915459|Stroke|stroke
5357338|NCT01915459|Spasticity|spasticity
5357339|NCT01915446|EVAR|evar
5357340|NCT01915446|endovascular aortic repair|endovascular aortic repair
5357341|NCT01915446|acute kidney failure|acute kidney failure
5357342|NCT01915446|mesenteric ischemia|mesenteric ischemia
5357343|NCT01915433|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5357344|NCT01915433|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5357345|NCT01915433|Relapsing progressive multiple sclerosis|relapsing progressive multiple sclerosis
5357346|NCT01915433|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5357347|NCT01915433|Fatigue|fatigue
5357348|NCT01915433|Quality of life|quality of life
5357349|NCT01915433|Paleo|paleo
5357350|NCT01915433|Nutrition|nutrition
5357351|NCT01915433|Ketogenic|ketogenic
5357352|NCT01915420|Drug eluting stent|drug eluting stent
5357353|NCT01915420|Bioabsorbable|bioabsorbable
5357354|NCT01915420|Bioresorbable|bioresorbable
5357355|NCT01915420|Coronary Stent|coronary stent
5357356|NCT01915420|Scaffold|scaffold
5357360|NCT01915420|Stentthrombosis|stentthrombosis
5357361|NCT01915420|Rotational atherectomy|rotational atherectomy
5357362|NCT01915394|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5357363|NCT01915394|Epidemics|epidemics
5357364|NCT01915394|Neonatal Intensive Care Unit|neonatal intensive care unit
5357365|NCT01915394|Newborn infants|newborn infants
5357366|NCT01915381|Intellectual disability|intellectual disability
5357367|NCT01915381|mHealth|mhealth
5357369|NCT01915381|Physical activity|physical activity
5357370|NCT01915381|Adherence|adherence
5357371|NCT01915368|Exercise|exercise
5357372|NCT01915368|Rehabilitation|rehabilitation
5357373|NCT01915368|Dose|dose
5357374|NCT01915368|Randomized controlled trial|randomized controlled trial
5357375|NCT01915368|Stroke|stroke
5357376|NCT01915355|onychomycosis|onychomycosis
5357377|NCT01915355|nail|nail
5357378|NCT01915355|fungus|fungus
5357379|NCT01915342|Monosynaptic reflex|monosynaptic reflex
5357380|NCT01915342|H-reflex|h-reflex
5357381|NCT01915329|CRPS|crps
5357382|NCT01915329|repetitive sensory stimulation|repetitive sensory stimulation
5357383|NCT01915329|cortical reorganization|cortical reorganization
5357384|NCT01915329|2-point-discrimination|2-point-discrimination
5357385|NCT01915303|Cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, UFC, hormone disorder, cortisol, adrenocorticotropic hormone|cushing's disease, pituitary tumors, pasireotide, cabergoline, combination treatment, ufc, hormone disorder, cortisol, adrenocorticotropic hormone
5357386|NCT01915290|physical activity|physical activity
5964029|NCT04171141|Colorectal cancer|colorectal cancer
5964030|NCT04171141|Advanced esophageal cancer|advanced esophageal cancer
5964031|NCT04171141|Metastatic esophageal cancer|metastatic esophageal cancer
5964032|NCT04171141|Advanced colorectal cancer|advanced colorectal cancer
5964033|NCT04171141|Metastatic gastric cancer|metastatic gastric cancer
5964034|NCT04171141|Advanced gastric cancer|advanced gastric cancer
5964035|NCT04171141|Metastatic colorectal cancer|metastatic colorectal cancer
5964036|NCT04171141|GUCY2c|gucy2c
5964037|NCT04171141|Anti-PD1|anti-pd1
5964038|NCT04171141|Anti-VEGF|anti-vegf
5964039|NCT04171141|Measurable disease|measurable disease
5964040|NCT04171141|PF-07062119|pf-07062119
5964041|NCT04171141|PF-06801591|pf-06801591
5964042|NCT04171141|Bevacizumab|bevacizumab
5964043|NCT04170894|Atrial Fibrillation|atrial fibrillation
5224084|NCT02598570|Duvelisib|duvelisib
5357387|NCT01915290|maximal oxygen uptake|maximal oxygen uptake
5357388|NCT01915277|Pediatric corrective cardiac surgery|pediatric corrective cardiac surgery
5357389|NCT01915264|Diabetes Mellitus|diabetes mellitus
5357390|NCT01915264|Type 2 Diabetes|type 2 diabetes
5357391|NCT01915264|Acarbose (25/50mg) and Metformin (500mg) in fixed dose combination|acarbose (25/50mg) and metformin (500mg) in fixed dose combination
5357392|NCT01915251|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5357393|NCT01915251|Amoxicilin|amoxicilin
5357394|NCT01915251|Microbiome|microbiome
5357395|NCT01915238|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5357396|NCT01915238|AMD|amd
5357400|NCT01915212|Vaccination|vaccination
5357401|NCT01915212|Replication-Defective|replication-defective
5357402|NCT01915212|Genital Herpes|genital herpes
5357403|NCT01915212|Safety|safety
5357404|NCT01915212|Immune Responses|immune responses
5357405|NCT01915186|DHEA|dhea
5357406|NCT01915186|Poor ovarian reserve|poor ovarian reserve
5357407|NCT01915186|Normal ovarian reserve|normal ovarian reserve
5357408|NCT01915186|In vitro fertilization treatment|in vitro fertilization treatment
5357409|NCT01915186|Ovarian response|ovarian response
5357410|NCT01915186|Pregnancy outcomes|pregnancy outcomes
5357411|NCT01915173|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5357412|NCT01915173|Heartburn|heartburn
5357413|NCT01915173|Dyspepsia|dyspepsia
5357414|NCT01915147|oxycodone naloxone combination|oxycodone naloxone combination
5357415|NCT01915147|severe chronic pain|severe chronic pain
5357416|NCT01915147|non-malignant pain|non-malignant pain
5357417|NCT01915147|Non-malignant pain that requires around-the-clock opioid therapy|non-malignant pain that requires around-the-clock opioid therapy
5357418|NCT01915134|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5357419|NCT01915134|Recombinant Human Endostatin|recombinant human endostatin
5357420|NCT01915134|chemotherapy|chemotherapy
5357421|NCT01915134|gemcitabine and cisplatin|gemcitabine and cisplatin
5357422|NCT01915121|Bladder Cancer|bladder cancer
5357423|NCT01915121|Intervention|intervention
5357424|NCT01915121|Education|education
5357425|NCT01915121|Randomized Controlled Trials|randomized controlled trials
5357426|NCT01915095|spinal cord injury|spinal cord injury
5357427|NCT01915095|neural control|neural control
5357428|NCT01915095|motor function|motor function
5357429|NCT01915095|hand movement|hand movement
5357430|NCT01915082|Lung Function|lung function
5357431|NCT01915082|Allograft Outcome|allograft outcome
5357432|NCT01915069|contraception|contraception
5357433|NCT01915069|Cilostazol|cilostazol
5357434|NCT01915069|phosphodiesterase inhibitors|phosphodiesterase inhibitors
5357435|NCT01915069|To assess the ability of Cilostazol to act as a contraceptive agent|to assess the ability of cilostazol to act as a contraceptive agent
5357436|NCT01915056|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
5357437|NCT01915056|GA-driven interventions|ga-driven interventions
5357438|NCT01915056|Toxicity|toxicity
5357439|NCT01915056|Outcomes|outcomes
5357440|NCT01915056|providing information|providing information
5357441|NCT01915056|older cancer patients|older cancer patients
5357442|NCT01915056|first-line chemotherapy|first-line chemotherapy
5357443|NCT01915056|second-line chemotherapy|second-line chemotherapy
5357444|NCT01915043|lymphedema, prevention, ehealth, cancer|lymphedema, prevention, ehealth, cancer
5357445|NCT01915030|Muscle|muscle
5357446|NCT01915030|Physical performance|physical performance
5357447|NCT01915030|Protein|protein
5357448|NCT01915030|Diet|diet
5357449|NCT01915030|Caloric restriction|caloric restriction
5357450|NCT01915017|Cognitive Adaptation Training|cognitive adaptation training
5357451|NCT01915017|Cognitive Behavior Therapy for Psychosis|cognitive behavior therapy for psychosis
5357452|NCT01915017|Schizophrenia|schizophrenia
5357453|NCT01915004|Pediatric Urology|pediatric urology
5357454|NCT01915004|Urotherapy|urotherapy
5357455|NCT01915004|Nonneurogenic Lower Urinary Tract Dysfunction|nonneurogenic lower urinary tract dysfunction
5357456|NCT01915004|Dysfunctional Elimination Syndrome|dysfunctional elimination syndrome
5357457|NCT01915004|Randomized Controlled Trial|randomized controlled trial
5357458|NCT01914991|proximal interphalangeal joint|proximal interphalangeal joint
5357459|NCT01914991|Orthoses|orthoses
5357460|NCT01914965|Huntington's disease|huntington's disease
5357461|NCT01914965|Apathy|apathy
5357462|NCT01914965|Bupropion|bupropion
5357463|NCT01914952|CaHMB|cahmb
5357464|NCT01914952|HMB free acid|hmb free acid
5357465|NCT01914952|HMB|hmb
5357466|NCT01914939|autism spectrum disorder|autism spectrum disorder
5357467|NCT01914939|social skills deficits|social skills deficits
5357468|NCT01914939|cognitive behavioral therapy|cognitive behavioral therapy
5357469|NCT01914939|oxytocin|oxytocin
5357470|NCT01914939|young adult|young adult
5357471|NCT01914926|metoprolol|metoprolol
5357472|NCT01914926|diltiazem|diltiazem
5357473|NCT01914926|heart rate|heart rate
5357474|NCT01914913|retinitis pigmentosa|retinitis pigmentosa
5357475|NCT01914913|Bone marrow|bone marrow
5357476|NCT01914913|stem cell|stem cell
5964044|NCT04170894|Radiofrequency Ablation|radiofrequency ablation
5964045|NCT04170894|Ablation|ablation
5964046|NCT04170894|Arrhythmia|arrhythmia
5964047|NCT04170829|MERS-CoV|mers-cov
5236222|NCT02526082|frailty|frailty
5357477|NCT01914913|BMMNC|bmmnc
5357478|NCT01914900|oral cavity cancer|oral cavity cancer
5357479|NCT01914900|induction chemotherapy|induction chemotherapy
5357480|NCT01914900|TP53|tp53
5357481|NCT01914900|beta tubulin II|beta tubulin ii
5357482|NCT01914887|Ulcerative Colitis|ulcerative colitis
5357483|NCT01914887|Inflammatory Bowel Disease|inflammatory bowel disease
5357484|NCT01914887|Mesenchymal stem cells|mesenchymal stem cells
5357485|NCT01914874|Community Sample|community sample
5357486|NCT01914835|cocaine dependence|cocaine dependence
5357487|NCT01914835|neuropsychological rehabilitation|neuropsychological rehabilitation
5357488|NCT01914835|executive functions|executive functions
5357489|NCT01914822|Ritalin|ritalin
5357490|NCT01914822|methylphenidate hydrochloride|methylphenidate hydrochloride
5357491|NCT01914822|experimental pain|experimental pain
5357492|NCT01914796|Phase 1|phase 1
5357493|NCT01914796|Randomized|randomized
5357494|NCT01914796|Double Blind|double blind
5357495|NCT01914796|Placebo-Controlled|placebo-controlled
5357496|NCT01914796|Single-Dose Escalation|single-dose escalation
5357497|NCT01914796|Safety|safety
5357498|NCT01914796|Tolerability|tolerability
5357499|NCT01914796|PK|pk
5357500|NCT01914796|PD|pd
5357501|NCT01914796|PF-06412562|pf-06412562
5357502|NCT01914783|air pollution|air pollution
5357503|NCT01914783|ozone|ozone
5357504|NCT01914783|fine particle|fine particle
5357505|NCT01914783|cytokine|cytokine
5357506|NCT01914783|chemokine|chemokine
5357507|NCT01914783|oxidative stress|oxidative stress
5357508|NCT01914783|inflammation|inflammation
5357509|NCT01914783|heart rate variability|heart rate variability
5357510|NCT01914783|autonomic nervous system|autonomic nervous system
5357511|NCT01914783|sympathetic nerve activity|sympathetic nerve activity
5357512|NCT01914783|plasma catecholamine|plasma catecholamine
5357513|NCT01914770|pooled analyses|pooled analyses
5357514|NCT01914770|quality of life|quality of life
5357515|NCT01914770|SELENA SLEDAI|selena sledai
5357516|NCT01914770|SLE|sle
5357517|NCT01914770|steroid use|steroid use
5357518|NCT01914770|responder rate|responder rate
5357519|NCT01914770|flares|flares
5357520|NCT01914770|belimumab|belimumab
5357521|NCT01914770|BILAG|bilag
5423312|NCT01616251|Legumes|legumes
5423313|NCT01616225|Infertility|infertility
5423314|NCT01616225|Poor Responder|poor responder
5357522|NCT01914757|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
5357523|NCT01914744|NHL|nhl
5357524|NCT01914744|HBV|hbv
5357525|NCT01914744|entecavir|entecavir
5357526|NCT01914744|lamivudine|lamivudine
5357527|NCT01914731|Fecal Microbiota Transplant|fecal microbiota transplant
5357528|NCT01914731|Clostridium difficile|clostridium difficile
5357529|NCT01914731|Diarrhea|diarrhea
5357530|NCT01914718|DLBCL|dlbcl
5357531|NCT01914718|DA-EPOCH-R|da-epoch-r
5357532|NCT01914705|Landmark|landmark
5357533|NCT01914705|Ultrasound|ultrasound
5357534|NCT01914705|central venous catheter|central venous catheter
5357535|NCT01914679|Fibromyalgia|fibromyalgia
5357536|NCT01914679|Pain|pain
5357537|NCT01914679|Brain|brain
5357538|NCT01914679|Stimulation|stimulation
5357539|NCT01914679|Device|device
5357540|NCT01914679|Treatment|treatment
5357541|NCT01914666|Chronic Low Back Pain|chronic low back pain
5357542|NCT01914666|CLBP|clbp
5357543|NCT01914640|Waist circumference, Metabolic Syndrome, Cardiovascular risk|waist circumference, metabolic syndrome, cardiovascular risk
5357544|NCT01914627|Psoriasis capitis|psoriasis capitis
5357545|NCT01914627|Scaling|scaling
5357546|NCT01914627|Salicylic acid|salicylic acid
5357547|NCT01914627|Dimethicone|dimethicone
5357548|NCT01914627|Plaque removal|plaque removal
5357549|NCT01914614|Breast Cancer|breast cancer
5357550|NCT01914614|Working Women|working women
5357551|NCT01914601|Laryngoscope|laryngoscope
5357552|NCT01914601|Macintosh|macintosh
5357553|NCT01914601|King Vision|king vision
5357554|NCT01914601|tracheal intubation|tracheal intubation
5357555|NCT01914601|cervical spines|cervical spines
5357556|NCT01914536|POMPE|pompe
5357557|NCT01914536|Glycogenosis type II|glycogenosis type ii
5357558|NCT01914536|Acid maltase deficiency|acid maltase deficiency
5357559|NCT01914523|Laryngoscope|laryngoscope
5357560|NCT01914523|Macintosh|macintosh
5357561|NCT01914523|Glidescope|glidescope
5357562|NCT01914523|King Vision|king vision
5357563|NCT01914523|AirTraq|airtraq
5357564|NCT01914523|tracheal intubation|tracheal intubation
5357565|NCT01914510|ovarian|ovarian
5357566|NCT01914510|cancer|cancer
5357567|NCT01914510|clear cell|clear cell
5357568|NCT01914510|ENMD-2076|enmd-2076
5964048|NCT04170829|ChAdOx1 MERS|chadox1 mers
5357569|NCT01914510|oral|oral
5357570|NCT01914510|capsule|capsule
5357571|NCT01914484|tyrosine kinase inhibitor resistance|tyrosine kinase inhibitor resistance
5357572|NCT01914484|chronic myeloid leukemia|chronic myeloid leukemia
5357573|NCT01914484|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5357574|NCT01914484|nilotinib|nilotinib
5357575|NCT01914484|ruxolitinib|ruxolitinib
5357576|NCT01914458|Lung cancer|lung cancer
5357577|NCT01914458|Low-dose computed tomography scan|low-dose computed tomography scan
5357578|NCT01914419|Postpartum hemorrhage|postpartum hemorrhage
5357579|NCT01914419|Oxytocin|oxytocin
5357580|NCT01914419|Prevention|prevention
5357581|NCT01914419|Third stage of labor|third stage of labor
5357582|NCT01914419|Hemoglobin|hemoglobin
5357583|NCT01914419|Intravenous|intravenous
5357584|NCT01914419|Intramuscular|intramuscular
5357585|NCT01914419|Bolus|bolus
5357586|NCT01914406|Heart transplant recipients|heart transplant recipients
5357587|NCT01914406|Exercise capacity|exercise capacity
5357588|NCT01914406|endothelial function|endothelial function
5357589|NCT01914406|Quality of life|quality of life
5357590|NCT01914393|Schizophrenia|schizophrenia
5357591|NCT01914393|Autism|autism
5357592|NCT01914393|Lurasidone|lurasidone
5357593|NCT01914393|Latuda|latuda
5357972|NCT01912261|Anemia|anemia
5357594|NCT01914380|Wet age-related macular degeneration|wet age-related macular degeneration
5357595|NCT01914380|Anti-VEGF-Therapy|anti-vegf-therapy
5357596|NCT01914380|Observational study|observational study
5357597|NCT01914354|T cells|t cells
5357598|NCT01914354|Human Alloimmune Reactivity|human alloimmune reactivity
5357599|NCT01914354|immunosuppression|immunosuppression
5357600|NCT01914341|Infant|infant
5357601|NCT01914341|Newborn|newborn
5357602|NCT01914341|Music|music
5357603|NCT01914328|Postoperative Pulmonary Complications|postoperative pulmonary complications
5357604|NCT01914328|PORC|porc
5357605|NCT01914328|Surgical Related Outcome|surgical related outcome
5357606|NCT01914328|Surgical Related Mortality|surgical related mortality
5357607|NCT01914328|Postoperative ICU length of stay|postoperative icu length of stay
5357608|NCT01914315|Rehabilitation|rehabilitation
5357609|NCT01914315|Heart failure|heart failure
5357610|NCT01914315|HFPEF|hfpef
5357611|NCT01914315|Exercise training|exercise training
5357612|NCT01914289|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5357613|NCT01914289|Prognosis|prognosis
5357614|NCT01914289|Resection|resection
5357615|NCT01914289|Radiotherapy|radiotherapy
5357616|NCT01914263|Cord blood-Derived cytokine induced killer cells,|cord blood-derived cytokine induced killer cells,
5357617|NCT01914263|Radical resection|radical resection
5357618|NCT01914250|Frenotomy|frenotomy
5357619|NCT01914250|Pain|pain
5357620|NCT01914237|Single-Branched Stent Graft System|single-branched stent graft system
5357621|NCT01914237|Aortic Dissection|aortic dissection
5357622|NCT01914237|Endovascular Repair|endovascular repair
5357623|NCT01914224|Prehypertension|prehypertension
5357624|NCT01914224|Hypertension|hypertension
5357626|NCT01914224|Potassium|potassium
5357627|NCT01914224|renin|renin
5357628|NCT01914224|aldosterone|aldosterone
5357629|NCT01914198|sleep study|sleep study
5357630|NCT01914198|NCH|nch
5357631|NCT01914185|Childhood|childhood
5357632|NCT01914185|Physical activity|physical activity
5357633|NCT01914185|Nutrition|nutrition
5357634|NCT01914185|Health Promotion|health promotion
5357635|NCT01914172|rare disease|rare disease
5357636|NCT01914172|community-based participatory research|community-based participatory research
5357637|NCT01914172|health promotion|health promotion
5357638|NCT01914172|quantitative research|quantitative research
5357639|NCT01914172|qualitative research|qualitative research
5357640|NCT01914172|focus group|focus group
5357641|NCT01914146|Diabetes|diabetes
5357642|NCT01914146|Insulin|insulin
5357643|NCT01914146|Orthostatic Hypotension|orthostatic hypotension
5357644|NCT01914146|Falls|falls
5357645|NCT01914146|Syncope|syncope
5357649|NCT01914133|Syncope|syncope
5357651|NCT01914120|lung cancer|lung cancer
5357652|NCT01914120|quality of life|quality of life
5357653|NCT01914120|FACT-L|fact-l
5357654|NCT01914107|malignancy|malignancy
5357655|NCT01914107|solid tumor|solid tumor
5357656|NCT01914107|cancer pain|cancer pain
5357657|NCT01914094|Preoperative care|preoperative care
5357658|NCT01914094|Exercise therapy|exercise therapy
5357659|NCT01914094|Cardiac surgery|cardiac surgery
5357660|NCT01914081|dilated cardiomyopathy|dilated cardiomyopathy
5357661|NCT01914081|Resveratrol|resveratrol
5357662|NCT01914068|Neoadjuvant chemoradiotherapy (NACRT)|neoadjuvant chemoradiotherapy (nacrt)
5357663|NCT01914068|Rectal cancer|rectal cancer
5357664|NCT01914068|Physical fitness|physical fitness
5357665|NCT01914068|Exercise programme|exercise programme
5357666|NCT01914068|Surgery|surgery
5357667|NCT01914068|Stage III/IV|stage iii/iv
5357668|NCT01914068|Locally advanced operable|locally advanced operable
5357669|NCT01914068|patients|patients
5357670|NCT01914042|Opioid induced hyperalgesia|opioid induced hyperalgesia
5357671|NCT01914042|Neuropathic pain|neuropathic pain
5357672|NCT01914042|Opioids|opioids
5357673|NCT01914042|Sciatica|sciatica
5357674|NCT01914042|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
5357675|NCT01913990|Nausea|nausea
5357676|NCT01913990|Vomiting|vomiting
5964049|NCT04170725|POTS|pots
5964050|NCT04169373|Upadacitinib|upadacitinib
5964051|NCT04169373|Axial Spondyloarthritis (axSpA)|axial spondyloarthritis (axspa)
5964052|NCT04169373|Spondyloarthritis|spondyloarthritis
5964053|NCT04169373|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
5964054|NCT04168320|Phase I|phase i
5357677|NCT01913938|Hemophagocytosis, adults, rhG-CSF|hemophagocytosis, adults, rhg-csf
5357678|NCT01913899|phantom limb pain|phantom limb pain
5357679|NCT01913899|mirror therapy|mirror therapy
5357680|NCT01913899|amputees|amputees
5357681|NCT01913899|phantom limb|phantom limb
5357682|NCT01913899|occupational therapy|occupational therapy
5357683|NCT01913886|Cardiovascular Diseases|cardiovascular diseases
5357684|NCT01913886|Myocardial Ischemia|myocardial ischemia
5357685|NCT01913886|Coronary Artery Disease|coronary artery disease
5357686|NCT01913886|Heart Diseases|heart diseases
5357687|NCT01913886|Coronary Disease|coronary disease
5357688|NCT01913886|Ventricular Dysfunction|ventricular dysfunction
5357689|NCT01913886|Arteriosclerosis|arteriosclerosis
5357690|NCT01913873|High-sensitivity Cardiac Troponin|high-sensitivity cardiac troponin
5357691|NCT01913873|Creatinin Kinase MB|creatinin kinase mb
5357692|NCT01913873|Cardiac Surgery|cardiac surgery
5357693|NCT01913873|Myocardial injury|myocardial injury
5357694|NCT01913873|Myocardial infarction|myocardial infarction
5357695|NCT01913873|Concentration change|concentration change
5357696|NCT01913860|UTI|uti
5357697|NCT01913860|antibiotics|antibiotics
5357698|NCT01913860|prescribing|prescribing
5357699|NCT01913860|primary care|primary care
5357700|NCT01913834|Parathyroid hormone 1-34|parathyroid hormone 1-34
5357701|NCT01913808|Postoperative anemia|postoperative anemia
5357702|NCT01913808|Total knee arthroplasty|total knee arthroplasty
5357703|NCT01913808|Iron therapy|iron therapy
5357704|NCT01913782|Chronic low back pain, CLBC, fMRI|chronic low back pain, clbc, fmri
5357705|NCT01913769|post-RT|post-rt
5357706|NCT01913769|myocardial perfusion images|myocardial perfusion images
5357707|NCT01913743|fMRI|fmri
5357708|NCT01913743|cognitive strategies|cognitive strategies
5357709|NCT01913743|obesity|obesity
5357710|NCT01913743|weight loss|weight loss
5357711|NCT01913743|mindsets|mindsets
5357712|NCT01913730|Multiple Myeloma|multiple myeloma
5357713|NCT01913730|Refractory|refractory
5357714|NCT01913730|Relapsed|relapsed
5357715|NCT01913717|Prostate cancer|prostate cancer
5357716|NCT01913717|Radiotherapy|radiotherapy
5357717|NCT01913717|hypofractionated radiotherapy|hypofractionated radiotherapy
5357718|NCT01913704|venous leg ulcer|venous leg ulcer
5357719|NCT01913704|mixed aetiology leg ulcers|mixed aetiology leg ulcers
5357720|NCT01913691|Neuroendocrine Skin Cancer|neuroendocrine skin cancer
5357721|NCT01913691|Merkel Cell Polyomavirus|merkel cell polyomavirus
5357722|NCT01913691|Immunotherapy|immunotherapy
5357723|NCT01913652|dedifferentiated liposarcoma|dedifferentiated liposarcoma
5357724|NCT01913652|cabazitaxel|cabazitaxel
5357725|NCT01913639|BAY 73-4506 (REGORAFENIB)|bay 73-4506 (regorafenib)
5357726|NCT01913639|FLUOROURACIL|fluorouracil
5357727|NCT01913639|LEUCOVORIN|leucovorin
5357728|NCT01913639|OXALIPLATIN|oxaliplatin
5357729|NCT01913626|subjective memory complains|subjective memory complains
5357730|NCT01913600|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5357731|NCT01913600|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5357732|NCT01913600|Coronary Artery Disease|coronary artery disease
5357733|NCT01913600|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5357734|NCT01913600|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5357735|NCT01913600|STENT THROMBOSIS|stent thrombosis
5357736|NCT01913600|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5357737|NCT01913561|Electrocardiogram|electrocardiogram
5357738|NCT01913561|gel electrodes|gel electrodes
5357739|NCT01913561|textile electrodes|textile electrodes
5357740|NCT01913535|Depression|depression
5357741|NCT01913535|Treatment Resistant Depression|treatment resistant depression
5357743|NCT01913535|Major Depression|major depression
5357745|NCT01913509|hemiplegic shoulder pain|hemiplegic shoulder pain
5357746|NCT01913509|poststroke fatigue|poststroke fatigue
5357747|NCT01913509|functional electrical stimulation|functional electrical stimulation
5357748|NCT01913509|stroke rehabilitation|stroke rehabilitation
5357749|NCT01913496|web application|web application
5357750|NCT01913496|nutrition knowledge|nutrition knowledge
5357751|NCT01913496|physical activity|physical activity
5357752|NCT01913470|NAFLD|nafld
5357753|NCT01913470|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5357754|NCT01913470|Obesity|obesity
5357755|NCT01913470|Pediatrics|pediatrics
5357756|NCT01913470|Children|children
5357757|NCT01913470|Losartan|losartan
5357758|NCT01913470|Cozaar|cozaar
5357759|NCT01913457|Ultrasound Doppler|ultrasound doppler
5357760|NCT01913457|Lungs|lungs
5357761|NCT01913457|Pulmonary artery hypertension|pulmonary artery hypertension
5357762|NCT01913444|Recombinant Antithrombin|recombinant antithrombin
5357763|NCT01913444|ATryn|atryn
5357764|NCT01913444|Pharmacokinetics|pharmacokinetics
5357765|NCT01913444|ECMO|ecmo
5357766|NCT01913444|Neonates|neonates
5357767|NCT01913418|Traditional Chinese Medicine|traditional chinese medicine
5357768|NCT01913418|Suan-Zao-Ren Tang|suan-zao-ren tang
5357769|NCT01913418|Methadone|methadone
5357770|NCT01913418|Opiate dependence|opiate dependence
5357771|NCT01913418|Sleep|sleep
5357772|NCT01913379|Phase 1|phase 1
5357773|NCT01913379|MDV3100|mdv3100
5357774|NCT01913379|Gemfibrozil|gemfibrozil
5224470|NCT02596126|Adherence|adherence
5357775|NCT01913379|Itraconazole|itraconazole
5357776|NCT01913379|Xtandi|xtandi
5357777|NCT01913379|enzalutamide|enzalutamide
5357778|NCT01913340|erythropoietin|erythropoietin
5357779|NCT01913340|therapeutic hypothermia|therapeutic hypothermia
5357780|NCT01913327|cognition|cognition
5357781|NCT01913327|executive function|executive function
5357782|NCT01913327|prefrontal cortex|prefrontal cortex
5357783|NCT01913327|locus coeruleus|locus coeruleus
5357784|NCT01913288|neonatal care, preterm, maternal sounds, auditory stimulation|neonatal care, preterm, maternal sounds, auditory stimulation
5357785|NCT01913275|cholecystojejunostomy|cholecystojejunostomy
5357786|NCT01913275|whipple's pancreaticoduodenectomy|whipple's pancreaticoduodenectomy
5357787|NCT01913275|endoscopic stenting|endoscopic stenting
5357788|NCT01913275|hyperbilirubinemia|hyperbilirubinemia
5357789|NCT01913262|depression|depression
5357790|NCT01913262|phq9|phq9
5357791|NCT01913262|phq-9|phq-9
5357792|NCT01913262|standard treatment|standard treatment
5357793|NCT01913249|Anorectal fistula|anorectal fistula
5357794|NCT01913249|LIFT|lift
5357795|NCT01913249|Seton|seton
5357796|NCT01913236|Tailored implementation interventions|tailored implementation interventions
5357797|NCT01913236|Primary care|primary care
5357798|NCT01913236|Depression in the elderly|depression in the elderly
5357799|NCT01913223|Endoscopic submucosal dissection|endoscopic submucosal dissection
5357800|NCT01913223|jet injector|jet injector
5357801|NCT01913223|saline solution|saline solution
5357802|NCT01913223|safety|safety
5357803|NCT01913223|effectiveness|effectiveness
5357804|NCT01913197|Prostate Brachytherapy|prostate brachytherapy
5357805|NCT01913132|NPWT; vascular surgery; inguinal incisions|npwt; vascular surgery; inguinal incisions
5357806|NCT01913119|extranodal NKTcell lymphoma|extranodal nktcell lymphoma
5357807|NCT01913093|Childhood leukemia survivors|childhood leukemia survivors
5357808|NCT01913093|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5357809|NCT01913093|Leukemia|leukemia
5357810|NCT01913093|Late effects|late effects
5357811|NCT01913093|Folate|folate
5357812|NCT01913093|Blood folate|blood folate
5357813|NCT01913093|Neurotoxicity|neurotoxicity
5357814|NCT01913093|Methotrexate|methotrexate
5357815|NCT01913093|Pharmacogenetics|pharmacogenetics
5357816|NCT01913093|Cognitive|cognitive
5357817|NCT01913093|Cognitive late effects|cognitive late effects
5357818|NCT01913093|N-PhenoGENICS|n-phenogenics
5357819|NCT01913080|health management|health management
5357820|NCT01913067|brain metastasis|brain metastasis
5357821|NCT01913067|breast cancer|breast cancer
5357828|NCT01913041|Epidemiology|epidemiology
5357829|NCT01913041|Tympanic temperature|tympanic temperature
5357830|NCT01913028|safety, tolerability, pharmacokinetics,immunogenicity, MEDI9929, Japanese|safety, tolerability, pharmacokinetics,immunogenicity, medi9929, japanese
5357831|NCT01912989|motivational interviewing|motivational interviewing
5357832|NCT01912989|obesity|obesity
5357833|NCT01912989|parent|parent
5357834|NCT01912976|Bowen's disease|bowen's disease
5357835|NCT01912976|Er:YAG|er:yag
5357836|NCT01912976|AFL-assisted|afl-assisted
5357837|NCT01912976|MAL-PDT|mal-pdt
5357838|NCT01912963|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5357839|NCT01912963|Metastatic Breast Cancer|metastatic breast cancer
5357840|NCT01912950|intense pulsed light|intense pulsed light
5357842|NCT01912950|healthy volunteer|healthy volunteer
5481309|NCT01373697|sprains|sprains
5357973|NCT01912261|Postoperative fatigue|postoperative fatigue
5357843|NCT01912950|light-based hair removal|light-based hair removal
5357846|NCT01912950|laser hair removal|laser hair removal
5357847|NCT01912950|permanent hair reduction|permanent hair reduction
5357848|NCT01912937|Paclitaxel|paclitaxel
5357849|NCT01912937|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5357850|NCT01912937|Balloon Catheter|balloon catheter
5357851|NCT01912937|Pharmacokinetic|pharmacokinetic
5357852|NCT01912937|Peripheral Artery Disease|peripheral artery disease
5357854|NCT01912924|chronic pain from failed knee surgery|chronic pain from failed knee surgery
5357855|NCT01912846|End-of-life care|end-of-life care
5357856|NCT01912846|Preference of end-of-life care|preference of end-of-life care
5357858|NCT01912846|Terminally ill cancer patients|terminally ill cancer patients
5357859|NCT01912833|postpartum depression|postpartum depression
5357860|NCT01912807|Postoperative vomiting|postoperative vomiting
5357861|NCT01912807|Children|children
5357862|NCT01912794|Cerebrovascular Accident|cerebrovascular accident
5357863|NCT01912794|Rehabilitation|rehabilitation
5357864|NCT01912794|Sensory System|sensory system
5357865|NCT01912781|contact lenses|contact lenses
5357866|NCT01912781|contact lens solution|contact lens solution
5357867|NCT01912781|gas permeable contact lenses|gas permeable contact lenses
5357868|NCT01912768|contact lenses|contact lenses
5357869|NCT01912768|contact lens solution|contact lens solution
5357870|NCT01912768|soft contact lenses|soft contact lenses
5964055|NCT04168320|Bystander effect|bystander effect
5964056|NCT04168320|Abscopal effect|abscopal effect
5964057|NCT04168320|Tumor hypoxia|tumor hypoxia
5964058|NCT04167891|cardiac arrest|cardiac arrest
5964059|NCT04167891|hypothermia induced|hypothermia induced
5964060|NCT04167891|intensive care unit|intensive care unit
5357871|NCT01912755|Pulpitis|pulpitis
5357872|NCT01912755|Hot tooth|hot tooth
5357873|NCT01912755|Articaine|articaine
5357874|NCT01912755|Lidocaine|lidocaine
5357875|NCT01912755|Local anesthetics|local anesthetics
5357876|NCT01912742|Weight loss|weight loss
5357877|NCT01912742|Speed of weight loss|speed of weight loss
5357878|NCT01912742|Metabolic compensation|metabolic compensation
5357879|NCT01912742|Diet therapy|diet therapy
5357880|NCT01912729|Depression prevention|depression prevention
5357881|NCT01912729|Technology Assisted|technology assisted
5357882|NCT01912729|Adolescents|adolescents
5357883|NCT01912729|Peer networked|peer networked
5357884|NCT01912716|pancreatitis|pancreatitis
5357885|NCT01912716|ERCP|ercp
5357886|NCT01912677|hypertension in pregnancy|hypertension in pregnancy
5357887|NCT01912677|preeclampsia|preeclampsia
5357888|NCT01912677|anti-hypertension|anti-hypertension
5357889|NCT01912677|labetalol|labetalol
5357890|NCT01912677|nifedipine|nifedipine
5357891|NCT01912677|methyldopa|methyldopa
5357892|NCT01912651|facial skin wound|facial skin wound
5357893|NCT01912651|facial wound|facial wound
5357894|NCT01912651|skin wound|skin wound
5357895|NCT01912651|facial defect|facial defect
5357896|NCT01912651|reconstructive skin graft|reconstructive skin graft
5357897|NCT01912638|Trabeculectomy|trabeculectomy
5357898|NCT01912638|Glaucoma|glaucoma
5357899|NCT01912638|Steroids|steroids
5357900|NCT01912638|Ologen|ologen
5357901|NCT01912638|Viscoelastic|viscoelastic
5357902|NCT01912612|Breast cancer|breast cancer
5357903|NCT01912612|Pain sensitivity|pain sensitivity
5357904|NCT01912599|Glaucoma|glaucoma
5357905|NCT01912599|Intraocular Pressure|intraocular pressure
5357906|NCT01912599|Blood Pressure|blood pressure
5357907|NCT01912586|erectile dysfunction|erectile dysfunction
5357908|NCT01912586|laparoscopic surgery|laparoscopic surgery
5357909|NCT01912586|rectal cancer|rectal cancer
5357910|NCT01912586|sildenafil|sildenafil
5357911|NCT01912586|vacuum erection device|vacuum erection device
5357912|NCT01912573|heroin|heroin
5357913|NCT01912573|prescription pain killers|prescription pain killers
5357915|NCT01912534|Sarcomere Mutations|sarcomere mutations
5357916|NCT01912521|HIV|hiv
5357917|NCT01912521|Stigma|stigma
5357918|NCT01912521|Social support|social support
5357919|NCT01912521|Social network|social network
5357920|NCT01912521|Kenya|kenya
5357921|NCT01912508|cervical length|cervical length
5357922|NCT01912508|cervical curvature|cervical curvature
5357923|NCT01912469|Muscle|muscle
5357924|NCT01912469|exercise|exercise
5357925|NCT01912469|soreness|soreness
5357926|NCT01912469|Damage|damage
5357927|NCT01912469|Traumeel|traumeel
5357928|NCT01912456|Hereditary Angioedema|hereditary angioedema
5357929|NCT01912430|Integrated Care Coaching|integrated care coaching
5357930|NCT01912430|Chronic Care Coaching|chronic care coaching
5357931|NCT01912430|Care Coaching|care coaching
5357932|NCT01912417|HEMODIALYSIS|hemodialysis
5357933|NCT01912417|Kidney Failure, Chronic|kidney failure, chronic
5357934|NCT01912417|AEROBIC EXERCISE|aerobic exercise
5357935|NCT01912404|alcoholic hepatitis|alcoholic hepatitis
5357936|NCT01912391|Depression|depression
5357937|NCT01912391|Anxiety|anxiety
5357938|NCT01912391|Headaches|headaches
5357939|NCT01912391|Migraines|migraines
5357940|NCT01912391|Irritable Bowel Syndrome IBS|irritable bowel syndrome ibs
5357941|NCT01912391|Neurodermatitis|neurodermatitis
5357942|NCT01912391|Fibromyalgia|fibromyalgia
5357943|NCT01912391|Premenstrual Syndrome PMS|premenstrual syndrome pms
5357944|NCT01912391|Temporomandibular Joint Dysfunction TMJ|temporomandibular joint dysfunction tmj
5357945|NCT01912365|Fracture|fracture
5357946|NCT01912365|Supracondylar|supracondylar
5357947|NCT01912365|Pediatric|pediatric
5357948|NCT01912365|Orthopedic|orthopedic
5357950|NCT01912352|ADRA2A|adra2a
5357957|NCT01912326|atrial fibrillation|atrial fibrillation
5357958|NCT01912313|IBS patients|ibs patients
5357959|NCT01912313|healthy subjects|healthy subjects
5357960|NCT01912287|Generalized Anxiety Disorder|generalized anxiety disorder
5357962|NCT01912287|Yoga|yoga
5357963|NCT01912287|CBT|cbt
5357964|NCT01912274|AML|aml
5357965|NCT01912274|open label|open label
5357966|NCT01912274|nonrandomized|nonrandomized
5357967|NCT01912274|single arm|single arm
5357968|NCT01912274|elderly patients|elderly patients
5357969|NCT01912274|HMA|hma
5357970|NCT01912274|newly diagnosed|newly diagnosed
5357971|NCT01912261|Coronary artery bypass grafting|coronary artery bypass grafting
5357974|NCT01912261|Functional Capacity|functional capacity
5357975|NCT01912261|Iron|iron
5357976|NCT01912261|Adherence|adherence
5357977|NCT01912261|Quality of Life|quality of life
5357978|NCT01912248|acute rise of systolic and diastolic bloodpressure|acute rise of systolic and diastolic bloodpressure
5357979|NCT01912235|Arginine synthesis|arginine synthesis
5357980|NCT01912235|15N2 arginine, 1-13C Glutamine, 2-15N Glutamine, 15N Proline|15n2 arginine, 1-13c glutamine, 2-15n glutamine, 15n proline
5357981|NCT01912209|employees|employees
5357982|NCT01912209|metabolic syndrome|metabolic syndrome
5357983|NCT01912209|obesity|obesity
5964061|NCT04167670|Vonoprazan|vonoprazan
5236715|NCT02522884|PAD|pad
5357984|NCT01912209|sub-clinical cardiovascular disease|sub-clinical cardiovascular disease
5357985|NCT01912209|weight loss|weight loss
5357986|NCT01912209|diet|diet
5357987|NCT01912196|Depressive Disorder|depressive disorder
5357988|NCT01912183|pediatric obesity|pediatric obesity
5357989|NCT01912183|e-learning|e-learning
5357990|NCT01912183|personal health record|personal health record
5357991|NCT01912183|personal electronic device|personal electronic device
5357992|NCT01912183|pilot|pilot
5357993|NCT01912170|omega-3 fatty acid|omega-3 fatty acid
5357994|NCT01912170|gestational diabetes|gestational diabetes
5357995|NCT01912170|insulin sensitivity|insulin sensitivity
5357996|NCT01912131|13-120|13-120
5357997|NCT01912118|Nociception|nociception
5357998|NCT01912118|General anesthesia|general anesthesia
5357999|NCT01912105|endotracheal tube|endotracheal tube
5358000|NCT01912105|ct scan|ct scan
5358001|NCT01912105|cleaning device|cleaning device
5358002|NCT01912105|biofilm|biofilm
5358003|NCT01912105|mechanical ventilation|mechanical ventilation
5358004|NCT01912053|Intra-hepatic Cholangiocarcinoma treatment|intra-hepatic cholangiocarcinoma treatment
5358005|NCT01912040|Safety profile|safety profile
5358006|NCT01912040|locally produced 123 Iodine MIBG|locally produced 123 iodine mibg
5358007|NCT01912014|stroke|stroke
5358008|NCT01912014|psychosocial|psychosocial
5358009|NCT01912014|intervention|intervention
5358010|NCT01912014|quality of life|quality of life
5358011|NCT01912001|end stage renal disease|end stage renal disease
5358012|NCT01912001|kidney failure|kidney failure
5358013|NCT01912001|home dialysis|home dialysis
5358014|NCT01912001|hemodialysis|hemodialysis
5358015|NCT01912001|peritoneal dialysis|peritoneal dialysis
5358016|NCT01912001|gaps in care|gaps in care
5358017|NCT01912001|co-morbidity|co-morbidity
5358018|NCT01912001|transitions of care settings|transitions of care settings
5358019|NCT01911988|Peripheral immune cells|peripheral immune cells
5358020|NCT01911988|Colorectal Cancers|colorectal cancers
5358021|NCT01911988|Stage II/ Stage III|stage ii/ stage iii
5358022|NCT01911988|Recurrence|recurrence
5358029|NCT01911949|ultrasound guided|ultrasound guided
5358030|NCT01911949|total hip arthroplasty|total hip arthroplasty
5358031|NCT01911936|CLJM716,|cljm716,
5358032|NCT01911936|Japanese patients,|japanese patients,
5358033|NCT01911936|Neoplasms|neoplasms
5358034|NCT01911910|primary prevention|primary prevention
5358035|NCT01911910|Cardiovascular disease|cardiovascular disease
5358036|NCT01911910|Cardiovascular magnetic resonance (CMR)|cardiovascular magnetic resonance (cmr)
5358037|NCT01911910|Electronic coaching (e-coaching)|electronic coaching (e-coaching)
5358038|NCT01911897|Hypertension|hypertension
5358039|NCT01911884|Rokitansky syndrome|rokitansky syndrome
5358040|NCT01911884|surgical or vaginal dilatation of vaginal aplasia|surgical or vaginal dilatation of vaginal aplasia
5358041|NCT01911884|quality of global and sexual life|quality of global and sexual life
5358042|NCT01911871|Thalassemia|thalassemia
5358043|NCT01911871|sickle cell disease|sickle cell disease
5358044|NCT01911871|myelodysplasia|myelodysplasia
5358045|NCT01911871|transfusion|transfusion
5358046|NCT01911871|chelation|chelation
5358047|NCT01911845|HCV Genotype 1|hcv genotype 1
5358048|NCT01911845|Hepatitis Genotype 1|hepatitis genotype 1
5358049|NCT01911845|Interferon Free|interferon free
5358050|NCT01911845|methadone|methadone
5358051|NCT01911845|HCV|hcv
5358052|NCT01911845|Buprenorphine|buprenorphine
5358053|NCT01911845|Hepatitis C|hepatitis c
5358054|NCT01911845|Viekira Pak|viekira pak
5358055|NCT01911845|paritaprevir|paritaprevir
5358056|NCT01911845|Viekira|viekira
5358057|NCT01911845|ombitasvir|ombitasvir
5358058|NCT01911845|dasabuvir|dasabuvir
5358059|NCT01911832|Cancer of the esophagogastric junction|cancer of the esophagogastric junction
5358060|NCT01911832|Reconstruction of gastric tube|reconstruction of gastric tube
5358062|NCT01911832|Width|width
5358063|NCT01911832|Regurgitation|regurgitation
5358064|NCT01911819|Histomorphometric Analysis|histomorphometric analysis
5358065|NCT01911819|New bone Formation|new bone formation
5358066|NCT01911819|Sinus Augmentation|sinus augmentation
5358067|NCT01911819|Bone Graft Materials|bone graft materials
5358068|NCT01911806|Back care pillow|back care pillow
5358069|NCT01911806|chronic non-specific low back pain|chronic non-specific low back pain
5358070|NCT01911806|randomized controlled trial|randomized controlled trial
5358071|NCT01911793|stoma|stoma
5358072|NCT01911793|ileus|ileus
5358073|NCT01911793|postoperative|postoperative
5358074|NCT01911793|stoma tube|stoma tube
5358075|NCT01911741|Phase I|phase i
5358076|NCT01911741|Enzalutamide|enzalutamide
5358077|NCT01911741|Relative bioavailability of MDV3100|relative bioavailability of mdv3100
5358078|NCT01911741|Immediate release oral formulation|immediate release oral formulation
5358079|NCT01911741|Xtandi|xtandi
5358080|NCT01911728|Drug-Drug Interaction|drug-drug interaction
5358081|NCT01911728|Phase 1|phase 1
5358082|NCT01911728|MDV3100|mdv3100
5358083|NCT01911728|Xtandi|xtandi
5358084|NCT01911728|Enzalutamide|enzalutamide
5358085|NCT01911715|Phase 1|phase 1
5964062|NCT04167670|Lansoprazole|lansoprazole
5358086|NCT01911715|Mass Balance|mass balance
5358087|NCT01911715|MDV3100|mdv3100
5236798|NCT02522377|Ketamine|ketamine
5358088|NCT01911715|Xtandi|xtandi
5358089|NCT01911715|Enzalutamide|enzalutamide
5358090|NCT01911715|Metabolism|metabolism
5358091|NCT01911715|Excretion|excretion
5358092|NCT01911689|pancreatitis|pancreatitis
5358093|NCT01911689|MRI|mri
5358094|NCT01911689|APACHEⅡ|apacheⅱ
5358095|NCT01911689|T2*|t2*
5358096|NCT01911689|T2 star|t2 star
5358097|NCT01911650|Achilles|achilles
5358098|NCT01911650|tendinopathy|tendinopathy
5358099|NCT01911637|Healthy|healthy
5358100|NCT01911637|Subjects|subjects
5358101|NCT01911637|Safety|safety
5358102|NCT01911637|Tolerability|tolerability
5358103|NCT01911637|VBY-036|vby-036
5358104|NCT01911637|Maximum|maximum
5358105|NCT01911637|Pharmacodynamic|pharmacodynamic
5358106|NCT01911637|Pharmacokinetic|pharmacokinetic
5358107|NCT01911585|Posttraumatic Stress Disorder|posttraumatic stress disorder
5358108|NCT01911585|PTSD|ptsd
5358109|NCT01911585|Prolonged Exposure Therapy|prolonged exposure therapy
5358110|NCT01911585|Cognitive Behavioral Therapy|cognitive behavioral therapy
5358111|NCT01911572|Streptococcus species|streptococcus species
5358112|NCT01911572|Streptococcus pyogenes|streptococcus pyogenes
5358113|NCT01911572|Streptococcus agalactiae|streptococcus agalactiae
5358114|NCT01911572|Necrotising fasciitis|necrotising fasciitis
5358115|NCT01911572|Sepsis|sepsis
5358116|NCT01911559|Standing-frame|standing-frame
5358117|NCT01911559|Chronic constipation|chronic constipation
5361929|NCT01893320|AML|aml
5358118|NCT01911559|Cerebral palsy|cerebral palsy
5358119|NCT01911559|Quadriplegia|quadriplegia
5358120|NCT01911559|Severe diplegia|severe diplegia
5358121|NCT01911494|cluster randomized controlled trial|cluster randomized controlled trial
5358122|NCT01911494|pre-eclampsia|pre-eclampsia
5358124|NCT01911494|maternal mortality|maternal mortality
5358125|NCT01911468|PCOS|pcos
5358126|NCT01911468|obesity|obesity
5358127|NCT01911468|GLP-1 receptor agonist|glp-1 receptor agonist
5358128|NCT01911468|liraglutide|liraglutide
5358129|NCT01911468|metformin|metformin
5358130|NCT01911455|Fragile X Syndrome|fragile x syndrome
5358131|NCT01911442|Autism, Lurasidone, Latuda|autism, lurasidone, latuda
5358132|NCT01911429|schizophrenia|schizophrenia
5358133|NCT01911429|Lurasidone|lurasidone
5358134|NCT01911429|Latuda|latuda
5358135|NCT01911403|Femoral Artery puncture|femoral artery puncture
5358136|NCT01911390|High cholesterol.|high cholesterol.
5358137|NCT01911364|Frequent exacerbators|frequent exacerbators
5358138|NCT01911351|nitrous oxide|nitrous oxide
5358139|NCT01911351|pediatric pain and anxiety|pediatric pain and anxiety
5358140|NCT01911338|Spinal Manipulation|spinal manipulation
5358141|NCT01911338|Teaching|teaching
5358142|NCT01911338|Thoracic Vertebrae|thoracic vertebrae
5358143|NCT01911338|Feedback|feedback
5358144|NCT01911325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
5358145|NCT01911325|NSCLC|nsclc
5358146|NCT01911325|Docetaxel|docetaxel
5358147|NCT01911325|Buparlisib|buparlisib
5358148|NCT01911325|BKM120|bkm120
5358149|NCT01911325|Metastatic|metastatic
5358150|NCT01911325|Stage IIIb|stage iiib
5358152|NCT01911325|PI3K inhibitor|pi3k inhibitor
5358153|NCT01911299|Choline|choline
5358154|NCT01911299|Glycerophosphocholine|glycerophosphocholine
5358155|NCT01911299|Choline alphoscerate|choline alphoscerate
5358156|NCT01911299|Fetal alcohol spectrum disorders|fetal alcohol spectrum disorders
5358157|NCT01911299|Fetal alcohol syndrome|fetal alcohol syndrome
5358158|NCT01911299|Partial fetal alcohol syndrome|partial fetal alcohol syndrome
5358159|NCT01911299|Alcohol-related neurodevelopmental disorder|alcohol-related neurodevelopmental disorder
5358160|NCT01911299|Prenatal alcohol exposure|prenatal alcohol exposure
5358161|NCT01911299|Fetal Alcohol Effects|fetal alcohol effects
5358162|NCT01911299|Pregnancy Complications|pregnancy complications
5358163|NCT01911299|Alcohol-Induced Disorders|alcohol-induced disorders
5358164|NCT01911299|Alcohol-Related Disorders|alcohol-related disorders
5358165|NCT01911299|Central Nervous System Agents|central nervous system agents
5358166|NCT01911299|Therapeutic Uses|therapeutic uses
5358167|NCT01911273|Hepatocellular carcinoma|hepatocellular carcinoma
5358168|NCT01911273|monoclonal antibody|monoclonal antibody
5358169|NCT01911273|ALK-1|alk-1
5358170|NCT01911273|best supportive care|best supportive care
5358171|NCT01911260|Zinc|zinc
5358172|NCT01911260|Growth|growth
5358173|NCT01911260|Child|child
5358174|NCT01911260|Dietary Supplements|dietary supplements
5358175|NCT01911260|Randomized Controlled Trial|randomized controlled trial
5358176|NCT01911221|Meningococcal disease,|meningococcal disease,
5358177|NCT01911221|Adults|adults
5358178|NCT01911208|Minority|minority
5358179|NCT01911208|Recruitment|recruitment
5358180|NCT01911195|General anesthesia|general anesthesia
5358181|NCT01911195|cognition|cognition
5358182|NCT01911195|consciousness|consciousness
5358183|NCT01911182|apnea of prematurity|apnea of prematurity
5358184|NCT01911182|control of breathing|control of breathing
5358185|NCT01911182|newborn|newborn
5964063|NCT04167423|quality of life|quality of life
5358186|NCT01911182|CO2 inhalation|co2 inhalation
5358187|NCT01911169|atherosclerosis|atherosclerosis
5964064|NCT04167423|EQ5D|eq5d
5236893|NCT02521792|Heterotopic ossification|heterotopic ossification
5236894|NCT02521792|Fibrodysplasia Ossificans Progressiva|fibrodysplasia ossificans progressiva
5358188|NCT01911169|systemic lupus erythematosus|systemic lupus erythematosus
5358189|NCT01911169|flow mediated dilation|flow mediated dilation
5358190|NCT01911169|interferon gene signature|interferon gene signature
5358191|NCT01911156|Chronic Hepatitis B|chronic hepatitis b
5358192|NCT01911130|outcomes measures|outcomes measures
5358193|NCT01911130|strength measurement|strength measurement
5358194|NCT01911130|disease progression|disease progression
5358195|NCT01911104|muscle|muscle
5358196|NCT01911104|mitochondrial function|mitochondrial function
5358197|NCT01911104|exercise resistance|exercise resistance
5358198|NCT01911104|human|human
5358199|NCT01911104|myotubes|myotubes
5358200|NCT01911104|epigenetics|epigenetics
5358201|NCT01911091|skeletal muscle|skeletal muscle
5358202|NCT01911091|adipose tissue|adipose tissue
5358203|NCT01911091|metabolism|metabolism
5358204|NCT01911091|oxidation|oxidation
5253234|NCT02427178|MNGIE|mngie
5358205|NCT01911091|mitochondrial capacity|mitochondrial capacity
5358206|NCT01911078|Metabolic syndrome|metabolic syndrome
5358207|NCT01911078|Renal denervation|renal denervation
5358208|NCT01911078|Renal artery|renal artery
5358209|NCT01911078|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
5358210|NCT01911065|Herpes zoster|herpes zoster
5358211|NCT01911065|immune response|immune response
5358212|NCT01911065|Zostavax|zostavax
5358213|NCT01911065|twins|twins
5358214|NCT01911065|non-twins|non-twins
5358215|NCT01911052|Bowel preparation|bowel preparation
5358216|NCT01911039|GVHD|gvhd
5358217|NCT01911039|cGVHD|cgvhd
5358218|NCT01911026|Bowel preparation|bowel preparation
5358219|NCT01911013|degenerative cervical disease|degenerative cervical disease
5358220|NCT01911013|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5358221|NCT01911013|plate and cage|plate and cage
5358222|NCT01911013|cage alone|cage alone
5358223|NCT01910987|Multiple Myeloma|multiple myeloma
5358224|NCT01910987|bortezomib|bortezomib
5358226|NCT01910987|First or Second Relapse|first or second relapse
5358227|NCT01910987|retreatment|retreatment
5358228|NCT01910987|Prolonged therapy|prolonged therapy
5358229|NCT01910974|oesophagus|oesophagus
5358230|NCT01910974|stomach|stomach
5358231|NCT01910974|intestine|intestine
5358232|NCT01910974|rectum|rectum
5358233|NCT01910948|omega-3 gastric cancer perioperation|omega-3 gastric cancer perioperation
5358234|NCT01910935|Physical activity|physical activity
5358235|NCT01910935|Hypertension|hypertension
5358236|NCT01910935|Scheme reference|scheme reference
5358237|NCT01910935|Primary care|primary care
5358238|NCT01910922|vegetable acceptance|vegetable acceptance
5358239|NCT01910922|vegetable intake|vegetable intake
5358240|NCT01910922|vegetable liking|vegetable liking
5358241|NCT01910922|learning mechanisms|learning mechanisms
5358242|NCT01910922|repeated exposure to flavor|repeated exposure to flavor
5358243|NCT01910922|flavor learning|flavor learning
5358244|NCT01910922|replace salt with spice|replace salt with spice
5358245|NCT01910909|Hepatocellular carcinoma|hepatocellular carcinoma
5358246|NCT01910909|unresectable|unresectable
5358247|NCT01910909|small size|small size
5358248|NCT01910909|Stereotactic body radiotherapy|stereotactic body radiotherapy
5358250|NCT01910883|Tolerability|tolerability
5358251|NCT01910883|Pharmacokinetic|pharmacokinetic
5358252|NCT01910870|Early-relapse|early-relapse
5358253|NCT01910844|triple negative breast cancer|triple negative breast cancer
5358254|NCT01910844|late-relapse|late-relapse
5358255|NCT01910831|bruising, reduction, older age, aging|bruising, reduction, older age, aging
5358256|NCT01910818|radiation|radiation
5358257|NCT01910818|dermatitis|dermatitis
5358258|NCT01910818|laser|laser
5358259|NCT01910818|fractional|fractional
5358261|NCT01910818|chronic|chronic
5358262|NCT01910818|fibrosis|fibrosis
5358263|NCT01910818|scar|scar
5358264|NCT01910805|Gestational diabetes|gestational diabetes
5358265|NCT01910805|Diabetes mellitus|diabetes mellitus
5358266|NCT01910805|diabetes in pregnancy|diabetes in pregnancy
5358269|NCT01910805|African-American|african-american
5358270|NCT01910805|Women|women
5358271|NCT01910779|Atrial Fibrillation|atrial fibrillation
5358272|NCT01910779|Cardioversion|cardioversion
5358273|NCT01910779|Biphasic Shock|biphasic shock
5358274|NCT01910766|pcos|pcos
5358275|NCT01910766|coenzymeQ10|coenzymeq10
5358276|NCT01910766|clomiphene citrate|clomiphene citrate
5358277|NCT01910753|Head and neck cancer,|head and neck cancer,
5358278|NCT01910753|physical activity,|physical activity,
5358279|NCT01910753|nutrition therapeutic education|nutrition therapeutic education
5358280|NCT01910740|Randomized Controlled Trial|randomized controlled trial
5358281|NCT01910740|Exercise Movement Techniques|exercise movement techniques
5358282|NCT01910740|Frail Elderly|frail elderly
5358283|NCT01910740|Gait|gait
5358284|NCT01910727|American Indian|american indian
5358285|NCT01910727|Diabetes|diabetes
5358286|NCT01910727|Pre-diabetes|pre-diabetes
5964065|NCT04167423|ThyPRO-39|thypro-39
5964066|NCT04167423|pregnancy|pregnancy
5964067|NCT04167423|thyroid disease|thyroid disease
5964068|NCT04167423|thyrotropin|thyrotropin
5358287|NCT01910727|Family health Coach|family health coach
5358288|NCT01910714|HIV/AIDS|hiv/aids
5358289|NCT01910714|Prevention|prevention
5358290|NCT01910714|American Indian|american indian
5358291|NCT01910714|Substance use|substance use
5358292|NCT01910714|CBPR|cbpr
5358293|NCT01910701|Home visiting interventions|home visiting interventions
5358294|NCT01910701|American Indian|american indian
5358295|NCT01910701|Community based participatory research|community based participatory research
5358296|NCT01910688|RGB Salvage, RFA|rgb salvage, rfa
5358297|NCT01910662|Suction Skin Blister|suction skin blister
5358298|NCT01910662|Induration|induration
5358299|NCT01910662|Tuberculin Purified Protein Derivative|tuberculin purified protein derivative
5358300|NCT01910662|Erythema|erythema
5344418|NCT01974518|Rituximab|rituximab
5358301|NCT01910662|Biopsy|biopsy
5253331|NCT02426632|JNJ-53718678|jnj-53718678
5358302|NCT01910662|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
5358303|NCT01910662|Delayed Type Hypersensitivity|delayed type hypersensitivity
5358304|NCT01910649|drisapersen|drisapersen
5358305|NCT01910636|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5358306|NCT01910623|Quality of life|quality of life
5358307|NCT01910623|Health related quality of life outcomes|health related quality of life outcomes
5358308|NCT01910623|Long-term|long-term
5358309|NCT01910623|Aida 0493|aida 0493
5358310|NCT01910623|AIDA 2000|aida 2000
5358311|NCT01910610|wild-type RAS metastatic colorectal cancer|wild-type ras metastatic colorectal cancer
5358312|NCT01910584|quality of life|quality of life
5358313|NCT01910584|sexual activity|sexual activity
5358314|NCT01910584|Novasure endometrial ablation|novasure endometrial ablation
5358315|NCT01910584|menorrhagia|menorrhagia
5358316|NCT01910558|Alpha-cyclodextrin|alpha-cyclodextrin
5358317|NCT01910558|Dietary fiber|dietary fiber
5358318|NCT01910558|Fecal fat|fecal fat
5358319|NCT01910558|Saturated fat|saturated fat
5358320|NCT01910519|influenza A (H5N1) virus|influenza a (h5n1) virus
5358321|NCT01910519|H5N1 influenza|h5n1 influenza
5358322|NCT01910519|influenza A/H5/N1|influenza a/h5/n1
5358323|NCT01910519|monovalent H5N1 influenza vaccine|monovalent h5n1 influenza vaccine
5358324|NCT01910519|systems biology|systems biology
5358325|NCT01910519|AS03 adjuvant|as03 adjuvant
5358326|NCT01910519|unadjuvanted|unadjuvanted
5358328|NCT01910493|mobile health|mobile health
5358329|NCT01910493|SMS|sms
5358330|NCT01910493|SMS reminders|sms reminders
5358331|NCT01910493|ART retention in care|art retention in care
5358332|NCT01910493|PMTCT|pmtct
5358333|NCT01910493|PMTCT cascade|pmtct cascade
5358334|NCT01910493|retention in care|retention in care
5358335|NCT01910454|Stroke|stroke
5358336|NCT01910454|Occupational Therapy|occupational therapy
5358337|NCT01910454|Cognition|cognition
5358338|NCT01910441|Type 2 Diabetes Mellitus, Glycemic variability|type 2 diabetes mellitus, glycemic variability
5358339|NCT01910428|L-asparaginase encapsulated in RBCs, leukemia, lymphoma|l-asparaginase encapsulated in rbcs, leukemia, lymphoma
5358340|NCT01910402|antiretroviral therapy naïve|antiretroviral therapy naïve
5358341|NCT01910402|women|women
5358342|NCT01910402|once daily|once daily
5358343|NCT01910402|HIV infection|hiv infection
5358344|NCT01910402|atazanavir|atazanavir
5358345|NCT01910402|tenofovir/emtricitabine|tenofovir/emtricitabine
5358346|NCT01910402|dolutegravir/abacavir/lamivudine fixed dose combination|dolutegravir/abacavir/lamivudine fixed dose combination
5358347|NCT01910402|integrase inhibitor|integrase inhibitor
5358348|NCT01910402|ritonavir|ritonavir
5358349|NCT01910389|Heart failure|heart failure
5358350|NCT01910389|Pulmonary hypertension|pulmonary hypertension
5358351|NCT01910389|tadalafil|tadalafil
5358352|NCT01910389|Phosphodiesterase Type 5 Inhibition|phosphodiesterase type 5 inhibition
5358353|NCT01910363|poststroke spasticity|poststroke spasticity
5358354|NCT01910363|lower limb|lower limb
5358355|NCT01910363|botulinum toxin|botulinum toxin
5358356|NCT01910363|A2|a2
5358357|NCT01910350|Breast & cervical cancer prevention & screening|breast & cervical cancer prevention & screening
5358358|NCT01910337|ASA I patients|asa i patients
5358359|NCT01910324|Juvenile Offenders|juvenile offenders
5354051|NCT01930422|Craving|craving
5358360|NCT01910324|HIV/STD Prevention|hiv/std prevention
5358361|NCT01910324|Adolescent Substance Abuse|adolescent substance abuse
5358362|NCT01910324|Multidimensional Family Therapy|multidimensional family therapy
5358363|NCT01910298|Breast reconstruction|breast reconstruction
5358364|NCT01910298|Breast implant|breast implant
5358365|NCT01910298|Breast cancer|breast cancer
5358366|NCT01910298|Mastectomy|mastectomy
5358367|NCT01910285|Anesthetic induction|anesthetic induction
5358368|NCT01910285|Intubation conditions|intubation conditions
5358369|NCT01910285|Tooth extraction|tooth extraction
5358370|NCT01910285|Propofol|propofol
5358371|NCT01910285|Sufentanil|sufentanil
5358372|NCT01910285|Remifentanil|remifentanil
5358373|NCT01910272|Radiation attenuation|radiation attenuation
5358374|NCT01910272|Fluoroscopy|fluoroscopy
5358375|NCT01910272|Invasive cardiac procedures|invasive cardiac procedures
5358376|NCT01910272|Cardiac Catheterization|cardiac catheterization
5358377|NCT01910259|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5358378|NCT01910259|Neuroprotective|neuroprotective
5964069|NCT04167423|thyroxine|thyroxine
5964070|NCT04167423|thyroid autoantibodies|thyroid autoantibodies
5358379|NCT01910259|Repurposed drugs|repurposed drugs
5358380|NCT01910259|Brain atrophy|brain atrophy
5358381|NCT01910259|Percentage Brain Volume Change|percentage brain volume change
5358382|NCT01910259|Magnetic Resonance Imaging|magnetic resonance imaging
5358383|NCT01910259|Optical Coherence Tomography|optical coherence tomography
5358384|NCT01910259|Cerebrospinal fluid|cerebrospinal fluid
5358385|NCT01910259|Amiloride|amiloride
5358386|NCT01910259|Riluzole|riluzole
5358387|NCT01910259|Double blind|double blind
5358388|NCT01910259|Placebo|placebo
5358389|NCT01910259|Fluoxetine|fluoxetine
5358390|NCT01910246|Metformin|metformin
5358391|NCT01910246|Insulin Resistance|insulin resistance
5358392|NCT01910246|Cardiac Function|cardiac function
5358393|NCT01910233|dyspnea|dyspnea
5358394|NCT01910233|registry|registry
5358395|NCT01910233|baseline characteristics|baseline characteristics
5358396|NCT01910233|mortality|mortality
5358397|NCT01910233|risk assessment|risk assessment
5358398|NCT01910233|emergency department|emergency department
5358399|NCT01910142|bone metabolism|bone metabolism
5358400|NCT01910129|vagus nerve stimulation|vagus nerve stimulation
5358401|NCT01910129|vagal nerve stimulation|vagal nerve stimulation
5358402|NCT01910129|nVNS|nvns
5358404|NCT01910129|epilepsy|epilepsy
5358405|NCT01910129|non invasive|non invasive
5358406|NCT01910129|gammacore|gammacore
5358407|NCT01910116|osteoarthritis|osteoarthritis
5358408|NCT01910116|hand|hand
5358409|NCT01910116|Shinbaro|shinbaro
5358410|NCT01910116|GCSB-5|gcsb-5
5358411|NCT01910103|Breast Neoplasms/radiography|breast neoplasms/radiography
5358412|NCT01910103|Mammography/methods|mammography/methods
5358413|NCT01910103|Mass Screening|mass screening
5358414|NCT01910103|Tomography, X-Ray Computed/methods|tomography, x-ray computed/methods
5358415|NCT01910103|Predictive Value of Tests|predictive value of tests
5358416|NCT01910103|False Positive Reactions|false positive reactions
5358417|NCT01910090|fasting condition|fasting condition
5358418|NCT01910077|tacrolimus|tacrolimus
5358419|NCT01910077|tacrobell capsule|tacrobell capsule
5358420|NCT01910077|prograf capsule|prograf capsule
5358421|NCT01910077|bioequivalence|bioequivalence
5358422|NCT01910064|Acne Vulgaris|acne vulgaris
5358423|NCT01910025|Argininosuccinate Synthetase|argininosuccinate synthetase
5358424|NCT01910025|Arginine|arginine
5358425|NCT01910025|Arginine deiminase|arginine deiminase
5358426|NCT01910025|Failed prior systemic therapy|failed prior systemic therapy
5358427|NCT01910012|Argininosuccinate Synthetase|argininosuccinate synthetase
5358428|NCT01910012|Arginine|arginine
5358429|NCT01910012|Arginine deiminase|arginine deiminase
5358430|NCT01910012|Failed prior systemic therapy|failed prior systemic therapy
5358431|NCT01909999|Dental Implants|dental implants
5358432|NCT01909999|Osseointegration|osseointegration
5358433|NCT01909999|Immediate Dental Implant Loading|immediate dental implant loading
5358434|NCT01909999|Bone formation|bone formation
5358435|NCT01909986|ONO-4053|ono-4053
5358436|NCT01909986|Healthy adult male subjects|healthy adult male subjects
5358437|NCT01909986|pharmacokinetics|pharmacokinetics
5358438|NCT01909986|metabolism|metabolism
5358439|NCT01909986|excretion|excretion
5358440|NCT01909986|mass balance|mass balance
5358441|NCT01909973|Depression|depression
5358442|NCT01909973|Antidepressant Medication|antidepressant medication
5358443|NCT01909973|Adherence|adherence
5358444|NCT01909973|Mobile Smartphone Intervention|mobile smartphone intervention
5358445|NCT01909973|Telemedicine|telemedicine
5358446|NCT01909973|Primary Care|primary care
5358447|NCT01909960|Normal pressure hydrocephalus|normal pressure hydrocephalus
5358448|NCT01909960|Flow MRI|flow mri
5358449|NCT01909960|Dementia|dementia
5358450|NCT01909960|Cerebrospinal fluid|cerebrospinal fluid
5358451|NCT01909960|Shunt|shunt
5358452|NCT01909947|Respiratory rate variability|respiratory rate variability
5358453|NCT01909947|Heart rate variability|heart rate variability
5358454|NCT01909947|Extubation readiness|extubation readiness
5358455|NCT01909947|Extubation failure|extubation failure
5358456|NCT01909947|Clinical predictors|clinical predictors
5354152|NCT01929759|HIV|hiv
5358457|NCT01909934|Lymphoma|lymphoma
5358458|NCT01909934|Anaplastic Large-cell|anaplastic large-cell
5358459|NCT01909934|Relapsed|relapsed
5358460|NCT01909934|Refractory|refractory
5358461|NCT01909934|Antigens, CD30|antigens, cd30
5358462|NCT01909934|Antibody-Drug Conjugate|antibody-drug conjugate
5358463|NCT01909934|Antibodies, Monoclonal|antibodies, monoclonal
5358464|NCT01909934|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5358465|NCT01909934|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5358466|NCT01909934|monomethyl auristatin E|monomethyl auristatin e
5358467|NCT01909934|Drug Therapy|drug therapy
5358468|NCT01909934|Immunotherapy|immunotherapy
5964071|NCT04166877|magnesium sulfate|magnesium sulfate
5964072|NCT04166877|trauma|trauma
5964073|NCT04166877|acute pain|acute pain
5964074|NCT04166812|small airway disease|small airway disease
5964075|NCT04166812|peripheral airway tone|peripheral airway tone
5964076|NCT04166461|Mucosal impedance|mucosal impedance
5964077|NCT04166461|Sleeve gastrectomy|sleeve gastrectomy
5964078|NCT04166461|GERD|gerd
5964079|NCT04166396|resveratrol|resveratrol
5964080|NCT04166396|nicotinamide riboside|nicotinamide riboside
5358469|NCT01909934|Hematologic Diseases|hematologic diseases
5358470|NCT01909908|Wounds and injuries|wounds and injuries
5358471|NCT01909908|Ulcer|ulcer
5358472|NCT01909908|Diabetic angiopathies|diabetic angiopathies
5358473|NCT01909908|Diabetic foot|diabetic foot
5358474|NCT01909908|Venous insufficiency|venous insufficiency
5358475|NCT01909908|Extracellular matrix|extracellular matrix
5358476|NCT01909882|Family member's massage therapy|family member's massage therapy
5358477|NCT01909882|Vital signs|vital signs
5358478|NCT01909882|Glasgow coma scale|glasgow coma scale
5358479|NCT01909882|Intensive care unit|intensive care unit
5358480|NCT01909882|Randomized controlled Clinical Trial|randomized controlled clinical trial
5358481|NCT01909882|Iran|iran
5358482|NCT01909869|MACE|mace
5358483|NCT01909869|TVR|tvr
5358484|NCT01909869|MI|mi
5358485|NCT01909869|TLF|tlf
5358486|NCT01909869|Death|death
5358487|NCT01909830|Colorectal Cancer Metastatic|colorectal cancer metastatic
5358488|NCT01909830|pretreated|pretreated
5358489|NCT01909804|Hepatitis|hepatitis
5358490|NCT01909804|Genotype 1|genotype 1
5358491|NCT01909804|Genotype 3|genotype 3
5358492|NCT01909804|Treatment experienced|treatment experienced
5358493|NCT01909791|Diabetic Macular Edema|diabetic macular edema
5358494|NCT01909791|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5358495|NCT01909765|Circumcision|circumcision
5358496|NCT01909765|postoperative pain|postoperative pain
5358497|NCT01909752|Lung cancer|lung cancer
5358498|NCT01909752|DRibble Vaccine|dribble vaccine
5358499|NCT01909752|Imiquimod|imiquimod
5358500|NCT01909752|GM-CSF|gm-csf
5358501|NCT01909752|HPV vaccine (Ceravix)|hpv vaccine (ceravix)
5358502|NCT01909752|Cyclophosphamide|cyclophosphamide
5358503|NCT01909739|AKI, atrovastatin, Valvular heart surgery|aki, atrovastatin, valvular heart surgery
5358504|NCT01909726|Hospital Design|hospital design
5358505|NCT01909726|Technology|technology
5358506|NCT01909726|Anxiety|anxiety
5358507|NCT01909713|acne, pediatric|acne, pediatric
5358508|NCT01909700|Single Incision, Mesh, Complications|single incision, mesh, complications
5358509|NCT01909687|blood glucose monitoring systems|blood glucose monitoring systems
5358510|NCT01909687|ISO 15197|iso 15197
5358511|NCT01909687|system accuracy|system accuracy
5358512|NCT01909661|allergy|allergy
5358513|NCT01909661|Cow's milk protein|cow's milk protein
5358514|NCT01909661|Tolerance|tolerance
5358515|NCT01909661|Efficacy|efficacy
5358516|NCT01909661|Infants' growth|infants' growth
5358517|NCT01909622|Vitamin D|vitamin d
5358518|NCT01909622|Milk fortification|milk fortification
5358519|NCT01909622|Children|children
5358520|NCT01909622|Colombia|colombia
5358521|NCT01909609|male|male
5358522|NCT01909583|congenital|congenital
5358523|NCT01909583|surgery|surgery
5358524|NCT01909583|peri-operative|peri-operative
5358525|NCT01909583|counselling|counselling
5358526|NCT01909557|Acetyl-L-carnitine|acetyl-l-carnitine
5358527|NCT01909557|Interferons|interferons
5358528|NCT01909557|Ribavirin|ribavirin
5358529|NCT01909557|Hepatitis C|hepatitis c
5358530|NCT01909557|Fatigue|fatigue
5358531|NCT01909544|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5358532|NCT01909544|Muscle fatigue|muscle fatigue
5358533|NCT01909544|Energy metabolism|energy metabolism
5358534|NCT01909544|Muscle oxygenation|muscle oxygenation
5358535|NCT01909531|Deep Brain Stimulation|deep brain stimulation
5358536|NCT01909531|Parkinsons Disease|parkinsons disease
5358537|NCT01909531|Essential Tremor|essential tremor
5358538|NCT01909531|Asleep DBS|asleep dbs
5358539|NCT01909518|Esophageal Squamous Intraepithelial Neoplasia|esophageal squamous intraepithelial neoplasia
5358540|NCT01909518|surface maturation scoring|surface maturation scoring
5358541|NCT01909518|probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
5358542|NCT01909518|virtual chromoendoscopy|virtual chromoendoscopy
5358543|NCT01909492|Multiple Sclerosis|multiple sclerosis
5358545|NCT01909492|Relaxin|relaxin
5358546|NCT01909466|OPC-14597|opc-14597
5358547|NCT01909466|Aripiprazole|aripiprazole
5358548|NCT01909466|Schizophrenia|schizophrenia
5358549|NCT01909453|Melanoma|melanoma
5358550|NCT01909453|Cutaneous melanoma|cutaneous melanoma
5358551|NCT01909453|Skin disease|skin disease
5358552|NCT01909453|Skin cancer|skin cancer
5358553|NCT01909453|Skin Neoplasms|skin neoplasms
5358554|NCT01909453|Neoplasm Metastasis|neoplasm metastasis
5358555|NCT01909453|BRAF mutant|braf mutant
5358556|NCT01909453|BRAF V600E|braf v600e
5358557|NCT01909453|BRAF V600K|braf v600k
5358559|NCT01909453|LGX818|lgx818
5358560|NCT01909453|MEK162|mek162
5358562|NCT01909453|combination|combination
5358563|NCT01909453|BRAF inhibitor|braf inhibitor
5358564|NCT01909453|resistance|resistance
5358565|NCT01909453|The combination of a selective BRAF- and a MEK1/2-inhibitor|the combination of a selective braf- and a mek1/2-inhibitor
5358566|NCT01909453|Prior immunotherapy|prior immunotherapy
5358567|NCT01909453|MEK inhibitor|mek inhibitor
5358568|NCT01909453|Phase III|phase iii
5358569|NCT01909453|Combo 300, Combo 450|combo 300, combo 450
5358570|NCT01909427|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
5358571|NCT01909427|CNTO 6785|cnto 6785
5358572|NCT01909427|Methotrexate|methotrexate
5358573|NCT01909401|Liver Transplantation|liver transplantation
5358574|NCT01909388|Cancer|cancer
5358575|NCT01909388|Prostate Cancer|prostate cancer
5358576|NCT01909388|Brachytherapy|brachytherapy
5358577|NCT01909388|Dose escalation|dose escalation
5358578|NCT01909388|High Dose Rate|high dose rate
5358579|NCT01909388|MRI-TRUS fusion|mri-trus fusion
5358580|NCT01909388|Detection of DILs by MRI|detection of dils by mri
5358581|NCT01909362|advanced metastatic colorectal cancer|advanced metastatic colorectal cancer
5358582|NCT01909362|mCRC|mcrc
5358583|NCT01909362|Colorectal Cancer|colorectal cancer
5358584|NCT01909362|Colorectal Carcinoma|colorectal carcinoma
5358585|NCT01909362|Colorectal Tumors|colorectal tumors
5358586|NCT01909362|Genetic mutation testing|genetic mutation testing
5358587|NCT01909362|Tumor tissue sampling|tumor tissue sampling
5358588|NCT01909349|medical rehabilitation|medical rehabilitation
5358589|NCT01909349|aftercare|aftercare
5358590|NCT01909349|multiple health behavior change|multiple health behavior change
5358591|NCT01909349|diet|diet
5358592|NCT01909349|physical activity|physical activity
5358593|NCT01909349|computer|computer
5358594|NCT01909349|international study|international study
5358595|NCT01909349|ETHNOPSYCHOLOGY|ethnopsychology
5358596|NCT01909349|HABIT|habit
5358597|NCT01909349|HEALTH|health
5358598|NCT01909349|eHealth|ehealth
5358599|NCT01909349|eLearning|elearning
5358600|NCT01909310|anesthesia, cardiac arrest, resuscitation, ventilation|anesthesia, cardiac arrest, resuscitation, ventilation
5358601|NCT01909297|airway management|airway management
5358602|NCT01909271|Stroke|stroke
5358603|NCT01909271|Community Health Education|community health education
5358604|NCT01909271|Minority Health|minority health
5358605|NCT01909271|healthcare disparities|healthcare disparities
5358606|NCT01909245|Islet cells|islet cells
5358607|NCT01909245|hypoglycemia|hypoglycemia
5358608|NCT01909245|hypoglycemia unawareness|hypoglycemia unawareness
5358609|NCT01909245|islet after kidney transplantation|islet after kidney transplantation
5358610|NCT01909245|islet transplant|islet transplant
5358611|NCT01909245|insulin independence|insulin independence
5358612|NCT01909245|insulin dependence|insulin dependence
5358613|NCT01909245|labile diabetes|labile diabetes
5358614|NCT01909232|Depression|depression
5358615|NCT01909232|Depressive Disorder|depressive disorder
5358617|NCT01909232|Major depressive disorder|major depressive disorder
5358618|NCT01909232|MDD|mdd
5358619|NCT01909232|Treatment resistant depression|treatment resistant depression
5358620|NCT01909232|Treatment intolerant depression|treatment intolerant depression
5358621|NCT01909232|TRMD|trmd
5358622|NCT01909232|TIMD|timd
5358623|NCT01909232|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5358624|NCT01909232|TMS|tms
5358625|NCT01909219|preparation, cleansing, colon|preparation, cleansing, colon
5358626|NCT01909167|Pregnancy|pregnancy
5358627|NCT01909167|symptoms of depression|symptoms of depression
5358628|NCT01909167|anxiety|anxiety
5358629|NCT01909167|online CBT therapy|online cbt therapy
5358630|NCT01909167|treatment as usual|treatment as usual
5358631|NCT01909167|maternal bonding|maternal bonding
5358632|NCT01909167|postnatal period|postnatal period
5358633|NCT01909154|neurophysiological parameters improvement|neurophysiological parameters improvement
5358634|NCT01909154|spinal cord injury|spinal cord injury
5358635|NCT01909154|biology therapy|biology therapy
5358636|NCT01909141|letrozole|letrozole
5358637|NCT01909141|clomiphene citrate|clomiphene citrate
5358638|NCT01909141|pioglitazone|pioglitazone
5358639|NCT01909141|metformin|metformin
5358640|NCT01909141|ovulation induction|ovulation induction
5358642|NCT01909128|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections|children, fermented milk fermented rice, gastrointestinal infections, respiratory infections
5358643|NCT01909102|Acceptance and Commitment Therapy|acceptance and commitment therapy
5358644|NCT01909102|Cardiac rehabilitation|cardiac rehabilitation
5358645|NCT01909050|celiac disease|celiac disease
5358646|NCT01909050|refractory celiac disease|refractory celiac disease
5358647|NCT01909050|gluten sensitivity|gluten sensitivity
5358648|NCT01909037|osteoarthritis|osteoarthritis
5358649|NCT01909037|curcumin|curcumin
5358650|NCT01909037|biomarker|biomarker
5358651|NCT01909037|pain|pain
5358652|NCT01909024|Randomised controlled trial|randomised controlled trial
5358653|NCT01909024|Endovenous laser treatment|endovenous laser treatment
5358654|NCT01909024|Transjugular coil embolisation|transjugular coil embolisation
5358655|NCT01908998|Y-Balance test|y-balance test
5358656|NCT01908985|glaucoma|glaucoma
5358657|NCT01908985|high intensity focused ultrasound|high intensity focused ultrasound
5358658|NCT01908985|aqueous humor|aqueous humor
5358659|NCT01908985|fluorophotometry|fluorophotometry
5358660|NCT01908972|Hemangioma|hemangioma
5358661|NCT01908972|Propranolol|propranolol
5358662|NCT01908972|prednisolone|prednisolone
5358663|NCT01908972|steroid|steroid
5358664|NCT01908959|Hispanic Women|hispanic women
5358665|NCT01908959|Postpartum|postpartum
5358666|NCT01908959|Overweight Hispanic Women|overweight hispanic women
5358667|NCT01908959|Low-income|low-income
5358668|NCT01908959|Physical Activity|physical activity
5225340|NCT02591212|Prevention|prevention
5358669|NCT01908959|Walking|walking
5358670|NCT01908946|Polio|polio
5358671|NCT01908933|Advanced Emphysema|advanced emphysema
5358672|NCT01908933|Heterogeneous Lower Lobe Predominant Emphysema|heterogeneous lower lobe predominant emphysema
5358673|NCT01908933|Heterogeneous Upper and Lower Lobe Predominant|heterogeneous upper and lower lobe predominant
5358674|NCT01908907|Premature Infants|premature infants
5358675|NCT01908907|DHA(docosahexaenoic acid)|dha(docosahexaenoic acid)
5358676|NCT01908907|DHA deficit|dha deficit
5358677|NCT01908881|Child Development|child development
5358678|NCT01908881|Mother-Child relations|mother-child relations
5358679|NCT01908881|Primary Health Care|primary health care
5358680|NCT01908881|Public Policy|public policy
5358681|NCT01908855|somatoform symptoms|somatoform symptoms
5358682|NCT01908855|somatic symptoms|somatic symptoms
5358683|NCT01908855|somatoform disorder|somatoform disorder
5358684|NCT01908855|somatic symptom disorder|somatic symptom disorder
5358685|NCT01908855|cognitive-behavioral therapy|cognitive-behavioral therapy
5358686|NCT01908855|emotion regulation training|emotion regulation training
5358687|NCT01908842|Opioid|opioid
5358688|NCT01908842|Dependence|dependence
5358689|NCT01908842|agonist|agonist
5358690|NCT01908842|buprenorphine|buprenorphine
5358691|NCT01908842|naloxone|naloxone
5358692|NCT01908842|BUP/NAL|bup/nal
5358693|NCT01908829|Vesitrim|vesitrim
5358694|NCT01908829|Betanis|betanis
5358695|NCT01908829|Urgency|urgency
5358696|NCT01908829|Frequency|frequency
5358697|NCT01908829|Mirabegron|mirabegron
5358698|NCT01908829|YM178|ym178
5358699|NCT01908829|Betmiga|betmiga
5358700|NCT01908829|Vesicare|vesicare
5358701|NCT01908829|Micturition|micturition
5358702|NCT01908829|YM905|ym905
5358703|NCT01908829|Solifenacin|solifenacin
5358704|NCT01908829|Urinary incontinence|urinary incontinence
5358705|NCT01908829|Overactive Bladder (OAB)|overactive bladder (oab)
5358706|NCT01908829|Myrbetriq|myrbetriq
5358707|NCT01908829|Vesikur|vesikur
5358708|NCT01908829|Urgency incontinence|urgency incontinence
5358709|NCT01908803|AOMT|aomt
5358710|NCT01908803|tympanostomy tubes|tympanostomy tubes
5358711|NCT01908803|Otorrhea|otorrhea
5358712|NCT01908803|anti-infective|anti-infective
5358713|NCT01908790|venous oximeter|venous oximeter
5358714|NCT01908790|non-invasive monitor|non-invasive monitor
5358715|NCT01908790|heart failure (HF)|heart failure (hf)
5358717|NCT01908764|tympanostomy tubes|tympanostomy tubes
5358718|NCT01908764|Otitis Media at the time of Tympanostomy Tube surgery|otitis media at the time of tympanostomy tube surgery
5358719|NCT01908764|OMTT|omtt
5358720|NCT01908738|Endometrial biopsy|endometrial biopsy
5358721|NCT01908738|paracervical block|paracervical block
5358722|NCT01908738|Lidocaine spray|lidocaine spray
5358723|NCT01908738|women|women
5358724|NCT01908738|abnormal uterine bleeding|abnormal uterine bleeding
5358725|NCT01908686|ASD|asd
5358726|NCT01908673|heart rate variability biofeedback|heart rate variability biofeedback
5358727|NCT01908673|automatic self transcedental meditation|automatic self transcedental meditation
5358728|NCT01908660|HIV|hiv
5358729|NCT01908660|hepatitis C virus|hepatitis c virus
5358730|NCT01908660|hepatitis B virus|hepatitis b virus
5358731|NCT01908660|antiretroviral drugs|antiretroviral drugs
5358732|NCT01908660|nucleos(t)ide reverse transcriptase inhibitors|nucleos(t)ide reverse transcriptase inhibitors
5358733|NCT01908660|non-nucleos(t)ide reverse transcriptase inhibitors|non-nucleos(t)ide reverse transcriptase inhibitors
5358734|NCT01908660|protease inhibitors|protease inhibitors
5482438|NCT01368848|NSCLC|nsclc
5358735|NCT01908660|integrase inhibitors|integrase inhibitors
5358736|NCT01908660|entry inhibitors|entry inhibitors
5358737|NCT01908660|transaminase elevations|transaminase elevations
5358738|NCT01908660|alanine aminotransferase|alanine aminotransferase
5358739|NCT01908660|aspartate aminotransferase|aspartate aminotransferase
5358740|NCT01908660|bilirubin elevations|bilirubin elevations
5358741|NCT01908660|hepatic fibrosis|hepatic fibrosis
5358742|NCT01908647|mTBI|mtbi
5358743|NCT01908647|PTSD|ptsd
5358744|NCT01908634|Bioavailability|bioavailability
5358745|NCT01908634|Strawberry polyphenols|strawberry polyphenols
5358746|NCT01908634|Fruit Beverage Matrix|fruit beverage matrix
5358747|NCT01908621|multiple myeloma|multiple myeloma
5358748|NCT01908621|mobilization|mobilization
5358749|NCT01908621|G-CSF|g-csf
5358750|NCT01908621|filgrastim|filgrastim
5358751|NCT01908621|cytosine arabinoside|cytosine arabinoside
5358752|NCT01908621|autologous stem cell transplantation|autologous stem cell transplantation
5358753|NCT01908569|MACS, time-lapse, embryo, spermatozoid, sperm|macs, time-lapse, embryo, spermatozoid, sperm
5358754|NCT01908543|Iron deficiency|iron deficiency
5358756|NCT01908530|Diabetes|diabetes
5358757|NCT01908530|Continuous Glucose Monitoring|continuous glucose monitoring
5358758|NCT01908530|Microprobes|microprobes
5358759|NCT01908517|HPV Vaccine Adherence|hpv vaccine adherence
5358760|NCT01908517|Electronic Reminders|electronic reminders
5358761|NCT01908491|patient controlled analgesia|patient controlled analgesia
5358762|NCT01908491|wound catheter infusion|wound catheter infusion
5964081|NCT04166396|exercise intolerance|exercise intolerance
5964082|NCT04166383|Nonreplicating adenovirus|nonreplicating adenovirus
5358763|NCT01908491|postoperative pain control|postoperative pain control
5358764|NCT01908491|pectus excavatum|pectus excavatum
5358765|NCT01908491|pain score|pain score
5358766|NCT01908478|locally advanced|locally advanced
5358767|NCT01908478|unresectable|unresectable
5358768|NCT01908478|pancreatic|pancreatic
5358769|NCT01908478|pancreas|pancreas
5358770|NCT01908478|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5358771|NCT01908452|Schizophrenia|schizophrenia
5358772|NCT01908452|pyridoxal kinase activity|pyridoxal kinase activity
5358773|NCT01908452|plasma pyridoxal level|plasma pyridoxal level
5358774|NCT01908439|muscle electrical activity|muscle electrical activity
5358775|NCT01908439|whole-body vibration|whole-body vibration
5358776|NCT01908439|latency|latency
5358777|NCT01908426|cabozantinib|cabozantinib
5358778|NCT01908426|XL184|xl184
5358779|NCT01908426|liver cancer|liver cancer
5358780|NCT01908426|hepatocellular carcinoma|hepatocellular carcinoma
5358781|NCT01908426|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5358782|NCT01908426|MET kinase|met kinase
5680231|NCT00578591|posttransplant|posttransplant
5680232|NCT00578591|Rituximab|rituximab
5465018|NCT01440686|Safety|safety
5358783|NCT01908426|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
5358784|NCT01908413|Advanced Solid Tumors|advanced solid tumors
5358785|NCT01908413|Lymphoma|lymphoma
5358786|NCT01908413|Open-Label|open-label
5358787|NCT01908413|Dose-Escalation|dose-escalation
5358788|NCT01908413|IAP|iap
5358789|NCT01908400|Mental retardation , stem cell,BMMNC|mental retardation , stem cell,bmmnc
5358790|NCT01908387|Oral azacitidine|oral azacitidine
5358791|NCT01908387|CC-486|cc-486
5358792|NCT01908387|Hematological neoplasms|hematological neoplasms
5358793|NCT01908387|Phase 1|phase 1
5358794|NCT01908374|Active-placebo controlled double blind cross over|active-placebo controlled double blind cross over
5358795|NCT01908361|comparative efficacy research|comparative efficacy research
5358796|NCT01908361|combination therapy|combination therapy
5358797|NCT01908361|neurorehabilitation|neurorehabilitation
5358798|NCT01908361|robotic rehabilitation|robotic rehabilitation
5358799|NCT01908361|restraint therapy|restraint therapy
5358800|NCT01908348|Erythritol|erythritol
5358801|NCT01908348|Endothelial function|endothelial function
5358802|NCT01908335|interferon|interferon
5358803|NCT01908335|ribavirin|ribavirin
5358804|NCT01908335|virological response|virological response
5358805|NCT01908322|Hepatocellular carcinoma|hepatocellular carcinoma
5358806|NCT01908322|Intermediate stage|intermediate stage
5358807|NCT01908322|Observational study|observational study
5358808|NCT01908309|acute kidney injury|acute kidney injury
5358809|NCT01908309|contrast media|contrast media
5358810|NCT01908309|cystatin-C|cystatin-c
5358811|NCT01908296|FK949E|fk949e
5358812|NCT01908296|fluvoxamine|fluvoxamine
5358813|NCT01908296|Antipsychotic|antipsychotic
5358814|NCT01908296|Quetiapine|quetiapine
5358815|NCT01908244|Preterm infants, music, Neonatal Intensive Care Unit (NICU)|preterm infants, music, neonatal intensive care unit (nicu)
5358816|NCT01908231|Pulmonary embolism, plasma lactate, right ventricular dysfunction|pulmonary embolism, plasma lactate, right ventricular dysfunction
5358817|NCT01908218|ULBT, diffficult laryngoscopy, Predictive Value of Tests|ulbt, diffficult laryngoscopy, predictive value of tests
5358818|NCT01908205|Autism|autism
5358819|NCT01908205|Social|social
5358820|NCT01908205|Functioning|functioning
5358821|NCT01908205|Cognition|cognition
5358822|NCT01908205|Repetitive Behaviors|repetitive behaviors
5358823|NCT01908205|Anxiety|anxiety
5358824|NCT01908205|Quality of Life|quality of life
5358825|NCT01908192|Sodium Benzoate|sodium benzoate
5358826|NCT01908192|Schizophrenia|schizophrenia
5358827|NCT01908192|Adolescent|adolescent
5358828|NCT01908192|Antipsychotic|antipsychotic
5358829|NCT01908192|Anti-psychotic|anti-psychotic
5358830|NCT01908192|NMDA|nmda
5358831|NCT01908192|NaBen|naben
5358832|NCT01908192|pediatric|pediatric
5358833|NCT01908179|Sterotactic Radiosurgery|sterotactic radiosurgery
5358834|NCT01908153|Picture food type|picture food type
5358835|NCT01908153|Taste type|taste type
5358836|NCT01908127|film modelling|film modelling
5358837|NCT01908127|dental anxiety|dental anxiety
5358838|NCT01908127|cooperative behaviour|cooperative behaviour
5358839|NCT01908127|children|children
5358840|NCT01908114|Polio disease|polio disease
5358841|NCT01908114|Intervention Package|intervention package
5358842|NCT01908114|Polio sero prevalence and sero conversion|polio sero prevalence and sero conversion
5358843|NCT01908114|Polio high risk areas of Pakistan|polio high risk areas of pakistan
5358844|NCT01908088|Epidermolysis Bullosa mitten hand deformity autologous cultured fibroblast|epidermolysis bullosa mitten hand deformity autologous cultured fibroblast
5358941|NCT01907607|PD-0332991|pd-0332991
5358845|NCT01908088|amniotic membrane|amniotic membrane
5358846|NCT01908075|Primary care|primary care
5358847|NCT01908075|Asthma management|asthma management
5358849|NCT01908075|Observational|observational
5358850|NCT01908075|Fostair|fostair
5358851|NCT01908075|Seretide|seretide
5358852|NCT01908062|Substance related disorders|substance related disorders
5964083|NCT04166383|Antitumor Immunity|antitumor immunity
5964084|NCT04166383|PD-1 inhibition|pd-1 inhibition
5358854|NCT01908062|naltrexone|naltrexone
5358855|NCT01908049|Probiotic|probiotic
5358856|NCT01908049|HIV|hiv
5358857|NCT01908049|Microbial translocation|microbial translocation
5358858|NCT01908049|inflammation|inflammation
5358859|NCT01908049|microbiota composition|microbiota composition
5358860|NCT01908036|Chronic fatigue syndrome|chronic fatigue syndrome
5358861|NCT01908036|CFS|cfs
5358862|NCT01908036|myalgic encephalomyelitis|myalgic encephalomyelitis
5358863|NCT01908036|M.E.|m.e.
5358864|NCT01908036|activity monitor|activity monitor
5358865|NCT01908023|exercise therapy|exercise therapy
5358866|NCT01908023|oxygen consumption|oxygen consumption
5358867|NCT01908010|Alzheimer's disease|alzheimer's disease
5358868|NCT01907997|Systemic lidocaine, Intravenous lidocaine infusion, postoperative pain, quality of recovery, Robot-assisted thyroidectomy, thyroid cancer|systemic lidocaine, intravenous lidocaine infusion, postoperative pain, quality of recovery, robot-assisted thyroidectomy, thyroid cancer
5358869|NCT01907984|premedication|premedication
5358870|NCT01907984|diclofenac|diclofenac
5358871|NCT01907984|postoperative headache|postoperative headache
5358872|NCT01907984|Visual Analog Scale|visual analog scale
5358873|NCT01907958|Microalbuminuria|microalbuminuria
5358874|NCT01907958|Hypertensive|hypertensive
5358875|NCT01907958|Diabetics|diabetics
5358876|NCT01907958|urine albumin|urine albumin
5358877|NCT01907945|Household water treatment|household water treatment
5358878|NCT01907945|Waterborne illness|waterborne illness
5358879|NCT01907945|ceramic filters|ceramic filters
5358880|NCT01907945|social network|social network
5358881|NCT01907932|splenomegaly|splenomegaly
5358882|NCT01907932|ultrasound|ultrasound
5358883|NCT01907932|VScan|vscan
5358884|NCT01907919|Pulp capping, Diode laser 808 nm, Tertiary dentin, RM-GIC|pulp capping, diode laser 808 nm, tertiary dentin, rm-gic
5358885|NCT01907906|Pathogen reduction technology|pathogen reduction technology
5358886|NCT01907880|breast|breast
5358887|NCT01907880|bone|bone
5358888|NCT01907880|pain|pain
5358889|NCT01907841|Investigate IPC on EIMD|investigate ipc on eimd
5358890|NCT01907789|Ovarian Carcinoma|ovarian carcinoma
5358891|NCT01907789|Ovary|ovary
5358892|NCT01907789|BRCA Mutation Carriers|brca mutation carriers
5358893|NCT01907789|BRCA1 or BRCA2 mutation|brca1 or brca2 mutation
5358894|NCT01907789|High risk for developing ovarian cancer|high risk for developing ovarian cancer
5358895|NCT01907789|Ovarian cancer screening|ovarian cancer screening
5358896|NCT01907789|Risk-reducing salpingo-oophorectomy|risk-reducing salpingo-oophorectomy
5358897|NCT01907789|RRSO|rrso
5358898|NCT01907789|Prophylactic salpingectomy with delayed oophorectomy|prophylactic salpingectomy with delayed oophorectomy
5358899|NCT01907789|PSDO|psdo
5358900|NCT01907789|Questionnaire|questionnaire
5358901|NCT01907789|Quality of life|quality of life
5358902|NCT01907789|QOL|qol
5358903|NCT01907789|Survey|survey
5358904|NCT01907789|Transvaginal ultrasound|transvaginal ultrasound
5358905|NCT01907789|Phone call|phone call
5358906|NCT01907763|asthma|asthma
5358907|NCT01907763|SOTB07|sotb07
5358908|NCT01907750|biliary fistula|biliary fistula
5358909|NCT01907750|biliary stricture|biliary stricture
5358910|NCT01907750|biliary drainage tube|biliary drainage tube
5358911|NCT01907724|Chronic hepatitis C|chronic hepatitis c
5358912|NCT01907724|Hepatitis C virus|hepatitis c virus
5358913|NCT01907724|HCV|hcv
5358914|NCT01907711|Acupuncture.|acupuncture.
5358915|NCT01907711|Fatigue syndrome chronic.|fatigue syndrome chronic.
5358916|NCT01907711|Sleep disturbances.|sleep disturbances.
5358917|NCT01907711|Pain.|pain.
5358918|NCT01907711|Cognitive impairment.|cognitive impairment.
5358919|NCT01907698|vaginal intercourse|vaginal intercourse
5358920|NCT01907698|labour|labour
5358921|NCT01907698|term pregnancy|term pregnancy
5358922|NCT01907672|Malaria|malaria
5358923|NCT01907672|Rapid Diagnostic Tests for Malaria|rapid diagnostic tests for malaria
5358924|NCT01907672|Chemical Shops|chemical shops
5358925|NCT01907672|Drug Shops|drug shops
5358926|NCT01907672|Diagnostics|diagnostics
5358927|NCT01907672|Testing for Malaria|testing for malaria
5358928|NCT01907659|Respiratory|respiratory
5358929|NCT01907659|Viruses|viruses
5358930|NCT01907659|Bacterial|bacterial
5358931|NCT01907659|Antibiotics|antibiotics
5358932|NCT01907659|Procalcitonin|procalcitonin
5358933|NCT01907646|bladder training, radical hysterectomy,gynaecologic cancer|bladder training, radical hysterectomy,gynaecologic cancer
5358934|NCT01907633|Death, Sudden, Cardiac|death, sudden, cardiac
5358935|NCT01907633|Risk of Sudden Cardiac Death|risk of sudden cardiac death
5358936|NCT01907633|Domperidone|domperidone
5358937|NCT01907633|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
5358938|NCT01907633|Metoclopramide|metoclopramide
5358939|NCT01907633|Observational Study|observational study
5358940|NCT01907607|Advanced Gastrointestinal Stromal Tumor Refractory to Imatinib and Sunitinib|advanced gastrointestinal stromal tumor refractory to imatinib and sunitinib
5358951|NCT01907464|Teenagers or young women|teenagers or young women
5358952|NCT01907464|Bone remodelling markers|bone remodelling markers
5358954|NCT01907438|estrogen|estrogen
5358955|NCT01907438|epithelial breast cells|epithelial breast cells
5358956|NCT01907438|genome profile|genome profile
5358957|NCT01907412|First time parents|first time parents
5358958|NCT01907412|Coparenting|coparenting
5358959|NCT01907412|Family Foundations|family foundations
5358960|NCT01907399|obese patients|obese patients
5358961|NCT01907399|obese patients with type 2 diabetes|obese patients with type 2 diabetes
5358962|NCT01907399|healthy volunteers|healthy volunteers
5358963|NCT01907386|Endoleaks|endoleaks
5358964|NCT01907386|Non-invasive vascular elastography|non-invasive vascular elastography
5358965|NCT01907373|olmesartan|olmesartan
5358966|NCT01907373|probenecid|probenecid
5358967|NCT01907373|pharmacokinetics|pharmacokinetics
5358968|NCT01907373|tolerability|tolerability
5358969|NCT01907347|intensive care unit (ICU)|intensive care unit (icu)
5358970|NCT01907347|body composition|body composition
5358971|NCT01907347|phase angle|phase angle
5358972|NCT01907347|mortality|mortality
5358973|NCT01907347|nosocomial infection|nosocomial infection
5358974|NCT01907347|bioimpedance analysis|bioimpedance analysis
5358975|NCT01907347|nutrition|nutrition
5358976|NCT01907334|oscillometry|oscillometry
5358978|NCT01907334|methacholine|methacholine
5358980|NCT01907321|dysphagia|dysphagia
5358981|NCT01907321|dystussia|dystussia
5358982|NCT01907321|cough|cough
5358983|NCT01907321|maximum expiratory pressure|maximum expiratory pressure
5358984|NCT01907308|Bladder cancer|bladder cancer
5358985|NCT01907308|Urothelial cancer|urothelial cancer
5358986|NCT01907308|Urothelial carcinoma|urothelial carcinoma
5358987|NCT01907295|idiopathic|idiopathic
5358988|NCT01907295|heritable|heritable
5358989|NCT01907295|anorexigen|anorexigen
5358990|NCT01907282|Schizophrenia|schizophrenia
5358991|NCT01907282|psychosis|psychosis
5358992|NCT01907230|Rheumatoid arthritis|rheumatoid arthritis
5358993|NCT01907230|Inactive HBV carrier|inactive hbv carrier
5358994|NCT01907230|Resolved Hepatitis B|resolved hepatitis b
5358995|NCT01907230|HBV reactivation|hbv reactivation
5358996|NCT01907230|Anti-tumor necrotic factor-alfa|anti-tumor necrotic factor-alfa
5358997|NCT01907217|Electroconvulsive therapy|electroconvulsive therapy
5358998|NCT01907217|ECT|ect
5358999|NCT01907217|electrode placement|electrode placement
5359000|NCT01907217|effectiveness|effectiveness
5359001|NCT01907217|cognition|cognition
5359002|NCT01907217|autobiographical memory|autobiographical memory
5359003|NCT01907191|Hip Arthroscopy|hip arthroscopy
5359004|NCT01907191|Liposomal Bupivacaine|liposomal bupivacaine
5359005|NCT01907191|Bupivacaine|bupivacaine
5359006|NCT01907178|total knee arthroplasty|total knee arthroplasty
5359007|NCT01907152|malnutrition|malnutrition
5359008|NCT01907152|undernourishment|undernourishment
5359009|NCT01907152|loss of muscle mass|loss of muscle mass
5359010|NCT01907139|comparative efficacy research|comparative efficacy research
5359011|NCT01907139|combination therapy|combination therapy
5359012|NCT01907139|neurorehabilitation|neurorehabilitation
5359013|NCT01907139|robot-assisted therapy|robot-assisted therapy
5359014|NCT01907139|constraint-induced therapy|constraint-induced therapy
5359016|NCT01907126|Sexually transmitted infections|sexually transmitted infections
5359017|NCT01907126|Sexual abuse|sexual abuse
5359018|NCT01907126|Physical abuse|physical abuse
5359019|NCT01907126|Women|women
5359020|NCT01907126|Prison|prison
5359021|NCT01907087|Late infantile Neuronal Ceroid Lipofuscinosis Type 2|late infantile neuronal ceroid lipofuscinosis type 2
5359022|NCT01907087|LINCL|lincl
5359023|NCT01907087|NCL2|ncl2
5359024|NCT01907087|CLN2|cln2
5359025|NCT01907087|Jansky-Bielschowsky disease|jansky-bielschowsky disease
5359036|NCT01907022|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5359037|NCT01907022|chronic tinnitus|chronic tinnitus
5359038|NCT01907022|relaxation|relaxation
5359039|NCT01906944|trigger point injection|trigger point injection
5359040|NCT01906944|transversus abdominis plane|transversus abdominis plane
5359041|NCT01906944|abdominal wall pain|abdominal wall pain
5359042|NCT01906931|Interstitial lung disease|interstitial lung disease
5359043|NCT01906931|Oxygen therapy|oxygen therapy
5359044|NCT01906931|Walk|walk
5359045|NCT01906918|ischemia|ischemia
5359046|NCT01906918|reperfusion|reperfusion
5359047|NCT01906918|myocardial ischemia|myocardial ischemia
5359048|NCT01906918|myocardial reperfusion|myocardial reperfusion
5359049|NCT01906866|Sleep disturbance|sleep disturbance
5359050|NCT01906866|Circadian|circadian
5359051|NCT01906866|Prolong release melatonin|prolong release melatonin
5359052|NCT01906866|Autism Spectrum Disorder|autism spectrum disorder
5359053|NCT01906866|Smith-Magenis Syndrome|smith-magenis syndrome
5359054|NCT01906866|Angelman Syndrome|angelman syndrome
5359055|NCT01906866|tuberous sclerosis|tuberous sclerosis
5359056|NCT01906853|BCG|bcg
5359057|NCT01906853|Bacille Calmette Guérin|bacille calmette guérin
5359058|NCT01906853|Allergy|allergy
5359059|NCT01906853|Immunity|immunity
5359060|NCT01906853|Immune response|immune response
5359061|NCT01906853|Vaccine|vaccine
5359062|NCT01906853|Infants|infants
5359063|NCT01906853|Children|children
5359064|NCT01906853|Infection|infection
5359065|NCT01906840|Chronic renal failure|chronic renal failure
5359066|NCT01906840|Hemodialysis|hemodialysis
5359067|NCT01906840|Oxidative stress|oxidative stress
5359068|NCT01906840|Turmeric|turmeric
5237861|NCT02515448|VAP|vap
5359069|NCT01906827|cholestasis|cholestasis
5359070|NCT01906827|pregnancy|pregnancy
5359071|NCT01906827|p wave dispersion|p wave dispersion
5359072|NCT01906827|arrhythmia|arrhythmia
5359073|NCT01906801|Osteoarthritis|osteoarthritis
5359074|NCT01906801|Glucosamine sulfate|glucosamine sulfate
5359075|NCT01906801|Diacerein|diacerein
5359076|NCT01906801|Randomized controlled trial|randomized controlled trial
5359078|NCT01906775|ventricular tachyarrhythmia|ventricular tachyarrhythmia
5359079|NCT01906775|shock|shock
5359080|NCT01906775|sub-threshold pacing|sub-threshold pacing
5359081|NCT01906762|Morphine, Acetaminophen, Renal colic, Emergency treatment|morphine, acetaminophen, renal colic, emergency treatment
5359082|NCT01906749|Acute coronary syndrome|acute coronary syndrome
5359083|NCT01906749|Colchicine|colchicine
5359084|NCT01906710|Adverse Drug Events|adverse drug events
5359085|NCT01906710|Drug related problems|drug related problems
5359086|NCT01906710|Medication Reconciliation|medication reconciliation
5359087|NCT01906710|Medication review|medication review
5359088|NCT01906710|discharge counseling|discharge counseling
5359089|NCT01906710|Hospital Pharmacy based|hospital pharmacy based
5359090|NCT01906710|integrated medicines management|integrated medicines management
5359091|NCT01906710|patient safety|patient safety
5359092|NCT01906684|Acthar Gel|acthar gel
5359093|NCT01906684|MS relapse|ms relapse
5359094|NCT01906684|7T MRI imaging|7t mri imaging
5359095|NCT01906684|Quality of Life|quality of life
5359096|NCT01906671|6-mercaptopurine|6-mercaptopurine
5359097|NCT01906671|Drug formulation|drug formulation
5359098|NCT01906658|H.P. Acthar Gel|h.p. acthar gel
5359099|NCT01906658|Acthar|acthar
5359100|NCT01906658|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5359101|NCT01906658|ALS|als
5359102|NCT01906645|Patient Readmission|patient readmission
5359103|NCT01906645|Continuity of Patient Care|continuity of patient care
5359104|NCT01906619|Febrile Seizure|febrile seizure
5359105|NCT01906619|Respiratory physiology|respiratory physiology
5359106|NCT01906619|Respiratory drive|respiratory drive
5359107|NCT01906619|Respiratory alkalosis|respiratory alkalosis
5359108|NCT01906606|child nutritional status|child nutritional status
5359109|NCT01906606|child development|child development
5359110|NCT01906606|maternal depression|maternal depression
5359111|NCT01906593|safety|safety
5359112|NCT01906593|influenza vaccine|influenza vaccine
5359113|NCT01906593|post-marketing|post-marketing
5359114|NCT01906580|HBV|hbv
5359115|NCT01906580|entecavir|entecavir
5359116|NCT01906580|peginterferon|peginterferon
5359117|NCT01906567|cadmium|cadmium
5359118|NCT01906567|lead|lead
5359119|NCT01906567|mercury|mercury
5359120|NCT01906567|preeclampsia|preeclampsia
5359121|NCT01906567|pregnancy|pregnancy
5359122|NCT01906541|X-CGD|x-cgd
5359123|NCT01906541|chronic granulomatous disease|chronic granulomatous disease
5359124|NCT01906541|gene-therapy|gene-therapy
5359125|NCT01906528|Nondepolarizing neuromuscular blocking drug|nondepolarizing neuromuscular blocking drug
5359126|NCT01906528|Mivacurium|mivacurium
5359127|NCT01906528|Sensitivity|sensitivity
5359128|NCT01906528|Sex|sex
5359129|NCT01906515|Anemia|anemia
5359130|NCT01906515|Blood transfusion|blood transfusion
5359131|NCT01906515|non invasive hemoglobin monitoring|non invasive hemoglobin monitoring
5359132|NCT01906515|patient safety|patient safety
5359133|NCT01906489|anemia|anemia
5359134|NCT01906489|chronic kidney disease|chronic kidney disease
5359135|NCT01906489|CKD|ckd
5359136|NCT01906489|chronic renal insufficiency|chronic renal insufficiency
5359137|NCT01906489|renal impairment|renal impairment
5359138|NCT01906489|erythropoietin|erythropoietin
5359139|NCT01906489|kidney|kidney
5359140|NCT01906489|oral anemia treatment|oral anemia treatment
5359142|NCT01906489|hypoxia-inducible factor|hypoxia-inducible factor
5359143|NCT01906489|HIF|hif
5359341|NCT01905371|amphetamine|amphetamine
5359144|NCT01906489|hypoxia-inducible factor prolyl-hydroxylase inhibitor|hypoxia-inducible factor prolyl-hydroxylase inhibitor
5359145|NCT01906489|HIF-PHI|hif-phi
5359146|NCT01906489|efficacy|efficacy
5359147|NCT01906489|safety|safety
5359148|NCT01906489|pharmacokinetics|pharmacokinetics
5359149|NCT01906476|Depression|depression
5359150|NCT01906476|Telephone Cognitive Behavior Therapy|telephone cognitive behavior therapy
5359151|NCT01906476|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
5359152|NCT01906437|Cardiac fibrosis and Lymphoma|cardiac fibrosis and lymphoma
5359153|NCT01906424|spinal cord injury|spinal cord injury
5359154|NCT01906424|quadriplegia|quadriplegia
5359155|NCT01906424|tetraplegia|tetraplegia
5359156|NCT01906424|stimulation|stimulation
5359157|NCT01906398|Refractory epilepsy|refractory epilepsy
5359158|NCT01906398|ketogenic diet|ketogenic diet
5359159|NCT01906398|efficacy|efficacy
5359160|NCT01906385|Glioma|glioma
5359161|NCT01906385|Brain Tumor|brain tumor
5359162|NCT01906385|Radiotherapy|radiotherapy
5964085|NCT04166383|Immune Checkpoint Inhibition|immune checkpoint inhibition
5964086|NCT04165941|Newly diagnosed brain tumor|newly diagnosed brain tumor
5964087|NCT04165941|Phase 1|phase 1
5359163|NCT01906372|dermatomyositis|dermatomyositis
5359165|NCT01906359|Interesterified fat|interesterified fat
5964088|NCT04165941|Drug Resistant Immunotherapy|drug resistant immunotherapy
5359166|NCT01906359|Stereospecific number 2|stereospecific number 2
5359167|NCT01906359|Gut hormones|gut hormones
5359168|NCT01906359|GIP|gip
5359169|NCT01906359|Insulin sensitivity|insulin sensitivity
5359170|NCT01906359|Postprandial lipaemia|postprandial lipaemia
5359171|NCT01906359|Haemostatic markers|haemostatic markers
5359172|NCT01906333|Exercise|exercise
5359173|NCT01906333|Ectopic fat accumulation|ectopic fat accumulation
5359174|NCT01906320|anorexia nervosa|anorexia nervosa
5359175|NCT01906320|restricting type|restricting type
5359176|NCT01906320|muscle strength|muscle strength
5359177|NCT01906320|exercise|exercise
5359178|NCT01906320|body composition|body composition
5359179|NCT01906320|physical activity|physical activity
5359180|NCT01906307|hepatorenal syndrome|hepatorenal syndrome
5359181|NCT01906294|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5359182|NCT01906281|adipocytokines|adipocytokines
5359183|NCT01906281|osteoarthritis|osteoarthritis
5359184|NCT01906281|cardiovascular risk|cardiovascular risk
5359185|NCT01906268|Generalized Anxiety Disorder|generalized anxiety disorder
5359186|NCT01906268|Social Anxiety Disorder|social anxiety disorder
5359187|NCT01906268|Panic Disorder|panic disorder
5359188|NCT01906268|Antidepressants Resistant|antidepressants resistant
5359189|NCT01906268|Attentional Bias Modification Treatment (ABMT)|attentional bias modification treatment (abmt)
5359190|NCT01906268|Attentional Retraining|attentional retraining
5359191|NCT01906268|Adjuvant Therapy|adjuvant therapy
5359192|NCT01906255|HIV-1|hiv-1
5359193|NCT01906255|Truvada|truvada
5359194|NCT01906255|FTC/TDF|ftc/tdf
5359195|NCT01906255|Pre-exposure prophylaxis|pre-exposure prophylaxis
5359196|NCT01906255|PrEP|prep
5359197|NCT01906255|Adherence|adherence
5359198|NCT01906255|Resistance|resistance
5359199|NCT01906216|Hepatocellular carcinoma|hepatocellular carcinoma
5359200|NCT01906216|sorafenib|sorafenib
5359201|NCT01906216|transarterial chemoembolization|transarterial chemoembolization
5359202|NCT01906203|Ultramarathon|ultramarathon
5359203|NCT01906203|bioelectrical impedance|bioelectrical impedance
5359204|NCT01906203|Phase-Angle|phase-angle
5359205|NCT01906190|influenza vaccine|influenza vaccine
5359206|NCT01906190|immune response|immune response
5359207|NCT01906190|persistence|persistence
5359208|NCT01906164|RSV|rsv
5359209|NCT01906125|Bioequivalence|bioequivalence
5359210|NCT01906125|Cmax|cmax
5359211|NCT01906125|AUC|auc
5359212|NCT01906073|fentanyl|fentanyl
5359213|NCT01906073|administration, intranasal|administration, intranasal
5359214|NCT01906073|morphine|morphine
5359215|NCT01906073|patient satisfaction|patient satisfaction
5359216|NCT01906073|patient preference|patient preference
5359217|NCT01906047|Non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis
5359218|NCT01906021|Thermomap|thermomap
5359219|NCT01906021|Hepatic Lesions|hepatic lesions
5359220|NCT01906021|Radiofrequency Ablation|radiofrequency ablation
5359221|NCT01906021|Microwave|microwave
5359222|NCT01906021|Non-Invasive Technique|non-invasive technique
5359223|NCT01906008|Colorectal cancer|colorectal cancer
5359224|NCT01906008|CRC|crc
5359225|NCT01906008|Acute peripheral neuropathy|acute peripheral neuropathy
5359226|NCT01906008|Numbness|numbness
5359227|NCT01906008|Pain|pain
5359228|NCT01906008|Loss of motor function|loss of motor function
5359229|NCT01906008|Minocycline|minocycline
5359230|NCT01906008|Dynacin|dynacin
5359231|NCT01906008|Minocin|minocin
5359232|NCT01906008|Minocin PAC|minocin pac
5359233|NCT01906008|Myrac|myrac
5359234|NCT01906008|Solodyn|solodyn
5359235|NCT01906008|Placebo|placebo
5359236|NCT01906008|Questionnaires|questionnaires
5359237|NCT01906008|Surveys|surveys
5359238|NCT01906008|Sensory tests|sensory tests
5359239|NCT01905995|deep brain sitimulation|deep brain sitimulation
5359240|NCT01905995|local field potentials|local field potentials
5359241|NCT01905969|Gastric caner, adjuvant chemotherapy|gastric caner, adjuvant chemotherapy
5359243|NCT01905904|electroconvulsive therapy|electroconvulsive therapy
5359244|NCT01905904|seizures|seizures
5359245|NCT01905904|sevoflurane|sevoflurane
5359250|NCT01905852|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5359252|NCT01905852|Fractional Flow Reserve|fractional flow reserve
5359253|NCT01905852|Myocardial Fibrosis|myocardial fibrosis
5359254|NCT01905839|Rigidity|rigidity
5359255|NCT01905839|Assessment|assessment
5359256|NCT01905839|Parkinson's Disease|parkinson's disease
5359257|NCT01905839|Physiological Measures|physiological measures
5359263|NCT01905800|Vertigo and dizziness.|vertigo and dizziness.
5359264|NCT01905800|semicircular canals|semicircular canals
5359265|NCT01905774|Renal Function|renal function
5359266|NCT01905761|obesity|obesity
5964089|NCT04165941|Temozolomide|temozolomide
5359267|NCT01905748|Coagulation|coagulation
5359268|NCT01905735|RA|ra
5359269|NCT01905722|MRI|mri
5359270|NCT01905722|metabolism|metabolism
5359271|NCT01905722|healthy|healthy
5359272|NCT01905722|7 Tesla|7 tesla
5359273|NCT01905709|C diff|c diff
5359274|NCT01905709|CDI|cdi
5359275|NCT01905709|clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5359276|NCT01905670|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5964090|NCT04165811|bariatric surgey|bariatric surgey
5238027|NCT02514356|HIV|hiv
5359288|NCT01905631|Pruritus|pruritus
5359289|NCT01905631|Atopic Dermatitis|atopic dermatitis
5359290|NCT01905618|Medical Education|medical education
5359291|NCT01905618|Tobacco Dependence Treatment|tobacco dependence treatment
5359292|NCT01905618|Physician Delivered Intervention|physician delivered intervention
5359293|NCT01905592|Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|human epidermal growth factor 2 negative carcinoma of breast
5359294|NCT01905592|BRCA1 Gene Mutation|brca1 gene mutation
5359295|NCT01905592|BRCA2 Gene Mutation|brca2 gene mutation
5359296|NCT01905592|Parp Inhibitor|parp inhibitor
5359298|NCT01905579|flaremetry|flaremetry
5359299|NCT01905579|aqueous proteins|aqueous proteins
5359300|NCT01905579|clinical grading|clinical grading
5254421|NCT02420873|Leukemia|leukemia
5359301|NCT01905579|Compare flaremetry readings with the protein content of the aqueous|compare flaremetry readings with the protein content of the aqueous
5359302|NCT01905579|Compare flaremetry readings with clinical grading of flare|compare flaremetry readings with clinical grading of flare
5359303|NCT01905566|Plaque, Atherosclerotic|plaque, atherosclerotic
5359304|NCT01905566|clopidogrel|clopidogrel
5359305|NCT01905566|ticagrelor|ticagrelor
5359306|NCT01905566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5359307|NCT01905566|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
5359308|NCT01905527|Multiple Sclerosis|multiple sclerosis
5359309|NCT01905527|Relapsing-Remitting|relapsing-remitting
5359310|NCT01905527|Rebif|rebif
5359311|NCT01905527|Quintiles Geographic Area Group|quintiles geographic area group
5359312|NCT01905527|Standard Subgroup|standard subgroup
5359313|NCT01905527|Custom Subgroup|custom subgroup
5359314|NCT01905527|RxCrossroads Geographic Area Group|rxcrossroads geographic area group
5359315|NCT01905501|Balanced anesthesia|balanced anesthesia
5359316|NCT01905501|Inhalation anesthesia|inhalation anesthesia
5359317|NCT01905501|Reperfusion injury|reperfusion injury
5359318|NCT01905501|Microsurgical Free flap|microsurgical free flap
5359319|NCT01905475|STEMI|stemi
5359320|NCT01905475|AMI|ami
5359321|NCT01905475|repair|repair
5359322|NCT01905462|Cervarix|cervarix
5359323|NCT01905462|Spontaneous abortion|spontaneous abortion
5359324|NCT01905462|Vaccine|vaccine
5359325|NCT01905462|Human Papillomavirus|human papillomavirus
5359326|NCT01905436|Filariasis|filariasis
5359327|NCT01905436|Onchocerciasis|onchocerciasis
5359328|NCT01905436|Albendazole|albendazole
5359329|NCT01905436|Ivermectin|ivermectin
5359330|NCT01905436|STH Soil Transmitted Helminth infections|sth soil transmitted helminth infections
5423315|NCT01616225|In Vitro Fertilization|in vitro fertilization
5359331|NCT01905436|MDA Mass Drug Administration|mda mass drug administration
5359332|NCT01905423|Filariasis|filariasis
5359333|NCT01905423|Albendazole|albendazole
5359334|NCT01905423|Diethylcarbamazine|diethylcarbamazine
5359335|NCT01905423|STH Soil Transmitted Helminths|sth soil transmitted helminths
5359336|NCT01905423|MDA Mass Drug Administration|mda mass drug administration
5359337|NCT01905384|pancreatic cancer|pancreatic cancer
5359338|NCT01905384|cholangiocarcinoma|cholangiocarcinoma
5359339|NCT01905384|metastatic malignancy|metastatic malignancy
5359340|NCT01905384|jaundice|jaundice
5359342|NCT01905371|stroke recovery|stroke recovery
5359343|NCT01905319|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5359344|NCT01905319|incidence rate|incidence rate
5359345|NCT01905306|dental implants|dental implants
5359346|NCT01905306|immediate loading|immediate loading
5359347|NCT01905306|full-arch|full-arch
5359348|NCT01905306|computer guided implant surgery|computer guided implant surgery
5359349|NCT01905280|allograft|allograft
5359350|NCT01905280|acellular dermal matrix|acellular dermal matrix
5359351|NCT01905280|alveolar ridge|alveolar ridge
5359352|NCT01905267|mindfulness|mindfulness
5359353|NCT01905267|relapse prevention|relapse prevention
5359354|NCT01905267|recovery|recovery
5359355|NCT01905267|depression|depression
5359356|NCT01905267|adolescents|adolescents
5359357|NCT01905254|Transient elastography|transient elastography
5359358|NCT01905254|mini-laparoscopy|mini-laparoscopy
5359359|NCT01905254|liver biopsy|liver biopsy
5359360|NCT01905254|liver cirrhosis|liver cirrhosis
5359361|NCT01905254|autoimmune hepatitis|autoimmune hepatitis
5355055|NCT01925573|RECURRENT GLIOBLASTOMA|recurrent glioblastoma
5359373|NCT01905202|Bile Acid|bile acid
5359374|NCT01905189|pulmonary arterial hypertension|pulmonary arterial hypertension
5359375|NCT01905189|cardiac resynchronization therapy|cardiac resynchronization therapy
5359376|NCT01905176|Heart Failure|heart failure
5359377|NCT01905176|Randomized Control Trial|randomized control trial
5359378|NCT01905176|Disease management|disease management
5359379|NCT01905176|Self-care|self-care
5359380|NCT01905176|Nursing|nursing
5359381|NCT01905176|Patient education as topic|patient education as topic
5359382|NCT01905163|Laparoscopy, interval debulking surgery|laparoscopy, interval debulking surgery
5359383|NCT01905150|pancreatic Cancer|pancreatic cancer
5359384|NCT01905150|G-FLIP, Gemcitabine 5FU Leucovorin Irinotecan Oxaliplatin|g-flip, gemcitabine 5fu leucovorin irinotecan oxaliplatin
5359385|NCT01905150|G-FLIP-DM (G-FLIP + Low doses Docetaxel and Mitomycin C)|g-flip-dm (g-flip + low doses docetaxel and mitomycin c)
5359386|NCT01905150|Vitamin C (ascorbic acid)|vitamin c (ascorbic acid)
5964091|NCT04165811|morbid obesity|morbid obesity
5238118|NCT02513784|Esophagus|esophagus
5238119|NCT02513784|Endoscopy|endoscopy
5238120|NCT02513784|Mouthwash|mouthwash
5238121|NCT02513771|Sitagliptin|sitagliptin
5238122|NCT02513771|Inflammation|inflammation
5238125|NCT02513771|HIV-1|hiv-1
5359387|NCT01905137|Myofascial pelvic pain|myofascial pelvic pain
5359388|NCT01905124|Uveitis|uveitis
5359389|NCT01905124|Intermediate uveitis|intermediate uveitis
5359390|NCT01905124|Posterior uveitis|posterior uveitis
5359391|NCT01905098|Detoxification|detoxification
5359392|NCT01905098|Sauna|sauna
5359393|NCT01905098|Hyperthermia|hyperthermia
5359394|NCT01905072|Obesity|obesity
5359395|NCT01905072|Breastfeeding|breastfeeding
5359396|NCT01905072|Educational Intervention|educational intervention
5359397|NCT01905059|HIV infection|hiv infection
5359398|NCT01905059|second line ART|second line art
5359399|NCT01905059|maintenance strategies|maintenance strategies
5359400|NCT01905059|Protease inhibitors|protease inhibitors
5359401|NCT01905059|mono or bi-therapy|mono or bi-therapy
5359402|NCT01905033|Sepsis|sepsis
5359403|NCT01905033|Pneumonia|pneumonia
5359404|NCT01905033|Peritonitis|peritonitis
5359405|NCT01905033|Biomarkers|biomarkers
5359406|NCT01905033|Transcriptomics|transcriptomics
5359407|NCT01905033|Pathogen detection|pathogen detection
5359408|NCT01905020|Type 1 diabetes|type 1 diabetes
5359409|NCT01905020|Hypoglycemia|hypoglycemia
5359410|NCT01905020|Insulin|insulin
5359411|NCT01905020|Glucagon|glucagon
5359412|NCT01905020|Closed-loop system|closed-loop system
5359413|NCT01905020|Artificial pancreas|artificial pancreas
5359414|NCT01905007|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5359415|NCT01905007|Defibrillation threshold testing|defibrillation threshold testing
5359416|NCT01904994|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
5359417|NCT01904994|ART (antiretroviral therapy)|art (antiretroviral therapy)
5359418|NCT01904994|financial incentive|financial incentive
5359419|NCT01904994|linkage|linkage
5359420|NCT01904994|retention|retention
5359421|NCT01904994|SMS (Short Message Service) appointment reminder|sms (short message service) appointment reminder
5359422|NCT01904994|accelerated ART|accelerated art
5359423|NCT01904994|CD4+ count|cd4+ count
5359424|NCT01904903|Breast Cancer HER2 Positive|breast cancer her2 positive
5359425|NCT01904903|Cardiac Safety|cardiac safety
5359426|NCT01904890|Asian Americans|asian americans
5359427|NCT01904890|colorectal cancer screening|colorectal cancer screening
5359428|NCT01904890|cancer prevention|cancer prevention
5359429|NCT01904890|Filipinos Americans|filipinos americans
5359430|NCT01904890|Hmong Americans|hmong americans
5359431|NCT01904890|Korean Americans|korean americans
5359432|NCT01904890|Randomized Controlled Trials|randomized controlled trials
5359433|NCT01904877|HIV testing|hiv testing
5359434|NCT01904877|linkage|linkage
5359435|NCT01904877|care|care
5359436|NCT01904864|randomized controlled trial|randomized controlled trial
5359437|NCT01904864|iron medication|iron medication
5359438|NCT01904864|Anemia|anemia
5359439|NCT01904864|Hematologic Disease|hematologic disease
5359440|NCT01904864|Anemia, Iron deficiency|anemia, iron deficiency
5359441|NCT01904864|anemia, nutritional|anemia, nutritional
5359442|NCT01904864|ferrous sulfate|ferrous sulfate
5359443|NCT01904864|NovaFerrum®|novaferrum®
5359444|NCT01904851|Peripheral Arterial Disease|peripheral arterial disease
5359446|NCT01904851|Registry|registry
5359455|NCT01904760|delirium|delirium
5359456|NCT01904760|dexmedetomidine|dexmedetomidine
5359457|NCT01904760|head and neck surgery|head and neck surgery
5359458|NCT01904760|microvascular free tissue transfer|microvascular free tissue transfer
5359459|NCT01904760|flap|flap
5359460|NCT01904747|Food|food
5359461|NCT01904747|Bioavailability|bioavailability
5359462|NCT01904747|Fasted|fasted
5359463|NCT01904747|Fed|fed
5359464|NCT01904734|testosterone|testosterone
5359465|NCT01904734|hypogonadism|hypogonadism
5359466|NCT01904734|pituitary|pituitary
5359467|NCT01904708|Phenylketonuria|phenylketonuria
5359468|NCT01904708|PKU|pku
5359469|NCT01904708|Exercise|exercise
5359470|NCT01904708|Muscle Protein Synthesis|muscle protein synthesis
5359471|NCT01904708|Plasma Phenylalanine concentration|plasma phenylalanine concentration
5359472|NCT01904695|resistant hypertension|resistant hypertension
5359473|NCT01904695|causal inference|causal inference
5359474|NCT01904695|a chorot study|a chorot study
5359475|NCT01904695|recipe of removing both phlegm and blood stasis|recipe of removing both phlegm and blood stasis
5359476|NCT01904682|Erythrocyte transfusion|erythrocyte transfusion
5359477|NCT01904682|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5359478|NCT01904682|International Prognostic Scoring System|international prognostic scoring system
5359479|NCT01904669|Fertility|fertility
5359480|NCT01904669|Infertility|infertility
5359481|NCT01904669|Pregnancy|pregnancy
5359482|NCT01904669|Conception|conception
5359483|NCT01904669|Behavioral|behavioral
5359484|NCT01904669|Lifestyle|lifestyle
5964092|NCT04165811|aerobic exercise|aerobic exercise
5964093|NCT04165811|lower extremity functions|lower extremity functions
5964094|NCT04165798|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5964095|NCT04165798|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5964096|NCT04165564|Indeterminate pulmonary nodules|indeterminate pulmonary nodules
5359485|NCT01904669|Preconception Care|preconception care
5359486|NCT01904669|Women's Health|women's health
5359487|NCT01904669|Abortion, Spontaneous|abortion, spontaneous
5359488|NCT01904669|Cohort Studies|cohort studies
5359489|NCT01904669|Epidemiology|epidemiology
5359491|NCT01904656|Colorectal Cancer Screening|colorectal cancer screening
5359492|NCT01904656|Ohio Appalachia|ohio appalachia
5359493|NCT01904630|gene sequencing|gene sequencing
5359494|NCT01904630|familial|familial
5359495|NCT01904630|risk factors|risk factors
5359496|NCT01904617|Length of labor|length of labor
5359497|NCT01904617|second stage of labor|second stage of labor
5359498|NCT01904617|intravenous hydration of labor|intravenous hydration of labor
5359499|NCT01904617|intravenous glucose|intravenous glucose
5359500|NCT01904604|Peanut Allergy|peanut allergy
5359501|NCT01904604|Food Allergy|food allergy
5359502|NCT01904604|Viaskin peanut patch|viaskin peanut patch
5359503|NCT01904604|Allergen Immunotherapy|allergen immunotherapy
5359504|NCT01904604|Epicutaneous Immunotherapy|epicutaneous immunotherapy
5359505|NCT01904604|Whole peanut extract|whole peanut extract
5359506|NCT01904604|Allergenic product|allergenic product
5359507|NCT01904604|Immediate hypersensitivity|immediate hypersensitivity
5359508|NCT01904591|Spinal Cord Injury|spinal cord injury
5359509|NCT01904591|Antioxidants|antioxidants
5359510|NCT01904591|tractography|tractography
5359511|NCT01904591|ASIA assessment|asia assessment
5359512|NCT01904578|Menopause|menopause
5359513|NCT01904578|Sleep quality|sleep quality
5359514|NCT01904578|Acupressure|acupressure
5359515|NCT01904565|Hyperthermia,|hyperthermia,
5359516|NCT01904565|Proton beam therapy|proton beam therapy
5359517|NCT01904565|Soft Tissue Sarcoma|soft tissue sarcoma
5359518|NCT01904565|Radiotherapy|radiotherapy
5359519|NCT01904565|Phase I/II trial|phase i/ii trial
5359520|NCT01904552|Apical periodontitis|apical periodontitis
5359521|NCT01904552|Dentaport ZX|dentaport zx
5359522|NCT01904552|electronic apex locators|electronic apex locators
5359524|NCT01904552|Raypex 5|raypex 5
5359525|NCT01904552|working length|working length
5359527|NCT01904526|PK/PD|pk/pd
5359528|NCT01904526|Smokers|smokers
5359529|NCT01904513|Metals|metals
5359530|NCT01904513|Pesticides|pesticides
5359531|NCT01904513|Toxicity|toxicity
5359532|NCT01904500|Cesarean delivery|cesarean delivery
5359533|NCT01904474|obesity|obesity
5359534|NCT01904474|overweight|overweight
5359535|NCT01904474|technology|technology
5359536|NCT01904474|internet|internet
5359537|NCT01904474|intervention|intervention
5359538|NCT01904474|adolescents|adolescents
5359546|NCT01904448|pediatric|pediatric
5359547|NCT01904448|profound hearing loss|profound hearing loss
5359548|NCT01904448|auditory brainstem implant|auditory brainstem implant
5359549|NCT01904448|cochlear implant|cochlear implant
5359550|NCT01904448|developmental or acquired cochlear nerve deficiency (CND)|developmental or acquired cochlear nerve deficiency (cnd)
5359551|NCT01904448|cochlear aplasia (Michel)|cochlear aplasia (michel)
5359552|NCT01904448|post-meningitis cochlear ossification|post-meningitis cochlear ossification
5359553|NCT01904448|cochlear malformation|cochlear malformation
5359554|NCT01904448|CND|cnd
5359555|NCT01904422|Diabetes mellitus.|diabetes mellitus.
5359556|NCT01904422|Periodontitis|periodontitis
5359557|NCT01904422|Periodontal treatment.|periodontal treatment.
5359558|NCT01904357|Cefazolin, Pediatric|cefazolin, pediatric
5359559|NCT01904344|Sleep|sleep
5359560|NCT01904344|Sleep- related breathing disorders|sleep- related breathing disorders
5359561|NCT01904344|Respiratory pathology|respiratory pathology
5359562|NCT01904331|Cardiotoxicity|cardiotoxicity
5359563|NCT01904331|long-term effects|long-term effects
5359564|NCT01904331|chemotherapy|chemotherapy
5359565|NCT01904331|radiotherapy|radiotherapy
5359566|NCT01904318|male|male
5359567|NCT01904318|Phase I|phase i
5359568|NCT01904318|A dose block-randomized|a dose block-randomized
5359569|NCT01904318|Double-blinded|double-blinded
5359570|NCT01904318|Placebo controlled|placebo controlled
5359571|NCT01904318|Single Dose|single dose
5359572|NCT01904318|dose Escalation|dose escalation
5359573|NCT01904318|IDP-73152 mesylate|idp-73152 mesylate
5359574|NCT01904318|Food Effect|food effect
5359575|NCT01904318|Pharmacokinetics|pharmacokinetics
5359576|NCT01904318|health male volunteer|health male volunteer
5359577|NCT01904318|PDF inhibitor|pdf inhibitor
5359578|NCT01904305|Pneumonia|pneumonia
5359579|NCT01904253|Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based chemotherapy|second line small cell lung cancer, (sclc), refractory or sensitive to first line platinum based chemotherapy
5359580|NCT01904240|Parkinson's disease|parkinson's disease
5359581|NCT01904240|GI tract|gi tract
5359582|NCT01904240|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
5359583|NCT01904227|Borderline Personality Disorder|borderline personality disorder
5359584|NCT01904227|Dialectical Behavior Therapy|dialectical behavior therapy
5359585|NCT01904214|renal impairement|renal impairement
5359586|NCT01904214|pharmacokinetics|pharmacokinetics
5359587|NCT01904201|Immune function|immune function
5359588|NCT01904201|Interferon-gamma release assays|interferon-gamma release assays
5359589|NCT01904201|Active HIV cell Reservoirs|active hiv cell reservoirs
5359590|NCT01904188|microbial identification|microbial identification
5359591|NCT01904188|antibiotic resistance|antibiotic resistance
5359592|NCT01904188|GeneZ and other techniques as developed|genez and other techniques as developed
5359593|NCT01904188|sepsis|sepsis
5359594|NCT01904188|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5359595|NCT01904175|Stem cell transplantation, non-myeloablative|stem cell transplantation, non-myeloablative
5359596|NCT01904149|Moderate to severe acute pain|moderate to severe acute pain
5359597|NCT01904149|Postoperative pain|postoperative pain
5359598|NCT01904149|Abdominal hysterectomy|abdominal hysterectomy
5359599|NCT01904149|Analgesics|analgesics
5359600|NCT01904149|Dexketoprofen|dexketoprofen
5359601|NCT01904149|Tramadol|tramadol
5359602|NCT01904110|Risedronate,cholecalciferol,BMD,montly,weekly,compliance|risedronate,cholecalciferol,bmd,montly,weekly,compliance
5359603|NCT01904097|Fibromyalgia|fibromyalgia
5359604|NCT01904097|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5359605|NCT01904097|tDCS|tdcs
5359606|NCT01904097|Pregabalin|pregabalin
5359607|NCT01904097|Functional Neuroimaging|functional neuroimaging
5359608|NCT01904097|Near Infrared Spectroscopy|near infrared spectroscopy
5359609|NCT01904097|NIRS|nirs
5359610|NCT01904097|Chronic Pain|chronic pain
5359611|NCT01904097|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5359612|NCT01904097|TMS|tms
5359613|NCT01904084|Distal radius fracture|distal radius fracture
5359614|NCT01904071|Hip Fracture|hip fracture
5359615|NCT01904071|Ultrasound|ultrasound
5359616|NCT01904071|Nerve Block|nerve block
5359617|NCT01904058|PBC|pbc
5359618|NCT01904032|Vitamin D|vitamin d
5359619|NCT01904032|Diabetes|diabetes
5359620|NCT01904032|Self-Management|self-management
5359621|NCT01904032|Depression|depression
5359622|NCT01904032|Women|women
5359623|NCT01904019|arthroplasty|arthroplasty
5359624|NCT01904019|trapezio-metacarpial|trapezio-metacarpial
5359625|NCT01904006|grouped embryo culture|grouped embryo culture
5359628|NCT01904006|benchtop incubator|benchtop incubator
5359629|NCT01904006|culture condition|culture condition
5359630|NCT01903980|Epipericardial Fat Necrosis|epipericardial fat necrosis
5359631|NCT01903980|Fat Necrosis|fat necrosis
5359632|NCT01903980|Chest Pain|chest pain
5359633|NCT01903980|Pericardial Necrosis|pericardial necrosis
5359634|NCT01903980|Pleuritic pain|pleuritic pain
5359635|NCT01903967|Pituitary|pituitary
5359636|NCT01903967|CGH array|cgh array
5359638|NCT01903941|exercise|exercise
5359639|NCT01903928|cytomegalovirus|cytomegalovirus
5359640|NCT01903928|HCT|hct
5359641|NCT01903928|DNA vaccine|dna vaccine
5359642|NCT01903928|transplantation|transplantation
5359643|NCT01903902|Coronary artery disease|coronary artery disease
5359644|NCT01903902|Balloon angioplasty|balloon angioplasty
5359645|NCT01903902|Drug-eluting balloon|drug-eluting balloon
5359646|NCT01903889|AE adverse event|ae adverse event
5359647|NCT01903889|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5359648|NCT01903889|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5359649|NCT01903889|ART antiretroviral therapy|art antiretroviral therapy
5359650|NCT01903889|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5359651|NCT01903889|DCF data collection forms|dcf data collection forms
5359652|NCT01903889|DMC Data Monitoring Committee|dmc data monitoring committee
5359653|NCT01903889|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5359654|NCT01903889|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5359655|NCT01903889|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5359656|NCT01903889|ICH International Conference of Harmonization|ich international conference of harmonization
5359657|NCT01903889|IND Investigational New Drug Application|ind investigational new drug application
5359658|NCT01903889|IRB Institutional Review Board|irb institutional review board
5359659|NCT01903889|IU International units|iu international units
5359660|NCT01903889|mg milligram(s)|mg milligram(s)
5359661|NCT01903889|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5359662|NCT01903889|PCR polymerase chain reaction|pcr polymerase chain reaction
5359663|NCT01903889|SAE serious adverse event|sae serious adverse event
5359664|NCT01903889|µg microgram|µg microgram
5359665|NCT01903889|ULN upper limit of the normal range|uln upper limit of the normal range
5359666|NCT01903889|WB Western Blot|wb western blot
5359667|NCT01903889|ANC Antenatal care|anc antenatal care
5359668|NCT01903889|ARV Antiretroviral|arv antiretroviral
5359669|NCT01903889|C&T Care and treatment|c&t care and treatment
5359670|NCT01903889|CPR Contraceptive prevalence rate|cpr contraceptive prevalence rate
5680233|NCT00578578|Omega3 fatty acids|omega3 fatty acids
5359671|NCT01903889|DHS Demographic and Health Survey|dhs demographic and health survey
5359672|NCT01903889|EGPAF Elizabeth Glaser Pediatric AIDS Foundation|egpaf elizabeth glaser pediatric aids foundation
5359673|NCT01903889|FP Family planning|fp family planning
5359674|NCT01903889|HIV Human immunodeficiency virus|hiv human immunodeficiency virus
5359675|NCT01903889|HTC HIV testing and counseling|htc hiv testing and counseling
5359676|NCT01903889|IUCD Intrauterine contraceptive device|iucd intrauterine contraceptive device
5359677|NCT01903889|MCH Maternal/child health|mch maternal/child health
5359678|NCT01903889|PDA Personal digital assistant|pda personal digital assistant
5359679|NCT01903889|PEPFAR President's Emergency Plan for AIDS Relief|pepfar president's emergency plan for aids relief
5359680|NCT01903889|PHSC Protection of Human Subjects Committee|phsc protection of human subjects committee
5359681|NCT01903889|PMTCT Prevention of maternal to child transmission|pmtct prevention of maternal to child transmission
5359682|NCT01903889|STAR-SW Strengthening TB and HIV/AIDS Response in the South Western Region of Uganda|star-sw strengthening tb and hiv/aids response in the south western region of uganda
5359683|NCT01903889|STI Sexually transmitted infection|sti sexually transmitted infection
5359684|NCT01903889|TM Technical monitor|tm technical monitor
5359685|NCT01903889|USAID United States Agency for International Development|usaid united states agency for international development
5359686|NCT01903889|WHO World Health Organization|who world health organization
5359687|NCT01903863|FFP|ffp
5359688|NCT01903863|fresh frozen plasma|fresh frozen plasma
5359689|NCT01903863|ECMO|ecmo
5359690|NCT01903863|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5359691|NCT01903863|anticoagulation|anticoagulation
5359692|NCT01903863|transfusion|transfusion
5359693|NCT01903850|Benign central airway obstruction|benign central airway obstruction
5359694|NCT01903850|Malignant central airway obstruction|malignant central airway obstruction
5359695|NCT01903850|Spray cryotherapy|spray cryotherapy
5359696|NCT01903850|Endoluminal tumors|endoluminal tumors
5359697|NCT01903850|Airway granulation tissue|airway granulation tissue
5359698|NCT01903837|Schizophrenia|schizophrenia
5359699|NCT01903837|Olanzapine|olanzapine
5359700|NCT01903837|Samidorphan|samidorphan
5359701|NCT01903837|Alkermes|alkermes
5359702|NCT01903824|Irdabisant|irdabisant
5359703|NCT01903824|cognitive impairment|cognitive impairment
5359705|NCT01903811|relapsed|relapsed
5359706|NCT01903811|refractory|refractory
5359707|NCT01903811|multiple myeloma|multiple myeloma
5359708|NCT01903785|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
5359709|NCT01903785|inhaled salbutamol|inhaled salbutamol
5359710|NCT01903785|performance enhancing|performance enhancing
5359712|NCT01903733|Subjects|subjects
5359713|NCT01903733|Chronic Myeloid Leukemia|chronic myeloid leukemia
5359715|NCT01903733|Bosutinib|bosutinib
5359716|NCT01903733|Extension|extension
5359717|NCT01903707|Schizophrenia|schizophrenia
5359718|NCT01903707|Psychosis|psychosis
5359719|NCT01903707|Cognitive deficits|cognitive deficits
5359720|NCT01903681|Sleep problems, autism spectrum disorder, prolonged-release melatonin, Circadin, endogenous saliva melatonin|sleep problems, autism spectrum disorder, prolonged-release melatonin, circadin, endogenous saliva melatonin
5359721|NCT01903681|Smith-Magenis syndrome, Angelman syndrome, Tuberous Sclerosis|smith-magenis syndrome, angelman syndrome, tuberous sclerosis
5359722|NCT01903603|cerebral palsy|cerebral palsy
5359723|NCT01903603|multi-modal brain techniques|multi-modal brain techniques
5359725|NCT01903603|Kinematic|kinematic
5359726|NCT01903603|motor control|motor control
5359727|NCT01903590|TVT,TOT,Randomized|tvt,tot,randomized
5359728|NCT01903577|Ergonomics|ergonomics
5359729|NCT01903577|Robotic Surgery|robotic surgery
5359730|NCT01903577|Laparoscopic Surgery|laparoscopic surgery
5359731|NCT01903564|fetus|fetus
5359732|NCT01903564|fetal arrhythmia|fetal arrhythmia
5359733|NCT01903564|fetal heart rate|fetal heart rate
5359734|NCT01903564|long QT syndrome|long qt syndrome
5359735|NCT01903551|post-operative pain|post-operative pain
5359736|NCT01903551|loco-regional analgesia|loco-regional analgesia
5359737|NCT01903551|minimally invasive surgery|minimally invasive surgery
5359738|NCT01903512|TMJ arthrocentesis|tmj arthrocentesis
5359739|NCT01903512|internal derangement|internal derangement
5359740|NCT01903512|conservative treatment|conservative treatment
5359741|NCT01903486|Trouble swallowing|trouble swallowing
5359742|NCT01903486|dysphagia|dysphagia
5359743|NCT01903486|disorder of the esophagus|disorder of the esophagus
5359744|NCT01903473|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5359745|NCT01903473|GVHD|gvhd
5359746|NCT01903473|Regulatory T cells|regulatory t cells
5359747|NCT01903473|Steroid refractory|steroid refractory
5359748|NCT01903473|Rapamycin|rapamycin
5359749|NCT01903473|Immune recovery|immune recovery
5359750|NCT01903473|Infusion|infusion
5359751|NCT01903473|HLA-identical sibling|hla-identical sibling
5359752|NCT01903473|HLA-matched unrelated donor|hla-matched unrelated donor
5359753|NCT01903473|IL-2|il-2
5359754|NCT01903447|Internalizing psychopathologies|internalizing psychopathologies
5359755|NCT01903447|Depression|depression
5359756|NCT01903447|Anxiety|anxiety
5359757|NCT01903447|MRI|mri
5359758|NCT01903447|medication treatment|medication treatment
5359759|NCT01903447|psychotherapy|psychotherapy
5359760|NCT01903447|brain function|brain function
5359761|NCT01903421|Elderly surgical patients|elderly surgical patients
5359762|NCT01903421|Alzheimer's disease|alzheimer's disease
5359763|NCT01903421|Dementia|dementia
5359764|NCT01903421|Elderly|elderly
5359765|NCT01903421|Surgery|surgery
5359766|NCT01903395|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
5359767|NCT01903395|Health Services Accessibility|health services accessibility
5359768|NCT01903395|Humans|humans
5359770|NCT01903395|Psychooncology|psychooncology
5359771|NCT01903395|Primary Health Care/*methods|primary health care/*methods
5359772|NCT01903395|Treatment Outcome|treatment outcome
5359773|NCT01903395|Socioeconomic Factors|socioeconomic factors
5359774|NCT01903395|Quality Assurance, Health Care|quality assurance, health care
5359775|NCT01903395|Adult|adult
5359776|NCT01903395|Aged|aged
5359777|NCT01903395|Aged, 80 and over|aged, 80 and over
5359778|NCT01903369|Shear wave|shear wave
5359779|NCT01903369|Elastography|elastography
5359780|NCT01903369|Repeatability and Reproducibility|repeatability and reproducibility
5359781|NCT01903343|Shear wave|shear wave
5359782|NCT01903343|Elastography|elastography
5359783|NCT01903343|Repeatability and Reproducibility|repeatability and reproducibility
5359784|NCT01903330|ERC1671|erc1671
5359785|NCT01903330|GM-CSF|gm-csf
5359786|NCT01903330|Cyclophosphamide|cyclophosphamide
5359787|NCT01903330|Bevacizumab|bevacizumab
5359788|NCT01903304|Olive oil|olive oil
5359789|NCT01903304|DTH|dth
5359790|NCT01903304|elderly|elderly
5359791|NCT01903278|interferon|interferon
5359792|NCT01903278|ribavirin|ribavirin
5359793|NCT01903278|sustained virological response|sustained virological response
5359794|NCT01903265|pain|pain
5359795|NCT01903265|sleep|sleep
5359796|NCT01903252|UC|uc
5359797|NCT01903226|spinal cord injury|spinal cord injury
5359798|NCT01903226|physical capacity|physical capacity
5359799|NCT01903226|energy expenditure|energy expenditure
5359800|NCT01903226|training|training
5359801|NCT01903213|Peritoneal dialysis|peritoneal dialysis
5359813|NCT01903174|Breast Reconstruction|breast reconstruction
5359814|NCT01903174|Breast Tissue Expansion|breast tissue expansion
5359815|NCT01903174|Breast Tissue Expander|breast tissue expander
5359816|NCT01903174|Two Stage Breast Reconstruction|two stage breast reconstruction
5359817|NCT01903161|delayed remote ischemic preconditioning|delayed remote ischemic preconditioning
5359818|NCT01903161|troponin|troponin
5359819|NCT01903161|valve replacement surgery|valve replacement surgery
5359820|NCT01903148|ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS|anemia in chronic kidney disease patients not on dialysis
5359821|NCT01903135|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5359822|NCT01903135|Prevalence|prevalence
5359823|NCT01903135|Bicarbonate|bicarbonate
5359824|NCT01903096|Panic disorder|panic disorder
5359825|NCT01903096|Generalized anxiety disorder|generalized anxiety disorder
5359826|NCT01903096|Social phobia|social phobia
5359827|NCT01903096|Specific phobia|specific phobia
5359828|NCT01903096|Major depressive disorder|major depressive disorder
5359829|NCT01903096|Dysthymia|dysthymia
5359830|NCT01903096|Somatizations disorder|somatizations disorder
5359831|NCT01903096|Pain disorder|pain disorder
5359832|NCT01903083|Pancreas|pancreas
5359833|NCT01903083|Pancreatic cancer|pancreatic cancer
5359834|NCT01903083|Immunotherapy|immunotherapy
5359835|NCT01903083|Chemotherapy|chemotherapy
5359836|NCT01903083|Radiation|radiation
5359837|NCT01903083|Surgery|surgery
5359838|NCT01903083|Pancreaticoduodenectomy|pancreaticoduodenectomy
5359839|NCT01903057|Mass Drug Administration|mass drug administration
5359840|NCT01903057|Neglected Tropical Diseases|neglected tropical diseases
5359841|NCT01903057|Preventive Chemotherapy and Transmission Control|preventive chemotherapy and transmission control
5359842|NCT01903057|Preventive Chemotherapy|preventive chemotherapy
5359843|NCT01903044|Lowe extremity ischemia|lowe extremity ischemia
5359844|NCT01903044|Bone marrow|bone marrow
5359845|NCT01903044|Neoangiogenesis|neoangiogenesis
5359846|NCT01903005|Opioid, Dependence, agonist, Buprenorphine, Naloxone|opioid, dependence, agonist, buprenorphine, naloxone
5359847|NCT01902966|Cervical Cancer|cervical cancer
5359848|NCT01902966|Propranolol|propranolol
5359849|NCT01902966|Betachron|betachron
5359850|NCT01902966|Inderal|inderal
5359851|NCT01902966|Beta blocker|beta blocker
5359852|NCT01902966|Questionnaires|questionnaires
5359853|NCT01902966|Surveys|surveys
5359854|NCT01902966|Symptom inventory|symptom inventory
5359855|NCT01902966|Anxiety and depression survey|anxiety and depression survey
5359856|NCT01902966|Pain inventory|pain inventory
5359857|NCT01902966|Quality of life survey|quality of life survey
5359858|NCT01902966|Relaxation audio recording|relaxation audio recording
5359859|NCT01902966|MP3 player|mp3 player
5359860|NCT01902966|Diary|diary
5359861|NCT01902953|Sentinel lymph nodes|sentinel lymph nodes
5359862|NCT01902953|colon cancer|colon cancer
5359863|NCT01902953|rectal cancer|rectal cancer
5359864|NCT01902953|immunohistochemistry|immunohistochemistry
5359865|NCT01902927|Exercise tolerance|exercise tolerance
5359866|NCT01902927|Dyspnea|dyspnea
5359867|NCT01902927|Affective distraction|affective distraction
5359868|NCT01902914|hearing aids|hearing aids
5359869|NCT01902914|hearing disability|hearing disability
5359870|NCT01902914|community|community
5359871|NCT01902914|hearing aids service|hearing aids service
5359872|NCT01902901|Whole Genome Sequencing|whole genome sequencing
5359873|NCT01902901|Carrier status|carrier status
5359874|NCT01902901|Genetics|genetics
5359875|NCT01902888|popliteal artery|popliteal artery
5226506|NCT02583854|Compression device|compression device
5226508|NCT02583802|ear pills|ear pills
5226509|NCT02583802|Shengmai capsule|shengmai capsule
5226510|NCT02583802|Chinese medicine treatment|chinese medicine treatment
5226511|NCT02583776|continuous glucose monitoring (cgm)|continuous glucose monitoring (cgm)
5359876|NCT01902888|aneurysm|aneurysm
5359877|NCT01902888|popliteal artery aneurysm|popliteal artery aneurysm
5359878|NCT01902888|asymptomatic aneurysm|asymptomatic aneurysm
5359879|NCT01902888|mural thrombus|mural thrombus
5359880|NCT01902888|Viabahn|viabahn
5359881|NCT01902888|Gore|gore
5359882|NCT01902888|Endoprosthesis|endoprosthesis
5359883|NCT01902862|Lymphoma, follicular|lymphoma, follicular
5359884|NCT01902862|Bortezomib|bortezomib
5359885|NCT01902862|Rituximab|rituximab
5359886|NCT01902849|intravenous anesthesia|intravenous anesthesia
5359887|NCT01902849|inhalational anesthesia|inhalational anesthesia
5359891|NCT01902836|Transferon|transferon
5359892|NCT01902836|atopic dermatitis|atopic dermatitis
5359893|NCT01902823|Nurse Navigator|nurse navigator
5359894|NCT01902823|Satisfaction with Care|satisfaction with care
5359895|NCT01902823|Quality of Life|quality of life
5359896|NCT01902823|Symptom Distress|symptom distress
5359897|NCT01902797|Refugee camps|refugee camps
5359898|NCT01902797|Household residence|household residence
5359899|NCT01902797|Treated bednets|treated bednets
5359901|NCT01902784|Intensive Care Unit patients and families|intensive care unit patients and families
5359902|NCT01902784|Surrogate decision making|surrogate decision making
5359903|NCT01902784|Life Sustaining Treatments (LST)|life sustaining treatments (lst)
5359904|NCT01902771|Dendritic Cell Vaccine|dendritic cell vaccine
5359905|NCT01902771|DCV|dcv
5359906|NCT01902771|Pediatric|pediatric
5359907|NCT01902771|Brain Tumor|brain tumor
5359908|NCT01902771|In Situ|in situ
5359909|NCT01902771|Lysate|lysate
5359910|NCT01902771|Tumor Lysate|tumor lysate
5359911|NCT01902771|Glioblastoma Multiforme|glioblastoma multiforme
5359912|NCT01902771|GBM|gbm
5359913|NCT01902771|Pheresis|pheresis
5359914|NCT01902771|Leukapheresis|leukapheresis
5359915|NCT01902771|High Grade Glioma|high grade glioma
5359916|NCT01902771|HGG|hgg
5359917|NCT01902758|exercise performance|exercise performance
5359918|NCT01902693|HIV|hiv
5359919|NCT01902693|Chemotherapy|chemotherapy
5359920|NCT01902693|Cohort|cohort
5359921|NCT01902693|Cancer|cancer
5359924|NCT01902680|Prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance|prostate cancer, permanent implant brachytherapy, image fusion, focal therapy, active surveillance
5359925|NCT01902667|Retroperitoneal Sarcoma|retroperitoneal sarcoma
5359926|NCT01902667|Magnetic Resonance Imaging|magnetic resonance imaging
5359927|NCT01902654|Osteoarthritis|osteoarthritis
5359928|NCT01902654|cardiovascular disease|cardiovascular disease
5359929|NCT01902641|succinylcholine|succinylcholine
5359930|NCT01902641|rocuronium|rocuronium
5359931|NCT01902641|sugammadex|sugammadex
5359932|NCT01902641|Intubating Conditions|intubating conditions
5359933|NCT01902641|short Procedures|short procedures
5359934|NCT01902563|osteopathic manipulative treatment|osteopathic manipulative treatment
5359935|NCT01902563|newborns|newborns
5359936|NCT01902563|preterm infants|preterm infants
5359937|NCT01902563|procedures|procedures
5359938|NCT01902550|Healthy|healthy
5359939|NCT01902550|JNJ-54452840|jnj-54452840
5359940|NCT01902550|Metoprolol Tartrate Immediate-Release|metoprolol tartrate immediate-release
5359941|NCT01902550|Placebo|placebo
5359942|NCT01902550|Male|male
5359943|NCT01902537|Constipation|constipation
5359944|NCT01902537|Prucalopride|prucalopride
5359945|NCT01902524|Chronic Pain|chronic pain
5359946|NCT01902524|Fentanyl-TTS|fentanyl-tts
5359947|NCT01902524|Fentanyl Patch|fentanyl patch
5359948|NCT01902524|Transdermal|transdermal
5359949|NCT01902524|Non-cancer Pain|non-cancer pain
5359950|NCT01902498|aspirin|aspirin
5359951|NCT01902485|Contraception|contraception
5359952|NCT01902485|Medical Abortion|medical abortion
5359953|NCT01902485|Implant|implant
5359954|NCT01902485|Injectable|injectable
5359955|NCT01902485|Quickstart|quickstart
5359956|NCT01902472|HIV-1|hiv-1
5359957|NCT01902472|Truvada|truvada
5359958|NCT01902472|FTC/TDF|ftc/tdf
5359959|NCT01902472|Pre-exposure prophylaxis|pre-exposure prophylaxis
5359960|NCT01902472|PrEP|prep
5964097|NCT04165564|Molecular biomarkers for lung cancer diagnosis|molecular biomarkers for lung cancer diagnosis
5964098|NCT04165564|Imaging for lung cancer diagnosis|imaging for lung cancer diagnosis
5964099|NCT04165564|High risk smokers|high risk smokers
5964100|NCT04165317|PF-06801591|pf-06801591
5964101|NCT04165317|Bacillus Calmette Guerin|bacillus calmette guerin
5964102|NCT04165317|BCG|bcg
5964103|NCT04165317|Bladder cancer|bladder cancer
5964104|NCT04165252|Preterm birth|preterm birth
5964105|NCT04165252|Microbiota|microbiota
5964106|NCT04165252|Mycobiota|mycobiota
5964107|NCT04165252|Short Cervix|short cervix
5964108|NCT04165252|Progesterone|progesterone
5964109|NCT04165135|Hemophilia A|hemophilia a
5964110|NCT04165135|Factor VIII|factor viii
5964111|NCT04165096|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
5964112|NCT04165096|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
5964113|NCT04165096|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
5964114|NCT04165070|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5359961|NCT01902472|Resistance|resistance
5359962|NCT01902459|Hemostasis|hemostasis
5359963|NCT01902446|Chlorhexidine|chlorhexidine
5359964|NCT01902446|Randomized Controlled Trial|randomized controlled trial
5359965|NCT01902446|Emergency Medical Services|emergency medical services
5359966|NCT01902446|Intubation, Endotracheal|intubation, endotracheal
5359967|NCT01902407|Pcrit|pcrit
5359968|NCT01902407|Critical closing pressure|critical closing pressure
5359969|NCT01902407|Down syndrome|down syndrome
5359970|NCT01902407|Obstructive Sleep Apnea|obstructive sleep apnea
5359971|NCT01902407|Sleep MRI|sleep mri
5359972|NCT01902394|digestive health and natural defenses|digestive health and natural defenses
5359973|NCT01902368|Gluten free diet|gluten free diet
5359974|NCT01902355|Central Venous Catheterization|central venous catheterization
5359975|NCT01902329|Acute Myeloid Leukemia|acute myeloid leukemia
5359976|NCT01902329|Antibody-Drug Conjugate|antibody-drug conjugate
5359977|NCT01902329|CD33 Antigen|cd33 antigen
5359978|NCT01902329|Immunotherapy|immunotherapy
5359979|NCT01902329|Drug Therapy|drug therapy
5359980|NCT01902329|Acute Myelogenous Leukemia|acute myelogenous leukemia
5359981|NCT01902329|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5359983|NCT01902316|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5359984|NCT01902316|peptide biomarker|peptide biomarker
5359985|NCT01902316|early diagnosis|early diagnosis
5359986|NCT01902316|label free|label free
5359987|NCT01902303|Herpes Labialis|herpes labialis
5359988|NCT01902303|Herpes Simplex|herpes simplex
5359989|NCT01902303|Herpes|herpes
5359990|NCT01902303|Ultra Violet (UV) Induced|ultra violet (uv) induced
5359991|NCT01902290|Inadequately controlled asthma, brodalumab, AMG 827|inadequately controlled asthma, brodalumab, amg 827
5359992|NCT01902277|Delirium|delirium
5359993|NCT01902277|Intensive Care Unit|intensive care unit
5359994|NCT01902277|Critical illness|critical illness
5359995|NCT01902264|Levomefolate calcium|levomefolate calcium
5359996|NCT01902264|Contraceptives, oral, combined|contraceptives, oral, combined
5359997|NCT01902264|Neural tube defects|neural tube defects
5359998|NCT01902251|Phase 1|phase 1
5359999|NCT01902251|Prostate cancer|prostate cancer
5360000|NCT01902251|Bioavailability|bioavailability
5360001|NCT01902251|Food effect|food effect
5360002|NCT01902251|Pharmacokinetics|pharmacokinetics
5360003|NCT01902251|Xtandi|xtandi
5360004|NCT01902251|Enzalutamide|enzalutamide
5360005|NCT01902251|MDV3100|mdv3100
5360006|NCT01902238|neuroendocrine tumor|neuroendocrine tumor
5360007|NCT01902238|ethanol|ethanol
5360008|NCT01902238|endoscopic ultrasonography|endoscopic ultrasonography
5360009|NCT01902225|Lymphoma|lymphoma
5360010|NCT01902225|T-Cell|t-cell
5360011|NCT01902225|Cutaneous|cutaneous
5360012|NCT01902225|Doxil|doxil
5360013|NCT01902225|romidepsin|romidepsin
5360014|NCT01902225|skin|skin
5360016|NCT01902186|osteopenia|osteopenia
5360017|NCT01902186|t-score|t-score
5360018|NCT01902186|DEXA|dexa
5360019|NCT01902186|tenofovir|tenofovir
5360020|NCT01902186|raltegravir|raltegravir
5360021|NCT01902147|abdominal|abdominal
5360022|NCT01902147|thoracic|thoracic
5360023|NCT01902147|arthroplasty|arthroplasty
5360024|NCT01902134|Moderate to severe acute pain|moderate to severe acute pain
5360026|NCT01902134|Hip arthroplasty|hip arthroplasty
5360027|NCT01902134|Analgesics|analgesics
5360028|NCT01902134|Dexketoprofen|dexketoprofen
5360029|NCT01902134|Tramadol|tramadol
5360030|NCT01902108|clonidine|clonidine
5360031|NCT01902108|bupivacaine|bupivacaine
5360032|NCT01902108|post-operative pain|post-operative pain
5360033|NCT01902108|arthrodesis|arthrodesis
5360034|NCT01902108|discectomy|discectomy
5360035|NCT01902108|local infiltration|local infiltration
5360036|NCT01902095|tooth pastes|tooth pastes
5360037|NCT01902095|tooth powders|tooth powders
5360038|NCT01902095|Stain Index|stain index
5360039|NCT01902082|ARDS|ards
5360040|NCT01902082|mesenchymal stem cells|mesenchymal stem cells
5360041|NCT01902082|Safety|safety
5360042|NCT01902082|Cytokines|cytokines
5360043|NCT01902069|sweet and fat preference|sweet and fat preference
5360044|NCT01902056|allograft|allograft
5360045|NCT01902056|acellular dermal matrix|acellular dermal matrix
5360046|NCT01902056|Alloderm|alloderm
5360047|NCT01902043|diabetes mellitus|diabetes mellitus
5360048|NCT01902043|cohort study|cohort study
5360049|NCT01902043|quality of care|quality of care
5360050|NCT01902043|quality indicators, Health care|quality indicators, health care
5360051|NCT01902043|quality of Health Care|quality of health care
5360052|NCT01902043|outcome and process assessment|outcome and process assessment
5360053|NCT01902043|health services research|health services research
5360054|NCT01902043|chronic diseases prevention and management|chronic diseases prevention and management
5360055|NCT01902017|Joint|joint
5360056|NCT01902017|Contracture|contracture
5445480|NCT01521546|cardiomyopathy|cardiomyopathy
5964115|NCT04165070|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5964116|NCT04164901|vorasidenib|vorasidenib
5964117|NCT04164628|quality of life|quality of life
5964118|NCT04164628|depression|depression
5964119|NCT04164628|anxiety|anxiety
5964120|NCT04164628|social function|social function
5964121|NCT04164420|Stroke|stroke
5964122|NCT04164420|Dysphagia|dysphagia
5964123|NCT04164420|Treatment|treatment
5964124|NCT04164420|Intervention|intervention
5238814|NCT02509754|catheter ablation|catheter ablation
5360057|NCT01902017|Elbow|elbow
5360058|NCT01902017|Fracture|fracture
5360059|NCT01902017|Dislocation|dislocation
5360060|NCT01902004|Major Depression|major depression
5360061|NCT01902004|Geriatric Major Depression|geriatric major depression
5360062|NCT01902004|Executive Cognitive Dysfunction|executive cognitive dysfunction
5360063|NCT01902004|Mild Cognitive Impairment|mild cognitive impairment
5360064|NCT01902004|Older Adults|older adults
5360065|NCT01902004|Geriatric|geriatric
5360066|NCT01902004|Executive Cognitive Impairment|executive cognitive impairment
5360067|NCT01902004|Quality of Life|quality of life
5360068|NCT01902004|Disability|disability
5360069|NCT01902004|Comorbidity|comorbidity
5360070|NCT01902004|Medical Burden|medical burden
5360071|NCT01902004|Safety|safety
5360072|NCT01902004|Candidate Genes|candidate genes
5360073|NCT01901991|Nonpalpable breast lesions|nonpalpable breast lesions
5360074|NCT01901991|Breast Cancer and carcinoma in situ|breast cancer and carcinoma in situ
5360075|NCT01901991|Radioactive seed localization|radioactive seed localization
5360076|NCT01901991|Wire-guided localization|wire-guided localization
5360077|NCT01901991|Randomized study|randomized study
5360079|NCT01901978|Insulin Resistance|insulin resistance
5360080|NCT01901978|Weight loss|weight loss
5360081|NCT01901978|Women|women
5360082|NCT01901952|Self management diabetes intervention|self management diabetes intervention
5360083|NCT01901939|exercise|exercise
5360084|NCT01901939|elderly|elderly
5360085|NCT01901939|activities of daily living|activities of daily living
5360086|NCT01901939|disability|disability
5360087|NCT01901913|Type 1 Diabetes|type 1 diabetes
5360088|NCT01901913|Artificial pancreas|artificial pancreas
5360090|NCT01901887|Adults|adults
5360091|NCT01901887|Suicidality|suicidality
5360092|NCT01901874|Stroke|stroke
5360093|NCT01901874|Carotid Artery Stenting (CAS)|carotid artery stenting (cas)
5360094|NCT01901874|Embolic Protection Device (EPD)|embolic protection device (epd)
5360095|NCT01901874|Stent|stent
5360096|NCT01901874|Carotid Stenosis|carotid stenosis
5360097|NCT01901874|Constriction, Pathologic|constriction, pathologic
5360098|NCT01901874|Carotid Artery Diseases|carotid artery diseases
5360099|NCT01901874|Cerebrovascular Disorders|cerebrovascular disorders
5360100|NCT01901874|Brain Diseases|brain diseases
5360101|NCT01901874|Central Nervous System Diseases|central nervous system diseases
5360102|NCT01901874|Nervous System Diseases|nervous system diseases
5360103|NCT01901874|Arterial Occlusive Diseases|arterial occlusive diseases
5360104|NCT01901874|Vascular Diseases|vascular diseases
5360105|NCT01901874|Cardiovascular Diseases|cardiovascular diseases
5360106|NCT01901874|Pathological Conditions, Anatomical|pathological conditions, anatomical
5360107|NCT01901874|Angioplasty|angioplasty
5360108|NCT01901861|GLP-1, GIP, DPP-4 inhibition, iset function|glp-1, gip, dpp-4 inhibition, iset function
5360109|NCT01901848|Smoking Cessation|smoking cessation
5360110|NCT01901848|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5360111|NCT01901848|Psychotherapy|psychotherapy
5360112|NCT01901822|acellular dermal matrix|acellular dermal matrix
5360113|NCT01901809|Heart failure, diastolic|heart failure, diastolic
5360114|NCT01901809|HFpEF|hfpef
5360115|NCT01901809|Diuretics|diuretics
5360116|NCT01901809|Dopamine|dopamine
5360117|NCT01901796|Anxiety|anxiety
5360118|NCT01901796|Depression|depression
5360120|NCT01901783|allograft|allograft
5360121|NCT01901783|regeneration|regeneration
5360122|NCT01901783|alveolar ridge|alveolar ridge
5360123|NCT01901770|HPV|hpv
5360124|NCT01901770|Ohio Appalachia|ohio appalachia
5360125|NCT01901770|HPV vaccine|hpv vaccine
5360126|NCT01901770|No evidence of disease|no evidence of disease
5360127|NCT01901744|Contrast Sensitivity , Pediatric Cataract Surgery,|contrast sensitivity , pediatric cataract surgery,
5360128|NCT01901731|transjugular coil embolisation|transjugular coil embolisation
5360129|NCT01901731|endovenous treatment of varicose veins|endovenous treatment of varicose veins
5360130|NCT01901731|pelvic venous reflux|pelvic venous reflux
5360131|NCT01901731|recurrent varicose veins|recurrent varicose veins
5360132|NCT01901718|Breakthrough Pain|breakthrough pain
5360133|NCT01901718|Subsys|subsys
5360134|NCT01901718|Fentanyl|fentanyl
5360135|NCT01901718|Opioid|opioid
5360136|NCT01901718|Persistent Pain|persistent pain
5360137|NCT01901705|Psoriasis|psoriasis
5360138|NCT01901705|Indigo Naturalis|indigo naturalis
5360139|NCT01901705|chinese medicine|chinese medicine
5360140|NCT01901692|liver cancer|liver cancer
5360141|NCT01901692|first-line|first-line
5360142|NCT01901692|tumor thrombus|tumor thrombus
5360143|NCT01901692|vascular invasion|vascular invasion
5360144|NCT01901679|Obesity|obesity
5360145|NCT01901679|Post-menopausal|post-menopausal
5255316|NCT02416453|Safety|safety
5360146|NCT01901666|growth hormone, Chronic Myelogenous Leukemia, Imatinib,serum IGF-1|growth hormone, chronic myelogenous leukemia, imatinib,serum igf-1
5360147|NCT01901653|Small cell lung cancer|small cell lung cancer
5360148|NCT01901627|Spondylitis, Ankylosing|spondylitis, ankylosing
5360149|NCT01901627|adalimumab|adalimumab
5360150|NCT01901627|Prospective Studies|prospective studies
5360151|NCT01901614|Keratoconus|keratoconus
5360152|NCT01901614|Corneal Opacity|corneal opacity
5964125|NCT04163991|Rheumatoid Arthritis|rheumatoid arthritis
5964126|NCT04163991|RA|ra
5360153|NCT01901614|Keratoplasty|keratoplasty
5360154|NCT01901601|KERATOPLASTY|keratoplasty
5360155|NCT01901601|STROMAL OPACITIES|stromal opacities
5360156|NCT01901588|strabismus|strabismus
5360157|NCT01901588|pediatric|pediatric
5360158|NCT01901588|emergence delirium|emergence delirium
5360159|NCT01901588|precedex/dexmedetomidine|precedex/dexmedetomidine
5360160|NCT01901575|idiopathic ventricular tachycardia|idiopathic ventricular tachycardia
5360161|NCT01901562|ductoscopy|ductoscopy
5360162|NCT01901562|nipple discharge|nipple discharge
5360163|NCT01901562|breast|breast
5360164|NCT01901562|papilloma|papilloma
5360165|NCT01901536|First time parents|first time parents
5360166|NCT01901536|Coparenting|coparenting
5360167|NCT01901536|Family Foundations|family foundations
5360168|NCT01901523|Discrepancy|discrepancy
5360169|NCT01901523|Committee on Publication Ethics|committee on publication ethics
5360170|NCT01901523|Correction|correction
5360171|NCT01901523|Erratum|erratum
5360172|NCT01901523|Retraction|retraction
5360173|NCT01901510|polyp|polyp
5360174|NCT01901497|non invasive ventilation|non invasive ventilation
5360175|NCT01901497|single limb circuit ventilator|single limb circuit ventilator
5360176|NCT01901497|bilevel|bilevel
5360177|NCT01901497|nebulization|nebulization
5360178|NCT01901497|nebulizer|nebulizer
5360179|NCT01901497|vibrating mesh nebulizer|vibrating mesh nebulizer
5360180|NCT01901497|amikacin|amikacin
5360181|NCT01901484|Schistosoma mansoni|schistosoma mansoni
5360182|NCT01901484|morbidity|morbidity
5360183|NCT01901484|chemotherapy|chemotherapy
5360184|NCT01901471|Cyclosporine, cardiogenic shock, SOFA score,|cyclosporine, cardiogenic shock, sofa score,
5360185|NCT01901458|apheresis|apheresis
5360186|NCT01901458|peripheral blood progenitor cells|peripheral blood progenitor cells
5360190|NCT01901445|Focus groups|focus groups
5360191|NCT01901445|Health education|health education
5360192|NCT01901445|Problem-based learning|problem-based learning
5360193|NCT01901432|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
5360194|NCT01901432|Polycythemia Vera|polycythemia vera
5360195|NCT01901432|Essential Thrombocythemia|essential thrombocythemia
5360196|NCT01901432|Primary Myelofibrosis|primary myelofibrosis
5360197|NCT01901432|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5360198|NCT01901432|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5360199|NCT01901432|Givinostat|givinostat
5360200|NCT01901419|nitroglycerin|nitroglycerin
5360201|NCT01901419|cardiopulmonary bypass|cardiopulmonary bypass
5360202|NCT01901419|cardiac surgery|cardiac surgery
5360203|NCT01901406|epiretinal membrane, stereopsis, aniseikonia|epiretinal membrane, stereopsis, aniseikonia
5360204|NCT01901393|Post Operative Pain,|post operative pain,
5360205|NCT01901393|Pail relief|pail relief
5360206|NCT01901367|Adiponectin, Glucose, Insulin, Leptin|adiponectin, glucose, insulin, leptin
5360207|NCT01901354|Acute lung injury (ALI)|acute lung injury (ali)
5360208|NCT01901354|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
5360209|NCT01901354|Low-tidal-volume strategy|low-tidal-volume strategy
5360210|NCT01901354|ARDSNet|ardsnet
5360211|NCT01901354|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
5360212|NCT01901354|biomarkers of lung injury|biomarkers of lung injury
5360214|NCT01901341|Constipation|constipation
5360215|NCT01901341|Chronic|chronic
5360216|NCT01901341|Pain|pain
5360217|NCT01901328|Opioid|opioid
5360218|NCT01901328|Constipation|constipation
5360219|NCT01901328|Chronic|chronic
5360220|NCT01901328|Pain|pain
5360221|NCT01901315|telepsychiatry|telepsychiatry
5360222|NCT01901315|telemental health|telemental health
5360223|NCT01901315|teleassistance|teleassistance
5360224|NCT01901315|health care delivery|health care delivery
5360225|NCT01901315|depression|depression
5360226|NCT01901315|Telemedicine|telemedicine
5360227|NCT01901315|Remote Consultation|remote consultation
5360228|NCT01901315|Videoconferencing|videoconferencing
5360229|NCT01901315|Community Mental Health Services|community mental health services
5360231|NCT01901302|Constipation|constipation
5360232|NCT01901302|Chronic|chronic
5360233|NCT01901302|Pain|pain
5360234|NCT01901289|Peripheral Vascular Disease|peripheral vascular disease
5360235|NCT01901289|Femoral Artery|femoral artery
5360236|NCT01901289|Popliteal Artery|popliteal artery
5360237|NCT01901289|Drug-Eluting Stent|drug-eluting stent
5360238|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors
5360239|NCT01901276|Microbiome|microbiome
5360240|NCT01901276|Clostridium difficile|clostridium difficile
5360241|NCT01901263|Cognitive and behavioral units|cognitive and behavioral units
5360242|NCT01901263|Alzheimer Disease|alzheimer disease
5360243|NCT01901263|Dementia|dementia
5360244|NCT01901250|Dental Caries|dental caries
5360245|NCT01901250|Xylitol|xylitol
5360246|NCT01901250|Prevention|prevention
5360247|NCT01901237|Cancer|cancer
5360248|NCT01901237|Adolescent and Young Adult|adolescent and young adult
5360249|NCT01901237|Exercise|exercise
5360250|NCT01901237|Physical Activity|physical activity
5360251|NCT01901237|Quality of Life|quality of life
5360252|NCT01901237|End-of-Life|end-of-life
5360253|NCT01901237|Palliative|palliative
5360255|NCT01901237|Yoga|yoga
5360256|NCT01901237|Alternative Therapies|alternative therapies
5360257|NCT01901237|Fitness|fitness
5360258|NCT01901237|Fatigue|fatigue
5360259|NCT01901211|Cerebral palsy|cerebral palsy
5360260|NCT01901211|Interactive computer play|interactive computer play
5360261|NCT01901211|Multi-player gaming|multi-player gaming
5360262|NCT01901211|Exercise|exercise
5360263|NCT01901146|Human Epidermal Growth Factor Receptor 2 (HER2)|human epidermal growth factor receptor 2 (her2)
5360264|NCT01901146|Positive Early Breast Cancer|positive early breast cancer
5360265|NCT01901133|Phase 1|phase 1
5360266|NCT01901133|MDV3100|mdv3100
5360267|NCT01901133|Hepatic Impairment|hepatic impairment
5360268|NCT01901133|Kidney Diseases|kidney diseases
5360269|NCT01901133|Xtandi|xtandi
5360270|NCT01901133|enzalutamide|enzalutamide
5360271|NCT01901120|Betanis®|betanis®
5360272|NCT01901120|mirabegron|mirabegron
5360273|NCT01901120|Overactive Bladder|overactive bladder
5360274|NCT01901107|Hemodialysis|hemodialysis
5360275|NCT01901107|CKD (chronic kidney disease)|ckd (chronic kidney disease)
5360277|NCT01901107|Hyperphosphatemia|hyperphosphatemia
5360278|NCT01901081|Implantable Myoelectric Sensor|implantable myoelectric sensor
5360279|NCT01901081|IMES|imes
5360280|NCT01901081|transradial|transradial
5360281|NCT01901081|amputation|amputation
5360282|NCT01901081|myoelectric|myoelectric
5360283|NCT01901081|prosthesis|prosthesis
5360284|NCT01901081|prosthetic control|prosthetic control
5360285|NCT01901068|Laparotomy|laparotomy
5360286|NCT01901068|Surgical Procedures, Elective|surgical procedures, elective
5360287|NCT01901068|Sutures|sutures
5360288|NCT01901068|Abdominal Wound Closure Techniques|abdominal wound closure techniques
5360289|NCT01901055|sleep apnea|sleep apnea
5360290|NCT01901055|diabetes|diabetes
5360291|NCT01901042|Quality of life|quality of life
5360292|NCT01901042|Symbiotic|symbiotic
5360293|NCT01901042|Proctitis/Radiotherapy|proctitis/radiotherapy
5360294|NCT01901029|Male Reproductive Health|male reproductive health
5360295|NCT01901029|Floating Population|floating population
5360296|NCT01901029|Sexual Behavior|sexual behavior
5360297|NCT01901029|Erectile Dysfunction|erectile dysfunction
5360298|NCT01901029|Premature Ejaculation|premature ejaculation
5360299|NCT01901016|HIV|hiv
5360300|NCT01901016|depressive symptoms|depressive symptoms
5360301|NCT01901016|quality of life|quality of life
5360302|NCT01901016|relaxation|relaxation
5360303|NCT01901016|viral load|viral load
5360304|NCT01901016|CD4+ T cell count|cd4+ t cell count
5360305|NCT01900990|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5360306|NCT01900990|Invasive Positive Pressure Ventilation|invasive positive pressure ventilation
5360307|NCT01900990|tracheotomy|tracheotomy
5360308|NCT01900977|Universal Test and Treat (UTT)|universal test and treat (utt)
5360309|NCT01900977|Combination Prevention|combination prevention
5360310|NCT01900964|Regeneration|regeneration
5360311|NCT01900964|Bone regeneration|bone regeneration
5360312|NCT01900964|Grafting, Bone|grafting, bone
5360313|NCT01900964|Allograft|allograft
5360314|NCT01900964|Xenograft|xenograft
5360324|NCT01900912|social networks|social networks
5360325|NCT01900912|cooperation|cooperation
5360326|NCT01900899|Healthy|healthy
5360327|NCT01900899|Immunogenicity|immunogenicity
5360328|NCT01900899|Children|children
5360329|NCT01900899|Neisseria meningitidis|neisseria meningitidis
5360330|NCT01900899|Long-term antibody persistence|long-term antibody persistence
5360331|NCT01900899|Safety|safety
5360332|NCT01900899|Serogroups A, C, W-135, and Y|serogroups a, c, w-135, and y
5360333|NCT01900886|prison, disorder, hepatitis c|prison, disorder, hepatitis c
5360334|NCT01900873|Inspiratory Muscle Training|inspiratory muscle training
5360336|NCT01900873|Inspiratory Muscle Function|inspiratory muscle function
5360337|NCT01900873|Dyspnea|dyspnea
5360338|NCT01900860|Vitamin D|vitamin d
5360339|NCT01900860|Bone quality|bone quality
5360340|NCT01900860|Bone density|bone density
5360341|NCT01900860|calcium metabolism|calcium metabolism
5360342|NCT01900860|High resolution peripheral quantitative computed tomography|high resolution peripheral quantitative computed tomography
5360343|NCT01900860|Dual X-ray absorptiometry|dual x-ray absorptiometry
5360344|NCT01900860|Quality of life|quality of life
5360345|NCT01900847|Ketamine|ketamine
5360346|NCT01900847|Acute Pain|acute pain
5360347|NCT01900795|Postsurgical pain|postsurgical pain
5360348|NCT01900743|Sarcoma|sarcoma
5360349|NCT01900743|Metastatic|metastatic
5360350|NCT01900743|Regorafenib|regorafenib
5360362|NCT01900691|Esophageal Fistula|esophageal fistula
5360363|NCT01900691|Esophageal Neoplasms|esophageal neoplasms
5360364|NCT01900691|Esophageal Perforation|esophageal perforation
5360365|NCT01900691|Esophageal Stenosis|esophageal stenosis
5360366|NCT01900691|Stents|stents
5360367|NCT01900639|aspirin|aspirin
5360368|NCT01900639|circadian rhythm|circadian rhythm
5964127|NCT04163991|VIB4920|vib4920
5964128|NCT04163991|MEDI4920|medi4920
5964129|NCT04163692|Muscle Relaxation|muscle relaxation
5964130|NCT04163692|Pain|pain
5964131|NCT04163692|Quality of Life|quality of life
5964132|NCT04163458|Controlled Ovarian Stimulation|controlled ovarian stimulation
5964133|NCT04163458|Assisted Reproductive Technology|assisted reproductive technology
5318106|NCT02094118|RBC|rbc
5360369|NCT01900639|platelet reactivity|platelet reactivity
5360370|NCT01900639|platelet activation|platelet activation
5360371|NCT01900639|time dependent|time dependent
5360372|NCT01900613|child obesity|child obesity
5360373|NCT01900613|Mexican-American|mexican-american
5360374|NCT01900613|Nutrition education|nutrition education
5360375|NCT01900613|Intervention|intervention
5360376|NCT01900587|Healthy|healthy
5360377|NCT01900587|Bio-equivalence|bio-equivalence
5360378|NCT01900587|Tapentadol extended release|tapentadol extended release
5360379|NCT01900587|Tamper-resistant formulation|tamper-resistant formulation
5360380|NCT01900574|Colitis, Ulcerative|colitis, ulcerative
5360381|NCT01900574|Ulcerative Colitis|ulcerative colitis
5360382|NCT01900574|Moderately to Severely Active Ulcerative Colitis|moderately to severely active ulcerative colitis
5360383|NCT01900574|Golimumab|golimumab
5360384|NCT01900574|Simponi|simponi
5360385|NCT01900574|Human anti-TNFα Antibody|human anti-tnfα antibody
5360386|NCT01900574|Pediatric participants|pediatric participants
5360387|NCT01900574|Safety and Pharmacokinetics|safety and pharmacokinetics
5360388|NCT01900561|prostate cancer|prostate cancer
5360389|NCT01900561|survivorship|survivorship
5360390|NCT01900561|intervention|intervention
5360391|NCT01900561|telemedicine|telemedicine
5360392|NCT01900548|Osteopenia|osteopenia
5360393|NCT01900548|Sarcopenia|sarcopenia
5360394|NCT01900548|Osteoporosis|osteoporosis
5360395|NCT01900548|Physical function|physical function
5360396|NCT01900548|Body composition|body composition
5360397|NCT01900548|Muscle protein|muscle protein
5360398|NCT01900548|Leucine|leucine
5360399|NCT01900548|Ketogenic amino acids|ketogenic amino acids
5360400|NCT01900548|Resistance Training|resistance training
5360401|NCT01900548|Whey protein|whey protein
5360402|NCT01900548|Soy protein|soy protein
5360403|NCT01900548|Bone turnover|bone turnover
5360404|NCT01900535|chlorhexidine|chlorhexidine
5360405|NCT01900535|gingivitis|gingivitis
5360406|NCT01900535|periodontitis|periodontitis
5360407|NCT01900522|Drug therapy|drug therapy
5360408|NCT01900509|Childhood leukemia|childhood leukemia
5360409|NCT01900509|Childhood lymphoma|childhood lymphoma
5360410|NCT01900509|Bendamustine|bendamustine
5360411|NCT01900496|cHL|chl
5360412|NCT01900496|Hodgkin lymphoma|hodgkin lymphoma
5360413|NCT01900496|Lymphoma|lymphoma
5360414|NCT01900496|relapsed Lymphoma|relapsed lymphoma
5360415|NCT01900496|SGN-35|sgn-35
5360619|NCT01899586|Vascular|vascular
5360416|NCT01900496|Brentuximab Vedotin|brentuximab vedotin
5360417|NCT01900496|Rituxan|rituxan
5360418|NCT01900496|Rituximab|rituximab
5360419|NCT01900470|Multiple chronic conditions|multiple chronic conditions
5360420|NCT01900444|Japanese encephalitis|japanese encephalitis
5360421|NCT01900444|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5360422|NCT01900444|IMOJEV®|imojev®
5360423|NCT01900418|breast cancer|breast cancer
5360424|NCT01900418|aromatase inhibitors|aromatase inhibitors
5360425|NCT01900418|physical activity|physical activity
5360426|NCT01900418|joint pain|joint pain
5360427|NCT01900405|Dexmedetomidine|dexmedetomidine
5360428|NCT01900405|Administration, Intranasal|administration, intranasal
5360429|NCT01900405|Children|children
5360430|NCT01900405|Computerized Tomography|computerized tomography
5360431|NCT01900379|Obstructive sleep apneas syndrome|obstructive sleep apneas syndrome
5360432|NCT01900379|Continuous positive airway pressure treatment|continuous positive airway pressure treatment
5360433|NCT01900379|Heart failure|heart failure
5360434|NCT01900379|Coronary reperfusion surgery|coronary reperfusion surgery
5360435|NCT01900366|Obesity|obesity
5360436|NCT01900366|Healthy Volunteers|healthy volunteers
5360437|NCT01900340|GLP-1|glp-1
5360438|NCT01900340|satiation peptides|satiation peptides
5360439|NCT01900340|food intake|food intake
5360440|NCT01900327|pancreatic cancer|pancreatic cancer
5360441|NCT01900327|surgery|surgery
5360442|NCT01900327|chemoradiation|chemoradiation
5356152|NCT01920568|China|china
5360444|NCT01900327|overall survival|overall survival
5360445|NCT01900314|Major Depression|major depression
5360446|NCT01900314|Major Depressive Disorder|major depressive disorder
5360447|NCT01900314|TMS|tms
5360448|NCT01900314|rTMS|rtms
5360449|NCT01900301|exposure|exposure
5360450|NCT01900301|scopolamine|scopolamine
5360451|NCT01900301|extinction learning|extinction learning
5360452|NCT01900301|social anxiety|social anxiety
5360453|NCT01900288|short bowel disorder|short bowel disorder
5360454|NCT01900288|short bowel syndrome|short bowel syndrome
5360455|NCT01900288|home parenteral nutrition|home parenteral nutrition
5360456|NCT01900288|HPN|hpn
5964134|NCT04162444|Aortic Valve Insufficiency/surgery|aortic valve insufficiency/surgery
5964135|NCT04162444|Aortic Valve/surgery|aortic valve/surgery
5964136|NCT04162444|Child|child
5964137|NCT04162444|Reconstructive Surgical Procedures/methods|reconstructive surgical procedures/methods
5964138|NCT04162444|Cardiac Surgical Procedures|cardiac surgical procedures
5964139|NCT04162444|Hemodynamics|hemodynamics
5964140|NCT04162444|Pericardium/transplantation|pericardium/transplantation
5964141|NCT04162444|Transplantation, Autologous|transplantation, autologous
5964142|NCT04162444|Treatment Outcome|treatment outcome
5964143|NCT04162444|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5964144|NCT04162210|Belantamab mafodotin|belantamab mafodotin
5360457|NCT01900288|total parenteral nutrition|total parenteral nutrition
5360458|NCT01900288|TPN|tpn
5360459|NCT01900288|telehealth|telehealth
5360460|NCT01900288|telemedicine|telemedicine
5360461|NCT01900275|Sepsis|sepsis
5360462|NCT01900275|Trauma|trauma
5360463|NCT01900275|Shock|shock
5360464|NCT01900275|Acute kidney injury|acute kidney injury
5360465|NCT01900275|Heparanase|heparanase
5360466|NCT01900262|Biomechanics|biomechanics
5360467|NCT01900262|Ankle Strength|ankle strength
5360468|NCT01900262|Postural Control|postural control
5360469|NCT01900262|Running Mechanics|running mechanics
5360470|NCT01900236|Patients newly initiating outpatient HIV medical care|patients newly initiating outpatient hiv medical care
5360471|NCT01900210|Criminal justice|criminal justice
5360472|NCT01900210|substance abuse treatment|substance abuse treatment
5360473|NCT01900210|HIV risk behaviors|hiv risk behaviors
5360474|NCT01900158|Phase I|phase i
5360475|NCT01900158|CCA|cca
5360476|NCT01900158|Cholangiocarcinoma|cholangiocarcinoma
5360477|NCT01900158|bile duct cancer|bile duct cancer
5360478|NCT01900158|klatskin|klatskin
5360479|NCT01900158|perihilar|perihilar
5360480|NCT01900158|Amphinex|amphinex
5360481|NCT01900158|Gemcitabine|gemcitabine
5360482|NCT01900158|Photochemical internalisation|photochemical internalisation
5360483|NCT01900158|Safety|safety
5360484|NCT01900158|Tolerability|tolerability
5360485|NCT01900158|Efficacy|efficacy
5360486|NCT01900158|Cisplatin|cisplatin
5360487|NCT01900158|PCI|pci
5360488|NCT01900158|extrahepatic|extrahepatic
5360489|NCT01900158|local control|local control
5360490|NCT01900158|local tumour treatment|local tumour treatment
5360491|NCT01900158|biliary|biliary
5360492|NCT01900158|fimaporfin|fimaporfin
5360493|NCT01900132|Electrophysiology|electrophysiology
5360494|NCT01900132|Neuromuscular Disease|neuromuscular disease
5360495|NCT01900119|Oral Microbiome|oral microbiome
5360496|NCT01900119|Next Generation Sequencing|next generation sequencing
5360497|NCT01900106|late presenter|late presenter
5360498|NCT01900106|naïve|naïve
5360499|NCT01900106|advanced HIV disease|advanced hiv disease
5360500|NCT01900080|HIV|hiv
5360501|NCT01900080|AIDS|aids
5360502|NCT01900080|Antiretroviral therapy|antiretroviral therapy
5360503|NCT01900080|Retention in care|retention in care
5360504|NCT01900080|Adherence|adherence
5360505|NCT01900080|Cost-effectiveness|cost-effectiveness
5360506|NCT01900054|TAU-284|tau-284
5360507|NCT01900054|Bepotastine besilate|bepotastine besilate
5360508|NCT01900054|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
5360509|NCT01900054|children|children
5360510|NCT01900028|oncology,|oncology,
5360511|NCT01900028|cancer,|cancer,
5360512|NCT01900028|tumour,|tumour,
5360513|NCT01900028|anticancer drug,|anticancer drug,
5360514|NCT01900028|pharmacokinetics,|pharmacokinetics,
5360515|NCT01900028|olaparib,itraconazole,|olaparib,itraconazole,
5360516|NCT01900028|neoplasm,|neoplasm,
5360517|NCT01900028|QT interval|qt interval
5360618|NCT01899586|Peripheral Adaptations|peripheral adaptations
5360525|NCT01899963|Diabetic Macular Edema|diabetic macular edema
5360526|NCT01899963|Telemedicine|telemedicine
5360527|NCT01899963|Teleophthalmology|teleophthalmology
5360528|NCT01899963|Time to Treatment|time to treatment
5360529|NCT01899950|Niemann-Pick disease type C|niemann-pick disease type c
5360530|NCT01899950|Lysosomal disease|lysosomal disease
5360531|NCT01899937|Endothelial dysfunction|endothelial dysfunction
5360532|NCT01899937|Flow mediated dilation|flow mediated dilation
5360533|NCT01899937|Brachial artery flow mediated dilation|brachial artery flow mediated dilation
5360534|NCT01899937|FMD|fmd
5360535|NCT01899898|Refractory epilepsy|refractory epilepsy
5360536|NCT01899898|Dietary therapy|dietary therapy
5360537|NCT01899898|Non-Pharmacological therapy|non-pharmacological therapy
5360538|NCT01899898|Simplified Modified Atkins Diet|simplified modified atkins diet
5360539|NCT01899885|Emergency laparotomy|emergency laparotomy
5360540|NCT01899885|Emergency laparoscopy|emergency laparoscopy
5360541|NCT01899872|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5360542|NCT01899872|Endothelial progenitor cell|endothelial progenitor cell
5360543|NCT01899872|Endothelial function|endothelial function
5360544|NCT01899872|Exercise|exercise
5360545|NCT01899859|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5360546|NCT01899846|Makena|makena
5360547|NCT01899846|Pharmacokinetics|pharmacokinetics
5360548|NCT01899846|Prior preterm delivery|prior preterm delivery
5356257|NCT01920217|SNP|snp
5360549|NCT01899846|Hydroxyprogesterone Caproate|hydroxyprogesterone caproate
5360551|NCT01899833|Coronary Artery Disease|coronary artery disease
5360552|NCT01899833|CAD|cad
5360556|NCT01899768|efficacy|efficacy
5360557|NCT01899768|hypertussive challenge|hypertussive challenge
5360558|NCT01899768|voltage gated sodium channels (VGSC)|voltage gated sodium channels (vgsc)
5360559|NCT01899768|anaesthesia|anaesthesia
5360560|NCT01899768|Safety and tolerability|safety and tolerability
5360561|NCT01899768|capsaicin challenge|capsaicin challenge
5360562|NCT01899768|cough|cough
5360563|NCT01899768|citric acid challenge|citric acid challenge
5360564|NCT01899768|pharmacokinetics|pharmacokinetics
5360565|NCT01899755|monoclonal antibody|monoclonal antibody
5360566|NCT01899755|healthy volunteer|healthy volunteer
5360567|NCT01899755|TNF alpha|tnf alpha
5360568|NCT01899729|plaque psoriasis|plaque psoriasis
5360569|NCT01899729|autoimmune disease|autoimmune disease
5360570|NCT01899729|Toll like receptor|toll like receptor
5360571|NCT01899716|Severe Depression|severe depression
5360572|NCT01899716|Quality of life|quality of life
5360573|NCT01899716|Exercise|exercise
5360574|NCT01899716|BDNF|bdnf
5360575|NCT01899716|TBARS|tbars
5360576|NCT01899703|Intestinal bile acid transport inhibitor|intestinal bile acid transport inhibitor
5360577|NCT01899703|Pruritus|pruritus
5360578|NCT01899703|Primary biliary cirrhosis|primary biliary cirrhosis
5360579|NCT01899703|Ursodeoxycholic acid|ursodeoxycholic acid
5360580|NCT01899703|GSK2330672|gsk2330672
5360581|NCT01899703|Pharmacokinetics|pharmacokinetics
5360582|NCT01899690|breast reconstruction|breast reconstruction
5360583|NCT01899690|cancer|cancer
5360584|NCT01899690|expander|expander
5360585|NCT01899690|antibiotics|antibiotics
5360586|NCT01899690|infection|infection
5360587|NCT01899690|surgical site infection|surgical site infection
5360588|NCT01899690|surgery|surgery
5360589|NCT01899690|oncology|oncology
5360590|NCT01899690|plastic surgery|plastic surgery
5360591|NCT01899677|Symbiotic,cytokines, necrotising enterocolitis|symbiotic,cytokines, necrotising enterocolitis
5360592|NCT01899664|peripheral nerves|peripheral nerves
5360593|NCT01899664|quadriplegia|quadriplegia
5360594|NCT01899664|nerve transfer|nerve transfer
5360595|NCT01899664|surgical procedures, operative|surgical procedures, operative
5360596|NCT01899664|hand|hand
5360597|NCT01899664|upper extremity|upper extremity
5360598|NCT01899664|quality of life|quality of life
5360599|NCT01899651|EEG|eeg
5360600|NCT01899651|Brain|brain
5360601|NCT01899651|Infants|infants
5360602|NCT01899651|Preterm|preterm
5360603|NCT01899651|Hemorrhage|hemorrhage
5360604|NCT01899651|Bleeding|bleeding
5360605|NCT01899625|Obesity|obesity
5360606|NCT01899625|weight loss|weight loss
5360607|NCT01899625|young adults|young adults
5360608|NCT01899612|menopause|menopause
5360609|NCT01899612|vaginal atrophy|vaginal atrophy
5360610|NCT01899612|cytokine|cytokine
5360611|NCT01899612|IL-1beta|il-1beta
5360612|NCT01899612|IL-6|il-6
5360613|NCT01899612|IL-8|il-8
5360614|NCT01899612|TNF-alpha|tnf-alpha
5360615|NCT01899586|Aging|aging
5360616|NCT01899586|Functional Capacity|functional capacity
5360620|NCT01899573|Heart failure|heart failure
5360621|NCT01899573|mitral regurgitation|mitral regurgitation
5360622|NCT01899573|mitral valve|mitral valve
5360623|NCT01899560|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5360624|NCT01899560|positive end expiratory pressure (PEEP)|positive end expiratory pressure (peep)
5360625|NCT01899560|Staircase recruitment maneuver (SRM)|staircase recruitment maneuver (srm)
5360626|NCT01899560|Lung elastance|lung elastance
5360627|NCT01899560|chest wall elastance|chest wall elastance
5360628|NCT01899534|Pregnancy|pregnancy
5360629|NCT01899534|Mental Health|mental health
5360630|NCT01899534|Screening|screening
5360631|NCT01899534|Computer|computer
5360632|NCT01899534|Feasibility|feasibility
5360633|NCT01899521|alcoholism|alcoholism
5360634|NCT01899521|lung health|lung health
5360635|NCT01899521|pulmonary|pulmonary
5360636|NCT01899521|macrophage|macrophage
5360638|NCT01899521|SAMe|same
5360639|NCT01899521|S-adenosylmethionine|s-adenosylmethionine
5360640|NCT01899521|alveolar|alveolar
5360641|NCT01899495|blood pressure|blood pressure
5360642|NCT01899495|hypertension|hypertension
5360643|NCT01899495|salt sensitivity|salt sensitivity
5360644|NCT01899482|Venous Insufficiency|venous insufficiency
5360645|NCT01899482|Physical Therapy Techniques|physical therapy techniques
5360646|NCT01899482|Manual Lymphatic Drainage|manual lymphatic drainage
5360647|NCT01899443|total hip replacement|total hip replacement
5360648|NCT01899443|total knee replacement|total knee replacement
5360649|NCT01899443|patient outcomes|patient outcomes
5360650|NCT01899443|health services research|health services research
5360651|NCT01899430|PCOS|pcos
5360652|NCT01899430|obesity|obesity
5360653|NCT01899430|GLP-1 receptor agonist|glp-1 receptor agonist
5360654|NCT01899430|liraglutide|liraglutide
5360655|NCT01899430|metformin|metformin
5360656|NCT01899417|osteoarthritis|osteoarthritis
5360657|NCT01899417|knee replacement|knee replacement
5360658|NCT01899417|patient-specific|patient-specific
5360668|NCT01899339|submassive pulmonary embolism|submassive pulmonary embolism
5360669|NCT01899339|Ultrasonic energy|ultrasonic energy
5360670|NCT01899339|Ekosonic Endovascular Device|ekosonic endovascular device
5360671|NCT01899339|RV:LV function after Pulmonary Embolism|rv:lv function after pulmonary embolism
5360672|NCT01899313|methamphetamine dependence|methamphetamine dependence
5360674|NCT01899313|short message service|short message service
5360675|NCT01899313|addiction|addiction
5360676|NCT01899313|amphetamine|amphetamine
5360677|NCT01899313|outpatient|outpatient
5360678|NCT01899300|Refractory Benign Esophageal Strictures caused by Caustic Ingestion|refractory benign esophageal strictures caused by caustic ingestion
5360679|NCT01899287|workers education|workers education
5227295|NCT02579382|HBV|hbv
5360680|NCT01899287|occupational|occupational
5360681|NCT01899209|Obstructed Defecation|obstructed defecation
5360682|NCT01899209|Rectal rectocele|rectal rectocele
5360683|NCT01899209|Intussusception|intussusception
5360684|NCT01899209|STARR|starr
5360685|NCT01899209|Ventral Rectopexy|ventral rectopexy
5360686|NCT01899196|Cardiac surgery|cardiac surgery
5360687|NCT01899183|Chronic cough|chronic cough
5360688|NCT01899183|Esophagus|esophagus
5360689|NCT01899183|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
5360690|NCT01899183|Esophageal surgery|esophageal surgery
5360691|NCT01899183|Minimally invasive surgery|minimally invasive surgery
5360692|NCT01899183|Extra-esophageal reflux symptoms.|extra-esophageal reflux symptoms.
5360693|NCT01899170|deep brain stimulation|deep brain stimulation
5680234|NCT00578578|hsCRP|hscrp
5680235|NCT00578578|CAD|cad
5360694|NCT01899170|multi-coil transcranial magnetic stimulation|multi-coil transcranial magnetic stimulation
5360696|NCT01899170|personalized treatment|personalized treatment
5360697|NCT01899157|Nutritional status|nutritional status
5360698|NCT01899157|Nutritional situation|nutritional situation
5360699|NCT01899144|Albuterol Spiromax|albuterol spiromax
5360700|NCT01899144|ProAir HFA|proair hfa
5360701|NCT01899144|albuterol sulfate|albuterol sulfate
5360702|NCT01899131|dental implants|dental implants
5360703|NCT01899131|crestal bone|crestal bone
5360704|NCT01899131|gingival margin|gingival margin
5360705|NCT01899118|locally advanced rectal cancer|locally advanced rectal cancer
5360706|NCT01899118|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5360707|NCT01899118|Nimotuzumab|nimotuzumab
5360708|NCT01899092|Genotype 1|genotype 1
5360709|NCT01899092|Chronic Hepatitis C|chronic hepatitis c
5360710|NCT01899092|CHC|chc
5360711|NCT01899092|HCV|hcv
5360712|NCT01899092|Hepatitis|hepatitis
5360713|NCT01899092|RNAi|rnai
5360714|NCT01899092|shRNA|shrna
5360715|NCT01899092|ddRNAi|ddrnai
5360716|NCT01899092|AAV8|aav8
5360718|NCT01899092|Adeno-associated virus|adeno-associated virus
5360719|NCT01899092|Adeno-associated viral vectors|adeno-associated viral vectors
5360720|NCT01899079|Breast Cancer|breast cancer
5360721|NCT01899079|Prosigna|prosigna
5360722|NCT01899079|FFPE|ffpe
5360723|NCT01899079|node negative|node negative
5360724|NCT01899079|estrogen receptor positive|estrogen receptor positive
5360725|NCT01899079|HER2 negative|her2 negative
5360726|NCT01899066|Efficacy|efficacy
5360727|NCT01899053|Drug Therapy|drug therapy
5360728|NCT01899053|TAK-228|tak-228
5360729|NCT01899053|TAK-117|tak-117
5360730|NCT01899040|neuromodulation|neuromodulation
5360731|NCT01899040|migraine headache|migraine headache
5360732|NCT01899027|Arterial hypertension|arterial hypertension
5360733|NCT01899027|Radiofrequency ablation|radiofrequency ablation
5360734|NCT01899027|Renal function|renal function
5360735|NCT01899001|Polycystic Ovary Syndrome|polycystic ovary syndrome
5360736|NCT01899001|PCOS|pcos
5360737|NCT01899001|Depression|depression
5360738|NCT01899001|Anxiety|anxiety
5360739|NCT01899001|Weight loss|weight loss
5360740|NCT01899001|Exercise|exercise
5360741|NCT01899001|Nutrition|nutrition
5360742|NCT01899001|Therapy|therapy
5360743|NCT01899001|Mood symptoms|mood symptoms
5360744|NCT01899001|Stress|stress
5360745|NCT01898975|Neurosurgical patients|neurosurgical patients
5360746|NCT01898975|Fluid loading|fluid loading
5360747|NCT01898975|Fluid responsiveness|fluid responsiveness
5360748|NCT01898975|NICOM|nicom
5360749|NCT01898975|Stroke volume variation|stroke volume variation
5360750|NCT01898975|Pulse pressure variation|pulse pressure variation
5360751|NCT01898975|Total peripheral resistance|total peripheral resistance
5360752|NCT01898975|Gray zone approach|gray zone approach
5360753|NCT01898962|Oligometastases|oligometastases
5360754|NCT01898962|Metastatic cancer|metastatic cancer
5360755|NCT01898962|Stereotactic radiosurgery|stereotactic radiosurgery
5360756|NCT01898949|Diet-induced thermogenesis|diet-induced thermogenesis
5360757|NCT01898949|Cold-induced thermogenesis|cold-induced thermogenesis
5360758|NCT01898949|Brown adipose tissue|brown adipose tissue
5360759|NCT01898949|Brown fat|brown fat
5360760|NCT01898923|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
5360761|NCT01898845|Neoplasms|neoplasms
5360762|NCT01898832|Cholestasis, pregnant, interleukin 17|cholestasis, pregnant, interleukin 17
5360763|NCT01898819|DEXMEDETOMIDINE|dexmedetomidine
5360764|NCT01898819|intraocular pressure|intraocular pressure
5360765|NCT01898806|Alopecia Areata|alopecia areata
5360767|NCT01898806|Triamcinolone|triamcinolone
5360768|NCT01898767|mild|mild
5360769|NCT01898767|asthma|asthma
5360770|NCT01898767|allergic|allergic
5360771|NCT01898754|Transmitted Drug Resistance|transmitted drug resistance
5360772|NCT01898741|Pancreatic cancer|pancreatic cancer
5964145|NCT04162210|Pomalidomide|pomalidomide
5964146|NCT04162210|Dexamethasone|dexamethasone
5964147|NCT04162210|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5964148|NCT04161755|personalized tumor vaccines|personalized tumor vaccines
5360773|NCT01898741|Radiotherapy|radiotherapy
5360774|NCT01898741|SBRT|sbrt
5360775|NCT01898715|Adrenocortical carcinoma|adrenocortical carcinoma
5964149|NCT04161755|PCVs|pcvs
5964150|NCT04161755|PD-L1 Blocker|pd-l1 blocker
5360776|NCT01898715|Adrenal cancer|adrenal cancer
5360778|NCT01898676|Extended-release divalproex sodium|extended-release divalproex sodium
5360779|NCT01898676|Depakote ER|depakote er
5360780|NCT01898650|craniosynostosis|craniosynostosis
5360781|NCT01898650|sagittal synostosis|sagittal synostosis
5360782|NCT01898650|metopic synostosis|metopic synostosis
5360783|NCT01898650|coronal synostosis|coronal synostosis
5360784|NCT01898650|lambdoid synostosis|lambdoid synostosis
5360785|NCT01898637|pulmonary embolism|pulmonary embolism
5360786|NCT01898637|pulse oximetry|pulse oximetry
5360787|NCT01898637|change in oxygen saturation|change in oxygen saturation
5360788|NCT01898637|hypoxemia|hypoxemia
5360789|NCT01898637|emergency department|emergency department
5360790|NCT01898637|deep inspiration|deep inspiration
5360791|NCT01898637|vital capacity|vital capacity
5360792|NCT01898637|clinical diagnosis|clinical diagnosis
5360793|NCT01898624|mirabegron|mirabegron
5360794|NCT01898624|Overactive Bladder|overactive bladder
5360795|NCT01898624|Betanis®|betanis®
5360796|NCT01898624|glaucoma|glaucoma
5360797|NCT01898611|Frailty|frailty
5360798|NCT01898611|Sarcopenia|sarcopenia
5360799|NCT01898611|Weight Loss|weight loss
5360800|NCT01898611|Exercise|exercise
5360801|NCT01898611|Aging|aging
5360802|NCT01898611|Ghrelin|ghrelin
5360803|NCT01898611|Elderly|elderly
5360804|NCT01898572|Newly Diagnosed Type II Diabetes Mellitus|newly diagnosed type ii diabetes mellitus
5360805|NCT01898572|Carotid Intimae-media Thickness|carotid intimae-media thickness
5360806|NCT01898572|Carotid Plaque|carotid plaque
5360807|NCT01898572|Cardiovascular Disease|cardiovascular disease
5360808|NCT01898559|little cigars|little cigars
5360809|NCT01898559|cigarettes|cigarettes
5360810|NCT01898559|smoking|smoking
5360811|NCT01898546|Ischemic postconditioning|ischemic postconditioning
5360812|NCT01898546|Myocardial Infarction|myocardial infarction
5360813|NCT01898546|Microvascular Obstruction|microvascular obstruction
5360814|NCT01898520|Spasticity|spasticity
5360815|NCT01898507|low nicotine|low nicotine
5360816|NCT01898507|cigarettes|cigarettes
5360817|NCT01898507|NMR|nmr
5360818|NCT01898481|Health care decision making|health care decision making
5360819|NCT01898468|Neuropathic pain symptoms|neuropathic pain symptoms
5360821|NCT01898468|Pericostal Suture Closure Technique|pericostal suture closure technique
5360822|NCT01898468|Post surgical pain|post surgical pain
5360823|NCT01898468|Post thoracotomy pain|post thoracotomy pain
5360824|NCT01898455|Migraine|migraine
5360825|NCT01898455|Cluster headache|cluster headache
5360826|NCT01898455|headache|headache
5360827|NCT01898442|platelet function|platelet function
5360828|NCT01898442|ticagrelor|ticagrelor
5360829|NCT01898442|STEMI|stemi
5360830|NCT01898429|Treatment Resistant Depression|treatment resistant depression
5360831|NCT01898429|Treatment Refractory Depression|treatment refractory depression
5360832|NCT01898429|Treatment Resistant Bipolar Disorder|treatment resistant bipolar disorder
5360833|NCT01898429|Treatment Refractory Bipolar Disorder|treatment refractory bipolar disorder
5360834|NCT01898429|Deep brain stimulation|deep brain stimulation
5360835|NCT01898429|DBS|dbs
5360836|NCT01898390|Parkinson's Disease|parkinson's disease
5360837|NCT01898390|Allo-Transplantation|allo-transplantation
5360838|NCT01898390|Fetal Ventral Mesencephalic Tissue|fetal ventral mesencephalic tissue
5360839|NCT01898377|Children|children
5360840|NCT01898377|Chronic graft-versus-host disease|chronic graft-versus-host disease
5360841|NCT01898351|Alternative sources of plant proteins|alternative sources of plant proteins
5360842|NCT01898351|High protein diets|high protein diets
5360843|NCT01898351|Satiety|satiety
5360844|NCT01898351|Postprandial effects|postprandial effects
5360845|NCT01898351|Bioactive phytochemicals|bioactive phytochemicals
5360846|NCT01898351|Phytochemicals bioactivity and metabolism|phytochemicals bioactivity and metabolism
5256094|NCT02411877|Mild hypothermia|mild hypothermia
5360850|NCT01898351|Satiety of meals rich in plant proteins|satiety of meals rich in plant proteins
5360851|NCT01898351|Postprandial effects of meals rich in plant proteins|postprandial effects of meals rich in plant proteins
5360852|NCT01898351|Plant phytochemicals and macronutrients bioavailability and metabolism|plant phytochemicals and macronutrients bioavailability and metabolism
5360854|NCT01898338|bacteremia|bacteremia
5360855|NCT01898338|therapy|therapy
5360856|NCT01898325|Fibrosis|fibrosis
5360857|NCT01898325|Gaucher disease|gaucher disease
5360858|NCT01898299|Schizophrenia|schizophrenia
5360859|NCT01898286|C peptide|c peptide
5360860|NCT01898286|beta cell function|beta cell function
5360861|NCT01898286|immune modulation of type 1 diabetes|immune modulation of type 1 diabetes
5360862|NCT01898286|immune intervention in type 1 diabetes|immune intervention in type 1 diabetes
5360863|NCT01898273|Glioma|glioma
5360864|NCT01898273|Glioblastoma Multiforme|glioblastoma multiforme
5360865|NCT01898273|PET|pet
5360866|NCT01898273|Imaging|imaging
5360867|NCT01898273|Radiopharmaceutical|radiopharmaceutical
5360868|NCT01898273|Diagnostic|diagnostic
5360869|NCT01898260|contact lenses|contact lenses
5360870|NCT01898260|daily disposable contact lenses|daily disposable contact lenses
5360871|NCT01898260|silicone hydrogel|silicone hydrogel
5360872|NCT01898260|contact lens comfort|contact lens comfort
5360873|NCT01898260|near-sighted|near-sighted
5360874|NCT01898247|Thoracentesis|thoracentesis
5360875|NCT01898247|Simulation Based Mastery Learning|simulation based mastery learning
5360876|NCT01898247|Medical Education|medical education
5360877|NCT01898247|Length of Stay|length of stay
5360878|NCT01898247|Cost of Care|cost of care
5360879|NCT01898234|Hemodynamics|hemodynamics
5360880|NCT01898234|intradialytic hypotension|intradialytic hypotension
5360881|NCT01898234|subjective tolerance|subjective tolerance
5360882|NCT01898234|dialysis membranes|dialysis membranes
5360883|NCT01898234|high flux|high flux
5360884|NCT01898234|low flux|low flux
5360885|NCT01898234|hemodialysis|hemodialysis
5360886|NCT01898208|Bacteremia|bacteremia
5360887|NCT01898208|Fungemia|fungemia
5360888|NCT01898208|Bloodstream infection|bloodstream infection
5360889|NCT01898208|susceptibility|susceptibility
5360890|NCT01898208|MRSA|mrsa
5360891|NCT01898208|VRE|vre
5360892|NCT01898143|Whole body vibration, cardiorespiratory response|whole body vibration, cardiorespiratory response
5360895|NCT01898104|rectal|rectal
5360896|NCT01898104|low risk|low risk
5360897|NCT01898104|moderate risk|moderate risk
5360898|NCT01898091|Oral|oral
5360899|NCT01898091|Mucositis|mucositis
5360900|NCT01898091|Stomatitis|stomatitis
5360901|NCT01898091|Radiotherapy|radiotherapy
5360902|NCT01898078|MLN8237|mln8237
5360903|NCT01898078|Alisertib|alisertib
5360904|NCT01898078|Food effects|food effects
5360905|NCT01898065|Hypoxia|hypoxia
5360906|NCT01898065|radiotherapy|radiotherapy
5360907|NCT01898065|PET with 18-F-MISO|pet with 18-f-miso
5360908|NCT01898065|MRI|mri
5360909|NCT01898052|pain control|pain control
5360910|NCT01898052|periarticular injection|periarticular injection
5360911|NCT01898052|Total knee arthroplasty|total knee arthroplasty
5360912|NCT01898052|levobupivacaine|levobupivacaine
5360913|NCT01898052|multimodal drug injection|multimodal drug injection
5360915|NCT01898039|vaccine|vaccine
5360916|NCT01898039|cell line|cell line
5360917|NCT01898039|high risk|high risk
5360918|NCT01898039|residual disease|residual disease
5360919|NCT01898026|PGX|pgx
5360920|NCT01898026|fibre|fibre
5360921|NCT01898026|postprandial glycemia|postprandial glycemia
5360922|NCT01898013|pain|pain
5360923|NCT01898013|pregnenolone|pregnenolone
5360924|NCT01898013|Veterans|veterans
5360925|NCT01898013|clinical trial|clinical trial
5360926|NCT01898013|neurosteroid|neurosteroid
5360927|NCT01898013|allopregnanolone|allopregnanolone
5360928|NCT01898013|low back|low back
5360929|NCT01898013|placebo controlled|placebo controlled
5360930|NCT01898013|randomized|randomized
5360931|NCT01898013|musculoskeletal|musculoskeletal
5360932|NCT01898000|Gingivitis|gingivitis
5360933|NCT01898000|Herbal medicine|herbal medicine
5360934|NCT01898000|Plaque control|plaque control
5360935|NCT01897987|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
5360936|NCT01897987|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5360937|NCT01897987|Premature infants|premature infants
5360938|NCT01897935|Uveitis|uveitis
5360939|NCT01897896|Chorea|chorea
5360940|NCT01897896|Huntington Disease|huntington disease
5360941|NCT01897870|continuity of care|continuity of care
5360942|NCT01897870|medicines management|medicines management
5360943|NCT01897870|home visit|home visit
5360944|NCT01897870|drug-related problems|drug-related problems
5360945|NCT01897857|diabetes mellitus(DM)|diabetes mellitus(dm)
5360946|NCT01897857|radial artery cannulation|radial artery cannulation
5360947|NCT01897857|artery blood flow|artery blood flow
5360948|NCT01897857|complication|complication
5360949|NCT01897857|End stage renal disease undergoing kidney transplantation|end stage renal disease undergoing kidney transplantation
5360950|NCT01897844|volunteers|volunteers
5445481|NCT01521546|aldosterone antagonist|aldosterone antagonist
5360951|NCT01897831|Piperacillin Sodium and sulbactam sodium|piperacillin sodium and sulbactam sodium
5360952|NCT01897831|Phase IV clinical studies|phase iv clinical studies
5360953|NCT01897831|Respiratory and urinary tract infections|respiratory and urinary tract infections
5360954|NCT01897805|Coronary artery disease|coronary artery disease
5360955|NCT01897766|Genotropin|genotropin
5360956|NCT01897766|Somatropin|somatropin
5360957|NCT01897766|Long Term Follow-Up|long term follow-up
5360958|NCT01897766|Special Investigation|special investigation
5360959|NCT01897766|Small for Gestational Age|small for gestational age
5360961|NCT01897753|SGA|sga
5360962|NCT01897753|Growth hormone|growth hormone
5360963|NCT01897740|sildenafil|sildenafil
5360964|NCT01897740|pulmonary arterial hypertension|pulmonary arterial hypertension
5360965|NCT01897740|PAH|pah
5360966|NCT01897727|sleep apnea|sleep apnea
5360967|NCT01897727|hypertension|hypertension
5360968|NCT01897727|aldosterone|aldosterone
5360969|NCT01897727|hyperaldosteronism|hyperaldosteronism
5360970|NCT01897727|spironolactone|spironolactone
5360971|NCT01897727|blood pressure|blood pressure
5964151|NCT04161755|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5964152|NCT04161755|19-039|19-039
5964153|NCT04161079|Mitral valve|mitral valve
5360972|NCT01897727|resistant|resistant
5360973|NCT01897701|H7N9|h7n9
5360974|NCT01897688|Diabetes|diabetes
5360975|NCT01897688|Islet|islet
5964154|NCT04161079|Mitral surgery|mitral surgery
5964155|NCT04161079|Mitral repair|mitral repair
5360976|NCT01897688|Pancreas|pancreas
5360977|NCT01897688|Hypoglycemia|hypoglycemia
5360978|NCT01897688|T1D|t1d
5360979|NCT01897688|Transplant|transplant
5360980|NCT01897675|Cutaneous Abscess|cutaneous abscess
5360981|NCT01897675|Emergency Department|emergency department
5360982|NCT01897662|overweight|overweight
5360983|NCT01897662|satiety|satiety
5360984|NCT01897662|functional food|functional food
5360985|NCT01897662|food intake|food intake
5360986|NCT01897662|digestive tolerance|digestive tolerance
5360987|NCT01897649|functional food|functional food
5360988|NCT01897649|digestive tolerance|digestive tolerance
5360989|NCT01897649|microbiota|microbiota
5360990|NCT01897649|bifidogenic effect|bifidogenic effect
5680236|NCT00578565|Rheumatoid Arthritis|rheumatoid arthritis
5360991|NCT01897636|endoscopic ultrasound-guided fine-needle injection|endoscopic ultrasound-guided fine-needle injection
5360992|NCT01897636|dendritic cell|dendritic cell
5360994|NCT01897610|Immuncell-LC, advanced hepatocellular carcinoma|immuncell-lc, advanced hepatocellular carcinoma
5360995|NCT01897584|laparoscopy, Trendelenburg Position, ventilation|laparoscopy, trendelenburg position, ventilation
5360996|NCT01897545|Arterial hypertension|arterial hypertension
5360997|NCT01897545|Atrial Fibrillation|atrial fibrillation
5360998|NCT01897545|Percutaneous renal denervation|percutaneous renal denervation
5360999|NCT01897519|High risk surgery|high risk surgery
5361000|NCT01897519|Acute Kidney Injury|acute kidney injury
5361001|NCT01897506|Food insecurity|food insecurity
5361002|NCT01897506|Health literacy|health literacy
5361003|NCT01897506|Quality of life|quality of life
5361004|NCT01897402|Central Nervous System Infections|central nervous system infections
5361005|NCT01897402|Meningitis|meningitis
5361006|NCT01897402|toxoid|toxoid
5361007|NCT01897402|Meningococcal vaccine|meningococcal vaccine
5361008|NCT01897402|conjugate vaccines|conjugate vaccines
5361009|NCT01897389|Healthy volunteers|healthy volunteers
5361010|NCT01897389|Bioavailability|bioavailability
5361011|NCT01897389|Abiraterone acetate|abiraterone acetate
5361012|NCT01897389|ZYTIGA|zytiga
5361014|NCT01897376|infection|infection
5361015|NCT01897376|cesarean delivery|cesarean delivery
5361016|NCT01897376|obesity|obesity
5361017|NCT01897363|Prader Willi Syndrome|prader willi syndrome
5361018|NCT01897363|Hypoglycemia|hypoglycemia
5361019|NCT01897363|Fasting study|fasting study
5361020|NCT01897350|STEMI|stemi
5361021|NCT01897350|Myocardial edema|myocardial edema
5361022|NCT01897350|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
5361023|NCT01897324|Poor Ovarian Response|poor ovarian response
5361024|NCT01897324|Poor Responders|poor responders
5361025|NCT01897324|IVF/ICSI|ivf/icsi
5361026|NCT01897324|Growth Hormone|growth hormone
5361027|NCT01897311|cesarean section|cesarean section
5361028|NCT01897311|pain|pain
5361029|NCT01897311|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5361030|NCT01897311|postpartum period|postpartum period
5361031|NCT01897298|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5361032|NCT01897298|urban training|urban training
5361033|NCT01897298|physical activity|physical activity
5361034|NCT01897298|active aging|active aging
5361035|NCT01897285|Performance and safety of the AQUACEL® foam adhesive dressing|performance and safety of the aquacel® foam adhesive dressing
5361036|NCT01897272|carpal tunnel syndrome|carpal tunnel syndrome
5361037|NCT01897272|splinting|splinting
5361038|NCT01897272|nerve decompression|nerve decompression
5361039|NCT01897259|tennis elbow|tennis elbow
5361040|NCT01897259|lateral epicondylitis|lateral epicondylitis
5361041|NCT01897246|distal radius malunion|distal radius malunion
5361042|NCT01897246|extra-articular|extra-articular
5361043|NCT01897220|Noncardiac surgery;|noncardiac surgery;
5361044|NCT01897220|Perioperative ischemic complications;|perioperative ischemic complications;
5361045|NCT01897220|Perioperative bleeding complications;|perioperative bleeding complications;
5361046|NCT01897220|Antithrombotic therapy;|antithrombotic therapy;
5361047|NCT01897220|Coronary artery disease;|coronary artery disease;
5361048|NCT01897220|Stent thrombosis;|stent thrombosis;
5361049|NCT01897220|Perioperative infarction.|perioperative infarction.
5361050|NCT01897207|prostate cancer|prostate cancer
5361051|NCT01897207|dendritic cells|dendritic cells
5361052|NCT01897207|vaccination|vaccination
5361053|NCT01897181|Central auditory processing|central auditory processing
5361054|NCT01897181|Bilateral sensorineural hearing loss|bilateral sensorineural hearing loss
5361055|NCT01897181|Hearing aids|hearing aids
5361056|NCT01897155|analgesia, postoperative;|analgesia, postoperative;
5361057|NCT01897155|analgesics opioid;|analgesics opioid;
5361058|NCT01897155|hyperalgesia;|hyperalgesia;
5361059|NCT01897155|remifentanil;|remifentanil;
5361060|NCT01897155|hypertension.|hypertension.
5361061|NCT01897103|Peripheral Artery Disease|peripheral artery disease
5964156|NCT04161079|Mitral annuloplasty|mitral annuloplasty
5964157|NCT04161079|Mitral valve surgery|mitral valve surgery
5964158|NCT04161079|Mitral valve repair|mitral valve repair
5964159|NCT04161079|Mitral valve annuloplasty|mitral valve annuloplasty
5964160|NCT04160494|D2C7|d2c7
5964161|NCT04160494|D2C7-IT|d2c7-it
5964162|NCT04160494|Atezolizumab|atezolizumab
5964163|NCT04160494|Randazzo|randazzo
5964164|NCT04160494|Glioblastoma|glioblastoma
5964165|NCT04160494|Glioma|glioma
5964166|NCT04160494|Bigner|bigner
5361062|NCT01897103|Endarterectomy (Carotid)|endarterectomy (carotid)
5361063|NCT01897103|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5361064|NCT01897103|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
5361065|NCT01897103|Amputation|amputation
5361066|NCT01897103|Platelet Activity|platelet activity
5361067|NCT01897103|Thrombin|thrombin
5361068|NCT01897103|Transcriptomics|transcriptomics
5361069|NCT01897090|Elimination Diet|elimination diet
5361070|NCT01897090|Crohn's disease|crohn's disease
5361071|NCT01897077|Food Allergy|food allergy
5361072|NCT01897077|Peanut|peanut
5361073|NCT01897077|Sublingual Immunotherapy|sublingual immunotherapy
5361074|NCT01897064|Schizophrenia|schizophrenia
5361075|NCT01897064|Cognition|cognition
5361076|NCT01897064|Aerobic Exercise|aerobic exercise
5361077|NCT01897051|Liver cirrhosis|liver cirrhosis
5361078|NCT01897051|Portal hypertension|portal hypertension
5361079|NCT01897051|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5361080|NCT01897051|Rifaximin|rifaximin
5361081|NCT01897025|Stroke|stroke
5361082|NCT01897025|Noninvasive brain stimulation|noninvasive brain stimulation
5361083|NCT01897025|Brain-computer interface|brain-computer interface
5361084|NCT01897025|Motor imagery|motor imagery
5361085|NCT01897025|Rehabilitation|rehabilitation
5361086|NCT01896986|Special risk patients|special risk patients
5361087|NCT01896986|Immunosuppressive biologic treatments|immunosuppressive biologic treatments
5361216|NCT01896245|hoarseness|hoarseness
5361088|NCT01896986|PRD (Paediatric Rheumatological Disease)|prd (paediatric rheumatological disease)
5361089|NCT01896986|IBD (Inflammatory Bowel Disease)|ibd (inflammatory bowel disease)
5361090|NCT01896973|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5361091|NCT01896973|BPH|bph
5361092|NCT01896973|LUTS|luts
5361093|NCT01896973|Vortx Rx|vortx rx
5361094|NCT01896973|Histotripsy|histotripsy
5361095|NCT01896960|Post spinal hypotension|post spinal hypotension
5361096|NCT01896960|Cesarian Section|cesarian section
5361097|NCT01896960|ET50|et50
5361098|NCT01896960|Bupivacaine|bupivacaine
5361099|NCT01896960|Fentanyl|fentanyl
5361100|NCT01896934|Depression|depression
5361101|NCT01896934|Antidepressants|antidepressants
5361102|NCT01896934|Elderly|elderly
5361103|NCT01896934|Geriatrics|geriatrics
5361104|NCT01896921|HIV|hiv
5361105|NCT01896908|diastolic dysfunction|diastolic dysfunction
5361106|NCT01896908|Sodium restriction|sodium restriction
5361107|NCT01896908|Randomized clinical trial|randomized clinical trial
5361108|NCT01896882|Diet, Sodium-Restricted|diet, sodium-restricted
5361109|NCT01896882|Food and Nutrition Education|food and nutrition education
5361110|NCT01896882|Renal Dialyisis|renal dialyisis
5361111|NCT01896869|Pancreatic Cancer|pancreatic cancer
5361112|NCT01896869|Vaccine|vaccine
5361113|NCT01896869|Immunotherapy|immunotherapy
5361114|NCT01896869|Ipilimumab|ipilimumab
5361115|NCT01896869|CTLA-4|ctla-4
5361116|NCT01896869|antibody|antibody
5361117|NCT01896869|FOLFIRINOX|folfirinox
5361118|NCT01896856|SGI-110|sgi-110
5361119|NCT01896856|irinotecan|irinotecan
5361120|NCT01896856|regorafenib|regorafenib
5361121|NCT01896856|methylation|methylation
5361122|NCT01896856|colorectal|colorectal
5361123|NCT01896856|metastatic|metastatic
5361124|NCT01896856|TAS-102|tas-102
5361125|NCT01896856|lonsurf|lonsurf
5361126|NCT01896843|Positron Emission Tomography (PET)|positron emission tomography (pet)
5361127|NCT01896843|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
5361128|NCT01896830|Clostridium difficile infection|clostridium difficile infection
5445482|NCT01521533|Relapsed Multiple Myeloma|relapsed multiple myeloma
5361129|NCT01896830|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
5361130|NCT01896739|Healthy infants with over than 37 weeks gestation periods.|healthy infants with over than 37 weeks gestation periods.
5361131|NCT01896739|over than 2.5Kg at at birth weight.|over than 2.5kg at at birth weight.
5361132|NCT01896713|Prostate Cancer|prostate cancer
5361133|NCT01896713|MRI|mri
5361134|NCT01896713|TRUSBx|trusbx
5361135|NCT01896700|Multiple sclerosis|multiple sclerosis
5361136|NCT01896700|postural balance|postural balance
5361137|NCT01896700|walking|walking
5361138|NCT01896687|nonspecific low back pain|nonspecific low back pain
5361139|NCT01896687|chronic low back pain|chronic low back pain
5361140|NCT01896674|Computed tomography|computed tomography
5361141|NCT01896661|Sleep apnea|sleep apnea
5361142|NCT01896661|Hypertension|hypertension
5361143|NCT01896661|Treatment|treatment
5361144|NCT01896661|Diuretics|diuretics
5361145|NCT01896661|Chlorthalidone|chlorthalidone
5361146|NCT01896661|Amlodipine|amlodipine
5361147|NCT01896635|Ulcerative Colitis|ulcerative colitis
5361148|NCT01896635|Inflammatory Bowel Disease|inflammatory bowel disease
5361149|NCT01896635|Fecal Transplantation|fecal transplantation
5361150|NCT01896635|Fecal Microbiota Transplantation|fecal microbiota transplantation
5361151|NCT01896622|Dabigatran Etexilate|dabigatran etexilate
5361152|NCT01896622|Ritonavir|ritonavir
5361153|NCT01896622|Cobicistat|cobicistat
5361154|NCT01896622|P-Glycoprotein|p-glycoprotein
5361155|NCT01896609|Chronic hepatitis c|chronic hepatitis c
5361156|NCT01896609|Egyptian population|egyptian population
5964167|NCT04160494|Pro00101898|pro00101898
5964168|NCT04160494|Genentech|genentech
5964169|NCT04160494|CTEP|ctep
5964170|NCT04160494|Duke|duke
5361157|NCT01896609|Reiferon Retard|reiferon retard
5361158|NCT01896609|Ribavirin|ribavirin
5361159|NCT01896609|Nitazoxanide|nitazoxanide
5361160|NCT01896609|Bon one|bon one
5361161|NCT01896596|vaccines|vaccines
5361162|NCT01896596|immunogenicity|immunogenicity
5361163|NCT01896596|adverse reactions|adverse reactions
5361164|NCT01896570|atrial fibrillation|atrial fibrillation
5361165|NCT01896570|catheter ablation|catheter ablation
5361166|NCT01896570|subsequent atrial tachycardia|subsequent atrial tachycardia
5361167|NCT01896570|mechanisms|mechanisms
5361168|NCT01896557|clopidogrel|clopidogrel
5361169|NCT01896557|omeprazole|omeprazole
5361170|NCT01896557|ranitidin|ranitidin
5361171|NCT01896557|interaction|interaction
5361172|NCT01896557|aggregability|aggregability
5361173|NCT01896544|cholecalciferol|cholecalciferol
5361174|NCT01896544|vitamin D|vitamin d
5361175|NCT01896544|sepsis|sepsis
5361176|NCT01896544|infection|infection
5361177|NCT01896518|second hand smoke exposure; children|second hand smoke exposure; children
5361178|NCT01896505|bone|bone
5361179|NCT01896505|soft-tissue|soft-tissue
5361180|NCT01896505|sarcoma|sarcoma
5361181|NCT01896505|KPT-330|kpt-330
5361182|NCT01896505|food|food
5361183|NCT01896505|effects|effects
5361184|NCT01896505|Selinexor|selinexor
5361185|NCT01896492|PCOS,|pcos,
5361186|NCT01896492|NAC,|nac,
5361187|NCT01896492|OVULATION INDUCTION,|ovulation induction,
5361188|NCT01896492|CLOMOPHEN CITRATE|clomophen citrate
5361189|NCT01896479|thyroid cancer|thyroid cancer
5361190|NCT01896479|medullary thyroid cancer|medullary thyroid cancer
5361191|NCT01896466|Fall Risk|fall risk
5361192|NCT01896466|Gait|gait
5361193|NCT01896466|Dynamic Balance|dynamic balance
5361194|NCT01896466|Static Balance|static balance
5361195|NCT01896466|Neuromodulation|neuromodulation
5361196|NCT01896440|Pediatric|pediatric
5361197|NCT01896440|Ondansetron|ondansetron
5361198|NCT01896440|Cardiac repolarization|cardiac repolarization
5361199|NCT01896440|QTc interval|qtc interval
5361200|NCT01896427|Third Molar|third molar
5361201|NCT01896427|Edema|edema
5361202|NCT01896427|pain|pain
5361203|NCT01896427|trismus|trismus
5361204|NCT01896414|Metabolic Syndrome|metabolic syndrome
5361205|NCT01896414|Omega 3 Fish Oil|omega 3 fish oil
5361206|NCT01896401|large bore endovascular catheterization procedures|large bore endovascular catheterization procedures
5361207|NCT01896401|Vascular Closure Device|vascular closure device
5361208|NCT01896388|PTSD/ifenprodil|ptsd/ifenprodil
5361209|NCT01896375|Gutkha|gutkha
5364989|NCT01880151|EEG|eeg
5361210|NCT01896375|Pan masala ban|pan masala ban
5361212|NCT01896375|Smokeless tobacco|smokeless tobacco
5361213|NCT01896349|Psychotherapy, Treatment Resistant Depression, depression|psychotherapy, treatment resistant depression, depression
5361219|NCT01896245|vocal cord injuries|vocal cord injuries
5361220|NCT01896245|sevoflurane|sevoflurane
5361221|NCT01896232|Secondary Hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, CKD, SHPT|secondary hyperparathyroidism, renal, kidney, kidneys, dialysis, hemodialysis, chronic kidney disease, ckd, shpt
5361222|NCT01896219|Medical device|medical device
5361224|NCT01896219|Needle|needle
5361225|NCT01896219|Navigation|navigation
5361226|NCT01896219|IMACTIS-CT®|imactis-ct®
5361227|NCT01896219|Thoraco-abdominal level|thoraco-abdominal level
5361228|NCT01896219|anesthesia needles|anesthesia needles
5361229|NCT01896180|POAG|poag
5361230|NCT01896180|OHT|oht
5361231|NCT01896180|OHTN|ohtn
5361232|NCT01896180|IOP|iop
5361233|NCT01896167|Headache|headache
5361234|NCT01896167|Migraine|migraine
5361235|NCT01896167|Aura|aura
5361236|NCT01896167|Cerebral hemodynamics|cerebral hemodynamics
5361237|NCT01896154|dietary fibers, influenza vaccination, HI titres|dietary fibers, influenza vaccination, hi titres
5361238|NCT01896128|stroke|stroke
5361239|NCT01896128|CVA|cva
5361240|NCT01896128|cerebrovascular accident|cerebrovascular accident
5361241|NCT01896128|hemiparesis|hemiparesis
5361242|NCT01896128|impairment|impairment
5361243|NCT01896128|motor recovery|motor recovery
5361244|NCT01896128|neuroplasticity|neuroplasticity
5361245|NCT01896128|nuvigil|nuvigil
5361247|NCT01896115|Stimulation, implantable pulse generator, deep brain stimulation|stimulation, implantable pulse generator, deep brain stimulation
5361252|NCT01896076|caudal space|caudal space
5361253|NCT01896076|children|children
5361254|NCT01896076|ultrasound evaluation|ultrasound evaluation
5361255|NCT01896063|Electroacupuncture, Sedation|electroacupuncture, sedation
5361256|NCT01896050|Joint pain|joint pain
5361257|NCT01896050|Grip strength|grip strength
5361258|NCT01896050|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5361259|NCT01896037|Spinal cord injury|spinal cord injury
5361260|NCT01896037|Tetraplegia|tetraplegia
5361261|NCT01896037|Quadraplegia|quadraplegia
5361262|NCT01896037|Cholesterol|cholesterol
5361264|NCT01896037|LDL-c|ldl-c
5361265|NCT01896037|Omega-3 fatty acids|omega-3 fatty acids
5361266|NCT01895998|sickle cell disease|sickle cell disease
5361267|NCT01895998|pulmonary hypertension|pulmonary hypertension
5361268|NCT01895998|airway hyperreactivity|airway hyperreactivity
5361269|NCT01895998|acute chest syndrome|acute chest syndrome
5361270|NCT01895959|knee osteoarthritis (OA)|knee osteoarthritis (oa)
5361271|NCT01895959|hyaluronic acid injection|hyaluronic acid injection
5361272|NCT01895946|Advanced solid malignancy, AZD5363,|advanced solid malignancy, azd5363,
5361273|NCT01895946|food effect,|food effect,
5361274|NCT01895946|formulation comparison|formulation comparison
5361275|NCT01895933|Investigational device (chitosan gel)|investigational device (chitosan gel)
5361276|NCT01895933|Wound healing|wound healing
5361277|NCT01895933|Endoscopic sinus surgery|endoscopic sinus surgery
5361278|NCT01895933|SurgiShield|surgishield
5361279|NCT01895920|HIV|hiv
5361280|NCT01895920|Biofilm|biofilm
5361281|NCT01895920|Transmission|transmission
5361282|NCT01895907|Special Olympics|special olympics
5361283|NCT01895907|occupational therapy|occupational therapy
5361284|NCT01895907|SCOPE|scope
5361285|NCT01895907|life participation improvement|life participation improvement
5361286|NCT01895894|Mycophenolate mofetil|mycophenolate mofetil
5361287|NCT01895894|Immunosuppressive Agents|immunosuppressive agents
5361288|NCT01895894|Nephrosis|nephrosis
5361289|NCT01895881|Intracranial Aneurysm|intracranial aneurysm
5361290|NCT01895881|Estradiol|estradiol
5361291|NCT01895868|Ultrasound training|ultrasound training
5361292|NCT01895868|Ultrasound simulation|ultrasound simulation
5361293|NCT01895868|Ultrasound assessment|ultrasound assessment
5361294|NCT01895868|Technology-enhanced learning|technology-enhanced learning
5361295|NCT01895868|virtual reality simulation|virtual reality simulation
5361296|NCT01895842|Leukemia|leukemia
5361297|NCT01895842|Myelodysplastic syndrome|myelodysplastic syndrome
5361299|NCT01895842|Low or intermediate-1 risk|low or intermediate-1 risk
5361300|NCT01895842|Maximum tolerated dose|maximum tolerated dose
5361301|NCT01895842|MTD|mtd
5361302|NCT01895842|Ruxolitinib|ruxolitinib
5361303|NCT01895842|Jakafi|jakafi
5361304|NCT01895842|INCB018424|incb018424
5361305|NCT01895842|INC424|inc424
5361306|NCT01895829|Head and Neck Cancer|head and neck cancer
5361307|NCT01895829|Squamous cell carcinomas of the head and neck|squamous cell carcinomas of the head and neck
5361308|NCT01895829|HNSCC|hnscc
5361309|NCT01895829|Magnetic resonance imaging|magnetic resonance imaging
5361310|NCT01895829|MRI|mri
5361311|NCT01895829|Ferumoxytol|ferumoxytol
5361410|NCT01895556|Demand|demand
5361411|NCT01895530|Probiotics|probiotics
5361312|NCT01895829|Ultra-small superparamagnetic iron oxide nanoparticle|ultra-small superparamagnetic iron oxide nanoparticle
5361313|NCT01895829|USPIO|uspio
5361314|NCT01895829|Contrast agent|contrast agent
5361315|NCT01895829|Dynamic contrast imaging|dynamic contrast imaging
5361316|NCT01895829|DCI|dci
5361317|NCT01895816|male infertility,oligo spermia|male infertility,oligo spermia
5361318|NCT01895803|smoking woman|smoking woman
5361319|NCT01895790|Pancreatic Cancer|pancreatic cancer
5361320|NCT01895790|Pancreatic Duct|pancreatic duct
5361321|NCT01895790|Stent|stent
5361322|NCT01895790|Pancreatic Duct Stent|pancreatic duct stent
5361323|NCT01895790|Cancer|cancer
5361324|NCT01895790|Pain|pain
5361325|NCT01895790|Obstructive Pain|obstructive pain
5361326|NCT01895790|Palliative|palliative
5361327|NCT01895764|ankylosing spondylitis|ankylosing spondylitis
5361328|NCT01895751|Non-ST elevation myocardial infarction (NSTEMI)|non-st elevation myocardial infarction (nstemi)
5361329|NCT01895751|Non-ST elevation acute coronary syndrome (NSTE-ACS)|non-st elevation acute coronary syndrome (nste-acs)
5361330|NCT01895751|Unstable Angina|unstable angina
5361331|NCT01895751|Medical therapy|medical therapy
5361332|NCT01895751|Coronary angiogram|coronary angiogram
5445483|NCT01521533|NOX-A12|nox-a12
5361333|NCT01895751|Percutaneous coronary intervention|percutaneous coronary intervention
5361334|NCT01895751|Coronary artery bypass surgery|coronary artery bypass surgery
5361335|NCT01895751|Coronary revascularization|coronary revascularization
5361336|NCT01895751|Health economics|health economics
5361337|NCT01895738|Trauma|trauma
5361338|NCT01895738|Injuries|injuries
5361339|NCT01895738|Violence|violence
5361340|NCT01895738|Adolescent|adolescent
5361341|NCT01895738|WrapAround care|wraparound care
5361342|NCT01895712|International|international
5357048|NCT01916954|Malaria|malaria
5361345|NCT01895712|Orsiro Drug Eluting Stents (DES)|orsiro drug eluting stents (des)
5361347|NCT01895712|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5361348|NCT01895712|Coronary revascularization|coronary revascularization
5361349|NCT01895712|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5361350|NCT01895712|Diabetes Mellitus Type 1|diabetes mellitus type 1
5361351|NCT01895712|Diabetes Mellitus Type 2|diabetes mellitus type 2
5361352|NCT01895712|STEMI|stemi
5361353|NCT01895712|NSTEMI|nstemi
5361354|NCT01895712|Ischemia|ischemia
5361355|NCT01895712|Angina|angina
5361356|NCT01895712|Subgroups|subgroups
5361357|NCT01895712|Acute Myocardial Infarction|acute myocardial infarction
5361358|NCT01895712|Small vessels|small vessels
5361359|NCT01895712|Chronic Total Occlusion|chronic total occlusion
5361360|NCT01895699|Contrast agent|contrast agent
5361361|NCT01895699|endothelium|endothelium
5361362|NCT01895699|Free radical|free radical
5361363|NCT01895699|Alpha lipoic acid|alpha lipoic acid
5361364|NCT01895686|open angle glaucoma|open angle glaucoma
5361365|NCT01895686|narrow angles|narrow angles
5361366|NCT01895686|angle closure glaucoma|angle closure glaucoma
5361367|NCT01895686|gonioscopy|gonioscopy
5361368|NCT01895686|anterior segment OCT|anterior segment oct
5361369|NCT01895673|FDG-PET|fdg-pet
5361370|NCT01895673|Radiofrequency Ablation|radiofrequency ablation
5361371|NCT01895673|Magnetic Resonance Imaging|magnetic resonance imaging
5361372|NCT01895660|P-CIMT|p-cimt
5361373|NCT01895660|Pediatric Constraint Induced Movement Therapy|pediatric constraint induced movement therapy
5361374|NCT01895660|Hemiparesis|hemiparesis
5361375|NCT01895660|Cerebral Palsy|cerebral palsy
5361376|NCT01895660|Children|children
5361377|NCT01895647|electric muscle stimulation|electric muscle stimulation
5361378|NCT01895647|respiratory failure|respiratory failure
5361379|NCT01895647|sepsis|sepsis
5361380|NCT01895647|interleukin 6|interleukin 6
5361381|NCT01895647|interleukin 15|interleukin 15
5361382|NCT01895634|Ischemia|ischemia
5361383|NCT01895634|Stroke|stroke
5361384|NCT01895634|Ischemic Stroke|ischemic stroke
5361385|NCT01895634|Thrombectomy|thrombectomy
5361386|NCT01895634|Brain clot|brain clot
5361387|NCT01895634|Cerebrovascular disease|cerebrovascular disease
5361388|NCT01895634|Recanalization|recanalization
5361389|NCT01895634|Revascularization|revascularization
5361390|NCT01895634|Clot Retriever|clot retriever
5361391|NCT01895634|Neurovascular Intervention|neurovascular intervention
5361392|NCT01895634|Interventional Neuroradiology|interventional neuroradiology
5361393|NCT01895634|neurovascular clinical trial|neurovascular clinical trial
5361394|NCT01895608|aged or aged 80 and over|aged or aged 80 and over
5361395|NCT01895608|gait disorder|gait disorder
5361396|NCT01895608|attention|attention
5361397|NCT01895595|obesity|obesity
5361398|NCT01895595|stress|stress
5361399|NCT01895595|intuitive eating|intuitive eating
5361400|NCT01895595|guided imagery|guided imagery
5361401|NCT01895595|latinos|latinos
5361402|NCT01895595|adolescents|adolescents
5361403|NCT01895595|insulin resistance|insulin resistance
5361404|NCT01895582|Ageing|ageing
5361405|NCT01895582|Tuberculosis|tuberculosis
5361406|NCT01895582|Interferon gamma releasing tests|interferon gamma releasing tests
5361407|NCT01895556|Malawi|malawi
5361408|NCT01895556|Risk Compensation|risk compensation
5361409|NCT01895556|Male Circumcision|male circumcision
5361412|NCT01895530|colorectal cancer|colorectal cancer
5361413|NCT01895530|postoperative infection|postoperative infection
5361451|NCT01895361|hepatic sequestration|hepatic sequestration
5361452|NCT01895361|splenic sequestration|splenic sequestration
5361453|NCT01895361|chest syndrome|chest syndrome
5361454|NCT01895361|SCD|scd
5361455|NCT01895322|Tolvaptan|tolvaptan
5361456|NCT01895322|dialysis|dialysis
5361457|NCT01895309|Rheumatoid Arthritis|rheumatoid arthritis
5361458|NCT01895309|Etanercept|etanercept
5361459|NCT01895309|Biosimilar|biosimilar
5361460|NCT01895296|dumping syndrome|dumping syndrome
5361461|NCT01895296|OGTT|ogtt
5361462|NCT01895296|hypoglycemia|hypoglycemia
5361463|NCT01895283|Aerobic training|aerobic training
5361464|NCT01895283|VO2max|vo2max
5361465|NCT01895283|Bethlem myopathy|bethlem myopathy
5361466|NCT01895270|opioid dependence|opioid dependence
5361467|NCT01895270|buprenorphine|buprenorphine
5361468|NCT01895270|isradipine|isradipine
5361469|NCT01895270|opioid withdrawal|opioid withdrawal
5361470|NCT01895270|opioid detoxification|opioid detoxification
5361471|NCT01895257|TTP1|ttp1
5361472|NCT01895257|TTP2|ttp2
5361473|NCT01895257|PFS|pfs
5361474|NCT01895257|Safety|safety
5361475|NCT01895257|R0 resection rate|r0 resection rate
5361476|NCT01895257|Quality of life|quality of life
5361477|NCT01895257|Overall Survival|overall survival
5361482|NCT01895192|sperm morphology|sperm morphology
5361484|NCT01895192|fertile|fertile
5361485|NCT01895192|Motile Sperm Organellar Morphology Examination|motile sperm organellar morphology examination
5361486|NCT01895192|high magnification|high magnification
5361487|NCT01895192|reference values|reference values
5361488|NCT01895179|Time-restricted feeding|time-restricted feeding
5361489|NCT01895179|Intermittent fasting|intermittent fasting
5361490|NCT01895179|Prediabetes|prediabetes
5361491|NCT01895179|Insulin resistance|insulin resistance
5361492|NCT01895179|Glucose tolerance|glucose tolerance
5361493|NCT01895179|Insulin sensitivity|insulin sensitivity
5361494|NCT01895179|Circadian rhythms|circadian rhythms
5361496|NCT01895166|Endobronchial ultrasonography with a guide sheath|endobronchial ultrasonography with a guide sheath
5361497|NCT01895166|Peripheral pulmonary lesions|peripheral pulmonary lesions
5361498|NCT01895166|Transbronchial biopsy|transbronchial biopsy
5361499|NCT01895153|bladder pain syndrome|bladder pain syndrome
5361500|NCT01895153|pentosan polysulfate|pentosan polysulfate
5361501|NCT01895153|hydrodistension|hydrodistension
5361502|NCT01895140|Treatment-resistant hypertension|treatment-resistant hypertension
5361503|NCT01895140|Renal denervation|renal denervation
5361504|NCT01895140|Ambulatory blood pressure|ambulatory blood pressure
5361505|NCT01895127|Kidney Transplant|kidney transplant
5361506|NCT01895127|Renal Transplant|renal transplant
5361507|NCT01895127|Rejection|rejection
5361508|NCT01895127|Antibody mediated|antibody mediated
5361509|NCT01895127|Humoral|humoral
5361510|NCT01895127|Eculizumab|eculizumab
5361804|NCT01893827|Vivitrol|vivitrol
5361511|NCT01895114|Renal function|renal function
5361512|NCT01895114|cirrhotic patients|cirrhotic patients
5361513|NCT01895114|transplant evaluation|transplant evaluation
5361514|NCT01895101|blood loss|blood loss
5361516|NCT01895101|cardiac surgery|cardiac surgery
5361517|NCT01895088|presbyopia|presbyopia
5361518|NCT01895075|Budesonide|budesonide
5361519|NCT01895075|Inhalation|inhalation
5361520|NCT01895075|Premature infants|premature infants
5361521|NCT01895062|colonoscopy|colonoscopy
5361522|NCT01895062|oxygen desaturation|oxygen desaturation
5361523|NCT01895049|Tacrolimus|tacrolimus
5361524|NCT01895049|Everolimus|everolimus
5361525|NCT01895049|Cytomegalovirus|cytomegalovirus
5361526|NCT01895049|Thymoglobulin|thymoglobulin
5361527|NCT01895049|Deceased donors|deceased donors
5361528|NCT01895049|Expanded criteria|expanded criteria
5361529|NCT01895036|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult|maintained on 2 mg or less of buprenorphine, in which discontinuation of agonist treatment is clinically feasible but difficult
5361530|NCT01895010|prevention and treatment|prevention and treatment
5361531|NCT01895010|improvement of the patient's appetite|improvement of the patient's appetite
5361532|NCT01895010|TACE|tace
5361533|NCT01894997|Deep Vein Thrombosis|deep vein thrombosis
5361534|NCT01894997|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5361535|NCT01894997|Intermittent Pneumatic Compression|intermittent pneumatic compression
5361536|NCT01894997|Doppler Ultrasound|doppler ultrasound
5361537|NCT01894984|Schizophrenia|schizophrenia
5361538|NCT01894984|Risperidone|risperidone
5361539|NCT01894984|Risperdal Consta|risperdal consta
5361540|NCT01894984|Oral antipsychotic|oral antipsychotic
5361541|NCT01894958|Fragile X disorder|fragile x disorder
5361542|NCT01894958|Autism|autism
5361543|NCT01894932|Psychotherapy, Group|psychotherapy, group
5361544|NCT01894919|Meningococcal B disease,|meningococcal b disease,
5361545|NCT01894919|Antibody persistence|antibody persistence
5361546|NCT01894906|Soluble Ferric Pyrophosphate,|soluble ferric pyrophosphate,
5361547|NCT01894906|Pharmacokinetics,|pharmacokinetics,
5361548|NCT01894906|Iron, Mass Transfer,|iron, mass transfer,
5361549|NCT01894906|Hemodialysis|hemodialysis
5361550|NCT01894906|chronic therapy;|chronic therapy;
5361551|NCT01894867|LIVER CIRRHOSIS|liver cirrhosis
5361552|NCT01894867|MAGNESIUM|magnesium
5361553|NCT01894867|MINIMAL ENCEPHALOPATHY|minimal encephalopathy
5361554|NCT01894867|MUSCLE WEAKNESS|muscle weakness
5361555|NCT01894854|Radiostereometry|radiostereometry
5361556|NCT01894854|Total Hip Arthroplasty|total hip arthroplasty
5361557|NCT01894854|Stem design|stem design
5361558|NCT01894841|depression|depression
5361559|NCT01894841|prevention|prevention
5361560|NCT01894841|Veterans health|veterans health
5361561|NCT01894828|Nutritional support|nutritional support
5361562|NCT01894828|Gastrointestinal cancer|gastrointestinal cancer
5361563|NCT01894828|Malnutrition|malnutrition
5361564|NCT01894815|major depressive disorder|major depressive disorder
5365388|NCT01878487|Acute MI|acute mi
5361565|NCT01894815|major depression|major depression
5361566|NCT01894815|depressive disorder|depressive disorder
5361567|NCT01894815|major depressive episode|major depressive episode
5361568|NCT01894802|Tetraplegia|tetraplegia
5361569|NCT01894802|Quadriplegia|quadriplegia
5361570|NCT01894802|Spinal cord injury|spinal cord injury
5361571|NCT01894802|Brainstem or spinal stroke|brainstem or spinal stroke
5361572|NCT01894802|Neuroprosthetic|neuroprosthetic
5361573|NCT01894802|Brain-machine interface|brain-machine interface
5361574|NCT01894802|Brain-computer interface|brain-computer interface
5361575|NCT01894802|Neural activity|neural activity
5361576|NCT01894802|Sensory stimulation|sensory stimulation
5361577|NCT01894802|Microstimulation|microstimulation
5357278|NCT01915641|OSA|osa
5361581|NCT01894789|positron emission tomography|positron emission tomography
5361582|NCT01894789|adenosine|adenosine
5361583|NCT01894789|ticagrelor|ticagrelor
5361584|NCT01894789|clopidogrel|clopidogrel
5361585|NCT01894776|healthy volunteers|healthy volunteers
5361586|NCT01894763|esophagus|esophagus
5361587|NCT01894763|cancer|cancer
5361588|NCT01894750|Heart Failure|heart failure
5361589|NCT01894750|Self-Care|self-care
5361590|NCT01894685|Colorectal|colorectal
5361591|NCT01894685|Adenoma|adenoma
5361592|NCT01894685|Recurrence|recurrence
5361593|NCT01894685|Mesalazine|mesalazine
5361594|NCT01894685|Chemoprevention|chemoprevention
5361595|NCT01894672|LGX818|lgx818
5361596|NCT01894672|BRAF Inhibitor|braf inhibitor
5361597|NCT01894672|Stage IV melanoma|stage iv melanoma
5361598|NCT01894672|unresectable stage III melanoma|unresectable stage iii melanoma
5361599|NCT01894672|BRAFV600 mutation|brafv600 mutation
5361600|NCT01894672|13-053|13-053
5361601|NCT01894633|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5361602|NCT01894633|Metastasis|metastasis
5361603|NCT01894633|Cloroquine|cloroquine
5361604|NCT01894620|Alzheimer's|alzheimer's
5361605|NCT01894620|rTMS|rtms
5361606|NCT01894620|sleep quality|sleep quality
5361607|NCT01894620|dementia|dementia
5361608|NCT01894620|memory|memory
5361609|NCT01894607|Kidney Cancer|kidney cancer
5361610|NCT01894607|Renal Mass|renal mass
5361611|NCT01894607|Open partial nephrectomy|open partial nephrectomy
5361612|NCT01894607|Ultrasound-guided surgery|ultrasound-guided surgery
5361614|NCT01894607|Contrast agent|contrast agent
5361615|NCT01894607|Phone call|phone call
5361616|NCT01894594|Sickle cell disease|sickle cell disease
5361617|NCT01894594|Chronic kidney disease|chronic kidney disease
5361618|NCT01894594|Bicarbonate therapy|bicarbonate therapy
5361619|NCT01894555|Platelet Transcriptome|platelet transcriptome
5361620|NCT01894555|Coronary Artery Disease|coronary artery disease
5361621|NCT01894555|Myocardial Ischemia|myocardial ischemia
5361622|NCT01894555|Coronary Disease|coronary disease
5361623|NCT01894555|Heart Diseases|heart diseases
5361624|NCT01894555|Cardiovascular Diseases|cardiovascular diseases
5361625|NCT01894555|Arteriosclerosis|arteriosclerosis
5361626|NCT01894555|Arterial Occlusive Diseases|arterial occlusive diseases
5361627|NCT01894555|Vascular Diseases|vascular diseases
5361629|NCT01894529|ischemic stroke|ischemic stroke
5361630|NCT01894529|immune biomarkers|immune biomarkers
5361631|NCT01894529|stroke-associated infection|stroke-associated infection
5361632|NCT01894529|functional outcome|functional outcome
5361633|NCT01894529|prediction|prediction
5361634|NCT01894490|Gastrointestinal surgery, complications, length of hospital stay, mortality|gastrointestinal surgery, complications, length of hospital stay, mortality
5361635|NCT01894464|truancy|truancy
5361636|NCT01894464|attendance|attendance
5361637|NCT01894464|education|education
5361638|NCT01894464|primary school|primary school
5361639|NCT01894464|elementary school|elementary school
5361640|NCT01894451|Inflammatory Breast Carcinoma|inflammatory breast carcinoma
5361641|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab
5361642|NCT01894438|NAFLD|nafld
5361643|NCT01894438|NASH|nash
5361644|NCT01894438|Mediterranean diet|mediterranean diet
5361645|NCT01894438|Mediterranean lifestyle|mediterranean lifestyle
5361646|NCT01894425|Medically assisted procreation|medically assisted procreation
5361647|NCT01894425|Assisted reproductive technology|assisted reproductive technology
5361648|NCT01894425|Human papilloma virus|human papilloma virus
5361649|NCT01894399|HM61713|hm61713
5361650|NCT01894399|pharmacokinetics|pharmacokinetics
5361651|NCT01894399|Phase I|phase i
5361652|NCT01894399|healthy|healthy
5361653|NCT01894399|olmutinib|olmutinib
5361654|NCT01894386|GW642444 (Vilanterol)|gw642444 (vilanterol)
5361655|NCT01894386|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
5361656|NCT01894386|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
5361657|NCT01894386|pharmacokinetics|pharmacokinetics
5361658|NCT01894386|Healthy subjects|healthy subjects
5361659|NCT01894360|Pharmacokinetics|pharmacokinetics
5361660|NCT01894360|Phase 1|phase 1
5361661|NCT01894360|Healthy Subjects|healthy subjects
5361662|NCT01894360|Comparability|comparability
5361663|NCT01894360|Belimumab|belimumab
5361664|NCT01894347|Colistin, MDR, inhalative therapy|colistin, mdr, inhalative therapy
5361665|NCT01894334|Aortic dissection|aortic dissection
5361666|NCT01894334|acute lung injury|acute lung injury
5361667|NCT01894334|injury mechanism|injury mechanism
5361668|NCT01894334|early intervention|early intervention
5361669|NCT01894321|Acute cholecystitis|acute cholecystitis
5361670|NCT01894321|Elderly|elderly
5361671|NCT01894321|Critically ill patients|critically ill patients
5361672|NCT01894321|Surgical high risk|surgical high risk
5361673|NCT01894321|Percutaneous cholecystostomy|percutaneous cholecystostomy
5361674|NCT01894321|Cholecystectomy|cholecystectomy
5361675|NCT01894308|Male Hormone Replacement|male hormone replacement
5361676|NCT01894308|Multiple Dose|multiple dose
5361677|NCT01894308|Single Period|single period
5361679|NCT01894308|Dose Ranging|dose ranging
5361680|NCT01894308|Adult Male Subjects|adult male subjects
5361681|NCT01894308|Testosterone Replacement|testosterone replacement
5361682|NCT01894295|Vitamin D analogues|vitamin d analogues
5361683|NCT01894295|Resting Metabolic rate|resting metabolic rate
5361684|NCT01894295|obesity|obesity
5361685|NCT01894282|Chronic Lower Back Pain|chronic lower back pain
5361686|NCT01894282|Manual Therapy|manual therapy
5361687|NCT01894282|Cognitive Behavioral Therapy|cognitive behavioral therapy
5361688|NCT01894256|oncology,|oncology,
5361689|NCT01894256|cancer,|cancer,
5361690|NCT01894256|neoplasm,|neoplasm,
5361691|NCT01894256|anticancer drug,|anticancer drug,
5361692|NCT01894256|pharmacokinetics,|pharmacokinetics,
5361693|NCT01894256|area under curve,|area under curve,
5361694|NCT01894256|olaparib,|olaparib,
5361695|NCT01894256|solid tumour,|solid tumour,
5361696|NCT01894256|mild renal impairment,|mild renal impairment,
5361697|NCT01894256|moderate renal impairment|moderate renal impairment
5361698|NCT01894243|oncology,|oncology,
5361699|NCT01894243|cancer,|cancer,
5361700|NCT01894243|neoplasm,|neoplasm,
5361701|NCT01894243|anticancer drug,|anticancer drug,
5361702|NCT01894243|pharmacokinetics,|pharmacokinetics,
5361703|NCT01894243|area under curve,|area under curve,
5361704|NCT01894243|olaparib,|olaparib,
5361705|NCT01894243|solid tumour,|solid tumour,
5361706|NCT01894243|mild hepatic impairment,|mild hepatic impairment,
5361713|NCT01894230|pharmacogenetics|pharmacogenetics
5361714|NCT01894217|high cholesterol|high cholesterol
5361715|NCT01894217|genetic testing|genetic testing
5361716|NCT01894217|medication adherence|medication adherence
5361718|NCT01894217|Adverse Effects|adverse effects
5361719|NCT01894217|Pharmacogenetic|pharmacogenetic
5361720|NCT01894204|HTTPE|httpe
5361721|NCT01894204|Idiopathic Pulmonary embolism|idiopathic pulmonary embolism
5361722|NCT01894191|adenoma detection rate|adenoma detection rate
5361723|NCT01894191|colonoscopy|colonoscopy
5361724|NCT01894191|water exchange|water exchange
5680237|NCT00578565|Interstitial Pneumonia|interstitial pneumonia
5361725|NCT01894165|molybdenum cofactor deficiency (MoCD)|molybdenum cofactor deficiency (mocd)
5361726|NCT01894165|deficiency of activity of molybdenum-dependent enzymes|deficiency of activity of molybdenum-dependent enzymes
5361727|NCT01894152|XIENCE PRIME EECSS|xience prime eecss
5361728|NCT01894152|XIENCE V EECSS|xience v eecss
5361729|NCT01894152|XIENCE PRIME|xience prime
5361730|NCT01894152|SPIRIT PRIME|spirit prime
5361731|NCT01894152|XIENCE PRIME SV (Small Vessel)|xience prime sv (small vessel)
5361732|NCT01894152|XIENCE PRIME LL (Long Lesion)|xience prime ll (long lesion)
5361733|NCT01894152|Coronary Artery Disease|coronary artery disease
5361734|NCT01894152|Coronary Heart Disease|coronary heart disease
5361735|NCT01894152|Cardiovascular Disease|cardiovascular disease
5361736|NCT01894152|Myocardial Infarction|myocardial infarction
5361737|NCT01894152|Stent Thrombosis|stent thrombosis
5361738|NCT01894139|Gestational weight gain|gestational weight gain
5361739|NCT01894139|Obese women|obese women
5361740|NCT01894139|Fetal programming|fetal programming
5361741|NCT01894139|Metabolic disorders|metabolic disorders
5361742|NCT01894139|Development of obesity|development of obesity
5361743|NCT01894139|Development og overweight|development og overweight
5361744|NCT01894139|Complications during pregnancy and birth|complications during pregnancy and birth
5361745|NCT01894113|interstitial lung disease|interstitial lung disease
5361746|NCT01894113|transbronchial biopsy|transbronchial biopsy
5361747|NCT01894113|cryobiopsy|cryobiopsy
5361748|NCT01894074|Subfertility|subfertility
5361749|NCT01894074|Anovulatory|anovulatory
5361750|NCT01894074|Obese|obese
5361751|NCT01894074|Women|women
5361758|NCT01894048|asthma control|asthma control
5361759|NCT01894048|small airways|small airways
5361760|NCT01894048|extra-fine particle inhaled corticosteroids|extra-fine particle inhaled corticosteroids
5361761|NCT01894035|Pulmonary Hypertension|pulmonary hypertension
5361762|NCT01894035|Ventavis|ventavis
5361763|NCT01894035|Patient compliance|patient compliance
5361764|NCT01894022|Inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist|inoperable chronic thromboembolic pulmonary hypertension, endothelin receptor antagonist
5361765|NCT01894009|Osteopathic manipulation|osteopathic manipulation
5361766|NCT01894009|Exercise therapy|exercise therapy
5361767|NCT01894009|Pregnancy pelvic girdle pain|pregnancy pelvic girdle pain
5361768|NCT01893996|rheumatoid|rheumatoid
5361769|NCT01893996|arthritis|arthritis
5361770|NCT01893996|cardiovascular|cardiovascular
5361771|NCT01893996|adalimumab|adalimumab
5361772|NCT01893996|tnf|tnf
5361773|NCT01893996|biologic|biologic
5361774|NCT01893983|Mental Health|mental health
5361775|NCT01893983|Veterans Health|veterans health
5361776|NCT01893983|Rural|rural
5361777|NCT01893983|Motivational Interviewing|motivational interviewing
5361778|NCT01893957|breast cancer|breast cancer
5361779|NCT01893957|physical therapy|physical therapy
5361780|NCT01893957|electrical stimulation|electrical stimulation
5361781|NCT01893957|tactile sensitivity|tactile sensitivity
5361782|NCT01893957|flow blood|flow blood
5361783|NCT01893944|Breast cancer|breast cancer
5361784|NCT01893944|vibratory therapy|vibratory therapy
5361785|NCT01893944|virtual reality|virtual reality
5361786|NCT01893931|Geriatrics|geriatrics
5361787|NCT01893931|Emergency Medicine|emergency medicine
5361788|NCT01893931|Care Transitions|care transitions
5361789|NCT01893918|Smoking|smoking
5361790|NCT01893918|Dyspnea|dyspnea
5361791|NCT01893892|Basal Cell Carcinoma|basal cell carcinoma
5361792|NCT01893892|Gorlin syndrome|gorlin syndrome
5361793|NCT01893892|Erivedge|erivedge
5361794|NCT01893892|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5361795|NCT01893853|dehydration|dehydration
5361796|NCT01893853|fluid balance|fluid balance
5361797|NCT01893853|exercise|exercise
5361798|NCT01893853|heat|heat
5361799|NCT01893853|body weight|body weight
5361800|NCT01893853|performance|performance
5361801|NCT01893827|Naltrexone|naltrexone
5361802|NCT01893827|Extended-release naltrexone|extended-release naltrexone
5361803|NCT01893827|Oral naltrexone|oral naltrexone
5361806|NCT01893827|alcohol dependence|alcohol dependence
5361807|NCT01893827|primary care|primary care
5361808|NCT01893827|Medical Management|medical management
5361809|NCT01893801|pancreatic cancer|pancreatic cancer
5361810|NCT01893801|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5361811|NCT01893801|Stage IV pancreatic cancer|stage iv pancreatic cancer
5361812|NCT01893801|pancreas|pancreas
5361813|NCT01893801|pancreatic|pancreatic
5361814|NCT01893788|hypertension|hypertension
5361815|NCT01893788|left ventricular hypertrophy|left ventricular hypertrophy
5361816|NCT01893788|renin angiotensin system|renin angiotensin system
5361817|NCT01893788|aldosterone|aldosterone
5361818|NCT01893788|aliskiren|aliskiren
5361819|NCT01893788|eplerenone|eplerenone
5361820|NCT01893788|P3NP|p3np
5361821|NCT01893775|Anti CD 122|anti cd 122
5361822|NCT01893775|Monoclonal Antibody Therapy|monoclonal antibody therapy
5361823|NCT01893775|Autoimmune Inflammatory Enteropathy|autoimmune inflammatory enteropathy
5361824|NCT01893762|neutrophil|neutrophil
5361825|NCT01893762|exercise|exercise
5361826|NCT01893762|URTI|urti
5361827|NCT01893762|Innate|innate
5361828|NCT01893762|Immune|immune
5361829|NCT01893749|depression|depression
5361830|NCT01893749|prevention|prevention
5361831|NCT01893749|teen|teen
5361832|NCT01893749|at risk|at risk
5361833|NCT01893749|internet|internet
5361834|NCT01893736|Breastfeeding|breastfeeding
5361835|NCT01893736|professional support|professional support
5361836|NCT01893736|postnatal|postnatal
5361837|NCT01893736|interventions|interventions
5361838|NCT01893736|exclusive breastfeeding|exclusive breastfeeding
5361839|NCT01893736|randomized controlled trial|randomized controlled trial
5361840|NCT01893723|autonomous nervous system monitoring|autonomous nervous system monitoring
5361841|NCT01893723|analgesia nociception balance|analgesia nociception balance
5361842|NCT01893723|remifentanil|remifentanil
5361843|NCT01893723|analgesia nociception index|analgesia nociception index
5361844|NCT01893723|hemodynamic reactivity|hemodynamic reactivity
5361845|NCT01893710|peritoneal dialysis|peritoneal dialysis
5361846|NCT01893710|parietal peritoneum|parietal peritoneum
5361847|NCT01893710|omentum|omentum
5361848|NCT01893710|chronic kidney disease|chronic kidney disease
5361849|NCT01893710|vasculopathy|vasculopathy
5361850|NCT01893684|protein|protein
5361851|NCT01893684|physical function|physical function
5361852|NCT01893684|muscle quality|muscle quality
5361853|NCT01893684|fatigue|fatigue
5361854|NCT01893684|weight loss|weight loss
5361855|NCT01893671|LASIK|lasik
5361856|NCT01893671|corneal power|corneal power
5361857|NCT01893671|astigmatism|astigmatism
5361859|NCT01893671|Optical Coherence Tomography|optical coherence tomography
5361860|NCT01893658|Interstitial Nephritis|interstitial nephritis
5361861|NCT01893658|Nephritis|nephritis
5361862|NCT01893658|Tubulointerstitial|tubulointerstitial
5361863|NCT01893658|Renal disease|renal disease
5361864|NCT01893658|Kidney|kidney
5361865|NCT01893645|Pronto-7|pronto-7
5361866|NCT01893645|SpHb|sphb
5361867|NCT01893645|Obstetric patients|obstetric patients
5361868|NCT01893632|Benzodiazepines|benzodiazepines
5361869|NCT01893632|clonazepam|clonazepam
5361870|NCT01893632|alprazolam|alprazolam
5361871|NCT01893632|Klonopin|klonopin
5361872|NCT01893632|Xanax|xanax
5361873|NCT01893632|diazepam|diazepam
5361874|NCT01893632|Valium|valium
5361875|NCT01893632|lorazepam|lorazepam
5361876|NCT01893632|Ativan|ativan
5361877|NCT01893619|Chronic fatigue syndrome|chronic fatigue syndrome
5361878|NCT01893619|Karnofsky score|karnofsky score
5361879|NCT01893619|supplements|supplements
5361880|NCT01893606|diarrhea|diarrhea
5361881|NCT01893606|abdominal pain|abdominal pain
5361882|NCT01893593|Cardiovascular risk|cardiovascular risk
5361883|NCT01893593|lifestyle change|lifestyle change
5361884|NCT01893593|blood pressure|blood pressure
5361885|NCT01893593|body mass index|body mass index
5361886|NCT01893593|tobacco|tobacco
5361887|NCT01893580|Cancer|cancer
5361888|NCT01893580|Rehabilitation|rehabilitation
5361889|NCT01893580|Exercise|exercise
5361890|NCT01893580|Lung cancer|lung cancer
5361892|NCT01893541|CIRRHOTIC|cirrhotic
5361893|NCT01893541|VARICEAL BLEEDING|variceal bleeding
5361894|NCT01893541|PRIMARY PROPHYLAXIS|primary prophylaxis
5361895|NCT01893489|positron emission tomography|positron emission tomography
5361896|NCT01893489|macrophage|macrophage
5361897|NCT01893489|neomannosyl human serum albumin|neomannosyl human serum albumin
5361898|NCT01893476|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5361899|NCT01893476|implementation|implementation
5361900|NCT01893463|hemorrhage control|hemorrhage control
5361901|NCT01893463|wound closure|wound closure
5361902|NCT01893450|Graves ophthalmopathy|graves ophthalmopathy
5361903|NCT01893450|Exophthalmos|exophthalmos
5361904|NCT01893450|Proptosis|proptosis
5361905|NCT01893450|Quality of life|quality of life
5361906|NCT01893424|Biological Availability|biological availability
5361907|NCT01893424|Pharmacokinetics|pharmacokinetics
5361908|NCT01893385|vitamin D|vitamin d
5361909|NCT01893385|supplementation|supplementation
5361924|NCT01893346|Ceftazidime, Avibactam, Anti-Infectives|ceftazidime, avibactam, anti-infectives
5361925|NCT01893333|cervical cancer|cervical cancer
5361926|NCT01893333|nerve sparing radical hysterectomy|nerve sparing radical hysterectomy
5964171|NCT04160195|Autologous T Cells Infusion|autologous t cells infusion
5964172|NCT04160195|Hu1928-Hu20BB|hu1928-hu20bb
5964173|NCT04160195|Hodgkin Reed-Sternberg Cells|hodgkin reed-sternberg cells
5361927|NCT01893320|Leukemia|leukemia
5361928|NCT01893320|Acute Myeloid Leukemia|acute myeloid leukemia
5361930|NCT01893320|High-risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5964174|NCT04160195|Adoptive T Cell Therapy|adoptive t cell therapy
5361932|NCT01893320|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5361933|NCT01893320|CMM|cmm
5361934|NCT01893320|Maximum tolerated dose|maximum tolerated dose
5361935|NCT01893320|MTD|mtd
5361936|NCT01893320|Vosaroxin|vosaroxin
5361937|NCT01893320|Decitabine|decitabine
5361938|NCT01893320|Dacogen|dacogen
5361939|NCT01893307|Head And Neck Cancer|head and neck cancer
5361940|NCT01893307|Oropharyngeal Cancer|oropharyngeal cancer
5361941|NCT01893307|Squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5361942|NCT01893307|Acute and late toxicity|acute and late toxicity
5361943|NCT01893307|Intensity modulated photon therapy|intensity modulated photon therapy
5361944|NCT01893307|IMRT|imrt
5361945|NCT01893307|Intensity modulated proton therapy|intensity modulated proton therapy
5361946|NCT01893307|IMPT|impt
5361947|NCT01893307|Modified barium swallow|modified barium swallow
5361948|NCT01893307|MBS|mbs
5361949|NCT01893307|Questionnaires|questionnaires
5361950|NCT01893307|Surveys|surveys
5361951|NCT01893229|Bipolar disorder|bipolar disorder
5361952|NCT01893229|Comparative Effectiveness Research|comparative effectiveness research
5361953|NCT01893229|Therapeutics|therapeutics
5361954|NCT01893229|Patient Dropouts|patient dropouts
5361955|NCT01893216|anxiety|anxiety
5361956|NCT01893216|depression|depression
5361957|NCT01893216|sexual dysfunction|sexual dysfunction
5361958|NCT01893216|infertility|infertility
5361959|NCT01893190|Ruptured saccular aneurysm|ruptured saccular aneurysm
5361960|NCT01893190|nimodipine|nimodipine
5361961|NCT01893190|safety|safety
5361962|NCT01893190|tolerability|tolerability
5361963|NCT01893190|Subarachnoid hemorrhage|subarachnoid hemorrhage
5361964|NCT01893177|Influenza|influenza
5361965|NCT01893177|Virus|virus
5361966|NCT01893177|Vaccination|vaccination
5361967|NCT01893177|Inflexal V|inflexal v
5361968|NCT01893164|cubital tunnel syndrome|cubital tunnel syndrome
5361969|NCT01893164|simple decompression|simple decompression
5361970|NCT01893164|anterior subcutaneous transposition of ulnar nerve|anterior subcutaneous transposition of ulnar nerve
5361971|NCT01893164|anterior intramuscular transposition of ulnar nerve|anterior intramuscular transposition of ulnar nerve
5361972|NCT01893164|severity scale|severity scale
5361973|NCT01893151|Iguratimod|iguratimod
5361974|NCT01893151|MRI|mri
5361975|NCT01893151|Rheumatoid Arthritis|rheumatoid arthritis
5361976|NCT01893138|Urinary Incontinence, Stress|urinary incontinence, stress
5361977|NCT01893138|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
5361978|NCT01893138|Transplantation, Autologous|transplantation, autologous
5361979|NCT01893060|Prematurity|prematurity
5361980|NCT01893060|Central line care|central line care
5257202|NCT02405338|AML|aml
5361981|NCT01893060|Umbilical line colonization|umbilical line colonization
5361982|NCT01893060|Colonization|colonization
5361983|NCT01893060|Newborn Intensive Care Unit|newborn intensive care unit
5361984|NCT01893060|Neonatal Intensive Care Unit|neonatal intensive care unit
5361985|NCT01893047|breast milk production|breast milk production
5361986|NCT01893034|Femoroacetabular Impingement|femoroacetabular impingement
5361987|NCT01893034|Arthroscopy|arthroscopy
5361988|NCT01893034|Physiotherapy|physiotherapy
5361989|NCT01893034|Randomised Controlled Trial|randomised controlled trial
5361990|NCT01893008|Esophageal cancer|esophageal cancer
5361991|NCT01893008|Surgery|surgery
5361992|NCT01892995|suicide|suicide
5365873|NCT01876147|AMD|amd
5361993|NCT01892995|ketamine|ketamine
5361994|NCT01892995|low-dose ketamine|low-dose ketamine
5361995|NCT01892995|suicidal ideations|suicidal ideations
5361996|NCT01892995|emergency department|emergency department
5361997|NCT01892982|Maternal Depression|maternal depression
5361998|NCT01892982|Preterm Birth|preterm birth
5361999|NCT01892982|Preterm Outcomes|preterm outcomes
5362000|NCT01892982|Child Development|child development
5362001|NCT01892917|International|international
5362003|NCT01892917|Observational registry|observational registry
5362004|NCT01892917|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5362005|NCT01892917|Stenting|stenting
5362006|NCT01892917|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5362112|NCT01892579|Dementia|dementia
5362007|NCT01892917|Coronary revascularization|coronary revascularization
5362008|NCT01892917|Percutaneous Coronary Intervention|percutaneous coronary intervention
5362010|NCT01892917|NSTEMI|nstemi
5362011|NCT01892917|Ischemia|ischemia
5362012|NCT01892917|Subgroups|subgroups
5362013|NCT01892917|Acute Myocardial Infarction|acute myocardial infarction
5362014|NCT01892917|Diabetes|diabetes
5362015|NCT01892917|Small Vessels|small vessels
5362016|NCT01892917|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5362017|NCT01892904|YAZ|yaz
5362018|NCT01892904|Flexible regimen|flexible regimen
5362019|NCT01892904|Drospirenone|drospirenone
5362020|NCT01892904|Ethinylestradiol Betadex|ethinylestradiol betadex
5964175|NCT04160195|Gene Therapy|gene therapy
5964176|NCT04160065|Advanced|advanced
5964177|NCT04160065|MCC|mcc
5964178|NCT04160065|cSCC|cscc
5964179|NCT04160065|pDNA|pdna
5964180|NCT04160065|plasmid DNA|plasmid dna
5964181|NCT04160065|pAc/emm55|pac/emm55
5964182|NCT04160065|Gene Therapy|gene therapy
5964183|NCT04160065|Immuno-Oncology|immuno-oncology
5964184|NCT04160065|Therapeutic Cancer Vaccine|therapeutic cancer vaccine
5362021|NCT01892904|Dysmenorrhea|dysmenorrhea
5362022|NCT01892904|Japanese patients|japanese patients
5362023|NCT01892891|Healthy|healthy
5362024|NCT01892891|Subjects|subjects
5362025|NCT01892891|Safety|safety
5362026|NCT01892891|Tolerability|tolerability
5362027|NCT01892891|VBY036|vby036
5362028|NCT01892891|maximum|maximum
5362029|NCT01892891|pharmacodynamic|pharmacodynamic
5362030|NCT01892891|pharmacokinetic|pharmacokinetic
5362031|NCT01892865|Operating room utilization|operating room utilization
5362032|NCT01892852|Acupuncture|acupuncture
5362033|NCT01892852|Traditional Korean Medicine|traditional korean medicine
5362034|NCT01892826|FET|fet
5362035|NCT01892826|Blastocyst|blastocyst
5362036|NCT01892826|natural cycle|natural cycle
5362037|NCT01892826|hCG|hcg
5362038|NCT01892826|Spontaneous LH pic|spontaneous lh pic
5362039|NCT01892813|Nicotine dependence|nicotine dependence
5362040|NCT01892813|Smoking cessation|smoking cessation
5362041|NCT01892813|Telehealth|telehealth
5362042|NCT01892813|Alcohol use|alcohol use
5362043|NCT01892813|Depression|depression
5362044|NCT01892813|Body weight|body weight
5362045|NCT01892800|Lung Cancer|lung cancer
5362046|NCT01892800|Ventricular function, Right|ventricular function, right
5362047|NCT01892787|Asthma|asthma
5362048|NCT01892787|Small airways|small airways
5362049|NCT01892787|Extra fine particle long-acting beta agonists|extra fine particle long-acting beta agonists
5362050|NCT01892774|LSPAF|lspaf
5362051|NCT01892774|asymptomatic|asymptomatic
5362052|NCT01892774|exercise tolerance|exercise tolerance
5362053|NCT01892761|mycophenolate mofetil|mycophenolate mofetil
5362054|NCT01892761|mycophenolic acid|mycophenolic acid
5362055|NCT01892761|MPA|mpa
5362056|NCT01892761|MMF|mmf
5362057|NCT01892761|Pharmacokinetics|pharmacokinetics
5362058|NCT01892761|renal transplantation|renal transplantation
5362059|NCT01892748|Lupus|lupus
5362060|NCT01892748|Juvenile|juvenile
5362061|NCT01892748|Cholecalciferol|cholecalciferol
5362062|NCT01892748|Disease activity|disease activity
5362063|NCT01892748|Bone Mass|bone mass
5362064|NCT01892748|Fatigue|fatigue
5362065|NCT01892748|Safety|safety
5362066|NCT01892722|pediatric|pediatric
5362067|NCT01892722|multiple sclerosis|multiple sclerosis
5362068|NCT01892709|acute|acute
5362069|NCT01892709|pain|pain
5362070|NCT01892709|emergency department|emergency department
5362071|NCT01892709|hydromorphone|hydromorphone
5362072|NCT01892709|in ER|in er
5362073|NCT01892696|inspiratory flow pattern|inspiratory flow pattern
5362074|NCT01892696|mechanical ventilation|mechanical ventilation
5362075|NCT01892696|cardiac preload|cardiac preload
5362076|NCT01892696|arterial pulse pressure variation|arterial pulse pressure variation
5362077|NCT01892696|inferior vena cava collapsibility|inferior vena cava collapsibility
5362078|NCT01892683|propofol|propofol
5362079|NCT01892683|exhaled|exhaled
5362080|NCT01892683|monitoring|monitoring
5362081|NCT01892683|anesthesia|anesthesia
5362082|NCT01892670|Blood|blood
5362083|NCT01892670|Whole blood|whole blood
5362084|NCT01892670|Cold-storage|cold-storage
5362085|NCT01892670|Filtration|filtration
5362086|NCT01892670|Transfusion|transfusion
5362087|NCT01892670|Platelet-function|platelet-function
5362088|NCT01892657|Cetaphil Daily Facial Moisturizer with SPF 50+|cetaphil daily facial moisturizer with spf 50+
5362089|NCT01892657|Hypoallergenicity|hypoallergenicity
5362090|NCT01892657|Skin Irritation|skin irritation
5362091|NCT01892644|Hemochromatosis|hemochromatosis
5362092|NCT01892644|Myelodysplastic syndromes|myelodysplastic syndromes
5362093|NCT01892644|Iron overload|iron overload
5362094|NCT01892644|Deferasirox|deferasirox
5362095|NCT01892644|Chelation therapy|chelation therapy
5362096|NCT01892644|Venesection|venesection
5362102|NCT01892605|first unprovoked seizure|first unprovoked seizure
5362103|NCT01892605|epileptiform discharges|epileptiform discharges
5362104|NCT01892605|music therapy|music therapy
5362105|NCT01892605|children|children
5362106|NCT01892592|Hypertension|hypertension
5362107|NCT01892592|African American|african american
5362108|NCT01892592|Health Disparities|health disparities
5362109|NCT01892592|Stroke|stroke
5357744|NCT01913535|MDD|mdd
5362118|NCT01892553|Dyspnea|dyspnea
5362119|NCT01892553|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5362120|NCT01892553|Perception|perception
5362121|NCT01892527|Colorectal Cancer Metastatic|colorectal cancer metastatic
5362122|NCT01892527|wild type KRAS|wild type kras
5362123|NCT01892527|C-met overexpression|c-met overexpression
5362124|NCT01892527|Tivantinib|tivantinib
5362125|NCT01892527|Cetuximab|cetuximab
5362126|NCT01892514|osteonecrosis|osteonecrosis
5362127|NCT01892514|bone marrow concentrate|bone marrow concentrate
5362128|NCT01892514|demineralized bone matrix|demineralized bone matrix
5362129|NCT01892514|homologous lyophilized bone chips|homologous lyophilized bone chips
5362130|NCT01892514|autologous platelet rich fibrin|autologous platelet rich fibrin
5362131|NCT01892514|mesenchymal stromal cells|mesenchymal stromal cells
5362132|NCT01892501|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5362133|NCT01892501|PET CT to 18FDG|pet ct to 18fdg
5362134|NCT01892501|EUS|eus
5362135|NCT01892488|COPD|copd
5240799|NCT02498795|Patella|patella
5362136|NCT01892488|AE-COPD|ae-copd
5362137|NCT01892488|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5362138|NCT01892488|acute exacerbations of Chronic obstructive pulmonary disease|acute exacerbations of chronic obstructive pulmonary disease
5362139|NCT01892475|Physical Activity|physical activity
5362140|NCT01892475|Incentives|incentives
5362141|NCT01892475|Mental Accounting|mental accounting
5362142|NCT01892475|Older adults|older adults
5362143|NCT01892436|Extension study, psoriatic arthritis, pre-filled syringe|extension study, psoriatic arthritis, pre-filled syringe
5362144|NCT01892397|intracranial supratentorial meningioma|intracranial supratentorial meningioma
5362145|NCT01892397|Atypical and Anaplastic Meningioma|atypical and anaplastic meningioma
5362146|NCT01892397|Optune (NovoTTF-100A)|optune (novottf-100a)
5362147|NCT01892397|13-067|13-067
5362148|NCT01892358|injection drug use|injection drug use
5362149|NCT01892345|Neuromyelitis Optica|neuromyelitis optica
5362150|NCT01892345|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5362151|NCT01892345|Devic's disease, Transverse Myelitis|devic's disease, transverse myelitis
5362152|NCT01892345|Optic Neuritis|optic neuritis
5362153|NCT01892345|relapse|relapse
5362154|NCT01892345|eculizumab|eculizumab
5362155|NCT01892345|soliris|soliris
5362156|NCT01892345|NMO-IgG|nmo-igg
5362157|NCT01892345|CNS Autoimmune Disorders|cns autoimmune disorders
5362158|NCT01892345|Demyelinating Disorders|demyelinating disorders
5362159|NCT01892345|NMO|nmo
5362160|NCT01892345|NMOSD|nmosd
5362161|NCT01892293|Multiple Myeloma|multiple myeloma
5362162|NCT01892293|Autologous stem cell transplantation|autologous stem cell transplantation
5362163|NCT01892293|Received initial treatment previously|received initial treatment previously
5362164|NCT01892267|PEGJ|pegj
5362165|NCT01892267|PEG-J|peg-j
5362166|NCT01892267|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
5362167|NCT01892267|Feeding tube|feeding tube
5362168|NCT01892267|Gastroparesis|gastroparesis
5362169|NCT01892267|Acute pancreatitis|acute pancreatitis
5362170|NCT01892267|Stroke|stroke
5362171|NCT01892267|Respiratory failure|respiratory failure
5362172|NCT01892267|GERD|gerd
5362173|NCT01892267|Balloon|balloon
5362174|NCT01892267|Self-propelled|self-propelled
5362175|NCT01892254|incretin effect|incretin effect
5362176|NCT01892254|PCOS|pcos
5362177|NCT01892254|insulin resistance|insulin resistance
5362178|NCT01892254|OGTT|ogtt
5362179|NCT01892254|IIGI|iigi
5362180|NCT01892241|Chronic hepatitis B,Spontaneous Decline of HBV DNA,Peginterferon a-2a, entecavir|chronic hepatitis b,spontaneous decline of hbv dna,peginterferon a-2a, entecavir
5362181|NCT01892228|antiretroviral therapy|antiretroviral therapy
5362182|NCT01892228|education|education
5362183|NCT01892228|mortality|mortality
5362184|NCT01892215|Uterine incision.|uterine incision.
5362185|NCT01892215|Blunt transversal expansion.|blunt transversal expansion.
5362186|NCT01892215|Blunt cephalad-caudad expansion.|blunt cephalad-caudad expansion.
5362187|NCT01892189|Drug therapy|drug therapy
5365981|NCT01875679|Surgical education|surgical education
5362188|NCT01892176|coenzyme Q10, Parkinson disease, oxidative damage|coenzyme q10, parkinson disease, oxidative damage
5362189|NCT01892163|Diabetic macular edema, Ozurdex|diabetic macular edema, ozurdex
5362191|NCT01892137|Histopathology|histopathology
5362192|NCT01892137|Reflectance Confocal Microscopy|reflectance confocal microscopy
5362193|NCT01892137|Local Skin Reaction|local skin reaction
5362194|NCT01892124|Motivational Interviewing|motivational interviewing
5362195|NCT01892124|Cognitive Therapy|cognitive therapy
5362196|NCT01892124|Community-Based Participatory Research|community-based participatory research
5357853|NCT01912937|PAD|pad
5362197|NCT01892124|Indians, North American|indians, north american
5362199|NCT01892111|infertility|infertility
5362200|NCT01892111|IVF/ICSI|ivf/icsi
5362201|NCT01892111|pregnancy|pregnancy
5362202|NCT01892098|Zinc|zinc
5362203|NCT01892098|Bone|bone
5362204|NCT01892098|Adolescents|adolescents
5362205|NCT01892098|Growth|growth
5362206|NCT01892085|Breast milk|breast milk
5362207|NCT01892085|lactogenesis stage two|lactogenesis stage two
5362208|NCT01892085|premature infant|premature infant
5362209|NCT01892085|insufficient milk supply|insufficient milk supply
5362210|NCT01892085|breast milk expression|breast milk expression
5362211|NCT01892072|hepatocellular carcinoma|hepatocellular carcinoma
5362212|NCT01892072|HCC|hcc
5362213|NCT01892072|VEGF signaling pathway|vegf signaling pathway
5362214|NCT01892059|renal tumour|renal tumour
5362215|NCT01892059|partial nephrectomy|partial nephrectomy
5362216|NCT01892059|laparoscope|laparoscope
5362217|NCT01892059|segmental renal artery clamping|segmental renal artery clamping
5362218|NCT01892046|Small Cell Lung Cancer|small cell lung cancer
5362219|NCT01892046|Non Small Cell Lung Cancer|non small cell lung cancer
5362220|NCT01892046|Hsp90|hsp90
5362221|NCT01892033|Posttraumatic Stress Disorder|posttraumatic stress disorder
5362222|NCT01892033|PTSD|ptsd
5362223|NCT01892033|Aerobic Exercise|aerobic exercise
5362224|NCT01892033|Women|women
5362225|NCT01892033|Veteran|veteran
5362226|NCT01892007|Hearing loss|hearing loss
5362227|NCT01892007|Hearing aid|hearing aid
5964185|NCT04160065|Immunotherapy|immunotherapy
5362228|NCT01892007|Speech intelligibility|speech intelligibility
5362229|NCT01892007|Speech perception|speech perception
5362230|NCT01892007|Cognitive training|cognitive training
5362231|NCT01892007|Working memory|working memory
5362232|NCT01892007|Working memory training|working memory training
5362233|NCT01891994|Cytokine|cytokine
5362234|NCT01891994|Hematopoiesis|hematopoiesis
5362235|NCT01891994|Autoimmunity|autoimmunity
5362236|NCT01891994|Thrombocytopenia|thrombocytopenia
5362237|NCT01891994|Neutropenia|neutropenia
5362238|NCT01891981|Leukemia|leukemia
5362239|NCT01891981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5362240|NCT01891981|ALL|all
5362241|NCT01891981|Relapsed and/or refractory|relapsed and/or refractory
5362242|NCT01891981|Moxetumomab Pasudotox|moxetumomab pasudotox
5362243|NCT01891981|Maximum tolerated dose|maximum tolerated dose
5362244|NCT01891981|MTD|mtd
5362245|NCT01891968|Leukemia|leukemia
5362246|NCT01891968|Myelodysplastic syndrome|myelodysplastic syndrome
5362247|NCT01891968|MDS|mds
5362248|NCT01891968|Low or intermediate-1|low or intermediate-1
5362249|NCT01891968|Bortezomib|bortezomib
5362250|NCT01891968|Velcade|velcade
5362251|NCT01891968|LDP-341|ldp-341
5362252|NCT01891968|MLN341|mln341
5362253|NCT01891968|PS-341|ps-341
5362254|NCT01891955|Diabetes mellitus type 2|diabetes mellitus type 2
5362255|NCT01891955|Cereals|cereals
5362256|NCT01891955|Dairy|dairy
5362257|NCT01891955|Dietary carbohydrates|dietary carbohydrates
5362258|NCT01891955|Dietary fiber|dietary fiber
5362259|NCT01891955|Food|food
5362260|NCT01891955|Metabolic syndrome|metabolic syndrome
5362261|NCT01891955|Satiety|satiety
5362262|NCT01891942|Normal|normal
5362263|NCT01891942|subjects|subjects
5362264|NCT01891929|Schizophrenia|schizophrenia
5362265|NCT01891929|Cognitive Remediation|cognitive remediation
5362266|NCT01891929|Working abilities and social functioning|working abilities and social functioning
5362267|NCT01891890|Pediatrics|pediatrics
5362268|NCT01891877|Sickle Cell Trait|sickle cell trait
5362269|NCT01891877|Football|football
5362270|NCT01891877|Sickling|sickling
5362271|NCT01891877|Heat Illness|heat illness
5362272|NCT01891877|SCT|sct
5362273|NCT01891851|Healthy|healthy
5362274|NCT01891851|Hepatitis C|hepatitis c
5362275|NCT01891851|TMC435350|tmc435350
5362276|NCT01891851|Ritonavir|ritonavir
5445484|NCT01521533|Velcade|velcade
5362277|NCT01891851|Pharmacokinetics|pharmacokinetics
5362278|NCT01891838|surgery|surgery
5362279|NCT01891838|transsphenoidal surgery|transsphenoidal surgery
5362280|NCT01891838|pituitary adenoma|pituitary adenoma
5362281|NCT01891838|mechanical ventilation|mechanical ventilation
5362282|NCT01891838|bleeding|bleeding
5362283|NCT01891825|Atrial fibrillation|atrial fibrillation
5362284|NCT01891825|Persistent atrial fibrillation|persistent atrial fibrillation
5362285|NCT01891825|Atrial fibrillation ablation|atrial fibrillation ablation
5362286|NCT01891812|Sickle cell disease|sickle cell disease
5362287|NCT01891812|Vaso-occlusive crisis|vaso-occlusive crisis
5362288|NCT01891812|Nitrous oxide|nitrous oxide
5366101|NCT01875250|PSA|psa
5362290|NCT01891799|HIV/AIDS|hiv/aids
5362291|NCT01891799|PMTCT|pmtct
5362292|NCT01891799|Option B+|option b+
5362293|NCT01891799|Swaziland|swaziland
5362294|NCT01891773|Asthma|asthma
5362295|NCT01891773|Inhaled Corticosteroids|inhaled corticosteroids
5362296|NCT01891773|School Nurses|school nurses
5362297|NCT01891747|gliomas|gliomas
5362298|NCT01891734|Veterans|veterans
5362299|NCT01891734|Health Services|health services
5362300|NCT01891734|Mental Health|mental health
5362301|NCT01891734|Technology|technology
5362302|NCT01891734|Primary Health Care|primary health care
5362310|NCT01891682|Methionine Metabolism|methionine metabolism
5362311|NCT01891682|Parenteral Nutrition|parenteral nutrition
5362312|NCT01891682|Pediatric|pediatric
5362313|NCT01891682|Pediatrics|pediatrics
5362314|NCT01891682|Sepsis|sepsis
5362315|NCT01891682|Observational Study|observational study
5362316|NCT01891669|ADC 5T4|adc 5t4
5362317|NCT01891669|PF-06263507|pf-06263507
5362318|NCT01891669|solid tumors|solid tumors
5362319|NCT01891669|lung cancer|lung cancer
5362320|NCT01891669|breast cancer|breast cancer
5362321|NCT01891669|ovarian cancer|ovarian cancer
5362322|NCT01891669|cancer|cancer
5362323|NCT01891669|tumors|tumors
5362324|NCT01891669|neoplasm metastasis|neoplasm metastasis
5362325|NCT01891656|Motivational Interviewing|motivational interviewing
5362326|NCT01891656|Internet|internet
5362327|NCT01891656|Treatment|treatment
5362328|NCT01891656|Substance-Related Disorders|substance-related disorders
5362329|NCT01891656|Criminal Justice|criminal justice
5362330|NCT01891630|African American|african american
5362331|NCT01891630|Asthma|asthma
5362332|NCT01891617|exercise|exercise
5671937|NCT00613535|meniscectomy|meniscectomy
5362333|NCT01891617|high carbohydrate and high fat diets|high carbohydrate and high fat diets
5362334|NCT01891617|insulin|insulin
5362335|NCT01891617|gut peptides|gut peptides
5362336|NCT01891617|appetite|appetite
5362337|NCT01891617|metabolism|metabolism
5362338|NCT01891617|glucose|glucose
5362339|NCT01891591|Obesity|obesity
5362340|NCT01891591|Gastric bypass|gastric bypass
5240999|NCT02497456|HIV|hiv
5362341|NCT01891591|Energy balance|energy balance
5362342|NCT01891591|Nutritional status|nutritional status
5362343|NCT01891591|Protein balance|protein balance
5362344|NCT01891552|Colon Cancer, Liver Metastasis, DEBIRI, cetuximab, efficacy|colon cancer, liver metastasis, debiri, cetuximab, efficacy
5362345|NCT01891539|Hepatocellular carcinoma, doxorubicin, chemoembolization|hepatocellular carcinoma, doxorubicin, chemoembolization
5362467|NCT01891175|hypotension|hypotension
5362346|NCT01891526|Metabolisation of 9-cis-retinoic acid|metabolisation of 9-cis-retinoic acid
5362347|NCT01891526|hepatic patients|hepatic patients
5362348|NCT01891526|investigation of urine and blood samples|investigation of urine and blood samples
5362349|NCT01891513|Physical activity|physical activity
5362350|NCT01891513|Hypertension|hypertension
5362351|NCT01891513|Physical function|physical function
5362352|NCT01891513|Aging|aging
5362353|NCT01891500|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
5362354|NCT01891500|Infant, Newborn|infant, newborn
5362355|NCT01891500|Nitric Oxide|nitric oxide
5362356|NCT01891500|Oxidative Stress|oxidative stress
5362357|NCT01891500|Endothelin 1|endothelin 1
5362358|NCT01891500|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5362359|NCT01891487|Eyebrow|eyebrow
5362360|NCT01891487|Hypotrichosis|hypotrichosis
5362361|NCT01891487|Thinning|thinning
5362362|NCT01891487|Bimatoprost|bimatoprost
5362363|NCT01891461|total knee arthroplasty|total knee arthroplasty
5362364|NCT01891461|post-operative bleeding|post-operative bleeding
5362365|NCT01891461|floseal|floseal
5362366|NCT01891435|antipyretics|antipyretics
5362367|NCT01891435|oral paracetamol|oral paracetamol
5362368|NCT01891435|intravenous paracetamol|intravenous paracetamol
5362369|NCT01891435|intramuscular diclofenac|intramuscular diclofenac
5362370|NCT01891435|emergency department|emergency department
5362371|NCT01891422|Glycoprotein Storage Disease|glycoprotein storage disease
5362372|NCT01891422|Lysosomal Storage Disease|lysosomal storage disease
5362373|NCT01891422|mannosidase deficiency disorders|mannosidase deficiency disorders
5362374|NCT01891422|Neuraminidase deficiency with beta-galactosidase deficiency|neuraminidase deficiency with beta-galactosidase deficiency
5362375|NCT01891422|mucolipidoses|mucolipidoses
5362376|NCT01891422|Oligosaccharidoses|oligosaccharidoses
5362377|NCT01891422|Lysosomal Disease|lysosomal disease
5362378|NCT01891422|Metabolic Disease, Inborn|metabolic disease, inborn
5362379|NCT01891422|aspartylglucosaminuria|aspartylglucosaminuria
5362380|NCT01891422|fucosidosis|fucosidosis
5362381|NCT01891422|galactosialidosis|galactosialidosis
5362382|NCT01891422|alpha mannosidosis|alpha mannosidosis
5362383|NCT01891422|beta mannosidosis|beta mannosidosis
5362384|NCT01891422|mucolipidosis II|mucolipidosis ii
5362385|NCT01891422|mucolipidosis III|mucolipidosis iii
5362386|NCT01891422|Schindler disease|schindler disease
5362387|NCT01891422|sialidosis|sialidosis
5362388|NCT01891409|HIV prevention|hiv prevention
5362389|NCT01891409|Male Circumcision|male circumcision
5362390|NCT01891409|Children|children
5362391|NCT01891409|Childhood|childhood
5362393|NCT01891396|Knee osteoarthritis|knee osteoarthritis
5362394|NCT01891396|Hyaluronic acid|hyaluronic acid
5362395|NCT01891396|HA Injection|ha injection
5362396|NCT01891396|Steroid Injection|steroid injection
5362397|NCT01891396|Knee injection|knee injection
5362398|NCT01891383|Dementia|dementia
5362399|NCT01891383|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
5362400|NCT01891383|Mild cognitive impairment (MCI)|mild cognitive impairment (mci)
5362401|NCT01891383|Chronic traumatic encephalopathy (CTE)|chronic traumatic encephalopathy (cte)
5362402|NCT01891383|Remote effects of TBI|remote effects of tbi
5362403|NCT01891383|Post-traumatic stress disorder (PTSD_|post-traumatic stress disorder (ptsd_
5362404|NCT01891357|Unilateral primary invasive carcinoma of the breast|unilateral primary invasive carcinoma of the breast
5362405|NCT01891344|ovarian cancer|ovarian cancer
5363187|NCT01887834|bloating|bloating
5362406|NCT01891344|fallopian tube cancer|fallopian tube cancer
5362407|NCT01891344|primary peritoneal cancer|primary peritoneal cancer
5362408|NCT01891344|peritoneal cancer|peritoneal cancer
5362409|NCT01891344|platinum sensitive|platinum sensitive
5362410|NCT01891344|relapsed disease|relapsed disease
5362411|NCT01891344|PARP Inhibitor|parp inhibitor
5362412|NCT01891344|rucaparib|rucaparib
5362413|NCT01891344|homologous recombination|homologous recombination
5362414|NCT01891344|homologous recombination deficiency|homologous recombination deficiency
5362415|NCT01891344|genomic scarring|genomic scarring
5362416|NCT01891344|loss of heterozygosity|loss of heterozygosity
5362417|NCT01891344|CO-338|co-338
5362418|NCT01891344|PF 01367338|pf 01367338
5362419|NCT01891344|AG 14699|ag 14699
5362420|NCT01891344|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5671938|NCT00613535|meniscus|meniscus
5362421|NCT01891344|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
5362422|NCT01891344|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
5362423|NCT01891344|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
5362424|NCT01891344|gynecological cancer|gynecological cancer
5964186|NCT04159818|Triple negative|triple negative
5964187|NCT04159818|Metastatic disease|metastatic disease
5362426|NCT01891344|Clovis Oncology|clovis oncology
5362427|NCT01891344|ARIEL2|ariel2
5362428|NCT01891344|ARIEL 2|ariel 2
5362429|NCT01891344|ARIEL3|ariel3
5362430|NCT01891344|ARIEL 3|ariel 3
5362431|NCT01891279|short bowel syndrome|short bowel syndrome
5362432|NCT01891279|Elemental formula|elemental formula
5362433|NCT01891279|partially hydrolyzed formula|partially hydrolyzed formula
5362434|NCT01891279|Enteral feeding|enteral feeding
5362435|NCT01891279|TPN dependency|tpn dependency
5362436|NCT01891279|Intestinal adaptation|intestinal adaptation
5362437|NCT01891279|TPN cholestasis|tpn cholestasis
5362438|NCT01891253|cardiac output|cardiac output
5362439|NCT01891253|mechanical ventilation|mechanical ventilation
5362440|NCT01891253|inert gas rebreathing|inert gas rebreathing
5362441|NCT01891253|pulse contour analysis|pulse contour analysis
5362442|NCT01891240|Diagnostic|diagnostic
5362443|NCT01891240|Pre-eclampsia|pre-eclampsia
5362444|NCT01891240|Pregnancy outcome|pregnancy outcome
5362445|NCT01891240|Mass screening|mass screening
5362446|NCT01891240|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5362447|NCT01891227|Bendamustine|bendamustine
5362448|NCT01891227|Capecitabine|capecitabine
5362449|NCT01891227|Pretreated|pretreated
5362450|NCT01891227|Her2 negative|her2 negative
5362451|NCT01891227|Advanced breast cancer|advanced breast cancer
5362452|NCT01891227|Metastatic breast cancer|metastatic breast cancer
5362453|NCT01891227|Anthracycline pretreatment|anthracycline pretreatment
5362454|NCT01891227|Taxane pretreatment|taxane pretreatment
5362455|NCT01891214|Inflammatory bowel diseases|inflammatory bowel diseases
5362456|NCT01891214|Inflammatory Bowel Disease Questionnaire (IBDQ)|inflammatory bowel disease questionnaire (ibdq)
5362457|NCT01891201|Bonding|bonding
5362458|NCT01891201|Oxytocin|oxytocin
5362459|NCT01891201|Breastfeeding|breastfeeding
5362460|NCT01891201|Newborn|newborn
5362461|NCT01891201|Delivery|delivery
5362462|NCT01891188|hepatic blood,|hepatic blood,
5362463|NCT01891188|cardiac cath,|cardiac cath,
5362464|NCT01891188|hepatic oxygenation,|hepatic oxygenation,
5362465|NCT01891188|pediatrics|pediatrics
5362466|NCT01891175|Caesarean|caesarean
5362468|NCT01891175|Spinal Anaesthesia|spinal anaesthesia
5362469|NCT01891175|intermittent pneumatic compression|intermittent pneumatic compression
5362470|NCT01891175|lower extremities|lower extremities
5362471|NCT01891162|quality of life, incontinence urinary, socioeconomic|quality of life, incontinence urinary, socioeconomic
5362472|NCT01891136|Peanut allergy|peanut allergy
5362473|NCT01891123|Non-small Cell Lung Cancer|non-small cell lung cancer
5362474|NCT01891123|Breast cancer|breast cancer
5362475|NCT01891123|plasma drug concentration|plasma drug concentration
5362476|NCT01891123|Nasopharygeal carcinoma|nasopharygeal carcinoma
5362477|NCT01891110|electric stimulation|electric stimulation
5362478|NCT01891110|tilt-table|tilt-table
5362482|NCT01891097|Aricular acupuncture|aricular acupuncture
5362483|NCT01891097|Randomized Clinical Trial|randomized clinical trial
5362484|NCT01891097|Traditional Chinese Medicine|traditional chinese medicine
5362485|NCT01891084|Influenza|influenza
5362486|NCT01891084|Antipyretics|antipyretics
5362488|NCT01891071|Multiple sclerosis|multiple sclerosis
5362489|NCT01891071|Lung volume recruitment|lung volume recruitment
5362490|NCT01891071|Pulmonary function impairment|pulmonary function impairment
5362491|NCT01891071|Cough impairment|cough impairment
5362492|NCT01891045|Psychotherapy|psychotherapy
5362493|NCT01891045|Drug addiction|drug addiction
5362494|NCT01891045|Drop-out|drop-out
5362496|NCT01891045|Clinical trial|clinical trial
5362497|NCT01891045|Randomized Controlled Trail|randomized controlled trail
5362498|NCT01891032|acute kidney injury, partial nephrectomy, biomarker|acute kidney injury, partial nephrectomy, biomarker
5362499|NCT01891006|Randomized Controlled Trial|randomized controlled trial
5362500|NCT01891006|Economical Evaluation|economical evaluation
5363292|NCT01887379|Furosemide|furosemide
5362501|NCT01891006|Caesarean Section|caesarean section
5362502|NCT01891006|Cesarean Section|cesarean section
5362503|NCT01891006|Postoperative Wound Treatment|postoperative wound treatment
5362504|NCT01891006|Surgical Site Infections|surgical site infections
5362505|NCT01891006|Wound Infections|wound infections
5362506|NCT01891006|Infectious Morbidity|infectious morbidity
5362507|NCT01891006|Negative Pressure Wound Therapy|negative pressure wound therapy
5362508|NCT01890980|WT-1-vaccine Montanide|wt-1-vaccine montanide
5362510|NCT01890980|Wilms Tumor-1 vaccine|wilms tumor-1 vaccine
5362511|NCT01890980|immunotherapy|immunotherapy
5362512|NCT01890980|Montanide|montanide
5362513|NCT01890980|Sargramostim|sargramostim
5362514|NCT01890980|Granulocyte Macrophage Colony Stimulating Factor|granulocyte macrophage colony stimulating factor
5362515|NCT01890980|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5362516|NCT01890980|MPM|mpm
5362517|NCT01890980|soluble mesothelin related protein|soluble mesothelin related protein
5362518|NCT01890980|SMRP|smrp
5362519|NCT01890967|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia|low density lipoprotein, heterozygous familial hypercholesterolemia, polygenic hypercholesterolemia
5362520|NCT01890954|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5362521|NCT01890954|Closed Loop Control (CLC)|closed loop control (clc)
5362522|NCT01890954|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5362523|NCT01890954|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5362524|NCT01890941|Dry eye syndromes|dry eye syndromes
5362525|NCT01890941|Corneal diseases|corneal diseases
5362526|NCT01890941|Conjunctival diseases|conjunctival diseases
5362527|NCT01890928|Gluconeogenesis|gluconeogenesis
5362528|NCT01890928|Glycogenolysis|glycogenolysis
5362529|NCT01890928|Pyruvate cycling|pyruvate cycling
5362530|NCT01890928|Glucose production rates|glucose production rates
5362531|NCT01890928|Mitochondria|mitochondria
5362532|NCT01890928|Acylcarnitines|acylcarnitines
5362533|NCT01890915|Spinal cord injury|spinal cord injury
5362534|NCT01890915|Body temperature|body temperature
5362535|NCT01890915|Executive function|executive function
5362536|NCT01890915|Sweat|sweat
5362537|NCT01890889|Total Cholesterol|total cholesterol
5362538|NCT01890889|LDL|ldl
5362539|NCT01890876|glucose tolerance, hypoxia, myokines, exercise|glucose tolerance, hypoxia, myokines, exercise
5362540|NCT01890863|asthma|asthma
5362541|NCT01890863|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5362542|NCT01890863|PK equivalence|pk equivalence
5362543|NCT01890863|COPD|copd
5362544|NCT01890863|pharmacokinetics|pharmacokinetics
5362545|NCT01890863|fluticasone propionate/salmeterol in a capsule-based inhaler|fluticasone propionate/salmeterol in a capsule-based inhaler
5362546|NCT01890863|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler|fluticasone propionate/salmeterol in a multi-dose dry powder inhaler
5362547|NCT01890863|Respiratory|respiratory
5362548|NCT01890850|Risk factors|risk factors
5362549|NCT01890850|U.S. commercially insured population|u.s. commercially insured population
5362550|NCT01890850|Pertussis/whooping cough infection|pertussis/whooping cough infection
5362551|NCT01890850|Retrospective database study|retrospective database study
5362552|NCT01890837|Rectal Compliance|rectal compliance
5362553|NCT01890837|Rectal Sensation|rectal sensation
5362554|NCT01890837|Rectal Tone|rectal tone
5362555|NCT01890824|Breast Cancer|breast cancer
5362556|NCT01890824|Fat metabolism|fat metabolism
5362557|NCT01890824|Fat digestion|fat digestion
5362558|NCT01890824|physical activity|physical activity
5362559|NCT01890824|muscle function|muscle function
5362560|NCT01890811|CKD|ckd
5362561|NCT01890811|Hemodialysis|hemodialysis
5362562|NCT01890811|Protein Digestion|protein digestion
5362563|NCT01890811|Fat Digestion|fat digestion
5362564|NCT01890811|Gut Function|gut function
5362565|NCT01890811|Glucose Absorption|glucose absorption
5362566|NCT01890811|Muscle Function|muscle function
5362567|NCT01890798|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5362568|NCT01890798|GSK2402968|gsk2402968
5362569|NCT01890798|drisapersen|drisapersen
5362570|NCT01890772|Hepatitis C Genotype 1|hepatitis c genotype 1
5362571|NCT01890772|Vitamin D|vitamin d
5362572|NCT01890772|treatment-naive|treatment-naive
5362573|NCT01890759|Meningitis|meningitis
5362574|NCT01890759|Meningococcal Infection|meningococcal infection
5362575|NCT01890759|Menactra®|menactra®
5362576|NCT01890746|AML|aml
5362577|NCT01890746|de novo AML|de novo aml
5362578|NCT01890746|leukemia|leukemia
5362580|NCT01890746|acute myeloid leukemia|acute myeloid leukemia
5362581|NCT01890746|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5362582|NCT01890746|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5362583|NCT01890746|ETB115|etb115
5362584|NCT01890746|Eltrombopag|eltrombopag
5362585|NCT01890746|thrombocytopenia|thrombocytopenia
5362586|NCT01890746|oral thrombopoietin receptor agonist|oral thrombopoietin receptor agonist
5362587|NCT01890733|Massive Rotator Cuff Tear, Sub-acromial spacer, Best repair of rotator cuff,|massive rotator cuff tear, sub-acromial spacer, best repair of rotator cuff,
5362588|NCT01890720|Randomized Controlled Trial|randomized controlled trial
5362589|NCT01890720|Economical Evaluation|economical evaluation
5362590|NCT01890720|Caesarean Section|caesarean section
5362591|NCT01890720|postoperative wound treatment|postoperative wound treatment
5362592|NCT01890720|surgical site infections|surgical site infections
5362593|NCT01890720|wound infections|wound infections
5362594|NCT01890720|infectious morbidity|infectious morbidity
5362595|NCT01890720|Negative Pressure Wound Therapy|negative pressure wound therapy
5362596|NCT01890720|Incisional Negative Pressure Wound Therapy|incisional negative pressure wound therapy
5362597|NCT01890720|Obesity|obesity
5362598|NCT01890707|Gynecology|gynecology
5362599|NCT01890707|Pain|pain
5362600|NCT01890707|Anesthesia|anesthesia
5362601|NCT01890707|Quality of Recovery 40|quality of recovery 40
5362602|NCT01890694|Hyponatremia|hyponatremia
5362603|NCT01890694|Dilutional Hyponatremia|dilutional hyponatremia
5362604|NCT01890694|Euvolemic Hyponatremia|euvolemic hyponatremia
5362605|NCT01890694|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5362607|NCT01890694|Tolvaptan|tolvaptan
5362608|NCT01890681|childhood obesity|childhood obesity
5362609|NCT01890681|child care|child care
5362610|NCT01890681|infant|infant
5362611|NCT01890681|toddler|toddler
5964188|NCT04159571|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5964189|NCT04159571|Brain Stimulation|brain stimulation
5964190|NCT04159571|Treatment|treatment
5964191|NCT04159571|Neuroimaging|neuroimaging
5229164|NCT02569307|Psychosis|psychosis
5362612|NCT01890668|Breastfeeding behaviour|breastfeeding behaviour
5362613|NCT01890668|OMT (Osteopathic Manipulative Treatment)|omt (osteopathic manipulative treatment)
5362614|NCT01890668|suboptimal infant breastfeeding behaviour|suboptimal infant breastfeeding behaviour
5362615|NCT01890668|healthy newborns|healthy newborns
5362616|NCT01890655|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5362617|NCT01890655|RRMS|rrms
5362618|NCT01890642|Pain|pain
5362619|NCT01890642|Children|children
5362620|NCT01890642|Venipuncture|venipuncture
5362621|NCT01890642|J tip|j tip
5362622|NCT01890642|Lidocaine|lidocaine
5362623|NCT01890642|video observation|video observation
5362624|NCT01890629|diabetes mellitus|diabetes mellitus
5362625|NCT01890603|Care coordination, primary care|care coordination, primary care
5362626|NCT01890603|nurse care management|nurse care management
5362627|NCT01890603|practice facilitation|practice facilitation
5362628|NCT01890590|Renal Cell Carcinoma|renal cell carcinoma
5362629|NCT01890590|Cyberknife|cyberknife
5362630|NCT01890577|Chronic kidney disease|chronic kidney disease
5362631|NCT01890577|Dialysis|dialysis
5362632|NCT01890577|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
5362633|NCT01890577|South Africa|south africa
5362634|NCT01890551|Adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging|adoloescent, patellofemoral, instability,biomechanics, magnetic resonance imaging
5362635|NCT01890538|vertigo|vertigo
5362636|NCT01890538|dimenhydrinate|dimenhydrinate
5362637|NCT01890538|piracetam|piracetam
5362638|NCT01890525|radiation|radiation
5362639|NCT01890499|tolerability|tolerability
5362640|NCT01890499|diet after operation|diet after operation
5362641|NCT01890447|Cocooning|cocooning
5362642|NCT01890447|Web-based questionnaire|web-based questionnaire
5362643|NCT01890447|Italy|italy
5362644|NCT01890447|Pertussis|pertussis
5362645|NCT01890447|Spain|spain
5362646|NCT01890447|Survey|survey
5445485|NCT01521533|Dexamethasone|dexamethasone
5362647|NCT01890434|Myocardial Perfusion Imaging|myocardial perfusion imaging
5362648|NCT01890421|Myocardial Perfusion Imaging|myocardial perfusion imaging
5362649|NCT01890408|Laparotomy|laparotomy
5362650|NCT01890408|Hepatic resection|hepatic resection
5362651|NCT01890408|continuous wound catheter analgesia|continuous wound catheter analgesia
5362652|NCT01890408|morphine|morphine
5362653|NCT01890408|post operative recovery|post operative recovery
5362654|NCT01890395|mitochondrial DAMPS|mitochondrial damps
5362655|NCT01890382|resistance exercise|resistance exercise
5362656|NCT01890382|protein|protein
5362657|NCT01890382|creatine|creatine
5362658|NCT01890382|leucine|leucine
5362659|NCT01890382|aging|aging
5362660|NCT01890369|Old Age|old age
5362661|NCT01890369|Sarcopenia|sarcopenia
5362662|NCT01890369|Amino Acid|amino acid
5362663|NCT01890369|Muscle|muscle
5362664|NCT01890356|Depression|depression
5362665|NCT01890356|Treatment|treatment
5362666|NCT01890356|Transcranial electrical stimulation|transcranial electrical stimulation
5362667|NCT01890356|Maintenance|maintenance
5362668|NCT01890330|Canola Oil|canola oil
5362669|NCT01890330|Metabolic Syndrome|metabolic syndrome
5362670|NCT01890330|Serum LDL cholesterol|serum ldl cholesterol
5362671|NCT01890317|Cardiogenic shock|cardiogenic shock
5362672|NCT01890317|acute myocardial infarction|acute myocardial infarction
5362673|NCT01890317|mild hypothermia|mild hypothermia
5362674|NCT01890304|Traumatic Brain Injury|traumatic brain injury
5362676|NCT01890304|Concussion|concussion
5362677|NCT01890304|Sports related injury|sports related injury
5362678|NCT01890291|Immuncell-LC, Hepatocellular carcinoma|immuncell-lc, hepatocellular carcinoma
5362679|NCT01890278|Brain Cancer|brain cancer
5362680|NCT01890278|Metastatic Brain Cancer|metastatic brain cancer
5362681|NCT01890278|IMRT|imrt
5362682|NCT01890265|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
5362683|NCT01890213|alphavirus|alphavirus
5362684|NCT01890213|colon cancer|colon cancer
5362685|NCT01890213|immune response|immune response
5362686|NCT01890213|CEA|cea
5363389|NCT01886924|Dependence|dependence
5362687|NCT01890200|add-on treatment|add-on treatment
5362688|NCT01890200|botanical drug|botanical drug
5362689|NCT01890200|HCV genotype 1|hcv genotype 1
5362690|NCT01890200|TCM-700C|tcm-700c
5362691|NCT01890161|asthma|asthma
5362692|NCT01890148|Asthma|asthma
5362693|NCT01890135|randomized|randomized
5362694|NCT01890135|double blind|double blind
5362695|NCT01890135|blood flow|blood flow
5362696|NCT01890135|muscle perfusion|muscle perfusion
5362697|NCT01890135|safety|safety
5362698|NCT01890122|Drug therapy|drug therapy
5362699|NCT01890109|Vasomotor symptoms; Hot Flashes; Menopause|vasomotor symptoms; hot flashes; menopause
5362700|NCT01890096|HDR|hdr
5964192|NCT04158648|Mild Hemophilia A Without Factor VIII Inhibitors|mild hemophilia a without factor viii inhibitors
5964193|NCT04158648|Moderate Hemophilia A Without Factor VIII Inhibitors|moderate hemophilia a without factor viii inhibitors
5964194|NCT04157335|Benralizumab|benralizumab
5964195|NCT04157335|Nasal Polyposis|nasal polyposis
5964196|NCT04157335|Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis|eosinophilic chronic rhinosinusitis with nasal polyposis
5964197|NCT04157335|Nasal Polyps|nasal polyps
5362701|NCT01890096|monotherapy|monotherapy
5362702|NCT01890096|low|low
5362703|NCT01890096|intermediate|intermediate
5362704|NCT01890096|prostate cancer|prostate cancer
5362705|NCT01890083|Hepatitis C|hepatitis c
5362706|NCT01890083|Interferon-alpha|interferon-alpha
5362707|NCT01890083|Depression|depression
5362708|NCT01890083|Major Depressive Disorder|major depressive disorder
5362709|NCT01890083|Exercise|exercise
5362710|NCT01890083|Physical Activity|physical activity
5362711|NCT01890070|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress|mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress
5362712|NCT01890044|VTE|vte
5362713|NCT01890044|DVT|dvt
5362714|NCT01890044|Venous Thromboembolism|venous thromboembolism
5362715|NCT01890044|Deep Vein Thrombosis|deep vein thrombosis
5362716|NCT01890044|Pulmonary embolus|pulmonary embolus
5362717|NCT01890044|Trauma|trauma
5362718|NCT01890031|cardiovascular disease|cardiovascular disease
5362719|NCT01890031|cholesterol|cholesterol
5680238|NCT00578565|Rheumatology|rheumatology
5362720|NCT01890018|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5362721|NCT01890018|taking a statin medication|taking a statin medication
5362722|NCT01890018|also have a medication adherence ratio (MPR)|also have a medication adherence ratio (mpr)
5362723|NCT01890005|Preeclampsia|preeclampsia
5362724|NCT01890005|Low dose aspirin|low dose aspirin
5362725|NCT01890005|Fetal growth restriction|fetal growth restriction
5362726|NCT01890005|Neonatal death|neonatal death
5362727|NCT01890005|Stillbirth|stillbirth
5362728|NCT01890005|Abruptio placenta|abruptio placenta
5362729|NCT01889992|Heart transplantation|heart transplantation
5362730|NCT01889992|Cardiac allograft remodeling|cardiac allograft remodeling
5362731|NCT01889992|Immunosuppression|immunosuppression
5362732|NCT01889992|Cardiac MRI|cardiac mri
5362733|NCT01889992|M-TOR inhibitor|m-tor inhibitor
5362734|NCT01889979|Pain during labour|pain during labour
5362735|NCT01889979|Duration of labour|duration of labour
5362736|NCT01889979|Apgar score|apgar score
5362737|NCT01889979|Umbilical cord pH|umbilical cord ph
5362738|NCT01889966|vasoreactivity testing|vasoreactivity testing
5362739|NCT01889966|Sildenafil|sildenafil
5362740|NCT01889966|precapillary pulmonary hypertension|precapillary pulmonary hypertension
5362741|NCT01889966|connective tissue disease|connective tissue disease
5362742|NCT01889966|mean pressure in the pulmonary artery 25 mmHg or more|mean pressure in the pulmonary artery 25 mmhg or more
5362743|NCT01889966|mean pulmonary capillary wedge pressure below 16 mmHg|mean pulmonary capillary wedge pressure below 16 mmhg
5362744|NCT01889953|EUS-Guided Biliary Drainage|eus-guided biliary drainage
5362745|NCT01889953|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5362746|NCT01889953|Malignant Biliary Obstruction|malignant biliary obstruction
5362747|NCT01889940|Acute Spinal Cord Injury|acute spinal cord injury
5362748|NCT01889940|Patient Satisfaction|patient satisfaction
5362749|NCT01889940|Psychological Distress|psychological distress
5362750|NCT01889940|Rehabilitation|rehabilitation
5362751|NCT01889940|Training Professionals|training professionals
5362752|NCT01889940|Burnout|burnout
5362753|NCT01889940|Job Content|job content
5362754|NCT01889927|exercise|exercise
5362755|NCT01889927|physiotherapy|physiotherapy
5362756|NCT01889927|lung function|lung function
5362757|NCT01889927|quality of life|quality of life
5362758|NCT01889888|Male urethral stricture|male urethral stricture
5362759|NCT01889888|ADRC|adrc
5362760|NCT01889888|Adipose-derived regenerative cells|adipose-derived regenerative cells
5362761|NCT01889888|Fat tissue|fat tissue
5362762|NCT01889888|Stem cells|stem cells
5362763|NCT01889862|PKU|pku
5362764|NCT01889862|PEG-PAL|peg-pal
5362765|NCT01889862|Prism|prism
5362766|NCT01889862|BioMarin|biomarin
5362767|NCT01889862|rAvPAL-PEG|ravpal-peg
5362769|NCT01889836|meningococcal conjugate vaccine serogroup C|meningococcal conjugate vaccine serogroup c
5362770|NCT01889836|Prevention|prevention
5362771|NCT01889823|Oxygen|oxygen
5362772|NCT01889823|Hypoxia|hypoxia
5362773|NCT01889823|Hyperoxia|hyperoxia
5362774|NCT01889823|Inflammation|inflammation
5362775|NCT01889823|Innate immunity|innate immunity
5362776|NCT01889810|Vitamin D, Pre-diabetes, Insulin Resistance|vitamin d, pre-diabetes, insulin resistance
5362777|NCT01889797|Untreated Non-Hodgkin's Lymphoma|untreated non-hodgkin's lymphoma
5362778|NCT01889797|Low Tumor Burden Non-Hodgkin's Lymphoma|low tumor burden non-hodgkin's lymphoma
5362779|NCT01889797|NHL|nhl
5362780|NCT01889797|Indolent|indolent
5362781|NCT01889797|Rituximab|rituximab
5362782|NCT01889797|Rituxan|rituxan
5362783|NCT01889797|GA101|ga101
5362784|NCT01889797|Obinutuzumab|obinutuzumab
5362785|NCT01889784|diabetes mellitus, type 2|diabetes mellitus, type 2
5362786|NCT01889784|phototherapy|phototherapy
5362787|NCT01889784|physical exercise|physical exercise
5362788|NCT01889784|oxygen consumption|oxygen consumption
5362789|NCT01889784|arterial blood pressure|arterial blood pressure
5362790|NCT01889784|heart rate|heart rate
5362791|NCT01889784|baroreflex sensitivity|baroreflex sensitivity
5362792|NCT01889784|cardiovascular autonomic control|cardiovascular autonomic control
5362793|NCT01889758|bioequivalence|bioequivalence
5362794|NCT01889758|tacrolimus|tacrolimus
5362795|NCT01889758|kidney|kidney
5362796|NCT01889758|liver|liver
5362797|NCT01889758|transplant|transplant
5362798|NCT01889719|HIV Prevention|hiv prevention
5362799|NCT01889706|Type 1 diabetes mellitus,|type 1 diabetes mellitus,
5362800|NCT01889706|metformin,|metformin,
5362801|NCT01889706|insulin resistance,|insulin resistance,
5362802|NCT01889706|obesity|obesity
5362803|NCT01889693|positron emission tomography|positron emission tomography
5362804|NCT01889693|macrophage|macrophage
5362805|NCT01889693|neomannosyl human serum albumin|neomannosyl human serum albumin
5362806|NCT01889680|colorectal cancer|colorectal cancer
5362807|NCT01889680|metastatic colorectal cancer|metastatic colorectal cancer
5362808|NCT01889680|ziv-aflibercept|ziv-aflibercept
5362809|NCT01889680|NSABP|nsabp
5362810|NCT01889667|Oral Insulin|oral insulin
5362811|NCT01889667|Diabetes Mellitus Type 2|diabetes mellitus type 2
5362812|NCT01889667|Safety|safety
5680239|NCT00578565|Rituximab|rituximab
5362813|NCT01889667|Pharmacodynamics|pharmacodynamics
5362814|NCT01889667|Pharmacokinetics|pharmacokinetics
5362815|NCT01889628|Glycaemic response|glycaemic response
5362816|NCT01889628|Glycaemic Index|glycaemic index
5362817|NCT01889628|Nutritional formula|nutritional formula
5362818|NCT01889628|Asia|asia
5362819|NCT01889628|Ethnic differences|ethnic differences
5362820|NCT01889628|Chinese|chinese
5362821|NCT01889628|Malay|malay
5362822|NCT01889628|Indian|indian
5362823|NCT01889615|Ovarian cancer|ovarian cancer
5362824|NCT01889615|PET/CT|pet/ct
5362825|NCT01889615|glucose 6 phosphatase|glucose 6 phosphatase
5362826|NCT01889602|Healthy volunteers|healthy volunteers
5362827|NCT01889602|Topiramate|topiramate
5362828|NCT01889602|Neurocognition|neurocognition
5362829|NCT01889602|Drug-induced cognitive deficits|drug-induced cognitive deficits
5362830|NCT01889576|glucose|glucose
5362831|NCT01889563|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5362832|NCT01889563|heart rate variability|heart rate variability
5362833|NCT01889563|physical training|physical training
5362834|NCT01889550|Screening|screening
5362835|NCT01889550|Downs syndrome|downs syndrome
5362836|NCT01889550|Informed choice|informed choice
5362837|NCT01889550|eHealth|ehealth
5362838|NCT01889537|Virtual Reality Ketamine|virtual reality ketamine
5362839|NCT01889511|Text Messaging|text messaging
5362840|NCT01889511|Medication Adherence|medication adherence
5362841|NCT01889511|Oral Agents|oral agents
5362842|NCT01889498|Acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery|acetazolamide, intracranial/cerebrospinal fluid pressure, paraplegia, thoracoabdominal aortic surgery
5362843|NCT01889485|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5362844|NCT01889485|Carotid Stenosis|carotid stenosis
5362845|NCT01889485|Peripheral Arterial Disease|peripheral arterial disease
5362846|NCT01889485|Health Services Accessibility|health services accessibility
5362847|NCT01889472|CPAP compliance|cpap compliance
5362848|NCT01889472|leaks|leaks
5362849|NCT01889472|Respiratory disturbances index|respiratory disturbances index
5362850|NCT01889472|quality of life|quality of life
5362851|NCT01889446|Propionic acid|propionic acid
5362852|NCT01889446|Food preservatives|food preservatives
5362853|NCT01889433|Hepatitis C|hepatitis c
5362854|NCT01889433|Cepeginterferon alfa|cepeginterferon alfa
5362855|NCT01889433|Peginterferon|peginterferon
5362856|NCT01889433|Treatment|treatment
5362865|NCT01889420|dexamethasone|dexamethasone
5362866|NCT01889407|Acute Myeloid Leukemia|acute myeloid leukemia
5362867|NCT01889394|pilonidal sinus|pilonidal sinus
5362869|NCT01889394|primary wound closure|primary wound closure
5362870|NCT01889394|limberg flap|limberg flap
5362871|NCT01889381|Facial Injuries|facial injuries
5362872|NCT01889381|Face Transplant|face transplant
5362873|NCT01889381|Facial Transplantation|facial transplantation
5362875|NCT01889368|Insulin resistance|insulin resistance
5362876|NCT01889368|Central adiposity|central adiposity
5362877|NCT01889368|Elevated blood pressure|elevated blood pressure
5362878|NCT01889368|Vascular reactivity|vascular reactivity
5362879|NCT01889368|Elevated triglycerides|elevated triglycerides
5362880|NCT01889368|Low high-density lipoprotein (HDL)|low high-density lipoprotein (hdl)
5362881|NCT01889355|diabetes|diabetes
5362883|NCT01889355|glucometer|glucometer
5362885|NCT01889342|Metacognitive therapy|metacognitive therapy
5362886|NCT01889342|Anxiety disorders|anxiety disorders
5362887|NCT01889342|Transdiagnostic|transdiagnostic
5362888|NCT01889316|Fetal monitoring|fetal monitoring
5362890|NCT01889303|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5362891|NCT01889303|FOLFOX6|folfox6
5362892|NCT01889303|chemotherapy|chemotherapy
5362894|NCT01889303|cisplatin|cisplatin
5362895|NCT01889303|gastric cancer|gastric cancer
5362896|NCT01889290|methylnaltrexone|methylnaltrexone
5362897|NCT01889290|opioid-antagonist|opioid-antagonist
5362898|NCT01889290|Obstipation|obstipation
5362899|NCT01889290|pharmacokinetics|pharmacokinetics
5362900|NCT01889277|Diabetic Nephropathy|diabetic nephropathy
5362901|NCT01889264|Methionine Metabolism|methionine metabolism
5362902|NCT01889264|Enteral Nutrition|enteral nutrition
5362903|NCT01889264|Pediatric|pediatric
5362904|NCT01889264|Pediatrics|pediatrics
5362905|NCT01889264|Sepsis|sepsis
5321196|NCT02079402|ICU|icu
5229464|NCT02567773|Safety|safety
5362906|NCT01889264|Observational Study|observational study
5362907|NCT01889251|Vitreomacular Adhesion|vitreomacular adhesion
5362908|NCT01889251|Vitreomacular Traction|vitreomacular traction
5362909|NCT01889251|Vitreomacular Traction Syndrome|vitreomacular traction syndrome
5362910|NCT01889251|Vitrectomy|vitrectomy
5362911|NCT01889251|Central Visual Field Defect|central visual field defect
5362912|NCT01889251|Blind Spot|blind spot
5362913|NCT01889251|Intravitreal Injection|intravitreal injection
5362914|NCT01889251|Macula|macula
5362915|NCT01889251|Retina|retina
5362916|NCT01889251|Decreased Visual Acuity|decreased visual acuity
5362917|NCT01889251|Visual Complaint|visual complaint
5362918|NCT01889251|SD-OCT|sd-oct
5362919|NCT01889251|Macular Hole|macular hole
5362920|NCT01889238|breast cancer|breast cancer
5362921|NCT01889238|triple negative|triple negative
5362922|NCT01889238|androgen receptor positive|androgen receptor positive
5362923|NCT01889199|polycystic ovary syndrome|polycystic ovary syndrome
5362924|NCT01889199|hirsutism|hirsutism
5362925|NCT01889199|anovulation|anovulation
5362926|NCT01889199|oligomenorrhea|oligomenorrhea
5362927|NCT01889199|amenorrhea|amenorrhea
5362928|NCT01889199|hyperandrogenism|hyperandrogenism
5362929|NCT01889199|antiandrogen effect|antiandrogen effect
5362930|NCT01889186|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5362931|NCT01889186|17 p Deletion|17 p deletion
5362932|NCT01889160|Healthy volunteers, Phase 1|healthy volunteers, phase 1
5362933|NCT01889147|Peak plasma concentration|peak plasma concentration
5362934|NCT01889147|safety and efficacy|safety and efficacy
5362935|NCT01889147|therapeutic agent|therapeutic agent
5362936|NCT01889147|LPS-mediated diseases|lps-mediated diseases
5362937|NCT01889147|Pharmacokinetics of administered hRESCAP|pharmacokinetics of administered hrescap
5362938|NCT01889147|Determine half-time|determine half-time
5362939|NCT01889134|primary hyperparathyroidism|primary hyperparathyroidism
5362941|NCT01889134|osteoprotegerin|osteoprotegerin
5362942|NCT01889134|bone mineral density|bone mineral density
5362943|NCT01889134|alendronate|alendronate
5362944|NCT01889134|parathyroidectomy|parathyroidectomy
5362945|NCT01889108|Premature|premature
5362946|NCT01889108|Development|development
5362947|NCT01889108|Motor|motor
5362948|NCT01889108|Cognitive|cognitive
5362949|NCT01889108|Parent|parent
5362950|NCT01889082|Obesity|obesity
5362951|NCT01889082|weight loss|weight loss
5362952|NCT01889082|young adults|young adults
5362953|NCT01889056|Erythropoietin|erythropoietin
5362954|NCT01889056|Cognition|cognition
5362957|NCT01889043|Noninvasive Ventilation|noninvasive ventilation
5362958|NCT01889043|Polysomnography|polysomnography
5362959|NCT01889030|Cardiovascular primary prevention|cardiovascular primary prevention
5362960|NCT01889030|Cardiovascular risk strtification|cardiovascular risk strtification
5362961|NCT01889017|generic immunosuppressive|generic immunosuppressive
5362962|NCT01889004|Cerebral blood flow|cerebral blood flow
5362963|NCT01889004|Consciousness|consciousness
5362964|NCT01889004|Dexmedetomidine|dexmedetomidine
5362966|NCT01889004|Event related potentials|event related potentials
5362967|NCT01889004|Functional magnetic resonance imaging|functional magnetic resonance imaging
5362968|NCT01889004|General anesthesia|general anesthesia
5362969|NCT01889004|Positron emission tomography|positron emission tomography
5362970|NCT01889004|Propofol|propofol
5362971|NCT01888991|Glucose|glucose
5362972|NCT01888991|Exercise|exercise
5362973|NCT01888991|Metabolic flexibility|metabolic flexibility
5362974|NCT01888991|Substrate Oxidation|substrate oxidation
5362975|NCT01888991|Food intake|food intake
5362976|NCT01888978|Pancreas|pancreas
5362977|NCT01888978|cancer|cancer
5362978|NCT01888978|metastatic|metastatic
5362979|NCT01888978|chemotherapy|chemotherapy
5362980|NCT01888965|Maintenance therapy|maintenance therapy
5362981|NCT01888965|Adjuvant Therapy|adjuvant therapy
5362982|NCT01888939|Executive Function|executive function
5362984|NCT01888939|Obesity|obesity
5362985|NCT01888939|Exercise|exercise
5362986|NCT01888939|Insulin Sensitivity|insulin sensitivity
5362987|NCT01888926|rPAS|rpas
5362988|NCT01888926|Dystonia|dystonia
5362989|NCT01888913|Body Weight|body weight
5362990|NCT01888913|Virtual Environment|virtual environment
5362991|NCT01888900|Hepatitis C|hepatitis c
5362992|NCT01888900|Non-Responders|non-responders
5362993|NCT01888900|Direct Acting Antivirals|direct acting antivirals
5362994|NCT01888900|Interferon Free|interferon free
5362995|NCT01888900|Cirrhosis|cirrhosis
5362996|NCT01888874|Methotrexate insufficient responders|methotrexate insufficient responders
5362997|NCT01888861|length of stay in ICU|length of stay in icu
5964198|NCT04157127|Immunotherapy|immunotherapy
5964199|NCT04157127|Adjuvant therapy|adjuvant therapy
5964200|NCT04157036|Inferior alveolar nerve block|inferior alveolar nerve block
5964201|NCT04157036|Symptomatic irreversible pulpitis|symptomatic irreversible pulpitis
5964202|NCT04157036|Preoperative steroid|preoperative steroid
5964203|NCT04157036|Preoperative NSAID|preoperative nsaid
5964204|NCT04156503|Chylomicron|chylomicron
5964205|NCT04156503|fatty acid composition|fatty acid composition
5964206|NCT04156503|lard|lard
5964207|NCT04156503|palm olein|palm olein
5964208|NCT04156009|aromatherapy|aromatherapy
5964209|NCT04156009|lavender|lavender
5964210|NCT04156009|anxiety|anxiety
5362998|NCT01888861|ventilator free days|ventilator free days
5362999|NCT01888848|Postural Balance|postural balance
5363000|NCT01888848|Walking|walking
5363001|NCT01888848|Gait|gait
5363002|NCT01888848|Cognition|cognition
5363003|NCT01888848|Learning|learning
5363004|NCT01888848|Memory|memory
5363005|NCT01888848|Blueberry|blueberry
5363006|NCT01888848|Antioxidants|antioxidants
5363007|NCT01888848|Anti-Inflammatory Agents|anti-inflammatory agents
5363008|NCT01888848|Brain|brain
5363009|NCT01888835|HIV|hiv
5363010|NCT01888835|sexual behavior|sexual behavior
5363011|NCT01888822|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5363012|NCT01888822|Prophylactic antibiotics|prophylactic antibiotics
5363013|NCT01888809|teen parents|teen parents
5363014|NCT01888809|early childhood development|early childhood development
5363015|NCT01888809|home visitation|home visitation
5363016|NCT01888809|evidence-based treatment|evidence-based treatment
5363017|NCT01888796|T2DM|t2dm
5363018|NCT01888796|diastolic dysfunction|diastolic dysfunction
5363019|NCT01888783|CRPS Type I|crps type i
5363020|NCT01888783|tactile acuity|tactile acuity
5363021|NCT01888783|2-point-discrimination|2-point-discrimination
5363022|NCT01888783|Grating Orientation Task|grating orientation task
5363023|NCT01888783|sensory signs|sensory signs
5363024|NCT01888757|Bioequivalence|bioequivalence
5363025|NCT01888757|Lamotrigine Extended Release|lamotrigine extended release
5363026|NCT01888757|crossover|crossover
5445486|NCT01521533|Spiegelmer|spiegelmer
5363027|NCT01888744|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
5363028|NCT01888744|PGD|pgd
5363029|NCT01888744|GnrH agonist|gnrh agonist
5363030|NCT01888744|GnRH antagonist|gnrh antagonist
5363031|NCT01888731|Bioequivalence|bioequivalence
5363032|NCT01888731|Lamotrigine Extended Release|lamotrigine extended release
5363033|NCT01888731|crossover|crossover
5363034|NCT01888705|COPD|copd
5363035|NCT01888705|Complexity|complexity
5363036|NCT01888705|Entropy Sampling|entropy sampling
5363037|NCT01888705|Variability|variability
5363038|NCT01888705|Respiratory Mechanics|respiratory mechanics
5363039|NCT01888705|FOT|fot
5363040|NCT01888692|PET/CT|pet/ct
5363041|NCT01888692|Radiotherapy|radiotherapy
5363042|NCT01888692|Lung Cancer|lung cancer
5363043|NCT01888679|Airway|airway
5363044|NCT01888679|Endotracheal intubation|endotracheal intubation
5363045|NCT01888679|selective intubation|selective intubation
5363046|NCT01888653|PTSD|ptsd
5363047|NCT01888653|Attention Bias to threat|attention bias to threat
5363048|NCT01888653|Attention Bias Modification Treatment|attention bias modification treatment
5363049|NCT01888640|TENS|tens
5363050|NCT01888640|Fibromyalgia|fibromyalgia
5363051|NCT01888640|Accelerometer|accelerometer
5363052|NCT01888627|Schizophrenia|schizophrenia
5363053|NCT01888627|Bipolar disorder|bipolar disorder
5363054|NCT01888627|Assertive community treatment|assertive community treatment
5363055|NCT01888627|Integrated care|integrated care
5363056|NCT01888627|Severe and persistent mental disorder|severe and persistent mental disorder
5363057|NCT01888614|carbon mono oxide|carbon mono oxide
5363058|NCT01888614|sickle cell|sickle cell
5363059|NCT01888614|hemolysis|hemolysis
5363060|NCT01888588|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
5363061|NCT01888588|Low dose aspirin (ASA)|low dose aspirin (asa)
5363062|NCT01888588|Acid-suppressing drugs|acid-suppressing drugs
5363063|NCT01888588|Epidemiology|epidemiology
5363064|NCT01888575|Discontinuation of low dose ASA,|discontinuation of low dose asa,
5363065|NCT01888575|Secondary cardiovascular prevention,|secondary cardiovascular prevention,
5363066|NCT01888575|Acid-suppressing drugs,|acid-suppressing drugs,
5363067|NCT01888575|Gastrointestinal risk,|gastrointestinal risk,
5363068|NCT01888575|Epidemiology|epidemiology
5363069|NCT01888549|Chronic cough, proton pump inhibitor, GERD, nonacid reflux,|chronic cough, proton pump inhibitor, gerd, nonacid reflux,
5363070|NCT01888497|Sleeplessness|sleeplessness
5363071|NCT01888484|PID|pid
5363072|NCT01888471|Streptococcal disease|streptococcal disease
5363073|NCT01888471|Feasibility|feasibility
5363074|NCT01888471|Infants|infants
5363075|NCT01888458|Adult|adult
5363076|NCT01888458|allo-Stem Cell Transplantation|allo-stem cell transplantation
5363077|NCT01888458|Cord Blood|cord blood
5358716|NCT01908764|ear tubes|ear tubes
5363078|NCT01888445|Chronic Renal Failure|chronic renal failure
5363079|NCT01888445|ASP1517|asp1517
5363080|NCT01888445|Renal anemia|renal anemia
5363081|NCT01888432|liver transplantation|liver transplantation
5363082|NCT01888432|everolimus|everolimus
5363083|NCT01888432|tacrolimus|tacrolimus
5363084|NCT01888432|reduced calcineuron inhibitor|reduced calcineuron inhibitor
5363085|NCT01888432|renal function|renal function
5363086|NCT01888432|living donor|living donor
5363087|NCT01888432|RAD001H2307|rad001h2307
5964211|NCT04156009|spine intervention|spine intervention
5964212|NCT04155918|Hyperuricemia|hyperuricemia
5964213|NCT04155918|Gout|gout
5964214|NCT04155918|URAT1|urat1
5964215|NCT04155541|VIZIMPRO|vizimpro
5964216|NCT04155541|EGFR mutation-positive inoperable or recurrent NSCLC|egfr mutation-positive inoperable or recurrent nsclc
5964217|NCT04155541|non-small cell lung cancer|non-small cell lung cancer
5964218|NCT04155268|Healthy|healthy
5964219|NCT04155268|Virtual Reality|virtual reality
5964220|NCT04155268|Floatation-REST|floatation-rest
5363088|NCT01888432|RAD001H|rad001h
5363089|NCT01888419|Post Breast Therapy Pain Syndrome|post breast therapy pain syndrome
5363090|NCT01888419|Lipotransplantation|lipotransplantation
5363091|NCT01888419|Breast Cancer|breast cancer
5363092|NCT01888419|Pain|pain
5363093|NCT01888406|Obesity|obesity
5363094|NCT01888406|Weight gain prevention|weight gain prevention
5363095|NCT01888406|Eating disorder|eating disorder
5363096|NCT01888406|Binge eating|binge eating
5363097|NCT01888393|pharmacokinetics, hepatic impairment|pharmacokinetics, hepatic impairment
5363098|NCT01888380|Autopsy|autopsy
5363099|NCT01888380|Minimally invasive|minimally invasive
5363100|NCT01888380|Foetuses|foetuses
5363101|NCT01888380|Newborns|newborns
5363102|NCT01888380|Children|children
5363103|NCT01888380|Adolescents|adolescents
5363104|NCT01888354|MS|ms
5363105|NCT01888354|Multiple Sclerosis|multiple sclerosis
5363106|NCT01888315|Hypertension|hypertension
5363107|NCT01888315|Heart Failure|heart failure
5363108|NCT01888315|Sympathetic activity|sympathetic activity
5363109|NCT01888276|Words generation, compulsive gamblers|words generation, compulsive gamblers
5363110|NCT01888263|Bioequivalence|bioequivalence
5363111|NCT01888263|Lamotrigine Extended Release|lamotrigine extended release
5363112|NCT01888263|crossover|crossover
5363113|NCT01888250|Bioequivalence|bioequivalence
5363114|NCT01888250|Lamotrigine Extended Release|lamotrigine extended release
5363115|NCT01888250|crossover|crossover
5363116|NCT01888237|Dyspepsia|dyspepsia
5363117|NCT01888237|Helicobacter pylori|helicobacter pylori
5363118|NCT01888237|Clarithromycin resistance|clarithromycin resistance
5680240|NCT00578552|tobacco|tobacco
5363119|NCT01888237|Other Specified Disorders of Function of Stomach|other specified disorders of function of stomach
5363120|NCT01888198|ablation|ablation
5363121|NCT01888198|quality of Life (QOL)|quality of life (qol)
5363122|NCT01888198|kidney|kidney
5363123|NCT01888198|registry|registry
5363124|NCT01888198|Ablation of Renal Masses Outcomes Registry (ARMOR)|ablation of renal masses outcomes registry (armor)
5363125|NCT01888198|13-116|13-116
5363126|NCT01888185|Parkinson's|parkinson's
5363127|NCT01888185|PD|pd
5363128|NCT01888185|nigrostriatal|nigrostriatal
5363129|NCT01888185|substantia nigra|substantia nigra
5363130|NCT01888185|MRI|mri
5363131|NCT01888185|DTI|dti
5363132|NCT01888185|FA|fa
5363133|NCT01888185|R2*|r2*
5363134|NCT01888185|Parkinson's Disease Biomarkers Program|parkinson's disease biomarkers program
5363135|NCT01888185|PDBP|pdbp
5363136|NCT01888185|ferritin|ferritin
5363137|NCT01888185|transferrin|transferrin
5363138|NCT01888185|Fe|fe
5363139|NCT01888185|iron protein|iron protein
5363140|NCT01888185|PSP|psp
5363141|NCT01888185|MSA|msa
5363142|NCT01888146|Pain management|pain management
5363143|NCT01888146|Opioid use|opioid use
5363144|NCT01888146|Pragmatic|pragmatic
5363145|NCT01888146|Collaborative care|collaborative care
5363146|NCT01888146|Primary care|primary care
5363147|NCT01888107|Schizophrenia|schizophrenia
5363148|NCT01888107|Schizoaffective Disorder|schizoaffective disorder
5363149|NCT01888107|Antipsychotics|antipsychotics
5363150|NCT01888107|Risperidone|risperidone
5363151|NCT01888107|Long-acting injectable|long-acting injectable
5363152|NCT01888094|Central venous catheter|central venous catheter
5363153|NCT01888094|Complications|complications
5363154|NCT01888094|Ultrasound|ultrasound
5363155|NCT01888094|Subclavian vein cannulation|subclavian vein cannulation
5363156|NCT01888094|Critical care|critical care
5363157|NCT01888094|Echocardiography|echocardiography
5363158|NCT01888094|Chest radiographyiography|chest radiographyiography
5363159|NCT01888055|Healthy older adults Cortical Plasticity|healthy older adults cortical plasticity
5363160|NCT01888055|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5363161|NCT01888029|mild cognitive impairment|mild cognitive impairment
5363162|NCT01888029|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5363163|NCT01888029|Cortical Plasticity|cortical plasticity
5363164|NCT01888003|anemia|anemia
5363165|NCT01887977|Orthognathic surgery|orthognathic surgery
5363166|NCT01887977|Speech production|speech production
5363168|NCT01887964|Diabetes|diabetes
5363169|NCT01887964|Obesity|obesity
5363170|NCT01887964|Cardiovascular disease|cardiovascular disease
5363171|NCT01887964|Metabolic syndrome|metabolic syndrome
5363172|NCT01887925|breast neoplasms|breast neoplasms
5363173|NCT01887925|sleep|sleep
5363174|NCT01887925|anxiety|anxiety
5363175|NCT01887925|depression|depression
5363176|NCT01887925|life quality|life quality
5363177|NCT01887912|Clostridium difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
5363178|NCT01887912|Clostridium difficile infection|clostridium difficile infection
5363179|NCT01887912|Cdiffense|cdiffense
5363180|NCT01887899|cortical plasticity|cortical plasticity
5363181|NCT01887899|transcranial direct current stimulation|transcranial direct current stimulation
5964221|NCT04155268|Float Tank|float tank
5964222|NCT04155268|Floating|floating
5964223|NCT04155268|Overview Effect|overview effect
5964224|NCT04155190|High Frequency Basal Cell Carcinoma|high frequency basal cell carcinoma
5964225|NCT04155190|non-gorlin|non-gorlin
5964226|NCT04155190|HF-BCC|hf-bcc
5964227|NCT04155190|Bazex-Dupré-Christol Syndrome|bazex-dupré-christol syndrome
5363182|NCT01887873|open angle glaucoma|open angle glaucoma
5363184|NCT01887860|Cetaphil Daily Facial Moisturizer SPF 50|cetaphil daily facial moisturizer spf 50
5363185|NCT01887847|nicotine|nicotine
5363186|NCT01887847|pharmacokinetics|pharmacokinetics
5363188|NCT01887834|constipation|constipation
5363189|NCT01887834|diarrhea|diarrhea
5363191|NCT01887834|mucous|mucous
5363192|NCT01887834|cramping|cramping
5363193|NCT01887808|Determine|determine
5363194|NCT01887808|Hypoallergenicity|hypoallergenicity
5363195|NCT01887808|Cetaphil DermaControl Oil Control Moisturizer SPF 30|cetaphil dermacontrol oil control moisturizer spf 30
5363196|NCT01887795|Informed Consent;|informed consent;
5363197|NCT01887795|Ethical Principles;|ethical principles;
5363198|NCT01887795|Data collection|data collection
5363199|NCT01887782|depression|depression
5363200|NCT01887782|magnetic|magnetic
5363201|NCT01887782|brain stimulation|brain stimulation
5363202|NCT01887782|treatment-resistant|treatment-resistant
5363203|NCT01887769|Lung cancer|lung cancer
5363204|NCT01887769|Body composition analysis|body composition analysis
5363205|NCT01887769|Ct-Scan|ct-scan
5363206|NCT01887769|Muscle mass|muscle mass
5363207|NCT01887769|Cachexia|cachexia
5363208|NCT01887756|telerehabilitation stroke virtual reatlity|telerehabilitation stroke virtual reatlity
5363209|NCT01887743|GERD|gerd
5363210|NCT01887743|Obesity|obesity
5363211|NCT01887743|Pediatric|pediatric
5363212|NCT01887743|Pantoprazole|pantoprazole
5363213|NCT01887743|CYP2C19|cyp2c19
5363214|NCT01887743|Pharmacokinetic|pharmacokinetic
5363215|NCT01887730|Hand Hygiene|hand hygiene
5363216|NCT01887730|Communicable Diseases|communicable diseases
5363217|NCT01887730|Prevention|prevention
5363218|NCT01887717|hepatocellular carcinoma|hepatocellular carcinoma
5363219|NCT01887717|portal vein thrombosis|portal vein thrombosis
5363220|NCT01887691|Diabetes|diabetes
5363221|NCT01887691|Prediabetic|prediabetic
5363222|NCT01887691|Prediabetes|prediabetes
5363223|NCT01887691|Glucose intolerance|glucose intolerance
5363224|NCT01887691|Sleep quality|sleep quality
5363225|NCT01887691|Continuous glucose monitoring|continuous glucose monitoring
5363226|NCT01887691|Diabetes risk|diabetes risk
5363227|NCT01887691|eszopiclone|eszopiclone
5363228|NCT01887665|substance use disorders|substance use disorders
5363229|NCT01887665|substance abuse|substance abuse
5363230|NCT01887665|substance abuse treatment|substance abuse treatment
5363231|NCT01887665|contingency management|contingency management
5363232|NCT01887652|In Vitro Fertilization|in vitro fertilization
5363233|NCT01887652|ovulation induction|ovulation induction
5363234|NCT01887652|anti-mullerian hormone|anti-mullerian hormone
5363235|NCT01887639|Non-psychotic unipolar major depression|non-psychotic unipolar major depression
5363236|NCT01887639|Resistant depression|resistant depression
5363237|NCT01887626|Phase 1, pharmacokinetic, safety, Ticagrelor|phase 1, pharmacokinetic, safety, ticagrelor
5363238|NCT01887613|Gabapentin|gabapentin
5363240|NCT01887600|chronic kidney disease (CKD)|chronic kidney disease (ckd)
5363241|NCT01887600|Hemoglobin (Hb)|hemoglobin (hb)
5363242|NCT01887600|non-dialysis|non-dialysis
5363243|NCT01887548|Crohn's disease|crohn's disease
5363244|NCT01887548|inflammatory bowel disease|inflammatory bowel disease
5363245|NCT01887548|quality of life|quality of life
5363246|NCT01887548|personality|personality
5363247|NCT01887548|neuroticism|neuroticism
5363248|NCT01887535|Healthy|healthy
5363249|NCT01887535|Elderly|elderly
5363250|NCT01887535|Safety|safety
5363251|NCT01887535|Tolerability|tolerability
5363252|NCT01887535|Pharmacokinetic|pharmacokinetic
5363253|NCT01887535|Alzheimer's Disease|alzheimer's disease
5367071|NCT01870687|PMS|pms
5363255|NCT01887522|Children|children
5363256|NCT01887522|Adolescents|adolescents
5363257|NCT01887522|Young Adults|young adults
5363258|NCT01887509|Rectal cancer|rectal cancer
5363259|NCT01887509|Tumor margin|tumor margin
5363260|NCT01887509|Confocal endomicroscopy|confocal endomicroscopy
5363261|NCT01887509|Virtual biopsy|virtual biopsy
5363262|NCT01887509|Fluorescein|fluorescein
5363263|NCT01887496|Varicella|varicella
5363264|NCT01887496|Turkey|turkey
5363265|NCT01887496|hospitalization|hospitalization
5363266|NCT01887496|varicella vaccine|varicella vaccine
5363268|NCT01887483|bowel function|bowel function
5363269|NCT01887483|probiotic|probiotic
5363270|NCT01887470|Bowel Evacuation|bowel evacuation
5363271|NCT01887470|Colonoscopy Preparation|colonoscopy preparation
5363272|NCT01887457|voriconazole|voriconazole
5363273|NCT01887457|VFEND|vfend
5363274|NCT01887457|individualised|individualised
5363275|NCT01887457|personalised|personalised
5363276|NCT01887444|Pediatric Gastroenterology|pediatric gastroenterology
5363277|NCT01887444|Probiotics|probiotics
5363278|NCT01887444|Lactobacillus reuteri|lactobacillus reuteri
5363279|NCT01887431|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5363280|NCT01887431|Adult|adult
5363281|NCT01887431|Insulin Infusion Systems|insulin infusion systems
5363282|NCT01887431|Telecare|telecare
5964228|NCT04155190|Rombo Syndrome|rombo syndrome
5964229|NCT04155190|Oley Syndrome|oley syndrome
5964230|NCT04155190|Xeroderma Pigmentosum (XP) Syndrome|xeroderma pigmentosum (xp) syndrome
5964231|NCT04155190|BCC|bcc
5964232|NCT04155190|SEB|seb
5363283|NCT01887418|Hypogonadism|hypogonadism
5363284|NCT01887418|Testosterone enanthate|testosterone enanthate
5363285|NCT01887405|Adrenaline|adrenaline
5363286|NCT01887405|Auto-injector|auto-injector
5363288|NCT01887405|Epipen|epipen
5363289|NCT01887392|Long-term Care|long-term care
5363290|NCT01887392|Knowledge Translation|knowledge translation
5363291|NCT01887379|Gastroretentive drug formulation|gastroretentive drug formulation
5363293|NCT01887379|Magnetic Marker Monitoring|magnetic marker monitoring
5363294|NCT01887379|Magnetic marker|magnetic marker
5363295|NCT01887379|Oedema|oedema
5363296|NCT01887366|Cocaine addiction|cocaine addiction
5363297|NCT01887366|TV-1380|tv-1380
5363298|NCT01887366|Recombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)|recombinant human serum albumin (hsa) mutated butyrylcholinesterase (albubche)
5363299|NCT01887353|atrial fibrillation|atrial fibrillation
5363300|NCT01887353|heart failure|heart failure
5363301|NCT01887353|ranolazine|ranolazine
5363302|NCT01887353|cardioversion|cardioversion
5363303|NCT01887353|persistent AF|persistent af
5363304|NCT01887353|paroxysmal AF|paroxysmal af
5363305|NCT01887327|G6PD deficiency|g6pd deficiency
5363306|NCT01887327|Antibody (ABO) incompatibility|antibody (abo) incompatibility
5445487|NCT01521533|Chemosensitization|chemosensitization
5363307|NCT01887327|Coombs positive ABO/ rhesus factor (RH) incompatibility|coombs positive abo/ rhesus factor (rh) incompatibility
5363308|NCT01887327|Intensive phototherapy in neonates|intensive phototherapy in neonates
5363309|NCT01887314|Cancer|cancer
5363310|NCT01887314|Cisplatin|cisplatin
5363311|NCT01887314|Nausea|nausea
5363312|NCT01887314|Ginger|ginger
5363313|NCT01887314|Zingiber officinale|zingiber officinale
5363314|NCT01887314|5HT3|5ht3
5363315|NCT01887314|Dexamethasone|dexamethasone
5363316|NCT01887314|Neurokinin-1 (NK-1)|neurokinin-1 (nk-1)
5363317|NCT01887314|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5363318|NCT01887314|Tumor necrosis factor-alpha (TNF-alpha)|tumor necrosis factor-alpha (tnf-alpha)
5363319|NCT01887314|Insulin like growth factor-1 (IGF-1)|insulin like growth factor-1 (igf-1)
5363320|NCT01887314|Placebo|placebo
5363321|NCT01887314|FLIE|flie
5363322|NCT01887314|BFI|bfi
5363323|NCT01887275|Chronic hepatitis B|chronic hepatitis b
5363324|NCT01887275|Medical Ozone|medical ozone
5363325|NCT01887275|Interferon-α|interferon-α
5363326|NCT01887275|Efficacy|efficacy
5363327|NCT01887262|fluid|fluid
5363328|NCT01887262|edema|edema
5363329|NCT01887223|Encapsulated blebs|encapsulated blebs
5363330|NCT01887223|trabeculectomy failure|trabeculectomy failure
5363331|NCT01887223|glaucoma|glaucoma
5363332|NCT01887210|HIV|hiv
5363333|NCT01887210|youth|youth
5363334|NCT01887210|medical adherence|medical adherence
5363335|NCT01887197|cystic fibrosis|cystic fibrosis
5363336|NCT01887197|mucociliary clearance|mucociliary clearance
5363337|NCT01887197|airway surface liquid|airway surface liquid
5363338|NCT01887197|nuclear medicine|nuclear medicine
5363339|NCT01887197|mannitol|mannitol
5363340|NCT01887171|Liver transplantation|liver transplantation
5363341|NCT01887171|Early allograft dysfunction|early allograft dysfunction
5363342|NCT01887171|Ischemic reperfusion injury|ischemic reperfusion injury
5363343|NCT01887171|Portal and arterial ex vivo HTK flush|portal and arterial ex vivo htk flush
5363344|NCT01887145|Carpal tunnel syndrome|carpal tunnel syndrome
5363345|NCT01887145|Surgery|surgery
5363346|NCT01887145|Outcomes|outcomes
5363347|NCT01887132|Sleep Architecture|sleep architecture
5363348|NCT01887132|Autism|autism
5363349|NCT01887132|Language Development|language development
5363350|NCT01887093|coronary artery disease|coronary artery disease
5363351|NCT01887093|walking|walking
5363352|NCT01887093|lipids|lipids
5363353|NCT01887093|inflammatory markers|inflammatory markers
5363354|NCT01887093|time of day|time of day
5363355|NCT01887080|Cardiovascular rehabilitation home-based|cardiovascular rehabilitation home-based
5363356|NCT01887080|Acute myocardial infarction|acute myocardial infarction
5363357|NCT01887080|Obesity|obesity
5363358|NCT01887080|Microcurrent|microcurrent
5363359|NCT01887067|Hypertension|hypertension
5363360|NCT01887067|Diabetes Mellitus|diabetes mellitus
5363361|NCT01887041|Advanced, metastasising pancreatic head carcinoma|advanced, metastasising pancreatic head carcinoma
5363362|NCT01887041|Jaundice|jaundice
5363363|NCT01887041|Biliodigestive anastomosis|biliodigestive anastomosis
5363364|NCT01887041|Endoscopically inserted biliary tract drainage|endoscopically inserted biliary tract drainage
5363365|NCT01887041|Quality of Life|quality of life
5363366|NCT01887028|Carbon deoxide pneumoperitoneum|carbon deoxide pneumoperitoneum
5363367|NCT01887028|Intraperitoneal pressure|intraperitoneal pressure
5363368|NCT01887028|Peritoneum|peritoneum
5363369|NCT01887028|Gene expression|gene expression
5363370|NCT01887028|Post-operative recovery|post-operative recovery
5363371|NCT01887028|Laparoscopic Humidification System|laparoscopic humidification system
5363372|NCT01887015|Postoperative pulmonary complications|postoperative pulmonary complications
5363373|NCT01887015|Oxygen therapy|oxygen therapy
5964233|NCT04155190|Hedgehog inhibitor|hedgehog inhibitor
5964234|NCT04155190|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5964235|NCT04155190|Basal Cell Carcinoma|basal cell carcinoma
5964236|NCT04155190|Surgically Eligible Basal Cell Carcinoma|surgically eligible basal cell carcinoma
5964237|NCT04155190|patidegib|patidegib
5964238|NCT04155190|HFBCC|hfbcc
5964239|NCT04155190|HHI|hhi
5229942|NCT02564965|Walled-Off Pancreatic Necrosis|walled-off pancreatic necrosis
5363374|NCT01887015|Nasal high flow oxygen therapy|nasal high flow oxygen therapy
5363375|NCT01887015|Nasal high flow cannula|nasal high flow cannula
5363376|NCT01887002|Irritable Bowel Syndrome|irritable bowel syndrome
5363377|NCT01887002|IBS|ibs
5363378|NCT01887002|ONO-2952|ono-2952
5363379|NCT01886989|diabetes|diabetes
5359015|NCT01907126|HIV|hiv
5363380|NCT01886989|cocoa polyphenols|cocoa polyphenols
5363381|NCT01886989|postprandial glycemia|postprandial glycemia
5363382|NCT01886989|postprandial lipemia|postprandial lipemia
5363383|NCT01886976|multiple myeloma|multiple myeloma
5363385|NCT01886950|Bone histomorphometry|bone histomorphometry
5363386|NCT01886950|Renal transplantation|renal transplantation
5363387|NCT01886924|Tobacco|tobacco
5363388|NCT01886924|Nicotine|nicotine
5363390|NCT01886924|Quitline|quitline
5363391|NCT01886911|prosocial behavior|prosocial behavior
5363392|NCT01886911|prosocial|prosocial
5363393|NCT01886911|attention training|attention training
5363394|NCT01886911|attention|attention
5363395|NCT01886911|empathy|empathy
5363396|NCT01886911|emotion recognition|emotion recognition
5363397|NCT01886885|Mindfulness|mindfulness
5363398|NCT01886885|Meditation|meditation
5363399|NCT01886885|Chronic Pain|chronic pain
5363400|NCT01886833|Rotavirus|rotavirus
5363401|NCT01886833|Diarrhoea|diarrhoea
5363402|NCT01886833|Immunisation|immunisation
5363403|NCT01886833|Seroconversion|seroconversion
5363404|NCT01886833|Breastmilk|breastmilk
5363406|NCT01886833|Zinc|zinc
5363407|NCT01886833|Vitamin A|vitamin a
5363408|NCT01886833|Failure|failure
5363409|NCT01886820|Dementia|dementia
5363410|NCT01886820|Alzheimer's Disease|alzheimer's disease
5363411|NCT01886820|Terminally Ill|terminally ill
5363412|NCT01886794|pelvic floor dysfunction|pelvic floor dysfunction
5363413|NCT01886794|pelvic organ prolapse|pelvic organ prolapse
5363414|NCT01886794|vaginal estrogen effects|vaginal estrogen effects
5363415|NCT01886781|only constipation and diarrhea predominant|only constipation and diarrhea predominant
5363416|NCT01886781|no mixed or alternating types|no mixed or alternating types
5363417|NCT01886768|Nasal anesthesia|nasal anesthesia
5363418|NCT01886768|endoscopes|endoscopes
5363419|NCT01886768|transnasal endoscopy|transnasal endoscopy
5363420|NCT01886755|Acute gastroenteritis|acute gastroenteritis
5363421|NCT01886755|Probiotics|probiotics
5363422|NCT01886755|Lactobacillus reuteri|lactobacillus reuteri
5363423|NCT01886755|Zinc supplementation|zinc supplementation
5363424|NCT01886755|Infants|infants
5363425|NCT01886755|Age 6 months to 36 months|age 6 months to 36 months
5363426|NCT01886742|Perioperative antibiotic prophylaxis|perioperative antibiotic prophylaxis
5363427|NCT01886742|Morbidly Obese|morbidly obese
5363428|NCT01886729|transcranial direct current stimulation|transcranial direct current stimulation
5363429|NCT01886729|time shift|time shift
5363430|NCT01886716|Alcohol Abuse|alcohol abuse
5363431|NCT01886716|Alcohol Dependence|alcohol dependence
5363432|NCT01886716|Alcohol Drinking|alcohol drinking
5363433|NCT01886716|Social Anxiety|social anxiety
5363434|NCT01886716|Social Phobia|social phobia
5363435|NCT01886716|Anxiety Disorders|anxiety disorders
5363436|NCT01886703|Physical activity|physical activity
5363437|NCT01886703|Exercise|exercise
5363438|NCT01886703|Quality of Life|quality of life
5363439|NCT01886703|Radiation Therapy|radiation therapy
5363440|NCT01886703|Breast Cancer|breast cancer
5363441|NCT01886703|Head and Neck Cancer|head and neck cancer
5363442|NCT01886677|prostate cancer|prostate cancer
5363443|NCT01886677|intervention|intervention
5363444|NCT01886677|diet|diet
5363445|NCT01886677|physical activity|physical activity
5363446|NCT01886677|exercise|exercise
5363447|NCT01886677|weight loss|weight loss
5363448|NCT01886677|biomarkers|biomarkers
5363449|NCT01886677|cancer progression|cancer progression
5363450|NCT01886651|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5363451|NCT01886651|child|child
5363452|NCT01886651|6-mercaptopurine|6-mercaptopurine
5363453|NCT01886651|methotrexate|methotrexate
5363454|NCT01886638|Platelets|platelets
5363455|NCT01886638|HIV|hiv
5964240|NCT04154475|yogurt|yogurt
5964241|NCT04154475|dairy|dairy
5964242|NCT04154475|calcium|calcium
5964243|NCT04154475|weight reduction|weight reduction
5964244|NCT04154475|obesity|obesity
5964245|NCT04154475|randomized controlled trial|randomized controlled trial
5964246|NCT04154475|body composition|body composition
5964247|NCT04154475|microbiome|microbiome
5964248|NCT04153994|Erector Spinae Plane Blockade|erector spinae plane blockade
5964249|NCT04153994|Pediatric Scoliosis|pediatric scoliosis
5964250|NCT04153916|Eye blinking, facial nerve paralysis, nano electrode|eye blinking, facial nerve paralysis, nano electrode
5964251|NCT04153864|Depression|depression
5964252|NCT04153864|Anxiety|anxiety
5964253|NCT04153864|Maternal mental health|maternal mental health
5964254|NCT04153864|Behavioral Activation|behavioral activation
5964255|NCT04153422|Small Fiber Neuropathy|small fiber neuropathy
5964256|NCT04153422|Neuropathy|neuropathy
5964257|NCT04153422|Intravenous Immunoglobulin|intravenous immunoglobulin
5964258|NCT04153422|IVIG|ivig
5964259|NCT04153422|Gammagard|gammagard
5964260|NCT04153422|TS-HDS antibody|ts-hds antibody
5964261|NCT04153422|FGFR-3 antibody|fgfr-3 antibody
5964262|NCT04153422|FGFR3 antibody|fgfr3 antibody
5964263|NCT04153422|Immune mediated small fiber neuropathy|immune mediated small fiber neuropathy
5964264|NCT04153370|airtraq|airtraq
5242094|NCT02491476|Safety|safety
5363456|NCT01886638|Cardiovascular disease|cardiovascular disease
5363457|NCT01886638|Acute myocardial infarction|acute myocardial infarction
5363458|NCT01886638|Abacavir|abacavir
5363459|NCT01886638|Antiretrovirals|antiretrovirals
5363460|NCT01886612|Deep Vein Thrombosis|deep vein thrombosis
5363461|NCT01886612|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5363462|NCT01886612|Intermittent Pneumatic Compression|intermittent pneumatic compression
5363463|NCT01886612|Doppler Ultrasound|doppler ultrasound
5363464|NCT01886586|Mild Cognitive Impairment|mild cognitive impairment
5363465|NCT01886586|memory impairment|memory impairment
5363466|NCT01886586|problem-solving therapy|problem-solving therapy
5258861|NCT02395458|Eradication|eradication
5363467|NCT01886586|depression prevention|depression prevention
5363468|NCT01886586|caregiver stress|caregiver stress
5363469|NCT01886586|exercise|exercise
5363470|NCT01886534|Heart failure|heart failure
5363471|NCT01886534|Heart diseases|heart diseases
5363472|NCT01886534|Cardiovascular diseases|cardiovascular diseases
5363473|NCT01886534|Health information technology|health information technology
5363474|NCT01886534|Disease management|disease management
5363475|NCT01886534|Patient care management|patient care management
5363476|NCT01886534|Self care|self care
5363477|NCT01886534|Informal caregiver|informal caregiver
5363478|NCT01886534|Care partner|care partner
5363479|NCT01886534|Peer support|peer support
5363480|NCT01886534|Transitional care|transitional care
5363481|NCT01886534|Patient education|patient education
5363482|NCT01886534|Teach-back|teach-back
5363483|NCT01886534|Clinical decision aid|clinical decision aid
5363485|NCT01886443|Transplantation|transplantation
5363486|NCT01886443|Ischemia-reperfusion|ischemia-reperfusion
5363487|NCT01886443|Safety|safety
5363488|NCT01886404|HIV|hiv
5363489|NCT01886404|efavirenz|efavirenz
5363491|NCT01886404|pharmacokinetics|pharmacokinetics
5363492|NCT01886404|Pharmacogenomics|pharmacogenomics
5363493|NCT01886391|Heart Failure|heart failure
5363494|NCT01886391|Dyspnea|dyspnea
5363495|NCT01886391|Diaphragmatic breathing retraining|diaphragmatic breathing retraining
5363496|NCT01886391|Fatigue|fatigue
5363497|NCT01886391|Health-related Outcomes|health-related outcomes
5363498|NCT01886378|FAOD|faod
5363499|NCT01886378|VLCAD|vlcad
5363500|NCT01886378|CPT II|cpt ii
5363501|NCT01886378|CPT2|cpt2
5363502|NCT01886378|CPT 2|cpt 2
5363503|NCT01886378|LCHAD|lchad
5363504|NCT01886378|UX007|ux007
5363505|NCT01886378|Triheptanoin|triheptanoin
5363506|NCT01886378|TFP|tfp
5363507|NCT01886378|C7|c7
5363508|NCT01886365|Computer based glycemic control, insulin, blood glucose|computer based glycemic control, insulin, blood glucose
5363509|NCT01886352|laparoscopic|laparoscopic
5363510|NCT01886352|pain|pain
5363511|NCT01886326|Obesity|obesity
5363512|NCT01886326|energy balance|energy balance
5363513|NCT01886326|variety|variety
5363514|NCT01886326|nut intake|nut intake
5363515|NCT01886313|Herpes Zoster|herpes zoster
5363516|NCT01886313|Postherpetic Neuralgia|postherpetic neuralgia
5363517|NCT01886313|Shingles|shingles
5363518|NCT01886313|Civamide|civamide
5363519|NCT01886313|Zucapsaicin|zucapsaicin
5363520|NCT01886313|Neuropeptides|neuropeptides
5363521|NCT01886313|TRPV-1|trpv-1
5363522|NCT01886287|endocrine system|endocrine system
5363523|NCT01886287|neuroendocrine tumors|neuroendocrine tumors
5363524|NCT01886287|neuroendocrine cancer|neuroendocrine cancer
5363525|NCT01886287|metastatic|metastatic
5363526|NCT01886287|neuroendocrine|neuroendocrine
5363527|NCT01886287|gastrointestinal (GI)|gastrointestinal (gi)
5363528|NCT01886287|high-dose octreotide|high-dose octreotide
5363529|NCT01886287|flushing|flushing
5363530|NCT01886287|diarrhea|diarrhea
5363531|NCT01886287|quality of life in patients|quality of life in patients
5363532|NCT01886287|disease-related symptoms|disease-related symptoms
5363533|NCT01886274|EEG|eeg
5363534|NCT01886274|migraine|migraine
5363535|NCT01886274|pain|pain
5363536|NCT01886274|phosphene|phosphene
5363537|NCT01886274|tDCs|tdcs
5363538|NCT01886274|TMS|tms
5363539|NCT01886261|validation|validation
5363540|NCT01886261|physical activity|physical activity
5363541|NCT01886261|place-based interventions|place-based interventions
5363542|NCT01886261|construct validity|construct validity
5363543|NCT01886261|divergent validity|divergent validity
5363544|NCT01886261|usability|usability
5964265|NCT04153370|glidescope|glidescope
5964266|NCT04153370|c-mac|c-mac
5964267|NCT04153370|videolaryngoscope|videolaryngoscope
5964268|NCT04153370|intubation|intubation
5363545|NCT01886261|gps|gps
5363546|NCT01886261|PALMS|palms
5363547|NCT01886248|hepatic veno-occlusive disease after hematopoietic stem cell transplantation|hepatic veno-occlusive disease after hematopoietic stem cell transplantation
5964269|NCT04153370|infant|infant
5363548|NCT01886222|Traumatic brain injury|traumatic brain injury
5363549|NCT01886196|elderly|elderly
5363550|NCT01886196|women|women
5363551|NCT01886196|exercise|exercise
5363552|NCT01886196|pQCT|pqct
5363553|NCT01886196|ibuprofen|ibuprofen
5964270|NCT04153357|airtraq|airtraq
5964271|NCT04153357|glidescope|glidescope
5964272|NCT04153357|c-mac|c-mac
5363554|NCT01886183|Postural Balance|postural balance
5363555|NCT01886183|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5363556|NCT01886183|Gait|gait
5363557|NCT01886183|Stroke|stroke
5363558|NCT01886170|Adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the University of Pennsylvania|adults with self-reported diagnosis of diabetes recruited from waiting rooms at outpatient primary care sites at the university of pennsylvania
5363559|NCT01886157|trigger finger|trigger finger
5363560|NCT01886157|orthotic intervention|orthotic intervention
5363561|NCT01886144|OA|oa
5363562|NCT01886144|arthritis|arthritis
5363563|NCT01886144|knee OA|knee oa
5363564|NCT01886131|REM behaviour disorder|rem behaviour disorder
5363565|NCT01886131|Subthalamic nucleus|subthalamic nucleus
5363566|NCT01886131|Local field potential|local field potential
5363567|NCT01886131|Motor control|motor control
5363568|NCT01886118|In vitro fertilization|in vitro fertilization
5363569|NCT01886118|Autologous Endometrial Co-Culture|autologous endometrial co-culture
5363570|NCT01886105|Osteosarcoma|osteosarcoma
5363571|NCT01886105|Osteogenic Sarcoma|osteogenic sarcoma
5363572|NCT01886105|Sarcoma|sarcoma
5363573|NCT01886105|Bone Cancer|bone cancer
5363574|NCT01886092|tinnitus|tinnitus
5363575|NCT01886027|IBS|ibs
5363576|NCT01886027|Relaxation|relaxation
5363577|NCT01886027|Emotional exposure|emotional exposure
5363578|NCT01886027|Emotional Processing|emotional processing
5363579|NCT01886014|pain|pain
5363580|NCT01886014|pain modulation|pain modulation
5363581|NCT01886014|placebo analgesia|placebo analgesia
5363582|NCT01886001|Newborn Intensive Care Unit|newborn intensive care unit
5363583|NCT01886001|Neonatal Intensive Care Unit|neonatal intensive care unit
5363584|NCT01886001|Colonization|colonization
5363585|NCT01886001|Line Colonization|line colonization
5363586|NCT01886001|Umbilical line|umbilical line
5363587|NCT01886001|Umbilical Cord Care|umbilical cord care
5363588|NCT01885988|Erectile dysfunction|erectile dysfunction
5363589|NCT01885975|Apical Ballooning syndrome|apical ballooning syndrome
5363590|NCT01885975|Personality|personality
5363591|NCT01885962|pressure ulcer prevention|pressure ulcer prevention
5363592|NCT01885962|spinal cord injury|spinal cord injury
5363593|NCT01885962|internet delivered pressure ulcer intervention|internet delivered pressure ulcer intervention
5363595|NCT01885936|LOPD|lopd
5363596|NCT01885936|Pompe Disease|pompe disease
5363597|NCT01885923|schizophrenia; relapse prevention; information technology|schizophrenia; relapse prevention; information technology
5363598|NCT01885897|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5363599|NCT01885897|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
5363600|NCT01885897|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5363601|NCT01885897|Lymphoma|lymphoma
5363602|NCT01885897|Myeloma|myeloma
5363603|NCT01885897|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5363604|NCT01885897|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
5363605|NCT01885884|Supportive Care|supportive care
5363606|NCT01885884|Palliative Care|palliative care
5363607|NCT01885884|Pancreatic Cancer|pancreatic cancer
5363608|NCT01885884|Embedded, coordinated model of supportive care within oncology care|embedded, coordinated model of supportive care within oncology care
5363609|NCT01885884|Patient and Caregiver support|patient and caregiver support
5363611|NCT01885871|Age|age
5363612|NCT01885871|Spot|spot
5363613|NCT01885858|health services research|health services research
5363614|NCT01885858|family planning|family planning
5363615|NCT01885858|ethnicity|ethnicity
5363616|NCT01885858|healthcare disparities|healthcare disparities
5363617|NCT01885845|postpartum blood loss measurement|postpartum blood loss measurement
5363618|NCT01885845|BRASSS-V drape|brasss-v drape
5680242|NCT00578552|gabapentin|gabapentin
5363619|NCT01885832|autologous adipose stem cells|autologous adipose stem cells
5363620|NCT01885832|stromal vascular fraction|stromal vascular fraction
5363621|NCT01885832|osteoarthritis|osteoarthritis
5363622|NCT01885819|Adipose stromal vascular fraction|adipose stromal vascular fraction
5363623|NCT01885819|Rheumatoid arthritis|rheumatoid arthritis
5363624|NCT01885819|adult stem cells|adult stem cells
5363625|NCT01885806|Apathy; Alzheimer's disease; Cognition; Burden of Care|apathy; alzheimer's disease; cognition; burden of care
5363626|NCT01885780|Astigmatism, arcuate incisions, astigmatic keratotomy|astigmatism, arcuate incisions, astigmatic keratotomy
5363627|NCT01885767|Neurofibromatosis|neurofibromatosis
5363628|NCT01885767|NF|nf
5363629|NCT01885767|Neurofibromatosis 1|neurofibromatosis 1
5363630|NCT01885767|NF1|nf1
5363631|NCT01885767|Neurofibromatosis 2|neurofibromatosis 2
5363632|NCT01885767|NF2|nf2
5363633|NCT01885767|Schwannomatosis|schwannomatosis
5363634|NCT01885754|Biopsy|biopsy
5363635|NCT01885754|Maximal incremental cardiopulmonary test|maximal incremental cardiopulmonary test
5363636|NCT01885754|Muscle strength test|muscle strength test
5964273|NCT04153357|videolaryngoscope|videolaryngoscope
5964274|NCT04153357|pediatric|pediatric
5964275|NCT04153357|intubatioon|intubatioon
5964276|NCT04152967|PTFE valved conduit|ptfe valved conduit
5964277|NCT04152967|right ventricular outflow tract|right ventricular outflow tract
5964278|NCT04152863|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5964279|NCT04152863|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5964280|NCT04152863|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5363637|NCT01885754|magnetic stimulation|magnetic stimulation
5363638|NCT01885702|Dendritic cell vaccination|dendritic cell vaccination
5363639|NCT01885702|MSI-high colorectal cancer (CRC)|msi-high colorectal cancer (crc)
5363641|NCT01885702|Immunotherapy|immunotherapy
5363642|NCT01885702|CRC|crc
5363643|NCT01885702|Germline MMR-gene mutation without disease criteria of CRC|germline mmr-gene mutation without disease criteria of crc
5363644|NCT01885663|Umbilical cord blood|umbilical cord blood
5363645|NCT01885663|Acquired brain injury|acquired brain injury
5363646|NCT01885650|Non invasive ventilation|non invasive ventilation
5363647|NCT01885650|Chest physiotherapy|chest physiotherapy
5363648|NCT01885650|Airway clearance|airway clearance
5363649|NCT01885637|Palliative|palliative
5363650|NCT01885637|Palliation|palliation
5363651|NCT01885637|Cancer|cancer
5363652|NCT01885637|Care|care
5363653|NCT01885637|SPC|spc
5363661|NCT01885611|Leprosy|leprosy
5363662|NCT01885572|breast reconstruction|breast reconstruction
5363663|NCT01885572|mastectomy|mastectomy
5363664|NCT01885572|mesh|mesh
5363665|NCT01885572|breast cancer|breast cancer
5363666|NCT01885559|polycystic kidney disease|polycystic kidney disease
5363667|NCT01885559|polycystic|polycystic
5363668|NCT01885559|kidney|kidney
5363669|NCT01885559|disease|disease
5363670|NCT01885559|adpkd|adpkd
5363671|NCT01885559|halt|halt
5363672|NCT01885559|pkd|pkd
5363673|NCT01885559|blood pressure|blood pressure
5363674|NCT01885559|bp|bp
5363675|NCT01885559|hypertension|hypertension
5363676|NCT01885559|renal|renal
5363677|NCT01885559|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
5363678|NCT01885559|RAAS|raas
5363679|NCT01885546|diabetes|diabetes
5363680|NCT01885546|glucose|glucose
5363681|NCT01885546|glucometer|glucometer
5363682|NCT01885533|Graves' disease|graves' disease
5363683|NCT01885533|radioiodine|radioiodine
5363684|NCT01885533|thyroid|thyroid
5363685|NCT01885533|hypothyroidism|hypothyroidism
5363686|NCT01885533|Graves' orbitopathy|graves' orbitopathy
5363687|NCT01885520|low back pain|low back pain
5363699|NCT01885429|Protein Turnover|protein turnover
5363701|NCT01885429|Whey Protein|whey protein
5363702|NCT01885429|Leucine|leucine
5363703|NCT01885403|Acute Cardiogenic Pulmonary Edema,|acute cardiogenic pulmonary edema,
5363704|NCT01885403|Acute Decompensated Heart Failure,|acute decompensated heart failure,
5363705|NCT01885403|BiLevel Positive Airway Pressure,|bilevel positive airway pressure,
5363706|NCT01885403|Continuous Positive Airway Pressure|continuous positive airway pressure
5363707|NCT01885390|Hypertension|hypertension
5363708|NCT01885390|High blood pressure|high blood pressure
5363709|NCT01885390|Resistant blood pressure|resistant blood pressure
5363710|NCT01885390|Uncontrolled blood pressure|uncontrolled blood pressure
5363716|NCT01885364|esmolol|esmolol
5363717|NCT01885364|pain|pain
5363718|NCT01885364|propofol|propofol
5363719|NCT01885364|remifentanil|remifentanil
5363725|NCT01885338|Schizophrenia|schizophrenia
5363726|NCT01885338|Cognition|cognition
5363727|NCT01885338|Neurocognition|neurocognition
5363728|NCT01885338|N-Acetylcysteine|n-acetylcysteine
5363729|NCT01885338|NAC|nac
5363730|NCT01885338|EEG|eeg
5363731|NCT01885325|Physical Activity|physical activity
5363732|NCT01885325|Sedentary Behavior|sedentary behavior
5363733|NCT01885325|Preschool Children|preschool children
5363734|NCT01885312|Drinking|drinking
5363735|NCT01885312|Heavy Drinking|heavy drinking
5363736|NCT01885312|Technology|technology
5363737|NCT01885312|Mobile Phone|mobile phone
5363738|NCT01885312|Text Message|text message
5363739|NCT01885312|Problem Drinking|problem drinking
5363740|NCT01885312|Alcohol Problems|alcohol problems
5363741|NCT01885312|Alcoholism|alcoholism
5363742|NCT01885312|Moderation-Oriented Treatment|moderation-oriented treatment
5363743|NCT01885312|Controlled Drinking|controlled drinking
5363744|NCT01885312|Reduced Drinking|reduced drinking
5363745|NCT01885299|Radiosurgery|radiosurgery
5363746|NCT01885299|CyberKnife|cyberknife
5363747|NCT01885299|Benign tumors|benign tumors
5363748|NCT01885299|Malignant tumors|malignant tumors
5363749|NCT01885299|Cranial tumors|cranial tumors
5363750|NCT01885299|Extracranial tumors|extracranial tumors
5363752|NCT01885299|Liver|liver
5363753|NCT01885299|Pancreas|pancreas
5363754|NCT01885299|Prostate|prostate
5363755|NCT01885299|Stereotactic radiosurgery|stereotactic radiosurgery
5363756|NCT01885299|Stereotactic body radiotherapy|stereotactic body radiotherapy
5363757|NCT01885286|circumcision|circumcision
5363758|NCT01885286|HIV prevention|hiv prevention
5363759|NCT01885273|pressurized irrigation|pressurized irrigation
5964281|NCT04152863|Coxsackievirus A21|coxsackievirus a21
5363760|NCT01885273|wound cleansing method|wound cleansing method
5363761|NCT01885273|irrigation|irrigation
5363762|NCT01885273|swabbing|swabbing
5363763|NCT01885273|appropriate pressure for irrigation|appropriate pressure for irrigation
5363764|NCT01885260|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5363765|NCT01885260|T2DM|t2dm
5363766|NCT01885234|Glycated hemoglobin|glycated hemoglobin
5363767|NCT01885234|HOMA|homa
5230322|NCT02562638|NPO|npo
5363768|NCT01885234|Pregnancy|pregnancy
5363769|NCT01885234|aerobic exercise|aerobic exercise
5367564|NCT01868360|cornea|cornea
5363770|NCT01885221|smokeless tobacco cessation|smokeless tobacco cessation
5363771|NCT01885221|social support|social support
5363772|NCT01885221|partner support|partner support
5363773|NCT01885195|RAS, RAF, MEK, NF1, MEK162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, NSCLC, acute myelogenous leukemia, AML|ras, raf, mek, nf1, mek162, signature, papillary thyroid, small intestine, bladder, esophagus, lung cancer, nsclc, acute myelogenous leukemia, aml
5363774|NCT01885169|Cystic fibrosis|cystic fibrosis
5363775|NCT01885169|Influenza|influenza
5363776|NCT01885169|Vaccine|vaccine
5363777|NCT01885143|Mammography|mammography
5363778|NCT01885117|Influenza,|influenza,
5363779|NCT01885117|Adults,|adults,
5363780|NCT01885117|Elderly,|elderly,
5363781|NCT01885117|Immunology,|immunology,
5363782|NCT01885117|Safety|safety
5363783|NCT01885052|Smoking Cessation Clinical Trial|smoking cessation clinical trial
5363784|NCT01885052|Text Messaging Program|text messaging program
5363785|NCT01885052|Smoking Cessation Aid|smoking cessation aid
5363793|NCT01885026|Internet|internet
5363794|NCT01885026|Screening|screening
5363795|NCT01885026|Brief intervention|brief intervention
5363796|NCT01885013|HER2 negative|her2 negative
5363797|NCT01885013|metastatic breast cancer|metastatic breast cancer
5363798|NCT01885013|non endocrine responsive disease|non endocrine responsive disease
5363799|NCT01884974|Myeloproliferative disease|myeloproliferative disease
5363800|NCT01884974|Pulmonary Hypertension|pulmonary hypertension
5363801|NCT01884948|at least 1 segment|at least 1 segment
5363802|NCT01884948|multiple wedge resections (≥3)|multiple wedge resections (≥3)
5363803|NCT01884935|Pediatric|pediatric
5363804|NCT01884922|Children|children
5363805|NCT01884922|adolescents|adolescents
5363806|NCT01884922|young adults|young adults
5363807|NCT01884870|Asymptomatic|asymptomatic
5363808|NCT01884870|ureteral|ureteral
5363809|NCT01884870|calculi|calculi
5363810|NCT01884870|renal function|renal function
5363811|NCT01884870|treatment|treatment
5363812|NCT01884831|damage to the skin, the skin equivalent, cell therapy|damage to the skin, the skin equivalent, cell therapy
5483348|NCT01364961|FMD|fmd
5363813|NCT01884818|Thoracic spine, pain, manipulation|thoracic spine, pain, manipulation
5363814|NCT01884805|Adaptive Optics Visual Simulator|adaptive optics visual simulator
5363816|NCT01884805|Optical Aberrations|optical aberrations
5363817|NCT01884805|Hyperopia|hyperopia
5363818|NCT01884792|prediabetes|prediabetes
5363819|NCT01884792|physical inactivity|physical inactivity
5363820|NCT01884792|sedentary|sedentary
5363821|NCT01884792|standing|standing
5363823|NCT01884779|Histoplasmosis|histoplasmosis
5363824|NCT01884779|Histoplasma capsulatum var.capsulatum|histoplasma capsulatum var.capsulatum
5363825|NCT01884779|ELISA test|elisa test
5363826|NCT01884753|lower urinary tract symptoms|lower urinary tract symptoms
5363827|NCT01884753|overactive bladder syndrome|overactive bladder syndrome
5363828|NCT01884753|antimuscarinic drug|antimuscarinic drug
5363829|NCT01884753|three-dimensional power Doppler ultrasound|three-dimensional power doppler ultrasound
5363830|NCT01884753|sexual dysfunction|sexual dysfunction
5363831|NCT01884740|GBM|gbm
5363832|NCT01884740|AA|aa
5363833|NCT01884740|FA|fa
5363834|NCT01884740|PXA|pxa
5363835|NCT01884740|AOA|aoa
5363836|NCT01884740|High grade glioma|high grade glioma
5363837|NCT01884727|Obesity|obesity
5363838|NCT01884727|Overweight|overweight
5363839|NCT01884727|Over nutrition|over nutrition
5363840|NCT01884727|nutrition disorders|nutrition disorders
5363841|NCT01884727|energy expenditure|energy expenditure
5363842|NCT01884727|metabolic rate|metabolic rate
5363843|NCT01884714|diabetes|diabetes
5363844|NCT01884714|obesity|obesity
5363845|NCT01884714|metabolism|metabolism
5363846|NCT01884714|clinical study|clinical study
5363847|NCT01884701|Chronic Total Occlusion CTO|chronic total occlusion cto
5363848|NCT01884688|Asymptomatic Multiple Myeloma|asymptomatic multiple myeloma
5363849|NCT01884688|Auto-ENK Cell Therapy|auto-enk cell therapy
5363850|NCT01884688|Natural Killer Cells|natural killer cells
5363851|NCT01884675|Endothelin Receptor Antagonist|endothelin receptor antagonist
5363852|NCT01884675|Inoperable Chronic Thromboembolic Pulmonary Hypertension|inoperable chronic thromboembolic pulmonary hypertension
5363853|NCT01884662|spinal cord injury|spinal cord injury
5363854|NCT01884662|neuropathic pain|neuropathic pain
5363855|NCT01884649|Acute phase reactant, fetuin A, Hashimoto thyroiditis|acute phase reactant, fetuin a, hashimoto thyroiditis
5964282|NCT04152863|Intracellular Adhesion Molecule-1 (ICAM-1)|intracellular adhesion molecule-1 (icam-1)
5964283|NCT04152512|Questionnaire|questionnaire
5964284|NCT04152512|EORTC QLQ C30 + VU34|eortc qlq c30 + vu34
5964285|NCT04152512|Hospital Depression and Anxiety Scale|hospital depression and anxiety scale
5964286|NCT04152512|EORTC-PATSAT|eortc-patsat
5964287|NCT04152512|Supportive Care Needs Survey Short Form|supportive care needs survey short form
5964288|NCT04152369|ESBL+|esbl+
5964289|NCT04152369|Antimicrobial prophylaxis|antimicrobial prophylaxis
5964290|NCT04152161|Mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
5964291|NCT04152161|Healthy adolescents|healthy adolescents
5964292|NCT04152161|Healthy participants|healthy participants
5964293|NCT04152161|BCG vaccine|bcg vaccine
5964294|NCT04151784|Susceptibility to Electronic Cigarette Use|susceptibility to electronic cigarette use
5964295|NCT04150913|Non Hodgkin Lymphoma|non hodgkin lymphoma
5363856|NCT01884636|Isavuconazole|isavuconazole
5363857|NCT01884636|Pharmacokinetics|pharmacokinetics
5363858|NCT01884636|Healthy Subjects|healthy subjects
5363859|NCT01884636|BAL8557|bal8557
5363860|NCT01884636|BAL4815|bal4815
5363861|NCT01884636|methotrexate|methotrexate
5363862|NCT01884597|PEARL2|pearl2
5363864|NCT01884597|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5363865|NCT01884571|Immunosuppression|immunosuppression
5363866|NCT01884571|ALS|als
5363867|NCT01884571|Neuromuscular Disorders|neuromuscular disorders
5363868|NCT01884558|Isavuconazole|isavuconazole
5363869|NCT01884558|Pharmacokinetics|pharmacokinetics
5363870|NCT01884558|Healthy Subjects|healthy subjects
5363871|NCT01884558|BAL8557|bal8557
5363872|NCT01884558|BAL4815|bal4815
5363873|NCT01884558|metformin|metformin
5363874|NCT01884545|heart disease|heart disease
5363886|NCT01884532|Revised ASR-XL Metal-on-Metal|revised asr-xl metal-on-metal
5363887|NCT01884519|Elderly|elderly
5363888|NCT01884519|Influenza|influenza
5363889|NCT01884519|Safety|safety
5363890|NCT01884519|Adults|adults
5363891|NCT01884519|Immunogenicity|immunogenicity
5363892|NCT01884493|Parkinson's Disease|parkinson's disease
5363893|NCT01884493|Freezing of Gait|freezing of gait
5363894|NCT01884493|movement-related cortical potential|movement-related cortical potential
5363895|NCT01884493|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5363896|NCT01884480|Advagraf, pharmacogenetics, Cyp3A5|advagraf, pharmacogenetics, cyp3a5
5363897|NCT01884467|Urinary Tract Infections|urinary tract infections
5363898|NCT01884467|Gentamicin|gentamicin
5363899|NCT01884454|sleep|sleep
5363900|NCT01884454|obstructive sleep apnea|obstructive sleep apnea
5363901|NCT01884454|reproduction|reproduction
5363902|NCT01884454|sperm|sperm
5363903|NCT01884454|hormones|hormones
5363904|NCT01884454|men|men
5363905|NCT01884441|Hodgkin|hodgkin
5363906|NCT01884441|Lymphoma|lymphoma
5363907|NCT01884441|refractory|refractory
5363908|NCT01884441|relapsed|relapsed
5363909|NCT01884428|Hodgkin|hodgkin
5363910|NCT01884428|Lymphoma|lymphoma
5363911|NCT01884389|HIV|hiv
5363912|NCT01884389|Chronic disease|chronic disease
5363913|NCT01884389|Early palliative care|early palliative care
5363914|NCT01884389|Patient navigation|patient navigation
5363915|NCT01884376|nerve biopsy|nerve biopsy
5363916|NCT01884376|nerve regeneration|nerve regeneration
5363917|NCT01884376|neuroma pain|neuroma pain
5363918|NCT01884376|loss of sensation|loss of sensation
5363919|NCT01884363|Endothelial function|endothelial function
5363920|NCT01884363|walnuts|walnuts
5363921|NCT01884363|clinical trial|clinical trial
5363922|NCT01884363|Nutrition|nutrition
5363923|NCT01884363|cardiovascular disease|cardiovascular disease
5363924|NCT01884324|Gastroschisis|gastroschisis
5363925|NCT01884324|Cesarean delivery|cesarean delivery
5363926|NCT01884324|Neonatal outcomes|neonatal outcomes
5363927|NCT01884311|Primary Immune Deficiency Disorders|primary immune deficiency disorders
5363928|NCT01884311|Common Variable Immunodeficiency|common variable immunodeficiency
5363929|NCT01884311|X-linked agammaglobulinaemia|x-linked agammaglobulinaemia
5363930|NCT01884311|Hyper-IgM Syndrome|hyper-igm syndrome
5363931|NCT01884311|Subcutaneous|subcutaneous
5363932|NCT01884311|Immunoglobulins|immunoglobulins
5363933|NCT01884298|remifentanil|remifentanil
5363934|NCT01884298|isolated systolic hypertension|isolated systolic hypertension
5363935|NCT01884298|morbidity|morbidity
5363936|NCT01884298|epidural combined general anesthesia|epidural combined general anesthesia
5363937|NCT01884285|Advanced Castrate-resistant Prostate Cancer(CRPC)|advanced castrate-resistant prostate cancer(crpc)
5363938|NCT01884285|Squamous Non-Small Cell Lung Cancer(sqNSCLC)|squamous non-small cell lung cancer(sqnsclc)
5363939|NCT01884285|Triple Negative Breast Cancer(TNBC)|triple negative breast cancer(tnbc)
5363940|NCT01884285|PTEN-deficient/mutated Advanced Solid Malignancies|pten-deficient/mutated advanced solid malignancies
5363941|NCT01884285|PIK3CB mutated/amplified advanced solid malignancies|pik3cb mutated/amplified advanced solid malignancies
5363942|NCT01884259|local advanced squamous cell carcinoma|local advanced squamous cell carcinoma
5363943|NCT01884259|Larynx|larynx
5363944|NCT01884259|Hypopharynx|hypopharynx
5363945|NCT01884259|Oropharynx|oropharynx
5363946|NCT01884259|Cavum oris|cavum oris
5363947|NCT01884259|docetaxel|docetaxel
5363948|NCT01884259|cisplatin|cisplatin
5363949|NCT01884259|5-fluorouracil|5-fluorouracil
5363950|NCT01884259|Cetuximab|cetuximab
5363951|NCT01884246|lifestyle change|lifestyle change
5363952|NCT01884246|behavior change|behavior change
5363953|NCT01884246|obesity|obesity
5363954|NCT01884246|hypertension|hypertension
5363955|NCT01884246|hyperlipidemia|hyperlipidemia
5363956|NCT01884246|physical inactivity|physical inactivity
5363957|NCT01884246|depression|depression
5363958|NCT01884233|HIV|hiv
5363959|NCT01884233|Opioid Abuse|opioid abuse
5363960|NCT01884233|Mobile technology|mobile technology
5363961|NCT01884220|Wolman Disease|wolman disease
5363964|NCT01884220|Natural History|natural history
5363965|NCT01884220|Medical Records Review|medical records review
5363966|NCT01884194|retinoblastoma|retinoblastoma
5363967|NCT01884194|pineoblastoma|pineoblastoma
5363968|NCT01884181|Huntington Disease, diffusion MRI, diagnosis, fast imaging|huntington disease, diffusion mri, diagnosis, fast imaging
5363969|NCT01884129|Circulating tumor cells|circulating tumor cells
5363970|NCT01884129|Head and neck cancer|head and neck cancer
5363971|NCT01884129|Squamous cell carcinoma|squamous cell carcinoma
5363972|NCT01884129|Survival|survival
5363973|NCT01884129|Prognosis|prognosis
5363974|NCT01884116|Capsaicin|capsaicin
5363975|NCT01884116|myofascial pain syndrome|myofascial pain syndrome
5363976|NCT01884116|non-steroidal anti-inflammatory agents|non-steroidal anti-inflammatory agents
5363977|NCT01884116|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5363978|NCT01884103|TBI|tbi
5363979|NCT01884103|Trauma|trauma
5363980|NCT01884103|Traumatic Brain Injury|traumatic brain injury
5363981|NCT01884090|Empowerment|empowerment
5363982|NCT01884090|Youth|youth
5363983|NCT01884090|Violence|violence
5363984|NCT01884090|Community|community
5363985|NCT01884090|Prevention|prevention
5363986|NCT01884077|patient outcomes two years after shoulder replacement|patient outcomes two years after shoulder replacement
5363987|NCT01884077|seventy years of age and older|seventy years of age and older
5363988|NCT01884064|focal hand dystonia|focal hand dystonia
5363989|NCT01884064|rehabilitation|rehabilitation
5363990|NCT01884064|rTMS|rtms
5363991|NCT01884064|writer's cramp|writer's cramp
5363992|NCT01884064|clinical|clinical
5363993|NCT01884051|Pulmonary arterial hypertension|pulmonary arterial hypertension
5363994|NCT01884038|Liver Transplant|liver transplant
5363995|NCT01884038|Prostacyclin|prostacyclin
5363996|NCT01884038|Treprostinil sodium|treprostinil sodium
5363997|NCT01884038|Remodulin|remodulin
5363998|NCT01884038|Reperfusion Injury|reperfusion injury
5363999|NCT01884038|Primary Nonfunction|primary nonfunction
5364000|NCT01884025|patient centered care|patient centered care
5364001|NCT01884025|physical activity|physical activity
5364002|NCT01884025|behavioral activation|behavioral activation
5364003|NCT01884025|self efficacy|self efficacy
5364004|NCT01884025|serious mental illness|serious mental illness
5364005|NCT01883986|palliative care|palliative care
5364007|NCT01883973|DBS|dbs
5364008|NCT01883960|cerebral palsy|cerebral palsy
5364009|NCT01883960|cerebral vascular accident|cerebral vascular accident
5364010|NCT01883960|multi-modal brain techniques|multi-modal brain techniques
5364011|NCT01883960|MRI|mri
5364012|NCT01883960|motor control|motor control
5364013|NCT01883947|Stroke|stroke
5364014|NCT01883947|Massage|massage
5364015|NCT01883947|General Health|general health
5364016|NCT01883947|Independence|independence
5364017|NCT01883934|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5364018|NCT01883934|Embryo donation|embryo donation
5364019|NCT01883921|Primary Immunodeficiency|primary immunodeficiency
5364020|NCT01883921|Immunodeficiencies|immunodeficiencies
5364021|NCT01883921|Primary Immunodeficiency Diseases|primary immunodeficiency diseases
5364022|NCT01883921|PIDD|pidd
5364025|NCT01883921|Common Variable Immunodeficiency|common variable immunodeficiency
5364026|NCT01883921|Hypogammaglobulinemia|hypogammaglobulinemia
5364027|NCT01883921|Acquired Hypogammaglobulinemia|acquired hypogammaglobulinemia
5364028|NCT01883921|Immunology|immunology
5364029|NCT01883921|Autoimmune Deficiency|autoimmune deficiency
5364030|NCT01883921|Intravenous Immunoglobulin|intravenous immunoglobulin
5364031|NCT01883921|Subcutaneous Immunoglobulin|subcutaneous immunoglobulin
5364032|NCT01883921|IVIg|ivig
5364033|NCT01883921|SCIg|scig
5364034|NCT01883921|Immune Globulin|immune globulin
5364035|NCT01883921|Outcomes Research|outcomes research
5364036|NCT01883921|Immunodeficiency|immunodeficiency
5364037|NCT01883908|Acupuncture therapy|acupuncture therapy
5364038|NCT01883908|Mucositis|mucositis
5364039|NCT01883908|oropharyngeal cancer|oropharyngeal cancer
5364040|NCT01883895|Pain|pain
5364041|NCT01883895|exercise-induced hypoalgesia|exercise-induced hypoalgesia
5364042|NCT01883882|chronic non-cancer pain|chronic non-cancer pain
5364043|NCT01883882|opioid taper|opioid taper
5364044|NCT01883882|chronic pain self-management|chronic pain self-management
5364045|NCT01883882|motivational interviewing|motivational interviewing
5364046|NCT01883869|Platelet inhibition|platelet inhibition
5364047|NCT01883869|Platelet-leukocyte aggregates|platelet-leukocyte aggregates
5364048|NCT01883869|Platelet-neutrophil aggregates|platelet-neutrophil aggregates
5364049|NCT01883869|CAP|cap
5364050|NCT01883869|HAP|hap
5364051|NCT01883869|ALI|ali
5364052|NCT01883869|Blood Platelets|blood platelets
5364053|NCT01883856|Refractory Glaucoma|refractory glaucoma
5364054|NCT01883856|Intractable Glaucoma|intractable glaucoma
5680243|NCT00578552|abstinence|abstinence
5364055|NCT01883856|Primary Open Angle Glaucoma|primary open angle glaucoma
5364056|NCT01883856|Neovascular Glaucoma|neovascular glaucoma
5364057|NCT01883843|Chronic Stroke|chronic stroke
5364058|NCT01883843|tDCS|tdcs
5364059|NCT01883843|transcranial direct current stimulation|transcranial direct current stimulation
5364060|NCT01883843|task oriented circuit training|task oriented circuit training
5364061|NCT01883843|TOCT|toct
5364062|NCT01883843|gait training|gait training
5364063|NCT01883830|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5242689|NCT02487550|Renal neoplasma|renal neoplasma
5242690|NCT02487550|CIK cells|cik cells
5242691|NCT02487537|incretin release|incretin release
5364064|NCT01883830|balance disorders|balance disorders
5364065|NCT01883830|attention deficits|attention deficits
5364066|NCT01883830|x-box|x-box
5364067|NCT01883830|gaming|gaming
5364068|NCT01883830|virtual reality|virtual reality
5364069|NCT01883817|ADHD|adhd
5364070|NCT01883804|Diabetes|diabetes
5364071|NCT01883804|Diabetes Mellitus|diabetes mellitus
5364072|NCT01883804|Type 1 Diabetes|type 1 diabetes
5364073|NCT01883791|substance abuse prevention and treatment|substance abuse prevention and treatment
5364074|NCT01883791|comorbidity|comorbidity
5364075|NCT01883791|SBIRT|sbirt
5364076|NCT01883778|Attitudes of health personnel|attitudes of health personnel
5364077|NCT01883778|Attitudes of patients|attitudes of patients
5364078|NCT01883778|Medical compliance|medical compliance
5364079|NCT01883778|Cost awareness|cost awareness
5364080|NCT01883778|Cost analysis|cost analysis
5364081|NCT01883778|Patient knowledge|patient knowledge
5364082|NCT01883778|Physician knowledge|physician knowledge
5364086|NCT01883778|Health literacy|health literacy
5364087|NCT01883765|ADHD, Neurofeedback, CBT|adhd, neurofeedback, cbt
5364088|NCT01883752|Goal-directed fluid therapy|goal-directed fluid therapy
5364089|NCT01883739|Parental anxiety|parental anxiety
5364090|NCT01883739|Children's safety|children's safety
5364091|NCT01883739|Family Centered Care|family centered care
5364092|NCT01883739|Bedside Transfer Rounds|bedside transfer rounds
5364093|NCT01883739|Pediatric Cardiac Intensive Care|pediatric cardiac intensive care
5364094|NCT01883726|Unilateral complete cleft lip, Nasoalveolar molding|unilateral complete cleft lip, nasoalveolar molding
5364095|NCT01883713|anemia|anemia
5364096|NCT01883713|CPB|cpb
5364097|NCT01883713|methemoglobin|methemoglobin
5364098|NCT01883713|hypoxia|hypoxia
5364099|NCT01883700|Healthy|healthy
5364100|NCT01883700|Glycemic Index|glycemic index
5364101|NCT01883700|Glycemic Load|glycemic load
5364102|NCT01883700|Blood Glucose|blood glucose
5364103|NCT01883700|Arterial Stiffness|arterial stiffness
5364104|NCT01883674|Sarcopenia|sarcopenia
5364105|NCT01883674|Physical capacity|physical capacity
5364106|NCT01883674|Muscle force|muscle force
5364107|NCT01883674|Muscle quality|muscle quality
5364108|NCT01883674|Milk proteins|milk proteins
5364109|NCT01883674|Essential amino acids|essential amino acids
5364110|NCT01883674|Proteins|proteins
5364111|NCT01883674|Resistance training|resistance training
5364112|NCT01883674|Exercise|exercise
5364113|NCT01883661|stem cell|stem cell
5364114|NCT01883661|Multiple Sclerosis|multiple sclerosis
5364115|NCT01883661|BMMNC|bmmnc
5364116|NCT01883648|Mild to Moderate Alzheimer's disease|mild to moderate alzheimer's disease
5364117|NCT01883622|diabetes|diabetes
5364118|NCT01883622|pregnancy|pregnancy
5364119|NCT01883622|glucose variability|glucose variability
5364120|NCT01883622|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5364121|NCT01883622|gestational diabetes mellitus (GDM)|gestational diabetes mellitus (gdm)
5364133|NCT01883570|visual search strategy, training, chest x-ray|visual search strategy, training, chest x-ray
5364134|NCT01883544|Safety|safety
5364135|NCT01883544|Tolerability|tolerability
5364136|NCT01883544|Pharmacokinetics|pharmacokinetics
5364137|NCT01883544|Pharmacodynamics|pharmacodynamics
5364138|NCT01883544|ALXN1007|alxn1007
5364139|NCT01883544|Healthy Male and Female Subjects|healthy male and female subjects
5364140|NCT01883531|improving lung function|improving lung function
5364141|NCT01883531|paediatric and adolescent|paediatric and adolescent
5364142|NCT01883531|FEV1|fev1
5364143|NCT01883518|Fibrosarcoma|fibrosarcoma
5364144|NCT01883518|Neurofibrosarcoma|neurofibrosarcoma
5364145|NCT01883518|Histiocytoma|histiocytoma
5364146|NCT01883518|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
5364147|NCT01883518|Chondrosarcoma|chondrosarcoma
5364148|NCT01883518|Synovial Sarcoma|synovial sarcoma
5364149|NCT01883518|Leiomyosarcoma|leiomyosarcoma
5364150|NCT01883518|Liposarcoma|liposarcoma
5364151|NCT01883518|Myosarcoma|myosarcoma
5364152|NCT01883518|Rhabdomyosarcoma|rhabdomyosarcoma
5364153|NCT01883518|Sarcoma, Alveolar Soft Part|sarcoma, alveolar soft part
5364154|NCT01883518|NY-ESO-1|ny-eso-1
5364155|NCT01883518|MAGE|mage
5364156|NCT01883518|MAGE A3|mage a3
5364157|NCT01883518|Vaccine|vaccine
5364158|NCT01883518|Immunotherapy|immunotherapy
5364159|NCT01883505|Motor fluctuations|motor fluctuations
5364160|NCT01883505|levodopa pharmacokinetics|levodopa pharmacokinetics
5364161|NCT01883505|levodopa and carbidopa solution|levodopa and carbidopa solution
5364162|NCT01883505|continuous subcutaneous delivery|continuous subcutaneous delivery
5364163|NCT01883505|Patch-pump|patch-pump
5964296|NCT04150913|Refractory Non-Hodgkin Lymphoma|refractory non-hodgkin lymphoma
5964297|NCT04150913|Relapsed Non Hodgkin Lymphoma|relapsed non hodgkin lymphoma
5964298|NCT04150913|Neurotoxicity|neurotoxicity
5364166|NCT01883466|Air Pollution|air pollution
5364167|NCT01883466|Biodiesel exhaust|biodiesel exhaust
5364168|NCT01883466|Diesel exhaust|diesel exhaust
5364169|NCT01883466|Vascular function|vascular function
5364170|NCT01883466|Fibrinolysis|fibrinolysis
5364171|NCT01883466|Acute endothelial responses|acute endothelial responses
5364172|NCT01883440|Duration|duration
5364173|NCT01883427|Days with URTI symptoms|days with urti symptoms
5364174|NCT01883414|Ulthera, Ultherapy, Surgical scar, scar,|ulthera, ultherapy, surgical scar, scar,
5364175|NCT01883401|Strawberries|strawberries
5364176|NCT01883401|Heart health|heart health
5364177|NCT01883401|Anthocyanins|anthocyanins
5364178|NCT01883388|Lung Cancer|lung cancer
5364179|NCT01883388|blood sample|blood sample
5364180|NCT01883375|Palliative Care|palliative care
5364181|NCT01883375|Family|family
5364182|NCT01883375|adaptation, psychological|adaptation, psychological
5364183|NCT01883362|acute myeloid leukemia|acute myeloid leukemia
5364185|NCT01883362|FLT3-ITD|flt3-itd
5364186|NCT01883362|midostaurin|midostaurin
5364187|NCT01883362|PKC412|pkc412
5364188|NCT01883362|allogeneic hematopoeitic stem cell tranplant|allogeneic hematopoeitic stem cell tranplant
5364190|NCT01883362|HSCT|hsct
5364192|NCT01883362|adult|adult
5364193|NCT01883336|Incidental pancreatic cysts|incidental pancreatic cysts
5364194|NCT01883323|Measurable|measurable
5364195|NCT01883323|Unresectable|unresectable
5364196|NCT01883323|Stage III|stage iii
5364197|NCT01883323|Stage IV|stage iv
5364198|NCT01883323|Metastatic|metastatic
5364199|NCT01883323|Melanoma|melanoma
5364200|NCT01883323|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
5364201|NCT01883323|Low-Dose Interleukin-2|low-dose interleukin-2
5364202|NCT01883323|Cyclophosphamide|cyclophosphamide
5364203|NCT01883323|Fludarabine|fludarabine
5364204|NCT01883310|Multiple Sclerosis|multiple sclerosis
5364205|NCT01883310|transcranial direct current stimulation|transcranial direct current stimulation
5364206|NCT01883310|TOCT|toct
5364207|NCT01883310|task-oriented circuit training|task-oriented circuit training
5364208|NCT01883310|locomotor function|locomotor function
5364209|NCT01883310|mobility|mobility
5364210|NCT01883310|balance|balance
5364211|NCT01883297|Measurable|measurable
5364212|NCT01883297|Recurrent|recurrent
5364213|NCT01883297|Platinum resistant|platinum resistant
5364214|NCT01883297|Tumor-Infiltrating Lymphocytes|tumor-infiltrating lymphocytes
5364218|NCT01883297|High grade serous ovarian, fallopian tube, or primary peritoneal cancer|high grade serous ovarian, fallopian tube, or primary peritoneal cancer
5364219|NCT01883297|Cyclophosphamide|cyclophosphamide
5364220|NCT01883284|Cystic Fibrosis|cystic fibrosis
5364221|NCT01883284|nasal epithelia|nasal epithelia
5364222|NCT01883284|mucins|mucins
5364223|NCT01883245|Orofacial chronic pain|orofacial chronic pain
5364224|NCT01883245|tDCS|tdcs
5364225|NCT01883245|Transcranial direct current stimulation|transcranial direct current stimulation
5364226|NCT01883245|Brain stimulation|brain stimulation
5364227|NCT01883219|Philadelphia chromosome|philadelphia chromosome
5364228|NCT01883219|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5364229|NCT01883219|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5364230|NCT01883219|Minimal residual disease|minimal residual disease
5364231|NCT01883219|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5364232|NCT01883206|Cytomegalovirus|cytomegalovirus
5364233|NCT01883193|preconception maternal nutrition|preconception maternal nutrition
5364234|NCT01883193|LBW|lbw
5364235|NCT01883193|Length-for-age|length-for-age
5364236|NCT01883193|maternal nutrition supplement|maternal nutrition supplement
5364237|NCT01883193|multi-micronutrient fortified lipid-based supplement|multi-micronutrient fortified lipid-based supplement
5364238|NCT01883193|infant growth|infant growth
5364239|NCT01883193|low-resource settings|low-resource settings
5364240|NCT01883180|haploidentical hematopoietic Stem Cell Transplantation|haploidentical hematopoietic stem cell transplantation
5364241|NCT01883180|Antithymocyte globulin|antithymocyte globulin
5364242|NCT01883180|viral infection|viral infection
5364243|NCT01883128|Biochemical Failure|biochemical failure
5364244|NCT01883128|Radiotherapy|radiotherapy
5364245|NCT01883128|Radiorecurrent Prostate Cancer|radiorecurrent prostate cancer
5364246|NCT01883128|MRI Prostate|mri prostate
5364247|NCT01883128|Whole Body MRI|whole body mri
5350343|NCT01947374|Cartilage|cartilage
5364248|NCT01883128|Bone Scan|bone scan
5364249|NCT01883128|Choline PET|choline pet
5364250|NCT01883128|Focal Salvage Treatment|focal salvage treatment
5364251|NCT01883128|HIFU|hifu
5364252|NCT01883128|Cryotherapy|cryotherapy
5364253|NCT01883115|Telescopic extraperitoneal dissection|telescopic extraperitoneal dissection
5364254|NCT01883115|Single incision laparosocpic surgery|single incision laparosocpic surgery
5364255|NCT01883115|Inguinal hernia|inguinal hernia
5364256|NCT01883115|Triport system|triport system
5364257|NCT01883076|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5964299|NCT04150913|Neurotoxicity Syndromes|neurotoxicity syndromes
5964300|NCT04150913|Cytokine Release Syndrome|cytokine release syndrome
5964301|NCT04150562|Antibody Dependent Cellular Cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
5964302|NCT04150562|Anti-PD-L1 monoclonal antibody|anti-pd-l1 monoclonal antibody
5964303|NCT04150224|PBTZ169|pbtz169
5964304|NCT04150224|Macozinone|macozinone
5964305|NCT04150224|Antimycobacterial|antimycobacterial
5964306|NCT04150224|Tuberculosis|tuberculosis
5964307|NCT04150224|Drug Resistant Tubercolosis|drug resistant tubercolosis
5964308|NCT04150224|MDR-TB|mdr-tb
5964309|NCT04150224|XDR-TB|xdr-tb
5964310|NCT04150029|MBG453|mbg453
5964311|NCT04150029|Venetoclax|venetoclax
5964312|NCT04150029|Azacitidine|azacitidine
5964313|NCT04150029|Phase 2|phase 2
5242870|NCT02486627|UTI|uti
5364259|NCT01883076|Congenital Heart Disease|congenital heart disease
5364260|NCT01883076|Umbilical cord blood|umbilical cord blood
5364261|NCT01883076|UCB|ucb
5364262|NCT01883076|Cord blood|cord blood
5364263|NCT01883076|Stem cells|stem cells
5364264|NCT01883076|Regenerative therapy|regenerative therapy
5364265|NCT01883076|Stage II Glenn|stage ii glenn
5364266|NCT01883076|Glenn Surgery|glenn surgery
5364267|NCT01883050|Coronary artery disease|coronary artery disease
5364268|NCT01883050|Percutaneous Intervention|percutaneous intervention
5364269|NCT01883050|Stent|stent
5364270|NCT01883050|Balloon angioplasty|balloon angioplasty
5364271|NCT01883050|Angiogram|angiogram
5364272|NCT01883050|Coronary angiogram|coronary angiogram
5364273|NCT01883037|Cystic Fibrosis|cystic fibrosis
5364274|NCT01883037|Cystic Fibrosis related diabetes|cystic fibrosis related diabetes
5364275|NCT01883037|Oral glucose tolerance test|oral glucose tolerance test
5364276|NCT01883024|Real time continuous glucose monitoring, decision support software, smartphone application.|real time continuous glucose monitoring, decision support software, smartphone application.
5364277|NCT01883011|Piracetam|piracetam
5364278|NCT01883011|Stroke|stroke
5364279|NCT01883011|Aphasia|aphasia
5364280|NCT01883011|Acute|acute
5364281|NCT01883011|Cerebral|cerebral
5364282|NCT01883011|Ischemic|ischemic
5364283|NCT01883011|Nootropil|nootropil
5364284|NCT01882998|HIV and pregnancy|hiv and pregnancy
5364285|NCT01882998|HIV and breastfeeding|hiv and breastfeeding
5364286|NCT01882998|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
5364287|NCT01882998|Africa|africa
5364288|NCT01882998|Uganda|uganda
5364289|NCT01882985|docetaxel|docetaxel
5364290|NCT01882985|lycopene|lycopene
5364291|NCT01882985|prostate cancer|prostate cancer
5364292|NCT01882933|Gastric adenocarcinoma|gastric adenocarcinoma
5364293|NCT01882933|HIPEC|hipec
5364294|NCT01882933|Oxaliplatin|oxaliplatin
5364295|NCT01882933|Signet ring cell|signet ring cell
5364296|NCT01882920|Cytoreductive surgery|cytoreductive surgery
5364297|NCT01882920|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5364298|NCT01882920|Goal directed fluid therapy|goal directed fluid therapy
5364299|NCT01882907|vildagliptin|vildagliptin
5364300|NCT01882907|metformin|metformin
5364301|NCT01882894|Plantar fasciitis, orthotic, functional outcome|plantar fasciitis, orthotic, functional outcome
5364302|NCT01882842|Infertility|infertility
5364303|NCT01882842|Endometrium|endometrium
5364304|NCT01882842|Live birth|live birth
5364305|NCT01882829|depression|depression
5364306|NCT01882829|major depressive disorder|major depressive disorder
5364307|NCT01882829|treatment resistant|treatment resistant
5364308|NCT01882829|Nuedexta|nuedexta
5364309|NCT01882829|dextromethorphan|dextromethorphan
5364310|NCT01882829|antidepressant|antidepressant
5364311|NCT01882829|glutamate|glutamate
5364312|NCT01882829|NMDA receptor|nmda receptor
5364313|NCT01882816|non-anaplastic|non-anaplastic
5364314|NCT01882816|non-medullary|non-medullary
5364315|NCT01882816|radiation|radiation
5364316|NCT01882816|IMRT|imrt
5364317|NCT01882816|Doxorubicin|doxorubicin
5364318|NCT01882816|13-070|13-070
5364319|NCT01882803|PI3K Inhibitor|pi3k inhibitor
5364320|NCT01882790|coronary artery spasm|coronary artery spasm
5364321|NCT01882790|hypertension|hypertension
5364322|NCT01882790|Pathophysiology|pathophysiology
5364323|NCT01882790|atrioventricular block|atrioventricular block
5364324|NCT01882790|blood pressure|blood pressure
5364325|NCT01882790|autonomic nervous function|autonomic nervous function
5364326|NCT01882751|kinematics|kinematics
5364327|NCT01882751|knee joint|knee joint
5364328|NCT01882738|Cervical length|cervical length
5364329|NCT01882738|BMI|bmi
5364330|NCT01882699|Insomnia|insomnia
5364331|NCT01882686|Pain|pain
5364332|NCT01882686|Back Pain|back pain
5364333|NCT01882686|Low Back Pain|low back pain
5364334|NCT01882686|Chronic Low Back Pain|chronic low back pain
5364335|NCT01882686|Cognitive Functional Therapy|cognitive functional therapy
5364336|NCT01882686|Intervention|intervention
5364337|NCT01882686|Subclassification|subclassification
5364338|NCT01882686|Multidimensional|multidimensional
5364339|NCT01882673|Tobacco|tobacco
5364340|NCT01882673|nicotine|nicotine
5364341|NCT01882673|dependence|dependence
5364342|NCT01882673|quitline|quitline
5364343|NCT01882647|psoriasis|psoriasis
5964314|NCT04150029|AML|aml
5964315|NCT04150029|Acute myeloid Leukemia|acute myeloid leukemia
5964316|NCT04149691|FGFR|fgfr
5964317|NCT04149691|kinase inhibitor|kinase inhibitor
5964318|NCT04149691|advanced solid tumors|advanced solid tumors
5964319|NCT04149691|carcinoma|carcinoma
5964320|NCT04149691|neoplasms|neoplasms
5964321|NCT04149691|gastric cancer|gastric cancer
5964322|NCT04149691|bladder cancer|bladder cancer
5964323|NCT04149691|squamous non-small cell lung cancer|squamous non-small cell lung cancer
5964324|NCT04149691|squamous immunophenotype|squamous immunophenotype
5964325|NCT04149275|Cabozantinib|cabozantinib
5964326|NCT04149275|Nivolumab|nivolumab
5964327|NCT04149275|Ipilimumab|ipilimumab
5964328|NCT04149275|tyrosine-kinase inhibitor|tyrosine-kinase inhibitor
5964329|NCT04149275|anti-PD-1|anti-pd-1
5964330|NCT04149275|anti-CTLA-4|anti-ctla-4
5964331|NCT04148937|Triple Negative Breast Cancer|triple negative breast cancer
5964332|NCT04148937|Pancreatic Cancer|pancreatic cancer
5364344|NCT01882647|lotion|lotion
5364345|NCT01882647|investigator's global assessment|investigator's global assessment
5364346|NCT01882621|NSCLC|nsclc
5364347|NCT01882621|Monosialoganglioside(GM1)|monosialoganglioside(gm1)
5364348|NCT01882621|neurotoxicity|neurotoxicity
5364349|NCT01882608|psychiatry|psychiatry
5364350|NCT01882608|mental health|mental health
5364351|NCT01882608|mood disorders|mood disorders
5364352|NCT01882608|mood diaries|mood diaries
5364353|NCT01882608|electronic diaries|electronic diaries
5364354|NCT01882608|cell phones|cell phones
5364355|NCT01882608|software|software
5364356|NCT01882608|mental health telemetry|mental health telemetry
5364360|NCT01882556|Post stroke spasticity.|post stroke spasticity.
5364361|NCT01882543|Interstitial cystitis|interstitial cystitis
5364362|NCT01882543|Bladder pain syndrome|bladder pain syndrome
5364363|NCT01882543|IC/BPS|ic/bps
5364364|NCT01882543|AQX-1125|aqx-1125
5364365|NCT01882543|SHIP1|ship1
5364366|NCT01882530|Post operative analgesia ;|post operative analgesia ;
5364367|NCT01882530|Paracetamol ;|paracetamol ;
5364368|NCT01882530|Ketoprofen ;|ketoprofen ;
5364369|NCT01882530|Nefopam ;|nefopam ;
5364370|NCT01882530|Morphine|morphine
5364371|NCT01882504|Pyoderma Gangrenosum|pyoderma gangrenosum
5364372|NCT01882504|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
5364373|NCT01882504|Atypical Pyoderma Gangrenosum|atypical pyoderma gangrenosum
5364374|NCT01882504|Peristomal Pyoderma Gangrenosum|peristomal pyoderma gangrenosum
5364375|NCT01882491|Erosive Osteoarthritis|erosive osteoarthritis
5364376|NCT01882491|Osteoarthritis|osteoarthritis
5364377|NCT01882491|Osteoarthritis of the Hand|osteoarthritis of the hand
5364378|NCT01882478|Barrett's esophagus|barrett's esophagus
5364379|NCT01882478|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
5364380|NCT01882478|Radio Frequency Ablation|radio frequency ablation
5364381|NCT01882478|Cryotherapy|cryotherapy
5364382|NCT01882452|Memory specificity training|memory specificity training
5364383|NCT01882452|Autobiographical memory|autobiographical memory
5364384|NCT01882452|Major depressive disorder|major depressive disorder
5364385|NCT01882439|psoriatic arthritis|psoriatic arthritis
5364386|NCT01882439|tofacitinib|tofacitinib
5364387|NCT01882439|ACR20|acr20
5364388|NCT01882439|HAQ-DI|haq-di
5364389|NCT01882439|TNF inhibitor failure|tnf inhibitor failure
5364390|NCT01882426|CONSTRUCT|construct
5364391|NCT01882426|Cluster randomization controlled trial|cluster randomization controlled trial
5364392|NCT01882426|Gastroenterology practices in North America|gastroenterology practices in north america
5364393|NCT01882400|Osteoporosis|osteoporosis
5364394|NCT01882400|Severe muscular dystrophy|severe muscular dystrophy
5364395|NCT01882400|Cystic fibrosis|cystic fibrosis
5364396|NCT01882387|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
5364397|NCT01882387|Graft-vs-Host Disease|graft-vs-host disease
5364398|NCT01882387|Neutrophil Engraftment|neutrophil engraftment
5364399|NCT01882387|Platelet Engraftment|platelet engraftment
5364400|NCT01882387|Immune Reconstitution|immune reconstitution
5364401|NCT01882387|Mucositis|mucositis
5364402|NCT01882374|Double Umbilical Cord Blood Transplantation|double umbilical cord blood transplantation
5364403|NCT01882374|Acute Graft versus Host Disease|acute graft versus host disease
5364404|NCT01882374|Neutrophil Engraftment|neutrophil engraftment
5364405|NCT01882374|Platelet Recovery|platelet recovery
5364406|NCT01882374|Immune Reconstitution|immune reconstitution
5364408|NCT01882361|opioid addiction|opioid addiction
5364409|NCT01882361|opioid treatment|opioid treatment
5364410|NCT01882361|naloxone|naloxone
5364411|NCT01882348|tobacco control, tobacco treatment, pediatrics, parents|tobacco control, tobacco treatment, pediatrics, parents
5364412|NCT01882335|Human capital formation|human capital formation
5364413|NCT01882322|FK506|fk506
5364414|NCT01882322|tacrolimus|tacrolimus
5364415|NCT01882322|immunosuppressant|immunosuppressant
5364416|NCT01882283|serum lipids|serum lipids
5364417|NCT01882283|cholesterol|cholesterol
5364418|NCT01882283|serum cholesterol|serum cholesterol
5364419|NCT01882283|black tea|black tea
5364420|NCT01882283|flavonoids|flavonoids
5364421|NCT01882283|crossover trial|crossover trial
5364422|NCT01882283|randomized control trial|randomized control trial
5364423|NCT01882283|diet controlled|diet controlled
5364424|NCT01882270|pericoronitis|pericoronitis
5364425|NCT01882270|periodontal|periodontal
5364426|NCT01882257|obstructive sleep apnea|obstructive sleep apnea
5364427|NCT01882257|sleep-disordered breathing|sleep-disordered breathing
5364428|NCT01882257|hypercapnia|hypercapnia
5364429|NCT01882257|spinal cord injury|spinal cord injury
5364430|NCT01882244|traumatic brain injury|traumatic brain injury
5364431|NCT01882244|cognition|cognition
5364432|NCT01882244|rehabilitation|rehabilitation
5364433|NCT01882244|attentional regulation|attentional regulation
5364434|NCT01882244|working memory|working memory
5364435|NCT01882231|Osteosarcoma|osteosarcoma
5964333|NCT04148937|Non-small Cell Lung Cancer|non-small cell lung cancer
5964334|NCT04148937|Renal Cell Carcinoma, Clear Cell|renal cell carcinoma, clear cell
5964335|NCT04148937|Cutaneous Melanoma|cutaneous melanoma
5964336|NCT04148937|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5964337|NCT04148937|Epithelial Ovarian Cancer|epithelial ovarian cancer
5964338|NCT04148937|Metastatic Cancer|metastatic cancer
5364436|NCT01882231|Ewing sarcoma|ewing sarcoma
5364437|NCT01882231|Paget's disease|paget's disease
5364438|NCT01882231|bone cancer|bone cancer
5364439|NCT01882231|childhood cancers|childhood cancers
5364440|NCT01882231|DCE MRI|dce mri
5364441|NCT01882231|DW MRI|dw mri
5364442|NCT01882231|CEST MRI|cest mri
5364443|NCT01882231|MT MRI|mt mri
5364444|NCT01882218|Liver cancer|liver cancer
5364445|NCT01882205|Ulcerative colitis|ulcerative colitis
5368251|NCT01864954|Smoking|smoking
5364447|NCT01882205|chromoendoscopy|chromoendoscopy
5364448|NCT01882205|dysplasia|dysplasia
5364449|NCT01882205|virtual chromoendoscopy|virtual chromoendoscopy
5364450|NCT01882205|FICE|fice
5364451|NCT01882205|NBI|nbi
5364452|NCT01882205|I-scan|i-scan
5364453|NCT01882192|family|family
5364454|NCT01882192|physical activity|physical activity
5364455|NCT01882192|planning|planning
5364456|NCT01882179|Reperfusion injury|reperfusion injury
5364457|NCT01882179|myocardial infarct size|myocardial infarct size
5364458|NCT01882179|MRI|mri
5364459|NCT01882179|spironolactone|spironolactone
5364460|NCT01882166|Fertilization in Vitro|fertilization in vitro
5364461|NCT01882166|Sperm Injections, Intracytoplasmic|sperm injections, intracytoplasmic
5364462|NCT01882166|Follicle Stimulating Hormone|follicle stimulating hormone
5364463|NCT01882166|Embryonic Development|embryonic development
5364464|NCT01882140|burns|burns
5364465|NCT01882140|wound healing|wound healing
5364466|NCT01882140|magnetic field therapy|magnetic field therapy
5364467|NCT01882127|Purpura|purpura
5364468|NCT01882127|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5364469|NCT01882114|atherosclerosis|atherosclerosis
5364470|NCT01882114|cardiovascular events|cardiovascular events
5364471|NCT01882114|ankle-brachial index|ankle-brachial index
5364472|NCT01882114|carotid disease|carotid disease
5364473|NCT01882114|echocardiography|echocardiography
5364474|NCT01882114|mediterranean diet|mediterranean diet
5364475|NCT01882114|platelet activation|platelet activation
5364476|NCT01882101|Fecal incontinence|fecal incontinence
5364477|NCT01882101|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5364478|NCT01882101|biofeedback|biofeedback
5364479|NCT01882101|quality of life|quality of life
5364481|NCT01882088|psyllium|psyllium
5364482|NCT01882088|Lower esophageal sphincter|lower esophageal sphincter
5364483|NCT01882088|Esophageal motility|esophageal motility
5364484|NCT01882088|Dietary fiber|dietary fiber
5364485|NCT01882088|Heartburn|heartburn
5364486|NCT01882088|gastroesophageal reflux|gastroesophageal reflux
5364487|NCT01882088|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
5364488|NCT01882075|Anesthesia|anesthesia
5364489|NCT01882075|Fluid administration|fluid administration
5364491|NCT01882023|EDNOS|ednos
5364492|NCT01882023|adolescents|adolescents
5364493|NCT01882010|Parkinson's disease|parkinson's disease
5364494|NCT01882010|motor function|motor function
5364495|NCT01882010|immune activation|immune activation
5364496|NCT01882010|T cells|t cells
5364498|NCT01882010|GMCSF|gmcsf
5364499|NCT01882010|leukine|leukine
5364500|NCT01882010|sargramostim|sargramostim
5364501|NCT01882010|magnetoencephalography|magnetoencephalography
5364502|NCT01881997|Procedure|procedure
5364503|NCT01881997|Abscess|abscess
5364504|NCT01881997|Emergency Department|emergency department
5364505|NCT01881997|Opioid|opioid
5364506|NCT01881997|Fentanyl|fentanyl
5364507|NCT01881984|Medium-chain acyl-CoA dehydrogenase deficiency|medium-chain acyl-coa dehydrogenase deficiency
5364508|NCT01881984|MCAD deficiency|mcad deficiency
5364509|NCT01881984|MCADD|mcadd
5364513|NCT01881984|K304E mutation|k304e mutation
5364515|NCT01881984|glycerol phenylbutyrate|glycerol phenylbutyrate
5364516|NCT01881971|HIV|hiv
5364517|NCT01881971|lung|lung
5364518|NCT01881971|lipids|lipids
5364519|NCT01881971|no lipid lowering medication|no lipid lowering medication
5364520|NCT01881971|normal liver and kidney function|normal liver and kidney function
5364521|NCT01881971|on stable ART regimen|on stable art regimen
5364522|NCT01881971|not pregnant|not pregnant
5364523|NCT01881945|Swallowing|swallowing
5364524|NCT01881945|Hyperventilation|hyperventilation
5364525|NCT01881932|acupuncture therapy|acupuncture therapy
5364526|NCT01881932|sham acupuncture therapy|sham acupuncture therapy
5364527|NCT01881932|chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
5364528|NCT01881919|Functional Food|functional food
5364529|NCT01881906|aerobic exercise|aerobic exercise
5364530|NCT01881906|Lung cancer|lung cancer
5364531|NCT01881906|psyco-social|psyco-social
5364532|NCT01881893|Quality of life|quality of life
5364533|NCT01881893|Psychosocial Support Systems|psychosocial support systems
5364534|NCT01881893|Randomized Controls as Topic|randomized controls as topic
5364535|NCT01881893|Cognitive Therapy|cognitive therapy
5964339|NCT04147923|Probiotic|probiotic
5964340|NCT04147923|Digestive Health|digestive health
5964341|NCT04147923|Healthy|healthy
5964342|NCT04147923|Nutrient analysis|nutrient analysis
5964343|NCT04147923|Constipation|constipation
5964344|NCT04147819|Human epidermal growth factor receptor 2(HER2)|human epidermal growth factor receptor 2(her2)
5964345|NCT04147819|Targeted alpha therapy|targeted alpha therapy
5964346|NCT04147819|Thorium-227|thorium-227
5964347|NCT04147767|oxysterol|oxysterol
5364536|NCT01881893|Feasibility Studies|feasibility studies
5364537|NCT01881880|Tomosynthesis|tomosynthesis
5364538|NCT01881880|Mammography|mammography
5364539|NCT01881880|Breast cancer|breast cancer
5364540|NCT01881841|Alcohol abuse|alcohol abuse
5364541|NCT01881841|Substance use|substance use
5364542|NCT01881841|Tobacco use disorder|tobacco use disorder
5364543|NCT01881841|Motivational Enhancement Therapy|motivational enhancement therapy
5364544|NCT01881841|Adolescents|adolescents
5364545|NCT01881815|Chronic wounds with different etiologies|chronic wounds with different etiologies
5364546|NCT01881815|Diabetic foot ulcers|diabetic foot ulcers
5364547|NCT01881815|venous leg ulcers|venous leg ulcers
5364549|NCT01881815|acute wounds|acute wounds
5364550|NCT01881802|Opioid drug Abuse|opioid drug abuse
5364552|NCT01881802|Immune Function|immune function
5364553|NCT01881789|multiple myeloma|multiple myeloma
5364554|NCT01881789|proteasome inhibitor|proteasome inhibitor
5364555|NCT01881789|oprozomib|oprozomib
5364556|NCT01881789|orpozomib tablets|orpozomib tablets
5364557|NCT01881776|Single injection interscalene brachial plexus block|single injection interscalene brachial plexus block
5364558|NCT01881776|Continuous interscalene brachial plexus block|continuous interscalene brachial plexus block
5364559|NCT01881776|General anesthesia|general anesthesia
5364560|NCT01881776|Postoperative pain|postoperative pain
5364561|NCT01881776|Recovery profile|recovery profile
5364562|NCT01881763|Electroconvulsive Therapy|electroconvulsive therapy
5364563|NCT01881763|Ketamine|ketamine
5364564|NCT01881763|anesthesia|anesthesia
5364565|NCT01881763|depression|depression
5364566|NCT01881763|unipolar|unipolar
5364567|NCT01881763|bipolar|bipolar
5364568|NCT01881750|Autism PRT|autism prt
5364569|NCT01881737|autism|autism
5364570|NCT01881711|hydrocephalus|hydrocephalus
5364571|NCT01881711|CSF shunt|csf shunt
5364572|NCT01881711|shunt malfunction|shunt malfunction
5364573|NCT01881711|shunt obstruction|shunt obstruction
5364574|NCT01881711|ShuntCheck|shuntcheck
5364575|NCT01881711|ShuntCheck-Micro-Pumper|shuntcheck-micro-pumper
5364576|NCT01881698|pregnancy|pregnancy
5364577|NCT01881698|platelet function|platelet function
5364578|NCT01881698|monitoring|monitoring
5364579|NCT01881698|multiple electrode aggregometry|multiple electrode aggregometry
5364580|NCT01881672|Aspiration pneumonia|aspiration pneumonia
5364581|NCT01881672|Coma|coma
5364582|NCT01881672|Mechanical ventilation|mechanical ventilation
5364583|NCT01881659|cervical cancer|cervical cancer
5364584|NCT01881659|cancer prevention|cancer prevention
5364585|NCT01881659|cervical screening|cervical screening
5364586|NCT01881659|HPV testing|hpv testing
5364587|NCT01881659|triage techniques|triage techniques
5364588|NCT01881646|Neuroinflammation|neuroinflammation
5364589|NCT01881646|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5364590|NCT01881633|gaucher disease, imiglucerase, ISU302|gaucher disease, imiglucerase, isu302
5364591|NCT01881620|PET scan|pet scan
5364592|NCT01881620|CT scan|ct scan
5364593|NCT01881620|Diagnostic performance|diagnostic performance
5364594|NCT01881607|tobacco smoke pollution|tobacco smoke pollution
5364595|NCT01881607|Tobacco use|tobacco use
5364596|NCT01881594|ileostomy closure,postoperative ileus,stimulation ileostomy|ileostomy closure,postoperative ileus,stimulation ileostomy
5364597|NCT01881581|Therapeutic|therapeutic
5364598|NCT01881581|Vaccine|vaccine
5364599|NCT01881581|HIV|hiv
5364600|NCT01881581|MVA|mva
5364601|NCT01881581|DNA|dna
5364602|NCT01881568|Total Knee Arthroplasty, TKA, blood loss|total knee arthroplasty, tka, blood loss
5364603|NCT01881555|fractional flow reserve|fractional flow reserve
5364604|NCT01881555|multivessel coronary artery disease|multivessel coronary artery disease
5364605|NCT01881555|angiography|angiography
5364606|NCT01881542|preeclampsia|preeclampsia
5364607|NCT01881542|proteinuria|proteinuria
5364608|NCT01881542|urine collection|urine collection
5364609|NCT01881529|limited scleroderma|limited scleroderma
5364610|NCT01881529|diffuse scleroderma|diffuse scleroderma
5364611|NCT01881529|Sclerosis|sclerosis
5364612|NCT01881529|Progressive|progressive
5364613|NCT01881529|Limited|limited
5364614|NCT01881503|life-threatening anemia|life-threatening anemia
5364615|NCT01881503|blood alternative|blood alternative
5364616|NCT01881503|HBOC|hboc
5364617|NCT01881490|Crohn's Disease|crohn's disease
5364618|NCT01881490|MRE|mre
5364619|NCT01881490|Pelvic MRI|pelvic mri
5364620|NCT01881490|P-MRI|p-mri
5364621|NCT01881490|colonoscopy|colonoscopy
5364622|NCT01881490|gastroscopy|gastroscopy
5364623|NCT01881477|immobilization|immobilization
5364624|NCT01881477|physical therapy|physical therapy
5364625|NCT01881477|intensive care|intensive care
5364626|NCT01881477|bed rest|bed rest
5364627|NCT01881477|movement|movement
5364628|NCT01881451|Tumour hypoxia|tumour hypoxia
5364629|NCT01881451|Clear Cell Ovarian Cancer|clear cell ovarian cancer
5364630|NCT01881451|Recurrent|recurrent
5364631|NCT01881451|Metastatic|metastatic
5364632|NCT01881438|Retinal Detachment|retinal detachment
5364633|NCT01881438|Fluoroquinolones|fluoroquinolones
5364634|NCT01881438|Ciprofloxacin|ciprofloxacin
5364635|NCT01881438|Levofloxacin|levofloxacin
5364636|NCT01881438|Gatifloxacin|gatifloxacin
5364637|NCT01881438|Gemifloxacin|gemifloxacin
5364638|NCT01881438|Moxifloxacin|moxifloxacin
5364639|NCT01881438|Norfloxacin|norfloxacin
5364640|NCT01881438|Ofloxacin|ofloxacin
5364641|NCT01881438|Beta-Lactam|beta-lactam
5364642|NCT01881425|POAG|poag
5364643|NCT01881412|Asthma|asthma
5364644|NCT01881412|Children|children
5364645|NCT01881412|Inhaled Corticosteroids|inhaled corticosteroids
5364646|NCT01881412|Emergency Department|emergency department
5364647|NCT01881399|Cholelithiasis|cholelithiasis
5364648|NCT01881399|Gallbladder polyps|gallbladder polyps
5364649|NCT01881399|Fluorescence|fluorescence
5364650|NCT01881399|Indocyanine green (ICG)|indocyanine green (icg)
5364651|NCT01881399|Intraoperative cholangiography (IOC)|intraoperative cholangiography (ioc)
5364652|NCT01881399|da Vinci surgical system|da vinci surgical system
5364653|NCT01881386|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5364654|NCT01881386|Lactate|lactate
5364655|NCT01881373|Obesity|obesity
5364656|NCT01881373|Child|child
5364657|NCT01881373|Food|food
5364658|NCT01881373|Physical Activity|physical activity
5364659|NCT01881373|Pacific|pacific
5364660|NCT01881360|fibromyalgia|fibromyalgia
5364661|NCT01881360|celiac-type symptoms|celiac-type symptoms
5364662|NCT01881360|gluten-free diet|gluten-free diet
5364663|NCT01881360|hypocaloric diet|hypocaloric diet
5364664|NCT01881347|endothelium|endothelium
5364665|NCT01881347|mitochondria|mitochondria
5364666|NCT01881347|reactive oxygen species|reactive oxygen species
5364667|NCT01881347|vascular biology|vascular biology
5364668|NCT01881347|arterial stiffness|arterial stiffness
5364669|NCT01881347|nitric oxide|nitric oxide
5364670|NCT01881334|Haploidentical Donor|haploidentical donor
5364671|NCT01881334|T-cell depleted Stem Cells|t-cell depleted stem cells
5364672|NCT01881334|Allogeneic Transplant|allogeneic transplant
5364673|NCT01881334|Umbilical Cord Blood Donor|umbilical cord blood donor
5364674|NCT01881334|High Risk Malignancies|high risk malignancies
5364675|NCT01881334|Metabolic Disorders|metabolic disorders
5364676|NCT01881334|Immune Deficiency|immune deficiency
5364677|NCT01881334|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5364678|NCT01881334|Acute Myelogenous Leukemia|acute myelogenous leukemia
5364679|NCT01881334|Myelodysplastic Syndrome|myelodysplastic syndrome
5364680|NCT01881334|ALL|all
5364681|NCT01881334|AML|aml
5364682|NCT01881334|MDS|mds
5364683|NCT01881334|CGD|cgd
5364684|NCT01881334|SCID|scid
5364685|NCT01881334|Adrenoleukodystrophy|adrenoleukodystrophy
5364686|NCT01881334|Metachromaticleukodystrophy|metachromaticleukodystrophy
5364687|NCT01881334|Krabbe|krabbe
5364688|NCT01881334|PMD|pmd
5364689|NCT01881334|Hunter's|hunter's
5364690|NCT01881334|Hurler's|hurler's
5364691|NCT01881334|Severe Aplastic Anemia|severe aplastic anemia
5364692|NCT01881334|Lymphoma|lymphoma
5364693|NCT01881334|Sickle Cell Disease|sickle cell disease
5364694|NCT01881334|Thalassemia|thalassemia
5364695|NCT01881321|Contraception|contraception
5364696|NCT01881321|Counseling|counseling
5364697|NCT01881295|Potassium|potassium
5364698|NCT01881295|Potato|potato
5364699|NCT01881295|French Fries|french fries
5364700|NCT01881295|Bioavailability|bioavailability
5364701|NCT01881295|Blood Pressure|blood pressure
5364702|NCT01881282|Hemorrhoids|hemorrhoids
5364703|NCT01881282|Carraghenates|carraghenates
5364704|NCT01881282|Mayinglong Musk|mayinglong musk
5364705|NCT01881282|Titanoreine|titanoreine
5364706|NCT01881256|Preterm birth|preterm birth
5364707|NCT01881256|Parenteral and enteral nutrition|parenteral and enteral nutrition
5364708|NCT01881256|Body composition in preterm infants|body composition in preterm infants
5862821|NCT00001491|Nerve Conduction Studies|nerve conduction studies
5364709|NCT01881243|Cardiac Arrest, Hyperoxia, Ischemia-reperfusion Injury, Reactive Oxygen Species, Oxidative Stress, Neuropsychological Tests|cardiac arrest, hyperoxia, ischemia-reperfusion injury, reactive oxygen species, oxidative stress, neuropsychological tests
5364710|NCT01881230|Breast Cancer|breast cancer
5364711|NCT01881230|Cancer of the Breast|cancer of the breast
5364712|NCT01881230|Metastatic Breast Cancer|metastatic breast cancer
5364713|NCT01881230|Metastatic Triple Negative Breast Cancer|metastatic triple negative breast cancer
5364714|NCT01881230|Triple Negative Breast Cancer|triple negative breast cancer
5364715|NCT01881230|Triple Negative Metastatic Breast Cancer|triple negative metastatic breast cancer
5364716|NCT01881230|Basal-like breast cancer|basal-like breast cancer
5364717|NCT01881230|Hormone receptor negative breast cancer|hormone receptor negative breast cancer
5364718|NCT01881230|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
5364719|NCT01881230|Progesterone negative receptor breast cancer|progesterone negative receptor breast cancer
5964348|NCT04147767|breast cancer|breast cancer
5964349|NCT04147767|phytosterols|phytosterols
5964350|NCT04147767|cholesterol metabolism|cholesterol metabolism
5964351|NCT04147715|Pharmacokinetics|pharmacokinetics
5964352|NCT04147715|S-648414|s-648414
5964353|NCT04147715|Food effect|food effect
5964354|NCT04147715|Antiretroviral|antiretroviral
5964355|NCT04147715|Drug-drug interaction|drug-drug interaction
5964356|NCT04147533|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5964357|NCT04147533|drug withdrawal|drug withdrawal
5964358|NCT04147533|chronic myeloid leukemia, chronic phase|chronic myeloid leukemia, chronic phase
5964359|NCT04147312|Traditional Chinese medicine|traditional chinese medicine
5964360|NCT04147312|Fufang E'Jiao Jiang|fufang e'jiao jiang
5364720|NCT01881230|HER2 Negative Breast Cancer|her2 negative breast cancer
5364721|NCT01881230|Abraxane|abraxane
5364722|NCT01881230|nab-Paclitaxel|nab-paclitaxel
5364723|NCT01881230|ABI-007|abi-007
5364724|NCT01881230|gemcitabine|gemcitabine
5364725|NCT01881230|Gemzar|gemzar
5364726|NCT01881230|carboplatin|carboplatin
5364727|NCT01881230|Paraplatin|paraplatin
5364728|NCT01881230|Paraplatin AQ|paraplatin aq
5364729|NCT01881230|Phase 2|phase 2
5364730|NCT01881230|Phase 3|phase 3
5364731|NCT01881217|Phase I|phase i
5364732|NCT01881217|Dose escalation|dose escalation
5364733|NCT01881217|Advanced, refractory solid tumors|advanced, refractory solid tumors
5364734|NCT01881217|FGFR2|fgfr2
5364735|NCT01881204|Hesperidin|hesperidin
5364736|NCT01881204|Osteoporosis|osteoporosis
5364737|NCT01881204|Bone Loss|bone loss
5364738|NCT01881191|multiple sclerosis|multiple sclerosis
5364739|NCT01881191|relapsing remitting|relapsing remitting
5364740|NCT01881191|MRI|mri
5364741|NCT01881191|teriflunomide|teriflunomide
5350879|NCT01944904|XOS|xos
5364742|NCT01881191|aubagio|aubagio
5364743|NCT01881191|gray matter atrophy|gray matter atrophy
5364744|NCT01881191|gray matter pathology|gray matter pathology
5364745|NCT01881178|CRP|crp
5364746|NCT01881178|Nopalea|nopalea
5364747|NCT01881178|Fruit|fruit
5364748|NCT01881178|Juice|juice
5364749|NCT01881152|Stroke|stroke
5364750|NCT01881152|Community education|community education
5364751|NCT01881152|Awareness|awareness
5364752|NCT01881152|Prehospital delay|prehospital delay
5364753|NCT01881139|Exercise|exercise
5364754|NCT01881139|Lipid|lipid
5364755|NCT01881139|Left ventricular|left ventricular
5364756|NCT01881139|heart function|heart function
5364757|NCT01881100|resin infiltration|resin infiltration
5364758|NCT01881100|randomized clinical trial|randomized clinical trial
5364759|NCT01881100|fluoride varnish|fluoride varnish
5364760|NCT01881100|caries lesion|caries lesion
5364761|NCT01881100|deciduous teeth|deciduous teeth
5364762|NCT01881087|Knee Arthroscopy|knee arthroscopy
5364763|NCT01881087|Levobupivacaine|levobupivacaine
5364764|NCT01881087|Spinal Anesthesia|spinal anesthesia
5364765|NCT01881087|Motor Block|motor block
5364766|NCT01881074|Type II Diabetes|type ii diabetes
5364767|NCT01881074|Periodontal Disease|periodontal disease
5364768|NCT01881074|Periodontitis|periodontitis
5364769|NCT01881074|Gum Disease|gum disease
5364770|NCT01881074|Gingivitis|gingivitis
5364771|NCT01881074|Triclosan|triclosan
5364772|NCT01881074|Inflammatory Markers|inflammatory markers
5364773|NCT01881074|Immune Response|immune response
5364774|NCT01881061|Sonography|sonography
5364775|NCT01881061|ICU|icu
5364776|NCT01881061|PEEP|peep
5364777|NCT01881048|Breast cancer|breast cancer
5365881|NCT01876121|NSAIDs|nsaids
5364778|NCT01881048|Omega-3 Fatty Acid|omega-3 fatty acid
5364779|NCT01881048|Celecoxib|celecoxib
5364780|NCT01881048|Celebrex|celebrex
5364782|NCT01881035|Hypertension|hypertension
5364783|NCT01881035|End stage renal disease|end stage renal disease
5364784|NCT01881022|Breast Cancer|breast cancer
5364785|NCT01881022|Couples|couples
5364786|NCT01881022|Sexual Dysfunction|sexual dysfunction
5364787|NCT01881022|Psychosexual Intervention|psychosexual intervention
5364788|NCT01881022|Sex Therapy|sex therapy
5364789|NCT01881022|Online Support|online support
5364790|NCT01881022|e-health|e-health
5364791|NCT01881009|Diabetes|diabetes
5364792|NCT01881009|Insulin|insulin
5364793|NCT01881009|Closed loop|closed loop
5364794|NCT01881009|Nocturnal glucose control|nocturnal glucose control
5364795|NCT01880996|Ovarian Cancer|ovarian cancer
5364796|NCT01880996|Gynecological Malignancies|gynecological malignancies
5364797|NCT01880996|Chemotherapy|chemotherapy
5364798|NCT01880996|Tai-chi|tai-chi
5364799|NCT01880996|Qigong|qigong
5364800|NCT01880996|Fatigue|fatigue
5364801|NCT01880996|Quality of life|quality of life
5364802|NCT01880996|Sleep disturbance|sleep disturbance
5364803|NCT01880983|EPP|epp
5364804|NCT01880983|Bloomer|bloomer
5364805|NCT01880983|Porphyria|porphyria
5364806|NCT01880957|bipolar disorder|bipolar disorder
5364807|NCT01880957|bipolar depression|bipolar depression
5364808|NCT01880957|serotonin transporter|serotonin transporter
5364809|NCT01880957|serotonin receptors|serotonin receptors
5364810|NCT01880957|binding potential|binding potential
5364811|NCT01880957|brain imaging|brain imaging
5364812|NCT01880957|unipolar depression|unipolar depression
5364813|NCT01880944|spine|spine
5364814|NCT01880944|trauma|trauma
5364815|NCT01880944|MRI|mri
5364816|NCT01880944|contrast|contrast
5364817|NCT01880918|Compression Anastomosis|compression anastomosis
5364818|NCT01880905|the length of uterine ovarian ligament|the length of uterine ovarian ligament
5364819|NCT01880879|coronary artery disease|coronary artery disease
5364820|NCT01880879|PCI|pci
5364821|NCT01880879|stent|stent
5364822|NCT01880866|PAH|pah
5364823|NCT01880853|breast cancer|breast cancer
5364824|NCT01880853|screening|screening
5364825|NCT01880853|mammography|mammography
5364826|NCT01880853|ultrasound|ultrasound
5364827|NCT01880827|GIP|gip
5364828|NCT01880827|GLP-1|glp-1
5364829|NCT01880827|type 2 diabetes|type 2 diabetes
5364831|NCT01880827|splanchnic blood flow|splanchnic blood flow
5364832|NCT01880827|incretin hormones|incretin hormones
5364833|NCT01880814|Depression, child, cognitive behavioral treatment, parent training, personalized treatment|depression, child, cognitive behavioral treatment, parent training, personalized treatment
5364834|NCT01880801|ITP|itp
5364835|NCT01880788|Age Related Macular Degeneration|age related macular degeneration
5364836|NCT01880788|Choroidal Neovascularization|choroidal neovascularization
5364837|NCT01880788|Central Serous Chorioretinopathy|central serous chorioretinopathy
5364838|NCT01880762|PET MR development and validation|pet mr development and validation
5364839|NCT01880723|exhaled breath condensate|exhaled breath condensate
5364840|NCT01880723|diffusion capacity of the lungs for carbon monoxide and nitric oxide|diffusion capacity of the lungs for carbon monoxide and nitric oxide
5364841|NCT01880723|albuterol|albuterol
5364842|NCT01880723|peripheral oxygen saturation|peripheral oxygen saturation
5364843|NCT01880723|ion regulation|ion regulation
5364844|NCT01880710|long term follow-up|long term follow-up
5364845|NCT01880710|urinary incontinence|urinary incontinence
5364846|NCT01880710|pelvic organ prolapse|pelvic organ prolapse
5364847|NCT01880710|total versus subtotal hysterectomy|total versus subtotal hysterectomy
5364848|NCT01880697|Influenza|influenza
5364849|NCT01880697|adults|adults
5364850|NCT01880697|elderly|elderly
5364851|NCT01880697|immunology|immunology
5364852|NCT01880697|safety|safety
5364859|NCT01880658|Maintenance therapy|maintenance therapy
5364860|NCT01880658|Capecitabine|capecitabine
5364861|NCT01880658|Adjuvant chemotherapy|adjuvant chemotherapy
5364862|NCT01880658|Post-operation|post-operation
5364863|NCT01880645|Breast Cancer|breast cancer
5364864|NCT01880645|Invasive breast cancer|invasive breast cancer
5364865|NCT01880645|Axillary lymph node metastases|axillary lymph node metastases
5364866|NCT01880645|Ultrasound|ultrasound
5364867|NCT01880645|Fine needle aspiration|fine needle aspiration
5364868|NCT01880645|FNA|fna
5364869|NCT01880645|Lymph node surgery|lymph node surgery
5364870|NCT01880645|Partial mastectomy|partial mastectomy
5364871|NCT01880645|Total mastectomy|total mastectomy
5364872|NCT01880632|XELOX|xelox
5364873|NCT01880632|perioperative treatment|perioperative treatment
5364874|NCT01880632|locally advanced gastric adenocarcinoma|locally advanced gastric adenocarcinoma
5364875|NCT01880632|D2 resection|d2 resection
5364876|NCT01880619|Double J|double j
5364877|NCT01880619|Ureteral stents|ureteral stents
5364878|NCT01880619|Symptoms|symptoms
5364879|NCT01880619|Alpha blockers|alpha blockers
5364880|NCT01880619|Anticholinergic|anticholinergic
5364881|NCT01880593|Ketamine|ketamine
5364882|NCT01880593|glutamate|glutamate
5364883|NCT01880593|N-methyl-D-aspartate|n-methyl-d-aspartate
5364884|NCT01880593|depression|depression
5364885|NCT01880593|major depressive disorder|major depressive disorder
5364886|NCT01880593|treatment resistant|treatment resistant
5364887|NCT01880593|antidepressant|antidepressant
5364888|NCT01880593|lithium|lithium
5364889|NCT01880554|Liver metastases|liver metastases
5364890|NCT01880554|Colorectal primary cancer|colorectal primary cancer
5364891|NCT01880554|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5364892|NCT01880554|Sonovue®|sonovue®
5364893|NCT01880541|Patients with breast cancer and breast surgery requiring|patients with breast cancer and breast surgery requiring
5364894|NCT01880515|Lung cancer|lung cancer
5364895|NCT01880515|BIBW 2992|bibw 2992
5364896|NCT01880515|Skin Rash|skin rash
5364897|NCT01880515|Tetracycline|tetracycline
5364898|NCT01880515|Afatinib|afatinib
5364899|NCT01880502|Healthy, Volunteers|healthy, volunteers
5364900|NCT01880489|transgender women|transgender women
5364901|NCT01880489|sexual risk|sexual risk
5364902|NCT01880489|substance use|substance use
5364903|NCT01880489|HIV prevention|hiv prevention
5364904|NCT01880489|behavioral intervention|behavioral intervention
5364905|NCT01880476|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5364906|NCT01880476|Comorbidity|comorbidity
5364907|NCT01880476|Aged|aged
5364908|NCT01880476|Health Services|health services
5364909|NCT01880463|Dry eye disease|dry eye disease
5364910|NCT01880463|incidence|incidence
5364911|NCT01880463|progression|progression
5364912|NCT01880411|PEK fusion protein Healthbanks|pek fusion protein healthbanks
5364913|NCT01880398|FIstula in ano; Bhagandar|fistula in ano; bhagandar
5364915|NCT01880385|inflammatory breast cancer|inflammatory breast cancer
5364916|NCT01880385|non metastatic|non metastatic
5364917|NCT01880385|Avastin|avastin
5364918|NCT01880372|Diabetes|diabetes
5364919|NCT01880372|Diabetic Retinopathy|diabetic retinopathy
5364920|NCT01880372|Retinopathy|retinopathy
5364921|NCT01880372|Free radical|free radical
5364922|NCT01880372|Retinal diseases|retinal diseases
5364923|NCT01880372|Antioxidants|antioxidants
5364924|NCT01880372|Protective agents|protective agents
5364925|NCT01880372|Thioctic acid|thioctic acid
5364926|NCT01880346|Cystic Fibrosis|cystic fibrosis
5364927|NCT01880346|Vitamin D|vitamin d
5364928|NCT01880346|absorption|absorption
5364929|NCT01880346|vitamin Deficiency|vitamin deficiency
5364930|NCT01880346|fat soluble|fat soluble
5364931|NCT01880333|Refractory epilepsy|refractory epilepsy
5231483|NCT02555683|Asthma|asthma
5364932|NCT01880333|dietary therapy|dietary therapy
5364933|NCT01880333|non-pharmacological therapy|non-pharmacological therapy
5364934|NCT01880333|Modified Atkin Diet|modified atkin diet
5364935|NCT01880307|Crohn's disease|crohn's disease
5364936|NCT01880307|pediatric|pediatric
5364937|NCT01880307|infliximab|infliximab
5364938|NCT01880307|top-down|top-down
5364939|NCT01880307|ITSKids|itskids
5364940|NCT01880294|Constipation|constipation
5364941|NCT01880294|Chronic constipation|chronic constipation
5364942|NCT01880294|Asia-Pacific|asia-pacific
5364943|NCT01880294|Gastroentrology|gastroentrology
5364944|NCT01880294|Asian participants|asian participants
5364945|NCT01880281|G protein-coupled receptor 99|g protein-coupled receptor 99
5364946|NCT01880281|2-oxoglutarate receptor 1|2-oxoglutarate receptor 1
5364947|NCT01880281|alpha-ketoglutarate|alpha-ketoglutarate
5364948|NCT01880281|urine|urine
5364949|NCT01880281|pH|ph
5364950|NCT01880281|acidosis|acidosis
5364951|NCT01880281|alkalosis|alkalosis
5364956|NCT01880255|Working Memory|working memory
5364957|NCT01880242|International|international
5364958|NCT01880242|Multicenter|multicenter
5364959|NCT01880242|Observational registry|observational registry
5364960|NCT01880242|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5364961|NCT01880242|Stenting|stenting
5364962|NCT01880242|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5364963|NCT01880242|Coronary revascularization|coronary revascularization
5364964|NCT01880242|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5364965|NCT01880242|STEMI|stemi
5364966|NCT01880242|NSTEMI|nstemi
5364967|NCT01880242|Ischemia|ischemia
5364968|NCT01880242|Angina|angina
5364969|NCT01880242|Subgroups|subgroups
5364970|NCT01880242|Acute Myocardial Infarction|acute myocardial infarction
5364971|NCT01880242|Diabetes|diabetes
5364972|NCT01880242|Small Vessels|small vessels
5364973|NCT01880242|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5364974|NCT01880216|Deep vein thrombosis|deep vein thrombosis
5364976|NCT01880216|Treatment|treatment
5364977|NCT01880216|Low molecular weight heparin|low molecular weight heparin
5364978|NCT01880216|Bemiparin|bemiparin
5364979|NCT01880216|Enoxaparin|enoxaparin
5364980|NCT01880203|thyroid|thyroid
5364981|NCT01880203|elastography SWE|elastography swe
5364982|NCT01880203|indeterminate cytology|indeterminate cytology
5364983|NCT01880164|Scoliosis|scoliosis
5364984|NCT01880164|Kyphosis|kyphosis
5364985|NCT01880164|Sagittal plane deformity|sagittal plane deformity
5364986|NCT01880151|Alzheimer's disease|alzheimer's disease
5364987|NCT01880151|Dementia|dementia
5364988|NCT01880151|Prodromal|prodromal
5364990|NCT01880151|ERP|erp
5364991|NCT01880151|Biomarkers|biomarkers
5364992|NCT01880138|Animated cartoon, Emergence agitation|animated cartoon, emergence agitation
5364993|NCT01880125|Tramadol|tramadol
5364994|NCT01880125|Acetaminophen|acetaminophen
5364995|NCT01880125|Pharmacokinetics|pharmacokinetics
5364996|NCT01880125|Sustained release|sustained release
5364997|NCT01880125|Immediate release|immediate release
5364998|NCT01880112|Infection|infection
5364999|NCT01880112|Cesarean delivery|cesarean delivery
5365000|NCT01880112|Antibiotic prophylaxis|antibiotic prophylaxis
5365001|NCT01880112|Cefazolin dosing|cefazolin dosing
5365002|NCT01880099|addiction|addiction
5365003|NCT01880099|smoking|smoking
5365004|NCT01880099|tobacco|tobacco
5365005|NCT01880099|cigarettes|cigarettes
5365006|NCT01880086|Chronic pain|chronic pain
5365007|NCT01880086|Low testosterone|low testosterone
5365008|NCT01880086|Hypogonadism|hypogonadism
5365009|NCT01880086|Opioid analgesics|opioid analgesics
5365010|NCT01880086|Narcotics|narcotics
5365011|NCT01880086|Opioid-induced androgen deficiency|opioid-induced androgen deficiency
5365012|NCT01880086|OPIAD|opiad
5365013|NCT01880086|Male infertility|male infertility
5365014|NCT01880086|Clomiphene citrate|clomiphene citrate
5365015|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
5365016|NCT01880086|Testosterone replacement therapy|testosterone replacement therapy
5365017|NCT01880060|Worksite|worksite
5365018|NCT01880060|weight loss|weight loss
5365019|NCT01880060|obesity|obesity
5365020|NCT01880047|Immune Thrombocytopenia|immune thrombocytopenia
5365021|NCT01880047|ITP|itp
5365022|NCT01880047|Eltrombopag|eltrombopag
5365023|NCT01880047|Promacta|promacta
5365024|NCT01880008|positron emission tomography|positron emission tomography
5365025|NCT01880008|magnetic resonance imaging|magnetic resonance imaging
5365026|NCT01880008|diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
5365027|NCT01880008|radionuclide imaging|radionuclide imaging
5365028|NCT01880008|disease management|disease management
5365029|NCT01880008|radiation therapy|radiation therapy
5365030|NCT01879982|Bipolar disorder|bipolar disorder
5365031|NCT01879982|subtypes|subtypes
5964361|NCT04147312|Randomized controlled trial|randomized controlled trial
5365032|NCT01879969|computer-assisted orthognathic surgery; facial asymmetry|computer-assisted orthognathic surgery; facial asymmetry
5365033|NCT01879956|Executive Functions|executive functions
5365034|NCT01879956|Schizophrenia|schizophrenia
5365035|NCT01879956|Occupational Therapy|occupational therapy
5365036|NCT01879943|Colorectal cancer|colorectal cancer
5365037|NCT01879943|Follow up|follow up
5365038|NCT01879943|Colonoscopy|colonoscopy
5365039|NCT01879943|Videocapsule|videocapsule
5365040|NCT01879930|randomized|randomized
5365041|NCT01879930|placebo-controlled|placebo-controlled
5365042|NCT01879930|double-blind study|double-blind study
5365043|NCT01879930|doxycycline|doxycycline
5365044|NCT01879917|c-peptide|c-peptide
5365045|NCT01879917|insulin|insulin
5365046|NCT01879917|hypoglycemia|hypoglycemia
5365047|NCT01879917|Newly onset|newly onset
5365048|NCT01879917|Diabetes|diabetes
5365050|NCT01879917|Beta cell|beta cell
5365051|NCT01879917|Autoimmune|autoimmune
5365052|NCT01879917|Glucagon|glucagon
5365053|NCT01879917|Meal test|meal test
5365054|NCT01879904|Colorectal Neoplasms|colorectal neoplasms
5365055|NCT01879891|Exercise Intensity|exercise intensity
5365056|NCT01879891|Metabolism|metabolism
5365057|NCT01879891|Insulin|insulin
5365058|NCT01879878|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5365059|NCT01879878|broccoli sprouts|broccoli sprouts
5365060|NCT01879878|sulforaphane|sulforaphane
5365061|NCT01879878|palliative chemotherapy|palliative chemotherapy
5365062|NCT01879878|cancer stem cells|cancer stem cells
5365063|NCT01879865|PKPD|pkpd
5365064|NCT01879865|Dexmedetomidine|dexmedetomidine
5365065|NCT01879865|Auditory Stimulation|auditory stimulation
5365066|NCT01879865|Cardiac Output|cardiac output
5365067|NCT01879852|Quadriceps strength|quadriceps strength
5365068|NCT01879852|Knee|knee
5365069|NCT01879852|Rehabilitation|rehabilitation
5365070|NCT01879826|Aculaser|aculaser
5365071|NCT01879826|Microlight ML830|microlight ml830
5365072|NCT01879826|Kidney biopsy|kidney biopsy
5365073|NCT01879826|Pain|pain
5365074|NCT01879826|Anxiety|anxiety
5365075|NCT01879826|Sedation|sedation
5365076|NCT01879813|Memory|memory
5365077|NCT01879813|Attention|attention
5365078|NCT01879787|Stroke|stroke
5365079|NCT01879787|transcranial direct current stimulation|transcranial direct current stimulation
5365080|NCT01879787|constraint-induced movement therapy|constraint-induced movement therapy
5365081|NCT01879787|mental practice|mental practice
5365082|NCT01879774|Hyponatremia|hyponatremia
5365083|NCT01879761|Immunosuppressed|immunosuppressed
5365084|NCT01879761|Sepsis|sepsis
5365085|NCT01879761|Staphylococcus Aureus|staphylococcus aureus
5365086|NCT01879761|Bacteremia|bacteremia
5365087|NCT01879761|HLA-DR|hla-dr
5365088|NCT01879748|Parkinson's disease|parkinson's disease
5365089|NCT01879748|Azilect|azilect
5365090|NCT01879748|rasagiline mesylate|rasagiline mesylate
5365091|NCT01879722|Drug therapy|drug therapy
5365092|NCT01879709|schizophrenia|schizophrenia
5365093|NCT01879709|Cognition|cognition
5365094|NCT01879709|Independent living skills|independent living skills
5365095|NCT01879683|Hunner's lesion|hunner's lesion
5365096|NCT01879644|ADHD|adhd
5365097|NCT01879644|Neurofeedback|neurofeedback
5365098|NCT01879644|Self-Management|self-management
5365099|NCT01879644|Parental Psychoeducation|parental psychoeducation
5365100|NCT01879644|Social Support|social support
5365101|NCT01879631|radial keratotomy; keratoconus; optical rehabilitation|radial keratotomy; keratoconus; optical rehabilitation
5365102|NCT01879618|Fragmin|fragmin
5365103|NCT01879618|dalteparin|dalteparin
5365104|NCT01879618|hemodialysis|hemodialysis
5365105|NCT01879618|anticoagulation|anticoagulation
5365106|NCT01879618|Renal Failure|renal failure
5365107|NCT01879605|Spinal surgery|spinal surgery
5365108|NCT01879605|Bowel preparation|bowel preparation
5365109|NCT01879605|Ileus|ileus
5365110|NCT01879605|Constipation|constipation
5365111|NCT01879605|Well-being|well-being
5365112|NCT01879592|Sickle cell disease|sickle cell disease
5365113|NCT01879592|Asthma|asthma
5365114|NCT01879592|Metabolomics|metabolomics
5365115|NCT01879592|Gene expression|gene expression
5365116|NCT01879579|Insulin|insulin
5365117|NCT01879579|Telemedicine|telemedicine
5365118|NCT01879553|Influenza,|influenza,
5365119|NCT01879553|Adults,|adults,
5365120|NCT01879553|Elderly,|elderly,
5365121|NCT01879553|Immunology,|immunology,
5365122|NCT01879553|Safety|safety
5365123|NCT01879540|Influenza,|influenza,
5365124|NCT01879540|Elderly,|elderly,
5365125|NCT01879540|Immunology,|immunology,
5365126|NCT01879540|Safety|safety
5365127|NCT01879514|IgA nephropathy|iga nephropathy
5365131|NCT01879501|Randomized controlled trial|randomized controlled trial
5365132|NCT01879501|Quality of life|quality of life
5365133|NCT01879501|Self efficacy|self efficacy
5365134|NCT01879501|Effectiveness|effectiveness
5964362|NCT04147156|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5964363|NCT04147156|Vertigo|vertigo
5964364|NCT04147156|Dizziness|dizziness
5964365|NCT04147156|Vestibular diseases|vestibular diseases
5964366|NCT04147156|Epley Maneuver|epley maneuver
5365135|NCT01879501|Chronic eye diseases management|chronic eye diseases management
5365136|NCT01879488|Aerosol|aerosol
5365137|NCT01879488|Lung deposition|lung deposition
5365138|NCT01879488|Mechanical ventilation|mechanical ventilation
5365139|NCT01879462|chronic hepatitis C (CHC)|chronic hepatitis c (chc)
5964367|NCT04147156|Semont Maneuver|semont maneuver
5243728|NCT02481726|68Ga|68ga
5365140|NCT01879462|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5365141|NCT01879462|NS5B|ns5b
5365142|NCT01879462|pharmacokinetics|pharmacokinetics
5365143|NCT01879462|GSK2878175|gsk2878175
5365144|NCT01879462|safety|safety
5365145|NCT01879462|FTIH|ftih
5365146|NCT01879462|healthy subjects|healthy subjects
5365147|NCT01879449|Spasticity|spasticity
5365148|NCT01879449|Veterans|veterans
5365149|NCT01879449|Prevalence|prevalence
5365150|NCT01879436|Pregnancy, Placenta, Cancer|pregnancy, placenta, cancer
5365151|NCT01879410|GSK573719|gsk573719
5365152|NCT01879410|lung function|lung function
5365153|NCT01879410|salmeterol (SAL)|salmeterol (sal)
5365154|NCT01879410|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
5365155|NCT01879410|GW642444|gw642444
5365156|NCT01879410|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5365157|NCT01879410|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
5365158|NCT01879410|fluticasone propionate (FP)|fluticasone propionate (fp)
5365160|NCT01879397|atherosclerosis|atherosclerosis
5365161|NCT01879397|arteriosclerosis|arteriosclerosis
5365162|NCT01879397|carotid stenosis|carotid stenosis
5365163|NCT01879397|carotid endarterectomy|carotid endarterectomy
5365164|NCT01879397|Stroke|stroke
5365165|NCT01879384|microdialysis|microdialysis
5365166|NCT01879384|bone free flap|bone free flap
5365167|NCT01879384|head and neck|head and neck
5365168|NCT01879384|monitoring free flap|monitoring free flap
5365169|NCT01879384|reconstructive surgery|reconstructive surgery
5365170|NCT01879358|Drug-eluting stent|drug-eluting stent
5365171|NCT01879358|Safety|safety
5365172|NCT01879358|Efficacy|efficacy
5365173|NCT01879345|Anticonvulsant|anticonvulsant
5365174|NCT01879332|Anticonvulsant|anticonvulsant
5365175|NCT01879319|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
5365176|NCT01879293|Metformin|metformin
5365177|NCT01879293|Left ventricular mass|left ventricular mass
5365178|NCT01879293|Endothelial dysfunction|endothelial dysfunction
5365179|NCT01879293|cardiac magnetic resonance|cardiac magnetic resonance
5365180|NCT01879293|aortic pulse wave|aortic pulse wave
5365181|NCT01879280|pterional craniotomy|pterional craniotomy
5365182|NCT01879280|osteoplastic craniotomy|osteoplastic craniotomy
5365183|NCT01879280|temporalis|temporalis
5365184|NCT01879280|minimally-invasive|minimally-invasive
5365185|NCT01879254|obsessive compulsive disorder (OCD)|obsessive compulsive disorder (ocd)
5365186|NCT01879254|deep brain stimulation (DBS)|deep brain stimulation (dbs)
5365187|NCT01879254|psychosurgery|psychosurgery
5365188|NCT01879254|long-term follow-up|long-term follow-up
5365189|NCT01879241|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5365190|NCT01879241|survival time|survival time
5365191|NCT01879241|ALS functioning Rating Scale|als functioning rating scale
5365192|NCT01879241|quality of life|quality of life
5365193|NCT01879241|survival|survival
5365194|NCT01879228|Cystic Fibrosis|cystic fibrosis
5365195|NCT01879228|Diabetes|diabetes
5365196|NCT01879228|Pancreatic Insufficiency|pancreatic insufficiency
5365197|NCT01879202|multiple sclerosis|multiple sclerosis
5365198|NCT01879202|fatigue|fatigue
5365199|NCT01879202|fatigue severity scale|fatigue severity scale
5365200|NCT01879202|fatigue impact scale|fatigue impact scale
5365201|NCT01879202|quality of life|quality of life
5365202|NCT01879163|Vaccine|vaccine
5365203|NCT01879163|Immunogenicity|immunogenicity
5365204|NCT01879137|Copeptin|copeptin
5365205|NCT01879137|Arginin stimulation test|arginin stimulation test
5365206|NCT01879111|Depressive episode|depressive episode
5365207|NCT01879111|Chronic ischaemic heart disease|chronic ischaemic heart disease
5365208|NCT01879111|Hypertension|hypertension
5365209|NCT01879098|probiotics|probiotics
5365210|NCT01879098|inflammation|inflammation
5365211|NCT01879098|bile|bile
5365212|NCT01879098|hunger|hunger
5365213|NCT01879098|satiety|satiety
5365214|NCT01879085|advanced|advanced
5365215|NCT01879085|metastatic|metastatic
5365216|NCT01879085|unresectable|unresectable
5365217|NCT01879085|soft|soft
5365218|NCT01879085|tissue|tissue
5365219|NCT01879085|sarcomas|sarcomas
5365220|NCT01879072|Biomarkers|biomarkers
5365221|NCT01879072|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5365222|NCT01879059|insulin resistance|insulin resistance
5365223|NCT01879059|exercise|exercise
5365224|NCT01879059|continuous glucose monitoring|continuous glucose monitoring
5365225|NCT01879059|blood flow|blood flow
5365227|NCT01879046|Mesenchymal stem cells|mesenchymal stem cells
5365228|NCT01879046|articular cartilage|articular cartilage
5365229|NCT01879046|tissue engineering|tissue engineering
5365230|NCT01879046|immunomodulation|immunomodulation
5365231|NCT01879046|osteo-arthritis|osteo-arthritis
5365232|NCT01879033|Obesity|obesity
5365233|NCT01879033|endothelial function|endothelial function
5365234|NCT01879033|Rh-PAT|rh-pat
5365235|NCT01879033|adipocytokines|adipocytokines
5365236|NCT01879020|MT-8995|mt-8995
5365237|NCT01879020|Dyslipidemia|dyslipidemia
5365238|NCT01879020|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
5365239|NCT01878994|Overweight|overweight
5964368|NCT04147156|Repositioning chair|repositioning chair
5365240|NCT01878994|Obesity|obesity
5365241|NCT01878994|Children|children
5365242|NCT01878994|Behaviour|behaviour
5365243|NCT01878994|Physical Activity|physical activity
5365244|NCT01878994|Nutrition|nutrition
5365245|NCT01878981|Catheter Ablation versus Drug Therapy in AF in China|catheter ablation versus drug therapy in af in china
5365246|NCT01878955|Antimullarian hormone(AMH)|antimullarian hormone(amh)
5365247|NCT01878955|Polycystic Ovary|polycystic ovary
5365248|NCT01878955|Multicystic Ovary|multicystic ovary
5365250|NCT01878942|Pharmacology|pharmacology
5365251|NCT01878942|Pharmacokinetics|pharmacokinetics
5365252|NCT01878942|Pharmacodynamics|pharmacodynamics
5365253|NCT01878942|Mechanism of action|mechanism of action
5365254|NCT01878942|Psychedelic|psychedelic
5365255|NCT01878942|Serotonin|serotonin
5365256|NCT01878942|Prepulse inhibition|prepulse inhibition
5365257|NCT01878942|LSD-induced neuroendocrine effects|lsd-induced neuroendocrine effects
5365258|NCT01878942|Long-term psychological effects|long-term psychological effects
5365260|NCT01878929|allergen immunotherapy|allergen immunotherapy
5365261|NCT01878929|subcutaneous allergen immunotherapy|subcutaneous allergen immunotherapy
5365262|NCT01878929|SCIT|scit
5365263|NCT01878916|the incidence of thrombosis,|the incidence of thrombosis,
5365264|NCT01878916|the effect of Hcy on thrombosis formation,|the effect of hcy on thrombosis formation,
5365265|NCT01878916|the relation between Hcy and plasma vitamin levels,|the relation between hcy and plasma vitamin levels,
5365266|NCT01878916|to compare these results with the control group|to compare these results with the control group
5365267|NCT01878890|Solid tumors (other than pancreas)|solid tumors (other than pancreas)
5365268|NCT01878877|Chronic pain|chronic pain
5365269|NCT01878877|neuropathic pain|neuropathic pain
5365270|NCT01878864|Pain, Discomfort, Periodontitis, Scaling and Root Planning, Visual Analogue Scale, McGills Pain Questionnaire|pain, discomfort, periodontitis, scaling and root planning, visual analogue scale, mcgills pain questionnaire
5365271|NCT01878825|Immunogenicity|immunogenicity
5365272|NCT01878825|Trivalent|trivalent
5365273|NCT01878825|Safety|safety
5365274|NCT01878825|Adults|adults
5365275|NCT01878825|Elderly|elderly
5365276|NCT01878825|Influenza|influenza
5365277|NCT01878812|Immunogenicity|immunogenicity
5365278|NCT01878812|Influenza|influenza
5365279|NCT01878812|Adults|adults
5365280|NCT01878812|Safety|safety
5365281|NCT01878812|Elderly|elderly
5365282|NCT01878799|Direct Acting Antiviral|direct acting antiviral
5365283|NCT01878799|Treatment Naive|treatment naive
5365284|NCT01878799|Interferon Sparing|interferon sparing
5365285|NCT01878799|Ribavirin Sparing|ribavirin sparing
5365323|NCT01878643|ventilator-associated pneumonia|ventilator-associated pneumonia
5365324|NCT01878643|bacterial resistance|bacterial resistance
5365325|NCT01878643|ventilator -associated tracheobronchitis|ventilator -associated tracheobronchitis
5490723|NCT01334203|ETT|ett
5365326|NCT01878643|clinical pulmonary infection score|clinical pulmonary infection score
5365327|NCT01878630|Chronic Heart Failure|chronic heart failure
5365328|NCT01878630|CHF|chf
5365366|NCT01878591|labour|labour
5365367|NCT01878591|dystocia|dystocia
5365368|NCT01878591|operative delivery|operative delivery
5365369|NCT01878591|vacuum|vacuum
5365370|NCT01878591|ultrasound|ultrasound
5365371|NCT01878578|Anticonvulsant, BIA 2-093|anticonvulsant, bia 2-093
5365372|NCT01878565|HBIg|hbig
5365373|NCT01878565|GM-CSF|gm-csf
5365374|NCT01878565|HBV vaccine|hbv vaccine
5260863|NCT02383771|Ticagrelor|ticagrelor
5365375|NCT01878565|immune regulatory therapy|immune regulatory therapy
5365376|NCT01878526|gastroesophageal reflux disease|gastroesophageal reflux disease
5365377|NCT01878526|heart burn|heart burn
5365378|NCT01878526|regurgitation|regurgitation
5365379|NCT01878526|systemic sclerosis|systemic sclerosis
5365380|NCT01878526|scleroderma|scleroderma
5365381|NCT01878526|proton pump inhibitor|proton pump inhibitor
5365382|NCT01878526|alginic acid|alginic acid
5365383|NCT01878526|omeprazole|omeprazole
5365384|NCT01878526|prokinetic|prokinetic
5365389|NCT01878487|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5365390|NCT01878487|thrombus aspiration, IVUS|thrombus aspiration, ivus
5365392|NCT01878474|Dyslipidemia|dyslipidemia
5365393|NCT01878474|Cholesteryl ester transfer proteins|cholesteryl ester transfer proteins
5365394|NCT01878435|Short Message System|short message system
5365395|NCT01878435|SMS reminder|sms reminder
5365396|NCT01878435|mobile phone|mobile phone
5365397|NCT01878435|cell phone|cell phone
5365398|NCT01878435|vaccination|vaccination
5365399|NCT01878435|immunization|immunization
5365402|NCT01878409|Parkinson Disease|parkinson disease
5365403|NCT01878409|BISF|bisf
5365404|NCT01878409|IIEF|iief
5365405|NCT01878409|FSFI|fsfi
5365406|NCT01878396|Circulating Melanoma cells in metastatic melanoma|circulating melanoma cells in metastatic melanoma
5365407|NCT01878383|(HSV)|(hsv)
5365408|NCT01878357|MST|mst
5365409|NCT01878357|Malaria|malaria
5365410|NCT01878357|Indonesia|indonesia
5964369|NCT04147130|Primary Health Care|primary health care
5964370|NCT04147130|Medication Adherence|medication adherence
5964371|NCT04147130|Disability|disability
5964372|NCT04147130|Patient-Centered Care|patient-centered care
5964373|NCT04147130|Ariadne Principles|ariadne principles
5964374|NCT04147013|Analgesia|analgesia
5964375|NCT04147013|Analgesic opioids|analgesic opioids
5365411|NCT01878357|Transmission|transmission
5365412|NCT01878305|hepatic encephalopathy|hepatic encephalopathy
5365413|NCT01878305|brain waves|brain waves
5365414|NCT01878305|electroencephalogram|electroencephalogram
5365415|NCT01878305|transcranial Doppler ultrasonography|transcranial doppler ultrasonography
5365416|NCT01878305|physiological monitoring|physiological monitoring
5365417|NCT01878305|intensive care|intensive care
5365418|NCT01878266|Diffuse Intrinsic Pontine Glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
5365419|NCT01878266|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5365420|NCT01878266|Radiotherapy|radiotherapy
5365421|NCT01878266|Median survival|median survival
5365422|NCT01878253|Total Shoulder Arthoplasty|total shoulder arthoplasty
5365423|NCT01878240|Vascular surgery|vascular surgery
5365424|NCT01878240|Abdominal Aortic aneurysm|abdominal aortic aneurysm
5365433|NCT01878201|antihypertension|antihypertension
5365434|NCT01878188|inodiftagene vixteplasmid|inodiftagene vixteplasmid
5365435|NCT01878175|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5365436|NCT01878175|Veterans|veterans
5365437|NCT01878175|Exercise|exercise
5365438|NCT01878162|Prevention|prevention
5365439|NCT01878162|Wellness|wellness
5365440|NCT01878162|Occupation|occupation
5365441|NCT01878162|Work|work
5365442|NCT01878162|Law Enforcement|law enforcement
5365443|NCT01878162|Exercise|exercise
5365444|NCT01878123|Arthritis|arthritis
5365445|NCT01878123|Rheumatoid Arthritis|rheumatoid arthritis
5365446|NCT01878123|Joint Diseases|joint diseases
5365447|NCT01878123|Musculoskeletal Diseases|musculoskeletal diseases
5365448|NCT01878123|Rheumatic Diseases|rheumatic diseases
5365449|NCT01878123|Connective Tissue Diseases|connective tissue diseases
5365450|NCT01878123|Autoimmune Diseases|autoimmune diseases
5365451|NCT01878123|Immune System Diseases|immune system diseases
5365452|NCT01878123|Antirheumatic agents|antirheumatic agents
5365453|NCT01878110|Trichotillomania|trichotillomania
5365454|NCT01878110|Hair pulling|hair pulling
5365455|NCT01878110|Behavior therapy|behavior therapy
5365462|NCT01878058|Prostate cancer|prostate cancer
5365463|NCT01878058|Brachytherapy|brachytherapy
5365464|NCT01878058|Seed implant|seed implant
5365465|NCT01878045|American Indians|american indians
5365466|NCT01878045|Diabetic Nephropathy|diabetic nephropathy
5365467|NCT01878045|Kidney Biopsy|kidney biopsy
5365468|NCT01878045|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5365469|NCT01878045|Retinopathy|retinopathy
5365470|NCT01878032|Retinal Disease|retinal disease
5365471|NCT01878032|Inherited Retinal Degeneration|inherited retinal degeneration
5365473|NCT01878019|Placebo|placebo
5365474|NCT01878019|Opiate Antagonist|opiate antagonist
5365475|NCT01878006|Opiate Receptor|opiate receptor
5365476|NCT01878006|Genotype|genotype
5365477|NCT01878006|PET Imaging|pet imaging
5365478|NCT01877993|coronary artery spasm|coronary artery spasm
5365479|NCT01877993|pathophysiology|pathophysiology
5365480|NCT01877993|atrioventricular block|atrioventricular block
5365481|NCT01877993|blood pressure|blood pressure
5365482|NCT01877993|autonomic nervous function|autonomic nervous function
5365483|NCT01877954|hydrofluoroalkane beclomethasone|hydrofluoroalkane beclomethasone
5365484|NCT01877954|fluticasone|fluticasone
5365485|NCT01877954|paediatrics|paediatrics
5365486|NCT01877954|real-life|real-life
5365487|NCT01877954|observational|observational
5365488|NCT01877954|primary care|primary care
5365489|NCT01877941|cardiac output|cardiac output
5365490|NCT01877941|pulse oximetry|pulse oximetry
5365491|NCT01877941|hemodynamics|hemodynamics
5365492|NCT01877928|Obstructive sleep apnea, CPAP, Boussignac|obstructive sleep apnea, cpap, boussignac
5365493|NCT01877915|Heart Failure|heart failure
5365494|NCT01877915|Coronary Artery Disease|coronary artery disease
5365495|NCT01877915|Stroke|stroke
5365496|NCT01877915|Myocardial Infarction|myocardial infarction
5365497|NCT01877915|Anticoagulation|anticoagulation
5365498|NCT01877889|Healthy|healthy
5365499|NCT01877889|Canagliflozin|canagliflozin
5365500|NCT01877889|INVOKANA|invokana
5365501|NCT01877889|Dapagliflozin|dapagliflozin
5365502|NCT01877889|FORXIGA|forxiga
5365503|NCT01877889|Pharmacodynamics|pharmacodynamics
5365504|NCT01877863|intradialytic exercise|intradialytic exercise
5365505|NCT01877863|hemodialysis|hemodialysis
5365506|NCT01877837|Stem cell transplant|stem cell transplant
5365507|NCT01877837|Sickle cell|sickle cell
5365508|NCT01877837|Stem cell transplantation|stem cell transplantation
5365509|NCT01877837|Related|related
5365510|NCT01877837|Unrelated|unrelated
5365511|NCT01877824|Surgery|surgery
5365512|NCT01877824|Training|training
5361013|NCT01897376|wound|wound
5365513|NCT01877811|Lung Cancer|lung cancer
5365514|NCT01877811|RET Inhibitor|ret inhibitor
5365515|NCT01877811|Solid Tumors|solid tumors
5365516|NCT01877811|RET mutations or rearrangements|ret mutations or rearrangements
5365517|NCT01877811|BRAF mutations or rearrangements|braf mutations or rearrangements
5365518|NCT01877811|Squamous NSCLC|squamous nsclc
5365519|NCT01877811|KRAS mutation|kras mutation
5365520|NCT01877811|Other Lung adenocarcinomas|other lung adenocarcinomas
5964376|NCT04147013|Nasal Polyposis|nasal polyposis
5365521|NCT01877772|cuff repair|cuff repair
5365522|NCT01877772|arthroscopic|arthroscopic
5365523|NCT01877772|Trephination|trephination
5365524|NCT01877772|Bone|bone
5365525|NCT01877772|cuff tear|cuff tear
5365526|NCT01877759|Stem cell ,liver cirrhosis|stem cell ,liver cirrhosis
5365528|NCT01877746|myocarditis|myocarditis
5365529|NCT01877746|cardiomyopathy|cardiomyopathy
5365530|NCT01877746|endomyocardial biopsy|endomyocardial biopsy
5365531|NCT01877746|immunosuppression|immunosuppression
5365532|NCT01877733|Resistance training|resistance training
5365533|NCT01877720|Preterm infant less than 32 weeks of gestation age|preterm infant less than 32 weeks of gestation age
5365534|NCT01877720|intubated more than 48 hours after birth|intubated more than 48 hours after birth
5365535|NCT01877720|postextubation|postextubation
5365536|NCT01877694|pink eye|pink eye
5365537|NCT01877668|psoriatic arthritis|psoriatic arthritis
5365538|NCT01877668|radiographic changes|radiographic changes
5365539|NCT01877668|active comparator|active comparator
5365540|NCT01877668|tofacitinib|tofacitinib
5365541|NCT01877655|ASP0113|asp0113
5365542|NCT01877655|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5365543|NCT01877655|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
5365544|NCT01877642|ADASUVE|adasuve
5365545|NCT01877642|inhaled loxapine|inhaled loxapine
5365546|NCT01877642|drug drug interaction|drug drug interaction
5365547|NCT01877642|lorazepam|lorazepam
5365548|NCT01877642|acute treatment of agitation|acute treatment of agitation
5365549|NCT01877629|Pharmacokinetics|pharmacokinetics
5365550|NCT01877629|Tolerability|tolerability
5365551|NCT01877629|Safety|safety
5365552|NCT01877629|ACT-129968|act-129968
5365553|NCT01877616|sleep disorders|sleep disorders
5365554|NCT01877616|insomnia|insomnia
5365555|NCT01877616|hypersomnia|hypersomnia
5365556|NCT01877616|sleep-disordered breathing|sleep-disordered breathing
5365557|NCT01877616|cardiovascular health|cardiovascular health
5365558|NCT01877616|stroke|stroke
5365559|NCT01877616|ischemic heart disease|ischemic heart disease
5365560|NCT01877616|Atahualpa|atahualpa
5365562|NCT01877551|Protease inhibitor|protease inhibitor
5365563|NCT01877551|insulin resistance|insulin resistance
5365564|NCT01877551|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
5365565|NCT01877525|colorectal polyps|colorectal polyps
5365566|NCT01877525|resect and discard|resect and discard
5365567|NCT01877525|endoscopic prediction|endoscopic prediction
5365568|NCT01877525|histological diagnosis|histological diagnosis
5365569|NCT01877525|narrow band imaging|narrow band imaging
5365570|NCT01877499|Hemodiafiltration|hemodiafiltration
5365571|NCT01877499|Convection volume|convection volume
5365572|NCT01877499|Filtration fraction|filtration fraction
5365573|NCT01877499|Blood flow|blood flow
5365574|NCT01877499|Treatment time|treatment time
5365575|NCT01877486|atrial fibrillation|atrial fibrillation
5365576|NCT01877486|cryoballoon ablation|cryoballoon ablation
5365577|NCT01877486|persistent AF|persistent af
5365578|NCT01877486|paroxysmal AF|paroxysmal af
5365579|NCT01877486|dofetilide|dofetilide
5365580|NCT01877473|atrial fibrillation|atrial fibrillation
5365581|NCT01877473|persistent AF|persistent af
5365582|NCT01877473|catheter ablation|catheter ablation
5365882|NCT01876121|Acute pain|acute pain
5365583|NCT01877473|duration of 7 days to one year|duration of 7 days to one year
5261102|NCT02382341|ACL|acl
5365584|NCT01877473|with symptoms and failure of at least one antiarrhythmic drug|with symptoms and failure of at least one antiarrhythmic drug
5365585|NCT01877460|sodium alginate|sodium alginate
5365586|NCT01877460|chocolate milk|chocolate milk
5365587|NCT01877460|satiety|satiety
5365588|NCT01877460|energy intake|energy intake
5365589|NCT01877460|glycemia|glycemia
5365590|NCT01877460|insulinemia|insulinemia
5365591|NCT01877447|tDCS|tdcs
5365592|NCT01877447|Brain stimulation|brain stimulation
5365593|NCT01877447|depressive disorder|depressive disorder
5365594|NCT01877434|Reversed shoulder arthroplasty|reversed shoulder arthroplasty
5365595|NCT01877434|Treatment|treatment
5365596|NCT01877434|TESS|tess
5365597|NCT01877421|Reducing plaque|reducing plaque
5365598|NCT01877421|Reducing gingivitis|reducing gingivitis
5365599|NCT01877421|safety|safety
5365600|NCT01877421|proof of concept|proof of concept
5365601|NCT01877421|antiplaque chewing gum|antiplaque chewing gum
5365602|NCT01877408|disposable circumcision device|disposable circumcision device
5365603|NCT01877408|Tissue adhesive|tissue adhesive
5365604|NCT01877408|Open surgical circumcision|open surgical circumcision
5365605|NCT01877408|Minimally-invasive circumcision|minimally-invasive circumcision
5365606|NCT01877395|Rabies|rabies
5365607|NCT01877395|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
5365608|NCT01877395|Human Diploid Cell Vaccine|human diploid cell vaccine
5365609|NCT01877395|Imovax® Rabies|imovax® rabies
5365611|NCT01877356|spinal anesthesia|spinal anesthesia
5365612|NCT01877356|micturition|micturition
5365613|NCT01877356|bladder retention|bladder retention
5365614|NCT01877356|unilateral block|unilateral block
5365615|NCT01877356|prilocaine hyperbaric|prilocaine hyperbaric
5365616|NCT01877356|prilocaine plain|prilocaine plain
5365617|NCT01877356|local anaesthetic dose|local anaesthetic dose
5423316|NCT01616225|Growth Hormone|growth hormone
5964377|NCT04147013|Treatment|treatment
5365618|NCT01877343|cardiac functional health classification|cardiac functional health classification
5365619|NCT01877343|Congenital heart failure|congenital heart failure
5365620|NCT01877343|chronic heart failure|chronic heart failure
5365621|NCT01877330|shoulder arthroscopy|shoulder arthroscopy
5365622|NCT01877330|ultrasound guided nerve block|ultrasound guided nerve block
5365623|NCT01877330|interscalene nerve block|interscalene nerve block
5365624|NCT01877317|Audiology|audiology
5365625|NCT01877317|hearing loss|hearing loss
5365626|NCT01877317|hearing healthcare|hearing healthcare
5365627|NCT01877317|mobile app|mobile app
5365628|NCT01877317|hearing aid fitting|hearing aid fitting
5365629|NCT01877317|audiometry|audiometry
5365630|NCT01877317|audiogram|audiogram
5365631|NCT01877291|smoking, nasal lavage, exhaled breath condensate, mucociliary transport|smoking, nasal lavage, exhaled breath condensate, mucociliary transport
5365632|NCT01877278|Osteoarthritis|osteoarthritis
5365633|NCT01877278|Pulsed electromagnetic fields|pulsed electromagnetic fields
5351598|NCT01941693|alcohol|alcohol
5365634|NCT01877278|Device|device
5365635|NCT01877278|Pain|pain
5365636|NCT01877278|Pressure algometry|pressure algometry
5365637|NCT01877252|critical limb ischemia|critical limb ischemia
5365638|NCT01877252|endovascular treatment|endovascular treatment
5365639|NCT01877252|open surgical repair|open surgical repair
5365640|NCT01877252|diabetic foot|diabetic foot
5365641|NCT01877226|Healthy|healthy
5365642|NCT01877226|Tapentadol|tapentadol
5365643|NCT01877213|coaching|coaching
5365644|NCT01877213|therapeutic education|therapeutic education
5365645|NCT01877213|hospital admission|hospital admission
5365646|NCT01877213|quality improvement strategies|quality improvement strategies
5365647|NCT01877213|management program|management program
5365648|NCT01877213|nurse follow up|nurse follow up
5365649|NCT01877213|discharge planning|discharge planning
5365650|NCT01877213|rehospitalization|rehospitalization
5365651|NCT01877187|Primary liver cancer|primary liver cancer
5365652|NCT01877187|Metastatic liver cancer|metastatic liver cancer
5365653|NCT01877174|Internal Carotid Stenosis|internal carotid stenosis
5365654|NCT01877174|Reverse Flow|reverse flow
5365655|NCT01877174|Carotid stenting|carotid stenting
5365656|NCT01877174|MICHI(TM) NPS+f|michi(tm) nps+f
5365657|NCT01877148|Parkinson, rehabilitation, tDCS|parkinson, rehabilitation, tdcs
5365658|NCT01877135|anal carcinoma|anal carcinoma
5365659|NCT01877135|AIN3|ain3
5365660|NCT01877135|cohort study|cohort study
5365661|NCT01877109|Lymphoma|lymphoma
5365662|NCT01877109|Prognosis|prognosis
5365663|NCT01877109|Biomarker|biomarker
5365664|NCT01877109|Quality of life|quality of life
5365665|NCT01877096|Motivational Interviewing|motivational interviewing
5365666|NCT01877096|Screening Colonoscopy|screening colonoscopy
5365667|NCT01877096|Cancer Prevention|cancer prevention
5365668|NCT01877083|KIF5B-RET-Positive Adenocarcinoma|kif5b-ret-positive adenocarcinoma
5365669|NCT01877083|Lung Cancer|lung cancer
5365670|NCT01877083|NSCLC|nsclc
5365671|NCT01877083|Non-Small Cell Lung Cancer|non-small cell lung cancer
5365672|NCT01877070|assessments|assessments
5365673|NCT01877070|13-076|13-076
5365674|NCT01877057|Pea protein|pea protein
5365675|NCT01877057|Satiety hormone|satiety hormone
5365676|NCT01877057|Ussing Chamber|ussing chamber
5365677|NCT01877044|Prebiotics|prebiotics
5365678|NCT01877044|Intestinal permeability|intestinal permeability
5365679|NCT01877044|Gut barrier function|gut barrier function
5365680|NCT01877044|Immunity|immunity
5365681|NCT01877031|central line|central line
5365682|NCT01877031|ultrasound guided central line insertion|ultrasound guided central line insertion
5365683|NCT01877031|virtual reality|virtual reality
5365684|NCT01877031|augmented reality|augmented reality
5365685|NCT01877018|Comparative Effectiveness Research|comparative effectiveness research
5365686|NCT01877018|Reminder Systems|reminder systems
5365687|NCT01877018|Patient Participation|patient participation
5365688|NCT01877018|Primary Health Care|primary health care
5365689|NCT01877018|Early Detection of Cancer|early detection of cancer
5365690|NCT01877018|Colorectal Neoplasms|colorectal neoplasms
5365691|NCT01877005|Multicenter, single arm and opened label phase II study|multicenter, single arm and opened label phase ii study
5365692|NCT01876992|diabetes|diabetes
5365693|NCT01876992|pediatrics|pediatrics
5365694|NCT01876992|obesity|obesity
5365695|NCT01876992|healthy volunteers|healthy volunteers
5365696|NCT01876992|metformin|metformin
5365697|NCT01876992|nutrition|nutrition
5365698|NCT01876992|healthy controls|healthy controls
5365700|NCT01876966|HIV|hiv
5365701|NCT01876966|pharmacokinetic interaction|pharmacokinetic interaction
5361211|NCT01896375|Legislation|legislation
5365702|NCT01876966|healthy HIV-negative person|healthy hiv-negative person
5365703|NCT01876940|supraglottic airway|supraglottic airway
5365705|NCT01876940|tracheal intubation|tracheal intubation
5365706|NCT01876940|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5365707|NCT01876927|Locally|locally
5365708|NCT01876927|Advanced|advanced
5365709|NCT01876927|Resectable|resectable
5365710|NCT01876927|Gastric Cancer|gastric cancer
5964378|NCT04147000|Pharmacokinetics|pharmacokinetics
5964379|NCT04147000|Pharmacodynamics|pharmacodynamics
5365711|NCT01876914|Diabetes|diabetes
5365712|NCT01876914|Edema|edema
5365713|NCT01876914|DME|dme
5365714|NCT01876914|OCT|oct
5365715|NCT01876901|Rectal cancer|rectal cancer
5365716|NCT01876901|Coloanal anastomosis|coloanal anastomosis
5365717|NCT01876901|Phase 2 clinical trial|phase 2 clinical trial
5365718|NCT01876888|patient satisfaction|patient satisfaction
5365719|NCT01876888|physical therapy|physical therapy
5365720|NCT01876888|MedRisk instrument|medrisk instrument
5365721|NCT01876875|psoriasis|psoriasis
5365722|NCT01876875|obesity|obesity
5365723|NCT01876862|HIV-1|hiv-1
5365724|NCT01876862|chronic infection|chronic infection
5365725|NCT01876862|cure|cure
5365726|NCT01876862|remission|remission
5365727|NCT01876849|diabetes|diabetes
5365728|NCT01876849|exenatide|exenatide
5365729|NCT01876849|Byetta|byetta
5365730|NCT01876849|Amylin|amylin
5365731|NCT01876849|Lilly|lilly
5365732|NCT01876836|i-gel|i-gel
5365733|NCT01876836|C-LMA|c-lma
5365734|NCT01876836|gastroeosephageal reflux|gastroeosephageal reflux
5365735|NCT01876836|sore troat|sore troat
5365736|NCT01876823|Memory Decline|memory decline
5365737|NCT01876823|Depression|depression
5365738|NCT01876823|Elderly|elderly
5365739|NCT01876823|Antidepressants|antidepressants
5365740|NCT01876823|Treatment|treatment
5365741|NCT01876823|memantine|memantine
5365742|NCT01876810|Gemfibrozil|gemfibrozil
5365743|NCT01876810|Nicotine Dependence|nicotine dependence
5365744|NCT01876810|Smoking|smoking
5365745|NCT01876810|Cigarettes|cigarettes
5365746|NCT01876784|vandetanib, AZD 6474, Differentiated Thyroid Cancer|vandetanib, azd 6474, differentiated thyroid cancer
5365747|NCT01876771|177lutetium-DOTA(O)Tyr3)octreotate|177lutetium-dota(o)tyr3)octreotate
5365748|NCT01876758|ECT|ect
5365749|NCT01876758|Memory Training|memory training
5365750|NCT01876758|Cognitive Remediation|cognitive remediation
5365751|NCT01876758|Electroconvulsive Therapy|electroconvulsive therapy
5365752|NCT01876758|Treatment Resistant Depression|treatment resistant depression
5365753|NCT01876758|Depression|depression
5365754|NCT01876758|Geriatric Depression|geriatric depression
5365755|NCT01876758|Memory Loss|memory loss
5365756|NCT01876758|Cognitive Training|cognitive training
5365757|NCT01876732|hemodialysis|hemodialysis
5365758|NCT01876732|viatmin B12 deficiency|viatmin b12 deficiency
5365759|NCT01876732|Epogen|epogen
5365760|NCT01876719|ADHD|adhd
5365761|NCT01876719|AR08|ar08
5365762|NCT01876719|adrenergic receptor agonists|adrenergic receptor agonists
5365763|NCT01876719|randomized, placebo-controlled clinical trial|randomized, placebo-controlled clinical trial
5365764|NCT01876706|UroLift System|urolift system
5365765|NCT01876680|chronic|chronic
5365766|NCT01876680|neck|neck
5365767|NCT01876680|shoulder|shoulder
5365768|NCT01876680|exercise|exercise
5365769|NCT01876654|Total Knee Replacement|total knee replacement
5365770|NCT01876654|Patient specific instrumentation|patient specific instrumentation
5365771|NCT01876641|Metastatic melanoma|metastatic melanoma
5365772|NCT01876641|melanoma|melanoma
5365773|NCT01876641|BRAF-mutated Metastatic Melanoma|braf-mutated metastatic melanoma
5365774|NCT01876641|V600EBRAF-mutated metastatic melanoma|v600ebraf-mutated metastatic melanoma
5365775|NCT01876641|Decitabine|decitabine
5365776|NCT01876641|Vemurafenib|vemurafenib
5365777|NCT01876628|Clindamycin|clindamycin
5365778|NCT01876628|Cellulitis|cellulitis
5365779|NCT01876628|Flucloxacillin|flucloxacillin
5365780|NCT01876628|Group A streptococcus|group a streptococcus
5366478|NCT01873534|Anemia|anemia
5365781|NCT01876628|Staphylococcus aureus|staphylococcus aureus
5365782|NCT01876615|safety/tolerability and pharmacokinetics/pharmacodynamics|safety/tolerability and pharmacokinetics/pharmacodynamics
5365783|NCT01876602|adolescents|adolescents
5365784|NCT01876602|exercise|exercise
5365785|NCT01876602|fitness|fitness
5365786|NCT01876602|school-based|school-based
5365787|NCT01876589|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5365788|NCT01876589|Invasive coronary angiography (ICA)|invasive coronary angiography (ica)
5365789|NCT01876589|Positron Emission Tomography (PET)|positron emission tomography (pet)
5365790|NCT01876576|colonoscopy|colonoscopy
5365791|NCT01876563|thioredoxin|thioredoxin
5365792|NCT01876563|TBP-2|tbp-2
5365793|NCT01876563|thioredoxin reductase|thioredoxin reductase
5365794|NCT01876563|vitamin D|vitamin d
5365795|NCT01876563|DIABETES|diabetes
5365796|NCT01876550|Mupirocin Calcium Cream 2%|mupirocin calcium cream 2%
5365797|NCT01876550|Bactroban® Cream|bactroban® cream
5365798|NCT01876550|Secondarily infected traumatic skin lesions|secondarily infected traumatic skin lesions
5365799|NCT01876524|Substance Use Disorder|substance use disorder
5365800|NCT01876524|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
5365801|NCT01876524|Schizophrenia|schizophrenia
5964380|NCT04146389|adrenal steroidogenesis|adrenal steroidogenesis
5365840|NCT01876277|Body image|body image
5365841|NCT01876277|Adolescent|adolescent
5365842|NCT01876264|Colorectal surgery|colorectal surgery
5365843|NCT01876264|Colonoscopy|colonoscopy
5365844|NCT01876264|Randomized controlled trial|randomized controlled trial
5365845|NCT01876251|Breast cancer metastatic|breast cancer metastatic
5365846|NCT01876251|docetaxel|docetaxel
5365847|NCT01876251|PF-03084014|pf-03084014
5365848|NCT01876238|Breast Cancer|breast cancer
5365849|NCT01876238|Patient-Doctor Communication|patient-doctor communication
5365850|NCT01876238|Supportive Care|supportive care
5365851|NCT01876225|cervical biopsy|cervical biopsy
5365852|NCT01876225|forced cough|forced cough
5365853|NCT01876225|pain|pain
5365854|NCT01876225|VAS scale|vas scale
5365855|NCT01876212|melanoma|melanoma
5365856|NCT01876212|metastatic|metastatic
5365857|NCT01876212|vaccine|vaccine
5365858|NCT01876212|BRAF|braf
5365859|NCT01876199|HIV-1|hiv-1
5365860|NCT01876199|acute|acute
5365861|NCT01876199|diagnosis|diagnosis
5365862|NCT01876199|pharmacies|pharmacies
5365863|NCT01876199|healthcare facilities|healthcare facilities
5365864|NCT01876186|antimuscarinic treatment|antimuscarinic treatment
5365865|NCT01876186|urodynamic studies|urodynamic studies
5365871|NCT01876147|Vision testing|vision testing
5365872|NCT01876147|Retinitis Pigmentosa|retinitis pigmentosa
5365874|NCT01876147|Visual acuity|visual acuity
5365875|NCT01876147|Poor vision|poor vision
5365876|NCT01876147|Quantification|quantification
5365877|NCT01876134|Cardiac surgery|cardiac surgery
5365878|NCT01876134|Acute kidney injury|acute kidney injury
5365880|NCT01876134|Pulse wave analysis|pulse wave analysis
5365883|NCT01876108|Steatohepatitis|steatohepatitis
5365884|NCT01876108|Helicobacter pylori|helicobacter pylori
5365885|NCT01876108|Alanine aminotransferase|alanine aminotransferase
5365886|NCT01876108|Aspartate aminotransferase|aspartate aminotransferase
5365887|NCT01876108|Fatty Liver|fatty liver
5365888|NCT01876108|Liver Diseases|liver diseases
5365889|NCT01876108|Digestive System Diseases|digestive system diseases
5365890|NCT01876082|Desmoids tumors|desmoids tumors
5365891|NCT01876082|Pazopanib|pazopanib
5365892|NCT01876082|Phase 2 clinical trial|phase 2 clinical trial
5365893|NCT01876082|Cross over|cross over
5365894|NCT01876056|Psychosis|psychosis
5365895|NCT01876056|Culture|culture
5365896|NCT01876056|CBT|cbt
5365897|NCT01876030|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
5365898|NCT01876030|Sub acute stroke|sub acute stroke
5365899|NCT01876030|Gait analysis|gait analysis
5365900|NCT01876017|CRF|crf
5365901|NCT01876017|STEM CELL|stem cell
5365902|NCT01876017|CKD|ckd
5365903|NCT01876004|ectopic pregnancy|ectopic pregnancy
5365904|NCT01876004|methotrexate|methotrexate
5365905|NCT01876004|human chorionic gonadotropin beta subunit|human chorionic gonadotropin beta subunit
5365906|NCT01876004|expectant management|expectant management
5365907|NCT01875978|Phytosterols|phytosterols
5365908|NCT01875978|Endothelial progenitor cells|endothelial progenitor cells
5365909|NCT01875952|Latent tuberculosis infection|latent tuberculosis infection
5365910|NCT01875952|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5365911|NCT01875952|Treatment|treatment
5365912|NCT01875952|Isoniazid|isoniazid
5365913|NCT01875939|healthy volunteers|healthy volunteers
5365914|NCT01875913|Curiosity|curiosity
5365915|NCT01875913|Intention|intention
5365916|NCT01875913|Follow Through|follow through
5365917|NCT01875900|neonatal resuscitation|neonatal resuscitation
5365918|NCT01875900|video-assisted learning|video-assisted learning
5365919|NCT01875900|self-directed training|self-directed training
5365920|NCT01875900|simulation|simulation
5365921|NCT01875900|simulation-based training|simulation-based training
5365922|NCT01875900|simulation-based medical education|simulation-based medical education
5365923|NCT01875900|objective structured clinical examination|objective structured clinical examination
5365924|NCT01875874|liver failure|liver failure
5365925|NCT01875874|acute liver failure|acute liver failure
5365926|NCT01875874|fulminant hepatic failure|fulminant hepatic failure
5365927|NCT01875874|primary graft non-function|primary graft non-function
5365928|NCT01875874|surgically-induced liver failure|surgically-induced liver failure
5365929|NCT01875874|ELAD|elad
5365931|NCT01875874|FHF|fhf
5365933|NCT01875861|Antipsychotic Agents|antipsychotic agents
5365934|NCT01875861|Metabolic Syndrome|metabolic syndrome
5365935|NCT01875861|Quality Improvement|quality improvement
5365936|NCT01875848|pain management|pain management
5365937|NCT01875835|Acute myocardiac infarction|acute myocardiac infarction
5365938|NCT01875835|Bare-metal stent|bare-metal stent
5365939|NCT01875835|Everolimus-eluting stent|everolimus-eluting stent
5365940|NCT01875835|Optical coherence tomography|optical coherence tomography
5365941|NCT01875822|Curcumin|curcumin
5365942|NCT01875822|Epigenetics|epigenetics
5365943|NCT01875822|Schizophrenia|schizophrenia
5365944|NCT01875822|Nitric Oxide synthetase|nitric oxide synthetase
5365945|NCT01875822|cognition|cognition
5365946|NCT01875822|negative symptoms|negative symptoms
5365947|NCT01875809|RDN|rdn
5365948|NCT01875809|renal denervation|renal denervation
5365949|NCT01875809|catecholamine|catecholamine
5365950|NCT01875809|spill-over|spill-over
5365951|NCT01875809|blood pressure|blood pressure
5365952|NCT01875809|electrophysiology|electrophysiology
5365953|NCT01875809|ablation|ablation
5365954|NCT01875796|cannabis|cannabis
5365955|NCT01875796|marijuana|marijuana
5365956|NCT01875796|anxiety|anxiety
5365957|NCT01875796|transdiagnostic|transdiagnostic
5365958|NCT01875796|dual diagnosis|dual diagnosis
5365959|NCT01875796|cannabis abuse|cannabis abuse
5365960|NCT01875796|cannabis dependence|cannabis dependence
5365961|NCT01875796|cannabis use disorder|cannabis use disorder
5365962|NCT01875783|diabetes|diabetes
5365963|NCT01875783|diabetic macular edema|diabetic macular edema
5365964|NCT01875783|diabetic retinopathy|diabetic retinopathy
5365965|NCT01875783|optical coherence tomography|optical coherence tomography
5365966|NCT01875770|Retinal Vein Occlusion|retinal vein occlusion
5365967|NCT01875757|Vitamin D|vitamin d
5365968|NCT01875757|Acute bronchitis|acute bronchitis
5365969|NCT01875757|Upper respiratory tract infection|upper respiratory tract infection
5365970|NCT01875757|Recurrent bronchitis|recurrent bronchitis
5365971|NCT01875757|Acute bronchiolitis|acute bronchiolitis
5365972|NCT01875757|Infants|infants
5365973|NCT01875744|constipation|constipation
5365974|NCT01875744|children|children
5365975|NCT01875744|polyethylene glycol|polyethylene glycol
5365976|NCT01875731|Pneumonia|pneumonia
5365977|NCT01875731|Acute respiratory infection|acute respiratory infection
5365978|NCT01875731|Decision-support techniques|decision-support techniques
5365979|NCT01875692|Metagenomic|metagenomic
5365980|NCT01875692|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
5366772|NCT01872338|Veterans|veterans
5365986|NCT01875666|Kinome|kinome
5365987|NCT01875666|HER two positive|her two positive
5365988|NCT01875653|metastatic melanoma|metastatic melanoma
5365989|NCT01875653|dendritic cells|dendritic cells
5365990|NCT01875653|immunotherapy|immunotherapy
5365991|NCT01875653|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
5365992|NCT01875653|overall survival|overall survival
5365993|NCT01875653|autologous|autologous
5365994|NCT01875653|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5365995|NCT01875653|treatment|treatment
5365996|NCT01875653|phase 3|phase 3
5365997|NCT01875653|tumor cells|tumor cells
5365998|NCT01875640|disorder of sex development|disorder of sex development
5365999|NCT01875640|intersex|intersex
5366000|NCT01875640|46,XX congenital adrenal hyperplasia|46,xx congenital adrenal hyperplasia
5366001|NCT01875640|hypospadias|hypospadias
5366002|NCT01875640|decision support tool|decision support tool
5366003|NCT01875601|NK Cells|nk cells
5366004|NCT01875601|Cytokine|cytokine
5366005|NCT01875601|Lymphodepleting Chemotherapy|lymphodepleting chemotherapy
5366006|NCT01875601|Immunotherapy|immunotherapy
5366007|NCT01875601|Pediatric|pediatric
5366013|NCT01875575|glucagon-like peptide-1|glucagon-like peptide-1
5366014|NCT01875575|peptide tyrosine tyrosine|peptide tyrosine tyrosine
5366015|NCT01875575|ghrelin|ghrelin
5366016|NCT01875575|stomach|stomach
5366017|NCT01875575|small intestine|small intestine
5366018|NCT01875575|gastric emptying|gastric emptying
5366019|NCT01875562|Neck pain|neck pain
5366020|NCT01875562|Cervical radiculopathy|cervical radiculopathy
5366021|NCT01875562|Qishe Pill|qishe pill
5261506|NCT02380313|Afuresertib|afuresertib
5366022|NCT01875562|Traditional Chinese Medicine|traditional chinese medicine
5366023|NCT01875536|transcranial magnetic stimulation|transcranial magnetic stimulation
5366024|NCT01875536|spasticity|spasticity
5366025|NCT01875536|physiotherapy|physiotherapy
5366026|NCT01875536|Rehabilitation|rehabilitation
5366027|NCT01875523|Renal disease|renal disease
5366028|NCT01875523|renal impairment|renal impairment
5366029|NCT01875523|End stage renal disease|end stage renal disease
5366030|NCT01875523|Healthy volunteer|healthy volunteer
5366031|NCT01875523|Pharmacokinetics|pharmacokinetics
5366032|NCT01875497|athletes, polyphenols, nutrition, oxidative stress|athletes, polyphenols, nutrition, oxidative stress
5366033|NCT01875484|miR-126|mir-126
5366034|NCT01875484|Left Ventricular Remodeling|left ventricular remodeling
5366035|NCT01875484|Myocardial Infarction|myocardial infarction
5366036|NCT01875484|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5366037|NCT01875484|left ventricular end diastolic volume|left ventricular end diastolic volume
5366038|NCT01875484|left ventricular ejection fraction|left ventricular ejection fraction
5366039|NCT01875484|major adverse cardiovascular events|major adverse cardiovascular events
5366040|NCT01875458|Aclasta|aclasta
5366041|NCT01875458|Actonel|actonel
5366042|NCT01875458|alendronate|alendronate
5366043|NCT01875458|alendronate/cholecalciferol|alendronate/cholecalciferol
5366044|NCT01875458|Aredia|aredia
5366045|NCT01875458|Atelvia|atelvia
5366046|NCT01875458|Boniva|boniva
5366047|NCT01875458|Didronel|didronel
5366048|NCT01875458|etidronate|etidronate
5366049|NCT01875458|Fosamax|fosamax
5366050|NCT01875458|Fosamax Plus D|fosamax plus d
5366051|NCT01875458|ibandronate|ibandronate
5366052|NCT01875458|pamidronate|pamidronate
5366053|NCT01875458|Reclast|reclast
5366054|NCT01875458|risedronate|risedronate
5366055|NCT01875458|Skelid|skelid
5366056|NCT01875458|tiludronate|tiludronate
5366057|NCT01875458|zoledronic acid|zoledronic acid
5366058|NCT01875458|Zometa|zometa
5366059|NCT01875458|Bisphosphonate|bisphosphonate
5964381|NCT04146389|doping|doping
5964382|NCT04146129|CDX-0159|cdx-0159
5964383|NCT04145934|fall prevention|fall prevention
5964384|NCT04145934|walking aid|walking aid
5964385|NCT04145934|physical therapy|physical therapy
5964386|NCT04145869|Fluorescence|fluorescence
5244522|NCT02476955|Carboplatin|carboplatin
5244523|NCT02476955|Paclitaxel|paclitaxel
5244524|NCT02476955|AKT inhibitor in combination therapy|akt inhibitor in combination therapy
5244525|NCT02476955|Targeted therapy|targeted therapy
5366060|NCT01875458|Atypical Femur Fracture (AFF)|atypical femur fracture (aff)
5366061|NCT01875458|Osteoporosis|osteoporosis
5366062|NCT01875458|Bisphosphonate Related Osteonecrosis of the Jaw (BRONJ)|bisphosphonate related osteonecrosis of the jaw (bronj)
5366063|NCT01875445|Inositol|inositol
5366064|NCT01875445|Trichotillomania|trichotillomania
5366065|NCT01875445|Hair Pulling|hair pulling
5366066|NCT01875445|Impulse Control Disorder|impulse control disorder
5366067|NCT01875393|Prostatic Disease|prostatic disease
5366068|NCT01875393|Genital Neoplasm,male|genital neoplasm,male
5366069|NCT01875393|Urogenital neoplasm|urogenital neoplasm
5366070|NCT01875393|Genital disease,male|genital disease,male
5366071|NCT01875393|Male urogenital disease|male urogenital disease
5366072|NCT01875393|Neoplasms|neoplasms
5366073|NCT01875393|Neoplasms by site|neoplasms by site
5366074|NCT01875393|Prostatic neoplasm|prostatic neoplasm
5366075|NCT01875393|Carcinoma|carcinoma
5366076|NCT01875380|metastatic colorectal cancer|metastatic colorectal cancer
5366077|NCT01875380|frail and unfit patient|frail and unfit patient
5366078|NCT01875380|regorafenib|regorafenib
5366079|NCT01875367|Subcutaneous trastuzumab|subcutaneous trastuzumab
5366080|NCT01875367|Intravenous trastuzumab|intravenous trastuzumab
5366081|NCT01875367|HER2 positive|her2 positive
5366082|NCT01875367|Advanced Breast Cancer|advanced breast cancer
5366083|NCT01875341|type 2 diabetes|type 2 diabetes
5366084|NCT01875341|diabetic nephropathy|diabetic nephropathy
5366085|NCT01875341|hypertension|hypertension
5366086|NCT01875341|sleep apnea|sleep apnea
5366087|NCT01875341|sympathetic hyperactivity|sympathetic hyperactivity
5366088|NCT01875328|stroke|stroke
5366089|NCT01875328|blood pressure|blood pressure
5366090|NCT01875328|telemedicine|telemedicine
5366091|NCT01875302|COPD PRO Instraments equivalency|copd pro instraments equivalency
5366092|NCT01875276|Rhinitis|rhinitis
5366093|NCT01875276|Antihistamine|antihistamine
5366094|NCT01875276|Nasal Steroid Therapy|nasal steroid therapy
5366095|NCT01875263|catheter-related bacteremia, SAMS|catheter-related bacteremia, sams
5366096|NCT01875263|catheter related bacteremia|catheter related bacteremia
5366097|NCT01875263|susceptible|susceptible
5366098|NCT01875263|aureus meticillin|aureus meticillin
5366099|NCT01875250|Gene Transfer|gene transfer
5366100|NCT01875250|Androgen Receptor Antagonist|androgen receptor antagonist
5366102|NCT01875250|Immune Response|immune response
5366103|NCT01875250|Immunotherapy|immunotherapy
5366104|NCT01875237|Leukemia|leukemia
5366105|NCT01875237|Myeloma|myeloma
5366106|NCT01875237|Myeloproliferative Diseases|myeloproliferative diseases
5366107|NCT01875237|Myelodysplastic syndrome|myelodysplastic syndrome
5366109|NCT01875237|Lymphoma|lymphoma
5366110|NCT01875237|Hodgkin disease|hodgkin disease
5366111|NCT01875237|Multiple myeloma|multiple myeloma
5366112|NCT01875237|MM|mm
5366113|NCT01875237|Transplant donor|transplant donor
5366114|NCT01875237|T-cells|t-cells
5366115|NCT01875237|G-versus-host disease|g-versus-host disease
5366116|NCT01875237|GvHD|gvhd
5366117|NCT01875237|G-CSF|g-csf
5366118|NCT01875237|Filgrastim|filgrastim
5366119|NCT01875237|Neupogen|neupogen
5366120|NCT01875237|Fludarabine|fludarabine
5366121|NCT01875237|Fludarabine phosphate|fludarabine phosphate
5366122|NCT01875237|Fludara|fludara
5366123|NCT01875237|Melphalan|melphalan
5366124|NCT01875237|Alkeran|alkeran
5366125|NCT01875237|Alemtuzumab|alemtuzumab
5366126|NCT01875237|CAMPATH-1H|campath-1h
5366127|NCT01875237|Campath|campath
5366128|NCT01875237|Tacrolimus|tacrolimus
5366129|NCT01875237|Prograf|prograf
5366130|NCT01875237|Mini-methotrexate|mini-methotrexate
5366131|NCT01875237|AP 1903|ap 1903
5366132|NCT01875237|Methylprednisolone|methylprednisolone
5366133|NCT01875237|Depo-Medrol|depo-medrol
5366134|NCT01875237|Medrol|medrol
5366135|NCT01875237|Solu-Medrol|solu-medrol
5366136|NCT01875237|Stem cell infusion|stem cell infusion
5366137|NCT01875237|Donor lymphocyte infusion|donor lymphocyte infusion
5366138|NCT01875237|DLI|dli
5366139|NCT01875237|Questionnaire|questionnaire
5366140|NCT01875237|Survey|survey
5366141|NCT01875224|kidney transplant|kidney transplant
5366142|NCT01875224|diabetes after transplant|diabetes after transplant
5366143|NCT01875224|belatacept|belatacept
5366144|NCT01875198|Splenectomy;|splenectomy;
5366145|NCT01875198|Spleen-preserving|spleen-preserving
5366146|NCT01875185|acute coronary syndrome|acute coronary syndrome
5366147|NCT01875185|clotting|clotting
5366148|NCT01875185|hormones|hormones
5366149|NCT01875185|women|women
5366150|NCT01875172|bupropion SR|bupropion sr
5366151|NCT01875172|randomized controlled trial|randomized controlled trial
5964387|NCT04145869|Cholangriography|cholangriography
5964388|NCT04145869|Cholecystectomy|cholecystectomy
5964389|NCT04145349|soft tissue sarcoma|soft tissue sarcoma
5964390|NCT04145349|adolescents and young adults (AYAs)|adolescents and young adults (ayas)
5366152|NCT01875172|pregnancy|pregnancy
5366153|NCT01875159|Prematurity|prematurity
5964391|NCT04145349|adolescent|adolescent
5964392|NCT04145141|Molecular Markers|molecular markers
5366154|NCT01875159|Apnea of prematurity|apnea of prematurity
5366155|NCT01875159|Intermittent hypoxia|intermittent hypoxia
5366156|NCT01875133|airway disease|airway disease
5366157|NCT01875133|bronchitis|bronchitis
5366158|NCT01875133|emphysema|emphysema
5366159|NCT01875133|lung|lung
5366160|NCT01875120|Anxiety|anxiety
5366161|NCT01875120|Somatoform Disorders|somatoform disorders
5366162|NCT01875068|referrals|referrals
5366163|NCT01875068|nurse practitioners|nurse practitioners
5366164|NCT01875068|physician assistants|physician assistants
5366165|NCT01875068|consultative general internal medicine|consultative general internal medicine
5366166|NCT01875055|Cerebral|cerebral
5366167|NCT01875055|desaturation|desaturation
5366168|NCT01875029|Low back pain|low back pain
5366169|NCT01875029|chronic pain|chronic pain
5366170|NCT01875029|tDCS|tdcs
5366171|NCT01875029|transcranial direct current stimulation|transcranial direct current stimulation
5366172|NCT01875016|Cryo ablation|cryo ablation
5366173|NCT01875016|Cardiomyopathy|cardiomyopathy
5366174|NCT01874977|rheumatoid arthritis|rheumatoid arthritis
5366175|NCT01874977|fatigue|fatigue
5366176|NCT01874977|physical activity|physical activity
5366177|NCT01874964|HIV Prevention|hiv prevention
5366178|NCT01874964|Opioid-Related Disorders|opioid-related disorders
5366179|NCT01874964|Medication Assisted Treatment|medication assisted treatment
5366180|NCT01874964|Methadone|methadone
5366181|NCT01874951|Depression|depression
5366182|NCT01874951|Recurrence|recurrence
5366183|NCT01874951|Relapse|relapse
5366184|NCT01874951|Antidepressants|antidepressants
5366185|NCT01874951|Naltrexone|naltrexone
5366186|NCT01874951|Drug augmentation|drug augmentation
5366187|NCT01874886|Magnetic resonance imaging|magnetic resonance imaging
5366188|NCT01874886|Diffusion tensor imaging|diffusion tensor imaging
5366189|NCT01874886|Hippocampus|hippocampus
5366190|NCT01874886|Cannabis|cannabis
5366191|NCT01874886|Geriatrics|geriatrics
5366192|NCT01874886|Neuropsychology|neuropsychology
5366193|NCT01874886|Apolipoprotein E|apolipoprotein e
5366194|NCT01874847|melatonin|melatonin
5366196|NCT01874847|post-concussion syndrome|post-concussion syndrome
5366197|NCT01874847|mild traumatic brain injury|mild traumatic brain injury
5366198|NCT01874847|concussion|concussion
5366199|NCT01874847|treatment|treatment
5366200|NCT01874847|outcome|outcome
5366201|NCT01874847|children|children
5366202|NCT01874847|functional magnetic resonance imaging|functional magnetic resonance imaging
5366203|NCT01874847|transcranial magnetic stimulation|transcranial magnetic stimulation
5366204|NCT01874847|sleep|sleep
5366205|NCT01874834|ozone|ozone
5366206|NCT01874834|diesel|diesel
5366207|NCT01874834|lung function|lung function
5366208|NCT01874834|cardiac electrophysiology|cardiac electrophysiology
5366209|NCT01874834|mediators of inflammation and clotting|mediators of inflammation and clotting
5366210|NCT01874821|Frozen Shoulder|frozen shoulder
5366211|NCT01874821|Adhesive Capsulitis|adhesive capsulitis
5366213|NCT01874821|Dynasplint|dynasplint
5366214|NCT01874808|movement preparation|movement preparation
5366215|NCT01874808|gait|gait
5366216|NCT01874808|gait initiation|gait initiation
5366217|NCT01874808|postural control|postural control
5366218|NCT01874808|neuroimaging|neuroimaging
5366219|NCT01874795|Autonomic Nervous System|autonomic nervous system
5366220|NCT01874795|Neuromodulation|neuromodulation
5366221|NCT01874795|Exercise|exercise
5366222|NCT01874795|Pulmonary oxygen kinetics|pulmonary oxygen kinetics
5366223|NCT01874795|Oxygen uptake|oxygen uptake
5366224|NCT01874782|spinal cord injury|spinal cord injury
5366225|NCT01874782|cardiovascular|cardiovascular
5366226|NCT01874782|orthostatic hypotension|orthostatic hypotension
5366227|NCT01874782|transcranial electrical stimulation|transcranial electrical stimulation
5366228|NCT01874782|electrotherapy|electrotherapy
5366229|NCT01874769|RDEB|rdeb
5366230|NCT01874769|COL7A1|col7a1
5366231|NCT01874769|Collagen VII|collagen vii
5423318|NCT01616212|Parenting|parenting
5366233|NCT01874756|Estrogen receptor agonist|estrogen receptor agonist
5366234|NCT01874756|cognitive impairment|cognitive impairment
5366236|NCT01874743|HIV,|hiv,
5366237|NCT01874743|Rosuvastatine,|rosuvastatine,
5366238|NCT01874743|Antiretroviral therapy|antiretroviral therapy
5366239|NCT01874730|colorectal surgery|colorectal surgery
5366240|NCT01874730|fluid therapy|fluid therapy
5366241|NCT01874717|Conscious sedation|conscious sedation
5366242|NCT01874717|Dental anxiety|dental anxiety
5366243|NCT01874717|Oral midazolam|oral midazolam
5366244|NCT01874717|Intravenous midazolam|intravenous midazolam
5366245|NCT01874717|Behaviour|behaviour
5366246|NCT01874704|Stress, occupation, biomarkers, emergency, physicians|stress, occupation, biomarkers, emergency, physicians
5366247|NCT01874691|acute myocardial infarction|acute myocardial infarction
5366248|NCT01874691|China|china
5366249|NCT01874691|Registry|registry
5366250|NCT01874665|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5366251|NCT01874665|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5366252|NCT01874665|mesenchymal tumor|mesenchymal tumor
5366253|NCT01874639|Hepatectomy|hepatectomy
5366254|NCT01874639|blood loss|blood loss
5366255|NCT01874639|hemostasis|hemostasis
5232648|NCT02548741|diabetes|diabetes
5366256|NCT01874639|coagulation|coagulation
5366257|NCT01874639|Liver surgery (benign or malign)|liver surgery (benign or malign)
5366258|NCT01874639|Resection of 2 or more segments|resection of 2 or more segments
5366259|NCT01874626|acute ankle sprain|acute ankle sprain
5366260|NCT01874626|Grade I or Grade II|grade i or grade ii
5366261|NCT01874613|Craniofacial bone reconstruction|craniofacial bone reconstruction
5366262|NCT01874613|Fibre-reinforced composite|fibre-reinforced composite
5366263|NCT01874613|Bioactive glass|bioactive glass
5366264|NCT01874613|Craniotomy|craniotomy
5366265|NCT01874613|Skull bone defect|skull bone defect
5366266|NCT01874587|Adaptative radiotherapy|adaptative radiotherapy
5366267|NCT01874587|oropharynx carcinoma|oropharynx carcinoma
5366268|NCT01874587|xerostomia|xerostomia
5366269|NCT01874574|Knee Osteoarthritis|knee osteoarthritis
5366270|NCT01874574|Corticosteroid|corticosteroid
5366271|NCT01874574|Hyaluronic acid|hyaluronic acid
5366272|NCT01874574|Intra-articular injection|intra-articular injection
5366273|NCT01874561|Custirsen sodium|custirsen sodium
5366274|NCT01874561|TV1011|tv1011
5366275|NCT01874561|OGX-011|ogx-011
5366276|NCT01874561|Thorough QT study|thorough qt study
5366277|NCT01874561|cancer|cancer
5366279|NCT01874548|Cancer metabolism|cancer metabolism
5366280|NCT01874548|Cervical cancer|cervical cancer
5366281|NCT01874548|Diffusion weighted imaging|diffusion weighted imaging
5366282|NCT01874548|Human papillomavirus|human papillomavirus
5366283|NCT01874548|Magnetic resonance spectroscopy.|magnetic resonance spectroscopy.
5366284|NCT01874522|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
5366285|NCT01874405|Iron overload|iron overload
5366286|NCT01874405|thalassaemia|thalassaemia
5366287|NCT01874405|deferasirox|deferasirox
5366288|NCT01874405|magnetic resonance|magnetic resonance
5366289|NCT01874405|endocrine function|endocrine function
5366290|NCT01874379|Joint Replacement|joint replacement
5366291|NCT01874379|Hip Replacement|hip replacement
5366292|NCT01874379|Knee Replacement|knee replacement
5366293|NCT01874379|Complementary Medicine Intervention|complementary medicine intervention
5366294|NCT01874353|BRCA|brca
5366295|NCT01874353|Ovarian cancer|ovarian cancer
5366296|NCT01874353|Chemotherapy|chemotherapy
5366297|NCT01874353|PARP Inhibitor|parp inhibitor
5366298|NCT01874353|Platinum sensitive|platinum sensitive
5366299|NCT01874340|Multiple Sclerosis|multiple sclerosis
5366300|NCT01874340|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5366301|NCT01874340|AIN457|ain457
5366302|NCT01874340|Secukinumab|secukinumab
5366303|NCT01874340|Magnetic Resonance Imaging|magnetic resonance imaging
5261846|NCT02378402|MRS|mrs
5366304|NCT01874340|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5366305|NCT01874340|Autoimmune Diseases|autoimmune diseases
5366306|NCT01874340|Nervous System Diseases|nervous system diseases
5366307|NCT01874340|Immune System Diseases|immune system diseases
5366308|NCT01874340|Demyelinating Diseases|demyelinating diseases
5366309|NCT01874314|tuberculosis, SQ109, QTc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center|tuberculosis, sq109, qtc, moxifloxacin, crossover, placebo, pharmacokinetic, randomized, single-center
5366311|NCT01874288|Immunocytokine|immunocytokine
5366312|NCT01874288|Lymphoma|lymphoma
5366313|NCT01874288|Non-Hodgkin|non-hodgkin
5366314|NCT01874288|B-cell|b-cell
5366315|NCT01874288|IL (interleukin)|il (interleukin)
5366316|NCT01874249|Hepatic fibrosis|hepatic fibrosis
5366317|NCT01874249|Steatosis|steatosis
5366318|NCT01874249|Noninvasive markers.|noninvasive markers.
5366319|NCT01874236|SI joint pain, SI joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption|si joint pain, si joint dysfunction, degenerative sacroiliitis, sacroiliac joint disruption
5366320|NCT01874223|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
5366321|NCT01874223|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5366322|NCT01874197|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
5366323|NCT01874197|Branched vessels|branched vessels
5366324|NCT01874158|Trichomonas vaginalis|trichomonas vaginalis
5366325|NCT01874145|Multiple Sclerosis|multiple sclerosis
5366326|NCT01874145|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5366327|NCT01874145|Glatiramer Acetate|glatiramer acetate
5366328|NCT01874145|Glatiramer|glatiramer
5366329|NCT01874132|Exercise|exercise
5366330|NCT01874132|Blood pressure|blood pressure
5366332|NCT01874132|Body composition|body composition
5366334|NCT01874132|Bone density|bone density
5366335|NCT01874132|Quality of life|quality of life
5366336|NCT01874119|melanoma|melanoma
5366337|NCT01874119|renal cell carcinoma|renal cell carcinoma
5366338|NCT01874119|interleukin-2|interleukin-2
5366339|NCT01874106|Hemodialysis|hemodialysis
5366340|NCT01874106|Diet|diet
5366341|NCT01874106|Inflammation|inflammation
5366342|NCT01874106|Malnutrition|malnutrition
5366343|NCT01874054|Antibody-Drug Conjugate|antibody-drug conjugate
5366344|NCT01874054|Antibodies, Monoclonal|antibodies, monoclonal
5964393|NCT04145141|Predictors for Response or Resistance to Immunotherapy|predictors for response or resistance to immunotherapy
5964394|NCT04145141|Sample Collection|sample collection
5964395|NCT04145141|Genetic Analysis|genetic analysis
5964396|NCT04144751|Blood Draw|blood draw
5366345|NCT01874054|Hodgkin Disease|hodgkin disease
5366346|NCT01874054|Hematologic Diseases|hematologic diseases
5366347|NCT01874054|Drug Therapy|drug therapy
5366348|NCT01874054|Immunotherapy|immunotherapy
5366349|NCT01874054|Antigens, CD30|antigens, cd30
5366350|NCT01874054|Lymphoma|lymphoma
5366351|NCT01874054|monomethylauristatin E|monomethylauristatin e
5366352|NCT01874041|Physical Therapy Modalities|physical therapy modalities
5366353|NCT01874041|Facial Pain|facial pain
5366354|NCT01874041|Orthodontic Appliances|orthodontic appliances
5366355|NCT01874028|Trientine|trientine
5366356|NCT01874028|Pharmacokinetics|pharmacokinetics
5366357|NCT01874015|Crohn's disease|crohn's disease
5366358|NCT01874015|mesenchymal stem cell|mesenchymal stem cell
5366359|NCT01874015|fistula|fistula
5366360|NCT01874002|Stents|stents
5366361|NCT01874002|Stent|stent
5366362|NCT01874002|Drug eluting|drug eluting
5366363|NCT01874002|Drug eluting stent|drug eluting stent
5366364|NCT01874002|Drug eluting stents|drug eluting stents
5366365|NCT01874002|Endothelial progenitor cell|endothelial progenitor cell
5366366|NCT01874002|Endothelial progenitor cell capturing|endothelial progenitor cell capturing
5366367|NCT01874002|Sirolimus|sirolimus
5366368|NCT01874002|Sirolimus eluting|sirolimus eluting
5366369|NCT01874002|Percutaneous Coronary Intervention|percutaneous coronary intervention
5366370|NCT01874002|PCI|pci
5366371|NCT01874002|Registry|registry
5366372|NCT01874002|Registries|registries
5366373|NCT01874002|Multi center|multi center
5366374|NCT01874002|Multi centre|multi centre
5366375|NCT01873989|Chronic pain|chronic pain
5366376|NCT01873989|Opioid addiction|opioid addiction
5368249|NCT01864967|fibroblasts|fibroblasts
5366379|NCT01873989|Opioid agonist maintenance|opioid agonist maintenance
5366381|NCT01873989|Buprenorphine|buprenorphine
5366382|NCT01873937|Lasertherapy|lasertherapy
5366383|NCT01873937|Ledtherapy|ledtherapy
5366384|NCT01873937|TMJs|tmjs
5366385|NCT01873937|pain relief|pain relief
5366386|NCT01873937|oral aperture|oral aperture
5366390|NCT01873911|MPS IIIA|mps iiia
5366391|NCT01873911|MPS IIIB|mps iiib
5261921|NCT02377960|SMS|sms
5366392|NCT01873911|Sanfilippo syndrome type A|sanfilippo syndrome type a
5366393|NCT01873911|Sanfilippo syndrome type B|sanfilippo syndrome type b
5366394|NCT01873911|Hurler syndrome|hurler syndrome
5366395|NCT01873911|cognitive decline|cognitive decline
5366396|NCT01873911|MPS IH|mps ih
5366397|NCT01873898|femoral artery|femoral artery
5366398|NCT01873898|access site|access site
5366399|NCT01873898|hemostasis|hemostasis
5366400|NCT01873885|PB1046, VIP, Essential Hypertension, Vasomera|pb1046, vip, essential hypertension, vasomera
5366401|NCT01873859|Lactic acidosis|lactic acidosis
5366402|NCT01873859|Contrast media|contrast media
5366403|NCT01873859|Angiography|angiography
5366404|NCT01873859|Diabetic|diabetic
5366405|NCT01873859|Metformin|metformin
5366406|NCT01873820|Vitamin C|vitamin c
5366407|NCT01873820|calcium ascorbate|calcium ascorbate
5366408|NCT01873820|ascorbic acid|ascorbic acid
5366409|NCT01873807|Idarubicin|idarubicin
5366410|NCT01873807|Etoposide|etoposide
5366411|NCT01873807|HSCT|hsct
5366412|NCT01873807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5366413|NCT01873794|Fatigue|fatigue
5366414|NCT01873794|Sleep|sleep
5366415|NCT01873794|Quality of life|quality of life
5366416|NCT01873794|Cancer|cancer
5366417|NCT01873794|Light|light
5366418|NCT01873768|Tranexamic acid|tranexamic acid
5366419|NCT01873768|6-Aminocaproic Acid|6-aminocaproic acid
5366420|NCT01873768|Arthroplasty|arthroplasty
5366421|NCT01873768|Osteoarthritis|osteoarthritis
5366422|NCT01873768|Arthritis|arthritis
5366423|NCT01873768|Joint Diseases|joint diseases
5366424|NCT01873768|Musculoskeletal Diseases|musculoskeletal diseases
5366425|NCT01873768|Rheumatic Diseases|rheumatic diseases
5366426|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents
5366427|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents
5366428|NCT01873768|Pharmacologic Actions|pharmacologic actions
5370165|NCT01857011|iron|iron
5366429|NCT01873768|Coagulants|coagulants
5366430|NCT01873768|Therapeutic Uses|therapeutic uses
5366431|NCT01873755|asthma|asthma
5366432|NCT01873755|children|children
5366433|NCT01873755|physical activity|physical activity
5366434|NCT01873755|school|school
5366435|NCT01873742|Psychotherapy feedback|psychotherapy feedback
5366436|NCT01873729|ADHD|adhd
5366437|NCT01873729|Naltrexone|naltrexone
5366438|NCT01873729|Adults|adults
5366439|NCT01873716|Atherosclerosis|atherosclerosis
5366440|NCT01873716|Molecular Imaging|molecular imaging
5366441|NCT01873716|Vascular Biology|vascular biology
5366442|NCT01873716|Inflammation|inflammation
5366443|NCT01873716|Fluorescence|fluorescence
5366445|NCT01873703|High risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5366446|NCT01873703|Intermediate-2 Myelodysplastic syndrome|intermediate-2 myelodysplastic syndrome
5366447|NCT01873703|Untreated|untreated
5964397|NCT04144738|Sample Collection|sample collection
5964398|NCT04144738|Stool DNA|stool dna
5964399|NCT04144738|Colonoscopy|colonoscopy
5366448|NCT01873690|Antibiotics|antibiotics
5366449|NCT01873690|Shock Wave Lithotripsy|shock wave lithotripsy
5964400|NCT04143581|GFR decline|gfr decline
5366450|NCT01873690|Urinary Tract Infection|urinary tract infection
5366451|NCT01873664|fMRI|fmri
5366452|NCT01873664|Jaw tapping|jaw tapping
5366453|NCT01873664|Memory disorder|memory disorder
5366454|NCT01873664|Mild cognitive impairment|mild cognitive impairment
5366455|NCT01873664|MCI|mci
5366456|NCT01873664|Working memory|working memory
5366457|NCT01873638|5-year outcome after cholecystectomy|5-year outcome after cholecystectomy
5366458|NCT01873625|mesenchymal stem cells|mesenchymal stem cells
5366459|NCT01873625|osteoarthritis|osteoarthritis
5366460|NCT01873625|arthritis rheumatoid|arthritis rheumatoid
5366461|NCT01873612|Dexmedetomidine|dexmedetomidine
5366462|NCT01873612|Propofol|propofol
5366463|NCT01873612|Hypoxic ventilatory response|hypoxic ventilatory response
5366464|NCT01873612|Hypercapnic ventilatory response|hypercapnic ventilatory response
5366465|NCT01873573|radiation-induced stricture|radiation-induced stricture
5366466|NCT01873573|anastomotic stricture|anastomotic stricture
5366467|NCT01873573|esophagogastroduodenoscopy (EGD)|esophagogastroduodenoscopy (egd)
5366468|NCT01873573|dilation|dilation
5366469|NCT01873573|steroid injection|steroid injection
5366470|NCT01873573|triamcinolone|triamcinolone
5366471|NCT01873573|difficulty swallowing|difficulty swallowing
5366472|NCT01873560|fractional flow reserve|fractional flow reserve
5366473|NCT01873560|drug eluting stent|drug eluting stent
5366474|NCT01873560|coronary atherosclerosis|coronary atherosclerosis
5366475|NCT01873547|spinal cord injury|spinal cord injury
5366476|NCT01873547|cell transplantation|cell transplantation
5366477|NCT01873547|rehabilitation|rehabilitation
5366479|NCT01873521|Positive Pressure Ventilation|positive pressure ventilation
5366483|NCT01873521|Infant|infant
5366484|NCT01873469|glioblastoma multiforme|glioblastoma multiforme
5366485|NCT01873469|radiotherapy|radiotherapy
5366486|NCT01873430|Melatonin|melatonin
5366487|NCT01873430|Sunburn|sunburn
5366488|NCT01873430|Erythema|erythema
5366489|NCT01873430|Sunlight|sunlight
5366490|NCT01873430|Ultraviolet rays|ultraviolet rays
5366491|NCT01873391|Diagnostic hysteroscopy|diagnostic hysteroscopy
5366492|NCT01873391|Pain|pain
5366494|NCT01873391|Multivariate analysis|multivariate analysis
5366495|NCT01873391|Normal saline|normal saline
5366496|NCT01873391|Carbon dioxide|carbon dioxide
5366497|NCT01873378|Uterine myoma|uterine myoma
5366498|NCT01873378|GnRHa|gnrha
5366499|NCT01873378|Hysteroscopy|hysteroscopy
5366500|NCT01873378|Cold loop|cold loop
5366501|NCT01873365|Quality of life|quality of life
5366502|NCT01873365|Herpes zoster|herpes zoster
5366503|NCT01873365|Postherpetic neuralgia|postherpetic neuralgia
5366504|NCT01873365|Japan|japan
5366505|NCT01873365|Physician-practice|physician-practice
5366506|NCT01873365|Adults|adults
5366507|NCT01873365|Health economics|health economics
5366508|NCT01873339|Drug interaction, healthy volunteer, SB-480848, Lp-PLA2, darapladib, atherosclerosis, midazolam|drug interaction, healthy volunteer, sb-480848, lp-pla2, darapladib, atherosclerosis, midazolam
5366509|NCT01873326|newly diagnosed GCT|newly diagnosed gct
5366510|NCT01873326|Intermediate|intermediate
5366511|NCT01873326|Poor-Risk|poor-risk
5366512|NCT01873326|BLEOMYCIN|bleomycin
5366513|NCT01873326|CISPLATIN|cisplatin
5366514|NCT01873326|ETOPOSIDE (VP-16)|etoposide (vp-16)
5366515|NCT01873326|IFOSFAMIDE|ifosfamide
5366516|NCT01873326|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5366517|NCT01873326|13-074|13-074
5366518|NCT01873300|Achalasia|achalasia
5366519|NCT01873300|Dysphagia|dysphagia
5366520|NCT01873300|Endoscopic|endoscopic
5366521|NCT01873300|Myotomy|myotomy
5366522|NCT01873300|Heller|heller
5366523|NCT01873300|NOTES|notes
5366524|NCT01873300|POEM|poem
5366525|NCT01873287|Concussions|concussions
5366526|NCT01873287|Persistent post-concussion symptoms|persistent post-concussion symptoms
5366527|NCT01873287|PCS|pcs
5366528|NCT01873287|Clinical Prediction Rule|clinical prediction rule
5366529|NCT01873261|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5366530|NCT01873261|Pediatric Acute Respiratory Failure|pediatric acute respiratory failure
5366531|NCT01873261|non-invasive ventilation|non-invasive ventilation
5366532|NCT01873248|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5366533|NCT01873222|Coronary Artery Disease|coronary artery disease
5366534|NCT01873222|Percutaneous Coronary Intervention|percutaneous coronary intervention
5352513|NCT01937481|Parents|parents
5366535|NCT01873222|Optical Frequency Domain Imaging|optical frequency domain imaging
5366536|NCT01873222|Intravascular Ultrasound|intravascular ultrasound
5366537|NCT01873183|echocardiography|echocardiography
5366538|NCT01873183|morbid obesity|morbid obesity
5366539|NCT01873183|bariatric surgery|bariatric surgery
5366540|NCT01873183|venous return|venous return
5366541|NCT01873183|mean arterial blood pressure|mean arterial blood pressure
5366542|NCT01873170|immune cells|immune cells
5366543|NCT01873170|contraception|contraception
5366544|NCT01873170|intrauterine device|intrauterine device
5366545|NCT01873170|IUD|iud
5366546|NCT01873170|copper|copper
5366547|NCT01873170|microflora|microflora
5964401|NCT04143581|Glomerular hyperfiltration|glomerular hyperfiltration
5366548|NCT01873170|DMPA|dmpa
5366549|NCT01873170|etonogestrel|etonogestrel
5964402|NCT04143581|SGLT2 inhibitors|sglt2 inhibitors
5366550|NCT01873170|subdermal implant|subdermal implant
5366551|NCT01873157|Kidney transplantation|kidney transplantation
5366552|NCT01873157|Antibody formation|antibody formation
5366553|NCT01873157|Graft rejection|graft rejection
5366554|NCT01873157|Proteasome inhibitors|proteasome inhibitors
5366555|NCT01873157|Randomized controlled trial|randomized controlled trial
5366556|NCT01873144|Bronchiolitis|bronchiolitis
5366557|NCT01873144|Hypertonic saline solution|hypertonic saline solution
5366558|NCT01873144|High-flow oxygen therapy|high-flow oxygen therapy
5366559|NCT01873144|Respiratory distress|respiratory distress
5366560|NCT01873144|Comfort|comfort
5366561|NCT01873131|hemangioma|hemangioma
5366562|NCT01873131|infantile hemangioma|infantile hemangioma
5366563|NCT01873131|pulsed dye laser|pulsed dye laser
5366564|NCT01873131|PDL|pdl
5366565|NCT01873131|topical beta blocker|topical beta blocker
5366566|NCT01873131|timolol maleate|timolol maleate
5366567|NCT01873131|timolol|timolol
5366568|NCT01873118|hospital discharge|hospital discharge
5366569|NCT01873118|discharge readiness|discharge readiness
5366570|NCT01873118|readmission|readmission
5366571|NCT01873118|Emergency Department visits|emergency department visits
5366572|NCT01873118|Nurse assessment|nurse assessment
5366573|NCT01873092|Oximetry|oximetry
5362097|NCT01892644|Phlebotomy|phlebotomy
5366575|NCT01873079|ERCP|ercp
5366576|NCT01873079|sphincterotomy|sphincterotomy
5366577|NCT01873079|proton pump inhibitor|proton pump inhibitor
5366578|NCT01873066|Type 1 diabetes|type 1 diabetes
5366579|NCT01873066|Closed-loop glucose control|closed-loop glucose control
5366580|NCT01873066|Artificial Pancreas|artificial pancreas
5366581|NCT01873066|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5366582|NCT01873066|Continuous glucose monitoring|continuous glucose monitoring
5366583|NCT01873053|Osteoarthritis, Knee|osteoarthritis, knee
5366584|NCT01873053|WIN-34B|win-34b
5366585|NCT01873040|Social Media|social media
5366586|NCT01873040|Vaccine|vaccine
5366587|NCT01873040|Immunization|immunization
5366588|NCT01873027|Coronary Artery Disease|coronary artery disease
5366589|NCT01873027|Percutaneous Coronary Intervention|percutaneous coronary intervention
5366590|NCT01873027|Optical Frequency Domain Imaging|optical frequency domain imaging
5366591|NCT01873027|Intravascular Ultrasound|intravascular ultrasound
5366592|NCT01873001|Healthy volunteers|healthy volunteers
5366593|NCT01873001|Drug-drug Interaction|drug-drug interaction
5366594|NCT01873001|Pharmacokinetics|pharmacokinetics
5366595|NCT01873001|Abiraterone|abiraterone
5366596|NCT01873001|JNJ-589485|jnj-589485
5366597|NCT01873001|Abiraterone acetate|abiraterone acetate
5366598|NCT01873001|JNJ-212082|jnj-212082
5366599|NCT01873001|Pioglitazone HCl|pioglitazone hcl
5366600|NCT01872988|antiviral therapy|antiviral therapy
5366601|NCT01872988|intermediate stage|intermediate stage
5366602|NCT01872988|hepatitis B virus|hepatitis b virus
5366603|NCT01872962|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5366604|NCT01872962|Induction chemotherapy|induction chemotherapy
5366605|NCT01872962|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5366606|NCT01872962|Clinical trial|clinical trial
5366607|NCT01872949|Heart Failure|heart failure
5366608|NCT01872949|NYHA Class III|nyha class iii
5366609|NCT01872949|NYHA Class IV|nyha class iv
5366610|NCT01872923|Amphinex|amphinex
5366612|NCT01872923|Bleomycin|bleomycin
5366613|NCT01872923|Cutaneous malignancies|cutaneous malignancies
5366614|NCT01872923|Sub-cutaneous malignancies|sub-cutaneous malignancies
5366615|NCT01872923|Safety|safety
5366616|NCT01872923|Phase I|phase i
5366617|NCT01872923|Photochemical Internalisation|photochemical internalisation
5366618|NCT01872923|Squamous Cell Carcinoma|squamous cell carcinoma
5366619|NCT01872923|Head and Neck cancer|head and neck cancer
5366620|NCT01872923|Breast Cancer|breast cancer
5366621|NCT01872923|HNSCC|hnscc
5366622|NCT01872923|SCCHN|scchn
5366623|NCT01872923|Advanced or metastatic cancer|advanced or metastatic cancer
5366624|NCT01872923|Dose finding|dose finding
5366625|NCT01872910|Wisdom tooth extraction|wisdom tooth extraction
5366626|NCT01872897|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5366627|NCT01872897|GERD|gerd
5366628|NCT01872897|Acid reflux|acid reflux
5366629|NCT01872897|Compound Sodium Alginate Double Action Chewable Tablet|compound sodium alginate double action chewable tablet
5474690|NCT01402102|LDL|ldl
5366630|NCT01872897|Gaviscon Double Action Tablets|gaviscon double action tablets
5366631|NCT01872884|Stroke|stroke
5366632|NCT01872884|Ischemic stroke|ischemic stroke
5366633|NCT01872884|Acute stroke|acute stroke
5366634|NCT01872884|Embolectomy|embolectomy
5366635|NCT01872884|Endovascular therapy|endovascular therapy
5366636|NCT01872884|Intra-arterial therapy|intra-arterial therapy
5366637|NCT01872884|Sedation|sedation
5366638|NCT01872884|Anesthesia|anesthesia
5366639|NCT01872845|Statin|statin
5366640|NCT01872845|CIMT|cimt
5366642|NCT01872793|bioelectrical impedance vector analysis|bioelectrical impedance vector analysis
5366643|NCT01872793|nutritional assessment|nutritional assessment
5366644|NCT01872793|nutritional status|nutritional status
5366645|NCT01872793|mortality|mortality
5366646|NCT01872793|complications|complications
5366647|NCT01872780|CYP2C8|cyp2c8
5366648|NCT01872780|genetic polymorphism|genetic polymorphism
5366649|NCT01872780|rosiglitazone|rosiglitazone
5366651|NCT01872767|Acute on Chronic Liver Failure (ACLF),Cirrhosis,|acute on chronic liver failure (aclf),cirrhosis,
5366652|NCT01872767|Institute of Liver & Biliary Sciences (ILBS)|institute of liver & biliary sciences (ilbs)
5366653|NCT01872754|Bronchial fibroscopy|bronchial fibroscopy
5366654|NCT01872754|Remifentanil|remifentanil
5366655|NCT01872754|Propofol|propofol
5366656|NCT01872754|Sedation|sedation
5366657|NCT01872754|Target Controlled Infusion|target controlled infusion
5366658|NCT01872741|craniotomy,|craniotomy,
5366659|NCT01872741|intracerebral aneurysms,|intracerebral aneurysms,
5366660|NCT01872741|atrophy,|atrophy,
5366661|NCT01872741|temporal muscle,|temporal muscle,
5366662|NCT01872741|outcome|outcome
5366663|NCT01872728|facial block|facial block
5366664|NCT01872728|levobupivacaine|levobupivacaine
5366665|NCT01872728|regional anesthesia|regional anesthesia
5366666|NCT01872728|rhinoplasty|rhinoplasty
5366667|NCT01872728|outpatient|outpatient
5366668|NCT01872715|Papulopustular Rosacea|papulopustular rosacea
5366670|NCT01872715|anti inflammatory doxycycline|anti inflammatory doxycycline
5366671|NCT01872702|Malaria elimination|malaria elimination
5366673|NCT01872702|Epidemiology|epidemiology
5366674|NCT01872702|South East Asia|south east asia
5366675|NCT01872702|Artemisinin resistance|artemisinin resistance
5368649|NCT01863459|Attention|attention
5366676|NCT01872702|Dihydroartemisinin piperaquine|dihydroartemisinin piperaquine
5366677|NCT01872702|Primaquine|primaquine
5366678|NCT01872676|Thermography|thermography
5366679|NCT01872676|Skin Temperature|skin temperature
5366680|NCT01872676|Manipulation, Spinal|manipulation, spinal
5366681|NCT01872676|Physical Therapy Modalities|physical therapy modalities
5366682|NCT01872663|Morbid obesity|morbid obesity
5366683|NCT01872663|Bariatric surgery|bariatric surgery
5366684|NCT01872663|Pulmonary atelectasis|pulmonary atelectasis
5366685|NCT01872663|Spirometry|spirometry
5366686|NCT01872663|Continuos Positive Airway Pressure|continuos positive airway pressure
5366687|NCT01872663|Physical therapy speciality|physical therapy speciality
5366688|NCT01872650|postoperative adhesions|postoperative adhesions
5366689|NCT01872650|adhesion prevention|adhesion prevention
5366690|NCT01872650|colorectal surgery|colorectal surgery
5366691|NCT01872650|temporary ostomy|temporary ostomy
5366692|NCT01872611|Diabetes Type I|diabetes type i
5366693|NCT01872611|Diabetes Type II|diabetes type ii
5366694|NCT01872611|Non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
5366695|NCT01872611|Macular edema|macular edema
5366696|NCT01872611|Cataract|cataract
5366697|NCT01872598|Alzheimer|alzheimer
5366698|NCT01872598|dementia|dementia
5366699|NCT01872598|cognitive disease|cognitive disease
5366700|NCT01872598|memory loss|memory loss
5366701|NCT01872598|cerebrovascular disease|cerebrovascular disease
5366702|NCT01872598|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5366703|NCT01872585|Parenting|parenting
5366704|NCT01872585|Mental Illness|mental illness
5366705|NCT01872585|Maternal sensitivity|maternal sensitivity
5366706|NCT01872585|Parent-child relationship|parent-child relationship
5366707|NCT01872533|obesity|obesity
5366708|NCT01872533|hypoxia|hypoxia
5366709|NCT01872533|insulin sensitivity|insulin sensitivity
5366710|NCT01872533|altitude|altitude
5366711|NCT01872520|the Injection of DanShenDuoFenSuanYan|the injection of danshenduofensuanyan
5366712|NCT01872520|Magnesium Lithospermate B|magnesium lithospermate b
5366713|NCT01872520|Safety|safety
5366714|NCT01872520|Real World Study|real world study
5366715|NCT01872507|cerebral palsy|cerebral palsy
5366716|NCT01872507|autonomic nerveus system|autonomic nerveus system
5366717|NCT01872507|heart rate variability|heart rate variability
5366718|NCT01872494|Local analgesia system|local analgesia system
5366719|NCT01872494|Ropivacaine|ropivacaine
5366720|NCT01872494|Analgesic efficacy after operation|analgesic efficacy after operation
5366721|NCT01872494|Postoperative|postoperative
5366722|NCT01872481|Phantom limb pain syndrome|phantom limb pain syndrome
5366723|NCT01872481|Neuropathic pain|neuropathic pain
5366724|NCT01872481|Antipersonnel landmines|antipersonnel landmines
5366725|NCT01872481|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5366726|NCT01872468|Glomerular filtration Rate.|glomerular filtration rate.
5366727|NCT01872468|Primary Health Care.|primary health care.
5366728|NCT01872468|Cluster Clinical Trial.|cluster clinical trial.
5366729|NCT01872429|subtotal parathyroidectomy|subtotal parathyroidectomy
5366730|NCT01872429|calcium|calcium
5366731|NCT01872429|phosphorus|phosphorus
5366732|NCT01872429|parathyroid hormone|parathyroid hormone
5366733|NCT01872429|hyperparathyroidism|hyperparathyroidism
5366734|NCT01872416|Refractory and relapsed small cell lung cancer|refractory and relapsed small cell lung cancer
5366735|NCT01872416|Liposomal Doxorubicin|liposomal doxorubicin
5366736|NCT01872416|ifosfamide|ifosfamide
5366737|NCT01872403|Squamous Cell Carcinoma of the lung|squamous cell carcinoma of the lung
5366738|NCT01872390|Lesotho|lesotho
5366739|NCT01872390|TB|tb
5366740|NCT01872390|tuberculosis|tuberculosis
5366741|NCT01872390|HIV|hiv
5366742|NCT01872390|antiretroviral therapy|antiretroviral therapy
5233139|NCT02545699|CRC|crc
5245234|NCT02473042|Zofran|zofran
5366743|NCT01872390|ART|art
5366744|NCT01872390|adherence|adherence
5366745|NCT01872390|combination intervention package|combination intervention package
5366746|NCT01872390|retention|retention
5366747|NCT01872377|pancreas|pancreas
5366748|NCT01872377|pancreatic|pancreatic
5366749|NCT01872377|unresectable|unresectable
5366750|NCT01872377|CyberKnife|cyberknife
5366751|NCT01872377|SBRT|sbrt
5366752|NCT01872364|Hernia repair|hernia repair
5366753|NCT01872364|Hydrocelectomy|hydrocelectomy
5366754|NCT01872364|Global Health|global health
5366755|NCT01872364|Global Disease Burden|global disease burden
5366756|NCT01872364|Surgical Mission|surgical mission
5366757|NCT01872364|Dominican Republic|dominican republic
5366758|NCT01872364|Cost-minimization|cost-minimization
5366759|NCT01872364|Procedural cost|procedural cost
5366760|NCT01872364|Material cost|material cost
5366761|NCT01872364|Item utilization|item utilization
5366762|NCT01872364|Excision of benign cutaneous mass|excision of benign cutaneous mass
5366763|NCT01872364|Minor procedure|minor procedure
5366764|NCT01872351|chronic fatigue syndrome|chronic fatigue syndrome
5366765|NCT01872351|mitochondrial disorder|mitochondrial disorder
5366766|NCT01872351|conditioning exercise|conditioning exercise
5366767|NCT01872351|nutraceutical supplements|nutraceutical supplements
5366768|NCT01872351|high protein diet|high protein diet
5366769|NCT01872338|suicide prevention|suicide prevention
5366770|NCT01872338|minfulness-based cognitive therapy|minfulness-based cognitive therapy
5366771|NCT01872338|mindfulness meditation|mindfulness meditation
5366779|NCT01872286|Capsule Endoscopy|capsule endoscopy
5366780|NCT01872273|Metabolic Syndrome|metabolic syndrome
5366781|NCT01872273|Obese|obese
5366782|NCT01872273|Overweight|overweight
5366783|NCT01872273|Hypertension|hypertension
5366784|NCT01872273|Hyperlipidemia|hyperlipidemia
5366785|NCT01872273|Glucose Intolerant|glucose intolerant
5366786|NCT01872273|High blood sugar|high blood sugar
5366787|NCT01872273|Exercise in obesity|exercise in obesity
5366788|NCT01872273|Platelets|platelets
5366789|NCT01872260|Hormone-receptor positive|hormone-receptor positive
5366790|NCT01872234|Heart Failure|heart failure
5366791|NCT01872234|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5366792|NCT01872234|Mild systolic dysfunction|mild systolic dysfunction
5366793|NCT01872234|Left Bundle Branch Block|left bundle branch block
5366794|NCT01872221|Glioblastoma|glioblastoma
5366795|NCT01872221|Spectroscopy|spectroscopy
5366797|NCT01872221|Glioma stem cells|glioma stem cells
5366798|NCT01872221|Surgery|surgery
5366799|NCT01872221|Radioresistance|radioresistance
5366807|NCT01872195|Checklist|checklist
5366808|NCT01872195|In-Hospital Mortality|in-hospital mortality
5366809|NCT01872195|In-Hospital Morbidity|in-hospital morbidity
5366810|NCT01872156|Smoking|smoking
5366811|NCT01872156|Primary care|primary care
5366812|NCT01872130|Moh's Surgery|moh's surgery
5366813|NCT01872130|mosaicing algorithm|mosaicing algorithm
5366814|NCT01872130|intraoperative imaging|intraoperative imaging
5366815|NCT01872130|12-239|12-239
5366816|NCT01872104|rectal cancer|rectal cancer
5366817|NCT01872104|rectal adenocarcinoma|rectal adenocarcinoma
5366818|NCT01872104|photodynamic therapy|photodynamic therapy
5366819|NCT01872104|chemothrapy|chemothrapy
5366820|NCT01872078|Pharmacokinetics, Pharmacodynamics, endocrinopathies, PCOS, female, hormone, LH|pharmacokinetics, pharmacodynamics, endocrinopathies, pcos, female, hormone, lh
5366821|NCT01872039|Nicardipine|nicardipine
5366822|NCT01872039|Hypertension|hypertension
5366823|NCT01872039|Calcium blocker|calcium blocker
5366824|NCT01872026|ASP7991|asp7991
5366825|NCT01872026|Plasma concentration|plasma concentration
5366826|NCT01872026|Pharmacodynamics|pharmacodynamics
5366827|NCT01872026|Pharmacokinetics|pharmacokinetics
5366828|NCT01872013|Plasma concentration|plasma concentration
5366829|NCT01872013|Urinary concentration|urinary concentration
5366830|NCT01872013|ASP7991|asp7991
5366831|NCT01872000|Intraocular lens|intraocular lens
5366832|NCT01872000|Phacoemulsification|phacoemulsification
5366833|NCT01871987|FK949E|fk949e
5366834|NCT01871987|Quetiapine|quetiapine
5366835|NCT01871987|Antipsychotic|antipsychotic
5474913|NCT01401049|Lusedra|lusedra
5366841|NCT01871896|Morbid Obesity|morbid obesity
5366842|NCT01871896|Weight Loss|weight loss
5366843|NCT01871896|Bariatrics|bariatrics
5366844|NCT01871896|Surgical Revision|surgical revision
5366845|NCT01871883|Sensitive skin|sensitive skin
5366846|NCT01871883|Transient potential receptor vanilloid 1|transient potential receptor vanilloid 1
5366847|NCT01871883|TRPV1|trpv1
5366848|NCT01871883|Transepidermal water loss|transepidermal water loss
5366849|NCT01871883|Skin Phototype|skin phototype
5964403|NCT04143581|Residual proteinuria|residual proteinuria
5366850|NCT01871883|Lactic acid test|lactic acid test
5366851|NCT01871883|Skin irritancy tests|skin irritancy tests
5366852|NCT01871818|Multiple sclerosis|multiple sclerosis
5366853|NCT01871818|Rehabilitation|rehabilitation
5366854|NCT01871818|Chronic evolutive disease|chronic evolutive disease
5366855|NCT01871818|Physiotherapy|physiotherapy
5366856|NCT01871818|Resistance training|resistance training
5964404|NCT04143581|Obesity|obesity
5366857|NCT01871818|Endurance training|endurance training
5366858|NCT01871792|Contrast-induced nephropathy|contrast-induced nephropathy
5366859|NCT01871792|Prevention|prevention
5366861|NCT01871792|Pitavastatin|pitavastatin
5366862|NCT01871766|Rhabdomyosarcoma|rhabdomyosarcoma
5366863|NCT01871766|Radiation therapy|radiation therapy
5366864|NCT01871766|Proton beam|proton beam
5366865|NCT01871740|Folic acid|folic acid
5366866|NCT01871740|Renal function decline|renal function decline
5366867|NCT01871740|Hypertension|hypertension
5366868|NCT01871740|Hyperhomocysteinemia|hyperhomocysteinemia
5366869|NCT01871740|Chronic kidney disease|chronic kidney disease
5366870|NCT01871740|MTHFR C677T genotype|mthfr c677t genotype
5366876|NCT01871714|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5366877|NCT01871714|X Linked Hypohidrotic Ectodermal Dysplasia|x linked hypohidrotic ectodermal dysplasia
5366878|NCT01871701|Corrected QT interval prolongation|corrected qt interval prolongation
5366879|NCT01871701|Psychotropic drugs|psychotropic drugs
5366880|NCT01871688|pelvic floor dysfunction|pelvic floor dysfunction
5366882|NCT01871688|rehabilitation|rehabilitation
5366883|NCT01871675|Lymphoma|lymphoma
5366884|NCT01871675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5366885|NCT01871675|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5366886|NCT01871675|T-cell Lymphoma|t-cell lymphoma
5366887|NCT01871675|Rituxan|rituxan
5366892|NCT01871662|HCV|hcv
5366893|NCT01871662|Hepatitis C|hepatitis c
5366894|NCT01871649|psoriatic arthritis|psoriatic arthritis
5366895|NCT01871649|golimumab|golimumab
5366896|NCT01871649|methotrexate|methotrexate
5366897|NCT01871649|minimal disease activity|minimal disease activity
5366898|NCT01871649|safety|safety
5366899|NCT01871649|withdrawal|withdrawal
5366900|NCT01871636|endoscopy|endoscopy
5366901|NCT01871636|WESD|wesd
5366902|NCT01871636|EMR|emr
5366903|NCT01871623|Cleft lip and palate|cleft lip and palate
5366904|NCT01871623|Cone-Beam Computed Tomography|cone-beam computed tomography
5366905|NCT01871623|Le Fort I Osteotomy|le fort i osteotomy
5366906|NCT01871623|Segmental Osteotomy|segmental osteotomy
5366907|NCT01871623|Stability|stability
5366908|NCT01871610|Traumatic brain injury|traumatic brain injury
5366909|NCT01871610|mild TBI|mild tbi
5366910|NCT01871610|Alzheimer's disease|alzheimer's disease
5366911|NCT01871610|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
5366912|NCT01871597|Lung cancer|lung cancer
5366913|NCT01871597|VATS procedure|vats procedure
5366914|NCT01871597|Pulmonary Artery Sealing|pulmonary artery sealing
5366915|NCT01871584|A colon hydrotherapy system|a colon hydrotherapy system
5366916|NCT01871584|Hydrocolonic preparation|hydrocolonic preparation
5366917|NCT01871584|Preparation for colonoscopy|preparation for colonoscopy
5366918|NCT01871558|type 2 diabetes|type 2 diabetes
5366919|NCT01871558|basal insulin|basal insulin
5366920|NCT01871558|vildagliptin|vildagliptin
5366921|NCT01871545|hepatocellular carcinoma|hepatocellular carcinoma
5366922|NCT01871545|HCC|hcc
5366923|NCT01871545|liver cancer|liver cancer
5366924|NCT01871545|liver disease|liver disease
5366925|NCT01871545|magnetic resonance imaging|magnetic resonance imaging
5366926|NCT01871545|MRI|mri
5366927|NCT01871532|Monofollicular Development|monofollicular development
5366928|NCT01871532|Gonal-f®|gonal-f®
5366929|NCT01871532|Recombinant Follicle Stimulating Hormone|recombinant follicle stimulating hormone
5366930|NCT01871532|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
5366931|NCT01871519|vertebral body compression fracture|vertebral body compression fracture
5366932|NCT01871480|NSCLC|nsclc
5366933|NCT01871480|CIK|cik
5366934|NCT01871480|Gefitinib|gefitinib
5366935|NCT01871480|Adenocarcinoma|adenocarcinoma
5366936|NCT01871402|psoriasis|psoriasis
5366937|NCT01871402|lotion|lotion
5366938|NCT01871402|investigator's global assessment|investigator's global assessment
5366939|NCT01871376|PCV|pcv
5366940|NCT01871363|Preoperative Chemoradiotherapy|preoperative chemoradiotherapy
5366941|NCT01871363|Bevacizumab|bevacizumab
5366942|NCT01871363|Locally Advanced Rectal Cancer|locally advanced rectal cancer
5366943|NCT01871350|Cancer|cancer
5366944|NCT01871350|Chemotherapy|chemotherapy
5964405|NCT04143503|ICU|icu
5964406|NCT04143503|parenteral nutrition|parenteral nutrition
5964407|NCT04143503|enteral nutrition|enteral nutrition
5964408|NCT04143503|energy intake|energy intake
5964409|NCT04143503|protein intake|protein intake
5964410|NCT04143308|Schizophrenia|schizophrenia
5964411|NCT04143308|Cognitive functional training|cognitive functional training
5964412|NCT04143308|Dual-task training|dual-task training
5964413|NCT04143308|Aerobic exercise|aerobic exercise
5964414|NCT04143308|Mobile application|mobile application
5964415|NCT04142814|Lower respiratory airways clearance|lower respiratory airways clearance
5964416|NCT04142814|Deep lung clearance|deep lung clearance
5964417|NCT04142814|Secretions overproduction|secretions overproduction
5964418|NCT04142814|Positive Expiratory Pressure|positive expiratory pressure
5964419|NCT04142814|Intrapulmonary Percussive Ventilation|intrapulmonary percussive ventilation
5964420|NCT04142814|Tetraplegia|tetraplegia
5964421|NCT04142814|Tracheotomy|tracheotomy
5964422|NCT04142814|Critical Care Unit|critical care unit
5964423|NCT04142814|Mechanical ventilation|mechanical ventilation
5964424|NCT04142814|Respiratory physiotherapy|respiratory physiotherapy
5964425|NCT04142021|coronary artery bypass graft|coronary artery bypass graft
5964426|NCT04142021|coronary computed tomography angiography|coronary computed tomography angiography
5233333|NCT02544399|Playing golf|playing golf
5366945|NCT01871350|Chemo related toxicity|chemo related toxicity
5366946|NCT01871350|Protein digestion|protein digestion
5366947|NCT01871350|Fat digestion|fat digestion
5366948|NCT01871350|Gut function|gut function
5366949|NCT01871350|Glucose absorption|glucose absorption
5366950|NCT01871350|Muscle function|muscle function
5366951|NCT01871337|Multiple Sclerosis|multiple sclerosis
5366952|NCT01871337|urinary incontinence|urinary incontinence
5366953|NCT01871311|metastatic Kras wildtype|metastatic kras wildtype
5366954|NCT01871311|squamous cell carcinoma|squamous cell carcinoma
5366955|NCT01871311|cetuximab|cetuximab
5366956|NCT01871311|nilotinib|nilotinib
5366957|NCT01871298|internet and mobile technology use|internet and mobile technology use
5366958|NCT01871298|history of drug use|history of drug use
5366959|NCT01871298|injection drug user (IDU) syringe customers|injection drug user (idu) syringe customers
5366960|NCT01871285|ATC, Opioid, withdrawal, switch|atc, opioid, withdrawal, switch
5366961|NCT01871259|Sedation, sleep apnea, propofol|sedation, sleep apnea, propofol
5366962|NCT01871233|anti-epileptic drug|anti-epileptic drug
5366963|NCT01871233|Extended Access Program|extended access program
5366964|NCT01871233|partial onset seizures|partial onset seizures
5366965|NCT01871233|Perampanel|perampanel
5366966|NCT01871220|Implant Abutments|implant abutments
5366967|NCT01871220|Oral Mucosa Changes|oral mucosa changes
5366968|NCT01871220|Implant Esthetics|implant esthetics
5366969|NCT01871207|Erythropoietin (EPO)|erythropoietin (epo)
5366970|NCT01871207|Diabetes|diabetes
5366971|NCT01871207|Diabetic Retinopathy|diabetic retinopathy
5366972|NCT01871207|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5366973|NCT01871207|Erythropoiesis Stimulating Agents (ESA)|erythropoiesis stimulating agents (esa)
5366974|NCT01871142|5 Hydroxymethyl 2 Furfural|5 hydroxymethyl 2 furfural
5366975|NCT01871142|AES103|aes103
5366976|NCT01871142|Exercise|exercise
5366977|NCT01871129|Dexmedetomidine|dexmedetomidine
5366978|NCT01871129|Postoperative Period|postoperative period
5366979|NCT01871129|Airway extubation|airway extubation
5366980|NCT01871129|Systolic Pressure|systolic pressure
5366981|NCT01871116|breast cancer|breast cancer
5366982|NCT01871116|early stage|early stage
5366983|NCT01871116|weight loss|weight loss
5366984|NCT01871103|Soft tissue defect|soft tissue defect
5366985|NCT01871103|dorsal branch of the digital artery|dorsal branch of the digital artery
5366986|NCT01871103|dorsal branch of the digital nerve|dorsal branch of the digital nerve
5366987|NCT01871103|dorsal homodigital island flap|dorsal homodigital island flap
5366988|NCT01871090|Remote Monitoring|remote monitoring
5366989|NCT01871090|Remote Care|remote care
5366990|NCT01871090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5366991|NCT01871090|Pacemaker|pacemaker
5366992|NCT01871090|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5366993|NCT01871064|Laparotomy|laparotomy
5366994|NCT01871064|laparoscopic surgery|laparoscopic surgery
5366995|NCT01871064|general anesthesia|general anesthesia
5366996|NCT01871064|Neuromuscular Block|neuromuscular block
5366997|NCT01871038|vaccine effectiveness|vaccine effectiveness
5366998|NCT01871038|rotavirus|rotavirus
5366999|NCT01871038|acute gastroenteritis|acute gastroenteritis
5367000|NCT01871025|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5367001|NCT01871012|Nerve Block|nerve block
5367002|NCT01871012|Intraoperative Care|intraoperative care
5367003|NCT01871012|Postoperative Recovery and Complications|postoperative recovery and complications
5367004|NCT01871012|Stress and Inflammation|stress and inflammation
5367005|NCT01870986|Healthy Volunteers|healthy volunteers
5367006|NCT01870986|Phase 1|phase 1
5367008|NCT01870986|adalimumab|adalimumab
5367009|NCT01870986|Single-dose|single-dose
5367010|NCT01870986|Immunology|immunology
5367011|NCT01870986|Bioequivalence|bioequivalence
5367012|NCT01870986|Biosimilarity|biosimilarity
5367013|NCT01870986|Similarity.|similarity.
5367014|NCT01870973|postoperative pain|postoperative pain
5367015|NCT01870973|root canal treatment|root canal treatment
5367016|NCT01870947|Stage I endometrial adenocarcinoma|stage i endometrial adenocarcinoma
5367017|NCT01870947|Obesity|obesity
5367018|NCT01870947|Exercise and Physical Fitness|exercise and physical fitness
5367019|NCT01870947|Diet|diet
5367020|NCT01870947|Cancer|cancer
5367021|NCT01870934|Telemedicine|telemedicine
5367022|NCT01870934|Diabetes|diabetes
5367023|NCT01870934|Foot Ulcers|foot ulcers
5367024|NCT01870895|YM060|ym060
5367025|NCT01870895|Ramosetron|ramosetron
5964427|NCT04142021|fractional flow reserve derived from computed tomography angiography|fractional flow reserve derived from computed tomography angiography
5964428|NCT04142021|invasive coronary angiography, revascularization|invasive coronary angiography, revascularization
5964429|NCT04141748|shape capture|shape capture
5964430|NCT04141748|prosthetic sockets|prosthetic sockets
5964431|NCT04141696|Anesthetics|anesthetics
5964432|NCT04141696|Signs and Symptoms|signs and symptoms
5964433|NCT04141696|Midazolam|midazolam
5964434|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs
5964435|NCT04141657|neonates|neonates
5964436|NCT04141657|antimicrobial pharmacotherapy|antimicrobial pharmacotherapy
5964437|NCT04141657|pharmacotherapy adverse events|pharmacotherapy adverse events
5964438|NCT04141657|neonatal Intensive Care Unit|neonatal intensive care unit
5964439|NCT04141657|safety|safety
5964440|NCT04141566|Pseudocontinent perineal colostomy|pseudocontinent perineal colostomy
5233435|NCT02543827|Vaccine|vaccine
5245465|NCT02471937|Streptococcus agalactiae|streptococcus agalactiae
5245466|NCT02471937|Group B Streptococcus|group b streptococcus
5245467|NCT02471937|Neonates|neonates
5245468|NCT02471937|colonization|colonization
5367026|NCT01870895|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5367027|NCT01870882|Opioid-Related Disorders|opioid-related disorders
5367028|NCT01870882|Cocaine-Related Disorders|cocaine-related disorders
5367029|NCT01870882|Substance-Related Disorders|substance-related disorders
5367030|NCT01870882|Mental Disorders|mental disorders
5367031|NCT01870882|Cocaine|cocaine
5367032|NCT01870882|Methadone|methadone
5367033|NCT01870882|Therapeutic Uses|therapeutic uses
5367034|NCT01870856|Ocular discomfort|ocular discomfort
5367035|NCT01870856|Contact lenses|contact lenses
5367036|NCT01870856|Myopia|myopia
5367037|NCT01870843|Depressive Disorder, Major|depressive disorder, major
5367038|NCT01870843|Depressive Disorder|depressive disorder
5367039|NCT01870843|Depression|depression
5367040|NCT01870843|Anxiety|anxiety
5367041|NCT01870843|Escitalopram|escitalopram
5367042|NCT01870843|Quality of life|quality of life
5367043|NCT01870843|Social functionality|social functionality
5367044|NCT01870817|Randomized|randomized
5367045|NCT01870817|Jejunostomy|jejunostomy
5367046|NCT01870817|Enteral|enteral
5367047|NCT01870817|Nutrition|nutrition
5367048|NCT01870817|Esophagectomy|esophagectomy
5367049|NCT01870817|Gastrectomy|gastrectomy
5367050|NCT01870804|Statins|statins
5367051|NCT01870804|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
5367052|NCT01870804|Periprocedural Myocardial Damage|periprocedural myocardial damage
5367053|NCT01870791|Esophageal adenocarcinoma|esophageal adenocarcinoma
5367054|NCT01870791|Gastric adenocarcinoma|gastric adenocarcinoma
5367055|NCT01870778|acute heart failure,|acute heart failure,
5367056|NCT01870778|AHF,|ahf,
5367057|NCT01870778|multi-center,|multi-center,
5367058|NCT01870778|randomized,|randomized,
5367059|NCT01870778|double-blind|double-blind
5367060|NCT01870739|LCZ696,|lcz696,
5367061|NCT01870739|Hypertension,|hypertension,
5367062|NCT01870739|Aortic stiffness,|aortic stiffness,
5367063|NCT01870739|Central blood pressure,|central blood pressure,
5367064|NCT01870739|Cardiovascular MRI|cardiovascular mri
5367166|NCT01870258|artificial neural networks|artificial neural networks
5368752|NCT01863043|Enteral|enteral
5671939|NCT00613535|cartilage lesion|cartilage lesion
5367065|NCT01870726|Glioblastoma multiforme (GBM), glioblastoma, Grade IV Astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma|glioblastoma multiforme (gbm), glioblastoma, grade iv astrocytoma, brain tumor, brain cancer, giant cell glioblastoma, gliosarcoma
5367066|NCT01870713|gastric bypass surgery|gastric bypass surgery
5367067|NCT01870713|proteomics|proteomics
5367068|NCT01870687|vitex agnus castus|vitex agnus castus
5367069|NCT01870687|clinical trial|clinical trial
5367070|NCT01870687|cyclic mastodynia|cyclic mastodynia
5367072|NCT01870687|prospective|prospective
5367073|NCT01870674|safety|safety
5367074|NCT01870674|tolerability|tolerability
5367075|NCT01870674|pharmacokinetics|pharmacokinetics
5367076|NCT01870674|pharmacodynamics|pharmacodynamics
5367077|NCT01870661|Intravenous placement|intravenous placement
5367078|NCT01870661|Ultrasound|ultrasound
5367079|NCT01870648|Low-middle income country|low-middle income country
5367080|NCT01870648|Dehydration|dehydration
5367081|NCT01870648|Intravenous Rehydration|intravenous rehydration
5367082|NCT01870648|Pakistan|pakistan
5367083|NCT01870635|Low-middle income country|low-middle income country
5367084|NCT01870635|Dehydration|dehydration
5367085|NCT01870635|Intravenous Rehydration|intravenous rehydration
5367086|NCT01870635|Pakistan|pakistan
5367087|NCT01870622|Newborn,|newborn,
5367089|NCT01870622|Endotracheal Intubation,|endotracheal intubation,
5367090|NCT01870622|Carbon dioxide detector,|carbon dioxide detector,
5367091|NCT01870622|Flow waves|flow waves
5367092|NCT01870583|Cesarean delivery|cesarean delivery
5367093|NCT01870583|Surgical site infection|surgical site infection
5367094|NCT01870583|Pregnancy|pregnancy
5367095|NCT01870583|Postpartum|postpartum
5367096|NCT01870570|Glycaemia|glycaemia
5367097|NCT01870570|Insulinemia|insulinemia
5367098|NCT01870557|Diabetes Mellitus|diabetes mellitus
5367099|NCT01870557|Bone|bone
5367100|NCT01870557|Bone Status|bone status
5367101|NCT01870557|Glycemic Markers|glycemic markers
5367102|NCT01870557|Osteoporosis|osteoporosis
5367103|NCT01870557|Osteopenia|osteopenia
5367104|NCT01870544|gastric bypass|gastric bypass
5367105|NCT01870544|microbiota|microbiota
5367106|NCT01870544|probiotic|probiotic
5367107|NCT01870531|Transient Ischemic Attack|transient ischemic attack
5367108|NCT01870518|Parkinson's disease|parkinson's disease
5964441|NCT04141566|Abdominoperineal resection|abdominoperineal resection
5367109|NCT01870518|Dementia|dementia
5367110|NCT01870505|BYL719|byl719
5367111|NCT01870505|Letrozole|letrozole
5367112|NCT01870505|Exemestane|exemestane
5964442|NCT04141566|colostomy|colostomy
5964443|NCT04141566|Cost effectiveness|cost effectiveness
5964444|NCT04141566|quality of life|quality of life
5964445|NCT04141124|medical education|medical education
5964446|NCT04141124|simulated critical situation|simulated critical situation
5233528|NCT02543294|HF|hf
5367113|NCT01870505|13-027|13-027
5367114|NCT01870492|IV-tPA|iv-tpa
5367115|NCT01870492|Activase|activase
5367116|NCT01870492|endovascular therapy|endovascular therapy
5367117|NCT01870479|Malignant Lymphoma|malignant lymphoma
5367118|NCT01870479|Chemotherapy|chemotherapy
5367119|NCT01870479|Music therapy|music therapy
5367120|NCT01870453|Alzheimer Disease|alzheimer disease
5367121|NCT01870453|Dementia|dementia
5367122|NCT01870453|Postoperative Care|postoperative care
5367123|NCT01870453|Cognitive Reserve|cognitive reserve
5367124|NCT01870440|Uveitis|uveitis
5367125|NCT01870440|Macular Edema|macular edema
5367126|NCT01870427|Macular Edema|macular edema
5262756|NCT02373085|Pyelonephritis|pyelonephritis
5367127|NCT01870427|Central Retinal Vein Occlusion|central retinal vein occlusion
5367128|NCT01870427|CRVO|crvo
5367129|NCT01870427|Aflibercept|aflibercept
5367130|NCT01870427|VEGF Trap-Eye|vegf trap-eye
5367131|NCT01870427|Eylea|eylea
5367132|NCT01870427|Ranibizumab|ranibizumab
5367133|NCT01870427|Bevacizumab|bevacizumab
5367134|NCT01870375|Mucopolysaccharidosis|mucopolysaccharidosis
5475291|NCT01399398|HV|hv
5367135|NCT01870375|Longitudinal|longitudinal
5367136|NCT01870375|Brain|brain
5367137|NCT01870375|Cognition|cognition
5367138|NCT01870375|Quality-of-Life|quality-of-life
5367139|NCT01870375|Hurler syndrome|hurler syndrome
5367140|NCT01870375|Hunter syndrome|hunter syndrome
5367141|NCT01870375|Hurler-Scheie syndrome|hurler-scheie syndrome
5367142|NCT01870375|Scheie syndrome|scheie syndrome
5367143|NCT01870375|Maroteaux-Lamy syndrome|maroteaux-lamy syndrome
5367144|NCT01870375|MPS I|mps i
5367145|NCT01870375|MPS II|mps ii
5367146|NCT01870375|MPS VI|mps vi
5367147|NCT01870375|Mucopolysaccharidosis type I|mucopolysaccharidosis type i
5367148|NCT01870375|Mucopolysaccharidosis type II|mucopolysaccharidosis type ii
5367149|NCT01870375|Mucopolysaccharidosis type VI|mucopolysaccharidosis type vi
5367150|NCT01870375|MPS IV|mps iv
5367151|NCT01870375|MPS VII|mps vii
5367152|NCT01870375|Mucopolysaccharidosis type IV|mucopolysaccharidosis type iv
5367153|NCT01870375|Mucopolysaccharidosis type VII|mucopolysaccharidosis type vii
5367154|NCT01870375|Morquio syndrome|morquio syndrome
5367155|NCT01870375|Sly syndrome|sly syndrome
5367156|NCT01870349|cytokines|cytokines
5367157|NCT01870349|dental implants|dental implants
5367158|NCT01870349|peri-implantitis|peri-implantitis
5367159|NCT01870310|Heart failure|heart failure
5367160|NCT01870310|Renal denervation|renal denervation
5367161|NCT01870271|PTSD|ptsd
5367162|NCT01870271|childhood sexual abuse|childhood sexual abuse
5367163|NCT01870271|physical abuse|physical abuse
5367164|NCT01870271|developmentally adapted cognitive processing therapy|developmentally adapted cognitive processing therapy
5367165|NCT01870258|Myocardial infarction|myocardial infarction
5367167|NCT01870258|Electrocardiography|electrocardiography
5367168|NCT01870232|Greater palatine nerve Block|greater palatine nerve block
5367169|NCT01870232|Inferior Alveolar nerve block|inferior alveolar nerve block
5367170|NCT01870232|dental anesthesia|dental anesthesia
5367171|NCT01870232|Ultrasonography|ultrasonography
5367172|NCT01870219|sevoflurane|sevoflurane
5367173|NCT01870219|ketamine|ketamine
5367174|NCT01870219|QT interval|qt interval
5367175|NCT01870206|Immunogenicity|immunogenicity
5367176|NCT01870206|Safety|safety
5367177|NCT01870206|Efficacy|efficacy
5367178|NCT01870206|Poliomyelitis|poliomyelitis
5367179|NCT01870206|Newborn|newborn
5367180|NCT01870193|Glutathione deficiency in aging|glutathione deficiency in aging
5367181|NCT01870193|Impaired mitochondrial fatty-acid oxidation in aging|impaired mitochondrial fatty-acid oxidation in aging
5367182|NCT01870180|Meibomian Glad Dysfunction|meibomian glad dysfunction
5367184|NCT01870180|Hot Compress|hot compress
5367185|NCT01870180|Dry Eyes|dry eyes
5367186|NCT01870167|PEG|peg
5367187|NCT01870167|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
5367188|NCT01870167|antibiotic prophylaxis|antibiotic prophylaxis
5367189|NCT01870154|Burnout syndrome|burnout syndrome
5367190|NCT01870154|Job stressors|job stressors
5367191|NCT01870154|Primary Health Care|primary health care
5367192|NCT01870154|Health professional|health professional
5367193|NCT01870141|Glucose Control|glucose control
5367194|NCT01870141|Depression|depression
5367195|NCT01870141|Self-Efficacy|self-efficacy
5367196|NCT01870128|Rheumatoid arthritis|rheumatoid arthritis
5367197|NCT01870128|Steroid|steroid
5367198|NCT01870115|Melatonin|melatonin
5367199|NCT01870115|Strontium Citrate|strontium citrate
5367200|NCT01870115|Osteoporosis|osteoporosis
5367201|NCT01870115|Osteopenia|osteopenia
5367202|NCT01870089|Non invasive ventilation|non invasive ventilation
5367203|NCT01870089|Computer-driven system|computer-driven system
5367204|NCT01870089|Acute respiratory failure|acute respiratory failure
5964447|NCT04141124|stress management and performance|stress management and performance
5367205|NCT01870063|5 minute bleeding test|5 minute bleeding test
5367206|NCT01870063|swamb|swamb
5367207|NCT01870063|fibtem|fibtem
5367208|NCT01870063|extem|extem
5367209|NCT01870050|lichen simplex chronicus|lichen simplex chronicus
5367210|NCT01870050|prurigo|prurigo
5367211|NCT01870037|Overactive Bladder|overactive bladder
5367212|NCT01870037|OAB|oab
5367213|NCT01870037|gene therapy|gene therapy
5367214|NCT01870024|status epilepticus|status epilepticus
5367215|NCT01870024|epilepsy|epilepsy
5367216|NCT01870024|seizures|seizures
5367217|NCT01870024|convulsive seizures|convulsive seizures
5367218|NCT01870024|convulsions|convulsions
5367219|NCT01870024|benzodiazepines|benzodiazepines
5367220|NCT01870024|anticonvulsants|anticonvulsants
5367221|NCT01870011|Propofol, renal protection, kidney transplantation|propofol, renal protection, kidney transplantation
5367222|NCT01869998|Vortex|vortex
5367223|NCT01869998|Thrombus|thrombus
5367473|NCT01868828|Combination Therapy|combination therapy
5367224|NCT01869998|Contrast echocardiography|contrast echocardiography
5367225|NCT01869998|Prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using Vortex parameters.|prediction and prevention of apical thrombus formation in acute myocardial infarction patient by using vortex parameters.
5367226|NCT01869985|HCP1104|hcp1104
5367227|NCT01869985|Eperisone Hydrochloride|eperisone hydrochloride
5367228|NCT01869985|Aceclofenac|aceclofenac
5367229|NCT01869972|PKU|pku
5353197|NCT01934088|Propofol|propofol
5367230|NCT01869972|phenylketonuria|phenylketonuria
5367231|NCT01869972|hyperphenylalaninemia|hyperphenylalaninemia
5367232|NCT01869972|Kuvan|kuvan
5367233|NCT01869972|sapropterin|sapropterin
5367234|NCT01869946|Hip arthroplasty|hip arthroplasty
5367235|NCT01869933|Proliferative, Diabetic, Retinopathy|proliferative, diabetic, retinopathy
5367236|NCT01869920|breastfeeding|breastfeeding
5367237|NCT01869920|education|education
5367238|NCT01869920|intervention|intervention
5367239|NCT01869894|Malignant biliary obstruction|malignant biliary obstruction
5367240|NCT01869894|metal stent|metal stent
5367241|NCT01869894|patency|patency
5367242|NCT01869855|chronic subdural hematoma|chronic subdural hematoma
5367243|NCT01869855|traumatic brain injury|traumatic brain injury
5367244|NCT01869855|burr hole trepanation|burr hole trepanation
5367245|NCT01869855|drainage after evacuation of chronic subdural hematoma|drainage after evacuation of chronic subdural hematoma
5367246|NCT01869855|intracranial bleed|intracranial bleed
5367247|NCT01869842|Resolute zotarolumus-eluting stent|resolute zotarolumus-eluting stent
5367248|NCT01869842|optical coherence tomography|optical coherence tomography
5367249|NCT01869829|Candida|candida
5367250|NCT01869829|Pediatric|pediatric
5367251|NCT01869829|Antifungal|antifungal
5367252|NCT01869738|heart attack|heart attack
5367253|NCT01869725|Neuroendocrine Tumor|neuroendocrine tumor
5367254|NCT01869725|Ga-DOTATOC PET|ga-dotatoc pet
5367255|NCT01869725|Imaging|imaging
5367256|NCT01869712|cupping therapy|cupping therapy
5367257|NCT01869712|acupuncture|acupuncture
5367258|NCT01869712|partially randomized|partially randomized
5367259|NCT01869712|patient preference|patient preference
5367260|NCT01869712|fibromyalgia|fibromyalgia
5671940|NCT00613535|articular cartilage lesion|articular cartilage lesion
5367261|NCT01869712|criteria formulated by American College Rheumatology 2002|criteria formulated by american college rheumatology 2002
5367263|NCT01869699|Acetaminophen|acetaminophen
5367264|NCT01869699|Critical Care|critical care
5367265|NCT01869699|ICU|icu
5367266|NCT01869699|Febrile|febrile
5367267|NCT01869673|Difficult mask ventilation|difficult mask ventilation
5367268|NCT01869673|extubation|extubation
5367269|NCT01869673|nasal surgery|nasal surgery
5367270|NCT01869660|First hospitalization|first hospitalization
5367271|NCT01869647|kidney stones|kidney stones
5367272|NCT01869634|HIV|hiv
5367273|NCT01869634|cardiovascular risk|cardiovascular risk
5367280|NCT01869582|Neonatal resuscitation|neonatal resuscitation
5367281|NCT01869569|Radiation|radiation
5367282|NCT01869569|Neuropathic Pain|neuropathic pain
5367283|NCT01869569|Pregabalin|pregabalin
5367284|NCT01869556|pregnancy|pregnancy
5367285|NCT01869556|postpartum hemorrhage|postpartum hemorrhage
5367286|NCT01869556|Cesarean delivery|cesarean delivery
5367287|NCT01869556|failure to progress in labor|failure to progress in labor
5367288|NCT01869504|Ballooned intercostal drain|ballooned intercostal drain
5367289|NCT01869504|Pleural effusion|pleural effusion
5367290|NCT01869491|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5367291|NCT01869491|GERD|gerd
5367292|NCT01869491|Dyspepsia|dyspepsia
5367293|NCT01869491|Indigestion|indigestion
5367294|NCT01869491|Heartburn|heartburn
5367295|NCT01869491|Acid reflux|acid reflux
5367296|NCT01869491|Compound Sodium Alginate Double Action Chewable Tablets|compound sodium alginate double action chewable tablets
5367297|NCT01869491|Gaviscon Double Action Tablets|gaviscon double action tablets
5367298|NCT01869452|education|education
5367299|NCT01869452|risk factors|risk factors
5367300|NCT01869452|quality of life|quality of life
5367301|NCT01869452|coronary disease|coronary disease
5367302|NCT01869452|telephone follow up|telephone follow up
5367303|NCT01869452|dedicated nurse|dedicated nurse
5367304|NCT01869439|Pressure Ulcers|pressure ulcers
5367305|NCT01869439|Bed Sores|bed sores
5367306|NCT01869439|Measuring|measuring
5367307|NCT01869439|Visual Images|visual images
5367308|NCT01869439|Thermal Images|thermal images
5367309|NCT01869439|External Wounds|external wounds
5367310|NCT01869439|Area|area
5367311|NCT01869439|Length|length
5964448|NCT04140422|Corneal edema|corneal edema
5245797|NCT02469948|stroke|stroke
5367312|NCT01869439|Width|width
5367313|NCT01869439|Gradient|gradient
5367314|NCT01869426|colics|colics
5367315|NCT01869413|urothelial cell carcinoma|urothelial cell carcinoma
5367316|NCT01869413|transition cell carcinoma|transition cell carcinoma
5367317|NCT01869413|bladder cancer|bladder cancer
5367318|NCT01869413|radical cystectomy|radical cystectomy
5367319|NCT01869413|cystectomy|cystectomy
5367320|NCT01869413|bladder removal|bladder removal
5367321|NCT01869413|tranexamic acid|tranexamic acid
5367322|NCT01869413|cyklokapron|cyklokapron
5367323|NCT01869374|Depression|depression
5367324|NCT01869374|Brain Stimulation|brain stimulation
5367325|NCT01869374|Seizure therapy|seizure therapy
5367326|NCT01869374|Convulsive Therapy|convulsive therapy
5367327|NCT01869361|preterm labor|preterm labor
5367329|NCT01869361|indomethacin|indomethacin
5367330|NCT01869348|Physical activity|physical activity
5367331|NCT01869348|Activity monitor|activity monitor
5367332|NCT01869348|Technology|technology
5367333|NCT01869348|Obesity|obesity
5367334|NCT01869348|Aging muscle|aging muscle
5367335|NCT01869335|breast cancer|breast cancer
5367336|NCT01869335|MRI|mri
5367337|NCT01869335|mammography|mammography
5367338|NCT01869335|microcalcifications|microcalcifications
5367339|NCT01869335|Local staging of breast microcalcifications|local staging of breast microcalcifications
5367340|NCT01869335|Evaluation of ex vivo MRI for breast malignancies detected by MRI only|evaluation of ex vivo mri for breast malignancies detected by mri only
5367341|NCT01869322|Humerus|humerus
5367342|NCT01869322|Fracture|fracture
5367343|NCT01869322|Sling|sling
5367344|NCT01869322|Splint|splint
5367345|NCT01869322|Coaptation|coaptation
5367346|NCT01869309|Coronary artery disease|coronary artery disease
5367347|NCT01869309|anti-platelet medications|anti-platelet medications
5367348|NCT01869309|Platelet-aggregation Inhibitors|platelet-aggregation inhibitors
5367349|NCT01869296|unsedated|unsedated
5367350|NCT01869296|water immersion colonoscopy|water immersion colonoscopy
5367351|NCT01869296|endoscope water pump flow rates|endoscope water pump flow rates
5367352|NCT01869283|Physical Therapy Modalities|physical therapy modalities
5367353|NCT01869283|Myofascial Pain Syndromes|myofascial pain syndromes
5367354|NCT01869283|Skeletal Muscle|skeletal muscle
5367355|NCT01869270|hexosaminidase deficiency|hexosaminidase deficiency
5367356|NCT01869270|Tay-Sachs disease|tay-sachs disease
5367357|NCT01869270|Sandhoff disease|sandhoff disease
5367358|NCT01869270|late-onset Tay-Sachs disease|late-onset tay-sachs disease
5367359|NCT01869270|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
5367360|NCT01869270|late onset Tay Sachs disease|late onset tay sachs disease
5367753|NCT01867463|Assay|assay
5367361|NCT01869270|adult onset Tay Sachs disease|adult onset tay sachs disease
5367362|NCT01869270|retrospective|retrospective
5362857|NCT01889420|myeloma|myeloma
5367366|NCT01869270|natural history|natural history
5367367|NCT01869270|hexosaminidase|hexosaminidase
5367368|NCT01869257|triclosan|triclosan
5367369|NCT01869257|colorectal|colorectal
5367370|NCT01869257|surgery|surgery
5367371|NCT01869257|surgical site infection|surgical site infection
5367372|NCT01869218|Cancer|cancer
5367373|NCT01869218|Advanced|advanced
5367374|NCT01869218|Solid|solid
5367375|NCT01869218|Hematological|hematological
5367376|NCT01869218|Malignancy|malignancy
5367377|NCT01869218|Tissue|tissue
5367378|NCT01869218|Bank|bank
5367379|NCT01869205|COPD|copd
5367380|NCT01869205|Emphysema|emphysema
5367381|NCT01869205|Bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
5367382|NCT01869205|Endobronchial valve|endobronchial valve
5367383|NCT01869192|Malignant|malignant
5367384|NCT01869192|Neoplasm|neoplasm
5367385|NCT01869192|Cancer|cancer
5367386|NCT01869192|Female|female
5367387|NCT01869192|Breast|breast
5367388|NCT01869192|Stage II|stage ii
5367389|NCT01869192|Stage III|stage iii
5367390|NCT01869179|Well being|well being
5367391|NCT01869179|Low income|low income
5367392|NCT01869179|Choir singing|choir singing
5367393|NCT01869179|Spanish speaking|spanish speaking
5367394|NCT01869179|Community based|community based
5367395|NCT01869179|Seniors|seniors
5367396|NCT01869179|60+ aged adults|60+ aged adults
5367397|NCT01869179|health disparities|health disparities
5367398|NCT01869166|chemotherapy and/or EGFR-antibody/kinase inhibitor therapy refractory solid tumors|chemotherapy and/or egfr-antibody/kinase inhibitor therapy refractory solid tumors
5367399|NCT01869153|Growth, weight|growth, weight
5367400|NCT01869127|hookworm|hookworm
5367401|NCT01869127|necator americanus|necator americanus
5367402|NCT01869127|ancyclostoma duodenale|ancyclostoma duodenale
5964449|NCT04140422|Descemet membrane endothelial keratoplasty (DMEK)|descemet membrane endothelial keratoplasty (dmek)
5964450|NCT04140422|Hyperosmolar eye drops|hyperosmolar eye drops
5964451|NCT04140305|Multiple Sclerosis|multiple sclerosis
5964452|NCT04140305|RPC-1063|rpc-1063
5964453|NCT04140305|Ozanimod|ozanimod
5367403|NCT01869127|shoes|shoes
5964454|NCT04139434|BCL-2 inhibitor|bcl-2 inhibitor
5367404|NCT01869127|anaemia|anaemia
5367405|NCT01869127|children|children
5367406|NCT01869101|Prediabetes|prediabetes
5367407|NCT01869101|Diabetes prevention|diabetes prevention
5964455|NCT04139434|AML|aml
5964456|NCT04139434|MDS|mds
5367408|NCT01869088|TACE|tace
5367409|NCT01869088|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5367410|NCT01869088|Liver Neoplasms|liver neoplasms
5367411|NCT01869088|overall survival|overall survival
5367412|NCT01869088|Recombinant Human Adenovirus Type 5 Injection|recombinant human adenovirus type 5 injection
5367413|NCT01869075|Quality Improvement|quality improvement
5367414|NCT01869075|Patient Safety|patient safety
5367415|NCT01869075|Knowledge Translation|knowledge translation
5367417|NCT01869049|Immune Thrombocytopenia|immune thrombocytopenia
5367418|NCT01869049|macrophage|macrophage
5367419|NCT01869049|spleen tissue|spleen tissue
5367420|NCT01869036|Caudal|caudal
5367421|NCT01869036|anesthesia|anesthesia
5367422|NCT01869036|morphine|morphine
5367423|NCT01869036|children|children
5367424|NCT01869023|Advanced Malignant Pleural Mesothelioma|advanced malignant pleural mesothelioma
5367425|NCT01869023|Gemcitabine and cisplatin|gemcitabine and cisplatin
5367426|NCT01869023|Gemcitabine continuous infusion|gemcitabine continuous infusion
5367427|NCT01869010|HIV infection|hiv infection
5367428|NCT01869010|Antiretroviral treatment|antiretroviral treatment
5367429|NCT01869010|Renal disease|renal disease
5367430|NCT01869010|Renal tubular damage|renal tubular damage
5367431|NCT01869010|Free-water clearance|free-water clearance
5367432|NCT01868997|Thyroid Eye Disease, Graves Orbitopathy, Thyroid Associated|thyroid eye disease, graves orbitopathy, thyroid associated
5367433|NCT01868997|Ophthalmopathy|ophthalmopathy
5367434|NCT01868971|EndoRings|endorings
5367435|NCT01868958|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5367436|NCT01868958|Diffusion tensor imaging|diffusion tensor imaging
5367437|NCT01868958|Spine|spine
5367438|NCT01868945|Vitamin D3|vitamin d3
5367439|NCT01868945|Calcifediol 25|calcifediol 25
5367440|NCT01868945|Frail|frail
5367441|NCT01868945|Dose-response|dose-response
5367442|NCT01868932|wheeze|wheeze
5367443|NCT01868932|early childhood|early childhood
5367444|NCT01868932|asthma|asthma
5367445|NCT01868932|bronchiolitis|bronchiolitis
5367446|NCT01868932|infection triggered|infection triggered
5367447|NCT01868919|"Pilot Projects[Mesh]"|"pilot projects[mesh]"
5367448|NCT01868919|"Parenting[Mesh]"|"parenting[mesh]"
5367449|NCT01868919|"Child Behaviour[Mesh]"|"child behaviour[mesh]"
5367450|NCT01868919|"Mental Health[Mesh]"|"mental health[mesh]"
5367451|NCT01868919|"Family Practice[Mesh]"|"family practice[mesh]"
5367452|NCT01868906|Anaplastic Astrocytoma|anaplastic astrocytoma
5367453|NCT01868906|Brain Tumors|brain tumors
5367454|NCT01868906|Cancer Imaging|cancer imaging
5367455|NCT01868906|Fluoromisonidazole|fluoromisonidazole
5367456|NCT01868906|FMISO PET|fmiso pet
5367458|NCT01868906|High Grade Glioma|high grade glioma
5367459|NCT01868906|Hypoxia Modification|hypoxia modification
5367460|NCT01868906|Positron Emission Tomography|positron emission tomography
5367461|NCT01868906|Radiation-Sensitizing Agents|radiation-sensitizing agents
5367754|NCT01867450|Biomarkers|biomarkers
5367462|NCT01868906|Spinal Cord Stimulation|spinal cord stimulation
5367463|NCT01868906|Tumor Hypoxia Measurement|tumor hypoxia measurement
5367464|NCT01868854|Tip catheter|tip catheter
5367465|NCT01868854|Peritoneal Dialysis|peritoneal dialysis
5367466|NCT01868854|Risk Factot|risk factot
5367467|NCT01868854|Mecanical Function|mecanical function
5367468|NCT01868841|123I-mIBG|123i-mibg
5367469|NCT01868841|AdreView|adreview
5367471|NCT01868841|Heart to Mediastinal Ratio|heart to mediastinal ratio
5367472|NCT01868828|Multiple Myeloma|multiple myeloma
5367474|NCT01868802|Ketamine|ketamine
5367475|NCT01868802|Depression|depression
5367476|NCT01868802|Depressive Disorder|depressive disorder
5367477|NCT01868789|Adult-acquired flatfoot disorder (AAFD)|adult-acquired flatfoot disorder (aafd)
5367478|NCT01868789|flexible flatfoot|flexible flatfoot
5367479|NCT01868789|computed tomography (CT)|computed tomography (ct)
5367480|NCT01868763|telemedicine|telemedicine
5367481|NCT01868763|coaching|coaching
5367482|NCT01868763|lifestyle change|lifestyle change
5367483|NCT01868763|weight loss|weight loss
5367484|NCT01868737|Human Immunodeficiency Virus|human immunodeficiency virus
5367485|NCT01868737|Necrotizing Enterocolitis|necrotizing enterocolitis
5367486|NCT01868737|Premature infant|premature infant
5367487|NCT01868737|Probiotic|probiotic
5367488|NCT01868737|Very Low Birth Weight|very low birth weight
5367489|NCT01868724|Kidney Renal|kidney renal
5367490|NCT01868711|Major Depressive Disorder|major depressive disorder
5367491|NCT01868711|Cognitive Behavior Therapy|cognitive behavior therapy
5367492|NCT01868711|Psychological Mindedness|psychological mindedness
5367493|NCT01868698|Physical Therapy Modalities|physical therapy modalities
5367494|NCT01868698|Electric Stimulation Therapy|electric stimulation therapy
5367495|NCT01868698|Hyperthermia, Induced|hyperthermia, induced
5964457|NCT04139434|CMML|cmml
5964458|NCT04139434|relapse|relapse
5964459|NCT04139434|refractory|refractory
5964460|NCT04139434|LP-108|lp-108
5964461|NCT04139317|capmatinib, pembrolizumab, NSCLC, PD-L1, EGFR, ALK, MET, squamous, non-squamous|capmatinib, pembrolizumab, nsclc, pd-l1, egfr, alk, met, squamous, non-squamous
5964462|NCT04138628|Muscle Invasive Bladder Cancer (MIBC)|muscle invasive bladder cancer (mibc)
5964463|NCT04138628|biomarkers|biomarkers
5964464|NCT04138628|ctDNA|ctdna
5964465|NCT04138628|immunotherapy|immunotherapy
5964466|NCT04138628|circulating tumor DNA|circulating tumor dna
5964467|NCT04138628|liquid biopsies|liquid biopsies
5367496|NCT01868698|Diabetes Mellitus|diabetes mellitus
5367497|NCT01868685|Muscle, anabolism, cachexia, respiratory failure, diaphragm|muscle, anabolism, cachexia, respiratory failure, diaphragm
5367498|NCT01868672|Secondhand smoke exposure|secondhand smoke exposure
5367499|NCT01868672|Smoke-free homes|smoke-free homes
5367500|NCT01868672|Smoke-free home bans|smoke-free home bans
5367501|NCT01868646|Combined Treatment of Patients With Type II Diabetes Mellitus|combined treatment of patients with type ii diabetes mellitus
5367502|NCT01868633|Cesarean delivery|cesarean delivery
5367503|NCT01868633|Analgesia|analgesia
5367504|NCT01868633|Pain|pain
5367505|NCT01868633|Dexamethasone|dexamethasone
5367506|NCT01868633|intrathecal morphine|intrathecal morphine
5367507|NCT01868633|spinal anesthesia|spinal anesthesia
5367508|NCT01868620|Progressive keratoconus|progressive keratoconus
5367509|NCT01868620|standard CXL|standard cxl
5367510|NCT01868620|iontophoretic CXL|iontophoretic cxl
5367511|NCT01868620|keratometry|keratometry
5367512|NCT01868607|Respiratory resistance|respiratory resistance
5367513|NCT01868607|Respiratory reactance|respiratory reactance
5367514|NCT01868607|Adult lung function|adult lung function
5367515|NCT01868607|Forced oscillation technique|forced oscillation technique
5367516|NCT01868607|subjects|subjects
5680244|NCT00578539|Stem Cell Transplantation|stem cell transplantation
5367517|NCT01868594|Combined treatment of patients with type I diabetes mellitus|combined treatment of patients with type i diabetes mellitus
5367519|NCT01868490|Cytokine induced killer cells|cytokine induced killer cells
5367520|NCT01868490|CIK|cik
5367521|NCT01868490|Treg|treg
5367525|NCT01868477|myelodysplasia|myelodysplasia
5367526|NCT01868477|blood disorder|blood disorder
5367527|NCT01868477|cytopenias|cytopenias
5367528|NCT01868477|low blood counts|low blood counts
5367529|NCT01868477|progressive bone marrow failure|progressive bone marrow failure
5367530|NCT01868477|adult|adult
5367531|NCT01868477|ICL570|icl570
5367532|NCT01868477|deferasirox|deferasirox
5367533|NCT01868477|erythropoietin|erythropoietin
5367534|NCT01868477|erythropoiesis|erythropoiesis
5367535|NCT01868477|NF-kB pathway|nf-kb pathway
5367536|NCT01868477|hematopoiesis.|hematopoiesis.
5367537|NCT01868464|challenge|challenge
5367538|NCT01868464|Mycobacterium tuberculosis|mycobacterium tuberculosis
5367539|NCT01868464|parent protocol|parent protocol
5367540|NCT01868464|TB|tb
5367541|NCT01868464|Tice BCG|tice bcg
5367542|NCT01868464|tuberculosis|tuberculosis
5367543|NCT01868451|DACARBAZINE|dacarbazine
5367544|NCT01868451|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5367545|NCT01868451|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
5367546|NCT01868451|VINBLASTINE|vinblastine
5367547|NCT01868451|Involved-site radiation therapy (ISRT)|involved-site radiation therapy (isrt)
5367548|NCT01868451|Early stage|early stage
5367549|NCT01868451|13-034|13-034
5367550|NCT01868438|Pyronaridine artesunate tablet|pyronaridine artesunate tablet
5367551|NCT01868438|Pyronaridine artesunate granules|pyronaridine artesunate granules
5367552|NCT01868438|Pyramax tablet|pyramax tablet
5367553|NCT01868438|Pyramax granules|pyramax granules
5367554|NCT01868438|Bioavailability|bioavailability
5367555|NCT01868412|Wound healing|wound healing
5367556|NCT01868412|Wound infection|wound infection
5367557|NCT01868412|Resin salve|resin salve
5367558|NCT01868412|Medical honey|medical honey
5367566|NCT01868360|graft|graft
5367567|NCT01868360|neovascularization|neovascularization
5367568|NCT01868347|obese patients|obese patients
5367569|NCT01868347|specific elastance|specific elastance
5367570|NCT01868347|Trendelenburg Position|trendelenburg position
5367571|NCT01868347|Pneumoperitoneum|pneumoperitoneum
5367572|NCT01868347|robotic surgery|robotic surgery
5367573|NCT01868347|Prostatectomy|prostatectomy
5367574|NCT01868334|influenza vaccine|influenza vaccine
5367576|NCT01868334|Tdap|tdap
5367577|NCT01868334|vaccination|vaccination
5367578|NCT01868334|adult|adult
5367579|NCT01868321|Mechanical ventilation|mechanical ventilation
5367580|NCT01868321|Acute respiratory failure|acute respiratory failure
5367581|NCT01868321|Acute respiratory distress syndrome|acute respiratory distress syndrome
5367582|NCT01868282|anterior cruciate ligament repair, Obturator nerve block, Hamstrings graft, Ropivacaine,|anterior cruciate ligament repair, obturator nerve block, hamstrings graft, ropivacaine,
5367583|NCT01868282|Postoperative pain|postoperative pain
5367584|NCT01868256|myocardial infarction|myocardial infarction
5367585|NCT01868256|primary percutaneous intervention|primary percutaneous intervention
5367586|NCT01868256|prognosis|prognosis
5367587|NCT01868256|early discharge|early discharge
5367588|NCT01868243|Atrial Fibrillation|atrial fibrillation
5367589|NCT01868243|Bioprosthesis|bioprosthesis
5367590|NCT01868243|Stroke|stroke
5367591|NCT01868243|Dabigatran|dabigatran
5367592|NCT01868243|Warfarin|warfarin
5367593|NCT01868204|Obesity|obesity
5367594|NCT01868204|Binge eating disorder|binge eating disorder
5367595|NCT01868204|Pharmacogenetic|pharmacogenetic
5367596|NCT01868204|Food craving|food craving
5367597|NCT01868204|Brain areas|brain areas
5964468|NCT04138550|Social determinants|social determinants
5964469|NCT04138550|Oral health|oral health
5964470|NCT04138550|Women|women
5964471|NCT04138550|Egypt|egypt
5964472|NCT04138277|Pompe|pompe
5964473|NCT04138277|rhGAA|rhgaa
5367598|NCT01868204|Topiramate|topiramate
5367599|NCT01868191|Diabetes|diabetes
5367600|NCT01868191|Neuropathy|neuropathy
5367601|NCT01868178|awareness|awareness
5263269|NCT02370095|ARDS|ards
5367602|NCT01868165|Cognitive decline|cognitive decline
5367603|NCT01868165|High blood pressure|high blood pressure
5367604|NCT01868165|Hypertension|hypertension
5367606|NCT01868165|Dementia|dementia
5367607|NCT01868165|Antihypertensives|antihypertensives
5367608|NCT01868152|sufentanil|sufentanil
5367609|NCT01868152|individual variation|individual variation
5367610|NCT01868152|pain threshold|pain threshold
5367611|NCT01868152|narcotrend index|narcotrend index
5367620|NCT01868126|Santen|santen
5367621|NCT01868126|Eye|eye
5367622|NCT01868126|Glaucoma|glaucoma
5367623|NCT01868126|Ocular hypertension|ocular hypertension
5367624|NCT01868113|Children U-5|children u-5
5367625|NCT01868113|ALRI|alri
5367626|NCT01868113|Inhaled Corticosteroids|inhaled corticosteroids
5367627|NCT01868100|Cancer|cancer
5367628|NCT01868100|quality of life|quality of life
5367629|NCT01868100|palliative care|palliative care
5367630|NCT01868100|supportive care|supportive care
5367631|NCT01868100|Financial distress|financial distress
5367632|NCT01868087|nutritional supplement|nutritional supplement
5367633|NCT01868087|immune system|immune system
5367634|NCT01868087|RC surgery|rc surgery
5367635|NCT01868074|pregnancy, arch height, collapsed arch|pregnancy, arch height, collapsed arch
5367636|NCT01868048|Spasticity|spasticity
5367647|NCT01868022|squamous non-small cell lung cancer|squamous non-small cell lung cancer
5367648|NCT01868022|paclitaxel|paclitaxel
5367649|NCT01868009|fluticasone furoate|fluticasone furoate
5367650|NCT01868009|COPD|copd
5367651|NCT01868009|ELLIPTA|ellipta
5367652|NCT01868009|fluticasone propionate|fluticasone propionate
5367653|NCT01868009|DISKUS|diskus
5367654|NCT01868009|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
5367655|NCT01868009|device preference|device preference
5367656|NCT01868009|salmeterol|salmeterol
5367657|NCT01868009|vilanterol|vilanterol
5367658|NCT01867996|Retosiban, Efavirenz, Induction|retosiban, efavirenz, induction
5367659|NCT01867983|Tobacco cessation|tobacco cessation
5368052|NCT01865955|Ultrasound|ultrasound
5367660|NCT01867983|Weight gain prevention|weight gain prevention
5367661|NCT01867970|remote sensing technology|remote sensing technology
5367662|NCT01867970|physical activity|physical activity
5367663|NCT01867970|self-management support|self-management support
5367664|NCT01867970|primary care nursing|primary care nursing
5367665|NCT01867957|anthrax|anthrax
5367666|NCT01867957|vaccine|vaccine
5367667|NCT01867957|bioterrorism|bioterrorism
5367668|NCT01867957|efficacy|efficacy
5367669|NCT01867957|safety|safety
5367670|NCT01867944|Chronic constipation|chronic constipation
5367671|NCT01867944|Hemorrhoids|hemorrhoids
5367672|NCT01867944|Acupressure|acupressure
5367673|NCT01867905|Severe sepsis|severe sepsis
5367674|NCT01867905|Septic shock|septic shock
5367675|NCT01867905|Bacteremia|bacteremia
5367676|NCT01867905|Antibiotics|antibiotics
5367677|NCT01867905|Blood culture positivity|blood culture positivity
5367678|NCT01867892|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5367679|NCT01867879|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
5367680|NCT01867866|Advanced solid tumors (excluding breast cancer) for which no standard therapy exists|advanced solid tumors (excluding breast cancer) for which no standard therapy exists
5367681|NCT01867801|PCI|pci
5367682|NCT01867801|Coronary disease|coronary disease
5367684|NCT01867775|Alzheimer's disease|alzheimer's disease
5367686|NCT01867775|Mirtazapine|mirtazapine
5367687|NCT01867775|Treatment|treatment
5367688|NCT01867775|Intervention|intervention
5367689|NCT01867775|insomnia|insomnia
5367690|NCT01867762|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5367691|NCT01867762|JNJ 49095397|jnj 49095397
5367692|NCT01867762|RV568|rv568
5367693|NCT01867762|Forced expiratory volume in one second|forced expiratory volume in one second
5367694|NCT01867762|FEV1|fev1
5367695|NCT01867749|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5367696|NCT01867749|Miscarriage|miscarriage
5367697|NCT01867749|Stillbirth|stillbirth
5367698|NCT01867749|Neonatal death|neonatal death
5367699|NCT01867749|Interpersonal psychotherapy|interpersonal psychotherapy
5367700|NCT01867749|Group Therapy|group therapy
5367701|NCT01867749|Coping with Depression (CWD)|coping with depression (cwd)
5367702|NCT01867736|Stenosis|stenosis
5367703|NCT01867736|Occlusions|occlusions
5367704|NCT01867736|Infrapopliteal arteries|infrapopliteal arteries
5367705|NCT01867736|Below the knee arteries|below the knee arteries
5367706|NCT01867736|PTA|pta
5367707|NCT01867736|POBA|poba
5367708|NCT01867736|DRB|drb
5367709|NCT01867723|Cancer internet support program|cancer internet support program
5367710|NCT01867710|Mineralocorticoid Excess ; Chemotherapy-Naïve; Metastatic Castration-Resistant Prostate Cancer; Abiraterone Acetate; Zytiga; Prednisone; dexamethasone|mineralocorticoid excess ; chemotherapy-naïve; metastatic castration-resistant prostate cancer; abiraterone acetate; zytiga; prednisone; dexamethasone
5367711|NCT01867684|Stroke|stroke
5367712|NCT01867684|Acquired brain injury|acquired brain injury
5367713|NCT01867671|Allergy, Peanut|allergy, peanut
5367714|NCT01867671|Peanut allergy|peanut allergy
5367715|NCT01867671|Hypersensitivity|hypersensitivity
5367716|NCT01867671|Immunotherapy|immunotherapy
5367717|NCT01867671|Desensitization, Immunologic|desensitization, immunologic
5367718|NCT01867658|Pleural Air Leak|pleural air leak
5367719|NCT01867658|Pulmonary resection|pulmonary resection
5367720|NCT01867658|Video Assisted|video assisted
5367721|NCT01867658|Robotic Assisted|robotic assisted
5367723|NCT01867645|Critical illness polyneuropathy and/or myopathy|critical illness polyneuropathy and/or myopathy
5367724|NCT01867645|Intravenous immunoglobulins|intravenous immunoglobulins
5367725|NCT01867645|Multiple organ failure|multiple organ failure
5367726|NCT01867645|SIRS|sirs
5367727|NCT01867645|Sepsis|sepsis
5367728|NCT01867632|Palatoplasty|palatoplasty
5367729|NCT01867632|Acellular Dermal Matrix|acellular dermal matrix
5367730|NCT01867593|Newly diagnosed|newly diagnosed
5367731|NCT01867567|cesarean|cesarean
5367732|NCT01867567|bandage removal|bandage removal
5367733|NCT01867567|infection|infection
5367734|NCT01867567|disruption|disruption
5367735|NCT01867567|satisfaction|satisfaction
5367736|NCT01867567|patient satisfaction|patient satisfaction
5367737|NCT01867554|Intellectual disability|intellectual disability
5367738|NCT01867554|Autism spectrum disorders|autism spectrum disorders
5367739|NCT01867554|gene|gene
5367740|NCT01867554|Next generation sequencing|next generation sequencing
5367741|NCT01867541|cataract surgery|cataract surgery
5367742|NCT01867541|intraocular lens power calculation|intraocular lens power calculation
5367743|NCT01867541|effective lens position|effective lens position
5367744|NCT01867541|improving the refractive outcome after cataract surgery|improving the refractive outcome after cataract surgery
5367745|NCT01867541|predicting the IOL position|predicting the iol position
5367746|NCT01867515|Hearing|hearing
5367747|NCT01867515|Hearing Loss, sensorineural|hearing loss, sensorineural
5367748|NCT01867515|Speech Perception|speech perception
5367749|NCT01867463|Antigen|antigen
5367750|NCT01867463|Ookinetes|ookinetes
5367751|NCT01867463|Mosquito|mosquito
5367752|NCT01867463|Membrane|membrane
5367765|NCT01867424|Prostatectomy|prostatectomy
5367766|NCT01867424|Gadolinium-Based Contrast Agent|gadolinium-based contrast agent
5367770|NCT01867398|Conduct Disorder|conduct disorder
5367771|NCT01867398|Antipsychotic|antipsychotic
5367772|NCT01867398|Treatment Study|treatment study
5367773|NCT01867398|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5367774|NCT01867398|Adolescents|adolescents
5367775|NCT01867385|Fatigue|fatigue
5367776|NCT01867385|Chronic Hepatitis|chronic hepatitis
5367777|NCT01867385|Chronic Hepatitis B|chronic hepatitis b
5367778|NCT01867385|Chronic Hepatitis C|chronic hepatitis c
5367779|NCT01867385|Hepatitis|hepatitis
5367780|NCT01867372|Alzheimer's Disease|alzheimer's disease
5367781|NCT01867359|Alzheimer Disease|alzheimer disease
5367782|NCT01867359|Molecular|molecular
5367783|NCT01867359|Molecular Genetics|molecular genetics
5367785|NCT01867346|Cognition|cognition
5367786|NCT01867346|Aging|aging
5367787|NCT01867346|Cognitive Decline|cognitive decline
5367788|NCT01867346|Dementia|dementia
5367789|NCT01867346|Alzheimer's Disease|alzheimer's disease
5367800|NCT01867281|aspirin|aspirin
5367801|NCT01867281|asthma|asthma
5367802|NCT01867281|Aspirin desensitization|aspirin desensitization
5367803|NCT01867281|Aspirin induced asthma|aspirin induced asthma
5367804|NCT01867281|Immune System Diseases|immune system diseases
5367805|NCT01867281|Respiratory Hypersensitivity|respiratory hypersensitivity
5367806|NCT01867268|Acetazolamide administration|acetazolamide administration
5367807|NCT01867268|prone positioning|prone positioning
5367808|NCT01867268|Cerebrospinal fluid leakage|cerebrospinal fluid leakage
5367809|NCT01867268|Cerebrospinal fluid collection|cerebrospinal fluid collection
5367810|NCT01867268|wound dehiscence|wound dehiscence
5367812|NCT01867255|Effexor|effexor
5367813|NCT01867255|antidepressive agent|antidepressive agent
5367814|NCT01867242|cigarette|cigarette
5367815|NCT01867242|snus|snus
5367816|NCT01867242|smoking|smoking
5367817|NCT01867242|tobacco|tobacco
5367818|NCT01867229|pre-menauposal|pre-menauposal
5367819|NCT01867229|neo-adjuvant or adjuvant chemotherapy|neo-adjuvant or adjuvant chemotherapy
5367820|NCT01867229|no metastases|no metastases
5367821|NCT01867190|CLI|cli
5367822|NCT01867177|HIV|hiv
5367823|NCT01867177|health care utilization|health care utilization
5367824|NCT01867177|HIV testing|hiv testing
5367825|NCT01867177|access to care|access to care
5367826|NCT01867164|Vaginitis|vaginitis
5367827|NCT01867164|Infectious vaginosis|infectious vaginosis
5367828|NCT01867164|Terconazole|terconazole
5367829|NCT01867164|Clindamycin|clindamycin
5367830|NCT01867164|Fluocinolone|fluocinolone
5367831|NCT01867164|Metronidazole|metronidazole
5367832|NCT01867164|Nystatin|nystatin
5367833|NCT01867151|Burning Mouth Syndrome|burning mouth syndrome
5367834|NCT01867151|Gluten|gluten
5367835|NCT01867151|Gluten Free Diet|gluten free diet
5367836|NCT01867138|Coagulase negative staphylococcus|coagulase negative staphylococcus
5367837|NCT01867138|nosocomial neonatal sepsis|nosocomial neonatal sepsis
5367838|NCT01867138|cefazolin|cefazolin
5263518|NCT02368496|DXA|dxa
5367839|NCT01867138|vancomycin|vancomycin
5367840|NCT01867138|newborn|newborn
5367841|NCT01867086|ovarian cancer|ovarian cancer
5367842|NCT01867060|Cardiac monitoring|cardiac monitoring
5367843|NCT01867060|Biomarkers|biomarkers
5367844|NCT01867060|Transthoracic echocardiography|transthoracic echocardiography
5367845|NCT01867034|non ST segment myocardial infarction|non st segment myocardial infarction
5367846|NCT01867021|Trivalent inactivated subunit influenza vaccines|trivalent inactivated subunit influenza vaccines
5367847|NCT01867021|50 years and above|50 years and above
5367848|NCT01867021|healthy subjects|healthy subjects
5367849|NCT01866995|Ginseng|ginseng
5367850|NCT01866995|Prostatostasis|prostatostasis
5367851|NCT01866995|Erectile Dysfunction|erectile dysfunction
5367852|NCT01866982|umbilical cord milking|umbilical cord milking
5367853|NCT01866982|delayed cord clamping|delayed cord clamping
5367854|NCT01866943|Blood Loss|blood loss
5368248|NCT01864967|macrophags|macrophags
5367858|NCT01866943|Post Operative|post operative
5367859|NCT01866943|Prevent Post Operative Blood Loss|prevent post operative blood loss
5367860|NCT01866917|Transversis Abdominis Plane Block|transversis abdominis plane block
5367861|NCT01866917|obese|obese
5367862|NCT01866917|robotic surgery|robotic surgery
5367863|NCT01866917|laparoscopic surgery|laparoscopic surgery
5367864|NCT01866904|Coronary artery disease, Myocardial infarction|coronary artery disease, myocardial infarction
5367865|NCT01866891|hemodialysis|hemodialysis
5367866|NCT01866891|microcirculation|microcirculation
5367867|NCT01866891|physical perdialytic activity|physical perdialytic activity
5367868|NCT01866891|cycling|cycling
5367869|NCT01866878|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,Reeducation through labor tactile discrimination|transcutaneous electrical nerve stimulation, sensitivity, multiple sclerosis,reeducation through labor tactile discrimination
5367870|NCT01866865|BRCA1|brca1
5367871|NCT01866865|BRCA2|brca2
5367872|NCT01866852|Longitudinal Study|longitudinal study
5367873|NCT01866839|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5367874|NCT01866839|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5367875|NCT01866839|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5367876|NCT01866839|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5671941|NCT00613535|articular cartilage|articular cartilage
5367877|NCT01866839|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5367881|NCT01866813|breast cancer|breast cancer
5367882|NCT01866813|cancer survivors|cancer survivors
5367883|NCT01866800|TAVI|tavi
5367884|NCT01866800|TAVR|tavr
5367885|NCT01866800|CIN|cin
5367886|NCT01866800|AKI|aki
5367887|NCT01866787|Postoperative orthostatic intolerance|postoperative orthostatic intolerance
5367888|NCT01866787|Surgical inflammatory response|surgical inflammatory response
5367889|NCT01866722|nicotine dependence|nicotine dependence
5367890|NCT01866722|smoking cessation|smoking cessation
5367891|NCT01866722|lapse|lapse
5367892|NCT01866722|relapse|relapse
5367893|NCT01866722|tobacco|tobacco
5367894|NCT01866722|quit attempts|quit attempts
5367895|NCT01866722|abstinence|abstinence
5367896|NCT01866722|motivation|motivation
5367897|NCT01866722|reduction|reduction
5367898|NCT01866696|Computer assisted implant surgery,|computer assisted implant surgery,
5367899|NCT01866696|Immediate loading,|immediate loading,
5367900|NCT01866696|CAD/CAM|cad/cam
5367901|NCT01866683|Yoga|yoga
5367902|NCT01866683|Electroencephalography|electroencephalography
5367903|NCT01866683|Heart rate variability|heart rate variability
5367904|NCT01866683|Breathing Exercises|breathing exercises
5367905|NCT01866683|Quality of life|quality of life
5367906|NCT01866670|spiritual distress|spiritual distress
5367907|NCT01866670|nursing|nursing
5367908|NCT01866670|breast neoplasms|breast neoplasms
5367909|NCT01866657|cerebral oximetry|cerebral oximetry
5367910|NCT01866657|randomized controlled pilot study|randomized controlled pilot study
5367911|NCT01866657|thoracic surgery|thoracic surgery
5367912|NCT01866657|single lung ventilation|single lung ventilation
5367913|NCT01866644|Liver transplantation, n-acetylcysteine|liver transplantation, n-acetylcysteine
5367914|NCT01866618|Natural|natural
5367915|NCT01866618|IVF Cycle|ivf cycle
5367916|NCT01866605|anxiety|anxiety
5367917|NCT01866605|midazolam|midazolam
5367918|NCT01866605|forced-air warming|forced-air warming
5367919|NCT01866592|Psoriasis|psoriasis
5367920|NCT01866592|Cardiovascular Disease|cardiovascular disease
5367921|NCT01866592|Vascular Inflammation|vascular inflammation
5367922|NCT01866592|Lipid Biomarkers|lipid biomarkers
5367923|NCT01866592|Metabolic biomarkers|metabolic biomarkers
5367924|NCT01866592|FDG-PET/CT|fdg-pet/ct
5367925|NCT01866579|Retinal Nerve Fiber Layer Thickness, Optical Coherence Tomography, Ethambutol optic neuropathy|retinal nerve fiber layer thickness, optical coherence tomography, ethambutol optic neuropathy
5367926|NCT01866553|CML|cml
5367927|NCT01866553|suboptimal molecular response|suboptimal molecular response
5367928|NCT01866553|nilotinib|nilotinib
5367929|NCT01866553|pegylated interferon α2b|pegylated interferon α2b
5367930|NCT01866540|influenza, LAIV, immune response|influenza, laiv, immune response
5964474|NCT04138043|GSK2330811|gsk2330811
5246407|NCT02466997|Vitiligo|vitiligo
5367931|NCT01866527|Developmental dysplasia of the hip,|developmental dysplasia of the hip,
5367932|NCT01866527|DDH,|ddh,
5367933|NCT01866527|avascular necrosis,|avascular necrosis,
5367934|NCT01866527|late detected cases|late detected cases
5367935|NCT01866514|EZ-IO|ez-io
5367936|NCT01866514|IO|io
5367937|NCT01866514|Intraosseous Vascular Access|intraosseous vascular access
5367938|NCT01866501|Intraosseous Vascular Access|intraosseous vascular access
5367939|NCT01866501|IO Access|io access
5367940|NCT01866501|IO Vascular Access|io vascular access
5367941|NCT01866501|EZ-IO|ez-io
5367942|NCT01866488|Labor induction|labor induction
5367943|NCT01866488|Misoprostol|misoprostol
5367944|NCT01866488|Cytotec|cytotec
5367945|NCT01866488|Cook Obstetric Double Balloon Catheter|cook obstetric double balloon catheter
5367946|NCT01866475|IO access|io access
5367947|NCT01866475|Intraosseous vascular access|intraosseous vascular access
5367948|NCT01866475|EZ-IO|ez-io
5367949|NCT01866436|Cognitive skills|cognitive skills
5367950|NCT01866436|Multimedia|multimedia
5367951|NCT01866436|Education|education
5367952|NCT01866436|Colorectal surgery|colorectal surgery
5367953|NCT01866397|cidofovir|cidofovir
5367954|NCT01866397|cvvh|cvvh
5367955|NCT01866397|renal replacement therapy|renal replacement therapy
5367957|NCT01866397|Pharmacokinetics of cidofovir during CVVH|pharmacokinetics of cidofovir during cvvh
5367958|NCT01866397|continuous venovenous hemofiltration|continuous venovenous hemofiltration
5367959|NCT01866371|Retina|retina
5367960|NCT01866371|imaging|imaging
5367961|NCT01866371|retinal degeneration|retinal degeneration
5367962|NCT01866345|orthodontics|orthodontics
5367963|NCT01866345|Tooth Movement|tooth movement
5367964|NCT01866345|Bone Remodeling|bone remodeling
5367965|NCT01866345|Mandible|mandible
5367966|NCT01866345|Osteotomy|osteotomy
5367967|NCT01866332|back pain|back pain
5367968|NCT01866332|tape|tape
5367969|NCT01866332|chronic|chronic
5367970|NCT01866319|PD-1|pd-1
5367971|NCT01866319|PD1|pd1
5367972|NCT01866319|PD-L1|pd-l1
5367973|NCT01866319|PDL1|pdl1
5367974|NCT01866293|Cabozantinib (XL184)|cabozantinib (xl184)
5367975|NCT01866293|12-240|12-240
5367976|NCT01866280|Sleep|sleep
5367977|NCT01866280|Sleep duration|sleep duration
5367978|NCT01866280|Meals|meals
5367979|NCT01866280|Food intake|food intake
5367980|NCT01866280|Obesity|obesity
5671942|NCT00613535|knee|knee
5367981|NCT01866267|Human Immunodeficiency Virus|human immunodeficiency virus
5367982|NCT01866267|AIDS|aids
5367983|NCT01866254|Hydromorphone|hydromorphone
5367984|NCT01866254|Morphine|morphine
5367985|NCT01866254|cesarean delivery|cesarean delivery
5367986|NCT01866254|pain management|pain management
5367987|NCT01866254|respiratory depression|respiratory depression
5367988|NCT01866228|Consultation Recording|consultation recording
5367989|NCT01866228|Brain Tumor|brain tumor
5367990|NCT01866228|Neuroendocrine Cancer|neuroendocrine cancer
5367991|NCT01866228|Quality of Life|quality of life
5367992|NCT01866228|Patient Satisfaction|patient satisfaction
5367993|NCT01866215|gluconeogenesis|gluconeogenesis
5367994|NCT01866215|de novo lipogenesis|de novo lipogenesis
5367995|NCT01866215|intramyocellular lipids|intramyocellular lipids
5367996|NCT01866215|muscle glycogen|muscle glycogen
5367997|NCT01866215|fructose|fructose
5367998|NCT01866189|ischemic stroke|ischemic stroke
5367999|NCT01866189|hypoxic tissues|hypoxic tissues
5368000|NCT01866189|F-MISO uptake|f-miso uptake
5368001|NCT01866189|Magnetic Resonance Imaging|magnetic resonance imaging
5368002|NCT01866189|F-MISO Positon Emission Tomography|f-miso positon emission tomography
5368003|NCT01866137|Copeptin|copeptin
5368004|NCT01866137|psychological stress|psychological stress
5368005|NCT01866137|The Trier Social Stress Test (TSST)|the trier social stress test (tsst)
5368006|NCT01866124|acute malnutrition|acute malnutrition
5368007|NCT01866124|multiannual and seasonal cash transfers|multiannual and seasonal cash transfers
5368008|NCT01866124|safety nets|safety nets
5368009|NCT01866124|Burkina Faso|burkina faso
5368010|NCT01866098|antipsychotic|antipsychotic
5368011|NCT01866098|severe mental illness|severe mental illness
5368012|NCT01866098|weight loss|weight loss
5368013|NCT01866085|stress urinary incontinence|stress urinary incontinence
5368014|NCT01866085|post prostatectomy|post prostatectomy
5368015|NCT01866072|ACLF|aclf
5368016|NCT01866072|AVH|avh
5368017|NCT01866072|Fibroscan|fibroscan
5368018|NCT01866072|Transient elastography|transient elastography
5368019|NCT01866059|root caries|root caries
5368020|NCT01866059|GIC|gic
5368021|NCT01866059|RMGIC|rmgic
5368022|NCT01866059|Biodentine|biodentine
5368023|NCT01866059|Calcium silicate|calcium silicate
5368024|NCT01866046|battered women|battered women
5368025|NCT01866046|HIV risk|hiv risk
5368026|NCT01866046|STI risk|sti risk
5368027|NCT01866033|Healthy volunteer|healthy volunteer
5368028|NCT01866033|PCI-32765|pci-32765
5368029|NCT01866033|PCI 45227|pci 45227
5964475|NCT04138043|Healthy participants|healthy participants
5368030|NCT01866033|13C6 PCI-32765|13c6 pci-32765
5368031|NCT01866033|Pharmacokinetic|pharmacokinetic
5368032|NCT01866033|Bioavailability|bioavailability
5368033|NCT01866020|aspergillosis|aspergillosis
5368034|NCT01866020|fungal infection|fungal infection
5368035|NCT01866020|ICU|icu
5368036|NCT01866007|Healthy|healthy
5368037|NCT01866007|Guselkumab|guselkumab
5368038|NCT01866007|CNTO1959|cnto1959
5368039|NCT01866007|Pharmacokinetics|pharmacokinetics
5368040|NCT01866007|UltraSafe Passive Delivery System (PFS-U)|ultrasafe passive delivery system (pfs-u)
5368041|NCT01866007|Prefilled syringe facilitated injection device (PFS FID)|prefilled syringe facilitated injection device (pfs fid)
5368042|NCT01865994|Cardiac Output|cardiac output
5368043|NCT01865994|esCCO|escco
5368044|NCT01865994|TEE|tee
5368045|NCT01865994|Pediatric cardiac surgery|pediatric cardiac surgery
5368046|NCT01865981|iPS cells|ips cells
5368047|NCT01865981|cardiomyocytes|cardiomyocytes
5368048|NCT01865981|Brugada|brugada
5368049|NCT01865981|Ventricular Fibrillation|ventricular fibrillation
5368050|NCT01865981|electrophysiology|electrophysiology
5368051|NCT01865968|inactivated HAV vaccine; live attenuated HAV vaccine; immunogenicity; safety|inactivated hav vaccine; live attenuated hav vaccine; immunogenicity; safety
5368053|NCT01865955|Spinal anesthesia|spinal anesthesia
5368054|NCT01865955|Cesarean section|cesarean section
5368055|NCT01865942|spinal metastases|spinal metastases
5368056|NCT01865942|spine surgery|spine surgery
5368057|NCT01865942|metastatic spinal cord compression|metastatic spinal cord compression
5368058|NCT01865942|EQ-5D|eq-5d
5368059|NCT01865942|HRQOL|hrqol
5368060|NCT01865903|NSCLC|nsclc
5368061|NCT01865903|sarcopenia|sarcopenia
5368062|NCT01865903|cachexia|cachexia
5368063|NCT01865890|Plavix or clopidogrel resistance|plavix or clopidogrel resistance
5368064|NCT01865877|Parkinson's disease|parkinson's disease
5368065|NCT01865877|Motor|motor
5368066|NCT01865877|Non-motor|non-motor
5368067|NCT01865877|Progression|progression
5368068|NCT01865877|Complications|complications
5368069|NCT01865864|CPAP|cpap
5368070|NCT01865864|diurnal blood pressure|diurnal blood pressure
5368071|NCT01865864|obstructive sleep apnea|obstructive sleep apnea
5368072|NCT01865864|24 hour blood pressure monitor|24 hour blood pressure monitor
5368073|NCT01865851|Inspired oxygen|inspired oxygen
5368074|NCT01865851|end-tidal oxygen|end-tidal oxygen
5368075|NCT01865851|end-tidal carbon dioxide|end-tidal carbon dioxide
5368076|NCT01865851|respiratory rate|respiratory rate
5368077|NCT01865851|preoxygenation|preoxygenation
5368078|NCT01865851|classic face mask|classic face mask
5368079|NCT01865851|NuMask|numask
5368080|NCT01865838|Total thyroidectomy|total thyroidectomy
5368081|NCT01865838|Seprafilm|seprafilm
5368082|NCT01865838|Swallowing difficulty post thyroidectomy|swallowing difficulty post thyroidectomy
5368083|NCT01865825|Erosive Esophagitis|erosive esophagitis
5368084|NCT01865825|Gastroesophageal reflux disease|gastroesophageal reflux disease
5368085|NCT01865799|FTC/TDF|ftc/tdf
5368086|NCT01865799|PrEP|prep
5368087|NCT01865799|Truvada|truvada
5368088|NCT01865799|Drug utilization|drug utilization
5368089|NCT01865786|FTC/TDF|ftc/tdf
5368090|NCT01865786|Truvada|truvada
5368091|NCT01865786|PrEP|prep
5368092|NCT01865786|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
5368093|NCT01865760|Glucagon like peptide 1|glucagon like peptide 1
5368094|NCT01865760|Insulin secretion|insulin secretion
5368095|NCT01865760|Hypoglycemia|hypoglycemia
5368096|NCT01865747|renal cell cancer|renal cell cancer
5368097|NCT01865747|kidney|kidney
5368098|NCT01865747|vascular endothelial growth factor receptor 2 (VEGFR2)|vascular endothelial growth factor receptor 2 (vegfr2)
5368099|NCT01865747|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5368100|NCT01865747|hepatocyte growth factor receptor protein (MET)|hepatocyte growth factor receptor protein (met)
5368101|NCT01865747|von Hippel-Lindau gene|von hippel-lindau gene
5368102|NCT01865734|Fasciitis, Plantar|fasciitis, plantar
5368103|NCT01865734|Heel Pain|heel pain
5368112|NCT01865721|Side effects|side effects
5368113|NCT01865721|Colonoscopy|colonoscopy
5368114|NCT01865708|Ethanol Lock|ethanol lock
5368115|NCT01865708|Alcohol lock|alcohol lock
5368116|NCT01865708|Urinary catheter|urinary catheter
5368117|NCT01865708|Safety|safety
5368118|NCT01865695|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5368119|NCT01865695|faecal elastase|faecal elastase
5368120|NCT01865695|diarrhoea|diarrhoea
5368121|NCT01865695|coeliac|coeliac
5368122|NCT01865695|creon|creon
5368123|NCT01865695|gastrointestinal|gastrointestinal
5368124|NCT01865682|Ankle|ankle
5368125|NCT01865682|Knee|knee
5368126|NCT01865682|Orthosis|orthosis
5368127|NCT01865682|Kinematics|kinematics
5368128|NCT01865682|Kinetics|kinetics
5368129|NCT01865669|Uterine contraction|uterine contraction
5368130|NCT01865669|Dose response|dose response
5368131|NCT01865669|Oxytocin|oxytocin
5368132|NCT01865656|provider skill and self-efficacy|provider skill and self-efficacy
5368133|NCT01865656|Appropriate and timely referral for obstetric emergencies|appropriate and timely referral for obstetric emergencies
5368134|NCT01865656|Intervention feasibility and acceptability|intervention feasibility and acceptability
5368135|NCT01865643|Laryngoscopy|laryngoscopy
5368136|NCT01865643|Intubation|intubation
5368137|NCT01865643|Glidescope|glidescope
5964476|NCT04138043|Japanese|japanese
5246615|NCT02465710|Surgical treatment|surgical treatment
5368138|NCT01865630|Prophylactic treatment with Etanercept in aSAH.|prophylactic treatment with etanercept in asah.
5368139|NCT01865630|Safety of Etanercept in the prevention of DCI in aSAH.|safety of etanercept in the prevention of dci in asah.
5368140|NCT01865591|hypertension|hypertension
5368141|NCT01865591|uncontrolled hypertension|uncontrolled hypertension
5368142|NCT01865591|resistant hypertension|resistant hypertension
5368143|NCT01865565|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5368147|NCT01865552|Pharmacokinetics|pharmacokinetics
5368148|NCT01865539|Chronic lower back pain|chronic lower back pain
5368149|NCT01865539|Custom foot orthotics|custom foot orthotics
5368150|NCT01865539|Veterans|veterans
5368151|NCT01865526|Chronic kidney disease|chronic kidney disease
5368152|NCT01865526|Low protein diet|low protein diet
5368153|NCT01865526|CKD stage 3b-5|ckd stage 3b-5
5368154|NCT01865513|Anaesthesia|anaesthesia
5368155|NCT01865513|Anaesthesiology|anaesthesiology
5368156|NCT01865513|muscle Relaxants|muscle relaxants
5368157|NCT01865513|POPULAR|popular
5368158|NCT01865513|postoperative pulmonary complications|postoperative pulmonary complications
5368159|NCT01865513|Respiratory failure|respiratory failure
5368160|NCT01865513|Suspected pulmonary infection|suspected pulmonary infection
5368161|NCT01865513|Pulmonary infiltrates|pulmonary infiltrates
5368162|NCT01865513|Pleural effusion|pleural effusion
5368163|NCT01865513|Atelectasis|atelectasis
5368164|NCT01865513|Pneumothorax|pneumothorax
5368165|NCT01865513|Bronchospasm|bronchospasm
5368166|NCT01865513|Aspiration pneumonitis|aspiration pneumonitis
5368167|NCT01865513|Cardiopulmonary oedema|cardiopulmonary oedema
5368168|NCT01865513|European Society of Anaesthesiology|european society of anaesthesiology
5368169|NCT01865513|neuromuscular blockade|neuromuscular blockade
5368170|NCT01865513|europe|europe
5368171|NCT01865500|COPD exacerbation|copd exacerbation
5368172|NCT01865500|Nebulized budesonide|nebulized budesonide
5368173|NCT01865500|Parenteral steroid|parenteral steroid
5368174|NCT01865487|BCG Vaccinated|bcg vaccinated
5368175|NCT01865487|HIV Negative|hiv negative
5368176|NCT01865474|DLBS1033, Type 2 DM, fibrinolytic, hypercoagulation|dlbs1033, type 2 dm, fibrinolytic, hypercoagulation
5368177|NCT01865461|Magnetic Resonance Imaging|magnetic resonance imaging
5368178|NCT01865448|Docosahexaenoic Acids|docosahexaenoic acids
5368179|NCT01865448|Fatty Acids, Omega-3|fatty acids, omega-3
5368180|NCT01865448|Obesity|obesity
5368181|NCT01865448|Inflammation|inflammation
5368182|NCT01865409|Newborn|newborn
5368183|NCT01865409|Prematures|prematures
5368184|NCT01865409|Feeding difficulty|feeding difficulty
5368185|NCT01865409|Kangaroo Care|kangaroo care
5368186|NCT01865409|Heart rate variability|heart rate variability
5368187|NCT01865266|ventilator-associated pneumonia|ventilator-associated pneumonia
5368188|NCT01865266|mechanical ventilation|mechanical ventilation
5368189|NCT01865266|ulinastatin for injection|ulinastatin for injection
5368190|NCT01865266|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
5368191|NCT01865266|inflammatory factors|inflammatory factors
5368192|NCT01865253|renal denervation|renal denervation
5368193|NCT01865253|blood pressure|blood pressure
5368194|NCT01865253|cardiovascular risk|cardiovascular risk
5368195|NCT01865253|target organ damage|target organ damage
5368196|NCT01865253|sympathetic activity|sympathetic activity
5368197|NCT01865253|chronic kidney disease|chronic kidney disease
5368198|NCT01865253|non-compliance|non-compliance
5368199|NCT01865240|renal denervation|renal denervation
5368200|NCT01865240|blood pressure|blood pressure
5368201|NCT01865240|cardiovascular risk|cardiovascular risk
5368202|NCT01865240|target organ damage|target organ damage
5368203|NCT01865240|sympathetic activity|sympathetic activity
5368204|NCT01865227|Obesity|obesity
5368205|NCT01865227|Bariatric surgery|bariatric surgery
5368206|NCT01865227|Binge Eating Disorder|binge eating disorder
5368207|NCT01865227|Psychological Health|psychological health
5368208|NCT01865227|Counselling|counselling
5368209|NCT01865201|Radiotherapy|radiotherapy
5368210|NCT01865201|Radiation-induced brain necrosis|radiation-induced brain necrosis
5368211|NCT01865201|Edaravone|edaravone
5368212|NCT01865201|Effectiveness|effectiveness
5368213|NCT01865201|Safety|safety
5368214|NCT01865188|LCZ696,|lcz696,
5368215|NCT01865188|amlodipine,|amlodipine,
5368216|NCT01865188|hypertension,|hypertension,
5368217|NCT01865188|ABPM|abpm
5368218|NCT01865162|Glioblastoma multiforme, ketogenic diet, neoplasm|glioblastoma multiforme, ketogenic diet, neoplasm
5368219|NCT01865149|Child|child
5368220|NCT01865149|Optic nerve sheath diameter|optic nerve sheath diameter
5368221|NCT01865149|Hydrocephalus|hydrocephalus
5368222|NCT01865149|Intracranial hypertension|intracranial hypertension
5368223|NCT01865123|post-traumatic stress disorder|post-traumatic stress disorder
5368224|NCT01865123|transcendental meditation|transcendental meditation
5368225|NCT01865123|cognitive behavioral therapy|cognitive behavioral therapy
5368226|NCT01865123|prolonged exposure|prolonged exposure
5368227|NCT01865110|Mantle Cell Lymphoma|mantle cell lymphoma
5368228|NCT01865110|RCHOP|rchop
5368229|NCT01865110|RHAD|rhad
5368230|NCT01865110|rituximab|rituximab
5964477|NCT04138043|Pharmacokinetics|pharmacokinetics
5964478|NCT04138043|Safety|safety
5234593|NCT02536417|End-of-life|end-of-life
5368231|NCT01865110|lenalidomide|lenalidomide
5368233|NCT01865097|Pain|pain
5368234|NCT01865097|Depression|depression
5368235|NCT01865097|Non-Motor|non-motor
5368236|NCT01865071|ileostomy|ileostomy
5368237|NCT01865071|rectal resection|rectal resection
5368238|NCT01865071|proctectomy|proctectomy
5368239|NCT01865071|stoma closure|stoma closure
5368241|NCT01864993|non celiac gluten sensitivity|non celiac gluten sensitivity
5368242|NCT01864993|gluten|gluten
5368243|NCT01864993|irritable bowel syndrome|irritable bowel syndrome
5368244|NCT01864993|functional disorders|functional disorders
5368245|NCT01864967|carbon dioxide infusion|carbon dioxide infusion
5368246|NCT01864967|dilatation of peripheral blood vessels|dilatation of peripheral blood vessels
5368247|NCT01864967|capillaries|capillaries
5368254|NCT01864954|Quit|quit
5368255|NCT01864954|Tobacco|tobacco
5368256|NCT01864954|Abstinence|abstinence
5368257|NCT01864954|Relapse|relapse
5368258|NCT01864954|Relapse prevention|relapse prevention
5368259|NCT01864941|Multiple Sclerosis|multiple sclerosis
5368260|NCT01864941|MS|ms
5368261|NCT01864941|CCSVI|ccsvi
5368262|NCT01864941|Zamboni|zamboni
5368263|NCT01864941|catheter venography|catheter venography
5368264|NCT01864941|balloon angioplasty|balloon angioplasty
5368265|NCT01864928|Acute Ischemic stroke|acute ischemic stroke
5368266|NCT01864928|ePRISM|eprism
5368267|NCT01864915|colon capsule|colon capsule
5368268|NCT01864915|bowel preparation|bowel preparation
5368269|NCT01864915|booster|booster
5368270|NCT01864915|prucalopride|prucalopride
5368271|NCT01864915|picosalax|picosalax
5368272|NCT01864902|CD33 positive acute myeloid leukemia (AML)|cd33 positive acute myeloid leukemia (aml)
5368273|NCT01864850|HNSCC|hnscc
5368274|NCT01864850|Elderly|elderly
5368275|NCT01864850|Geriatry|geriatry
5368276|NCT01864837|tongue coating thickness|tongue coating thickness
5368277|NCT01864837|tongue diagnosis system|tongue diagnosis system
5368278|NCT01864837|tongue coating percentage|tongue coating percentage
5368279|NCT01864837|availability|availability
5368280|NCT01864837|diagnostic device|diagnostic device
5368281|NCT01864824|air pollution|air pollution
5368282|NCT01864824|particulate matter 2.5 (PM2.5)|particulate matter 2.5 (pm2.5)
5368283|NCT01864824|methyl donor|methyl donor
5368284|NCT01864824|DNA methylation|dna methylation
5368285|NCT01864824|mRNA|mrna
5368286|NCT01864824|epigenetics|epigenetics
5368287|NCT01864824|controlled human exposures|controlled human exposures
5368288|NCT01864824|cardiovascular responses|cardiovascular responses
5368289|NCT01864811|infants|infants
5368290|NCT01864811|unilateral cerebral pares|unilateral cerebral pares
5368291|NCT01864811|hand function|hand function
5368292|NCT01864811|early intervention|early intervention
5368293|NCT01864811|constraint induced movement therapy|constraint induced movement therapy
5368294|NCT01864798|Young|young
5368295|NCT01864798|Breast Neoplasms|breast neoplasms
5368296|NCT01864798|Denosumab|denosumab
5368297|NCT01864798|RANKL|rankl
5368298|NCT01864785|Operative treatment|operative treatment
5368299|NCT01864785|internal fixation|internal fixation
5368300|NCT01864785|posterior spinal fusion|posterior spinal fusion
5368301|NCT01864772|HNSCC|hnscc
5368302|NCT01864772|Metastatic|metastatic
5368315|NCT01864733|Physical exercise|physical exercise
5368316|NCT01864733|Nutrition|nutrition
5368317|NCT01864733|n-3 fatty acids|n-3 fatty acids
5368318|NCT01864733|Androgen|androgen
5368319|NCT01864733|Testosterone|testosterone
5368320|NCT01864720|stepped care model|stepped care model
5368321|NCT01864720|insomnia|insomnia
5368322|NCT01864720|cancer|cancer
5368323|NCT01864720|cognitive-behavioural therapy|cognitive-behavioural therapy
5368324|NCT01864720|self-help treatment|self-help treatment
5368325|NCT01864720|Internet|internet
5368326|NCT01864720|non-inferiority design|non-inferiority design
5368327|NCT01864720|cost-effectiveness|cost-effectiveness
5368328|NCT01864707|multiple sclerosis, fatigue|multiple sclerosis, fatigue
5368329|NCT01864694|behavioral research|behavioral research
5368330|NCT01864694|diet|diet
5368331|NCT01864694|health information systems|health information systems
5368332|NCT01864681|NSCLC|nsclc
5368333|NCT01864681|TKIs|tkis
5368334|NCT01864681|Metformin|metformin
5368335|NCT01864681|PFS|pfs
5368336|NCT01864681|overall survival|overall survival
5368337|NCT01864681|IL-6|il-6
5368338|NCT01864668|Acute respiratory distress syndrome|acute respiratory distress syndrome
5368339|NCT01864668|lung strain|lung strain
5368340|NCT01864668|small tidal volume|small tidal volume
5368341|NCT01864616|Vitamin D|vitamin d
5964479|NCT04138043|Subcutaneous dose|subcutaneous dose
5368342|NCT01864616|Crohn disease|crohn disease
5368343|NCT01864616|Disease activity|disease activity
5368344|NCT01864616|Inflammation|inflammation
5368345|NCT01864616|prevention|prevention
5368350|NCT01864590|Open Abdomen|open abdomen
5368351|NCT01864590|Negative Pressure Wound Therapy|negative pressure wound therapy
5368352|NCT01864590|Temporary Abdominal Closure|temporary abdominal closure
5368354|NCT01864590|Abdominal reconstruction|abdominal reconstruction
5234689|NCT02535689|Lupus|lupus
5246844|NCT02464436|RP|rp
5368355|NCT01864564|Gestational diabetes|gestational diabetes
5368356|NCT01864564|Screening|screening
5368357|NCT01864564|Obesity|obesity
5368358|NCT01864564|Anhydroglucitol|anhydroglucitol
5368359|NCT01864538|TH-302|th-302
5368360|NCT01864538|Advanced Melanoma|advanced melanoma
5368361|NCT01864538|Metastatic|metastatic
5368362|NCT01864538|Biomarker|biomarker
5368363|NCT01864538|Mucosal Melanoma|mucosal melanoma
5368364|NCT01864538|Evofosfamide|evofosfamide
5368365|NCT01864525|voice|voice
5368366|NCT01864525|tremor|tremor
5368367|NCT01864525|essential tremor|essential tremor
5368368|NCT01864525|essential voice tremor|essential voice tremor
5368369|NCT01864525|voice treatment|voice treatment
5368370|NCT01864525|octanoic acid|octanoic acid
5368371|NCT01864525|octanol|octanol
5368372|NCT01864525|voice disorder|voice disorder
5368373|NCT01864525|dysphonia|dysphonia
5368374|NCT01864512|Immune Thrombocytopenia|immune thrombocytopenia
5368375|NCT01864512|eltrombopag|eltrombopag
5368376|NCT01864512|immune regulation|immune regulation
5368377|NCT01864473|Fistula , Bhagandar|fistula , bhagandar
5368378|NCT01864460|autonomic|autonomic
5368379|NCT01864460|neuropathy|neuropathy
5368380|NCT01864460|balance|balance
5368381|NCT01864460|exercise|exercise
5368382|NCT01864447|VTE|vte
5368383|NCT01864447|Exercise|exercise
5368384|NCT01864447|Diet|diet
5368385|NCT01864447|Weight loss|weight loss
5368386|NCT01864447|DVT|dvt
5368387|NCT01864447|PE|pe
5368388|NCT01864434|Knee Prosthesis|knee prosthesis
5368389|NCT01864434|Total Knee Arthroplasty|total knee arthroplasty
5368390|NCT01864434|Cruciate Retaining|cruciate retaining
5671943|NCT00613522|Sleep apnea, Berlin, Stroke|sleep apnea, berlin, stroke
5368391|NCT01864434|Posterior Cruciate Retaining|posterior cruciate retaining
5368392|NCT01864421|Infant, Newborn|infant, newborn
5368393|NCT01864421|Delivery, Obstetric|delivery, obstetric
5368394|NCT01864421|Umbilical Cord|umbilical cord
5368395|NCT01864408|Patient counseling|patient counseling
5368396|NCT01864408|Patient satisfaction|patient satisfaction
5368397|NCT01864408|Pelvic organ prolapse|pelvic organ prolapse
5368398|NCT01864395|cardiovascular surgery|cardiovascular surgery
5368399|NCT01864395|cardiac surgery|cardiac surgery
5368400|NCT01864395|cardiopulmonary bypass|cardiopulmonary bypass
5363881|NCT01884532|Serum|serum
5368403|NCT01864395|heart-lung machine|heart-lung machine
5368405|NCT01864395|online MUF|online muf
5368406|NCT01864395|offline MUF|offline muf
5368407|NCT01864395|modified ultrafiltration|modified ultrafiltration
5368408|NCT01864395|multiple-pass hemofiltration|multiple-pass hemofiltration
5368409|NCT01864395|centrifugation method|centrifugation method
5368410|NCT01864395|blood transfusion|blood transfusion
5368411|NCT01864395|plasma proteins|plasma proteins
5368412|NCT01864395|post-cardiopulmonary bypass|post-cardiopulmonary bypass
5368413|NCT01864395|hemoglobin|hemoglobin
5368414|NCT01864395|clotting factors|clotting factors
5368415|NCT01864395|systemic blood pressure|systemic blood pressure
5368416|NCT01864395|cardiac index|cardiac index
5368417|NCT01864395|cytokines|cytokines
5368418|NCT01864395|post-operative bleeding|post-operative bleeding
5368419|NCT01864395|protamine administration|protamine administration
5368420|NCT01864395|patient size|patient size
5368421|NCT01864395|allogeneic transfusion|allogeneic transfusion
5368422|NCT01864395|total protein|total protein
5368424|NCT01864395|vasoactive inotrope score|vasoactive inotrope score
5368425|NCT01864395|fluid balance|fluid balance
5368426|NCT01864395|chest tube loss|chest tube loss
5368427|NCT01864395|length of stay|length of stay
5368428|NCT01864395|ventilation time|ventilation time
5368429|NCT01864395|markers of inflammation|markers of inflammation
5368430|NCT01864382|Trunk performance|trunk performance
5368431|NCT01864382|exercise,|exercise,
5368432|NCT01864382|"core stability,"|"core stability,"
5368433|NCT01864382|sitting balance|sitting balance
5368434|NCT01864369|Heart Failure|heart failure
5368435|NCT01864369|e-counseling|e-counseling
5368436|NCT01864369|quality of life|quality of life
5368437|NCT01864369|self-care|self-care
5368438|NCT01864356|IVF failure|ivf failure
5368439|NCT01864356|Repeated IVF failure|repeated ivf failure
5368440|NCT01864356|Implantation failure|implantation failure
5368441|NCT01864356|Repeated implantation failure|repeated implantation failure
5368442|NCT01864356|IVF|ivf
5368443|NCT01864356|NT100|nt100
5368444|NCT01864343|Myocardial Infarction|myocardial infarction
5368445|NCT01864343|Myocardial Reperfusion Injury|myocardial reperfusion injury
5368446|NCT01864343|Reperfusion Injury|reperfusion injury
5368447|NCT01864343|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
5368448|NCT01864343|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
5368449|NCT01864343|Myocardial Ischemia|myocardial ischemia
5368450|NCT01864330|topical lubricants|topical lubricants
5964480|NCT04136821|Oxidative Stress|oxidative stress
5368451|NCT01864330|optical coherence tomography|optical coherence tomography
5368452|NCT01864330|tear break up time|tear break up time
5964481|NCT04136821|Muscle Strength|muscle strength
5368453|NCT01864330|Schirmer I test|schirmer i test
5964482|NCT04136821|Resistance Training|resistance training
5234800|NCT02534701|stroke|stroke
5368454|NCT01864317|7-Tesla Magnetic Resonance Imaging|7-tesla magnetic resonance imaging
5368455|NCT01864317|Intraocular Pressure|intraocular pressure
5369052|NCT01861717|Somatuline|somatuline
5368456|NCT01864317|Retinal Nerve Fiber Thickness|retinal nerve fiber thickness
5368457|NCT01864317|Visual Field Test|visual field test
5368458|NCT01864304|Williams Syndrome|williams syndrome
5368459|NCT01864291|Auditory Brainstem Implant|auditory brainstem implant
5368461|NCT01864291|Nucleus 24|nucleus 24
5368462|NCT01864291|Deafness|deafness
5368463|NCT01864291|Hearing loss|hearing loss
5368464|NCT01864291|Non-tumor|non-tumor
5368465|NCT01864291|Non-NF2|non-nf2
5368466|NCT01864291|Pediatric|pediatric
5368467|NCT01864291|ABI541|abi541
5368468|NCT01864265|Rheumatoid arthritis|rheumatoid arthritis
5368469|NCT01864265|functional MRI|functional mri
5368470|NCT01864265|Prediction of Response|prediction of response
5368471|NCT01864265|Certolizumab Pegol|certolizumab pegol
5368472|NCT01864239|Adherence|adherence
5368473|NCT01864187|Pharmacokinetics|pharmacokinetics
5368474|NCT01864187|Dexmedetomidine|dexmedetomidine
5368475|NCT01864187|Obesity|obesity
5368476|NCT01864122|nutrient biomarkers|nutrient biomarkers
5368477|NCT01864122|food frequency questionnaire|food frequency questionnaire
5368478|NCT01864122|predictors of CVD|predictors of cvd
5368479|NCT01864122|fatty acids|fatty acids
5368480|NCT01864122|phylloquinone|phylloquinone
5368481|NCT01864122|dihydrophylloquinone|dihydrophylloquinone
5368482|NCT01864109|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5368483|NCT01864109|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5368484|NCT01864109|ETOPOSIDE (VP-16)|etoposide (vp-16)
5368485|NCT01864109|IFOSFAMIDE|ifosfamide
5368486|NCT01864109|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5494610|NCT01317602|AF|af
5368487|NCT01864109|TEMOZOLOMIDE|temozolomide
5368488|NCT01864109|VINCRISTINE|vincristine
5368489|NCT01864109|13-068|13-068
5368490|NCT01864096|localized|localized
5368491|NCT01864096|prostate|prostate
5368492|NCT01864096|cancer|cancer
5368493|NCT01864096|metformin|metformin
5368494|NCT01864096|active surveillance|active surveillance
5368495|NCT01864083|FACBC PET/PEM|facbc pet/pem
5368496|NCT01864083|MR|mr
5368497|NCT01864083|11-177|11-177
5368498|NCT01864070|Liver cancer|liver cancer
5368500|NCT01864070|NET|net
5368501|NCT01864070|Liver dominant disease|liver dominant disease
5368502|NCT01864070|TheraSphere|therasphere
5368503|NCT01864070|Yttrium-90|yttrium-90
5368504|NCT01864070|Y-90|y-90
5368505|NCT01864070|Everolimus|everolimus
5368506|NCT01864070|Afinitor|afinitor
5368507|NCT01864070|Zortress|zortress
5368508|NCT01864070|RAD001|rad001
5368509|NCT01864070|Microspheres|microspheres
5368510|NCT01864057|thiamine deficiency|thiamine deficiency
5368511|NCT01864031|Alcohol|alcohol
5368512|NCT01864031|Drinking|drinking
5368513|NCT01864031|Abstainers|abstainers
5368514|NCT01864031|Former drinkers|former drinkers
5368515|NCT01864031|Ex-drinkers|ex-drinkers
5368516|NCT01864031|Aetiology|aetiology
5368517|NCT01864031|Initial presentation|initial presentation
5368518|NCT01864031|Chronic Stable Angina|chronic stable angina
5368519|NCT01864031|Unstable Angina|unstable angina
5368520|NCT01864031|Coronary Heart Disease Not Otherwise Specified|coronary heart disease not otherwise specified
5368521|NCT01864031|Acute Myocardial Infarction|acute myocardial infarction
5368522|NCT01864031|Heart Failure|heart failure
5368523|NCT01864031|ST elevation Myocardial Infarction (STEMI)|st elevation myocardial infarction (stemi)
5368524|NCT01864031|non-ST elevation Myocardial Infarction (nSTEMI)|non-st elevation myocardial infarction (nstemi)
5368525|NCT01864031|Myocardial Infarction Not Otherwise Specified (MI NOS)|myocardial infarction not otherwise specified (mi nos)
5368526|NCT01864031|Ventricular Arrhythmias|ventricular arrhythmias
5368527|NCT01864031|Cardiac Arrest|cardiac arrest
5368528|NCT01864031|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5368529|NCT01864031|Peripheral Arterial Disease|peripheral arterial disease
5368530|NCT01864031|Ischaemic Stroke|ischaemic stroke
5368531|NCT01864031|Subarachnoid Haemorrhagic Stroke|subarachnoid haemorrhagic stroke
5368532|NCT01864031|Intracerebral haemorrhagic Stroke|intracerebral haemorrhagic stroke
5368533|NCT01864031|Stroke Not Otherwise Specified|stroke not otherwise specified
5368534|NCT01864031|Sudden Cardiac Death|sudden cardiac death
5368535|NCT01864031|Unheralded Coronary Death|unheralded coronary death
5368536|NCT01864031|Mortality|mortality
5964483|NCT04136821|Antioxidants|antioxidants
5964484|NCT04136756|relapsed|relapsed
5964485|NCT04136756|refractory|refractory
5964486|NCT04136756|NKTR-255|nktr-255
5964487|NCT04136756|CAR-T|car-t
5964488|NCT04136756|daratumumab|daratumumab
5964489|NCT04136756|interleukin-15 (IL-15)|interleukin-15 (il-15)
5964490|NCT04136756|MM|mm
5964491|NCT04136756|NHL|nhl
5964492|NCT04136275|Leukemia|leukemia
5964493|NCT04136275|Hematologic Malignancy|hematologic malignancy
5964494|NCT04136275|Lymphoma|lymphoma
5964495|NCT04136275|CAR-T|car-t
5964496|NCT04135495|cystic fibrosis|cystic fibrosis
5964497|NCT04135495|ELX-02|elx-02
5964498|NCT04135495|G542X allele|g542x allele
5964499|NCT04135495|eukaryotic ribosomal selective glycoside|eukaryotic ribosomal selective glycoside
5964500|NCT04134195|Transcranial direct current stimulation|transcranial direct current stimulation
5964501|NCT04134195|Healthy seniors|healthy seniors
5368537|NCT01864031|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5368538|NCT01864031|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5368539|NCT01864031|Fatal Cardiovascular Disease (fatal CVD)|fatal cardiovascular disease (fatal cvd)
5368540|NCT01864005|Non-ST or ST Elevation Acute Coronary Syndromes, Ticagrelor, Clopidogrel, Antiplatelet Effect|non-st or st elevation acute coronary syndromes, ticagrelor, clopidogrel, antiplatelet effect
5368541|NCT01863992|home ventilation|home ventilation
5368542|NCT01863979|Atrial Fibrillation|atrial fibrillation
5368543|NCT01863979|Thromboembolism|thromboembolism
5368544|NCT01863966|Achalasia|achalasia
5368545|NCT01863966|Hot water drinking therapy|hot water drinking therapy
5368546|NCT01863966|Pneumatic dilation|pneumatic dilation
5368547|NCT01863914|ESRD|esrd
5368548|NCT01863914|Diabetes mellitus|diabetes mellitus
5368549|NCT01863914|Endothelial progenitor cells|endothelial progenitor cells
5368550|NCT01863914|Hemodialysis|hemodialysis
5368551|NCT01863914|rosuvastatin|rosuvastatin
5368552|NCT01863875|Cochlear Implant|cochlear implant
5368553|NCT01863875|Hearing loss|hearing loss
5368554|NCT01863875|Language Development|language development
5368555|NCT01863875|Quality of life|quality of life
5368556|NCT01863862|Rectal cancer|rectal cancer
5368557|NCT01863862|Chemoradiation|chemoradiation
5368558|NCT01863862|Complete pathological response|complete pathological response
5354493|NCT01928134|Vitamin K2|vitamin k2
5368559|NCT01863849|uncontrolled,|uncontrolled,
5368560|NCT01863849|open,|open,
5368561|NCT01863849|multi-centre|multi-centre
5368562|NCT01863849|immunogenicity and tolerability|immunogenicity and tolerability
5368563|NCT01863849|two groups according to age (18-59 years and ≥60 years)|two groups according to age (18-59 years and ≥60 years)
5368564|NCT01863836|Radial endobronchial ultrasound|radial endobronchial ultrasound
5368565|NCT01863836|Peripheral lung lesion|peripheral lung lesion
5368566|NCT01863836|Fluoroscopy|fluoroscopy
5368567|NCT01863836|Lung cancer|lung cancer
5368568|NCT01863823|Symptomatic patients|symptomatic patients
5368569|NCT01863823|asymptomatic individuals|asymptomatic individuals
5368570|NCT01863823|clinical trial|clinical trial
5368571|NCT01863810|Diabetic Neuropathy|diabetic neuropathy
5368572|NCT01863810|Neuropathic Pain|neuropathic pain
5368573|NCT01863810|Pregabalin|pregabalin
5368574|NCT01863784|Hepatic Impairment|hepatic impairment
5368575|NCT01863784|Mild and moderate hepatic impairment|mild and moderate hepatic impairment
5368576|NCT01863784|Normal hepatic function|normal hepatic function
5368577|NCT01863784|Pharmacokinetics|pharmacokinetics
5368578|NCT01863784|JNJ-38518168|jnj-38518168
5368579|NCT01863771|Ulcerative Colitis|ulcerative colitis
5368580|NCT01863771|Japanese|japanese
5368581|NCT01863771|Subcutaneous|subcutaneous
5368582|NCT01863771|Golimumab|golimumab
5368583|NCT01863745|ggastrointestinal stromal tumors|ggastrointestinal stromal tumors
5368584|NCT01863745|gastrointestinal,|gastrointestinal,
5368585|NCT01863745|stromal,|stromal,
5368586|NCT01863745|tumors,|tumors,
5368587|NCT01863745|GIST,|gist,
5368588|NCT01863745|AMN107,|amn107,
5368590|NCT01863732|AIN457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, PFS, pre-filled syringe, secukinumab, self-injection|ain457, ankylosing spondylitis, chronic inflammatory disease, inflammatory back pain, pfs, pre-filled syringe, secukinumab, self-injection
5368591|NCT01863719|Colistin|colistin
5368592|NCT01863719|Multi Drug Resistant|multi drug resistant
5368593|NCT01863719|Nosocomial Pneumonia|nosocomial pneumonia
5368594|NCT01863719|Pneumococcal Infections|pneumococcal infections
5368595|NCT01863706|Misoprostol|misoprostol
5368596|NCT01863706|Oxytocin|oxytocin
5368597|NCT01863706|Post Partum Hemorrhage (PPH)|post partum hemorrhage (pph)
5368598|NCT01863706|Third stage of labour|third stage of labour
5368599|NCT01863680|Infertility|infertility
5368600|NCT01863680|COL-1620|col-1620
5368601|NCT01863680|progesterone gel|progesterone gel
5368602|NCT01863680|Fertilization in Vitro|fertilization in vitro
5368603|NCT01863680|Embryo Transfer|embryo transfer
5368604|NCT01863654|Bioequivalence|bioequivalence
5368605|NCT01863654|Mexico|mexico
5368606|NCT01863654|Asthma|asthma
5368607|NCT01863654|Montelukast|montelukast
5368608|NCT01863654|Chewable|chewable
5368609|NCT01863641|lupus nephritis|lupus nephritis
5368610|NCT01863641|proteinuria|proteinuria
5368611|NCT01863641|SLE|sle
5368612|NCT01863641|calcitriol|calcitriol
5368613|NCT01863628|Prodromal Symptoms|prodromal symptoms
5368614|NCT01863628|bipolar disorder|bipolar disorder
5368615|NCT01863628|Neuropsychological Tests|neuropsychological tests
5368616|NCT01863628|Magnetic Resonance Imaging|magnetic resonance imaging
5368617|NCT01863628|Treatment Outcome|treatment outcome
5368618|NCT01863628|aerobic exercise|aerobic exercise
5368619|NCT01863628|psychotherapy|psychotherapy
5368620|NCT01863615|pharmacokinetics|pharmacokinetics
5368621|NCT01863615|Isotretinoin|isotretinoin
5368622|NCT01863615|bioequivalence|bioequivalence
5368623|NCT01863615|Mexico|mexico
5368624|NCT01863576|Chagas disease|chagas disease
5368625|NCT01863576|Chagas Cardiomyopathy|chagas cardiomyopathy
5368626|NCT01863576|Trypanosoma cruzi|trypanosoma cruzi
5368627|NCT01863576|Omega-3|omega-3
5368628|NCT01863576|Cytokines|cytokines
5368629|NCT01863576|Lipid profile|lipid profile
5328330|NCT02047357|Mother|mother
5368630|NCT01863576|Nutritional assessment|nutritional assessment
5368631|NCT01863563|tonsillectomy|tonsillectomy
5368632|NCT01863563|adenoidectomy|adenoidectomy
5368633|NCT01863563|obstructive sleep apnea|obstructive sleep apnea
5368634|NCT01863524|Abdominal Aortic Aneurysm (AAA),|abdominal aortic aneurysm (aaa),
5368635|NCT01863524|Echocardiography (TTE),|echocardiography (tte),
5368636|NCT01863524|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5368637|NCT01863524|Patients over 65 years old|patients over 65 years old
5368638|NCT01863511|Treatment options for acute decompensated heart failure|treatment options for acute decompensated heart failure
5368639|NCT01863511|Ultrafiltration|ultrafiltration
5368640|NCT01863511|tolvaptan|tolvaptan
5368641|NCT01863498|pectus excavatum|pectus excavatum
5368642|NCT01863498|pain control|pain control
5368643|NCT01863485|advanced cancer|advanced cancer
5368644|NCT01863459|ADHD|adhd
5368646|NCT01863459|Anxiety|anxiety
5368647|NCT01863459|Anxiety Disorders|anxiety disorders
5368648|NCT01863459|Depression|depression
5368650|NCT01863459|Attention Deficit|attention deficit
5368651|NCT01863446|Pregnancy|pregnancy
5368652|NCT01863446|Melatonin|melatonin
5368653|NCT01863446|Contractions|contractions
5368654|NCT01863446|Light|light
5368655|NCT01863420|gastric cancer|gastric cancer
5368656|NCT01863420|rectal cancer|rectal cancer
5368657|NCT01863420|bone marrow toxicity|bone marrow toxicity
5368658|NCT01863420|IMRT|imrt
5368659|NCT01863420|hematologic toxicity|hematologic toxicity
5368660|NCT01863407|Ileus|ileus
5368661|NCT01863407|Intestinal Obstruction|intestinal obstruction
5368662|NCT01863407|Intestinal Diseases|intestinal diseases
5368663|NCT01863407|Gastrointestinal Diseases|gastrointestinal diseases
5368664|NCT01863407|Digestive System Diseases|digestive system diseases
5368665|NCT01863394|Screening|screening
5368666|NCT01863394|Malnutrition|malnutrition
5368667|NCT01863394|Community Management of Acute Malnutrition|community management of acute malnutrition
5368668|NCT01863381|Hydrocephalus|hydrocephalus
5368669|NCT01863381|Idiopathic intracranial hypertension|idiopathic intracranial hypertension
5368670|NCT01863381|Pseudotumor cerebri|pseudotumor cerebri
5368671|NCT01863381|ICP|icp
5368672|NCT01863381|Intracranial pressure|intracranial pressure
5368673|NCT01863381|CSF pressure|csf pressure
5368674|NCT01863381|VIIP|viip
5368675|NCT01863368|Dry eye syndrome|dry eye syndrome
5368676|NCT01863368|Systane Ultra|systane ultra
5368677|NCT01863368|Optive|optive
5368678|NCT01863368|Ocular Surface Staining|ocular surface staining
5368679|NCT01863368|OSDI|osdi
5368680|NCT01863368|Eye drops|eye drops
5368681|NCT01863355|IntravenousPCA, fentanyl, postoperative pain, laparoscopic gastrectomy|intravenouspca, fentanyl, postoperative pain, laparoscopic gastrectomy
5368682|NCT01863342|central sensitization; osteoarthritis; epidural analgesia|central sensitization; osteoarthritis; epidural analgesia
5368683|NCT01863329|Optic nerve sheath diameter|optic nerve sheath diameter
5368684|NCT01863329|Hydrocephalus|hydrocephalus
5368685|NCT01863329|Intracranial hypertension|intracranial hypertension
5368686|NCT01863316|LMA Supreme, i-gel, supraglottic airway|lma supreme, i-gel, supraglottic airway
5368688|NCT01863303|epidemiology|epidemiology
5368689|NCT01863303|industry|industry
5368690|NCT01863303|genetic|genetic
5368691|NCT01863290|prison|prison
5368692|NCT01863290|reentry|reentry
5368693|NCT01863290|health care utilization|health care utilization
5368694|NCT01863264|dysphagia|dysphagia
5368695|NCT01863264|swallowing|swallowing
5368696|NCT01863264|infant|infant
5368697|NCT01863264|premature|premature
5368698|NCT01863264|neonate|neonate
5368699|NCT01863264|thermal|thermal
5368700|NCT01863264|cold|cold
5368701|NCT01863264|bolus|bolus
5368702|NCT01863264|temperature|temperature
5368703|NCT01863264|deglutition|deglutition
5368704|NCT01863264|NICU|nicu
5368705|NCT01863264|bottle|bottle
5368706|NCT01863264|nippling|nippling
5368707|NCT01863251|Opiates|opiates
5368708|NCT01863251|ATS|ats
5368709|NCT01863251|HIV Risks|hiv risks
5368710|NCT01863238|Cystic Fibrosis|cystic fibrosis
5368711|NCT01863199|Wet AMD|wet amd
5368712|NCT01863199|AMD|amd
5368713|NCT01863199|Choroidal neovascularization|choroidal neovascularization
5368714|NCT01863199|Neovascular membrane|neovascular membrane
5368715|NCT01863186|lofexidine|lofexidine
5368716|NCT01863186|opioid dependence|opioid dependence
5964502|NCT04134195|Healthy adults|healthy adults
5964503|NCT04133909|COPD|copd
5964504|NCT04133909|Mepolizumab|mepolizumab
5964505|NCT04133909|Exacerbations|exacerbations
5964506|NCT04133909|MATINEE|matinee
5368717|NCT01863186|acute withdrawal syndrome|acute withdrawal syndrome
5368718|NCT01863186|opioid withdrawal|opioid withdrawal
5368719|NCT01863173|Thalassemia cardiomyopathy|thalassemia cardiomyopathy
5368720|NCT01863173|metoprolol succinate|metoprolol succinate
5368721|NCT01863173|echocardiography|echocardiography
5368722|NCT01863173|six minute walk test|six minute walk test
5368723|NCT01863160|Safety|safety
5368724|NCT01863160|Tolerability|tolerability
5368725|NCT01863160|Pharmacokinetic profile|pharmacokinetic profile
5964507|NCT04133571|catheter-related bladder discomfort|catheter-related bladder discomfort
5964508|NCT04133571|lidocaine|lidocaine
5964509|NCT04133142|Zoster,|zoster,
5368726|NCT01863160|ZEP-3 Cream (0.1% and 1.0%)|zep-3 cream (0.1% and 1.0%)
5368727|NCT01863160|administered topically|administered topically
5368728|NCT01863147|Type 2 diabetes|type 2 diabetes
5368729|NCT01863147|left ventricular mass|left ventricular mass
5368730|NCT01863147|inhibitor of dipeptidyl peptidase-4|inhibitor of dipeptidyl peptidase-4
5368731|NCT01863121|cirrhosis|cirrhosis
5368732|NCT01863121|CTPK|ctpk
5368733|NCT01863121|CTP|ctp
5368734|NCT01863121|MELD|meld
5368735|NCT01863121|Severity Score|severity score
5368736|NCT01863108|Melanoma|melanoma
5368737|NCT01863108|Immunotherapy|immunotherapy
5368738|NCT01863108|Dermatology|dermatology
5368739|NCT01863108|cancer vaccine|cancer vaccine
5368740|NCT01863108|Plasmacytoid dendritic cell line|plasmacytoid dendritic cell line
5368741|NCT01863108|Advanced Medicinal Therapy Product|advanced medicinal therapy product
5368742|NCT01863108|allogeneic|allogeneic
5368743|NCT01863082|Resistant Hypertension|resistant hypertension
5368744|NCT01863069|inhaled|inhaled
5368745|NCT01863069|interferon beta-1a|interferon beta-1a
5368746|NCT01863069|healthy subjects|healthy subjects
5368747|NCT01863056|Sedentary time|sedentary time
5368748|NCT01863056|Non Exercise Activity|non exercise activity
5368749|NCT01863056|Sit Stand Workstation|sit stand workstation
5368750|NCT01863043|Premature Infant|premature infant
5368751|NCT01863043|Nutrition|nutrition
5368758|NCT01862991|Mifepristone|mifepristone
5354689|NCT01927302|Aphasia|aphasia
5368759|NCT01862991|Dilation and Evacuation|dilation and evacuation
5368760|NCT01862991|Cervical Preparation|cervical preparation
5368761|NCT01862991|Osmotic Dilators|osmotic dilators
5368762|NCT01862978|Stroke|stroke
5368763|NCT01862978|Heparin|heparin
5368764|NCT01862978|Nadroparin|nadroparin
5368765|NCT01862965|firstline|firstline
5368766|NCT01862965|treatment|treatment
5368767|NCT01862965|prednisone|prednisone
5368768|NCT01862965|everolimus|everolimus
5368769|NCT01862939|type 2 diabetes mellitus|type 2 diabetes mellitus
5368770|NCT01862926|connective tissue disease|connective tissue disease
5368771|NCT01862926|interstitial lung disease|interstitial lung disease
5368772|NCT01862926|pulmonary fibrosis|pulmonary fibrosis
5368773|NCT01862926|rituximab|rituximab
5368774|NCT01862926|scleroderma|scleroderma
5368775|NCT01862926|polymyositis|polymyositis
5368776|NCT01862926|dermatomyositis|dermatomyositis
5368777|NCT01862913|depression|depression
5368778|NCT01862913|adolescents|adolescents
5368779|NCT01862900|Breast Cancer|breast cancer
5368780|NCT01862900|Metastatic|metastatic
5368781|NCT01862900|Lung metastases|lung metastases
5368782|NCT01862900|Liver metastases|liver metastases
5368783|NCT01862900|Stereotactic body radiation|stereotactic body radiation
5368784|NCT01862900|anti-OX40 antibody|anti-ox40 antibody
5368785|NCT01862900|MEDI6469|medi6469
5368786|NCT01862900|Immunotherapy|immunotherapy
5368787|NCT01862861|Bioidentical Hormone Replacement Therapy|bioidentical hormone replacement therapy
5368788|NCT01862848|Topical Compounded Pain Creams and Pain Perception|topical compounded pain creams and pain perception
5368789|NCT01862822|Paediatrics|paediatrics
5368790|NCT01862822|Urinary tract infection|urinary tract infection
5368791|NCT01862822|Urine collection|urine collection
5368792|NCT01862809|Oral Microbiota|oral microbiota
5368793|NCT01862809|Cigarette Smoking|cigarette smoking
5368799|NCT01862783|Parasites|parasites
5368800|NCT01862783|Plasmodium Falciparum|plasmodium falciparum
5368801|NCT01862783|Placenta|placenta
5368802|NCT01862783|Resistant|resistant
5368803|NCT01862770|Lung Cancer|lung cancer
5368804|NCT01862770|Smokers|smokers
5368805|NCT01862770|Genetic Risk Communication|genetic risk communication
5368806|NCT01862770|Smoking Cessation|smoking cessation
5368807|NCT01862757|Obesity|obesity
5368808|NCT01862757|Insulin|insulin
5368809|NCT01862757|Skeletal Muscle|skeletal muscle
5264500|NCT02362893|RCT|rct
5368810|NCT01862757|Strength Testing|strength testing
5368811|NCT01862744|Parkinson's Disease|parkinson's disease
5368813|NCT01862744|Cognitive|cognitive
5368819|NCT01862718|Fusion|fusion
5368820|NCT01862718|Tracking|tracking
5368821|NCT01862718|Ablation|ablation
5368822|NCT01862718|Hepatic Neoplasms|hepatic neoplasms
5368823|NCT01862666|Barrett's Esophagus|barrett's esophagus
5368824|NCT01862666|Dysplasia|dysplasia
5368825|NCT01862666|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
5368826|NCT01862666|EMR|emr
5368827|NCT01862666|Endoscopy|endoscopy
5368828|NCT01862653|Post Traumatic Stress Disorder|post traumatic stress disorder
5368829|NCT01862653|Sleep Disturbance|sleep disturbance
5368830|NCT01862653|Acupuncture|acupuncture
5368831|NCT01862640|OPC-34712|opc-34712
5368832|NCT01862640|brexpiprazole|brexpiprazole
5368833|NCT01862640|Dementia|dementia
5368834|NCT01862640|Alzheimer's Disease|alzheimer's disease
5368835|NCT01862640|Cognitive Disorders|cognitive disorders
5368836|NCT01862640|Memory|memory
5368837|NCT01862640|Agitation|agitation
5964510|NCT04133142|Pain relief|pain relief
5964511|NCT04133142|regional anesthesia|regional anesthesia
5368838|NCT01862627|Macular retinoschisis|macular retinoschisis
5368839|NCT01862627|Macular detachment|macular detachment
5368840|NCT01862627|vitrectomy|vitrectomy
5368841|NCT01862614|Degree of pulpal anesthesia obtained.|degree of pulpal anesthesia obtained.
5368842|NCT01862614|Primary infiltration in the lower first molar.|primary infiltration in the lower first molar.
5368843|NCT01862614|Buffered local anesthetic.|buffered local anesthetic.
5368844|NCT01862588|septic shock|septic shock
5368845|NCT01862588|acute kidney injury|acute kidney injury
5368846|NCT01862588|renal resistive index|renal resistive index
5368847|NCT01862562|Laparoscopic surgery|laparoscopic surgery
5368848|NCT01862562|Colorectal cancer|colorectal cancer
5368849|NCT01862562|Elderly patient|elderly patient
5368850|NCT01862562|Randomized control study|randomized control study
5368851|NCT01862536|Randomized trial|randomized trial
5368852|NCT01862536|COPD|copd
5368853|NCT01862536|tadalafil|tadalafil
5368854|NCT01862536|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
5368855|NCT01862536|Pulmonary hypertension|pulmonary hypertension
5368861|NCT01862497|Hemodialysis|hemodialysis
5368862|NCT01862497|Hypertension|hypertension
5368863|NCT01862497|Extracellular Volume|extracellular volume
5368864|NCT01862497|Endothelial Cell Dysfunction|endothelial cell dysfunction
5368865|NCT01862497|Endothelin 1|endothelin 1
5368866|NCT01862497|Carvedilol|carvedilol
5368867|NCT01862484|ADHD|adhd
5368868|NCT01862484|Diet|diet
5354802|NCT01926691|stress|stress
5368869|NCT01862484|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5368870|NCT01862471|Deep Vein Thrombosis|deep vein thrombosis
5368871|NCT01862471|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5368872|NCT01862471|Intermittent Pneumatic Compression|intermittent pneumatic compression
5368873|NCT01862471|Doppler Ultrasound|doppler ultrasound
5368874|NCT01862458|empyema|empyema
5368876|NCT01862458|dornase|dornase
5368877|NCT01862445|Chronic Lymphoid Leukemia, Chlorambucil, Rituximab|chronic lymphoid leukemia, chlorambucil, rituximab
5368878|NCT01862393|electrical stimulation|electrical stimulation
5368879|NCT01862393|torque|torque
5368880|NCT01862380|Adrenocortical function|adrenocortical function
5368881|NCT01862380|Adrenal hyperplasia, Congenital|adrenal hyperplasia, congenital
5368882|NCT01862380|21-hydroxylase|21-hydroxylase
5368883|NCT01862380|deficiency|deficiency
5368884|NCT01862380|cortisol|cortisol
5368885|NCT01862380|replacement therapy|replacement therapy
5368886|NCT01862380|Woman|woman
5368887|NCT01862380|Healthy people|healthy people
5368888|NCT01862354|Postoperative analgesia|postoperative analgesia
5368889|NCT01862354|Abdominoplasty|abdominoplasty
5368890|NCT01862354|Continuous wound infusion|continuous wound infusion
5368891|NCT01862354|Transverse abdominal plan block|transverse abdominal plan block
5671944|NCT00613509|Melanoma, Cancer|melanoma, cancer
5368892|NCT01862354|Local anesthetics : Ropivacaine|local anesthetics : ropivacaine
5368893|NCT01862354|Regional anesthesia|regional anesthesia
5368894|NCT01862341|Constipation|constipation
5368895|NCT01862341|Bowel movement|bowel movement
5368896|NCT01862341|Intestinal health|intestinal health
5368898|NCT01862328|Solid Tumors|solid tumors
5368899|NCT01862315|Hepatic Arterial Infusion (HAI)|hepatic arterial infusion (hai)
5368900|NCT01862315|Floxuridine (FUDR)|floxuridine (fudr)
5368901|NCT01862315|Dexamethasone (DEX)|dexamethasone (dex)
5368902|NCT01862315|Gemcitabine|gemcitabine
5368903|NCT01862315|Oxaliplatin|oxaliplatin
5368905|NCT01862302|Prevention delirium|prevention delirium
5368906|NCT01862302|Cardiac surgery|cardiac surgery
5368907|NCT01862289|difficult asthma|difficult asthma
5368908|NCT01862289|hyperventilation syndrome|hyperventilation syndrome
5368909|NCT01862289|prevalence|prevalence
5368910|NCT01862263|Diabetes,|diabetes,
5368911|NCT01862263|Type 2 diabetes,|type 2 diabetes,
5368912|NCT01862263|Diabetes mellitus,|diabetes mellitus,
5368913|NCT01862263|insulin,|insulin,
5368914|NCT01862237|Type II diabetes|type ii diabetes
5368915|NCT01862237|aortic valve stenosis|aortic valve stenosis
5368916|NCT01862237|left ventricular remodeling|left ventricular remodeling
5368917|NCT01862237|aortic valve replacement surgery|aortic valve replacement surgery
5368918|NCT01862224|Active rheumatoid arthritis despite methotrexate therapy|active rheumatoid arthritis despite methotrexate therapy
5368919|NCT01862224|JNJ-38518168|jnj-38518168
5368920|NCT01862224|Synovial|synovial
5368921|NCT01862211|alpha antitrypsin, hepatic disease, genetic, polymorphism|alpha antitrypsin, hepatic disease, genetic, polymorphism
5368922|NCT01862185|semiquantitative|semiquantitative
5368923|NCT01862185|procalcitonin|procalcitonin
5368924|NCT01862185|sepsis|sepsis
5368925|NCT01862185|antibiotics|antibiotics
5368926|NCT01862185|mortality|mortality
5368927|NCT01862172|Cortical focal atrophy|cortical focal atrophy
5368928|NCT01862172|Stroke|stroke
5368929|NCT01862172|Internal capsule|internal capsule
5368930|NCT01862172|Corticospinal tract|corticospinal tract
5964512|NCT04133142|Prevention post herpetic neuralgia|prevention post herpetic neuralgia
5964513|NCT04132869|physical activity|physical activity
5964514|NCT04132869|social emotional learning|social emotional learning
5964515|NCT04132869|healthy eating|healthy eating
5964516|NCT04132869|sports readiness|sports readiness
5964517|NCT04132700|energy expenditure|energy expenditure
5964518|NCT04132700|respiratory quotient|respiratory quotient
5964519|NCT04132700|Intensive Care Unit (ICU)|intensive care unit (icu)
5964520|NCT04132700|indirect calorimetry|indirect calorimetry
5328702|NCT02045888|fat|fat
5368931|NCT01862172|Wallerian degeneration|wallerian degeneration
5368932|NCT01862172|Primary motor area.|primary motor area.
5368933|NCT01862159|bariatric surgery|bariatric surgery
5368934|NCT01862159|postoperative complications|postoperative complications
5368935|NCT01862146|TCA|tca
5368936|NCT01862146|FMD|fmd
5368937|NCT01862146|IMT|imt
5368938|NCT01862146|Smoking|smoking
5368939|NCT01862133|Electronic Health Record|electronic health record
5368940|NCT01862133|Health Information Technology|health information technology
5368941|NCT01862133|Patient Privacy|patient privacy
5368942|NCT01862133|Personal Health Information|personal health information
5368943|NCT01862120|Recently diagnosed|recently diagnosed
5368944|NCT01862120|Regulatory T Cells|regulatory t cells
5368945|NCT01862120|Tolerance Induction|tolerance induction
5368946|NCT01862120|Paediatrics|paediatrics
5368947|NCT01862120|Low dose|low dose
5368948|NCT01862120|IL-2|il-2
5368954|NCT01862068|Pronostic factors|pronostic factors
5368955|NCT01862068|Neutrophils|neutrophils
5368956|NCT01862068|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5368957|NCT01862068|Microscopic polyangiitis|microscopic polyangiitis
5368958|NCT01862068|ANCA associated vasculitis|anca associated vasculitis
5368959|NCT01862068|Proteomics|proteomics
5368960|NCT01862055|Stress|stress
5368961|NCT01862055|Anxiety|anxiety
5368962|NCT01862055|Cesarean Section|cesarean section
5368963|NCT01862055|Spinal anesthesia|spinal anesthesia
5368964|NCT01862055|Hypotension|hypotension
5368965|NCT01862042|Spinal Muscular Atrophy (SMA) type 1|spinal muscular atrophy (sma) type 1
5368966|NCT01862042|Supportive care|supportive care
5368967|NCT01862042|Palliative care|palliative care
5354897|NCT01926353|Vantris|vantris
5368968|NCT01862029|Mitochondria in Diabetes|mitochondria in diabetes
5368969|NCT01862029|Obesity|obesity
5368970|NCT01862029|Roflumilast|roflumilast
5368971|NCT01862029|Phosphodiesterase-4|phosphodiesterase-4
5368972|NCT01862029|Pre-Diabetes|pre-diabetes
5368973|NCT01862016|Acute respiratory distress syndrome|acute respiratory distress syndrome
5368974|NCT01862016|APRV ventilatory mode|aprv ventilatory mode
5368975|NCT01862016|Spontaneous breathing|spontaneous breathing
5368976|NCT01862016|Intensive Care Unit|intensive care unit
5368977|NCT01862003|Colorectal cancer|colorectal cancer
5368978|NCT01862003|Metastatic Colorectal cancer|metastatic colorectal cancer
5368979|NCT01862003|Recurrent Colorectal cancer|recurrent colorectal cancer
5368980|NCT01862003|FOLFIRI|folfiri
5368981|NCT01862003|AZD8931|azd8931
5368982|NCT01862003|Chemotherapy|chemotherapy
5368983|NCT01862003|EGFR|egfr
5368984|NCT01861990|Glioma|glioma
5368985|NCT01861990|Glioblastoma|glioblastoma
5368986|NCT01861990|Pediatric|pediatric
5368987|NCT01861990|Child|child
5368988|NCT01861990|Brain tumor|brain tumor
5368989|NCT01861990|Astrocytoma|astrocytoma
5368990|NCT01861990|Medulloblastoma|medulloblastoma
5368991|NCT01861990|PNET|pnet
5368992|NCT01861977|Cognitive Therapy|cognitive therapy
5368993|NCT01861977|Health Education|health education
5368994|NCT01861977|Secondary Prevention|secondary prevention
5368995|NCT01861977|Cardiovascular Disease|cardiovascular disease
5368997|NCT01861964|Xylooligosarcharide|xylooligosarcharide
5368998|NCT01861964|Prebiotic|prebiotic
5368999|NCT01861951|soft tissue sarcoma|soft tissue sarcoma
5369000|NCT01861951|firstline treatment|firstline treatment
5369001|NCT01861951|eldery patients|eldery patients
5369002|NCT01861938|melanoma|melanoma
5369003|NCT01861938|vaccine|vaccine
5369004|NCT01861938|Resectable AJCC stage IV|resectable ajcc stage iv
5369005|NCT01861938|AJCC stages IIb-c, III|ajcc stages iib-c, iii
5369006|NCT01861938|Patients with low-burden|patients with low-burden
5369008|NCT01861938|respond|respond
5369009|NCT01861938|one treatment line|one treatment line
5369010|NCT01861912|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5369011|NCT01861912|Arsenic trioxide|arsenic trioxide
5369012|NCT01861899|Sacro-iliac Joint|sacro-iliac joint
5369013|NCT01861886|Birth control|birth control
5369014|NCT01861886|Permanent Contraception|permanent contraception
5369015|NCT01861873|liver function|liver function
5369016|NCT01861873|galactose|galactose
5369017|NCT01861873|18-F-deoxy-galactose|18-f-deoxy-galactose
5369018|NCT01861860|stenting using IVUS in long lEsion|stenting using ivus in long lesion
5369019|NCT01861834|Total parenteral nutrition|total parenteral nutrition
5369020|NCT01861834|TPN|tpn
5369021|NCT01861834|Intestinal Failure|intestinal failure
5369022|NCT01861834|Short Bowel Syndrome|short bowel syndrome
5369023|NCT01861834|Cholestasis|cholestasis
5369024|NCT01861834|Intestinal failure associated liver disease|intestinal failure associated liver disease
5964521|NCT04131465|HIV testing|hiv testing
5964522|NCT04131465|HIV status knowledge|hiv status knowledge
5964523|NCT04131465|Health system|health system
5964524|NCT04131465|Community health workers|community health workers
5964525|NCT04131088|Midline catheter|midline catheter
5964526|NCT04131088|adverse event|adverse event
5964527|NCT04131088|catheter-related bloodstream infections|catheter-related bloodstream infections
5964528|NCT04131088|thrombosis|thrombosis
5964529|NCT04130646|stroke|stroke
5964530|NCT04130646|recovery|recovery
5964531|NCT04130646|TMS|tms
5964532|NCT04130646|VNS|vns
5964533|NCT04130646|motor|motor
5964534|NCT04130646|motor cortex|motor cortex
5247473|NCT02460848|Cluster randomize trial|cluster randomize trial
5369025|NCT01861834|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5369026|NCT01861821|Epidural catheter|epidural catheter
5369027|NCT01861821|Epidural analgesia|epidural analgesia
5369028|NCT01861821|Labor epidural analgesia|labor epidural analgesia
5369029|NCT01861821|Analgesic efficacy|analgesic efficacy
5369030|NCT01861821|Multiport epidural catheter|multiport epidural catheter
5369031|NCT01861821|Uniport epidural catheter|uniport epidural catheter
5369032|NCT01861821|Flexible epidural catheter|flexible epidural catheter
5369033|NCT01861808|Spinal Cord Injuries|spinal cord injuries
5369034|NCT01861808|Cerebrospinal Fluid|cerebrospinal fluid
5369035|NCT01861795|Drug therapy|drug therapy
5369036|NCT01861769|Cognitive Processing Therapy|cognitive processing therapy
5369037|NCT01861769|Consultation|consultation
5369038|NCT01861756|Shared Decision Making|shared decision making
5369039|NCT01861756|Decision Aids|decision aids
5369040|NCT01861743|Multi-modal Pain Management|multi-modal pain management
5369041|NCT01861743|Lumbar fusion|lumbar fusion
5369042|NCT01861743|misTLIF|mistlif
5369043|NCT01861730|BCG Vaccinated|bcg vaccinated
5369044|NCT01861730|HIV Negative|hiv negative
5369045|NCT01861717|excess growth hormone|excess growth hormone
5369046|NCT01861717|excess GH|excess gh
5369047|NCT01861717|gigantism|gigantism
5369048|NCT01861717|pituitary tumor|pituitary tumor
5369049|NCT01861717|pituitary adenoma|pituitary adenoma
5369050|NCT01861717|growth hormone tumor|growth hormone tumor
5369051|NCT01861717|GH secreting adenoma|gh secreting adenoma
5369053|NCT01861717|lanreotide|lanreotide
5369054|NCT01861704|Mild to moderate hearing loss|mild to moderate hearing loss
5369055|NCT01861691|Transverse colon cancer|transverse colon cancer
5369056|NCT01861691|Descending colon cancer|descending colon cancer
5369057|NCT01861691|Laparoscopic surgery|laparoscopic surgery
5369058|NCT01861691|Randomized controlled trial|randomized controlled trial
5369059|NCT01861678|Rectal cancer|rectal cancer
5369060|NCT01861678|Anterior resection|anterior resection
5369061|NCT01861678|High tie of inferior mesenteric artery|high tie of inferior mesenteric artery
5369062|NCT01861678|Low tie of inferior mesenteric artery|low tie of inferior mesenteric artery
5369063|NCT01861678|Randomized controlled trial|randomized controlled trial
5423319|NCT01616212|Substance Abuse|substance abuse
5369064|NCT01861652|Restless legs syndrome, Ekbom syndrome, Restless legs|restless legs syndrome, ekbom syndrome, restless legs
5369065|NCT01861600|Stool composition|stool composition
5369067|NCT01861535|Imiquimod|imiquimod
5369068|NCT01861535|Surgery|surgery
5369069|NCT01861535|HPV|hpv
5369070|NCT01861535|Patient satisfaction|patient satisfaction
5369071|NCT01861522|TAU-284|tau-284
5369072|NCT01861522|Bepotastine besilate|bepotastine besilate
5264820|NCT02361008|occlusion|occlusion
5369073|NCT01861522|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
5369074|NCT01861522|children|children
5369075|NCT01861509|BP-C1|bp-c1
5369076|NCT01861509|Metronomic chemotherapy|metronomic chemotherapy
5369077|NCT01861509|Platinum analogue|platinum analogue
5369078|NCT01861509|Cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
5369079|NCT01861509|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
5369080|NCT01861509|Breast cancer|breast cancer
5369081|NCT01861509|Cisplatin|cisplatin
5369082|NCT01861509|Metastatic Breast Cancer|metastatic breast cancer
5671198|NCT00616811|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5671199|NCT00616785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5369083|NCT01861509|Cis-diammineplatinum(II) complex, containing mono-deprotonated benzene-poly-carboxylic acids, derived from lignin, and hydroxyl group as O-donor ligands|cis-diammineplatinum(ii) complex, containing mono-deprotonated benzene-poly-carboxylic acids, derived from lignin, and hydroxyl group as o-donor ligands
5369084|NCT01861496|Cisplatin|cisplatin
5369085|NCT01861496|Liposomal formulation|liposomal formulation
5369086|NCT01861496|DRP (Drug Response Prediction)|drp (drug response prediction)
5369087|NCT01861457|nasal sanitizer®|nasal sanitizer®
5369088|NCT01861457|S. aureus|s. aureus
5369089|NCT01861457|general bacteria|general bacteria
5369090|NCT01861457|nasal carriage|nasal carriage
5369091|NCT01861457|decolonization|decolonization
5369092|NCT01861431|HIV, prevention, microfinance, sex work, Mongolia|hiv, prevention, microfinance, sex work, mongolia
5369093|NCT01861418|chronic low back pain|chronic low back pain
5369094|NCT01861418|low back pain|low back pain
5369095|NCT01861418|lumbopelvic manipulation|lumbopelvic manipulation
5369096|NCT01861418|Chicago manipulation|chicago manipulation
5369097|NCT01861418|EMG median frequency|emg median frequency
5369098|NCT01861418|electromyography|electromyography
5369099|NCT01861418|reliability|reliability
5369100|NCT01861392|postural balance sensory motor trayning physical therapy modalities diabetes mellitus|postural balance sensory motor trayning physical therapy modalities diabetes mellitus
5369101|NCT01861366|Implementation|implementation
5369102|NCT01861366|Guidelines|guidelines
5369103|NCT01861366|Nutrition|nutrition
5964535|NCT04130555|ventral rectopexy|ventral rectopexy
5964536|NCT04130555|biological mesh|biological mesh
5964539|NCT04129970|Theta Burst Stimulation|theta burst stimulation
5964541|NCT04129970|Psychiatric Disorders|psychiatric disorders
5964542|NCT04129970|Eating Disorders|eating disorders
5964543|NCT04129944|Osteoarthritis|osteoarthritis
5964544|NCT04129944|Painful Osteoarthritis|painful osteoarthritis
5964545|NCT04129944|Osteoarthritis, Knee|osteoarthritis, knee
5964546|NCT04129944|Senescence|senescence
5964547|NCT04128969|dyslipidemia|dyslipidemia
5964548|NCT04128969|arterial stiffness|arterial stiffness
5964549|NCT04128969|pediatric obesity|pediatric obesity
5964550|NCT04128969|metabolic syndrome|metabolic syndrome
5964551|NCT04128969|insulin resistance|insulin resistance
5964552|NCT04128735|Diastolic dysfunction|diastolic dysfunction
5964553|NCT04128735|Morbid Obesity|morbid obesity
5964554|NCT04128735|Bariatric surgery|bariatric surgery
5964555|NCT04128696|GSK3359609|gsk3359609
5964556|NCT04128696|Pembrolizumab|pembrolizumab
5964557|NCT04128696|Programmed death receptor 1-ligand 1|programmed death receptor 1-ligand 1
5964558|NCT04128696|Head and neck squamous cell carcinoma/cancer|head and neck squamous cell carcinoma/cancer
5964559|NCT04128696|Inducible T cell co-stimulatory receptor|inducible t cell co-stimulatory receptor
5964560|NCT04128696|Keynote-A01|keynote-a01
5964561|NCT04128696|Head & neck|head & neck
5964562|NCT04128696|Phase II|phase ii
5964563|NCT04128657|Quality of life|quality of life
5964564|NCT04128657|Sphincter sparing surgery|sphincter sparing surgery
5964565|NCT04128657|Wexner score|wexner score
5964566|NCT04128657|LARS score|lars score
5964567|NCT04128618|knee OA|knee oa
5964568|NCT04128618|arthritis|arthritis
5964569|NCT04128618|knee pain|knee pain
5964570|NCT04127539|Exercise|exercise
5964571|NCT04127539|Fall prevention|fall prevention
5964572|NCT04126031|Gram-negative, ceftazidime-avibactam, neonate, infant|gram-negative, ceftazidime-avibactam, neonate, infant
5964573|NCT04125901|Chronic Neck Pain|chronic neck pain
5964574|NCT04125901|Adolescents|adolescents
5964575|NCT04125901|Pain Neuroscience Education|pain neuroscience education
5964576|NCT04125901|Exercise|exercise
5964577|NCT04124965|UCB7665|ucb7665
5964578|NCT04124965|Myasthenia Gravis|myasthenia gravis
5964579|NCT04124965|Rozanolixizumab|rozanolixizumab
5964580|NCT04124029|Mild Traumatic Brain Injury|mild traumatic brain injury
5964581|NCT04124029|Moderate Traumatic Brain Injury|moderate traumatic brain injury
5964582|NCT04124029|Alzheimer's Disease|alzheimer's disease
5964583|NCT04124029|Chronic Traumatic Encephalopathy|chronic traumatic encephalopathy
5964584|NCT04124029|Neurodegeneration|neurodegeneration
5964585|NCT04123795|Chronic plaque psoriasis|chronic plaque psoriasis
5964586|NCT04123795|Certolizumab pegol|certolizumab pegol
5964587|NCT04123795|Cimzia|cimzia
5964588|NCT04123795|Pediatric study|pediatric study
5964589|NCT04123795|Phase 3|phase 3
5964590|NCT04123418|Multiple Myeloma, phase 1|multiple myeloma, phase 1
5964591|NCT04123314|Psilocybin|psilocybin
5964592|NCT04123314|Hallucinogen|hallucinogen
5964593|NCT04123314|Psychedelic|psychedelic
5964594|NCT04122950|Exercise therapy|exercise therapy
5964595|NCT04122950|Physical fitness|physical fitness
5964596|NCT04122950|Gaming|gaming
5964597|NCT04122950|Child|child
5964598|NCT04122950|Healthy lifestyle|healthy lifestyle
5964599|NCT04122950|Fitness testing|fitness testing
5964600|NCT04122924|Postpartum|postpartum
5964601|NCT04122924|Abdominal Muscle Training|abdominal muscle training
5964602|NCT04122924|Exercise|exercise
5964603|NCT04122638|Older adults|older adults
5964604|NCT04121650|Executive Functioning|executive functioning
5964605|NCT04121650|ADHD|adhd
5964606|NCT04121650|Behavior Problems|behavior problems
5964607|NCT04121650|Youth|youth
5964608|NCT04121650|CPS|cps
5964609|NCT04121650|Collaborative Problem Solving|collaborative problem solving
5964610|NCT04121650|Disruptive Behavior|disruptive behavior
5964611|NCT04121650|Parenting|parenting
5964612|NCT04120883|P23H-RHO|p23h-rho
5964613|NCT04120883|eye disease|eye disease
5964614|NCT04119700|fistulectomy|fistulectomy
5964615|NCT04119700|fistula|fistula
5964616|NCT04119700|advancement flap|advancement flap
5964617|NCT04119700|transsphincteric fistula|transsphincteric fistula
5964618|NCT04119700|sphincteroplasty|sphincteroplasty
5964619|NCT04119700|primary sphincter reconstruction|primary sphincter reconstruction
5964620|NCT04119700|high fistula|high fistula
5964621|NCT04119700|endorectal flap|endorectal flap
5964622|NCT04119336|Refractory Multiple Myeloma|refractory multiple myeloma
5964623|NCT04119336|Relapsed Multiple Myeloma|relapsed multiple myeloma
5964624|NCT04119115|lung disease|lung disease
5964625|NCT04119115|pulmonary fibrosis|pulmonary fibrosis
5964626|NCT04119115|precision medicine|precision medicine
5964627|NCT04119115|metabolomics|metabolomics
5964628|NCT04119011|probiotics|probiotics
5964629|NCT04118998|Rehabilitation|rehabilitation
5964630|NCT04118998|Arm|arm
5964631|NCT04118998|Flexion Synergy|flexion synergy
5964632|NCT04118998|Longitudinal|longitudinal
5964633|NCT04118998|Targetted|targetted
5964634|NCT04118998|Quantitative|quantitative
5964635|NCT04118088|Drug therapy|drug therapy
5964636|NCT04117542|Loss of Control Eating|loss of control eating
5964637|NCT04117542|Working Memory|working memory
5964638|NCT04117425|Epilepsy|epilepsy
5964639|NCT04117425|pharmacokinetic|pharmacokinetic
5964640|NCT04117425|levetiracetam|levetiracetam
5964641|NCT04117425|placental transfer.|placental transfer.
5964642|NCT04115826|pancreatic duct stone|pancreatic duct stone
5964643|NCT04115826|extracorporeal shock-wave lithotripsy|extracorporeal shock-wave lithotripsy
5964644|NCT04115826|pancreatoscopy|pancreatoscopy
5964645|NCT04115826|quality of life|quality of life
5964646|NCT04115826|chronic pancreatitis|chronic pancreatitis
5964647|NCT04115553|Intracranial Hypertension|intracranial hypertension
5964648|NCT04115553|venous drainage|venous drainage
5964649|NCT04115553|MRI|mri
5964650|NCT04115553|blood flow|blood flow
5964651|NCT04115553|cerebrospinal fluid flow|cerebrospinal fluid flow
5964652|NCT04115189|Sunitinib -|sunitinib -
5964653|NCT04114266|Urologic Surgical Procedure|urologic surgical procedure
5964654|NCT04114266|Female|female
5964655|NCT04112186|Mindfulness|mindfulness
5964656|NCT04112186|Opiate Use Disorder|opiate use disorder
5964657|NCT04112186|Drug Cue Reactivity|drug cue reactivity
5964660|NCT04111848|Magnisum sulfate|magnisum sulfate
5964662|NCT04111848|Analgesia|analgesia
5964663|NCT04111848|Breast Cancer Surgeries|breast cancer surgeries
5964664|NCT04111731|Radiofrequency catheter ablation|radiofrequency catheter ablation
5964665|NCT04111731|Cryoballoon pulmonary vein isolation|cryoballoon pulmonary vein isolation
5964666|NCT04111731|Rhythmia|rhythmia
5964667|NCT04111731|Orion catheter|orion catheter
5964668|NCT04111731|Posterior wall isolation|posterior wall isolation
5964669|NCT04111731|Electrophysiological study|electrophysiological study
5964670|NCT04111731|Omron device|omron device
5964671|NCT04111692|hepatic cyst|hepatic cyst
5964672|NCT04111692|Kidney Cyst|kidney cyst
5964673|NCT04111692|Autosomal Polycystic Liver Disease|autosomal polycystic liver disease
5964674|NCT04111692|Autosomal Polycystic Kidney Disease|autosomal polycystic kidney disease
5964675|NCT04111471|Microbiome|microbiome
5964676|NCT04111471|Prebiotic|prebiotic
5964677|NCT04109976|Psoriatic Arthritis|psoriatic arthritis
5964678|NCT04109976|PsA|psa
5964679|NCT04109976|Auto-Injector|auto-injector
5964680|NCT04109976|Bimekizumab|bimekizumab
5964681|NCT04109950|schizophrenia|schizophrenia
5964682|NCT04109443|Adolescent sexual minority males (ASMM)|adolescent sexual minority males (asmm)
5964683|NCT04109443|gay, bisexual, and other men who have sex with me (GBMSM)|gay, bisexual, and other men who have sex with me (gbmsm)
5964684|NCT04109443|Online sexual health media literacy intervention|online sexual health media literacy intervention
5964685|NCT04109443|HIV prevention|hiv prevention
5964686|NCT04109443|Healthy sexual behaviors|healthy sexual behaviors
5964687|NCT04109235|HbA1C|hba1c
5964688|NCT04109235|blood pressure|blood pressure
5964689|NCT04109235|blood glucose|blood glucose
5964690|NCT04109235|physical activity|physical activity
5964691|NCT04109235|HIIT|hiit
5964692|NCT04109066|Nivolumab|nivolumab
5964693|NCT04109066|Breast Cancer|breast cancer
5964694|NCT04109066|Cancer|cancer
5964695|NCT04109066|Estrogen Receptor-Positive (ER+)|estrogen receptor-positive (er+)
5964696|NCT04109066|Human Epidermal Growth Factor 2 Negative (HER2-)|human epidermal growth factor 2 negative (her2-)
5964697|NCT04109066|Neoadjuvant|neoadjuvant
5964698|NCT04109066|Adjuvant|adjuvant
5964699|NCT04109066|Primary Breast Cancer|primary breast cancer
5964700|NCT04108741|Parkinson Disease|parkinson disease
5964701|NCT04108429|Mental health|mental health
5964702|NCT04108429|App|app
5964703|NCT04108429|Mobile phone|mobile phone
5964704|NCT04108429|Stress management|stress management
5964705|NCT04108143|Telehealth|telehealth
5964706|NCT04108143|Telemonitoring|telemonitoring
5964707|NCT04108143|COPD|copd
5964708|NCT04107818|polytrauma|polytrauma
5964709|NCT04107818|coagulopathy|coagulopathy
5964710|NCT04107818|viscoelastic tests|viscoelastic tests
5964711|NCT04107610|oculomotor,|oculomotor,
5964712|NCT04107610|vestibular,|vestibular,
5964713|NCT04107610|concussion,|concussion,
5964714|NCT04107610|mild traumatic brain injury|mild traumatic brain injury
5964715|NCT04106739|Alcohol dependence|alcohol dependence
5964716|NCT04106739|Peripheral electrical nerve field stimulation (PENFS)|peripheral electrical nerve field stimulation (penfs)
5964717|NCT04106739|Auricular nerve stimulation|auricular nerve stimulation
5964718|NCT04106739|Vagus nerve stimulation|vagus nerve stimulation
5964719|NCT04106739|relapse prevention|relapse prevention
5964720|NCT04105855|Organism|organism
5964721|NCT04105855|Seasonal|seasonal
5964722|NCT04105855|Blood Smear|blood smear
5964723|NCT04105855|Burden|burden
5964724|NCT04105855|Infections|infections
5964725|NCT04104204|Total hip replacement|total hip replacement
5964726|NCT04104204|Ultrasound guided supra-inguinal fascia iliaca block|ultrasound guided supra-inguinal fascia iliaca block
5964727|NCT04104204|Intrathecal morphine|intrathecal morphine
5964728|NCT04104204|postoperative pain|postoperative pain
5964729|NCT04103827|Usability|usability
5964730|NCT04103827|Elderly|elderly
5964731|NCT04103827|Old people|old people
5964732|NCT04103827|Physical activity|physical activity
5964733|NCT04103827|Balance|balance
5964734|NCT04103593|exercise training|exercise training
5964735|NCT04103593|video telehealth|video telehealth
5964736|NCT04103593|DNA methylation|dna methylation
5964737|NCT04103593|Aging|aging
5964738|NCT04103593|HIV|hiv
5964739|NCT04103567|rectal|rectal
5964740|NCT04103567|cancer|cancer
5964741|NCT04103385|interoception|interoception
5964742|NCT04103385|suicidal ideation|suicidal ideation
5964743|NCT04103385|suicide|suicide
5964744|NCT04103385|military|military
5964745|NCT04103385|intervention|intervention
5964746|NCT04103385|clinical trial|clinical trial
5964747|NCT04103307|Cooling|cooling
5964748|NCT04103307|CRRT|crrt
5964749|NCT04103034|Secondary Stroke Prevention|secondary stroke prevention
5964750|NCT04102449|Ultrasound|ultrasound
5964751|NCT04102449|Psoriatic arthritis|psoriatic arthritis
5964752|NCT04102449|Outcome measures|outcome measures
5964753|NCT04102449|Apremilast|apremilast
5964754|NCT04102449|Disease activity|disease activity
5964755|NCT04102436|Adoptive Cell Therapy|adoptive cell therapy
5964756|NCT04102436|Cell Therapy|cell therapy
5964757|NCT04102436|Immunotherapy|immunotherapy
5964758|NCT04102436|Gene Therapy|gene therapy
5964759|NCT04102423|Cytopenia|cytopenia
5964760|NCT04102423|Myelodysplastic Syndrome|myelodysplastic syndrome
5964761|NCT04102423|Somatic Mutations|somatic mutations
5964762|NCT04102020|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5964763|NCT04102020|Venetoclax|venetoclax
5964764|NCT04102020|Azacitidine|azacitidine
5964765|NCT04102020|Maintenance Therapy|maintenance therapy
5964766|NCT04102020|Conventional Chemotherapy|conventional chemotherapy
5964767|NCT04102020|Best supportive care (BSC)|best supportive care (bsc)
5964768|NCT04100902|Allergic asthma|allergic asthma
5964769|NCT04100902|Allergen Immunotherapy|allergen immunotherapy
5964770|NCT04100902|Anti-viral immunity|anti-viral immunity
5964771|NCT04100902|House dust mite|house dust mite
5964772|NCT04100733|Flexible cystoscopy|flexible cystoscopy
5964773|NCT04100733|Xpert Bladder Cancer Monitor|xpert bladder cancer monitor
5964774|NCT04099966|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5964775|NCT04099966|t-cell depletion|t-cell depletion
5964776|NCT04099966|alpha beta cell depletion|alpha beta cell depletion
5964777|NCT04099797|Gene Therapy|gene therapy
5964778|NCT04099797|CAR T-cells|car t-cells
5964779|NCT04099797|chimeric antigen receptor|chimeric antigen receptor
5964780|NCT04099797|Brain Cancer|brain cancer
5964781|NCT04099797|Immunotherapy|immunotherapy
5964783|NCT04099797|Brain tumor|brain tumor
5964784|NCT04099485|anticoagulation|anticoagulation
5964785|NCT04099485|decision sciences|decision sciences
5964786|NCT04099485|clinical informatics|clinical informatics
5964787|NCT04099485|implementation research|implementation research
5964788|NCT04098952|temporomandibular disorders|temporomandibular disorders
5964789|NCT04098952|electric massage|electric massage
5964790|NCT04098952|temporomandibular joint|temporomandibular joint
5964791|NCT04098952|local techniques|local techniques
5964792|NCT04098250|headache|headache
5964793|NCT04098250|post-traumatic headache|post-traumatic headache
5964794|NCT04098042|Bioresorbable scaffolds|bioresorbable scaffolds
5964795|NCT04098042|Magnesium made bioresorbable scaffolds|magnesium made bioresorbable scaffolds
5964796|NCT04098042|Magmaris|magmaris
5964797|NCT04098042|coronary artery disease|coronary artery disease
5964798|NCT04098042|Percutaneous coronary intervention|percutaneous coronary intervention
5964799|NCT04098042|Myocardia infarction|myocardia infarction
5964800|NCT04098042|multivessel coronary disease|multivessel coronary disease
5964801|NCT04097717|Tubal Ligation|tubal ligation
5964802|NCT04097717|Decision Aid|decision aid
5964803|NCT04097483|Comorbidity|comorbidity
5964804|NCT04097483|Depression|depression
5964805|NCT04097483|Type 2 Diabetes|type 2 diabetes
5964806|NCT04097483|Primary Health Care|primary health care
5964807|NCT04097483|Randomized-Controlled Trial|randomized-controlled trial
5964808|NCT04097483|Treatment Adherence|treatment adherence
5964809|NCT04097483|Telephone-Based Intervention|telephone-based intervention
5964810|NCT04096560|Drug therapy|drug therapy
5964811|NCT04096248|Large vessel occlusion|large vessel occlusion
5964812|NCT04096248|CT [Computed Tomography]|ct [computed tomography]
5964813|NCT04096248|CTP [Computed Tomography (CT) Perfusion]|ctp [computed tomography (ct) perfusion]
5964814|NCT04096248|Modified Rankin score|modified rankin score
5964815|NCT04096248|ASPECTS (Alberta Stroke Program Early CT Score)|aspects (alberta stroke program early ct score)
5964816|NCT04095273|DDR (Deoxyribonucleic acid damage repair),|ddr (deoxyribonucleic acid damage repair),
5964817|NCT04095273|ATR (ataxia-telangiectasia and Rad3 related protein)inhibitor,|atr (ataxia-telangiectasia and rad3 related protein)inhibitor,
5964818|NCT04094974|Heart rate variability,|heart rate variability,
5964819|NCT04094974|supratentorial brain tumors|supratentorial brain tumors
5964820|NCT04094974|optic nerve sheath diameter|optic nerve sheath diameter
5964821|NCT04094519|ASP9785|asp9785
5964822|NCT04094519|enzalutamide|enzalutamide
5964823|NCT04094519|prostate cancer|prostate cancer
5964824|NCT04094064|Dialysis|dialysis
5964825|NCT04094064|Hemodialysis|hemodialysis
5964826|NCT04094064|Diabetes|diabetes
5964827|NCT04094064|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5964828|NCT04093908|deep brain stimulation|deep brain stimulation
5964829|NCT04093908|motor outcome|motor outcome
5964830|NCT04093908|prediction model|prediction model
5964831|NCT04093908|machine learning|machine learning
5964832|NCT04093908|Subthalamic nucleus|subthalamic nucleus
5964833|NCT04093479|labor|labor
5964834|NCT04093479|obesity|obesity
5964835|NCT04093479|oxytocin|oxytocin
5964836|NCT04093414|Pacemaker|pacemaker
5964837|NCT04093414|Bundle of His|bundle of his
5964838|NCT04093414|Left Bundle Branch|left bundle branch
5964839|NCT04093076|Healthy volunteer|healthy volunteer
5964840|NCT04092894|Suvorexant|suvorexant
5964841|NCT04092894|Sleep architecture|sleep architecture
5964842|NCT04092894|Delirium|delirium
5964843|NCT04092894|Intensive care unit|intensive care unit
5964844|NCT04092686|acute psychosis|acute psychosis
5964845|NCT04092686|Schizophrenia|schizophrenia
5964846|NCT04092231|Hearing loss|hearing loss
5964847|NCT04091451|Shingles|shingles
5964848|NCT04091451|Shingles recurrence|shingles recurrence
5964849|NCT04091451|HZ|hz
5964850|NCT04091451|Vaccine response rate|vaccine response rate
5964851|NCT04091360|COPD|copd
5964852|NCT04091360|Adults|adults
5964853|NCT04091360|Phase II|phase ii
5964854|NCT04091360|RPL554|rpl554
5964855|NCT04091360|Ensifentrine|ensifentrine
5964856|NCT04091126|Bortezomib, lenalidomide and dexamethasone|bortezomib, lenalidomide and dexamethasone
5964857|NCT04091126|Belantamab mafodotin|belantamab mafodotin
5964858|NCT04091126|Dose escalation|dose escalation
5964859|NCT04091126|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5964860|NCT04091022|topical chemoprevention|topical chemoprevention
5964861|NCT04090736|Leukemia|leukemia
5964862|NCT04090736|Myeloid|myeloid
5964863|NCT04090736|Acute|acute
5964864|NCT04090736|Pevonedistat|pevonedistat
5964865|NCT04090736|Azacitidine|azacitidine
5964866|NCT04090736|Randomized|randomized
5964867|NCT04090736|Clinical trial|clinical trial
5964868|NCT04090580|dapagliflozin|dapagliflozin
5964869|NCT04090580|glycemic variability|glycemic variability
5964870|NCT04090554|esophagus|esophagus
5964871|NCT04090554|esophageal cancer|esophageal cancer
5964872|NCT04090554|cytosponge|cytosponge
5964873|NCT04090554|Tanzania|tanzania
5964874|NCT04090060|Anus neoplasm|anus neoplasm
5964875|NCT04090060|Digital anal rectal examination|digital anal rectal examination
5964876|NCT04090060|Self anal examination|self anal examination
5964877|NCT04089761|Migraine treatment, Adolescence|migraine treatment, adolescence
5964878|NCT04089553|Prostate cancer|prostate cancer
5964879|NCT04089553|AZD4635|azd4635
5964880|NCT04089553|oleclumab|oleclumab
5964881|NCT04089553|durvalumab|durvalumab
5964882|NCT04089553|MEDI9447|medi9447
5964883|NCT04089553|Adenosine 2A Receptor Antagonist|adenosine 2a receptor antagonist
5964884|NCT04089553|A2AR|a2ar
5964885|NCT04089527|Lymphoma|lymphoma
5964886|NCT04089527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5964887|NCT04089527|CC-95775|cc-95775
5964888|NCT04089527|Solid Tumors|solid tumors
5964889|NCT04089527|Safety|safety
5964890|NCT04089527|Relapsed/Refractory|relapsed/refractory
5964891|NCT04089319|Chronic Pain|chronic pain
5964892|NCT04089319|Acupuncture|acupuncture
5964893|NCT04089319|Mindfulness|mindfulness
5964894|NCT04089319|Interoceptive Awareness|interoceptive awareness
5964895|NCT04089059|Heart Failure|heart failure
5964896|NCT04089059|Heart Disease|heart disease
5964897|NCT04089059|Cardiovascular Disease|cardiovascular disease
5964898|NCT04089059|Pulmonary Artery Pressure|pulmonary artery pressure
5964899|NCT04088591|Sepsis; Shock, Septic; ascorbic acid;|sepsis; shock, septic; ascorbic acid;
5964900|NCT04088175|Topography|topography
5964901|NCT04087174|Metastatic|metastatic
5964907|NCT04086953|Endurance Time|endurance time
5964908|NCT04086953|Rehabilitation|rehabilitation
5964909|NCT04086485|Carcinoids|carcinoids
5964910|NCT04086485|Somatostatin Receptors|somatostatin receptors
5964911|NCT04086485|Ionizing Radiation|ionizing radiation
5964912|NCT04086394|Pain|pain
5964913|NCT04086394|Narcotics|narcotics
5964914|NCT04086394|Nerve block|nerve block
5964915|NCT04086134|constipation|constipation
5964916|NCT04084470|Non-Coeliac Gluten Sensitivity|non-coeliac gluten sensitivity
5964917|NCT04084470|Non-Coeliac Wheat Sensitivity|non-coeliac wheat sensitivity
5964918|NCT04084470|Gluten Sensitivity|gluten sensitivity
5964919|NCT04084470|Bread|bread
5964920|NCT04084470|Wheat|wheat
5964921|NCT04084470|Gastrointestinal symptoms|gastrointestinal symptoms
5964922|NCT04084470|Microbiota|microbiota
5964923|NCT04084470|Immune response|immune response
5964924|NCT04084470|Gluten|gluten
5964925|NCT04084288|Acupuncture, Total Knee Replacement|acupuncture, total knee replacement
5964926|NCT04083859|Mass screening|mass screening
5964927|NCT04083859|Early detection of cancer|early detection of cancer
5964928|NCT04083859|Digital health interventions|digital health interventions
5964929|NCT04083859|Decision making, computer assisted|decision making, computer assisted
5964930|NCT04082962|Dexamethasone|dexamethasone
5964931|NCT04082962|Uveal Melanoma|uveal melanoma
5964932|NCT04082962|Steroid-Implant|steroid-implant
5964933|NCT04082962|Exudative Retinal Detachment|exudative retinal detachment
5964934|NCT04082936|Lymphoma|lymphoma
5964935|NCT04082936|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5964936|NCT04082936|DLBCL|dlbcl
5964937|NCT04082936|Follicular Lymphoma|follicular lymphoma
5964938|NCT04082936|relapsed or refractory|relapsed or refractory
5964939|NCT04081831|Esophageal cancer|esophageal cancer
5964940|NCT04081831|Gastric cancer|gastric cancer
5964941|NCT04081831|Colorectal cancer|colorectal cancer
5964942|NCT04081779|Cancer survivors|cancer survivors
5964943|NCT04081779|survivorship care plans|survivorship care plans
5964944|NCT04081779|primary care|primary care
5964945|NCT04081363|ADHD|adhd
5964946|NCT04080362|Mitral Regurgitation|mitral regurgitation
5964947|NCT04080362|Mitral Valve Repair|mitral valve repair
5964948|NCT04080362|Transapical|transapical
5964949|NCT04080297|Vasomotor Symptoms, Breast Cancer, Hot Flashes, Tamoxifen, Aromatase Inhibitors, Estrogen Antagonists, Hormone Antagonists, Hormones, Hormone Substitutes|vasomotor symptoms, breast cancer, hot flashes, tamoxifen, aromatase inhibitors, estrogen antagonists, hormone antagonists, hormones, hormone substitutes
5964950|NCT04080297|Hormone Antagonists, Physiological Effects of Drugs, Antineoplastic Agents, Hormonal Antineoplastic, Selective Estrogen Receptor Modulators|hormone antagonists, physiological effects of drugs, antineoplastic agents, hormonal antineoplastic, selective estrogen receptor modulators
5964951|NCT04080297|Estrogen Receptor Modulators, Bone Density Conservation Agents, Steroid Synthesis Inhibitors, Enzyme Inhibitors, Molecular Mechanisms of Pharmacological Action|estrogen receptor modulators, bone density conservation agents, steroid synthesis inhibitors, enzyme inhibitors, molecular mechanisms of pharmacological action
5964952|NCT04079296|ASP7517|asp7517
5964953|NCT04079296|Safety|safety
5964954|NCT04079296|Efficacy|efficacy
5964955|NCT04079296|Tolerability|tolerability
5964956|NCT04078568|Kawasaki disease|kawasaki disease
5964957|NCT04078568|prednisolone|prednisolone
5964958|NCT04078568|coronary artery lesion|coronary artery lesion
5964959|NCT04078282|Depression|depression
5964960|NCT04078282|Elderly|elderly
5964961|NCT04078282|Family Practice|family practice
5964962|NCT04078126|COPD|copd
5964963|NCT04077827|Admnistration Fat Transfer|admnistration fat transfer
5964964|NCT04077827|Autologous Fat Transfer|autologous fat transfer
5964965|NCT04077827|Breast Reconstruction|breast reconstruction
5964966|NCT04077827|TIVA|tiva
5964967|NCT04077827|volatile anesthesia|volatile anesthesia
5964968|NCT04077827|stress levels|stress levels
5964969|NCT04077827|pain levels|pain levels
5964970|NCT04077450|Stress|stress
5964971|NCT04077450|Caregiver Burden|caregiver burden
5964972|NCT04077450|Alzheimer's Disease Caregiver|alzheimer's disease caregiver
5964973|NCT04077450|Informal Caregiver|informal caregiver
5964974|NCT04077450|Anxiety|anxiety
5964975|NCT04077450|Heart-Focused Breathing|heart-focused breathing
5964976|NCT04077229|ACS|acs
5964977|NCT04077229|Text Message|text message
5964978|NCT04077229|Positive Psychology|positive psychology
5964979|NCT04077229|Health Behavior|health behavior
5964980|NCT04077073|stroke rehabilitation|stroke rehabilitation
5964981|NCT04077073|hand opening|hand opening
5964982|NCT04077073|flexion synergy|flexion synergy
5964983|NCT04077073|robot assisted treatment|robot assisted treatment
5964984|NCT04077073|functional electrical stimulation|functional electrical stimulation
5964985|NCT04077073|motor recovery|motor recovery
5964986|NCT04077073|brain plasticity|brain plasticity
5964987|NCT04076540|Safety|safety
5964988|NCT04076540|Tolerability|tolerability
5964989|NCT04076540|Pharmacokinetics|pharmacokinetics
5964990|NCT04076540|Healthy Volunteers|healthy volunteers
5964991|NCT04075604|Nivolumab|nivolumab
5964992|NCT04075604|Breast Cancer|breast cancer
5964993|NCT04075604|Cancer|cancer
5964994|NCT04075604|ER+|er+
5964995|NCT04075604|HER2-|her2-
5964996|NCT04075604|Neoadjuvant|neoadjuvant
5964997|NCT04075500|atrial fibrillation|atrial fibrillation
5964998|NCT04075500|monitoring|monitoring
5964999|NCT04075500|ECG|ecg
5965000|NCT04075500|ischemic attack|ischemic attack
5965001|NCT04075435|cannabidiol|cannabidiol
5965002|NCT04075435|older adults|older adults
5965003|NCT04074135|Pancreatic tumors|pancreatic tumors
5965004|NCT04074135|68-Gallium DOTATATE|68-gallium dotatate
5965005|NCT04074135|MEN1 syndrome|men1 syndrome
5965006|NCT04074135|NETest|netest
5965007|NCT04074135|PNET|pnet
5965008|NCT04073628|Mild Cognitive Impairment, sleep and memory|mild cognitive impairment, sleep and memory
5965009|NCT04073472|crohn disease|crohn disease
5965010|NCT04073472|mesenchymal stem cells|mesenchymal stem cells
5965011|NCT04073472|pouch fistulas|pouch fistulas
5965012|NCT04072354|acute psychosis|acute psychosis
5965013|NCT04072354|schizophrenia|schizophrenia
5965014|NCT04072276|EV71 Vaccine|ev71 vaccine
5965015|NCT04072107|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5965016|NCT04072107|EBV DNA|ebv dna
5965017|NCT04072107|Biomarker-guided|biomarker-guided
5965034|NCT04070157|Opioid withdrawal|opioid withdrawal
5965035|NCT04070157|Opioid reduction|opioid reduction
5965036|NCT04070157|Stopping opioids|stopping opioids
5965037|NCT04070157|Opioid discontinuation|opioid discontinuation
5965038|NCT04070157|non-opioid pain management|non-opioid pain management
5965039|NCT04069026|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5965040|NCT04069026|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5965041|NCT04069026|Colorectal cancer microsatellite stable (MSS)|colorectal cancer microsatellite stable (mss)
5965042|NCT04069026|Advanced cancer|advanced cancer
5965043|NCT04069026|Immunotherapy|immunotherapy
5965044|NCT04069026|Immuno oncology|immuno oncology
5965045|NCT04069026|Aryl Hydrocarbon Receptor inhibitor(AhRi)|aryl hydrocarbon receptor inhibitor(ahri)
5965046|NCT04069026|Aryl Hydrocarbon Receptor|aryl hydrocarbon receptor
5965047|NCT04068610|Microsatellite|microsatellite
5965048|NCT04068610|colorectal|colorectal
5965050|NCT04068610|colon cancer|colon cancer
5965051|NCT04068467|Schizophrenia|schizophrenia
5965052|NCT04068467|Schizoaffective Disorder|schizoaffective disorder
5965053|NCT04068467|Mobile Application|mobile application
5965054|NCT04068467|SMI|smi
5965055|NCT04068467|EHealth|ehealth
5965056|NCT04068467|E-Health|e-health
5965057|NCT04068467|Health Technology|health technology
5965058|NCT04068467|mHealth|mhealth
5965059|NCT04068467|m-Health|m-health
5965060|NCT04068467|Mobile Health|mobile health
5965061|NCT04068467|Serious Mental Illness|serious mental illness
5965062|NCT04068467|Electronic Health|electronic health
5965063|NCT04068233|Diastolic function|diastolic function
5965064|NCT04068233|Cardiac output|cardiac output
5965065|NCT04068233|Pacemaker stimulation mode|pacemaker stimulation mode
5965066|NCT04068233|Stroke volume|stroke volume
5965067|NCT04068207|Retinitis Pigmentosa|retinitis pigmentosa
5965068|NCT04068207|Minocycline|minocycline
5965069|NCT04068207|ERG|erg
5965070|NCT04068207|Inherited Retinal Dystrophy|inherited retinal dystrophy
5965071|NCT04068207|Retinal Degenerative Disease|retinal degenerative disease
5965072|NCT04068181|Melanoma|melanoma
5965073|NCT04068181|Talimogene Laherparepvec|talimogene laherparepvec
5965074|NCT04068181|Pembrolizumab|pembrolizumab
5965075|NCT04068181|Oncolytic immunotherapy|oncolytic immunotherapy
5965076|NCT04068181|Anti-PD-1|anti-pd-1
5965077|NCT04068181|Checkpoint inhibitor|checkpoint inhibitor
5965078|NCT04068181|MASTERKEY-115|masterkey-115
5965079|NCT04067895|human bone graft screw|human bone graft screw
5965080|NCT04067895|epiphysiodesis|epiphysiodesis
5965081|NCT04067895|leg length inequality|leg length inequality
5965082|NCT04067895|primordial gigantism|primordial gigantism
5965083|NCT04067310|barrier film|barrier film
5965084|NCT04067310|spray skin protection|spray skin protection
5965085|NCT04067310|liquid-film|liquid-film
5965086|NCT04067310|barrier product|barrier product
5965087|NCT04067076|Mass Screening|mass screening
5965088|NCT04067076|Health Surveys|health surveys
5965089|NCT04067076|Mental Health|mental health
5965090|NCT04067076|Suicidal Ideation|suicidal ideation
5965091|NCT04067076|Young Adult|young adult
5965092|NCT04067076|Interpersonal Relations|interpersonal relations
5965093|NCT04067076|Smartphone|smartphone
5965094|NCT04067011|Antibiotics|antibiotics
5965095|NCT04067011|Pharmacokinetics|pharmacokinetics
5965096|NCT04067011|Vaccine|vaccine
5965097|NCT04067011|Ciprofloxacin|ciprofloxacin
5965098|NCT04067011|Doxycycline|doxycycline
5965099|NCT04067011|CPG 7909|cpg 7909
5965100|NCT04067011|Bacillus anthracis|bacillus anthracis
5965101|NCT04067011|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
5965102|NCT04067011|Post-exposure Prophylaxis|post-exposure prophylaxis
5965103|NCT04067011|Adjuvant|adjuvant
5965104|NCT04066868|patient-reported outcomes (PRO)|patient-reported outcomes (pro)
5965105|NCT04066868|common terminology criteria for adverse events (CTCAE)|common terminology criteria for adverse events (ctcae)
5965106|NCT04066868|quality of life|quality of life
5965107|NCT04066868|electronic data assessment|electronic data assessment
5965108|NCT04066114|adult living-donor kidney transplant recipients|adult living-donor kidney transplant recipients
5965109|NCT04066114|novel immunosuppressive (IS) therapy regimen|novel immunosuppressive (is) therapy regimen
5965110|NCT04066114|lulizumab pegol (BMS-931699)|lulizumab pegol (bms-931699)
5965111|NCT04066114|CD28 and IL-6 biologic blockade|cd28 and il-6 biologic blockade
5965112|NCT04066114|CD28 and IL-6 receptor antagonists|cd28 and il-6 receptor antagonists
5965113|NCT04066114|T regulatory cells (Treg) modulation|t regulatory cells (treg) modulation
5965114|NCT04064762|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
5965115|NCT04064762|Prolonged Exposure Therapy (PE)|prolonged exposure therapy (pe)
5965116|NCT04064762|PTSD|ptsd
5965117|NCT04064762|Post Traumatic Stress Disorder|post traumatic stress disorder
5965118|NCT04064697|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5965119|NCT04064697|CytoMegaloVirus (CMV)|cytomegalovirus (cmv)
5965120|NCT04064697|Vedolizumab|vedolizumab
5965126|NCT04064476|long-acting antipsychotics|long-acting antipsychotics
5965128|NCT04064060|Luspatercept|luspatercept
5965129|NCT04064060|MDS|mds
5965130|NCT04064060|Beta-thalassemia|beta-thalassemia
5965131|NCT04064060|Myeloproliferative neoplasm (MPN)-associated myelofibrosis|myeloproliferative neoplasm (mpn)-associated myelofibrosis
5965132|NCT04063150|inactivated poliovirus vaccine|inactivated poliovirus vaccine
5965133|NCT04063150|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
5965134|NCT04063150|intradermal|intradermal
5965135|NCT04063150|intramuscular|intramuscular
5965136|NCT04063137|Black rice|black rice
5965137|NCT04063137|Anthocyanin|anthocyanin
5965138|NCT04063137|Lipidemia|lipidemia
5965139|NCT04063137|High-fat diet|high-fat diet
5965140|NCT04060732|Flash Glucose Monitoring|flash glucose monitoring
5965141|NCT04060732|Glucose Monitoring|glucose monitoring
5965142|NCT04060732|Diabetes Mellitus Type 1|diabetes mellitus type 1
5965143|NCT04060667|vital sign monitoring|vital sign monitoring
5965144|NCT04060667|maternal near miss|maternal near miss
5965145|NCT04060667|maternal mortality|maternal mortality
5965146|NCT04060667|maternal morbidity|maternal morbidity
5965147|NCT04060667|physiologic monitoring|physiologic monitoring
5965148|NCT04060667|quality of care|quality of care
5965149|NCT04060667|inpatient monitoring|inpatient monitoring
5965150|NCT04060550|Atopic dermatitis|atopic dermatitis
5965151|NCT04060550|Eczema herpeticum|eczema herpeticum
5965152|NCT04060550|Immunoglobulin E|immunoglobulin e
5965153|NCT04060550|Herpes simplex virus|herpes simplex virus
5965154|NCT04059406|Thalassaemia|thalassaemia
5965155|NCT04059406|Beta Thalassemia|beta thalassemia
5965156|NCT04059406|IONIS TMPRSS6-LRx|ionis tmprss6-lrx
5965157|NCT04058756|Phase Ib|phase ib
5965158|NCT04058756|PDR001|pdr001
5965159|NCT04058756|PD-1|pd-1
5965160|NCT04058756|continued access|continued access
5965161|NCT04058561|Spinal deformity, early onset scoliosis|spinal deformity, early onset scoliosis
5965162|NCT04058262|in vitro fertilization|in vitro fertilization
5965163|NCT04058262|assisted reproduction|assisted reproduction
5965164|NCT04058262|pregnancy rate|pregnancy rate
5965165|NCT04058262|meditation|meditation
5965166|NCT04058262|Reiki|reiki
5965167|NCT04057664|Coping|coping
5965168|NCT04057664|Multidisciplinary|multidisciplinary
5965169|NCT04057664|Group Therapy|group therapy
5965170|NCT04057664|Psychotherapy|psychotherapy
5965171|NCT04057664|Physiotherapy|physiotherapy
5965172|NCT04056689|LRRK2|lrrk2
5965173|NCT04056689|Movement Disorders|movement disorders
5965174|NCT04056650|N-of-1|n-of-1
5965175|NCT04056650|Caffeine|caffeine
5965176|NCT04056650|L-theanine|l-theanine
5965177|NCT04056650|Nootropic|nootropic
5965178|NCT04056650|Cognition|cognition
5965179|NCT04056650|Individualized|individualized
5965180|NCT04056299|CODIT™ (characterized oral desensitization immunotherapy™)|codit™ (characterized oral desensitization immunotherapy™)
5965181|NCT04056299|Hen Egg Allergic Children|hen egg allergic children
5965182|NCT04056299|Desensitization|desensitization
5965183|NCT04056299|AR201|ar201
5965184|NCT04056299|Allergy|allergy
5965185|NCT04056299|Hen Egg Allergy|hen egg allergy
5965186|NCT04056299|Characterized Hen Egg Allergen|characterized hen egg allergen
5965187|NCT04056299|Oral Immunotherapy|oral immunotherapy
5965188|NCT04056299|CHEA (Characterized Hen Egg Allergen)|chea (characterized hen egg allergen)
5965189|NCT04056299|Food Allergy|food allergy
5965190|NCT04055909|Septic Shock|septic shock
5965191|NCT04055844|AML|aml
5965192|NCT04055844|MDS|mds
5965193|NCT04055428|Natriuretic Peptides|natriuretic peptides
5965194|NCT04055428|Diabetes|diabetes
5965195|NCT04055428|Insulin Sensitivity|insulin sensitivity
5965196|NCT04055428|Energy Expenditure|energy expenditure
5965197|NCT04054986|Breast Cancer|breast cancer
5965198|NCT04054986|18F-Var3|18f-var3
5965199|NCT04054986|First in human|first in human
5965200|NCT04054986|Acidosis imaging|acidosis imaging
5965201|NCT04054986|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5965202|NCT04054986|19-147|19-147
5965203|NCT04054895|Physiological pacing|physiological pacing
5965204|NCT04054895|Resynchronization therapy|resynchronization therapy
5965205|NCT04054895|Electrocardiographic imaging|electrocardiographic imaging
5965206|NCT04054765|prevention|prevention
5965207|NCT04054765|intervention|intervention
5965208|NCT04054752|Breast Cancer|breast cancer
5965209|NCT04054752|Colorectal Cancer|colorectal cancer
5965210|NCT04054752|Immune Insufficiency|immune insufficiency
5965211|NCT04054752|Bladder Cancer|bladder cancer
5965212|NCT04054752|Immunocompromised Host|immunocompromised host
5965213|NCT04054544|Celiac disease|celiac disease
5965214|NCT04053881|Plaque psoriasis|plaque psoriasis
5965215|NCT04053881|Cimzia|cimzia
5965216|NCT04053881|Certolizumab pegol|certolizumab pegol
5965217|NCT04053842|Prostate Cancer|prostate cancer
5965218|NCT04053842|PSMA PET|psma pet
5965219|NCT04053842|[18F]DCFPyL PET/CT imaging|[18f]dcfpyl pet/ct imaging
5965220|NCT04053842|Radical Prostatectomy|radical prostatectomy
5965221|NCT04053842|Sodium MRI|sodium mri
5965222|NCT04053842|Sodium Imaging|sodium imaging
5965223|NCT04053634|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5965224|NCT04053634|COPD|copd
5965225|NCT04053634|benralizumab|benralizumab
5965226|NCT04053634|Fasenra|fasenra
5965227|NCT04053634|ICS|ics
5965228|NCT04053634|inhaled corticosteroids|inhaled corticosteroids
5965229|NCT04053634|exacerbations|exacerbations
5965230|NCT04053634|Lung Disease|lung disease
5965231|NCT04053634|LABA/LAMA|laba/lama
5965232|NCT04053582|Early life adversity|early life adversity
5965233|NCT04053582|Adolescents|adolescents
5965234|NCT04053582|Mindfulness|mindfulness
5965235|NCT04053582|Neurobiology|neurobiology
5965236|NCT04053582|Stress and resilience|stress and resilience
5965237|NCT04053348|Mobile App|mobile app
5965238|NCT04053348|Telerehabilitation|telerehabilitation
5965239|NCT04053348|Physiotherapy|physiotherapy
5965240|NCT04053348|Hip Fractures|hip fractures
5965242|NCT04052854|WM|wm
5965243|NCT04052854|Treatment naive|treatment naive
5965244|NCT04052854|Relapsed/refractory|relapsed/refractory
5965245|NCT04052828|pregnant|pregnant
5965246|NCT04052828|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
5965247|NCT04052815|pre-diabetes|pre-diabetes
5965248|NCT04052815|female|female
5965249|NCT04052815|Diabetes type 2|diabetes type 2
5965250|NCT04052815|Hispanic/Latino|hispanic/latino
5965251|NCT04052815|community based programs|community based programs
5965252|NCT04052815|diabetes prevention program|diabetes prevention program
5965253|NCT04052074|Music Therapy|music therapy
5965254|NCT04052074|Palliative Care|palliative care
5965255|NCT04052074|Caregivers|caregivers
5965256|NCT04052074|Nurses|nurses
5965257|NCT04052074|Quality of Life|quality of life
5965258|NCT04052074|Cost efficiency analysis|cost efficiency analysis
5965259|NCT04051827|Drug therapy|drug therapy
5965260|NCT04051346|dietary oxalate|dietary oxalate
5965261|NCT04051346|diet therapy|diet therapy
5965262|NCT04050839|pain neuroscience education|pain neuroscience education
5965263|NCT04050839|patient education|patient education
5965264|NCT04050436|Oncolytic Virus|oncolytic virus
5965265|NCT04050436|Carcinoma|carcinoma
5965266|NCT04050436|Carcinoma, Squamous Cell|carcinoma, squamous cell
5965267|NCT04050436|Cemiplimab|cemiplimab
5965268|NCT04050436|Metastatic Cutaneous Squamous Cell Carcinoma|metastatic cutaneous squamous cell carcinoma
5965269|NCT04050436|Oncolytic Immuno-gene therapy|oncolytic immuno-gene therapy
5965270|NCT04050176|insomnia|insomnia
5965271|NCT04050176|sedative hypnotics|sedative hypnotics
5965272|NCT04050176|hypnotic tapering|hypnotic tapering
5965273|NCT04049656|Sevoflurane-Fentanyl Anesthesia|sevoflurane-fentanyl anesthesia
5965274|NCT04049643|Presbycusis|presbycusis
5965275|NCT04049643|Hearing aid|hearing aid
5965276|NCT04049643|Alzheimer Disease|alzheimer disease
5965277|NCT04049604|Prenatal Clinical Care|prenatal clinical care
5965278|NCT04049604|Prenatal Screen|prenatal screen
5965279|NCT04049604|Cell-Free DNA (cfDNA) test|cell-free dna (cfdna) test
5965280|NCT04049604|Pregnant Women|pregnant women
5965281|NCT04049604|Predictive Values|predictive values
5965282|NCT04049513|Lymphomas Non-Hodgkin's B-Cell|lymphomas non-hodgkin's b-cell
5965283|NCT04049513|Chimeric antigen receptor T-cell|chimeric antigen receptor t-cell
5965284|NCT04049331|testosterone|testosterone
5965285|NCT04049331|hypogonadism|hypogonadism
5965286|NCT04049331|cancer related fatigue|cancer related fatigue
5965287|NCT04049305|nipple sparing mastectomy|nipple sparing mastectomy
5965288|NCT04049305|robotic nipple sparing mastectomy (R-NSM)|robotic nipple sparing mastectomy (r-nsm)
5965289|NCT04049305|conventional nipple sparing mastectomy (C-NSM)|conventional nipple sparing mastectomy (c-nsm)
5965290|NCT04049305|endoscopic assisted nipple sparing mastectomy (E-NSM)|endoscopic assisted nipple sparing mastectomy (e-nsm)
5965291|NCT04049305|immediate breast reconstruction|immediate breast reconstruction
5965292|NCT04049305|immediate prothesis breast reconstruction|immediate prothesis breast reconstruction
5965293|NCT04048876|Non-Alcoholic Steatohepatitia|non-alcoholic steatohepatitia
5965294|NCT04048876|NASH|nash
5965295|NCT04048876|Non-Alcoholic Fatty Liver|non-alcoholic fatty liver
5965296|NCT04048876|Liver Fibrosis|liver fibrosis
5965297|NCT04048876|CC-90001|cc-90001
5965298|NCT04048551|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
5965299|NCT04048551|HIV (Human Immunodeficiency Virus)|hiv (human immunodeficiency virus)
5965300|NCT04048551|Adolescent Girls and Young Women (AGYW)|adolescent girls and young women (agyw)
5965301|NCT04048551|Stigma and Discrimination (S&D)|stigma and discrimination (s&d)
5965302|NCT04048551|Gender-based violence (GBV)|gender-based violence (gbv)
5965303|NCT04048551|Substance use|substance use
5965304|NCT04047654|anticoagulant drugs|anticoagulant drugs
5965305|NCT04046913|Dietary intervention|dietary intervention
5965306|NCT04046224|Sangamo|sangamo
5965307|NCT04046224|Rare|rare
5965308|NCT04046224|Lysosomal Storage Disease|lysosomal storage disease
5965309|NCT04046224|Gene Therapy|gene therapy
5965310|NCT04046107|Hepatitis B|hepatitis b
5965311|NCT04046107|Chronic hepatitis B|chronic hepatitis b
5965312|NCT04046107|Functional cure|functional cure
5965313|NCT04046107|Immunotherapy|immunotherapy
5965314|NCT04046107|Checkpoint inhibitor therapy|checkpoint inhibitor therapy
5965315|NCT04045665|Anticoagulation|anticoagulation
5965316|NCT04045665|Antiplatelet Therapy|antiplatelet therapy
5965317|NCT04045665|Post Operative Atrial Fibrillation|post operative atrial fibrillation
5965318|NCT04045002|'MyPinkMom' educational intervention|'mypinkmom' educational intervention
5965319|NCT04045002|haemoglobin level|haemoglobin level
5965320|NCT04045002|dietary iron intake|dietary iron intake
5965321|NCT04045002|knowledge level|knowledge level
5965322|NCT04045002|Theory of Planned Behavior construct|theory of planned behavior construct
5965323|NCT04044950|Intratumoral Injection|intratumoral injection
5965324|NCT04044950|Biomarkers|biomarkers
5965325|NCT04044950|T Cell Receptor|t cell receptor
5965326|NCT04044950|Immunotherapy|immunotherapy
5965327|NCT04044950|Neoadjuvant therapy|neoadjuvant therapy
5965328|NCT04044859|Cell Therapy|cell therapy
5965329|NCT04044859|T Cell Therapy|t cell therapy
5965330|NCT04044859|SPEAR T Cell|spear t cell
5965331|NCT04044859|MAGE-A4|mage-a4
5965332|NCT04044859|Immuno-oncology|immuno-oncology
5965333|NCT04044859|Metastatic|metastatic
5965334|NCT04044859|Synovial Sarcoma|synovial sarcoma
5965335|NCT04044859|Myxoid/Round Cell Liposarcoma (MRCLS)|myxoid/round cell liposarcoma (mrcls)
5965336|NCT04044859|Melanoma|melanoma
5965337|NCT04044859|Urothelial|urothelial
5965338|NCT04044859|Head and Neck|head and neck
5965339|NCT04044859|Ovarian|ovarian
5965340|NCT04044859|Gastric (stomach)|gastric (stomach)
5965341|NCT04044859|Esophagogastric Junction (EGJ)|esophagogastric junction (egj)
5965342|NCT04044859|Non-small Cell Lung (NSCLC)|non-small cell lung (nsclc)
5965343|NCT04044859|Esophageal Cancer|esophageal cancer
5965344|NCT04044768|Cell Therapy|cell therapy
5965345|NCT04044768|T Cell Therapy|t cell therapy
5965346|NCT04044768|SPEAR T Cell|spear t cell
5965347|NCT04044365|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5965348|NCT04044365|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5965349|NCT04044365|Phototherapies|phototherapies
5965350|NCT04044365|Graft Vs Host Disease|graft vs host disease
5965351|NCT04044352|A/Bethesda/MM2/H1N1 Virus|a/bethesda/mm2/h1n1 virus
5965352|NCT04044352|Challenge|challenge
5965353|NCT04044352|Dose Escalation|dose escalation
5965354|NCT04044352|Healthy Subjects|healthy subjects
5965355|NCT04044352|Influenza|influenza
5965357|NCT04042493|Overweight|overweight
5965358|NCT04042493|Obesity|obesity
5965359|NCT04042493|Pediatric|pediatric
5965360|NCT04042493|Implementation|implementation
5965361|NCT04042493|Dissemination|dissemination
5965362|NCT04042480|HER2-negative breast cancer|her2-negative breast cancer
5965363|NCT04041830|Appetite|appetite
5965364|NCT04041830|Food Reward|food reward
5965365|NCT04041830|Methodological approach|methodological approach
5965366|NCT04041362|HIV|hiv
5965367|NCT04041362|UB-421|ub-421
5965368|NCT04041271|Temporomandibular disorder|temporomandibular disorder
5965369|NCT04041271|Nonspecific chronic neck pain|nonspecific chronic neck pain
5965370|NCT04041271|Jaw kinematics|jaw kinematics
5965371|NCT04041271|Muscle activity|muscle activity
5965372|NCT04041271|Muscle sensitivity|muscle sensitivity
5965373|NCT04041271|Forward head|forward head
5965374|NCT04040751|Telehealth|telehealth
5965375|NCT04040751|Rehabilitation|rehabilitation
5965376|NCT04040751|Care partner|care partner
5965377|NCT04040751|Sub-acute stroke|sub-acute stroke
5965378|NCT04040751|CARE-CITE|care-cite
5965379|NCT04040751|Stroke survivors|stroke survivors
5965380|NCT04040621|nosocomial pneumonia, NP|nosocomial pneumonia, np
5965381|NCT04040322|systemic sclerosis|systemic sclerosis
5965382|NCT04040322|raynaud's phenomenon|raynaud's phenomenon
5965383|NCT04039854|Anaesthesia|anaesthesia
5965384|NCT04039854|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5965385|NCT04039854|Cardioprotection|cardioprotection
5965386|NCT04039477|Autoimmune|autoimmune
5965387|NCT04039477|Hemolytic|hemolytic
5965388|NCT04039477|Anemia|anemia
5965389|NCT04039477|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
5965390|NCT04039477|AIHA|aiha
5965391|NCT04039477|Immune|immune
5965392|NCT04039477|Thrombocytopenia|thrombocytopenia
5965393|NCT04039477|Immune Thrombocytopenia|immune thrombocytopenia
5965394|NCT04039477|ITP|itp
5965395|NCT04039477|Blood disorders|blood disorders
5965396|NCT04039477|Hematology|hematology
5965397|NCT04039113|COPD|copd
5965398|NCT04039113|Moderate COPD|moderate copd
5965399|NCT04039113|Severe COPD|severe copd
5965400|NCT04039113|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5965401|NCT04039074|Yoga|yoga
5965402|NCT04039074|Meditation|meditation
5965403|NCT04039074|Progressive muscle relaxation|progressive muscle relaxation
5965404|NCT04039074|Stress|stress
5965405|NCT04039074|Education|education
5965406|NCT04037605|Testosterone|testosterone
5965407|NCT04037605|Cortisol|cortisol
5965408|NCT04037527|Grade II sarcoma|grade ii sarcoma
5965409|NCT04037527|Grade III sarcoma|grade iii sarcoma
5965410|NCT04037072|Complex|complex
5965411|NCT04036721|anti-PD-1|anti-pd-1
5965412|NCT04036721|anti-PD-L1|anti-pd-l1
5965413|NCT04036721|pneumonitis|pneumonitis
5965414|NCT04036721|NSCLC|nsclc
5965415|NCT04036721|treatment|treatment
5965416|NCT04036721|programmed-death receptor|programmed-death receptor
5965417|NCT04034615|Mesenchyme Stem Cells|mesenchyme stem cells
5965418|NCT04034615|Cesarean Section|cesarean section
5965419|NCT04034615|Scars|scars
5965420|NCT04034355|colorectal cancer|colorectal cancer
5965421|NCT04034355|cancer|cancer
5965422|NCT04034355|peripheral neuropathy|peripheral neuropathy
5965423|NCT04034355|neuropathy|neuropathy
5965424|NCT04034264|Next Generation Sequencing|next generation sequencing
5965425|NCT04034264|Vector-Borne Diseases|vector-borne diseases
5965426|NCT04034264|Southeast Asia|southeast asia
5965427|NCT04034264|Agnostic Tools|agnostic tools
5965428|NCT04034264|Febrile Surveillance|febrile surveillance
5965429|NCT04034251|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
5965430|NCT04034251|Intravenous Chemotherapy|intravenous chemotherapy
5965431|NCT04034251|Progression Free Survival|progression free survival
5965432|NCT04034251|Peritoneal Metastasis|peritoneal metastasis
5965433|NCT04034251|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
5965434|NCT04033926|Myositis|myositis
5965435|NCT04033926|Idiopathic inflammatory myopathies|idiopathic inflammatory myopathies
5965436|NCT04033926|Polymyositis|polymyositis
5965437|NCT04033926|Dermatomyositis|dermatomyositis
5965438|NCT04033926|Musculoskeletal Diseases|musculoskeletal diseases
5965439|NCT04033926|Muscular Diseases|muscular diseases
5965440|NCT04033731|cognitive process|cognitive process
5965441|NCT04033731|visuospatial attention|visuospatial attention
5965442|NCT04033211|Minimal invasive surgery|minimal invasive surgery
5965443|NCT04033211|Appendectomy|appendectomy
5965444|NCT04033211|Cholecystectomy|cholecystectomy
5965445|NCT04032704|SCLC|sclc
5965446|NCT04032704|NSCLC-squamous|nsclc-squamous
5965447|NCT04032704|NSCLC-nonsquamous|nsclc-nonsquamous
5965448|NCT04032704|HNSCC|hnscc
5965449|NCT04032704|GEJ adenocarcinoma|gej adenocarcinoma
5965450|NCT04032041|Ankle Foot Orthosis|ankle foot orthosis
5965451|NCT04032041|Adult|adult
5965452|NCT04032041|3D Limb Scanning|3d limb scanning
5965453|NCT04032041|Limb Geometry|limb geometry
5965454|NCT04031859|Total Knee Replacement|total knee replacement
5965455|NCT04031859|Venous thromboembolism (VTE)|venous thromboembolism (vte)
5965456|NCT04031859|Risk Stratification|risk stratification
5965457|NCT04030754|pediatric burns, dressings, amniotic membrane, duoderm|pediatric burns, dressings, amniotic membrane, duoderm
5965458|NCT04030741|Acute Appendicitis.|acute appendicitis.
5965459|NCT04030741|Pediatric Appendicitis Score (PAS).|pediatric appendicitis score (pas).
5965460|NCT04030741|Visual Analogue Scale (VAS) Score.|visual analogue scale (vas) score.
5965461|NCT04030598|IONIS PKK-LRx|ionis pkk-lrx
5965462|NCT04030169|MDMA|mdma
5965463|NCT04030169|methylenedioxymethamphetamine|methylenedioxymethamphetamine
5965464|NCT04030169|psychotherapy|psychotherapy
5965465|NCT04029974|Spinal cord injury|spinal cord injury
5965466|NCT04029974|Orthostatic hypotension|orthostatic hypotension
5965467|NCT04029974|Verticalization|verticalization
5965468|NCT04029974|ErigoPro|erigopro
5965469|NCT04029974|Finapres Nova|finapres nova
5965470|NCT04027946|Immunotherapy|immunotherapy
5965471|NCT04027946|Checkpoint Inhibitor|checkpoint inhibitor
5965472|NCT04027946|Monoclonal Antibody|monoclonal antibody
5965473|NCT04027946|Lung Adenocarcinoma|lung adenocarcinoma
5965474|NCT04027348|bowel obstruction|bowel obstruction
5965475|NCT04025567|Gut Bacteria|gut bacteria
5965476|NCT04025567|Anti-Tumor Effects|anti-tumor effects
5965477|NCT04025567|NKT cells|nkt cells
5965478|NCT04023812|prospective|prospective
5965479|NCT04023812|observational|observational
5965480|NCT04023812|stage III NSCLC|stage iii nsclc
5965481|NCT04023747|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
5965482|NCT04023747|Asymptomatic Chronic Lymphocytic Leukaemia|asymptomatic chronic lymphocytic leukaemia
5965483|NCT04023747|IgM Monoclonal Gammopathy|igm monoclonal gammopathy
5965484|NCT04023747|Asymptomatic Waldenstrom's Macroglobulinaemia|asymptomatic waldenstrom's macroglobulinaemia
5965485|NCT04023747|Immunoglobulin A or G Monoclonal Gammopathy|immunoglobulin a or g monoclonal gammopathy
5965486|NCT04023747|Smouldering Myeloma|smouldering myeloma
5965487|NCT04023747|Pre-cancerous|pre-cancerous
5965488|NCT04023747|Lymphoproliferative Disorders|lymphoproliferative disorders
5965489|NCT04023552|Lipoprotein(a), Lp(a),CVD, myocardial infarction, PAD,Stroke|lipoprotein(a), lp(a),cvd, myocardial infarction, pad,stroke
5965490|NCT04022070|foot|foot
5965491|NCT04022070|fasciitis|fasciitis
5965492|NCT04022070|tapping|tapping
5965493|NCT04021654|Preterm birth; growth; neonatology; Pregnancy; Delivery|preterm birth; growth; neonatology; pregnancy; delivery
5965494|NCT04021290|Current antiretroviral regimen (CAR), HIV-1, Long-term antiviral activity, Dolutegravir/lamivudine, Fixed dose combination|current antiretroviral regimen (car), hiv-1, long-term antiviral activity, dolutegravir/lamivudine, fixed dose combination
5965495|NCT04020887|Telemedicine|telemedicine
5965496|NCT04020887|Post Anesthesia Care Unit (PACU)|post anesthesia care unit (pacu)
5965497|NCT04020861|Electrophysical agents|electrophysical agents
5965498|NCT04020861|Low-level laser therapy|low-level laser therapy
5965499|NCT04020861|TENS|tens
5965500|NCT04020861|Neck pain|neck pain
5965501|NCT04020861|Chronic pain|chronic pain
5965502|NCT04020809|atezolizumab|atezolizumab
5965503|NCT04020809|neoadjuvant|neoadjuvant
5965504|NCT04020809|cutaneous melanoma|cutaneous melanoma
5965505|NCT04019990|Sports for Persons with Disabilities|sports for persons with disabilities
5965506|NCT04019990|Basketball|basketball
5965507|NCT04019990|Exercise|exercise
5965508|NCT04019912|Gait rehabilitation|gait rehabilitation
5965509|NCT04019912|Rhythmic auditory stimulation|rhythmic auditory stimulation
5965510|NCT04019912|GaitTrainer3|gaittrainer3
5965511|NCT04019912|Multiple sclerosis|multiple sclerosis
5965512|NCT04019808|Gastric Cancer|gastric cancer
5965513|NCT04019808|Personalized medicine|personalized medicine
5965514|NCT04019808|Oncology|oncology
5965515|NCT04019808|Solid tumor|solid tumor
5965516|NCT04019808|Primary Intervention|primary intervention
5965517|NCT04019574|Difelikefalin|difelikefalin
5965518|NCT04019574|CR845|cr845
5965519|NCT04019574|QTc|qtc
5965520|NCT04019574|TQT|tqt
5965521|NCT04019392|cooling rates|cooling rates
5965522|NCT04019028|low frequency rTMS|low frequency rtms
5965523|NCT04019028|fNIRS|fnirs
5965524|NCT04019028|Hemodynamic Response|hemodynamic response
5965525|NCT04019028|Non-invasive brain stimulation|non-invasive brain stimulation
5965526|NCT04017351|Plastic|plastic
5965527|NCT04017351|Virtual Assistant|virtual assistant
5965528|NCT04017013|Pain|pain
5965529|NCT04017013|Abdominal Surgery|abdominal surgery
5965530|NCT04017013|Epidural analgesia|epidural analgesia
5965531|NCT04017013|lidocaine|lidocaine
5965532|NCT04016454|handover|handover
5965533|NCT04016454|intraoperative|intraoperative
5965534|NCT04016454|anesthesia|anesthesia
5965535|NCT04016454|adverse outcomes|adverse outcomes
5965536|NCT04016415|Stress, Psychological|stress, psychological
5965537|NCT04016415|Mindfulness|mindfulness
5965538|NCT04016415|Meditation|meditation
5965539|NCT04016415|Mind-Body Therapies|mind-body therapies
5965540|NCT04016415|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5965541|NCT04016324|Overactive Bladder|overactive bladder
5965542|NCT04016324|Urinary Urge Incontinence|urinary urge incontinence
5965543|NCT04016324|Urgency-frequency Syndrome|urgency-frequency syndrome
5965544|NCT04016103|Acute Compartment Syndrome|acute compartment syndrome
5965545|NCT04015102|Prostate Cancer Patients|prostate cancer patients
5965546|NCT04015102|myRisk genetic testing|myrisk genetic testing
5965547|NCT04014673|Frontotemporal Dementia,|frontotemporal dementia,
5965548|NCT04014673|biomarkers,|biomarkers,
5965549|NCT04014673|brain Imaging PET|brain imaging pet
5965550|NCT04014491|Shoulder impingement syndrome|shoulder impingement syndrome
5965551|NCT04014491|Transcranial magnetic stimulation|transcranial magnetic stimulation
5965552|NCT04014491|Corticospinal system|corticospinal system
5965553|NCT04014491|Scapular control exercise|scapular control exercise
5965554|NCT04014491|Kinematics|kinematics
5965555|NCT04014348|Neighborhood Environment|neighborhood environment
5965556|NCT04014348|Cardiovascular Disease Risk|cardiovascular disease risk
5965557|NCT04014348|Social Determinants of Health|social determinants of health
5965558|NCT04014348|Diagnostic Behavioral study|diagnostic behavioral study
5965559|NCT04014348|Socio-Economic|socio-economic
5965560|NCT04014270|Electrical stimulation|electrical stimulation
5965561|NCT04014270|Upper limb rehabilitation|upper limb rehabilitation
5965562|NCT04014270|Hemiplegia|hemiplegia
5965563|NCT04014075|Human epidermal receptor 2 positive|human epidermal receptor 2 positive
5965564|NCT04014075|Unresectable or metastatic|unresectable or metastatic
5965565|NCT04014075|HER2|her2
5965566|NCT04014075|Prior treatment regimen included trastuzumab|prior treatment regimen included trastuzumab
5265949|NCT02354534|CIN|cin
5965567|NCT04013854|nivolumab|nivolumab
5965568|NCT04013854|ipilimumab|ipilimumab
5965569|NCT04013854|adjuvant|adjuvant
5965570|NCT04013854|neoadjuvant|neoadjuvant
5965571|NCT04013854|surgery|surgery
5965572|NCT04013802|cytomegalovirus (CMV)|cytomegalovirus (cmv)
5965573|NCT04013802|BK virus|bk virus
5965574|NCT04013802|Epstein-Barr virus (EBV)|epstein-barr virus (ebv)
5965575|NCT04013802|adenovirus|adenovirus
5965576|NCT04013490|physiological parameters|physiological parameters
5965577|NCT04013490|consumption safety|consumption safety
5965578|NCT04013490|cassava|cassava
5965579|NCT04013490|food supplement|food supplement
5965580|NCT04013490|overweight female|overweight female
5965581|NCT04013269|Sepsis|sepsis
5965582|NCT04013269|Critically ill|critically ill
5965583|NCT04013269|Intensive care medicine|intensive care medicine
5965584|NCT04013269|CytoSorb|cytosorb
5965585|NCT04013269|Hemoadsorption|hemoadsorption
5965586|NCT04013269|Pharmacokinetic|pharmacokinetic
5965587|NCT04012723|Acute Compartment Syndrome|acute compartment syndrome
5965588|NCT04012151|Blood pressure measurement|blood pressure measurement
5965589|NCT04012151|Conicity index|conicity index
5965590|NCT04012151|Mid arm circumference|mid arm circumference
5965591|NCT04012151|Cuff size|cuff size
5965592|NCT04011410|Prostate Cancer|prostate cancer
5965593|NCT04011410|Oligometastatic Prostate Cancer|oligometastatic prostate cancer
5965594|NCT04011410|Limited Metastatic Disease|limited metastatic disease
5965595|NCT04011410|Metastatic Prostate Cancer|metastatic prostate cancer
5965596|NCT04011189|Postoperative pain|postoperative pain
5965597|NCT04011189|Automated video analysis|automated video analysis
5965598|NCT04011189|Pain score|pain score
5965599|NCT04011189|Face recognition|face recognition
5965600|NCT04011163|Postoperative pain|postoperative pain
5965601|NCT04011163|Respiratory depression|respiratory depression
5965602|NCT04011163|Bradypnoea|bradypnoea
5965603|NCT04011163|Morphine|morphine
5965604|NCT04011163|Infusion pump|infusion pump
5965605|NCT04011150|Labor Pain|labor pain
5965606|NCT04011150|Breakthrough Pain|breakthrough pain
5965607|NCT04011150|Infusion pump|infusion pump
5965608|NCT04009577|Insomnia|insomnia
5965609|NCT04009577|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5965610|NCT04009577|Insomnia Disorder|insomnia disorder
5965611|NCT04009577|Sleeplessness|sleeplessness
5965612|NCT04009577|E2006|e2006
5965613|NCT04009577|Zolpidem|zolpidem
5965614|NCT04009577|Lemborexant|lemborexant
5965615|NCT04009018|scale|scale
5965616|NCT04009018|validity|validity
5965617|NCT04009018|reliability|reliability
5965618|NCT04008797|Solid Tumor|solid tumor
5965619|NCT04008797|Hepatocellular carcinoma|hepatocellular carcinoma
5965620|NCT04008797|E7386|e7386
5965621|NCT04008797|Lenvatinib|lenvatinib
5965622|NCT04008706|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5965623|NCT04008706|Acalabrutinib|acalabrutinib
5965624|NCT04008368|Graft-Versus-Host Disease|graft-versus-host disease
5965625|NCT04008368|Donor Apheresis|donor apheresis
5965626|NCT04008368|Host-Donor Chimerism|host-donor chimerism
5965627|NCT04007536|MPS-II|mps-ii
5965628|NCT04007536|Mucopolysaccharidosis-II|mucopolysaccharidosis-ii
5965629|NCT04007536|Lysosomal Storage Disease|lysosomal storage disease
5965630|NCT04007458|Screening|screening
5965631|NCT04006847|Omega-3 Fatty Acid|omega-3 fatty acid
5965632|NCT04006847|Eicosapentaenoic Acid|eicosapentaenoic acid
5965633|NCT04006847|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5965634|NCT04006847|TKI|tki
5965635|NCT04006847|GoldAID Eicosapentaenoic Acid|goldaid eicosapentaenoic acid
5965636|NCT04006847|Fish Oil|fish oil
5965637|NCT04006457|Alopecia|alopecia
5965638|NCT04006457|Alopecia Areata|alopecia areata
5965639|NCT04006457|Alopecia totalis|alopecia totalis
5965640|NCT04006457|Alopecia universalis|alopecia universalis
5965641|NCT04006457|Patchy hair loss|patchy hair loss
5965642|NCT04006457|Diffuse hair loss|diffuse hair loss
5965643|NCT04006457|Hair loss|hair loss
5965644|NCT04006457|Hair disease|hair disease
5965645|NCT04006457|PF-06651600|pf-06651600
5965646|NCT04004520|stress|stress
5965647|NCT04004520|cortisol|cortisol
5965648|NCT04004520|alpha-amylase|alpha-amylase
5965649|NCT04004520|homelessness|homelessness
5965650|NCT04004520|biomarkers|biomarkers
5965651|NCT04004520|virtual reality|virtual reality
5965652|NCT04004520|meditation|meditation
5965653|NCT04004052|Meralgia paresthetica|meralgia paresthetica
5965654|NCT04004052|Ultrasound-guided injection|ultrasound-guided injection
5965655|NCT04004052|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5965656|NCT04003896|Biliary Tract Carcinoma|biliary tract carcinoma
5965657|NCT04003896|Abemaciclib|abemaciclib
5965658|NCT04003714|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5965659|NCT04003714|back pain|back pain
5965660|NCT04003714|failed back surgery syndrome|failed back surgery syndrome
5965661|NCT04003636|Programmed cell death 1 (PD-1)|programmed cell death 1 (pd-1)
5965662|NCT04003636|Pembrolizumab|pembrolizumab
5965663|NCT04003636|Cholangiocarcinoma|cholangiocarcinoma
5266071|NCT02354014|Bedaquiline|bedaquiline
5965664|NCT04003636|Gallbladder cancer|gallbladder cancer
5965665|NCT04003636|Checkpoint inhibitor|checkpoint inhibitor
5965666|NCT04003636|Immunotherapy|immunotherapy
5965667|NCT04003636|Biliary|biliary
5965668|NCT04003636|Keytruda|keytruda
5965669|NCT04003636|Bile Duct Cancer|bile duct cancer
5965670|NCT04003389|menopause|menopause
5965671|NCT04003389|fezolinetant|fezolinetant
5965672|NCT04003389|ESN364|esn364
5965673|NCT04003389|vasomotor symptoms|vasomotor symptoms
5965674|NCT04003246|Lung|lung
5965675|NCT04003155|menopause|menopause
5965676|NCT04003155|ESN364|esn364
5965677|NCT04003155|vasomotor symptoms|vasomotor symptoms
5965678|NCT04003155|fezolinetant|fezolinetant
5965679|NCT04003142|ESN364|esn364
5965680|NCT04003142|menopause|menopause
5965681|NCT04003142|fezolinetant|fezolinetant
5965682|NCT04003142|vasomotor symptoms|vasomotor symptoms
5965683|NCT04002986|increased risk of breast cancer|increased risk of breast cancer
5965684|NCT04002661|Low libido|low libido
5965685|NCT04002661|Erectile Dysfunction|erectile dysfunction
5965686|NCT04002661|Sexual desire|sexual desire
5965687|NCT04002115|Clofarabine|clofarabine
5965688|NCT04002115|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5965689|NCT04002115|Non-remission AML|non-remission aml
5965690|NCT04001374|Thrombosis|thrombosis
5965691|NCT04001374|Platelets|platelets
5965692|NCT04001374|Platelet Aggregation|platelet aggregation
5965693|NCT04001374|Blood Thrombogenicity|blood thrombogenicity
5965694|NCT04000997|endotracheal tube|endotracheal tube
5965695|NCT04000997|extubation|extubation
5965696|NCT04000997|peak cough flow|peak cough flow
5965697|NCT04000997|predictive value|predictive value
5965698|NCT04000685|low back pain|low back pain
5965699|NCT04000685|exercise|exercise
5965700|NCT04000685|cognitive|cognitive
5965701|NCT04000685|aerobic|aerobic
5965702|NCT04000685|yoga|yoga
5965703|NCT03999736|tDCS|tdcs
5965704|NCT03999736|fMRI|fmri
5965705|NCT03999736|fear|fear
5965706|NCT03999736|vigilance|vigilance
5965707|NCT03999736|biomarkers|biomarkers
5965708|NCT03999515|Prostate|prostate
5965709|NCT03999164|neuroinflammation|neuroinflammation
5965710|NCT03999164|activated microglia|activated microglia
5965711|NCT03999164|TSPO|tspo
5965712|NCT03999164|Traumatic Brain Injury|traumatic brain injury
5965713|NCT03999164|TBI|tbi
5965714|NCT03999164|Positron emission tomography|positron emission tomography
5965715|NCT03998787|Parkinson's disease|parkinson's disease
5965716|NCT03998787|Neurophysiology|neurophysiology
5965717|NCT03998358|Circadian Rhythm|circadian rhythm
5965718|NCT03998358|Biomarkers|biomarkers
5965719|NCT03998358|Neuroendocrine|neuroendocrine
5965720|NCT03998358|Sleep|sleep
5965721|NCT03998358|Traumatic Brain Injury|traumatic brain injury
5965722|NCT03998163|Hemodialysis|hemodialysis
5965723|NCT03998163|Pruritus|pruritus
5965724|NCT03998163|Uremic Pruritus|uremic pruritus
5965725|NCT03998163|Dialysis|dialysis
5965726|NCT03998163|CR845|cr845
5965727|NCT03998163|Chronic Itch|chronic itch
5965728|NCT03998163|CKD|ckd
5965733|NCT03998163|Itch|itch
5965734|NCT03998163|Itching|itching
5965735|NCT03998163|KALM|kalm
5965736|NCT03998163|Chronic Kidney Disease|chronic kidney disease
5965737|NCT03998163|Kidney failure, chronic|kidney failure, chronic
5965738|NCT03998163|Kidney dysfunction|kidney dysfunction
5965739|NCT03998163|Generalized pruritus|generalized pruritus
5965740|NCT03997123|Breast Cancer;|breast cancer;
5965741|NCT03997123|Triple-negative Breast Cancer|triple-negative breast cancer
5965742|NCT03996551|kidney transplant|kidney transplant
5965743|NCT03996551|weight gain prevention|weight gain prevention
5965744|NCT03996551|behavior change techniques|behavior change techniques
5965745|NCT03996551|dietary advice|dietary advice
5965746|NCT03996551|physical activity advice|physical activity advice
5965747|NCT03996473|NSCLC|nsclc
5965748|NCT03994887|General anesthesia|general anesthesia
5965749|NCT03994887|Surgery|surgery
5965750|NCT03994887|Free Head|free head
5965751|NCT03994458|Musculoskeletal Rehabilitation|musculoskeletal rehabilitation
5965752|NCT03994458|Smartphone application|smartphone application
5965753|NCT03994458|Occupational Stress|occupational stress
5965754|NCT03994276|Chickpea|chickpea
5965755|NCT03994276|Cell Wall|cell wall
5965756|NCT03994276|Dietary Fibre|dietary fibre
5965757|NCT03994276|Postprandial|postprandial
5965758|NCT03994276|Metabolism|metabolism
5965759|NCT03994276|Enteroendocrine|enteroendocrine
5965760|NCT03993145|Mentoring|mentoring
5965761|NCT03993145|Healthy life style|healthy life style
5965762|NCT03993145|Postpartum Period|postpartum period
5965763|NCT03992092|cervical spine injury|cervical spine injury
5965764|NCT03992027|cystic fibrosis|cystic fibrosis
5266186|NCT02353299|Balance|balance
5965765|NCT03992027|cognitive-behavioral therapy|cognitive-behavioral therapy
5965766|NCT03992027|prevention|prevention
5965767|NCT03992027|coping|coping
5965768|NCT03991936|Nail Psoriasis|nail psoriasis
5965769|NCT03991936|Nail Diseases|nail diseases
5965770|NCT03991936|Triamcinolone acetonide|triamcinolone acetonide
5965771|NCT03991936|Triamcinolone|triamcinolone
5965772|NCT03991091|Multicenter|multicenter
5965773|NCT03991091|randomized|randomized
5965774|NCT03991091|control study|control study
5965775|NCT03991091|Oxytocin discontinuation|oxytocin discontinuation
5965776|NCT03991091|Neonatal acidosis|neonatal acidosis
5965777|NCT03990844|Glucose|glucose
5965778|NCT03990844|Insulin|insulin
5965779|NCT03990844|Ghrelin|ghrelin
5965780|NCT03990844|GLP-1|glp-1
5965781|NCT03989674|Glycemic index|glycemic index
5965782|NCT03989674|Postprandial hyperglycemia|postprandial hyperglycemia
5965783|NCT03989674|Anthocyanin|anthocyanin
5965784|NCT03989674|Black rice|black rice
5965785|NCT03989102|Pregnancy|pregnancy
5965786|NCT03989102|Tolerability|tolerability
5965787|NCT03989102|Immune|immune
5965788|NCT03989102|Response|response
5965789|NCT03989102|Vaccination|vaccination
5965790|NCT03988595|Exercise|exercise
5965791|NCT03988595|19-113|19-113
5965792|NCT03988582|cytotoxic T cells|cytotoxic t cells
5965793|NCT03988582|HLA-haplotype|hla-haplotype
5965794|NCT03988582|18-315|18-315
5965795|NCT03987620|Vaginitis|vaginitis
5965796|NCT03987620|Yeast infection|yeast infection
5965797|NCT03987464|Alzheimer's Disease|alzheimer's disease
5965798|NCT03987464|maladaptive|maladaptive
5965799|NCT03987464|behavior|behavior
5965800|NCT03986346|scar|scar
5965801|NCT03986346|pulsed dye laser|pulsed dye laser
5965802|NCT03986216|Stroke rehabilitation|stroke rehabilitation
5965803|NCT03986216|Hand opening|hand opening
5965804|NCT03986216|Functional electrical stimulation|functional electrical stimulation
5965805|NCT03986216|Home-based intervention|home-based intervention
5965806|NCT03986216|Task-specific practice|task-specific practice
5965807|NCT03986216|Device-assisted practice|device-assisted practice
5965808|NCT03986034|ramp up|ramp up
5965809|NCT03986034|Rituximab|rituximab
5965810|NCT03986034|Tumor|tumor
5965811|NCT03986034|Treatment|treatment
5965812|NCT03986034|Cancer|cancer
5965813|NCT03985059|Verticalization|verticalization
5965814|NCT03985059|Doppler|doppler
5965815|NCT03985059|Intracranial hemodynamic|intracranial hemodynamic
5965816|NCT03985059|Cerebral artery velocity|cerebral artery velocity
5965817|NCT03984565|Cannabidiol|cannabidiol
5965818|NCT03984565|Medical Marijuana|medical marijuana
5965819|NCT03984344|Theta Burst Stimulation|theta burst stimulation
5965820|NCT03984344|Neuromodulation|neuromodulation
5965821|NCT03984344|Psychiatric Disorders|psychiatric disorders
5965822|NCT03984344|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5965823|NCT03984344|Anorexia Nervosa|anorexia nervosa
5965824|NCT03984344|Eating Disorders|eating disorders
5965825|NCT03983863|NIH|nih
5965826|NCT03983863|Panel|panel
5965827|NCT03983863|Member/Staff|member/staff
5965828|NCT03983837|Inflammatory Bowel Disease|inflammatory bowel disease
5965829|NCT03983837|Crohn's Disease|crohn's disease
5965830|NCT03983837|Ulcerative Colitis|ulcerative colitis
5965831|NCT03983837|Glucocorticoids|glucocorticoids
5965832|NCT03983837|Microbiome|microbiome
5965833|NCT03982537|Head and neck squamous cell cancer|head and neck squamous cell cancer
5965834|NCT03980730|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
5965835|NCT03980730|ADAS-cog|adas-cog
5965836|NCT03980730|CDR-sb|cdr-sb
5965837|NCT03980223|HIV|hiv
5965838|NCT03980223|Post-Exposure Prophylaxis|post-exposure prophylaxis
5965839|NCT03980223|Men who have sex with men (MSM)|men who have sex with men (msm)
5965840|NCT03980223|Doxycycline|doxycycline
5965841|NCT03980223|HIV Pre-Exposure Prophylaxis|hiv pre-exposure prophylaxis
5965842|NCT03980223|Sexually transmitted infection|sexually transmitted infection
5965843|NCT03980132|Thyroid Surgery|thyroid surgery
5965844|NCT03980132|Grave' Disease|grave' disease
5965845|NCT03980132|Lugol Solution|lugol solution
5965846|NCT03979664|Skin Lesions|skin lesions
5965847|NCT03979404|Theta Burst Stimulation|theta burst stimulation
5965848|NCT03979404|Neuromodulation|neuromodulation
5965849|NCT03979404|Psychiatric Disorders|psychiatric disorders
5965850|NCT03979404|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5965851|NCT03979404|Anorexia Nervosa|anorexia nervosa
5965852|NCT03979404|Eating Disorders|eating disorders
5965853|NCT03978546|glaucoma|glaucoma
5965854|NCT03977389|Long-term result|long-term result
5965855|NCT03977389|Denervation|denervation
5965856|NCT03976869|glucocorticoid receptor (GR) modulator (SGRM)|glucocorticoid receptor (gr) modulator (sgrm)
5965857|NCT03976869|non-steroidal|non-steroidal
5965859|NCT03976869|Adolescents|adolescents
5965860|NCT03976375|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5266293|NCT02352584|QIV|qiv
5965861|NCT03976375|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5965862|NCT03976375|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5965863|NCT03976362|PD-1|pd-1
5965864|NCT03976362|PD L1|pd l1
5965865|NCT03976362|PD L2|pd l2
5965866|NCT03976323|Lung cancer|lung cancer
5965867|NCT03976323|PD-1|pd-1
5965868|NCT03976323|PD L1|pd l1
5965869|NCT03976323|PD L2|pd l2
5965870|NCT03976245|Tumour Necrosis Factor|tumour necrosis factor
5965871|NCT03976245|Janus kinase inhibitor|janus kinase inhibitor
5965872|NCT03975621|Exercise|exercise
5965873|NCT03975621|Feasibility|feasibility
5965874|NCT03975621|Acceptability|acceptability
5965875|NCT03975621|Supportive Care Platform|supportive care platform
5965876|NCT03974087|Mild Cognitive Impairment|mild cognitive impairment
5965877|NCT03974087|Transcranial direct current stimulation|transcranial direct current stimulation
5965878|NCT03973814|continuous renal replacement therapy|continuous renal replacement therapy
5965879|NCT03973346|risk prediction|risk prediction
5965880|NCT03972891|speech sound disorders|speech sound disorders
5965881|NCT03972891|children|children
5965882|NCT03972215|Hyperglycemic Clamp|hyperglycemic clamp
5965883|NCT03971071|Chronic Migraine (CM)|chronic migraine (cm)
5965884|NCT03971071|Medication Overuse Headache (MOH)|medication overuse headache (moh)
5965885|NCT03970720|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5965886|NCT03970538|CLI|cli
5965887|NCT03970538|CLTI|clti
5965888|NCT03970538|Amputation|amputation
5965889|NCT03970538|Desert Foot|desert foot
5965890|NCT03970538|PAD|pad
5965891|NCT03970538|Peripheral Artery Disease|peripheral artery disease
5965892|NCT03970538|Critical Limb Ischemia|critical limb ischemia
5965893|NCT03970538|Chronic Limb-Threatening Ischemia|chronic limb-threatening ischemia
5965894|NCT03970447|Glioblastoma|glioblastoma
5965895|NCT03970447|Newly diagnosed|newly diagnosed
5965896|NCT03970447|recurrent|recurrent
5965897|NCT03970447|O6-methylguanine-DNA-methyltransferase (MGMT) methylated|o6-methylguanine-dna-methyltransferase (mgmt) methylated
5965898|NCT03970447|MGMT unmethylated|mgmt unmethylated
5965899|NCT03970447|isocitrate dehydrogenase (IDH) wild-type|isocitrate dehydrogenase (idh) wild-type
5965900|NCT03970447|Bayesian|bayesian
5965901|NCT03970447|adaptive randomization|adaptive randomization
5965902|NCT03970447|Master Protocol|master protocol
5965903|NCT03970447|Platform Trial|platform trial
5965904|NCT03970447|Phase 2|phase 2
5965905|NCT03970447|Phase 3|phase 3
5965906|NCT03970343|OPTIMIZER|optimizer
5965907|NCT03970343|Heart Failure|heart failure
5965908|NCT03970343|CCM|ccm
5965909|NCT03970343|Post-Approval Study|post-approval study
5965910|NCT03970343|NYHA class III|nyha class iii
5965911|NCT03970343|FIX-HF-5C|fix-hf-5c
5965912|NCT03970343|Chronic heart failure|chronic heart failure
5965913|NCT03970343|Ejection fraction between 25 and 45|ejection fraction between 25 and 45
5965914|NCT03970343|cardiac contractility modulation|cardiac contractility modulation
5965915|NCT03969667|fatigue|fatigue
5965916|NCT03969667|assessment|assessment
5965917|NCT03969667|reliability|reliability
5965918|NCT03969667|validity|validity
5965919|NCT03969667|Chalder Fatigue Scale|chalder fatigue scale
5965920|NCT03969667|Turkish version|turkish version
5965921|NCT03969667|healthy young adults|healthy young adults
5965922|NCT03969602|Pain Catastrophizing|pain catastrophizing
5965923|NCT03969602|Cognitive Behavioral Therapy|cognitive behavioral therapy
5965924|NCT03969602|Rehabilitation|rehabilitation
5965925|NCT03969602|Spinal disease|spinal disease
5965926|NCT03969602|Spinal fusion|spinal fusion
5965927|NCT03969355|Paediatric|paediatric
5965928|NCT03969355|Intensive care|intensive care
5965929|NCT03969355|Mortality|mortality
5965930|NCT03969329|Secondary hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
5965931|NCT03969329|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
5965932|NCT03969329|Pediatric|pediatric
5965933|NCT03969121|Palbociclib|palbociclib
5965934|NCT03969121|Breast Cancer|breast cancer
5965935|NCT03969121|PEPI|pepi
5965936|NCT03967587|Neonatal|neonatal
5965937|NCT03967587|Umbilical Arteries|umbilical arteries
5965938|NCT03967587|Umbilical Veins|umbilical veins
5965939|NCT03967587|Oxygen Partial Pressure|oxygen partial pressure
5965940|NCT03967275|Bone marrow harvest|bone marrow harvest
5965941|NCT03967275|Bone Marrow derived Mesenchymal Stem Cells (BM-MSC)|bone marrow derived mesenchymal stem cells (bm-msc)
5965942|NCT03967275|Pre-clinical|pre-clinical
5965943|NCT03967249|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
5965944|NCT03967223|Adoptive T-cell therapy|adoptive t-cell therapy
5965945|NCT03967223|Advanced metastatic synovial sarcoma|advanced metastatic synovial sarcoma
5965946|NCT03967223|GSK3377794|gsk3377794
5965947|NCT03967223|Positive solid tumors|positive solid tumors
5965948|NCT03967223|T-cell receptors|t-cell receptors
5965949|NCT03965572|cabergoline, lactation, suppression, postpartum care|cabergoline, lactation, suppression, postpartum care
5965950|NCT03965195|Influenza|influenza
5965951|NCT03965195|Vaccine|vaccine
5965952|NCT03965195|Vaccination|vaccination
5965953|NCT03965195|Nursing Home|nursing home
5965954|NCT03965195|Respiratory-Related Hospitalizations|respiratory-related hospitalizations
5965955|NCT03965195|Cluster Randomized Trial|cluster randomized trial
5965956|NCT03965195|MACE (Major Adverse Cardiovascular Event)|mace (major adverse cardiovascular event)
5965957|NCT03965195|Cardiorespiratory-Related Hospitalizations|cardiorespiratory-related hospitalizations
5965958|NCT03965195|All-Cause Hospitalization|all-cause hospitalization
5965959|NCT03965065|Aortic Stenosis|aortic stenosis
5965960|NCT03965065|Heart Valve Prosthesis|heart valve prosthesis
5965961|NCT03965065|Hemodynamics|hemodynamics
5965962|NCT03965065|Sutureless|sutureless
5965963|NCT03965065|Standard aortic valve prosthesis|standard aortic valve prosthesis
5965964|NCT03964610|optical coherence tomography (OCT-A)|optical coherence tomography (oct-a)
5965965|NCT03964610|color fundus photography (CFP)|color fundus photography (cfp)
5965966|NCT03964610|Retinal microvascularization|retinal microvascularization
5965967|NCT03964610|Cerebral microangiopathy|cerebral microangiopathy
5965968|NCT03964584|dolutegravir|dolutegravir
5965969|NCT03964584|dictegravir|dictegravir
5965970|NCT03964584|Neurological disorder|neurological disorder
5965971|NCT03964584|Psychiatric disorder|psychiatric disorder
5965972|NCT03964584|HIV integrase Inhibitors|hiv integrase inhibitors
5965973|NCT03964584|Adverse drug event|adverse drug event
5965974|NCT03964532|Breast Cancer|breast cancer
5965975|NCT03964532|Advanced Breast Cancer|advanced breast cancer
5965976|NCT03964532|Talazoparib|talazoparib
5965977|NCT03964532|Avelumab|avelumab
5965978|NCT03964493|TNP-2092|tnp-2092
5965979|NCT03964493|ABSSSI|absssi
5965980|NCT03964493|Safety|safety
5965981|NCT03964493|PK|pk
5965982|NCT03964493|Efficacy|efficacy
5965983|NCT03964454|Breastfeeding duration|breastfeeding duration
5965984|NCT03964454|WIC|wic
5965985|NCT03964454|low-income|low-income
5965986|NCT03964454|health incentives|health incentives
5965987|NCT03963401|Spondyloarthritis|spondyloarthritis
5965988|NCT03963115|Large local reaction|large local reaction
5965989|NCT03963115|adrenaline, epinephrine|adrenaline, epinephrine
5965990|NCT03963037|Apolipoprotein B|apolipoprotein b
5965991|NCT03963037|Cholesterol|cholesterol
5965992|NCT03963037|Lipoprotein|lipoprotein
5965993|NCT03963037|Metabolism|metabolism
5965994|NCT03963037|Steatosis|steatosis
5965995|NCT03963037|Cirrhosis|cirrhosis
5965996|NCT03963037|Hepatocellular Carcinoma|hepatocellular carcinoma
5965997|NCT03962309|Screening|screening
5965998|NCT03962309|General Practice|general practice
5965999|NCT03962309|Self Assessment|self assessment
5966000|NCT03962309|Algorithms for risk stratification|algorithms for risk stratification
5966001|NCT03960008|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5966002|NCT03960008|Liver transplant|liver transplant
5966003|NCT03960008|Bridge to transplant|bridge to transplant
5966004|NCT03960008|Stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5966005|NCT03960008|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
5966006|NCT03959488|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5966007|NCT03959488|Preterm Infants|preterm infants
5966008|NCT03959488|Lower Respiratory Infection|lower respiratory infection
5966009|NCT03958734|Vascular Dysfunction|vascular dysfunction
5966010|NCT03958461|periodontitis|periodontitis
5966011|NCT03958461|exudative age-related macular degeneration|exudative age-related macular degeneration
5966012|NCT03958461|wet age-related macular degeneration|wet age-related macular degeneration
5966013|NCT03958461|AMD|amd
5966014|NCT03958461|BAB|bab
5966015|NCT03958461|aqueous flare|aqueous flare
5966016|NCT03957096|HNSCC|hnscc
5966017|NCT03957096|NSCLC|nsclc
5966018|NCT03956108|Active Surveillance|active surveillance
5966019|NCT03956030|Female Contraception|female contraception
5966020|NCT03956030|Education|education
5966021|NCT03955939|aurora kinase A|aurora kinase a
5966022|NCT03955939|kinase|kinase
5966023|NCT03955939|aurora A|aurora a
5966024|NCT03955939|aurora kinase inhibitor|aurora kinase inhibitor
5966025|NCT03955939|aurora kinase A inhibitor|aurora kinase a inhibitor
5966026|NCT03955939|kinase inhibitor|kinase inhibitor
5966027|NCT03955939|AURKA|aurka
5966028|NCT03955939|AurA|aura
5966029|NCT03955458|EXPAREL|exparel
5966030|NCT03955458|FICB|ficb
5966031|NCT03955458|Fascia Iliaca Compartment Block|fascia iliaca compartment block
5966032|NCT03955458|Ropivacaine|ropivacaine
5966033|NCT03954067|immunotherapy|immunotherapy
5966034|NCT03954067|vaccinia virus|vaccinia virus
5966035|NCT03954067|visceral lesions|visceral lesions
5966036|NCT03954067|cutaneous lesions|cutaneous lesions
5966037|NCT03954067|intratumoral injection|intratumoral injection
5966038|NCT03954067|ASP9801|asp9801
5966039|NCT03954067|subcutaneous lesions|subcutaneous lesions
5966040|NCT03954067|oncolytic virus|oncolytic virus
5966041|NCT03953495|stress|stress
5966042|NCT03953495|stigma-related stress|stigma-related stress
5966043|NCT03953495|relationship quality|relationship quality
5966044|NCT03953495|depressive symptoms|depressive symptoms
5966045|NCT03953495|anxiety|anxiety
5966046|NCT03953495|couples|couples
5966047|NCT03953495|intimate relationships|intimate relationships
5966048|NCT03953495|lesbian|lesbian
5966049|NCT03953300|Asthma|asthma
5966050|NCT03953300|Eosinophilic Asthma|eosinophilic asthma
5966051|NCT03953300|Lung Diseases|lung diseases
5966052|NCT03953300|Inhaled Corticosteroids|inhaled corticosteroids
5966053|NCT03953300|ICS|ics
5966054|NCT03953300|LABA|laba
5966055|NCT03953300|benralizumab|benralizumab
5966056|NCT03953300|Fasenra|fasenra
5966057|NCT03953300|mechanism of action|mechanism of action
5966058|NCT03953300|remodeling|remodeling
5966059|NCT03952806|Multiple System Atrophy (MSA)|multiple system atrophy (msa)
5966060|NCT03952650|Field|field
5966061|NCT03952650|Immunity|immunity
5966062|NCT03952650|Chemoprophylaxis with Sporozoites|chemoprophylaxis with sporozoites
5966063|NCT03952650|Vaccine|vaccine
5966064|NCT03952650|Malaria-Experienced|malaria-experienced
5966065|NCT03952598|Imaging|imaging
5966066|NCT03952598|Higher-Grade Transformation|higher-grade transformation
5966067|NCT03952598|Biomarker for Cancer|biomarker for cancer
5966068|NCT03952598|High Grade Gliomas|high grade gliomas
5966069|NCT03952559|eczema|eczema
5966070|NCT03952559|atopic eczema|atopic eczema
5966071|NCT03952481|Dry Eye|dry eye
5966072|NCT03952481|Lifitegrast|lifitegrast
5966073|NCT03952481|Xiidra|xiidra
5966074|NCT03952299|Transdermal Oxybutynin|transdermal oxybutynin
5966075|NCT03952039|MF|mf
5966076|NCT03952039|myeloproliferative neoplasms|myeloproliferative neoplasms
5966077|NCT03952039|MPN|mpn
5966078|NCT03952039|myelofibrosis|myelofibrosis
5966079|NCT03952039|PMF|pmf
5966080|NCT03952039|post-PV|post-pv
5966081|NCT03952039|Post-Polycythemia Vera|post-polycythemia vera
5966082|NCT03952039|post-ET MF|post-et mf
5966083|NCT03952039|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5966084|NCT03951766|mHealth|mhealth
5966085|NCT03951766|smartphone|smartphone
5966086|NCT03951766|smoking cessation|smoking cessation
5966087|NCT03951766|app|app
5966088|NCT03951766|happiness|happiness
5966089|NCT03951766|positive psychology|positive psychology
5966090|NCT03951766|nondaily smoking|nondaily smoking
5966091|NCT03951337|64Cu-ATSM|64cu-atsm
5966092|NCT03951337|neoadjuvant treatment|neoadjuvant treatment
5966093|NCT03951337|chemoradiotherapy|chemoradiotherapy
5966094|NCT03951337|surgery|surgery
5966095|NCT03951337|Positron Emission Tomography (PET)/CT scan|positron emission tomography (pet)/ct scan
5966096|NCT03951337|Prediction of response to treatment|prediction of response to treatment
5966097|NCT03951337|Rodel score|rodel score
5966098|NCT03950960|Cytochrome P450 3A4 Inhibition|cytochrome p450 3a4 inhibition
5966099|NCT03949647|LGR|lgr
5966100|NCT03949647|Aging|aging
5966101|NCT03949647|CD44|cd44
5966102|NCT03949647|Stem Cells|stem cells
5966103|NCT03949647|Progenitor Cells|progenitor cells
5966104|NCT03949283|Ovarian cancer|ovarian cancer
5966105|NCT03949283|Platinum resistant|platinum resistant
5966106|NCT03949283|ChemoID|chemoid
5966107|NCT03949283|Cytotoxicity assay|cytotoxicity assay
5966108|NCT03949283|Cancer Stem Cells|cancer stem cells
5966109|NCT03948763|cancer|cancer
5966110|NCT03948763|solid tumors|solid tumors
5966111|NCT03948763|therapeutic vaccine|therapeutic vaccine
5966112|NCT03948763|Pembrolizumab|pembrolizumab
5966113|NCT03948763|PD1|pd1
5966114|NCT03948763|PD-1|pd-1
5966115|NCT03948763|PDL1|pdl1
5966116|NCT03948763|PD-L1|pd-l1
5966117|NCT03948763|KRAS|kras
5966118|NCT03948763|mRNA|mrna
5966119|NCT03948334|atopic dermatitis, AD, eczema, itch, pruritus, H4R, ZPL389|atopic dermatitis, ad, eczema, itch, pruritus, h4r, zpl389
5966120|NCT03948152|Sleep Apnea|sleep apnea
5966121|NCT03947255|CD30-expression|cd30-expression
5966122|NCT03947255|sALCL|salcl
5966123|NCT03947255|PTCL|ptcl
5966124|NCT03947255|cHL|chl
5966125|NCT03945981|GSK3515864, dolutegravir, Dovato, lamivudine, 3TC, HIV-1, Test and Treat|gsk3515864, dolutegravir, dovato, lamivudine, 3tc, hiv-1, test and treat
5966126|NCT03944902|BRCA Wild-Type|brca wild-type
5966127|NCT03944902|Resistant BRCA|resistant brca
5966128|NCT03944902|Poly (ADP-ribose) polymerase (PARP) Inhibitor Therapy|poly (adp-ribose) polymerase (parp) inhibitor therapy
5966129|NCT03944798|Soft Tissue Sarcoma|soft tissue sarcoma
5966130|NCT03944798|Lung Metastases|lung metastases
5966131|NCT03944798|Overall Survival|overall survival
5966132|NCT03944798|Surveillance|surveillance
5966133|NCT03944798|Randomized Controlled Trial|randomized controlled trial
5966134|NCT03944785|Parkinson's disease|parkinson's disease
5966135|NCT03944785|Safinamide|safinamide
5966136|NCT03944785|Xadago|xadago
5966137|NCT03944785|MAO-B inhibitor|mao-b inhibitor
5966138|NCT03944785|off|off
5966139|NCT03944785|non-motor symptoms|non-motor symptoms
5966140|NCT03944785|motor symptoms|motor symptoms
5966141|NCT03944785|levodopa|levodopa
5966142|NCT03944785|PD|pd
5966143|NCT03944772|Non-small cell lung cancer|non-small cell lung cancer
5966144|NCT03944772|Phase II|phase ii
5966145|NCT03944772|Platform study|platform study
5966146|NCT03944772|Biomarker-directed|biomarker-directed
5966147|NCT03944772|Durvalumab|durvalumab
5966148|NCT03944772|Osimertinib|osimertinib
5966149|NCT03944772|Savolitinib|savolitinib
5966150|NCT03944772|Gefitinib|gefitinib
5966151|NCT03944772|Necitumumab|necitumumab
5966152|NCT03944772|Platinum-containing doublet|platinum-containing doublet
5966153|NCT03944772|Pemetrexed|pemetrexed
5966154|NCT03944772|Carboplatin|carboplatin
5966155|NCT03944772|EGFR positive|egfr positive
5966156|NCT03944772|NSCLC|nsclc
5966157|NCT03944512|Pregnancy|pregnancy
5966158|NCT03944512|Preeclampsia|preeclampsia
5966159|NCT03943446|Drug Therapy|drug therapy
5966160|NCT03942094|Nilotinib|nilotinib
5966161|NCT03941990|Spinal puncture|spinal puncture
5966162|NCT03941990|Nitrous oxide|nitrous oxide
5966163|NCT03941990|Pain|pain
5966164|NCT03941990|Anxiety|anxiety
5966165|NCT03941990|Emergency|emergency
5966166|NCT03941964|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5966167|NCT03941964|cancer|cancer
5966168|NCT03941964|treatment naive|treatment naive
5966169|NCT03941964|venetoclax|venetoclax
5966170|NCT03941964|azacitidine|azacitidine
5966171|NCT03941964|decitabine|decitabine
5966172|NCT03941964|outpatient setting|outpatient setting
5966173|NCT03941093|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5966174|NCT03941093|unresectable pancreatic cancer|unresectable pancreatic cancer
5966175|NCT03940703|Tepotinib|tepotinib
5966176|NCT03940703|Osimertinib|osimertinib
5966177|NCT03940703|Non-Small Cell Lung Cancer|non-small cell lung cancer
5966178|NCT03940703|INSIGHT 2|insight 2
5966179|NCT03940352|Phase Ib|phase ib
5966180|NCT03940352|BHLRM|bhlrm
5966181|NCT03940352|AML|aml
5966182|NCT03940352|MDS|mds
5966183|NCT03940352|HDM201|hdm201
5966184|NCT03940352|TP53|tp53
5966185|NCT03940352|MBG453|mbg453
5966186|NCT03940352|TIM-3|tim-3
5966187|NCT03940352|venetoclax|venetoclax
5966188|NCT03940352|Bcl-2|bcl-2
5966189|NCT03939689|bone metastases|bone metastases
5966190|NCT03939689|18F-DCFPyL|18f-dcfpyl
5966191|NCT03939689|PSMA PET|psma pet
5966192|NCT03939689|PSMA-avidity|psma-avidity
5966193|NCT03939689|biomarker|biomarker
5966194|NCT03939689|radioligand therapy|radioligand therapy
5966195|NCT03939689|adjunct radiation therapy|adjunct radiation therapy
5966196|NCT03939689|dosimetry|dosimetry
5966197|NCT03939689|SPECT/CT|spect/ct
5966198|NCT03939689|docetaxel|docetaxel
5966199|NCT03939637|ITP|itp
5966200|NCT03939637|Immune Thrombocytopenia|immune thrombocytopenia
5966201|NCT03939637|Newly Diagnosed Immune Thrombocytopenia|newly diagnosed immune thrombocytopenia
5966202|NCT03939637|Newly Diagnosed ITP|newly diagnosed itp
5966203|NCT03939312|Migraine|migraine
5966204|NCT03939312|Aura|aura
5966205|NCT03938389|African American|african american
5966206|NCT03938389|Black|black
5966207|NCT03938389|Prediabetes|prediabetes
5966208|NCT03938389|Impaired Glucose Tolerance|impaired glucose tolerance
5966209|NCT03937830|Combined Treatment|combined treatment
5966210|NCT03937830|Immunotherapy|immunotherapy
5966211|NCT03937830|Anti-Tumor Immunity|anti-tumor immunity
5966212|NCT03937830|Inhinition of the Blood Vessels Surrounding a Tumor|inhinition of the blood vessels surrounding a tumor
5966213|NCT03937154|Chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
5966214|NCT03937154|Non-small Cell Lung Cancer|non-small cell lung cancer
5966215|NCT03937154|Ovarian Cancer|ovarian cancer
5966216|NCT03937154|Breast Cancer|breast cancer
5966217|NCT03936829|panniculitis associated acquired generalised lipodystrophy|panniculitis associated acquired generalised lipodystrophy
5966218|NCT03936829|cyclophosphamide|cyclophosphamide
5966219|NCT03936270|Palbociclib|palbociclib
5966220|NCT03936270|Letrozole|letrozole
5966221|NCT03936270|Ovarian Cancer|ovarian cancer
5966222|NCT03935919|perioperative glucose management|perioperative glucose management
5966223|NCT03935919|continuous glucose monitoring|continuous glucose monitoring
5966224|NCT03935919|diabetes|diabetes
5966225|NCT03935906|Point of Care|point of care
5966226|NCT03935906|Direct Acting Antivirals|direct acting antivirals
5966227|NCT03935906|Community Pharmacy|community pharmacy
5966228|NCT03935906|Opiate Substitution Therapy|opiate substitution therapy
5966229|NCT03935269|High-grade glioma|high-grade glioma
5966231|NCT03935269|Caregivers|caregivers
5966232|NCT03934918|cervical preparation|cervical preparation
5966233|NCT03934918|cervical ripening|cervical ripening
5966234|NCT03934918|NTSV|ntsv
5966235|NCT03934918|induction of labor|induction of labor
5966236|NCT03934671|Chronic wound|chronic wound
5966237|NCT03934671|Wound healing|wound healing
5966238|NCT03934671|Hard-to-heal wounds|hard-to-heal wounds
5966239|NCT03934671|Antioxidant dressing|antioxidant dressing
5966240|NCT03934671|Oxidative stress|oxidative stress
5966241|NCT03934658|PTSD|ptsd
5966242|NCT03934658|Nightmare Disorder|nightmare disorder
5966243|NCT03934658|Post-traumatic stress disorder|post-traumatic stress disorder
5966244|NCT03934658|Veteran|veteran
5966245|NCT03934658|Digital therapeutic|digital therapeutic
5966246|NCT03934658|Digital medicine|digital medicine
5966247|NCT03934658|Nightmares|nightmares
5966248|NCT03933488|Drug therapy|drug therapy
5966249|NCT03933449|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966250|NCT03933449|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966251|NCT03933449|Programmed Death-Ligand 2 (PDL2, PD-L2)|programmed death-ligand 2 (pdl2, pd-l2)
5966252|NCT03933449|Gene expression profiling (GEP)|gene expression profiling (gep)
5966253|NCT03929913|Ventricular Dysfunction|ventricular dysfunction
5966254|NCT03929913|Functional Mitral Regurgitation|functional mitral regurgitation
5966255|NCT03929913|Heart Failure|heart failure
5966256|NCT03929913|Mitral Implant|mitral implant
5966257|NCT03929913|Secondary Mitral Regurgitation|secondary mitral regurgitation
5966258|NCT03928925|Intubation|intubation
5966259|NCT03928925|Bougie|bougie
5966260|NCT03928743|Ankylosing spondylitis|ankylosing spondylitis
5966261|NCT03928743|AS|as
5966262|NCT03928743|Bimekizumab|bimekizumab
5966263|NCT03928743|Axial spondyloarthritis|axial spondyloarthritis
5966264|NCT03928704|Nonradiographic axial spondyloarthritis|nonradiographic axial spondyloarthritis
5966265|NCT03928704|Axial spondyloarthritis|axial spondyloarthritis
5966266|NCT03928704|Nr-axSpA|nr-axspa
5966267|NCT03928704|Bimekizumab|bimekizumab
5966268|NCT03928639|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5966269|NCT03928639|Mitral Valve Disease|mitral valve disease
5966270|NCT03928639|Transcatheter Mitral Valve Replacement|transcatheter mitral valve replacement
5966271|NCT03928639|Tricuspid Valve Disease|tricuspid valve disease
5966272|NCT03927404|Transfemoral Amputees|transfemoral amputees
5966273|NCT03927404|Transtibial Amputees|transtibial amputees
5966274|NCT03927404|Prosthesis|prosthesis
5966275|NCT03927040|Alzheimer's Disease|alzheimer's disease
5966276|NCT03927040|Transcranial Electromagnetic Treatment|transcranial electromagnetic treatment
5966277|NCT03927040|Cognitive Assessment|cognitive assessment
5966278|NCT03927040|Alzheimer's markers in blood and CSF|alzheimer's markers in blood and csf
5966279|NCT03926039|Hepatocarcinoma|hepatocarcinoma
5966280|NCT03926039|sharing decision-making|sharing decision-making
5966281|NCT03926039|Health Literacy|health literacy
5966282|NCT03926039|decisional conflicts|decisional conflicts
5966283|NCT03924895|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966284|NCT03924895|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966285|NCT03924895|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
5966286|NCT03924869|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966287|NCT03924869|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966288|NCT03924856|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966289|NCT03924856|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966290|NCT03924856|Pembrolizumab (MK-3475)|pembrolizumab (mk-3475)
5966291|NCT03924856|Chemotherapy|chemotherapy
5966292|NCT03924635|Airway inflammation|airway inflammation
5966293|NCT03924635|Anti-inflammatory reliever|anti-inflammatory reliever
5966294|NCT03924635|Symbicort|symbicort
5966295|NCT03924635|Maintenance anti-inflammatory therapy|maintenance anti-inflammatory therapy
5966296|NCT03924635|Reliever medication|reliever medication
5966297|NCT03924635|Salbutamol|salbutamol
5966298|NCT03923946|Stroke|stroke
5966299|NCT03923946|Compassion Focused Therapy|compassion focused therapy
5966300|NCT03923946|CFT|cft
5966301|NCT03923946|Distress|distress
5966302|NCT03923946|Feasibility RCT|feasibility rct
5966303|NCT03923699|Telemedicine|telemedicine
5966304|NCT03923699|Anesthesia Control Tower|anesthesia control tower
5966305|NCT03923699|Machine Learning|machine learning
5966306|NCT03923699|Forecasting Algorithms|forecasting algorithms
5966307|NCT03923699|Decision Support|decision support
5966308|NCT03923699|Randomized Controlled Trial|randomized controlled trial
5966309|NCT03923426|ceftazidime-avibactam|ceftazidime-avibactam
5966310|NCT03923426|Zavicefta|zavicefta
5966311|NCT03922724|Autoimmunity|autoimmunity
5966312|NCT03922724|Immune Dysregulation|immune dysregulation
5966313|NCT03922724|Congenital|congenital
5966314|NCT03922724|Opportunistic Infection|opportunistic infection
5966315|NCT03922204|First-in-human|first-in-human
5966316|NCT03922204|MCLA-145|mcla-145
5966317|NCT03922204|Antibodies|antibodies
5966318|NCT03922204|Bispecific|bispecific
5966319|NCT03921944|shoulder surgery|shoulder surgery
5966320|NCT03921944|arthritis|arthritis
5966321|NCT03921944|rotator cuff|rotator cuff
5966322|NCT03921541|ARG1-D|arg1-d
5966323|NCT03921515|Hyper-Immunuglobulin E.Syndrome|hyper-immunuglobulin e.syndrome
5966324|NCT03921515|Chronic Granulomatous Disease|chronic granulomatous disease
5966325|NCT03921515|Tumor Necrosis Factor Alpha|tumor necrosis factor alpha
5966326|NCT03921515|Staphylococcus Aureus|staphylococcus aureus
5966327|NCT03921437|Chronic Renal Diseases|chronic renal diseases
5966328|NCT03921437|Decision-making|decision-making
5966329|NCT03921424|Pneumococcal conjugate vaccine (PCV), 15-valent, 22F, 33F|pneumococcal conjugate vaccine (pcv), 15-valent, 22f, 33f
5966330|NCT03920631|B Cell Lymphomas|b cell lymphomas
5966331|NCT03920631|Microtransplantation|microtransplantation
5966332|NCT03920631|Nivolumab|nivolumab
5966333|NCT03919409|TS-161|ts-161
5966334|NCT03919409|CSF|csf
5966335|NCT03919409|first-in-human|first-in-human
5966336|NCT03919292|Colon Cancer|colon cancer
5966337|NCT03919292|Pancreatic Cancer|pancreatic cancer
5966338|NCT03919292|Other solid tumor|other solid tumor
5966339|NCT03919292|Advanced solid tumor|advanced solid tumor
5966340|NCT03919292|Tumor progression|tumor progression
5966341|NCT03918564|Weightloss|weightloss
5966342|NCT03918031|Psychological Distress|psychological distress
5966343|NCT03918031|Tobacco|tobacco
5966344|NCT03918031|Smoking|smoking
5966345|NCT03918031|Feedback|feedback
5966346|NCT03918031|Stress|stress
5966347|NCT03918031|Anxiety Disorders|anxiety disorders
5966348|NCT03918031|Depression|depression
5966349|NCT03917901|Anxiety Disorders|anxiety disorders
5966350|NCT03917901|Depression|depression
5966351|NCT03917901|Anxiety Sensitivity|anxiety sensitivity
5966353|NCT03917901|Eating|eating
5966354|NCT03917901|Physical Activity|physical activity
5966355|NCT03917901|Exercise|exercise
5966356|NCT03917654|Randomized|randomized
5966357|NCT03917654|Assays|assays
5966358|NCT03917654|Blood Smear|blood smear
5966359|NCT03917654|Antibody|antibody
5966360|NCT03917654|Parasites|parasites
5966361|NCT03915769|Ulcerative colitis|ulcerative colitis
5966362|NCT03915769|Ozanimod|ozanimod
5966363|NCT03915769|colitis|colitis
5966364|NCT03915769|Ulcerative|ulcerative
5966365|NCT03915496|atopic dermatitis|atopic dermatitis
5966366|NCT03915496|atopic eczema|atopic eczema
5966367|NCT03915496|eczema|eczema
5966368|NCT03915496|JAK|jak
5966369|NCT03915496|janus kinase|janus kinase
5966370|NCT03913143|LCA10|lca10
5966371|NCT03913143|CEP290|cep290
5966372|NCT03913143|p.Cys998X|p.cys998x
5966373|NCT03913143|c.2991+1655A>G|c.2991+1655a>g
5966374|NCT03913143|Leber's Congenital Amaurosis|leber's congenital amaurosis
5966375|NCT03913143|Antisense oligonucleotide|antisense oligonucleotide
5966376|NCT03913143|RNA therapy|rna therapy
5966377|NCT03913143|QR-110|qr-110
5966378|NCT03913143|sepofarsen|sepofarsen
5966379|NCT03912493|Subacromial Impingement Syndrome|subacromial impingement syndrome
5966380|NCT03912493|Physiotherapy and Rehabilitation|physiotherapy and rehabilitation
5966381|NCT03912493|Virtual Reality|virtual reality
5966382|NCT03912493|Technologic Rehabilitation|technologic rehabilitation
5966383|NCT03911388|Brain Tumor, Recurrent|brain tumor, recurrent
5966384|NCT03911388|Glioma|glioma
5966385|NCT03911388|Glioblastoma Multiforme|glioblastoma multiforme
5966386|NCT03911388|Gliosarcoma|gliosarcoma
5966387|NCT03911388|Medulloblastoma|medulloblastoma
5966388|NCT03911388|Anaplastic Astrocytoma|anaplastic astrocytoma
5966389|NCT03911388|Oligodendroglioma|oligodendroglioma
5966390|NCT03911388|Rhabdoid Tumor|rhabdoid tumor
5966391|NCT03911388|Ependymoma|ependymoma
5966392|NCT03911388|Germ Cell Tumor|germ cell tumor
5966393|NCT03911388|Choroid Plexus Carcinoma|choroid plexus carcinoma
5966394|NCT03911388|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
5966395|NCT03911388|Giant Cell Glioblastoma|giant cell glioblastoma
5966396|NCT03911388|Atypical teratoid/rhabdoid tumor|atypical teratoid/rhabdoid tumor
5966397|NCT03911388|Secondary Malignant Cerebellar Tumor|secondary malignant cerebellar tumor
5966398|NCT03911388|Embryonal Tumor|embryonal tumor
5966399|NCT03911388|Neoplasms|neoplasms
5966400|NCT03911388|Oncolytic Virus Therapy|oncolytic virus therapy
5966401|NCT03911388|Virotherapy, Oncolytic|virotherapy, oncolytic
5966402|NCT03911388|Immunotherapy|immunotherapy
5966403|NCT03911388|Central Nervous System Agents|central nervous system agents
5966404|NCT03911388|Antineoplastic Agents|antineoplastic agents
5966405|NCT03911388|Pediatric|pediatric
5966406|NCT03911388|Pediatrics|pediatrics
5966407|NCT03911388|Oncolytic|oncolytic
5966408|NCT03911388|Virus|virus
5966409|NCT03911388|HSV|hsv
5966410|NCT03911388|Herpes Virus|herpes virus
5966411|NCT03911388|G207|g207
5966412|NCT03911388|Oncolytic Herpes Virus|oncolytic herpes virus
5966413|NCT03911206|Asthma|asthma
5966414|NCT03910439|Monoclonal Antibody|monoclonal antibody
5966415|NCT03910439|Radiotherapy|radiotherapy
5966416|NCT03910062|VA-ECMO|va-ecmo
5966417|NCT03910062|VA-ECLS|va-ecls
5966418|NCT03910062|Near-Infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5966419|NCT03909672|low back pain|low back pain
5966420|NCT03909672|cupping therapy|cupping therapy
5966421|NCT03908268|Co-regulation|co-regulation
5966422|NCT03908268|Emotional Connection|emotional connection
5966423|NCT03908268|Family Nurture Intervention|family nurture intervention
5966424|NCT03908268|Preschool Intervention|preschool intervention
5966425|NCT03908268|Martha G. Welch MD|martha g. welch md
5966426|NCT03908268|Multiple Family Group Intervention|multiple family group intervention
5966427|NCT03908268|Randomized Controlled Trial|randomized controlled trial
5966428|NCT03906396|xbox kinect|xbox kinect
5966429|NCT03906396|gaming technology|gaming technology
5966430|NCT03906396|stress|stress
5966431|NCT03906396|anxiety|anxiety
5966432|NCT03906396|depression|depression
5966433|NCT03906396|randomised control trial|randomised control trial
5966434|NCT03906396|sleep quality|sleep quality
5966435|NCT03906396|intervention|intervention
5966436|NCT03906071|Sitravatinib|sitravatinib
5966437|NCT03906071|Nivolumab|nivolumab
5966438|NCT03906071|Docetaxel|docetaxel
5966439|NCT03906071|Checkpoint inhibitor|checkpoint inhibitor
5966440|NCT03906071|MGCD516|mgcd516
5966441|NCT03906071|NSCLC|nsclc
5966442|NCT03906045|COPD|copd
5966443|NCT03906045|scintigraphy|scintigraphy
5966444|NCT03906045|budesonide|budesonide
5966445|NCT03906045|glycopyrronium|glycopyrronium
5966446|NCT03906045|formoterol|formoterol
5966447|NCT03905928|smoking|smoking
5966448|NCT03905928|electronic cigarettes|electronic cigarettes
5966449|NCT03905928|flavor|flavor
5966450|NCT03905928|cue-reactivity|cue-reactivity
5966451|NCT03905525|Sjögren|sjögren
5966452|NCT03905525|fatigue|fatigue
5966453|NCT03905525|dryness|dryness
5966454|NCT03905525|anti-CD40|anti-cd40
5966455|NCT03905525|CFZ533|cfz533
5966456|NCT03905525|iscalimab|iscalimab
5966457|NCT03905525|TWINSS|twinss
5966458|NCT03905525|autoimmune|autoimmune
5966459|NCT03905135|T-cell Lymphoproliferative Disorder|t-cell lymphoproliferative disorder
5966460|NCT03905135|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5966461|NCT03905135|Anti-PD-L1 monoclonal antibody|anti-pd-l1 monoclonal antibody
5966462|NCT03905135|Antibody Dependent Cellular Cytotoxicity|antibody dependent cellular cytotoxicity
5966463|NCT03904264|tinnitus|tinnitus
5966464|NCT03904264|hearing aids|hearing aids
5966465|NCT03904264|normal hearing|normal hearing
5966466|NCT03903445|Parenting Program|parenting program
5966467|NCT03901157|satiety|satiety
5966468|NCT03901157|lipids in alginate gel|lipids in alginate gel
5966469|NCT03901157|food intake|food intake
5966470|NCT03901053|Ankle Foot Orthoses|ankle foot orthoses
5966471|NCT03901053|Carbon Fiber|carbon fiber
5966472|NCT03901053|Gait|gait
5966473|NCT03901053|Adult|adult
5966474|NCT03901053|Biomechanics|biomechanics
5966475|NCT03901053|Materials Testing|materials testing
5966476|NCT03901053|Physical Performance|physical performance
5966477|NCT03900455|Patients at risk|patients at risk
5966482|NCT03900104|Paraaortic nodes involvement|paraaortic nodes involvement
5966483|NCT03899545|serratus plane block|serratus plane block
5966485|NCT03899545|breast cancer surgery|breast cancer surgery
5966486|NCT03899545|perioperative analgesia|perioperative analgesia
5966487|NCT03898596|Neonates|neonates
5966488|NCT03898596|Electrocardiogram|electrocardiogram
5966489|NCT03898596|Umbilical Vein Catheterization|umbilical vein catheterization
5966490|NCT03898180|Advanced or metastatic urothelial cancer|advanced or metastatic urothelial cancer
5966491|NCT03898180|Lenvatinib|lenvatinib
5966492|NCT03898180|Pembrolizumab|pembrolizumab
5966493|NCT03898180|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966494|NCT03898180|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966495|NCT03897998|Naloxone|naloxone
5966496|NCT03897998|fMRI|fmri
5966497|NCT03897998|EEG|eeg
5966498|NCT03897998|Observation|observation
5966499|NCT03897998|Healthy Volunteers|healthy volunteers
5966500|NCT03897738|succinate|succinate
5966501|NCT03897738|B complex vitamins|b complex vitamins
5966502|NCT03897738|perimenopause|perimenopause
5966503|NCT03896581|Psoriatic Arthritis|psoriatic arthritis
5966504|NCT03896581|PsA|psa
5966505|NCT03896581|Bimekizumab|bimekizumab
5966506|NCT03896516|Alcohol Problems|alcohol problems
5966507|NCT03896516|Alcohol Craving|alcohol craving
5966508|NCT03896516|Food-Seeking Behaviors|food-seeking behaviors
5966509|NCT03896516|Ghrelin|ghrelin
5966510|NCT03896516|Ghrelin 0-acyltransferase|ghrelin 0-acyltransferase
5966511|NCT03896035|Chronic Back Pain|chronic back pain
5966512|NCT03896035|Depression|depression
5966513|NCT03896035|Veterans|veterans
5966514|NCT03896035|Aging|aging
5966515|NCT03895658|Brain Stimulation|brain stimulation
5966516|NCT03895658|Neurocognitive|neurocognitive
5966517|NCT03895658|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5966518|NCT03895645|Stored Samples|stored samples
5966519|NCT03895255|lymph node dissection|lymph node dissection
5966520|NCT03895255|high tie|high tie
5966521|NCT03895255|low tie|low tie
5966522|NCT03895255|splenic flexure mobilization|splenic flexure mobilization
5966523|NCT03895255|anastomotic leak|anastomotic leak
5966524|NCT03895203|Psoriatic Arthritis|psoriatic arthritis
5966525|NCT03895203|PsA|psa
5966526|NCT03895203|Bimekizumab|bimekizumab
5966527|NCT03894774|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
5966528|NCT03894774|Neuroses, Posttraumatic|neuroses, posttraumatic
5966529|NCT03894774|PTSD|ptsd
5966530|NCT03894007|Neoadjuvant therapy|neoadjuvant therapy
5966531|NCT03894007|PD-L1 positive breast cancer|pd-l1 positive breast cancer
5966532|NCT03893422|glucose control|glucose control
5966533|NCT03893422|inflammation|inflammation
5966534|NCT03893422|safety|safety
5966535|NCT03893422|microbiome|microbiome
5966536|NCT03891654|Radiation|radiation
5966537|NCT03891654|Metastases|metastases
5966538|NCT03891654|Dynamic Contrast Enhanced Computed Tomography|dynamic contrast enhanced computed tomography
5966539|NCT03891654|Pilot|pilot
5966540|NCT03888534|Drug Therapy|drug therapy
5966541|NCT03887793|quality improvement|quality improvement
5966542|NCT03887793|HPV vaccine|hpv vaccine
5966543|NCT03887793|integrated healthcare delivery systems|integrated healthcare delivery systems
5966544|NCT03887520|CVD, Lipoprotein (a),|cvd, lipoprotein (a),
5966545|NCT03886285|Multimorbidity|multimorbidity
5966546|NCT03886285|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
5966547|NCT03886285|Caregivers|caregivers
5966548|NCT03886168|Pediatric Hearing Loss|pediatric hearing loss
5966549|NCT03885908|Automated Geriatric Co-Management Program|automated geriatric co-management program
5966550|NCT03885908|Perioperative Care|perioperative care
5966551|NCT03885908|Solid mass|solid mass
5966552|NCT03885908|Nodule|nodule
5966553|NCT03885908|19-066|19-066
5966554|NCT03884816|HIV|hiv
5966555|NCT03884816|Pre-exposure prophylaxis|pre-exposure prophylaxis
5966556|NCT03884816|Sexually Transmitted Diseases|sexually transmitted diseases
5966557|NCT03884478|Social Norms|social norms
5966558|NCT03884478|Personalized Normative Feedback|personalized normative feedback
5966559|NCT03884478|Sexual Minority Women|sexual minority women
5966560|NCT03883165|Concussion|concussion
5966561|NCT03883165|Contact sport|contact sport
5966562|NCT03883165|Collision sport|collision sport
5966563|NCT03883165|Neck strengthening|neck strengthening
5966564|NCT03883165|Soccer|soccer
5966565|NCT03883165|Head Acceleration|head acceleration
5966566|NCT03881085|minorities|minorities
5966567|NCT03881085|stress reactivity|stress reactivity
5966568|NCT03881085|allostatic load|allostatic load
5966569|NCT03881085|disparities|disparities
5966570|NCT03880526|Cancer prevention control|cancer prevention control
5966571|NCT03880526|Cancer navigation|cancer navigation
5966572|NCT03880032|anxiety|anxiety
5966573|NCT03880032|depression|depression
5966574|NCT03880032|birth outcomes|birth outcomes
5966575|NCT03879109|Locally recurrent rectal cancer|locally recurrent rectal cancer
5966576|NCT03879109|Pelvic reirradiation|pelvic reirradiation
5966577|NCT03879109|Oncological surgery|oncological surgery
5966578|NCT03878134|Photon Counting CT|photon counting ct
5966579|NCT03878134|Computed Tomography|computed tomography
5966580|NCT03878134|Photon Counting Detectors|photon counting detectors
5966581|NCT03877510|motor fluctuations|motor fluctuations
5966582|NCT03877510|IPX203|ipx203
5966583|NCT03877328|heart failure|heart failure
5966584|NCT03877328|exercise|exercise
5966585|NCT03877328|life coach|life coach
5966586|NCT03876431|Knee prosthesis|knee prosthesis
5966587|NCT03876431|Physiotherapy|physiotherapy
5966588|NCT03876431|Range of motion|range of motion
5966589|NCT03876132|regular consumption of alcohol|regular consumption of alcohol
5966590|NCT03876132|young adults|young adults
5966591|NCT03876132|Moderate or severe alcohol use disorders|moderate or severe alcohol use disorders
5966592|NCT03875885|Head and Neck Cancer Caregivers|head and neck cancer caregivers
5966593|NCT03875820|KRAS|kras
5966594|NCT03875820|RAS mutant|ras mutant
5966595|NCT03875729|T1D, type 1 diabetes, recent-onset T1D|t1d, type 1 diabetes, recent-onset t1d
5966598|NCT03875235|First-Line Advanced Biliary Tract Cancers (BTC)|first-line advanced biliary tract cancers (btc)
5966600|NCT03875235|Gemcitabine/Cisplatin|gemcitabine/cisplatin
5966601|NCT03875235|Placebo|placebo
5966602|NCT03874845|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5966603|NCT03874845|Muscle Relaxation|muscle relaxation
5966604|NCT03874845|fMRI|fmri
5966605|NCT03874845|Group Psychotherapy|group psychotherapy
5966606|NCT03874663|HIV|hiv
5966607|NCT03874663|HIV self-testing|hiv self-testing
5966608|NCT03874663|young people|young people
5966609|NCT03874663|Nigeria|nigeria
5966610|NCT03872492|REDRESS|redress
5966611|NCT03872492|Depression|depression
5966612|NCT03872492|Application|application
5966613|NCT03872492|Mobile|mobile
5966614|NCT03869957|omega 3 polyunsaturated fatty acids|omega 3 polyunsaturated fatty acids
5966615|NCT03869957|intestinal failure|intestinal failure
5966616|NCT03869957|oxidative stress|oxidative stress
5966617|NCT03869853|nutritional status|nutritional status
5966618|NCT03869853|agripreneurs|agripreneurs
5966619|NCT03869853|women farmers|women farmers
5966620|NCT03867084|Programmed Cell Death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5966621|NCT03867084|Programmed Cell Death Ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5966622|NCT03867084|Checkpoint Inhibitor|checkpoint inhibitor
5966623|NCT03867084|Immunotherapy|immunotherapy
5966624|NCT03867084|Adjuvant|adjuvant
5966625|NCT03866759|Sexually Transmitted Infection|sexually transmitted infection
5966626|NCT03866759|HIV Vaccine Trials Network|hiv vaccine trials network
5966627|NCT03866759|Pre-exposure prophylaxis|pre-exposure prophylaxis
5966628|NCT03866603|Parkinson disease|parkinson disease
5966629|NCT03866603|Biomarker|biomarker
5966630|NCT03866590|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
5966631|NCT03866590|Chronic anaemia|chronic anaemia
5966632|NCT03866590|Biomarker|biomarker
5966633|NCT03865095|Critical Care|critical care
5966634|NCT03865095|Muscle loss|muscle loss
5966635|NCT03865095|Rectus femoris cross sectional area|rectus femoris cross sectional area
5966636|NCT03865095|Muscle ultrasound|muscle ultrasound
5966637|NCT03863964|tranexamic acid|tranexamic acid
5966638|NCT03863964|pharmacodynamics|pharmacodynamics
5966639|NCT03863964|pharmacokinetics|pharmacokinetics
5966640|NCT03863964|pregnancy|pregnancy
5966641|NCT03863964|thromboelastometry|thromboelastometry
5966642|NCT03862677|Epithelial ovarian cancer|epithelial ovarian cancer
5966643|NCT03862677|Fallopian tube cancer|fallopian tube cancer
5966644|NCT03862677|Primary peritoneal cancer|primary peritoneal cancer
5966645|NCT03862677|EOC|eoc
5966646|NCT03862677|Immunity|immunity
5966647|NCT03862677|IMPrOVE|improve
5966648|NCT03862677|Prognostic|prognostic
5966649|NCT03862677|Immune markers|immune markers
5966650|NCT03862352|Coronary artery perforation|coronary artery perforation
5966651|NCT03862352|Covered coronary stent|covered coronary stent
5966652|NCT03862352|Calcific coronary disease|calcific coronary disease
5966653|NCT03861481|Chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5966654|NCT03861481|CIDP|cidp
5966655|NCT03861481|UCB7665|ucb7665
5966656|NCT03861481|rozanolixizumab|rozanolixizumab
5966657|NCT03861000|Healthy Control Subjects|healthy control subjects
5966658|NCT03861000|PET Imaging|pet imaging
5966659|NCT03861000|Receptor Occupancy|receptor occupancy
5966660|NCT03861000|Depression|depression
5966661|NCT03860935|Amyloidosis|amyloidosis
5966662|NCT03860935|ATTR-CM|attr-cm
5966663|NCT03860935|Transthyretin|transthyretin
5966664|NCT03860935|Amyloid|amyloid
5966665|NCT03860935|TTR|ttr
5966666|NCT03860610|Total Hip Arthroplasty|total hip arthroplasty
5966667|NCT03860610|Total Knee Arthroplasty|total knee arthroplasty
5966668|NCT03860610|Osteoarthritis|osteoarthritis
5966669|NCT03860610|Muscle strength deficits|muscle strength deficits
5966670|NCT03860610|Dynamic stability|dynamic stability
5966671|NCT03859427|Bone Marrow Cancer|bone marrow cancer
5966672|NCT03859024|anterior urethroplasty|anterior urethroplasty
5966673|NCT03859024|pain management|pain management
5966674|NCT03859024|postoperative pain|postoperative pain
5966675|NCT03859024|opioid use|opioid use
5966676|NCT03856567|Anxiety|anxiety
5966677|NCT03856567|OCD|ocd
5966678|NCT03856567|Obsessive Compulsive Disorder|obsessive compulsive disorder
5966679|NCT03856567|Generalized Anxiety Disorder|generalized anxiety disorder
5966680|NCT03856567|Social Phobia|social phobia
5966681|NCT03856567|Separation Anxiety|separation anxiety
5966682|NCT03856567|GAD|gad
5966683|NCT03856567|Youth|youth
5966684|NCT03856567|Teen|teen
5966685|NCT03856567|Therapy|therapy
5966686|NCT03856567|Specific Phobia|specific phobia
5966687|NCT03856567|Children|children
5966688|NCT03853564|DNA methylation|dna methylation
5966689|NCT03853564|Epigenetic regulation|epigenetic regulation
5966690|NCT03853564|Video-feedback intervention|video-feedback intervention
5966691|NCT03853564|Developmental disability|developmental disability
5966692|NCT03853564|Cerebral palsy|cerebral palsy
5966693|NCT03853564|Genetic syndromes|genetic syndromes
5966694|NCT03853564|Parent-infant interaction|parent-infant interaction
5966695|NCT03853564|Early intervention|early intervention
5966696|NCT03853564|Neuroendocrine regulation|neuroendocrine regulation
5966697|NCT03852875|Cardiac Rehabilitation|cardiac rehabilitation
5966698|NCT03852875|Stress Testing|stress testing
5966699|NCT03852875|Education|education
5966700|NCT03852550|Health Care Transition|health care transition
5966701|NCT03852550|Brain-Based Disabilities|brain-based disabilities
5966702|NCT03852550|CHILD-BRIGHT|child-bright
5966703|NCT03852550|e-health application|e-health application
5966704|NCT03852550|randomized controlled trial|randomized controlled trial
5966705|NCT03850522|smoldering|smoldering
5966706|NCT03850522|myeloma|myeloma
5966707|NCT03850522|vaccination|vaccination
5966708|NCT03850522|PD-L1|pd-l1
5966709|NCT03850522|high-risk|high-risk
5966710|NCT03850483|psoriasis|psoriasis
5966711|NCT03850483|topical|topical
5966712|NCT03850171|Breast Cancer|breast cancer
5966713|NCT03850171|Exercise Training Therapy|exercise training therapy
5966714|NCT03850171|Global longitudinal strain|global longitudinal strain
5966715|NCT03850171|Barriers|barriers
5966716|NCT03850171|Left ventricular dysfunction|left ventricular dysfunction
5966721|NCT03849898|Fracture fixation|fracture fixation
5966722|NCT03849898|Surgical treatment|surgical treatment
5966723|NCT03849898|Non-Surgical treatment|non-surgical treatment
5966724|NCT03849118|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5966725|NCT03849118|PET/CT imaging|pet/ct imaging
5966726|NCT03849118|89Zr-girentuximab|89zr-girentuximab
5966727|NCT03848507|hyperoncotic albumin, blood loss, fluid replacement, cystectomy|hyperoncotic albumin, blood loss, fluid replacement, cystectomy
5966728|NCT03848481|PWS|pws
5966729|NCT03848481|Prader- Willi Syndrome|prader- willi syndrome
5966730|NCT03848481|Irritability|irritability
5966731|NCT03848481|CBDV|cbdv
5966732|NCT03848481|Cannabinoids|cannabinoids
5966733|NCT03847090|kidney stone|kidney stone
5966734|NCT03847090|hyperoxaluria|hyperoxaluria
5966735|NCT03847090|enteric hyperoxaluria|enteric hyperoxaluria
5966736|NCT03847090|oxalate|oxalate
5966737|NCT03847090|kidney calcification|kidney calcification
5966738|NCT03846427|BGB-3111|bgb-3111
5966739|NCT03846427|Zanubrutinib|zanubrutinib
5966740|NCT03844789|Artificial Pancreas (AP)|artificial pancreas (ap)
5966741|NCT03844789|Control-IQ System|control-iq system
5966742|NCT03844789|Insulin Pump|insulin pump
5966743|NCT03844789|Closed Loop Control (CLC)|closed loop control (clc)
5966744|NCT03844789|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5267191|NCT02347007|Cholesterol|cholesterol
5966745|NCT03844789|Multiple Daily Injections (MDI)|multiple daily injections (mdi)
5966746|NCT03843502|kava|kava
5966747|NCT03843502|dietary supplement|dietary supplement
5966748|NCT03843502|anxiety|anxiety
5966749|NCT03843502|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
5966750|NCT03843437|Atopic Dermatitis|atopic dermatitis
5966751|NCT03843437|Tencel fabric|tencel fabric
5966752|NCT03843437|cotton fabric|cotton fabric
5966753|NCT03843125|SLE|sle
5966754|NCT03841474|Brain derived neurotrophic factor|brain derived neurotrophic factor
5966755|NCT03841474|BDNF|bdnf
5966756|NCT03841474|Psychosocial indicators|psychosocial indicators
5966757|NCT03841474|Depression|depression
5966758|NCT03841474|Cardiovascular disease|cardiovascular disease
5966759|NCT03840915|Non-small Cell Lung Cancer|non-small cell lung cancer
5966760|NCT03840915|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
5966761|NCT03840915|M7824|m7824
5966762|NCT03840915|Stage IV|stage iv
5966763|NCT03840915|INTR@PID LUNG 024|intr@pid lung 024
5966764|NCT03840902|Non-small Cell Lung Cancer|non-small cell lung cancer
5966765|NCT03840902|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
5966766|NCT03840902|M7824|m7824
5966767|NCT03840902|Durvalumab|durvalumab
5966768|NCT03840902|Stage III|stage iii
5966769|NCT03840902|INTR@PID LUNG 005|intr@pid lung 005
5966770|NCT03840733|physical activity|physical activity
5966771|NCT03840733|sleep|sleep
5966772|NCT03840733|eating patterns|eating patterns
5966773|NCT03840733|energy expenditure|energy expenditure
5966774|NCT03840525|qigong|qigong
5966775|NCT03840525|HIV|hiv
5966776|NCT03840343|Mesenchymal Stem Cell|mesenchymal stem cell
5966777|NCT03840343|Mesencymal Stromal Cell|mesencymal stromal cell
5966778|NCT03840343|Stem Cell|stem cell
5966779|NCT03840343|Regenerative Medicine|regenerative medicine
5966780|NCT03840343|Cell therapy|cell therapy
5966781|NCT03840343|Rejuvenation|rejuvenation
5966782|NCT03839654|Obstructive Sleep Apnea|obstructive sleep apnea
5966783|NCT03839654|heart valve replacement|heart valve replacement
5966784|NCT03839654|CPAP treatment|cpap treatment
5966785|NCT03839654|loop gain|loop gain
5966786|NCT03838367|TNBC|tnbc
5966787|NCT03838367|PRO 140|pro 140
5966788|NCT03837249|Older People|older people
5966789|NCT03837249|Sleep Disturbance|sleep disturbance
5966790|NCT03837249|Self-Monitoring|self-monitoring
5966791|NCT03837249|Self-Management|self-management
5966792|NCT03837249|Social Support|social support
5966793|NCT03837249|Wrist-worn Actigraphy|wrist-worn actigraphy
5966794|NCT03836469|Lung cancer|lung cancer
5966795|NCT03836469|Non-small cell|non-small cell
5966796|NCT03836209|Gilteritinib|gilteritinib
5966797|NCT03836209|Midostaurin|midostaurin
5966798|NCT03836209|Daunorubicin|daunorubicin
5966799|NCT03836209|Cytarabine|cytarabine
5966800|NCT03836209|FLT3|flt3
5966801|NCT03836209|FLT3 Mutation|flt3 mutation
5966802|NCT03836209|FLT3 Internal Tandem Duplication (ITD)|flt3 internal tandem duplication (itd)
5966803|NCT03836209|FLT3 ITD|flt3 itd
5966804|NCT03836209|FLT3 Tyrosine Kinase Domain (TKD)|flt3 tyrosine kinase domain (tkd)
5966805|NCT03836209|FLT3 TKD|flt3 tkd
5966806|NCT03834688|Venetoclax|venetoclax
5966807|NCT03834688|Bendamustine|bendamustine
5966808|NCT03834688|Rituximab|rituximab
5966809|NCT03834688|Bcl-2 Family Protein Inhibitor|bcl-2 family protein inhibitor
5966810|NCT03834584|Lymphoma|lymphoma
5966811|NCT03834584|DHODH|dhodh
5966812|NCT03834584|Hodgkins Lymphoma|hodgkins lymphoma
5966813|NCT03834584|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5966814|NCT03834584|T-Cell Lymphoma|t-cell lymphoma
5966815|NCT03834519|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966816|NCT03834519|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966817|NCT03834506|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966818|NCT03834506|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966819|NCT03834493|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5966820|NCT03834493|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5966821|NCT03833700|Solid Tumor|solid tumor
5966822|NCT03833700|Colorectal Cancer|colorectal cancer
5966823|NCT03833700|E7386|e7386
5966824|NCT03833167|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
5966825|NCT03833167|Programmed Cell Death 1|programmed cell death 1
5966826|NCT03833167|PD1|pd1
5966827|NCT03833167|Programmed Cell Death Ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
5966828|NCT03833167|Programmed Cell Death Ligand 2 (PD-L2)|programmed cell death ligand 2 (pd-l2)
5966829|NCT03833167|PDL1|pdl1
5966830|NCT03833167|PDL2|pdl2
5966831|NCT03833154|NSCLC|nsclc
5966832|NCT03833154|Double- Blind|double- blind
5966833|NCT03833154|PD-L1|pd-l1
5943471|NCT04276506|Anxiety|anxiety
5943472|NCT04276506|Coronary Angiography|coronary angiography
5943473|NCT04276506|Nursing Interventions|nursing interventions
5966834|NCT03833154|MEDI4736|medi4736
5966835|NCT03833154|Durvalumab|durvalumab
5966836|NCT03833154|PFS|pfs
5966837|NCT03833154|OS|os
5966838|NCT03833154|Unresected lung cancer|unresected lung cancer
5966839|NCT03833037|Synovial sarcoma|synovial sarcoma
5966840|NCT03832946|TD139|td139
5264631|NCT02362035|Btk|btk
5966841|NCT03832946|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5966842|NCT03832946|Galectin-3 inhibitor|galectin-3 inhibitor
5966843|NCT03832569|Pembrolizumab|pembrolizumab
5966844|NCT03832569|18-399|18-399
5966845|NCT03831958|Body Mass Index Z Score|body mass index z score
5966846|NCT03831958|Adult Height|adult height
5966847|NCT03831958|Endocrine Function|endocrine function
5966848|NCT03831958|Neuropsychological Outcome|neuropsychological outcome
5966849|NCT03831958|Metabolic Syndrome|metabolic syndrome
5966850|NCT03831113|Buprenorphine|buprenorphine
5966851|NCT03831113|medication-assisted treatment (MAT) programs|medication-assisted treatment (mat) programs
5966852|NCT03831048|Heart preservation|heart preservation
5966853|NCT03831048|Beating heart transplant|beating heart transplant
5966854|NCT03830866|Durvalumab|durvalumab
5966855|NCT03830866|Chemoradiotherapy|chemoradiotherapy
5966856|NCT03830866|Locally Advanced Cervical Cancer|locally advanced cervical cancer
5966857|NCT03829761|rTMS|rtms
5966858|NCT03829332|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5966859|NCT03829332|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5966860|NCT03829332|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5966861|NCT03829319|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5966862|NCT03829319|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5966863|NCT03829319|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5966864|NCT03829215|targeted temperature management|targeted temperature management
5966865|NCT03829215|prehospital cooling|prehospital cooling
5966866|NCT03829215|cardiac arrest|cardiac arrest
5966867|NCT03829215|postresuscitation encephalopathy|postresuscitation encephalopathy
5966868|NCT03829215|resuscitation|resuscitation
5966869|NCT03829215|heart arrest|heart arrest
5966870|NCT03829033|Tonsil Cancer|tonsil cancer
5966871|NCT03829033|Early Tonsil Cancer|early tonsil cancer
5966872|NCT03829033|Radiotherapy|radiotherapy
5966873|NCT03829033|Photons|photons
5966874|NCT03829033|Protons|protons
5966875|NCT03829033|Acute Side Effects|acute side effects
5966876|NCT03829033|Late Side Effects|late side effects
5966877|NCT03829033|Locoregional Control|locoregional control
5966878|NCT03829033|Disease Free Survival|disease free survival
5966879|NCT03829033|Quality of Life|quality of life
5966880|NCT03829033|Health Economic|health economic
5966881|NCT03828942|advrese event|advrese event
5966882|NCT03828942|hematotoxicity|hematotoxicity
5966883|NCT03828942|drugs|drugs
5966884|NCT03828942|chemotherapies|chemotherapies
5966885|NCT03828331|Rehabilitation|rehabilitation
5966886|NCT03828110|Robotic-Assisted Gait Training|robotic-assisted gait training
5966887|NCT03828110|Gait Rehabilitation|gait rehabilitation
5966888|NCT03827395|Adult|adult
5966889|NCT03827395|Healthy|healthy
5966890|NCT03827395|Hecolin|hecolin
5966891|NCT03827395|Hepatitis E|hepatitis e
5966892|NCT03827395|HEV239|hev239
5966893|NCT03827395|Immunogenicity|immunogenicity
5966894|NCT03827395|Placebo|placebo
5966895|NCT03827395|Population|population
5966896|NCT03827395|Reactogenicity|reactogenicity
5966897|NCT03827395|Route|route
5966898|NCT03827395|Safety|safety
5966899|NCT03827395|Vaccine|vaccine
5966900|NCT03827330|Candida Parapsilosis|candida parapsilosis
5966901|NCT03827330|Candida Auris|candida auris
5966902|NCT03827330|Candida Lusitaniae|candida lusitaniae
5966903|NCT03827330|Candida Glabrata|candida glabrata
5966904|NCT03827330|Candida Albicans|candida albicans
5966905|NCT03827044|colon cancer|colon cancer
5966906|NCT03827044|dMMR|dmmr
5966907|NCT03827044|POLE exonuclease domain mutant|pole exonuclease domain mutant
5966908|NCT03826758|chronic kidney disease|chronic kidney disease
5966909|NCT03826758|clinical decision support|clinical decision support
5966910|NCT03826758|health informatics|health informatics
5966911|NCT03826758|pragmatic clinical trial|pragmatic clinical trial
5966912|NCT03825965|Total knee arthroplasty|total knee arthroplasty
5966913|NCT03825965|Cannabis|cannabis
5966914|NCT03825965|Pilot trial|pilot trial
5966915|NCT03825965|Persistent post-surgical pain|persistent post-surgical pain
5966916|NCT03825575|Fecal Incontinence|fecal incontinence
5966917|NCT03825575|Anorectal manometry|anorectal manometry
5966918|NCT03825146|relapse/refractory acute myeloid leukaemia|relapse/refractory acute myeloid leukaemia
5966919|NCT03825146|autologous progenitor cells|autologous progenitor cells
5966920|NCT03823534|Toradol|toradol
5966921|NCT03823534|Ketorolac|ketorolac
5966922|NCT03823534|Prophylactic intramedullary nail|prophylactic intramedullary nail
5966923|NCT03823534|bone metastases|bone metastases
5966924|NCT03823534|Opioid use|opioid use
5966925|NCT03823534|post-operative pain|post-operative pain
5966926|NCT03823300|AMD|amd
5966927|NCT03823300|nAMD|namd
5966928|NCT03823300|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5966929|NCT03823300|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
5966930|NCT03823287|AMD|amd
5966931|NCT03823287|nAMD|namd
5966932|NCT03823287|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5267395|NCT02346162|Pre-pregnancy|pre-pregnancy
5966933|NCT03823287|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
5966934|NCT03822741|seizure|seizure
5966935|NCT03822468|Breast Cancer|breast cancer
5966936|NCT03822468|HR-positive|hr-positive
5966937|NCT03822468|HER2-negative|her2-negative
5966938|NCT03822468|ER-positive|er-positive
5966939|NCT03822468|advanced breast cancer|advanced breast cancer
5966940|NCT03822468|ribociclib|ribociclib
5966941|NCT03822468|LEE011|lee011
5966942|NCT03822468|premenopausal|premenopausal
5966943|NCT03822468|postmenopausal|postmenopausal
5966944|NCT03821961|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5966945|NCT03821961|PreDiabetes|prediabetes
5966946|NCT03821961|Obesity|obesity
5966947|NCT03821467|doppler optical coherence tomography|doppler optical coherence tomography
5966948|NCT03821467|dynamic vessel analyzer|dynamic vessel analyzer
5966949|NCT03821272|Squamous cell carcinoma|squamous cell carcinoma
5966950|NCT03821233|HER2|her2
5966951|NCT03821233|Bispecific antibody|bispecific antibody
5966952|NCT03821233|Biparatopic antibody|biparatopic antibody
5966953|NCT03821233|Immunotherapy|immunotherapy
5966954|NCT03821233|Gastric cancers|gastric cancers
5966955|NCT03821233|Esophageal cancers|esophageal cancers
5966956|NCT03821233|Gastroesophageal junction (GEJ) cancers|gastroesophageal junction (gej) cancers
5966961|NCT03821233|Cholangiocarcinoma|cholangiocarcinoma
5966962|NCT03820986|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5966963|NCT03820986|programmed cell death-ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5966964|NCT03820986|programmed cell death-ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5966965|NCT03820973|brief Cognitive Behavioral Therapy|brief cognitive behavioral therapy
5966966|NCT03820973|VA Video Connect to home|va video connect to home
5966967|NCT03820466|Aspirin|aspirin
5966968|NCT03820466|Atorvastatin|atorvastatin
5966969|NCT03820466|Troponin|troponin
5966970|NCT03819517|COPD|copd
5966971|NCT03819465|First-Line Stage IV Metastatic Non-Small Cell Lung Cancer|first-line stage iv metastatic non-small cell lung cancer
5966972|NCT03819465|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
5966973|NCT03819465|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5966974|NCT03819465|Non-Small Cell Lung Cancer|non-small cell lung cancer
5966975|NCT03819465|Non-Small Cell Lung|non-small cell lung
5966976|NCT03819465|Non-Small Cell|non-small cell
5966977|NCT03819465|NSCLC|nsclc
5966978|NCT03819465|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5966979|NCT03819062|Constipation|constipation
5966980|NCT03819062|spinal cord injury|spinal cord injury
5966981|NCT03819062|back pain|back pain
5966982|NCT03819062|High-Resolution Colonic Manometry|high-resolution colonic manometry
5966983|NCT03819062|Anorectal Manometry|anorectal manometry
5966984|NCT03818607|Marchiafava-Micheli Syndrome|marchiafava-micheli syndrome
5966985|NCT03818607|Paroxysmal Cold Hemoglobinuria|paroxysmal cold hemoglobinuria
5966986|NCT03818009|Cognitive function postoperative|cognitive function postoperative
5966987|NCT03817892|No-Flow|no-flow
5966988|NCT03817892|Chest Compression Fraction|chest compression fraction
5966989|NCT03817892|Out Hospital|out hospital
5966990|NCT03817892|External Chest Compression Relay|external chest compression relay
5966991|NCT03817892|External Chest Compression Guidance|external chest compression guidance
5966992|NCT03817892|External Chest Compression Quality|external chest compression quality
5966993|NCT03817892|Correct Compression Score|correct compression score
5966994|NCT03817632|Navigation|navigation
5966995|NCT03817632|Computer Assisted Orthopedic Surgery|computer assisted orthopedic surgery
5966996|NCT03817632|OrthoPilot®|orthopilot®
5966997|NCT03817632|Total Knee Arthroplasty|total knee arthroplasty
5966998|NCT03817138|Primary Care|primary care
5966999|NCT03817138|Disease Progression|disease progression
5967000|NCT03817138|Electronic Health Records|electronic health records
5967001|NCT03817138|Medical Records|medical records
5967002|NCT03817138|Prognosis|prognosis
5967003|NCT03815565|analgesia|analgesia
5967004|NCT03815565|continuous|continuous
5967005|NCT03815565|femoral block|femoral block
5967006|NCT03815552|type 1 diabetes|type 1 diabetes
5967007|NCT03815552|pediatrics|pediatrics
5967008|NCT03815552|blood sugar devices|blood sugar devices
5967009|NCT03814746|Sickle Cell Disease|sickle cell disease
5967010|NCT03814746|SEG101|seg101
5967011|NCT03814746|Crizanlizumab|crizanlizumab
5967012|NCT03814746|Hydroxyurea/ Hydroxycarbamide Therapy|hydroxyurea/ hydroxycarbamide therapy
5967013|NCT03814746|Vaso-Occlusive Crises|vaso-occlusive crises
5967015|NCT03814746|blood disorders|blood disorders
5967016|NCT03814746|hemoglobin|hemoglobin
5967017|NCT03814746|red blood cells|red blood cells
5967018|NCT03814746|sickle-like shape|sickle-like shape
5967019|NCT03814746|mutation in hemoglobin gene|mutation in hemoglobin gene
5967020|NCT03814746|sickle-cell trait|sickle-cell trait
5967021|NCT03814746|sickle-cell crisis|sickle-cell crisis
5967022|NCT03813342|stroke|stroke
5967023|NCT03813342|gait training|gait training
5967024|NCT03813342|visual feedback|visual feedback
5967025|NCT03813290|Brain Computer Interface|brain computer interface
5967026|NCT03813290|Neuro technological intervention|neuro technological intervention
5967027|NCT03813290|Neurofeedback|neurofeedback
5967028|NCT03813160|dermatomyositis|dermatomyositis
5967029|NCT03813160|cannabinoid receptor type 2 agonist|cannabinoid receptor type 2 agonist
5967030|NCT03813160|JBT-101|jbt-101
5967031|NCT03813160|lenabasum|lenabasum
5967032|NCT03812354|infant|infant
5967033|NCT03812354|airway management|airway management
5967034|NCT03812354|apneic oxygenation|apneic oxygenation
5967035|NCT03812172|Heart Failure|heart failure
5967036|NCT03812172|Cardiac Amyloidosis|cardiac amyloidosis
5967037|NCT03812172|TTR mutation|ttr mutation
5967038|NCT03812172|Blacks|blacks
5967039|NCT03812172|Hispanics|hispanics
5967040|NCT03812172|Aging|aging
5967041|NCT03811743|Youth|youth
5967042|NCT03811743|Parents|parents
5967043|NCT03811743|Overweight|overweight
5967044|NCT03811743|Families|families
5967045|NCT03811587|Diet|diet
5967046|NCT03811587|Fasting|fasting
5967047|NCT03810807|Dacomitinib|dacomitinib
5967048|NCT03810807|Osimertinib|osimertinib
5967049|NCT03810807|EGFR Mutant Lung Cancers|egfr mutant lung cancers
5967050|NCT03810807|18-411|18-411
5967051|NCT03810313|Visual impairment|visual impairment
5967052|NCT03810313|Macular edema|macular edema
5967053|NCT03810313|Central retinal vein occlusion|central retinal vein occlusion
5967054|NCT03810313|CRVO|crvo
5967055|NCT03810313|Brolucizumab|brolucizumab
5967056|NCT03810313|Aflibercept|aflibercept
5967057|NCT03810313|Vascular endothelial growth factor|vascular endothelial growth factor
5967058|NCT03810313|VEGF|vegf
5967059|NCT03810313|anti-VEGF|anti-vegf
5967060|NCT03809663|Atopic Dermatitis|atopic dermatitis
5967061|NCT03809663|eczema|eczema
5967062|NCT03809663|tezepelumab|tezepelumab
5967063|NCT03809663|dermatology|dermatology
5967064|NCT03809663|dermatitis|dermatitis
5967065|NCT03809663|inflammation|inflammation
5967066|NCT03809663|skin|skin
5967067|NCT03809663|moderate dermatitis|moderate dermatitis
5967068|NCT03809663|severe dermatitis|severe dermatitis
5967069|NCT03809624|Phase 1|phase 1
5967070|NCT03809624|Phase 1 Clinical Trial|phase 1 clinical trial
5967071|NCT03809624|Solid Tumors|solid tumors
5967072|NCT03809624|Hodgkin Lymphoma|hodgkin lymphoma
5967073|NCT03809624|Non Hodgkin Lymphoma|non hodgkin lymphoma
5967074|NCT03809624|Lung Cancer|lung cancer
5967075|NCT03809624|Melanoma|melanoma
5967076|NCT03809624|Head and Neck Cancer|head and neck cancer
5967077|NCT03809624|Stomach Cancer|stomach cancer
5967078|NCT03809624|Gastric Cancer|gastric cancer
5967079|NCT03809624|Kidney Cancer|kidney cancer
5967080|NCT03809624|Renal cell carcinoma|renal cell carcinoma
5967081|NCT03809624|Renal Cancer|renal cancer
5967082|NCT03809624|Urothelial Carcinoma|urothelial carcinoma
5967083|NCT03809624|PDL1|pdl1
5967084|NCT03809624|41BB|41bb
5967085|NCT03809624|PD-L1|pd-l1
5967086|NCT03809624|4-1BB|4-1bb
5967087|NCT03808922|Parainfluenza|parainfluenza
5967088|NCT03808922|PIV|piv
5967089|NCT03808922|Immunocompromised|immunocompromised
5967090|NCT03808922|Lower Respiratory Tract Infection|lower respiratory tract infection
5967091|NCT03808922|LRTI|lrti
5967092|NCT03808675|Parkinson's disease|parkinson's disease
5967093|NCT03808675|Exercise|exercise
5967094|NCT03808675|Aerobic exercise|aerobic exercise
5967095|NCT03808675|Cognition|cognition
5967096|NCT03808675|Driving|driving
5967097|NCT03808675|Diffusion tensor imaging|diffusion tensor imaging
5967098|NCT03808675|DTI|dti
5967099|NCT03808675|MRI|mri
5967100|NCT03808675|Depression|depression
5967101|NCT03808675|Cardiorespiratory Fitness|cardiorespiratory fitness
5967102|NCT03808675|Quality of life|quality of life
5967103|NCT03808675|Health education|health education
5967104|NCT03808675|Executive functions|executive functions
5967105|NCT03808506|Ulcerative colitis|ulcerative colitis
5967106|NCT03808506|Therapeutic drug monitoring|therapeutic drug monitoring
5967107|NCT03808506|fecal calprotectin|fecal calprotectin
5967108|NCT03808506|adalimumab|adalimumab
5967109|NCT03808506|bowel ultrasound|bowel ultrasound
5967110|NCT03808454|Platelet rich plasma, proprioception, ankle sprain|platelet rich plasma, proprioception, ankle sprain
5967111|NCT03808155|Urinary retention|urinary retention
5967112|NCT03808155|Tamsulosin|tamsulosin
5967113|NCT03808077|prostate cancer|prostate cancer
5967114|NCT03808077|robotic surgery|robotic surgery
5967115|NCT03808077|muscle relaxants|muscle relaxants
5967116|NCT03808077|neuromuscular blockade|neuromuscular blockade
5967117|NCT03808077|18-408|18-408
5967118|NCT03808077|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5967119|NCT03807310|COPD|copd
5967120|NCT03807310|nutrient supplementation|nutrient supplementation
5967121|NCT03807310|Physical activity|physical activity
5967122|NCT03807310|Health related quality of life|health related quality of life
5967123|NCT03806842|shoulder arthroplasty|shoulder arthroplasty
5967124|NCT03806842|reverse shoulder replacement|reverse shoulder replacement
5967125|NCT03805984|Healthy volunteer|healthy volunteer
5967126|NCT03805308|Stroke|stroke
5967127|NCT03805308|Ischemic Stroke|ischemic stroke
5967128|NCT03805308|Thrombectomy|thrombectomy
5967129|NCT03804788|alcohol|alcohol
5967130|NCT03804788|drinking|drinking
5967131|NCT03804788|sleep|sleep
5967132|NCT03804788|insomnia|insomnia
5967133|NCT03804788|veteran|veteran
5967134|NCT03804515|EGFR|egfr
5967135|NCT03804515|HER2 mutations|her2 mutations
5967136|NCT03804515|EGFR/HER2 overexpression/amplification|egfr/her2 overexpression/amplification
5967137|NCT03803943|Hearing Loss|hearing loss
5967138|NCT03803943|Toddlers|toddlers
5967139|NCT03803943|Early Intervention|early intervention
5967140|NCT03803943|Parent-mediated intervention|parent-mediated intervention
5967141|NCT03803813|sepsis|sepsis
5967142|NCT03803813|septic shock|septic shock
5967143|NCT03803813|infection|infection
5967144|NCT03803813|craniotomy|craniotomy
5967145|NCT03803813|outcome|outcome
5967146|NCT03803345|Food timing|food timing
5967147|NCT03803345|Gestational diabetes mellitus|gestational diabetes mellitus
5967148|NCT03803345|Glucose tolerance|glucose tolerance
5967149|NCT03803345|Night-eating|night-eating
5967150|NCT03803345|Pregnancy outcomes|pregnancy outcomes
5967151|NCT03803345|Snacking|snacking
5967152|NCT03802916|iron overload|iron overload
5967153|NCT03802916|chelation|chelation
5967154|NCT03802916|deferiprone|deferiprone
5967155|NCT03802916|Ferriprox|ferriprox
5967156|NCT03802630|Visual impairment|visual impairment
5967157|NCT03802630|Macular edema|macular edema
5967158|NCT03802630|Branch retinal vein occlusion|branch retinal vein occlusion
5967159|NCT03802630|BRVO|brvo
5967160|NCT03802630|Brolucizumab|brolucizumab
5967161|NCT03802630|Aflibercept|aflibercept
5967162|NCT03802630|Vascular endothelial growth factor|vascular endothelial growth factor
5967163|NCT03802630|VEGF|vegf
5967164|NCT03802630|anti-VEGF|anti-vegf
5967165|NCT03802032|infertility|infertility
5967166|NCT03802032|hysterosalpingography|hysterosalpingography
5967167|NCT03802032|pain|pain
5967168|NCT03801915|Well Tolerated Agent|well tolerated agent
5967169|NCT03801915|Pancreas and Liver Resections|pancreas and liver resections
5967170|NCT03801915|Recurrence Free Survival|recurrence free survival
5967171|NCT03801889|chelator|chelator
5967172|NCT03801382|cognitive model|cognitive model
5967173|NCT03801382|cognitive assessment|cognitive assessment
5967174|NCT03801382|digital cognitive tests|digital cognitive tests
5967175|NCT03801382|automated scoring|automated scoring
5967176|NCT03801382|algorithms|algorithms
5967177|NCT03800862|Stenoses|stenoses
5967178|NCT03800862|Chest pain|chest pain
5967179|NCT03800862|Myocardial Infarction|myocardial infarction
5967180|NCT03800862|Heart Attack|heart attack
5967181|NCT03800862|Radiology|radiology
5967182|NCT03800862|Cardiac Imaging|cardiac imaging
5967183|NCT03800862|Coronary artery disease|coronary artery disease
5967184|NCT03799289|Obesity|obesity
5967185|NCT03799289|Weight loss|weight loss
5967186|NCT03799289|physical activity|physical activity
5967187|NCT03799289|yoga|yoga
5967188|NCT03799289|exercise|exercise
5967189|NCT03797924|Intercostobrachial Nerve Block|intercostobrachial nerve block
5967190|NCT03797924|Tourniquet Pain|tourniquet pain
5967191|NCT03797924|Upper Limb Surgeries|upper limb surgeries
5967192|NCT03796663|Disruptive Behavioral Problems|disruptive behavioral problems
5967193|NCT03796663|ADHD|adhd
5967194|NCT03796663|Oppositional Defiant Disorder|oppositional defiant disorder
5967195|NCT03796663|Conduct Disorder|conduct disorder
5967196|NCT03796663|Mindfulness|mindfulness
5967197|NCT03796663|Mindful Parenting|mindful parenting
5967198|NCT03796663|Behavioral Parent Training|behavioral parent training
5967199|NCT03795987|PTSD|ptsd
5967200|NCT03795987|Nightmare|nightmare
5967201|NCT03795987|Nightmare Disorder|nightmare disorder
5967202|NCT03795987|Post-traumatic stress disorder|post-traumatic stress disorder
5967209|NCT03795233|fecal microbiome|fecal microbiome
5967210|NCT03795233|C difficile infection|c difficile infection
5967211|NCT03793894|Community health worker (CHW)|community health worker (chw)
5967212|NCT03793894|Shared decision making (SDM)|shared decision making (sdm)
5967213|NCT03793894|Low-dose computed tomography (LDCT)|low-dose computed tomography (ldct)
5967214|NCT03791814|HCV treatment|hcv treatment
5967215|NCT03791814|Zepatier|zepatier
5967216|NCT03791814|Dialysis patients|dialysis patients
5967217|NCT03790150|Ventilator-associated pneumonia|ventilator-associated pneumonia
5967218|NCT03790150|Mechanical Ventilation|mechanical ventilation
5967219|NCT03790150|Ventilator-associated events|ventilator-associated events
5967220|NCT03790150|Intensive care unit|intensive care unit
5967221|NCT03790150|Quality improvement project|quality improvement project
5967222|NCT03789747|incidence|incidence
5967223|NCT03789747|outcome|outcome
5967224|NCT03789747|acute kidney injury|acute kidney injury
5967225|NCT03789747|risk factor|risk factor
5967226|NCT03789591|Hydroxyurea|hydroxyurea
5967227|NCT03789591|HbSS|hbss
5967228|NCT03789591|HbSD|hbsd
5967229|NCT03789591|TREAT|treat
5967230|NCT03788746|Urothelial Carcinoma|urothelial carcinoma
5967231|NCT03788746|Registry|registry
5967232|NCT03786627|Clinical lumbar instability|clinical lumbar instability
5967233|NCT03786627|History of low back pain|history of low back pain
5967234|NCT03786627|Arthrogenic muscle inhibition|arthrogenic muscle inhibition
5967235|NCT03786627|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5967236|NCT03786627|Motor control training|motor control training
5967237|NCT03785964|PF-03084014|pf-03084014
5967238|NCT03785964|GSI|gsi
5967239|NCT03785964|gamma secretase inhibitor|gamma secretase inhibitor
5967240|NCT03785964|notch pathway|notch pathway
5967241|NCT03785405|heart failure|heart failure
5967242|NCT03785405|pediatric|pediatric
5967243|NCT03785405|LCZ696|lcz696
5967244|NCT03785405|sacubitril/valsartan|sacubitril/valsartan
5967245|NCT03785405|open-label study|open-label study
5967246|NCT03785405|angiotensin receptor neprilysin inhibitor|angiotensin receptor neprilysin inhibitor
5967247|NCT03785314|Optic Nerve Sheath Diameter Different Position|optic nerve sheath diameter different position
5967248|NCT03784612|Smartphone application|smartphone application
5967249|NCT03784612|HbA1c|hba1c
5967250|NCT03784612|Blood lipids|blood lipids
5967251|NCT03784612|Dietary intake|dietary intake
5967252|NCT03784339|Patellofemoral|patellofemoral
5967253|NCT03784339|Knee|knee
5967254|NCT03783819|Hypericum perforatum|hypericum perforatum
5967255|NCT03783819|Saint John's Wort|saint john's wort
5967256|NCT03783819|St. John's Wort|st. john's wort
5967257|NCT03783403|Antibody|antibody
5967258|NCT03783403|CC-95251|cc-95251
5967259|NCT03783403|SIRPα|sirpα
5967260|NCT03783403|Advanced Solid Cancers|advanced solid cancers
5967261|NCT03783403|Advanced Hematologic Cancers|advanced hematologic cancers
5967262|NCT03783260|Gut Microbiome|gut microbiome
5967263|NCT03783260|Metabolites|metabolites
5967264|NCT03783260|Endocannabinoid|endocannabinoid
5967265|NCT03783260|Mediterranean diet|mediterranean diet
5967266|NCT03783143|Febrile|febrile
5967267|NCT03783143|Human|human
5967268|NCT03783143|Lassa Fever|lassa fever
5967269|NCT03783143|Seroconversion|seroconversion
5967270|NCT03783026|Psoriatic Arthritis|psoriatic arthritis
5967271|NCT03783026|CC-10004|cc-10004
5967272|NCT03783026|MRI|mri
5967273|NCT03783026|apremilast|apremilast
5967274|NCT03780140|S-649266|s-649266
5967275|NCT03780140|cefiderocol|cefiderocol
5967276|NCT03780140|Gram-negative|gram-negative
5967277|NCT03779997|Buprenorphine|buprenorphine
5967278|NCT03779997|Directly Observed Therapy|directly observed therapy
5967279|NCT03779997|mHealth|mhealth
5967280|NCT03779997|Opioid Abuse|opioid abuse
5967281|NCT03779711|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5967282|NCT03779711|HLHS|hlhs
5967283|NCT03779711|Congenital Heart Disease|congenital heart disease
5967284|NCT03779711|Umbilical Cord Blood|umbilical cord blood
5967285|NCT03779711|UCB|ucb
5967286|NCT03779711|Cord blood|cord blood
5967287|NCT03779711|Stem cells|stem cells
5967288|NCT03779711|Regenerative therapy|regenerative therapy
5967289|NCT03779711|Stage II Glenn|stage ii glenn
5967290|NCT03779711|Glenn Surgery|glenn surgery
5967291|NCT03779711|single ventricle|single ventricle
5967292|NCT03778658|Adolescent/Young Adult|adolescent/young adult
5967293|NCT03778658|Cancer|cancer
5967294|NCT03778658|Physical Activity|physical activity
5967295|NCT03778658|Psychosocial Health|psychosocial health
5967296|NCT03777436|Genital Psoriasis|genital psoriasis
5967297|NCT03777436|CC-10004|cc-10004
5967298|NCT03777436|Apremilast|apremilast
5967299|NCT03777436|Plaque Psoriasis|plaque psoriasis
5967300|NCT03777410|functional|functional
5967301|NCT03777410|biomarker|biomarker
5967302|NCT03777410|multiple myeloma|multiple myeloma
5967303|NCT03777410|phenotypic|phenotypic
5967304|NCT03777410|biophysical|biophysical
5967305|NCT03774667|Placenta Previa|placenta previa
5967306|NCT03774667|Risk Factors|risk factors
5967307|NCT03774667|Perinatal Complications|perinatal complications
5967308|NCT03774667|Perinatal Outcomes|perinatal outcomes
5967309|NCT03774238|Flow-mediated dilatation|flow-mediated dilatation
5967310|NCT03774238|COPD|copd
5967311|NCT03774238|Pulmonary Rehabilitation|pulmonary rehabilitation
5967312|NCT03774238|Comorbidities|comorbidities
5967313|NCT03774238|endothelial cell|endothelial cell
5967314|NCT03774238|oxidative stress|oxidative stress
5967315|NCT03773978|Polyarticular JIA|polyarticular jia
5967316|NCT03773978|Oligoarthritis|oligoarthritis
5967317|NCT03773978|Juvenile psoriatic arthritis (JPsA)|juvenile psoriatic arthritis (jpsa)
5967318|NCT03773978|Enthesitis‑related juvenile idiopathic arthritis (ERA)|enthesitis‑related juvenile idiopathic arthritis (era)
5967319|NCT03773965|Polyarticular JIA|polyarticular jia
5967320|NCT03773965|Oligoarthritis|oligoarthritis
5967327|NCT03771833|cancer|cancer
5967328|NCT03771833|breast cancer|breast cancer
5967329|NCT03771833|imaging|imaging
5967330|NCT03770962|Midwifery intervention|midwifery intervention
5967331|NCT03770962|Birth experience|birth experience
5967332|NCT03770962|Obstetric anal sphincter injuries|obstetric anal sphincter injuries
5967333|NCT03770962|Perineal tears|perineal tears
5967334|NCT03769675|spinal cord stimulation|spinal cord stimulation
5967335|NCT03769675|type 2 diabetes|type 2 diabetes
5967336|NCT03769532|AML|aml
5967337|NCT03769532|NPM1mut|npm1mut
5967338|NCT03769532|molecular relapse|molecular relapse
5967339|NCT03769532|pembrolizumab|pembrolizumab
5967340|NCT03769532|azacitidine|azacitidine
5967341|NCT03767777|Aortic arch|aortic arch
5967342|NCT03767777|Aortic disease|aortic disease
5967343|NCT03767777|Aortic Dissection|aortic dissection
5967344|NCT03767777|Stent Graft|stent graft
5967345|NCT03767621|Left Main Coronary Artery|left main coronary artery
5967346|NCT03767621|Intermediate Coronary Lesions|intermediate coronary lesions
5967347|NCT03767621|iFR|ifr
5967348|NCT03767621|Coronary Physiology|coronary physiology
5967349|NCT03767621|IVUS|ivus
5967350|NCT03767335|Advanced Breast Cancer|advanced breast cancer
5967351|NCT03767335|Metastatic Breast Cancer|metastatic breast cancer
5967352|NCT03767335|PI3K inhibitor|pi3k inhibitor
5967353|NCT03767335|HER2-positive|her2-positive
5967354|NCT03765918|PD-1|pd-1
5967355|NCT03765918|PD1|pd1
5967356|NCT03765918|Programmed Cell Death-1|programmed cell death-1
5967357|NCT03765918|Programmed Cell Death 1|programmed cell death 1
5967358|NCT03765918|Programmed Cell Death-Ligand 1 (PD-L1)|programmed cell death-ligand 1 (pd-l1)
5967359|NCT03765918|Programmed Cell Death-Ligand 2 (PD-L2)|programmed cell death-ligand 2 (pd-l2)
5967360|NCT03765918|PDL1|pdl1
5967361|NCT03765918|PDL2|pdl2
5967362|NCT03764670|tacrolimus|tacrolimus
5967363|NCT03764670|clinical outcomes|clinical outcomes
5967364|NCT03764670|genetic polymorphism|genetic polymorphism
5967365|NCT03764670|clinical factors|clinical factors
5967366|NCT03764319|ARDS, ECMO, Ventilation|ards, ecmo, ventilation
5967367|NCT03764059|Universal restorative|universal restorative
5967368|NCT03764059|Composite posterior restorative|composite posterior restorative
5967369|NCT03763448|Infrapatellar Fat Pad|infrapatellar fat pad
5967370|NCT03763448|Knee Osteoarthritis|knee osteoarthritis
5967371|NCT03763448|Total Knee Arthroplasty|total knee arthroplasty
5967372|NCT03763448|Randomized Clinical Trial|randomized clinical trial
5967373|NCT03762733|Biobanking|biobanking
5967374|NCT03762733|Tissue Repository|tissue repository
5967375|NCT03762733|Genetic Analysis|genetic analysis
5967376|NCT03761849|HD, RG6042, intrathecal, ASO, antisense oligonucleotide|hd, rg6042, intrathecal, aso, antisense oligonucleotide
5967377|NCT03761420|Medication Adherence|medication adherence
5967378|NCT03761420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5967379|NCT03761420|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5967380|NCT03761420|Treatment Outcome|treatment outcome
5967381|NCT03760133|Gut microbiota|gut microbiota
5967382|NCT03760133|Colonoscopy|colonoscopy
5967383|NCT03760133|Bowel preparation|bowel preparation
5967384|NCT03760133|Probiotics|probiotics
5967385|NCT03760003|ABX464|abx464
5967386|NCT03760003|Refractory patients|refractory patients
5967387|NCT03760003|Phase 2b|phase 2b
5967388|NCT03760003|Dose Ranging|dose ranging
5967389|NCT03759236|Health Messaging|health messaging
5967390|NCT03759236|Health Education|health education
5967391|NCT03759236|Human Papilloma Virus|human papilloma virus
5967392|NCT03759236|HPV Vaccination|hpv vaccination
5967393|NCT03759184|Monoclonal Antibody Treatment|monoclonal antibody treatment
5967394|NCT03759184|Recombinant Human Interleukin-15|recombinant human interleukin-15
5967395|NCT03759184|Lymphoid Malignancy|lymphoid malignancy
5967396|NCT03759184|Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)|antibody-dependent cell-mediated cytotoxicity (adcc)
5967397|NCT03758976|Metastatic breast cancer|metastatic breast cancer
5967398|NCT03758976|Molecular profiling|molecular profiling
5967399|NCT03758976|Circulating tumor DNA|circulating tumor dna
5967400|NCT03758976|Circulating tumor cells|circulating tumor cells
5967401|NCT03758612|TB|tb
5967402|NCT03758612|Tuberculosis|tuberculosis
5967403|NCT03758612|TBI-223|tbi-223
5967404|NCT03758612|Pulmonary Tuberculosis|pulmonary tuberculosis
5967405|NCT03758352|ischemia reperfusion injury|ischemia reperfusion injury
5967406|NCT03758352|remote ischemic preconditioning|remote ischemic preconditioning
5967407|NCT03758352|liver transplantation|liver transplantation
5967408|NCT03757013|Plaque Psoriasis|plaque psoriasis
5967409|NCT03757013|Apremilast|apremilast
5967410|NCT03757013|France|france
5967411|NCT03757013|CC-10004|cc-10004
5967412|NCT03756649|IBD|ibd
5967413|NCT03756649|Ulcerative colitis|ulcerative colitis
5967414|NCT03756649|Crohn's|crohn's
5967415|NCT03755791|liver|liver
5967416|NCT03755791|cancer|cancer
5967417|NCT03755791|hepatocellular|hepatocellular
5967418|NCT03755791|carcinoma|carcinoma
5967419|NCT03755518|Myelofibrosis (MF)|myelofibrosis (mf)
5967420|NCT03755518|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
5967421|NCT03755518|Post-Polycythemia vera (Post-PV)|post-polycythemia vera (post-pv)
5967422|NCT03755518|Post-essential thrombocythemia (Post-ET)|post-essential thrombocythemia (post-et)
5967423|NCT03755518|Myeloproliferative neoplasms (MPN)|myeloproliferative neoplasms (mpn)
5967424|NCT03751800|Heavy Menstrual Bleeding|heavy menstrual bleeding
5967425|NCT03751514|Bordetella Pertussis|bordetella pertussis
5967426|NCT03751124|Heavy menstrual bleeding|heavy menstrual bleeding
5967427|NCT03751124|Menorrhagia|menorrhagia
5967428|NCT03751124|Uterine Fibroids|uterine fibroids
5967429|NCT03751124|Uterine Leiomyoma|uterine leiomyoma
5967430|NCT03750903|aging|aging
5967431|NCT03750318|Vital sign monitoring|vital sign monitoring
5967432|NCT03750318|Heart rate|heart rate
5967433|NCT03750318|Respiratory rate|respiratory rate
5967434|NCT03749967|Depression|depression
5967435|NCT03749629|Depression|depression
5967436|NCT03749629|Major Depressive Disorder|major depressive disorder
5967437|NCT03749629|Pharmacogenomic testing|pharmacogenomic testing
5967438|NCT03489018|Pneumococcal Vaccines;|pneumococcal vaccines;
5967439|NCT03489018|Immunogenicity, Vaccine|immunogenicity, vaccine
5967440|NCT03489018|10-valent pneumococcal vaccine|10-valent pneumococcal vaccine
5967441|NCT03489018|13-valent pneumococcal vaccine|13-valent pneumococcal vaccine
5967442|NCT03489018|Schedule|schedule
5967443|NCT03489018|Pneumococcal Infection|pneumococcal infection
5967444|NCT03489018|Kenya|kenya
5967445|NCT03489018|Infant|infant
5967446|NCT03489018|Vaccines, Conjugate|vaccines, conjugate
5967447|NCT03489018|Humans|humans
5967448|NCT03489018|Immunization schedule|immunization schedule
5967449|NCT03489018|Streptococcus pneumoniae|streptococcus pneumoniae
5967450|NCT03489018|vaccine|vaccine
5967451|NCT03489018|Dose-Response Relationship, immunologic|dose-response relationship, immunologic
5967452|NCT03489018|Equivalence Trial as Topic|equivalence trial as topic
5967453|NCT03748121|Posttraumatic Stress Disorder|posttraumatic stress disorder
5967454|NCT03748121|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5967455|NCT03748121|Complementary Therapies|complementary therapies
5967456|NCT03748121|Yoga|yoga
5967457|NCT03748121|Pranayama|pranayama
5967458|NCT03748121|Effectiveness|effectiveness
5967459|NCT03748121|Safety|safety
5967460|NCT03748121|Randomized Controlled Trial|randomized controlled trial
5967461|NCT03747939|Oligoarthritis|oligoarthritis
5967462|NCT03747939|PsA|psa
5967463|NCT03747939|Apremilast|apremilast
5967464|NCT03747939|Oral tablet|oral tablet
5967465|NCT03747939|Background therapy|background therapy
5967466|NCT03747939|Standard of care|standard of care
5967467|NCT03747250|Videolaryngoscopy|videolaryngoscopy
5967468|NCT03747250|Laryngoscopy|laryngoscopy
5967469|NCT03747250|Tracheal intubation|tracheal intubation
5967470|NCT03747250|Success rate|success rate
5967471|NCT03747185|Clinical lumbar instability|clinical lumbar instability
5967472|NCT03747185|History of low back pain|history of low back pain
5967473|NCT03747185|Corticospinal excitability|corticospinal excitability
5967474|NCT03747185|Stretching exercise|stretching exercise
5967475|NCT03747185|Movement system impairment|movement system impairment
5967476|NCT03746769|islet|islet
5967477|NCT03746769|islet cell|islet cell
5967478|NCT03746769|transplant|transplant
5967479|NCT03746769|gastrin|gastrin
5967480|NCT03746769|hypoglycemia|hypoglycemia
5967481|NCT03746769|labile diabetes|labile diabetes
5967482|NCT03746483|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5967483|NCT03746483|EPI|epi
5967484|NCT03746483|Cystic Fibrosis|cystic fibrosis
5967485|NCT03746483|CF|cf
5967486|NCT03746483|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5967487|NCT03746483|Lipase|lipase
5967488|NCT03745521|XLH|xlh
5967489|NCT03744910|Chronic Active|chronic active
5967490|NCT03744910|Antibody-mediated Rejection (AMR)|antibody-mediated rejection (amr)
5967491|NCT03744572|atherectomy|atherectomy
5967492|NCT03744572|Drug coated balloon|drug coated balloon
5967493|NCT03744416|birth plan|birth plan
5967494|NCT03744416|share decision making|share decision making
5967495|NCT03744416|pregnant women|pregnant women
5967496|NCT03744416|midwife|midwife
5967497|NCT03744416|satisfaction|satisfaction
5967498|NCT03743636|Peripheral Artery Disease|peripheral artery disease
5967499|NCT03743636|PAD|pad
5967500|NCT03743636|Resveratrol|resveratrol
5967501|NCT03743636|Nicotinamide riboside (NR)|nicotinamide riboside (nr)
5967502|NCT03743636|Six-minute walk|six-minute walk
5967503|NCT03743636|Functional performance|functional performance
5967504|NCT03742102|Breast Cancer|breast cancer
5967505|NCT03742102|TNBC|tnbc
5967506|NCT03742102|Triple Negative|triple negative
5967507|NCT03742102|Triple Negative Breast Cancer|triple negative breast cancer
5967508|NCT03742102|Triple-Negative Breast Cancer|triple-negative breast cancer
5967509|NCT03742102|Triple-Negative Breast Neoplasm|triple-negative breast neoplasm
5967510|NCT03742102|ER-Negative PR-Negative HER2-Negative Breast Cancer|er-negative pr-negative her2-negative breast cancer
5967511|NCT03742102|ER-Negative PR-Negative HER2-Negative Breast Neoplasms|er-negative pr-negative her2-negative breast neoplasms
5967512|NCT03741218|Polyphenols|polyphenols
5967513|NCT03741218|Obesity|obesity
5967514|NCT03741218|Grape|grape
5967515|NCT03741218|Postprandial|postprandial
5967516|NCT03741218|Insulin resistance|insulin resistance
5967517|NCT03741218|Second meal effect|second meal effect
5967518|NCT03740997|Contrast-enhanced echocardiography (CE-ECHO)|contrast-enhanced echocardiography (ce-echo)
5967519|NCT03740997|Transthoracic echocardiogram|transthoracic echocardiogram
5967520|NCT03740997|Child|child
5967521|NCT03740997|Left ventricular opacification (LVO)|left ventricular opacification (lvo)
5967522|NCT03740997|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
5967523|NCT03740997|Left ventricular endocardial border delineation (LV EBD)|left ventricular endocardial border delineation (lv ebd)
5967524|NCT03740919|prandial insulin|prandial insulin
5967525|NCT03740919|multiple daily injections|multiple daily injections
5967526|NCT03740919|pediatric patients|pediatric patients
5967527|NCT03740919|postmeal dosing|postmeal dosing
5967528|NCT03740893|AZD6738|azd6738
5967529|NCT03740893|Olaparib|olaparib
5967530|NCT03740893|Durvalumab|durvalumab
5967531|NCT03740893|Window of opportunity|window of opportunity
5967532|NCT03740893|Triple negative breast cancer|triple negative breast cancer
5967533|NCT03740893|Breast cancer|breast cancer
5967534|NCT03740360|Pancreatic cystic neoplasm|pancreatic cystic neoplasm
5967535|NCT03740360|Molecular analysis|molecular analysis
5967536|NCT03740360|Mucinous cystic neoplasm|mucinous cystic neoplasm
5967537|NCT03740360|Serous cystic neoplasm|serous cystic neoplasm
5967538|NCT03740360|Intraductal papillary neoplasm|intraductal papillary neoplasm
5967539|NCT03740035|Prostate Cancer|prostate cancer
5967540|NCT03740035|eHealth|ehealth
5967541|NCT03740035|movement|movement
5967542|NCT03739957|COPD|copd
5967543|NCT03739957|Telemonitoring systems|telemonitoring systems
5967544|NCT03739840|Epilepsy|epilepsy
5967545|NCT03739840|Padsevonil|padsevonil
5967546|NCT03739710|Non-small cell lung cancer|non-small cell lung cancer
5967547|NCT03739710|Inducible t-cell co-stimulator (ICOS)|inducible t-cell co-stimulator (icos)
5967548|NCT03739710|docetaxel|docetaxel
5967549|NCT03739710|Standard of care|standard of care
5967550|NCT03739710|Immuno-oncology agents|immuno-oncology agents
5967551|NCT03738241|A/H7N9 Inactivated Influenza Vaccine|a/h7n9 inactivated influenza vaccine
5967552|NCT03738241|AS03 Adjuvant|as03 adjuvant
5967553|NCT03738241|Immunogenicity|immunogenicity
5967554|NCT03738241|Influenza|influenza
5967555|NCT03738241|Phase II|phase ii
5967556|NCT03738241|Reactogenicity|reactogenicity
5967557|NCT03738241|Safety|safety
5967558|NCT03738241|Vaccine|vaccine
5967559|NCT03737396|Preanaesthesia health assessment|preanaesthesia health assessment
5967560|NCT03737396|Computerized health assessment|computerized health assessment
5967561|NCT03736343|impulsivity|impulsivity
5967562|NCT03736343|family history|family history
5967563|NCT03736343|heavy drinking|heavy drinking
5967564|NCT03736343|blood alcohol content (BAC)|blood alcohol content (bac)
5967565|NCT03736343|breath alcohol content (BrAC)|breath alcohol content (brac)
5967566|NCT03735992|Hematologic Neoplasms|hematologic neoplasms
5967567|NCT03735992|Supportive Therapy|supportive therapy
5967568|NCT03735992|Fatigue|fatigue
5967569|NCT03735992|Mind-body medicine|mind-body medicine
5967570|NCT03735992|Complementary and alternative medicine|complementary and alternative medicine
5967571|NCT03735433|aspirin|aspirin
5967572|NCT03735433|obesity|obesity
5967573|NCT03735342|Hospital discharge|hospital discharge
5967574|NCT03735342|Audio-recording|audio-recording
5967575|NCT03735342|Cardiology|cardiology
5967576|NCT03735342|Provider-patient communication|provider-patient communication
5967577|NCT03735017|Virtual Reality|virtual reality
5967578|NCT03733665|Hospital Episode Statistics|hospital episode statistics
5967579|NCT03733665|HES|hes
5967580|NCT03733665|National Institute for Cardiovascular Outcomes Research|national institute for cardiovascular outcomes research
5967581|NCT03733665|NICOR|nicor
5967582|NCT03733665|National Heart Failure Audit|national heart failure audit
5967583|NCT03733210|Head and Neck Cancer|head and neck cancer
5967584|NCT03733093|HIV|hiv
5967585|NCT03733093|Opportunistic Diseases|opportunistic diseases
5967586|NCT03733093|Tuberculosis|tuberculosis
5967587|NCT03733093|AIDS|aids
5967588|NCT03733093|Sexually Transmitted Infection|sexually transmitted infection
5967589|NCT03733067|Regulatory T Cells|regulatory t cells
5967590|NCT03733067|T-cell hyperactivation|t-cell hyperactivation
5967591|NCT03733067|Autoimmune Cytopenia|autoimmune cytopenia
5967592|NCT03733067|Adult Rheumatoid Arthritis|adult rheumatoid arthritis
5967593|NCT03733067|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5967594|NCT03732807|Alopecia|alopecia
5967595|NCT03732807|Alopecia totalis|alopecia totalis
5967596|NCT03732807|Alopecia universalis|alopecia universalis
5967597|NCT03732807|Patchy hair loss|patchy hair loss
5967598|NCT03732807|Diffuse hair loss|diffuse hair loss
5967599|NCT03732807|Hair loss|hair loss
5967600|NCT03732807|Hair disease|hair disease
5967601|NCT03732807|PF-06651600|pf-06651600
5967602|NCT03732261|postpartum, lactation, bone density, exercise, yogurt|postpartum, lactation, bone density, exercise, yogurt
5967603|NCT03731702|Oral Microbiota|oral microbiota
5967604|NCT03731702|Fecal Microbiota|fecal microbiota
5967605|NCT03731702|Stability|stability
5967606|NCT03730844|Functional outcomes|functional outcomes
5967607|NCT03730844|Skeletal muscle|skeletal muscle
5967608|NCT03730051|Breast MRI|breast mri
5967609|NCT03730051|Mammography|mammography
5967610|NCT03730051|Dotarem contrast|dotarem contrast
5967611|NCT03730051|Gadobutrol contrast|gadobutrol contrast
5967612|NCT03730051|wash-in/wash-out contrast curve|wash-in/wash-out contrast curve
5967613|NCT03730051|Contrast enhanced MRI|contrast enhanced mri
5967614|NCT03729310|Propel Implant|propel implant
5967615|NCT03729310|Nasopore|nasopore
5967616|NCT03729310|Triamcinolone|triamcinolone
5967617|NCT03729232|Catheter Ablation|catheter ablation
5967618|NCT03729232|Cardiac Arrhythmias|cardiac arrhythmias
5967619|NCT03729232|Registry|registry
5967620|NCT03729232|Complication|complication
5967621|NCT03729232|REDCap|redcap
5967622|NCT03728881|Fewer Doses|fewer doses
5967623|NCT03728881|Human Papillomavirus|human papillomavirus
5967624|NCT03728881|Cervical Cancer|cervical cancer
5967625|NCT03728881|Costa Rica|costa rica
5967626|NCT03728881|HPV-Associated Cancers|hpv-associated cancers
5967627|NCT03728868|Faecalibacterium prausnitzii|faecalibacterium prausnitzii
5967628|NCT03728868|Desulfovibrio piger|desulfovibrio piger
5967629|NCT03728868|tolerability|tolerability
5967630|NCT03728868|blood glucose levels|blood glucose levels
5967631|NCT03727802|TRK-250|trk-250
5967632|NCT03727802|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5967633|NCT03727217|Thyroidectomy|thyroidectomy
5967634|NCT03727217|Paralysis of Vocal Cords|paralysis of vocal cords
5967635|NCT03727217|Ultrasound|ultrasound
5967636|NCT03726749|GCA|gca
5967637|NCT03726749|Tocilizumab|tocilizumab
5967638|NCT03726749|Prednisone|prednisone
5967639|NCT03726099|Concomitant Therapy|concomitant therapy
5967640|NCT03726099|Rescue treatment|rescue treatment
5967641|NCT03725059|PD1|pd1
5967642|NCT03725059|PD-1|pd-1
5967643|NCT03725059|PDL1|pdl1
5967644|NCT03725059|PD-L1|pd-l1
5967645|NCT03724747|Metastatic castration resistant prostate cancer, thorium-227, targeted alpha therapy,PSMA|metastatic castration resistant prostate cancer, thorium-227, targeted alpha therapy,psma
5967646|NCT03724539|Drug utilization review|drug utilization review
5967647|NCT03724539|Old age|old age
5967648|NCT03724526|Diabetes Mellitus|diabetes mellitus
5967649|NCT03724526|cardiovascular disease|cardiovascular disease
5967650|NCT03724526|text message|text message
5967651|NCT03724396|weight loss|weight loss
5967652|NCT03724396|executive function|executive function
5967653|NCT03724214|Gastroschisis|gastroschisis
5967654|NCT03724214|Sub-Saharan Africa|sub-saharan africa
5967655|NCT03724214|Low-resource settings|low-resource settings
5967656|NCT03724214|Low- and middle-income countries|low- and middle-income countries
5967657|NCT03724214|Mortality|mortality
5967658|NCT03724214|Outcomes|outcomes
5967659|NCT03724214|Implementation science|implementation science
5967660|NCT03724214|Intervention|intervention
5967661|NCT03722797|energy metabolism|energy metabolism
5967662|NCT03722797|walking|walking
5967663|NCT03722797|exercise|exercise
5967664|NCT03722511|Enterade|enterade
5967665|NCT03722511|Medical Food/Drink|medical food/drink
5967666|NCT03721965|Acute graft-versus-host disease|acute graft-versus-host disease
5967667|NCT03721965|GVHD|gvhd
5967668|NCT03721965|pediatric|pediatric
5967669|NCT03721965|JAK1 inhibitor|jak1 inhibitor
5967670|NCT03721965|corticosteroids|corticosteroids
5967671|NCT03721172|Phase 3|phase 3
5967672|NCT03721172|Double-Blind|double-blind
5967673|NCT03721172|Efficacy|efficacy
5967674|NCT03721172|Safety|safety
5967675|NCT03721172|Apremilast|apremilast
5967676|NCT03721172|Otezla|otezla
5967677|NCT03721172|CC-10004|cc-10004
5967678|NCT03721172|Plaque Psoriasis|plaque psoriasis
5967679|NCT03721172|Mild|mild
5967680|NCT03721172|Moderate|moderate
5967689|NCT03719924|ESCC NAL-IRI|escc nal-iri
5967691|NCT03719599|Infection|infection
5967692|NCT03719599|Seasonal|seasonal
5967693|NCT03719599|Parasitemia|parasitemia
5967694|NCT03719599|Organisms|organisms
5967695|NCT03719521|Adolescents|adolescents
5967696|NCT03719521|Youth|youth
5967697|NCT03719521|Sexual and reproductive health|sexual and reproductive health
5967698|NCT03719521|Africa|africa
5967699|NCT03719521|community-based|community-based
5967700|NCT03719183|M-FISH, FISH, AML|m-fish, fish, aml
5967701|NCT03718533|Eltrombopag, hematological response; poor graft function, stem cell transplantation. CETB115EES03, adult, ELTION, phase II|eltrombopag, hematological response; poor graft function, stem cell transplantation. cetb115ees03, adult, eltion, phase ii
5967702|NCT03718429|aspirin|aspirin
5967703|NCT03718429|clopidogrel|clopidogrel
5967704|NCT03718429|ticagrelor|ticagrelor
5967705|NCT03718429|rivaroxaban|rivaroxaban
5967706|NCT03718429|pharmacodynamic (PD)|pharmacodynamic (pd)
5967707|NCT03716726|Sickle Cell Disease|sickle cell disease
5967708|NCT03716726|Social Determinants of Health|social determinants of health
5967709|NCT03716726|Unmet Social Needs|unmet social needs
5967710|NCT03716726|WE CARE|we care
5967711|NCT03716583|melatonin|melatonin
5967712|NCT03713619|acne inversa|acne inversa
5967713|NCT03713619|Hidradenitis suppurativa|hidradenitis suppurativa
5967714|NCT03713619|maladie de Verneuil|maladie de verneuil
5967715|NCT03713619|inflammatory disease|inflammatory disease
5967716|NCT03713619|AIN457|ain457
5967717|NCT03713619|AIN457M|ain457m
5967718|NCT03713593|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5967719|NCT03713593|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5967720|NCT03713593|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5967721|NCT03713593|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5967722|NCT03712345|Granulomatosis with Polyangiitis (GPA)|granulomatosis with polyangiitis (gpa)
5967723|NCT03712345|Microscopic Polyangiitis (MPA)|microscopic polyangiitis (mpa)
5967724|NCT03712345|IFS-1|ifs-1
5967725|NCT03712345|ANCA|anca
5967726|NCT03712345|AAV|aav
5967727|NCT03711734|Acupuncture|acupuncture
5967728|NCT03711591|Proximal humerus fracture fixation|proximal humerus fracture fixation
5967729|NCT03711591|Trauma|trauma
5967730|NCT03711591|Proximal Humerus|proximal humerus
5967731|NCT03711591|Fixation|fixation
5967732|NCT03711435|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5967733|NCT03711435|Metabolomics|metabolomics
5967734|NCT03711435|Chinese medicine|chinese medicine
5967735|NCT03711032|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5967736|NCT03711032|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
5967737|NCT03711032|anti-PD-1|anti-pd-1
5967738|NCT03711032|anti-PD-L1|anti-pd-l1
5967739|NCT03711032|BCG|bcg
5967740|NCT03711032|HR NMIBC|hr nmibc
5967741|NCT03711032|Patient Reported Outcome (PRO)|patient reported outcome (pro)
5967742|NCT03710720|Traumatic stress|traumatic stress
5967743|NCT03710720|substance use prevention|substance use prevention
5967744|NCT03710720|HIV prevention|hiv prevention
5967745|NCT03710720|adolescents|adolescents
5967746|NCT03709992|ureteral stent|ureteral stent
5967747|NCT03709992|USSQ|ussq
5967748|NCT03709992|Tamsulosin|tamsulosin
5967749|NCT03709992|Trospium Chloride|trospium chloride
5967750|NCT03709680|Solid tumor, Ewing and Rhabdomyosarcoma, Neuroblastoma, brain|solid tumor, ewing and rhabdomyosarcoma, neuroblastoma, brain
5967751|NCT03709680|tumor|tumor
5967752|NCT03709459|Syphilis, Gonorrhea, Chlamydia, Doxycycline, PrEP, Syphilaxis|syphilis, gonorrhea, chlamydia, doxycycline, prep, syphilaxis
5967753|NCT03709212|Chronic Kidney Disease|chronic kidney disease
5967754|NCT03709212|Physical Activity|physical activity
5967755|NCT03709212|Cultural influences|cultural influences
5967756|NCT03709212|Exercise|exercise
5967757|NCT03708003|lymphocytic leukemia|lymphocytic leukemia
5967758|NCT03708003|relapsed/refractory chronic lymphocytic leukemia|relapsed/refractory chronic lymphocytic leukemia
5967759|NCT03708003|Ibrutinib|ibrutinib
5967760|NCT03708003|venetoclax|venetoclax
5967761|NCT03707600|Nicotine Abstinence|nicotine abstinence
5967762|NCT03707600|Metaplasticity|metaplasticity
5967763|NCT03707600|Nicotine|nicotine
5967764|NCT03707600|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5967765|NCT03707600|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5967766|NCT03706677|Ablation|ablation
5967767|NCT03706677|Cryoballoon|cryoballoon
5967768|NCT03706677|Radiofrequency|radiofrequency
5967769|NCT03706365|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5967770|NCT03706365|mCRPC|mcrpc
5967771|NCT03705663|HIV prevention, PrEP cascade, women|hiv prevention, prep cascade, women
5967772|NCT03705624|falciparum|falciparum
5967773|NCT03705624|gametocyte|gametocyte
5967774|NCT03705624|elimination|elimination
5967775|NCT03705624|anopheles|anopheles
5967776|NCT03705624|transmission|transmission
5967777|NCT03705624|diagnostic|diagnostic
5967778|NCT03704623|Acute renal colic|acute renal colic
5967779|NCT03704623|Ureteric stone|ureteric stone
5967780|NCT03704623|Selective COX2 inhibitor|selective cox2 inhibitor
5967781|NCT03704623|Parecoxib|parecoxib
5967782|NCT03704623|Paracetamol|paracetamol
5967783|NCT03703440|Transition care|transition care
5967784|NCT03703440|Pediatric|pediatric
5967785|NCT03703440|Adolescent|adolescent
5967786|NCT03703440|Education|education
5967787|NCT03703440|Hemaglobin A1c|hemaglobin a1c
5967788|NCT03703440|Health Services|health services
5967789|NCT03703440|Randomized Controlled Trial|randomized controlled trial
5967790|NCT03701763|Pediatric|pediatric
5967791|NCT03701763|6 through 17 years|6 through 17 years
5967792|NCT03701763|Plaque Psoriasis|plaque psoriasis
5967793|NCT03701763|Psoriasis|psoriasis
5967794|NCT03701763|CC-10004|cc-10004
5967796|NCT03701763|Otezla|otezla
5967797|NCT03701763|Children|children
5967798|NCT03701763|Adolescents|adolescents
5967799|NCT03701763|SPROUT|sprout
5967800|NCT03700736|post-partum women|post-partum women
5967801|NCT03700736|social media|social media
5967802|NCT03700736|Facebook|facebook
5967803|NCT03700736|digital health|digital health
5967804|NCT03699085|Opioid Use|opioid use
5967805|NCT03699085|Emergency Department|emergency department
5967806|NCT03699085|Collaborative Care|collaborative care
5967807|NCT03697252|Schizophrenia|schizophrenia
5967808|NCT03695276|Health coaching|health coaching
5967809|NCT03695276|COPD|copd
5967810|NCT03695276|Asthma|asthma
5967811|NCT03695276|Access to specialty care|access to specialty care
5967812|NCT03695185|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5967813|NCT03695185|ABBV-323|abbv-323
5967814|NCT03693612|advanced solid tumor|advanced solid tumor
5967815|NCT03693612|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5967816|NCT03693612|standard of care|standard of care
5967817|NCT03693612|GSK3359609|gsk3359609
5967818|NCT03693612|urothelial carcinoma of the upper and lower urinary tract|urothelial carcinoma of the upper and lower urinary tract
5268329|NCT02341209|MF|mf
5967819|NCT03693612|non-small cell lung cancer|non-small cell lung cancer
5967820|NCT03693612|cutaneous melanoma|cutaneous melanoma
5967821|NCT03693612|Tremelimumab|tremelimumab
5967822|NCT03693612|clear cell renal carcinoma|clear cell renal carcinoma
5967823|NCT03693612|castrate resistant prostate adenocarcinoma|castrate resistant prostate adenocarcinoma
5967824|NCT03690739|Symptom Benefit|symptom benefit
5967825|NCT03690388|Thyroid cancer, papillary|thyroid cancer, papillary
5967826|NCT03690388|Papillary thyroid carcinoma|papillary thyroid carcinoma
5967827|NCT03690388|Nonmedullary thyroid carcinoma|nonmedullary thyroid carcinoma
5967828|NCT03690388|Cancer of the thyroid|cancer of the thyroid
5967829|NCT03690388|Thyroid cancer|thyroid cancer
5967830|NCT03690388|Follicular thyroid cancer|follicular thyroid cancer
5967831|NCT03690388|Thyroid cancer, follicular|thyroid cancer, follicular
5967832|NCT03690388|Hürthle cell cancer|hürthle cell cancer
5967833|NCT03689712|Oral Mucositis|oral mucositis
5967834|NCT03689712|Superoxide Dismutase Mimetic|superoxide dismutase mimetic
5967835|NCT03689712|Cisplatin|cisplatin
5967836|NCT03689712|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
5967837|NCT03689712|Chemoradiation|chemoradiation
5967838|NCT03689712|OM|om
5967839|NCT03689712|IMRT|imrt
5967840|NCT03689712|Head and Neck Cancer|head and neck cancer
5967841|NCT03689712|Squamous Cell Carcinoma|squamous cell carcinoma
5967842|NCT03689712|SCC|scc
5967843|NCT03689712|Oral Cavity|oral cavity
5967844|NCT03689712|Oropharnyx|oropharnyx
5967845|NCT03689712|Mouth Sores|mouth sores
5967846|NCT03687411|spinal anaesthesia|spinal anaesthesia
5967847|NCT03687411|Neuraxial ultrasonography|neuraxial ultrasonography
5967848|NCT03687411|landmark identification|landmark identification
5967849|NCT03686241|Tibiotalocalcaneal arthrodesis|tibiotalocalcaneal arthrodesis
5967850|NCT03686241|Intramedullary Nail|intramedullary nail
5967851|NCT03686241|Sustained Compression|sustained compression
5967852|NCT03686124|T-cell therapy|t-cell therapy
5967853|NCT03686124|immunotherapy|immunotherapy
5967854|NCT03686033|E2082|e2082
5967855|NCT03686033|Epilepsy|epilepsy
5967856|NCT03686033|Photosensitive|photosensitive
5967857|NCT03686033|Anti-epileptic|anti-epileptic
5967858|NCT03686033|Seizures|seizures
5967859|NCT03686033|Photoparoxysmal response|photoparoxysmal response
5967860|NCT03686033|PPR|ppr
5967861|NCT03685422|Virtual Reality|virtual reality
5967862|NCT03685422|Pain|pain
5967863|NCT03685422|Anxiety|anxiety
5967864|NCT03685422|Analgesia|analgesia
5967865|NCT03685422|Patient satisfaction|patient satisfaction
5967866|NCT03685162|addiction|addiction
5967867|NCT03685162|opioid addiction|opioid addiction
5967868|NCT03685162|levomethadone|levomethadone
5967869|NCT03685162|methadone|methadone
5967870|NCT03685162|opioid maintenance treatment|opioid maintenance treatment
5967871|NCT03684889|CAR T cell, CD19, pediatric, young adults|car t cell, cd19, pediatric, young adults
5967872|NCT03684694|Loncastuximab Tesirine in Combination with Ibrutinib|loncastuximab tesirine in combination with ibrutinib
5967873|NCT03683355|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5967874|NCT03683355|Infective endocarditis|infective endocarditis
5967875|NCT03683355|Radionuclide imaging|radionuclide imaging
5967876|NCT03683355|Radiolabeled tracer uptake pattern|radiolabeled tracer uptake pattern
5967877|NCT03683186|Prostacyclin|prostacyclin
5967878|NCT03683186|Connective Tissue Disease-Associated|connective tissue disease-associated
5967879|NCT03683186|6 Minute Walk Test|6 minute walk test
5967880|NCT03683186|6 Minute Walk Distance|6 minute walk distance
5967881|NCT03683186|Pulmonary Vascular Resistance|pulmonary vascular resistance
5967882|NCT03683186|Right Ventricular Function|right ventricular function
5967883|NCT03682900|e-cigarettes|e-cigarettes
5967884|NCT03682900|prevention|prevention
5967885|NCT03682900|middle school|middle school
5967886|NCT03682900|smoking|smoking
5967887|NCT03682536|Luspatercept|luspatercept
5967888|NCT03682536|ACE-536|ace-536
5967889|NCT03682536|Anemia|anemia
5967890|NCT03682536|Myelodysplastic Syndromes|myelodysplastic syndromes
5967891|NCT03682536|MDS|mds
5967892|NCT03682536|Blood Transfusion|blood transfusion
5967893|NCT03682536|RBC Transfusion|rbc transfusion
5967894|NCT03682120|A/H7N9|a/h7n9
5967895|NCT03682120|Healthy Adults|healthy adults
5967896|NCT03682120|Immunogenicity|immunogenicity
5967897|NCT03682120|Influenza vaccine|influenza vaccine
5967898|NCT03682120|MF59(R) adjuvant|mf59(r) adjuvant
5967899|NCT03682120|Reactogenicity|reactogenicity
5967900|NCT03682120|Safety|safety
5967901|NCT03682107|Andes Virus DNA|andes virus dna
5967902|NCT03682107|ANDV DNA|andv dna
5967903|NCT03682107|Hantavirus|hantavirus
5967904|NCT03682107|Immunogenicity|immunogenicity
5967905|NCT03682107|PharmaJet Stratis|pharmajet stratis
5967906|NCT03682107|Pulmonary Syndrome|pulmonary syndrome
5967907|NCT03682107|Safety|safety
5967908|NCT03682107|Vaccine|vaccine
5967909|NCT03681600|audit|audit
5967910|NCT03681600|cancer|cancer
5967911|NCT03681600|guidelines|guidelines
5967912|NCT03681600|ouctomes|ouctomes
5967913|NCT03681600|survival|survival
5967914|NCT03681600|digestive cancer surgery|digestive cancer surgery
5967915|NCT03681249|Diabetic Kidney Disease，Traditional Chinese medicine|diabetic kidney disease，traditional chinese medicine
5967916|NCT03679195|24h ambulatory blood pressure vascular function inflammation|24h ambulatory blood pressure vascular function inflammation
5967917|NCT03677596|Leukemia|leukemia
5967925|NCT03677284|Elderly people|elderly people
5967926|NCT03676153|Integrative medicine|integrative medicine
5967927|NCT03676153|Supportive and Palliative care|supportive and palliative care
5967928|NCT03675737|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5967929|NCT03675737|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5967930|NCT03675737|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5967931|NCT03675724|Frailty|frailty
5967932|NCT03675724|Inflammation|inflammation
5967933|NCT03675724|Elderly|elderly
5967934|NCT03675724|Aging|aging
5967935|NCT03675308|KEEPsAKE 1|keepsake 1
5967936|NCT03675308|KEEPsAKE1|keepsake1
5967937|NCT03674593|Mitral Valve Chordae|mitral valve chordae
5967938|NCT03674593|Degenerative Mitral Valve Disease|degenerative mitral valve disease
5967939|NCT03674593|Mitral Valve Chordae Replacement|mitral valve chordae replacement
5967940|NCT03674593|Mitral Valve Chordae Translocation|mitral valve chordae translocation
5967941|NCT03674593|Mitral Valve Chordae Prosthetics|mitral valve chordae prosthetics
5967942|NCT03674437|Quality of Life|quality of life
5967943|NCT03674437|Cognitive Function|cognitive function
5967944|NCT03674437|18-294|18-294
5967945|NCT03674255|Stress Echocardiography|stress echocardiography
5967946|NCT03674255|Blood Biomarkers|blood biomarkers
5967947|NCT03674255|Extracellular Vesicles|extracellular vesicles
5967948|NCT03674255|Imaging Biomarkers|imaging biomarkers
5967949|NCT03674255|Machine Learning|machine learning
5967950|NCT03674255|Artificial Intelligence|artificial intelligence
5967951|NCT03674255|Ischaemic Heart Disease|ischaemic heart disease
5967952|NCT03674255|Coronary Artery Disease|coronary artery disease
5967953|NCT03674255|Angina Pectoris|angina pectoris
5967954|NCT03674099|Multiple Sclerosis relaps|multiple sclerosis relaps
5967955|NCT03674099|Imatinib|imatinib
5967956|NCT03674099|Methylprednisolone|methylprednisolone
5967957|NCT03672630|NTM|ntm
5967958|NCT03672630|MAC|mac
5967959|NCT03672630|mycobacteria|mycobacteria
5967960|NCT03672630|nontuberculous mycobacteria|nontuberculous mycobacteria
5967961|NCT03672630|azithromycin|azithromycin
5967962|NCT03672630|ethambutol|ethambutol
5967963|NCT03672630|rifampin|rifampin
5967964|NCT03672058|Cystic Fibrosis, CF|cystic fibrosis, cf
5967965|NCT03671954|knee osteoarthritis|knee osteoarthritis
5967966|NCT03671954|rehabilitation strategies|rehabilitation strategies
5967967|NCT03671954|soft tissue balance|soft tissue balance
5967968|NCT03671759|Caffeine|caffeine
5967969|NCT03671759|Coffee|coffee
5967970|NCT03671759|Arrhythmias|arrhythmias
5967971|NCT03671759|Palpitations|palpitations
5967972|NCT03671759|Cardiac ectopy|cardiac ectopy
5967973|NCT03671759|PACs|pacs
5967974|NCT03671759|PVCs|pvcs
5967975|NCT03670966|Lymphoid Leukemia|lymphoid leukemia
5967976|NCT03670966|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5967977|NCT03670966|Other Hematopoietic|other hematopoietic
5967978|NCT03670953|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5967979|NCT03670953|Lewy Body Parkinson's Disease|lewy body parkinson's disease
5967980|NCT03670953|Paralysis Agitans|paralysis agitans
5967981|NCT03670953|Primary Parkinsonism|primary parkinsonism
5967982|NCT03670810|acute treatment|acute treatment
5967983|NCT03670810|migraine pain|migraine pain
5967984|NCT03670810|multiple attacks|multiple attacks
5967985|NCT03670810|headache|headache
5967986|NCT03670290|hip fracture|hip fracture
5967987|NCT03670290|fascia iliaca compartment catheter|fascia iliaca compartment catheter
5967988|NCT03670290|epidural catheter|epidural catheter
5967989|NCT03670290|delirium|delirium
5967990|NCT03670290|postoperative complications|postoperative complications
5967991|NCT03669926|Diagnostic Imaging|diagnostic imaging
5967992|NCT03669926|Mammography|mammography
5967993|NCT03669926|Tomosynthesis|tomosynthesis
5967994|NCT03669926|Breast cancer screening|breast cancer screening
5967995|NCT03669926|Subsequent screening|subsequent screening
5967996|NCT03669926|Cancer detection|cancer detection
5967997|NCT03669926|Cost effectiveness|cost effectiveness
5967998|NCT03669926|Early performance measures|early performance measures
5967999|NCT03669926|Interval cancer|interval cancer
5968000|NCT03669835|Hepatitis C|hepatitis c
5968001|NCT03669835|Mare milk|mare milk
5968002|NCT03669835|Liver function|liver function
5968003|NCT03668951|Pediatric|pediatric
5968004|NCT03668951|Sedation|sedation
5968005|NCT03668951|Dexmedetomidine|dexmedetomidine
5968006|NCT03666572|Severe Acute Malnutrition|severe acute malnutrition
5968007|NCT03666572|Young Infants under 6 months age|young infants under 6 months age
5968008|NCT03666572|Microbiome|microbiome
5968009|NCT03666572|Prebiotics|prebiotics
5968010|NCT03666572|Probiotics|probiotics
5968011|NCT03665597|Programmed Cell Death 1|programmed cell death 1
5968012|NCT03665597|PD1|pd1
5968013|NCT03665597|PD-1|pd-1
5268527|NCT02339844|dopamine|dopamine
5968014|NCT03665597|Programmed Cell Death-Ligand 1|programmed cell death-ligand 1
5968015|NCT03665597|PDL1|pdl1
5968016|NCT03665597|PD-L1|pd-l1
5968017|NCT03665519|Primary Biliary Cirrhosis|primary biliary cirrhosis
5968018|NCT03665519|Primary Biliary Cholangitis|primary biliary cholangitis
5968019|NCT03665519|Mare Milk|mare milk
5968020|NCT03664674|Meniere's Disease|meniere's disease
5968021|NCT03664674|Vertigo|vertigo
5968022|NCT03664674|Endolymphatic Hydrops|endolymphatic hydrops
5968023|NCT03664674|Labyrinth Diseases|labyrinth diseases
5968024|NCT03664674|Ear Diseases|ear diseases
5968025|NCT03664674|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5968026|NCT03664596|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5968027|NCT03664596|Mare milk|mare milk
5968028|NCT03664596|Immune markers|immune markers
5968029|NCT03663933|Haploidentical|haploidentical
5944671|NCT04187482|aerobic exercise|aerobic exercise
5968031|NCT03663933|Immune Dysregulation|immune dysregulation
5968032|NCT03663933|Congenital|congenital
5968033|NCT03663933|Opportunistic Infection|opportunistic infection
5968034|NCT03661866|Atopic Dermatitis|atopic dermatitis
5968035|NCT03661866|IMISC|imisc
5968036|NCT03661866|Registry|registry
5968037|NCT03661866|Observational|observational
5968038|NCT03661866|Immune-mediated Inflammatory Skin Conditions|immune-mediated inflammatory skin conditions
5968039|NCT03661333|dialectical behavior therapy|dialectical behavior therapy
5968040|NCT03661047|Nutrition|nutrition
5968041|NCT03661047|Omega-3 fatty acid|omega-3 fatty acid
5968042|NCT03661047|Fish oil|fish oil
5968043|NCT03661047|Tumor microenvironment|tumor microenvironment
5968044|NCT03661047|Immune response|immune response
5968045|NCT03661047|Gut microbiota|gut microbiota
5968046|NCT03660644|COPD|copd
5968047|NCT03660644|Physical Activity|physical activity
5968048|NCT03660644|Pulmonary rehabilitation|pulmonary rehabilitation
5968049|NCT03660592|Lung ultrasound|lung ultrasound
5968050|NCT03660592|heart failure|heart failure
5968051|NCT03660592|diagnosis|diagnosis
5968052|NCT03658252|steroid phobia|steroid phobia
5968053|NCT03658252|topical corticosteroids|topical corticosteroids
5968054|NCT03658252|eczema|eczema
5968055|NCT03658252|psoriasis|psoriasis
5968056|NCT03658252|adherence|adherence
5968057|NCT03658252|quality of life|quality of life
5968058|NCT03657836|Acute Bronchitis|acute bronchitis
5968059|NCT03657836|Mare milk|mare milk
5968060|NCT03657836|Gut mucosa|gut mucosa
5968061|NCT03657836|Antibiotics|antibiotics
5968062|NCT03657043|Platinum-resistant|platinum-resistant
5968063|NCT03657043|Antibody drug conjugate|antibody drug conjugate
5968064|NCT03657043|Tisotumab vedotin|tisotumab vedotin
5968065|NCT03657043|PROC|proc
5968066|NCT03656263|echocardiography|echocardiography
5968067|NCT03656263|Portal Doppler|portal doppler
5968068|NCT03656263|Cardiac surgery|cardiac surgery
5968069|NCT03655756|Unresectable|unresectable
5968070|NCT03655756|Melanoma|melanoma
5968071|NCT03655756|pDNA|pdna
5968072|NCT03655756|Plasmid DNA|plasmid dna
5968073|NCT03655756|Gene Therapy|gene therapy
5968074|NCT03654898|pregnant women|pregnant women
5968075|NCT03654898|viral suppression|viral suppression
5968076|NCT03654898|retention|retention
5968077|NCT03654898|video intervention|video intervention
5968078|NCT03654898|pre-ART|pre-art
5968079|NCT03654898|counseling|counseling
5968080|NCT03654898|HIV|hiv
5968081|NCT03654898|adherence|adherence
5968082|NCT03654898|PMTCT|pmtct
5968083|NCT03654729|Metastatic|metastatic
5968084|NCT03654729|Colorectal|colorectal
5968085|NCT03654729|Cancer|cancer
5968086|NCT03654729|Metastatic Colorectal Cancer|metastatic colorectal cancer
5968087|NCT03654729|Oxaliplatin induced CIPN|oxaliplatin induced cipn
5968088|NCT03654729|CIPN|cipn
5968089|NCT03654729|Oxaliplatin|oxaliplatin
5968090|NCT03654378|Quetiapine|quetiapine
5968091|NCT03654378|Pregnancy|pregnancy
5968092|NCT03653806|PEEP|peep
5968093|NCT03653806|Electrical Impedance Tomography|electrical impedance tomography
5968094|NCT03653637|Suicide|suicide
5968095|NCT03653637|Safety Plan|safety plan
5968096|NCT03653637|Group Treatment|group treatment
5968097|NCT03653637|Veterans|veterans
5968098|NCT03653507|CLDN 18.2|cldn 18.2
5968099|NCT03653507|gastroesophageal junction cancer|gastroesophageal junction cancer
5968100|NCT03653507|adenocarcinoma|adenocarcinoma
5968101|NCT03653507|IMAB362|imab362
5968102|NCT03653507|oxaliplatin|oxaliplatin
5968103|NCT03653507|HER2|her2
5968104|NCT03653507|claudiximab|claudiximab
5968105|NCT03653507|capecitabine|capecitabine
5968106|NCT03653507|gastric cancer|gastric cancer
5968107|NCT03653507|HER2 Negative|her2 negative
5968108|NCT03653507|zolbetuximab|zolbetuximab
5968109|NCT03653169|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5968110|NCT03652675|Heavy Drinking|heavy drinking
5968111|NCT03652675|HIV|hiv
5968112|NCT03652675|Hepatitis C|hepatitis c
5968113|NCT03652610|Meningitis|meningitis
5968114|NCT03652610|Liquid formulation|liquid formulation
5968115|NCT03652610|Meningococcal disease|meningococcal disease
5968116|NCT03651245|Alpha-Mannosidosis disease|alpha-mannosidosis disease
5968117|NCT03651245|prevalence|prevalence
5968118|NCT03651167|skin care|skin care
5968119|NCT03651167|skin tone|skin tone
5968120|NCT03651167|tanning|tanning
5968121|NCT03651167|skin tone preference|skin tone preference
5968122|NCT03650920|HCV|hcv
5968123|NCT03650452|Drug Therapy|drug therapy
5968124|NCT03650452|Brain Diseases|brain diseases
5968125|NCT03650452|Central Nervous System Diseases|central nervous system diseases
5968126|NCT03650452|Tuberous Sclerosis|tuberous sclerosis
5968127|NCT03650452|CDKL5 deficiency disorder|cdkl5 deficiency disorder
5968128|NCT03650452|Duplication 15 Q syndrome|duplication 15 q syndrome
5968129|NCT03650452|Dup15Q syndrome|dup15q syndrome
5968130|NCT03650452|Anoxic brain injury|anoxic brain injury
5968131|NCT03650452|Infantile spams|infantile spams
5968132|NCT03650452|West syndrome|west syndrome
5968133|NCT03650452|Cortical dysplasia|cortical dysplasia
5968134|NCT03650452|SCN1A|scn1a
5968135|NCT03650452|OV-935|ov-935
5968136|NCT03650452|Cholesterol 24 hydroxylase inhibitor|cholesterol 24 hydroxylase inhibitor
5968137|NCT03650452|Cholesterol 24S-hydroxylase inhibitor|cholesterol 24s-hydroxylase inhibitor
5968138|NCT03650452|Seizure|seizure
5968139|NCT03650452|Anti-epilepsy drug|anti-epilepsy drug
5968140|NCT03650452|Anticonvulsants|anticonvulsants
5968141|NCT03650452|Nervous System Diseases|nervous system diseases
5968142|NCT03650452|Drop seizure|drop seizure
5968143|NCT03650452|Atonic seizure|atonic seizure
5968144|NCT03649477|PWS|pws
5968145|NCT03649477|Prader-Willi syndrome|prader-willi syndrome
5968146|NCT03649477|carbetocin|carbetocin
5968147|NCT03647449|Juice fasting; methylation; microbiome; caloric restriction|juice fasting; methylation; microbiome; caloric restriction
5968148|NCT03647228|ION-827359|ion-827359
5968149|NCT03647228|ENaC|enac
5968150|NCT03647124|Mantle Cell Lymphoma|mantle cell lymphoma
5968151|NCT03647124|MCL|mcl
5968152|NCT03647124|Revlimid|revlimid
5968153|NCT03647124|Non-Interventional|non-interventional
5968154|NCT03647124|PASS|pass
5968155|NCT03647124|CC-5013|cc-5013
5968156|NCT03647124|Relapsed|relapsed
5968157|NCT03647124|Refractory|refractory
5968158|NCT03647124|TFR|tfr
5968159|NCT03647124|Tumor Flare Reaction|tumor flare reaction
5968160|NCT03647124|High Tumor Burden|high tumor burden
5968161|NCT03646669|Older adults|older adults
5968162|NCT03646669|Asthma|asthma
5968163|NCT03646669|Symptom perception|symptom perception
5968164|NCT03646669|Self-management behaviors|self-management behaviors
5968165|NCT03646669|Medication adherence|medication adherence
5968166|NCT03646123|Brentuximab vedotin|brentuximab vedotin
5968167|NCT03646123|Doxorubicin|doxorubicin
5968168|NCT03646123|Vinblastine|vinblastine
5968169|NCT03646123|Dacarbazine|dacarbazine
5968170|NCT03646123|Nivolumab|nivolumab
5968171|NCT03645928|LN-144|ln-144
5968172|NCT03645928|LN-145|ln-145
5968173|NCT03645928|Cell Therapy|cell therapy
5968174|NCT03645928|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
5968175|NCT03645928|Autologous Adoptive Cell Therapy|autologous adoptive cell therapy
5968176|NCT03645928|Cellular Immuno-therapy|cellular immuno-therapy
5968177|NCT03645928|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5968178|NCT03645928|TIL|til
5968179|NCT03645928|IL-2|il-2
5968180|NCT03645928|Multiple Tumor Type|multiple tumor type
5968181|NCT03645928|Lifileucel|lifileucel
5968182|NCT03645928|Pembrolizumab|pembrolizumab
5968183|NCT03645928|LN-145-S1|ln-145-s1
5968184|NCT03645239|Postoperative pain|postoperative pain
5968185|NCT03645239|Cesarean delivery|cesarean delivery
5968186|NCT03645239|Postoperative nausea and vomiting|postoperative nausea and vomiting
5968187|NCT03645122|Spike timing-dependent plasticity|spike timing-dependent plasticity
5968188|NCT03645122|cerebrovasculor accident|cerebrovasculor accident
5968189|NCT03645122|paralysis|paralysis
5968190|NCT03645122|hemiparesis|hemiparesis
5968191|NCT03645122|stimulation|stimulation
5968192|NCT03644550|Checkpoint Inhibitor|checkpoint inhibitor
5968193|NCT03644550|Immunotherapy|immunotherapy
5968194|NCT03643211|Xljanz|xljanz
5968195|NCT03643211|Ulcerative colitis|ulcerative colitis
5968196|NCT03643211|UC|uc
5968197|NCT03643211|Long-term|long-term
5968198|NCT03643042|Myelodysplastic Syndromes|myelodysplastic syndromes
5968199|NCT03643042|Transfusion|transfusion
5968200|NCT03643042|Quality of life|quality of life
5968201|NCT03643042|Physical performance|physical performance
5968202|NCT03642912|ECMO|ecmo
5968203|NCT03642912|haemostasis|haemostasis
5968204|NCT03642912|coagulation|coagulation
5968205|NCT03642912|haemostatic alterations|haemostatic alterations
5968206|NCT03642028|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5968207|NCT03642028|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5968208|NCT03642028|Suvorexant|suvorexant
5968209|NCT03642028|Veterans|veterans
5968210|NCT03641989|Toothpaste|toothpaste
5968211|NCT03641989|Inflammation|inflammation
5968212|NCT03641989|Periodontal Disease|periodontal disease
5968213|NCT03641989|hsCRP|hscrp
5968214|NCT03641989|Oral health|oral health
5968215|NCT03641989|Oral hygiene|oral hygiene
5968216|NCT03641469|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5968217|NCT03641469|thoracolumbosacral orthosis|thoracolumbosacral orthosis
5968218|NCT03641469|spinal orthotic|spinal orthotic
5968219|NCT03641469|health-related quality of life|health-related quality of life
5968220|NCT03641469|treatment adherence|treatment adherence
5968221|NCT03640793|Snoring, Obstructive Sleep Apnea|snoring, obstructive sleep apnea
5968222|NCT03640754|Hot Flashes|hot flashes
5968223|NCT03640754|Vasomotor Symptoms|vasomotor symptoms
5968224|NCT03640754|Menopause|menopause
5968225|NCT03640689|Venous ulcer|venous ulcer
5968226|NCT03640689|Great saphenous incompetence|great saphenous incompetence
5968227|NCT03640689|Iliac vein|iliac vein
5968228|NCT03640689|Endovenous therapy|endovenous therapy
5968229|NCT03639584|Vitamin D Deficiency|vitamin d deficiency
5968230|NCT03639584|Critical Illness|critical illness
5968231|NCT03639389|Robot assisted surgery|robot assisted surgery
5968232|NCT03639389|Prostatectomy|prostatectomy
5968233|NCT03639389|Spinal anesthesia|spinal anesthesia
5968234|NCT03639389|Postoperative pain|postoperative pain
5968235|NCT03639389|Home discharge|home discharge
5968236|NCT03638622|Oral cancer, Photodynamic Therapy, Photosensitizer, ALA|oral cancer, photodynamic therapy, photosensitizer, ala
5968237|NCT03638167|CNS, CAR T cell, EGFR-positive|cns, car t cell, egfr-positive
5968238|NCT03638167|pediatric, young adults, brain tumor|pediatric, young adults, brain tumor
5968239|NCT03637803|MK-3475|mk-3475
5968240|NCT03637803|pembrolizumab|pembrolizumab
5968241|NCT03637803|MRx0518|mrx0518
5968242|NCT03637803|PD-1 Inhibitor|pd-1 inhibitor
5968243|NCT03637803|Oncology|oncology
5968244|NCT03637803|Live Biotherapeutic Product|live biotherapeutic product
5968245|NCT03637790|healthy volunteers|healthy volunteers
5968246|NCT03637491|KRAS|kras
5968247|NCT03637491|NRAS|nras
5968248|NCT03637491|PDAC|pdac
5968249|NCT03637491|Pancreatic Cancer|pancreatic cancer
5968250|NCT03636269|Hemodialysis|hemodialysis
5968251|NCT03636269|difelikefalin|difelikefalin
5968252|NCT03636269|CR845|cr845
5968253|NCT03636269|Pruritus|pruritus
5968254|NCT03636269|Chronic Itch|chronic itch
5968255|NCT03636269|Itch|itch
5968256|NCT03636269|Itching|itching
5968257|NCT03636269|Uremic Pruritus|uremic pruritus
5968258|NCT03636269|Dialysis|dialysis
5968259|NCT03636269|CKD|ckd
5968260|NCT03636269|CKD-associated pruritus|ckd-associated pruritus
5968261|NCT03636269|CKD-aP|ckd-ap
5968262|NCT03636269|ESRD (end stage renal disease)|esrd (end stage renal disease)
5968263|NCT03636269|KALM|kalm
5968264|NCT03636269|Chronic Kidney Disease|chronic kidney disease
5968265|NCT03636269|Kidney failure, chronic|kidney failure, chronic
5968266|NCT03636269|Kidney dysfunction|kidney dysfunction
5968267|NCT03636269|Generalized pruritus|generalized pruritus
5968268|NCT03636035|dietary supplement|dietary supplement
5968269|NCT03636035|arthritis|arthritis
5968270|NCT03636035|joint|joint
5968271|NCT03636035|complementary medicine|complementary medicine
5968272|NCT03635983|NKTR-214|nktr-214
5968273|NCT03635983|Nivolumab|nivolumab
5968274|NCT03635983|Immunotherapy|immunotherapy
5968275|NCT03631758|Screening|screening
5968276|NCT03631758|Mammography|mammography
5968277|NCT03631758|Patient Decision Aid|patient decision aid
5968278|NCT03631407|programmed cell death 1 (PD-1, PD1 )|programmed cell death 1 (pd-1, pd1 )
5968279|NCT03631407|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5968280|NCT03631407|microsatellite stable (MSS) colorectal cancer (CRC)|microsatellite stable (mss) colorectal cancer (crc)
5968281|NCT03631407|chemokine receptor type 5 (CCR5)|chemokine receptor type 5 (ccr5)
5968282|NCT03631225|Rheumatoid Arthritis|rheumatoid arthritis
5968283|NCT03631225|Vectra DA|vectra da
5968284|NCT03631225|Radiographic Projections|radiographic projections
5968285|NCT03630666|Oligometastatic pelvic lymph nod, IADT, radiotherapy|oligometastatic pelvic lymph nod, iadt, radiotherapy
5968286|NCT03630250|meningitis|meningitis
5968288|NCT03630159|Lymphoma tisagenlecleucel|lymphoma tisagenlecleucel
5968289|NCT03630159|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5968290|NCT03630159|CTL019|ctl019
5968291|NCT03630159|PORTIA|portia
5968292|NCT03630159|DLBCL|dlbcl
5968293|NCT03630159|tisagenlecleucel|tisagenlecleucel
5968294|NCT03630159|pembrolizumab|pembrolizumab
5968295|NCT03630159|r/r Diffuse large B-cell Lymphoma|r/r diffuse large b-cell lymphoma
5968296|NCT03630159|relapsed/refractory Diffuse large B-cell Lymphoma|relapsed/refractory diffuse large b-cell lymphoma
5968297|NCT03629275|Efficacy|efficacy
5968298|NCT03629275|Neural Stem cells|neural stem cells
5968299|NCT03629275|Intracerebral|intracerebral
5968300|NCT03629275|Cerebral Infarction|cerebral infarction
5968301|NCT03629275|Cerebrovascular disorders|cerebrovascular disorders
5968302|NCT03629275|Brain diseases|brain diseases
5968303|NCT03629275|Stereotactic surgery|stereotactic surgery
5968304|NCT03627767|atopic dermatitis|atopic dermatitis
5968305|NCT03627767|atopic eczema|atopic eczema
5968306|NCT03627767|eczema|eczema
5968307|NCT03627767|JAK|jak
5968308|NCT03627767|janus kinase|janus kinase
5968309|NCT03627208|LYMPHOBLASTIC LYMPHOMA|lymphoblastic lymphoma
5968310|NCT03627208|Minimal Residual Disease|minimal residual disease
5968311|NCT03627208|Childhood All|childhood all
5968312|NCT03627208|B-Cell Malignancies|b-cell malignancies
5968313|NCT03626831|CVD|cvd
5968314|NCT03626831|LDL|ldl
5968315|NCT03626831|heart failure|heart failure
5968316|NCT03626831|PCSK9|pcsk9
5968317|NCT03626688|Prostacyclin|prostacyclin
5968318|NCT03626688|Connective Tissue Disease-Associated|connective tissue disease-associated
5968319|NCT03626688|6 Minute Walk Test|6 minute walk test
5968320|NCT03626688|6 Minute Walk Distance|6 minute walk distance
5968321|NCT03626688|Pulmonary Vascular Resistance|pulmonary vascular resistance
5968322|NCT03626688|Right Ventricular Function|right ventricular function
5968323|NCT03624062|New onset|new onset
5968324|NCT03623477|Cognitive Remediation|cognitive remediation
5968325|NCT03623477|Social Cognition Training|social cognition training
5968326|NCT03623477|Emotion Regulation|emotion regulation
5968327|NCT03623477|Urgency|urgency
5968328|NCT03622905|Mild Probable Alzheimer's Disease|mild probable alzheimer's disease
5968329|NCT03621657|FMT|fmt
5968330|NCT03621657|Fecal Microbiota Transplant|fecal microbiota transplant
5968331|NCT03621033|transendoscopic enteral tubing|transendoscopic enteral tubing
5968332|NCT03621033|Microbiota Transplantation|microbiota transplantation
5968333|NCT03621033|transparent cap-assisted colonoscopy|transparent cap-assisted colonoscopy
5968334|NCT03620942|Maternal hypotension|maternal hypotension
5968335|NCT03620942|Spinal anaesthesia|spinal anaesthesia
5968336|NCT03620942|Caesarean section|caesarean section
5968337|NCT03620903|Waldenstrom Macroglobulinemia, Ibrutinib, Bortezomib|waldenstrom macroglobulinemia, ibrutinib, bortezomib
5968338|NCT03620617|Raspberry|raspberry
5968339|NCT03620617|Diet|diet
5968340|NCT03620591|Lidocaine|lidocaine
5968341|NCT03620591|Postoperative Pain|postoperative pain
5968342|NCT03620591|Opioid consumption|opioid consumption
5968343|NCT03620591|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5968344|NCT03620474|Hepatitis C virus|hepatitis c virus
5968345|NCT03620474|Hepatitis B virus|hepatitis b virus
5968346|NCT03620474|liver Cirrhosis|liver cirrhosis
5968347|NCT03620279|motor training for cerebral palsy|motor training for cerebral palsy
5968348|NCT03618849|Acquired Brain Injury|acquired brain injury
5968349|NCT03618849|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5968350|NCT03618849|Pediatric|pediatric
5968351|NCT03618849|Safety|safety
5968352|NCT03618849|Feasibility|feasibility
5968353|NCT03617666|avelumab|avelumab
5968354|NCT03617536|difelikefalin|difelikefalin
5968355|NCT03617536|CR845|cr845
5968356|NCT03617536|Pruritus|pruritus
5968357|NCT03617536|Chronic Itch|chronic itch
5968358|NCT03617536|Itch|itch
5968359|NCT03617536|Itching|itching
5968360|NCT03617536|uremic pruritus|uremic pruritus
5968361|NCT03617536|CKD|ckd
5968362|NCT03617536|CKD-aP|ckd-ap
5968363|NCT03617536|CKD-associated pruritus|ckd-associated pruritus
5968364|NCT03617536|Chronic Kidney Disease|chronic kidney disease
5968365|NCT03617536|Kidney dysfunction|kidney dysfunction
5968366|NCT03617536|Generalized pruritus|generalized pruritus
5968367|NCT03617536|Hemodialysis|hemodialysis
5968368|NCT03617536|Dialysis|dialysis
5968369|NCT03617536|ESRD (end stage renal disease)|esrd (end stage renal disease)
5968370|NCT03617536|Kidney failure, chronic|kidney failure, chronic
5968371|NCT03617263|NAFLD|nafld
5968372|NCT03617263|PCOS|pcos
5968373|NCT03617263|Saroglitazar Magnesium|saroglitazar magnesium
5968374|NCT03617003|WST-11|wst-11
5968375|NCT03617003|Phototherapy|phototherapy
5968376|NCT03617003|18-140|18-140
5968377|NCT03616912|SLE|sle
5968378|NCT03616470|acute myeloid leukemia|acute myeloid leukemia
5968379|NCT03616470|AML|aml
5968380|NCT03616470|Relapsed AML|relapsed aml
5968381|NCT03616470|Refractory AML|refractory aml
5968382|NCT03615924|Sickle Cell Disease|sickle cell disease
5968383|NCT03615924|Sickle Cell Anemia|sickle cell anemia
5968384|NCT03615924|SCD|scd
5968385|NCT03615924|Platelet aggregation|platelet aggregation
5968386|NCT03615924|Ticagrelor|ticagrelor
5968387|NCT03615924|Brilinta|brilinta
5968388|NCT03615924|VOC|voc
5968389|NCT03615924|Vaso-Occlusive Crises|vaso-occlusive crises
5968390|NCT03615924|ACS|acs
5968391|NCT03615924|painful crisis|painful crisis
5968392|NCT03615872|quality of life|quality of life
5968393|NCT03615872|efficiency|efficiency
5968394|NCT03615495|Esophageal|esophageal
5968395|NCT03615495|Atresia|atresia
5968396|NCT03615495|Congential|congential
5968397|NCT03615469|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5968398|NCT03615469|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5968399|NCT03615469|6 minute walk test|6 minute walk test
5968400|NCT03615469|DXA|dxa
5968401|NCT03615469|Double Blinded randomized control trial|double blinded randomized control trial
5968402|NCT03615469|ActivPal|activpal
5968403|NCT03615469|EMPI Continuum Device|empi continuum device
5968404|NCT03615326|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5968405|NCT03615326|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
5968406|NCT03615326|anti-PD-1|anti-pd-1
5968407|NCT03615326|anti PD-1|anti pd-1
5968408|NCT03615326|GEJ|gej
5968418|NCT03614676|Neonates|neonates
5968419|NCT03614676|Respiratory Tract Illness|respiratory tract illness
5968420|NCT03614351|protein|protein
5968421|NCT03614351|nutritional guidance|nutritional guidance
5968422|NCT03614351|ACL surgery|acl surgery
5968423|NCT03613532|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5968424|NCT03613532|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5968425|NCT03613532|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5968426|NCT03613532|MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-unclassifiable)|mds/myeloproliferative neoplasm-unclassifiable (mds/mpn-unclassifiable)
5968427|NCT03613532|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5968428|NCT03612960|Tobacco|tobacco
5968429|NCT03612960|Nicotine|nicotine
5968430|NCT03612960|Smoking|smoking
5968431|NCT03612960|Functional magnetic resonance imaging|functional magnetic resonance imaging
5968432|NCT03612960|Addiction|addiction
5968433|NCT03611517|Endometrial cancer|endometrial cancer
5968434|NCT03611517|Cervical cancer|cervical cancer
5968435|NCT03611517|Vaginal cancer|vaginal cancer
5968436|NCT03611517|sexuality|sexuality
5968437|NCT03611517|sexual problems|sexual problems
5968438|NCT03611517|dilator|dilator
5968439|NCT03611517|radiotherapy|radiotherapy
5968440|NCT03611517|gynaecological cancer|gynaecological cancer
5968441|NCT03611517|sexual rehabilitation programme|sexual rehabilitation programme
5968442|NCT03610282|Propofol|propofol
5968443|NCT03610282|Methylphenidate|methylphenidate
5968444|NCT03610282|Ritalin|ritalin
5968445|NCT03610282|Anesthetics|anesthetics
5968446|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous
5968447|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5968448|NCT03610282|Anesthetics, General|anesthetics, general
5968449|NCT03610282|Neurotransmitter Agents|neurotransmitter agents
5968450|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs
5968451|NCT03609840|Thiotepa|thiotepa
5968452|NCT03609840|TEPA|tepa
5968453|NCT03609840|Pediatric|pediatric
5968454|NCT03609840|Hematopoietic|hematopoietic
5968455|NCT03609840|Transplant|transplant
5968456|NCT03609827|Melphalan|melphalan
5968457|NCT03609827|Pharmacokinetics|pharmacokinetics
5968458|NCT03609827|Pediatric|pediatric
5968459|NCT03609827|Allogeneic|allogeneic
5968460|NCT03609814|fludarabine|fludarabine
5968461|NCT03609814|clofarabine|clofarabine
5968462|NCT03609814|pharmacokinetics|pharmacokinetics
5968463|NCT03609814|pediatric|pediatric
5968464|NCT03609814|allogeneic|allogeneic
5968465|NCT03609177|Cancer Care|cancer care
5968466|NCT03608488|balance|balance
5968467|NCT03608488|vitamin D|vitamin d
5968468|NCT03608488|exercise|exercise
5968469|NCT03608488|fall risk|fall risk
5968470|NCT03606915|pain|pain
5968471|NCT03606408|Cushing's syndrome|cushing's syndrome
5968472|NCT03606408|osilodrostat|osilodrostat
5968473|NCT03606408|LCI699|lci699
5968474|NCT03606408|endogenous Cushing's syndrome|endogenous cushing's syndrome
5968475|NCT03605550|DIPG|dipg
5968476|NCT03605550|High Grade Glioma|high grade glioma
5968477|NCT03605277|ABL001|abl001
5968478|NCT03605277|asciminib|asciminib
5968479|NCT03605277|impaired renal function|impaired renal function
5968480|NCT03605277|pharmacokinetics|pharmacokinetics
5968481|NCT03605069|Recessive Dystrophic Epidermolysis Bullosa|recessive dystrophic epidermolysis bullosa
5968482|NCT03605069|EB|eb
5968483|NCT03605069|COL7A1|col7a1
5968484|NCT03605069|RNA Therapies|rna therapies
5968485|NCT03605069|Antisense oligonucleotide|antisense oligonucleotide
5968486|NCT03605069|Exon skipping|exon skipping
5968487|NCT03605069|WINGS|wings
5968488|NCT03605069|Topical treatment|topical treatment
5968489|NCT03605069|RDEB|rdeb
5968490|NCT03605069|Exon 73|exon 73
5968491|NCT03605069|Mutations in exon 73|mutations in exon 73
5968492|NCT03605069|Dominant Dystrophic Epidermolysis Bullosa|dominant dystrophic epidermolysis bullosa
5968493|NCT03605069|DDEB|ddeb
5968494|NCT03604094|central venous catheter, pediatrics, ultrasound imaging|central venous catheter, pediatrics, ultrasound imaging
5968495|NCT03603730|Functional Dyspepsia|functional dyspepsia
5968496|NCT03603730|Gastroparesis|gastroparesis
5968497|NCT03603535|Stress urinary incontinence|stress urinary incontinence
5968498|NCT03603535|objective outcome|objective outcome
5968499|NCT03603171|myotonic dystrophy type 2|myotonic dystrophy type 2
5968500|NCT03603171|outcome scale|outcome scale
5968501|NCT03603171|muscle strength|muscle strength
5968502|NCT03603171|outcome measures|outcome measures
5968503|NCT03603171|disease specific severity scale|disease specific severity scale
5968504|NCT03602612|B-cell Maturation Antigen|b-cell maturation antigen
5968505|NCT03602612|Immunotherapy|immunotherapy
5968506|NCT03602612|Chimeric Antigen Receptors|chimeric antigen receptors
5968507|NCT03602612|Adoptive T Cell Therapy|adoptive t cell therapy
5968508|NCT03602053|diarrhea|diarrhea
5968509|NCT03602053|Rotavirus|rotavirus
5968510|NCT03602053|ROTAVAC|rotavac
5968511|NCT03602053|Rotavirus vaccine|rotavirus vaccine
5968512|NCT03601702|acute ischemic stroke|acute ischemic stroke
5968513|NCT03601702|endovascular treatment|endovascular treatment
5968514|NCT03601702|stent retriever device|stent retriever device
5968515|NCT03601702|mechanical thrombectomy|mechanical thrombectomy
5968516|NCT03601442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5968517|NCT03601442|ALL|all
5968518|NCT03601442|Pediatric|pediatric
5968519|NCT03601442|Diffuse Large b-cell Lymphoma|diffuse large b-cell lymphoma
5968520|NCT03601442|DLBCL|dlbcl
5968521|NCT03601442|Adult|adult
5968522|NCT03601442|Relapse|relapse
5968523|NCT03601442|Refractory|refractory
5968524|NCT03601442|CTL019|ctl019
5968525|NCT03601442|tisagenlecleucel|tisagenlecleucel
5968526|NCT03601442|Kymriah|kymriah
5968527|NCT03601442|CART19|cart19
5968528|NCT03601442|CART|cart
5968529|NCT03601442|CAR T cells|car t cells
5968530|NCT03601442|Chimeric antigen receptor|chimeric antigen receptor
5968531|NCT03601442|Manufacturing|manufacturing
5968532|NCT03601442|Expanded Access|expanded access
5968533|NCT03601442|Out of Specification|out of specification
5968534|NCT03600714|Hepatitis D|hepatitis d
5968535|NCT03600714|Hepatitis D Virus|hepatitis d virus
5968536|NCT03600714|Cirrhosis|cirrhosis
5968537|NCT03598439|influenza vaccine|influenza vaccine
5968538|NCT03598439|adults|adults
5968539|NCT03598439|Immune response|immune response
5968540|NCT03598257|Inflammatory breast cancer|inflammatory breast cancer
5968541|NCT03598257|Olaparib|olaparib
5968542|NCT03598257|Radiation therapy|radiation therapy
5968543|NCT03596866|Drug Therapy|drug therapy
5968544|NCT03596060|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality|hip fracture, general anesthesia, regional anesthesia, clopidogrel, cognitive impairment, mortality
5968545|NCT03595878|Whole Brain Radiation|whole brain radiation
5968546|NCT03594877|mare milk|mare milk
5968547|NCT03594877|gut microbiome|gut microbiome
5968548|NCT03594877|psoriasis|psoriasis
5968549|NCT03594877|immune markers|immune markers
5968550|NCT03594045|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
5968551|NCT03593759|Cardiac Sarcoidosis|cardiac sarcoidosis
5968552|NCT03593759|Prednisone|prednisone
5968553|NCT03593759|Methotrexate|methotrexate
5968554|NCT03592225|General Practitioners|general practitioners
5968555|NCT03592225|France|france
5968556|NCT03592225|RCT|rct
5968557|NCT03592225|HPV vaccination|hpv vaccination
5968558|NCT03591965|HCC|hcc
5968559|NCT03591601|Tension-type headache|tension-type headache
5968560|NCT03591601|Pain|pain
5968561|NCT03590626|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5968562|NCT03590626|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5968563|NCT03590626|GLP-1 receptor agonist|glp-1 receptor agonist
5968564|NCT03590626|Dulaglutide|dulaglutide
5968565|NCT03590626|MRI-Proton density fat fraction|mri-proton density fat fraction
5968566|NCT03590626|Fat Mapping|fat mapping
5968567|NCT03590626|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
5968568|NCT03590574|T cell lymphoma|t cell lymphoma
5968569|NCT03590574|Relapsed T cell Non-Hodgkin Lymphoma|relapsed t cell non-hodgkin lymphoma
5968570|NCT03590574|Refractory T cell Non-Hodgkin Lymphoma|refractory t cell non-hodgkin lymphoma
5968571|NCT03590574|AUTO4|auto4
5968572|NCT03590002|Patient Transfer|patient transfer
5968573|NCT03590002|Patient Discharge Summaries|patient discharge summaries
5968574|NCT03590002|Continuity of Patient Care|continuity of patient care
5968575|NCT03590002|Intensive Care Unit|intensive care unit
5968576|NCT03590002|Critical Care|critical care
5968577|NCT03590002|Health Information Exchange|health information exchange
5968578|NCT03590002|Medical Order Entry Systems|medical order entry systems
5968579|NCT03590002|Point-of-Care Systems|point-of-care systems
5968580|NCT03590002|Medical Informatics|medical informatics
5968581|NCT03589807|A/H7N9|a/h7n9
5968582|NCT03589807|Adults|adults
5968583|NCT03589807|AS03|as03
5968584|NCT03589807|Immunogenicity|immunogenicity
5968585|NCT03589807|Influenza|influenza
5968586|NCT03589807|Prime-Boost|prime-boost
5968587|NCT03589807|Reactogenicity|reactogenicity
5968588|NCT03589807|Safety|safety
5968589|NCT03589807|Vaccine|vaccine
5968590|NCT03589768|BOOSTRIX|boostrix
5968591|NCT03589768|Immunogenicity|immunogenicity
5968592|NCT03589768|Infant|infant
5968593|NCT03589768|Mali|mali
5968594|NCT03589768|Phase II|phase ii
5968595|NCT03589768|Pregnant Women|pregnant women
5968596|NCT03589768|Safety|safety
5968597|NCT03589768|Tdap|tdap
5968598|NCT03589456|lung cancer|lung cancer
5968599|NCT03589456|lung carcinoma|lung carcinoma
5968600|NCT03589456|lung metastases|lung metastases
5968601|NCT03589456|metastases|metastases
5968602|NCT03588715|HIV|hiv
5968603|NCT03588715|HIV/AIDS|hiv/aids
5968604|NCT03588715|HIV Cure|hiv cure
5968605|NCT03588715|HIV-1|hiv-1
5968606|NCT03588715|HIV-1 Infection|hiv-1 infection
5968607|NCT03588715|BEAT-HIV|beat-hiv
5968608|NCT03588715|bNAbs|bnabs
5968609|NCT03588715|Broadly neutralizing antibodies|broadly neutralizing antibodies
5968610|NCT03587727|bariatric surgery|bariatric surgery
5968611|NCT03587727|hepatic mitochondria|hepatic mitochondria
5968612|NCT03587727|insulin secretion|insulin secretion
5274108|NCT02308241|14-211|14-211
5968613|NCT03584789|Decision Support Systems, Clinical|decision support systems, clinical
5968614|NCT03584789|Pain Management|pain management
5968615|NCT03584789|Analgesics|analgesics
5968616|NCT03582618|Oncology|oncology
5968617|NCT03582618|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5968618|NCT03582618|Sorafenib|sorafenib
5968619|NCT03582618|Hepatoma|hepatoma
5968620|NCT03582033|RRMM|rrmm
5968621|NCT03582033|Antibodies, monoclonal|antibodies, monoclonal
5968622|NCT03582033|Antigens, BCMA|antigens, bcma
5968623|NCT03582033|Immunotherapy|immunotherapy
5968624|NCT03582033|Hematologic diseases|hematologic diseases
5968625|NCT03582033|Myeloma|myeloma
5968626|NCT03581981|posttraumatic stress disorder|posttraumatic stress disorder
5968627|NCT03581318|MRI Technology Improvement|mri technology improvement
5968628|NCT03581305|11C-DASB|11c-dasb
5968629|NCT03581305|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
5968630|NCT03581305|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5968631|NCT03581305|HIV|hiv
5968632|NCT03581305|Depression|depression
5968633|NCT03580317|Classical trigeminal neuralgia|classical trigeminal neuralgia
5968634|NCT03580317|Electroacupuncture|electroacupuncture
5968635|NCT03580317|Randomized controlled clinical trial|randomized controlled clinical trial
5968636|NCT03576118|biotrauma|biotrauma
5968637|NCT03576118|laparoscopic surgery|laparoscopic surgery
5968638|NCT03576118|neuromuscular block|neuromuscular block
5968639|NCT03576118|sugammadex|sugammadex
5968640|NCT03575351|Non-Hodgkin Lymphomas|non-hodgkin lymphomas
5968641|NCT03575351|DLBCL|dlbcl
5968642|NCT03575351|Efficacy|efficacy
5968643|NCT03575351|Safety|safety
5968644|NCT03575351|JCAR017|jcar017
5968645|NCT03575351|Liso-cel|liso-cel
5968646|NCT03575351|High-Risk|high-risk
5968647|NCT03575351|Relapsed|relapsed
5968648|NCT03575351|Refractory|refractory
5968650|NCT03574480|mHealth|mhealth
5968651|NCT03574480|Lifestyles|lifestyles
5968652|NCT03574480|Elderly|elderly
5968653|NCT03574480|Body composition|body composition
5968654|NCT03574480|Cognitive performance|cognitive performance
5968655|NCT03574480|Quality of life|quality of life
5968656|NCT03574220|pembrolizumab|pembrolizumab
5968657|NCT03574220|radiotherapy|radiotherapy
5968658|NCT03574220|immunotherapy|immunotherapy
5968659|NCT03573453|Critical Care|critical care
5968660|NCT03573453|Enteral Nutrition|enteral nutrition
5968661|NCT03573453|Ventilator Associated Pneumonia|ventilator associated pneumonia
5968662|NCT03573453|Gastric Residual Volume|gastric residual volume
5968663|NCT03573323|biologic|biologic
5968664|NCT03573323|biologic therapy|biologic therapy
5968665|NCT03573310|Lower risk MDS|lower risk mds
5968666|NCT03573310|Low risk MDS|low risk mds
5968667|NCT03573310|Lower-risk MDS|lower-risk mds
5968668|NCT03573310|Low-risk MDS|low-risk mds
5968669|NCT03573310|Intermediate 1 risk MDS|intermediate 1 risk mds
5968670|NCT03573310|Intermediate-1 risk MDS|intermediate-1 risk mds
5968671|NCT03572309|trauma induced coagulopathy|trauma induced coagulopathy
5968672|NCT03572309|multiple trauma|multiple trauma
5968673|NCT03572309|fibrinogen|fibrinogen
5968674|NCT03572166|Copeptin|copeptin
5968675|NCT03571581|Medication adherence|medication adherence
5968676|NCT03571581|Heart failure|heart failure
5968677|NCT03571581|Mindfulness interventions|mindfulness interventions
5968678|NCT03570892|Non-Hodgkin's Lympoma|non-hodgkin's lympoma
5968679|NCT03570892|B-Cell Lymphoma|b-cell lymphoma
5968680|NCT03570892|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5968681|NCT03570892|High Grade B-cell Lymphoma|high grade b-cell lymphoma
5968682|NCT03570892|Follicular Lymphoma grade 3B|follicular lymphoma grade 3b
5968683|NCT03570892|CAR-T|car-t
5968684|NCT03570892|Tisagenlecleucel|tisagenlecleucel
5968685|NCT03570892|Kymriah|kymriah
5968686|NCT03570892|Immunotherapy|immunotherapy
5968687|NCT03570892|Cellular therapy|cellular therapy
5968688|NCT03570892|CTL019|ctl019
5968689|NCT03570619|Metastatic Cancer|metastatic cancer
5968690|NCT03570619|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5968691|NCT03570619|mCRPC|mcrpc
5968692|NCT03570619|Immunotherapy|immunotherapy
5968693|NCT03570619|CDK12|cdk12
5968694|NCT03570216|acute exercise|acute exercise
5968695|NCT03570216|High-intensity interval exercise|high-intensity interval exercise
5968696|NCT03570216|feasibility|feasibility
5968697|NCT03570216|arterial stiffness|arterial stiffness
5968698|NCT03569982|Integrative medicine|integrative medicine
5968699|NCT03569982|Peri-operative anxiety|peri-operative anxiety
5968700|NCT03569982|Pain|pain
5968701|NCT03569982|MOHS surgery|mohs surgery
5968702|NCT03569293|Atopic Dermatitis|atopic dermatitis
5968703|NCT03569293|Upadacitinib|upadacitinib
5968704|NCT03569111|Lung Nodule|lung nodule
5968705|NCT03569111|Bronchoscopy|bronchoscopy
5968706|NCT03569111|Ablation, Microwave|ablation, microwave
5968707|NCT03568461|Refractory or relapsed Follicular Lymphoma|refractory or relapsed follicular lymphoma
5968708|NCT03568461|Refractory|refractory
5968709|NCT03568461|Relapsed|relapsed
5968710|NCT03568461|Follicular lymphoma|follicular lymphoma
5968711|NCT03568461|CTL019|ctl019
5968712|NCT03568461|Tisagenlecleucel|tisagenlecleucel
5968713|NCT03568461|Chimeric antigen receptor|chimeric antigen receptor
5968714|NCT03568318|Atopic Dermatitis|atopic dermatitis
5968715|NCT03568318|Upadacitinib|upadacitinib
5968716|NCT03565445|NSCLC|nsclc
5968717|NCT03565445|Tumors|tumors
5968718|NCT03565445|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5968719|NCT03565445|Oncology|oncology
5968720|NCT03565445|breast cancer|breast cancer
5968721|NCT03565445|ASP1948|asp1948
5968722|NCT03565445|mCRPC|mcrpc
5968723|NCT03565445|ovarian cancer|ovarian cancer
5968724|NCT03565445|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
5968725|NCT03565445|pancreatic cancer|pancreatic cancer
5968726|NCT03565445|Advanced solid tumors|advanced solid tumors
5968727|NCT03565393|Tolerability|tolerability
5968728|NCT03565393|Acceptability|acceptability
5968729|NCT03565393|Fibersol-2|fibersol-2
5968730|NCT03565393|Children|children
5968731|NCT03563560|Newly diagnosed AML|newly diagnosed aml
5968732|NCT03563560|Relapsed/refractory AML|relapsed/refractory aml
5968733|NCT03563560|Alvocidib|alvocidib
5968734|NCT03563027|Physical activity|physical activity
5968735|NCT03563027|Incentive|incentive
5968736|NCT03563027|Wearable device|wearable device
5968737|NCT03563027|Gamification|gamification
5968738|NCT03562221|coeliac disease|coeliac disease
5968739|NCT03562221|celiac disease autoimmunity|celiac disease autoimmunity
5968740|NCT03560960|Early AD diagnosis|early ad diagnosis
5968741|NCT03560960|Pramlintide challenge test|pramlintide challenge test
5968742|NCT03560960|Amyloid|amyloid
5968743|NCT03560960|Amyloid PET imaging|amyloid pet imaging
5968744|NCT03560960|CSF Aβ|csf aβ
5968745|NCT03560960|CSF pTau|csf ptau
5968746|NCT03560960|Cognitive evaluation|cognitive evaluation
5968747|NCT03560388|Integrative medicine|integrative medicine
5968748|NCT03560388|Acupuncture|acupuncture
5968749|NCT03560388|Gynecological oncology|gynecological oncology
5968750|NCT03560388|Surgery|surgery
5968751|NCT03560388|Analgesia|analgesia
5968752|NCT03560388|Pain|pain
5968753|NCT03560388|Anxiety|anxiety
5968754|NCT03559270|eczema|eczema
5968755|NCT03559270|atopic eczema|atopic eczema
5968756|NCT03559205|Musculoskeletal|musculoskeletal
5968757|NCT03559205|MSK|msk
5968758|NCT03556202|IL-23|il-23
5968759|NCT03556202|Interleukin-23|interleukin-23
5968760|NCT03556202|Psoriasis|psoriasis
5968761|NCT03555994|0382, T2DM, Cotadutide, Overweight, Obese, MEDI0382|0382, t2dm, cotadutide, overweight, obese, medi0382
5968762|NCT03554993|Healthy Volunteer|healthy volunteer
5968763|NCT03554993|Safety|safety
5968764|NCT03554993|CC-99677|cc-99677
5968765|NCT03554655|Shared decision making|shared decision making
5968766|NCT03554655|Patient activation|patient activation
5968767|NCT03554655|Schizophrenia|schizophrenia
5968768|NCT03554655|First-episode psychosis|first-episode psychosis
5968769|NCT03554655|mHealth|mhealth
5968770|NCT03554655|Randomized clinical trial|randomized clinical trial
5968771|NCT03554603|Long term care|long term care
5968772|NCT03554603|Urine culture|urine culture
5968773|NCT03553940|H3N2 M2SR Prime|h3n2 m2sr prime
5968774|NCT03553940|Immunogenicity|immunogenicity
5968775|NCT03553940|Influenza|influenza
5968778|NCT03553940|Safety|safety
5968779|NCT03553940|Vaccine|vaccine
5968780|NCT03553849|Very low calorie diet|very low calorie diet
5968781|NCT03553849|General surgery|general surgery
5968782|NCT03553836|Programmed Cell Death Receptor 1 (PD1)|programmed cell death receptor 1 (pd1)
5968783|NCT03553836|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5968784|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PDL1)|programmed cell death receptor ligand 1 (pdl1)
5968785|NCT03553836|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5968786|NCT03552614|robot-assisted rehabilitation|robot-assisted rehabilitation
5968787|NCT03552614|Armeo®Spring|armeo®spring
5968788|NCT03552614|quantitative assessment|quantitative assessment
5968789|NCT03552406|Solid tumor|solid tumor
5968790|NCT03552406|Breast cancer|breast cancer
5968791|NCT03552406|Head & Neck cancer|head & neck cancer
5968792|NCT03549845|Healthcare Utilization|healthcare utilization
5968793|NCT03549845|Emergency Department|emergency department
5968794|NCT03549845|Hospitalization|hospitalization
5968795|NCT03549845|Low Income|low income
5968796|NCT03549845|Social Housing|social housing
5968797|NCT03549845|Older Adults|older adults
5968798|NCT03549845|Quality of Life|quality of life
5968799|NCT03548064|dmLT|dmlt
5968800|NCT03548064|E. coli|e. coli
5968801|NCT03548064|Enterotoxigenic Escherichia coli (ETEC)|enterotoxigenic escherichia coli (etec)
5968802|NCT03548064|LTR192G/L211A|ltr192g/l211a
5968803|NCT03545607|ischemic stroke|ischemic stroke
5968804|NCT03545607|adult stem cells|adult stem cells
5968805|NCT03545594|Randomized trial,|randomized trial,
5968806|NCT03545594|Health care needs|health care needs
5968807|NCT03545594|Traumatic brain injury|traumatic brain injury
5968808|NCT03545594|Community|community
5968809|NCT03545594|Goal attainment|goal attainment
5968810|NCT03545542|Microbiome|microbiome
5968811|NCT03545542|Volatile organic compounds|volatile organic compounds
5968812|NCT03545542|Neuroblastoma|neuroblastoma
5968813|NCT03545425|Parkinson's Disease|parkinson's disease
5968814|NCT03545425|Biomarker|biomarker
5968815|NCT03545425|LRRK2|lrrk2
5968816|NCT03545334|transcutaneous identification of SLNs with ICG|transcutaneous identification of slns with icg
5968817|NCT03545139|pulp revascularization|pulp revascularization
5968818|NCT03545139|endodontic regeneration|endodontic regeneration
5968819|NCT03545139|NeoMTA|neomta
5968820|NCT03544723|head and neck cancer|head and neck cancer
5968821|NCT03544723|checkpoint inhibitor|checkpoint inhibitor
5968822|NCT03544723|anti-PD-1|anti-pd-1
5968823|NCT03544723|anti-PD-L1|anti-pd-l1
5968824|NCT03544723|immune therapy|immune therapy
5968825|NCT03544723|squamous cell cancer|squamous cell cancer
5968826|NCT03544229|Drug Therapy|drug therapy
5968827|NCT03542513|Human Papillomavirus|human papillomavirus
5968828|NCT03542513|Biomarker|biomarker
5968829|NCT03542513|Self-sampling|self-sampling
5968830|NCT03542513|First-void urine|first-void urine
5968831|NCT03542513|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5968832|NCT03542513|LLETZ|lletz
5968833|NCT03542227|Antibodies|antibodies
5968834|NCT03542227|Vaccination|vaccination
5968835|NCT03542227|Self-sampling|self-sampling
5968836|NCT03542227|First-void urine|first-void urine
5968837|NCT03542136|Polyneuropathy|polyneuropathy
5968838|NCT03542136|Oxaliplatin|oxaliplatin
5968839|NCT03542136|Colorectal cancer|colorectal cancer
5968840|NCT03541980|sickle cell|sickle cell
5968841|NCT03541980|acetaminophen in pain crises|acetaminophen in pain crises
5968842|NCT03541980|opioid-sparing|opioid-sparing
5968843|NCT03541499|B. pertussis Vaccine|b. pertussis vaccine
5968844|NCT03541499|BPZE1|bpze1
5968845|NCT03541499|Immunogenicity|immunogenicity
5968846|NCT03541499|Safety|safety
5968847|NCT03539757|Liver fibrosis|liver fibrosis
5968848|NCT03539757|Fontan surgery|fontan surgery
5968849|NCT03539757|MRI|mri
5968850|NCT03539757|Novel Methods|novel methods
5968851|NCT03538665|Endometrial Cancer|endometrial cancer
5968852|NCT03538665|Somatic Mutations|somatic mutations
5968853|NCT03538665|Early Detection|early detection
5968854|NCT03538665|Tampon Sampling|tampon sampling
5968855|NCT03538665|Tissue Discovery|tissue discovery
5968856|NCT03538652|CBT|cbt
5968857|NCT03538652|Mindfulness|mindfulness
5968858|NCT03538652|Opiates|opiates
5968859|NCT03538652|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
5968860|NCT03538652|Microrandomized Trial|microrandomized trial
5968861|NCT03537547|treatment naive|treatment naive
5968862|NCT03537547|major depression|major depression
5968863|NCT03537547|pharmacotherapy|pharmacotherapy
5968864|NCT03537547|pharmacogenomic|pharmacogenomic
5968865|NCT03537547|genomics|genomics
5968866|NCT03537508|Meningococcal meningitis|meningococcal meningitis
5968867|NCT03537508|MenACYW conjugate vaccine|menacyw conjugate vaccine
5968868|NCT03537508|Quadrivalent meningococcal vaccine|quadrivalent meningococcal vaccine
5968869|NCT03536897|breast cancer|breast cancer
5968870|NCT03536897|invasive ductal carcinoma|invasive ductal carcinoma
5968871|NCT03536897|intraoperative radiation therapy|intraoperative radiation therapy
5968872|NCT03536897|iort|iort
5968873|NCT03536884|Bimekizumab|bimekizumab
5968874|NCT03536884|PSO|pso
5968875|NCT03536884|Psoriasis|psoriasis
5968876|NCT03536858|End Stage Renal Disease|end stage renal disease
5968877|NCT03536858|Hemodialysis|hemodialysis
5968878|NCT03536858|Social Network|social network
5968879|NCT03536182|Pancreas|pancreas
5968880|NCT03536182|Adenocarcinoma.|adenocarcinoma.
5968881|NCT03535155|Ultrasound image, Neuraxial anesthesia, Landmark|ultrasound image, neuraxial anesthesia, landmark
5968882|NCT03535129|Alcohol|alcohol
5968883|NCT03535129|Socioemotional|socioemotional
5968884|NCT03535129|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5968885|NCT03535129|Neurofeedback|neurofeedback
5968886|NCT03535129|Drug Relapse|drug relapse
5968887|NCT03534466|treadmill|treadmill
5968888|NCT03534466|infants|infants
5968889|NCT03534466|neonatal encephalopathy|neonatal encephalopathy
5968890|NCT03534466|neonatal brain injury|neonatal brain injury
5968891|NCT03534245|Mosquito Salivary Protein|mosquito salivary protein
5968892|NCT03534245|Dengue Fever|dengue fever
5968893|NCT03534245|Zika|zika
5968894|NCT03534245|Chikungunya|chikungunya
5968895|NCT03534245|Kampong Speu|kampong speu
5968896|NCT03532542|Duchenne muscular dystrophy|duchenne muscular dystrophy
5968897|NCT03532542|Exon Skipping|exon skipping
5968898|NCT03532542|DMD|dmd
5968899|NCT03532542|Exon 53|exon 53
5968900|NCT03532542|Exon 45|exon 45
5968904|NCT03529669|Oesophageal Cancer|oesophageal cancer
5968905|NCT03529669|Gastrointestinal|gastrointestinal
5968906|NCT03528694|Durvalumab|durvalumab
5968907|NCT03528694|BCG|bcg
5968908|NCT03528694|MEDI4736|medi4736
5968909|NCT03528694|NMIBC|nmibc
5968910|NCT03528694|PD-L1|pd-l1
5968911|NCT03528694|DFS|dfs
5968912|NCT03528694|OS|os
5968913|NCT03528122|amniotic membrane|amniotic membrane
5968914|NCT03528122|retinal detachment|retinal detachment
5968915|NCT03528122|Myopic|myopic
5968916|NCT03528122|macular hole|macular hole
5968917|NCT03528122|internal limiting membrane|internal limiting membrane
5968918|NCT03527147|Acalabrutinib|acalabrutinib
5968919|NCT03527147|CALQUENCE®|calquence®
5968920|NCT03527147|ACP-196|acp-196
5968921|NCT03527147|Platform study|platform study
5968922|NCT03527147|Master protocol|master protocol
5968923|NCT03527147|PRISM|prism
5968924|NCT03527147|Hu-5F9|hu-5f9
5968925|NCT03527147|Rituximab|rituximab
5968926|NCT03527147|ATR|atr
5968927|NCT03527147|STAT3|stat3
5968928|NCT03527147|Anti-CD47|anti-cd47
5968929|NCT03527147|BRD4|brd4
5968930|NCT03527108|Non-small cell lung cancer|non-small cell lung cancer
5968931|NCT03527108|Immunotherapy|immunotherapy
5968932|NCT03525808|Pancreatic necrosis|pancreatic necrosis
5968933|NCT03524105|Socio Economic Adversity|socio economic adversity
5968934|NCT03524105|Child Development|child development
5968935|NCT03524105|Poverty|poverty
5968936|NCT03524105|racial disparity|racial disparity
5968937|NCT03524105|ethnic disparity|ethnic disparity
5968938|NCT03524092|Interleukin-23 (IL-23)|interleukin-23 (il-23)
5968939|NCT03524092|IL-23p19|il-23p19
5968940|NCT03524092|Inflammatory Bowel Disease|inflammatory bowel disease
5968941|NCT03523689|Malignant neoplasms of respiratory and intrathoracic organs|malignant neoplasms of respiratory and intrathoracic organs
5968942|NCT03523689|Endobronchial ultrasound-guided transbronchial needle aspiration|endobronchial ultrasound-guided transbronchial needle aspiration
5968943|NCT03523689|EBUS-TBNA|ebus-tbna
5968944|NCT03522298|newly diagnosed|newly diagnosed
5968945|NCT03522298|unmethylated O6 methylguanine-methyltransferase (MGMT) promoter status|unmethylated o6 methylguanine-methyltransferase (mgmt) promoter status
5968946|NCT03522051|teeth|teeth
5968947|NCT03522051|pulpitis|pulpitis
5968948|NCT03522051|deep caries|deep caries
5968949|NCT03522051|pulpotomy|pulpotomy
5968950|NCT03522051|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
5968951|NCT03521180|Celiac Disease|celiac disease
5968952|NCT03521180|Gluten|gluten
5968953|NCT03521180|Immune Response|immune response
5968954|NCT03521180|Challenge|challenge
5968955|NCT03520556|EPA|epa
5968956|NCT03520556|DHA|dha
5968957|NCT03520556|low-grade inflammation|low-grade inflammation
5968958|NCT03520556|CRP|crp
5968959|NCT03520556|IL-6|il-6
5968960|NCT03520556|TNF-alpha|tnf-alpha
5968961|NCT03520556|adiponectin|adiponectin
5968962|NCT03520556|randomized controlled trials|randomized controlled trials
5968963|NCT03520556|systematic review and meta-analysis|systematic review and meta-analysis
5968964|NCT03519945|Inflammatory Bowel Disease|inflammatory bowel disease
5968965|NCT03518294|NAFLD|nafld
5968966|NCT03518294|NASH|nash
5968967|NCT03518086|Interleukin-23 (IL-23) antibody|interleukin-23 (il-23) antibody
5968968|NCT03518086|IL-23p19|il-23p19
5968969|NCT03518060|2 drug regimen|2 drug regimen
5968970|NCT03518060|Juluca|juluca
5968971|NCT03518060|Rilpivirine|rilpivirine
5968972|NCT03518060|Dolutegravir|dolutegravir
5968973|NCT03518060|Antiretroviral|antiretroviral
5968974|NCT03518060|One pill regimen|one pill regimen
5968975|NCT03517891|Physical activity|physical activity
5968976|NCT03517891|Sleep pattern|sleep pattern
5968977|NCT03517891|Nutrition|nutrition
5968978|NCT03517891|Education|education
5968979|NCT03517488|DUET-2|duet-2
5968980|NCT03517488|Melanoma|melanoma
5968981|NCT03517488|Triple Negative Breast Cancer|triple negative breast cancer
5968982|NCT03517488|Hepatocellular Cancer|hepatocellular cancer
5968983|NCT03517488|Urothelial Cancer|urothelial cancer
5968984|NCT03517488|Renal Cell Cancer|renal cell cancer
5968985|NCT03517488|Head and Neck Cancer|head and neck cancer
5968986|NCT03517488|MSI-high Colorectal Cancer|msi-high colorectal cancer
5968987|NCT03517488|MSI-high Endometrial Cancer|msi-high endometrial cancer
5968988|NCT03517488|Non-small Cell Lung Cancer|non-small cell lung cancer
5968989|NCT03517488|Gastric Cancer|gastric cancer
5968990|NCT03517488|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5968991|NCT03517488|Mesothelioma|mesothelioma
5968992|NCT03517488|High-grade Neuroendocrine Cancer|high-grade neuroendocrine cancer
5968993|NCT03517488|Cervical Cancer|cervical cancer
5968994|NCT03517488|Small Cell Lung Cancer|small cell lung cancer
5968995|NCT03517488|Anal Cancer|anal cancer
5968996|NCT03517488|Prostate Cancer|prostate cancer
5968997|NCT03517488|Nasopharyngeal Cancer|nasopharyngeal cancer
5968998|NCT03517488|Bile Duct Cancer|bile duct cancer
5968999|NCT03517488|Basal Cell Skin Cancer|basal cell skin cancer
5969000|NCT03517488|Ovarian Cancer|ovarian cancer
5969001|NCT03517488|Fallopian Tube Cancer|fallopian tube cancer
5969002|NCT03517488|Malignant Adnexal Tumor|malignant adnexal tumor
5969003|NCT03517488|Thymus Cancer|thymus cancer
5969004|NCT03517488|Penile Cancer|penile cancer
5969005|NCT03517488|Vulvar Cancer|vulvar cancer
5969006|NCT03517488|Salivary Gland Cancer|salivary gland cancer
5969007|NCT03516981|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5969008|NCT03516981|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5969009|NCT03515941|chemotherapy|chemotherapy
5969010|NCT03515941|chemoradiation|chemoradiation
5969011|NCT03515837|PD1|pd1
5969012|NCT03515837|PD-1|pd-1
5969013|NCT03515837|PDL1|pdl1
5969014|NCT03515837|PD-L1|pd-l1
5969015|NCT03515499|Adherence|adherence
5969016|NCT03515499|Incentives|incentives
5969017|NCT03515460|vascular endothelial function|vascular endothelial function
5969018|NCT03515460|systemic microvascular reactivity|systemic microvascular reactivity
5969019|NCT03515460|dysglycemia|dysglycemia
5969020|NCT03515460|dyslipidemia|dyslipidemia
5969021|NCT03515070|Gastrointestinal Microbiome|gastrointestinal microbiome
5969022|NCT03515070|Genetics|genetics
5969023|NCT03514108|Heart failure|heart failure
5969024|NCT03514108|Diabetes|diabetes
5969025|NCT03514108|Insulin resistance|insulin resistance
5969026|NCT03514108|Metformin|metformin
5969027|NCT03514108|Hydralazine|hydralazine
5969028|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate
5969029|NCT03514056|Fibromyalgia|fibromyalgia
5969030|NCT03514056|Behcet Disease|behcet disease
5969031|NCT03514056|Trigger points|trigger points
5969032|NCT03513159|transitional care, geriatric, readmission|transitional care, geriatric, readmission
5969033|NCT03513042|intensity-modulated proton therapy|intensity-modulated proton therapy
5969034|NCT03513042|therapy response evaluation|therapy response evaluation
5969035|NCT03513042|positron emission tomography (PET)|positron emission tomography (pet)
5969036|NCT03513042|hypoxia|hypoxia
5969037|NCT03513042|metabolism|metabolism
5969038|NCT03513042|18F-fluoroazomycin-arabinoside (FAZA)|18f-fluoroazomycin-arabinoside (faza)
5969039|NCT03513042|18F-2-fluoro-2-deoxy-D-glucose (FDG)|18f-2-fluoro-2-deoxy-d-glucose (fdg)
5969040|NCT03513042|head and neck neoplasms|head and neck neoplasms
5969041|NCT03513042|image-guided proton therapy|image-guided proton therapy
5969042|NCT03513042|treatment outcome|treatment outcome
5969043|NCT03513042|predictive biomarker|predictive biomarker
5969044|NCT03512418|HIV prevention|hiv prevention
5969045|NCT03512418|Pre-exposure prophylaxis|pre-exposure prophylaxis
5969046|NCT03512418|Digital Pill|digital pill
5969047|NCT03512418|Substance use disorder|substance use disorder
5969048|NCT03512418|Stimulant use|stimulant use
5969049|NCT03511794|Hepatitis B Reactivation|hepatitis b reactivation
5969050|NCT03511794|Allogenic Stem Cell Transplant|allogenic stem cell transplant
5969051|NCT03510923|Appendix|appendix
5969052|NCT03510923|Appendectomy|appendectomy
5969053|NCT03510923|Gallbladder|gallbladder
5969054|NCT03510923|Cholecystectomy|cholecystectomy
5969055|NCT03510923|Neoplasms|neoplasms
5969056|NCT03510923|Pathology|pathology
5969057|NCT03510923|Selective|selective
5969058|NCT03510923|Routine|routine
5969059|NCT03509116|patient experience|patient experience
5969060|NCT03509116|disease-related malnutrition|disease-related malnutrition
5969061|NCT03509116|nutritional care|nutritional care
5969062|NCT03509116|dietetic consultation|dietetic consultation
5969063|NCT03509116|older adults|older adults
5969064|NCT03509116|oral nutritional support|oral nutritional support
5969065|NCT03508466|hypersensitivity|hypersensitivity
5969066|NCT03507686|NightstaRx|nightstarx
5969067|NCT03507686|NSR-REP1|nsr-rep1
5969068|NCT03507686|Choroideremia|choroideremia
5969069|NCT03507686|CHM|chm
5969070|NCT03507686|Gene Therapy|gene therapy
5969071|NCT03507686|AAV|aav
5969072|NCT03507686|REP1|rep1
5969073|NCT03507686|Timrepigene Emparvovec|timrepigene emparvovec
5969074|NCT03507556|immature teeth, necrotic teeth|immature teeth, necrotic teeth
5969075|NCT03507257|Cognitively Normal|cognitively normal
5969076|NCT03507257|Amyloid|amyloid
5969077|NCT03507257|Plaques|plaques
5969078|NCT03507257|Neuroimaging|neuroimaging
5969079|NCT03507257|Biomarkers|biomarkers
5969080|NCT03507257|Cognition Disorder|cognition disorder
5969081|NCT03507257|Dementia|dementia
5969082|NCT03507257|Tau|tau
5969083|NCT03507257|Early Onset Alzheimer's Disease|early onset alzheimer's disease
5969084|NCT03507257|Alzheimer's Disease|alzheimer's disease
5969085|NCT03507257|Mild Cognitive Impairment|mild cognitive impairment
5969086|NCT03505008|Methotrexate|methotrexate
5969087|NCT03505008|Adalimumab|adalimumab
5969088|NCT03505008|Autoimmune Disease|autoimmune disease
5969089|NCT03505008|Connective Tissue Diseases|connective tissue diseases
5969090|NCT03505008|Rheumatic Disease|rheumatic disease
5969091|NCT03505008|Rheumatoid Arthritis|rheumatoid arthritis
5969092|NCT03504982|Vericiguat|vericiguat
5969093|NCT03504982|Stable CAD|stable cad
5969094|NCT03504982|QT/QTc|qt/qtc
5969095|NCT03504670|Labor induction|labor induction
5969096|NCT03504670|Cesarean delivery|cesarean delivery
5969097|NCT03504670|Preterm labor induction|preterm labor induction
5969098|NCT03504670|Duration of labor induction|duration of labor induction
5969099|NCT03503903|Wet cupping therapy|wet cupping therapy
5969100|NCT03503903|antioxidant capacity|antioxidant capacity
5969101|NCT03502317|Prehabilitation|prehabilitation
5969102|NCT03502317|Gastrointestinal Cancer|gastrointestinal cancer
5969103|NCT03502317|Physical Activity|physical activity
5969104|NCT03502317|Exercise|exercise
5969105|NCT03502317|Surgery|surgery
5969106|NCT03500718|cochlear implant|cochlear implant
5969107|NCT03500718|threshold of electrically evoked compound action potential|threshold of electrically evoked compound action potential
5969108|NCT03500718|neural response telemetry|neural response telemetry
5969109|NCT03500237|anxiety|anxiety
5969110|NCT03500237|depression|depression
5969111|NCT03500237|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5969112|NCT03500237|randomized controlled trial|randomized controlled trial
5969113|NCT03500237|patient-centered|patient-centered
5269727|NCT02332512|apatinib|apatinib
5969114|NCT03500237|knowledge implementation|knowledge implementation
5969115|NCT03500237|mental health system|mental health system
5969116|NCT03500237|therapist-assistance|therapist-assistance
5969117|NCT03499353|Neoadjuvant Therapy, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE Breast Cancer, BRACA Positive|neoadjuvant therapy, human epidermal growth factor receptor 2 negative breast cancer, braca positive
5969118|NCT03498612|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5969119|NCT03497598|D-mannose|d-mannose
5969120|NCT03496610|Bupivacaine|bupivacaine
5969121|NCT03496610|Living donor nephrectomy|living donor nephrectomy
5969122|NCT03496012|NightstaRx|nightstarx
5969123|NCT03496012|NSR-REP1|nsr-rep1
5969124|NCT03496012|Choroideremia|choroideremia
5969125|NCT03496012|CHM|chm
5969126|NCT03496012|Gene Therapy|gene therapy
5969127|NCT03496012|AAV|aav
5969128|NCT03496012|REP1|rep1
5969129|NCT03496012|Timrepigene Emparvovec|timrepigene emparvovec
5969130|NCT03495986|Functional Electrical Stimulation|functional electrical stimulation
5969131|NCT03495986|Exercise|exercise
5969132|NCT03495986|Body Composition|body composition
5969133|NCT03495726|Contemplative|contemplative
5969134|NCT03495726|Applications|applications
5969135|NCT03495726|Well-being|well-being
5969136|NCT03493945|Immunotherapy|immunotherapy
5969137|NCT03493945|Combined Treatment|combined treatment
5969138|NCT03493945|PD-1/PD-L1|pd-1/pd-l1
5969139|NCT03493945|Tumor-Specific T Cells|tumor-specific t cells
5969140|NCT03493945|Novel Cancer Vaccine|novel cancer vaccine
5969141|NCT03493932|Glioblastoma|glioblastoma
5969142|NCT03493932|Glioma|glioma
5969143|NCT03493932|Brain Tumor|brain tumor
5969144|NCT03493932|Immune Therapy|immune therapy
5969145|NCT03493932|Checkpoint Inhibition|checkpoint inhibition
5969146|NCT03492983|Cocoa|cocoa
5969147|NCT03492983|Vascular function|vascular function
5969152|NCT03492658|abatacept|abatacept
5969153|NCT03492658|ACPA expressing B cells|acpa expressing b cells
5969154|NCT03492047|paclitaxel|paclitaxel
5969155|NCT03492047|peripheral neuropathy|peripheral neuropathy
5969156|NCT03492047|N-acetyl cysteine|n-acetyl cysteine
5969157|NCT03491215|Graft versus host disease|graft versus host disease
5969158|NCT03491215|GvHD|gvhd
5969159|NCT03491215|acute graft versus host disease|acute graft versus host disease
5969160|NCT03491215|aGvHD|agvhd
5969161|NCT03491215|Steroid refractory acute graft versus host disease|steroid refractory acute graft versus host disease
5969162|NCT03491215|SR-aGvHD|sr-agvhd
5969163|NCT03491215|Ruxolitinib|ruxolitinib
5969164|NCT03491215|INC424|inc424
5969165|NCT03491215|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5969166|NCT03490084|multiple myeloma|multiple myeloma
5969167|NCT03490084|elderly patients|elderly patients
5969168|NCT03490084|health outcomes|health outcomes
5969169|NCT03490084|hospital-at-home|hospital-at-home
5969170|NCT03490084|day hospitalization|day hospitalization
5969171|NCT03490084|quality of life|quality of life
5969172|NCT03490084|medico-economic evaluation|medico-economic evaluation
5969173|NCT03490084|qualitative study|qualitative study
5969174|NCT03489525|multiple myeloma|multiple myeloma
5969175|NCT03489525|relapsed/refractory|relapsed/refractory
5969176|NCT03489525|open-label|open-label
5969177|NCT03489408|Proximal humerus fracture fixation|proximal humerus fracture fixation
5969178|NCT03489408|trauma|trauma
5969179|NCT03487211|Fibromyalgia treatment|fibromyalgia treatment
5969180|NCT03487211|Duloxetine|duloxetine
5969181|NCT03487211|Escitalopram|escitalopram
5969182|NCT03487185|CPAP|cpap
5969183|NCT03487185|Apnea|apnea
5969184|NCT03487185|pregnancy|pregnancy
5969186|NCT03486873|PD-1|pd-1
5969187|NCT03486873|PDL1|pdl1
5969188|NCT03486873|PD-L1|pd-l1
5969189|NCT03485612|Optic Nerve Sheath Diameter|optic nerve sheath diameter
5969190|NCT03485612|Urological Anaesthesia|urological anaesthesia
5969191|NCT03485612|point of care USG|point of care usg
5969192|NCT03485222|Cardiovascular diseases|cardiovascular diseases
5969193|NCT03485222|Heart Failure|heart failure
5969194|NCT03485222|LV remodeling|lv remodeling
5969195|NCT03485222|SGLT-2 Inhibitors|sglt-2 inhibitors
5969196|NCT03485222|Empagliflozin|empagliflozin
5969197|NCT03485222|Cardiac MRI|cardiac mri
5969198|NCT03485209|Colorectal cancer|colorectal cancer
5969199|NCT03485209|NSCLC|nsclc
5969200|NCT03485209|SCCHN|scchn
5969201|NCT03485209|CRC|crc
5969202|NCT03485209|Pancreatic cancer|pancreatic cancer
5969203|NCT03485209|Head and neck cancer|head and neck cancer
5969204|NCT03483116|Dose ranging|dose ranging
5969205|NCT03483116|Neonatal vaccine|neonatal vaccine
5969206|NCT03483116|RV3-BB vaccine|rv3-bb vaccine
5969207|NCT03483038|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5969208|NCT03483038|neoadjuvant|neoadjuvant
5969209|NCT03483038|ONIVYDE|onivyde
5969210|NCT03483038|chemotherapy|chemotherapy
5969211|NCT03483038|borderline resectable|borderline resectable
5969212|NCT03483038|resectable|resectable
5969213|NCT03482973|Cardiopulmonary Bypass|cardiopulmonary bypass
5969214|NCT03482973|Cardiac Surgery|cardiac surgery
5969215|NCT03482973|Sternotomy|sternotomy
5969216|NCT03482778|PROMIS|promis
5969217|NCT03482778|AYA|aya
5969218|NCT03482778|ONCOLOGY|oncology
5969219|NCT03482778|HRQOL|hrqol
5969220|NCT03482778|Adolescent and Young Adult|adolescent and young adult
5969221|NCT03482778|Health Related Quality of Life Measurement|health related quality of life measurement
5969222|NCT03482778|Patient-Reported Outcomes Measurement Information System|patient-reported outcomes measurement information system
5969223|NCT03481881|pharmacokinetics|pharmacokinetics
5969224|NCT03481816|mCRPC|mcrpc
5969225|NCT03481816|Therapeutic Cancer Vaccines|therapeutic cancer vaccines
5969226|NCT03481816|ETBX-071|etbx-071
5969227|NCT03481816|ETBX-061|etbx-061
5969228|NCT03481816|ETBX-051|etbx-051
5969229|NCT03481660|Diabetic Macular Edema|diabetic macular edema
5969230|NCT03481660|intravitreal injection|intravitreal injection
5969231|NCT03481660|brolucizumab|brolucizumab
5969232|NCT03481660|aflibercept|aflibercept
5969233|NCT03481660|double-masked|double-masked
5969234|NCT03481634|Diabetic Macular Edema|diabetic macular edema
5969235|NCT03481634|intravitreal injection|intravitreal injection
5969236|NCT03481634|brolucizumab|brolucizumab
5969237|NCT03481634|aflibercept|aflibercept
5969238|NCT03481634|double-masked|double-masked
5969239|NCT03481283|Amylin|amylin
5969240|NCT03481114|radiation therapy|radiation therapy
5969241|NCT03481114|chemotherapy|chemotherapy
5969242|NCT03481114|PET Imaging|pet imaging
5969243|NCT03480555|Enteral nutrition, Intensive Care Units, caloric restriction, infections, insulin, mortality, protein catabolism, NUTRIC score|enteral nutrition, intensive care units, caloric restriction, infections, insulin, mortality, protein catabolism, nutric score
5969244|NCT03480477|Adverse Childhood Experiences|adverse childhood experiences
5969245|NCT03480139|Prematurity|prematurity
5969246|NCT03480139|Perinatal Mortality|perinatal mortality
5969247|NCT03480139|Pregnancy Complications|pregnancy complications
5969248|NCT03480139|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
5969249|NCT03480139|Premature Rupture of Membranes|premature rupture of membranes
5969250|NCT03478917|Vasoocclusive Crisis|vasoocclusive crisis
5969251|NCT03478917|Sickle Cell Disease|sickle cell disease
5969252|NCT03478917|Acute Chest Syndrome|acute chest syndrome
5969253|NCT03478917|Pulmonary Syndrome|pulmonary syndrome
5969254|NCT03478917|Pneumonia|pneumonia
5969255|NCT03478904|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5969256|NCT03478904|Androgen Receptor|androgen receptor
5969257|NCT03478878|Eye Examinations|eye examinations
5969258|NCT03478878|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5969259|NCT03478878|Retinal Pigment Epithelium|retinal pigment epithelium
5969260|NCT03478865|Eye Examinations|eye examinations
5969261|NCT03478865|Retinal Pigment Epithelium|retinal pigment epithelium
5969262|NCT03478852|Seizure Disorder|seizure disorder
5969263|NCT03478852|Seizures|seizures
5969264|NCT03478852|Antiepileptic Drug|antiepileptic drug
5969265|NCT03478852|Natural History Study|natural history study
5969266|NCT03478852|Screening Protocol|screening protocol
5969267|NCT03478462|medulloblastoma|medulloblastoma
5969268|NCT03478462|ependymoma|ependymoma
5969269|NCT03478462|high-grade glioma|high-grade glioma
5969270|NCT03478462|glioblastoma|glioblastoma
5969271|NCT03478462|DIPG|dipg
5969272|NCT03478462|diffuse-intrinsic pontine glioma|diffuse-intrinsic pontine glioma
5969273|NCT03478462|ATRT|atrt
5969274|NCT03478462|atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
5969275|NCT03478462|PNET|pnet
5969276|NCT03478462|primitive neuroectodermal tumor|primitive neuroectodermal tumor
5969277|NCT03478462|gliosarcoma|gliosarcoma
5969278|NCT03478462|gliomatosis cerebri|gliomatosis cerebri
5969279|NCT03478462|neuroblastoma|neuroblastoma
5969280|NCT03478462|rhabdomyosarcoma|rhabdomyosarcoma
5969281|NCT03478462|Ewing sarcoma|ewing sarcoma
5969282|NCT03478462|osteosarcoma|osteosarcoma
5969283|NCT03478462|DSRCT|dsrct
5969284|NCT03478462|desmoplastic small round cell tumor|desmoplastic small round cell tumor
5969285|NCT03478462|sarcoma|sarcoma
5969286|NCT03478462|malignant germ cell tumor|malignant germ cell tumor
5969287|NCT03478462|synovial sarcoma|synovial sarcoma
5969288|NCT03478462|rare cancer|rare cancer
5969289|NCT03478462|Wilms tumor|wilms tumor
5969290|NCT03478462|lymphoma|lymphoma
5969291|NCT03478462|Hodgkin Lymphoma|hodgkin lymphoma
5969292|NCT03478462|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5969293|NCT03477630|gonarthrosis|gonarthrosis
5969294|NCT03477591|Screening|screening
5969295|NCT03477591|PSA testing|psa testing
5969296|NCT03477591|Patient Decision Aid|patient decision aid
5969297|NCT03475056|Marburg virus|marburg virus
5969298|NCT03475056|Marburg vaccine|marburg vaccine
5969299|NCT03475056|cAd3-Marburg vaccine|cad3-marburg vaccine
5969300|NCT03474653|Stress urinary incontinence|stress urinary incontinence
5969301|NCT03474653|Bulking|bulking
5969302|NCT03474653|Bulkamid|bulkamid
5969303|NCT03474172|Pediatric Tuina|pediatric tuina
5969304|NCT03474172|Massage therapy|massage therapy
5969305|NCT03474172|Sham Tuina|sham tuina
5969306|NCT03474172|Sham massage|sham massage
5969307|NCT03474172|Sham device|sham device
5969308|NCT03474107|antibody drug conjugate|antibody drug conjugate
5969309|NCT03474107|enfortumab vedotin (EV)|enfortumab vedotin (ev)
5969310|NCT03474107|ASG-22ME|asg-22me
5969311|NCT03474107|ASG-22CE|asg-22ce
5969312|NCT03474107|urothelial cancer|urothelial cancer
5969313|NCT03473756|Locally advanced or metastatic urothelial carcinoma|locally advanced or metastatic urothelial carcinoma
5969314|NCT03473756|Bladder cancer|bladder cancer
5969315|NCT03473756|Checkpoint inhibition|checkpoint inhibition
5969316|NCT03473756|FGFR inhibition|fgfr inhibition
5969317|NCT03473639|Residual invasive breast cancer|residual invasive breast cancer
5969318|NCT03473639|Metastatic breast cancer|metastatic breast cancer
5969319|NCT03472976|Healthy Young Adults|healthy young adults
5969320|NCT03472976|Immunogenicity|immunogenicity
5969321|NCT03472976|Inactivated Influenza A/H5N1 Vaccine|inactivated influenza a/h5n1 vaccine
5969322|NCT03472976|Phase I Clinical Trial|phase i clinical trial
5969323|NCT03472976|Reactogenicity|reactogenicity
5969324|NCT03472976|Safety|safety
5969325|NCT03472976|Topical Aldara(R)|topical aldara(r)
5969326|NCT03472729|Social isolation|social isolation
5969327|NCT03472729|Older adults|older adults
5969328|NCT03472729|Technology|technology
5969329|NCT03472092|headache|headache
5969330|NCT03472092|migraine|migraine
5969331|NCT03472092|cognitive behavioral therapy|cognitive behavioral therapy
5969332|NCT03472092|amitriptyline|amitriptyline
5969333|NCT03472092|functional magnetic resonance imaging|functional magnetic resonance imaging
5969334|NCT03472092|conditioned pain modulation|conditioned pain modulation
5969335|NCT03472092|brain connectivity|brain connectivity
5969336|NCT03472092|pediatrics|pediatrics
5969337|NCT03471065|Transcatheter|transcatheter
5969338|NCT03471065|Transcatheter Valve Replacement|transcatheter valve replacement
5969339|NCT03471065|SAPIEN 3 Ultra|sapien 3 ultra
5969340|NCT03470311|Eosinophils|eosinophils
5969341|NCT03470311|asthma|asthma
5969342|NCT03470311|inflammation|inflammation
5969343|NCT03470311|prednisone|prednisone
5969344|NCT03470181|Chronic nausea, intermittent vomiting, impaired accommodation|chronic nausea, intermittent vomiting, impaired accommodation
5969345|NCT03470103|Wet age-related macular degeneration(wAMD)|wet age-related macular degeneration(wamd)
5969346|NCT03470103|Diabetic macular edema(DME)|diabetic macular edema(dme)
5969347|NCT03467958|Crohn's Disease|crohn's disease
5969348|NCT03467958|Crohn Disease|crohn disease
5969349|NCT03467958|Oral|oral
5969350|NCT03467958|Ozanimod|ozanimod
5969351|NCT03467958|Moderately active|moderately active
5969352|NCT03467958|Severely active|severely active
5969353|NCT03467958|RPC01|rpc01
5969354|NCT03467958|RPC01-3204|rpc01-3204
5969355|NCT03467152|E2027|e2027
5969356|NCT03467152|Montreal Cognitive Assessment|montreal cognitive assessment
5969357|NCT03467152|Neuropsychiatric Inventory|neuropsychiatric inventory
5969358|NCT03467152|Mini-Mental State Examination|mini-mental state examination
5969359|NCT03467152|Cognitive Fluctuation Inventory|cognitive fluctuation inventory
5969360|NCT03466385|Non-invasive ventilation|non-invasive ventilation
5969361|NCT03466385|Nasal High Flow|nasal high flow
5969362|NCT03464097|Crohn's Disease|crohn's disease
5969363|NCT03464097|Crohn Disease|crohn disease
5969364|NCT03464097|Oral|oral
5969365|NCT03464097|Ozanimod|ozanimod
5969366|NCT03464097|Moderately active|moderately active
5969367|NCT03464097|Severely active|severely active
5969368|NCT03464097|RPC01|rpc01
5969369|NCT03464097|RPC01-3203|rpc01-3203
5969370|NCT03463954|less than or equal to 15 mm|less than or equal to 15 mm
5969371|NCT03463902|Gesture|gesture
5969372|NCT03463902|tDCS|tdcs
5969373|NCT03463902|schizophrenia|schizophrenia
5969374|NCT03463902|nonverbal communication|nonverbal communication
5969375|NCT03463304|Gut Microbiota|gut microbiota
5969376|NCT03463304|endocannabinoide|endocannabinoide
5969377|NCT03463304|Metabolic health|metabolic health
5969378|NCT03463304|Gastrointestinal health|gastrointestinal health
5969379|NCT03463304|Mental wellbeing|mental wellbeing
5969380|NCT03463239|Autologous tissue engineered corpora|autologous tissue engineered corpora
5969381|NCT03460977|efficacy|efficacy
5969382|NCT03460977|safety|safety
5969383|NCT03460977|pharmacokinetics|pharmacokinetics
5969384|NCT03460977|pharmacodynamics|pharmacodynamics
5969385|NCT03460977|dose escalation|dose escalation
5969386|NCT03460977|dose expansion|dose expansion
5969387|NCT03460977|open-label|open-label
5945996|NCT04067518|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5969388|NCT03460977|EZH2|ezh2
5969389|NCT03460977|enhancer of zeste homolog 2|enhancer of zeste homolog 2
5969390|NCT03460977|castrate resistant prostate cancer|castrate resistant prostate cancer
5969391|NCT03460977|CRPC|crpc
5969392|NCT03460977|small cell lung cancer|small cell lung cancer
5969393|NCT03460977|SCLC|sclc
5969394|NCT03460977|follicular lymphoma|follicular lymphoma
5969395|NCT03460977|FL|fl
5969396|NCT03460977|relapsed|relapsed
5969397|NCT03460977|refractory|refractory
5969398|NCT03459729|Anti-tumor B|anti-tumor b
5969399|NCT03459729|ACAPHA|acapha
5969400|NCT03459729|Pharmacokinetics|pharmacokinetics
5969401|NCT03459690|Meditation, EEG|meditation, eeg
5969402|NCT03459664|stepped care|stepped care
5969403|NCT03459664|common mental disorders|common mental disorders
5969404|NCT03459664|managed care|managed care
5969405|NCT03459664|integrated care|integrated care
5969406|NCT03459664|psychiatric disorders|psychiatric disorders
5969407|NCT03459664|psychotherapy|psychotherapy
5969408|NCT03459664|severe mental disorders|severe mental disorders
5969409|NCT03458728|Phase I: relapsed or refractory solid tumors or lymphoma|phase i: relapsed or refractory solid tumors or lymphoma
5969410|NCT03458728|Phase II: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or Ewing sarcoma)|phase ii: relapsed or refractory solid tumors (neuroblastoma, osteosarcoma, rhabdomyosarcoma or ewing sarcoma)
5969411|NCT03457870|Intermittent fasting|intermittent fasting
5969412|NCT03457870|Adult hippocampal neurogenesis|adult hippocampal neurogenesis
5969413|NCT03457870|Mastication|mastication
5969414|NCT03457870|Pattern separation|pattern separation
5969415|NCT03457870|Recognition memory|recognition memory
5969416|NCT03457870|Klotho|klotho
5969417|NCT03457675|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5969418|NCT03457675|Treatment Resistant OCD|treatment resistant ocd
5969419|NCT03457675|Intractable OCD|intractable ocd
5969420|NCT03457675|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5969421|NCT03457675|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
5969422|NCT03457675|Exposure and Response Prevention (ERP)|exposure and response prevention (erp)
5969423|NCT03457402|delay discounting|delay discounting
5969424|NCT03457402|shaping|shaping
5969425|NCT03456830|Kidney stones|kidney stones
5969426|NCT03456830|Hyperoxaluria|hyperoxaluria
5969427|NCT03456830|Enteric hyperoxaluria|enteric hyperoxaluria
5969428|NCT03456830|Oxalate|oxalate
5969429|NCT03455270|Breast Cancer|breast cancer
5969430|NCT03455270|Oral SERD|oral serd
5969431|NCT03455270|SERD|serd
5969432|NCT03455270|HER2-Negative|her2-negative
5969433|NCT03455270|ER-Positive|er-positive
5969434|NCT03455270|ER+|er+
5969435|NCT03455270|HER2-|her2-
5969436|NCT03455270|HER2 -ve|her2 -ve
5969437|NCT03455270|ER +ve|er +ve
5969438|NCT03455270|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5969439|NCT03454841|prasugrel|prasugrel
5969440|NCT03454841|ticagrelor|ticagrelor
5969441|NCT03454841|VASP|vasp
5969442|NCT03454841|platelet reactivity|platelet reactivity
5969443|NCT03454841|STEMI|stemi
5969444|NCT03454841|NSTEMI|nstemi
5969445|NCT03454568|Stem Cell Transplant|stem cell transplant
5969446|NCT03454412|Cerebral Palsy|cerebral palsy
5969447|NCT03454412|Rehabilitation|rehabilitation
5969448|NCT03454412|Hand|hand
5969449|NCT03453593|Trauma|trauma
5969450|NCT03453593|India|india
5969451|NCT03453593|Computed tomography|computed tomography
5969452|NCT03452878|Amygdala, neurosurgery, aggressive behavior|amygdala, neurosurgery, aggressive behavior
5969453|NCT03452670|Workplace|workplace
5969454|NCT03452670|Applications|applications
5969455|NCT03452670|Anxiety|anxiety
5969456|NCT03452670|Burnout|burnout
5969457|NCT03452670|Meditation|meditation
5969458|NCT03452670|Mindfulness|mindfulness
5969459|NCT03451370|Bevacizumab|bevacizumab
5969460|NCT03451370|Capecitabine|capecitabine
5969461|NCT03451370|Oxaliplatin|oxaliplatin
5969462|NCT03451370|CRASH score|crash score
5969463|NCT03451370|ECOG PS|ecog ps
5969464|NCT03451370|G8 score|g8 score
5969465|NCT03450668|neonatal, incubator, thermal-regulation|neonatal, incubator, thermal-regulation
5969466|NCT03450538|Trauma|trauma
5969467|NCT03450538|Computed tomography|computed tomography
5969468|NCT03450538|India|india
5969469|NCT03449914|ECOG PS|ecog ps
5969470|NCT03449914|Timed Up and Go test|timed up and go test
5969471|NCT03449914|G8 score|g8 score
5969472|NCT03449706|Reservoir|reservoir
5969473|NCT03449485|Bariatric surgery|bariatric surgery
5969474|NCT03449485|Gastrointestinal tract|gastrointestinal tract
5969475|NCT03449485|Biological availability|biological availability
5969476|NCT03449485|Pharmacokinetics|pharmacokinetics
5969477|NCT03449485|Chlorprothixene|chlorprothixene
5969478|NCT03449030|Drug Therapy|drug therapy
5969479|NCT03448783|Bariatric surgery|bariatric surgery
5969480|NCT03448783|Gastrointestinal tract|gastrointestinal tract
5969481|NCT03448783|Biological availability|biological availability
5969482|NCT03448783|Pharmacokinetics|pharmacokinetics
5969483|NCT03448783|Apixaban|apixaban
5969484|NCT03448692|Proteinuria|proteinuria
5969485|NCT03448575|Youth|youth
5969486|NCT03448575|Mental Health|mental health
5969487|NCT03448575|Psychotropic|psychotropic
5969488|NCT03448575|Medication Safety|medication safety
5969489|NCT03448575|Quality Improvement|quality improvement
5969490|NCT03447769|Non-Small Cell Lung Cancer|non-small cell lung cancer
5969491|NCT03447769|NSCLC|nsclc
5969492|NCT03447769|ACZ885|acz885
5969493|NCT03447769|canakinumab|canakinumab
5969494|NCT03447769|adjuvant|adjuvant
5969495|NCT03447769|AJCC/UICC v. 8 stages II-IIIA and IIIB (T>5cm N2)|ajcc/uicc v. 8 stages ii-iiia and iiib (t>5cm n2)
5969496|NCT03447314|pembrolizumab|pembrolizumab
5969497|NCT03447314|GSK1795091|gsk1795091
5969498|NCT03447314|Dose-escalation|dose-escalation
5969499|NCT03447314|204686|204686
5969500|NCT03447314|Immunotherapies|immunotherapies
5969501|NCT03447314|GSK3359609|gsk3359609
5969502|NCT03447314|Phase I|phase i
5969503|NCT03447314|anticancer agent|anticancer agent
5969504|NCT03447314|OX40|ox40
5969505|NCT03447314|201212|201212
5969506|NCT03447314|204691|204691
5969507|NCT03447314|ICOS|icos
5969508|NCT03447314|TLR4|tlr4
5969509|NCT03447314|GSK3174998|gsk3174998
5969510|NCT03447314|Advanced Solid Tumors|advanced solid tumors
5969511|NCT03446950|vaginal surgery|vaginal surgery
5969512|NCT03446950|patient position|patient position
5969513|NCT03446950|stirrups|stirrups
5969514|NCT03446950|functional status|functional status
5969515|NCT03446950|urogynecology|urogynecology
5969516|NCT03446651|Sodium Homeostasis|sodium homeostasis
5969517|NCT03445663|Relapsed/ Refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
5969518|NCT03445663|Multiple Myeloma|multiple myeloma
5969519|NCT03445663|Oncology/Hematology|oncology/hematology
5969520|NCT03445663|Immunotherapy|immunotherapy
5969521|NCT03444701|Solid tumors|solid tumors
5969522|NCT03444701|Her2-negative breast cancer|her2-negative breast cancer
5969523|NCT03444701|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5969524|NCT03443700|SCI|sci
5969525|NCT03443700|gait|gait
5969526|NCT03443700|incomplete motor SCI|incomplete motor sci
5969527|NCT03443700|robotic gait training|robotic gait training
5969528|NCT03443700|locomotor training|locomotor training
5969529|NCT03443700|walking training|walking training
5969530|NCT03443700|rehabilitation|rehabilitation
5969531|NCT03443700|exoskeleton|exoskeleton
5969532|NCT03443700|EKSO|ekso
5969533|NCT03443700|EKSO-GT|ekso-gt
5969534|NCT03443700|neuroplasticity|neuroplasticity
5969535|NCT03443700|brain cortical plasticity|brain cortical plasticity
5969536|NCT03441308|Dieting|dieting
5969537|NCT03441308|learning to eat|learning to eat
5969538|NCT03441308|group treatment|group treatment
5969539|NCT03441100|T-Cell therapy|t-cell therapy
5969540|NCT03441100|Immunotherapy|immunotherapy
5969541|NCT03441100|Adoptive cellular therapy|adoptive cellular therapy
5969542|NCT03441100|T-Cell Receptor|t-cell receptor
5969543|NCT03441100|Cell Therapy|cell therapy
5969544|NCT03441100|Cytotherapy|cytotherapy
5969545|NCT03441100|IMA202|ima202
5969546|NCT03440970|Chloride homeostasisH|chloride homeostasish
5969547|NCT03440385|Crohn's Disease|crohn's disease
5969548|NCT03440385|Crohn Disease|crohn disease
5969549|NCT03440385|Oral|oral
5969550|NCT03440385|Ozanimod|ozanimod
5969551|NCT03440385|Moderately active|moderately active
5969552|NCT03440385|Severely active|severely active
5969553|NCT03440385|RPC01|rpc01
5969554|NCT03440385|RPC01-3202|rpc01-3202
5969555|NCT03440372|Crohn's Disease|crohn's disease
5969556|NCT03440372|Crohn Disease|crohn disease
5969557|NCT03440372|Oral|oral
5969558|NCT03440372|Ozanimod|ozanimod
5969559|NCT03440372|Moderately active|moderately active
5969560|NCT03440372|Severely active|severely active
5969561|NCT03440372|RPC01|rpc01
5969562|NCT03440372|RPC01-3201|rpc01-3201
5969563|NCT03440190|Bariatric surgery|bariatric surgery
5969564|NCT03440190|Gastrointestinal tract|gastrointestinal tract
5969565|NCT03440190|Biological availability|biological availability
5969566|NCT03440190|Pharmacokinetics|pharmacokinetics
5969567|NCT03440190|Methylphenidate|methylphenidate
5969568|NCT03440177|Bariatric surgery|bariatric surgery
5969569|NCT03440177|Gastrointestinal tract|gastrointestinal tract
5969570|NCT03440177|Biological availability|biological availability
5969571|NCT03440177|Pharmacokinetics|pharmacokinetics
5969572|NCT03440177|Ramipril|ramipril
5969573|NCT03436745|Insomnia|insomnia
5969574|NCT03436745|Enzyme Expression|enzyme expression
5969575|NCT03436745|PSA|psa
5969576|NCT03436745|TESTOSTERONE|testosterone
5969577|NCT03436745|Recommended Dose|recommended dose
5969578|NCT03435991|Experience Sampling Method|experience sampling method
5969579|NCT03435991|Ecological Momentary Assessment|ecological momentary assessment
5969580|NCT03435991|Momentary Symptom Assessment|momentary symptom assessment
5969581|NCT03435991|Patient Reported Outcome Measure|patient reported outcome measure
5969582|NCT03435796|Long-term follow up|long-term follow up
5969583|NCT03435796|Gene-Modified T Cells|gene-modified t cells
5969584|NCT03435796|CAR T Cell|car t cell
5969585|NCT03434080|Infant and Toddler at Risk|infant and toddler at risk
5969586|NCT03434080|Pediatric|pediatric
5969587|NCT03434080|Neuroimaging|neuroimaging
5969588|NCT03434080|Brain Function|brain function
5969589|NCT03434080|Voluntary Movement|voluntary movement
5969590|NCT03432351|EEG|eeg
5969591|NCT03432351|Electroencephalography|electroencephalography
5969592|NCT03432351|Pediatric anesthesia|pediatric anesthesia
5969593|NCT03432286|pediatric|pediatric
5969594|NCT03432286|children|children
5969595|NCT03431571|ReLEx|relex
5969596|NCT03431571|SMILE|smile
5969597|NCT03431571|Hyperopia|hyperopia
5969598|NCT03431571|VisuMax|visumax
5969599|NCT03431571|Small Incision Lenticule Extraction|small incision lenticule extraction
5969600|NCT03431571|Lenticule|lenticule
5969601|NCT03431571|Farsightedness|farsightedness
5969602|NCT03430843|Unresectable|unresectable
5969603|NCT03430843|metastatic|metastatic
5969604|NCT03430843|second-line|second-line
5969605|NCT03430843|squamous|squamous
5969606|NCT03430843|esophagus|esophagus
5969607|NCT03430843|chemotherapy|chemotherapy
5969608|NCT03430843|paclitaxel|paclitaxel
5969609|NCT03430843|docetaxel|docetaxel
5270228|NCT02329483|rhFSH|rhfsh
5969610|NCT03430843|irinotecan|irinotecan
5969611|NCT03430037|Inflammation|inflammation
5969612|NCT03430037|Frailty|frailty
5969613|NCT03429322|traumatic brain injury|traumatic brain injury
5969614|NCT03429322|pragmatic clinical trial|pragmatic clinical trial
5969615|NCT03429322|telemedicine|telemedicine
5969616|NCT03429322|cost|cost
5969617|NCT03429218|Tolero|tolero
5969618|NCT03429218|Phase 1|phase 1
5969619|NCT03429218|First in human|first in human
5969620|NCT03429218|Solid Tumors|solid tumors
5969621|NCT03429218|Advanced Malignancy|advanced malignancy
5969622|NCT03429218|Cancer|cancer
5969623|NCT03429075|depression|depression
5969624|NCT03429075|mdd|mdd
5969625|NCT03429075|major depression|major depression
5969626|NCT03429075|major depressive disorder|major depressive disorder
5969627|NCT03429075|unipolar depression|unipolar depression
5969628|NCT03429075|psilocybin|psilocybin
5969629|NCT03429075|psychedelics|psychedelics
5969630|NCT03429075|psychedelic|psychedelic
5969631|NCT03429075|escitalopram|escitalopram
5969632|NCT03429075|ssri|ssri
5969633|NCT03428919|ICSI|icsi
5969634|NCT03428919|Conventional IVF|conventional ivf
5969635|NCT03428919|Non-male factor|non-male factor
5969636|NCT03426878|Lynch syndrome|lynch syndrome
5969637|NCT03426878|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
5969638|NCT03426670|HIV self-testing|hiv self-testing
5969639|NCT03426670|Pre-exposure prophylaxis|pre-exposure prophylaxis
5969640|NCT03426670|Sex workers|sex workers
5969641|NCT03425773|HER2/neu|her2/neu
5969642|NCT03425773|IHC 1+|ihc 1+
5969643|NCT03425773|BVAC|bvac
5969644|NCT03425773|Cellid|cellid
5969645|NCT03425773|B-cell|b-cell
5969646|NCT03425773|Monocyte|monocyte
5969647|NCT03425773|Immunotherapeutic vaccine|immunotherapeutic vaccine
5969648|NCT03425773|Breast cancer|breast cancer
5969654|NCT03425747|hypoparathyroidism|hypoparathyroidism
5969656|NCT03425747|calicum oxalate saturation|calicum oxalate saturation
5969657|NCT03425747|kydney stone|kydney stone
5969658|NCT03424473|tucatinib|tucatinib
5969659|NCT03424473|Breast Cancer|breast cancer
5969660|NCT03424473|ARRY-380|arry-380
5969661|NCT03424473|ONT-380|ont-380
5969662|NCT03424473|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
5969663|NCT03424473|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
5969664|NCT03424473|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5969665|NCT03424473|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
5969666|NCT03424473|Recurrent Breast Carcinoma|recurrent breast carcinoma
5969667|NCT03424473|Stage IV Breast Cancer|stage iv breast cancer
5969668|NCT03424473|Metastatic Breast Cancer|metastatic breast cancer
5969669|NCT03424473|Breast Carcinoma|breast carcinoma
5969670|NCT03424473|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
5969671|NCT03424473|Brain Metastases in Breast Cancer|brain metastases in breast cancer
5969672|NCT03424473|Breast Neoplasms|breast neoplasms
5969673|NCT03424473|Neoplasms by Site|neoplasms by site
5969674|NCT03424473|Neoplasms|neoplasms
5969675|NCT03424473|Breast Diseases|breast diseases
5969676|NCT03423914|writing|writing
5969677|NCT03423914|postraumatic stress|postraumatic stress
5969678|NCT03423914|coping|coping
5969679|NCT03423511|MiStent|mistent
5969680|NCT03423511|Coronary Artery Disease|coronary artery disease
5969681|NCT03423511|Coronary Disease|coronary disease
5969682|NCT03423511|Myocardial Ischemia|myocardial ischemia
5969683|NCT03423511|Heart Disease|heart disease
5969684|NCT03423511|Cardiovascular Diseases|cardiovascular diseases
5969685|NCT03423511|Arteriosclerosis|arteriosclerosis
5969686|NCT03423511|Arterial Occlusive Diseases|arterial occlusive diseases
5969687|NCT03423511|Vascular Diseases|vascular diseases
5969688|NCT03422861|Nabilone|nabilone
5969689|NCT03422861|Inflammatory Bowel Disease|inflammatory bowel disease
5969690|NCT03422861|Opioid|opioid
5969691|NCT03422822|atopic dermatitis|atopic dermatitis
5969692|NCT03422822|atopic eczema|atopic eczema
5969693|NCT03422822|eczema|eczema
5969694|NCT03422822|JAK|jak
5969695|NCT03422822|janus kinase|janus kinase
5969696|NCT03422770|Myocardium|myocardium
5969697|NCT03422770|Predictive Value of Tests|predictive value of tests
5969698|NCT03422770|Prognosis|prognosis
5969699|NCT03422770|Clinical Decision-making|clinical decision-making
5969700|NCT03422770|Heart Ventricles|heart ventricles
5969701|NCT03422770|Echocardiography|echocardiography
5969702|NCT03421340|ERCP|ercp
5969703|NCT03421340|DSC|dsc
5969704|NCT03421340|Spy Glass|spy glass
5969705|NCT03421340|Biliary Stones|biliary stones
5969706|NCT03421340|Choledocholithiasis|choledocholithiasis
5969707|NCT03421340|Non-Complex|non-complex
5969708|NCT03421340|Stones|stones
5969709|NCT03417245|RNAi therapeutic|rnai therapeutic
5969710|NCT03417245|Hemophilia A|hemophilia a
5969711|NCT03417245|Hemophilia B|hemophilia b
5969712|NCT03417245|Hemophilia A, Severe|hemophilia a, severe
5969713|NCT03417245|Hemophilia B, Severe|hemophilia b, severe
5969714|NCT03417245|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5969715|NCT03417245|Blood Coagulation Disorders|blood coagulation disorders
5969716|NCT03417245|Hematologic Diseases|hematologic diseases
5969717|NCT03417245|Coagulation Protein Disorders|coagulation protein disorders
5969718|NCT03417245|Hemorrhagic Disorders|hemorrhagic disorders
5969719|NCT03417245|Genetic Diseases, Inborn|genetic diseases, inborn
5969720|NCT03417245|Genetic Diseases, X-Linked|genetic diseases, x-linked
5969721|NCT03417245|Factor VIII|factor viii
5969722|NCT03417245|Factor IX|factor ix
5969723|NCT03417245|Coagulants|coagulants
5969724|NCT03417245|Fitusiran|fitusiran
5969725|NCT03417102|RNAi therapeutic|rnai therapeutic
5969726|NCT03417102|Hemophilia A|hemophilia a
5969727|NCT03417102|Hemophilia B|hemophilia b
5969728|NCT03417102|Hemophilia A, Severe|hemophilia a, severe
5969729|NCT03417102|Hemophilia B, Severe|hemophilia b, severe
5969730|NCT03417102|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
5969731|NCT03417102|Blood Coagulation Disorders|blood coagulation disorders
5969732|NCT03417102|Hematologic Diseases|hematologic diseases
5969733|NCT03417102|Coagulation Protein Disorders|coagulation protein disorders
5969734|NCT03417102|Hemorrhagic Disorders|hemorrhagic disorders
5969735|NCT03417102|Genetic Diseases, Inborn|genetic diseases, inborn
5969736|NCT03417102|Genetic Diseases, X-Linked|genetic diseases, x-linked
5969737|NCT03417102|Factor VIII|factor viii
5969738|NCT03417102|Factor IX|factor ix
5969739|NCT03417102|Inhibitor|inhibitor
5969740|NCT03417102|Bypassing agents|bypassing agents
5969741|NCT03417102|Coagulants|coagulants
5969742|NCT03417102|Fitusiran|fitusiran
5969743|NCT03416621|Light Smoker|light smoker
5969744|NCT03415321|Postpartum, Nurse, Mothers, Anxiety, Depression, Mobile Support Application|postpartum, nurse, mothers, anxiety, depression, mobile support application
5969745|NCT03415074|low protein diet|low protein diet
5969746|NCT03415074|Diabetic Kidney Disease|diabetic kidney disease
5969747|NCT03415022|SAD|sad
5969748|NCT03415022|Social Anxiety|social anxiety
5969749|NCT03415022|Social Phobia|social phobia
5969750|NCT03414268|Chronic plantar fasciitis|chronic plantar fasciitis
5969751|NCT03414268|Heel pain|heel pain
5969752|NCT03409614|Stage IIIB|stage iiib
5969753|NCT03409614|Stage IIIC|stage iiic
5969754|NCT03409614|Stage IV|stage iv
5969755|NCT03409614|Non-squamous NSCLC|non-squamous nsclc
5969756|NCT03409614|Squamous NSCLC|squamous nsclc
5969757|NCT03409419|Advanced|advanced
5969758|NCT03409419|Recurrent|recurrent
5969759|NCT03409419|Immune Therapy|immune therapy
5969760|NCT03409133|Prosthesis User|prosthesis user
5969761|NCT03409133|Phantom Sensation|phantom sensation
5969762|NCT03409133|Sensory Feedback|sensory feedback
5969763|NCT03409107|Non-Dialysis|non-dialysis
5969764|NCT03409107|Anemia|anemia
5969765|NCT03409107|Chronic kidney disease|chronic kidney disease
5969766|NCT03409107|Recombinant human erythropoietin naïve|recombinant human erythropoietin naïve
5969767|NCT03409107|Hemoglobin|hemoglobin
5969768|NCT03409107|Daprodustat|daprodustat
5969769|NCT03408925|elite orienteering|elite orienteering
5969770|NCT03408717|Breast cancer|breast cancer
5969771|NCT03408717|Chronic pain|chronic pain
5969772|NCT03408717|Acute Pain|acute pain
5969773|NCT03408717|Depression|depression
5969774|NCT03408717|Anxiety|anxiety
5969775|NCT03408392|Single dose|single dose
5969776|NCT03408392|Oral suspension|oral suspension
5969777|NCT03408392|Bioequivalence|bioequivalence
5969778|NCT03408392|Cefixime|cefixime
5969779|NCT03408392|Two-way crossover|two-way crossover
5969780|NCT03408379|intracranial aneurysms|intracranial aneurysms
5969781|NCT03408379|ruptured aneurysm|ruptured aneurysm
5969782|NCT03408379|platelet activity|platelet activity
5969783|NCT03407495|Hepatocellular Carcinoma|hepatocellular carcinoma
5969784|NCT03407495|Magnetic Resonance Imaging|magnetic resonance imaging
5969785|NCT03407144|Programmed Death-1 (PD-1)|programmed death-1 (pd-1)
5969786|NCT03407144|PD1|pd1
5969787|NCT03407144|Programmed Death-Ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
5969788|NCT03407144|PDL1|pdl1
5969789|NCT03407079|Drug Metabolism|drug metabolism
5969790|NCT03407079|Artificial Sweetner|artificial sweetner
5969791|NCT03407079|P-Glycoprotein|p-glycoprotein
5969792|NCT03407079|Cytochrome P 450|cytochrome p 450
5969793|NCT03407079|Microbiome|microbiome
5969794|NCT03407053|Calories|calories
5969795|NCT03407053|Food Intake|food intake
5969796|NCT03407053|Glucose|glucose
5969797|NCT03407053|Body Composition|body composition
5969798|NCT03407053|Body Weight Regulation|body weight regulation
5969799|NCT03406884|stem cells|stem cells
5969800|NCT03406884|pediatric|pediatric
5969801|NCT03406780|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5969802|NCT03406780|Cell Therapy|cell therapy
5969803|NCT03406780|Performance of the Upper Limb|performance of the upper limb
5969804|NCT03406780|Pulmonary Function|pulmonary function
5969805|NCT03406780|Ambulatory|ambulatory
5969806|NCT03406780|Non-Ambulatory|non-ambulatory
5969807|NCT03406780|Glucocorticoids|glucocorticoids
5969808|NCT03406286|Post Marketing Surveillance|post marketing surveillance
5969809|NCT03405714|Epilepsy|epilepsy
5969810|NCT03405714|Brivaracetam|brivaracetam
5969811|NCT03405714|Briviact|briviact
5969812|NCT03405714|Open-label|open-label
5969813|NCT03405714|pediatric|pediatric
5969814|NCT03405714|intravenous|intravenous
5969815|NCT03401099|Radiofrequency ablation|radiofrequency ablation
5969816|NCT03401099|Cavo-tricuspid isthmus|cavo-tricuspid isthmus
5969817|NCT03401099|Pulmonary Vein Isolation|pulmonary vein isolation
5969818|NCT03401099|Cryoballoon ablation|cryoballoon ablation
5969819|NCT03400956|Uterine fibroids|uterine fibroids
5969820|NCT03400956|Heavy menstrual bleeding|heavy menstrual bleeding
5969821|NCT03400033|CKD, EPO, rhEPO, Hemodialysis dependent, Daprodustat|ckd, epo, rhepo, hemodialysis dependent, daprodustat
5969822|NCT03399292|Lipid based eye drops|lipid based eye drops
5969823|NCT03399292|Tearfilm lipid layer thickness|tearfilm lipid layer thickness
5969824|NCT03399227|Bone microarchitecture|bone microarchitecture
5969825|NCT03398733|Obstructive Sleep Apnea|obstructive sleep apnea
5969826|NCT03398733|heart valve replacement|heart valve replacement
5969827|NCT03398733|CPAP treatment|cpap treatment
5969828|NCT03398655|Recurrent Ovarian cancer|recurrent ovarian cancer
5969829|NCT03398655|Platinum resistant ovarian cancer|platinum resistant ovarian cancer
5969830|NCT03398655|Ovarian cancer|ovarian cancer
5969831|NCT03398655|Ovarian carcinoma|ovarian carcinoma
5969832|NCT03398655|Epithelial ovarian cancer|epithelial ovarian cancer
5969833|NCT03398655|paclitaxel|paclitaxel
5969834|NCT03395977|uric acid|uric acid
5969835|NCT03395977|xanthin oxydoreductase|xanthin oxydoreductase
5969836|NCT03395977|febuxostat|febuxostat
5969837|NCT03395977|uricase|uricase
5969838|NCT03395899|Atezolizumab|atezolizumab
5969839|NCT03395899|Bevacizumab|bevacizumab
5969840|NCT03395899|Cobimetinib|cobimetinib
5969841|NCT03395899|Ipatasertib|ipatasertib
5969842|NCT03395899|pre-operative|pre-operative
5969843|NCT03395899|Window of opportunity|window of opportunity
5969844|NCT03395405|Efficacy|efficacy
5969845|NCT03395405|Hematopoietic Stem Cell|hematopoietic stem cell
5969846|NCT03395405|Nitazoxanide|nitazoxanide
5969847|NCT03395405|Norovirus|norovirus
5969848|NCT03395405|Prospective, Randomized, Double-Blind Study|prospective, randomized, double-blind study
5969849|NCT03395405|Safety|safety
5969850|NCT03395405|Solid Organ Transplant Recipients|solid organ transplant recipients
5969851|NCT03395405|Treatment|treatment
5969852|NCT03395197|mCRPC (metastatic castration-resistant prostate cancer)|mcrpc (metastatic castration-resistant prostate cancer)
5969853|NCT03393676|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5969854|NCT03393676|elderly patients|elderly patients
5969855|NCT03393676|Preoperative Pain|preoperative pain
5969856|NCT03392090|Cancer|cancer
5969857|NCT03391973|CUP|cup
5969858|NCT03391973|Pembrolizumab|pembrolizumab
5969859|NCT03391973|KEYTRUDA|keytruda
5969860|NCT03391882|Parkinson's Disease|parkinson's disease
5969861|NCT03391882|"Off Episodes"|"off episodes"
5969862|NCT03391882|motor fluctuations associated with Parkinson's Disease|motor fluctuations associated with parkinson's disease
5969863|NCT03391804|Oxalate|oxalate
5969864|NCT03391804|Kidney Stones|kidney stones
5969865|NCT03391804|oxalate nephropathy|oxalate nephropathy
5969866|NCT03391804|systemic oxalosis|systemic oxalosis
5969867|NCT03388359|asthma|asthma
5969868|NCT03388359|eosinophils|eosinophils
5969869|NCT03388359|Extracellular matrix|extracellular matrix
5969870|NCT03388359|airway smooth muscle|airway smooth muscle
5969871|NCT03388359|airway remodelling|airway remodelling
5969872|NCT03388359|fibroblast|fibroblast
5969873|NCT03388190|Colorectal|colorectal
5969874|NCT03388190|Cancer|cancer
5969875|NCT03388190|Neoplasm|neoplasm
5969876|NCT03388190|Nivolumab|nivolumab
5969877|NCT03388190|Fluorouracil|fluorouracil
5969878|NCT03388190|Metastatic|metastatic
5969879|NCT03388190|Oxaliplatin|oxaliplatin
5969880|NCT03388190|Leucovorin|leucovorin
5969881|NCT03386266|Biomarkers|biomarkers
5969882|NCT03386266|CMT1A|cmt1a
5969883|NCT03386266|Charcot-Marie-Tooth disease|charcot-marie-tooth disease
5969884|NCT03386006|bariatric surgery|bariatric surgery
5969885|NCT03386006|mobile health (mHealth)|mobile health (mhealth)
5969886|NCT03386006|psychosocial functioning|psychosocial functioning
5969887|NCT03386006|obesity|obesity
5969888|NCT03386006|weight loss|weight loss
5969889|NCT03386006|behavioral activation|behavioral activation
5969890|NCT03385798|Endo-GIA Stapler|endo-gia stapler
5969891|NCT03385798|Endowrist Stapler|endowrist stapler
5969893|NCT03385330|Prematurity|prematurity
5969894|NCT03385330|Supplemental Oxygen|supplemental oxygen
5969895|NCT03385330|Oximetry|oximetry
5969896|NCT03385330|Infants|infants
5969897|NCT03385252|complementary feeding|complementary feeding
5969898|NCT03385252|eggs|eggs
5969899|NCT03385252|infant growth|infant growth
5969900|NCT03385252|stunting|stunting
5969901|NCT03385252|cognitive development|cognitive development
5969902|NCT03385252|choline|choline
5969903|NCT03385252|vitamin B12|vitamin b12
5969904|NCT03385252|microbiome|microbiome
5969905|NCT03384836|Melanoma|melanoma
5969906|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
5969907|NCT03384836|Beta Adrenergic Blockers|beta adrenergic blockers
5969908|NCT03378167|Paediatrics|paediatrics
5969909|NCT03378167|Pediatrics|pediatrics
5969910|NCT03378167|Crohn's|crohn's
5969911|NCT03378167|Crohn|crohn
5969912|NCT03378167|Microbiome|microbiome
5969913|NCT03378167|Microbiota|microbiota
5969914|NCT03378167|FMT|fmt
5969915|NCT03378167|Fecal Transplant|fecal transplant
5969916|NCT03378167|Fecal Microbiota Transplant|fecal microbiota transplant
5969917|NCT03378167|IBD-U|ibd-u
5969918|NCT03378167|Inflammatory Bowel Disease Unclassified|inflammatory bowel disease unclassified
5969919|NCT03378167|Inflammatory Bowel Disease Indeterminate|inflammatory bowel disease indeterminate
5969920|NCT03378167|IBD|ibd
5969921|NCT03378167|Colitis|colitis
5969922|NCT03377504|complex regional pain syndrome|complex regional pain syndrome
5969923|NCT03377504|mirror therapy|mirror therapy
5969924|NCT03377504|rehabilitation|rehabilitation
5969925|NCT03377491|Locally Advanced Pancreatic Adenocarcinoma|locally advanced pancreatic adenocarcinoma
5969926|NCT03377491|TTFields|ttfields
5969927|NCT03377491|Tumor Treating Fields|tumor treating fields
5969928|NCT03377491|Gemcitabine|gemcitabine
5969929|NCT03377491|nab-Paclitaxel|nab-paclitaxel
5969930|NCT03377491|Minimal toxicity|minimal toxicity
5969931|NCT03377491|TTF|ttf
5969932|NCT03377491|Novocure|novocure
5969933|NCT03375294|PTSD|ptsd
5969934|NCT03374462|Pediatrics|pediatrics
5969935|NCT03374254|CRC, MSS, non-MSI-H, PD-1, anti-PD-1, anti PD-1, MEK, MEK inhibitor|crc, mss, non-msi-h, pd-1, anti-pd-1, anti pd-1, mek, mek inhibitor
5969936|NCT03374215|Adrenal Adenoma|adrenal adenoma
5969937|NCT03374215|Molecular Genetics|molecular genetics
5969938|NCT03374215|African-American|african-american
5969939|NCT03374215|Biomarkers|biomarkers
5969940|NCT03374215|Primary Aldosteronism|primary aldosteronism
5969941|NCT03373994|FDG, perfusion, hypoxia, tumor, PET|fdg, perfusion, hypoxia, tumor, pet
5969942|NCT03373461|glomerunephritis, complement driven, chronic kidney disease|glomerunephritis, complement driven, chronic kidney disease
5969943|NCT03373045|Severe asthma|severe asthma
5969944|NCT03373045|Monoclonal antibody|monoclonal antibody
5969945|NCT03373045|Corticosteroid|corticosteroid
5969946|NCT03373045|Non-interventional|non-interventional
5969947|NCT03372161|lumbosacral radicular pain|lumbosacral radicular pain
5969948|NCT03372161|sciatica|sciatica
5969949|NCT03372161|leg pain|leg pain
5969950|NCT03371836|pediatrics|pediatrics
5969951|NCT03371784|Acute myocardial infarction|acute myocardial infarction
5969952|NCT03371784|Left ventricular remodeling|left ventricular remodeling
5969953|NCT03371784|Coronary wedge pressure|coronary wedge pressure
5969954|NCT03371784|Glucocorticoid therapy|glucocorticoid therapy
5969955|NCT03370562|dexmedetomidine|dexmedetomidine
5969956|NCT03370562|cesarean|cesarean
5969957|NCT03370562|spinal anesthesia|spinal anesthesia
5969958|NCT03370120|Drug-Resistant Epilepsy|drug-resistant epilepsy
5969959|NCT03370120|Padsevonil|padsevonil
5969960|NCT03370016|Radical Prostatectomy|radical prostatectomy
5969961|NCT03370016|Robotic Assisted Radical Prostatectomy|robotic assisted radical prostatectomy
5969962|NCT03368638|Degenerative lumbar spinal stenosis|degenerative lumbar spinal stenosis
5969963|NCT03368638|Neural mobilization|neural mobilization
5969964|NCT03368638|Hip extension mobilization|hip extension mobilization
5969965|NCT03368638|Case series|case series
5969966|NCT03368638|Neurogenic claudication|neurogenic claudication
5969967|NCT03367078|tDCS|tdcs
5969968|NCT03367078|transcranial direct current stimulation|transcranial direct current stimulation
5969969|NCT03367078|acquired brain injury|acquired brain injury
5969970|NCT03367078|coma|coma
5969971|NCT03367078|vigilance|vigilance
5969972|NCT03366168|Diabetes|diabetes
5969973|NCT03366168|Fungiform Papillae|fungiform papillae
5969974|NCT03366168|Insulin|insulin
5969975|NCT03366129|CEREBROVASCULAR DISEASE|cerebrovascular disease
5969976|NCT03366129|Vascular Cognitive Impairment|vascular cognitive impairment
5969977|NCT03366129|Stroke|stroke
5969978|NCT03366129|Permeability Imaging|permeability imaging
5969979|NCT03365791|PDR001|pdr001
5969980|NCT03365791|LAG525|lag525
5969981|NCT03365791|Immune checkpoint blockade|immune checkpoint blockade
5969982|NCT03365791|Solid tumor malignancy|solid tumor malignancy
5969983|NCT03365791|lymphoma|lymphoma
5969984|NCT03365791|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5969985|NCT03365791|Gastric/esophageal adenocarcinoma|gastric/esophageal adenocarcinoma
5969986|NCT03365791|Castration resistant prostate adenocarcinoma (CRPC)|castration resistant prostate adenocarcinoma (crpc)
5969987|NCT03365791|Soft tissue sarcoma|soft tissue sarcoma
5969988|NCT03365791|Ovarian adenocarcinoma|ovarian adenocarcinoma
5969989|NCT03365791|Advanced well-differentiated neuroendocrine tumors (NETs)|advanced well-differentiated neuroendocrine tumors (nets)
5969990|NCT03365791|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
5969991|NCT03364491|Tranexamic Acid|tranexamic acid
5969992|NCT03364491|Hemorrhage|hemorrhage
5969993|NCT03364491|Cesarean|cesarean
5969994|NCT03364036|Multiple sclerosis|multiple sclerosis
5969995|NCT03364036|Mavenclad ®|mavenclad ®
5969996|NCT03364036|Cladribine|cladribine
5969997|NCT03362541|multiple sclerosis|multiple sclerosis
5969998|NCT03362541|fatigue|fatigue
5969999|NCT03362541|self-management|self-management
5970000|NCT03362541|rehabilitation|rehabilitation
5970001|NCT03360929|Lung Cancer|lung cancer
5970002|NCT03359551|Choroideremia|choroideremia
5970003|NCT03359551|REP1|rep1
5970004|NCT03359551|Retina|retina
5970005|NCT03359551|Retinal Degeneration|retinal degeneration
5970006|NCT03359551|Retinal Dystrophy|retinal dystrophy
5970007|NCT03359551|Natural History|natural history
5970008|NCT03359434|Acute Stroke|acute stroke
5970009|NCT03359434|Blood Pressure|blood pressure
5970010|NCT03359434|Cerebral Hemorrhage|cerebral hemorrhage
5970011|NCT03359421|prehospital|prehospital
5970012|NCT03359421|aeromedical|aeromedical
5970014|NCT03359421|ems|ems
5970015|NCT03359421|helicopter|helicopter
5970016|NCT03359395|Anesthesia|anesthesia
5970017|NCT03355495|Colonoscopy|colonoscopy
5970018|NCT03355495|Cecal Intubation Rate|cecal intubation rate
5970019|NCT03354390|genetically modified lymphocytes|genetically modified lymphocytes
5970020|NCT03354390|tumor antigens|tumor antigens
5970021|NCT03354390|T cell receptor immunotherapy|t cell receptor immunotherapy
5970022|NCT03354390|genomic retroviral elements|genomic retroviral elements
5970023|NCT03351803|BRCA|brca
5970024|NCT03351803|BFOR|bfor
5970025|NCT03351803|Ashkenazi|ashkenazi
5970026|NCT03351803|17-568|17-568
5970027|NCT03350997|Exercise|exercise
5970028|NCT03350815|Ankylosing spondylitis, ASDAS inactive disease, secukinumab|ankylosing spondylitis, asdas inactive disease, secukinumab
5970029|NCT03350347|Renal anemia|renal anemia
5970030|NCT03347227|AF ablation|af ablation
5970031|NCT03347227|Pulmonary vein isolation|pulmonary vein isolation
5970032|NCT03347227|Atrial scar ablation|atrial scar ablation
5970033|NCT03347110|Bimekizumab|bimekizumab
5970034|NCT03347110|Psoriatic Arthritis|psoriatic arthritis
5970035|NCT03347110|PsA|psa
5970036|NCT03345836|Upadacitinib|upadacitinib
5970037|NCT03345836|Crohn's Disease|crohn's disease
5970038|NCT03345836|Efficacy|efficacy
5970039|NCT03345836|Safety|safety
5970040|NCT03345628|sedation|sedation
5970041|NCT03345628|critical care|critical care
5970042|NCT03345628|infant|infant
5970043|NCT03345628|neurodevelopment|neurodevelopment
5970044|NCT03345459|Internet-based treatment|internet-based treatment
5970045|NCT03344796|Skin Cancer|skin cancer
5970046|NCT03344796|Sunburn, erythema|sunburn, erythema
5970047|NCT03344796|UV Exposure, Sunburn|uv exposure, sunburn
5970048|NCT03344796|Wearable UV Device|wearable uv device
5970049|NCT03344640|Overuse tendinopathy|overuse tendinopathy
5970050|NCT03344640|shoulder|shoulder
5970051|NCT03344640|rotator cuff|rotator cuff
5970052|NCT03344640|IL-17A-Ab|il-17a-ab
5970053|NCT03344640|AIN457X|ain457x
5970054|NCT03343613|IDO-1 Inhibitor|ido-1 inhibitor
5970055|NCT03343613|IDO1 Inhibitor|ido1 inhibitor
5970056|NCT03343613|IDO Inhibitor|ido inhibitor
5970057|NCT03341962|Ulcerative Colitis|ulcerative colitis
5970058|NCT03341962|IMU-838|imu-838
5970059|NCT03341962|vidofludimus calcium|vidofludimus calcium
5970060|NCT03341143|Unresectable|unresectable
5970061|NCT03341143|Stage III|stage iii
5970062|NCT03341143|Stage IV|stage iv
5970063|NCT03340701|progesterone|progesterone
5970064|NCT03340701|pharmacology|pharmacology
5970065|NCT03340701|pharmacokinetics|pharmacokinetics
5970066|NCT03340129|Immunotherapy|immunotherapy
5970067|NCT03340129|Radiotherapy|radiotherapy
5970068|NCT03340129|Brain metastases|brain metastases
5970069|NCT03340129|Stereotactic radiotherapy|stereotactic radiotherapy
5970070|NCT03340129|Stereotactic radiosurgery|stereotactic radiosurgery
5970071|NCT03340129|Cognitive function|cognitive function
5970072|NCT03340129|Neurological-specific cause of death|neurological-specific cause of death
5970073|NCT03338777|melanoma|melanoma
5970074|NCT03338777|lipoplexes|lipoplexes
5970075|NCT03338777|plasmid|plasmid
5970076|NCT03338777|herpes simplex thymidine kinase|herpes simplex thymidine kinase
5970077|NCT03338777|interleukin-2|interleukin-2
5970078|NCT03338777|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
5970079|NCT03338777|tumor vaccine|tumor vaccine
5970080|NCT03338777|suicide gene|suicide gene
5970081|NCT03338699|Early infant male circumcision|early infant male circumcision
5970082|NCT03338699|ShangRing|shangring
5970083|NCT03338699|sub-Saharan Africa|sub-saharan africa
5970084|NCT03338699|HIV|hiv
5970085|NCT03338699|WHO|who
5970086|NCT03338296|body mass index|body mass index
5970087|NCT03338296|weight loss|weight loss
5970088|NCT03338296|adolescents|adolescents
5970089|NCT03338296|lifestyle modification|lifestyle modification
5970090|NCT03337763|LV-LV conduction delay|lv-lv conduction delay
5970091|NCT03336034|IBS-C|ibs-c
5970092|NCT03336034|Experience sampling method|experience sampling method
5970093|NCT03336034|Ecological momentary assessment|ecological momentary assessment
5970094|NCT03336034|Abdominal pain|abdominal pain
5970095|NCT03336034|Constipation|constipation
5970096|NCT03335839|tPA|tpa
5970097|NCT03334838|Food effect|food effect
5970098|NCT03334838|Dose proportionality|dose proportionality
5970099|NCT03334630|ablation|ablation
5970100|NCT03334630|electrophysiology|electrophysiology
5970101|NCT03334630|atrial fibrillation|atrial fibrillation
5970102|NCT03334630|catheter|catheter
5970103|NCT03334630|paroxysmal|paroxysmal
5970104|NCT03334617|Non-small cell lung cancer|non-small cell lung cancer
5970105|NCT03334617|NSCLC|nsclc
5970106|NCT03334617|anti-PD-1/PD-L1|anti-pd-1/pd-l1
5970107|NCT03334617|umbrella study|umbrella study
5970108|NCT03334617|Durvalumab|durvalumab
5970109|NCT03334617|MEDI4736|medi4736
5970110|NCT03334617|Olaparib|olaparib
5970111|NCT03334617|AZD2281|azd2281
5970112|NCT03334617|AZD9150|azd9150
5970113|NCT03334617|AZD6738|azd6738
5970114|NCT03334617|Vistusertib|vistusertib
5970115|NCT03334617|AZD2014|azd2014
5970116|NCT03334617|Oleclumab|oleclumab
5970117|NCT03334617|MEDI9447|medi9447
5970118|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan
5970119|NCT03334617|DS-8201a|ds-8201a
5970120|NCT03334617|cediranib|cediranib
5970121|NCT03334617|AZD2171|azd2171
5970122|NCT03334435|eczema|eczema
5970123|NCT03334435|atopic eczema|atopic eczema
5970124|NCT03333590|DMD|dmd
5970125|NCT03333590|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5970126|NCT03333551|AL Cardiac Amyloidosis|al cardiac amyloidosis
5970127|NCT03333551|18F-Florbetapir (Amyvid)|18f-florbetapir (amyvid)
5970128|NCT03331380|1.5 T CMR|1.5 t cmr
5970129|NCT03331380|Low SAR CMR|low sar cmr
5970130|NCT03331380|Gadolinium|gadolinium
5970131|NCT03331380|Regadenoson|regadenoson
5970132|NCT03331380|Adenosine|adenosine
5970133|NCT03330847|Germline BRCA mutation|germline brca mutation
5970134|NCT03330847|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5970135|NCT03330847|Olaparib|olaparib
5970136|NCT03330847|Homologous Recombinant Repair (HRR)-related Genes|homologous recombinant repair (hrr)-related genes
5970137|NCT03330405|NSCLC, TNBC, hormone receptor positive (HR+) breast cancer, recurrent epithelial ovarian cancer, UC, and castration resistant prostate cancer (CRPC).|nsclc, tnbc, hormone receptor positive (hr+) breast cancer, recurrent epithelial ovarian cancer, uc, and castration resistant prostate cancer (crpc).
5970144|NCT03329092|Hosptial acquired pneumonia|hosptial acquired pneumonia
5970145|NCT03329092|Ventilator associated pneumonia|ventilator associated pneumonia
5970146|NCT03329092|Gram negative infections|gram negative infections
5970147|NCT03329092|Metallo-beta lactamase|metallo-beta lactamase
5970148|NCT03329092|Multi drug resistant pathogens|multi drug resistant pathogens
5970149|NCT03328689|prevention|prevention
5970150|NCT03328689|exercise|exercise
5970151|NCT03328689|randomized controlled trial|randomized controlled trial
5970152|NCT03328689|physical activity|physical activity
5970153|NCT03327714|mindfulness|mindfulness
5970154|NCT03327714|children|children
5970155|NCT03327714|anxiety|anxiety
5970156|NCT03327714|depression|depression
5970157|NCT03327714|mental disorder|mental disorder
5970158|NCT03327714|risk factor|risk factor
5970159|NCT03324503|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5970160|NCT03324503|HRCT|hrct
5970161|NCT03324503|Glucocorticoid|glucocorticoid
5970162|NCT03324503|Prednisone|prednisone
5970164|NCT03324503|Prednisolone|prednisolone
5970165|NCT03323112|influenza|influenza
5970166|NCT03323112|vaccination|vaccination
5970167|NCT03323112|health care workers|health care workers
5970168|NCT03323112|immune responses|immune responses
5970169|NCT03323112|humoral immunity|humoral immunity
5970170|NCT03323112|cellular immunity|cellular immunity
5970171|NCT03320122|Telemedicine|telemedicine
5970172|NCT03320057|medication abortion|medication abortion
5970173|NCT03320057|mifepristone|mifepristone
5970174|NCT03318952|lidocaine injection|lidocaine injection
5970175|NCT03318952|articaine injections|articaine injections
5970176|NCT03318952|pediatric dental anesthesia|pediatric dental anesthesia
5970177|NCT03318952|post dental procedure pain|post dental procedure pain
5970178|NCT03318939|EGFR|egfr
5970179|NCT03318939|HER2|her2
5970180|NCT03318939|Exon 20 insertion mutation|exon 20 insertion mutation
5970181|NCT03318757|bupivacaine liposomal injectable|bupivacaine liposomal injectable
5970182|NCT03318757|post operative pain|post operative pain
5970183|NCT03318757|post operative narcotic use|post operative narcotic use
5970184|NCT03318757|bupivacaine hydrochloride|bupivacaine hydrochloride
5970185|NCT03318523|BIIB054|biib054
5970186|NCT03318523|Alpha-synuclein|alpha-synuclein
5970187|NCT03317990|Prostate Cancer|prostate cancer
5970188|NCT03317990|Nerve sparing|nerve sparing
5970189|NCT03317990|NeuroSAFE|neurosafe
5970190|NCT03317990|Frozen section|frozen section
5970191|NCT03317561|troponin|troponin
5970192|NCT03317561|major surgery|major surgery
5970193|NCT03317158|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5970194|NCT03317158|BCG|bcg
5970195|NCT03317158|immunotherapy|immunotherapy
5970196|NCT03316066|Stellate Ganglion|stellate ganglion
5970197|NCT03316066|Local Anesthetic|local anesthetic
5970198|NCT03314506|exercise|exercise
5970199|NCT03314246|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5970200|NCT03314246|Ramadan Fasting|ramadan fasting
5970201|NCT03314246|Randomized controlled trial|randomized controlled trial
5970202|NCT03313999|Lymphedema indentometer|lymphedema indentometer
5970203|NCT03313999|Durometer|durometer
5970204|NCT03312400|Telomeres|telomeres
5970205|NCT03312400|Aplastic Anemia|aplastic anemia
5970206|NCT03312400|Pulmonary Fibrosis|pulmonary fibrosis
5970207|NCT03312400|Androgens|androgens
5970208|NCT03312400|Hepatic Fibrosis|hepatic fibrosis
5970209|NCT03311074|Sonication Linker Medicated Polymerase Chain Reaction|sonication linker medicated polymerase chain reaction
5970210|NCT03311074|Previously GSK2696273|previously gsk2696273
5970211|NCT03311074|Gene therapy|gene therapy
5970212|NCT03311074|Adenosine deaminase deficiency|adenosine deaminase deficiency
5970213|NCT03311074|Retroviral insertion site|retroviral insertion site
5970214|NCT03311074|Severe combined immunodeficiency|severe combined immunodeficiency
5970215|NCT03311074|Strimvelis|strimvelis
5970216|NCT03310957|Breast cancer|breast cancer
5970217|NCT03310957|Breast carcinoma|breast carcinoma
5970218|NCT03310957|Triple negative breast cancer|triple negative breast cancer
5970219|NCT03310957|Locally-advanced breast cancer|locally-advanced breast cancer
5970220|NCT03310957|Metastatic breast cancer|metastatic breast cancer
5970221|NCT03310957|Tumors, breast|tumors, breast
5970222|NCT03310957|Breast tumors|breast tumors
5970223|NCT03310957|pembrolizumab|pembrolizumab
5970224|NCT03310957|LIV-1 protein, human|liv-1 protein, human
5970225|NCT03310957|Ladiratuzumab vedotin|ladiratuzumab vedotin
5970226|NCT03310957|hLIV22-vcMMAE|hliv22-vcmmae
5970227|NCT03310619|JCAR017|jcar017
5970228|NCT03310619|B-Cell Malignancies|b-cell malignancies
5970229|NCT03310619|NHL|nhl
5970230|NCT03310619|non-Hodgkin lymphoma|non-hodgkin lymphoma
5970231|NCT03310619|CAR T cells|car t cells
5970232|NCT03310619|chimeric antigen receptor|chimeric antigen receptor
5970233|NCT03310619|CC-220|cc-220
5970234|NCT03310619|Ibrutinib|ibrutinib
5970235|NCT03308578|Obsructive sleep apnea|obsructive sleep apnea
5970236|NCT03308578|Adipose tissue|adipose tissue
5970237|NCT03307330|Obstructive Sleep Apnea|obstructive sleep apnea
5970238|NCT03307330|Adipose Tissue|adipose tissue
5970239|NCT03307304|Batten Disease|batten disease
5970240|NCT03307304|Neurodegenerative|neurodegenerative
5970241|NCT03307304|Lysosomal Storage|lysosomal storage
5970242|NCT03307304|Biomarkers|biomarkers
5970243|NCT03307304|Longitudinal Study|longitudinal study
5970244|NCT03306615|Muscle Stiffness|muscle stiffness
5970245|NCT03306615|Muscle Spasticity|muscle spasticity
5970246|NCT03306615|Stroke|stroke
5970247|NCT03306615|Cerebral Palsy|cerebral palsy
5970248|NCT03306615|Hyperreflexia|hyperreflexia
5970249|NCT03305991|tuberculosis|tuberculosis
5970250|NCT03305991|pregnancy|pregnancy
5970251|NCT03305991|ethiopia|ethiopia
5970252|NCT03305016|Human Growth Hormone|human growth hormone
5970253|NCT03305016|hGH|hgh
5970254|NCT03305016|GHD|ghd
5970255|NCT03305016|rhGH|rhgh
5970256|NCT03305016|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
5970257|NCT03305016|Long Acting Growth Hormone|long acting growth hormone
5970258|NCT03305016|Somatropin|somatropin
5970259|NCT03305016|Prodrug|prodrug
5970260|NCT03305016|Growth Failure|growth failure
5970261|NCT03305016|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5970262|NCT03305016|Sustained Release Growth Hormone|sustained release growth hormone
5970263|NCT03305016|Growth Hormone Deficiency|growth hormone deficiency
5970264|NCT03305016|TransCon GH|transcon gh
5970265|NCT03304704|Assays|assays
5970266|NCT03304704|Direct Skin Feeds|direct skin feeds
5970267|NCT03304704|Infection|infection
5970268|NCT03304704|Parasite|parasite
5970269|NCT03304704|Gametocyte|gametocyte
5970270|NCT03304691|Malaria|malaria
5970271|NCT03304691|Parasitemia|parasitemia
5970272|NCT03304691|Anemia|anemia
5970273|NCT03304691|Ligand|ligand
5970274|NCT03304691|Anopheles gambiae|anopheles gambiae
5970275|NCT03304392|anxiety|anxiety
5970276|NCT03304392|depression|depression
5970277|NCT03304392|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5970278|NCT03304392|randomized controlled trial|randomized controlled trial
5970279|NCT03304392|patient-centered|patient-centered
5970280|NCT03304392|knowledge implementation|knowledge implementation
5970281|NCT03304392|mental health system|mental health system
5970282|NCT03304392|therapist-assistance|therapist-assistance
5970283|NCT03304145|Treatment Care Planning|treatment care planning
5970284|NCT03301415|Asymptomatic|asymptomatic
5970285|NCT03301415|Congenital CMV Infection|congenital cmv infection
5970286|NCT03301415|Valganciclovir Therapy|valganciclovir therapy
5970287|NCT03300648|coma|coma
5970288|NCT03300648|pediatrics|pediatrics
5970289|NCT03300284|Quality of Life|quality of life
5970290|NCT03300284|Decision Making|decision making
5970291|NCT03300284|17-382|17-382
5970292|NCT03299309|Glioma|glioma
5970293|NCT03299309|Medulloblastoma|medulloblastoma
5970294|NCT03299309|PRiME|prime
5970295|NCT03299309|Pro00079843|pro00079843
5970296|NCT03299309|Thompson|thompson
5970297|NCT03299309|Pediatric|pediatric
5970298|NCT03299309|Landi|landi
5970299|NCT03298451|Hepatocellular Carcinoma Non-Resectable|hepatocellular carcinoma non-resectable
5970300|NCT03296696|Phase 1/1b|phase 1/1b
5970301|NCT03296696|EGFRvIII-positive glioblastoma or malignant glioma|egfrviii-positive glioblastoma or malignant glioma
5970302|NCT03296696|safety and tolerability|safety and tolerability
5970303|NCT03296696|AMG 596|amg 596
5970304|NCT03296033|enoxaparin|enoxaparin
5970305|NCT03296033|thromboembolism|thromboembolism
5970306|NCT03296033|coagulation|coagulation
5970307|NCT03296033|factor Xa|factor xa
5970308|NCT03294460|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5970309|NCT03294460|Alcohol Use|alcohol use
5970310|NCT03294460|Polymorphism, Genetic|polymorphism, genetic
5970311|NCT03294460|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5970312|NCT03292913|HIV|hiv
5970313|NCT03292484|AR101|ar101
5970314|NCT03292484|Characterized Peanut Allergen|characterized peanut allergen
5970315|NCT03292484|OIT (oral immunotherapy)|oit (oral immunotherapy)
5970316|NCT03292484|Peanut Allergy|peanut allergy
5970317|NCT03292484|Allergy|allergy
5970318|NCT03292484|Peanut-Allergic Children|peanut-allergic children
5970319|NCT03292484|Peanut-Allergic Adults|peanut-allergic adults
5970320|NCT03292484|Desensitization|desensitization
5970321|NCT03292484|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5970322|NCT03292458|spasmodic dysphonia|spasmodic dysphonia
5970323|NCT03292458|laryngeal dystonia|laryngeal dystonia
5970324|NCT03292458|functional MRI|functional mri
5970325|NCT03292458|Xyrem|xyrem
5970326|NCT03291808|Obesity|obesity
5970327|NCT03291808|Asthma|asthma
5970328|NCT03291808|Weight loss|weight loss
5970329|NCT03290950|Daratumumab|daratumumab
5970330|NCT03290950|Carfilzomib|carfilzomib
5970331|NCT03290950|Lenalidomide|lenalidomide
5970332|NCT03290950|Dexamethasone|dexamethasone
5970333|NCT03290950|17-352|17-352
5970334|NCT03290287|COPD|copd
5970335|NCT03290079|metastatic progressive high-grade neuroendocrine|metastatic progressive high-grade neuroendocrine
5970336|NCT03290079|progressive high-grade neuroendocrine|progressive high-grade neuroendocrine
5970337|NCT03290079|high grade neuroendocrine|high grade neuroendocrine
5970338|NCT03290079|carcinoma originating outside of the lung|carcinoma originating outside of the lung
5970339|NCT03290079|poorly differentiated neuroendocrine|poorly differentiated neuroendocrine
5970340|NCT03289962|Cancer vaccine|cancer vaccine
5970341|NCT03289962|Neoantigen|neoantigen
5970342|NCT03289962|Personalized|personalized
5970343|NCT03289962|Atezolizumab|atezolizumab
5970344|NCT03289962|Vaccine|vaccine
5970345|NCT03289962|Immunotherapy|immunotherapy
5970346|NCT03289962|Anti-PDL1|anti-pdl1
5970347|NCT03289962|Checkpoint Inhibitor|checkpoint inhibitor
5970348|NCT03289962|Personalized vaccine|personalized vaccine
5970349|NCT03289923|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5970350|NCT03289923|Major Depressive Disorder|major depressive disorder
5970351|NCT03289923|Cognitive Therapy|cognitive therapy
5970352|NCT03288389|Membrane Lipid Replacement|membrane lipid replacement
5970353|NCT03288389|NTFactor Lipids|ntfactor lipids
5970354|NCT03288389|Fibromyalgia|fibromyalgia
5970355|NCT03288389|Pain|pain
5970356|NCT03288389|Fatigue|fatigue
5970357|NCT03288389|Gastrointestinal symptoms|gastrointestinal symptoms
5970358|NCT03288246|adolescent|adolescent
5970359|NCT03288246|HIV|hiv
5970360|NCT03288246|point-of-care|point-of-care
5970361|NCT03288246|viral load|viral load
5970362|NCT03288220|Stroke|stroke
5970363|NCT03287960|LEPR deficiency obesity|lepr deficiency obesity
5970364|NCT03287960|setmelanotide|setmelanotide
5970365|NCT03287960|RM-493|rm-493
5970366|NCT03287960|Leptin receptor|leptin receptor
5970367|NCT03287960|Obesity|obesity
5970368|NCT03287960|Melanocortin 4 receptor|melanocortin 4 receptor
5970369|NCT03287817|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5970370|NCT03287817|Relapsed Diffuse Large B Cell Lymphoma|relapsed diffuse large b cell lymphoma
5970371|NCT03287817|Refractory Diffuse Large B Cell Lymphoma|refractory diffuse large b cell lymphoma
5970372|NCT03287817|AUTO3|auto3
5970373|NCT03287817|PD-1|pd-1
5970374|NCT03287817|Anti PD-1 antibody|anti pd-1 antibody
5970375|NCT03287778|Pyridoxine|pyridoxine
5970376|NCT03287778|Vitamin B6|vitamin b6
5970377|NCT03287778|Neurologic Manifestations|neurologic manifestations
5970378|NCT03287778|Involuntary Movements|involuntary movements
5970379|NCT03287778|Movement Disorder|movement disorder
5970380|NCT03287778|Dyskinesias|dyskinesias
5970381|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs
5970382|NCT03287778|Psychotic Disorders|psychotic disorders
5970383|NCT03287778|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
5970384|NCT03287778|Signs and Symptoms|signs and symptoms
5970385|NCT03287336|tranexamic acid|tranexamic acid
5970386|NCT03287336|postpartum hemorrhage|postpartum hemorrhage
5970387|NCT03286231|gluteal venous vasculature|gluteal venous vasculature
5970388|NCT03286231|prone position|prone position
5970389|NCT03286231|jackknife position|jackknife position
5970390|NCT03284840|dietary intake|dietary intake
5970391|NCT03284840|nutritional status|nutritional status
5970392|NCT03284840|micronutrients|micronutrients
5970393|NCT03284840|thyroid health|thyroid health
5970394|NCT03284268|Gene therapy|gene therapy
5970395|NCT03283670|Depression|depression
5970396|NCT03283670|treatment-resistant|treatment-resistant
5970397|NCT03282318|Bladder Pain Syndrome|bladder pain syndrome
5970398|NCT03282318|Interstitial Cystitis|interstitial cystitis
5970399|NCT03282318|ASP6294|asp6294
5970400|NCT03281824|HER2 Positive Breast Cancer|her2 positive breast cancer
5970401|NCT03281824|ALT-P7|alt-p7
5970402|NCT03281824|Antibody-Drug Conjugate|antibody-drug conjugate
5970403|NCT03281538|CR845|cr845
5970404|NCT03281538|difelikefalin|difelikefalin
5970405|NCT03281538|Pruritus|pruritus
5970406|NCT03281538|Chronic Itch|chronic itch
5970407|NCT03281538|Itch|itch
5970408|NCT03281538|Itching|itching
5970409|NCT03281538|hemodialysis|hemodialysis
5970410|NCT03281538|Uremic Pruritus|uremic pruritus
5970411|NCT03281538|Dialysis|dialysis
5970412|NCT03281538|CKD|ckd
5970413|NCT03281538|CKD-associated pruritus|ckd-associated pruritus
5970414|NCT03281538|CKD-aP|ckd-ap
5970415|NCT03281538|ESRD (end stage renal disease)|esrd (end stage renal disease)
5970416|NCT03281538|Chronic Kidney Disease|chronic kidney disease
5970417|NCT03281538|Kidney failure, chronic|kidney failure, chronic
5970418|NCT03281538|Kidney dysfunction|kidney dysfunction
5970419|NCT03281538|Generalized pruritus|generalized pruritus
5970420|NCT03278912|Inflammatory Bowel Disease|inflammatory bowel disease
5970421|NCT03278912|Chronic Granulomatous Disease|chronic granulomatous disease
5970422|NCT03278912|Dysbiosis|dysbiosis
5970423|NCT03278912|Microbiome|microbiome
5970424|NCT03278912|Immunodeficiency|immunodeficiency
5970425|NCT03272893|psychoneuroimmunology|psychoneuroimmunology
5970426|NCT03271580|Wound healing|wound healing
5970427|NCT03271580|Diabetes|diabetes
5970428|NCT03271580|Inflammatory cells|inflammatory cells
5970429|NCT03271580|Macrophage|macrophage
5970430|NCT03270995|breast cancer|breast cancer
5970431|NCT03270995|gynecological cancer|gynecological cancer
5970432|NCT03270995|fear of cancer recurrence|fear of cancer recurrence
5970433|NCT03270995|clinical trial|clinical trial
5970434|NCT03270995|randomized controlled trial|randomized controlled trial
5970435|NCT03270995|group therapy|group therapy
5970436|NCT03270995|intervention|intervention
5970437|NCT03270995|cognitive-existential|cognitive-existential
5970438|NCT03270917|Parenchymal preserving|parenchymal preserving
5970439|NCT03270917|Postero-superior|postero-superior
5970440|NCT03270917|Laparoscopy|laparoscopy
5970441|NCT03270917|Hepatectomy|hepatectomy
5970442|NCT03268148|neonates|neonates
5970443|NCT03268148|pain|pain
5970444|NCT03268148|low level laser|low level laser
5970445|NCT03266185|paclitaxel-containing chemotherapy|paclitaxel-containing chemotherapy
5970446|NCT03266055|Blueberry|blueberry
5970447|NCT03266055|Diet|diet
5970448|NCT03265652|Intense Pulsed Light|intense pulsed light
5970449|NCT03265652|Meibomian Gland Dysfunction|meibomian gland dysfunction
5970450|NCT03265652|Dry Eye Disease|dry eye disease
5970451|NCT03265288|Inflammation|inflammation
5970452|NCT03265288|Essential Fatty Acids|essential fatty acids
5970453|NCT03265288|Inflammation resolution|inflammation resolution
5970454|NCT03265288|Docosahexaenoic acid|docosahexaenoic acid
5970455|NCT03265288|Lung function|lung function
5970456|NCT03265210|Middle-aged and Older Adults|middle-aged and older adults
5970457|NCT03265210|Primary Care|primary care
5970458|NCT03264924|physical activity|physical activity
5970459|NCT03264924|motivation|motivation
5970460|NCT03264924|behaviour change|behaviour change
5970461|NCT03263780|Diagnostic imaging|diagnostic imaging
5970462|NCT03263780|High-Intensity Focused Ultrasound|high-intensity focused ultrasound
5970463|NCT03263780|HIFU|hifu
5970464|NCT03263780|18F-Fluciclovine|18f-fluciclovine
5970465|NCT03263780|high resolution diffusion-weighted imaging|high resolution diffusion-weighted imaging
5970466|NCT03263715|Polymyalgia Rheumatica|polymyalgia rheumatica
5970467|NCT03263715|Tocilizumab|tocilizumab
5970468|NCT03263715|Glucocorticoid|glucocorticoid
5970469|NCT03263715|Glucocorticoid-Sparing|glucocorticoid-sparing
5970470|NCT03263611|disc degeneration|disc degeneration
5970471|NCT03263611|Intervertebral disc|intervertebral disc
5970472|NCT03263611|discogenic pain|discogenic pain
5970473|NCT03263611|chronic discogenic lumbar back pain|chronic discogenic lumbar back pain
5970474|NCT03263598|liver cirrhosis|liver cirrhosis
5970475|NCT03263598|ascites|ascites
5970476|NCT03262688|INL-001|inl-001
5970477|NCT03262688|Bupivacaine|bupivacaine
5970478|NCT03262688|Collagen|collagen
5970479|NCT03262688|Children|children
5970480|NCT03262688|Pediatric|pediatric
5970481|NCT03262688|Inguinal hernia|inguinal hernia
5970482|NCT03261700|women Veterans|women veterans
5970483|NCT03261700|interpersonal violence|interpersonal violence
5970484|NCT03261076|Specific Learning Disorder|specific learning disorder
5970485|NCT03261076|Learning Disorders|learning disorders
5970486|NCT03261076|Neurodevelopmental Disorders|neurodevelopmental disorders
5970487|NCT03261076|Mental Disorders|mental disorders
5970488|NCT03261076|Developmental Reading Disability|developmental reading disability
5970489|NCT03261076|Reading Disorder|reading disorder
5970490|NCT03261076|Conduct Disorder|conduct disorder
5970491|NCT03260920|oxytocin|oxytocin
5970492|NCT03260920|frontotemporal dementia|frontotemporal dementia
5970493|NCT03260920|apathy|apathy
5970494|NCT03260920|empathy|empathy
5970495|NCT03260491|Oncology|oncology
5970496|NCT03260491|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5970497|NCT03260491|Inoperable Non-small Cell Lung Cancer|inoperable non-small cell lung cancer
5970498|NCT03260491|Metastatic|metastatic
5271186|NCT02324296|cisplatin|cisplatin
5970499|NCT03260491|Unresectable|unresectable
5970500|NCT03260491|Epidermal growth factor receptor|epidermal growth factor receptor
5970501|NCT03260491|EGFR|egfr
5970502|NCT03260387|pediatric|pediatric
5970503|NCT03260387|total pancreatectomy|total pancreatectomy
5970504|NCT03260387|acute pancreatitis|acute pancreatitis
5970505|NCT03260387|chronic pancreatitis|chronic pancreatitis
5970506|NCT03260387|islet transplant|islet transplant
5970507|NCT03260387|islet autotransplant|islet autotransplant
5970509|NCT03260322|Oncology|oncology
5970510|NCT03260322|Tumors|tumors
5970511|NCT03260322|ASP8374|asp8374
5970512|NCT03260322|Locally advanced or metastatic solid tumor malignancies|locally advanced or metastatic solid tumor malignancies
5970513|NCT03260140|weight loss|weight loss
5970514|NCT03260140|lifestyle|lifestyle
5970515|NCT03260140|diet|diet
5970516|NCT03260140|exercise|exercise
5970517|NCT03260140|randomized controlled trial|randomized controlled trial
5970518|NCT03259685|Non-nutritive sweeteners|non-nutritive sweeteners
5970519|NCT03259685|High Sugar Sweetened Beverages|high sugar sweetened beverages
5970520|NCT03259685|Diet|diet
5970521|NCT03258606|Surrogate|surrogate
5970522|NCT03258606|Decision Making|decision making
5970523|NCT03258606|Capacity to Consent|capacity to consent
5970524|NCT03258606|Cognitive Impairment|cognitive impairment
5970525|NCT03258606|Enrollment|enrollment
5970526|NCT03258580|Pain|pain
5970527|NCT03258580|Visual Analogue Pain Scale|visual analogue pain scale
5970528|NCT03258580|Healthy Volunteer|healthy volunteer
5970529|NCT03258580|EYE TRACKING|eye tracking
5970530|NCT03258580|Eye Movement|eye movement
5970531|NCT03258567|Monoclonal Antibody|monoclonal antibody
5970532|NCT03258515|Mesenchymal epithelial transition (MET) receptor|mesenchymal epithelial transition (met) receptor
5970533|NCT03258515|Small molecule kinase inhibitors|small molecule kinase inhibitors
5970534|NCT03258515|Moxifloxacin (Avelox)|moxifloxacin (avelox)
5970535|NCT03258515|QT prolongation|qt prolongation
5970536|NCT03256578|Resuscitation|resuscitation
5970537|NCT03256578|Neonatal Prematurity|neonatal prematurity
5970538|NCT03256578|Positive-Pressure Ventilation|positive-pressure ventilation
5970539|NCT03256578|Respiratory Function Monitor|respiratory function monitor
5970540|NCT03256227|Posttraumatic Stress Disorder|posttraumatic stress disorder
5970541|NCT03256227|family therapy|family therapy
5970542|NCT03256227|patient adherence|patient adherence
5970543|NCT03256227|Prolonged Exposure Therapy|prolonged exposure therapy
5970544|NCT03254212|Heart failure|heart failure
5970545|NCT03254212|Central sleep apnea|central sleep apnea
5970546|NCT03254212|oxygen therapy|oxygen therapy
5970547|NCT03253718|Healthy Volunteers|healthy volunteers
5970548|NCT03252522|ADHD|adhd
5970549|NCT03252522|ODD|odd
5970550|NCT03252522|DMDD|dmdd
5970551|NCT03252522|Inattention|inattention
5970552|NCT03252522|Impulsivity|impulsivity
5970553|NCT03252522|Irritability|irritability
5970554|NCT03252522|Anger|anger
5970555|NCT03252522|Micronutrients|micronutrients
5970556|NCT03252522|Emotional Dysregulation|emotional dysregulation
5970557|NCT03250663|topical therapy, atopic dermatitis,|topical therapy, atopic dermatitis,
5970558|NCT03246867|isolytic stretching|isolytic stretching
5970559|NCT03246867|static stretching|static stretching
5970560|NCT03246867|Glenohumeral Internal Rotation Deficit|glenohumeral internal rotation deficit
5970561|NCT03242421|test-retest reliability|test-retest reliability
5970562|NCT03242421|Binocular vision tests|binocular vision tests
5970563|NCT03240692|Major Depressive Disorder|major depressive disorder
5970564|NCT03240692|Treatment-Resistant Depression|treatment-resistant depression
5970565|NCT03240692|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5970566|NCT03240692|Theta-Burst Stimulation|theta-burst stimulation
5970567|NCT03240536|Rheumatology Referral|rheumatology referral
5970568|NCT03240536|Choosing Wisely|choosing wisely
5970569|NCT03240328|CAR-T HIV therapy|car-t hiv therapy
5970570|NCT03240328|immunotherapy|immunotherapy
5970571|NCT03240328|function cure|function cure
5970572|NCT03239639|Substitute decision makers of patient|substitute decision makers of patient
5970573|NCT03238911|Iron Deficiency Anaemia|iron deficiency anaemia
5970574|NCT03238911|Iron Deficiency Anemia|iron deficiency anemia
5970575|NCT03238911|IDA|ida
5970576|NCT03238911|Intravenous iron replacement therapy|intravenous iron replacement therapy
5970577|NCT03238911|Iron deficiency|iron deficiency
5970578|NCT03238911|Iron isomaltoside|iron isomaltoside
5970579|NCT03238911|Ferric derisomaltose|ferric derisomaltose
5970580|NCT03238911|Monofer|monofer
5970581|NCT03238911|Monoferric|monoferric
5970582|NCT03238911|Monover|monover
5970583|NCT03238911|Monofar|monofar
5970584|NCT03238911|Monoferro|monoferro
5970585|NCT03238911|Hypophosphatemia|hypophosphatemia
5970586|NCT03238911|Ferric carboxymaltose|ferric carboxymaltose
5970587|NCT03238586|hiv|hiv
5970588|NCT03238586|aids|aids
5970589|NCT03238586|alcohol|alcohol
5970590|NCT03238586|health|health
5970591|NCT03238586|knowledge|knowledge
5970592|NCT03238586|motivation|motivation
5970593|NCT03238586|skills|skills
5970594|NCT03238586|behavior|behavior
5970595|NCT03237182|whole genome sequencing;|whole genome sequencing;
5970596|NCT03237065|Iron Deficiency Anaemia|iron deficiency anaemia
5970597|NCT03237065|Iron Deficiency Anemia|iron deficiency anemia
5970598|NCT03237065|IDA|ida
5970599|NCT03237065|Iron deficiency|iron deficiency
5970600|NCT03237065|Intravenous iron replacement therapy|intravenous iron replacement therapy
5970601|NCT03237065|Iron isomaltoside|iron isomaltoside
5970602|NCT03237065|Ferric derisomaltose|ferric derisomaltose
5970603|NCT03237065|Hypophosphatemia|hypophosphatemia
5970604|NCT03237065|Ferric carboxymaltose|ferric carboxymaltose
5970605|NCT03237065|Monofer|monofer
5970606|NCT03237065|Monoferric|monoferric
5970607|NCT03237065|Monover|monover
5970608|NCT03237065|Monofar|monofar
5970609|NCT03237065|Monoferro|monoferro
5970610|NCT03235674|Cardiac rehabilitation|cardiac rehabilitation
5970611|NCT03235674|interval exercise|interval exercise
5970612|NCT03235388|Trauma|trauma
5970613|NCT03235388|Injury|injury
5970614|NCT03235388|Audit filter|audit filter
5970615|NCT03235388|Quality improvement|quality improvement
5970616|NCT03235388|India|india
5970617|NCT03235245|cutaneous melanoma|cutaneous melanoma
5970618|NCT03235245|mucosal melanoma|mucosal melanoma
5970619|NCT03235245|BRAF mutation|braf mutation
5970620|NCT03229473|Balance|balance
5970621|NCT03229473|Falls|falls
5970622|NCT03229473|Screening|screening
5970623|NCT03229473|COPD|copd
5970624|NCT03229213|cystic fibrosis|cystic fibrosis
5970625|NCT03229213|video games|video games
5970626|NCT03229213|exercise|exercise
5970627|NCT03229213|maximal oxygen consumption|maximal oxygen consumption
5970628|NCT03228667|Pembrolizumab|pembrolizumab
5970629|NCT03228667|Nivolumab|nivolumab
5970630|NCT03228667|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5970631|NCT03228667|Immunotherapy|immunotherapy
5970632|NCT03228667|Interleukin-15|interleukin-15
5970633|NCT03228667|PD-1 Checkpoint Inhibitor|pd-1 checkpoint inhibitor
5970634|NCT03228667|ALT-803|alt-803
5970635|NCT03228667|Atezolizumab|atezolizumab
5970636|NCT03228667|Avelumab|avelumab
5970637|NCT03228667|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5970638|NCT03228667|Urothelial Carcinoma|urothelial carcinoma
5970639|NCT03228667|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5970640|NCT03228667|Merkel Cell Carcinoma (MCC)|merkel cell carcinoma (mcc)
5970641|NCT03228667|Melanoma|melanoma
5970642|NCT03228667|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
5970643|NCT03228667|Gastric Cancer|gastric cancer
5970644|NCT03228667|Cervical Cancer|cervical cancer
5970645|NCT03228667|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5970646|NCT03228667|Microsatellite Instability-High (MSI-H)|microsatellite instability-high (msi-h)
5970647|NCT03228667|PD-L1 Checkpoint Inhibitor|pd-l1 checkpoint inhibitor
5970648|NCT03228667|Mismatch Repair Deficient (dMMR) Solid Tumor Cancer|mismatch repair deficient (dmmr) solid tumor cancer
5970649|NCT03228667|Colorectal Cancer (CRC)|colorectal cancer (crc)
5970650|NCT03228134|treatment； bronchial asthma|treatment； bronchial asthma
5970651|NCT03227796|osteoarthritis|osteoarthritis
5970652|NCT03227796|knee|knee
5970653|NCT03227796|healthy|healthy
5970654|NCT03227796|volunteer|volunteer
5970655|NCT03227796|LEVI-04|levi-04
5970656|NCT03227276|Litramine|litramine
5970657|NCT03227276|Opuntia ficus-indica|opuntia ficus-indica
5970658|NCT03227276|weight loss|weight loss
5970659|NCT03226392|QAW039, uncontrolled asthma|qaw039, uncontrolled asthma
5970660|NCT03225196|Extracellular RNA|extracellular rna
5970661|NCT03225196|MicroRNA|microrna
5970662|NCT03225170|Decision-Making|decision-making
5970663|NCT03225170|BRCA1|brca1
5970664|NCT03225170|BRCA2|brca2
5970665|NCT03225170|Generic Counseling|generic counseling
5970666|NCT03225170|HBOC|hboc
5970667|NCT03225105|Solid Tumors|solid tumors
5970668|NCT03225105|M3541|m3541
5970669|NCT03225105|Palliative radiotherapy|palliative radiotherapy
5970670|NCT03225105|Adenosine triphosphate-competitive inhibitor|adenosine triphosphate-competitive inhibitor
5970671|NCT03224091|Eating disorders|eating disorders
5970672|NCT03224091|psychopathology|psychopathology
5970673|NCT03224091|pathophysiology|pathophysiology
5970674|NCT03224091|prospective|prospective
5970675|NCT03224091|longitudinal|longitudinal
5970676|NCT03223012|Adalimumab|adalimumab
5970677|NCT03223012|Humira®|humira®
5970678|NCT03223012|AbbVie patient care support program|abbvie patient care support program
5970679|NCT03223012|Psoriasis|psoriasis
5970680|NCT03223012|Axial Spondyloarthritis|axial spondyloarthritis
5970681|NCT03223012|Rheumatoid Arthritis|rheumatoid arthritis
5970682|NCT03223012|Ulcerative Colitis|ulcerative colitis
5970683|NCT03222609|Post-polycythemia vera MF (PPV-MF)|post-polycythemia vera mf (ppv-mf)
5970684|NCT03222609|Post-essential thrombocythemia (PET-MF)|post-essential thrombocythemia (pet-mf)
5970685|NCT03222609|ruxolitinib|ruxolitinib
5970686|NCT03222609|navitoclax|navitoclax
5970687|NCT03222609|splenic volume|splenic volume
5970688|NCT03222609|Primary Myelofibrosis|primary myelofibrosis
5970689|NCT03222609|Jakafi|jakafi
5970690|NCT03222609|enlarged spleen|enlarged spleen
5970691|NCT03222609|splenomegaly|splenomegaly
5970692|NCT03222609|ABT 263|abt 263
5970693|NCT03222609|bone marrow fibrosis|bone marrow fibrosis
5970694|NCT03222349|interictal state|interictal state
5970695|NCT03222349|ictal/peri-ictal state|ictal/peri-ictal state
5970696|NCT03221426|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5970697|NCT03221426|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5970698|NCT03220451|pressure ulcer|pressure ulcer
5970699|NCT03220451|pressure sore|pressure sore
5970700|NCT03220451|decubitus ulcer|decubitus ulcer
5970701|NCT03220451|spinal cord injury|spinal cord injury
5970702|NCT03220451|adhesive elastic bandage|adhesive elastic bandage
5970703|NCT03220451|taping|taping
5970704|NCT03220451|kinesio taping|kinesio taping
5970705|NCT03220451|neuro taping|neuro taping
5970706|NCT03220347|Non-Hodgkin's Lymphomas|non-hodgkin's lymphomas
5970707|NCT03220347|Safety|safety
5970708|NCT03220347|Efficacy|efficacy
5970709|NCT03220347|CC-90010|cc-90010
5970710|NCT03220347|Solid Tumors|solid tumors
5970711|NCT03220347|Relapsed/Refractory|relapsed/refractory
5970712|NCT03219333|Enfortumab vedotin|enfortumab vedotin
5970713|NCT03219333|Metastatic Urothelial Cancer|metastatic urothelial cancer
5970714|NCT03219333|ASG-22CE|asg-22ce
5970715|NCT03219333|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
5970716|NCT03219333|Antibody-Drug Conjugate|antibody-drug conjugate
5970717|NCT03219333|Nectin-4|nectin-4
5970718|NCT03219333|Platinum-naïve|platinum-naïve
5970719|NCT03219333|Cisplatin-ineligible|cisplatin-ineligible
5970720|NCT03219333|Antineoplastic Agents|antineoplastic agents
5970721|NCT03219333|Drug Therapy|drug therapy
5970722|NCT03219333|ASG-22ME|asg-22me
5970723|NCT03218644|Proprioception|proprioception
5970724|NCT03217669|epacadostat|epacadostat
5970725|NCT03217669|sirolimus|sirolimus
5970726|NCT03217422|Type 1, Type 2, autoimmune hepatitis, AIH,|type 1, type 2, autoimmune hepatitis, aih,
5970727|NCT03215303|Asthma|asthma
5970728|NCT03215303|Continuous positive airway pressure|continuous positive airway pressure
5970729|NCT03215303|Oxygen consumption|oxygen consumption
5970730|NCT03213873|Balance control|balance control
5970731|NCT03213873|Exercise|exercise
5970732|NCT03213873|Magnetic Resonance Imaging|magnetic resonance imaging
5970733|NCT03213873|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5970734|NCT03213418|tobacco|tobacco
5970735|NCT03213418|smoking|smoking
5970736|NCT03213418|Tobacco Use|tobacco use
5970737|NCT03213418|Tobacco Dependence|tobacco dependence
5970738|NCT03213418|Smoking, Tobacco|smoking, tobacco
5970739|NCT03213418|Cigarette Smoking|cigarette smoking
5970740|NCT03213418|Cigarette|cigarette
5970741|NCT03213418|Nicotine|nicotine
5970742|NCT03208387|17-338|17-338
5970743|NCT03208387|Cognitive function|cognitive function
5970744|NCT03208387|Behavioral function|behavioral function
5970745|NCT03207672|E7389 liposomal formulation|e7389 liposomal formulation
5970746|NCT03207672|dose escalation|dose escalation
5970747|NCT03207672|maximum tolerated dose|maximum tolerated dose
5970748|NCT03207672|pharmacokinetics|pharmacokinetics
5970749|NCT03207477|Infant|infant
5970750|NCT03207477|Prematurely born|prematurely born
5970751|NCT03207477|maturation|maturation
5970752|NCT03206541|Neurological syndromes|neurological syndromes
5970753|NCT03206541|Arbovirus infection|arbovirus infection
5970763|NCT03204318|Pain|pain
5970764|NCT03204318|Dysmenorrhea|dysmenorrhea
5970765|NCT03201900|perampanel|perampanel
5970766|NCT03200613|Spinal cord injury|spinal cord injury
5970767|NCT03200613|Venous thromboembolism|venous thromboembolism
5970768|NCT03200613|Hemorrhage|hemorrhage
5970769|NCT03197623|Glucocorticoids|glucocorticoids
5970770|NCT03196895|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5970771|NCT03196895|Continuous Glucose Monitoring|continuous glucose monitoring
5970772|NCT03196895|Lifestyle Modification|lifestyle modification
5970773|NCT03196258|fracture|fracture
5970774|NCT03196258|persistent pain|persistent pain
5970775|NCT03196258|cognitive behavioural therapy|cognitive behavioural therapy
5970776|NCT03196258|post surgical pain|post surgical pain
5970777|NCT03196258|health-related quality of life|health-related quality of life
5970778|NCT03196024|Diabetes; CVD; Lifestyle; Hispanic; Promotora|diabetes; cvd; lifestyle; hispanic; promotora
5970779|NCT03196024|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5970780|NCT03196024|Cardiovascular Diseases|cardiovascular diseases
5970781|NCT03196024|Risk Reduction Behavior|risk reduction behavior
5970782|NCT03196024|Hispanic Americans; Latinos|hispanic americans; latinos
5970783|NCT03196024|Community Health Workers|community health workers
5970784|NCT03195699|STAT3, cancer, inhibitor, advanced cancer|stat3, cancer, inhibitor, advanced cancer
5970785|NCT03194646|Uterine Fibroid|uterine fibroid
5970786|NCT03194542|Luspatercept|luspatercept
5970787|NCT03194542|ACE-536|ace-536
5970788|NCT03194542|Myeloproliferative Neoplasm-Associated Myelofibrosis|myeloproliferative neoplasm-associated myelofibrosis
5970789|NCT03194542|Primary Myelofibrosis|primary myelofibrosis
5970790|NCT03194542|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5970791|NCT03194542|Post-Essential Thrombocythemia|post-essential thrombocythemia
5970792|NCT03194542|Anemia|anemia
5970793|NCT03194542|Red Blood Cell (RBC) Transfusion|red blood cell (rbc) transfusion
5970794|NCT03194542|Ruxolitinib|ruxolitinib
5970795|NCT03192722|Filters|filters
5970796|NCT03192722|Illumination|illumination
5970797|NCT03192722|Low vision|low vision
5970798|NCT03192722|Reading|reading
5970799|NCT03191864|Esophagitis|esophagitis
5970800|NCT03191864|Eosinophilic Esophagitis|eosinophilic esophagitis
5970801|NCT03191864|Fluticasone|fluticasone
5970802|NCT03191864|Dysphagia|dysphagia
5970803|NCT03191864|Safety|safety
5970804|NCT03191864|Efficacy|efficacy
5970805|NCT03191864|Pharmacokinetics|pharmacokinetics
5970806|NCT03191864|Esophageal Diseases|esophageal diseases
5970807|NCT03191864|Gastrointestinal Diseases|gastrointestinal diseases
5970808|NCT03191864|Digestive System Diseases|digestive system diseases
5970809|NCT03191864|Glucocorticoids|glucocorticoids
5970810|NCT03191864|Orally Disintegrating Tablet|orally disintegrating tablet
5970811|NCT03190928|Disease Monitoring|disease monitoring
5970812|NCT03190928|Molecular Monitoring|molecular monitoring
5970813|NCT03190928|Novel Biomarker Identification|novel biomarker identification
5970814|NCT03190928|Gene Expression Analyses|gene expression analyses
5970815|NCT03190928|Watchful-Waiting|watchful-waiting
5970816|NCT03188419|Prospective Donors|prospective donors
5970817|NCT03188419|Immunodeficiency|immunodeficiency
5970818|NCT03186703|Cancer prevention|cancer prevention
5970819|NCT03186703|Knowledge translation|knowledge translation
5970820|NCT03186703|Physical activity|physical activity
5970821|NCT03186703|Diet|diet
5970822|NCT03186703|Alcohol|alcohol
5970823|NCT03186703|Smoking|smoking
5970824|NCT03185546|smoking|smoking
5970825|NCT03185546|vaping|vaping
5970826|NCT03184792|Spinal electrical stimulation|spinal electrical stimulation
5970827|NCT03183817|Person-centred care|person-centred care
5970828|NCT03183479|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5970829|NCT03183479|fibrinogen concentrate|fibrinogen concentrate
5970830|NCT03183479|perioperative blood loss|perioperative blood loss
5970831|NCT03183479|transfusion|transfusion
5970832|NCT03181230|Turner syndrome|turner syndrome
5970833|NCT03181230|45,XO|45,xo
5970834|NCT03181230|body composition|body composition
5970835|NCT03181230|cardiometabolism|cardiometabolism
5970836|NCT03181230|quality of life|quality of life
5970837|NCT03181230|fitness|fitness
5970838|NCT03181087|Mesenchymal Stem Cells|mesenchymal stem cells
5970839|NCT03181087|Cesarean Section|cesarean section
5970840|NCT03181087|Uterine Scar|uterine scar
5970841|NCT03180554|chronic widespread pain|chronic widespread pain
5970842|NCT03180554|heart rate variability|heart rate variability
5970843|NCT03180554|pain intensity|pain intensity
5970844|NCT03180554|diaphragmatic breathing|diaphragmatic breathing
5970845|NCT03180554|vagus nerve stimulation|vagus nerve stimulation
5970846|NCT03180554|fibromyalgia|fibromyalgia
5970847|NCT03179319|PrEP|prep
5970848|NCT03179319|HIV testing|hiv testing
5970849|NCT03179319|Sexually transmitted disease (STD) testing|sexually transmitted disease (std) testing
5970850|NCT03179319|Mobile app|mobile app
5970851|NCT03179319|Young men who have sex with men|young men who have sex with men
5970852|NCT03179319|Technology|technology
5970853|NCT03178799|Fractures|fractures
5970854|NCT03178799|Osteoporosis|osteoporosis
5970855|NCT03178799|Care management|care management
5970856|NCT03178799|cost-effeciveness|cost-effeciveness
5970857|NCT03178799|Randomized controlled trial|randomized controlled trial
5970858|NCT03178279|physical health|physical health
5970859|NCT03177616|Migraine|migraine
5970860|NCT03177616|Women|women
5970861|NCT03177616|Adult|adult
5970862|NCT03177616|Feasibility|feasibility
5970863|NCT03177616|Safety|safety
5947481|NCT03904693|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5947482|NCT03904693|PAH|pah
5947483|NCT03904693|macitentan|macitentan
5970864|NCT03177616|Pilot Randomized Trial|pilot randomized trial
5970865|NCT03177616|Randomized Control Trial|randomized control trial
5970866|NCT03177616|Chiropractic|chiropractic
5970867|NCT03173963|Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor|sodium glucose co-transporter 2 (sglt2) inhibitor
5970868|NCT03173963|Kidney Biopsy|kidney biopsy
5970869|NCT03173963|Morphometry|morphometry
5970870|NCT03173963|American Indians|american indians
5970871|NCT03173963|Glomerular Filtration Rate|glomerular filtration rate
5970872|NCT03171480|Preeclampsia|preeclampsia
5970873|NCT03171480|Induction|induction
5970874|NCT03170960|Kidney|kidney
5970875|NCT03170960|Bladder|bladder
5970876|NCT03170960|Renal pelvis|renal pelvis
5970877|NCT03170960|Ureter|ureter
5970878|NCT03170960|Urethra|urethra
5970879|NCT03170960|Cancer|cancer
5970880|NCT03170960|Prostate|prostate
5970881|NCT03170960|Castration-resistant|castration-resistant
5970882|NCT03170960|Lung|lung
5970883|NCT03170960|Breast|breast
5970884|NCT03170960|Ovarian|ovarian
5970885|NCT03170960|Endometrial|endometrial
5970886|NCT03170960|Liver|liver
5970887|NCT03170960|Stomach|stomach
5970888|NCT03170557|Persistent pain|persistent pain
5970889|NCT03170557|Spinal cord injury|spinal cord injury
5970890|NCT03170557|Acupuncture|acupuncture
5970891|NCT03170557|Randomized Controlled Trial|randomized controlled trial
5970892|NCT03170557|RCT|rct
5970893|NCT03168893|deep brain stimulation|deep brain stimulation
5970894|NCT03168061|advanced solid tumor|advanced solid tumor
5970895|NCT03168061|unresectable soft tissue sarcoma|unresectable soft tissue sarcoma
5970896|NCT03168009|BAT|bat
5970897|NCT03168009|Bariatric Surgery|bariatric surgery
5970898|NCT03168009|Energy Metabolism|energy metabolism
5970899|NCT03167905|Anesthesia, Obstetrical|anesthesia, obstetrical
5970900|NCT03167905|Epidural anesthesia|epidural anesthesia
5970901|NCT03167905|Postnatal depression|postnatal depression
5970902|NCT03167905|Persistent pain|persistent pain
5970903|NCT03165721|Renal Cancer|renal cancer
5970904|NCT03165721|DNA Hypermethylation|dna hypermethylation
5970905|NCT03165721|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5970906|NCT03165721|DNA Methyltransferase (DNMT) Inhibitor|dna methyltransferase (dnmt) inhibitor
5970907|NCT03165721|Succinate Dehydrogenase (SDH) Deficiency|succinate dehydrogenase (sdh) deficiency
5970908|NCT03164616|NSCLC|nsclc
5970909|NCT03164616|PD-L1|pd-l1
5970910|NCT03164616|Durvalumab|durvalumab
5970911|NCT03164616|Tremelimumab|tremelimumab
5970912|NCT03164616|PFS|pfs
5970913|NCT03164616|Overall survival (OS)|overall survival (os)
5970914|NCT03164616|Tumor Mutational Burden (TMB)|tumor mutational burden (tmb)
5970915|NCT03162107|adherence|adherence
5970916|NCT03162107|HIV|hiv
5970917|NCT03162107|MDR/XDR TB|mdr/xdr tb
5970918|NCT03162107|Health Care Worker|health care worker
5970919|NCT03161483|CC-220|cc-220
5970920|NCT03161483|Safety|safety
5970921|NCT03161483|Efficacy|efficacy
5970922|NCT03161483|Active Systemic Lupus Erythematosus|active systemic lupus erythematosus
5970923|NCT03161028|multiple sclerosis|multiple sclerosis
5970924|NCT03161028|magnetic resonance imaging|magnetic resonance imaging
5970925|NCT03161028|gait|gait
5970926|NCT03161028|neuroprotective agents|neuroprotective agents
5970927|NCT03161028|thioctic acid|thioctic acid
5970928|NCT03161028|alpha-lipoic acid|alpha-lipoic acid
5970929|NCT03161028|mobility|mobility
5970930|NCT03161028|chronic progressive multiple sclerosis|chronic progressive multiple sclerosis
5970931|NCT03160846|Inotrope|inotrope
5970932|NCT03160846|Milrinone|milrinone
5970933|NCT03160846|Dopamine|dopamine
5970934|NCT03160846|Dobutamine|dobutamine
5970935|NCT03160677|Acute Stroke|acute stroke
5970936|NCT03160677|Blood Pressure|blood pressure
5970937|NCT03160677|Cerebral Hemorrhage|cerebral hemorrhage
5970938|NCT03158857|Myanmar|myanmar
5970939|NCT03158857|HIV|hiv
5970940|NCT03158389|MGMT methylation|mgmt methylation
5970941|NCT03158389|targeted therapy|targeted therapy
5970942|NCT03158389|umbrella protocol|umbrella protocol
5970943|NCT03154411|ABY-029|aby-029
5970944|NCT03154411|Affibody|affibody
5970945|NCT03154411|molecular fluorescence-guided surgery|molecular fluorescence-guided surgery
5970946|NCT03154411|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5970947|NCT03154008|reward|reward
5970948|NCT03154008|emotion regulation|emotion regulation
5970949|NCT03154008|electroencephalogram|electroencephalogram
5970950|NCT03154008|event-related potentials|event-related potentials
5970951|NCT03154008|cognitive behavior therapy|cognitive behavior therapy
5970952|NCT03153956|AposTherapy® System|apostherapy® system
5970953|NCT03153956|Osteoarthritis|osteoarthritis
5970954|NCT03153956|Total knee arthroplasties|total knee arthroplasties
5970955|NCT03153956|Degenerative joint disease|degenerative joint disease
5970956|NCT03151811|Refractory Multiple Myeloma|refractory multiple myeloma
5970957|NCT03151811|Relapsed Multiple Myeloma|relapsed multiple myeloma
5970958|NCT03151811|Melflufen|melflufen
5970959|NCT03151811|Pomalidomide|pomalidomide
5970960|NCT03151811|Dexamethasone|dexamethasone
5970961|NCT03149393|Functional Dyspepsia|functional dyspepsia
5970962|NCT03149393|Qizhi Weitong Granules|qizhi weitong granules
5970963|NCT03149393|Traditional Chinese Medicine|traditional chinese medicine
5970964|NCT03146741|Heart Failure|heart failure
5970965|NCT03145857|Gallium-68|gallium-68
5970966|NCT03145857|Positron Emission Tomography|positron emission tomography
5970967|NCT03145857|68Ga-HA-DOTATATE|68ga-ha-dotatate
5970968|NCT03145688|Behavioural|behavioural
5970969|NCT03145688|Family physical activity habit|family physical activity habit
5970970|NCT03144492|Cell Culture|cell culture
5970971|NCT03144492|Microgravity co-culture|microgravity co-culture
5970972|NCT03142152|Functional Mitral Regurgitation|functional mitral regurgitation
5970973|NCT03142152|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
5970974|NCT03142152|Percutaneous Mitral Valve Annuloplasty|percutaneous mitral valve annuloplasty
5970975|NCT03142152|Coronary Sinus Annuloplasty|coronary sinus annuloplasty
5970976|NCT03142152|Secondary Mitral Regurgitation|secondary mitral regurgitation
5970977|NCT03142152|Functional MR|functional mr
5970978|NCT03142152|FMR|fmr
5970979|NCT03139604|Acute graft-versus-host disease|acute graft-versus-host disease
5970980|NCT03139604|Janus kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5970981|NCT03139604|itacitinib|itacitinib
5970982|NCT03139604|corticosteroids|corticosteroids
5970983|NCT03139604|allogeneic hematopoietic stem cell transplant (allo-HSCT)|allogeneic hematopoietic stem cell transplant (allo-hsct)
5970984|NCT03139461|Physical Therapy|physical therapy
5970985|NCT03139461|Capacity Building|capacity building
5970986|NCT03139461|Clinical-Community Linkages|clinical-community linkages
5947613|NCT03878212|app|app
5970991|NCT03136744|Co-morbidity|co-morbidity
5970992|NCT03136744|Intervention|intervention
5970993|NCT03136653|DARPin|darpin
5970994|NCT03136653|MP0250|mp0250
5970995|NCT03136653|VEGF|vegf
5970996|NCT03136653|HGF|hgf
5970997|NCT03136653|RRMM|rrmm
5970998|NCT03136445|Tranexamic acid|tranexamic acid
5970999|NCT03136445|Platelet transfusion|platelet transfusion
5971000|NCT03136341|Upper Limb|upper limb
5971001|NCT03136341|Tremor|tremor
5971002|NCT03136341|task-dependent|task-dependent
5971003|NCT03136094|American Indian|american indian
5971004|NCT03136094|Alaska Native|alaska native
5971005|NCT03136094|Youth and Young Adult|youth and young adult
5971006|NCT03136094|SBIRT|sbirt
5971007|NCT03136029|HFrEF|hfref
5971008|NCT03136029|Exercise Intolerance|exercise intolerance
5971009|NCT03136029|Nitric Oxide|nitric oxide
5971010|NCT03134209|Monocryl|monocryl
5971011|NCT03134209|Dermabond|dermabond
5971012|NCT03134209|Polyester mesh|polyester mesh
5971013|NCT03134209|Joint Disease|joint disease
5971014|NCT03134209|Arthropathy|arthropathy
5971015|NCT03134209|Joint Replacement|joint replacement
5971016|NCT03132792|Alpha-fetoprotein|alpha-fetoprotein
5971017|NCT03132792|Cell Therapy|cell therapy
5971018|NCT03132792|T Cell Therapy|t cell therapy
5971019|NCT03132792|SPEAR T Cell|spear t cell
5971020|NCT03132792|Immuno-oncology|immuno-oncology
5971021|NCT03132792|Metastatic|metastatic
5971022|NCT03132792|Previously treated|previously treated
5971023|NCT03132792|T Cell Receptor|t cell receptor
5971024|NCT03132675|Melanoma|melanoma
5971025|NCT03132675|pIL-12|pil-12
5971026|NCT03132675|pembrolizumab|pembrolizumab
5971027|NCT03132675|tavokinogene telseplasmid|tavokinogene telseplasmid
5971028|NCT03132675|Keynote 695|keynote 695
5971029|NCT03131921|Energy expenditure|energy expenditure
5971030|NCT03131921|Nutrition|nutrition
5971031|NCT03131921|Colorectal cancer|colorectal cancer
5971032|NCT03131921|Dietary needs|dietary needs
5971033|NCT03130036|Memory|memory
5971034|NCT03130036|Cognitive|cognitive
5971035|NCT03128515|Hydroxyurea|hydroxyurea
5971036|NCT03126773|non-interventional|non-interventional
5971037|NCT03126773|cohort|cohort
5971038|NCT03126773|Angeliq Micro|angeliq micro
5971039|NCT03126773|menopause|menopause
5971040|NCT03126773|Russia|russia
5971041|NCT03126552|hookworm|hookworm
5971042|NCT03126552|controlled human infection model|controlled human infection model
5971043|NCT03126539|aging|aging
5971044|NCT03126539|ultraviolet exposure|ultraviolet exposure
5971045|NCT03126539|skin fragility|skin fragility
5971046|NCT03126539|sulforaphane|sulforaphane
5971047|NCT03126110|cervical cancer|cervical cancer
5971048|NCT03126110|endometrial cancer|endometrial cancer
5971049|NCT03126110|gastric cancer (stomach, esophageal, and gastroesophageal junction [GEJ])|gastric cancer (stomach, esophageal, and gastroesophageal junction [gej])
5971050|NCT03126110|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5971051|NCT03126110|melanoma|melanoma
5971052|NCT03126110|Merkel cell carcinoma|merkel cell carcinoma
5971053|NCT03126110|mesothelioma|mesothelioma
5971054|NCT03126110|microsatellite instability-high (MSI-H) colorectal cancer (CRC)|microsatellite instability-high (msi-h) colorectal cancer (crc)
5971055|NCT03126110|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5971056|NCT03126110|ovarian cancer|ovarian cancer
5971057|NCT03126110|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5971058|NCT03126110|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5971059|NCT03126110|renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5971060|NCT03126110|triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
5971061|NCT03126110|urothelial carcinoma|urothelial carcinoma
5971062|NCT03126110|glucocorticoid-induced tumor necrosis factor receptor (GITR)|glucocorticoid-induced tumor necrosis factor receptor (gitr)
5971063|NCT03125915|couples HIV testing; drug intervention; communication skills|couples hiv testing; drug intervention; communication skills
5971064|NCT03122509|Durvalumab|durvalumab
5971065|NCT03122509|Tremelimumab|tremelimumab
5971066|NCT03122509|Radiation Therapy|radiation therapy
5971067|NCT03122509|Ablation|ablation
5971068|NCT03122509|17-139|17-139
5971069|NCT03119584|chronic constipation|chronic constipation
5971070|NCT03119584|diabetes|diabetes
5971071|NCT03117634|anti vegf|anti vegf
5971072|NCT03117634|aflibercept|aflibercept
5971073|NCT03117634|treat and extend|treat and extend
5971074|NCT03117621|Blincyto|blincyto
5971075|NCT03116399|Older adults|older adults
5971076|NCT03116399|Social Support|social support
5971077|NCT03116399|Technology uptake|technology uptake
5971078|NCT03112629|Quality of Care|quality of care
5971079|NCT03112629|aortic stenosis|aortic stenosis
5971080|NCT03112629|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5971081|NCT03112629|surgical aortic valve replacement|surgical aortic valve replacement
5971082|NCT03112629|facilitated data relay|facilitated data relay
5971083|NCT03111992|Myeloma,|myeloma,
5971084|NCT03111992|Multiple Myeloma,|multiple myeloma,
5971085|NCT03111992|Hematologic Diseases,|hematologic diseases,
5971086|NCT03111992|Myeloma, Multiple,|myeloma, multiple,
5971087|NCT03111992|Myeloma-Multiple,|myeloma-multiple,
5971088|NCT03111992|Programmed Cell Death 1 Receptor|programmed cell death 1 receptor
5971089|NCT03111745|Reactivation or Proliferation of Latent Viral Infections.|reactivation or proliferation of latent viral infections.
5971090|NCT03111745|Viral Infection|viral infection
5971091|NCT03111745|Lymphoproliferation|lymphoproliferation
5971092|NCT03111732|Immune-Based Strategies|immune-based strategies
5971093|NCT03111732|Anti-PD1 Therapy|anti-pd1 therapy
5971094|NCT03111732|Chronic Inflammation|chronic inflammation
5971095|NCT03111732|Combination Chemotherapy|combination chemotherapy
5971096|NCT03110562|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5971097|NCT03110562|RRMM|rrmm
5971098|NCT03110562|Bortezomib|bortezomib
5971099|NCT03110562|Dexamethasone|dexamethasone
5971100|NCT03109899|mHealth|mhealth
5971101|NCT03109899|HIV Prevention|hiv prevention
5971102|NCT03109522|axillary reverse mapping (ARM)|axillary reverse mapping (arm)
5971103|NCT03109522|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5971104|NCT03109522|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
5971106|NCT03109522|breast cancer|breast cancer
5971107|NCT03109522|surgery|surgery
5971108|NCT03109288|Targeted Therapy|targeted therapy
5971109|NCT03109288|Multiple Sclerosis|multiple sclerosis
5971110|NCT03109288|Biomarkers|biomarkers
5971111|NCT03109288|Combination Therapy|combination therapy
5971112|NCT03109288|Progressive Multiple Sclerosis|progressive multiple sclerosis
5971113|NCT03106779|Phase 3|phase 3
5971114|NCT03106779|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5971115|NCT03106779|CML|cml
5971116|NCT03106779|bosutinib|bosutinib
5971117|NCT03106779|ABL001|abl001
5971118|NCT03106779|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5971119|NCT03106779|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
5971120|NCT03106779|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5971121|NCT03106779|chronic myelocytic leukemia (CML)|chronic myelocytic leukemia (cml)
5971122|NCT03106779|chronic granulocytic leukemia (CGL)|chronic granulocytic leukemia (cgl)
5971123|NCT03106779|cancer of the white blood cells|cancer of the white blood cells
5971124|NCT03106779|clonal bone marrow stem cell disorder|clonal bone marrow stem cell disorder
5971125|NCT03106779|proliferation of mature granulocytes|proliferation of mature granulocytes
5971126|NCT03106740|Microglia|microglia
5971127|NCT03106740|Minocycline|minocycline
5971128|NCT03106740|Magnetic Resonance Imaging|magnetic resonance imaging
5971129|NCT03106740|Positron Emission Tomography|positron emission tomography
5971130|NCT03106740|Pain|pain
5971131|NCT03106740|Astrocytes|astrocytes
5971132|NCT03106740|Glia|glia
5971133|NCT03106740|Human|human
5971134|NCT03106740|Back Pain|back pain
5971135|NCT03106428|MEDI7247|medi7247
5971136|NCT03106428|Acute Myeloid Leukemia|acute myeloid leukemia
5971137|NCT03106428|Multiple Myeloma|multiple myeloma
5971138|NCT03106428|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5971139|NCT03106428|AML|aml
5971140|NCT03106428|MM|mm
5971141|NCT03106428|DLBCL|dlbcl
5971142|NCT03106324|Multiple Myeloma|multiple myeloma
5971143|NCT03106324|Non transplant eligible|non transplant eligible
5971144|NCT03106324|Revlimid|revlimid
5971145|NCT03106324|PASS|pass
5971146|NCT03106324|Non-interventional|non-interventional
5971147|NCT03106324|Lenalidomide|lenalidomide
5971148|NCT03105700|epilepsy|epilepsy
5971149|NCT03105700|depression|depression
5971150|NCT03105700|refractory|refractory
5971151|NCT03105700|TMS|tms
5971152|NCT03105362|Oral Rehydration Solutions|oral rehydration solutions
5971153|NCT03104725|5-S-Cysteinyldopamine|5-s-cysteinyldopamine
5971154|NCT03104725|Cerebrospinal Fluid|cerebrospinal fluid
5971155|NCT03104725|PARKINSONS DISEASE|parkinsons disease
5971156|NCT03104725|MONOAMINE OXIDASE INHIBITOR|monoamine oxidase inhibitor
5971157|NCT03104517|Urinary Incontinence|urinary incontinence
5971158|NCT03104517|Urinary Stress Incontinence|urinary stress incontinence
5971159|NCT03104517|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5971160|NCT03104517|Urinary Bladder|urinary bladder
5971161|NCT03104517|Urinary Tract Diseases|urinary tract diseases
5971162|NCT03104517|Bladder|bladder
5971163|NCT03104517|Urinary Leak|urinary leak
5971164|NCT03104517|Urine Leak|urine leak
5971165|NCT03104517|Bladder Leak|bladder leak
5971166|NCT03104517|Urethra|urethra
5971167|NCT03104517|Urethral Sphincter|urethral sphincter
5971168|NCT03104413|ABBV-066|abbv-066
5971169|NCT03104413|BI 655066|bi 655066
5971170|NCT03104205|frail elderly|frail elderly
5971171|NCT03104205|telemedicine|telemedicine
5971172|NCT03104205|obesity|obesity
5971173|NCT03104205|rural health|rural health
5971174|NCT03104205|health promotion|health promotion
5971175|NCT03104205|weight loss|weight loss
5971176|NCT03103412|Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects|active mild ulcerative colitis, active moderate ulcerative colitis, healthy subjects
5971177|NCT03102606|Plinabulin|plinabulin
5971178|NCT03102606|Pegfilgrastim|pegfilgrastim
5971179|NCT03102606|Duration of Severe Neutropenia|duration of severe neutropenia
5971180|NCT03102606|Bone Pain|bone pain
5971181|NCT03100045|HPV|hpv
5971182|NCT03100045|suppository|suppository
5971183|NCT03100045|Artesunate|artesunate
5971184|NCT03100045|artemisinin|artemisinin
5971185|NCT03100045|anal dysplasia|anal dysplasia
5971186|NCT03100045|treatment|treatment
5971187|NCT03100045|alternative treatment|alternative treatment
5971188|NCT03100045|anal precancer|anal precancer
5971189|NCT03100045|Johns Hopkins|johns hopkins
5971190|NCT03100045|Sandy Fang|sandy fang
5971191|NCT03100045|Frantz Viral Therapeutics|frantz viral therapeutics
5971192|NCT03100045|Wisconsin|wisconsin
5971193|NCT03100045|Evie Carchman|evie carchman
5971194|NCT03096808|adaptive radiotherapy|adaptive radiotherapy
5971195|NCT03096808|ART|art
5971196|NCT03096808|intensity modulated radiation therapy|intensity modulated radiation therapy
5971197|NCT03096808|IMRT|imrt
5971198|NCT03093116|ALK|alk
5971199|NCT03093116|ROS1|ros1
5971200|NCT03093116|NTRK|ntrk
5971201|NCT03093116|Sarcoma|sarcoma
5971202|NCT03093116|Lung Neoplasms|lung neoplasms
5971203|NCT03093116|Carcinoma, NSCL|carcinoma, nscl
5971204|NCT03093116|NSCLC|nsclc
5971205|NCT03093116|Non Small Cell Lung|non small cell lung
5971206|NCT03093116|Thyroid Disease|thyroid disease
5971207|NCT03093116|Colonic Neoplasms|colonic neoplasms
5971208|NCT03093116|Thyroid Neoplasms|thyroid neoplasms
5971209|NCT03093116|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
5971210|NCT03093116|Respiratory Tract Neoplasms|respiratory tract neoplasms
5971211|NCT03093116|Thoracic Neoplasms|thoracic neoplasms
5971212|NCT03093116|Neoplasms by Site|neoplasms by site
5971213|NCT03093116|Neoplasms|neoplasms
5971214|NCT03093116|Lung Disease|lung disease
5971215|NCT03093116|Respiratory Tract Disease|respiratory tract disease
5971216|NCT03093116|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5971217|NCT03093116|Bronchial Neoplasms|bronchial neoplasms
5971218|NCT03093116|Endocrine System Disease|endocrine system disease
5971219|NCT03093116|Colorectol Neoplasms|colorectol neoplasms
5971220|NCT03093116|Intestinal Neoplasms|intestinal neoplasms
5971221|NCT03093116|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5971222|NCT03093116|Digestive System Neoplasms|digestive system neoplasms
5971223|NCT03093116|Gastrointestinal Disease|gastrointestinal disease
5971224|NCT03093116|Colonic Disease|colonic disease
5971225|NCT03093116|Intestinal Disease|intestinal disease
5971226|NCT03093116|Endocrine Gland Neoplasms|endocrine gland neoplasms
5971227|NCT03093116|Head and Neck Neoplasms|head and neck neoplasms
5971228|NCT03093116|Neuroendocrine Tumors|neuroendocrine tumors
5971229|NCT03093116|Neuroectodermal Tumors|neuroectodermal tumors
5971230|NCT03093116|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5971231|NCT03093116|Neoplasms by Histologic Type|neoplasms by histologic type
5971232|NCT03093116|Adenocarcinoma|adenocarcinoma
5971233|NCT03093116|Non Small Cell Lung Cancer|non small cell lung cancer
5971234|NCT03093116|Solid Tumors|solid tumors
5971235|NCT03093116|Rearrangements|rearrangements
5971236|NCT03093116|TRIDENT-1|trident-1
5971237|NCT03093116|TKI|tki
5971238|NCT03093116|TKI naive|tki naive
5971239|NCT03093116|TKI pretreated|tki pretreated
5971240|NCT03093116|Anti-tumor activity|anti-tumor activity
5971241|NCT03093116|Repotrectinib|repotrectinib
5971242|NCT03093116|Advanced Solid Malignancies|advanced solid malignancies
5971243|NCT03092518|Surgical Resection|surgical resection
5971244|NCT03092518|Progression Free Survival|progression free survival
5971245|NCT03092518|Gastroesophageal Junction (Siewert III) Adenocarcinoma|gastroesophageal junction (siewert iii) adenocarcinoma
5971246|NCT03092505|HSV|hsv
5971247|NCT03092505|Uganda|uganda
5971248|NCT03092505|Sample|sample
5971249|NCT03092492|Age Related Macular Degeneration|age related macular degeneration
5971250|NCT03092492|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5971251|NCT03092492|Reticular Pseudodrusen|reticular pseudodrusen
5971252|NCT03092375|HCV|hcv
5971253|NCT03092375|Previously treated|previously treated
5971254|NCT03089268|sessile serrated polyp|sessile serrated polyp
5971255|NCT03089268|prevalence|prevalence
5971256|NCT03089268|colorectal cancer|colorectal cancer
5971257|NCT03089268|molecular biology|molecular biology
5971258|NCT03088202|cancer|cancer
5971259|NCT03088202|palliative care|palliative care
5971260|NCT03088202|PROMs|proms
5971261|NCT03088202|survival|survival
5971262|NCT03088202|QoL|qol
5971263|NCT03088202|referral|referral
5971264|NCT03087396|bone marrow defect|bone marrow defect
5971265|NCT03087396|bone marrow lesion|bone marrow lesion
5971266|NCT03087396|stress fracture|stress fracture
5971267|NCT03087396|calcium phosphate|calcium phosphate
5971268|NCT03087396|bone substitute material|bone substitute material
5971269|NCT03086408|airway management|airway management
5971270|NCT03086408|high flow nasal oxygen|high flow nasal oxygen
5971271|NCT03086408|high flow nasal cannula|high flow nasal cannula
5971272|NCT03086408|THRIVE|thrive
5971273|NCT03084211|emergency department|emergency department
5971274|NCT03084211|concussion|concussion
5971275|NCT03084211|head injury|head injury
5971276|NCT03083730|Atopic Dermatitis|atopic dermatitis
5971277|NCT03083730|Eczema|eczema
5971278|NCT03083730|Systemic Inflammation|systemic inflammation
5971279|NCT03083730|UVB Phototherapy|uvb phototherapy
5971280|NCT03083665|Epilepsy|epilepsy
5971281|NCT03083665|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
5971282|NCT03083665|Brivaracetam|brivaracetam
5971283|NCT03083665|Briviact|briviact
5971284|NCT03080818|Probiotic, Cognitive Function, Mood|probiotic, cognitive function, mood
5971285|NCT03078803|fecal transplant|fecal transplant
5971286|NCT03078803|inflammatory bowel disease|inflammatory bowel disease
5971287|NCT03078751|Hormone receptor-positive|hormone receptor-positive
5971288|NCT03078751|Estrogen and/or progesterone receptor-positive|estrogen and/or progesterone receptor-positive
5971289|NCT03078751|HER2-negative|her2-negative
5971290|NCT03078751|High risk early breast cancer|high risk early breast cancer
5971291|NCT03078751|Adjuvant|adjuvant
5971292|NCT03078751|Ribociclib|ribociclib
5971293|NCT03078751|LEE011|lee011
5971294|NCT03078751|CDK4/6 inhibitor|cdk4/6 inhibitor
5971295|NCT03078751|Endocrine therapy|endocrine therapy
5971296|NCT03078751|Phase II|phase ii
5971297|NCT03078751|Breast carcinoma|breast carcinoma
5971298|NCT03078751|Breast cancer|breast cancer
5971299|NCT03078595|periodontal disease|periodontal disease
5971300|NCT03078595|plaque-induced gingivitis|plaque-induced gingivitis
5971301|NCT03078595|bleeding on probing|bleeding on probing
5971302|NCT03078595|von willebrand disease|von willebrand disease
5971303|NCT03078595|gingival bleeding|gingival bleeding
5971304|NCT03077243|Human Papillomavirus|human papillomavirus
5971305|NCT03077243|Oropharynx|oropharynx
5971306|NCT03077243|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5971307|NCT03077243|Squamous Cell Carcinoma|squamous cell carcinoma
5971308|NCT03077243|Radiation Therapy|radiation therapy
5971309|NCT03077243|Chemotherapy|chemotherapy
5971310|NCT03077243|p16|p16
5971311|NCT03076567|Epidemiology|epidemiology
5971312|NCT03076567|Cancer|cancer
5971313|NCT03076567|Methylation|methylation
5971314|NCT03076567|Genetics|genetics
5971315|NCT03076567|Screening|screening
5971316|NCT03075930|Atrial fibrillation|atrial fibrillation
5971317|NCT03075930|ECG|ecg
5971318|NCT03075930|Body surface potential map|body surface potential map
5971319|NCT03075930|Recurrence of AF|recurrence of af
5971320|NCT03073876|Alzheimer Disease|alzheimer disease
5971321|NCT03073876|Attention|attention
5971322|NCT03073876|Donepezil hydrochloride|donepezil hydrochloride
5971323|NCT03072927|Lumbar Spinal Stenosis|lumbar spinal stenosis
5971324|NCT03072927|Interspinous process decompression|interspinous process decompression
5971325|NCT03072927|MILD|mild
5971326|NCT03072927|Medicare|medicare
5971327|NCT03072862|Cochlear implant treatment, aging adults|cochlear implant treatment, aging adults
5971328|NCT03071536|furosemide stress test|furosemide stress test
5971329|NCT03071536|kidney transplantation|kidney transplantation
5971330|NCT03071536|urine output|urine output
5971331|NCT03071536|perioperation|perioperation
5971332|NCT03071536|delayed graft function|delayed graft function
5971333|NCT03070301|LEE011|lee011
5971334|NCT03070301|Everolimus|everolimus
5971335|NCT03070301|16-1535|16-1535
5971336|NCT03070093|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5971337|NCT03070093|FMS-like Tyrosine kinase-3 (FLT3) mutations|fms-like tyrosine kinase-3 (flt3) mutations
5971338|NCT03070093|gilteritinib|gilteritinib
5971339|NCT03070093|Expanded access|expanded access
5971340|NCT03070093|ASP2215|asp2215
5971341|NCT03069859|Post partum hemorrhage|post partum hemorrhage
5971342|NCT03069859|Tranexamic acid|tranexamic acid
5971343|NCT03069859|Spontaneous vaginal delivery|spontaneous vaginal delivery
5971344|NCT03069859|C-section|c-section
5971345|NCT03069755|India|india
5971346|NCT03069755|Perioperative mortality|perioperative mortality
5971347|NCT03069755|Trauma|trauma
5971348|NCT03069755|Surgery|surgery
5971349|NCT03069716|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5971350|NCT03069378|Metastatic|metastatic
5971351|NCT03069378|Locally Advanced|locally advanced
5971352|NCT03069378|Talimogene Laherparepvec (T-VEC)|talimogene laherparepvec (t-vec)
5971353|NCT03069378|Pembrolizumab|pembrolizumab
5971354|NCT03069378|16-1534|16-1534
5971355|NCT03069352|Acute Myeloid Leukemia|acute myeloid leukemia
5971356|NCT03069352|Leukemia|leukemia
5971357|NCT03069352|Treatment naïve|treatment naïve
5971358|NCT03069352|Venetoclax|venetoclax
5971359|NCT03069352|Cytarabine|cytarabine
5971360|NCT03068715|transcranial magnetic stimulation|transcranial magnetic stimulation
5971361|NCT03068715|theta burst|theta burst
5971362|NCT03068546|Oral Microbiota|oral microbiota
5971363|NCT03068104|Trauma|trauma
5971364|NCT03068104|Haemorrhage|haemorrhage
5971365|NCT03068104|Massive transfusion|massive transfusion
5971366|NCT03068104|India|india
5971367|NCT03067428|Fructose|fructose
5971368|NCT03067428|Diet|diet
5971369|NCT03066193|Motor tics|motor tics
5971370|NCT03066193|Vocal tics|vocal tics
5971371|NCT03066193|Cannabinoids|cannabinoids
5971372|NCT03066193|Dronabinol|dronabinol
5971373|NCT03066193|PEA|pea
5971374|NCT03066193|Palmitoylethanolamide|palmitoylethanolamide
5971375|NCT03066193|Tourettes|tourettes
5971376|NCT03066193|TS|ts
5971377|NCT03064555|Renal|renal
5971378|NCT03064555|Acute|acute
5971379|NCT03064555|Exercise|exercise
5971380|NCT03064555|Dialysis|dialysis
5971381|NCT03064555|Hemodialysis|hemodialysis
5971382|NCT03064555|End stage renal disease|end stage renal disease
5971383|NCT03064555|Aerobic|aerobic
5971384|NCT03060837|RIRS|rirs
5971385|NCT03060837|Kidney Stone|kidney stone
5971386|NCT03060837|Single lung ventilation|single lung ventilation
5971387|NCT03060837|Simultaneous normal ventilation|simultaneous normal ventilation
5971388|NCT03059680|Potassium|potassium
5971389|NCT03059680|Nutrition|nutrition
5971390|NCT03057184|Adult Day Care Center|adult day care center
5971391|NCT03057184|behavioral problems|behavioral problems
5971392|NCT03057184|caregivers|caregivers
5971393|NCT03056157|Moral Injury|moral injury
5971394|NCT03056157|Post-traumatic Stress Disorder|post-traumatic stress disorder
5971395|NCT03056157|Traumatic Loss|traumatic loss
5971396|NCT03056157|Adaptive Disclosure|adaptive disclosure
5971397|NCT03056157|Veterans|veterans
5971398|NCT03055195|subcutaneous|subcutaneous
5971399|NCT03055195|safety|safety
5971400|NCT03055195|mepolizumab|mepolizumab
5971401|NCT03055195|efficacy|efficacy
5971402|NCT03055195|atopic dermatitis|atopic dermatitis
5971403|NCT03053323|Preconception|preconception
5971404|NCT03053323|Pregnancy|pregnancy
5971405|NCT03053323|Lifestyle|lifestyle
5971406|NCT03053271|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
5971407|NCT03053271|ATR-101|atr-101
5971408|NCT03053271|CS|cs
5971409|NCT03050801|Explicit Memory|explicit memory
5971410|NCT03050801|Implicit Memory|implicit memory
5971411|NCT03050801|Memory Disorder|memory disorder
5971412|NCT03050385|cognitive rehabilitation|cognitive rehabilitation
5971413|NCT03050060|Kidney|kidney
5971414|NCT03050060|Lung|lung
5971415|NCT03050060|Melanoma, Skin|melanoma, skin
5971416|NCT03049462|Brown Adipose Tissue|brown adipose tissue
5971417|NCT03049462|Energy Expenditure|energy expenditure
5971418|NCT03049462|Energy Metabolism|energy metabolism
5971419|NCT03049462|Obesity|obesity
5971420|NCT03049293|COPD,IVF|copd,ivf
5971421|NCT03048201|Physica KR|physica kr
5971422|NCT03048201|Physica CR|physica cr
5971423|NCT03048201|Physica PS|physica ps
5971424|NCT03048201|Kinematic Retaining|kinematic retaining
5971425|NCT03048201|Cruciate Retaining|cruciate retaining
5971426|NCT03048201|Posterior Stabilized|posterior stabilized
5971427|NCT03048201|Physica System|physica system
5971428|NCT03046745|Gastric cancer, endoscopy, pepsinogen, TFF3, biomarker|gastric cancer, endoscopy, pepsinogen, tff3, biomarker
5971429|NCT03044314|pulmonary hypertension|pulmonary hypertension
5971430|NCT03044314|vasodilator challenge|vasodilator challenge
5971431|NCT03044314|echocardiography|echocardiography
5971432|NCT03044314|outcomes|outcomes
5971433|NCT03044314|iloprost|iloprost
5971434|NCT03044314|inhaled nitric oxide|inhaled nitric oxide
5971435|NCT03044249|Psychotic Disorders|psychotic disorders
5971436|NCT03043313|HER2|her2
5971437|NCT03043313|ERBB2|erbb2
5971438|NCT03043313|Colorectal cancer|colorectal cancer
5971439|NCT03042975|spasmodic dysphonia|spasmodic dysphonia
5971440|NCT03042975|dystonia|dystonia
5971441|NCT03042975|laryngeal dystonia|laryngeal dystonia
5971442|NCT03042975|imaging|imaging
5971443|NCT03042975|genetics|genetics
5971444|NCT03042962|dystonia|dystonia
5971445|NCT03042962|imaging|imaging
5971446|NCT03042962|genetics|genetics
5971447|NCT03042962|neuropathology|neuropathology
5971448|NCT03041831|frail elderly|frail elderly
5971449|NCT03041831|telemedicine|telemedicine
5971450|NCT03041831|obesity|obesity
5971451|NCT03041831|rural health|rural health
5971452|NCT03041831|health promotion|health promotion
5971453|NCT03041129|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5971454|NCT03040999|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5971455|NCT03040999|Programmed Cell Death Receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5971456|NCT03040999|Programmed Cell Death Receptor Ligand 1 (PD-L1)|programmed cell death receptor ligand 1 (pd-l1)
5971457|NCT03040999|Programmed Cell Death Receptor Ligand 2 (PD-L2)|programmed cell death receptor ligand 2 (pd-l2)
5971458|NCT03040999|PD1|pd1
5971459|NCT03040999|PD-1|pd-1
5971460|NCT03040999|PDL1|pdl1
5971461|NCT03040999|PD-L1|pd-l1
5971462|NCT03040999|PDL2|pdl2
5971463|NCT03040973|capmatinib|capmatinib
5971464|NCT03040973|Nazartinib|nazartinib
5971465|NCT03040973|Gefitinib|gefitinib
5971466|NCT03040973|rollover protocol|rollover protocol
5971467|NCT03040973|parent study|parent study
5971468|NCT03038984|IBD|ibd
5971469|NCT03038984|Telemedicine|telemedicine
5971470|NCT03038984|At-home monitoring|at-home monitoring
5971471|NCT03038984|Disease activity|disease activity
5971472|NCT03038984|fecal calprotectin|fecal calprotectin
5971473|NCT03038984|Total inflammation burden|total inflammation burden
5971474|NCT03038984|11 years follow up|11 years follow up
5971475|NCT03037437|Hepatocellular Cancer|hepatocellular cancer
5971476|NCT03037437|Sorafenib|sorafenib
5971477|NCT03037437|Hydroxychloroquine|hydroxychloroquine
5971478|NCT03036488|PD1|pd1
5971479|NCT03036488|PD-1|pd-1
5971480|NCT03036488|PDL1|pdl1
5971481|NCT03036488|PD-L1|pd-l1
5971482|NCT03036280|Elenbecestat|elenbecestat
5971483|NCT03036280|E2609|e2609
5971485|NCT03036280|Early Alzheimer's Disease|early alzheimer's disease
5971486|NCT03036280|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
5971487|NCT03036280|Dementia|dementia
5971488|NCT03036280|Dementia, Alzheimer's type|dementia, alzheimer's type
5971489|NCT03036280|Mild Cognitive Impairment|mild cognitive impairment
5971490|NCT03036280|MissionAD2|missionad2
5971491|NCT03036150|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5971492|NCT03036150|Cardiovascular Events (CV)|cardiovascular events (cv)
5971493|NCT03036150|Phase III outcome trial|phase iii outcome trial
5971494|NCT03036059|Twice a year treatment|twice a year treatment
5971495|NCT03036059|Biannual treatment|biannual treatment
5971496|NCT03036059|Wuchereria bancrofti|wuchereria bancrofti
5971497|NCT03035578|Pharmacokinetics|pharmacokinetics
5971498|NCT03035578|Pharmacodynamics|pharmacodynamics
5971499|NCT03035578|Morphine|morphine
5971500|NCT03035578|Neonatal|neonatal
5971501|NCT03035448|Malignant neoplasms of independent (primary) multiple sites|malignant neoplasms of independent (primary) multiple sites
5971502|NCT03035448|Advanced cancer|advanced cancer
5971503|NCT03035448|Recurrent cancer|recurrent cancer
5971504|NCT03035448|Metastatic disease|metastatic disease
5971505|NCT03035448|Palliative care|palliative care
5971506|NCT03035448|Videos|videos
5971507|NCT03035448|Questionnaires|questionnaires
5971508|NCT03035448|Surveys|surveys
5971509|NCT03035279|Advanced colorectal cancer|advanced colorectal cancer
5971510|NCT03035279|Cancer|cancer
5971511|NCT03035279|Metastatic colorectal cancer|metastatic colorectal cancer
5971512|NCT03035279|Unresectable colorectal cancer|unresectable colorectal cancer
5971513|NCT03035279|Maximum tolerated dose|maximum tolerated dose
5971514|NCT03035279|Pharmacokinetics|pharmacokinetics
5971515|NCT03032380|Hospital-acquired pneumonia (HAP)|hospital-acquired pneumonia (hap)
5971516|NCT03032380|S-649266|s-649266
5971517|NCT03032380|linezolid|linezolid
5971518|NCT03032380|meropenem|meropenem
5971519|NCT03032380|Healthcare-associated pneumonia (HCAP)|healthcare-associated pneumonia (hcap)
5971520|NCT03032380|nosocomial pneumonia|nosocomial pneumonia
5971521|NCT03032380|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
5971522|NCT03032380|Gram-negative pathogens|gram-negative pathogens
5971523|NCT03032380|pneumonia|pneumonia
5971524|NCT03032380|cefiderocol|cefiderocol
5971525|NCT03030404|Genetics|genetics
5971526|NCT03030404|Familial Background|familial background
5971527|NCT03030404|Inherited Cancer Syndrome|inherited cancer syndrome
5971528|NCT03030404|Germline Mutation in the CDH1 Gene|germline mutation in the cdh1 gene
5971529|NCT03030404|Lobular Breast Cancer|lobular breast cancer
5971530|NCT03030183|PNH|pnh
5971531|NCT03030066|DS-1001b|ds-1001b
5971532|NCT03030066|IDH1 mutation|idh1 mutation
5971533|NCT03030066|Developmental Phase I|developmental phase i
5971534|NCT03030066|Glioma|glioma
5971535|NCT03029507|Obesity|obesity
5971536|NCT03029507|Military|military
5971537|NCT03029507|Acceptance and Commitment Therapy|acceptance and commitment therapy
5971538|NCT03029507|Overweight|overweight
5971539|NCT03029507|Weight-management|weight-management
5971540|NCT03029507|Navy Personnel|navy personnel
5971541|NCT03029507|Fitness|fitness
5971542|NCT03027440|Stress Response|stress response
5971543|NCT03027440|Neurodevelopment|neurodevelopment
5971544|NCT03027440|Biomarkers|biomarkers
5971545|NCT03027440|Cohort Study|cohort study
5971546|NCT03027193|Vaccine|vaccine
5971547|NCT03027193|MAP|map
5971548|NCT03026816|epidural stimulation|epidural stimulation
5971549|NCT03026816|spinal cord stimulation|spinal cord stimulation
5971550|NCT03026816|autonomic dysfunction|autonomic dysfunction
5971551|NCT03026296|Physical Fitness|physical fitness
5971552|NCT03026296|Health Status|health status
5971553|NCT03026296|Exercise|exercise
5971554|NCT03026296|Tobacco Use Cessation|tobacco use cessation
5971555|NCT03026296|Quality of Life|quality of life
5971556|NCT03026296|Healthy Diet|healthy diet
5971557|NCT03026296|Health Promotion|health promotion
5971558|NCT03026296|Patient Education as Topic|patient education as topic
5971559|NCT03026296|Counseling|counseling
5971560|NCT03026036|Depression|depression
5971561|NCT03026036|MRI|mri
5971562|NCT03026036|PET|pet
5971563|NCT03026036|Reward|reward
5971564|NCT03025646|Maternal depression|maternal depression
5971565|NCT03025646|ASD|asd
5971566|NCT03025646|Home based training program|home based training program
5971567|NCT03022409|Treatment naïve- or a second tumour|treatment naïve- or a second tumour
5971568|NCT03022409|Head and Neck Squamous Cell Carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5971569|NCT03022409|DNA Damage Repair (DDR)|dna damage repair (ddr)
5971570|NCT03020992|Axial Spondyloarthritis|axial spondyloarthritis
5971571|NCT03020992|axSpA|axspa
5971572|NCT03020992|Anterior Uveitis|anterior uveitis
5971573|NCT03020992|Certolizumab Pegol|certolizumab pegol
5971574|NCT03020992|Cimzia|cimzia
5971575|NCT03020199|Psoriasis|psoriasis
5971576|NCT03019367|Premature infants|premature infants
5971577|NCT03019367|Umbilical cord milking|umbilical cord milking
5971578|NCT03019367|Delayed cord clamping|delayed cord clamping
5971579|NCT03019367|Intraventricular Hemorrhage|intraventricular hemorrhage
5971580|NCT03019367|Death|death
5971581|NCT03018262|Surround Inhibition|surround inhibition
5971582|NCT03018262|Motor Control|motor control
5971583|NCT03018262|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5971584|NCT03018262|TMS-Evoked Potential|tms-evoked potential
5971585|NCT03016598|oxytocin|oxytocin
5971586|NCT03016598|substance-related disorders|substance-related disorders
5971587|NCT03016598|Opioid Replacement Therapy|opioid replacement therapy
5971588|NCT03016598|Psychophysiology|psychophysiology
5971589|NCT03016598|Stress Biomarkers|stress biomarkers
5971590|NCT03016429|pacemaker|pacemaker
5971591|NCT03016429|defibrillator|defibrillator
5971592|NCT03016429|magnetic resonance imaging|magnetic resonance imaging
5971593|NCT03016429|cardiac implantable electronic device|cardiac implantable electronic device
5971594|NCT03016377|CAR T cells|car t cells
5971595|NCT03016377|CD19|cd19
5971596|NCT03016377|Leukemia|leukemia
5971597|NCT03016377|T Lymphocytes|t lymphocytes
5971598|NCT03016377|AP1903|ap1903
5971599|NCT03016377|Cytokine Release Syndrome|cytokine release syndrome
5971600|NCT03016377|Rimiducid|rimiducid
5971601|NCT03016377|ICANS|icans
5971602|NCT03016377|Immune effector cell mediated neurotoxicity syndrome|immune effector cell mediated neurotoxicity syndrome
5971603|NCT03015181|Broadly Neutralizing|broadly neutralizing
5971604|NCT03015181|HIV Prevention|hiv prevention
5971605|NCT03015181|Anti-Drug Antibody|anti-drug antibody
5971612|NCT03009539|eHealth Familias Unidas|ehealth familias unidas
5971613|NCT03009539|effectiveness trial|effectiveness trial
5971614|NCT03009539|sexually transmitted disease|sexually transmitted disease
5971615|NCT03009539|parent-centered|parent-centered
5971616|NCT03009539|Hispanic|hispanic
5971617|NCT03009539|sexual risk behavior|sexual risk behavior
5971618|NCT03009292|solid tumor|solid tumor
5971619|NCT03009292|Lenvatinib|lenvatinib
5971620|NCT03009292|pharmacokinetics|pharmacokinetics
5971621|NCT03008122|Flavivirus|flavivirus
5971622|NCT03008122|Inactivated|inactivated
5971623|NCT03008122|Phase I|phase i
5971624|NCT03008122|Vaccine|vaccine
5971625|NCT03008122|ZIKA|zika
5971626|NCT03008122|ZPIV|zpiv
5971627|NCT03007394|Cocaine Use Disorder|cocaine use disorder
5971628|NCT03007329|SGLT2 inhibitor|sglt2 inhibitor
5971629|NCT03007329|GLP1 agonist|glp1 agonist
5971630|NCT03007329|type 2 Diabetes|type 2 diabetes
5971631|NCT03007329|steatosis of the liver|steatosis of the liver
5971632|NCT03007329|ectopic lipids|ectopic lipids
5971633|NCT03007329|combined therapy|combined therapy
5971634|NCT03006887|solid tumors|solid tumors
5971635|NCT03006887|non-small cell lung cancer|non-small cell lung cancer
5971636|NCT03006887|predominantly clear cell renal cell carcinoma|predominantly clear cell renal cell carcinoma
5971637|NCT03006887|endometrial carcinoma|endometrial carcinoma
5971638|NCT03006887|urothelial carcinoma|urothelial carcinoma
5971639|NCT03006887|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5971640|NCT03006887|non-uveal melanoma|non-uveal melanoma
5971641|NCT03006887|E7080|e7080
5971642|NCT03006887|lenvatinib|lenvatinib
5971643|NCT03006887|pembrolizumab|pembrolizumab
5971644|NCT03006887|Japan|japan
5971645|NCT03006393|Neuroscience|neuroscience
5971646|NCT03006393|Behavioral|behavioral
5971647|NCT03006393|Social|social
5971648|NCT03000244|Natural History|natural history
5971649|NCT03000244|HCT|hct
5971650|NCT02998138|Chronic Pain|chronic pain
5971651|NCT02998138|Pain, Postoperative|pain, postoperative
5971652|NCT02994615|Index of Microvascular Resistance|index of microvascular resistance
5971653|NCT02994615|Microvascular dysfunction|microvascular dysfunction
5971654|NCT02993523|Acute Myeloid Leukemia|acute myeloid leukemia
5971655|NCT02993523|Venetoclax|venetoclax
5971656|NCT02993523|Treatment Naïve|treatment naïve
5971657|NCT02993523|Azacitidine|azacitidine
5971658|NCT02993302|vitamin D|vitamin d
5971659|NCT02993302|graves' disease|graves' disease
5971660|NCT02993302|dendritic cells|dendritic cells
5971661|NCT02992080|Patient with Cystic Fibrosis|patient with cystic fibrosis
5971662|NCT02992080|Patient without Cystic fibrosis|patient without cystic fibrosis
5971663|NCT02990455|alcohol|alcohol
5971664|NCT02990455|drinking|drinking
5971665|NCT02990455|smoking|smoking
5971666|NCT02990455|cigarette|cigarette
5971667|NCT02990455|nicotine|nicotine
5971668|NCT02988440|HCC|hcc
5971669|NCT02988440|Hepatocellular carcinoma|hepatocellular carcinoma
5971670|NCT02988440|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5971671|NCT02988440|PDR001|pdr001
5971672|NCT02988440|liver cancer|liver cancer
5971673|NCT02988440|immunotherapy liver|immunotherapy liver
5971674|NCT02988440|malignant hepatoma|malignant hepatoma
5971675|NCT02988440|Hepatocellular cancer|hepatocellular cancer
5971676|NCT02988440|advanced hepatocellular carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
5971677|NCT02988440|advanced liver cancer|advanced liver cancer
5971678|NCT02988440|liver cancer progression|liver cancer progression
5971679|NCT02988440|sorafenib|sorafenib
5971680|NCT02988440|anti-PD1|anti-pd1
5971681|NCT02988440|first line|first line
5971682|NCT02987309|indirect calorimetry|indirect calorimetry
5971683|NCT02987309|method comparison|method comparison
5971684|NCT02985541|Birth Control|birth control
5971685|NCT02985541|Heavy menstrual bleeding|heavy menstrual bleeding
5971686|NCT02985268|MitraClip|mitraclip
5971687|NCT02985268|Cardiovascular resynchronization therapy|cardiovascular resynchronization therapy
5971688|NCT02985268|Six minute walk test|six minute walk test
5971689|NCT02985268|Mitral regurgitation|mitral regurgitation
5971690|NCT02985268|CRT-D|crt-d
5971691|NCT02984397|pain|pain
5971692|NCT02984397|ketotifen|ketotifen
5971693|NCT02984397|pediatric|pediatric
5971694|NCT02984397|mast cell|mast cell
5971695|NCT02979873|Rapamycin|rapamycin
5971696|NCT02979873|Relapse Prevention|relapse prevention
5971697|NCT02979873|Immune Tolerance|immune tolerance
5971698|NCT02978040|Antiplatelet therapy|antiplatelet therapy
5971699|NCT02978040|Cangrelor|cangrelor
5971700|NCT02978040|Tirofiban|tirofiban
5971701|NCT02978040|Prasugrel|prasugrel
5971702|NCT02978040|Acute Myocardial Infarction|acute myocardial infarction
5971703|NCT02978040|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5971704|NCT02978040|Pharmacokinetic/Pharmacodynamic|pharmacokinetic/pharmacodynamic
5971705|NCT02977780|Glioblastoma|glioblastoma
5971706|NCT02977403|Binge Eating|binge eating
5971707|NCT02977403|Eating Behavior|eating behavior
5971708|NCT02977403|Children|children
5971709|NCT02977403|Magnetoencephalography|magnetoencephalography
5971710|NCT02977403|Loss of Control|loss of control
5971711|NCT02977195|First in Human|first in human
5971712|NCT02977195|monoclonal antibody|monoclonal antibody
5971713|NCT02977195|Netrin-1|netrin-1
5971714|NCT02974647|Ruxolitinib|ruxolitinib
5971715|NCT02974647|T or NK Cell|t or nk cell
5971716|NCT02974647|Relapsed|relapsed
5971717|NCT02974647|Refractory|refractory
5971718|NCT02973789|Non-Small Cell Lung Cancer|non-small cell lung cancer
5971719|NCT02973789|NSCLC|nsclc
5971720|NCT02973789|Treatment|treatment
5971721|NCT02973789|Minimal Toxicity|minimal toxicity
5971722|NCT02973789|TTFields|ttfields
5971723|NCT02973789|TTF|ttf
5971725|NCT02973789|Novocure|novocure
5971726|NCT02973789|Docetaxel|docetaxel
5971727|NCT02973789|PD-1 inhibitor|pd-1 inhibitor
5971728|NCT02973789|PD-L1 inhibitor|pd-l1 inhibitor
5971729|NCT02973789|Immune checkpoint inhibitor|immune checkpoint inhibitor
5971730|NCT02973113|Nivolumab|nivolumab
5971731|NCT02973113|Hodgkin Lymphoma|hodgkin lymphoma
5971732|NCT02973113|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5971733|NCT02973113|Lymphoproliferative Disorders|lymphoproliferative disorders
5971734|NCT02973113|EBV-specific T Cells|ebv-specific t cells
5971735|NCT02972957|intranasal|intranasal
5971736|NCT02972957|flu vaccine|flu vaccine
5971737|NCT02972957|Gambian children|gambian children
5971738|NCT02972671|MiStent|mistent
5971739|NCT02971137|Smoking|smoking
5971740|NCT02971137|Cigarette Smoking|cigarette smoking
5971741|NCT02971137|Veterans|veterans
5971742|NCT02971137|Tobacco Use|tobacco use
5971743|NCT02971137|Pain|pain
5971744|NCT02970448|LITT|litt
5971745|NCT02970448|Brain Tumor|brain tumor
5971746|NCT02970448|Temozolomide|temozolomide
5971747|NCT02970097|infraclavicular brachial plexus block|infraclavicular brachial plexus block
5971748|NCT02970097|wrist arthroscopy|wrist arthroscopy
5971749|NCT02970097|quality of recovery score|quality of recovery score
5971750|NCT02970097|pain score|pain score
5971751|NCT02970097|modified sleep quality assessment|modified sleep quality assessment
5971752|NCT02969915|people who inject drugs|people who inject drugs
5971753|NCT02969915|men who have sex with men|men who have sex with men
5971754|NCT02969915|HIV|hiv
5971755|NCT02969915|India|india
5971756|NCT02968459|Mesenchymal Stem Cells|mesenchymal stem cells
5971757|NCT02968459|Cesarean Section|cesarean section
5971758|NCT02968459|Uterine Scar|uterine scar
5971759|NCT02966834|PBC|pbc
5971760|NCT02966834|itch|itch
5971761|NCT02966834|GSK2330672|gsk2330672
5971762|NCT02966834|GLIMMER|glimmer
5971763|NCT02966834|primary biliary cholangitis|primary biliary cholangitis
5971764|NCT02966834|pruritus|pruritus
5971765|NCT02966093|Differentiated thyroid cancer|differentiated thyroid cancer
5971766|NCT02966093|Chinese participants|chinese participants
5971767|NCT02966093|Phase 3|phase 3
5971768|NCT02966093|Lenvatinib|lenvatinib
5971769|NCT02966093|E7080|e7080
5971770|NCT02963766|Pediatrics|pediatrics
5971771|NCT02961907|periconceptional habits|periconceptional habits
5971772|NCT02961907|Pregnancy|pregnancy
5971773|NCT02961907|Infertility|infertility
5971774|NCT02960490|E6011|e6011
5971775|NCT02960490|rheumatoid arthritis|rheumatoid arthritis
5971776|NCT02959931|Dietary Potassium|dietary potassium
5971777|NCT02959177|prevention|prevention
5971778|NCT02959177|prophylaxis|prophylaxis
5971779|NCT02959177|headache|headache
5971780|NCT02957682|Hyperlipidemias|hyperlipidemias
5971781|NCT02957682|Dyslipidemias|dyslipidemias
5971782|NCT02957682|Lipid Metabolism Disorders|lipid metabolism disorders
5971783|NCT02956486|Elenbecestat|elenbecestat
5971784|NCT02956486|E2609|e2609
5971785|NCT02956486|Alzheimer's Disease|alzheimer's disease
5971786|NCT02956486|Early Alzheimer's Disease|early alzheimer's disease
5971787|NCT02956486|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
5971788|NCT02956486|Dementia|dementia
5971789|NCT02956486|Dementia, Alzheimer's type|dementia, alzheimer's type
5971790|NCT02956486|Mild Cognitive Impairment|mild cognitive impairment
5971791|NCT02956486|MissionAD1|missionad1
5971792|NCT02956031|cancer prevention|cancer prevention
5971793|NCT02956031|cervical screening|cervical screening
5971794|NCT02956031|cervical cancer|cervical cancer
5971795|NCT02956031|cervical disease|cervical disease
5971796|NCT02956031|cervical neoplasm|cervical neoplasm
5971797|NCT02956031|HPV testing|hpv testing
5971798|NCT02956031|immunocytochemistry|immunocytochemistry
5971799|NCT02956031|triage techniques|triage techniques
5971800|NCT02955069|Advanced or metastatic|advanced or metastatic
5971801|NCT02955069|NET|net
5971802|NCT02955069|pNET|pnet
5971803|NCT02955069|GI NET|gi net
5971804|NCT02955069|thoracic NET|thoracic net
5971805|NCT02955069|GEP-NEC|gep-nec
5971806|NCT02954523|NSCLC|nsclc
5971807|NCT02954523|Non-small cell|non-small cell
5971808|NCT02954523|Lung Cancer|lung cancer
5971809|NCT02954523|Dasatinib|dasatinib
5971810|NCT02954523|Osimertinib|osimertinib
5971811|NCT02954523|AZD9291|azd9291
5971812|NCT02954523|EGFR Mutations|egfr mutations
5971813|NCT02954523|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5971814|NCT02953938|Ranibizumab|ranibizumab
5971815|NCT02953938|Grid&Direct short pulse laser photocoagulation|grid&direct short pulse laser photocoagulation
5971816|NCT02953938|Macular edema|macular edema
5971817|NCT02953938|Branch retinal vein occlusion|branch retinal vein occlusion
5971818|NCT02953938|BRVO|brvo
5971819|NCT02953938|BCVA|bcva
5971820|NCT02953938|CSFT|csft
5971821|NCT02953938|pro re nata|pro re nata
5971822|NCT02953860|Advanced Breast Cancer|advanced breast cancer
5971823|NCT02953860|ER+/Her2 Advanced Breast Cancer|er+/her2 advanced breast cancer
5971824|NCT02953509|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5971825|NCT02953509|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5971826|NCT02953509|indolent lymphoma|indolent lymphoma
5971827|NCT02953509|Hu5F9-G4|hu5f9-g4
5971828|NCT02953509|CD47|cd47
5971829|NCT02953509|magrolimab|magrolimab
5971830|NCT02950961|Anxiety [F01.470.132]|anxiety [f01.470.132]
5971831|NCT02950961|Depression [F01.145.126.350]|depression [f01.145.126.350]
5971832|NCT02950961|Stress Disorders, Post-Traumatic [F03.950.750.500]|stress disorders, post-traumatic [f03.950.750.500]
5971833|NCT02950961|Primary Health Care [N04.590.233.727]|primary health care [n04.590.233.727]
5971834|NCT02950961|Mental Health [F02.418]|mental health [f02.418]
5971835|NCT02950961|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
5971836|NCT02950961|Patient Satisfaction [N05.300.150.600.630]|patient satisfaction [n05.300.150.600.630]
5971837|NCT02950961|Patient Preference [N05.300.150.600.630.500]|patient preference [n05.300.150.600.630.500]
5971838|NCT02950961|Physicians, Primary Care [M01.526.485.810.800]|physicians, primary care [m01.526.485.810.800]
5971839|NCT02950961|Physicians, Women [M01.526.485.810.820]|physicians, women [m01.526.485.810.820]
5971840|NCT02950961|Health Behavior [F01.145.488]|health behavior [f01.145.488]
5971841|NCT02950467|HIV/AIDS|hiv/aids
5971842|NCT02950467|Demoralization|demoralization
5971843|NCT02950467|Psilocybin|psilocybin
5971844|NCT02950467|Group therapy|group therapy
5971845|NCT02947230|Mobility|mobility
5971846|NCT02947230|Aging|aging
5971847|NCT02947230|Knowledge Translation|knowledge translation
5971849|NCT02945150|hemodialysis|hemodialysis
5971850|NCT02945150|peritoneal dialysis|peritoneal dialysis
5971851|NCT02945150|renal failure|renal failure
5971852|NCT02945150|kidney transplant|kidney transplant
5971853|NCT02943785|Transcatheter Aortic Valve Implantation -- TAVI|transcatheter aortic valve implantation -- tavi
5971854|NCT02943785|Anticoagulation|anticoagulation
5971855|NCT02943785|Atrial Fibrillation|atrial fibrillation
5971856|NCT02943785|ENVISAGE-TAVI-AF|envisage-tavi-af
5971857|NCT02943161|Obesity|obesity
5971858|NCT02943161|L-citrulline|l-citrulline
5971859|NCT02943070|Rezum|rezum
5971860|NCT02943070|Water Vapor Ablation|water vapor ablation
5971861|NCT02941783|Kovaltry|kovaltry
5971862|NCT02941783|hemophilia A|hemophilia a
5971863|NCT02941783|Japan|japan
5971864|NCT02941783|Post-marketing surveillance|post-marketing surveillance
5971865|NCT02941263|Eye Disease|eye disease
5971866|NCT02940678|Trauma|trauma
5971867|NCT02940678|Clinical prediction models|clinical prediction models
5971868|NCT02940678|Transferability studies|transferability studies
5971869|NCT02940678|Sweden|sweden
5971870|NCT02940392|Rezum|rezum
5971871|NCT02939651|Metastatic|metastatic
5971872|NCT02939651|High grade|high grade
5971873|NCT02939599|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
5971874|NCT02939599|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
5971875|NCT02939599|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
5971876|NCT02939599|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
5971877|NCT02939599|Shortness of breath|shortness of breath
5971878|NCT02939599|Dizziness|dizziness
5971879|NCT02939599|Fainting|fainting
5971880|NCT02939599|Leg swelling|leg swelling
5971881|NCT02939599|Cough|cough
5971882|NCT02939599|Angina pector|angina pector
5971883|NCT02939014|Drug therapy|drug therapy
5971884|NCT02937818|Platinum Refractory Extensive-Stage Carcinoma, Small Cell Lung|platinum refractory extensive-stage carcinoma, small cell lung
5971885|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Carcinoma of Lung|platinum refractory extensive-stage oat cell carcinoma of lung
5971886|NCT02937818|Platinum Refractory Extensive-Stage Oat Cell Lung Cancer|platinum refractory extensive-stage oat cell lung cancer
5971887|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Cancer Of The Lung|platinum refractory extensive-stage small cell cancer of the lung
5971888|NCT02937818|Platinum Refractory Extensive-Stage Small Cell Lung Cancer|platinum refractory extensive-stage small cell lung cancer
5971889|NCT02937207|Bronchial Asthma|bronchial asthma
5971890|NCT02937207|Traditional Chinese Medicine|traditional chinese medicine
5971891|NCT02936037|progressive multiple sclerosis|progressive multiple sclerosis
5971892|NCT02936037|MS|ms
5971893|NCT02936037|EDSS|edss
5971894|NCT02936037|TW25|tw25
5971895|NCT02936037|multiple sclerosis|multiple sclerosis
5971896|NCT02934997|sepsis|sepsis
5971897|NCT02934997|septic shock|septic shock
5971898|NCT02934997|cholesterol|cholesterol
5971899|NCT02934997|high density lipoprotein|high density lipoprotein
5971900|NCT02934620|pregnancy|pregnancy
5971901|NCT02934620|condom|condom
5971902|NCT02934620|HIV|hiv
5971903|NCT02934620|sexually transmitted infections|sexually transmitted infections
5971904|NCT02934516|Obstructed labor|obstructed labor
5971905|NCT02934516|C section. push method|c section. push method
5971906|NCT02934516|reverse breech|reverse breech
5971907|NCT02933996|immunosuppression|immunosuppression
5971908|NCT02933996|cardiac surgery|cardiac surgery
5971909|NCT02933996|TEAS(Transcutaneous electrical acupoint stimulation)|teas(transcutaneous electrical acupoint stimulation)
5971910|NCT02933996|postoperative|postoperative
5971911|NCT02933801|metastatic castration resistant prostate cancer (mCRPC)|metastatic castration resistant prostate cancer (mcrpc)
5971912|NCT02933801|Prostate Cancer|prostate cancer
5971913|NCT02933801|phase II trial|phase ii trial
5971914|NCT02933801|ODM-201|odm-201
5971915|NCT02933801|maintenance therapy|maintenance therapy
5971916|NCT02933255|Safety|safety
5971917|NCT02933255|Neoadjuvant|neoadjuvant
5971918|NCT02933255|Prostatectomy|prostatectomy
5971919|NCT02933255|Immunotherapy|immunotherapy
5971920|NCT02933255|Vaccine|vaccine
5971921|NCT02930941|tranexamic acid|tranexamic acid
5971922|NCT02930941|epistaxis|epistaxis
5971923|NCT02930941|emergency medicine|emergency medicine
5971924|NCT02930941|intranasal|intranasal
5971925|NCT02930941|TXA|txa
5971926|NCT02929134|Lymphedema|lymphedema
5971927|NCT02929134|Lymphatic Filariasis|lymphatic filariasis
5971928|NCT02929134|Filariasis|filariasis
5971929|NCT02929134|Doxycycline|doxycycline
5971930|NCT02929121|Lymphedema|lymphedema
5971931|NCT02929121|Lymphatic Filariasis|lymphatic filariasis
5971932|NCT02929121|Filariasis|filariasis
5971933|NCT02929121|Doxycycline|doxycycline
5971934|NCT02928029|Radium-223 dichloride|radium-223 dichloride
5971935|NCT02928029|Bortezomib|bortezomib
5971936|NCT02928029|Dexamethasone|dexamethasone
5971937|NCT02928029|Relapsed multiple myeloma|relapsed multiple myeloma
5971938|NCT02928029|Combination therapy multiple myeloma|combination therapy multiple myeloma
5971939|NCT02927873|Safety|safety
5971940|NCT02927873|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5971941|NCT02927873|Immunogenicity|immunogenicity
5971942|NCT02927873|Reactogenicity|reactogenicity
5971943|NCT02927873|Infants|infants
5971944|NCT02927873|Vaccine|vaccine
5971945|NCT02927496|Lymphedema|lymphedema
5971946|NCT02927496|Lymphatic Filariasis|lymphatic filariasis
5971947|NCT02927496|Filariasis|filariasis
5971948|NCT02927496|Doxycycline|doxycycline
5971949|NCT02927366|Pulmonary hypertension (PH),|pulmonary hypertension (ph),
5971950|NCT02927366|Increase blood pressure in the pulmonary artery|increase blood pressure in the pulmonary artery
5971951|NCT02927366|Increased blood pressure in the pulmonary vein|increased blood pressure in the pulmonary vein
5971952|NCT02927366|Increased blood pressure in the lung vasculature|increased blood pressure in the lung vasculature
5971953|NCT02927366|Shortness of breath|shortness of breath
5971954|NCT02927366|Dizziness|dizziness
5971955|NCT02927366|Fainting|fainting
5971956|NCT02927366|Leg swelling|leg swelling
5971957|NCT02927366|Cough|cough
5971958|NCT02927366|QCC374|qcc374
5971959|NCT02925104|cMET, INC280, food,|cmet, inc280, food,
5971960|NCT02924688|umeclidinium bromide|umeclidinium bromide
5971961|NCT02924688|fluticasone furoate|fluticasone furoate
5971962|NCT02924688|vilanterol|vilanterol
5971963|NCT02924688|fixed dose combination|fixed dose combination
5971964|NCT02924688|lung function|lung function
5971965|NCT02924688|albuterol/salbutamol|albuterol/salbutamol
5971966|NCT02924688|asthma|asthma
5971967|NCT02924688|closed triple therapy|closed triple therapy
5971968|NCT02923063|Chronic Kidney Disease|chronic kidney disease
5971969|NCT02923063|Mitochondrial Metabolism|mitochondrial metabolism
5971970|NCT02923063|Physical Performance|physical performance
5971971|NCT02923063|Exercise Intolerance|exercise intolerance
5971972|NCT02923063|Muscle Fatigue|muscle fatigue
5971973|NCT02922751|transient elastography|transient elastography
5971974|NCT02922751|pediatric liver disease|pediatric liver disease
5971975|NCT02922751|biliary atresia|biliary atresia
5971976|NCT02922751|Alagille Syndrome|alagille syndrome
5971977|NCT02922751|Alpha1 Anti-Trypsin Deficiency|alpha1 anti-trypsin deficiency
5971978|NCT02922751|liver fibrosis|liver fibrosis
5971979|NCT02922751|cholestasis|cholestasis
5971980|NCT02921737|metastatic|metastatic
5971981|NCT02921737|pancreatic|pancreatic
5971982|NCT02921737|adenocarcinoma|adenocarcinoma
5971983|NCT02919228|cerebral oxygen metabolism|cerebral oxygen metabolism
5971984|NCT02919228|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5971985|NCT02919228|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5971986|NCT02919228|heart rate variability|heart rate variability
5971987|NCT02919228|blood pressure|blood pressure
5971988|NCT02919228|affect|affect
5971989|NCT02919228|mood|mood
5971990|NCT02919228|respiration|respiration
5971991|NCT02919228|systematic randomized cross-over study|systematic randomized cross-over study
5971992|NCT02919228|systemic physiology|systemic physiology
5971993|NCT02919228|electro-dermal activity|electro-dermal activity
5971994|NCT02919228|pulse-respiratory quotient|pulse-respiratory quotient
5971995|NCT02919189|cerebral oxygen metabolism|cerebral oxygen metabolism
5971996|NCT02919189|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5971997|NCT02919189|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5971998|NCT02919189|heart rate variability|heart rate variability
5971999|NCT02919189|blood pressure|blood pressure
5972000|NCT02919189|affect|affect
5972001|NCT02919189|mood|mood
5972002|NCT02919189|respiration|respiration
5972003|NCT02919189|systematic randomized cross-over study|systematic randomized cross-over study
5972004|NCT02919189|systemic physiology|systemic physiology
5972005|NCT02919189|electro-dermal activity|electro-dermal activity
5972006|NCT02919189|pulse-respiratory quotient|pulse-respiratory quotient
5972007|NCT02917876|Obstructive Sleep Apnea|obstructive sleep apnea
5972008|NCT02917876|Pregnancy|pregnancy
5972009|NCT02917876|Obesity|obesity
5972010|NCT02917876|Fluid shifts|fluid shifts
5972011|NCT02917876|Body composition|body composition
5972012|NCT02917876|Sleep|sleep
5972013|NCT02915783|unresectable advanced|unresectable advanced
5972014|NCT02915783|metastatic|metastatic
5972015|NCT02913495|Progesterone|progesterone
5972016|NCT02913495|Prevention of preterm birth|prevention of preterm birth
5972017|NCT02906943|Molecular Profiling|molecular profiling
5972018|NCT02906943|Advanced Cancer|advanced cancer
5972019|NCT02906943|Advanced Solid Tumors|advanced solid tumors
5972020|NCT02906943|Phase I Clinical Trial Candidates|phase i clinical trial candidates
5972021|NCT02906943|Next Generation Sequencing|next generation sequencing
5972022|NCT02904291|Bariatric surgery|bariatric surgery
5972023|NCT02904291|Gastrointestinal tract|gastrointestinal tract
5972024|NCT02904291|Biological availability|biological availability
5972025|NCT02904291|Pharmacokinetics|pharmacokinetics
5972026|NCT02904291|Amlodipine|amlodipine
5972027|NCT02903914|Immuno-Oncology|immuno-oncology
5972028|NCT02903914|Checkpoint Inhibitors|checkpoint inhibitors
5972029|NCT02903914|Tumor Metabolism|tumor metabolism
5972030|NCT02903914|Programmed cell death protein-1 (PD-1) inhibitor|programmed cell death protein-1 (pd-1) inhibitor
5972031|NCT02903914|Programmed death ligand 1 (PD-L1) inhibitor|programmed death ligand 1 (pd-l1) inhibitor
5972032|NCT02903914|Solid Tumors|solid tumors
5972033|NCT02903914|RCC|rcc
5972034|NCT02903914|MEL|mel
5972035|NCT02903914|NSCLC|nsclc
5972036|NCT02903914|Arginase|arginase
5972037|NCT02903914|Arginase Inhibitor|arginase inhibitor
5972038|NCT02903914|INCB001158 (CB-1158)|incb001158 (cb-1158)
5972039|NCT02903914|SCCHN|scchn
5972040|NCT02903914|GEJ|gej
5972041|NCT02903914|Immune Therapy|immune therapy
5972042|NCT02902757|FDG|fdg
5972043|NCT02902757|PET/CT very early response (48 hrs)|pet/ct very early response (48 hrs)
5972044|NCT02901626|Short cervix|short cervix
5972045|NCT02901626|Preterm delivery|preterm delivery
5972046|NCT02901626|Singletons|singletons
5972047|NCT02901626|Pregnancy|pregnancy
5972048|NCT02901626|Pessary|pessary
5972049|NCT02900664|CRC|crc
5972050|NCT02900664|TNBC|tnbc
5972051|NCT02900664|NSCLC (adenocarcinoma)|nsclc (adenocarcinoma)
5972052|NCT02900664|Immunomodulation|immunomodulation
5972053|NCT02900664|Biomarkers|biomarkers
5972054|NCT02900664|Bayesian logistic regression model|bayesian logistic regression model
5972055|NCT02900664|PDR001|pdr001
5972056|NCT02900664|Immunotherapy|immunotherapy
5972057|NCT02900651|MAK683, DLBCL, EED - Embryonic ectoderm development, EZH2 - Enhancer of zeste homolog 2|mak683, dlbcl, eed - embryonic ectoderm development, ezh2 - enhancer of zeste homolog 2
5972058|NCT02900495|Nocturnal Enuresis|nocturnal enuresis
5972059|NCT02900495|Bedwetting|bedwetting
5972060|NCT02900495|TENS|tens
5972061|NCT02900157|Advanced Solid Tumor|advanced solid tumor
5972062|NCT02900157|Immunotherapy|immunotherapy
5972063|NCT02900157|MEDI9090|medi9090
5972064|NCT02900157|MEDI4736|medi4736
5972065|NCT02900157|Durvalumab|durvalumab
5972066|NCT02899754|lung cancer|lung cancer
5972067|NCT02899754|decision support|decision support
5972068|NCT02899754|implementation|implementation
5972069|NCT02898688|Influenza vaccine|influenza vaccine
5972070|NCT02898688|Pertussis vaccine|pertussis vaccine
5972071|NCT02898688|Perinatal vaccination|perinatal vaccination
5972072|NCT02898688|Infant vaccination|infant vaccination
5972073|NCT02896192|POMC deficiency obesity|pomc deficiency obesity
5972074|NCT02896192|PCSK1 deficiency obesity|pcsk1 deficiency obesity
5972075|NCT02890745|Empagliflozin|empagliflozin
5972076|NCT02890745|Oxidative stress|oxidative stress
5972077|NCT02890745|Oxidative nucleic acid modifications|oxidative nucleic acid modifications
5972078|NCT02890745|8-oxo-7,8-dihydro-2'-deoxyguanosine|8-oxo-7,8-dihydro-2'-deoxyguanosine
5972079|NCT02890745|8-oxo-7,8-dihydroguanosine|8-oxo-7,8-dihydroguanosine
5972080|NCT02889809|Growth Velocity|growth velocity
5972081|NCT02889809|Prepubertal|prepubertal
5972082|NCT02889809|Asthma|asthma
5972083|NCT02889809|Paediatric|paediatric
5972084|NCT02889510|diabetes|diabetes
5972085|NCT02889510|liraglutide|liraglutide
5972086|NCT02889510|lung function|lung function
5972087|NCT02883673|Postpartum Hemorrhage|postpartum hemorrhage
5972088|NCT02882542|cerebral oxygen metabolism|cerebral oxygen metabolism
5972089|NCT02882542|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5972090|NCT02882542|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5972096|NCT02882542|systematic randomized cross-over study|systematic randomized cross-over study
5972097|NCT02882542|systemic physiology|systemic physiology
5972098|NCT02882542|electro-dermal activity|electro-dermal activity
5972099|NCT02882542|pulse-respiratory quotient|pulse-respiratory quotient
5972100|NCT02882529|cerebral oxygen metabolism|cerebral oxygen metabolism
5972101|NCT02882529|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5972102|NCT02882529|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5972103|NCT02882529|heart rate variability|heart rate variability
5972104|NCT02882529|blood pressure|blood pressure
5972105|NCT02882529|affect|affect
5972106|NCT02882529|mood|mood
5972107|NCT02882529|respiration|respiration
5972108|NCT02882529|systematic randomized cross-over study|systematic randomized cross-over study
5972109|NCT02882529|systemic physiology|systemic physiology
5972110|NCT02882529|electro-dermal activity|electro-dermal activity
5972111|NCT02882529|pulse-respiratory quotient|pulse-respiratory quotient
5972112|NCT02882516|cerebral oxygen metabolism|cerebral oxygen metabolism
5972113|NCT02882516|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5972114|NCT02882516|partial pressure of carbon dioxide|partial pressure of carbon dioxide
5972115|NCT02882516|heart rate variability|heart rate variability
5972116|NCT02882516|blood pressure|blood pressure
5972117|NCT02882516|affect|affect
5972118|NCT02882516|mood|mood
5972119|NCT02882516|respiration|respiration
5972120|NCT02882516|systematic randomized cross-over study|systematic randomized cross-over study
5972121|NCT02882516|systemic physiology|systemic physiology
5972122|NCT02882516|electro-dermal activity|electro-dermal activity
5972123|NCT02882516|pulse-respiratory quotient|pulse-respiratory quotient
5972124|NCT02880878|Subcortical Intracerebral Hemorrhage|subcortical intracerebral hemorrhage
5972125|NCT02880878|Intracerebral Hemorrhage|intracerebral hemorrhage
5972126|NCT02880878|Intracranial Hemorrhages|intracranial hemorrhages
5972127|NCT02880878|ICH|ich
5972128|NCT02880878|Hemorrhage|hemorrhage
5972129|NCT02880878|Cerebrovascular Disorders|cerebrovascular disorders
5972130|NCT02880878|Brain Diseases|brain diseases
5972131|NCT02880878|Central Nervous System Diseases|central nervous system diseases
5972132|NCT02880878|Nervous System Diseases|nervous system diseases
5972133|NCT02880878|Vascular Diseases|vascular diseases
5972134|NCT02880878|Cardiovascular Diseases|cardiovascular diseases
5972135|NCT02880878|Pathologic Processes|pathologic processes
5972136|NCT02880878|MIPS|mips
5972137|NCT02880878|Minimally Invasive Parafascicular Surgery|minimally invasive parafascicular surgery
5972138|NCT02880878|Neurosurgery|neurosurgery
5972139|NCT02880878|Medical Economic|medical economic
5972140|NCT02880878|Hospital Economics|hospital economics
5972141|NCT02880722|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5972142|NCT02880722|Experience Sampling Method (ESM)|experience sampling method (esm)
5972143|NCT02880722|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
5972144|NCT02880722|Abdominal pain|abdominal pain
5972145|NCT02879500|Systematic review and meta-analysis|systematic review and meta-analysis
5972146|NCT02879500|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5972147|NCT02879500|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5972148|NCT02879500|Clinical practice guidelines|clinical practice guidelines
5972149|NCT02879500|Randomized controlled trials|randomized controlled trials
5972150|NCT02879500|Prospective cohort studies|prospective cohort studies
5972151|NCT02879500|Body weight|body weight
5972152|NCT02879500|Body mass index|body mass index
5972153|NCT02879500|Adiposity|adiposity
5972154|NCT02879500|Overweight|overweight
5972155|NCT02879500|Obesity|obesity
5972156|NCT02879305|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5972157|NCT02879305|GSK1278863|gsk1278863
5972158|NCT02879305|daprodustat|daprodustat
5972159|NCT02879305|anemia|anemia
5972160|NCT02879305|chronic kidney disease|chronic kidney disease
5972161|NCT02879305|hemoglobin|hemoglobin
5972162|NCT02879305|recombinant human erythropoietin|recombinant human erythropoietin
5972163|NCT02876835|GSK1278863|gsk1278863
5972164|NCT02876835|hemoglobin|hemoglobin
5972165|NCT02876835|anemia|anemia
5972166|NCT02876835|non-dialysis|non-dialysis
5972167|NCT02876835|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5972168|NCT02876835|daprodustat|daprodustat
5972169|NCT02876835|chronic kidney disease|chronic kidney disease
5972170|NCT02876328|Ebola Vaccine|ebola vaccine
5972171|NCT02876302|Inflammatory Breast Cancer|inflammatory breast cancer
5972172|NCT02876302|Breast Cancer|breast cancer
5972173|NCT02876302|Triple Negative Breast Cancer|triple negative breast cancer
5972174|NCT02871297|adolescent|adolescent
5972175|NCT02871297|children|children
5972176|NCT02865473|Schlemm's canal lumen area|schlemm's canal lumen area
5972177|NCT02865473|PEX|pex
5972178|NCT02863601|Buprenorphine|buprenorphine
5972179|NCT02863601|Opiate Substitution Treatment|opiate substitution treatment
5972180|NCT02861859|Breast cancer|breast cancer
5972181|NCT02861859|Breast Carcinoma|breast carcinoma
5972182|NCT02861859|Breast Tumors|breast tumors
5972183|NCT02861859|Chemotherapy|chemotherapy
5972184|NCT02861859|Antiemetic effects|antiemetic effects
5972185|NCT02861859|Antiemetic drugs|antiemetic drugs
5972186|NCT02861859|Drug Therapy|drug therapy
5972187|NCT02861846|epilepsy|epilepsy
5972188|NCT02861846|Alzheimer|alzheimer
5972189|NCT02861846|biomarkers|biomarkers
5972190|NCT02861846|predictive value|predictive value
5972191|NCT02861508|Ultrasonography|ultrasonography
5972192|NCT02859454|PD-L1 Expression|pd-l1 expression
5972193|NCT02859454|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5972194|NCT02859454|Juvenile-onset Disease|juvenile-onset disease
5972195|NCT02859454|Papillomatous Lesions|papillomatous lesions
5972196|NCT02859454|Monoclonal Antibody|monoclonal antibody
5972197|NCT02859428|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5972198|NCT02858895|High grade glioma|high grade glioma
5972199|NCT02858895|malignant glioma|malignant glioma
5972200|NCT02858895|recurrent glioblastoma|recurrent glioblastoma
5972201|NCT02858895|recurrent GBM|recurrent gbm
5972202|NCT02858895|recurrent GB|recurrent gb
5972203|NCT02858895|glioblastoma (GB)|glioblastoma (gb)
5972204|NCT02858895|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5972205|NCT02858895|progressive glioblastoma|progressive glioblastoma
5972206|NCT02858895|Brain tumor|brain tumor
5972207|NCT02858895|Brain cancer|brain cancer
5972208|NCT02858895|immunotherapy|immunotherapy
5972209|NCT02858895|targeted|targeted
5972210|NCT02858895|IL4R|il4r
5972211|NCT02858310|Vulvar High Grade Squamous Intraepithelial Lesion|vulvar high grade squamous intraepithelial lesion
5972212|NCT02858310|Vulvar Intraepithelial Neoplasia|vulvar intraepithelial neoplasia
5972213|NCT02858310|Vaccine|vaccine
5972214|NCT02858310|Immunotherapy|immunotherapy
5972215|NCT02858310|Human Papillomavirus|human papillomavirus
5972216|NCT02857673|Children with Special Health Care Needs|children with special health care needs
5972217|NCT02857673|Violence Prevention|violence prevention
5972218|NCT02857270|MAPK|mapk
5972219|NCT02857270|RAS|ras
5972220|NCT02857270|BRAF|braf
5972221|NCT02856360|Football|football
5972222|NCT02856360|Cleats|cleats
5972223|NCT02856360|Stiffness|stiffness
5972224|NCT02855268|Kidney disease|kidney disease
5972225|NCT02855268|Nephritis|nephritis
5972226|NCT02855268|Hereditary nephritis|hereditary nephritis
5972227|NCT02855268|Hereditary kidney disease|hereditary kidney disease
5972228|NCT02855164|LJN452|ljn452
5972229|NCT02855164|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5972230|NCT02855164|NASH|nash
5972231|NCT02855164|phase 2|phase 2
5972232|NCT02855164|adaptive design|adaptive design
5972233|NCT02855164|randomized|randomized
5972234|NCT02853305|PD1|pd1
5972235|NCT02853305|PD-1|pd-1
5972236|NCT02853305|PDL1|pdl1
5972237|NCT02853305|PD-L1|pd-l1
5972238|NCT02849535|Oral chemotherapy|oral chemotherapy
5972239|NCT02849535|Relative dose intensity|relative dose intensity
5972240|NCT02849535|Health related program|health related program
5972241|NCT02849535|Secured drug intake|secured drug intake
5273031|NCT02314572|Photopic Vision|photopic vision
5972242|NCT02849223|Mild Traumatic Brain Injury|mild traumatic brain injury
5972243|NCT02849223|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5972244|NCT02849223|Working Memory|working memory
5972245|NCT02843529|biomarkers|biomarkers
5972246|NCT02843529|CSF|csf
5972247|NCT02843529|EEG|eeg
5972248|NCT02843529|MRI|mri
5972249|NCT02843529|Digital biomarkers|digital biomarkers
5972250|NCT02842671|autism|autism
5972251|NCT02842671|ambassador|ambassador
5972252|NCT02842658|Chemotherapy|chemotherapy
5972253|NCT02842658|Exercise|exercise
5972254|NCT02840994|CV301, NSCLC, Pembrolizumab, Nivolumab|cv301, nsclc, pembrolizumab, nivolumab
5972255|NCT02840799|Heart Failure|heart failure
5972256|NCT02840799|Exercise Intolerance|exercise intolerance
5972257|NCT02840799|Ejection Fraction|ejection fraction
5972258|NCT02840084|breast implant capsular contracture|breast implant capsular contracture
5972259|NCT02836496|Safety|safety
5972260|NCT02836496|Mepolizumab|mepolizumab
5972261|NCT02836496|Hypereosinophilic syndrome|hypereosinophilic syndrome
5972262|NCT02836496|HES flare|hes flare
5972263|NCT02836496|Efficacy|efficacy
5972264|NCT02831010|prematurity|prematurity
5972265|NCT02830724|Metastatic Solid Cancers|metastatic solid cancers
5972266|NCT02830724|Renal Cell Cancer|renal cell cancer
5972267|NCT02830724|Cell Therapy|cell therapy
5972268|NCT02830724|CAR T Cells|car t cells
5972269|NCT02829723|Phase I/II|phase i/ii
5972270|NCT02829723|BLZ945|blz945
5972271|NCT02829723|PDR001|pdr001
5972272|NCT02829723|CSF-1R|csf-1r
5972273|NCT02829723|PD-1|pd-1
5972274|NCT02827032|Hypertension|hypertension
5972275|NCT02823821|End-Stage Kidney Disease|end-stage kidney disease
5972276|NCT02823821|Hemodialysis|hemodialysis
5972277|NCT02823821|Dialysate|dialysate
5972278|NCT02823821|Sodium|sodium
5972279|NCT02823821|Cluster-randomisation|cluster-randomisation
5972280|NCT02823821|Dialysis|dialysis
5972281|NCT02823821|RESOLVE|resolve
5972282|NCT02822235|Drug Therapy|drug therapy
5972283|NCT02821780|Stroke|stroke
5972284|NCT02821780|progressive white matter degeneration, and debilitating dementia.|progressive white matter degeneration, and debilitating dementia.
5972285|NCT02821780|progressive chronic hypoperfusion|progressive chronic hypoperfusion
5972286|NCT02821780|Biospecimen Procurement|biospecimen procurement
5972287|NCT02821780|Laboratory Research Specimens|laboratory research specimens
5972288|NCT02819973|Patient Education|patient education
5972289|NCT02819973|ICD|icd
5972290|NCT02819973|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5972291|NCT02819973|Video|video
5972292|NCT02819973|Decision|decision
5972293|NCT02819973|Decision making|decision making
5972294|NCT02819349|Relapse Prevention|relapse prevention
5972295|NCT02819349|People with Schizophrenia|people with schizophrenia
5972296|NCT02819349|Text-Messaging|text-messaging
5972297|NCT02819349|Assertive Community Treatment (ACT)|assertive community treatment (act)
5972298|NCT02819011|Ankle Foot Orthoses|ankle foot orthoses
5972299|NCT02819011|falls|falls
5972300|NCT02819011|Fall Prevention|fall prevention
5972301|NCT02819011|Frailty|frailty
5972302|NCT02819011|Concern for falls|concern for falls
5972303|NCT02819011|Footwear|footwear
5972304|NCT02819011|Mobility|mobility
5972305|NCT02818764|serum biomarkers|serum biomarkers
5972306|NCT02818764|cerebral blood flow|cerebral blood flow
5972307|NCT02818764|modified Blessed Dementia Rating scale|modified blessed dementia rating scale
5972308|NCT02818764|Confusion Assessment Method|confusion assessment method
5972309|NCT02818764|Delirium Rating Scale-98|delirium rating scale-98
5972310|NCT02816047|wearable cardioverter defibrillator|wearable cardioverter defibrillator
5972311|NCT02816047|LifeVest|lifevest
5972312|NCT02816047|sudden death|sudden death
5972313|NCT02816047|defibrillator|defibrillator
5972314|NCT02811809|Prostate cancer|prostate cancer
5972315|NCT02811809|Apalutamide|apalutamide
5972316|NCT02811809|IHT|iht
5972317|NCT02811809|BCR|bcr
5972318|NCT02811809|Biochemical recurrence|biochemical recurrence
5972319|NCT02811809|intermittent hormone therapy|intermittent hormone therapy
5972320|NCT02810860|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5972321|NCT02810678|Tuberculosis|tuberculosis
5972322|NCT02808819|Asthma|asthma
5972323|NCT02808819|Bronchial Diseases|bronchial diseases
5972324|NCT02808819|Respiratory Tract Diseases|respiratory tract diseases
5972325|NCT02808819|Lung Diseases|lung diseases
5972326|NCT02808819|Obstructive Lung Diseases|obstructive lung diseases
5972327|NCT02807844|Triple negative breast cancer|triple negative breast cancer
5972328|NCT02807844|Pancreatic carcinoma|pancreatic carcinoma
5972329|NCT02807844|Melanoma|melanoma
5972330|NCT02807844|Endometrial Carcinoma|endometrial carcinoma
5972331|NCT02807844|Immuno oncology|immuno oncology
5972332|NCT02807844|Monoclonal antibody|monoclonal antibody
5972333|NCT02807844|PDR001|pdr001
5972334|NCT02807844|MCS110|mcs110
5972335|NCT02807337|Oral mucositis|oral mucositis
5972336|NCT02804178|ATR-101|atr-101
5972337|NCT02804178|classic congenital adrenal hyperplasia|classic congenital adrenal hyperplasia
5972338|NCT02804178|21-hydroxylase deficiency|21-hydroxylase deficiency
5972339|NCT02804178|CAH|cah
5972340|NCT02804022|Respiratory Depression|respiratory depression
5972341|NCT02803190|Spine curve|spine curve
5972342|NCT02803190|Posture|posture
5972343|NCT02803190|Fracture|fracture
5972344|NCT02803190|sarcopenia|sarcopenia
5972345|NCT02803190|Exercise|exercise
5972346|NCT02802618|Validity|validity
5972347|NCT02802618|Reliability|reliability
5972348|NCT02802618|Rehabilitation|rehabilitation
5972349|NCT02802618|Translation|translation
5972350|NCT02802618|Education|education
5972351|NCT02801578|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5972352|NCT02801578|CLL|cll
5972353|NCT02801578|Malignant neoplasms stated as primary lymphoid haematopoietic|malignant neoplasms stated as primary lymphoid haematopoietic
5972354|NCT02801578|Ibrutinib|ibrutinib
5972355|NCT02801578|PCI-32765|pci-32765
5972356|NCT02801578|Imbruvica|imbruvica
5972357|NCT02801578|Pharmacodynamics|pharmacodynamics
5972358|NCT02797951|cluster headache|cluster headache
5972359|NCT02797951|headache|headache
5972360|NCT02797951|brain diseases|brain diseases
5972361|NCT02797951|central nervous system diseases|central nervous system diseases
5972362|NCT02797951|headache disorders|headache disorders
5972363|NCT02797951|headache disorders, primary|headache disorders, primary
5972364|NCT02797951|nervous system diseases|nervous system diseases
5972365|NCT02797951|neurologic manifestations|neurologic manifestations
5972366|NCT02797951|pain|pain
5972367|NCT02797951|trigeminal autonomic cephalalgias|trigeminal autonomic cephalalgias
5972368|NCT02795806|Address|address
5972369|NCT02792114|T-Cell|t-cell
5972370|NCT02792114|Chimeric antigen receptor (CAR)|chimeric antigen receptor (car)
5972371|NCT02792114|CAR T cells|car t cells
5972372|NCT02792114|Triple-negative breast cancer|triple-negative breast cancer
5972373|NCT02792114|Immunotherapy T-cell therapy|immunotherapy t-cell therapy
5972374|NCT02792114|16-040|16-040
5972375|NCT02792114|immunotherapy|immunotherapy
5972376|NCT02792114|CAR|car
5972377|NCT02791230|amyloidosis|amyloidosis
5972378|NCT02791230|amyloid|amyloid
5972379|NCT02791230|transthyretin|transthyretin
5972380|NCT02791230|TTR|ttr
5972381|NCT02791230|ATTR-CM|attr-cm
5972382|NCT02788227|Ebola Vaccine|ebola vaccine
5972383|NCT02788201|COXEN|coxen
5972384|NCT02788201|Bladder Cancer|bladder cancer
5972385|NCT02788201|Molecular Profiles|molecular profiles
5972386|NCT02788175|HIV Immune Therapy|hiv immune therapy
5972387|NCT02788175|Monoclonal Antibody|monoclonal antibody
5972388|NCT02788175|Integrin|integrin
5972389|NCT02787863|Pneumococcal vaccines|pneumococcal vaccines
5972390|NCT02786472|Bystander behaviors|bystander behaviors
5972391|NCT02786472|Incoming students|incoming students
5972392|NCT02786472|CampusSave|campussave
5972393|NCT02786472|Prevention|prevention
5972394|NCT02786472|Sexual Assault|sexual assault
5972395|NCT02786472|Incapacitation|incapacitation
5972396|NCT02786186|Psoriasis|psoriasis
5972397|NCT02786186|Plaque Psoriasis|plaque psoriasis
5972398|NCT02786186|Chronic Plaque Psoriasis|chronic plaque psoriasis
5972399|NCT02786186|Cosentyx|cosentyx
5972400|NCT02786186|Secukinumab|secukinumab
5972401|NCT02786186|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5972402|NCT02786186|PURE registry|pure registry
5972403|NCT02786186|Registry|registry
5972404|NCT02784600|Partial-thickness|partial-thickness
5972405|NCT02784600|Full-thickness|full-thickness
5972406|NCT02784210|Centripetal Enhancement|centripetal enhancement
5972407|NCT02784210|MRI|mri
5972408|NCT02784210|7 Tesla|7 tesla
5972409|NCT02784210|Gadolinium|gadolinium
5972410|NCT02784210|MS|ms
5972411|NCT02784080|Liver Transplantation|liver transplantation
5972412|NCT02784080|HLA alloantibodies|hla alloantibodies
5972413|NCT02784080|donor specific antibodies|donor specific antibodies
5972414|NCT02784080|Mortality|mortality
5972415|NCT02784080|Re-transplantation|re-transplantation
5972416|NCT02784080|Rejection|rejection
5972417|NCT02784080|Acute rejection|acute rejection
5972418|NCT02784080|Chronic rejection|chronic rejection
5972419|NCT02784080|Biliary complications|biliary complications
5972420|NCT02784080|Biliary stricture|biliary stricture
5972421|NCT02784080|Arterial thrombosis|arterial thrombosis
5972422|NCT02784080|Arterial stenosis|arterial stenosis
5972423|NCT02784080|Portal vein thrombosis|portal vein thrombosis
5972424|NCT02784080|Fibrosis|fibrosis
5972425|NCT02784080|Single antigen bead|single antigen bead
5972426|NCT02784080|Cross-match|cross-match
5972427|NCT02782780|insomnia|insomnia
5972428|NCT02782780|insomnia disorder|insomnia disorder
5972429|NCT02782780|Gulf War Illness|gulf war illness
5972430|NCT02782780|Chronic Multisymptom Illness|chronic multisymptom illness
5972431|NCT02781129|Memory|memory
5972432|NCT02781129|Responsive Neurostimulator System|responsive neurostimulator system
5972433|NCT02776904|Concussion|concussion
5972434|NCT02776904|Football player|football player
5972435|NCT02776904|Movement assessment|movement assessment
5972436|NCT02776904|Soccer player|soccer player
5972437|NCT02775461|Pancreas Cancer|pancreas cancer
5972438|NCT02775461|Chronic Pancreatitis|chronic pancreatitis
5972439|NCT02775461|Pancreatic Cyst|pancreatic cyst
5972440|NCT02775461|BRCA1|brca1
5972441|NCT02775461|BRCA2|brca2
5972442|NCT02775461|Lynch Syndrome|lynch syndrome
5972443|NCT02775461|Peutz-Jeghers syndrome|peutz-jeghers syndrome
5972444|NCT02775461|ATM mutation|atm mutation
5972445|NCT02775461|FAMMM Syndrome|fammm syndrome
5972446|NCT02775461|Pancreatitis|pancreatitis
5972447|NCT02775461|Family History of Pancreas Cancer|family history of pancreas cancer
5972448|NCT02775461|Family History of Cancer|family history of cancer
5972449|NCT02771249|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
5972450|NCT02771249|Antiretrovirals (ARVs)|antiretrovirals (arvs)
5972451|NCT02771249|HIV|hiv
5972452|NCT02771249|UGT1A1|ugt1a1
5972453|NCT02771249|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
5972454|NCT02769962|PARP Inhibitor|parp inhibitor
5972455|NCT02769962|Topoisomerase I (Top1)|topoisomerase i (top1)
5972456|NCT02769962|Camptothecins|camptothecins
5972457|NCT02769962|Nanoparticle Drug Conjugate|nanoparticle drug conjugate
5972458|NCT02769962|Solid Tumors|solid tumors
5972459|NCT02769949|Genetics|genetics
5972460|NCT02769949|Metabolic|metabolic
5972461|NCT02769949|Dysmorphic Syndromes|dysmorphic syndromes
5972462|NCT02769949|Developmental Delay|developmental delay
5972463|NCT02769949|Genetic Counseling|genetic counseling
5972464|NCT02769234|EEG|eeg
5972465|NCT02769234|ERP|erp
5972466|NCT02769234|Event-related Potentials|event-related potentials
5972467|NCT02769234|Alzheimer's|alzheimer's
5972468|NCT02769234|P300|p300
5972469|NCT02768558|Lung Cancer|lung cancer
5972470|NCT02768558|NSCLC|nsclc
5972471|NCT02768558|Nivolumab|nivolumab
5972472|NCT02763566|Hormone Receptor-Positive|hormone receptor-positive
5972473|NCT02763566|HER2-Negative|her2-negative
5972474|NCT02763566|CDK4|cdk4
5972475|NCT02763566|CDK6|cdk6
5972476|NCT02763436|Neonatal transition|neonatal transition
5972477|NCT02763436|Umbilical cord clamping|umbilical cord clamping
5972478|NCT02763436|Regional cerebral oxygen saturation|regional cerebral oxygen saturation
5972479|NCT02763436|Cerebral blood volume|cerebral blood volume
5972480|NCT02763436|Near-infrared spectroscopy|near-infrared spectroscopy
5972481|NCT02763436|Arterial oxygen saturation|arterial oxygen saturation
5972482|NCT02763436|Term infants|term infants
5972483|NCT02762006|durvalumab|durvalumab
5972484|NCT02762006|tremelimumab|tremelimumab
5972485|NCT02762006|Phase Ib|phase ib
5972486|NCT02762006|Locally Advanced|locally advanced
5972487|NCT02759835|EGFR Tyrosine Kinase Inhibitors|egfr tyrosine kinase inhibitors
5972488|NCT02759835|T790M Mutation|t790m mutation
5972489|NCT02759835|Local Ablative Therapies|local ablative therapies
5972490|NCT02759835|Oligoprogressive Disease|oligoprogressive disease
5972491|NCT02759835|Acquired Resistance|acquired resistance
5972492|NCT02759744|Thermal Ablation|thermal ablation
5972493|NCT02759744|Localized Prostate Cancer|localized prostate cancer
5972494|NCT02759744|Medtronic-Visualase|medtronic-visualase
5972495|NCT02759744|Thermal Damage|thermal damage
5972496|NCT02759744|PSA Levels|psa levels
5972497|NCT02758002|atrial fibrillation ablation|atrial fibrillation ablation
5972498|NCT02758002|ablation|ablation
5972499|NCT02758002|atrial fibrillation rotors|atrial fibrillation rotors
5972500|NCT02755818|high density lipoprotein (HDL)|high density lipoprotein (hdl)
5972501|NCT02755818|lipid|lipid
5972502|NCT02755818|insulin resistance|insulin resistance
5972503|NCT02755818|glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
5972504|NCT02755818|obesity|obesity
5972505|NCT02755597|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5972506|NCT02755597|relapsed multiple myeloma|relapsed multiple myeloma
5972507|NCT02755597|refractory multiple myeloma|refractory multiple myeloma
5972508|NCT02755597|multiple myeloma|multiple myeloma
5972509|NCT02754388|LDCT, screening, health behavior, psychological factors|ldct, screening, health behavior, psychological factors
5972510|NCT02750202|Genital warts|genital warts
5972511|NCT02750202|HPV types|hpv types
5972512|NCT02750202|HPV vaccine|hpv vaccine
5972513|NCT02750202|Cervical cytology|cervical cytology
5972514|NCT02750202|Therapeutic vaccine|therapeutic vaccine
5972515|NCT02750202|Quadrivalent HPV vaccine|quadrivalent hpv vaccine
5972516|NCT02749292|rituximab|rituximab
5972517|NCT02749292|maintenance|maintenance
5972518|NCT02749292|remission|remission
5972519|NCT02749006|Bipolar disorder|bipolar disorder
5972520|NCT02749006|Depression|depression
5972521|NCT02749006|intermittent Theta-Burst Stimulation (rTMS)|intermittent theta-burst stimulation (rtms)
5972522|NCT02749006|neuromodulatory technique|neuromodulatory technique
5972523|NCT02743598|HIV infection|hiv infection
5972524|NCT02743598|Diabetes Mellitus type 2|diabetes mellitus type 2
5972525|NCT02743598|Obesity|obesity
5972526|NCT02743598|Neurocognitive function|neurocognitive function
5972527|NCT02743468|Bronchoscopy|bronchoscopy
5972528|NCT02743468|Pollutants|pollutants
5972529|NCT02743468|Human Pulmonary Cells|human pulmonary cells
5972530|NCT02743468|Macrophage Function|macrophage function
5972531|NCT02743468|Soluble Epoxide Hydrolase|soluble epoxide hydrolase
5972532|NCT02741128|Dengue Fever|dengue fever
5273361|NCT02312687|XLH|xlh
5972533|NCT02741128|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5972534|NCT02741128|Human Immunodeficiency Virus|human immunodeficiency virus
5972535|NCT02741128|CYD Dengue Vaccine|cyd dengue vaccine
5972536|NCT02736968|Amebic|amebic
5972537|NCT02736968|Auranofin|auranofin
5972538|NCT02736968|GI Protozoa|gi protozoa
5972539|NCT02736968|Giardiasis|giardiasis
5972540|NCT02736968|Reprofiled|reprofiled
5972541|NCT02734615|LSZ102|lsz102
5972542|NCT02734615|LEE011|lee011
5972543|NCT02734615|ribociclib|ribociclib
5972544|NCT02734615|Kisqali|kisqali
5972545|NCT02734615|BYL719|byl719
5972546|NCT02734615|alpelisib|alpelisib
5972547|NCT02734615|ER+ breast cancer|er+ breast cancer
5972548|NCT02734615|advanced ER+ breast cancer|advanced er+ breast cancer
5972549|NCT02734615|metastatic ER+ breast cancer|metastatic er+ breast cancer
5972550|NCT02734615|SERD|serd
5972551|NCT02734615|SERM|serm
5972552|NCT02734615|fulvestrant|fulvestrant
5972553|NCT02734615|tamoxifen|tamoxifen
5972554|NCT02734615|aromatase inhibitor|aromatase inhibitor
5972555|NCT02734615|ESR1|esr1
5972556|NCT02734615|mtESR1|mtesr1
5972557|NCT02734615|wtESR1|wtesr1
5972558|NCT02734615|estrogen receptor|estrogen receptor
5972559|NCT02734615|endocrine therapy|endocrine therapy
5972560|NCT02734576|Venous Sinus Stenting|venous sinus stenting
5972561|NCT02734576|Dural Sinus Stenting|dural sinus stenting
5972562|NCT02734303|Dietary Radioactivity|dietary radioactivity
5972563|NCT02734303|Dietary Assessment|dietary assessment
5972564|NCT02734303|Retrospective Recall|retrospective recall
5972565|NCT02734303|Focus Group|focus group
5972566|NCT02731612|Bipolar Disorder|bipolar disorder
5972567|NCT02731612|Cognition|cognition
5972568|NCT02731612|Euthymic|euthymic
5972569|NCT02731612|Lurasidone|lurasidone
5972570|NCT02731443|dreaming|dreaming
5972571|NCT02731443|epilepsy|epilepsy
5972572|NCT02731443|neurosurgery|neurosurgery
5972573|NCT02731443|temporal lobectomy|temporal lobectomy
5972574|NCT02729259|VRD|vrd
5972575|NCT02729116|Extended-Spectrum ß-lactamase-producing Escherichia coli|extended-spectrum ß-lactamase-producing escherichia coli
5972576|NCT02729116|Extended-Spectrum ß-lactamase-producing Klebsiella pneumoniae|extended-spectrum ß-lactamase-producing klebsiella pneumoniae
5972577|NCT02729116|Kidney Transplantation|kidney transplantation
5972578|NCT02729116|Urinary Tract Infections|urinary tract infections
5972579|NCT02728752|DM|dm
5972580|NCT02725489|Vigil|vigil
5972581|NCT02725489|durvalumab|durvalumab
5972582|NCT02725489|MEDI4736|medi4736
5972583|NCT02725489|PD-L1|pd-l1
5972584|NCT02725489|anti PD-L1|anti pd-l1
5972585|NCT02725489|immunotherapy|immunotherapy
5972586|NCT02725489|PD-L1 inhibitor|pd-l1 inhibitor
5972587|NCT02725489|breast cancer|breast cancer
5972588|NCT02725489|ovarian cancer|ovarian cancer
5972589|NCT02725489|fallopian tube cancer|fallopian tube cancer
5972590|NCT02725489|primary peritoneal cancer|primary peritoneal cancer
5972591|NCT02725489|uterine cancer|uterine cancer
5972592|NCT02725489|cervical cancer|cervical cancer
5972593|NCT02725489|endometrial cancer|endometrial cancer
5972594|NCT02724748|Aggression|aggression
5972595|NCT02724748|Mental Health|mental health
5972596|NCT02724748|Education, Continuing|education, continuing
5972597|NCT02719899|NLRP3 Inflammasome|nlrp3 inflammasome
5972598|NCT02719899|Sirtuin 3|sirtuin 3
5972599|NCT02719899|T-Cell Polarity|t-cell polarity
5972600|NCT02719899|Caloric Restriction|caloric restriction
5972601|NCT02718651|ALK rearrangement|alk rearrangement
5972602|NCT02718651|Circulating tumor DNA|circulating tumor dna
5972603|NCT02718651|Plasma DNA|plasma dna
5972604|NCT02718651|Non-small cell lung cancer|non-small cell lung cancer
5972605|NCT02718651|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5972606|NCT02717078|diet|diet
5972607|NCT02717078|carbohydrate|carbohydrate
5972608|NCT02717078|protein|protein
5972609|NCT02717078|glucose|glucose
5972610|NCT02717078|type 2 diabetes mellitus|type 2 diabetes mellitus
5972611|NCT02716675|HIV-1 Infections|hiv-1 infections
5972612|NCT02716116|NSCLC|nsclc
5972613|NCT02716116|EGFR|egfr
5972614|NCT02716116|HER2|her2
5972615|NCT02716116|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5972616|NCT02716116|exon 20 insertions|exon 20 insertions
5972617|NCT02716116|exon 19 deletions|exon 19 deletions
5972618|NCT02716116|exon 21 substitution|exon 21 substitution
5972619|NCT02716116|T790M|t790m
5972620|NCT02716116|ErbB-2|erbb-2
5972621|NCT02716116|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5972622|NCT02715375|asthma environment|asthma environment
5972623|NCT02712801|HIV|hiv
5972624|NCT02712801|antiretroviral treatment|antiretroviral treatment
5972625|NCT02712801|child|child
5972626|NCT02712801|testing|testing
5972627|NCT02710721|Fasting|fasting
5972628|NCT02710721|Prostatic Neoplasms|prostatic neoplasms
5972629|NCT02710721|Complementary Therapies|complementary therapies
5972630|NCT02710721|Urology|urology
5972631|NCT02709655|paediatric|paediatric
5972632|NCT02709226|Brain Tumor|brain tumor
5972633|NCT02709226|Astrocytoma|astrocytoma
5972634|NCT02709226|GBM|gbm
5972635|NCT02709226|Radiation Therapy|radiation therapy
5972636|NCT02708875|Microvascular|microvascular
5972637|NCT02708875|Insulin resistance|insulin resistance
5972638|NCT02708875|Mixed Meal|mixed meal
5972639|NCT02708875|Glucose tolerance|glucose tolerance
5972640|NCT02707276|Bipolar Depression|bipolar depression
5972641|NCT02707276|Geriatric|geriatric
5972642|NCT02707276|Low Field Magnetic Stimulation|low field magnetic stimulation
5972643|NCT02706873|Musculoskeletal disease|musculoskeletal disease
5972644|NCT02706873|Arthritis|arthritis
5972645|NCT02706873|Joint disease|joint disease
5972646|NCT02706873|Anti-inflammatory agents|anti-inflammatory agents
5972647|NCT02706873|Antirheumatic agents|antirheumatic agents
5972648|NCT02706873|ABT-494|abt-494
5972649|NCT02706873|Upadacitinib|upadacitinib
5972650|NCT02706847|Musculoskeletal Disease|musculoskeletal disease
5972651|NCT02706847|Arthritis|arthritis
5972652|NCT02706847|Joint Disease|joint disease
5972653|NCT02706847|Anti-inflammatory agents|anti-inflammatory agents
5972654|NCT02706847|Antirheumatic agents|antirheumatic agents
5972655|NCT02706847|ABT-494|abt-494
5972656|NCT02706847|upadacitinib|upadacitinib
5972657|NCT02705352|Skin graft|skin graft
5972658|NCT02705352|5-Fluorouracil|5-fluorouracil
5972659|NCT02705352|Periocular reconstruction|periocular reconstruction
5972660|NCT02701829|taxi cab drivers|taxi cab drivers
5972661|NCT02701829|high blood pressure|high blood pressure
5972662|NCT02701829|16-038|16-038
5972663|NCT02701413|Apex M|apex m
5972664|NCT02701413|Postpartum|postpartum
5972665|NCT02701413|Pelvic Floor rehabilitation|pelvic floor rehabilitation
5972666|NCT02699606|Tumor|tumor
5972667|NCT02699606|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5972668|NCT02699606|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5972669|NCT02699606|Erdafitinib|erdafitinib
5972670|NCT02699606|Urothelial Cancer|urothelial cancer
5972671|NCT02699606|Esophageal Cancer|esophageal cancer
5972672|NCT02699606|Cholangiocarcinoma|cholangiocarcinoma
5972673|NCT02697734|Cushing's disease|cushing's disease
5972674|NCT02697734|LCI699|lci699
5972675|NCT02697734|osilodrostat|osilodrostat
5972676|NCT02697734|Pituitary Gland|pituitary gland
5972677|NCT02697734|Adrenocorticotropic|adrenocorticotropic
5972678|NCT02697734|Hormone|hormone
5972679|NCT02697734|ACTH|acth
5972680|NCT02697734|UFC|ufc
5972681|NCT02696109|Transition age youth|transition age youth
5972682|NCT02696109|Mental health|mental health
5972683|NCT02696109|Mental health services|mental health services
5972684|NCT02696109|Engagement|engagement
5972685|NCT02695342|Balance|balance
5972686|NCT02695342|Falls|falls
5972687|NCT02695342|Exercise|exercise
5972688|NCT02695342|COPD|copd
5972689|NCT02693834|foot drop|foot drop
5972690|NCT02693834|Subacute stroke|subacute stroke
5972691|NCT02693834|AFO|afo
5972692|NCT02693834|gait symmetry|gait symmetry
5972693|NCT02693834|Gait endurance|gait endurance
5972694|NCT02693535|cancer|cancer
5972695|NCT02693535|off-label|off-label
5972696|NCT02693535|precision medicine|precision medicine
5972697|NCT02693535|targeted therapy|targeted therapy
5972698|NCT02693301|Asthma|asthma
5972699|NCT02693301|Respiratory symptoms|respiratory symptoms
5972700|NCT02693301|Exercise program|exercise program
5972701|NCT02693301|Functional capacity|functional capacity
5972702|NCT02693301|Body composition|body composition
5972703|NCT02692924|Pregnancy Complications|pregnancy complications
5972704|NCT02692924|Ultrasound|ultrasound
5972705|NCT02692755|African American|african american
5972706|NCT02689206|Chronic kidney disease|chronic kidney disease
5972707|NCT02689206|Efficacy|efficacy
5972708|NCT02689206|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5972709|NCT02689206|GSK1278863|gsk1278863
5972710|NCT02689206|Safety|safety
5972711|NCT02689206|Hemodialysis-dependent anemia|hemodialysis-dependent anemia
5972712|NCT02689206|Pharmacokinetics|pharmacokinetics
5972713|NCT02689076|Patient transfer|patient transfer
5972714|NCT02689076|Patient care management|patient care management
5972715|NCT02689076|Health information exchange|health information exchange
5972717|NCT02688140|acute promyelocytic leukemia (M3)|acute promyelocytic leukemia (m3)
5273509|NCT02311686|Ethanol|ethanol
5972718|NCT02688140|high-risk acute promyelocytic leukemia (APL/AML M3)|high-risk acute promyelocytic leukemia (apl/aml m3)
5972719|NCT02688140|acute myeloid leukemia with t(15;17)(q22;q12)|acute myeloid leukemia with t(15;17)(q22;q12)
5972720|NCT02688140|newly diagnosed|newly diagnosed
5972721|NCT02688140|high-risk|high-risk
5972722|NCT02687958|GEP/ NEC|gep/ nec
5972723|NCT02687243|pediatrics|pediatrics
5972724|NCT02687243|anxiety|anxiety
5972725|NCT02687243|anesthesia|anesthesia
5972726|NCT02687243|preoperative|preoperative
5972727|NCT02684006|Cancer|cancer
5972728|NCT02684006|renal cell cancer|renal cell cancer
5972729|NCT02684006|kidney disease|kidney disease
5972730|NCT02684006|kidney neoplasms|kidney neoplasms
5972731|NCT02684006|axitinib, sunitinib|axitinib, sunitinib
5972732|NCT02682069|Diabetic foot ulcer|diabetic foot ulcer
5972733|NCT02682069|venous leg ulcer|venous leg ulcer
5972734|NCT02682069|fluorescence imaging|fluorescence imaging
5972735|NCT02682069|wound imaging|wound imaging
5972736|NCT02680756|Iron Deficiency|iron deficiency
5972737|NCT02680756|Anaemia|anaemia
5972738|NCT02680756|Crohn's Disease|crohn's disease
5972739|NCT02680756|Deficiency Diseases|deficiency diseases
5972740|NCT02680756|Inflammatory Bowel Diseases|inflammatory bowel diseases
5972741|NCT02680756|Intestinal Diseases|intestinal diseases
5972742|NCT02679573|Pneumonia|pneumonia
5972743|NCT02678312|Pediatric Heart failure,|pediatric heart failure,
5972744|NCT02678312|systemic left ventricle,|systemic left ventricle,
5972745|NCT02678312|reduced ejection fraction|reduced ejection fraction
5972746|NCT02676986|Primary Breast Cancer|primary breast cancer
5972747|NCT02676986|ER|er
5972748|NCT02676986|AR|ar
5972749|NCT02676986|TNBC|tnbc
5972750|NCT02670707|vinblastine|vinblastine
5972751|NCT02670707|prednisone|prednisone
5972752|NCT02670707|cytarabine|cytarabine
5972753|NCT02670707|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
5972754|NCT02669576|Breast cancer|breast cancer
5972755|NCT02669576|meopausal syptoms|meopausal syptoms
5972756|NCT02669576|mind body medecine|mind body medecine
5972757|NCT02669576|yoga|yoga
5972758|NCT02669576|acupuncture|acupuncture
5972759|NCT02667327|diabetic foot ulcer|diabetic foot ulcer
5972760|NCT02667327|diabetic complications|diabetic complications
5972761|NCT02667327|diabetes|diabetes
5972762|NCT02667327|wound healing|wound healing
5972763|NCT02667327|Granexin gel|granexin gel
5972764|NCT02667327|FirstString Research|firststring research
5972765|NCT02665962|newly diagnosed patients|newly diagnosed patients
5972766|NCT02662309|Muscle invasive bladder cancer|muscle invasive bladder cancer
5972767|NCT02662309|Transitional cell carcinoma|transitional cell carcinoma
5972768|NCT02660034|Dose Escalation|dose escalation
5972769|NCT02660034|Dose Expansion|dose expansion
5972770|NCT02660034|BGB-A317|bgb-a317
5972771|NCT02660034|BGB-290|bgb-290
5972772|NCT02659514|Poziotinib|poziotinib
5972773|NCT02659514|Metastatic Breast Cancer|metastatic breast cancer
5972774|NCT02659514|HER2-positive|her2-positive
5972775|NCT02659514|Pan-HER inhibitor|pan-her inhibitor
5972776|NCT02656771|THA|tha
5972777|NCT02656771|Hip|hip
5972778|NCT02656771|arthroplasties|arthroplasties
5972779|NCT02654990|multiple myeloma|multiple myeloma
5972780|NCT02654990|relapsed or relapsed/refractory|relapsed or relapsed/refractory
5972781|NCT02654990|LBH589|lbh589
5972782|NCT02654990|panobinostat|panobinostat
5972783|NCT02654990|bortezomib|bortezomib
5972784|NCT02654990|dexamethasone|dexamethasone
5972785|NCT02651974|neoplasm|neoplasm
5972786|NCT02651974|colorectal|colorectal
5972787|NCT02651974|cancer|cancer
5972788|NCT02651974|uninsured|uninsured
5972789|NCT02651974|FIT|fit
5972790|NCT02651974|fecal immunochemical test|fecal immunochemical test
5972791|NCT02651116|cough, acute cough, pediatric, Dextromethorphan Hydrobromide, antitussive, ambulatory cough recording device|cough, acute cough, pediatric, dextromethorphan hydrobromide, antitussive, ambulatory cough recording device
5972792|NCT02650856|Blood loss|blood loss
5972793|NCT02650856|Tranexamic acid|tranexamic acid
5972794|NCT02650856|Platelet rich plasma|platelet rich plasma
5972795|NCT02650856|Total knee arthroplasty|total knee arthroplasty
5972796|NCT02649855|PSA|psa
5972797|NCT02649855|Vaccine|vaccine
5972798|NCT02649855|Immunotherapy|immunotherapy
5972799|NCT02649855|Immune Response|immune response
5972800|NCT02649855|Androgen Deprivation Therapy|androgen deprivation therapy
5972801|NCT02648074|asthma|asthma
5972802|NCT02648074|eosinophils|eosinophils
5972803|NCT02648074|airway smooth muscle|airway smooth muscle
5972804|NCT02648074|airway remodelling|airway remodelling
5972805|NCT02648074|integrins|integrins
5972806|NCT02648074|cytokines|cytokines
5972807|NCT02647112|Bladder cancer|bladder cancer
5972808|NCT02647112|Urine|urine
5972809|NCT02647112|Methylation|methylation
5972810|NCT02645409|Fluorescence|fluorescence
5972811|NCT02645409|Imaging|imaging
5972812|NCT02645409|Partial nephrectomy|partial nephrectomy
5972813|NCT02645409|Radical nephrectomy|radical nephrectomy
5972814|NCT02644525|Cameroon|cameroon
5972815|NCT02644525|Filaricidal|filaricidal
5972816|NCT02644525|Randomized|randomized
5972817|NCT02644525|Blinded|blinded
5273596|NCT02311192|B scan|b scan
5972818|NCT02644525|Diethylcarbamazine|diethylcarbamazine
5972819|NCT02644382|breast cancer|breast cancer
5972820|NCT02644382|decision making|decision making
5972821|NCT02644382|surgery|surgery
5972822|NCT02644382|qualitative|qualitative
5972823|NCT02642796|Percutaneous Electric Nerve Stimulation|percutaneous electric nerve stimulation
5972824|NCT02642796|Lumbosacral plexus|lumbosacral plexus
5972825|NCT02642796|surgical wound|surgical wound
5972826|NCT02642796|postoperative analgesia|postoperative analgesia
5972827|NCT02642796|transcutaneous electrical stimulation|transcutaneous electrical stimulation
5972828|NCT02642172|Inulin, OFS (oligofructose)|inulin, ofs (oligofructose)
5972829|NCT02640690|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5972830|NCT02640690|Yoga|yoga
5972831|NCT02640690|Cognitive Therapy|cognitive therapy
5972832|NCT02640690|Chronic Pain|chronic pain
5972833|NCT02640690|Veterans|veterans
5972834|NCT02640690|cytokines|cytokines
5972835|NCT02640690|acoustic startle reflex|acoustic startle reflex
5972836|NCT02640014|Food allergy|food allergy
5972837|NCT02640014|Health-related quality of life (HRQL)|health-related quality of life (hrql)
5972838|NCT02640014|Quality-adjusted life-years (QALYs)|quality-adjusted life-years (qalys)
5972840|NCT02640014|Cow´s milk allergy (CMA)|cow´s milk allergy (cma)
5972841|NCT02640014|Milk oral immunotherapy (MOIT)|milk oral immunotherapy (moit)
5972843|NCT02639325|Brain Cancer|brain cancer
5972844|NCT02639325|Seizure Disorder|seizure disorder
5972845|NCT02639325|Seizures|seizures
5972846|NCT02639299|Subjects|subjects
5972847|NCT02639299|Venipuncture|venipuncture
5972848|NCT02639299|Research|research
5972849|NCT02639299|Evaluate|evaluate
5972850|NCT02639299|Recruit|recruit
5972851|NCT02639273|Alcohol Infusion study|alcohol infusion study
5972852|NCT02639273|Nalmefene|nalmefene
5972853|NCT02639273|fMRI|fmri
5972854|NCT02639273|Genetics|genetics
5972855|NCT02639273|NIAAA|niaaa
5972856|NCT02635360|advanced|advanced
5972857|NCT02635360|cervical cancer|cervical cancer
5972858|NCT02635360|pembrolizumab|pembrolizumab
5972859|NCT02635360|chemoradiation|chemoradiation
5972860|NCT02635360|immunotherapy|immunotherapy
5972861|NCT02635022|Fracture|fracture
5972862|NCT02635022|Sarcopenia|sarcopenia
5972863|NCT02635022|Osteoporosis|osteoporosis
5972864|NCT02635022|Care management|care management
5972865|NCT02635022|Medication adherence|medication adherence
5972866|NCT02634697|Atrial Fibrillation|atrial fibrillation
5972867|NCT02634697|Relaxation Response Resiliency Program Intervention|relaxation response resiliency program intervention
5972868|NCT02634697|AF Symptom Severity and Burden|af symptom severity and burden
5972869|NCT02634697|Stress, Anxiety, Depression and Hostility|stress, anxiety, depression and hostility
5972870|NCT02634697|Quality of Life|quality of life
5972871|NCT02634697|AF|af
5972872|NCT02634697|QOL|qol
5972873|NCT02634697|3RP|3rp
5972874|NCT02633293|Treprostinil|treprostinil
5972875|NCT02633293|PH|ph
5972876|NCT02633293|ILD|ild
5972877|NCT02633293|CPFE|cpfe
5972878|NCT02633293|6 Minute Walk Test|6 minute walk test
5972879|NCT02631538|Subcutaneous|subcutaneous
5972880|NCT02631538|Rituximab|rituximab
5972881|NCT02631538|Intravenous|intravenous
5972882|NCT02631538|Safety|safety
5972883|NCT02631538|Efficacy|efficacy
5972884|NCT02631538|Sjogren's syndrome|sjogren's syndrome
5972885|NCT02631538|Belimumab|belimumab
5972886|NCT02630316|Treprostinil|treprostinil
5972887|NCT02630316|PH|ph
5972888|NCT02630316|ILD|ild
5972889|NCT02630316|CPFE|cpfe
5972890|NCT02630316|6 Minute Walk Test|6 minute walk test
5972891|NCT02629172|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5972892|NCT02629172|Paritaprevir|paritaprevir
5972893|NCT02629172|Ombitasvir|ombitasvir
5972894|NCT02629172|Ritonavir|ritonavir
5972895|NCT02629172|Genotype 1|genotype 1
5972896|NCT02628964|smoking|smoking
5972897|NCT02628964|cigarettes|cigarettes
5972898|NCT02628886|maternal and neonatal pneumococcal conjugate vaccination|maternal and neonatal pneumococcal conjugate vaccination
5972899|NCT02628886|pneumococcal carriage|pneumococcal carriage
5972900|NCT02627456|Malaria|malaria
5972901|NCT02627456|Cryopreserved|cryopreserved
5972902|NCT02627456|Infection|infection
5972903|NCT02627456|Human|human
5972904|NCT02627456|Immunization|immunization
5972905|NCT02625961|PD1|pd1
5972906|NCT02625961|PDL1|pdl1
5972907|NCT02625961|PD-L1|pd-l1
5972908|NCT02625961|PD-1|pd-1
5972909|NCT02625883|Resuscitation, quality of life|resuscitation, quality of life
5972910|NCT02623894|Vascular aging.|vascular aging.
5972911|NCT02623894|Arterial stiffness.|arterial stiffness.
5972912|NCT02623894|Lifestyles.|lifestyles.
5972913|NCT02623894|Vascular structure.|vascular structure.
5972914|NCT02623894|Telomere length,|telomere length,
5972915|NCT02623894|Psychological factors.|psychological factors.
5972916|NCT02623894|Inflammatory factors.|inflammatory factors.
5972917|NCT02623894|Oxidative stress|oxidative stress
5972918|NCT02623699|IONIS-SOD1Rx|ionis-sod1rx
5972919|NCT02623699|SOD1|sod1
5972920|NCT02623699|ALS|als
5972921|NCT02623426|uveitic macular edema|uveitic macular edema
5972922|NCT02623426|uveitis|uveitis
5273703|NCT02310568|outpatient|outpatient
5972923|NCT02622763|Tolerogenic Dendritic Cells|tolerogenic dendritic cells
5972924|NCT02622386|Psoriasis|psoriasis
5972925|NCT02617966|Retina|retina
5972926|NCT02617966|Retinal Degeneration|retinal degeneration
5972927|NCT02617966|Retinitis Pigmentosa|retinitis pigmentosa
5972928|NCT02617966|Stargardt's Disease|stargardt's disease
5972929|NCT02617966|Dark Adaptation|dark adaptation
5972930|NCT02617875|Pre-hospital|pre-hospital
5972931|NCT02617875|Emergency medical system|emergency medical system
5972932|NCT02617875|Telemedicine|telemedicine
5972933|NCT02617875|Tele consultation|tele consultation
5972934|NCT02617875|Remote treatment|remote treatment
5972935|NCT02615002|Cognition|cognition
5972936|NCT02615002|mild Alzheimer's disease|mild alzheimer's disease
5972937|NCT02615002|Sleep|sleep
5972938|NCT02614794|Tucatinib|tucatinib
5972939|NCT02614794|Capecitabine|capecitabine
5972940|NCT02614794|Trastuzumab|trastuzumab
5972941|NCT02614794|Xeloda|xeloda
5972942|NCT02614794|Herceptin|herceptin
5972943|NCT02614794|Breast Cancer|breast cancer
5972944|NCT02614794|ARRY-380|arry-380
5972945|NCT02614794|ONT-380|ont-380
5972946|NCT02614794|HER2 Positive Breast Carcinoma|her2 positive breast carcinoma
5972947|NCT02614794|HER2 Positive Locally Advanced Breast Cancer|her2 positive locally advanced breast cancer
5972948|NCT02614794|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5972949|NCT02614794|HER-2 Positive Breast Carcinoma|her-2 positive breast carcinoma
5972950|NCT02614794|HER-2 Positive Locally Advanced Breast Cancer|her-2 positive locally advanced breast cancer
5972951|NCT02614794|Recurrent Breast Carcinoma|recurrent breast carcinoma
5972952|NCT02614794|Stage IV Breast Cancer|stage iv breast cancer
5972953|NCT02614794|Metastatic Breast Cancer|metastatic breast cancer
5972954|NCT02614794|Breast Carcinoma|breast carcinoma
5972955|NCT02614794|Metastatic Malignant Neoplasm in the Brain|metastatic malignant neoplasm in the brain
5972956|NCT02614794|Brain Metastases in Breast Cancer|brain metastases in breast cancer
5972957|NCT02614794|Asymptomatic Brain Metastases in Breast Cancer|asymptomatic brain metastases in breast cancer
5972958|NCT02614794|Low Symptomatic Brain Metastases in Breast Cancer|low symptomatic brain metastases in breast cancer
5972959|NCT02613234|Epilepsy|epilepsy
5972960|NCT02613234|128-Channel EEG|128-channel eeg
5972961|NCT02613234|Dipole Localization|dipole localization
5972962|NCT02613234|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5972965|NCT02612662|Safety|safety
5972966|NCT02612662|Subcutaneous|subcutaneous
5972967|NCT02612662|Tolerability|tolerability
5972968|NCT02612129|NPC1|npc1
5972969|NCT02612129|Niemann-Pick Type C|niemann-pick type c
5972970|NCT02612129|Niemann-Pick|niemann-pick
5972971|NCT02612129|arimoclomol|arimoclomol
5972972|NCT02612129|lysosomal storage disorder|lysosomal storage disorder
5972973|NCT02612129|lysosomal storage disease|lysosomal storage disease
5972974|NCT02612129|NPC2|npc2
5972975|NCT02612129|NP-C|np-c
5972976|NCT02611960|PD-1|pd-1
5972978|NCT02611960|PD-L1|pd-l1
5972979|NCT02611960|PDL1|pdl1
5972980|NCT02610465|Computed Tomography|computed tomography
5972981|NCT02610465|Image Reconstruction|image reconstruction
5972982|NCT02610465|Iterative Reconstruction|iterative reconstruction
5972983|NCT02609828|Metastatic cancer bone pain|metastatic cancer bone pain
5972984|NCT02609828|Multiple myeloma|multiple myeloma
5972985|NCT02609776|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5972986|NCT02609776|JNJ-61186372|jnj-61186372
5972987|NCT02609776|First-in-Human|first-in-human
5972988|NCT02609776|Human Bispecific Epidermal Growth Factor Receptor (EGFR)|human bispecific epidermal growth factor receptor (egfr)
5972989|NCT02609776|c-Mesenchymal-Epithelial Transition (cMet) Antibody|c-mesenchymal-epithelial transition (cmet) antibody
5972990|NCT02609776|JNJ372|jnj372
5972991|NCT02609776|Exon 20|exon 20
5972992|NCT02609776|Exon 20 insertion|exon 20 insertion
5972993|NCT02609776|Tyrosine Kinase Inhibitor (TKI) Resistant|tyrosine kinase inhibitor (tki) resistant
5972994|NCT02609776|TKI Resistance|tki resistance
5972995|NCT02609776|EGFR C797s|egfr c797s
5972996|NCT02609776|Met Amplification|met amplification
5972997|NCT02609776|Met + EGFR bispecific|met + egfr bispecific
5972998|NCT02607111|Dalteparin|dalteparin
5972999|NCT02607111|Dosage|dosage
5973000|NCT02607111|Home Hemodialysis|home hemodialysis
5973001|NCT02605967|PDR001,|pdr001,
5973002|NCT02605967|nasopharyngeal cancer,|nasopharyngeal cancer,
5973003|NCT02605967|moderately differentiated/undifferentiated,|moderately differentiated/undifferentiated,
5973004|NCT02605967|locally advanced,|locally advanced,
5973005|NCT02605967|recurrent or metastatic NPC,|recurrent or metastatic npc,
5973006|NCT02605967|after first- line platinum-based therapy|after first- line platinum-based therapy
5973007|NCT02603445|BCL201|bcl201
5973008|NCT02603445|idelalisib|idelalisib
5973009|NCT02603445|Follicular lymphoma|follicular lymphoma
5973010|NCT02603445|FL|fl
5973011|NCT02603445|mantle cell lymphoma|mantle cell lymphoma
5973012|NCT02603445|MCL|mcl
5973013|NCT02603146|RA prevention|ra prevention
5973014|NCT02603146|hydroxychloroquine (HCQ)|hydroxychloroquine (hcq)
5973015|NCT02603146|anti-CCP3|anti-ccp3
5973016|NCT02601378|Uveal melanoma|uveal melanoma
5973017|NCT02601378|Metastatic uveal melanoma|metastatic uveal melanoma
5973018|NCT02601378|Phase I|phase i
5973019|NCT02601378|LXS196|lxs196
5973020|NCT02601378|PKC inhibitor|pkc inhibitor
5973021|NCT02601378|HDM201|hdm201
5973022|NCT02601378|HDM2 inhibitor|hdm2 inhibitor
5973023|NCT02601378|dose escalation|dose escalation
5973024|NCT02598973|Parkinson Disease|parkinson disease
5973025|NCT02598973|exercise|exercise
5973026|NCT02598115|collaborative pharmaceutical care|collaborative pharmaceutical care
5973027|NCT02595957|Return of Results|return of results
5973028|NCT02595957|Exome Sequencing|exome sequencing
5973029|NCT02595957|Secondary Findings|secondary findings
5973030|NCT02593539|APDS|apds
5973031|NCT02593539|Safety|safety
5973032|NCT02593539|Pharmacokinetics|pharmacokinetics
5973033|NCT02593539|GSK2269557|gsk2269557
5973034|NCT02593539|PASLI|pasli
5973035|NCT02593227|TNBC|tnbc
5973036|NCT02592434|Arthritis|arthritis
5973037|NCT02592434|Pediatric|pediatric
5973038|NCT02592434|Long-term|long-term
5973039|NCT02592434|JIA|jia
5973040|NCT02592434|polyarticular|polyarticular
5973041|NCT02592434|CP-690,550|cp-690,550
5973042|NCT02592434|tofacitinib|tofacitinib
5973043|NCT02592434|Xeljanz|xeljanz
5973044|NCT02588092|Camidanlumab tesirine|camidanlumab tesirine
5973045|NCT02583542|breast|breast
5973046|NCT02583542|lung|lung
5973047|NCT02583542|squamous|squamous
5973048|NCT02583542|KRAS|kras
5973049|NCT02583542|AZD|azd
5973050|NCT02583542|selumetinib|selumetinib
5973051|NCT02581358|scoliosis|scoliosis
5973052|NCT02581358|spinal deformity|spinal deformity
5973053|NCT02581358|Cobb angle|cobb angle
5973054|NCT02581358|assessment|assessment
5973055|NCT02581358|ultrasound|ultrasound
5973056|NCT02581007|CML|cml
5973057|NCT02581007|AML|aml
5973058|NCT02581007|MDS|mds
5973059|NCT02581007|ALL|all
5973060|NCT02581007|CLL/CPL|cll/cpl
5973061|NCT02581007|HD|hd
5973062|NCT02581007|NHL|nhl
5973063|NCT02581007|MPS|mps
5973064|NCT02581007|CMML|cmml
5973065|NCT02581007|MM|mm
5973066|NCT02579759|PXT3003|pxt3003
5973067|NCT02578901|Thrombocytopenia|thrombocytopenia
5973068|NCT02578901|Tranexamic Acid|tranexamic acid
5973069|NCT02578901|TXA|txa
5973070|NCT02578901|Chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5973071|NCT02577406|AG-221|ag-221
5973072|NCT02577406|CC-90007|cc-90007
5973073|NCT02577406|Efficacy|efficacy
5973074|NCT02577406|Safety|safety
5973075|NCT02577406|Leukemia|leukemia
5973076|NCT02577406|Acute myeloid meukemia|acute myeloid meukemia
5973077|NCT02577406|Isocitrate dehydrogenase 2 mutation|isocitrate dehydrogenase 2 mutation
5973078|NCT02577406|Enasidenib|enasidenib
5973079|NCT02576990|PD1|pd1
5973080|NCT02576990|PD-1|pd-1
5973081|NCT02576990|PDL1|pdl1
5973082|NCT02576990|PD-L1|pd-l1
5973083|NCT02576678|Psoriasis|psoriasis
5973084|NCT02576678|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5973085|NCT02576678|Plaque Psoriasis|plaque psoriasis
5973086|NCT02576678|CC-10004|cc-10004
5973087|NCT02576678|Apremilast|apremilast
5973088|NCT02576678|Pharmacokinetics|pharmacokinetics
5973089|NCT02576678|Open-label|open-label
5973090|NCT02576678|Safety|safety
5973091|NCT02576678|Pediatric|pediatric
5973092|NCT02576496|phase 1 clinical trial|phase 1 clinical trial
5973093|NCT02576496|multiple myeloma|multiple myeloma
5973094|NCT02576496|Hodgkin's lymphoma|hodgkin's lymphoma
5973095|NCT02576496|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5973096|NCT02576496|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5973097|NCT02576496|T-cell Prolymphocytic Leukemia|t-cell prolymphocytic leukemia
5973098|NCT02576496|tinostamustine|tinostamustine
5973099|NCT02573688|Obesity|obesity
5973100|NCT02573688|Metabolic Syndrome X|metabolic syndrome x
5973101|NCT02573688|Interdisciplinary Studies|interdisciplinary studies
5973102|NCT02570854|Anemia|anemia
5973103|NCT02569333|ulcerative colitis|ulcerative colitis
5973104|NCT02569333|inflammatory bowel disease|inflammatory bowel disease
5973105|NCT02569333|education|education
5973106|NCT02569333|patient-reported outcomes|patient-reported outcomes
5973107|NCT02568215|HIV-1 Infections|hiv-1 infections
5973108|NCT02567032|Oxytocin|oxytocin
5973109|NCT02567032|Syntocinon|syntocinon
5973110|NCT02567032|Social Cognition|social cognition
5973111|NCT02567032|Schizophrenia|schizophrenia
5973112|NCT02567032|Psychosis|psychosis
5973113|NCT02567032|Schizoaffective Disorder|schizoaffective disorder
5973114|NCT02567032|Schizophreniform Disorder|schizophreniform disorder
5973115|NCT02567032|Psychotic Disorders|psychotic disorders
5973116|NCT02566161|Genetics|genetics
5973117|NCT02566161|Genomics|genomics
5973118|NCT02565004|Genetic|genetic
5973119|NCT02565004|Sample Collection|sample collection
5973120|NCT02564991|Alcoholism|alcoholism
5973122|NCT02564991|Structural MRI|structural mri
5973123|NCT02564991|Cerebellum|cerebellum
5973124|NCT02563717|Resuscitation|resuscitation
5973125|NCT02563717|Positive-Pressure Respiration|positive-pressure respiration
5273910|NCT02309476|DMO|dmo
5973126|NCT02563717|Infant, Extremely Premature|infant, extremely premature
5973127|NCT02563717|Continuous Positive Airway Pressure|continuous positive airway pressure
5973128|NCT02563717|Intubation|intubation
5973129|NCT02562235|Pulmonary arterial hypertension|pulmonary arterial hypertension
5973130|NCT02562131|PET-MR|pet-mr
5973131|NCT02562131|recidive|recidive
5973132|NCT02562131|PET/MR imaging|pet/mr imaging
5973133|NCT02562131|18F-Fluciclovine|18f-fluciclovine
5973134|NCT02562131|radical treatment|radical treatment
5973135|NCT02562131|recurrence|recurrence
5973136|NCT02559869|Biofluid|biofluid
5973137|NCT02559869|ALS|als
5973138|NCT02559869|MRI|mri
5973139|NCT02559869|PET|pet
5973140|NCT02559869|Imaging|imaging
5973141|NCT02559869|Biomarkers|biomarkers
5973142|NCT02559869|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5973143|NCT02559869|TRACK ALS|track als
5973144|NCT02559869|pathology|pathology
5973145|NCT02559739|Stroke|stroke
5973146|NCT02559739|Ischemic Attack, Transient|ischemic attack, transient
5973147|NCT02559739|Cardiovascular Diseases|cardiovascular diseases
5973148|NCT02559739|Sleep Apnea Syndromes|sleep apnea syndromes
5973149|NCT02559739|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5973150|NCT02559739|Insomnia|insomnia
5973151|NCT02559739|Restless Legs Syndrome|restless legs syndrome
5973152|NCT02559739|Sleep Deprivation|sleep deprivation
5973153|NCT02559037|acupuncture|acupuncture
5973154|NCT02559037|moxibustion|moxibustion
5973155|NCT02559037|intestinal microbiota|intestinal microbiota
5973156|NCT02559037|Peripheral immunity|peripheral immunity
5973157|NCT02559037|Brain functional and structural changes|brain functional and structural changes
5973158|NCT02558465|Xarelto, rivaroxaban, VTE, PE, DVT, Japan, PMS, SDUI|xarelto, rivaroxaban, vte, pe, dvt, japan, pms, sdui
5973159|NCT02556931|immunosuppression|immunosuppression
5973160|NCT02556931|nonmyeloablative|nonmyeloablative
5973161|NCT02556931|non-myeloablative|non-myeloablative
5973162|NCT02556931|allogeneic|allogeneic
5973163|NCT02556931|tacrolimus|tacrolimus
5973164|NCT02556931|peripheral blood|peripheral blood
5973165|NCT02556931|cyclophosphamide|cyclophosphamide
5973166|NCT02556931|mycophenolate mofetil|mycophenolate mofetil
5973167|NCT02555657|PD1|pd1
5973168|NCT02555657|PD-1|pd-1
5973169|NCT02555657|PDL1|pdl1
5973170|NCT02555657|PD-LI|pd-li
5973171|NCT02555059|Ciprofloxacin|ciprofloxacin
5973172|NCT02555059|Japan|japan
5973173|NCT02555059|Post-marketing surveillance|post-marketing surveillance
5973174|NCT02554487|stroke|stroke
5973175|NCT02554487|sleep disordered breathing|sleep disordered breathing
5973176|NCT02554487|sleep apnea|sleep apnea
5973177|NCT02554487|infarct volume|infarct volume
5973178|NCT02554487|penumbra|penumbra
5973179|NCT02550106|CHRONIC SPONTANEOUS URTICARIA|chronic spontaneous urticaria
5973180|NCT02550106|OMALIZUMAB|omalizumab
5973181|NCT02550106|URTICARIA CONTROL TEST|urticaria control test
5973182|NCT02550106|IGE025|ige025
5973183|NCT02546284|CMML|cmml
5973184|NCT02544711|Pelvis|pelvis
5973185|NCT02544711|Surgical resection|surgical resection
5973186|NCT02544711|Patient specific instrument|patient specific instrument
5973187|NCT02544646|trabeculectomy|trabeculectomy
5973188|NCT02544022|Pain Scale|pain scale
5973189|NCT02544022|QOL|qol
5973190|NCT02544022|Tool Validation|tool validation
5973191|NCT02544022|Cognitive Interviews|cognitive interviews
5973192|NCT02544009|Energy Expenditure|energy expenditure
5973193|NCT02544009|Obesity|obesity
5973194|NCT02544009|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5973195|NCT02543996|Sample Collection|sample collection
5973196|NCT02543996|Laboratory Research Specimens|laboratory research specimens
5973197|NCT02543996|Biospecimen Procurement|biospecimen procurement
5973198|NCT02543996|Rare Diseases|rare diseases
5973199|NCT02543983|Neurobiology|neurobiology
5973200|NCT02543983|Suicide|suicide
5973201|NCT02543983|Ketamine|ketamine
5973202|NCT02543983|Major Depression Disorder|major depression disorder
5973203|NCT02543983|Biomarkers|biomarkers
5973204|NCT02535702|fMRI|fmri
5973205|NCT02535702|EEG|eeg
5973206|NCT02534727|Pharmacokinetic-Moedeling|pharmacokinetic-moedeling
5973207|NCT02534727|Tuberculosis|tuberculosis
5973208|NCT02534727|Therapeutic Drug Monitoring|therapeutic drug monitoring
5973209|NCT02534727|Drug-Levels|drug-levels
5973210|NCT02534727|Caseum|caseum
5973211|NCT02533141|Investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin|investigation of the changes of flicker induced vasodilatation before, during and after withdrawal of therapy with simvastatin
5973212|NCT02532790|Mild proteinuria|mild proteinuria
5973213|NCT02532374|nicotine absorption|nicotine absorption
5973214|NCT02532374|nicotine containing product|nicotine containing product
5973215|NCT02532374|adult smoker|adult smoker
5973216|NCT02532374|Nicorette|nicorette
5973217|NCT02532374|nicotine delivery system|nicotine delivery system
5973218|NCT02532244|distal hereditary motor neuronopathy|distal hereditary motor neuronopathy
5973219|NCT02531880|MRI|mri
5973220|NCT02531880|Manganese Enhanced MRI|manganese enhanced mri
5973221|NCT02531880|Seizure Disorder|seizure disorder
5973222|NCT02531880|Seizures|seizures
5973223|NCT02531880|Epileptic Focus|epileptic focus
5973224|NCT02530320|Palbociclib|palbociclib
5973225|NCT02530320|oligodendroglioma|oligodendroglioma
5973226|NCT02530320|oligoastrocytoma anaplastic|oligoastrocytoma anaplastic
5973227|NCT02528942|Lung cancer|lung cancer
5973228|NCT02528942|Radiation therapy|radiation therapy
5973229|NCT02528942|4DCT-ventilation imaging|4dct-ventilation imaging
5973230|NCT02528357|mAb|mab
5973231|NCT02528357|GSK3174998|gsk3174998
5973232|NCT02528357|anticancer agent|anticancer agent
5973233|NCT02528357|checkpoint|checkpoint
5973234|NCT02528357|OX40|ox40
5973235|NCT02528357|Pembrolizumab|pembrolizumab
5973236|NCT02528357|MK-3475-167|mk-3475-167
5973237|NCT02528357|solid tumor|solid tumor
5973238|NCT02528357|immunotherapy|immunotherapy
5973239|NCT02528357|KEYNOTE-167|keynote-167
5973240|NCT02528357|monoclonal antibody|monoclonal antibody
5973241|NCT02528357|antitumor|antitumor
5973242|NCT02528253|Chronic low back pain|chronic low back pain
5973243|NCT02528253|Chronic pain|chronic pain
5973244|NCT02528123|Small incision lenticule extraction (SMILE)|small incision lenticule extraction (smile)
5973245|NCT02528123|Femtosecond laser|femtosecond laser
5973246|NCT02521311|multiple sclerosis|multiple sclerosis
5973247|NCT02521311|eye pain|eye pain
5973248|NCT02521311|vision loss|vision loss
5973249|NCT02519985|VHF digital ultrasound|vhf digital ultrasound
5973250|NCT02519985|Corneal thickness|corneal thickness
5973251|NCT02519985|Epithelial thickness|epithelial thickness
5973252|NCT02519985|Angle diameter|angle diameter
5973253|NCT02519985|Sulcus diameter|sulcus diameter
5973254|NCT02519985|Anterior chamber depth|anterior chamber depth
5973255|NCT02519985|Repeatability|repeatability
5973256|NCT02519985|Reproducibility|reproducibility
5973257|NCT02518594|women|women
5973258|NCT02518594|cervical length of less than 30 millimeters|cervical length of less than 30 millimeters
5973259|NCT02518594|carrying twins|carrying twins
5973260|NCT02518594|short cervix|short cervix
5973261|NCT02516813|M3814|m3814
5973262|NCT02516813|Advanced solid tumors|advanced solid tumors
5973263|NCT02516813|DNA-PK Inhibitor|dna-pk inhibitor
5973264|NCT02516813|Radiotherapy|radiotherapy
5973265|NCT02516813|Chemotherapy|chemotherapy
5973266|NCT02514278|Organ preservation|organ preservation
5973267|NCT02514278|Local excision|local excision
5973268|NCT02514278|Radiochemotherapy|radiochemotherapy
5973269|NCT02514278|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5973270|NCT02514278|Folfirinox|folfirinox
5973271|NCT02514278|Tumour response|tumour response
5973272|NCT02513472|Eribulin Mesylate|eribulin mesylate
5973273|NCT02513472|Pembrolizumab|pembrolizumab
5973274|NCT02513472|Metastatic Triple-Negative Breast Cancer|metastatic triple-negative breast cancer
5973275|NCT02513472|mTNBC|mtnbc
5973276|NCT02512887|Hypospadias|hypospadias
5973277|NCT02512887|Caudal Block|caudal block
5973278|NCT02512887|Dorsal Penile Block|dorsal penile block
5973279|NCT02512887|Anesthesia|anesthesia
5973280|NCT02512887|Complications|complications
5973281|NCT02512887|Post-operative|post-operative
5973282|NCT02512887|Urethrocutaneous Fistula|urethrocutaneous fistula
5973283|NCT02512887|Glans dehiscence|glans dehiscence
5973284|NCT02511028|MRI|mri
5973285|NCT02511028|Multiple Sclerosis|multiple sclerosis
5973286|NCT02511028|Healthy Volunteer|healthy volunteer
5973287|NCT02511015|Early Onset Parkinson's Disease|early onset parkinson's disease
5973288|NCT02511015|Cellular Quality Control Programs|cellular quality control programs
5973289|NCT02511015|Mitochondria|mitochondria
5973290|NCT02511015|Neuroinflammation|neuroinflammation
5973291|NCT02511015|Immunology|immunology
5973292|NCT02510664|Adolescence|adolescence
5973293|NCT02510664|Adherence|adherence
5973294|NCT02509260|colorectal surgery|colorectal surgery
5973295|NCT02507180|Clinical Decision Rule|clinical decision rule
5973296|NCT02507180|Ultrasound|ultrasound
5376862|NCT01827228|HIV|hiv
5973297|NCT02507180|Suspected Deep Vein Thrombosis|suspected deep vein thrombosis
5973298|NCT02507180|D-Dimer|d-dimer
5973299|NCT02507180|LEFt|left
5973300|NCT02504879|Osteosclerosis|osteosclerosis
5973301|NCT02504879|Hyperostosis|hyperostosis
5973302|NCT02504866|Aerobic Exercise Training|aerobic exercise training
5973303|NCT02504866|Balance|balance
5973304|NCT02504866|TBI|tbi
5973305|NCT02504853|Eosinophilic Esophagitis|eosinophilic esophagitis
5973306|NCT02504853|Loeys-Dietz Syndrome|loeys-dietz syndrome
5973307|NCT02504853|TGFbeta|tgfbeta
5973308|NCT02500550|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5973309|NCT02500550|Graft versus host disease|graft versus host disease
5973310|NCT02500550|Immune reconstitution|immune reconstitution
5973311|NCT02500550|Alloreactive T-cells|alloreactive t-cells
5973312|NCT02500550|Photodynamic treatment|photodynamic treatment
5973313|NCT02500550|Hematologic malignancy|hematologic malignancy
5973314|NCT02500550|Transplant-related mortality|transplant-related mortality
5973315|NCT02499003|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5973316|NCT02499003|Follicular lymphoma|follicular lymphoma
5973317|NCT02499003|Transformed indolent lymphoma|transformed indolent lymphoma
5973318|NCT02496520|dendritic cell vaccination|dendritic cell vaccination
5973319|NCT02496520|sarcoma|sarcoma
5973320|NCT02496520|central nervous system tumor|central nervous system tumor
5973321|NCT02496520|childhood|childhood
5973322|NCT02496520|adolescent|adolescent
5973323|NCT02496520|immunotherapy|immunotherapy
5973324|NCT02494167|Acute Myeloid Leukemia|acute myeloid leukemia
5973325|NCT02494167|Myelodysplastic Syndrome|myelodysplastic syndrome
5973326|NCT02494167|MultiTAA Specific T cells|multitaa specific t cells
5973327|NCT02490631|skin flora|skin flora
5973328|NCT02489695|locally advanced or metastatic|locally advanced or metastatic
5973329|NCT02487095|RB1 Inactivation|rb1 inactivation
5973330|NCT02487095|Kinase Inhibitor|kinase inhibitor
5973331|NCT02487095|DNA Damage Response Network|dna damage response network
5973332|NCT02487095|MYC And CCNE1 Activation|myc and ccne1 activation
5973333|NCT02487095|Defective ATM-p53 Signaling Pathway|defective atm-p53 signaling pathway
5973334|NCT02485678|ambulatory toxicity management|ambulatory toxicity management
5973335|NCT02485678|adjuvant or neoadjuvant chemotherapy|adjuvant or neoadjuvant chemotherapy
5973336|NCT02485639|HA-specific plasmablasts|ha-specific plasmablasts
5973337|NCT02485639|humoral immunity|humoral immunity
5973338|NCT02485639|influenza|influenza
5973343|NCT02481414|HSIL, CIN II/III|hsil, cin ii/iii
5973344|NCT02481154|Glioma|glioma
5973345|NCT02481154|IDH1|idh1
5973346|NCT02481154|IDH2|idh2
5973347|NCT02481154|Dual Mutation|dual mutation
5973348|NCT02481154|AG-881|ag-881
5973349|NCT02478177|Anticoagulant|anticoagulant
5973350|NCT02478177|Stroke|stroke
5973351|NCT02478177|Ischemic Stroke|ischemic stroke
5973352|NCT02478177|Intracerebral hemorrhage|intracerebral hemorrhage
5973353|NCT02477839|Epilepsy, children, partial-onset seizures, lacosamide, LCM, pediatric|epilepsy, children, partial-onset seizures, lacosamide, lcm, pediatric
5973354|NCT02477774|Anterolateral Thigh|anterolateral thigh
5973355|NCT02476916|Pyruvate Kinase Deficiency|pyruvate kinase deficiency
5973356|NCT02476916|Hemolytic anemia|hemolytic anemia
5973357|NCT02476916|Protein Kinase R (PKR)|protein kinase r (pkr)
5973358|NCT02476916|Drive PK|drive pk
5973359|NCT02475707|leukemia|leukemia
5973360|NCT02475707|lymphoblastic|lymphoblastic
5973361|NCT02475707|ALL|all
5973362|NCT02475707|multiTAA-specific T cells|multitaa-specific t cells
5973363|NCT02475707|HSCT|hsct
5973364|NCT02472795|Systemic lupus erythematosus|systemic lupus erythematosus
5973365|NCT02471378|Assays|assays
5973366|NCT02471378|Women|women
5973367|NCT02471378|Infected|infected
5973368|NCT02471378|Antibodies|antibodies
5973369|NCT02471378|Plasmodium Falciparum|plasmodium falciparum
5973370|NCT02471352|Dermatologic Condition|dermatologic condition
5973371|NCT02471352|Skin Disease|skin disease
5973372|NCT02471352|Biospecimen|biospecimen
5973373|NCT02471352|Healthy Volunteers|healthy volunteers
5973374|NCT02471352|Merkel Cell Carcinoma|merkel cell carcinoma
5973375|NCT02471339|Psychological Intervention|psychological intervention
5973376|NCT02471339|Coping|coping
5973377|NCT02471339|Mindfulness|mindfulness
5973378|NCT02471339|Randomized|randomized
5973379|NCT02470299|ketorolac|ketorolac
5973380|NCT02470299|GTPase|gtpase
5973381|NCT02470299|cancer|cancer
5973382|NCT02470299|peritoneal|peritoneal
5973383|NCT02470299|fallopian|fallopian
5973384|NCT02470299|ovarian|ovarian
5973385|NCT02468661|Non-Small Cell Lung Cancer|non-small cell lung cancer
5973386|NCT02468661|NSCLC|nsclc
5973387|NCT02468661|INC280|inc280
5973388|NCT02468661|erlotinib|erlotinib
5973389|NCT02468661|advanced/metastatic non-small cell lung cancer|advanced/metastatic non-small cell lung cancer
5973390|NCT02468661|EGFR mutation|egfr mutation
5973391|NCT02468661|cMET amplification|cmet amplification
5973392|NCT02468661|EGFR tyrosine kinase inhibitor (EGFR TKI)|egfr tyrosine kinase inhibitor (egfr tki)
5973393|NCT02466802|Advanced|advanced
5973394|NCT02465307|Consciousness|consciousness
5973395|NCT02465307|Alertness|alertness
5973396|NCT02465307|Cognition|cognition
5973397|NCT02465307|Activity level|activity level
5973398|NCT02465307|Delirium|delirium
5973399|NCT02465307|Hyperactive delirium|hyperactive delirium
5973400|NCT02465307|Hypoactive delirium|hypoactive delirium
5973401|NCT02465307|Facial expression|facial expression
5973402|NCT02465307|Posture|posture
5973403|NCT02465307|Intensive care unit|intensive care unit
5973404|NCT02465034|Neural plasticity|neural plasticity
5973405|NCT02465034|Noninvasive brain stimulation|noninvasive brain stimulation
5973406|NCT02465034|Motor cortex|motor cortex
5973407|NCT02460913|acupuncture|acupuncture
5973408|NCT02460913|morphine|morphine
5973409|NCT02460913|acute pain|acute pain
5973410|NCT02460575|Safety|safety
5973411|NCT02460224|Non-small cell lung cancer|non-small cell lung cancer
5973412|NCT02460224|Melanoma|melanoma
5973413|NCT02460224|Renal cancer|renal cancer
5973414|NCT02460224|Mesothelioma|mesothelioma
5973415|NCT02460224|Triple Negative Breast|triple negative breast
5973416|NCT02460224|TNBC|tnbc
5973417|NCT02460224|Renal|renal
5973418|NCT02460198|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5973419|NCT02460198|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5973420|NCT02460198|MSI-H|msi-h
5973421|NCT02460198|MSI|msi
5973422|NCT02459002|Advanced lung cancer|advanced lung cancer
5973423|NCT02459002|NSCLC|nsclc
5973424|NCT02459002|palliative care|palliative care
5973425|NCT02457845|Brain Tumor, Recurrent|brain tumor, recurrent
5973426|NCT02457845|Glioma|glioma
5973427|NCT02457845|Glioblastoma|glioblastoma
5973428|NCT02457845|Gliosarcoma|gliosarcoma
5973429|NCT02457845|Anaplastic Astrocytoma|anaplastic astrocytoma
5973430|NCT02457845|Oligodendroglioma|oligodendroglioma
5973431|NCT02457845|Rhabdoid Tumor|rhabdoid tumor
5973432|NCT02457845|Cerebral Primitive Neuroectodermal Tumor|cerebral primitive neuroectodermal tumor
5973433|NCT02457845|PNET|pnet
5973434|NCT02457845|Ependymoma|ependymoma
5973435|NCT02457845|Germ Cell Tumor|germ cell tumor
5973436|NCT02457845|Choroid Plexus Carcinoma|choroid plexus carcinoma
5973437|NCT02457845|Oncolytic Virus Therapy|oncolytic virus therapy
5973438|NCT02457845|Virotherapy, Oncolytic|virotherapy, oncolytic
5973439|NCT02457845|Immunotherapy|immunotherapy
5973440|NCT02457845|Central Nervous System Agents|central nervous system agents
5973441|NCT02457845|Antineoplastic Agents|antineoplastic agents
5973442|NCT02457845|Neoplasms|neoplasms
5973443|NCT02457845|Pediatric|pediatric
5973444|NCT02457845|Pediatrics|pediatrics
5973445|NCT02457845|Embryonal Tumor|embryonal tumor
5973446|NCT02457845|Oncolytic|oncolytic
5973447|NCT02457845|Virus|virus
5973448|NCT02457845|HSV|hsv
5973449|NCT02457845|Herpes Virus|herpes virus
5973450|NCT02456389|Probable cancer|probable cancer
5973451|NCT02456389|Proven cancer|proven cancer
5973452|NCT02456389|Elective cancer surgery|elective cancer surgery
5973453|NCT02456389|Postoperative death|postoperative death
5973454|NCT02456389|Postoperative complications|postoperative complications
5973455|NCT02456389|Healthcare utilization|healthcare utilization
5973456|NCT02456389|Quality of life|quality of life
5973457|NCT02456389|Adjuvant therapy|adjuvant therapy
5973458|NCT02456389|Disease-free survival|disease-free survival
5973459|NCT02456389|Overall survival|overall survival
5973460|NCT02451436|Adolescents, sleep, media use, obesity, type 2 diabetes|adolescents, sleep, media use, obesity, type 2 diabetes
5973461|NCT02448589|Advanced Solid Tumors|advanced solid tumors
5973469|NCT02445248|Relapsed/refractory,|relapsed/refractory,
5973470|NCT02445248|CTL019|ctl019
5973471|NCT02445248|CART19|cart19
5973472|NCT02445248|CART|cart
5973473|NCT02445248|CAR T cells|car t cells
5973474|NCT02445248|Chimeric antigen receptor|chimeric antigen receptor
5973475|NCT02444572|Enoxaparin|enoxaparin
5973476|NCT02444572|Immunogenicity|immunogenicity
5973477|NCT02435849|Pediatric|pediatric
5973479|NCT02435849|Cell therapy|cell therapy
5973480|NCT02435810|Neuroinflammation|neuroinflammation
5973481|NCT02435810|Infections|infections
5973482|NCT02434120|MRI|mri
5973483|NCT02434120|Orbital neoplasm|orbital neoplasm
5973484|NCT02433158|Rivipansel|rivipansel
5973485|NCT02433158|GMI-1070|gmi-1070
5973486|NCT02433158|Selectin Inhibitor|selectin inhibitor
5973487|NCT02433158|SCD|scd
5973488|NCT02433158|VOC|voc
5973489|NCT02432274|E7080|e7080
5973490|NCT02432274|Lenvatinib|lenvatinib
5973491|NCT02432274|Solid malignancies|solid malignancies
5973492|NCT02432274|Osteosarcoma|osteosarcoma
5973493|NCT02432274|Differentiated Thyroid Cancer|differentiated thyroid cancer
5973494|NCT02432235|Camidanlumab tesirine|camidanlumab tesirine
5973495|NCT02428647|growth|growth
5973496|NCT02428647|plasma zinc concentration|plasma zinc concentration
5973497|NCT02424188|weight management|weight management
5973498|NCT02424188|physical activity|physical activity
5973499|NCT02424188|Tobacco smoking|tobacco smoking
5973500|NCT02424188|Serious mental illness|serious mental illness
5973501|NCT02423603|Triple Negative Breast Cancer|triple negative breast cancer
5973502|NCT02423603|Metastatic|metastatic
5973503|NCT02423603|AKT Inhibitor|akt inhibitor
5973504|NCT02423603|Advanced|advanced
5973505|NCT02423603|AZD5363|azd5363
5973506|NCT02423603|Paclitaxel|paclitaxel
5973507|NCT02423603|PAKT|pakt
5973508|NCT02423603|Capivasertib|capivasertib
5973509|NCT02422550|MRI|mri
5973510|NCT02422550|15-073|15-073
5973511|NCT02422550|participants undergoing radiation therapy|participants undergoing radiation therapy
5973512|NCT02422524|Hepatic|hepatic
5973513|NCT02422524|impairment|impairment
5973514|NCT02422524|PA-824|pa-824
5973515|NCT02422524|Pharmacokinetics|pharmacokinetics
5973516|NCT02422524|Safety|safety
5973517|NCT02422524|Tuberculosis|tuberculosis
5973518|NCT02416206|Multiple myeloma|multiple myeloma
5973519|NCT02416206|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5973520|NCT02415881|Panitumumab|panitumumab
5973521|NCT02415881|Optical Imaging|optical imaging
5973522|NCT02415621|metastatic|metastatic
5973523|NCT02415621|castration resistant|castration resistant
5973524|NCT02415621|abiraterone therapy|abiraterone therapy
5973525|NCT02414282|Dementia|dementia
5973526|NCT02414282|Brain Diseases|brain diseases
5973527|NCT02414282|mild cognitive impairment|mild cognitive impairment
5973528|NCT02414282|Central Nervous System Diseases|central nervous system diseases
5973529|NCT02414282|Neurodegenerative Disease|neurodegenerative disease
5973530|NCT02414269|modified T cells|modified t cells
5973531|NCT02414269|cyclophosphamide|cyclophosphamide
5973532|NCT02414269|CAR T cells|car t cells
5973533|NCT02414269|15-007|15-007
5973534|NCT02414269|CAR|car
5973535|NCT02414269|immunotherapy|immunotherapy
5973536|NCT02414139|Non Small Cell Lung|non small cell lung
5973537|NCT02414139|Non Small Cell Lung Cancer|non small cell lung cancer
5973538|NCT02414139|Non-small cell lung cancer|non-small cell lung cancer
5973539|NCT02414139|NSCLC|nsclc
5973540|NCT02414139|INC280|inc280
5973541|NCT02414139|EGFR wild-type (wt)|egfr wild-type (wt)
5973542|NCT02414139|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5973543|NCT02414139|advanced/metastatic disease|advanced/metastatic disease
5973544|NCT02414139|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5973545|NCT02414139|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5973546|NCT02414139|lung cancer|lung cancer
5973547|NCT02414139|lung adenocarcinoma|lung adenocarcinoma
5973548|NCT02414139|Non small cell lung carcinoma|non small cell lung carcinoma
5973549|NCT02414139|MET exon 14 deletion|met exon 14 deletion
5973550|NCT02414139|MET exon 14 skipping|met exon 14 skipping
5973551|NCT02414139|MET exon 14 mutation|met exon 14 mutation
5973552|NCT02414139|MET mutation|met mutation
5973553|NCT02414139|MET amplification|met amplification
5973554|NCT02414139|MET inhibitor|met inhibitor
5973555|NCT02414139|MET dysregulation|met dysregulation
5973556|NCT02414139|MET activation|met activation
5973557|NCT02414139|MET signaling|met signaling
5973558|NCT02414139|MET pathway|met pathway
5973559|NCT02414139|met|met
5973560|NCT02414139|cMET|cmet
5973561|NCT02412722|Drug therapy|drug therapy
5973562|NCT02412696|placental morphology|placental morphology
5973563|NCT02412696|CPAP|cpap
5973564|NCT02412696|placental secretory function|placental secretory function
5973565|NCT02412579|HCC|hcc
5973566|NCT02412579|Liver Cancer|liver cancer
5973567|NCT02407236|Ustekinumab|ustekinumab
5973568|NCT02407236|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
5973569|NCT02407236|Colitis, Ulcerative|colitis, ulcerative
5973570|NCT02407197|T1 mapping|t1 mapping
5973571|NCT02407197|CMR|cmr
5973572|NCT02407197|Outcome|outcome
5973573|NCT02407197|multicenter|multicenter
5973574|NCT02406742|CC-122|cc-122
5973575|NCT02406742|Pharmacokinetics|pharmacokinetics
5973576|NCT02406742|Safety|safety
5973577|NCT02406742|Ibrutinib|ibrutinib
5973578|NCT02406742|Obinutuzumab|obinutuzumab
5973579|NCT02406742|GA101|ga101
5973580|NCT02406742|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5950183|NCT03520751|CMT1A|cmt1a
5973581|NCT02406742|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5973582|NCT02404441|Phase I/II, PDR001, Checkpoint inhibitor, PD-1, PD-L1|phase i/ii, pdr001, checkpoint inhibitor, pd-1, pd-l1
5973583|NCT02401035|candidate for acid suppression therapy|candidate for acid suppression therapy
5973584|NCT02401035|presumptive diagnosis of GERD|presumptive diagnosis of gerd
5973585|NCT02401035|clinical diagnosis of suspected GERD|clinical diagnosis of suspected gerd
5973586|NCT02401035|symptomatic GERD|symptomatic gerd
5973587|NCT02401035|endoscopically proven GERD|endoscopically proven gerd
5973589|NCT02399124|Renal Cell Carcinoma|renal cell carcinoma
5973590|NCT02399124|Kidney tumors|kidney tumors
5973591|NCT02398331|Spinal cord injuries|spinal cord injuries
5973592|NCT02398331|Sexual function|sexual function
5973593|NCT02398331|Sexual response|sexual response
5973594|NCT02398331|Sexuality|sexuality
5973595|NCT02398331|Women|women
5973596|NCT02397837|Bipolar Disorder|bipolar disorder
5973597|NCT02397837|Cognition|cognition
5973598|NCT02394548|Locally advanced, inoperable non-small cell lung carcinoma|locally advanced, inoperable non-small cell lung carcinoma
5973599|NCT02394548|Limited stage small cell lung carcinoma|limited stage small cell lung carcinoma
5973600|NCT02394548|Acute esophagitis|acute esophagitis
5973601|NCT02394548|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5973602|NCT02394509|Epilepsy Memory Problems|epilepsy memory problems
5973603|NCT02394509|Self-Management|self-management
5973604|NCT02392351|Hypertension|hypertension
5973605|NCT02392351|Renal Denervation|renal denervation
5973606|NCT02390765|Stress Response|stress response
5973607|NCT02390765|Binge Eating|binge eating
5973608|NCT02390765|Eating Behavior|eating behavior
5973609|NCT02390765|Obesity|obesity
5973610|NCT02390765|Disordered Eating|disordered eating
5973611|NCT02388737|Drug therapy|drug therapy
5973612|NCT02388165|Staphylococcal Vaccine|staphylococcal vaccine
5973613|NCT02388165|Post-operative Surgical Site Infection|post-operative surgical site infection
5973614|NCT02388165|Spinal Surgery|spinal surgery
5973615|NCT02388165|MRSA|mrsa
5973616|NCT02388165|Staphylococcus aureus|staphylococcus aureus
5973617|NCT02387229|Atrial Fibrillation|atrial fibrillation
5973618|NCT02387229|Stroke|stroke
5973619|NCT02387229|Neurocognitive decline|neurocognitive decline
5973620|NCT02387229|Rivaroxaban|rivaroxaban
5973621|NCT02387229|Acetylsalicylic acid|acetylsalicylic acid
5973622|NCT02387229|Anticoagulation|anticoagulation
5973623|NCT02385123|ex-vivo|ex-vivo
5973624|NCT02385123|Healthy Volunteers|healthy volunteers
5973625|NCT02385123|Immune Response|immune response
5973626|NCT02385123|Influenza|influenza
5973627|NCT02385123|plasmablasts|plasmablasts
5973628|NCT02385123|Vaccine|vaccine
5973629|NCT02384733|Radiation induced morbidity, recurrence|radiation induced morbidity, recurrence
5973630|NCT02381457|Microdeletion Syndrome|microdeletion syndrome
5973631|NCT02381457|Aneuploidy|aneuploidy
5973632|NCT02381457|22q|22q
5973633|NCT02381457|Non-Invasive Prenatal Screening|non-invasive prenatal screening
5973634|NCT02381457|DiGeorge Syndrome|digeorge syndrome
5973635|NCT02380274|Prostate Cancer|prostate cancer
5973636|NCT02380274|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5973637|NCT02380274|Metastatic Prostate Cancer|metastatic prostate cancer
5973638|NCT02377297|dental atraumatic restorative treatment|dental atraumatic restorative treatment
5973639|NCT02377297|primary tooth|primary tooth
5973640|NCT02377297|occlusal restoration|occlusal restoration
5973641|NCT02377297|glass-ionomer cement|glass-ionomer cement
5973642|NCT02376699|CD40 Antigen|cd40 antigen
5973643|NCT02376699|Drug Therapy|drug therapy
5973644|NCT02376699|Follicular Lymphoma|follicular lymphoma
5973645|NCT02376699|Hodgkin Disease|hodgkin disease
5973646|NCT02376699|Immunotherapy|immunotherapy
5973647|NCT02376699|Indolent Lymphoma|indolent lymphoma
5973648|NCT02376699|Lymphoma|lymphoma
5973649|NCT02376699|Lymphoma, B-Cell|lymphoma, b-cell
5973650|NCT02376699|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5973651|NCT02376699|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5973652|NCT02376699|Monoclonal Antibody|monoclonal antibody
5973653|NCT02376699|Neoplasms|neoplasms
5973654|NCT02376699|Neoplasm Metastasis|neoplasm metastasis
5973655|NCT02376699|Solid tumor|solid tumor
5973656|NCT02375958|PCA062|pca062
5973657|NCT02375958|Triple Negative Breast Cancer|triple negative breast cancer
5973658|NCT02375958|Head & Neck Cancer|head & neck cancer
5973659|NCT02375958|Esophageal Cancer|esophageal cancer
5973660|NCT02375958|pCAD, pcadherin, solid-tumors|pcad, pcadherin, solid-tumors
5973661|NCT02371681|Treatment-Response|treatment-response
5973662|NCT02371681|Radiological Imaging|radiological imaging
5973663|NCT02371681|Biomarkers|biomarkers
5973664|NCT02371681|Antitubercular Agents|antitubercular agents
5973665|NCT02371681|Log-CFU Reduction|log-cfu reduction
5973666|NCT02369016|indolent Non-Hodgkin lymphoma|indolent non-hodgkin lymphoma
5973667|NCT02369016|rituximab-refractory|rituximab-refractory
5973668|NCT02363504|Magnetic Resonance Imaging|magnetic resonance imaging
5973669|NCT02363504|Noradrenaline|noradrenaline
5973670|NCT02363504|locus coeruleus|locus coeruleus
5973671|NCT02363504|memory|memory
5973672|NCT02363309|13C|13c
5973673|NCT02363309|Fatty Liver|fatty liver
5973674|NCT02363309|Acetate|acetate
5973675|NCT02363309|Breath Tests|breath tests
5973676|NCT02363309|Palmitate|palmitate
5973677|NCT02362451|Dendritic Cell Vaccine|dendritic cell vaccine
5973678|NCT02362451|Multi Epitope Tarp Peptide|multi epitope tarp peptide
5973679|NCT02362451|Autolougous Dendritic Cell|autolougous dendritic cell
5973680|NCT02362451|D0 Prostate Cancer|d0 prostate cancer
5973681|NCT02362451|Vaccine Therapy|vaccine therapy
5973682|NCT02362438|Intrathecal|intrathecal
5973683|NCT02362438|AAVp Mediated Gene Transfer|aavp mediated gene transfer
5973684|NCT02362438|Phase 1|phase 1
5973685|NCT02362438|Safety Study|safety study
5973686|NCT02362438|Giant Axonal Neuropathy|giant axonal neuropathy
5973687|NCT02356848|self-care|self-care
5973688|NCT02356848|self-monitoring|self-monitoring
5973689|NCT02356848|secondary prevention|secondary prevention
5973690|NCT02356848|foot ulcer|foot ulcer
5973691|NCT02356848|Diabetic Foot Ulcer|diabetic foot ulcer
5973692|NCT02355262|Insurance Coverage|insurance coverage
5973693|NCT02355262|Insurance Continuity|insurance continuity
5973694|NCT02354144|Human papillomavirus|human papillomavirus
5973695|NCT02354144|Carrageenan|carrageenan
5973696|NCT02354144|Microbicide|microbicide
5973697|NCT02354144|Anal HPV infection|anal hpv infection
5973698|NCT02352974|Diamyd|diamyd
5973699|NCT02352974|Diabetes|diabetes
5973700|NCT02352974|Juvenile Diabetes|juvenile diabetes
5274497|NCT02306252|Oncology|oncology
5973701|NCT02352974|Diabetes Type 1|diabetes type 1
5973702|NCT02352974|Type 1 Diabetes|type 1 diabetes
5973703|NCT02352974|Autoimmune Diabetes|autoimmune diabetes
5973704|NCT02352974|Insulin Dependent Diabetes|insulin dependent diabetes
5973705|NCT02352974|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5973707|NCT02352974|GAD65|gad65
5973708|NCT02352974|GAD-Alum|gad-alum
5973709|NCT02352974|Diabetes Mellitus|diabetes mellitus
5973710|NCT02352974|Diabetes mellitus Type 1|diabetes mellitus type 1
5973711|NCT02352974|Glucose Metabolism Disorders|glucose metabolism disorders
5973712|NCT02352974|Metabolic Diseases|metabolic diseases
5973713|NCT02352974|Vitamin D|vitamin d
5973714|NCT02351726|aortic valve replacement|aortic valve replacement
5973715|NCT02351726|aortic stenosis|aortic stenosis
5973716|NCT02351726|aortic steno-insufficiency|aortic steno-insufficiency
5973717|NCT02351388|Alzheimer's disease|alzheimer's disease
5973718|NCT02351388|Depressive symptoms|depressive symptoms
5973719|NCT02351388|Neuropsychiatric symptoms|neuropsychiatric symptoms
5973720|NCT02351388|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5973721|NCT02351388|Neuromodulation|neuromodulation
5973722|NCT02351388|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5973723|NCT02349815|Drug Utilization Study|drug utilization study
5973724|NCT02346136|Tai Chi|tai chi
5973725|NCT02346136|Cluster randomized controlled trial|cluster randomized controlled trial
5973726|NCT02346136|Intervention|intervention
5973727|NCT02346136|Elderly|elderly
5973728|NCT02346136|Mobility|mobility
5973729|NCT02346136|Health care utilization|health care utilization
5973730|NCT02345954|Uterus Prolapse|uterus prolapse
5973731|NCT02345954|Laparoscopic Sacropexy|laparoscopic sacropexy
5973732|NCT02345954|Laparoscopic Hysteropexy|laparoscopic hysteropexy
5973733|NCT02345850|Acute Leukemia|acute leukemia
5973734|NCT02345850|Myelodysplasia|myelodysplasia
5973735|NCT02345850|GVHD Prophylaxis|gvhd prophylaxis
5973736|NCT02345850|Chronic GVHD|chronic gvhd
5973737|NCT02343172|Liposarcoma,|liposarcoma,
5973738|NCT02343172|MDM2 inhibition,|mdm2 inhibition,
5973739|NCT02343172|cdk4 inhibition,|cdk4 inhibition,
5973740|NCT02343172|HDM201,|hdm201,
5973741|NCT02343172|LEE011|lee011
5973742|NCT02342665|Non Hodgkin's Lymphomas|non hodgkin's lymphomas
5973743|NCT02341495|Azacitidine|azacitidine
5973744|NCT02341495|Vidaza|vidaza
5973745|NCT02341495|Deferasirox|deferasirox
5973746|NCT02341495|Exjade|exjade
5973747|NCT02341495|Cholecalciferol|cholecalciferol
5973748|NCT02341495|Vitamin D|vitamin d
5973749|NCT02339064|Parkinson's disease,|parkinson's disease,
5973750|NCT02339064|apomorphine|apomorphine
5973751|NCT02339064|Apokyn|apokyn
5973752|NCT02339064|dopamine agonist|dopamine agonist
5973753|NCT02339064|levodopa|levodopa
5973754|NCT02339064|advanced|advanced
5973755|NCT02339064|PD|pd
5973756|NCT02339064|carbidopa|carbidopa
5973757|NCT02339064|pramipexole|pramipexole
5973758|NCT02339064|ropinirole|ropinirole
5973759|NCT02339064|rotigotine|rotigotine
5973760|NCT02339064|MAO-B inhibitors|mao-b inhibitors
5973761|NCT02339064|COMT inhibitors|comt inhibitors
5973762|NCT02339064|off|off
5973763|NCT02339064|dyskinesia|dyskinesia
5973764|NCT02339012|Genome Wide Association|genome wide association
5973765|NCT02339012|Biomarkers|biomarkers
5973766|NCT02339012|Methylation|methylation
5973767|NCT02339012|Phenotype|phenotype
5973768|NCT02339012|Cytometry|cytometry
5973769|NCT02338999|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5973770|NCT02338999|Arteriosclerosis|arteriosclerosis
5973771|NCT02338999|Adult|adult
5973772|NCT02336815|Multiple myeloma|multiple myeloma
5973773|NCT02336815|Karyopharm|karyopharm
5973774|NCT02336815|KPT-330|kpt-330
5973775|NCT02336815|Selinexor|selinexor
5973776|NCT02336815|Refractory|refractory
5973777|NCT02336815|Bortezomib|bortezomib
5973778|NCT02336815|Carfilzomib|carfilzomib
5973779|NCT02336815|Lenalidomide|lenalidomide
5973780|NCT02336815|Pomalidomide|pomalidomide
5973781|NCT02336815|Dexamethasone|dexamethasone
5973782|NCT02336815|STORM|storm
5973783|NCT02336815|Daratumumab|daratumumab
5973784|NCT02336451|ALK-positive|alk-positive
5973785|NCT02336451|NSCLC|nsclc
5973786|NCT02336451|non-small cell lung cancer|non-small cell lung cancer
5973787|NCT02336451|brain metastasis|brain metastasis
5973788|NCT02336451|metastatic to the brain and/or to leptomeninges|metastatic to the brain and/or to leptomeninges
5973789|NCT02336451|ceritinib|ceritinib
5973790|NCT02336451|LDK378|ldk378
5973791|NCT02336451|NSCLC metastatic to the brain|nsclc metastatic to the brain
5973792|NCT02336451|leptomeninges harboring a confirmed ALK rearrangement|leptomeninges harboring a confirmed alk rearrangement
5973793|NCT02335411|Gastric cancer|gastric cancer
5973794|NCT02335411|Gastroesophageal junction cancer|gastroesophageal junction cancer
5973795|NCT02335411|PD1|pd1
5973796|NCT02335411|PD-1|pd-1
5973797|NCT02335411|PDL1|pdl1
5973798|NCT02335411|PD-L1|pd-l1
5973799|NCT02327884|Genetics|genetics
5973800|NCT02327884|Dry Mouth|dry mouth
5973801|NCT02327884|Sjogren's Syndrome|sjogren's syndrome
5973802|NCT02327884|Gland Dysfuntion|gland dysfuntion
5973803|NCT02327884|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
5973804|NCT02327169|Drug therapy|drug therapy
5973805|NCT02326857|Molecular Profiles of Breast Cancer in Latin American Women|molecular profiles of breast cancer in latin american women
5973806|NCT02326857|AJCC 7 Clinical Stage II to III|ajcc 7 clinical stage ii to iii
5973807|NCT02326857|Breast Cancer Observational Study|breast cancer observational study
5973808|NCT02326857|Prospective Cohort|prospective cohort
5973809|NCT02326857|Epidemiological, Histological, and Clinical Data|epidemiological, histological, and clinical data
5973810|NCT02326818|Dystonia|dystonia
5973811|NCT02326818|Botulinum Toxin|botulinum toxin
5973812|NCT02326818|Musician's Dystonia|musician's dystonia
5973813|NCT02326818|Spasticity|spasticity
5973814|NCT02325921|Magnetic Resonance Imaging|magnetic resonance imaging
5973815|NCT02325921|Diffusion Weighted MRI|diffusion weighted mri
5973816|NCT02325921|Diffusion Tensor Imaging|diffusion tensor imaging
5973817|NCT02325739|FGF401, PDR001, PD-1, FGFR4, FGF19, HCC|fgf401, pdr001, pd-1, fgfr4, fgf19, hcc
5973818|NCT02322203|Niacin|niacin
5973819|NCT02322203|Cholesterol|cholesterol
5973820|NCT02322203|High-Density Lipoprotein|high-density lipoprotein
5973821|NCT02322203|Low-Density Lipoprotein|low-density lipoprotein
5973822|NCT02322203|Lipoproteins|lipoproteins
5973823|NCT02322021|E2609|e2609
5973824|NCT02322021|Mild Cognitive Impairment|mild cognitive impairment
5973825|NCT02322021|Mild to Moderate Dementia|mild to moderate dementia
5973826|NCT02322021|Alzheimer's Disease|alzheimer's disease
5973827|NCT02322021|Prodromal Alzheimer's Disease|prodromal alzheimer's disease
5973833|NCT02313428|Topical Oxygen Therapy|topical oxygen therapy
5973835|NCT02313428|Standard of Care|standard of care
5973836|NCT02313428|Diabetic Wounds|diabetic wounds
5973837|NCT02311322|Growth Disorder|growth disorder
5973838|NCT02311322|Growth|growth
5973839|NCT02311322|Exome Sequencing|exome sequencing
5973840|NCT02310724|youth onset type 2 diabetes|youth onset type 2 diabetes
5973841|NCT02310724|insulin sensitivity|insulin sensitivity
5973842|NCT02310724|beta cell function|beta cell function
5973843|NCT02310724|macrovascular comorbidities|macrovascular comorbidities
5973844|NCT02310724|microvascular comorbidities|microvascular comorbidities
5973845|NCT02309892|Non-Small Cell Lung Cancer|non-small cell lung cancer
5973846|NCT02309892|Neoplasms|neoplasms
5973847|NCT02309892|Immunoconjugate|immunoconjugate
5973848|NCT02309892|Tumor microenvironment alkalinization|tumor microenvironment alkalinization
5973849|NCT02308280|High-risk myeloma|high-risk myeloma
5973850|NCT02308280|Non myeloablative allogeneic transplantation|non myeloablative allogeneic transplantation
5973851|NCT02308280|Bortezomib|bortezomib
5973852|NCT02305433|elderly|elderly
5973853|NCT02305433|functional-based physiotherapy|functional-based physiotherapy
5973854|NCT02305433|frailty syndrome|frailty syndrome
5973855|NCT02305433|osteoporotic hip fractures|osteoporotic hip fractures
5973856|NCT02305433|home-based physiotherapy|home-based physiotherapy
5973857|NCT02305433|home-dwelling|home-dwelling
5973858|NCT02305433|intervention|intervention
5973859|NCT02305433|randomised controlled trial|randomised controlled trial
5973860|NCT02305433|costs of social and health care|costs of social and health care
5973861|NCT02305433|quality of life|quality of life
5973862|NCT02305433|physical functioning|physical functioning
5973863|NCT02305433|mobility|mobility
5973864|NCT02305433|nutrition|nutrition
5973865|NCT02304367|TIO|tio
5973866|NCT02304367|ENS|ens
5973867|NCT02304367|FGF23|fgf23
5973868|NCT02304367|KRN23|krn23
5973869|NCT02302326|reticulum endoplasmic stress|reticulum endoplasmic stress
5973870|NCT02302326|Polycystic Ovary Syndrome|polycystic ovary syndrome
5973871|NCT02302326|mitochondrial function|mitochondrial function
5973872|NCT02302326|insulin resistance|insulin resistance
5973873|NCT02302326|inflammation|inflammation
5973874|NCT02302326|myoinositol|myoinositol
5973875|NCT02302326|metformin|metformin
5973876|NCT02302326|oxidative stress|oxidative stress
5973877|NCT02302066|Drug therapy|drug therapy
5973878|NCT02301260|Processing Speed|processing speed
5973879|NCT02301260|Intervention|intervention
5973880|NCT02301260|Multiple Sclerosis|multiple sclerosis
5973881|NCT02301260|Cognition|cognition
5973882|NCT02299505|LDK378|ldk378
5973883|NCT02299505|ceritinib|ceritinib
5973884|NCT02299505|Alk+|alk+
5973885|NCT02299505|Alk positive|alk positive
5973886|NCT02299505|NSCLC|nsclc
5973887|NCT02299505|lung Cancer|lung cancer
5973888|NCT02299414|Pregnancy|pregnancy
5973889|NCT02299414|Chronic hypertension|chronic hypertension
5973890|NCT02298907|colorectal cancer|colorectal cancer
5973891|NCT02298907|surgery|surgery
5973892|NCT02298907|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5973893|NCT02298907|perioperative|perioperative
5973894|NCT02298907|fitness|fitness
5973895|NCT02297282|Depression|depression
5973896|NCT02297282|Behavioural Activation|behavioural activation
5973897|NCT02296307|Aged|aged
5973898|NCT02296307|Algorithms|algorithms
5973899|NCT02296307|CA-125 Antigen/blood*|ca-125 antigen/blood*
5973900|NCT02296307|Chi-Square Distribution|chi-square distribution
5973901|NCT02296307|Early Detection of Cancer*|early detection of cancer*
5973902|NCT02296307|Feasibility Studies|feasibility studies
5973903|NCT02296307|Female|female
5973904|NCT02296307|Humans|humans
5973905|NCT02296307|Logistic Models|logistic models
5973906|NCT02296307|Mass Screening/methods*|mass screening/methods*
5973907|NCT02296307|Middle Aged|middle aged
5973908|NCT02296307|Neoplasm Grading|neoplasm grading
5973909|NCT02296307|Neoplasm Invasiveness|neoplasm invasiveness
5973910|NCT02296307|Neoplasm Staging|neoplasm staging
5973911|NCT02296307|Ovarian Neoplasms/diagnosis*|ovarian neoplasms/diagnosis*
5973912|NCT02296307|Ovarian Neoplasms/epidemiology|ovarian neoplasms/epidemiology
5973913|NCT02296307|Ovarian Neoplasms/immunology|ovarian neoplasms/immunology
5973914|NCT02296307|Ovarian Neoplasms/ultrasonography|ovarian neoplasms/ultrasonography
5973915|NCT02296307|Pilot Projects|pilot projects
5973916|NCT02296307|Predictive Value of Tests|predictive value of tests
5973917|NCT02296307|Prevalence|prevalence
5973918|NCT02296307|Prognosis|prognosis
5973919|NCT02296307|Prospective Studies|prospective studies
5973920|NCT02296307|Quebec/epidemiology|quebec/epidemiology
5973921|NCT02296307|Tumor Burden|tumor burden
5973922|NCT02291978|back pain|back pain
5973923|NCT02291978|facet joint|facet joint
5973924|NCT02291978|spine|spine
5973925|NCT02289313|obesity prevention|obesity prevention
5973926|NCT02289313|CBPR|cbpr
5973927|NCT02289313|high risk youth|high risk youth
5973928|NCT02289313|school health|school health
5973929|NCT02288676|genomics|genomics
5973930|NCT02288676|somatic mutations|somatic mutations
5973931|NCT02288676|genetic mutations|genetic mutations
5973932|NCT02288676|high-grade serous cancer|high-grade serous cancer
5973933|NCT02288676|ovarian cancer|ovarian cancer
5973934|NCT02288676|endometrial cancer|endometrial cancer
5973935|NCT02288676|DNA tagging|dna tagging
5973936|NCT02281955|Human Papillomavirus|human papillomavirus
5973937|NCT02281955|Oropharynx|oropharynx
5973938|NCT02281955|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5973939|NCT02281955|Squamous Cell Carcinoma|squamous cell carcinoma
5973940|NCT02281955|Radiation Therapy|radiation therapy
5973941|NCT02281955|Chemotherapy|chemotherapy
5973942|NCT02281955|p16|p16
5973943|NCT02278601|Breakthrough pain|breakthrough pain
5973944|NCT02276547|Mitral|mitral
5973945|NCT02276547|Regurgitation|regurgitation
5973951|NCT02276547|Symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery|symptomatic, severe mitral valve regurgitation, high risk for open mitral valve surgery
5973953|NCT02275910|Solid Tumors|solid tumors
5973954|NCT02275910|E7090|e7090
5973955|NCT02266407|Revision TKA|revision tka
5973956|NCT02266407|Septic|septic
5973957|NCT02266407|Aseptic|aseptic
5973958|NCT02266407|Transfusion|transfusion
5973959|NCT02266407|Blood Loss|blood loss
5973960|NCT02264990|veliparib|veliparib
5973961|NCT02264990|carboplatin|carboplatin
5973962|NCT02264990|paclitaxel|paclitaxel
5973963|NCT02264990|cisplatin|cisplatin
5973964|NCT02264990|pemetrexed|pemetrexed
5973965|NCT02264990|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
5973966|NCT02264990|Metastatic|metastatic
5973967|NCT02264990|Non-squamous|non-squamous
5973968|NCT02264990|Non-small cell lung cancer|non-small cell lung cancer
5973969|NCT02263859|Obstructive Sleep Apnea|obstructive sleep apnea
5973970|NCT02259452|Radiation Therapy|radiation therapy
5973971|NCT02256865|Sleep Restriction|sleep restriction
5973972|NCT02256865|Insulin Resistance|insulin resistance
5973973|NCT02256865|Testosterone|testosterone
5973974|NCT02256865|Cortisol|cortisol
5973975|NCT02251353|breast cancer, intervention to metastasis|breast cancer, intervention to metastasis
5973976|NCT02246725|Colorectal Neoplasms|colorectal neoplasms
5973977|NCT02246725|Depression|depression
5973978|NCT02246725|Intestinal Neoplasms|intestinal neoplasms
5973979|NCT02246725|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5973980|NCT02246725|Digestive System Neoplasms|digestive system neoplasms
5973981|NCT02246725|Digestive System Diseases|digestive system diseases
5973982|NCT02246725|Gastrointestinal Diseases|gastrointestinal diseases
5973983|NCT02246725|Intestinal Diseases|intestinal diseases
5973984|NCT02246725|Palliative chemotherapy|palliative chemotherapy
5973985|NCT02246725|Palliative care|palliative care
5973986|NCT02246725|Palliative treatment|palliative treatment
5973987|NCT02246725|Quality of life|quality of life
5973988|NCT02246725|Quality of life for relatives|quality of life for relatives
5973989|NCT02246725|Survival|survival
5973990|NCT02241499|Digestive System Diseases|digestive system diseases
5973991|NCT02241499|Esophageal cancer|esophageal cancer
5973992|NCT02241499|Intestinal Neoplasms|intestinal neoplasms
5973993|NCT02241499|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5973994|NCT02241499|Digestive System Neoplasms|digestive system neoplasms
5973995|NCT02241499|Endoscopic response|endoscopic response
5973996|NCT02241499|Fluorouracil|fluorouracil
5973997|NCT02241499|Metabolic response|metabolic response
5973998|NCT02241499|Oxaliplatin|oxaliplatin
5973999|NCT02241499|Radiotherapy|radiotherapy
5974000|NCT02239068|CT, sedation, oral contrast|ct, sedation, oral contrast
5974001|NCT02233868|Imaging Studies|imaging studies
5974002|NCT02233868|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
5974003|NCT02233868|Inflammation|inflammation
5974004|NCT02233829|C-11 Raclopride|c-11 raclopride
5974005|NCT02233829|015 PET|015 pet
5974006|NCT02233829|Circadian Rhythm|circadian rhythm
5974007|NCT02231892|Repetitive TMS (rTMS)|repetitive tms (rtms)
5974008|NCT02231892|Parameter Development|parameter development
5974009|NCT02231892|Cognitive Tasks|cognitive tasks
5974010|NCT02231892|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5974011|NCT02229565|prostate cancer|prostate cancer
5974012|NCT02229565|prostate biopsy|prostate biopsy
5974013|NCT02229565|prostatectomy|prostatectomy
5974014|NCT02228889|Hernia|hernia
5974015|NCT02228889|Abdominal wall reconstruction|abdominal wall reconstruction
5974016|NCT02228889|Abdominal wall defect|abdominal wall defect
5974017|NCT02228889|Porcine mesh|porcine mesh
5974018|NCT02228889|Component separation|component separation
5974019|NCT02228889|Abdominal wall tumor|abdominal wall tumor
5974020|NCT02228889|Desmoid|desmoid
5974021|NCT02228369|Non Small Cell Lung Cancer, EGFR, Tyrosine kinase inhibitor,EGFR mutation positive, Brain Metastasis, Leptomeningeal Metastasis|non small cell lung cancer, egfr, tyrosine kinase inhibitor,egfr mutation positive, brain metastasis, leptomeningeal metastasis
5974022|NCT02227927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5974023|NCT02227927|GERD|gerd
5974024|NCT02227927|Gastroparesis|gastroparesis
5974025|NCT02227927|Domperidone|domperidone
5974026|NCT02225925|brachytherapy|brachytherapy
5974027|NCT02225886|Renal anaemia|renal anaemia
5974028|NCT02225886|Intravenous ascorbic acid|intravenous ascorbic acid
5974029|NCT02225886|Intravenous iron administration|intravenous iron administration
5974030|NCT02223741|Cerebral palsy|cerebral palsy
5974031|NCT02223741|GMFM-66|gmfm-66
5974032|NCT02223741|PEDI|pedi
5974033|NCT02223624|eccentric|eccentric
5974034|NCT02223624|exercise|exercise
5974035|NCT02223624|heart disease|heart disease
5974036|NCT02223624|chronic heart failure|chronic heart failure
5974037|NCT02223624|rehabilitation|rehabilitation
5974038|NCT02223299|Depression|depression
5974039|NCT02223299|SSRI|ssri
5974040|NCT02223299|Nutritional Supplements|nutritional supplements
5974041|NCT02223299|Beck Depression Scale|beck depression scale
5974042|NCT02222402|Quality of Life|quality of life
5974043|NCT02222402|Exercise|exercise
5974044|NCT02222402|Functional Capacity|functional capacity
5974045|NCT02220894|PD-1|pd-1
5974046|NCT02220894|PD1|pd1
5974047|NCT02220894|PD-L1|pd-l1
5974048|NCT02220894|PDL1|pdl1
5974049|NCT02220582|Cardiac Magnetic Resonance (CMR)|cardiac magnetic resonance (cmr)
5974050|NCT02220582|Cardiovascular Diseases|cardiovascular diseases
5974051|NCT02220582|socio-environmental factors|socio-environmental factors
5974052|NCT02220582|Contextual factors|contextual factors
5974053|NCT02219334|Children|children
5974054|NCT02219334|Nasal suction devices|nasal suction devices
5974055|NCT02219334|Suctioning|suctioning
5974056|NCT02217462|pregnancy|pregnancy
5974057|NCT02217462|gestational weight gain|gestational weight gain
5974058|NCT02217462|dietary intake|dietary intake
5974059|NCT02217462|food reward|food reward
5974060|NCT02215551|laminectomy|laminectomy
5974061|NCT02213952|Ulcer|ulcer
5974062|NCT02213952|Platelet-Rich Plasma|platelet-rich plasma
5974063|NCT02213289|Gastric|gastric
5974064|NCT02213289|Esophagogastric|esophagogastric
5974065|NCT02211755|Purine Nucleoside Inhibitor|purine nucleoside inhibitor
5974066|NCT02211755|Proteasome Inhibitor|proteasome inhibitor
5974067|NCT02211755|Combination Treatment|combination treatment
5974068|NCT02211755|Solid Tumors|solid tumors
5974069|NCT02211755|Hematologic|hematologic
5974070|NCT02210832|smoking|smoking
5974071|NCT02210832|pregnancy|pregnancy
5974072|NCT02210832|cessation|cessation
5974073|NCT02210832|incentives|incentives
5974074|NCT02209545|fibroids, leiomyomata, blood loss, misoprostol|fibroids, leiomyomata, blood loss, misoprostol
5974075|NCT02207075|SPMS|spms
5974076|NCT02207075|Myelin Water Fraction|myelin water fraction
5974077|NCT02207075|activated microglia|activated microglia
5974078|NCT02205424|Ischaemic stroke|ischaemic stroke
5974079|NCT02205424|Alzheimer's disease|alzheimer's disease
5974080|NCT02205424|Brain volume|brain volume
5974081|NCT02205424|Cortical thickness|cortical thickness
5974082|NCT02205424|Magnetic Resonance Imaging|magnetic resonance imaging
5974083|NCT02203526|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5974084|NCT02203526|ABC DLBCL|abc dlbcl
5974085|NCT02203526|Lymphoma in Brain and CNS|lymphoma in brain and cns
5974086|NCT02203526|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
5974087|NCT02202265|Heart Diseases|heart diseases
5974088|NCT02201589|Lesions in the ascending thoracic aorta|lesions in the ascending thoracic aorta
5974089|NCT02200705|cryoablation, cryotherapy, breast cancer|cryoablation, cryotherapy, breast cancer
5974090|NCT02200666|Type 2 diabetes mellitus|type 2 diabetes mellitus
5974091|NCT02200666|Diabetes|diabetes
5974092|NCT02200666|Forxiga|forxiga
5974093|NCT02200666|Long-term use|long-term use
5974094|NCT02199964|Dry eye|dry eye
5974095|NCT02199964|environmental stress|environmental stress
5974096|NCT02199964|artificial tears|artificial tears
5974097|NCT02199964|cyclosporin|cyclosporin
5974098|NCT02199964|Restasis|restasis
5974099|NCT02194712|circulating anodic antigen|circulating anodic antigen
5974100|NCT02194660|Fractures Liaison Service|fractures liaison service
5974101|NCT02194660|Osteoporosis|osteoporosis
5974102|NCT02194660|Fracture|fracture
5974103|NCT02194660|Medication adherence|medication adherence
5974104|NCT02194647|Osteoporosis|osteoporosis
5974105|NCT02194647|Medication Monitoring|medication monitoring
5974106|NCT02194647|Education|education
5974107|NCT02194647|Adherence|adherence
5974108|NCT02194647|Management|management
5974109|NCT02194595|type 2 diabetes|type 2 diabetes
5974110|NCT02194595|beta-cell function|beta-cell function
5974111|NCT02194595|GLP-1|glp-1
5974112|NCT02194595|insulin|insulin
5974113|NCT02193425|fMRI|fmri
5974114|NCT02193425|Brain Connectivity|brain connectivity
5974115|NCT02193425|PET|pet
5974116|NCT02193425|18FDG|18fdg
5974117|NCT02192424|beta-cell function,|beta-cell function,
5974118|NCT02192424|type 2 diabetes,|type 2 diabetes,
5974119|NCT02192424|intermittent insulin|intermittent insulin
5974120|NCT02191397|Escitalopram|escitalopram
5974121|NCT02191397|Major depressive disorder|major depressive disorder
5974122|NCT02191397|Non-inferiority|non-inferiority
5974123|NCT02191397|Bupropion|bupropion
5974124|NCT02190266|Extrapulmonary|extrapulmonary
5974125|NCT02190266|Immunodeficiency|immunodeficiency
5974126|NCT02190266|Genetics|genetics
5974127|NCT02190266|Infection|infection
5974128|NCT02190266|Fungal|fungal
5974129|NCT02189031|Upper limb Amputee|upper limb amputee
5974130|NCT02189031|Targeted Muscle Reinnervation|targeted muscle reinnervation
5974131|NCT02189031|Prosthetic|prosthetic
5974132|NCT02188745|metastatic|metastatic
5974133|NCT02188745|locally advanced|locally advanced
5974134|NCT02188745|ER+|er+
5974135|NCT02188745|Estrogen therapy|estrogen therapy
5974136|NCT02188745|Estradiol therapy|estradiol therapy
5974137|NCT02186730|Computerised Cognitive Behaviour Therapy|computerised cognitive behaviour therapy
5974138|NCT02186730|Adolescents|adolescents
5974139|NCT02186730|Depression|depression
5974140|NCT02186730|Low Mood|low mood
5974141|NCT02185274|Transsexualism|transsexualism
5974142|NCT02185274|Cross-sex hormone treatment|cross-sex hormone treatment
5974143|NCT02185274|Sex hormones|sex hormones
5974144|NCT02185274|Mood|mood
5974145|NCT02185274|Stress|stress
5974146|NCT02185274|Cortisol|cortisol
5974147|NCT02185274|Cardiovascular|cardiovascular
5974148|NCT02185274|Metabolome|metabolome
5974149|NCT02184780|Neurodevelopment|neurodevelopment
5974150|NCT02184780|General Anaesthesia|general anaesthesia
5974151|NCT02184780|Infants|infants
5974152|NCT02184780|Epidural|epidural
5974153|NCT02184780|Spinal|spinal
5974154|NCT02184780|Anxiety and depression|anxiety and depression
5974155|NCT02181569|Addiction Severity Index|addiction severity index
5974156|NCT02181569|Addiction|addiction
5974157|NCT02181569|Sleep Measures|sleep measures
5974158|NCT02181569|Sleep Disorders|sleep disorders
5974159|NCT02181257|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5974160|NCT02181257|Lung Transplantation|lung transplantation
5974161|NCT02181257|Extracorporeal Photopheresis|extracorporeal photopheresis
5974162|NCT02181257|Methoxsalen|methoxsalen
5974163|NCT02179749|Alcohol-Related Disorders|alcohol-related disorders
5974164|NCT02179749|Substance-Related Disorders|substance-related disorders
5974165|NCT02179749|Mental Disorders|mental disorders
5974166|NCT02179749|Mifepristone|mifepristone
5974167|NCT02179749|Glucocorticoid Antagonists|glucocorticoid antagonists
5974168|NCT02179749|Alcohol Treatment|alcohol treatment
5974169|NCT02179749|Alcohol|alcohol
5974170|NCT02179047|SYNTAX ,NGAL,Cystatin C,Galectin-3,Copeptin.MR-ProANP,sST2.|syntax ,ngal,cystatin c,galectin-3,copeptin.mr-proanp,sst2.
5974171|NCT02177110|advanced melanoma|advanced melanoma
5974172|NCT02177110|metastatic melanoma|metastatic melanoma
5974173|NCT02177110|fresh frozen tissue|fresh frozen tissue
5974174|NCT02177110|FFPE tissue|ffpe tissue
5974175|NCT02169791|hematologic malignancies|hematologic malignancies
5974176|NCT02168101|MLN9708|mln9708
5974177|NCT02168101|allogeneic stem cell transplant|allogeneic stem cell transplant
5974178|NCT02168101|multiple myeloma|multiple myeloma
5974179|NCT02168101|ixazomib|ixazomib
5974180|NCT02168101|autologous stem cell transplant|autologous stem cell transplant
5974181|NCT02167477|Intubation, Endotracheal|intubation, endotracheal
5974182|NCT02165397|Ibrutinib|ibrutinib
5974183|NCT02165397|Pharmacyclics|pharmacyclics
5974184|NCT02165397|PCYC|pcyc
5974186|NCT02165397|Btk inhibitor|btk inhibitor
5974188|NCT02165397|Rituximab|rituximab
5974189|NCT02165397|Rituxan|rituxan
5974190|NCT02165397|Waldenström's|waldenström's
5974191|NCT02165397|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5974192|NCT02165397|non-Hodgkin lymphoma|non-hodgkin lymphoma
5974193|NCT02165397|NHL|nhl
5974194|NCT02165137|trauma|trauma
5974195|NCT02165137|major trauma|major trauma
5974196|NCT02165137|multiple trauma|multiple trauma
5974197|NCT02165137|outcome|outcome
5974198|NCT02165137|quality|quality
5974199|NCT02165137|process Management|process management
5974200|NCT02165137|emergency room|emergency room
5974201|NCT02165137|trauma center|trauma center
5974202|NCT02162953|eye disease|eye disease
5974203|NCT02162953|retinal|retinal
5974204|NCT02162953|best1|best1
5974205|NCT02162303|Atherosclerosis|atherosclerosis
5974206|NCT02162303|Vascular|vascular
5974207|NCT02162303|Cardiovascular|cardiovascular
5974208|NCT02162303|Coronary artery disease|coronary artery disease
5974209|NCT02162303|Imaging|imaging
5974210|NCT02162303|PET|pet
5974211|NCT02162303|Scan|scan
5974212|NCT02162303|anti-inflammatory|anti-inflammatory
5974213|NCT02161705|Immediate breast reconstruction|immediate breast reconstruction
5974214|NCT02161705|pain control|pain control
5974215|NCT02161705|post mastectomy pain control|post mastectomy pain control
5974216|NCT02158234|squamous cell carcinoma|squamous cell carcinoma
5974217|NCT02158234|head and neck cancer|head and neck cancer
5974218|NCT02158234|paranasal sinuses|paranasal sinuses
5974219|NCT02158234|nasal cavity|nasal cavity
5974220|NCT02158234|nasopharynx|nasopharynx
5974221|NCT02158234|oropharynx|oropharynx
5974222|NCT02158234|oral cavity|oral cavity
5974223|NCT02158234|larynx|larynx
5974224|NCT02158234|hypopharynx|hypopharynx
5974225|NCT02158234|salivary glands|salivary glands
5974226|NCT02158234|cervical lymph nodes|cervical lymph nodes
5974227|NCT02156115|Lymphangiomatosis|lymphangiomatosis
5974228|NCT02156115|Lymphangiogenesis|lymphangiogenesis
5974229|NCT02156115|Smooth Muscle Cell|smooth muscle cell
5974230|NCT02156115|Vascular Anomalies|vascular anomalies
5974231|NCT02156102|Genetic Disorders|genetic disorders
5974232|NCT02156102|Health contributors|health contributors
5974233|NCT02156102|Multifactorial|multifactorial
5974234|NCT02156102|African American|african american
5974235|NCT02154971|HIV Seropositivity|hiv seropositivity
5974236|NCT02154971|Audiometry|audiometry
5974237|NCT02154971|Hearing Loss|hearing loss
5974238|NCT02154022|PK|pk
5974239|NCT02154009|Autonomic Nervous System|autonomic nervous system
5974240|NCT02154009|Catecholamines|catecholamines
5974241|NCT02154009|Dysautonomia|dysautonomia
5974242|NCT02154009|Parasympathetic Cholinergic System|parasympathetic cholinergic system
5974243|NCT02154009|Sympathetic Adrenergic System|sympathetic adrenergic system
5974244|NCT02153957|Exercise|exercise
5974245|NCT02153957|Memory|memory
5974246|NCT02153957|BDNF|bdnf
5974247|NCT02153957|Zamzee|zamzee
5974248|NCT02153957|QOL|qol
5974249|NCT02151591|Quit smoking|quit smoking
5974250|NCT02151591|Quit drinking|quit drinking
5974251|NCT02148250|Type 2 diabetes|type 2 diabetes
5974252|NCT02148250|Insulin resistance|insulin resistance
5974253|NCT02148250|High insulin requirements|high insulin requirements
5974254|NCT02148250|U 500|u 500
5974255|NCT02147405|FDG PET/CT Scan|fdg pet/ct scan
5974256|NCT02147405|Lymph Node Biopsy|lymph node biopsy
5974257|NCT02147405|Apheresis|apheresis
5974258|NCT02146170|Sample Acquisition|sample acquisition
5974259|NCT02146170|Generic and Epigenetic Alterations|generic and epigenetic alterations
5974260|NCT02146170|Mig6 Expression|mig6 expression
5974261|NCT02146170|Proteomic Analysis|proteomic analysis
5974262|NCT02146170|Genomic Analysis|genomic analysis
5974263|NCT02145143|Radioiodine (RAI) Incorporation|radioiodine (rai) incorporation
5974264|NCT02145143|Vemurafenib|vemurafenib
5974265|NCT02145143|14-031|14-031
5974266|NCT02143466|Phase I|phase i
5974267|NCT02143466|Safety|safety
5974268|NCT02143466|Tolerability|tolerability
5974269|NCT02143466|Efficacy|efficacy
5974270|NCT02143466|Anti-tumour|anti-tumour
5974271|NCT02143466|AZD9291|azd9291
5974272|NCT02143466|AZD6094|azd6094
5974273|NCT02143466|MEDI4736|medi4736
5974274|NCT02143466|Osimertinib|osimertinib
5974275|NCT02143466|Savolitinib|savolitinib
5974276|NCT02143466|Selumetinib|selumetinib
5974277|NCT02143466|Durvalumab|durvalumab
5974278|NCT02143466|Ascending Doses|ascending doses
5974279|NCT02143466|Expansion cohorts|expansion cohorts
5974280|NCT02143466|EGFR|egfr
5974281|NCT02143466|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5974282|NCT02143466|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5974283|NCT02141438|Radium-223|radium-223
5974284|NCT02141438|CRPC|crpc
5974285|NCT02141438|Phase IV|phase iv
5974286|NCT02141438|Safety study|safety study
5974287|NCT02140177|Screening|screening
5974288|NCT02140177|Adults|adults
5974289|NCT02140177|Medical Inpatients|medical inpatients
5974290|NCT02140177|Suicide|suicide
5974291|NCT02138747|Overactive bladder (OAB)|overactive bladder (oab)
5974292|NCT02138747|tolterodine ER|tolterodine er
5974293|NCT02138747|mirabegron|mirabegron
5974294|NCT02137759|Glioblastoma|glioblastoma
5974295|NCT02134067|advanced solid tumors|advanced solid tumors
5974296|NCT02134067|tumor|tumor
5974297|NCT02134067|Dose Escalation|dose escalation
5974298|NCT02134067|TAS-119|tas-119
5974299|NCT02134067|Taxane|taxane
5974300|NCT02134067|Paclitaxel|paclitaxel
5974301|NCT02134067|Aurora A kinase inhibitor|aurora a kinase inhibitor
5974302|NCT02134067|AurA|aura
5974303|NCT02133742|Axitinib and MK-3475|axitinib and mk-3475
5974304|NCT02133742|patients with advanced Renal Cell Cancer.|patients with advanced renal cell cancer.
5974305|NCT02133196|Metastatic|metastatic
5974306|NCT02133196|Non-Small Cell Lung Cancer|non-small cell lung cancer
5974307|NCT02133196|NSCLC|nsclc
5974308|NCT02133196|Lung Cancer|lung cancer
5974309|NCT02133105|Heart failure|heart failure
5974310|NCT02133105|Renal failure|renal failure
5974311|NCT02133105|Inotropic drugs|inotropic drugs
5974312|NCT02133105|Levosimendan|levosimendan
5974313|NCT02133105|Dobutamine|dobutamine
5974314|NCT02128282|Cholangiocarcinoma|cholangiocarcinoma
5974315|NCT02128282|Bile duct cancer|bile duct cancer
5974316|NCT02128282|Biliary tract cancer|biliary tract cancer
5974318|NCT02127710|Savolitinib|savolitinib
5974319|NCT02127710|Papillary Renal Cell Cancer|papillary renal cell cancer
5974320|NCT02122575|Inflammasome|inflammasome
5974321|NCT02122575|Fasting|fasting
5974322|NCT02122575|Sirt3|sirt3
5974323|NCT02120352|bi-monthly|bi-monthly
5974324|NCT02120352|GSK744|gsk744
5974325|NCT02120352|injectable|injectable
5974326|NCT02120352|long acting|long acting
5974327|NCT02120352|maintenance|maintenance
5974328|NCT02120352|abacavir|abacavir
5974329|NCT02120352|every other month|every other month
5974330|NCT02120352|rilpivirine|rilpivirine
5974331|NCT02120352|HIV-1 infection|hiv-1 infection
5974332|NCT02120352|integrase inhibitor|integrase inhibitor
5974333|NCT02120352|TMC278 LA|tmc278 la
5974334|NCT02120352|RPV|rpv
5974335|NCT02120352|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5974336|NCT02120352|LA|la
5974337|NCT02120352|once monthly|once monthly
5974338|NCT02120352|GSK1265744|gsk1265744
5974339|NCT02120352|induction|induction
5974340|NCT02120352|treatment satisfication|treatment satisfication
5974341|NCT02120352|once daily|once daily
5974342|NCT02120352|lamivudine|lamivudine
5974343|NCT02120352|adherence|adherence
5974344|NCT02120352|TMC278|tmc278
5974345|NCT02120352|therapy-naive|therapy-naive
5974346|NCT02119611|Deep Brain Stimulation|deep brain stimulation
5974347|NCT02119611|Movement Disorders|movement disorders
5974348|NCT02119611|Parkinson's Disease|parkinson's disease
5974349|NCT02119611|Essential Tremor|essential tremor
5974350|NCT02114372|Alzheimer's disease|alzheimer's disease
5974351|NCT02114372|Asymptomatic at risk for Alzheimer's disease|asymptomatic at risk for alzheimer's disease
5974352|NCT02114372|Retinal diagnosis for Alzheimer's disease|retinal diagnosis for alzheimer's disease
5974353|NCT02111850|Gene Therapy|gene therapy
5974354|NCT02111850|Tumor Regression|tumor regression
5974355|NCT02111850|Immunotherapy|immunotherapy
5974356|NCT02111850|Adoptive Cell Therapy|adoptive cell therapy
5974357|NCT02108080|Alcohol|alcohol
5974358|NCT02108080|Biomarkers|biomarkers
5974359|NCT02108080|Adults|adults
5974360|NCT02108080|Phenotype|phenotype
5974361|NCT02108080|Imaging|imaging
5974362|NCT02107989|Epilepsy|epilepsy
5974363|NCT02107989|MRI|mri
5974364|NCT02107989|fMRI|fmri
5974365|NCT02107989|MEG|meg
5974366|NCT02106546|veliparib|veliparib
5974367|NCT02106546|carboplatin|carboplatin
5974368|NCT02106546|paclitaxel|paclitaxel
5974369|NCT02106546|Poly Adenosine diphosphate (ADP)-ribose Polymerase (PARP)|poly adenosine diphosphate (adp)-ribose polymerase (parp)
5974370|NCT02106546|Overall Survival|overall survival
5974371|NCT02106546|Advanced|advanced
5974372|NCT02106546|Metastatic|metastatic
5974373|NCT02106546|ABT-888|abt-888
5974374|NCT02106546|Squamous|squamous
5974375|NCT02106546|Randomized|randomized
5974376|NCT02106546|non-small cell lung cancer|non-small cell lung cancer
5974377|NCT02106546|placebo controlled|placebo controlled
5974378|NCT02105844|atrial fibrillation|atrial fibrillation
5974379|NCT02105844|dementia|dementia
5974380|NCT02105844|cognitive dysfunction|cognitive dysfunction
5974381|NCT02105844|stroke|stroke
5974382|NCT02105844|Magnetic resonance imaging|magnetic resonance imaging
5974383|NCT02104258|Hamstring|hamstring
5974384|NCT02104258|Muscle|muscle
5974385|NCT02104258|Injury|injury
5974386|NCT02104258|Treatment|treatment
5974387|NCT02104258|Rehabilitation|rehabilitation
5974388|NCT02100930|Anti-GD2 3F8 Monoclonal Antibody|anti-gd2 3f8 monoclonal antibody
5974389|NCT02100930|oral isotretinoin|oral isotretinoin
5974390|NCT02100930|GM-CSF|gm-csf
5974391|NCT02100930|Sargramostim|sargramostim
5974392|NCT02100930|13-260|13-260
5974393|NCT02099734|14-016|14-016
5974394|NCT02099058|Cancer|cancer
5974395|NCT02099058|Advanced Solid Tumor|advanced solid tumor
5974396|NCT02099058|Neoplasm|neoplasm
5974397|NCT02091999|enfortumab vedotin|enfortumab vedotin
5974398|NCT02091999|Metastatic Urothelial Cancer|metastatic urothelial cancer
5974399|NCT02091999|Safety|safety
5974400|NCT02091999|AGS-22C3E|ags-22c3e
5974401|NCT02091999|EV-101|ev-101
5974402|NCT02091999|Nectin 4 protein, humans|nectin 4 protein, humans
5974403|NCT02091999|Clinical Trial, Phase 1|clinical trial, phase 1
5974404|NCT02091999|ASG-22CE|asg-22ce
5974405|NCT02091999|ASG-22ME|asg-22me
5974406|NCT02091999|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
5974407|NCT02090712|myocardial infarction|myocardial infarction
5974408|NCT02090712|acute coronary syndrome|acute coronary syndrome
5974409|NCT02090712|coronary disease|coronary disease
5974410|NCT02088671|NeuroSENSE|neurosense
5974411|NCT02088671|Anesthesia|anesthesia
5974412|NCT02088671|Hypnosis|hypnosis
5974413|NCT02088671|Desflurane|desflurane
5974414|NCT02088671|Propofol|propofol
5974415|NCT02087852|Questionnaire|questionnaire
5974416|NCT02087852|DNA|dna
5974417|NCT02087852|saliva|saliva
5974418|NCT02087852|kidney cancer|kidney cancer
5974419|NCT02087852|13-218|13-218
5974420|NCT02087852|high risk|high risk
5974421|NCT02083549|Massive Transfusion Protocol|massive transfusion protocol
5974422|NCT02082977|Refractory|refractory
5974423|NCT02082977|Phase I study, dose escalation study|phase i study, dose escalation study
5974424|NCT02082977|diffuse large B cell lymphoma|diffuse large b cell lymphoma
5974425|NCT02082977|Relapsed|relapsed
5974426|NCT02082977|Solid tumors|solid tumors
5974427|NCT02082977|transformed follicular lymphoma|transformed follicular lymphoma
5974428|NCT02082977|Multiple myeloma|multiple myeloma
5974429|NCT02082977|GSK2816126|gsk2816126
5974430|NCT02082977|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5974431|NCT02081625|Duchenne muscular dystrophy|duchenne muscular dystrophy
5974432|NCT02081625|NS-065/NCNP-01|ns-065/ncnp-01
5974433|NCT02081625|exon 53 skipping|exon 53 skipping
5974434|NCT02081625|morpholino|morpholino
5974435|NCT02076672|prevention|prevention
5974436|NCT02076672|non-malignant asbestos-related disease|non-malignant asbestos-related disease
5974437|NCT02076672|benign pleural disease|benign pleural disease
5974438|NCT02076672|asbestosis|asbestosis
5974439|NCT02075359|Total Energy Expenditure|total energy expenditure
5974440|NCT02075359|Physical Activity Levels|physical activity levels
5974441|NCT02075359|Body Mass Index|body mass index
5974442|NCT02075359|Children|children
5974443|NCT02075047|Bipolar I Disorder (current or most recent episode manic). Children and adolescents aged 10 to 17 years.|bipolar i disorder (current or most recent episode manic). children and adolescents aged 10 to 17 years.
5974444|NCT02070315|heart failure|heart failure
5974445|NCT02070315|liver failure|liver failure
5974446|NCT02070315|post liver transplant|post liver transplant
5974447|NCT02067819|Tourette's|tourette's
5974448|NCT02067819|Tic Disorder|tic disorder
5974449|NCT02067819|Dental Appliance|dental appliance
5974450|NCT02067819|Oral Orthotic|oral orthotic
5974451|NCT02067819|Mouthguard|mouthguard
5974452|NCT02066311|lupus|lupus
5974453|NCT02066311|SLE|sle
5974454|NCT02063399|NPC|npc
5974455|NCT02063399|Cancer screening|cancer screening
5974456|NCT02063399|Plasma EBV DNA|plasma ebv dna
5974457|NCT02062697|Neoplasms|neoplasms
5974458|NCT02062697|Glandular and Epithelial|glandular and epithelial
5974459|NCT02062697|Ovarian Neoplasms|ovarian neoplasms
5974460|NCT02062697|Ovarian cancer|ovarian cancer
5974461|NCT02060851|EPO|epo
5974462|NCT02060851|Intravenous iron|intravenous iron
5974463|NCT02060851|iron storage|iron storage
5974464|NCT02060851|preterm anemia|preterm anemia
5974465|NCT02060630|Surgical revascularization|surgical revascularization
5974466|NCT02060630|Endovascular revascularization|endovascular revascularization
5974467|NCT02060630|Amputation|amputation
5974468|NCT02060630|Peripheral artery disease|peripheral artery disease
5974469|NCT02060630|Critical limb ischemia|critical limb ischemia
5974470|NCT02060630|claudication|claudication
5974471|NCT02060630|leg pain|leg pain
5974472|NCT02060630|leg ulcer|leg ulcer
5974473|NCT02060630|gangrene|gangrene
5974474|NCT02060487|pulmonary arterial hypertension|pulmonary arterial hypertension
5974475|NCT02060487|pulmonary hypertension|pulmonary hypertension
5974476|NCT02060487|PAH|pah
5974477|NCT02060487|sildenafil|sildenafil
5974478|NCT02060487|revatio|revatio
5974479|NCT02060370|Genitourinary Cancer|genitourinary cancer
5974480|NCT02060370|Kidney Cancer|kidney cancer
5974481|NCT02060370|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5974482|NCT02060370|mRCC|mrcc
5974483|NCT02060370|Sunitinib|sunitinib
5974484|NCT02060370|Sunitinib malate|sunitinib malate
5974485|NCT02060370|SUO11248|suo11248
5974486|NCT02060370|Sutent|sutent
5974487|NCT02060370|Questionnaire|questionnaire
5974488|NCT02060370|Survey|survey
5974489|NCT02059239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5974490|NCT02059239|Hodgkin's Lymphoma|hodgkin's lymphoma
5974491|NCT02059239|Lymphoma|lymphoma
5974492|NCT02059239|Transplant|transplant
5974493|NCT02055248|Genetic Counseling|genetic counseling
5974494|NCT02055248|Mobius Syndrome|mobius syndrome
5974495|NCT02055248|Birth Defects|birth defects
5974496|NCT02055248|Congenital Malformations|congenital malformations
5974497|NCT02055248|Gene Identification|gene identification
5974498|NCT02055222|COPD|copd
5974499|NCT02055222|Smoking|smoking
5974500|NCT02055222|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5974501|NCT02055209|African American|african american
5974502|NCT02055053|Post Operative Pain|post operative pain
5974503|NCT02055053|hernia repair|hernia repair
5974504|NCT02052778|Breast Cancer|breast cancer
5974505|NCT02052778|Non Small Cell Lung Cancer|non small cell lung cancer
5974506|NCT02052778|Gastric Cancer|gastric cancer
5974507|NCT02052778|FGF|fgf
5974508|NCT02052778|FGFR|fgfr
5974509|NCT02052778|FGFR abnormality|fgfr abnormality
5974510|NCT02052778|TAS-120|tas-120
5974511|NCT02052778|Dose Escalation|dose escalation
5974512|NCT02051218|metastatic breast cancer|metastatic breast cancer
5974513|NCT02051218|castration resistant metastatic prostate cancer|castration resistant metastatic prostate cancer
5974514|NCT02051218|bone metastases|bone metastases
5974515|NCT02051218|Denosumab|denosumab
5974516|NCT02051218|XGEVA|xgeva
5974517|NCT02051218|de-escalation|de-escalation
5974518|NCT02050750|Must have registered with the ICORG 06-31 TAILORx trial|must have registered with the icorg 06-31 tailorx trial
5974519|NCT02050737|Curative resection|curative resection
5974520|NCT02050737|Adjuvant chemotherapy|adjuvant chemotherapy
5974521|NCT02049632|Breast cancer|breast cancer
5974522|NCT02049632|Sentinel Node Biopsy|sentinel node biopsy
5974523|NCT02049632|Micrometastasis|micrometastasis
5974524|NCT02049632|Axillary lymph node dissection|axillary lymph node dissection
5974525|NCT02048059|ANG1005|ang1005
5974526|NCT02048059|GRN1005|grn1005
5974527|NCT02048059|Low-density lipoprotein receptor-related protein (LRP-1)|low-density lipoprotein receptor-related protein (lrp-1)
5974528|NCT02048059|Targeted therapy|targeted therapy
5974529|NCT02048059|Breast cancer|breast cancer
5974530|NCT02048059|Brain metastases|brain metastases
5974531|NCT02048059|Brain tumor|brain tumor
5974532|NCT02048059|Blood-brain barrier|blood-brain barrier
5974533|NCT02048059|Trastuzumab|trastuzumab
5974534|NCT02048059|Herceptin|herceptin
5974535|NCT02048059|Paclitaxel|paclitaxel
5974536|NCT02048059|Taxol|taxol
5974537|NCT02048059|Breast cancer with brain metastases|breast cancer with brain metastases
5974538|NCT02048059|Triple Negative|triple negative
5974539|NCT02048059|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5974540|NCT02048059|Herceptin 2 (HER2)-positive|herceptin 2 (her2)-positive
5974541|NCT02048059|HER2-negative|her2-negative
5974542|NCT02048059|Metastatic brain tumors|metastatic brain tumors
5974543|NCT02044887|Physical activity|physical activity
5974544|NCT02044887|dementia|dementia
5974545|NCT02044887|relative caregivers|relative caregivers
5974546|NCT02044887|podometer|podometer
5974547|NCT02044887|cardiovascular risk|cardiovascular risk
5974548|NCT02042768|Glucose|glucose
5974549|NCT02042768|Dialysate|dialysate
5974550|NCT02042768|Peritoneal Dialysis|peritoneal dialysis
5974551|NCT02042768|patients|patients
5974552|NCT02042768|non-diabetic|non-diabetic
5974553|NCT02042287|Bacterial Infections and Mycoses|bacterial infections and mycoses
5974554|NCT02042287|Pharmaceutical Preparations|pharmaceutical preparations
5974555|NCT02042287|Health Occupations|health occupations
5974556|NCT02038179|Pre-hypertension|pre-hypertension
5974557|NCT02038179|JNC 7 stage I hypertension|jnc 7 stage i hypertension
5974558|NCT02038036|Polycythemia Vera|polycythemia vera
5974559|NCT02038036|Hematologic Diseases|hematologic diseases
5974560|NCT02038036|Myeloproliferative Disorders|myeloproliferative disorders
5974561|NCT02038036|Bone Marrow Diseases|bone marrow diseases
5974562|NCT02038036|Hydroxyurea|hydroxyurea
5974563|NCT02038036|INC424|inc424
5974564|NCT02038036|Ruxolitinib|ruxolitinib
5974565|NCT02037022|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5974566|NCT02037022|Autism|autism
5974567|NCT02034461|Micro-Electrodes|micro-electrodes
5974568|NCT02034461|Peripheral Nerve Injury|peripheral nerve injury
5974569|NCT02034461|Amputation|amputation
5974570|NCT02034461|Spinal Cord Injury|spinal cord injury
5974572|NCT02026388|primary hyperoxaluria|primary hyperoxaluria
5974573|NCT02026388|hyperoxaluria|hyperoxaluria
5974574|NCT02026388|primary oxalosis|primary oxalosis
5974575|NCT02026388|Primary Hyperoxaluria Type 1|primary hyperoxaluria type 1
5974576|NCT02026388|Primary Hyperoxaluria Type 2|primary hyperoxaluria type 2
5974577|NCT02026388|Primary Hyperoxaluria Type 3|primary hyperoxaluria type 3
5974578|NCT02026388|Dent|dent
5974579|NCT02026388|Dents|dents
5974580|NCT02026388|Dent Disease|dent disease
5974581|NCT02026388|Dent 1|dent 1
5974582|NCT02026388|Dent 2|dent 2
5974583|NCT02026388|Cystinuria|cystinuria
5974584|NCT02026388|APRT|aprt
5974585|NCT02026388|APRT deficiency|aprt deficiency
5974586|NCT02026388|Biobank|biobank
5974587|NCT02026297|postpartum hemorrhage|postpartum hemorrhage
5974588|NCT02026297|estimated blood loss|estimated blood loss
5974589|NCT02026297|coagulation|coagulation
5974590|NCT02026297|thromboelastography|thromboelastography
5974591|NCT02026297|tranexamic acid|tranexamic acid
5974592|NCT02024204|World Trade Center Disaster|world trade center disaster
5974593|NCT02024204|Environmental Exposure|environmental exposure
5974594|NCT02024204|Respiratory Physiology|respiratory physiology
5974595|NCT02024204|Inflammation|inflammation
5974596|NCT02024204|Gastrointestinal Diseases|gastrointestinal diseases
5974597|NCT02024204|Sinus Symptoms|sinus symptoms
5974598|NCT02024204|PTSD|ptsd
5974599|NCT02024204|Anxiety|anxiety
5974600|NCT02024204|Depression|depression
5974601|NCT02024204|Hypersensitivity|hypersensitivity
5974602|NCT02024204|Spirometry|spirometry
5974603|NCT02024204|Oscillometry|oscillometry
5974604|NCT02022969|atelectasis|atelectasis
5974605|NCT02022969|SPO2 - oscillations|spo2 - oscillations
5974606|NCT02021214|Methylphenidate|methylphenidate
5974607|NCT02021214|Fear extinction|fear extinction
5974608|NCT02021214|fMRI|fmri
5974609|NCT02021214|mPFC|mpfc
5974610|NCT02019888|Ear, Middle|ear, middle
5974611|NCT02019888|Ear, Inner|ear, inner
5974612|NCT02019888|Audiometry|audiometry
5974613|NCT02019888|Acoustic impedance tests|acoustic impedance tests
5974614|NCT02019693|Hereditary Papillary Renal Cell Carcinoma|hereditary papillary renal cell carcinoma
5974615|NCT02019693|VEGF Pathway|vegf pathway
5974616|NCT02019693|mTOR Inhibitor|mtor inhibitor
5974617|NCT02019693|Kidney Cancer|kidney cancer
5974618|NCT02019667|GABA|gaba
5974619|NCT02019667|Seizures|seizures
5974620|NCT02019667|Neurotransmitters|neurotransmitters
5974621|NCT02019654|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5974622|NCT02019654|Traumatic Brain Injury|traumatic brain injury
5974623|NCT02019654|Neuroendocrine|neuroendocrine
5974624|NCT02019654|Epigenetics|epigenetics
5974625|NCT02019641|Exercise|exercise
5974626|NCT02019641|Interstitial Lung Disease|interstitial lung disease
5974627|NCT02019641|Pulmonary Rehabilitation|pulmonary rehabilitation
5974628|NCT02017210|Hyperinsulinaemic-euglycaemic clamp|hyperinsulinaemic-euglycaemic clamp
5974629|NCT02017210|Body fat composition|body fat composition
5974630|NCT02017210|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5974631|NCT02017210|Obesity|obesity
5974632|NCT02017210|Insulin resistance|insulin resistance
5974633|NCT02017171|Kidney Diseases|kidney diseases
5974634|NCT02017171|Diabetic Nephropathies|diabetic nephropathies
5974635|NCT02017171|Diabetes Mellitus|diabetes mellitus
5974636|NCT02017171|Diabetes Complications|diabetes complications
5974637|NCT02017171|Uric acid|uric acid
5974638|NCT02017171|Allopurinol|allopurinol
5974639|NCT02017171|Glomerular filtration rate|glomerular filtration rate
5974640|NCT02017171|Coronary artery disease|coronary artery disease
5974641|NCT02016014|Physical activity|physical activity
5974642|NCT02016014|Alimentation|alimentation
5974643|NCT02016014|Information and communication Technology|information and communication technology
5974644|NCT02016014|Arterial aging|arterial aging
5974645|NCT02014246|Movement Disorders|movement disorders
5974646|NCT02014246|Polymorphisms|polymorphisms
5974647|NCT02014246|DNA|dna
5974648|NCT02014246|Lymphoblast Cell Lines|lymphoblast cell lines
5974649|NCT02000622|Breast Cancer|breast cancer
5974650|NCT02000622|Metastatic|metastatic
5974651|NCT02000622|Olaparib|olaparib
5974652|NCT02000622|BRCA|brca
5974653|NCT02000622|PARP inhibitor|parp inhibitor
5974654|NCT02000622|HER2|her2
5974655|NCT02000622|chemotherapy|chemotherapy
5974656|NCT01997840|Multiple Myeloma|multiple myeloma
5974657|NCT01997840|Neoplasms, Plasma Cell|neoplasms, plasma cell
5974658|NCT01997840|Neoplasms by Histologic Type|neoplasms by histologic type
5974659|NCT01997840|Neoplasms|neoplasms
5974660|NCT01997840|Blood Protein Disorders|blood protein disorders
5974661|NCT01997840|Hematologic Diseases|hematologic diseases
5974662|NCT01997840|Dexamethasone|dexamethasone
5974663|NCT01997840|Dexamethasone acetate|dexamethasone acetate
5974664|NCT01997840|Pomalidomide|pomalidomide
5974665|NCT01996865|Lymphoma, Mantle cell Lymphoma, Follicular Lymphoma, Marginal zone Lymphoma, Lenalidomide treatment, rituximab treatment, Non Hodgkins Lymphoma|lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, lenalidomide treatment, rituximab treatment, non hodgkins lymphoma
5974666|NCT01988506|IL2,|il2,
5974667|NCT01988506|Interleukin 2,|interleukin 2,
5974668|NCT01988506|ILT101|ilt101
5974669|NCT01988506|Proleukin®, RhIL-2|proleukin®, rhil-2
5974670|NCT01988506|Auto-immune disease|auto-immune disease
5974671|NCT01988506|Inflammatory disease|inflammatory disease
5974672|NCT01988506|Inflammation|inflammation
5974673|NCT01988506|Regulatory T cells,|regulatory t cells,
5974674|NCT01988506|Treg|treg
5974675|NCT01988506|Immunoregulation|immunoregulation
5974676|NCT01988506|Immune tolerance|immune tolerance
5974677|NCT01988246|Diabetes|diabetes
5974678|NCT01988246|Diabetic Retinopathy|diabetic retinopathy
5974679|NCT01985568|Obesity|obesity
5974680|NCT01985568|weight-loss|weight-loss
5974681|NCT01985568|Physical activity|physical activity
5974682|NCT01981525|TP53 Mutation|tp53 mutation
5974683|NCT01981525|Autosomal Dominant Hereditary Disorder|autosomal dominant hereditary disorder
5974684|NCT01981525|Chemoprevention|chemoprevention
5974685|NCT01981330|vocal fold scarring|vocal fold scarring
5974686|NCT01981330|mesenchymal stem cells|mesenchymal stem cells
5974687|NCT01979445|CAD|cad
5974688|NCT01979211|head and neck cancer|head and neck cancer
5974689|NCT01978574|Cognitive reserve|cognitive reserve
5974690|NCT01978574|intellectual enrichment|intellectual enrichment
5974691|NCT01978509|Colonoscopy|colonoscopy
5974692|NCT01976715|HIV|hiv
5974694|NCT01976715|Drug Resistance|drug resistance
5974695|NCT01972360|SPECT|spect
5974696|NCT01972360|CMR|cmr
5974697|NCT01972360|High risk for ischemic cardiovascular events|high risk for ischemic cardiovascular events
5974698|NCT01969643|Breast cancer|breast cancer
5974699|NCT01969643|Monomethyl auristatin E|monomethyl auristatin e
5974700|NCT01969643|Antibody-drug conjugate|antibody-drug conjugate
5275594|NCT02299843|RFA|rfa
5974701|NCT01969643|Drug therapy|drug therapy
5974702|NCT01969643|Metastatic|metastatic
5974703|NCT01969643|LIV-1 protein, human|liv-1 protein, human
5974704|NCT01969643|Trastuzumab|trastuzumab
5974705|NCT01969643|Ladiratuzumab vedotin|ladiratuzumab vedotin
5974706|NCT01969643|hLIV22-vcMMAE|hliv22-vcmmae
5974707|NCT01968213|ARIEL3|ariel3
5974708|NCT01968213|ARIEL 3|ariel 3
5974709|NCT01968213|platinum sensitive|platinum sensitive
5974710|NCT01968213|PARP Inhibitor|parp inhibitor
5974711|NCT01968213|rucaparib|rucaparib
5974712|NCT01968213|homologous recombination|homologous recombination
5974713|NCT01968213|homologous recombination deficiency|homologous recombination deficiency
5974714|NCT01968213|CO-338|co-338
5974715|NCT01968213|PF 01367338|pf 01367338
5974716|NCT01968213|AG 14699|ag 14699
5974717|NCT01968213|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5974718|NCT01968213|platinum sensitive fallopian tube cancer|platinum sensitive fallopian tube cancer
5974719|NCT01968213|platinum sensitive primary peritoneal cancer|platinum sensitive primary peritoneal cancer
5974720|NCT01968213|platinum sensitive peritoneal cancer|platinum sensitive peritoneal cancer
5974721|NCT01968213|gynecological cancer|gynecological cancer
5974722|NCT01968213|Clovis|clovis
5974723|NCT01968213|Clovis Oncology|clovis oncology
5974724|NCT01967810|glioma|glioma
5974725|NCT01967810|glioblastoma|glioblastoma
5974726|NCT01967810|brain cancer|brain cancer
5974727|NCT01967810|brain tumor|brain tumor
5974728|NCT01967810|recurrent|recurrent
5974729|NCT01964378|cancer pain|cancer pain
5974730|NCT01964378|neuropathic related cancer pain|neuropathic related cancer pain
5974731|NCT01964378|morphine|morphine
5974732|NCT01964378|cebranopadol (GRT6005)|cebranopadol (grt6005)
5974733|NCT01964378|Numerical Rating Scale|numerical rating scale
5974734|NCT01962714|Behavior therapies, cognitive|behavior therapies, cognitive
5974735|NCT01962714|Mindfulness|mindfulness
5974736|NCT01962714|Emotion|emotion
5974737|NCT01962714|Group therapy|group therapy
5974738|NCT01961362|Pulmonary fibrosis|pulmonary fibrosis
5974739|NCT01961362|Interstitial lung disease|interstitial lung disease
5974740|NCT01961362|Connective tissue disease|connective tissue disease
5974741|NCT01961362|Chronic hypersensitivity pneumonitis|chronic hypersensitivity pneumonitis
5974742|NCT01961362|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5974743|NCT01961362|Pulmonary fibrosis of any cause|pulmonary fibrosis of any cause
5974744|NCT01961362|Primary supporters/caregivers|primary supporters/caregivers
5974745|NCT01960699|Prognosis|prognosis
5974746|NCT01960699|Neurological outcome|neurological outcome
5974747|NCT01960699|Resuscitation|resuscitation
5974748|NCT01960699|Biomarker|biomarker
5974749|NCT01960075|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid|status epilepticus, refractory, benzodiazepine, fosphenytoin, levetiracetam, valproic acid
5974750|NCT01953432|Cocaine-Related Disorders|cocaine-related disorders
5974751|NCT01953432|Cocaine|cocaine
5974752|NCT01953432|Doxazosin|doxazosin
5974753|NCT01953432|Cardiovascular Agents|cardiovascular agents
5974754|NCT01953432|Antihypertensive Agents|antihypertensive agents
5974755|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists
5974756|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5974757|NCT01953432|Adrenergic Antagonists|adrenergic antagonists
5974758|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5974759|NCT01953432|Neurotransmitter Agents|neurotransmitter agents
5974760|NCT01953432|Therapeutic Uses|therapeutic uses
5974761|NCT01953432|Pharmacologic Actions|pharmacologic actions
5974762|NCT01953432|Substance-Related Disorders|substance-related disorders
5974763|NCT01953016|Job Syndrome/HIES|job syndrome/hies
5974764|NCT01953016|GATA2|gata2
5974765|NCT01953016|Primary Immunodeficiencies|primary immunodeficiencies
5974766|NCT01953016|SCID|scid
5974767|NCT01953016|DOCK8|dock8
5974768|NCT01952847|Advanced Cancers|advanced cancers
5974769|NCT01952847|Mucositis|mucositis
5974770|NCT01952847|Esophagitis|esophagitis
5974771|NCT01952847|mTOR Inhibitor-based Regimen|mtor inhibitor-based regimen
5974772|NCT01952847|Radiation to the Esophagus|radiation to the esophagus
5974773|NCT01952847|Thoracic malignancies|thoracic malignancies
5974774|NCT01952847|Placebo|placebo
5974775|NCT01952847|Glutamine|glutamine
5974776|NCT01952847|Enterex|enterex
5974777|NCT01952847|Glutapak-10|glutapak-10
5974778|NCT01952847|NutreStore|nutrestore
5974779|NCT01952847|Resource|resource
5974780|NCT01952847|GlutaSolve|glutasolve
5974781|NCT01952847|Sympt-X G.I.|sympt-x g.i.
5974782|NCT01952847|Sympt-X|sympt-x
5974783|NCT01952847|Questionnaires|questionnaires
5974784|NCT01952847|Surveys|surveys
5974785|NCT01952171|Genomics|genomics
5974786|NCT01952171|Birth Defects|birth defects
5974787|NCT01952171|Congenital Heart Disease|congenital heart disease
5974788|NCT01950429|Microbiome|microbiome
5974789|NCT01950429|Sickle Cell Disease|sickle cell disease
5974790|NCT01950429|Bone Marrow Transplant|bone marrow transplant
5974791|NCT01947439|multivessel stenting|multivessel stenting
5974792|NCT01943851|leukemia|leukemia
5974793|NCT01943851|Acute myeloid leukemia|acute myeloid leukemia
5974794|NCT01943851|BET inhibitor|bet inhibitor
5974795|NCT01943851|lymphoma|lymphoma
5974796|NCT01943851|Myelodysplastic syndromes|myelodysplastic syndromes
5974797|NCT01943851|Oncology|oncology
5974798|NCT01943851|multiple myeloma|multiple myeloma
5974799|NCT01943851|GSK525762|gsk525762
5974800|NCT01940081|Cardiomyopathy, Dilated|cardiomyopathy, dilated
5974801|NCT01940081|Tachycardia, Ventricular|tachycardia, ventricular
5974802|NCT01940081|Ventricular Fibrillation|ventricular fibrillation
5974803|NCT01940081|Arrhythmias, Cardiac/etiology|arrhythmias, cardiac/etiology
5974804|NCT01940081|Arrhythmias, Cardiac/physiopathology|arrhythmias, cardiac/physiopathology
5974805|NCT01940081|Magnetic Resonance Imaging|magnetic resonance imaging
5974806|NCT01940081|3-Iodobenzylguanidine/diagnostic use|3-iodobenzylguanidine/diagnostic use
5974807|NCT01940081|Sympathetic Nervous System/radionuclide imaging|sympathetic nervous system/radionuclide imaging
5974808|NCT01940081|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
5974809|NCT01940081|Biopsy|biopsy
5974810|NCT01940081|Genetic Testing|genetic testing
5974811|NCT01940081|Echocardiography|echocardiography
5974812|NCT01940081|Electrocardiography, Ambulatory|electrocardiography, ambulatory
5974819|NCT01936532|multiple myeloma|multiple myeloma
5974820|NCT01933984|Bronchodilator agents,|bronchodilator agents,
5974821|NCT01933984|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5974822|NCT01933984|endotracheal intubation,|endotracheal intubation,
5974823|NCT01933984|mechanical ventilator|mechanical ventilator
5974824|NCT01933958|Regorafenib|regorafenib
5974825|NCT01933958|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5974826|NCT01933620|Multidrug-Resistant Organism|multidrug-resistant organism
5974827|NCT01933620|Nosocomial Infection|nosocomial infection
5974828|NCT01931852|Acute Coronary Syndrome|acute coronary syndrome
5974829|NCT01931852|Chest pain|chest pain
5974830|NCT01931852|Cardiac MRI|cardiac mri
5974831|NCT01931852|Risk Stratification|risk stratification
5974832|NCT01931852|Emergency Department|emergency department
5974833|NCT01931852|Elevated Troponin|elevated troponin
5974834|NCT01931852|Troponin|troponin
5974835|NCT01931852|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
5974836|NCT01931046|prostate cancer|prostate cancer
5974837|NCT01931046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5974838|NCT01924806|debridement|debridement
5974839|NCT01924806|post-debridement|post-debridement
5974840|NCT01924806|infection|infection
5974841|NCT01924806|prevention|prevention
5974842|NCT01924806|wound|wound
5974843|NCT01924806|wound tissue|wound tissue
5974844|NCT01924806|wound management|wound management
5974845|NCT01924806|WoundWand|woundwand
5974846|NCT01924806|wound size reduction|wound size reduction
5974847|NCT01924806|wound bed debridement|wound bed debridement
5974848|NCT01924806|WoundWand Debridement Device|woundwand debridement device
5974849|NCT01924806|chronic wound|chronic wound
5974850|NCT01924806|delayed healing|delayed healing
5974851|NCT01924806|cellular senescence|cellular senescence
5974852|NCT01924806|acute wound|acute wound
5974853|NCT01924806|diabetic foot ulcer|diabetic foot ulcer
5974854|NCT01924806|venous leg ulcers|venous leg ulcers
5974855|NCT01924806|radiofrequency debridement|radiofrequency debridement
5974856|NCT01924806|necrotic tissue|necrotic tissue
5974857|NCT01924806|wound healing|wound healing
5974858|NCT01924806|skin|skin
5974859|NCT01919411|Chronic rhinosinusitis|chronic rhinosinusitis
5974860|NCT01919411|Sinus surgery|sinus surgery
5974861|NCT01919411|Antibiotics|antibiotics
5974862|NCT01919073|Attention Deficit, ADD, ADHD, ODD, Oppositional Behavior, Disruptive Behavior, Behavior Modification, Parent Management Training, Pre-School|attention deficit, add, adhd, odd, oppositional behavior, disruptive behavior, behavior modification, parent management training, pre-school
5974863|NCT01916148|Hypoglycemia|hypoglycemia
5974864|NCT01916148|Hyperinsulinism|hyperinsulinism
5974865|NCT01912339|Hyperlasia|hyperlasia
5974866|NCT01912339|Retention|retention
5974867|NCT01912339|Prostate|prostate
5974868|NCT01907074|liver function tests|liver function tests
5974869|NCT01907074|end stage liver disease|end stage liver disease
5974870|NCT01907074|cirrhosis|cirrhosis
5974871|NCT01907074|living liver donor|living liver donor
5974872|NCT01907061|acute renal failure|acute renal failure
5974873|NCT01907061|post liver transplant|post liver transplant
5974874|NCT01905826|Myelodysplastic Syndromes|myelodysplastic syndromes
5974875|NCT01905826|Herpesvirus|herpesvirus
5974876|NCT01905826|Disseminated nontuberculous Mycobacterial (NTM)|disseminated nontuberculous mycobacterial (ntm)
5974877|NCT01905826|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5974878|NCT01905826|Leukemia|leukemia
5974879|NCT01900730|Breast cancer|breast cancer
5974880|NCT01900730|Metastatic|metastatic
5974881|NCT01900730|Indwelling pleural catheter|indwelling pleural catheter
5974882|NCT01900730|Valproic acid|valproic acid
5974884|NCT01900730|Depakene|depakene
5974885|NCT01900730|Placebo|placebo
5974886|NCT01900730|Pill diary|pill diary
5974887|NCT01900730|Drainage diary|drainage diary
5974888|NCT01900730|Questionnaires|questionnaires
5974889|NCT01900730|Surveys|surveys
5974890|NCT01899989|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5974891|NCT01899989|Chemotherapy|chemotherapy
5974892|NCT01899989|13-113|13-113
5974893|NCT01898117|Triple negative|triple negative
5974894|NCT01898117|Metastatic|metastatic
5974895|NCT01894061|adult giant cell glioblastoma|adult giant cell glioblastoma
5974896|NCT01894061|adult glioblastoma|adult glioblastoma
5974897|NCT01894061|adult gliosarcoma|adult gliosarcoma
5974898|NCT01894061|recurrent adult brain tumor|recurrent adult brain tumor
5974899|NCT01894061|Bevacizumab-naive|bevacizumab-naive
5974900|NCT01894061|NovoTTF-100A|novottf-100a
5974901|NCT01885455|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5974902|NCT01885377|Subacromial pain|subacromial pain
5974903|NCT01885377|Impingement|impingement
5974904|NCT01885377|Exercises|exercises
5974905|NCT01885377|Physical therapy|physical therapy
5974906|NCT01885377|Primary care|primary care
5974907|NCT01885351|Colorectal Cancer Screening|colorectal cancer screening
5974908|NCT01885351|Ambulatory Care|ambulatory care
5974909|NCT01885351|Patient-Centered Care|patient-centered care
5974910|NCT01885351|Intervention Studies|intervention studies
5974911|NCT01885351|Longitudinal Studies|longitudinal studies
5974912|NCT01885039|Cancer|cancer
5974913|NCT01885039|Breast Cancer|breast cancer
5974914|NCT01885039|Molecular Subtypes|molecular subtypes
5974915|NCT01885039|Asian Breast Cancer|asian breast cancer
5974916|NCT01875588|Healthy Controls|healthy controls
5974917|NCT01875588|HIV-positive|hiv-positive
5974918|NCT01875588|Neurophyschological Testing|neurophyschological testing
5974919|NCT01875588|Thinking and Memory|thinking and memory
5974920|NCT01875588|Lumbar Drain/Puncture|lumbar drain/puncture
5974921|NCT01872208|PAD|pad
5974922|NCT01872208|Atherosclerosis|atherosclerosis
5974923|NCT01872208|Peripheral circulation|peripheral circulation
5974924|NCT01872208|Blood Vessel Prosthesis|blood vessel prosthesis
5974925|NCT01872208|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
5974926|NCT01872208|Vascular Prosthesis Implantation|vascular prosthesis implantation
5974927|NCT01872208|Femoro-Popliteal Bypass|femoro-popliteal bypass
5974928|NCT01871727|Persistent or Recurrent Cutaneous T-Cell Lymphoma|persistent or recurrent cutaneous t-cell lymphoma
5974930|NCT01868139|Cryotherapy|cryotherapy
5974931|NCT01868139|Esophageal cancer|esophageal cancer
5974932|NCT01868139|Esophageal carcinoma|esophageal carcinoma
5974933|NCT01868139|Liquid nitrogen|liquid nitrogen
5974934|NCT01868139|Esophageal adenocarcinoma|esophageal adenocarcinoma
5974935|NCT01868139|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5974936|NCT01868139|Endoscopy|endoscopy
5974937|NCT01868139|Ablation|ablation
5974938|NCT01867411|Smoking Cessation|smoking cessation
5974939|NCT01867411|fMRI|fmri
5974940|NCT01867411|e-Cigarettes|e-cigarettes
5974941|NCT01867333|Immunotherapy|immunotherapy
5974942|NCT01867333|Gene Transfer|gene transfer
5974943|NCT01867333|Androgen Receptor Antagonist|androgen receptor antagonist
5974944|NCT01867333|PSA|psa
5974945|NCT01867333|Immune Response|immune response
5974946|NCT01867320|PVL|pvl
5974947|NCT01867320|Immune|immune
5974948|NCT01867320|Activation|activation
5974949|NCT01867320|HTLV-1|htlv-1
5974950|NCT01867320|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
5974951|NCT01866826|HIV|hiv
5974952|NCT01866826|Eradication Strategies|eradication strategies
5974953|NCT01866826|Immune Activation|immune activation
5974954|NCT01864603|HIV treatment and prevention|hiv treatment and prevention
5974955|NCT01864603|Tuberculosis|tuberculosis
5974956|NCT01864603|Community health campaign|community health campaign
5974957|NCT01864603|PrEP|prep
5974958|NCT01862731|Muscle Force|muscle force
5974959|NCT01862731|Knee|knee
5974960|NCT01862731|Magnetic Resonance Imaging|magnetic resonance imaging
5974961|NCT01862731|Quadriceps|quadriceps
5974962|NCT01862731|Ultrasound|ultrasound
5974963|NCT01862107|Biomarkers|biomarkers
5974964|NCT01862107|Immune Responses|immune responses
5974965|NCT01862107|Lumbar Puncture|lumbar puncture
5974966|NCT01862107|Neurological Diseases|neurological diseases
5974967|NCT01862107|Novel Pathogens|novel pathogens
5974968|NCT01860404|Concussion|concussion
5974969|NCT01860404|Branched chain amino acids|branched chain amino acids
5974970|NCT01860404|BCAA|bcaa
5974971|NCT01860404|HIT HEADS|hit heads
5974972|NCT01860365|Quality of life|quality of life
5974973|NCT01860365|Integrative medicine|integrative medicine
5974974|NCT01860365|Supportive care|supportive care
5974975|NCT01860365|Cancer|cancer
5974976|NCT01860365|Chemotherapy|chemotherapy
5974977|NCT01857219|fMRI|fmri
5974978|NCT01854775|Adolescents|adolescents
5974979|NCT01854775|HIV-1|hiv-1
5974980|NCT01854775|HIV|hiv
5974981|NCT01854775|Treatment-naive|treatment-naive
5974982|NCT01854775|Virologically suppressed|virologically suppressed
5974983|NCT01853644|Cancer|cancer
5974984|NCT01853644|Recurrent|recurrent
5974985|NCT01853644|Ovary|ovary
5974986|NCT01853644|Fallopian Tube|fallopian tube
5974987|NCT01853644|Primary Peritioneal|primary peritioneal
5974988|NCT01853644|Phase II|phase ii
5974989|NCT01853644|Platinum Resistant|platinum resistant
5974990|NCT01852071|gene therapy, hematopoietic stem cell, SCID, lentivirus|gene therapy, hematopoietic stem cell, scid, lentivirus
5974991|NCT01849211|ventilation|ventilation
5974992|NCT01849211|face mask|face mask
5974993|NCT01849211|NMBA|nmba
5974994|NCT01842399|Vascular Stiffness|vascular stiffness
5974995|NCT01842399|Aging|aging
5974996|NCT01842399|Resveratrol|resveratrol
5974997|NCT01842399|Aerobic Capacity|aerobic capacity
5974998|NCT01842399|Inflammation|inflammation
5974999|NCT01840020|bariatric surgery|bariatric surgery
5975000|NCT01840020|alcohol drinking|alcohol drinking
5975001|NCT01840020|alcoholism|alcoholism
5975002|NCT01840020|ethanol|ethanol
5975003|NCT01840020|metabolism|metabolism
5975004|NCT01838824|Processing Speed|processing speed
5975005|NCT01838824|Intervention|intervention
5975006|NCT01838824|Multiple Sclerosis|multiple sclerosis
5975007|NCT01838824|Cognition|cognition
5975008|NCT01835067|Macular degeneration|macular degeneration
5975009|NCT01835067|Submacular haemorrhage|submacular haemorrhage
5975010|NCT01832961|COPD|copd
5975011|NCT01832961|physiotherapy care|physiotherapy care
5975012|NCT01832961|lung function testing|lung function testing
5975013|NCT01832961|inflammation|inflammation
5975014|NCT01832688|iron and folic acid supplements|iron and folic acid supplements
5975015|NCT01832688|anemia|anemia
5975016|NCT01832688|gestational weight gain|gestational weight gain
5975017|NCT01829724|Functional Brain Imaging|functional brain imaging
5975018|NCT01829724|Cerebral Palsy|cerebral palsy
5975019|NCT01829724|Motion Analysis|motion analysis
5975020|NCT01829724|Macro- EMG|macro- emg
5975021|NCT01824537|Human papillomavirus (HPV)|human papillomavirus (hpv)
5975022|NCT01824537|Vaccination|vaccination
5975023|NCT01824537|Cervical cancer prevention|cervical cancer prevention
5975024|NCT01824537|Herd immunity|herd immunity
5975025|NCT01822444|Colorectal Cancer|colorectal cancer
5975026|NCT01822444|Advanced Colorectal Cancer|advanced colorectal cancer
5975027|NCT01822444|Metastatic Colorectal Cancer|metastatic colorectal cancer
5975028|NCT01822444|Locally Advanced Colorectal Cancer|locally advanced colorectal cancer
5975029|NCT01822444|Colon Cancer|colon cancer
5975030|NCT01822444|Rectal Cancer|rectal cancer
5975031|NCT01821833|omega-3|omega-3
5975032|NCT01821833|fatty acids|fatty acids
5975033|NCT01821833|paclitaxel|paclitaxel
5975034|NCT01821833|acute pain syndrome|acute pain syndrome
5975035|NCT01821833|peripheral neuropathy|peripheral neuropathy
5975036|NCT01821833|chemotherapy induced neuropathy|chemotherapy induced neuropathy
5975037|NCT01818609|sarcopenia|sarcopenia
5975038|NCT01818609|muscle|muscle
5975039|NCT01818609|reduced activity|reduced activity
5975040|NCT01818609|insulin sensitivity|insulin sensitivity
5975041|NCT01818609|protein|protein
5975042|NCT01818609|step reduction|step reduction
5975043|NCT01818609|muscle protein synthesis|muscle protein synthesis
5975044|NCT01818609|whey protein|whey protein
5975045|NCT01818609|leg strength|leg strength
5975046|NCT01818609|whole body protein|whole body protein
5975047|NCT01811862|Acupuncture|acupuncture
5975048|NCT01811862|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5975049|NCT01811862|13-038|13-038
5975050|NCT01811784|Nipah virus infection|nipah virus infection
5975051|NCT01811784|date palm sap|date palm sap
5975052|NCT01811784|community intervention|community intervention
5975053|NCT01811784|capacity building|capacity building
5975054|NCT01811784|disease prevention|disease prevention
5975055|NCT01811784|Bangladesh|bangladesh
5975056|NCT01811784|Healthy Community people|healthy community people
5975057|NCT01811784|Sap harvesters|sap harvesters
5975058|NCT01811784|Date palm three owners|date palm three owners
5975059|NCT01811784|Date palm sap consumers|date palm sap consumers
5975060|NCT01811654|Patellofemoral|patellofemoral
5975061|NCT01811654|Hyaluronan|hyaluronan
5975062|NCT01811654|Intra-articular|intra-articular
5975063|NCT01811654|Hyaluronic acid|hyaluronic acid
5975065|NCT01809288|Diet|diet
5975066|NCT01809288|Obesity|obesity
5975067|NCT01809288|African|african
5975068|NCT01809288|Physical Activity|physical activity
5975069|NCT01807819|Heart Failure|heart failure
5975070|NCT01807819|Myocardial Strain|myocardial strain
5975071|NCT01807819|Functional Capacity|functional capacity
5975072|NCT01807299|Physical Training|physical training
5975073|NCT01807299|ADHD-Attention deficit hyperactivity disorder|adhd-attention deficit hyperactivity disorder
5975074|NCT01807299|Omega 3|omega 3
5975075|NCT01805869|Third Molar|third molar
5975076|NCT01805869|Specimen Acquisition|specimen acquisition
5975077|NCT01803438|paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5975078|NCT01803438|Cryoablation|cryoablation
5975079|NCT01803438|Pulmonary Vein Isolation|pulmonary vein isolation
5975080|NCT01797263|fibromyalgia|fibromyalgia
5975081|NCT01797263|yoga|yoga
5975082|NCT01797263|exercise|exercise
5975083|NCT01797263|pain|pain
5975084|NCT01796262|ADHD|adhd
5975085|NCT01796262|DHA|dha
5975086|NCT01796262|neuropsychological task|neuropsychological task
5975087|NCT01796262|fNIRS|fnirs
5975088|NCT01796262|Docosahexaenoic Acid|docosahexaenoic acid
5975089|NCT01796262|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
5975090|NCT01796262|cognition|cognition
5975091|NCT01796262|behavior|behavior
5975092|NCT01794520|relapsed multiple myeloma|relapsed multiple myeloma
5975093|NCT01794520|refractory multiple myeloma|refractory multiple myeloma
5975094|NCT01794520|multiple myeloma|multiple myeloma
5975095|NCT01794520|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5975096|NCT01788189|Lymphoma|lymphoma
5975097|NCT01788189|CD20|cd20
5975098|NCT01788189|Relapse|relapse
5975099|NCT01788189|Lenalidomide|lenalidomide
5975100|NCT01787292|Exercise|exercise
5975101|NCT01787292|Magnetic Resonance Imaging|magnetic resonance imaging
5975102|NCT01787292|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5975103|NCT01787292|Aging|aging
5975104|NCT01780168|Mitochondrial Disorders|mitochondrial disorders
5975105|NCT01780168|Urea Cycle Disorders|urea cycle disorders
5975106|NCT01780168|Organic Acidemias|organic acidemias
5975107|NCT01780168|Fatty Acid Oxidation Defects|fatty acid oxidation defects
5975108|NCT01780155|Oxidative Stress|oxidative stress
5975109|NCT01780155|Hyperoxia|hyperoxia
5975110|NCT01780155|Brochopulmonary Dysplasia|brochopulmonary dysplasia
5975111|NCT01780155|Retinopathy of Prematurity|retinopathy of prematurity
5975112|NCT01780155|Very Low Birth Rate|very low birth rate
5975113|NCT01780142|Airflow Obstruction|airflow obstruction
5975114|NCT01780142|Airflow Inflammation|airflow inflammation
5975115|NCT01780142|Corticosteroid Resistance|corticosteroid resistance
5975116|NCT01780142|Exacerbations|exacerbations
5975117|NCT01780142|Quality of Life|quality of life
5975118|NCT01778569|Imaging|imaging
5975119|NCT01778569|Cardiovascular Risk Factors|cardiovascular risk factors
5975120|NCT01778569|Inflammation|inflammation
5975121|NCT01778569|Lipoproteins|lipoproteins
5975122|NCT01778569|Metabolic Dysfunction|metabolic dysfunction
5975123|NCT01778543|Genetics|genetics
5975124|NCT01778543|Repository|repository
5975125|NCT01778543|Advanced Retinal Disease|advanced retinal disease
5975126|NCT01778504|Natural History Study|natural history study
5975127|NCT01778504|Mental Illness|mental illness
5975128|NCT01778504|Autism|autism
5975129|NCT01778504|Obsessive Compulsive Disorder|obsessive compulsive disorder
5975130|NCT01767441|bariatric surgery|bariatric surgery
5975131|NCT01767441|gastric bypass|gastric bypass
5975132|NCT01767441|gastric banding|gastric banding
5975133|NCT01767441|sleeve gastrectomy|sleeve gastrectomy
5975134|NCT01767441|weight loss|weight loss
5975135|NCT01767441|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5975136|NCT01767441|GLP1|glp1
5975137|NCT01767441|obesity|obesity
5975138|NCT01767441|mixed meal test|mixed meal test
5975139|NCT01767311|Alzheimer's Disease|alzheimer's disease
5975140|NCT01767311|BAN2401|ban2401
5975141|NCT01764321|Certolizumab Pegol|certolizumab pegol
5975142|NCT01764321|Cimzia®|cimzia®
5975143|NCT01764321|TNF inhibitor|tnf inhibitor
5975144|NCT01764321|DMARD|dmard
5975145|NCT01764321|Rheumatoid Arthritis|rheumatoid arthritis
5975146|NCT01761305|Idiopathic scoliosis|idiopathic scoliosis
5975147|NCT01761305|Brace|brace
5975148|NCT01761305|Scoliosis specific exercise|scoliosis specific exercise
5975149|NCT01761305|Physical activity|physical activity
5975150|NCT01758250|Autoimmune diseases with cutaneous involvement|autoimmune diseases with cutaneous involvement
5975151|NCT01758250|Systemic sclerosis|systemic sclerosis
5975152|NCT01758250|Scleroderma|scleroderma
5975153|NCT01758250|Morphea|morphea
5975154|NCT01758250|Dermatomyositis|dermatomyositis
5975155|NCT01758250|Cutaneous lupus|cutaneous lupus
5975156|NCT01758250|Vasculitis|vasculitis
5975157|NCT01758250|Sickle Cell Disease|sickle cell disease
5975158|NCT01758250|Graft versus Host Disease|graft versus host disease
5975159|NCT01757223|Diffuse Coronary Artery Disease (CAD)|diffuse coronary artery disease (cad)
5975160|NCT01755195|Dual Inhibitor of MET and VEGFR|dual inhibitor of met and vegfr
5975161|NCT01755195|XL184|xl184
5975162|NCT01755195|Metastatic Refractory|metastatic refractory
5975163|NCT01755195|Soft Tissue Sarcoma|soft tissue sarcoma
5975164|NCT01755195|Rare Heterogeneous Tumor|rare heterogeneous tumor
5975165|NCT01754441|Spinal Muscular Atrophy|spinal muscular atrophy
5975166|NCT01754441|SMA|sma
5975167|NCT01754441|Motor Neuron Abnormalities|motor neuron abnormalities
5975168|NCT01754064|Bradycardia|bradycardia
5975169|NCT01754064|Tachycardia|tachycardia
5975170|NCT01754064|Arrhythmia|arrhythmia
5975171|NCT01754064|ICD|icd
5975172|NCT01754064|pacemaker|pacemaker
5975173|NCT01754064|pacing lead|pacing lead
5975174|NCT01753583|optical coherence tomography|optical coherence tomography
5975175|NCT01753583|corneal abrasion|corneal abrasion
5975176|NCT01753583|corneal infiltrate|corneal infiltrate
5975177|NCT01753401|SLE|sle
5975178|NCT01753401|Lupus|lupus
5975179|NCT01752426|Leukemia|leukemia
5975180|NCT01752426|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5975182|NCT01752426|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5975183|NCT01752426|SLL|sll
5975184|NCT01752426|PCI-32765|pci-32765
5975185|NCT01752426|Ibrutinib|ibrutinib
5975186|NCT01752426|Btk inhibitor|btk inhibitor
5975187|NCT01752426|Heavy water|heavy water
5975188|NCT01752426|2H2O|2h2o
5975189|NCT01747447|Vitamin D|vitamin d
5975190|NCT01747447|Vitamin K|vitamin k
5975191|NCT01746693|retinal vessel diameter|retinal vessel diameter
5975192|NCT01746693|retinal oxygen saturation|retinal oxygen saturation
5975193|NCT01746693|high resolution functional and anatomical imaging|high resolution functional and anatomical imaging
5975194|NCT01746693|inner retinal function|inner retinal function
5975195|NCT01746693|flicker response|flicker response
5975196|NCT01746381|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5975197|NCT01746381|non-invasive ventilation|non-invasive ventilation
5975198|NCT01746381|home ventilation|home ventilation
5975199|NCT01746381|IVAPS|ivaps
5975200|NCT01746381|neuromuscular diseases|neuromuscular diseases
5975201|NCT01744418|ESRD|esrd
5975202|NCT01744418|HEMODIALYSIS|hemodialysis
5975203|NCT01744418|CHRONIC RENAL INSUFFICIENCY|chronic renal insufficiency
5975204|NCT01744418|Renal Dialysis|renal dialysis
5975205|NCT01744418|Hemodiafiltration|hemodiafiltration
5975206|NCT01744418|Blood Vessel Prosthesis|blood vessel prosthesis
5975207|NCT01744418|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
5975208|NCT01744418|Vascular Prosthesis Implantation|vascular prosthesis implantation
5975209|NCT01743716|Major Depressive Disorder|major depressive disorder
5975210|NCT01743716|MDD|mdd
5975211|NCT01743716|depression|depression
5975212|NCT01743716|adolescent|adolescent
5975213|NCT01741428|CVD Risk score|cvd risk score
5975214|NCT01741428|Physical activity|physical activity
5975215|NCT01741428|Overweight|overweight
5975216|NCT01741428|Cholesterol|cholesterol
5975217|NCT01741428|LDL-Cholesterol|ldl-cholesterol
5975218|NCT01741428|HDL-Cholesterol|hdl-cholesterol
5975219|NCT01741428|Triglycerides|triglycerides
5975220|NCT01741428|HbA1C|hba1c
5975221|NCT01741428|Quality of life|quality of life
5975222|NCT01740427|breast cancer|breast cancer
5975223|NCT01740427|postmenopausal women|postmenopausal women
5975224|NCT01740427|estrogen-receptor positive|estrogen-receptor positive
5975225|NCT01740427|HER2 negative|her2 negative
5975226|NCT01740427|locoregionally recurrent|locoregionally recurrent
5975227|NCT01740427|metastatic|metastatic
5975228|NCT01740427|Palbociclib (PD-0332991)|palbociclib (pd-0332991)
5975229|NCT01740427|PALOMA-2|paloma-2
5975230|NCT01737827|INC280, advanced hepatocellular carcinoma, c-MET pathway dysregulation|inc280, advanced hepatocellular carcinoma, c-met pathway dysregulation
5975231|NCT01736644|blood loss|blood loss
5975232|NCT01736644|bipolar sealer|bipolar sealer
5975233|NCT01736644|aquamantys|aquamantys
5975234|NCT01736644|total knee replacement|total knee replacement
5975235|NCT01736644|primary total knee arthroplasty|primary total knee arthroplasty
5975236|NCT01736306|Breast Cancer|breast cancer
5975237|NCT01736306|Breast Milk|breast milk
5975238|NCT01736306|Epigenetics|epigenetics
5975239|NCT01735006|Human Papillomavirus 16|human papillomavirus 16
5975240|NCT01735006|Human Papillomavirus 18|human papillomavirus 18
5975241|NCT01735006|vaccine|vaccine
5975242|NCT01735006|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5975243|NCT01735006|cervical Cancer|cervical cancer
5975244|NCT01735006|Vaginal intraepithelial neoplasia|vaginal intraepithelial neoplasia
5975245|NCT01735006|Vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia
5975246|NCT01734733|Parkinson's Disease|parkinson's disease
5975247|NCT01734733|Xenotransplantation|xenotransplantation
5975248|NCT01734733|choroid plexus|choroid plexus
5975249|NCT01734369|Dermatomyositis|dermatomyositis
5975250|NCT01734369|Inclusion Body Myositis|inclusion body myositis
5975251|NCT01734369|Myositis|myositis
5975252|NCT01734369|Polymyositis|polymyositis
5975253|NCT01734369|Military|military
5975254|NCT01729208|myopia progression|myopia progression
5975255|NCT01729208|myopia control|myopia control
5975256|NCT01722890|HER2-positive breast cancer|her2-positive breast cancer
5975257|NCT01722890|durable complete response|durable complete response
5975258|NCT01722890|cytogenetic characteristics|cytogenetic characteristics
5975259|NCT01722890|molecular characteristics|molecular characteristics
5975260|NCT01722890|trastuzumab|trastuzumab
5975261|NCT01722188|Optim|optim
5975262|NCT01722188|Insulation|insulation
5975263|NCT01717508|MDD|mdd
5975264|NCT01717508|depression|depression
5975265|NCT01717508|major depressive disorder|major depressive disorder
5975266|NCT01717508|adolescent|adolescent
5975267|NCT01716806|Antibody-Drug Conjugate|antibody-drug conjugate
5975268|NCT01716806|Antibodies, Monoclonal|antibodies, monoclonal
5975269|NCT01716806|Hematologic Diseases|hematologic diseases
5975270|NCT01716806|Hodgkin Disease|hodgkin disease
5975271|NCT01716806|Antigens, CD30|antigens, cd30
5975272|NCT01716806|Lymphoma|lymphoma
5975273|NCT01716806|monomethylauristatin E|monomethylauristatin e
5975274|NCT01716806|Drug Therapy|drug therapy
5975275|NCT01716806|CD30-expression|cd30-expression
5975276|NCT01716806|PTCL|ptcl
5975277|NCT01716312|Safety Of Omalizumab In Patients With SLE|safety of omalizumab in patients with sle
5975278|NCT01716312|Systemic Lupus Erythematosus|systemic lupus erythematosus
5975279|NCT01715714|Coronary Artery Disease|coronary artery disease
5975280|NCT01715714|Statins|statins
5975281|NCT01715714|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5975282|NCT01715714|Cardiac Surgery|cardiac surgery
5975283|NCT01712672|Dental Plaque|dental plaque
5975284|NCT01712672|Biofilm|biofilm
5975285|NCT01712672|Bacterial Interactions|bacterial interactions
5975286|NCT01712672|Receptor Polysaccharide|receptor polysaccharide
5975287|NCT01712672|Oral Streptococci|oral streptococci
5975288|NCT01712659|JAK 1/2|jak 1/2
5975289|NCT01712659|Human T-Cell Lymphotropic Virus 1|human t-cell lymphotropic virus 1
5975290|NCT01712659|HTLV-1|htlv-1
5975291|NCT01712659|Janus Kinase Inhibitor|janus kinase inhibitor
5975292|NCT01702636|Intracerebral Hemorrhage|intracerebral hemorrhage
5975293|NCT01702636|ICH|ich
5975294|NCT01702636|Stroke|stroke
5975295|NCT01702636|Cerebrovascular Disorders|cerebrovascular disorders
5975296|NCT01702636|Brain Diseases|brain diseases
5975297|NCT01702636|Central Nervous System Diseases|central nervous system diseases
5975298|NCT01702636|Nervous System Diseases|nervous system diseases
5975299|NCT01702636|Vascular Diseases|vascular diseases
5975300|NCT01702636|Cardiovascular Diseases|cardiovascular diseases
5975301|NCT01702636|Tranexamic Acid|tranexamic acid
5975302|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents
5975303|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents
5975304|NCT01702636|Pharmacologic Actions|pharmacologic actions
5975305|NCT01702636|Cardiovascular Agents|cardiovascular agents
5975306|NCT01702636|Therapeutic Uses|therapeutic uses
5975307|NCT01702636|Hematologic Agents|hematologic agents
5975308|NCT01702636|Hemostatics|hemostatics
5975309|NCT01702636|Contrast Media|contrast media
5975310|NCT01702636|Angiography|angiography
5975311|NCT01702636|Cerebral Angiography|cerebral angiography
5975312|NCT01702636|Tomography, X-Ray Computed|tomography, x-ray computed
5975313|NCT01698918|metastatic breast cancer, locally advanced breast cancer, HER2-, ER+, everolimus, Afinitor|metastatic breast cancer, locally advanced breast cancer, her2-, er+, everolimus, afinitor
5975314|NCT01697267|vasculitis|vasculitis
5975315|NCT01697267|ANCA vasculitis|anca vasculitis
5975316|NCT01697267|microscopic polyangiitis|microscopic polyangiitis
5975317|NCT01697267|granulomatosis|granulomatosis
5975318|NCT01697267|Wegener's|wegener's
5975319|NCT01697267|AAV|aav
5975320|NCT01697267|vasculitides|vasculitides
5975321|NCT01693042|heart failure|heart failure
5975322|NCT01693042|old myocardial infarction|old myocardial infarction
5975323|NCT01693042|bone marrow-derived mononuclear cells|bone marrow-derived mononuclear cells
5975324|NCT01693042|chronic|chronic
5975325|NCT01693042|ischemic|ischemic
5975326|NCT01691950|Trauma|trauma
5975327|NCT01691950|Limb reconstruction|limb reconstruction
5975328|NCT01691950|Amputation|amputation
5975329|NCT01691950|Functional outcome|functional outcome
5975330|NCT01691950|Sensing|sensing
5975331|NCT01678352|Glioma|glioma
5975332|NCT01678352|Vaccine|vaccine
5975333|NCT01678352|Immunotherapy|immunotherapy
5975334|NCT01678352|WHO Grade II|who grade ii
5975335|NCT01678222|Lymphocyte|lymphocyte
5975336|NCT01678222|Prostaglandin Endoperoxidase Synthase 2|prostaglandin endoperoxidase synthase 2
5975337|NCT01678222|COX-2|cox-2
5975338|NCT01670799|Ketorolac|ketorolac
5975339|NCT01670799|Bioavailability|bioavailability
5975340|NCT01670799|Pain|pain
5975341|NCT01668355|Delivery of Healthcare|delivery of healthcare
5975342|NCT01668355|Health Services Research|health services research
5975343|NCT01668355|Integrated Healthcare Systems|integrated healthcare systems
5975344|NCT01668355|Healthcare Quality, Access, and Evaluation|healthcare quality, access, and evaluation
5975345|NCT01668355|Primary Care|primary care
5975346|NCT01668355|Quality Improvement|quality improvement
5975347|NCT01668355|Psychotic Disorders|psychotic disorders
5975348|NCT01668355|Medical Home|medical home
5975349|NCT01668355|Psychiatry|psychiatry
5975350|NCT01668355|Patient Care Management|patient care management
5975351|NCT01668355|Nursing Care Management|nursing care management
5975352|NCT01668355|Treatment Costs|treatment costs
5975353|NCT01668186|Peroxisome biogenesis disorders|peroxisome biogenesis disorders
5975354|NCT01668186|PBD|pbd
5975355|NCT01668186|Zellweger spectrum|zellweger spectrum
5975356|NCT01668186|Rhizomelic chondrodysplasia punctata|rhizomelic chondrodysplasia punctata
5975357|NCT01668186|RCDP|rcdp
5975358|NCT01668186|DBP|dbp
5975359|NCT01668186|ACOX1|acox1
5975360|NCT01668186|AMACR|amacr
5975361|NCT01668186|ARD|ard
5975362|NCT01668186|XALD|xald
5975363|NCT01668186|ACBD5|acbd5
5975364|NCT01665144|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5975365|NCT01661387|Adrenal insufficiency|adrenal insufficiency
5975366|NCT01661387|DuoCort|duocort
5975367|NCT01661387|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5975368|NCT01661387|Modified release|modified release
5975369|NCT01661387|Hydrocortisone|hydrocortisone
5975370|NCT01659606|dyskeratosis congenita|dyskeratosis congenita
5975371|NCT01659606|bone marrow failure|bone marrow failure
5975372|NCT01659606|aplastic anemia|aplastic anemia
5975373|NCT01659606|bone marrow transplantation|bone marrow transplantation
5975374|NCT01659606|reduced intensity conditioning|reduced intensity conditioning
5975375|NCT01659606|campath|campath
5975376|NCT01659606|fludarabine|fludarabine
5975377|NCT01659606|telomere|telomere
5975378|NCT01656642|PD-L1|pd-l1
5975379|NCT01656642|PD-1|pd-1
5975380|NCT01656642|PDL1|pdl1
5975381|NCT01656642|antiPD-L1|antipd-l1
5975382|NCT01656642|MPDL3280A|mpdl3280a
5975383|NCT01656642|Melanoma|melanoma
5975384|NCT01656642|BRAF|braf
5975385|NCT01656642|MPDL320A|mpdl320a
5975386|NCT01650311|IBD, CD, UC, Serotonin, 5-HT|ibd, cd, uc, serotonin, 5-ht
5975387|NCT01649765|SLE Flare Index|sle flare index
5975388|NCT01649765|SRI|sri
5975389|NCT01649765|belimumab|belimumab
5975390|NCT01649765|efficacy|efficacy
5975391|NCT01649765|safety|safety
5975392|NCT01649765|B lymphocyte|b lymphocyte
5975393|NCT01649765|BLyS|blys
5975394|NCT01649765|SELENA SLEDAI|selena sledai
5975395|NCT01649765|BILAG|bilag
5975396|NCT01649765|Lupus|lupus
5975397|NCT01649765|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5975398|NCT01649765|PGA|pga
5975399|NCT01649765|Pharmacokinetics|pharmacokinetics
5975400|NCT01649765|placebo|placebo
5975401|NCT01649765|PRINTO|printo
5975402|NCT01648296|Heart Failure|heart failure
5975403|NCT01648296|Obesity|obesity
5975404|NCT01648296|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5975405|NCT01648296|Health Normal Volunteer Subjects|health normal volunteer subjects
5975406|NCT01643850|Pigmented Villonodular Synovitis|pigmented villonodular synovitis
5975407|NCT01643850|PVNS|pvns
5975408|NCT01643850|Giant cell tumor of the tendon sheath|giant cell tumor of the tendon sheath
5975409|NCT01643850|GCCTS|gccts
5975410|NCT01643850|Tenosynovial giant cell tumor (localized or diffused type)|tenosynovial giant cell tumor (localized or diffused type)
5975411|NCT01643850|GCTS|gcts
5975412|NCT01643850|MCS110|mcs110
5975413|NCT01640366|surgical incision|surgical incision
5975414|NCT01640366|reduction mammoplasty|reduction mammoplasty
5975415|NCT01640366|healing complications|healing complications
5975416|NCT01640366|negative pressure wound therapy|negative pressure wound therapy
5975417|NCT01633372|Primary Myelofibrosis|primary myelofibrosis
5975418|NCT01633372|PMF|pmf
5975419|NCT01633372|Post Polycythemia Vera Fibrosis|post polycythemia vera fibrosis
5975420|NCT01633372|PPV-MF|ppv-mf
5975421|NCT01633372|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
5975422|NCT01633372|PET-MF|pet-mf
5975423|NCT01633190|Surveillance|surveillance
5975424|NCT01633190|Rotavirus|rotavirus
5975425|NCT01633190|Gastroenteritis|gastroenteritis
5975426|NCT01629095|Liver Transplantation|liver transplantation
5975427|NCT01629095|Genetics|genetics
5975428|NCT01627756|Thoracic Surgery|thoracic surgery
5975429|NCT01627756|Endotoxins|endotoxins
5975430|NCT01627756|Respiration, Artificial|respiration, artificial
5975434|NCT01626586|Group Therapy|group therapy
5975435|NCT01626586|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5975436|NCT01626586|Self-Management|self-management
5975437|NCT01623843|FAI|fai
5975438|NCT01623843|randomized|randomized
5975439|NCT01623843|hip arthroscopy|hip arthroscopy
5975440|NCT01623843|lavage|lavage
5975441|NCT01623843|osteochondroplasty|osteochondroplasty
5975442|NCT01621568|VEGF|vegf
5975443|NCT01621568|Anti-Angiogenesis|anti-angiogenesis
5975444|NCT01621568|Targeted Agent|targeted agent
5975445|NCT01621217|Anal cancer|anal cancer
5975446|NCT01621217|Locally advanced anal cancer|locally advanced anal cancer
5975447|NCT01621217|Cetuximab|cetuximab
5975448|NCT01621217|5-fluoruracil|5-fluoruracil
5975449|NCT01621217|Mitomycin C|mitomycin c
5975450|NCT01621217|Radiotherapy|radiotherapy
5975451|NCT01621204|Thrombocytopenia|thrombocytopenia
5975452|NCT01621204|ITP|itp
5975453|NCT01621204|Platelets|platelets
5975454|NCT01621204|Bleeding|bleeding
5975455|NCT01621204|Immune|immune
5975456|NCT01621204|Eltrombopag|eltrombopag
5975457|NCT01621204|IVIG|ivig
5975458|NCT01617408|Theta Burst Stimulation|theta burst stimulation
5975459|NCT01617408|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5975460|NCT01617408|Visual Cortex|visual cortex
5975461|NCT01617408|Visual Processing|visual processing
5975462|NCT01615029|Multiple Myeloma|multiple myeloma
5975463|NCT01615029|Daratumumab|daratumumab
5975464|NCT01615029|Lenalidomide|lenalidomide
5975465|NCT01615029|Dexamethasone|dexamethasone
5975466|NCT01615029|Dose-escalation|dose-escalation
5975467|NCT01615029|Relapsed multiple myeloma|relapsed multiple myeloma
5975468|NCT01615029|Relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
5975469|NCT01611350|Indoor Air Pollution|indoor air pollution
5975470|NCT01611350|Marketing Methods for Increasing Technology Adoption|marketing methods for increasing technology adoption
5975471|NCT01611350|Optimal Contracts for Technology Adoption|optimal contracts for technology adoption
5975472|NCT01610908|Adolescent|adolescent
5975473|NCT01610908|Idiopathic|idiopathic
5975474|NCT01610908|Scoliosis|scoliosis
5975475|NCT01610908|Schroth|schroth
5975476|NCT01610908|Exercises|exercises
5975477|NCT01610908|Conservative treatment|conservative treatment
5975478|NCT01596699|conditioning|conditioning
5975479|NCT01596699|allogeneic|allogeneic
5975480|NCT01596699|hematopoietic|hematopoietic
5975481|NCT01596699|cell|cell
5975482|NCT01596699|transplantation|transplantation
5975483|NCT01596699|HCT|hct
5975484|NCT01596595|ICD|icd
5975485|NCT01596595|CRT-D|crt-d
5975486|NCT01596595|Defibrillation lead|defibrillation lead
5975487|NCT01595529|antibiotic therapy|antibiotic therapy
5975488|NCT01595529|antimicrobial resistance|antimicrobial resistance
5975489|NCT01595529|children|children
5975490|NCT01595529|E.coli|e.coli
5975491|NCT01595529|K.pneumoniae|k.pneumoniae
5975492|NCT01595529|parent study|parent study
5975493|NCT01595529|SCOUT Study|scout study
5975494|NCT01595529|spectrum stool bacteria|spectrum stool bacteria
5975495|NCT01595529|stool culture|stool culture
5376025|NCT01830868|ZNS|zns
5975496|NCT01595529|urinary tract infections|urinary tract infections
5975497|NCT01586455|umbilical cord blood|umbilical cord blood
5975498|NCT01586455|stem cell transplantation|stem cell transplantation
5975499|NCT01586455|placental stem cell|placental stem cell
5975500|NCT01586455|inborn errors of metabolism|inborn errors of metabolism
5975501|NCT01586455|marrow failure|marrow failure
5975502|NCT01586455|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
5975503|NCT01586455|AML|aml
5975504|NCT01586455|ALL|all
5975505|NCT01586455|MDS|mds
5975506|NCT01585688|NHL|nhl
5975507|NCT01585688|CLL|cll
5975508|NCT01583283|Multiple Myeloma|multiple myeloma
5975509|NCT01583283|Relapsed|relapsed
5975510|NCT01583283|Refractory|refractory
5975511|NCT01583283|Histone deacetylase inhibitors|histone deacetylase inhibitors
5975512|NCT01583283|Lenalidomide|lenalidomide
5975513|NCT01583283|Revlimid|revlimid
5975514|NCT01583283|Dexamethasone|dexamethasone
5975515|NCT01582074|Ultrasound Tomography|ultrasound tomography
5975516|NCT01582074|Tamoxifen|tamoxifen
5975517|NCT01582074|Breast Cancer|breast cancer
5975518|NCT01582074|Estrogen Receptor Positive|estrogen receptor positive
5975519|NCT01582074|Breast Density|breast density
5975520|NCT01579994|adenocarcinoma|adenocarcinoma
5975521|NCT01579994|Lung|lung
5975522|NCT01579994|Metastatic|metastatic
5975523|NCT01579994|Crizotinib|crizotinib
5975524|NCT01579994|Ganetespib|ganetespib
5975525|NCT01579994|STA-9090|sta-9090
5975526|NCT01579994|ALK Positive Lung Cancers|alk positive lung cancers
5975527|NCT01579994|12-015|12-015
5975528|NCT01579539|Methylprednisolone|methylprednisolone
5975529|NCT01579539|Dry Eye Syndrome|dry eye syndrome
5975530|NCT01579539|Tear Film|tear film
5975531|NCT01579539|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5975532|NCT01574053|Huntington's Disease|huntington's disease
5975533|NCT01574053|Huntington Disease|huntington disease
5975534|NCT01574053|Juvenile Huntington's Disease|juvenile huntington's disease
5975535|NCT01574053|Registry|registry
5975536|NCT01574053|Cohort|cohort
5975537|NCT01574053|CHDI|chdi
5975538|NCT01572506|Anemia|anemia
5975539|NCT01572506|Elderly|elderly
5975540|NCT01572506|Mechanisms|mechanisms
5975541|NCT01572506|Red Cell Survival|red cell survival
5975542|NCT01572480|Proteasome Inhibitor|proteasome inhibitor
5975543|NCT01572480|Immunomodulatory Agents|immunomodulatory agents
5975544|NCT01572480|Combination Therapy|combination therapy
5975545|NCT01572480|Anti-Myeloma Activity|anti-myeloma activity
5975546|NCT01572480|Smoldering Multiple Myeloma|smoldering multiple myeloma
5975547|NCT01572480|SMM|smm
5975548|NCT01571752|Drug Abuse|drug abuse
5975549|NCT01571752|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
5975550|NCT01571752|Environment|environment
5975551|NCT01571752|Genetic|genetic
5975552|NCT01571752|Longitudinal|longitudinal
5975553|NCT01571752|Drug Dependence|drug dependence
5952146|NCT03218683|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5975554|NCT01568697|Microbiome|microbiome
5975558|NCT01568697|Immune Disorder|immune disorder
5975559|NCT01568697|Periodontal Disease|periodontal disease
5975561|NCT01568697|Healthy Volunteer|healthy volunteer
5975562|NCT01568697|HV|hv
5975563|NCT01563874|Antibodies|antibodies
5975564|NCT01563874|Reverse Phase Microarrays|reverse phase microarrays
5975565|NCT01563874|Epigenetics|epigenetics
5975566|NCT01563874|Acetylation|acetylation
5975567|NCT01563874|Methylation|methylation
5975568|NCT01563874|Lymphoma|lymphoma
5975569|NCT01558804|Streptococcus pyogenes|streptococcus pyogenes
5975570|NCT01558804|Streptococcus|streptococcus
5975571|NCT01557244|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5975572|NCT01557244|neurogenic bladder|neurogenic bladder
5975573|NCT01557244|neuropathic bladder|neuropathic bladder
5975574|NCT01557244|neurologic disease|neurologic disease
5975575|NCT01557244|fesoterodine|fesoterodine
5975576|NCT01554618|exenatide|exenatide
5975577|NCT01554618|type 2 diabetes|type 2 diabetes
5975578|NCT01554618|GLP-1 receptor agonist|glp-1 receptor agonist
5975579|NCT01553461|Transplant|transplant
5975580|NCT01553461|Umbilical Cord Blood|umbilical cord blood
5975581|NCT01553461|Graft Rejection|graft rejection
5975582|NCT01553461|Graft Versus Host Disease|graft versus host disease
5975583|NCT01553214|Neutrophils|neutrophils
5975584|NCT01553214|Infection|infection
5975585|NCT01553214|Granulocytapheresis|granulocytapheresis
5975586|NCT01553214|Mobilization|mobilization
5975587|NCT01553214|Transfusion|transfusion
5975588|NCT01553214|Healthy Volunteer|healthy volunteer
5975589|NCT01553214|HV|hv
5975590|NCT01543659|89Zr-DFO-huJ591|89zr-dfo-huj591
5975591|NCT01543659|prostate|prostate
5975592|NCT01543659|Pet scan|pet scan
5975593|NCT01543659|11-126|11-126
5975594|NCT01542021|prostate|prostate
5975595|NCT01542021|Degarelix|degarelix
5975596|NCT01542021|injections|injections
5975597|NCT01542021|radical prostatectomy|radical prostatectomy
5975598|NCT01542021|11-182|11-182
5975599|NCT01534598|DNA Methylation|dna methylation
5975600|NCT01534598|Advanced Cancer|advanced cancer
5975601|NCT01534598|Methyltransferase Inhibitor|methyltransferase inhibitor
5975602|NCT01534598|Epigenetics|epigenetics
5975603|NCT01534598|Gene Re-Expression|gene re-expression
5975604|NCT01534598|Cancer|cancer
5975605|NCT01534598|Solid Tumor|solid tumor
5975606|NCT01528254|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5975607|NCT01528254|Vildagliptin|vildagliptin
5975608|NCT01528254|Elderly Patients|elderly patients
5975609|NCT01524822|Military|military
5975610|NCT01524822|Traumatic Brain Injury|traumatic brain injury
5975611|NCT01524822|Cognitive Testing|cognitive testing
5975612|NCT01524822|Neuroimaging|neuroimaging
5975613|NCT01524822|Brain Function|brain function
5975614|NCT01524536|Hypereosinophilia|hypereosinophilia
5975615|NCT01524536|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5975616|NCT01524536|Corticosteroids|corticosteroids
5975617|NCT01524536|Therapy|therapy
5975618|NCT01524536|HES|hes
5975619|NCT01519869|peritoneal|peritoneal
5975620|NCT01519869|carcinoma|carcinoma
5975621|NCT01519869|ovarian|ovarian
5975622|NCT01519869|fallopian tube|fallopian tube
5975623|NCT01519869|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5975624|NCT01519869|surgical debulking|surgical debulking
5975625|NCT01517087|Cerebrospinal Fluid|cerebrospinal fluid
5975626|NCT01517087|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5975627|NCT01517087|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5975628|NCT01517087|Diffusion Tensor Imaging|diffusion tensor imaging
5975629|NCT01517087|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5975630|NCT01517087|Healthy Volunteer|healthy volunteer
5975631|NCT01517087|HV|hv
5975632|NCT01514799|gastric bypass|gastric bypass
5975633|NCT01514799|morbid obesity|morbid obesity
5975634|NCT01514799|gut function|gut function
5975635|NCT01514799|weight loss|weight loss
5975636|NCT01504932|black raspberry|black raspberry
5975637|NCT01504932|Appalachia|appalachia
5975638|NCT01504932|oral cancer|oral cancer
5975639|NCT01504932|cancer recurrence|cancer recurrence
5975640|NCT01500447|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5975641|NCT01500447|Kallmann Syndrome|kallmann syndrome
5975642|NCT01500447|Delayed Puberty|delayed puberty
5975643|NCT01500447|Hypothalamic Amenorrhea|hypothalamic amenorrhea
5975644|NCT01500447|Precocious Puberty|precocious puberty
5975645|NCT01496599|Brain Imaging|brain imaging
5975646|NCT01496599|Parkinson's Disease|parkinson's disease
5975647|NCT01496599|Parkinsonism|parkinsonism
5975648|NCT01496599|Parkinson Disease|parkinson disease
5975649|NCT01496599|PD|pd
5975650|NCT01496599|Healthy Volunteer|healthy volunteer
5975651|NCT01496599|HV|hv
5975652|NCT01495598|Human Herpesvirus-8/HHV8|human herpesvirus-8/hhv8
5975653|NCT01495598|Immune Modulation|immune modulation
5975654|NCT01495598|CC-4047|cc-4047
5975655|NCT01495598|IMiD|imid
5975656|NCT01495598|Kaposi Sarcoma|kaposi sarcoma
5975657|NCT01492010|skeletal muscle|skeletal muscle
5975658|NCT01492010|FSR|fsr
5975659|NCT01492010|resistance exercise|resistance exercise
5975660|NCT01492010|leucine|leucine
5975661|NCT01492010|protein|protein
5975662|NCT01491789|spinal cord injury|spinal cord injury
5975663|NCT01491789|Virtual sailing|virtual sailing
5975664|NCT01491789|Vsail|vsail
5975665|NCT01470781|Bipolar Disorder|bipolar disorder
5975666|NCT01470781|Psychosis|psychosis
5975667|NCT01470781|Cognition|cognition
5975668|NCT01470781|Cognitive Remediation|cognitive remediation
5975669|NCT01469429|oral cancer|oral cancer
5975670|NCT01468922|Pazopanib|pazopanib
5975671|NCT01468922|Tivantinib|tivantinib
5975672|NCT01468922|MET Inhibitor|met inhibitor
5975673|NCT01468922|Advanced Cancer|advanced cancer
5975674|NCT01468922|Anti-Angiogenesis|anti-angiogenesis
5975675|NCT01468922|Cancer|cancer
5975676|NCT01468922|Solid Tumor|solid tumor
5975677|NCT01468922|Sarcoma|sarcoma
5975678|NCT01468883|Breast Cancer|breast cancer
5975679|NCT01468883|Surgery|surgery
5975680|NCT01468883|Radiation|radiation
5975681|NCT01468844|Visual Acuity|visual acuity
5975682|NCT01468844|Retinal Vein Occlusion|retinal vein occlusion
5975683|NCT01468844|Central Retinal Vein Occlusion|central retinal vein occlusion
5975684|NCT01468844|CRVO|crvo
5975685|NCT01468831|Minocycline|minocycline
5975686|NCT01468831|Macular Edema|macular edema
5975687|NCT01464164|Diamond Blackfan anemia|diamond blackfan anemia
5975688|NCT01464164|DBA|dba
5975689|NCT01464164|Blackfan Diamond anemia|blackfan diamond anemia
5975690|NCT01464164|Congenital pure red cell aplasia|congenital pure red cell aplasia
5975691|NCT01464164|Aase-Smith II Syndrome|aase-smith ii syndrome
5975692|NCT01464164|Aase Syndrome|aase syndrome
5975693|NCT01464164|Anemia, Congenital Pure Red Cell|anemia, congenital pure red cell
5975694|NCT01464164|Aplasia, Congenital Pure Red Cell|aplasia, congenital pure red cell
5975695|NCT01464164|BDA|bda
5975696|NCT01464164|Congenital Hypoplastic Anemia|congenital hypoplastic anemia
5975697|NCT01464164|Erythrogenesis Imperfecta|erythrogenesis imperfecta
5975698|NCT01464164|Hypoplastic Congenital Anemia|hypoplastic congenital anemia
5975699|NCT01464164|Inherited Erythroblastopenia|inherited erythroblastopenia
5975700|NCT01464164|pure red cell aplasia|pure red cell aplasia
5975701|NCT01464164|bone marrow failure syndrome|bone marrow failure syndrome
5975702|NCT01463306|safety|safety
5975703|NCT01463306|partial onset seizures|partial onset seizures
5975704|NCT01463306|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
5975705|NCT01463306|pregabalin|pregabalin
5975706|NCT01463306|pediatric|pediatric
5975707|NCT01463306|adult|adult
5975708|NCT01463306|open-label|open-label
5975709|NCT01463306|long term|long term
5975710|NCT01450020|cancer survivor|cancer survivor
5975711|NCT01447277|ACL reconstruction|acl reconstruction
5975712|NCT01447277|Femoral Block|femoral block
5975713|NCT01447277|Sciatic Block|sciatic block
5975714|NCT01445561|Interleukin-2|interleukin-2
5975715|NCT01445561|IL-2|il-2
5975716|NCT01445561|Stem Cells|stem cells
5975717|NCT01445561|Regulatory T Cells (T regs)|regulatory t cells (t regs)
5975718|NCT01445561|Natural Killer Cells (NK cells)|natural killer cells (nk cells)
5975719|NCT01445561|Healthy Volunteer|healthy volunteer
5975720|NCT01445561|HV|hv
5975721|NCT01445509|Angiogenesis|angiogenesis
5975722|NCT01445509|VEGF|vegf
5975723|NCT01445509|SRC|src
5975724|NCT01445509|Targeted Therapy|targeted therapy
5975725|NCT01445509|Cancer|cancer
5975726|NCT01445509|Solid Tumor|solid tumor
5975727|NCT01445483|Cancer|cancer
5975728|NCT01445483|Radiation|radiation
5975729|NCT01445483|Brain|brain
5975730|NCT01445483|Neuropsychological Outcome|neuropsychological outcome
5975731|NCT01445483|Metastasis|metastasis
5975732|NCT01445483|Brain Metastasis|brain metastasis
5975733|NCT01445314|Stored Data|stored data
5975734|NCT01445314|Neurobehavioral|neurobehavioral
5975735|NCT01445314|Behavior|behavior
5975736|NCT01445314|Quality of Life|quality of life
5975737|NCT01445288|Neurotoxicity|neurotoxicity
5975738|NCT01445288|Brain Tumor|brain tumor
5975739|NCT01445288|Children|children
5975740|NCT01445288|Angiogenesis|angiogenesis
5975741|NCT01445288|Imaging|imaging
5975742|NCT01445288|Central Nervous System Tumor|central nervous system tumor
5975743|NCT01445288|CNS Tumor|cns tumor
5975744|NCT01443910|Body Weight|body weight
5975745|NCT01443910|Healthy Volunteer|healthy volunteer
5975746|NCT01441856|Open|open
5975747|NCT01441856|Laparoscopic|laparoscopic
5975748|NCT01441856|Hemihepatectomy|hemihepatectomy
5975749|NCT01441856|Hepatectomy|hepatectomy
5975750|NCT01441856|Enhanced Recovery After Surgery|enhanced recovery after surgery
5975751|NCT01441856|Functional recovery|functional recovery
5975752|NCT01438177|myeloma|myeloma
5975753|NCT01438177|multiple myeloma|multiple myeloma
5975754|NCT01438177|relapsed myeloma|relapsed myeloma
5975755|NCT01438177|refractory myeloma|refractory myeloma
5975756|NCT01437631|colon polyp|colon polyp
5975757|NCT01437631|endoscopic polypectomy|endoscopic polypectomy
5975758|NCT01437631|postpolypectomy bleeding|postpolypectomy bleeding
5975759|NCT01437631|prophylactic clip application|prophylactic clip application
5975760|NCT01434602|Chemotherapy|chemotherapy
5975761|NCT01434602|Brain Tumor|brain tumor
5975762|NCT01434602|Glioblastoma|glioblastoma
5975763|NCT01434602|Anaplastic Glioma|anaplastic glioma
5975764|NCT01432847|Best Disease|best disease
5975765|NCT01432847|Late-Onset Retinal Degeneration (L-ORD)|late-onset retinal degeneration (l-ord)
5975766|NCT01432847|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5975767|NCT01432847|Retinal Degeneration|retinal degeneration
5975768|NCT01432847|Age-Related Macular Degeneration|age-related macular degeneration
5975769|NCT01432847|AMD|amd
5975770|NCT01426776|Cheyne-Stokes respiration|cheyne-stokes respiration
5975771|NCT01426776|Heart valve disease|heart valve disease
5975772|NCT01426776|Central Sleep Apnea|central sleep apnea
5975773|NCT01425892|Salivary Gland|salivary gland
5975774|NCT01425892|Sjogren's Syndrome|sjogren's syndrome
5975775|NCT01425892|Sj(SqrRoot)(Delta)gren s Syndrome|sj(sqrroot)(delta)gren s syndrome
5975776|NCT01425892|Pathogenesis|pathogenesis
5975777|NCT01425892|Sjogren Syndrome|sjogren syndrome
5975778|NCT01423851|Keywords provided by NS Pharma, Inc.:|keywords provided by ns pharma, inc.:
5975779|NCT01423851|JAK2 kinase inhibitor|jak2 kinase inhibitor
5975780|NCT01423851|NS-018|ns-018
5975781|NCT01423851|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5975782|NCT01423851|Primary Myelofibrosis|primary myelofibrosis
5975783|NCT01423851|post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5975784|NCT01423851|post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5975785|NCT01423851|Additional relevant MeSH terms:|additional relevant mesh terms:
5975786|NCT01423851|Bone Marrow Diseases|bone marrow diseases
5975787|NCT01423851|Hematologic Diseases|hematologic diseases
5975788|NCT01423851|Polycythemia Vera|polycythemia vera
5975789|NCT01423851|Thrombocythemia, Essential|thrombocythemia, essential
5975790|NCT01423851|PMF|pmf
5975791|NCT01423851|post-PV MF|post-pv mf
5975792|NCT01423851|post-ET MF|post-et mf
5975793|NCT01422694|Sacroiliitis|sacroiliitis
5975794|NCT01422694|Ankylosing Spondylitis|ankylosing spondylitis
5975795|NCT01422694|Spondyloarthritis|spondyloarthritis
5975796|NCT01422694|HLA-B27|hla-b27
5975797|NCT01422694|Enthesitis-Related Arthritis|enthesitis-related arthritis
5975798|NCT01418313|Atherosclerosis|atherosclerosis
5975799|NCT01418313|Non-invasive imaging|non-invasive imaging
5975800|NCT01418313|Magnetic Resonance Imaging|magnetic resonance imaging
5975801|NCT01418313|MRI|mri
5276743|NCT02293447|Uterine|uterine
5975802|NCT01418313|Positron Emission Tomography|positron emission tomography
5952387|NCT03164772|anti-CTLA-4|anti-ctla-4
5975804|NCT01418313|PET/MRI|pet/mri
5975805|NCT01418313|Inflammation|inflammation
5975806|NCT01418313|Neovascularization|neovascularization
5975807|NCT01411267|Relapse|relapse
5975808|NCT01411267|Lymphoblastic|lymphoblastic
5975809|NCT01411267|Leukemia|leukemia
5975810|NCT01411267|AC220|ac220
5975811|NCT01411267|Refractory|refractory
5975812|NCT01411267|Myelogenous|myelogenous
5975813|NCT01411267|Acute|acute
5975814|NCT01411267|Childhood|childhood
5975815|NCT01411267|Pediatric|pediatric
5975817|NCT01411267|AML|aml
5975818|NCT01407263|radical prostatectomy|radical prostatectomy
5975819|NCT01407263|anastomotic suturing|anastomotic suturing
5975820|NCT01407263|lymph node dissection|lymph node dissection
5975821|NCT01407263|11-096|11-096
5975822|NCT01400269|PACE|pace
5975823|NCT01386424|Future|future
5975824|NCT01386424|Influenza|influenza
5975825|NCT01386424|Flu|flu
5975826|NCT01386424|Observation|observation
5975827|NCT01386424|Vaccine|vaccine
5975828|NCT01386424|Healthy Volunteer|healthy volunteer
5975829|NCT01386424|HV|hv
5975830|NCT01383525|SLT, LTP, DSLT|slt, ltp, dslt
5975831|NCT01383525|non contact|non contact
5975832|NCT01383525|Trabeculoplasty|trabeculoplasty
5975833|NCT01383525|Laser|laser
5975834|NCT01383525|intraocular pressure|intraocular pressure
5975835|NCT01376778|Perinatology|perinatology
5975836|NCT01376778|Cytomegalovirus immune globulin|cytomegalovirus immune globulin
5975837|NCT01376778|Cytogam|cytogam
5975838|NCT01376778|CMVIG infusions|cmvig infusions
5975839|NCT01375621|Farming|farming
5975840|NCT01375621|Antibiotic Resistant|antibiotic resistant
5975841|NCT01375621|Bacteria|bacteria
5975842|NCT01372631|Reduction mammoplasty|reduction mammoplasty
5975843|NCT01372631|mastectomy|mastectomy
5975844|NCT01372631|partial mastectomy|partial mastectomy
5975845|NCT01372631|lumpectomy|lumpectomy
5975846|NCT01372631|breast conserving surgery|breast conserving surgery
5975847|NCT01372631|breast cancer|breast cancer
5975848|NCT01369199|Hepatitis B|hepatitis b
5975849|NCT01369199|Immune-tolerant hepatitis B|immune-tolerant hepatitis b
5975850|NCT01369199|HBV|hbv
5975851|NCT01365975|Cohort Study|cohort study
5975852|NCT01365975|Folic Acid Peri-Conception|folic acid peri-conception
5975853|NCT01365975|Pediatric Leukemia|pediatric leukemia
5975854|NCT01365975|Pediatric Cancer|pediatric cancer
5975855|NCT01364597|Brivaracetam|brivaracetam
5975856|NCT01364597|Epilepsy|epilepsy
5975857|NCT01364597|Child|child
5975858|NCT01364597|Infant|infant
5975859|NCT01364597|Adolescents|adolescents
5975860|NCT01364597|Partial onset seizures|partial onset seizures
5975861|NCT01362127|Histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.Suitable for surgery.|histologically confirmed squamos cell carcinoma or adenocarcinoma of the esophagus and gastric cardia.suitable for surgery.
5975862|NCT01360736|Suicide Prevention|suicide prevention
5975863|NCT01360736|Suicide Attempt|suicide attempt
5975864|NCT01360736|Suicide Ideation|suicide ideation
5975865|NCT01360736|Randomized Controlled Trial|randomized controlled trial
5975866|NCT01360736|Safety Planning|safety planning
5975867|NCT01356186|Suicide|suicide
5975868|NCT01356186|Cognitive Therapy|cognitive therapy
5975869|NCT01356186|Inpatient|inpatient
5975870|NCT01356186|Military|military
5975871|NCT01355913|Myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5975872|NCT01355913|chromosmal aberrations|chromosmal aberrations
5975873|NCT01355913|cytogenetics|cytogenetics
5975874|NCT01355913|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
5975875|NCT01355913|CD34+ cells|cd34+ cells
5975876|NCT01355913|peripheral blood|peripheral blood
5975877|NCT01353625|Neoplasm|neoplasm
5975878|NCT01353625|Malignancy|malignancy
5975879|NCT01353625|Carcinoma|carcinoma
5975880|NCT01353625|Lymphoma|lymphoma
5975881|NCT01353625|Leukemia|leukemia
5975882|NCT01353625|Multiple myeloma|multiple myeloma
5975883|NCT01353625|mTOR kinase inhibitor|mtor kinase inhibitor
5975884|NCT01353625|Castration-resistant prostate cancer|castration-resistant prostate cancer
5975885|NCT01353625|Hormone-resistant prostate cancer|hormone-resistant prostate cancer
5975886|NCT01353625|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5975887|NCT01353313|NICHD Neonatal Research Network|nichd neonatal research network
5975888|NCT01353313|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5975889|NCT01353313|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5975890|NCT01353313|Prematurity|prematurity
5975891|NCT01353313|Mechanical ventilation|mechanical ventilation
5975892|NCT01353313|Intubation|intubation
5975893|NCT01353313|Neurodevelopmental impairment|neurodevelopmental impairment
5975894|NCT01352962|Dose Limiting Toxicity|dose limiting toxicity
5975895|NCT01352962|Urethra Cancer|urethra cancer
5975896|NCT01352962|Carcinoma of the Bladder|carcinoma of the bladder
5975897|NCT01352962|Cancer of the Renal Pelvis|cancer of the renal pelvis
5975898|NCT01352962|Ureter Cancer|ureter cancer
5975899|NCT01352962|Urethral Cancer|urethral cancer
5975900|NCT01352962|Solid Tumor|solid tumor
5975901|NCT01352962|Pancreatic Cancer|pancreatic cancer
5975902|NCT01352962|Ovarian Cancer|ovarian cancer
5975903|NCT01352962|Non-Small Cell Lung Cancer|non-small cell lung cancer
5975904|NCT01352949|Anthropometry|anthropometry
5975905|NCT01352949|Stereophotogrammetry|stereophotogrammetry
5975906|NCT01352949|Torso|torso
5975907|NCT01351584|Breast Cancer|breast cancer
5975908|NCT01351584|Advanced Breast Cancer|advanced breast cancer
5975909|NCT01351584|Epidemiology|epidemiology
5975910|NCT01351584|Registry|registry
5975911|NCT01351584|Health Services Research|health services research
5975912|NCT01351584|Germany|germany
5975913|NCT01351584|Palliative Treatment|palliative treatment
5975914|NCT01351584|Adjuvant Drug Therapy|adjuvant drug therapy
5975915|NCT01351584|Nutrition Assessment|nutrition assessment
5975916|NCT01351584|Physical Activity|physical activity
5975917|NCT01350648|Viral Hepatitis|viral hepatitis
5975918|NCT01350648|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
5975919|NCT01350648|Hepatocellular Carcinoma|hepatocellular carcinoma
5975920|NCT01350648|HIV-HCV Co-Infection|hiv-hcv co-infection
5975921|NCT01350648|Liver Neoplasms|liver neoplasms
5975922|NCT01349101|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5975923|NCT01349101|HSCT|hsct
5975924|NCT01349101|allogeneic marrow transplantation|allogeneic marrow transplantation
5975925|NCT01349101|cyclophosphamide|cyclophosphamide
5975926|NCT01349101|graft-versus-host disease|graft-versus-host disease
5975927|NCT01349101|GVHD|gvhd
5975928|NCT01348542|Chronic Insomnia|chronic insomnia
5975929|NCT01348542|Short Sleep Duration|short sleep duration
5975930|NCT01348542|Trazodone|trazodone
5975931|NCT01348542|Cognitive Behavioral Therapy|cognitive behavioral therapy
5975932|NCT01348542|Efficacy|efficacy
5975933|NCT01345175|rectal|rectal
5975934|NCT01345175|colon|colon
5975935|NCT01345175|PLACEBO|placebo
5975936|NCT01345175|RIFAXIMIN|rifaximin
5975937|NCT01345175|metronidazole|metronidazole
5975938|NCT01345175|11-045|11-045
5975939|NCT01345136|Neurofibromatosis Type 2|neurofibromatosis type 2
5975940|NCT01345136|Vestibular schwannoma|vestibular schwannoma
5975941|NCT01345136|Hearing|hearing
5975942|NCT01343342|omega-3|omega-3
5975943|NCT01343342|PUFA|pufa
5975944|NCT01343342|fatty acids|fatty acids
5975945|NCT01343342|cardiovascular disease|cardiovascular disease
5975946|NCT01343342|gene expression|gene expression
5975947|NCT01343043|T Cell Receptor|t cell receptor
5975948|NCT01343043|Sarcoma|sarcoma
5975949|NCT01343043|Cell Therapy|cell therapy
5975950|NCT01343043|T Cell Therapy|t cell therapy
5975951|NCT01343043|Previously treated|previously treated
5975952|NCT01343043|NY-ESO-1|ny-eso-1
5975953|NCT01343043|Metastatic|metastatic
5975954|NCT01343043|Immuno-oncology|immuno-oncology
5975955|NCT01340859|Suicide|suicide
5975956|NCT01340859|Cognitive Therapy|cognitive therapy
5975957|NCT01340859|Inpatient|inpatient
5975958|NCT01340859|Military|military
5975959|NCT01338285|Industry Hygiene|industry hygiene
5975960|NCT01338285|Molecular Epidemiology|molecular epidemiology
5975961|NCT01338285|Cancer Susceptability|cancer susceptability
5975962|NCT01338285|Genotoxocity|genotoxocity
5975963|NCT01338285|FISH|fish
5975964|NCT01337700|ASD|asd
5975965|NCT01337700|Autism|autism
5975966|NCT01337700|Autism Spectrum Disorder|autism spectrum disorder
5975967|NCT01337700|Asperger Syndrome|asperger syndrome
5975968|NCT01337700|Asperger|asperger
5975969|NCT01337700|PDD|pdd
5975970|NCT01337700|PDD-NOS|pdd-nos
5975971|NCT01337687|Autism|autism
5975972|NCT01337687|Autism Spectrum Disorders|autism spectrum disorders
5975973|NCT01337687|Oxytocin|oxytocin
5975974|NCT01337687|Hollander|hollander
5975975|NCT01337687|ASD|asd
5975976|NCT01337687|Asperger Syndrome|asperger syndrome
5975977|NCT01337687|Asperger|asperger
5975978|NCT01327196|dementia|dementia
5975979|NCT01327196|cardiovascular risk|cardiovascular risk
5975980|NCT01327196|elderly|elderly
5975981|NCT01327196|aging|aging
5975982|NCT01327196|older 65-100 years|older 65-100 years
5975983|NCT01326715|Mangafodipir|mangafodipir
5975984|NCT01326715|Brain|brain
5975985|NCT01326715|MEMRI|memri
5975986|NCT01326715|Healthy Volunteer|healthy volunteer
5975987|NCT01326715|Multiple Sclerosis|multiple sclerosis
5975988|NCT01326143|MRD|mrd
5975989|NCT01326143|Narval|narval
5975990|NCT01326143|Oral appliance|oral appliance
5975991|NCT01326143|Obstructive Sleep apnea|obstructive sleep apnea
5975992|NCT01326143|OSAH|osah
5975993|NCT01326143|OSA treatment|osa treatment
5975994|NCT01325064|Carotid Artery Diseases|carotid artery diseases
5975995|NCT01325064|Blood Pressure|blood pressure
5975996|NCT01325064|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5975997|NCT01325064|Peripheral Vascular Diseases|peripheral vascular diseases
5975998|NCT01325064|Retinal Vessels|retinal vessels
5975999|NCT01323309|Supportive Psychotherapy|supportive psychotherapy
5976000|NCT01323309|Therapy|therapy
5976001|NCT01323309|11-021|11-021
5976002|NCT01317160|Achilles Tendon|achilles tendon
5976003|NCT01317160|Immobilization|immobilization
5976004|NCT01317160|Wound Healing|wound healing
5976005|NCT01317160|Intermittent Pneumatic Compression|intermittent pneumatic compression
5976006|NCT01317160|Ultrasonography|ultrasonography
5976007|NCT01317160|Microdialysis|microdialysis
5976008|NCT01316783|Cardiometabolic Diseases|cardiometabolic diseases
5976009|NCT01316783|African Descent|african descent
5976010|NCT01316783|Cardiovascular Disease|cardiovascular disease
5976011|NCT01316783|Diabetes|diabetes
5976012|NCT01316549|fludarabine|fludarabine
5976013|NCT01316549|pharmacokinetics|pharmacokinetics
5976014|NCT01316549|pediatric|pediatric
5976015|NCT01316549|allogeneic|allogeneic
5976016|NCT01316549|hematopoietic cell transplantation|hematopoietic cell transplantation
5976017|NCT01313429|Metastatic Cancer|metastatic cancer
5976018|NCT01313429|Cancer Vaccine|cancer vaccine
5976019|NCT01313429|Immunotherapy|immunotherapy
5976020|NCT01313429|Adjuvant Therapy|adjuvant therapy
5976021|NCT01313429|Chest Metastases|chest metastases
5976022|NCT01313429|Cancer|cancer
5976023|NCT01313429|Melanoma|melanoma
5976024|NCT01313429|Lung Cancer|lung cancer
5976025|NCT01313429|Sarcoma|sarcoma
5976026|NCT01312545|orbital implant|orbital implant
5976027|NCT01312545|evisceration|evisceration
5976028|NCT01312545|economic|economic
5976029|NCT01312545|polyethylene|polyethylene
5976030|NCT01312545|porous|porous
5976031|NCT01311648|recombinant factor VIII|recombinant factor viii
5976032|NCT01311648|pediatric use|pediatric use
5976033|NCT01306045|AZD6244|azd6244
5976034|NCT01306045|MK-2206|mk-2206
5976035|NCT01306045|Lapatinib|lapatinib
5976036|NCT01306045|Erlotinib|erlotinib
5976037|NCT01306045|Sunitinib|sunitinib
5976038|NCT01295645|Stem Cell Transplant|stem cell transplant
5976039|NCT01295645|Hemorrhagic Cystitis|hemorrhagic cystitis
5976040|NCT01295645|Bladder inflammation|bladder inflammation
5976041|NCT01295645|Frequent urination|frequent urination
5976042|NCT01295645|Pain|pain
5976043|NCT01295645|Polyomavirus hominis type I|polyomavirus hominis type i
5976044|NCT01295645|BK virus|bk virus
5976045|NCT01295645|BKV|bkv
5976046|NCT01295645|Cidofovir|cidofovir
5976047|NCT01295645|Vistide|vistide
5976048|NCT01294670|ETOPOSIDE (VP-16)|etoposide (vp-16)
5976049|NCT01294670|SAHA (SUBEROYLANILIDE HYDROXAMIC ACID) (Vorinostat)|saha (suberoylanilide hydroxamic acid) (vorinostat)
5976050|NCT01294670|Pediatric|pediatric
5976051|NCT01294670|10-096|10-096
5976052|NCT01294670|POETIC|poetic
5976053|NCT01294670|phase II component: the population will be restricted to relapsed/refractory sarcomas.|phase ii component: the population will be restricted to relapsed/refractory sarcomas.
5976054|NCT01294345|Genomics|genomics
5976055|NCT01294345|Personalized|personalized
5976056|NCT01294345|Congenital Malformations|congenital malformations
5976057|NCT01294345|Birth Defects|birth defects
5976066|NCT01289457|Clolar|clolar
5976067|NCT01289457|Idarubicin|idarubicin
5976068|NCT01289457|Idamycin|idamycin
5976069|NCT01289457|Cytarabine|cytarabine
5976070|NCT01289457|Ara-C|ara-c
5976071|NCT01289457|Cytosar|cytosar
5976072|NCT01289457|DepoCyt|depocyt
5976073|NCT01289457|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5976074|NCT01287156|Recruitment|recruitment
5976075|NCT01287156|TBI|tbi
5976076|NCT01287156|Screening|screening
5976077|NCT01287156|Traumatic Brain Injury|traumatic brain injury
5976078|NCT01284010|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5976079|NCT01273610|Breast Neoplasms|breast neoplasms
5976080|NCT01273610|HER2 protein, human|her2 protein, human
5976081|NCT01273610|Geriatric Health Services|geriatric health services
5976082|NCT01273610|Antineoplastic Agents, Combined|antineoplastic agents, combined
5976083|NCT01273610|Geriatric Assessment|geriatric assessment
5976084|NCT01273610|Pharmacokinetics|pharmacokinetics
5976085|NCT01273610|Toxicity|toxicity
5976086|NCT01273610|Patient Adherence|patient adherence
5976087|NCT01273220|Epidemiology|epidemiology
5976088|NCT01273220|Epidemiologic Survey|epidemiologic survey
5976089|NCT01273220|Alcohol|alcohol
5976090|NCT01273168|Pharmacokinetics|pharmacokinetics
5976091|NCT01273168|Advanced Cancer|advanced cancer
5976092|NCT01273168|Cytochrome P 450|cytochrome p 450
5976093|NCT01273168|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
5976094|NCT01273168|Tamoxifen Metabolite|tamoxifen metabolite
5976095|NCT01273168|Gynecologic Cancer|gynecologic cancer
5976096|NCT01273168|Breast Cancer|breast cancer
5976097|NCT01273168|Desmoid Tumor|desmoid tumor
5976098|NCT01273168|Endometrial Cancer|endometrial cancer
5976099|NCT01273168|Ovarian Cancer|ovarian cancer
5976100|NCT01273168|Uterine Cancer|uterine cancer
5976101|NCT01273168|Fallopian Tube Cancer|fallopian tube cancer
5976102|NCT01273168|Peritoneal Cancer|peritoneal cancer
5976103|NCT01266902|HIV-1 Infection|hiv-1 infection
5976104|NCT01266902|HIV-1|hiv-1
5976105|NCT01266902|HIV|hiv
5976106|NCT01266902|TMC278-TiDP6-C222|tmc278-tidp6-c222
5976107|NCT01266902|TMC278-C222|tmc278-c222
5976108|NCT01266902|TMC278|tmc278
5976109|NCT01266902|Rilpivirine|rilpivirine
5976110|NCT01266577|Brain Metabolism|brain metabolism
5976111|NCT01266577|Neurochemistry|neurochemistry
5976112|NCT01266577|Magnetic Resonance Imaging|magnetic resonance imaging
5976113|NCT01266577|Mental Illness|mental illness
5976114|NCT01266577|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5976115|NCT01265381|Cohort|cohort
5976116|NCT01265381|Radiation|radiation
5976117|NCT01265381|Thyroid Cancer|thyroid cancer
5976118|NCT01261832|Acute Myocardial Infarction|acute myocardial infarction
5976119|NCT01261832|Percutaneous coronary intervention|percutaneous coronary intervention
5976120|NCT01257100|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5976121|NCT01257100|Epstein-Barr Virus|epstein-barr virus
5976122|NCT01257100|NPC|npc
5976123|NCT01251900|Triple Negative Disease|triple negative disease
5976124|NCT01251900|BRCA1|brca1
5976125|NCT01251900|BRCA2|brca2
5976126|NCT01251900|Hispanic/Latino|hispanic/latino
5976127|NCT01251900|Breast Cancer|breast cancer
5976128|NCT01251393|Cocaine|cocaine
5976129|NCT01251393|crack|crack
5976130|NCT01251393|treatment|treatment
5976131|NCT01251393|dependence|dependence
5976132|NCT01251393|biperiden|biperiden
5976133|NCT01248767|cohort|cohort
5976134|NCT01248767|cognitive distortions|cognitive distortions
5976135|NCT01248767|impulsivity|impulsivity
5976136|NCT01248767|psychiatric comorbidities|psychiatric comorbidities
5976137|NCT01248767|addiction|addiction
5976138|NCT01248767|gambling disorder|gambling disorder
5976139|NCT01248767|sexual addiction|sexual addiction
5976140|NCT01248767|videogame disorder|videogame disorder
5976141|NCT01248767|food addiction|food addiction
5976142|NCT01248767|eating disorders|eating disorders
5976143|NCT01248767|compulsive buying|compulsive buying
5976144|NCT01248767|behavioral addictions|behavioral addictions
5976145|NCT01247597|Thyroid Cancer|thyroid cancer
5976146|NCT01247597|Germline DICER1 Mutation|germline dicer1 mutation
5976147|NCT01247597|MicroRNA Biogenesis|microrna biogenesis
5976148|NCT01247597|Pleuropulmonary Blastoma|pleuropulmonary blastoma
5976149|NCT01247597|PPB|ppb
5976150|NCT01243879|fasting|fasting
5976151|NCT01243879|starvation|starvation
5976152|NCT01243879|calorie restriction|calorie restriction
5976153|NCT01243879|fMRI|fmri
5976154|NCT01243476|myelodysplastic syndrome|myelodysplastic syndrome
5976155|NCT01243476|5q deletion|5q deletion
5976156|NCT01243476|anemia|anemia
5976157|NCT01243476|lenalidomide|lenalidomide
5976158|NCT01243476|red blood cells transfusion|red blood cells transfusion
5976159|NCT01238250|16p11.2|16p11.2
5976160|NCT01238250|16p11.2 del|16p11.2 del
5976161|NCT01238250|16p11.2 deletion|16p11.2 deletion
5976162|NCT01238250|16p11.2 dup|16p11.2 dup
5976163|NCT01238250|16p11.2 duplication|16p11.2 duplication
5976164|NCT01238250|chromosome 16|chromosome 16
5976165|NCT01238250|chromosome 16p|chromosome 16p
5976166|NCT01238250|chromosome 16p11|chromosome 16p11
5976167|NCT01238250|chromosome 16p11.2|chromosome 16p11.2
5976168|NCT01238250|1q21.1|1q21.1
5976169|NCT01238250|1q21.1 del|1q21.1 del
5976170|NCT01238250|1q21.1 deletion|1q21.1 deletion
5976171|NCT01238250|1q21.1 dup|1q21.1 dup
5976172|NCT01238250|1q21.1 duplication|1q21.1 duplication
5976173|NCT01238250|chromosome 1|chromosome 1
5976174|NCT01238250|chromosome 1q|chromosome 1q
5976175|NCT01238250|chromosome 1q21|chromosome 1q21
5976176|NCT01238250|chromosome 1q21.1|chromosome 1q21.1
5976178|NCT01238250|genetic variant|genetic variant
5976179|NCT01238250|gene variant|gene variant
5976181|NCT01238250|ADNP|adnp
5976182|NCT01238250|ANKRD11|ankrd11
5976183|NCT01238250|ARID1B|arid1b
5976184|NCT01238250|ASXL3|asxl3
5976185|NCT01238250|ACTL6B|actl6b
5976186|NCT01238250|AHDC1|ahdc1
5976187|NCT01238250|BAF190|baf190
5976188|NCT01238250|ANK2|ank2
5976189|NCT01238250|ASH1L|ash1l
5976190|NCT01238250|BCL11A|bcl11a
5976191|NCT01238250|CHD2|chd2
5976192|NCT01238250|CHD8|chd8
5976193|NCT01238250|CTNNB1|ctnnb1
5976194|NCT01238250|CUL3|cul3
5976195|NCT01238250|DST|dst
5976196|NCT01238250|DYRK1A|dyrk1a
5976197|NCT01238250|FOXP1|foxp1
5976198|NCT01238250|GRIN2B|grin2b
5976199|NCT01238250|KDM6B|kdm6b
5976200|NCT01238250|KMT2E|kmt2e
5976201|NCT01238250|MBD5|mbd5
5976202|NCT01238250|MED13L|med13l
5976203|NCT01238250|PTEN|pten
5976204|NCT01238250|REST|rest
5976205|NCT01238250|SCN2A|scn2a
5976206|NCT01238250|SMARCC1|smarcc1
5976207|NCT01238250|SMARCC2|smarcc2
5976208|NCT01238250|SYNGAP1|syngap1
5976209|NCT01238250|HIVEP2|hivep2
5976210|NCT01238250|HNRNPH2|hnrnph2
5976211|NCT01238250|PPP2R5D|ppp2r5d
5976212|NCT01238250|CHAMP1|champ1
5976213|NCT01238250|CSNK2A1|csnk2a1
5976214|NCT01238250|CTBP1|ctbp1
5976215|NCT01238250|DDX3X|ddx3x
5976216|NCT01238250|DNMT3A|dnmt3a
5976217|NCT01238250|DSCAM|dscam
5976218|NCT01238250|GRIN2A|grin2a
5976219|NCT01238250|KAT6A|kat6a
5976220|NCT01238250|KATNAL2|katnal2
5976221|NCT01238250|KDM5B|kdm5b
5976222|NCT01238250|KMT2C|kmt2c
5976223|NCT01238250|KMT5B|kmt5b
5976224|NCT01238250|SUV420H1|suv420h1
5976225|NCT01238250|PACS1|pacs1
5976226|NCT01238250|PBRM1|pbrm1
5976227|NCT01238250|PTCHD1|ptchd1
5976228|NCT01238250|PURA|pura
5976229|NCT01238250|SETBP1|setbp1
5976230|NCT01238250|SETD5|setd5
5976231|NCT01238250|SMARCA4|smarca4
5976232|NCT01238250|STXBP1|stxbp1
5976233|NCT01238250|TBR1|tbr1
5976234|NCT01238250|ARHGEF9|arhgef9
5976235|NCT01238250|HNRNPU|hnrnpu
5976236|NCT01238250|KCNQ2|kcnq2
5976237|NCT01238250|PPP2B|ppp2b
5976238|NCT01238250|PPP2R1A|ppp2r1a
5976239|NCT01238250|SLC6A1|slc6a1
5976240|NCT01231932|Fatigue|fatigue
5976241|NCT01231932|Cytokines|cytokines
5976242|NCT01231932|Cancer Therapy|cancer therapy
5976243|NCT01231932|Cancer Treatment|cancer treatment
5976244|NCT01231932|Gene Expression Patterns|gene expression patterns
5976245|NCT01231932|Cancer|cancer
5976246|NCT01224691|TGF Beta|tgf beta
5976247|NCT01224691|Asthma|asthma
5976248|NCT01224691|Healthy Volunteer|healthy volunteer
5976249|NCT01224691|Respiratory Syncytial Virus|respiratory syncytial virus
5976250|NCT01224691|RSV|rsv
5976251|NCT01218854|Biopsy|biopsy
5976252|NCT01218854|Surgical Navigation|surgical navigation
5976253|NCT01218854|Image-guided Therapy|image-guided therapy
5976254|NCT01218854|CT- Guided Biopsy|ct- guided biopsy
5976255|NCT01218854|Cancer|cancer
5976256|NCT01212029|fNIRS|fnirs
5976257|NCT01212029|Healthy Volunteer|healthy volunteer
5976258|NCT01212029|HV|hv
5976259|NCT01212003|TB|tb
5976260|NCT01212003|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5976261|NCT01212003|Active Tuberculosis|active tuberculosis
5976262|NCT01212003|Latent Tuberculosis|latent tuberculosis
5976263|NCT01212003|MDR TB|mdr tb
5976264|NCT01212003|Tuberculosis|tuberculosis
5976265|NCT01204684|dendritic cells|dendritic cells
5976266|NCT01204684|glioma|glioma
5976267|NCT01204684|vaccine|vaccine
5976268|NCT01204684|glioma of WHO Grade III or IV|glioma of who grade iii or iv
5976269|NCT01202409|Ampulla of Vater|ampulla of vater
5976270|NCT01202409|Adenocarcinoma of the small bowel|adenocarcinoma of the small bowel
5976271|NCT01202409|Metastatic|metastatic
5976272|NCT01202409|Kirsten rat sarcoma|kirsten rat sarcoma
5976273|NCT01202409|KRAS|kras
5976274|NCT01202409|Capecitabine|capecitabine
5976275|NCT01202409|Xeloda|xeloda
5976276|NCT01202409|Oxaliplatin|oxaliplatin
5976277|NCT01202409|Eloxatin|eloxatin
5976278|NCT01202409|CAPOX|capox
5976279|NCT01202409|Panitumumab|panitumumab
5976280|NCT01202409|Vectibix|vectibix
5976281|NCT01200940|GLP-1|glp-1
5976282|NCT01200940|Glucose Tolerance|glucose tolerance
5976283|NCT01200940|Gut Hormones|gut hormones
5976284|NCT01191853|Post Swine Flu Blood Samples|post swine flu blood samples
5976285|NCT01191853|Biologic Sample Collection|biologic sample collection
5976286|NCT01191853|Laboratory Research Samples|laboratory research samples
5976287|NCT01191853|Healthy Volunteer|healthy volunteer
5976288|NCT01191853|HV|hv
5976289|NCT01182311|Hepatitis B Virus|hepatitis b virus
5976290|NCT01182311|Hepatitis B Vaccine|hepatitis b vaccine
5976291|NCT01182311|Immunity|immunity
5976292|NCT01182311|B-Cell Response|b-cell response
5976293|NCT01182311|T-Cell Response|t-cell response
5976294|NCT01182311|Hepatitis B Immunity|hepatitis b immunity
5976295|NCT01182311|Hepatitis B Virus Vaccine|hepatitis b virus vaccine
5976296|NCT01178918|Influenza H1N1|influenza h1n1
5976297|NCT01178918|Vaccine|vaccine
5976298|NCT01178918|Adjuvant|adjuvant
5976299|NCT01178918|T Lymphocytes|t lymphocytes
5976300|NCT01178918|Non-specific response|non-specific response
5976301|NCT01178918|Interleukin-2|interleukin-2
5976302|NCT01178918|Non-specific T cell response|non-specific t cell response
5976303|NCT01175993|Motor Training|motor training
5976304|NCT01175993|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5976305|NCT01175993|Balance|balance
5976306|NCT01174108|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5976307|NCT01174108|Severe Aplastic Anemia|severe aplastic anemia
5976308|NCT01174108|Pure Red Cell Aplasia|pure red cell aplasia
5976309|NCT01174108|Paroxysmal Nocturnal Hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5976310|NCT01174108|Miltenyi CD34 Reagent System|miltenyi cd34 reagent system
5976311|NCT01160549|Pregnancy|pregnancy
5976312|NCT01160549|Hormones|hormones
5976313|NCT01160549|Mongolia|mongolia
5976314|NCT01160549|Asian|asian
5976315|NCT01160549|Breast Cancer|breast cancer
5976316|NCT01160510|Breast|breast
5976317|NCT01160510|Mammographic Density|mammographic density
5976318|NCT01150721|COMPUTERIZED TOMOGRAPHY|computerized tomography
5976319|NCT01150721|COLONY FORMING UNITS|colony forming units
5976320|NCT01150721|Cystic Fibrosis|cystic fibrosis
5976321|NCT01150721|Analysis of Variance|analysis of variance
5976322|NCT01150721|Forced Expiratory Volume|forced expiratory volume
5976323|NCT01150708|Syringomyelia|syringomyelia
5976324|NCT01150708|Magnetic Resonance Imaging|magnetic resonance imaging
5976325|NCT01150708|Natural History Study|natural history study
5976326|NCT01150708|Neurological Examination|neurological examination
5976327|NCT01148381|Genotype|genotype
5976328|NCT01148381|Phenotype|phenotype
5976329|NCT01148381|Characterization|characterization
5976330|NCT01148381|fMRI|fmri
5976331|NCT01145196|Retinal Disease|retinal disease
5976332|NCT01145196|Plaquenil-Induced|plaquenil-induced
5976333|NCT01143571|Microbiome|microbiome
5976334|NCT01143571|Samples|samples
5976335|NCT01143532|African-Americans|african-americans
5976336|NCT01143532|MYH9|myh9
5976337|NCT01143532|Chronic Allograft Nephropathy|chronic allograft nephropathy
5976338|NCT01143532|Chronic Kidney Disease|chronic kidney disease
5976339|NCT01143532|Proteinuria|proteinuria
5976340|NCT01143532|Kidney Disease|kidney disease
5976341|NCT01143532|Kidney Transplant|kidney transplant
5976342|NCT01143532|African-American|african-american
5976343|NCT01140516|Antenatal|antenatal
5976344|NCT01132937|Diffusion/Perfusion-MRI|diffusion/perfusion-mri
5976345|NCT01132937|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5976346|NCT01132937|Stroke|stroke
5976347|NCT01132937|Brain Imaging|brain imaging
5976348|NCT01132937|Brain Injuries|brain injuries
5976349|NCT01132937|Traumatic Brain Injury|traumatic brain injury
5976350|NCT01132937|TBI|tbi
5976351|NCT01132924|Early Pregnancy|early pregnancy
5976352|NCT01132924|Gestational Age|gestational age
5976353|NCT01132924|Fecundability|fecundability
5976354|NCT01132924|Ovulation|ovulation
5976355|NCT01132924|Recall|recall
5976356|NCT01132859|Specimen Collection|specimen collection
5976357|NCT01132859|Mucosal Immunity|mucosal immunity
5976358|NCT01132859|Immune Responses|immune responses
5976359|NCT01132859|Immunity|immunity
5976360|NCT01132859|Vaccines|vaccines
5976361|NCT01132859|Healthy Volunteer|healthy volunteer
5976362|NCT01132859|HV|hv
5976363|NCT01130519|Immunotherapy|immunotherapy
5976364|NCT01130519|Biomarker|biomarker
5976365|NCT01130519|Kidney Cancer|kidney cancer
5976366|NCT01130519|Renal Cell Cancer|renal cell cancer
5976367|NCT01130519|Hereditary Leiomyomatosis and Renal Cell Cancer|hereditary leiomyomatosis and renal cell cancer
5976368|NCT01130519|HLRCC|hlrcc
5976369|NCT01125228|HIV|hiv
5976370|NCT01123499|G-CSF|g-csf
5976371|NCT01123499|Plerixafor|plerixafor
5976372|NCT01123499|Mozobil|mozobil
5976373|NCT01123499|Apheresis|apheresis
5976374|NCT01123499|Healthy Volunteer|healthy volunteer
5976375|NCT01123499|HV|hv
5976376|NCT01118026|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5976377|NCT01118026|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5976378|NCT01118026|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5976379|NCT01118026|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5976380|NCT01118026|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5976381|NCT01118026|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5976382|NCT01118026|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5976383|NCT01118026|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5976384|NCT01114971|Labetalol|labetalol
5976385|NCT01114971|Esmolol|esmolol
5976386|NCT01114971|Fentanyl|fentanyl
5976387|NCT01114971|Anesthetic adjuvant|anesthetic adjuvant
5976388|NCT01114971|Ambulatory surgery|ambulatory surgery
5976389|NCT01114971|Outpatient surgery|outpatient surgery
5976390|NCT01114971|Pain management|pain management
5976391|NCT01114971|Hemodynamic stability|hemodynamic stability
5976392|NCT01114971|Perioperative outcomes|perioperative outcomes
5976393|NCT01098955|Cancer|cancer
5976394|NCT01098955|Smoking Cessation Treatment|smoking cessation treatment
5976395|NCT01098955|Acceptance and Commitment Therapy|acceptance and commitment therapy
5976396|NCT01098955|ACT Theory|act theory
5976397|NCT01098955|Motivational and Behavioral Counseling|motivational and behavioral counseling
5976398|NCT01098955|MBC|mbc
5976399|NCT01098955|abstinence|abstinence
5976400|NCT01098955|Varenicline|varenicline
5976401|NCT01098955|Chantix|chantix
5976402|NCT01098006|Immunological assays|immunological assays
5976403|NCT01098006|Chronic hepatitis B|chronic hepatitis b
5976404|NCT01096550|opioid dependence|opioid dependence
5976405|NCT01096550|outpatient treatment|outpatient treatment
5976406|NCT01096550|intensive outpatient treatment|intensive outpatient treatment
5976407|NCT01094782|Pain|pain
5976408|NCT01094782|Pain management|pain management
5976409|NCT01087346|Risk Perception|risk perception
5976410|NCT01087346|Obesity Risk|obesity risk
5976411|NCT01087346|Healthy Volunteer|healthy volunteer
5976412|NCT01087346|HV|hv
5976413|NCT01086670|Coordination|coordination
5976414|NCT01086670|Neuroimaging|neuroimaging
5976415|NCT01086670|Motion Analysis|motion analysis
5976416|NCT01086670|Locomotor|locomotor
5976417|NCT01086670|Cerebral Palsy|cerebral palsy
5976418|NCT01086670|Pediatrics|pediatrics
5976419|NCT01083082|lifestyles|lifestyles
5976420|NCT01083082|diet|diet
5976421|NCT01083082|exercise|exercise
5976422|NCT01083082|central blood pressure|central blood pressure
5976423|NCT01083082|arterial stiffness|arterial stiffness
5976424|NCT01083082|endothelial dysfunction|endothelial dysfunction
5976425|NCT01083082|Healthy people|healthy people
5976426|NCT01080404|Obstructive sleep apnea|obstructive sleep apnea
5976427|NCT01080404|Obesity|obesity
5976428|NCT01080404|Metabolism|metabolism
5976429|NCT01080404|Bariatric surgery|bariatric surgery
5976430|NCT01080404|CPAP|cpap
5976431|NCT01076387|Bladder|bladder
5976432|NCT01076387|Cystectomy|cystectomy
5976433|NCT01076387|Robotic|robotic
5976434|NCT01076387|Open Radical|open radical
5976435|NCT01076387|10-016|10-016
5976436|NCT01065454|Pulmonary Hypertension|pulmonary hypertension
5976437|NCT01065454|Left ventricular dysfunction|left ventricular dysfunction
5976438|NCT01063517|Poly(ADP ribose)|poly(adp ribose)
5976439|NCT01063517|polymerase (PARP)|polymerase (parp)
5976440|NCT01063517|Gastric cancer|gastric cancer
5976441|NCT01063517|olaparib|olaparib
5976442|NCT01063517|PARP inhibitor|parp inhibitor
5976443|NCT01063517|ATM AZD2281|atm azd2281
5976444|NCT01063517|Ku0059436|ku0059436
5976445|NCT01063517|Homologous Recombination deficiency (HRD)|homologous recombination deficiency (hrd)
5976446|NCT01063517|Recurrent gastric cancer|recurrent gastric cancer
5976447|NCT01063517|metastatic gastric cancer|metastatic gastric cancer
5976448|NCT01061684|fatty liver disease|fatty liver disease
5976450|NCT01061684|NAFLD|nafld
5976451|NCT01061684|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5976452|NCT01059786|Monoclonal Antibody|monoclonal antibody
5976453|NCT01059786|Purine Analog|purine analog
5976454|NCT01059786|Soluble CD25|soluble cd25
5976455|NCT01059786|Minimal Residual Disease MRD|minimal residual disease mrd
5976456|NCT01059786|CD20|cd20
5976457|NCT01039285|Very premature infant|very premature infant
5976458|NCT01039285|Surfactant|surfactant
5976459|NCT01039285|Respiratory Distress|respiratory distress
5976460|NCT01039285|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5976461|NCT01031641|Patient-Reported Outcomes|patient-reported outcomes
5976462|NCT01031641|Symptoms|symptoms
5976463|NCT01031641|Instrument Development|instrument development
5976464|NCT01031641|Adverse Events|adverse events
5976465|NCT01031641|Questionnaire|questionnaire
5976466|NCT01031641|Patient Reported Outcomes|patient reported outcomes
5976467|NCT01031160|Health Indicators|health indicators
5976468|NCT01031160|Health Behaviors|health behaviors
5976469|NCT01031160|Health Study|health study
5976470|NCT01031160|Substance Abuse|substance abuse
5976471|NCT01031160|Adolescence|adolescence
5976472|NCT01031160|Obesity|obesity
5976473|NCT01030484|NAFLD|nafld
5976474|NCT01030484|NASH|nash
5976475|NCT01030484|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5976476|NCT01030484|fatty liver disease|fatty liver disease
5976477|NCT01021033|Ischemia|ischemia
5976478|NCT01021033|Hemorrhage|hemorrhage
5976479|NCT01021033|Rehabilitation|rehabilitation
5976480|NCT01011712|Genetics|genetics
5976481|NCT01011712|Virus|virus
5976482|NCT01011712|Defense|defense
5976483|NCT01011712|Immunity|immunity
5976484|NCT01011712|Immunodeficiency|immunodeficiency
5976485|NCT01011712|Respiratory Viruses|respiratory viruses
5976486|NCT01011712|Herpesvirus|herpesvirus
5976487|NCT01011712|Cytomegalovirus|cytomegalovirus
5976488|NCT01011712|Human Papillomavirus|human papillomavirus
5976489|NCT01011712|Adenovirus|adenovirus
5976490|NCT01011413|HIV|hiv
5976491|NCT01011413|Antiretroviral Therapy (ART)|antiretroviral therapy (art)
5976492|NCT01011413|Efavirenz (EFV)|efavirenz (efv)
5976493|NCT01011413|Dose reduction|dose reduction
5976494|NCT01009996|Coronary bifurcation lesions|coronary bifurcation lesions
5976495|NCT01008501|hydatidiform moles|hydatidiform moles
5976496|NCT01008501|complete hydatidiform moles|complete hydatidiform moles
5976497|NCT01008501|partial hydatidiform moles|partial hydatidiform moles
5976498|NCT01008501|Molar pregnancy|molar pregnancy
5976499|NCT01008501|NLRP7|nlrp7
5976500|NCT01008501|pregnancy wastage|pregnancy wastage
5976501|NCT01008501|imprinting|imprinting
5976502|NCT01008501|sporadic hydatidiform moles|sporadic hydatidiform moles
5976503|NCT01008501|recurrent hydatidiform moles|recurrent hydatidiform moles
5976504|NCT00981474|cardiac surgery; brain injury; cerebral autoregulation|cardiac surgery; brain injury; cerebral autoregulation
5976505|NCT00979810|PET scan|pet scan
5976506|NCT00979810|CT scan|ct scan
5976507|NCT00979810|09-060|09-060
5976508|NCT00979810|CNS|cns
5976509|NCT00978406|Dietary Assessment Methods|dietary assessment methods
5976510|NCT00978406|Measurement of Diet|measurement of diet
5976511|NCT00978406|24-Hour Diet Recall|24-hour diet recall
5976512|NCT00978406|Validation|validation
5976513|NCT00978406|Feeding Study|feeding study
5976514|NCT00977977|Kidney Disease|kidney disease
5976515|NCT00977977|Nephrotic Syndrome|nephrotic syndrome
5976516|NCT00977977|Autoimmune Diseases|autoimmune diseases
5976517|NCT00977977|Clinical Trial|clinical trial
5976518|NCT00977977|Proteinuria|proteinuria
5976519|NCT00969332|liver|liver
5976520|NCT00969332|parenteral nutrition|parenteral nutrition
5976521|NCT00969332|fish oil|fish oil
5976522|NCT00969332|omegaven|omegaven
5976523|NCT00969332|children|children
5976524|NCT00968214|stage IA breast cancer|stage ia breast cancer
5976525|NCT00968214|stage IB breast cancer|stage ib breast cancer
5976526|NCT00968214|stage II breast cancer|stage ii breast cancer
5976527|NCT00968214|stage IIIA breast cancer|stage iiia breast cancer
5976528|NCT00968214|stage IIIB breast cancer|stage iiib breast cancer
5976529|NCT00968214|stage IIIC breast cancer|stage iiic breast cancer
5976530|NCT00968214|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5976531|NCT00968214|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5976532|NCT00967941|Vascular Surgery|vascular surgery
5976533|NCT00952588|Acute Myeloid Leukaemia,|acute myeloid leukaemia,
5976534|NCT00952588|AML|aml
5976535|NCT00949819|Prostate Cancer|prostate cancer
5976536|NCT00949819|Low risk|low risk
5976537|NCT00949819|Gleason 6|gleason 6
5976538|NCT00949819|Active surveillance|active surveillance
5976539|NCT00948064|Leukemia|leukemia
5976540|NCT00948064|Acute Myelogenous Leukemia|acute myelogenous leukemia
5976541|NCT00948064|AML|aml
5976542|NCT00948064|Myelodysplastic Syndrome|myelodysplastic syndrome
5976543|NCT00948064|MDS|mds
5976544|NCT00948064|Vorinostat|vorinostat
5976545|NCT00948064|SAHA|saha
5976546|NCT00948064|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5976547|NCT00948064|MSK-390|msk-390
5976548|NCT00948064|Zolinza|zolinza
5976549|NCT00948064|Azacitidine|azacitidine
5976550|NCT00948064|5-Azacitidine|5-azacitidine
5976551|NCT00948064|5-Aza|5-aza
5976552|NCT00948064|Vidaza|vidaza
5976553|NCT00948064|5-AZC|5-azc
5976554|NCT00948064|AZA-CR|aza-cr
5976555|NCT00948064|Ladakamycin|ladakamycin
5976556|NCT00948064|NSC-102816|nsc-102816
5976557|NCT00943514|Variant Cystic Fibrosis|variant cystic fibrosis
5976558|NCT00943514|Bronchopulmonary Mycosis|bronchopulmonary mycosis
5976559|NCT00943514|Airway Infection Susceptibility|airway infection susceptibility
5976560|NCT00943514|Chronic Respiratory Infection|chronic respiratory infection
5976561|NCT00943514|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5976562|NCT00943514|Bronchiectasis|bronchiectasis
5976563|NCT00936325|SCLS|scls
5976564|NCT00936325|Systemic Capillary Leak Syndrome|systemic capillary leak syndrome
5976565|NCT00929227|Inconclusive Noninvasive Cardiac Stress Test|inconclusive noninvasive cardiac stress test
5976566|NCT00929227|Cardiac Computed Tomography|cardiac computed tomography
5976567|NCT00929227|Coronary Artery Disease|coronary artery disease
5976568|NCT00929227|Atherosclerosis|atherosclerosis
5976569|NCT00924196|Plexiform Neurofibroma|plexiform neurofibroma
5976570|NCT00924196|Optic Pathway Tumor|optic pathway tumor
5976571|NCT00924196|Neurofibroma|neurofibroma
5976572|NCT00924196|Malignant Peripheral Nerve Sheath Tumor|malignant peripheral nerve sheath tumor
5976573|NCT00924196|Volumetric MRI|volumetric mri
5976574|NCT00924196|Neurofibromatosis Type 1|neurofibromatosis type 1
5976575|NCT00924196|NF1|nf1
5976576|NCT00924196|Optic Glioma|optic glioma
5976577|NCT00924027|Radiation|radiation
5976578|NCT00924027|Cancer|cancer
5976579|NCT00924027|HDR|hdr
5976580|NCT00924027|Brachytherapy|brachytherapy
5976581|NCT00924027|Training|training
5976582|NCT00923442|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5976583|NCT00923442|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5976584|NCT00923442|Pediatric Blood Disorders|pediatric blood disorders
5976585|NCT00923442|Hodgkins and non-Hodgkins lymphoma|hodgkins and non-hodgkins lymphoma
5976586|NCT00923442|MDS|mds
5976587|NCT00923026|Gene Therapy|gene therapy
5976588|NCT00923026|Follow-Up|follow-up
5976589|NCT00923026|Delayed Toxicity|delayed toxicity
5976590|NCT00923026|Adenocarcinoma|adenocarcinoma
5976591|NCT00923026|Melanoma|melanoma
5976592|NCT00923026|Neuroendocrine Tumors|neuroendocrine tumors
5976593|NCT00923026|Carcinoma|carcinoma
5976594|NCT00914537|Anal Cancer|anal cancer
5976595|NCT00914537|AIN|ain
5976596|NCT00914537|HPV|hpv
5976597|NCT00914537|Cytology|cytology
5976598|NCT00914537|HIV|hiv
5976599|NCT00914537|HIV Positive|hiv positive
5976600|NCT00910819|Colorectal Cancer|colorectal cancer
5976601|NCT00910819|Advanced Colorectal Cancer|advanced colorectal cancer
5976602|NCT00910819|Epidemiology|epidemiology
5976603|NCT00910819|Health Services Research|health services research
5976604|NCT00910819|Germany|germany
5976605|NCT00910819|Registry|registry
5976606|NCT00910819|Palliative Care|palliative care
5976607|NCT00910819|Palliative Treatment|palliative treatment
5976608|NCT00910819|Adjuvant Drug Therapy|adjuvant drug therapy
5976609|NCT00910819|Nutrition Assessment|nutrition assessment
5976610|NCT00910819|Physical Activity|physical activity
5976611|NCT00910650|Adoptive transfer therapy|adoptive transfer therapy
5976612|NCT00910650|Dendritic cell vaccines|dendritic cell vaccines
5976613|NCT00909714|stroke|stroke
5976614|NCT00909714|non-invasive cortical stimulation|non-invasive cortical stimulation
5976615|NCT00909714|motor recovery|motor recovery
5976616|NCT00909714|cortical plasticity|cortical plasticity
5976617|NCT00909714|TDCS|tdcs
5976618|NCT00904579|Organ Transplants|organ transplants
5976619|NCT00904579|Immunosuppression|immunosuppression
5976620|NCT00904579|Cancer|cancer
5976621|NCT00904579|End Stage Renal Disease|end stage renal disease
5976622|NCT00904579|ESRD|esrd
5976623|NCT00904579|Cancer Risk|cancer risk
5976624|NCT00900198|Tissue Collection|tissue collection
5976625|NCT00900198|Biospecimen|biospecimen
5976626|NCT00900198|Assay Development|assay development
5976627|NCT00900198|Tissue Acquisition|tissue acquisition
5976628|NCT00900198|Tissue Biopsies|tissue biopsies
5976629|NCT00898638|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5976630|NCT00898638|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5976631|NCT00898638|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5976632|NCT00898638|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5277537|NCT02289391|Dexmedetomidine|dexmedetomidine
5976633|NCT00898638|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5976634|NCT00898638|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5976635|NCT00898638|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5976636|NCT00898638|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5976637|NCT00898638|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5976638|NCT00898638|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5976639|NCT00898638|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5976640|NCT00898638|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5976641|NCT00898638|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5976642|NCT00898638|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5976643|NCT00898638|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5976644|NCT00898638|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5976645|NCT00898638|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5976646|NCT00898638|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5976647|NCT00898638|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5976648|NCT00898638|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5976649|NCT00898638|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5976650|NCT00898638|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5976651|NCT00898638|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5976652|NCT00898638|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5976653|NCT00898638|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5976654|NCT00898638|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5976655|NCT00898638|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5976656|NCT00898638|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5976657|NCT00898638|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5976658|NCT00898638|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5976659|NCT00898638|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5976660|NCT00898638|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5976661|NCT00898638|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5976662|NCT00898638|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5976663|NCT00898638|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5976664|NCT00898638|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5976665|NCT00898638|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5976666|NCT00898638|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5976667|NCT00898638|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5976668|NCT00898638|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5976669|NCT00898638|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5976671|NCT00898638|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5976672|NCT00898638|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5976673|NCT00898638|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5976674|NCT00898638|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5976675|NCT00898638|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5976676|NCT00898638|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5976677|NCT00898638|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5976678|NCT00898638|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5976679|NCT00898638|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5976680|NCT00898638|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5976681|NCT00898638|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5976682|NCT00898638|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5976683|NCT00898638|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5976684|NCT00898638|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5976685|NCT00898638|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5976686|NCT00898638|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5277646|NCT02288871|hemodynamics|hemodynamics
5976687|NCT00898638|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5976688|NCT00898638|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5976689|NCT00898638|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5976690|NCT00898638|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5976691|NCT00898638|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5976692|NCT00898638|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5976693|NCT00898638|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5976694|NCT00898638|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5976695|NCT00898638|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5976696|NCT00898638|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5976697|NCT00898638|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5976698|NCT00898638|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5976699|NCT00898638|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5976700|NCT00898638|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5976701|NCT00898638|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5976702|NCT00898638|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5976703|NCT00898638|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5976704|NCT00898638|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5976705|NCT00898638|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5976706|NCT00898638|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5976707|NCT00898638|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5976708|NCT00898638|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5976709|NCT00898638|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5976710|NCT00898638|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5976711|NCT00898638|stage I salivary gland cancer|stage i salivary gland cancer
5976712|NCT00898638|stage II salivary gland cancer|stage ii salivary gland cancer
5976713|NCT00898638|stage III salivary gland cancer|stage iii salivary gland cancer
5976714|NCT00898638|stage IV salivary gland cancer|stage iv salivary gland cancer
5976715|NCT00898638|recurrent salivary gland cancer|recurrent salivary gland cancer
5976716|NCT00898638|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5976717|NCT00896610|Diabetes Type II|diabetes type ii
5976718|NCT00896610|Diabetes Type 1|diabetes type 1
5976719|NCT00896610|Autoimmunity|autoimmunity
5976720|NCT00896610|Type 1 Diabetes|type 1 diabetes
5976721|NCT00896610|Type 2 Diabetes|type 2 diabetes
5976722|NCT00896610|Autoimmune Diabetes|autoimmune diabetes
5976723|NCT00896610|At Risk Diabetes|at risk diabetes
5976724|NCT00895271|FIBROBLAST|fibroblast
5976725|NCT00895271|Skin Biopsy|skin biopsy
5976726|NCT00895271|Primary Immunodeficiency|primary immunodeficiency
5976727|NCT00895271|Immunodysregulation|immunodysregulation
5976728|NCT00895271|Common Variable Immunodeficiency|common variable immunodeficiency
5976729|NCT00895271|Severe Combined Immunodeficiency|severe combined immunodeficiency
5976730|NCT00895271|Healthy Volunteer|healthy volunteer
5976731|NCT00895271|HV|hv
5976732|NCT00875342|Traumatic Event|traumatic event
5976733|NCT00875342|Trauma Survivor|trauma survivor
5976734|NCT00875342|Exposure Therapy|exposure therapy
5976735|NCT00875342|PTSD DCS|ptsd dcs
5976736|NCT00875342|Telemedicine|telemedicine
5976737|NCT00875342|Telepsychiatry|telepsychiatry
5976738|NCT00875342|Telemental health|telemental health
5976739|NCT00874614|radiotherapy|radiotherapy
5976740|NCT00874614|MIBG|mibg
5976741|NCT00874614|Azedra|azedra
5976742|NCT00874614|neuroendocrine tumors|neuroendocrine tumors
5976743|NCT00874614|Iobenguane I 131|iobenguane i 131
5976744|NCT00874614|progenics|progenics
5976745|NCT00868166|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5976746|NCT00868166|TRO19622|tro19622
5976747|NCT00868166|Trophos|trophos
5976748|NCT00867464|Vaccine Efficacy|vaccine efficacy
5976749|NCT00867464|Long-Term Protection|long-term protection
5976750|NCT00867464|Immune Response|immune response
5976751|NCT00867464|Human Papillomavirus|human papillomavirus
5976752|NCT00867464|HPV|hpv
5976753|NCT00867464|Vaccine|vaccine
5976754|NCT00867269|Opportunistic Infection|opportunistic infection
5976755|NCT00867269|Immunodeficiency Syndrome|immunodeficiency syndrome
5976756|NCT00867269|Autoimmune Disease|autoimmune disease
5976757|NCT00867269|CD4+ Lymphocytes|cd4+ lymphocytes
5976758|NCT00867269|Idiopathic CD4 Lymphocytopenia|idiopathic cd4 lymphocytopenia
5976759|NCT00862433|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
5976760|NCT00862433|Vitamin C|vitamin c
5976761|NCT00862433|Antioxidant|antioxidant
5976762|NCT00862433|Lipid Peroxidation|lipid peroxidation
5976763|NCT00862433|Non-Insulin Requiring Diabetics|non-insulin requiring diabetics
5976764|NCT00862433|Alpha-Tocopherol|alpha-tocopherol
5976765|NCT00862433|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5976766|NCT00862433|Health Volunteer|health volunteer
5976768|NCT00862433|Normal Weight|normal weight
5976769|NCT00862433|Overweight|overweight
5976770|NCT00862433|Type 2 Diabetes|type 2 diabetes
5976771|NCT00862407|Cardiopulmonary bypass|cardiopulmonary bypass
5976772|NCT00862407|Non-pulsatile perfusion|non-pulsatile perfusion
5976773|NCT00862407|Pulsatile perfusion|pulsatile perfusion
5976774|NCT00862407|plasma proteins|plasma proteins
5976775|NCT00860886|Mongolia|mongolia
5976776|NCT00860886|Asia|asia
5976777|NCT00860886|GROWTH FACTORS|growth factors
5976778|NCT00860886|Hormones|hormones
5976779|NCT00860886|Premenopausal|premenopausal
5976780|NCT00860886|Breast Cancer|breast cancer
5976781|NCT00859781|Prostate|prostate
5976782|NCT00858078|Qualitative Research|qualitative research
5976783|NCT00858078|Semi-Structured Telephone Interview|semi-structured telephone interview
5976784|NCT00858078|BRCA 1/2|brca 1/2
5976785|NCT00858078|Psychosocial/Behavioral Research|psychosocial/behavioral research
5976786|NCT00858078|Hereditary Cancer Risk|hereditary cancer risk
5976787|NCT00858078|BRCA|brca
5976788|NCT00858078|BRCA1 Gene|brca1 gene
5976789|NCT00858078|BRCA2 Gene|brca2 gene
5976790|NCT00854555|incomplete spinal cord injury|incomplete spinal cord injury
5976791|NCT00854555|locomotor activity|locomotor activity
5976792|NCT00854555|walking function|walking function
5976793|NCT00854555|gait|gait
5976794|NCT00852943|Autoimmune Disease|autoimmune disease
5976795|NCT00852943|GENETIC DISEASE|genetic disease
5976796|NCT00852943|Inherited Allergic Disease|inherited allergic disease
5976797|NCT00852943|Allergy|allergy
5976798|NCT00852943|Immunodeficiency Disease|immunodeficiency disease
5976799|NCT00852904|Childhood Growth and Development|childhood growth and development
5976800|NCT00852904|Genetics|genetics
5976801|NCT00852904|Children|children
5976802|NCT00852904|Environment|environment
5976803|NCT00852904|Longitudinal Study|longitudinal study
5976804|NCT00852904|National Children's Study|national children's study
5976805|NCT00852111|Fatigue|fatigue
5976806|NCT00852111|Radiotherapy|radiotherapy
5976807|NCT00852111|Cancer Therapy|cancer therapy
5976808|NCT00852111|Cancer|cancer
5976809|NCT00848627|Bladder cancer|bladder cancer
5976810|NCT00848627|Smokers|smokers
5976811|NCT00848627|Hematuria|hematuria
5976812|NCT00846742|Hodgkin Lymphoma|hodgkin lymphoma
5976813|NCT00844285|Certolizumab Pegol, Cimzia ®|certolizumab pegol, cimzia ®
5976814|NCT00844285|Crohn's Disease|crohn's disease
5976815|NCT00843726|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5976816|NCT00843726|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5976817|NCT00838435|Phenylketonuria|phenylketonuria
5976818|NCT00838435|PKU|pku
5976819|NCT00838435|Kuvan|kuvan
5976820|NCT00838435|Phenoptin|phenoptin
5976821|NCT00838435|Biopten|biopten
5976822|NCT00838435|Neurocognitive Function|neurocognitive function
5976823|NCT00838435|Phenylalanine|phenylalanine
5976824|NCT00837642|Vascular function in offspring of ART|vascular function in offspring of art
5976825|NCT00837122|African|african
5976826|NCT00836407|pancreatic cancer|pancreatic cancer
5976827|NCT00836407|vaccine|vaccine
5976828|NCT00836407|immunotherapy|immunotherapy
5976829|NCT00836407|antibody|antibody
5976830|NCT00836407|CTLA-4|ctla-4
5976831|NCT00831142|Prostate Cancer|prostate cancer
5976832|NCT00831142|MRI|mri
5976833|NCT00831142|Prostatectomy|prostatectomy
5976834|NCT00826059|acute ischemic stroke|acute ischemic stroke
5976835|NCT00826059|randomized clinical trial|randomized clinical trial
5976836|NCT00826059|effectiveness|effectiveness
5976837|NCT00826059|safety|safety
5976838|NCT00821470|osteonecrosis|osteonecrosis
5976839|NCT00821470|bone marrow|bone marrow
5976840|NCT00821470|core decompression|core decompression
5976841|NCT00821470|femoral head|femoral head
5976842|NCT00814827|Interferon-Gamma|interferon-gamma
5976843|NCT00814827|Autoantibodies|autoantibodies
5277848|NCT02287649|ITP|itp
5976844|NCT00814827|Disseminated Infection|disseminated infection
5976845|NCT00814827|Pulmonary Infection|pulmonary infection
5976846|NCT00814827|Blood Donor|blood donor
5976847|NCT00804154|Vanilloid|vanilloid
5976848|NCT00804154|Capsaicin|capsaicin
5976849|NCT00804154|Cancer Pain|cancer pain
5976850|NCT00804154|Nerve Block|nerve block
5976851|NCT00798265|HPV Vaccination|hpv vaccination
5976852|NCT00798265|HPV Immunogenicity|hpv immunogenicity
5976853|NCT00798265|HIV Infection|hiv infection
5976854|NCT00798265|HIV Negative|hiv negative
5976855|NCT00798265|Adolescents and Young Adults|adolescents and young adults
5976856|NCT00798265|Healthy Volunteer|healthy volunteer
5976857|NCT00798265|HV|hv
5976858|NCT00798265|Adolescent|adolescent
5976859|NCT00798226|Asthma|asthma
5976860|NCT00798226|Eczema|eczema
5976861|NCT00798226|Sensitization|sensitization
5976862|NCT00798226|Allergy|allergy
5976863|NCT00794352|Inflammation|inflammation
5976864|NCT00794352|Multiple Sclerosis|multiple sclerosis
5976865|NCT00794352|Neuroimmunology|neuroimmunology
5976866|NCT00794352|Immune Disorder|immune disorder
5976867|NCT00794352|Neuroimaging|neuroimaging
5976868|NCT00794352|Central Nervous System Disease|central nervous system disease
5976869|NCT00794352|Healthy Volunteers|healthy volunteers
5976870|NCT00794352|HV|hv
5976871|NCT00791505|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5976872|NCT00791505|pulmonary infection|pulmonary infection
5976873|NCT00791505|antibiotic|antibiotic
5976874|NCT00788684|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5976875|NCT00788684|Rituximab|rituximab
5976876|NCT00788684|Chronic Lymphoid Leukemia|chronic lymphoid leukemia
5976877|NCT00788684|Hematological Malignancies|hematological malignancies
5976878|NCT00788684|ABT-263|abt-263
5976879|NCT00788684|Navitoclax|navitoclax
5976880|NCT00788684|CD20-Positive Lymphoid Malignancies|cd20-positive lymphoid malignancies
5976881|NCT00788125|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5976882|NCT00788125|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5976883|NCT00788125|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5976884|NCT00788125|metastatic osteosarcoma|metastatic osteosarcoma
5976885|NCT00788125|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5976886|NCT00788125|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5976887|NCT00788125|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5976889|NCT00788125|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5976890|NCT00788125|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5976891|NCT00788125|recurrent neuroblastoma|recurrent neuroblastoma
5976892|NCT00788125|stage 4S neuroblastoma|stage 4s neuroblastoma
5976893|NCT00788125|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5976894|NCT00788125|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5976895|NCT00788125|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5976896|NCT00788125|childhood teratoma|childhood teratoma
5976897|NCT00788125|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5976898|NCT00788125|childhood renal cell carcinoma|childhood renal cell carcinoma
5976899|NCT00788125|recurrent renal cell cancer|recurrent renal cell cancer
5976900|NCT00788125|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5976901|NCT00788125|cystic nephroma|cystic nephroma
5976902|NCT00788125|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5976903|NCT00788125|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5976904|NCT00788125|disseminated neuroblastoma|disseminated neuroblastoma
5976905|NCT00788125|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5976906|NCT00788125|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5976907|NCT00788125|recurrent childhood liver cancer|recurrent childhood liver cancer
5976908|NCT00788125|stage IV childhood liver cancer|stage iv childhood liver cancer
5976909|NCT00788125|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5976910|NCT00788125|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5976911|NCT00788125|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5976912|NCT00788125|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5976913|NCT00788125|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5976914|NCT00788125|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5976915|NCT00788125|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5976916|NCT00788125|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5976917|NCT00788125|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5976918|NCT00788125|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5976919|NCT00788125|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5976920|NCT00788125|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5976921|NCT00788125|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5976922|NCT00788125|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5976923|NCT00788125|Burkitt lymphoma|burkitt lymphoma
5976924|NCT00788125|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5976925|NCT00788125|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5976926|NCT00788125|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5976927|NCT00788125|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5976928|NCT00788125|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5976929|NCT00788125|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5976930|NCT00788125|childhood central nervous system germinoma|childhood central nervous system germinoma
5976931|NCT00788125|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5976932|NCT00788125|childhood central nervous system teratoma|childhood central nervous system teratoma
5976933|NCT00788125|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5976934|NCT00788125|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5976935|NCT00788125|childhood choroid plexus tumor|childhood choroid plexus tumor
5976936|NCT00788125|childhood craniopharyngioma|childhood craniopharyngioma
5976937|NCT00788125|childhood ependymoblastoma|childhood ependymoblastoma
5976938|NCT00788125|childhood medulloepithelioma|childhood medulloepithelioma
5976939|NCT00788125|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5976940|NCT00788125|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5976941|NCT00788125|childhood oligodendroglioma|childhood oligodendroglioma
5976942|NCT00788125|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5976943|NCT00788125|childhood grade I meningioma|childhood grade i meningioma
5976944|NCT00788125|childhood grade II meningioma|childhood grade ii meningioma
5976945|NCT00788125|childhood grade III meningioma|childhood grade iii meningioma
5976946|NCT00788125|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5976947|NCT00788125|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5976948|NCT00788125|recurrent childhood ependymoma|recurrent childhood ependymoma
5976949|NCT00788125|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5976950|NCT00788125|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5976951|NCT00788125|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5976952|NCT00788125|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5976953|NCT00788125|recurrent uterine sarcoma|recurrent uterine sarcoma
5976954|NCT00788125|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5976955|NCT00788125|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5976956|NCT00788125|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5976957|NCT00788125|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5976958|NCT00788125|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5976959|NCT00788125|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5976960|NCT00788125|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5976961|NCT00788125|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5976962|NCT00788125|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5976963|NCT00788125|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5976964|NCT00788125|recurrent childhood brain tumor|recurrent childhood brain tumor
5976965|NCT00788125|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
5976966|NCT00787722|High dose immunosuppressive therapy|high dose immunosuppressive therapy
5976967|NCT00787722|Hematopoietic stem cell support|hematopoietic stem cell support
5976968|NCT00787423|Field Tools|field tools
5976969|NCT00787423|Stress|stress
5976970|NCT00787423|Psychological Stress|psychological stress
5976971|NCT00787423|Ecological Monetary Assessment (EMA)|ecological monetary assessment (ema)
5976972|NCT00787423|Global Positioning Units|global positioning units
5976973|NCT00783653|AML|aml
5976974|NCT00783653|FLT3|flt3
5976975|NCT00783653|acute myeloid leukemia|acute myeloid leukemia
5976976|NCT00783653|FLT 3 inhibitor|flt 3 inhibitor
5976977|NCT00783653|FLT3 mutated AML|flt3 mutated aml
5976978|NCT00776178|Survival Study|survival study
5976979|NCT00776178|Bladder Cancer|bladder cancer
5976980|NCT00776178|Cancer Recurrence|cancer recurrence
5976981|NCT00776178|Tumor Markers/Heterogeneity|tumor markers/heterogeneity
5976982|NCT00775853|Biomarkers|biomarkers
5976983|NCT00775853|Catecholamines|catecholamines
5976984|NCT00775853|18F-Fluoro-L-dopa|18f-fluoro-l-dopa
5976985|NCT00775853|Fluorodopamine|fluorodopamine
5976986|NCT00775853|Parkinson's Disease|parkinson's disease
5976987|NCT00775853|Parkinson Disease|parkinson disease
5976989|NCT00774254|Virtual Reality Technology|virtual reality technology
5976990|NCT00774254|Communication|communication
5976991|NCT00774254|Doctor-Patient Communication|doctor-patient communication
5976992|NCT00758719|Spinal Fusion|spinal fusion
5976993|NCT00758719|Degenerative Disc Disease|degenerative disc disease
5976994|NCT00753948|Tetraplegia|tetraplegia
5976995|NCT00753948|Mild asthma|mild asthma
5976996|NCT00753948|Exhaled Nitric Oxide|exhaled nitric oxide
5976997|NCT00753948|NOS inhibitor|nos inhibitor
5976998|NCT00753948|Spinal cord injury|spinal cord injury
5976999|NCT00753948|Pulmonary Function|pulmonary function
5977000|NCT00749320|MRI|mri
5977001|NCT00749320|Sunitinib|sunitinib
5977002|NCT00749320|Pazopanib|pazopanib
5977003|NCT00739362|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5977004|NCT00739362|Obesity|obesity
5977005|NCT00739362|Appetite Control|appetite control
5977006|NCT00739362|Weight Loss|weight loss
5977007|NCT00739362|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5977008|NCT00734955|Partial Mastectomy|partial mastectomy
5977009|NCT00734955|Lumpectomy|lumpectomy
5977010|NCT00734955|Mastectomy|mastectomy
5977011|NCT00727441|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5977012|NCT00727441|stage I pancreatic cancer|stage i pancreatic cancer
5977013|NCT00727441|stage II pancreatic cancer|stage ii pancreatic cancer
5977014|NCT00726284|Herniated nucleus pulposus (HNP)|herniated nucleus pulposus (hnp)
5977015|NCT00726128|Degenerative Disc disease (DDD)|degenerative disc disease (ddd)
5977016|NCT00719719|Antigen Specific|antigen specific
5977017|NCT00719719|Mast Cell|mast cell
5977018|NCT00719719|Tryptase|tryptase
5977019|NCT00719719|Bone Marrow|bone marrow
5977020|NCT00719719|Hives|hives
5977021|NCT00719719|Adult|adult
5977022|NCT00719719|Anaphylaxis|anaphylaxis
5977023|NCT00713492|Alcohol|alcohol
5977024|NCT00713492|Self -Administration|self -administration
5977025|NCT00713492|Intoxication|intoxication
5977026|NCT00713492|Healthy Volunteer|healthy volunteer
5977027|NCT00713492|HV|hv
5977028|NCT00704834|Multiple Sclerosis|multiple sclerosis
5977029|NCT00704834|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5977030|NCT00704834|Chronic Progressive Multiple Sclerosis|chronic progressive multiple sclerosis
5977031|NCT00704834|Clinically Isolated Syndrome|clinically isolated syndrome
5977032|NCT00704834|Normal Controls|normal controls
5977033|NCT00704834|Blood Draw|blood draw
5977034|NCT00702533|Gastric Acid Output|gastric acid output
5977035|NCT00702533|Hyper/Hyposecretion|hyper/hyposecretion
5977036|NCT00702533|Gastric Analysis|gastric analysis
5977037|NCT00702533|Gastric pH|gastric ph
5977038|NCT00702533|SmartPill|smartpill
5977039|NCT00702533|ph Monitoring|ph monitoring
5977040|NCT00702533|Gastric Secretion|gastric secretion
5977041|NCT00702533|Healthy Volunteer|healthy volunteer
5977042|NCT00702533|HV|hv
5977043|NCT00700882|stage IV melanoma|stage iv melanoma
5977044|NCT00700882|acral melanoma|acral melanoma
5977045|NCT00700882|mucosal melanoma|mucosal melanoma
5977046|NCT00700882|vulvovaginal melanoma|vulvovaginal melanoma
5977047|NCT00700882|stage III melanoma|stage iii melanoma
5977048|NCT00697411|Aicardi syndrome|aicardi syndrome
5977049|NCT00697411|Microphthalmia with linear skin defects (MLS) syndrome|microphthalmia with linear skin defects (mls) syndrome
5977050|NCT00697411|X-linked disorders|x-linked disorders
5977051|NCT00695981|Rotator cuff|rotator cuff
5977052|NCT00695981|Arthroscopic surgery|arthroscopic surgery
5977053|NCT00695981|Open surgery|open surgery
5977054|NCT00695981|Physiotherapy|physiotherapy
5977055|NCT00695981|Physical therapy|physical therapy
5977056|NCT00695981|Effectiveness|effectiveness
5977057|NCT00695981|RCT|rct
5977058|NCT00695981|cost-effectiveness|cost-effectiveness
5977059|NCT00694850|Interstitial lung disease associated pulmonary hypertension|interstitial lung disease associated pulmonary hypertension
5977060|NCT00693342|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5977061|NCT00693342|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5977062|NCT00693342|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5977063|NCT00693342|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5977064|NCT00693342|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5977065|NCT00693342|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5977066|NCT00693342|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5977067|NCT00693342|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5977068|NCT00693342|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5977069|NCT00693342|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5977070|NCT00693342|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5977071|NCT00693342|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5977072|NCT00693342|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5977073|NCT00693342|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5977074|NCT00693342|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5977075|NCT00693342|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5977076|NCT00693342|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5977077|NCT00693342|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5977078|NCT00693342|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5977079|NCT00693342|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5977080|NCT00693342|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5977081|NCT00693342|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5977082|NCT00693342|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5977083|NCT00693342|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5977084|NCT00693342|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5977085|NCT00693342|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5977086|NCT00693342|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5977087|NCT00693342|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5977088|NCT00693342|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5977089|NCT00693342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5977090|NCT00691756|renal failure|renal failure
5977091|NCT00691756|thoracoabdominal aortic aneurysm repair|thoracoabdominal aortic aneurysm repair
5977092|NCT00691756|cold crystalloid|cold crystalloid
5977093|NCT00691756|cold blood|cold blood
5977094|NCT00691756|renal perfusion|renal perfusion
5977095|NCT00691223|Focal dermal hypoplasia|focal dermal hypoplasia
5977096|NCT00691223|Goltz syndrome|goltz syndrome
5977097|NCT00691223|X linked disorders|x linked disorders
5977098|NCT00691223|PORCN|porcn
5977099|NCT00691223|Wnt signaling|wnt signaling
5977100|NCT00687115|24 Hour Energy Expenditure|24 hour energy expenditure
5977101|NCT00687115|Respiratory Chamber|respiratory chamber
5977102|NCT00687115|Obesity|obesity
5977103|NCT00687115|Weight Loss|weight loss
5977104|NCT00687115|Overfeeding|overfeeding
5977105|NCT00678821|Interstitial Lung Disease|interstitial lung disease
5977106|NCT00678821|Pulmonary Rehabilitation|pulmonary rehabilitation
5977107|NCT00678821|Pulmonary Hypertension|pulmonary hypertension
5977108|NCT00678821|Exercise|exercise
5977109|NCT00677157|Fatigue|fatigue
5977110|NCT00677157|Fibromyalgia|fibromyalgia
5977111|NCT00677157|Pain|pain
5977112|NCT00677157|Complex Regional Pain Syndrome|complex regional pain syndrome
5977113|NCT00677157|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5977114|NCT00676689|Pulmonic|pulmonic
5977115|NCT00676689|Regurgitation|regurgitation
5977116|NCT00676689|Pulmonary Valve Conduit|pulmonary valve conduit
5977117|NCT00676689|Stenosis|stenosis
5977118|NCT00676689|Congenital Heart Defect|congenital heart defect
5977119|NCT00674440|Congenital Hyperinsulinism|congenital hyperinsulinism
5977120|NCT00674440|Hyperinsulinism|hyperinsulinism
5977121|NCT00674440|Persistent Hyperinsulinemic Hypoglycemia of Infancy|persistent hyperinsulinemic hypoglycemia of infancy
5977122|NCT00674440|CHI|chi
5977123|NCT00674440|PHHI|phhi
5977124|NCT00674440|F-DOPA|f-dopa
5977125|NCT00674440|L-fluoro-dihydroxyphenylalanine|l-fluoro-dihydroxyphenylalanine
5977126|NCT00673790|nebivolol|nebivolol
5977127|NCT00673790|BYSTOLIC ™|bystolic ™
5977128|NCT00673790|hydrochlorothiazide|hydrochlorothiazide
5977129|NCT00673790|lisinopril|lisinopril
5977130|NCT00673790|Prinivil (TM)|prinivil (tm)
5977131|NCT00673790|Zestril (TM)|zestril (tm)
5977132|NCT00673790|losartan|losartan
5977133|NCT00673790|Cozaar (TM)|cozaar (tm)
5977134|NCT00673790|Impaired Fasting Glucose|impaired fasting glucose
5977135|NCT00673790|Impaired Glucose Tolerance|impaired glucose tolerance
5977136|NCT00673790|hypertension|hypertension
5977137|NCT00669305|Genetics|genetics
5977138|NCT00669305|Blood cells|blood cells
5977139|NCT00669305|Vector-mediated gene transfer|vector-mediated gene transfer
5977140|NCT00669305|Bone marrow|bone marrow
5977141|NCT00669305|CD34 cells|cd34 cells
5977142|NCT00667251|recurrent breast cancer|recurrent breast cancer
5977143|NCT00667251|HER2-positive breast cancer|her2-positive breast cancer
5977144|NCT00667251|stage IV breast cancer|stage iv breast cancer
5977145|NCT00661193|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5977146|NCT00661193|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5977147|NCT00661193|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5977148|NCT00661193|adenocarcinoma of the lung|adenocarcinoma of the lung
5977149|NCT00661193|large cell lung cancer|large cell lung cancer
5977150|NCT00661193|squamous cell lung cancer|squamous cell lung cancer
5977151|NCT00656955|Kidney Cancer|kidney cancer
5977152|NCT00656955|Molecular Epidemiology|molecular epidemiology
5977153|NCT00656955|Survival|survival
5977154|NCT00656955|Occupational Exposures|occupational exposures
5977155|NCT00656955|Renal Cancer|renal cancer
5977156|NCT00645645|Holoprosencephaly|holoprosencephaly
5977157|NCT00645645|Agenesis of Corpus|agenesis of corpus
5977158|NCT00645645|Callosum|callosum
5977159|NCT00645645|Genetic Tests|genetic tests
5977160|NCT00645060|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5977161|NCT00642057|chorea|chorea
5977162|NCT00642057|dyskinesia|dyskinesia
5977163|NCT00642057|hyperkinetic|hyperkinetic
5977164|NCT00639639|adult giant cell glioblastoma|adult giant cell glioblastoma
5977165|NCT00639639|adult gliosarcoma|adult gliosarcoma
5977166|NCT00637013|Subacromial impingement|subacromial impingement
5977167|NCT00637013|Shoulder|shoulder
5977168|NCT00637013|RCT|rct
5977169|NCT00637013|Effectiveness|effectiveness
5977170|NCT00637013|Cost-effectiveness|cost-effectiveness
5977171|NCT00628745|TRANSTHYRETIN|transthyretin
5977172|NCT00628745|AMYLOIDOSIS|amyloidosis
5977173|NCT00628745|TRANSTHYRETIN AMYLOIDOSIS|transthyretin amyloidosis
5977174|NCT00616967|stage II breast cancer|stage ii breast cancer
5977175|NCT00616967|stage IIIA breast cancer|stage iiia breast cancer
5977176|NCT00616967|stage IIIB breast cancer|stage iiib breast cancer
5977177|NCT00616967|stage IIIC breast cancer|stage iiic breast cancer
5977178|NCT00616967|ductal breast carcinoma|ductal breast carcinoma
5977179|NCT00616967|lobular breast carcinoma|lobular breast carcinoma
5977180|NCT00616317|Antiphospholipid Syndrome|antiphospholipid syndrome
5977181|NCT00604201|Nonmyeloablative|nonmyeloablative
5977182|NCT00604201|Haploidentical|haploidentical
5977183|NCT00604201|Umbilical Cord Blood|umbilical cord blood
5977184|NCT00604201|SAA|saa
5977185|NCT00604201|Severe Aplastic Anemia|severe aplastic anemia
5977186|NCT00604201|Myelodysplastic Syndrome|myelodysplastic syndrome
5977187|NCT00604201|MDS|mds
5977188|NCT00598351|Meningioma|meningioma
5977189|NCT00598351|Ependymoma|ependymoma
5977190|NCT00598351|Schwannoma|schwannoma
5977191|NCT00598351|Acoustic Neuroma|acoustic neuroma
5977192|NCT00598351|Vestibular Schwannoma|vestibular schwannoma
5977193|NCT00598351|Neurofibromatosis Type 2|neurofibromatosis type 2
5977194|NCT00598351|NF2|nf2
5977195|NCT00595491|Asthma|asthma
5977196|NCT00595491|Inflammation|inflammation
5977197|NCT00595491|Allergic|allergic
5977198|NCT00595491|Airway|airway
5977199|NCT00595491|Challenge|challenge
5977200|NCT00595491|Chemokines|chemokines
5977201|NCT00571272|Cholestatic Liver Disease|cholestatic liver disease
5977202|NCT00571272|Cholestasis|cholestasis
5977203|NCT00571272|Childhood Diseases|childhood diseases
5977204|NCT00571272|Genetic Diseases|genetic diseases
5977205|NCT00571272|Bile Acid Synthesis and Metabolism Defects|bile acid synthesis and metabolism defects
5977206|NCT00571272|Progressive Familial Intrahepatic Cholestasis|progressive familial intrahepatic cholestasis
5977207|NCT00571129|Primary,silicone tube,revision,mitomycin C,endoscopic DCR|primary,silicone tube,revision,mitomycin c,endoscopic dcr
5977208|NCT00568243|Visuomotor Integration|visuomotor integration
5977209|NCT00568243|Visual Attention|visual attention
5977210|NCT00568243|Healthy Volunteer|healthy volunteer
5977211|NCT00568243|HV|hv
5977212|NCT00557726|Inflammation|inflammation
5977213|NCT00557726|Infection|infection
5977214|NCT00557726|Fever|fever
5977215|NCT00544700|stage IV colon cancer|stage iv colon cancer
5977216|NCT00544700|stage IV rectal cancer|stage iv rectal cancer
5977217|NCT00542230|Erythrocytes|erythrocytes
5977218|NCT00542230|Drug Screen|drug screen
5977219|NCT00542230|Sickle Cell Trait|sickle cell trait
5977220|NCT00542230|Sickle Hemoglobin|sickle hemoglobin
5977221|NCT00542230|Sickle Cell Disease|sickle cell disease
5977222|NCT00539643|Liver Cancer|liver cancer
5977223|NCT00539643|Hepatoma|hepatoma
5977224|NCT00539643|07-099|07-099
5977225|NCT00538668|Prostate|prostate
5977226|NCT00538668|Prostate Cancer|prostate cancer
5977227|NCT00538668|Prostate Ca|prostate ca
5977228|NCT00534703|Chronic Heart Failure|chronic heart failure
5977229|NCT00533182|Pregnant|pregnant
5977230|NCT00533182|Children|children
5977231|NCT00533182|Adults|adults
5977232|NCT00533182|Flu|flu
5977233|NCT00533182|Infection|infection
5977234|NCT00533182|Influenza Infection|influenza infection
5977235|NCT00532844|6R-BH4|6r-bh4
5977236|NCT00532844|BH4|bh4
5977237|NCT00532844|BH4 deficiency|bh4 deficiency
5977238|NCT00532844|sapropterin dihydrochloride|sapropterin dihydrochloride
5977239|NCT00532844|endothelial dysfunction|endothelial dysfunction
5977240|NCT00532844|NO|no
5977241|NCT00532844|Hypertension|hypertension
5977242|NCT00532844|Nitric Oxide|nitric oxide
5977243|NCT00532844|Vitamin C|vitamin c
5977244|NCT00523627|Energy Expenditure|energy expenditure
5977245|NCT00523627|Adaptive Thermogenesis|adaptive thermogenesis
5977246|NCT00523627|Low-protein Overfeeding|low-protein overfeeding
5977247|NCT00523627|Fasting|fasting
5977248|NCT00523627|Weight Gain|weight gain
5977249|NCT00509080|mitral regurgitation|mitral regurgitation
5977250|NCT00509080|BNP|bnp
5977251|NCT00509080|NT-proBNP|nt-probnp
5977252|NCT00509080|natriuretic peptides|natriuretic peptides
5977253|NCT00509080|valvular heart disease|valvular heart disease
5977254|NCT00505310|Kidney Cancer|kidney cancer
5977255|NCT00505310|Renal Cell Carcinoma|renal cell carcinoma
5977256|NCT00505310|Emotional Expression|emotional expression
5977257|NCT00505310|Writing|writing
5977258|NCT00505310|Questionnaire|questionnaire
5977259|NCT00505310|Survey|survey
5977260|NCT00500994|Conversion Disorder|conversion disorder
5977261|NCT00500994|Psychogenic Movement Disorders|psychogenic movement disorders
5977262|NCT00500994|Non-Epileptic Seizure|non-epileptic seizure
5977263|NCT00500994|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5977264|NCT00500994|Genetic Polymorphisms|genetic polymorphisms
5977265|NCT00500994|Psychogenic Movement Disorder|psychogenic movement disorder
5977266|NCT00500994|PMD|pmd
5977267|NCT00500994|NES|nes
5977268|NCT00500994|Healthy Volunteer|healthy volunteer
5977269|NCT00500994|HV|hv
5977270|NCT00500890|Choroid Plexus Tumors|choroid plexus tumors
5977271|NCT00500890|Carboplatin|carboplatin
5977272|NCT00500890|Cyclophosphamide|cyclophosphamide
5977273|NCT00500890|Etoposide|etoposide
5977274|NCT00500890|Vincristine|vincristine
5977275|NCT00500890|Paraplatin|paraplatin
5977276|NCT00500890|Cytoxan|cytoxan
5977277|NCT00500890|Neosar|neosar
5977278|NCT00499317|Urgency|urgency
5977279|NCT00499317|Frequency|frequency
5977280|NCT00499317|Pelvic pain|pelvic pain
5977281|NCT00499317|Sexual dysfunction|sexual dysfunction
5977282|NCT00499317|Erectile dysfunction|erectile dysfunction
5977283|NCT00499317|Painful intercourse|painful intercourse
5977284|NCT00498316|Myelodysplastic Syndrome|myelodysplastic syndrome
5977285|NCT00498316|Leukemia|leukemia
5977286|NCT00498316|Cord Blood Expansion|cord blood expansion
5977287|NCT00498316|Umbilical Cord Blood|umbilical cord blood
5977288|NCT00498316|Mesenchymal Stem Cells|mesenchymal stem cells
5977289|NCT00498316|Acute Myelogenous Leukemia|acute myelogenous leukemia
5977290|NCT00498316|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5977291|NCT00498316|ALL|all
5977292|NCT00498316|AML|aml
5977293|NCT00498316|MDS|mds
5977294|NCT00495300|Data Collection|data collection
5977295|NCT00495300|CIBMTR Samples|cibmtr samples
5977296|NCT00495300|NMDP Repository|nmdp repository
5977297|NCT00495300|Hematopoietic Stem Cells|hematopoietic stem cells
5977298|NCT00495300|Bone Marrow Transplant Data Collection|bone marrow transplant data collection
5977299|NCT00495300|Samples|samples
5977300|NCT00493298|disease progression|disease progression
5977301|NCT00493298|Multiple Sclerosis|multiple sclerosis
5977302|NCT00493298|disease activity|disease activity
5977303|NCT00493298|Tysabri|tysabri
5977304|NCT00493298|natalizumab|natalizumab
5977305|NCT00493298|long-term safety|long-term safety
5977306|NCT00492167|recurrent neuroblastoma|recurrent neuroblastoma
5977307|NCT00492167|regional neuroblastoma|regional neuroblastoma
5977308|NCT00492167|stage 4S neuroblastoma|stage 4s neuroblastoma
5977309|NCT00492167|disseminated neuroblastoma|disseminated neuroblastoma
5977310|NCT00491842|Huntington's Disease|huntington's disease
5977311|NCT00491842|Disclosure|disclosure
5977312|NCT00491842|Adaptation|adaptation
5977313|NCT00491842|Communication|communication
5977314|NCT00491842|Huntington Disease|huntington disease
5977315|NCT00491842|HD|hd
5977316|NCT00491842|Phone Interview|phone interview
5977317|NCT00486746|sleep apnea|sleep apnea
5977318|NCT00486746|lifestyle intervention|lifestyle intervention
5977319|NCT00486746|cardiovascular|cardiovascular
5977320|NCT00475761|Breast biopsy|breast biopsy
5977321|NCT00475761|Breast imaging|breast imaging
5977322|NCT00475761|Breast Cancer|breast cancer
5977323|NCT00475761|Mammographic Density|mammographic density
5977324|NCT00475761|Breast|breast
5977325|NCT00473096|Decision making|decision making
5977326|NCT00473096|Patient Education|patient education
5977327|NCT00473096|Indigency|indigency
5977328|NCT00473096|Minority group|minority group
5977329|NCT00471302|Immunology|immunology
5977330|NCT00471302|Mali|mali
5977331|NCT00471302|Donor|donor
5977332|NCT00471250|Lung Infection Susceptibility|lung infection susceptibility
5977333|NCT00471250|Bronchoalveolar Lavage|bronchoalveolar lavage
5977334|NCT00471250|Nasal Biopsy|nasal biopsy
5977335|NCT00471250|Sputum Sample|sputum sample
5977336|NCT00471250|Infection Susceptibility|infection susceptibility
5977337|NCT00471250|Healthy Volunteer|healthy volunteer
5977338|NCT00471250|HV|hv
5977339|NCT00469339|Breast Cancer|breast cancer
5977340|NCT00469339|Diabetes|diabetes
5977341|NCT00469339|Colon Cancer|colon cancer
5977342|NCT00469339|Cardiovascular Disease|cardiovascular disease
5977343|NCT00461903|essential hypertension|essential hypertension
5977344|NCT00461903|symptomatic paroxysmal or persistent atrial fibrillation|symptomatic paroxysmal or persistent atrial fibrillation
5977345|NCT00451022|Gene Therapy|gene therapy
5977349|NCT00450788|Carcinogens|carcinogens
5977350|NCT00450788|Esophageal Cancer|esophageal cancer
5977351|NCT00445978|Sickle Cell Disease|sickle cell disease
5977352|NCT00445978|SCD|scd
5977353|NCT00445978|6R-BH4|6r-bh4
5977354|NCT00445978|BH4|bh4
5977355|NCT00445978|sapropterin dihydrochloride|sapropterin dihydrochloride
5977356|NCT00445978|endothelial dysfunction|endothelial dysfunction
5977357|NCT00445978|Nitric Oxide|nitric oxide
5977358|NCT00445978|NO|no
5977359|NCT00444405|lumbar|lumbar
5977360|NCT00444405|disc|disc
5977361|NCT00444405|herniation|herniation
5977362|NCT00444405|discectomy|discectomy
5977363|NCT00444405|fusion|fusion
5977364|NCT00444405|spine|spine
5977365|NCT00442195|Tissue Procurement|tissue procurement
5977366|NCT00442195|Sample Collection|sample collection
5977367|NCT00442195|Biologic Samples|biologic samples
5977368|NCT00442195|Laboratory Research Specimens|laboratory research specimens
5977369|NCT00442195|Healthy Volunteer|healthy volunteer
5977370|NCT00442195|HV|hv
5977371|NCT00428987|Energy Expenditure|energy expenditure
5977372|NCT00428987|Body Composition|body composition
5977373|NCT00428987|Obesity|obesity
5977374|NCT00428987|Metabolism|metabolism
5977375|NCT00428987|Phenotype|phenotype
5977376|NCT00428987|Morbid Obesity|morbid obesity
5977377|NCT00428987|Overweight|overweight
5977378|NCT00428987|Healthy Volunteer|healthy volunteer
5977379|NCT00410241|Genome|genome
5977380|NCT00410241|Cardiovascular|cardiovascular
5977381|NCT00410241|Volunteers|volunteers
5977382|NCT00410241|Genes|genes
5977383|NCT00410241|Atherosclerosis|atherosclerosis
5977384|NCT00406445|p53 Mutation|p53 mutation
5977385|NCT00406445|Li-Fraumeni Syndrome|li-fraumeni syndrome
5977386|NCT00406445|Aerobic Metabolism|aerobic metabolism
5977387|NCT00406445|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5977388|NCT00397111|Morphometry|morphometry
5977389|NCT00397111|BOLD|bold
5977390|NCT00397111|fMRI|fmri
5977391|NCT00397111|Spectrometry|spectrometry
5977392|NCT00397111|Relaxometry|relaxometry
5977393|NCT00397111|Healthy Volunteer|healthy volunteer
5977394|NCT00397111|HV|hv
5977395|NCT00393250|Pain Management|pain management
5977396|NCT00393250|Sickle Cell|sickle cell
5977397|NCT00393250|Sickle Cell Disease|sickle cell disease
5977398|NCT00393250|Pain|pain
5977399|NCT00393250|Hypnosis|hypnosis
5977400|NCT00393224|Epidemiology|epidemiology
5977401|NCT00393224|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5977402|NCT00393224|Genetic|genetic
5977403|NCT00393224|Viruses|viruses
5977404|NCT00393224|Cancer|cancer
5977405|NCT00393224|NPC|npc
5977406|NCT00378742|Glaucoma|glaucoma
5977407|NCT00378742|Gene|gene
5977408|NCT00378742|Phenotype-Genotype correlation|phenotype-genotype correlation
5977409|NCT00378742|Molecular Diagnosis|molecular diagnosis
5977410|NCT00378742|Retinal Degeneration|retinal degeneration
5977411|NCT00378742|Inherited Eye Disease|inherited eye disease
5977412|NCT00378742|Retinitis Pigmentosa|retinitis pigmentosa
5977413|NCT00378742|Macular Dystrophy|macular dystrophy
5977414|NCT00378742|Congenital Glaucoma|congenital glaucoma
5977415|NCT00368082|EBV-Positive Lymphoma|ebv-positive lymphoma
5977416|NCT00368082|Hodgkin´s Disease (HD)|hodgkin´s disease (hd)
5977417|NCT00368082|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5977418|NCT00368082|relapsed Hodgkin's disease|relapsed hodgkin's disease
5977419|NCT00368082|relapsed non-Hodgkin's disease|relapsed non-hodgkin's disease
5977420|NCT00368082|lymphoma|lymphoma
5977421|NCT00368082|TGFbeta resistant LMP-specific CTLs|tgfbeta resistant lmp-specific ctls
5977422|NCT00368082|cytotoxic T cells|cytotoxic t cells
5977423|NCT00367900|Diet|diet
5977424|NCT00367900|Lifestyle|lifestyle
5977425|NCT00367900|Neurodegenerative Diseases|neurodegenerative diseases
5977426|NCT00367900|Elderly Population|elderly population
5977427|NCT00367900|Public Health|public health
5977428|NCT00367900|Parkinson Disease|parkinson disease
5977429|NCT00367900|Environment|environment
5977430|NCT00367458|Viremia|viremia
5977431|NCT00367458|Statin|statin
5977432|NCT00367458|HIV Replication|hiv replication
5977433|NCT00367458|Cholesterol|cholesterol
5977434|NCT00367458|Lipid Raft|lipid raft
5977435|NCT00367458|HIV Infection|hiv infection
5977436|NCT00367458|HIV Positive|hiv positive
5977437|NCT00362843|11C-Leucine|11c-leucine
5977438|NCT00362843|Positron Emission Tomography (PET)|positron emission tomography (pet)
5977439|NCT00362843|Cerebral Protein Synthesis|cerebral protein synthesis
5977440|NCT00362843|Propofol|propofol
5977441|NCT00362843|Fragile X|fragile x
5977442|NCT00362843|Fragile X Syndrome|fragile x syndrome
5977443|NCT00361829|Development|development
5977444|NCT00361829|Childhood Growth|childhood growth
5977445|NCT00359684|Cystinosis|cystinosis
5977446|NCT00359684|Cystine|cystine
5977447|NCT00359684|Lysomal Storage Disease|lysomal storage disease
5977448|NCT00359684|Mutation Analysis|mutation analysis
5977449|NCT00359684|Metabolic Disease|metabolic disease
5977450|NCT00359268|Polymerase Chain Reaction|polymerase chain reaction
5977451|NCT00359268|Random Priming|random priming
5977452|NCT00359268|Nucleic Acid|nucleic acid
5977453|NCT00359268|Viral Genome|viral genome
5977454|NCT00353782|Triglyceride|triglyceride
5977455|NCT00353782|Phospholipids|phospholipids
5977456|NCT00353782|Free and Esterfied Cholesterol|free and esterfied cholesterol
5977457|NCT00353782|Polydisperse|polydisperse
5977458|NCT00353782|Lipoprotein Transport System|lipoprotein transport system
5977459|NCT00353639|Ulcera|ulcera
5977460|NCT00353639|Telomerase|telomerase
5977461|NCT00353639|TERT|tert
5977462|NCT00353639|TERC|terc
5977463|NCT00353639|SBDS|sbds
5977464|NCT00353639|DNA Helicase|dna helicase
5977465|NCT00353639|Inflammatory Bowel Disease|inflammatory bowel disease
5977466|NCT00353639|IBD|ibd
5977467|NCT00352924|Cancer|cancer
5977468|NCT00352924|Pesticides|pesticides
5977469|NCT00352924|Agriculture|agriculture
5977470|NCT00352573|Instrument|instrument
5977471|NCT00352573|Physicians|physicians
5977472|NCT00352573|Resources|resources
5977474|NCT00352573|Ethics|ethics
5977475|NCT00345553|Biliary Atresia|biliary atresia
5977476|NCT00345553|Cholestasis|cholestasis
5977477|NCT00344188|Cutaneous|cutaneous
5977478|NCT00344188|Visceral|visceral
5977479|NCT00344188|Leishmanial Infection|leishmanial infection
5977480|NCT00344188|MucocutaneousLeishmaniasis|mucocutaneousleishmaniasis
5977481|NCT00344188|Leishmaniasis|leishmaniasis
5977482|NCT00342992|Vitamin E|vitamin e
5977483|NCT00342992|Micronutrients|micronutrients
5977484|NCT00342992|Genetics|genetics
5977485|NCT00342992|Smoking|smoking
5977486|NCT00342992|Biomarkers|biomarkers
5977487|NCT00342927|American Indians|american indians
5977488|NCT00342927|Complications|complications
5977489|NCT00342927|Genetics|genetics
5977490|NCT00342927|Linkage|linkage
5977491|NCT00342927|Type 2 Diabetes|type 2 diabetes
5977492|NCT00342927|Diabetic Kidney Disease|diabetic kidney disease
5977493|NCT00342888|Childhood Cancer|childhood cancer
5977494|NCT00342888|Pesticides|pesticides
5977495|NCT00342888|Polychlorinated Biphenyls|polychlorinated biphenyls
5977496|NCT00342888|Organochlorines|organochlorines
5977497|NCT00342888|Polybrominated Diphenyl Ethers|polybrominated diphenyl ethers
5977498|NCT00342875|Bladder Cancer|bladder cancer
5977499|NCT00342875|Exposure|exposure
5977500|NCT00342875|Drinking Water|drinking water
5977501|NCT00342797|second primary cancer|second primary cancer
5977502|NCT00342797|retinoblastoma|retinoblastoma
5977503|NCT00342797|RB1 germline mutation|rb1 germline mutation
5977504|NCT00342654|Epidemiology|epidemiology
5977505|NCT00342654|Cancer|cancer
5977506|NCT00342654|Environment|environment
5977507|NCT00342654|Genetics|genetics
5977508|NCT00342654|Nutrition|nutrition
5977509|NCT00342589|Pneumocystis|pneumocystis
5977510|NCT00342589|HIV|hiv
5977511|NCT00342589|Oral Wash|oral wash
5977512|NCT00342589|PCR|pcr
5977513|NCT00342589|Drug Resistance|drug resistance
5977514|NCT00342550|Pregnancy|pregnancy
5977515|NCT00342550|Preterm Birth|preterm birth
5977516|NCT00342550|Pregnancy Complications|pregnancy complications
5977517|NCT00342537|Pathology|pathology
5977518|NCT00342537|Genetics|genetics
5977519|NCT00342537|Testicular Cancer|testicular cancer
5977520|NCT00342537|Familial|familial
5977521|NCT00342537|Cancer Epidemiology|cancer epidemiology
5977522|NCT00342446|Gonadotropins|gonadotropins
5977523|NCT00342446|CLOMIPHENE|clomiphene
5977524|NCT00342446|Ovulation-Stimulating Drugs|ovulation-stimulating drugs
5977525|NCT00342342|Association|association
5977526|NCT00342342|Linkage Study|linkage study
5977527|NCT00342342|Familial Aggregation|familial aggregation
5977528|NCT00342342|Linkage Disequilibrium|linkage disequilibrium
5977529|NCT00342186|China|china
5977530|NCT00342186|Cancer|cancer
5977531|NCT00342186|Hepatitis B|hepatitis b
5977532|NCT00342186|Genetics|genetics
5977533|NCT00342186|Liver Disease|liver disease
5977534|NCT00342186|HBV|hbv
5977535|NCT00342173|Cervix|cervix
5977536|NCT00342173|Natural History|natural history
5977537|NCT00342173|Neoplasia|neoplasia
5977538|NCT00342173|HPV|hpv
5977539|NCT00342173|Costa Rica|costa rica
5977540|NCT00341991|DNA Repair|dna repair
5977541|NCT00341991|Genes|genes
5977542|NCT00341991|Pigmentation|pigmentation
5977543|NCT00341991|Skin Cancer|skin cancer
5977544|NCT00341991|Sun Exposure|sun exposure
5977545|NCT00341939|Drug Therapy|drug therapy
5977546|NCT00341939|Pharmacogenetics|pharmacogenetics
5977547|NCT00341939|Cancer|cancer
5977548|NCT00341939|Pharmacodynamics|pharmacodynamics
5977549|NCT00341939|Parmacokinetics|parmacokinetics
5977550|NCT00341874|DNA Mutations|dna mutations
5977551|NCT00341874|Genetic Variation|genetic variation
5977552|NCT00341874|GENETIC LINKAGE|genetic linkage
5977553|NCT00341874|Usher Syndrome|usher syndrome
5977554|NCT00341874|BLINDNESS|blindness
5977555|NCT00341679|Autoimmune Diseases|autoimmune diseases
5977556|NCT00341679|Polymyositis|polymyositis
5977557|NCT00341679|Dermatomyositis|dermatomyositis
5977558|NCT00341679|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5977559|NCT00341679|CONNECTIVE TISSUE DISEASES|connective tissue diseases
5977560|NCT00341679|IIM|iim
5977561|NCT00341588|Testicular Cancer|testicular cancer
5977562|NCT00341588|Epidemiology|epidemiology
5977563|NCT00341588|Testicular Germ Cell Cancer|testicular germ cell cancer
5977564|NCT00341588|TGCT|tgct
5977565|NCT00341588|Healthy Volunteer|healthy volunteer
5977566|NCT00341549|Genetics|genetics
5977567|NCT00341549|Mapping|mapping
5977568|NCT00341549|Gene|gene
5977569|NCT00341549|Myopia|myopia
5977570|NCT00341549|Nearsightedness|nearsightedness
5977571|NCT00341523|Cytology|cytology
5977572|NCT00341523|Endoscopy|endoscopy
5977573|NCT00341523|Esophageal Cancer|esophageal cancer
5977574|NCT00341523|Early Detection|early detection
5977575|NCT00341523|Treatment|treatment
5977576|NCT00341458|Breast Cancer|breast cancer
5977577|NCT00341458|Environment|environment
5977578|NCT00341458|Genetics|genetics
5977579|NCT00341458|Epidemiology|epidemiology
5977580|NCT00341406|Multisizer 3|multisizer 3
5977581|NCT00341406|Signaling|signaling
5977582|NCT00341406|Obesity|obesity
5977583|NCT00341406|Type 2 Diabetes|type 2 diabetes
5977584|NCT00341406|Adipose Cell Turn Over|adipose cell turn over
5977585|NCT00341315|Epidemiology|epidemiology
5977586|NCT00341315|DDT|ddt
5977587|NCT00341315|BMI|bmi
5977588|NCT00341315|Serum|serum
5977589|NCT00341315|Case-Control Study|case-control study
5977590|NCT00341276|Esophageal Cancer|esophageal cancer
5977591|NCT00341276|Genetics|genetics
5977592|NCT00341276|Polymorphism|polymorphism
5977593|NCT00341276|Susceptibility Genes|susceptibility genes
5977594|NCT00341276|Tumor|tumor
5977595|NCT00341263|Twins|twins
5977596|NCT00341263|Clinical Research|clinical research
5977597|NCT00341263|Endocrinology|endocrinology
5977598|NCT00341263|Breast Cancer|breast cancer
5977599|NCT00341263|Biochemical Epidemiology|biochemical epidemiology
5977600|NCT00341237|Genotype|genotype
5977601|NCT00341237|Phenotype|phenotype
5977602|NCT00341237|Environmental Factor|environmental factor
5977603|NCT00341237|Single Nucleotide Polymorphism|single nucleotide polymorphism
5977604|NCT00341094|Cohort|cohort
5977605|NCT00341094|Radiation|radiation
5977606|NCT00341094|In Utero|in utero
5977607|NCT00341094|Genomic|genomic
5977608|NCT00341016|Radiation|radiation
5977609|NCT00340873|Molecular Epidemiology|molecular epidemiology
5977610|NCT00340873|Cross-Sectional|cross-sectional
5977611|NCT00340873|Gene-Enviroment Interaction|gene-enviroment interaction
5977612|NCT00340808|Endometrial Cancer|endometrial cancer
5977613|NCT00340808|Epidemiology|epidemiology
5977614|NCT00340808|Questionnaire|questionnaire
5977615|NCT00340808|Etiology|etiology
5977616|NCT00340808|Biomarkers|biomarkers
5977617|NCT00340535|Disinfection byproducts|disinfection byproducts
5977618|NCT00340535|Genetic Variation|genetic variation
5977619|NCT00340535|Trihalomethanes|trihalomethanes
5977620|NCT00340132|Insulin Sensitivity|insulin sensitivity
5977621|NCT00340132|Insulin Secretion|insulin secretion
5977622|NCT00340132|Glucose Tolerance|glucose tolerance
5977623|NCT00340132|Adipose Tissue|adipose tissue
5977624|NCT00340132|Preadipocytes|preadipocytes
5977625|NCT00340028|Ovulation|ovulation
5977626|NCT00340028|Diary Record|diary record
5977627|NCT00340028|Urine Collection|urine collection
5977628|NCT00340028|Blood Collection|blood collection
5977629|NCT00340028|Hormone|hormone
5977630|NCT00340015|Cancer|cancer
5977631|NCT00340015|Mortality|mortality
5977632|NCT00340015|Lifestyle Factors|lifestyle factors
5977633|NCT00340015|Nutrition|nutrition
5977634|NCT00340015|Prospective Cohort|prospective cohort
5977635|NCT00339989|Molecular Markers|molecular markers
5977636|NCT00339989|Human Papillomavirus|human papillomavirus
5977637|NCT00339989|Cervix|cervix
5977638|NCT00339989|Cancer|cancer
5977639|NCT00339989|Microarray|microarray
5977640|NCT00339963|Microarray|microarray
5977641|NCT00339963|Lymphoma|lymphoma
5977642|NCT00339963|Gene Expression|gene expression
5977643|NCT00339963|Molecular Diagnosis|molecular diagnosis
5977644|NCT00339963|Prognosis|prognosis
5977645|NCT00339963|Leukemia|leukemia
5977646|NCT00339963|Myeloma|myeloma
5977647|NCT00339963|Lymphoid Malignancy|lymphoid malignancy
5977648|NCT00339937|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
5977649|NCT00339937|Kaposi sarcoma (KS)|kaposi sarcoma (ks)
5977650|NCT00339742|Esophageal Cancer|esophageal cancer
5977651|NCT00339742|Case-Control Study|case-control study
5977652|NCT00339742|Environmental Risk Factors|environmental risk factors
5977653|NCT00339742|Genetic Risk Factors|genetic risk factors
5977654|NCT00339677|Measurement Error|measurement error
5977655|NCT00339677|Dietary Assessment|dietary assessment
5977656|NCT00339677|Dietary Intake|dietary intake
5977657|NCT00339677|Energy|energy
5977658|NCT00339677|Protein|protein
5977659|NCT00339651|Precursors|precursors
5977660|NCT00339651|Endometrial Cancer|endometrial cancer
5977661|NCT00339651|Hyperplasia|hyperplasia
5977662|NCT00339651|Progression|progression
5977663|NCT00339625|Intervention|intervention
5977664|NCT00339625|Diet|diet
5977665|NCT00339625|Colon|colon
5977666|NCT00339573|Asthma|asthma
5977667|NCT00339573|Exposure|exposure
5977668|NCT00339573|Home|home
5977669|NCT00339573|Indoor|indoor
5977670|NCT00339573|Allergy|allergy
5977671|NCT00339560|Ampulla of Vater|ampulla of vater
5977672|NCT00339560|Gallbaldder|gallbaldder
5977673|NCT00339560|Cancer|cancer
5977674|NCT00339560|Extrahepatic Bile Duct|extrahepatic bile duct
5977675|NCT00339495|Prostate|prostate
5977676|NCT00339495|Screening Trail|screening trail
5977677|NCT00339495|Ovarian|ovarian
5977678|NCT00339495|Lung|lung
5977679|NCT00339495|Colorectal|colorectal
5977680|NCT00339482|AMERICAN INDIAN|american indian
5977681|NCT00339482|Diabetes|diabetes
5977682|NCT00339482|Renal Diseases|renal diseases
5977683|NCT00339482|Cardiovascular Disease|cardiovascular disease
5977684|NCT00339287|Virulence|virulence
5977685|NCT00339287|PHAGOCYTOSIS|phagocytosis
5977686|NCT00339287|Neutrophils|neutrophils
5977687|NCT00339287|Pathogenesis|pathogenesis
5977688|NCT00339222|Genetics|genetics
5977689|NCT00339222|Kindreds|kindreds
5977690|NCT00339222|Mediterranean Population|mediterranean population
5977691|NCT00339222|Nevi|nevi
5977692|NCT00339222|Pigmentation|pigmentation
5977693|NCT00339222|Melanoma-Prone Families|melanoma-prone families
5977694|NCT00339222|Sun Exposure|sun exposure
5977695|NCT00339222|Melanoma|melanoma
5977696|NCT00331331|Uveitis|uveitis
5977697|NCT00331331|Intermediate Uveitis|intermediate uveitis
5977698|NCT00331331|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
5977699|NCT00331331|Macular Edema|macular edema
5977700|NCT00331331|Vasculitis|vasculitis
5977701|NCT00327964|malaria|malaria
5977702|NCT00327964|fever|fever
5977703|NCT00327964|Uganda|uganda
5977704|NCT00327964|children|children
5977705|NCT00327964|rapid diagnostic tests|rapid diagnostic tests
5977706|NCT00327964|RDTs|rdts
5977707|NCT00327964|Africa|africa
5977708|NCT00326482|Drug Toxicity|drug toxicity
5977709|NCT00326482|Steatohepatitis|steatohepatitis
5977710|NCT00326482|Hepatotoxicity|hepatotoxicity
5977711|NCT00326482|Liver Biopsy|liver biopsy
5977712|NCT00326482|Liver Disease|liver disease
5977713|NCT00326482|HIV|hiv
5977714|NCT00326482|Liver Fibrosis|liver fibrosis
5977715|NCT00294632|Mantle Cell Lymphoma|mantle cell lymphoma
5977716|NCT00294632|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5977717|NCT00294632|Transformed Large Cell Lymphoma|transformed large cell lymphoma
5977718|NCT00294632|Follicular Lymphoma|follicular lymphoma
5977719|NCT00294632|Lymphoma|lymphoma
5977720|NCT00294632|MCL|mcl
5977721|NCT00294632|Lenalidomide|lenalidomide
5977722|NCT00294632|CC-5013|cc-5013
5977723|NCT00294632|Revlimid™|revlimid™
5977724|NCT00294632|Rituximab|rituximab
5977725|NCT00294632|Rituxan|rituxan
5977726|NCT00278538|Stem cell, Autoimmune disease, Systemic Lupus Erythematosus|stem cell, autoimmune disease, systemic lupus erythematosus
5977727|NCT00275067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5977728|NCT00275067|adult gliosarcoma|adult gliosarcoma
5977729|NCT00275067|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5977730|NCT00275067|adult mixed glioma|adult mixed glioma
5977731|NCT00275067|adult glioblastoma|adult glioblastoma
5977732|NCT00275067|adult giant cell glioblastoma|adult giant cell glioblastoma
5977733|NCT00275067|recurrent adult brain tumor|recurrent adult brain tumor
5977734|NCT00271622|Developmental Delay|developmental delay
5977735|NCT00271622|Pediatric|pediatric
5977736|NCT00271622|Pervasive Developmental Disorder|pervasive developmental disorder
5977737|NCT00271622|Early Development|early development
5977738|NCT00271622|Healthy Control Subjects|healthy control subjects
5977739|NCT00271622|Autism Spectrum Disorders|autism spectrum disorders
5977740|NCT00271622|Healthy Volunteer|healthy volunteer
5977741|NCT00271622|HV|hv
5977742|NCT00268476|Stage III Prostate Cancer|stage iii prostate cancer
5977743|NCT00268476|Stage IV Prostate Cancer|stage iv prostate cancer
5977744|NCT00268476|Recurrent Prostate Cancer|recurrent prostate cancer
5977745|NCT00268476|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5977746|NCT00267904|Adrenaline|adrenaline
5977747|NCT00267904|Normal Physiology|normal physiology
5977748|NCT00267904|Catecholamines|catecholamines
5977749|NCT00267904|Catechols|catechols
5977750|NCT00267904|Sympathetic Nervous System|sympathetic nervous system
5977751|NCT00267904|Healthy Volunteer|healthy volunteer
5977752|NCT00267904|HV|hv
5977753|NCT00262782|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5977754|NCT00262782|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5977755|NCT00262782|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5977756|NCT00262782|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5977757|NCT00250159|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5977758|NCT00250159|Familial Male Precocious Puberty (FMPP)|familial male precocious puberty (fmpp)
5977759|NCT00250159|21-hydroxylast deficiency|21-hydroxylast deficiency
5977760|NCT00250159|Adrenal Insufficiency|adrenal insufficiency
5977761|NCT00250159|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5977762|NCT00250159|CAH|cah
5977763|NCT00250159|Familial Male Precocious Puberty|familial male precocious puberty
5977764|NCT00250159|FMPP|fmpp
5977765|NCT00248261|ziprasidone, sertraline, PTSD|ziprasidone, sertraline, ptsd
5977766|NCT00246857|Apoptosis|apoptosis
5977767|NCT00246857|T-cell|t-cell
5977768|NCT00246857|Autoimmunity|autoimmunity
5977769|NCT00246857|Lymphoproliferation|lymphoproliferation
5977770|NCT00246857|B-Cell|b-cell
5977771|NCT00246857|Inherited Lymphhocyte Homeostasis|inherited lymphhocyte homeostasis
5977772|NCT00246857|Genetic Disease|genetic disease
5977773|NCT00242723|Biopsy|biopsy
5977774|NCT00242723|Staging Studies|staging studies
5977775|NCT00242723|Screening|screening
5977776|NCT00242723|Potentially Malignant or Suspicious Legions|potentially malignant or suspicious legions
5977777|NCT00242723|Cancer Primary Evaluation|cancer primary evaluation
5977778|NCT00242723|Lung Cancer|lung cancer
5977779|NCT00242723|Esophageal Cancer|esophageal cancer
5977780|NCT00242723|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5977781|NCT00229450|depression|depression
5977782|NCT00229450|menopause|menopause
5977783|NCT00229450|perimenopause|perimenopause
5977784|NCT00229450|mood|mood
5977785|NCT00229450|memory|memory
5977786|NCT00229450|perimenopausal|perimenopausal
5977787|NCT00229450|antidepressant|antidepressant
5977788|NCT00229450|estrogen|estrogen
5977789|NCT00228917|Hib & Neisseria meningitidis serogroups A & C diseases|hib & neisseria meningitidis serogroups a & c diseases
5977790|NCT00200889|Acupuncture|acupuncture
5977791|NCT00200889|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5977792|NCT00200889|Brain Mapping|brain mapping
5977793|NCT00200889|healthy volunteers|healthy volunteers
5977794|NCT00200889|Neuromodulation|neuromodulation
5977795|NCT00200889|gastric MRI|gastric mri
5977796|NCT00182858|Biologic Sample Collection|biologic sample collection
5977797|NCT00182858|Tissue Procurement|tissue procurement
5977798|NCT00176852|high risk hemoglobinopathy|high risk hemoglobinopathy
5977799|NCT00176852|stem cell transplant|stem cell transplant
5977800|NCT00176852|donor lymphocyte infusion|donor lymphocyte infusion
5977801|NCT00176852|transfusion dependent|transfusion dependent
5977802|NCT00176852|stem cell donor|stem cell donor
5977803|NCT00176852|cord blood|cord blood
5977804|NCT00176852|marrow|marrow
5977805|NCT00176852|transfusion dependent non-malignant hematologic disorders|transfusion dependent non-malignant hematologic disorders
5977806|NCT00156767|ACTH|acth
5977807|NCT00156767|Cortisol|cortisol
5977808|NCT00146263|mild cognitive impairment|mild cognitive impairment
5977809|NCT00146263|dementia|dementia
5977810|NCT00146263|Alzheimer's Disease|alzheimer's disease
5977811|NCT00146263|cognitive training|cognitive training
5977812|NCT00145158|Melanoma|melanoma
5977813|NCT00145158|Vaccine|vaccine
5977814|NCT00145158|Peptide|peptide
5977815|NCT00145158|Montanide|montanide
5977816|NCT00138853|RSA|rsa
5977817|NCT00138853|Genoarthrosis|genoarthrosis
5977818|NCT00138853|Knee arthroplasty|knee arthroplasty
5977819|NCT00138853|Micromotion of polyethylene liner|micromotion of polyethylene liner
5977820|NCT00136604|Prophylaxis diphtheria|prophylaxis diphtheria
5977821|NCT00136604|Hib & meningococcal serogroup A & C disease|hib & meningococcal serogroup a & c disease
5977822|NCT00132353|Magnetic Stimulation|magnetic stimulation
5977823|NCT00132353|Single Fiber EMG|single fiber emg
5977824|NCT00132353|Ultrasonography|ultrasonography
5977825|NCT00132353|Autonomic Testing|autonomic testing
5977826|NCT00132353|Near-nerve recording|near-nerve recording
5977827|NCT00132353|Neurological Disorders|neurological disorders
5977828|NCT00132353|Neuromuscular Transmission Disorders|neuromuscular transmission disorders
5977829|NCT00132353|Central Demyelinating Disorders|central demyelinating disorders
5977830|NCT00132353|Myelopathy|myelopathy
5977831|NCT00132353|Motor Neuron Disease|motor neuron disease
5977832|NCT00132353|Movement Disorders|movement disorders
5977833|NCT00132353|Healthy Volunteer|healthy volunteer
5977834|NCT00128973|CGD|cgd
5977835|NCT00128973|LAD|lad
5977836|NCT00128973|XSCID|xscid
5977837|NCT00128973|cGVHD|cgvhd
5977838|NCT00128973|Infection|infection
5977839|NCT00128973|Genetic|genetic
5977840|NCT00128973|Inherited Disease|inherited disease
5977841|NCT00128973|Immunity|immunity
5977842|NCT00128973|Chronic|chronic
5977843|NCT00128973|Abnormal Immune Function|abnormal immune function
5977844|NCT00128973|Recurrent Infection|recurrent infection
5977845|NCT00128973|Chronic Granulomatous Disease|chronic granulomatous disease
5977846|NCT00128973|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5977847|NCT00128973|Leukocyte Adhesion Deficiency 1|leukocyte adhesion deficiency 1
5977848|NCT00128973|Healthy Volunteer|healthy volunteer
5977849|NCT00128973|HV|hv
5977850|NCT00128960|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5977851|NCT00128960|Health Related Quality of Life|health related quality of life
5977852|NCT00128960|Symptom Experience|symptom experience
5977853|NCT00128960|Fatigue|fatigue
5977854|NCT00128960|Functional Status|functional status
5977855|NCT00114647|Blood Collection|blood collection
5977856|NCT00114647|Apheresis|apheresis
5977857|NCT00111384|Phenotype|phenotype
5977858|NCT00111384|NF1-associated tumors|nf1-associated tumors
5977859|NCT00111384|NF1|nf1
5977860|NCT00111384|EQTL|eqtl
5977861|NCT00111384|Modifier Genes|modifier genes
5977862|NCT00111384|Neurofibroma|neurofibroma
5977863|NCT00111384|Neurofibromatosis Type 1|neurofibromatosis type 1
5977864|NCT00109174|Glutamate|glutamate
5977865|NCT00109174|Excitatory Amino Acid|excitatory amino acid
5977866|NCT00109174|Neurochemistry|neurochemistry
5977867|NCT00109174|Brain|brain
5977868|NCT00109174|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5977869|NCT00106977|Coronal Craniosynostosis|coronal craniosynostosis
5977870|NCT00106977|Hearing Loss|hearing loss
5977871|NCT00106977|Pro250 Arg Mutation|pro250 arg mutation
5977872|NCT00106977|Tarsal Coalition|tarsal coalition
5977873|NCT00106977|Carpal Coalition|carpal coalition
5977874|NCT00106977|Muenke Syndrome|muenke syndrome
5977875|NCT00106977|Craniosynostosis|craniosynostosis
5977876|NCT00106925|Peripheral Blood Stem Cells|peripheral blood stem cells
5977877|NCT00106925|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5977878|NCT00106925|Graft-Versus-Host Disease|graft-versus-host disease
5977879|NCT00106925|Whole Body Irradiation|whole body irradiation
5278927|NCT02280876|CNS|cns
5977880|NCT00106925|Leukemic Relapse|leukemic relapse
5977881|NCT00106925|Allogeneic Stem Cell Transplantation Recipient|allogeneic stem cell transplantation recipient
5977882|NCT00104325|White Blood Cells|white blood cells
5977883|NCT00104325|Immune Studies|immune studies
5977884|NCT00104325|Cell Function|cell function
5977885|NCT00104325|Cell Seperation|cell seperation
5977886|NCT00104325|Machine Seperation|machine seperation
5977887|NCT00102544|CT-Guided|ct-guided
5977888|NCT00102544|Electromagnetic Tracking|electromagnetic tracking
5977889|NCT00102544|Ultrasound-Guided Biopsy|ultrasound-guided biopsy
5977890|NCT00102544|Ablation|ablation
5977891|NCT00102544|Surgical Navigation|surgical navigation
5977892|NCT00091871|Hypereosinophilia|hypereosinophilia
5977893|NCT00091871|Eosinophil|eosinophil
5977894|NCT00091871|Interlukin 5|interlukin 5
5977895|NCT00091871|Familial|familial
5977896|NCT00091871|Familial Hypereosinophilia|familial hypereosinophilia
5977897|NCT00091871|FE|fe
5977898|NCT00090662|Cerebrospinal Fluid|cerebrospinal fluid
5977899|NCT00090662|Stool|stool
5977900|NCT00090662|Urine|urine
5977901|NCT00090662|Healthy Volunteer|healthy volunteer
5977902|NCT00090662|HV|hv
5977903|NCT00088426|GENETIC DISEASE|genetic disease
5977904|NCT00088426|Multiple Abnormalies|multiple abnormalies
5977905|NCT00088426|Birth Defects|birth defects
5977906|NCT00088426|Holoprosencephaly|holoprosencephaly
5977907|NCT00088426|HPE|hpe
5977908|NCT00085982|Rabson Mendenhall|rabson mendenhall
5977909|NCT00085982|Type B Insulin Resistance|type b insulin resistance
5977910|NCT00085982|Type A Insulin Resistance|type a insulin resistance
5977911|NCT00085670|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
5977912|NCT00085670|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5977913|NCT00085670|Transforming Growth Factor Beta 1 (TGF-B1)|transforming growth factor beta 1 (tgf-b1)
5977914|NCT00085670|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5977915|NCT00085670|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5977916|NCT00083512|Blood|blood
5977917|NCT00083512|Urine|urine
5977918|NCT00083512|GBM|gbm
5977919|NCT00083512|Radiation|radiation
5977920|NCT00083512|Glioblastoma Multiforme|glioblastoma multiforme
5977921|NCT00082706|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5977922|NCT00082706|recurrent bladder cancer|recurrent bladder cancer
5977923|NCT00082706|stage IV bladder cancer|stage iv bladder cancer
5977924|NCT00082706|recurrent urethral cancer|recurrent urethral cancer
5977925|NCT00082706|anterior urethral cancer|anterior urethral cancer
5977926|NCT00082706|posterior urethral cancer|posterior urethral cancer
5977927|NCT00082706|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5977928|NCT00082706|stage III bladder cancer|stage iii bladder cancer
5977929|NCT00081523|Hemoglobin|hemoglobin
5977930|NCT00081523|Acute Chest Syndrome|acute chest syndrome
5977931|NCT00081523|Treatment Options|treatment options
5977932|NCT00081523|Nitric Oxide|nitric oxide
5977933|NCT00081523|Pulmonary Hypertension|pulmonary hypertension
5977934|NCT00081523|Sickle Cell Disease|sickle cell disease
5977935|NCT00081523|Sickle Cell Trait|sickle cell trait
5977936|NCT00081523|Red Blood Cell Disorder|red blood cell disorder
5977937|NCT00081523|Thalassemia|thalassemia
5977938|NCT00081523|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5977939|NCT00081523|Hemolytic Disorders|hemolytic disorders
5977940|NCT00081354|Biopsy Tissue|biopsy tissue
5977941|NCT00081354|Barrett Esophagus|barrett esophagus
5977942|NCT00081354|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5977943|NCT00081354|GERD|gerd
5977944|NCT00081354|Dysphagia|dysphagia
5977945|NCT00081354|Swallowing Difficulty|swallowing difficulty
5977946|NCT00081289|stage III rectal cancer|stage iii rectal cancer
5977947|NCT00081289|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5977948|NCT00081289|stage II rectal cancer|stage ii rectal cancer
5977949|NCT00078949|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5977950|NCT00078949|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5977951|NCT00078949|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5977952|NCT00078949|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5977953|NCT00077909|Proteomics|proteomics
5977954|NCT00077909|Infection|infection
5977955|NCT00077909|Pneumonia|pneumonia
5977956|NCT00077909|Mass Spectrometry|mass spectrometry
5977957|NCT00077909|BAL|bal
5977958|NCT00077909|Lung|lung
5977959|NCT00077909|Pulmonary Disease|pulmonary disease
5977960|NCT00077909|Lung Infiltrates|lung infiltrates
5977961|NCT00073801|Myofascial Dysfunction|myofascial dysfunction
5977962|NCT00073801|Sensitization|sensitization
5977963|NCT00073801|Healthy Volunteers|healthy volunteers
5977964|NCT00073801|Overlapping Pain Conditions|overlapping pain conditions
5977965|NCT00073801|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
5977966|NCT00073060|Hypocalcemia|hypocalcemia
5977967|NCT00073060|Plateletpheresis|plateletpheresis
5977968|NCT00073060|Calcium|calcium
5977969|NCT00073060|Citrate|citrate
5977970|NCT00073060|Bone Density|bone density
5977971|NCT00073060|Healthy Volunteer|healthy volunteer
5977972|NCT00073060|HV|hv
5977973|NCT00071526|Vitamin C|vitamin c
5977974|NCT00071526|Diabetes Mellitus|diabetes mellitus
5977975|NCT00071526|Proteinuria|proteinuria
5977976|NCT00071526|Plasma Concentrations|plasma concentrations
5977977|NCT00071526|Healthy Volunteer|healthy volunteer
5977978|NCT00068159|Hereditary Disease|hereditary disease
5977979|NCT00068159|Diastolic Dysfunction|diastolic dysfunction
5977980|NCT00068159|Exercise Tolerance|exercise tolerance
5977981|NCT00068159|Exercise Stress Echocardiography|exercise stress echocardiography
5977982|NCT00068159|MRI|mri
5977983|NCT00068003|Adoptive Cell Therapy|adoptive cell therapy
5977984|NCT00068003|Screening|screening
5977985|NCT00068003|Cell Harvest|cell harvest
5977986|NCT00068003|Blood|blood
5977987|NCT00068003|Tumor Tissue|tumor tissue
5977988|NCT00067821|Brain Tumor|brain tumor
5977989|NCT00067821|Children|children
5977990|NCT00067821|Metabolic|metabolic
5977991|NCT00067821|Spectroscopy|spectroscopy
5977992|NCT00067821|PET|pet
5977993|NCT00065676|Hyperglycemia|hyperglycemia
5977994|NCT00065676|Hyperinsulinemia|hyperinsulinemia
5977995|NCT00065676|OGTT|ogtt
5977996|NCT00065676|GLUT2|glut2
5977997|NCT00065676|Post-Prandial|post-prandial
5977998|NCT00065676|Type 2 Diabetes|type 2 diabetes
5977999|NCT00065676|Obesity|obesity
5978000|NCT00064883|Radiation Therapy|radiation therapy
5978001|NCT00064883|Children|children
5978002|NCT00064883|Cancer|cancer
5978003|NCT00064883|Late Effects|late effects
5978004|NCT00064883|Natural History|natural history
5978005|NCT00064883|Radiation|radiation
5978006|NCT00060775|Magnetic Resonance Imaging|magnetic resonance imaging
5978007|NCT00060775|Adolescence|adolescence
5978008|NCT00060775|Emotion|emotion
5978009|NCT00060775|Behavioral Inhibition|behavioral inhibition
5978010|NCT00060775|Depression|depression
5978011|NCT00060541|Brain Tumor|brain tumor
5978012|NCT00060541|Epilepsy|epilepsy
5978013|NCT00060541|Pituitary Adenoma|pituitary adenoma
5978014|NCT00060541|Parkinson's Disease|parkinson's disease
5978015|NCT00060541|Spinal Cord Tumor|spinal cord tumor
5978016|NCT00059748|Myositis|myositis
5978017|NCT00059748|JDM|jdm
5978018|NCT00059748|Immune Dysregulation|immune dysregulation
5978019|NCT00059748|Skin Rash|skin rash
5978020|NCT00059748|Inflammation|inflammation
5978021|NCT00059748|Neonatal Onset Multisystem Imflammatory|neonatal onset multisystem imflammatory
5978022|NCT00059748|Disease|disease
5978023|NCT00059748|NOMID|nomid
5978024|NCT00056095|recurrent renal cell cancer|recurrent renal cell cancer
5978025|NCT00056095|stage IV renal cell cancer|stage iv renal cell cancer
5978026|NCT00055224|Anxiety Disorder|anxiety disorder
5978027|NCT00055224|Psychophysiology|psychophysiology
5978028|NCT00055224|Shock Threat|shock threat
5978029|NCT00055224|Context Conditioning|context conditioning
5978030|NCT00055224|Agoraphobia|agoraphobia
5978031|NCT00055224|Panic Disorder|panic disorder
5978032|NCT00055224|Generalized Anxiety Disorder|generalized anxiety disorder
5978033|NCT00055224|GAD|gad
5978034|NCT00055224|Healthy Volunteer|healthy volunteer
5978035|NCT00055224|HV|hv
5978036|NCT00055172|Cytokines|cytokines
5978037|NCT00055172|Inherited Immunodeficiency|inherited immunodeficiency
5978038|NCT00055172|Immunodeficiency|immunodeficiency
5978039|NCT00055055|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5978040|NCT00055055|Microarray Analyses|microarray analyses
5978041|NCT00055055|Microchimerism|microchimerism
5978042|NCT00055055|Genetic and Environmental Risk Factors|genetic and environmental risk factors
5978043|NCT00055055|Adult and Pediatric Disease|adult and pediatric disease
5978044|NCT00055055|Rheumatoid Arthritis|rheumatoid arthritis
5978045|NCT00055055|Systemic Lupus Erythematosus|systemic lupus erythematosus
5978046|NCT00055055|Systemic Sclerosis|systemic sclerosis
5978047|NCT00055055|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5978048|NCT00055055|Juvenile Polymyositis|juvenile polymyositis
5978049|NCT00055055|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5978050|NCT00055055|Inflammatory Myopathies|inflammatory myopathies
5978051|NCT00055055|Dermatomyositis|dermatomyositis
5978052|NCT00055055|Scleroderma|scleroderma
5978053|NCT00055055|SLE|sle
5978054|NCT00055055|Lupus|lupus
5978055|NCT00055055|Rheumatic Disease|rheumatic disease
5978056|NCT00055055|RA|ra
5978057|NCT00055055|Healthy Volunteer|healthy volunteer
5978058|NCT00055055|HV|hv
5978059|NCT00055029|Retinoschisis|retinoschisis
5978060|NCT00055029|Genomic DNA|genomic dna
5978061|NCT00055029|Pedigree Analysis|pedigree analysis
5978062|NCT00055029|Genetic Analysis|genetic analysis
5978063|NCT00055029|Macular Degeneration|macular degeneration
5978064|NCT00055029|Juvenile Retinoschisis|juvenile retinoschisis
5978065|NCT00055029|X-Linked Juvenile Retinoschisis|x-linked juvenile retinoschisis
5978066|NCT00055029|XLRS|xlrs
5978067|NCT00047060|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5978068|NCT00047060|Allogeneic PBSCT|allogeneic pbsct
5978069|NCT00047060|Low Intensity Regimen|low intensity regimen
5978070|NCT00047060|Mycosis Fungoides|mycosis fungoides
5978071|NCT00047060|Sezary Syndrome|sezary syndrome
5978072|NCT00047060|CTCL|ctcl
5978073|NCT00006256|stage II breast cancer|stage ii breast cancer
5978074|NCT00006256|stage IIIA breast cancer|stage iiia breast cancer
5978075|NCT00006256|stage IIIB breast cancer|stage iiib breast cancer
5978076|NCT00006256|stage IIIC breast cancer|stage iiic breast cancer
5978077|NCT00003838|Graft vs. Host Disease|graft vs. host disease
5978078|NCT00003838|Peripheral Blood Stem Cells|peripheral blood stem cells
5978079|NCT00003838|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5978080|NCT00003838|Engraftment|engraftment
5978081|NCT00003838|Graft-Versus-Leukemia|graft-versus-leukemia
5978082|NCT00050752|Renal Cancer|renal cancer
5978083|NCT00050752|Hereditary Leiomyomatosis|hereditary leiomyomatosis
5978084|NCT00050752|Uterine Fibroid|uterine fibroid
5978085|NCT00050752|Cutaneous Leiomyoma|cutaneous leiomyoma
5978086|NCT00050115|Bone Marrow Failure|bone marrow failure
5978087|NCT00050115|Seronegative Hepatitis|seronegative hepatitis
5978088|NCT00050115|Fulminate Hepatitis|fulminate hepatitis
5978089|NCT00050115|Hepatitis|hepatitis
5978090|NCT00050115|Aplastic Anemia|aplastic anemia
5978091|NCT00050115|Hepatitis Associated Aplastic Anemia|hepatitis associated aplastic anemia
5978092|NCT00047996|DNA|dna
5978093|NCT00047996|Endothelial Function|endothelial function
5978094|NCT00047996|Leukocyte Gene Expression|leukocyte gene expression
5978095|NCT00047996|RNA|rna
5978096|NCT00047996|Sickle Cell|sickle cell
5978097|NCT00047996|Coronary Artery Disease|coronary artery disease
5978098|NCT00047996|CAD|cad
5978099|NCT00047996|Healthy Volunteer|healthy volunteer
5978100|NCT00047996|HV|hv
5978101|NCT00047853|Stress|stress
5978102|NCT00047853|Fear|fear
5978103|NCT00047853|Anxiety|anxiety
5978104|NCT00047853|Neuroimaging|neuroimaging
5978106|NCT00047853|Healthy Volunteer|healthy volunteer
5978107|NCT00047853|HV|hv
5978108|NCT00046202|Inborn Error of Cholesterol Synthesis|inborn error of cholesterol synthesis
5978109|NCT00046202|Cholesterol|cholesterol
5978110|NCT00046202|Lysosomal Storage|lysosomal storage
5978111|NCT00046202|Inborn Errors of Cholesterol Synthesis|inborn errors of cholesterol synthesis
5978112|NCT00046202|Smith-Lemli-Optiz Syndrome|smith-lemli-optiz syndrome
5978113|NCT00046202|Lathosterolosis|lathosterolosis
5978114|NCT00046202|Desmosterols|desmosterols
5978115|NCT00046202|CHILD Syndrome|child syndrome
5978116|NCT00046202|Greenberg Dysplasia|greenberg dysplasia
5978117|NCT00046202|X Linked Dominant Chrondrodysplasia|x linked dominant chrondrodysplasia
5978118|NCT00046189|Sun Exposure|sun exposure
5978119|NCT00046189|Xeroderma Pigmentosum|xeroderma pigmentosum
5978120|NCT00046189|Skin Cancer|skin cancer
5978121|NCT00046189|Family History|family history
5978122|NCT00046189|HETEROZYGOTE|heterozygote
5978123|NCT00046189|XP|xp
5978124|NCT00046059|Linkage|linkage
5978125|NCT00046059|Gene Identification|gene identification
5978126|NCT00046059|Hyperactivity|hyperactivity
5978127|NCT00046059|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5978128|NCT00046059|ADHD|adhd
5978129|NCT00044174|Infant|infant
5978130|NCT00044174|maternal health|maternal health
5978131|NCT00044122|Mastocytosis|mastocytosis
5978132|NCT00043472|Screening|screening
5978133|NCT00043472|Oophorectomy|oophorectomy
5978134|NCT00043472|Hereditary|hereditary
5978135|NCT00043472|Genetics|genetics
5978136|NCT00043472|Cancer|cancer
5978137|NCT00043225|Type III Secretion Pathways|type iii secretion pathways
5978138|NCT00043225|Exotoxin A Polymorphisms|exotoxin a polymorphisms
5978139|NCT00043225|Cystic Fibrosis and Pseudomonas Aeruginosa|cystic fibrosis and pseudomonas aeruginosa
5978140|NCT00043225|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5978141|NCT00043225|Severe Combined Immune Deficiency|severe combined immune deficiency
5978142|NCT00043225|SCID|scid
5978143|NCT00043225|ADA-SCID|ada-scid
5978144|NCT00043225|Immune Deficiency|immune deficiency
5978145|NCT00040352|Genetics|genetics
5978146|NCT00040352|Risk Factors|risk factors
5978147|NCT00040352|Natural History|natural history
5978148|NCT00040352|Melanoma Precursors|melanoma precursors
5978149|NCT00040352|Skin Cancer|skin cancer
5978150|NCT00040352|Melanoma|melanoma
5978151|NCT00040222|Counseling/behavioral/psychosocial|counseling/behavioral/psychosocial
5978152|NCT00040222|Gene discovery|gene discovery
5978153|NCT00040222|Cancer prevention|cancer prevention
5978154|NCT00040222|Risk-reduction|risk-reduction
5978155|NCT00040222|Hereditary|hereditary
5978156|NCT00040222|Breast Cancer|breast cancer
5978157|NCT00040222|Ovarian Cancer|ovarian cancer
5978158|NCT00040222|Cowden Syndrome|cowden syndrome
5978159|NCT00040222|Peutz-Jegher Syndrome|peutz-jegher syndrome
5978160|NCT00040222|Li-Fraumeni Syndrome|li-fraumeni syndrome
5978161|NCT00039689|Cellular Immunity|cellular immunity
5978162|NCT00039689|Chronic HIV Infection|chronic hiv infection
5978163|NCT00039689|Antiretroviral Therapy|antiretroviral therapy
5978164|NCT00039689|Primary HIV Infection|primary hiv infection
5978165|NCT00039689|Humoral Immunity|humoral immunity
5978166|NCT00039689|HIV Infection|hiv infection
5978167|NCT00039689|Acute Infection|acute infection
5978168|NCT00039689|Treatment Naive|treatment naive
5978169|NCT00039676|Genetics|genetics
5978170|NCT00039676|Risk Factors|risk factors
5978171|NCT00039676|Natural History|natural history
5978172|NCT00039676|Lymphoma|lymphoma
5978173|NCT00039676|Leukemia|leukemia
5279221|NCT02279537|Naïve patients|naïve patients
5978174|NCT00039676|Lymph Node Cancer|lymph node cancer
5978175|NCT00033774|Leukapheresis|leukapheresis
5978176|NCT00033774|G-CSF|g-csf
5978177|NCT00033774|Mobilization|mobilization
5978178|NCT00033774|Stem Cells|stem cells
5978179|NCT00033774|Adult|adult
5978180|NCT00033774|Healthy Volunteer|healthy volunteer
5978181|NCT00033774|HV|hv
5978182|NCT00033774|Normal Control|normal control
5978183|NCT00033137|Pneumothorax|pneumothorax
5978184|NCT00033137|Kidney|kidney
5978185|NCT00033137|Fibrofolliculoma|fibrofolliculoma
5978186|NCT00033137|BHD|bhd
5978187|NCT00033137|Neoplasms|neoplasms
5978188|NCT00032513|Herpes|herpes
5978189|NCT00032513|Hemophagocytosis|hemophagocytosis
5978190|NCT00032513|Epstein-Barr Virus|epstein-barr virus
5978191|NCT00032513|Lymphoproliferative Disease|lymphoproliferative disease
5978192|NCT00032513|Mononucleosis|mononucleosis
5978193|NCT00032513|Epstein-Barr|epstein-barr
5978194|NCT00032513|EBV|ebv
5978195|NCT00032513|CAEBV|caebv
5978196|NCT00032513|Chronic Active Epstein-Barr Virus|chronic active epstein-barr virus
5978197|NCT00032513|Virus|virus
5978198|NCT00031174|Apheresis|apheresis
5978199|NCT00031174|Healthy Volunteer|healthy volunteer
5978200|NCT00031174|Rheumatoid Disease|rheumatoid disease
5978201|NCT00031174|Rheumatic Disease|rheumatic disease
5978202|NCT00031174|Lupus|lupus
5978203|NCT00031174|Rheumatoid Arthritis|rheumatoid arthritis
5978204|NCT00031174|Myositis|myositis
5978205|NCT00031174|HV|hv
5978206|NCT00031174|Normal Control|normal control
5978207|NCT00029965|Sialidosis|sialidosis
5978208|NCT00029965|Lysosomal Storage Disease|lysosomal storage disease
5978209|NCT00029965|Glycoprotein Disorders|glycoprotein disorders
5978210|NCT00029965|GM1 Gangliosidosis|gm1 gangliosidosis
5978211|NCT00029965|GM2 Gangliosidosis|gm2 gangliosidosis
5978212|NCT00029965|Lysosomal Storage Disorder|lysosomal storage disorder
5978213|NCT00029965|Tay-Sachs|tay-sachs
5978214|NCT00029965|Sandhoff|sandhoff
5978215|NCT00029965|Gaucher|gaucher
5978216|NCT00029445|Long-Term Non-Progressor (LTNP)|long-term non-progressor (ltnp)
5978217|NCT00029445|Apheresis|apheresis
5978218|NCT00029445|HLA B*5701|hla b*5701
5978219|NCT00028080|Borrelia Burgdorferi|borrelia burgdorferi
5978220|NCT00028080|Lyme Disease|lyme disease
5978221|NCT00028080|Infection|infection
5978222|NCT00028080|Therapy|therapy
5978223|NCT00028080|Lyme|lyme
5978224|NCT00027326|Blood|blood
5978225|NCT00027326|Samples|samples
5978226|NCT00027326|Radiation|radiation
5978227|NCT00027326|Urine|urine
5978228|NCT00027326|Cancer|cancer
5978229|NCT00027326|Radiation Therapy|radiation therapy
5978230|NCT00027183|Cystic Fibrosis|cystic fibrosis
5978231|NCT00027183|Effector Proteins|effector proteins
5978232|NCT00027183|Cytotoxin|cytotoxin
5978234|NCT00027183|Genetic Screen|genetic screen
5978235|NCT00026884|Serum|serum
5978236|NCT00026884|Collection of Tissue|collection of tissue
5978237|NCT00026884|Malignant Disease|malignant disease
5978238|NCT00026884|Molecular Basis|molecular basis
5978239|NCT00026884|Genome Sequencing|genome sequencing
5978240|NCT00026793|Kaposi Sarcoma|kaposi sarcoma
5978241|NCT00026793|Doppler|doppler
5978242|NCT00026793|Infrared|infrared
5978243|NCT00026793|HIV|hiv
5978244|NCT00026793|Imaging|imaging
5978245|NCT00026793|Kaposi's Sarcoma|kaposi's sarcoma
5978246|NCT00026793|Laser Imaging|laser imaging
5978247|NCT00026793|Infrared Imaging|infrared imaging
5978248|NCT00026754|Screening|screening
5978249|NCT00026754|Cancer|cancer
5978250|NCT00026754|HIV Infection|hiv infection
5978251|NCT00026754|Scans|scans
5978252|NCT00026754|Laboratory Tests|laboratory tests
5978253|NCT00026754|HIV|hiv
5978254|NCT00026754|Skin Disorders|skin disorders
5978255|NCT00026663|Assays|assays
5978256|NCT00026663|Resistance|resistance
5978257|NCT00026663|Biopsy Samples|biopsy samples
5978258|NCT00026663|Specimen Acquisition|specimen acquisition
5978259|NCT00026663|Cancer Cells|cancer cells
5978260|NCT00026650|Late Effects|late effects
5978261|NCT00026650|Radiation Therapy|radiation therapy
5978262|NCT00026650|Cancer|cancer
5978263|NCT00026559|Classical Conditioning|classical conditioning
5978264|NCT00026559|Fear Conditioning|fear conditioning
5978265|NCT00026559|Stress|stress
5978266|NCT00026559|Learning|learning
5978267|NCT00026559|Normal Volunteers|normal volunteers
5978268|NCT00026559|Healthy Volunteer|healthy volunteer
5978269|NCT00026559|Normal Control|normal control
5978270|NCT00025935|Neuroimaging|neuroimaging
5978271|NCT00025935|Mood Disorder|mood disorder
5978272|NCT00025935|Conduct Disorder|conduct disorder
5978273|NCT00025935|Children and Adolescents|children and adolescents
5978274|NCT00025935|Affective Neuroscience|affective neuroscience
5978275|NCT00025935|Behavioral Dysregulation|behavioral dysregulation
5978276|NCT00025935|Behavior|behavior
5978277|NCT00025935|Children|children
5978278|NCT00025935|Adolescent|adolescent
5978279|NCT00025935|Healthy Volunteer|healthy volunteer
5978280|NCT00025935|HV|hv
5978281|NCT00025935|Normal Control|normal control
5978282|NCT00024622|Neurological Disorder|neurological disorder
5978283|NCT00024622|Regional Cerebral Blood Flow|regional cerebral blood flow
5978284|NCT00024622|Dopamine|dopamine
5978285|NCT00024622|Schizophrenia|schizophrenia
5978286|NCT00024622|Parkinson's Disease|parkinson's disease
5978287|NCT00024622|PD|pd
5978288|NCT00024622|Parkinson|parkinson
5978289|NCT00024622|Healthy Control|healthy control
5978290|NCT00024622|HV|hv
5978291|NCT00024622|Normal Control|normal control
5978292|NCT00023504|Antibody|antibody
5978293|NCT00023504|Vaccination|vaccination
5978294|NCT00023036|Genetics|genetics
5978295|NCT00023036|Deafness|deafness
5978296|NCT00023036|Genetic Markers|genetic markers
5978297|NCT00023036|Genetic Analysis|genetic analysis
5978298|NCT00023036|GENETIC LINKAGE|genetic linkage
5978299|NCT00023036|Hearing Impairment|hearing impairment
5978300|NCT00023036|Nonsyndromic Hereditary Hearing Impairment|nonsyndromic hereditary hearing impairment
5978301|NCT00023036|SNHL|snhl
5978302|NCT00023036|Inner Ear|inner ear
5978303|NCT00023036|Enlarged Vestibular Aqueducts|enlarged vestibular aqueducts
5978304|NCT00023036|EVA|eva
5978305|NCT00018044|Mycobacterium Abscessus|mycobacterium abscessus
5978306|NCT00018044|Pulmonary|pulmonary
5978307|NCT00018044|Mycobacterium Chelonae|mycobacterium chelonae
5978308|NCT00018044|Mycobacterium Avium Complex (MAC)|mycobacterium avium complex (mac)
5978309|NCT00018044|Nontuberculous Mycobacteria (NTM)|nontuberculous mycobacteria (ntm)
5978310|NCT00018044|Mycobacterial Infection|mycobacterial infection
5978311|NCT00018044|Mycobacterium|mycobacterium
5978312|NCT00018044|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
5978313|NCT00018044|NTM|ntm
5978314|NCT00018044|Job's Syndrome|job's syndrome
5978315|NCT00018044|Job Syndrome|job syndrome
5978316|NCT00018044|Cystic Fibrosis|cystic fibrosis
5978317|NCT00018044|CF|cf
5978318|NCT00017914|Adult and Pediatric Disease|adult and pediatric disease
5978319|NCT00017914|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5978320|NCT00017914|Disease Assessment|disease assessment
5978321|NCT00017914|Genetic and Environmental Risk Factors|genetic and environmental risk factors
5978322|NCT00017914|Myositis|myositis
5978323|NCT00013559|Sleep Disturbance|sleep disturbance
5978324|NCT00013559|Developmental Delay/ MR|developmental delay/ mr
5978325|NCT00013559|Deletion 17p11.2|deletion 17p11.2
5978326|NCT00013559|Chromosomal Abnormalities|chromosomal abnormalities
5978327|NCT00013559|Behavioral Phenotype|behavioral phenotype
5978328|NCT00013559|Smith-Magenis Syndrome|smith-magenis syndrome
5978329|NCT00013559|Genetics|genetics
5978330|NCT00012545|Stem Cells|stem cells
5978331|NCT00012545|Sickle Cell Disease|sickle cell disease
5978332|NCT00012545|Umbilical Cord Blood|umbilical cord blood
5978333|NCT00011648|Echocardiogram|echocardiogram
5978334|NCT00011648|Morbidity|morbidity
5978335|NCT00011648|Mortality|mortality
5978336|NCT00011648|Sickle Cell Anemia|sickle cell anemia
5978337|NCT00011648|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5978338|NCT00011492|Oral Cancer|oral cancer
5978339|NCT00011492|Squamous Cell Cancer|squamous cell cancer
5978340|NCT00011492|Head and Neck Cancer|head and neck cancer
5978341|NCT00011492|Laryngeal Cancer|laryngeal cancer
5978342|NCT00011492|Pharnygeal Cancer|pharnygeal cancer
5978343|NCT00009243|Stroke|stroke
5978344|NCT00009243|Natural History|natural history
5978345|NCT00009243|Magnetic Resonance Imaging|magnetic resonance imaging
5978346|NCT00009243|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5978347|NCT00009243|Acute Stroke|acute stroke
5978348|NCT00009243|TIA|tia
5978349|NCT00007644|cancer of the prostate (CAP)|cancer of the prostate (cap)
5978350|NCT00007644|cancer treatment|cancer treatment
5978351|NCT00007644|chronic diseases|chronic diseases
5978352|NCT00007644|expectant management|expectant management
5978353|NCT00007644|genitourinary|genitourinary
5978354|NCT00007644|prostate|prostate
5978355|NCT00007644|prostate specific cancer mortality|prostate specific cancer mortality
5978356|NCT00007644|radical prostatectomy|radical prostatectomy
5978357|NCT00007150|Phlebotomy Therapy|phlebotomy therapy
5978358|NCT00007150|Hemochromatosis|hemochromatosis
5978359|NCT00007150|Iron Overload|iron overload
5978360|NCT00007150|Hereditary Hemochromatosis|hereditary hemochromatosis
5978361|NCT00007150|Blood Donation|blood donation
5978363|NCT00006518|Viruses|viruses
5978364|NCT00006518|HIV|hiv
5978365|NCT00006518|KSHV|kshv
5978366|NCT00006518|AIDS|aids
5978367|NCT00006505|Islet Isolation|islet isolation
5978368|NCT00006505|Diabetes|diabetes
5978369|NCT00006435|Tissue Repository|tissue repository
5978370|NCT00006435|Growth Rate|growth rate
5978371|NCT00006435|Volumetric MRI|volumetric mri
5978372|NCT00006425|Breast MRI|breast mri
5978373|NCT00006425|Ductal lavage|ductal lavage
5978374|NCT00006425|Nipple Aspirate Fluid|nipple aspirate fluid
5978375|NCT00006425|Transvaginal ultrasound|transvaginal ultrasound
5978376|NCT00006421|Breast MRI|breast mri
5978377|NCT00006421|Nipple Aspirate Fluid|nipple aspirate fluid
5978378|NCT00006421|Transvaginal ultrasound|transvaginal ultrasound
5978379|NCT00006421|Ductal lavage|ductal lavage
5978380|NCT00006411|cornea transplant|cornea transplant
5978381|NCT00006411|corneal endothelial cell density|corneal endothelial cell density
5978382|NCT00006411|moderate risk corneal diseases|moderate risk corneal diseases
5978383|NCT00006411|corneal transplantation|corneal transplantation
5978384|NCT00006319|X-Linked Agammagloblinemia|x-linked agammagloblinemia
5978385|NCT00006319|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5978386|NCT00006319|Jak-3 SCID|jak-3 scid
5978387|NCT00006319|X-Linked SCID|x-linked scid
5978388|NCT00006319|X-Linked Hyper-IgM Syndrome|x-linked hyper-igm syndrome
5978389|NCT00006177|Emotion|emotion
5978390|NCT00006177|Affective Neuroscience|affective neuroscience
5978391|NCT00006177|Bipolar Disorder|bipolar disorder
5978392|NCT00006177|Child|child
5978393|NCT00006177|Child Bipolar|child bipolar
5978394|NCT00006177|BPD|bpd
5978395|NCT00006177|Adolescent Bipolar|adolescent bipolar
5978396|NCT00005917|Albinism|albinism
5978397|NCT00005917|Giant Granules|giant granules
5978398|NCT00005917|Infection|infection
5978399|NCT00005917|Melanosomes|melanosomes
5978400|NCT00005917|Platelet Storage Pool Defect|platelet storage pool defect
5978401|NCT00005909|Homogentisic Acid|homogentisic acid
5978402|NCT00005909|Ochronosis|ochronosis
5978403|NCT00005909|Inborn Error of Metabolism|inborn error of metabolism
5978404|NCT00005909|Arthritis|arthritis
5978405|NCT00005909|Enzyme Defect|enzyme defect
5978406|NCT00005909|Alkaptonuria|alkaptonuria
5978407|NCT00005902|Brain|brain
5978408|NCT00005902|Brainstem|brainstem
5978409|NCT00005902|Cyst|cyst
5978410|NCT00005902|Magnetic Resonance Imaging|magnetic resonance imaging
5978411|NCT00005902|Spinal Cord|spinal cord
5978412|NCT00005780|Lymphoma Vaccines|lymphoma vaccines
5978413|NCT00005780|Immune Response Against Lymphoma|immune response against lymphoma
5978414|NCT00005780|Molecular Complete Remissions|molecular complete remissions
5978415|NCT00005780|Novel Treatment Approach|novel treatment approach
5978416|NCT00005780|Mantle Cell Lymphoma|mantle cell lymphoma
5978417|NCT00004850|HCV Coinfection|hcv coinfection
5978418|NCT00004850|Transfusion-Transmission|transfusion-transmission
5978419|NCT00004850|Hepatitis C|hepatitis c
5978420|NCT00004850|Hepatitis B|hepatitis b
5978421|NCT00004847|Genetics|genetics
5978422|NCT00004847|Metanephrines|metanephrines
5978423|NCT00004847|PET|pet
5978424|NCT00004847|Catecholamines|catecholamines
5978425|NCT00004847|Pheochromocytoma|pheochromocytoma
5978426|NCT00004738|Arnold Chiari Malformation|arnold chiari malformation
5978427|NCT00004738|Skeletal Dysplasia|skeletal dysplasia
5978428|NCT00004738|Syringomyelia|syringomyelia
5978429|NCT00004738|Genetics|genetics
5978430|NCT00004738|Chiari I Malformation|chiari i malformation
5978431|NCT00004577|Brain Morphology|brain morphology
5978432|NCT00004577|Cerebral Blood Volume|cerebral blood volume
5978433|NCT00004577|Functional Imaging|functional imaging
5978434|NCT00004577|Development|development
5978435|NCT00004577|MEG|meg
5978436|NCT00004571|Magnetic Resonance Imaging|magnetic resonance imaging
5978437|NCT00004571|Brain Metabolism|brain metabolism
5978438|NCT00004571|Brain Physiology|brain physiology
5978439|NCT00004571|Neuropsychiatric Disorders|neuropsychiatric disorders
5978440|NCT00004571|Cognitition|cognitition
5978441|NCT00004568|Myopathy|myopathy
5978442|NCT00004568|Muscular Dystrophy|muscular dystrophy
5978443|NCT00004568|Motor Neuron Disease|motor neuron disease
5978444|NCT00001987|Diabetes Mellitus|diabetes mellitus
5978445|NCT00001987|Severe Insulin Resistance|severe insulin resistance
5978446|NCT00001987|Type B Insulin Resistance|type b insulin resistance
5978447|NCT00001981|Acromegaly|acromegaly
5978448|NCT00001979|Kidney Disease|kidney disease
5978449|NCT00001979|Autoimmune Diseases|autoimmune diseases
5978450|NCT00001979|Nephrotic Syndrome|nephrotic syndrome
5978451|NCT00001978|Kidney Disease|kidney disease
5978452|NCT00001978|Kidney Function Tests|kidney function tests
5978453|NCT00001978|Proteinuria|proteinuria
5978454|NCT00001971|Hepatitis B|hepatitis b
5978455|NCT00001971|Hepatitis C|hepatitis c
5978456|NCT00001971|Hepatitis D|hepatitis d
5978457|NCT00001971|Chronic Cholestatic Syndromes|chronic cholestatic syndromes
5978458|NCT00001971|Primary Biliary Cirrhosis|primary biliary cirrhosis
5978459|NCT00001971|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5978460|NCT00001971|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5978461|NCT00001971|Wilson's Disease|wilson's disease
5978462|NCT00001971|Hemochromatosis|hemochromatosis
5978463|NCT00001971|Liver Biopsy|liver biopsy
5978464|NCT00001971|Noncirrhotic Portal Hypertension|noncirrhotic portal hypertension
5978465|NCT00001971|Liver Disease|liver disease
5978466|NCT00001964|Hematopoiesis|hematopoiesis
5978467|NCT00001964|Bone Marrow Failure|bone marrow failure
5978468|NCT00001964|Aplastic Anemia|aplastic anemia
5978469|NCT00001888|Induced Sputum|induced sputum
5978470|NCT00001888|Exhaled Breath Condensate|exhaled breath condensate
5978471|NCT00001888|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5978472|NCT00001888|Bronchoscopy|bronchoscopy
5978473|NCT00001888|mRNA|mrna
5978474|NCT00001876|Interstitial Lung Disease|interstitial lung disease
5978475|NCT00001876|Collagen Vascular Disease|collagen vascular disease
5978476|NCT00001876|Extracellular Matrix|extracellular matrix
5978477|NCT00001876|Pulmonary Function|pulmonary function
5978478|NCT00001876|DTPA Lung Clearance Scan|dtpa lung clearance scan
5978479|NCT00001876|Rheumatoid Arthritis|rheumatoid arthritis
5978480|NCT00001876|Pulmonary Fibrosis|pulmonary fibrosis
5978481|NCT00001876|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5978482|NCT00001853|Healthy Volunteers|healthy volunteers
5978483|NCT00001853|Health Disparities|health disparities
5978484|NCT00001853|Diabetes|diabetes
5978485|NCT00001853|Cardiovascular Disease|cardiovascular disease
5978486|NCT00001850|Reproductive Surgery|reproductive surgery
5978487|NCT00001850|Infertility|infertility
5978488|NCT00001850|Hormone Replacement Therapy|hormone replacement therapy
5978489|NCT00001850|GATA 2|gata 2
5978490|NCT00001850|Sickle Cell|sickle cell
5978491|NCT00001846|Volunteer Donor|volunteer donor
5978492|NCT00001846|Research Samples|research samples
5978493|NCT00001846|Leukapheresis|leukapheresis
5978494|NCT00001846|Plateletpheresis|plateletpheresis
5978495|NCT00001846|Plasmapheresis|plasmapheresis
5978496|NCT00001846|Healthy Volunteer|healthy volunteer
5978497|NCT00001846|Normal Volunteer|normal volunteer
5978498|NCT00001823|Cancer|cancer
5978499|NCT00001823|Gene Therapy|gene therapy
5978500|NCT00001823|Immunotherapy|immunotherapy
5978501|NCT00001823|Melanoma|melanoma
5978502|NCT00001823|Clinical Trial|clinical trial
5978503|NCT00001813|Xeroderma Pigmentosum|xeroderma pigmentosum
5978504|NCT00001813|Trichothiodystrophy|trichothiodystrophy
5978505|NCT00001813|Cockayne Syndrome|cockayne syndrome
5978506|NCT00001813|Skin Cancer|skin cancer
5978507|NCT00001813|DNA Repair|dna repair
5978508|NCT00001721|Cholesterol|cholesterol
5978509|NCT00001721|Microephaly|microephaly
5978510|NCT00001721|Cleft Palate|cleft palate
5978511|NCT00001721|Smith-Lemli-Opitz Syndrome (SLO)|smith-lemli-opitz syndrome (slo)
5978512|NCT00001711|Magnetic Resonance Imaging|magnetic resonance imaging
5978513|NCT00001711|Gadolinium|gadolinium
5978514|NCT00001711|MRA|mra
5978515|NCT00001711|Diagnostic Tool|diagnostic tool
5978516|NCT00001711|Contrast|contrast
5978517|NCT00001711|Normal Volunteer|normal volunteer
5978518|NCT00001651|HIV Infection|hiv infection
5978519|NCT00001651|Lymphocyte Turnover|lymphocyte turnover
5978520|NCT00001627|Bone Marrow|bone marrow
5978521|NCT00001627|Hematopoiesis|hematopoiesis
5978522|NCT00001627|DNA|dna
5978523|NCT00001627|RNA|rna
5978524|NCT00001627|Viruses|viruses
5978525|NCT00001621|Teaching|teaching
5978526|NCT00001621|Pulmonary Disease|pulmonary disease
5978527|NCT00001621|Routine Testing|routine testing
5978528|NCT00001621|Medically Indicated|medically indicated
5978529|NCT00001621|Pulmonary Function Test|pulmonary function test
5978530|NCT00001620|Thrombocytopenia|thrombocytopenia
5978531|NCT00001620|Anemia|anemia
5978532|NCT00001620|Neutropenia|neutropenia
5978533|NCT00001620|Dysplasia|dysplasia
5978534|NCT00001620|Hematopoiesis|hematopoiesis
5978535|NCT00001620|Cytopenia|cytopenia
5978536|NCT00001620|Hematologic Malignancy|hematologic malignancy
5978537|NCT00001604|DNA Samples|dna samples
5978538|NCT00001604|Buccal Swab|buccal swab
5978539|NCT00001604|Genotyping|genotyping
5978540|NCT00001604|Statistical Analysis|statistical analysis
5978541|NCT00001604|Computers|computers
5978542|NCT00001604|Stuttering|stuttering
5978543|NCT00001595|Developmental Defect|developmental defect
5978544|NCT00001595|Oncogenesis|oncogenesis
5978545|NCT00001595|Evaluation and Management|evaluation and management
5978546|NCT00001595|Psychological|psychological
5978547|NCT00001595|Cushing Disease|cushing disease
5978548|NCT00001563|Lymphomagenesis|lymphomagenesis
5978549|NCT00001563|Molecular markers of drug resistance|molecular markers of drug resistance
5978550|NCT00001563|Refractory, progressive, or relapsed HIV + NHL|refractory, progressive, or relapsed hiv + nhl
5978551|NCT00001563|AIDS-related NHL|aids-related nhl
5978552|NCT00001529|G-CSF|g-csf
5978553|NCT00001529|Donor Apheresis|donor apheresis
5978554|NCT00001529|Graft vs. Host Disease|graft vs. host disease
5978555|NCT00001529|Graft-Versus-Leukemia|graft-versus-leukemia
5978556|NCT00001529|Normal Volunteer|normal volunteer
5978557|NCT00001521|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5978558|NCT00001521|Intervention|intervention
5978559|NCT00001521|Children|children
5978560|NCT00001506|Natural History|natural history
5978561|NCT00001506|Consultation|consultation
5978562|NCT00001506|Standard Therapy|standard therapy
5978563|NCT00001506|Standard Tests|standard tests
5978564|NCT00001506|Training|training
5978565|NCT00001505|Biopsy|biopsy
5978566|NCT00001505|Research|research
5978567|NCT00001505|Autoimmune|autoimmune
5978568|NCT00001505|Blistering|blistering
5978569|NCT00001505|Compensation|compensation
5978570|NCT00001486|Cognition|cognition
5978571|NCT00001486|Genetics|genetics
5978572|NCT00001486|Hallucinations|hallucinations
5978573|NCT00001486|MRI|mri
5978574|NCT00001486|Psychosis and Schizophrenia|psychosis and schizophrenia
5978575|NCT00001481|Postpartum Disorders|postpartum disorders
5978576|NCT00001481|Mood|mood
5978577|NCT00001481|Hormones|hormones
5978578|NCT00001481|GnRH Agonist|gnrh agonist
5978579|NCT00001481|Postpartum Depression|postpartum depression
5978580|NCT00001471|AIDS|aids
5978581|NCT00001471|HIV|hiv
5978582|NCT00001471|Retrovirus|retrovirus
5978583|NCT00001471|Therapy|therapy
5978584|NCT00001471|Response|response
5978585|NCT00001467|Primary Immunodeficiency Disorders|primary immunodeficiency disorders
5978586|NCT00001467|Immunologic Disorders|immunologic disorders
5978587|NCT00001467|Mutation|mutation
5978588|NCT00001467|Genetic Analysis|genetic analysis
5978589|NCT00001465|Smooth Muscle Proliferation|smooth muscle proliferation
5978590|NCT00001465|Bronchoscopy|bronchoscopy
5978591|NCT00001465|Female|female
5978592|NCT00001465|Pneumothorax|pneumothorax
5978593|NCT00001465|Tuberous Sclerosis|tuberous sclerosis
5978594|NCT00001458|Cardiovascular Treatment|cardiovascular treatment
5978595|NCT00001458|Cardiovascular Disease|cardiovascular disease
5978596|NCT00001458|Cardiovascular Testing|cardiovascular testing
5978597|NCT00001458|Heart Disease|heart disease
5978598|NCT00001458|Muscle Leg Pain|muscle leg pain
5978599|NCT00001458|Leg Pain|leg pain
5978600|NCT00001458|Circulation|circulation
5978601|NCT00001458|Peripheral Arterial Disease|peripheral arterial disease
5978602|NCT00001458|Intermittent Claudication|intermittent claudication
5978603|NCT00001458|Renal Vascular Disease|renal vascular disease
5978604|NCT00001458|Uncontrolled Hypertension|uncontrolled hypertension
5978605|NCT00001406|Eosinophils|eosinophils
5978606|NCT00001406|Helminth Parasites|helminth parasites
5978607|NCT00001406|Hypereosinophilia|hypereosinophilia
5978608|NCT00001406|Allergy|allergy
5978609|NCT00001406|Asthma|asthma
5978610|NCT00001405|Chronic Granulomatous Disease|chronic granulomatous disease
5978611|NCT00001405|CD34 Cells|cd34 cells
5978612|NCT00001405|Infection|infection
5978613|NCT00001405|Nadph Oxidase|nadph oxidase
5978614|NCT00001405|Healthy Volunteer|healthy volunteer
5978615|NCT00001405|Normal Volunteer|normal volunteer
5978616|NCT00001403|Sporadic|sporadic
5978617|NCT00001403|Mosaic|mosaic
5978618|NCT00001403|Growth Disorder|growth disorder
5978619|NCT00001403|Progressive|progressive
5978620|NCT00001403|Multiple Abnormalities|multiple abnormalities
5978621|NCT00001397|Hematopoiesis|hematopoiesis
5978622|NCT00001397|Thrombocytopenia|thrombocytopenia
5978623|NCT00001397|Anemia|anemia
5978624|NCT00001397|Neutropenia|neutropenia
5978625|NCT00001397|Dysplasia|dysplasia
5978626|NCT00001397|Hematologic Malignancies|hematologic malignancies
5978627|NCT00001393|Collapsing Glomerulopathy|collapsing glomerulopathy
5978628|NCT00001393|Renal Diseases|renal diseases
5978629|NCT00001393|HIV Associated Nephropathy|hiv associated nephropathy
5978630|NCT00001392|Rituximab|rituximab
5978631|NCT00001392|Renal Biopsy|renal biopsy
5978632|NCT00001392|Viral Infection|viral infection
5978633|NCT00001392|Biomarkers|biomarkers
5978634|NCT00001379|Epstein-Barr Virus|epstein-barr virus
5978635|NCT00001379|Lymphoproliferative Disorder|lymphoproliferative disorder
5978636|NCT00001379|Viral|viral
5978637|NCT00001379|Immunosuppression|immunosuppression
5978638|NCT00001379|Lymphoma|lymphoma
5978639|NCT00001373|Auto-Inflammation|auto-inflammation
5978640|NCT00001373|Familial Mediterranean Fever|familial mediterranean fever
5978641|NCT00001373|Genetics|genetics
5978642|NCT00001373|Periodic Fever|periodic fever
5978643|NCT00001372|Systemic Lupus Erythematosus|systemic lupus erythematosus
5978644|NCT00001372|Natural History|natural history
5978645|NCT00001372|Lupus Nephritis|lupus nephritis
5978646|NCT00001372|Lupus|lupus
5978647|NCT00001372|Systemic Lupus|systemic lupus
5978648|NCT00001372|SLE|sle
5978649|NCT00001360|Cognition|cognition
5978650|NCT00001360|Vision|vision
5978651|NCT00001360|Cortex|cortex
5978652|NCT00001360|Visual Processing|visual processing
5978653|NCT00001360|Magnetic Resonance Imaging|magnetic resonance imaging
5978654|NCT00001355|Immune Deficiency|immune deficiency
5978655|NCT00001355|Infection|infection
5978656|NCT00001355|Phagocytes|phagocytes
5978657|NCT00001355|Cytokines|cytokines
5978658|NCT00001355|Genetics|genetics
5978659|NCT00001352|Cryptococcus|cryptococcus
5978660|NCT00001351|Human|human
5978661|NCT00001351|Disease|disease
5978662|NCT00001351|Infection|infection
5978663|NCT00001351|Immunology|immunology
5978664|NCT00001350|Immunoregulation|immunoregulation
5978665|NCT00001350|T Cell Receptor Alpha/Beta|t cell receptor alpha/beta
5978666|NCT00001350|Lymphadenopathy|lymphadenopathy
5978667|NCT00001350|ALPS|alps
5978668|NCT00001350|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5978669|NCT00001349|Plasmapheresis|plasmapheresis
5978670|NCT00001349|Lymphocytes|lymphocytes
5978671|NCT00001349|Eosinophils|eosinophils
5978672|NCT00001349|Neutrophils|neutrophils
5978673|NCT00001337|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
5978674|NCT00001337|CD20 +|cd20 +
5978675|NCT00001337|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5978676|NCT00001337|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5279749|NCT02276781|PAD|pad
5978677|NCT00001337|De Novo|de novo
5978678|NCT00001322|Gonadal Steroids|gonadal steroids
5978679|NCT00001322|Mood|mood
5978680|NCT00001322|Menstrual Cycle|menstrual cycle
5978681|NCT00001322|Neuropsychological Testing|neuropsychological testing
5978682|NCT00001322|Estrogen|estrogen
5978683|NCT00001322|Dexamethasone|dexamethasone
5978684|NCT00001322|Progesterone|progesterone
5978685|NCT00001322|Central Nervous System Function|central nervous system function
5978686|NCT00001322|Estradiol|estradiol
5978687|NCT00001322|GnRH Agonist|gnrh agonist
5978688|NCT00001316|Lymph Node|lymph node
5978689|NCT00001316|Polymerase Chain Reaction (PCR)|polymerase chain reaction (pcr)
5978690|NCT00001316|In Situ Hybridization|in situ hybridization
5978691|NCT00001316|AIDS|aids
5978692|NCT00001316|Excisional Biopsy|excisional biopsy
5978693|NCT00001309|Pharmacokinetics|pharmacokinetics
5978694|NCT00001309|Biodistribution|biodistribution
5978695|NCT00001309|Ascorbic Acid|ascorbic acid
5978696|NCT00001281|Lymphocytes|lymphocytes
5978697|NCT00001281|Venipuncture|venipuncture
5978698|NCT00001281|Mononuclear Cells|mononuclear cells
5978699|NCT00001277|Hypoglycemia|hypoglycemia
5978700|NCT00001277|Genetics|genetics
5978701|NCT00001277|Hyperparathyroidism|hyperparathyroidism
5978702|NCT00001276|Hypoglycemia|hypoglycemia
5978703|NCT00001276|Insulinoma|insulinoma
5978704|NCT00001265|Autoimmune Diseases|autoimmune diseases
5978705|NCT00001265|Idiopathic Inflammatory Myopathies|idiopathic inflammatory myopathies
5978706|NCT00001265|Dermatomyositis|dermatomyositis
5978707|NCT00001265|Inclusion Body Myositis|inclusion body myositis
5978708|NCT00001265|Pathogenesis|pathogenesis
5978709|NCT00001265|Connective Tissue Diseases|connective tissue diseases
5978710|NCT00001259|Depression|depression
5978711|NCT00001259|Menstrual Cycle|menstrual cycle
5978712|NCT00001259|Gonadal Steroids|gonadal steroids
5978713|NCT00001259|Estradiol|estradiol
5978714|NCT00001259|Progesterone|progesterone
5978715|NCT00001259|Mood Disorders|mood disorders
5978716|NCT00001254|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5978717|NCT00001252|Biomechanics|biomechanics
5978718|NCT00001252|Kinesiology|kinesiology
5978719|NCT00001252|Walking|walking
5978720|NCT00001248|Multiple Sclerosis|multiple sclerosis
5978721|NCT00001248|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5978722|NCT00001247|Schizophrenia|schizophrenia
5978723|NCT00001247|Psychosis|psychosis
5978724|NCT00001247|Schizoaffective|schizoaffective
5978725|NCT00001247|Neuroimaging|neuroimaging
5978726|NCT00001247|Cognition|cognition
5978727|NCT00001247|Schizoaffective Disorder|schizoaffective disorder
5978728|NCT00001246|Cognitive|cognitive
5978729|NCT00001246|Genetics|genetics
5978730|NCT00001246|Development|development
5978731|NCT00001246|Klinefelter Syndrome|klinefelter syndrome
5978732|NCT00001246|Jacob Syndrome|jacob syndrome
5978733|NCT00001246|Trisomy X|trisomy x
5978734|NCT00001246|Healthy Volunteer|healthy volunteer
5978735|NCT00001246|XXY|xxy
5978736|NCT00001246|XXXY|xxxy
5978737|NCT00001246|XXXXY|xxxxy
5978738|NCT00001246|XYY|xyy
5978739|NCT00001246|XXYY|xxyy
5978740|NCT00001246|XO|xo
5978741|NCT00001246|XXXX|xxxx
5978742|NCT00001246|XXX|xxx
5978743|NCT00001246|XXXXX|xxxxx
5978744|NCT00001246|Triple X|triple x
5978745|NCT00001246|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5978746|NCT00001246|Twin|twin
5978747|NCT00001244|Agammaglobulinemia|agammaglobulinemia
5978748|NCT00001244|CVID|cvid
5978749|NCT00001244|XLA|xla
5978750|NCT00001244|Humoral Immunodeficiency|humoral immunodeficiency
5978751|NCT00001242|Rickets|rickets
5978752|NCT00001242|Hypocalcemia|hypocalcemia
5978753|NCT00001242|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5978754|NCT00001242|Pseudohypoaldosteronism|pseudohypoaldosteronism
5978755|NCT00001238|Urologic Malignant Disorders|urologic malignant disorders
5978756|NCT00001238|Birt Hogg Dube|birt hogg dube
5978757|NCT00001238|Von Hippel Lindau|von hippel lindau
5978758|NCT00001238|Hereditary Papillary Renal Cancer/Renal Cell Acarcinoma|hereditary papillary renal cancer/renal cell acarcinoma
5978759|NCT00001231|Mood|mood
5978760|NCT00001231|Behavior|behavior
5978761|NCT00001231|Cognition|cognition
5978762|NCT00001231|Midlife|midlife
5978763|NCT00001231|Depression|depression
5978764|NCT00001230|Wuchereria Bancrofti|wuchereria bancrofti
5978765|NCT00001230|Loa Loa|loa loa
5978766|NCT00001230|Brugia Malayi|brugia malayi
5978767|NCT00001230|Onchocerca Volvulus|onchocerca volvulus
5978768|NCT00001230|Filarial Infections|filarial infections
5978769|NCT00001230|Filarial Infection|filarial infection
5978770|NCT00001223|Cystic Fibrosis|cystic fibrosis
5978771|NCT00001223|Pancreatic Insufficiency|pancreatic insufficiency
5978772|NCT00001223|Bronchiectasis|bronchiectasis
5978773|NCT00001219|MR Technology|mr technology
5978774|NCT00001219|Pulse Sequences|pulse sequences
5978775|NCT00001219|FDA Approved|fda approved
5978776|NCT00001219|MRI Sequences|mri sequences
5978777|NCT00001219|Investigational Coils|investigational coils
5978778|NCT00001215|Variants|variants
5978779|NCT00001215|Chemical Phenotype|chemical phenotype
5978780|NCT00001215|Proteins|proteins
5978781|NCT00001215|Phenotype|phenotype
5978782|NCT00001214|Bone Marrow Failure|bone marrow failure
5978783|NCT00001214|Lymphocytapheresis|lymphocytapheresis
5978784|NCT00001214|Pancytopenia|pancytopenia
5978785|NCT00001214|Aplastic Anemia|aplastic anemia
5978786|NCT00001214|Hematosuppressive Disease|hematosuppressive disease
5978787|NCT00001208|Spasmodic Torticollis|spasmodic torticollis
5978788|NCT00001208|Writer's Cramp|writer's cramp
5978789|NCT00001208|Spasmodic Dysphonia|spasmodic dysphonia
5978790|NCT00001208|Stuttering|stuttering
5978791|NCT00001208|Oromandibular Dystonia|oromandibular dystonia
5978792|NCT00001208|Palatal Myoclonus|palatal myoclonus
5978793|NCT00001208|Dystonia|dystonia
5978794|NCT00001208|Essential Tremor|essential tremor
5978795|NCT00001208|Movement Disorders|movement disorders
5978796|NCT00001204|Dyslipoprotein|dyslipoprotein
5978797|NCT00001204|Hypercholesterolemia|hypercholesterolemia
5978798|NCT00001204|Atherosclerosis|atherosclerosis
5978799|NCT00001186|Psychosocial|psychosocial
5978800|NCT00001186|Self Esteem|self esteem
5978801|NCT00001186|Oncology|oncology
5978802|NCT00001186|Well-Being|well-being
5978803|NCT00001186|Pediatrics|pediatrics
5978804|NCT00001184|CGD related IBD|cgd related ibd
5978805|NCT00001184|IBD Hermansky-Pudlak Syndrom|ibd hermansky-pudlak syndrom
5978806|NCT00001184|Ulcerative Colitis|ulcerative colitis
5978807|NCT00001184|Inflammatory Bowel Disease|inflammatory bowel disease
5978808|NCT00001184|IBD|ibd
5978809|NCT00001174|Affective Disorder|affective disorder
5978810|NCT00001174|Depression|depression
5978811|NCT00001174|Genetic Polymorphisms|genetic polymorphisms
5978812|NCT00001174|Major Depression|major depression
5978813|NCT00001174|Genome-Wide Scan|genome-wide scan
5978814|NCT00001174|Panic Disorder|panic disorder
5978815|NCT00001174|Bipolar Disorder|bipolar disorder
5978816|NCT00001168|Dyslipoproteinemia|dyslipoproteinemia
5978817|NCT00001168|Hypercholesterolemia|hypercholesterolemia
5978818|NCT00001168|Hypertriglyceridemia|hypertriglyceridemia
5978819|NCT00001168|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
5978820|NCT00001168|Atherosclerosis|atherosclerosis
5978821|NCT00001168|High Cholesterol|high cholesterol
5978822|NCT00001168|High HDL|high hdl
5978823|NCT00001168|Low HDL|low hdl
5978824|NCT00001168|LCAT Defiency|lcat defiency
5978825|NCT00001168|Type III Hyperlipoproteinemia|type iii hyperlipoproteinemia
5978826|NCT00001168|Plasma Lipoproteins|plasma lipoproteins
5978827|NCT00001160|Thyroid Fine Needle Biopsy|thyroid fine needle biopsy
5978828|NCT00001160|Radioiodine|radioiodine
5978829|NCT00001160|Dosimetry|dosimetry
5978830|NCT00001159|Hyperthyroidism|hyperthyroidism
5978831|NCT00001159|Hypothyroidism|hypothyroidism
5978832|NCT00001159|Thyroid-Stimulating Hormone Secreting Pituitary Adenomas|thyroid-stimulating hormone secreting pituitary adenomas
5978833|NCT00001159|Grave's Disease|grave's disease
5978834|NCT00001154|Metabolism|metabolism
5978835|NCT00001154|HDL|hdl
5978836|NCT00001154|Cholesterol|cholesterol
5978837|NCT00001154|LDL|ldl
5978838|NCT00001154|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
5262008|NCT02377427|pediatric|pediatric
5251562|NCT02436200|IC|ic
5350730|NCT01945619|CMV|cmv
5248814|NCT02452411|Online therapy|online therapy
5943492|NCT04276246|Removable partial dentures (RPDs)|removable partial dentures (rpds)
5943493|NCT04276246|Supplementary implants|supplementary implants
5943494|NCT04276233|Mepolizumab|mepolizumab
5943495|NCT04276233|Oral corticosteroids|oral corticosteroids
5943496|NCT04276233|Prednisolone|prednisolone
5943497|NCT04276233|Prednisone|prednisone
5943498|NCT04276233|Eosinophilic asthma|eosinophilic asthma
5943499|NCT04276194|Craniospinal|craniospinal
5943500|NCT04276194|Proton Therapy|proton therapy
5943501|NCT04276194|Pediatric|pediatric
5943506|NCT04276129|early wound healing|early wound healing
5943507|NCT04276129|real-time polymerase chain reaction|real-time polymerase chain reaction
5943508|NCT04276129|gingiva|gingiva
5943509|NCT04276129|oral mucosa|oral mucosa
5943510|NCT04276129|palatal tissue|palatal tissue
5943511|NCT04276129|Chlorhexidine|chlorhexidine
5943512|NCT04276116|smoking cessation|smoking cessation
5943513|NCT04276116|generally practice|generally practice
5943514|NCT04276116|pulmonary age|pulmonary age
5943515|NCT04276116|motivation|motivation
5943521|NCT04276051|Obesity|obesity
5943522|NCT04276051|Diabetes|diabetes
5943523|NCT04276051|Neurophysiology|neurophysiology
5943524|NCT04276051|Cryovagotomy|cryovagotomy
5943525|NCT04276051|Glycemic control|glycemic control
5943526|NCT04276025|F18-FDG-PET/CT|f18-fdg-pet/ct
5943527|NCT04276025|Radiomics|radiomics
5943528|NCT04276025|Texture analysis|texture analysis
5943529|NCT04276025|Lung cancer|lung cancer
5943530|NCT04276025|Molecular pathology|molecular pathology
5943531|NCT04275986|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5943532|NCT04275986|Endoscopic resection|endoscopic resection
5943533|NCT04275986|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5943534|NCT04275973|Prostheses|prostheses
5943535|NCT04275973|Orthoses|orthoses
5943536|NCT04275960|Healthy volunteers|healthy volunteers
5943537|NCT04275960|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5943538|NCT04275960|Neurotrophic tyrosine receptor kinase (NTRK) gene fusion|neurotrophic tyrosine receptor kinase (ntrk) gene fusion
5943539|NCT04275960|Tyrosine receptor kinase (TRK)|tyrosine receptor kinase (trk)
5943540|NCT04275960|TRK inhibitor|trk inhibitor
5943541|NCT04275960|Drug formulation|drug formulation
5943542|NCT04275960|Liquid suspension|liquid suspension
5943543|NCT04275921|MRI|mri
5943544|NCT04275921|Radiotherapy|radiotherapy
5943549|NCT04275882|Echocardiography|echocardiography
5943550|NCT04275882|retrospective|retrospective
5943551|NCT04275882|electrocardiography|electrocardiography
5943552|NCT04275882|hypertension|hypertension
5943553|NCT04275882|cardiomyopathy|cardiomyopathy
5943581|NCT04275700|Platelet Rich Plasma|platelet rich plasma
5943585|NCT04275609|Endoscopic Report|endoscopic report
5943586|NCT04275609|Artificial Intelligence|artificial intelligence
5943587|NCT04275609|Gastrointestinal Disease|gastrointestinal disease
5943588|NCT04275609|Writing Efficiency|writing efficiency
5943589|NCT04275570|motivational interview|motivational interview
5943591|NCT04275570|ethanol intake|ethanol intake
5943592|NCT04275557|Pancreatic Lesions|pancreatic lesions
5943593|NCT04275544|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
5943594|NCT04275544|Risk factor|risk factor
5943595|NCT04275544|Postoperative complication|postoperative complication
5943599|NCT04275505|shortwave diathermy, ulnar nerve entrapment at elbow|shortwave diathermy, ulnar nerve entrapment at elbow
5943600|NCT04275492|Pramipexole Dihydrochloride Sustained Release Tablets|pramipexole dihydrochloride sustained release tablets
5943601|NCT04275479|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
5943602|NCT04275479|Atypical Diabetes|atypical diabetes
5943603|NCT04275479|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5943604|NCT04275466|acute pancreatitis|acute pancreatitis
5943605|NCT04275466|infected pancreatic necrosis|infected pancreatic necrosis
5943606|NCT04275466|laparoscope-assisted debridement|laparoscope-assisted debridement
5943607|NCT04275466|necrotic cavity lavage|necrotic cavity lavage
5943611|NCT04275414|COVID-19|covid-19
5943612|NCT04275414|Bevacizumab|bevacizumab
5943613|NCT04275414|pneumonia|pneumonia
5943614|NCT04275362|Knee osteoarthritis|knee osteoarthritis
5943615|NCT04275362|Total knee arthroplasty|total knee arthroplasty
5943616|NCT04275362|Lateral pivot|lateral pivot
5943617|NCT04275349|Registry|registry
5943618|NCT04275349|Cohort study|cohort study
5943619|NCT04275349|Mixed methods|mixed methods
5943620|NCT04275349|Prehospital|prehospital
5943621|NCT04275349|Stroke|stroke
5943622|NCT04275336|Children|children
5943623|NCT04275336|Distress|distress
5943624|NCT04275336|Pain|pain
5943625|NCT04275336|Venipuncture|venipuncture
5943626|NCT04275323|HGF|hgf
5943627|NCT04275323|Gene|gene
5943628|NCT04275323|Critical Limb Ischemia|critical limb ischemia
5943629|NCT04275297|interstitial cystitis|interstitial cystitis
5943630|NCT04275297|bladder pain syndrome|bladder pain syndrome
5943631|NCT04275297|clinical trial|clinical trial
5943632|NCT04275297|psychosocial intervention|psychosocial intervention
5943633|NCT04275297|pelvic pain|pelvic pain
5943634|NCT04275297|therapy|therapy
5943635|NCT04275297|urological chronic pelvic pain syndrome|urological chronic pelvic pain syndrome
5943636|NCT04275297|chronic prostatitis|chronic prostatitis
5943637|NCT04275297|self-management|self-management
5943638|NCT04275297|cognitive behavioral therapy|cognitive behavioral therapy
5943643|NCT04275219|stroke-associated pneumonia|stroke-associated pneumonia
5943644|NCT04275219|Chinese medicine|chinese medicine
5943645|NCT04275219|gut microbiota|gut microbiota
5943647|NCT04275193|Safety|safety
5943648|NCT04275193|Efficacy|efficacy
5943649|NCT04275193|Systemic Lupus Erythematosus|systemic lupus erythematosus
5943737|NCT04272372|breast cancer|breast cancer
5943738|NCT04272372|treatment|treatment
5266529|NCT02351037|AML|aml
5943759|NCT04271969|HFCWO|hfcwo
5943760|NCT04271969|Bronchiectasis|bronchiectasis
5943761|NCT04271969|SmartVest|smartvest
5943768|NCT04271696|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5943769|NCT04271696|Minimal Clinically Important Difference|minimal clinically important difference
5943770|NCT04271696|Pain Measurement|pain measurement
5943771|NCT04271696|Patient Reported Outcome Measures|patient reported outcome measures
5943772|NCT04271696|Plantar Fasciitis|plantar fasciitis
5943773|NCT04271696|Responsiveness|responsiveness
5331532|NCT02033369|MDD|mdd
5943806|NCT04269330|mesh size|mesh size
5943807|NCT04269330|lichtenstein hernia repair|lichtenstein hernia repair
5943808|NCT04269330|surgical technique|surgical technique
5943809|NCT04268940|Unfractionated heparin|unfractionated heparin
5943810|NCT04268940|Extracorporeal Membrane Oxygenation (ECMO)|extracorporeal membrane oxygenation (ecmo)
5943811|NCT04268940|Thromboelastography|thromboelastography
5943812|NCT04268940|Anticoagulation monitoring|anticoagulation monitoring
5943813|NCT04268940|aPTT|aptt
5943814|NCT04268940|Anti-factor Xa|anti-factor xa
5943815|NCT04268940|Point-of-care|point-of-care
5943820|NCT04268277|Hematology|hematology
5943821|NCT04268277|Oncology|oncology
5943822|NCT04268277|Relapse|relapse
5943823|NCT04268277|MALT|malt
5943824|NCT04268277|Pembrolizumab|pembrolizumab
5943825|NCT04268277|Rituximab|rituximab
5280064|NCT02274506|CLL|cll
5943826|NCT04268134|Aromatase inhibitor|aromatase inhibitor
5943827|NCT04268134|Omega-3 fatty acid|omega-3 fatty acid
5943885|NCT04264065|Severe Burn|severe burn
5943886|NCT04264065|acute respiratory distress|acute respiratory distress
5943887|NCT04264065|acute kidney injury|acute kidney injury
5943888|NCT04264065|Albumin|albumin
5237540|NCT02517684|TISKids|tiskids
5944075|NCT04246437|PET|pet
5944109|NCT04243954|Orally|orally
5944110|NCT04243954|PCA intravenously|pca intravenously
5944111|NCT04243954|Analgesia|analgesia
5944112|NCT04243954|Severe cancer pain|severe cancer pain
5945123|NCT04152499|TROP2, ADC|trop2, adc
5947008|NCT03954834|glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
5947009|NCT03954834|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5947010|NCT03954834|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
5947011|NCT03954834|T2DM|t2dm
5334841|NCT02017808|OCT|oct
5947574|NCT03886909|Quality of Life|quality of life
5947590|NCT03883217|Gait|gait
5947591|NCT03883217|Balance|balance
5947598|NCT03882229|Registry|registry
5947599|NCT03882229|Observational Study|observational study
5947612|NCT03878212|mHealth|mhealth
5253093|NCT02428036|HSV-1|hsv-1
5948178|NCT03807297|total intravenous anesthesia|total intravenous anesthesia
5948186|NCT03804853|Reverse total shoulder|reverse total shoulder
5948247|NCT03798769|Pancreas Cancer|pancreas cancer
5948369|NCT03775421|Congenital Heart Failure|congenital heart failure
5948370|NCT03775421|macitentan|macitentan
5948371|NCT03775421|Univentricular Heart|univentricular heart
5948372|NCT03775421|Cavopulmonary Anastomosis|cavopulmonary anastomosis
5948373|NCT03775421|Fontan circulation|fontan circulation
5948374|NCT03774966|total knee arthroplasty|total knee arthroplasty
5948375|NCT03774966|regional block|regional block
5948380|NCT03774407|remyelination|remyelination
5948381|NCT03774407|urogenital health|urogenital health
5948382|NCT03774407|multiple sclerosis|multiple sclerosis
5948398|NCT03772990|inotropic support|inotropic support
5948399|NCT03772990|calcium chloride|calcium chloride
5948400|NCT03772990|cardiopulmonary bypass|cardiopulmonary bypass
5948401|NCT03772990|cardiac surgery|cardiac surgery
5253419|NCT02425995|ACL|acl
5948454|NCT03762200|bleeding|bleeding
5948455|NCT03762200|broad area oozing bleeding|broad area oozing bleeding
5948456|NCT03762200|hemostat|hemostat
5948457|NCT03762200|topical hemostatic agents|topical hemostatic agents
5948458|NCT03762200|adjunctive hemostats|adjunctive hemostats
5948491|NCT03757975|quality of life|quality of life
5948492|NCT03757975|urethral length|urethral length
5948493|NCT03757975|sexual function|sexual function
5948494|NCT03757572|Pilonidal|pilonidal
5948495|NCT03757572|Fistula|fistula
5948496|NCT03757572|Cyst|cyst
5948497|NCT03757572|Alginate|alginate
5948498|NCT03757572|Gauze|gauze
5948499|NCT03757572|Dressings|dressings
5948500|NCT03757572|Prospective|prospective
5948501|NCT03757572|Randomized Controlled Trial|randomized controlled trial
5948520|NCT03751176|Clinical trial, phase II|clinical trial, phase ii
5948521|NCT03751176|Aged (at least 18 years old)|aged (at least 18 years old)
5948522|NCT03751176|Progression -Free - Survival|progression -free - survival
5948523|NCT03751176|Safety|safety
5948524|NCT03751176|Conversion rate of RAS/BRAF status in liquid biopsy|conversion rate of ras/braf status in liquid biopsy
5948525|NCT03751176|Chemotherapy regimen|chemotherapy regimen
5948526|NCT03751176|Monoclonal antibody|monoclonal antibody
5948527|NCT03751176|FOLFIRI|folfiri
5948528|NCT03751176|Panitumumab|panitumumab
5948529|NCT03751176|RAS/BRAF Wild-type|ras/braf wild-type
5948699|NCT03733028|posttraumatic stress disorder|posttraumatic stress disorder
5948700|NCT03733028|hostile interpretation bias|hostile interpretation bias
5948701|NCT03733028|mHealth|mhealth
5948716|NCT03730662|GIP|gip
5948717|NCT03730662|GLP-1|glp-1
5948718|NCT03730662|glucose metabolism disorders|glucose metabolism disorders
5948719|NCT03730662|metabolic diseases|metabolic diseases
5948720|NCT03730662|endocrine system diseases|endocrine system diseases
5948721|NCT03730662|cardiovascular risk|cardiovascular risk
5949027|NCT03684109|Glioma|glioma
5949028|NCT03684109|Brain Tumor|brain tumor
5949029|NCT03684109|Primary Brain Tumor|primary brain tumor
5949030|NCT03684109|Malignant Primary Brain Tumor|malignant primary brain tumor
5949031|NCT03684109|Malignant Glioma|malignant glioma
5949032|NCT03684109|Non-invasive glioma characterization|non-invasive glioma characterization
5949033|NCT03684109|Molecular Imaging|molecular imaging
5949034|NCT03684109|Isocitrate Dehydrogenase (IDH) Mutations|isocitrate dehydrogenase (idh) mutations
5949035|NCT03684109|MRI-Based Sequencing|mri-based sequencing
5949072|NCT03682055|Epstein-Barr Virus|epstein-barr virus
5949073|NCT03682055|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5949075|NCT03682055|EBV|ebv
5949076|NCT03682055|EBNA1 inhibitor|ebna1 inhibitor
5949077|NCT03682055|VK-2019|vk-2019
5949078|NCT03682055|Nasopharynx cancer|nasopharynx cancer
5949079|NCT03682055|Nasopharynx carcinoma|nasopharynx carcinoma
5949087|NCT03680768|Health|health
5949088|NCT03680768|Risk of disease|risk of disease
5949089|NCT03680768|Prediction|prediction
5949090|NCT03680768|Lifestyle|lifestyle
5259575|NCT02391051|PSA|psa
5280142|NCT02274155|Immunotherapy|immunotherapy
5949498|NCT03627065|Primary Sjögren's syndrome|primary sjögren's syndrome
5949499|NCT03627065|PI3Kδ inhibitor|pi3kδ inhibitor
5359368|NCT01905215|Safety|safety
5254364|NCT02421081|CD133|cd133
5949565|NCT03616808|Traumatic brain injury|traumatic brain injury
5949566|NCT03616808|Craniotomy|craniotomy
5949567|NCT03616808|Goal-directed treatment|goal-directed treatment
5949568|NCT03616808|Thromboelastometry|thromboelastometry
5949661|NCT03607825|aneurysmal|aneurysmal
5949664|NCT03606538|metabolism|metabolism
5949665|NCT03606538|methylenedioxymethamphetamine|methylenedioxymethamphetamine
5949839|NCT03575897|Premature Infants|premature infants
5949840|NCT03575897|Body composition|body composition
5949932|NCT03564691|PD1|pd1
5949933|NCT03564691|PD-1|pd-1
5949934|NCT03564691|PDL1|pdl1
5949935|NCT03564691|PD-L1|pd-l1
5260518|NCT02385591|SMS|sms
5950004|NCT03549299|limbal stem cell deficiency|limbal stem cell deficiency
5950005|NCT03549299|ABCB5|abcb5
5950006|NCT03549299|Limbal stem cells|limbal stem cells
5950007|NCT03549299|LSCs|lscs
5950008|NCT03549299|LSC|lsc
5950009|NCT03549299|allogeneic|allogeneic
5950010|NCT03549299|tissue engineered product|tissue engineered product
5950011|NCT03549299|phase I/IIa|phase i/iia
5950046|NCT03542240|curcumin|curcumin
5950047|NCT03542240|microbiome|microbiome
5950048|NCT03542240|dietary supplements|dietary supplements
5950049|NCT03542240|gut bacteria|gut bacteria
5950098|NCT03535194|Interleukin-23 (IL-23)|interleukin-23 (il-23)
5950405|NCT03492177|Pediatric|pediatric
5950441|NCT03485807|stress|stress
5950442|NCT03485807|mindfulness|mindfulness
5950443|NCT03485807|active coping|active coping
5950447|NCT03485287|PTSD|ptsd
5950448|NCT03485287|MDMA|mdma
5950449|NCT03485287|Psychotherapy|psychotherapy
5273623|NCT02311101|BCG|bcg
5951106|NCT03401398|hydrocortisone|hydrocortisone
5951107|NCT03401398|refractory septic shock|refractory septic shock
5951108|NCT03401398|sepsis|sepsis
5951109|NCT03401398|new/progressive MODS|new/progressive mods
5951110|NCT03401398|mortality|mortality
5951111|NCT03401398|health-related quality of life|health-related quality of life
5951112|NCT03401398|corticosteroid adverse events|corticosteroid adverse events
5951113|NCT03401398|sepsis biomarkers|sepsis biomarkers
5951120|NCT03400943|Uterine fibroids|uterine fibroids
5951121|NCT03400943|Heavy menstrual bleeding|heavy menstrual bleeding
5951122|NCT03400163|First Line Therapy|first line therapy
5951123|NCT03400163|NASH|nash
5951184|NCT03387462|Adherence|adherence
5951185|NCT03387462|PrEP|prep
5951186|NCT03387462|HIV Prevention|hiv prevention
5951187|NCT03387462|Truvada|truvada
5951188|NCT03387462|HIV Risk Reduction|hiv risk reduction
5951189|NCT03387462|Mobile App|mobile app
5951721|NCT03289195|MRI|mri
5951722|NCT03289195|Biopsy|biopsy
5951723|NCT03289195|17-390|17-390
5951772|NCT03282123|MDMA|mdma
5951773|NCT03282123|methylenedioxymethamphetamine|methylenedioxymethamphetamine
5951774|NCT03282123|psychotherapy|psychotherapy
5951800|NCT03276533|dexmedetomidine; lidocaine; cytokine|dexmedetomidine; lidocaine; cytokine
5951821|NCT03267784|diabetic neuropathic ulcer|diabetic neuropathic ulcer
5951822|NCT03267784|ABCB5|abcb5
5951823|NCT03267784|allogeneic|allogeneic
5951824|NCT03267784|mesenchymal stem cells|mesenchymal stem cells
5951825|NCT03267784|skin ulcer|skin ulcer
5951826|NCT03267784|advanced therapy medicinal product|advanced therapy medicinal product
5951827|NCT03267784|somatic cell therapy|somatic cell therapy
5951828|NCT03267784|phase I/IIa|phase i/iia
5951829|NCT03267784|Diabetic Foot Ulcer|diabetic foot ulcer
5951861|NCT03262766|Acute Intermittent Hypoxia|acute intermittent hypoxia
5951862|NCT03262766|Upper Extremity Training|upper extremity training
5256319|NCT02410655|Bolus|bolus
5953312|NCT02962414|Tuberous sclerosis complex|tuberous sclerosis complex
5953313|NCT02962414|TSC|tsc
5953314|NCT02962414|Refractory seizure|refractory seizure
5953315|NCT02962414|Roll over study|roll over study
5953316|NCT02962414|Long term safety|long term safety
5953317|NCT02962414|PASS|pass
5257552|NCT02403505|SNP|snp
5954122|NCT02750319|N-Acetylcysteine|n-acetylcysteine
5954123|NCT02750319|16-307|16-307
5954146|NCT02742844|phase I/IIa|phase i/iia
5954147|NCT02742844|mesenchymal stem cells|mesenchymal stem cells
5954148|NCT02742844|ABCB5+|abcb5+
5954149|NCT02742844|APZ2|apz2
5954150|NCT02742844|chronic venous ulcer|chronic venous ulcer
5954151|NCT02742844|varicose ulcer|varicose ulcer
5954152|NCT02742844|skin ulcer|skin ulcer
5954153|NCT02742844|advanced therapy medicinal product|advanced therapy medicinal product
5954154|NCT02742844|APZ2-II-01|apz2-ii-01
5954155|NCT02742844|autologous use|autologous use
5954156|NCT02742844|somatic cell therapy|somatic cell therapy
5954161|NCT02740205|Patients with Enteral Feeding|patients with enteral feeding
5245831|NCT02469766|ureter|ureter
5954205|NCT02729064|Intranasal Insulin|intranasal insulin
5954206|NCT02729064|Insulin concentration|insulin concentration
5954207|NCT02729064|Blood glucose|blood glucose
5954208|NCT02729064|Cerebro Spinal Fluid insulin|cerebro spinal fluid insulin
5954209|NCT02729064|Intraoperative blood glucose|intraoperative blood glucose
5954210|NCT02729064|Cardiac Surgery|cardiac surgery
5280250|NCT02273648|PCI|pci
5954211|NCT02729064|Thoracic Surgery|thoracic surgery
5954697|NCT02598271|Acute Kidney Injury|acute kidney injury
5954698|NCT02598271|Cardiac Surgery|cardiac surgery
5955364|NCT02388230|Breast cancer|breast cancer
5955365|NCT02388230|Elastography|elastography
5955366|NCT02388230|Ultrasound imaging|ultrasound imaging
5955367|NCT02388230|Quantification of toxicity|quantification of toxicity
5955368|NCT02388230|Side-effects|side-effects
5955395|NCT02377505|Treatment-Resistant Schizophrenia|treatment-resistant schizophrenia
5955396|NCT02377505|Deep Brain Stimulation|deep brain stimulation
5955642|NCT02304302|Memantine|memantine
5955643|NCT02304302|Episodic Memory|episodic memory
5955644|NCT02304302|CVLT|cvlt
5955645|NCT02304302|Hippocampus dependent memory|hippocampus dependent memory
5955646|NCT02304302|Short-term memory|short-term memory
5955673|NCT02298816|Monoclonal gammopathy of undetermined significance (MGUS)|monoclonal gammopathy of undetermined significance (mgus)
5955674|NCT02298816|Smoldering multiple myeloma (SMM)|smoldering multiple myeloma (smm)
5955675|NCT02298816|Multiple myeloma (MM)|multiple myeloma (mm)
5955676|NCT02298816|Waldenstroms Macroglobulinemia (WM)|waldenstroms macroglobulinemia (wm)
5955677|NCT02298816|Monoclonal B-cell lymphocytosis (MBL)|monoclonal b-cell lymphocytosis (mbl)
5955678|NCT02298816|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5955679|NCT02298816|B-Cell Non-Hodgkin lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
5955680|NCT02298816|B-Cell Hematologic Malignancies|b-cell hematologic malignancies
5955681|NCT02298816|immunization|immunization
5955682|NCT02298816|Vaccination|vaccination
5955683|NCT02298816|Influenza, Human|influenza, human
5955684|NCT02298816|Pneumonia|pneumonia
5956114|NCT02141451|DLBCL|dlbcl
5279539|NCT02277977|sepsis|sepsis
5956182|NCT02117791|Riociguat, Adempas, sGC stimulator, CTEPH, Japan, PMS|riociguat, adempas, sgc stimulator, cteph, japan, pms
5956268|NCT02078804|Colorectal cancer|colorectal cancer
5956269|NCT02078804|Mortality|mortality
5956270|NCT02078804|Incidence|incidence
5956271|NCT02078804|Screening|screening
5956272|NCT02078804|Health-economy|health-economy
5956303|NCT02060721|Chronic thromboembolic pulmonary hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5956383|NCT02047994|Gastric cancer mortality|gastric cancer mortality
5956384|NCT02047994|Helicobacter pylori treatment|helicobacter pylori treatment
5956385|NCT02047994|Pepsinogen testing|pepsinogen testing
5956386|NCT02047994|Endoscopy|endoscopy
5956387|NCT02047994|Volatile marker|volatile marker
5247703|NCT02459548|OSA|osa
5956455|NCT02020590|Delayed-Union Fractures|delayed-union fractures
5956456|NCT02020590|Impaired Healing|impaired healing
5956457|NCT02020590|Fractures|fractures
5956458|NCT02020590|Orthopedics|orthopedics
5260152|NCT02387593|Adenoma|adenoma
5956459|NCT02020590|Bone|bone
5956460|NCT02020590|Musculoskeletal Disorders|musculoskeletal disorders
5956517|NCT01990820|Pediatric Chronic Rhinosinusitis|pediatric chronic rhinosinusitis
5267543|NCT02345252|HIV|hiv
5247805|NCT02458976|PDL|pdl
5260259|NCT02387021|analgesia|analgesia
5956597|NCT01960946|Hypertension|hypertension
5956598|NCT01960946|Galectin 3|galectin 3
5956599|NCT01960946|Fibrosis|fibrosis
5956600|NCT01960946|Vascular Stiffness|vascular stiffness
5956601|NCT01960946|Echocardiography|echocardiography
5956607|NCT01957176|myelodysplastic syndromes|myelodysplastic syndromes
5956608|NCT01957176|thrombocytopenia|thrombocytopenia
5956609|NCT01957176|acute myeloid leukemia|acute myeloid leukemia
5956610|NCT01957176|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5956611|NCT01957176|Eltrombopag|eltrombopag
5956612|NCT01957176|pediatrics|pediatrics
5248263|NCT02455973|obesity|obesity
5260677|NCT02384863|Cardiac|cardiac
5957125|NCT01736085|tobacco cessation|tobacco cessation
5957126|NCT01736085|smoking cessation|smoking cessation
5957127|NCT01736085|nicotine|nicotine
5957128|NCT01736085|telephone counseling|telephone counseling
5957129|NCT01736085|self-help|self-help
5957130|NCT01736085|smoking abstinence|smoking abstinence
5957131|NCT01736085|tobacco use disorder|tobacco use disorder
5957132|NCT01736085|nicotine replacement therapy|nicotine replacement therapy
5957133|NCT01736085|voucher|voucher
5345632|NCT01969240|Cardiac|cardiac
5261200|NCT02381834|Infant|infant
5261201|NCT02381834|Neonate|neonate
5261202|NCT02381834|Bacterial Infection|bacterial infection
5261203|NCT02381821|junctional zone|junctional zone
5261204|NCT02381821|Implantation|implantation
5261206|NCT02381717|ultrasound|ultrasound
5261599|NCT02379754|acoustic neuroma|acoustic neuroma
5958234|NCT01192464|Hodgkin's Lymphoma|hodgkin's lymphoma
5958235|NCT01192464|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5958241|NCT01184183|Patch for Carotid Endarterectomy|patch for carotid endarterectomy
5958444|NCT01014390|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant|benign biliary strictures secondary to chronic pancreatitis/post abdominal surgery/post liver transplant
5958529|NCT00939653|relapse|relapse
5958530|NCT00939653|refractory|refractory
5958531|NCT00939653|AML|aml
5958532|NCT00939653|Acute myelogenous leukemia|acute myelogenous leukemia
5958533|NCT00939653|Relapsed AML|relapsed aml
5282010|NCT02263040|adult|adult
5269631|NCT02333058|ALL|all
5266985|NCT02348489|AML|aml
5254570|NCT02420106|OMM|omm
5267328|NCT02346461|GNE Gene|gne gene
5267544|NCT02345226|HIV|hiv
5255089|NCT02417298|pain|pain
5268180|NCT02341807|AAV|aav
5256131|NCT02411695|Otsuka,|otsuka,
5269021|NCT02336828|MEWS|mews
5269022|NCT02336828|deteriorate|deteriorate
5269023|NCT02336828|oncology|oncology
5269024|NCT02336828|ICU|icu
5269025|NCT02336828|predicting outcomes|predicting outcomes
5269026|NCT02336828|MEWS in predicting outcomes in oncology patients|mews in predicting outcomes in oncology patients
5269039|NCT02336802|Anxiety|anxiety
5269040|NCT02336802|Fear|fear
5269041|NCT02336802|Avoidance|avoidance
5269042|NCT02336776|Chronic Kidney Disease|chronic kidney disease
5269043|NCT02336776|Electrical Stimulation|electrical stimulation
5269143|NCT02336074|Infection|infection
5269955|NCT02331017|Bimodal|bimodal
5372279|NCT01848223|QoL|qol
5271208|NCT02324062|Cancer Genetics|cancer genetics
5271329|NCT02323477|ischemic heart disease|ischemic heart disease
5258982|NCT02394665|GBM|gbm
5271633|NCT02322034|multiple neurohormonal axis disequilibrium|multiple neurohormonal axis disequilibrium
5271634|NCT02322034|growth hormone deficiency|growth hormone deficiency
5271635|NCT02322034|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
5271636|NCT02322034|metabolic deficiency syndrome|metabolic deficiency syndrome
5358260|NCT01910818|CO2|co2
5271832|NCT02321072|critical care|critical care
5272040|NCT02319798|IBD|ibd
5272144|NCT02319265|sepsis|sepsis
5272240|NCT02318797|Mixed methods|mixed methods
5358977|NCT01907334|asthma|asthma
5272664|NCT02316457|RNA|rna
5359523|NCT01904552|i-Root|i-root
5273146|NCT02313909|Blood Thinner|blood thinner
5273147|NCT02313909|Stroke|stroke
5273148|NCT02313909|Ischemic Stroke|ischemic stroke
5273149|NCT02313909|Cryptogenic Stroke|cryptogenic stroke
5273150|NCT02313909|Embolic stroke of undetermined source|embolic stroke of undetermined source
5260928|NCT02383316|Shp2|shp2
5273620|NCT02311114|Ontario Telemedicine Network|ontario telemedicine network
5273621|NCT02311101|bladder cancer|bladder cancer
5273622|NCT02311101|mitomycin|mitomycin
5273624|NCT02311101|intravesical|intravesical
5273625|NCT02311101|non-muscle invasive|non-muscle invasive
5273928|NCT02309281|Eylea|eylea
5261737|NCT02378883|Apollo|apollo
5274336|NCT02307097|IAPT|iapt
5261943|NCT02377856|SVR|svr
5275065|NCT02302820|Advance Directive|advance directive
5275915|NCT02298348|NANT|nant
5263401|NCT02369263|DVT|dvt
5276363|NCT02295397|ED05|ed05
5276561|NCT02294435|TAAA|taaa
5364856|NCT01880684|Leg|leg
5277556|NCT02289235|Ginger|ginger
5265826|NCT02355249|MIE|mie
5278755|NCT02281812|Stage 1|stage 1
5367007|NCT01870986|PK|pk
5266764|NCT02349828|HSV|hsv
5279852|NCT02275897|Anesthesia|anesthesia
5280058|NCT02274506|NHL|nhl
5385329|NCT01788527|CGM|cgm
5281516|NCT02266563|amyloid|amyloid
5281804|NCT02264704|Fatigue|fatigue
5282199|NCT02261935|Palliative care|palliative care
5283394|NCT02255032|UME|ume
5271159|NCT02324426|CNS|cns
5283678|NCT02253329|Ageing|ageing
5374238|NCT01838941|PBD|pbd
5924148|NCT04274777|Lipid Peroxidation|lipid peroxidation
5924149|NCT04274764|Telemedicine|telemedicine
5924150|NCT04274764|Motivational interviewing|motivational interviewing
5924151|NCT04274764|Health Coaching|health coaching
5924152|NCT04274751|Transcatheter aortic valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
5924153|NCT04274751|Transaxillary approach|transaxillary approach
5924154|NCT04274712|liquid biopsy|liquid biopsy
5924156|NCT04274699|Liver Transplantation|liver transplantation
5924157|NCT04274699|Thromboelastography|thromboelastography
5924158|NCT04274699|Coagulopathy|coagulopathy
5924161|NCT04274582|oxidative stress|oxidative stress
5924162|NCT04274582|handball players|handball players
5924175|NCT04274439|Chronic Pain|chronic pain
5924176|NCT04274439|Telerehabilitation|telerehabilitation
5924177|NCT04274439|Telemedicine|telemedicine
5924178|NCT04274439|Physical Therapy|physical therapy
5924179|NCT04274387|cognitive reappraisal, mindfulness, emotion regulation, emotional distress|cognitive reappraisal, mindfulness, emotion regulation, emotional distress
5924180|NCT04274374|spondyloarthritis|spondyloarthritis
5924181|NCT04274374|ankylosing spondylitis|ankylosing spondylitis
5924182|NCT04274374|gluten-free diet|gluten-free diet
5924183|NCT04274374|gut microbiota|gut microbiota
5924184|NCT04274322|Critically Ill|critically ill
5924185|NCT04274322|Coronavirus Infections|coronavirus infections
5924186|NCT04274322|Nutritional Risk|nutritional risk
5924187|NCT04274322|Nutrition|nutrition
5924188|NCT04274322|Intensive Care Unit|intensive care unit
5924189|NCT04274270|lung cancer, SBRT, s1,endostar|lung cancer, sbrt, s1,endostar
5924190|NCT04274244|Periodontitis|periodontitis
5924191|NCT04274244|Hyaluronic acid|hyaluronic acid
5924192|NCT04274244|Periodontal regeneration|periodontal regeneration
5924202|NCT04274179|ketogenic|ketogenic
5924203|NCT04274179|diet|diet
5924204|NCT04274179|absence|absence
5924205|NCT04274153|Human Papilloma Virus|human papilloma virus
5924206|NCT04274153|HPV|hpv
5924207|NCT04274153|Immunization|immunization
5924208|NCT04274127|Autism Spectrum Disorder|autism spectrum disorder
5924209|NCT04274127|screening|screening
5924210|NCT04274127|ITC|itc
5924211|NCT04274127|M-CHAT-R|m-chat-r
5924212|NCT04274114|generalized anxiety disorder|generalized anxiety disorder
5924213|NCT04274114|randomized controlled trial|randomized controlled trial
5924214|NCT04274114|psychopharmacology|psychopharmacology
5924215|NCT04274114|drug therapy|drug therapy
5924216|NCT04274114|glutamine|glutamine
5924218|NCT04274062|placenta previa|placenta previa
5924219|NCT04274062|Nursing|nursing
5924220|NCT04274062|antepartum hemorrhage|antepartum hemorrhage
5924221|NCT04274062|randomized trial|randomized trial
5924222|NCT04274049|HGF|hgf
5924223|NCT04274049|Gene|gene
5924224|NCT04274049|Critical Limb Ischemia|critical limb ischemia
5924225|NCT04274036|Fibromyalgia|fibromyalgia
5924226|NCT04274036|Social Support|social support
5924227|NCT04274036|Stigma|stigma
5924228|NCT04274023|advanced clear cell sarcoma|advanced clear cell sarcoma
5924229|NCT04274023|anti-PDL1|anti-pdl1
5924230|NCT04274010|capsule endoscopy|capsule endoscopy
5924231|NCT04274010|ileocolonoscopy|ileocolonoscopy
5924232|NCT04274010|magnetic resonance enterography|magnetic resonance enterography
5924233|NCT04273984|misoprostol|misoprostol
5924234|NCT04273984|IUCD|iucd
5924235|NCT04273971|Adult|adult
5924236|NCT04273971|Lower extermity|lower extermity
5924237|NCT04273971|Plyometric exercise|plyometric exercise
5924238|NCT04273971|Muscle properties|muscle properties
5924239|NCT04273958|pain|pain
5924240|NCT04273958|virtual reality|virtual reality
5924241|NCT04273958|anxiety|anxiety
5924242|NCT04273958|emergency department|emergency department
5924243|NCT04273958|procedural pain|procedural pain
5924244|NCT04273932|Lithium|lithium
5924245|NCT04273932|Alpha-synuclein|alpha-synuclein
5924246|NCT04273906|Musculoskeletal Manipulations|musculoskeletal manipulations
5924247|NCT04273906|Osteoarthritis, Knee|osteoarthritis, knee
5924248|NCT04273906|Pain Threshold|pain threshold
5924249|NCT04273893|Lymphocyte Depletion and Change|lymphocyte depletion and change
5924250|NCT04273893|SBRT|sbrt
5924251|NCT04273893|NSCLC|nsclc
5924252|NCT04273828|back pain|back pain
5924253|NCT04273828|lumbar disc herniation|lumbar disc herniation
5924254|NCT04273828|lumbar spinal stenosis|lumbar spinal stenosis
5924255|NCT04273828|Decompression, surgical|decompression, surgical
5924256|NCT04273802|MDS high risk|mds high risk
5924257|NCT04273737|cerebral palsy|cerebral palsy
5924258|NCT04273737|amantadine|amantadine
5924259|NCT04273737|cognitive function|cognitive function
5924260|NCT04273737|gross motor skills|gross motor skills
5924261|NCT04273737|fine motor skills|fine motor skills
5924262|NCT04273737|mood|mood
5924310|NCT04273386|Systemic sclerosis|systemic sclerosis
5924311|NCT04273386|Mouth|mouth
5924315|NCT04273308|older adults|older adults
5924316|NCT04273308|community|community
5924317|NCT04273308|frailty biomarkers|frailty biomarkers
5924318|NCT04273308|health belief|health belief
5924319|NCT04273308|prefrailty|prefrailty
5924320|NCT04273308|quasi-experimental design|quasi-experimental design
5924321|NCT04273308|whole-body vibration training|whole-body vibration training
5924322|NCT04273295|Constipation|constipation
5924323|NCT04273295|Laxatives|laxatives
5924324|NCT04273295|Massage|massage
5924325|NCT04273269|GM1 Gangliosidosis|gm1 gangliosidosis
5924326|NCT04273269|Lysosomal Storage Disease|lysosomal storage disease
5924327|NCT04273269|Landing Disease|landing disease
5924328|NCT04273256|Myo-inositol, In-vitro fertilization, Poor Ovarian Responders, Infertility|myo-inositol, in-vitro fertilization, poor ovarian responders, infertility
5924332|NCT04273217|Healthy volunteers|healthy volunteers
5924333|NCT04273217|Monoclonal antibody|monoclonal antibody
5924334|NCT04273217|AV-1|av-1
5924335|NCT04273217|Safety|safety
5924336|NCT04273217|Dengue virus|dengue virus
5924337|NCT04273204|cerebral palsy,|cerebral palsy,
5924338|NCT04273204|gait,|gait,
5924339|NCT04273204|Gross Motor Function Measurement,|gross motor function measurement,
5924340|NCT04273204|stability,|stability,
5924341|NCT04273204|foot pressure|foot pressure
5924342|NCT04273191|Postpartum Depression|postpartum depression
5924343|NCT04273191|ZULRESSO|zulresso
5925273|NCT04207086|RECIST response|recist response
5925274|NCT04207086|Metabolic response|metabolic response
5925275|NCT04207086|Translational research|translational research
5925276|NCT04206826|natural film|natural film
5925286|NCT04206371|Defibrillation threshold testing|defibrillation threshold testing
5925287|NCT04206371|Defibrillation lead|defibrillation lead
5925288|NCT04206371|Defibrillator replacement|defibrillator replacement
5925297|NCT04206072|D-0316|d-0316
5925298|NCT04206072|EGFR mutated NSCLC|egfr mutated nsclc
5673679|NCT00607347|Atenolol|atenolol
5925451|NCT04192890|Irreversible Electroporation|irreversible electroporation
5925452|NCT04192890|Prostate Cancer|prostate cancer
5925453|NCT04192747|Coronary Ste|coronary ste
5925454|NCT04192747|Bioadaptor|bioadaptor
5925455|NCT04192747|Percutaneous Coronary Intervention|percutaneous coronary intervention
5925458|NCT04192227|Spouse|spouse
5925460|NCT04192227|Caregivers|caregivers
5925461|NCT04192227|Brain Injuries|brain injuries
4955415|NCT04267666|asthma|asthma
5926548|NCT04040894|Human monoclonal antibody|human monoclonal antibody
5926549|NCT04040894|insulin-like growth factor-1 receptor|insulin-like growth factor-1 receptor
5926550|NCT04040894|Thyroid-Associated Ophthalmopathy|thyroid-associated ophthalmopathy
5926551|NCT04040894|Hyperthyroidism|hyperthyroidism
5887509|NCT04253548|Adherence|adherence
5928136|NCT03832491|Pulmonary Rehabilitation|pulmonary rehabilitation
5928137|NCT03832491|Airway Clearance Techniques|airway clearance techniques
5928138|NCT03832491|Exergame|exergame
5928597|NCT03778229|epidermal growth factor receptor mutation positive|epidermal growth factor receptor mutation positive
5928598|NCT03778229|hepatocyte growth factor receptor|hepatocyte growth factor receptor
5928599|NCT03778229|savolitinib|savolitinib
5928600|NCT03778229|Osimertinib|osimertinib
5928601|NCT03778229|AZD9291|azd9291
5928602|NCT03778229|AZD6094|azd6094
5928603|NCT03778229|volitinib|volitinib
5928604|NCT03777488|pharmacokinetics, tranexamic acid|pharmacokinetics, tranexamic acid
5928615|NCT03777046|Post Partum|post partum
5928616|NCT03777046|Post Partum Depression|post partum depression
5928622|NCT03775109|Canakinumab|canakinumab
5928623|NCT03775109|Alcoholic Hepatitis|alcoholic hepatitis
5928624|NCT03775109|Alcohol Use Disorder|alcohol use disorder
5928625|NCT03775109|Interleukin|interleukin
5928626|NCT03775109|Treatment|treatment
5928627|NCT03775109|Ilaris|ilaris
5928628|NCT03775109|Liver disease|liver disease
5928629|NCT03775044|Telemedicine|telemedicine
5928630|NCT03775044|Medication Adherence|medication adherence
5928631|NCT03775044|Mental Health Issue|mental health issue
5929317|NCT03682679|large-to-massive rotator cuff tears|large-to-massive rotator cuff tears
5929318|NCT03682679|reparability|reparability
5930068|NCT03575390|Hearing|hearing
5930079|NCT03574818|Neoadjuvant Chemotherapy; NSCLC; nacitumumab|neoadjuvant chemotherapy; nsclc; nacitumumab
5931318|NCT03434262|CDK 4/6 inhibitor|cdk 4/6 inhibitor
5931319|NCT03434262|CDK 4/6 pathway|cdk 4/6 pathway
5931320|NCT03434262|CDK 4/6/cyclin/RB/E2F pathway|cdk 4/6/cyclin/rb/e2f pathway
5931321|NCT03434262|CDK6 amplification|cdk6 amplification
5931322|NCT03434262|CyclinD1|cyclind1
5931323|NCT03434262|DAWN|dawn
5931324|NCT03434262|D-type Cyclins|d-type cyclins
5931325|NCT03434262|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
5931326|NCT03434262|HGG|hgg
5932613|NCT03244644|C.Difficile Diarrhea|c.difficile diarrhea
5932614|NCT03244644|Fecal Transplant|fecal transplant
5932615|NCT03244644|Fecal Microbiota Transplant|fecal microbiota transplant
5932616|NCT03244644|Microbiota Restoration Therapy|microbiota restoration therapy
5932617|NCT03244644|Diarrhea|diarrhea
5932618|NCT03244644|FMT|fmt
5932619|NCT03244644|Microbial Suspension|microbial suspension
5932620|NCT03244540|postoperative pain|postoperative pain
5932621|NCT03244540|transversus abdominis plane block|transversus abdominis plane block
5932622|NCT03244540|quadratus lumborum block|quadratus lumborum block
5932623|NCT03244540|neuropathic pain|neuropathic pain
5932626|NCT03242850|Reading|reading
5932627|NCT03242850|Text Messages|text messages
5932628|NCT03242850|Video|video
5932629|NCT03242850|Cognitive Development|cognitive development
5932630|NCT03242850|Child Development|child development
5932631|NCT03242850|Infants|infants
5933198|NCT03151681|Romantic relationships|romantic relationships
5933225|NCT03138538|Advanced Solid Tumors|advanced solid tumors
5933226|NCT03138538|M8891|m8891
5933227|NCT03138538|Methionine Aminopeptidase 2 Inhibitor|methionine aminopeptidase 2 inhibitor
5900048|NCT02137070|Weightloss and brain function|weightloss and brain function
5934016|NCT02995824|Antiretroviral therapy|antiretroviral therapy
5901554|NCT01498328|CDX-110|cdx-110
5935543|NCT02628067|neuroendocrine tumor|neuroendocrine tumor
5935545|NCT02628067|endometrial carcinoma|endometrial carcinoma
5935546|NCT02628067|endometrial cancer|endometrial cancer
5935547|NCT02628067|cervical carcinoma|cervical carcinoma
5935548|NCT02628067|cervical cancer|cervical cancer
5935549|NCT02628067|vulvar carcinoma|vulvar carcinoma
5935550|NCT02628067|vulvar cancer|vulvar cancer
5935551|NCT02628067|small cell lung carcinoma|small cell lung carcinoma
5935552|NCT02628067|small cell lung cancer|small cell lung cancer
5935554|NCT02628067|mesothelioma|mesothelioma
5935555|NCT02628067|thyroid carcinoma|thyroid carcinoma
5935556|NCT02628067|thyroid cancer|thyroid cancer
5935557|NCT02628067|salivary gland carcinoma|salivary gland carcinoma
5935558|NCT02628067|salivary gland cancer|salivary gland cancer
5935559|NCT02628067|salivary cancer|salivary cancer
5935560|NCT02628067|parotid gland cancer|parotid gland cancer
5935561|NCT02628067|advanced solid tumors|advanced solid tumors
5935562|NCT02628067|colorectal carcinoma|colorectal carcinoma
5356733|NCT01918241|Efficacy|efficacy
5356734|NCT01918241|Satety|satety
5356735|NCT01918202|Enzyme occupancy|enzyme occupancy
5356737|NCT01918202|Phosphodiesterase 10 inhibitor|phosphodiesterase 10 inhibitor
5356738|NCT01918189|back pain|back pain
5356739|NCT01918189|low back pain|low back pain
5356740|NCT01918189|chronic pain|chronic pain
5356741|NCT01918189|cognitive behavior therapy|cognitive behavior therapy
5356742|NCT01918189|behavior therapy|behavior therapy
5356743|NCT01918176|Palbociclib|palbociclib
5356744|NCT01918176|PD-0332991|pd-0332991
5356745|NCT01918176|Proton Pump Inhibitor|proton pump inhibitor
5356746|NCT01918176|DDI|ddi
5356747|NCT01918176|Healthy Volunteers|healthy volunteers
5356748|NCT01918176|Pharmacokinetics|pharmacokinetics
5356749|NCT01918176|Rabeprazole|rabeprazole
5356750|NCT01918163|pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress|pomegranate pills, male infertility, pregnancy rate, semen analysis, ros, oxidative stress
5356751|NCT01918124|disease free survival, overall survival|disease free survival, overall survival
5356752|NCT01918111|Renal denervation, Exercise diastolic function, Atherosclerosis, New methods|renal denervation, exercise diastolic function, atherosclerosis, new methods
5356753|NCT01918072|Women's Health|women's health
5356754|NCT01918072|Hospitals, Veterans|hospitals, veterans
5356755|NCT01918072|Education|education
5356756|NCT01918072|Remote consultation|remote consultation
5356757|NCT01918072|Videoconferencing|videoconferencing
5356758|NCT01918059|Trauma|trauma
5356759|NCT01918059|Eyelid|eyelid
5005963|NCT03959475|healthcare|healthcare
5005965|NCT03959475|emergency department|emergency department
5005967|NCT03959462|tDCS|tdcs
5005968|NCT03959449|Motor imagery|motor imagery
5005969|NCT03959449|Action observation|action observation
5005970|NCT03959449|Hypoalgesia|hypoalgesia
5005972|NCT03959410|cervical cancer|cervical cancer
5005973|NCT03959410|microbiome|microbiome
5005974|NCT03959397|Breast cancer; neoadjuvant therapy; Nab-paclitaxel|breast cancer; neoadjuvant therapy; nab-paclitaxel
5005975|NCT03959371|Myelofibrosis|myelofibrosis
5005976|NCT03959371|Ruxolitinib|ruxolitinib
5005977|NCT03959371|Real world data|real world data
5005978|NCT03959319|clinical trial|clinical trial
5005979|NCT03959319|rehabilitation|rehabilitation
5005980|NCT03959319|joint mobilization|joint mobilization
5005981|NCT03959319|movement training|movement training
5005982|NCT03959306|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5005983|NCT03959306|Black Seed Oil|black seed oil
5005984|NCT03959306|Endothelial Dysfunction|endothelial dysfunction
5005985|NCT03959280|obstructive sleep apnea|obstructive sleep apnea
5005986|NCT03959280|CPAP therapy|cpap therapy
5005987|NCT03959280|exercise|exercise
5005988|NCT03959280|diet|diet
5005989|NCT03959280|quality of life|quality of life
5005990|NCT03959267|Latinas|latinas
5005991|NCT03959267|Survivors|survivors
5005992|NCT03959241|Acute Leukemia|acute leukemia
5005993|NCT03959241|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5005994|NCT03959241|Myelodysplasia (MDS)|myelodysplasia (mds)
5886523|NCT04273061|Phase 2|phase 2
5886524|NCT04273061|Precision targeting|precision targeting
5886525|NCT04273035|Preanesthetic medication|preanesthetic medication
5886526|NCT04273035|Handheld computer|handheld computer
5886527|NCT04273035|Midazolam|midazolam
5886528|NCT04273035|Multimedia|multimedia
5886529|NCT04273035|Anxiety|anxiety
5886567|NCT04272840|Gestational Diabetes|gestational diabetes
5886568|NCT04272840|Glycaemic or Glycemic Index|glycaemic or glycemic index
5886569|NCT04272840|Nutrition|nutrition
5886570|NCT04272840|Education|education
5886571|NCT04272840|Behaviour|behaviour
5886572|NCT04272827|Lipedema|lipedema
5886573|NCT04272827|complex decongestive therapy(CDT)|complex decongestive therapy(cdt)
5886574|NCT04272827|liposuction|liposuction
5886575|NCT04272801|breast cancer|breast cancer
5886576|NCT04272801|endocrine therapy|endocrine therapy
5886577|NCT04272801|radiation|radiation
5886578|NCT04272801|letrozole|letrozole
5886579|NCT04272801|anastrozole|anastrozole
5886580|NCT04272801|exemestane|exemestane
5886581|NCT04272801|tamoxifen|tamoxifen
5886582|NCT04272801|survey|survey
5886583|NCT04272801|questionnaire|questionnaire
5886584|NCT04272801|geriatric|geriatric
5886585|NCT04272788|Crohn Disease|crohn disease
5886586|NCT04272788|Infliximab|infliximab
5886587|NCT04272788|Treg|treg
5886588|NCT04272788|Breg|breg
5886590|NCT04272762|Atrial Fibrillation|atrial fibrillation
5886591|NCT04272762|Ablation|ablation
5886592|NCT04272762|Cryoablation|cryoablation
5886593|NCT04272749|milk|milk
5886594|NCT04272749|dairy|dairy
5886595|NCT04272749|plant-based milk alternatives|plant-based milk alternatives
5886596|NCT04272749|consumer choices|consumer choices
5886597|NCT04272749|consumer behavior|consumer behavior
5886598|NCT04272723|Survey|survey
5886599|NCT04272723|Venous Thromboembolism|venous thromboembolism
5886600|NCT04272723|Deep Vein Thrombosis|deep vein thrombosis
5886601|NCT04272723|Pulmonary Embolism|pulmonary embolism
5886602|NCT04272723|Anticoagulant|anticoagulant
5886603|NCT04272723|Clinical Practice|clinical practice
5886604|NCT04272723|Therapeutic management|therapeutic management
5886605|NCT04272697|Familial hypercholesterolaemia|familial hypercholesterolaemia
5886606|NCT04272697|Primary dyslipidaemia|primary dyslipidaemia
5886607|NCT04272697|Cardiovascular disease prevention|cardiovascular disease prevention
5886608|NCT04272697|LDL cholesterol|ldl cholesterol
5886609|NCT04272697|Genetic lipids disorders|genetic lipids disorders
5886610|NCT04272684|Driving|driving
5886611|NCT04272671|De-Prescribing|de-prescribing
5886612|NCT04272671|Falls in Older Adults|falls in older adults
5886613|NCT04272671|Benzodiazepines|benzodiazepines
5886615|NCT04272632|Coload|coload
5886616|NCT04272632|Inferior vena cava collapsibility index|inferior vena cava collapsibility index
5886617|NCT04272632|Norepinephrine|norepinephrine
5886618|NCT04272632|Cesarean section|cesarean section
5886619|NCT04272632|Dose-finding|dose-finding
5886626|NCT04272593|pattern recognition|pattern recognition
5886627|NCT04272593|home trial|home trial
5886628|NCT04272593|randomized cross-over trial|randomized cross-over trial
5886629|NCT04272593|prosthesis|prosthesis
5886630|NCT04272593|electromyography|electromyography
5886631|NCT04272580|Preload|preload
5886654|NCT04272476|cerebral function|cerebral function
4960854|NCT04234113|Thymic Cancer|thymic cancer
4960928|NCT04233840|HCC|hcc
5886660|NCT04272450|respiratory muscle strenght|respiratory muscle strenght
5886661|NCT04272450|Turkey|turkey
5886662|NCT04272450|Istanbul|istanbul
5886663|NCT04272437|Nursing Homes|nursing homes
5886664|NCT04272437|TCM herbal extracts|tcm herbal extracts
5886665|NCT04272398|cerebral palsy|cerebral palsy
5886666|NCT04272398|dynamic orthoses|dynamic orthoses
5886667|NCT04272398|gait analysis|gait analysis
5886668|NCT04272398|movement|movement
5886669|NCT04272398|neoprene|neoprene
5886670|NCT04272398|rehabilitation|rehabilitation
5886671|NCT04272385|trigeminal neuralgia, treatment outcome, outcome measure, patient related outcome measures|trigeminal neuralgia, treatment outcome, outcome measure, patient related outcome measures
5886675|NCT04272359|Sulfaniluree/glinidi|sulfaniluree/glinidi
5886676|NCT04272333|precision oncology|precision oncology
5886677|NCT04272333|intratumoral microdosing|intratumoral microdosing
5886678|NCT04272333|microdose injection|microdose injection
5886679|NCT04272333|microdosing|microdosing
5886680|NCT04272333|in vivo oncology|in vivo oncology
5886681|NCT04272333|in vivo drug sensitivity|in vivo drug sensitivity
5886682|NCT04272333|tumor microenvironment|tumor microenvironment
5886683|NCT04272333|multiplexed immunohistochemistry|multiplexed immunohistochemistry
5886684|NCT04272333|HNSCC|hnscc
5886685|NCT04272333|SCCHN|scchn
5886686|NCT04272333|pharmacodynamic biomarkers|pharmacodynamic biomarkers
5886687|NCT04272333|CIVO|civo
5886700|NCT04272203|Advanced Solid Tumors Cancer|advanced solid tumors cancer
5886701|NCT04272203|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5886702|NCT04272203|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5886703|NCT04272203|Blood Cancer|blood cancer
5886704|NCT04272203|ABBV-184|abbv-184
5886705|NCT04272203|Cancer|cancer
5886706|NCT04272190|Cervical cancer|cervical cancer
5886707|NCT04272190|Preoperative treatment|preoperative treatment
5886708|NCT04272190|Surgical approach|surgical approach
5886709|NCT04272190|Hysterectomy type|hysterectomy type
5886710|NCT04272190|Radiochemotherapy|radiochemotherapy
5886711|NCT04272177|shared decision making, sugammadex, patient decision aids|shared decision making, sugammadex, patient decision aids
5886712|NCT04272164|Taekwondo, Physical fitness, weighted rope jump training.|taekwondo, physical fitness, weighted rope jump training.
5886713|NCT04272151|Multiple Myeloma|multiple myeloma
5886714|NCT04272151|Chimeric Antigen Receptor T cell|chimeric antigen receptor t cell
5886715|NCT04272151|BCMA|bcma
5886716|NCT04272125|Leukemia|leukemia
5886717|NCT04272125|Acute Myeloid Leukemia|acute myeloid leukemia
5886718|NCT04272125|CD123|cd123
5886719|NCT04272125|CAR-T|car-t
5886759|NCT04271943|COGNITIVE EXERCISE|cognitive exercise
5886760|NCT04271930|Sleep|sleep
5886761|NCT04271930|Insomnia|insomnia
5886762|NCT04271930|Mindfulness Awareness Practices for Insomnia|mindfulness awareness practices for insomnia
5886763|NCT04271930|Sleep Health Education|sleep health education
5886764|NCT04271930|Multiple Myeloma|multiple myeloma
5886765|NCT04271930|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
5886766|NCT04271930|Depression|depression
5886767|NCT04271930|Inflammation|inflammation
5886768|NCT04271930|Sleep hygiene|sleep hygiene
5886769|NCT04271930|Fatigue|fatigue
5886770|NCT04271917|cannabidiol|cannabidiol
5886771|NCT04271917|CBD|cbd
5886772|NCT04271917|acute pain|acute pain
5886773|NCT04271917|alternative pain management|alternative pain management
5886774|NCT04271917|simple extraction|simple extraction
5886775|NCT04271878|postural tachycardia|postural tachycardia
5886776|NCT04271878|autonomic|autonomic
5886777|NCT04271878|orthostatic intolerance|orthostatic intolerance
5886778|NCT04271878|dysautonomia|dysautonomia
5886779|NCT04271865|HCV treated patients|hcv treated patients
5886780|NCT04271865|Anemia|anemia
5886781|NCT04271865|Dates|dates
5886782|NCT04271800|Leukemia|leukemia
5886783|NCT04271800|Lymphoma|lymphoma
5886784|NCT04271800|CD19|cd19
5886785|NCT04271800|CAR-T|car-t
5886786|NCT04271787|Classification|classification
5886787|NCT04271787|Periodontal diseases|periodontal diseases
5886788|NCT04271787|Periodontitis|periodontitis
5886789|NCT04271787|Peri-implantitis|peri-implantitis
5886790|NCT04271774|autism|autism
5886791|NCT04271774|microbiome|microbiome
5886792|NCT04271774|infants|infants
5886793|NCT04271774|pregnancy|pregnancy
5886794|NCT04271774|genetic|genetic
5285006|NCT02246972|PTSD|ptsd
5886796|NCT04271748|Fasting|fasting
5886797|NCT04271748|Time Restricted Feeding|time restricted feeding
5280846|NCT02270060|Music Therapy|music therapy
5886798|NCT04271748|Intermittent Fasting|intermittent fasting
5886799|NCT04271748|Inflammatory Bowel Diseases (IBD)|inflammatory bowel diseases (ibd)
5886800|NCT04271748|IBD|ibd
5886832|NCT04271657|Pathologic complete response|pathologic complete response
5886833|NCT04271657|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5886835|NCT04271644|BCMA|bcma
5886836|NCT04271644|Chimeric Antigen Receptor T Cell|chimeric antigen receptor t cell
5886837|NCT04271631|Type 2 diabetes mellitus|type 2 diabetes mellitus
5886838|NCT04271631|Mobile Application-Based Diabetes Education|mobile application-based diabetes education
5886839|NCT04271631|Health Coaching|health coaching
5886840|NCT04271605|osteoporosis|osteoporosis
5886841|NCT04271605|chronic kidney disease|chronic kidney disease
5886842|NCT04271605|mineral-bone disorder|mineral-bone disorder
5886843|NCT04271579|prostate cancer recurrence|prostate cancer recurrence
5886844|NCT04271579|salvage lymph node dissection|salvage lymph node dissection
5886845|NCT04271553|anxiety|anxiety
5886846|NCT04271553|pre-operation|pre-operation
5886847|NCT04271527|prostate cancer|prostate cancer
5886848|NCT04271527|cognitive fusion targeted biopsy|cognitive fusion targeted biopsy
5886849|NCT04271527|software-based fusion targeted biopsy|software-based fusion targeted biopsy
5886850|NCT04271501|Vitiligo|vitiligo
5886851|NCT04271488|Hepatic Impairment|hepatic impairment
5886852|NCT04271488|E7090|e7090
5886855|NCT04271410|Leukemia|leukemia
5886856|NCT04271410|Lymphoma|lymphoma
5886857|NCT04271384|Non-small cell lung cancer|non-small cell lung cancer
5886858|NCT04271384|nivolumab|nivolumab
5886859|NCT04271384|pd-1|pd-1
5886860|NCT04271384|radiotherapy|radiotherapy
5886861|NCT04271384|stereotactic body radiotherapy|stereotactic body radiotherapy
5886862|NCT04271384|radiosurgery|radiosurgery
5886863|NCT04271384|immunotherapy|immunotherapy
5886864|NCT04271371|Smoking|smoking
5886865|NCT04271371|Smoking Reduction|smoking reduction
5886866|NCT04271371|Electronic Cigarette Use|electronic cigarette use
5886867|NCT04271371|Prison|prison
5886868|NCT04271319|musculoskeletal disorder|musculoskeletal disorder
5886869|NCT04271319|median nerve|median nerve
5886870|NCT04271319|carpal tunnel|carpal tunnel
5886871|NCT04271319|hand numbness|hand numbness
5886872|NCT04271319|electric stimulation|electric stimulation
5886873|NCT04271319|microcurrent|microcurrent
5886874|NCT04271306|Vaccine|vaccine
5886903|NCT04271163|Alzheimer's, electromagnetic, cognition, A-beta, tau|alzheimer's, electromagnetic, cognition, a-beta, tau
5886905|NCT04271137|PEEK|peek
5886906|NCT04271137|orbital mesh|orbital mesh
5886907|NCT04271137|computer-guided surgery|computer-guided surgery
5886913|NCT04271085|Patients in the last phase of life|patients in the last phase of life
5886914|NCT04271072|Neuroinflammation|neuroinflammation
5886915|NCT04271072|Biomarker|biomarker
5886916|NCT04271072|Cesarean delivery|cesarean delivery
5886917|NCT04271072|Cytokines|cytokines
5886918|NCT04271072|Cerebrospinal fluid|cerebrospinal fluid
5886919|NCT04271059|TBI|tbi
5886920|NCT04271033|Stenting|stenting
5886921|NCT04271007|Topison|topison
5886922|NCT04271007|Atopic dermatitis|atopic dermatitis
5886923|NCT04271007|mometasone furoate|mometasone furoate
5886927|NCT04270929|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
5886928|NCT04270929|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5886929|NCT04270929|Oxaliplatin|oxaliplatin
5886930|NCT04270929|Pancreatic Cancer|pancreatic cancer
5886931|NCT04270890|ablative stereotactic radiotherapy,|ablative stereotactic radiotherapy,
5886932|NCT04270890|lung cancer|lung cancer
5886933|NCT04270890|compression device|compression device
5886934|NCT04270838|Vaccine|vaccine
5886935|NCT04270799|Incidental lung nodules|incidental lung nodules
5886936|NCT04270799|Radiomics|radiomics
5886937|NCT04270799|Artificial Intelligence|artificial intelligence
5886938|NCT04270799|Machine Learning|machine learning
5886939|NCT04270786|neutropenic fever, empiric, antibiotics|neutropenic fever, empiric, antibiotics
5886940|NCT04270760|AMG 890|amg 890
5886941|NCT04270760|siRNA|sirna
5886942|NCT04270760|lipoprotein (a) Lp(a)|lipoprotein (a) lp(a)
5886943|NCT04270760|Cardiovascular|cardiovascular
5886944|NCT04270760|Cardiovascular disease|cardiovascular disease
5886945|NCT04270760|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5886946|NCT04270760|Cholesterol|cholesterol
5886947|NCT04270760|Apolipoprotein (B)|apolipoprotein (b)
5886948|NCT04270760|Hyperlipidemia|hyperlipidemia
5886949|NCT04270760|Dyslipidemia|dyslipidemia
5886950|NCT04270734|time perception|time perception
5886951|NCT04270734|rhythm|rhythm
5886952|NCT04270734|EEG|eeg
5886953|NCT04270734|fNIRS|fnirs
5886954|NCT04270734|ERP|erp
5886955|NCT04270734|premature neonates|premature neonates
5886956|NCT04270734|discrimination|discrimination
5886957|NCT04270721|anastomotic leak|anastomotic leak
5886958|NCT04270721|right colectomy|right colectomy
5886959|NCT04270721|cluster randomised study|cluster randomised study
5886960|NCT04270721|leak prediction|leak prediction
5886961|NCT04270708|Sedation|sedation
5886962|NCT04270682|Cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
5886963|NCT04270682|CTX|ctx
5886964|NCT04270682|Cholestanol|cholestanol
5886965|NCT04270682|Leukodystrophy|leukodystrophy
5886966|NCT04270682|CYP27A1|cyp27a1
5886967|NCT04270630|Shared decision making|shared decision making
5886968|NCT04270630|Left heart catheterization|left heart catheterization
5886969|NCT04270630|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
5886970|NCT04270630|Decisional conflict|decisional conflict
5886971|NCT04270630|Decision aid|decision aid
5886972|NCT04270604|stem cell|stem cell
5886973|NCT04270604|observational|observational
5886986|NCT04270565|wearable sensors|wearable sensors
5886987|NCT04270552|allergic rhinitis|allergic rhinitis
5886988|NCT04270552|seasonal allergic rhinitis|seasonal allergic rhinitis
5886989|NCT04270552|children|children
5886990|NCT04270552|grass pollen season|grass pollen season
5886991|NCT04270552|bacterial lysate|bacterial lysate
5886992|NCT04270552|Th2 inflammation|th2 inflammation
5886993|NCT04270552|eosinophils|eosinophils
5886994|NCT04270552|specific immunoglobulin E|specific immunoglobulin e
5886995|NCT04270539|primary school children|primary school children
5886996|NCT04270539|nap|nap
5886997|NCT04270539|sleep deprivation|sleep deprivation
5886998|NCT04270513|endovascular treatment|endovascular treatment
5886999|NCT04270513|stroke|stroke
5887000|NCT04270513|large vessel occlusion|large vessel occlusion
5887001|NCT04270513|telemedicine|telemedicine
5887002|NCT04270513|helicopter|helicopter
5887003|NCT04270513|thrombectomy|thrombectomy
5887004|NCT04270513|mobile interventionalist|mobile interventionalist
5887005|NCT04270513|flying intervention team|flying intervention team
5887006|NCT04270500|Colo-rectal Cancer|colo-rectal cancer
5887007|NCT04270500|Colo-rectal Surgery|colo-rectal surgery
5887008|NCT04270500|Prehabilitation|prehabilitation
5887009|NCT04270500|Sleep quality|sleep quality
5887010|NCT04270500|Sleep duration|sleep duration
5887011|NCT04270500|Physical exercise|physical exercise
5887016|NCT04270461|NKG2D-based CAR T-cells|nkg2d-based car t-cells
5887017|NCT04270461|solid tumors|solid tumors
5887018|NCT04270448|Motor learning|motor learning
5887019|NCT04270448|Feedback|feedback
5887026|NCT04270396|dental implant survival|dental implant survival
5887027|NCT04270396|implant failure|implant failure
5887028|NCT04270396|early implant failure|early implant failure
5887029|NCT04270396|late implant failure|late implant failure
5887030|NCT04270383|2019-nCoV infection|2019-ncov infection
5887031|NCT04270383|2019-nCoV pneumonia|2019-ncov pneumonia
5887032|NCT04270383|Children|children
5887042|NCT04270318|calcium hydroxide|calcium hydroxide
5887043|NCT04270318|mineral trioxide aggregate|mineral trioxide aggregate
5887044|NCT04270318|sodium hypochlorite|sodium hypochlorite
5887045|NCT04270292|Arteriovenous fistula|arteriovenous fistula
5887046|NCT04270292|Antegrade direction|antegrade direction
5887047|NCT04270292|Dialysis adequacy|dialysis adequacy
5887048|NCT04270292|Nursing care|nursing care
5887049|NCT04270292|Cannulation practices|cannulation practices
5887050|NCT04270279|Coronary heart disease|coronary heart disease
5887051|NCT04270279|Stable angina|stable angina
5887052|NCT04270279|Traditional Chinese medicine|traditional chinese medicine
5887053|NCT04270279|Xueshuanxinmaining tablet|xueshuanxinmaining tablet
5887054|NCT04270253|Musculoskeletal Manipulations|musculoskeletal manipulations
5887055|NCT04270253|Osteoarthritis, Knee|osteoarthritis, knee
5887056|NCT04270253|Conservative Treatment|conservative treatment
5887058|NCT04270201|Oral squamous cell carcinoma|oral squamous cell carcinoma
5887059|NCT04270201|ALDH1b1|aldh1b1
5887060|NCT04270201|ALDH2|aldh2
5887061|NCT04270201|polymorphism|polymorphism
5005996|NCT03959241|GVHD prophylaxis|gvhd prophylaxis
5887082|NCT04270071|Randomized controlled trial|randomized controlled trial
5887083|NCT04270058|Hereditary transthyretin amyloidosis with polyneuropathy|hereditary transthyretin amyloidosis with polyneuropathy
5887084|NCT04270058|Hereditary transthyretin amyloidosis|hereditary transthyretin amyloidosis
5887086|NCT04270058|hATTR-PN|hattr-pn
5887087|NCT04270058|Rare disease|rare disease
5887088|NCT04270006|Periodontitis|periodontitis
5887089|NCT04270006|SRP|srp
5887090|NCT04270006|ADSCs|adscs
5887091|NCT04270006|Exosomes|exosomes
5887092|NCT04270006|treatment|treatment
5887093|NCT04269954|Cerebral Venous Sinus Thrombosis|cerebral venous sinus thrombosis
5887094|NCT04269928|Primary Aldosteronism|primary aldosteronism
5887095|NCT04269928|Hypertension|hypertension
5887096|NCT04269928|Adrenal Artery Ablation|adrenal artery ablation
5887097|NCT04269928|Adrenalectomy|adrenalectomy
5887104|NCT04269863|Aspirin|aspirin
5887105|NCT04269824|Sanitation|sanitation
5887106|NCT04269824|Norms|norms
5887107|NCT04269824|Toilet Use|toilet use
5887108|NCT04269824|Toilet Ownership|toilet ownership
5887109|NCT04269785|atrial fibrillation|atrial fibrillation
5887110|NCT04269785|ablation|ablation
5887111|NCT04269785|radiofrequency|radiofrequency
5887112|NCT04269785|cryoballoon|cryoballoon
5887113|NCT04269785|inflammation|inflammation
5887114|NCT04269785|endothelial function|endothelial function
5887115|NCT04269785|recurrence|recurrence
5887116|NCT04269759|prevention|prevention
5887117|NCT04269759|dental care|dental care
5887118|NCT04269759|pregnancy|pregnancy
5887119|NCT04269720|biofeedback|biofeedback
5887120|NCT04269720|pediatric|pediatric
5887128|NCT04269668|Hybrid Closed Loop|hybrid closed loop
5887129|NCT04269668|Closed Loop|closed loop
5887130|NCT04269668|Artificial Pancreas|artificial pancreas
5887131|NCT04269655|Diabetes|diabetes
5887132|NCT04269655|Continuous Glucose Monitor|continuous glucose monitor
5887144|NCT04269655|Clinical Decision-Making|clinical decision-making
5887145|NCT04269655|Wireless Transmission|wireless transmission
5887146|NCT04269616|Decision making|decision making
5887147|NCT04269616|Neonatal resuscitation|neonatal resuscitation
5887148|NCT04269616|Order effect|order effect
5887149|NCT04269616|Prenatal counseling|prenatal counseling
5887150|NCT04269603|light transmission aggregometry|light transmission aggregometry
5887151|NCT04269603|platelets|platelets
5887184|NCT04268641|Hemiplegia|hemiplegia
5887186|NCT04268641|Wheelchair positioning|wheelchair positioning
5887187|NCT04268641|Propulsion|propulsion
5887188|NCT04268641|Pelvic posterior tilt|pelvic posterior tilt
5887189|NCT04268641|Obliquity|obliquity
5887190|NCT04268589|geriatric pain|geriatric pain
5887191|NCT04268589|geriatric depression|geriatric depression
5887193|NCT04268368|cancer|cancer
5887194|NCT04268368|immune checkpoint inhibitors|immune checkpoint inhibitors
5887195|NCT04268368|immune related adverse events|immune related adverse events
5887196|NCT04268368|nivolumab|nivolumab
5887197|NCT04268368|pembrolizumab|pembrolizumab
5887198|NCT04268368|avelumab|avelumab
5887199|NCT04268368|durvalumab|durvalumab
5887200|NCT04268368|atezolizumab|atezolizumab
5887225|NCT04267744|NYHA II-IV|nyha ii-iv
5692651|NCT00527228|deflazacort|deflazacort
5887226|NCT04267744|Reduced Ejection Fraction|reduced ejection fraction
5887227|NCT04267744|Cardiology|cardiology
5887228|NCT04267627|Telemedicine|telemedicine
5887229|NCT04267627|Cancer Survivorship|cancer survivorship
5887230|NCT04267627|Rural Health Disparities|rural health disparities
5887231|NCT04267562|excessive menstrual bleeding|excessive menstrual bleeding
5887232|NCT04267562|menorrhagia|menorrhagia
5887233|NCT04267562|heavy menstrual bleeding|heavy menstrual bleeding
5887234|NCT04267562|heavy uterine bleeding|heavy uterine bleeding
5887235|NCT04267562|menstrual disorders|menstrual disorders
5887317|NCT04264442|Muscular Dystrophies|muscular dystrophies
5887318|NCT04264442|Facioscapulohumeral Muscular Disorders|facioscapulohumeral muscular disorders
5887319|NCT04264442|Musculoskeletal Diseases|musculoskeletal diseases
5887320|NCT04264442|Neuromuscular Diseases|neuromuscular diseases
5887365|NCT04261803|Healthy Volunteers|healthy volunteers
5887366|NCT04261244|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5887367|NCT04261244|preoperative radiotherapy|preoperative radiotherapy
5887368|NCT04261244|capsular contraction|capsular contraction
5887369|NCT04261244|immediate reconstruction|immediate reconstruction
5887370|NCT04261192|Organoid|organoid
5887371|NCT04261114|Chronic pain|chronic pain
5887372|NCT04261114|Adolescents|adolescents
5887373|NCT04261114|Emotional distress|emotional distress
5887374|NCT04261114|Burdensomeness|burdensomeness
5887375|NCT04261114|Self-harm|self-harm
5887376|NCT04261114|Hopelessness|hopelessness
5887383|NCT04260503|Biliary atresia|biliary atresia
5887384|NCT04260503|Microbiota|microbiota
5887385|NCT04260503|Cholangitis|cholangitis
5887391|NCT04259970|Cystic Fibrosis|cystic fibrosis
5887392|NCT04259970|CFTR modulator therapy|cftr modulator therapy
5887393|NCT04259970|129Xe MRI|129xe mri
5887394|NCT04259970|hyperpolarized xenon|hyperpolarized xenon
5887396|NCT04259892|contact subject|contact subject
5887397|NCT04259892|high/moderate risk of transmission|high/moderate risk of transmission
5887398|NCT04259879|Short-term Fasting|short-term fasting
5887399|NCT04259879|molecular mechanisms|molecular mechanisms
5887400|NCT04259879|p21|p21
5887401|NCT04259879|Peripheral blood mononuclear cells (PBMCs)|peripheral blood mononuclear cells (pbmcs)
5887402|NCT04259879|PPARalpha|pparalpha
5887542|NCT04250493|Neurodegenerative disease|neurodegenerative disease
5887543|NCT04250493|Alpha synuclein|alpha synuclein
5887544|NCT04250493|Insulin resistance|insulin resistance
5887556|NCT04249245|Olfaction|olfaction
5887557|NCT04249245|Microbiota|microbiota
5887558|NCT04249245|Dysbiosis|dysbiosis
5887559|NCT04249245|Metagenomic analysis|metagenomic analysis
5887595|NCT04245111|Immunofluorescence|immunofluorescence
5887596|NCT04245111|Orthopaedic|orthopaedic
5887935|NCT04218604|catheter-based ablation|catheter-based ablation
4961293|NCT04231695|MODS|mods
5890485|NCT03989427|Tooth brushing|tooth brushing
5890517|NCT03985631|Tai Chi|tai chi
5890518|NCT03985631|Telerehabilitation|telerehabilitation
5890519|NCT03985631|Parkinson Disease|parkinson disease
5707172|NCT00475410|Fibrin glue|fibrin glue
5890568|NCT03977779|Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis|post-endoscopic retrograde choloangiopancreatography pancreatitis
5890573|NCT03977649|erenumab|erenumab
5890574|NCT03977649|functional MRI|functional mri
5890575|NCT03977649|connectivity|connectivity
5891239|NCT03913429|Orthognathic Surgery|orthognathic surgery
5891240|NCT03913429|Maxillary nerve blockade|maxillary nerve blockade
5891419|NCT03896347|DBM|dbm
5891420|NCT03896347|BMP|bmp
5891421|NCT03896347|DDD|ddd
5891422|NCT03896295|M281|m281
5891423|NCT03896295|Generalized Myasthenia Gravis|generalized myasthenia gravis
5891445|NCT03893708|pregnancy|pregnancy
5891446|NCT03893708|prenatal yoga|prenatal yoga
5891447|NCT03893708|excessive gestational weight gain|excessive gestational weight gain
5891774|NCT03845504|adolescent|adolescent
5891775|NCT03845504|treatment refractory|treatment refractory
5891790|NCT03842189|M281|m281
5891791|NCT03842189|Hemolytic Disease of the Fetus and Newborn|hemolytic disease of the fetus and newborn
5891792|NCT03842189|HDFN|hdfn
5891793|NCT03842189|Rhesus Disease|rhesus disease
5891794|NCT03842189|Hemolytic disease due to fetomaternal alloimmunization|hemolytic disease due to fetomaternal alloimmunization
5891795|NCT03842189|Hemolytic disease of the newborn with Kell alloimmunization|hemolytic disease of the newborn with kell alloimmunization
5891796|NCT03842189|Rhesus (Rh) isoimmunization of foetus or newborn|rhesus (rh) isoimmunization of foetus or newborn
5891797|NCT03842189|Isoimmunization due to other red cell factors|isoimmunization due to other red cell factors
5891798|NCT03842189|ABO isoimmunization of foetus or newborn|abo isoimmunization of foetus or newborn
5891799|NCT03842189|Haemolytic anaemia due to other unclassified antibodies|haemolytic anaemia due to other unclassified antibodies
5892896|NCT03640286|Weight loss|weight loss
5892897|NCT03640286|Diet|diet
5892898|NCT03640286|Atherogenic index|atherogenic index
5892899|NCT03640286|Prediabetes|prediabetes
5892900|NCT03639714|neoantigen cancer vaccine|neoantigen cancer vaccine
5892901|NCT03639714|personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
5892902|NCT03639714|GRT-C901|grt-c901
5892903|NCT03639714|GRT-R902|grt-r902
5892904|NCT03639714|immunotherapy|immunotherapy
5892905|NCT03639714|nivolumab|nivolumab
5892906|NCT03639714|ipilimumab|ipilimumab
5892907|NCT03639714|PD-1|pd-1
5892908|NCT03639714|CTLA-4|ctla-4
5893226|NCT03597594|TCRα/β/CD19-depleted graft|tcrα/β/cd19-depleted graft
5893227|NCT03597594|CD45RA-depleted DLI|cd45ra-depleted dli
5893228|NCT03597594|Graft-Versus-Host-Disease|graft-versus-host-disease
5893230|NCT03597295|Squamous carcinoma of the anal canal|squamous carcinoma of the anal canal
5893231|NCT03597295|anti-PD-1 antibody|anti-pd-1 antibody
5893232|NCT03597295|IgG4 monoclonal antibody|igg4 monoclonal antibody
5893233|NCT03597295|INCMGA00012|incmga00012
5893237|NCT03595774|nitric oxide|nitric oxide
5893250|NCT03593174|Amputation|amputation
5893422|NCT03568084|physical activity|physical activity
5893424|NCT03568084|frailty|frailty
5894052|NCT03484702|Follicular lymphoma Grade 3B|follicular lymphoma grade 3b
5894053|NCT03484702|JCAR017|jcar017
5894054|NCT03484702|Liso-Cel|liso-cel
5894074|NCT03480581|Neurological|neurological
5894075|NCT03480581|Gait|gait
5894076|NCT03480581|Cardiorespiratory fitness|cardiorespiratory fitness
5894077|NCT03480581|Rehabilitation|rehabilitation
5894078|NCT03480581|Walking|walking
5894079|NCT03480581|Locomotor training|locomotor training
5894080|NCT03480581|Robotics|robotics
5894088|NCT03479437|Obesity|obesity
5894089|NCT03479437|Melanocortin|melanocortin
5894090|NCT03479437|TEMPO|tempo
5894091|NCT03479437|MC4R|mc4r
5894092|NCT03479437|Genetic Obesity|genetic obesity
5894093|NCT03479437|hypothalamic|hypothalamic
5894094|NCT03479437|POMC|pomc
5894095|NCT03479437|LEPR|lepr
5894096|NCT03479437|PCSK1|pcsk1
4963808|NCT04215666|ARDS|ards
5894909|NCT03385239|Vascular Diseases|vascular diseases
5894919|NCT03380754|Vomiting|vomiting
5894920|NCT03380754|Knee Arthroplasty|knee arthroplasty
5894921|NCT03380754|PONV|ponv
5894922|NCT03380754|TKA|tka
5894948|NCT03377816|Emotion Processing|emotion processing
5894949|NCT03377816|Art Therapy|art therapy
5894950|NCT03377816|Breast Cancer|breast cancer
5894951|NCT03377816|Cholinergic anti-inflammatory pathway|cholinergic anti-inflammatory pathway
5897015|NCT02984995|FLT3-ITD|flt3-itd
5901608|NCT01475162|corticosteroids|corticosteroids
5901609|NCT01475162|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5901834|NCT01375530|Screen|screen
5902952|NCT00717756|liver cancer, second line|liver cancer, second line
5902953|NCT00714129|Steatosis|steatosis
5902954|NCT00714129|Diabetes|diabetes
5903210|NCT00558311|PIVLAZ|pivlaz
5903211|NCT00558311|surgical clipping|surgical clipping
5342841|NCT01981785|Common variable immune deficiencies|common variable immune deficiencies
5342842|NCT01981785|Primary Immunodeficiencies|primary immunodeficiencies
5342843|NCT01981785|Immunoglobulin|immunoglobulin
5342844|NCT01981785|IgG|igg
5342845|NCT01981785|IVIG|ivig
5342846|NCT01981785|Recurrent Infections|recurrent infections
5342847|NCT01981759|Schizophrenia|schizophrenia
5342848|NCT01981759|Delusions|delusions
5342849|NCT01981759|D-Cycloserine|d-cycloserine
5342850|NCT01981759|CBT|cbt
5342851|NCT01981746|adductor canal block|adductor canal block
5342852|NCT01981746|healthy volunteers|healthy volunteers
5342853|NCT01981746|US-guided peripheral nerve block|us-guided peripheral nerve block
5342854|NCT01981746|lower limb|lower limb
5342855|NCT01981733|Deep Vein Thrombosis|deep vein thrombosis
5342856|NCT01981720|PRX-102|prx-102
5342857|NCT01981720|pegunigalsidase alfa|pegunigalsidase alfa
5342858|NCT01981720|Fabry Disease|fabry disease
5342859|NCT01981707|castration-resistant prostate cancer|castration-resistant prostate cancer
5342860|NCT01981707|abiraterone acetate|abiraterone acetate
5342861|NCT01981707|enzalutamide|enzalutamide
5342862|NCT01981707|choline pet|choline pet
5342863|NCT01981694|Phase 1|phase 1
5342864|NCT01981694|Randomized|randomized
5342865|NCT01981694|Double Blind|double blind
5342866|NCT01981694|Placebo-Controlled|placebo-controlled
5342867|NCT01981694|Single-Dose Escalation|single-dose escalation
5342868|NCT01981694|Safety|safety
5342869|NCT01981694|Tolerability|tolerability
5342870|NCT01981694|PK|pk
5342871|NCT01981694|PD|pd
5342872|NCT01981694|PF-06649751|pf-06649751
5342873|NCT01981681|Phase 1|phase 1
5342874|NCT01981681|Randomized|randomized
5342875|NCT01981681|Placebo-Controlled|placebo-controlled
5342876|NCT01981681|Multiple Dose Escalation|multiple dose escalation
5342877|NCT01981681|Tolerability|tolerability
5872813|NCT03782363|advanced sarcoma|advanced sarcoma
5872814|NCT03782363|osteosarcoma|osteosarcoma
5872815|NCT03782363|soft tissue sarcoma|soft tissue sarcoma
5872816|NCT03781817|procedural sedation|procedural sedation
5872817|NCT03781817|ketamine|ketamine
5872818|NCT03781817|pediatric|pediatric
5872819|NCT03781817|fracture|fracture
5872820|NCT03781817|intranasal|intranasal
5872821|NCT03781817|intravenous|intravenous
5872822|NCT03781817|emergency department|emergency department
5872823|NCT03780517|BOS172738|bos172738
5872824|NCT03780517|RET gene|ret gene
5872825|NCT03780517|Medullary Thyroid Cancer|medullary thyroid cancer
5872826|NCT03780517|Non-Small Cell Lung Cancer|non-small cell lung cancer
4974056|NCT04154189|E7080|e7080
4955184|NCT04269005|"stepped and collaborative care model (SCCM)"|"stepped and collaborative care model (sccm)"
4955185|NCT04268992|Cardiovascular Diseases|cardiovascular diseases
4955186|NCT04268992|Exercise|exercise
4955187|NCT04268992|Hemostasis|hemostasis
4955188|NCT04268992|Inflammation|inflammation
4955189|NCT04268979|Neuro Oncology|neuro oncology
4955197|NCT04268927|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
4955198|NCT04268914|virtual reality|virtual reality
4955212|NCT04268914|myringotomy|myringotomy
4955213|NCT04268914|pilondial cyst excision|pilondial cyst excision
4955216|NCT04268901|phlebotomy|phlebotomy
4955217|NCT04268901|radiology|radiology
4955218|NCT04268901|orthopedics|orthopedics
4955219|NCT04268901|infusion|infusion
4955220|NCT04268901|IV stick|iv stick
4955221|NCT04268901|cast removal|cast removal
4955222|NCT04268901|pain|pain
4955223|NCT04268901|anxiety|anxiety
4955224|NCT04268901|virtual reality|virtual reality
4955225|NCT04268888|Intermediate Stage|intermediate stage
4955226|NCT04268875|In-stent restenosis|in-stent restenosis
4955227|NCT04268875|optical coherence tomography (OCT)|optical coherence tomography (oct)
4955228|NCT04268875|coronary angiography|coronary angiography
4955229|NCT04268862|Beta cell function|beta cell function
4955230|NCT04268862|Insulin Resistance|insulin resistance
4955231|NCT04268862|Arabs|arabs
4955232|NCT04268862|Asian Indians|asian indians
4955233|NCT04268849|Bariatric Surgery|bariatric surgery
4955234|NCT04268849|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
4955235|NCT04268849|Vertical Sleeve Gastrectomy (VSG)|vertical sleeve gastrectomy (vsg)
4955236|NCT04268836|dry AMD|dry amd
4955237|NCT04268836|wet AMD|wet amd
4955238|NCT04268836|neovascular AMD|neovascular amd
4955239|NCT04268836|age-related macular degeneration|age-related macular degeneration
4955240|NCT04268810|painful bladder syndrome|painful bladder syndrome
4955248|NCT04268706|r/r Hodgkin Lymphoma, CD30, adult, pediatrics|r/r hodgkin lymphoma, cd30, adult, pediatrics
4955251|NCT04268693|doxorubicin|doxorubicin
4955258|NCT04268615|Saccadic Eye Movements|saccadic eye movements
4955259|NCT04268615|Bilateral Vestibulopathy|bilateral vestibulopathy
4955260|NCT04268615|Bilateral Vestibular Hypofunction|bilateral vestibular hypofunction
4955261|NCT04268602|FBSS|fbss
4955262|NCT04268602|Failed Back Surgery Syndrome|failed back surgery syndrome
4955263|NCT04268602|Chronic Pain|chronic pain
4955264|NCT04268602|local anesthetic|local anesthetic
4955265|NCT04268602|Intradermal Injection|intradermal injection
4955268|NCT04268576|hysterectomy, post operative,|hysterectomy, post operative,
4955269|NCT04268563|metformin|metformin
4955270|NCT04268563|sitagliptin|sitagliptin
4955271|NCT04268563|Polycystic Ovary Syndrome|polycystic ovary syndrome
4955272|NCT04268563|Intracytoplastic sperm injection|intracytoplastic sperm injection
4955273|NCT04268537|2019-ncov|2019-ncov
4955274|NCT04268537|immunotherapy|immunotherapy
4955275|NCT04268537|PD-1|pd-1
4955276|NCT04268537|respiratory failure|respiratory failure
4955277|NCT04268524|miltefosine|miltefosine
4955286|NCT04268498|Lenalidomide|lenalidomide
4955287|NCT04268498|Dexamethasone|dexamethasone
4955288|NCT04268498|VRD|vrd
4955289|NCT04268498|KRD|krd
4955290|NCT04268498|KRD+DARA|krd+dara
4955291|NCT04268498|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4955292|NCT04268498|19-339|19-339
4955293|NCT04268485|KL-6|kl-6
4955294|NCT04268485|Krebs von den Lungen-6|krebs von den lungen-6
4955295|NCT04268485|Biomarker|biomarker
5281333|NCT02267486|patients|patients
4955296|NCT04268459|voice prosthesis, laryngectomy, complications|voice prosthesis, laryngectomy, complications
4955297|NCT04268446|brief BESTest|brief bestest
4955298|NCT04268446|stroke patients|stroke patients
4955357|NCT04268004|Parenthood|parenthood
4955362|NCT04267965|Voice impairment|voice impairment
4955363|NCT04267965|airway invasion|airway invasion
4955364|NCT04267965|respiratory function|respiratory function
4955365|NCT04267952|Health education|health education
4955366|NCT04267952|Theory of planned behavior|theory of planned behavior
4955367|NCT04267952|Primary schools|primary schools
4955368|NCT04267926|Multiple Sclerosis|multiple sclerosis
4955369|NCT04267926|Fatigue|fatigue
4955370|NCT04267926|Mitochondrial|mitochondrial
4955371|NCT04267900|SPECT/CT|spect/ct
4955372|NCT04267900|HER2 imaging|her2 imaging
4955373|NCT04267861|Skin Neoplasms|skin neoplasms
4955374|NCT04267861|Immunotherapy|immunotherapy
4955375|NCT04267861|Anti-PD-1|anti-pd-1
4955376|NCT04267835|Coronary artery bypass grafting|coronary artery bypass grafting
4955377|NCT04267835|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
4955378|NCT04267835|Off-pump CABG|off-pump cabg
4955386|NCT04267809|Metformin|metformin
4955387|NCT04267809|Endoplasmic Reticulum Stress|endoplasmic reticulum stress
4955388|NCT04267809|YF17D infection|yf17d infection
4955389|NCT04267809|Symptomatic|symptomatic
4955390|NCT04267809|Metabolic|metabolic
4955391|NCT04267809|Immunometabolism|immunometabolism
4955392|NCT04267783|postpartum hemorrhage|postpartum hemorrhage
4955393|NCT04267783|uterine atony|uterine atony
4955394|NCT04267783|shear wave|shear wave
4955395|NCT04267783|elastography|elastography
4955399|NCT04267731|Gut microbiota|gut microbiota
4955400|NCT04267731|Postbiotics|postbiotics
4955401|NCT04267731|Inflammation|inflammation
4955402|NCT04267705|Pulses|pulses
4955403|NCT04267705|gut microbiota|gut microbiota
4955436|NCT04267523|Parenting|parenting
4955437|NCT04267523|Psychological flexibility|psychological flexibility
4955438|NCT04267523|Third-wave therapies|third-wave therapies
4955439|NCT04267523|Web-based intervention|web-based intervention
4955440|NCT04267523|Emotion regulation|emotion regulation
4955441|NCT04267510|genetic sequencing|genetic sequencing
4955451|NCT04267458|HCV|hcv
4955452|NCT04267458|egyption patients|egyption patients
4955453|NCT04267419|malondialdehyde|malondialdehyde
4955454|NCT04267419|nitric oxide|nitric oxide
4955455|NCT04267419|salivary biomarkers|salivary biomarkers
4955456|NCT04267406|Von willebrand factor|von willebrand factor
4955457|NCT04267406|ADAMTS-13|adamts-13
4955458|NCT04267406|Children|children
4955459|NCT04267406|Cirrhosis|cirrhosis
4955460|NCT04267406|Portal hypertension|portal hypertension
4955465|NCT04267367|Dietitian|dietitian
4955466|NCT04267367|Dietary approach|dietary approach
4955467|NCT04267367|Management|management
4955468|NCT04267367|Diabetes|diabetes
4955469|NCT04267367|Nepal|nepal
4955470|NCT04267237|Cancer vaccine|cancer vaccine
4955471|NCT04267237|Neoantigen|neoantigen
4955472|NCT04267237|Personalized|personalized
4955473|NCT04267237|Atezolizumab|atezolizumab
4955474|NCT04267237|Vaccine|vaccine
4955475|NCT04267237|Immunotherapy|immunotherapy
4955476|NCT04267237|Anti-PDL1|anti-pdl1
4955477|NCT04267237|Checkpoint Inhibitor|checkpoint inhibitor
4955478|NCT04267237|Personalized vaccine|personalized vaccine
4955479|NCT04267237|Non-small cell lung cancer|non-small cell lung cancer
4955480|NCT04267237|NSCLC|nsclc
4955481|NCT04267237|Adjuvant|adjuvant
4955482|NCT04267198|aphasia|aphasia
4955483|NCT04267198|language|language
4955488|NCT04267185|Physical Activity|physical activity
4955505|NCT04267029|Allergic Reaction|allergic reaction
4955602|NCT04266327|radiotherapy|radiotherapy
4955548|NCT04266717|preterm|preterm
4955549|NCT04266717|parent education|parent education
4955550|NCT04266717|play|play
4955551|NCT04266691|Regional Lymph nodes|regional lymph nodes
4955552|NCT04266691|Molecular metastasis|molecular metastasis
4955553|NCT04266691|Driver gene mutation|driver gene mutation
4955557|NCT04266665|dexmedetomidine|dexmedetomidine
4955558|NCT04266665|brain oxygenation|brain oxygenation
4955559|NCT04266665|biomarkers|biomarkers
4955560|NCT04266665|neuroinflammation|neuroinflammation
4955561|NCT04266665|brain metabolism|brain metabolism
4955562|NCT04266665|neurocognitive outcome|neurocognitive outcome
4955563|NCT04266652|tooth block|tooth block
4955564|NCT04266652|Dental implants|dental implants
4955565|NCT04266639|Remote Ischemic Conditioning|remote ischemic conditioning
4955566|NCT04266639|Neuroprotection|neuroprotection
4955567|NCT04266626|dysphagia, drooling, kinsesiotaping therapy, manipulation therapy|dysphagia, drooling, kinsesiotaping therapy, manipulation therapy
4955568|NCT04266561|Laparoscopy|laparoscopy
4955569|NCT04266561|Recurrent inguinal hernia|recurrent inguinal hernia
4955570|NCT04266561|Children|children
4955571|NCT04266548|indocynide green|indocynide green
4955572|NCT04266548|Image guide surgery|image guide surgery
4955573|NCT04266548|near infra-red laparoscopy|near infra-red laparoscopy
4955574|NCT04266548|laparoscopic hepatectomy|laparoscopic hepatectomy
4955586|NCT04266457|REMBD|rembd
4955587|NCT04266457|REM Behavioural Disorder|rem behavioural disorder
5281486|NCT02266693|PD|pd
4955588|NCT04266457|prodromal α-synucleinopathies|prodromal α-synucleinopathies
4955593|NCT04266379|Type 1 diabetes|type 1 diabetes
4955594|NCT04266379|Hypoglycemia|hypoglycemia
4955595|NCT04266379|Closed-loop insulin infusion|closed-loop insulin infusion
4955601|NCT04266327|I-125 seed implantation|i-125 seed implantation
4955621|NCT04266275|Infectious disease|infectious disease
4955622|NCT04266275|HPV|hpv
4955623|NCT04266275|Preventive medicine|preventive medicine
4955624|NCT04266262|Active Surveillance|active surveillance
4955625|NCT04266262|Prostate Cancer|prostate cancer
4955626|NCT04266262|High-intensity interval training|high-intensity interval training
4955627|NCT04266262|Resistance training|resistance training
4955628|NCT04266236|lumbar plexus block|lumbar plexus block
4955629|NCT04266236|quadratus lumorum block|quadratus lumorum block
4955630|NCT04266236|total hip arthroplasty|total hip arthroplasty
4955631|NCT04266236|single-needle|single-needle
4955632|NCT04266236|shamrock approach|shamrock approach
4955641|NCT04266197|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4955642|NCT04266184|kinesio tape|kinesio tape
4955643|NCT04266184|pelvic belt|pelvic belt
4955644|NCT04266184|functional mobility|functional mobility
4955645|NCT04266184|pain|pain
4955646|NCT04266184|kinesiophobia|kinesiophobia
4955647|NCT04266184|neuroscience education|neuroscience education
4955648|NCT04266184|ergonomic education|ergonomic education
4955649|NCT04266184|activity limitation|activity limitation
4955650|NCT04266171|continuous glucose monitor|continuous glucose monitor
4955651|NCT04266171|diet education|diet education
4955652|NCT04266171|Precision nutrition|precision nutrition
4955653|NCT04266145|dexmedetomidine-adductor canal block|dexmedetomidine-adductor canal block
4955654|NCT04266132|Retrolaminar block|retrolaminar block
4955655|NCT04266132|Ilioinguinal nerve block|ilioinguinal nerve block
4955660|NCT04266080|Game-Based|game-based
4955661|NCT04266080|Physical Activity|physical activity
4955662|NCT04266080|20-040|20-040
4955663|NCT04266067|PNF exercise|pnf exercise
4955664|NCT04266067|Frenkel exercise|frenkel exercise
4955665|NCT04266041|Electroencephalogram (EEG)|electroencephalogram (eeg)
4955666|NCT04266041|Epilepsy|epilepsy
4955667|NCT04266041|Lesion|lesion
4955668|NCT04266041|Brain|brain
4955669|NCT04266041|Language|language
4955670|NCT04266041|Movement|movement
4955671|NCT04266041|Sensation|sensation
4955672|NCT04266041|Mapping|mapping
4955677|NCT04266002|Global Deficit Score|global deficit score
4955678|NCT04266002|Cytokines|cytokines
4955679|NCT04266002|CSF Inflammation|csf inflammation
4955684|NCT04265911|Pneumococcal vaccine|pneumococcal vaccine
4955685|NCT04265911|ASP3772|asp3772
4955686|NCT04265833|deep caries|deep caries
4955687|NCT04265833|indirect pulp capping|indirect pulp capping
4955688|NCT04265820|unilateral cataract|unilateral cataract
4955689|NCT04265820|binocular functional vision|binocular functional vision
5356771|NCT01918033|Immune System Diseases|immune system diseases
4955690|NCT04265820|Multifocal Intraocular Lenses|multifocal intraocular lenses
4955691|NCT04265807|reperfusion injury|reperfusion injury
4955692|NCT04265807|remote ischemic conditioning|remote ischemic conditioning
4955693|NCT04265794|Sugar-sweetened beverage|sugar-sweetened beverage
4961712|NCT04229056|stroke|stroke
4955695|NCT04265794|Youth empowerment|youth empowerment
4955696|NCT04265794|Water consumption|water consumption
4955697|NCT04265781|Refractory or unexplained chronic cough|refractory or unexplained chronic cough
4955698|NCT04265781|Healthy volunteers|healthy volunteers
4955699|NCT04265781|P2X3 receptor antagonist|p2x3 receptor antagonist
4955700|NCT04265768|soft tissue regeneration|soft tissue regeneration
4955701|NCT04265768|soft tissue graft|soft tissue graft
4955702|NCT04265768|dental implant|dental implant
4955704|NCT04265755|Episodic and Chronic Migraine|episodic and chronic migraine
4955705|NCT04265755|Link between clinical response and biomarker|link between clinical response and biomarker
4955706|NCT04265755|Phase 4|phase 4
4955707|NCT04265742|Bone microarchitecture|bone microarchitecture
4955708|NCT04265742|intestinal microbiote|intestinal microbiote
4955709|NCT04265742|post-menopausal women|post-menopausal women
4955710|NCT04265742|bone remodeling|bone remodeling
4955711|NCT04265703|Central venous access|central venous access
4955712|NCT04265703|Ultrasound-guided catheterization|ultrasound-guided catheterization
4955713|NCT04265703|Innominate vein|innominate vein
4955714|NCT04265703|Brachiocephalic vein|brachiocephalic vein
4955715|NCT04265690|Healthy eating behaviors|healthy eating behaviors
4955716|NCT04265690|Eating competence|eating competence
4955717|NCT04265690|Centering pregnancy|centering pregnancy
4955718|NCT04265690|Centering parenting|centering parenting
4955719|NCT04265664|Telerehabilitation|telerehabilitation
4955720|NCT04265664|Lower extremity|lower extremity
4955721|NCT04265664|Stroke|stroke
4955722|NCT04265651|Skeletal dysplasia|skeletal dysplasia
4955723|NCT04265651|Endochondral ossification|endochondral ossification
4955724|NCT04265651|ACH|ach
4955725|NCT04265651|Shortened proximal limbs|shortened proximal limbs
4955726|NCT04265651|Fibroblast growth factor receptor 3|fibroblast growth factor receptor 3
4955727|NCT04265651|FGFR3|fgfr3
4955728|NCT04265651|Endochondral bone formation|endochondral bone formation
5281527|NCT02266433|Tenosynovitis|tenosynovitis
4955729|NCT04265651|Short-limb disproportionate dwarfism|short-limb disproportionate dwarfism
4955730|NCT04265651|dwarfism|dwarfism
4955731|NCT04265651|Bone disease|bone disease
4955732|NCT04265651|Bone diseases, developmental|bone diseases, developmental
4955733|NCT04265651|Musculoskeletal diseases|musculoskeletal diseases
4955734|NCT04265651|Osteochondrodysplasia|osteochondrodysplasia
4955735|NCT04265651|Genetic diseases, inborn|genetic diseases, inborn
4955736|NCT04265651|Inborn|inborn
4955737|NCT04265625|Percutaneous tracheostomy, Fiberoptic bronchoscopic guidance|percutaneous tracheostomy, fiberoptic bronchoscopic guidance
4955738|NCT04265586|Health-related Quality of Life|health-related quality of life
4955739|NCT04265586|Anxiety|anxiety
4955740|NCT04265586|Pain intensity|pain intensity
4955741|NCT04265586|Pain interference|pain interference
4955742|NCT04265586|Symptoms of insomnia|symptoms of insomnia
4955743|NCT04265573|Uncomplicated malaria|uncomplicated malaria
4955744|NCT04265573|Multiple First-lines Therapies|multiple first-lines therapies
4955745|NCT04265573|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
4955746|NCT04265573|Acceptability|acceptability
4955747|NCT04265573|Feasability|feasability
4955748|NCT04265573|Costs|costs
4955749|NCT04265560|Spinal Cord Injury|spinal cord injury
4955750|NCT04265560|Progressive Resistance Training|progressive resistance training
4955751|NCT04265560|Physical Therapy|physical therapy
4955752|NCT04265560|Physiotherapy|physiotherapy
4955753|NCT04265560|Strength Training|strength training
4955754|NCT04265547|Breast Cancer|breast cancer
4955755|NCT04265547|Xenoestrogen|xenoestrogen
4955756|NCT04265547|Household Intervention|household intervention
4955757|NCT04265534|NSCLC|nsclc
4955758|NCT04265534|KEAP1|keap1
4955759|NCT04265534|NERF2|nerf2
4955760|NCT04265534|NFE2l2|nfe2l2
4955761|NCT04265534|LKB1|lkb1
4955762|NCT04265534|STK11|stk11
4955763|NCT04265534|Next Generation Sequencing|next generation sequencing
4955764|NCT04265534|NGS|ngs
4955765|NCT04265534|Mutation|mutation
4955766|NCT04265534|Pembrolizumab|pembrolizumab
4955781|NCT04265534|Keytruda|keytruda
4955782|NCT04265534|Alimta|alimta
4955783|NCT04265495|Dual trigger implantation,|dual trigger implantation,
4955784|NCT04265495|HCG|hcg
4955785|NCT04265495|OHSS|ohss
4955786|NCT04265495|ANTAGONIST|antagonist
4955787|NCT04265482|Cognitive Ageing|cognitive ageing
4955788|NCT04265482|Subjective Cognitive Complaint|subjective cognitive complaint
4955789|NCT04265482|Dementia|dementia
4955790|NCT04265482|Alzheimer|alzheimer
4955791|NCT04265482|Functional decline|functional decline
4955792|NCT04265482|Geroscience|geroscience
4955793|NCT04265469|Diabetic foot, mobile application, patient education|diabetic foot, mobile application, patient education
4955794|NCT04265443|fractional flow reserve|fractional flow reserve
4955795|NCT04265443|non-hyperemic pressure ratio|non-hyperemic pressure ratio
4955796|NCT04265443|percutaneous coronary intervention|percutaneous coronary intervention
4955797|NCT04265443|prognosis|prognosis
4955798|NCT04265443|myocardial ischemia|myocardial ischemia
4955799|NCT04265391|snakehead fish cookies|snakehead fish cookies
4961799|NCT04228575|randomized controlled trial|randomized controlled trial
4955822|NCT04265235|Fatigue|fatigue
4955823|NCT04265235|Liver|liver
4955824|NCT04265222|Orthopedics|orthopedics
4955825|NCT04265222|Cam Decompression|cam decompression
4955826|NCT04265222|Femoroplasty|femoroplasty
4955827|NCT04265222|Femoroacetabular Impingement|femoroacetabular impingement
4955828|NCT04265183|preformed metal crowns|preformed metal crowns
4955829|NCT04265183|Hall technique|hall technique
4955830|NCT04265144|Cohort study|cohort study
4955831|NCT04265144|systemic sclerosis|systemic sclerosis
4955832|NCT04265144|prognosis|prognosis
4955833|NCT04265131|art therapy|art therapy
4955834|NCT04265131|emotion regulation|emotion regulation
4955835|NCT04265131|treatment|treatment
4955836|NCT04265105|asthma|asthma
4955837|NCT04265105|fluticasone|fluticasone
4955838|NCT04265105|LABA|laba
4955839|NCT04265105|fluticasone-vilanterol|fluticasone-vilanterol
4955840|NCT04265105|Long acting Beta agonist|long acting beta agonist
4955841|NCT04265092|Gait|gait
4955842|NCT04265092|Multiple Sclerosis|multiple sclerosis
4955843|NCT04265092|Spasticity|spasticity
4955844|NCT04265092|Toxin|toxin
4955845|NCT04265092|Triceps surae|triceps surae
4955846|NCT04265066|Microcirculation|microcirculation
4955847|NCT04265066|prehospital care|prehospital care
4955848|NCT04265066|risk stratification|risk stratification
4955849|NCT04265040|Cardiomyopathies, registry, data, biomaterial, genetics|cardiomyopathies, registry, data, biomaterial, genetics
4955850|NCT04265027|Ongentys|ongentys
4955851|NCT04265001|recurrent aphthous stomatitis|recurrent aphthous stomatitis
4955852|NCT04265001|chlorhexidine|chlorhexidine
4955853|NCT04265001|hyaluronic acid|hyaluronic acid
4955854|NCT04265001|pain|pain
5285792|NCT02243280|HCV GT4|hcv gt4
4955855|NCT04265001|topical|topical
4955861|NCT04264949|Chronic Low Back Pain|chronic low back pain
4955862|NCT04264949|Physical activity|physical activity
4955863|NCT04264949|Adherence|adherence
4955864|NCT04264897|Blood Glucose Regulation|blood glucose regulation
4975348|NCT04146064|breathprint analysis|breathprint analysis
4955875|NCT04264780|Epilepsy|epilepsy
4955876|NCT04264780|surgery|surgery
4955877|NCT04264780|temporal lobe|temporal lobe
4955878|NCT04264767|Cancer|cancer
4955879|NCT04264767|Methylation|methylation
4955880|NCT04264767|cfDNA|cfdna
4955881|NCT04264767|Solid Tumor|solid tumor
4955882|NCT04264767|Hematologic Neoplasms|hematologic neoplasms
4955883|NCT04264754|Cirrhosis|cirrhosis
4955884|NCT04264754|Hepatocellular Carcinoma|hepatocellular carcinoma
4955885|NCT04264754|Methylation|methylation
4955887|NCT04264741|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
4955888|NCT04264741|methamphetamine abuse|methamphetamine abuse
4955889|NCT04264741|methadone maintenance therapy|methadone maintenance therapy
4955890|NCT04264741|urine test|urine test
4955891|NCT04264741|relapse|relapse
4955892|NCT04264728|Morphea|morphea
4955893|NCT04264728|Generalized Morphea|generalized morphea
4955894|NCT04264728|Localized Scleroderma|localized scleroderma
4955924|NCT04264559|infrared thermal imaging|infrared thermal imaging
4955925|NCT04264533|Vitamin C|vitamin c
4955926|NCT04264533|2019-novel coronavirus pneumonia|2019-novel coronavirus pneumonia
4955927|NCT04264533|Severe acute respiratory infection|severe acute respiratory infection
4955928|NCT04264468|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4955929|NCT04264468|Mammaprint|mammaprint
4955930|NCT04264468|blueprint|blueprint
5695969|NCT00514540|Docetaxel|docetaxel
4955951|NCT04264390|physical activity|physical activity
4955952|NCT04264390|telehealth|telehealth
4955953|NCT04264377|Epigenetics|epigenetics
4955954|NCT04264377|Airway wall remodeling|airway wall remodeling
4955955|NCT04264351|Frailty|frailty
4955956|NCT04264351|Anesthesia|anesthesia
4955957|NCT04264351|complications|complications
4955958|NCT04264325|Dyspnea|dyspnea
4955959|NCT04264325|Malignant pleural effusion|malignant pleural effusion
4955960|NCT04264325|Lung Neoplasms|lung neoplasms
4955961|NCT04264325|Therapeutic thoracocentesis|therapeutic thoracocentesis
4955962|NCT04264325|Lung ultrasound|lung ultrasound
4955963|NCT04264325|Diaphragmatic ultrasound|diaphragmatic ultrasound
4955964|NCT04264325|Diaphragmatic dysfunction|diaphragmatic dysfunction
4955965|NCT04264312|HBV|hbv
4955966|NCT04264312|Antiviral Treatment Rate|antiviral treatment rate
4955967|NCT04264312|China|china
4955968|NCT04264312|Baseline Investigation|baseline investigation
4955969|NCT04264299|choledochorraphy|choledochorraphy
4955970|NCT04264299|T-tube|t-tube
4955971|NCT04264286|Esmolol|esmolol
4955972|NCT04264286|Extubation|extubation
4955973|NCT04264286|Hemodynamic instability|hemodynamic instability
4955974|NCT04264273|Alpha synuclein|alpha synuclein
4955975|NCT04264260|hepatocellular carcinoma|hepatocellular carcinoma
4955976|NCT04264260|Cholangiocarcinoma|cholangiocarcinoma
4955977|NCT04264260|primary hepatic malignancy|primary hepatic malignancy
4955978|NCT04264260|palliative treatment|palliative treatment
4955979|NCT04264260|colchicine|colchicine
4955980|NCT04264247|Fetal thymus volume|fetal thymus volume
4955981|NCT04264247|Preeclampsia|preeclampsia
4955982|NCT04264247|Screening|screening
4955983|NCT04264247|Prediction|prediction
4955989|NCT04264195|Recovery of function|recovery of function
4955990|NCT04264195|Modified CIMT|modified cimt
4955991|NCT04264182|LVAD|lvad
4955992|NCT04264182|ICD|icd
4955993|NCT04264182|Shock|shock
4955994|NCT04264182|Ventricular arrhythmia|ventricular arrhythmia
4955995|NCT04264169|placenta accrete spectrum|placenta accrete spectrum
4955996|NCT04264169|ultrasound|ultrasound
4956024|NCT04264013|Sarcopenia|sarcopenia
4956025|NCT04264013|Vascular health|vascular health
4956026|NCT04264000|Ulnar Neuropathy at Elbow|ulnar neuropathy at elbow
4956027|NCT04264000|platelet-rich plasma|platelet-rich plasma
4956028|NCT04264000|Perineural injection|perineural injection
4956029|NCT04263961|Severe Early-Onset COPD (SEO-COPD)|severe early-onset copd (seo-copd)
4956030|NCT04263961|Genotyping|genotyping
4956031|NCT04263961|Phenotyping|phenotyping
4956032|NCT04263961|Susceptibility|susceptibility
4956033|NCT04263948|pancreas cancer|pancreas cancer
4956034|NCT04263948|Plateform monitoring|plateform monitoring
4956035|NCT04263935|Lymphoma|lymphoma
5695970|NCT00514540|Taxotere|taxotere
4956036|NCT04263935|Driver Gene Abnormalities|driver gene abnormalities
4956037|NCT04263935|Disease Prognosis|disease prognosis
4956041|NCT04263909|sufentanil SL|sufentanil sl
4956042|NCT04263909|Postoperative Pain|postoperative pain
4956043|NCT04263909|Spine Surgery|spine surgery
4956044|NCT04263870|adenocarcinoma of the stomach or esophagogastric junction|adenocarcinoma of the stomach or esophagogastric junction
4956045|NCT04263870|conversion therapy|conversion therapy
4956046|NCT04263870|Sintilimab|sintilimab
4956047|NCT04263870|CAPOX|capox
4956048|NCT04263870|unresectable locally advanced|unresectable locally advanced
4956049|NCT04263870|limited metastasis|limited metastasis
4956050|NCT04263857|autologous & allogenic blood stem cell transplantations|autologous & allogenic blood stem cell transplantations
4956051|NCT04263844|emergence, delirium, dexmedetomidine, midazolam, pediatric|emergence, delirium, dexmedetomidine, midazolam, pediatric
4956052|NCT04263831|Inflammatory bowel disease|inflammatory bowel disease
4956053|NCT04263831|Interleukin 2|interleukin 2
4956054|NCT04263831|Regulatory T Cells|regulatory t cells
4956057|NCT04263779|Default Options|default options
4956058|NCT04263779|Order of Options|order of options
4956060|NCT04263779|Video|video
4956061|NCT04263779|Decision Aid|decision aid
4956062|NCT04263779|Mobile Application|mobile application
4956070|NCT04263701|cerebral palsy|cerebral palsy
4956071|NCT04263701|dual task training|dual task training
4956072|NCT04263701|gait|gait
4956073|NCT04263701|balance|balance
4956074|NCT04263688|Multicenter Observational Study|multicenter observational study
4956075|NCT04263688|Tumor Mutation Burden (TMB)|tumor mutation burden (tmb)
4956076|NCT04263688|immunotherapy|immunotherapy
4956077|NCT04263688|Pleural effusion|pleural effusion
4956078|NCT04263662|Analgesia|analgesia
4956079|NCT04263662|Sedation|sedation
4956080|NCT04263662|Dexmedetomidine|dexmedetomidine
4956081|NCT04263662|Mechanical Ventilation|mechanical ventilation
4956082|NCT04263662|Delirium|delirium
4956083|NCT04263636|pseudophakic presbyopic correction|pseudophakic presbyopic correction
4956084|NCT04263636|trifocal intraocular lens|trifocal intraocular lens
4956085|NCT04263636|light intensity|light intensity
4956086|NCT04263636|eye light transmittance|eye light transmittance
4956087|NCT04263636|light efficiency function|light efficiency function
4956088|NCT04263623|sweaty palms|sweaty palms
4971382|NCT04169659|EBM|ebm
4956089|NCT04263610|Dimethyl fumarate|dimethyl fumarate
4956090|NCT04263610|Tildrakizumab|tildrakizumab
4956091|NCT04263610|Moderate-to-severe plaque psoriasis|moderate-to-severe plaque psoriasis
4956098|NCT04263480|CXCR4 mutation|cxcr4 mutation
4956099|NCT04263480|Carfilzomib|carfilzomib
4956100|NCT04263480|Ibrutinib|ibrutinib
4956101|NCT04263480|Hematology|hematology
4956102|NCT04263480|Oncology|oncology
4956103|NCT04263454|neuroinflammation|neuroinflammation
4956104|NCT04263454|neuroimaging|neuroimaging
4956105|NCT04263454|fibromyalgia|fibromyalgia
4956106|NCT04263454|endotoxin|endotoxin
4956107|NCT04263454|chronic pain|chronic pain
4956108|NCT04263441|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4956109|NCT04263389|chronic mechanical cervical pain, shoulder proprioception,|chronic mechanical cervical pain, shoulder proprioception,
4956110|NCT04263363|Respiratory Complication|respiratory complication
4956111|NCT04263363|Clinical Decision Support|clinical decision support
4956112|NCT04263363|Sugammadex|sugammadex
4956113|NCT04263350|Healthy volunteers|healthy volunteers
4956114|NCT04263337|Concussion|concussion
4956115|NCT04263337|Former NFL Players|former nfl players
4956116|NCT04263337|Football|football
4956117|NCT04263337|Neurologic|neurologic
4975554|NCT04144686|Gait|gait
4956127|NCT04263233|Hemodialysis|hemodialysis
4956128|NCT04263233|Education|education
4956129|NCT04263233|Evaluation|evaluation
4956130|NCT04263220|industrial exoskeleton|industrial exoskeleton
4956131|NCT04263220|exoskeleton|exoskeleton
4956132|NCT04263220|passive industrial exoskeleton|passive industrial exoskeleton
4956133|NCT04263207|HIV/AIDS|hiv/aids
4956134|NCT04263207|Immune responses|immune responses
4956136|NCT04263207|HIV reservoire|hiv reservoire
4956137|NCT04263207|Biomarkers|biomarkers
4956138|NCT04263194|TMS|tms
4956139|NCT04263194|rTMS|rtms
4956140|NCT04263194|Alzheimer Disease|alzheimer disease
4956141|NCT04263155|Eating disorder prevention|eating disorder prevention
4956142|NCT04263155|Body Project|body project
4956143|NCT04263155|Female|female
4956144|NCT04263155|Adolescence|adolescence
4956145|NCT04263155|Peer delivery|peer delivery
4956146|NCT04263142|Healthy participants|healthy participants
4956147|NCT04263142|GSK3640254|gsk3640254
4956148|NCT04263142|Human immunodeficiency virus|human immunodeficiency virus
4956149|NCT04263142|Relative Bioavailability|relative bioavailability
4956150|NCT04263129|artificial trachea|artificial trachea
4956151|NCT04263129|tracheal reconstruction|tracheal reconstruction
4956152|NCT04263129|bronchial reconstruction|bronchial reconstruction
4956153|NCT04263103|Intermittent Exotropia|intermittent exotropia
4956154|NCT04263090|KRAS|kras
4956155|NCT04263090|Metastatic|metastatic
4956156|NCT04263090|Rigosertib|rigosertib
4956157|NCT04263090|Immunotherapy|immunotherapy
4956158|NCT04263090|Nivolumab|nivolumab
4956159|NCT04263077|KINESIOTAPING|kinesiotaping
4956160|NCT04263038|subsegmental pulmonary embolism|subsegmental pulmonary embolism
4956161|NCT04263025|Prostate cancer|prostate cancer
4956162|NCT04263025|Bilateral, nerve-sparing prostatectomy|bilateral, nerve-sparing prostatectomy
4956163|NCT04263025|Prostatectomy|prostatectomy
4956168|NCT04262986|Lifestyle modification|lifestyle modification
4956169|NCT04262986|Obstructive sleep apnoea|obstructive sleep apnoea
4956170|NCT04262986|Overweight|overweight
4956171|NCT04262973|dementia|dementia
4956172|NCT04262973|hospital|hospital
4956173|NCT04262973|acute care|acute care
4956174|NCT04262973|interprofessional education|interprofessional education
4956175|NCT04262973|interprofessional practice|interprofessional practice
4956176|NCT04262960|Obstructive sleep apnea|obstructive sleep apnea
4956177|NCT04262960|Continuous positive airway pressure|continuous positive airway pressure
4956178|NCT04262960|Elders|elders
4956179|NCT04262960|Chronotype|chronotype
4956180|NCT04262960|Cardiovascular risk|cardiovascular risk
4956181|NCT04262960|Food intake|food intake
4956182|NCT04262947|Near-Infrared Vein Imaging|near-infrared vein imaging
4956212|NCT04262739|failed approved standard therapies|failed approved standard therapies
4956213|NCT04262739|advanced solid tumors|advanced solid tumors
4956214|NCT04262726|Transdiagnostic|transdiagnostic
4956215|NCT04262726|Blended therapy|blended therapy
4956216|NCT04262726|Internet-based|internet-based
4956217|NCT04262726|Emotion regulation|emotion regulation
4956218|NCT04262687|immunotherapy|immunotherapy
4956219|NCT04262687|immune infiltrate|immune infiltrate
4956220|NCT04262687|first line|first line
4956221|NCT04262622|thoracic epidural analgesia|thoracic epidural analgesia
4956222|NCT04262622|rectus sheath block|rectus sheath block
4956223|NCT04262609|hypofractionated radiotherapy|hypofractionated radiotherapy
4956224|NCT04262609|quality of life|quality of life
4956225|NCT04262609|cancer survivors|cancer survivors
4975658|NCT04144062|Crowns|crowns
4956247|NCT04262518|Metastatic Breast Cancer|metastatic breast cancer
4956249|NCT04262518|Patient Navigation|patient navigation
4956250|NCT04262518|Treatment Options|treatment options
4956251|NCT04262518|Clinical Trial Options|clinical trial options
4956252|NCT04262518|Symptom Management|symptom management
4956253|NCT04262492|antiphospholipid syndrome|antiphospholipid syndrome
4956254|NCT04262492|direct oral anticoagulants|direct oral anticoagulants
4956255|NCT04262479|Glutamic Acid Decarboxylase|glutamic acid decarboxylase
4956256|NCT04262479|Alum Compounds|alum compounds
4956257|NCT04262479|Injections|injections
4956258|NCT04262479|Inguinal Canal|inguinal canal
4956259|NCT04262479|Diamyd|diamyd
4956260|NCT04262479|rhGAD65|rhgad65
4956261|NCT04262479|Vitamin D|vitamin d
4956262|NCT04262453|Upper Aerodigestive Tract Neoplasms|upper aerodigestive tract neoplasms
4956263|NCT04262453|Obstructive Sleep Apnea-hypopnea Syndrome|obstructive sleep apnea-hypopnea syndrome
4956264|NCT04262453|Epworth score|epworth score
4956265|NCT04262453|Ventilatory Polygraphy|ventilatory polygraphy
4956266|NCT04262414|Balance|balance
4956267|NCT04262414|Functional Electrical Stimulation|functional electrical stimulation
4956268|NCT04262336|Ototoxicity|ototoxicity
4956269|NCT04262336|Hearing loss|hearing loss
4956270|NCT04262336|Chemotherapy-induced|chemotherapy-induced
4956271|NCT04262297|Amputees|amputees
4956272|NCT04262297|Quadriceps MuscleMuscle Strength|quadriceps musclemuscle strength
4956273|NCT04262297|Muscle Strength|muscle strength
4956276|NCT04262180|MVPA|mvpa
4956277|NCT04262180|Fitbit|fitbit
4956278|NCT04262154|Abiraterone Acetate|abiraterone acetate
4956279|NCT04262154|Atezolizumab|atezolizumab
4956280|NCT04262154|Lupron|lupron
4956281|NCT04262154|Radiation Therapy|radiation therapy
4956282|NCT04262154|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
4956283|NCT04262154|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4956284|NCT04262154|SBRT|sbrt
4956285|NCT04262154|Metastatic prostate cancer|metastatic prostate cancer
4956286|NCT04262154|19-461|19-461
4956287|NCT04262154|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4956288|NCT04262128|diabetes|diabetes
4956289|NCT04262128|sedentary behavior|sedentary behavior
4956290|NCT04262128|cardiovascular disease|cardiovascular disease
4956307|NCT04262063|tell show do|tell show do
4956308|NCT04262063|tell play do|tell play do
4956309|NCT04262063|dental anxiety|dental anxiety
4956310|NCT04262063|child behavior|child behavior
4956311|NCT04262050|Tinnitus, tDCS, TMS|tinnitus, tdcs, tms
4956312|NCT04262024|Nursing|nursing
4956313|NCT04262024|health education|health education
4956314|NCT04262024|prolactin|prolactin
4956315|NCT04262024|hyperprolactinemia|hyperprolactinemia
4962209|NCT04226053|Poverty|poverty
4956332|NCT04261855|peptide receptor radionuclide therapy|peptide receptor radionuclide therapy
4956333|NCT04261855|neuroendocrine tumour|neuroendocrine tumour
4956334|NCT04261855|rare cancer|rare cancer
4956335|NCT04261855|merkel cell|merkel cell
4956336|NCT04261855|carcinoma|carcinoma
4956337|NCT04261855|immunotherapy|immunotherapy
4956338|NCT04261842|Military Identity|military identity
4956339|NCT04261842|Military psychological health|military psychological health
4975767|NCT04143347|TBI|tbi
4956355|NCT04261764|Obesity|obesity
4956356|NCT04261764|Fasting-mimicking diet|fasting-mimicking diet
4956357|NCT04261764|Chinese medicine|chinese medicine
4956358|NCT04261738|hyperbaric oxygen|hyperbaric oxygen
4956359|NCT04261738|continuous glucose monitor|continuous glucose monitor
4956360|NCT04261738|hbo|hbo
4956361|NCT04261738|cgm|cgm
4956362|NCT04261712|Acromegaly|acromegaly
4956363|NCT04261712|ACROBAT|acrobat
4956364|NCT04261712|ADVANCE|advance
4956365|NCT04261712|paltusotine|paltusotine
4956366|NCT04261699|Adjustable strabismus surgery|adjustable strabismus surgery
5369118|NCT01861275|thrombolysis in cerebral palsy|thrombolysis in cerebral palsy
4956367|NCT04261699|Target-controlled infusion of Propofol-Reminfentanyl|target-controlled infusion of propofol-reminfentanyl
4956369|NCT04261647|coccydynia|coccydynia
4956370|NCT04261634|multiple gingival recession|multiple gingival recession
4956371|NCT04261634|platelet rich fibrin|platelet rich fibrin
4956372|NCT04261634|concentrate growth factor|concentrate growth factor
4956373|NCT04261621|Infection|infection
4956375|NCT04261621|Worsening|worsening
4956376|NCT04261621|Emergency Department|emergency department
4956377|NCT04261595|Dates|dates
4956378|NCT04261595|Autism|autism
4956379|NCT04261595|microbiota|microbiota
4956380|NCT04261595|antioxidant|antioxidant
4956381|NCT04261595|anti- inflammatory|anti- inflammatory
4956382|NCT04261569|Parkinson's disease (PD)|parkinson's disease (pd)
4956383|NCT04261569|Intraventricular illumination by near-infrared light (Ev-NIRT)|intraventricular illumination by near-infrared light (ev-nirt)
4956384|NCT04261569|Positron Emission Tomography (PET)|positron emission tomography (pet)
4956385|NCT04261569|Substantia Nigra Pars Compacta (SNpc)|substantia nigra pars compacta (snpc)
4956386|NCT04261569|Photobiomodulation|photobiomodulation
4956387|NCT04261569|Medical Device (MD)|medical device (md)
4956388|NCT04261556|Multiple sclerosis|multiple sclerosis
4956389|NCT04261556|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5695971|NCT00514540|Paraplatin|paraplatin
4956406|NCT04261517|2019-new coronavirus|2019-new coronavirus
4956407|NCT04261517|hydroxychloroquine|hydroxychloroquine
4956409|NCT04261478|Tandem occlusion|tandem occlusion
4956410|NCT04261478|Carotid stenting|carotid stenting
4956411|NCT04261439|NIZ985, Spartalizumab, immunotherapy, checkpoint Inhibitor, checkpoint inhibitor resistance, melanoma|niz985, spartalizumab, immunotherapy, checkpoint inhibitor, checkpoint inhibitor resistance, melanoma
4956412|NCT04261374|Microcirculation|microcirculation
4956413|NCT04261374|dehydration|dehydration
4956414|NCT04261374|risk stratification|risk stratification
4956415|NCT04261361|telephone follow-up|telephone follow-up
4956416|NCT04261361|sustainability|sustainability
4956417|NCT04261361|cognitive behavioural therapy|cognitive behavioural therapy
4956418|NCT04261335|Hypoxia-Ischemia, Brain|hypoxia-ischemia, brain
4956419|NCT04261335|Infant, Newborn|infant, newborn
4956420|NCT04261335|Mesenchymal Stem Cells|mesenchymal stem cells
4956421|NCT04261309|prognosis, prognostic factors, subgroups, burden of disease,|prognosis, prognostic factors, subgroups, burden of disease,
4956422|NCT04261296|dry needling|dry needling
4956423|NCT04261296|spa|spa
4956424|NCT04261283|Dizziness|dizziness
4956425|NCT04261283|Exercise|exercise
4956426|NCT04261283|Vestibular|vestibular
4956427|NCT04261283|Vertigo|vertigo
4956432|NCT04261205|Chronic hemodialysis|chronic hemodialysis
4956434|NCT04261153|Cognition|cognition
4956435|NCT04261140|High-viscosity glass ionomer|high-viscosity glass ionomer
4956440|NCT04261127|autosomal recessive cerebellar ataxia|autosomal recessive cerebellar ataxia
4956442|NCT04261127|genetic diagnosis|genetic diagnosis
4956453|NCT04261036|Vitamin C, CAUTI, Ascorbic Acid|vitamin c, cauti, ascorbic acid
4956454|NCT04261023|Abatacept (Orencia)|abatacept (orencia)
4956455|NCT04261010|Synovium, Biologics, Genomics|synovium, biologics, genomics
4956457|NCT04260984|ultrasound-guided injection|ultrasound-guided injection
4956458|NCT04260984|intra-articular injection|intra-articular injection
4956461|NCT04260958|Exercise-based cardiac rehabilitation|exercise-based cardiac rehabilitation
4956462|NCT04260958|Secondary prevention|secondary prevention
4956463|NCT04260958|EHealth|ehealth
4956464|NCT04260958|Telerehabilitation|telerehabilitation
4956465|NCT04260958|Physical fitness|physical fitness
4956466|NCT04260958|Health-related quality of life|health-related quality of life
4956467|NCT04260958|cost-effectiveness|cost-effectiveness
4956468|NCT04260919|bronchiolitis|bronchiolitis
4956469|NCT04260919|chest physiotherapy|chest physiotherapy
4956470|NCT04260919|children|children
4956471|NCT04260906|Fibromyalgia Syndrome|fibromyalgia syndrome
4956472|NCT04260906|Auricular Vagus Nerve Stimulation|auricular vagus nerve stimulation
4956473|NCT04260841|fluid responsiveness|fluid responsiveness
4956474|NCT04260737|Localized Prostate Cancer|localized prostate cancer
4956475|NCT04260737|Decision Aid|decision aid
4956476|NCT04260737|Medical Decision Making|medical decision making
4956477|NCT04260711|multiple sclerosis|multiple sclerosis
4956478|NCT04260711|disease modifying therapy|disease modifying therapy
4956479|NCT04260685|esmolol|esmolol
4956480|NCT04260685|lidocaine|lidocaine
4956481|NCT04260685|surgical field|surgical field
4956482|NCT04260672|Child nutrition|child nutrition
4956483|NCT04260672|Child physical activity|child physical activity
4956484|NCT04260672|Child sleeping routines|child sleeping routines
4956492|NCT04260620|SoftVue|softvue
4956493|NCT04260620|Mammography|mammography
4956494|NCT04260620|Ultrasound|ultrasound
4956495|NCT04260620|Reader Study|reader study
4956496|NCT04260620|ROC AUC|roc auc
4956497|NCT04260620|Dense Breasts|dense breasts
4956498|NCT04260620|Breast Density|breast density
4956499|NCT04260620|Dense Breast Tissue|dense breast tissue
4956500|NCT04260620|Breast Neoplasms|breast neoplasms
4956501|NCT04260607|ketamine|ketamine
4956502|NCT04260581|Parkinson's disease|parkinson's disease
5342896|NCT01981590|breathing, heart failure, sleep apnea|breathing, heart failure, sleep apnea
4956503|NCT04260581|Amantadine|amantadine
4956504|NCT04260581|Long-term effect|long-term effect
4956505|NCT04260568|PPPD|pppd
4956506|NCT04260568|dizziness|dizziness
4956507|NCT04260568|Illness perceptions|illness perceptions
4956508|NCT04260568|qualitative|qualitative
4956509|NCT04260542|adipose tissue|adipose tissue
4956510|NCT04260542|insulin resistance|insulin resistance
4956511|NCT04260542|obesity|obesity
4956512|NCT04260542|ketogenic diet|ketogenic diet
4956513|NCT04260542|de novo lipogenesis|de novo lipogenesis
4956514|NCT04260529|Cancer|cancer
4956515|NCT04260529|Tumour|tumour
4956516|NCT04260529|Oncology|oncology
4956517|NCT04260529|Immunotherapy|immunotherapy
4956518|NCT04260529|Oncolytic|oncolytic
4956519|NCT04260529|CD8|cd8
4956520|NCT04260529|Intratumoral|intratumoral
4956521|NCT04260529|Neoplasm|neoplasm
4956525|NCT04260490|Multiple myeloma|multiple myeloma
4956526|NCT04260490|pesticide|pesticide
4956527|NCT04260490|chlordecone|chlordecone
4956528|NCT04260490|Guadeloupe|guadeloupe
4956529|NCT04260490|Martinique|martinique
5695972|NCT00514514|Everolimus|everolimus
4956530|NCT04260477|rifampicin-susceptible-TB|rifampicin-susceptible-tb
4956531|NCT04260477|Tuberculosis|tuberculosis
4956532|NCT04260477|first-line|first-line
4956533|NCT04260477|TB relapse|tb relapse
4956534|NCT04260477|TB treatment failure|tb treatment failure
4956535|NCT04260477|high dose retreatment|high dose retreatment
4956536|NCT04260464|Pharmacokinetics|pharmacokinetics
4956537|NCT04260386|Maternal Cardiac Arrest|maternal cardiac arrest
4956538|NCT04260386|Clinical Scenarios Simulation|clinical scenarios simulation
4956539|NCT04260360|docetaxel|docetaxel
4956540|NCT04260334|Adnexal mass|adnexal mass
4956541|NCT04260334|Preoperative education|preoperative education
4956542|NCT04260334|Anxiety|anxiety
4956543|NCT04260321|Artificial Intelligence|artificial intelligence
4956544|NCT04260295|Microbiome|microbiome
4956545|NCT04260295|Lung Cancer|lung cancer
4956546|NCT04260204|retrograde autologous priming pulmonary mechanics|retrograde autologous priming pulmonary mechanics
4956547|NCT04260178|COPD|copd
4956548|NCT04260178|dyspnea|dyspnea
4956549|NCT04260178|self-care management|self-care management
4956550|NCT04260178|nurse education.|nurse education.
4956551|NCT04260165|Wrist Osteoarthritis|wrist osteoarthritis
4956562|NCT04260139|colon cancer|colon cancer
4956563|NCT04260139|Staging|staging
4956564|NCT04260126|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4956565|NCT04260126|Human Papillomavirus|human papillomavirus
4956566|NCT04260126|Immunotherapy|immunotherapy
4956567|NCT04260126|PDS0101|pds0101
4956587|NCT04259983|Endothelial Dysfunction|endothelial dysfunction
4956588|NCT04259983|Arterial Stiffness|arterial stiffness
4956607|NCT04259905|cancer survivor|cancer survivor
4956608|NCT04259905|women's health|women's health
4956609|NCT04259905|support group|support group
4956610|NCT04259905|survivorship|survivorship
4956611|NCT04259905|mhealth|mhealth
4956619|NCT04259853|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4956620|NCT04259853|Multi-Vessel Coronary Artery Stenosis|multi-vessel coronary artery stenosis
4956621|NCT04259853|Coronary physiological function|coronary physiological function
4956622|NCT04259853|Quantitative fractional ratio|quantitative fractional ratio
4956623|NCT04259853|Percutaneous coronary intervention|percutaneous coronary intervention
4956624|NCT04259814|speech delay|speech delay
4956625|NCT04259814|one-sided weakness|one-sided weakness
4956626|NCT04259788|Diet|diet
4956627|NCT04259775|automated insulin dose adjustment|automated insulin dose adjustment
4956628|NCT04259775|continuous glucose monitor|continuous glucose monitor
4956629|NCT04259762|breast neoplasm|breast neoplasm
4956630|NCT04259762|colorectal neoplasm|colorectal neoplasm
4956631|NCT04259762|cervical neoplasm|cervical neoplasm
4956632|NCT04259762|screening|screening
4956633|NCT04259762|behavioral interventions|behavioral interventions
4956634|NCT04259762|American Indians|american indians
4956635|NCT04259762|cost-effectiveness analysis|cost-effectiveness analysis
4956636|NCT04259762|cluster randomization|cluster randomization
4956637|NCT04259762|community-based participatory research|community-based participatory research
4956638|NCT04259736|Lower Respiratory Tract|lower respiratory tract
4956639|NCT04259736|Microbes|microbes
4956640|NCT04259736|COPD|copd
4956641|NCT04259723|TAVI|tavi
4956642|NCT04259723|VR|vr
4956643|NCT04259723|3D glasses|3d glasses
4956644|NCT04259697|postmenopausal osteoporosis|postmenopausal osteoporosis
4971692|NCT04167683|PRO|pro
4973044|NCT04160507|ESKD|eskd
4973664|NCT04156269|CD269|cd269
4975666|NCT04143932|MM|mm
4976012|NCT04141930|flu|flu
4976162|NCT04141150|AD|ad
4977827|NCT04130802|Pain|pain
4978812|NCT04124562|Turkey|turkey
4979703|NCT04119492|MRI|mri
4980819|NCT04112667|retina|retina
4982204|NCT04103723|Surgery|surgery
4982346|NCT04102657|CGM|cgm
4982945|NCT04098783|Nursing|nursing
4983396|NCT04095793|MSA|msa
4983568|NCT04094883|Vaccine|vaccine
4984081|NCT04091516|lipids|lipids
4984530|NCT04088916|HIV|hiv
4985718|NCT04080765|HIV|hiv
4986373|NCT04076774|FC2|fc2
4986724|NCT04074733|ULD|uld
4988319|NCT04064619|OAB|oab
4988454|NCT04063735|Dry Eye|dry eye
4956645|NCT04259697|clinical pilates|clinical pilates
4956646|NCT04259697|whole body vibration|whole body vibration
4956647|NCT04259697|bone turnover markers|bone turnover markers
4956648|NCT04259697|strength|strength
4956649|NCT04259697|flexibility|flexibility
4956650|NCT04259697|balance|balance
4956651|NCT04259697|quality of life|quality of life
4956652|NCT04259658|calcium|calcium
4956653|NCT04259658|electroporation|electroporation
4956654|NCT04259658|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
4956655|NCT04259658|cancer|cancer
4956656|NCT04259658|metastases|metastases
4956657|NCT04259645|Hip|hip
4956658|NCT04259645|Anesthesia,conduction|anesthesia,conduction
4956659|NCT04259645|arhtroplasty|arhtroplasty
4956660|NCT04259606|Cassia cinnamon|cassia cinnamon
4956661|NCT04259606|Endothelial function|endothelial function
4956662|NCT04259606|Pulse wave velocity|pulse wave velocity
4956663|NCT04259606|Brachial - ankle index|brachial - ankle index
4956664|NCT04259593|Exercise training, Complementary therapy|exercise training, complementary therapy
4956665|NCT04259567|Cerebrovascular Autoregulation|cerebrovascular autoregulation
4956666|NCT04259567|Septic Shock|septic shock
4956667|NCT04259567|Cytokine|cytokine
4956668|NCT04259554|rTMS|rtms
4956700|NCT04259333|celecoxib|celecoxib
4956701|NCT04259268|Patient Health Questionnaire|patient health questionnaire
4956702|NCT04259268|Electronic Health Records|electronic health records
4956703|NCT04259255|biomarkers|biomarkers
4956704|NCT04259255|edaravone|edaravone
4956705|NCT04259255|Radicava®|radicava®
4956706|NCT04259255|motor neuron disease|motor neuron disease
4956707|NCT04259229|Mediterranean|mediterranean
4956708|NCT04259229|Mushrooms|mushrooms
4956709|NCT04259216|cyber-victimization|cyber-victimization
4956710|NCT04259216|mobile application|mobile application
4956711|NCT04259216|mhealth|mhealth
4956712|NCT04259216|remote intervention|remote intervention
4956713|NCT04259203|No-motor symptoms|no-motor symptoms
4956714|NCT04259203|Pain perception|pain perception
4956715|NCT04259203|Quality of life|quality of life
4956716|NCT04259203|Hypnosis|hypnosis
4956717|NCT04259203|Auto-hypnosis|auto-hypnosis
4956718|NCT04259190|anxiety sensitivity|anxiety sensitivity
4956719|NCT04259190|panic|panic
4956720|NCT04259190|interoceptive exposure|interoceptive exposure
4956721|NCT04259190|exposure therapy|exposure therapy
4956723|NCT04259177|Reliability|reliability
4956724|NCT04259177|Validity|validity
4956725|NCT04259177|Hammersmith Infant Neurological Evaluation (HINE)|hammersmith infant neurological evaluation (hine)
4956726|NCT04259177|Turkish version|turkish version
4956727|NCT04259177|Infant|infant
4956728|NCT04259164|Asthma|asthma
4956729|NCT04259164|Anti-inflammatory|anti-inflammatory
4956730|NCT04259164|Allergen|allergen
4956731|NCT04259125|Neonatal seizure|neonatal seizure
4956732|NCT04259125|Inflammation|inflammation
4956733|NCT04259125|Cytokine|cytokine
4956734|NCT04259125|Micro-RNA|micro-rna
4956735|NCT04259125|Epilepsy|epilepsy
4956736|NCT04259125|EEG|eeg
4956737|NCT04259099|osteoporosis|osteoporosis
4956738|NCT04259099|Questionnaire|questionnaire
4956739|NCT04259099|Quality of Life|quality of life
4956740|NCT04259099|QUALEFFO|qualeffo
4956741|NCT04259086|Lateral Canthal Wrinkle|lateral canthal wrinkle
4956742|NCT04259086|crow's feet lines|crow's feet lines
4956743|NCT04259086|LCL|lcl
4956744|NCT04259086|Forehead Lines|forehead lines
4956745|NCT04259086|Glabellar Lines|glabellar lines
4956746|NCT04259086|Frown Lines|frown lines
4956747|NCT04259086|Upper facial lines|upper facial lines
4956748|NCT04259073|postoperative pain|postoperative pain
4956749|NCT04259073|pregabalin|pregabalin
4956750|NCT04259073|cesarean section|cesarean section
4956751|NCT04259060|Ulcerative Colitis|ulcerative colitis
4956752|NCT04259060|Inflammatory Bowel Disease|inflammatory bowel disease
4956753|NCT04259060|Butyrate|butyrate
4956754|NCT04259060|Hydroxocobalamin|hydroxocobalamin
4956755|NCT04259047|Mild Cognitive Impairment|mild cognitive impairment
4956756|NCT04259047|Diabetes|diabetes
4956757|NCT04259047|African American|african american
4956763|NCT04258969|Sarcopenia|sarcopenia
4956764|NCT04258969|Quality of Life|quality of life
4956765|NCT04258943|Philadelphia Chromosome Positive CML|philadelphia chromosome positive cml
4956766|NCT04258917|crutches|crutches
4956767|NCT04258917|gait|gait
4956768|NCT04258917|mobility|mobility
4956769|NCT04258917|adult|adult
4956770|NCT04258917|knee replacement|knee replacement
4956771|NCT04258917|ACL tear|acl tear
4956772|NCT04258904|Type 1 Diabetes|type 1 diabetes
4956773|NCT04258891|Kidney Transplantation|kidney transplantation
4956774|NCT04258891|Graft survival|graft survival
4956775|NCT04258891|Kidney function|kidney function
4956776|NCT04258891|Prediction|prediction
4956777|NCT04258891|Dynamic|dynamic
4956778|NCT04258865|CKD-348|ckd-348
4956779|NCT04258839|Autism|autism
4956904|NCT04258150|SBRT|sbrt
4956788|NCT04258787|Pseudophakic Bullous Keratopathy|pseudophakic bullous keratopathy
4956789|NCT04258787|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
4956790|NCT04258787|PBK|pbk
4956801|NCT04258696|Gingival displacement|gingival displacement
4956802|NCT04258696|Diode laser|diode laser
4956803|NCT04258683|Hematologic Diseases|hematologic diseases
4956804|NCT04258683|Pembrolizumab|pembrolizumab
4956805|NCT04258683|Keytruda|keytruda
4956806|NCT04258683|Neoplasms|neoplasms
4956807|NCT04258683|Plasma Cell|plasma cell
4956808|NCT04258683|Cardiovascular Diseases|cardiovascular diseases
4956809|NCT04258683|Immune System Diseases|immune system diseases
4956810|NCT04258683|Cyclophosphamide|cyclophosphamide
4956811|NCT04258683|Dexamethasone|dexamethasone
4956812|NCT04258683|Bortezomib|bortezomib
4956813|NCT04258683|Anti-Inflammatory Agents|anti-inflammatory agents
4956814|NCT04258683|Bone Marrow|bone marrow
4956815|NCT04258670|diagnostics|diagnostics
4956816|NCT04258670|cross-reactivity|cross-reactivity
4956818|NCT04258592|norepinephrine transporter imaging|norepinephrine transporter imaging
4956819|NCT04258592|18F-MFBG|18f-mfbg
4956820|NCT04258579|Mental Health|mental health
4956824|NCT04258553|thiol disulfide hemostasis|thiol disulfide hemostasis
4956825|NCT04258553|screening|screening
4956826|NCT04258553|early diagnosis|early diagnosis
4956827|NCT04258540|mental health|mental health
4956828|NCT04258540|public health|public health
4956829|NCT04258540|depression|depression
4956830|NCT04258540|anxiety|anxiety
4956831|NCT04258540|sleep problems|sleep problems
4956832|NCT04258540|insomnia|insomnia
4956833|NCT04258540|yoga|yoga
4956834|NCT04258540|students|students
4956835|NCT04258488|Aortic valve replacement|aortic valve replacement
4956836|NCT04258488|Mechanical valve|mechanical valve
4956837|NCT04258475|Raltegravir|raltegravir
4956838|NCT04258475|Calcium|calcium
4956839|NCT04258475|PK|pk
4956849|NCT04258436|Post thoractomy pain|post thoractomy pain
4956850|NCT04258436|Fascial plane blocks|fascial plane blocks
4956851|NCT04258436|Early recovery after thoractomy|early recovery after thoractomy
4956852|NCT04258436|Serratus anterior fascial block|serratus anterior fascial block
4955278|NCT04268524|Thermotherapy|thermotherapy
4955279|NCT04268511|Ultrasound|ultrasound
4955280|NCT04268511|Pudendal nerve block|pudendal nerve block
4955281|NCT04268511|Caudal epidural block|caudal epidural block
4955282|NCT04268511|Pain|pain
4955283|NCT04268498|Multiple Myeloma|multiple myeloma
4955284|NCT04268498|Daratumumab|daratumumab
4955285|NCT04268498|Carfilzomib|carfilzomib
4956853|NCT04258410|estrogen deficiency|estrogen deficiency
4956854|NCT04258410|post-menopause|post-menopause
4956855|NCT04258410|cardiac diastolic function|cardiac diastolic function
4956856|NCT04258410|skeletal muscle function|skeletal muscle function
4956857|NCT04258410|skeletal muscle structure|skeletal muscle structure
4956858|NCT04258410|cardiac structure|cardiac structure
4956859|NCT04258397|Fibrosis|fibrosis
4956860|NCT04258397|Scarring|scarring
4956861|NCT04258397|CKD|ckd
4956862|NCT04258384|Rheumatoid Arthritis, pain, coping, validity, reliability|rheumatoid arthritis, pain, coping, validity, reliability
4956863|NCT04258371|SGLT2 inhibition|sglt2 inhibition
4956864|NCT04258371|Cardiovascular risk|cardiovascular risk
4956865|NCT04258371|Dapagliflozin|dapagliflozin
4956866|NCT04258358|Dementia care|dementia care
4956867|NCT04258358|Community integrated care|community integrated care
4956868|NCT04258358|Strengths-based approach|strengths-based approach
4956869|NCT04258358|Technology|technology
4956870|NCT04258358|Person centered care|person centered care
4962715|NCT04223063|Exercise prehabilitation|exercise prehabilitation
4956886|NCT04258241|Femoral triangle block|femoral triangle block
4957482|NCT04254380|Lispro|lispro
4956894|NCT04258163|Overall Survival|overall survival
4956895|NCT04258163|Safety|safety
4956896|NCT04258150|pancreatic cancer|pancreatic cancer
4956897|NCT04258150|nivolumab|nivolumab
4956898|NCT04258150|Opdivo|opdivo
4956899|NCT04258150|ipilimumab|ipilimumab
4956900|NCT04258150|Yervoy|yervoy
4956901|NCT04258150|tocilizumab|tocilizumab
4956902|NCT04258150|RoACTEMRA|roactemra
4956903|NCT04258150|radiation|radiation
4956905|NCT04258137|advanced|advanced
4956906|NCT04258137|metastatic|metastatic
4956907|NCT04258137|liquid biopsy|liquid biopsy
4956908|NCT04258137|genetic profiling|genetic profiling
4956915|NCT04258085|breast cancer|breast cancer
4956917|NCT04258085|early detection|early detection
4956922|NCT04257994|cardiac arrhythmias|cardiac arrhythmias
4956923|NCT04257968|Head and Neck Cancer|head and neck cancer
4956924|NCT04257968|Radiotherapy|radiotherapy
4956925|NCT04257968|Complications|complications
4956926|NCT04257968|Vascular|vascular
4956927|NCT04257955|doctor- patient interaction|doctor- patient interaction
4956928|NCT04257955|pancreatic cancer|pancreatic cancer
4956929|NCT04257955|diagnosis communication|diagnosis communication
4956930|NCT04257929|PWS|pws
4956936|NCT04257903|Myofacial Pain|myofacial pain
4956937|NCT04257903|Occlusal Splint|occlusal splint
4956938|NCT04257903|Low-Level Laser Therapy|low-level laser therapy
4956939|NCT04257877|plasma proteomics|plasma proteomics
4956940|NCT04257877|children|children
4956941|NCT04257877|diabetes type 1|diabetes type 1
4956942|NCT04257877|nerve conduction|nerve conduction
4956943|NCT04257851|Post-dural puncture headache|post-dural puncture headache
4956944|NCT04257851|Spinal anesthesia|spinal anesthesia
4956945|NCT04257851|Sumatriptan|sumatriptan
4956946|NCT04257851|Theophylline|theophylline
4956947|NCT04257838|Sepsis|sepsis
4956948|NCT04257838|Septic Shock|septic shock
4956949|NCT04257838|Piperacillin-Tazobactam|piperacillin-tazobactam
4956950|NCT04257838|Meropenem|meropenem
4956951|NCT04257838|Plasmatic Levels|plasmatic levels
4956952|NCT04257838|Critical Patients|critical patients
4956953|NCT04257838|Dose adjustment|dose adjustment
4956954|NCT04257812|Ceftolozane-Tazobactam|ceftolozane-tazobactam
4956955|NCT04257812|Plasmatic Levels|plasmatic levels
4956956|NCT04257812|Serious Infection|serious infection
4956957|NCT04257812|Dose adjustment|dose adjustment
4956958|NCT04257760|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4956959|NCT04257760|palliative care|palliative care
4956960|NCT04257760|caregivers|caregivers
4956961|NCT04257747|vascularized composite allotransplantation|vascularized composite allotransplantation
4956962|NCT04257747|hand allotransplantation|hand allotransplantation
4956963|NCT04257747|radial forearm flap|radial forearm flap
4956964|NCT04257747|magnetic resonance imaging|magnetic resonance imaging
4956965|NCT04257747|flow MRI|flow mri
4956966|NCT04257747|radial artery|radial artery
4956967|NCT04257747|ulnar artery|ulnar artery
4956969|NCT04257721|jaw osteonecrosis|jaw osteonecrosis
4956970|NCT04257721|biphosphonates|biphosphonates
4956971|NCT04257721|antiangiogenic agents|antiangiogenic agents
4956972|NCT04257721|oral surgery|oral surgery
4956973|NCT04257695|opioid|opioid
4956974|NCT04257695|tapering|tapering
4956975|NCT04257695|chronic pain|chronic pain
4956976|NCT04257669|Iron Status|iron status
4956977|NCT04257669|Iron deficiency|iron deficiency
4956978|NCT04257669|Cognition|cognition
4956979|NCT04257669|Mood|mood
4956980|NCT04257669|Fatigue|fatigue
4956981|NCT04257669|Well-being|well-being
4956982|NCT04257669|Women's Health|women's health
4956983|NCT04257643|Aquatic exercise-|aquatic exercise-
4956984|NCT04257643|Land based exercise|land based exercise
4956985|NCT04257643|lymphedema|lymphedema
4956986|NCT04257630|coping strategies|coping strategies
4956987|NCT04257630|psychological burden|psychological burden
4956988|NCT04257630|anxiety|anxiety
4956989|NCT04257630|depression|depression
4956996|NCT04257604|Focal seizures|focal seizures
4956997|NCT04257591|exercise|exercise
4956998|NCT04257591|therapeutics|therapeutics
4956999|NCT04257591|prevention|prevention
4957000|NCT04257578|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4957001|NCT04257565|Foot Ulcer|foot ulcer
4957002|NCT04257552|contraception|contraception
4957003|NCT04257552|postpartum care|postpartum care
4957004|NCT04257552|breast feeding|breast feeding
4957005|NCT04257552|interconception care|interconception care
4957006|NCT04257539|Sedentary|sedentary
4957007|NCT04257526|colorectal cancer|colorectal cancer
4957008|NCT04257526|prevention|prevention
4957009|NCT04257513|Huntington Disease|huntington disease
4957010|NCT04257513|Cholesterol|cholesterol
4957011|NCT04257487|Venous thromboembolism|venous thromboembolism
4957013|NCT04257487|Sulodexide|sulodexide
4957014|NCT04257474|Pathogenic BRCA 1/2 Mutation|pathogenic brca 1/2 mutation
4957016|NCT04257409|diabetic foot|diabetic foot
4957017|NCT04257409|biomechanics|biomechanics
4957018|NCT04257409|quality of life|quality of life
4957019|NCT04257409|prevention|prevention
4957020|NCT04257370|Diabetic foot ulcer|diabetic foot ulcer
4957021|NCT04257370|DFU|dfu
4957022|NCT04257370|Dehisced amputation|dehisced amputation
4957023|NCT04257370|Acute amputation|acute amputation
4957024|NCT04257370|Fish skin|fish skin
4957025|NCT04257370|Kerecis|kerecis
4957031|NCT04257344|Wearables|wearables
4957032|NCT04257344|Emergency surgery|emergency surgery
4957033|NCT04257344|Abdominal surgery|abdominal surgery
4957034|NCT04257344|Patient reported outcome measures|patient reported outcome measures
4957035|NCT04257344|Recovery|recovery
4957036|NCT04257344|Continues Glucose Monitoring|continues glucose monitoring
4957044|NCT04257305|Venous thromboembolism|venous thromboembolism
4957045|NCT04257305|deep venous thrombosis|deep venous thrombosis
4957046|NCT04257305|neurosurgery|neurosurgery
4957047|NCT04257305|pulmonary embolism|pulmonary embolism
4957048|NCT04257292|Infective Endocarditis|infective endocarditis
4957049|NCT04257292|Staphylococcus aureus|staphylococcus aureus
4957050|NCT04257292|Next-Generation Sequencing|next-generation sequencing
4957051|NCT04257279|spine|spine
4957052|NCT04257253|low back pain; paraspinal muscle; exercise; diagnostic imaging; randomized controlled trial|low back pain; paraspinal muscle; exercise; diagnostic imaging; randomized controlled trial
4957053|NCT04257240|ischemia reperfusion injury|ischemia reperfusion injury
4957054|NCT04257240|liver surgery|liver surgery
4957055|NCT04257240|cancer recurrence|cancer recurrence
4957056|NCT04257240|malignancy|malignancy
4957057|NCT04257240|hepatectomy|hepatectomy
4957058|NCT04257227|palliative care|palliative care
4957059|NCT04257227|end of life|end of life
4957060|NCT04257227|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4957061|NCT04257227|dose-finding|dose-finding
4957062|NCT04257227|feasibility|feasibility
4957063|NCT04257214|Opioid Use|opioid use
4957064|NCT04257214|Buprenorphine|buprenorphine
4957065|NCT04257214|Psychosocial Treatment|psychosocial treatment
4957066|NCT04257214|Medication Assisted Treatment|medication assisted treatment
4957067|NCT04257214|Cognitive Behavioral Therapy|cognitive behavioral therapy
4957068|NCT04257214|Peer Support|peer support
4957069|NCT04257214|Opioid Use Disorder|opioid use disorder
4957070|NCT04257201|Mediterranean|mediterranean
4957071|NCT04257201|Mushrooms|mushrooms
4957072|NCT04257201|Metabolomics|metabolomics
4957073|NCT04257188|Sub-tenon Anesthesia|sub-tenon anesthesia
4957074|NCT04257188|Vitrectomy|vitrectomy
4957075|NCT04257188|Sutureless vitrectomy|sutureless vitrectomy
4957076|NCT04257175|Chimeric antigen receptors; Mixed phenotype acute leukemia; T cells.|chimeric antigen receptors; mixed phenotype acute leukemia; t cells.
4957077|NCT04257110|Maximum tolerated dose|maximum tolerated dose
4957078|NCT04257110|Recommended Phase 2 dose|recommended phase 2 dose
4957079|NCT04257110|First-in-human|first-in-human
4957081|NCT04257084|narrow band image|narrow band image
4957082|NCT04257084|surveillance|surveillance
4957083|NCT04257071|Financial toxicity|financial toxicity
4957084|NCT04257071|Financial burden|financial burden
4957085|NCT04257071|Financial distress|financial distress
4957086|NCT04257071|Medical expense|medical expense
4957087|NCT04257071|Out of Pocket cost|out of pocket cost
4957093|NCT04257058|Social study|social study
4957094|NCT04257058|Pediatric cancer|pediatric cancer
4957095|NCT04257019|lavender|lavender
4957096|NCT04257019|procedural pain|procedural pain
4957097|NCT04257019|patient experience|patient experience
4957099|NCT04256993|Prostate cancer metastatic, prostate cancer, bone fractures, overall survival|prostate cancer metastatic, prostate cancer, bone fractures, overall survival
4957100|NCT04256980|CCA|cca
4957101|NCT04256980|FGFR2|fgfr2
4957102|NCT04256980|Pemigatinib|pemigatinib
4957105|NCT04256915|Adolescents|adolescents
4957106|NCT04256915|Youth|youth
4957107|NCT04256915|Light therapy|light therapy
4957108|NCT04256902|self-identification|self-identification
4957109|NCT04256902|discrimination|discrimination
4957110|NCT04256902|mental health|mental health
4957111|NCT04256837|Vagus Nerve|vagus nerve
4957113|NCT04256837|Immune System|immune system
4957114|NCT04256785|probiotic|probiotic
4957115|NCT04256785|efficacy|efficacy
4957116|NCT04256785|tolerability|tolerability
4957117|NCT04256772|CYSTIC FIBROSIS|cystic fibrosis
4957118|NCT04256772|BIOTHERAPY|biotherapy
4957119|NCT04256772|ANTI-IL5|anti-il5
4957120|NCT04256772|BENRALIZUMAB|benralizumab
4957121|NCT04256772|APBA|apba
4957122|NCT04256772|SEVERE ASTHMA|severe asthma
4957123|NCT04256759|Dupilumab|dupilumab
4957124|NCT04256733|chronic cough|chronic cough
4957125|NCT04256733|behavioral therapy|behavioral therapy
4957126|NCT04256733|cough hypersensitivity|cough hypersensitivity
4957127|NCT04256707|non-small cell lung carcinoma|non-small cell lung carcinoma
4957128|NCT04256707|selinexor|selinexor
4957129|NCT04256707|docetaxel|docetaxel
4957130|NCT04256707|colorectal cancer|colorectal cancer
4957131|NCT04256707|KPT-330|kpt-330
4957132|NCT04256707|bioequivalence|bioequivalence
4957133|NCT04256707|relative bioavailability|relative bioavailability
4957145|NCT04256629|Placebo-Controlled|placebo-controlled
4957146|NCT04256629|3-Period Crossover|3-period crossover
4957147|NCT04256629|Verinurad|verinurad
4957148|NCT04256629|Allopurinol|allopurinol
4957149|NCT04256629|Phase 1|phase 1
4957150|NCT04256603|neuropathic pain|neuropathic pain
4957151|NCT04256603|spinal cord injury|spinal cord injury
4957152|NCT04256590|children|children
4957153|NCT04256590|tongue disease|tongue disease
4957154|NCT04256590|ultrasonography|ultrasonography
4957155|NCT04256590|enlarge tongue|enlarge tongue
4957156|NCT04256590|adenoid|adenoid
4957157|NCT04256564|Central venous catheter|central venous catheter
4957158|NCT04256564|Ultrasound|ultrasound
4957159|NCT04256564|Jugular vein|jugular vein
4957160|NCT04256564|Brachiocephalic vein|brachiocephalic vein
4957161|NCT04256564|Endocavity micro-convex probe|endocavity micro-convex probe
4957163|NCT04256551|high fermented, oligio-, di-, monosaccharide, and polyols|high fermented, oligio-, di-, monosaccharide, and polyols
4957164|NCT04256551|mobile app|mobile app
4957165|NCT04256551|irritable bowel syndrome|irritable bowel syndrome
4957166|NCT04256525|implantable venous access ports|implantable venous access ports
4957167|NCT04256525|Catheter Related thrombosis|catheter related thrombosis
4957168|NCT04256525|thromboprophylaxis|thromboprophylaxis
4957169|NCT04256525|anticoagulants|anticoagulants
4957170|NCT04256525|aspirin|aspirin
4957171|NCT04256525|low molecule heparin|low molecule heparin
4957172|NCT04256525|rivaroxaban|rivaroxaban
4957173|NCT04256525|cancer|cancer
4957174|NCT04256499|hyponatremia|hyponatremia
4957175|NCT04256499|SIAD|siad
4957176|NCT04256499|water load test|water load test
4957177|NCT04256486|Family Model|family model
4957178|NCT04256486|Marshallese|marshallese
4957179|NCT04256486|Pacific Islander|pacific islander
4957180|NCT04256486|Diabetes Education|diabetes education
4957186|NCT04256460|prediabetes|prediabetes
4957187|NCT04256460|life style intervention|life style intervention
4957188|NCT04256460|peer support|peer support
4957189|NCT04256460|self management support|self management support
4957214|NCT04256278|antioxidants|antioxidants
4957215|NCT04256252|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4957216|NCT04256252|Rituximab|rituximab
4957217|NCT04256239|Dignity Therapy; Terminally ill patients; Demoralization; Spiritual Well-Being; Dignity-related Distress|dignity therapy; terminally ill patients; demoralization; spiritual well-being; dignity-related distress
4957218|NCT04256213|Cervix cancer|cervix cancer
4957219|NCT04256213|Immune combination|immune combination
4957220|NCT04256200|endometriosis|endometriosis
4957221|NCT04256200|oral contraceptive pills|oral contraceptive pills
4957222|NCT04256200|progestin|progestin
4957223|NCT04256187|botulinum toxin|botulinum toxin
4957224|NCT04256187|cerebral palsy|cerebral palsy
4957225|NCT04256187|experiences|experiences
4957226|NCT04256187|spasticity|spasticity
4957236|NCT04256135|Maitland mobilization|maitland mobilization
4957237|NCT04256135|Manual therapy|manual therapy
4957238|NCT04256109|eHealth|ehealth
4957239|NCT04256109|mHealth|mhealth
4957240|NCT04256109|Health promotion|health promotion
4957241|NCT04256109|Rural area|rural area
4957242|NCT04256096|stroke|stroke
4957243|NCT04256096|ischemic stroke|ischemic stroke
4957244|NCT04256096|thrombectomy|thrombectomy
4957245|NCT04256096|treatment|treatment
4957246|NCT04256096|acute stroke|acute stroke
4957247|NCT04256070|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4957248|NCT04256070|nursing|nursing
4957249|NCT04256070|quality of life|quality of life
4957250|NCT04256070|self-efficacy|self-efficacy
4957251|NCT04256070|Watson's Human Care Theory|watson's human care theory
4957252|NCT04256031|Smartphone addiction|smartphone addiction
4957253|NCT04256031|Forward head posture|forward head posture
4957254|NCT04256031|Rounded shoulder|rounded shoulder
4957255|NCT04256031|Neck pain|neck pain
4957256|NCT04256031|Shoulder pain|shoulder pain
4957262|NCT04255966|osteolysis|osteolysis
4957263|NCT04255966|wear particles|wear particles
4957264|NCT04255966|cup loosening|cup loosening
4957265|NCT04255966|malpositioned cup|malpositioned cup
4957266|NCT04255901|acupuncture|acupuncture
4957274|NCT04255875|First in human|first in human
4957386|NCT04255173|osteoporosis|osteoporosis
4957313|NCT04255589|Acute Gastritis|acute gastritis
4957314|NCT04255589|Chronic Gastritis|chronic gastritis
4957315|NCT04255589|Cinnamic acid|cinnamic acid
4957317|NCT04255537|Myocardial Infarction|myocardial infarction
4957318|NCT04255537|Quality Indicator|quality indicator
4957319|NCT04255537|Percutaneous Coronary Intervention|percutaneous coronary intervention
4957320|NCT04255537|Unstable Angina|unstable angina
4957321|NCT04255524|OCTA|octa
4957322|NCT04255524|Myopia|myopia
4957323|NCT04255524|Choroid|choroid
4957324|NCT04255498|Anti-neuroinflammatory|anti-neuroinflammatory
4957325|NCT04255498|Homeostatic regulation|homeostatic regulation
4957326|NCT04255498|HPA axis regulator|hpa axis regulator
4957327|NCT04255485|infant|infant
4957328|NCT04255485|anesthesia|anesthesia
4957329|NCT04255485|neurobehavioral development|neurobehavioral development
4957344|NCT04255407|bone bruise|bone bruise
4957345|NCT04255407|pain|pain
4957346|NCT04255407|ACL reconstruction|acl reconstruction
4957347|NCT04255381|type 1 diabetes|type 1 diabetes
4957348|NCT04255381|artificial pancreas|artificial pancreas
4957349|NCT04255381|closed-loop|closed-loop
4957350|NCT04255381|automated insulin delivery|automated insulin delivery
4957351|NCT04255368|Dietary precursor|dietary precursor
4957352|NCT04255368|Metabolism|metabolism
4957353|NCT04255368|Gut microbiota|gut microbiota
4957354|NCT04255355|Shoulder|shoulder
4957355|NCT04255355|Pelvis|pelvis
4957356|NCT04255355|Regional interdependence|regional interdependence
4957357|NCT04255355|Diaphragm|diaphragm
4957358|NCT04255342|alveolar bone|alveolar bone
4957359|NCT04255342|alveolar ridge|alveolar ridge
4957360|NCT04255342|bone grafting|bone grafting
4957361|NCT04255342|bone resorption|bone resorption
4957362|NCT04255342|dental implant|dental implant
4957363|NCT04255329|Non pharmacological interventions|non pharmacological interventions
4957364|NCT04255329|Cognitive stimulation|cognitive stimulation
4957365|NCT04255329|Non-verbal communication|non-verbal communication
4957366|NCT04255329|Montessori Lifestyle|montessori lifestyle
4957367|NCT04255316|carotid endarterectomy|carotid endarterectomy
4957368|NCT04255316|eversion carotid endarterectomy|eversion carotid endarterectomy
4957369|NCT04255316|prophylaxis of ischemic stroke|prophylaxis of ischemic stroke
4957370|NCT04255316|carotid arteriosclerosis|carotid arteriosclerosis
4957371|NCT04255316|carotid artery plasty|carotid artery plasty
4957382|NCT04255186|shoulder pain|shoulder pain
4957383|NCT04255186|shoulder impingement syndrome|shoulder impingement syndrome
4957384|NCT04255186|radiofrequency treatment|radiofrequency treatment
4957385|NCT04255186|electrophysical agents|electrophysical agents
4957390|NCT04255160|Vasodilation|vasodilation
4957391|NCT04255160|Estrogen|estrogen
5286877|NCT02237781|AMH|amh
4957392|NCT04255147|Phase I clinical trial|phase i clinical trial
4957393|NCT04255147|Stem cells|stem cells
4957394|NCT04255147|Mesenchymal stromal cell|mesenchymal stromal cell
4957395|NCT04255147|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4957396|NCT04255147|Preterm birth|preterm birth
4957397|NCT04255147|Cell therapy|cell therapy
4957398|NCT04255095|Pancreatic duct negative-pressure suction|pancreatic duct negative-pressure suction
4957399|NCT04255030|Caregiver|caregiver
4957400|NCT04255030|Self-directed interventions|self-directed interventions
4957402|NCT04255030|Self-management|self-management
4957403|NCT04255030|Stepped care|stepped care
4957404|NCT04255030|Psychosocial oncology|psychosocial oncology
4957405|NCT04255030|Cancer|cancer
4957406|NCT04255030|Sequential Multiple Assignment Randomized Trial (SMART)|sequential multiple assignment randomized trial (smart)
4957407|NCT04255004|autologous peripheral blood mononuclear cell, diabetic foot|autologous peripheral blood mononuclear cell, diabetic foot
4957408|NCT04254965|music therapy|music therapy
4957409|NCT04254965|chronic psychosis|chronic psychosis
4957410|NCT04254965|negative symptoms|negative symptoms
4957411|NCT04254965|occupational therapy|occupational therapy
4957412|NCT04254965|biosignal analysis|biosignal analysis
4976650|NCT04138225|yeast|yeast
4957419|NCT04254861|PRGF|prgf
4957420|NCT04254848|oral stereognosis|oral stereognosis
4957421|NCT04254848|completely edentulous|completely edentulous
4957422|NCT04254822|Transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4957423|NCT04254822|Endoscopic variceal ligation|endoscopic variceal ligation
4957424|NCT04254822|Non-selective β-blocker therapy|non-selective β-blocker therapy
4957425|NCT04254822|Hepatic venous pressure gradient|hepatic venous pressure gradient
4957438|NCT04254692|abdominoplasty|abdominoplasty
4957439|NCT04254692|enhanced recovery after surgery|enhanced recovery after surgery
4957440|NCT04254692|Liposomal bupivacaine|liposomal bupivacaine
4957441|NCT04254679|Opioids|opioids
4957442|NCT04254679|Surgery|surgery
4957443|NCT04254679|Postoperative Period|postoperative period
4957444|NCT04254679|Postoperative Pain|postoperative pain
4957445|NCT04254679|Analgesia|analgesia
4957446|NCT04254679|Pain Management|pain management
4957447|NCT04254666|physical literacy|physical literacy
4957448|NCT04254666|food literacy|food literacy
4957449|NCT04254627|Gulf War Illness|gulf war illness
4957450|NCT04254627|Veterans|veterans
4957451|NCT04254614|Biologic treatment|biologic treatment
4957452|NCT04254614|Mobile application|mobile application
4957453|NCT04254588|Emergency Department, Telemedicine, Telehealth|emergency department, telemedicine, telehealth
4957454|NCT04254562|Supported Employment|supported employment
4957455|NCT04254562|Supported Education|supported education
4957456|NCT04254562|Mental Health|mental health
4957457|NCT04254562|Behavioral Health|behavioral health
4957458|NCT04254562|Cognitive Remediation|cognitive remediation
4957459|NCT04254536|diebetic macular edema|diebetic macular edema
4957460|NCT04254536|optical coherence tomography|optical coherence tomography
4957461|NCT04254536|conbercept|conbercept
4957462|NCT04254523|Anesthesia, Epidural|anesthesia, epidural
4957463|NCT04254523|Postoperative Period|postoperative period
4957464|NCT04254523|Analgesia, Patient-Controlled|analgesia, patient-controlled
4957465|NCT04254458|Cornea,|cornea,
4957466|NCT04254458|density,|density,
4957467|NCT04254458|laser peripheral iridotomy,|laser peripheral iridotomy,
4957468|NCT04254458|primary angle closure glaucoma|primary angle closure glaucoma
4957472|NCT04254432|hypertension|hypertension
4957473|NCT04254432|remote ischemic conditioning|remote ischemic conditioning
4957474|NCT04254406|Peri-Implantitis surgery|peri-implantitis surgery
4957475|NCT04254406|Treatment outcome|treatment outcome
4957476|NCT04254406|Risk factors|risk factors
4957477|NCT04254380|Diabetes|diabetes
4957478|NCT04254380|Diabetes Type 1|diabetes type 1
4957479|NCT04254380|Type 1|type 1
4957480|NCT04254380|Basal|basal
4957481|NCT04254380|Insulin|insulin
4957486|NCT04254367|health literacy|health literacy
4957487|NCT04254367|sense of coherence|sense of coherence
4957489|NCT04254367|patient education as topic|patient education as topic
4957490|NCT04254367|health-related quality of life|health-related quality of life
4957491|NCT04254367|coping strategies|coping strategies
5697131|NCT00510523|Balance|balance
4957496|NCT04254328|inspiratory muscle training|inspiratory muscle training
4957498|NCT04254315|Group based cognitive therapy|group based cognitive therapy
4957499|NCT04254315|Ischemic Heart Disease|ischemic heart disease
4957500|NCT04254315|Heart Valve Diseases|heart valve diseases
4957501|NCT04254315|Psychological Distress|psychological distress
4957506|NCT04254289|Exercise|exercise
4957507|NCT04254289|Six-minute walk|six-minute walk
4957508|NCT04254289|Heart rate monitor|heart rate monitor
4957509|NCT04254276|Musculoskeletal pain|musculoskeletal pain
4957510|NCT04254276|Muscle tone|muscle tone
4957511|NCT04254276|Muscle stiffness|muscle stiffness
4957512|NCT04254276|Pain-pressure threshold|pain-pressure threshold
4957513|NCT04254276|Neck|neck
4957514|NCT04254276|Shoulder|shoulder
5377179|NCT01825681|FTD|ftd
5286919|NCT02237586|Malaria|malaria
4957515|NCT04254276|Office work|office work
4957516|NCT04254237|Trocar site hernia|trocar site hernia
4957517|NCT04254237|Laparoscopy|laparoscopy
4957518|NCT04254237|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4957519|NCT04254237|Minimally invasive surgery|minimally invasive surgery
4957520|NCT04254224|Diverticulitis|diverticulitis
4957521|NCT04254224|Surgery|surgery
4957522|NCT04254224|Hinchey|hinchey
4957523|NCT04254224|Treatment|treatment
4957524|NCT04254224|Quality of Life|quality of life
4957525|NCT04254198|Immigrant|immigrant
4957544|NCT04254081|Abortion|abortion
4957545|NCT04254081|Osmotic dilators|osmotic dilators
4957546|NCT04254081|Cervical preparation|cervical preparation
4957547|NCT04254068|Secondary prevention|secondary prevention
4957548|NCT04254068|Parent-based prevention|parent-based prevention
4957554|NCT04254042|Angiotensin Converting Enzymes Inhibitor|angiotensin converting enzymes inhibitor
4957555|NCT04254042|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
4957556|NCT04254042|Blood pressure|blood pressure
4957557|NCT04254042|Oxidative status|oxidative status
4957558|NCT04254029|Diastolic function|diastolic function
4957559|NCT04254029|Blood pressure profile|blood pressure profile
4957560|NCT04254029|moringa oleifera|moringa oleifera
4957572|NCT04254003|astigmatism|astigmatism
4957573|NCT04253990|Colonic polyps|colonic polyps
4957574|NCT04253990|Colonoscopy|colonoscopy
4957575|NCT04253951|abnormal swallowing|abnormal swallowing
4957576|NCT04253951|infants and young children with neurological impairment|infants and young children with neurological impairment
4957577|NCT04253951|lung ultrasound|lung ultrasound
4957578|NCT04253951|apparent aspiration|apparent aspiration
4957579|NCT04253951|silent aspiration|silent aspiration
4957580|NCT04253925|Kegel exercise|kegel exercise
4957581|NCT04253925|Postural Correction|postural correction
4957594|NCT04253847|Pancreatic Body and Tail Adenocarcinoma|pancreatic body and tail adenocarcinoma
4957595|NCT04253834|Cardiac surgery|cardiac surgery
4957596|NCT04253821|forward head posture|forward head posture
4957597|NCT04253821|muscle elasticity|muscle elasticity
4957598|NCT04253808|non-metastatic|non-metastatic
4957604|NCT04253756|Plasma exchange|plasma exchange
4957605|NCT04253756|Photopheresis|photopheresis
4957606|NCT04253756|Red blood Cell exchanges|red blood cell exchanges
4957607|NCT04253743|Food security|food security
4957608|NCT04253743|Hunger|hunger
4957609|NCT04253743|Young children|young children
4957610|NCT04253743|Supplemental Nutrition Assistance Program (SNAP)|supplemental nutrition assistance program (snap)
4957611|NCT04253743|Food expenditures|food expenditures
4957612|NCT04253730|Body Temperature, Skin Temperature, Cooling|body temperature, skin temperature, cooling
4957613|NCT04253717|Physical activity|physical activity
4957614|NCT04253717|Non-invasive treatment|non-invasive treatment
4957615|NCT04253704|transepidermal water loss|transepidermal water loss
4957616|NCT04253704|skin hydration|skin hydration
4957617|NCT04253704|vapometer|vapometer
4957618|NCT04253704|novameter|novameter
4957619|NCT04253691|Sleep|sleep
4957620|NCT04253691|Pain|pain
4957621|NCT04253691|Virtual Reality|virtual reality
4957622|NCT04253678|depression|depression
4957623|NCT04253678|cancer|cancer
4957624|NCT04253678|vortioxetine|vortioxetine
4957625|NCT04253678|cognition|cognition
4957626|NCT04253678|quality of life|quality of life
4957627|NCT04253678|antidepressant|antidepressant
4957628|NCT04253665|Discharge teaching|discharge teaching
4957629|NCT04253665|Nursing|nursing
4957630|NCT04253665|Multimorbidity|multimorbidity
4957631|NCT04253639|TENS|tens
4957632|NCT04253639|Predictive factors|predictive factors
4957633|NCT04253639|Compliance|compliance
4957634|NCT04253639|Chronic pain|chronic pain
4957635|NCT04253613|periodontitis|periodontitis
4957641|NCT04253600|Neural correlates|neural correlates
4957642|NCT04253600|Neurocognitive basis|neurocognitive basis
4957643|NCT04253600|Language development|language development
4957644|NCT04253600|Natural-sleep MRI protocol|natural-sleep mri protocol
4957645|NCT04253587|amnestic MCI without dementia|amnestic mci without dementia
4957646|NCT04253587|cognitive training|cognitive training
4957647|NCT04253574|Malignant Melanoma|malignant melanoma
4957648|NCT04253574|Staging|staging
4957649|NCT04253574|18F-FDG PET/CT|18f-fdg pet/ct
4957650|NCT04253574|Ultrasound|ultrasound
4957658|NCT04253522|Cognitive Rehabilitation|cognitive rehabilitation
4957659|NCT04253522|Mental flexibility|mental flexibility
4957660|NCT04253522|Ecological tasks|ecological tasks
4957661|NCT04253522|Functional Connectivity|functional connectivity
4957662|NCT04253522|Electroencephalogram|electroencephalogram
4957663|NCT04253522|Traumatic Brain Injury|traumatic brain injury
4957664|NCT04253522|CerebroVascular Accident|cerebrovascular accident
4957665|NCT04253509|Lung Cancer|lung cancer
4957666|NCT04253509|Methylation Sequencing|methylation sequencing
4957667|NCT04253509|Liquid Biopsy|liquid biopsy
4957668|NCT04253496|PCNSL|pcnsl
4957669|NCT04253496|Mathematical modeling|mathematical modeling
4957670|NCT04253496|Next-generation sequencing|next-generation sequencing
4957671|NCT04253496|Radiomics|radiomics
4957675|NCT04253444|slow deep breathing|slow deep breathing
4957676|NCT04253444|vagal nerve stimulation|vagal nerve stimulation
4957690|NCT04253314|Venclexta|venclexta
4957691|NCT04253288|MMR|mmr
4957692|NCT04253288|Radiation toxicity|radiation toxicity
4957693|NCT04253288|Radiosensitivity|radiosensitivity
4957694|NCT04253288|Late effects|late effects
4957695|NCT04253223|hyperglycemia|hyperglycemia
4957696|NCT04253223|lymphoma|lymphoma
4957697|NCT04253223|anti-glucagon receptor antibody|anti-glucagon receptor antibody
4957698|NCT04253223|glucagon receptor|glucagon receptor
4957699|NCT04253080|cutaneous melanoma|cutaneous melanoma
4957700|NCT04253080|marker for prognosis and response to targeted treatment and/or immune checkpoint inhibitor|marker for prognosis and response to targeted treatment and/or immune checkpoint inhibitor
4957701|NCT04253080|Programmed Death ligand 1 (PD1)|programmed death ligand 1 (pd1)
4957702|NCT04253080|Cytotoxic T Lymphocyte Associated 4 (CTLA-A4)|cytotoxic t lymphocyte associated 4 (ctla-a4)
4957703|NCT04253067|Laser Therapy|laser therapy
4957704|NCT04253015|Tumour|tumour
4957705|NCT04253015|Brain tumour|brain tumour
4957706|NCT04253015|Paediatrics|paediatrics
4957707|NCT04253002|Suicide|suicide
4957708|NCT04253002|African American Adolescents|african american adolescents
4957709|NCT04253002|Prevention|prevention
4957710|NCT04253002|Coping|coping
4957711|NCT04253002|Hope|hope
4957712|NCT04253002|Hopelessness|hopelessness
4957713|NCT04252989|atropine|atropine
4957714|NCT04252950|PAD|pad
4957715|NCT04252950|peripheral artery disease|peripheral artery disease
4957716|NCT04252950|claudication|claudication
4957717|NCT04252950|revascularization|revascularization
4957718|NCT04252950|community-based exercise|community-based exercise
4957719|NCT04252937|Acute heart failure treatment Adrecizumab Safety|acute heart failure treatment adrecizumab safety
4957720|NCT04252924|Mediterranean diet|mediterranean diet
4957721|NCT04252924|physical activity|physical activity
4957723|NCT04252924|stress|stress
4957724|NCT04252924|orthorexia nervosa|orthorexia nervosa
4957727|NCT04252898|Food labeling|food labeling
4957728|NCT04252898|nutritional quality|nutritional quality
4957729|NCT04252898|food purchases|food purchases
4957730|NCT04252885|Coronavirus infection|coronavirus infection
4957731|NCT04252885|Lopinarvir plus ritonavir|lopinarvir plus ritonavir
4957732|NCT04252885|Arbidol|arbidol
4957733|NCT04252885|Efficacy|efficacy
4957734|NCT04252846|Perampanel|perampanel
4957735|NCT04252846|Fycompa|fycompa
4957736|NCT04252846|Epilepsy|epilepsy
4957737|NCT04252846|Seizures|seizures
4957738|NCT04252846|Prospective|prospective
4957739|NCT04252833|Safety|safety
4957740|NCT04252833|Tolerability|tolerability
4957741|NCT04252833|Single Dose|single dose
4957742|NCT04252833|Pharmacokinetics|pharmacokinetics
4957743|NCT04252833|PK|pk
4957744|NCT04252833|CT-044 HCl|ct-044 hcl
4957745|NCT04252833|Food Effect|food effect
4976946|NCT04136665|children|children
4957751|NCT04252781|comorbidities|comorbidities
4957752|NCT04252781|trajectories|trajectories
4957753|NCT04252755|Electroencephalography (EEG)|electroencephalography (eeg)
4957754|NCT04252755|Neurofeedback|neurofeedback
4957755|NCT04252755|Alcohol Use|alcohol use
4957756|NCT04252755|Cognition|cognition
4957757|NCT04252729|Psychotherapy|psychotherapy
4957758|NCT04252729|Syncope|syncope
4957759|NCT04252729|Quality of life|quality of life
4957760|NCT04252729|Psychoanalytic psychosomatics|psychoanalytic psychosomatics
4957761|NCT04252703|ischemic heart disease|ischemic heart disease
4957762|NCT04252703|multivessel|multivessel
4957763|NCT04252703|octogenarians|octogenarians
4957764|NCT04252703|acute coronary syndrome|acute coronary syndrome
4957765|NCT04252690|lymphedema,|lymphedema,
4957766|NCT04252690|auto-adjustable MOBIDERM® Autofit stocking|auto-adjustable mobiderm® autofit stocking
4957767|NCT04252690|lymphoscintigraphy|lymphoscintigraphy
4957768|NCT04252690|mechanism of action|mechanism of action
4957769|NCT04252677|health literacy|health literacy
4957770|NCT04252677|obesity|obesity
4957771|NCT04252677|diet|diet
4957772|NCT04252677|physical activity|physical activity
4957773|NCT04252677|information-motivation-behavioral skills model|information-motivation-behavioral skills model
4957774|NCT04252677|adolescent|adolescent
4957786|NCT04252573|Juxtarenal Abdominal Aortic Aneurysm|juxtarenal abdominal aortic aneurysm
4957787|NCT04252573|Pararenal Abdominal Aortic Aneurysm|pararenal abdominal aortic aneurysm
5356772|NCT01918033|Cholinergic Antagonists|cholinergic antagonists
4957793|NCT04252547|oxygen saturation|oxygen saturation
4957794|NCT04252547|preterm infants|preterm infants
4957795|NCT04252534|Retinitis pigmentosa|retinitis pigmentosa
4963546|NCT04217759|social media|social media
4957798|NCT04252534|Magnovision|magnovision
4957799|NCT04252534|Ellipsoid zone|ellipsoid zone
4957800|NCT04252508|Preoperative- Child|preoperative- child
4957801|NCT04252508|Double-reading movie|double-reading movie
4957802|NCT04252495|Liver Diseases|liver diseases
4957803|NCT04252482|sleep healthcare, actigraph devices, smart watches, questionnaires|sleep healthcare, actigraph devices, smart watches, questionnaires
4957804|NCT04252469|oral care|oral care
4957805|NCT04252469|Anesthesia|anesthesia
4957806|NCT04252469|surgery|surgery
5287136|NCT02236663|App|app
4957807|NCT04252469|Intratracheal Intubation|intratracheal intubation
4957808|NCT04252443|Opioid|opioid
4957809|NCT04252443|Knowledge|knowledge
4957810|NCT04252443|Attitude|attitude
4957811|NCT04252443|Nursing|nursing
4957812|NCT04252404|low cardiac output syndrome|low cardiac output syndrome
4957813|NCT04252404|cardiogenic shock|cardiogenic shock
4957814|NCT04252365|PD-1 inhibitors, immunotherapy, NSCLC, PD-L!|pd-1 inhibitors, immunotherapy, nsclc, pd-l!
4957815|NCT04252352|Fractional CO2 laser|fractional co2 laser
4957816|NCT04252352|Radio-frequency microneedling|radio-frequency microneedling
4957817|NCT04252339|Solid Tumors|solid tumors
4957818|NCT04252339|Advanced or Metastatic Solid Tumors|advanced or metastatic solid tumors
4957819|NCT04252339|Phase 1|phase 1
4957820|NCT04252339|First in Human (FIH)|first in human (fih)
4957821|NCT04252339|SHP2 inhibition|shp2 inhibition
4957822|NCT04252339|PTPN11|ptpn11
4957823|NCT04252339|Bypass Resistance|bypass resistance
4957824|NCT04252326|Healthcare workers|healthcare workers
4957825|NCT04252326|Adverse drug reactions|adverse drug reactions
4957826|NCT04252313|Music|music
4957827|NCT04252313|Neonatal Circumcision|neonatal circumcision
4957836|NCT04252274|Pneumonia|pneumonia
4957837|NCT04252274|2019-new coronavirus|2019-new coronavirus
4957838|NCT04252274|Darunavir|darunavir
4957839|NCT04252274|Cobicistat|cobicistat
4957840|NCT04252261|Sulforaphane|sulforaphane
4957841|NCT04252261|frontal brain damage|frontal brain damage
4957842|NCT04252261|cognitive deficits|cognitive deficits
4957843|NCT04252261|cognitive function|cognitive function
4957844|NCT04252261|brain metabolites|brain metabolites
4957845|NCT04252261|gut microbiota|gut microbiota
4957849|NCT04252157|saliva|saliva
4957850|NCT04252157|taping|taping
4957851|NCT04252144|food diversity|food diversity
4957852|NCT04252144|dietary pattern|dietary pattern
4957853|NCT04252144|healthy eating pattern|healthy eating pattern
4957856|NCT04252131|Schizophrenia|schizophrenia
4957857|NCT04252131|Cassia seed|cassia seed
4957858|NCT04252131|obesity|obesity
4957859|NCT04252131|Therapeutic effect assessment|therapeutic effect assessment
4957860|NCT04252131|clinical trial|clinical trial
4957866|NCT04252092|Electrical stimulation|electrical stimulation
4957867|NCT04252092|Sensory education|sensory education
4957868|NCT04252092|Sensory evaluation|sensory evaluation
4957869|NCT04252092|Stroke|stroke
4957870|NCT04252092|Proprioception|proprioception
4957871|NCT04252066|migalastat|migalastat
4957872|NCT04252066|Fabry Disease|fabry disease
4957873|NCT04252066|Women with Fabry Disease|women with fabry disease
4957874|NCT04252053|Multiple sclerosis|multiple sclerosis
4957875|NCT04252053|Pilates|pilates
4957876|NCT04252053|Core stability|core stability
4957877|NCT04252053|Isokinetic strength|isokinetic strength
4957878|NCT04252053|Postural sway|postural sway
4957879|NCT04252027|Pharmacokinetics|pharmacokinetics
4957880|NCT04252027|Fluconazole|fluconazole
4957881|NCT04252027|Variability|variability
4957882|NCT04252027|Target attainment|target attainment
4957883|NCT04252001|Serious game|serious game
4957884|NCT04252001|Endocrinology|endocrinology
4957885|NCT04252001|Transition|transition
4957886|NCT04251988|virtual reality, voiding cystourethrogram, catheterization|virtual reality, voiding cystourethrogram, catheterization
4957887|NCT04251975|Obstructive sleep apnea|obstructive sleep apnea
4957888|NCT04251975|Masked hypertension|masked hypertension
4957889|NCT04251949|Oral cancer|oral cancer
4957890|NCT04251949|Radiotherapy|radiotherapy
4957891|NCT04251949|Radio-chemotherapy|radio-chemotherapy
4957892|NCT04251949|Mucositis|mucositis
4957893|NCT04251949|LED photobiomodulation (PLED)|led photobiomodulation (pled)
4957894|NCT04251949|Oropharyngeal cancer|oropharyngeal cancer
4957895|NCT04251936|tobacco use disorder|tobacco use disorder
4957896|NCT04251936|fMRI|fmri
4957897|NCT04251936|physical exercise|physical exercise
4957898|NCT04251936|reward system|reward system
4957899|NCT04251936|cognitive control|cognitive control
4957900|NCT04251858|Periodontal Diseases|periodontal diseases
4957901|NCT04251858|Athletes|athletes
4957902|NCT04251858|Caries, dental|caries, dental
4957903|NCT04251858|Periodontal index|periodontal index
4957904|NCT04251806|polysomnogram|polysomnogram
4957905|NCT04251806|development|development
4957906|NCT04251806|sleep apnea|sleep apnea
4957908|NCT04251780|Hyperaldosteronism|hyperaldosteronism
4957909|NCT04251780|Potassium|potassium
4957910|NCT04251780|Magnetic Resonance Imaging|magnetic resonance imaging
4957911|NCT04251741|Adalimumab|adalimumab
4957914|NCT04251741|Drug level|drug level
4957915|NCT04251741|Switching|switching
4957917|NCT04251741|Non-response|non-response
4957918|NCT04251741|Subsequent biological|subsequent biological
4957919|NCT04251715|Cholangiocarcinoma|cholangiocarcinoma
4957920|NCT04251715|Hepatic arterial infusion liver pump|hepatic arterial infusion liver pump
4957921|NCT04251715|Unresectable liver cancer|unresectable liver cancer
4957923|NCT04251702|labor dystocia|labor dystocia
4957924|NCT04251702|cesarean delivery|cesarean delivery
4957925|NCT04251702|uterine monitoring|uterine monitoring
4957926|NCT04251650|subgingival microbiota|subgingival microbiota
5287218|NCT02236377|Trauma|trauma
4957927|NCT04251650|chronic periodontitis|chronic periodontitis
4957928|NCT04251650|dysbiosis|dysbiosis
4957929|NCT04251650|deep sequencing|deep sequencing
5698161|NCT00507481|Sleep|sleep
4957930|NCT04251650|gingival crevicular fluid|gingival crevicular fluid
4957931|NCT04251637|esophageal Doppler|esophageal doppler
4957932|NCT04251637|thoracic surgery|thoracic surgery
4957933|NCT04251637|pulmonary exeresis|pulmonary exeresis
4957934|NCT04251624|cognitive remediation|cognitive remediation
4957935|NCT04251624|public safety personnel|public safety personnel
4957936|NCT04251624|psychosocial education|psychosocial education
4957937|NCT04251624|first responders|first responders
4957938|NCT04251624|military|military
4957939|NCT04251611|Cardiac Rehabilitation|cardiac rehabilitation
4957940|NCT04251611|Myocardial Ischemia|myocardial ischemia
4957941|NCT04251611|Physical Exercise|physical exercise
4957942|NCT04251611|Cardiovascular Risk Factors|cardiovascular risk factors
5283056|NCT02257125|arm|arm
4957943|NCT04251611|Randomized Controlled Trial|randomized controlled trial
4957944|NCT04251598|Skin Cancer|skin cancer
4957945|NCT04251598|Sun Protection|sun protection
4957946|NCT04251598|Parent Behavior|parent behavior
4957947|NCT04251598|Social Cognitive Theory|social cognitive theory
4957948|NCT04251598|Public Health Nursing|public health nursing
4957949|NCT04251585|intranasal|intranasal
4957950|NCT04251585|insulin|insulin
4957951|NCT04251559|menarche|menarche
4957952|NCT04251559|gestational diabetes mellitus|gestational diabetes mellitus
4957953|NCT04251559|cycle, menstrual|cycle, menstrual
4957954|NCT04251546|Prostate Cancer|prostate cancer
4957955|NCT04251546|PSA|psa
4957956|NCT04251546|PHI|phi
4957962|NCT04251533|nab-paclitaxel|nab-paclitaxel
4957963|NCT04251533|PIK3CA mutation|pik3ca mutation
4957964|NCT04251533|PTEN loss|pten loss
4957965|NCT04251520|Pharmacogenomics|pharmacogenomics
4957966|NCT04251520|Symptom management|symptom management
4957967|NCT04251507|Virtual Reality|virtual reality
4957968|NCT04251507|Pain|pain
4957969|NCT04251507|Anxiety|anxiety
4957970|NCT04251507|Ultrasound Guided Needle Localization|ultrasound guided needle localization
4957971|NCT04251494|PKU|pku
4957972|NCT04251494|CVD|cvd
4957973|NCT04251494|Cardiovascular disease risk|cardiovascular disease risk
4957974|NCT04251468|plasma potassium measurement|plasma potassium measurement
4957975|NCT04251468|saliva potassium measurement|saliva potassium measurement
4957976|NCT04251468|hemodialysis|hemodialysis
4957979|NCT04251468|Förster resonance energy transfer|förster resonance energy transfer
4957983|NCT04251429|employee engagement|employee engagement
4957984|NCT04251429|process evaluation|process evaluation
4957985|NCT04251429|work ability|work ability
4957986|NCT04251390|exoskeleton device|exoskeleton device
4957987|NCT04251377|Surgery|surgery
4957988|NCT04251377|Biofilm inhibitor|biofilm inhibitor
4957989|NCT04251377|Chronic infections|chronic infections
4957990|NCT04251377|Total Hip Arthroplasties (THA)|total hip arthroplasties (tha)
4957991|NCT04251377|Defensive Antibacterial Coating (DAC®)|defensive antibacterial coating (dac®)
4957992|NCT04251377|Novagenit®|novagenit®
4957993|NCT04251377|Hip Prosthesis|hip prosthesis
4957994|NCT04251351|Severe Malaria|severe malaria
4957995|NCT04251351|Falciparum|falciparum
4957996|NCT04251351|Paracetamol|paracetamol
4957997|NCT04251351|Renoprotection|renoprotection
4957998|NCT04251351|Acute Kidney Injury|acute kidney injury
4957999|NCT04251338|delayed visual maturation|delayed visual maturation
4958000|NCT04251286|Hyperbilirubinemia|hyperbilirubinemia
4958001|NCT04251286|screening|screening
4958002|NCT04251286|follow-up|follow-up
4958003|NCT04251273|E-cigarette Cessation|e-cigarette cessation
4958004|NCT04251273|Vaping Cessation|vaping cessation
4958005|NCT04251273|Mobile Intervention|mobile intervention
4958009|NCT04251260|snuggle up|snuggle up
4958010|NCT04251260|general movements|general movements
4958011|NCT04251234|Circadian|circadian
4958012|NCT04251234|Light Intensity|light intensity
4958013|NCT04251208|Pregnancy|pregnancy
4958014|NCT04251208|Infant, Newborn|infant, newborn
4958015|NCT04251208|Buprenorphine|buprenorphine
4958016|NCT04251208|Methadone|methadone
4958017|NCT04251208|Opiate Substitution Treatment|opiate substitution treatment
4958018|NCT04251208|Comparative Effectiveness|comparative effectiveness
4958019|NCT04251208|Integrated Care|integrated care
4958020|NCT04251208|Referral-based Care|referral-based care
4958033|NCT04251091|robotics|robotics
4958034|NCT04251091|Stroke|stroke
4958035|NCT04251091|walking|walking
4958036|NCT04251065|CD38 positive|cd38 positive
5698162|NCT00507481|ICU|icu
4958038|NCT04251065|relapsed/refractory angioimmunoblastic T-cell lymphoma (AITL)|relapsed/refractory angioimmunoblastic t-cell lymphoma (aitl)
4958039|NCT04251065|relapsed/refractory nodal lymphomas of T follicular helper (TFH) cells|relapsed/refractory nodal lymphomas of t follicular helper (tfh) cells
4958040|NCT04251065|Daratumumab|daratumumab
4958041|NCT04251065|Gemcitabine|gemcitabine
4958042|NCT04251065|Dexamethasone|dexamethasone
4958043|NCT04251065|Cisplatin|cisplatin
4958047|NCT04250961|cardiac surgery|cardiac surgery
4958048|NCT04250961|pain|pain
4958049|NCT04250961|patient comfort|patient comfort
4958050|NCT04250961|satisfaction|satisfaction
4958051|NCT04250961|showering|showering
4958052|NCT04250961|wound infection|wound infection
4958053|NCT04250948|Perioperative Therapy|perioperative therapy
4958054|NCT04250948|PD-1 antibody|pd-1 antibody
4958055|NCT04250948|Gastric Cancer|gastric cancer
4958056|NCT04250922|malignant|malignant
4958057|NCT04250896|Randomised controlled trial|randomised controlled trial
4958058|NCT04250896|Text messaging|text messaging
4958059|NCT04250896|Infant feeding practice|infant feeding practice
4958060|NCT04250896|health unit|health unit
4958061|NCT04250896|BMI|bmi
4958062|NCT04250896|Mobile phone|mobile phone
4958063|NCT04250896|prevention|prevention
4958064|NCT04250870|aging|aging
4958075|NCT04250818|cytokine, breast cancer|cytokine, breast cancer
4958076|NCT04250805|Cancer|cancer
4958077|NCT04250805|Gastrostomy|gastrostomy
4958078|NCT04250805|Percutaneous technique|percutaneous technique
4958089|NCT04250753|neurogenic claudication|neurogenic claudication
4958090|NCT04250753|gait parameters|gait parameters
4958091|NCT04250753|walking impairment|walking impairment
4958092|NCT04250701|Postural Control,|postural control,
4958093|NCT04250701|Body Posture|body posture
4958094|NCT04250701|Hand Grip|hand grip
4958095|NCT04250688|exoskeleton|exoskeleton
4958096|NCT04250688|ambulation|ambulation
4958097|NCT04250688|robotics|robotics
4958098|NCT04250688|Functional electrical stimulation|functional electrical stimulation
4958099|NCT04250688|acute spinal cord injuries|acute spinal cord injuries
4958100|NCT04250649|subcutaneous desinfection, P. acnes, electric cautery|subcutaneous desinfection, p. acnes, electric cautery
4958101|NCT04250636|3BNC117-LS|3bnc117-ls
4958102|NCT04250636|10-1074-LS|10-1074-ls
4958103|NCT04250636|Broadly Neutralizing Antibody|broadly neutralizing antibody
4958104|NCT04250610|Postoperative delirium|postoperative delirium
4958105|NCT04250610|POD|pod
4958106|NCT04250610|Anesthetics|anesthetics
4958107|NCT04250610|Neurocognitive Disorders|neurocognitive disorders
4958108|NCT04250610|Central Nervous System|central nervous system
4958109|NCT04250610|Confusion|confusion
4958110|NCT04250610|Neurologic Manifestations|neurologic manifestations
4958122|NCT04250480|beta-alanine|beta-alanine
4958123|NCT04250480|immune cells|immune cells
4958124|NCT04250467|Adhesions|adhesions
4958125|NCT04250467|Postoperative|postoperative
4958126|NCT04250454|Early intervention|early intervention
4958127|NCT04250454|Contractures|contractures
4958128|NCT04250428|antenatal iron and folic acid supplementation|antenatal iron and folic acid supplementation
4958129|NCT04250428|malaria chemoprophylaxis|malaria chemoprophylaxis
4958130|NCT04250428|maternal and child health|maternal and child health
4958131|NCT04250428|Randomized controlled trial|randomized controlled trial
4958132|NCT04250428|Health and demographic surveillance site|health and demographic surveillance site
4958133|NCT04250428|Cost-effectiveness|cost-effectiveness
4958134|NCT04250415|Adolescent|adolescent
4958135|NCT04250402|Gallstones|gallstones
4958136|NCT04250402|Gastric cancer|gastric cancer
4958137|NCT04250402|Gastrectomy|gastrectomy
4958138|NCT04250402|ESD|esd
4958139|NCT04250402|Vagus nerve|vagus nerve
4958140|NCT04250389|Methylene Blue|methylene blue
4958141|NCT04250363|Healthy Participants|healthy participants
4958142|NCT04250363|M5717|m5717
4958143|NCT04250363|Malaria|malaria
4958144|NCT04250363|Plasmodium falciparum|plasmodium falciparum
4958145|NCT04250350|Eczema|eczema
4958146|NCT04250350|Dermatitis|dermatitis
4958147|NCT04250350|Dermatitis, Atopic|dermatitis, atopic
4958158|NCT04250246|melanoma|melanoma
4958160|NCT04250246|ipilimumab|ipilimumab
4958161|NCT04250246|nivolumab|nivolumab
4958162|NCT04250246|guadecitabine|guadecitabine
4958165|NCT04250168|Ebola Virus Disease|ebola virus disease
4958166|NCT04250168|EVD|evd
4958167|NCT04250168|Bacterial infections|bacterial infections
4958168|NCT04250168|bacteriology|bacteriology
4958169|NCT04250168|blood cultures|blood cultures
4958170|NCT04250168|CRP|crp
4958171|NCT04250168|DR Congo|dr congo
4958172|NCT04250168|Antibiotic Resistance|antibiotic resistance
4958173|NCT04250168|Bacterial bloodstream infection|bacterial bloodstream infection
4958174|NCT04250142|Dental caries|dental caries
4958175|NCT04250142|Selective Caries Removal|selective caries removal
4958176|NCT04250142|Self-etching adhesive|self-etching adhesive
4958177|NCT04250142|Composite Resin|composite resin
4958178|NCT04250142|Glass ionomer|glass ionomer
4958668|NCT04246827|obesity|obesity
4958182|NCT04250129|sentinel lymph node biopsy, Neoadjuvan chemotherapy|sentinel lymph node biopsy, neoadjuvan chemotherapy
4958183|NCT04250103|Home health care|home health care
4958184|NCT04250103|Super-aged society|super-aged society
4958193|NCT04249973|Metabolomics|metabolomics
4958194|NCT04249973|Microbiome analysis|microbiome analysis
4958195|NCT04249960|adolescents|adolescents
4958196|NCT04249960|psychiatric disorders|psychiatric disorders
4958197|NCT04249960|CAMHS|camhs
4958198|NCT04249960|AMHS|amhs
4958199|NCT04249960|transition|transition
4958200|NCT04249947|CAR-T cells|car-t cells
4958201|NCT04249947|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
4958202|NCT04249895|Carcinoma|carcinoma
4958203|NCT04249895|Radiomics|radiomics
5287425|NCT02235545|HV Lead|hv lead
4958204|NCT04249895|Image Processing|image processing
4958205|NCT04249895|Radiology|radiology
4958206|NCT04249895|Molecular Biology|molecular biology
4958207|NCT04249895|Data Analytics Center|data analytics center
4958208|NCT04249895|Artificial Intelligence|artificial intelligence
4958209|NCT04249895|Medical Physics|medical physics
4958210|NCT04249895|Big Data|big data
4958211|NCT04249895|Radiation Oncology|radiation oncology
4958214|NCT04249869|Chinese Herbal Medicine|chinese herbal medicine
4958215|NCT04249869|Alzheimer's disease|alzheimer's disease
4958216|NCT04249869|Complementary Medicine|complementary medicine
4958217|NCT04249856|Colposcopy|colposcopy
4958218|NCT04249856|Dynamic Spectral Imaging, DySIS|dynamic spectral imaging, dysis
4958219|NCT04249856|Colposcopy Directed Biopsy|colposcopy directed biopsy
4958226|NCT04249804|Magnesium Sulfate - postspinal shivering -intrathecal - infusion|magnesium sulfate - postspinal shivering -intrathecal - infusion
4958227|NCT04249791|uterine transplant|uterine transplant
4958228|NCT04249791|robotic surgery|robotic surgery
4958229|NCT04249791|donor|donor
4958230|NCT04249791|recipient|recipient
4958231|NCT04249791|uterine anomaly|uterine anomaly
4958232|NCT04249778|hospitalization|hospitalization
4958233|NCT04249778|mortality|mortality
4958234|NCT04249778|time of initiation of therapy|time of initiation of therapy
4958235|NCT04249778|quality of life|quality of life
4958236|NCT04249778|cost-effectiveness|cost-effectiveness
4958237|NCT04249778|dapagliflozin|dapagliflozin
4958238|NCT04249778|clinical trial|clinical trial
4958239|NCT04249778|diabetes|diabetes
4958241|NCT04249752|chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
4958242|NCT04249752|immunostaining|immunostaining
4958243|NCT04249752|autoantibodies|autoantibodies
4958244|NCT04249713|Hidradenitis Suppurativa|hidradenitis suppurativa
4958245|NCT04249713|Acne Inversa|acne inversa
4958246|NCT04249713|Brodalumab|brodalumab
4958247|NCT04249674|Cytochrome|cytochrome
4958248|NCT04249674|Polymorphism|polymorphism
4958249|NCT04249674|Genotyping|genotyping
4958250|NCT04249674|Phenotyping|phenotyping
4958251|NCT04249674|Tramadol|tramadol
4958252|NCT04249674|CYP2D6 inhibitor|cyp2d6 inhibitor
4958253|NCT04249674|Phenoconversion|phenoconversion
4958254|NCT04249674|Environment|environment
4958255|NCT04249648|Hyperkalaemia|hyperkalaemia
4958256|NCT04249648|Heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5698163|NCT00507481|Delirium|delirium
4958257|NCT04249648|Renin-angiotensin-aldosterone system inhibitors|renin-angiotensin-aldosterone system inhibitors
4958258|NCT04249635|Maternal obesity|maternal obesity
4958259|NCT04249635|Body composition|body composition
4958260|NCT04249635|DHA|dha
4958261|NCT04249635|n-3 LCPUFA|n-3 lcpufa
4958262|NCT04249609|Exercise|exercise
4958263|NCT04249609|Appetite|appetite
4958264|NCT04249609|Gastrointestinal hormones|gastrointestinal hormones
4958265|NCT04249609|Macronutrient|macronutrient
4958266|NCT04249609|Fat oxidation|fat oxidation
4958267|NCT04249609|Thermic effect of food|thermic effect of food
4963992|NCT04214444|Lymphoma|lymphoma
4958279|NCT04249505|spectacle dispensing|spectacle dispensing
4958280|NCT04249492|Intraocular Lens|intraocular lens
4958281|NCT04249492|EDOF|edof
4958282|NCT04249492|hydrophobic|hydrophobic
4958284|NCT04249492|monofocal|monofocal
4958285|NCT04249453|Back pain|back pain
4958286|NCT04249453|Lumbar spine|lumbar spine
4958299|NCT04249362|Radiation therapy|radiation therapy
4958300|NCT04249362|Phase II|phase ii
4958301|NCT04249362|Palliative Radiotherapy|palliative radiotherapy
4958302|NCT04249349|Stroke|stroke
4958303|NCT04249349|Ankle foot orthosis|ankle foot orthosis
4958304|NCT04249349|Gait|gait
4958305|NCT04249349|Active orthosis|active orthosis
4958306|NCT04249336|Dentine hypersensitivity|dentine hypersensitivity
4958307|NCT04249336|Dentine Sensitivity|dentine sensitivity
4958308|NCT04249336|Oral dentifrices|oral dentifrices
4958309|NCT04249336|Bio-active glasses|bio-active glasses
4958310|NCT04249297|dydrogesterone|dydrogesterone
4958311|NCT04249297|Duphaston|duphaston
4958312|NCT04249297|Assisted Reproductive Technology|assisted reproductive technology
4958313|NCT04249297|In-Vitro Fertilization|in-vitro fertilization
4958314|NCT04249297|luteal phase support|luteal phase support
4958315|NCT04249271|thyroid|thyroid
4958316|NCT04249271|antibody|antibody
4958317|NCT04249271|pregnancy|pregnancy
4958318|NCT04249271|infertility|infertility
4958323|NCT04249232|abaloparatide|abaloparatide
4958324|NCT04249206|root canal obturation|root canal obturation
4958325|NCT04249206|hydraulic sealer|hydraulic sealer
4958326|NCT04249206|single cone|single cone
4958327|NCT04249206|endodontic outcome|endodontic outcome
4958328|NCT04249193|Transfusion|transfusion
4958329|NCT04249193|Intermittent hypoxia|intermittent hypoxia
4958330|NCT04249180|primitive corneal ectasia|primitive corneal ectasia
4958331|NCT04249180|Ophthalmology|ophthalmology
4958332|NCT04249180|Eyes rubbing|eyes rubbing
4958333|NCT04249180|Keratoconus|keratoconus
4958334|NCT04249154|Eligard|eligard
4958335|NCT04249154|Post-Operative Hypofractionation|post-operative hypofractionation
5275032|NCT02302950|women|women
5287524|NCT02235025|dyspnea|dyspnea
4958336|NCT04249076|Cataract Surgery|cataract surgery
4958337|NCT04249076|Inflammation|inflammation
4958338|NCT04249076|Pain|pain
4958339|NCT04249076|Clobetasol propionate|clobetasol propionate
4958340|NCT04249076|Ophthalmology|ophthalmology
4958341|NCT04249063|Abnormal Uterine Bleeding|abnormal uterine bleeding
4958342|NCT04249063|Endometrial Ablation|endometrial ablation
4958343|NCT04249063|NovaSure|novasure
4958344|NCT04249063|Pain|pain
4958345|NCT04249024|Peri-implantitis|peri-implantitis
4958346|NCT04249024|Laser treatment|laser treatment
4958347|NCT04249024|Surgical treatment|surgical treatment
4958348|NCT04249024|Randomized controlled trial|randomized controlled trial
4958349|NCT04249024|Patient reported outcomes|patient reported outcomes
4958350|NCT04249024|Clinical outcomes|clinical outcomes
4958351|NCT04249024|Microbiology|microbiology
4958352|NCT04249024|Immunology|immunology
4958353|NCT04248998|Triple-negative breast cancer|triple-negative breast cancer
4958354|NCT04248998|Fasting-Mimicking Diet|fasting-mimicking diet
4958355|NCT04248998|Metformin|metformin
4958356|NCT04248998|Tumor Metabolism|tumor metabolism
4958357|NCT04248998|Cytotoxic Chemotherapy|cytotoxic chemotherapy
4958358|NCT04248959|Preoperative Care|preoperative care
4958359|NCT04248959|Exercise Therapy|exercise therapy
4958360|NCT04248959|Prehabilitation|prehabilitation
4958361|NCT04248959|Extremity Sarcoma|extremity sarcoma
5698361|NCT00506675|Patching|patching
4958362|NCT04248959|Adolescents and Young Adults|adolescents and young adults
4958363|NCT04248933|Substance-Related Disorders|substance-related disorders
4958364|NCT04248933|Opioid Medication Assisted Treatment|opioid medication assisted treatment
4958365|NCT04248933|Opioid Crisis|opioid crisis
4958366|NCT04248933|Epidemic, Opioid|epidemic, opioid
4958367|NCT04248933|Opioid Addiction|opioid addiction
4958368|NCT04248933|Treatment Adherence|treatment adherence
4958369|NCT04248933|Retention in Care|retention in care
4958370|NCT04248920|Health Care Utilization|health care utilization
4958371|NCT04248920|Emergency Department|emergency department
4958372|NCT04248881|Nigeria|nigeria
4958373|NCT04248881|Cancer Prevention|cancer prevention
4958374|NCT04248881|Cancer Screening|cancer screening
4958384|NCT04248829|Metastatic EGFR Sensitizing Mutation|metastatic egfr sensitizing mutation
4958386|NCT04248829|Ex19del|ex19del
4958387|NCT04248829|L858R|l858r
4958388|NCT04248829|First-line|first-line
4958394|NCT04248829|Lazertinib|lazertinib
4958395|NCT04248816|Behavioral Economics|behavioral economics
4958396|NCT04248816|Screening|screening
4958397|NCT04248816|Outreach|outreach
4958398|NCT04248777|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
4958399|NCT04248777|Percutaneous Coronary Intervention (PCI).|percutaneous coronary intervention (pci).
4958400|NCT04248764|Recreational athlete|recreational athlete
4958401|NCT04248764|Soft Tissue Mobilization|soft tissue mobilization
4958402|NCT04248764|Delayed Onset Muscle Soreness|delayed onset muscle soreness
4958403|NCT04248725|chronic pain|chronic pain
4958404|NCT04248725|cognitive therapy|cognitive therapy
4958405|NCT04248725|mindfulness meditation|mindfulness meditation
4958406|NCT04248725|activation skills|activation skills
4958408|NCT04248725|employment|employment
4958409|NCT04248725|telehealth|telehealth
4958410|NCT04248699|Nutritional Supplement|nutritional supplement
4958411|NCT04248660|Uterine artery doppler|uterine artery doppler
4958412|NCT04248660|type of delivery|type of delivery
4958413|NCT04248660|obstetric outcomes|obstetric outcomes
4958414|NCT04248647|Psychological prehabilitation|psychological prehabilitation
4958415|NCT04248647|Colorectal cancer|colorectal cancer
4958416|NCT04248647|Functional capacity|functional capacity
4958417|NCT04248647|Physical activity|physical activity
4958418|NCT04248647|Nutrition|nutrition
4958419|NCT04248647|Psychological counselling|psychological counselling
4958423|NCT04248621|Androgen Antagonists|androgen antagonists
4958424|NCT04248621|Bone Density|bone density
4958425|NCT04248621|Prostatic Neoplasms|prostatic neoplasms
4958426|NCT04248595|Acute myeloid leukemia|acute myeloid leukemia
4958427|NCT04248595|Homoharringtonie|homoharringtonie
4958428|NCT04248595|Azacitidine|azacitidine
4958429|NCT04248595|Demethylation|demethylation
4958430|NCT04248582|Cryotherapy|cryotherapy
4958431|NCT04248582|Cryoablation|cryoablation
4958432|NCT04248569|DNAJB1-PRKACA Peptide Vaccine|dnajb1-prkaca peptide vaccine
4958433|NCT04248569|Nivolumab|nivolumab
4958434|NCT04248569|Ipilimumab|ipilimumab
4958435|NCT04248569|Anti-PD-1 (receptor blocking antibody)|anti-pd-1 (receptor blocking antibody)
4958436|NCT04248569|Anti-CTLA-4 (receptor blocking antibody)|anti-ctla-4 (receptor blocking antibody)
4958437|NCT04248569|Neoantigen Vaccines|neoantigen vaccines
4958438|NCT04248569|Cancer Vaccines|cancer vaccines
4958439|NCT04248569|Immunotherapy|immunotherapy
4958440|NCT04248569|Fibrolamellar Hepatocellular Cancer (FLC)|fibrolamellar hepatocellular cancer (flc)
4958441|NCT04248543|Vertebral compression fracture|vertebral compression fracture
4958442|NCT04248543|Radiation induced myelopathy|radiation induced myelopathy
4958443|NCT04248530|Uncontrolled Hypertension|uncontrolled hypertension
5275128|NCT02302508|active metabolite|active metabolite
4958444|NCT04248530|Renal Denervation|renal denervation
4958445|NCT04248517|mHealth|mhealth
4958446|NCT04248517|Schizophrenia|schizophrenia
4958448|NCT04248491|Chronic Pelvic Pain|chronic pelvic pain
4958449|NCT04248478|Chronic Pain|chronic pain
4958450|NCT04248478|Eating Habits|eating habits
4958451|NCT04248465|Ravulizumab|ravulizumab
4958452|NCT04248465|ALXN1210|alxn1210
4958453|NCT04248465|Ultomiris|ultomiris
4958454|NCT04248465|Motor Neuron Disease|motor neuron disease
4958455|NCT04248465|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4958457|NCT04248439|anemia|anemia
4958458|NCT04248439|bone marrow failure|bone marrow failure
4958459|NCT04248439|gene therapy|gene therapy
4958463|NCT04248348|Thrombosis|thrombosis
4958464|NCT04248348|Cancer|cancer
4958465|NCT04248348|Heparin, Low Molecular Weight|heparin, low molecular weight
4958466|NCT04248322|Quality of Life|quality of life
4958467|NCT04248322|Participation|participation
4958468|NCT04248322|Barrier|barrier
4958469|NCT04248322|Connected Catheter|connected catheter
4958470|NCT04248296|Gastroesophageal Reflux|gastroesophageal reflux
4958471|NCT04248296|intestinal microbiome|intestinal microbiome
5283433|NCT02254915|Synergo|synergo
4958476|NCT04248283|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4958494|NCT04248088|exercise|exercise
4958496|NCT04248088|tele-health|tele-health
4958497|NCT04248049|platelet-rich fibrin|platelet-rich fibrin
4958498|NCT04248049|platelet concentrates|platelet concentrates
4958499|NCT04248049|periodontal diseases|periodontal diseases
4958500|NCT04248036|Parenting|parenting
4958501|NCT04248023|Alcohol Misuse|alcohol misuse
4958502|NCT04248023|Alcohol Abuse|alcohol abuse
4958503|NCT04248023|Practice Facilitation|practice facilitation
4958504|NCT04248023|Motivational Interviewing|motivational interviewing
4958505|NCT04248023|Preventive Services|preventive services
4958506|NCT04247997|postoperative chronic cough|postoperative chronic cough
4958507|NCT04247997|pulmonary vagus nerve branch|pulmonary vagus nerve branch
4958508|NCT04247997|autonomic nervous system|autonomic nervous system
4958509|NCT04247997|pulmonary nerves|pulmonary nerves
4958510|NCT04247997|thoracoscopic lobectomy|thoracoscopic lobectomy
4958511|NCT04247984|XELIRI|xeliri
4958512|NCT04247984|FOLFIRI|folfiri
4958513|NCT04247932|Adolescent|adolescent
4958514|NCT04247932|Disabled Persons|disabled persons
4958515|NCT04247932|Immigrants|immigrants
4958516|NCT04247867|medium cut-off dialysis membrane|medium cut-off dialysis membrane
4958517|NCT04247867|p-cresol sulphate|p-cresol sulphate
4958518|NCT04247867|indoxyl-sulphate|indoxyl-sulphate
4958519|NCT04247867|trimethylamine-N-oxide (TMAO)|trimethylamine-n-oxide (tmao)
4958520|NCT04247867|hemodiafiltration|hemodiafiltration
4958521|NCT04247867|uremic toxins|uremic toxins
4958522|NCT04247867|dietary fibre|dietary fibre
4958523|NCT04247867|end stage renal disease|end stage renal disease
4958524|NCT04247841|Risk|risk
4958525|NCT04247841|Preoperative Assessment|preoperative assessment
4958526|NCT04247841|Myocardial Injury|myocardial injury
4958527|NCT04247841|Perioperative Medicine|perioperative medicine
4958528|NCT04247841|Personalized Medicine|personalized medicine
4958529|NCT04247841|Communication|communication
4958530|NCT04247828|Communication|communication
4958531|NCT04247828|Severe Physical Impairments|severe physical impairments
4958532|NCT04247828|Spinal Cord Injury|spinal cord injury
4958533|NCT04247815|Arthritis|arthritis
4958534|NCT04247815|Rheumatoid|rheumatoid
4958540|NCT04247763|Breast Cancer|breast cancer
4958541|NCT04247750|rapamycin|rapamycin
4958542|NCT04247750|erythroid differentiation|erythroid differentiation
4958543|NCT04247750|γ-globin|γ-globin
4958544|NCT04247750|fetal haemoglobin|fetal haemoglobin
4958545|NCT04247737|non-celiac glutensensitivity|non-celiac glutensensitivity
4958546|NCT04247737|irritable bowel syndrom|irritable bowel syndrom
4958547|NCT04247711|First-Episode Psychosis|first-episode psychosis
4958548|NCT04247711|Implementation Science|implementation science
4958549|NCT04247711|Coordinated Specialty Care|coordinated specialty care
4958550|NCT04247711|Global Mental Health|global mental health
4958551|NCT04247659|massive cerebral infarction|massive cerebral infarction
4958552|NCT04247659|asymmetric vascular sign of cortex|asymmetric vascular sign of cortex
4958553|NCT04247659|Sodium aescinate|sodium aescinate
4958554|NCT04247620|Peer Support|peer support
4958555|NCT04247620|Adherence|adherence
4958556|NCT04247620|Young Adult|young adult
4958557|NCT04247620|Quality of Life|quality of life
4958558|NCT04247620|Transition|transition
4958559|NCT04247620|Resilience|resilience
4958560|NCT04247620|Strengths-based|strengths-based
4958561|NCT04247607|persistent critical illness|persistent critical illness
4958562|NCT04247607|chronic critical illness|chronic critical illness
4958563|NCT04247607|prolonged intensive care|prolonged intensive care
4958564|NCT04247607|weaning from mechanical ventilation|weaning from mechanical ventilation
4958565|NCT04247607|decannulation|decannulation
4958584|NCT04247477|PEEP titration|peep titration
4958585|NCT04247477|Mechanical Ventilation|mechanical ventilation
4958586|NCT04247464|Short-term Fasting|short-term fasting
4958587|NCT04247464|Colorectal Cancer|colorectal cancer
4958588|NCT04247464|Chemotherapy|chemotherapy
4958590|NCT04247464|Immune response|immune response
4958591|NCT04247438|dental biofilm|dental biofilm
4958592|NCT04247438|dental plaque|dental plaque
4958593|NCT04247438|polysaccharides|polysaccharides
4958605|NCT04247347|Resourcefulness|resourcefulness
4958606|NCT04247347|Self-Management|self-management
4958607|NCT04247308|Preterm|preterm
4958608|NCT04247308|Neonate|neonate
4957103|NCT04256915|Insomnia|insomnia
4957104|NCT04256915|Eveningness|eveningness
4958609|NCT04247308|Multi-modal stimulation|multi-modal stimulation
4958615|NCT04247256|colorectal|colorectal
4958616|NCT04247256|cancer|cancer
4958617|NCT04247256|resistant|resistant
4958618|NCT04247256|FOLFIRI|folfiri
4958619|NCT04247256|metastatic|metastatic
4958620|NCT04247165|pancreatic cancer|pancreatic cancer
4958621|NCT04247165|locally advanced pancreatic cancer|locally advanced pancreatic cancer
4958622|NCT04247165|LAPC|lapc
4958623|NCT04247139|high cholesterol, kefir|high cholesterol, kefir
4958624|NCT04247113|bariatric surgery|bariatric surgery
4958625|NCT04247113|Parent-based prevention|parent-based prevention
4958626|NCT04247087|coronary calcification|coronary calcification
4958627|NCT04247087|phytomenadione|phytomenadione
4958628|NCT04247087|chronic kidney disease|chronic kidney disease
4958629|NCT04247087|hemodialysis|hemodialysis
4958633|NCT04247009|postprandial|postprandial
4958634|NCT04247009|inflammation|inflammation
4958635|NCT04247009|rheumatoid arthritis|rheumatoid arthritis
4958636|NCT04247009|RA|ra
4958637|NCT04247009|diet|diet
4958638|NCT04247009|PIRA|pira
4958639|NCT04246996|gentamicin sulfate|gentamicin sulfate
4958640|NCT04246996|pelvic organ prolapse surgery|pelvic organ prolapse surgery
4958641|NCT04246996|midurethral sling|midurethral sling
4958642|NCT04246996|bladder instillation|bladder instillation
4958643|NCT04246983|HIV|hiv
4958644|NCT04246983|Opportunistic disease|opportunistic disease
4958645|NCT04246983|Ultrasound|ultrasound
4958646|NCT04246970|Prehabilitation|prehabilitation
4958647|NCT04246970|Therapeutic Exercise|therapeutic exercise
4958648|NCT04246970|Functional capacity|functional capacity
4958649|NCT04246957|alopecia|alopecia
4958650|NCT04246957|quality of life|quality of life
4958651|NCT04246957|partner|partner
4958652|NCT04246944|induced membrane|induced membrane
4958653|NCT04246944|critical size defect|critical size defect
4958654|NCT04246918|Chronic Liver Disease|chronic liver disease
4958655|NCT04246918|Sarcopenia|sarcopenia
4958656|NCT04246918|Myostatin|myostatin
4958657|NCT04246918|Health related quality of life|health related quality of life
4958658|NCT04246918|muscle histology|muscle histology
4958659|NCT04246905|Sulforaphane|sulforaphane
4958660|NCT04246905|Depression|depression
4958661|NCT04246905|Fatigue|fatigue
4958662|NCT04246905|Cognition|cognition
4958663|NCT04246879|Laser Interstitial Thermal Therapy (LITT)|laser interstitial thermal therapy (litt)
4958664|NCT04246879|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
4958665|NCT04246879|Magnetic resonance image (MRI)|magnetic resonance image (mri)
4958666|NCT04246827|rheumatoid arthritis|rheumatoid arthritis
4958667|NCT04246827|pain|pain
4958670|NCT04246801|Inflammation|inflammation
4958671|NCT04246801|Pain|pain
4958672|NCT04246801|Clobetasol propionate|clobetasol propionate
4958673|NCT04246801|Ophthalmology|ophthalmology
4958674|NCT04246788|Infantile hemiplegia|infantile hemiplegia
4958675|NCT04246788|Cerebral palsy|cerebral palsy
4958676|NCT04246788|Intensive robotic rehabilitation|intensive robotic rehabilitation
4958677|NCT04246762|moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
4958678|NCT04246762|severe Rheumatoid Arthritis|severe rheumatoid arthritis
4958679|NCT04246762|subcutaneous|subcutaneous
4958680|NCT04246762|Olokizumab|olokizumab
4958681|NCT04246736|sleep|sleep
4958682|NCT04246736|fatigue|fatigue
4958683|NCT04246736|stress|stress
4958684|NCT04246736|recovery|recovery
4958685|NCT04246736|occupational|occupational
4958686|NCT04246736|shiftwork|shiftwork
4958687|NCT04246736|strategies|strategies
4958688|NCT04246736|work performance|work performance
4958689|NCT04246736|burnout|burnout
4958690|NCT04246736|sleepiness|sleepiness
4958691|NCT04246736|newly graduated nurses|newly graduated nurses
4977847|NCT04130711|haptic|haptic
4958707|NCT04246567|total intravenous anesthesia|total intravenous anesthesia
4958708|NCT04246567|inhalation anesthesia|inhalation anesthesia
4958709|NCT04246554|ACL reconstruction|acl reconstruction
4958710|NCT04246554|Ketorolac|ketorolac
4958711|NCT04246554|Pain|pain
4958712|NCT04246554|Narcotic|narcotic
4958713|NCT04246541|ketorolac|ketorolac
4958714|NCT04246541|meniscus tear|meniscus tear
4958715|NCT04246541|analgesics|analgesics
4958716|NCT04246541|pain|pain
4958717|NCT04246528|Scleroderma|scleroderma
4957232|NCT04256148|WAIHA|waiha
4957233|NCT04256148|Immunoglobulin G (IgG)-mediated autoimmune disorder|immunoglobulin g (igg)-mediated autoimmune disorder
4957234|NCT04256148|Pathogenesis|pathogenesis
4958718|NCT04246528|Self-management|self-management
4958719|NCT04246528|E-health|e-health
4958720|NCT04246528|Intervention|intervention
4958721|NCT04246528|Systemic Sclerosis|systemic sclerosis
4958722|NCT04246515|Hamstring injury|hamstring injury
4958723|NCT04246515|Shear Wave Elastography|shear wave elastography
4958724|NCT04246515|Blood Flow Restriction|blood flow restriction
4958725|NCT04246489|M7824|m7824
4958726|NCT04246489|INTR@PID|intr@pid
4958727|NCT04246489|Bintrafusp alfa|bintrafusp alfa
4958728|NCT04246489|programmed death-ligand 1|programmed death-ligand 1
4958729|NCT04246489|Cervical Cancer|cervical cancer
4958730|NCT04246489|Transforming growth factor-β (TGF-β)|transforming growth factor-β (tgf-β)
4958731|NCT04246476|parkinson disease|parkinson disease
4958732|NCT04246476|music|music
4958733|NCT04246476|imaging|imaging
4958734|NCT04246476|mental singing|mental singing
4958735|NCT04246476|gait|gait
4958736|NCT04246450|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
4958737|NCT04246450|Sudden cardiac death risk stratification|sudden cardiac death risk stratification
4958738|NCT04246450|Tiered two-step approach|tiered two-step approach
4958739|NCT04246450|Noninvasive risk factors|noninvasive risk factors
4958740|NCT04246450|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
4958741|NCT04246450|Programmed ventricular stimulation|programmed ventricular stimulation
4958744|NCT04246398|Fecal microbiota transplant|fecal microbiota transplant
4958745|NCT04246398|autism spectrum disorder|autism spectrum disorder
4958746|NCT04246398|children|children
4958747|NCT04246372|Interferon|interferon
4958748|NCT04246372|Autoimmunity|autoimmunity
4958749|NCT04246372|Down syndrome|down syndrome
4958750|NCT04246372|Skin disorder|skin disorder
4958751|NCT04246372|JAK inhibitor|jak inhibitor
4958752|NCT04246372|Inflammation|inflammation
4958753|NCT04246372|JAK/STAT|jak/stat
4958754|NCT04246372|Dermatology|dermatology
4958755|NCT04246359|indolent B-cell lymphoma|indolent b-cell lymphoma
4958756|NCT04246359|Rituximab(HLX01)|rituximab(hlx01)
4958757|NCT04246359|Pegylated Interferon α-2b|pegylated interferon α-2b
4958758|NCT04246359|HBsAg clearance rate|hbsag clearance rate
4958759|NCT04246333|Duodenal feeds|duodenal feeds
4958760|NCT04246333|Transpyloric feeds|transpyloric feeds
4958761|NCT04246333|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4958762|NCT04246333|BPD|bpd
4958763|NCT04246333|Premature infant|premature infant
4958764|NCT04246333|Neonate|neonate
4958765|NCT04246320|goal directed therapy (GDT)|goal directed therapy (gdt)
4958766|NCT04246320|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4958767|NCT04246320|neurocognitive testing|neurocognitive testing
4958768|NCT04246307|end-stage liver disease|end-stage liver disease
4958769|NCT04246307|liver transplantation|liver transplantation
4958901|NCT04245540|pau d' arco|pau d' arco
4958778|NCT04246294|Temporal Summation of Pain|temporal summation of pain
4958779|NCT04246294|Conditioned Pain Modulation|conditioned pain modulation
4958780|NCT04246294|Pain Catastrophizing|pain catastrophizing
4958788|NCT04246229|neonatal icterus|neonatal icterus
4958789|NCT04246229|neonatal jaundice|neonatal jaundice
4958790|NCT04246229|newborn|newborn
4958791|NCT04246177|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
4958792|NCT04246177|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
4958793|NCT04246177|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
4958794|NCT04246125|Dose archiving and communication systems|dose archiving and communication systems
4958815|NCT04246034|microsurgery|microsurgery
4958816|NCT04246008|acute coronary syndrome|acute coronary syndrome
4958817|NCT04246008|neuromuscular training|neuromuscular training
4958818|NCT04246008|cardiac rehabilitation|cardiac rehabilitation
4958819|NCT04246008|functional capacity|functional capacity
4958820|NCT04245982|Diabetes Mellitus|diabetes mellitus
4958821|NCT04245982|NF-κB|nf-κb
4958822|NCT04245982|PPAR-γ|ppar-γ
4958823|NCT04245982|Periodontitis|periodontitis
4958825|NCT04245982|VDR|vdr
4958826|NCT04245956|Mitral Regurgitation|mitral regurgitation
4958827|NCT04245956|MitraClip|mitraclip
4958828|NCT04245956|iFR|ifr
4958829|NCT04245956|Coronary microcirculation|coronary microcirculation
4958830|NCT04245956|Coronary hemodynamics|coronary hemodynamics
4958831|NCT04245943|Rehabilitation|rehabilitation
4958832|NCT04245943|Physical exercise|physical exercise
4958833|NCT04245943|Return to work|return to work
4958835|NCT04245943|Cancer survivors|cancer survivors
4958836|NCT04245904|basketball, respiratory, physical fitness|basketball, respiratory, physical fitness
4958837|NCT04245865|Colorectal cancer|colorectal cancer
4958838|NCT04245865|Tocotrienol|tocotrienol
4958839|NCT04245865|Natural killer cells|natural killer cells
4958840|NCT04245865|Circulating tumor DNA|circulating tumor dna
4958841|NCT04245839|B-cell Non-Hodgkin Lymphoma (NHL)|b-cell non-hodgkin lymphoma (nhl)
4958843|NCT04245839|Relapsed or Refractory|relapsed or refractory
4958853|NCT04245800|Influenza|influenza
4958854|NCT04245800|self-testing|self-testing
4958855|NCT04245800|diagnostic accuracy|diagnostic accuracy
4958856|NCT04245774|Saddle block|saddle block
4958857|NCT04245774|Hyperbaric levobupivacaine and bupivacaine|hyperbaric levobupivacaine and bupivacaine
4958858|NCT04245774|Outpatient anorectal surgery|outpatient anorectal surgery
4958859|NCT04245748|Anxious Depression|anxious depression
4958860|NCT04245722|Lymphoma|lymphoma
4958861|NCT04245722|Leukemia|leukemia
4958862|NCT04245696|RF, Micro-needling, Submental Skin Laxity|rf, micro-needling, submental skin laxity
4958863|NCT04245657|Breast Cancer|breast cancer
4958864|NCT04245657|Lymphedema|lymphedema
4958865|NCT04245657|Upper Extremity Function|upper extremity function
4958866|NCT04245657|Hand Grip Strength|hand grip strength
4958867|NCT04245644|aspirin,|aspirin,
4958868|NCT04245644|metformin|metformin
4958869|NCT04245644|statin|statin
4958870|NCT04245644|ACE-inhibitors|ace-inhibitors
4958871|NCT04245644|beta-blockers|beta-blockers
4958872|NCT04245644|pancreatic cancer|pancreatic cancer
4958873|NCT04245644|survival|survival
4958874|NCT04245631|recombinase aided amplification assay|recombinase aided amplification assay
4958875|NCT04245631|2019-nCoV|2019-ncov
4958876|NCT04245631|diagnosis|diagnosis
4958877|NCT04245631|Specificity|specificity
4958878|NCT04245631|Sensitivity|sensitivity
4958879|NCT04245605|Coronary angiography|coronary angiography
4958880|NCT04245605|Invasive strategy|invasive strategy
4958881|NCT04245605|Myocardial infarction|myocardial infarction
4958882|NCT04245605|Troponin|troponin
4978047|NCT04129164|SS|ss
4958890|NCT04245579|cognitive training|cognitive training
4958891|NCT04245579|memory failures|memory failures
4958892|NCT04245579|APOE|apoe
4958893|NCT04245579|brain volume|brain volume
4958894|NCT04245579|cognitive reserve|cognitive reserve
4958895|NCT04245553|Paracentesis|paracentesis
4958896|NCT04245553|Point of Care Ultrasound (POCUS)|point of care ultrasound (pocus)
4958897|NCT04245540|primary dysmenorrhea|primary dysmenorrhea
4958898|NCT04245540|dysmenorrhea|dysmenorrhea
4958899|NCT04245540|tabebuia avellanedae|tabebuia avellanedae
4958900|NCT04245540|tabebuia impetiginosa|tabebuia impetiginosa
5698362|NCT00506649|protocol|protocol
4958902|NCT04245540|taheebo bark|taheebo bark
4958903|NCT04245540|menstrual pain|menstrual pain
4958904|NCT04245540|pelvic pain|pelvic pain
4958905|NCT04245540|menstrual cramps|menstrual cramps
4958915|NCT04245540|plant extracts|plant extracts
4958917|NCT04245514|Immune-modulatory radiotherapy|immune-modulatory radiotherapy
4958918|NCT04245514|neoadjuvant PD-L1 blockade|neoadjuvant pd-l1 blockade
4958919|NCT04245514|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4958920|NCT04245514|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4958921|NCT04245514|NSCLC|nsclc
4958922|NCT04245514|Surgery|surgery
4958923|NCT04245514|abscopal effect|abscopal effect
4958924|NCT04245501|Child|child
4958925|NCT04245501|Adolescent|adolescent
4958926|NCT04245501|Pediatric|pediatric
4958927|NCT04245501|Youth|youth
4958928|NCT04245501|Anxiety|anxiety
4958929|NCT04245501|Separation anxiety|separation anxiety
4958930|NCT04245501|Social phobia|social phobia
4958931|NCT04245501|Social anxiety|social anxiety
4958932|NCT04245501|Generalized anxiety|generalized anxiety
4958933|NCT04245501|Interpretation bias|interpretation bias
4958934|NCT04245501|Cognitive bias|cognitive bias
4958935|NCT04245501|Cognitive bias modification|cognitive bias modification
4958936|NCT04245501|Interpretation bias modification|interpretation bias modification
4958937|NCT04245501|Randomized controlled trial|randomized controlled trial
4958938|NCT04245501|Threat bias|threat bias
4958939|NCT04245501|Threat interpretation|threat interpretation
4958940|NCT04245501|Intervention|intervention
4958941|NCT04245501|Randomized|randomized
4958942|NCT04245501|Cognitive training|cognitive training
4958943|NCT04245501|National Institute of Mental Health|national institute of mental health
4958944|NCT04245501|Personalized|personalized
4958945|NCT04245475|pain control|pain control
4957492|NCT04254367|bio-psycho-social model|bio-psycho-social model
4957493|NCT04254328|heart failure|heart failure
4957494|NCT04254328|older|older
4957495|NCT04254328|physical activity|physical activity
4957497|NCT04254328|nintendo|nintendo
4958946|NCT04245462|Protein intake|protein intake
4958947|NCT04245462|Older adults|older adults
4958948|NCT04245462|Physical disability|physical disability
4958949|NCT04245462|Mexican adults|mexican adults
4958950|NCT04245423|Opioid-use disorder|opioid-use disorder
4958951|NCT04245423|Depression|depression
4958952|NCT04245423|Anxiety|anxiety
4958953|NCT04245423|Post-traumatic stress disorder|post-traumatic stress disorder
4958954|NCT04245410|Renal cell carcinoma|renal cell carcinoma
4958955|NCT04245410|Pancreatic metastases|pancreatic metastases
4958956|NCT04245410|Resection|resection
4958957|NCT04245397|Immunotherapy|immunotherapy
4958958|NCT04245397|Chemokine receptor blockade|chemokine receptor blockade
4958959|NCT04245397|Myeloid-derived supressor cells|myeloid-derived supressor cells
4958960|NCT04245384|dietetics|dietetics
4958961|NCT04245384|telemedicine|telemedicine
4958962|NCT04245384|dietitian|dietitian
4958963|NCT04245345|AV Synchrony|av synchrony
4958964|NCT04245345|Micra AV|micra av
4959360|NCT04243096|gait|gait
4958978|NCT04245228|Heart Transplant|heart transplant
4958979|NCT04245228|Lung Transplant|lung transplant
4958980|NCT04245228|Stress|stress
4958983|NCT04245202|Acute Bronchiolitis|acute bronchiolitis
4958984|NCT04245202|High Flow Nasal Cannula|high flow nasal cannula
4958985|NCT04245202|Standard Face Mask|standard face mask
4958986|NCT04245176|Breast Cancer|breast cancer
4958987|NCT04245176|Invasive Breast Cancer|invasive breast cancer
4958988|NCT04245176|in Situ Breast Cancer|in situ breast cancer
4958989|NCT04245176|Genetic Testing|genetic testing
4958990|NCT04245176|Quantitative genetic counseling|quantitative genetic counseling
4958991|NCT04245176|Standard genetic counseling|standard genetic counseling
4958992|NCT04245163|medication adherence|medication adherence
4958994|NCT04245163|intervention|intervention
4958995|NCT04245124|COGNITIVE REHABILITATION|cognitive rehabilitation
4958999|NCT04245098|carpal tunnel syndrome|carpal tunnel syndrome
4959000|NCT04245098|amyloidosis|amyloidosis
4959001|NCT04245072|fundus diseases|fundus diseases
4959002|NCT04245072|antiangiogenic therapy|antiangiogenic therapy
4959003|NCT04245072|choroidal neovascularization|choroidal neovascularization
5283827|NCT02252653|FAC|fac
4959004|NCT04245072|intravitreal injection|intravitreal injection
4959005|NCT04245072|anti-VEGF|anti-vegf
4964693|NCT04209920|MIH|mih
4959018|NCT04245020|Randomised control trial|randomised control trial
4959019|NCT04245020|Virtual clinic|virtual clinic
4959020|NCT04245020|Text messaging|text messaging
4959021|NCT04245020|General surgery|general surgery
4959022|NCT04245020|Outpatients|outpatients
4959023|NCT04245020|Satisfaction|satisfaction
4959024|NCT04245020|Telemedicine|telemedicine
4959025|NCT04245007|obese|obese
4959026|NCT04245007|intermittent fasting|intermittent fasting
4959027|NCT04245007|fat mass|fat mass
4959028|NCT04245007|body fat reduction|body fat reduction
4959029|NCT04244994|Chlamydia trachomatis|chlamydia trachomatis
4959030|NCT04244994|Neisseria gonorrhoeae|neisseria gonorrhoeae
4959031|NCT04244994|Mycoplasma genitalium|mycoplasma genitalium
4959032|NCT04244981|prothrombin complex concentrate|prothrombin complex concentrate
4959033|NCT04244981|fresh frozen plasma|fresh frozen plasma
4959034|NCT04244981|perioperative blood loss|perioperative blood loss
4959035|NCT04244981|efficacy|efficacy
4959036|NCT04244981|cardiac surgery|cardiac surgery
4959037|NCT04244981|cardiopulmonary bypass|cardiopulmonary bypass
4959038|NCT04244968|Physiotherapy Triage|physiotherapy triage
4959039|NCT04244968|Musculoskeletal Pain|musculoskeletal pain
4959040|NCT04244968|Patient Satisfaction VSQ 9|patient satisfaction vsq 9
4959041|NCT04244968|MSK HQ|msk hq
4959042|NCT04244916|Systemic sclerosis|systemic sclerosis
4959043|NCT04244916|diffuse|diffuse
4959044|NCT04244916|interstitial lung disease|interstitial lung disease
4959045|NCT04244916|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
4959046|NCT04244916|mycophenolate mofetil|mycophenolate mofetil
4959049|NCT04244864|Post Traumatic Stress Disorder|post traumatic stress disorder
4959050|NCT04244864|Refugees|refugees
4959051|NCT04244864|Cross-sectoral collaboration|cross-sectoral collaboration
4959052|NCT04244864|Treatment|treatment
4959053|NCT04244851|Malnutrition,|malnutrition,
4959054|NCT04244851|qualitative study|qualitative study
4959055|NCT04244838|Medially stabilized total knee arthroplasty|medially stabilized total knee arthroplasty
4959056|NCT04244838|In vivo kinematics|in vivo kinematics
4959057|NCT04244838|gait analysis|gait analysis
4959058|NCT04244812|meridians|meridians
4959059|NCT04244812|acupuncture|acupuncture
4959060|NCT04244812|chronic stable angina pectoris|chronic stable angina pectoris
4959061|NCT04244812|meridian phenomena|meridian phenomena
4959062|NCT04244799|Handwashing|handwashing
4959066|NCT04244799|Health behavior|health behavior
4959067|NCT04244799|Nudge|nudge
4959068|NCT04244799|Environmental cue|environmental cue
4959069|NCT04244799|Behavior change|behavior change
4959070|NCT04244786|Transcranial direct current stimulation|transcranial direct current stimulation
4959071|NCT04244786|Transcranial electric stimulation|transcranial electric stimulation
4959072|NCT04244786|non-invasive brain stimulation|non-invasive brain stimulation
4959073|NCT04244786|tDCS|tdcs
4959074|NCT04244760|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
4959075|NCT04244760|Cerebral Palsy|cerebral palsy
4959076|NCT04244760|Conditioned Pain Modulation|conditioned pain modulation
4959077|NCT04244760|Chronic Postsurgical Pain|chronic postsurgical pain
4959078|NCT04244760|Quantitative Sensory Testing|quantitative sensory testing
4959079|NCT04244760|Pain Management|pain management
4959080|NCT04244747|labor induction,|labor induction,
4959081|NCT04244747|previous caesarean section|previous caesarean section
4959082|NCT04244747|hormonal levels|hormonal levels
4959083|NCT04244747|breast stimulation|breast stimulation
4959084|NCT04244747|intracervical balloon|intracervical balloon
4959085|NCT04244734|lung transplantation|lung transplantation
4959086|NCT04244734|rehabilitation|rehabilitation
4959087|NCT04244734|respiratory muscle training|respiratory muscle training
4959088|NCT04244734|early mobilisation|early mobilisation
4959089|NCT04244734|Neuromuscular electrostimulation|neuromuscular electrostimulation
4959090|NCT04244734|in-bed cycling|in-bed cycling
4964815|NCT04209335|aging|aging
4959114|NCT04244617|Primary Care|primary care
4959115|NCT04244617|Anxiety|anxiety
4959116|NCT04244617|Drop-out|drop-out
4959117|NCT04244617|Peer-support|peer-support
4959118|NCT04244617|Mixed method design|mixed method design
4959119|NCT04244604|blood pressure|blood pressure
4959120|NCT04244604|racial disparities|racial disparities
4959121|NCT04244604|cardiovascular health|cardiovascular health
4959122|NCT04244604|physical fitness|physical fitness
4959123|NCT04244604|sleep|sleep
4959124|NCT04244604|dietary sodium|dietary sodium
4959125|NCT04244604|dietary salt|dietary salt
4959126|NCT04244604|diet|diet
4959127|NCT04244578|tDCS|tdcs
4959128|NCT04244578|transcranial direct current stimulation|transcranial direct current stimulation
4959129|NCT04244578|transcranial electric stimulation|transcranial electric stimulation
4959130|NCT04244578|developmental dyslexia|developmental dyslexia
4959131|NCT04244578|specific learning disorders|specific learning disorders
4959132|NCT04244578|treatment|treatment
4959133|NCT04244565|Self-directed, Traditional Clinical Learning|self-directed, traditional clinical learning
4959134|NCT04244513|Deep brain stimulation|deep brain stimulation
4959135|NCT04244513|Chorea|chorea
4959136|NCT04244513|Huntington Disease|huntington disease
4959137|NCT04244500|emergency room|emergency room
4959138|NCT04244500|epidemiology|epidemiology
4959139|NCT04244487|Vagus nerve|vagus nerve
4959140|NCT04244487|Esophageal variceal re-bleeding|esophageal variceal re-bleeding
4959141|NCT04244487|Cirrhosis|cirrhosis
4959142|NCT04244487|Hypertension|hypertension
4959143|NCT04244487|laparoscopy|laparoscopy
4959144|NCT04244461|alcohol|alcohol
4959145|NCT04244461|mental health|mental health
4959146|NCT04244461|treatment initiation|treatment initiation
4959147|NCT04244435|coronary artery bypass grafting|coronary artery bypass grafting
4959148|NCT04244435|prevention of complication|prevention of complication
4959149|NCT04244435|neuroaxial prophylaxis|neuroaxial prophylaxis
4959150|NCT04244435|thoracic epidural analgesia|thoracic epidural analgesia
4959151|NCT04244409|Gynaecology|gynaecology
4959152|NCT04244409|Immunosuppression|immunosuppression
4959153|NCT04244409|In-vitro Fertilisation|in-vitro fertilisation
4959154|NCT04244409|Infertility|infertility
4959166|NCT04244370|Arterial Embolization|arterial embolization
4959167|NCT04244370|Vascular Plug|vascular plug
4959168|NCT04244344|Intervention|intervention
4959169|NCT04244344|Fall|fall
4959170|NCT04244344|Fall Prevention|fall prevention
4959171|NCT04244318|Video Feedback intervention|video feedback intervention
4959172|NCT04244318|randomized controlled trial|randomized controlled trial
4959173|NCT04244318|parenting skills|parenting skills
4959174|NCT04244318|ODISEA|odisea
4959175|NCT04244318|video-feedback|video-feedback
4959176|NCT04244305|Exercise Therapy|exercise therapy
4959177|NCT04244305|Physical Therapy Modalities|physical therapy modalities
4959178|NCT04244305|Functional Capacity|functional capacity
4959183|NCT04244279|De Quervain syndrome|de quervain syndrome
4959184|NCT04244279|Low back pain|low back pain
4959185|NCT04244279|Neck pain|neck pain
4959186|NCT04244279|Wrist pain|wrist pain
4959187|NCT04244240|Sickle Cell Disease|sickle cell disease
4959188|NCT04244240|Drepanocytosis|drepanocytosis
4959193|NCT04244201|diabetic foot|diabetic foot
4959194|NCT04244201|leg ulcer|leg ulcer
4959195|NCT04244201|skin ulcer|skin ulcer
4959196|NCT04244188|Numerical simulation|numerical simulation
4959197|NCT04244188|stent-graft|stent-graft
4959198|NCT04244188|aortic arch aneurysms|aortic arch aneurysms
4959216|NCT04244058|Positron emission tomography|positron emission tomography
4959222|NCT04244058|Traumatic brain injury|traumatic brain injury
4959223|NCT04244058|Disorders of consciousness|disorders of consciousness
4959224|NCT04244032|Cognitive Training|cognitive training
4959225|NCT04244032|Alcohol Use Disorder|alcohol use disorder
4959226|NCT04243967|Hysterectomy|hysterectomy
4959227|NCT04243967|Music therapy|music therapy
4959228|NCT04243967|Laparoscopy|laparoscopy
4959229|NCT04243967|Anxiety|anxiety
4959230|NCT04243967|Stress|stress
4959231|NCT04243967|Pain|pain
4959232|NCT04243967|Minimally invasive surgery|minimally invasive surgery
4959238|NCT04243915|Percutaneous neuromuscular electrical stimulation|percutaneous neuromuscular electrical stimulation
4959239|NCT04243915|Percutaneous electrical nerve stimulation|percutaneous electrical nerve stimulation
4959240|NCT04243915|Percutaneous electrical stimulation|percutaneous electrical stimulation
4959241|NCT04243915|Motor control exercise|motor control exercise
4959242|NCT04243915|Multifidus|multifidus
4959243|NCT04243915|Abdominal transverse|abdominal transverse
4959244|NCT04243915|Non-specific chronic low back pain|non-specific chronic low back pain
4959245|NCT04243915|Transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
4959246|NCT04243915|Exercise therapy|exercise therapy
4959247|NCT04243902|urinary catheter|urinary catheter
5288242|NCT02231710|Dyskeratosis Congenita|dyskeratosis congenita
4959248|NCT04243902|IDC|idc
4959249|NCT04243889|Neox Cord 1K|neox cord 1k
4959250|NCT04243889|Fetoscopic repair|fetoscopic repair
4959251|NCT04243889|Cryopreserved human umbilical cord|cryopreserved human umbilical cord
4959252|NCT04243876|Myocardial infarction, Paraoxonase|myocardial infarction, paraoxonase
4959253|NCT04243863|VNRX-7145|vnrx-7145
4959254|NCT04243863|Safety|safety
4959255|NCT04243863|Pharmacokinetics|pharmacokinetics
4959256|NCT04243850|Sodium Glucose Cotransporter 2|sodium glucose cotransporter 2
4959257|NCT04243811|pediatric patient|pediatric patient
4959258|NCT04243811|injection pain|injection pain
4959259|NCT04243811|lllt|lllt
4959963|NCT04239053|Bupivacaine|bupivacaine
4959272|NCT04243694|caregiver|caregiver
4959273|NCT04243694|parent|parent
4959274|NCT04243694|asd|asd
4959275|NCT04243694|autism|autism
4959276|NCT04243694|autism spectrum disorder|autism spectrum disorder
4959277|NCT04243681|Mesenchymal Stem Cell|mesenchymal stem cell
4959278|NCT04243681|Hematopoetic Stem cell|hematopoetic stem cell
4959279|NCT04243681|Autologous transfusion|autologous transfusion
4959280|NCT04243629|Artificial pancreas|artificial pancreas
4959281|NCT04243629|Closed-loop system|closed-loop system
4959282|NCT04243629|Amylin|amylin
4959283|NCT04243629|Pramlintide|pramlintide
4959284|NCT04243629|Type 1 Diabetes|type 1 diabetes
4959285|NCT04243629|Glycemic control|glycemic control
4959286|NCT04243603|Non-suicidal Self-injury|non-suicidal self-injury
4959287|NCT04243603|Internet-based intervention|internet-based intervention
4959288|NCT04243590|brachial plexus|brachial plexus
4959289|NCT04243590|unilateral cerebral palsy|unilateral cerebral palsy
4959290|NCT04243590|hand function|hand function
4959295|NCT04243499|gamma delta T cells|gamma delta t cells
4959296|NCT04243499|butyrophilin|butyrophilin
4959297|NCT04243473|Brachytherapy|brachytherapy
4959298|NCT04243460|Dental Implants|dental implants
4959305|NCT04243434|Hematology|hematology
4959306|NCT04243434|Hematological Malignancy|hematological malignancy
4959307|NCT04243434|CHOP|chop
4959308|NCT04243434|R-CHOP|r-chop
4959309|NCT04243421|implant|implant
4959310|NCT04243421|soft tissue|soft tissue
4959311|NCT04243408|cerebral palsy, autologous umbilical cord blood|cerebral palsy, autologous umbilical cord blood
4959312|NCT04243382|Autistic Spectrum Disorder, autologous umblical cord blood|autistic spectrum disorder, autologous umblical cord blood
4978447|NCT04126707|HQP1351|hqp1351
4959322|NCT04243304|UCB-J|ucb-j
4959323|NCT04243304|PE2I|pe2i
4959324|NCT04243291|risk factor|risk factor
4959325|NCT04243291|physician|physician
4959326|NCT04243291|road accident|road accident
4959327|NCT04243291|prevalence|prevalence
4959328|NCT04243265|Patellofemoral Dislocation|patellofemoral dislocation
4959329|NCT04243265|MPFL reconstruction|mpfl reconstruction
4959330|NCT04243252|food insecurity|food insecurity
4959331|NCT04243226|physical health care|physical health care
4959332|NCT04243226|Activity of Daily Living,ADL|activity of daily living,adl
4959333|NCT04243213|early mobilisation after hospitalisation|early mobilisation after hospitalisation
4959334|NCT04243187|phaseolus|phaseolus
4959335|NCT04243187|symptoms|symptoms
4959336|NCT04243187|expired hydrogen|expired hydrogen
4959337|NCT04243187|bloating|bloating
4959338|NCT04243187|bean|bean
4959339|NCT04243187|tolerance|tolerance
4959340|NCT04243187|beans|beans
4959341|NCT04243161|Spinal Cord Injury|spinal cord injury
4959342|NCT04243161|Rehabilitation|rehabilitation
4959343|NCT04243161|Respiratory Muscle Training|respiratory muscle training
4959355|NCT04243109|Pomalidomide|pomalidomide
4959356|NCT04243109|Cyclophosphamide|cyclophosphamide
4959357|NCT04243109|Dexamethasone|dexamethasone
4959358|NCT04243096|physical therapy|physical therapy
4959359|NCT04243096|wearable sensors|wearable sensors
4959366|NCT04243018|Homelessness|homelessness
4959367|NCT04243018|Well-being|well-being
4959368|NCT04243005|Neurosurgical procedures|neurosurgical procedures
4959370|NCT04242992|Retention|retention
4959371|NCT04242992|Viral suppression|viral suppression
4959372|NCT04242992|Violence|violence
4959373|NCT04242992|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
4959374|NCT04242992|Common Elements Treatment Approach (CETA)|common elements treatment approach (ceta)
4959375|NCT04242979|Albumin use in liver cirrhosis|albumin use in liver cirrhosis
4959381|NCT04242914|Ketamine, Midazolam, Non-Suicidal Self-Injury, Intravenous|ketamine, midazolam, non-suicidal self-injury, intravenous
4959382|NCT04242901|FIT|fit
4959383|NCT04242901|Symptomatic FIT|symptomatic fit
4959384|NCT04242862|General Practitioners|general practitioners
4959385|NCT04242862|Private Practice|private practice
4959386|NCT04242862|Models, Organizational|models, organizational
4959387|NCT04242862|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
4959388|NCT04242862|Test Anxiety Scale|test anxiety scale
4959389|NCT04242862|Surveys and Questionnaires|surveys and questionnaires
4959390|NCT04242862|Cross-Sectional Studies|cross-sectional studies
4959391|NCT04242836|digital near vision chart|digital near vision chart
4959392|NCT04242836|critical print size|critical print size
4959393|NCT04242836|reading acuity|reading acuity
5288393|NCT02231008|SMS|sms
4959394|NCT04242836|reading speed|reading speed
4959395|NCT04242836|digital Greek MNREAD|digital greek mnread
4959396|NCT04242797|Idiopathic|idiopathic
4959397|NCT04242797|diabetic|diabetic
4959398|NCT04242797|chemotherapy-induced|chemotherapy-induced
4959399|NCT04242745|Elderly|elderly
4959400|NCT04242745|fluid consumption|fluid consumption
4959401|NCT04242745|fluid deficiency|fluid deficiency
4959402|NCT04242745|nursing home|nursing home
4959403|NCT04242745|audible alarm|audible alarm
4959404|NCT04242732|Patello femoral dislocation|patello femoral dislocation
4959405|NCT04242732|Medial patello-femoral ligament|medial patello-femoral ligament
4959406|NCT04242732|Sport trauma|sport trauma
4959407|NCT04242719|Deep retinal capillary ischemia|deep retinal capillary ischemia
4959408|NCT04242719|Paracentral acute middle maculopathy|paracentral acute middle maculopathy
4959409|NCT04242719|Acute macular neuroretinopathy|acute macular neuroretinopathy
4959410|NCT04242719|Electromagnetic stimulation|electromagnetic stimulation
4959411|NCT04242719|Magnovision|magnovision
4959412|NCT04242719|Platelet-rich plasma|platelet-rich plasma
4959413|NCT04242680|Children|children
4959414|NCT04242680|Adolescents|adolescents
4959415|NCT04242680|tRNS|trns
4959416|NCT04242680|transcranial random noise stimulation|transcranial random noise stimulation
4959417|NCT04242680|EEG|eeg
4959418|NCT04242680|numerical abilities|numerical abilities
4959419|NCT04242680|neurodevelopmental disorders|neurodevelopmental disorders
4978545|NCT04126044|Pharmacokinetics|pharmacokinetics
4959426|NCT04242628|LSNS-6 scale|lsns-6 scale
4959427|NCT04242589|Vertebroplasty|vertebroplasty
4959428|NCT04242589|Vertebral Compression Fracture|vertebral compression fracture
4959429|NCT04242589|Radiotherapy|radiotherapy
4959431|NCT04242576|Graded motor imagery|graded motor imagery
4959432|NCT04242576|Exercise|exercise
4959433|NCT04242576|Action Observation|action observation
4959434|NCT04242576|Right/Left judgment tasks|right/left judgment tasks
4959435|NCT04242563|interventional cardiopathy|interventional cardiopathy
4959436|NCT04242563|preoperative anxiety|preoperative anxiety
4959437|NCT04242563|virtual reality|virtual reality
4959438|NCT04242524|insulin|insulin
4959439|NCT04242524|adipocyte|adipocyte
4959440|NCT04242524|gene expression|gene expression
4959441|NCT04242511|Tuberculosis|tuberculosis
4959442|NCT04242511|Diabetes|diabetes
4959443|NCT04242511|Rifampicin|rifampicin
4959444|NCT04242511|Therapeutic Drug Monitoring|therapeutic drug monitoring
4959445|NCT04242498|Bimekizumab|bimekizumab
4959446|NCT04242498|UCB4940|ucb4940
4959447|NCT04242498|HS|hs
4959450|NCT04242485|heart rate|heart rate
4959451|NCT04242485|heart rate variability|heart rate variability
4959452|NCT04242485|blood pressure|blood pressure
4959453|NCT04242485|rugby match|rugby match
4959454|NCT04242485|atlethes|atlethes
5903435|NCT00392756|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
4959455|NCT04242485|recovery|recovery
4959456|NCT04242485|osteopathy|osteopathy
4959457|NCT04242472|Tuberculosis|tuberculosis
4959479|NCT04242407|Postoperative|postoperative
4959480|NCT04242407|DMTS|dmts
4959481|NCT04242394|ERCP|ercp
4959482|NCT04242394|Acute purulent cholecystitis|acute purulent cholecystitis
4959483|NCT04242394|Bile duct stone|bile duct stone
4959484|NCT04242394|Post-ERCP-Choledocholithiasis PEC|post-ercp-choledocholithiasis pec
4959485|NCT04242381|Kinesiotape|kinesiotape
4959486|NCT04242381|exercise|exercise
4959487|NCT04242381|ultrasound|ultrasound
4959488|NCT04242368|chronic rhinosinusitis|chronic rhinosinusitis
4959489|NCT04242368|nasal rinses|nasal rinses
4959490|NCT04242368|nasal irrigations|nasal irrigations
4959491|NCT04242355|TMS|tms
4959492|NCT04242342|liver cancer|liver cancer
4959493|NCT04242329|Immunotherapy|immunotherapy
4959494|NCT04242329|Metastatic surgery|metastatic surgery
4959495|NCT04242329|Surgical oncology|surgical oncology
4959496|NCT04242316|Stroke|stroke
4959497|NCT04242316|Mirror therapy|mirror therapy
4959498|NCT04242316|Bilateral arm training|bilateral arm training
4959499|NCT04242316|Upper limb function|upper limb function
4959500|NCT04242290|Cervicogenic headache|cervicogenic headache
4959501|NCT04242290|Disability|disability
4959502|NCT04242290|Pain|pain
4959517|NCT04242251|Palliative Care|palliative care
4959518|NCT04242251|Cancer|cancer
4959519|NCT04242251|Health Services Research|health services research
4959520|NCT04242238|Advanced High Grade Sarcoma|advanced high grade sarcoma
4959521|NCT04242238|CSF1R Inhibitor|csf1r inhibitor
4959522|NCT04242238|DCC-3014|dcc-3014
4959523|NCT04242238|Anti-PD-L1 Antibody|anti-pd-l1 antibody
4959524|NCT04242238|Anti-PD-L1|anti-pd-l1
4959525|NCT04242238|Avelumab|avelumab
4959526|NCT04242238|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4959527|NCT04242238|19-340|19-340
4959528|NCT04242238|Leiomyosarcoma|leiomyosarcoma
4959652|NCT04241367|KRAS mutations|kras mutations
4959529|NCT04242238|Undifferentiated Pleomorphic Sarcoma|undifferentiated pleomorphic sarcoma
4959530|NCT04242238|Myxofibrosarcoma|myxofibrosarcoma
5275951|NCT02298166|FLT3 mutations|flt3 mutations
4959531|NCT04242238|Dedifferentiated Liposarcoma|dedifferentiated liposarcoma
4959534|NCT04242199|Advanced Solid Tumor|advanced solid tumor
4959535|NCT04242186|Nursing Homes|nursing homes
4959536|NCT04242186|Elderly|elderly
4959537|NCT04242186|Dementia|dementia
4959538|NCT04242082|GLUT 1|glut 1
4959539|NCT04242082|PEDF|pedf
4959540|NCT04242082|Psoriasis Vulgaris|psoriasis vulgaris
4959544|NCT04242030|meridians|meridians
4959545|NCT04242030|acupuncture|acupuncture
4958037|NCT04251065|relapsed/refractory Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)|relapsed/refractory peripheral t-cell lymphoma not otherwise specified (ptcl-nos)
4959546|NCT04242030|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4959547|NCT04242030|meridian phenomena|meridian phenomena
4959548|NCT04242017|pN0|pn0
4959549|NCT04242017|biochemical recurrence|biochemical recurrence
4959550|NCT04242017|salvage radiation therapy|salvage radiation therapy
4959551|NCT04242017|hormonal treatment|hormonal treatment
4959557|NCT04241991|Photobiomodulation|photobiomodulation
4959558|NCT04241991|Muscle function|muscle function
4959559|NCT04241991|Elderly|elderly
4959560|NCT04241991|Resistance exercise|resistance exercise
4959561|NCT04241991|Balance|balance
4959569|NCT04241952|Rehabilitation|rehabilitation
4959570|NCT04241952|Exercise|exercise
4959571|NCT04241952|Bedcycling|bedcycling
4959572|NCT04241939|Adolescent|adolescent
4959573|NCT04241926|PICC|picc
4959574|NCT04241926|CICC|cicc
4959575|NCT04241926|Cardiac output|cardiac output
4959576|NCT04241926|shock|shock
4959577|NCT04241913|biobehavioral self-regulation|biobehavioral self-regulation
4959578|NCT04241913|psychopathology|psychopathology
4959579|NCT04241913|parenting behavior|parenting behavior
4959580|NCT04241900|heat loss|heat loss
4959581|NCT04241900|aging|aging
4959582|NCT04241900|aerobic fitness level|aerobic fitness level
4959583|NCT04241900|heat stress|heat stress
4959584|NCT04241887|Paravertebral block|paravertebral block
4959585|NCT04241887|Anaesthesia|anaesthesia
4959586|NCT04241887|Analgesia|analgesia
4959587|NCT04241887|regional anaesthesia|regional anaesthesia
4959588|NCT04241887|pain|pain
4959589|NCT04241887|patient satisfaction|patient satisfaction
4959590|NCT04241887|patient comfort|patient comfort
4959591|NCT04241887|operator satisfaction|operator satisfaction
4959592|NCT04241848|Stroke|stroke
4959593|NCT04241848|Exoskeleton Device|exoskeleton device
4959594|NCT04241848|Walking|walking
4959595|NCT04241848|Neurological Rehabilitation|neurological rehabilitation
4959596|NCT04241848|Paresis|paresis
4959597|NCT04241848|Hemiplegia|hemiplegia
4959609|NCT04241757|Signs and symptoms|signs and symptoms
4959610|NCT04241757|Feasibility studies|feasibility studies
4959611|NCT04241705|Targeted mass drug administration|targeted mass drug administration
4959612|NCT04241705|Reactive case detection|reactive case detection
4959613|NCT04241679|Cochlear implant|cochlear implant
4959614|NCT04241679|Vestibular schwannoma|vestibular schwannoma
4959615|NCT04241679|Acoustic Neuroma|acoustic neuroma
4959616|NCT04241679|Sensorineural hearing loss|sensorineural hearing loss
4959617|NCT04241679|Asymmetric sensorineural hearing loss|asymmetric sensorineural hearing loss
4959618|NCT04241679|Single-sided deafness|single-sided deafness
4959619|NCT04241679|Auditory nerve|auditory nerve
4959620|NCT04241614|radiomics|radiomics
4959621|NCT04241614|lung cancer|lung cancer
4959622|NCT04241614|classification|classification
4959624|NCT04241614|raw data|raw data
4959625|NCT04241601|Acute Coronary Syndromes|acute coronary syndromes
4959626|NCT04241575|Fatty liver|fatty liver
4959627|NCT04241575|Non-invasive assessment|non-invasive assessment
4959628|NCT04241575|Case identification|case identification
4959629|NCT04241536|Age-related Macular Degeneration|age-related macular degeneration
4959630|NCT04241536|Metabolomics|metabolomics
4959631|NCT04241510|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4959632|NCT04241510|Mechanical Correction|mechanical correction
4959633|NCT04241510|Facilitation|facilitation
4959634|NCT04241510|Thoracic Taping|thoracic taping
4959635|NCT04241510|Kinesio Taping|kinesio taping
4959636|NCT04241510|Respiratory Muscle Strength|respiratory muscle strength
4959637|NCT04241510|Pulmonary Functions|pulmonary functions
4959638|NCT04241510|Functional Exercise Capacity|functional exercise capacity
4959639|NCT04241471|Emergency Medicine, Abscess, Incision and Drainage, Incision and Loop Drainage, Sterile Glove|emergency medicine, abscess, incision and drainage, incision and loop drainage, sterile glove
4959643|NCT04241406|transcutaneous spinal cor stimulation|transcutaneous spinal cor stimulation
4959644|NCT04241406|neuromodulation|neuromodulation
4959645|NCT04241406|motor activity|motor activity
4959650|NCT04241367|Pancreas Adenocarcinoma|pancreas adenocarcinoma
4959651|NCT04241367|Circulating-tumor DNA|circulating-tumor dna
4959653|NCT04241367|Cancer Panel|cancer panel
4959654|NCT04241367|Prognostic markers|prognostic markers
4959655|NCT04241354|platelet-rich plasma|platelet-rich plasma
4959656|NCT04241354|leukocyte poor platelet rich plasma|leukocyte poor platelet rich plasma
4958153|NCT04250298|blood donors|blood donors
4958154|NCT04250298|donor rejection|donor rejection
4958155|NCT04250298|sucrosomal iron|sucrosomal iron
4958156|NCT04250298|dietary supplements|dietary supplements
4958157|NCT04250259|Child Class A or B|child class a or b
4958159|NCT04250246|NSCLC|nsclc
4959658|NCT04241354|hip osteoarthritis|hip osteoarthritis
4978738|NCT04124978|adjustable|adjustable
4959659|NCT04241354|osteoarthritis|osteoarthritis
4959664|NCT04241341|Lymphatic Reconstruction|lymphatic reconstruction
4959665|NCT04241341|20-021|20-021
4959666|NCT04241315|Intraoperative Imaging|intraoperative imaging
4959667|NCT04241302|Mobile App|mobile app
4959668|NCT04241302|Clinical trial|clinical trial
4959669|NCT04241302|Audiology|audiology
4959670|NCT04241302|Deafness|deafness
4959671|NCT04241289|covert stroke|covert stroke
4959672|NCT04241289|cognitive decline|cognitive decline
4959673|NCT04241289|delirium|delirium
4959674|NCT04241289|clinical stroke|clinical stroke
4959675|NCT04241289|CABG surgery|cabg surgery
4959676|NCT04241289|near infrared spectroscopy|near infrared spectroscopy
4959677|NCT04241289|cerebral oxygenation|cerebral oxygenation
4959678|NCT04241263|Patient monitoring|patient monitoring
4959679|NCT04241263|Medical device|medical device
4959680|NCT04241263|Wireless|wireless
4959681|NCT04241250|Robotic Exoskeleton|robotic exoskeleton
4959682|NCT04241250|Epidural Stimulation|epidural stimulation
4959683|NCT04241250|Transspinal stimulation|transspinal stimulation
4959684|NCT04241250|Spinal cord injury|spinal cord injury
4959685|NCT04241250|Rehabilitation|rehabilitation
4959686|NCT04241237|Breast Cancer|breast cancer
4959687|NCT04241237|Circulating Tumor Cells|circulating tumor cells
4959688|NCT04241237|Circulating Tumor DNA|circulating tumor dna
4959709|NCT04241107|Cesarean Scar defect|cesarean scar defect
4959710|NCT04241094|Posttraumatic Stress Disorder|posttraumatic stress disorder
4959711|NCT04241094|Couples therapy|couples therapy
4959712|NCT04241094|Psychotherapy|psychotherapy
4959713|NCT04241094|Veterans|veterans
4959715|NCT04241016|endoscopic sinus surgery|endoscopic sinus surgery
4959716|NCT04240977|Refractory epilepsy, self-management|refractory epilepsy, self-management
4959717|NCT04240977|Quality of life|quality of life
4959718|NCT04240964|Diabetic Foot Osteomyelitis|diabetic foot osteomyelitis
4959719|NCT04240964|16S rRNA|16s rrna
4959720|NCT04240964|Metagenomes|metagenomes
4959721|NCT04240964|Microbiome|microbiome
4959722|NCT04240951|sweating rate|sweating rate
4959723|NCT04240951|sweat electrolytes|sweat electrolytes
4959724|NCT04240951|sweat patch|sweat patch
4959725|NCT04240951|wearable|wearable
4959726|NCT04240951|epidermal|epidermal
4959727|NCT04240951|sweat electrolyte concentrations|sweat electrolyte concentrations
4959728|NCT04240912|Epidural labor analgesia|epidural labor analgesia
4959729|NCT04240912|Epidural catheter assessment|epidural catheter assessment
4959730|NCT04240899|Yoga, anxiety, Parkinson's Disease, telerehabilitation|yoga, anxiety, parkinson's disease, telerehabilitation
4959732|NCT04240886|APX001A|apx001a
4959733|NCT04240886|fosmanogepix|fosmanogepix
4959734|NCT04240886|manogepix|manogepix
4959735|NCT04240873|osteoarthritis|osteoarthritis
4959736|NCT04240873|mesenchymal stem cell|mesenchymal stem cell
4959737|NCT04240847|skin incision|skin incision
4959738|NCT04240847|numbness|numbness
4959739|NCT04240847|kneeling|kneeling
4959740|NCT04240847|total knee arthroplasty|total knee arthroplasty
4959743|NCT04240834|DAPI|dapi
4959744|NCT04240834|Aspirin|aspirin
4959745|NCT04240834|Ticagrelor|ticagrelor
4959746|NCT04240808|Car T|car t
4959747|NCT04240808|Car T Cells|car t cells
4959748|NCT04240808|Cancer|cancer
4959749|NCT04240808|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
4959750|NCT04240808|B-NHL|b-nhl
4959751|NCT04240795|Food Structure|food structure
4959753|NCT04240795|Satiety|satiety
4959754|NCT04240795|Appetite|appetite
4959755|NCT04240795|Food intake|food intake
4959756|NCT04240795|Salivary biomarkers|salivary biomarkers
4959757|NCT04240795|Mucin|mucin
4959758|NCT04240795|Amylase|amylase
4959759|NCT04240795|Hunger|hunger
4959760|NCT04240795|Fullness|fullness
4959761|NCT04240769|physical activity|physical activity
4959762|NCT04240769|rehabilitation|rehabilitation
4959769|NCT04240730|Early stage endometrial cancer|early stage endometrial cancer
4959770|NCT04240730|extreme obesity|extreme obesity
4959771|NCT04240730|transvaginal NOTES|transvaginal notes
4959772|NCT04240717|Shared Decision Making|shared decision making
4959773|NCT04240717|Patient Empowerment|patient empowerment
4959774|NCT04240717|Immunotherapy|immunotherapy
4959775|NCT04240717|Melanoma|melanoma
4959776|NCT04240717|Patient Decision Aid|patient decision aid
4959778|NCT04240704|NHL|nhl
4959779|NCT04240704|CCR7|ccr7
4959794|NCT04240600|chemotherapy recovery|chemotherapy recovery
4959796|NCT04240587|Contact Lens Discomfort|contact lens discomfort
4959797|NCT04240561|mild cognitive impairment|mild cognitive impairment
4959798|NCT04240548|breast cancer|breast cancer
4959799|NCT04240548|regional nodal irradiation|regional nodal irradiation
4959800|NCT04240548|preoperative chemotherapy|preoperative chemotherapy
4959801|NCT04240522|Eczema|eczema
4959802|NCT04240522|Dermatitis|dermatitis
4959803|NCT04240522|Atopy|atopy
4959804|NCT04240483|low back pain|low back pain
4965511|NCT04205253|edema|edema
4959812|NCT04240470|mechanical thrombectomy|mechanical thrombectomy
4959813|NCT04240392|opioid|opioid
4959814|NCT04240392|pregnant|pregnant
4959815|NCT04240379|Multiple Sclerosis|multiple sclerosis
4959816|NCT04240379|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
4959817|NCT04240379|Metacognition|metacognition
4959818|NCT04240340|coeliac disease|coeliac disease
4959819|NCT04240340|celiac disease|celiac disease
4959820|NCT04240340|adolescent|adolescent
4959821|NCT04240340|wellbeing|wellbeing
4959822|NCT04240340|mental health|mental health
4959823|NCT04240340|disclosure|disclosure
4959824|NCT04240340|stigma|stigma
4959828|NCT04240275|Cerebral Palsy|cerebral palsy
4959829|NCT04240275|Gait Assessment|gait assessment
4959830|NCT04240275|G-Walk|g-walk
4959831|NCT04240275|Reliability|reliability
4959832|NCT04240106|BRCA mutations|brca mutations
4959833|NCT04240106|homologous recombination deficiency|homologous recombination deficiency
4959834|NCT04240106|Luminal like|luminal like
4959835|NCT04240054|Multiple Myeloma|multiple myeloma
4959836|NCT04240054|Renal Insufficiency|renal insufficiency
4959837|NCT04240054|Isatuximab|isatuximab
4959838|NCT04240015|oral health related quality of life|oral health related quality of life
4959839|NCT04240015|periodontal disease|periodontal disease
4959840|NCT04240002|ASP2215|asp2215
5284393|NCT02249793|social sensing|social sensing
4959841|NCT04240002|Acute Myeloid Leukemia|acute myeloid leukemia
4959842|NCT04240002|FLT3|flt3
4959844|NCT04240002|gilteritinib|gilteritinib
4959845|NCT04239924|Community Care|community care
4959846|NCT04239924|Coaching|coaching
4959847|NCT04239924|Paramedic|paramedic
4959848|NCT04239924|Caregivers|caregivers
4959849|NCT04239911|home health aides|home health aides
4959850|NCT04239911|home health care|home health care
4959851|NCT04239911|home care agency|home care agency
4959852|NCT04239794|Postoperative pain|postoperative pain
4959853|NCT04239794|Opioid consumption|opioid consumption
4959854|NCT04239794|Intraoperative anesthesia|intraoperative anesthesia
4959855|NCT04239742|18F-PSMA-1007|18f-psma-1007
4959856|NCT04239742|18F-Fluciclovine|18f-fluciclovine
4959857|NCT04239703|donor derived cell-free DNA|donor derived cell-free dna
4959858|NCT04239703|blood|blood
4959859|NCT04239703|kidney biopsy|kidney biopsy
4959860|NCT04239690|Extremely preterm infant|extremely preterm infant
4959861|NCT04239690|Blood sampling|blood sampling
4959862|NCT04239690|Blood transfusion|blood transfusion
4959863|NCT04239677|retrograde autologous priming|retrograde autologous priming
4959864|NCT04239677|ROTEM|rotem
4959868|NCT04239651|Treatment of Resistant Depression|treatment of resistant depression
4959869|NCT04239651|Patient - Centered Randomized Controlled Pilot Trial|patient - centered randomized controlled pilot trial
4959870|NCT04239612|Psychotic disorders|psychotic disorders
4959871|NCT04239612|Exercise|exercise
4959872|NCT04239612|Cognition|cognition
4959873|NCT04239612|Metabolic markers|metabolic markers
4959874|NCT04239586|Maturity onset diabetes in the young|maturity onset diabetes in the young
4959875|NCT04239586|Childhood diabetes|childhood diabetes
4978933|NCT04123808|Robotics|robotics
4959883|NCT04239547|pulmonary complication|pulmonary complication
4959884|NCT04239547|oxygenisation|oxygenisation
4959885|NCT04239534|Hybrid Procedure|hybrid procedure
4959886|NCT04239521|Alopecia areata|alopecia areata
4959887|NCT04239521|Common mental health conditions|common mental health conditions
4959888|NCT04239521|Depression|depression
4959889|NCT04239521|Anxiety|anxiety
4999585|NCT03997383|TTR|ttr
4959890|NCT04239521|Autoimmune disease|autoimmune disease
4959891|NCT04239521|Atopic conditions|atopic conditions
4959892|NCT04239521|Epidemiology|epidemiology
4959893|NCT04239521|Incidence|incidence
4959894|NCT04239521|Prevalence|prevalence
4959895|NCT04239469|cannabis|cannabis
4959896|NCT04239469|fibromyalgia|fibromyalgia
4959897|NCT04239469|phytocannabinoids|phytocannabinoids
4959898|NCT04239469|cannabinoid|cannabinoid
4959899|NCT04239456|TBI|tbi
4959900|NCT04239456|Face memory|face memory
4959901|NCT04239456|Verbal Memory|verbal memory
4959902|NCT04239456|Learning|learning
4959903|NCT04239456|Cognition|cognition
4959904|NCT04239456|Memory training|memory training
4959905|NCT04239456|Pilot study|pilot study
4959906|NCT04239456|compensatory memory strategies|compensatory memory strategies
4967096|NCT04195308|theta burst|theta burst
4959922|NCT04239352|Pentraxin 3|pentraxin 3
4959923|NCT04239352|Lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
4959924|NCT04239352|preeclampsia|preeclampsia
4959925|NCT04239352|risk markers|risk markers
4959926|NCT04239339|Serotonin|serotonin
4959927|NCT04239339|Cognition|cognition
4959929|NCT04239339|Neural Activation|neural activation
4959930|NCT04239313|Tuberculosis|tuberculosis
4959931|NCT04239313|Vaccine|vaccine
4959933|NCT04239287|Lung function|lung function
4959934|NCT04239287|Exercise|exercise
4959935|NCT04239235|Opioid Medication Assisted Treatment|opioid medication assisted treatment
5369119|NCT01861275|sleep registration|sleep registration
4959936|NCT04239235|Community Reinforcement Approach and Family Training|community reinforcement approach and family training
4959937|NCT04239222|Prosthetic foot, lower limb amputation|prosthetic foot, lower limb amputation
4959938|NCT04239183|stomy|stomy
4959939|NCT04239183|stomatherapy|stomatherapy
4959940|NCT04239183|colestomy|colestomy
4959941|NCT04239144|Ventricular Tachycardia,|ventricular tachycardia,
4959942|NCT04239144|Chagas Disease|chagas disease
4959943|NCT04239144|Catheter Ablation|catheter ablation
4959944|NCT04239144|Left Sympathectomy|left sympathectomy
4959945|NCT04239118|ulcer|ulcer
4959946|NCT04239118|bleeding|bleeding
4959947|NCT04239118|treatment|treatment
4959948|NCT04239118|aseptisorb-A|aseptisorb-a
4959949|NCT04239105|Breast Cancer|breast cancer
4959950|NCT04239105|Circulating Tumor Cells|circulating tumor cells
4959951|NCT04239105|Microfluidic|microfluidic
4959952|NCT04239105|Raman Spectrum|raman spectrum
4959953|NCT04239092|9-ING-41|9-ing-41
4959954|NCT04239092|GSK3beta|gsk3beta
4959955|NCT04239092|Glycogen Synthase Kinase 3 Beta inhibitor|glycogen synthase kinase 3 beta inhibitor
4959956|NCT04239092|ATR/Chk1|atr/chk1
4959957|NCT04239079|Autoimmune features|autoimmune features
4959958|NCT04239079|Parkinson's disease|parkinson's disease
4959959|NCT04239079|Alzheimer's disease|alzheimer's disease
4959960|NCT04239079|Mild Cognitive Impairment|mild cognitive impairment
4959961|NCT04239066|Tourniquet|tourniquet
4959962|NCT04239066|Hypospadias|hypospadias
4959974|NCT04239001|PEG-rhG-CSF|peg-rhg-csf
4959975|NCT04238949|Community Health Worker|community health worker
4959976|NCT04238949|Lay Worker|lay worker
4959977|NCT04238949|Community Intervention|community intervention
4959978|NCT04238936|Gestational Diabetes|gestational diabetes
4959979|NCT04238936|Serum amyloid A|serum amyloid a
4959980|NCT04238936|Interleukin-1 (IL-1) receptor antagonist|interleukin-1 (il-1) receptor antagonist
4959981|NCT04238910|traumatic brain injury|traumatic brain injury
4959982|NCT04238910|fatigue|fatigue
4959983|NCT04238910|self-management|self-management
4959984|NCT04238897|myopia control|myopia control
4959985|NCT04238897|soft contact lens|soft contact lens
4959991|NCT04238845|Malaria|malaria
4959992|NCT04238845|Malnutrition|malnutrition
4959993|NCT04238845|Chemoprevention|chemoprevention
4960010|NCT04238767|HIV-1|hiv-1
4960011|NCT04238767|AIDS|aids
4960012|NCT04238767|dolutegravir|dolutegravir
4960013|NCT04238767|antiretroviral therapy|antiretroviral therapy
4960014|NCT04238767|Lesotho|lesotho
4960015|NCT04238767|sub-Saharan Africa|sub-saharan africa
4960016|NCT04238715|E7090|e7090
4960017|NCT04238715|Cholangiocarcinoma|cholangiocarcinoma
4960018|NCT04238715|Unresectable cholangiocarcinoma|unresectable cholangiocarcinoma
4960019|NCT04238715|Metastatic cholangiocarcinoma|metastatic cholangiocarcinoma
4960020|NCT04238715|Fibroblast Growth Factor Receptor 2 (FGFR2)|fibroblast growth factor receptor 2 (fgfr2)
4960021|NCT04238715|FGFR2 gene fusion|fgfr2 gene fusion
4960022|NCT04238702|RAS inhibition|ras inhibition
4960023|NCT04238702|Sodium Glucose Cotransport 2 inhibitors|sodium glucose cotransport 2 inhibitors
4960030|NCT04238637|Intrahepatic Bile Duct Cancer|intrahepatic bile duct cancer
4960040|NCT04238624|BRAF Mutation-Related Tumors|braf mutation-related tumors
4960042|NCT04238624|19-464|19-464
4960043|NCT04238624|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4960044|NCT04238611|Minimally-invasive|minimally-invasive
4960045|NCT04238611|Microneedle|microneedle
4960046|NCT04238585|Sugar-sweetened beverages|sugar-sweetened beverages
4960047|NCT04238585|Early life nutrition|early life nutrition
4960048|NCT04238585|First 1000 Days|first 1000 days
4960049|NCT04238572|Audiovisual distraction device|audiovisual distraction device
4960050|NCT04238572|Peroperative opioid analgesia|peroperative opioid analgesia
4960051|NCT04238572|Ambulatory care|ambulatory care
4960052|NCT04238572|Outpatient|outpatient
4960053|NCT04238572|Analgesia nociception index|analgesia nociception index
4960054|NCT04238572|Anxiety|anxiety
4960055|NCT04238572|Remifentanil|remifentanil
4960056|NCT04238572|Remifentanil added to local anesthesia|remifentanil added to local anesthesia
5342897|NCT01981577|Parkinson Disease|parkinson disease
5342898|NCT01981577|Subthalamic Nucleus|subthalamic nucleus
5672668|NCT00611286|landmark analysis|landmark analysis
4960069|NCT04238494|myosteatosis (Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and fibrosis following skeletal muscle injury)|myosteatosis (myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and fibrosis following skeletal muscle injury)
4960072|NCT04238481|imaging agent|imaging agent
4960073|NCT04238481|near infrared fluorescence|near infrared fluorescence
4960074|NCT04238455|Serratus Anterior Plane Block|serratus anterior plane block
4960075|NCT04238455|segmentectomy|segmentectomy
4960076|NCT04238455|lobectomy|lobectomy
4960077|NCT04238455|19-470|19-470
4960078|NCT04238429|Toothpastes|toothpastes
4960079|NCT04238429|Controlled Clinical Trial|controlled clinical trial
4960080|NCT04238416|branched chain amino acids|branched chain amino acids
4960081|NCT04238416|hepatic encephalopathy|hepatic encephalopathy
4960082|NCT04238416|lactulose|lactulose
4960083|NCT04238416|acute on chronic liver failure|acute on chronic liver failure
4960084|NCT04238416|bispectral index|bispectral index
5276397|NCT02295124|Nausea|nausea
4960085|NCT04238377|Stellate Ganglion Block , Neuropathic pain syndromes|stellate ganglion block , neuropathic pain syndromes
4960086|NCT04238364|CSF1R Inhibitor|csf1r inhibitor
4960087|NCT04238364|Safety|safety
4960088|NCT04238364|Tolerability|tolerability
4960089|NCT04238364|Pharmacokinetics|pharmacokinetics
4960090|NCT04238364|EI1071|ei1071
4960091|NCT04238338|monocyte / lymphocyte ratio|monocyte / lymphocyte ratio
4960092|NCT04238338|peritoneal dialysis|peritoneal dialysis
4960093|NCT04238338|cardiovascular disease|cardiovascular disease
4960094|NCT04238338|Inflammation|inflammation
4960095|NCT04238338|death|death
4960096|NCT04238286|Fibromyalgia|fibromyalgia
4960097|NCT04238286|Female|female
4960098|NCT04238286|Myofascial trigger points|myofascial trigger points
4960099|NCT04238273|Hemodynamic changes|hemodynamic changes
4960100|NCT04238273|High flow nasal cannula|high flow nasal cannula
4960101|NCT04238273|Nasal continuous positive airway pressure|nasal continuous positive airway pressure
4960102|NCT04238273|Respiratory distress syndrome|respiratory distress syndrome
4960103|NCT04238273|Prematurity|prematurity
4960104|NCT04238260|Stroke|stroke
4960125|NCT04238143|Degenerative|degenerative
4960126|NCT04238143|Joint Disease|joint disease
4960127|NCT04238143|Rheumatoid Arthritis|rheumatoid arthritis
4960128|NCT04238130|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
4960129|NCT04238130|Resectable|resectable
4960130|NCT04238130|Dynamic Monitoring|dynamic monitoring
4960131|NCT04238130|PEAC|peac
4960132|NCT04238117|Laser acupuncture therapy|laser acupuncture therapy
4960133|NCT04238117|Low back pain|low back pain
4960134|NCT04238117|Postpartum|postpartum
4960135|NCT04238117|low-level laser therapy|low-level laser therapy
4960144|NCT04238065|Amblyopia; Virtual Reality|amblyopia; virtual reality
4960145|NCT04238039|Major Depressive Disorder, ketamine, follow up, relapse|major depressive disorder, ketamine, follow up, relapse
4960146|NCT04238000|repetitive Transcranial Magnetic stimulation|repetitive transcranial magnetic stimulation
4960147|NCT04238000|rTMS|rtms
4960148|NCT04238000|wearing sensors|wearing sensors
4960149|NCT04238000|wearables|wearables
4960167|NCT04237896|Clinical practice guidelines|clinical practice guidelines
4960168|NCT04237896|Bronchodilators|bronchodilators
4960169|NCT04237896|Compliance|compliance
4960170|NCT04237883|Behavioral Economics|behavioral economics
4960171|NCT04237883|Primary Health Care|primary health care
4960172|NCT04237883|Health Maintenance|health maintenance
4960173|NCT04237883|Physician Reimbursement|physician reimbursement
4960174|NCT04237857|Sleeve gastrectomy|sleeve gastrectomy
4960175|NCT04237857|Gastroesophageal reflux|gastroesophageal reflux
4960176|NCT04237857|Chinese|chinese
4960177|NCT04237805|ALK-rearranged|alk-rearranged
4960178|NCT04237805|ALK-positive|alk-positive
4960179|NCT04237805|ROS1-rearranged|ros1-rearranged
4960180|NCT04237805|ROS1-positive|ros1-positive
4960185|NCT04237766|Hemophilic arthropathy|hemophilic arthropathy
4960186|NCT04237766|Educative intervention|educative intervention
4960187|NCT04237766|Pain|pain
4960188|NCT04237766|Quality of life|quality of life
4960189|NCT04237766|Anxiety|anxiety
4960190|NCT04237766|Stress|stress
4960191|NCT04237753|women's health|women's health
4960192|NCT04237753|Veterans|veterans
4960193|NCT04237753|telemedicine|telemedicine
4960194|NCT04237753|urinary incontinence|urinary incontinence
4960195|NCT04237753|overactive urinary bladder|overactive urinary bladder
4960196|NCT04237753|urinary bladder diseases|urinary bladder diseases
4960197|NCT04237753|stress urinary incontinence|stress urinary incontinence
4960198|NCT04237753|urge urinary incontinence|urge urinary incontinence
4960199|NCT04237753|health education|health education
4960200|NCT04237740|recurrent hepatocellular carcinoma|recurrent hepatocellular carcinoma
4960201|NCT04237740|liver transplantation|liver transplantation
4960202|NCT04237740|relenvatinib|relenvatinib
4960206|NCT04237714|Internet intervention|internet intervention
4960207|NCT04237714|Internet based Cognitive Therapy|internet based cognitive therapy
4960208|NCT04237714|Cultural adapted treatment|cultural adapted treatment
4960209|NCT04237688|electrocardiogram|electrocardiogram
4960210|NCT04237649|Solid Tumors|solid tumors
4960211|NCT04237649|KAZ954|kaz954
4960212|NCT04237649|PDR001|pdr001
4960213|NCT04237649|Spartalizumab|spartalizumab
4960214|NCT04237649|NIR178|nir178
4960215|NCT04237649|NZV930|nzv930
4960216|NCT04237649|Immunotherapy|immunotherapy
4960217|NCT04237649|Phase I/Ib|phase i/ib
4960218|NCT04237610|reinforcement learning|reinforcement learning
4960222|NCT04237571|fruits|fruits
4960223|NCT04237571|vegetables|vegetables
4960228|NCT04237558|Laparoscopic hysterectomy|laparoscopic hysterectomy
4960229|NCT04237519|Multimodal intervention|multimodal intervention
4960230|NCT04237519|Cognitive training|cognitive training
4960231|NCT04237519|Physical training|physical training
4960232|NCT04237519|Social interactions|social interactions
4960233|NCT04237519|Prevention|prevention
4960234|NCT04237519|Frailty|frailty
4960235|NCT04237493|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4960236|NCT04237493|Fasting|fasting
4960237|NCT04237493|Hypoglycemic Agents|hypoglycemic agents
4960238|NCT04237493|Hypoglycemia|hypoglycemia
4960239|NCT04237493|Hyperglycemia|hyperglycemia
4960240|NCT04237493|Diabetic Ketoacidosis|diabetic ketoacidosis
4960241|NCT04237493|Hyperglycemic Hyperosmolar Nonketotic Coma|hyperglycemic hyperosmolar nonketotic coma
4960242|NCT04237493|Metformin|metformin
4960243|NCT04237493|Glimepiride|glimepiride
4960244|NCT04237493|Vildagliptin|vildagliptin
4960245|NCT04237493|Insulin Glargine|insulin glargine
4960246|NCT04237493|Insulin, Regular, Human|insulin, regular, human
4960247|NCT04237480|vitamin D|vitamin d
4960248|NCT04237480|1-alpha hydroxylase|1-alpha hydroxylase
4960249|NCT04237480|magnesium|magnesium
4960250|NCT04237480|renal insufficiency|renal insufficiency
4960251|NCT04237389|persistent atrial fibrillation|persistent atrial fibrillation
4960252|NCT04237389|catheter ablation|catheter ablation
4960255|NCT04237389|Box-lesion|box-lesion
4960256|NCT04237389|ablation index|ablation index
4960257|NCT04237389|high-density mapping|high-density mapping
4960258|NCT04237389|hybrid procedure|hybrid procedure
4960259|NCT04237363|Spinal Cord Injury|spinal cord injury
4960260|NCT04237363|Exercise|exercise
4960261|NCT04237363|Walking|walking
4960262|NCT04237363|Aquatics|aquatics
4960263|NCT04237337|pharmacovigilance|pharmacovigilance
4960264|NCT04237311|Semen|semen
4960265|NCT04237311|Micronutrient|micronutrient
4960266|NCT04237311|Inflammation|inflammation
4960272|NCT04237285|aromatherapy|aromatherapy
4960275|NCT04237181|Infectious Diarrhea|infectious diarrhea
4960276|NCT04237181|Colitis|colitis
5284681|NCT02248246|Hemostasis|hemostasis
4960277|NCT04237181|PCR multiplex|pcr multiplex
4960279|NCT04237168|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
4960280|NCT04237168|immunoglobulin gene next generation sequencing|immunoglobulin gene next generation sequencing
4960281|NCT04237168|liquid biopsy|liquid biopsy
5939473|NCT01212783|depression|depression
4960283|NCT04237142|Preterm premature rupture of membranes|preterm premature rupture of membranes
4960284|NCT04237142|Biomarkers|biomarkers
4960285|NCT04237142|Latency period|latency period
4960286|NCT04237142|Predictive Value of Tests|predictive value of tests
4960287|NCT04237129|Diabetes|diabetes
4960288|NCT04237129|Insulin|insulin
4960289|NCT04237129|Diabetes Mellitus|diabetes mellitus
4960290|NCT04237129|Basal|basal
4960291|NCT04237129|Bolus|bolus
4960292|NCT04237116|plaque psoriasis|plaque psoriasis
4960293|NCT04237116|NAFLD|nafld
4960294|NCT04237116|NASH|nash
4960295|NCT04237116|PASI|pasi
4960296|NCT04237116|secukinumab|secukinumab
4960297|NCT04237116|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4960298|NCT04237103|vitiligo|vitiligo
4960299|NCT04237103|pigmentation|pigmentation
4960300|NCT04237103|phototherapy|phototherapy
4960301|NCT04237103|methotrexate|methotrexate
4960302|NCT04237051|knowledge|knowledge
4960303|NCT04237051|attitude|attitude
4960304|NCT04237051|practice|practice
4960305|NCT04237051|KAP|kap
4960306|NCT04237051|ergonomics|ergonomics
4960307|NCT04237051|dental ergonomics|dental ergonomics
4960308|NCT04237038|Laparoscopic fundoplication|laparoscopic fundoplication
4960309|NCT04237038|Short gastric vessel|short gastric vessel
4960310|NCT04237025|exercise therapy|exercise therapy
4960311|NCT04237025|mobility limitation|mobility limitation
4960312|NCT04237025|walk test|walk test
4960313|NCT04237025|biomarkers|biomarkers
4960314|NCT04236999|Adolescents|adolescents
4960315|NCT04236999|Unplugged|unplugged
4960316|NCT04236999|Prevention|prevention
4960317|NCT04236999|Schools|schools
4960318|NCT04236986|Neuroimmune System|neuroimmune system
4960319|NCT04236986|Lipopolysaccharide|lipopolysaccharide
4960320|NCT04236960|Meningitis, Meningococcal, Serogroup A|meningitis, meningococcal, serogroup a
4960321|NCT04236960|Meningitis, Meningococcal, Serogroup C|meningitis, meningococcal, serogroup c
4960322|NCT04236960|Meningitis, Meningococcal, Serogroup Y|meningitis, meningococcal, serogroup y
4960323|NCT04236960|Meningitis, Meningococcal, Serogroup W135|meningitis, meningococcal, serogroup w135
4960324|NCT04236947|Adolescents|adolescents
4960325|NCT04236947|Prevention|prevention
4960326|NCT04236947|School|school
4960331|NCT04236895|Diabetes Type 1|diabetes type 1
4960332|NCT04236895|Type 1|type 1
4960333|NCT04236895|Basal|basal
4960334|NCT04236895|Insulin|insulin
4960335|NCT04236895|Glargine|glargine
4960336|NCT04236895|T1DM|t1dm
4960337|NCT04236895|Diabetes Mellitus|diabetes mellitus
4960338|NCT04236895|Insulin Dependent Diabetes|insulin dependent diabetes
4960339|NCT04236843|Fecal microbiota transplantation|fecal microbiota transplantation
4960340|NCT04236843|Intestinal microbiota|intestinal microbiota
4960341|NCT04236843|Donor|donor
4960342|NCT04236843|Dysbiosis|dysbiosis
4960343|NCT04236843|Abdominal symptom|abdominal symptom
4960344|NCT04236843|Fatigue|fatigue
4960345|NCT04236843|Quality of life|quality of life
4960346|NCT04236830|Silver diamine fluoride/ potassium iodide|silver diamine fluoride/ potassium iodide
4960347|NCT04236830|glass ionomer cement|glass ionomer cement
4960348|NCT04236817|Medication Adherence|medication adherence
4960349|NCT04236817|Medication compliance|medication compliance
4960350|NCT04236817|Pill-packaging|pill-packaging
5369120|NCT01861262|emergency|emergency
5289054|NCT02228317|Telemedicine|telemedicine
4960351|NCT04236804|Virtual Autonomic Neuromodulation Induced Systemic Healing|virtual autonomic neuromodulation induced systemic healing
4960353|NCT04236765|Tuberculosis|tuberculosis
4960354|NCT04236765|Latent Tuberculosis|latent tuberculosis
4960355|NCT04236765|Children|children
4960356|NCT04236765|Immigrant|immigrant
4960357|NCT04236765|Incidence|incidence
4960358|NCT04236765|Travel-Related Infection|travel-related infection
4960359|NCT04236765|Tuberculin Test|tuberculin test
4960360|NCT04236765|Interferon-gamma Release Assay|interferon-gamma release assay
4960361|NCT04236739|Cartilage|cartilage
4960362|NCT04236739|Cartilage damage|cartilage damage
4960363|NCT04236739|Cell therapy|cell therapy
4960364|NCT04236739|MSC|msc
4960365|NCT04236739|ATMP|atmp
4960366|NCT04236739|Knee|knee
4960367|NCT04236739|IMPACT|impact
4960368|NCT04236739|ACI|aci
4960369|NCT04236739|Chondrons|chondrons
4960381|NCT04236674|Paracentesis|paracentesis
4960382|NCT04236661|chilipad|chilipad
4960383|NCT04236661|Sleep disorders|sleep disorders
4960384|NCT04236622|dental implants|dental implants
4960385|NCT04236622|periodontal index|periodontal index
4960386|NCT04236622|peri-implantitis|peri-implantitis
4960387|NCT04236596|pudendal nerve mapping|pudendal nerve mapping
4960391|NCT04236570|Excitatory mechanisms|excitatory mechanisms
4960392|NCT04236570|Inhibitory mechanisms|inhibitory mechanisms
4960393|NCT04236570|Thermode(hot plate)|thermode(hot plate)
4960394|NCT04236570|Cold water bath|cold water bath
5284779|NCT02247726|RSV|rsv
4960395|NCT04236570|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4960396|NCT04236557|Music|music
4960397|NCT04236557|Agitation|agitation
4960398|NCT04236557|Dementia|dementia
4960399|NCT04236557|De-escalation|de-escalation
4960400|NCT04236544|multiple sclerosis|multiple sclerosis
4960401|NCT04236544|decision making|decision making
4960402|NCT04236544|decision support|decision support
5672866|NCT00610311|Tumor Regression|tumor regression
4960403|NCT04236544|web-based experiential information|web-based experiential information
4960404|NCT04236544|patient experiences|patient experiences
4960405|NCT04236544|narrative information|narrative information
4960406|NCT04236531|source-monitoring|source-monitoring
4960408|NCT04236531|MRI|mri
4960409|NCT04236531|neuroimaging|neuroimaging
4960410|NCT04236518|Metabolomics|metabolomics
4960411|NCT04236518|Plant Proteins, Dietary|plant proteins, dietary
4960412|NCT04236518|Meat Proteins|meat proteins
4960413|NCT04236518|Dietary Proteins|dietary proteins
4960414|NCT04236518|Metabolic Syndrome|metabolic syndrome
4960415|NCT04236518|Hypertriglyceridemia|hypertriglyceridemia
4960416|NCT04236518|Waist Circumference|waist circumference
4960417|NCT04236505|Mindfulness|mindfulness
4960418|NCT04236505|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
4960419|NCT04236505|Student mental health|student mental health
4960420|NCT04236492|fresh osteochondral allografts|fresh osteochondral allografts
4960421|NCT04236492|integration|integration
4960422|NCT04236492|osteochondral defect|osteochondral defect
4960423|NCT04236492|knee|knee
4960424|NCT04236492|chondral lesion|chondral lesion
4960425|NCT04236466|maxillary expansion|maxillary expansion
4960426|NCT04236414|Cancer|cancer
4960432|NCT04236401|abdominal incision|abdominal incision
4960433|NCT04236388|D-β-hydroxybutyrate|d-β-hydroxybutyrate
4960434|NCT04236388|low carbohydrate high fat diet|low carbohydrate high fat diet
4960436|NCT04236388|cognitive function|cognitive function
4960437|NCT04236388|flow mediated dilation|flow mediated dilation
4960438|NCT04236349|Tuberculosis, cohort, lost of follow up|tuberculosis, cohort, lost of follow up
4960439|NCT04236323|hyperalgesia|hyperalgesia
4960440|NCT04236323|brachial plexus block|brachial plexus block
4960441|NCT04236323|remifentanil|remifentanil
4960442|NCT04236297|bite block, transesophageal echocardiography|bite block, transesophageal echocardiography
4960443|NCT04236271|connected objects|connected objects
4960445|NCT04236245|superficial vein reflux|superficial vein reflux
4960446|NCT04236245|venous reflux|venous reflux
4960447|NCT04236245|venous insufficiency|venous insufficiency
4960448|NCT04236245|varicose veins|varicose veins
4960449|NCT04236219|hyperuricemia|hyperuricemia
4960450|NCT04236219|gout|gout
4960451|NCT04236219|urate oxidase|urate oxidase
4960452|NCT04236219|uric acid|uric acid
4960453|NCT04236206|Diabetes|diabetes
4960454|NCT04236206|Medication adherence|medication adherence
4960455|NCT04236206|Telemedicine|telemedicine
4960456|NCT04236206|mhealth|mhealth
4960457|NCT04236206|SMS|sms
4960468|NCT04236089|robotic mirror therapy|robotic mirror therapy
4960469|NCT04236089|Electroencephalography|electroencephalography
4960470|NCT04236063|Cross sectional study|cross sectional study
4960472|NCT04236050|Qor-40|qor-40
4960473|NCT04236050|lumbar discectomy|lumbar discectomy
4960474|NCT04236050|muscle strength|muscle strength
4960475|NCT04236024|Nursing students|nursing students
4960476|NCT04236024|Board game|board game
4960477|NCT04236024|Medication knowledge|medication knowledge
4960478|NCT04236011|Fast|fast
4960479|NCT04236011|Chimeric Antigen Receptor T|chimeric antigen receptor t
4960480|NCT04236011|BCMA|bcma
4960485|NCT04235946|cancer related fatigue|cancer related fatigue
4960486|NCT04235946|adapted physical activity|adapted physical activity
4960487|NCT04235920|Stroke; ASPEACTS, Modified Rankin Scale, National Institutes of Health Stroke Scale. Higher cortical functions, Biomarkers of cognitive impairment.|stroke; aspeacts, modified rankin scale, national institutes of health stroke scale. higher cortical functions, biomarkers of cognitive impairment.
4960488|NCT04235907|Rehabilitation|rehabilitation
4960489|NCT04235907|Telerehabilitation|telerehabilitation
4960490|NCT04235894|Propofol;|propofol;
4960491|NCT04235894|Endoscopy, Gastrointestinal;|endoscopy, gastrointestinal;
4960492|NCT04235894|Dreams;|dreams;
4960493|NCT04235894|Facial expression;|facial expression;
4960494|NCT04235894|Smiling|smiling
4960495|NCT04235881|Implantable automatic defibrillator|implantable automatic defibrillator
4960496|NCT04235881|Emotional regulation|emotional regulation
4960497|NCT04235881|MBSR|mbsr
4960498|NCT04235881|App|app
4960499|NCT04235881|Quality of life|quality of life
4960500|NCT04235881|Mindfulness|mindfulness
4960501|NCT04235881|Anxiety|anxiety
4960502|NCT04235881|Depression|depression
4960503|NCT04235829|sleeve gastrectomy|sleeve gastrectomy
4960504|NCT04235829|morbid obesity|morbid obesity
4960505|NCT04235829|predicting outcomes|predicting outcomes
4960506|NCT04235829|early weight loss|early weight loss
4960507|NCT04235829|hypertension|hypertension
4960508|NCT04235829|diabetes mellitus|diabetes mellitus
4960509|NCT04235816|Infant|infant
4960511|NCT04235816|Azithromycin|azithromycin
4960512|NCT04235816|Intermittent preventive treatment for infants|intermittent preventive treatment for infants
4960513|NCT04235816|Expanded Program on Immunization|expanded program on immunization
4960514|NCT04235803|Oculoplastic|oculoplastic
4960515|NCT04235803|Eye plastic|eye plastic
4960516|NCT04235803|Eyelid surgery|eyelid surgery
4960517|NCT04235803|Telemedicine|telemedicine
4960518|NCT04235803|Remote follow-up|remote follow-up
4960519|NCT04235803|Remote visit|remote visit
4960520|NCT04235803|Blepharoplasty|blepharoplasty
4960521|NCT04235803|Ptosis repair|ptosis repair
4960522|NCT04235803|External levator resection|external levator resection
4960523|NCT04235803|Internal levator resection|internal levator resection
4960524|NCT04235803|Ectropion repair|ectropion repair
4960525|NCT04235803|Entropion repair|entropion repair
4960534|NCT04235673|Preterm neonate|preterm neonate
4960535|NCT04235673|Neuroprotection|neuroprotection
4960536|NCT04235673|Malondialdehyde|malondialdehyde
4960537|NCT04235673|Melatonin|melatonin
4960538|NCT04235647|sedentary|sedentary
4960539|NCT04235647|older adults|older adults
4960540|NCT04235647|risk factor|risk factor
4960541|NCT04235647|intervention|intervention
4960542|NCT04235647|pedometer|pedometer
4960543|NCT04235647|clinical trial|clinical trial
4960544|NCT04235634|Non-occlusive mesenteric ischemia|non-occlusive mesenteric ischemia
4960545|NCT04235634|Shock|shock
4960546|NCT04235634|Intra-arterial prostglandin therapy|intra-arterial prostglandin therapy
4960547|NCT04235608|ARDS|ards
4960548|NCT04235608|Sedation|sedation
4960549|NCT04235608|Inhaled sevoflurane|inhaled sevoflurane
4960550|NCT04235595|Primary dysmenorrhea|primary dysmenorrhea
4960551|NCT04235595|Connective tissue manipulation (CTM)|connective tissue manipulation (ctm)
4960552|NCT04235595|Transcutaneous electrical nerve stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4960553|NCT04235595|Pain|pain
4960554|NCT04235582|opioid-use disorder|opioid-use disorder
4960555|NCT04235582|substance-use disorder|substance-use disorder
4960560|NCT04235569|anticoagulation|anticoagulation
4960561|NCT04235569|mitral valve replacement|mitral valve replacement
4960562|NCT04235556|care pathway|care pathway
4960563|NCT04235556|satisfaction|satisfaction
4960565|NCT04235556|treatment delay|treatment delay
4960566|NCT04235543|Autism|autism
4960567|NCT04235543|traumatized teeth in autistic children|traumatized teeth in autistic children
4960568|NCT04235543|prevalence of dental trauma|prevalence of dental trauma
4960569|NCT04235530|thoracoscopic surgery video assisted|thoracoscopic surgery video assisted
4960570|NCT04235530|serratus anterior|serratus anterior
4960571|NCT04235530|paravertebral block|paravertebral block
4960572|NCT04235504|Advanced Hybrid Closed Loop|advanced hybrid closed loop
4960573|NCT04235504|Multiple Daily Injections|multiple daily injections
4960574|NCT04235504|Flash Glucose Monitoring|flash glucose monitoring
4960575|NCT04235504|Continuous Glucose Monitoring|continuous glucose monitoring
4960580|NCT04235465|Dynamic Gait Index|dynamic gait index
4960581|NCT04235465|Validity and Reliability|validity and reliability
4960582|NCT04235465|Balance|balance
4960583|NCT04235465|Gait|gait
4960584|NCT04235452|Myoclonus, Evoked potential|myoclonus, evoked potential
4960585|NCT04235439|Diabetes|diabetes
4960586|NCT04235439|Insulin|insulin
4960587|NCT04235439|Lispro|lispro
4960588|NCT04235439|Diabetes Mellitus|diabetes mellitus
4960589|NCT04235439|Basal|basal
4960590|NCT04235439|Bolus|bolus
4960603|NCT04235348|Mucosal barrier|mucosal barrier
4960604|NCT04235348|Red meat|red meat
4960605|NCT04235348|Whole grain|whole grain
4960606|NCT04235348|Dietary fibers|dietary fibers
4960607|NCT04235348|Inflammation|inflammation
4960609|NCT04235335|domestic violence|domestic violence
4960610|NCT04235335|exposure to violence|exposure to violence
4960611|NCT04235283|Total knee arthroplasty|total knee arthroplasty
4960612|NCT04235283|pinless|pinless
4960613|NCT04235283|navigation|navigation
4960614|NCT04235283|alignment|alignment
4960615|NCT04235283|minimal invasive|minimal invasive
4960616|NCT04235244|subcutaneous ınjectıon|subcutaneous ınjectıon
4960617|NCT04235244|cold application|cold application
4960618|NCT04235244|pain|pain
4960619|NCT04235244|ecchymosis|ecchymosis
4960620|NCT04235244|heparin injection|heparin injection
4960621|NCT04235231|Lung Inhomogeneity|lung inhomogeneity
4960622|NCT04235231|Lung Collapse|lung collapse
4960623|NCT04235231|Atelectasis|atelectasis
4960624|NCT04235231|Mechanical Ventilation|mechanical ventilation
4960625|NCT04235231|EIT|eit
4960626|NCT04235231|Bed tilting|bed tilting
4960627|NCT04235231|Positioning|positioning
4960628|NCT04235231|Neurocritical Care|neurocritical care
4960629|NCT04235231|Unconsciousness|unconsciousness
4960630|NCT04235231|Acute Brain Disease|acute brain disease
4960631|NCT04235231|Preventive Strategy|preventive strategy
4960632|NCT04235218|non-malignant pain|non-malignant pain
4960633|NCT04235205|Elobixibat|elobixibat
4960634|NCT04235205|Cholestyramine|cholestyramine
4960635|NCT04235205|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4960636|NCT04235205|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4960637|NCT04235205|phase 2 trial|phase 2 trial
4960638|NCT04235205|Combination therapy|combination therapy
4960639|NCT04235192|risk factor|risk factor
4960640|NCT04235127|nested case-control study|nested case-control study
4960641|NCT04235127|electronic healthcare records|electronic healthcare records
4960642|NCT04235127|register-based study|register-based study
4960643|NCT04235127|incidence|incidence
4960644|NCT04235127|risk factors|risk factors
4960645|NCT04235127|risk prediction|risk prediction
4960646|NCT04235127|machine learning techniques|machine learning techniques
4960665|NCT04235088|somatosensory processing|somatosensory processing
4960666|NCT04235088|motor performance|motor performance
4960667|NCT04235088|participation|participation
4960668|NCT04235088|quality of live|quality of live
4960669|NCT04235088|occupational performance|occupational performance
4960670|NCT04235075|Signal Database|signal database
4960671|NCT04235075|Pregnancy|pregnancy
4960672|NCT04235075|Electrocardiogram|electrocardiogram
4960673|NCT04235075|Usability|usability
4960674|NCT04235075|Multimodal signal acquisition|multimodal signal acquisition
4960675|NCT04235049|HCV infection|hcv infection
4960676|NCT04235049|Incarcerated individuals|incarcerated individuals
4960677|NCT04235036|ibrutinib|ibrutinib
4960678|NCT04235036|rituximab|rituximab
4960679|NCT04235036|cGVHD|cgvhd
4960680|NCT04235036|chronic GVHD|chronic gvhd
4960681|NCT04235023|PTP1B|ptp1b
4960682|NCT04235023|macrophage|macrophage
4960683|NCT04235010|Genius toothbrush|genius toothbrush
4960684|NCT04235010|Orthodontic treatment|orthodontic treatment
4960685|NCT04235010|Periodontal health|periodontal health
4960686|NCT04234984|Conventional radiofrequency|conventional radiofrequency
4960687|NCT04234971|alveolar bone graft|alveolar bone graft
4960688|NCT04234971|Bone Morphogenic Protein|bone morphogenic protein
4960689|NCT04234971|Demineralized Bone Matrix|demineralized bone matrix
4960690|NCT04234971|cleft lip|cleft lip
4960691|NCT04234958|heart rate variability|heart rate variability
4960692|NCT04234958|autonomous nervous system|autonomous nervous system
4960693|NCT04234958|osteopathy|osteopathy
4960694|NCT04234958|osteopathy manipulative treatment|osteopathy manipulative treatment
4960695|NCT04234958|visceral|visceral
4960696|NCT04234958|pericardium|pericardium
4960705|NCT04234893|De novo|de novo
4960706|NCT04234893|Bifurcation|bifurcation
4960707|NCT04234893|Coronary Artery Disease|coronary artery disease
4960708|NCT04234854|Stenting|stenting
4960709|NCT04234841|TAVI|tavi
4960710|NCT04234841|SAVR|savr
4960711|NCT04234828|Sleep Apnea|sleep apnea
4960712|NCT04234828|Sleep Apnea Syndromes|sleep apnea syndromes
4960713|NCT04234828|Respiration Disorders|respiration disorders
4960714|NCT04234828|Respiratory Tract Diseases|respiratory tract diseases
4960715|NCT04234828|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
4960716|NCT04234828|Signs and Symptoms|signs and symptoms
4960717|NCT04234828|Sleep Apnea, Obstructive|sleep apnea, obstructive
4960718|NCT04234828|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
4960719|NCT04234828|Dyssomnias|dyssomnias
4960720|NCT04234828|Sleep Wake Disorders|sleep wake disorders
4960721|NCT04234828|Nervous System Diseases|nervous system diseases
4960722|NCT04234828|Apnea|apnea
4960723|NCT04234815|Mental health|mental health
4960724|NCT04234815|Psychosocial support|psychosocial support
4960725|NCT04234815|Intervention|intervention
4960726|NCT04234815|Depression|depression
4960727|NCT04234815|Post-traumatic stress|post-traumatic stress
4960728|NCT04234815|Functioning|functioning
4960729|NCT04234789|dynamic hyperinflation|dynamic hyperinflation
4960730|NCT04234789|oscillometry|oscillometry
4960732|NCT04234776|Ketamine|ketamine
4960733|NCT04234776|Treatment Resistant Depression|treatment resistant depression
4960734|NCT04234763|Glycemic Index|glycemic index
4960735|NCT04234763|NMR metabolomics|nmr metabolomics
4960736|NCT04234763|Postmeal glucose|postmeal glucose
4960737|NCT04234737|dental anxiety|dental anxiety
4960738|NCT04234737|hypnotherapy|hypnotherapy
4960739|NCT04234737|pediatric dentistry|pediatric dentistry
4960740|NCT04234724|Angiopoietin-like protein 3 deficiency|angiopoietin-like protein 3 deficiency
4960741|NCT04234724|Lipid Metabolism|lipid metabolism
4960743|NCT04234711|Surgical strategy|surgical strategy
4960744|NCT04234711|PVO|pvo
4960745|NCT04234711|outcomes|outcomes
4960746|NCT04234698|oral anticoagulants|oral anticoagulants
4960747|NCT04234698|apixaban|apixaban
4960748|NCT04234698|rivaroxaban|rivaroxaban
4960749|NCT04234698|dabigatran|dabigatran
4960750|NCT04234698|warfarin|warfarin
4960751|NCT04234698|non valvular atrial fibrillation|non valvular atrial fibrillation
4960753|NCT04234581|lysine|lysine
4960754|NCT04234581|vitamin C|vitamin c
4960755|NCT04234581|zinc|zinc
4960756|NCT04234581|hemoglobin A1c|hemoglobin a1c
4960954|NCT04233671|cortisol|cortisol
4960769|NCT04234542|transcranial magnetic stimulation|transcranial magnetic stimulation
4960770|NCT04234542|electromyography|electromyography
4960771|NCT04234529|AMATEA|amatea
4960772|NCT04234529|video games|video games
4960773|NCT04234529|gaming|gaming
4960774|NCT04234529|energy supplement|energy supplement
4960775|NCT04234503|nurse managers|nurse managers
4960776|NCT04234503|ethical activity profile|ethical activity profile
4960777|NCT04234490|Intestinal failure|intestinal failure
4960778|NCT04234490|Quality of life|quality of life
4960779|NCT04234490|Carer burden|carer burden
4960789|NCT04234438|Retinitis pigmentosa|retinitis pigmentosa
4960790|NCT04234438|Cystoid macular edema|cystoid macular edema
4960791|NCT04234438|Intraretinal cysts|intraretinal cysts
4960792|NCT04234438|Subliminal micropulse laser|subliminal micropulse laser
4960793|NCT04234412|osteoarthritis|osteoarthritis
4960794|NCT04234412|knee|knee
4960795|NCT04234412|high tibial osteotomy|high tibial osteotomy
4960796|NCT04234412|umbilical cord blood stem cell|umbilical cord blood stem cell
4960797|NCT04234412|cartilage regeneration|cartilage regeneration
4960798|NCT04234399|Recurrence|recurrence
4960799|NCT04234399|Fluciclovine|fluciclovine
4960800|NCT04234399|Axumin|axumin
4960802|NCT04234334|eggs|eggs
4960803|NCT04234334|lutein|lutein
4960804|NCT04234334|zeaxanthin|zeaxanthin
4960805|NCT04234334|choline|choline
4960806|NCT04234334|metabolic syndrome|metabolic syndrome
4960807|NCT04234334|plant-based diet|plant-based diet
4960808|NCT04234321|basic fibroblast growth factor,Kangfuxin,Wound Healing|basic fibroblast growth factor,kangfuxin,wound healing
4960809|NCT04234308|dental suture|dental suture
4960810|NCT04234308|suture infection|suture infection
4960811|NCT04234308|Mechanical properties|mechanical properties
4960832|NCT04234191|Withdrawal Management|withdrawal management
4960833|NCT04234152|Photo-protection of Multivitamins|photo-protection of multivitamins
4960834|NCT04234152|Oxidative Stress|oxidative stress
4960835|NCT04234152|Ascorbyl peroxide|ascorbyl peroxide
4960836|NCT04234152|Urine peroxides|urine peroxides
4960837|NCT04234139|liver transplant|liver transplant
4960838|NCT04234139|alcoholic liver disease|alcoholic liver disease
4960839|NCT04234126|ERCP|ercp
4960840|NCT04234126|Acute purulent cholecystitis|acute purulent cholecystitis
4960841|NCT04234126|Bile duct stone|bile duct stone
4960842|NCT04234126|PEC(post-ERCP-choledocholithiasis)|pec(post-ercp-choledocholithiasis)
4960843|NCT04234113|thyroid cancer|thyroid cancer
4960844|NCT04234113|Renal Cell Carcinoma|renal cell carcinoma
4960845|NCT04234113|Non Small Cell Lung Cancer|non small cell lung cancer
4960846|NCT04234113|Small-cell Lung Cancer|small-cell lung cancer
4960847|NCT04234113|Bladder Cancer|bladder cancer
4960848|NCT04234113|Melanoma|melanoma
4960849|NCT04234113|Merkel Cell Carcinoma|merkel cell carcinoma
4960850|NCT04234113|Skin Squamous Cell Carcinoma|skin squamous cell carcinoma
4960851|NCT04234113|Microsatellite Instability High|microsatellite instability high
4960852|NCT04234113|Triple Negative Breast Cancer|triple negative breast cancer
4960853|NCT04234113|Mesothelioma|mesothelioma
4961057|NCT04233034|c-peptide|c-peptide
4960856|NCT04234113|Biliary Tract Cancer|biliary tract cancer
4960857|NCT04234113|Hepatocellular Carcinoma|hepatocellular carcinoma
4960858|NCT04234113|Ovarian Cancer|ovarian cancer
4960859|NCT04234113|Gastric Cancer|gastric cancer
4960860|NCT04234113|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4960861|NCT04234113|Anal Cancer|anal cancer
4960862|NCT04234100|Hypertension|hypertension
4960863|NCT04234100|Flavonoids|flavonoids
4960864|NCT04234100|Orange juice|orange juice
4960865|NCT04234100|Metabotypes|metabotypes
4960866|NCT04234087|Cardiac rehabilitation|cardiac rehabilitation
4960867|NCT04234087|Exercise training|exercise training
4960868|NCT04234087|Resistance training|resistance training
4960869|NCT04234087|Balance training|balance training
4960870|NCT04234087|Physical capacity|physical capacity
4960871|NCT04234087|Valve surgery|valve surgery
4960872|NCT04234087|Valve intervention|valve intervention
4960873|NCT04234087|Functional capacity|functional capacity
4960874|NCT04234061|ibrutinib|ibrutinib
4960875|NCT04234061|Tisagenlecleucel|tisagenlecleucel
4960876|NCT04234061|Chimeric Antigen Receptor - Tcell (CAR-T)|chimeric antigen receptor - tcell (car-t)
4960877|NCT04234061|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
4960878|NCT04234061|TP53 mutation|tp53 mutation
4960879|NCT04234061|bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
4960880|NCT04234048|Lymphoma|lymphoma
4960882|NCT04234048|Sézary syndrome|sézary syndrome
4960883|NCT04234048|mycosis fungoides|mycosis fungoides
4960884|NCT04234048|PTCL|ptcl
4960885|NCT04234048|AITL|aitl
4960886|NCT04234048|cALCL|calcl
4960887|NCT04233996|Febrile neutropenia|febrile neutropenia
4960888|NCT04233996|Beta-lactam antibiotics|beta-lactam antibiotics
4960889|NCT04233996|Cefepime|cefepime
4960890|NCT04233996|Meropenem|meropenem
4960891|NCT04233996|Piperacillin-tazobactam|piperacillin-tazobactam
4960892|NCT04233996|Extended infusion|extended infusion
4960893|NCT04233983|Endometriosis|endometriosis
4960894|NCT04233983|Laparoscopy|laparoscopy
4960895|NCT04233983|Infertility|infertility
4960896|NCT04233983|Ovarian Reserve|ovarian reserve
4960897|NCT04233983|Endometrioma|endometrioma
4966563|NCT04198636|LY01011|ly01011
4960914|NCT04233944|Wasting|wasting
4960915|NCT04233944|Uganda|uganda
4960916|NCT04233944|Anemia|anemia
4960917|NCT04233918|HoFH|hofh
4960918|NCT04233892|thin endometrium|thin endometrium
4960919|NCT04233892|infertility|infertility
4960920|NCT04233853|Primary mental care|primary mental care
4960921|NCT04233853|Collaborative care|collaborative care
4960922|NCT04233853|Health services research|health services research
4960923|NCT04233853|Common mental disorders|common mental disorders
4960924|NCT04233853|Implementation|implementation
4960925|NCT04233853|Disease management|disease management
4960926|NCT04233840|P1101|p1101
4960927|NCT04233840|Anti-PD1|anti-pd1
4960929|NCT04233840|Hepatocellular Carcinoma|hepatocellular carcinoma
4960930|NCT04233788|Magnetic Resonance Spectroscopic Imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
4960931|NCT04233788|Chemical exchange saturation transfer imaging (CEST)|chemical exchange saturation transfer imaging (cest)
4960932|NCT04233788|Pulse sequence development|pulse sequence development
4960933|NCT04233788|Preoperative prediction of IDH-status|preoperative prediction of idh-status
4960934|NCT04233788|Quantitative MR(S)I|quantitative mr(s)i
4960935|NCT04233788|Signal processing|signal processing
4960936|NCT04233775|congenital heart disease|congenital heart disease
4960937|NCT04233775|brain imaging|brain imaging
4960938|NCT04233775|neurodevelopmental outcome|neurodevelopmental outcome
4960939|NCT04233710|robotic rehabilitation|robotic rehabilitation
4960940|NCT04233710|tDCS|tdcs
4960941|NCT04233710|non-invasive brain stimulation|non-invasive brain stimulation
4960942|NCT04233697|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
4960943|NCT04233697|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
4960944|NCT04233697|Copanlisib|copanlisib
4960945|NCT04233697|Romidepsin|romidepsin
4960946|NCT04233671|Opioid Use Disorder|opioid use disorder
4960947|NCT04233671|Mindfulness based therapy|mindfulness based therapy
4960948|NCT04233671|cravings|cravings
4960949|NCT04233671|relapse prevention|relapse prevention
4960950|NCT04233671|treatment retention|treatment retention
4960974|NCT04233489|child development|child development
4960975|NCT04233489|Diabetes Mellitus, Gestational|diabetes mellitus, gestational
4960976|NCT04233476|99mTc-3PRGD2|99mtc-3prgd2
4960977|NCT04233476|Integrin ανβ3;|integrin ανβ3;
4960978|NCT04233476|lung cancer|lung cancer
4960979|NCT04233450|mother anorexia nervosa|mother anorexia nervosa
4960980|NCT04233450|body perception|body perception
4960981|NCT04233450|post-partum|post-partum
4960982|NCT04233450|baby body|baby body
4960983|NCT04233424|Surgical site infection|surgical site infection
4960984|NCT04233424|Abdominal surgery|abdominal surgery
4960985|NCT04233424|Colon and small bowl surgery|colon and small bowl surgery
4960990|NCT04233359|Pleural effusion|pleural effusion
4960991|NCT04233359|Malignant Pleural effusion|malignant pleural effusion
4960992|NCT04233359|Pleura diagnostics|pleura diagnostics
4960993|NCT04233359|US-guided pleural biopsy|us-guided pleural biopsy
4960994|NCT04233359|Local anesthetic thoracoscopy|local anesthetic thoracoscopy
4960995|NCT04233320|Scar|scar
4960996|NCT04233320|Allium Cepa|allium cepa
4960997|NCT04233320|post-cesarean|post-cesarean
4960998|NCT04233307|perfusion|perfusion
4960999|NCT04233281|Kori tofu|kori tofu
4961000|NCT04233281|Glucose response|glucose response
4961001|NCT04233281|Pre-diabetics|pre-diabetics
4961013|NCT04233203|insulin pump|insulin pump
4961014|NCT04233203|Faster aspart|faster aspart
4961015|NCT04233203|insulin|insulin
4961016|NCT04233203|glycemic variability|glycemic variability
4961017|NCT04233177|Common carotid artery|common carotid artery
4961018|NCT04233177|Trendelenburg|trendelenburg
4961019|NCT04233177|Pneumoperitoneum|pneumoperitoneum
4961034|NCT04233099|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4961036|NCT04233099|Diagnosis|diagnosis
4961037|NCT04233073|Urgent Surgery|urgent surgery
4961038|NCT04233073|Thrombosis|thrombosis
4961039|NCT04233073|Anticoagulant|anticoagulant
4961040|NCT04233073|Surgery|surgery
4961041|NCT04233073|Surgical|surgical
4961042|NCT04233073|Abdominal|abdominal
4961043|NCT04233073|Thoracic|thoracic
4961044|NCT04233073|Orthopedic|orthopedic
4961045|NCT04233073|Gynecological|gynecological
4961046|NCT04233073|Laparoscopic|laparoscopic
4961047|NCT04233073|Neurosurgery|neurosurgery
4961048|NCT04233047|Human Immunodeficiency Virus 1 (HIV-1)|human immunodeficiency virus 1 (hiv-1)
4961049|NCT04233034|new onset|new onset
4961050|NCT04233034|verapamil|verapamil
4961051|NCT04233034|hybrid closed loop|hybrid closed loop
4961053|NCT04233034|beta cell|beta cell
4961054|NCT04233034|diabetes|diabetes
4961055|NCT04233034|children|children
4961056|NCT04233034|T1D|t1d
4961062|NCT04233008|Neonatal Outcomes|neonatal outcomes
4961063|NCT04232995|Diabetes Mellitus type 2|diabetes mellitus type 2
4961064|NCT04232995|Diabetic neuropathy|diabetic neuropathy
4961065|NCT04232995|Rehabilitation|rehabilitation
4961066|NCT04232995|Balance exercises|balance exercises
4961067|NCT04232995|Berg Balance Scale|berg balance scale
4961068|NCT04232982|Boston keratoprosthesis|boston keratoprosthesis
4961069|NCT04232982|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
4961070|NCT04232982|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
4961071|NCT04232982|G-Probe Transscleral cyclophotocoagulation|g-probe transscleral cyclophotocoagulation
4961072|NCT04232969|Parkinson's Disease, Exenatide|parkinson's disease, exenatide
4961073|NCT04232904|living liver donor|living liver donor
4961074|NCT04232904|TAP block|tap block
4961075|NCT04232904|cytokine|cytokine
4961076|NCT04232904|bupivacaine|bupivacaine
4961077|NCT04232891|liquid biopsy|liquid biopsy
4961078|NCT04232891|metastatic colorectal cancer|metastatic colorectal cancer
4961079|NCT04232891|early detection of metastases|early detection of metastases
4961080|NCT04232852|metabolic syndrome|metabolic syndrome
4961081|NCT04232852|probiotics|probiotics
4961082|NCT04232852|cardiovascular risk factor|cardiovascular risk factor
4961083|NCT04232813|Vaginal dryness|vaginal dryness
4961084|NCT04232813|Vaginal soreness|vaginal soreness
4961085|NCT04232813|Vaginal irritation|vaginal irritation
4961086|NCT04232813|Dyspareunia|dyspareunia
4961087|NCT04232800|Glutamate|glutamate
4961088|NCT04232800|Riboflavin|riboflavin
4961089|NCT04232787|Brugada Syndrome|brugada syndrome
4961090|NCT04232787|Genetics|genetics
4961091|NCT04232787|Epidemiology|epidemiology
4961092|NCT04232787|Thai|thai
4961093|NCT04232787|Southeast Asia|southeast asia
4961094|NCT04232774|Denervation|denervation
4961095|NCT04232774|T2DM|t2dm
4961096|NCT04232774|Hypertension|hypertension
4961097|NCT04232774|Obesity|obesity
4961098|NCT04232761|Bone metastases|bone metastases
4961099|NCT04232761|Radium-223 dichloride|radium-223 dichloride
4961100|NCT04232748|cancer|cancer
4961101|NCT04232748|survival|survival
4961102|NCT04232748|chemotherapy|chemotherapy
4961103|NCT04232748|weight|weight
4961104|NCT04232735|Prediction models|prediction models
4961105|NCT04232735|Tailored information|tailored information
4961106|NCT04232735|Stepped Wedge Trial|stepped wedge trial
4961107|NCT04232735|Oesophageal cancer|oesophageal cancer
4961108|NCT04232735|Gastric cancer|gastric cancer
4961109|NCT04232735|Webtool|webtool
4961110|NCT04232735|Health care provider training|health care provider training
4961111|NCT04232709|systemic therapy|systemic therapy
4961112|NCT04232709|chemotherapy|chemotherapy
4961113|NCT04232709|targeted therapy|targeted therapy
4961114|NCT04232709|immunotherapy|immunotherapy
4961115|NCT04232709|after-hours telemedicine|after-hours telemedicine
4961116|NCT04232709|shared electronic patient record|shared electronic patient record
4961117|NCT04232709|symptom management|symptom management
4961118|NCT04232709|oncology|oncology
4961120|NCT04232683|Female Pelvic Floor Disorders|female pelvic floor disorders
4961121|NCT04232683|Postoperative Urinary Retention|postoperative urinary retention
4961122|NCT04232683|Tamsulosin|tamsulosin
4961123|NCT04232670|pancreas|pancreas
4961124|NCT04232670|pancreatic duct|pancreatic duct
4966781|NCT04197284|knee|knee
4961133|NCT04232566|obesity|obesity
4961134|NCT04232566|nash|nash
4961135|NCT04232566|adipose tissue inflammation|adipose tissue inflammation
4961136|NCT04232566|insulin resistance|insulin resistance
4961137|NCT04232540|HIV infection|hiv infection
4961138|NCT04232540|Medication Adherence|medication adherence
4961139|NCT04232540|Hair|hair
4961140|NCT04232540|Dolutegravir|dolutegravir
4961141|NCT04232540|Emtricitabine|emtricitabine
4961142|NCT04232540|Antiretrovirals|antiretrovirals
4961147|NCT04232488|coronary disease|coronary disease
4961148|NCT04232488|snuff box|snuff box
4961149|NCT04232488|radial access|radial access
4961150|NCT04232462|Deep Learning|deep learning
4961151|NCT04232449|Upper Respiratory Tract Infection|upper respiratory tract infection
4961152|NCT04232449|oral corticosteroid treatment|oral corticosteroid treatment
4961153|NCT04232449|Cough-related Quality of Life (QoL)|cough-related quality of life (qol)
4961154|NCT04232436|Mode of delivery|mode of delivery
4961156|NCT04232436|Survival at discharge|survival at discharge
4961157|NCT04232436|Survival without severe morbidity|survival without severe morbidity
4961162|NCT04232371|New Ablation Technique|new ablation technique
4961163|NCT04232371|Standard Ablation Technique|standard ablation technique
4961169|NCT04232319|Breast cancer, sleep, intervention|breast cancer, sleep, intervention
4961170|NCT04232319|Sleep|sleep
4961171|NCT04232319|Intervention|intervention
4961172|NCT04232319|Self-management|self-management
4961173|NCT04232306|Postoperative analgesia|postoperative analgesia
4961174|NCT04232306|Postoperative opioid use|postoperative opioid use
4961175|NCT04232293|NASH|nash
4961176|NCT04232293|NAFLD|nafld
4961177|NCT04232293|Fibrosis|fibrosis
4961178|NCT04232293|Cirrhosis|cirrhosis
4961179|NCT04232293|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4961180|NCT04232280|Moderna|moderna
4961181|NCT04232280|mRNA-1647|mrna-1647
4961182|NCT04232280|Cytomegalovirus|cytomegalovirus
4961184|NCT04232280|Cytomegalovirus Vaccine|cytomegalovirus vaccine
4961185|NCT04232280|Cytomegalovirus Infections|cytomegalovirus infections
4961186|NCT04232280|Cytomegalovirus Congenital|cytomegalovirus congenital
4961187|NCT04232280|Virus Diseases|virus diseases
4961188|NCT04232280|Infection Viral|infection viral
4961189|NCT04232280|DNA Virus Infections|dna virus infections
4961190|NCT04232280|Messenger RNA|messenger rna
4961191|NCT04232241|Acute Myeloid Leukemia|acute myeloid leukemia
4961192|NCT04232241|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4961193|NCT04232241|Myelodysplastic Syndromes|myelodysplastic syndromes
4961194|NCT04232241|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
4961195|NCT04232241|Matched Unrelated Allogeneic Stem Cell Transplantation|matched unrelated allogeneic stem cell transplantation
5342899|NCT01981577|Ultrahigh field Magnetic Resonance imaging|ultrahigh field magnetic resonance imaging
4961196|NCT04232241|Haploidentical Allogeneic Stem Cell Transplantation|haploidentical allogeneic stem cell transplantation
4961197|NCT04232241|anti-leukemic activity|anti-leukemic activity
4961198|NCT04232241|Cyclophosphamide as GVHD prophylaxis|cyclophosphamide as gvhd prophylaxis
4961199|NCT04232202|tooth extraction|tooth extraction
4961200|NCT04232202|alveolar bone|alveolar bone
4961201|NCT04232202|bone regeneration|bone regeneration
4961202|NCT04232202|laser|laser
4961203|NCT04232189|placental protein|placental protein
4961204|NCT04232189|gestational age|gestational age
4961205|NCT04232189|abortion|abortion
4961206|NCT04232176|Endoscopic optical diagnosis|endoscopic optical diagnosis
4961207|NCT04232163|Stroke|stroke
4961208|NCT04232163|Upper extremity|upper extremity
4961209|NCT04232163|Rehabilitation|rehabilitation
4961210|NCT04232163|Wearable device|wearable device
4961211|NCT04232163|Exercise|exercise
4961212|NCT04232163|Randomized Controlled Trial|randomized controlled trial
4961213|NCT04232150|Midazolam|midazolam
4961214|NCT04232150|Orthopedic surgery|orthopedic surgery
4959623|NCT04241614|CT|ct
4961215|NCT04232150|total knee replacement|total knee replacement
4961216|NCT04232150|total hip replacement|total hip replacement
4961217|NCT04232137|Coffee ceremony|coffee ceremony
4961218|NCT04232137|Hospital-based deliveries|hospital-based deliveries
4961219|NCT04232137|Maternal health|maternal health
4961220|NCT04232137|Ethiopia|ethiopia
4961221|NCT04232085|Bone Marrow Transplantation|bone marrow transplantation
4961222|NCT04232072|Ibuprofen|ibuprofen
4961223|NCT04232072|Erector spina plane block|erector spina plane block
4961224|NCT04232072|Postoperative analgesia management|postoperative analgesia management
4961225|NCT04232072|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4961226|NCT04232059|posterior fossa|posterior fossa
4961227|NCT04232059|cerebral oximetry|cerebral oximetry
4961228|NCT04232059|hyperventilation|hyperventilation
4961229|NCT04232059|children|children
4961230|NCT04232046|Massage|massage
4961231|NCT04232046|Trigger point|trigger point
4961232|NCT04231994|Septic shock|septic shock
4961233|NCT04231994|Therapeutic plasma exchange|therapeutic plasma exchange
4961234|NCT04231994|Sepsis|sepsis
4961235|NCT04231981|Penile Cancer|penile cancer
4961236|NCT04231981|Penile squamous cell carcinoma|penile squamous cell carcinoma
4961237|NCT04231981|Locally advanced penile cancer|locally advanced penile cancer
4961238|NCT04231981|Metastatic penile cancer|metastatic penile cancer
4961239|NCT04231981|Unresectable locally advanced penile cancer|unresectable locally advanced penile cancer
4961240|NCT04231981|Unresectable penile cancer|unresectable penile cancer
4961241|NCT04231981|PSqCC|psqcc
4961242|NCT04231981|PSCC|pscc
4961243|NCT04231981|Penile Cancer stage IV|penile cancer stage iv
4961244|NCT04231955|numerical rating scale|numerical rating scale
4961245|NCT04231955|visual analogue scale|visual analogue scale
4961246|NCT04231955|color analogue scale|color analogue scale
4961247|NCT04231955|faces rating scale|faces rating scale
4961248|NCT04231955|pain intensity|pain intensity
4961250|NCT04231929|Unresectable|unresectable
4961251|NCT04231929|BioPearl®|biopearl®
4961252|NCT04231929|TACE|tace
4961838|NCT04228289|Oxytocin|oxytocin
4961253|NCT04231929|Chemoembolization|chemoembolization
4961254|NCT04231851|Therapy-Related AML|therapy-related aml
4961255|NCT04231851|AML with MDS related changes|aml with mds related changes
4961256|NCT04231838|e-cigarettes|e-cigarettes
4961257|NCT04231838|Combustion-Free Nicotine Delivery Systems|combustion-free nicotine delivery systems
4961258|NCT04231838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4961259|NCT04231838|Cardiovascular Risk Factor|cardiovascular risk factor
4961260|NCT04231838|Tobacco Cigarettes|tobacco cigarettes
4961261|NCT04231838|DIASMOKE 2.0|diasmoke 2.0
4961262|NCT04231838|Metabolic syndrome|metabolic syndrome
4961263|NCT04231812|Laparoscopic Tissue Morcellation|laparoscopic tissue morcellation
4961264|NCT04231799|First Bathing|first bathing
4961265|NCT04231799|TEWL|tewl
4961266|NCT04231799|Neonatal intensive care unit|neonatal intensive care unit
4961267|NCT04231799|Nursing care|nursing care
4961268|NCT04231799|Premature infant|premature infant
4961269|NCT04231799|Skin care|skin care
4961270|NCT04231799|Comfort|comfort
4961271|NCT04231786|breast diseases|breast diseases
4961272|NCT04231786|fibrocystic breast|fibrocystic breast
4961273|NCT04231786|polycystic ovari syndrome|polycystic ovari syndrome
4961274|NCT04231786|fibroadenoma|fibroadenoma
4961275|NCT04231747|Lymphoma|lymphoma
4961276|NCT04231747|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
4961277|NCT04231747|Agressive Lymphoma|agressive lymphoma
4961278|NCT04231747|Diffuse-large B-cell Lymphoma|diffuse-large b-cell lymphoma
4961279|NCT04231747|DLBCL|dlbcl
4961280|NCT04231747|NHL|nhl
4961281|NCT04231747|CC-97540|cc-97540
4961282|NCT04231747|CD19|cd19
4961410|NCT04230902|Knee|knee
4961283|NCT04231747|NEX-T chimeric antigen receptor (CAR) T cells|nex-t chimeric antigen receptor (car) t cells
4961284|NCT04231747|CAR-T|car-t
4961285|NCT04231747|CART|cart
4961286|NCT04231721|Neurogastroenterology|neurogastroenterology
4961287|NCT04231721|Colonic motility|colonic motility
4961288|NCT04231721|Manometry|manometry
5672867|NCT00610311|Skin Cancer|skin cancer
4961289|NCT04231721|High resolution colonic manometry|high resolution colonic manometry
4961290|NCT04231721|3D-Transit system|3d-transit system
4961291|NCT04231721|Healthy|healthy
4961292|NCT04231695|septic shock|septic shock
4961305|NCT04231656|Bioelectrical impedance|bioelectrical impedance
4961306|NCT04231656|Pulse contour analysis|pulse contour analysis
4961307|NCT04231643|cannabidiol|cannabidiol
4961308|NCT04231643|THC|thc
4961309|NCT04231578|Self-help|self-help
4961310|NCT04231578|Internet-delivered intervention|internet-delivered intervention
4961311|NCT04231565|hepatitis B virus|hepatitis b virus
4961312|NCT04231565|nucleoside|nucleoside
4961313|NCT04231565|nucleotide|nucleotide
4961314|NCT04231513|E2814|e2814
4961315|NCT04231513|Healthy Participants|healthy participants
5939474|NCT01212783|psychological treatments|psychological treatments
4961316|NCT04231513|Phase 1|phase 1
4961317|NCT04231513|Pharmacokinetics|pharmacokinetics
4961318|NCT04231513|Pharmacodynamics|pharmacodynamics
4961319|NCT04231513|Immunogenicity|immunogenicity
4961326|NCT04231422|platelet-rich plasma|platelet-rich plasma
4961327|NCT04231383|Dental caries|dental caries
4961328|NCT04231383|IGF-1|igf-1
4961329|NCT04231383|IGFBP-3|igfbp-3
4961330|NCT04231383|anthropometry|anthropometry
4961331|NCT04231383|sleeping|sleeping
4961332|NCT04231370|pegaspargase|pegaspargase
4961333|NCT04231370|sintilimab|sintilimab
4961334|NCT04231370|PD-1|pd-1
4961335|NCT04231370|lenalidomide|lenalidomide
4961336|NCT04231370|relapsed/refractory|relapsed/refractory
4967101|NCT04195269|THC|thc
4961337|NCT04231266|GNE Myopathy|gne myopathy
4961338|NCT04231266|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
4961339|NCT04231266|Distal Myopathy with Rimmed Vacuoles (DMRV)|distal myopathy with rimmed vacuoles (dmrv)
4961340|NCT04231266|Nonaka Myopathy|nonaka myopathy
4961341|NCT04231266|Inclusion Body Myopathy type 2 (IBM-2)|inclusion body myopathy type 2 (ibm-2)
4961342|NCT04231227|cerebral palsy|cerebral palsy
4961343|NCT04231227|selective motor control|selective motor control
4961344|NCT04231227|upper limb|upper limb
4961345|NCT04231227|upper limb functions|upper limb functions
4961346|NCT04231227|gross motor functions|gross motor functions
4961350|NCT04231175|Colorectal cancer|colorectal cancer
4961934|NCT04227717|19-476|19-476
4961362|NCT04231123|Elective Hip Surgery|elective hip surgery
4961368|NCT04231071|Small umbilical hernias|small umbilical hernias
4961369|NCT04231071|mesh repair|mesh repair
4961370|NCT04231071|suture repair|suture repair
4961371|NCT04231071|recurrence|recurrence
4961375|NCT04231045|acidosis|acidosis
4961376|NCT04231045|cardiac contractility|cardiac contractility
4961377|NCT04231045|acid-base disorder|acid-base disorder
4961378|NCT04231032|Apical hypertrophic cardiomyopathy|apical hypertrophic cardiomyopathy
4961379|NCT04231032|Pacemaker|pacemaker
4961380|NCT04231032|Perfusion|perfusion
4961381|NCT04231019|Molar incisor hypomineralization|molar incisor hypomineralization
4961382|NCT04231019|General dental practitioners|general dental practitioners
4961383|NCT04231019|Perception|perception
4961384|NCT04231019|knowledge|knowledge
4961385|NCT04231019|Oral health|oral health
4961388|NCT04230954|Recurrent Cervical Cancer|recurrent cervical cancer
4961389|NCT04230954|Cervical Cancer|cervical cancer
4961390|NCT04230954|Cervical Carcinoma|cervical carcinoma
4961391|NCT04230954|PD L1 positivity|pd l1 positivity
4961392|NCT04230954|Immunotherapy|immunotherapy
4961393|NCT04230954|Squamous Carcinoma|squamous carcinoma
4961394|NCT04230954|Adenocarcinoma|adenocarcinoma
4961395|NCT04230954|Adenosquamous Carcinoma|adenosquamous carcinoma
4961396|NCT04230928|Hypertension|hypertension
4961397|NCT04230928|Low carbohydrate diet|low carbohydrate diet
4961398|NCT04230928|African American race|african american race
4961399|NCT04230928|Cardiovascular disease risk|cardiovascular disease risk
4961400|NCT04230928|Weight loss|weight loss
4980331|NCT04115891|aromatherapy|aromatherapy
4961402|NCT04230915|Train of four (TOF)|train of four (tof)
4961403|NCT04230915|Rocuronium|rocuronium
4961404|NCT04230915|Operation Time|operation time
4961405|NCT04230902|mesenchymal stem cell|mesenchymal stem cell
4961406|NCT04230902|corticosteroid|corticosteroid
5698363|NCT00506649|analgesia|analgesia
4961407|NCT04230902|adipose stem cell|adipose stem cell
4961408|NCT04230902|MRI|mri
4961409|NCT04230902|pain|pain
4961411|NCT04230876|Auditory Training|auditory training
4961412|NCT04230863|Chemotherapy|chemotherapy
4961413|NCT04230863|Cognitive Impairment|cognitive impairment
4961414|NCT04230863|neuroplasticity-based computerized cognitive remediation|neuroplasticity-based computerized cognitive remediation
4961415|NCT04230863|nCCR|nccr
4961416|NCT04230850|Cupping therapy on lumbar stiffness|cupping therapy on lumbar stiffness
4961417|NCT04230837|definitive implant abutment|definitive implant abutment
4961418|NCT04230837|interproximal bone loss|interproximal bone loss
4961419|NCT04230837|soft tissue|soft tissue
4961420|NCT04230798|Sport|sport
4961421|NCT04230798|Strength|strength
4961422|NCT04230798|Plyometrics|plyometrics
4961423|NCT04230798|Core stability|core stability
4961424|NCT04230798|Prevention program|prevention program
4961425|NCT04230798|Young athletes|young athletes
4961426|NCT04230785|acute ischemic stroke|acute ischemic stroke
4961427|NCT04230785|noncoding RNA|noncoding rna
4961428|NCT04230785|endovascular treatment|endovascular treatment
4961429|NCT04230785|clinical significance|clinical significance
4961430|NCT04230785|outcome|outcome
4961431|NCT04230759|Anal Cancer|anal cancer
4961432|NCT04230759|Anal Carcinoma|anal carcinoma
4961433|NCT04230759|Durvalumab|durvalumab
4961434|NCT04230759|PD-L1 immune checkpoint inhibitor|pd-l1 immune checkpoint inhibitor
4961435|NCT04230746|microbiome|microbiome
4961436|NCT04230746|antibiotics|antibiotics
4961437|NCT04230746|resistance|resistance
4961438|NCT04230746|flora|flora
4961439|NCT04230733|Gait|gait
5939475|NCT01212783|Cognitive Behavioral Therapy|cognitive behavioral therapy
4961449|NCT04230668|Suicide|suicide
4961450|NCT04230668|Self-harm|self-harm
4961451|NCT04230655|Obesity|obesity
4961452|NCT04230655|Weight loss|weight loss
4961453|NCT04230655|Low energy diet|low energy diet
4961459|NCT04230655|Glucose metabolism|glucose metabolism
4961460|NCT04230655|Eating behavior|eating behavior
4961461|NCT04230655|Microbiomics|microbiomics
4961462|NCT04230655|Physical activity|physical activity
4961463|NCT04230655|Gastrointestinal symptoms|gastrointestinal symptoms
4961464|NCT04230655|Psychological parameters|psychological parameters
4961465|NCT04230603|hyperspectral imaging|hyperspectral imaging
4961466|NCT04230603|tissue detection|tissue detection
4961467|NCT04230603|tumor detection|tumor detection
4961468|NCT04230590|Schizophrenia|schizophrenia
4961469|NCT04230590|Digital phenotyping|digital phenotyping
4961470|NCT04230590|Relapse|relapse
5863587|NCT00001245|Immunosuppression|immunosuppression
4961475|NCT04230577|Attention|attention
4961476|NCT04230577|Memory|memory
4961477|NCT04230577|Photobiomodulation (PBM)|photobiomodulation (pbm)
4961478|NCT04230577|Low-level Laser Therapy (LLLT)|low-level laser therapy (lllt)
4961479|NCT04230577|Light-Emitting Diodes (LEDs)|light-emitting diodes (leds)
4961480|NCT04230577|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4961481|NCT04230577|functional MRI (fMRI)|functional mri (fmri)
4961482|NCT04230577|resting-state functional connectivity MRI (rs-fcMRI)|resting-state functional connectivity mri (rs-fcmri)
4961483|NCT04230577|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
4961484|NCT04230577|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
4961485|NCT04230564|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4961486|NCT04230551|HOCM|hocm
4961487|NCT04230551|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
4961488|NCT04230551|Left Ventricular Outflow Tract Obstruction|left ventricular outflow tract obstruction
4961489|NCT04230551|Adverse Remodeling|adverse remodeling
4961490|NCT04230551|Reverse Remodeling|reverse remodeling
4961491|NCT04230551|Alcohol Septal Ablation|alcohol septal ablation
4961492|NCT04230551|Percutaneous Transluminal Septal Myocardial Ablation|percutaneous transluminal septal myocardial ablation
4961493|NCT04230551|PTSMA|ptsma
4961494|NCT04230551|Extracellular Volume Fraction|extracellular volume fraction
4961495|NCT04230551|Global Longitudinal Strain|global longitudinal strain
4961496|NCT04230551|Deformation Imaging|deformation imaging
4961497|NCT04230551|4D Velocity Mapping|4d velocity mapping
4961498|NCT04230512|Amputation|amputation
4961499|NCT04230512|Prosthesis|prosthesis
4961500|NCT04230512|Gait|gait
5289977|NCT02224352|Lung Diseases|lung diseases
4961502|NCT04230460|Marijuana|marijuana
4961503|NCT04230460|Cannabis|cannabis
4961511|NCT04230460|EEG|eeg
4961512|NCT04230460|SDLP|sdlp
4961513|NCT04230447|Sepsis encephalopathy|sepsis encephalopathy
4961514|NCT04230434|Suicide|suicide
4961515|NCT04230434|Suicidal behavior|suicidal behavior
4961516|NCT04230434|Suicidal attempt|suicidal attempt
4961517|NCT04230434|Suicide prevention|suicide prevention
4961518|NCT04230434|Safety Planning Intervention|safety planning intervention
4961523|NCT04230395|Alcohol Use|alcohol use
4961531|NCT04230317|Computer simulation, Multislice computed tomography|computer simulation, multislice computed tomography
4961532|NCT04230239|Secondary AML|secondary aml
4961533|NCT04230239|High risk AML|high risk aml
4961534|NCT04230161|Long-lasting insecticidal net|long-lasting insecticidal net
4961535|NCT04230161|LLIN|llin
4961536|NCT04230161|Insecticide treated net|insecticide treated net
4961537|NCT04230161|ITN|itn
4961538|NCT04230161|Malaria|malaria
4961539|NCT04230161|Epidemiology|epidemiology
4961540|NCT04230161|Anthropology|anthropology
4961541|NCT04230161|Durability|durability
4961542|NCT04230161|Cost-effectiveness|cost-effectiveness
4961543|NCT04230148|Acute Fascioliasis|acute fascioliasis
4961544|NCT04230148|Chronic Fascioliasis|chronic fascioliasis
4961545|NCT04230148|Clinical Cure|clinical cure
4961546|NCT04230148|Parasitological Cure|parasitological cure
4961547|NCT04230148|Egaten|egaten
4961548|NCT04230148|Triclabendazole|triclabendazole
4961549|NCT04230148|Post-Marketing commitment|post-marketing commitment
5285720|NCT02243631|ATP|atp
4961550|NCT04230109|Invasive Breast Cancer|invasive breast cancer
4961551|NCT04230109|Triple Negative Breast Cancer|triple negative breast cancer
4961552|NCT04230109|ER-Negative Breast Cancer|er-negative breast cancer
5939476|NCT01212783|child development|child development
4961553|NCT04230109|PR-Negative Breast Cancer|pr-negative breast cancer
4961554|NCT04230109|HER2-negative Breast Cancer|her2-negative breast cancer
4961555|NCT04230096|pain|pain
4961556|NCT04230096|complications|complications
4961557|NCT04230096|movement|movement
4961558|NCT04230096|orthodontic|orthodontic
4961559|NCT04230096|duration|duration
4961560|NCT04230057|Pharmacokinetics, Antitumor B, healthy volunteer|pharmacokinetics, antitumor b, healthy volunteer
4961561|NCT04230044|E2007|e2007
4961562|NCT04230044|Fycompa|fycompa
4961563|NCT04230044|Perampanel|perampanel
4961564|NCT04230044|Partial onset seizures|partial onset seizures
4961565|NCT04230044|Epilepsy|epilepsy
4961566|NCT04230044|Seizures|seizures
4961567|NCT04230044|Post marketing surveillance|post marketing surveillance
4961568|NCT04230018|mCRC|mcrc
4961569|NCT04230018|primary focus|primary focus
4961570|NCT04230018|metastasis|metastasis
4961571|NCT04230018|heterogeneous metastasis|heterogeneous metastasis
4961572|NCT04230018|gene|gene
4961573|NCT04230005|Movement|movement
4961574|NCT04230005|Rehabilitation|rehabilitation
4961575|NCT04230005|Learning|learning
4961576|NCT04229940|Laparoscopy,|laparoscopy,
4961577|NCT04229940|Hernia repair|hernia repair
4961578|NCT04229888|dry eye|dry eye
4961579|NCT04229888|meibomian gland dysfunction|meibomian gland dysfunction
4961586|NCT04229823|SCA3|sca3
4961587|NCT04229823|Biomarker|biomarker
4961588|NCT04229823|Natural history|natural history
4961589|NCT04229823|Video-oculography|video-oculography
4961590|NCT04229823|Eye movement|eye movement
4961591|NCT04229823|Surrogate biomarker|surrogate biomarker
4961592|NCT04229823|Oculomotor neurophysiology|oculomotor neurophysiology
4961593|NCT04229797|Class III malocclusion|class iii malocclusion
4961594|NCT04229797|Mandibular buccal shelf|mandibular buccal shelf
4961595|NCT04229797|Mini-screws|mini-screws
4961596|NCT04229797|Extra-radicular mini-screws|extra-radicular mini-screws
4961597|NCT04229797|Distalization|distalization
4961598|NCT04229797|Temporary Anchorage device|temporary anchorage device
4961599|NCT04229784|hemorrhoids|hemorrhoids
4961600|NCT04229784|radiofrequency surgery|radiofrequency surgery
4961601|NCT04229771|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
4961602|NCT04229771|Probe and irrigation|probe and irrigation
4961603|NCT04229758|Anticoagulation|anticoagulation
4961604|NCT04229758|Anticoagulant|anticoagulant
4961605|NCT04229758|Anticoagulants|anticoagulants
4961606|NCT04229758|Restart|restart
4961607|NCT04229758|Delay|delay
4961608|NCT04229758|Hemorrhage|hemorrhage
4961609|NCT04229758|ICH|ich
4961610|NCT04229758|SAH|sah
4961611|NCT04229758|SDH|sdh
4961612|NCT04229758|DOAC|doac
4961613|NCT04229758|NOAC|noac
4961614|NCT04229758|apixaban|apixaban
4961615|NCT04229758|rivaroxaban|rivaroxaban
4961616|NCT04229758|edoxaban|edoxaban
4961617|NCT04229706|hyperplasia of breast|hyperplasia of breast
5003228|NCT03975985|falls|falls
4961618|NCT04229706|Xiangjurupining capsule|xiangjurupining capsule
4961619|NCT04229680|Dietary sodium|dietary sodium
4961620|NCT04229680|Gut microbiota|gut microbiota
4961621|NCT04229654|knowledge|knowledge
4961622|NCT04229654|expectations|expectations
4961623|NCT04229654|anomaly scan|anomaly scan
4961624|NCT04229589|Syncope, pacemaker, bradyarrhythmias|syncope, pacemaker, bradyarrhythmias
4961626|NCT04229537|SCT200|sct200
4961627|NCT04229524|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4961628|NCT04229524|blood supply|blood supply
4961629|NCT04229524|anastomotic fistula|anastomotic fistula
4961630|NCT04229524|fluorescence angiography|fluorescence angiography
4961631|NCT04229511|Carbapenem resistant Klebsiella pneumoniae|carbapenem resistant klebsiella pneumoniae
4961632|NCT04229511|Colonization|colonization
4961633|NCT04229511|Bloodstream Infections|bloodstream infections
4961634|NCT04229511|Invasive Infections|invasive infections
4961635|NCT04229511|Risk score model|risk score model
4961636|NCT04229511|Decision Tree Algorithm|decision tree algorithm
4961637|NCT04229498|Carbapenem resistant Klebsiella pneumoniae|carbapenem resistant klebsiella pneumoniae
4961638|NCT04229498|Carbapenem heteroresistant Klebsiella pneumoniae|carbapenem heteroresistant klebsiella pneumoniae
4961639|NCT04229498|Bloodstream Infections|bloodstream infections
4961640|NCT04229498|Sepsis|sepsis
4961641|NCT04229498|Septic shock|septic shock
4961642|NCT04229498|Relapses/re-infections|relapses/re-infections
4961643|NCT04229498|Mortality|mortality
4961644|NCT04229485|chronic kidney diseae|chronic kidney diseae
4961645|NCT04229485|mineral bone disease|mineral bone disease
4961646|NCT04229485|cardiovascular events|cardiovascular events
4961647|NCT04229485|mobile communication|mobile communication
4961648|NCT04229459|Esophageal Cancer|esophageal cancer
4961653|NCT04229420|ultrasound|ultrasound
4961654|NCT04229420|rectus sheath|rectus sheath
4961655|NCT04229420|pain|pain
4961656|NCT04229394|2ccPA|2ccpa
4961657|NCT04229368|joint replacement|joint replacement
4961658|NCT04229368|hip arthroplasty|hip arthroplasty
4961659|NCT04229368|knee arthroplasty|knee arthroplasty
4961660|NCT04229368|clinical outcomes|clinical outcomes
4961661|NCT04229368|Vitamin D Deficiency|vitamin d deficiency
4961662|NCT04229316|stabilization, facet arthritis, spondylolisthesis, stenosis, fusion|stabilization, facet arthritis, spondylolisthesis, stenosis, fusion
4961663|NCT04229303|ABPA|abpa
4961664|NCT04229303|Asthma|asthma
4961665|NCT04229303|Voriconazole|voriconazole
4961666|NCT04229303|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
4961668|NCT04229290|Second-line|second-line
4961669|NCT04229290|Switch|switch
4961670|NCT04229290|Protease inhibitor|protease inhibitor
4961671|NCT04229290|Dolutegravir|dolutegravir
4961672|NCT04229290|Treatment experienced|treatment experienced
4961673|NCT04229290|Non-inferiority|non-inferiority
4967331|NCT04193696|advanced HCC|advanced hcc
4961674|NCT04229264|Post-infrapopliteal angioplasty|post-infrapopliteal angioplasty
4961675|NCT04229251|Mindfulness|mindfulness
4961676|NCT04229251|Online intervention|online intervention
4961677|NCT04229251|Malaysia|malaysia
4961678|NCT04229238|Nutritional status|nutritional status
4961679|NCT04229238|Polypharmacy|polypharmacy
4961680|NCT04229238|Home-dwelling|home-dwelling
4961681|NCT04229238|Potentially inappropriate medication use|potentially inappropriate medication use
4961686|NCT04229212|Intertrochanteric Fractures|intertrochanteric fractures
4961687|NCT04229212|Proximal Femoral Nail Antirotation (PFNA)|proximal femoral nail antirotation (pfna)
4961688|NCT04229212|closed suction drainage system|closed suction drainage system
4961689|NCT04229186|Mild Cognitive Impairment|mild cognitive impairment
4961690|NCT04229186|Alzheimer's Disease|alzheimer's disease
4961691|NCT04229186|Extra Virgin Olive Oil|extra virgin olive oil
4961692|NCT04229173|MSA|msa
4961693|NCT04229173|MRI|mri
4961694|NCT04229173|Dat spect|dat spect
4961695|NCT04229173|Atrophy|atrophy
4961696|NCT04229173|Biomarkers|biomarkers
4961697|NCT04229160|pulmonary vein isolation|pulmonary vein isolation
4961698|NCT04229160|cardioversion|cardioversion
4961699|NCT04229147|Radiotherapy|radiotherapy
4961700|NCT04229147|Pain|pain
4961701|NCT04229147|Side effect|side effect
4961702|NCT04229147|Satisfaction|satisfaction
4961703|NCT04229134|Chronic pain|chronic pain
4961704|NCT04229069|acid-base balance|acid-base balance
4961705|NCT04229069|energy metabolism|energy metabolism
4961706|NCT04229069|protein-rich diet|protein-rich diet
4961707|NCT04229069|alkaline supplementation|alkaline supplementation
4961708|NCT04229069|calorimetry|calorimetry
4961709|NCT04229069|microdialysis|microdialysis
4961714|NCT04229056|executive dysfunction|executive dysfunction
4961715|NCT04229056|cognitive dysfunction|cognitive dysfunction
4961716|NCT04229056|computer-based cognitive rehabilitation|computer-based cognitive rehabilitation
4961717|NCT04229017|cervical spine|cervical spine
4961718|NCT04229017|myelopathy|myelopathy
5903436|NCT00392756|GnRH deficiency|gnrh deficiency
4961719|NCT04229017|radiculopathy|radiculopathy
4961720|NCT04229017|cervical spine fusion|cervical spine fusion
4961721|NCT04229017|circumferential cervical fusion|circumferential cervical fusion
4961722|NCT04229017|degenerative disease|degenerative disease
4961723|NCT04228991|Hypofractionated|hypofractionated
4961724|NCT04228991|Locoregional|locoregional
4961725|NCT04228991|Breast Cancer|breast cancer
4961726|NCT04228991|Lymphedema|lymphedema
4961727|NCT04228965|Smoking Cessation|smoking cessation
4961728|NCT04228952|CYP2A6, Nicotine Metabolite Ratio, NNAL, NNK α-hydroxylation|cyp2a6, nicotine metabolite ratio, nnal, nnk α-hydroxylation
4961729|NCT04228913|cold lateral condensation|cold lateral condensation
4961730|NCT04228913|Postoperative Pain|postoperative pain
4961731|NCT04228913|GuttaCore|guttacore
4961732|NCT04228913|GuttaFlow 2|guttaflow 2
4961733|NCT04228913|Obturation Techniques|obturation techniques
4961734|NCT04228900|Malnutrition|malnutrition
4961735|NCT04228900|Polypharmacy|polypharmacy
4961736|NCT04228900|Drug side effects|drug side effects
4961737|NCT04228900|Nutritional improvement|nutritional improvement
4961738|NCT04228900|Medication review|medication review
4961739|NCT04228887|Parkinson's Disease|parkinson's disease
4961740|NCT04228887|Inspiratory Muscle Training|inspiratory muscle training
4961741|NCT04228887|Balance Training|balance training
4961742|NCT04228874|Stent length|stent length
4961743|NCT04228874|Stent diameter|stent diameter
4961744|NCT04228861|Familial transmission|familial transmission
4961745|NCT04228861|Candida|candida
4961746|NCT04228861|Lactobacillus|lactobacillus
4961747|NCT04228861|S. mutans|s. mutans
4961748|NCT04228861|newborn|newborn
4961749|NCT04228835|Symptomatic and Complicated Cholelithiasis|symptomatic and complicated cholelithiasis
4961750|NCT04228757|Nutritional Supplement|nutritional supplement
4961751|NCT04228731|Cost|cost
4961752|NCT04228731|Total Knee Replacement|total knee replacement
4961753|NCT04228731|Outpatient Surgery|outpatient surgery
4961754|NCT04228731|Satisfaction|satisfaction
4961755|NCT04228731|Arthroplasty|arthroplasty
4961756|NCT04228718|Spinal Muscular Atrophy|spinal muscular atrophy
4961757|NCT04228718|Caregiver Burden|caregiver burden
4961758|NCT04228718|Disabled persons|disabled persons
4961759|NCT04228718|Caregivers|caregivers
4961760|NCT04228692|deep endometriosis surgery|deep endometriosis surgery
4961761|NCT04228692|voiding dysfunction|voiding dysfunction
4961762|NCT04228692|self-catheterization|self-catheterization
4961763|NCT04228692|posterior tibial nerve stimulation|posterior tibial nerve stimulation
4961764|NCT04228666|Alzheimer's disease|alzheimer's disease
4961765|NCT04228666|stem cells|stem cells
4961766|NCT04228666|adipose derived mesenchymal stem cells|adipose derived mesenchymal stem cells
4961767|NCT04228653|Parkinson|parkinson
4961769|NCT04228653|Drug Delivery System|drug delivery system
4961770|NCT04228653|Intracerebral|intracerebral
4961771|NCT04228653|Parkinson Disease|parkinson disease
4961772|NCT04228653|Nervous System Disease|nervous system disease
4961773|NCT04228653|Movement Disorders|movement disorders
4961774|NCT04228653|Brain Diseases|brain diseases
4961775|NCT04228653|Neurodegenerative Diseases|neurodegenerative diseases
4961776|NCT04228653|Parkinsonian Disorders|parkinsonian disorders
5863588|NCT00001245|Skin Test|skin test
4961781|NCT04228653|Sympathomimetrics|sympathomimetrics
4961782|NCT04228653|Autonomic Agents|autonomic agents
4961902|NCT04227886|Irinotecan|irinotecan
4961783|NCT04228653|Peripheral Nervous System Agents|peripheral nervous system agents
4961784|NCT04228653|Physiological Effects of Drugs|physiological effects of drugs
4961785|NCT04228653|Dopamine Agents|dopamine agents
4961786|NCT04228653|Neurotransmitter Agents|neurotransmitter agents
4961787|NCT04228653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4961788|NCT04228653|Protective Agents|protective agents
4961789|NCT04228640|Anti- Aging|anti- aging
4961790|NCT04228640|Workout Enhancer|workout enhancer
4961791|NCT04228627|anemia, ferritin|anemia, ferritin
4961792|NCT04228588|severe asthma|severe asthma
4961793|NCT04228588|mepolizumab|mepolizumab
4961794|NCT04228588|anti IL-5 monoclonal antibody|anti il-5 monoclonal antibody
4961795|NCT04228588|pragmatic study|pragmatic study
4961796|NCT04228575|anxiety|anxiety
4961797|NCT04228575|depression|depression
4980725|NCT04113239|GPAQ|gpaq
4961798|NCT04228575|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
4961800|NCT04228575|patient-centred|patient-centred
4961801|NCT04228575|personalized therapy|personalized therapy
4961802|NCT04228575|knowledge implementation|knowledge implementation
4961803|NCT04228575|mental health system|mental health system
4961804|NCT04228575|therapist-assistance|therapist-assistance
4961805|NCT04228575|booster session|booster session
4961806|NCT04228575|factorial design|factorial design
4961807|NCT04228536|chronic pain|chronic pain
4961808|NCT04228523|Therapeutic education|therapeutic education
4961809|NCT04228523|Parkinson Disease|parkinson disease
5698364|NCT00506649|sedation|sedation
4961810|NCT04228523|Socials representations|socials representations
4961811|NCT04228497|Gastric residual volume; children; ultrasound; fasting|gastric residual volume; children; ultrasound; fasting
4961812|NCT04228484|Type 2 Diabetes,|type 2 diabetes,
4961813|NCT04228484|Incretin Effect|incretin effect
4961814|NCT04228484|GIP|gip
4961815|NCT04228484|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
4961816|NCT04228471|Airway Pressure Release Ventilation|airway pressure release ventilation
4961817|NCT04228471|Bilevel Continuous Positive Airway Pressure|bilevel continuous positive airway pressure
4961818|NCT04228471|Biphasic Continuous Positive Airway Pressure|biphasic continuous positive airway pressure
5290298|NCT02223052|GBM|gbm
4961819|NCT04228471|Mechanical Ventilation|mechanical ventilation
4961820|NCT04228471|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4961821|NCT04228471|Spontaneous Breathing|spontaneous breathing
4961822|NCT04228432|Breast Cancer|breast cancer
4961823|NCT04228432|Hormonotherapy|hormonotherapy
4961824|NCT04228432|E-monitoring|e-monitoring
4961825|NCT04228419|arthroplasty|arthroplasty
4961826|NCT04228419|glenohumeral osteoarthritis|glenohumeral osteoarthritis
4961827|NCT04228419|surgical management|surgical management
4961828|NCT04228393|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4961829|NCT04228393|6-mercaptopurine|6-mercaptopurine
4961830|NCT04228393|children|children
4961831|NCT04228393|individualized treatment|individualized treatment
4961832|NCT04228315|primaquine|primaquine
4961833|NCT04228315|biomarker|biomarker
4961834|NCT04228315|hypnozoite|hypnozoite
4961835|NCT04228315|efficacy|efficacy
4961836|NCT04228289|PTSD|ptsd
4961837|NCT04228289|Veterans|veterans
4961841|NCT04228276|Magnetic resonance imaging|magnetic resonance imaging
4961842|NCT04228276|Transcranial magnetic stimulation|transcranial magnetic stimulation
4961844|NCT04228276|Reward processing|reward processing
4961845|NCT04228250|opioid analgesics|opioid analgesics
4961846|NCT04228250|physical dependence|physical dependence
4961847|NCT04228250|buprenorphine|buprenorphine
4961848|NCT04228237|lung cancer|lung cancer
4961849|NCT04228237|bronchogenic carcinoma|bronchogenic carcinoma
4961850|NCT04228237|diagnosis|diagnosis
4961851|NCT04228237|treatment|treatment
4961852|NCT04228237|non-interventional|non-interventional
4961853|NCT04228224|Stroke|stroke
4961854|NCT04228224|Hemiparesis|hemiparesis
4961855|NCT04228224|Gait|gait
4961856|NCT04228224|Brain-Computer Interface|brain-computer interface
4961857|NCT04228224|Rehabilitation|rehabilitation
4961858|NCT04228224|Exoskeleton|exoskeleton
4961859|NCT04228211|prostate cancer|prostate cancer
4961860|NCT04228211|trials within cohorts (TwiCs) design|trials within cohorts (twics) design
4961861|NCT04228185|Sleeve gastrectomy|sleeve gastrectomy
4961862|NCT04228185|banded sleeve|banded sleeve
4961863|NCT04228185|obesity surgery|obesity surgery
4961864|NCT04228172|GBA|gba
4961865|NCT04228172|genetic|genetic
4961866|NCT04228172|progression|progression
4961867|NCT04228172|PD|pd
4961868|NCT04228159|Accidental Falls, Frail Elderly, Physical Therapy Specialty|accidental falls, frail elderly, physical therapy specialty
4961885|NCT04227964|survival analysis|survival analysis
4961886|NCT04227964|Complication free survival|complication free survival
4961887|NCT04227964|Recurrence analysis|recurrence analysis
4961888|NCT04227964|Oral health related quality of life|oral health related quality of life
4961889|NCT04227951|Gastrectomy|gastrectomy
4961890|NCT04227951|Drain|drain
4961891|NCT04227951|Drainage|drainage
4961892|NCT04227938|steroid-resistant acute graft versus host disease|steroid-resistant acute graft versus host disease
4961893|NCT04227938|steroid-refractory acute graft versus host disease|steroid-refractory acute graft versus host disease
4961894|NCT04227899|Infrapopliteal lesions|infrapopliteal lesions
4961918|NCT04227795|Detection|detection
4961919|NCT04227795|Computer-aided|computer-aided
4961920|NCT04227782|magnetic resonance spectroscopy|magnetic resonance spectroscopy
4961921|NCT04227782|magnetic resonance imaging|magnetic resonance imaging
4961922|NCT04227782|isotope tracer studies|isotope tracer studies
4961923|NCT04227782|fatty acid oxidation|fatty acid oxidation
4961924|NCT04227782|de-novo lipogenesis|de-novo lipogenesis
4961925|NCT04227782|liver phosphorus MR spectroscopy|liver phosphorus mr spectroscopy
4961926|NCT04227769|anakinra|anakinra
4961927|NCT04227769|cephalic phase of insulin secretion|cephalic phase of insulin secretion
4961928|NCT04227717|Thoracic lesions|thoracic lesions
4961929|NCT04227717|Lumbar lesions|lumbar lesions
4961930|NCT04227717|Sacral spine lesions|sacral spine lesions
4961931|NCT04227717|MRI Coil|mri coil
4961932|NCT04227717|spine radiotherapy|spine radiotherapy
4961933|NCT04227717|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4961950|NCT04227613|prospective studies|prospective studies
4961951|NCT04227613|breast neoplasms|breast neoplasms
4961952|NCT04227613|breast|breast
4961953|NCT04227613|patient satisfaction|patient satisfaction
4961954|NCT04227613|patient reported outcome measures|patient reported outcome measures
4961955|NCT04227613|oncoplastic breast surgery|oncoplastic breast surgery
4961956|NCT04227613|follow-up studies|follow-up studies
4961957|NCT04227613|mastectomy|mastectomy
4961958|NCT04227613|quality of life|quality of life
4961959|NCT04227613|Sweden|sweden
4961960|NCT04227587|insomnia|insomnia
4961961|NCT04227574|Insomnia|insomnia
4961964|NCT04227548|Critical illness myopathy|critical illness myopathy
4961965|NCT04227548|Critical illness neuropathy|critical illness neuropathy
4961966|NCT04227548|direct muscle stimulation|direct muscle stimulation
4961967|NCT04227535|Rheumatoid Arthritis|rheumatoid arthritis
4961968|NCT04227535|Interstitial lung disease|interstitial lung disease
4961969|NCT04227522|Rucaparib|rucaparib
4961970|NCT04227522|maintenance therapy|maintenance therapy
4961971|NCT04227522|Bevacizumab|bevacizumab
4961972|NCT04227522|Ovarian Cancer|ovarian cancer
4961974|NCT04227483|ABPA|abpa
4961975|NCT04227483|Asthma|asthma
4961976|NCT04227483|Glucocorticoids|glucocorticoids
4961977|NCT04227470|NMOSD|nmosd
4961978|NCT04227457|Lung Cancer|lung cancer
4961979|NCT04227379|text messaging|text messaging
4961980|NCT04227379|Health Equity|health equity
4961981|NCT04227379|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
4961982|NCT04227366|anti-IL-6R|anti-il-6r
4961983|NCT04227366|IL-6 receptor inhibitors|il-6 receptor inhibitors
4961984|NCT04227353|colorectal|colorectal
4961985|NCT04227353|cancer|cancer
4961986|NCT04227353|diet|diet
4961987|NCT04227353|physical activity|physical activity
4961988|NCT04227353|survivorship|survivorship
4960407|NCT04236531|at-risk|at-risk
4961989|NCT04227353|behaviour|behaviour
4962001|NCT04227327|abemaciclib|abemaciclib
4962002|NCT04227327|Hormone-Receptor-Positive (HR+)|hormone-receptor-positive (hr+)
4980923|NCT04111939|Naloxone|naloxone
4962015|NCT04227236|Sexual|sexual
4962016|NCT04227236|health|health
4962017|NCT04227223|neurological condition|neurological condition
4962018|NCT04227223|opioids|opioids
4962019|NCT04227223|oxidative balance|oxidative balance
4962020|NCT04227223|pain|pain
4962021|NCT04227210|vaccine|vaccine
4962022|NCT04227210|live attenuated|live attenuated
4962023|NCT04227210|safety|safety
4962024|NCT04227210|immunogenicity|immunogenicity
4962025|NCT04227210|viral shedding|viral shedding
4962026|NCT04227210|phase 1 clinical trial|phase 1 clinical trial
4962027|NCT04227197|Online Health Tool|online health tool
4962028|NCT04227197|Health evaluations|health evaluations
4962029|NCT04227197|Celiac Screen|celiac screen
4962030|NCT04227197|Sleep Study|sleep study
4962031|NCT04227197|Thyroid Test|thyroid test
4962032|NCT04227197|Audiogram|audiogram
4962033|NCT04227197|Ophthalmology evaluation|ophthalmology evaluation
5903437|NCT00392756|Pulsatile GnRH|pulsatile gnrh
4962034|NCT04227197|Healthcare outcomes survey|healthcare outcomes survey
4962035|NCT04227197|Experience survey|experience survey
4962036|NCT04227184|Urinary Incontinence|urinary incontinence
4962037|NCT04227184|Urgency urinary incontinence|urgency urinary incontinence
4962038|NCT04227184|Trospium|trospium
4962039|NCT04227158|red blood cell|red blood cell
4962040|NCT04227158|mean corpuscular hemoglobin|mean corpuscular hemoglobin
4962041|NCT04227158|hemoglobin|hemoglobin
4962042|NCT04227158|Hemodialysis patients|hemodialysis patients
4962043|NCT04227145|contraception|contraception
4962044|NCT04227145|sexhealth mobile|sexhealth mobile
4962045|NCT04227145|substance abuse|substance abuse
4962046|NCT04227132|Neglect|neglect
4962047|NCT04227132|Recovery of function|recovery of function
4962048|NCT04227132|Rehabilitation|rehabilitation
4962049|NCT04227132|Videogame|videogame
4962050|NCT04227132|Post-stroke|post-stroke
4962051|NCT04227119|Cardiology|cardiology
4962052|NCT04227119|Electrophysiology|electrophysiology
4962053|NCT04227106|chronic wounds|chronic wounds
4962054|NCT04227093|Acetazolamide|acetazolamide
4962055|NCT04227093|Carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
4962056|NCT04227093|Upper airway stimulation|upper airway stimulation
4962057|NCT04227093|Surgery|surgery
4962058|NCT04227080|Phenylketonuria, PAH Deficiency, Kuvan|phenylketonuria, pah deficiency, kuvan
4962059|NCT04227067|TENS, back pain, ibuprofen|tens, back pain, ibuprofen
4962060|NCT04226963|treatment resistant depression|treatment resistant depression
4962061|NCT04226963|bipolar depression|bipolar depression
4962062|NCT04226963|ketamine|ketamine
4962063|NCT04226963|multiple series|multiple series
4962064|NCT04226963|major depressive disorder|major depressive disorder
4962065|NCT04226950|Essential Thrombocythemia|essential thrombocythemia
4962066|NCT04226950|Childhood|childhood
4962067|NCT04226950|Interferon Alfa|interferon alfa
4962068|NCT04226950|Pegylated Interferon Alfa-2b|pegylated interferon alfa-2b
4962069|NCT04226924|OPMD|opmd
4962070|NCT04226924|DMOP|dmop
4962071|NCT04226924|Dysphagia|dysphagia
4962072|NCT04226898|Schizophrenia|schizophrenia
4962073|NCT04226898|Schizoaffective Disorder|schizoaffective disorder
4962074|NCT04226898|Synbiotics|synbiotics
4962075|NCT04226898|Synbiotic|synbiotic
4962076|NCT04226885|fentanyl ,midazolam, dexmeditomidine|fentanyl ,midazolam, dexmeditomidine
4962077|NCT04226872|Caregivers|caregivers
4962078|NCT04226872|Quality of life|quality of life
4962079|NCT04226872|Dementia|dementia
4962080|NCT04226872|Web-based intervention|web-based intervention
4962081|NCT04226859|Kidney Transplantation|kidney transplantation
4962082|NCT04226859|Graft Survival|graft survival
4962083|NCT04226859|Glomerular Filtration Rate|glomerular filtration rate
4962084|NCT04226859|Trajectories|trajectories
4962085|NCT04226833|Hepatic Impairment|hepatic impairment
4962086|NCT04226820|diabetes mellitus|diabetes mellitus
4962087|NCT04226820|muscular oxygenation|muscular oxygenation
4962088|NCT04226820|vascular function|vascular function
4962089|NCT04226807|Postpartum Care|postpartum care
4962090|NCT04226807|Visit Attendance|visit attendance
4962091|NCT04226781|tissue perfusion|tissue perfusion
4962092|NCT04226781|hyperspectral imaging|hyperspectral imaging
4962093|NCT04226781|fluorescence imaging|fluorescence imaging
4962094|NCT04226781|idocyaningreen (ICG)|idocyaningreen (icg)
4962095|NCT04226768|Myelodysplastic syndrome|myelodysplastic syndrome
4962096|NCT04226768|Acute myeloid leukemia|acute myeloid leukemia
4962098|NCT04226755|Sodium|sodium
4962099|NCT04226755|Salt|salt
4962100|NCT04226755|Heart Failure|heart failure
4962101|NCT04226716|Postural control|postural control
4962102|NCT04226716|Body perception|body perception
5939477|NCT01212783|parenting|parenting
4962103|NCT04226716|Psychosocial factors|psychosocial factors
4962104|NCT04226703|airway|airway
4962105|NCT04226703|laryngoscopy|laryngoscopy
4962106|NCT04226703|ultrasonography|ultrasonography
4962107|NCT04226677|gaming disorder|gaming disorder
4962108|NCT04226677|aerobic exercise|aerobic exercise
4962109|NCT04226677|exergame|exergame
4962110|NCT04226664|Bariatric Surgery|bariatric surgery
4962111|NCT04226638|Slipping rib syndrome|slipping rib syndrome
4962118|NCT04226599|Dialysis scoring Fistulas|dialysis scoring fistulas
4962119|NCT04226586|essential amino acids|essential amino acids
4962121|NCT04226573|Preoperative anxiety|preoperative anxiety
4962122|NCT04226573|Umbilical cord blood|umbilical cord blood
4962123|NCT04226573|Cytokines|cytokines
4962124|NCT04226560|Nearsightedness|nearsightedness
4962125|NCT04226560|Eye wear|eye wear
4962126|NCT04226560|Myopia control|myopia control
4962127|NCT04226560|Contact lens|contact lens
4962128|NCT04226521|Heart transplant|heart transplant
4962129|NCT04226521|vasculopathy|vasculopathy
5698365|NCT00506649|delirium|delirium
5003861|NCT03972046|T-VEC|t-vec
4962130|NCT04226521|extracorporeal photopheresis|extracorporeal photopheresis
4962131|NCT04226521|prevention|prevention
4962132|NCT04226521|optical coherence tomography|optical coherence tomography
4962133|NCT04226482|Appendectomy|appendectomy
4962134|NCT04226482|Laparoscopic Surgery|laparoscopic surgery
4962135|NCT04226482|Equipment Reuse|equipment reuse
4962145|NCT04226443|Patient Satisfaction|patient satisfaction
4962146|NCT04226443|Arteriovenous Fistula|arteriovenous fistula
4962147|NCT04226430|Endocan|endocan
4962148|NCT04226430|Copeptin|copeptin
4962149|NCT04226430|Interleukin-6|interleukin-6
4962150|NCT04226430|Cytosorb|cytosorb
4962151|NCT04226430|Sepsis|sepsis
4962152|NCT04226417|transcranial direct current stimulation, stroke, motor function|transcranial direct current stimulation, stroke, motor function
4962157|NCT04226365|concussion|concussion
4962158|NCT04226365|headache|headache
4962159|NCT04226365|mild TBI|mild tbi
4962160|NCT04226365|post concussion|post concussion
4962161|NCT04226339|total knee arthroplasty|total knee arthroplasty
4962162|NCT04226339|prosthesis|prosthesis
4962163|NCT04226339|kinetic alignment|kinetic alignment
4962164|NCT04226339|mechanical alignment|mechanical alignment
4962165|NCT04226326|Microvascular Resistance|microvascular resistance
4962166|NCT04226326|Percutaneous Coronary Intervention|percutaneous coronary intervention
4962167|NCT04226313|human papillomavirus|human papillomavirus
4962168|NCT04226313|HPV|hpv
4962169|NCT04226313|self-sampling|self-sampling
4962170|NCT04226313|cervicovaginal swab|cervicovaginal swab
4962171|NCT04226313|cervical cancer screening|cervical cancer screening
4962172|NCT04226313|non-attendance|non-attendance
4962173|NCT04226300|transversus abdominus plane|transversus abdominus plane
4962174|NCT04226300|nerve block|nerve block
4962175|NCT04226300|TAP block|tap block
4962176|NCT04226300|laparoscopic vs. ultrasound|laparoscopic vs. ultrasound
4962177|NCT04226300|post-op pain|post-op pain
4962178|NCT04226248|Parkinson Disease|parkinson disease
4962179|NCT04226248|Parkinson|parkinson
4962180|NCT04226248|Rivastigmine|rivastigmine
4962181|NCT04226248|Falls|falls
4962182|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors
4962183|NCT04226248|Phase III|phase iii
4962184|NCT04226209|scoliosis|scoliosis
4962185|NCT04226209|PSSE|psse
4962186|NCT04226209|balance|balance
4962187|NCT04226209|plantar pressure|plantar pressure
4962188|NCT04226196|Intraocular lens rotation|intraocular lens rotation
4962189|NCT04226196|capsular tension ring|capsular tension ring
4962190|NCT04226196|postoperative tilt & decentration|postoperative tilt & decentration
4962191|NCT04226183|Antioxidants|antioxidants
4962192|NCT04226183|Malondialdehyde level|malondialdehyde level
4962193|NCT04226183|the third trimester of pregnancy|the third trimester of pregnancy
4962194|NCT04226183|exercise|exercise
4962195|NCT04226183|anti oxidant|anti oxidant
4962196|NCT04226183|stress oxidative|stress oxidative
4962197|NCT04226157|Blood Pressure|blood pressure
4962198|NCT04226157|Stroke|stroke
4962199|NCT04226157|Hypertension|hypertension
4962216|NCT04226040|emergency department|emergency department
4962221|NCT04226014|pancreatic echogenecity|pancreatic echogenecity
4962222|NCT04226014|Hepatic Steatosis|hepatic steatosis
4962223|NCT04226014|Metabolic Syndrome|metabolic syndrome
4962224|NCT04226014|Obesity|obesity
4962225|NCT04225988|kidney transplant|kidney transplant
4962226|NCT04225988|rejection|rejection
4962227|NCT04225988|donor-specific antibodies|donor-specific antibodies
5290608|NCT02221466|foot|foot
4962228|NCT04225975|Anoxia-Ischemia, Brain|anoxia-ischemia, brain
4962229|NCT04225975|postpartum|postpartum
4962230|NCT04225975|Electroencephalography|electroencephalography
4962231|NCT04225975|Cerebral oxymetry|cerebral oxymetry
4962232|NCT04225975|Near Infrared spectroscopy|near infrared spectroscopy
4962233|NCT04225975|EEG|eeg
4962234|NCT04225975|NIRS|nirs
4962235|NCT04225975|Neonate|neonate
4968005|NCT04189809|HCC|hcc
4960656|NCT04235114|PET|pet
4962246|NCT04225897|sisunatovir|sisunatovir
4962247|NCT04225858|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4962248|NCT04225858|Sentinel lymph node biopsy|sentinel lymph node biopsy
4962249|NCT04225858|Breast cancer|breast cancer
4962250|NCT04225858|Complete response|complete response
4962251|NCT04225832|Latino/Hispanic/Latinx|latino/hispanic/latinx
5698366|NCT00506649|coma|coma
5003996|NCT03971097|Opiates|opiates
4962252|NCT04225832|men who have sex with men|men who have sex with men
4962253|NCT04225819|Vitamin D3|vitamin d3
4962254|NCT04225819|Cholecalciferol|cholecalciferol
4962256|NCT04225819|Inflammatory Bowel Disease|inflammatory bowel disease
4962257|NCT04225819|Adjunctive treatment|adjunctive treatment
4962258|NCT04225819|Crohn's Disease|crohn's disease
4962259|NCT04225819|Ulcerative Colitis|ulcerative colitis
4962260|NCT04225793|colorectal cancer|colorectal cancer
4962261|NCT04225793|colonoscopy|colonoscopy
4962262|NCT04225793|Eziclen|eziclen
4962267|NCT04225741|Mammography|mammography
4962268|NCT04225741|Breast self-examination|breast self-examination
4962269|NCT04225741|Early diagnosis|early diagnosis
4962270|NCT04225728|oxidative stress|oxidative stress
4962271|NCT04225728|exercise tolerance|exercise tolerance
4962272|NCT04225728|intravenous route (IV)|intravenous route (iv)
4962273|NCT04225728|intramuscular route (IM)|intramuscular route (im)
4962274|NCT04225689|food reintroduction|food reintroduction
4962275|NCT04225689|dietary intervention|dietary intervention
4962276|NCT04225689|dietary triggers|dietary triggers
4962277|NCT04225689|faecal calprotectin|faecal calprotectin
4962278|NCT04225689|CD-TREAT|cd-treat
4962279|NCT04225689|Exclusive enteral nutrition|exclusive enteral nutrition
4962280|NCT04225676|CTL019|ctl019
4962281|NCT04225676|Kymriah|kymriah
4962282|NCT04225676|Tisagenlecleucel|tisagenlecleucel
4962283|NCT04225676|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
4962284|NCT04225676|Leukemia|leukemia
4962285|NCT04225676|ALL|all
4962286|NCT04225676|Pediatric|pediatric
4962287|NCT04225676|Young Adult|young adult
4962291|NCT04225650|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4962292|NCT04225650|Asthma|asthma
4962293|NCT04225650|Epidemiology|epidemiology
4962294|NCT04225650|Inflammatory Bowel Diseases|inflammatory bowel diseases
4962295|NCT04225637|Rapid Palatal Expansion|rapid palatal expansion
4962296|NCT04225637|Slow Palatal Expansion|slow palatal expansion
4962297|NCT04225637|Miniscrew|miniscrew
4962298|NCT04225637|Bone-borne Expander|bone-borne expander
4962299|NCT04225624|OCD|ocd
4962300|NCT04225624|GAD|gad
4962301|NCT04225624|MDD|mdd
4962302|NCT04225624|Rumination|rumination
4981228|NCT04110041|fMRI|fmri
4962317|NCT04225520|Mechanical dyssynchrony|mechanical dyssynchrony
4962318|NCT04225520|Echocardiography|echocardiography
4962319|NCT04225520|Apical rocking|apical rocking
4962320|NCT04225520|Septal flash|septal flash
4962321|NCT04225520|Left ventricle|left ventricle
4962322|NCT04225494|Retroperitoneal Sarcoma|retroperitoneal sarcoma
4962323|NCT04225494|Surgery|surgery
4962324|NCT04225494|Haemodynamic assessment|haemodynamic assessment
4962325|NCT04225494|Adrenalectomy|adrenalectomy
4962329|NCT04225442|Chronobiome|chronobiome
4962330|NCT04225442|Multiomics|multiomics
4962331|NCT04225442|Molecular networks|molecular networks
4962332|NCT04225442|Circadian clocks|circadian clocks
4962333|NCT04225442|Remote sensing|remote sensing
4962334|NCT04225429|Epithelioid Sarcoma|epithelioid sarcoma
4962335|NCT04225429|Oncology|oncology
4962336|NCT04225429|SMARC-B|smarc-b
4962337|NCT04225429|loss of INI 1|loss of ini 1
4962338|NCT04225429|EZH2|ezh2
4962339|NCT04225429|Expanded Access|expanded access
4962340|NCT04225429|Compassionate Use|compassionate use
4962341|NCT04225416|hemodialysis|hemodialysis
4962349|NCT04225390|resistance|resistance
4962350|NCT04225390|dacarbazine|dacarbazine
4962351|NCT04225364|neoadjuvant immunotherapy|neoadjuvant immunotherapy
4962352|NCT04225364|Stage II-IVA|stage ii-iva
4962353|NCT04225364|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4962354|NCT04225364|ctDNA|ctdna
4962355|NCT04225364|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4962356|NCT04225338|renal transplantation|renal transplantation
4962357|NCT04225338|transplated renal artery stenosis|transplated renal artery stenosis
4962358|NCT04225338|percutaneous intervention|percutaneous intervention
4962359|NCT04225325|antiretroviral drugs|antiretroviral drugs
4962360|NCT04225325|HIV viral reservoir|hiv viral reservoir
4962361|NCT04225325|HIV acute infection|hiv acute infection
4962362|NCT04225312|Natalizumab|natalizumab
4962363|NCT04225312|Extended interval dosing|extended interval dosing
4962364|NCT04225299|Prostatic Disease|prostatic disease
4962365|NCT04225299|Genital Neoplasm,male|genital neoplasm,male
4962366|NCT04225299|Urogenital neoplasm|urogenital neoplasm
4962367|NCT04225299|Genital disease,male|genital disease,male
4962368|NCT04225299|Male urogenital disease|male urogenital disease
4962369|NCT04225299|Neoplasms|neoplasms
5939478|NCT01212783|home visitation|home visitation
4962370|NCT04225299|Neoplasms by site|neoplasms by site
4962371|NCT04225299|Prostatic neoplasm|prostatic neoplasm
4962372|NCT04225299|Carcinoma|carcinoma
4962391|NCT04225117|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
4962393|NCT04225117|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4962394|NCT04225117|Hormone receptor-positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer|hormone receptor-positive/ human epidermal growth factor receptor 2-negative (hr+/her2-) breast cancer
4962395|NCT04225117|non-squamous NSCLC|non-squamous nsclc
4962396|NCT04225117|locally advanced or metastatic malignant solid tumors|locally advanced or metastatic malignant solid tumors
4962397|NCT04225117|Head and neck cancer|head and neck cancer
4962398|NCT04225117|EV-202|ev-202
4962399|NCT04225117|Gastric or gastroesophageal junction (GEJ) or esophageal cancer|gastric or gastroesophageal junction (gej) or esophageal cancer
4962405|NCT04225013|Diagnosis|diagnosis
4962406|NCT04225000|Tibiofemoral Mobilization|tibiofemoral mobilization
4962407|NCT04225000|Kujala Anterior Knee Pain Scale|kujala anterior knee pain scale
4962408|NCT04225000|Numeric Pain Rating Scale|numeric pain rating scale
4962409|NCT04225000|Pressure Pain Threshold|pressure pain threshold
4962410|NCT04224987|Mass Treatment|mass treatment
4962411|NCT04224987|Azithromycin|azithromycin
4962412|NCT04224987|Childhood Mortality Rate|childhood mortality rate
4962413|NCT04224987|Antimicrobial Resistance|antimicrobial resistance
4962414|NCT04224987|Implementation and Cost Analysis|implementation and cost analysis
4962415|NCT04224948|Retroperitoneal Sarcoma|retroperitoneal sarcoma
4962416|NCT04224948|Retroperitoneal|retroperitoneal
4962417|NCT04224948|Sarcoma|sarcoma
4962418|NCT04224948|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4962419|NCT04224948|preoperative Chemotherapy|preoperative chemotherapy
4962420|NCT04224883|gastrointestinal function|gastrointestinal function
4962421|NCT04224883|enteral feeding|enteral feeding
4962422|NCT04224883|critical|critical
4962428|NCT04224831|Central serous chorioretinopathy|central serous chorioretinopathy
4962429|NCT04224831|Electromagnetic stimulation|electromagnetic stimulation
4962430|NCT04224831|Platelet rich plasma|platelet rich plasma
4962431|NCT04224831|Growth factors|growth factors
4962432|NCT04224831|Iontophoresis|iontophoresis
4962433|NCT04224805|Le Fort|le fort
4962434|NCT04224805|Orthognathic surgery|orthognathic surgery
4962435|NCT04224805|Virtual surgical planning|virtual surgical planning
4962438|NCT04224766|suprascapular and costoclavicular blocks|suprascapular and costoclavicular blocks
4962440|NCT04224714|microcirculation resistance index (IMR)|microcirculation resistance index (imr)
4962441|NCT04224714|fractional flow reserve(FFR)|fractional flow reserve(ffr)
4962442|NCT04224688|ITP|itp
4962443|NCT04224688|UCB7665|ucb7665
4962444|NCT04224688|Rozanolixizumab|rozanolixizumab
4962445|NCT04224688|Primary Immune Thrombocytopenia|primary immune thrombocytopenia
4962446|NCT04224597|enthesitis|enthesitis
4962447|NCT04224597|acne vulgaris|acne vulgaris
4962448|NCT04224597|Guess|guess
4962449|NCT04224571|Relapsed ALL|relapsed all
4962450|NCT04224545|Colchicine|colchicine
4962451|NCT04224545|Postoperative atrial fibrillation|postoperative atrial fibrillation
4962452|NCT04224545|Anti-inflammatory|anti-inflammatory
4962453|NCT04224545|Cardiac surgery|cardiac surgery
4962454|NCT04224545|Sympatholytic|sympatholytic
4962455|NCT04224532|optic nerve sheath diameter|optic nerve sheath diameter
4962456|NCT04224532|intracranial pressure|intracranial pressure
4962457|NCT04224532|laparoscopic cholecystectomy|laparoscopic cholecystectomy
4962458|NCT04224532|pneumoperitoneum|pneumoperitoneum
4962459|NCT04224454|Vaccine|vaccine
4962460|NCT04224454|Coverage|coverage
4962461|NCT04224454|Sjögren's syndrome|sjögren's syndrome
4962462|NCT04224441|drug repurposing|drug repurposing
4962463|NCT04224441|antipsychotic drugs|antipsychotic drugs
4962464|NCT04224441|glioblastoma|glioblastoma
4962465|NCT04224376|ACL rupture|acl rupture
4962466|NCT04224376|return to sports|return to sports
4962467|NCT04224363|Lugol's solution|lugol's solution
4962468|NCT04224363|staining sequence|staining sequence
4962472|NCT04224298|Human; Biosignature; Artificial intelligence; Image analysis|human; biosignature; artificial intelligence; image analysis
4962474|NCT04224285|sleep deficiency|sleep deficiency
4962475|NCT04224285|workplace health|workplace health
4962476|NCT04224285|occupational health|occupational health
4962477|NCT04224285|workplace health promotion|workplace health promotion
4962483|NCT04224272|Biparatopic antibody|biparatopic antibody
4962484|NCT04224272|Immunotherapy|immunotherapy
4962485|NCT04224272|Breast cancer|breast cancer
4962486|NCT04224272|Chemotherapy|chemotherapy
4962487|NCT04224272|Palbociclib|palbociclib
4962488|NCT04224272|Fulvestrant|fulvestrant
4962489|NCT04224259|Ultrasound|ultrasound
4962490|NCT04224259|pre-scan|pre-scan
4962491|NCT04224259|right internal jugular vein|right internal jugular vein
4962492|NCT04224233|Physical activity|physical activity
4962493|NCT04224233|Home-based|home-based
4962494|NCT04224233|Interstitial lung diseases|interstitial lung diseases
4962495|NCT04224233|Lifestyle|lifestyle
4962496|NCT04224207|Retinitis pigmentosa|retinitis pigmentosa
4962497|NCT04224207|Wharton's jelly derived mesenchimal stem cell|wharton's jelly derived mesenchimal stem cell
4962504|NCT04224181|Endothelial Dysfunction|endothelial dysfunction
4962505|NCT04224181|Cardiovascular Disease Risk|cardiovascular disease risk
4962506|NCT04224142|Maternal|maternal
4962508|NCT04224142|Phenylketonuria|phenylketonuria
4962510|NCT04224142|Glycomacropeptide|glycomacropeptide
4962511|NCT04224116|tranexamic acid|tranexamic acid
4962512|NCT04224116|Antifibrinolytic agents|antifibrinolytic agents
4962513|NCT04224116|bleeding|bleeding
4962514|NCT04224116|blood transfusion|blood transfusion
4962515|NCT04224116|thoracic surgery.|thoracic surgery.
4962516|NCT04224103|Venoarterial ECMO|venoarterial ecmo
4962517|NCT04224103|VA-ECMO weaning|va-ecmo weaning
4962518|NCT04224103|Inhaled nitric oxide|inhaled nitric oxide
4962519|NCT04224103|Right ventricle|right ventricle
4962520|NCT04224090|Coronary arteries abnormalities|coronary arteries abnormalities
4962521|NCT04224090|Coronary arteries anomaly|coronary arteries anomaly
4962522|NCT04224090|Coronary origin from the wrong sinus of Valsalva|coronary origin from the wrong sinus of valsalva
4962523|NCT04224090|Echocardiography|echocardiography
4962524|NCT04224077|Radiculopathy Lumbar|radiculopathy lumbar
4962525|NCT04224077|MRI|mri
4962526|NCT04224077|Diffusion tensor imaging|diffusion tensor imaging
4962527|NCT04224077|Multiband technique|multiband technique
4962528|NCT04224064|Liposarcoma|liposarcoma
4962529|NCT04224064|Cancer|cancer
4962530|NCT04224064|Atypical Lipomatous Tumor|atypical lipomatous tumor
4963014|NCT04221542|AMG 509|amg 509
4962540|NCT04223999|TTFields|ttfields
4962541|NCT04223999|Clinical trial|clinical trial
4962542|NCT04223999|Phase 2|phase 2
4962543|NCT04223999|Skullremodeling surgery|skullremodeling surgery
4962544|NCT04223999|Enhancing tumor treating fields|enhancing tumor treating fields
4962545|NCT04223999|Optimizing tumor treating fields|optimizing tumor treating fields
4962546|NCT04223999|tumor treating fields|tumor treating fields
4962547|NCT04223999|Skull remodeling surgery|skull remodeling surgery
4962548|NCT04223999|SR-surgery|sr-surgery
4962549|NCT04223999|Brain cancer|brain cancer
4962550|NCT04223999|Experimental neurosurgery|experimental neurosurgery
4962551|NCT04223973|diabetes management|diabetes management
4962552|NCT04223973|Insulin Pump|insulin pump
4962557|NCT04223921|Medication reconciliation|medication reconciliation
4962558|NCT04223908|major hypertriglyceridemia|major hypertriglyceridemia
4962559|NCT04223908|health burden|health burden
4962561|NCT04223869|Periodontitis|periodontitis
4962562|NCT04223869|Interleukin 34|interleukin 34
4962563|NCT04223869|RANKL|rankl
4962564|NCT04223869|OPG|opg
4962565|NCT04223869|gingival crevicular fluid|gingival crevicular fluid
4962566|NCT04223856|Urothelial Cancer|urothelial cancer
4962567|NCT04223856|Enfortumab vedotin|enfortumab vedotin
4962568|NCT04223856|metastatic urothelial cancer|metastatic urothelial cancer
4962569|NCT04223856|pembrolizumab|pembrolizumab
4962570|NCT04223856|locally advanced urothelial cancer|locally advanced urothelial cancer
4962579|NCT04223765|CAR T cells|car t cells
4962580|NCT04223765|Kappa|kappa
4962581|NCT04223765|CD28|cd28
4962582|NCT04223765|Lymphoma|lymphoma
4962583|NCT04223765|T lymphocytes|t lymphocytes
4962584|NCT04223739|Cardiac Surgery|cardiac surgery
4962585|NCT04223739|Atrial Fibrillation|atrial fibrillation
4962586|NCT04223726|chronic kidney disease|chronic kidney disease
4962587|NCT04223726|quality of life|quality of life
4962588|NCT04223713|aortic stenosis|aortic stenosis
4962589|NCT04223713|aortic regurgitation|aortic regurgitation
4962590|NCT04223713|Trileaflet reconstruction of the aortic valve|trileaflet reconstruction of the aortic valve
4962601|NCT04223674|screen|screen
4962602|NCT04223674|treat|treat
4962603|NCT04223674|recurrent|recurrent
4962604|NCT04223674|vivax|vivax
4962605|NCT04223661|multiple myeloma|multiple myeloma
4962606|NCT04223635|Moderate hepatic impaired|moderate hepatic impaired
4962610|NCT04223635|Tenosynovial giant cell tumor (TGCT)|tenosynovial giant cell tumor (tgct)
4962611|NCT04223622|mesenchymal stem/stromal cells|mesenchymal stem/stromal cells
4962612|NCT04223622|conditioned medium|conditioned medium
4962613|NCT04223622|extracellular vesicles|extracellular vesicles
4962615|NCT04223596|Lung cancer|lung cancer
4962616|NCT04223596|ALK +|alk +
4962617|NCT04223596|locally advanced|locally advanced
4962618|NCT04223596|metastasic SCLC|metastasic sclc
4962619|NCT04223596|brigatinib|brigatinib
4962620|NCT04223596|non small cell lung cancer|non small cell lung cancer
4962621|NCT04223570|Photodynamic Therapy|photodynamic therapy
4962622|NCT04223570|Protoporphyrin IX Measurement|protoporphyrin ix measurement
4962623|NCT04223570|Actinic Keratoses|actinic keratoses
4962631|NCT04223492|Breast Cancer|breast cancer
4962632|NCT04223492|Neoadjuvant|neoadjuvant
4962633|NCT04223492|Response Prediction|response prediction
4962634|NCT04223492|Liquid Biopsies|liquid biopsies
4962635|NCT04223492|Magnetic resonance imaging|magnetic resonance imaging
4962636|NCT04223492|Circulating Tumor DNA|circulating tumor dna
4962637|NCT04223479|Ulcerative Colitis|ulcerative colitis
4962638|NCT04223479|immune system|immune system
4962639|NCT04223479|Inflammatory markers|inflammatory markers
4962640|NCT04223479|Probiotics|probiotics
4962641|NCT04223466|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4962642|NCT04223466|Subxiphoid approach|subxiphoid approach
4962643|NCT04223440|Rotator Cuff Tears|rotator cuff tears
4962645|NCT04223440|Ultrasonographic explorations|ultrasonographic explorations
4962646|NCT04223414|volume expansion|volume expansion
4962647|NCT04223414|fluid responsiveness|fluid responsiveness
4962648|NCT04223414|stroke volume|stroke volume
4962649|NCT04223414|perioperative optimization|perioperative optimization
4962650|NCT04223414|analgesia nociception index|analgesia nociception index
4962651|NCT04223388|Probiotics|probiotics
4962652|NCT04223388|Healthy|healthy
4962653|NCT04223388|Gut Health|gut health
4962654|NCT04223388|Gastrointestinal Health|gastrointestinal health
4962655|NCT04223375|microbiata|microbiata
4962656|NCT04223375|food groups|food groups
4962657|NCT04223362|Physical activity|physical activity
4962658|NCT04223362|Community|community
4962659|NCT04223362|Behavioural change|behavioural change
4962660|NCT04223362|COPD|copd
4962661|NCT04223336|smoking cessation|smoking cessation
4962662|NCT04223336|physical activity|physical activity
4962663|NCT04223336|diet|diet
4962664|NCT04223336|primary care|primary care
4962665|NCT04223336|screening|screening
4962666|NCT04223336|brief intervention|brief intervention
4962667|NCT04223336|integrated care pathway|integrated care pathway
4962668|NCT04223323|Almond|almond
4962669|NCT04223323|Gastrointestinal microbiota|gastrointestinal microbiota
4962670|NCT04223323|Metabolic health|metabolic health
4962671|NCT04223323|Bile acid profiles|bile acid profiles
4962672|NCT04223310|Recurred Atrial Fibrillation After AFCA|recurred atrial fibrillation after afca
4962673|NCT04223310|AF catheter ablation|af catheter ablation
4962674|NCT04223310|Virtual antiarrhythmic drug test|virtual antiarrhythmic drug test
4962675|NCT04223297|dyspnea|dyspnea
4962676|NCT04223297|lung ultrasound|lung ultrasound
4962677|NCT04223297|emergency medicine|emergency medicine
4962678|NCT04223297|blue protocol|blue protocol
4962679|NCT04223284|D-limonene|d-limonene
4962680|NCT04223284|lavender oil (SLVO)|lavender oil (slvo)
4962681|NCT04223284|Olfactory stimulation|olfactory stimulation
4962682|NCT04223284|Obesity|obesity
4962683|NCT04223284|glucose metabolism|glucose metabolism
4962684|NCT04223258|Preterm Infants|preterm infants
4962685|NCT04223258|Automatic oxygen control|automatic oxygen control
4962686|NCT04223258|Respiratory support|respiratory support
4962687|NCT04223245|multimodal|multimodal
4962688|NCT04223245|real-time feedback|real-time feedback
4962693|NCT04223206|gut microbiota dysbiosis|gut microbiota dysbiosis
4962694|NCT04223206|sarcopenia|sarcopenia
4962695|NCT04223206|hemodialysis|hemodialysis
4962696|NCT04223180|Rehabilitation|rehabilitation
4962697|NCT04223180|Upper Limb|upper limb
4962698|NCT04223180|Methylation|methylation
4962699|NCT04223180|Single nucleotide polymorphism|single nucleotide polymorphism
4962700|NCT04223180|BDNF|bdnf
4962701|NCT04223180|SLC6A4|slc6a4
4962702|NCT04223180|Rehabilomics|rehabilomics
4962703|NCT04223167|Energy drink|energy drink
4962704|NCT04223167|heart rate variability|heart rate variability
4962705|NCT04223167|habituation|habituation
4962710|NCT04223076|Periodontal Index|periodontal index
4962711|NCT04223063|Bladder Cancer|bladder cancer
4962712|NCT04223063|Urothelial Carcinoma|urothelial carcinoma
4962713|NCT04223063|Chemotherapy|chemotherapy
4962714|NCT04223063|Neoadjuvant|neoadjuvant
4962784|NCT04222764|Right ventricular failure|right ventricular failure
4962786|NCT04222764|Intensive Care Units|intensive care units
4962787|NCT04222738|Diabetes mellitus|diabetes mellitus
4962788|NCT04222738|Diastolic function|diastolic function
4962789|NCT04222738|Blood pressure|blood pressure
4962790|NCT04222738|Zingiber officinale|zingiber officinale
4962796|NCT04222699|intranasal mupirocin|intranasal mupirocin
4962797|NCT04222699|topical chlorhexidine|topical chlorhexidine
4962798|NCT04222686|Angiotensin Converting Enzymes Inhibitor|angiotensin converting enzymes inhibitor
4962799|NCT04222686|Angiotensin II Receptor Blockers|angiotensin ii receptor blockers
4962800|NCT04222686|Type 2 Diabetes|type 2 diabetes
4962801|NCT04222686|Exercise induced urinary albumin excretion|exercise induced urinary albumin excretion
4962802|NCT04222686|Blood pressure|blood pressure
4962803|NCT04222673|Suicide|suicide
4962809|NCT04222621|Population-based healthcare database|population-based healthcare database
4962810|NCT04222621|Registry|registry
4962811|NCT04222621|Pregnant women and offspring|pregnant women and offspring
4962812|NCT04222621|Longitudinal study|longitudinal study
4962813|NCT04222608|Cardio-Oncology|cardio-oncology
4962814|NCT04222608|Interventional Cardiology|interventional cardiology
4962815|NCT04222608|Cancer|cancer
4962816|NCT04222608|Oncology|oncology
4962817|NCT04222608|Acute Coronary Syndrome|acute coronary syndrome
4962818|NCT04222608|Myocardial Infarction|myocardial infarction
4962819|NCT04222582|Schizophrenia|schizophrenia
5369121|NCT01861262|drug poisoning|drug poisoning
4962820|NCT04222582|Transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4962841|NCT04222530|Magnifying narrowband endoscopy|magnifying narrowband endoscopy
4962842|NCT04222530|Diagnostic accuracy|diagnostic accuracy
4962843|NCT04222517|hernia|hernia
4962844|NCT04222491|food allergy|food allergy
4962845|NCT04222478|Auriculotherapy|auriculotherapy
4962846|NCT04222478|Xerostomia|xerostomia
4962847|NCT04222478|ENT cancer|ent cancer
4962848|NCT04222465|Advanced ovarian cancer, BRCA1/2|advanced ovarian cancer, brca1/2
4962849|NCT04222452|Burden of disease|burden of disease
4962850|NCT04222452|Bone microstructure|bone microstructure
4962851|NCT04222452|Cognition|cognition
4962852|NCT04222452|Physical functioning|physical functioning
4962862|NCT04222400|Advanced Heart Failure|advanced heart failure
4962863|NCT04222400|Ventricular Assist Device|ventricular assist device
4962864|NCT04222400|Heart Transplantation|heart transplantation
4962865|NCT04222400|Frailty|frailty
4962866|NCT04222400|Sarcopenia|sarcopenia
4962867|NCT04222400|Bioelectrical Impedance Analysis|bioelectrical impedance analysis
4962868|NCT04222400|Muscle Mass|muscle mass
4962869|NCT04222387|MEK Inhibitor-Associated Serous Retinopathy|mek inhibitor-associated serous retinopathy
4962870|NCT04222387|Hair dye|hair dye
4962871|NCT04222387|Aromatic amines|aromatic amines
4962872|NCT04222374|Renal Cell Carcinoma|renal cell carcinoma
4962873|NCT04222374|Expanded Genome-Wide Association|expanded genome-wide association
4962874|NCT04222335|Lung cancer|lung cancer
4962875|NCT04222335|Targeted therapy|targeted therapy
4962876|NCT04222335|resistance|resistance
4962877|NCT04222309|blood brain barrier|blood brain barrier
4962878|NCT04222309|omental free flap|omental free flap
4962879|NCT04222270|Children|children
4962880|NCT04222270|HIV|hiv
4962881|NCT04222270|Caregivers|caregivers
4962882|NCT04222270|Peer|peer
4962883|NCT04222270|Mentors|mentors
4962884|NCT04222270|suppression|suppression
4962885|NCT04222257|Infective endocarditis|infective endocarditis
4962886|NCT04222257|short-course|short-course
4962887|NCT04222257|antibiotic therapy|antibiotic therapy
4962888|NCT04222244|Headache Attributed to Rhinosinusitis|headache attributed to rhinosinusitis
4962889|NCT04222244|Neck Pain|neck pain
4962890|NCT04222244|Musculoskeletal|musculoskeletal
4962891|NCT04222244|Cervical|cervical
4962892|NCT04222244|Joint Laxity|joint laxity
4962893|NCT04222244|Range of Motion|range of motion
4962894|NCT04222244|Segmental Mobility|segmental mobility
4962895|NCT04222244|Sinus Headache|sinus headache
4962896|NCT04222231|Insulin sensitivity|insulin sensitivity
4962900|NCT04222231|Hypoxia|hypoxia
4962901|NCT04222218|repetitive Transcranial Magnetic stimulation|repetitive transcranial magnetic stimulation
4962902|NCT04222218|cerebellum|cerebellum
4962903|NCT04222218|wearing sensors|wearing sensors
4962904|NCT04222218|static balance|static balance
4962905|NCT04222205|Clinical trial|clinical trial
4962908|NCT04222205|Spontaneous breathing trial|spontaneous breathing trial
4962909|NCT04222205|Weaning|weaning
4962910|NCT04222153|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
4962911|NCT04222153|Gut microbiota|gut microbiota
4962912|NCT04222153|Uremic toxins|uremic toxins
4962913|NCT04222140|sports medicine|sports medicine
4962914|NCT04222140|regenerative medicine|regenerative medicine
4962915|NCT04222140|bone marrow derived mesenchymal stem cells|bone marrow derived mesenchymal stem cells
4962916|NCT04222140|platelet rich plasma|platelet rich plasma
4962932|NCT04222075|Acute Pancreatitis|acute pancreatitis
4962933|NCT04222075|Quality of Life|quality of life
4962934|NCT04222049|Neurorehabilitation|neurorehabilitation
4962935|NCT04222049|Vibration|vibration
4962936|NCT04222049|Neurotransmission|neurotransmission
4962937|NCT04222049|cerebral palsy|cerebral palsy
4962938|NCT04222049|Dysarthria|dysarthria
4962939|NCT04222036|Reliability|reliability
4962940|NCT04222036|Validity|validity
4962941|NCT04222036|Chronic Pain Treatment Expectations Scale|chronic pain treatment expectations scale
4962943|NCT04222010|Anesthesia, Local|anesthesia, local
4962944|NCT04222010|Pain, Postoperative|pain, postoperative
4962948|NCT04221932|Intensive Care Unit|intensive care unit
4962949|NCT04221932|Critical Illness|critical illness
4962950|NCT04221932|Acute Kidney Injury|acute kidney injury
4962951|NCT04221932|Continuous Renal Replacement Therapy|continuous renal replacement therapy
4962952|NCT04221932|Quality Improvement|quality improvement
4962957|NCT04221867|Esophageal Stricture|esophageal stricture
4962958|NCT04221867|Fat Graft|fat graft
4962959|NCT04221867|Dilation|dilation
4962963|NCT04221828|paclitaxel|paclitaxel
4962965|NCT04221789|treatment supervision, success default|treatment supervision, success default
4962966|NCT04221776|Method|method
4962967|NCT04221763|Cardiac resynchronization therapy|cardiac resynchronization therapy
4962968|NCT04221763|His bundle pacing|his bundle pacing
4962969|NCT04221763|Haemodynamics|haemodynamics
4962970|NCT04221763|ECGI|ecgi
4962971|NCT04221737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4962972|NCT04221737|Acute Lung Injury|acute lung injury
4962973|NCT04221737|Mechanical Ventilation|mechanical ventilation
4962974|NCT04221737|APRV|aprv
4962975|NCT04221724|Exercise|exercise
4962976|NCT04221724|Physical Activity|physical activity
5291149|NCT02219139|Roxolid|roxolid
4962977|NCT04221724|Aging|aging
4962978|NCT04221711|Tendinopathy|tendinopathy
4962979|NCT04221711|Achilles|achilles
4962980|NCT04221711|Repetitive Magnetic Stimulation|repetitive magnetic stimulation
4962981|NCT04221698|Gait Analysis|gait analysis
4962982|NCT04221698|Triathlon|triathlon
4962983|NCT04221698|Running|running
4962984|NCT04221698|Gait Retraining|gait retraining
4962985|NCT04221685|Articaine|articaine
4962986|NCT04221685|Extraction primary teeth|extraction primary teeth
4962987|NCT04221685|Infiltration technique|infiltration technique
4962988|NCT04221685|Postoperative pain|postoperative pain
4962989|NCT04221685|Intraoperative pain|intraoperative pain
4962990|NCT04221672|hepatectomy|hepatectomy
4962991|NCT04221672|terlipressin|terlipressin
4962992|NCT04221672|liver failure|liver failure
4962993|NCT04221672|acute kidney injury|acute kidney injury
4962994|NCT04221620|EEG neurofeedback|eeg neurofeedback
4962995|NCT04221620|occupational therapy|occupational therapy
4962996|NCT04221607|intimacy|intimacy
4962997|NCT04221607|sensate focus|sensate focus
4962998|NCT04221607|survivorship|survivorship
4962999|NCT04221607|breast cancer|breast cancer
4963000|NCT04221607|prostate cancer|prostate cancer
4963001|NCT04221594|Fractional flow reserve|fractional flow reserve
4963002|NCT04221594|Myocardial blood flow|myocardial blood flow
4963003|NCT04221594|Relative flow reserve|relative flow reserve
4963004|NCT04221594|Non-invasive measure|non-invasive measure
4963005|NCT04221594|Cardiac catheterization|cardiac catheterization
4963006|NCT04221594|CT coronary angiography|ct coronary angiography
4963007|NCT04221594|Dynamic PET|dynamic pet
4963008|NCT04221594|Invasive coronary angiography|invasive coronary angiography
4963009|NCT04221594|3D fusion dPET/CTA|3d fusion dpet/cta
4963010|NCT04221594|FFRCT|ffrct
4963011|NCT04221581|Knee|knee
4963012|NCT04221581|Arthroplasty|arthroplasty
4963013|NCT04221581|Replacement|replacement
4963016|NCT04221542|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
4963017|NCT04221542|Prostate cancer|prostate cancer
4963018|NCT04221542|PSMA|psma
4963019|NCT04221542|STEAP1|steap1
4963020|NCT04221542|STEAP1 targeted therapy|steap1 targeted therapy
4963021|NCT04221542|Solid tumor|solid tumor
4968528|NCT04186429|epigenetic|epigenetic
4963026|NCT04221542|BiTE®|bite®
4963027|NCT04221542|XmAb®|xmab®
4963028|NCT04221529|Atezolizumab|atezolizumab
4963029|NCT04221386|Melodic Intonation Therapy|melodic intonation therapy
4963030|NCT04221386|Music|music
4963031|NCT04221386|Tone language|tone language
4963034|NCT04221373|Exoskeletons|exoskeletons
4963035|NCT04221308|inflammation mediators|inflammation mediators
4963036|NCT04221308|lymphocyte activation|lymphocyte activation
4963037|NCT04221308|natural orifice endoscopic surgery|natural orifice endoscopic surgery
4963038|NCT04221308|neutrophil activation|neutrophil activation
4963039|NCT04221308|platelet activation|platelet activation
4963040|NCT04221308|vaginal hysterectomy|vaginal hysterectomy
4963041|NCT04221282|epilepsy|epilepsy
4963042|NCT04221282|elderly|elderly
4963043|NCT04221282|aging|aging
4963044|NCT04221282|zebinix|zebinix
4963045|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate
4963046|NCT04221282|tolerance|tolerance
4963047|NCT04221282|antiepileptic drug|antiepileptic drug
4963048|NCT04221269|psychiatric hospitalization|psychiatric hospitalization
4963049|NCT04221269|suicide prevention|suicide prevention
4963050|NCT04221269|psychosis|psychosis
4963051|NCT04221269|psychosocial intervention|psychosocial intervention
4963052|NCT04221256|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
4963053|NCT04221256|Neuroplasticity|neuroplasticity
4963054|NCT04221256|Paired Associative Stimulation|paired associative stimulation
4963055|NCT04221243|space maintainer|space maintainer
4963056|NCT04221243|3D printing|3d printing
4963057|NCT04221178|Plasma Cell Myeloma|plasma cell myeloma
4963058|NCT04221178|MRD-Negative|mrd-negative
4963059|NCT04221178|MRD-Negative Remission|mrd-negative remission
4963060|NCT04221178|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4963061|NCT04221178|19-422|19-422
4963062|NCT04221165|Pain|pain
4963063|NCT04221165|Analgesia|analgesia
4963064|NCT04221152|insulin resistance|insulin resistance
4963065|NCT04221152|refractory diabetes mellitus|refractory diabetes mellitus
4963066|NCT04221139|Virtual reality|virtual reality
4963067|NCT04221139|active gaming|active gaming
4963068|NCT04221139|Physical activity|physical activity
4963069|NCT04221139|exercise-induced hypoalgesia|exercise-induced hypoalgesia
4963070|NCT04221126|protoporphyrin ix|protoporphyrin ix
4963071|NCT04221126|5-aminolevulinic acid|5-aminolevulinic acid
4963072|NCT04221126|thermo-mechanical intervention|thermo-mechanical intervention
4963073|NCT04221126|normal skin|normal skin
4963074|NCT04221087|bronchiolitis|bronchiolitis
4963075|NCT04221087|non-RSV bronchiolitis|non-rsv bronchiolitis
4963076|NCT04221087|dexamethasone|dexamethasone
4963077|NCT04221087|treatment|treatment
4963078|NCT04221087|steroid|steroid
4963079|NCT04221048|Risk score|risk score
4963080|NCT04221048|Maternal complication|maternal complication
4963081|NCT04221022|Physical Activity|physical activity
4963082|NCT04221022|academic stress|academic stress
4963083|NCT04221022|Light Physical activity|light physical activity
4963084|NCT04221022|Moderate Physical Activity|moderate physical activity
4963085|NCT04221022|Vigorous Physical Activity|vigorous physical activity
4963086|NCT04215094|Procalcitonin|procalcitonin
4963087|NCT04215094|C-reactive protein|c-reactive protein
4963088|NCT04215094|white blood cell count|white blood cell count
4963089|NCT04215094|intracranial infection|intracranial infection
4963090|NCT04221009|Feasibility Studies|feasibility studies
4963091|NCT04221009|Continuous Positive Airway Pressure|continuous positive airway pressure
4963092|NCT04221009|Psychotherapy, Brief|psychotherapy, brief
4963093|NCT04221009|Cognitive Behavioral Therapy|cognitive behavioral therapy
4963094|NCT04221009|Motivational Interviewing|motivational interviewing
4963095|NCT04221009|Sleep Apnea, Obstructive|sleep apnea, obstructive
4963096|NCT04221009|Brain Injuries, Traumatic|brain injuries, traumatic
4963097|NCT04221009|Veterans|veterans
4963098|NCT04220970|BIA-ALCL|bia-alcl
4963099|NCT04220944|HCC|hcc
4963100|NCT04220944|Microwave ablation|microwave ablation
4963101|NCT04220944|TACE|tace
4963102|NCT04220944|Immunotherapy|immunotherapy
4963103|NCT04220931|distal pancreatectomy|distal pancreatectomy
4963104|NCT04220918|pediatrics|pediatrics
4963105|NCT04220918|personalized medicine|personalized medicine
4963106|NCT04220918|GWAS|gwas
4963107|NCT04220918|Taste|taste
4963108|NCT04220918|Side effects|side effects
4963109|NCT04220918|clindamycin|clindamycin
4963110|NCT04220892|Immunotherapy|immunotherapy
4963111|NCT04220892|Pembrolizumab|pembrolizumab
4963112|NCT04220892|Pemetrexed|pemetrexed
4963113|NCT04220892|Abemaciclib|abemaciclib
4963114|NCT04220892|Cyclin-dependent kinase 4 (CDK4)|cyclin-dependent kinase 4 (cdk4)
4963126|NCT04220814|Multiple sclerosis|multiple sclerosis
4963127|NCT04220814|MRI|mri
4963128|NCT04220814|pronostic|pronostic
4963129|NCT04220788|cardiovascular disease|cardiovascular disease
4963137|NCT04220736|pharmaco-invasive|pharmaco-invasive
4963138|NCT04220723|end stage liver disease|end stage liver disease
4963140|NCT04220723|exercise test|exercise test
4963141|NCT04220723|muscle weakness|muscle weakness
4963142|NCT04220723|exercise tolerance|exercise tolerance
4963143|NCT04220723|hand strength|hand strength
4963144|NCT04220723|muscle strength|muscle strength
4963145|NCT04220684|Recurrent Acute Myeloid Leukemia|recurrent acute myeloid leukemia
4963146|NCT04220684|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
4963147|NCT04220684|Myelodysplastic Syndrome|myelodysplastic syndrome
4963153|NCT04220489|Lumbar Spine Surgery|lumbar spine surgery
4963154|NCT04220489|Opioid Tolerant|opioid tolerant
4963155|NCT04220476|metastatic Breast cancer|metastatic breast cancer
4963156|NCT04220476|HR+HER2-|hr+her2-
4963157|NCT04220476|HR + BC|hr + bc
4963158|NCT04220476|SBRT|sbrt
4963159|NCT04220437|Neoatherosclerosis|neoatherosclerosis
4963160|NCT04220437|in-stent restenosis|in-stent restenosis
4963161|NCT04220437|Optical Coherence Tomography|optical coherence tomography
4963162|NCT04220437|angiography|angiography
4963163|NCT04220437|artificial intelligence|artificial intelligence
4963164|NCT04220424|Artificial intelligence|artificial intelligence
4963165|NCT04220424|MR images|mr images
4963166|NCT04220424|histopathology images|histopathology images
4963167|NCT04220424|sequencing|sequencing
4963168|NCT04220424|mechanism|mechanism
4963169|NCT04220385|Virtual reality exercise|virtual reality exercise
4963170|NCT04220385|Exercise Therapy/methods|exercise therapy/methods
4963171|NCT04220385|Health Promotion Physical Endurance/physiology|health promotion physical endurance/physiology
4963172|NCT04220385|Core Stability|core stability
4963173|NCT04220359|vital signs|vital signs
4963174|NCT04220359|clinical deterioration|clinical deterioration
4963175|NCT04220359|early prediction|early prediction
4963176|NCT04220359|non-invasive monitoring|non-invasive monitoring
4963177|NCT04220346|anxiety|anxiety
4963178|NCT04220346|children|children
4963179|NCT04220346|circumcision|circumcision
4963180|NCT04220346|nursing|nursing
4963181|NCT04220346|pain|pain
4963182|NCT04220307|Immuno-oncology|immuno-oncology
4963183|NCT04220307|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
4963186|NCT04220268|Ground glass nodule|ground glass nodule
4963187|NCT04220268|Family aggregation|family aggregation
4963188|NCT04220268|Hereditary susceptibility|hereditary susceptibility
4963189|NCT04220242|artificial intelligence|artificial intelligence
4963190|NCT04220242|colorectal surgery|colorectal surgery
4963191|NCT04220242|nearinfrared|nearinfrared
4963192|NCT04220242|perfusion|perfusion
4963193|NCT04220242|cancer|cancer
4963194|NCT04220242|anastomosis|anastomosis
4963195|NCT04220229|Soft Tissue / Sarcoma|soft tissue / sarcoma
4963204|NCT04220190|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
4963205|NCT04220190|Autologous TREG/Th2 cell therapy|autologous treg/th2 cell therapy
4963206|NCT04220190|RAPA-501|rapa-501
4963207|NCT04220151|Hepatocellular carcinoma|hepatocellular carcinoma
4963208|NCT04220151|Epigenetics|epigenetics
4963209|NCT04220151|DNA methylation|dna methylation
4963210|NCT04220151|Direct-acting antivirals|direct-acting antivirals
4963211|NCT04220047|off-pump coronary artery bypass|off-pump coronary artery bypass
4963212|NCT04220047|postoperative new-onset atrial fibrillation|postoperative new-onset atrial fibrillation
4963216|NCT04219956|Polyamine|polyamine
4963217|NCT04219956|Postoperative pain|postoperative pain
4963218|NCT04219956|Morphine|morphine
4963219|NCT04219956|Hypersensitivity|hypersensitivity
4963220|NCT04219930|Epilepsy|epilepsy
4963221|NCT04219930|Children|children
4963222|NCT04219930|NLRP3|nlrp3
4963223|NCT04219930|Interleukin B1|interleukin b1
4963224|NCT04219930|Nuclear Factor-Kappa B|nuclear factor-kappa b
4963225|NCT04219878|Sexually transmitted infections|sexually transmitted infections
4963226|NCT04219878|Behavioral intervention|behavioral intervention
4963227|NCT04219878|Public health|public health
4963228|NCT04219878|HIV preexposure prophylaxis (PrEP)|hiv preexposure prophylaxis (prep)
4963229|NCT04219865|Edaravone|edaravone
4963230|NCT04219865|Compound edaravone injection|compound edaravone injection
4963231|NCT04219839|patient education post-kidney transplant|patient education post-kidney transplant
4963232|NCT04219826|CK-3773274|ck-3773274
4963233|NCT04219826|CK-274|ck-274
4963234|NCT04219826|obstructive hypertrophic cardiomyopathy|obstructive hypertrophic cardiomyopathy
4963235|NCT04219826|oHCM|ohcm
4963236|NCT04219826|REDWOOD-HCM|redwood-hcm
4968735|NCT04184895|HDM|hdm
4963249|NCT04219735|delirium|delirium
4963250|NCT04219735|minocycline|minocycline
4963251|NCT04219735|intensive care unit|intensive care unit
4963252|NCT04219722|Vaginal dryness|vaginal dryness
4963253|NCT04219722|Vulvovaginal symptoms|vulvovaginal symptoms
4963261|NCT04219722|Placebo|placebo
4963262|NCT04219722|Open study|open study
4963263|NCT04219709|nutrition|nutrition
4963264|NCT04219709|very low carbohydrate diet|very low carbohydrate diet
4963265|NCT04219709|ketogenic diet|ketogenic diet
4963266|NCT04219709|nutritional ketosis|nutritional ketosis
5287055|NCT02237066|OCT|oct
4963267|NCT04219709|cognitive function|cognitive function
4963268|NCT04219709|brain|brain
4963269|NCT04219709|metabilism|metabilism
4963270|NCT04219709|ketones|ketones
4963271|NCT04219709|ketosis|ketosis
4963272|NCT04219683|free fibula flap - Mandibular reconstruction - Segmental Defects|free fibula flap - mandibular reconstruction - segmental defects
4963273|NCT04219670|Stroke|stroke
4963274|NCT04219670|Device Studies|device studies
4963275|NCT04219670|Noninvasive Procedures|noninvasive procedures
4963276|NCT04219670|Device Feasibility|device feasibility
4963277|NCT04219670|Inpatient Rehabilitation|inpatient rehabilitation
4963278|NCT04219670|Sensors|sensors
4963279|NCT04219670|MC10|mc10
4963283|NCT04219631|delivery|delivery
4963284|NCT04219631|cesarean|cesarean
4963285|NCT04219631|expiration|expiration
4963286|NCT04219631|exercise|exercise
4963287|NCT04219631|labor|labor
4963288|NCT04219618|LVAD|lvad
4963290|NCT04219592|IgG4|igg4
4963291|NCT04219579|antithrombin III|antithrombin iii
4963292|NCT04219579|liver transplantation|liver transplantation
4963293|NCT04219579|administration method|administration method
4963294|NCT04219579|dosage|dosage
4963295|NCT04219553|antimicrobial stewardship|antimicrobial stewardship
4963296|NCT04219553|pharmacies|pharmacies
4963297|NCT04219553|community pharmacy services|community pharmacy services
4963298|NCT04219553|anti-infective agents|anti-infective agents
4963299|NCT04219553|drug utilization|drug utilization
4963300|NCT04219527|Shoulder impingement|shoulder impingement
4963301|NCT04219527|Subacromial bursa|subacromial bursa
4963302|NCT04219527|Biceps tendon|biceps tendon
4963303|NCT04219514|hypoglycemia|hypoglycemia
4963304|NCT04219514|diabetes mellitus|diabetes mellitus
4963305|NCT04219488|eccentric exercise|eccentric exercise
4963306|NCT04219488|radial nerve mobilization|radial nerve mobilization
4963307|NCT04219462|extracorporal shock wave|extracorporal shock wave
4963308|NCT04219436|aesthetic crown lengthening|aesthetic crown lengthening
4963309|NCT04219436|suturing technique|suturing technique
4963310|NCT04219423|Hispanic American|hispanic american
4963311|NCT04219423|Physical Therapy|physical therapy
4963312|NCT04219423|Pilot study|pilot study
4963313|NCT04219423|Latino|latino
4963314|NCT04219397|opioid stewardship|opioid stewardship
4963315|NCT04219384|Critical Illness Related Cardiac Arrest|critical illness related cardiac arrest
4963316|NCT04219358|imiquimod|imiquimod
4963317|NCT04219358|nanoencapsulation|nanoencapsulation
4963318|NCT04219306|Machine learning|machine learning
4963319|NCT04219306|Artificial intelligence|artificial intelligence
4963320|NCT04219306|Dispatcher assisted telephone CPR|dispatcher assisted telephone cpr
4963321|NCT04219306|Heart Arrest|heart arrest
4963322|NCT04219306|Heart Diseases|heart diseases
4963323|NCT04219306|Cardiovascular Diseases|cardiovascular diseases
4963324|NCT04219267|self-esteem|self-esteem
5291403|NCT02218138|Depression|depression
4963325|NCT04219267|quality of life|quality of life
4963326|NCT04219267|depression|depression
4963327|NCT04219241|Huntington Disease|huntington disease
4963328|NCT04219241|Stem cell therapy|stem cell therapy
4963329|NCT04219241|Dental Pulp Stem Cell|dental pulp stem cell
4963330|NCT04219176|Spectral optical coherence tomography|spectral optical coherence tomography
4963331|NCT04219176|Ocular toxoplasmosis|ocular toxoplasmosis
4963333|NCT04219163|AML|aml
4963334|NCT04219098|THA|tha
4963335|NCT04219098|THR|thr
4963336|NCT04219085|gestational diabetes|gestational diabetes
4963337|NCT04219085|fetal or neonatal outcomes|fetal or neonatal outcomes
4963338|NCT04219085|maternal morbidity|maternal morbidity
4963344|NCT04219046|Radical cystectomy|radical cystectomy
4963345|NCT04219046|Postoperative ileus|postoperative ileus
4963346|NCT04219046|Enhanced Recovery After Surgery|enhanced recovery after surgery
4963347|NCT04219033|noncardiac surgery|noncardiac surgery
4963348|NCT04219033|elderly patients|elderly patients
4963349|NCT04219033|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4963350|NCT04219033|Electroencephalogram|electroencephalogram
4963351|NCT04219020|Pain intensity|pain intensity
4963352|NCT04219020|Pain prevalence|pain prevalence
4963353|NCT04219020|Pain interference|pain interference
4963359|NCT04218981|schizophrenia|schizophrenia
4963360|NCT04218981|bipolar disorder|bipolar disorder
4963361|NCT04218981|neuroimaging|neuroimaging
4963362|NCT04218981|major depressive disorder|major depressive disorder
4963363|NCT04218942|Urethral Device|urethral device
4963364|NCT04218942|Foley catheterization|foley catheterization
4963365|NCT04218929|Infant|infant
4963366|NCT04218929|Infant Formula|infant formula
4963367|NCT04218929|Healthy Subjects|healthy subjects
4963368|NCT04218903|Aging|aging
4963369|NCT04218903|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
4963370|NCT04218903|Concurrent Training|concurrent training
4963371|NCT04218903|Dose-response|dose-response
4963372|NCT04218877|atopic dermatitis|atopic dermatitis
4963373|NCT04218825|mycosis fungoides (MF)|mycosis fungoides (mf)
4963374|NCT04218825|cutaneous T cell lymphoma (CTCL)|cutaneous t cell lymphoma (ctcl)
4963375|NCT04218812|Sensitivity|sensitivity
4963376|NCT04218812|Specificity|specificity
4963377|NCT04218812|Accuracy|accuracy
4963378|NCT04218812|Automated ESI|automated esi
4963379|NCT04218812|Refractory epilepsy|refractory epilepsy
4963380|NCT04218812|Epilepsy surgery|epilepsy surgery
4963381|NCT04218812|Clinical Utility|clinical utility
4963382|NCT04218799|intranasal mupirocin|intranasal mupirocin
4963383|NCT04218799|topical chlorhexidine|topical chlorhexidine
4963384|NCT04218786|colchicine; outcome: myocardial infarction|colchicine; outcome: myocardial infarction
4963385|NCT04218773|Induced hypertension|induced hypertension
4963386|NCT04218773|Blood pressure augmentation|blood pressure augmentation
4963387|NCT04218773|Large-vessel occlusion|large-vessel occlusion
4963388|NCT04218773|Thrombectomy|thrombectomy
4963389|NCT04218773|Endovascular therapy|endovascular therapy
4963390|NCT04218747|Food Security|food security
4963391|NCT04218747|National School Lunch Program (NSLP)|national school lunch program (nslp)
4963392|NCT04218747|School Breakfast Program (SBP)|school breakfast program (sbp)
4963393|NCT04218747|Child and Adult Care Food Program (CACFP)|child and adult care food program (cacfp)
4963394|NCT04218747|Food Backpacks|food backpacks
4963395|NCT04218734|DBPR108|dbpr108
4963396|NCT04218734|Dipeptidyl peptidase-4 (DPP4) inhibitors|dipeptidyl peptidase-4 (dpp4) inhibitors
4963397|NCT04218734|metformin hydrochloride|metformin hydrochloride
4963398|NCT04218721|Symptom assessment|symptom assessment
4963399|NCT04218721|eHealth|ehealth
4963400|NCT04218721|Implementation|implementation
4963401|NCT04218721|Communication|communication
4963402|NCT04218721|Shared decision making|shared decision making
4963403|NCT04218669|sphincter of Oddi laxity|sphincter of oddi laxity
4963404|NCT04218669|hepatolithiasis|hepatolithiasis
4963405|NCT04218669|choledochojejunostomy|choledochojejunostomy
4963406|NCT04218643|peripheral intravenous catheter|peripheral intravenous catheter
4963407|NCT04218643|ultrasound-guided|ultrasound-guided
4963408|NCT04218643|IV insertion|iv insertion
4963424|NCT04218578|MitraClip|mitraclip
4963425|NCT04218578|Functional mitral regurgitation|functional mitral regurgitation
4963426|NCT04218578|Reverse remodeling|reverse remodeling
4963427|NCT04218539|psilocybin|psilocybin
4963428|NCT04218539|inflammation|inflammation
4963429|NCT04218539|calcitonin gene-related peptide (CGRP)|calcitonin gene-related peptide (cgrp)
4963430|NCT04218539|pituitary adenylate cyclase-activating peptide (PACAP)|pituitary adenylate cyclase-activating peptide (pacap)
4963431|NCT04218513|Drug-drug Interaction|drug-drug interaction
4963432|NCT04218513|Edaravone|edaravone
4963433|NCT04218513|2-Aminoethanesulfonic Acid|2-aminoethanesulfonic acid
4963434|NCT04218513|Compound Edaravone Injection|compound edaravone injection
4963435|NCT04218500|Occupational Hand Dermatitis|occupational hand dermatitis
4963436|NCT04218500|Moisturizer|moisturizer
4963437|NCT04218500|Niacinamide|niacinamide
4963438|NCT04218500|Virgin coconut oil|virgin coconut oil
4963440|NCT04218500|TEWL|tewl
4963441|NCT04218500|SCap|scap
5291506|NCT02217605|NAFLD|nafld
4963442|NCT04218487|Adaptive design|adaptive design
4963443|NCT04218487|Qizhi Xueyu Zheng|qizhi xueyu zheng
4963444|NCT04218487|Enrichment design|enrichment design
4963445|NCT04218435|chronickindeydisease, qualityoflife|chronickindeydisease, qualityoflife
4963446|NCT04218422|acupuncture|acupuncture
4963447|NCT04218422|pain|pain
4963448|NCT04218422|battlefield acupuncture|battlefield acupuncture
4963449|NCT04218422|hidradenitis|hidradenitis
4963451|NCT04218396|Virtual Reality|virtual reality
4963452|NCT04218396|Anxiolysis|anxiolysis
4963453|NCT04218396|Analgesia|analgesia
4963454|NCT04218396|Non-pharmacologic|non-pharmacologic
4963455|NCT04218396|Painful bedside procedure|painful bedside procedure
4963456|NCT04218396|Wound care|wound care
4963471|NCT04218253|Hepatectomy|hepatectomy
4963472|NCT04218214|depression|depression
4963473|NCT04218214|poverty|poverty
4963474|NCT04218188|pH-responsive chitosan|ph-responsive chitosan
4963475|NCT04218188|Cancer stem-like cell|cancer stem-like cell
4963476|NCT04218188|Cell detachment ratio|cell detachment ratio
4963477|NCT04218188|Prognostic factor|prognostic factor
4963478|NCT04218175|neuromobilization|neuromobilization
4963479|NCT04218175|elasticity|elasticity
4963480|NCT04218175|shear wave elastography|shear wave elastography
4963481|NCT04218149|serratus plane block, erector spinae plane block, postoperative analgesia|serratus plane block, erector spinae plane block, postoperative analgesia
4963483|NCT04218084|Sickle Cell Disease|sickle cell disease
4963484|NCT04218084|Transcranial Doppler Ultrasound (TCD)|transcranial doppler ultrasound (tcd)
4963485|NCT04218071|primary myelofibrosis|primary myelofibrosis
4963486|NCT04218071|post polycythemia vera myelofibrosis|post polycythemia vera myelofibrosis
4963487|NCT04218071|post essential thrombocythemia myelofibrosis|post essential thrombocythemia myelofibrosis
4963488|NCT04218071|Ruxolitinib|ruxolitinib
4963489|NCT04218071|Jak2 inhibitors|jak2 inhibitors
4963490|NCT04218071|glycogen synthase kinase 3 beta|glycogen synthase kinase 3 beta
4963491|NCT04218071|GSK3beta|gsk3beta
4963492|NCT04218071|9-ING-41|9-ing-41
4963493|NCT04218045|sleeve|sleeve
4963494|NCT04218045|laparoscopy|laparoscopy
4963495|NCT04218045|SASI|sasi
4963496|NCT04218045|Morbid obesity|morbid obesity
4963497|NCT04218045|metabolic surgery|metabolic surgery
4963498|NCT04218045|gastrectomy|gastrectomy
4963499|NCT04218006|CTX, Relatives, Index Cases, Kinship, Pedigree|ctx, relatives, index cases, kinship, pedigree
4963500|NCT04217980|pneumonia|pneumonia
4963501|NCT04217980|lung ultrasound|lung ultrasound
4963502|NCT04217980|biomarkers|biomarkers
4963503|NCT04217980|procalcitonin|procalcitonin
4963504|NCT04217980|childhood|childhood
4963505|NCT04217967|real-world|real-world
4963506|NCT04217967|dual-drug maintenance|dual-drug maintenance
4963507|NCT04217967|oral regimen|oral regimen
4963508|NCT04217941|Epistaxis|epistaxis
4963512|NCT04217915|sedation|sedation
4963513|NCT04217915|ICU|icu
4963514|NCT04217915|Delirium|delirium
4963515|NCT04217902|Diabete Type 1|diabete type 1
4963516|NCT04217902|Diabete Type 2|diabete type 2
4963517|NCT04217902|Diabete Care|diabete care
4963518|NCT04217889|Cystic Fibrosis|cystic fibrosis
4963519|NCT04217889|Adherence to chest physiotherapy|adherence to chest physiotherapy
4963520|NCT04217876|echocardiography|echocardiography
4963521|NCT04217876|cardiac magnetic resonance|cardiac magnetic resonance
4963522|NCT04217876|myocarditis|myocarditis
4963523|NCT04217863|Guided disclosure protocol|guided disclosure protocol
4963524|NCT04217863|Post-traumatic growth|post-traumatic growth
4963525|NCT04217863|psycho-physiological alterations|psycho-physiological alterations
4963526|NCT04217863|Trauma Symptom Checklist|trauma symptom checklist
4963527|NCT04217863|Sadaf Stress Scale|sadaf stress scale
4963528|NCT04217837|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4963529|NCT04217837|Major Depressive Disorder|major depressive disorder
4963530|NCT04217837|MDD|mdd
4963531|NCT04217837|TMS|tms
4963532|NCT04217837|NeuroStar Advanced Therapy System|neurostar advanced therapy system
4963533|NCT04217837|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4963534|NCT04217837|rTMS|rtms
4963535|NCT04217824|pilonidal sinus|pilonidal sinus
4963536|NCT04217824|presakral apse|presakral apse
4963537|NCT04217824|limberg flap|limberg flap
4963538|NCT04217824|karydakis flap|karydakis flap
4963539|NCT04217811|VLBW|vlbw
4963540|NCT04217811|Neutropenia|neutropenia
4963541|NCT04217798|platinum resistent/refractory, ovarian cancer|platinum resistent/refractory, ovarian cancer
4963542|NCT04217785|Umbilical Cord Serum Eyedrops|umbilical cord serum eyedrops
4963543|NCT04217785|Moderate To Severe Dry Eye|moderate to severe dry eye
5005356|NCT03963167|COPD|copd
4963550|NCT04217746|sputum|sputum
4963551|NCT04217746|clearability|clearability
4963552|NCT04217746|wetability|wetability
4963553|NCT04217746|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4963554|NCT04217746|COPD exacerbation|copd exacerbation
4963555|NCT04217681|chronic pain|chronic pain
4963556|NCT04217681|cancer|cancer
4963557|NCT04217681|self-hypnosis|self-hypnosis
4963558|NCT04217681|self-care|self-care
4963559|NCT04217681|music-therapy|music-therapy
4963560|NCT04217681|motivation|motivation
4963561|NCT04217642|Hip fractures|hip fractures
4963562|NCT04217642|Delay surgery|delay surgery
4963563|NCT04217642|Quality of life|quality of life
4963564|NCT04217642|Outcomes|outcomes
4963565|NCT04217616|Headache|headache
4963566|NCT04217616|Healthy|healthy
4963567|NCT04217616|Muscle Tenderness|muscle tenderness
4963568|NCT04217616|quantitative sensory testing|quantitative sensory testing
4963569|NCT04217616|cold pain threshold|cold pain threshold
4963595|NCT04217421|Neurodevelopmental outcome|neurodevelopmental outcome
4963596|NCT04217421|Cardiac surgery|cardiac surgery
4963597|NCT04217421|Hypoxic-ischemic brain injury|hypoxic-ischemic brain injury
4963598|NCT04217421|Neonates|neonates
4963599|NCT04217395|Obesity|obesity
4963600|NCT04217395|Overweight|overweight
4963601|NCT04217395|Empowerment|empowerment
4963602|NCT04217395|Autonomy|autonomy
4963603|NCT04217343|Heart|heart
4963604|NCT04217330|Pulmonary rehabilitation|pulmonary rehabilitation
4963610|NCT04217239|Thoracoscopic|thoracoscopic
4963611|NCT04217239|laparoscopic|laparoscopic
4963612|NCT04217239|esophagectomy|esophagectomy
4963613|NCT04217187|Botulinum Toxins|botulinum toxins
4963614|NCT04217187|Spasticity|spasticity
4963616|NCT04217187|Electrical Stimulation|electrical stimulation
4963623|NCT04217135|high-dose hydralazine|high-dose hydralazine
4963624|NCT04217135|mitral regurgitation|mitral regurgitation
4963625|NCT04217135|severe systolic heart failure|severe systolic heart failure
4963626|NCT04217135|heart failure rehospitalization|heart failure rehospitalization
4963627|NCT04217135|all-cause mortality|all-cause mortality
4963628|NCT04217122|Strawberry|strawberry
4963629|NCT04217122|polyphenols|polyphenols
4963630|NCT04217122|cholesterol|cholesterol
4963631|NCT04217109|Breast cancer|breast cancer
4963632|NCT04217109|Dog Detection|dog detection
4963633|NCT04217109|Volatile organic Compounds|volatile organic compounds
4963634|NCT04217044|Molecular|molecular
4963635|NCT04217044|Histopathology image|histopathology image
4963636|NCT04217044|Deep Learning|deep learning
4963637|NCT04217044|Machine Learning|machine learning
4963638|NCT04217031|Heart team|heart team
4963639|NCT04217031|Decision making|decision making
4963640|NCT04217031|Complex coronary artery disease|complex coronary artery disease
4963641|NCT04217018|molecular|molecular
4963642|NCT04217018|radiomics|radiomics
4963643|NCT04217018|deep learning|deep learning
4963644|NCT04217018|machine learning|machine learning
4963645|NCT04216992|Cone beam|cone beam
4963648|NCT04216992|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
4963650|NCT04216953|PDL1 inhibitor|pdl1 inhibitor
4963651|NCT04216901|Colonic Neoplasms|colonic neoplasms
4963652|NCT04216875|Best practice|best practice
4963653|NCT04216875|optimisation of treatment|optimisation of treatment
4963654|NCT04216875|diabetes score|diabetes score
4963655|NCT04216875|diabetes in primary care|diabetes in primary care
4963656|NCT04216862|Forward Head|forward head
4963657|NCT04216862|Rounded Shoulder|rounded shoulder
4963658|NCT04216862|Neck Pain|neck pain
4969158|NCT04182360|Pregnancy|pregnancy
4963678|NCT04216693|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4963679|NCT04216693|Digoxin|digoxin
4963680|NCT04216693|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4963681|NCT04216667|Catheter Ablation|catheter ablation
4963682|NCT04216667|Arrhythmia Recurrence|arrhythmia recurrence
4963683|NCT04216667|Embolic Stroke|embolic stroke
4963684|NCT04216667|Mortality|mortality
4963685|NCT04216641|cancer, nutrition disorder|cancer, nutrition disorder
4963686|NCT04216628|Amniotomy|amniotomy
4963687|NCT04216628|Cervical ripening|cervical ripening
4963688|NCT04216628|Oxytocin|oxytocin
4963689|NCT04216628|Exrea amniotic baloon|exrea amniotic baloon
4963690|NCT04216589|NAFLD|nafld
4963691|NCT04216589|HIV|hiv
4963692|NCT04216589|semaglutide|semaglutide
4963693|NCT04216576|Breast cancer|breast cancer
4963694|NCT04216576|Palbociclib|palbociclib
4963695|NCT04216576|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4963696|NCT04216576|19-458|19-458
4963697|NCT04216550|Therapeutic responses|therapeutic responses
4963698|NCT04216550|Radiological|radiological
4963699|NCT04216550|Histopathology Imaging|histopathology imaging
4963700|NCT04216550|Artificial intelligence|artificial intelligence
4963701|NCT04216550|Apatinib|apatinib
4963702|NCT04216537|Survival|survival
4963703|NCT04216537|Subgroup|subgroup
4963718|NCT04216420|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
4963719|NCT04216420|Ethiopia|ethiopia
4963720|NCT04216407|Remote organ ischemic preconditioning|remote organ ischemic preconditioning
4963721|NCT04216407|Ischemia reperfusion injury|ischemia reperfusion injury
4963722|NCT04216407|Glycocalyx integrity parameters|glycocalyx integrity parameters
4963723|NCT04216407|Systemic inflammation parameters|systemic inflammation parameters
4963724|NCT04216381|geriatric|geriatric
4963732|NCT04216303|hemoglobin A1c|hemoglobin a1c
4963733|NCT04216277|primary care|primary care
4963734|NCT04216277|acute respiratory tract infection|acute respiratory tract infection
4963735|NCT04216277|Procalcitonin|procalcitonin
4963736|NCT04216277|general practice|general practice
4963737|NCT04216277|Antibiotic use|antibiotic use
4963738|NCT04216264|infant|infant
4963739|NCT04216264|mother-baby|mother-baby
4963747|NCT04216238|cardiovascular surgical patient|cardiovascular surgical patient
4963748|NCT04216173|Acupuncture|acupuncture
4963749|NCT04216173|Post-traumatic headache|post-traumatic headache
4963750|NCT04216173|Traumatic brain injury|traumatic brain injury
4963751|NCT04216147|carpal tunnel syndrome|carpal tunnel syndrome
4963752|NCT04216147|nerve compression syndrome|nerve compression syndrome
4963753|NCT04216147|median nerve|median nerve
4963754|NCT04216147|physical therapy technique|physical therapy technique
4963755|NCT04216147|percutaneous needle electrolysis|percutaneous needle electrolysis
4963756|NCT04216121|First line osimertinib|first line osimertinib
4963757|NCT04216121|Local ablative therapy|local ablative therapy
4963758|NCT04216095|MST|mst
4963759|NCT04216095|ECT|ect
4963760|NCT04216095|MDD|mdd
4963761|NCT04216095|Depression|depression
4963762|NCT04216095|Major Depressive Disorder|major depressive disorder
4963766|NCT04216030|Biofortification|biofortification
4963771|NCT04215965|CRRT|crrt
4963772|NCT04215965|Renal failure|renal failure
4963773|NCT04215965|Citrate|citrate
4963774|NCT04215965|Phosphore|phosphore
4963775|NCT04215952|Anomia|anomia
4963776|NCT04215952|Semantic Feature Analysis|semantic feature analysis
4963777|NCT04215939|Spinal cord injury|spinal cord injury
4963778|NCT04215939|vasomotion|vasomotion
4963779|NCT04215939|core temperature|core temperature
4963780|NCT04215939|sudomotor|sudomotor
4963781|NCT04215939|thermoregulation|thermoregulation
4963782|NCT04215926|HIV infection|hiv infection
4963783|NCT04215926|NAFLD|nafld
4963784|NCT04215913|PSC|psc
4963785|NCT04215913|Integrative Analysis|integrative analysis
4963786|NCT04215913|IHC|ihc
4963787|NCT04215913|WES|wes
4963788|NCT04215913|RNA sequencing|rna sequencing
4963789|NCT04215874|dorsal penile nerve block|dorsal penile nerve block
4963790|NCT04215874|caudal epidural block|caudal epidural block
4963791|NCT04215874|postoperative pain|postoperative pain
4963792|NCT04215874|analgesia|analgesia
4963793|NCT04215874|hypospadias|hypospadias
4963794|NCT04215874|ultrasound|ultrasound
4963797|NCT04215783|Allergy, Asthma, Children, Birth cohort|allergy, asthma, children, birth cohort
4963798|NCT04215770|Co-amoxiclav|co-amoxiclav
4963799|NCT04215770|Benzyl Penicilli|benzyl penicilli
4963800|NCT04215770|Tonsillitis|tonsillitis
4963801|NCT04215718|fistula in ano|fistula in ano
4963802|NCT04215718|fistulectomy wound closure|fistulectomy wound closure
5287463|NCT02235363|thread lift|thread lift
4963803|NCT04215718|fistulotomy wound marsupialization|fistulotomy wound marsupialization
4964007|NCT04214314|Attention|attention
4963815|NCT04215627|Vasopressor support|vasopressor support
4963816|NCT04215601|phototherapy|phototherapy
4963817|NCT04215601|hypocalcemia|hypocalcemia
4963818|NCT04215588|anticoagulation|anticoagulation
4963819|NCT04215588|cardiopulmonary bypass|cardiopulmonary bypass
4963820|NCT04215510|endonasal endoscopic surgery|endonasal endoscopic surgery
4963821|NCT04215510|radiation therapy|radiation therapy
4963822|NCT04215510|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4963823|NCT04215497|scoliosis|scoliosis
4963824|NCT04215497|PSSE|psse
4963825|NCT04215497|proprioception|proprioception
4963826|NCT04215497|joint reposition|joint reposition
4963827|NCT04215484|placenta previa|placenta previa
4963828|NCT04215484|placenta accreta|placenta accreta
4963829|NCT04215484|BNP|bnp
4963830|NCT04215484|cesarean section|cesarean section
4963831|NCT04215484|pregnancy|pregnancy
4963832|NCT04215458|fungal colonization|fungal colonization
4963833|NCT04215458|inflammatory skin disease|inflammatory skin disease
4963834|NCT04215458|yeast infection in skin|yeast infection in skin
4963835|NCT04215432|dental implants|dental implants
4963836|NCT04215432|peri-implant mucosits|peri-implant mucosits
4963837|NCT04215432|toothpaste|toothpaste
4963838|NCT04215432|propolis|propolis
4963839|NCT04215432|nanovitamin|nanovitamin
4963840|NCT04215419|Kidney|kidney
4963841|NCT04215419|Furosemide|furosemide
4963842|NCT04215419|Renal Index|renal index
4963843|NCT04215419|Stress Test|stress test
4963844|NCT04215419|sodium|sodium
4963845|NCT04215419|Potassium|potassium
4963846|NCT04215419|Chloride|chloride
4963852|NCT04215367|CLL|cll
4963853|NCT04215367|oleocanthal|oleocanthal
4963854|NCT04215367|Extra Virgin Olive Oil (EVOO)|extra virgin olive oil (evoo)
4963855|NCT04215367|phenols|phenols
4963856|NCT04215367|apoptosis|apoptosis
4963857|NCT04215354|MULTIPLE SCLEROSIS|multiple sclerosis
4963858|NCT04215354|FATIGUE|fatigue
4963859|NCT04215354|BALANCE|balance
4963860|NCT04215328|Obesity|obesity
4963861|NCT04215328|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4963862|NCT04215328|Nutrient|nutrient
4963863|NCT04215289|qNox Values, Hemodynamic changes, Predictor of pain|qnox values, hemodynamic changes, predictor of pain
4963871|NCT04215224|Prognosis|prognosis
4963872|NCT04215224|Histopathology imaging|histopathology imaging
4963873|NCT04215224|Deep Learning|deep learning
4963874|NCT04215224|Machine Learning|machine learning
4963875|NCT04215211|Prognosis|prognosis
4963876|NCT04215211|Radiomics|radiomics
4963877|NCT04215211|Deep Learning|deep learning
4963878|NCT04215211|Machine Learning|machine learning
4963879|NCT04215198|exercise-induced|exercise-induced
4963880|NCT04215198|joint pain|joint pain
4963881|NCT04215198|joint stiffness|joint stiffness
4963882|NCT04215198|cartilage turnover|cartilage turnover
4963883|NCT04215198|CTX-II|ctx-ii
4963884|NCT04215198|exercise recovery|exercise recovery
4963885|NCT04215159|HER-2 Protein Overexpression|her-2 protein overexpression
4963886|NCT04215159|HER-2 Gene Amplification|her-2 gene amplification
4963887|NCT04215159|HER2 targeted-treatment|her2 targeted-treatment
4969326|NCT04181203|PSA|psa
4963914|NCT04215003|neo-adjuvant therapy|neo-adjuvant therapy
4963915|NCT04215003|molecular pathway|molecular pathway
4963916|NCT04215003|umbrella trial|umbrella trial
4963918|NCT04214990|Gastric cancer prevention|gastric cancer prevention
4963919|NCT04214990|Endoscopic submucosal dissection|endoscopic submucosal dissection
4963920|NCT04214977|Anorectal surgeries|anorectal surgeries
4963922|NCT04214977|spinal anaesthesia|spinal anaesthesia
4963923|NCT04214977|general anaesthesia|general anaesthesia
4963924|NCT04214977|laryngeal mask|laryngeal mask
4963925|NCT04214964|real world study|real world study
4963926|NCT04214964|China|china
4963927|NCT04214951|Immune Thrombocytopenia|immune thrombocytopenia
4963928|NCT04214951|Recombinant human thrombopoietin|recombinant human thrombopoietin
4963929|NCT04214951|Eltrombopag|eltrombopag
4963930|NCT04214951|switching|switching
4963931|NCT04214938|hypertonic saline solutions|hypertonic saline solutions
4963932|NCT04214938|lidocaine|lidocaine
4963933|NCT04214938|oxymetazoline|oxymetazoline
4963934|NCT04214938|isotonic saline|isotonic saline
4963935|NCT04214938|discomfort|discomfort
4963936|NCT04214925|Scleroderma|scleroderma
4963937|NCT04214925|Tai Chi|tai chi
4963938|NCT04214925|sleep|sleep
4963939|NCT04214925|fatique|fatique
4963940|NCT04214925|depression|depression
4963941|NCT04214925|anxiety|anxiety
4963942|NCT04214912|Oral Cancer|oral cancer
4963943|NCT04214912|Intervention|intervention
4963944|NCT04214912|Return to work|return to work
4963950|NCT04214847|glaucoma-ahmed-valve-S2-FP7-IOP-encapsulation|glaucoma-ahmed-valve-s2-fp7-iop-encapsulation
4963951|NCT04214834|NOWS|nows
4963952|NCT04214821|Pharmacokinetic|pharmacokinetic
4963953|NCT04214821|Levofloxacin 1.5%|levofloxacin 1.5%
4963954|NCT04214821|Moxifloxacin 0.5%|moxifloxacin 0.5%
4963955|NCT04214743|Conjunctival microcirculation|conjunctival microcirculation
4963956|NCT04214743|retinal vessels|retinal vessels
4963957|NCT04214743|fundus imaging|fundus imaging
4963958|NCT04214743|IDF imaging|idf imaging
4963959|NCT04214743|sepsis|sepsis
4963960|NCT04214704|lancing device|lancing device
4963961|NCT04214704|HbA1c|hba1c
4963962|NCT04214704|painless lancing|painless lancing
4963963|NCT04214704|SMBG adherence|smbg adherence
4963964|NCT04214678|Endosocpic submucosal dissection|endosocpic submucosal dissection
4963965|NCT04214678|Underwater clip closure|underwater clip closure
4963966|NCT04214665|alpha-lipoic acid|alpha-lipoic acid
4963967|NCT04214665|bioequivalence|bioequivalence
4963968|NCT04214665|replicate design|replicate design
4963969|NCT04214626|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
4963970|NCT04214626|R-CHOP|r-chop
4963971|NCT04214626|Lenalidomide|lenalidomide
4963972|NCT04214600|Type 2 diabetes|type 2 diabetes
4963973|NCT04214600|Depression|depression
4963974|NCT04214600|Treatment adherence|treatment adherence
4963975|NCT04214600|Cognitive behavioral therapy|cognitive behavioral therapy
4963976|NCT04214600|Randomized controlled trial|randomized controlled trial
4963977|NCT04214548|microbiome|microbiome
4963978|NCT04214535|Cervical Fusion|cervical fusion
4963979|NCT04214535|Cervical Disc Degeneration|cervical disc degeneration
4963980|NCT04214535|Spinal Fusion|spinal fusion
4963981|NCT04214535|Tritanium® C Anterior Cervical Cage|tritanium® c anterior cervical cage
4963984|NCT04214496|Delirium|delirium
4963985|NCT04214496|Postoperative Delirium|postoperative delirium
4963986|NCT04214496|Postoperative Subsyndromal Delirium|postoperative subsyndromal delirium
4963987|NCT04214496|Biomarker|biomarker
4964002|NCT04214353|Positron-Emission Tomography|positron-emission tomography
4964004|NCT04214353|18FDG-PET/CT|18fdg-pet/ct
4964005|NCT04214353|Androgen deprivation therapy|androgen deprivation therapy
4964006|NCT04214340|laparoscopic surgery|laparoscopic surgery
4964008|NCT04214314|Acquired Brain Injury|acquired brain injury
4964009|NCT04214314|Attentional Program|attentional program
4964010|NCT04214314|Intervention of attention|intervention of attention
4964011|NCT04214314|Spanish adults|spanish adults
4964012|NCT04214314|Rehabilitation program|rehabilitation program
5005882|NCT03959956|IMCI|imci
4964013|NCT04214288|Open-Label|open-label
4964014|NCT04214288|Parallel-Group|parallel-group
4964015|NCT04214288|Fulvestrant|fulvestrant
4964016|NCT04214288|ER-Positive HER2-Negative Breast Cancer|er-positive her2-negative breast cancer
4964017|NCT04214288|Metastatic|metastatic
4964018|NCT04214288|AZD9833|azd9833
4964019|NCT04214288|Oral SERD|oral serd
4964020|NCT04214275|coronary artery bypass|coronary artery bypass
4964021|NCT04214275|pulmonary rehabilitation|pulmonary rehabilitation
4964022|NCT04214275|quality of life|quality of life
4964023|NCT04214275|respiratory functions|respiratory functions
4964024|NCT04214236|Closed-incision negative pressure therapy|closed-incision negative pressure therapy
4964025|NCT04214236|Negative pressure wound therapy|negative pressure wound therapy
4964026|NCT04214236|Wound care|wound care
4964027|NCT04214236|Surgical incision|surgical incision
4964028|NCT04214236|Wound complication|wound complication
4964029|NCT04214236|Dehiscence|dehiscence
4964030|NCT04214236|Surgical Site Infection|surgical site infection
4964031|NCT04214236|Seroma|seroma
4964032|NCT04214236|Hematoma|hematoma
4964033|NCT04214236|Wound Healing|wound healing
4964034|NCT04214236|Inflammation|inflammation
4964035|NCT04214236|Incisional Wound|incisional wound
4964036|NCT04214236|Abdominoplasty|abdominoplasty
4964037|NCT04214236|Abdominal panniculectomy|abdominal panniculectomy
4964038|NCT04214236|Body contouring|body contouring
4964039|NCT04214223|Pregnancy|pregnancy
4964040|NCT04214210|cascade genetic testing|cascade genetic testing
4964041|NCT04214210|disclosure of genetic test results|disclosure of genetic test results
4964042|NCT04214210|family communication|family communication
4964043|NCT04214210|web-based platform|web-based platform
4964044|NCT04214210|efficacy|efficacy
4964045|NCT04214210|implementation outcomes|implementation outcomes
4964046|NCT04214158|dance|dance
4964047|NCT04214158|proprioception|proprioception
4964048|NCT04214158|physical fitness|physical fitness
4964049|NCT04214132|Virtual reality|virtual reality
4964050|NCT04214132|Learning|learning
4964051|NCT04214132|Technology|technology
4964052|NCT04214132|Patients|patients
4964053|NCT04214093|AZD0466|azd0466
4964054|NCT04214093|Advanced solid tumors|advanced solid tumors
4964055|NCT04214093|Relapsed, refractory hematologic malignancies|relapsed, refractory hematologic malignancies
4964056|NCT04214093|Multiple myeloma|multiple myeloma
4964057|NCT04214093|Tumor lysis syndrome|tumor lysis syndrome
4964058|NCT04214080|Trunk Stabilization Exercises|trunk stabilization exercises
4964059|NCT04214080|Oral Motor|oral motor
4964060|NCT04214080|Quality of Life|quality of life
4964061|NCT04214080|Communication|communication
4964062|NCT04214054|maxillary sinus lift|maxillary sinus lift
4964063|NCT04214054|Piezosurgery|piezosurgery
4964064|NCT04214054|Grafting materials|grafting materials
4964065|NCT04214028|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4964066|NCT04214028|Chronic Hepatitis C (CHC)|chronic hepatitis c (chc)
4964067|NCT04214028|Maviret|maviret
4964068|NCT04214028|Mavyret|mavyret
4964069|NCT04214002|DEB|deb
4964070|NCT04214002|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
4964071|NCT04214002|COL7A1|col7a1
4964072|NCT04213976|ileostomy|ileostomy
4964073|NCT04213976|enteral nutrition|enteral nutrition
4964074|NCT04213976|complications of stoma|complications of stoma
4964075|NCT04213963|Resistant Hypertension|resistant hypertension
4964076|NCT04213963|Primary Aldosteronism|primary aldosteronism
4964077|NCT04213963|Renin-Angiotensin System|renin-angiotensin system
4964078|NCT04213963|Blood Pressure|blood pressure
4964079|NCT04213963|Cardiometabolic Risk|cardiometabolic risk
4964080|NCT04213963|Early Atherosclerotic Damage|early atherosclerotic damage
4964081|NCT04213963|Oxidative Stress|oxidative stress
4964082|NCT04213950|rabies immune globulin|rabies immune globulin
4964084|NCT04213950|rabies postexposure prophylaxis|rabies postexposure prophylaxis
4964092|NCT04213911|pleural pressure|pleural pressure
4964093|NCT04213911|chest CT scan|chest ct scan
4964094|NCT04213872|breast cancer survivors|breast cancer survivors
4964095|NCT04213872|gene expression|gene expression
4964096|NCT04213872|emotional distress|emotional distress
4964097|NCT04213833|palatable lidocaine|palatable lidocaine
4964098|NCT04213833|dexmedetomidine|dexmedetomidine
4964099|NCT04213833|gag reflex|gag reflex
4964100|NCT04213833|gastrointestinal endoscopy|gastrointestinal endoscopy
4964101|NCT04213807|atrial fibrillation|atrial fibrillation
4964102|NCT04213807|flutter|flutter
4964103|NCT04213807|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
4964104|NCT04213807|stroke|stroke
4964108|NCT04213729|Inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
4964110|NCT04213729|CD|cd
4964111|NCT04213729|IBD|ibd
4964112|NCT04213729|Psychological support|psychological support
4964113|NCT04213729|Family member|family member
4964114|NCT04213729|Low fat, high fiber|low fat, high fiber
4964115|NCT04213729|Dyadic|dyadic
4964116|NCT04213716|Keywords provided by rawda mohammad abdel rahman baghdady, Cairo University:|keywords provided by rawda mohammad abdel rahman baghdady, cairo university:
4964117|NCT04213716|root canal retreatment|root canal retreatment
4964118|NCT04213716|calcium hydroxide|calcium hydroxide
4964119|NCT04213716|distilled water|distilled water
4964120|NCT04213716|silver nanoparticles|silver nanoparticles
4964121|NCT04213716|postoperative pain|postoperative pain
4964122|NCT04213677|Polycystic Ovary Syndrome|polycystic ovary syndrome
4964123|NCT04213677|SGLT2 inhibitor|sglt2 inhibitor
4964124|NCT04213664|renal cancer|renal cancer
4964125|NCT04213664|lymphocyte to monocyte ratio|lymphocyte to monocyte ratio
4964126|NCT04213664|non metastatic|non metastatic
4964127|NCT04213664|prognosis|prognosis
4964128|NCT04213664|meta-analysis|meta-analysis
4964129|NCT04213664|nephrectomy|nephrectomy
5292017|NCT02215122|Salmeterol|salmeterol
4964130|NCT04213599|STEMI|stemi
4964131|NCT04213599|Ruptrue|ruptrue
4964132|NCT04213599|Angiography|angiography
4964133|NCT04213586|Protein supplementation|protein supplementation
4964134|NCT04213586|Amino acids|amino acids
4964135|NCT04213586|Resistance exercise|resistance exercise
4964136|NCT04213586|Muscle strength|muscle strength
4964137|NCT04213586|Muscle hypertrophy|muscle hypertrophy
4964138|NCT04213560|Weighted waist-hooping|weighted waist-hooping
4964139|NCT04213560|Balance|balance
4964140|NCT04213560|Proprioception|proprioception
4964141|NCT04213560|Neurocom|neurocom
4964142|NCT04213534|gout|gout
4964143|NCT04213534|management|management
4964144|NCT04213534|semen quality|semen quality
4964145|NCT04213534|male fertility|male fertility
4964146|NCT04213534|allopurinol|allopurinol
4964147|NCT04213534|febuxostat|febuxostat
4964148|NCT04213534|benzbromarone|benzbromarone
4964152|NCT04213482|pediatric oncology|pediatric oncology
4964153|NCT04213482|fractal analysis|fractal analysis
4964154|NCT04213482|panoramic mandibular indices|panoramic mandibular indices
4964155|NCT04213482|radiotherapy|radiotherapy
4964156|NCT04213482|chemotherapy|chemotherapy
4964157|NCT04213456|sport performance|sport performance
4964158|NCT04213417|stroke survivor|stroke survivor
4964159|NCT04213417|spasticity|spasticity
4964160|NCT04213417|Matrix Rhythm Therapy|matrix rhythm therapy
4964161|NCT04213417|balance|balance
4964162|NCT04213417|gait|gait
4964163|NCT04213404|ribociclib|ribociclib
4964164|NCT04213404|spartalizumab|spartalizumab
4964165|NCT04213404|PDR001|pdr001
4964166|NCT04213404|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
4964167|NCT04213313|Infectious Keratitis|infectious keratitis
4964168|NCT04213313|surfactant protein D|surfactant protein d
4964169|NCT04213313|single nucleotide polymorphisms|single nucleotide polymorphisms
4964170|NCT04213313|Met11Thr|met11thr
4964171|NCT04213313|rs721917|rs721917
4964172|NCT04213300|Quality of life|quality of life
4964173|NCT04213300|Glycaemic control|glycaemic control
4964174|NCT04213274|neutrophilic urticarial dermatosis|neutrophilic urticarial dermatosis
4964175|NCT04213274|autoinflammatory syndrome|autoinflammatory syndrome
4964176|NCT04213274|monoclonal gammopathy|monoclonal gammopathy
4964177|NCT04213274|neutrophilic dermatosis|neutrophilic dermatosis
4964178|NCT04213274|interleukin-1|interleukin-1
4964179|NCT04213274|Schnitzler syndrome|schnitzler syndrome
5287829|NCT02233595|MRI|mri
4964185|NCT04213222|colorectal cancer|colorectal cancer
4964186|NCT04213222|liver metastasis|liver metastasis
4964187|NCT04213222|bevacizumab|bevacizumab
4964199|NCT04213092|Common bile duct stones|common bile duct stones
4964200|NCT04213092|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4964201|NCT04213092|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4964202|NCT04213092|Open Cholecystectomy|open cholecystectomy
4964203|NCT04213079|Mal de Debarquement Syndrome|mal de debarquement syndrome
4964204|NCT04213079|Motion Sickness|motion sickness
4969611|NCT04179617|JUUL|juul
4964216|NCT04213040|Cardiopulmonary bypass|cardiopulmonary bypass
4964217|NCT04213040|Procalcitonin|procalcitonin
4964218|NCT04213040|C-reactive protein|c-reactive protein
4964221|NCT04213040|Postoperative Complications|postoperative complications
4964222|NCT04213014|exercise|exercise
4964223|NCT04213014|nutrition|nutrition
4964224|NCT04213014|parent|parent
4964225|NCT04213014|adolescent|adolescent
4964226|NCT04213014|overweight|overweight
4964227|NCT04213014|percent body fat|percent body fat
4964228|NCT04213014|cardiorespiratory fitness|cardiorespiratory fitness
4964229|NCT04213014|body mass index|body mass index
4964230|NCT04213014|obesity|obesity
4964231|NCT04213001|Lymphedema|lymphedema
4964232|NCT04213001|Circumferential measurements|circumferential measurements
4964233|NCT04213001|ultrasonography|ultrasonography
4964235|NCT04212975|pain|pain
4964236|NCT04212949|lumbar radiculopathy|lumbar radiculopathy
4964237|NCT04212949|rTMS|rtms
4964238|NCT04212949|TESI|tesi
4964239|NCT04212949|treatment|treatment
4964240|NCT04212923|eHealth|ehealth
4964241|NCT04212923|self-management|self-management
4964242|NCT04212923|chronic kidney disease|chronic kidney disease
4964243|NCT04212910|endometrium|endometrium
4964244|NCT04212910|cancer|cancer
4964245|NCT04212910|PET-MRI|pet-mri
4964246|NCT04212910|stratification|stratification
4964247|NCT04212897|Parkinson Disease|parkinson disease
4964248|NCT04212897|Music Therapy|music therapy
4964249|NCT04212897|fNIRS|fnirs
4964250|NCT04212897|Controlled Trials|controlled trials
4964251|NCT04212897|Explicit & Implicit Timing|explicit & implicit timing
4964252|NCT04212897|Motor Control|motor control
4964253|NCT04212897|Synchronous finger tapping|synchronous finger tapping
4964254|NCT04212871|mukbang|mukbang
4964255|NCT04212871|desire to eat|desire to eat
4964256|NCT04212858|Zinc finger 217 protein gene .|zinc finger 217 protein gene .
4964257|NCT04212858|Multiple myeloma|multiple myeloma
4964258|NCT04212819|Erythrocyte suspension|erythrocyte suspension
4964259|NCT04212819|Total antioxidant status|total antioxidant status
4964260|NCT04212819|Total oxidant status|total oxidant status
4964261|NCT04212819|Asymmetric dimethylarginine|asymmetric dimethylarginine
4964262|NCT04212806|Validation|validation
4964263|NCT04212806|BASFI|basfi
4964264|NCT04212806|Dougados Functional Index|dougados functional index
4964265|NCT04212806|BAS-G|bas-g
4964266|NCT04212767|Tooth extraction|tooth extraction
4964267|NCT04212767|Platelet-rich fibrin|platelet-rich fibrin
4964268|NCT04212767|Soft tissue|soft tissue
4964274|NCT04212676|Asthma|asthma
4964275|NCT04212676|Body Awareness Treatment|body awareness treatment
4964276|NCT04212676|Postural Stability|postural stability
4964277|NCT04212676|Balance|balance
4964278|NCT04212676|Fear of Falling|fear of falling
4964279|NCT04212663|Musculi tibialis posterior|musculi tibialis posterior
4964280|NCT04212663|Tendon release|tendon release
4964281|NCT04212663|Anterior tibial tendon transfer|anterior tibial tendon transfer
4964282|NCT04212650|Cartilage Microfracture|cartilage microfracture
4964283|NCT04212650|Losartan|losartan
4964284|NCT04212650|Transforming growth factor beta 1|transforming growth factor beta 1
4964285|NCT04212650|Hip Arthroscopy|hip arthroscopy
4964292|NCT04212572|Primary sjögren's syndrome|primary sjögren's syndrome
4964293|NCT04212572|ultrasonography|ultrasonography
4964294|NCT04212572|salivary glands|salivary glands
4964295|NCT04212572|auto-immune disease|auto-immune disease
4964296|NCT04212546|prebiotic|prebiotic
4964297|NCT04212546|probiotic|probiotic
4964298|NCT04212546|synbiotic|synbiotic
4964299|NCT04212546|hunger and satiety hormones|hunger and satiety hormones
4964300|NCT04212533|hypocalcaemia, thyroidectomy, vit D, calcium|hypocalcaemia, thyroidectomy, vit d, calcium
4964301|NCT04212520|non-fasting lipid|non-fasting lipid
4964302|NCT04212520|cardiovascular and cerebrovascular events|cardiovascular and cerebrovascular events
4964303|NCT04212520|major adverse cardiovascular events|major adverse cardiovascular events
4964308|NCT04212481|Non Small Cell Lung Cancer|non small cell lung cancer
4964309|NCT04212481|Perioperative Efficacy|perioperative efficacy
4964310|NCT04212481|multi-port|multi-port
4964311|NCT04212468|Blood Pressure|blood pressure
4964312|NCT04212468|Elderly|elderly
4964313|NCT04212455|Hypertension|hypertension
4964314|NCT04212455|Cardiovascular Diseases|cardiovascular diseases
4964315|NCT04212455|Mortality|mortality
4964316|NCT04212455|Biomarker|biomarker
4964317|NCT04212442|aging in place|aging in place
4964318|NCT04212442|physical activity|physical activity
4964319|NCT04212442|cognitive impairment|cognitive impairment
4964335|NCT04212364|social networks|social networks
4964336|NCT04212325|Diabetic foot|diabetic foot
4964337|NCT04212325|Sciatic nerve catheter|sciatic nerve catheter
4964338|NCT04212325|wound heal|wound heal
4964339|NCT04212312|Betamethasone|betamethasone
4964340|NCT04212312|Twin pregnancy|twin pregnancy
4964341|NCT04212312|Repeat course|repeat course
4964342|NCT04212312|Single course|single course
4964343|NCT04212286|Hepatocellular Cancer|hepatocellular cancer
4964344|NCT04212286|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4964346|NCT04212286|Diagnostic Efficacy|diagnostic efficacy
4964347|NCT04212273|Hepatocellular carcinoma|hepatocellular carcinoma
4964348|NCT04212273|Sonazoid Contrast-enhanced ultrasound|sonazoid contrast-enhanced ultrasound
4964349|NCT04212273|EOB-MRI|eob-mri
4964350|NCT04212273|Diagnostic Efficacy|diagnostic efficacy
4964351|NCT04212260|oropharyngeal exercises|oropharyngeal exercises
4964352|NCT04212260|obstructive sleep apnea|obstructive sleep apnea
4964353|NCT04212260|stroke|stroke
4964354|NCT04212260|home sleep apnea test|home sleep apnea test
4964355|NCT04212260|randomized controlled trial|randomized controlled trial
4964356|NCT04212260|transient ischemic attack|transient ischemic attack
4964357|NCT04212260|feasibility|feasibility
4964358|NCT04212260|speech language pathology|speech language pathology
4964359|NCT04212247|systemic sclerosis, well-being, psychological distress, suffering, mental pain, well-being therapy, psychotherapy|systemic sclerosis, well-being, psychological distress, suffering, mental pain, well-being therapy, psychotherapy
4964360|NCT04212234|fetal ultrasound|fetal ultrasound
4964361|NCT04212234|ultrasound propagation velocity|ultrasound propagation velocity
4964362|NCT04212234|image quality|image quality
4964363|NCT04212234|obese women|obese women
4964364|NCT04212195|Genetic modifiers|genetic modifiers
4964365|NCT04212195|Biomarkers|biomarkers
4964366|NCT04212169|MEDI3506|medi3506
4964367|NCT04212169|Safety|safety
4964368|NCT04212169|Efficacy|efficacy
4964369|NCT04212169|Atopic Dermatitis|atopic dermatitis
4964370|NCT04212169|Eczema|eczema
4964371|NCT04212130|Intensive care unit|intensive care unit
4964372|NCT04212130|Infection Control|infection control
4964373|NCT04212130|Microbiological Monitoring|microbiological monitoring
4964374|NCT04212130|High-touch surfaces|high-touch surfaces
4964375|NCT04212130|Fluorescent marker|fluorescent marker
4964376|NCT04212130|Hospital environment|hospital environment
4964377|NCT04212130|Cleanliness assessment|cleanliness assessment
4964378|NCT04212104|mukbang|mukbang
4964387|NCT04212052|Non-small Cell Lung Cancer|non-small cell lung cancer
4964388|NCT04212052|Split-course radiotherapy|split-course radiotherapy
4964389|NCT04212052|Severe Impairment of Baseline Pulmonary Function|severe impairment of baseline pulmonary function
4964390|NCT04212052|Nab-paclitaxel|nab-paclitaxel
4964391|NCT04212026|metastatic Pancreatic Cancer|metastatic pancreatic cancer
4964392|NCT04212026|Irreversible electroporation (IRE)|irreversible electroporation (ire)
4964394|NCT04212026|Phase II trial|phase ii trial
4964994|NCT04208425|ASD|asd
4964405|NCT04211831|pVAX/hSlo|pvax/hslo
4964406|NCT04211831|Overactive Bladder|overactive bladder
4964407|NCT04211831|Urge Urinary Incontinence|urge urinary incontinence
4964408|NCT04211805|Chronic Hepatitis B|chronic hepatitis b
4964409|NCT04211805|Pregnancy|pregnancy
4964410|NCT04211805|Mother to Child Transmission|mother to child transmission
4964411|NCT04211805|Vertical Transmission|vertical transmission
4964412|NCT04211792|Tonometry, Ocular|tonometry, ocular
4964413|NCT04211792|Concordance|concordance
4964414|NCT04211792|Intraocular Pressure|intraocular pressure
4964415|NCT04211779|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4964416|NCT04211779|Aerobic Exercise|aerobic exercise
4964417|NCT04211779|Performance|performance
4964418|NCT04211766|Colon|colon
4964419|NCT04211766|Rectum|rectum
4964420|NCT04211753|Borderline personality disorder|borderline personality disorder
4964425|NCT04211727|Cancer|cancer
4964426|NCT04211701|Connective Tissue|connective tissue
4964427|NCT04211701|Massage|massage
4964428|NCT04211701|Peripheral Nervous System|peripheral nervous system
4964429|NCT04211662|Family caregiver -Stroke - Care burden - Intervention|family caregiver -stroke - care burden - intervention
4964430|NCT04211649|neglected infectious|neglected infectious
4964431|NCT04211649|tropical diseases|tropical diseases
4964432|NCT04211649|emerging diseases|emerging diseases
4964433|NCT04211649|mild leptospirosis|mild leptospirosis
4964434|NCT04211649|insular context|insular context
4964435|NCT04211649|antibiotics|antibiotics
4964436|NCT04211649|short treatment period|short treatment period
4964437|NCT04211649|non-inferiority trial|non-inferiority trial
4964438|NCT04211623|Cerebral Palsy|cerebral palsy
4964439|NCT04211623|Neurorehabilitation|neurorehabilitation
4964440|NCT04211623|Spasticity|spasticity
4964441|NCT04211584|Transradial intervention,radial artery,anatomic snuffbox|transradial intervention,radial artery,anatomic snuffbox
4964446|NCT04211558|Healthy Volunteer|healthy volunteer
4964447|NCT04211558|Pharmacokinetics (PK)|pharmacokinetics (pk)
4964448|NCT04211558|Ozanimod|ozanimod
4964449|NCT04211558|Adult Chinese Subjects|adult chinese subjects
4964450|NCT04211545|Healthy Subjects|healthy subjects
4964451|NCT04211545|CC-92480|cc-92480
4964452|NCT04211545|Pharmacokinetics|pharmacokinetics
4964453|NCT04211532|Surgical risk|surgical risk
4964454|NCT04211532|ACS NSQIP|acs nsqip
4964455|NCT04211519|Endodontic disease|endodontic disease
4964456|NCT04211519|Microbiome|microbiome
4964457|NCT04211519|Permanent teeth|permanent teeth
4964458|NCT04211519|Primary teeth|primary teeth
4964459|NCT04211506|Neurobehavioral performance|neurobehavioral performance
4964461|NCT04211493|Physical Activity|physical activity
4964462|NCT04211493|Physical Exercise|physical exercise
4964463|NCT04211493|Mental Disorder|mental disorder
4964464|NCT04211493|Depression|depression
4964465|NCT04211493|Mental Health|mental health
4964466|NCT04211493|Health Behaviour|health behaviour
4964467|NCT04211493|Electromyostimulation|electromyostimulation
4964469|NCT04211493|Strength Training|strength training
4964470|NCT04211415|Atopic Dermatitis|atopic dermatitis
4964471|NCT04211415|DS-2741a|ds-2741a
4964472|NCT04211350|Positional Obstructive Sleep Apnea|positional obstructive sleep apnea
4964475|NCT04211285|comprehensive geriatric assessment|comprehensive geriatric assessment
4964476|NCT04211285|telemedicine|telemedicine
4964477|NCT04211285|multidisciplinary approach of elderly care|multidisciplinary approach of elderly care
4964478|NCT04211285|electronic geriatric assessment bundle|electronic geriatric assessment bundle
4964479|NCT04211233|invasive grid electrode|invasive grid electrode
4964480|NCT04211233|functional outcome|functional outcome
4964481|NCT04211233|predictors for seizures|predictors for seizures
4964482|NCT04211220|Real time continuous glucose monitoring|real time continuous glucose monitoring
4983217|NCT04096989|TCM|tcm
4964496|NCT04211168|Lenvatinib|lenvatinib
4964497|NCT04211168|biomarker|biomarker
4964498|NCT04211142|Hernia, Inguinal|hernia, inguinal
4964499|NCT04211142|Pain|pain
4964500|NCT04211142|Chronic Pain|chronic pain
4964501|NCT04211142|Quality of Life|quality of life
4964502|NCT04211142|Laparoscopic Surgery|laparoscopic surgery
4964503|NCT04211142|Cyanoacrylates|cyanoacrylates
4964504|NCT04211142|Mesh, Surgical|mesh, surgical
4964505|NCT04211129|acupuncture|acupuncture
4964506|NCT04211129|Crohn's disease|crohn's disease
4964507|NCT04211129|brain functional activity|brain functional activity
4964512|NCT04211090|Non-squamous Non-small-cell Lung Cancer|non-squamous non-small-cell lung cancer
4964513|NCT04211090|Brain Metastases|brain metastases
4964514|NCT04211077|Suicide attempt|suicide attempt
4964515|NCT04211077|Analgesics|analgesics
4964516|NCT04211077|Opioid|opioid
4964517|NCT04211077|pharmacoepiemiology|pharmacoepiemiology
4964518|NCT04211064|optic nerve sheath diameter|optic nerve sheath diameter
4964519|NCT04211064|deep neuromuscular block|deep neuromuscular block
4964520|NCT04211064|moderate neuromuscular block|moderate neuromuscular block
4964521|NCT04211064|intracranial hypertension|intracranial hypertension
4964522|NCT04211051|lung neoplasm|lung neoplasm
4964523|NCT04211051|localization of lung nodules|localization of lung nodules
4964524|NCT04211051|ground glass opacity|ground glass opacity
4964525|NCT04211025|Sociodemographic Screening|sociodemographic screening
4964526|NCT04211025|Income|income
4964527|NCT04211025|Primary Care|primary care
4964528|NCT04211025|Social Needs|social needs
4964529|NCT04210986|Fisetin|fisetin
4964530|NCT04210986|Inflammation|inflammation
4964531|NCT04210986|Osteoarthritis|osteoarthritis
4964532|NCT04210960|Multiple sclerosis, serum lactate and MRS|multiple sclerosis, serum lactate and mrs
4964533|NCT04210947|sports physiotherapy|sports physiotherapy
4964534|NCT04210947|self-myofascial release|self-myofascial release
4964535|NCT04210947|foam-roller|foam-roller
5863589|NCT00001245|Diagnosis|diagnosis
4964538|NCT04210934|multi-omics|multi-omics
4964539|NCT04210908|Biofeedback|biofeedback
4964540|NCT04210908|Second stage of labor|second stage of labor
4964541|NCT04210908|Operative delivery|operative delivery
4964542|NCT04210908|Transperineal ultrasound|transperineal ultrasound
4964543|NCT04210882|Cardiovascular|cardiovascular
4964544|NCT04210882|Neuroscience|neuroscience
4964545|NCT04210882|Exercise|exercise
4964546|NCT04210869|Brain Insulin Sensitivity|brain insulin sensitivity
4964547|NCT04210869|Cognitive Performance|cognitive performance
4964548|NCT04210856|landscape|landscape
4964549|NCT04210856|exposure|exposure
4964551|NCT04210856|fNIRS|fnirs
4964552|NCT04210856|depression|depression
4964553|NCT04210856|stress|stress
4964554|NCT04210856|urban|urban
4964555|NCT04210856|anxiety|anxiety
4964556|NCT04210856|contemplative|contemplative
4964557|NCT04210843|Anti-IgE|anti-ige
4964558|NCT04210843|chronic spontaneous urticaria|chronic spontaneous urticaria
4964559|NCT04210843|hives severity score|hives severity score
4964560|NCT04210843|itch severity score|itch severity score
4964561|NCT04210843|urticaria activity score|urticaria activity score
4964562|NCT04210843|CSU|csu
4964563|NCT04210804|Omega-3|omega-3
4964564|NCT04210804|Bipolar Disorder|bipolar disorder
4964565|NCT04210804|Depression|depression
4964566|NCT04210791|AL amyloidosis|al amyloidosis
4964567|NCT04210791|autologous stem cell transplantation|autologous stem cell transplantation
4964568|NCT04210791|induction therapy|induction therapy
4964569|NCT04210791|bortezomib|bortezomib
4964570|NCT04210791|lenalidomide|lenalidomide
4964571|NCT04210791|ixazomib|ixazomib
4964572|NCT04210791|daratumumab|daratumumab
4964573|NCT04210791|melphalan|melphalan
4983311|NCT04096339|procedural sequence|procedural sequence
4964577|NCT04210778|Adult cancer survivors|adult cancer survivors
4964578|NCT04210778|Functional treatment|functional treatment
4964579|NCT04210765|infertility|infertility
4964580|NCT04210765|unexplained infertility|unexplained infertility
4964581|NCT04210765|ovulation induction|ovulation induction
4964582|NCT04210765|clomiphene citrate|clomiphene citrate
4964583|NCT04210713|Minocycline|minocycline
4964584|NCT04210674|Argan oil|argan oil
4964585|NCT04210674|Infant|infant
4964586|NCT04210674|Children|children
4964587|NCT04210674|Diaper Dermatitis|diaper dermatitis
4964588|NCT04210674|Topical Steroid Ointment|topical steroid ointment
4964591|NCT04210596|connective tissue graft|connective tissue graft
4964592|NCT04210596|collagen matrix|collagen matrix
4964593|NCT04210596|dental implant, single tooth|dental implant, single tooth
4964601|NCT04210570|Healthcare Cost|healthcare cost
4964602|NCT04210570|Greenhouse gas|greenhouse gas
4964603|NCT04210570|Environment Healthcare|environment healthcare
4964605|NCT04210557|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4964606|NCT04210544|Satiety|satiety
4964607|NCT04210544|Hunger|hunger
4964608|NCT04210544|Obesity|obesity
4964609|NCT04210544|Ghrelin|ghrelin
4964610|NCT04210544|Visual Analogue Scale|visual analogue scale
4964611|NCT04210544|Gastrointestinal hormones|gastrointestinal hormones
4964612|NCT04210544|Energy compensation|energy compensation
4964613|NCT04210505|Dialysis|dialysis
4964614|NCT04210505|povidone-iodine|povidone-iodine
4964615|NCT04210466|chronic pain|chronic pain
4964616|NCT04210466|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
4964617|NCT04210466|Compassion|compassion
4964618|NCT04210453|Postoperative acute kidney injury|postoperative acute kidney injury
4964619|NCT04210440|hip avascular necrosis|hip avascular necrosis
4964620|NCT04210440|hip conservative surgery|hip conservative surgery
4964621|NCT04210427|Cystic Fibrosis|cystic fibrosis
4964622|NCT04210427|Gut Dysmotility|gut dysmotility
4964623|NCT04210427|Polyethylene Glycol|polyethylene glycol
4964627|NCT04210375|heart failure|heart failure
4964628|NCT04210375|HFrEF|hfref
4964629|NCT04210375|neuregulin 1|neuregulin 1
4964630|NCT04210375|NRG-1|nrg-1
4964631|NCT04210375|heregulin|heregulin
4964632|NCT04210375|HER3|her3
4964633|NCT04210375|HER4|her4
4964634|NCT04210375|ErbB3|erbb3
4964635|NCT04210375|ErbB4|erbb4
4964636|NCT04210375|reduced ejection fraction|reduced ejection fraction
4964637|NCT04210362|neurodevelopment|neurodevelopment
4964638|NCT04210362|responsive caregiving|responsive caregiving
4964639|NCT04210362|nuturing care|nuturing care
4964641|NCT04210323|omalizumab|omalizumab
4964642|NCT04210323|subcutaneous|subcutaneous
4964643|NCT04210323|injection|injection
4964644|NCT04210323|ShotBlocker|shotblocker
4964647|NCT04210297|radiomics|radiomics
4964650|NCT04210206|cognitive function adults|cognitive function adults
4964651|NCT04210167|heart failure|heart failure
4964652|NCT04210167|web-based training|web-based training
4964653|NCT04210167|telephone monitoring|telephone monitoring
4964654|NCT04210167|symptom assessment|symptom assessment
4964655|NCT04210167|quality of life|quality of life
4964656|NCT04210154|Haemodiafiltration|haemodiafiltration
4964657|NCT04210154|Haemodialysis|haemodialysis
4964658|NCT04210154|Children|children
4964659|NCT04210128|Glucose Monitoring|glucose monitoring
4964664|NCT04210076|attentional performance|attentional performance
4964665|NCT04210076|psychological well-being|psychological well-being
4964666|NCT04210076|operational performance|operational performance
4964667|NCT04210063|Breathing|breathing
4964668|NCT04210063|Diaphragm|diaphragm
4964669|NCT04210063|Balance|balance
4964670|NCT04210063|Blood Pressure|blood pressure
4964671|NCT04210024|Diabetes Empowerment Education Program (DEEP)|diabetes empowerment education program (deep)
4964672|NCT04210024|social network analysis|social network analysis
4964673|NCT04210024|Integrated Behavioral Model (IBM)|integrated behavioral model (ibm)
4964674|NCT04210024|rural|rural
4964675|NCT04210024|community|community
4964676|NCT04210024|Appalachia|appalachia
4964677|NCT04210011|Pediatric oncology|pediatric oncology
4964678|NCT04210011|Parental resilience|parental resilience
4964679|NCT04209998|transcutaneous oximetry|transcutaneous oximetry
4964680|NCT04209998|oxygen|oxygen
4964681|NCT04209998|peripheral artery disease|peripheral artery disease
4964682|NCT04209998|follow-up|follow-up
4964683|NCT04209985|Health coaching|health coaching
4964684|NCT04209985|Adherence to treatment|adherence to treatment
4964685|NCT04209985|Health disparities|health disparities
4964686|NCT04209972|Ultra-high resolution CT|ultra-high resolution ct
4964687|NCT04209972|volume measumerents|volume measumerents
4964688|NCT04209946|Premature Infants|premature infants
4964689|NCT04209946|Respiratory Distress Syndrome|respiratory distress syndrome
4964715|NCT04209816|Non-alcoholic Fatty Liver|non-alcoholic fatty liver
4964716|NCT04209816|Apoproteins|apoproteins
4964717|NCT04209816|Genetic variants|genetic variants
4964718|NCT04209790|Glioblastoma|glioblastoma
4964719|NCT04209751|Microbiologic diagnosis|microbiologic diagnosis
4964720|NCT04209751|summer diarrhea|summer diarrhea
4964721|NCT04209751|pediatric population|pediatric population
4964722|NCT04209738|Tai Chi; eurythmy; HRV; PWA; sleep quality; fall prevention|tai chi; eurythmy; hrv; pwa; sleep quality; fall prevention
4964724|NCT04209686|Nab-Paclitaxel|nab-paclitaxel
4964725|NCT04209686|Olaparib|olaparib
4964726|NCT04209686|Pembrolizumab|pembrolizumab
4964727|NCT04209686|Immunotherapy|immunotherapy
4964728|NCT04209686|Anti-PD-1|anti-pd-1
4964729|NCT04209686|PARP inhibitors|parp inhibitors
4964730|NCT04209686|Gastric Cancer|gastric cancer
4964734|NCT04209634|CD55-deficient PLE|cd55-deficient ple
4964735|NCT04209634|complement hyperactivation, angiopathic thrombosis, protein-losing enteropathy (CHAPLE disease)|complement hyperactivation, angiopathic thrombosis, protein-losing enteropathy (chaple disease)
4964749|NCT04209543|Estetrol|estetrol
4964750|NCT04209543|Hot Flushes|hot flushes
4964751|NCT04209543|Vasomotor Symptoms|vasomotor symptoms
4964752|NCT04209517|Preoperative anxiety|preoperative anxiety
4964753|NCT04209517|ethology|ethology
4964754|NCT04209517|behavioural markers|behavioural markers
4964755|NCT04209517|objective detection|objective detection
4964756|NCT04209504|Rotator Cuff Repair|rotator cuff repair
4964757|NCT04209504|Shoulder Surgery|shoulder surgery
4964758|NCT04209504|Hemidiaphragmatic paralysis|hemidiaphragmatic paralysis
4964759|NCT04209504|Interscalene Block|interscalene block
4964760|NCT04209504|Interscalene Catheter|interscalene catheter
4964761|NCT04209504|Interscalene Liposomal Bupivacaine|interscalene liposomal bupivacaine
4964762|NCT04209478|quadratus lumborum block|quadratus lumborum block
4964763|NCT04209478|pediatric anesthesia|pediatric anesthesia
4964764|NCT04209478|transverse abdominal block|transverse abdominal block
4964765|NCT04209465|solid tumor|solid tumor
4964766|NCT04209465|HER2 mutation|her2 mutation
4964767|NCT04209465|exon 20 insertion mutation|exon 20 insertion mutation
4964768|NCT04209465|HER2 positive|her2 positive
4964769|NCT04209465|Genes, HER2|genes, her2
4964770|NCT04209465|Genes, erbb2|genes, erbb2
4964771|NCT04209465|HER2 amplification|her2 amplification
4964772|NCT04209465|HER2 overexpression|her2 overexpression
4964773|NCT04209465|genes, exon 20 insertion|genes, exon 20 insertion
4964774|NCT04209465|lung cancer|lung cancer
4964775|NCT04209465|non-small cell lung cancer|non-small cell lung cancer
4964776|NCT04209465|breast cancer|breast cancer
4964777|NCT04209465|colon cancer|colon cancer
4964778|NCT04209465|colorectal cancer|colorectal cancer
4964779|NCT04209465|bladder cancer|bladder cancer
4964780|NCT04209465|endometrial cancer|endometrial cancer
4964781|NCT04209465|gastric cancer|gastric cancer
4964782|NCT04209465|biliary tract cancer|biliary tract cancer
4964783|NCT04209426|total hip arthroplasty|total hip arthroplasty
4964786|NCT04209426|hemispherical dual-mobility acetabular cup|hemispherical dual-mobility acetabular cup
4964787|NCT04209426|safety|safety
4964788|NCT04209426|efficacy|efficacy
4964789|NCT04209426|implant survival|implant survival
4964790|NCT04209426|prosthetic dislocation|prosthetic dislocation
4964796|NCT04209400|Sci-B-Vac®|sci-b-vac®
4964797|NCT04209400|Prophylactic vaccine|prophylactic vaccine
4964798|NCT04209400|HepB vaccines|hepb vaccines
4964800|NCT04209400|pre-S1|pre-s1
4964801|NCT04209400|pre-S2|pre-s2
4964802|NCT04209400|Surface antigen|surface antigen
4964803|NCT04209374|primary total hip arthroplasty|primary total hip arthroplasty
4964805|NCT04209374|safety|safety
4964806|NCT04209374|efficacy|efficacy
4964807|NCT04209374|implant survival|implant survival
4964808|NCT04209374|prosthetic dislocation|prosthetic dislocation
4964809|NCT04209374|Harris hip score HHS|harris hip score hhs
4964810|NCT04209361|Child abuse|child abuse
4964811|NCT04209361|Dentists|dentists
4964812|NCT04209348|Exercise|exercise
4964813|NCT04209348|Contraception|contraception
4964814|NCT04209348|Vaccination|vaccination
4964822|NCT04209335|Biering-Sorensen|biering-sorensen
4964823|NCT04209335|sideplank|sideplank
4964824|NCT04209322|sciatica|sciatica
4964825|NCT04209322|lumbar disc herniation|lumbar disc herniation
4964826|NCT04209322|radiofrequency|radiofrequency
4964827|NCT04209322|non invasive treatment|non invasive treatment
4964828|NCT04209309|sexual arousal|sexual arousal
4964829|NCT04209283|Intrusive memories|intrusive memories
4964830|NCT04209257|Cerebral Palsy|cerebral palsy
4964831|NCT04209257|Functional electrical stimulation|functional electrical stimulation
4964832|NCT04209257|Neurotherapeutic|neurotherapeutic
4964833|NCT04209231|periodontitis|periodontitis
4964834|NCT04209231|gingivitis|gingivitis
4964835|NCT04209231|vitamin D|vitamin d
4964836|NCT04209218|Lung Cancer|lung cancer
4964837|NCT04209218|Radical Resection|radical resection
4964838|NCT04209218|Blood Pressure Management|blood pressure management
4964839|NCT04209218|Dexamethasone|dexamethasone
4964840|NCT04209218|Overall Survival|overall survival
4964841|NCT04209218|Postoperative Complications|postoperative complications
4964842|NCT04209205|Active Psoriatic Arthritis|active psoriatic arthritis
4964843|NCT04209205|Intravenous secukinumab|intravenous secukinumab
4964844|NCT04209192|UTI|uti
4964845|NCT04209192|Prophylaxis|prophylaxis
4964846|NCT04209192|Urinary Tract Infections|urinary tract infections
4964847|NCT04209192|TURB|turb
4964848|NCT04209192|Fosfomycin|fosfomycin
4964849|NCT04209192|Amikacin|amikacin
4964850|NCT04209192|Transurethral Resection of Bladder|transurethral resection of bladder
4964851|NCT04209153|Tobacco|tobacco
4964852|NCT04209153|addiction|addiction
4964853|NCT04209153|transcranial non invasive direct brain stimulation|transcranial non invasive direct brain stimulation
4964854|NCT04209153|adults|adults
4964858|NCT04209101|Medical student|medical student
4964859|NCT04209101|Psychoactive substances|psychoactive substances
4964860|NCT04209101|Alcohol|alcohol
4964861|NCT04209101|Tobacco|tobacco
4964862|NCT04209101|At risk consumption|at risk consumption
4964863|NCT04209088|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4964864|NCT04209088|premature newborn|premature newborn
4964865|NCT04209088|ultrasonography|ultrasonography
4964871|NCT04209062|Open Access|open access
4964872|NCT04209062|Medical Devices|medical devices
4964873|NCT04209062|Low Cost|low cost
4964874|NCT04209036|3D laparoscopy|3d laparoscopy
4964875|NCT04209036|2D laparoscopy|2d laparoscopy
4964876|NCT04209036|surgeons in training|surgeons in training
4964877|NCT04209023|glioma|glioma
4964878|NCT04209023|transcranial magnetic stimulation|transcranial magnetic stimulation
4964879|NCT04209023|neurofunctional inhibition|neurofunctional inhibition
4964880|NCT04209023|fMRI verification|fmri verification
4964881|NCT04208997|Ventricular Tachycardia|ventricular tachycardia
4964882|NCT04208997|Catheter Ablation|catheter ablation
4964883|NCT04208997|Antiarrhythmic drugs|antiarrhythmic drugs
4964884|NCT04208984|induction|induction
4964885|NCT04208984|anesthesia|anesthesia
4964886|NCT04208984|children|children
4964887|NCT04208958|Metastatic Cancer|metastatic cancer
4964888|NCT04208958|VE800|ve800
4964889|NCT04208958|Nivolumab|nivolumab
4964890|NCT04208958|Opdivo|opdivo
4964891|NCT04208958|Melanoma|melanoma
4964892|NCT04208958|Gastric Cancer|gastric cancer
4964898|NCT04208958|BMS|bms
4964899|NCT04208945|Ventilator Associated Pneumonia|ventilator associated pneumonia
4964900|NCT04208945|Pneumonia|pneumonia
4964901|NCT04208945|Gram negative bacteria|gram negative bacteria
4964902|NCT04208945|Ventilator Associated Infection|ventilator associated infection
4964903|NCT04208945|inhaled antibiotics|inhaled antibiotics
4964904|NCT04208945|colistin|colistin
4964905|NCT04208919|Regulatory Dendritic Cells|regulatory dendritic cells
4964906|NCT04208893|Pediatrics|pediatrics
4964907|NCT04208893|Tetralogy of Fallot|tetralogy of fallot
4964908|NCT04208893|Exercise intervention|exercise intervention
4964909|NCT04208893|Physical fitness|physical fitness
4964910|NCT04208893|Congenital Heart Defects|congenital heart defects
4964911|NCT04208893|Exercise rehabilitation|exercise rehabilitation
4964912|NCT04208880|Subjective Memory|subjective memory
4964914|NCT04208880|Brain Health|brain health
4964915|NCT04208880|Educational Program|educational program
4964916|NCT04208880|Well-being|well-being
4964917|NCT04208867|Maternal Health|maternal health
4964918|NCT04208867|Delivery|delivery
4964919|NCT04208867|Person-centered Care|person-centered care
4964920|NCT04208867|India|india
4964921|NCT04208867|Family Planning|family planning
4964922|NCT04208841|Maternal Health|maternal health
4964944|NCT04208659|acupuncture|acupuncture
4964947|NCT04208659|fibromyalgia|fibromyalgia
4964948|NCT04208659|low back pain|low back pain
4964950|NCT04208659|neuropathic pain|neuropathic pain
4964951|NCT04208659|neuropathy|neuropathy
4964952|NCT04208659|self-treatment|self-treatment
4964953|NCT04208659|musculoskeletal pain|musculoskeletal pain
4964954|NCT04208659|prosthesis-guided acupuncture|prosthesis-guided acupuncture
4964955|NCT04208659|device-guided acupuncture|device-guided acupuncture
4964956|NCT04208659|device-facilitated acupuncture|device-facilitated acupuncture
4964957|NCT04208633|cataract|cataract
4964958|NCT04208633|pseudophakia|pseudophakia
4964959|NCT04208633|intraocular lens|intraocular lens
4964960|NCT04208633|ciliary sulcus|ciliary sulcus
4964961|NCT04208633|anatomy|anatomy
4964962|NCT04208620|Diabetes|diabetes
4964963|NCT04208620|Cotadutide|cotadutide
4964964|NCT04208620|MEDI0382|medi0382
4964965|NCT04208620|D5671C00003|d5671c00003
4964966|NCT04208620|Type 2 Diabetes|type 2 diabetes
4964967|NCT04208581|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4964968|NCT04208581|Chronic Respiratory Failure|chronic respiratory failure
4964969|NCT04208581|Yiqi Huoxue Huatan Granule|yiqi huoxue huatan granule
4964970|NCT04208542|Thoracic surgical procedures|thoracic surgical procedures
4964971|NCT04208516|intravenous lidocaine|intravenous lidocaine
4964972|NCT04208516|erector spinae plane block|erector spinae plane block
4964976|NCT04208516|continuous peripheral nerve block|continuous peripheral nerve block
4964977|NCT04208503|thyroid volume|thyroid volume
4964979|NCT04208503|preterm infants|preterm infants
4964980|NCT04208503|thyroid hormone|thyroid hormone
4964982|NCT04208477|stellate ganglion block|stellate ganglion block
4964983|NCT04208477|brain hemodynamics|brain hemodynamics
4964984|NCT04208477|brain inflammatory response|brain inflammatory response
4964985|NCT04208451|hemodialysis|hemodialysis
4964986|NCT04208451|anemia|anemia
4964987|NCT04208451|oxidative stress|oxidative stress
4964988|NCT04208451|inflammation|inflammation
4964989|NCT04208425|Anxiety|anxiety
4964990|NCT04208425|Depression|depression
4964991|NCT04208425|Autism|autism
4964992|NCT04208425|Autism Spectrum Disorder|autism spectrum disorder
4964993|NCT04208425|Single Session Intervention|single session intervention
4965019|NCT04208217|evidence-based psychotherapy|evidence-based psychotherapy
5342901|NCT01981577|Structural connectivity|structural connectivity
4965020|NCT04208217|evidence-based pharmacotherapy|evidence-based pharmacotherapy
4965021|NCT04208217|addiction|addiction
4965022|NCT04208217|mental health/behavioral health|mental health/behavioral health
4965023|NCT04208204|provoked localized vulvodynia|provoked localized vulvodynia
4965024|NCT04208204|provoked vestibulodynia|provoked vestibulodynia
4965025|NCT04208204|vestibulitt|vestibulitt
4965026|NCT04208204|physiotherapy|physiotherapy
4965027|NCT04208191|Maternal Health|maternal health
4965028|NCT04208191|Family Planning|family planning
4965029|NCT04208191|Quality Improvement|quality improvement
4965030|NCT04208191|Person Centered Care|person centered care
4965031|NCT04208191|Kenya|kenya
4965032|NCT04208191|Delivery|delivery
4965033|NCT04208178|BYL719|byl719
4965034|NCT04208178|alpelisib|alpelisib
4965035|NCT04208178|Advance Breast Cancer|advance breast cancer
4965036|NCT04208178|maintenance|maintenance
4965042|NCT04208165|Ultrasound- guided|ultrasound- guided
4965044|NCT04208165|TAP|tap
4965045|NCT04208165|Hepatic|hepatic
4965046|NCT04208165|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4965047|NCT04208152|anle138b|anle138b
4965048|NCT04208152|alpha-Synuclein|alpha-synuclein
4965049|NCT04208152|Oligomer modulator|oligomer modulator
4965050|NCT04208152|Parkinson Disease|parkinson disease
4965051|NCT04208152|Multiple System Atrophy|multiple system atrophy
4965052|NCT04208152|Neurodegenerative diseases|neurodegenerative diseases
4965053|NCT04208152|Alzheimer Disease|alzheimer disease
4965054|NCT04208152|Tauopathies|tauopathies
4965055|NCT04208152|Amyloid|amyloid
4965056|NCT04208126|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4965057|NCT04208126|Extracorporal membrane Oxygenation|extracorporal membrane oxygenation
4965058|NCT04208126|Outcome|outcome
4965059|NCT04208126|Ventilation Therapy|ventilation therapy
4965060|NCT04208126|QOL|qol
4965061|NCT04208113|School-based intervention|school-based intervention
4965062|NCT04208113|Population-based preventive strategy|population-based preventive strategy
4965063|NCT04208113|Public health|public health
4965064|NCT04208087|Bladder|bladder
4965065|NCT04208087|Intravesical Injection|intravesical injection
4965066|NCT04208087|Interstitial Cystitis|interstitial cystitis
4965071|NCT04208022|Musicians|musicians
4965072|NCT04208022|Respiratory|respiratory
4965073|NCT04208022|Hypermobility|hypermobility
4965074|NCT04207931|alopecia|alopecia
4965075|NCT04207931|Hair loss|hair loss
4965076|NCT04207931|Female hair loss|female hair loss
4965077|NCT04207931|Minoxidil|minoxidil
4965078|NCT04207931|Topical Steroid|topical steroid
4965079|NCT04207905|Medicaid Expansion|medicaid expansion
4970442|NCT04175353|dairy|dairy
4965095|NCT04207827|mHealth|mhealth
4965096|NCT04207827|smoking|smoking
4965097|NCT04207827|postpartum|postpartum
4965098|NCT04207801|AUR101|aur101
4965101|NCT04207736|reproxalap|reproxalap
4965102|NCT04207736|INVIGORATE|invigorate
4965103|NCT04207736|ADX-102|adx-102
4965104|NCT04207710|Pain Ease|pain ease
4965105|NCT04207710|Ethyl Chloride|ethyl chloride
4963242|NCT04219761|ACS|acs
4965106|NCT04207710|Safety|safety
4965107|NCT04207710|Topical anesthetic|topical anesthetic
4965108|NCT04207710|ChloraPrep|chloraprep
4965109|NCT04207710|Topical refrigerant|topical refrigerant
4965110|NCT04207710|Microbial growth|microbial growth
4965111|NCT04207684|Testosterone|testosterone
4965112|NCT04207684|Anti-doping control|anti-doping control
4965113|NCT04207684|Athletic performance|athletic performance
4965114|NCT04207671|Tubeless|tubeless
4965115|NCT04207671|Wedge resection|wedge resection
4965116|NCT04207671|Improved drainage strategy|improved drainage strategy
4965117|NCT04207658|pushing technıques|pushing technıques
4965118|NCT04207658|maternal health|maternal health
4965119|NCT04207658|fetal health|fetal health
4965120|NCT04207645|Appendicitis|appendicitis
4965121|NCT04207645|modified RIPASA score|modified ripasa score
5288476|NCT02230722|chronic pain|chronic pain
4965122|NCT04207645|Clinical prediction rule|clinical prediction rule
4965123|NCT04207645|Validation|validation
4965124|NCT04207645|Ethnic group|ethnic group
4965138|NCT04207554|Pregnancy|pregnancy
4965139|NCT04207554|hCG|hcg
4965140|NCT04207554|IVD|ivd
4965141|NCT04207554|POCT|poct
4965142|NCT04207541|Type 2 diabetes|type 2 diabetes
4965143|NCT04207541|insulin initiation|insulin initiation
4965144|NCT04207541|Brief motivational interview|brief motivational interview
4965145|NCT04207541|Psychological insulin resistance|psychological insulin resistance
4965146|NCT04207502|dementia|dementia
4965147|NCT04207502|depression|depression
4965148|NCT04207502|brain structure|brain structure
4965149|NCT04207502|system biology|system biology
4965150|NCT04207450|Clinical trials|clinical trials
4965151|NCT04207450|Dentin Sensitivity|dentin sensitivity
4965152|NCT04207450|glutaraldehyde|glutaraldehyde
4965159|NCT04207411|Persistent dentoalveolar pain|persistent dentoalveolar pain
4965160|NCT04207411|bupivacaine|bupivacaine
4965161|NCT04207411|lidocaine|lidocaine
4965162|NCT04207411|clinical trial|clinical trial
4965163|NCT04207411|randomization|randomization
4965164|NCT04207385|pharmacogenomics|pharmacogenomics
4965165|NCT04207385|PGx|pgx
4965166|NCT04207385|therapeutic drug monitoring|therapeutic drug monitoring
4965167|NCT04207385|TDM|tdm
4965168|NCT04207385|Venlafaxine|venlafaxine
4965169|NCT04207385|depression|depression
4965170|NCT04207372|Digestibility|digestibility
4965171|NCT04207372|Whey|whey
4965172|NCT04207372|Zein|zein
4965173|NCT04207372|Protein|protein
4965174|NCT04207372|Ileostomates|ileostomates
4965175|NCT04207359|Special Populations|special populations
4965176|NCT04207359|Exercise Oncology|exercise oncology
4965177|NCT04207359|Creatine Supplementation|creatine supplementation
4965178|NCT04207359|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
4965179|NCT04207346|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4965180|NCT04207346|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4965181|NCT04207307|older people|older people
4965182|NCT04207307|oldest old|oldest old
4965183|NCT04207307|frailty|frailty
4965184|NCT04207307|sarcopenia|sarcopenia
4965185|NCT04207307|exercise|exercise
4965186|NCT04207307|resistance training|resistance training
4965187|NCT04207307|elderly|elderly
4965188|NCT04207307|falls|falls
4965191|NCT04207294|Chicken|chicken
4965192|NCT04207294|Bioavailability|bioavailability
4965193|NCT04207294|25 hydroxyvitamin D|25 hydroxyvitamin d
4965194|NCT04207294|Adults|adults
4965195|NCT04207294|RCT|rct
4965196|NCT04207294|Crossover|crossover
4965197|NCT04207268|Cardiovascular disease|cardiovascular disease
4965198|NCT04207203|Healthy diet|healthy diet
4965199|NCT04207203|Quality of life|quality of life
4965200|NCT04207203|Uremic toxins|uremic toxins
4965201|NCT04207203|Hyperkalemia|hyperkalemia
4965202|NCT04207203|Chronic kidney disease|chronic kidney disease
4965203|NCT04207203|Gut microbiota|gut microbiota
4965992|NCT04201938|Probiotic|probiotic
4965230|NCT04207008|decision making|decision making
4965231|NCT04206982|Persistent atrial fibrillation|persistent atrial fibrillation
4965232|NCT04206982|Pulmonary vein isolation|pulmonary vein isolation
4965233|NCT04206982|Catheter ablation|catheter ablation
4965234|NCT04206982|Ethanolisation|ethanolisation
4965235|NCT04206982|Ligament of Marshall|ligament of marshall
5292819|NCT02211365|CVD|cvd
4965236|NCT04206969|Transcultural psychotherapy|transcultural psychotherapy
4965237|NCT04206969|migrant|migrant
4965238|NCT04206969|child|child
4965239|NCT04206969|adolescent|adolescent
4965240|NCT04206969|Depressive Disorder|depressive disorder
4965241|NCT04206969|psychiatric care|psychiatric care
4965242|NCT04206969|mixed studies|mixed studies
4965243|NCT04206969|bayesian design|bayesian design
4965244|NCT04206969|qualitative study|qualitative study
4965245|NCT04206969|Randomized Controlled Trial|randomized controlled trial
4965246|NCT04206956|pediatric department|pediatric department
4965247|NCT04206956|children|children
4965248|NCT04206956|chronic postsurgical pain|chronic postsurgical pain
4965249|NCT04206956|perioperative anxiety|perioperative anxiety
4965250|NCT04206943|CAR-T Cell|car-t cell
4965251|NCT04206943|CD19|cd19
4965253|NCT04206943|NHL|nhl
4965254|NCT04206943|Cancer|cancer
4965255|NCT04206943|Chimeric Antigen Receptor|chimeric antigen receptor
4965256|NCT04206904|older adults|older adults
4965257|NCT04206904|cardiovascular diseases|cardiovascular diseases
4965258|NCT04206904|maximal exercise test|maximal exercise test
4965260|NCT04206878|POC|poc
4965261|NCT04206878|EID|eid
4965262|NCT04206878|Pediatrics|pediatrics
4965263|NCT04206865|ARNI|arni
4965264|NCT04206865|Sacubitril-Valsartan|sacubitril-valsartan
4965265|NCT04206865|Cardiogenic Shock|cardiogenic shock
4965266|NCT04206865|Tailored Therapy|tailored therapy
4965267|NCT04206865|Cardiac Intensive Care|cardiac intensive care
4965274|NCT04206800|in-vitro fertilization|in-vitro fertilization
4965275|NCT04206800|total motile sperm|total motile sperm
4965276|NCT04206800|male infertility|male infertility
4965277|NCT04206800|ejaculatory abstinence|ejaculatory abstinence
4965278|NCT04206761|QVM149|qvm149
4965279|NCT04206761|Indacaterol|indacaterol
4965280|NCT04206761|Glycopyrronium|glycopyrronium
4965281|NCT04206761|Mometasone|mometasone
4965282|NCT04206761|Xenon|xenon
4965283|NCT04206761|Triple Therapy|triple therapy
4965284|NCT04206735|interprofessional training|interprofessional training
4965285|NCT04206735|education|education
4965286|NCT04206735|noninvasive ventilation|noninvasive ventilation
4983903|NCT04092777|ACOs|acos
4965288|NCT04206709|exercise induced analgesia|exercise induced analgesia
4965289|NCT04206683|brain saturation|brain saturation
4965290|NCT04206683|burst suppression|burst suppression
4965291|NCT04206683|general anesthesia|general anesthesia
4965292|NCT04206683|pediatric|pediatric
4965297|NCT04206644|Systemic sclerosis, macrophage, ruxolitinib|systemic sclerosis, macrophage, ruxolitinib
4965298|NCT04206631|comedone extraction|comedone extraction
4965299|NCT04206631|oral doxycycline|oral doxycycline
4965300|NCT04206631|moderate acne vulgaris|moderate acne vulgaris
4965301|NCT04206631|HIF-1 alpha expression|hif-1 alpha expression
4965302|NCT04206592|Laryngeal mask|laryngeal mask
4965303|NCT04206592|Oropharyngeal leak pressure|oropharyngeal leak pressure
4965316|NCT04206501|Guideline Directed Medical Therapy|guideline directed medical therapy
4965317|NCT04206449|Infrared thermography system|infrared thermography system
4965318|NCT04206449|Standard Polysomnography|standard polysomnography
4965319|NCT04206449|Validity|validity
4965320|NCT04206449|Cost-effectiveness|cost-effectiveness
4965321|NCT04206423|Disability evaluation|disability evaluation
4965322|NCT04206423|Hand Strength|hand strength
4965323|NCT04206423|Quality of life|quality of life
4965325|NCT04206423|Pinch Strength|pinch strength
4965326|NCT04206423|Tennis elbow|tennis elbow
4965327|NCT04206410|Irritable Bowel Syndrome, probiotics|irritable bowel syndrome, probiotics
4965331|NCT04206358|melanoma, Liver Metastasis|melanoma, liver metastasis
4965332|NCT04206345|blood flow restriction|blood flow restriction
4965333|NCT04206345|acute|acute
4965342|NCT04206306|Intensive Care Unit Acquired Delirium|intensive care unit acquired delirium
4965343|NCT04206306|Intensive Care Unit Survivor|intensive care unit survivor
4965344|NCT04206306|Intensive Care Unit Acquired Weakness|intensive care unit acquired weakness
4965345|NCT04206306|Functional recovery|functional recovery
4965346|NCT04206280|radical prostatectomy|radical prostatectomy
4965347|NCT04206280|pedometer|pedometer
4965361|NCT04206215|Transcranial Ultrasound|transcranial ultrasound
4965362|NCT04206215|Noninvasive brain stimulation|noninvasive brain stimulation
4965363|NCT04206176|antiplatelet drugs|antiplatelet drugs
4965364|NCT04206176|clopidogrel|clopidogrel
4965365|NCT04206176|ticagrelor|ticagrelor
4965366|NCT04206176|high on-treatment platelet reactivity|high on-treatment platelet reactivity
4965367|NCT04206176|platelet function|platelet function
4965368|NCT04206163|Myocarditis|myocarditis
4965369|NCT04206163|Cardiac sarcoidosis|cardiac sarcoidosis
4965370|NCT04206163|Inflammatory cardiomyopathy|inflammatory cardiomyopathy
4965371|NCT04206163|Cardiomyopathy|cardiomyopathy
4965372|NCT04206163|Heart disease|heart disease
4965373|NCT04206163|Cardiovascular disease|cardiovascular disease
4965374|NCT04206163|Somatostatin|somatostatin
4965375|NCT04206163|68Ga-DOTA-TOC|68ga-dota-toc
4965376|NCT04206163|Positron emission tomography|positron emission tomography
4965377|NCT04206137|Muscle pain|muscle pain
4965378|NCT04206137|Low Back Disorder|low back disorder
4965379|NCT04206137|Exercise|exercise
4965380|NCT04206137|Physical Therapy|physical therapy
4965381|NCT04206137|Surface Electromyography|surface electromyography
4965382|NCT04206124|Autophagy|autophagy
4965383|NCT04206124|Inflammation|inflammation
4965384|NCT04206124|Metabolism|metabolism
4965385|NCT04206124|Adipocyte|adipocyte
4965386|NCT04206124|mTORC1|mtorc1
4965387|NCT04206124|Obesity|obesity
4965388|NCT04206124|Thermogenesis|thermogenesis
4965389|NCT04206098|COPD|copd
4965392|NCT04206046|arthroplasty, knee|arthroplasty, knee
4965393|NCT04206046|chronic pain|chronic pain
4965394|NCT04206020|Dry Eye|dry eye
4965395|NCT04206020|Dry Eye Syndrome|dry eye syndrome
4965396|NCT04206020|SkQ1|skq1
4965398|NCT04206020|Keratoconjunctivitis|keratoconjunctivitis
4965399|NCT04206007|COPD|copd
4965400|NCT04205929|Contraceptive implant|contraceptive implant
4965401|NCT04205929|Irregular bleeding|irregular bleeding
4965402|NCT04205890|intravenous ketamine|intravenous ketamine
4966999|NCT04195776|Tenofovir|tenofovir
4965403|NCT04205890|treatment-resistant depression|treatment-resistant depression
4965404|NCT04205851|Spondylitis, Ankylosing|spondylitis, ankylosing
4965405|NCT04205825|Nursing|nursing
4965406|NCT04205825|Patient Safety|patient safety
4965407|NCT04205825|Checklist|checklist
4965408|NCT04205825|Cardiology|cardiology
4965409|NCT04205812|Metastatic|metastatic
4965410|NCT04205812|non-small cell lung cancer|non-small cell lung cancer
4965411|NCT04205812|nonsquamous|nonsquamous
4965412|NCT04205812|squamous|squamous
4965413|NCT04205812|PD-1|pd-1
4965421|NCT04205760|end-stage heart failure|end-stage heart failure
4965422|NCT04205760|cardiac surgery|cardiac surgery
4965423|NCT04205760|nutrition therapy|nutrition therapy
4965424|NCT04205760|exercise|exercise
4965425|NCT04205760|cycling|cycling
4965426|NCT04205721|HIV prevention|hiv prevention
4965427|NCT04205721|School-based programming|school-based programming
4965428|NCT04205721|Pregnancy prevention|pregnancy prevention
4965429|NCT04205721|South Africa|south africa
4965430|NCT04205721|Genital herpes|genital herpes
4965431|NCT04205708|silica|silica
4965432|NCT04205708|public health|public health
4965433|NCT04205708|early prevention|early prevention
4965434|NCT04205708|silicosis|silicosis
4965435|NCT04205708|screening|screening
4965436|NCT04205708|Oklahoma|oklahoma
4965437|NCT04205708|lung disease|lung disease
4965438|NCT04205708|pulmonology|pulmonology
4965439|NCT04205708|Pneumoconiosis|pneumoconiosis
4965440|NCT04205708|lung|lung
4965441|NCT04205708|dust exposure|dust exposure
4965442|NCT04205708|occupational health|occupational health
4965443|NCT04205708|community health|community health
4965444|NCT04205695|infraclavicular catheter|infraclavicular catheter
4965445|NCT04205695|upper extremity surgery|upper extremity surgery
4965446|NCT04205695|Postoperative analgesia|postoperative analgesia
4965451|NCT04205656|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
4965452|NCT04205656|anterior cruciate ligament reconstruction (ACLR)|anterior cruciate ligament reconstruction (aclr)
4965453|NCT04205617|Produce prescription|produce prescription
4965455|NCT04205617|Nutrition education|nutrition education
4965456|NCT04205591|split bone block|split bone block
4965458|NCT04205578|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
4965459|NCT04205578|Revascularization surgery|revascularization surgery
4965460|NCT04205578|Extracranial-to-intracranial revascularization|extracranial-to-intracranial revascularization
4965461|NCT04205578|Direct bypass surgery|direct bypass surgery
4965462|NCT04205578|Combined bypass surgery|combined bypass surgery
4965463|NCT04205578|Indirect bypass surgery|indirect bypass surgery
4965464|NCT04205565|L-oxiracetam|l-oxiracetam
4965465|NCT04205565|Cognitive Impairment|cognitive impairment
4965466|NCT04205565|Craniocerebral Injury|craniocerebral injury
4965467|NCT04205539|dexmedetomidine|dexmedetomidine
4965468|NCT04205539|lymphatic system|lymphatic system
4965469|NCT04205513|Telemonitoring|telemonitoring
4965470|NCT04205513|Titration|titration
4965471|NCT04205513|Remote monitoring|remote monitoring
4965472|NCT04205500|juvenile|juvenile
4965473|NCT04205500|arthritis|arthritis
4965474|NCT04205500|diet|diet
4965475|NCT04205474|valve sparing procedure|valve sparing procedure
4965476|NCT04205474|reimplantation|reimplantation
4965477|NCT04205461|programmed ventricular stimulation|programmed ventricular stimulation
4965478|NCT04205461|catheter ablation|catheter ablation
4965479|NCT04205461|electrophysiology study|electrophysiology study
4965480|NCT04205461|tetralogy of Fallot|tetralogy of fallot
4965481|NCT04205461|pulmonary valve replacement|pulmonary valve replacement
4965482|NCT04205422|metabolic requirements|metabolic requirements
4965483|NCT04205422|respiratory mechanics|respiratory mechanics
4965484|NCT04205396|cirrhosis|cirrhosis
4965485|NCT04205396|hepatic encephalopathy|hepatic encephalopathy
4965486|NCT04205396|ascites|ascites
4965487|NCT04205396|varices|varices
4965488|NCT04205396|liver disease|liver disease
4965489|NCT04205396|resilience training|resilience training
4965490|NCT04205396|expressive writing|expressive writing
4965491|NCT04205344|Bupivacaine|bupivacaine
4965492|NCT04205344|Obesity|obesity
4965494|NCT04205344|Subarachnoid|subarachnoid
4965495|NCT04205344|Cesarean|cesarean
4965496|NCT04205344|Subdural|subdural
4965497|NCT04205318|obesity|obesity
4965498|NCT04205318|gene-diet interaction|gene-diet interaction
4965499|NCT04205318|FTO gene variant|fto gene variant
4965500|NCT04205305|Acute ischemic stroke|acute ischemic stroke
4965501|NCT04205305|blood pressure|blood pressure
4965502|NCT04205305|hypertension|hypertension
4965505|NCT04205279|Reactive balance|reactive balance
4965506|NCT04205279|Virtual reality training|virtual reality training
4965517|NCT04205214|Alopecia Areata|alopecia areata
4965518|NCT04205214|Alopecia Universalis|alopecia universalis
4965519|NCT04205214|Alopecia Totalis|alopecia totalis
4965520|NCT04205214|Psychology|psychology
4965521|NCT04205214|Health Psychology|health psychology
4965522|NCT04205136|Spironolactone|spironolactone
4965523|NCT04205136|Positive Airway Pressure|positive airway pressure
4965524|NCT04205123|sickle cell disease|sickle cell disease
4965525|NCT04205123|nephropathy|nephropathy
4965526|NCT04205110|Intravascular Ultrasound|intravascular ultrasound
4965527|NCT04205110|Near Infrared Spectroscopy|near infrared spectroscopy
4965528|NCT04205110|Positron Emission Tomography|positron emission tomography
4965529|NCT04205084|Diabetes Technology|diabetes technology
4965530|NCT04205058|Randomised clinical trial|randomised clinical trial
4965531|NCT04205058|Pancreatic surgery|pancreatic surgery
4965532|NCT04205045|milk digestibility|milk digestibility
4965533|NCT04205045|gastro-intestinal discomfort|gastro-intestinal discomfort
4965534|NCT04205045|milk proteins|milk proteins
4965535|NCT04205045|lactose|lactose
4965536|NCT04205045|gut permeability|gut permeability
4965537|NCT04205045|gut microbiota|gut microbiota
4965540|NCT04205006|ischemic stroke|ischemic stroke
4965541|NCT04205006|secondary prevention|secondary prevention
4965542|NCT04205006|transient ischemic attack|transient ischemic attack
4965543|NCT04205006|disease management|disease management
4965545|NCT04204980|Allosensitization|allosensitization
4965546|NCT04204980|Kidney Transplantation|kidney transplantation
4965547|NCT04204915|Asymptomatic aortic stenosis|asymptomatic aortic stenosis
4965548|NCT04204915|Aortic valve replacement|aortic valve replacement
4965549|NCT04204915|Randomised controlled trial|randomised controlled trial
4965550|NCT04204915|Expectant management|expectant management
4970848|NCT04172571|Anti-PD-1|anti-pd-1
4965561|NCT04204811|Ovarian Cancer|ovarian cancer
4965562|NCT04204811|Primary peritoneal carcinoma|primary peritoneal carcinoma
4965563|NCT04204811|Fallopian tube cancer|fallopian tube cancer
4965564|NCT04204811|19-347|19-347
4965565|NCT04204811|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4965566|NCT04204798|Elderly|elderly
4965567|NCT04204798|Surgery|surgery
4965568|NCT04204798|Intensive Care Unit|intensive care unit
4965569|NCT04204798|Dexmedetomidine|dexmedetomidine
4965570|NCT04204798|Overall survival|overall survival
4965571|NCT04204785|Operating Room Environment|operating room environment
4965572|NCT04204785|Noise|noise
4965573|NCT04204785|General Anesthesia|general anesthesia
4965574|NCT04204772|activated charcoal|activated charcoal
4965575|NCT04204759|transcranial direct curren stimulation|transcranial direct curren stimulation
4965576|NCT04204759|antisocial behavior|antisocial behavior
4965577|NCT04204746|general anesthesia|general anesthesia
4965578|NCT04204746|fresh gas|fresh gas
4965579|NCT04204746|moisture|moisture
4965580|NCT04204746|temperature|temperature
4965581|NCT04204746|respiratory circuit|respiratory circuit
4965582|NCT04204681|ultrasonography|ultrasonography
4965583|NCT04204681|children|children
4965584|NCT04204681|tonsil|tonsil
4965585|NCT04204681|diagnostic imaging|diagnostic imaging
4965586|NCT04204590|Deprescribing|deprescribing
4965587|NCT04204564|paclitaxel|paclitaxel
4965588|NCT04204564|drug coated balloon|drug coated balloon
4965589|NCT04204564|drug eluting stent|drug eluting stent
4965590|NCT04204564|perihpheral vascular intervention|perihpheral vascular intervention
4965591|NCT04204564|registry|registry
4965592|NCT04204551|Parkinson's Disease|parkinson's disease
4965593|NCT04204551|Physical Activity|physical activity
4965594|NCT04204551|Neurorehabilitation|neurorehabilitation
4965595|NCT04204551|Neuroplasticity|neuroplasticity
4965596|NCT04204551|Motor Function|motor function
4965613|NCT04204499|Screen-detected cancer|screen-detected cancer
4965614|NCT04204499|Non-invasive biological and radiological parameters|non-invasive biological and radiological parameters
4965615|NCT04204486|Exercise|exercise
4965616|NCT04204486|Strength|strength
4965617|NCT04204486|Source Memory|source memory
4965618|NCT04204486|Context Memory|context memory
4965619|NCT04204486|Inhibition|inhibition
4965620|NCT04204486|Executive Function|executive function
4965621|NCT04204486|SOSI|sosi
4965622|NCT04204486|Shift work|shift work
4965623|NCT04204486|police|police
4965624|NCT04204486|law enforcement|law enforcement
4965625|NCT04204486|military|military
4965626|NCT04204486|Oral health|oral health
4965627|NCT04204486|Quality of Sleep|quality of sleep
4965628|NCT04204486|Cognition|cognition
4965629|NCT04204486|Fitness|fitness
4965630|NCT04204460|eccentric squatting|eccentric squatting
4965631|NCT04204460|electromyografic activation|electromyografic activation
4965632|NCT04204460|exercise|exercise
4965633|NCT04204460|patellar tendinopathy|patellar tendinopathy
4965635|NCT04204434|Advanced|advanced
4965636|NCT04204434|Solid Tumor|solid tumor
4965637|NCT04204434|Advanced Solid Tumor|advanced solid tumor
4965638|NCT04204395|Peanut Ball|peanut ball
4965639|NCT04204395|Labor Pain|labor pain
4965640|NCT04204395|Support and Control|support and control
4965641|NCT04204395|Anxiety|anxiety
4965642|NCT04204395|Labor Duration|labor duration
4965643|NCT04204369|point of care ultrasound|point of care ultrasound
4965644|NCT04204369|musculoskeletal ultrasound|musculoskeletal ultrasound
4965645|NCT04204369|sonography|sonography
4965646|NCT04204369|resident education|resident education
4965647|NCT04204369|orthopaedic surgery|orthopaedic surgery
4965648|NCT04204369|online curriculum|online curriculum
4965649|NCT04204343|Erector Spinae Plane Block|erector spinae plane block
4965650|NCT04204343|Caudal Block|caudal block
4965651|NCT04204343|Ultrasound guidance|ultrasound guidance
4965652|NCT04204343|Postoperative analgesia|postoperative analgesia
4965653|NCT04204343|Upper abdominal surgery|upper abdominal surgery
4965654|NCT04204330|atrial fibrillation|atrial fibrillation
4965655|NCT04204330|electronic health|electronic health
4965656|NCT04204330|mobile health|mobile health
4965657|NCT04204317|autofluorescence|autofluorescence
4965658|NCT04204317|parathyroid glands|parathyroid glands
4965659|NCT04204317|thyroidectomy|thyroidectomy
4965660|NCT04204317|FLUOBEAM XS|fluobeam xs
4965662|NCT04204304|D02.455.326.271.665.202.495.325|d02.455.326.271.665.202.495.325
4965663|NCT04204304|C17.800.030.150|c17.800.030.150
4965664|NCT04204291|lung|lung
4965665|NCT04204291|nasal mucosa|nasal mucosa
4965666|NCT04204291|respiratory mucosa|respiratory mucosa
4965667|NCT04204278|Hyaluronic Acid|hyaluronic acid
4965668|NCT04204265|Sodium Hyaluronate|sodium hyaluronate
4965669|NCT04204265|Hyaluronic Acid|hyaluronic acid
4965670|NCT04204252|Inhaled Alpha 1-Antitrypsin Nebulizer|inhaled alpha 1-antitrypsin nebulizer
4965671|NCT04204226|Autism spectrum disorder|autism spectrum disorder
4965672|NCT04204226|Sequential Multiple Assignment Randomized Trial|sequential multiple assignment randomized trial
4965673|NCT04204148|postoperative cough|postoperative cough
4965674|NCT04204148|Multivariate analysis|multivariate analysis
4965675|NCT04204148|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4965676|NCT04204148|Uniport Video-assisted Thoracoscopic Surgery|uniport video-assisted thoracoscopic surgery
4965682|NCT04204096|Typhoid conjugate vaccine|typhoid conjugate vaccine
4965683|NCT04204096|Vi-DT|vi-dt
4965684|NCT04204096|Safety|safety
4965685|NCT04204096|Immunogenicity|immunogenicity
4965686|NCT04204083|Hyaluronic acid|hyaluronic acid
4965691|NCT04204031|Long term oxygen therapy|long term oxygen therapy
4965692|NCT04204031|adherence|adherence
4965693|NCT04204031|electronic monitoring|electronic monitoring
4965694|NCT04204005|Low protein diet|low protein diet
4965695|NCT04204005|Chronic kidney disease|chronic kidney disease
4965698|NCT04204005|Probiotic bacteria|probiotic bacteria
4965699|NCT04204005|Intestinal dysbiosis|intestinal dysbiosis
4965703|NCT04203914|Hypertension|hypertension
4965704|NCT04203914|Empagliflozin|empagliflozin
5007738|NCT03947970|CKD|ckd
4965705|NCT04203914|Left ventricular diastolic function|left ventricular diastolic function
4965706|NCT04203914|Blood pressure|blood pressure
4965707|NCT04203888|N-of-1|n-of-1
4965722|NCT04203732|Retrospective Cohort|retrospective cohort
4965723|NCT04203732|Anesthetic Technique|anesthetic technique
4965724|NCT04203732|Total Joint Arthroplasty|total joint arthroplasty
4965725|NCT04203693|Ilumetri®|ilumetri®
4965726|NCT04203693|Tildrakizumab|tildrakizumab
4965727|NCT04203693|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
4965728|NCT04203654|Methamphetamine|methamphetamine
4965729|NCT04203654|Cognitive behavior group therapy|cognitive behavior group therapy
4965730|NCT04203641|pancreatic cancer|pancreatic cancer
4965731|NCT04203641|immunoconjugate|immunoconjugate
4965732|NCT04203641|tumor microenvironment alkalinization|tumor microenvironment alkalinization
4965733|NCT04203602|obesity|obesity
4965734|NCT04203602|bariatric surgery|bariatric surgery
4965735|NCT04203589|Premature|premature
4965736|NCT04203589|Developmental Disability|developmental disability
4965737|NCT04203589|Motor Disorder|motor disorder
4965738|NCT04203589|Cerebral Palsy|cerebral palsy
4965739|NCT04203589|Early Intervention|early intervention
4965740|NCT04203589|developmental Support|developmental support
4965741|NCT04203576|Stable|stable
4965742|NCT04203576|Cardiovascular Disease|cardiovascular disease
4965743|NCT04203550|Chronic Subdural hematoma|chronic subdural hematoma
4965744|NCT04203550|Surgical evacuation|surgical evacuation
4965745|NCT04203550|Recurrence|recurrence
4965746|NCT04203550|Irrigation fluid|irrigation fluid
4965747|NCT04203524|Procalcitonin|procalcitonin
4965748|NCT04203524|Sepsis|sepsis
4965749|NCT04203524|Septic shock|septic shock
4965750|NCT04203524|Cancer|cancer
4965751|NCT04203524|Critical illness|critical illness
4965752|NCT04203511|Non-small cell lung cancer|non-small cell lung cancer
4965754|NCT04203511|Stage III|stage iii
4965755|NCT04203511|PD-1|pd-1
4965756|NCT04203511|PD-L1|pd-l1
4965757|NCT04203498|Spasticity|spasticity
4965758|NCT04203472|inhalation technique|inhalation technique
4965759|NCT04203472|Dry Powder Inhaler|dry powder inhaler
4965760|NCT04203472|pressurized Metered Dose Inhaler|pressurized metered dose inhaler
4965761|NCT04203459|pancreatic cancer|pancreatic cancer
4965762|NCT04203459|chimeric antigen receptor T cell|chimeric antigen receptor t cell
4965763|NCT04203459|gut microbiota|gut microbiota
4965764|NCT04203459|Acyl-CoA|acyl-coa
4965765|NCT04203459|cholesterol acyltransferase 1|cholesterol acyltransferase 1
4965766|NCT04203459|Mesothelin|mesothelin
4965767|NCT04203446|inhalation technique|inhalation technique
4965768|NCT04203394|Schroth exercise, conservative treatment, scoliosis|schroth exercise, conservative treatment, scoliosis
4965770|NCT04203368|CABG|cabg
4965771|NCT04203368|verapamil|verapamil
4965772|NCT04203368|adenosine|adenosine
4965773|NCT04203342|Tinea pedis|tinea pedis
4965774|NCT04203342|Ketoconazole|ketoconazole
4965775|NCT04203290|Minumum alveoler concentration|minumum alveoler concentration
4965776|NCT04203290|Entropy monitorining|entropy monitorining
4965777|NCT04203290|General anesthesia|general anesthesia
5863590|NCT00001245|Intestinal Helminth|intestinal helminth
4965782|NCT04203251|Artificial Intelligence|artificial intelligence
4965783|NCT04203251|Cardiac Monitoring|cardiac monitoring
4965784|NCT04203212|endometriosis|endometriosis
4965785|NCT04203212|bone mineral density|bone mineral density
4965786|NCT04203212|myokines|myokines
4965787|NCT04203212|sclerotin|sclerotin
4965788|NCT04203212|periostin|periostin
4965789|NCT04203199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4965790|NCT04203199|Brain Stimulation|brain stimulation
4965791|NCT04203199|Healthy controls|healthy controls
4965792|NCT04203199|Treatment|treatment
4965810|NCT04203004|Hypothermic oxygenated perfusion (HOPE)|hypothermic oxygenated perfusion (hope)
4965812|NCT04203004|Liver transplantation|liver transplantation
4965813|NCT04202991|COPD, balance, gait, pain|copd, balance, gait, pain
4965814|NCT04202926|deep transcranial magnetic stimulation|deep transcranial magnetic stimulation
4965815|NCT04202926|methamphetamine addiction|methamphetamine addiction
4965816|NCT04202900|elderly|elderly
4965817|NCT04202900|LED phototherapy|led phototherapy
4965818|NCT04202900|meridian energy|meridian energy
4965819|NCT04202900|sleep quality|sleep quality
4965820|NCT04202900|fatigue|fatigue
4965821|NCT04202900|cold limbs|cold limbs
4965822|NCT04202900|long-term care institution|long-term care institution
4965823|NCT04202887|Anesthesia|anesthesia
4965824|NCT04202887|Aspiration|aspiration
4965825|NCT04202887|Epidural opioids|epidural opioids
4965826|NCT04202887|Gastric ultrasound|gastric ultrasound
4965827|NCT04202887|Gastric emptying|gastric emptying
4965828|NCT04202887|Labor fasting guidelines|labor fasting guidelines
4965829|NCT04202874|randomized controlled trial|randomized controlled trial
4965830|NCT04202874|Transversus Abdominis Plane block|transversus abdominis plane block
4965831|NCT04202848|Flora|flora
4965832|NCT04202835|post transplant cyclophosphamide|post transplant cyclophosphamide
4965833|NCT04202835|anti-thymocyte globulin|anti-thymocyte globulin
4965838|NCT04202796|catheter ablation|catheter ablation
4965839|NCT04202718|ECG Interpretation|ecg interpretation
4965841|NCT04202705|5T4|5t4
4965842|NCT04202705|solid tumors|solid tumors
4965843|NCT04202705|duocarmycin|duocarmycin
4965844|NCT04202666|peristomy skin complication|peristomy skin complication
4965845|NCT04202666|convex skin barrier|convex skin barrier
4965846|NCT04202640|Breast Cancer|breast cancer
4965847|NCT04202640|Mechanical Stimulation|mechanical stimulation
4965848|NCT04202640|Mastectomy|mastectomy
4965849|NCT04202627|LGMD|lgmd
4965850|NCT04202627|FKRP|fkrp
4965851|NCT04202627|Clinical Research|clinical research
4965852|NCT04202627|ML Bio Solutions|ml bio solutions
4965853|NCT04202627|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
4965854|NCT04202627|LGMDR9|lgmdr9
4965855|NCT04202627|LGMD 2i|lgmd 2i
4965856|NCT04202562|Glaucoma|glaucoma
4965857|NCT04202562|Ocular hypertension|ocular hypertension
4965858|NCT04202562|Glaucoma, Open-Angle|glaucoma, open-angle
4965859|NCT04202562|Ab interno trabeculectomy|ab interno trabeculectomy
4965860|NCT04202562|Phacoemulsification|phacoemulsification
4965861|NCT04202562|Combined surgery|combined surgery
4965862|NCT04202562|Minimally Invasive Glaucoma Surgery|minimally invasive glaucoma surgery
4965863|NCT04202497|Drug Therapy|drug therapy
4965864|NCT04202484|Immunotherapy|immunotherapy
4965865|NCT04202484|Efficacy|efficacy
4965866|NCT04202484|Safety|safety
4965870|NCT04202445|Actinic keratosis|actinic keratosis
4965871|NCT04202445|Field treatment|field treatment
4965872|NCT04202445|Ingenol mebutate|ingenol mebutate
4965873|NCT04202445|Picato|picato
4965874|NCT04202445|Mikado|mikado
4965875|NCT04202432|Mean Systemic Filling Pressure|mean systemic filling pressure
4965876|NCT04202432|Pms|pms
4965877|NCT04202432|Pmsf|pmsf
4965878|NCT04202432|Hypovolemia|hypovolemia
4965879|NCT04202432|Cardiac Output|cardiac output
4965880|NCT04202432|Transpulmonary thermodilution|transpulmonary thermodilution
4965881|NCT04202432|Transesophageal echocardiography|transesophageal echocardiography
4965882|NCT04202432|Volume state|volume state
4965883|NCT04202432|Critical Care|critical care
4965884|NCT04202432|Cardiosurgery|cardiosurgery
4965885|NCT04202432|Intensive Care|intensive care
4965886|NCT04202432|Carotid ultrasound|carotid ultrasound
4965887|NCT04202432|Pulsed Wave|pulsed wave
4965888|NCT04202432|Inspiratory breath hold|inspiratory breath hold
4965889|NCT04202406|Postoperative pain|postoperative pain
4965890|NCT04202406|Paracetamol|paracetamol
4965891|NCT04202406|Placebo|placebo
4965892|NCT04202406|Single visit root canal treatment|single visit root canal treatment
4965893|NCT04202367|Transversus abdominis plane block|transversus abdominis plane block
4965921|NCT04202250|continuous nerve block|continuous nerve block
4965922|NCT04202211|ulcerative colitis|ulcerative colitis
4965923|NCT04202211|Fecal Microbiota transplant|fecal microbiota transplant
4965925|NCT04202211|Inflammatory bowel disease|inflammatory bowel disease
4965927|NCT04202185|Auditory neuropathy|auditory neuropathy
4965928|NCT04202185|DFNB9|dfnb9
4965929|NCT04202185|Children|children
4965930|NCT04202185|Hearing loss|hearing loss
4965931|NCT04202185|Deafness|deafness
4965932|NCT04202172|endothelial function|endothelial function
4965933|NCT04202159|E2007|e2007
4965934|NCT04202159|Perampanel|perampanel
4965935|NCT04202159|Fycompa|fycompa
4965936|NCT04202159|Primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
4965937|NCT04202159|Secondarily generalized tonic-clonic seizures|secondarily generalized tonic-clonic seizures
4965938|NCT04202133|obesity|obesity
4965939|NCT04202133|weight loss|weight loss
4965940|NCT04202133|neuroimaging|neuroimaging
4965941|NCT04202133|fMRI|fmri
4965942|NCT04202133|behavioral obesity treatment|behavioral obesity treatment
4965943|NCT04202120|Age stereotypes|age stereotypes
4965944|NCT04202120|episodic memory|episodic memory
4965945|NCT04202120|social participation|social participation
4965946|NCT04202107|Dietary assessment|dietary assessment
4965947|NCT04202107|Food Frequency Questionnaire|food frequency questionnaire
4965948|NCT04202107|multi-pass 24 hour food recall|multi-pass 24 hour food recall
4965949|NCT04202107|semi-quantitative|semi-quantitative
4965950|NCT04202094|Male fertility preservation|male fertility preservation
4965951|NCT04202094|Testicular tissue biopsy|testicular tissue biopsy
4965952|NCT04202094|Male fertility status|male fertility status
4965953|NCT04202094|Tanner stage|tanner stage
4965954|NCT04202094|Testicular volume|testicular volume
4965955|NCT04202094|Hormones|hormones
4965956|NCT04202094|Semen analysis|semen analysis
4965957|NCT04202081|patient-reported outcomes|patient-reported outcomes
4965958|NCT04202081|observational|observational
4965959|NCT04202081|HCV|hcv
4965960|NCT04202081|Hepatitis C|hepatitis c
4965961|NCT04202081|Chronic Liver Disease|chronic liver disease
4965962|NCT04202081|Liver Disease|liver disease
4965963|NCT04202081|Research|research
4965964|NCT04202081|Participation|participation
4965965|NCT04202042|PFA|pfa
4965966|NCT04202042|PTSD|ptsd
4965967|NCT04202042|Public safety personnel|public safety personnel
4965968|NCT04202029|ASA|asa
4965969|NCT04202029|American Socity of Anesthesiologists physical status classification system|american socity of anesthesiologists physical status classification system
4965970|NCT04202029|Thoracic Impedance monitoring|thoracic impedance monitoring
4965972|NCT04202029|ECG|ecg
4965973|NCT04202029|echocardiography|echocardiography
4965974|NCT04202029|sedation|sedation
4965975|NCT04202029|propofol|propofol
4965976|NCT04202029|monitoring|monitoring
4965977|NCT04202029|NAPS|naps
4965978|NCT04202029|nurse-administered propofol sedation|nurse-administered propofol sedation
4965979|NCT04202029|O2|o2
4965980|NCT04202029|oxygen|oxygen
4965981|NCT04202029|PEG|peg
4965982|NCT04202029|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
4965983|NCT04202016|Canine retraction|canine retraction
4965984|NCT04202016|Space closure|space closure
4965985|NCT04202016|Rate of tooth movement|rate of tooth movement
4965986|NCT04202016|Facial divergence|facial divergence
4965997|NCT04201938|Obesity|obesity
4965998|NCT04201938|Type2 Diabetes|type2 diabetes
4965999|NCT04201938|Insulin Resistance|insulin resistance
4966000|NCT04201925|blepharoplasty, visual field|blepharoplasty, visual field
4966001|NCT04201899|Phosphate|phosphate
4966005|NCT04201795|fascia|fascia
4966006|NCT04201795|myofascial|myofascial
4966007|NCT04201795|plantar fascia|plantar fascia
4966008|NCT04201795|postural balance|postural balance
4966009|NCT04201795|stabilometry|stabilometry
4966010|NCT04201795|platform|platform
4966011|NCT04201782|HIV|hiv
4966012|NCT04201782|gene editing|gene editing
4966013|NCT04201782|CCR5|ccr5
4966014|NCT04201769|nausea|nausea
4966015|NCT04201769|vomiting|vomiting
4966026|NCT04201704|Critical Care|critical care
4966027|NCT04201704|Wounds and Injuries|wounds and injuries
4966028|NCT04201704|Multiple Trauma|multiple trauma
4966029|NCT04201704|Treatment Outcome|treatment outcome
4966030|NCT04201704|Postoperative Complications|postoperative complications
4966031|NCT04201704|Resuscitation|resuscitation
4966032|NCT04201704|Hemodynamics|hemodynamics
4966033|NCT04201704|Infusions, Intravenous|infusions, intravenous
4966034|NCT04201704|Isotonic Solutions|isotonic solutions
4966035|NCT04201704|Crystalloid Solutions|crystalloid solutions
4966037|NCT04201704|Organism Hydration Status|organism hydration status
4966038|NCT04201704|Body Water|body water
4966039|NCT04201678|Kyphoplasty|kyphoplasty
4966040|NCT04201678|Erector Spinae Block|erector spinae block
4966041|NCT04201678|conventional local infiltration anesthesia|conventional local infiltration anesthesia
4966042|NCT04201678|Extrapedicular infiltration anesthesia|extrapedicular infiltration anesthesia
4966043|NCT04201665|electohysterography|electohysterography
4966044|NCT04201665|postpartum hemorrhage|postpartum hemorrhage
4966045|NCT04201665|uterine electromyography|uterine electromyography
4966046|NCT04201652|Local Anesthetic|local anesthetic
4966047|NCT04201652|WALANT|walant
4966048|NCT04201613|Stroke|stroke
4966049|NCT04201613|Stroke Rehabilitation|stroke rehabilitation
4966050|NCT04201613|Robotic Exoskeleton|robotic exoskeleton
4966051|NCT04201600|Glucose Variability|glucose variability
4966052|NCT04201600|Continuous Glucose Monitoring System (CGMS)|continuous glucose monitoring system (cgms)
4966053|NCT04201600|Prediabetes|prediabetes
4966054|NCT04201600|Aging|aging
4966055|NCT04201600|Physical Functioning|physical functioning
4966056|NCT04201600|Neurocognition|neurocognition
4966057|NCT04201600|Cognitive Decline|cognitive decline
4966058|NCT04201587|Chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4966059|NCT04201587|Henna|henna
4966060|NCT04201587|Nursing|nursing
4966061|NCT04201561|peripheral neuropathy|peripheral neuropathy
4966062|NCT04201561|recurrent ovarian cancer|recurrent ovarian cancer
4966063|NCT04201561|high-dose inorganic selenium|high-dose inorganic selenium
4966064|NCT04201561|sodium selenite|sodium selenite
4966065|NCT04201522|Respiratory training|respiratory training
4966066|NCT04201522|COPD|copd
4966067|NCT04201522|Muscle oxygenation|muscle oxygenation
4966068|NCT04201522|Muscle fatigue|muscle fatigue
4966069|NCT04201522|Oxygen kinetic|oxygen kinetic
4966070|NCT04201522|Exercise tolerance|exercise tolerance
4966071|NCT04201509|Intelligence|intelligence
4966072|NCT04201509|Anxiety|anxiety
4966073|NCT04201509|Attention|attention
4966074|NCT04201509|Conduct behavior|conduct behavior
4966075|NCT04201509|Follow-up|follow-up
4966076|NCT04201509|Children|children
4966084|NCT04201470|Atypical multiple sclerosis|atypical multiple sclerosis
4966085|NCT04201470|Cavitary multiple sclerosis|cavitary multiple sclerosis
4966086|NCT04201470|Myelocortical multiple sclerosis|myelocortical multiple sclerosis
4966087|NCT04201457|LGG|lgg
4966088|NCT04201457|HGG|hgg
4966089|NCT04201457|BRAF|braf
4966090|NCT04201457|NF-1|nf-1
4966091|NCT04201444|UFC|ufc
4966092|NCT04201444|LNSC|lnsc
4966093|NCT04201444|Hair cortisol|hair cortisol
4966094|NCT04201444|medical treatment|medical treatment
4966096|NCT04201418|Valine to isoleucine substitution at position 122|valine to isoleucine substitution at position 122
5356773|NCT01918033|Cholinergic Agents|cholinergic agents
4966098|NCT04201418|Threonine to alanine substitution at position 60|threonine to alanine substitution at position 60
4966100|NCT04201418|Familial Amyloid Polyneuropathies|familial amyloid polyneuropathies
4966101|NCT04201418|ATTR|attr
4966102|NCT04201418|Transthyretin amyloidosis|transthyretin amyloidosis
4966103|NCT04201418|Transthyretin|transthyretin
4966104|NCT04201418|Amyloidosis|amyloidosis
4966105|NCT04201418|TTR-mediated Amyloidosis|ttr-mediated amyloidosis
4966106|NCT04201418|RNAi therapeutic|rnai therapeutic
4966107|NCT04201418|FAP|fap
4966116|NCT04201418|Proteostasis deficiencies|proteostasis deficiencies
4966117|NCT04201418|Metabolic diseases|metabolic diseases
4966118|NCT04201418|Heredodegenerative disorders, nervous system|heredodegenerative disorders, nervous system
4966126|NCT04201379|lowback pain|lowback pain
4966127|NCT04201366|neck pain|neck pain
4966128|NCT04201366|musculoskeletal pain|musculoskeletal pain
4966129|NCT04201366|young adults|young adults
4966130|NCT04201366|risk factors|risk factors
4966131|NCT04201353|Antiretroviral Treatment Adherence|antiretroviral treatment adherence
4966132|NCT04201353|Conditional Cash Transfers|conditional cash transfers
4966133|NCT04201353|Tanzania|tanzania
4966134|NCT04201353|People Living With HIV|people living with hiv
4966135|NCT04201353|Behavioral Economics|behavioral economics
4966136|NCT04201288|Medication adherence|medication adherence
4966137|NCT04201288|Treatment adherence|treatment adherence
4966139|NCT04201288|Acceptance and Commitment Therapy|acceptance and commitment therapy
4966140|NCT04201288|Retention|retention
4966141|NCT04201262|Neuromyelitis Optica|neuromyelitis optica
4966142|NCT04201262|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4966143|NCT04201262|Devic's Disease|devic's disease
4966144|NCT04201262|Transverse Myelitis|transverse myelitis
4966145|NCT04201262|Optic Neuritis|optic neuritis
4966146|NCT04201262|Relapse|relapse
4966147|NCT04201262|Ravulizumab|ravulizumab
4966148|NCT04201262|Ultomiris|ultomiris
4966149|NCT04201262|ALXN1210|alxn1210
4966150|NCT04201262|CNS Autoimmune Disorders|cns autoimmune disorders
4966151|NCT04201262|Demyelinating Disorders|demyelinating disorders
4966152|NCT04201262|NMO|nmo
4966153|NCT04201262|NMOSD|nmosd
4966154|NCT04201236|obstructive sleep apnea|obstructive sleep apnea
4966155|NCT04201236|oropharyngeal exercises|oropharyngeal exercises
4966156|NCT04201236|inspiratory muscle training|inspiratory muscle training
4966157|NCT04201236|sleep quality|sleep quality
4966158|NCT04201223|Education|education
4966159|NCT04201223|Prevention and Control|prevention and control
4966160|NCT04201223|Behavioral Research|behavioral research
4966161|NCT04201184|Native American|native american
4966162|NCT04201171|T1D|t1d
4966163|NCT04201171|CSII|csii
4966164|NCT04201171|CGM|cgm
4966165|NCT04201171|diabetic ketoacidosis|diabetic ketoacidosis
4966166|NCT04201171|hypoglycemia|hypoglycemia
4966167|NCT04201158|Physical Fitness|physical fitness
4966168|NCT04201158|Exercise Capacity|exercise capacity
4966169|NCT04201158|Activities of Daily Living|activities of daily living
4966170|NCT04201158|Quality of Life|quality of life
4966171|NCT04201145|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
4966172|NCT04201106|Placebo|placebo
4966173|NCT04201106|Adolescent Depression|adolescent depression
4966174|NCT04201106|MRI|mri
4966175|NCT04201054|Fluconazole|fluconazole
4966176|NCT04201054|Anti-doping control|anti-doping control
4966177|NCT04201054|Athletic performance|athletic performance
4966178|NCT04201028|telehealth|telehealth
4966179|NCT04201028|video conferencing|video conferencing
4966180|NCT04201028|blood pressure|blood pressure
4966181|NCT04201028|lipids|lipids
4966182|NCT04201028|weight loss|weight loss
4966183|NCT04201028|usual care|usual care
4966184|NCT04201028|obesity medicine|obesity medicine
4966185|NCT04201002|Pilonidal sinus|pilonidal sinus
4966186|NCT04201002|Squamous cell carcinoma|squamous cell carcinoma
4966187|NCT04201002|Surgery|surgery
4966188|NCT04201002|Intraoperative radiotherapy|intraoperative radiotherapy
4966189|NCT04201002|Chemotherapy|chemotherapy
4966190|NCT04200963|IK-175|ik-175
4966191|NCT04200963|KYN-175|kyn-175
4966207|NCT04200859|pain|pain
4966208|NCT04200859|cold aplication|cold aplication
4966209|NCT04200859|nursing|nursing
4966210|NCT04200833|Biological|biological
4966211|NCT04200833|Uveitis|uveitis
4966212|NCT04200833|adalimumab|adalimumab
4966213|NCT04200833|golimumab|golimumab
4966217|NCT04200794|group-setting|group-setting
4966218|NCT04200794|randomized-controlled-trial|randomized-controlled-trial
4966219|NCT04200794|multiple-transfer-effects|multiple-transfer-effects
4966220|NCT04200794|cognitive|cognitive
4966221|NCT04200794|sensorimotor|sensorimotor
4966222|NCT04200794|matrix-reasoning|matrix-reasoning
4966223|NCT04200794|string-instruments|string-instruments
4964234|NCT04212975|tmj|tmj
4966224|NCT04200781|acute hemorrhagic stroke|acute hemorrhagic stroke
4966225|NCT04200781|Shengdi Dahuang Decoction|shengdi dahuang decoction
4966226|NCT04200768|Breast Cancer|breast cancer
4966227|NCT04200768|Body Mass Index|body mass index
4966228|NCT04200768|Adiposity|adiposity
4966229|NCT04200768|Obesity|obesity
4966230|NCT04200768|Inflammatory Breast Cancer|inflammatory breast cancer
4966231|NCT04200768|Lobular Breast Cancer|lobular breast cancer
4966257|NCT04200599|delayed oxytocin|delayed oxytocin
4966258|NCT04200573|Symptomatic neurogenic orthostatic hypertension|symptomatic neurogenic orthostatic hypertension
4966259|NCT04200573|hepatic impairment|hepatic impairment
4966260|NCT04200560|Aging|aging
4966261|NCT04200560|Endothelial Cell Autophagy|endothelial cell autophagy
4966262|NCT04200534|current smoker|current smoker
4966263|NCT04200534|health care provider|health care provider
4966264|NCT04200534|primary care doctor|primary care doctor
4966265|NCT04200521|Gut peptide|gut peptide
4966266|NCT04200521|Energy metabolism|energy metabolism
4966267|NCT04200521|Appetite|appetite
4966268|NCT04200482|Breast Cancer Survivors|breast cancer survivors
4966269|NCT04200482|Diet|diet
4966270|NCT04200482|eHealth|ehealth
4966271|NCT04200482|Nutrition|nutrition
4966272|NCT04200482|Physical Activity|physical activity
4966273|NCT04200469|Quantitative Flow Ratio|quantitative flow ratio
4966274|NCT04200469|QFR|qfr
4966275|NCT04200469|Percutaneous Coronary Intervention|percutaneous coronary intervention
4966276|NCT04200456|ITP|itp
4966277|NCT04200456|UCB7665|ucb7665
4966278|NCT04200456|Rozanolixizumab|rozanolixizumab
4966279|NCT04200456|Primary immune thrombocytopenia|primary immune thrombocytopenia
4966280|NCT04200417|Unresectable Lung Cancer|unresectable lung cancer
4966281|NCT04200417|Unresectable Endobronchial Mestastases|unresectable endobronchial mestastases
4966282|NCT04200417|Unresectable Pleural Metastases|unresectable pleural metastases
4966283|NCT04200417|Unresectable Mediastinal Metastases|unresectable mediastinal metastases
4966284|NCT04200417|Lung Chemoembolization|lung chemoembolization
4966285|NCT04200417|19-371|19-371
4966286|NCT04200417|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4966287|NCT04200391|nutrition|nutrition
4967392|NCT04193423|training|training
4966297|NCT04200365|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
4966298|NCT04200365|Corticosteroids|corticosteroids
4966299|NCT04200365|Immunosuppressive therapies|immunosuppressive therapies
4966300|NCT04200339|Screening|screening
4966301|NCT04200339|Adolecents|adolecents
4966302|NCT04200339|SBIRT|sbirt
4966303|NCT04200339|Substance Use|substance use
4966304|NCT04200313|Artificial Pancreas|artificial pancreas
4966305|NCT04200313|Closed-loop Insulin Delivery|closed-loop insulin delivery
4966306|NCT04200300|Professional quality of life|professional quality of life
4966307|NCT04200300|Compassion satisfaction|compassion satisfaction
4966308|NCT04200300|Burnout|burnout
4966309|NCT04200300|Nursing|nursing
4966310|NCT04200300|Mental disorder|mental disorder
4966311|NCT04200300|Mental health|mental health
4966312|NCT04200274|Physical Activity|physical activity
4966313|NCT04200274|Mental Disorder|mental disorder
4966314|NCT04200274|Recommendation Behaviour|recommendation behaviour
4966315|NCT04200274|Mental Health|mental health
4966316|NCT04200274|Exercise|exercise
4966320|NCT04200196|anxiety|anxiety
4966321|NCT04200196|children|children
4966322|NCT04200183|chronic pain|chronic pain
4966323|NCT04200183|contextual behavioral intervention|contextual behavioral intervention
4966324|NCT04200183|acceptance and commitment therapy|acceptance and commitment therapy
4966325|NCT04200183|mindfulness|mindfulness
4966326|NCT04200183|compassion-based therapy|compassion-based therapy
4966327|NCT04200183|online intervention|online intervention
4966328|NCT04200170|mobile health|mobile health
4966329|NCT04200118|Sperm DNA fragmentation|sperm dna fragmentation
4966330|NCT04200118|Sperm epigenetics|sperm epigenetics
4984903|NCT04086264|AML|aml
4966346|NCT04200001|quality of life|quality of life
4966347|NCT04199962|sepsis|sepsis
4966348|NCT04199962|infection|infection
4966349|NCT04199962|pneumonia|pneumonia
4966350|NCT04199962|organ dysfunction|organ dysfunction
4966351|NCT04199962|critical illness|critical illness
4966352|NCT04199936|muscle|muscle
4966353|NCT04199936|atrophy|atrophy
4966354|NCT04199936|postoperative|postoperative
4966355|NCT04199936|disuse|disuse
4966356|NCT04199936|electrical muscle stimulation|electrical muscle stimulation
4966357|NCT04199897|Dental Caries|dental caries
4971599|NCT04168242|scalp cooling|scalp cooling
4966368|NCT04199858|Learning|learning
4966369|NCT04199858|Negative suggestions|negative suggestions
4966370|NCT04199845|probiotics|probiotics
4966371|NCT04199845|gut permeability|gut permeability
4966372|NCT04199845|inflammation|inflammation
4966373|NCT04199819|occult hepatitis b|occult hepatitis b
4966374|NCT04199819|liver transplantation|liver transplantation
4966375|NCT04199819|novel biomarkers|novel biomarkers
4966392|NCT04199754|CBCT- Cone Beam CT|cbct- cone beam ct
4966411|NCT04199637|Preschoolers|preschoolers
4966412|NCT04199637|Anxiety|anxiety
4966413|NCT04199637|Resisting behavior|resisting behavior
4966414|NCT04199611|Body Image Satisfaction|body image satisfaction
4966415|NCT04199611|Liposuction|liposuction
4966416|NCT04199611|Psychological Therapy|psychological therapy
4966417|NCT04199598|Open-label|open-label
4966418|NCT04199598|Long-acting beta-2 agonist|long-acting beta-2 agonist
4966419|NCT04199598|COPD|copd
4966420|NCT04199598|Bioavailability|bioavailability
4966421|NCT04199598|Phase 1|phase 1
4966422|NCT04199598|Abediterol|abediterol
4966423|NCT04199598|Healthy subjects|healthy subjects
4966424|NCT04199598|Crossover|crossover
4966425|NCT04199481|unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
4966426|NCT04199481|retrospective study|retrospective study
4966427|NCT04199481|Knee Society Score|knee society score
4966428|NCT04199455|acute ischemic stroke|acute ischemic stroke
4966429|NCT04199455|neurologic impairment|neurologic impairment
4966430|NCT04199455|integrative therapy|integrative therapy
4966431|NCT04199455|Chinese herbs|chinese herbs
4966432|NCT04199455|prospective randomized double-blind controlled trial|prospective randomized double-blind controlled trial
4966433|NCT04199429|Relationship-based care|relationship-based care
4966434|NCT04199429|Pediatric|pediatric
4966435|NCT04199429|Caregiver anxiety|caregiver anxiety
4966436|NCT04199429|Nurse job satisfaction|nurse job satisfaction
4966437|NCT04199429|Nurse|nurse
4966438|NCT04199403|spleen|spleen
4966439|NCT04199403|asplenic patients|asplenic patients
4966440|NCT04199403|splenectomy|splenectomy
4966441|NCT04199403|asplenia|asplenia
4966442|NCT04199390|total hip arthroplasty|total hip arthroplasty
4966443|NCT04199390|physical therapy|physical therapy
4966444|NCT04199364|RDS|rds
4966445|NCT04199364|Surfactant|surfactant
4966446|NCT04199364|Threshold|threshold
4966447|NCT04199364|Oxygen|oxygen
4966448|NCT04199364|Preterm|preterm
4966449|NCT04199364|Infant|infant
4966450|NCT04199351|Obesity|obesity
4966451|NCT04199338|peritoneal dialysis,|peritoneal dialysis,
4966452|NCT04199338|Orem' self defiency theory|orem' self defiency theory
4966453|NCT04199338|Nursing|nursing
4966454|NCT04199338|Randomized Controlled Trial|randomized controlled trial
4966455|NCT04199338|Renal Dialysis|renal dialysis
4966456|NCT04199325|gout|gout
4966457|NCT04199325|hyperuricemia|hyperuricemia
4966458|NCT04199325|probiotics|probiotics
4966467|NCT04199208|perioperative period|perioperative period
4966468|NCT04199208|coloncancer|coloncancer
4966470|NCT04199182|Veterans|veterans
4966471|NCT04199182|Aged|aged
4966472|NCT04199182|Exercise|exercise
4966473|NCT04199182|HRQOL|hrqol
4966474|NCT04199169|Nipah, Vaccine, Henipah|nipah, vaccine, henipah
4966475|NCT04199143|Magnetic Resonance Imaging|magnetic resonance imaging
4966476|NCT04199143|Ultrasound|ultrasound
4966477|NCT04199143|Tissue Pulsatility Imaging|tissue pulsatility imaging
4966490|NCT04199065|nurses' Workplace|nurses' workplace
4966491|NCT04199065|Good Practices Guides|good practices guides
4966492|NCT04199065|Hospital|hospital
4967393|NCT04193423|endurance|endurance
4966493|NCT04199052|HIV Care Continuum, Mobile Apps|hiv care continuum, mobile apps
4966494|NCT04199039|endotracheal tube|endotracheal tube
4966496|NCT04199013|0.75% ROPIVACAINE|0.75% ropivacaine
4966497|NCT04199013|FENTANYL|fentanyl
4966498|NCT04199013|SPINAL ANAESTHESIA|spinal anaesthesia
4966499|NCT04198974|Prevention|prevention
4966500|NCT04198974|Early intervention|early intervention
4966501|NCT04198974|Substance Use and Misuse|substance use and misuse
4966502|NCT04198974|Mental Health|mental health
4971714|NCT04167566|Impact|impact
4966508|NCT04198909|electrocochleography|electrocochleography
4966509|NCT04198896|Atherosclerosis, cancers|atherosclerosis, cancers
4966510|NCT04198870|MitraClip|mitraclip
4966511|NCT04198831|acupuncture|acupuncture
4966512|NCT04198831|Crohn's disease|crohn's disease
4966513|NCT04198818|Melanoma|melanoma
4966514|NCT04198818|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
4966515|NCT04198818|Erdheim-Chester Disease|erdheim-chester disease
4966516|NCT04198818|MAPK pathway|mapk pathway
4966517|NCT04198818|ERK1|erk1
4966518|NCT04198818|ERK2|erk2
4966519|NCT04198805|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4966520|NCT04198805|Non-Alcoholic Fatty Liver|non-alcoholic fatty liver
4966521|NCT04198805|NAFL|nafl
4966522|NCT04198805|NAFLD|nafld
4966523|NCT04198805|Vitamin E|vitamin e
4966524|NCT04198805|DHA|dha
4966525|NCT04198766|Phase 1|phase 1
4966526|NCT04198766|Phase 1 Clinical Trial|phase 1 clinical trial
4966527|NCT04198766|Solid Tumors|solid tumors
4966528|NCT04198766|Melanoma|melanoma
4966529|NCT04198766|Head and Neck Cancer|head and neck cancer
4966530|NCT04198766|Stomach Cancer|stomach cancer
4966531|NCT04198766|Gastric Cancer|gastric cancer
4966532|NCT04198766|Lung Cancer|lung cancer
4966533|NCT04198766|Non-Small Cell Lung Cancer|non-small cell lung cancer
4966534|NCT04198766|Kidney Cancer|kidney cancer
4966535|NCT04198766|Renal Cell Carcinoma|renal cell carcinoma
4966536|NCT04198766|Bladder Cancer|bladder cancer
4966537|NCT04198766|Urothelial Carcinoma|urothelial carcinoma
4966538|NCT04198766|OX40|ox40
4966539|NCT04198766|PD-1|pd-1
4966540|NCT04198766|Pembrolizumab|pembrolizumab
4966541|NCT04198766|Keytruda|keytruda
4966542|NCT04198740|Lacrimal fingerprint|lacrimal fingerprint
4966543|NCT04198740|Metabolomics|metabolomics
4966544|NCT04198740|Proteomics|proteomics
4966545|NCT04198740|Ocular surface|ocular surface
4966546|NCT04198688|National database|national database
4966547|NCT04198688|Effectiveness|effectiveness
4966548|NCT04198688|Gold Standard Programme|gold standard programme
4966549|NCT04198688|Intensive intervention|intensive intervention
4966550|NCT04198675|Surface Electromyography|surface electromyography
4966551|NCT04198675|Biofeedback|biofeedback
4966552|NCT04198675|Forward Head Posture|forward head posture
4966553|NCT04198675|Posture|posture
4966554|NCT04198675|Trapezius Muscle|trapezius muscle
4966555|NCT04198675|Task- specific Performance|task- specific performance
4966556|NCT04198675|Exercise|exercise
4966557|NCT04198675|Office Worker|office worker
4966558|NCT04198636|Compare|compare
4966559|NCT04198636|Pharmacokinetics|pharmacokinetics
4966560|NCT04198636|Pharmacodynamics|pharmacodynamics
4966561|NCT04198636|Safety|safety
4966562|NCT04198636|Immunogenicity|immunogenicity
4966585|NCT04198519|Endothelial dysfunction|endothelial dysfunction
4966586|NCT04198506|lung transplantation|lung transplantation
4966587|NCT04198506|dosing immunosuppression|dosing immunosuppression
4966588|NCT04198506|toxicity|toxicity
4966589|NCT04198493|Down Syndrome|down syndrome
4966590|NCT04198493|Polysomnography|polysomnography
4966591|NCT04198467|Platelet rich plasma|platelet rich plasma
4966592|NCT04198415|Cancer|cancer
4966593|NCT04198415|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4966594|NCT04198415|Small Lymphocytic Leukemia (SLL)|small lymphocytic leukemia (sll)
4966602|NCT04198311|insomnia|insomnia
4966603|NCT04198311|outpatient|outpatient
4966604|NCT04198298|Cone-Beam Computed Tomography|cone-beam computed tomography
4966605|NCT04198298|Microsurgery|microsurgery
4966606|NCT04198298|Bone Regeneration|bone regeneration
4966607|NCT04198298|Biocompatible Materials|biocompatible materials
4966608|NCT04198285|laparoscopy, urinary retention|laparoscopy, urinary retention
4966609|NCT04198272|Adolescent health|adolescent health
4966610|NCT04198272|Unintended pregnancy|unintended pregnancy
4966611|NCT04198272|Global health|global health
4966612|NCT04198272|Access to contraceptives|access to contraceptives
5293841|NCT02206451|Direct Skin Feed|direct skin feed
4966613|NCT04198259|TIPS|tips
4966614|NCT04198259|HVPG|hvpg
4966615|NCT04198259|BRTO|brto
4966616|NCT04198259|NSBB|nsbb
4966617|NCT04198246|Motor symptoms|motor symptoms
4966618|NCT04198246|Nonmotor symptoms|nonmotor symptoms
4966619|NCT04198246|Natural history|natural history
4966620|NCT04198246|The Essential Tremor Rating Assessment Scale (TETRAS)|the essential tremor rating assessment scale (tetras)
4966621|NCT04198220|Obesity|obesity
4966622|NCT04198220|BIOMONITOR|biomonitor
4966623|NCT04198220|BIOMONITOR III|biomonitor iii
4966624|NCT04198220|Syncope|syncope
4966647|NCT04198077|Intensive Care Unit|intensive care unit
4966648|NCT04198038|palliative care|palliative care
4966650|NCT04198038|music therapy|music therapy
4966651|NCT04198025|psoas muscle density|psoas muscle density
4966652|NCT04198025|frailty|frailty
4966653|NCT04198012|HemoCare™ Hemodialysis System|hemocare™ hemodialysis system
4966654|NCT04198012|HemoCare™|hemocare™
4966655|NCT04198012|Hemodialysis|hemodialysis
4966656|NCT04197999|GMI-1359|gmi-1359
4966657|NCT04197999|breast cancer|breast cancer
4966658|NCT04197999|HR+ metastatic breast cancer|hr+ metastatic breast cancer
4966673|NCT04197960|Papillary Thyroid Carcinoma|papillary thyroid carcinoma
4966674|NCT04197960|Microwave ablation|microwave ablation
4966675|NCT04197960|Surgical resection|surgical resection
4966681|NCT04197882|complete resectable|complete resectable
4966682|NCT04197882|melanoma|melanoma
4966683|NCT04197882|neoadjuvant treatment|neoadjuvant treatment
5289601|NCT02225756|Drug therapy|drug therapy
4966684|NCT04197856|hereditary cancer risk|hereditary cancer risk
4966685|NCT04197856|prevention|prevention
4966686|NCT04197856|family-mediated disclosure|family-mediated disclosure
4966687|NCT04197856|healthcare-assisted disclosure|healthcare-assisted disclosure
4966688|NCT04197856|information disclosure|information disclosure
4966689|NCT04197856|risk information|risk information
4966690|NCT04197856|genetic risk|genetic risk
4966691|NCT04197791|Core Stabilization Exercises|core stabilization exercises
4966692|NCT04197752|Obesity|obesity
4966693|NCT04197752|Neuroaxial blocks|neuroaxial blocks
4966704|NCT04197661|Healthy Elderly Subjects|healthy elderly subjects
4966705|NCT04197635|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5342902|NCT01981564|Pediatric|pediatric
4966706|NCT04197635|Functional Capacity|functional capacity
4966707|NCT04197635|Type 2 Diabetes|type 2 diabetes
4966708|NCT04197635|Quality of life|quality of life
4966709|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide
4966710|NCT04197622|Anti-doping control|anti-doping control
4966711|NCT04197622|Athletic performance|athletic performance
4966722|NCT04197557|bone age|bone age
4966723|NCT04197557|bone mineral density|bone mineral density
4966724|NCT04197557|X-ray|x-ray
4966725|NCT04197557|Chinese child|chinese child
4966726|NCT04197531|EndoActivator|endoactivator
4966727|NCT04197531|Irrigation|irrigation
4966728|NCT04197531|Postoperative pain|postoperative pain
4966729|NCT04197531|Primary teeth|primary teeth
4966730|NCT04197492|Hypofractionated Stereotactic Radiotherapy|hypofractionated stereotactic radiotherapy
4966731|NCT04197492|Recurrent High-grade Glioma|recurrent high-grade glioma
4966732|NCT04197492|Anlotinib|anlotinib
4966733|NCT04197479|NAFLD|nafld
4966734|NCT04197479|NASH|nash
4966735|NCT04197479|Hyperlipidemia|hyperlipidemia
4966736|NCT04197479|Resmetirom|resmetirom
4966737|NCT04197479|Thyroid hormone receptor beta|thyroid hormone receptor beta
4966738|NCT04197479|Hepatic|hepatic
4966739|NCT04197479|Fibrosis|fibrosis
4966741|NCT04197479|Thyroid hormone receptor agonist|thyroid hormone receptor agonist
4966742|NCT04197479|Cardiovascular|cardiovascular
4966743|NCT04197479|Dyslipidemia|dyslipidemia
4966744|NCT04197479|Fatty liver disease|fatty liver disease
4966745|NCT04197479|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
4966755|NCT04197401|Barbershop|barbershop
4966756|NCT04197401|Screening|screening
4966757|NCT04197401|Health Education|health education
4966758|NCT04197401|Cardiology|cardiology
4966759|NCT04197401|DACIMA Clinical Suite|dacima clinical suite
4966760|NCT04197375|heat stress|heat stress
4966761|NCT04197375|heat strain|heat strain
4966762|NCT04197375|performance|performance
4966763|NCT04197375|children|children
4966764|NCT04197375|exercise|exercise
4966765|NCT04197375|thermal|thermal
4966766|NCT04197362|activity shoes|activity shoes
4966767|NCT04197362|forces|forces
4966768|NCT04197362|torques|torques
4966769|NCT04197362|cartilage|cartilage
4966770|NCT04197362|bones|bones
4966771|NCT04197310|Carcinoid Tumor|carcinoid tumor
4966772|NCT04197310|Carcinoid Tumor of GI System|carcinoid tumor of gi system
4966773|NCT04197310|Neuroendocrine Tumors|neuroendocrine tumors
4966774|NCT04197297|Radiation Therapy|radiation therapy
4966775|NCT04197297|Radiotherapy|radiotherapy
4966785|NCT04197271|outcome|outcome
4966786|NCT04197271|hernia|hernia
4966787|NCT04197271|emergency|emergency
4966788|NCT04197258|Stroke|stroke
4966789|NCT04197258|Peer support|peer support
4966790|NCT04197245|Acne|acne
4966791|NCT04197245|Scars|scars
4966792|NCT04197245|DLQI|dlqi
4966793|NCT04197206|ultrasound guided block|ultrasound guided block
4966794|NCT04197180|Gastric low grade intraepithelial neoplasia|gastric low grade intraepithelial neoplasia
4966795|NCT04197180|Hybrid APC|hybrid apc
4966813|NCT04197102|PTSD, CBD, trauma-focused therapy, cannabidiol, CBT|ptsd, cbd, trauma-focused therapy, cannabidiol, cbt
4964645|NCT04210297|noninvasive|noninvasive
4964646|NCT04210297|portal hypertension|portal hypertension
4966815|NCT04197089|Urinary tract|urinary tract
4966816|NCT04197089|Cystectomy|cystectomy
4966817|NCT04197089|Vitamin D|vitamin d
4966818|NCT04197089|Tissue phenotype|tissue phenotype
4966819|NCT04197063|sweetened beverage|sweetened beverage
4966820|NCT04197063|portion size|portion size
4966821|NCT04197063|policy|policy
4966822|NCT04197050|Connective Tissue Diseases|connective tissue diseases
4966823|NCT04197050|sacubitril/valsartan|sacubitril/valsartan
4966824|NCT04197050|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
4966825|NCT04197050|Extracellular Volume|extracellular volume
4966826|NCT04197050|exercise tolerance|exercise tolerance
4966827|NCT04197037|Schizophrenia|schizophrenia
4966828|NCT04197037|Sialorrhea|sialorrhea
4966829|NCT04197037|Quality of life|quality of life
4966830|NCT04197037|Prevalence|prevalence
4966834|NCT04197011|Prosthetics|prosthetics
4966835|NCT04197011|Microprocessor|microprocessor
4966836|NCT04197011|Hydraulic|hydraulic
4966837|NCT04196998|hepatitis b virus|hepatitis b virus
4966838|NCT04196998|compensated cirrhosis|compensated cirrhosis
4966839|NCT04196998|nucleoside|nucleoside
4966840|NCT04196998|nucleotide|nucleotide
4966841|NCT04196985|PET-imaging|pet-imaging
4966842|NCT04196985|local recurrence|local recurrence
4966843|NCT04196985|PET/MRI|pet/mri
4966844|NCT04196985|chemoradiotherapy|chemoradiotherapy
4966845|NCT04196959|Tyrosinaemia|tyrosinaemia
4966847|NCT04196959|Food for Special Medical Purposes|food for special medical purposes
4966848|NCT04196946|intrathecally fentanyl|intrathecally fentanyl
4966849|NCT04196946|alfentanil|alfentanil
4966850|NCT04196946|visual pain scale|visual pain scale
4966851|NCT04196946|analgesia|analgesia
4966852|NCT04196933|sensory integration|sensory integration
4966853|NCT04196933|cochlear implant|cochlear implant
4966854|NCT04196933|vestibular implant|vestibular implant
4966855|NCT04196933|balance|balance
4966856|NCT04196933|dizziness|dizziness
4966857|NCT04196933|vestibular disorders|vestibular disorders
4966858|NCT04196920|Crohn's disease|crohn's disease
4966859|NCT04196920|ulcerated ulcerative colitis|ulcerated ulcerative colitis
4966860|NCT04196894|Thrombolysis|thrombolysis
4966861|NCT04196894|Obesity|obesity
4966862|NCT04196894|Acute ischemic stroke|acute ischemic stroke
4966863|NCT04196881|Saudi|saudi
4966864|NCT04196881|Abha|abha
4966865|NCT04196881|Training|training
4966866|NCT04196881|ADHD|adhd
4966867|NCT04196881|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
4966868|NCT04196868|rheumatoid arthritis|rheumatoid arthritis
4966869|NCT04196868|methotrexate|methotrexate
4966870|NCT04196868|metformin|metformin
4966871|NCT04196868|clinical trial|clinical trial
4966872|NCT04196842|Heart Failure|heart failure
4966873|NCT04196842|Multi-omics|multi-omics
4966874|NCT04196842|Phenomapping|phenomapping
4966875|NCT04196842|Precision medicine|precision medicine
4966876|NCT04196842|Telemonitoring|telemonitoring
4966877|NCT04196816|Surgery|surgery
4966878|NCT04196816|Metastasis surgery|metastasis surgery
4966879|NCT04196816|Survival|survival
4966880|NCT04196816|Multimodal treatment|multimodal treatment
4966898|NCT04196595|Reproduction|reproduction
4966934|NCT04196361|Diaphragm|diaphragm
4966935|NCT04196361|Holistic|holistic
4966936|NCT04196361|Extubation|extubation
4966937|NCT04196348|Bariatric Surgery|bariatric surgery
4966938|NCT04196348|Gastric Bypass|gastric bypass
4966940|NCT04196348|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
4966941|NCT04196348|Metabolic Syndrome|metabolic syndrome
4966942|NCT04196309|radial artery occlusion|radial artery occlusion
4966943|NCT04196309|coronary catheterization|coronary catheterization
4966944|NCT04196309|coronary artery disease|coronary artery disease
4966945|NCT04196309|anticoagulation|anticoagulation
4966951|NCT04196270|dose finding study|dose finding study
4966952|NCT04196231|type 2 diabetes|type 2 diabetes
4966953|NCT04196231|GLP-1RA|glp-1ra
4966954|NCT04196231|SGLT-2i|sglt-2i
4966955|NCT04196231|basal insulin|basal insulin
4966956|NCT04196231|basal bolus|basal bolus
4966957|NCT04196231|glycemic control|glycemic control
4966958|NCT04196205|acute lymphoblastic leukemia ;Lymphomas|acute lymphoblastic leukemia ;lymphomas
4966959|NCT04196166|preoperative evaluation|preoperative evaluation
4966960|NCT04196166|orthopedic surgery|orthopedic surgery
4966961|NCT04196140|T1D|t1d
4966962|NCT04196140|Omnipod|omnipod
4966963|NCT04196127|Bite force|bite force
4966964|NCT04196127|Temporomandibular disorder|temporomandibular disorder
4966965|NCT04196127|Neck pain|neck pain
4966966|NCT04196114|spinal cord injury|spinal cord injury
4966967|NCT04196101|RSV|rsv
4966968|NCT04196062|Colonic ESD|colonic esd
4966969|NCT04196062|Robotic Endoscope|robotic endoscope
4966970|NCT04196049|organized blood clot|organized blood clot
5385945|NCT01785680|MAM|mam
4966971|NCT04196049|fragmatome|fragmatome
4966972|NCT04196049|exudative age related macular denegeration|exudative age related macular denegeration
4966975|NCT04195971|CT|ct
4966978|NCT04195932|exercise|exercise
4966979|NCT04195932|hyperlipidemia|hyperlipidemia
4966980|NCT04195932|TNF-alpha|tnf-alpha
4966981|NCT04195932|atherogenesis|atherogenesis
4966982|NCT04195932|LDL-cholesterol|ldl-cholesterol
4966983|NCT04195932|oxidized LDL-C|oxidized ldl-c
4966984|NCT04195906|Calciphylaxis|calciphylaxis
4966985|NCT04195906|Calcific Uremic Arteriolopathy|calcific uremic arteriolopathy
4966986|NCT04195906|Wound|wound
4966987|NCT04195906|ESRD|esrd
4966988|NCT04195867|Salmeterol|salmeterol
4966989|NCT04195867|Anti-doping control|anti-doping control
4966990|NCT04195867|Athletic performance|athletic performance
4966991|NCT04195841|implant incisions|implant incisions
4966992|NCT04195841|bone loss|bone loss
4966993|NCT04195841|Z shaped incision|z shaped incision
4966994|NCT04195815|Chronic Fatigue Syndrome|chronic fatigue syndrome
4966995|NCT04195815|Myalgic Encephalomyelitis|myalgic encephalomyelitis
4966996|NCT04195815|ME/CFS|me/cfs
4966997|NCT04195815|Physical activity|physical activity
4966998|NCT04195815|Activity armband|activity armband
4967000|NCT04195776|Tenofovir douche|tenofovir douche
4967001|NCT04195763|Pediatric-onset hypophosphatasia|pediatric-onset hypophosphatasia
4967002|NCT04195763|Pediatric-onset|pediatric-onset
4967003|NCT04195763|Hypophosphatasia|hypophosphatasia
4967004|NCT04195763|HPP|hpp
4967005|NCT04195763|Patient reported outcome|patient reported outcome
4967006|NCT04195750|Hypoxia inducible Factor (HIF)|hypoxia inducible factor (hif)
4967007|NCT04195750|Hypoxia inducible factor 1B (HIF-1B)|hypoxia inducible factor 1b (hif-1b)
4967008|NCT04195750|Hypoxia inducible factor 2 alpha (HIF-2 alpha)|hypoxia inducible factor 2 alpha (hif-2 alpha)
4967009|NCT04195750|Hypoxia inducible factor 2α (HIF-2α)|hypoxia inducible factor 2α (hif-2α)
4967010|NCT04195750|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
4967011|NCT04195750|Kidney Cancer|kidney cancer
4967012|NCT04195750|PT-2977|pt-2977
4967013|NCT04195750|PT2977|pt2977
4967014|NCT04195750|MK6482|mk6482
4967015|NCT04195737|Gingival Recession Coverage|gingival recession coverage
4967016|NCT04195724|gut microbial translocation|gut microbial translocation
4967017|NCT04195724|metagenomic next-generation sequencing|metagenomic next-generation sequencing
4967018|NCT04195724|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
4967019|NCT04195711|vision screening, amblyopia|vision screening, amblyopia
4967023|NCT04195698|RINVOQ|rinvoq
4967024|NCT04195685|Neurofeedback|neurofeedback
4967025|NCT04195685|Infra-Low Frequency Neurofeedback|infra-low frequency neurofeedback
4967026|NCT04195685|Veterans|veterans
4967027|NCT04195685|Integrative Health Treatment|integrative health treatment
4967028|NCT04195685|mTBI|mtbi
4967029|NCT04195685|Concussion|concussion
4967030|NCT04195685|Post-concussive Symptoms|post-concussive symptoms
4967031|NCT04195685|Chronic Headaches|chronic headaches
4967032|NCT04195685|Chronic Insomnia|chronic insomnia
4967033|NCT04195685|Chronic Attention Disorder|chronic attention disorder
4967034|NCT04195685|Quality of Life|quality of life
4967035|NCT04195685|Emotional Responses|emotional responses
4967036|NCT04195685|PTSD|ptsd
4967037|NCT04195685|Depression|depression
4967038|NCT04195672|Pediatric|pediatric
4967039|NCT04195672|Pain|pain
4967040|NCT04195672|Heart rate variability|heart rate variability
4967041|NCT04195672|Intensive care unit|intensive care unit
4967042|NCT04195672|Analgesia|analgesia
4967043|NCT04195620|Loneliness|loneliness
4967044|NCT04195620|Sympathetic Nervous System|sympathetic nervous system
4967045|NCT04195620|Parasympathetic Nervous System|parasympathetic nervous system
4967046|NCT04195620|Vulnerability|vulnerability
4967047|NCT04195620|Self-disclosure|self-disclosure
4967048|NCT04195594|Ketogenic Diet|ketogenic diet
4967049|NCT04195594|Nic's keto diet|nic's keto diet
4967050|NCT04195594|Cardiovascular health|cardiovascular health
4967051|NCT04195594|Elevated LDL levels|elevated ldl levels
4967052|NCT04195542|Spina Bifida|spina bifida
4967053|NCT04195542|Spinal dysraphism|spinal dysraphism
4967054|NCT04195542|vitamin B9 supplementation|vitamin b9 supplementation
4967055|NCT04195542|folic acid|folic acid
4967056|NCT04195542|neural tube closure defects|neural tube closure defects
4967057|NCT04195542|folate|folate
4967058|NCT04195516|health promotion|health promotion
4967059|NCT04195516|university students|university students
4967060|NCT04195516|obesity|obesity
4967061|NCT04195490|feminizing genitoplasty|feminizing genitoplasty
4967062|NCT04195451|Fontan palliation|fontan palliation
4967063|NCT04195438|Hepatectomy|hepatectomy
4967067|NCT04195425|breastfeeding|breastfeeding
4967068|NCT04195425|early nutrition|early nutrition
4967069|NCT04195425|intestinal microbiota|intestinal microbiota
4967070|NCT04195412|Stroke Rehabilitation|stroke rehabilitation
4967071|NCT04195412|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4967072|NCT04195412|Neuroimaging|neuroimaging
4967073|NCT04195412|Neuronal Plasticity|neuronal plasticity
4967074|NCT04195386|Dental caries|dental caries
4967075|NCT04195386|Deciduous teeth|deciduous teeth
4967076|NCT04195386|Permanent dental restoration|permanent dental restoration
4967077|NCT04195373|Colorectal cancer|colorectal cancer
4967078|NCT04195373|Esophageal cancer|esophageal cancer
4967079|NCT04195373|Gastric cancer|gastric cancer
4967080|NCT04195373|TMV-018|tmv-018
4967081|NCT04195373|anti-PD-1|anti-pd-1
4967082|NCT04195373|5-FC|5-fc
4967083|NCT04195373|oncolytic virus|oncolytic virus
4967084|NCT04195347|Acute Pancreatitis|acute pancreatitis
4967085|NCT04195347|Asparaginase|asparaginase
4967086|NCT04195347|Asparaginase Associated Pancreatitis|asparaginase associated pancreatitis
4967087|NCT04195347|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4967088|NCT04195347|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
4967089|NCT04195347|CM4620|cm4620
4967090|NCT04195347|Children|children
4967091|NCT04195347|SIRS|sirs
4967092|NCT04195347|Systemic Inflammatory Response|systemic inflammatory response
4967093|NCT04195347|Young Adults|young adults
4967094|NCT04195334|intramedullary nail|intramedullary nail
4967095|NCT04195308|transcranial magnetic stimulation|transcranial magnetic stimulation
4967097|NCT04195282|hepatitis b virus|hepatitis b virus
4967098|NCT04195282|acute-on-chronic liver failure|acute-on-chronic liver failure
4967099|NCT04195282|artificial liver|artificial liver
4967102|NCT04195269|Cannabidiol|cannabidiol
4967103|NCT04195269|Tetrahydrocannabinol|tetrahydrocannabinol
4967104|NCT04195269|Osteoarthritis|osteoarthritis
4967105|NCT04195269|Knee|knee
4967106|NCT04195269|Pain|pain
4967107|NCT04195243|Dapagliflozin|dapagliflozin
4967108|NCT04195243|Empagliflozin|empagliflozin
4967109|NCT04195243|FMD|fmd
4967110|NCT04195243|T2DM|t2dm
4967111|NCT04195243|Endothelial disfunction|endothelial disfunction
4967112|NCT04195230|Cognitive Training|cognitive training
4967113|NCT04195230|Executive Functions|executive functions
4967114|NCT04195230|Attention|attention
4967115|NCT04195230|Multi-tasking|multi-tasking
4967116|NCT04195230|Aging|aging
4967117|NCT04195230|Healthy Adults|healthy adults
4967118|NCT04195217|ONCOLOGY|oncology
4967119|NCT04195217|ART THERAPY|art therapy
4967120|NCT04195165|glucose tolerance|glucose tolerance
4967121|NCT04195165|exercise|exercise
4967122|NCT04195165|insulin sensitivity|insulin sensitivity
4967123|NCT04195152|Difficult intubation|difficult intubation
4972322|NCT04164433|Men|men
4967133|NCT04195113|venous thromboembolism|venous thromboembolism
4967134|NCT04195113|arterial vascular disease|arterial vascular disease
4967136|NCT04195113|oral anticoagulant|oral anticoagulant
4967137|NCT04195113|blood thinner|blood thinner
4967138|NCT04195113|warfarin|warfarin
4967139|NCT04195113|DOAC|doac
4967140|NCT04195113|interruption|interruption
4967141|NCT04195113|discontinue|discontinue
4967142|NCT04195113|emergency|emergency
4967143|NCT04195113|perioperative|perioperative
4967144|NCT04195113|vitamin k antagonist|vitamin k antagonist
4967148|NCT04195087|cesarean section|cesarean section
4967149|NCT04195087|perfusion index|perfusion index
4967150|NCT04195087|Pleth variability index|pleth variability index
4967151|NCT04195087|sitting position|sitting position
4967152|NCT04195074|chronic hepatitis b|chronic hepatitis b
4967153|NCT04195074|nucleoside|nucleoside
4967154|NCT04195074|nucleotide|nucleotide
4967155|NCT04195048|Ischemic Stroke, Cancer|ischemic stroke, cancer
4967156|NCT04195035|obesity|obesity
4967157|NCT04195035|Air QTM intubating airway|air qtm intubating airway
4967158|NCT04195035|Ambu-Aura intubating laryngeal mask|ambu-aura intubating laryngeal mask
4967159|NCT04195022|Dental caries|dental caries
4967160|NCT04195022|Deciduous teeth|deciduous teeth
4967161|NCT04195022|Permanent dental restoration|permanent dental restoration
4967162|NCT04194996|Cervical deformity|cervical deformity
4967163|NCT04194996|Kyphosis|kyphosis
4967164|NCT04194996|Scoliosis|scoliosis
4967165|NCT04194983|Ageing|ageing
4967166|NCT04194983|Mitochondrial Function|mitochondrial function
4967167|NCT04194983|Physical Function|physical function
4967168|NCT04194983|Cognitive Function|cognitive function
4967169|NCT04194983|Dietary Fat|dietary fat
4967170|NCT04194970|Weight bearing monitoring,|weight bearing monitoring,
4967171|NCT04194970|Live-biofeedback|live-biofeedback
4967172|NCT04194970|Lower extremity|lower extremity
4967173|NCT04194970|Rehabilitation|rehabilitation
4967174|NCT04194970|MarWAS|marwas
4967175|NCT04194957|Fluoropyrimidines|fluoropyrimidines
4967176|NCT04194957|Phenotyping|phenotyping
4967177|NCT04194957|Genotyping|genotyping
4967178|NCT04194957|Dose-individualization|dose-individualization
4967179|NCT04194957|Capecitabine|capecitabine
4967180|NCT04194957|5-Fluorouracil|5-fluorouracil
4967181|NCT04194957|5-FU|5-fu
4967182|NCT04194944|targeted therapy|targeted therapy
4967183|NCT04194931|Relapsed and refractory multiple myeloma; CAR-T|relapsed and refractory multiple myeloma; car-t
4967184|NCT04194866|circadian clock|circadian clock
4967185|NCT04194866|postoperative cognitive function|postoperative cognitive function
4967186|NCT04194866|general anesthesia|general anesthesia
4967187|NCT04194866|elderly patients|elderly patients
4967188|NCT04194827|Adalimumab|adalimumab
4967189|NCT04194827|Rheumatoid arthritis|rheumatoid arthritis
4967190|NCT04194827|Therapeutic Drug Monitoring|therapeutic drug monitoring
4967191|NCT04194827|Drug level|drug level
4967192|NCT04194827|Dose reduction|dose reduction
4967193|NCT04194736|Percutaneous central venous catheter|percutaneous central venous catheter
4967194|NCT04194736|Thrombosis|thrombosis
4967195|NCT04194736|Children|children
4967196|NCT04194736|Ultrasound scan|ultrasound scan
4967197|NCT04194723|Antireflux Mucosectomy|antireflux mucosectomy
4967198|NCT04194723|GERD|gerd
4967199|NCT04194697|Exercise program|exercise program
4967204|NCT04194606|Distal radial access|distal radial access
4967205|NCT04194606|Radial artery occlusion|radial artery occlusion
4967206|NCT04194606|Coronary catheterization|coronary catheterization
4967207|NCT04194606|Radial artery|radial artery
4967208|NCT04194567|polyphenols|polyphenols
4967209|NCT04194567|iron deficiency|iron deficiency
4967210|NCT04194567|finger millet|finger millet
4967211|NCT04194567|iron bioavailability|iron bioavailability
4967212|NCT04194515|Bile acid|bile acid
4967213|NCT04194515|Microbiota|microbiota
4967214|NCT04194502|Transesophageal echocardiography|transesophageal echocardiography
4967215|NCT04194476|neonates|neonates
4967216|NCT04194476|glucose|glucose
4967217|NCT04194411|Neurofilament light|neurofilament light
4967219|NCT04194411|Delirium|delirium
4967220|NCT04194411|Valvular heart surgery|valvular heart surgery
4967221|NCT04194385|Postoperative pain, Costoclavicular block, Upper trunk block, Bupivacaine|postoperative pain, costoclavicular block, upper trunk block, bupivacaine
4967226|NCT04194359|RAS-mutant Metastatic Colorectal Cancer|ras-mutant metastatic colorectal cancer
4967227|NCT04194359|Immunotherapy|immunotherapy
4967228|NCT04194359|Anti-PD-1|anti-pd-1
4967229|NCT04194359|Checkpoint|checkpoint
4967230|NCT04194359|Efficacy|efficacy
4967231|NCT04194359|Safety|safety
4967232|NCT04194333|Lung Nodule|lung nodule
4967233|NCT04194333|Lung Mass|lung mass
4967234|NCT04194333|Lung Lesion|lung lesion
4967242|NCT04194229|Ishemic stroke|ishemic stroke
4967243|NCT04194229|Post-intensive care syndrome|post-intensive care syndrome
4967244|NCT04194229|Cytoflavin|cytoflavin
4967245|NCT04194229|Rehabilitation|rehabilitation
4967246|NCT04194229|Metabolography|metabolography
4967247|NCT04194229|Utilization O2|utilization o2
4967248|NCT04194229|Velokinesis|velokinesis
4967249|NCT04194229|Verticalization|verticalization
4967252|NCT04194164|Hemodialysis|hemodialysis
4967253|NCT04194164|End stage renal disease on dialysis|end stage renal disease on dialysis
4967254|NCT04194164|Fluid intake|fluid intake
4967255|NCT04194164|Interdialytic weight gain|interdialytic weight gain
4967256|NCT04194151|propofol synergy|propofol synergy
4967257|NCT04194151|fentanyl|fentanyl
4967258|NCT04194151|anesthesia induction|anesthesia induction
4967259|NCT04194138|Scoliosis|scoliosis
4967260|NCT04194138|Kyphosis|kyphosis
4967261|NCT04194138|Saggittal Imbalance|saggittal imbalance
4967262|NCT04194138|Spinal deformity|spinal deformity
4967263|NCT04194125|PRRT - Peptide Receptor Radionuclide Therapy|prrt - peptide receptor radionuclide therapy
4967264|NCT04194125|CAPTEM - Capecitabine-temozolomide|captem - capecitabine-temozolomide
4967265|NCT04194125|GET-NET - Gastro-Entero-Pancreatic Neuroendocrine Tumours|get-net - gastro-entero-pancreatic neuroendocrine tumours
4967266|NCT04194125|PFS - progression free survival|pfs - progression free survival
4967267|NCT04194125|OS - overall survival|os - overall survival
4967268|NCT04194099|Spinal Cord Injuries|spinal cord injuries
4967269|NCT04194099|Trans-cranial magnetic stimulation|trans-cranial magnetic stimulation
4967270|NCT04194099|Trans-spinal direct current stimulation|trans-spinal direct current stimulation
4967271|NCT04194060|ERAS|eras
4967272|NCT04194060|Emergency surgery|emergency surgery
4967273|NCT04194060|Fast track surgery|fast track surgery
4967274|NCT04194060|Perioperative Care|perioperative care
4965132|NCT04207606|epidural steroid|epidural steroid
4965133|NCT04207606|lumbar back pain|lumbar back pain
4965134|NCT04207606|Pharmacokinetics|pharmacokinetics
4965135|NCT04207606|Timeline|timeline
4965136|NCT04207606|Natural History|natural history
4965137|NCT04207580|Cohort - Idiopathic nephrotic syndrome - child|cohort - idiopathic nephrotic syndrome - child
4967275|NCT04194060|Enhanced recovery after surgery|enhanced recovery after surgery
4967276|NCT04194021|HIV/AIDS|hiv/aids
4967277|NCT04194021|Antiretroviral therapy|antiretroviral therapy
4967278|NCT04194021|Darunavir|darunavir
4967279|NCT04194021|Etravirine|etravirine
4967280|NCT04194021|Treatment-experienced HIV|treatment-experienced hiv
4967281|NCT04194021|Pediatrics|pediatrics
4967282|NCT04194021|Adolescents|adolescents
4967283|NCT04194021|Young people|young people
4967284|NCT04194021|Drug resistance mutations|drug resistance mutations
4967285|NCT04194021|Cameroon|cameroon
4967286|NCT04194021|Eswatini|eswatini
4967287|NCT04194021|Ethiopia|ethiopia
4967288|NCT04194021|Kenya|kenya
4967289|NCT04194021|Lesotho|lesotho
4967290|NCT04194021|Nigeria|nigeria
4967291|NCT04194021|Uganda|uganda
4967292|NCT04194021|Zambia|zambia
4967293|NCT04194021|Zimbabwe|zimbabwe
4967294|NCT04194021|Viral load|viral load
4967295|NCT04194021|Protease inhibitor|protease inhibitor
4967296|NCT04194021|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
4967300|NCT04193969|radiculopathy|radiculopathy
4967301|NCT04193969|conditioned pain modulation|conditioned pain modulation
4967302|NCT04193969|temporal summation|temporal summation
4967303|NCT04193956|Immunotherapy|immunotherapy
4967304|NCT04193956|Anti-PD1 checkpoint inhibitor|anti-pd1 checkpoint inhibitor
4967305|NCT04193917|Ocular surface microbiome|ocular surface microbiome
4967306|NCT04193917|Temporal stability|temporal stability
4967307|NCT04193917|Confounding factors|confounding factors
4967308|NCT04193865|Extracorporeal life support|extracorporeal life support
4967309|NCT04193865|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4967310|NCT04193865|Acute Kidney Injury|acute kidney injury
4967311|NCT04193865|Renal replacement therapy|renal replacement therapy
4967312|NCT04193865|Renal Support therapy|renal support therapy
4967313|NCT04193865|Kidney support therapy|kidney support therapy
4967314|NCT04193839|Computerized Provider Order entry|computerized provider order entry
4967315|NCT04193839|Patient safety|patient safety
4967316|NCT04193839|Quality improvement|quality improvement
4967317|NCT04193839|Medication errors|medication errors
4967318|NCT04193839|Adverse events|adverse events
4972527|NCT04163406|Infants|infants
4967347|NCT04193644|tumor-specific fatigue syndrome|tumor-specific fatigue syndrome
4967348|NCT04193644|mindfulness|mindfulness
4967349|NCT04193644|self-compassion|self-compassion
4967351|NCT04193631|Cannabidiol|cannabidiol
4967352|NCT04193631|Musculoskeletal Pain|musculoskeletal pain
4967353|NCT04193631|Pain|pain
4967354|NCT04193592|safety|safety
4967355|NCT04193592|efficacy|efficacy
4967356|NCT04193592|patient reported outcomes|patient reported outcomes
4967357|NCT04193579|Premature Birth|premature birth
4967358|NCT04193579|Obstetric Labor, Premature|obstetric labor, premature
4967359|NCT04193579|Obstetric Labor Complications|obstetric labor complications
4967360|NCT04193579|Pregnancy Complications|pregnancy complications
4967361|NCT04193553|Gastro Intestinal Stromal Tumour|gastro intestinal stromal tumour
4967362|NCT04193553|Locally advanced or metastatic|locally advanced or metastatic
4967363|NCT04193553|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
4967364|NCT04193540|Intensive Care Unit patient|intensive care unit patient
4965259|NCT04206878|HIV|hiv
4967365|NCT04193540|Mechanical Ventilation|mechanical ventilation
4967366|NCT04193540|Sedatives|sedatives
4967367|NCT04193540|Decision-making capacity|decision-making capacity
4967368|NCT04193540|Confusion|confusion
4967369|NCT04193501|Melatonin|melatonin
4967370|NCT04193501|gut microbiota|gut microbiota
4967371|NCT04193501|dysbiosis|dysbiosis
4967372|NCT04193488|spinal surgery|spinal surgery
4967373|NCT04193488|Erector spina plan block|erector spina plan block
4967374|NCT04193488|Mid-transverse process to pleura block|mid-transverse process to pleura block
4967375|NCT04193488|post-operative analgesia|post-operative analgesia
4967376|NCT04193475|Chest pain|chest pain
4967377|NCT04193475|Angina|angina
4967378|NCT04193475|Deformation imaging|deformation imaging
4967379|NCT04193475|Tissue doppler imaging|tissue doppler imaging
4967380|NCT04193475|Strain|strain
4967381|NCT04193475|Velocity|velocity
4967382|NCT04193462|Post-partum depression|post-partum depression
4967383|NCT04193462|dyadic psychotherapy|dyadic psychotherapy
4967384|NCT04193462|oxytocin|oxytocin
4967385|NCT04193449|colonoscopy|colonoscopy
4967386|NCT04193449|indications|indications
4967413|NCT04193371|Acupuncture|acupuncture
4967414|NCT04193371|Lifestyle management|lifestyle management
4967415|NCT04193345|Delayed Umbilical Cord Clamping|delayed umbilical cord clamping
4967416|NCT04193345|Preeclamptic Patients|preeclamptic patients
4967417|NCT04193332|thyroide surgery|thyroide surgery
4967418|NCT04193332|total thyroidectomy|total thyroidectomy
4967419|NCT04193332|compltion thyroidectomy|compltion thyroidectomy
4967420|NCT04193332|parathyroidectomy|parathyroidectomy
4967421|NCT04193332|autofluorescense|autofluorescense
4967423|NCT04193332|near-infrared|near-infrared
4967424|NCT04193332|optical imaging|optical imaging
4967429|NCT04193280|Preoperative fasting time,|preoperative fasting time,
4967430|NCT04193280|Blood glucose level|blood glucose level
4967431|NCT04193280|Postoperative Delirium|postoperative delirium
4967432|NCT04193267|Primary Progressive Aphasia|primary progressive aphasia
4967433|NCT04193267|Brain Stimulation|brain stimulation
4967434|NCT04193254|lung protective ventilation|lung protective ventilation
4967435|NCT04193254|mechanical power|mechanical power
4967436|NCT04193254|driving pressure|driving pressure
4967437|NCT04193254|SOFA|sofa
4967444|NCT04193202|Cough|cough
4967445|NCT04193202|Respiration disorders|respiration disorders
4967446|NCT04193202|Respiratory tract diseases|respiratory tract diseases
4967447|NCT04193202|Signs and symptoms, respiratory|signs and symptoms, respiratory
4967448|NCT04193202|Signs and symptoms|signs and symptoms
4967449|NCT04193176|Cough|cough
4967450|NCT04193176|Urinary Incontinence, Stress|urinary incontinence, stress
4967451|NCT04193176|Respiration disorders|respiration disorders
4967452|NCT04193176|Respiratory tract diseases|respiratory tract diseases
4967453|NCT04193176|Signs and symptoms, respiratory|signs and symptoms, respiratory
4985892|NCT04079309|Lavender Oil|lavender oil
4967454|NCT04193176|Signs and symptoms|signs and symptoms
4967455|NCT04193163|Arthroplasty|arthroplasty
4967456|NCT04193163|Hip replacement|hip replacement
4967457|NCT04193150|disease control|disease control
4967458|NCT04193150|socioeconomics|socioeconomics
4967459|NCT04193150|difficult-to-treat|difficult-to-treat
4967460|NCT04193137|primary aldosteronism,|primary aldosteronism,
4967461|NCT04193137|oral sodium loading test|oral sodium loading test
4967462|NCT04193137|captopril challenge test,|captopril challenge test,
4967463|NCT04193137|Saline infusion test|saline infusion test
4967464|NCT04193124|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4967465|NCT04193124|Vasospasm, Intracranial|vasospasm, intracranial
4967466|NCT04193124|Transcranial doppler|transcranial doppler
4967467|NCT04193111|orofacial pain|orofacial pain
4967468|NCT04193111|DC/TMD|dc/tmd
4967469|NCT04193085|Spinal Muscular Atrophy|spinal muscular atrophy
4967470|NCT04193085|SMA|sma
4967471|NCT04193085|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4967472|NCT04193085|DMD|dmd
4967473|NCT04193085|instrumented insole|instrumented insole
4967474|NCT04193085|neuromuscular disease|neuromuscular disease
4967475|NCT04193085|six minute walk test|six minute walk test
4967476|NCT04193085|machine learning model|machine learning model
4967477|NCT04193085|gait analysis|gait analysis
4967478|NCT04193085|wearable|wearable
4967479|NCT04193085|ambulatory|ambulatory
4967480|NCT04193085|stride|stride
4967481|NCT04193085|foot-worn|foot-worn
4967482|NCT04193072|brachial plexus|brachial plexus
4967483|NCT04193072|imagery|imagery
4967484|NCT04193072|body image|body image
4967485|NCT04193072|sensation|sensation
4967486|NCT04193072|questionnaires|questionnaires
4967487|NCT04193059|adjuvant chemotherapy|adjuvant chemotherapy
4967488|NCT04193059|epirubicin|epirubicin
4967489|NCT04193059|cyclophosphamide|cyclophosphamide
4967490|NCT04193059|docetaxel|docetaxel
4967491|NCT04193059|paclitaxel|paclitaxel
4967492|NCT04193059|carboplatin|carboplatin
4967493|NCT04193059|trastuzumab|trastuzumab
4967508|NCT04192916|Real world data|real world data
4967512|NCT04192877|Validation Studies|validation studies
4965397|NCT04206020|KCS|kcs
4967513|NCT04192877|Vagus Nerve Diseases|vagus nerve diseases
4967514|NCT04192877|Diagnostic imaging|diagnostic imaging
4967515|NCT04192877|Motion analysis|motion analysis
4967516|NCT04192877|Healthy Volunteers|healthy volunteers
4967517|NCT04192838|Incisional hernia|incisional hernia
4967518|NCT04192838|Laparoscopic surgery|laparoscopic surgery
4967519|NCT04192838|Recurrence|recurrence
4967520|NCT04192838|Health Related Quality of Life|health related quality of life
4967521|NCT04192786|Multiple Sclerosis|multiple sclerosis
4967522|NCT04192786|Spasticity|spasticity
4967523|NCT04192786|Local Vibration|local vibration
4967524|NCT04192786|Muscle Architecture|muscle architecture
4967525|NCT04192786|Functionality|functionality
4967526|NCT04192773|tinnitus|tinnitus
4967527|NCT04192773|normal control|normal control
4967528|NCT04192773|hearing loss|hearing loss
4967529|NCT04192773|IV lidocaine|iv lidocaine
4967530|NCT04192773|fMRI|fmri
4967531|NCT04192760|PCI|pci
4967532|NCT04192760|stent|stent
4967533|NCT04192760|bifurcation|bifurcation
4967534|NCT04192760|Culotte|culotte
4967535|NCT04192760|DK-Crush|dk-crush
4967536|NCT04192760|restenosis|restenosis
4967547|NCT04192708|pain management|pain management
4967548|NCT04192682|Small Cell Lung Cancer|small cell lung cancer
4967550|NCT04192682|Sintilimab|sintilimab
4967551|NCT04192682|Third-line Treatment or Beyond|third-line treatment or beyond
4967552|NCT04192643|uterin fibroid, laparoscopic myomectomy|uterin fibroid, laparoscopic myomectomy
4967553|NCT04192604|Work-related musculoskeletal pain|work-related musculoskeletal pain
4967554|NCT04192604|pain management|pain management
4967555|NCT04192604|prevention|prevention
4967556|NCT04192604|screening|screening
4967557|NCT04192591|Lumbar Spinal Stenosis|lumbar spinal stenosis
4967558|NCT04192591|LSS|lss
4967559|NCT04192591|Chronic Pain|chronic pain
4967560|NCT04192591|Leg Pain|leg pain
4967561|NCT04192578|Remote ischemic conditioning|remote ischemic conditioning
4967562|NCT04192578|2,3-Bisphosphoglycerate|2,3-bisphosphoglycerate
4967563|NCT04192578|Erythrocyte|erythrocyte
4967564|NCT04192578|Oxygen|oxygen
4967565|NCT04192578|healthy subjects|healthy subjects
4967566|NCT04192565|Colorectal Neoplasms|colorectal neoplasms
4967567|NCT04192565|Colorectal Polyp|colorectal polyp
4967568|NCT04192565|Colorectal Adenoma|colorectal adenoma
4967569|NCT04192552|anticoagulant|anticoagulant
4967570|NCT04192552|atrial fibrillation|atrial fibrillation
4967571|NCT04192552|surgery|surgery
4967572|NCT04192552|oral anticoagulant|oral anticoagulant
4967573|NCT04192552|high risk|high risk
4967574|NCT04192552|blood thinner|blood thinner
4967575|NCT04192552|DOAC|doac
4967576|NCT04192552|interruption|interruption
4967583|NCT04192487|Combination Antiretroviral Therapy (CART)|combination antiretroviral therapy (cart)
4967584|NCT04192487|CD4 Cell Count|cd4 cell count
4967585|NCT04192487|Gut Microbiome|gut microbiome
4967586|NCT04192487|Non-Infectious Diarrhea|non-infectious diarrhea
4967587|NCT04192487|Diarrhea|diarrhea
4967588|NCT04192448|Sexual Violence|sexual violence
4967589|NCT04192448|Alcohol consumption|alcohol consumption
4967590|NCT04192409|Coronary Artery Disease|coronary artery disease
4967591|NCT04192409|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4967594|NCT04192409|Postoperative Management|postoperative management
4967595|NCT04192396|Endometrial receptivity assessment for customized embryo transfer|endometrial receptivity assessment for customized embryo transfer
4967596|NCT04192396|Human Reproduction|human reproduction
4967598|NCT04192396|Endometrial receptivity|endometrial receptivity
4967599|NCT04192383|Spinal Neoplasms|spinal neoplasms
4967600|NCT04192383|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4967601|NCT04192383|CyberKnife Radiosurgery|cyberknife radiosurgery
4967602|NCT04192383|Functional MRI|functional mri
4967603|NCT04192383|treatment outcome|treatment outcome
4967604|NCT04192331|nab-paclitaxel|nab-paclitaxel
4967605|NCT04192331|advanced breast cancer|advanced breast cancer
4967606|NCT04192331|HER2 negative|her2 negative
4967607|NCT04192331|dose|dose
4967608|NCT04192292|Metformin|metformin
4967609|NCT04192292|Sulphonylurea|sulphonylurea
4967610|NCT04192292|Gliclazide|gliclazide
4967611|NCT04192292|DPP4 Inhibitor|dpp4 inhibitor
4967612|NCT04192292|Sitagliptin|sitagliptin
4967613|NCT04192292|Continuous Glucose Monitoring|continuous glucose monitoring
4967614|NCT04192292|KCNJ11|kcnj11
4967615|NCT04192292|Incretin Effect|incretin effect
4967616|NCT04192279|sepsis|sepsis
4967617|NCT04192279|lactate|lactate
4967618|NCT04192279|early|early
4967619|NCT04192240|cerebrovascular disease|cerebrovascular disease
4967620|NCT04192240|rehabilitation|rehabilitation
4967621|NCT04192240|walking|walking
4967622|NCT04192240|balance|balance
4967634|NCT04192162|serotonin|serotonin
4967635|NCT04192149|Ultrasound|ultrasound
4967636|NCT04192149|Neuromodulation|neuromodulation
4967637|NCT04192149|Focused Ultrasound|focused ultrasound
4967638|NCT04192123|Physical rinsing|physical rinsing
4967639|NCT04192123|Cleansing solution|cleansing solution
4967640|NCT04192123|Wound bed preparation|wound bed preparation
4967641|NCT04192110|Chronic kidney disease|chronic kidney disease
4967642|NCT04192110|Diuretics|diuretics
5698570|NCT00505934|Intravenous|intravenous
5009868|NCT03934931|3HP|3hp
4967643|NCT04192110|Volume overload|volume overload
4967644|NCT04192110|Natriuretic peptides|natriuretic peptides
4967645|NCT04192110|Bioimpedance spectroscopy|bioimpedance spectroscopy
4967646|NCT04192110|Cardiovascular disease|cardiovascular disease
4967647|NCT04192097|Cardiopulmonary arrest|cardiopulmonary arrest
4967660|NCT04192006|inflammation|inflammation
4967661|NCT04192006|mako robot|mako robot
4967662|NCT04192006|makoplasty|makoplasty
4967663|NCT04192006|soft tissue injury|soft tissue injury
4967664|NCT04192006|total knee arthroplasty|total knee arthroplasty
4967665|NCT04192006|total knee replacement|total knee replacement
4967666|NCT04192006|thermal|thermal
4967667|NCT04191993|Total hip arthroplasty|total hip arthroplasty
4967668|NCT04191993|Direct superior approach|direct superior approach
4967669|NCT04191993|Minimally invasive surgery|minimally invasive surgery
4967670|NCT04191993|Implant position|implant position
4967671|NCT04191993|Osteoarthritis|osteoarthritis
4967672|NCT04191993|Posterior approach|posterior approach
4967673|NCT04191993|Radiostereometric analysis|radiostereometric analysis
4967674|NCT04191980|prostate segmentation|prostate segmentation
4967675|NCT04191980|MR images|mr images
4967676|NCT04191941|CD19-TriCAR-T|cd19-tricar-t
4967677|NCT04191941|1922-TriCAR-T|1922-tricar-t
4967678|NCT04191941|BCMA-TriCAR-T|bcma-tricar-t
4967679|NCT04191928|apixaban|apixaban
4967700|NCT04191811|Internet-delivered Cognitive Behavior Therapy|internet-delivered cognitive behavior therapy
4967702|NCT04191811|Moment-to-moment variability|moment-to-moment variability
4967703|NCT04191798|Arthroplasty|arthroplasty
4967704|NCT04191798|Knee Replacement|knee replacement
4967705|NCT04191798|Rehab at home|rehab at home
4967706|NCT04191798|Virtual PT|virtual pt
4967707|NCT04191798|Remote Patient Monitoring|remote patient monitoring
4967708|NCT04191798|Patient Engagement|patient engagement
4967710|NCT04191798|TKA|tka
4967711|NCT04191772|Sedentary time|sedentary time
4967712|NCT04191772|Exercise|exercise
4967713|NCT04191772|Brain volume|brain volume
4967714|NCT04191772|Health-related variables|health-related variables
4967715|NCT04191772|Immunological variables|immunological variables
4967716|NCT04191772|Multiple Sclerosis|multiple sclerosis
4967717|NCT04191720|anorexia nervosa|anorexia nervosa
4967718|NCT04191720|weighted blankets|weighted blankets
4967719|NCT04191720|occupational therapy|occupational therapy
4967720|NCT04191720|anxiety|anxiety
4967721|NCT04191720|deep pressure stimulation|deep pressure stimulation
4967722|NCT04191720|randomized control trial|randomized control trial
4967723|NCT04191681|continuous flow left ventricular assist device|continuous flow left ventricular assist device
4967724|NCT04191681|sacubitril-valsartan|sacubitril-valsartan
4967725|NCT04191681|oral vasodilator|oral vasodilator
4967726|NCT04191681|Heart failure|heart failure
4967727|NCT04191655|Colorectal cancer screening|colorectal cancer screening
4967728|NCT04191655|Inflammatory bowel disease|inflammatory bowel disease
4967729|NCT04191655|Chromocolonoscopy|chromocolonoscopy
4967730|NCT04191655|High definition white light colonoscopy|high definition white light colonoscopy
4967731|NCT04191642|Inflammasomes|inflammasomes
4967732|NCT04191642|Interleukin-18|interleukin-18
4967733|NCT04191642|Interleukin-1|interleukin-1
4967734|NCT04191642|NLR Family, Pyrin Domain-Containing 3 Protein|nlr family, pyrin domain-containing 3 protein
4967735|NCT04191642|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
4967750|NCT04191512|Obstructive Sleep Apnea|obstructive sleep apnea
4967751|NCT04191512|Continuous Positive Airway Pressure|continuous positive airway pressure
4967752|NCT04191460|cRGD-ZW800-1|crgd-zw800-1
4967753|NCT04191460|fluorescence-guided surgery|fluorescence-guided surgery
4967754|NCT04191460|image-guided surgery|image-guided surgery
4967755|NCT04191460|fluorescence imaging|fluorescence imaging
4967757|NCT04191447|Asthma|asthma
4967758|NCT04191434|Asthma|asthma
4967759|NCT04191304|benralizumab|benralizumab
4967760|NCT04191304|Hypereosinophilic Syndrome (HES)|hypereosinophilic syndrome (hes)
4967766|NCT04191265|tropinin|tropinin
4967767|NCT04191265|CKmb|ckmb
4967768|NCT04191265|cardiotoxicity|cardiotoxicity
4967769|NCT04191213|sickle cell anemia|sickle cell anemia
4967770|NCT04191213|Gum Arabic|gum arabic
4967771|NCT04191213|Fetal Hemoglobin|fetal hemoglobin
4967772|NCT04191200|Schizophrenia|schizophrenia
4967773|NCT04191200|Psychiatric institutions|psychiatric institutions
4967774|NCT04191200|Epidemiology|epidemiology
4967810|NCT04191018|gastrointestinal endoscopy|gastrointestinal endoscopy
4967812|NCT04190992|Breast reconstruction|breast reconstruction
4967813|NCT04190992|E-based Technology|e-based technology
4967814|NCT04190979|Endovascular aneurysm repair|endovascular aneurysm repair
4967816|NCT04190979|AAA|aaa
4967817|NCT04190979|Cannulation|cannulation
4967818|NCT04190979|Blood Flow Velocity|blood flow velocity
5290451|NCT02222337|Latina|latina
4967819|NCT04190966|Postoperative Pulmonary Complications|postoperative pulmonary complications
4967820|NCT04190966|Smoking Cessation Intervention|smoking cessation intervention
4967821|NCT04190940|Ultrasound|ultrasound
4967822|NCT04190940|Thalamus|thalamus
4967823|NCT04190940|Cerebellum|cerebellum
4967824|NCT04190940|Basal Ganglia|basal ganglia
4967825|NCT04190940|Deep Brain Stimulation|deep brain stimulation
4967826|NCT04190940|High Intensity Focused Ultrasound|high intensity focused ultrasound
4967827|NCT04190927|Menopause|menopause
4967828|NCT04190927|Hormone Replacement Therapy|hormone replacement therapy
4967829|NCT04190927|Bioidentical HRT|bioidentical hrt
4967830|NCT04190927|Transdermal HRT|transdermal hrt
4967831|NCT04190927|Rhythmic Dosing|rhythmic dosing
4967832|NCT04190927|Physiologic Restoration|physiologic restoration
4967833|NCT04190914|triple antibiotic paste|triple antibiotic paste
4967834|NCT04190888|Uric acid|uric acid
4967835|NCT04190875|Standard Protein Diet|standard protein diet
4967836|NCT04190875|High Protein Diet|high protein diet
4967837|NCT04190875|Targeted Fortification|targeted fortification
4967838|NCT04190875|Post-Discharge Growth|post-discharge growth
4967839|NCT04190875|Post-Discharge Body Compostion|post-discharge body compostion
4967840|NCT04190875|Post-Discharge Neurodevelopment|post-discharge neurodevelopment
4967841|NCT04190875|Protein|protein
4967842|NCT04190875|Human Milk Diet|human milk diet
4967843|NCT04190875|Prematurity|prematurity
4967844|NCT04190849|Cirrhosis|cirrhosis
4967845|NCT04190849|Liver disease|liver disease
4967846|NCT04190849|Hepatocellular carcinoma|hepatocellular carcinoma
4967847|NCT04190849|Type 2 diabetes|type 2 diabetes
4967848|NCT04190849|Atherosclerosis|atherosclerosis
4967849|NCT04190836|Shoulder pain|shoulder pain
4967850|NCT04190836|Persistent pain|persistent pain
4967851|NCT04190836|Self-management|self-management
4967852|NCT04190836|Exercise|exercise
4967853|NCT04190810|Approach and Avoidance Task (AAT)|approach and avoidance task (aat)
4967854|NCT04190810|Inhibition|inhibition
4967855|NCT04190810|fMRI|fmri
4967856|NCT04190797|Laser Therapy|laser therapy
4967857|NCT04190797|Osteoarthritis|osteoarthritis
4967858|NCT04190797|Knee|knee
4967859|NCT04190784|Randomized controlled trial|randomized controlled trial
4967860|NCT04190784|Myofascial Pain Syndrome|myofascial pain syndrome
4967861|NCT04190784|Stretching exercises|stretching exercises
4967862|NCT04190784|nerve root function|nerve root function
4967863|NCT04190771|multicomponent treatment|multicomponent treatment
4967864|NCT04190771|Nature therapy|nature therapy
4967865|NCT04190771|Mindfulness|mindfulness
4967866|NCT04190771|Physical therapy|physical therapy
4967867|NCT04190771|Pain Neuroscience Education (PNE)|pain neuroscience education (pne)
4967868|NCT04190732|infertility|infertility
4967869|NCT04190732|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
4967870|NCT04190732|anxiety|anxiety
4967872|NCT04190706|inflammation|inflammation
4967873|NCT04190706|cardiometabolic risk|cardiometabolic risk
4967874|NCT04190706|endotoxemia|endotoxemia
4967875|NCT04190706|polyphenols|polyphenols
4967876|NCT04190706|oxidative stress|oxidative stress
4967877|NCT04190706|slow digestible starch|slow digestible starch
4967878|NCT04190706|fibers|fibers
4967879|NCT04190706|gut microbiota|gut microbiota
4967880|NCT04190706|nutritional challenge test|nutritional challenge test
4967889|NCT04190628|Cholangiocarcinoma|cholangiocarcinoma
4967890|NCT04190628|Non-small Cell Lung Cancer|non-small cell lung cancer
4967891|NCT04190628|Thyroid Cancer|thyroid cancer
4967892|NCT04190628|Ovarian Cancer|ovarian cancer
4967893|NCT04190615|thromboelastometry|thromboelastometry
4967894|NCT04190615|viscoelastic testing|viscoelastic testing
4967895|NCT04190615|reference ranges|reference ranges
4967896|NCT04190602|NeoChord|neochord
4967897|NCT04190602|DS1000|ds1000
4967898|NCT04190602|Artificial Chordae|artificial chordae
4967903|NCT04190537|Paradoxial reaction midazolam|paradoxial reaction midazolam
4967904|NCT04190498|Sleep Apnea, Obstructive|sleep apnea, obstructive
4967905|NCT04190498|Hepatocellular carcinoma|hepatocellular carcinoma
4967906|NCT04190498|Non Alcoholic Steato Hepatitis|non alcoholic steato hepatitis
4967916|NCT04190420|Hypertensive heart disease|hypertensive heart disease
4967917|NCT04190420|Heart failure|heart failure
4967918|NCT04190420|Biomarkers|biomarkers
4967919|NCT04190420|Diastolic dysfunction|diastolic dysfunction
4967920|NCT04190407|Intravenous access|intravenous access
4967921|NCT04190407|Sevoflurane|sevoflurane
4967922|NCT04190407|Bispectral index|bispectral index
4967923|NCT04190407|Pediatric patient|pediatric patient
4967924|NCT04190381|deer antler velvet|deer antler velvet
4967925|NCT04190381|radiation-irritated skin|radiation-irritated skin
4967926|NCT04190368|Adolescents|adolescents
4967927|NCT04190368|Group Medical Visits|group medical visits
4967928|NCT04190355|Root canal|root canal
4967929|NCT04190355|irrigation|irrigation
4967930|NCT04190355|irrigant type|irrigant type
4967931|NCT04190355|postoperative pain|postoperative pain
4967932|NCT04190342|tai chi|tai chi
4967933|NCT04190342|breast cancer|breast cancer
4967934|NCT04190342|symptom cluster|symptom cluster
4967935|NCT04190342|fatigue|fatigue
4967936|NCT04190342|sleep disturbance|sleep disturbance
4967937|NCT04190342|depression|depression
4967938|NCT04190316|Extended-spectrum beta-lactamase|extended-spectrum beta-lactamase
4967939|NCT04190316|Carriage|carriage
4967940|NCT04190316|Cross transmission|cross transmission
4967941|NCT04190316|Intensive care unit|intensive care unit
4967942|NCT04190316|Fecal relative abundance|fecal relative abundance
4967943|NCT04190290|Anorexia nervosa|anorexia nervosa
4967944|NCT04190290|Muscle strength|muscle strength
4967945|NCT04190290|Peak-expiratory-flow|peak-expiratory-flow
4967946|NCT04190290|Quality of life|quality of life
4967947|NCT04190277|Artificial Pancreas|artificial pancreas
4967948|NCT04190277|Adolescents|adolescents
4967949|NCT04190277|Adults|adults
4967950|NCT04190251|Medication adherence|medication adherence
4967951|NCT04190251|Diabetes Mellitus|diabetes mellitus
4967952|NCT04190251|Renal Insufficiency, Chronic|renal insufficiency, chronic
4967953|NCT04190251|Interprofessional Relations|interprofessional relations
4967954|NCT04190225|physical activity|physical activity
4967955|NCT04190225|adolescents|adolescents
4967956|NCT04190225|teenagers|teenagers
4967957|NCT04190225|Latina|latina
4967958|NCT04190212|high-intensity interval training|high-intensity interval training
4967959|NCT04190212|glycemic variability|glycemic variability
4967960|NCT04190212|continuous glucose monitoring system|continuous glucose monitoring system
4967961|NCT04190199|Metabolomic|metabolomic
4967962|NCT04190199|Nutritype|nutritype
4967963|NCT04190199|Dietary Pattern|dietary pattern
4967964|NCT04190186|Biotronik BioMonitor3|biotronik biomonitor3
4967966|NCT04190186|AF Ablation|af ablation
4967967|NCT04190186|Atrial arrhythmia|atrial arrhythmia
4967968|NCT04190173|Prokinetic|prokinetic
4967969|NCT04190173|Prucalopride|prucalopride
4967970|NCT04190160|elderly, diabetes, safety, quality of life|elderly, diabetes, safety, quality of life
4967971|NCT04190147|Moderate-to-late preterm|moderate-to-late preterm
4967972|NCT04190134|robot|robot
4967973|NCT04190121|esophageal cancer,nutritional support|esophageal cancer,nutritional support
4967974|NCT04190082|Cerebral palsy|cerebral palsy
4967975|NCT04190082|Botulinum toxin|botulinum toxin
4967976|NCT04190082|Bispectral index monitor|bispectral index monitor
4967977|NCT04190082|Deep sedation|deep sedation
4967978|NCT04190082|Recovery|recovery
4967979|NCT04190069|weight loss, weight maintenance|weight loss, weight maintenance
4967981|NCT04189991|COPD|copd
4967982|NCT04189991|Long-term oxygen therapy|long-term oxygen therapy
4967983|NCT04189991|Six minutes walk test|six minutes walk test
4967984|NCT04189991|Exertion|exertion
4967985|NCT04189991|Rehabilitation|rehabilitation
4967986|NCT04189965|Pain|pain
4967987|NCT04189965|Traumatic Long-term Memory|traumatic long-term memory
4967993|NCT04189926|Physical Activity|physical activity
4967994|NCT04189926|Young Children|young children
4967995|NCT04189926|Sedentary Behavior|sedentary behavior
4967996|NCT04189926|Childcare Centers|childcare centers
4967997|NCT04189926|Family|family
4967998|NCT04189900|Triptorelin|triptorelin
4967999|NCT04189900|Anti-doping control|anti-doping control
4968000|NCT04189900|Athletic performance|athletic performance
4968001|NCT04189900|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
4968002|NCT04189822|Sudden Cardiac Arrest|sudden cardiac arrest
5369122|NCT01861262|StO2 measurement|sto2 measurement
4968003|NCT04189822|Inherited Heart Rhythm Conditions|inherited heart rhythm conditions
4968004|NCT04189822|Cardiogenetics|cardiogenetics
4968006|NCT04189809|Chronic liver diseases|chronic liver diseases
4986383|NCT04076722|Obesity|obesity
4968007|NCT04189809|Interventional Radiology|interventional radiology
4968008|NCT04189809|Surgical|surgical
4968009|NCT04189809|Therapy|therapy
4968010|NCT04189809|resection|resection
4968011|NCT04189796|Cheese intake|cheese intake
4968012|NCT04189796|Vitamin K|vitamin k
4968015|NCT04189744|Trichomonas Vaginitis|trichomonas vaginitis
4968016|NCT04189744|Zambia|zambia
4968017|NCT04189744|Intermittent Preventive Treatment in Pregnancy (IPTp)|intermittent preventive treatment in pregnancy (iptp)
4968018|NCT04189744|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
4968019|NCT04189744|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
4968020|NCT04189744|Metronidazole|metronidazole
4968021|NCT04189744|Sub-Saharan Africa|sub-saharan africa
4968022|NCT04189731|Shoulder surgery|shoulder surgery
4968023|NCT04189731|pain|pain
4968024|NCT04189731|suprascapular block|suprascapular block
4968025|NCT04189718|hounsfield|hounsfield
4968026|NCT04189692|Fatigue;|fatigue;
4968027|NCT04189692|Inflammatory Bowel Diseases|inflammatory bowel diseases
4968028|NCT04189692|Crohn Disease|crohn disease
4968029|NCT04189692|Ulcerative Colitis|ulcerative colitis
4968030|NCT04189679|Metabolomic|metabolomic
4968031|NCT04189679|Microbiota|microbiota
4968032|NCT04189653|Early Warning Scores|early warning scores
4968033|NCT04189653|Continuous Vital Sign Monitoring|continuous vital sign monitoring
4968034|NCT04189653|Escalation of Care|escalation of care
4968035|NCT04189653|ICU-Transfer|icu-transfer
4968036|NCT04189653|Deterioration prevention|deterioration prevention
4968037|NCT04189640|Adductor canal block|adductor canal block
4968038|NCT04189640|Postoperative pain management|postoperative pain management
4968039|NCT04189640|Knee arthroplasty surgery|knee arthroplasty surgery
5290642|NCT02221258|RA|ra
4968040|NCT04189627|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
4968041|NCT04189627|Chronic Hepatitis C (CHC)|chronic hepatitis c (chc)
4968049|NCT04189601|complement|complement
4968050|NCT04189575|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4968051|NCT04189575|ADHD|adhd
4968052|NCT04189575|SMS Intervention|sms intervention
4968053|NCT04189562|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4968054|NCT04189562|ADHD|adhd
4968055|NCT04189562|SMS Intervention|sms intervention
4968056|NCT04189549|Biomarker|biomarker
4968057|NCT04189549|Sepsis|sepsis
4968058|NCT04189536|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
4968059|NCT04189536|ADHD|adhd
4968060|NCT04189536|SMS Intervention|sms intervention
4968061|NCT04189523|Ultrasound|ultrasound
4968062|NCT04189523|Trauma|trauma
4968063|NCT04189523|Bone Fracture|bone fracture
4968064|NCT04189523|Opioid|opioid
4968065|NCT04189510|Diabetes|diabetes
4968066|NCT04189510|Kidney|kidney
4968067|NCT04189510|Transplant|transplant
4968068|NCT04189497|Ischemic Stroke|ischemic stroke
4968069|NCT04189497|Risk stratification|risk stratification
4968070|NCT04189497|Cardiovascular events|cardiovascular events
4968071|NCT04189484|Pharmacokinetics|pharmacokinetics
4968072|NCT04189484|Pharmacodynamics|pharmacodynamics
4968073|NCT04189471|hemorrhage|hemorrhage
4968074|NCT04189471|intracerebral hemorrhage|intracerebral hemorrhage
4968076|NCT04189471|Nontraumatic Haemorrhage|nontraumatic haemorrhage
4968077|NCT04189471|ICH|ich
4968078|NCT04189471|subarachnoid hemorrhage|subarachnoid hemorrhage
4968079|NCT04189458|Older adults|older adults
4968080|NCT04189458|Multimodal exercise program|multimodal exercise program
4968081|NCT04189458|Brain dynamics|brain dynamics
4968082|NCT04189458|Cognitive functioning|cognitive functioning
4968083|NCT04189458|Physical fitness|physical fitness
4968084|NCT04189445|Futibatinib|futibatinib
4968085|NCT04189445|Gastric cancer|gastric cancer
4968379|NCT04187222|Probiotics|probiotics
4968089|NCT04189445|Lymphoid neoplasm|lymphoid neoplasm
4968090|NCT04189445|FGFR|fgfr
4968091|NCT04189445|Amplification|amplification
4968092|NCT04189445|Rearrangement|rearrangement
4968093|NCT04189445|TAS-120|tas-120
4968094|NCT04189406|Minipuberty|minipuberty
4968095|NCT04189406|Turner Syndrome|turner syndrome
4968096|NCT04189406|Infertility|infertility
4968097|NCT04189406|Premature Ovarian Failure|premature ovarian failure
4968098|NCT04189380|Health literacy|health literacy
4968099|NCT04189380|liver transplanted patients|liver transplanted patients
4968100|NCT04189380|cognitive evaluation|cognitive evaluation
4968101|NCT04189380|social status|social status
4965913|NCT04202276|obesity|obesity
4965914|NCT04202276|nutrition|nutrition
4965915|NCT04202276|GERD|gerd
4965924|NCT04202211|FMT|fmt
4968102|NCT04189367|Burning Mouth Syndrome|burning mouth syndrome
4968103|NCT04189367|Traditional Chinese Medicine|traditional chinese medicine
4968104|NCT04189367|Automatic Tongue Diagnosis System|automatic tongue diagnosis system
4968105|NCT04189367|Body Constitution Questionnaire|body constitution questionnaire
4968106|NCT04189341|Modified-thoracolumbar interfascial plane block|modified-thoracolumbar interfascial plane block
4968107|NCT04189341|Erector spina plane block|erector spina plane block
4968108|NCT04189341|Postoperative analgesia management|postoperative analgesia management
4968109|NCT04189341|Lumbar spinal instrumentation surgery|lumbar spinal instrumentation surgery
4968110|NCT04189315|Hypophosphatasia|hypophosphatasia
4968111|NCT04189315|HPP|hpp
4968112|NCT04189315|Pediatric-Onset|pediatric-onset
4968146|NCT04189094|immunotherapy|immunotherapy
4968147|NCT04189094|PD-1 inhibitor|pd-1 inhibitor
4968148|NCT04189094|lung cancer|lung cancer
4968149|NCT04189094|small cell|small cell
4968150|NCT04189094|limited-stage|limited-stage
4968151|NCT04189068|Cerebral Infarction Hyaluronic Acid Embolism|cerebral infarction hyaluronic acid embolism
4968152|NCT04189055|Liver metastasis|liver metastasis
4968153|NCT04189055|KRAS|kras
4968154|NCT04189055|NRAS|nras
4968155|NCT04189003|ORL Cancers|orl cancers
4968156|NCT04189003|HPV+ tumor|hpv+ tumor
4968157|NCT04189003|molecular signature|molecular signature
4968158|NCT04189003|human papillomavirus|human papillomavirus
4968159|NCT04188990|disease-related malnutrition|disease-related malnutrition
4968160|NCT04188990|effectiveness|effectiveness
4968161|NCT04188990|cost effectiveness|cost effectiveness
4968162|NCT04188977|Implementation Facilitation|implementation facilitation
4968163|NCT04188977|Interim methadone treatment|interim methadone treatment
4968164|NCT04188977|Opioid Treatment Program|opioid treatment program
4968165|NCT04188951|Recurrent Head and Neck Cancer|recurrent head and neck cancer
4968166|NCT04188951|Recurrent Head and Neck Neoplasms|recurrent head and neck neoplasms
4968167|NCT04188938|Trauma|trauma
4968168|NCT04188938|Thorax|thorax
4968169|NCT04188938|Emergency|emergency
4968170|NCT04188938|Pneumothorax|pneumothorax
4968171|NCT04188925|Electroacupuncture|electroacupuncture
4968172|NCT04188925|Laser acupuncture|laser acupuncture
4968173|NCT04188925|Low-level laser therapy|low-level laser therapy
4968174|NCT04188925|Photobiomodulation|photobiomodulation
4968175|NCT04188925|Complementary medicine|complementary medicine
4968176|NCT04188834|Sensory Flicker Stimulation|sensory flicker stimulation
4968177|NCT04188834|Electrical Flicker Stimulation|electrical flicker stimulation
4968178|NCT04188834|Neurophysiological Effects|neurophysiological effects
4968179|NCT04188834|Behavioral Effects|behavioral effects
4968677|NCT04185389|cytology|cytology
4968182|NCT04188808|Open vascular surgery|open vascular surgery
4968183|NCT04188808|Vascular disease|vascular disease
4968184|NCT04188795|Care protocol|care protocol
4968185|NCT04188795|Delirium|delirium
4968186|NCT04188795|Nursing care|nursing care
4968187|NCT04188795|Hip fracture|hip fracture
4968188|NCT04188782|Anesthesia|anesthesia
4968189|NCT04188782|Electroencephalogram|electroencephalogram
4968190|NCT04188782|Spectral analysis|spectral analysis
4968191|NCT04188743|Fecal Microbiota Transplantation|fecal microbiota transplantation
4968192|NCT04188743|Hospitals, Isolation|hospitals, isolation
4968193|NCT04188743|Drug Resistance, Multiple, Bacterial|drug resistance, multiple, bacterial
4968194|NCT04188743|Gram-Negative Bacteria|gram-negative bacteria
4968195|NCT04188743|Gastrointestinal Microbiome|gastrointestinal microbiome
4968196|NCT04188717|liver transplantation|liver transplantation
4968197|NCT04188717|neurological complications|neurological complications
4968198|NCT04188717|postoperative complications|postoperative complications
4968200|NCT04188704|screw fixation|screw fixation
4968201|NCT04188704|graft inclination|graft inclination
4968202|NCT04188704|reconstruction|reconstruction
4986584|NCT04075630|oxytocin|oxytocin
4968208|NCT04188665|podoplanin|podoplanin
4968209|NCT04188665|pdpn|pdpn
4968210|NCT04188665|lectin|lectin
4968211|NCT04188665|oral squamous cell carcinoma|oral squamous cell carcinoma
4968215|NCT04188639|acquired Hemophilia A|acquired hemophilia a
4968216|NCT04188639|Factor VIII activity|factor viii activity
4966016|NCT04201769|lung cancer|lung cancer
4966017|NCT04201769|DEX-Sparing|dex-sparing
4966018|NCT04201743|Osteoarthritis|osteoarthritis
4966020|NCT04201743|Amniotic membrane|amniotic membrane
4966021|NCT04201743|Allograft|allograft
4966022|NCT04201717|total laparoscopic|total laparoscopic
4966023|NCT04201717|laparoscopic assisted|laparoscopic assisted
4966024|NCT04201704|Fluid Therapy|fluid therapy
4968236|NCT04188470|deprescriptions|deprescriptions
4968237|NCT04188470|patient-centered care|patient-centered care
4968238|NCT04188470|frail elderly|frail elderly
4968239|NCT04188470|interprofessional relations|interprofessional relations
4968240|NCT04188470|decision making|decision making
4968241|NCT04188444|Ovarian stimulation|ovarian stimulation
4968242|NCT04188444|thrombin generation|thrombin generation
4968243|NCT04188444|haemostasis|haemostasis
4968244|NCT04188444|thrombosis|thrombosis
4968245|NCT04188431|reintervention|reintervention
4968246|NCT04188431|children|children
4968249|NCT04188366|Coordinated Speciality Care|coordinated speciality care
4968250|NCT04188366|Family Engagement|family engagement
4968251|NCT04188366|First Episode Psychosis|first episode psychosis
4968252|NCT04188353|ONSD|onsd
4968253|NCT04188353|Mannitol|mannitol
4968255|NCT04188340|Su-Man formula massage oil|su-man formula massage oil
4968256|NCT04188340|Acupressure|acupressure
5295091|NCT02200887|Slow Wave Sleep|slow wave sleep
4968257|NCT04188340|Meridian energy|meridian energy
4968258|NCT04188340|Insomnia|insomnia
4968259|NCT04188327|Herpes Zoster|herpes zoster
4968260|NCT04188327|Stellate ganglion|stellate ganglion
4968261|NCT04188327|Post-herpetic neuralgia|post-herpetic neuralgia
4968262|NCT04188314|Anesthesia: General|anesthesia: general
4968263|NCT04188314|Outcome|outcome
4968264|NCT04188314|Quality of Recovery Score|quality of recovery score
4968265|NCT04188314|Anesthetics: Volatile|anesthetics: volatile
4968266|NCT04188314|Desflurane|desflurane
4968267|NCT04188314|Isoflurane|isoflurane
4968268|NCT04188301|ophthalmology|ophthalmology
4968269|NCT04188275|Prostate Cancer|prostate cancer
4968270|NCT04188275|Metastatic Castration-Resistant|metastatic castration-resistant
4968271|NCT04188275|Biomarker Tumor|biomarker tumor
4968272|NCT04188223|vaccine|vaccine
4968273|NCT04188223|hepatitis b|hepatitis b
4968274|NCT04188223|infection|infection
4968275|NCT04188223|virus|virus
4968276|NCT04188210|musculoskeletal pain|musculoskeletal pain
4968277|NCT04188210|elbow pain|elbow pain
4968278|NCT04188210|hemodialysis|hemodialysis
4968283|NCT04188093|Postoperative Care Unit|postoperative care unit
4968284|NCT04188093|Continous monitoring|continous monitoring
4968285|NCT04188093|PACU discharge criteria|pacu discharge criteria
4968286|NCT04188080|Jarlsberg cheese|jarlsberg cheese
4968287|NCT04188041|Project ECHO|project echo
4968288|NCT04188041|primary care|primary care
4968290|NCT04187976|Eosinophil|eosinophil
4968291|NCT04187976|asthma|asthma
4968292|NCT04187976|chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
4968293|NCT04187976|biotherapy|biotherapy
4968294|NCT04187976|endotype|endotype
5342903|NCT01981564|Emergency department visit|emergency department visit
5010706|NCT03929705|TB|tb
4968295|NCT04187950|gastrointestinal transit time, mood, emotion|gastrointestinal transit time, mood, emotion
4968298|NCT04187911|Feasibility|feasibility
4968299|NCT04187911|Randomised|randomised
4968300|NCT04187911|Optimisation|optimisation
4968301|NCT04187911|Partnerships|partnerships
4968302|NCT04187911|Cost effectiveness|cost effectiveness
4968303|NCT04187911|Clinical effectiveness|clinical effectiveness
4968304|NCT04187898|Neutropenia|neutropenia
4968340|NCT04187534|Albumin|albumin
4968341|NCT04187534|fluid resuscitation|fluid resuscitation
4968342|NCT04187534|de-adoption|de-adoption
4968343|NCT04187534|de-implementation|de-implementation
4968344|NCT04187534|low-value care|low-value care
4968345|NCT04187521|gestational diabetes|gestational diabetes
4968346|NCT04187521|pregnancy|pregnancy
4968347|NCT04187521|diet|diet
4968348|NCT04187521|nutrition|nutrition
4968349|NCT04187508|Allergen-induced inflammation|allergen-induced inflammation
4968351|NCT04187469|Pulmonary Tuberculosis|pulmonary tuberculosis
4968352|NCT04187469|Anti-tuberculosis therapy|anti-tuberculosis therapy
4968353|NCT04187469|Intensive phase|intensive phase
4968354|NCT04187469|Moxifloxacin|moxifloxacin
4968355|NCT04187469|initial regimen|initial regimen
4968356|NCT04187456|Pharmacokinetics|pharmacokinetics
4968357|NCT04187456|Safety|safety
4968358|NCT04187456|Small molecule kinase inhibitor|small molecule kinase inhibitor
4968359|NCT04187456|Open-label|open-label
4968360|NCT04187443|Diabetic Macular Edema|diabetic macular edema
4968361|NCT04187443|Macular Edema|macular edema
4968362|NCT04187443|Center-involved Diabetic Macular Edema|center-involved diabetic macular edema
4968363|NCT04187443|Center-involved DME|center-involved dme
4968365|NCT04187443|Diabetic Retinopathy|diabetic retinopathy
4968366|NCT04187404|adrenocortical carcinoma|adrenocortical carcinoma
4968367|NCT04187404|pheochromocytoma|pheochromocytoma
4968368|NCT04187404|paraganglioma|paraganglioma
4968369|NCT04187378|Hypothermia|hypothermia
4968370|NCT04187378|Surgical Wound Infection|surgical wound infection
4968371|NCT04187378|Herniorrhaphy|herniorrhaphy
4968372|NCT04187378|Nursing care|nursing care
4968373|NCT04187326|visual processing|visual processing
4968374|NCT04187313|Tuberculosis|tuberculosis
4968375|NCT04187313|Public-Private Sector Partnership|public-private sector partnership
4968376|NCT04187313|Mobile Applications|mobile applications
4968377|NCT04187222|Dental implants|dental implants
4968395|NCT04187170|Right ventricle|right ventricle
4968396|NCT04187170|cardiac physiology|cardiac physiology
4968397|NCT04187170|strength training|strength training
4968398|NCT04187170|echocardiography|echocardiography
4968399|NCT04187157|circadian|circadian
4968400|NCT04187157|cataracts|cataracts
4968401|NCT04187157|blue light|blue light
4968402|NCT04187157|survival|survival
4968403|NCT04187144|Acute cystitis|acute cystitis
4968404|NCT04187144|Gepotidacin|gepotidacin
4968405|NCT04187144|Nitrofurantoin|nitrofurantoin
4968419|NCT04187053|Low level laser therapy|low level laser therapy
4968420|NCT04187053|Peri-implant mucositis|peri-implant mucositis
4968421|NCT04187053|Peri-implantitis|peri-implantitis
4968422|NCT04187040|WHO-guideline on hand hygiene in healthcare|who-guideline on hand hygiene in healthcare
4968423|NCT04187040|3-step hand hygiene technique|3-step hand hygiene technique
4968424|NCT04187040|6-step hand hygiene technique|6-step hand hygiene technique
4968425|NCT04187027|Myelomeningocele|myelomeningocele
4968426|NCT04187027|Pulsed electromagnetic field therapy|pulsed electromagnetic field therapy
4968431|NCT04187001|smartphone|smartphone
4968432|NCT04187001|exercise|exercise
4968433|NCT04186975|FETAL MONITORING, CARDIOTOCOGRAPHY|fetal monitoring, cardiotocography
4968434|NCT04186949|birth cohort|birth cohort
4968435|NCT04186949|Chile|chile
4968436|NCT04186910|Multiple Sclerosis|multiple sclerosis
4968437|NCT04186910|Physical activity|physical activity
4968438|NCT04186910|Mobility|mobility
4968439|NCT04186910|Self efficacy|self efficacy
4968448|NCT04186793|Pediatrics|pediatrics
4968449|NCT04186793|Obesity|obesity
4968450|NCT04186793|Liver Disease|liver disease
4968451|NCT04186780|Lentinula edodes|lentinula edodes
4968452|NCT04186780|Clinical study|clinical study
4968453|NCT04186780|Cholesterolemia|cholesterolemia
4968454|NCT04186780|Nutraceuticals|nutraceuticals
4968455|NCT04186754|Occupational Therapy|occupational therapy
4968456|NCT04186754|Cancer|cancer
4968457|NCT04186754|Dyspnea|dyspnea
4968458|NCT04186728|athlete|athlete
4968459|NCT04186728|premature ventricular contraction|premature ventricular contraction
4968460|NCT04186728|premature atrial contraction|premature atrial contraction
4968461|NCT04186728|ectopic heartbeat|ectopic heartbeat
4968462|NCT04186728|palpitation|palpitation
4968463|NCT04186715|TOETVA|toetva
4968464|NCT04186715|Thyroidectomy|thyroidectomy
4968465|NCT04186715|near-infrared spectroscopy|near-infrared spectroscopy
4968466|NCT04186702|macula-injection- laser- ranibizumab-edema-thickness|macula-injection- laser- ranibizumab-edema-thickness
4968467|NCT04186676|MINOCA|minoca
4968468|NCT04186676|Myocardial Infarction|myocardial infarction
4968469|NCT04186676|Cardiac Computed Tomography Angiography|cardiac computed tomography angiography
4968470|NCT04186676|Angina|angina
4968471|NCT04186676|Leiden CTA risk score|leiden cta risk score
4968472|NCT04186676|Indexed Coronary Volume|indexed coronary volume
4968473|NCT04186663|child|child
4968474|NCT04186663|pharmacokinetics|pharmacokinetics
4968475|NCT04186663|silver diamine fluoride|silver diamine fluoride
4968476|NCT04186650|Genetic Therapy|genetic therapy
4968477|NCT04186650|Autologous Skin Graft|autologous skin graft
4968480|NCT04186650|COL7A1|col7a1
4968481|NCT04186624|Subacromial Impingement Syndrome|subacromial impingement syndrome
4968482|NCT04186624|Subacromial-subdeltoid bursa corticosteroid injection|subacromial-subdeltoid bursa corticosteroid injection
4968483|NCT04186624|Exercise Therapy|exercise therapy
4968484|NCT04186585|BP-C2|bp-c2
4968485|NCT04186585|Dose respons|dose respons
4968486|NCT04186585|Prostate Cancer|prostate cancer
4968487|NCT04186585|Hormon terapy|hormon terapy
4968488|NCT04186572|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
4968489|NCT04186572|Liver Failure|liver failure
4968490|NCT04186546|emphysema|emphysema
4968491|NCT04186546|endobronchial valve|endobronchial valve
4968492|NCT04186546|treatments|treatments
4968493|NCT04186546|pulmonary rehabilitation|pulmonary rehabilitation
4968494|NCT04186546|lung volume reduction|lung volume reduction
4968495|NCT04186533|food insecurity|food insecurity
4968496|NCT04186533|nutrition|nutrition
4968497|NCT04186533|obesity|obesity
4968498|NCT04186533|default option|default option
4968499|NCT04186533|online grocery shopping|online grocery shopping
4968500|NCT04186507|Lithium|lithium
4968501|NCT04186507|Biosensor|biosensor
4968502|NCT04186507|Sweat|sweat
4968503|NCT04186507|Major Depressive Disorder|major depressive disorder
4968504|NCT04186507|Schizoaffective Disorder|schizoaffective disorder
4968505|NCT04186507|Bipolar Mood Disorder|bipolar mood disorder
4968506|NCT04186507|Schizophrenia|schizophrenia
4968507|NCT04186494|Liraglutide|liraglutide
4968514|NCT04186468|Post Intensive Care Syndrome|post intensive care syndrome
4968515|NCT04186468|Follow-up clinic|follow-up clinic
4968516|NCT04186468|Intensive care unit-acquired weakness|intensive care unit-acquired weakness
4968517|NCT04186468|Critical illness polyneuropathy|critical illness polyneuropathy
4968518|NCT04186468|Health-related quality of life|health-related quality of life
4968519|NCT04186468|Critical care|critical care
4968520|NCT04186468|Muscle weakness|muscle weakness
5010935|NCT03928158|HF|hf
4968524|NCT04186429|traumatic brain injury|traumatic brain injury
4968525|NCT04186429|rehabilitation|rehabilitation
4968526|NCT04186429|neuropsychology|neuropsychology
4968530|NCT04186429|brain-derived neurotrophic factor|brain-derived neurotrophic factor
4968532|NCT04186429|neurobehavioral outcomes|neurobehavioral outcomes
4968533|NCT04186429|children|children
4968534|NCT04186429|childhood adversity|childhood adversity
4968535|NCT04186429|biomarkers|biomarkers
4968536|NCT04186416|Vascular filling in children|vascular filling in children
4968537|NCT04186416|Mostcare® device|mostcare® device
4968538|NCT04186416|Cardiac output|cardiac output
4968539|NCT04186416|Stroke volume|stroke volume
4968540|NCT04186416|Transthoracic cardiac echocardiography|transthoracic cardiac echocardiography
4968541|NCT04186364|Austism|austism
4968542|NCT04186364|Ambassador|ambassador
4968543|NCT04186351|automated notification service|automated notification service
4968544|NCT04186351|community healthcare providers|community healthcare providers
4968545|NCT04186351|randomized controlled trial|randomized controlled trial
4968546|NCT04186338|Activity energy expenditure|activity energy expenditure
4968547|NCT04186338|Moderate to vigorous physical activity|moderate to vigorous physical activity
4968548|NCT04186338|Myelomeningocele|myelomeningocele
4968549|NCT04186260|obesity|obesity
4968550|NCT04186260|overweight|overweight
4968551|NCT04186260|Mexican|mexican
4968552|NCT04186260|Mexican-American|mexican-american
4968553|NCT04186260|men|men
4968554|NCT04186260|weight loss|weight loss
4968555|NCT04186247|Microbiome|microbiome
4968556|NCT04186234|Liver cancer|liver cancer
4968557|NCT04186234|Stereotactic body radiation therapy|stereotactic body radiation therapy
4968558|NCT04186234|Bridging therapy|bridging therapy
4968559|NCT04186234|Liver transplantation|liver transplantation
4968560|NCT04186208|cartilage defect|cartilage defect
4968561|NCT04186208|knee|knee
4968562|NCT04186208|pediatric patients|pediatric patients
4968563|NCT04186195|Glycemic control|glycemic control
4968564|NCT04186195|Children|children
4968565|NCT04186195|Psychosocial and socioeconomic factors|psychosocial and socioeconomic factors
4968566|NCT04186182|Rehabilitation|rehabilitation
4968567|NCT04186117|colon cancer|colon cancer
4968568|NCT04186117|circulating tumoral cells|circulating tumoral cells
4968569|NCT04186104|Artificial Intelligence|artificial intelligence
4968570|NCT04186104|Outpatient|outpatient
4968571|NCT04186104|process improvement|process improvement
4968572|NCT04186065|white spot|white spot
4968573|NCT04186065|lesions|lesions
4968574|NCT04186065|tooth|tooth
4968575|NCT04186039|Functional magnetic resonance imaging|functional magnetic resonance imaging
4968578|NCT04186039|Omphalocele|omphalocele
4968579|NCT04186039|Gastroschisis|gastroschisis
4968580|NCT04186039|Fetal lung|fetal lung
4968581|NCT04186039|Respiratory failure|respiratory failure
4968582|NCT04186026|Neurotensin|neurotensin
4968583|NCT04186026|Glucagon like peptide-1 (GLP-1)|glucagon like peptide-1 (glp-1)
4968584|NCT04186000|Ad26.ZEBOV|ad26.zebov
4968585|NCT04186000|MVA-BN-Filo|mva-bn-filo
4968586|NCT04186000|DRC|drc
4968587|NCT04186000|health care providers|health care providers
4968588|NCT04185987|bacterial adhesion|bacterial adhesion
4968589|NCT04185987|elastomeric ligatures|elastomeric ligatures
4968590|NCT04185922|Prostate cancer|prostate cancer
4968591|NCT04185922|Hemopatch|hemopatch
4968592|NCT04185896|Social stigma|social stigma
4968593|NCT04185896|Access to care|access to care
4968594|NCT04185896|Facilitators|facilitators
4968595|NCT04185896|Barriers|barriers
4968596|NCT04185857|renin|renin
4968597|NCT04185857|aldosterone|aldosterone
4968598|NCT04185857|aldosterone to renin ratio|aldosterone to renin ratio
4968599|NCT04185831|mutation status|mutation status
4968600|NCT04185831|mutational burden|mutational burden
4968601|NCT04185831|molecular profiling|molecular profiling
4968602|NCT04185831|precision medicine|precision medicine
4968603|NCT04185818|sleep, book, read, bed|sleep, book, read, bed
4968604|NCT04185766|Prevention|prevention
4968605|NCT04185766|newborn|newborn
4968606|NCT04185766|oral destrogel|oral destrogel
4968607|NCT04185766|hypoglycaemia|hypoglycaemia
4968608|NCT04185727|feeding and eating disorders|feeding and eating disorders
4968609|NCT04185727|training|training
4968611|NCT04185727|muscle strength|muscle strength
4968612|NCT04185727|anorexia nervosa|anorexia nervosa
4968613|NCT04185727|bone health|bone health
4968614|NCT04185727|psychopathology|psychopathology
4968615|NCT04185727|pathophysiology|pathophysiology
4968616|NCT04185727|intervention|intervention
4968617|NCT04185727|prospective|prospective
4968618|NCT04185714|Episodic Migraine|episodic migraine
4968619|NCT04185714|Kinesiotape|kinesiotape
4968620|NCT04185714|Pain|pain
4968621|NCT04185714|Physiotherapy|physiotherapy
4968622|NCT04185714|Disability|disability
4968623|NCT04185714|Pressure Pain Threshold|pressure pain threshold
4968624|NCT04185714|Quality of Life|quality of life
4968625|NCT04185701|automatic sphere measurements|automatic sphere measurements
4968626|NCT04185701|eye examination|eye examination
4968631|NCT04185688|Validity|validity
4968632|NCT04185675|Visual laryngoscope|visual laryngoscope
4968633|NCT04185675|Direct laryngoscope|direct laryngoscope
4968634|NCT04185675|Tracheal intubation time|tracheal intubation time
4968635|NCT04185662|artificial sweetners|artificial sweetners
4968636|NCT04185662|glucose metabolism|glucose metabolism
4968637|NCT04185662|type 2 diabetic patients|type 2 diabetic patients
4968638|NCT04185636|Bacterial fluorescence|bacterial fluorescence
4968639|NCT04185623|denudation timing ICSI timing oocyte aging|denudation timing icsi timing oocyte aging
4968640|NCT04185610|Qi Gong|qi gong
4968641|NCT04185597|Bangladesh|bangladesh
4968642|NCT04185597|Nutrition|nutrition
4968643|NCT04185597|Multi-sectoral|multi-sectoral
4968644|NCT04185597|Randomized|randomized
4968645|NCT04185597|Household food production|household food production
4968646|NCT04185584|SCM-AGH|scm-agh
4968647|NCT04185584|Atopic Dermatitis|atopic dermatitis
4968648|NCT04185584|Stem cell therapy|stem cell therapy
4968652|NCT04185506|emotional eating|emotional eating
4968653|NCT04185506|Dialectical Behavioral Therapy|dialectical behavioral therapy
4968654|NCT04185493|Geometry|geometry
4968655|NCT04185493|Bifurcation Angle|bifurcation angle
4968656|NCT04185493|Cardiac Computed Tomography Angiography|cardiac computed tomography angiography
4968657|NCT04185493|Coronary Artery Disease|coronary artery disease
4966478|NCT04199143|Treatment Resistant Depression|treatment resistant depression
4966479|NCT04199143|Nitrous Oxyde|nitrous oxyde
4966489|NCT04199065|Evidence-Based Practice|evidence-based practice
4968658|NCT04185493|Vulnerable Coronary Plaque|vulnerable coronary plaque
4968659|NCT04185493|Indexed Coronary Volume|indexed coronary volume
4968660|NCT04185493|Risk Assessment|risk assessment
4968661|NCT04185467|lung cancer|lung cancer
4968662|NCT04185467|exercise|exercise
4968663|NCT04185467|rehabilitation|rehabilitation
4968664|NCT04185467|Tai Chi|tai chi
4968665|NCT04185467|health-related quality of life|health-related quality of life
4968666|NCT04185454|Healthy women|healthy women
4968667|NCT04185454|Dose respons|dose respons
4968668|NCT04185454|Jarlsberg cheese|jarlsberg cheese
4968669|NCT04185454|Osteocalcin|osteocalcin
4968670|NCT04185441|Erectile Dysfunction|erectile dysfunction
4968671|NCT04185441|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4968672|NCT04185415|Progressive Supranuclear Palsy|progressive supranuclear palsy
4968673|NCT04185415|UCB0107|ucb0107
4968674|NCT04185415|Phase 1 study|phase 1 study
4968675|NCT04185415|PSP|psp
4968676|NCT04185389|hpv testing|hpv testing
4968684|NCT04185363|PFIC2|pfic2
4968685|NCT04185363|Bile Duct Diseases|bile duct diseases
4968686|NCT04185363|Liver Diseases|liver diseases
4968687|NCT04185363|Biliary Tract Diseases|biliary tract diseases
4968688|NCT04185363|Digestive System Diseases|digestive system diseases
4968689|NCT04185363|Pediatric|pediatric
4968690|NCT04185285|PCI|pci
4968691|NCT04185246|Echo, Echocardiogram, Cardiac ultrasound|echo, echocardiogram, cardiac ultrasound
4968692|NCT04185246|suboptimal|suboptimal
4968693|NCT04185246|contrast agent, enhancing agent|contrast agent, enhancing agent
4968694|NCT04185246|LVO, LVEBD|lvo, lvebd
4968695|NCT04185233|nitrous oxide|nitrous oxide
4968696|NCT04185233|distraction|distraction
4968700|NCT04185207|Mental health|mental health
4968701|NCT04185207|Socioeconomic status|socioeconomic status
4968702|NCT04185194|myofascial pain syndrome, pain quality|myofascial pain syndrome, pain quality
4968703|NCT04185142|Combined procedure|combined procedure
4968704|NCT04185142|Cryoballoon ablation|cryoballoon ablation
4968705|NCT04185142|Left atrial appendage closure|left atrial appendage closure
4968706|NCT04185142|Chinese|chinese
4968707|NCT04185116|3D optic systems|3d optic systems
4968708|NCT04185116|Fatigue|fatigue
4968709|NCT04185116|Length of surgery|length of surgery
4968710|NCT04185116|3D laparoscopy|3d laparoscopy
4968711|NCT04185116|Intraoperative complications|intraoperative complications
4968712|NCT04185116|Bariatric and metabolic surgery|bariatric and metabolic surgery
4968713|NCT04185103|Heart Failure|heart failure
4968714|NCT04185103|Sacubitril-Valsartan|sacubitril-valsartan
4968715|NCT04185103|T-wave changes alternans|t-wave changes alternans
4968716|NCT04185077|STEMI|stemi
4968717|NCT04185077|late PCI|late pci
4968718|NCT04185077|Bivalirudin|bivalirudin
4968719|NCT04185077|anticoagulation|anticoagulation
4968721|NCT04185012|Benralizumab|benralizumab
4968732|NCT04184934|Predictors|predictors
4968733|NCT04184908|dry mouth|dry mouth
4968734|NCT04184895|Tolerability|tolerability
4968757|NCT04184791|Wearable Sensors|wearable sensors
4968758|NCT04184778|postoperative|postoperative
4968759|NCT04184778|Tube size|tube size
4968760|NCT04184778|Patient experience|patient experience
4968761|NCT04184765|hysterectomies|hysterectomies
4968762|NCT04184765|inflammation mediators|inflammation mediators
4968763|NCT04184765|lymphocyte|lymphocyte
4968764|NCT04184752|Bladder outlet obstruction|bladder outlet obstruction
4968765|NCT04184752|Detrusor underactivity|detrusor underactivity
4968766|NCT04184752|Voiding dysfunction|voiding dysfunction
4968767|NCT04184726|Mindfulness|mindfulness
4968768|NCT04184726|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
4968769|NCT04184713|malnutrition|malnutrition
4968770|NCT04184713|cancer|cancer
4968771|NCT04184713|nutrition|nutrition
4968772|NCT04184713|nutritional oral supplement|nutritional oral supplement
4968773|NCT04184713|clinical trial|clinical trial
4968774|NCT04184674|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4968775|NCT04184674|Mechanical ventilation|mechanical ventilation
4968973|NCT04183504|Parenting|parenting
4968784|NCT04184635|VA-ECMO|va-ecmo
4968785|NCT04184635|STEMI|stemi
4968786|NCT04184635|NSTEMI|nstemi
4968787|NCT04184635|Intraortic balloon pump|intraortic balloon pump
4968790|NCT04184609|Pediatric|pediatric
4968791|NCT04184609|Asthma|asthma
4968792|NCT04184609|Ventilatory limitations|ventilatory limitations
4968793|NCT04184609|Exercise|exercise
4968794|NCT04184596|Discrete Choice Experiment|discrete choice experiment
4968801|NCT04184531|Sensenbrenner Syndrome|sensenbrenner syndrome
4968802|NCT04184531|phenotypic analysis|phenotypic analysis
4968803|NCT04184531|craniofacial characteristics|craniofacial characteristics
4968804|NCT04184518|uveal melanoma|uveal melanoma
4968805|NCT04184518|cediranib|cediranib
4968806|NCT04184518|durvalumab|durvalumab
4968807|NCT04184518|liver metastasis|liver metastasis
4968808|NCT04184505|MDS|mds
4968809|NCT04184505|Transplant|transplant
4968810|NCT04184505|Azacitidine|azacitidine
4968811|NCT04184492|Pharmacokinetics|pharmacokinetics
4968812|NCT04184492|Pharmacodynamics|pharmacodynamics
4968813|NCT04184492|Biphasic Insulin Aspart|biphasic insulin aspart
4968814|NCT04184479|overweight|overweight
4968815|NCT04184479|randomized controlled trial|randomized controlled trial
4968816|NCT04184479|obesity|obesity
4968817|NCT04184479|weight loss|weight loss
4968818|NCT04184479|weight loss maintenance|weight loss maintenance
4968819|NCT04184466|Pharmacokinetics|pharmacokinetics
4968820|NCT04184466|Pharmacodynamics|pharmacodynamics
4968821|NCT04184466|Insulin Aspart|insulin aspart
4968822|NCT04184453|Aceruloplasminemia|aceruloplasminemia
4968823|NCT04184453|Deferiprone|deferiprone
4968824|NCT04184453|Pancreas MRI|pancreas mri
4968825|NCT04184440|Cyclocarya paliurus extract|cyclocarya paliurus extract
4968826|NCT04184440|hyperglycemia|hyperglycemia
4968827|NCT04184440|pre-diabetes and diabetes|pre-diabetes and diabetes
4968828|NCT04184401|Ascites|ascites
4968829|NCT04184401|Albumin|albumin
4968830|NCT04184401|Hartmann's solution|hartmann's solution
4968831|NCT04184401|Postoperative ilues|postoperative ilues
4968832|NCT04184388|Hydrolysed Red Ginseng Extract|hydrolysed red ginseng extract
4968833|NCT04184388|Cognitive Function|cognitive function
4968834|NCT04184349|pacemaker|pacemaker
4968835|NCT04184349|AICDS|aicds
4968836|NCT04184349|regional anesthesia|regional anesthesia
4968837|NCT04184323|endometriosis|endometriosis
4968838|NCT04184323|SIRT1|sirt1
4968839|NCT04184323|Progesterone resistance|progesterone resistance
4968841|NCT04184271|adult|adult
4968842|NCT04184271|fluoride|fluoride
4968843|NCT04184271|silver|silver
4968844|NCT04184271|silver diamine fluoride|silver diamine fluoride
4968845|NCT04184271|pharmacokinetics|pharmacokinetics
4968846|NCT04184258|Systemic Lupus Erythematosus|systemic lupus erythematosus
4968847|NCT04184258|mesenchymal stem cells|mesenchymal stem cells
4968848|NCT04184245|preterm infants|preterm infants
4968849|NCT04184245|hypoxic episodes|hypoxic episodes
4968852|NCT04184245|cardiac output|cardiac output
4968853|NCT04184245|cerebral oxygenation|cerebral oxygenation
4968854|NCT04184245|bradycardia|bradycardia
4968855|NCT04184245|cardiorespiratory events|cardiorespiratory events
4968856|NCT04184232|Bladder Cancer|bladder cancer
4968857|NCT04184232|Dendritic cells|dendritic cells
4968867|NCT04184180|frailty|frailty
4968868|NCT04184180|lung diseases|lung diseases
4968869|NCT04184180|respiratory tract diseases|respiratory tract diseases
4968870|NCT04184154|cervical and endometrial cancer|cervical and endometrial cancer
4968871|NCT04184154|brachytherapy|brachytherapy
4968872|NCT04184154|patient education program|patient education program
4968873|NCT04184154|sexual quality of life|sexual quality of life
4968874|NCT04184154|vaginal stenosis|vaginal stenosis
4968875|NCT04184154|patient-reported outcomes|patient-reported outcomes
4968876|NCT04184128|Bladder outlet obstruction|bladder outlet obstruction
4968877|NCT04184128|Detrusor underactivity|detrusor underactivity
4968878|NCT04184128|Cystocele|cystocele
4968879|NCT04184102|mastectomy|mastectomy
4968880|NCT04184102|education|education
4968881|NCT04184102|exercise|exercise
4968882|NCT04184076|fasting|fasting
4968883|NCT04184076|safety|safety
4968884|NCT04184076|compliance|compliance
4968885|NCT04184076|ischemic stroke|ischemic stroke
4968886|NCT04184076|time restricted feeding|time restricted feeding
4968887|NCT04184037|Mindfulness meditation|mindfulness meditation
4968888|NCT04184037|stress reduction|stress reduction
4968889|NCT04184037|mobile application|mobile application
4968890|NCT04184024|neck pain, massage, kinesio tape,|neck pain, massage, kinesio tape,
4968891|NCT04184011|Superficial Radiation Therapy|superficial radiation therapy
4968892|NCT04183972|peripheral nerve block|peripheral nerve block
4968893|NCT04183972|ultrasound image|ultrasound image
4968894|NCT04183972|deep neural network|deep neural network
4968895|NCT04183972|brachial plexus|brachial plexus
4968896|NCT04183946|generalized anxiety disorder|generalized anxiety disorder
4968897|NCT04183946|depression|depression
4968898|NCT04183946|cognitive behavioral therapy|cognitive behavioral therapy
4968899|NCT04183946|web-based cognitive behavioural therapy|web-based cognitive behavioural therapy
4968900|NCT04183946|web-based CBT|web-based cbt
4968901|NCT04183946|pregnancy|pregnancy
4968902|NCT04183946|prenatal depression|prenatal depression
4968903|NCT04183946|prenatal anxiety|prenatal anxiety
4968904|NCT04183946|postpartum anxiety|postpartum anxiety
4968905|NCT04183946|postpartum depression|postpartum depression
4968906|NCT04183894|eating disorder|eating disorder
4968907|NCT04183894|network analysis|network analysis
4968908|NCT04183894|personalized treatment|personalized treatment
4968909|NCT04183894|mobile app|mobile app
4968910|NCT04183868|Empagliflozin|empagliflozin
4968911|NCT04183868|Type 2 diabetes|type 2 diabetes
4968912|NCT04183868|Myocardial glucose uptake|myocardial glucose uptake
4968913|NCT04183868|Cardiovascular risk|cardiovascular risk
4968914|NCT04183816|Total cold-water immersion|total cold-water immersion
4968915|NCT04183816|ice massage|ice massage
5295650|NCT02198105|PAD|pad
4968916|NCT04183816|muscle damage|muscle damage
4968917|NCT04183816|delayed onset of muscle soreness|delayed onset of muscle soreness
4968918|NCT04183803|anterior cruciate ligament|anterior cruciate ligament
4968919|NCT04183803|reconstruction|reconstruction
4968920|NCT04183803|robot|robot
4968921|NCT04183803|tunnel|tunnel
4968922|NCT04183777|first dental visit|first dental visit
4968923|NCT04183777|oral health|oral health
4968924|NCT04183777|reasons of first dental visit|reasons of first dental visit
4968925|NCT04183777|dental treatment needs|dental treatment needs
4968926|NCT04183764|advanced solid tumors|advanced solid tumors
4968927|NCT04183751|Multiple Sclerosis|multiple sclerosis
4968928|NCT04183751|Kinesiophobia|kinesiophobia
4968929|NCT04183751|Balance|balance
4968930|NCT04183738|HIV|hiv
4968931|NCT04183738|IL-6|il-6
4968932|NCT04183738|EBV|ebv
4968933|NCT04183738|CMV|cmv
4968934|NCT04183738|HHV8|hhv8
4968935|NCT04183738|HPV|hpv
4968936|NCT04183738|inflammation|inflammation
4968937|NCT04183738|co-infections|co-infections
4968938|NCT04183738|opportunistic infections|opportunistic infections
4968939|NCT04183738|AIDS and non-AIDS defining cancers|aids and non-aids defining cancers
4968940|NCT04183725|Reduning injection|reduning injection
4968941|NCT04183725|efficacy and safety|efficacy and safety
4968942|NCT04183725|time of temperature recovery|time of temperature recovery
4968946|NCT04183725|multi-center clinical study|multi-center clinical study
4968947|NCT04183673|Laser Therapy|laser therapy
4968948|NCT04183673|Cryotherapy|cryotherapy
4968949|NCT04183673|Thermotherapy|thermotherapy
4968950|NCT04183673|Rehabilitation|rehabilitation
4968951|NCT04183673|knee replacement|knee replacement
4968952|NCT04183647|local vibration, whole body vibration, postural control|local vibration, whole body vibration, postural control
4968953|NCT04183634|adhesiveness|adhesiveness
4968954|NCT04183621|deglutition|deglutition
4968958|NCT04183595|NBMI|nbmi
4968959|NCT04183582|Psychoeducation, Mental Health, Depression, Postnatal|psychoeducation, mental health, depression, postnatal
4968960|NCT04183569|Proteomic|proteomic
4968961|NCT04183569|Mutations|mutations
4968962|NCT04183569|Predictive marker|predictive marker
4968963|NCT04183569|Rituximab-polychemotherapy|rituximab-polychemotherapy
4968964|NCT04183569|Integrative bioinformatics tool|integrative bioinformatics tool
5291350|NCT02218346|Healthy volunteers|healthy volunteers
4968965|NCT04183556|new onset primary dysmenorrhea|new onset primary dysmenorrhea
4968966|NCT04183556|turmeric|turmeric
4968967|NCT04183556|naproxen|naproxen
4968968|NCT04183543|PEMF|pemf
4968969|NCT04183504|Primary Health Care|primary health care
4968970|NCT04183504|Occupational Therapy|occupational therapy
4968971|NCT04183504|Child Development|child development
4968972|NCT04183504|Early Intervention|early intervention
4968974|NCT04183491|Pharmacokinetics|pharmacokinetics
4968975|NCT04183491|Pharmacodynamics|pharmacodynamics
4968976|NCT04183452|17-hydroxyprogesterone caproate|17-hydroxyprogesterone caproate
4968977|NCT04183426|Functional Response|functional response
4968978|NCT04183426|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4968979|NCT04183426|Cardiovascular Events|cardiovascular events
4968980|NCT04183413|Diabetes Mellitus|diabetes mellitus
4968981|NCT04183413|Diabetes|diabetes
4968982|NCT04183413|Hypertension|hypertension
4968983|NCT04183413|WHO-PEN|who-pen
4968984|NCT04183413|Health service decentralization|health service decentralization
4968985|NCT04183413|Community Health Worker|community health worker
4968986|NCT04183413|Eswatini|eswatini
4968987|NCT04183413|Swaziland|swaziland
4968988|NCT04183413|Scale-up|scale-up
4968989|NCT04183413|Implementation research|implementation research
4968990|NCT04183413|Cost-effectiveness|cost-effectiveness
4968991|NCT04183413|Mixed methods|mixed methods
4968992|NCT04183413|Comorbidity|comorbidity
4968993|NCT04183413|Non-Communicable Disease|non-communicable disease
4968994|NCT04183413|Cardiovascular disease risk factors|cardiovascular disease risk factors
4968995|NCT04183400|substance use|substance use
4968996|NCT04183400|victimization|victimization
4968997|NCT04183400|homeless youth|homeless youth
4968998|NCT04183400|youth experiencing homelessness|youth experiencing homelessness
4968999|NCT04183374|male infertility|male infertility
4969000|NCT04183374|DNA fragmentation Index|dna fragmentation index
4969002|NCT04183374|life style intervention|life style intervention
4969003|NCT04183361|noise|noise
4969004|NCT04183361|sensorineural hearing loss|sensorineural hearing loss
4969005|NCT04183361|ABR|abr
4969006|NCT04183361|cortisole|cortisole
4969007|NCT04183361|salivary|salivary
4969008|NCT04183322|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4969010|NCT04183322|Reactogenicity|reactogenicity
4969011|NCT04183322|Immunogenicity|immunogenicity
4969012|NCT04183322|Women childbearing age|women childbearing age
4969013|NCT04183309|Children|children
4969014|NCT04183309|Ultrasound|ultrasound
4969015|NCT04183296|Laparoscopic assisted gastrectomy|laparoscopic assisted gastrectomy
4969016|NCT04183296|Robotic assisted gastrectomy|robotic assisted gastrectomy
4969017|NCT04183257|Vitamin D|vitamin d
4969018|NCT04183257|T2DM|t2dm
4969019|NCT04183257|Insulin Resistance|insulin resistance
4969020|NCT04183244|Erector Spinae Plane Block|erector spinae plane block
4969021|NCT04183244|Infraclavicular Subomohyoid Block|infraclavicular subomohyoid block
4969022|NCT04183244|Shoulder Surgery|shoulder surgery
4969023|NCT04183231|adults|adults
4969024|NCT04183231|povidone iodine|povidone iodine
4969025|NCT04183231|sodium fluoride|sodium fluoride
4969026|NCT04183205|Treatment|treatment
4969027|NCT04183205|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
4969028|NCT04183205|selective serotonin re-uptake inhibitor (SSRI)|selective serotonin re-uptake inhibitor (ssri)
4969029|NCT04183205|loudness dependence of auditory evoked potentials|loudness dependence of auditory evoked potentials
4969030|NCT04183205|Electrophysiology|electrophysiology
4969031|NCT04183192|Pharmacokinetics|pharmacokinetics
4969032|NCT04183192|Pharmacodynamics|pharmacodynamics
4969033|NCT04183179|Obesity prevention|obesity prevention
4969034|NCT04183179|Early childhood|early childhood
4969035|NCT04183179|Intergenerational|intergenerational
4969036|NCT04183179|Healthy eating|healthy eating
4969037|NCT04183179|Life stress management|life stress management
4969038|NCT04183140|Complication|complication
4969039|NCT04183140|Primary Percutaneus Coronary Intervention|primary percutaneus coronary intervention
4969040|NCT04183140|Radial Artery|radial artery
4969041|NCT04183140|Ulnar Artery|ulnar artery
4969042|NCT04183127|ACP|acp
4969048|NCT04183114|Bio Farma|bio farma
4969049|NCT04183075|phase angle|phase angle
4969050|NCT04183075|nutritional supplement|nutritional supplement
4969051|NCT04183062|bone cancer|bone cancer
4969052|NCT04183062|sarcoma|sarcoma
4969053|NCT04183062|lung metastases|lung metastases
4969054|NCT04183062|pediatric cancers|pediatric cancers
4969055|NCT04183049|Dexmedetomidine|dexmedetomidine
4969056|NCT04183049|Analgesics|analgesics
4969057|NCT04183049|Opioid free anesthesia|opioid free anesthesia
4969058|NCT04183049|Chronic postsurgical pain|chronic postsurgical pain
4969070|NCT04182919|Phlai|phlai
4969071|NCT04182919|compound D|compound d
4969072|NCT04182919|herbal medicine|herbal medicine
4969079|NCT04182906|Primary Care|primary care
4969080|NCT04182906|Universal screening|universal screening
4969081|NCT04182893|bronchoalveolar lavage fluid|bronchoalveolar lavage fluid
4969082|NCT04182893|ctDNA|ctdna
4969083|NCT04182893|exosomes|exosomes
4969084|NCT04182854|furosemide|furosemide
4969085|NCT04182854|hydrochlorothiazide|hydrochlorothiazide
4969086|NCT04182854|residual renal function|residual renal function
4969087|NCT04182815|Bronchoscopy|bronchoscopy
4969088|NCT04182815|Robotic bronchoscopy|robotic bronchoscopy
4969089|NCT04182815|Lung Lesions|lung lesions
4969090|NCT04182815|Peripheral lesions|peripheral lesions
4969091|NCT04182815|Lung Cancer|lung cancer
4969092|NCT04182815|Monarch|monarch
4969093|NCT04182776|Pelvis|pelvis
4969094|NCT04182776|Fragility Fracture|fragility fracture
4969095|NCT04182776|Classification|classification
4969096|NCT04182776|Conservative|conservative
4969097|NCT04182776|Operative|operative
4969098|NCT04182763|Neurodegeneration with Brain Iron Accumulation|neurodegeneration with brain iron accumulation
4969099|NCT04182763|NBIA|nbia
4969100|NCT04182763|PKAN|pkan
4969101|NCT04182737|immunoglobulins|immunoglobulins
4969102|NCT04182737|septic shock|septic shock
4969103|NCT04182737|adjunctive treatment|adjunctive treatment
4969104|NCT04182737|critically ill patients|critically ill patients
4969105|NCT04182711|COPD|copd
4969106|NCT04182711|Asthma|asthma
4969107|NCT04182711|Pneumonia|pneumonia
4969108|NCT04182711|Congestive heart failure|congestive heart failure
4969109|NCT04182698|Alotinib non-small cell lung cancer|alotinib non-small cell lung cancer
4969110|NCT04182685|Zika virus|zika virus
4969111|NCT04182685|neurodevelopment|neurodevelopment
4969112|NCT04182685|neurological sequelae|neurological sequelae
4969113|NCT04182672|Hip bursitis|hip bursitis
4969114|NCT04182672|hip pain|hip pain
4969115|NCT04182672|Zilretta|zilretta
4969116|NCT04182659|rTMS|rtms
4969117|NCT04182659|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4969118|NCT04182659|Gulf War Illness|gulf war illness
4969119|NCT04182633|fecal transplant|fecal transplant
4969120|NCT04182633|fecal microbiota transplant|fecal microbiota transplant
4969121|NCT04182633|intestinal microbiota transplant|intestinal microbiota transplant
4969122|NCT04182633|microbiota transplant|microbiota transplant
4969123|NCT04182633|autism|autism
4969124|NCT04182633|autism spectrum disorder|autism spectrum disorder
4969129|NCT04182607|kidney|kidney
4969130|NCT04182607|transplant|transplant
4969131|NCT04182607|nephrectomy|nephrectomy
4969138|NCT04182516|HER2 negative breast cancer|her2 negative breast cancer
4969139|NCT04182516|Epithelial ovarian cancer|epithelial ovarian cancer
4969140|NCT04182516|Castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
4969141|NCT04182516|Pancreatic cancer|pancreatic cancer
4969142|NCT04182516|BRCA1 Gene Mutation|brca1 gene mutation
4969143|NCT04182516|BRCA2 Gene Mutation|brca2 gene mutation
4969144|NCT04182464|gut microbiota|gut microbiota
4969145|NCT04182464|incretins|incretins
4969146|NCT04182464|sucralose|sucralose
4969147|NCT04182464|hyperinsulinemic-euglycemic clamp|hyperinsulinemic-euglycemic clamp
4969148|NCT04182451|Chronic wounds|chronic wounds
4969149|NCT04182438|Low potassium content vegetables|low potassium content vegetables
4969150|NCT04182438|End-Stage Renal Disease|end-stage renal disease
4969151|NCT04182438|Hemodialysis|hemodialysis
4969152|NCT04182412|Laparoscopy|laparoscopy
4969153|NCT04182412|mesh reinforcement|mesh reinforcement
4969154|NCT04182412|abdominal stability|abdominal stability
4969155|NCT04182399|Parkinson's disease, zonisamide, motor, fluctuation|parkinson's disease, zonisamide, motor, fluctuation
4969156|NCT04182373|Preeclampsia|preeclampsia
4969157|NCT04182373|Antithrombin|antithrombin
4969187|NCT04182282|Online Training and Certification|online training and certification
4969188|NCT04182282|Allied Health Workers|allied health workers
4969189|NCT04182282|Patient Care|patient care
4969207|NCT04182152|Video-associated thoracic surgery|video-associated thoracic surgery
4969208|NCT04182152|Indocyanine green (ICG)|indocyanine green (icg)
4969209|NCT04182139|Static Stretching|static stretching
4969211|NCT04182139|Proprioception|proprioception
4969212|NCT04182139|Healthy adults|healthy adults
4969213|NCT04182126|Adaptive intervention|adaptive intervention
4969214|NCT04182126|Multiple assignment randomized trial (SMART)|multiple assignment randomized trial (smart)
4969215|NCT04182126|Cluster-randomized SMART trial|cluster-randomized smart trial
4969216|NCT04182126|Optimal intervention strategy|optimal intervention strategy
4969217|NCT04182126|Clinical malaria incidence|clinical malaria incidence
4969218|NCT04182126|Cost-effectiveness|cost-effectiveness
4969219|NCT04182113|schizophrenia|schizophrenia
4969220|NCT04182113|psychosis|psychosis
4969221|NCT04182113|early phase psychosis|early phase psychosis
4969222|NCT04182113|rTMS|rtms
4969223|NCT04182100|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4969224|NCT04182087|Behavioral performance|behavioral performance
4969225|NCT04182087|Cortical resection|cortical resection
4969226|NCT04182087|Stroke|stroke
4969227|NCT04182074|Pregnancy|pregnancy
4969228|NCT04182074|Treatment|treatment
4969229|NCT04182074|Diagnosis|diagnosis
4969230|NCT04182074|Delivery|delivery
4969231|NCT04182061|Transdiagnostic-CBT, anxiety, Depression, Internet-Delivered|transdiagnostic-cbt, anxiety, depression, internet-delivered
4969232|NCT04182035|stratified care|stratified care
4969233|NCT04182035|patient-tailored therapy|patient-tailored therapy
4969234|NCT04182035|subacute|subacute
4969235|NCT04182009|Asthma|asthma
5011736|NCT03923075|TOF|tof
4969254|NCT04181879|General Practitioners|general practitioners
4969255|NCT04181879|Behaviour Change Techniques|behaviour change techniques
4969256|NCT04181853|Type 2 diabetes mellitus|type 2 diabetes mellitus
4969257|NCT04181853|exercise|exercise
4969258|NCT04181853|aerobic|aerobic
4969259|NCT04181840|Obstetric Anal Sphincter Injury|obstetric anal sphincter injury
4969260|NCT04181840|Impedance Spectroscopy|impedance spectroscopy
4969261|NCT04181788|Advanced solid tumors|advanced solid tumors
4969262|NCT04181788|NSCLC|nsclc
4969263|NCT04181762|SLE|sle
4969264|NCT04181762|LN|ln
4969265|NCT04181762|secukinumab|secukinumab
4969266|NCT04181762|renal biopsy|renal biopsy
4969267|NCT04181762|eGFR|egfr
4969268|NCT04181762|UPCR|upcr
4969276|NCT04181710|Organ preservation|organ preservation
5356774|NCT01918033|Neurotransmitter Agents|neurotransmitter agents
5356775|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating
4969277|NCT04181684|Gliomas, Laser Interstitial Thermal Therapy, Brain, Brain Tumor, Radiotherapy, Proton Therapy, Hypofractionated Radiation Therapy, Malignant, Glioblastoma|gliomas, laser interstitial thermal therapy, brain, brain tumor, radiotherapy, proton therapy, hypofractionated radiation therapy, malignant, glioblastoma
4969278|NCT04181671|Exercise Training|exercise training
4969279|NCT04181645|pancreatic cancer|pancreatic cancer
4969280|NCT04181619|coffeeberry|coffeeberry
4969281|NCT04181619|caffeine|caffeine
4969282|NCT04181619|polyphenols|polyphenols
4969283|NCT04181619|chlorogenic acid|chlorogenic acid
4969284|NCT04181619|exercise|exercise
4969285|NCT04181619|soccer|soccer
4969286|NCT04181619|skill|skill
4969287|NCT04181619|performance|performance
4969290|NCT04181593|Dry Eye Disease|dry eye disease
4969291|NCT04181593|Ocular Surface Disease|ocular surface disease
4969292|NCT04181567|electroconvulsive therapy|electroconvulsive therapy
4969293|NCT04181567|agomelatine|agomelatine
4969294|NCT04181567|relapse|relapse
4969295|NCT04181567|major depressive disorder|major depressive disorder
4969296|NCT04181567|response|response
4969297|NCT04181541|Midlevel provider|midlevel provider
4969298|NCT04181502|Remote ischemic preconditioning|remote ischemic preconditioning
4969299|NCT04181502|liver resection|liver resection
4969300|NCT04181502|liver clearance.|liver clearance.
4969301|NCT04181489|Sintilimab|sintilimab
4969302|NCT04181489|R-CHOP|r-chop
4969303|NCT04181489|EBV-Positive DLBCL, nos|ebv-positive dlbcl, nos
4969304|NCT04181489|treatment-naive|treatment-naive
4969309|NCT04181346|pregabalin|pregabalin
4969310|NCT04181346|nausea|nausea
4969311|NCT04181320|Granulox|granulox
4969312|NCT04181320|venous ulcers|venous ulcers
4969313|NCT04181320|wound healing|wound healing
4969314|NCT04181320|wound reduction|wound reduction
4969318|NCT04181281|CEUS|ceus
4969319|NCT04181281|MRI|mri
4969320|NCT04181281|kidney perfusion|kidney perfusion
4969321|NCT04181255|Norwood procedure|norwood procedure
4969325|NCT04181203|Radical prostatectomy|radical prostatectomy
4969328|NCT04181190|Eosinophils|eosinophils
4969329|NCT04181190|Mepolizumab|mepolizumab
4969330|NCT04181190|Benralizumab|benralizumab
4969331|NCT04181190|Severe Asthma|severe asthma
4969332|NCT04181177|anticancer treatment|anticancer treatment
4969333|NCT04181177|targeted educational action|targeted educational action
4969334|NCT04181177|pruritus|pruritus
4969335|NCT04181177|quality of life|quality of life
4969336|NCT04181177|NCI CTCAE|nci ctcae
4969337|NCT04181177|Patient Global Assessment|patient global assessment
4969338|NCT04181177|Investigator Global Assessment|investigator global assessment
4969339|NCT04181177|Dermatology Life Quality Index (DLQI)|dermatology life quality index (dlqi)
4969340|NCT04181177|Hydration Index (HI)|hydration index (hi)
4969341|NCT04181177|Numeric Scale (NS)|numeric scale (ns)
4969346|NCT04181138|Pediatric Liver Disease|pediatric liver disease
4969347|NCT04181138|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
4969348|NCT04181112|Fecal Microbiota Transplantation|fecal microbiota transplantation
4969349|NCT04181099|dental implant|dental implant
4969350|NCT04181099|zirconia|zirconia
4969351|NCT04181099|biofilm|biofilm
4969352|NCT04181073|nebulisation|nebulisation
4969353|NCT04181073|vibrating mesh nebuliser|vibrating mesh nebuliser
4969354|NCT04181047|Eye movement desensitization and Reprocessing|eye movement desensitization and reprocessing
4969355|NCT04181034|Teen pregnancy prevention|teen pregnancy prevention
4969356|NCT04181034|Home visiting|home visiting
4969357|NCT04181034|Positive youth development|positive youth development
4969358|NCT04181034|Adolescent Family Life Program Positive Youth Development|adolescent family life program positive youth development
4969359|NCT04180930|Assessment|assessment
5342904|NCT01981551|Desmoid Tumor|desmoid tumor
4969360|NCT04180930|Post-Traumatic Stress Disorder|post-traumatic stress disorder
4969361|NCT04180930|PTSD|ptsd
4969362|NCT04180930|Veterans|veterans
4969363|NCT04180930|Military|military
4969372|NCT04180865|Cognition|cognition
4969373|NCT04180865|PET imaging|pet imaging
4969374|NCT04180865|Acetylcholine|acetylcholine
4969375|NCT04180865|Magnetic Resonance Imaging|magnetic resonance imaging
4969376|NCT04180865|Ophthalmology|ophthalmology
4969377|NCT04180865|Gastrointestinal Microbiome|gastrointestinal microbiome
4969378|NCT04180865|Neurodegenerative Diseases|neurodegenerative diseases
4969379|NCT04180865|Genetic subtyping|genetic subtyping
4969380|NCT04180774|gene modified vaccine|gene modified vaccine
4969381|NCT04180774|tag-7|tag-7
4969382|NCT04180774|immunotherapy|immunotherapy
4969383|NCT04180774|tumor cells-based vaccine|tumor cells-based vaccine
4969384|NCT04180748|Microbiome|microbiome
4969385|NCT04180748|Dermatology|dermatology
4969386|NCT04180748|Cosmetics|cosmetics
4969387|NCT04180748|Autofluorescence|autofluorescence
4969388|NCT04180735|Risk Factors|risk factors
4969389|NCT04180735|Survival|survival
4969390|NCT04180722|Home mechanical ventilation|home mechanical ventilation
4969391|NCT04180722|Ventilator assisted individuals|ventilator assisted individuals
4969392|NCT04180722|Virtual Intervention|virtual intervention
4969393|NCT04180709|Cognition|cognition
4969394|NCT04180709|Social Recovery|social recovery
4969395|NCT04180709|Immunopsychiatry|immunopsychiatry
4969396|NCT04180709|Daily function|daily function
4969397|NCT04180709|Sleep disturbances|sleep disturbances
4969398|NCT04180709|Insomnia|insomnia
4969399|NCT04180683|Depression|depression
4969400|NCT04180683|Depressive Disorder|depressive disorder
4969401|NCT04180683|Neurocognitive Disorders|neurocognitive disorders
4969402|NCT04180683|Dementia|dementia
4969403|NCT04180683|Elderly|elderly
4969404|NCT04180683|Geriatric Depression Scale|geriatric depression scale
4969405|NCT04180683|Beck Depression Inventory - II|beck depression inventory - ii
4969406|NCT04180670|chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4969407|NCT04180670|urinary incontinence|urinary incontinence
4969408|NCT04180670|self-activity assesment|self-activity assesment
4969409|NCT04180657|ghrelin|ghrelin
4969410|NCT04180657|growth hormone|growth hormone
4969411|NCT04180657|protein C deficiency|protein c deficiency
4969412|NCT04180657|appetite|appetite
4969413|NCT04180605|Atrial fibrillation|atrial fibrillation
4969414|NCT04180605|Left atrial appendage|left atrial appendage
4969415|NCT04180605|Transcatheter closure|transcatheter closure
4969457|NCT04180397|Deresuscitation|deresuscitation
4969459|NCT04180358|Navajo|navajo
4969460|NCT04180358|Sex|sex
4969461|NCT04180358|Abstain|abstain
4969462|NCT04180358|Culture|culture
4969463|NCT04180358|Random|random
4969464|NCT04180358|Control|control
4969467|NCT04180345|Flare|flare
4969468|NCT04180345|Inflammatory Bowel Diseases|inflammatory bowel diseases
4969469|NCT04180345|Questionnaire|questionnaire
4969470|NCT04180345|Internet|internet
4969471|NCT04180345|Mixed methods|mixed methods
4969472|NCT04180332|superoxide dismutase|superoxide dismutase
4969473|NCT04180332|catalase|catalase
4969474|NCT04180332|anti-oxidant|anti-oxidant
4969475|NCT04180332|diabetes mellitus|diabetes mellitus
4969476|NCT04180332|type 2|type 2
4969477|NCT04180332|periodontitis|periodontitis
4969478|NCT04180319|Natural History|natural history
4969479|NCT04180319|Epidemiology|epidemiology
4969480|NCT04180319|Registry|registry
4969481|NCT04180319|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
4969482|NCT04180293|Military|military
4969483|NCT04180293|Veteran|veteran
4969484|NCT04180293|Family|family
4969485|NCT04180293|Psychoeducation|psychoeducation
4969486|NCT04180293|Resiliency|resiliency
4969487|NCT04180293|Operational stress injuries|operational stress injuries
4969488|NCT04180293|Post traumatic stress disorder|post traumatic stress disorder
4969489|NCT04180267|Osteoporosis|osteoporosis
4969490|NCT04180267|Vibration Therapy|vibration therapy
4969491|NCT04180267|Disabled patient|disabled patient
4969492|NCT04180267|Vertebral BMD|vertebral bmd
4969493|NCT04180215|Vaccine|vaccine
4969494|NCT04180215|Gene Therepy|gene therepy
4969495|NCT04180215|TheraT®|therat®
4969496|NCT04180215|E7E6|e7e6
4969497|NCT04180215|HPV 16 E7E6|hpv 16 e7e6
4969498|NCT04180215|HNSCC|hnscc
4969499|NCT04180215|HPV 16+ head and neck squamous cell cancer|hpv 16+ head and neck squamous cell cancer
4969500|NCT04180215|Oropharyngeal cancer|oropharyngeal cancer
4969501|NCT04180215|Penile cancer|penile cancer
4969502|NCT04180215|Anal cancer|anal cancer
4969503|NCT04180215|Cervical cancer|cervical cancer
4969504|NCT04180215|Vaginal cancer|vaginal cancer
4969505|NCT04180215|Vulvar cancer|vulvar cancer
4969506|NCT04180189|children|children
4969507|NCT04180189|non-pharmacological intervention|non-pharmacological intervention
4969508|NCT04180189|ADHD|adhd
4969509|NCT04180189|sleep|sleep
4969510|NCT04180124|Gait pattern|gait pattern
4969511|NCT04180124|Treadmill walking|treadmill walking
4969512|NCT04180124|Arm swing|arm swing
4969513|NCT04180098|hereditary spastic paraplegia|hereditary spastic paraplegia
4969514|NCT04180098|C-mill|c-mill
4969515|NCT04180098|gait adaptability|gait adaptability
4969516|NCT04180098|rehabilitation|rehabilitation
4969517|NCT04180072|HCC , HBV infection|hcc , hbv infection
4987877|NCT04067167|Nutrition|nutrition
4969529|NCT04179981|Sleep Apnea, Obstructive|sleep apnea, obstructive
4969538|NCT04179968|PET/CT|pet/ct
4969539|NCT04179968|prostate cancer|prostate cancer
4969540|NCT04179968|Gallium-68|gallium-68
4969541|NCT04179968|PSMA-11|psma-11
4969542|NCT04179942|FeNO; ;;|feno; ;;
4969543|NCT04179942|Hs-CRP|hs-crp
4969544|NCT04179942|CPAP|cpap
4969547|NCT04179929|adult|adult
4969555|NCT04179916|HRV|hrv
4969556|NCT04179916|microcirculation|microcirculation
4969557|NCT04179903|osteoporosis|osteoporosis
4969558|NCT04179903|Gym Training|gym training
4969559|NCT04179903|physical activity|physical activity
4969560|NCT04179903|home training|home training
4969570|NCT04179799|SCI|sci
4969572|NCT04179799|respiratory impairment|respiratory impairment
4969573|NCT04179799|diaphragm stimulation|diaphragm stimulation
4969575|NCT04179786|Prophylactic vaccine|prophylactic vaccine
4969576|NCT04179786|Sci-B-Vac|sci-b-vac
4969577|NCT04179786|HepB vaccines|hepb vaccines
4969578|NCT04179786|Phase 4|phase 4
4969579|NCT04179786|pre-S1|pre-s1
4969580|NCT04179786|pre-S2|pre-s2
4969581|NCT04179786|Surface antigen|surface antigen
4969582|NCT04179773|Liver cirrhosis|liver cirrhosis
4969583|NCT04179773|chemotherapy|chemotherapy
4969584|NCT04179773|ENT cancers|ent cancers
4969585|NCT04179773|upper-digestive tract cancers|upper-digestive tract cancers
4969586|NCT04179773|colorectal cancers|colorectal cancers
4969587|NCT04179747|Sexual Dysfunctions, Men Health|sexual dysfunctions, men health
4969588|NCT04179734|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
4969589|NCT04179734|Bremelanotide|bremelanotide
4969590|NCT04179734|Functional MRI|functional mri
4969591|NCT04179734|Melanocortin-4 receptor|melanocortin-4 receptor
4969592|NCT04179721|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
4969593|NCT04179721|Alzheimer's Disease and Related Dementias|alzheimer's disease and related dementias
4969594|NCT04179721|Hospitalization|hospitalization
4969595|NCT04179708|Therapeutic Patient Education|therapeutic patient education
4969596|NCT04179708|Chronic Low Back Pain|chronic low back pain
4969597|NCT04179708|Chronic Pain|chronic pain
4969598|NCT04179708|Pain Neuroscience Education|pain neuroscience education
4969599|NCT04179708|Pain Neurophysiology Education|pain neurophysiology education
4969600|NCT04179708|Pain biology education|pain biology education
4969601|NCT04179695|Health pathway|health pathway
4969602|NCT04179695|patient centered care|patient centered care
4969603|NCT04179695|communication aid- tool|communication aid- tool
4969604|NCT04179695|primary care|primary care
4969605|NCT04179695|secondary care|secondary care
4969606|NCT04179682|cerebral palsy|cerebral palsy
4969607|NCT04179682|constraint-induced movement therapy|constraint-induced movement therapy
4969608|NCT04179682|botulinum toxin|botulinum toxin
4969609|NCT04179682|rehabilitation|rehabilitation
4987979|NCT04066491|INTR@PID|intr@pid
4969610|NCT04179682|occupational therapy|occupational therapy
4969612|NCT04179617|dual use|dual use
4969613|NCT04179617|multiple tobacco product use|multiple tobacco product use
5296141|NCT02195856|MRI|mri
4969614|NCT04179617|flavors|flavors
4969615|NCT04179617|tobacco regulatory science|tobacco regulatory science
4969616|NCT04179604|Poor left ventricule eyection fraction|poor left ventricule eyection fraction
4969617|NCT04179604|Levosimendan|levosimendan
4969618|NCT04179604|Cardiac surgery|cardiac surgery
4969619|NCT04179604|Preoperative Treatment|preoperative treatment
4969620|NCT04179604|Low cardiac output syndrome|low cardiac output syndrome
4969621|NCT04179604|Clinical Trial|clinical trial
4969622|NCT04179591|Pes planus|pes planus
4969623|NCT04179591|Foot posture|foot posture
4969624|NCT04179591|Plantar pressure variables|plantar pressure variables
4969625|NCT04179591|Balance|balance
4969626|NCT04179591|Short foot exercises|short foot exercises
4969627|NCT04179591|Tibials posterior strengthening|tibials posterior strengthening
4969628|NCT04179591|Intrinsic foot muscles|intrinsic foot muscles
4969629|NCT04179591|Custom-made insole|custom-made insole
4969630|NCT04179591|Arch support insole|arch support insole
4969631|NCT04179565|childhood obesity|childhood obesity
4969632|NCT04179565|parenting practices|parenting practices
4969633|NCT04179565|food and physical activity|food and physical activity
4969634|NCT04179526|transdiagnostic|transdiagnostic
4969635|NCT04179526|anxiety|anxiety
4969636|NCT04179526|depression|depression
4969637|NCT04179526|REBT|rebt
4969638|NCT04179526|adolescents|adolescents
4969639|NCT04179526|Internet intervention|internet intervention
4969640|NCT04179500|tuberculosis|tuberculosis
4969641|NCT04179500|TB|tb
4969642|NCT04179500|DR-TB|dr-tb
4969643|NCT04179500|pretomanid (PA)|pretomanid (pa)
4969644|NCT04179500|PA-824|pa-824
4969645|NCT04179500|XDR TB|xdr tb
4969646|NCT04179500|Pa|pa
4969647|NCT04179487|pulmonary embolism|pulmonary embolism
4969648|NCT04179487|pregnancy|pregnancy
4969649|NCT04179487|tomography xray computed|tomography xray computed
4969650|NCT04179487|radiation dosage|radiation dosage
4974860|NCT04149431|Derinat|derinat
4969652|NCT04179474|ubrogepant|ubrogepant
4969653|NCT04179474|erenumab|erenumab
4969654|NCT04179474|galcanezumab|galcanezumab
4969655|NCT04179474|safety|safety
4969656|NCT04179474|tolerability|tolerability
4969657|NCT04179474|interaction|interaction
4969658|NCT04179448|Keratinized Tissue|keratinized tissue
4969659|NCT04179448|Keratinized Gingiva|keratinized gingiva
4969660|NCT04179448|Gingival recession|gingival recession
4969661|NCT04179448|Mucogingival defect|mucogingival defect
4969662|NCT04179448|SAMRI|samri
4969663|NCT04179448|Acellular Dermal Matrix|acellular dermal matrix
4969664|NCT04179448|Sulcular tunnel technique|sulcular tunnel technique
4969665|NCT04179448|Patient-centered outcomes|patient-centered outcomes
4969668|NCT04179396|CRPC|crpc
4969669|NCT04179396|PARP inhibitor|parp inhibitor
4969680|NCT04179396|ADT|adt
4969681|NCT04179396|AR|ar
4969682|NCT04179396|ARi|ari
4969683|NCT04179383|Thunderclap headache|thunderclap headache
4969684|NCT04179370|vitamin D OR 25(OH)D|vitamin d or 25(oh)d
4969685|NCT04179370|African-Caribbean OR Afro-Caribbean|african-caribbean or afro-caribbean
4969686|NCT04179344|Pharmaceutical care|pharmaceutical care
4969687|NCT04179344|HIV|hiv
4969688|NCT04179344|TB|tb
4969689|NCT04179344|Internet|internet
4969690|NCT04179344|Surveys and questionnaires|surveys and questionnaires
4969691|NCT04179344|Humans|humans
4969692|NCT04179344|Pharmacovigilance|pharmacovigilance
4969693|NCT04179331|Appetite regulation|appetite regulation
4969694|NCT04179331|Food intake|food intake
4969695|NCT04179331|Ad libitum|ad libitum
4969696|NCT04179331|Hormone secretion|hormone secretion
4969700|NCT04179240|biospecific nonspecimen specimen|biospecific nonspecimen specimen
4969701|NCT04179240|child and adolescent|child and adolescent
4969702|NCT04179240|cartoon|cartoon
4969703|NCT04179240|questionnaire|questionnaire
4969704|NCT04179240|concent|concent
4969705|NCT04179214|Trigger Area|trigger area
4969706|NCT04179188|obesity|obesity
4969707|NCT04179188|Bariatric Surgery|bariatric surgery
4969708|NCT04179188|Obstructive Sleep Apnea|obstructive sleep apnea
4969709|NCT04179175|acne inversa|acne inversa
4969710|NCT04179175|Hidradenitis suppurativa|hidradenitis suppurativa
4969711|NCT04179175|maladie de Vemeuil|maladie de vemeuil
4969712|NCT04179175|inflammatory disease|inflammatory disease
4969713|NCT04179175|AIN457|ain457
4969714|NCT04179175|AIN457M|ain457m
4969715|NCT04179175|secukinumab|secukinumab
4969716|NCT04179175|Loss of response|loss of response
4969717|NCT04179175|HiSCR|hiscr
4969718|NCT04179175|IL-17A|il-17a
4969719|NCT04179162|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
4969720|NCT04179162|Gemcitabine|gemcitabine
4969721|NCT04179162|19-374|19-374
4969722|NCT04179149|endometriosis|endometriosis
4969723|NCT04179149|chronic pelvic pain|chronic pelvic pain
4969724|NCT04179149|quality of life|quality of life
4969725|NCT04179149|inflammation|inflammation
4969726|NCT04179149|stress|stress
4969727|NCT04179136|Cardiovascular system Polyphenols|cardiovascular system polyphenols
4969728|NCT04179097|Doppler|doppler
4969734|NCT04179058|Interstitial lung disease|interstitial lung disease
5369123|NCT01861262|blood pressure|blood pressure
4969735|NCT04179058|Interstitial pneumonia with autoimmune features|interstitial pneumonia with autoimmune features
4969736|NCT04179045|Bioresorbable Vascular Scaffold System|bioresorbable vascular scaffold system
4969737|NCT04179045|Percutaneous Coronary Intervention|percutaneous coronary intervention
4969744|NCT04179006|Major depressive disorder|major depressive disorder
4969745|NCT04179006|Supplement nutrients|supplement nutrients
4969746|NCT04179006|Antidepressants|antidepressants
4969747|NCT04178993|Methamphetamine|methamphetamine
4969748|NCT04178993|Methylphenidate|methylphenidate
4969749|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride
4969750|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants
4969751|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs
4969752|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
4969753|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
4969754|NCT04178993|Membrane Transport Modulators|membrane transport modulators
4969755|NCT04178993|Neurotransmitter Agents|neurotransmitter agents
4969756|NCT04178993|Dopamine Agents|dopamine agents
4969757|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4969758|NCT04178993|Sensory System Agents|sensory system agents
4969759|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents
4969760|NCT04178993|Vasoconstrictor Agents|vasoconstrictor agents
4969761|NCT04178993|Antidepressive Agents|antidepressive agents
4969762|NCT04178993|Psychotropic Drugs|psychotropic drugs
4969764|NCT04178967|Dermatitis|dermatitis
4969765|NCT04178967|Dermatitis, Atopic|dermatitis, atopic
4969766|NCT04178967|Skin Diseases|skin diseases
4969767|NCT04178954|Infertility;|infertility;
4969768|NCT04178954|male|male
4969769|NCT04178954|semen|semen
4969770|NCT04178902|Multiple Myeloma (MM)|multiple myeloma (mm)
4969771|NCT04178902|Relapse/Refractory|relapse/refractory
4969772|NCT04178902|Cancer|cancer
4969773|NCT04178889|Lung cancer|lung cancer
4969774|NCT04178889|Non-small cell lung cancer|non-small cell lung cancer
4969782|NCT04178824|Nutrition|nutrition
4969783|NCT04178798|CLL|cll
4969784|NCT04178785|laparoscopic|laparoscopic
4969785|NCT04178785|remifentanil|remifentanil
4969786|NCT04178785|fentanyl|fentanyl
4969787|NCT04178785|hysterectomy|hysterectomy
4969788|NCT04178759|Liver metastases|liver metastases
4969789|NCT04178759|Liver regeneration|liver regeneration
4969790|NCT04178759|Markers|markers
4969791|NCT04178746|intraventricular hemorrhage|intraventricular hemorrhage
4969792|NCT04178746|IVH|ivh
4969793|NCT04178746|stroke|stroke
4969794|NCT04178681|Humans|humans
4969795|NCT04178681|Milk fat|milk fat
4969796|NCT04178681|Clinical Trial|clinical trial
4969797|NCT04178681|Genomics|genomics
4969798|NCT04178681|Metabolism|metabolism
4969799|NCT04178681|Nutrition|nutrition
4969800|NCT04178668|molecular mobility|molecular mobility
4969801|NCT04178668|collagen denaturation|collagen denaturation
4969802|NCT04178668|oral mucosa|oral mucosa
4969803|NCT04178668|saliva|saliva
4969804|NCT04178668|ageing|ageing
4969805|NCT04178655|Tendon Injury, Tranexamic Acid|tendon injury, tranexamic acid
4969806|NCT04178629|Ceftobiprole|ceftobiprole
4969807|NCT04178629|External Ventricular Derivation|external ventricular derivation
4969808|NCT04178629|Cerebrospinal fluid penetration|cerebrospinal fluid penetration
4969809|NCT04178629|ATP Binding Cassette Transporter, Subfamily B, Member 1|atp binding cassette transporter, subfamily b, member 1
4969810|NCT04178629|Tissue Distribution|tissue distribution
4969811|NCT04178603|Exercise|exercise
4969812|NCT04178603|Insulin Resistance|insulin resistance
4969813|NCT04178603|Type 2 Diabetes|type 2 diabetes
4969814|NCT04178603|Glucose Uptake|glucose uptake
4969815|NCT04178603|Insulin Sensitivity|insulin sensitivity
4969816|NCT04178590|periodontitis|periodontitis
4969817|NCT04178590|therapy|therapy
4969818|NCT04178590|Platelet|platelet
4969819|NCT04178590|Rich|rich
4969820|NCT04178590|Fibrin|fibrin
4969821|NCT04178590|Nonsurgical|nonsurgical
4969822|NCT04178577|End State Renal Disease (ESRD)|end state renal disease (esrd)
4969823|NCT04178577|Renal Insufficiency|renal insufficiency
4969824|NCT04178577|Renal Impairment|renal impairment
4969825|NCT04178577|Renal Disease|renal disease
4969838|NCT04178538|Anterior cruciate ligament tear|anterior cruciate ligament tear
4969840|NCT04178525|Chronic wounds|chronic wounds
4969841|NCT04178525|Diabetic foot ulcer|diabetic foot ulcer
4969842|NCT04178525|Chitosan gel|chitosan gel
4969843|NCT04178486|Overweight|overweight
4969844|NCT04178486|Obesity|obesity
4969845|NCT04178486|Weight loss|weight loss
4969846|NCT04178486|Hypnosis|hypnosis
4969847|NCT04178486|Eating Behavior|eating behavior
4969848|NCT04178486|Free Will|free will
4969849|NCT04178473|hysterectomy|hysterectomy
4969850|NCT04178473|sacrocolpopexy|sacrocolpopexy
4969851|NCT04178434|Myocardial infarction|myocardial infarction
4969852|NCT04178434|Non-obstructive coronary arteries|non-obstructive coronary arteries
4969853|NCT04178434|Takotsubo syndrome|takotsubo syndrome
4969854|NCT04178421|Sustained attention|sustained attention
4969855|NCT04178421|Impulse control|impulse control
4969856|NCT04178421|Eye-tracking|eye-tracking
4969857|NCT04178421|Special needs|special needs
4969858|NCT04178421|Computerized training|computerized training
4969859|NCT04178395|transcranial direct current stimulation|transcranial direct current stimulation
4969860|NCT04178395|stroke rehabilitation|stroke rehabilitation
4969861|NCT04178395|neuromodulation|neuromodulation
4969862|NCT04178395|corticomotor excitability|corticomotor excitability
4969863|NCT04178395|repetitive peripheral nerve stimulation|repetitive peripheral nerve stimulation
4969864|NCT04178382|rapid diagnosis|rapid diagnosis
4969865|NCT04178382|severe pneumonia|severe pneumonia
4969866|NCT04178343|tomotherapy|tomotherapy
4969867|NCT04178343|leptomeningeal metastases|leptomeningeal metastases
4969868|NCT04178343|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
4969869|NCT04178330|multiple brain metastases|multiple brain metastases
4969870|NCT04178330|Tomotherapy|tomotherapy
4969871|NCT04178330|fractionated stereotactic radiotheray|fractionated stereotactic radiotheray
4969872|NCT04178317|Cancer|cancer
4969873|NCT04178317|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4969874|NCT04178317|Venetoclax|venetoclax
4969875|NCT04178304|primary knee osteoarthritis,|primary knee osteoarthritis,
4969876|NCT04178304|prolotherapy,|prolotherapy,
4969877|NCT04178304|musculoskeletal ultrasound|musculoskeletal ultrasound
4969878|NCT04178291|Periodontitis|periodontitis
4969879|NCT04178291|air polishing|air polishing
4969880|NCT04178291|randomised clinical trial|randomised clinical trial
4969881|NCT04178291|adjunct|adjunct
4975111|NCT04147702|Balance|balance
4969889|NCT04178239|fMRI|fmri
4969890|NCT04178226|acupuncture|acupuncture
4969891|NCT04178226|laser acupuncture|laser acupuncture
4969892|NCT04178226|Autonomic nerve activity|autonomic nerve activity
4969893|NCT04178226|dysmenorrhea|dysmenorrhea
4969894|NCT04178226|prostaglandin|prostaglandin
4969895|NCT04178226|quality of life|quality of life
4969896|NCT04178213|ADAPT|adapt
4969897|NCT04178213|aortic leaflet repair|aortic leaflet repair
4969898|NCT04178213|aortic valve|aortic valve
4969899|NCT04178200|Cataract|cataract
4969900|NCT04178200|Retrobulbar Block|retrobulbar block
4969901|NCT04178200|Ocular and eyelid|ocular and eyelid
4969902|NCT04178200|Akinesia|akinesia
4969903|NCT04178200|Anesthesia Recovery Period|anesthesia recovery period
5292066|NCT02214784|SUI|sui
4969904|NCT04178200|Patient Satisfaction|patient satisfaction
4969905|NCT04178200|Pain Score|pain score
4969906|NCT04178187|Helicobacter Pylori|helicobacter pylori
4969907|NCT04178187|Probiotics|probiotics
4969908|NCT04178187|Eradication treatment of H.Pylori|eradication treatment of h.pylori
4969909|NCT04178187|Antibiotics|antibiotics
4988271|NCT04064814|Flunarizine|flunarizine
4969912|NCT04178187|Bifidobacterium lactis|bifidobacterium lactis
4969913|NCT04178187|Lactobacillus acidophilus|lactobacillus acidophilus
4969914|NCT04178187|Lactobacillus plantarum|lactobacillus plantarum
4969915|NCT04178174|head and neck cander|head and neck cander
4969916|NCT04178174|Oropharynx cancer|oropharynx cancer
4969917|NCT04178174|Human papilloma virus|human papilloma virus
4969918|NCT04178174|Radiotherapy|radiotherapy
4969919|NCT04178174|Stereotactic body radiotherapy|stereotactic body radiotherapy
4969920|NCT04178174|Chemotherapy|chemotherapy
4969921|NCT04178174|De-intensification|de-intensification
4969922|NCT04178148|Pharmacokinetics|pharmacokinetics
4969923|NCT04178148|dose optimisation|dose optimisation
4969924|NCT04178148|aminoglycosides|aminoglycosides
4969925|NCT04178135|poor or suboptimal ovarian response,GnRH agonist long protocol|poor or suboptimal ovarian response,gnrh agonist long protocol
4969926|NCT04178096|Hepatitis C|hepatitis c
4969927|NCT04178096|Liver Diseases|liver diseases
4969928|NCT04178096|Hepatitis|hepatitis
4969929|NCT04178096|Virus Diseases|virus diseases
4969930|NCT04178096|Cirrhosis, Liver|cirrhosis, liver
4969931|NCT04178096|Liver Cirrhoses|liver cirrhoses
4969932|NCT04178096|Hepatic Cirrhoses|hepatic cirrhoses
4969933|NCT04178096|Implementation Science|implementation science
4969934|NCT04178096|Strategies|strategies
4969935|NCT04178096|Evaluation|evaluation
4969936|NCT04178083|laparoscopy|laparoscopy
4969937|NCT04178083|pelvic organ prolapse|pelvic organ prolapse
4969938|NCT04178083|modified lateral süspension|modified lateral süspension
4969939|NCT04178083|pectopexy|pectopexy
4969940|NCT04178083|sacrohysteropexy|sacrohysteropexy
4969941|NCT04178083|hysteropexy|hysteropexy
4969942|NCT04178083|sacropexy|sacropexy
4969943|NCT04178083|cervicopexy|cervicopexy
4969944|NCT04178083|sacrocervicopexy|sacrocervicopexy
4969945|NCT04177992|Neonatology|neonatology
4969946|NCT04177992|Servo-control|servo-control
4969947|NCT04177992|Transcutaneous oxygen|transcutaneous oxygen
4969948|NCT04177992|Saturation monitoring|saturation monitoring
4969949|NCT04177979|Near-assisted learning|near-assisted learning
4969950|NCT04177979|Cost|cost
4969951|NCT04177979|Education environment|education environment
4969952|NCT04177979|OSCE|osce
4969953|NCT04177979|Problem-based learning|problem-based learning
4969954|NCT04177914|Hydrocephalus|hydrocephalus
4969955|NCT04177914|Infants|infants
4969956|NCT04177914|Ventriculoperitoneal Shunt|ventriculoperitoneal shunt
4969957|NCT04177914|ETV+CPC|etv+cpc
4969958|NCT04177914|endoscopic third ventriculostomy|endoscopic third ventriculostomy
5283698|NCT02253238|RT|rt
4969959|NCT04177914|choroid plexus cauterization|choroid plexus cauterization
4969960|NCT04177888|Hot pack, Labor pain, Duration of labor, Satisfaction, Primigravid women|hot pack, labor pain, duration of labor, satisfaction, primigravid women
4969961|NCT04177875|neoadjuvant therapy；pd-1 antibody combined with Chemoradiotherapy|neoadjuvant therapy；pd-1 antibody combined with chemoradiotherapy
4969962|NCT04177849|Pain|pain
4969963|NCT04177849|Nerve root dysfunction|nerve root dysfunction
4969964|NCT04177849|Anterior Cervical Decompression and Fusion|anterior cervical decompression and fusion
4969965|NCT04177849|Posterior Foraminotomy|posterior foraminotomy
4967756|NCT04191460|cancer|cancer
4969966|NCT04177836|Romantic relationship quality|romantic relationship quality
4969967|NCT04177836|Mindfulness|mindfulness
4969971|NCT04177810|Plerixafor|plerixafor
4969972|NCT04177810|Cemiplimab|cemiplimab
4969973|NCT04177810|Immunotherapy|immunotherapy
5018203|NCT03883139|DTT|dtt
4969978|NCT04177810|Metastatic pancreatic cancer|metastatic pancreatic cancer
4969979|NCT04177797|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4969981|NCT04177797|Neoadjuvant treatment|neoadjuvant treatment
4969982|NCT04177797|Chemotherapy|chemotherapy
4969983|NCT04177745|Peripheral venous catheter|peripheral venous catheter
4969984|NCT04177745|hot application|hot application
4969985|NCT04177745|cold application|cold application
4969986|NCT04177745|pain|pain
4969987|NCT04177745|anxiety|anxiety
4969988|NCT04177732|biomarkers|biomarkers
4969989|NCT04177732|Calprotectin|calprotectin
4969990|NCT04177732|Cross-linked N-telopeptides|cross-linked n-telopeptides
4969991|NCT04177706|Ketamine|ketamine
4969992|NCT04177654|parasitology|parasitology
4969993|NCT04177654|helminth infections|helminth infections
5012623|NCT03917511|Stroke|stroke
4969994|NCT04177654|Ascaris|ascaris
4969995|NCT04177654|Trichuris|trichuris
4969996|NCT04177654|hookworm|hookworm
4969997|NCT04177654|qPCR|qpcr
4969998|NCT04177654|microscopy|microscopy
4969999|NCT04177654|drug resistance|drug resistance
4970000|NCT04177654|diagnosis|diagnosis
4970001|NCT04177654|drug efficacy|drug efficacy
4970002|NCT04177641|thiol disulfide balance|thiol disulfide balance
4970003|NCT04177641|preinvasive lesion|preinvasive lesion
4970004|NCT04177641|cervix|cervix
4970005|NCT04177641|oxidative stress|oxidative stress
4970007|NCT04177615|Basilar Artery Occlusion|basilar artery occlusion
4970008|NCT04177602|trifluridine tipiracil chemoradiation|trifluridine tipiracil chemoradiation
4970009|NCT04177602|locally advanced rectal cancer|locally advanced rectal cancer
4970011|NCT04177602|adenocarcinoma of the rectum|adenocarcinoma of the rectum
4970012|NCT04177576|Polycythemia Vera (PV)|polycythemia vera (pv)
4970013|NCT04177576|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
4970014|NCT04177576|Neutrophil Extracellular Trap (NET)|neutrophil extracellular trap (net)
4970015|NCT04177576|Thrombosis|thrombosis
4970016|NCT04177563|whole-body cryotherapy|whole-body cryotherapy
4970017|NCT04177563|healthy men|healthy men
4970018|NCT04177563|blood components|blood components
4970019|NCT04177550|empyema thoracis|empyema thoracis
4970020|NCT04177550|Thoracoscopic|thoracoscopic
4970021|NCT04177550|VATS|vats
4970022|NCT04177550|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
4970023|NCT04177550|Pediatric Empyema Thoracis|pediatric empyema thoracis
4970024|NCT04177537|low-intensity ultrasound|low-intensity ultrasound
4970025|NCT04177537|continuous ultrasound|continuous ultrasound
4970026|NCT04177537|long-duration ultrasound|long-duration ultrasound
4970027|NCT04177537|athletic training|athletic training
4970028|NCT04177537|clinical trial|clinical trial
4970029|NCT04177537|soft tissue|soft tissue
4970030|NCT04177537|pain|pain
4970031|NCT04177537|Musculoskeletal tissue|musculoskeletal tissue
4970032|NCT04177537|ZetrOZ System LLC|zetroz system llc
4970033|NCT04177511|Chronic pelvic pain|chronic pelvic pain
4970034|NCT04177511|Transcutaneous Auricular Vagus Nerve Stimulation|transcutaneous auricular vagus nerve stimulation
4970035|NCT04177485|SMS reminder|sms reminder
4970036|NCT04177485|vaccination|vaccination
4970037|NCT04177485|immunization|immunization
4970038|NCT04177485|vaccination drop-out|vaccination drop-out
4970039|NCT04177485|vaccination timeliness|vaccination timeliness
4970040|NCT04177485|text reminder|text reminder
4970041|NCT04177485|mHealth|mhealth
4970042|NCT04177485|cell phone|cell phone
4970043|NCT04177485|mobile phone|mobile phone
4970044|NCT04177472|nutrition|nutrition
4970045|NCT04177472|parenting|parenting
4970046|NCT04177472|intergenerational feeding influences|intergenerational feeding influences
4970047|NCT04177472|sensitive feeding|sensitive feeding
4970048|NCT04177459|Adolescent|adolescent
4970049|NCT04177459|Fatigue|fatigue
4970050|NCT04177459|Rehabilitation|rehabilitation
4970051|NCT04177459|Health Promotion|health promotion
4970052|NCT04177459|Health-related Quality of Life|health-related quality of life
4970053|NCT04177459|Sense of Coherence|sense of coherence
4970054|NCT04177459|Emotions|emotions
4970055|NCT04177459|Mood|mood
4970056|NCT04177459|Leisure Activities|leisure activities
4970057|NCT04177446|national support|national support
4970058|NCT04177446|protein|protein
4970059|NCT04177446|critical illness|critical illness
4970060|NCT04177420|Types 2 Diabetes Mellitus|types 2 diabetes mellitus
4970061|NCT04177420|Glycation|glycation
4970062|NCT04177420|AGEs|ages
4970063|NCT04177420|hemoglobin A1c, HbA1c|hemoglobin a1c, hba1c
4970064|NCT04177420|Fasting blood sugar, GLU-AC|fasting blood sugar, glu-ac
4970065|NCT04177420|Insulin|insulin
4967871|NCT04190732|distress|distress
4975331|NCT04146246|G6PD|g6pd
4970084|NCT04177316|methylation|methylation
4970089|NCT04177277|Dialysis|dialysis
4970090|NCT04177277|mHealth|mhealth
4970091|NCT04177264|osteopathic manipulative treatment|osteopathic manipulative treatment
4970092|NCT04177264|transcutaneous auricular vagus nerve stimulation|transcutaneous auricular vagus nerve stimulation
4970093|NCT04177264|cytokines|cytokines
4970094|NCT04177264|immune cells|immune cells
4970095|NCT04177264|parasympathetic nervous system|parasympathetic nervous system
4970096|NCT04177264|heart rate variability|heart rate variability
4970097|NCT04177186|Cerebral palsy|cerebral palsy
4970098|NCT04177186|Botox|botox
4970099|NCT04177173|Methotrexate|methotrexate
4970100|NCT04177173|Statins|statins
4970101|NCT04177173|Rheumatoid Arthritis|rheumatoid arthritis
4970102|NCT04177160|music|music
4970103|NCT04177160|anxiety|anxiety
4970104|NCT04177160|autonomic nervous system|autonomic nervous system
4970105|NCT04177160|subjective cognition decline|subjective cognition decline
4970106|NCT04177147|Hypoglycemia|hypoglycemia
4970107|NCT04177147|Diabetes mellitus|diabetes mellitus
4970108|NCT04177147|Clinical decision support|clinical decision support
5699533|NCT00502762|topotecan|topotecan
4970113|NCT04177121|Physiotherapy|physiotherapy
4970114|NCT04177121|Referral|referral
4970130|NCT04177056|stereotactic|stereotactic
4970131|NCT04177056|SBRT|sbrt
4970132|NCT04177056|Bone mets|bone mets
4970133|NCT04177056|palliation|palliation
4970134|NCT04177056|pain relief|pain relief
4970135|NCT04177056|quality of life|quality of life
4970136|NCT04177030|circadian clock|circadian clock
4970137|NCT04177030|pesticides|pesticides
4970138|NCT04177030|fruits|fruits
4970139|NCT04177030|vegetables|vegetables
4970140|NCT04177030|diet|diet
4970141|NCT04177030|time|time
4970142|NCT04177017|stress|stress
4970143|NCT04177017|empathy|empathy
4970144|NCT04177017|sociality|sociality
4970145|NCT04177017|cortisol|cortisol
4970150|NCT04176887|Levetireacetam|levetireacetam
4970151|NCT04176887|Phenytoin|phenytoin
4970152|NCT04176887|status epilepticus|status epilepticus
4970153|NCT04176887|children|children
4970154|NCT04176874|Diastasis recti|diastasis recti
4970155|NCT04176874|Rectus abdominis diastasis|rectus abdominis diastasis
4970156|NCT04176874|Robotic surgical procedure|robotic surgical procedure
4970157|NCT04176861|audio-visual stimulation|audio-visual stimulation
4970158|NCT04176861|brainwave entrainment|brainwave entrainment
4970159|NCT04176822|pediatric surgery|pediatric surgery
4970160|NCT04176822|preoperative preparation|preoperative preparation
4970161|NCT04176822|animation|animation
4970162|NCT04176822|fear|fear
4970163|NCT04176822|pain|pain
4970164|NCT04176822|nursing|nursing
4970171|NCT04176796|Applied Ethics|applied ethics
4970172|NCT04176796|Medical Students|medical students
4970173|NCT04176796|Human Behavior|human behavior
4970174|NCT04176796|Decision Psychology|decision psychology
4970175|NCT04176770|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
4970176|NCT04176770|Post Operative|post operative
4970177|NCT04176770|Analgesia|analgesia
4970178|NCT04176731|T1D|t1d
4970179|NCT04176731|Omnipod|omnipod
4970180|NCT04176718|Multiple Myeloma|multiple myeloma
4970181|NCT04176718|Refractory Multiple Myeloma|refractory multiple myeloma
4970182|NCT04176718|Multiple Myeloma in Relapse|multiple myeloma in relapse
4970183|NCT04176718|Relapse|relapse
4970184|NCT04176705|Fractional laser|fractional laser
4970185|NCT04176705|Ablative Laser|ablative laser
4970186|NCT04176705|Carbon Dioxide Laser|carbon dioxide laser
4970187|NCT04176692|scapula dyskinesia|scapula dyskinesia
4970188|NCT04176692|muscle stiffness|muscle stiffness
4970189|NCT04176692|scapulohumeral rhythm|scapulohumeral rhythm
4970190|NCT04176692|electromyography|electromyography
4970191|NCT04176679|Women|women
4970192|NCT04176679|Retained Products of conception, Arterio venous malformation|retained products of conception, arterio venous malformation
4970193|NCT04176679|color doppler ultrasound|color doppler ultrasound
4970194|NCT04176679|embolization|embolization
4970195|NCT04176679|fertility|fertility
4970196|NCT04176666|cyberbullying|cyberbullying
4970197|NCT04176666|cyberaggression|cyberaggression
4970198|NCT04176666|mobile application|mobile application
4970199|NCT04176640|pediatric traumatic brain injury|pediatric traumatic brain injury
4970200|NCT04176627|fluid overload|fluid overload
4970201|NCT04176627|peritoneal dialysis|peritoneal dialysis
4970202|NCT04176627|lung ultrasound|lung ultrasound
4970203|NCT04176614|cereal-based snack fortified with legumes|cereal-based snack fortified with legumes
4970204|NCT04176614|body weight reduction|body weight reduction
4970205|NCT04176549|Ectopic Pregnancy|ectopic pregnancy
4970206|NCT04176549|Biomarker|biomarker
4970207|NCT04176510|Comorbidity|comorbidity
4970208|NCT04176510|Self-Management|self-management
4970209|NCT04176510|Charlson Comorbidity Index|charlson comorbidity index
4970210|NCT04176510|Health Coach|health coach
4970211|NCT04176484|ovarian cancer|ovarian cancer
4970212|NCT04176484|Opportunistic salpingectomy|opportunistic salpingectomy
4970214|NCT04176445|Sitting Position|sitting position
4970215|NCT04176445|Tilt Table|tilt table
4970216|NCT04176445|Ultrasonography|ultrasonography
4970217|NCT04176432|Emergency surgery|emergency surgery
4970218|NCT04176432|Frailty|frailty
4970219|NCT04176432|Elderly|elderly
4970220|NCT04176432|Postoperative complications|postoperative complications
4970221|NCT04176419|Head & neck cancer|head & neck cancer
4970222|NCT04176419|Microvascular free flap reconstruction|microvascular free flap reconstruction
4970223|NCT04176380|Multiple Myeloma|multiple myeloma
4970224|NCT04176380|Autologous Th1/Tc1 cell Therapy|autologous th1/tc1 cell therapy
4970225|NCT04176380|RAPA-201|rapa-201
4970226|NCT04176367|Pharmacokinetics|pharmacokinetics
4970232|NCT04176341|non pharmacological interventions|non pharmacological interventions
4970233|NCT04176341|chronic pain|chronic pain
4970234|NCT04176341|slackline|slackline
4970235|NCT04176341|mindfulness|mindfulness
4970236|NCT04176341|adapted physical activity|adapted physical activity
4970237|NCT04176341|self-hypnosis|self-hypnosis
4970238|NCT04176341|Qi Gong|qi gong
4970239|NCT04176341|shared decision making|shared decision making
4970240|NCT04176328|Cystic Fibrosis|cystic fibrosis
4970241|NCT04176328|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
4970242|NCT04176328|Teicoplanin|teicoplanin
4970243|NCT04176302|Motor fluctuation|motor fluctuation
4970244|NCT04176302|Parkinson|parkinson
4970245|NCT04176302|Accelerometer|accelerometer
4970246|NCT04176302|Parkinson diary|parkinson diary
4970247|NCT04176289|Pupillary Pain Index|pupillary pain index
5292370|NCT02213731|Cryoballoon|cryoballoon
4970248|NCT04176289|Postoperative Pain|postoperative pain
4970249|NCT04176289|Infrared Pupillometry|infrared pupillometry
4970250|NCT04176289|Postoperative Opioid Consumption|postoperative opioid consumption
4970252|NCT04176276|miRNA-25|mirna-25
4970253|NCT04176276|miRNA-192|mirna-192
4970254|NCT04176263|Parkinson Disease|parkinson disease
4970255|NCT04176263|Freezing of Gait|freezing of gait
4970257|NCT04176263|Gait adaptation|gait adaptation
4970258|NCT04176263|Split-belt|split-belt
4970259|NCT04176263|Treadmill training|treadmill training
4970357|NCT04175743|Ascending|ascending
4970276|NCT04176185|Environmental exposure chamber|environmental exposure chamber
4970288|NCT04176133|Vaccination|vaccination
4970289|NCT04176133|Geriatric|geriatric
4970290|NCT04176133|Immunology|immunology
4970291|NCT04176133|Influenza|influenza
4970292|NCT04176107|Cesarean delivery|cesarean delivery
4970293|NCT04176107|Anxiety|anxiety
4970294|NCT04176107|Informative-video|informative-video
4970295|NCT04176094|health service and systems research|health service and systems research
4970296|NCT04176094|population health|population health
4970297|NCT04176081|Intraductal carcinoma|intraductal carcinoma
4970298|NCT04176081|SChLAP1|schlap1
4970299|NCT04176081|Radiation therapy|radiation therapy
4970300|NCT04176042|Daytime Sleepiness|daytime sleepiness
4970301|NCT04176042|Environmental Determinants|environmental determinants
4970302|NCT04176042|Sleep Beliefs|sleep beliefs
4970303|NCT04176042|Sleep Attitudes|sleep attitudes
4970304|NCT04176042|Educational Intervention|educational intervention
4970305|NCT04176042|Focus Group|focus group
4970306|NCT04176042|Epworth Sleepiness Scale|epworth sleepiness scale
4970307|NCT04176029|severe malaria|severe malaria
4970308|NCT04176029|lung ultrasound|lung ultrasound
4970309|NCT04176029|prevalence of pulmonary diagnoses|prevalence of pulmonary diagnoses
4970310|NCT04176003|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
4970311|NCT04176003|Outcome measures|outcome measures
4970312|NCT04176003|Qualitative research|qualitative research
4970313|NCT04175990|progestogen|progestogen
4970314|NCT04175990|ovarian stimulation regime|ovarian stimulation regime
4970315|NCT04175990|IVF outcome|ivf outcome
4970316|NCT04175951|cataract|cataract
4970317|NCT04175951|intraocular lens|intraocular lens
4970318|NCT04175951|intermediate vision|intermediate vision
4970319|NCT04175938|Fuch's Dystrophy, FECD, Fuch's Endothelial Corneal Dystrophy|fuch's dystrophy, fecd, fuch's endothelial corneal dystrophy
4970320|NCT04175899|Capecitabine|capecitabine
4970321|NCT04175899|Pharmacist Intervention|pharmacist intervention
4970322|NCT04175899|Adherence|adherence
4970323|NCT04175899|Relative Dose Intensity|relative dose intensity
4970324|NCT04175899|Medication Knowledge|medication knowledge
4970325|NCT04175899|Safety|safety
4970326|NCT04175886|rheumatoid arthritis|rheumatoid arthritis
4970327|NCT04175886|tofacitinib|tofacitinib
4970328|NCT04175886|body composition|body composition
4970329|NCT04175886|bone marrow adiposity|bone marrow adiposity
4970330|NCT04175886|bone marrow density|bone marrow density
4970334|NCT04175834|cetirizine|cetirizine
4970335|NCT04175834|diphenhydramine|diphenhydramine
4970336|NCT04175821|Breast cancer|breast cancer
4970337|NCT04175821|Hypofractionated radiotherapy|hypofractionated radiotherapy
4970338|NCT04175821|Post mastectomy|post mastectomy
4970339|NCT04175808|Thorough QT|thorough qt
5296725|NCT02193334|HGF|hgf
4970340|NCT04175808|QTc study|qtc study
4970341|NCT04175795|Goal-setting|goal-setting
4970342|NCT04175795|Goal specificity|goal specificity
4970343|NCT04175795|Chronic conditions|chronic conditions
4970344|NCT04175795|Health outcome profile|health outcome profile
4970352|NCT04175743|Tolerability|tolerability
4970353|NCT04175743|Escalation|escalation
4970354|NCT04175743|Pharmacokinetics|pharmacokinetics
4970355|NCT04175743|PK|pk
4970356|NCT04175743|CT-044 HCl|ct-044 hcl
4970371|NCT04175678|Exercise|exercise
4970372|NCT04175678|Diet|diet
4970377|NCT04175652|Laughter Yoga|laughter yoga
4970378|NCT04175652|Hemodialysis|hemodialysis
4970379|NCT04175652|Pain|pain
4970380|NCT04175652|Sleep|sleep
4970381|NCT04175652|Beta Endorphin|beta endorphin
4970382|NCT04175639|cancer|cancer
4970383|NCT04175639|pain|pain
4970384|NCT04175639|fatigue|fatigue
4970385|NCT04175639|distress|distress
4970386|NCT04175639|coping|coping
4970387|NCT04175639|mHealth|mhealth
4970388|NCT04175639|symptom management|symptom management
4970389|NCT04175639|physical disability|physical disability
4970394|NCT04175613|Plaque Psoriasis|plaque psoriasis
4970395|NCT04175613|CC-10004|cc-10004
4970396|NCT04175613|Apremilast|apremilast
4970397|NCT04175613|Pediatric|pediatric
4970398|NCT04175613|Age 6 - 17 years|age 6 - 17 years
4970399|NCT04175587|Realgar-Indigo Naturalis Formula, Retinoic Acid|realgar-indigo naturalis formula, retinoic acid
4970400|NCT04175574|post-operative pain relief|post-operative pain relief
4970401|NCT04175574|post-operative anxiety|post-operative anxiety
4970402|NCT04175574|non-pharmacological adjuvant|non-pharmacological adjuvant
4970403|NCT04175574|closed shaft femur fracture|closed shaft femur fracture
4970404|NCT04175574|randomised controlled trial|randomised controlled trial
4988679|NCT04062253|HIV|hiv
5292475|NCT02213211|Anaemia|anaemia
4970406|NCT04175561|Nature-based health intervention|nature-based health intervention
4970407|NCT04175561|Nature on prescription|nature on prescription
4970408|NCT04175561|Mental health|mental health
4970409|NCT04175561|Nature connectedness|nature connectedness
4970410|NCT04175561|Nature relatedness|nature relatedness
4970411|NCT04175561|Therapeutic horticulture|therapeutic horticulture
4970412|NCT04175535|cervical disc herniation|cervical disc herniation
4970413|NCT04175535|endoscope|endoscope
4970414|NCT04175535|posterior|posterior
4970415|NCT04175535|minimally invasive spine surgery|minimally invasive spine surgery
4970416|NCT04175509|Postoperative Pain|postoperative pain
4970417|NCT04175509|Minimally-invasive Hysterectomy|minimally-invasive hysterectomy
4970418|NCT04175509|Opioid Use|opioid use
4970419|NCT04175509|Acetaminophen|acetaminophen
4970420|NCT04175509|Hysterectomy|hysterectomy
4970421|NCT04175496|Glycemic index|glycemic index
4970422|NCT04175496|Insulinemic index|insulinemic index
4970423|NCT04175496|Low carbohydrate|low carbohydrate
4970425|NCT04175496|Type 1 diabetes|type 1 diabetes
4970426|NCT04175418|Multiple Sclerosis|multiple sclerosis
4970427|NCT04175418|Rehabilitation|rehabilitation
4970428|NCT04175418|Physical Activity|physical activity
4970429|NCT04175418|Exercise|exercise
4970430|NCT04175405|ATP, biostimulation, micro-screw, Periotest, semiconductor laser|atp, biostimulation, micro-screw, periotest, semiconductor laser
4970437|NCT04175366|Shared Decision Making|shared decision making
4970438|NCT04175366|Compulsory Care|compulsory care
4970439|NCT04175366|Psychiatric Care|psychiatric care
4970440|NCT04175353|older people|older people
4970441|NCT04175353|nutrition|nutrition
4970443|NCT04175353|berries|berries
4970444|NCT04175353|postprandial|postprandial
4970445|NCT04175353|glucose|glucose
4970446|NCT04175353|insulin|insulin
4970447|NCT04175301|neuroprotection|neuroprotection
4970448|NCT04175301|hydrogen|hydrogen
4970449|NCT04175301|antioxidant|antioxidant
4970450|NCT04175301|malignant glioma|malignant glioma
4970451|NCT04175249|Salt challenge|salt challenge
4970452|NCT04175249|Immune cell metabolism|immune cell metabolism
4970453|NCT04175249|Oxygen consumption rate|oxygen consumption rate
4970454|NCT04175249|Extracellular acidification rate|extracellular acidification rate
4970455|NCT04175249|Cytokine production|cytokine production
4970456|NCT04175197|Stenosis|stenosis
4970457|NCT04175197|Drug Coated Balloon|drug coated balloon
4970458|NCT04175197|Paclitaxel|paclitaxel
4970459|NCT04175197|Artery Disease|artery disease
4970460|NCT04175184|rotator cuff pain|rotator cuff pain
4970466|NCT04175145|correction|correction
4970467|NCT04175145|Pakistan|pakistan
4970469|NCT04175067|Early stage|early stage
4970470|NCT04175067|thiol disulfide hemostasis|thiol disulfide hemostasis
4970471|NCT04175067|malignancy|malignancy
4975707|NCT04143633|Nutritional status|nutritional status
4970486|NCT04174989|Plasminogen-Depleted Plasma|plasminogen-depleted plasma
4970487|NCT04174989|Plasma Transfusion|plasma transfusion
4970488|NCT04174950|Laryngeal cancer|laryngeal cancer
4970489|NCT04174950|enhanced recovery after surgery|enhanced recovery after surgery
4970491|NCT04174937|Safety|safety
4970492|NCT04174937|Iodine complex|iodine complex
4970493|NCT04174937|Pharmacokinetics|pharmacokinetics
4970494|NCT04174937|Antibiotic potentiator|antibiotic potentiator
5389319|NCT01770652|L1|l1
4970495|NCT04174898|human Mesenchymal Stem Cells (hMSC)|human mesenchymal stem cells (hmsc)
4970496|NCT04174898|Anti-Aging|anti-aging
4970497|NCT04174898|Regenerative Medicine|regenerative medicine
4970498|NCT04174898|Adipose Derived MSCs|adipose derived mscs
4970499|NCT04174898|Umbilical Cord Derived MSCs|umbilical cord derived mscs
4970500|NCT04174898|Autologous hMSC|autologous hmsc
4970501|NCT04174898|Allogenic hMSC|allogenic hmsc
4970502|NCT04174859|Atrial Fibrillation (AF)|atrial fibrillation (af)
4970503|NCT04174859|NVAF|nvaf
4970504|NCT04174833|GlideScope|glidescope
4970505|NCT04174833|Airway Management|airway management
4970506|NCT04174833|Videolaryngoscopic Intubation|videolaryngoscopic intubation
4970507|NCT04174820|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4970508|NCT04174807|gastroschisis|gastroschisis
4970509|NCT04174807|prenatal diagnosis|prenatal diagnosis
4970510|NCT04174807|gastrointestinal complications|gastrointestinal complications
4970511|NCT04174807|wall defect|wall defect
4970527|NCT04174690|Dynamic postural balance|dynamic postural balance
4970529|NCT04174690|Posturography|posturography
4970530|NCT04174690|Electromyography|electromyography
4970531|NCT04174677|cPRA, HLA antibodies, kidney transplantation|cpra, hla antibodies, kidney transplantation
4970532|NCT04174664|pulmonary exacerbation|pulmonary exacerbation
4970533|NCT04174638|Compliance|compliance
4970534|NCT04174638|Motivational Interviewing|motivational interviewing
4970535|NCT04174638|Models, Nursing|models, nursing
4970536|NCT04174638|Nursing|nursing
4970537|NCT04174638|Patient Satisfaction|patient satisfaction
4970538|NCT04174638|Quality of Life|quality of life
4970539|NCT04174638|Randomized Controlled Trial|randomized controlled trial
4970540|NCT04174638|Renal Dialysis|renal dialysis
4970541|NCT04174625|omega 3|omega 3
4970542|NCT04174625|25 hydroxyvitamin D|25 hydroxyvitamin d
4970543|NCT04174625|25OHD|25ohd
4970544|NCT04174625|Vitamin D|vitamin d
4970547|NCT04174573|tDCS|tdcs
4970548|NCT04174573|Quality of Life|quality of life
4970549|NCT04174573|Parkinson Disease|parkinson disease
4970550|NCT04174573|Neuronal Plasticity|neuronal plasticity
4970554|NCT04174547|Somatic mutations|somatic mutations
4970555|NCT04174547|Clonal hematopoiesis|clonal hematopoiesis
4970556|NCT04174547|Biomarkers|biomarkers
4970558|NCT04174547|Innovative predictive models|innovative predictive models
4970559|NCT04174547|EuroBloodNet|eurobloodnet
4970561|NCT04174469|neurotoxicity|neurotoxicity
4970562|NCT04174469|ATP binding cassette subfamily B member 1|atp binding cassette subfamily b member 1
4970563|NCT04174469|ABCB1/P-glycoprotein (P-gp)|abcb1/p-glycoprotein (p-gp)
4970564|NCT04174469|multidrug transporter|multidrug transporter
4970565|NCT04174469|drug adverse event|drug adverse event
4970566|NCT04174469|Ivermectin toxicity|ivermectin toxicity
4970567|NCT04174443|Trigeminal neuralgia|trigeminal neuralgia
4970568|NCT04174443|Pulsed radiofrequency|pulsed radiofrequency
4970569|NCT04174443|Continuous radiofrequency|continuous radiofrequency
4970570|NCT04174443|High-voltage pulsed radiofrequency combined with low-temperature continuous radiofrequency|high-voltage pulsed radiofrequency combined with low-temperature continuous radiofrequency
4970581|NCT04174404|Self-efficacy|self-efficacy
4970582|NCT04174404|Preoperative anxiety|preoperative anxiety
4970583|NCT04174391|breast cancer prognosis|breast cancer prognosis
4970584|NCT04174391|Mediterranean diet|mediterranean diet
4970585|NCT04174391|extra-virgin olive oil|extra-virgin olive oil
4970586|NCT04174391|low-fat diet|low-fat diet
4970587|NCT04174378|Luteal phase support|luteal phase support
4970588|NCT04174378|GnRH agonist|gnrh agonist
4970589|NCT04174378|in vitro fertilization|in vitro fertilization
4970590|NCT04174365|Autism|autism
4970591|NCT04174365|Irritability|irritability
5699534|NCT00502749|Leukemia|leukemia
4970592|NCT04174365|Autism Spectrum Disorder|autism spectrum disorder
4970593|NCT04174365|ASD|asd
4970594|NCT04174326|Cognitive Behavioral Therapy|cognitive behavioral therapy
4970595|NCT04174300|Manual Therapy|manual therapy
4970596|NCT04174300|Physiotherapy|physiotherapy
4970597|NCT04174300|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
4970598|NCT04174300|Fibromyalgia (FM)|fibromyalgia (fm)
4970599|NCT04174300|RNAseq|rnaseq
4970600|NCT04174300|microRNA|microrna
4970601|NCT04174300|mechanomiR|mechanomir
4970602|NCT04174287|18F-FDG PET scan|18f-fdg pet scan
4970603|NCT04174287|amyloid PET|amyloid pet
4970604|NCT04174287|Amyloid beta|amyloid beta
4970605|NCT04174287|Alzheimer's disease|alzheimer's disease
4970606|NCT04174287|metabolic connectivity|metabolic connectivity
4970607|NCT04174287|functional connectivity|functional connectivity
4970608|NCT04174248|breast cancer|breast cancer
4970609|NCT04174248|m-Health application|m-health application
4970610|NCT04174248|self-management|self-management
4970611|NCT04174248|life of quality|life of quality
4970612|NCT04174235|Fetal anomalies|fetal anomalies
4970613|NCT04174209|Keratoconus|keratoconus
4970614|NCT04174209|Corneal Topography|corneal topography
4970615|NCT04174209|Eyeglasses|eyeglasses
4970616|NCT04174209|Ocular Refraction|ocular refraction
4970617|NCT04174209|Jackson Cross Cylinder|jackson cross cylinder
4970618|NCT04174209|Astigmatic Dial Technique|astigmatic dial technique
4970619|NCT04174209|Stenopeic slit|stenopeic slit
4970620|NCT04174196|CC-486|cc-486
4970621|NCT04174196|Plasmacytoma|plasmacytoma
4970622|NCT04174196|lenalidomide|lenalidomide
4970623|NCT04174196|Plasmacytoma of Bone|plasmacytoma of bone
4970624|NCT04174196|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4970625|NCT04174196|19-284|19-284
4970626|NCT04174196|multiple myeloma with plasmacytomas|multiple myeloma with plasmacytomas
4970627|NCT04174196|multiple myeloma|multiple myeloma
4970628|NCT04174170|PTSD|ptsd
4970629|NCT04174144|Sagittal balance|sagittal balance
4970630|NCT04174144|Lumbar lordosis|lumbar lordosis
4970631|NCT04174144|Clinical outcomes|clinical outcomes
4970632|NCT04174092|Catastrophism|catastrophism
4970633|NCT04174079|adjuvant chemotherapy|adjuvant chemotherapy
4970634|NCT04174053|Temperature measurement|temperature measurement
4970635|NCT04174053|capsule thermometers|capsule thermometers
4970636|NCT04174053|Haematology|haematology
4970637|NCT04174040|music|music
4970638|NCT04174040|Cognitive Behavioral Therapy|cognitive behavioral therapy
4970639|NCT04174040|randomized controlled trial|randomized controlled trial
4970640|NCT04174040|rhythm|rhythm
4970641|NCT04174027|Chronic ankle instability ( CAI )|chronic ankle instability ( cai )
4970642|NCT04174027|Perturbration|perturbration
4970643|NCT04174027|reactive postural control|reactive postural control
4970644|NCT04174027|balance|balance
4970645|NCT04174027|center of pressure - COP|center of pressure - cop
4970647|NCT04173962|Ketamine|ketamine
4970648|NCT04173962|Resilience|resilience
4970649|NCT04173962|Stress|stress
4970650|NCT04173962|Healthy Volunteers|healthy volunteers
4970651|NCT04173923|Cervical Myelopathy|cervical myelopathy
5292663|NCT02212340|vitrectomy|vitrectomy
4970652|NCT04173923|Korean medicine treatment|korean medicine treatment
4970667|NCT04173754|Motion Style Acupuncture Treatment|motion style acupuncture treatment
4970668|NCT04173754|Shoulder pains|shoulder pains
4970669|NCT04173741|Positive Pressure Ventilation|positive pressure ventilation
4970670|NCT04173741|Fluid Responsiveness|fluid responsiveness
4970671|NCT04173741|Passive Leg Raise|passive leg raise
4970672|NCT04173741|Inferior Vena Cava|inferior vena cava
4975938|NCT04142372|digitalization|digitalization
4970682|NCT04173715|Physical Function|physical function
4970683|NCT04173715|Frailty Syndrome|frailty syndrome
4970684|NCT04173715|Energy Expenditure|energy expenditure
4970685|NCT04173715|Aging|aging
4970686|NCT04173702|Balance|balance
4970687|NCT04173702|Stance width|stance width
4970688|NCT04173702|Postural sway|postural sway
4970689|NCT04173702|Limits of stability|limits of stability
4970690|NCT04173689|Sarcoidosis|sarcoidosis
4970691|NCT04173650|Exosomes|exosomes
4970692|NCT04173637|IL12/23|il12/23
4970693|NCT04173624|EUS|eus
4970694|NCT04173624|MRCP|mrcp
4970695|NCT04173624|Intermediate Probability|intermediate probability
4970696|NCT04173611|Pharmacodynamics|pharmacodynamics
4970697|NCT04173611|Pharmacokinetics|pharmacokinetics
4970698|NCT04173611|Safety|safety
4970699|NCT04173611|Efficacy|efficacy
4970700|NCT04173598|schizophrenia|schizophrenia
4970701|NCT04173598|remediation|remediation
4970702|NCT04173598|cognitive|cognitive
4970703|NCT04173585|Acute Myeloid Leukemia|acute myeloid leukemia
4970704|NCT04173585|therapy resistance|therapy resistance
4970705|NCT04173585|refractory/relapsed|refractory/relapsed
4970706|NCT04173585|AML|aml
4970722|NCT04173481|Stroke|stroke
4970723|NCT04173481|Proprioceptive Neuromuscular Facility|proprioceptive neuromuscular facility
4970724|NCT04173481|Hemiplegia|hemiplegia
4970725|NCT04173481|Neurorehabilitation|neurorehabilitation
4970726|NCT04173481|Neural Plasticity|neural plasticity
4970727|NCT04173468|Anterior Knee Pain Syndrome|anterior knee pain syndrome
4970728|NCT04173429|Low molecular weight heparin|low molecular weight heparin
4970729|NCT04173429|warfarin|warfarin
4970730|NCT04173377|Orthopedic Surgery|orthopedic surgery
4970744|NCT04173351|childbirth fear|childbirth fear
4970745|NCT04173351|antenatal education|antenatal education
4970746|NCT04173351|counseling|counseling
4970747|NCT04173351|attitude|attitude
4970748|NCT04173351|pain|pain
4970749|NCT04173325|Lung cancer|lung cancer
4970750|NCT04173325|Relapsed lung cancer|relapsed lung cancer
4970751|NCT04173312|local anesthetic|local anesthetic
4970752|NCT04173312|continuous infusion|continuous infusion
4970753|NCT04173312|pain control|pain control
4970754|NCT04173273|Etrasimod|etrasimod
4970755|NCT04173273|Crohn's disease|crohn's disease
4970756|NCT04173273|APD334|apd334
4970757|NCT04173273|Inflammatory bowel disease|inflammatory bowel disease
4970773|NCT04173195|Comfort talk|comfort talk
4970774|NCT04173195|Outpatient clinic|outpatient clinic
4970775|NCT04173195|Emotional support|emotional support
4970776|NCT04173195|Pain|pain
4970777|NCT04173195|Nursing care|nursing care
4970778|NCT04173182|colonoscopy|colonoscopy
4970779|NCT04173182|diverticular disease|diverticular disease
4970780|NCT04173143|endurance training,|endurance training,
4970787|NCT04173091|tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle|tricuspid regurgitation, tricuspid valve, percutaneous treatment, right ventricle
4970788|NCT04173078|distress intolerance|distress intolerance
4970789|NCT04173078|stress|stress
4970790|NCT04173052|Infertility|infertility
4970791|NCT04173052|Electrical shock|electrical shock
4970792|NCT04173052|sperms activation|sperms activation
4970793|NCT04173052|Semen Analysis|semen analysis
4970794|NCT04172935|Presbyopia|presbyopia
4970795|NCT04172935|textile worker|textile worker
4970796|NCT04172896|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
4970797|NCT04172896|Prolapse Surgery|prolapse surgery
4970798|NCT04172883|Reactive ATP|reactive atp
4970799|NCT04172883|device based Management of Atrial fibrilation|device based management of atrial fibrilation
4970800|NCT04172883|AF Management|af management
4970806|NCT04172844|leukemia|leukemia
4970807|NCT04172844|acute myeloid leukemia|acute myeloid leukemia
4970808|NCT04172831|Pain|pain
4970809|NCT04172831|Sleep|sleep
4970810|NCT04172831|Fibromyalgia|fibromyalgia
4970812|NCT04172818|allogenic hematopoietic stem cell transplantation|allogenic hematopoietic stem cell transplantation
4970813|NCT04172818|diary|diary
4970814|NCT04172818|psychological disorders|psychological disorders
4970815|NCT04172779|hepatocellular carcinoma|hepatocellular carcinoma
4970816|NCT04172779|chemoprevention|chemoprevention
4970817|NCT04172766|Hearing Loss|hearing loss
4970818|NCT04172766|Noise Exposure|noise exposure
4970819|NCT04172766|Noise Induced Hearing Loss|noise induced hearing loss
4970820|NCT04172766|Listening Volume|listening volume
4970821|NCT04172766|Environmental Noise|environmental noise
4970822|NCT04172766|Music|music
4970823|NCT04172766|Audiometry|audiometry
4970824|NCT04172766|Speech-in-Noise|speech-in-noise
4970825|NCT04172766|Hearing Ability|hearing ability
4970826|NCT04172753|Radiotherapy|radiotherapy
4970827|NCT04172753|Adaptive Radiotherapy|adaptive radiotherapy
4970833|NCT04172688|Pain|pain
4970834|NCT04172688|Gut microbiota|gut microbiota
4970835|NCT04172688|Prebiotic|prebiotic
4970836|NCT04172675|Non muscle invasive bladder cancer (NMIBC)|non muscle invasive bladder cancer (nmibc)
4970837|NCT04172675|Bacillus calmette- guerin (BCG) failure|bacillus calmette- guerin (bcg) failure
4970838|NCT04172675|BCG unresponsive|bcg unresponsive
4970839|NCT04172649|prostate cancer|prostate cancer
4970840|NCT04172649|pain management|pain management
4970841|NCT04172649|acupuncture|acupuncture
4970842|NCT04172649|acupressure|acupressure
4970843|NCT04172597|EGFR activating mutations|egfr activating mutations
4970844|NCT04172597|HER2 activating mutations|her2 activating mutations
4970845|NCT04172597|HER2-positive breast cancer|her2-positive breast cancer
4970846|NCT04172597|HER2-negative breast cancer|her2-negative breast cancer
4970847|NCT04172571|VEGF|vegf
4989065|NCT04059614|HFNC|hfnc
4970852|NCT04172558|Eractile Dysfunction|eractile dysfunction
4970854|NCT04172519|pelvic floor muscles training|pelvic floor muscles training
4970855|NCT04172519|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
4970863|NCT04172454|PD1/CTLA4|pd1/ctla4
4970864|NCT04172454|PD-1/PD-L1 relapsed/refractory tumors|pd-1/pd-l1 relapsed/refractory tumors
4970865|NCT04172415|Procedural Sedation|procedural sedation
4970866|NCT04172415|Chart Review|chart review
4970867|NCT04172402|Advanced Biliary Tract Cancer|advanced biliary tract cancer
4970868|NCT04172402|Nivolumab|nivolumab
4970869|NCT04172402|Phase 2|phase 2
4970870|NCT04172376|basal ganglion hemorrhage|basal ganglion hemorrhage
4970871|NCT04172376|stereotactic surgery|stereotactic surgery
4970872|NCT04172376|thrombolysis|thrombolysis
4970873|NCT04172350|women|women
4970874|NCT04172350|breast cancer|breast cancer
4970875|NCT04172350|surgery|surgery
4970876|NCT04172350|perioperative care|perioperative care
4970877|NCT04172350|self-efficacy|self-efficacy
4970878|NCT04172350|randomised controlled trial|randomised controlled trial
4970879|NCT04172337|nutrition|nutrition
4970880|NCT04172337|front-of-pack label|front-of-pack label
4970881|NCT04172337|calories|calories
4970882|NCT04172337|online grocery store|online grocery store
4970883|NCT04172337|Singapore|singapore
4970884|NCT04172337|physical activity equivalent|physical activity equivalent
4970885|NCT04172324|gait|gait
4970886|NCT04172324|biomechanics|biomechanics
4970887|NCT04172298|Meridian|meridian
4970888|NCT04172298|Internal visceral organs|internal visceral organs
4970889|NCT04172298|Zusanli|zusanli
4970890|NCT04172298|Shaohai|shaohai
4970891|NCT04172298|Acupoint|acupoint
4970892|NCT04172272|Transversus abdominis plane block|transversus abdominis plane block
4970893|NCT04172272|Laparotomy|laparotomy
4970894|NCT04172272|Hysterectomy|hysterectomy
4970895|NCT04172272|Postoperative pain|postoperative pain
4970896|NCT04172272|Cytokines|cytokines
4970897|NCT04172272|Visual analogue scale|visual analogue scale
4970898|NCT04172272|Quality of recovery|quality of recovery
4970899|NCT04172259|Human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
4970900|NCT04172259|Pathology complete response|pathology complete response
4970901|NCT04172246|relapsed/refractory chronic lymphocytic leukemia|relapsed/refractory chronic lymphocytic leukemia
4970902|NCT04172246|relapsed/refractory small lymphocytic lymphoma|relapsed/refractory small lymphocytic lymphoma
4970903|NCT04172246|treatment-naïve chronic lymphocytic leukemia|treatment-naïve chronic lymphocytic leukemia
4970904|NCT04172246|treatment-naïve /small lymphocytic lymphoma|treatment-naïve /small lymphocytic lymphoma
4970905|NCT04172246|relapsed/refractory mantle cell lymphoma|relapsed/refractory mantle cell lymphoma
4970906|NCT04172246|relapsed/refractory marginal zone lymphoma|relapsed/refractory marginal zone lymphoma
4970907|NCT04172246|relapsed/refractory follicular lymphoma|relapsed/refractory follicular lymphoma
4970908|NCT04172246|relapsed/refractory Waldenström macroglobulinemia|relapsed/refractory waldenström macroglobulinemia
4970909|NCT04172246|treatment-naïve Waldenström macroglobulinemia|treatment-naïve waldenström macroglobulinemia
4970910|NCT04172233|IL12/23|il12/23
4970911|NCT04172220|Breast Cancer|breast cancer
4970912|NCT04172220|PECS|pecs
4970913|NCT04172220|Neutrophil to Lymphocyte ratio|neutrophil to lymphocyte ratio
4970914|NCT04172220|Quadrantectomy|quadrantectomy
4970915|NCT04172181|cord blood stem cell transplantation|cord blood stem cell transplantation
4970916|NCT04172181|severe combined immunodeficiency disease|severe combined immunodeficiency disease
4970917|NCT04172181|primary immunodeficiency|primary immunodeficiency
4970918|NCT04172168|Left Ventricular Free-wall Ruptrue|left ventricular free-wall ruptrue
4970919|NCT04172168|Acute myocardial infarction|acute myocardial infarction
4970920|NCT04172168|Coronary angiography|coronary angiography
4970921|NCT04172142|Pectus Carinatum|pectus carinatum
4970922|NCT04172142|Pectus Excavatum|pectus excavatum
4970923|NCT04172142|Physical Impairment|physical impairment
4970924|NCT04172142|Psychosocial Impairment|psychosocial impairment
4970925|NCT04172129|Nanos|nanos
4970933|NCT04172077|Self Efficacy|self efficacy
4970934|NCT04172077|Resiliency|resiliency
4970935|NCT04172077|Attachment style and youth with type 1 diabetes|attachment style and youth with type 1 diabetes
4970936|NCT04172038|stepped care|stepped care
4970937|NCT04172038|physical therapy|physical therapy
4970938|NCT04172038|mindfulness|mindfulness
4970939|NCT04172038|holistic health|holistic health
4970940|NCT04172038|military medicine|military medicine
4970953|NCT04171999|Clinical Trial|clinical trial
4970954|NCT04171999|Hunger|hunger
4970955|NCT04171999|Self-Efficacy|self-efficacy
4970956|NCT04171999|Health-Related Social Needs|health-related social needs
4970957|NCT04171986|Small Cell Lung Cancer|small cell lung cancer
4970958|NCT04171986|HHPG-19K|hhpg-19k
4970959|NCT04171960|i-STAT|i-stat
4970960|NCT04171960|Traumatic Brain Injury|traumatic brain injury
4970961|NCT04171960|Biomarkers|biomarkers
4970963|NCT04171947|Polyphenols|polyphenols
4970964|NCT04171947|Nugent score|nugent score
4970965|NCT04171947|Antioxidants|antioxidants
4970966|NCT04171947|Vaginal pH|vaginal ph
4970967|NCT04171947|complementary medicine|complementary medicine
4970968|NCT04171921|Open ventral hernia repair|open ventral hernia repair
4970969|NCT04171921|Robotic ventral hernia repair|robotic ventral hernia repair
4970970|NCT04171921|Surgical site complications|surgical site complications
4970971|NCT04171921|Esthetic satisfaction|esthetic satisfaction
4970972|NCT04171921|Pain|pain
4970973|NCT04171921|Pain-killers consumption|pain-killers consumption
4970974|NCT04171921|Costs|costs
4970975|NCT04171921|Operative time|operative time
4970976|NCT04171921|Early hernia recurrence|early hernia recurrence
4970977|NCT04171921|General complications|general complications
4970978|NCT04171895|Communication training|communication training
4970979|NCT04171895|19-398|19-398
4970980|NCT04171856|Acute stroke|acute stroke
4970981|NCT04171856|Motor skill learning|motor skill learning
4970982|NCT04171856|Upper limb|upper limb
4970983|NCT04171856|Rehabilitation|rehabilitation
4970984|NCT04171856|Subacute stroke|subacute stroke
4970985|NCT04171830|palliative care|palliative care
4970986|NCT04171830|end of life|end of life
4970987|NCT04171830|clinical surveillance|clinical surveillance
4970988|NCT04171817|therapy dog|therapy dog
4970989|NCT04171817|canine|canine
4970990|NCT04171817|animal assisted intervention|animal assisted intervention
4970991|NCT04171817|chlorhexidine|chlorhexidine
4970992|NCT04171817|child|child
4970993|NCT04171804|Parkinson's Disease|parkinson's disease
4970994|NCT04171804|Mild Cognitive Impairment|mild cognitive impairment
4970995|NCT04171804|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4970996|NCT04171804|Cognitive functions|cognitive functions
4970997|NCT04171804|Electrophysiology|electrophysiology
4970998|NCT04171804|Event related potentials|event related potentials
4971000|NCT04171778|proteinuria|proteinuria
4971001|NCT04171778|diet|diet
4971002|NCT04171778|plant-based diet|plant-based diet
4971003|NCT04171778|vegan|vegan
4971004|NCT04171778|randomized controlled trial|randomized controlled trial
4971005|NCT04171752|elafibranor|elafibranor
4971006|NCT04171726|Thrombosis|thrombosis
4971007|NCT04171726|Aortic Valve Stenosis|aortic valve stenosis
4971008|NCT04171726|Heart Valve Diseases|heart valve diseases
4971009|NCT04171726|Ventricular Outflow Obstruction|ventricular outflow obstruction
4971010|NCT04171726|Cardiovascular Diseases|cardiovascular diseases
4971011|NCT04171726|Embolism and Thrombosis|embolism and thrombosis
4971012|NCT04171726|Vascular Diseases|vascular diseases
4971013|NCT04171726|Heart Diseases|heart diseases
4971014|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors
4971015|NCT04171726|Anticoagulants|anticoagulants
4971016|NCT04171713|bariatric surgery|bariatric surgery
4971017|NCT04171713|weight regain|weight regain
4971018|NCT04171713|food behavior|food behavior
4971019|NCT04171713|mindfulness|mindfulness
4971020|NCT04171713|compassion|compassion
4971021|NCT04171713|empathy|empathy
4971022|NCT04171700|rucaparib|rucaparib
4971023|NCT04171700|PARPi|parpi
4971024|NCT04171700|rare tumor|rare tumor
4971025|NCT04171700|solid tumor|solid tumor
4971026|NCT04171700|CO-338|co-338
4971027|NCT04171700|ovarian cancer|ovarian cancer
4971028|NCT04171700|prostate cancer|prostate cancer
4971029|NCT04171700|pancreatic cancer|pancreatic cancer
4971030|NCT04171700|breast cancer|breast cancer
4971031|NCT04171700|lung cancer|lung cancer
4971032|NCT04171700|colon cancer|colon cancer
4971033|NCT04171700|gastric cancer|gastric cancer
4971034|NCT04171700|bladder cancer|bladder cancer
4971035|NCT04171700|colorectal cancer|colorectal cancer
4971036|NCT04171700|PARP inhibitor|parp inhibitor
4971037|NCT04171700|homologous recombination|homologous recombination
4971038|NCT04171700|DNA repair|dna repair
4971039|NCT04171700|LODESTAR|lodestar
4971040|NCT04171700|germline|germline
4971042|NCT04171700|BRCA1|brca1
4971043|NCT04171700|BRCA2|brca2
4971044|NCT04171700|PALB2|palb2
4971045|NCT04171700|RAD51C|rad51c
4971046|NCT04171700|RAD51D|rad51d
4971047|NCT04171700|BARD1|bard1
4971048|NCT04171700|BRIP1|brip1
4971049|NCT04171700|FANCA|fanca
4971050|NCT04171700|RAD51|rad51
4971074|NCT04171661|Skin Substitute|skin substitute
4971075|NCT04171648|diet management|diet management
4971076|NCT04171648|weight management|weight management
4971085|NCT04171583|cystic fibrosis|cystic fibrosis
4971086|NCT04171583|staphylococcus aureus|staphylococcus aureus
4971088|NCT04171570|Distal Transradial Access|distal transradial access
4971089|NCT04171570|Randomized Multicenter Trial|randomized multicenter trial
4971090|NCT04171570|Radial Access|radial access
4971091|NCT04171557|Exercise|exercise
4971092|NCT04171557|Physical Activity|physical activity
4971093|NCT04171557|Bicycling|bicycling
4971094|NCT04171531|urinary incontinence|urinary incontinence
4971095|NCT04171531|midurethral sling|midurethral sling
4971096|NCT04171531|Botulinum toxin A (Botox A ®)|botulinum toxin a (botox a ®)
4971097|NCT04171466|Gut microbiome|gut microbiome
4971098|NCT04171466|Dysbiosis|dysbiosis
4971099|NCT04171466|Antibiotic therapy|antibiotic therapy
4971100|NCT04171466|Rationally-defined consortia|rationally-defined consortia
4971101|NCT04171466|Short-chain fatty acids|short-chain fatty acids
4971102|NCT04171466|Gut metabolome|gut metabolome
4971103|NCT04171466|Metagenomic sequencing|metagenomic sequencing
4971104|NCT04171466|Ciproflozacin|ciproflozacin
4971105|NCT04171466|Metronidazole|metronidazole
4971106|NCT04171466|Probiotic Therapy|probiotic therapy
4971107|NCT04171440|minimal invasive, robotic, laparoscopic,open|minimal invasive, robotic, laparoscopic,open
4971108|NCT04171388|Low birthweight|low birthweight
4971109|NCT04171388|Preterm birth|preterm birth
4968736|NCT04184895|ASP2390|asp2390
4968737|NCT04184895|Safety|safety
4968742|NCT04184869|Belinostat|belinostat
4968743|NCT04184869|beleodaq|beleodaq
4968744|NCT04184869|Belinostat treatment extension|belinostat treatment extension
4968745|NCT04184856|reward sensitivity|reward sensitivity
4968746|NCT04184856|neuroimaging|neuroimaging
4971110|NCT04171388|Maternal nutrition|maternal nutrition
4971111|NCT04171388|Small for gestational age|small for gestational age
4971112|NCT04171388|Chlamydia|chlamydia
4971113|NCT04171388|Gonorrhea|gonorrhea
4971114|NCT04171388|Urinary tract infection|urinary tract infection
4971115|NCT04171388|Presumptive antibiotics|presumptive antibiotics
4971116|NCT04171349|Hemodialysis|hemodialysis
4971117|NCT04171284|Non-small cell lung cancer|non-small cell lung cancer
4971118|NCT04171284|Squamous cell carcinoma|squamous cell carcinoma
4971119|NCT04171245|Sleep, laughter, well-being, mental health|sleep, laughter, well-being, mental health
4971120|NCT04171232|Cerebral Palsy|cerebral palsy
4971121|NCT04171232|Child|child
4971122|NCT04171232|Hemiplegia|hemiplegia
4971123|NCT04171232|Motor Activity|motor activity
4971124|NCT04171232|Upper Extremity|upper extremity
4971125|NCT04171206|Interpersonal partner violence|interpersonal partner violence
4971126|NCT04171206|Dating violence|dating violence
4971127|NCT04171206|Internet-delivered intervention|internet-delivered intervention
4971128|NCT04171193|Isoflurane|isoflurane
4971129|NCT04171193|Anesthesia|anesthesia
4971130|NCT04171193|Treatment resistant depression|treatment resistant depression
4971131|NCT04171193|Deep anesthesia|deep anesthesia
4971132|NCT04171193|Burst suppression|burst suppression
4971133|NCT04171193|Depressive episode|depressive episode
4971134|NCT04171167|Nasal nitric oxide|nasal nitric oxide
4971135|NCT04171167|Nitric oxide metabolites|nitric oxide metabolites
4971156|NCT04171063|Conservative treatment|conservative treatment
4971157|NCT04171063|Thoracic wall|thoracic wall
4971158|NCT04171063|Pectus carinatum|pectus carinatum
4971159|NCT04171050|Pain Management|pain management
4971160|NCT04171050|Pudendal Nerve Block (PNB)|pudendal nerve block (pnb)
4971161|NCT04171050|Vaginal Reconstruction|vaginal reconstruction
4971162|NCT04171024|Diaphragm dysfunction|diaphragm dysfunction
4971163|NCT04171024|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
4971164|NCT04171024|Intensive care unit|intensive care unit
4971165|NCT04171024|Mechanical ventilation|mechanical ventilation
4971166|NCT04170959|Tumor Hypoxia|tumor hypoxia
4971168|NCT04170959|Radiotherapy|radiotherapy
4971169|NCT04170946|Talazoparib|talazoparib
4971170|NCT04170946|Thoracic Radiotherapy|thoracic radiotherapy
4971171|NCT04170946|Chemotherapy|chemotherapy
4971172|NCT04170933|Magnetic recanalization|magnetic recanalization
4971173|NCT04170933|Biliary Anastomotic Stricture|biliary anastomotic stricture
4971174|NCT04170933|Biliary Tract Diseases|biliary tract diseases
4971175|NCT04170933|Cholestasis, Extrahepatic|cholestasis, extrahepatic
4971176|NCT04170920|breast cancer|breast cancer
4971178|NCT04170920|aromatase inhibitor|aromatase inhibitor
4971179|NCT04170907|nicotine|nicotine
4976379|NCT04139915|Virus|virus
4971206|NCT04170777|Stereotactic Radiosurgery|stereotactic radiosurgery
4971207|NCT04170777|GammaKnife|gammaknife
4971208|NCT04170777|Cone-beam computed tomography (CBCT)|cone-beam computed tomography (cbct)
4971209|NCT04170751|lobectomy|lobectomy
4971210|NCT04170738|ADHD|adhd
4971211|NCT04170738|substance abuse risk|substance abuse risk
4971212|NCT04170738|Adderall|adderall
4971213|NCT04170738|fMRI|fmri
4971214|NCT04170738|ADHD Treatment|adhd treatment
4971215|NCT04170738|Medication|medication
4971217|NCT04170712|tampons; ovarian cancer|tampons; ovarian cancer
4971218|NCT04170686|cognitive behavioral therapy|cognitive behavioral therapy
4971219|NCT04170686|self-help|self-help
4971220|NCT04170686|irritable bowel syndrome|irritable bowel syndrome
4971221|NCT04170647|reperfusion|reperfusion
4971222|NCT04170647|IVT|ivt
4971223|NCT04170634|osteolytic secondary tumoral lesion|osteolytic secondary tumoral lesion
4971224|NCT04170634|femur|femur
4971225|NCT04170634|vertebrae|vertebrae
4971226|NCT04170634|qCT routine imagery|qct routine imagery
4971227|NCT04170582|Hemorrhage|hemorrhage
4971228|NCT04170582|Subdural|subdural
4971229|NCT04170582|Chronic Subdural Hematoma|chronic subdural hematoma
4971230|NCT04170582|Chronic|chronic
4971231|NCT04170556|hepatocellular|hepatocellular
4971232|NCT04170556|sorafenib|sorafenib
4971233|NCT04170556|regorafenib|regorafenib
4971234|NCT04170556|nivolumab|nivolumab
4971235|NCT04170530|Extramural Vascular Invasion|extramural vascular invasion
4971236|NCT04170530|Neoadjuvant|neoadjuvant
4971237|NCT04170530|chemotherapy|chemotherapy
4971238|NCT04170530|mFOLFOXIRI|mfolfoxiri
4971239|NCT04170504|Rheumatoid Arthritis|rheumatoid arthritis
4971240|NCT04170504|Qing Re Huo Xue|qing re huo xue
4971241|NCT04170504|Methotrexate|methotrexate
4971242|NCT04170504|Randomized controlled trial|randomized controlled trial
4971243|NCT04170478|Prostate Cancer|prostate cancer
4971244|NCT04170478|Transperineal laser ablation|transperineal laser ablation
4971245|NCT04170478|Prostate neoplasma|prostate neoplasma
4971246|NCT04170478|Focal laser ablation|focal laser ablation
4971247|NCT04170465|Metformin|metformin
4971248|NCT04170465|locally advanced breast cancer|locally advanced breast cancer
4971249|NCT04170465|neoadjuvant|neoadjuvant
4971254|NCT04170452|PCR|pcr
4971255|NCT04170413|contrast ultrasound|contrast ultrasound
4971256|NCT04170413|urodynamics|urodynamics
4971257|NCT04170387|Relaxometer|relaxometer
4971258|NCT04170387|Mini Mental State Examination|mini mental state examination
4971259|NCT04170387|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
4971260|NCT04170387|Cognitive Impairment|cognitive impairment
4971261|NCT04170387|Rehabilitation|rehabilitation
4971262|NCT04170387|Fingers|fingers
4971263|NCT04170361|COPD|copd
4971264|NCT04170361|incentive spirometry|incentive spirometry
4971265|NCT04170361|length of stay|length of stay
4971266|NCT04170361|hemodynamic responses|hemodynamic responses
4971267|NCT04170348|Sickle Cell Disease|sickle cell disease
4971268|NCT04170348|Acute Chest Syndrome|acute chest syndrome
4971269|NCT04170348|Respiratory Complication|respiratory complication
4971270|NCT04170348|Vitamin D Deficiency|vitamin d deficiency
4971271|NCT04170335|Breast cancer|breast cancer
4971272|NCT04170335|Morbid obesity|morbid obesity
4971273|NCT04170335|Bariatric surgery|bariatric surgery
4971274|NCT04170335|Mammography|mammography
4971275|NCT04170335|Inflammatory markers|inflammatory markers
4971276|NCT04170309|Cephalosporins|cephalosporins
4971277|NCT04170309|Retrospective Studies|retrospective studies
4971278|NCT04170309|Safety|safety
4971279|NCT04170283|Zanubrutinib|zanubrutinib
4976482|NCT04139421|Shinrin-Yoku|shinrin-yoku
4989463|NCT04057339|Fasting|fasting
4971305|NCT04170127|ATP, biostimulation, micro-screw, Periotest, semiconductor laser|atp, biostimulation, micro-screw, periotest, semiconductor laser
4971307|NCT04170114|Bronchiectasis|bronchiectasis
4971308|NCT04170114|Respiratory Physiotherapy|respiratory physiotherapy
4971309|NCT04170114|Pulmonary Function|pulmonary function
4971310|NCT04170114|Exercise Capacity|exercise capacity
4971311|NCT04170114|Six Minute Walk Test|six minute walk test
4971312|NCT04170114|Muscle Strength|muscle strength
4971313|NCT04170088|Melasma|melasma
4971314|NCT04170088|Tranexamic acid|tranexamic acid
4971315|NCT04170088|Mesotherapy|mesotherapy
4971316|NCT04170036|Protein supplement|protein supplement
4971317|NCT04170036|Serum creatinine|serum creatinine
4971318|NCT04170036|Serum sodium|serum sodium
4971319|NCT04170036|Glucose metabolism|glucose metabolism
4971320|NCT04170036|Lipid profile|lipid profile
4971321|NCT04170036|C-reactive protein|c-reactive protein
4971322|NCT04170010|Weight loss|weight loss
4971323|NCT04170010|Gut peptides|gut peptides
4971324|NCT04170010|Meal-induced thermogenesis|meal-induced thermogenesis
4971325|NCT04170010|Glycemia|glycemia
4971326|NCT04169971|trial|trial
4971327|NCT04169971|Anxiety|anxiety
4971328|NCT04169971|music|music
4971329|NCT04169971|intraoperative period|intraoperative period
4971330|NCT04169971|spinal anaesthesia|spinal anaesthesia
4971331|NCT04169945|periodontitis|periodontitis
4971332|NCT04169945|air polishing|air polishing
4971333|NCT04169945|randomised clinical trial|randomised clinical trial
4971334|NCT04169945|debridement|debridement
4971335|NCT04169932|CD20 CAR T Cells|cd20 car t cells
4971336|NCT04169932|Safety, tolerance and efficacy|safety, tolerance and efficacy
4971337|NCT04169880|Subacromial impingement syndrome|subacromial impingement syndrome
4971338|NCT04169880|High Intensity Laser Therapy|high intensity laser therapy
4971339|NCT04169880|Laser Therapy|laser therapy
4971340|NCT04169880|Shoulder Pain|shoulder pain
4971341|NCT04169867|Microbiome|microbiome
4971342|NCT04169867|Melanoma|melanoma
4971343|NCT04169867|Healthy Volunteers|healthy volunteers
4971344|NCT04169867|Immunotherapy|immunotherapy
4971345|NCT04169867|Stool samples|stool samples
4971361|NCT04169828|Arthritis|arthritis
4971362|NCT04169828|Arthritis, Juvenile|arthritis, juvenile
4971363|NCT04169828|Joint Diseases|joint diseases
4971364|NCT04169828|Rheumatic diseases|rheumatic diseases
4971365|NCT04169828|Pragmatic Trials|pragmatic trials
4971366|NCT04169828|Ondansetron|ondansetron
4971367|NCT04169828|Methotrexate|methotrexate
4971368|NCT04169828|Nausea|nausea
4971369|NCT04169815|Natriuretic Peptide|natriuretic peptide
4971370|NCT04169802|Age-Related Macular Degeneration|age-related macular degeneration
4971371|NCT04169802|visual acuity|visual acuity
4971372|NCT04169750|Rehabilitation|rehabilitation
4971373|NCT04169750|Cognitive impairment|cognitive impairment
4971374|NCT04169750|Exergames|exergames
4971375|NCT04169750|Neuroplasticity|neuroplasticity
4971376|NCT04169750|Clinical Trial|clinical trial
4971377|NCT04169698|Denosumab|denosumab
4971378|NCT04169698|Alendronate|alendronate
4971379|NCT04169698|Osteoporosis|osteoporosis
4971380|NCT04169698|renal transplant|renal transplant
4971381|NCT04169659|Kyphoplasty|kyphoplasty
4971383|NCT04169659|Titanium|titanium
4971384|NCT04169659|Microsphere|microsphere
4971385|NCT04169659|Vertebral fracture|vertebral fracture
4971386|NCT04169646|office-worker|office-worker
4989576|NCT04056637|MLPT|mlpt
4971390|NCT04169633|Everyday cognition|everyday cognition
4971391|NCT04169633|Older adult, aging|older adult, aging
4971392|NCT04169633|test Validation|test validation
4971393|NCT04169607|lung protective ventilation strategy|lung protective ventilation strategy
4971394|NCT04169607|individualized positive end-expiratory pressure|individualized positive end-expiratory pressure
4971395|NCT04169607|Laparoscopic bariatric surgery|laparoscopic bariatric surgery
4971396|NCT04169607|Mechanical ventilation|mechanical ventilation
4971397|NCT04169607|Anesthetic management|anesthetic management
4971398|NCT04169607|Lung dynamic compliance|lung dynamic compliance
4971399|NCT04169607|Postoperative Atelectasis|postoperative atelectasis
4971400|NCT04169581|Deep Learning|deep learning
4971401|NCT04169581|Temporal Lobe Epilepsy|temporal lobe epilepsy
4971402|NCT04169581|Positron-Emission Tomography|positron-emission tomography
4971403|NCT04169555|ultrasound|ultrasound
4971418|NCT04169464|insulin resistence|insulin resistence
4971419|NCT04169464|GFR|gfr
4971420|NCT04169438|Wound Heal|wound heal
4971421|NCT04169438|Scar|scar
4971422|NCT04169438|Keloid|keloid
4971423|NCT04169438|Surgical Wound|surgical wound
4971424|NCT04169399|Hepatocellular carcinoma|hepatocellular carcinoma
4971425|NCT04169399|Toripalimab|toripalimab
4971426|NCT04169399|Stereotactic body radiotherapy|stereotactic body radiotherapy
4971427|NCT04169399|Portal vein tumor thrombus|portal vein tumor thrombus
4971432|NCT04169321|cancer immunotherapy|cancer immunotherapy
4971433|NCT04169321|biomarkers, tumor|biomarkers, tumor
4971434|NCT04169321|positron-emission tomography|positron-emission tomography
4971435|NCT04169321|Granzymes|granzymes
4971436|NCT04169282|tracheobronchomalacia|tracheobronchomalacia
4971437|NCT04169282|TBM|tbm
4971438|NCT04169282|cough|cough
4971439|NCT04169256|pain|pain
4971440|NCT04169256|postoperative|postoperative
4971441|NCT04169256|local anesthesia|local anesthesia
4971442|NCT04169256|long-action|long-action
4971443|NCT04169230|Citalopram|citalopram
4971444|NCT04169230|Emotional Processing|emotional processing
4971445|NCT04169230|Antidepressants|antidepressants
4971446|NCT04169230|Self Processing|self processing
4971447|NCT04169230|Healthy Volunteers|healthy volunteers
4971448|NCT04169217|Prehabilitation|prehabilitation
4971449|NCT04169204|Microcirculation|microcirculation
4971450|NCT04169204|Intensive Care|intensive care
4971451|NCT04169204|Critical care|critical care
4971452|NCT04169204|shock|shock
4971453|NCT04169204|Very Old Intensive Care Patients|very old intensive care patients
4971454|NCT04169204|risk stratification|risk stratification
4971455|NCT04169204|SDF-measurement|sdf-measurement
4971456|NCT04169165|kidney stone|kidney stone
4971457|NCT04169165|calcium oxalate stone|calcium oxalate stone
4971458|NCT04169165|patient compliance|patient compliance
4971459|NCT04169165|nephrolithiasis|nephrolithiasis
4971460|NCT04169152|Cap-assisted endoscopic sclerotherapy|cap-assisted endoscopic sclerotherapy
4971461|NCT04169152|Internal Hemorrhoid|internal hemorrhoid
4971462|NCT04169152|Rectal Prolapse|rectal prolapse
4971463|NCT04169126|Dementia|dementia
4971464|NCT04169126|Tau PET scan|tau pet scan
4971465|NCT04169126|Tau neurofibrillary tangles|tau neurofibrillary tangles
4971466|NCT04169126|Amyloid deposition|amyloid deposition
4971467|NCT04169113|Hip Arthroscopy|hip arthroscopy
4971468|NCT04169113|Opiate Use|opiate use
4971469|NCT04169100|cytokines|cytokines
4971470|NCT04169074|Head and Neck Cancer|head and neck cancer
4969043|NCT04183127|Competence|competence
4969044|NCT04183127|Role identity|role identity
4969045|NCT04183114|Vaccine|vaccine
4969046|NCT04183114|Measles|measles
4969047|NCT04183114|Rubella|rubella
4971471|NCT04169074|HNSCC|hnscc
4971472|NCT04169074|Squamous Cell Cancer|squamous cell cancer
4971473|NCT04169074|abemaciclib|abemaciclib
4971474|NCT04169074|nivolumab|nivolumab
4971475|NCT04169061|Severe or recalcitrant keratitis|severe or recalcitrant keratitis
4971476|NCT04169022|AML|aml
4971477|NCT04169022|Chimeric Antigen Receptor T Cells|chimeric antigen receptor t cells
4971478|NCT04169022|Immunotherapy|immunotherapy
4971479|NCT04169009|immunology|immunology
5293279|NCT02209025|Apolipoprotein A-I|apolipoprotein a-i
4971480|NCT04168944|Hepatocellular Carcinoma|hepatocellular carcinoma
4971481|NCT04168944|Liver Transplantation|liver transplantation
4971482|NCT04168931|gastric cancer|gastric cancer
4971483|NCT04168931|HER2|her2
4971484|NCT04168931|trastuzumab|trastuzumab
4971485|NCT04168931|circulating tumor cells|circulating tumor cells
4971486|NCT04168905|chronic wounds Topical wound oxygen therapy|chronic wounds topical wound oxygen therapy
4971487|NCT04168853|cardiopulmonary bypass|cardiopulmonary bypass
4971488|NCT04168853|pulsatility|pulsatility
4971489|NCT04168853|systemic inflammatory response|systemic inflammatory response
4971490|NCT04168853|arterial graft|arterial graft
4971491|NCT04168840|ultrasound|ultrasound
4971499|NCT04168814|Nutritional status|nutritional status
4971500|NCT04168814|Oncology Patients|oncology patients
5014347|NCT03907319|STN|stn
4971501|NCT04168814|Anticancer treatments|anticancer treatments
4971502|NCT04168814|Quality of Life|quality of life
4971503|NCT04168801|Mild acute pancreatitis|mild acute pancreatitis
4971504|NCT04168801|Oral refeeding|oral refeeding
4971505|NCT04168801|Non inferiority clinical trial|non inferiority clinical trial
4971506|NCT04168788|Pharmacogenetics|pharmacogenetics
4976696|NCT04138069|Aerobic Training|aerobic training
4971510|NCT04168762|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4971511|NCT04168762|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
4971512|NCT04168736|genetic testing|genetic testing
4971514|NCT04168736|family disclosure|family disclosure
4971515|NCT04168658|Osteoporosis|osteoporosis
4971516|NCT04168658|Chinese women|chinese women
4971517|NCT04168658|nursing home|nursing home
4971518|NCT04168658|physical activity|physical activity
4971519|NCT04168658|RCT|rct
4971520|NCT04168632|children|children
4971521|NCT04168632|public meals|public meals
4971522|NCT04168632|sustainable diets|sustainable diets
4971523|NCT04168632|Agenda 2030|agenda 2030
4971524|NCT04168619|Liver Fibrosis|liver fibrosis
4971525|NCT04168619|Psoriasis|psoriasis
4971526|NCT04168619|Methotrexate|methotrexate
4971527|NCT04168619|Transient elastography|transient elastography
4971528|NCT04168619|Two-dimensional shear wave elastrography|two-dimensional shear wave elastrography
4971529|NCT04168606|placental abruption|placental abruption
4971530|NCT04168593|Acupuncture|acupuncture
4971531|NCT04168593|Cupping|cupping
4971532|NCT04168593|Osteoarthritis|osteoarthritis
4971533|NCT04168593|Pain|pain
4971534|NCT04168567|Microbiome|microbiome
4971535|NCT04168567|Microbiota|microbiota
4971536|NCT04168567|Obesity|obesity
4971537|NCT04168554|Telemedicine|telemedicine
4971538|NCT04168554|Respiratory distress|respiratory distress
4971539|NCT04168554|Pediatric|pediatric
4971540|NCT04168554|General practitioner|general practitioner
4971541|NCT04168528|PET/CT|pet/ct
4971542|NCT04168528|MMR-PET/CT|mmr-pet/ct
4971543|NCT04168528|Macrophage PET/CT|macrophage pet/ct
4971544|NCT04168502|De-novo|de-novo
4971545|NCT04168502|Favorable risk|favorable risk
4971546|NCT04168502|Intermediate risk|intermediate risk
4971547|NCT04168502|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
4971548|NCT04168502|Glasdegib|glasdegib
4971549|NCT04168502|Acute Myeloid Leukemia|acute myeloid leukemia
4971550|NCT04168489|rTMS|rtms
4971557|NCT04168463|Dementia|dementia
4971558|NCT04168463|Social robots|social robots
4971560|NCT04168463|Robot pets|robot pets
4971561|NCT04168463|Wellbeing|wellbeing
4971562|NCT04168463|Older adults|older adults
4971563|NCT04168463|Long-term care|long-term care
4971564|NCT04168463|Residential care|residential care
4971565|NCT04168437|Back Pain|back pain
4971566|NCT04168437|Quality of Life|quality of life
4971567|NCT04168437|PROMIS-29|promis-29
4971568|NCT04168437|PRECISION Pain Research Registry|precision pain research registry
4971569|NCT04168424|resource use|resource use
4971570|NCT04168424|assessment|assessment
4971571|NCT04168424|elderly|elderly
4971572|NCT04168411|metatarsal, fracture, muscle weakness, isokinetic test,|metatarsal, fracture, muscle weakness, isokinetic test,
5939541|NCT01163786|Bortezomib GVHD Bronchiolitis Obliterans|bortezomib gvhd bronchiolitis obliterans
4971573|NCT04168398|Clopidogrel, Apixiban and Lower Limb Revascularization|clopidogrel, apixiban and lower limb revascularization
4971574|NCT04168385|PFIC|pfic
4971575|NCT04168385|ALGS|algs
4971576|NCT04168385|Maralixibat|maralixibat
4971577|NCT04168385|Bile Duct Diseases|bile duct diseases
4971578|NCT04168385|Liver Diseases|liver diseases
4971579|NCT04168385|Biliary Tract Diseases|biliary tract diseases
4971580|NCT04168385|Digestive System Diseases|digestive system diseases
4971581|NCT04168385|Pediatric|pediatric
4971582|NCT04168372|Fructose|fructose
4971583|NCT04168372|Glucose|glucose
4971584|NCT04168372|Lipogenesis|lipogenesis
4971585|NCT04168333|Hepatitis B virus (HBV) infection|hepatitis b virus (hbv) infection
4971590|NCT04168307|ankle fracture|ankle fracture
4971591|NCT04168307|rehabilitation|rehabilitation
5293385|NCT02208635|Maize|maize
4971592|NCT04168294|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
4971593|NCT04168294|Deep Sedation|deep sedation
4971594|NCT04168294|Cognition Disorders|cognition disorders
4971595|NCT04168294|Patient Discharge|patient discharge
4971604|NCT04168203|secondary prevention|secondary prevention
4971606|NCT04168164|aquatic therapy; balance; acquired brain injury.|aquatic therapy; balance; acquired brain injury.
4971607|NCT04168151|post cardiac surgery,|post cardiac surgery,
4971608|NCT04168151|lung recruitment|lung recruitment
4971609|NCT04168151|trans alveolar pressure|trans alveolar pressure
4971610|NCT04168138|D-CTAG|d-ctag
4971611|NCT04168138|Acute Myeloid Leukemia|acute myeloid leukemia
4971612|NCT04168138|rhTPO|rhtpo
4971613|NCT04168112|Collagen Crosslinking|collagen crosslinking
4971614|NCT04168112|Keratoconus|keratoconus
4971615|NCT04168112|Dexamethasone|dexamethasone
4971616|NCT04168112|Intracanalicular Insert|intracanalicular insert
4971617|NCT04168086|Ultrasound|ultrasound
4971618|NCT04168086|Neuromodulation|neuromodulation
4971619|NCT04168086|Cerebellum|cerebellum
4971620|NCT04168086|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
4976792|NCT04137510|HBR|hbr
4971640|NCT04167969|Ultrasmall Silica Nanoparticles|ultrasmall silica nanoparticles
4971641|NCT04167969|PET/MRI|pet/mri
4971642|NCT04167969|64Cu-NOTA-PSMA-PEG-Cy5.5-C' dot tracer|64cu-nota-psma-peg-cy5.5-c' dot tracer
4971643|NCT04167969|19-333|19-333
4971644|NCT04167956|lumbar sympathetic|lumbar sympathetic
4971645|NCT04167956|ultrasound|ultrasound
4971646|NCT04167943|indirect pulp capping|indirect pulp capping
4971647|NCT04167943|direct pulp capping|direct pulp capping
4971648|NCT04167943|partial pulpotomy|partial pulpotomy
4971673|NCT04167800|orthosis|orthosis
4971674|NCT04167800|exercise|exercise
4971675|NCT04167787|Surgery|surgery
4971676|NCT04167774|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
4971677|NCT04167774|nb-Paclitaxel|nb-paclitaxel
4971678|NCT04167761|Epicardial Adipose Tissue|epicardial adipose tissue
4971679|NCT04167761|SGLT2 Inhibitor|sglt2 inhibitor
4971680|NCT04167722|Prostate Cancer|prostate cancer
4971681|NCT04167722|Obesity|obesity
4971682|NCT04167722|Exosomes|exosomes
4971683|NCT04167709|postpartum depression|postpartum depression
4971684|NCT04167709|immigrant women|immigrant women
4971685|NCT04167709|Child Health Services|child health services
4971686|NCT04167709|nurse|nurse
4971687|NCT04167709|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
4971688|NCT04167683|Muscle mass|muscle mass
4971689|NCT04167683|Muscle strength|muscle strength
4971690|NCT04167683|Complications|complications
4971691|NCT04167683|Patient reported outcomes|patient reported outcomes
4971693|NCT04167683|Physical function|physical function
4971694|NCT04167683|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4971697|NCT04167657|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
4971698|NCT04167657|Immunotherapy|immunotherapy
4971699|NCT04167657|Radiation|radiation
4971700|NCT04167657|PD-1|pd-1
4971701|NCT04167657|Sintilimab|sintilimab
4971702|NCT04167644|ICH, Hypertension, GCS , and mRS.|ich, hypertension, gcs , and mrs.
4971703|NCT04167631|VI-RADS|vi-rads
4971704|NCT04167631|Multiparametric MRI|multiparametric mri
4971705|NCT04167631|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4971706|NCT04167631|Muscle invasive bladder cancer (MIBC)|muscle invasive bladder cancer (mibc)
4971707|NCT04167605|Breast cancer|breast cancer
4971708|NCT04167605|Bone metastases|bone metastases
4971709|NCT04167605|SENP1|senp1
4971710|NCT04167592|propofol|propofol
4971711|NCT04167592|benzydamine hydrochloride|benzydamine hydrochloride
4971712|NCT04167592|sore throat|sore throat
4989859|NCT04054869|neck stiffness|neck stiffness
4971722|NCT04167540|Parkinson's disease|parkinson's disease
4971723|NCT04167540|Neurotrophic factor|neurotrophic factor
4971724|NCT04167540|Growth factor|growth factor
5356776|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists
4971747|NCT04167436|Colon cancer|colon cancer
4971748|NCT04167436|WHO performance status|who performance status
4971749|NCT04167436|Rectal cancer|rectal cancer
4972745|NCT04162197|Robotics|robotics
4971760|NCT04167410|Perioperative glycaemic management|perioperative glycaemic management
4971762|NCT04167410|Glycaemic protocol|glycaemic protocol
4971763|NCT04167410|Glycaemic management|glycaemic management
4971764|NCT04167410|Stress hyperglycaemia|stress hyperglycaemia
4971765|NCT04167410|Surgery and diabetes|surgery and diabetes
4971766|NCT04167397|Collaborative learning|collaborative learning
4971767|NCT04167358|Linerixibat|linerixibat
4971768|NCT04167358|Cholestasis|cholestasis
4971769|NCT04167358|Cholestatic pruritus|cholestatic pruritus
4971770|NCT04167358|Primary biliary cholangitis|primary biliary cholangitis
4971771|NCT04167332|Non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
4971772|NCT04167332|Progression|progression
4971773|NCT04167332|Recurrence|recurrence
4971774|NCT04167332|Registry|registry
4971775|NCT04167332|Prospective|prospective
4971776|NCT04167332|Biomarker|biomarker
4971777|NCT04167332|Multi-omics|multi-omics
4971778|NCT04167319|CIPN|cipn
4971781|NCT04167293|immunotherapy|immunotherapy
4971782|NCT04167293|PD-1|pd-1
4971783|NCT04167293|stereotactic body radiotherapy|stereotactic body radiotherapy
4971784|NCT04167280|ipratropium bromide|ipratropium bromide
4971785|NCT04167280|methacholine PD20|methacholine pd20
4971786|NCT04167280|tolerance|tolerance
4971787|NCT04167241|Right Ventricle Disfunction|right ventricle disfunction
4971788|NCT04167241|Pneumonectomy|pneumonectomy
4971789|NCT04167241|Echocardiography|echocardiography
4971792|NCT04167176|Cholecystectomy|cholecystectomy
4971793|NCT04167176|ESP block|esp block
4971794|NCT04167176|Port Site Infiltration|port site infiltration
4971795|NCT04167150|osteoporosis|osteoporosis
4971796|NCT04167150|biomarkers|biomarkers
4971797|NCT04167150|tart cherry|tart cherry
4971798|NCT04167150|functional food|functional food
4971799|NCT04167137|solid tumor|solid tumor
4971800|NCT04167098|Platelet-Rich Plasma|platelet-rich plasma
4971801|NCT04167098|Trigger Finger|trigger finger
4971802|NCT04167085|Epistaxis|epistaxis
4971803|NCT04167085|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
4971805|NCT04167085|Doxycycline|doxycycline
4971806|NCT04167085|Nosebleed|nosebleed
4971807|NCT04167059|Sedentary behaviour|sedentary behaviour
4971808|NCT04167059|Physical activity|physical activity
4971809|NCT04167059|Quality of life|quality of life
4971810|NCT04167059|Telehealth|telehealth
4971811|NCT04167033|Premature ovarian insufficiency|premature ovarian insufficiency
4971812|NCT04167033|QTc|qtc
4971813|NCT04167033|Torsade de pointe|torsade de pointe
4971814|NCT04167033|Hormone replacement therapy|hormone replacement therapy
4971815|NCT04167020|Muscle aging|muscle aging
4971816|NCT04167020|Hip fracture|hip fracture
4971817|NCT04167007|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
4971818|NCT04167007|Metastasis|metastasis
4971819|NCT04167007|Gemcitabine|gemcitabine
4971820|NCT04167007|FOLFOX|folfox
4971821|NCT04167007|first-line|first-line
4971822|NCT04166994|Diet|diet
4971823|NCT04166994|Exercise|exercise
4971826|NCT04166903|Prolonged exercise, marathon, cardiovascular disease, long term|prolonged exercise, marathon, cardiovascular disease, long term
4971827|NCT04166890|Articaine|articaine
4971828|NCT04166890|IANB|ianb
4971829|NCT04166890|Third molar surgery|third molar surgery
4971830|NCT04166890|Non-inferiority|non-inferiority
4971831|NCT04166890|Local anesthesia|local anesthesia
4971840|NCT04166851|men who have sex with men|men who have sex with men
4971841|NCT04166851|Neuroimaging|neuroimaging
4971842|NCT04166825|coagulation|coagulation
4971843|NCT04166825|fibrinolysis|fibrinolysis
4971844|NCT04166825|ovarian hyperstimulation|ovarian hyperstimulation
4971845|NCT04166825|infertility|infertility
4971848|NCT04166799|Barrier Film|barrier film
4971849|NCT04166799|Mepitel|mepitel
4971850|NCT04166799|Quality of life|quality of life
4971851|NCT04166799|Radiation Dermatitis|radiation dermatitis
4971871|NCT04166708|Center of mass|center of mass
4971872|NCT04166656|Meningococcal B vaccine|meningococcal b vaccine
4971873|NCT04166656|vaccine strategies|vaccine strategies
4971874|NCT04166656|splenectomized individuals|splenectomized individuals
4971875|NCT04166630|Biofeedback|biofeedback
4971876|NCT04166630|Muscular disorders|muscular disorders
4971877|NCT04166630|Neuromuscular disorders|neuromuscular disorders
4971878|NCT04166630|Rehabilitation|rehabilitation
4971879|NCT04166604|trifluridine/ tipiracil|trifluridine/ tipiracil
4971880|NCT04166604|G-CSF|g-csf
4971881|NCT04166604|neutropenia|neutropenia
4971882|NCT04166552|Scleroderma|scleroderma
4971883|NCT04166552|Systemic sclerosis|systemic sclerosis
4971884|NCT04166552|EHP-101 Oral Solution|ehp-101 oral solution
4971885|NCT04166539|Revision Surgery|revision surgery
4971886|NCT04166539|Hip|hip
4971887|NCT04166539|Knee|knee
4971888|NCT04166539|Metals|metals
4971889|NCT04166539|Metallosis|metallosis
4971890|NCT04166539|Toxicity|toxicity
4971891|NCT04166526|Sickle Cell|sickle cell
4971892|NCT04166526|MRI|mri
4971893|NCT04166526|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
4971894|NCT04166513|tDCS|tdcs
4971895|NCT04166513|treatment|treatment
4971896|NCT04166513|brain stimulation|brain stimulation
4971897|NCT04166500|Induced abortion|induced abortion
4971898|NCT04166500|Uterine adhesions|uterine adhesions
4971899|NCT04166500|Reproductive infertility|reproductive infertility
4971900|NCT04166500|Hysteroscopy|hysteroscopy
4971901|NCT04166487|NSCLC Stage IV|nsclc stage iv
4971902|NCT04166487|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
4971913|NCT04166370|Bangladesh|bangladesh
4971914|NCT04166370|Multisectoral|multisectoral
4971915|NCT04166370|Cash Transfer|cash transfer
4971916|NCT04166370|Randomized|randomized
4971917|NCT04166357|Guillain Barre Syndrome, neuromuscular ultrasound|guillain barre syndrome, neuromuscular ultrasound
4971918|NCT04166331|sepsis|sepsis
4971919|NCT04166331|Cardiomyopathies|cardiomyopathies
4971920|NCT04166331|Hypoperfusion|hypoperfusion
4971921|NCT04166331|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
4977017|NCT04136249|physical exercice|physical exercice
4971926|NCT04166292|face|face
4971927|NCT04166292|cheekbone|cheekbone
4971928|NCT04166292|chin|chin
4971929|NCT04166292|mandibular angle|mandibular angle
4971930|NCT04166292|hyaluronic acid|hyaluronic acid
4971931|NCT04166279|Breast Cancer|breast cancer
4971932|NCT04166279|Pain Chronic and Postoperative|pain chronic and postoperative
4971933|NCT04166279|Lymphedema|lymphedema
4971934|NCT04166279|Posture|posture
4971935|NCT04166279|Target - Reaching movement|target - reaching movement
4971936|NCT04166279|Breast surgery|breast surgery
4971937|NCT04166279|Functional impotence|functional impotence
4971938|NCT04166279|Rehabilitive treatment|rehabilitive treatment
4971939|NCT04166279|Physiotherapy|physiotherapy
4971940|NCT04166279|Scapula tilting|scapula tilting
4971941|NCT04166266|fibrosis|fibrosis
4971942|NCT04166266|bulevirtide|bulevirtide
4971943|NCT04166266|safety|safety
4971944|NCT04166266|efficacy|efficacy
4971945|NCT04166240|Diagnostic Errors|diagnostic errors
4971946|NCT04166240|Quality Improvement|quality improvement
4971947|NCT04166240|Patient Safety|patient safety
4971948|NCT04166240|Delayed Diagnosis|delayed diagnosis
4971949|NCT04166227|Hip Scope|hip scope
4971950|NCT04166227|Total Hip Replacement|total hip replacement
4971951|NCT04166162|Underage Drinking|underage drinking
4971968|NCT04166019|first-onset psychosis|first-onset psychosis
4971969|NCT04166019|randomized controlled trial|randomized controlled trial
4971970|NCT04166019|peer support|peer support
4971971|NCT04166019|self management|self management
4971972|NCT04166019|recovery|recovery
4971973|NCT04166019|re-hospitalization|re-hospitalization
4971974|NCT04166006|Head Neck Tumors|head neck tumors
4972004|NCT04165889|adult patient|adult patient
4972005|NCT04165889|Medication Error|medication error
4972006|NCT04165889|Clinical Pharmacist|clinical pharmacist
4972007|NCT04165876|tDCS|tdcs
4972008|NCT04165876|HD-tDCS|hd-tdcs
4972009|NCT04165876|Somatosensory function|somatosensory function
4972010|NCT04165876|QST|qst
4972011|NCT04165876|quantitative sensory testing|quantitative sensory testing
4972012|NCT04165876|Non-invasive brain stimulation|non-invasive brain stimulation
4972013|NCT04165876|NIBS|nibs
4972014|NCT04165876|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4972021|NCT04165785|Optimal pulsed technology intense pulsed light|optimal pulsed technology intense pulsed light
4972022|NCT04165785|meibomian gland dysfunction|meibomian gland dysfunction
4972023|NCT04165785|demodicosis|demodicosis
4972024|NCT04165785|Dry Eye Disease|dry eye disease
4972025|NCT04165772|PD1 blockade|pd1 blockade
4972026|NCT04165772|TSR-042|tsr-042
4972027|NCT04165772|Radiation|radiation
4972028|NCT04165772|Capecitabine|capecitabine
4972029|NCT04165772|5-FU|5-fu
4972030|NCT04165772|19-288|19-288
4972031|NCT04165746|Brazil|brazil
4972032|NCT04165746|children|children
4972033|NCT04165746|foster care|foster care
4972034|NCT04165746|institutionalization|institutionalization
4972035|NCT04165746|attachment|attachment
4972036|NCT04165746|brain function|brain function
4972037|NCT04165746|language|language
4972038|NCT04165746|growth|growth
4972039|NCT04165746|Intelligence Quotient (IQ)|intelligence quotient (iq)
4972040|NCT04165746|early intervention|early intervention
4972041|NCT04165733|Professional quality of life|professional quality of life
4972042|NCT04165733|Compassion satisfaction|compassion satisfaction
4972043|NCT04165733|Burnout|burnout
4972044|NCT04165733|Psychiatrists|psychiatrists
4972045|NCT04165733|Mental disorders|mental disorders
4972046|NCT04165733|Mental health|mental health
4972052|NCT04165707|diet|diet
4972053|NCT04165707|weight loss|weight loss
4972054|NCT04165707|ketogenic diet|ketogenic diet
4972055|NCT04165707|low carbohydrate|low carbohydrate
4972056|NCT04165694|weight loss failure|weight loss failure
4972057|NCT04165694|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4972058|NCT04165681|Adolescence|adolescence
4972059|NCT04165681|Cognitive Behavioral Therapy|cognitive behavioral therapy
4972060|NCT04165681|Virtual Reality|virtual reality
4972061|NCT04165681|Depression|depression
4972062|NCT04165681|Behavioral Activation|behavioral activation
4972063|NCT04165655|Autism spectrum condition|autism spectrum condition
4972064|NCT04165655|ASC|asc
4972065|NCT04165655|Children and young people|children and young people
4972066|NCT04165655|Social skills|social skills
4972067|NCT04165655|Problem behaviours|problem behaviours
4972068|NCT04165655|Activity intervention|activity intervention
4972070|NCT04165655|Self image|self image
4972071|NCT04165655|Social connectedness|social connectedness
4972072|NCT04165642|laser ballon ablation|laser ballon ablation
4972073|NCT04165642|laser ballon|laser ballon
4972074|NCT04165642|pulmonary vein isolation|pulmonary vein isolation
4972075|NCT04165642|atrial fibrillation|atrial fibrillation
4972081|NCT04165590|Plasmodiun vivax|plasmodiun vivax
4972086|NCT04165551|Streptococcus agalactiae|streptococcus agalactiae
4972087|NCT04165551|ProbioticsPrevention|probioticsprevention
4972088|NCT04165538|Hip Fracture|hip fracture
4972090|NCT04165538|Withdrawal|withdrawal
4972091|NCT04165538|surgical timing|surgical timing
4972092|NCT04165538|Thromboelastogram|thromboelastogram
4972093|NCT04165525|comparison of ablation devices|comparison of ablation devices
4972094|NCT04165512|lymphedema|lymphedema
4972095|NCT04165512|breast cancer|breast cancer
4972096|NCT04165512|stellate ganglion|stellate ganglion
4972097|NCT04165512|treatment|treatment
4972098|NCT04165512|ultrasound|ultrasound
4972099|NCT04165499|Hyperuricemia|hyperuricemia
4972100|NCT04165499|Plant extracts|plant extracts
4972101|NCT04165473|Training Program|training program
4972102|NCT04165473|Personal Resources|personal resources
4972103|NCT04165473|Social Resources|social resources
4972104|NCT04165473|Adults|adults
4972105|NCT04165473|Emotional Wellbeing|emotional wellbeing
4972106|NCT04165473|Physical Wellbeing|physical wellbeing
4972107|NCT04165473|Social Wellbeing|social wellbeing
4972108|NCT04165473|Perceived Stress|perceived stress
4972109|NCT04165473|Satisfaction with Life|satisfaction with life
4972110|NCT04165473|Health Behavior|health behavior
4972111|NCT04165473|Quality of Relationships|quality of relationships
4972112|NCT04165473|Health Status|health status
4972113|NCT04165473|Sense of Coherence|sense of coherence
4972114|NCT04165473|Life Goals|life goals
4972115|NCT04165473|Meaning in Life|meaning in life
4972116|NCT04165473|Transcendence|transcendence
4972117|NCT04165473|Evaluation|evaluation
4972118|NCT04165460|Cervical cancer|cervical cancer
4972119|NCT04165460|Quality of life|quality of life
4972120|NCT04165460|Coping|coping
4972121|NCT04165460|Distress|distress
4972122|NCT04165460|Anxiety|anxiety
4972123|NCT04165460|Depression|depression
4972124|NCT04165460|Therapeutic adherence|therapeutic adherence
4972125|NCT04165460|Sexual Satisfaction|sexual satisfaction
4972128|NCT04165447|calories|calories
4972129|NCT04165447|online grocery store|online grocery store
4972130|NCT04165447|diet|diet
4972131|NCT04165447|groceries|groceries
4972132|NCT04165447|obesity|obesity
4972133|NCT04165434|Concurrent Training|concurrent training
4972134|NCT04165434|Rehabilitation|rehabilitation
4972135|NCT04165395|Pressure Ulcers|pressure ulcers
4972136|NCT04165395|Pressure Injury|pressure injury
4972137|NCT04165395|Spinal Cord Injury|spinal cord injury
4972138|NCT04165395|Prophylactic|prophylactic
4972139|NCT04165395|Dressing|dressing
4972140|NCT04165382|nurse care|nurse care
4972141|NCT04165382|non-invasive ventilation|non-invasive ventilation
4972142|NCT04165382|preterm infants|preterm infants
4972143|NCT04165369|Acute kidney injury|acute kidney injury
4972144|NCT04165369|injury|injury
4972145|NCT04165369|surgery|surgery
4972146|NCT04165356|Chlorhexidine mouthwashes|chlorhexidine mouthwashes
4972147|NCT04165356|chlorhexidine efficacy|chlorhexidine efficacy
4972173|NCT04165239|KH176|kh176
4972174|NCT04165226|Stria alba|stria alba
4972175|NCT04165226|Fractional CO2|fractional co2
4972176|NCT04165226|Fractional carbon dioxide laser 00|fractional carbon dioxide laser 00
4972177|NCT04165226|Low level light therapy|low level light therapy
4972178|NCT04165226|Striae atrophicae|striae atrophicae
4972179|NCT04165226|Infra red diode laser|infra red diode laser
4972180|NCT04165226|808 nm|808 nm
4972181|NCT04165226|915 nm|915 nm
4972182|NCT04165226|10600 nm|10600 nm
4972183|NCT04165200|HIV infection, fecal microbiota transplantation|hiv infection, fecal microbiota transplantation
4972184|NCT04165187|knee osteoarthritis|knee osteoarthritis
4972185|NCT04165187|body awareness therapy|body awareness therapy
4972186|NCT04165187|pain|pain
4972187|NCT04165187|functional capacity|functional capacity
4972188|NCT04165174|HCC|hcc
4972189|NCT04165174|PVTT|pvtt
4972190|NCT04165174|PD-1|pd-1
4972191|NCT04165174|Apatinib|apatinib
4972192|NCT04165174|SBRT|sbrt
4972193|NCT04165148|Low Impact Laparoscopy|low impact laparoscopy
4972194|NCT04165148|laparoscopy|laparoscopy
4972195|NCT04165148|hysterectomy|hysterectomy
4972196|NCT04165148|ambulatory|ambulatory
4972199|NCT04165122|Herpes Genitalis|herpes genitalis
4972200|NCT04165109|Trial-Ready Cohort|trial-ready cohort
4972201|NCT04165109|Observational|observational
4972202|NCT04165109|Alzheimer's|alzheimer's
4972203|NCT04165109|Prevention|prevention
4972204|NCT04165109|Down Syndrome|down syndrome
4972214|NCT04165057|Optimal muscle tension|optimal muscle tension
4977220|NCT04134923|neurology|neurology
4972218|NCT04165044|Leukocyte and Platelet Rich Fibrin|leukocyte and platelet rich fibrin
4972219|NCT04165044|Connective tissue graft|connective tissue graft
4972220|NCT04165044|Gingival recession|gingival recession
4972221|NCT04165018|Pancreatic masses and lesions|pancreatic masses and lesions
4972223|NCT04165005|MBSR|mbsr
4972224|NCT04165005|cognitive functions|cognitive functions
4972225|NCT04165005|psychological status|psychological status
4972226|NCT04164992|endoscopic ultrasound radiofrequency ablation|endoscopic ultrasound radiofrequency ablation
4972227|NCT04164979|Gastric Adenocarcinoma|gastric adenocarcinoma
4972228|NCT04164979|Gastroesophageal Adenocarcinoma|gastroesophageal adenocarcinoma
4972229|NCT04164979|Cabozantinib|cabozantinib
4972230|NCT04164979|Pembrolizumab|pembrolizumab
4972231|NCT04164914|intestinal gas|intestinal gas
4972232|NCT04164914|healthy subjects|healthy subjects
4972233|NCT04164914|microbiota|microbiota
4972234|NCT04164914|prebiotics|prebiotics
4972236|NCT04164875|fever|fever
4972237|NCT04164875|epidural|epidural
4972238|NCT04164875|birth|birth
5293784|NCT02206776|OCD|ocd
4972239|NCT04164875|labour|labour
4972240|NCT04164862|AccuVein AV400 device|accuvein av400 device
4972241|NCT04164862|ultrasound-guided cannulation|ultrasound-guided cannulation
4972242|NCT04164849|Crohns Disease|crohns disease
4972250|NCT04164823|Taping|taping
4972251|NCT04164823|Pain|pain
4972252|NCT04164810|Spinal cord injury|spinal cord injury
4972253|NCT04164810|Neuropathic pain|neuropathic pain
4972254|NCT04164810|Quality of life|quality of life
4972255|NCT04164810|Catastrophization|catastrophization
4972256|NCT04164797|endostar Esophageal Cancer|endostar esophageal cancer
4972257|NCT04164771|Aerobic training|aerobic training
4972258|NCT04164771|Moringa|moringa
4972259|NCT04164771|Cardioprotection|cardioprotection
4972260|NCT04164732|non-obstructive|non-obstructive
5699536|NCT00502749|Exercise|exercise
4972261|NCT04164732|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4972262|NCT04164732|genetic cardiomyopathy|genetic cardiomyopathy
4972263|NCT04164706|Colorectal Cancer|colorectal cancer
4972264|NCT04164706|Colorectal Surgery|colorectal surgery
4972265|NCT04164706|Laparoscopic|laparoscopic
4972266|NCT04164706|Hypothermia|hypothermia
4972267|NCT04164693|manitenance hemodialysis patients|manitenance hemodialysis patients
4972268|NCT04164693|arteriovenous fistula operation|arteriovenous fistula operation
4972269|NCT04164693|Thrombosis|thrombosis
4972270|NCT04164693|anticoagulant therapy|anticoagulant therapy
4972271|NCT04164693|Efficacy|efficacy
4972272|NCT04164693|safety|safety
4972273|NCT04164680|Disorder of Consciousness|disorder of consciousness
4972274|NCT04164680|Unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4972275|NCT04164680|Multimodal Neuroimaging|multimodal neuroimaging
4972276|NCT04164667|Telehealth|telehealth
4972277|NCT04164667|Veterans|veterans
4972278|NCT04164667|Exercise|exercise
4972279|NCT04164667|Mindfulness|mindfulness
4972280|NCT04164667|Health Coaching|health coaching
4972285|NCT04164602|new-onset diabetes mellitus|new-onset diabetes mellitus
4972286|NCT04164602|pancreatic cancer|pancreatic cancer
4972287|NCT04164602|biomarker|biomarker
4972288|NCT04164602|screening|screening
4972289|NCT04164576|Lung transplantation|lung transplantation
4972290|NCT04164576|BKV|bkv
4972291|NCT04164576|Nephropathy|nephropathy
4972292|NCT04164576|Immunosuppression|immunosuppression
4972293|NCT04164563|Joint pain|joint pain
4972294|NCT04164563|Ankle fracture|ankle fracture
4972295|NCT04164563|Leg length discrepancy|leg length discrepancy
4972296|NCT04164563|CAM boot|cam boot
4972297|NCT04164563|Even-Up|even-up
4972298|NCT04164537|Hispanic Americans, Adolescent|hispanic americans, adolescent
4972299|NCT04164524|SSI|ssi
4972300|NCT04164524|Wound infection|wound infection
4972301|NCT04164511|pediatric|pediatric
4972302|NCT04164511|tonsillectomy|tonsillectomy
4972303|NCT04164511|ice cream|ice cream
4972304|NCT04164511|cryotherapy|cryotherapy
4972305|NCT04164511|postoperative pain|postoperative pain
4972306|NCT04164498|Noise ICU|noise icu
4972307|NCT04164498|delirium|delirium
4972308|NCT04164498|depression|depression
4972309|NCT04164498|burnout|burnout
4972310|NCT04164498|music|music
4972311|NCT04164472|Relational Aggression|relational aggression
4972314|NCT04164472|Universal prevention|universal prevention
4972315|NCT04164472|School-based|school-based
4972316|NCT04164472|Urban|urban
4972317|NCT04164446|oil palm phenolics|oil palm phenolics
4972318|NCT04164446|lipid profile|lipid profile
4972319|NCT04164446|LDL cholesterol|ldl cholesterol
4972320|NCT04164446|HDL cholesterol|hdl cholesterol
4972321|NCT04164433|HIV self-testing|hiv self-testing
4972323|NCT04164433|Workplace|workplace
4972324|NCT04164433|Security Services|security services
4972325|NCT04164433|Linkage|linkage
4972330|NCT04164407|Pseudophakic and aphakic bullous keratopathy|pseudophakic and aphakic bullous keratopathy
4972331|NCT04164407|Ophthalmology|ophthalmology
4972332|NCT04164407|Cornea|cornea
4972336|NCT04164407|Crosslinking|crosslinking
4972338|NCT04164394|Diarrhea|diarrhea
4972339|NCT04164394|Abdominal pain|abdominal pain
4972340|NCT04164394|Flatulence|flatulence
4972341|NCT04164381|Rehabilitation|rehabilitation
4972342|NCT04164381|Robotics|robotics
4972343|NCT04164381|Cognitive Function|cognitive function
4972344|NCT04164342|pain|pain
4972345|NCT04164342|critically ill|critically ill
4972346|NCT04164329|Neurotoxicity|neurotoxicity
4972347|NCT04164329|anesthesia|anesthesia
4972348|NCT04164329|Neurofilament Light|neurofilament light
4972352|NCT04164316|Clinical Outcomes|clinical outcomes
4972353|NCT04164303|DeQuervain's tendinopathy|dequervain's tendinopathy
4972354|NCT04164303|CMC manipulation|cmc manipulation
4972355|NCT04164303|Physical Therapy|physical therapy
4972356|NCT04164277|Obesity prevention, early childhood, intergenerational, family-based|obesity prevention, early childhood, intergenerational, family-based
4972357|NCT04164264|Propofol|propofol
4972358|NCT04164251|Breast Cancer Screening|breast cancer screening
4972359|NCT04164251|Mammography|mammography
4972360|NCT04164238|HNSCC|hnscc
4972361|NCT04164238|PD-1 antibody|pd-1 antibody
4972362|NCT04164238|Neoadjuvant|neoadjuvant
4972363|NCT04164238|Major pathologic response|major pathologic response
4972364|NCT04164160|Integrated care|integrated care
4972365|NCT04164160|Health and social care|health and social care
4972366|NCT04164160|Chronic disease|chronic disease
4972367|NCT04164160|Primary Health Care|primary health care
4972368|NCT04164160|Quality of life|quality of life
4972369|NCT04164147|Total Knee Arthroplasty|total knee arthroplasty
4972370|NCT04164147|Nexgen|nexgen
4972371|NCT04164147|Persona|persona
4972372|NCT04164147|Knee osteoarthritis|knee osteoarthritis
5700175|NCT00500591|Survey|survey
4972373|NCT04164134|Retinoblastoma|retinoblastoma
4972374|NCT04164134|blood test|blood test
4972375|NCT04164134|liquid biopsy|liquid biopsy
4972377|NCT04164134|cancer|cancer
4972378|NCT04164134|Secondary primary malignancies|secondary primary malignancies
4972379|NCT04164134|SPM|spm
4972380|NCT04164121|Tolerance|tolerance
4972381|NCT04164121|Safety|safety
4972382|NCT04164121|Pharmacokinetic characteristics|pharmacokinetic characteristics
4972383|NCT04164108|intensive care unit|intensive care unit
4972384|NCT04164043|Recreation Therapy|recreation therapy
4972385|NCT04164043|Community Based|community based
4972386|NCT04164043|Movement Disorder|movement disorder
4972387|NCT04164043|Wellness Recovery Program|wellness recovery program
4972388|NCT04164030|low income adults|low income adults
4972389|NCT04164030|feasibility pilot study|feasibility pilot study
4972390|NCT04164030|occupational therapy|occupational therapy
4972391|NCT04164030|nutrition education|nutrition education
4972392|NCT04164030|yoga|yoga
4972393|NCT04164004|Quality of life|quality of life
4972394|NCT04164004|Patient-reported outcomes|patient-reported outcomes
4972395|NCT04164004|Quality of care|quality of care
4972396|NCT04164004|Implementation research|implementation research
4972401|NCT04163978|nitric oxide, sinusitis|nitric oxide, sinusitis
4972402|NCT04163939|Neck pain|neck pain
4972403|NCT04163926|follow up|follow up
4972404|NCT04163926|post surgery|post surgery
4972405|NCT04163926|patient satisfaction|patient satisfaction
4972406|NCT04163926|optometrist|optometrist
4972407|NCT04163926|ophthalmologist|ophthalmologist
4972408|NCT04163926|community care|community care
4972409|NCT04163900|Adenocarcinoma|adenocarcinoma
4972410|NCT04163900|Ampullary|ampullary
4972411|NCT04163900|Antineoplastic Agents|antineoplastic agents
4972412|NCT04163900|Biliary Tract Cancer|biliary tract cancer
4972413|NCT04163900|Chemotherapy|chemotherapy
4972414|NCT04163900|Cholangiocarcinoma|cholangiocarcinoma
4972415|NCT04163900|Cisplatin|cisplatin
4972416|NCT04163900|Digestive System Neoplasms|digestive system neoplasms
4972417|NCT04163900|Distal Bile Duct|distal bile duct
4972418|NCT04163900|Extrahepatic|extrahepatic
4972419|NCT04163900|First-line Chemotherapy|first-line chemotherapy
4972420|NCT04163900|Gallbladder|gallbladder
4972421|NCT04163900|Gastrointestinal|gastrointestinal
4972432|NCT04163887|Laparoscopy|laparoscopy
4972433|NCT04163874|type 1 diabetes|type 1 diabetes
4972434|NCT04163874|artificial pancreas|artificial pancreas
4972435|NCT04163874|pramlintide|pramlintide
4972436|NCT04163874|fiasp|fiasp
4972437|NCT04163874|hyperglycemia|hyperglycemia
4972438|NCT04163874|closed-loop|closed-loop
4972439|NCT04163861|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4972440|NCT04163861|global longitudinal strain|global longitudinal strain
4972441|NCT04163861|2D speckle tracking echocardiography|2d speckle tracking echocardiography
4972442|NCT04163861|subclinical systolic dysfunction|subclinical systolic dysfunction
4972443|NCT04163861|GLS|gls
4972444|NCT04163848|Desflurane|desflurane
4972445|NCT04163848|Sevoflurane|sevoflurane
4972446|NCT04163848|Fresh gas flow|fresh gas flow
4977434|NCT04133519|IBS|ibs
4972449|NCT04163835|Dose-effect relationship|dose-effect relationship
4972458|NCT04163809|virtual reality|virtual reality
4972459|NCT04163809|anxiety|anxiety
4972460|NCT04163809|pain|pain
4972461|NCT04163809|regional anesthesia|regional anesthesia
4972462|NCT04163783|Phase 1|phase 1
4972463|NCT04163783|Pharmacokinetics|pharmacokinetics
4972464|NCT04163783|Safety|safety
4972465|NCT04163744|Induction of labour|induction of labour
4972466|NCT04163744|Double balloon catheter|double balloon catheter
4972467|NCT04163744|Vaginal delivery rate|vaginal delivery rate
4972468|NCT04163744|Mechanical method|mechanical method
4972469|NCT04163744|in-patient|in-patient
4972470|NCT04163744|out-patient|out-patient
4972471|NCT04163718|CLL|cll
4972472|NCT04163705|Multiple organ dysfunctions|multiple organ dysfunctions
4972476|NCT04163666|Stroke|stroke
4972477|NCT04163666|Upper member|upper member
4972478|NCT04163666|Neurorehabilitation|neurorehabilitation
4972479|NCT04163666|Mirror therapy|mirror therapy
4972480|NCT04163666|Therapeutic cognitive exercise|therapeutic cognitive exercise
4972481|NCT04163666|Perfetti|perfetti
4972482|NCT04163627|Technical procedure for treatment of HCC: either liver transplantation, liver resection, thermal ablation, chemoembolization, or radioembolization|technical procedure for treatment of hcc: either liver transplantation, liver resection, thermal ablation, chemoembolization, or radioembolization
4972483|NCT04163627|Chronic liver diseases|chronic liver diseases
4972484|NCT04163627|Interventional Radiology|interventional radiology
4972485|NCT04163627|Liver surgery|liver surgery
4972486|NCT04163614|End Stage Renal Disease|end stage renal disease
4972487|NCT04163614|Hypertension|hypertension
4972488|NCT04163614|Extracellular Volume|extracellular volume
4972489|NCT04163614|Intradialytic Hypotension|intradialytic hypotension
4972490|NCT04163614|Bioimpedance Spectroscopy|bioimpedance spectroscopy
4972491|NCT04163588|acute heart failure|acute heart failure
4972492|NCT04163588|decongestion|decongestion
4972493|NCT04163588|diuretics|diuretics
4972494|NCT04163588|outcomes|outcomes
4972495|NCT04163575|CAR-T|car-t
4972496|NCT04163575|Leukemia|leukemia
4972497|NCT04163575|lymphoma|lymphoma
4972498|NCT04163523|Phase 1, pharmacokinetics safety|phase 1, pharmacokinetics safety
4972499|NCT04163484|coronary artery disease|coronary artery disease
4972500|NCT04163484|iodinated contrast media|iodinated contrast media
4972501|NCT04163484|stable angina|stable angina
4972502|NCT04163484|unstable angina|unstable angina
4972503|NCT04163484|STEMI|stemi
4972504|NCT04163484|NSTEMI|nstemi
4972505|NCT04163484|PCI|pci
4972506|NCT04163484|acute kidney injury|acute kidney injury
4972507|NCT04163471|VasoStat|vasostat
4972508|NCT04163471|TR Band|tr band
4972509|NCT04163471|Transradial access|transradial access
4972510|NCT04163471|Coronary angiography|coronary angiography
4972511|NCT04163471|Peripheral arterial disease|peripheral arterial disease
4972512|NCT04163471|Coronary artery disease|coronary artery disease
4972513|NCT04163471|Peripheral angiography|peripheral angiography
4972514|NCT04163471|Stents|stents
4972517|NCT04163419|schwannoma|schwannoma
4972518|NCT04163419|nerve growth factor|nerve growth factor
4972519|NCT04163419|antibody|antibody
4972520|NCT04163419|NGF|ngf
4972521|NCT04163406|Anemia|anemia
4972522|NCT04163406|Iron-deficiency|iron-deficiency
4972523|NCT04163406|Iron absorption|iron absorption
4972524|NCT04163406|Prebiotic|prebiotic
4972525|NCT04163406|Galacto-oligosaccharides|galacto-oligosaccharides
4972530|NCT04163393|Percutaneous Coronary Intervention|percutaneous coronary intervention
4972535|NCT04163367|Parenting|parenting
4972536|NCT04163367|Randomized controlled trial|randomized controlled trial
4972537|NCT04163367|Parent-Child relations|parent-child relations
4972538|NCT04163367|Social services|social services
4972539|NCT04163367|Prevention|prevention
4972540|NCT04163354|Pit and Fissure Sealant|pit and fissure sealant
4972541|NCT04163354|Fluorides, Topical|fluorides, topical
4972542|NCT04163328|HydroEye®|hydroeye®
4972543|NCT04163328|Contact Lens Discomfort|contact lens discomfort
4972544|NCT04163328|Dry Eye|dry eye
4972545|NCT04163328|Supplement|supplement
4972546|NCT04163302|Lymphoma|lymphoma
4972547|NCT04163302|Chimeric antigen receptor T cell|chimeric antigen receptor t cell
4972549|NCT04163302|Immunotherapy|immunotherapy
4972550|NCT04163302|PD-1|pd-1
4972551|NCT04163302|CD19|cd19
4972552|NCT04163276|neurodegenerative disease|neurodegenerative disease
4972553|NCT04163276|digital brain PET exam|digital brain pet exam
4972554|NCT04163276|database|database
4972557|NCT04163250|Contrast media|contrast media
4972558|NCT04163250|Urinary cell-cycle arrest biomarkers|urinary cell-cycle arrest biomarkers
4972559|NCT04163250|Acute Kidney Injury|acute kidney injury
4972560|NCT04163224|multiple rib fractures|multiple rib fractures
4972561|NCT04163224|chest stabilization|chest stabilization
4972562|NCT04163224|rib plates|rib plates
4972563|NCT04163185|Migraine|migraine
4972564|NCT04163185|AXS-07|axs-07
4972565|NCT04163185|Meloxicam|meloxicam
4972566|NCT04163185|Rizatriptan|rizatriptan
4972567|NCT04163146|Asthma|asthma
4972568|NCT04163146|Lung function variability|lung function variability
4972579|NCT04163081|Emergency Department|emergency department
4972580|NCT04163081|Nicotine Dependence|nicotine dependence
4972581|NCT04163081|Tobacco Abstinence|tobacco abstinence
4972582|NCT04163081|Tobacco Treatment|tobacco treatment
4972583|NCT04163081|Cigarette|cigarette
4972584|NCT04163068|cancer|cancer
4972585|NCT04163068|survivorship|survivorship
4972586|NCT04163068|qualitative interviews|qualitative interviews
4972587|NCT04163068|treatment burden|treatment burden
4972588|NCT04163068|cancer aftercare|cancer aftercare
4972589|NCT04163068|self management|self management
4972590|NCT04163055|Diabetes|diabetes
4972591|NCT04163055|Foot Ulcer|foot ulcer
4972592|NCT04163055|Non-healing wound|non-healing wound
4972593|NCT04163055|Targeted debridement|targeted debridement
4972594|NCT04163042|Physical activity|physical activity
4972595|NCT04163042|Behavioural support|behavioural support
4972596|NCT04163042|Oncology|oncology
4972597|NCT04163042|Telehealth|telehealth
4972598|NCT04163042|Self-determination theory|self-determination theory
4972599|NCT04163042|Behaviour change techniques|behaviour change techniques
4972600|NCT04163042|Young adult cancer survivors|young adult cancer survivors
4972601|NCT04163016|Cimzia|cimzia
4972602|NCT04163016|Certolizumab Pegol|certolizumab pegol
4972603|NCT04163016|Pregnant Women|pregnant women
4972604|NCT04163016|Crohn's Disease (CD)|crohn's disease (cd)
4972605|NCT04163016|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
4972606|NCT04163016|Psoriatic Arthritis (PsA)|psoriatic arthritis (psa)
4972607|NCT04163016|Plaque Psoriasis (PSO)|plaque psoriasis (pso)
4972608|NCT04163016|Axial Spondyloarthritis (AxSpA)|axial spondyloarthritis (axspa)
4972609|NCT04163016|Pharmacokinetics|pharmacokinetics
4972610|NCT04163016|CZP|czp
4972611|NCT04162990|Subjective Memory Complaint|subjective memory complaint
4972612|NCT04162990|Alzheimer's disease|alzheimer's disease
4972613|NCT04162990|mild cognitive impairment|mild cognitive impairment
4972614|NCT04162990|Neuroinflammation|neuroinflammation
4972615|NCT04162990|lifestyle|lifestyle
4972616|NCT04162977|Substance Use and Misuse|substance use and misuse
4972617|NCT04162977|Prevention|prevention
4972618|NCT04162977|Early Intervention|early intervention
4972619|NCT04162977|Mental Health|mental health
4972620|NCT04162977|Complex Trauma|complex trauma
4972621|NCT04162977|Youth Protection Services.|youth protection services.
4972622|NCT04162977|Adolescence|adolescence
4972623|NCT04162977|Personality-targeted Interventions|personality-targeted interventions
4972624|NCT04162964|Dementia|dementia
4972625|NCT04162964|Stress|stress
4972626|NCT04162964|Caregiving|caregiving
4972656|NCT04162626|intervention|intervention
4972657|NCT04162626|home visit|home visit
4972658|NCT04162613|anterior cruciate ligament injury|anterior cruciate ligament injury
4972659|NCT04162613|re-injury|re-injury
4972660|NCT04162613|muscle function|muscle function
4972661|NCT04162613|functional performance|functional performance
4972662|NCT04162613|rehabilitation|rehabilitation
4972663|NCT04162613|physiotherapy|physiotherapy
4972664|NCT04162613|sensorimotor control|sensorimotor control
4972665|NCT04162600|Vaccine|vaccine
4972666|NCT04162587|Ischemic Stroke|ischemic stroke
4972667|NCT04162587|carotid stenosis|carotid stenosis
4972668|NCT04162561|quality of therapy|quality of therapy
4972669|NCT04162561|current clinical guidelines|current clinical guidelines
4972670|NCT04162548|frail|frail
4972671|NCT04162548|public health|public health
4972672|NCT04162535|Anesthesia|anesthesia
4972673|NCT04162535|Propofol|propofol
4972674|NCT04162535|Sevoflurane|sevoflurane
4972675|NCT04162535|Lidocaine|lidocaine
4972676|NCT04162535|Cell Culture|cell culture
4972677|NCT04162522|major depression|major depression
4972678|NCT04162522|major depressive disorder|major depressive disorder
4972679|NCT04162522|MDD|mdd
4972680|NCT04162522|escitalopram|escitalopram
4972681|NCT04162522|brexpiprazole|brexpiprazole
4972682|NCT04162522|neuroimaging|neuroimaging
4972683|NCT04162522|genomics|genomics
4972689|NCT04162496|Tech Neck|tech neck
4972690|NCT04162496|Necklace Lines|necklace lines
4972691|NCT04162496|Restylane|restylane
4972692|NCT04162496|Restylane Refyne|restylane refyne
4972704|NCT04162431|Raman|raman
4972705|NCT04162431|Lymphoma|lymphoma
4972709|NCT04162405|tinnitus|tinnitus
4972710|NCT04162405|sensorineural hearing loss|sensorineural hearing loss
4972711|NCT04162405|otoacoustic emission|otoacoustic emission
4972712|NCT04162405|normacusis|normacusis
4972713|NCT04162405|questionnaire|questionnaire
4990750|NCT04049682|Sleep Deprivation|sleep deprivation
4972714|NCT04162379|Steroid, analgesia, Prednisolone, Cancer, cancer Pain, pain WHO stepladder.|steroid, analgesia, prednisolone, cancer, cancer pain, pain who stepladder.
4972715|NCT04162366|Chronic kidney disease|chronic kidney disease
4972716|NCT04162353|BCMA|bcma
4972717|NCT04162353|CD19|cd19
4972718|NCT04162353|BCMA-CD19 cCAR T cells|bcma-cd19 ccar t cells
4972719|NCT04162353|multiple myeloma|multiple myeloma
4972720|NCT04162353|plasmacytoid lymphoma|plasmacytoid lymphoma
4972721|NCT04162340|CD4-specific CAR T|cd4-specific car t
4972722|NCT04162340|T cell leukemia|t cell leukemia
4972723|NCT04162340|T cell lymphoma|t cell lymphoma
4972724|NCT04162340|CD4CAR|cd4car
4972725|NCT04162314|non-infectious uveitis|non-infectious uveitis
4972726|NCT04162314|idiopathic uveitis|idiopathic uveitis
4972727|NCT04162288|Shared Decision Making|shared decision making
4972728|NCT04162288|Decision aid|decision aid
4972729|NCT04162288|Nurse|nurse
4972730|NCT04162288|Online Training|online training
4972731|NCT04162262|Plantar Fascitis|plantar fascitis
4972732|NCT04162262|Instrument-assisted soft tissue mobilization|instrument-assisted soft tissue mobilization
4972733|NCT04162262|Stretch and strengthening exercise|stretch and strengthening exercise
4972734|NCT04162262|Plantar fasciopathy|plantar fasciopathy
4972735|NCT04162249|Atrial fibrillation|atrial fibrillation
4972736|NCT04162249|Ablatión|ablatión
4972737|NCT04162249|High-power|high-power
4972738|NCT04162249|Radiofrequency|radiofrequency
4972739|NCT04162249|Esophageal lesion|esophageal lesion
4972744|NCT04162197|Stroke|stroke
4972752|NCT04162184|opioid use disorder|opioid use disorder
4972753|NCT04162184|patient navigation|patient navigation
4972754|NCT04162184|reproductive health|reproductive health
4972755|NCT04162184|sexual health|sexual health
4972756|NCT04162145|opioid withdrawal|opioid withdrawal
4972757|NCT04162145|opioid|opioid
4972758|NCT04162145|pain|pain
4972759|NCT04162145|craving|craving
4972760|NCT04162145|NSS-2 BRIDGE|nss-2 bridge
4972761|NCT04162145|percutaneous electrical nerve field stimulator (PENFS)|percutaneous electrical nerve field stimulator (penfs)
4972762|NCT04162132|contingency management|contingency management
4972763|NCT04162132|smartphone app|smartphone app
4972764|NCT04162132|substance use disorder|substance use disorder
4972765|NCT04162132|outpatient addiction treatment|outpatient addiction treatment
4972766|NCT04162132|BrightView|brightview
4972767|NCT04162132|DynamiCare|dynamicare
4972768|NCT04162119|BCMA|bcma
4972769|NCT04162119|Myeloma|myeloma
4972770|NCT04162119|PD-1|pd-1
4972771|NCT04162119|Immunotherapy|immunotherapy
4972772|NCT04162119|Plasmocytoma|plasmocytoma
4972773|NCT04162119|Chimeric antigen receptor T cell|chimeric antigen receptor t cell
4972774|NCT04162119|Chimeric antigen receptor|chimeric antigen receptor
4972775|NCT04162119|B cell maturation antigen|b cell maturation antigen
4972776|NCT04162093|Bladder Cancer|bladder cancer
4972777|NCT04162093|Orthotopic diversion|orthotopic diversion
4972778|NCT04162093|Wallace|wallace
4972779|NCT04162093|sub-serous extramural tunnel.|sub-serous extramural tunnel.
4972781|NCT04162067|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4972782|NCT04162067|hypoglycemia|hypoglycemia
4972783|NCT04162067|hemoglobin A1c|hemoglobin a1c
4972784|NCT04162067|time in range|time in range
4972785|NCT04162067|continuous glucose monitor|continuous glucose monitor
4972786|NCT04162015|Nivolumab|nivolumab
4972787|NCT04162015|Surgery|surgery
4972788|NCT04162015|Pemetrexed|pemetrexed
4972789|NCT04162015|Cisplatin|cisplatin
4972790|NCT04162015|Carboplatin|carboplatin
4972791|NCT04162015|19-272|19-272
4972792|NCT04161963|Cataract|cataract
4972793|NCT04161963|Glaucoma|glaucoma
4972794|NCT04161963|cystroid macular edema|cystroid macular edema
4972795|NCT04161950|echoendoscope|echoendoscope
4972796|NCT04161950|endoscopic ultrasonography|endoscopic ultrasonography
4972797|NCT04161937|Work-site|work-site
4972798|NCT04161937|Diabetes|diabetes
4972799|NCT04161937|Nepal|nepal
4972800|NCT04161898|Takayasu Arteritis (TAK)|takayasu arteritis (tak)
4970109|NCT04177147|Electronic health records|electronic health records
4970110|NCT04177134|spinal muscular atrophy|spinal muscular atrophy
4970111|NCT04177121|Musculoskeletal disorders|musculoskeletal disorders
4972810|NCT04161885|Cancer|cancer
4972811|NCT04161833|breast cancer|breast cancer
4972812|NCT04161833|luminal tumor|luminal tumor
4972813|NCT04161833|anti-aromatase inhibitors|anti-aromatase inhibitors
4972814|NCT04161833|arthralgia|arthralgia
4972815|NCT04161833|dietary supplement|dietary supplement
4972816|NCT04161820|Chronic Care Model|chronic care model
4972817|NCT04161820|Self-management|self-management
4972818|NCT04161820|Stroke|stroke
4972819|NCT04161820|Quality of Life|quality of life
4972820|NCT04161794|cachexia|cachexia
4972821|NCT04161794|cancer|cancer
4972822|NCT04161794|multimodal intervention|multimodal intervention
4972823|NCT04161781|18F-BMS-986229|18f-bms-986229
4972824|NCT04161781|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4972825|NCT04161781|19-122|19-122
4972839|NCT04161716|urinary disorder|urinary disorder
4972840|NCT04161677|Adverse event|adverse event
4972841|NCT04161677|Electronic reporting system|electronic reporting system
4972842|NCT04161677|Chiropractic|chiropractic
4972843|NCT04161677|Spinal manipulation|spinal manipulation
4972844|NCT04161651|eversense|eversense
4972845|NCT04161651|type 1 diabetes|type 1 diabetes
4972846|NCT04161625|Prevention and control|prevention and control
4972847|NCT04161625|Exercise therapy/methods*|exercise therapy/methods*
4972853|NCT04161625|Postural balance|postural balance
4972854|NCT04161625|Health behaviour|health behaviour
4972855|NCT04161625|mHealth|mhealth
4972856|NCT04161625|eHealth|ehealth
4972857|NCT04161625|Digital health|digital health
4972858|NCT04161625|Self-management|self-management
4972859|NCT04161625|Re-aim|re-aim
4972860|NCT04161612|Sleep quality|sleep quality
4972861|NCT04161586|Spinal Anesthesia|spinal anesthesia
4972863|NCT04161586|Ambulatory Surgery|ambulatory surgery
4972864|NCT04161586|Safety|safety
4972865|NCT04161573|Irony comprehension|irony comprehension
4972866|NCT04161560|Cetuximab-IRDye800|cetuximab-irdye800
4972867|NCT04161560|EGFR|egfr
4972868|NCT04161560|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4972869|NCT04161560|real-time imaging|real-time imaging
4972870|NCT04161547|CSPCHA115|cspcha115
4972871|NCT04161547|Asthma|asthma
4972872|NCT04161547|CRTH2|crth2
4972875|NCT04161508|sugammadex, anterior cervical spine surgery|sugammadex, anterior cervical spine surgery
4972876|NCT04161469|sphincter injury|sphincter injury
4972877|NCT04161469|anal abscess|anal abscess
4972878|NCT04161469|incontinence|incontinence
4972879|NCT04161456|Acne conglobata|acne conglobata
4972880|NCT04161456|Phosphodiesterase (PDE)-Inhibitor|phosphodiesterase (pde)-inhibitor
4972881|NCT04161443|MET, Quadratus lumborum, Sacroilliac joint|met, quadratus lumborum, sacroilliac joint
4972882|NCT04161430|DBPR108|dbpr108
4972883|NCT04161430|Type 2 diabetes mellitus|type 2 diabetes mellitus
4972884|NCT04161430|DPP4 inhibitor|dpp4 inhibitor
4972885|NCT04161404|Pharmacometabolomic|pharmacometabolomic
4972886|NCT04161404|Metformin|metformin
4972887|NCT04161404|Andrographis paniculata|andrographis paniculata
4972888|NCT04161404|Metabolomics|metabolomics
4972889|NCT04161404|Phase 1|phase 1
4972890|NCT04161404|Healthy volunteers|healthy volunteers
4972891|NCT04161404|Herbal Medicine|herbal medicine
4972892|NCT04161391|Non small cell lung cancer|non small cell lung cancer
4972893|NCT04161391|Non-small cell lung cancer|non-small cell lung cancer
4972894|NCT04161391|NSCLC|nsclc
4972895|NCT04161391|Medullary Thyroid Cancer|medullary thyroid cancer
4972897|NCT04161391|RET gene mutation|ret gene mutation
4972898|NCT04161391|RET gene alteration|ret gene alteration
4972899|NCT04161391|Advanced non small cell lung cancer|advanced non small cell lung cancer
4972900|NCT04161391|Advanced/metastatic disease|advanced/metastatic disease
4972901|NCT04161391|lung cancer|lung cancer
4972902|NCT04161391|lung adenocarcinoma|lung adenocarcinoma
4972903|NCT04161391|Metastatic solid tumor|metastatic solid tumor
4972904|NCT04161391|Advanced Solid Tumors|advanced solid tumors
4972905|NCT04161391|RET gene fusion|ret gene fusion
4972906|NCT04161391|RET inhibitor|ret inhibitor
4972907|NCT04161391|SRC|src
4972908|NCT04161391|TPX-0046|tpx-0046
4972909|NCT04161391|Thyroid cancer|thyroid cancer
4972910|NCT04161365|Urethral Stricture|urethral stricture
4972911|NCT04161365|Fat Graft|fat graft
4972922|NCT04161274|moist healing environment|moist healing environment
4972923|NCT04161274|fibroma|fibroma
4972924|NCT04161274|nursing|nursing
4972925|NCT04161274|skin diseases|skin diseases
4972926|NCT04161222|Knee stability.|knee stability.
4972927|NCT04161222|Core|core
4972928|NCT04161222|Gluteus medius|gluteus medius
4972929|NCT04161222|Warm-up|warm-up
4972930|NCT04161222|Football|football
4972931|NCT04161209|Citalopram|citalopram
4990950|NCT04048681|diet soda|diet soda
4972945|NCT04161092|colorectal cancer|colorectal cancer
4972946|NCT04161092|liver metastases|liver metastases
4972947|NCT04161092|liver transplant|liver transplant
4972948|NCT04161092|non-resectable colorectal cancer metastases|non-resectable colorectal cancer metastases
4972958|NCT04161040|Relapse|relapse
4972959|NCT04161040|Physical Activity|physical activity
4972960|NCT04161040|Sedentary Behavior|sedentary behavior
4972961|NCT04161040|Behavioral Momentum Theory|behavioral momentum theory
4972962|NCT04161040|Incentives|incentives
4972963|NCT04161027|Restless legs syndrome; pregabalin; Willis-Ekbom disease|restless legs syndrome; pregabalin; willis-ekbom disease
4972964|NCT04160975|Belief Updating|belief updating
4972965|NCT04160975|Preventive Care|preventive care
4972966|NCT04160975|Racial Disparity|racial disparity
4972967|NCT04160897|chronic hepatitis B|chronic hepatitis b
4972968|NCT04160897|hepatocellular carcinoma|hepatocellular carcinoma
4972969|NCT04160897|compensated cirrhosis|compensated cirrhosis
4972970|NCT04160897|Chinese|chinese
4972971|NCT04160897|entecavir|entecavir
4972972|NCT04160897|tenofovir disopropyl|tenofovir disopropyl
4972973|NCT04160897|multi-center|multi-center
4972974|NCT04160897|real-world|real-world
4972975|NCT04160897|respective|respective
4972976|NCT04160871|borderline personality disorder|borderline personality disorder
4972977|NCT04160871|family connections|family connections
4972978|NCT04160871|relatives|relatives
4972980|NCT04160871|intervention|intervention
4972981|NCT04160871|program|program
4972982|NCT04160871|caregivers|caregivers
4972983|NCT04160832|genetics|genetics
4972984|NCT04160832|polyps|polyps
4972985|NCT04160832|cancer|cancer
4972986|NCT04160832|multi-gene panel|multi-gene panel
4972987|NCT04160819|nutritional intervention|nutritional intervention
4972988|NCT04160819|malnutrition|malnutrition
4972989|NCT04160819|respiratory disease|respiratory disease
4972990|NCT04160806|Anxiety disorders|anxiety disorders
4972991|NCT04160806|Panic disorder|panic disorder
4972992|NCT04160806|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4972993|NCT04160806|Interoceptive accuracy|interoceptive accuracy
4972994|NCT04160806|Attention bias|attention bias
4972995|NCT04160806|Emotion recognition|emotion recognition
4972996|NCT04160806|Brain Stimulation|brain stimulation
4972998|NCT04160767|Gut microbiota|gut microbiota
4972999|NCT04160754|Trauma|trauma
4973000|NCT04160754|Delinquency|delinquency
4973001|NCT04160754|Substance Use|substance use
4973002|NCT04160754|Emotion Regulation|emotion regulation
4973003|NCT04160754|Impulsivity|impulsivity
4973004|NCT04160754|Executive Functioning|executive functioning
4973005|NCT04160741|heat stress|heat stress
4973006|NCT04160741|heat strain|heat strain
4973007|NCT04160741|solar radiation|solar radiation
4973008|NCT04160741|responses|responses
4973009|NCT04160741|cognition|cognition
4973010|NCT04160741|thermal|thermal
4973011|NCT04160728|heat stress|heat stress
4973012|NCT04160728|heat strain|heat strain
4973013|NCT04160728|productivity|productivity
4973014|NCT04160728|labor|labor
4973015|NCT04160728|occupation|occupation
4973016|NCT04160728|work|work
4973017|NCT04160728|thermal|thermal
4973018|NCT04160702|sexual assault prevention|sexual assault prevention
4973019|NCT04160702|motivational interviewing|motivational interviewing
4973020|NCT04160702|bystander intervention|bystander intervention
4973021|NCT04160676|Hydrocortison|hydrocortison
4973022|NCT04160676|Ascorbic acid|ascorbic acid
4973023|NCT04160676|Thiamine|thiamine
4973024|NCT04160637|parathyroid hormone|parathyroid hormone
4973025|NCT04160637|total thyroidectomy|total thyroidectomy
4973026|NCT04160637|hypocalcemia|hypocalcemia
4973104|NCT04160143|Surgical resection|surgical resection
4973105|NCT04160143|Stereotactic body radiation therapy|stereotactic body radiation therapy
4973106|NCT04160143|Pulmonary metastasectomy|pulmonary metastasectomy
4973107|NCT04160143|Lung Cancers|lung cancers
4973108|NCT04160130|Research in woman|research in woman
4973109|NCT04160130|Transcatheter Aortic Valve Implantation (TAVI)|transcatheter aortic valve implantation (tavi)
4973110|NCT04160130|surgical aortic valve replacement (SAVR)|surgical aortic valve replacement (savr)
4973111|NCT04160130|cardiovascular disease|cardiovascular disease
4973112|NCT04160130|heart disease|heart disease
4973113|NCT04160130|Sapien 3|sapien 3
4973114|NCT04160104|Bowel preparation|bowel preparation
4973115|NCT04160104|BBPS|bbps
4973116|NCT04160091|Osteoarthritis|osteoarthritis
4973117|NCT04160091|Adhesive Capsulitis|adhesive capsulitis
4973118|NCT04160091|Shoulder|shoulder
4973119|NCT04160091|Pain|pain
4973120|NCT04160091|Intra-articular|intra-articular
4973121|NCT04160091|Injection|injection
4973122|NCT04160091|Steroid|steroid
4973123|NCT04160078|Diabetes|diabetes
4973124|NCT04160078|Mindfulness|mindfulness
4973125|NCT04160078|Public health|public health
4973126|NCT04160078|Sleep|sleep
4973137|NCT04160039|Cycle Ergometry|cycle ergometry
4973138|NCT04160039|Physical Therapy|physical therapy
4973139|NCT04160039|Rehabilitation|rehabilitation
4973140|NCT04160000|Atrial fibrillation|atrial fibrillation
4973141|NCT04160000|Heart failure|heart failure
4973142|NCT04160000|Diastolic heart failure|diastolic heart failure
4973143|NCT04160000|Catheter Ablation|catheter ablation
4973144|NCT04160000|Antiarrhythmic Drugs|antiarrhythmic drugs
4973145|NCT04159948|Carbodydrate drink|carbodydrate drink
4973146|NCT04159909|vagus nerve stimulation (VNS), non-invasive intervention|vagus nerve stimulation (vns), non-invasive intervention
4973150|NCT04159805|Drug therapy|drug therapy
4973151|NCT04159792|stroke|stroke
4973152|NCT04159792|upper limb|upper limb
4973153|NCT04159792|lower limb|lower limb
4973156|NCT04159779|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
4973158|NCT04159779|Relapsed/Refractory|relapsed/refractory
4973159|NCT04159753|Spinal cord stimulator (SCS)|spinal cord stimulator (scs)
4973160|NCT04159727|gut microbiota|gut microbiota
4973161|NCT04159727|Bacterial translocation|bacterial translocation
4973162|NCT04159610|Excessive sweating|excessive sweating
4973163|NCT04159597|Expanded Access|expanded access
4973164|NCT04159597|Pre-approval Access|pre-approval access
4973165|NCT04159597|Compassionate Use|compassionate use
4973166|NCT04159597|Special Access Program|special access program
4973167|NCT04159597|Named Patient Basis|named patient basis
4973168|NCT04159597|Special Access Scheme|special access scheme
4973173|NCT04159519|Anti-Inflammatory|anti-inflammatory
4973174|NCT04159519|Reduction period|reduction period
4973175|NCT04159519|Inhaled corticosteroids|inhaled corticosteroids
4973176|NCT04159519|long-acting β2 agonist|long-acting β2 agonist
4973177|NCT04159506|equine therapy|equine therapy
4973178|NCT04159506|social functioning|social functioning
4991149|NCT04047511|elderly|elderly
4973181|NCT04159467|Obesity|obesity
4973182|NCT04159467|Diet|diet
4973183|NCT04159467|Pelvic floor muscles training|pelvic floor muscles training
4973195|NCT04159389|airway management|airway management
4973196|NCT04159389|pedagogy|pedagogy
4973197|NCT04159389|learning process|learning process
4973198|NCT04159389|mental visualization|mental visualization
4973199|NCT04159389|rapide sequence induction|rapide sequence induction
4973200|NCT04159363|psychosocial intervention|psychosocial intervention
4973201|NCT04159363|smartphone-based|smartphone-based
4973202|NCT04159363|patient|patient
4973203|NCT04159363|colorectal cancer|colorectal cancer
4973204|NCT04159363|caregiver|caregiver
4973205|NCT04159363|randomised controlled trial|randomised controlled trial
4973206|NCT04159324|Stroke|stroke
4973207|NCT04159324|Patient-reported outcomes (PROs)|patient-reported outcomes (pros)
4973208|NCT04159324|Cross-sectoral care|cross-sectoral care
4973209|NCT04159324|Stroke aftercare|stroke aftercare
4973210|NCT04159324|Aftercare coordination|aftercare coordination
4973211|NCT04159324|Post-rehabilitation support|post-rehabilitation support
4973212|NCT04159324|Evidence based treatment|evidence based treatment
4973213|NCT04159324|Patient-centred care|patient-centred care
4973214|NCT04159324|Quality of life|quality of life
4973215|NCT04159324|Morbidity|morbidity
4973216|NCT04159324|Mortality|mortality
4973217|NCT04159324|Functional status|functional status
4973218|NCT04159324|Feasibility|feasibility
4973219|NCT04159324|Acceptance|acceptance
4973220|NCT04159324|Process evaluation|process evaluation
4973221|NCT04159324|Health economics|health economics
4973222|NCT04159298|rehabilitation|rehabilitation
4973223|NCT04159298|sports medicine|sports medicine
4973224|NCT04159298|Test a New Treatment|test a new treatment
4973225|NCT04159298|randomized control trial|randomized control trial
4973226|NCT04159233|sleep|sleep
4973227|NCT04159233|pain|pain
4973228|NCT04159233|professional athlete|professional athlete
4973229|NCT04159233|National Football League|national football league
4973230|NCT04159233|Behavioral intervention|behavioral intervention
4973231|NCT04159207|Depression|depression
4973232|NCT04159207|Suicide|suicide
4973233|NCT04159207|Inflammation|inflammation
4973234|NCT04159207|Kynurenine|kynurenine
4973235|NCT04159207|Cytokine|cytokine
4973236|NCT04159194|soccer|soccer
4973237|NCT04159194|overtime|overtime
4973238|NCT04159194|performance|performance
4973239|NCT04159194|recovery|recovery
4973240|NCT04159181|Colon|colon
4973241|NCT04159181|PYYs|pyys
4973242|NCT04159181|GLP-1|glp-1
4973243|NCT04159181|Gut peptides|gut peptides
4973244|NCT04159181|Fermentation|fermentation
4973245|NCT04159181|Lactulose|lactulose
4973246|NCT04159181|human|human
4973247|NCT04159168|Attention [F02.830.104.214]|attention [f02.830.104.214]
4973248|NCT04159168|Temperament [F01.752.898]|temperament [f01.752.898]
4973249|NCT04159168|Problem Behavior [F01.145.179.750]|problem behavior [f01.145.179.750]
4973250|NCT04159168|Social Behavior [F01.145.813]|social behavior [f01.145.813]
4973251|NCT04159168|Electroencephalography [E01.370.405.245]|electroencephalography [e01.370.405.245]
4973252|NCT04159168|Neuropsychological Tests [F04.711.513]|neuropsychological tests [f04.711.513]
4973263|NCT04159103|mRNA-3927|mrna-3927
4973264|NCT04159103|Propionic Aciduria|propionic aciduria
4973265|NCT04159103|Metabolism, Inborn Errors|metabolism, inborn errors
4973266|NCT04159103|Genetic Diseases|genetic diseases
4973267|NCT04159103|Inborn Amino Acid Metabolism, Inborn Errors|inborn amino acid metabolism, inborn errors
4973268|NCT04159103|Acidosis|acidosis
4973269|NCT04159103|Acid-Base Imbalance|acid-base imbalance
4973270|NCT04159103|Metabolic Diseases|metabolic diseases
4973271|NCT04159103|Organic Acidemias|organic acidemias
4973273|NCT04159077|Post-operative urinary retention|post-operative urinary retention
4973274|NCT04159077|Tamsulosin|tamsulosin
4973275|NCT04159077|urinary tract infections|urinary tract infections
4973276|NCT04159077|catheter|catheter
4973277|NCT04159064|extracorporeal circulation|extracorporeal circulation
4973278|NCT04159064|coagulation disorder|coagulation disorder
4973279|NCT04159064|Extracorporeal Circulation of Blood; Thrombocytopenia|extracorporeal circulation of blood; thrombocytopenia
4973280|NCT04159038|Pilot Projects|pilot projects
4973281|NCT04159038|Randomized Controlled Trial|randomized controlled trial
4973282|NCT04158947|HER2-positive Breast Cancer|her2-positive breast cancer
4973283|NCT04158947|Brain metastases|brain metastases
4973284|NCT04158947|T-DM1|t-dm1
4973285|NCT04158947|Afatinib|afatinib
4973286|NCT04158921|Diabetes Mellitus|diabetes mellitus
4973303|NCT04158869|pediatric Major Depressive Disorder|pediatric major depressive disorder
4973304|NCT04158843|Breast Cancer|breast cancer
4973305|NCT04158843|Oligometastasis|oligometastasis
4973307|NCT04158843|Sternum|sternum
4973308|NCT04158830|prevention|prevention
4973309|NCT04158830|aspirin therapy|aspirin therapy
4973310|NCT04158817|68Ga-THP-PSMA|68ga-thp-psma
4973311|NCT04158817|PET/CT|pet/ct
4973312|NCT04158791|Ophthalmology|ophthalmology
4973313|NCT04158791|Epimacular membrane|epimacular membrane
4973314|NCT04158791|ILM peeling|ilm peeling
4973315|NCT04158791|mfERG|mferg
4973316|NCT04158791|OCT|oct
4973317|NCT04158778|Alcohol Use Disorder|alcohol use disorder
4973323|NCT04158661|Myasthenia Gravis|myasthenia gravis
4973324|NCT04158661|Robotic-assisted minimally-invasive thymectomy|robotic-assisted minimally-invasive thymectomy
4973325|NCT04158661|Mean daily prednisone dose|mean daily prednisone dose
4973328|NCT04158609|term pregnancy|term pregnancy
4973329|NCT04158609|Doppler parameters|doppler parameters
4973330|NCT04158609|Cerebroplacental ratio|cerebroplacental ratio
4973331|NCT04158609|Induction of labor|induction of labor
4973332|NCT04158583|RG6292|rg6292
4973333|NCT04158544|Immune monitoring|immune monitoring
4973334|NCT04158544|Immunotherapy|immunotherapy
4973335|NCT04158531|cortical electrical stimulation|cortical electrical stimulation
4973336|NCT04158531|seizure detection|seizure detection
4973337|NCT04158531|network stimulation|network stimulation
4973338|NCT04158518|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4973339|NCT04158518|De-escalation|de-escalation
4973340|NCT04158505|pyrotinib|pyrotinib
4973341|NCT04158492|antimicrobial stewardship|antimicrobial stewardship
4973342|NCT04158492|point-of-care test|point-of-care test
4973343|NCT04158492|comprehensive molecular tests|comprehensive molecular tests
4973344|NCT04158492|multiple PCR|multiple pcr
4973345|NCT04158453|Healthy Volunteer|healthy volunteer
4973346|NCT04158453|Schizophrenia|schizophrenia
4973347|NCT04158427|fatigue|fatigue
4973348|NCT04158427|microbiome|microbiome
4973349|NCT04158388|micronutrients|micronutrients
4973351|NCT04158388|therapy|therapy
4973352|NCT04158388|chronic disease|chronic disease
4973353|NCT04158375|Resistance Exercise|resistance exercise
4973354|NCT04158362|Abemaciclib|abemaciclib
4973355|NCT04158362|Breast Cancer|breast cancer
4973356|NCT04158362|High Burden Disease|high burden disease
4973357|NCT04158362|Visceral Metastasis|visceral metastasis
4973359|NCT04158323|flexible endoscopy|flexible endoscopy
4973360|NCT04158323|awake intubation|awake intubation
4973361|NCT04158297|Extracorporeal shock wave lithotripsy|extracorporeal shock wave lithotripsy
4973362|NCT04158297|Intraductal lithotripsy|intraductal lithotripsy
4973363|NCT04158284|Quality of life|quality of life
4973364|NCT04158284|Endocrinology|endocrinology
4973365|NCT04158284|Oncology|oncology
4973366|NCT04158284|Hypothalamus|hypothalamus
4973367|NCT04158284|Irradiation|irradiation
4973368|NCT04158284|Neurosurgery|neurosurgery
4973369|NCT04158284|Pediatric Brain tumors|pediatric brain tumors
4973370|NCT04158271|Airway Management|airway management
4973371|NCT04158271|Tube Exchange|tube exchange
4973372|NCT04158219|Behavioral randomized control trial|behavioral randomized control trial
4973373|NCT04158219|Behavioral activation|behavioral activation
4973374|NCT04158219|Multiple health behavior change|multiple health behavior change
4973375|NCT04158219|Integrated care|integrated care
4973376|NCT04158154|Hypertension|hypertension
4973377|NCT04158154|Nigeria|nigeria
4973378|NCT04158154|Primary Health Center|primary health center
4973379|NCT04158141|Mesothelioma|mesothelioma
4973380|NCT04158141|IMPRINT|imprint
4973381|NCT04158115|Lumber Spondylosis|lumber spondylosis
4973382|NCT04158115|Segmental Mobilization|segmental mobilization
4973386|NCT04158024|Pediatric Congenital Heart Disease|pediatric congenital heart disease
4973387|NCT04158011|CAR T cells|car t cells
4973388|NCT04158011|CNS leukemia|cns leukemia
4973389|NCT04157946|Respiratory Insufficiency|respiratory insufficiency
4973390|NCT04157946|Ventilator-Induced Lung Injury|ventilator-induced lung injury
4973391|NCT04157946|Ventilators, Mechanical|ventilators, mechanical
4973392|NCT04157920|Aortic stenosis|aortic stenosis
4973393|NCT04157920|DIRECT|direct
4973394|NCT04157920|ACURATE|acurate
4973395|NCT04157920|TAVI|tavi
4973405|NCT04157894|Anthropology|anthropology
4973407|NCT04157894|Cost-effectiveness|cost-effectiveness
4973408|NCT04157868|ST-Segment Elevated Myocardial Infarction|st-segment elevated myocardial infarction
4973409|NCT04157868|rhBNP|rhbnp
4973410|NCT04157868|non-invasive myocardial work|non-invasive myocardial work
4973411|NCT04157829|Dyslexia|dyslexia
4973412|NCT04157829|Reading disorder|reading disorder
4973413|NCT04157816|health worker training|health worker training
4973414|NCT04157816|non-specialist health worker|non-specialist health worker
4973415|NCT04157816|community health worker|community health worker
4973416|NCT04157816|task sharing|task sharing
4973417|NCT04157816|common mental disorders|common mental disorders
4973418|NCT04157816|low-resource setting|low-resource setting
4973419|NCT04157816|primary care|primary care
4973420|NCT04157816|global mental health|global mental health
4973421|NCT04157816|digital technology|digital technology
4973422|NCT04157816|mobile health|mobile health
4973423|NCT04157777|Perineum massage, perineal trauma,perineal laceration|perineum massage, perineal trauma,perineal laceration
4973424|NCT04157764|Telehealth|telehealth
4973425|NCT04157764|automated peritoneal dialysis|automated peritoneal dialysis
4973426|NCT04157738|Diabetes|diabetes
4973427|NCT04157738|Glycemic variability|glycemic variability
4973428|NCT04157738|Insulin|insulin
4973429|NCT04157738|Parental Stress|parental stress
4973430|NCT04157738|Advanced carbohydrates counting|advanced carbohydrates counting
4973431|NCT04157738|Insulin for meals|insulin for meals
4973432|NCT04157699|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
4973433|NCT04157647|hemadsorption|hemadsorption
4973434|NCT04157634|outcome|outcome
4973435|NCT04157634|paediatric critical care|paediatric critical care
4973436|NCT04157595|reproductive genetics|reproductive genetics
4973437|NCT04157595|carrier screening|carrier screening
4973438|NCT04157595|rare disease|rare disease
4973439|NCT04157517|Drug Therapy|drug therapy
4973440|NCT04157504|Burn Injury|burn injury
4973441|NCT04157504|Balance|balance
4973442|NCT04157504|Lower extremity function|lower extremity function
4973443|NCT04157504|burn scar|burn scar
4973444|NCT04157491|endometrial cancer|endometrial cancer
4973445|NCT04157491|anlotinib|anlotinib
4973446|NCT04157491|anti PD-1 antibody|anti pd-1 antibody
4973447|NCT04157478|Glioblastoma|glioblastoma
4973448|NCT04157478|Anlotinib hydrochloride|anlotinib hydrochloride
4973462|NCT04157413|amino acid intake|amino acid intake
4973463|NCT04157413|blood amino acid|blood amino acid
4973465|NCT04157413|linear growth|linear growth
4973466|NCT04157413|intestinal permeability|intestinal permeability
4973467|NCT04157413|lactulose mannitol ratio|lactulose mannitol ratio
4973468|NCT04157387|Adhesive Capsulitis|adhesive capsulitis
4973469|NCT04157387|Cyriax Manual Therapy|cyriax manual therapy
4973470|NCT04157387|Stretching|stretching
4973471|NCT04157361|Breath condensate|breath condensate
4973472|NCT04157361|Bronchial asthma|bronchial asthma
4973473|NCT04157361|Cystic Fibrosis|cystic fibrosis
4973474|NCT04157348|Benralizumab|benralizumab
4973475|NCT04157348|Inhaled corticosteroids|inhaled corticosteroids
4973476|NCT04157348|Eosinophilic Granulomatous Vasculitis|eosinophilic granulomatous vasculitis
4973484|NCT04157270|Large Vessel Occlusion|large vessel occlusion
4973485|NCT04157270|LVO|lvo
4973486|NCT04157270|Mechanical Thrombectomy|mechanical thrombectomy
4973487|NCT04157270|Penumbra System|penumbra system
4973488|NCT04157257|nucleoside (acid) therapy|nucleoside (acid) therapy
4973489|NCT04157231|Stroke|stroke
4973490|NCT04157231|Ischemic stroke|ischemic stroke
4973491|NCT04157231|hemorrhagic stroke|hemorrhagic stroke
4973492|NCT04157231|stroke package|stroke package
4973493|NCT04157205|sudden cardiac arrest|sudden cardiac arrest
4973494|NCT04157205|defibrillator|defibrillator
4973495|NCT04157192|Acupuncture|acupuncture
4973497|NCT04157166|Bone scan|bone scan
4973498|NCT04157166|solid state gama camera CZT-based detector|solid state gama camera czt-based detector
4973499|NCT04157166|hybrid SPECT/CT imaging|hybrid spect/ct imaging
4973500|NCT04157166|bone metastasis|bone metastasis
4973501|NCT04157140|anlotinib|anlotinib
4973502|NCT04157140|HCC|hcc
4973503|NCT04157140|TACE|tace
4973504|NCT04157140|RFA|rfa
4973507|NCT04157114|Alcohol-Related Disorders|alcohol-related disorders
4973508|NCT04157114|Substance-Related Disorders|substance-related disorders
4973509|NCT04157114|MAP4343|map4343
4973520|NCT04157049|ALPHA 1|alpha 1
4973528|NCT04157049|PiZZ|pizz
4973533|NCT04157023|simulator|simulator
4973534|NCT04157023|medical skills|medical skills
4973535|NCT04156997|Lipoproteins|lipoproteins
4973536|NCT04156997|Cholesterol|cholesterol
4973537|NCT04156997|High Density Lipoproteins|high density lipoproteins
4973538|NCT04156984|Pharmacokinetics|pharmacokinetics
4973539|NCT04156984|Pharmacodynamics|pharmacodynamics
4973540|NCT04156984|Safety|safety
4973541|NCT04156984|Golimumab|golimumab
4973542|NCT04156984|Reactive dose optimisation|reactive dose optimisation
4973543|NCT04156984|Proactive dose optimisation|proactive dose optimisation
4973544|NCT04156984|Golimumab concentration|golimumab concentration
4973545|NCT04156984|Mucosal healing|mucosal healing
4973546|NCT04156984|Therapeutic drug monitoring|therapeutic drug monitoring
4973547|NCT04156984|Inflammatory bowel disease|inflammatory bowel disease
4973551|NCT04156971|Life style modification|life style modification
4973552|NCT04156971|Omega 3|omega 3
4973553|NCT04156971|supplementation|supplementation
4973554|NCT04156958|biliary tract adenocarcinoma|biliary tract adenocarcinoma
4973555|NCT04156958|fruquintinib|fruquintinib
4973556|NCT04156958|anti-angiogenesis|anti-angiogenesis
4973557|NCT04156945|Hepatitis C virus (HCV) reinfection|hepatitis c virus (hcv) reinfection
4973558|NCT04156945|Men who have sex with men (MSM)|men who have sex with men (msm)
4973559|NCT04156906|Chronic Transfusion|chronic transfusion
4973560|NCT04156893|Chronic Transfusion|chronic transfusion
4973561|NCT04156880|mammography|mammography
4973562|NCT04156880|artificial intelligence|artificial intelligence
4973563|NCT04156880|deep learning|deep learning
4973564|NCT04156815|Acne vulgaris|acne vulgaris
4973565|NCT04156815|Acne scars|acne scars
4973566|NCT04156815|1,565 nm non-ablative fractional laser|1,565 nm non-ablative fractional laser
4973567|NCT04156815|Isotretinoin|isotretinoin
4973568|NCT04156815|pricking blood therapy|pricking blood therapy
4973569|NCT04156802|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4973570|NCT04156802|Brain Stimulation|brain stimulation
4973571|NCT04156802|Treatment|treatment
4973572|NCT04156802|Neuroimaging|neuroimaging
4973573|NCT04156802|Alternative|alternative
4973574|NCT04156776|Active Isolated Stretching|active isolated stretching
4973575|NCT04156776|Muscle Energy Technique|muscle energy technique
4973576|NCT04156776|Mechanical Low Back Pain|mechanical low back pain
4973577|NCT04156763|Strabismus Virtual Reality Prism Cover Test|strabismus virtual reality prism cover test
4973578|NCT04156711|Remote ISchemic Preconditioning (RIPC)|remote ischemic preconditioning (ripc)
4973579|NCT04156711|Acute surgery|acute surgery
4973580|NCT04156711|Acute cholecystitis|acute cholecystitis
4973581|NCT04156711|Endothelial dysfunction|endothelial dysfunction
4973582|NCT04156711|Heart Rate Variability (HRV)|heart rate variability (hrv)
4973583|NCT04156685|Type2 Diabetes Mellitus|type2 diabetes mellitus
4973584|NCT04156685|CKD-387|ckd-387
4973585|NCT04156659|r/r B-cell ALL|r/r b-cell all
4973586|NCT04156659|tisagenlecleucel|tisagenlecleucel
4973587|NCT04156659|CTL019|ctl019
4973589|NCT04156633|MALDI-TOF MS|maldi-tof ms
4973590|NCT04156633|Biofire FilmArray© Blood Culture Identification (BCID) panel|biofire filmarray© blood culture identification (bcid) panel
4973591|NCT04156633|shotgun metagenomic approach|shotgun metagenomic approach
4973592|NCT04156620|Active axSpA, Axial spondyloarthritis, non-radiographic-axSpA, nr-axSpA, ankylosing spondylitis, AS, inflammatory back pain, sacroiliitis|active axspa, axial spondyloarthritis, non-radiographic-axspa, nr-axspa, ankylosing spondylitis, as, inflammatory back pain, sacroiliitis
4973593|NCT04156607|Down Syndrome|down syndrome
4973594|NCT04156607|Postural Balance|postural balance
4973595|NCT04156607|Kinesio Taping|kinesio taping
4973596|NCT04156594|self-assessment|self-assessment
4973597|NCT04156594|post operative pulmonary complication|post operative pulmonary complication
4973598|NCT04156594|ExerciseTest|exercisetest
4973599|NCT04156568|Children|children
4973600|NCT04156568|LTBI|ltbi
4973601|NCT04156568|Intervention|intervention
4973602|NCT04156555|amoxicillin-clavulanate|amoxicillin-clavulanate
4973632|NCT04156451|Central Venous Pressure|central venous pressure
4973633|NCT04156451|Septic Shock|septic shock
4973634|NCT04156451|Furosemide|furosemide
4973635|NCT04156438|Airway pressure release ventilation|airway pressure release ventilation
4973636|NCT04156438|low tidal volume ventilation|low tidal volume ventilation
4973637|NCT04156438|APRV|aprv
4973638|NCT04156438|ARDSNet ventilation|ardsnet ventilation
4973639|NCT04156438|LTVV|ltvv
4973851|NCT04155372|dehydration|dehydration
4973643|NCT04156425|neuroimmunology|neuroimmunology
4973644|NCT04156425|Protein Kinase C|protein kinase c
4973645|NCT04156412|quadripolar LV leads|quadripolar lv leads
4973646|NCT04156399|sickle cell disease|sickle cell disease
4973647|NCT04156399|pain|pain
4973648|NCT04156399|chronic pain|chronic pain
4973649|NCT04156399|acupuncture|acupuncture
4973653|NCT04156386|Whey Proteins|whey proteins
4973654|NCT04156386|Plant Proteins|plant proteins
4973655|NCT04156386|Dietary supplements|dietary supplements
4973656|NCT04156373|immigration|immigration
4973657|NCT04156373|cultural factors|cultural factors
4973658|NCT04156373|prevention|prevention
4973659|NCT04156321|Moringa, quasi-experimental, vitamin A, haemoglobin|moringa, quasi-experimental, vitamin a, haemoglobin
4973660|NCT04156308|osteopathy, osteopathic treatment, non-specific|osteopathy, osteopathic treatment, non-specific
4973661|NCT04156269|BCMA|bcma
4973663|NCT04156269|BCMA-CS1 cCAR T cells|bcma-cs1 ccar t cells
4973665|NCT04156269|SLAMF7|slamf7
4973666|NCT04156256|CD123|cd123
4973667|NCT04156256|CD33|cd33
4973668|NCT04156256|CD123-CD33 cCAR|cd123-cd33 ccar
4973669|NCT04156256|Leukemia|leukemia
4973670|NCT04156256|Hematologic Malignancies|hematologic malignancies
4973671|NCT04156243|CD19|cd19
4973672|NCT04156243|CD19 CAR T cell|cd19 car t cell
4973673|NCT04156230|Positron-Emission Tomography|positron-emission tomography
4973674|NCT04156230|Ultrasonography|ultrasonography
4973675|NCT04156230|Platelet Activation|platelet activation
4973676|NCT04156230|Data Accuracy|data accuracy
4973677|NCT04156178|CD20|cd20
4973678|NCT04156178|CD19|cd19
4973679|NCT04156178|cCAR|ccar
4973680|NCT04156178|Leukemia|leukemia
4973681|NCT04156178|Lymphoma|lymphoma
4973682|NCT04156165|Body composition|body composition
4973683|NCT04156165|Metabolism|metabolism
4973684|NCT04156139|NPPV|nppv
4973685|NCT04156139|HFNC|hfnc
4973699|NCT04156074|25-hydroxyvitamin D|25-hydroxyvitamin d
4973700|NCT04156048|HIV|hiv
4973701|NCT04156048|AIDS|aids
4973702|NCT04156048|Antiretroviral therapy|antiretroviral therapy
4973703|NCT04156048|Aging|aging
4973704|NCT04156048|Heart failure|heart failure
4973705|NCT04156048|coronary heart disease|coronary heart disease
4973706|NCT04156048|myocardial infarction|myocardial infarction
4973707|NCT04156048|HIV-associated neurocognitive disorders|hiv-associated neurocognitive disorders
4973708|NCT04156022|Cervical dystonia|cervical dystonia
4973709|NCT04156022|Cranial dystonia|cranial dystonia
4973710|NCT04156022|Limb dystonia|limb dystonia
4973715|NCT04155983|gonarthrosis|gonarthrosis
4973716|NCT04155983|osteoarthritis|osteoarthritis
4973717|NCT04155983|knee|knee
4973718|NCT04155983|total knee arthroplasty|total knee arthroplasty
4973719|NCT04155983|adductor canal block|adductor canal block
4973720|NCT04155983|saphenous nerve block|saphenous nerve block
4973721|NCT04155983|multimodal pain control|multimodal pain control
4973722|NCT04155970|Manual Therapy|manual therapy
4973723|NCT04155970|Fluoroscope|fluoroscope
4973724|NCT04155970|Mechanics|mechanics
4973725|NCT04155970|Kinematics|kinematics
4973726|NCT04155944|M-PCR|m-pcr
4973727|NCT04155944|FISH|fish
4973728|NCT04155944|MLPA|mlpa
4973729|NCT04155944|deletion|deletion
4973730|NCT04155944|uniparental disomy|uniparental disomy
4973731|NCT04155944|imprinting mutation|imprinting mutation
4973732|NCT04155931|perioperative body tempreture|perioperative body tempreture
4973733|NCT04155931|hypothermia|hypothermia
4973734|NCT04155931|PONV|ponv
4973735|NCT04155931|Postoperative nausea and vomiting|postoperative nausea and vomiting
4973739|NCT04155905|simple anal fistula|simple anal fistula
4973740|NCT04155905|marsupialization|marsupialization
4973741|NCT04155892|Extubation criteria|extubation criteria
4973742|NCT04155892|Pediatric Anesthesia|pediatric anesthesia
4973743|NCT04155892|Outpatient surgery|outpatient surgery
4973744|NCT04155853|trapeziectomy|trapeziectomy
4973746|NCT04155853|interposition|interposition
4973749|NCT04155788|food exposure|food exposure
4973750|NCT04155788|feared food|feared food
4973751|NCT04155775|Electronic Health Records|electronic health records
4973752|NCT04155775|Best Practice Alerts|best practice alerts
4973753|NCT04155762|Amputees|amputees
4973754|NCT04155762|Artificial Limbs|artificial limbs
4973755|NCT04155762|Prosthetic designs|prosthetic designs
4973756|NCT04155762|Rehabilitation of prostheses users|rehabilitation of prostheses users
4973757|NCT04155762|Prosthetic suspension systems|prosthetic suspension systems
4973758|NCT04155749|BCMA|bcma
4973759|NCT04155749|Myeloma|myeloma
4973760|NCT04155749|Chimeric|chimeric
4973761|NCT04155723|Midlines|midlines
4973762|NCT04155710|Autologous Peripheral Blood Lymphocytes|autologous peripheral blood lymphocytes
4973763|NCT04155710|PBL|pbl
4973764|NCT04155710|IOV-2001|iov-2001
4973765|NCT04155710|CLL|cll
4973766|NCT04155710|IL-2|il-2
4973767|NCT04155710|Adoptive Cell Therapy|adoptive cell therapy
4973768|NCT04155710|SLL|sll
4973769|NCT04155684|microbiome|microbiome
4973770|NCT04155645|Multiple Ascending Dose|multiple ascending dose
4973771|NCT04155645|AZD8233|azd8233
4973772|NCT04155645|Safety|safety
4973773|NCT04155645|Tolerability|tolerability
4973774|NCT04155645|PK|pk
4973794|NCT04155580|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4973795|NCT04155580|Myelodysplastic syndrome|myelodysplastic syndrome
4973797|NCT04155554|Neurocognitive functions|neurocognitive functions
5294931|NCT02201628|temperature|temperature
4973798|NCT04155554|Neuropsychiatric side effects|neuropsychiatric side effects
4973799|NCT04155554|Bictegravir|bictegravir
4973800|NCT04155554|INSTI|insti
4973804|NCT04155528|Music therapy|music therapy
4973805|NCT04155528|Pain|pain
4973806|NCT04155528|Sleep quality|sleep quality
4973807|NCT04155528|Abdominal surgery|abdominal surgery
4973808|NCT04155515|Chronic Hepatics C Virus (HCV) Genotype 1|chronic hepatics c virus (hcv) genotype 1
4973809|NCT04155515|Non-Cirrhotic|non-cirrhotic
4973810|NCT04155515|Cirrhosis|cirrhosis
4973811|NCT04155515|Treatment naïve|treatment naïve
4973812|NCT04155515|efficacy|efficacy
4973813|NCT04155515|safety|safety
4973814|NCT04155515|TG-2349|tg-2349
4973815|NCT04155515|DAG181|dag181
4973816|NCT04155515|Ribavirin|ribavirin
4973817|NCT04155502|HIV|hiv
4973818|NCT04155502|Pre-exposure prophylaxis|pre-exposure prophylaxis
4973819|NCT04155502|Social media|social media
4973820|NCT04155502|Online advertising|online advertising
4971051|NCT04171700|RAD51B|rad51b
4971052|NCT04171700|sarcoma|sarcoma
4971053|NCT04171700|HRR|hrr
4971064|NCT04171700|esophageal cancer|esophageal cancer
4971065|NCT04171700|leiomyosarcoma|leiomyosarcoma
4971066|NCT04171700|ampullary carcinoma|ampullary carcinoma
4971067|NCT04171700|carcinosarcoma|carcinosarcoma
4971068|NCT04171700|endometrial cancer|endometrial cancer
4971069|NCT04171700|cervical cancer|cervical cancer
4971070|NCT04171674|community-acquired pneumonia|community-acquired pneumonia
4971071|NCT04171661|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
4971072|NCT04171661|Recessive Dystrophic Epidermolysis Bullosa|recessive dystrophic epidermolysis bullosa
4971073|NCT04171661|Tissue Engineering|tissue engineering
4971087|NCT04171583|mucoid|mucoid
4973821|NCT04155463|Dietary Intervention|dietary intervention
4973822|NCT04155463|Glyphosate|glyphosate
4973823|NCT04155463|Herbicide|herbicide
4973824|NCT04155463|Pregnancy|pregnancy
4973825|NCT04155463|Agricultural Communities|agricultural communities
4973826|NCT04155463|Organic food|organic food
4973827|NCT04155450|exercise|exercise
4973828|NCT04155450|manipulation, spinal|manipulation, spinal
4973829|NCT04155450|rehabilitation|rehabilitation
4973830|NCT04155450|therapy, manual|therapy, manual
4973831|NCT04155450|manual therapy|manual therapy
4973835|NCT04155424|Neuromyelitis Optica|neuromyelitis optica
4973836|NCT04155424|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4973837|NCT04155424|Devic's Disease|devic's disease
4973838|NCT04155424|Transverse Myelitis|transverse myelitis
4973839|NCT04155424|Optic Neuritis|optic neuritis
4973840|NCT04155424|Relapse|relapse
4973841|NCT04155424|Eculizumab|eculizumab
4973842|NCT04155424|Soliris|soliris
4973843|NCT04155424|CNS Autoimmune Disorders|cns autoimmune disorders
4973844|NCT04155424|Demyelinating Disorders|demyelinating disorders
4973845|NCT04155424|NMO|nmo
4973846|NCT04155424|NMOSD|nmosd
4973847|NCT04155411|Dasatinib, CML-CP|dasatinib, cml-cp
4973848|NCT04155398|liver stiffness|liver stiffness
4973849|NCT04155398|EUS elastography|eus elastography
4973850|NCT04155372|sports nutrition|sports nutrition
4973857|NCT04155346|Psychology|psychology
4973858|NCT04155346|Prehabilitation|prehabilitation
4973859|NCT04155320|contact tracing|contact tracing
4973860|NCT04155320|HIV prevention|hiv prevention
4973861|NCT04155320|partner notification|partner notification
4973862|NCT04155294|HPV infection|hpv infection
4973864|NCT04155294|HIV Infection|hiv infection
4973865|NCT04155294|Cervical cancer|cervical cancer
4973866|NCT04155294|Screening|screening
4973873|NCT04155242|Barrett's oesophagus|barrett's oesophagus
4973903|NCT04155099|encephalopathy|encephalopathy
4973904|NCT04155086|autoimmune disease|autoimmune disease
4973905|NCT04155086|pregnancy|pregnancy
4973906|NCT04155086|free fetal DNA circulant|free fetal dna circulant
4973907|NCT04155060|hyperlactatemia|hyperlactatemia
4973908|NCT04155047|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
4971177|NCT04170920|DCIS|dcis
4973909|NCT04154995|Long-term recovery|long-term recovery
4973910|NCT04154995|Critical Illness|critical illness
4973911|NCT04154982|Electrophysiology|electrophysiology
4973912|NCT04154982|Arrhythmias|arrhythmias
4973913|NCT04154982|Arrhythmia ablation|arrhythmia ablation
4973914|NCT04154982|Ionizing radiation risk|ionizing radiation risk
4973915|NCT04154982|Oxidative stress|oxidative stress
4973916|NCT04154982|DNA damage biomarkers|dna damage biomarkers
4973917|NCT04154969|balance|balance
4973918|NCT04154969|gait|gait
4973919|NCT04154969|post stroke rehabilitation|post stroke rehabilitation
4973920|NCT04154943|CSCC|cscc
4973921|NCT04154943|Stage II|stage ii
4973922|NCT04154943|Stage III|stage iii
4973923|NCT04154943|Stage IV|stage iv
4973924|NCT04154943|CSCC of Head/neck|cscc of head/neck
4973925|NCT04154943|CSCC of Extremity|cscc of extremity
4973926|NCT04154943|CSCC of Trunk|cscc of trunk
4973927|NCT04154930|Tear Trough|tear trough
4973928|NCT04154917|Discharge planning|discharge planning
4973929|NCT04154917|Frail older adults|frail older adults
4973930|NCT04154917|Comprehensive approach|comprehensive approach
4973931|NCT04154917|Patient-centered intervention|patient-centered intervention
4973932|NCT04154904|automated insulin delivery systems|automated insulin delivery systems
4973933|NCT04154904|Context patterns|context patterns
4973934|NCT04154891|Rare disease|rare disease
4973935|NCT04154891|Next generation sequencing genome|next generation sequencing genome
4973936|NCT04154891|Diagnostic study|diagnostic study
4973937|NCT04154891|Medico-economic study|medico-economic study
4973938|NCT04154839|Atopic dermatitis|atopic dermatitis
4973939|NCT04154839|Genetics|genetics
4973940|NCT04154839|Eczema|eczema
4973941|NCT04154839|Epidemiology|epidemiology
4973942|NCT04154800|Healthy Volunteers|healthy volunteers
4973949|NCT04154748|Argon Plasma Coagulation|argon plasma coagulation
4973950|NCT04154748|Endoscopic Treatment|endoscopic treatment
4973951|NCT04154735|Autologous Stem Cell Transplantation|autologous stem cell transplantation
4975552|NCT04144686|Vestibular|vestibular
4973958|NCT04154683|Cellvizio®|cellvizio®
4973959|NCT04154683|optical biopsy|optical biopsy
4973960|NCT04154683|unilateral or bilateral salpingectomy|unilateral or bilateral salpingectomy
4973961|NCT04154683|ovariectomy|ovariectomy
4973962|NCT04154683|Endometriosis|endometriosis
4973963|NCT04154683|surgery for cervical|surgery for cervical
4973964|NCT04154683|ovarian cancer|ovarian cancer
4973965|NCT04154657|HFpEF|hfpef
4973966|NCT04154657|pulmonary hypertension|pulmonary hypertension
4973967|NCT04154644|Cryotherapy|cryotherapy
4973968|NCT04154605|Cryotherapy|cryotherapy
4973969|NCT04154605|Cryoablation|cryoablation
4973970|NCT04154592|rotator cuff|rotator cuff
4973971|NCT04154592|tear|tear
4973972|NCT04154592|rehabilitation|rehabilitation
4973973|NCT04154579|Chronic health conditions|chronic health conditions
4973974|NCT04154579|Arts-based program|arts-based program
4973975|NCT04154579|Health education program|health education program
4973976|NCT04154579|Health|health
4973977|NCT04154579|Resilience|resilience
4973978|NCT04154579|Well-being|well-being
4973979|NCT04154566|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
4973980|NCT04154566|inhibitory control of executive functions.|inhibitory control of executive functions.
4973981|NCT04154566|aerobic exercise.|aerobic exercise.
4973982|NCT04154553|pharmacogenetics|pharmacogenetics
4973983|NCT04154553|single nucleotide polymorphism|single nucleotide polymorphism
4973984|NCT04154553|absorption, distribution, metabolism and excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
4973985|NCT04154553|genotyping|genotyping
4973986|NCT04154553|pharmacogenetic testing|pharmacogenetic testing
4973987|NCT04154540|Gait|gait
4973988|NCT04154540|Balance|balance
4973989|NCT04154540|Posture|posture
4973990|NCT04154540|Charcot-Marie-Tooth|charcot-marie-tooth
4973991|NCT04154540|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
4973992|NCT04154527|pelvic floor|pelvic floor
4973993|NCT04154527|abdominal muscles|abdominal muscles
4973994|NCT04154527|ultrasonography|ultrasonography
4973995|NCT04154527|postpartum|postpartum
4973996|NCT04154501|Chronic Pain|chronic pain
4973997|NCT04154501|Nociceptive Pain|nociceptive pain
4973998|NCT04154501|Mixed Pain|mixed pain
4973999|NCT04154501|Cannabinoid|cannabinoid
4974000|NCT04154501|Cannabinoid-2 Receptor Agonist|cannabinoid-2 receptor agonist
4974014|NCT04154423|Premature Birth|premature birth
4974015|NCT04154423|Group Prenatal Care|group prenatal care
4974016|NCT04154423|Respectful Care|respectful care
4974017|NCT04154423|Patient Satisfaction|patient satisfaction
4974018|NCT04154423|Prenatal Depression and Anxiety|prenatal depression and anxiety
4974019|NCT04154423|Low Income|low income
4974020|NCT04154423|Health Inequity|health inequity
4974021|NCT04154423|Prenatal Care|prenatal care
4974022|NCT04154410|Pre-operative anxiety|pre-operative anxiety
4974023|NCT04154410|pupillometry|pupillometry
4974024|NCT04154410|heart rate variability|heart rate variability
4974025|NCT04154410|cardiac coherence state|cardiac coherence state
4974026|NCT04154410|ambulatory surgery|ambulatory surgery
4974027|NCT04154397|Motor learning|motor learning
4974028|NCT04154397|Cerebellum transcranial electrical stimulation|cerebellum transcranial electrical stimulation
4974029|NCT04154397|Postural balance|postural balance
4974030|NCT04154397|Error feedback|error feedback
4974031|NCT04154397|Electroencephalography|electroencephalography
4974033|NCT04154384|Orthopedic surgery|orthopedic surgery
4974034|NCT04154384|Opioid addiction|opioid addiction
4974035|NCT04154384|Rehabilitation|rehabilitation
4974036|NCT04154384|Behavioral research|behavioral research
4974037|NCT04154371|Electromyography|electromyography
4974038|NCT04154371|Virtual Reality|virtual reality
4974039|NCT04154319|HPV vaccination|hpv vaccination
4974040|NCT04154319|Healthy Eating|healthy eating
4974041|NCT04154319|Latina immigrants|latina immigrants
4974042|NCT04154306|Isoflavones|isoflavones
4974043|NCT04154306|Red clover|red clover
4974044|NCT04154306|Muscle Function|muscle function
4974045|NCT04154306|Postmenopausal women|postmenopausal women
4974046|NCT04154267|Kidney Transplantation|kidney transplantation
4974047|NCT04154267|Protocol Biopsies|protocol biopsies
4974048|NCT04154267|Kidney Transplant Rejection|kidney transplant rejection
4974049|NCT04154228|Lymphoma|lymphoma
4975655|NCT04144075|Compassion|compassion
4974058|NCT04154189|Pediatrics|pediatrics
4974059|NCT04154189|Chemotherapy|chemotherapy
4974060|NCT04154137|non-celiac wheat sensitivity|non-celiac wheat sensitivity
4974061|NCT04154137|celiac disease|celiac disease
4974062|NCT04154137|wheat allergy|wheat allergy
4974063|NCT04154111|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4974064|NCT04154111|Brain Stimulation|brain stimulation
4974065|NCT04154111|Treatment|treatment
4974066|NCT04154111|Neuroimaging|neuroimaging
4974067|NCT04154098|Scapula alata|scapula alata
4974068|NCT04154098|Scapular winging|scapular winging
4974069|NCT04154098|Scapula orthosis|scapula orthosis
4974070|NCT04154098|Range of Motion|range of motion
4974071|NCT04154098|Movement control|movement control
4974072|NCT04154098|Manual Scapula Assistance|manual scapula assistance
4974073|NCT04154085|Narrative therapy|narrative therapy
4974074|NCT04154085|Group therapy|group therapy
4974075|NCT04154059|Rehabilitation|rehabilitation
4974076|NCT04154059|Arthrosis|arthrosis
4974077|NCT04154059|Therapeutic exercises|therapeutic exercises
4974078|NCT04154059|Feet|feet
4974079|NCT04154020|tenotomy|tenotomy
4974082|NCT04153955|Mobilization|mobilization
4974083|NCT04153955|Thrombectomy|thrombectomy
4974084|NCT04153955|Ischemia|ischemia
4974085|NCT04153955|Cerebrovascular Disorders|cerebrovascular disorders
4974086|NCT04153955|Brain Diseases|brain diseases
4974087|NCT04153955|Recovery|recovery
4974088|NCT04153942|Mobilization|mobilization
4974089|NCT04153942|Thrombolysis|thrombolysis
4974090|NCT04153942|Ischemia|ischemia
4974091|NCT04153942|Cerebrovascular Disorders|cerebrovascular disorders
4974092|NCT04153942|Brain Diseases|brain diseases
4974093|NCT04153942|Recovery|recovery
4974095|NCT04153890|advanced heart failure, breathlessness, supportive care|advanced heart failure, breathlessness, supportive care
4974100|NCT04153838|Neuropsychology|neuropsychology
4974101|NCT04153825|Physical therapy modalities|physical therapy modalities
4974102|NCT04153825|Osteoarthritis knee|osteoarthritis knee
4974103|NCT04153825|Central nervous system sensitization|central nervous system sensitization
4974104|NCT04153825|Pain|pain
4974105|NCT04153825|Electric Stimulation Therapy|electric stimulation therapy
4974106|NCT04153799|EGFR|egfr
4974107|NCT04153799|CAR-T cells|car-t cells
4974108|NCT04153799|NSCLC|nsclc
4974109|NCT04153760|deep vein thrombosis|deep vein thrombosis
4974110|NCT04153760|pulmonary embolism|pulmonary embolism
4974111|NCT04153760|postpartum|postpartum
4974112|NCT04153760|pregnancy|pregnancy
4974113|NCT04153760|thrombophilia|thrombophilia
4974114|NCT04153760|cesarean delivery|cesarean delivery
4974115|NCT04153760|pre-eclampsia|pre-eclampsia
4974116|NCT04153760|postpartum hemorrhage|postpartum hemorrhage
4974120|NCT04153734|Without radiation|without radiation
4974121|NCT04153734|Locally advanced|locally advanced
4974122|NCT04153734|PD-L1 ≥50%|pd-l1 ≥50%
4974123|NCT04153721|enhanced recovery|enhanced recovery
4974124|NCT04153721|rehabilitation|rehabilitation
4974125|NCT04153721|prehabilitation|prehabilitation
4974126|NCT04153721|patient engagement|patient engagement
4974127|NCT04153721|digital health|digital health
4974128|NCT04153721|e-health|e-health
4974129|NCT04153721|colorectal surgery|colorectal surgery
4974130|NCT04153721|preparation|preparation
4974131|NCT04153721|follow-up|follow-up
4974132|NCT04153721|patient empowerment|patient empowerment
4974133|NCT04153708|hepatitis C|hepatitis c
4974134|NCT04153708|lost to follow-up|lost to follow-up
4974135|NCT04153708|microelimination|microelimination
4974136|NCT04153695|Pregnant|pregnant
4974137|NCT04153695|Anxiety|anxiety
4974138|NCT04153695|Depression.|depression.
4974139|NCT04153695|Flamenco music|flamenco music
4974140|NCT04153682|Antimicrobial stewardship|antimicrobial stewardship
4974141|NCT04153682|hospital-acquired pneumonia|hospital-acquired pneumonia
4974142|NCT04153682|syndromic approach|syndromic approach
4974143|NCT04153682|rapid diagnostic testing|rapid diagnostic testing
4974144|NCT04153669|Cystic Fibrosis|cystic fibrosis
4974145|NCT04153669|Electrostimulation|electrostimulation
4974146|NCT04153669|Combined Training|combined training
4974147|NCT04153669|Physical Fitness|physical fitness
4974148|NCT04153656|Burnout|burnout
4974149|NCT04153656|Nurse wellbeing|nurse wellbeing
4974167|NCT04153487|Transfusion Related Complication|transfusion related complication
4974169|NCT04153487|Critical Care|critical care
4974170|NCT04153474|Percutaneous nephrolithotomy (PNL)|percutaneous nephrolithotomy (pnl)
4974171|NCT04153474|Nephrostomy tube (NT)|nephrostomy tube (nt)
4974172|NCT04153474|Pain|pain
4974173|NCT04153474|Patient satisfaction|patient satisfaction
4974174|NCT04153461|urolithiasis|urolithiasis
4974175|NCT04153461|stone, renal|stone, renal
4974176|NCT04153461|nephrolithiasis|nephrolithiasis
4974177|NCT04153461|PNL|pnl
4974178|NCT04153461|PCNL|pcnl
4974179|NCT04153461|NEPHROLITHOTOMY|nephrolithotomy
4974180|NCT04153461|MINIPERC|miniperc
4974181|NCT04153461|MINI-PERC|mini-perc
4974182|NCT04153461|BLOOD LOSS|blood loss
4974183|NCT04153461|NEPHROSTOMY SIZE|nephrostomy size
4974184|NCT04153448|Bronchiectasis|bronchiectasis
4974185|NCT04153448|Exercise capacity|exercise capacity
4974186|NCT04153448|Six-minute walk test|six-minute walk test
4974187|NCT04153448|Sit-to-stand test|sit-to-stand test
4974201|NCT04153396|Laminoplasty or Laminectomy|laminoplasty or laminectomy
4974202|NCT04153383|Milrinone|milrinone
4974203|NCT04153383|diastolic function|diastolic function
4974216|NCT04153344|Neurofibromatosis type 1|neurofibromatosis type 1
4974217|NCT04153344|Infrared hyperreflective areas|infrared hyperreflective areas
4974218|NCT04153344|Hyperactivity of the pigment epithelium|hyperactivity of the pigment epithelium
4974219|NCT04153344|Electro-oculogram|electro-oculogram
4974220|NCT04153344|Electroretinogram|electroretinogram
4974221|NCT04153305|survival|survival
4974222|NCT04153305|acute leukemia|acute leukemia
4974223|NCT04153305|second cancer|second cancer
4974224|NCT04153305|cardiovascular complication|cardiovascular complication
4974226|NCT04153305|disease management|disease management
4974227|NCT04153266|oral epithelial dysplasia|oral epithelial dysplasia
4974228|NCT04153266|Precancerous Conditions|precancerous conditions
4974229|NCT04153266|Precancerous Lesions|precancerous lesions
4974230|NCT04153266|Information Seeking Behavior|information seeking behavior
4974231|NCT04153266|Patient Preference|patient preference
4974232|NCT04153266|Oral Disease|oral disease
4974233|NCT04153266|Dental Diseases|dental diseases
4974234|NCT04153266|Dysplasia|dysplasia
4974235|NCT04153266|Quality of Life|quality of life
4974236|NCT04153266|Patient Satisfaction|patient satisfaction
4974237|NCT04153266|Patient Participation|patient participation
4974238|NCT04153266|information needs|information needs
4974239|NCT04153266|patient education|patient education
4974240|NCT04153266|patient information leaflet|patient information leaflet
4974241|NCT04153253|Aflibercept|aflibercept
4974242|NCT04153253|panretinal photocoagulation|panretinal photocoagulation
4974243|NCT04153253|vitrectomy|vitrectomy
4974244|NCT04153240|Positional Therapy|positional therapy
4974245|NCT04153240|Quality of Life|quality of life
4974246|NCT04153227|Osteoporosis|osteoporosis
4974247|NCT04153227|Trabecular bone score|trabecular bone score
4974248|NCT04153227|FRAX|frax
4974249|NCT04153227|Radical cystectomy|radical cystectomy
4974250|NCT04153227|Fracture risk|fracture risk
4974292|NCT04153123|cataract surgery|cataract surgery
4974295|NCT04153110|Transcranial direct current stimulation|transcranial direct current stimulation
4974296|NCT04153110|Transcranial magnetic stimulation|transcranial magnetic stimulation
4974297|NCT04153110|Spinocerebellar ataxia|spinocerebellar ataxia
4974298|NCT04153110|Cerebellar ataxia|cerebellar ataxia
4974299|NCT04153097|Non-small Cell Lung Cancer|non-small cell lung cancer
4974300|NCT04153084|Pediatric colonoscopy|pediatric colonoscopy
4974301|NCT04153084|Endoscopic preparations|endoscopic preparations
4974302|NCT04153084|PEG|peg
4974303|NCT04153084|Sodium picosulfate|sodium picosulfate
4974304|NCT04153084|Bohm solution|bohm solution
4974305|NCT04153084|Movicol|movicol
4974306|NCT04153084|Picoprep|picoprep
4974307|NCT04153084|Colonoscopic examination|colonoscopic examination
4974308|NCT04153032|Anal fissure|anal fissure
4974309|NCT04153032|MEBO|mebo
4974310|NCT04153032|topical diltiazem|topical diltiazem
4974311|NCT04153032|MEBO/Diltiazem combination|mebo/diltiazem combination
4974312|NCT04153019|cancer cachexia|cancer cachexia
4974313|NCT04153019|psychoeducational intervention|psychoeducational intervention
4974314|NCT04153019|rehabilitative intervention|rehabilitative intervention
5286717|NCT02238652|Aged|aged
4974315|NCT04153019|dyad|dyad
4974316|NCT04153019|palliative care|palliative care
4974317|NCT04153006|Troponin|troponin
4974318|NCT04153006|Point-of-care|point-of-care
4974319|NCT04153006|Minicare|minicare
4974320|NCT04152980|Pentoxifylline|pentoxifylline
4974321|NCT04152980|preterm infants|preterm infants
4974322|NCT04152980|sepsis treatment|sepsis treatment
4974323|NCT04152980|dose optimization|dose optimization
4974331|NCT04152850|Depression|depression
4974332|NCT04152850|Anxiety|anxiety
4974333|NCT04152850|Lifestyle Medicine|lifestyle medicine
4974334|NCT04152850|Self-help|self-help
4974335|NCT04152824|Physical Health|physical health
4974336|NCT04152824|Psychological Health|psychological health
4974337|NCT04152824|Well-Being|well-being
4974338|NCT04152824|Resilience|resilience
4974339|NCT04152824|Readiness|readiness
4974340|NCT04152824|Military|military
4974341|NCT04152824|Service Member|service member
4974342|NCT04152811|nutrition|nutrition
4974343|NCT04152811|cooking|cooking
4974344|NCT04152811|diabetes self-management education|diabetes self-management education
4974345|NCT04152785|environmental concerns|environmental concerns
4974380|NCT04152473|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4974381|NCT04152460|Bulk-fill resin Composite|bulk-fill resin composite
4974382|NCT04152460|Thermo-Viscous resin Composite|thermo-viscous resin composite
4974383|NCT04152460|Proximal Compound Cavities|proximal compound cavities
4974384|NCT04152408|diabetes management|diabetes management
4979146|NCT04122560|antifungal agents|antifungal agents
4974400|NCT04152291|E-EPA|e-epa
4974401|NCT04152291|LDL aggregation susceptibility|ldl aggregation susceptibility
4974402|NCT04152291|Lipidomics|lipidomics
4974403|NCT04152291|Resolvins|resolvins
4974404|NCT04152291|PON-1|pon-1
4974405|NCT04152291|LCAT|lcat
4974406|NCT04152291|PLTP|pltp
4974407|NCT04152291|CETP|cetp
4974408|NCT04152291|Proteglycan binding|proteglycan binding
4974409|NCT04152265|colorectal cancer|colorectal cancer
4974410|NCT04152265|zearalenone|zearalenone
4974411|NCT04152265|mycotoxin|mycotoxin
4974412|NCT04152265|gastrointestinal bacterial|gastrointestinal bacterial
4974413|NCT04152252|OHCA|ohca
4974414|NCT04152252|Feedback|feedback
4974415|NCT04152252|CPR quality|cpr quality
4974416|NCT04152239|enteroscopy|enteroscopy
4974417|NCT04152226|Dermatophytes|dermatophytes
4974418|NCT04152226|Dysbiosis|dysbiosis
4974419|NCT04152226|Microbiome|microbiome
4974420|NCT04152213|Chinese adult|chinese adult
4974421|NCT04152213|obesity|obesity
4974422|NCT04152213|low glycemic index diet|low glycemic index diet
4974423|NCT04152213|cardiometabolic|cardiometabolic
4974431|NCT04152187|pulmonary hypertension|pulmonary hypertension
4974432|NCT04152187|inspiratory muscle training|inspiratory muscle training
4974433|NCT04152187|muscle weakness|muscle weakness
4974434|NCT04152174|blood purification|blood purification
4974435|NCT04152174|CRRT|crrt
4974436|NCT04152174|septic shock|septic shock
4974437|NCT04152174|neurosurgery|neurosurgery
4974438|NCT04152174|cytokine removal|cytokine removal
4974443|NCT04152135|passive leg raising maneuver, vena cava inferior diameter|passive leg raising maneuver, vena cava inferior diameter
4974444|NCT04152109|complementary medicine|complementary medicine
4974445|NCT04152109|laying on of hands|laying on of hands
4974446|NCT04152109|cancer|cancer
4974459|NCT04151979|score scale|score scale
4974460|NCT04151979|diagnosis|diagnosis
4974461|NCT04151953|Pacemaker|pacemaker
4974462|NCT04151953|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
4974463|NCT04151953|Cardiac implantable electronic device (CIED)|cardiac implantable electronic device (cied)
4974464|NCT04151940|Lung|lung
4974465|NCT04151927|High altitude|high altitude
4974466|NCT04151927|Metabolic adaptations|metabolic adaptations
4974467|NCT04151927|Energy balance|energy balance
4974468|NCT04151875|orthodontics|orthodontics
4974469|NCT04151875|vertical dimension|vertical dimension
4974470|NCT04151875|premolars extraction|premolars extraction
4974471|NCT04151875|long face|long face
4974472|NCT04151849|GLP-1 receptor agonist|glp-1 receptor agonist
4974473|NCT04151849|SGLT-2 inhibitor|sglt-2 inhibitor
4974474|NCT04151836|Morbid obesity|morbid obesity
4974475|NCT04151836|Bariatric surgery|bariatric surgery
4974476|NCT04151836|Walking exercise|walking exercise
4974477|NCT04151836|Quality of life|quality of life
4974478|NCT04151836|Body composition|body composition
4974479|NCT04151823|Childhood obesity|childhood obesity
4974480|NCT04151823|Nutrition|nutrition
4974481|NCT04151823|Gut microbiota|gut microbiota
4974482|NCT04151823|Postbiotics|postbiotics
4974483|NCT04151797|Medication review|medication review
4974484|NCT04151797|clinical pharmacy|clinical pharmacy
4974485|NCT04151797|polypharmacy|polypharmacy
4974486|NCT04151797|older people|older people
4974487|NCT04151797|collaboration|collaboration
4974488|NCT04151797|inappropriate prescribing|inappropriate prescribing
4974490|NCT04151771|blood flow restriction training|blood flow restriction training
4974491|NCT04151771|pulmonary rehabilitation|pulmonary rehabilitation
4974492|NCT04151771|COPD|copd
4974493|NCT04151771|muscle weakness|muscle weakness
4974494|NCT04151758|Childhood obesity|childhood obesity
4974503|NCT04151693|Autonomic nervous system|autonomic nervous system
4974504|NCT04151693|Autonomic nervous system ganglio antibodies|autonomic nervous system ganglio antibodies
4974506|NCT04151693|Relaxation|relaxation
4974507|NCT04151680|coronary artery disease|coronary artery disease
4974508|NCT04151667|myeloma|myeloma
4974509|NCT04151667|daratumumab|daratumumab
4974510|NCT04151654|aged|aged
4974511|NCT04151654|shoe|shoe
4974512|NCT04151654|postural balance|postural balance
4974513|NCT04151654|accidental falls|accidental falls
4974514|NCT04151628|Intravascular Lithotripsy|intravascular lithotripsy
4974515|NCT04151628|Percutaneous Coronary Intervention|percutaneous coronary intervention
4974516|NCT04151615|Multiple Myeloma|multiple myeloma
4974517|NCT04151615|Treatment-naïve patients|treatment-naïve patients
4974518|NCT04151576|aromatherapy|aromatherapy
4974519|NCT04151576|massage|massage
4974520|NCT04151550|Presbyopia|presbyopia
4974521|NCT04151550|Sclera|sclera
4974522|NCT04151550|Laser Scleral Microporation|laser scleral microporation
4974523|NCT04151537|Hypertension|hypertension
4974524|NCT04151537|Exercise Therapy|exercise therapy
4974525|NCT04151537|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
4974526|NCT04151537|Physical activity monitoring|physical activity monitoring
4974527|NCT04151485|female infertility|female infertility
4974528|NCT04151485|assisted reproductive technology|assisted reproductive technology
4974529|NCT04151485|in vitro fertilization|in vitro fertilization
5295443|NCT02199158|angle|angle
4974530|NCT04151485|intra-cytoplasmic sperm injection|intra-cytoplasmic sperm injection
4974549|NCT04151446|Laser Scleral Microporation|laser scleral microporation
4974550|NCT04151407|VEGF; DME; bevacizumab; safety|vegf; dme; bevacizumab; safety
4974551|NCT04151368|breast surgery|breast surgery
4974552|NCT04151368|robotic surgery|robotic surgery
4974553|NCT04151368|nipple sparing mastectomy|nipple sparing mastectomy
4974554|NCT04151368|genetic predisposition|genetic predisposition
4974555|NCT04151368|breast cancer|breast cancer
4974556|NCT04151342|observational study|observational study
4974557|NCT04151342|cancer|cancer
4974558|NCT04151342|cancer therapies|cancer therapies
4974559|NCT04151342|molecular alterations|molecular alterations
4974560|NCT04151342|real-world evidence|real-world evidence
4974561|NCT04151342|real-world data|real-world data
4974562|NCT04151342|tyrosine kinase inhibitors|tyrosine kinase inhibitors
4974563|NCT04151342|ambispective|ambispective
4974564|NCT04151303|RDS|rds
4974565|NCT04151303|CERCLAGE|cerclage
4974566|NCT04151303|CERVIX INSUFFICIENCY|cervix insufficiency
4974567|NCT04151264|Hypotension|hypotension
4974568|NCT04151264|tumor of the oropharynx|tumor of the oropharynx
4974569|NCT04151264|tumor of the nasopharynx|tumor of the nasopharynx
4974570|NCT04151264|creatinine|creatinine
4974571|NCT04151225|Monoclonal antibody|monoclonal antibody
4974572|NCT04151225|Crohns Disease|crohns disease
4974573|NCT04151225|Oncostatin M|oncostatin m
4974574|NCT04151225|GSK2330811|gsk2330811
4974575|NCT04151186|CAR-T cells|car-t cells
4974576|NCT04151186|Immunologic Factors|immunologic factors
4974577|NCT04151186|TM4SF1;EpCAM|tm4sf1;epcam
4974578|NCT04151160|MuscleSound|musclesound
4974579|NCT04151147|Third molar surgery|third molar surgery
4974580|NCT04151147|Alveolar osteitis|alveolar osteitis
4974581|NCT04151147|Platelet concentrates|platelet concentrates
4974582|NCT04151121|chest pain|chest pain
4974583|NCT04151121|non-cardiac|non-cardiac
4974584|NCT04151121|mindfulness|mindfulness
4974585|NCT04151095|Mitochondria|mitochondria
4974586|NCT04151095|Exercise training|exercise training
4974587|NCT04151095|VO2|vo2
4974588|NCT04151095|Aerobic exercise|aerobic exercise
4974589|NCT04151095|Citrate Synthase|citrate synthase
4974590|NCT04151095|Blood flow restriction|blood flow restriction
4974591|NCT04151069|Tree Nut Allergy|tree nut allergy
4974592|NCT04151069|Walnut Allergy|walnut allergy
4974593|NCT04151069|Pistachio Allergy|pistachio allergy
4971761|NCT04167410|Nursing|nursing
4974594|NCT04151069|Cashew Allergy|cashew allergy
4974595|NCT04151069|Tree Nut Hypersensitivity|tree nut hypersensitivity
4974596|NCT04151069|Tree Nut Anaphylaxis|tree nut anaphylaxis
4974597|NCT04151056|social determinants of health, reporting socials problems|social determinants of health, reporting socials problems
4974598|NCT04150991|Fiber|fiber
4974610|NCT04150965|Relapsed|relapsed
4974611|NCT04150965|Refractory|refractory
4974612|NCT04150965|MM|mm
4974613|NCT04150965|Multiple Myeloma Research Consortium|multiple myeloma research consortium
4974614|NCT04150965|Multiple Myeloma Research Foundation|multiple myeloma research foundation
4974615|NCT04150965|MMRC|mmrc
4974616|NCT04150965|MMRF|mmrf
4974617|NCT04150952|Heart rate variability|heart rate variability
4974618|NCT04150952|Training|training
4974619|NCT04150952|Endurance|endurance
4974620|NCT04150952|Mood|mood
4974621|NCT04150952|Anxiety|anxiety
4974622|NCT04150952|Stress|stress
4974623|NCT04150926|berries|berries
4974624|NCT04150926|black currant|black currant
4974625|NCT04150926|glucose|glucose
4974626|NCT04150926|glycemia|glycemia
4974627|NCT04150926|quinoa|quinoa
4974637|NCT04150861|In vitro fertilisation|in vitro fertilisation
4974638|NCT04150861|Controlled ovarian stimulation|controlled ovarian stimulation
4974639|NCT04150835|Acute ischemic stroke|acute ischemic stroke
4974640|NCT04150835|Xingnaojing injection|xingnaojing injection
4974657|NCT04150666|primary aldosteronism|primary aldosteronism
4974660|NCT04150666|renal function|renal function
4974667|NCT04150497|BALLI-01|balli-01
4974668|NCT04150497|B-cell Acute Lymphoblastic Leukemia (B-ALL)|b-cell acute lymphoblastic leukemia (b-all)
4974669|NCT04150497|Universal Chimeric Antigen Receptor T-Cell (UCAR-T) Therapy|universal chimeric antigen receptor t-cell (ucar-t) therapy
4974670|NCT04150497|Allogeneic|allogeneic
4974671|NCT04150497|Transcription Activator-Like Effector Nuclease (TALEN®)|transcription activator-like effector nuclease (talen®)
4974672|NCT04150484|breast cancer survival|breast cancer survival
4974673|NCT04150484|mediterranean diet|mediterranean diet
4974674|NCT04150484|physical activity|physical activity
4974675|NCT04150484|mindfulness|mindfulness
4974676|NCT04150445|Overweight|overweight
4974677|NCT04150445|Obesity|obesity
4974678|NCT04150445|Body Weight|body weight
4974679|NCT04150419|Attentional bias modification training|attentional bias modification training
4974680|NCT04150419|chronic pelvi-perinal pain.|chronic pelvi-perinal pain.
4974681|NCT04150406|Curcuma|curcuma
4974682|NCT04150406|Endometriosis-associated pain|endometriosis-associated pain
4974683|NCT04150393|microbiota|microbiota
4974684|NCT04150393|microbiotherapy|microbiotherapy
4974688|NCT04150315|Targeted proteomics|targeted proteomics
4974689|NCT04150289|Farydak|farydak
4974690|NCT04150289|panobinostat|panobinostat
4974697|NCT04150263|intraocular lens, dislocation|intraocular lens, dislocation
4974705|NCT04150211|Harpagophytum|harpagophytum
4974706|NCT04150211|Zingiber officinae|zingiber officinae
4974707|NCT04150211|Bixa orellana|bixa orellana
4974708|NCT04150211|Joint pain|joint pain
4974709|NCT04150211|Inflammation|inflammation
4974710|NCT04150211|Biomechanics|biomechanics
4974711|NCT04150133|low residue diet|low residue diet
4974712|NCT04150120|e-health|e-health
4974713|NCT04150120|children|children
4974714|NCT04150120|culture|culture
4974715|NCT04150120|health economy|health economy
4974716|NCT04150120|quality of life|quality of life
4974717|NCT04150120|home care|home care
4974718|NCT04150081|T1 Colorectal Cancer|t1 colorectal cancer
4974719|NCT04150081|Early Colorectal Cancer|early colorectal cancer
4974720|NCT04150081|Endoscopic polypectomy|endoscopic polypectomy
4974721|NCT04150081|Oncological Surgery|oncological surgery
4974722|NCT04150081|Lymph node metastasis|lymph node metastasis
4974723|NCT04150081|Molecular signatures|molecular signatures
4974724|NCT04150081|Disease free survival|disease free survival
4974725|NCT04150055|mindfulness|mindfulness
4974726|NCT04150055|caregiver|caregiver
4974727|NCT04150055|palliative care|palliative care
4974728|NCT04150042|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4974731|NCT04150042|BRCA1|brca1
4974732|NCT04150042|BRCA2|brca2
4974733|NCT04150042|melphalan|melphalan
4974735|NCT04150042|carmustine|carmustine
4974736|NCT04150042|vitamin C|vitamin c
4974737|NCT04150042|vitamin B12b|vitamin b12b
4975755|NCT04143399|IPSS|ipss
4974748|NCT04150003|Venous Thromboembolic Disease|venous thromboembolic disease
4974750|NCT04150003|Rehabilitation program|rehabilitation program
4974751|NCT04150003|Exercise training|exercise training
4974752|NCT04149964|Post-operative pain|post-operative pain
4974753|NCT04149964|Sinus pain|sinus pain
4974754|NCT04149964|Sinus surgery|sinus surgery
4974755|NCT04149964|Septum Pain|septum pain
4974756|NCT04149964|deviated septum|deviated septum
4974757|NCT04149912|Professional quality of life|professional quality of life
5700276|NCT00500292|zactima|zactima
4974758|NCT04149912|Compassion satisfaction|compassion satisfaction
4974759|NCT04149912|Burnout|burnout
4974760|NCT04149912|Psychologists|psychologists
4974761|NCT04149912|Mental disorders|mental disorders
4974762|NCT04149912|Mental health|mental health
4974763|NCT04149899|POAG|poag
4974765|NCT04149899|Primary open-angle glaucoma|primary open-angle glaucoma
4974766|NCT04149899|ocular hypertension|ocular hypertension
4974767|NCT04149886|Cardioneuromablation|cardioneuromablation
4974768|NCT04149886|Ganglionated plexus|ganglionated plexus
4974769|NCT04149886|Sick Sinus Syndrome|sick sinus syndrome
4974770|NCT04149886|Pacing percentage|pacing percentage
4974790|NCT04149782|Antiretroviral therapy|antiretroviral therapy
4974792|NCT04149730|Pulseless electrical activity|pulseless electrical activity
4974793|NCT04149717|caffeine|caffeine
4974794|NCT04149717|taurine|taurine
4974795|NCT04149717|carnitine|carnitine
4974796|NCT04149717|energy drink|energy drink
4974797|NCT04149704|Advanced Cancer|advanced cancer
4974807|NCT04149678|Healthy Subjects|healthy subjects
4974808|NCT04149678|Ozanimod|ozanimod
4974809|NCT04149678|Cyclosporine|cyclosporine
4974810|NCT04149652|elastography|elastography
4974811|NCT04149652|ultrasound|ultrasound
4974812|NCT04149652|copd|copd
4974813|NCT04149652|smoke|smoke
4974814|NCT04149652|lung stiffness|lung stiffness
4974815|NCT04149652|lung ultrasound|lung ultrasound
4974816|NCT04149639|NeuroQ|neuroq
4974818|NCT04149639|PreCODE protocol|precode protocol
4974819|NCT04149639|ReCODE method|recode method
4974820|NCT04149639|cognitive decline|cognitive decline
4974821|NCT04149639|The End of Alzheimer's|the end of alzheimer's
4974822|NCT04149639|cognitive support|cognitive support
4974823|NCT04149639|cognitive health|cognitive health
4974824|NCT04149613|biomarker|biomarker
4974825|NCT04149613|colorectal cancer|colorectal cancer
4974826|NCT04149613|prognosis|prognosis
4974827|NCT04149613|prediction|prediction
4974828|NCT04149613|microRNA|microrna
4974829|NCT04149613|inflammation|inflammation
4974830|NCT04149613|dietary pattern|dietary pattern
4974831|NCT04149561|cerebral palsy|cerebral palsy
4974832|NCT04149561|communication|communication
4974833|NCT04149522|Radiotherapy breast|radiotherapy breast
4974834|NCT04149522|Mepitel Film|mepitel film
4974835|NCT04149509|NOWS|nows
4974836|NCT04149496|IVM|ivm
4974837|NCT04149496|in vitro maturation|in vitro maturation
4974838|NCT04149496|polycystic ovarian syndrome|polycystic ovarian syndrome
4974839|NCT04149496|PCOS|pcos
4974840|NCT04149496|Steiner-Tan needle|steiner-tan needle
4974841|NCT04149496|oocyte maturation|oocyte maturation
4974842|NCT04149483|High resolution magnetic resonance|high resolution magnetic resonance
4974843|NCT04149483|Atorvastatin|atorvastatin
4974844|NCT04149483|Ruptured risk|ruptured risk
4974845|NCT04149470|EoE|eoe
4974846|NCT04149470|PPI|ppi
4974847|NCT04149470|Proton Pump Inhibitor|proton pump inhibitor
4974848|NCT04149470|Omeprazole|omeprazole
4974849|NCT04149470|eosinophil|eosinophil
4974850|NCT04149470|TNE|tne
4974851|NCT04149470|Transnasal Endoscopy|transnasal endoscopy
4974852|NCT04149470|Esophageal Diseases|esophageal diseases
4974853|NCT04149470|Esophagitis|esophagitis
4974854|NCT04149470|Gastrointestinal Diseases|gastrointestinal diseases
4974855|NCT04149470|Eosinophilia|eosinophilia
4974856|NCT04149470|Gastroenteritis|gastroenteritis
4974857|NCT04149470|Eosinophilic Oesophagitis|eosinophilic oesophagitis
4974862|NCT04149431|Children|children
4974864|NCT04149418|obesity|obesity
4974865|NCT04149418|intestine|intestine
4974866|NCT04149405|sclerostin|sclerostin
4974867|NCT04149405|dickkopf-related protein-1|dickkopf-related protein-1
4974868|NCT04149392|CGM Diabetes Heart Failure|cgm diabetes heart failure
4974869|NCT04149379|Stroke|stroke
4974870|NCT04149379|Hyperbaric oxygen|hyperbaric oxygen
4974872|NCT04149314|Thoracic Surgery|thoracic surgery
4974873|NCT04149314|Single-Lung ventilation|single-lung ventilation
4974874|NCT04149301|musculoskeletal modelling|musculoskeletal modelling
4974875|NCT04149301|gait analysis|gait analysis
4974882|NCT04149249|quitting|quitting
4974883|NCT04149249|smoking|smoking
4974893|NCT04149210|Eye Diseases|eye diseases
4974894|NCT04149210|Eyelid Diseases|eyelid diseases
4974895|NCT04149210|trachomatous|trachomatous
4974897|NCT04149210|FLAME|flame
4974898|NCT04149210|TT Surgery|tt surgery
4974899|NCT04149197|Down Syndrome|down syndrome
4974900|NCT04149197|Alzheimer's Disease|alzheimer's disease
4974901|NCT04149145|Ovarian Cancer|ovarian cancer
4974902|NCT04149145|PARP Resistant|parp resistant
4974903|NCT04149145|ATR inhibitor|atr inhibitor
4974904|NCT04149145|M4344|m4344
4974905|NCT04149145|Niraparib|niraparib
4974906|NCT04149132|early diagnosis|early diagnosis
4974907|NCT04149132|infection|infection
4974908|NCT04149132|pulse photoplethysmography|pulse photoplethysmography
4974909|NCT04149119|Malaria|malaria
4974910|NCT04149119|Vector control|vector control
4974911|NCT04149119|ATSB|atsb
4974912|NCT04149119|Transmission|transmission
4974913|NCT04149119|Mali|mali
4974914|NCT04149106|SMC|smc
4974915|NCT04149106|Effectiveness|effectiveness
4974916|NCT04149106|SPAQ|spaq
4974917|NCT04149106|DHAPQ|dhapq
4974918|NCT04149106|Drug resistance|drug resistance
4974919|NCT04149080|Simvastatin|simvastatin
4974920|NCT04149080|Tooth extraction|tooth extraction
4974921|NCT04149080|Alveolar socket preservation|alveolar socket preservation
4974922|NCT04149080|Bone regeneration|bone regeneration
4974923|NCT04149028|Premature ovarian insuffiency|premature ovarian insuffiency
4974924|NCT04149028|Infertility|infertility
4974925|NCT04149028|PRP|prp
4974926|NCT04148989|Sepsis|sepsis
4974927|NCT04148989|Clinical Protocols|clinical protocols
4974928|NCT04148989|Emergency Medicine|emergency medicine
4974929|NCT04148976|hypercholesterolemia|hypercholesterolemia
4974930|NCT04148976|dietary portfolio|dietary portfolio
4974931|NCT04148976|soy protein|soy protein
4974932|NCT04148976|LDL-C|ldl-c
4974933|NCT04148976|lipoprotein subclasses|lipoprotein subclasses
4974934|NCT04148976|nopal|nopal
4974935|NCT04148976|chia seed|chia seed
4974936|NCT04148976|functional foods|functional foods
4974937|NCT04148963|schizophrenia|schizophrenia
4974938|NCT04148963|bipolar disorder|bipolar disorder
4974939|NCT04148963|agitation|agitation
4974940|NCT04148963|inhaled loxapine|inhaled loxapine
4974941|NCT04148963|ADASUVE|adasuve
4974942|NCT04148950|Chronic Venous Disease|chronic venous disease
4974943|NCT04148950|Kinesio Taping|kinesio taping
4974944|NCT04148950|Compression Stockings|compression stockings
4974945|NCT04148950|Pain|pain
4974946|NCT04148950|Edema|edema
4974966|NCT04148859|amniotic pressure|amniotic pressure
4974967|NCT04148833|ATHEROSCLEROSIS|atherosclerosis
4974968|NCT04148833|CORONARY ARTERY DISEASE|coronary artery disease
4974969|NCT04148833|INFLAMATION|inflamation
4974970|NCT04148833|NANOPARTICLES|nanoparticles
4974971|NCT04148833|PACLITAXEL|paclitaxel
4974972|NCT04148833|DRUG TARGETING|drug targeting
4974973|NCT04148833|DRUG DELIVERY SYSTEM|drug delivery system
4974974|NCT04148820|coronary artery disease|coronary artery disease
4974975|NCT04148794|advanced life support|advanced life support
4974976|NCT04148794|ultrasound|ultrasound
4974977|NCT04148794|point-of-care ultrasound|point-of-care ultrasound
4974978|NCT04148794|echo-assisted advanced life support|echo-assisted advanced life support
4974979|NCT04148781|Multiple sclerosis|multiple sclerosis
4974980|NCT04148781|Optic Neuritis|optic neuritis
4974981|NCT04148781|Fampyra|fampyra
4974982|NCT04148768|Knee pain|knee pain
4974984|NCT04148768|patello-femoral pain,|patello-femoral pain,
4974985|NCT04148768|Anetrior cruciate repair|anetrior cruciate repair
4974986|NCT04148768|Balance|balance
4974987|NCT04148768|Dynamic and static balance|dynamic and static balance
4974988|NCT04148768|Proprioception|proprioception
4974989|NCT04148755|EUS. Elastography, FNA|eus. elastography, fna
4974990|NCT04148729|erector spinae plane block|erector spinae plane block
4974991|NCT04148729|postoperative analgesia|postoperative analgesia
4974992|NCT04148729|spinal surgery|spinal surgery
5295734|NCT02197767|MabThera|mabthera
4974993|NCT04148703|Pacemaker, home monitoring, remote monitoring, ecocomic|pacemaker, home monitoring, remote monitoring, ecocomic
4974994|NCT04148690|Group antenatal care|group antenatal care
4975000|NCT04148651|vulvar atrophy|vulvar atrophy
4975001|NCT04148651|persistent itching|persistent itching
4975002|NCT04148651|leukoplakia|leukoplakia
4975003|NCT04148651|hyperkeratosis|hyperkeratosis
4975004|NCT04148651|sexual function|sexual function
4975005|NCT04148625|hybrid, LAA ligation|hybrid, laa ligation
4975006|NCT04148547|Transcranial direct current stimulation|transcranial direct current stimulation
4975007|NCT04148508|Promotion|promotion
5014884|NCT03903887|TIL|til
4972126|NCT04165447|nutrition|nutrition
4972127|NCT04165447|front-of-pack label|front-of-pack label
4975008|NCT04148508|Prevention|prevention
4975009|NCT04148508|Mobile App|mobile app
4975010|NCT04148508|Emotional Competence|emotional competence
4975011|NCT04148508|Emotional Resiliance|emotional resiliance
4975012|NCT04148508|Wellbeing|wellbeing
4975013|NCT04148495|Morphine|morphine
4975014|NCT04148495|acetaminophen|acetaminophen
4975015|NCT04148495|Acute pain|acute pain
4975016|NCT04148495|Analgesics|analgesics
4975017|NCT04148469|Miofascial pain syndrom.|miofascial pain syndrom.
4975018|NCT04148469|Trigger point.|trigger point.
4975019|NCT04148469|Dry needling.|dry needling.
4975020|NCT04148469|Transcotaneous Nerve Stimuilation.|transcotaneous nerve stimuilation.
4975021|NCT04148469|Hipoalgesia|hipoalgesia
4975022|NCT04148443|preoxygenation|preoxygenation
4975023|NCT04148443|intubation|intubation
4975024|NCT04148443|end-tidal of oxygen concentration|end-tidal of oxygen concentration
4975025|NCT04148443|intensive care unit|intensive care unit
4975026|NCT04148443|critically ill patients|critically ill patients
4975027|NCT04148365|Paediatrics|paediatrics
4975031|NCT04148300|Oral health literacy|oral health literacy
4975032|NCT04148300|Dental anxiety|dental anxiety
4975033|NCT04148300|Utilization of oral health services|utilization of oral health services
4975034|NCT04148300|Dental patients|dental patients
4975035|NCT04148209|First-in-human study|first-in-human study
4975036|NCT04148196|Older people|older people
4975037|NCT04148196|Adaptation|adaptation
4975038|NCT04148196|Life quality|life quality
4975039|NCT04148196|Nursing home|nursing home
4975040|NCT04148170|Endodiathermy Probe and Intubation Versus Intubation Only|endodiathermy probe and intubation versus intubation only
4976357|NCT04140058|hypotension|hypotension
4975053|NCT04148118|Recombinant Protective Antigen|recombinant protective antigen
4975054|NCT04148105|Delayed cerebral ischemia|delayed cerebral ischemia
4975055|NCT04148105|Cerebral vasospasm|cerebral vasospasm
4975056|NCT04148105|Cilostazol|cilostazol
4975057|NCT04148027|emergency medicine|emergency medicine
4975058|NCT04148027|geriatrics|geriatrics
4975059|NCT04148027|telemedicine|telemedicine
4975060|NCT04148014|eating disorders|eating disorders
4975061|NCT04148014|young adults|young adults
4975062|NCT04148014|emotion regulation skills|emotion regulation skills
4975063|NCT04148001|LDL Receptors|ldl receptors
4975064|NCT04148001|Gene Therapy|gene therapy
4975065|NCT04148001|Metabolic Diseases|metabolic diseases
4975066|NCT04148001|Rare Diseases|rare diseases
4975067|NCT04148001|Genetic Diseases|genetic diseases
4975068|NCT04148001|Atherosclerosis|atherosclerosis
4975069|NCT04148001|Cardiovascular Disease|cardiovascular disease
4975070|NCT04148001|Genotype|genotype
4975071|NCT04147962|intense pulsed light|intense pulsed light
4975072|NCT04147936|Amino acids, food study|amino acids, food study
4975078|NCT04147910|Healthy Male Subjects|healthy male subjects
4975079|NCT04147884|Functional Mitral Regurgitation|functional mitral regurgitation
4975080|NCT04147884|Mitral Repair|mitral repair
4975081|NCT04147845|Alopecia Areata|alopecia areata
4975082|NCT04147845|Transepidermal drug delivery|transepidermal drug delivery
4975083|NCT04147845|Fractional Carbon Dioxide Laser|fractional carbon dioxide laser
4975084|NCT04147845|Platelet-Rich Plasma|platelet-rich plasma
4975085|NCT04147845|Microneedling|microneedling
4975086|NCT04147845|Triamcinolone acetonide|triamcinolone acetonide
4975091|NCT04147793|Adolescent|adolescent
4975092|NCT04147793|urinary incontinence|urinary incontinence
4975098|NCT04147741|Supplement|supplement
4975099|NCT04147741|Pre-Workout|pre-workout
4975100|NCT04147741|Muscle|muscle
4975101|NCT04147741|Recovery|recovery
4975102|NCT04147741|Training|training
4975103|NCT04147741|Strength|strength
4975104|NCT04147741|Endurance|endurance
4975105|NCT04147741|Perceptual Response|perceptual response
4975118|NCT04147689|filler|filler
4975119|NCT04147689|hypotrophy|hypotrophy
4975120|NCT04147689|atrophy|atrophy
4975121|NCT04147663|emergency|emergency
4975122|NCT04147663|epileptic seizure|epileptic seizure
4975123|NCT04147663|epilepsy|epilepsy
4975124|NCT04147663|neurology|neurology
4975125|NCT04147650|Dry Eye Calcineurin Inhibitors|dry eye calcineurin inhibitors
4975139|NCT04147585|IBD|ibd
4975140|NCT04147585|Crohn's disease|crohn's disease
4975141|NCT04147585|Diet|diet
4975142|NCT04147585|Fasting|fasting
4975143|NCT04147585|Intermittent Reduced Calorie Diet|intermittent reduced calorie diet
4975144|NCT04147585|CD|cd
4975145|NCT04147585|intermittent fasting|intermittent fasting
4975146|NCT04147585|FMD|fmd
4975160|NCT04147403|pancreatic head adenocarcinoma; total mesopancreas excision;pancreaticoduodenectomy|pancreatic head adenocarcinoma; total mesopancreas excision;pancreaticoduodenectomy
4975163|NCT04147377|visual cue|visual cue
4975164|NCT04147377|auditory cue|auditory cue
4975165|NCT04147377|subthalamic nucleus|subthalamic nucleus
4975166|NCT04147377|deep brain stimulation|deep brain stimulation
4975170|NCT04147299|Right Ventricular Function|right ventricular function
4975171|NCT04147286|tuberculosis|tuberculosis
4975172|NCT04147286|HIV|hiv
4975173|NCT04147286|COPD|copd
4975174|NCT04147286|inflammation|inflammation
4975175|NCT04147221|beta-lactam|beta-lactam
4975176|NCT04147221|pharmacokinetics|pharmacokinetics
4975177|NCT04147208|Chronic HBeAg positive HBV Infection|chronic hbeag positive hbv infection
4975178|NCT04147195|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4975179|NCT04147195|NAFLD|nafld
4975180|NCT04147195|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4975181|NCT04147195|NASH|nash
4975182|NCT04147195|Platform design|platform design
4975183|NCT04147195|LYS006|lys006
4975184|NCT04147195|LJN452|ljn452
4975185|NCT04147195|Tropifexor|tropifexor
4975186|NCT04147169|Compassionate|compassionate
4975187|NCT04147169|End-of-Life Care|end-of-life care
4975188|NCT04147169|Interpersonal connections|interpersonal connections
4975201|NCT04147117|Preterm Birth|preterm birth
4975202|NCT04147117|Cervical Pessary|cervical pessary
4975203|NCT04147117|Obstetrical history|obstetrical history
4975204|NCT04147117|Cervical length|cervical length
4975205|NCT04147078|Cell therapy|cell therapy
4975206|NCT04147078|safety|safety
4975207|NCT04147078|clinical efficacy|clinical efficacy
4975208|NCT04147078|adjuvant treatment|adjuvant treatment
4975209|NCT04147078|locally advanced cancer|locally advanced cancer
4975210|NCT04147026|Biological therapy|biological therapy
4975211|NCT04147026|Predictive software|predictive software
4975212|NCT04147026|Quality of life|quality of life
4975219|NCT04146987|Rotator Cuff|rotator cuff
4975220|NCT04146987|Rotator Cuff Tear|rotator cuff tear
4975221|NCT04146987|Rotator Cuff Tendinopathy|rotator cuff tendinopathy
4975222|NCT04146987|Shoulder Arthroscopy|shoulder arthroscopy
4975223|NCT04146987|Rotator Cuff Repair|rotator cuff repair
4975224|NCT04146987|Open Rotator Cuff Repair|open rotator cuff repair
4975225|NCT04146974|Social services|social services
4975226|NCT04146974|Coordination|coordination
4975227|NCT04146974|Early childhood education|early childhood education
4975228|NCT04146974|State and local agencies|state and local agencies
4975229|NCT04146948|activities of daily living|activities of daily living
4975230|NCT04146948|accessory inspiratory muscles|accessory inspiratory muscles
4975235|NCT04146922|Enterobacteriaceae, bacteremia, step down oral therapy|enterobacteriaceae, bacteremia, step down oral therapy
4975237|NCT04146883|Cardiac implantable electronic device infection|cardiac implantable electronic device infection
4975239|NCT04146857|Sleep|sleep
4975240|NCT04146857|Heart rate variability|heart rate variability
4975241|NCT04146857|Sleep architecture|sleep architecture
4975246|NCT04146818|adapted Tango dancing|adapted tango dancing
4975247|NCT04146818|elderly people|elderly people
4975248|NCT04146818|music therapy|music therapy
4975249|NCT04146818|psycho-education|psycho-education
4975250|NCT04146753|Chest physiotherapy|chest physiotherapy
4975251|NCT04146753|Paediatric intensive care unit|paediatric intensive care unit
4975252|NCT04146753|Physiological instability|physiological instability
4975253|NCT04146753|Adverse events|adverse events
4975254|NCT04146740|exercise|exercise
4975255|NCT04146740|pregnancy|pregnancy
4975256|NCT04146688|Music|music
4975257|NCT04146688|Communication|communication
4975258|NCT04146688|Emotion|emotion
4975259|NCT04146688|Behavior|behavior
4975260|NCT04146688|Neurodegeneration disease|neurodegeneration disease
4975261|NCT04146675|Gerontology|gerontology
4975262|NCT04146675|elderly,|elderly,
4975263|NCT04146675|falls|falls
4975264|NCT04146675|balance and walking disorders.|balance and walking disorders.
4975265|NCT04146623|live-attenuated vaccine|live-attenuated vaccine
4975266|NCT04146623|influenza vaccine|influenza vaccine
4975267|NCT04146584|Skin Laxity|skin laxity
4975268|NCT04146584|Submental|submental
4975269|NCT04146584|Neck|neck
4975270|NCT04146584|Brow Lifting|brow lifting
4975271|NCT04146584|Laxity|laxity
4975272|NCT04146584|Saggy|saggy
4972376|NCT04164134|RB1|rb1
4975273|NCT04146571|ensartinib|ensartinib
4975274|NCT04146571|X-396|x-396
4975275|NCT04146571|X396|x396
4975276|NCT04146571|anaplastic lymphoma kinase|anaplastic lymphoma kinase
4975277|NCT04146571|ALK+|alk+
4975278|NCT04146571|ALK positive|alk positive
4975279|NCT04146571|NSCLC|nsclc
4975280|NCT04146571|Non-Small Cell Lung Cancer|non-small cell lung cancer
4975281|NCT04146571|ALK inhibitor|alk inhibitor
4975282|NCT04146571|carcinoma|carcinoma
4975283|NCT04146545|caregivers|caregivers
4975284|NCT04146545|dementia|dementia
4975285|NCT04146545|information-sharing|information-sharing
4975286|NCT04146545|Alzheimer's Disease|alzheimer's disease
4975287|NCT04146545|caregiving|caregiving
4975288|NCT04146545|community resources|community resources
4975289|NCT04146532|Aspirin|aspirin
4975290|NCT04146532|Acetylsalicylic acid|acetylsalicylic acid
4975291|NCT04146532|Emotional reactivity|emotional reactivity
4975292|NCT04146532|Memory|memory
4975293|NCT04146532|Risk-taking|risk-taking
4975294|NCT04146532|Inflammation|inflammation
4975295|NCT04146519|Parkinson's disease|parkinson's disease
4975296|NCT04146519|mesenchymal stem cells|mesenchymal stem cells
4975297|NCT04146519|intranasal transplantation|intranasal transplantation
4975298|NCT04146519|intravenous transplantation|intravenous transplantation
4975299|NCT04146519|combined transplantation|combined transplantation
4975300|NCT04146493|Heparin-binding protein|heparin-binding protein
4975301|NCT04146493|Heparin|heparin
4975302|NCT04146493|Biomarker|biomarker
4975303|NCT04146454|Parkinson's disease|parkinson's disease
4975304|NCT04146454|In-home balance training|in-home balance training
4975305|NCT04146454|Smartphone-based wearable telerehabilitation|smartphone-based wearable telerehabilitation
4975306|NCT04146441|Contrast agent BR|contrast agent br
4975307|NCT04146441|SonoVue|sonovue
4975308|NCT04146441|Ultrasonic therapy|ultrasonic therapy
4975309|NCT04146441|Microbubbles|microbubbles
4975310|NCT04146428|BOSCC|boscc
4975311|NCT04146428|ELSA-T|elsa-t
4975312|NCT04146428|JASPER|jasper
4975313|NCT04146428|autism|autism
4975316|NCT04146376|von Willebrand Disease|von willebrand disease
4975317|NCT04146376|von Willebrand Factor|von willebrand factor
4975318|NCT04146376|postpartum hemorrhage|postpartum hemorrhage
4975319|NCT04146363|Eczema|eczema
4975320|NCT04146363|Dermatitis|dermatitis
4975321|NCT04146363|Dermatitis, Atopic|dermatitis, atopic
4975322|NCT04146363|Skin Diseases|skin diseases
4975323|NCT04146324|Adjuvant|adjuvant
4975324|NCT04146324|nivolumab|nivolumab
4975325|NCT04146298|pancreatic cancer|pancreatic cancer
4975326|NCT04146298|TCR transduced T cells|tcr transduced t cells
4975327|NCT04146298|adoptive cell therapy|adoptive cell therapy
4975328|NCT04146298|KRAS|kras
4975329|NCT04146259|Sclerostin|sclerostin
4993041|NCT04037137|reliability|reliability
4975334|NCT04146168|cyanoacrylate closure|cyanoacrylate closure
4975335|NCT04146155|Glucagon-like peptide-1|glucagon-like peptide-1
4975336|NCT04146155|Claudication|claudication
4975337|NCT04146155|Peripheral vascular disease|peripheral vascular disease
4975338|NCT04146142|Prostate Cancer|prostate cancer
4975339|NCT04146142|Biopsy|biopsy
4975340|NCT04146142|Complication|complication
4975341|NCT04146142|Randomization|randomization
4975343|NCT04146116|nasal decolonization|nasal decolonization
4975344|NCT04146116|Orthopedic trauma surgery|orthopedic trauma surgery
4975360|NCT04145908|midline reinforcement|midline reinforcement
4975362|NCT04145908|mesh|mesh
4975369|NCT04145856|Probiotic|probiotic
4975370|NCT04145856|Antispasmodic|antispasmodic
4975371|NCT04145856|Rome-IV|rome-iv
4975372|NCT04145830|Glaucoma, ciliary body, ultrasound|glaucoma, ciliary body, ultrasound
4975375|NCT04145817|Breast cancer|breast cancer
4975376|NCT04145817|Ovarian cancer|ovarian cancer
4975383|NCT04145739|Breast Cancer|breast cancer
4975384|NCT04145739|Pain, Chronic and Postoperative|pain, chronic and postoperative
4975385|NCT04145739|Posture|posture
4975386|NCT04145739|Target - Reaching movement|target - reaching movement
4975387|NCT04145739|Mastectomy|mastectomy
4975388|NCT04145739|Quadrantectomy|quadrantectomy
4975389|NCT04145739|Lymphedema|lymphedema
4975390|NCT04145739|Rehabilitation|rehabilitation
4975391|NCT04145739|Scapula tilting|scapula tilting
4975392|NCT04145739|Shoulder|shoulder
4975393|NCT04145739|Biomechanics|biomechanics
4975394|NCT04145739|Upper limb|upper limb
4975396|NCT04145700|adolescents and young adults (AYAs)|adolescents and young adults (ayas)
4975397|NCT04145700|adolescent|adolescent
4975398|NCT04145635|mechanical circulatory support, percutaneous|mechanical circulatory support, percutaneous
4975399|NCT04145622|Advanced Solid Tumor|advanced solid tumor
4975400|NCT04145622|Malignant Tumor|malignant tumor
4975401|NCT04145622|DS-7300a|ds-7300a
4975402|NCT04145609|Acute Kidney Injury|acute kidney injury
4975403|NCT04145609|Acute Kidney Disease|acute kidney disease
4975404|NCT04145609|Chronic Kidney Disease|chronic kidney disease
4975406|NCT04145609|AKD|akd
4975407|NCT04145609|CKD|ckd
4975408|NCT04145609|Decision Support Systems, Clinical|decision support systems, clinical
4975409|NCT04145609|CDS|cds
4975410|NCT04145557|periodontitis|periodontitis
4975411|NCT04145557|diode laser|diode laser
4975412|NCT04145557|Myocardial infarction|myocardial infarction
4975413|NCT04145531|ALL|all
4975414|NCT04145531|LBL|lbl
4975415|NCT04145531|Asparaginase|asparaginase
4975416|NCT04145531|Leukemia|leukemia
4975417|NCT04145531|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
4975418|NCT04145518|pain|pain
4975419|NCT04145518|NSAID|nsaid
4975420|NCT04145518|women's health|women's health
4975421|NCT04145518|uterus|uterus
4975422|NCT04145518|MRI|mri
4975423|NCT04145505|SENTINEL NODE|sentinel node
4975424|NCT04145492|Hemodialysis and Vitamin K2|hemodialysis and vitamin k2
4975425|NCT04145479|gestational diabetes|gestational diabetes
4975426|NCT04145479|pregnancy|pregnancy
4975427|NCT04145479|exercise|exercise
4975428|NCT04145453|TAS2R38 Polymorphism|tas2r38 polymorphism
4975429|NCT04145453|bitter|bitter
4975430|NCT04145453|taste|taste
4975431|NCT04145453|PAV|pav
4975432|NCT04145453|AVI|avi
4975433|NCT04145453|vegetables|vegetables
4975434|NCT04145427|Liver Transplant, Low Carbohydrate Diet|liver transplant, low carbohydrate diet
4975435|NCT04145414|CSF|csf
4975436|NCT04145414|PC-MRI|pc-mri
4975437|NCT04145414|interventricular foramina|interventricular foramina
4975438|NCT04145401|Osteoarthritis|osteoarthritis
4975439|NCT04145401|traumatic arthritis|traumatic arthritis
4975440|NCT04145401|avascular necrosis|avascular necrosis
4975441|NCT04145401|rheumatoid arthritis|rheumatoid arthritis
4975442|NCT04145401|correction of functional deformity|correction of functional deformity
4975443|NCT04145401|revision procedures|revision procedures
4975444|NCT04145388|cancer|cancer
4975445|NCT04145388|family characteristics|family characteristics
4975446|NCT04145388|genetic predisposition|genetic predisposition
4975447|NCT04145388|primary care|primary care
4975448|NCT04145375|Zenith|zenith
4975464|NCT04145258|Tuberculous Meningitis|tuberculous meningitis
4975465|NCT04145258|Intensified treatment|intensified treatment
4975466|NCT04145258|High dose Rifampicin|high dose rifampicin
4975467|NCT04145258|Linezolid|linezolid
4975468|NCT04145258|Aspirin|aspirin
4975469|NCT04145258|Subsaharan Africa|subsaharan africa
4975470|NCT04145245|DPN, Levocarnitine|dpn, levocarnitine
4975471|NCT04145232|Cancer|cancer
4975472|NCT04145232|Non Small Cell Lung Cancer|non small cell lung cancer
4975473|NCT04145232|Neoepitopes|neoepitopes
4975474|NCT04145232|Neoantigens|neoantigens
4975475|NCT04145232|Immunotherapy|immunotherapy
4975476|NCT04145232|Nivolumab|nivolumab
4975477|NCT04145232|Ipilimumab|ipilimumab
4975478|NCT04145232|Atezolizumab|atezolizumab
4975479|NCT04145232|Neoantigen cancer vaccine|neoantigen cancer vaccine
4975480|NCT04145232|Personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
4975481|NCT04145232|FFPE|ffpe
4975482|NCT04145232|PBMC|pbmc
4975483|NCT04145232|Stool|stool
4975484|NCT04145232|Immuno-Oncology|immuno-oncology
4975485|NCT04145232|Next generation sequencing (NGS)|next generation sequencing (ngs)
4975486|NCT04145219|Allergic rhinitis|allergic rhinitis
4975487|NCT04145219|HDM|hdm
4975488|NCT04145219|pediatric|pediatric
4975489|NCT04145206|ankle|ankle
4975490|NCT04145206|dance|dance
4975491|NCT04145193|Microsatellite stable|microsatellite stable
4975492|NCT04145193|Colon Cancer|colon cancer
4975493|NCT04145193|colorectal cancer|colorectal cancer
4975494|NCT04145193|MSS-CRC|mss-crc
4975495|NCT04145193|adjuvant|adjuvant
4975496|NCT04145180|Pain|pain
4975497|NCT04145180|Function|function
4975502|NCT04145167|ischemic heart disease|ischemic heart disease
4975503|NCT04145154|Platelet|platelet
4975504|NCT04145154|Diabetic foot|diabetic foot
4975509|NCT04145128|Pharmacokinetic study|pharmacokinetic study
4975510|NCT04145128|AG-881|ag-881
4975511|NCT04145102|remineralization|remineralization
4975512|NCT04145102|carious dentin|carious dentin
4975513|NCT04145102|natural products|natural products
4975514|NCT04145102|antibacterial effect|antibacterial effect
4975515|NCT04145076|citalopram|citalopram
4975516|NCT04145076|tianeptine|tianeptine
4975517|NCT04145076|pharmacological imaging|pharmacological imaging
4975524|NCT04144985|Discomfort|discomfort
4975525|NCT04144985|Visual Analog Scale|visual analog scale
4975526|NCT04144985|Speculum|speculum
4975527|NCT04144985|Eyelid retraction|eyelid retraction
5300487|NCT02174900|safety|safety
4975528|NCT04144985|Cotton tipped applicator|cotton tipped applicator
4975529|NCT04144985|Eyelid Speculum|eyelid speculum
4975530|NCT04144985|Unimanual eyelid retraction|unimanual eyelid retraction
4975531|NCT04144972|Chronic Pain|chronic pain
4975532|NCT04144933|Opioid-free|opioid-free
4975533|NCT04144933|Opioid-sparing|opioid-sparing
4975534|NCT04144920|Interrupting sitting|interrupting sitting
4975535|NCT04144920|Continuous glucose monitroing|continuous glucose monitroing
4975536|NCT04144920|Pattern of sitting breaks|pattern of sitting breaks
4975537|NCT04144868|Cerebral Hemorrhage|cerebral hemorrhage
4975538|NCT04144868|Normobaric oxygen therapy|normobaric oxygen therapy
4975539|NCT04144868|Mask oxygen|mask oxygen
4975540|NCT04144868|edema|edema
4975541|NCT04144777|Smokers|smokers
4975542|NCT04144777|Prediabetes|prediabetes
4975543|NCT04144777|Cognitive Health|cognitive health
4975544|NCT04144764|upper trapezius|upper trapezius
4975545|NCT04144764|muscle stiffness|muscle stiffness
4975550|NCT04144699|wheeze|wheeze
4975551|NCT04144699|rhonchus|rhonchus
4975556|NCT04144686|dizziness|dizziness
4975557|NCT04144673|Immune Support|immune support
4975558|NCT04144673|Active lifestyle|active lifestyle
4975559|NCT04144673|Silver|silver
4975560|NCT04144673|Healthy Adults|healthy adults
4975561|NCT04144673|Cold|cold
4975562|NCT04144673|WURSS|wurss
4975563|NCT04144647|dual-tasking|dual-tasking
4975564|NCT04144647|CANTAB|cantab
4975565|NCT04144647|Gait|gait
4975566|NCT04144647|Cognition|cognition
4975567|NCT04144647|Sleep|sleep
4975568|NCT04144647|activity|activity
4975569|NCT04144621|Sperm DNA fragmentation|sperm dna fragmentation
4975570|NCT04144621|Implantation rate|implantation rate
4975571|NCT04144621|Pregnancy rate|pregnancy rate
4975572|NCT04144621|Blastocyst grading|blastocyst grading
4975573|NCT04144608|Toripalimab NSCLC|toripalimab nsclc
4975574|NCT04144595|Glucose Tolerance Test|glucose tolerance test
4975575|NCT04144595|Low Birth Weight|low birth weight
4975579|NCT04144517|Alkermes|alkermes
4975580|NCT04144517|IL-2|il-2
4975581|NCT04144517|Interleukin-2|interleukin-2
4975582|NCT04144517|Oncology|oncology
4975583|NCT04144517|Immuno-oncology|immuno-oncology
4975584|NCT04144517|Cytokine Immunotherapy|cytokine immunotherapy
4975585|NCT04144517|ALKS 4230|alks 4230
4975586|NCT04144517|Pembrolizumab|pembrolizumab
4975587|NCT04144517|Keytruda|keytruda
4975588|NCT04144517|PD-L1|pd-l1
4975589|NCT04144517|Solid Tumors|solid tumors
4975590|NCT04144491|Lactobacillus rhamnosus yoba 2012|lactobacillus rhamnosus yoba 2012
4975591|NCT04144491|Children|children
4975592|NCT04144478|Epilepsy|epilepsy
4975593|NCT04144478|Web based education|web based education
4975594|NCT04144478|Pediatric Nursing|pediatric nursing
4975595|NCT04144478|Parent|parent
4975596|NCT04144478|Adolescence|adolescence
4975597|NCT04144452|Back Pain|back pain
4975598|NCT04144452|Exercise Therapy|exercise therapy
4975599|NCT04144452|Functionality|functionality
4975600|NCT04144452|Microdiscectomy|microdiscectomy
4975601|NCT04144452|Patient Education|patient education
4975603|NCT04144361|post sleeve gastrectomy leak|post sleeve gastrectomy leak
4975604|NCT04144361|post sleeve gastrectomy|post sleeve gastrectomy
4975605|NCT04144348|ModernaTX|modernatx
4975606|NCT04144348|mRNA-1653|mrna-1653
5701153|NCT00498186|Rotigotine|rotigotine
4975607|NCT04144348|human metapneumovirus|human metapneumovirus
4975608|NCT04144348|human parainfluenza|human parainfluenza
4975609|NCT04144348|human parainfluenza vaccine|human parainfluenza vaccine
4975610|NCT04144348|virus diseases|virus diseases
4975611|NCT04144348|RNA virus infections|rna virus infections
4975612|NCT04144348|paramyxoviridae infections|paramyxoviridae infections
4975613|NCT04144348|mononegavirales infections|mononegavirales infections
4975614|NCT04144309|Acupuncture|acupuncture
4975615|NCT04144309|Insomnia|insomnia
4975616|NCT04144309|Breast cancer|breast cancer
4975617|NCT04144309|Chemotherapy|chemotherapy
4975625|NCT04144283|Targeted Memory Reactivation|targeted memory reactivation
4975626|NCT04144270|Urinary Bladder Neoplasm|urinary bladder neoplasm
4975627|NCT04144270|Urothelium Neoplasm|urothelium neoplasm
4975628|NCT04144270|Oncology|oncology
4975629|NCT04144270|Muscle function|muscle function
4975630|NCT04144270|Sarcopenia|sarcopenia
4975631|NCT04144244|microfluid chip|microfluid chip
4975632|NCT04144244|gradient-density|gradient-density
4975633|NCT04144244|intrauterine insemination|intrauterine insemination
4975634|NCT04144166|capillary refill time|capillary refill time
4975635|NCT04144166|peripheral perfusion|peripheral perfusion
4975636|NCT04144140|Advanced Solid Tumors|advanced solid tumors
4975638|NCT04144140|Intratumoral Injection|intratumoral injection
4975639|NCT04144140|Stimulator of Interferon Genes Agonist|stimulator of interferon genes agonist
4975640|NCT04144140|Interferons|interferons
4975641|NCT04144140|Antineoplastic Agents|antineoplastic agents
4975642|NCT04144140|Lymphoma|lymphoma
4975643|NCT04144140|Melanoma|melanoma
4975644|NCT04144140|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
4975645|NCT04144140|Breast Cancer|breast cancer
4975646|NCT04144140|Colorectal Cancer|colorectal cancer
4975647|NCT04144114|Amino Acids|amino acids
4975648|NCT04144114|Intramuscular Anabolic Signaling|intramuscular anabolic signaling
4975649|NCT04144114|Endocrine Response|endocrine response
4975650|NCT04144114|Resistance Training|resistance training
4975651|NCT04144101|etoricoxib aceclofenac efficacy safety Taiwanese|etoricoxib aceclofenac efficacy safety taiwanese
4975652|NCT04144075|Psychosis|psychosis
4975653|NCT04144075|Quality of life|quality of life
4975654|NCT04144075|Mindfulness|mindfulness
4975665|NCT04143932|multiple myeloma|multiple myeloma
4975667|NCT04143932|Registry|registry
4975668|NCT04143932|Turkey|turkey
4975669|NCT04143919|Heart failure|heart failure
4975670|NCT04143919|Cardiovascular risk factors|cardiovascular risk factors
4975671|NCT04143919|NT-proBNP|nt-probnp
4975672|NCT04143919|NYHA assessment|nyha assessment
4975673|NCT04143906|MBC, Vinorelbine, Carboplatin, Gemcitabine, PFS|mbc, vinorelbine, carboplatin, gemcitabine, pfs
4975674|NCT04143893|Cardiogenic shock|cardiogenic shock
4975675|NCT04143893|Mechanical Circulatory Support|mechanical circulatory support
4975676|NCT04143828|Infertility|infertility
4975677|NCT04143828|Mobile Health|mobile health
4975678|NCT04143828|Mindfulness|mindfulness
4975679|NCT04143776|hernia|hernia
4975680|NCT04143776|abdominal reconstruction|abdominal reconstruction
4975681|NCT04143776|intraabdominal pressure|intraabdominal pressure
4975682|NCT04143776|acute kidney injury|acute kidney injury
4975683|NCT04143776|restrictive lung disease|restrictive lung disease
4975684|NCT04143737|Community-based intervention|community-based intervention
4975685|NCT04143737|Arab women|arab women
4975686|NCT04143737|East jerusalem|east jerusalem
4975687|NCT04143737|Diabetes prevention|diabetes prevention
4975688|NCT04143737|Lifestyle intervention|lifestyle intervention
4975689|NCT04143737|Quasi-Experiment|quasi-experiment
4975690|NCT04143724|ACE-536|ace-536
4975691|NCT04143724|Luspatercept|luspatercept
4975692|NCT04143724|Pharmacokinetics|pharmacokinetics
4975693|NCT04143724|Beta-Thalassemia|beta-thalassemia
4975694|NCT04143724|Red Blood Cell Transfusion|red blood cell transfusion
4975695|NCT04143711|HER-2|her-2
4975696|NCT04143711|NK Cell|nk cell
4975697|NCT04143711|Immunotherapy|immunotherapy
4975698|NCT04143711|Metastatic Breast Cancer|metastatic breast cancer
4975699|NCT04143711|Urothelial Bladder Cancer|urothelial bladder cancer
4975700|NCT04143698|duodenoscopes; ERCP|duodenoscopes; ercp
4975701|NCT04143685|PROM|prom
4975702|NCT04143672|postoperative pain|postoperative pain
4975703|NCT04143672|pain sensitivity|pain sensitivity
4975704|NCT04143633|Irritable Bowel Syndrome|irritable bowel syndrome
4975705|NCT04143633|Ulcerative Colitis|ulcerative colitis
4975706|NCT04143633|Low FODMAP diet|low fodmap diet
4975719|NCT04143529|Musculoskeletal malignancy|musculoskeletal malignancy
4975720|NCT04143516|Optimizing Thermal Ablation|optimizing thermal ablation
4975721|NCT04143516|Rapid Tissue Analysis|rapid tissue analysis
4975722|NCT04143516|Metabolic Imaging Biomarker Validation|metabolic imaging biomarker validation
4975723|NCT04143516|Predictive Genetic Signatures|predictive genetic signatures
4975724|NCT04143516|19-332|19-332
4975730|NCT04143490|Ulcerative Colitis|ulcerative colitis
4975731|NCT04143490|Inflammatory Bowel Disease|inflammatory bowel disease
4975732|NCT04143490|Exercise|exercise
4975733|NCT04143490|Gastric emptying rate|gastric emptying rate
4975745|NCT04143425|Recurrent Glioblastoma; Bevacizumab; Imaging|recurrent glioblastoma; bevacizumab; imaging
4975746|NCT04143412|microalbuminuria|microalbuminuria
4975747|NCT04143412|Diabetic nephropathy|diabetic nephropathy
4975748|NCT04143412|Hperkalemia|hperkalemia
4975749|NCT04143412|Eplerenone|eplerenone
4975750|NCT04143412|Ramipril|ramipril
4975751|NCT04143399|BPH|bph
4975752|NCT04143399|enucleation|enucleation
4975753|NCT04143399|Large Prostate|large prostate
4975770|NCT04143347|Blunt|blunt
4975771|NCT04143334|blindness|blindness
4975772|NCT04143334|cataract blindness|cataract blindness
4975773|NCT04143334|diagnostic accuracy|diagnostic accuracy
4975774|NCT04143321|diabetes mellitus-refractory angina-empagliflozine|diabetes mellitus-refractory angina-empagliflozine
4975780|NCT04143269|Vagal nerve stimulation|vagal nerve stimulation
4975781|NCT04143269|Diabetes type 2|diabetes type 2
4975782|NCT04143269|Gastrointestinal symptoms|gastrointestinal symptoms
4975783|NCT04143256|Electronic Nicotine Delivery|electronic nicotine delivery
4975784|NCT04143256|Combustible Cigarettes|combustible cigarettes
4975785|NCT04143256|Nicotine|nicotine
4975786|NCT04143256|Exhaled Breath|exhaled breath
4975795|NCT04143230|palliative care|palliative care
4975796|NCT04143230|palliative care team|palliative care team
4975797|NCT04143230|palliative care unit|palliative care unit
4975798|NCT04143230|screening tool|screening tool
4975799|NCT04143230|end of life|end of life
4975800|NCT04143230|unplanned hospital admission|unplanned hospital admission
4975801|NCT04143230|end-stage disease|end-stage disease
4975803|NCT04143230|survival|survival
4975804|NCT04143230|prognostic score|prognostic score
4975805|NCT04143230|palliative sedation|palliative sedation
4975806|NCT04143178|Expressive writing|expressive writing
4975807|NCT04143178|Kidney transplant|kidney transplant
4975808|NCT04143178|Adherence|adherence
4975809|NCT04143178|Alexithymia|alexithymia
4975810|NCT04143178|Healthcare spending|healthcare spending
4975811|NCT04143139|Bone mineral density|bone mineral density
4975812|NCT04143139|Ileostomists|ileostomists
4975813|NCT04143139|Vitamin D|vitamin d
4975814|NCT04143139|Observational study|observational study
4975816|NCT04143139|Phytochemical|phytochemical
4975817|NCT04143126|Negative Symptoms|negative symptoms
4975818|NCT04143126|Cognition|cognition
4975819|NCT04143126|Social Cognition|social cognition
4975820|NCT04143113|stroke|stroke
4975821|NCT04143113|hemorrhagic stroke|hemorrhagic stroke
4975822|NCT04143113|shared decision making|shared decision making
4975823|NCT04143113|neurocritical care|neurocritical care
4975824|NCT04143113|decision aid|decision aid
4975825|NCT04143113|goals of care|goals of care
4975826|NCT04143113|palliative care|palliative care
4975827|NCT04143113|family communication|family communication
4975828|NCT04143113|end of life|end of life
4975829|NCT04143113|critical care|critical care
4975830|NCT04143113|neuroICU|neuroicu
4975831|NCT04143113|patient-centered care|patient-centered care
4975832|NCT04143022|acupuncture press needle|acupuncture press needle
4975833|NCT04143022|obstructive sleep apnea|obstructive sleep apnea
4975834|NCT04143022|polysomnography|polysomnography
4975850|NCT04142879|Large Vessel Occlusion|large vessel occlusion
4975851|NCT04142866|aphasia|aphasia
4975852|NCT04142866|stroke|stroke
4975853|NCT04142866|tDCS|tdcs
4975854|NCT04142866|language|language
4975855|NCT04142866|stimulation|stimulation
4975856|NCT04142866|brain|brain
4975879|NCT04142723|alcoholic, liver disease, cirrhosis|alcoholic, liver disease, cirrhosis
4975880|NCT04142710|telemedicine|telemedicine
4975881|NCT04142710|telehealth|telehealth
4975882|NCT04142710|randomized control trial|randomized control trial
4975883|NCT04142710|chronic disease|chronic disease
4975884|NCT04142710|health services research|health services research
4975885|NCT04142710|primary health care|primary health care
4975886|NCT04142710|primary care nursing|primary care nursing
4975887|NCT04142684|Unilateral Diaphragmatic Paralysis|unilateral diaphragmatic paralysis
4975888|NCT04142684|Diagnose|diagnose
4975899|NCT04142593|Risk Factors Assessment|risk factors assessment
4975901|NCT04142580|chronic lumbago|chronic lumbago
4975902|NCT04142580|degenerative|degenerative
4975903|NCT04142580|Modic 1|modic 1
4975904|NCT04142567|Drug drug interactions|drug drug interactions
4975905|NCT04142567|Pharmacist interventions|pharmacist interventions
4975906|NCT04142567|Cancer patients|cancer patients
4975907|NCT04142567|Out patient setting|out patient setting
4975908|NCT04142554|breast|breast
4975909|NCT04142554|triple negative|triple negative
4975910|NCT04142554|HER2-positive|her2-positive
4975911|NCT04142554|parsaclisib|parsaclisib
4975912|NCT04142502|spinal anesthesia|spinal anesthesia
4975913|NCT04142502|autonomic nervous system|autonomic nervous system
4975914|NCT04142502|dexmedetomidine|dexmedetomidine
4975915|NCT04142502|propofol|propofol
4975916|NCT04142476|Hormonotherpy|hormonotherpy
4975917|NCT04142476|Compliance|compliance
4975918|NCT04142463|Oral anticancer drugs|oral anticancer drugs
4975919|NCT04142463|Self-management|self-management
4975920|NCT04142463|Care pathway|care pathway
4975921|NCT04142463|Before-after study|before-after study
4975922|NCT04142463|Self-management support|self-management support
4975923|NCT04142424|Single-ascending-dose (SAD)|single-ascending-dose (sad)
4975924|NCT04142424|First-in-human (FiH)|first-in-human (fih)
4975925|NCT04142372|leukemia|leukemia
4975926|NCT04142372|lymphoma|lymphoma
4975927|NCT04142372|biomarker|biomarker
4975928|NCT04142372|prognosis|prognosis
4975929|NCT04142372|myeloma|myeloma
5015765|NCT03898791|kinase|kinase
4975930|NCT04142372|myelodysplasia|myelodysplasia
4975931|NCT04142372|myeloproliferative disorder|myeloproliferative disorder
4975932|NCT04142372|diagnostics|diagnostics
4975933|NCT04142372|tissue microarray|tissue microarray
4975934|NCT04142372|proteomics|proteomics
4975935|NCT04142372|genomics|genomics
4975936|NCT04142372|clinical outcome|clinical outcome
4975937|NCT04142372|biobanking|biobanking
4993545|NCT04034238|Immunotoxin|immunotoxin
4975948|NCT04142346|sitting time|sitting time
4975949|NCT04142346|physical inactivity|physical inactivity
4975950|NCT04142346|breaks|breaks
4975951|NCT04142346|glycemic control|glycemic control
4975952|NCT04142346|continuous glucose monitoring|continuous glucose monitoring
4975953|NCT04142346|older adults|older adults
4975954|NCT04142333|genetic counseling|genetic counseling
4975956|NCT04142307|biofeedback|biofeedback
4975957|NCT04142307|vision rehabilitation|vision rehabilitation
4975958|NCT04142307|nystagmus|nystagmus
4975959|NCT04142307|paediatric|paediatric
4975960|NCT04142281|Energy Balance|energy balance
4975961|NCT04142281|Metabolism|metabolism
4975962|NCT04142268|Preelampsia|preelampsia
4975963|NCT04142268|Cardio-ankle vascular index (CAVI)|cardio-ankle vascular index (cavi)
4975964|NCT04142268|Aortic stiffness|aortic stiffness
4975965|NCT04142268|Blood pressure|blood pressure
4975966|NCT04142268|LDL-cholesterol|ldl-cholesterol
4975967|NCT04142229|type 1 diabetes|type 1 diabetes
4975968|NCT04142229|automated insulin delivery|automated insulin delivery
4975969|NCT04142229|artificial pancreas|artificial pancreas
4975970|NCT04142229|stress|stress
4975971|NCT04142216|Thirst|thirst
4975972|NCT04142216|Weight gain|weight gain
4975973|NCT04142203|23 h surgery|23 h surgery
4975974|NCT04142203|recovery|recovery
4975975|NCT04142203|outcome|outcome
4975976|NCT04142203|patient satisfaction|patient satisfaction
4975977|NCT04142190|follicle-stimulating hormone|follicle-stimulating hormone
4975978|NCT04142190|embryo morphokinetics|embryo morphokinetics
4975979|NCT04142190|reproductive medicine|reproductive medicine
4975980|NCT04142177|chronic low back pain|chronic low back pain
4975981|NCT04142177|severe low back pain|severe low back pain
4975982|NCT04142177|pain|pain
4975983|NCT04142177|non-pharmacological treatment|non-pharmacological treatment
4975984|NCT04142177|self-management|self-management
4980473|NCT04114799|ClearSight|clearsight
4975986|NCT04142177|exercise|exercise
4975987|NCT04142177|yoga|yoga
4975988|NCT04142177|cognitive behavioral therapy|cognitive behavioral therapy
4975989|NCT04142177|spinal manipulation therapy|spinal manipulation therapy
4975990|NCT04142164|Informed Consent Process|informed consent process
4975991|NCT04142151|Ischemic stroke, Sanchitongshu, Aspirin, Clopidogrel|ischemic stroke, sanchitongshu, aspirin, clopidogrel
4975992|NCT04142138|inpatient|inpatient
4975993|NCT04142138|nutrition|nutrition
4975994|NCT04142125|Pilot study|pilot study
4975995|NCT04142125|Rivaroxaban|rivaroxaban
4975996|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors
4975997|NCT04142125|Intracranial Atherosclerotic Disease|intracranial atherosclerotic disease
4975998|NCT04142099|early maternal and child skin contact, neonatal sucking|early maternal and child skin contact, neonatal sucking
4975999|NCT04142073|wireless vitals|wireless vitals
4976000|NCT04142073|vitals monitor|vitals monitor
4976001|NCT04142073|cardiac|cardiac
4976007|NCT04141969|Lyme|lyme
4976008|NCT04141943|Breast cancer|breast cancer
4976009|NCT04141943|radiotherapy|radiotherapy
4976010|NCT04141943|virtual reality|virtual reality
4976011|NCT04141930|influenza|influenza
4976013|NCT04141930|antiviral|antiviral
4976014|NCT04141930|baloxavir|baloxavir
4976015|NCT04141930|Xofluza|xofluza
4976016|NCT04141930|rapid delivery|rapid delivery
4976017|NCT04141930|self-test|self-test
4976018|NCT04141917|Tamiflu|tamiflu
4976019|NCT04141917|Oseltamivir|oseltamivir
4976020|NCT04141917|Baloxavir|baloxavir
4976021|NCT04141917|Influenza|influenza
4976023|NCT04141917|Rapid Test|rapid test
4976024|NCT04141917|Xofluza|xofluza
4976025|NCT04141904|Depression|depression
4976026|NCT04141878|Diabetes|diabetes
4976027|NCT04141878|Dementia|dementia
4976028|NCT04141878|Prevention|prevention
4976029|NCT04141852|artero-venous fistula|artero-venous fistula
4976030|NCT04141852|non-Contrast Enhanced MRI|non-contrast enhanced mri
4976031|NCT04141852|hemodynamics|hemodynamics
4976032|NCT04141852|CFD simulations|cfd simulations
4976033|NCT04141852|VasQ|vasq
4976034|NCT04141813|mindfulness|mindfulness
4976035|NCT04141813|mental health|mental health
4976036|NCT04141813|well-being|well-being
4976037|NCT04141813|peregrination|peregrination
4976038|NCT04141813|walking|walking
4976048|NCT04141787|Deep-seated Infections|deep-seated infections
4976049|NCT04141787|Staphylococcus aureus|staphylococcus aureus
4976050|NCT04141787|Coagulase-negative Staphylococcus species|coagulase-negative staphylococcus species
4976051|NCT04141787|MSSA|mssa
4976052|NCT04141787|CoNS|cons
4976053|NCT04141774|aneurysm|aneurysm
4976054|NCT04141774|transient ischemic attack|transient ischemic attack
4976055|NCT04141761|Newly diagnosed|newly diagnosed
4973029|NCT04160611|IVF|ivf
4976074|NCT04141683|heart failure|heart failure
4976075|NCT04141683|right heart|right heart
4976076|NCT04141683|stress echocardiography|stress echocardiography
4976077|NCT04141683|tricuspid repair|tricuspid repair
4976078|NCT04141683|tricuspid replacement|tricuspid replacement
4976086|NCT04141631|Perioperative Erythropoietin|perioperative erythropoietin
4976087|NCT04141631|Perioperative Iron|perioperative iron
4976088|NCT04141631|ScVO2|scvo2
4976089|NCT04141631|Patient blood Management|patient blood management
5019038|NCT03877679|IL-33|il-33
4976090|NCT04141631|Blood Transfusion|blood transfusion
4976091|NCT04141618|recurrent miscarriage|recurrent miscarriage
4976092|NCT04141618|infertility|infertility
4976098|NCT04141540|22q11.2 Microdeletional|22q11.2 microdeletional
4976099|NCT04141527|Labor|labor
4976100|NCT04141527|Intrathecal sufentanil|intrathecal sufentanil
4976101|NCT04141527|Obstetrical|obstetrical
4976102|NCT04141527|Spinal analgesia|spinal analgesia
4976103|NCT04141501|Alcoholism|alcoholism
4976104|NCT04141501|Psilocybin|psilocybin
4976105|NCT04141501|Psychedelics|psychedelics
4976106|NCT04141501|clinical efficacy|clinical efficacy
4976107|NCT04141501|autobiographical memory|autobiographical memory
4976108|NCT04141501|cue-reactivity exposure|cue-reactivity exposure
4976109|NCT04141501|placebo-controlled|placebo-controlled
4976110|NCT04141501|proof-of-concept|proof-of-concept
4976111|NCT04141488|Lateral Epicondylitis|lateral epicondylitis
4976112|NCT04141488|electromyography|electromyography
4976113|NCT04141488|pain|pain
4976114|NCT04141488|scapula|scapula
4976115|NCT04141462|genetic mutations|genetic mutations
4976116|NCT04141462|early sporadic or familial cancer|early sporadic or familial cancer
4976117|NCT04141462|gene panel|gene panel
4976118|NCT04141462|exome analysis|exome analysis
4976119|NCT04141462|high-throughput exome sequencing|high-throughput exome sequencing
4976120|NCT04141436|Hypnofertility|hypnofertility
4976121|NCT04141436|fertility preparedness|fertility preparedness
4976122|NCT04141436|cortisol level|cortisol level
4976123|NCT04141436|pregnancy outcome|pregnancy outcome
4976124|NCT04141423|Oral Insulin|oral insulin
4976125|NCT04141410|Sepsis|sepsis
4976126|NCT04141410|Septic Shock|septic shock
4976127|NCT04141410|Cardiogenic Shock|cardiogenic shock
4976128|NCT04141410|Speckle Tracking Echocardiography|speckle tracking echocardiography
4980574|NCT04114292|tudca|tudca
4976134|NCT04141397|matching|matching
4976135|NCT04141397|clinical effectiveness|clinical effectiveness
5296523|NCT02194101|goal-directed therapy|goal-directed therapy
4976136|NCT04141384|Modular Interactive Tiles System, MITS|modular interactive tiles system, mits
4976137|NCT04141384|Stroke|stroke
4976138|NCT04141358|Vascular Access|vascular access
4976139|NCT04141358|Endothelial Dysfunction|endothelial dysfunction
4976140|NCT04141358|Vascular Stiffness|vascular stiffness
4976141|NCT04141358|Arteriovenous Fistula|arteriovenous fistula
4976142|NCT04141306|Radioiodine Bone Metastases|radioiodine bone metastases
4976143|NCT04141306|Thyroid Cancer|thyroid cancer
4976144|NCT04141280|Insomnia|insomnia
4976145|NCT04141280|Syndrome|syndrome
4976146|NCT04141280|Material basis|material basis
4976147|NCT04141280|Infrared image|infrared image
4976148|NCT04141280|Relativity|relativity
4976149|NCT04141254|Anticoagulant|anticoagulant
4976150|NCT04141254|Direct oral anticoagulant|direct oral anticoagulant
4976151|NCT04141254|Debriefing|debriefing
4976152|NCT04141254|Recurrent venous thromboembolism|recurrent venous thromboembolism
4976153|NCT04141254|anticoagulant-related bleeding|anticoagulant-related bleeding
4976160|NCT04141189|fetal growth|fetal growth
4976161|NCT04141176|Continuous positive airway pressure|continuous positive airway pressure
4976163|NCT04141150|MDAD|mdad
4976164|NCT04141150|HV|hv
4976165|NCT04141137|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
4976166|NCT04141137|Heart Valve Diseases|heart valve diseases
4976167|NCT04141137|Heart Diseases|heart diseases
4976168|NCT04141137|Cardiovascular Diseases|cardiovascular diseases
4976172|NCT04141111|continuous glucose monitoring|continuous glucose monitoring
4976173|NCT04141098|Degenerative Disc Disease|degenerative disc disease
4976174|NCT04141098|DDD|ddd
4976175|NCT04141098|Chronic Low-back Pain|chronic low-back pain
4976176|NCT04141098|Disc Herniation|disc herniation
4976177|NCT04141098|Nucleus Replacement|nucleus replacement
4976178|NCT04141098|Low back pain|low back pain
4976179|NCT04141072|CKD|ckd
4976180|NCT04141072|Creatinine|creatinine
4976181|NCT04141072|Cystatin C|cystatin c
4976182|NCT04141072|Cardiac surgery|cardiac surgery
4976183|NCT04141072|GFR|gfr
4976184|NCT04141059|Photoaging|photoaging
4976185|NCT04141059|Polyphenols|polyphenols
4976186|NCT04141059|Natural extracts|natural extracts
4976187|NCT04141059|Collagen metabolism|collagen metabolism
4976188|NCT04141046|Systemic lupus erythematosus|systemic lupus erythematosus
4976189|NCT04141046|Lupus|lupus
4976190|NCT04141046|SLE|sle
4976191|NCT04141046|Depression|depression
4976192|NCT04141046|Pain|pain
4976193|NCT04141046|Brain fog|brain fog
4976194|NCT04141046|Mood|mood
4976195|NCT04141033|Periodontitis|periodontitis
4976196|NCT04141033|Neopterin|neopterin
4976197|NCT04141033|Menopausal women|menopausal women
4976198|NCT04141033|Non-surgical periodontal therapy|non-surgical periodontal therapy
5903454|NCT00368446|Nontuberculous Mycobacterial Infection|nontuberculous mycobacterial infection
4976199|NCT04140968|Resting energy expenditure|resting energy expenditure
4976200|NCT04140955|Opioid tapering|opioid tapering
4976201|NCT04140955|Withdrawal symptoms|withdrawal symptoms
4976202|NCT04140955|Spine surgery|spine surgery
4976203|NCT04140955|Patient satisfaction|patient satisfaction
4976208|NCT04140903|Oral antibiotics|oral antibiotics
4976209|NCT04140890|prefrail|prefrail
4976210|NCT04140890|habit|habit
4976211|NCT04140890|exercise|exercise
4976212|NCT04140890|diet|diet
4976213|NCT04140877|Choroidal thickness|choroidal thickness
4976214|NCT04140877|Virtual reality|virtual reality
4976215|NCT04140864|Prevalence|prevalence
4976216|NCT04140864|Community Dwelling Elderly|community dwelling elderly
4976217|NCT04140864|Sarcopenia|sarcopenia
4976218|NCT04140864|Obesity|obesity
4976219|NCT04140851|Dietary Interventions|dietary interventions
4976220|NCT04140851|Intestinal Flora|intestinal flora
4976221|NCT04140851|Metabolism|metabolism
4976222|NCT04140812|Preterm|preterm
4976223|NCT04140812|Coagulation|coagulation
4976224|NCT04140812|LC-MS/MS|lc-ms/ms
4976225|NCT04140812|ICH|ich
4976226|NCT04140812|IVH|ivh
4976227|NCT04140812|Neonatal|neonatal
5394338|NCT01747174|STEMI|stemi
4976228|NCT04140786|Nonsense mutation|nonsense mutation
4976229|NCT04140734|Retraction Repair|retraction repair
4976230|NCT04140734|Hard Palate|hard palate
4976231|NCT04140734|Autologous Ear Cartilage|autologous ear cartilage
4976232|NCT04140734|porcine acellular dermal matrix|porcine acellular dermal matrix
4976233|NCT04140734|spacer graft|spacer graft
4976234|NCT04140721|postural tachycardia syndrome|postural tachycardia syndrome
4976235|NCT04140721|hyperadrenergic|hyperadrenergic
4976236|NCT04140721|moxonidine|moxonidine
4976237|NCT04140721|sympatholytic|sympatholytic
4976238|NCT04140721|orthostatic symptoms|orthostatic symptoms
4976248|NCT04140682|Prolonged mechanical ventilation|prolonged mechanical ventilation
4976254|NCT04140643|Pregnancy|pregnancy
4976255|NCT04140643|Oral Health|oral health
4976256|NCT04140643|Ozone therapy|ozone therapy
4976257|NCT04140643|Gingivitis|gingivitis
4976258|NCT04140630|vaping|vaping
4976263|NCT04140617|passive exposure|passive exposure
4976264|NCT04140617|e-cigarette|e-cigarette
4976265|NCT04140604|Probiotic|probiotic
4976266|NCT04140604|Lactobacillus salivarius AP-32|lactobacillus salivarius ap-32
4976267|NCT04140604|Bifidobacterium lactis CP-9|bifidobacterium lactis cp-9
4976268|NCT04140604|Safety|safety
4976269|NCT04140604|Healthy infant|healthy infant
4976270|NCT04140591|Portal hypertension|portal hypertension
4976271|NCT04140591|Peptic ulcer|peptic ulcer
4976272|NCT04140591|Non-selective beta-blocker|non-selective beta-blocker
4976273|NCT04140591|Proton pump inhibitor|proton pump inhibitor
4976274|NCT04140578|Gastric variceal rebleeding|gastric variceal rebleeding
4976275|NCT04140578|Sepsis|sepsis
4976276|NCT04140578|cyanoacrylate injection|cyanoacrylate injection
4976277|NCT04140565|Machine learning, deep neural networks, PET/CT|machine learning, deep neural networks, pet/ct
4976278|NCT04140552|gallbladder neoplasms|gallbladder neoplasms
4976285|NCT04140461|Amphotericin B|amphotericin b
4976286|NCT04140448|Ultra-wide field fundus fluorescein angiography|ultra-wide field fundus fluorescein angiography
4976287|NCT04140448|ischemic index|ischemic index
4976288|NCT04140448|vascular leakage index|vascular leakage index
4976289|NCT04140435|EUS-guided through the needle biopsy (EUS-guided TTNB)|eus-guided through the needle biopsy (eus-guided ttnb)
4976290|NCT04140435|Pancreatic cyst lesions (PCLs)|pancreatic cyst lesions (pcls)
4976294|NCT04140409|NET|net
4976295|NCT04140383|geriatry|geriatry
4976296|NCT04140383|cataract surgery|cataract surgery
4976297|NCT04140383|advanced age|advanced age
4976298|NCT04140344|Lumbar Fusion|lumbar fusion
4976299|NCT04140344|Text Message|text message
4976300|NCT04140331|Post-operative evolution|post-operative evolution
4976301|NCT04140331|Accelerometer|accelerometer
4976302|NCT04140331|Cardiac surgery|cardiac surgery
4976303|NCT04140331|Accelerometry|accelerometry
4976304|NCT04140331|Preoperative physical activity|preoperative physical activity
4976305|NCT04140318|second line|second line
4976306|NCT04140318|PD-1|pd-1
4976307|NCT04140318|nab-paclitaxel|nab-paclitaxel
4976311|NCT04140279|Eye Diseases|eye diseases
5702306|NCT00493909|thoracotomy|thoracotomy
4976312|NCT04140253|Stress urinary incontinence|stress urinary incontinence
4976313|NCT04140253|Pelvic floor muscle training|pelvic floor muscle training
4976314|NCT04140240|menopause management|menopause management
4976315|NCT04140240|progressive muscle relaxation|progressive muscle relaxation
4976317|NCT04140214|Respiratory|respiratory
4976318|NCT04140214|Mucoactive|mucoactive
4976319|NCT04140214|Exacerbation|exacerbation
4976320|NCT04140214|Hypertonic Saline|hypertonic saline
4976321|NCT04140214|Carbocisteine|carbocisteine
4976322|NCT04140214|Airway Clearance|airway clearance
4976323|NCT04140175|Endometriosis|endometriosis
4976324|NCT04140175|Chronic Pelvic Pain|chronic pelvic pain
4976325|NCT04140175|Dysmenorrhea|dysmenorrhea
4976326|NCT04140162|Dara-R|dara-r
4976327|NCT04140162|DaraRd|darard
4976328|NCT04140162|Dara-RVd|dara-rvd
4976329|NCT04140162|MRD|mrd
4976330|NCT04140149|Suicide|suicide
4976331|NCT04140149|Suicide Attempt|suicide attempt
4976332|NCT04140149|Suicidal Ideation|suicidal ideation
4976333|NCT04140149|Pilot|pilot
4976334|NCT04140149|Intervention|intervention
4976335|NCT04140136|ALS|als
4976336|NCT04140110|Acute ischemic stroke|acute ischemic stroke
4976337|NCT04140110|Large vessel occlusion|large vessel occlusion
4976338|NCT04140110|Mechanical thrombectomy|mechanical thrombectomy
4976339|NCT04140110|Blood pressure management|blood pressure management
4976340|NCT04140110|Antiplatelet therapy|antiplatelet therapy
4976341|NCT04140110|Anticoagulation therapy|anticoagulation therapy
4976342|NCT04140110|Randomised clinical trial|randomised clinical trial
4976343|NCT04140097|Predictor|predictor
4976344|NCT04140097|Development|development
4976345|NCT04140097|Pulmonary Rehabilitation|pulmonary rehabilitation
4976346|NCT04140084|Emergency Department|emergency department
4976347|NCT04140084|Mild Traumatic Brain Injury|mild traumatic brain injury
4976348|NCT04140084|Shared decision-making|shared decision-making
4976349|NCT04140084|Decision aids|decision aids
4976353|NCT04140071|Lifestyle habits|lifestyle habits
4976354|NCT04140071|Health|health
4976355|NCT04140071|Diet quality|diet quality
5301037|NCT02171195|BIA 2-093|bia 2-093
4976356|NCT04140058|Ondansetron|ondansetron
4976358|NCT04140058|nausea and vomiting|nausea and vomiting
4976359|NCT04140058|cesarean section|cesarean section
4976360|NCT04140032|obesity|obesity
4976361|NCT04140032|nutrition|nutrition
4976362|NCT04140032|physical activity|physical activity
4976363|NCT04140032|preschool|preschool
4976364|NCT04140032|child care centers|child care centers
4976365|NCT04140032|policy-system-environment intervention|policy-system-environment intervention
4976366|NCT04140019|NSTEMI|nstemi
4976367|NCT04140019|NSTE-ACS|nste-acs
4976368|NCT04140019|CMR|cmr
4976369|NCT04140019|Troponin T|troponin t
4976370|NCT04140019|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
4976371|NCT04139993|RBX7455|rbx7455
4976372|NCT04139993|adenocarcinoma|adenocarcinoma
4976373|NCT04139993|hormone receptor positive|hormone receptor positive
4976374|NCT04139993|HER2 positive|her2 positive
4976375|NCT04139993|triple negative|triple negative
4976376|NCT04139928|Magnesium|magnesium
4976377|NCT04139915|Mechanistic Target of Rapamycin (mTOR)|mechanistic target of rapamycin (mtor)
4976378|NCT04139915|Influenza|influenza
4976380|NCT04139915|Pneumonia|pneumonia
4976381|NCT04139915|Immunosenescence|immunosenescence
5296723|NCT02193347|Adult|adult
4976382|NCT04139915|Respiratory Tract Infections|respiratory tract infections
4976383|NCT04139889|Probe-based confocal laser endomicroscopy|probe-based confocal laser endomicroscopy
4976384|NCT04139889|Optical biopsy|optical biopsy
4976385|NCT04139876|Hemorrhoidectomy|hemorrhoidectomy
4976386|NCT04139876|Minimal Open hemorrhoidectomy|minimal open hemorrhoidectomy
4976387|NCT04139876|LigaSure hemorrhoidectomy|ligasure hemorrhoidectomy
4976388|NCT04139850|chronic hepatitis B|chronic hepatitis b
4976389|NCT04139850|cohort|cohort
4976390|NCT04139850|nationwide|nationwide
4976391|NCT04139850|prospective|prospective
4976392|NCT04139850|antiviral therapy|antiviral therapy
4976393|NCT04139811|Internal limiting membrane|internal limiting membrane
4976394|NCT04139811|multifocal electoretinogram (ERG)|multifocal electoretinogram (erg)
4976395|NCT04139811|OCT-Angiography|oct-angiography
4976396|NCT04139785|Depression|depression
4976397|NCT04139785|Anxiety|anxiety
4976398|NCT04139785|Prevention|prevention
4976399|NCT04139785|Public Mental Health|public mental health
4976400|NCT04139785|Primary Care|primary care
4976401|NCT04139772|metastatic castration-resistent prostate cancer|metastatic castration-resistent prostate cancer
4976402|NCT04139772|asymptomatic or oligosymptomatic|asymptomatic or oligosymptomatic
4976403|NCT04139772|hormone therapy|hormone therapy
4976404|NCT04139772|docetaxel|docetaxel
4976405|NCT04139759|Nursing|nursing
4976406|NCT04139759|Hemodialysis|hemodialysis
4976407|NCT04139759|Fatigue|fatigue
4976408|NCT04139759|Hand massage|hand massage
4976409|NCT04139759|Foot massage|foot massage
4976410|NCT04139733|Acute respiratory distress syndrome|acute respiratory distress syndrome
5342905|NCT01981551|Aggressive Fibromatosis|aggressive fibromatosis
4976411|NCT04139733|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
4976412|NCT04139733|Prone Position|prone position
4976413|NCT04139720|sexual harassment prevention|sexual harassment prevention
4976414|NCT04139720|nurse|nurse
4976415|NCT04139720|education|education
4976416|NCT04139720|e-book|e-book
4976417|NCT04139707|dementia|dementia
4976418|NCT04139707|care-giving|care-giving
4976419|NCT04139707|communication|communication
4976420|NCT04139707|mobile application|mobile application
4976421|NCT04139655|MINS|mins
4976422|NCT04139655|Colchicine|colchicine
4976423|NCT04139655|Myocardial Injury|myocardial injury
4976424|NCT04139655|Major Adverse Cardiac Events|major adverse cardiac events
4976425|NCT04139655|Myocardial Injury after Non-Cardiac Surgery|myocardial injury after non-cardiac surgery
4976426|NCT04139655|MACE|mace
4976427|NCT04139642|descriptive observational study|descriptive observational study
4976428|NCT04139642|balance measurement|balance measurement
4976429|NCT04139629|Antichlamydial antibodies|antichlamydial antibodies
4976430|NCT04139629|in vitro fertilization|in vitro fertilization
4976431|NCT04139629|ovarian stimulation|ovarian stimulation
4976432|NCT04139629|tubal factor infertility|tubal factor infertility
4976433|NCT04139616|atrioventricular block|atrioventricular block
4976434|NCT04139616|complete heart block|complete heart block
4976435|NCT04139616|high-degree atrioventricular block|high-degree atrioventricular block
4976436|NCT04139616|intraventricular conduction delay|intraventricular conduction delay
4976437|NCT04139616|left bundle branch block|left bundle branch block
4976438|NCT04139616|Permanent pacemaker implantation|permanent pacemaker implantation
4976439|NCT04139616|Right bundle branch block|right bundle branch block
4976440|NCT04139603|kinesio tape|kinesio tape
4976441|NCT04139603|pain|pain
4976442|NCT04139603|functional mobility|functional mobility
4976446|NCT04139603|timed up and go test|timed up and go test
4976447|NCT04139603|stair climb test|stair climb test
4976448|NCT04139590|postoperative pain|postoperative pain
4976449|NCT04139590|Visual Analogue Scale|visual analogue scale
4976450|NCT04139590|Numeric Rating Scale|numeric rating scale
4976451|NCT04139590|Smartphone|smartphone
5369124|NCT01861262|hemodynamic failure|hemodynamic failure
4976452|NCT04139577|Acute Graft-Versus-Host Disease (Gvhd) Grade|acute graft-versus-host disease (gvhd) grade
4976459|NCT04139499|sleep apnea|sleep apnea
4976460|NCT04139499|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
4976461|NCT04139499|Sleep manometry|sleep manometry
4976462|NCT04139486|Contact aspiration (CA)|contact aspiration (ca)
4976463|NCT04139486|Embotrap II|embotrap ii
4976464|NCT04139486|Susceptibility vessel sign (SVS)|susceptibility vessel sign (svs)
4976465|NCT04139486|Thrombus|thrombus
4976466|NCT04139460|Non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
4976467|NCT04139460|Heart failure|heart failure
4976468|NCT04139460|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
4976469|NCT04139460|Cardiac resynchronization therapy|cardiac resynchronization therapy
4976470|NCT04139460|Magnetic resonance imaging|magnetic resonance imaging
4976471|NCT04139460|Late gadolinium enhancement|late gadolinium enhancement
4976472|NCT04139447|Adrenal steroids|adrenal steroids
4976473|NCT04139447|mass spectroscopy|mass spectroscopy
4976474|NCT04139447|liquid chromatography|liquid chromatography
4976490|NCT04139382|Telephone|telephone
4976491|NCT04139382|Remote|remote
4976492|NCT04139369|INS gene|ins gene
4976493|NCT04139369|methylation|methylation
4976494|NCT04139369|next generation sequencing|next generation sequencing
4976495|NCT04139356|pulseoxymetry|pulseoxymetry
4976496|NCT04139356|capnography|capnography
4976497|NCT04139356|Dead space|dead space
4976498|NCT04139356|cardiac output|cardiac output
4976499|NCT04139356|lung recruitment|lung recruitment
4976500|NCT04139356|deep breaths|deep breaths
4976501|NCT04139343|nusinersen|nusinersen
4976502|NCT04139343|Spinraza|spinraza
4976503|NCT04139343|MUNE|mune
4976504|NCT04139343|CMAP|cmap
4976506|NCT04139291|breast cancer related lymphedema|breast cancer related lymphedema
4976507|NCT04139291|complex decongestive therapy|complex decongestive therapy
4976508|NCT04139291|ultrasound|ultrasound
4976509|NCT04139239|Disorders of consciousness|disorders of consciousness
4976510|NCT04139239|Coma Recovery Scale-revision|coma recovery scale-revision
4976511|NCT04139239|Diagnostic accuracy|diagnostic accuracy
4976512|NCT04139226|CC-11050|cc-11050
4976513|NCT04139226|Safety|safety
4976514|NCT04139226|Healthy Subjects|healthy subjects
4976515|NCT04139200|Physical activity|physical activity
4976516|NCT04139200|Tele coaching|tele coaching
4976517|NCT04139187|Adult|adult
4976518|NCT04139187|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
4976519|NCT04139187|Lower Extremity|lower extremity
4976520|NCT04139109|accidental falls|accidental falls
4976521|NCT04139109|activity restriction|activity restriction
4976522|NCT04139109|fear of falling|fear of falling
4976523|NCT04139109|participation restriction|participation restriction
4976524|NCT04139109|psychometrics|psychometrics
4976525|NCT04139083|Pelvic organ prolapse|pelvic organ prolapse
4976526|NCT04139083|Transvaginal mesh|transvaginal mesh
4976527|NCT04139083|Laparoscopic mesh suspension|laparoscopic mesh suspension
4976528|NCT04139070|Electrochemotherapy|electrochemotherapy
4976529|NCT04139070|Palliative treatment|palliative treatment
4976530|NCT04139044|ankle, joint instability, cross-education, rehabilitation|ankle, joint instability, cross-education, rehabilitation
4976531|NCT04139018|Epistaxis|epistaxis
4976532|NCT04138992|Bevacizumab|bevacizumab
4976533|NCT04138992|local advanced cervical cancer|local advanced cervical cancer
4976534|NCT04138992|concurrent chemoradiotherapy|concurrent chemoradiotherapy
4976535|NCT04138979|gut microbiota|gut microbiota
4976536|NCT04138979|16S rRNA gene|16s rrna gene
4976537|NCT04138979|breast cancer chemotherapy|breast cancer chemotherapy
4976538|NCT04138953|Electrophysiology|electrophysiology
4976539|NCT04138953|Magnetic Resonance imaging (MRI)|magnetic resonance imaging (mri)
4976540|NCT04138953|Neuroanatomy|neuroanatomy
4976541|NCT04138953|Neuroscience|neuroscience
4976542|NCT04138940|Stroke|stroke
4976543|NCT04138940|Speech and Language Therapy|speech and language therapy
4976544|NCT04138940|Speech and Language Treatment|speech and language treatment
4976545|NCT04138940|Communication Disorders|communication disorders
4976546|NCT04138940|Language Disorders|language disorders
4976547|NCT04138927|wAIHA|waiha
4976845|NCT04137198|sufentanil|sufentanil
4976556|NCT04138797|Signal Averaging ECG|signal averaging ecg
4976557|NCT04138797|HV interval|hv interval
4976558|NCT04138771|Conjunctival hyperemia|conjunctival hyperemia
4976559|NCT04138771|Pterygium|pterygium
4976560|NCT04138771|Intraocular lens dislocation|intraocular lens dislocation
4981009|NCT04111406|Epidural Analgesia|epidural analgesia
4976595|NCT04138563|Cerebrovascular physiology|cerebrovascular physiology
4976596|NCT04138563|Cardiovascular physiology|cardiovascular physiology
4976597|NCT04138563|Supine ergometric stepper|supine ergometric stepper
4976603|NCT04138537|Olfaction|olfaction
4976604|NCT04138537|Olfactory disorder|olfactory disorder
4976605|NCT04138524|Acquired Brain Injury|acquired brain injury
4976606|NCT04138524|Family|family
4976607|NCT04138524|Nursing interventions|nursing interventions
4976608|NCT04138524|Stroke|stroke
4976609|NCT04138524|Traumatic Brain Injury|traumatic brain injury
4976610|NCT04138524|Oncology|oncology
4976611|NCT04138524|caregivers|caregivers
4976612|NCT04138498|ADHD|adhd
4976613|NCT04138498|bioavailability|bioavailability
4976614|NCT04138498|dexmethylphenidate|dexmethylphenidate
4976615|NCT04138498|BA study|ba study
4976616|NCT04138498|dMPH|dmph
4976617|NCT04138498|d-MPH|d-mph
4976618|NCT04138472|Dexmedetomidine|dexmedetomidine
4976619|NCT04138472|Fentanyl|fentanyl
4976620|NCT04138472|Lignocaine|lignocaine
4976621|NCT04138472|Laryngoscopy|laryngoscopy
4976622|NCT04138472|Hemodynamic Response|hemodynamic response
4976623|NCT04138472|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4976624|NCT04138420|optical coherence tomography angiography|optical coherence tomography angiography
5296928|NCT02192398|Pain|pain
5296930|NCT02192398|Neck|neck
4976625|NCT04138420|optical coherence tomography angiography angiography|optical coherence tomography angiography angiography
4976626|NCT04138420|bevacizumab|bevacizumab
4976627|NCT04138420|vascular endothelial growth factor antagonists|vascular endothelial growth factor antagonists
4976628|NCT04138420|intravitreal injection|intravitreal injection
4976629|NCT04138381|GIST|gist
4976630|NCT04138381|MTD|mtd
4976631|NCT04138381|Imatinib|imatinib
4976632|NCT04138381|Selinexor|selinexor
4976633|NCT04138381|Phase II|phase ii
4976634|NCT04138381|Unresectable|unresectable
4976635|NCT04138381|Metastatic|metastatic
4976636|NCT04138316|headache disorders|headache disorders
4976639|NCT04138251|Empaglifozin|empaglifozin
4976640|NCT04138238|Supraflex Cruz|supraflex cruz
4976641|NCT04138238|Sirolimus-eluting Stent|sirolimus-eluting stent
4976642|NCT04138238|High Bleeding Risk|high bleeding risk
4976643|NCT04138238|Coronary Artery Disease|coronary artery disease
4976644|NCT04138238|Arteriosclerosis|arteriosclerosis
4976645|NCT04138238|Myocardial Ischemia|myocardial ischemia
4976651|NCT04138225|mycology|mycology
4976652|NCT04138225|gut|gut
4976653|NCT04138225|microbiota|microbiota
4976654|NCT04138225|gastrointestinal disorders|gastrointestinal disorders
4976655|NCT04138212|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4976656|NCT04138212|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4976657|NCT04138212|neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
4976658|NCT04138212|randomized controlled|randomized controlled
4976659|NCT04138212|survival|survival
4976665|NCT04138186|IBS|ibs
4976666|NCT04138186|Diarrhea|diarrhea
4976680|NCT04138108|Childhood illness|childhood illness
4976682|NCT04138108|Parents|parents
4976683|NCT04138108|Psychiatric Nursing|psychiatric nursing
4976684|NCT04138095|Palliative Care|palliative care
4976685|NCT04138095|Virtual Reality|virtual reality
4976686|NCT04138095|Pain|pain
4976687|NCT04138095|Anxiety|anxiety
4976688|NCT04138082|Situational Awareness|situational awareness
4976689|NCT04138082|Randomized-Control Trial|randomized-control trial
4976690|NCT04138082|Medical Simulation|medical simulation
4976691|NCT04138082|Patient Security|patient security
4976692|NCT04138069|COPD|copd
4976693|NCT04138069|Pursed Lips Breathing|pursed lips breathing
4976694|NCT04138069|Dyspnea|dyspnea
4976709|NCT04138004|polyethylene glycols|polyethylene glycols
4976710|NCT04138004|lubiprostone|lubiprostone
4976712|NCT04137965|Testicular Torsion|testicular torsion
4976713|NCT04137965|Testicular function|testicular function
4976714|NCT04137952|Posture training, Motor generalization, Aging, Cognition, High-density electroencephalography|posture training, motor generalization, aging, cognition, high-density electroencephalography
4976715|NCT04137913|mild cognitive impairment|mild cognitive impairment
4976716|NCT04137913|musical arts|musical arts
4976717|NCT04137913|whole brain network|whole brain network
4976718|NCT04137913|cognition|cognition
4976719|NCT04137913|aging|aging
4976720|NCT04137900|immunotherapy|immunotherapy
4976721|NCT04137900|BTLA|btla
4976722|NCT04137900|HVEM|hvem
4976723|NCT04137900|check point inhibitor|check point inhibitor
4976724|NCT04137900|solid tumor|solid tumor
4976725|NCT04137900|non-small cell lung cancer|non-small cell lung cancer
4976726|NCT04137900|NSCLC|nsclc
4976727|NCT04137900|melanoma|melanoma
4976728|NCT04137900|lymphoma|lymphoma
4976729|NCT04137900|monoclonal antibody|monoclonal antibody
4976730|NCT04137900|phase 1 trial|phase 1 trial
4976731|NCT04137835|osteoarthritis|osteoarthritis
4976732|NCT04137796|breastfeeding prevalence|breastfeeding prevalence
4976733|NCT04137796|infant nutrition|infant nutrition
4976734|NCT04137796|complimentary feeding|complimentary feeding
4976735|NCT04137783|respiratory distress syndrome|respiratory distress syndrome
4976736|NCT04137783|ABCA3 gene|abca3 gene
4976737|NCT04137783|exome sequencing|exome sequencing
4976738|NCT04137744|axillary reverse mapping|axillary reverse mapping
4976739|NCT04137744|arm lymphedema|arm lymphedema
4976740|NCT04137744|early breast cancer|early breast cancer
4976741|NCT04137718|Multicenter|multicenter
4976742|NCT04137718|Observational Study|observational study
4976743|NCT04137718|NSCLC|nsclc
4976744|NCT04137718|Rare Driver Gene|rare driver gene
4976745|NCT04137692|G1D|g1d
4976746|NCT04137692|Glucose transporter|glucose transporter
4976747|NCT04137666|Cancer Hospitalized Patients|cancer hospitalized patients
4976748|NCT04137666|Nutrition Disorders|nutrition disorders
4976749|NCT04137666|Scoring System|scoring system
4976750|NCT04137666|Nutrition Surveys|nutrition surveys
4976751|NCT04137666|Nutrition Assessment|nutrition assessment
4976752|NCT04137653|paclitaxel|paclitaxel
4976753|NCT04137653|albumin-bound paclitaxel|albumin-bound paclitaxel
4976754|NCT04137653|neoadjuvant therapy|neoadjuvant therapy
4976755|NCT04137640|adjuvant chemotherapy|adjuvant chemotherapy
4976756|NCT04137640|estrogen receptor|estrogen receptor
4976757|NCT04137640|palbociclib|palbociclib
4976758|NCT04137640|letrozole|letrozole
4976759|NCT04137627|Melatonin|melatonin
4976760|NCT04137627|Locally Advanced Oral Squamous Cell Carcinoma|locally advanced oral squamous cell carcinoma
4976761|NCT04137627|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4976762|NCT04137601|Congenital syphilis|congenital syphilis
4976763|NCT04137601|VDRL|vdrl
4976764|NCT04137601|CSF|csf
4976765|NCT04137601|Clinical manifestations|clinical manifestations
4976766|NCT04137575|Fear of Cancer Recurrence|fear of cancer recurrence
4976773|NCT04137562|AD|ad
4976774|NCT04137562|Inflammatory disease|inflammatory disease
4976775|NCT04137562|ADMC|admc
4976776|NCT04137562|Stem cell|stem cell
4976777|NCT04137562|ehlbio|ehlbio
4976778|NCT04137549|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
4976779|NCT04137549|nocturnal hypertension|nocturnal hypertension
4976780|NCT04137549|cardiovascular risk|cardiovascular risk
4976781|NCT04137536|EGFR-BAT|egfr-bat
4976782|NCT04137536|bispecific antibody-armed activated T cells|bispecific antibody-armed activated t cells
4976783|NCT04137536|Pancreatic cancer|pancreatic cancer
4976784|NCT04137536|memorial sloan kettering cancer center|memorial sloan kettering cancer center
4976785|NCT04137536|18-463|18-463
4976786|NCT04137523|potential marker|potential marker
4976787|NCT04137523|cytokine/adipokine|cytokine/adipokine
4976788|NCT04137523|multiple myeloma|multiple myeloma
4976789|NCT04137510|DAPT|dapt
4976790|NCT04137510|Dual antiplatelet therapy|dual antiplatelet therapy
4976791|NCT04137510|high bleeding risk|high bleeding risk
4976793|NCT04137510|Coronary artery disease|coronary artery disease
4976794|NCT04137510|Percutaneous coronary intervention|percutaneous coronary intervention
4976795|NCT04137510|PCI|pci
4976796|NCT04137497|disorders of consciousness|disorders of consciousness
4976797|NCT04137497|unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4976798|NCT04137497|minimally conscious state|minimally conscious state
4976799|NCT04137497|Nociception Coma Scale-Revised|nociception coma scale-revised
4976800|NCT04137484|Patient Blood Management Program|patient blood management program
4976801|NCT04137484|Transfusion|transfusion
4976802|NCT04137484|Postoperative anemia|postoperative anemia
4976803|NCT04137458|Psychiatry|psychiatry
4976804|NCT04137458|Blood Brain Barrie|blood brain barrie
4976805|NCT04137458|Suicide attempt|suicide attempt
4976806|NCT04137458|Inflammation|inflammation
4976807|NCT04137445|Complementary Feeding|complementary feeding
4976808|NCT04137432|loneliness|loneliness
4976809|NCT04137432|oxytocin-augmented intervention|oxytocin-augmented intervention
4976810|NCT04137432|fMRI|fmri
4976811|NCT04137419|Periodontitis|periodontitis
4976812|NCT04137419|Probiotic|probiotic
4976813|NCT04137419|Non-surgical therapy|non-surgical therapy
4976814|NCT04137406|Luminal A breast cancer|luminal a breast cancer
4976815|NCT04137406|Sirt 1|sirt 1
4976816|NCT04137406|lymph node metastasis|lymph node metastasis
4976817|NCT04137406|EMT|emt
4976818|NCT04137367|Rumination|rumination
4976819|NCT04137367|Attention bias modification|attention bias modification
4976820|NCT04137367|Transdiagnostic|transdiagnostic
4976821|NCT04137354|Intermittent Iron supplementation|intermittent iron supplementation
4976822|NCT04137354|Vitamin A|vitamin a
4976823|NCT04137354|Cognitive Development|cognitive development
4976824|NCT04137354|Anemia|anemia
4976825|NCT04137302|Hydrocortisone (cortisol)|hydrocortisone (cortisol)
4976826|NCT04137302|local administration of cortisol|local administration of cortisol
4976827|NCT04137302|systemic administration of cortisol|systemic administration of cortisol
4976828|NCT04137302|biomarkers|biomarkers
4976829|NCT04137276|sepsis|sepsis
4976830|NCT04137276|intravenous vitamin C|intravenous vitamin c
4976831|NCT04137276|SOFA score|sofa score
4976832|NCT04137250|ANTERIOR CRUCIATE LIGAMENT|anterior cruciate ligament
4976833|NCT04137250|INJURY|injury
4976834|NCT04137250|HAMSTRING|hamstring
4976835|NCT04137250|AUTOGRAFT|autograft
4976837|NCT04137237|Hand|hand
4976838|NCT04137237|Wrist|wrist
4976839|NCT04137237|Surgery|surgery
4976840|NCT04137224|scleroderma|scleroderma
4976841|NCT04137198|emergency|emergency
4976842|NCT04137198|pain|pain
4976843|NCT04137198|analgesia|analgesia
4976844|NCT04137198|intranasal|intranasal
4976853|NCT04137120|Macular edema secondary to branch retinal vein occlusion (BRVO)|macular edema secondary to branch retinal vein occlusion (brvo)
4976854|NCT04137120|Myopic choroidal neovascularization (mCNV)|myopic choroidal neovascularization (mcnv)
4976855|NCT04137120|Mexico|mexico
4976856|NCT04137081|Physicians|physicians
4976857|NCT04137068|Physical Activity|physical activity
4976858|NCT04137068|Sleep|sleep
4976859|NCT04137068|Sedentary|sedentary
4976860|NCT04137068|Cardiovascular|cardiovascular
4976861|NCT04137055|NASH|nash
4976862|NCT04137042|Metabolomics|metabolomics
4976863|NCT04137042|Fluid therapy|fluid therapy
4976864|NCT04137029|beta-receptors|beta-receptors
4976865|NCT04137029|metacholine|metacholine
4976866|NCT04137029|formoterol|formoterol
4976867|NCT04137029|tiotropium|tiotropium
4976868|NCT04137016|APP, old|app, old
4976869|NCT04137003|Acl|acl
4981335|NCT04109300|Infliximab|infliximab
4976873|NCT04136990|Lateral Extra-Articular Tenodesis|lateral extra-articular tenodesis
4976874|NCT04136990|Knee Laxity|knee laxity
5297143|NCT02191358|Elderly|elderly
4976875|NCT04136990|Porto Knee Testing Device|porto knee testing device
4976876|NCT04136964|Neck pain|neck pain
4976877|NCT04136964|COMI|comi
4976878|NCT04136964|Quality of life|quality of life
4976879|NCT04136964|Questionnaire|questionnaire
4976880|NCT04136964|Validity|validity
4976881|NCT04136964|Reliability|reliability
4976882|NCT04136964|Patient-reported outcome measures|patient-reported outcome measures
4976883|NCT04136951|home health|home health
4976884|NCT04136951|clinical decisions support|clinical decisions support
4976885|NCT04136951|care transitions|care transitions
4976886|NCT04136951|patient prioritization|patient prioritization
4976887|NCT04136951|health informatics|health informatics
4976888|NCT04136951|home care|home care
4976889|NCT04136938|Fall|fall
4976890|NCT04136938|Seniors|seniors
4976891|NCT04136938|Physical activity|physical activity
4976892|NCT04136938|Prevention|prevention
4976893|NCT04136912|Cancer Screening|cancer screening
4976894|NCT04136899|burn out|burn out
4976895|NCT04136899|quality of life|quality of life
4976896|NCT04136899|general practioners|general practioners
4976897|NCT04136899|french|french
4976898|NCT04136886|concurrent chemotherapy|concurrent chemotherapy
4976899|NCT04136886|IMRT|imrt
4976900|NCT04136886|recurrent NPC|recurrent npc
4976916|NCT04136782|adjuvant chemotherapy|adjuvant chemotherapy
4976918|NCT04136782|albumin-bound paclitaxel|albumin-bound paclitaxel
4976919|NCT04136782|carboplatin|carboplatin
4976920|NCT04136782|docetaxel|docetaxel
4976921|NCT04136782|epirubicin|epirubicin
4976922|NCT04136769|Arterial Invasion|arterial invasion
4976923|NCT04136769|Arterial reconstruction|arterial reconstruction
4976924|NCT04136769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4976925|NCT04136769|Tumor resection|tumor resection
4976937|NCT04136691|Simulation|simulation
4976938|NCT04136691|Nursing education|nursing education
4976939|NCT04136691|Burns|burns
4976940|NCT04136691|Nursing process|nursing process
4976941|NCT04136678|cerebral palsy|cerebral palsy
4976942|NCT04136678|treadmill|treadmill
4976943|NCT04136678|backward walking|backward walking
4976944|NCT04136678|balance|balance
4976945|NCT04136678|spasticity|spasticity
4976951|NCT04136613|Post placental insertion of intrauterine device|post placental insertion of intrauterine device
4976952|NCT04136613|Cesearean section|cesearean section
4976954|NCT04136613|Feasibility|feasibility
4976955|NCT04136574|hand dermatoses|hand dermatoses
4976956|NCT04136574|hand dermatitis|hand dermatitis
4976957|NCT04136574|occupationnal|occupationnal
4976958|NCT04136574|caregivers|caregivers
4976959|NCT04136574|hand hygiene|hand hygiene
4976960|NCT04136561|intravenous access|intravenous access
4976961|NCT04136561|vascular access|vascular access
4976962|NCT04136561|IV survival|iv survival
4976963|NCT04136561|IV catheter complication|iv catheter complication
4976964|NCT04136561|Central venous access|central venous access
4976965|NCT04136561|Central Line-associated Bloodstream Infection (CLABSI)|central line-associated bloodstream infection (clabsi)
4976966|NCT04136509|cone beam computed tomography (CBCT)|cone beam computed tomography (cbct)
4976967|NCT04136509|microcomputed tomography (micro-CT)|microcomputed tomography (micro-ct)
4976968|NCT04136509|histomorphometry|histomorphometry
4976969|NCT04136509|sinus floor elevation|sinus floor elevation
4976970|NCT04136509|allograft|allograft
4976971|NCT04136509|xenograft|xenograft
4976972|NCT04136470|Microbiome|microbiome
4976973|NCT04136470|Cancer|cancer
4976974|NCT04136470|Metagenome|metagenome
4976975|NCT04136470|Non Small Cell Lung Cancer|non small cell lung cancer
4976976|NCT04136470|Renal Cell Carcinoma|renal cell carcinoma
4976977|NCT04136470|Immunotherapy|immunotherapy
4976978|NCT04136470|Neoplasms|neoplasms
4976979|NCT04136470|Nivolumab|nivolumab
4976980|NCT04136470|Ipilimumab|ipilimumab
4976981|NCT04136470|Atezolizumab|atezolizumab
4976982|NCT04136470|Stool|stool
4976983|NCT04136470|FFPE|ffpe
4976984|NCT04136470|PBMC|pbmc
4976985|NCT04136470|Intestinal microbiota|intestinal microbiota
4976986|NCT04136470|Immuno-Oncology|immuno-oncology
4976987|NCT04136444|Padsevonil|padsevonil
4976988|NCT04136444|Phase 1|phase 1
4976989|NCT04136444|Pharmacokinetic|pharmacokinetic
4976990|NCT04136444|PSL|psl
4976991|NCT04136379|Warfarin therapy|warfarin therapy
4976992|NCT04136379|INR monitoring|inr monitoring
4976993|NCT04136366|ADX-2191|adx-2191
4976994|NCT04136366|recurrent retinal detachment|recurrent retinal detachment
4976995|NCT04136366|open globe injury|open globe injury
4976996|NCT04136353|clinically localised prostate cancer|clinically localised prostate cancer
4976997|NCT04136353|very high risk|very high risk
4976998|NCT04136353|darolutamide|darolutamide
4977002|NCT04136314|Decision-Framing|decision-framing
4977018|NCT04136184|Polyneuropathy|polyneuropathy
4977019|NCT04136184|Amyloidosis|amyloidosis
4977020|NCT04136184|ATTR|attr
4977021|NCT04136184|TTR|ttr
4977022|NCT04136171|TTR|ttr
4977023|NCT04136171|Amyloidosis|amyloidosis
4977024|NCT04136171|Cardiomyopathy|cardiomyopathy
4977025|NCT04136145|belimumab|belimumab
4977026|NCT04136145|Chinese|chinese
4977027|NCT04136145|intravenous|intravenous
4977028|NCT04136145|subcutaneous|subcutaneous
4977029|NCT04136145|auto-injector|auto-injector
4977030|NCT04136132|oncology|oncology
4977031|NCT04136132|Pancreatic|pancreatic
4977032|NCT04136119|micronutrient supplementation|micronutrient supplementation
4977033|NCT04136119|vitamins|vitamins
4977034|NCT04136093|Weight Loss Maintenance|weight loss maintenance
4977035|NCT04136093|Metabolic Disorders|metabolic disorders
4977036|NCT04136093|Postmenopausal Women|postmenopausal women
4977037|NCT04136093|Cardiometabolic Parameters|cardiometabolic parameters
4977038|NCT04136093|Diet Therapy|diet therapy
4977039|NCT04136093|Metabolic Syndrome|metabolic syndrome
4977040|NCT04136054|Cognitive Behaviour Therapy|cognitive behaviour therapy
4977041|NCT04136054|Psychological Intervention|psychological intervention
4977042|NCT04136028|Chronic Granulomatous Disease|chronic granulomatous disease
4977043|NCT04136028|Anakinra|anakinra
4977044|NCT04136028|Kineret|kineret
4977045|NCT04135976|physiotherapy|physiotherapy
4977046|NCT04135976|primary health care|primary health care
4977047|NCT04135976|ICF|icf
4977052|NCT04135937|Veterans|veterans
4977053|NCT04135924|Rehabilitation|rehabilitation
4977054|NCT04135924|Neurological disease|neurological disease
4977055|NCT04135885|Folic Acid|folic acid
4977057|NCT04135859|congenital heart disease|congenital heart disease
4977058|NCT04135859|physical activity|physical activity
4977059|NCT04135846|Alcohol use disorder, stress|alcohol use disorder, stress
4977060|NCT04135807|Grade II Glioma|grade ii glioma
4977061|NCT04135807|Grade III Glioma|grade iii glioma
4977062|NCT04135807|Grade IV Glioma|grade iv glioma
4977063|NCT04135807|Astrocytoma|astrocytoma
4977064|NCT04135807|Oligodendroglioma of Brain|oligodendroglioma of brain
4977065|NCT04135807|Anaplastic Astrocytoma of Brain|anaplastic astrocytoma of brain
4977066|NCT04135807|Glioblastoma|glioblastoma
4977067|NCT04135794|MRL|mrl
4977068|NCT04135781|nab-paclitaxel|nab-paclitaxel
4977069|NCT04135781|gastric cancer|gastric cancer
4977070|NCT04135768|Distal radius fracture|distal radius fracture
4977071|NCT04135768|Articular fracture|articular fracture
4977072|NCT04135768|Joint haematoma|joint haematoma
5702718|NCT00492310|tobacco|tobacco
4977073|NCT04135768|Volar wrist plating|volar wrist plating
4977074|NCT04135742|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
4977075|NCT04135742|Computerized Cognitive Training|computerized cognitive training
4977076|NCT04135729|Mental health|mental health
4977077|NCT04135729|Eating disorders|eating disorders
4977078|NCT04135729|Depression|depression
4977079|NCT04135729|Anxiety|anxiety
4977080|NCT04135729|Body dissatisfaction|body dissatisfaction
4977081|NCT04135729|Body image|body image
4977082|NCT04135729|Thinness|thinness
4977083|NCT04135729|Leanness|leanness
4977084|NCT04135729|Muscularity|muscularity
4977085|NCT04135729|Compulsive exercise|compulsive exercise
4977086|NCT04135729|Eating behavior|eating behavior
4977087|NCT04135729|Dieting|dieting
4977088|NCT04135729|Exercise|exercise
4977089|NCT04135729|Sexual harassment|sexual harassment
4977090|NCT04135690|Hepatocellular Carcinoma|hepatocellular carcinoma
4977091|NCT04135690|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4977092|NCT04135690|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
4977093|NCT04135690|Toripalimab|toripalimab
4977094|NCT04135690|Sorafenib|sorafenib
4977095|NCT04135664|esophagectomy|esophagectomy
4977096|NCT04135664|chemoradiation|chemoradiation
4977097|NCT04135664|esophageal cancer|esophageal cancer
4977098|NCT04135664|endoscopic submucosal dissection|endoscopic submucosal dissection
4977099|NCT04135651|Paratracheal pressure|paratracheal pressure
4977100|NCT04135651|Glottic view|glottic view
4977101|NCT04135651|Cricoid pressure|cricoid pressure
4977107|NCT04135573|Graves' disease|graves' disease
4977108|NCT04135573|Natural killer cell|natural killer cell
4977109|NCT04135560|Eczema|eczema
4977110|NCT04135534|nalbuphine dose|nalbuphine dose
4977115|NCT04135482|singcel cell sequencing|singcel cell sequencing
4977116|NCT04135469|Tax preparation service|tax preparation service
4977117|NCT04135469|Tax filing|tax filing
4977118|NCT04135469|Earned Income Tax Credit (EITC)|earned income tax credit (eitc)
4977119|NCT04135469|Child tax credit|child tax credit
4977120|NCT04135443|Healthy relationships|healthy relationships
4977121|NCT04135430|Bronchiolitis|bronchiolitis
4977122|NCT04135430|Infants|infants
4977123|NCT04135430|Chest physiotherapy|chest physiotherapy
4994652|NCT04027127|acs|acs
4977128|NCT04135378|vitamin C , salivary cortisol , heart rate , blood pressure|vitamin c , salivary cortisol , heart rate , blood pressure
4977129|NCT04135352|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5369125|NCT01861223|acquired resistance|acquired resistance
4977130|NCT04135352|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
4977131|NCT04135339|pain|pain
4977132|NCT04135339|trigger points|trigger points
4977133|NCT04135339|physical therapy|physical therapy
4977134|NCT04135339|dry needling|dry needling
4977135|NCT04135339|therapeutic exercise|therapeutic exercise
4977136|NCT04135313|rectal cancer|rectal cancer
4977137|NCT04135313|induction chemotherapy|induction chemotherapy
4977138|NCT04135313|consolidation chemotherapy|consolidation chemotherapy
4977139|NCT04135313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4977140|NCT04135300|Hemophilia B|hemophilia b
4977141|NCT04135300|gene therapy|gene therapy
4977142|NCT04135300|ADENO-ASSOCIATED VIRUSES|adeno-associated viruses
4977144|NCT04135261|advanced solid tumors|advanced solid tumors
4977145|NCT04135248|Flash Glucose Monitoring, Time-in-Range, Fasting, Ramadan|flash glucose monitoring, time-in-range, fasting, ramadan
4977147|NCT04135235|Pregnant woman|pregnant woman
4977148|NCT04135235|High viral load|high viral load
4977149|NCT04135235|Tenofovir fumarate|tenofovir fumarate
4977150|NCT04135209|Optical coherence tomography|optical coherence tomography
4977151|NCT04135209|Angiography|angiography
4977153|NCT04135196|bone|bone
4977154|NCT04135196|adaptation|adaptation
4977155|NCT04135196|mechanical stimuli|mechanical stimuli
4977156|NCT04135196|women|women
4977157|NCT04135196|peak bone mass|peak bone mass
4977158|NCT04135183|Community-acquired Pneumonia|community-acquired pneumonia
4977159|NCT04135183|Pneumonia severity scores|pneumonia severity scores
4977160|NCT04135170|Register based randomized control trial|register based randomized control trial
4977161|NCT04135170|Non-inferiority|non-inferiority
4977162|NCT04135170|Total knee arthroplasty|total knee arthroplasty
4977163|NCT04135170|Antibiotic loaded bone cement|antibiotic loaded bone cement
4977164|NCT04135170|Plain bone cement|plain bone cement
4977165|NCT04135170|Antibiotic resistance bacteria|antibiotic resistance bacteria
4977166|NCT04135170|Periprosthetic joint infection|periprosthetic joint infection
4977167|NCT04135170|Patient reported outcome measure|patient reported outcome measure
4977168|NCT04135170|Health related quality of life|health related quality of life
4977169|NCT04135170|Pain|pain
4977170|NCT04135170|Function|function
4977171|NCT04135170|Satisfaction|satisfaction
5702719|NCT00492310|women|women
4977172|NCT04135170|Revision surgery|revision surgery
4977173|NCT04135170|Primary surgery|primary surgery
4977174|NCT04135157|Regional Anesthesia|regional anesthesia
4977175|NCT04135157|Acute and chronical pain|acute and chronical pain
4977176|NCT04135157|Pectoralis nerve block|pectoralis nerve block
4977177|NCT04135157|Erector spine plane block|erector spine plane block
4977178|NCT04135131|Abdominal Muscles|abdominal muscles
4977179|NCT04135131|Exercise Therapy|exercise therapy
4977180|NCT04135131|Low back pain|low back pain
4977181|NCT04135131|Paraspinal Muscles|paraspinal muscles
4977182|NCT04135105|Speech Perception|speech perception
4977183|NCT04135105|Neuroimaging|neuroimaging
4977184|NCT04135105|Lexical Tone|lexical tone
4977186|NCT04135079|immune transcriptome profile|immune transcriptome profile
4977187|NCT04135079|Drop-seq|drop-seq
4977188|NCT04135079|immune signatures|immune signatures
4977189|NCT04135079|CyTOF|cytof
4977190|NCT04135079|cytokine profile|cytokine profile
4977191|NCT04135066|Brain structure and function|brain structure and function
4977192|NCT04135066|Nutrition|nutrition
4977193|NCT04135066|Microbiome|microbiome
4977194|NCT04135066|Continuous blood glucose monitoring|continuous blood glucose monitoring
4977195|NCT04135053|meningitis|meningitis
4977196|NCT04135053|healthy volunteer|healthy volunteer
4977197|NCT04135040|IAAO|iaao
4977198|NCT04135040|Lysine|lysine
4977199|NCT04135040|Children|children
4977200|NCT04135040|Cereal Grains|cereal grains
4977201|NCT04134988|Fall|fall
4977203|NCT04134988|Fear of falling|fear of falling
4977204|NCT04134988|Serious games|serious games
4977205|NCT04134988|Technology|technology
4977206|NCT04134988|Randomized controlled trial|randomized controlled trial
4977207|NCT04134975|spin surgery|spin surgery
4977208|NCT04134975|lumbar surgery|lumbar surgery
4977209|NCT04134975|image guided surgery|image guided surgery
4977210|NCT04134975|radiation exposure|radiation exposure
4977211|NCT04134975|intraoperative navigation|intraoperative navigation
4977212|NCT04134936|DLBCL|dlbcl
4977213|NCT04134936|CD19|cd19
4977214|NCT04134936|monoclonal antibody|monoclonal antibody
4977215|NCT04134936|tafasitamab|tafasitamab
4977216|NCT04134936|lenalidomide|lenalidomide
4977217|NCT04134936|MOR208|mor208
4977218|NCT04134936|MOR00208|mor00208
4977219|NCT04134923|Alzheimer's disease|alzheimer's disease
4977227|NCT04134897|rectal cancer|rectal cancer
4977228|NCT04134897|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4977229|NCT04134897|neoadjuvant radiotherapy|neoadjuvant radiotherapy
4977232|NCT04134858|coaching|coaching
4977233|NCT04134858|primary health care|primary health care
4977234|NCT04134845|Ventricul Tachycardia ablation|ventricul tachycardia ablation
4977235|NCT04134832|Pancreatic neuroendocrine tumors|pancreatic neuroendocrine tumors
5369126|NCT01861223|gefitinib|gefitinib
4977236|NCT04134832|Neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
4977237|NCT04134793|atrial fibrillation, ablation, microRNA|atrial fibrillation, ablation, microrna
4977238|NCT04134780|Ultrasound|ultrasound
4977239|NCT04134780|Spectroscopy|spectroscopy
4977240|NCT04134780|Characterization|characterization
4977241|NCT04134754|Epilepsy|epilepsy
4977242|NCT04134741|prevention|prevention
4977243|NCT04134741|back pain|back pain
4977248|NCT04134741|kinetic control|kinetic control
5297444|NCT02190188|goal|goal
4977249|NCT04134728|bDMARD, GM-CSF, GSK3196165, Rheumatoid Arthritis, sarilumab, Otilimab|bdmard, gm-csf, gsk3196165, rheumatoid arthritis, sarilumab, otilimab
4977250|NCT04134715|Oral contraceptive|oral contraceptive
4977251|NCT04134715|Drug-Drug Interaction (DDI)|drug-drug interaction (ddi)
4977252|NCT04134715|PF-06826647|pf-06826647
4977253|NCT04134689|Tuberculosis,|tuberculosis,
4977254|NCT04134689|Video Directly Observed Treatment|video directly observed treatment
4977255|NCT04134689|Directly Observed Treatment|directly observed treatment
4977256|NCT04134689|Uganda|uganda
4977257|NCT04134689|Treatment adherence|treatment adherence
4977258|NCT04134689|mHealth|mhealth
4977259|NCT04134676|Stem Cell|stem cell
4977260|NCT04134676|Conditioned Medium|conditioned medium
4977261|NCT04134663|vasoconstrictor|vasoconstrictor
4977262|NCT04134663|oxytocin|oxytocin
4977264|NCT04134663|peripheral nervous system response|peripheral nervous system response
4977265|NCT04134650|Prediabetes|prediabetes
4977266|NCT04134637|pecto intercostal fascial plane block|pecto intercostal fascial plane block
4977267|NCT04134637|sternotomy|sternotomy
4977268|NCT04134611|Hyaluronic acid injection|hyaluronic acid injection
4977269|NCT04134611|Knee Arthroscopy|knee arthroscopy
4977270|NCT04134611|lateral patellar retinaculae.|lateral patellar retinaculae.
4977271|NCT04134611|lateral patellar compression syndrome|lateral patellar compression syndrome
4977272|NCT04134598|Partial Breast Irradiation|partial breast irradiation
4977273|NCT04134598|Radiation Therapy|radiation therapy
4977274|NCT04134598|Endocrine Therapy|endocrine therapy
4977275|NCT04134598|Breast Conserving Surgery|breast conserving surgery
4977276|NCT04134598|Elderly|elderly
4977277|NCT04134598|Health Related Quality of Life|health related quality of life
4977278|NCT04134598|Patients Reported Outcome Measures|patients reported outcome measures
4977279|NCT04134598|Breast Cancer|breast cancer
4977280|NCT04134585|Fall|fall
4977281|NCT04134585|Prevention|prevention
4977282|NCT04134585|Seniors|seniors
4977283|NCT04134585|Physical activity|physical activity
4977284|NCT04134585|Interviews|interviews
4977285|NCT04134572|Disease Registry|disease registry
4977286|NCT04134572|Natural History Study|natural history study
4977287|NCT04134572|Genotype-Phenotype Correlation|genotype-phenotype correlation
4977288|NCT04134559|Hepatocellular Carcinoma, Childhood|hepatocellular carcinoma, childhood
4977289|NCT04134559|Hepatocellular Carcinoma|hepatocellular carcinoma
4977290|NCT04134559|Liver Cancer|liver cancer
4977291|NCT04134559|Liver Cancer Pediatric|liver cancer pediatric
4977292|NCT04134507|Post-LASIK|post-lasik
4977293|NCT04134507|Presbyopia-correcting IOL|presbyopia-correcting iol
4977294|NCT04134507|Monofocal IOL|monofocal iol
4977295|NCT04134481|clustered nursing interventions|clustered nursing interventions
4977296|NCT04134455|Mesh|mesh
4977297|NCT04134455|RTL(reinforced tension line)|rtl(reinforced tension line)
4977298|NCT04134455|Prevention|prevention
4977299|NCT04134455|Prophylactic Mesh|prophylactic mesh
4977300|NCT04134442|Exparel|exparel
4977301|NCT04134442|Bupivacaine Liposome|bupivacaine liposome
4977302|NCT04134442|Total Shoulder Replacement|total shoulder replacement
4977303|NCT04134442|Pain Management|pain management
4977304|NCT04134429|wearable device|wearable device
4977305|NCT04134429|Everion®|everion®
4977306|NCT04134429|Fever and Neutropenia|fever and neutropenia
4977307|NCT04134429|Pediatric Oncology|pediatric oncology
4977308|NCT04134416|Aphasia|aphasia
4977309|NCT04134416|Stroke|stroke
4977310|NCT04134416|Rehabilitation|rehabilitation
4977313|NCT04134416|Intensive Language-Action Therapy|intensive language-action therapy
4977315|NCT04134403|Thiamine|thiamine
4977319|NCT04134390|fragile|fragile
4977320|NCT04134390|renal carcinoma|renal carcinoma
4977321|NCT04134390|old age|old age
4977322|NCT04134325|Classic Hodgkin Lymphoma|classic hodgkin lymphoma
4977323|NCT04134325|Relapsed Hodgkin Lymphoma|relapsed hodgkin lymphoma
4977324|NCT04134325|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
4977325|NCT04134325|Relapsed/Refractory Hodgkin Lymphoma|relapsed/refractory hodgkin lymphoma
4977326|NCT04134325|CD30|cd30
4977327|NCT04134325|cell therapy|cell therapy
4977328|NCT04134325|CAR-T|car-t
4977329|NCT04134325|modified T cells|modified t cells
4977330|NCT04134299|Amino Acid|amino acid
4977331|NCT04134299|Food Study|food study
4977332|NCT04134260|Prostate Cancer|prostate cancer
4977333|NCT04134260|Apalutamide|apalutamide
4977334|NCT04134260|Abiraterone Acetate|abiraterone acetate
4977338|NCT04134117|Primary CNS Lymphoma|primary cns lymphoma
4977339|NCT04134117|Refractory Primary CNS Lymphoma|refractory primary cns lymphoma
4977350|NCT04134000|non-muscle|non-muscle
5017279|NCT03888378|MGD|mgd
4977351|NCT04134000|bladder cancer|bladder cancer
4977353|NCT04133987|tetravalent dengue vaccine|tetravalent dengue vaccine
4977354|NCT04133987|Phase II clinical trial|phase ii clinical trial
4977355|NCT04133961|Phenylephrine|phenylephrine
4977356|NCT04133961|Spinal anaesthesia|spinal anaesthesia
4977357|NCT04133948|Melanoma|melanoma
4977358|NCT04133948|Neo-adjuvant|neo-adjuvant
4977359|NCT04133948|Domatinostat|domatinostat
4977360|NCT04133948|Nivolumab|nivolumab
4977361|NCT04133948|Ipilimumab|ipilimumab
4977366|NCT04133883|joint health|joint health
4977367|NCT04133844|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4977368|NCT04133831|Heart Transplant|heart transplant
4977369|NCT04133831|Transplant Survival|transplant survival
4977370|NCT04133831|Applied Ethics|applied ethics
4977371|NCT04133831|Decision Psychology|decision psychology
4977372|NCT04133831|Human Behavior|human behavior
4977373|NCT04133818|Multidisciplinary education and exercise therapy program.|multidisciplinary education and exercise therapy program.
4977374|NCT04133818|Physical activity|physical activity
4977375|NCT04133818|Rehabilitation|rehabilitation
4977376|NCT04133805|viscous fiber|viscous fiber
4977377|NCT04133805|barley b-glucan|barley b-glucan
4977378|NCT04133805|oat b-glucan|oat b-glucan
4977379|NCT04133805|konjac glucomannan|konjac glucomannan
4977380|NCT04133805|psyllium|psyllium
4977381|NCT04133805|guar gum|guar gum
4977382|NCT04133805|pectin|pectin
4977383|NCT04133766|Nutrition|nutrition
4977384|NCT04133766|Breastfeeding|breastfeeding
4977385|NCT04133766|Handwashing|handwashing
4977386|NCT04133766|Food security|food security
4977387|NCT04133766|Low and Middle Income Country|low and middle income country
4977388|NCT04133766|Infant and Young Child Feeding|infant and young child feeding
4977389|NCT04133740|A before-and-after study|a before-and-after study
4977390|NCT04133740|Oxygenation targeting|oxygenation targeting
4977391|NCT04133727|randomised|randomised
4977392|NCT04133727|simulation|simulation
4977393|NCT04133701|Meal Timing|meal timing
4977394|NCT04133701|Blood Pressure|blood pressure
4977395|NCT04133701|Time-Restricted Feeding|time-restricted feeding
4977396|NCT04133701|Sympathetic Nerve Activity|sympathetic nerve activity
4977397|NCT04133688|mobile app, pilot study, addiction, sleep, ePRO|mobile app, pilot study, addiction, sleep, epro
4977398|NCT04133675|urinary incontinence|urinary incontinence
4977399|NCT04133675|urine leakage|urine leakage
4977400|NCT04133649|Aging|aging
4977401|NCT04133649|Gene therapy|gene therapy
4977403|NCT04133649|hTert|htert
4977404|NCT04133649|telomere|telomere
4977405|NCT04133649|Telomerase|telomerase
4977406|NCT04133623|osteoarticular acute pain|osteoarticular acute pain
4977407|NCT04133623|ketorolac|ketorolac
4977408|NCT04133623|ibuprofen|ibuprofen
4977409|NCT04133610|human papillomavirus|human papillomavirus
4977410|NCT04133610|HPV|hpv
4977411|NCT04133610|self-sampling|self-sampling
4977412|NCT04133610|cervical swab|cervical swab
4977413|NCT04133610|cervicovaginal swab|cervicovaginal swab
4977414|NCT04133610|cervical cancer screening|cervical cancer screening
4977415|NCT04133597|skin conductance|skin conductance
4977416|NCT04133597|anxiety|anxiety
4977417|NCT04133597|smartphone users|smartphone users
4977418|NCT04133597|smartphone addiction|smartphone addiction
4977419|NCT04133584|Immunogenicity|immunogenicity
4977420|NCT04133584|Safety|safety
4977421|NCT04133584|Enterovirus 71 Vaccine|enterovirus 71 vaccine
4977422|NCT04133584|seasonal influenza vaccine|seasonal influenza vaccine
4977425|NCT04133558|acute respiratory distress syndrome|acute respiratory distress syndrome
4977426|NCT04133558|microbiota|microbiota
4977427|NCT04133558|intensive care unit|intensive care unit
4977428|NCT04133532|Exercise tolerance|exercise tolerance
4977429|NCT04133532|NTproBNP|ntprobnp
4977438|NCT04133480|GWP42003-P|gwp42003-p
4977439|NCT04133480|EPIDIOLEX®|epidiolex®
4977440|NCT04133480|cannabidiol|cannabidiol
4977451|NCT04133428|Severe systolic disfunction|severe systolic disfunction
4977452|NCT04133428|Sacubitril-Valsartan|sacubitril-valsartan
4977453|NCT04133402|Hemorrhage Post-partum|hemorrhage post-partum
4977454|NCT04133402|Fertility|fertility
4977455|NCT04133402|Uterine balloon tamponade|uterine balloon tamponade
4977456|NCT04133402|Vaginal Birth|vaginal birth
4977457|NCT04133389|Growth mindset|growth mindset
4977458|NCT04133389|Implicit theory|implicit theory
4977459|NCT04133389|Adolescence|adolescence
4977460|NCT04133389|Mental Health|mental health
4977461|NCT04133389|Well-being|well-being
4977462|NCT04133389|students|students
4977463|NCT04133389|Secondary Schools|secondary schools
4977464|NCT04133389|Educational intervention|educational intervention
4977470|NCT04133337|Apatinib|apatinib
4977471|NCT04133337|SHR-1210|shr-1210
4977472|NCT04133337|NSCLC|nsclc
4977473|NCT04133337|neoadjuvant|neoadjuvant
4977474|NCT04133311|IOP|iop
4977475|NCT04133311|OSD|osd
4977476|NCT04133285|Disease Registry|disease registry
4977477|NCT04133285|Natural History Study|natural history study
4977478|NCT04133285|Genotype-Phenotype Correlation|genotype-phenotype correlation
4977479|NCT04133285|Multiple Exostoses|multiple exostoses
4977480|NCT04133272|Disease Registry|disease registry
5369127|NCT01861223|erlotinib|erlotinib
4977481|NCT04133272|Natural History Study|natural history study
4977482|NCT04133272|Genotype-Phenotype Correlation|genotype-phenotype correlation
4977483|NCT04133259|Hepatitis B, Chronic|hepatitis b, chronic
4977484|NCT04133259|Monoclonal antibody|monoclonal antibody
4977485|NCT04133246|cystic fibrosis|cystic fibrosis
4977487|NCT04133246|Psycho-social|psycho-social
4977488|NCT04133246|Qualitative study|qualitative study
4977489|NCT04133233|Low dose of IL-2|low dose of il-2
4977490|NCT04133233|Treg response|treg response
4977491|NCT04133220|hemostasis|hemostasis
4977492|NCT04133207|CDK|cdk
4977493|NCT04133207|Breast cancer|breast cancer
4977494|NCT04133207|toxicity|toxicity
4977495|NCT04133207|outcome|outcome
4977496|NCT04133181|Endodontic surgery|endodontic surgery
4977497|NCT04133181|Guided surgery|guided surgery
4977498|NCT04133181|3D guide|3d guide
4977499|NCT04133168|cryoablation|cryoablation
4977500|NCT04133155|Pancreatic cancer|pancreatic cancer
4977501|NCT04133155|FOLFIRINOX|folfirinox
4977502|NCT04133155|nab-paclitaxel plus gemcitabine|nab-paclitaxel plus gemcitabine
4977507|NCT04133129|HIIT|hiit
4977508|NCT04133129|High Intensity Interval Training|high intensity interval training
4977509|NCT04133129|Medium Intensity Continuous Training|medium intensity continuous training
4977510|NCT04133129|Interval Training|interval training
4977511|NCT04133129|Exercise|exercise
4977512|NCT04133129|Physical Activity|physical activity
4977513|NCT04133129|Exercise Training|exercise training
4977514|NCT04133103|early mobilisation|early mobilisation
4977515|NCT04133103|robot|robot
4977516|NCT04133103|spine|spine
4977517|NCT04133103|enhanced recovery|enhanced recovery
4977518|NCT04133090|Bone augmentation|bone augmentation
4977519|NCT04133090|Autogenous block bone graft|autogenous block bone graft
4977520|NCT04133090|Leukocytes and platelet-rich fibrin|leukocytes and platelet-rich fibrin
4977521|NCT04133090|Injectable platelet rich fibrin|injectable platelet rich fibrin
4977522|NCT04133090|Tent-pole technique|tent-pole technique
4977523|NCT04133077|PDX|pdx
4977524|NCT04133051|quadratus lumborum block|quadratus lumborum block
4977525|NCT04133051|epidural analgesia|epidural analgesia
4977526|NCT04133051|bladder cancer|bladder cancer
4977527|NCT04133051|radical cystectomy|radical cystectomy
4977528|NCT04133038|Feeding disorders|feeding disorders
4977529|NCT04133038|Eating disorders|eating disorders
4977530|NCT04133038|Evaluation|evaluation
4977531|NCT04133025|Vestibular Rehabilitation|vestibular rehabilitation
4977532|NCT04133025|Unilateral vestibular hypofunction|unilateral vestibular hypofunction
4977533|NCT04133012|Viral cartography|viral cartography
4977534|NCT04133012|Viral reservoir|viral reservoir
4977535|NCT04133012|Antiretroviral treatments diffusion|antiretroviral treatments diffusion
4977536|NCT04132999|Down Syndrome|down syndrome
4977537|NCT04132999|Obstructive Sleep Apnea|obstructive sleep apnea
4977538|NCT04132999|PAP|pap
4977539|NCT04132999|Positive Airway Pressure|positive airway pressure
4977540|NCT04132986|Ventral hernia repair|ventral hernia repair
4977541|NCT04132986|Contaminated surgery|contaminated surgery
4977556|NCT04132882|Hearing Loss|hearing loss
4977557|NCT04132882|Hepatoblastoma|hepatoblastoma
4977562|NCT04132856|pediatric|pediatric
4981968|NCT04105556|Pain|pain
4977591|NCT04132687|digital chest drain device|digital chest drain device
4977593|NCT04132648|Exercise|exercise
4977594|NCT04132648|Vasoconstrictor Responsiveness|vasoconstrictor responsiveness
4977595|NCT04132622|Euthyrox|euthyrox
4977596|NCT04132622|Paraquat Intoxication|paraquat intoxication
4977597|NCT04132583|Deflox®|deflox®
4977598|NCT04132583|Cataflam® DD|cataflam® dd
4977599|NCT04132583|Diclofenac potassium|diclofenac potassium
4977600|NCT04132583|Healthy|healthy
4977601|NCT04132570|Airborne pollution|airborne pollution
4977602|NCT04132570|Rhinitis|rhinitis
4977603|NCT04132570|Budesonide|budesonide
4977604|NCT04132544|risks factors|risks factors
4977605|NCT04132544|risks of falling|risks of falling
4977606|NCT04132544|elderly|elderly
4977607|NCT04132544|Urgent Medical Assistance Service|urgent medical assistance service
4977608|NCT04132544|Emergency Care|emergency care
4977609|NCT04132544|911|911
4977610|NCT04132531|Stem Cells|stem cells
4977611|NCT04132531|Obesity|obesity
4977612|NCT04132531|Cardiovascular Events|cardiovascular events
4977613|NCT04132531|Type 2 Diabetes|type 2 diabetes
4977614|NCT04132518|PLLA|plla
4977615|NCT04132518|Midface Volume Deficit|midface volume deficit
4977616|NCT04132427|microbiota transfer therapy|microbiota transfer therapy
4977617|NCT04132427|fecal transplant|fecal transplant
4977618|NCT04132427|fecal microbiota transplant|fecal microbiota transplant
4977619|NCT04132427|intestinal microbiota|intestinal microbiota
4977620|NCT04132401|fundus oculi|fundus oculi
4977621|NCT04132401|artificial intelligence|artificial intelligence
4977622|NCT04132401|computer assisted diagnosis|computer assisted diagnosis
4977623|NCT04132401|neural network computer|neural network computer
4977624|NCT04132401|Diabetic Retinopathy|diabetic retinopathy
4977625|NCT04132388|adalimumab|adalimumab
4977626|NCT04132388|medical adherence|medical adherence
4977630|NCT04132349|Ulipristal Acetate|ulipristal acetate
4977631|NCT04132336|Dental pain|dental pain
4977633|NCT04132310|Pregnancy|pregnancy
4977634|NCT04132310|body composition|body composition
4977635|NCT04132310|infant adiposity|infant adiposity
4977636|NCT04132271|oropharyngeal, dysphagia, nutrition|oropharyngeal, dysphagia, nutrition
4977637|NCT04132245|childhood obesity|childhood obesity
4977638|NCT04132245|minorities|minorities
4977640|NCT04132245|physical activity|physical activity
4977641|NCT04132245|parents|parents
4977642|NCT04132232|smoking in pregnancy|smoking in pregnancy
4977643|NCT04132232|substance use disorder|substance use disorder
4977644|NCT04132232|carbon monoxide|carbon monoxide
4977648|NCT04132219|obesity|obesity
4977649|NCT04132167|Rehabilitation|rehabilitation
4977650|NCT04132167|Multiple sclerosis|multiple sclerosis
4977651|NCT04132167|Tailored interventions|tailored interventions
4977652|NCT04132154|cesarean section|cesarean section
4977653|NCT04132154|C-Section|c-section
4977654|NCT04132154|Hypothermia|hypothermia
4977664|NCT04132063|Epilepsy|epilepsy
4977665|NCT04132063|Generic|generic
4977666|NCT04132063|Levetiracetam|levetiracetam
4977667|NCT04132063|Therapeutic equivalency|therapeutic equivalency
4977668|NCT04132037|Multiple Sclerosis|multiple sclerosis
4977669|NCT04132037|Urinary disorders|urinary disorders
4977670|NCT04132037|Intermittent Self Catheterisation|intermittent self catheterisation
4977671|NCT04132024|Cognitive Behavioral Therapy for Insomnia (CBT-I)|cognitive behavioral therapy for insomnia (cbt-i)
4977672|NCT04132024|Insomnia|insomnia
4977673|NCT04132024|Sleep|sleep
4977674|NCT04132024|Crohn's Disease|crohn's disease
4977675|NCT04132024|Ulcerative Colitis|ulcerative colitis
4977676|NCT04132011|opioid|opioid
4977677|NCT04131985|Laparoscopic inguinal hernia surgery,|laparoscopic inguinal hernia surgery,
4977678|NCT04131985|postoperative pain|postoperative pain
4977679|NCT04131972|Lumpectomy|lumpectomy
4977693|NCT04131790|Loneliness|loneliness
4977694|NCT04131790|Homebound|homebound
4977695|NCT04131790|Behavioral Activation|behavioral activation
4977696|NCT04131764|multiple sclerosis|multiple sclerosis
4977698|NCT04131764|Neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
4977699|NCT04131764|NMOSD|nmosd
4977700|NCT04131764|optic neuritis|optic neuritis
4977701|NCT04131764|pupillary response|pupillary response
4977702|NCT04131764|RAPD|rapd
4977703|NCT04131764|rapid afferent pupillary defect|rapid afferent pupillary defect
4977704|NCT04131751|Metagenomics|metagenomics
4977705|NCT04131712|Massage|massage
4977706|NCT04131712|Muscle|muscle
4977707|NCT04131712|Extracellular Vesicles|extracellular vesicles
4977708|NCT04131712|Atrophy|atrophy
4977709|NCT04131699|pediatric|pediatric
4977710|NCT04131699|thoracoscopic|thoracoscopic
4977711|NCT04131699|cardiometry|cardiometry
4977712|NCT04131699|cardiac output|cardiac output
4977713|NCT04131699|hemodynamics|hemodynamics
4977714|NCT04131686|rhinosinusitis|rhinosinusitis
4977715|NCT04131686|N-acetylcysteine|n-acetylcysteine
4977716|NCT04131673|multiple sclerosis|multiple sclerosis
4977717|NCT04131673|MS|ms
4977718|NCT04131673|Neuromyelitis optica spectrum disorder|neuromyelitis optica spectrum disorder
4977719|NCT04131673|NMOSD|nmosd
4977720|NCT04131673|African Americans|african americans
4977721|NCT04131660|non-invasive ventilation|non-invasive ventilation
4977722|NCT04131660|respiratory failure|respiratory failure
4977723|NCT04131660|obese|obese
4977724|NCT04131660|obesity|obesity
4977725|NCT04131660|Hypoventilation Syndrome|hypoventilation syndrome
4977726|NCT04131660|apnea|apnea
4977727|NCT04131660|hypercapnic|hypercapnic
4977728|NCT04131660|acidosis|acidosis
4977729|NCT04131660|AVAPS-AE|avaps-ae
4977730|NCT04131660|VONIVOO|vonivoo
4977731|NCT04131647|Exercise|exercise
4977732|NCT04131647|Diet|diet
4977733|NCT04131647|Obesity|obesity
4977734|NCT04131582|prediabetes|prediabetes
4977735|NCT04131569|ESBL-E|esbl-e
4977736|NCT04131569|fecal carriage|fecal carriage
4977737|NCT04131569|microbiota|microbiota
4977738|NCT04131569|nosocomial infection|nosocomial infection
4977739|NCT04131517|Padsevonil|padsevonil
4977740|NCT04131517|Contraceptives|contraceptives
4977741|NCT04131517|Healthy female participants|healthy female participants
4977742|NCT04131478|cancer cachexia|cancer cachexia
4977743|NCT04131478|TNF alfa|tnf alfa
4977744|NCT04131478|pharmacogenetics|pharmacogenetics
5020924|NCT03866070|Female|female
4977745|NCT04131478|mi-RNA|mi-rna
4977754|NCT04131426|Lung Cancer|lung cancer
4977755|NCT04131426|Gastrointestinal Cancer|gastrointestinal cancer
4977756|NCT04131387|Female Stress Urinary Incontinence|female stress urinary incontinence
4977757|NCT04131374|Caregivers|caregivers
4977758|NCT04131322|Loss of response|loss of response
4977759|NCT04131322|Switching|switching
4977760|NCT04131322|Adalimumab original|adalimumab original
4977761|NCT04131322|Adalimumab biosimilar|adalimumab biosimilar
4977762|NCT04131296|influenza|influenza
4977763|NCT04131296|microbiota|microbiota
4977764|NCT04131296|intensive care unit|intensive care unit
4977765|NCT04131283|spreading vasoconstriction|spreading vasoconstriction
4977766|NCT04131283|gingival microcirculation|gingival microcirculation
4977767|NCT04131270|Planning|planning
4977768|NCT04131270|Physical Activity|physical activity
4977776|NCT04131218|Sugammadex|sugammadex
4977777|NCT04131218|Obese|obese
5006004|NCT03959189|Excessive Daytime Sleepiness|excessive daytime sleepiness
5006005|NCT03959189|hypersomnia|hypersomnia
4977779|NCT04131140|Advance Care Planning|advance care planning
4977780|NCT04131140|Resuscitation Orders|resuscitation orders
4977782|NCT04131140|Brain Death|brain death
4977783|NCT04131140|Organ Donation|organ donation
4977784|NCT04131140|Critical Illness|critical illness
5297914|NCT02188420|PAS|pas
4977785|NCT04131140|Intensive Care Units|intensive care units
4977786|NCT04131101|Community organizing|community organizing
4977787|NCT04131101|Advocacy|advocacy
4977792|NCT04131075|Coronary microvascular dysfunction|coronary microvascular dysfunction
4977793|NCT04131075|Cerebral Small Vessel Diseases|cerebral small vessel diseases
4977794|NCT04131062|Inherited conditions|inherited conditions
4977795|NCT04131062|Biobank enrollment|biobank enrollment
4977796|NCT04131049|Adolescent|adolescent
4977797|NCT04131049|Carbohydrate Counting|carbohydrate counting
4977798|NCT04131049|Food Insulin Index|food insulin index
4977799|NCT04131049|Glycemic Index|glycemic index
4977800|NCT04131049|Type 1 diabetes|type 1 diabetes
4977801|NCT04131036|Hemophilia A|hemophilia a
4977802|NCT04131036|Joint Health|joint health
4977803|NCT04131036|Bone Density|bone density
4977804|NCT04131036|Emicizumab|emicizumab
4977805|NCT04131036|factor VIII prophylaxis|factor viii prophylaxis
4977806|NCT04130984|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4977807|NCT04130984|Intraosseous|intraosseous
4977808|NCT04130984|Intravenous|intravenous
4977809|NCT04130984|Resuscitation|resuscitation
4977812|NCT04130906|Binge Eating|binge eating
4977813|NCT04130906|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4977814|NCT04130906|Theta Burst Stimulation|theta burst stimulation
4977815|NCT04130906|Neuromodulation|neuromodulation
4977816|NCT04130906|Psychiatric Disorders|psychiatric disorders
4977817|NCT04130906|Eating Disorders|eating disorders
4977818|NCT04130893|ear acupuncture, auricular acupuncture|ear acupuncture, auricular acupuncture
4977819|NCT04130841|Internal limiting membrane peeling|internal limiting membrane peeling
4977820|NCT04130828|ferrous fumarate|ferrous fumarate
4977821|NCT04130828|oral iron treatment|oral iron treatment
4977822|NCT04130828|thrice-weekly|thrice-weekly
4977823|NCT04130828|thrice-daily|thrice-daily
4977824|NCT04130828|iron deficiency anemia|iron deficiency anemia
4977825|NCT04130802|post-cataract,|post-cataract,
4977826|NCT04130802|inflammation|inflammation
4977828|NCT04130802|post-surgery|post-surgery
4977829|NCT04130802|corticosteroid|corticosteroid
4977830|NCT04130802|anterior chamber cells|anterior chamber cells
4977831|NCT04130802|flares|flares
4977832|NCT04130789|clinical data warehouse (CDWH)|clinical data warehouse (cdwh)
4977833|NCT04130789|machine learning|machine learning
4977834|NCT04130789|data-driven algorithms|data-driven algorithms
4974863|NCT04149418|yogurt|yogurt
4977835|NCT04130789|multi-dimensional modelling|multi-dimensional modelling
4977836|NCT04130763|Immuno-checkpoint inhibitor therapy|immuno-checkpoint inhibitor therapy
4977837|NCT04130763|GI cancer|gi cancer
4977838|NCT04130763|FMT|fmt
4977839|NCT04130737|Peripheral Artery Disease|peripheral artery disease
4977840|NCT04130737|Superficial Femoral Artery|superficial femoral artery
4977841|NCT04130737|Popliteal Artery|popliteal artery
4977842|NCT04130737|Stent Graft|stent graft
4977843|NCT04130711|stroke|stroke
4977860|NCT04130620|Applied Kinesiology|applied kinesiology
4977861|NCT04130607|Teaching Strategies, Diagnostic reasoning|teaching strategies, diagnostic reasoning
4977863|NCT04130594|vector based vaccine|vector based vaccine
5903455|NCT00368446|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
4977864|NCT04130594|Middle East respiratory syndrome|middle east respiratory syndrome
4977865|NCT04130594|Immunologic Factors|immunologic factors
4977866|NCT04130594|Physiological Effects of Drugs|physiological effects of drugs
4977867|NCT04130594|MERS-Cov|mers-cov
4977870|NCT04130529|Cognitive Behaviour Therapy|cognitive behaviour therapy
4977871|NCT04130529|Psychological Intervention|psychological intervention
4977872|NCT04130464|Intraperitoneal|intraperitoneal
4977873|NCT04130464|Pain Pump|pain pump
4977874|NCT04130464|Ropivacaine|ropivacaine
4977875|NCT04130464|Ketorolac Tromethamine|ketorolac tromethamine
4977876|NCT04130412|Lateral patellar compression syndrome|lateral patellar compression syndrome
4977877|NCT04130412|Arthroscopic release|arthroscopic release
4977878|NCT04130412|Open release|open release
4977879|NCT04130399|Folfirinox|folfirinox
4977880|NCT04130399|Cancer|cancer
4977881|NCT04130399|Radiation Therapy|radiation therapy
4982265|NCT04103229|Saline|saline
4977898|NCT04130243|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4977899|NCT04130165|preterm infants|preterm infants
4977900|NCT04130165|human milk|human milk
4977901|NCT04130165|microbiome|microbiome
4977902|NCT04130165|donor human milk|donor human milk
4977903|NCT04130165|breastmilk|breastmilk
4977904|NCT04130152|Palbociclib, residual disease, Neoadjuvant treatment, Ki67|palbociclib, residual disease, neoadjuvant treatment, ki67
4977905|NCT04130087|Reward|reward
4977906|NCT04130087|Selegiline|selegiline
4977907|NCT04130087|Cognition|cognition
4977908|NCT04130048|Elasticity Imaging Techniques|elasticity imaging techniques
4977909|NCT04130048|Venous Thromboembolism|venous thromboembolism
4977910|NCT04130035|decision making|decision making
4977911|NCT04130035|degenerative lumbar disease|degenerative lumbar disease
4977912|NCT04130035|CT|ct
4977913|NCT04130035|MRI|mri
4977914|NCT04130009|Thigh pain|thigh pain
4977915|NCT04130009|Total knee Arthroplasty|total knee arthroplasty
4977916|NCT04130009|Tourniquet|tourniquet
4977917|NCT04129983|Hearing Loss, Sudden|hearing loss, sudden
4977918|NCT04129983|Prednisone acetate|prednisone acetate
4977919|NCT04129983|Hyperbaric oxygen|hyperbaric oxygen
4977920|NCT04129983|Somatic stimulus|somatic stimulus
4977927|NCT04129957|prediction|prediction
4977928|NCT04129957|dental implants|dental implants
4977929|NCT04129957|failure|failure
4977930|NCT04129957|peri-implantitis|peri-implantitis
4977935|NCT04129918|intensive care unit|intensive care unit
4977936|NCT04129918|sleep quality|sleep quality
4977937|NCT04129918|circadian rhythm|circadian rhythm
4977938|NCT04129905|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
4977939|NCT04129905|Endothelial Dysfunction|endothelial dysfunction
4977940|NCT04129905|Venous return|venous return
4977941|NCT04129905|Left ventricular outflow-tract obstruction|left ventricular outflow-tract obstruction
4977942|NCT04129905|Sudden cardiac death risk|sudden cardiac death risk
4977944|NCT04129892|Academic course|academic course
4977945|NCT04129892|College students|college students
4977946|NCT04129879|endometriosis|endometriosis
4977947|NCT04129879|methylene blue dye|methylene blue dye
4977948|NCT04129853|Wearable robotics|wearable robotics
4977949|NCT04129853|Unilateral Lower Limb Amputation|unilateral lower limb amputation
4977950|NCT04129840|antihypertensive treatment|antihypertensive treatment
4977951|NCT04129827|Return to Sport|return to sport
4977952|NCT04129827|ACL reconstruction|acl reconstruction
4977954|NCT04129827|Athletes|athletes
4977955|NCT04129814|Chronic periodontitis|chronic periodontitis
4977956|NCT04129814|Prognosis|prognosis
4977957|NCT04129814|Erectile Dysfunction|erectile dysfunction
4977958|NCT04129801|Severe obesity|severe obesity
4977959|NCT04129801|Body Composition|body composition
4977960|NCT04129801|Muscle Strength|muscle strength
4977961|NCT04129801|Electrical bioimpedance analysis|electrical bioimpedance analysis
4977962|NCT04129775|hearing loss|hearing loss
4977963|NCT04129775|speech-in-noise|speech-in-noise
4977964|NCT04129775|synaptopathy|synaptopathy
4977965|NCT04129775|hearing impairment|hearing impairment
4977966|NCT04129775|hidden hearing loss|hidden hearing loss
4977967|NCT04129645|Ureteral|ureteral
4977968|NCT04129645|ureteral stent|ureteral stent
4977969|NCT04129645|ureteral stricture|ureteral stricture
4977970|NCT04129632|burnout|burnout
4977971|NCT04129632|wellness|wellness
4977972|NCT04129632|mindfulness|mindfulness
4977973|NCT04129632|physician burnout|physician burnout
4977974|NCT04129619|Irritable Bowel Syndrome|irritable bowel syndrome
4977975|NCT04129619|IBS|ibs
4977976|NCT04129606|Perforation of Bladder|perforation of bladder
4977977|NCT04129606|Bladder Cancer|bladder cancer
4977978|NCT04129606|Resection Margin|resection margin
4977979|NCT04129567|Trans-nasal therapy|trans-nasal therapy
4977980|NCT04129567|acute migraine attack|acute migraine attack
4977981|NCT04129528|T1DM|t1dm
4977990|NCT04129450|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
4977991|NCT04129450|Medical group visits|medical group visits
4977992|NCT04129450|Primary care setting|primary care setting
4978003|NCT04129385|trendelenburg position|trendelenburg position
4978005|NCT04129372|vegetables|vegetables
4978006|NCT04129372|food neophobia|food neophobia
4978007|NCT04129372|preschool|preschool
4978008|NCT04129372|children|children
4978009|NCT04129346|Inactivity|inactivity
4978010|NCT04129346|Breast Cancer|breast cancer
4978011|NCT04129346|Metastatic Breast Cancer|metastatic breast cancer
4978012|NCT04129346|Quality of life|quality of life
4978013|NCT04129346|Sedentary|sedentary
4978014|NCT04129320|SCCHN|scchn
4978015|NCT04129320|head and neck|head and neck
4978016|NCT04129320|oropharyngeal|oropharyngeal
4978017|NCT04129320|oral cavity|oral cavity
4978018|NCT04129320|hypopharyngeal|hypopharyngeal
4978019|NCT04129320|laryngeal cancer|laryngeal cancer
4978020|NCT04129320|immunotherapy|immunotherapy
4978021|NCT04129320|PD-1|pd-1
4978022|NCT04129320|B7-H3|b7-h3
4978023|NCT04129307|Motor imagery|motor imagery
4978024|NCT04129307|Action observation|action observation
4978025|NCT04129294|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4978026|NCT04129281|Papillary Microcarcinoma of the Thyroid|papillary microcarcinoma of the thyroid
4978027|NCT04129281|Surgery|surgery
4978028|NCT04129281|Outcome|outcome
4978029|NCT04129281|Follow up|follow up
4978030|NCT04129255|Octreotide|octreotide
4978031|NCT04129255|neuroendocrine tumors|neuroendocrine tumors
4978032|NCT04129255|immunological response|immunological response
4978033|NCT04129242|Stroke|stroke
4978034|NCT04129242|Rehabilitation|rehabilitation
4978035|NCT04129242|Vagus Nerve Stimulation|vagus nerve stimulation
4978036|NCT04129242|Brain Stimulation|brain stimulation
4978037|NCT04129242|Occupational Therapy|occupational therapy
4978038|NCT04129216|breast cancer|breast cancer
4978039|NCT04129216|genomic assay|genomic assay
4978040|NCT04129216|hormone therapy|hormone therapy
4978041|NCT04129203|acute ischemic stroke|acute ischemic stroke
4978042|NCT04129177|Surgical site infection|surgical site infection
4978043|NCT04129177|Colorectal surgery|colorectal surgery
4978044|NCT04129177|Surveillance|surveillance
4978045|NCT04129177|Bundle approach|bundle approach
4978070|NCT04128956|Aspirin plus rivaroxaban vs. rivaroxaban for the prevention|aspirin plus rivaroxaban vs. rivaroxaban for the prevention
4978071|NCT04128943|electronic patient-reported outcomes|electronic patient-reported outcomes
4978072|NCT04128943|electronic health (eHealth) technology|electronic health (ehealth) technology
4978074|NCT04128943|ePRO application|epro application
4978075|NCT04128904|Infertility|infertility
4978076|NCT04128904|Non-male factor infertility|non-male factor infertility
4978077|NCT04128904|In vitro fertilisation (IVF)|in vitro fertilisation (ivf)
4978078|NCT04128904|Intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
4978079|NCT04128904|Assisted reproductive technologies (ART)|assisted reproductive technologies (art)
4978080|NCT04128904|Live birth rate|live birth rate
4978081|NCT04128904|Reproductive outcome|reproductive outcome
4978082|NCT04128865|phytotherapy|phytotherapy
4978083|NCT04128865|dietary supplement|dietary supplement
4978084|NCT04128865|food interaction|food interaction
4978085|NCT04128865|herb-drug interactions|herb-drug interactions
4978086|NCT04128839|gut microbiome|gut microbiome
4978087|NCT04128839|metabolome|metabolome
5342906|NCT01981551|Gamma-secretase Inhibitor|gamma-secretase inhibitor
4978088|NCT04128839|postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
4978089|NCT04128839|low-grade inflammation|low-grade inflammation
4978090|NCT04128839|visceral adipose tissue|visceral adipose tissue
4978091|NCT04128826|Partial Range of Motion|partial range of motion
4978092|NCT04128826|Full Range of Motion|full range of motion
4978093|NCT04128800|apatinib S-1|apatinib s-1
4978094|NCT04128800|Advanced lung cancer|advanced lung cancer
4978095|NCT04128787|Bioavailability Study|bioavailability study
4978096|NCT04128787|Pharmacokinetic study|pharmacokinetic study
4978097|NCT04128787|AG-881|ag-881
4978098|NCT04128774|Glioma|glioma
4978099|NCT04128774|Glioblastoma|glioblastoma
4978100|NCT04128774|Adult|adult
4978101|NCT04128774|Dexamethasone|dexamethasone
4978102|NCT04128774|B cells|b cells
4978103|NCT04128774|Regulatory B cells|regulatory b cells
5006006|NCT03959176|Brimonidine|brimonidine
4978117|NCT04128709|bladder|bladder
4978126|NCT04128670|kinesio tape|kinesio tape
4978127|NCT04128670|muscle soreness|muscle soreness
4982482|NCT04101929|S-1|s-1
4978136|NCT04128644|school|school
4978140|NCT04128579|Systemic Lupus Erythematosus|systemic lupus erythematosus
4978141|NCT04128579|Active Proliferative Lupus Nephritis|active proliferative lupus nephritis
4978147|NCT04128566|anterior cruciate ligament (ACL) injury|anterior cruciate ligament (acl) injury
4978148|NCT04128566|articular cartilage quality|articular cartilage quality
4978149|NCT04128553|elderly|elderly
4978150|NCT04128553|motivational interview|motivational interview
4978151|NCT04128553|Transtheoretical model|transtheoretical model
4978152|NCT04128553|exercise|exercise
4978153|NCT04128553|community health nursing|community health nursing
4978154|NCT04128514|Toric IOL|toric iol
4978155|NCT04128514|Panoptix|panoptix
4978156|NCT04128514|multifocal IOL|multifocal iol
4978157|NCT04128514|trifocal IOL|trifocal iol
4978164|NCT04128462|Overt HE diagnosis|overt he diagnosis
4978165|NCT04128449|performance|performance
4978166|NCT04128449|cyclists|cyclists
4978167|NCT04128449|docosahexaenoic acid|docosahexaenoic acid
4978168|NCT04128449|anaerobic threshold|anaerobic threshold
4978169|NCT04128436|luteal phase|luteal phase
4978170|NCT04128436|progesterone|progesterone
4978171|NCT04128436|in vitro fertilization|in vitro fertilization
4978172|NCT04128423|immunotherapy|immunotherapy
4978173|NCT04128423|anti-CD33|anti-cd33
4978174|NCT04128423|T-cell engager|t-cell engager
4978175|NCT04128410|S-flurbiprofen, R-flurbiprofen|s-flurbiprofen, r-flurbiprofen
4978176|NCT04128410|cerebrospinal fluid|cerebrospinal fluid
4978177|NCT04128410|aged|aged
4978178|NCT04128397|transcranial magnetic stimulation|transcranial magnetic stimulation
4978179|NCT04128397|fMRI|fmri
4978180|NCT04128384|Transcatheter valve replacement|transcatheter valve replacement
4978181|NCT04128384|Infranodal conduction time|infranodal conduction time
4978182|NCT04128384|High-degree AV block|high-degree av block
4978183|NCT04128384|Left Bundle-Branch Block|left bundle-branch block
4978184|NCT04128371|Absolute Neutrophil Count|absolute neutrophil count
4978185|NCT04128371|Cycling|cycling
4978186|NCT04128371|Gleich's Syndrome|gleich's syndrome
4978187|NCT04128371|Urticaria|urticaria
4978188|NCT04128371|Serum Interleukin 5|serum interleukin 5
4978189|NCT04128319|Steroid-refractory acute GVHD|steroid-refractory acute gvhd
4978190|NCT04128319|Acute GVHD|acute gvhd
4978191|NCT04128319|GVHD treatment|gvhd treatment
4978192|NCT04128306|Time to contact estimation|time to contact estimation
4978193|NCT04128306|awake brain surgery|awake brain surgery
4978194|NCT04128306|brain tumor|brain tumor
4978195|NCT04128306|cerebral mapping|cerebral mapping
4978196|NCT04128293|Healthy participants|healthy participants
4978197|NCT04128293|GSK3640254|gsk3640254
4978198|NCT04128293|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
4978200|NCT04128280|Chronic Prostatitis|chronic prostatitis
4978201|NCT04128241|Knowledge|knowledge
4978202|NCT04128241|Attitudes|attitudes
4978203|NCT04128241|Practice|practice
4978204|NCT04128241|Behaviours|behaviours
4978205|NCT04128241|Fad diets|fad diets
4978206|NCT04128241|Kap survey|kap survey
4978207|NCT04128228|Alcohol use disorder|alcohol use disorder
4978208|NCT04128228|Early trauma|early trauma
4978209|NCT04128228|fMRI|fmri
4978210|NCT04128228|Stress hormone|stress hormone
4978211|NCT04128228|Alcohol relapse|alcohol relapse
4978212|NCT04128215|High-Intensity Interval Training|high-intensity interval training
4978213|NCT04128215|Aerobic exercise|aerobic exercise
4978214|NCT04128215|Acute exercise|acute exercise
4978215|NCT04128176|Omalizumab|omalizumab
4978216|NCT04128176|Rituximab|rituximab
4978217|NCT04128176|Bullous Pemphigoid|bullous pemphigoid
4978218|NCT04128124|asynchronies|asynchronies
4978219|NCT04128124|mechanical ventilation|mechanical ventilation
4978220|NCT04128124|irregularity|irregularity
4978221|NCT04128124|complexity|complexity
4978222|NCT04128124|breathing pattern|breathing pattern
4978223|NCT04128124|self-extubation|self-extubation
4978231|NCT04128072|Total Skin Electron Beam therapy|total skin electron beam therapy
4978233|NCT04128059|vector based vaccine|vector based vaccine
4978234|NCT04128059|Immunologic Factors|immunologic factors
4978235|NCT04128059|MERS-CoV|mers-cov
4978236|NCT04128059|Middle East respiratory syndrome|middle east respiratory syndrome
4978237|NCT04128033|acupuncture|acupuncture
4978238|NCT04128033|perineum injury|perineum injury
4978239|NCT04128033|delivery|delivery
4978240|NCT04127981|18F-FDG PET Scan|18f-fdg pet scan
4978241|NCT04127981|Dexa Scan|dexa scan
4978242|NCT04127981|Quality of Life assessment tools|quality of life assessment tools
4978243|NCT04127942|platelet-rich plasma|platelet-rich plasma
4978244|NCT04127942|ultrasound guided injection.|ultrasound guided injection.
4978245|NCT04127942|Temporomandibular disorder|temporomandibular disorder
4978246|NCT04127929|glass ionomer, composite, clinical|glass ionomer, composite, clinical
4978247|NCT04127890|oxygen-enriched water|oxygen-enriched water
4978258|NCT04127760|Meningioma Atypical|meningioma atypical
4978259|NCT04127760|radiotherapy|radiotherapy
4978260|NCT04127747|Systemic lupus erythematosus|systemic lupus erythematosus
4978261|NCT04127747|rituximab|rituximab
4978262|NCT04127708|tinnitus|tinnitus
4978263|NCT04127708|acupuncture|acupuncture
4978264|NCT04127708|otology|otology
4978265|NCT04127708|prospective study|prospective study
4978266|NCT04127695|Parkinson's Disease|parkinson's disease
4978267|NCT04127669|residual symptoms|residual symptoms
4978268|NCT04127669|mental fatigue|mental fatigue
4978269|NCT04127669|dopamine stabilizer|dopamine stabilizer
4978270|NCT04127643|S-ICD|s-icd
4978271|NCT04127643|safety|safety
4978272|NCT04127643|feasibility|feasibility
4978273|NCT04127617|Manipulation, Osteopathic|manipulation, osteopathic
4978274|NCT04127617|Neurogenic Bowel|neurogenic bowel
4978275|NCT04127617|Nervous System Diseases|nervous system diseases
4978276|NCT04127617|Nursing|nursing
4978277|NCT04127604|Bipolar Disorder|bipolar disorder
4978278|NCT04127604|Substance Use Disorders|substance use disorders
4978279|NCT04127604|Treatment Adherence|treatment adherence
4978280|NCT04127604|Veterans|veterans
4978281|NCT04127604|Psychosocial intervention|psychosocial intervention
4978282|NCT04127578|Parkinson's Disease|parkinson's disease
4978283|NCT04127578|GBA1 mutation|gba1 mutation
4978284|NCT04127578|Glucocerebrosidase|glucocerebrosidase
4978285|NCT04127578|PD-GBA|pd-gba
4978286|NCT04127578|Parkinson's Disease Gene Therapy|parkinson's disease gene therapy
4978287|NCT04127578|AAV9|aav9
4978288|NCT04127578|Gene Therapy|gene therapy
4978289|NCT04127578|GBA|gba
4978290|NCT04127565|Telemedicine|telemedicine
4978291|NCT04127565|Emergency Medical Service|emergency medical service
4978294|NCT04127526|Dissociation|dissociation
4978295|NCT04127526|Psychosis|psychosis
4978296|NCT04127526|Trauma|trauma
4978297|NCT04127526|Hallucinations|hallucinations
4978298|NCT04127526|Psychological Therapies|psychological therapies
4978299|NCT04127513|xerosis cutis|xerosis cutis
4978300|NCT04127513|geriatric|geriatric
4978301|NCT04127513|12% ammonium lactate|12% ammonium lactate
4978302|NCT04127513|10% urea|10% urea
4978303|NCT04127487|NLRP3 (rs4612666), CARD8 (rs20432111)|nlrp3 (rs4612666), card8 (rs20432111)
4978304|NCT04127474|periodontitis|periodontitis
4978305|NCT04127474|saliva|saliva
4978306|NCT04127474|trefoil factor|trefoil factor
4978307|NCT04127474|adrenomedullin|adrenomedullin
4978308|NCT04127474|Coronary heart disease|coronary heart disease
4978309|NCT04127448|Aerobic Exercise|aerobic exercise
4978310|NCT04127448|Cognitive dysfunction|cognitive dysfunction
4978311|NCT04127448|Exergaming|exergaming
4978312|NCT04127448|T2DM.|t2dm.
5702720|NCT00492310|yoga|yoga
4978313|NCT04127422|Benign breast disease|benign breast disease
4978314|NCT04127422|Fibrocystic disease|fibrocystic disease
4978315|NCT04127409|Omega-3 Polyunsaturated Fatty Acids|omega-3 polyunsaturated fatty acids
4978330|NCT04127292|Empathy|empathy
4978331|NCT04127292|Emotional Self-Awareness|emotional self-awareness
4978332|NCT04127279|autonomic nervous system|autonomic nervous system
4978333|NCT04127279|HPA axis|hpa axis
4978334|NCT04127279|anxiety|anxiety
4978335|NCT04127279|non verbal behavior|non verbal behavior
4978336|NCT04127266|Donor pool|donor pool
4978337|NCT04127266|Brain death|brain death
4978338|NCT04127266|Unallocated organs|unallocated organs
4978339|NCT04127266|Histopathological quality|histopathological quality
4978340|NCT04127253|Motor imagery|motor imagery
4978341|NCT04127253|Transcranial direct current stimulation|transcranial direct current stimulation
4978342|NCT04127253|Action observation|action observation
4978343|NCT04127214|eating disorders|eating disorders
4978344|NCT04127214|anorexia nervosa|anorexia nervosa
4978345|NCT04127214|bulimia nervosa|bulimia nervosa
4978346|NCT04127214|binge eating|binge eating
4978347|NCT04127214|routine outcome monitoring|routine outcome monitoring
4978348|NCT04127214|psychological interventions|psychological interventions
4978349|NCT04127214|integrated treatment|integrated treatment
4978350|NCT04127214|effectiveness|effectiveness
4978351|NCT04127201|"online therapy"|"online therapy"
4978352|NCT04127201|"weight loss control program"|"weight loss control program"
4978353|NCT04127201|Internet|internet
4978354|NCT04127175|Breast cancer|breast cancer
4978361|NCT04127162|Temporal Dispersion of Repolarization Phase|temporal dispersion of repolarization phase
4978362|NCT04127162|proBNP|probnp
4978363|NCT04127162|QTVI|qtvi
4978364|NCT04127162|QT|qt
4978365|NCT04127162|Tpeak-Tend|tpeak-tend
4978366|NCT04127149|ultrasound scanner|ultrasound scanner
4978367|NCT04127149|sonogram|sonogram
4978368|NCT04127149|general practice|general practice
4978369|NCT04127136|obesity|obesity
4978370|NCT04127136|weight loss|weight loss
4978371|NCT04127136|Binge-Eating Disorder|binge-eating disorder
4978372|NCT04127123|arrhythmia|arrhythmia
4978373|NCT04127123|cardiac electrophysiology|cardiac electrophysiology
4978374|NCT04127123|ablation|ablation
4978375|NCT04127110|Anaplastic lymphoma kinase (ALK) positive non small cell lung cancer (NSCLC)|anaplastic lymphoma kinase (alk) positive non small cell lung cancer (nsclc)
4978376|NCT04127097|anxiety|anxiety
4978377|NCT04127097|fear|fear
4978378|NCT04127097|nursing|nursing
4978379|NCT04127084|Type 2 diabetes|type 2 diabetes
4978380|NCT04127084|Diabetic Nephropathy|diabetic nephropathy
4978381|NCT04127084|Albuminuria|albuminuria
4978382|NCT04127084|SGLT2 inhibitor|sglt2 inhibitor
4978383|NCT04127071|Ultrasound Guided Needle Aspiration|ultrasound guided needle aspiration
4978384|NCT04127071|Incision and Drainage|incision and drainage
4978385|NCT04127045|gait analysis|gait analysis
4978386|NCT04127045|hip fracture|hip fracture
4978387|NCT04127045|elderly|elderly
4978388|NCT04127045|mobility|mobility
4978389|NCT04127032|Internet|internet
4978390|NCT04127032|Cognitive Behavioral Therapy|cognitive behavioral therapy
4978391|NCT04127032|Telemedicine|telemedicine
4978392|NCT04127006|EYS mutation|eys mutation
4978393|NCT04127006|Retinitis Pigmentosa|retinitis pigmentosa
4978394|NCT04126993|SHR-1210|shr-1210
4978395|NCT04126993|Camrelizumab|camrelizumab
4978396|NCT04126993|Apatinib|apatinib
4978397|NCT04126993|Sarcoma|sarcoma
4978398|NCT04126993|Jilong Yang|jilong yang
4978399|NCT04126967|NGS|ngs
4978400|NCT04126967|MRD|mrd
4978401|NCT04126967|Allo-PBSCT|allo-pbsct
4995821|NCT04019873|2DR|2dr
4978405|NCT04126941|Teriparatide|teriparatide
4978406|NCT04126928|orthopantomograph|orthopantomograph
4978407|NCT04126928|periapical index|periapical index
4978408|NCT04126928|reliability|reliability
4978409|NCT04126928|sensitivity|sensitivity
4978410|NCT04126928|specificity|specificity
4978411|NCT04126915|Castration-Resistant Prostatic Cancer|castration-resistant prostatic cancer
5702829|NCT00491894|Drooling|drooling
4978412|NCT04126915|Whole Exome Sequencing|whole exome sequencing
4978413|NCT04126902|innate immunity|innate immunity
4978414|NCT04126902|macrophage|macrophage
4978415|NCT04126902|toll-like receptors|toll-like receptors
4978416|NCT04126902|trophoblasts|trophoblasts
4978417|NCT04126902|phagocytos|phagocytos
4978418|NCT04126850|Microbiome|microbiome
4978419|NCT04126850|Autoimmune Uveitis|autoimmune uveitis
4978420|NCT04126850|Vogt-Koyanagi-Harada Disease|vogt-koyanagi-harada disease
4978421|NCT04126850|Behçet Disease|behçet disease
4978422|NCT04126850|Idiopathic Uveitis|idiopathic uveitis
4978423|NCT04126850|Metatranscriptomic|metatranscriptomic
4978424|NCT04126850|Amplicon|amplicon
4978425|NCT04126837|Ankle|ankle
4978426|NCT04126837|Foot|foot
4978427|NCT04126837|Injuries|injuries
4978428|NCT04126837|Ottawa Rules|ottawa rules
4978429|NCT04126837|nurse|nurse
4978430|NCT04126824|Uterine Artery Embolization|uterine artery embolization
5302682|NCT02163291|safety|safety
4978431|NCT04126811|Soft tissue sarcoma|soft tissue sarcoma
4978432|NCT04126811|apatinib|apatinib
4978433|NCT04126811|Jilong Yang|jilong yang
4978434|NCT04126798|Cognition|cognition
4978435|NCT04126798|Motor performance|motor performance
4978436|NCT04126798|Dual-task|dual-task
4978437|NCT04126785|Aging|aging
4978438|NCT04126785|Blood Pressure|blood pressure
4978439|NCT04126785|Endothelial function|endothelial function
4978440|NCT04126785|Exercise|exercise
4978441|NCT04126785|Heart rate variability|heart rate variability
4978442|NCT04126759|Non-invasive glucose monitoring|non-invasive glucose monitoring
4979032|NCT04123158|MRI|mri
4978454|NCT04126655|5-FU|5-fu
4978455|NCT04126655|Arfolitixorin|arfolitixorin
4978456|NCT04126655|Calciumfolinate|calciumfolinate
4978457|NCT04126655|TS-inhibtion|ts-inhibtion
4978458|NCT04126642|improve symptom management|improve symptom management
4978459|NCT04126642|reduce treatment non-adherence|reduce treatment non-adherence
4978460|NCT04126629|Hypertensive Disorder of Pregnancy|hypertensive disorder of pregnancy
4978461|NCT04126629|Sleep-disordered Breathing|sleep-disordered breathing
4978462|NCT04126629|HDP|hdp
4978463|NCT04126629|SDB|sdb
4978464|NCT04126590|Adverse Event|adverse event
4978465|NCT04126590|Anti-Drug Antibodies|anti-drug antibodies
4978466|NCT04126590|Complete Response|complete response
4978468|NCT04126564|Stress|stress
4978469|NCT04126564|Anxiety|anxiety
4978470|NCT04126564|Depression|depression
4978471|NCT04126564|Meditation|meditation
4978472|NCT04126564|Inner Engineering Online|inner engineering online
4978473|NCT04126525|neoadjuvant|neoadjuvant
4978474|NCT04126525|pyrotinib|pyrotinib
4978475|NCT04126525|trastuzumab|trastuzumab
4978476|NCT04126525|paclitaxel|paclitaxel
4978477|NCT04126525|cisplatin|cisplatin
4978478|NCT04126473|aminoglycoside|aminoglycoside
4978479|NCT04126473|Nonsense Mutation|nonsense mutation
4978480|NCT04126473|Translational read through|translational read through
4978481|NCT04126460|Head and neck|head and neck
4978482|NCT04126460|recurrent disease|recurrent disease
4978483|NCT04126460|PD-1|pd-1
4978484|NCT04126460|salvage surgery|salvage surgery
4978485|NCT04126460|Second Primary|second primary
4978486|NCT04126421|Highly cross-linked polyethylene (HXLPE)|highly cross-linked polyethylene (hxlpe)
4978487|NCT04126421|Vitamin E infused polyethylene|vitamin e infused polyethylene
4978488|NCT04126395|motor development|motor development
4978489|NCT04126395|baby|baby
4978490|NCT04126395|infant|infant
4978491|NCT04126395|motor milestones|motor milestones
4978492|NCT04126395|crawling|crawling
4978493|NCT04126395|independent walking|independent walking
4978494|NCT04126382|NRDS|nrds
4978495|NCT04126382|preterm infants|preterm infants
4978496|NCT04126382|LISA|lisa
4978497|NCT04126382|INSURE|insure
4978498|NCT04126369|Drug Resistant Epilepsy|drug resistant epilepsy
4978499|NCT04126369|mindfulness|mindfulness
4978500|NCT04126369|self management|self management
4978501|NCT04126343|Healthy study participants|healthy study participants
4978502|NCT04126343|Padsevonil|padsevonil
4978503|NCT04126343|Moxifloxacin|moxifloxacin
4978504|NCT04126343|Cardiac repolarization|cardiac repolarization
4978505|NCT04126304|community-acquired pneumonia|community-acquired pneumonia
4978506|NCT04126304|common cold|common cold
4978507|NCT04126304|acute bronchitis|acute bronchitis
4978508|NCT04126304|Post-infection cough|post-infection cough
4978509|NCT04126304|Mycoplasma infection rate|mycoplasma infection rate
4978510|NCT04126304|macrolides resistance|macrolides resistance
4978515|NCT04126239|food Addiction|food addiction
4978516|NCT04126239|Obesity|obesity
4978517|NCT04126226|Speech therapy|speech therapy
4978518|NCT04126226|Dysphagia|dysphagia
4978519|NCT04126226|Speech Intelligibility|speech intelligibility
4978520|NCT04126226|Quality of Life|quality of life
4978531|NCT04126187|Panoptix|panoptix
4978532|NCT04126187|Trifocal IOL|trifocal iol
4978533|NCT04126187|Multifocal IOL|multifocal iol
4978534|NCT04126174|astigmatism, limbal relaxing incisions|astigmatism, limbal relaxing incisions
4978535|NCT04126161|muscle|muscle
4978536|NCT04126161|ultrasound|ultrasound
4978537|NCT04126161|CT|ct
4978538|NCT04126135|Smoking Cessation, Nicotine Replacement Therapy, Cytisine|smoking cessation, nicotine replacement therapy, cytisine
4978539|NCT04126083|Opioid tapering|opioid tapering
4978540|NCT04126083|Spine surgery|spine surgery
4978541|NCT04126070|Hormone Sensitive Prostate Cancer|hormone sensitive prostate cancer
4978542|NCT04126070|Prostate Adenocarcinoma|prostate adenocarcinoma
4978543|NCT04126070|Metastasis Prostate Adenocarcinoma|metastasis prostate adenocarcinoma
4978551|NCT04125992|cardiac catheterization|cardiac catheterization
4978552|NCT04125992|coronary angiography|coronary angiography
4978553|NCT04125992|coronary angioplasty|coronary angioplasty
4978554|NCT04125992|snuff-box|snuff-box
4978555|NCT04125992|snuffbox|snuffbox
4978556|NCT04125992|snuff box|snuff box
4978557|NCT04125992|radial fossa|radial fossa
4978558|NCT04125992|distal radial artery|distal radial artery
4978559|NCT04125992|radial artery|radial artery
4978560|NCT04125992|safeguard|safeguard
4978561|NCT04125992|distal radial access|distal radial access
4978562|NCT04125992|distal radial angiography|distal radial angiography
4978563|NCT04125992|radial access|radial access
4978564|NCT04125992|angiography|angiography
4978565|NCT04125992|distal radial|distal radial
4978566|NCT04125992|radial|radial
4978567|NCT04125992|coronary arteries|coronary arteries
4978568|NCT04125992|randomized controlled trial|randomized controlled trial
4978569|NCT04125992|left distal radial artery|left distal radial artery
4978570|NCT04125992|Percutaneous Coronary Intervention|percutaneous coronary intervention
4978571|NCT04125992|radial artery occlusion|radial artery occlusion
4978572|NCT04125992|forearm radial access|forearm radial access
4978573|NCT04125992|forearm radial artery|forearm radial artery
5298496|NCT02185963|MCA assay|mca assay
4978574|NCT04125992|coronary catheterization|coronary catheterization
4978575|NCT04125992|catheterization|catheterization
4978576|NCT04125992|left distal radial|left distal radial
4978577|NCT04125992|angioplasty|angioplasty
4978578|NCT04125992|coronary artery disease|coronary artery disease
4978579|NCT04125992|radial vs distal|radial vs distal
4978580|NCT04125966|NT-proBNP|nt-probnp
4978581|NCT04125966|Atrial Fibrillation|atrial fibrillation
4978582|NCT04125966|Heart Failure|heart failure
4978583|NCT04125940|Resync|resync
4978584|NCT04125940|Nitrate|nitrate
4978585|NCT04125940|Nitrite|nitrite
4978586|NCT04125940|Healthy|healthy
4978591|NCT04125849|Mediastinoscopy-assisted transhiatal esophagectomy (MATHE)|mediastinoscopy-assisted transhiatal esophagectomy (mathe)
4978592|NCT04125849|Minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
4978597|NCT04125810|Probiotic|probiotic
4978598|NCT04125810|Stress|stress
4978599|NCT04125810|Gut-brain axis|gut-brain axis
4978601|NCT04125784|HIV infection|hiv infection
4978602|NCT04125784|Dyslipidaemia|dyslipidaemia
4978603|NCT04125784|Diabetes mellitus|diabetes mellitus
4978604|NCT04125784|Diabetes mellitus type 2|diabetes mellitus type 2
4978605|NCT04125784|Cardiovascular Risk factor|cardiovascular risk factor
4978606|NCT04125784|Lipid profile|lipid profile
4978607|NCT04125784|Austria|austria
4978608|NCT04125784|HIV related treatment|hiv related treatment
4978609|NCT04125784|Antiretroviral therapy|antiretroviral therapy
4978610|NCT04125784|Follow-up Study|follow-up study
4978611|NCT04125732|Refractory angina|refractory angina
4978612|NCT04125732|Coronary Artery Disease|coronary artery disease
4978613|NCT04125732|Gene Therapy|gene therapy
4978614|NCT04125693|Fibroblast growth factor receptors (FGFR) Inhibitor|fibroblast growth factor receptors (fgfr) inhibitor
4978615|NCT04125693|FGFR 1-4|fgfr 1-4
4978616|NCT04125693|Non-small-cell lung cancer|non-small-cell lung cancer
4978617|NCT04125693|Small-cell lung cancer|small-cell lung cancer
4978618|NCT04125693|Urothelial carcinoma|urothelial carcinoma
4978619|NCT04125693|Adenoidcystic carcinoma|adenoidcystic carcinoma
4978620|NCT04125693|Head cancer|head cancer
4978621|NCT04125693|Neck cancer|neck cancer
4978622|NCT04125693|Breast cancer|breast cancer
4978623|NCT04125667|Circulating cancer cells|circulating cancer cells
4978624|NCT04125667|Biomedical polymer material|biomedical polymer material
4978625|NCT04125667|Cell affinity difference|cell affinity difference
4978626|NCT04125667|White blood cell attachment|white blood cell attachment
4978627|NCT04125654|Ascites infection|ascites infection
4978628|NCT04125654|ascites|ascites
4978630|NCT04125641|Elxaban|elxaban
4978631|NCT04125628|Uthoff's phenomenon|uthoff's phenomenon
4978632|NCT04125628|Thermosensitivity|thermosensitivity
4978633|NCT04125628|Functional capacity|functional capacity
4978634|NCT04125628|Exercise intolerance|exercise intolerance
4978635|NCT04125602|Personalized Nutrition|personalized nutrition
4978636|NCT04125602|Glucose Metabolism|glucose metabolism
4978637|NCT04125602|Gut Microbiota|gut microbiota
4978638|NCT04125589|Binge-Eating Disorder|binge-eating disorder
4978639|NCT04125589|Decision-Making|decision-making
4978640|NCT04125589|Brain Activity|brain activity
4978641|NCT04125576|burn|burn
4978642|NCT04125576|neuropathic pain|neuropathic pain
4978649|NCT04125537|Goals of Care Conversations|goals of care conversations
4978650|NCT04125537|Palliative Care|palliative care
4978651|NCT04125537|Palliative Medicine|palliative medicine
4978652|NCT04125537|Advanced Care Planning|advanced care planning
4978653|NCT04125537|Medical Management without Dialysis|medical management without dialysis
4978654|NCT04125537|Palliative Dialysis|palliative dialysis
4978655|NCT04125537|Conservative Kidney Management|conservative kidney management
4978656|NCT04125524|Tumour markers|tumour markers
4978658|NCT04125498|cicatrix|cicatrix
4978659|NCT04125498|c-section|c-section
4978660|NCT04125498|scar|scar
4978661|NCT04125498|manual treatment|manual treatment
4978662|NCT04125472|Hyperoxaluria|hyperoxaluria
4978663|NCT04125472|Primary Hyperoxaluria|primary hyperoxaluria
4978664|NCT04125472|Kidney Diseases|kidney diseases
4978665|NCT04125472|Urologic Diseases|urologic diseases
4978666|NCT04125472|Metabolism, Inborn Errors|metabolism, inborn errors
4978667|NCT04125472|Genetic Diseases, Inborn|genetic diseases, inborn
4978668|NCT04125472|Metabolic Diseases|metabolic diseases
4978669|NCT04125472|RNA Therapeutic|rna therapeutic
4978670|NCT04125472|siRNA|sirna
4978671|NCT04125446|cancer in pregnancy|cancer in pregnancy
4978672|NCT04125446|chemotherapy|chemotherapy
5302894|NCT02162498|Adherence|adherence
4978673|NCT04125446|offspring|offspring
4978674|NCT04125446|genotoxicity|genotoxicity
4978675|NCT04125394|corneal edema|corneal edema
4978676|NCT04125394|sodium chloride|sodium chloride
4978677|NCT04125394|single-dose|single-dose
4978683|NCT04125316|Asthma|asthma
4978684|NCT04125303|cannabis|cannabis
4978685|NCT04125303|cocaine|cocaine
4978686|NCT04125303|alcohol|alcohol
4978687|NCT04125303|entertainment workers|entertainment workers
4978688|NCT04125303|nursing interventions|nursing interventions
4978689|NCT04125290|capillary leak syndrome|capillary leak syndrome
4978690|NCT04125290|hemolytic uremic syndrome|hemolytic uremic syndrome
4978691|NCT04125290|renal toxicity|renal toxicity
5298592|NCT02185690|chemotherapy|chemotherapy
4978692|NCT04125290|infusion-related reaction|infusion-related reaction
4978693|NCT04125290|electrolyte abnormalities|electrolyte abnormalities
5356777|NCT01918033|Histamine Antagonists|histamine antagonists
4978694|NCT04125290|HCL and all relevant indications where LUMOXITI will be prescribed|hcl and all relevant indications where lumoxiti will be prescribed
4978695|NCT04125251|Maternal Depression|maternal depression
4978696|NCT04125251|Women Empowerment|women empowerment
4978697|NCT04125251|Life Skills Building|life skills building
4978698|NCT04125238|Delay Discounting|delay discounting
4978699|NCT04125238|Behavioral Economic Demand|behavioral economic demand
4978700|NCT04125238|Episodic Future Thinking|episodic future thinking
4978701|NCT04125238|Self-Administration|self-administration
4978712|NCT04125121|Propofol|propofol
4978713|NCT04125121|Healthy volunteers|healthy volunteers
4978714|NCT04125121|Consciousness|consciousness
4978715|NCT04125121|Cognitive|cognitive
4978716|NCT04125121|Fatigue|fatigue
4978717|NCT04125108|burn|burn
4978718|NCT04125108|Pulmonary Function Test|pulmonary function test
4978719|NCT04125108|Pulmonary Rehabilitation|pulmonary rehabilitation
4978721|NCT04125069|Mitochondrial dysfunction|mitochondrial dysfunction
4978722|NCT04125069|Acute Kidney Injury (AKI)|acute kidney injury (aki)
4978723|NCT04125069|Coronary Artery Bypass Graft (CABG) Surgery|coronary artery bypass graft (cabg) surgery
4978724|NCT04125069|Extracorporeal circulation|extracorporeal circulation
4978725|NCT04125069|Inflammatory response|inflammatory response
4978726|NCT04125069|Type 2 diabete|type 2 diabete
4978727|NCT04125043|Red reflex|red reflex
4978728|NCT04125043|Posterior ocular abnormalities|posterior ocular abnormalities
4978729|NCT04125004|virtual reality|virtual reality
4978730|NCT04125004|pediatric surgery|pediatric surgery
4978731|NCT04125004|general anesthesia|general anesthesia
4978732|NCT04125004|distraction technique|distraction technique
4978734|NCT04124991|Durvalumab|durvalumab
4978735|NCT04124978|obstructive sleep apnea|obstructive sleep apnea
4978736|NCT04124978|mandibular advancement device|mandibular advancement device
4979230|NCT04122053|genotype|genotype
4978745|NCT04124939|Botox/OnabotulinumtoxinA|botox/onabotulinumtoxina
4978747|NCT04124939|OAB|oab
4978760|NCT04124900|screening|screening
4978761|NCT04124900|prostate|prostate
4978762|NCT04124900|cancer|cancer
4978763|NCT04124900|biopsy|biopsy
4978764|NCT04124861|Immunoglobulin G4-Related Disease|immunoglobulin g4-related disease
4978765|NCT04124848|Somali-Americans|somali-americans
4978766|NCT04124848|Sleep Disordered Breathing|sleep disordered breathing
4978767|NCT04124848|Cardiovascular Diseases|cardiovascular diseases
4978768|NCT04124848|Sex and Racial Differences|sex and racial differences
4978769|NCT04124848|Respiratory Disorders|respiratory disorders
4978770|NCT04124848|Hypertension|hypertension
4978771|NCT04124848|Diabetes|diabetes
4978772|NCT04124848|Health Disparities|health disparities
4978773|NCT04124835|Labor, Obstetric|labor, obstetric
4978774|NCT04124835|Physical Therapy Modalities|physical therapy modalities
4978775|NCT04124809|blastocyst|blastocyst
4978776|NCT04124809|Vitrification|vitrification
4978777|NCT04124809|artificial collapse|artificial collapse
4978778|NCT04124809|survival rate|survival rate
4978779|NCT04124796|Carcinoma, Basal Cell|carcinoma, basal cell
4978780|NCT04124796|psycho-social factors|psycho-social factors
4978782|NCT04124731|Advanced|advanced
4978783|NCT04124731|Non-Small Cell Lung Cancer|non-small cell lung cancer
4978784|NCT04124731|Sintilimab|sintilimab
4978785|NCT04124731|PD-1|pd-1
4978786|NCT04124731|Anlotinib|anlotinib
4978787|NCT04124731|Anti-angiogenisis|anti-angiogenisis
4978788|NCT04124718|caries experience, VDR, TFIP11, enviromental risk factor|caries experience, vdr, tfip11, enviromental risk factor
4978789|NCT04124653|PF-06842874|pf-06842874
4978790|NCT04124653|first in human|first in human
4978791|NCT04124653|cyclin-dependent kinase 4|cyclin-dependent kinase 4
4978792|NCT04124653|cyclin-dependent kinase 6|cyclin-dependent kinase 6
4978793|NCT04124653|CDK4/6|cdk4/6
4978794|NCT04124653|healthy participants|healthy participants
4978795|NCT04124653|immediate release|immediate release
4978796|NCT04124653|modified release|modified release
4978797|NCT04124653|relative bioavailability|relative bioavailability
4978798|NCT04124627|Ultrasound guidance|ultrasound guidance
4978799|NCT04124627|surgery for lumbar spine|surgery for lumbar spine
4978800|NCT04124627|irradiation|irradiation
4978801|NCT04124627|wrong site surgery|wrong site surgery
4978802|NCT04124614|PTSD|ptsd
4978804|NCT04124601|Nivolumab|nivolumab
4978805|NCT04124601|Chemoradiotherapy|chemoradiotherapy
4978806|NCT04124601|Rectal cancer|rectal cancer
4978807|NCT04124575|Prevalence|prevalence
4978808|NCT04124575|Sarcopenia|sarcopenia
4978809|NCT04124575|Geriatric|geriatric
4978810|NCT04124562|Nitrous oxide|nitrous oxide
4978811|NCT04124562|Prevalence|prevalence
4978813|NCT04124549|End-Stage Renal Disease|end-stage renal disease
4978814|NCT04124549|Exercise|exercise
4978824|NCT04124523|CSF depletion|csf depletion
4978825|NCT04124523|ENT surgeon or neurosurgeon|ent surgeon or neurosurgeon
4978826|NCT04124497|Multiple Myeloma|multiple myeloma
4978827|NCT04124497|Monoclonal antibody|monoclonal antibody
4978828|NCT04124497|Immunomodulating agents|immunomodulating agents
4978830|NCT04124484|type 2 diabetes mellitus|type 2 diabetes mellitus
4978831|NCT04124484|DPP4 inhibitor|dpp4 inhibitor
4978832|NCT04124471|Down Syndrome|down syndrome
4978833|NCT04124471|Obstructive Sleep Apnea|obstructive sleep apnea
4978834|NCT04124445|Faceto-genic Cervical pain|faceto-genic cervical pain
4978835|NCT04124445|Chronic pain|chronic pain
4978836|NCT04124445|Pulsed Radiofrequency ablation|pulsed radiofrequency ablation
4978837|NCT04124445|Continues Radiofrequency ablation|continues radiofrequency ablation
4978838|NCT04124445|Medial Brunch Block|medial brunch block
4978839|NCT04124315|peripheral artery disease|peripheral artery disease
4978851|NCT04124263|Hypertension|hypertension
4978852|NCT04124263|Primary Health Care|primary health care
4978853|NCT04124237|Inherited Heart Rhythms|inherited heart rhythms
4978854|NCT04124237|Genetic Heart Conditions|genetic heart conditions
4978855|NCT04124237|Sudden Cardiac Arrest|sudden cardiac arrest
4978856|NCT04124237|Sudden Cardiac Death|sudden cardiac death
4978857|NCT04124211|Fecal Microbiome Transplantation (FMT)|fecal microbiome transplantation (fmt)
4978858|NCT04124198|Oropharyngeal squamous cell carcinoma T1-T2, N0-1|oropharyngeal squamous cell carcinoma t1-t2, n0-1
4978859|NCT04124198|Transoral robotic surgery|transoral robotic surgery
4978860|NCT04124198|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
4978861|NCT04124185|Achromatopsia|achromatopsia
4978862|NCT04124185|CNGB3|cngb3
4978863|NCT04124185|CNGA3|cnga3
4978864|NCT04124172|stroke|stroke
4978865|NCT04124172|rTMS|rtms
4978866|NCT04124172|upper limb rehabilitation|upper limb rehabilitation
4978867|NCT04124094|bioequivalence|bioequivalence
4978868|NCT04124094|fluticasone propionate|fluticasone propionate
4978869|NCT04124094|salmeterol xinafoate|salmeterol xinafoate
4978870|NCT04124094|SERETIDE|seretide
4978871|NCT04124094|charcoal blockade|charcoal blockade
4978872|NCT04124068|Teeth whitening|teeth whitening
4978873|NCT04124068|Teeth bleaching|teeth bleaching
4978874|NCT04124068|Tooth discoloration|tooth discoloration
4978875|NCT04124042|Inflammation|inflammation
4978876|NCT04124042|Pain|pain
4978877|NCT04124042|Interleukin|interleukin
4978878|NCT04124042|Gene Therapy|gene therapy
4978879|NCT04124042|plasmid DNA|plasmid dna
4978885|NCT04124016|flavan-3-ol|flavan-3-ol
4978886|NCT04124016|phenyl-y-valerolactones|phenyl-y-valerolactones
4978887|NCT04124016|catechins|catechins
4978888|NCT04124016|metabotype|metabotype
4978889|NCT04124016|gas production|gas production
4978890|NCT04124016|gut microbiota|gut microbiota
4978891|NCT04123977|thorax trauma|thorax trauma
4978892|NCT04123977|head injury|head injury
4978893|NCT04123977|Multi-modal analgesia|multi-modal analgesia
4978894|NCT04123977|Paravertebral block|paravertebral block
4978895|NCT04123977|Thoracic epidural|thoracic epidural
4978896|NCT04123977|Serratus Block|serratus block
4978897|NCT04123964|Peri-prosthetic infection|peri-prosthetic infection
4978898|NCT04123964|Joint infection|joint infection
4978899|NCT04123964|One-stage replacement|one-stage replacement
4978900|NCT04123964|Broad-spectrum β -lactam|broad-spectrum β -lactam
4978901|NCT04123951|Kidney Transplant|kidney transplant
4978902|NCT04123951|Cardiovascular Disease|cardiovascular disease
4978903|NCT04123951|Home-based Exercise|home-based exercise
4978904|NCT04123951|Exercise|exercise
4978905|NCT04123925|locally advanced colon|locally advanced colon
4978906|NCT04123925|neoadjuvant|neoadjuvant
4978907|NCT04123925|nivolumab|nivolumab
4978908|NCT04123873|RECIPE|recipe
4978909|NCT04123873|Hip arthroplasty|hip arthroplasty
4978910|NCT04123873|Postoperative pain|postoperative pain
4978911|NCT04123873|Analgesia|analgesia
4978912|NCT04123873|Multimodal analgesia|multimodal analgesia
4978913|NCT04123873|Non-opioid analgesia|non-opioid analgesia
4978914|NCT04123873|Acute pain|acute pain
4978915|NCT04123860|intralift|intralift
4978916|NCT04123860|maxillery sinus lift|maxillery sinus lift
4983229|NCT04096911|Cervical Cancer|cervical cancer
4978922|NCT04123834|anterior cruciate ligament|anterior cruciate ligament
4978923|NCT04123834|anterior cruciate ligament injury|anterior cruciate ligament injury
4978930|NCT04123808|Neurological Rehabilitation|neurological rehabilitation
4978931|NCT04123808|Neuronal Plasticity|neuronal plasticity
4978947|NCT04123691|transitional period|transitional period
4978949|NCT04123691|bradycardia|bradycardia
4978950|NCT04123691|apnea|apnea
4978951|NCT04123665|Oral Health|oral health
4978952|NCT04123665|Antiplaque|antiplaque
4978953|NCT04123665|Gingivitis|gingivitis
4978954|NCT04123652|Neuropathic pain|neuropathic pain
4978955|NCT04123652|Fibromyalgia|fibromyalgia
4978956|NCT04123652|Lidocaine infusion|lidocaine infusion
4978957|NCT04123652|Ketamine infusion|ketamine infusion
4978958|NCT04123652|Chronic pain|chronic pain
4978959|NCT04123626|adRP|adrp
4978960|NCT04123626|Retinitis Pigmentosa|retinitis pigmentosa
4978961|NCT04123626|P23H mutation|p23h mutation
4978962|NCT04123626|Rhodopsin|rhodopsin
4978963|NCT04123626|antisense oligonucleotide|antisense oligonucleotide
4978964|NCT04123626|IVT|ivt
4978965|NCT04123626|autosomal dominant|autosomal dominant
4978966|NCT04123600|Hip Replacement|hip replacement
4978967|NCT04123587|Sulfonylurea|sulfonylurea
4978968|NCT04123574|Pancreas|pancreas
4978969|NCT04123574|Cancer|cancer
4978970|NCT04123574|Neoplasms|neoplasms
4978971|NCT04123574|Pancreatic|pancreatic
4978972|NCT04123548|Alternative to Autograft|alternative to autograft
4978973|NCT04123535|Focused Ultrasound|focused ultrasound
4978974|NCT04123535|Sarcoma|sarcoma
4978975|NCT04123496|cognition|cognition
4978976|NCT04123496|adult|adult
4978977|NCT04123496|prefrontal cortex|prefrontal cortex
4978978|NCT04123496|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4978979|NCT04123496|Stress, Psychological|stress, psychological
4978980|NCT04123496|memory|memory
4978981|NCT04123496|attention|attention
4978982|NCT04123483|PMS|pms
4978983|NCT04123483|Folate|folate
4978984|NCT04123483|Omega-3 Fatty Acids|omega-3 fatty acids
4978985|NCT04123483|Vitamins|vitamins
4978986|NCT04123483|Women's Health|women's health
4978987|NCT04123483|Dietary Supplements|dietary supplements
4978988|NCT04123483|PMDD|pmdd
4978989|NCT04123483|MRMD|mrmd
4978990|NCT04123483|Menstrual Related Mood Disorder|menstrual related mood disorder
4978991|NCT04123483|Premenstrual Tension|premenstrual tension
4978992|NCT04123431|Total Hip Replacement|total hip replacement
4978993|NCT04123431|Patient reported outcome measures|patient reported outcome measures
4978994|NCT04123431|Post Market Clinical Follow-up / Post Market Surveillance|post market clinical follow-up / post market surveillance
4978996|NCT04123405|acute uncomplicated rhinosinusitis, acetylcysteine|acute uncomplicated rhinosinusitis, acetylcysteine
4978997|NCT04123379|Nivolumab|nivolumab
4978998|NCT04123379|CCR2/5-inhibitor|ccr2/5-inhibitor
4978999|NCT04123379|anti-IL-8|anti-il-8
4979007|NCT04123301|mixed depression|mixed depression
4979008|NCT04123301|depressive disorder|depressive disorder
4979009|NCT04123301|bipolar disorder|bipolar disorder
4979010|NCT04123301|transcranial magnetic stimulation|transcranial magnetic stimulation
4979011|NCT04123275|Validation studies|validation studies
4979012|NCT04123275|Withholding treatment|withholding treatment
4979013|NCT04123262|Tamoxifen|tamoxifen
4979014|NCT04123197|Cardiovascular disease|cardiovascular disease
4979015|NCT04123197|Daily life stressors|daily life stressors
4979016|NCT04123197|Mental stress-induced myocardial ischemia (MSI)|mental stress-induced myocardial ischemia (msi)
4979017|NCT04123184|Therapeutic patient education|therapeutic patient education
4979018|NCT04123184|Having one child who as less than 6 years old|having one child who as less than 6 years old
4979019|NCT04123184|Pediatric Dentistry|pediatric dentistry
4979020|NCT04123184|Oral Health|oral health
4979021|NCT04123184|Chronic Disease|chronic disease
4979022|NCT04123171|Dementia|dementia
4979023|NCT04123171|Cognitive performance|cognitive performance
4979024|NCT04123171|Vascular diseases|vascular diseases
4979025|NCT04123171|Rural Ecuador|rural ecuador
4979026|NCT04123171|Atahualpa|atahualpa
4979027|NCT04123171|El Tambo|el tambo
4979028|NCT04123171|Prosperidad|prosperidad
4979029|NCT04123171|Three villages study|three villages study
4979030|NCT04123158|Ultrasound|ultrasound
4979031|NCT04123158|Myoma|myoma
4979038|NCT04123106|Pain, Postoperative|pain, postoperative
4979039|NCT04123080|Colonic Polyp|colonic polyp
4979040|NCT04123080|Endoscopic mucosal resection|endoscopic mucosal resection
4979041|NCT04123054|Multiple Daily Injections,|multiple daily injections,
4979042|NCT04123054|Type 1 diabetes|type 1 diabetes
4979043|NCT04123054|Optimization algorithm|optimization algorithm
4983330|NCT04096222|pemphigus|pemphigus
4979058|NCT04122937|P2X7R-inflammasome|p2x7r-inflammasome
4979062|NCT04122911|Temozolomide|temozolomide
4979063|NCT04122911|second-line chemotherapy|second-line chemotherapy
4979064|NCT04122885|HIPEC|hipec
4979065|NCT04122885|PIPAC|pipac
4979066|NCT04122885|cytoreductive surgery|cytoreductive surgery
4979067|NCT04122885|immune function|immune function
4979068|NCT04122885|cytokines|cytokines
4979069|NCT04122885|plasma proteins|plasma proteins
4979070|NCT04122872|Sarcoma|sarcoma
4979071|NCT04122872|Soft Tissue Sarcoma|soft tissue sarcoma
4979072|NCT04122872|Sarcoma of Bone|sarcoma of bone
4979073|NCT04122872|Registry|registry
4979074|NCT04122859|Pediatrics|pediatrics
4979075|NCT04122833|next generation sequencing|next generation sequencing
4979076|NCT04122820|Specific Learning Disorder|specific learning disorder
4979077|NCT04122820|Developmental Coordination Disorder|developmental coordination disorder
4979078|NCT04122820|Specific Developmental Disorders of Speech and Language|specific developmental disorders of speech and language
4979079|NCT04122820|Dyslexia, Developmental|dyslexia, developmental
4979080|NCT04122820|Dyspraxia|dyspraxia
4979081|NCT04122807|AVNRT|avnrt
4979082|NCT04122807|Cryoablation|cryoablation
4979083|NCT04122807|PR interval|pr interval
5703045|NCT00490971|Mania|mania
5903456|NCT00368446|Cystic Fibrosis|cystic fibrosis
4979084|NCT04122794|Endothelial Cells|endothelial cells
4979085|NCT04122781|supracondylar humerus fracture|supracondylar humerus fracture
4979086|NCT04122781|Kirschner wire|kirschner wire
4979087|NCT04122768|physical activity|physical activity
4979088|NCT04122768|tele coaching|tele coaching
4979089|NCT04122768|comorbidities|comorbidities
4979090|NCT04122742|Epigenetics|epigenetics
4979091|NCT04122742|Acetylation|acetylation
4979092|NCT04122742|Diagnostic|diagnostic
4979093|NCT04122742|Induced pluripotent stem cells|induced pluripotent stem cells
4979094|NCT04122742|Rubinstein-Taybi syndrome|rubinstein-taybi syndrome
4979095|NCT04122729|Highly purified human follicle stimulating hormone (HP-FSH)|highly purified human follicle stimulating hormone (hp-fsh)
4979096|NCT04122729|Recombinant follicle stimulating hormone (rFSH)|recombinant follicle stimulating hormone (rfsh)
4979097|NCT04122729|FSH receptor (FSHR)|fsh receptor (fshr)
4979098|NCT04122729|Polymorphism N680S of the FSHR|polymorphism n680s of the fshr
4979099|NCT04122729|Polymorphism N312S of the LHCGR|polymorphism n312s of the lhcgr
4979100|NCT04122729|LHCG receptor (LHCGR)|lhcg receptor (lhcgr)
4979101|NCT04122729|Polymorphism c.2039G>A|polymorphism c.2039g>a
4979102|NCT04122729|Polymorphism c.935A>G|polymorphism c.935a>g
4979103|NCT04122716|Weight loss maintenance|weight loss maintenance
4979104|NCT04122716|Immunometabolic health|immunometabolic health
4979105|NCT04122716|Exercise intervention|exercise intervention
4979106|NCT04122716|GLP-1 receptor agonist (liraglutide)|glp-1 receptor agonist (liraglutide)
4979107|NCT04122703|Percutaneous Tibial Nerve Stimulation|percutaneous tibial nerve stimulation
4979108|NCT04122703|Female Sexual Dysfunction|female sexual dysfunction
4979109|NCT04122703|Sexual dysfunction|sexual dysfunction
4979110|NCT04122703|peripheral neuromodulation|peripheral neuromodulation
4979111|NCT04122690|motor control|motor control
4979112|NCT04122690|Parkinson disease|parkinson disease
4979113|NCT04122690|exercise|exercise
4979114|NCT04122690|neural imaging|neural imaging
4979115|NCT04122690|dance|dance
4979116|NCT04122690|spatial cognition|spatial cognition
4979117|NCT04122690|executive function|executive function
4979118|NCT04122690|substantia nigra|substantia nigra
4979119|NCT04122690|neurodegeneration|neurodegeneration
4979120|NCT04122690|rehabilitation|rehabilitation
4979121|NCT04122677|Knee Ligament Injury|knee ligament injury
4979122|NCT04122677|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
4979123|NCT04122677|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4979124|NCT04122677|Knee Ligament Rupture|knee ligament rupture
4979125|NCT04122677|Knee Ligament Reconstruction|knee ligament reconstruction
4979127|NCT04122612|microbiota|microbiota
4979128|NCT04122612|1000 days|1000 days
4979129|NCT04122612|maternal lifestyle|maternal lifestyle
4979130|NCT04122612|diet|diet
4979131|NCT04122612|pregnancy|pregnancy
4979132|NCT04122599|Melatonin|melatonin
4979133|NCT04122586|IBS-D|ibs-d
4979134|NCT04122573|Chest pain|chest pain
4979135|NCT04122573|Acute Aortic Dissection|acute aortic dissection
4979136|NCT04122573|Pulmonary Embolism|pulmonary embolism
4979137|NCT04122573|Acute Coronary Syndrome|acute coronary syndrome
4979138|NCT04122573|Acute myocardial infarction|acute myocardial infarction
4979144|NCT04122560|invasive fungal infections|invasive fungal infections
4979145|NCT04122560|mycoses|mycoses
4979151|NCT04122508|anxiety|anxiety
4979152|NCT04122508|siblings|siblings
4979153|NCT04122508|dental caries|dental caries
4979154|NCT04122508|oral health|oral health
4979155|NCT04122508|child abuse|child abuse
4979156|NCT04122495|probiotic|probiotic
4979157|NCT04122495|respiratory tract infections|respiratory tract infections
4979158|NCT04122495|Bifidobacterium|bifidobacterium
4979159|NCT04122495|children|children
4979160|NCT04122482|Mental health accommodation|mental health accommodation
5019150|NCT03877094|pain|pain
4979161|NCT04122482|Small- to mid-sized enterprises|small- to mid-sized enterprises
4979162|NCT04122482|Psychoeducation|psychoeducation
4979163|NCT04122482|ICBT|icbt
4979164|NCT04122469|SBRT|sbrt
4979165|NCT04122417|Therapeutic touch|therapeutic touch
4979166|NCT04122417|yakson|yakson
4979167|NCT04122417|gentle human touch|gentle human touch
4979168|NCT04122417|maternal attachment|maternal attachment
4979169|NCT04122417|preterm baby|preterm baby
4979170|NCT04122404|Point-of-care systems|point-of-care systems
4979171|NCT04122404|Tuberculosis/Diagnosis|tuberculosis/diagnosis
4979172|NCT04122404|Biomarkers/Urin|biomarkers/urin
4979173|NCT04122404|Lipopolysaccharides/urine|lipopolysaccharides/urine
4979174|NCT04122404|Audit intervention|audit intervention
4979175|NCT04122404|Diagnostic tests/Routine|diagnostic tests/routine
4979176|NCT04122404|Ultrasound|ultrasound
4979177|NCT04122404|Bedside|bedside
4979178|NCT04122404|Biobank|biobank
4979179|NCT04122404|Stepped wedge cluster randomised trial|stepped wedge cluster randomised trial
4979180|NCT04122404|Multicenter study|multicenter study
4979181|NCT04122404|Audit and feedback|audit and feedback
4979182|NCT04122404|Ghana|ghana
4979183|NCT04122404|Adult|adult
4979184|NCT04122404|Hospitalization|hospitalization
4979185|NCT04122391|simulation|simulation
4979186|NCT04122391|cardiac arrest|cardiac arrest
4979187|NCT04122391|perioperative cardiac arrest|perioperative cardiac arrest
4979188|NCT04122378|Pain, Acupuncture|pain, acupuncture
4979189|NCT04122365|Chest Wall Mobilization Program|chest wall mobilization program
4979190|NCT04122365|Respiratory Function|respiratory function
4979191|NCT04122352|temporomandibular joint|temporomandibular joint
4979192|NCT04122352|trigger points|trigger points
4979193|NCT04122352|myofascial pain syndrome|myofascial pain syndrome
4979194|NCT04122339|PD-1/L1|pd-1/l1
4979195|NCT04122339|immunotherapy|immunotherapy
4979196|NCT04122339|advanced solid tumors|advanced solid tumors
4979197|NCT04122287|Allergic|allergic
4979198|NCT04122287|Penicillin|penicillin
4979199|NCT04122287|Helicobacter pylori|helicobacter pylori
4979200|NCT04122287|Eradication|eradication
4979201|NCT04122287|Tetracycline|tetracycline
4979202|NCT04122274|Concussion, Education|concussion, education
4979203|NCT04122235|follow-up|follow-up
4979204|NCT04122235|app|app
4979205|NCT04122235|lifestyle|lifestyle
4979206|NCT04122235|empowerment|empowerment
4979207|NCT04122235|nurse-led|nurse-led
4979208|NCT04122222|ESRD|esrd
4979209|NCT04122222|hemodialysis|hemodialysis
4979210|NCT04122222|hemodiafiltration|hemodiafiltration
4979211|NCT04122222|influenza vaccine|influenza vaccine
4979212|NCT04122222|immune response|immune response
4979213|NCT04122209|Nutritional|nutritional
4979214|NCT04122209|Metabolic|metabolic
4979215|NCT04122209|Endocrine|endocrine
4979216|NCT04122183|Hearing Screening, Auditory Rehabilitation|hearing screening, auditory rehabilitation
4979217|NCT04122157|Uncoated SL PLUS® MIA stem|uncoated sl plus® mia stem
4979218|NCT04122144|pregnant woman|pregnant woman
4979219|NCT04122092|Multiple myeloma|multiple myeloma
4979220|NCT04122092|Minimal residual disease|minimal residual disease
4979221|NCT04122092|Chromosomal aneuploidy detection|chromosomal aneuploidy detection
4979222|NCT04122092|Chromosomal instability|chromosomal instability
4979223|NCT04122079|CORE-OM|core-om
4979224|NCT04122079|Outcome measures|outcome measures
4979225|NCT04122079|Psychometric validation|psychometric validation
4979226|NCT04122079|Psychological distress|psychological distress
4979227|NCT04122053|intake|intake
4979228|NCT04122053|caffeine|caffeine
4979229|NCT04122053|coffee|coffee
4979243|NCT04121949|coronary artery disease|coronary artery disease
4979244|NCT04121949|diagnostic strategies|diagnostic strategies
4979245|NCT04121910|Pharmacokinetics|pharmacokinetics
4979246|NCT04121910|Safety|safety
4979247|NCT04121910|Small molecule kinase inhibitor|small molecule kinase inhibitor
4979248|NCT04121910|Open-label|open-label
4979249|NCT04121884|Heart Rate Variability|heart rate variability
4979250|NCT04121884|Sleep|sleep
4979251|NCT04121884|Electrocardiogram|electrocardiogram
4979252|NCT04121884|Electroencephlogram|electroencephlogram
4983537|NCT04095026|Memory|memory
4979279|NCT04121780|cognition disorders|cognition disorders
4979280|NCT04121767|atrial fibrillation|atrial fibrillation
4979281|NCT04121767|thoracoscopic ablation|thoracoscopic ablation
4979282|NCT04121767|anticoagulation|anticoagulation
4979283|NCT04121741|Singing|singing
4979284|NCT04121728|metrological characteristics of EEG-ERP|metrological characteristics of eeg-erp
4979285|NCT04121728|Ginkgo Biloba|ginkgo biloba
4979286|NCT04121715|coronary heart disease|coronary heart disease
4979287|NCT04121715|fastigial nucleus stimulation|fastigial nucleus stimulation
4979288|NCT04121715|inflammatory factors|inflammatory factors
4979289|NCT04121702|Cardiac Rehabilitation|cardiac rehabilitation
5703046|NCT00490971|Depression|depression
4979290|NCT04121702|Telerehabilitation|telerehabilitation
4979291|NCT04121702|Secondary Prevention|secondary prevention
4979292|NCT04121702|Wearable Electronic Devices|wearable electronic devices
4979293|NCT04121702|Exercise Therapy|exercise therapy
4979295|NCT04121689|Amino Acids|amino acids
4979296|NCT04121689|Anabolic Signaling|anabolic signaling
4979297|NCT04121689|Muscle Mass|muscle mass
4979304|NCT04121663|Shoulder instability|shoulder instability
4979305|NCT04121663|Rotator cuff injury|rotator cuff injury
4979314|NCT04121611|Basilar|basilar
4979315|NCT04121611|Stroke|stroke
4979316|NCT04121611|Thrombus|thrombus
4979317|NCT04121611|Optical Coherence Tomography|optical coherence tomography
4979318|NCT04121598|Working Memory|working memory
4979319|NCT04121598|Executive Functioning|executive functioning
4979320|NCT04121598|Loss of Control Eating|loss of control eating
4979321|NCT04121585|HA (hydroxylapatite) coated SL-PLUS™ stem|ha (hydroxylapatite) coated sl-plus™ stem
4979322|NCT04121572|Diabetic ketoacidosis|diabetic ketoacidosis
4979323|NCT04121572|End tidal carbon dioxide|end tidal carbon dioxide
4979324|NCT04121572|Capnography|capnography
4979327|NCT04121494|ChAdOx1 85A|chadox1 85a
4979328|NCT04121494|Tuberculosis|tuberculosis
4979329|NCT04121494|vaccination|vaccination
4979330|NCT04121494|BCG|bcg
4979335|NCT04121468|youth|youth
4979336|NCT04121468|white matter|white matter
4979337|NCT04121468|neural precursor cells|neural precursor cells
4979338|NCT04121468|clinical trial|clinical trial
4979340|NCT04121455|Glioblastoma|glioblastoma
4979341|NCT04121455|NOX-A12|nox-a12
4979342|NCT04121455|Olaptesed pegol|olaptesed pegol
4979343|NCT04121455|Spiegelmer|spiegelmer
4979344|NCT04121455|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
4979345|NCT04121455|CXCL12|cxcl12
4979346|NCT04121455|Radiation|radiation
4979347|NCT04121455|MGMT promoter|mgmt promoter
4979348|NCT04121455|Brain tumor|brain tumor
4979349|NCT04121455|Radiotherapy|radiotherapy
4979350|NCT04121455|Brain cancer|brain cancer
4979351|NCT04121455|Tumor microenvironment|tumor microenvironment
4979352|NCT04121416|Oxycodone|oxycodone
4979353|NCT04121416|Sufentanil|sufentanil
4979354|NCT04121416|tracheal intubation|tracheal intubation
4979355|NCT04121403|multiple sclerosis|multiple sclerosis
4979357|NCT04121403|rms|rms
4979358|NCT04121403|rituximab|rituximab
4979359|NCT04121403|cladribine|cladribine
4979360|NCT04121403|probe|probe
4979361|NCT04121390|Newborn care|newborn care
4979362|NCT04121390|Maternal anxiety|maternal anxiety
4979371|NCT04121338|bowel dysmotility|bowel dysmotility
4979372|NCT04121299|Masked Hypertension|masked hypertension
4979373|NCT04121299|Sympathetic Activity|sympathetic activity
4979374|NCT04121299|Sympatholytic Therapy|sympatholytic therapy
4979375|NCT04121286|Src homology phosphatase 2 (SHP2)|src homology phosphatase 2 (shp2)
4979376|NCT04121286|PTPN11|ptpn11
4979377|NCT04121286|Kirsten rat sarcoma (KRAS) proto-oncogene, GTPase|kirsten rat sarcoma (kras) proto-oncogene, gtpase
4979378|NCT04121286|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4979379|NCT04121273|chimeric antigen receptor T cell (CAR- T)|chimeric antigen receptor t cell (car- t)
4979380|NCT04121273|glypican-3 (GPC3)|glypican-3 (gpc3)
4979381|NCT04121273|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
4979387|NCT04121234|High dependency unit; critical care; obstetric critical care; maternal mortality.|high dependency unit; critical care; obstetric critical care; maternal mortality.
4979392|NCT04121182|Nursing home|nursing home
4979393|NCT04121182|Prevention|prevention
4979394|NCT04121117|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4979395|NCT04121117|COPD|copd
4979396|NCT04121117|Chronic obstructive pulmonary disease population questionnaire|chronic obstructive pulmonary disease population questionnaire
4979397|NCT04121117|COPD-PS|copd-ps
4979398|NCT04121117|COPD-6|copd-6
4979399|NCT04121104|Spinal cord stimulation|spinal cord stimulation
4979400|NCT04121104|Electrodermal activity|electrodermal activity
4979401|NCT04121078|Drug Therapy|drug therapy
4979402|NCT04121065|ADA|ada
4979403|NCT04121065|Genetic polymorphism|genetic polymorphism
4979404|NCT04121065|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4979405|NCT04121065|Immune-reconstitution therapy|immune-reconstitution therapy
4979406|NCT04121065|2-CdA|2-cda
4979407|NCT04121065|single nucleotide polymorphisms|single nucleotide polymorphisms
4979408|NCT04121065|lymphopenia induced by 2-CdA treatment|lymphopenia induced by 2-cda treatment
4979409|NCT04121065|ADA genetic variant rs244072|ada genetic variant rs244072
4979410|NCT04121065|non-risk/risk allele T/C|non-risk/risk allele t/c
4979411|NCT04121013|thrombectomy|thrombectomy
4979412|NCT04121013|drip'n'ship versus mothership|drip'n'ship versus mothership
4979413|NCT04121013|cost/effectiveness|cost/effectiveness
4979414|NCT04121000|Erector Spinae Block,|erector spinae block,
4979415|NCT04121000|VATS|vats
4979416|NCT04120987|cataract|cataract
4979417|NCT04120987|lifitegrast|lifitegrast
4979418|NCT04120987|dry eye syndrome|dry eye syndrome
4979419|NCT04120987|ocular surface inflammation|ocular surface inflammation
4979420|NCT04120987|hyperosmolarity|hyperosmolarity
4979421|NCT04120987|MMP-9|mmp-9
4979422|NCT04120961|bivalirudin|bivalirudin
4979423|NCT04120961|delayed use|delayed use
4979424|NCT04120961|peri-operative myocardial injury|peri-operative myocardial injury
4979425|NCT04120961|percutaneous coronary intervention|percutaneous coronary intervention
4979426|NCT04120922|Dialysis|dialysis
4979835|NCT04118699|Rifaximin|rifaximin
4979428|NCT04120922|calcium isotope ratio|calcium isotope ratio
4979429|NCT04120922|bone mineral content|bone mineral content
4979430|NCT04120922|Calcium isotope fractions δ44/42Ca|calcium isotope fractions δ44/42ca
4979431|NCT04120909|cardiac resynchronization therapy, non-LBBB, QRS area|cardiac resynchronization therapy, non-lbbb, qrs area
4979434|NCT04120870|etomidate|etomidate
4979435|NCT04120870|ketamine|ketamine
4979436|NCT04120870|rapid sequence intubation|rapid sequence intubation
4979437|NCT04120870|trauma|trauma
4979438|NCT04120870|hemodynamics|hemodynamics
4979439|NCT04120857|stretching|stretching
4979440|NCT04120857|exercise|exercise
4979441|NCT04120844|Type 2 diabete|type 2 diabete
4979442|NCT04120844|Motivational interviewing|motivational interviewing
4979443|NCT04120844|Patient empowerment|patient empowerment
4979444|NCT04120844|Self-management|self-management
4979445|NCT04120844|China|china
4979446|NCT04120818|inflammatory cytokines|inflammatory cytokines
4979447|NCT04120779|e-health intervention|e-health intervention
4979448|NCT04120779|self-management|self-management
4979449|NCT04120779|primary care|primary care
4979450|NCT04120779|chronic care model|chronic care model
4979451|NCT04120766|TDP-43|tdp-43
4979452|NCT04120766|Hippocampal sclerosis|hippocampal sclerosis
4979462|NCT04120675|randomized double blind clinical trial|randomized double blind clinical trial
4979464|NCT04120636|Macula Edema|macula edema
4979465|NCT04120636|Radiation Retinopathy|radiation retinopathy
4979466|NCT04120636|Branch Retinal Vein Occlusion|branch retinal vein occlusion
4979467|NCT04120636|Epiretinal Membrane|epiretinal membrane
4979468|NCT04120636|Central Serous Retinopathy with Pit of Optic Disc|central serous retinopathy with pit of optic disc
4979469|NCT04120636|Commotio Retinae|commotio retinae
4979470|NCT04120636|Vitritis|vitritis
4979471|NCT04120623|Continuous Glucose Monitoring System (CGMS)|continuous glucose monitoring system (cgms)
4979472|NCT04120623|Dapagliflozin|dapagliflozin
4979473|NCT04120623|Continuous Subcutaneous Insulin Infusion ( CSII)|continuous subcutaneous insulin infusion ( csii)
4979474|NCT04120610|Peripheral Artery Disease|peripheral artery disease
4979475|NCT04120610|Claudication|claudication
4979476|NCT04120610|Critical Limb Ischemia|critical limb ischemia
4979477|NCT04120545|physical therapy modality|physical therapy modality
4979478|NCT04120545|Electric Stimulation Therapy|electric stimulation therapy
4979479|NCT04120545|Urologic Diseases|urologic diseases
4979480|NCT04120545|Pelvic Floor Disorders|pelvic floor disorders
4979481|NCT04120532|rehabilitation|rehabilitation
4979482|NCT04120532|Lumbar degenerative disease|lumbar degenerative disease
4979483|NCT04120532|Low Back Pain|low back pain
4979488|NCT04120493|AAV (adeno-associated virus)|aav (adeno-associated virus)
4979489|NCT04120493|serotype 5 AAV (adeno-associated virus)|serotype 5 aav (adeno-associated virus)
4979490|NCT04120493|serotype 5|serotype 5
4979491|NCT04120493|Viral vector|viral vector
4979492|NCT04120493|miHTT|mihtt
4979493|NCT04120493|muHTT|muhtt
4979494|NCT04120493|Huntington Disease (HD)|huntington disease (hd)
4979495|NCT04120480|Genomics|genomics
4979496|NCT04120467|Stroke|stroke
4979497|NCT04120467|Rehabilitation|rehabilitation
4979498|NCT04120467|Dance|dance
4979499|NCT04120428|Aquatic exercise|aquatic exercise
4979500|NCT04120428|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
4979501|NCT04120428|Sleep|sleep
4979502|NCT04120389|Bandage contact lens|bandage contact lens
4979503|NCT04120389|cataract surgery|cataract surgery
4979504|NCT04120389|dry eye|dry eye
4979505|NCT04120376|Contraception counseling|contraception counseling
4979506|NCT04120376|Adolescent pregnancy|adolescent pregnancy
4979507|NCT04120376|Contraception initiation|contraception initiation
4979508|NCT04120363|testosterone|testosterone
4979509|NCT04120363|anabolism|anabolism
4979510|NCT04120363|muscle mass|muscle mass
4979511|NCT04120363|military operational stress|military operational stress
4979512|NCT04120350|lenalidomide|lenalidomide
4979513|NCT04120350|rituximab|rituximab
4979514|NCT04120350|methorexate|methorexate
4979515|NCT04120350|Primary Central Nervous System Lymphoma|primary central nervous system lymphoma
4979516|NCT04120350|maintenance therapy|maintenance therapy
4979517|NCT04120324|complication|complication
4979518|NCT04120324|surgery|surgery
4979519|NCT04120311|Macular Edema|macular edema
4979520|NCT04120311|Radiation Retinopathy|radiation retinopathy
4979524|NCT04120311|Commotio Retinae|commotio retinae
4979526|NCT04120298|exercise|exercise
4979527|NCT04120298|cancer-related fatigue|cancer-related fatigue
4979528|NCT04120298|quality of life|quality of life
4979529|NCT04120285|Depression|depression
4979530|NCT04120285|eCBT|ecbt
4979531|NCT04120246|Breast - Female|breast - female
4979532|NCT04120246|Breast - Male|breast - male
4979533|NCT04120246|HER2+|her2+
4979534|NCT04120246|metastatic|metastatic
4979535|NCT04120246|refractory|refractory
4979536|NCT04120246|immunotherapy|immunotherapy
4979537|NCT04120246|breast|breast
4979544|NCT04120220|Normal weight|normal weight
4979545|NCT04120207|Pilates|pilates
4979546|NCT04120207|Home-based|home-based
4979547|NCT04120207|Anxiety|anxiety
4979549|NCT04120207|Fatigue|fatigue
4979550|NCT04120181|Neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
4979551|NCT04120181|Platelet-to-lymphocyte ratio|platelet-to-lymphocyte ratio
4979552|NCT04120181|cochlear implant|cochlear implant
4979553|NCT04120181|artificial implant|artificial implant
4979554|NCT04120181|infection|infection
4979555|NCT04120168|CPK|cpk
4979556|NCT04120168|Transaminase|transaminase
4979557|NCT04120168|DMD|dmd
4979558|NCT04120168|Pompe|pompe
4979559|NCT04120142|COPD|copd
4979560|NCT04120142|IMT|imt
4979561|NCT04120142|6MWT|6mwt
4979562|NCT04120142|Dyspoea|dyspoea
4979563|NCT04120142|SGRQ|sgrq
4979564|NCT04120129|trigmenial neuralgia|trigmenial neuralgia
4979565|NCT04120129|Chronic orofacial pain|chronic orofacial pain
4979566|NCT04120116|Intratympanic Administration|intratympanic administration
4979567|NCT04120116|Restoration of Hearing Function|restoration of hearing function
4979568|NCT04120103|Dementia|dementia
4979569|NCT04120103|Agitation|agitation
4979570|NCT04120103|Cognitive status|cognitive status
4979571|NCT04120103|Doll therapy|doll therapy
4979572|NCT04120051|Gut Microbiota|gut microbiota
4979573|NCT04120051|Metabolic syndrome|metabolic syndrome
4979574|NCT04120051|Obesity|obesity
4979575|NCT04120051|Supplement|supplement
4979576|NCT04120038|Occupational Therapy|occupational therapy
4979577|NCT04120038|Rehabilitation|rehabilitation
4979578|NCT04120038|Lower-Limb Amputations|lower-limb amputations
4979579|NCT04120038|Amputees|amputees
4979580|NCT04120038|Telehealth|telehealth
4979581|NCT04120038|Remote Rehabilitation|remote rehabilitation
4979582|NCT04120038|Telerehabilitation|telerehabilitation
4979583|NCT04120038|E-learning|e-learning
4979584|NCT04120038|Education|education
4979585|NCT04120038|Self-Management|self-management
4979586|NCT04120038|Ambulation|ambulation
4979587|NCT04120038|Coping Strategies|coping strategies
4979588|NCT04120038|Outcomes|outcomes
4979589|NCT04120038|Prevalence|prevalence
4979590|NCT04120025|Reflux|reflux
4979591|NCT04120025|Heartburn|heartburn
4979592|NCT04120012|Frailty|frailty
4979593|NCT04120012|Intraoperative Hypotension|intraoperative hypotension
4979594|NCT04120012|Perioperative Complication|perioperative complication
4979595|NCT04120012|Elderly|elderly
4979596|NCT04119999|sleep|sleep
4979615|NCT04119908|bleeding|bleeding
5703248|NCT00490100|Bone Age|bone age
5023066|NCT03853486|VWF|vwf
4979616|NCT04119895|Electric stimulation|electric stimulation
4979617|NCT04119895|Ultrasonography|ultrasonography
4979618|NCT04119895|Exercise Therapy|exercise therapy
4979619|NCT04119895|Rehabilitation|rehabilitation
4979620|NCT04119882|Acute Coronary Syndrome|acute coronary syndrome
4979621|NCT04119882|Myocardial Infarction|myocardial infarction
4979622|NCT04119882|Diagnosis|diagnosis
4979623|NCT04119882|Prognosis|prognosis
4979624|NCT04119882|Risk stratification|risk stratification
4979625|NCT04119869|Cancer|cancer
4979626|NCT04119869|Young Adults|young adults
4979627|NCT04119869|Behavioral Intervention|behavioral intervention
4979628|NCT04119869|Smartphone Application|smartphone application
4979629|NCT04119856|Cross-sectorial|cross-sectorial
4979630|NCT04119856|Hospitalization|hospitalization
4979631|NCT04119856|Self-efficacy|self-efficacy
4979632|NCT04119856|Patient Involvement|patient involvement
4979633|NCT04119856|Health Literacy|health literacy
4979634|NCT04119856|Anxiety|anxiety
4979635|NCT04119817|Gastrointestinal symptoms|gastrointestinal symptoms
4979636|NCT04119817|Nausea|nausea
4979637|NCT04119817|Heartburn|heartburn
4979638|NCT04119817|Reflux|reflux
4979639|NCT04119804|periprosthetic hip infection|periprosthetic hip infection
4979640|NCT04119804|cellular neural networks|cellular neural networks
4979641|NCT04119804|genetic algorithm|genetic algorithm
4979642|NCT04119804|radiography|radiography
4979643|NCT04119804|accuracy|accuracy
4979644|NCT04119804|early discrimination|early discrimination
4979645|NCT04119752|Curcumin|curcumin
4979646|NCT04119752|Endothelial dysfunction|endothelial dysfunction
4979647|NCT04119752|Aging|aging
4979648|NCT04119752|muscle oxygen saturation|muscle oxygen saturation
4979666|NCT04119648|Suicide|suicide
4979667|NCT04119648|Child|child
4979668|NCT04119648|CAMS|cams
4979669|NCT04119635|Crohn's disease|crohn's disease
4979670|NCT04119635|Penetrating complication|penetrating complication
4979671|NCT04119635|Pediatric|pediatric
4979672|NCT04119635|Inflammatory bowel disease|inflammatory bowel disease
4979673|NCT04119622|Toripalimab|toripalimab
4979674|NCT04119622|JS001|js001
4979675|NCT04119622|Gastric Cancer|gastric cancer
4979676|NCT04119622|neoadjvant chemotherapy|neoadjvant chemotherapy
4979677|NCT04119596|Gut Microbiota|gut microbiota
4979678|NCT04119596|Parkinson's disease|parkinson's disease
4979679|NCT04119596|Genetics|genetics
4979680|NCT04119596|Microbiome|microbiome
4979681|NCT04119596|FFQ|ffq
4979682|NCT04119596|GPAQ|gpaq
4979683|NCT04119596|HADS|hads
4979684|NCT04119596|MOCA|moca
4979685|NCT04119544|stroke|stroke
4979686|NCT04119544|mirror therapy|mirror therapy
4979687|NCT04119544|rehabilitation|rehabilitation
4979688|NCT04119544|hemiparesis|hemiparesis
4979689|NCT04119544|upper limb|upper limb
4979690|NCT04119544|function|function
4979691|NCT04119544|motor control|motor control
4979692|NCT04119531|anesthesia|anesthesia
4979693|NCT04119531|recovery|recovery
4979694|NCT04119531|insomnia|insomnia
4979695|NCT04119505|Diaphragmatic Excursion|diaphragmatic excursion
4979696|NCT04119505|Diaphragmatic Dysfunction|diaphragmatic dysfunction
4979697|NCT04119505|Emergency Department|emergency department
4979698|NCT04119505|Respiratory insufficiency|respiratory insufficiency
4979699|NCT04119505|Acute respiratory failure|acute respiratory failure
4979700|NCT04119492|developmental coordination disorder|developmental coordination disorder
4979701|NCT04119492|autism|autism
4979702|NCT04119492|brain imaging|brain imaging
4979704|NCT04119492|rehabilitation|rehabilitation
4979705|NCT04119492|CO-OP|co-op
4979706|NCT04119479|Functional recovery|functional recovery
4979707|NCT04119479|Neurorehabilitation|neurorehabilitation
4979708|NCT04119479|Stroke|stroke
4979709|NCT04119466|degenerative disc disease|degenerative disc disease
4979710|NCT04119466|stabilizing training|stabilizing training
4979711|NCT04119466|protrusion|protrusion
4979712|NCT04119466|extrusion|extrusion
4979713|NCT04119440|MERS-CoV|mers-cov
4979714|NCT04119440|CEPI|cepi
4979715|NCT04119440|viral vector vaccine|viral vector vaccine
4979716|NCT04119414|Early Infant Male Circumcision|early infant male circumcision
5903457|NCT00368446|Pseudohypoaldosteronism|pseudohypoaldosteronism
4979717|NCT04119414|HIV infection|hiv infection
4979718|NCT04119401|hemorrhoids|hemorrhoids
4979719|NCT04119401|hemorrhoidal piles|hemorrhoidal piles
4979720|NCT04119401|prolapse|prolapse
4979721|NCT04119401|doppler guided ligation|doppler guided ligation
4979722|NCT04119401|finger-guided artery ligation|finger-guided artery ligation
4979723|NCT04119388|osteogenesis imperfecta|osteogenesis imperfecta
4979724|NCT04119388|Adapted sport|adapted sport
4979725|NCT04119388|Quality of life|quality of life
4979726|NCT04119375|Keheala|keheala
4979727|NCT04119375|tuberculosis|tuberculosis
4979728|NCT04119375|adherence|adherence
4979729|NCT04119375|behavior change|behavior change
4979746|NCT04119284|Vertebral Body Tethering|vertebral body tethering
4979747|NCT04119284|curve|curve
4979748|NCT04119284|Shah|shah
4979749|NCT04119245|obesity|obesity
4979750|NCT04119245|Igel|igel
4979751|NCT04119245|suraglotic device|suraglotic device
4979752|NCT04119219|fundus diseases|fundus diseases
5299509|NCT02180308|MRI|mri
4979753|NCT04119219|antiangiogenic therapy|antiangiogenic therapy
4979754|NCT04119219|subretinal neovascular membrane|subretinal neovascular membrane
4979755|NCT04119219|intravitreal injection|intravitreal injection
4979756|NCT04119219|anti-VEGF|anti-vegf
4979762|NCT04119206|tolvaptan|tolvaptan
5019774|NCT03873467|Stroke|stroke
4979763|NCT04119206|pituitary surgery|pituitary surgery
4979764|NCT04119180|Dental Anxiety|dental anxiety
4979765|NCT04119180|Dental Caries|dental caries
4979766|NCT04119180|Conscious Sedation|conscious sedation
4979767|NCT04119180|Physical Restraint|physical restraint
4979768|NCT04119180|Cost-Efficacy Analysis|cost-efficacy analysis
4979769|NCT04119167|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4979770|NCT04119167|Diabetic Polyneuropathy|diabetic polyneuropathy
4979771|NCT04119167|Diabetic Nephropathy|diabetic nephropathy
4979772|NCT04119167|Growth Differentiation Factor 15|growth differentiation factor 15
4979773|NCT04119128|Sjogren's Syndrome|sjogren's syndrome
4979774|NCT04119128|fatigue|fatigue
4979775|NCT04119128|tDCS|tdcs
4979780|NCT04119076|school-based intervention|school-based intervention
4979781|NCT04119076|active classroom|active classroom
4979793|NCT04118985|Subjective cognitive complaint|subjective cognitive complaint
4979794|NCT04118959|Recurrent implantation failure|recurrent implantation failure
4979795|NCT04118959|IVF|ivf
4979796|NCT04118959|Atosiban|atosiban
4979797|NCT04118959|Embryo Transfer|embryo transfer
4979798|NCT04118920|Topical insulin|topical insulin
4979799|NCT04118920|Dendrite regeneration|dendrite regeneration
4979800|NCT04118907|tinnitus|tinnitus
4979801|NCT04118907|stimulation|stimulation
4979802|NCT04118868|CTCL|ctcl
4979803|NCT04118868|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
4979804|NCT04118868|MF/SS|mf/ss
4979805|NCT04118868|Mycosis Fungoides|mycosis fungoides
4979806|NCT04118868|Sezary Syndrome|sezary syndrome
4979807|NCT04118868|pembrolizumab|pembrolizumab
4979808|NCT04118868|PD-L1|pd-l1
4979809|NCT04118855|neoadjuvant therapy|neoadjuvant therapy
4979810|NCT04118855|Toripalimab|toripalimab
4979811|NCT04118855|axitinib|axitinib
4979812|NCT04118855|nephrectomy|nephrectomy
4979813|NCT04118855|partial nephrectomy|partial nephrectomy
4979814|NCT04118842|Solid tumors|solid tumors
4979815|NCT04118842|Small-molecule kinase inhibitor|small-molecule kinase inhibitor
4979816|NCT04118829|Perampanel|perampanel
4979817|NCT04118790|Fatigue|fatigue
4979818|NCT04118790|minor stroke|minor stroke
4979819|NCT04118790|TIA|tia
4979820|NCT04118790|Diffusion|diffusion
4979821|NCT04118790|MRI|mri
4979822|NCT04118790|Quantitative|quantitative
4979823|NCT04118790|Sequence|sequence
4979824|NCT04118790|Microstructure|microstructure
4979825|NCT04118790|Axon|axon
4979826|NCT04118790|Myelin|myelin
4979827|NCT04118790|Degeneration|degeneration
4979831|NCT04118751|Parental outcomes|parental outcomes
4979832|NCT04118751|Bonding|bonding
4979833|NCT04118751|NICU|nicu
4979834|NCT04118738|ZIKA|zika
4979837|NCT04118699|phase 2 trial|phase 2 trial
4979838|NCT04118699|CIPO|cipo
4979839|NCT04118699|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
4979846|NCT04118595|Musculoskeletal Pain|musculoskeletal pain
4979847|NCT04118595|Acute Pain|acute pain
4979848|NCT04118595|Emergency Department|emergency department
4979849|NCT04118595|Elderly|elderly
4979850|NCT04118595|Video|video
4979851|NCT04118582|severe obesity|severe obesity
4979852|NCT04118582|resting metabolic rate|resting metabolic rate
4979853|NCT04118582|indirect calorimetry|indirect calorimetry
5703441|NCT00489450|SK3530|sk3530
4979854|NCT04118582|body composition|body composition
4979855|NCT04118582|electrical bioimpedance analisys|electrical bioimpedance analisys
4979856|NCT04118556|DSC|dsc
4979857|NCT04118556|BAT|bat
4979858|NCT04118556|GVHD|gvhd
4979859|NCT04118556|HSCT|hsct
4979860|NCT04118543|Obesity|obesity
4979861|NCT04118543|Cardiometabolic|cardiometabolic
4979862|NCT04118543|Adolescence|adolescence
4979864|NCT04118530|Atrial Fibrillation|atrial fibrillation
4979865|NCT04118530|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4979866|NCT04118530|Atrial Flutter|atrial flutter
4979867|NCT04118517|protein quality, legume|protein quality, legume
4979868|NCT04118504|Coronary disease|coronary disease
4979869|NCT04118504|Life style|life style
4979870|NCT04118504|Mobile application|mobile application
4979871|NCT04118504|Clinical trial|clinical trial
4979872|NCT04118478|fitness|fitness
4979873|NCT04118478|program training|program training
4979874|NCT04118478|exercise|exercise
4979885|NCT04118452|care coordination|care coordination
4979887|NCT04118439|Shoulder Pain|shoulder pain
4979888|NCT04118439|Chronic Pain|chronic pain
4979889|NCT04118439|Prehabilitation|prehabilitation
4979890|NCT04118426|Cognitive function|cognitive function
4979891|NCT04118387|Central sleep apnea|central sleep apnea
4979892|NCT04118387|Polysomnography (PSG)|polysomnography (psg)
4979893|NCT04118387|Respiratory arousal threshold|respiratory arousal threshold
4976836|NCT04137250|QUADRICEPS|quadriceps
4979894|NCT04118387|Apnea Hypopnea index|apnea hypopnea index
4979895|NCT04118387|Central Apnea Hypopnea Index|central apnea hypopnea index
4979896|NCT04118387|Breathing instability|breathing instability
4979897|NCT04118387|Apneic Threshold (AT)|apneic threshold (at)
4979898|NCT04118387|Peripheral chemoreflex sensitivity|peripheral chemoreflex sensitivity
4979899|NCT04118387|CO2 reserve|co2 reserve
4979900|NCT04118387|Plant gain|plant gain
4979901|NCT04118387|Controller gain|controller gain
4979902|NCT04118374|low carbohydrate diet|low carbohydrate diet
4979903|NCT04118374|hyperinsulinemia|hyperinsulinemia
4979904|NCT04118374|insulin resistance|insulin resistance
4979905|NCT04118374|endothelial dysfunction|endothelial dysfunction
4979906|NCT04118374|vascular health|vascular health
4979907|NCT04118348|Optimal default|optimal default
4979908|NCT04118348|Best practice alert|best practice alert
4979909|NCT04118348|Health maintenance topic|health maintenance topic
4979910|NCT04118335|Oral mucositis in COPD patients|oral mucositis in copd patients
4979911|NCT04118335|complementary therapies|complementary therapies
4979912|NCT04118335|nursing interventions|nursing interventions
4979913|NCT04118335|oral care with black mulberry syrup|oral care with black mulberry syrup
4979914|NCT04118322|Aromatherapy|aromatherapy
4979915|NCT04118322|Chemotherapy|chemotherapy
4979916|NCT04118322|Nausea-Vomiting|nausea-vomiting
4979917|NCT04118322|Nursing|nursing
4979918|NCT04118322|Peppermint Oil|peppermint oil
4979919|NCT04118283|Veterans|veterans
4979920|NCT04118283|chronic pain|chronic pain
4979921|NCT04118283|psychotic disorders|psychotic disorders
4979922|NCT04118283|affective disorders, psychotic|affective disorders, psychotic
4979923|NCT04118283|cognitive behavioral therapy|cognitive behavioral therapy
4979924|NCT04118283|ecological momentary assessment|ecological momentary assessment
4979925|NCT04118257|Glucose control|glucose control
4979926|NCT04118257|Cardiovascular disease risk factors|cardiovascular disease risk factors
4979927|NCT04118257|Sugary beverages|sugary beverages
4979928|NCT04118257|Pulmonary function|pulmonary function
4979929|NCT04118231|Hamstring Shortness|hamstring shortness
4979930|NCT04118231|Dry Needling|dry needling
4979931|NCT04118231|Elastography|elastography
4979932|NCT04118218|DLF Questionnaire|dlf questionnaire
4979935|NCT04118192|HER2 positive|her2 positive
4979937|NCT04118192|Tumour bed core biopsies|tumour bed core biopsies
4979938|NCT04118140|Cancer|cancer
4979939|NCT04118140|acupressure|acupressure
4979940|NCT04118140|fatigue|fatigue
4979941|NCT04118140|depression|depression
4979942|NCT04118140|insomnia|insomnia
4979955|NCT04118010|Cystic Fibrosis|cystic fibrosis
4979956|NCT04118010|Gastrointestinal Dysbiosis|gastrointestinal dysbiosis
4979957|NCT04118010|Vitamin D|vitamin d
4979958|NCT04118010|Prebiotic|prebiotic
4979959|NCT04118010|Inulin|inulin
4979960|NCT04118010|Gut microbiome|gut microbiome
4979961|NCT04118010|Intestinal inflammation|intestinal inflammation
4979962|NCT04118010|Intestinal absorption|intestinal absorption
4979963|NCT04117984|Population-based survey|population-based survey
4979964|NCT04117984|HIV|hiv
4997296|NCT04011202|Stroke|stroke
4979965|NCT04117984|Antenatal care|antenatal care
4979966|NCT04117984|PMTCT|pmtct
4979967|NCT04117984|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
4979968|NCT04117984|Tuberculosis|tuberculosis
4979969|NCT04117971|Child abuse|child abuse
4979970|NCT04117971|Abuse diagnosis|abuse diagnosis
4979971|NCT04117971|Abuse report|abuse report
4979972|NCT04117971|dentists' knowledge|dentists' knowledge
4979973|NCT04117932|bullous pemphigoid|bullous pemphigoid
4979974|NCT04117932|ustekinumab|ustekinumab
4979975|NCT04117932|superpotent topical corticosteroids|superpotent topical corticosteroids
4979976|NCT04117932|efficacy|efficacy
4979977|NCT04117932|safety|safety
4979978|NCT04117893|Osteoarthritis, Knee|osteoarthritis, knee
4979979|NCT04117893|Chronic Pain|chronic pain
4979980|NCT04117893|hyaluronic acid|hyaluronic acid
4979981|NCT04117893|corticosteroid|corticosteroid
4979982|NCT04117893|duloxetine|duloxetine
4979983|NCT04117893|Intra-articular injection|intra-articular injection
4979984|NCT04117854|spinal cord injury|spinal cord injury
4979986|NCT04117854|qualitative interviews|qualitative interviews
4979987|NCT04117854|web survey|web survey
4979988|NCT04117854|international|international
4979989|NCT04117854|multicenter|multicenter
4979990|NCT04117854|traumatic SCI|traumatic sci
4979991|NCT04117854|atraumatic SCI|atraumatic sci
4979992|NCT04117776|Central venous catheter-related bacteremias|central venous catheter-related bacteremias
4979993|NCT04117776|Skin decolonization|skin decolonization
4979994|NCT04117776|Intensive care unit hospitalization|intensive care unit hospitalization
4979995|NCT04117763|empagliflozin|empagliflozin
4979996|NCT04117763|Diabetes|diabetes
4979997|NCT04117763|coronary heart disease|coronary heart disease
4979998|NCT04117750|PCOS|pcos
4979999|NCT04117750|VD supplementation|vd supplementation
4980000|NCT04117750|androgen level|androgen level
4980001|NCT04117750|cardio metabolic|cardio metabolic
4980002|NCT04117737|Parkinson|parkinson
4980003|NCT04117737|Virtual reality|virtual reality
4980004|NCT04117737|Anti-gravity treadmill|anti-gravity treadmill
4980005|NCT04117737|Rehabilitation|rehabilitation
4980006|NCT04117737|Gait disorders|gait disorders
4980007|NCT04117711|Classic Galactosemia|classic galactosemia
4980008|NCT04117711|Aldose Reductase Inhibition|aldose reductase inhibition
4980009|NCT04117711|Galactose, Galactitol|galactose, galactitol
4980010|NCT04117685|hip dysplasia|hip dysplasia
4980011|NCT04117685|ddh|ddh
4980012|NCT04117685|developmental dysplasia of the hip|developmental dysplasia of the hip
4980013|NCT04117685|congenital hip dysplasia|congenital hip dysplasia
4980014|NCT04117672|traumatic brain injury|traumatic brain injury
4980015|NCT04117672|cerebral edema|cerebral edema
4980016|NCT04117672|antisecretory factor|antisecretory factor
4980017|NCT04117672|inflammatory cytokines|inflammatory cytokines
4980018|NCT04117672|cerebral oxygen monitoring|cerebral oxygen monitoring
4980019|NCT04117672|intracranial pressure|intracranial pressure
4980020|NCT04117672|microdialysis|microdialysis
4980021|NCT04117659|Left ventricular assist device|left ventricular assist device
4980022|NCT04117659|postoperative right heart failure|postoperative right heart failure
4980023|NCT04117646|Chronic rhinosinusitis of children|chronic rhinosinusitis of children
4980024|NCT04117646|Sinus and nasal quality of life survey questionnaire (SN-5)|sinus and nasal quality of life survey questionnaire (sn-5)
4980025|NCT04117646|Translation in French of the SN-5|translation in french of the sn-5
4980026|NCT04117633|Rectal Prolapse|rectal prolapse
4980027|NCT04117633|Laparoscopy|laparoscopy
4980028|NCT04117633|Mesh|mesh
4980039|NCT04117594|Prostate cancer|prostate cancer
4980040|NCT04117594|WB-MRI|wb-mri
4980041|NCT04117594|Bone disease|bone disease
4980042|NCT04117581|Vitamin D|vitamin d
4980043|NCT04117581|Asthma|asthma
4980044|NCT04117581|Lung function|lung function
4980045|NCT04117581|Inflammation|inflammation
4980048|NCT04117529|Pemphigus Vulgaris|pemphigus vulgaris
4980049|NCT04117529|Pemphigus Foliaceus|pemphigus foliaceus
4980050|NCT04117529|B-cell|b-cell
4980051|NCT04117529|Dermatology|dermatology
4980052|NCT04117516|Percutaneous carpal tunnel release|percutaneous carpal tunnel release
4980053|NCT04117464|anxiety|anxiety
4980054|NCT04117464|depression|depression
4980055|NCT04117464|behavioral activation therapy|behavioral activation therapy
4980056|NCT04117464|acceptance and commitment therapy|acceptance and commitment therapy
4980057|NCT04117464|cognitive-behavioral therapy|cognitive-behavioral therapy
4980058|NCT04117464|transdiagnostic|transdiagnostic
4980059|NCT04117464|group therapy|group therapy
4980064|NCT04117399|COPD|copd
4980066|NCT04117399|CoP ML|cop ml
4980067|NCT04117399|CoP AP|cop ap
4980068|NCT04117399|Posture|posture
4980069|NCT04117386|HPV infection|hpv infection
4980070|NCT04117386|Pterygium|pterygium
4980071|NCT04117386|Cytokine|cytokine
4980072|NCT04117386|VEGF|vegf
4980073|NCT04117386|auto-inoculation|auto-inoculation
4980074|NCT04117360|Dentofacial Disharmony|dentofacial disharmony
4980075|NCT04117360|Skeletal malocclusion|skeletal malocclusion
4980076|NCT04117360|Speech Sound Disorder|speech sound disorder
4980077|NCT04117360|Spectral Moment Analysis|spectral moment analysis
4980079|NCT04117360|Orthognathic Surgery|orthognathic surgery
4980080|NCT04117347|Circadian timing|circadian timing
4980081|NCT04117347|Mood|mood
4980082|NCT04117347|Light|light
4980083|NCT04117334|Bracing|bracing
4980084|NCT04117334|Cost-effectiveness|cost-effectiveness
4980085|NCT04117334|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4980086|NCT04117321|Mommy|mommy
4980087|NCT04117308|Perinatal morbidity|perinatal morbidity
4980088|NCT04117308|Prolonged pregnancy|prolonged pregnancy
4980089|NCT04117308|Fetal active movement count|fetal active movement count
4980090|NCT04117295|Heart Replacement Therapy|heart replacement therapy
4980091|NCT04117295|Total Artificial Heart|total artificial heart
4980092|NCT04117295|Biventricular Heart Failure|biventricular heart failure
4980093|NCT04117256|Direct Current Stimulation|direct current stimulation
4980094|NCT04117256|Conditioned Pain Modulation|conditioned pain modulation
4980095|NCT04117256|Endogenous Pain Modulation|endogenous pain modulation
4980096|NCT04117256|Temporal Summation|temporal summation
4980097|NCT04117256|Pressure Pain Threshold|pressure pain threshold
4980098|NCT04117256|Pain|pain
4980099|NCT04117243|tranexamic acid|tranexamic acid
4980100|NCT04117243|misoprostol|misoprostol
4980102|NCT04117204|CVD|cvd
4980103|NCT04117204|Dietary Intervention|dietary intervention
4980104|NCT04117178|Therapeutic Drug Monitoring|therapeutic drug monitoring
4980105|NCT04117178|TDM|tdm
4980106|NCT04117178|Adverse effects|adverse effects
4980107|NCT04117178|Dementia|dementia
4980108|NCT04117178|Alzheimer's disease|alzheimer's disease
4980109|NCT04117165|predictive software|predictive software
4980110|NCT04117165|quality of life|quality of life
4980111|NCT04117139|Positron-Emission-Tomography/Magnetic Resonance Imaging|positron-emission-tomography/magnetic resonance imaging
4980112|NCT04117139|PET/MRI|pet/mri
4980113|NCT04117139|Cancer staging|cancer staging
4980114|NCT04117126|aged|aged
4980115|NCT04117126|Therapeutics|therapeutics
4980116|NCT04117126|hospitalization|hospitalization
4980117|NCT04117126|nursing care|nursing care
4980118|NCT04117126|rehabilitation|rehabilitation
4980119|NCT04117126|prompted voiding|prompted voiding
4980120|NCT04117087|KRAS Peptide Vaccine|kras peptide vaccine
4980121|NCT04117087|Nivolumab|nivolumab
4980122|NCT04117087|Ipilimumab|ipilimumab
4980123|NCT04117087|Anti-PD-1|anti-pd-1
4980124|NCT04117087|Anti-CTLA-4|anti-ctla-4
4980125|NCT04117087|Neoantigen Vaccines|neoantigen vaccines
4980126|NCT04117087|Cancer Vaccines|cancer vaccines
4980127|NCT04117087|Immunotherapy|immunotherapy
4980128|NCT04117087|Colon Cancer|colon cancer
4980129|NCT04117087|Pancreatic Ductal Adenocarcinoma (PDAC)|pancreatic ductal adenocarcinoma (pdac)
4980130|NCT04117087|Resected MMR-p Colorectal Cancer|resected mmr-p colorectal cancer
4980131|NCT04117087|Resected MMR-p Pancreatic Cancer|resected mmr-p pancreatic cancer
4980132|NCT04117048|INR|inr
4980133|NCT04117048|Labpad®|labpad®
4980134|NCT04117048|VKA|vka
4980135|NCT04117035|multiple sclerosis|multiple sclerosis
4980136|NCT04117035|trigeminal neuralgia|trigeminal neuralgia
4980137|NCT04117035|Pain|pain
4980138|NCT04117035|Quality of life|quality of life
4984381|NCT04089592|Intubation|intubation
4980139|NCT04117009|diastolic dysfunction|diastolic dysfunction
4980140|NCT04117009|remifentanil|remifentanil
4980141|NCT04116944|anxiety|anxiety
4980142|NCT04116931|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
4980143|NCT04116931|Platelet function|platelet function
4980144|NCT04116931|Clopidogrel|clopidogrel
4980145|NCT04116931|Ticagrelor|ticagrelor
4980146|NCT04116931|Switch|switch
4980147|NCT04116905|Metablolic syndrome|metablolic syndrome
4980148|NCT04116905|remission|remission
4980149|NCT04116905|life style|life style
4980150|NCT04116905|weight loss|weight loss
4980151|NCT04116892|Inverted Internal Limiting Membrane Flap Technique|inverted internal limiting membrane flap technique
4980152|NCT04116892|Large Macular Hole|large macular hole
4980153|NCT04116892|Macular hole surgery|macular hole surgery
4980154|NCT04116853|Weight Loss|weight loss
4980155|NCT04116853|Weight Maintenance|weight maintenance
4980156|NCT04116827|sleep disorder|sleep disorder
4980157|NCT04116827|breast cancer|breast cancer
4980158|NCT04116827|pre-menopausal|pre-menopausal
4980159|NCT04116827|tamoxifen|tamoxifen
4980160|NCT04116827|hormone therapy|hormone therapy
4980161|NCT04116775|Microbiota|microbiota
4980162|NCT04116775|Prostate|prostate
4980163|NCT04116775|Metastatic|metastatic
4980164|NCT04116775|Programmed cell death protein 1|programmed cell death protein 1
4980165|NCT04116775|Pembrolizumab|pembrolizumab
4980166|NCT04116775|Prostatic Neoplasms|prostatic neoplasms
4980167|NCT04116723|Flexible brace|flexible brace
4980168|NCT04116710|Cancer|cancer
4980169|NCT04116710|Immunotherapy|immunotherapy
4980170|NCT04116710|Vaccine|vaccine
4980171|NCT04116710|Intradermal|intradermal
4980172|NCT04116710|gp96|gp96
4980173|NCT04116710|OX40|ox40
4980174|NCT04116710|Combination Therapy|combination therapy
4980175|NCT04116710|Co-stimulation|co-stimulation
4980176|NCT04116710|Heat Biologics|heat biologics
4980180|NCT04116671|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4980182|NCT04116671|hemiparesis|hemiparesis
4980183|NCT04116671|walking|walking
4980184|NCT04116671|powered orthosis|powered orthosis
4980185|NCT04116658|Glioblastoma|glioblastoma
4980186|NCT04116658|Vaccine|vaccine
4980187|NCT04116658|Nivolumab|nivolumab
4980188|NCT04116658|Bevacizumab|bevacizumab
4980189|NCT04116658|Safety|safety
4980190|NCT04116658|Tolerability|tolerability
4980191|NCT04116606|P2X7|p2x7
4980192|NCT04116606|Major Depressive Disorder|major depressive disorder
4980193|NCT04116593|Nutrition education|nutrition education
4980194|NCT04116593|Dietary diversity|dietary diversity
4980195|NCT04116593|Adolescent girls|adolescent girls
4980196|NCT04116580|Food Allergy|food allergy
4980197|NCT04116580|Apple Allergy|apple allergy
4980198|NCT04116580|Oral Allergic Syndrome|oral allergic syndrome
4980199|NCT04116580|Ultra-Rush|ultra-rush
4980200|NCT04116580|Tolerance induction|tolerance induction
4980201|NCT04116580|Cross-Allergy|cross-allergy
4980202|NCT04116567|Pulmonary Atelectasis|pulmonary atelectasis
4980203|NCT04116567|Lung Ultrasound|lung ultrasound
4980204|NCT04116567|Laparoscopic Surgery|laparoscopic surgery
4980205|NCT04116554|transversus thoracic muscle plane block.|transversus thoracic muscle plane block.
4980206|NCT04116554|analgesic after open heart surgery.|analgesic after open heart surgery.
4980207|NCT04116541|Metastatic Solid Neoplasm|metastatic solid neoplasm
4980208|NCT04116541|Advanced Solid Tumor|advanced solid tumor
4980209|NCT04116541|Genomic alteration|genomic alteration
4980210|NCT04116541|Targeted therapy|targeted therapy
4980211|NCT04116541|Cabozantinib|cabozantinib
4980213|NCT04116541|HDM201|hdm201
4980214|NCT04116515|Active Video Game|active video game
4980215|NCT04116515|Physical Activity|physical activity
4980216|NCT04116515|Narrative|narrative
4980217|NCT04116515|Child Obesity|child obesity
4980218|NCT04116463|lower-wage workers|lower-wage workers
4980219|NCT04116463|chronic disease|chronic disease
4980220|NCT04116463|self-management|self-management
4980221|NCT04116437|BGB-3111|bgb-3111
4980222|NCT04116437|Zanubrutinib|zanubrutinib
4980223|NCT04116437|Ibrutinib Intolerance|ibrutinib intolerance
4980224|NCT04116437|BTK Inhibitor|btk inhibitor
4980225|NCT04116411|cytomegalovirus|cytomegalovirus
4980226|NCT04116411|valganciclovir|valganciclovir
4980227|NCT04116398|dexamethasone,|dexamethasone,
4980228|NCT04116398|loading dose,|loading dose,
4980229|NCT04116398|diabetic macular edema|diabetic macular edema
4980230|NCT04116398|pseudophakic|pseudophakic
4980231|NCT04116385|Viscoelastic testing|viscoelastic testing
4980232|NCT04116385|Coagulation|coagulation
4980233|NCT04116385|Quantra|quantra
4980234|NCT04116385|Hemostasis|hemostasis
4980235|NCT04116346|Fasting|fasting
4980236|NCT04116346|Cardiac Catheterization|cardiac catheterization
4980237|NCT04116346|Percutaneous coronary intervention|percutaneous coronary intervention
4980238|NCT04116320|Echopulse|echopulse
4980239|NCT04116320|Focused Ultrasound Ablation|focused ultrasound ablation
4980240|NCT04116320|FUSA|fusa
4980241|NCT04116320|imiquimod|imiquimod
4980242|NCT04116320|Aldara|aldara
4980243|NCT04116320|Pembrolizumab|pembrolizumab
4980244|NCT04116320|Keytruda|keytruda
4980245|NCT04116320|Atezolizumab|atezolizumab
4980246|NCT04116320|Tecentriq|tecentriq
4980254|NCT04116255|exercise therapy|exercise therapy
4980255|NCT04116255|occlusal splint|occlusal splint
4980256|NCT04116255|neuropathic pain|neuropathic pain
4980257|NCT04116242|immunoparesis|immunoparesis
4980258|NCT04116242|monocyte dysfunction|monocyte dysfunction
4980259|NCT04116242|MER receptor tyrosine kinase (MERTK)|mer receptor tyrosine kinase (mertk)
4980260|NCT04116242|innate immune dysfunction|innate immune dysfunction
4980261|NCT04116242|circulating monocytes/macrophages|circulating monocytes/macrophages
4980262|NCT04116242|MERTK signalling|mertk signalling
4980263|NCT04116229|Obesity|obesity
4980264|NCT04116229|Inflammation|inflammation
4980265|NCT04116229|Cognitive impairment|cognitive impairment
4980266|NCT04116229|Neuroimaging|neuroimaging
4980267|NCT04116229|Magnetic resonance imaging|magnetic resonance imaging
4980268|NCT04116216|Parkinson's disease|parkinson's disease
4980269|NCT04116203|Polycystic Ovary Syndrome|polycystic ovary syndrome
4980270|NCT04116203|metabolic and cardiovascular diseases|metabolic and cardiovascular diseases
4980274|NCT04116190|stroke|stroke
4980275|NCT04116177|Deep brain stimulation|deep brain stimulation
4980276|NCT04116177|Parkinson disease|parkinson disease
4980277|NCT04116177|Novel strategies|novel strategies
4980278|NCT04116164|Radiolabeled antibody|radiolabeled antibody
4980279|NCT04116164|Imaging|imaging
4980280|NCT04116151|CANCER|cancer
4980281|NCT04116151|DERMATITIS|dermatitis
4980282|NCT04116125|Breast cancer|breast cancer
4980283|NCT04116125|cN1, ycN0|cn1, ycn0
4980284|NCT04116125|Neoadjuvant cheotherapy|neoadjuvant cheotherapy
4980285|NCT04116125|Sentinel Lymph Node|sentinel lymph node
4980286|NCT04116125|Radiotherapy|radiotherapy
4980287|NCT04116112|Blood Pressure Control|blood pressure control
4980288|NCT04116099|Lymphedema of Leg|lymphedema of leg
4980289|NCT04116099|Chronic Venous Insufficiency|chronic venous insufficiency
4980290|NCT04116099|Primary Lymphedema|primary lymphedema
4980291|NCT04116099|Secondary Lymphedema|secondary lymphedema
4980292|NCT04116073|Antibody|antibody
4980293|NCT04116073|Anti-PD-1|anti-pd-1
4980294|NCT04116073|Human monoclonal immunoglobulin antibody|human monoclonal immunoglobulin antibody
4980295|NCT04116073|Immunotherapy|immunotherapy
4980296|NCT04116073|INCMGA00012 (anti-PD-1 antibody)|incmga00012 (anti-pd-1 antibody)
4980297|NCT04116073|Anti-PD-1 antibody (MGA012)|anti-pd-1 antibody (mga012)
4980298|NCT04116073|Metastatic adenosquamous pancreatic cancer|metastatic adenosquamous pancreatic cancer
4980299|NCT04116073|Unresectable adenosquamous pancreatic cancer|unresectable adenosquamous pancreatic cancer
4980300|NCT04116073|Adenosquamous pancreatic cancer|adenosquamous pancreatic cancer
4980301|NCT04116073|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
4980302|NCT04116073|Programmed death-ligand 1 (PD-L1)|programmed death-ligand 1 (pd-l1)
4980303|NCT04116047|Oropharyngeal cancer|oropharyngeal cancer
4980305|NCT04116021|mastectomy|mastectomy
4980307|NCT04115995|Perforator flaps|perforator flaps
4980308|NCT04115995|Computer Tomography|computer tomography
4980309|NCT04115995|Indocyanine green|indocyanine green
4980310|NCT04115995|Fluorescence angiography|fluorescence angiography
4980311|NCT04115995|Infrared thermography|infrared thermography
4980312|NCT04115995|Dynamic infrared thermography|dynamic infrared thermography
4980313|NCT04115995|Doppler ultrasound|doppler ultrasound
4980314|NCT04115995|Angiosome|angiosome
4980315|NCT04115995|Perforasome|perforasome
4980316|NCT04115995|Flap perfusion|flap perfusion
4980317|NCT04115982|digital nerve injury|digital nerve injury
4980318|NCT04115982|neuroma|neuroma
4980319|NCT04115982|cholecalciferol|cholecalciferol
4980320|NCT04115969|non-invasive ventilation|non-invasive ventilation
4980321|NCT04115969|critical care|critical care
4980322|NCT04115917|Scleral Depression|scleral depression
4980323|NCT04115917|Visual Analog Scale|visual analog scale
4980324|NCT04115917|Pain|pain
4980325|NCT04115917|Discomfort|discomfort
4980326|NCT04115917|Schocket Scleral Depressor|schocket scleral depressor
4980327|NCT04115917|Cotton Tipped Applicator|cotton tipped applicator
4980328|NCT04115917|Diabetes|diabetes
4980329|NCT04115891|lavandula|lavandula
4980330|NCT04115891|phytotherapy|phytotherapy
4980347|NCT04115813|Support Groups|support groups
4980348|NCT04115800|Sirolimus|sirolimus
4980349|NCT04115800|Liposomal|liposomal
4980350|NCT04115800|Subconjunctival|subconjunctival
4980351|NCT04115774|Disease Registry|disease registry
4980352|NCT04115774|Natural History Study|natural history study
4980359|NCT04115709|Ventilation|ventilation
4980360|NCT04115618|esophageal cancer|esophageal cancer
4980361|NCT04115618|Chemoradiotherapy|chemoradiotherapy
4980362|NCT04115618|Simultaneous Integrated Boost Intensity|simultaneous integrated boost intensity
4980363|NCT04115605|Single Incision Sling|single incision sling
4980370|NCT04115527|Standard lymphadenectomy|standard lymphadenectomy
4980371|NCT04115527|Extended lymphadenectomy|extended lymphadenectomy
4980372|NCT04115527|Pancreaticoduodenectomy|pancreaticoduodenectomy
4980373|NCT04115475|Muscular Diseases, Spinal Muscular Atrophy (SMA), MSOT|muscular diseases, spinal muscular atrophy (sma), msot
4980374|NCT04115449|dexmedetomidine, shoulder pain, spinal anesthesia.|dexmedetomidine, shoulder pain, spinal anesthesia.
5342907|NCT01981551|Notch Pathway|notch pathway
4980375|NCT04115436|LAA isolation, stroke, anticoagulation|laa isolation, stroke, anticoagulation
4980376|NCT04115423|Tocilizumab|tocilizumab
4980377|NCT04115423|Serious Infection|serious infection
4980378|NCT04115423|Rheumatoid Arthritis|rheumatoid arthritis
4980379|NCT04115423|Tumor necrosis factor inhibitors|tumor necrosis factor inhibitors
4980380|NCT04115410|PD-1 inhibitor|pd-1 inhibitor
4980381|NCT04115410|Nivolumab|nivolumab
4980390|NCT04115332|workplace violence|workplace violence
4980391|NCT04115332|resilience|resilience
4980392|NCT04115332|biofeedback training|biofeedback training
4980393|NCT04115332|physiological indicators|physiological indicators
4980394|NCT04115319|schizophrenia|schizophrenia
4980395|NCT04115267|Combined effect|combined effect
4980396|NCT04115267|Registry|registry
4980397|NCT04115267|Side effects|side effects
4980398|NCT04115267|Patient reported outcome|patient reported outcome
4980400|NCT04115254|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4980401|NCT04115254|MRIdian Linear Accelerator|mridian linear accelerator
4980402|NCT04115254|Pancreas Cancer|pancreas cancer
4980403|NCT04115254|Lung Cancer|lung cancer
4980404|NCT04115254|Renal Cancer|renal cancer
4980405|NCT04115241|leukemia|leukemia
4980406|NCT04115241|multiple myeloma|multiple myeloma
4980407|NCT04115241|myelodysplastic syndrome|myelodysplastic syndrome
4980408|NCT04115241|stem cell transplant|stem cell transplant
4980409|NCT04115215|Older adults|older adults
4980410|NCT04115215|Cognitive impairment|cognitive impairment
4980411|NCT04115215|Motoric Cognitive Risk Syndrome|motoric cognitive risk syndrome
4980412|NCT04115215|Physical disfunction|physical disfunction
4980413|NCT04115215|Multi-component physical exercise program|multi-component physical exercise program
4980414|NCT04115215|Transcranial electrical stimulation|transcranial electrical stimulation
4980416|NCT04115176|chronic periodontitis|chronic periodontitis
4980417|NCT04115176|smoking,|smoking,
4980418|NCT04115176|periodontal treatment,|periodontal treatment,
4980419|NCT04115176|IL-17,|il-17,
4980420|NCT04115176|oxidative stress|oxidative stress
4980421|NCT04115137|Pelvic Congestion Syndrome|pelvic congestion syndrome
4980422|NCT04115137|amplatzer vascular plug|amplatzer vascular plug
4980423|NCT04115137|Vascular plug|vascular plug
4980424|NCT04115137|metallic embolization device|metallic embolization device
4980723|NCT04113239|Microbiome|microbiome
4980426|NCT04115137|embolization procedure|embolization procedure
4980427|NCT04115111|malignant pleural mesothelioma|malignant pleural mesothelioma
4980428|NCT04115098|spondylitis|spondylitis
4980429|NCT04115085|Degeneration|degeneration
4980430|NCT04115085|Trapeziometacarpal osteoarthritis|trapeziometacarpal osteoarthritis
4980431|NCT04115085|Basal Joint Arthritis|basal joint arthritis
4980432|NCT04115085|Arthrosis|arthrosis
4980433|NCT04115085|Hand|hand
4980434|NCT04115085|Thumb|thumb
4980435|NCT04115072|Schistosomiasis|schistosomiasis
4980436|NCT04115072|Praziquantel|praziquantel
4980437|NCT04115072|Gynaecology|gynaecology
4980438|NCT04115072|Female|female
4980439|NCT04115059|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4980440|NCT04115059|DASATINIB|dasatinib
4980441|NCT04115033|Pain|pain
4980442|NCT04115033|Fibromyalgia|fibromyalgia
4980443|NCT04115033|Magnetic Resonance Imaging|magnetic resonance imaging
4980444|NCT04115033|Percutaneous Electrical Nerve Stimulation|percutaneous electrical nerve stimulation
4980445|NCT04115033|Myofascial Pain Syndromes|myofascial pain syndromes
4980446|NCT04115033|Veterans|veterans
4980447|NCT04114968|HPV self-sampling, cervical cancer screening in older women|hpv self-sampling, cervical cancer screening in older women
4980448|NCT04114955|transgender women|transgender women
4980449|NCT04114955|HIV prevention|hiv prevention
4980450|NCT04114955|HIV testing|hiv testing
4980451|NCT04114955|pre-exposure prophylaxis|pre-exposure prophylaxis
4980454|NCT04114942|college|college
4980455|NCT04114942|transitions|transitions
4980456|NCT04114942|career development|career development
4980457|NCT04114942|social skills|social skills
4980458|NCT04114929|ventilatory anaerobic threshold|ventilatory anaerobic threshold
4980459|NCT04114929|Intensity|intensity
4980460|NCT04114929|Exercise Dose|exercise dose
4980461|NCT04114929|Standard care|standard care
4980462|NCT04114903|Diabetes|diabetes
4980463|NCT04114903|Obesity|obesity
4980464|NCT04114903|Cannabis|cannabis
4980465|NCT04114903|Insulin Sensitivity|insulin sensitivity
4980466|NCT04114864|Adolescent|adolescent
4980467|NCT04114864|Acceptance and Commitment Therapy, Cognitive therapy|acceptance and commitment therapy, cognitive therapy
4980468|NCT04114864|Mindfulness|mindfulness
4980469|NCT04114864|Europe|europe
4980470|NCT04114825|Biochemical relapse|biochemical relapse
4997802|NCT04008004|HBV|hbv
4980484|NCT04114760|wireless technology|wireless technology
4980485|NCT04114760|simulation study|simulation study
4980486|NCT04114721|intubation|intubation
4980487|NCT04114721|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4980488|NCT04114721|Learning curve|learning curve
4980489|NCT04114721|videolaryngoscope|videolaryngoscope
4980490|NCT04114682|Type 2 diabetes|type 2 diabetes
4980491|NCT04114682|NAFLD|nafld
4980492|NCT04114682|Metformin|metformin
4980493|NCT04114682|Multiparametric MRI|multiparametric mri
4980495|NCT04114643|Frozen Plasma (FP)|frozen plasma (fp)
4980496|NCT04114643|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
4980497|NCT04114643|Octaplex|octaplex
4980498|NCT04114643|Coagulation Factor Replacement|coagulation factor replacement
4980499|NCT04114643|Transfusion|transfusion
4980500|NCT04114643|Bleeding Cardiac Surgical Patients|bleeding cardiac surgical patients
4980501|NCT04114643|Pilot|pilot
4980502|NCT04114643|Phase 2|phase 2
4980503|NCT04114630|Chronic migraine|chronic migraine
4980504|NCT04114630|Migraine|migraine
4980505|NCT04114630|Transformative migraine|transformative migraine
4980506|NCT04114630|Neurologic disease|neurologic disease
4980507|NCT04114630|Unremitting pain|unremitting pain
4980508|NCT04114630|Progressive over time|progressive over time
4980509|NCT04114630|Nausea|nausea
4980510|NCT04114630|Vomiting|vomiting
4980511|NCT04114630|Sensitivity to light,|sensitivity to light,
4980512|NCT04114630|Sensitivity to sound|sensitivity to sound
4980513|NCT04114630|Pain localized to one side of head,|pain localized to one side of head,
4980514|NCT04114630|Painful headache|painful headache
4980515|NCT04114630|Pain in head|pain in head
4980516|NCT04114630|Head throbbing|head throbbing
4980517|NCT04114630|Sinus headache|sinus headache
4980518|NCT04114630|Pounding headache|pounding headache
4980519|NCT04114617|Swallowing|swallowing
4980520|NCT04114617|Deglutition|deglutition
4980521|NCT04114565|prevalence|prevalence
4980522|NCT04114565|mood disorders|mood disorders
4980523|NCT04114565|affective disorders|affective disorders
4980529|NCT04114552|Ankle sprain|ankle sprain
4980530|NCT04114552|physical examination|physical examination
4980532|NCT04114552|recurrence|recurrence
4980533|NCT04114539|Tourette Syndrome|tourette syndrome
4980534|NCT04114513|Dietary fiber|dietary fiber
4980535|NCT04114513|Gut Microbiota|gut microbiota
4980536|NCT04114513|Cardiovascular risk factors|cardiovascular risk factors
4980537|NCT04114513|Lipid metabolism|lipid metabolism
4980538|NCT04114500|Estradiol|estradiol
4980541|NCT04114500|Progesterone|progesterone
4980546|NCT04114448|Hemophilia|hemophilia
4980547|NCT04114448|Therapeutic exercise|therapeutic exercise
4980548|NCT04114448|Physical therapy|physical therapy
4980549|NCT04114448|Randomized controlled trial|randomized controlled trial
4980550|NCT04114448|Pain perception|pain perception
4980551|NCT04114448|Range of movement|range of movement
4980552|NCT04114422|cancer|cancer
4980553|NCT04114422|surgery|surgery
4980554|NCT04114422|exercise training|exercise training
4980555|NCT04114422|physical therapy|physical therapy
4980556|NCT04114396|Severe Asthma|severe asthma
4980557|NCT04114396|Anti-IL5|anti-il5
4980558|NCT04114396|Asthma|asthma
4980559|NCT04114344|Woman|woman
4980560|NCT04114344|Inguinal Hernia|inguinal hernia
4980561|NCT04114344|TAPP|tapp
4980562|NCT04114344|TEP|tep
4980563|NCT04114344|Outpatient Surgery|outpatient surgery
4980564|NCT04114344|Ambulatory Surgery|ambulatory surgery
4980565|NCT04114331|forward head posture|forward head posture
4980566|NCT04114305|Human Immunodeficiency Virus|human immunodeficiency virus
4980567|NCT04114305|HIV-Exposed Uninfected Children|hiv-exposed uninfected children
4980568|NCT04114305|Prevention of Mother to Child Transmission of HIV|prevention of mother to child transmission of hiv
4980569|NCT04114305|Orphans and Vulnerable Children|orphans and vulnerable children
4980570|NCT04114305|Mentor Mothers|mentor mothers
4980571|NCT04114305|Swaziland|swaziland
4980572|NCT04114305|eSwatini|eswatini
4980573|NCT04114292|Ulcerative Colitis|ulcerative colitis
4980575|NCT04114292|tauroursodeoxycholic acid|tauroursodeoxycholic acid
4980576|NCT04114279|surgical simulator|surgical simulator
4980579|NCT04114253|Viscoelastic testing|viscoelastic testing
4980581|NCT04114253|Quantra|quantra
4980582|NCT04114253|Hemostasis|hemostasis
4980583|NCT04114240|erectil dysfunction|erectil dysfunction
4980584|NCT04114240|sildenafil|sildenafil
4980585|NCT04114240|xybilun|xybilun
4980586|NCT04114188|transplant medicine|transplant medicine
4980587|NCT04114175|amputees|amputees
4980588|NCT04114175|rehabilitation|rehabilitation
4980589|NCT04114175|energy expenditure|energy expenditure
4980590|NCT04114175|deep muscles of the back|deep muscles of the back
4980591|NCT04114162|ICU|icu
4980592|NCT04114162|Septic shock|septic shock
4980593|NCT04114162|Fluid overload|fluid overload
4980594|NCT04114162|Quantification|quantification
4980595|NCT04114162|Bioimpedancemetry|bioimpedancemetry
4980596|NCT04114162|Capillary leak|capillary leak
4980597|NCT04114162|Fluid responsiveness|fluid responsiveness
4980598|NCT04114149|Pain|pain
4980599|NCT04114149|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
4980600|NCT04114149|Analgesics, Opioid|analgesics, opioid
4980601|NCT04114136|Anti-PD-1 monoclonal antibody (mAb)|anti-pd-1 monoclonal antibody (mab)
4980602|NCT04114136|tumor infiltrating lymphocytes (TIL)|tumor infiltrating lymphocytes (til)
4980603|NCT04114123|Reward-driven Eating|reward-driven eating
4980604|NCT04114123|Infant|infant
4980605|NCT04114123|Maternal|maternal
4980606|NCT04114097|topical corticosteroids|topical corticosteroids
4980607|NCT04114097|topical calcineurin inhibitors|topical calcineurin inhibitors
4980608|NCT04114071|physical activity|physical activity
4980609|NCT04114071|older Black women|older black women
4980610|NCT04114071|overweight|overweight
4980611|NCT04114071|obesity|obesity
4980612|NCT04114071|text messages|text messages
4980613|NCT04114058|hip arthroscopy|hip arthroscopy
4980614|NCT04114032|High risk surgical patients|high risk surgical patients
4980615|NCT04114032|Risk stratification|risk stratification
4980616|NCT04114032|Natriuretic peptide testing|natriuretic peptide testing
4980617|NCT04114006|gastric intestinal metaplasia|gastric intestinal metaplasia
4980618|NCT04114006|gastric neoplasia|gastric neoplasia
4980619|NCT04113980|acute pain|acute pain
4980620|NCT04113980|anxiety|anxiety
4980621|NCT04113980|children|children
4980622|NCT04113980|blood collection|blood collection
4980623|NCT04113980|nursing|nursing
4980624|NCT04113967|Biodanza|biodanza
4980625|NCT04113967|Alzheimer Dementia|alzheimer dementia
4980626|NCT04113967|dance therapy|dance therapy
4980627|NCT04113967|complementary therapies|complementary therapies
4980628|NCT04113967|physical activity|physical activity
4980629|NCT04113954|Healthy volunteer|healthy volunteer
4980630|NCT04113954|Regional anesthesia|regional anesthesia
4980631|NCT04113954|Compartment Syndrome|compartment syndrome
4980632|NCT04113928|Broccoli|broccoli
4980633|NCT04113928|Bioavailability|bioavailability
4980634|NCT04113928|Ileostomists|ileostomists
4980635|NCT04113928|Randomised controlled trial|randomised controlled trial
4980636|NCT04113928|Phytochemical|phytochemical
4980637|NCT04113902|Human Papilloma Virus vaccine|human papilloma virus vaccine
4980638|NCT04113902|Health education|health education
4980639|NCT04113902|Nursing|nursing
4980640|NCT04113902|Adolescent Health|adolescent health
4980641|NCT04113889|PCOS|pcos
4980642|NCT04113889|Acetyl-L-Carnitine|acetyl-l-carnitine
4980643|NCT04113876|sleep quality|sleep quality
4980644|NCT04113876|circadian rhythm|circadian rhythm
4980645|NCT04113876|nursing activities|nursing activities
4980646|NCT04113837|foods, nutrient profile, dietary fiber, omega 3 fatty acids|foods, nutrient profile, dietary fiber, omega 3 fatty acids
4980647|NCT04113811|Prostate cancer|prostate cancer
4980648|NCT04113811|Focal therapy|focal therapy
4980649|NCT04113811|Microwave ablation|microwave ablation
4980650|NCT04113798|women|women
4980651|NCT04113798|exercise|exercise
4980652|NCT04113798|mental health|mental health
4980653|NCT04113785|total knee arthroplasty|total knee arthroplasty
4980654|NCT04113785|knee implant|knee implant
4980655|NCT04113785|osteoarthritis|osteoarthritis
4980656|NCT04113746|Asthma|asthma
4980657|NCT04113746|Obesity|obesity
4980658|NCT04113746|Self-management behaviors|self-management behaviors
4980659|NCT04113681|Embolization, Osteoarthritis, Knee, Geniculate Artery|embolization, osteoarthritis, knee, geniculate artery
4980661|NCT04113655|acellular pertussis vaccine|acellular pertussis vaccine
4980662|NCT04113655|antibody persistence at 2 years after vaccination|antibody persistence at 2 years after vaccination
4980663|NCT04113655|Pertagen|pertagen
4980664|NCT04113655|Boostagen|boostagen
4980665|NCT04113655|aP vaccine|ap vaccine
4980666|NCT04113642|abdominal muscles|abdominal muscles
4980667|NCT04113642|ultrasonography|ultrasonography
4980668|NCT04113642|exercise|exercise
4980669|NCT04113642|lumbar fascia|lumbar fascia
4980670|NCT04113590|cholecystectomy|cholecystectomy
4980671|NCT04113590|gall stone surgery|gall stone surgery
4980672|NCT04113590|scarless surgery|scarless surgery
4980673|NCT04113590|cholelithiasis|cholelithiasis
4980674|NCT04113577|old people|old people
4980675|NCT04113577|elderly|elderly
4980676|NCT04113577|minor neurocognitive disorder|minor neurocognitive disorder
4980677|NCT04113577|major neurocognitive disorder|major neurocognitive disorder
4984978|NCT04085783|IVF|ivf
4980678|NCT04113577|neurocognitive disorder|neurocognitive disorder
4980679|NCT04113577|mild cogntitive impairment|mild cogntitive impairment
4980681|NCT04113577|alzheimer disease|alzheimer disease
4980682|NCT04113577|app|app
4980683|NCT04113577|usability|usability
4980684|NCT04113577|ergonomic|ergonomic
4980685|NCT04113577|satisfaction|satisfaction
4980686|NCT04113525|Stroke Rehabilitation|stroke rehabilitation
4980687|NCT04113525|Neuromodulation|neuromodulation
4980688|NCT04113525|Transcutaneous Spinal Direct Current Stimulation|transcutaneous spinal direct current stimulation
4980689|NCT04113525|Robotic Therapy|robotic therapy
4980690|NCT04113525|Transcutaneous Peripheral Direct Current Stimulation|transcutaneous peripheral direct current stimulation
4980691|NCT04113525|Spasticity|spasticity
4980692|NCT04113525|Hemiparesis|hemiparesis
4980693|NCT04113499|pancreatic necrosis|pancreatic necrosis
4980694|NCT04113499|pancreatic necrotic collection|pancreatic necrotic collection
4980695|NCT04113499|transenteric drainage|transenteric drainage
4980696|NCT04113499|necrosectomy|necrosectomy
4980697|NCT04113486|renal cancer|renal cancer
4980698|NCT04113486|tumor biomarker|tumor biomarker
4980699|NCT04113434|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4980700|NCT04113434|ARDS|ards
4980701|NCT04113421|pulmonary embolism|pulmonary embolism
4980702|NCT04113421|anticoagulation|anticoagulation
4980703|NCT04113382|Colon Cleansing|colon cleansing
4980704|NCT04113382|Preparation for Colonoscopy|preparation for colonoscopy
4980705|NCT04113369|Cross-education|cross-education
4980706|NCT04113369|Interlimb transfer|interlimb transfer
4980707|NCT04113369|Electro muscular stimulation|electro muscular stimulation
4980708|NCT04113369|Muscle strength|muscle strength
4980709|NCT04113343|remimazolam|remimazolam
4980710|NCT04113304|Parenting Interventions|parenting interventions
4980711|NCT04113304|Parent Training|parent training
4980712|NCT04113304|Technology-based intervention|technology-based intervention
4980713|NCT04113304|Disruptive Behavior Problems|disruptive behavior problems
4980714|NCT04113304|Early Childhood|early childhood
4980715|NCT04113291|DASH Diet|dash diet
4980716|NCT04113291|Low socioeconomic status|low socioeconomic status
4980717|NCT04113291|HFPEF|hfpef
4980718|NCT04113252|opioid buyback|opioid buyback
4980719|NCT04113252|opioid misuse prevention|opioid misuse prevention
4980720|NCT04113239|Gut Metagenetics|gut metagenetics
4980721|NCT04113239|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4980722|NCT04113239|Genetics|genetics
4980729|NCT04113226|activities of patients daily living|activities of patients daily living
4980730|NCT04113226|Elderly|elderly
4980731|NCT04113226|Lenalidomide|lenalidomide
4980732|NCT04113187|angiogenesis|angiogenesis
4980733|NCT04113187|epistaxis|epistaxis
4980734|NCT04113187|propranolol|propranolol
4980735|NCT04113161|Peer Navigators|peer navigators
4980736|NCT04113161|Disruptive Behavior Disorder|disruptive behavior disorder
4980737|NCT04113161|Access Inequalities|access inequalities
4980738|NCT04113070|Child health care|child health care
4980739|NCT04113070|Weight status|weight status
4980740|NCT04113070|Environment|environment
4980741|NCT04113070|puberty|puberty
4980742|NCT04113044|PRO|pro
4980743|NCT04113044|HOOS|hoos
4980744|NCT04113044|KOOS|koos
4980745|NCT04113044|FAAM|faam
4980746|NCT04113044|PROMIS|promis
4980747|NCT04113044|QuickDASH|quickdash
4980748|NCT04113044|PSEQ|pseq
4980749|NCT04113044|PAM|pam
4980750|NCT04113031|Sprint|sprint
4980751|NCT04113031|Jump|jump
4980752|NCT04113031|Maximal Strength|maximal strength
4980753|NCT04113031|Power|power
4980754|NCT04112992|long bone defect|long bone defect
4980755|NCT04112979|Auditory stimulation|auditory stimulation
4980756|NCT04112979|adenotonsillectomy|adenotonsillectomy
4980758|NCT04112979|agitation|agitation
4980759|NCT04112979|awakening|awakening
4980760|NCT04112966|Lymphedema|lymphedema
4980761|NCT04112966|Prevention|prevention
4980762|NCT04112953|transesophagel echocardiography cardiac surgery kidney function|transesophagel echocardiography cardiac surgery kidney function
4980763|NCT04112940|Swallowing|swallowing
4980764|NCT04112927|Obstructive Sleep Apnea|obstructive sleep apnea
4980765|NCT04112927|OSA|osa
5398870|NCT01726946|HCV|hcv
4980766|NCT04112927|Respiratory Sound Analysis|respiratory sound analysis
4980767|NCT04112927|AwakeOSA|awakeosa
4980768|NCT04112901|Trans-femoral amputation|trans-femoral amputation
4980769|NCT04112901|Limb prosthesis|limb prosthesis
4980770|NCT04112901|Microprocessor Controlled Knee Joints|microprocessor controlled knee joints
4980771|NCT04112901|Community Outcome Measures|community outcome measures
4980772|NCT04112888|Episiotomy|episiotomy
4980773|NCT04112888|Pain|pain
4980774|NCT04112888|Colagen|colagen
4980775|NCT04112875|L-arginine|l-arginine
4980776|NCT04112875|Asymmetric Dimethylarginine|asymmetric dimethylarginine
4980777|NCT04112875|Arginase|arginase
4980778|NCT04112875|Sarcopenia|sarcopenia
4980786|NCT04112862|epilepsy|epilepsy
5703442|NCT00489450|alcohol|alcohol
4980788|NCT04112836|pancreatic cancer|pancreatic cancer
4980789|NCT04112836|locally advanced|locally advanced
4980790|NCT04112836|metastatic|metastatic
4980791|NCT04112836|nutritional status|nutritional status
4985071|NCT04084990|aPAP|apap
4980792|NCT04112836|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
4980794|NCT04112836|dose-intensity|dose-intensity
4980795|NCT04112810|Graft-versus-host disease|graft-versus-host disease
4980796|NCT04112771|Penehyclidine|penehyclidine
4980797|NCT04112771|Postoperative nausea and vomiting|postoperative nausea and vomiting
4980798|NCT04112771|Bimaxillary surgery|bimaxillary surgery
4980799|NCT04112758|HIIT|hiit
4980800|NCT04112758|executive function|executive function
4980801|NCT04112758|ADHD|adhd
4980802|NCT04112758|chronic exercise|chronic exercise
4980803|NCT04112745|Complementary Therapy|complementary therapy
4980804|NCT04112745|Static Magnet|static magnet
4980805|NCT04112745|Pain Relief|pain relief
4980806|NCT04112745|Hospitalized Patients|hospitalized patients
4980807|NCT04112732|Multivitamin|multivitamin
4980808|NCT04112732|Aging|aging
4980809|NCT04112732|Stress|stress
4980810|NCT04112732|Everyday Function|everyday function
4980811|NCT04112732|Well-Being|well-being
4980812|NCT04112693|Achalasia|achalasia
4980813|NCT04112693|peroral endoscopic myotomy|peroral endoscopic myotomy
4980814|NCT04112693|neuro-glio-epithelial unit|neuro-glio-epithelial unit
4980815|NCT04112680|Misinformation|misinformation
4980816|NCT04112680|Communication|communication
4980817|NCT04112680|Infectious diseases|infectious diseases
4980818|NCT04112667|vision|vision
4980820|NCT04112667|dark adaptation|dark adaptation
4980821|NCT04112667|light sensitivity|light sensitivity
4980822|NCT04112667|spectral domain optical coherence tomography|spectral domain optical coherence tomography
4980823|NCT04112667|quantitative autofluorescence|quantitative autofluorescence
4980824|NCT04112667|optical coherence tomography angiography|optical coherence tomography angiography
4980829|NCT04112602|mucopolysaccharidosis|mucopolysaccharidosis
4980831|NCT04112602|proteases inhibitors|proteases inhibitors
4980832|NCT04112602|glycosaminoglycans|glycosaminoglycans
4980833|NCT04112576|echocardiogram|echocardiogram
4980834|NCT04112550|lateral lumbar interbody fusion|lateral lumbar interbody fusion
4980835|NCT04112550|minimally invasive spinal surgery|minimally invasive spinal surgery
4980836|NCT04112537|Tuberous Sclerosis Complex|tuberous sclerosis complex
4980837|NCT04112537|MTOR associated protein|mtor associated protein
4980838|NCT04112537|Neurocutaneous Syndromes|neurocutaneous syndromes
4980839|NCT04112537|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4980840|NCT04112485|Lumbar disc herniation , Open Discectomy, Micrdiscectomy|lumbar disc herniation , open discectomy, micrdiscectomy
4980841|NCT04112433|Cardiac Signal|cardiac signal
4980842|NCT04112433|Ablation|ablation
4980843|NCT04112433|Signal Processing|signal processing
4980844|NCT04112433|Intracardiac Electrogram|intracardiac electrogram
4980845|NCT04112407|P. Acnes|p. acnes
4980846|NCT04112407|shoulder arthroplasty|shoulder arthroplasty
4980847|NCT04112407|blue light therapy|blue light therapy
4980848|NCT04112407|benzoyl peroxide|benzoyl peroxide
4980849|NCT04112342|pO2 Measurements, EPR, Carcinoma; India Ink; OxySPOT|po2 measurements, epr, carcinoma; india ink; oxyspot
4980850|NCT04112329|Exercise therapy|exercise therapy
4980851|NCT04112329|Physical fitness|physical fitness
4980852|NCT04112329|Gaming|gaming
4980853|NCT04112329|Child|child
4980854|NCT04112329|Healthy lifestyle|healthy lifestyle
4980855|NCT04112329|Fitness testing|fitness testing
4980856|NCT04112316|Heart Failure, HFrEF, Low T3 Syndrome|heart failure, hfref, low t3 syndrome
4980857|NCT04112290|Atrial fibrillation|atrial fibrillation
4980858|NCT04112290|Ventricular tachycardia|ventricular tachycardia
4980859|NCT04112290|Arrhythmia|arrhythmia
4980860|NCT04112290|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
4980861|NCT04112251|Childhood Obesity|childhood obesity
4980862|NCT04112251|Cocoa Flavanols|cocoa flavanols
4980863|NCT04112251|Adolescent Obesity|adolescent obesity
4980864|NCT04112212|Fluorescence|fluorescence
4980865|NCT04112212|Endoscopy|endoscopy
4980866|NCT04112212|Vedolizumab-800CW|vedolizumab-800cw
4980872|NCT04112173|balance|balance
4980873|NCT04112173|self-efficacy|self-efficacy
4980874|NCT04112173|exercise|exercise
4980875|NCT04112173|postural control|postural control
4980876|NCT04112160|stent removal, pain, kidney stones|stent removal, pain, kidney stones
4980881|NCT04112121|immunology|immunology
4980882|NCT04112121|psychoneuroimmunology|psychoneuroimmunology
4980883|NCT04112121|theology|theology
4980884|NCT04112121|fMRI|fmri
4980885|NCT04112108|percutaneous mitral commissurotomy|percutaneous mitral commissurotomy
4980886|NCT04112108|follow up|follow up
4980887|NCT04112095|Daily birth control|daily birth control
4980888|NCT04112082|neurofeedback|neurofeedback
4980889|NCT04112082|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
4980890|NCT04112082|attention|attention
4980891|NCT04112082|executive function|executive function
4980892|NCT04112082|electroencephalogram (EEG)|electroencephalogram (eeg)
4980893|NCT04112082|adult ADHD|adult adhd
4980894|NCT04112082|wearable sensors|wearable sensors
4980895|NCT04112069|Bionic pancreas|bionic pancreas
4980896|NCT04112069|Closed loop|closed loop
4980897|NCT04112069|Insulin|insulin
4980898|NCT04112069|Continuous glucose monitor|continuous glucose monitor
4980899|NCT04112056|Mild gastrointestinal disorders|mild gastrointestinal disorders
4980907|NCT04112017|Medical device|medical device
4980908|NCT04112004|liver transplantation|liver transplantation
4980909|NCT04112004|perioperative sodium|perioperative sodium
4980910|NCT04112004|sodium|sodium
4980911|NCT04111991|Behavior Therapy, Cognitive|behavior therapy, cognitive
5300495|NCT02174848|NBIA|nbia
4980912|NCT04111991|Post-Concussion Syndrome|post-concussion syndrome
4980913|NCT04111978|maintenance therapy|maintenance therapy
4980914|NCT04111978|aromatase inhibitor|aromatase inhibitor
4980915|NCT04111978|primary ovarian cancer|primary ovarian cancer
4980916|NCT04111978|estrogen-receptor|estrogen-receptor
4980917|NCT04111965|Dry eye|dry eye
4980918|NCT04111965|propylene glycol|propylene glycol
4980919|NCT04111939|opioid|opioid
4980920|NCT04111939|Opioid Use Disorder (OUD)|opioid use disorder (oud)
4980921|NCT04111939|overdose|overdose
4980922|NCT04111939|addiction|addiction
4980944|NCT04111783|Preoperative rapid POU ultrasound|preoperative rapid pou ultrasound
4980945|NCT04111783|clinical trials|clinical trials
4980948|NCT04111770|Left Main|left main
4980949|NCT04111770|QCA|qca
4980950|NCT04111770|Treatment Strategy|treatment strategy
4980951|NCT04111757|LASIK|lasik
4980952|NCT04111757|Excimer Laser|excimer laser
4980953|NCT04111744|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
4980954|NCT04111744|Physical Activity|physical activity
4980955|NCT04111744|Coronary Artery Disease|coronary artery disease
4980956|NCT04111744|Physical Training|physical training
4980964|NCT04111705|IFCT|ifct
4980965|NCT04111705|ORAKLE|orakle
4980966|NCT04111705|NSCLC|nsclc
4980967|NCT04111705|ALK-positive|alk-positive
4980968|NCT04111705|monotherapy|monotherapy
4980973|NCT04111679|Surgical skill|surgical skill
4980974|NCT04111679|Music|music
4980975|NCT04111679|Laparoscopy|laparoscopy
4980976|NCT04111653|mud therapy|mud therapy
4980977|NCT04111653|natural mineral water|natural mineral water
4980978|NCT04111653|barium|barium
4980979|NCT04111653|poultices|poultices
4980980|NCT04111653|skin transfer|skin transfer
4980981|NCT04111640|neurodegenerative diseas|neurodegenerative diseas
4980982|NCT04111640|non-pharmacological treatments|non-pharmacological treatments
4980983|NCT04111640|cognitive training|cognitive training
4980984|NCT04111588|Diagnosis|diagnosis
4980985|NCT04111588|Magnetic Resonance Imaging|magnetic resonance imaging
4980986|NCT04111588|Positron-Emission Tomography|positron-emission tomography
4980987|NCT04111588|PET-tracer|pet-tracer
4980988|NCT04111575|cesarean section|cesarean section
4980989|NCT04111575|Music therapy|music therapy
4980990|NCT04111575|Anxiety|anxiety
4980991|NCT04111575|Pain|pain
4980992|NCT04111562|Cranial defect|cranial defect
4980993|NCT04111562|skull bone defects|skull bone defects
4980994|NCT04111549|Veterans|veterans
4980995|NCT04111549|Rehabilitation|rehabilitation
4980996|NCT04111549|Cognitive training|cognitive training
4980997|NCT04111549|Telehealth|telehealth
4980998|NCT04111536|Heart Failure, HFpEF, Low T3 Syndrome|heart failure, hfpef, low t3 syndrome
4981001|NCT04111432|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
4981002|NCT04111432|Concomitant vaccination|concomitant vaccination
4981003|NCT04111432|Safety|safety
4981004|NCT04111432|Immunogenicity|immunogenicity
4981005|NCT04111432|Infant|infant
5021165|NCT03864679|fat|fat
4981006|NCT04111419|intensive management|intensive management
4981007|NCT04111419|blood pressure|blood pressure
4981008|NCT04111419|blood cholesterol|blood cholesterol
4981013|NCT04111354|mobilization|mobilization
4981014|NCT04111354|complication|complication
4981015|NCT04111341|Sjögren's syndrome|sjögren's syndrome
4981016|NCT04111341|Traditional Chinese Medicine|traditional chinese medicine
4981017|NCT04111341|Herbs|herbs
4981018|NCT04111341|Clinical trial|clinical trial
4981019|NCT04111341|Gan-Lu-Yin|gan-lu-yin
4981020|NCT04111341|Jia-wei-Xiao-yao-San|jia-wei-xiao-yao-san
4981021|NCT04111341|Ye-Jiao-Teng|ye-jiao-teng
4981022|NCT04111341|Suan-Zao-Ren|suan-zao-ren
4981023|NCT04111315|Pain medications|pain medications
4981046|NCT04111159|Sedation anesthesia fiberoptic bronchoscopy|sedation anesthesia fiberoptic bronchoscopy
4981047|NCT04111146|vitamin D|vitamin d
4981048|NCT04111146|liver transplant|liver transplant
4981049|NCT04111146|hospital stay|hospital stay
4981050|NCT04111133|Cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
4981051|NCT04111133|Left ventricular diatolic dysfunction|left ventricular diatolic dysfunction
4985334|NCT04083495|CD30|cd30
4981065|NCT04111068|Visual Acuity|visual acuity
4981066|NCT04111068|Uncrowded Visual Acuity|uncrowded visual acuity
4981067|NCT04111068|Crowded Visual Acuity|crowded visual acuity
4981068|NCT04111042|Malignant colonic obstruction|malignant colonic obstruction
4981069|NCT04111042|self-expandable metallic stent|self-expandable metallic stent
4981070|NCT04111029|Hepatocellular carcinoma|hepatocellular carcinoma
4981071|NCT04111029|Cell Free tumor DNA|cell free tumor dna
4981072|NCT04111029|Liquid Biopsy|liquid biopsy
4981073|NCT04111016|Early childhood development|early childhood development
4981074|NCT04111016|Responsive parenting|responsive parenting
4981075|NCT04111016|Nutrition|nutrition
4981076|NCT04111016|WASH|wash
4981077|NCT04111016|Stimulation|stimulation
4981078|NCT04111016|Parenting|parenting
4981079|NCT04111016|Integrated Interventions|integrated interventions
4981080|NCT04111003|fiber-reinforced composite|fiber-reinforced composite
4981081|NCT04110990|Influenza|influenza
4981082|NCT04110990|Grippe|grippe
4981083|NCT04110990|Emergency Services|emergency services
4981084|NCT04110990|Influenza, Human|influenza, human
4981085|NCT04110977|Head-and-neck cancer|head-and-neck cancer
4981086|NCT04110977|radiotherapy|radiotherapy
4981087|NCT04110977|radiation dermatitis|radiation dermatitis
4981088|NCT04110977|oral mucositis|oral mucositis
4981089|NCT04110977|reminder app|reminder app
4981090|NCT04110964|Telomeres|telomeres
4981091|NCT04110964|Telomerase|telomerase
4981092|NCT04110964|Critical limb ischemia|critical limb ischemia
4981093|NCT04110964|PAD|pad
4981094|NCT04110964|AAV|aav
4981095|NCT04110964|Gene therapy|gene therapy
4981096|NCT04110951|Asthma|asthma
4981097|NCT04110951|Yoga|yoga
4981098|NCT04110951|Breathing exercises|breathing exercises
4981099|NCT04110951|Quality of life|quality of life
4981100|NCT04110951|Nursing|nursing
4981101|NCT04110938|PICU|picu
4981102|NCT04110938|Paediatric|paediatric
4981103|NCT04110938|Early mobilisation|early mobilisation
4981104|NCT04110938|Early rehabilitation|early rehabilitation
4981105|NCT04110938|Observational|observational
4981106|NCT04110925|CT imaging|ct imaging
4981107|NCT04110925|next generation sequencing|next generation sequencing
4981108|NCT04110925|myelodysplastic syndrome|myelodysplastic syndrome
4981109|NCT04110912|Cardiac arrest, Trauma, Acute stroke, and Sepsis|cardiac arrest, trauma, acute stroke, and sepsis
4981110|NCT04110886|Pain|pain
4981111|NCT04110886|Postoperative Pain|postoperative pain
4981112|NCT04110873|antroquinonol, Atopic dermatitis|antroquinonol, atopic dermatitis
4981113|NCT04110782|223-Radium-dicloride|223-radium-dicloride
4981114|NCT04110782|Radical prostatectomy|radical prostatectomy
4981115|NCT04110782|overall survival|overall survival
4981116|NCT04110756|Alcohol- Prevention/Control|alcohol- prevention/control
4981117|NCT04110756|Adolescent behavior|adolescent behavior
4981118|NCT04110756|Video games- psychology|video games- psychology
4981119|NCT04110678|Parkinson Disease|parkinson disease
4981120|NCT04110678|Tolerance|tolerance
4981121|NCT04110678|NeuroEPO|neuroepo
4981122|NCT04110678|side effects|side effects
4981123|NCT04110678|UPDRS|updrs
4981124|NCT04110678|Cognition|cognition
4981125|NCT04110665|shoulder|shoulder
4981126|NCT04110665|surgery|surgery
4981127|NCT04110665|analgesia|analgesia
4981128|NCT04110665|opioid|opioid
4981129|NCT04110652|stroke|stroke
4981130|NCT04110652|rehabilitation|rehabilitation
4981131|NCT04110652|mortality|mortality
4981153|NCT04110548|Emotion and craving regulation|emotion and craving regulation
4981155|NCT04110522|Psoriasis|psoriasis
4981156|NCT04110509|Imaging biomarkers|imaging biomarkers
4981157|NCT04110509|Ultrasonography|ultrasonography
4981158|NCT04110509|Fragility|fragility
4981159|NCT04110509|Intensive Care Unit|intensive care unit
4981160|NCT04110431|cardiac resynchronization therapy|cardiac resynchronization therapy
4981161|NCT04110431|chronic heart failure|chronic heart failure
4981162|NCT04110431|left bundle branch pacing|left bundle branch pacing
4981163|NCT04110431|biventricular pacing|biventricular pacing
4981164|NCT04110418|methylene blue|methylene blue
4981165|NCT04110418|terlipressin|terlipressin
4981166|NCT04110418|septic shock|septic shock
4981167|NCT04110418|preterm neonate|preterm neonate
4981168|NCT04110379|virtual reality|virtual reality
4981169|NCT04110379|distraction|distraction
4981177|NCT04110353|Surgical Site infections|surgical site infections
4981178|NCT04110353|Negative Pressure Wound Therapy|negative pressure wound therapy
4981179|NCT04110353|Contaminated abdominal wounds|contaminated abdominal wounds
4981180|NCT04110353|Closed incision abdominal wound|closed incision abdominal wound
4981181|NCT04110353|Prophylactic therapy|prophylactic therapy
4981183|NCT04110327|Below the Knee|below the knee
4981185|NCT04110314|Vaccination|vaccination
4981186|NCT04110314|Reminder recall|reminder recall
4981187|NCT04110314|Patient Portal|patient portal
4981188|NCT04110301|CD20 ,Follicular Lymphoma,Marginal Zone Lymphoma,MIL62|cd20 ,follicular lymphoma,marginal zone lymphoma,mil62
4981189|NCT04110275|Acute Pulmonary Embolism|acute pulmonary embolism
4981190|NCT04110262|Blood pressure|blood pressure
4981191|NCT04110262|Sodium|sodium
4981192|NCT04110262|Salt|salt
4981193|NCT04110262|Randomized controlled trial|randomized controlled trial
4981194|NCT04110262|balance|balance
4981195|NCT04110262|humans|humans
4981196|NCT04110236|Child behavior problems|child behavior problems
4981197|NCT04110236|Caregiver child relationship|caregiver child relationship
4981198|NCT04110236|Primary care|primary care
4981199|NCT04110223|radiotherapy|radiotherapy
4981200|NCT04110223|radiosensitivity|radiosensitivity
4981201|NCT04110223|radiation toxity|radiation toxity
4981202|NCT04110223|NGS|ngs
4981203|NCT04110145|Functional constipation in children|functional constipation in children
4981204|NCT04110145|LINZESS|linzess
4981205|NCT04110119|Mechanical Low Back Pain|mechanical low back pain
4981206|NCT04110119|Chiropractics|chiropractics
4981207|NCT04110119|Analgesic-anti-inflammatory|analgesic-anti-inflammatory
4981208|NCT04110119|myorelaxant|myorelaxant
4998494|NCT04003935|aging|aging
4981222|NCT04110054|P2X3 receptor antagonist|p2x3 receptor antagonist
4981223|NCT04110054|Refractory chronic cough|refractory chronic cough
4981244|NCT04109898|anaesthesia|anaesthesia
4981245|NCT04109872|Lenalidomide|lenalidomide
4981246|NCT04109872|Mantle Cell Lymphoma|mantle cell lymphoma
4981247|NCT04109872|Relapsed|relapsed
4981248|NCT04109872|Refractory|refractory
4981249|NCT04109872|RRMCL spanish program|rrmcl spanish program
4981250|NCT04109846|Preimplantation Genetic Testing for Aneuploidy|preimplantation genetic testing for aneuploidy
4981251|NCT04109846|Preimplantation Genetic Screening|preimplantation genetic screening
4981252|NCT04109820|Basal platelet activation|basal platelet activation
4981253|NCT04109820|MitoQ|mitoq
4981254|NCT04109820|mitochondrial ROS (Reactive Oxygen Species)|mitochondrial ros (reactive oxygen species)
4981255|NCT04109781|short-term clinical outcome|short-term clinical outcome
4981256|NCT04109781|microscopic assisted discectomy|microscopic assisted discectomy
4981257|NCT04109781|lumbar disc herniation|lumbar disc herniation
4981258|NCT04109755|Rectal cancer|rectal cancer
4981259|NCT04109755|Immunotherapy|immunotherapy
5703641|NCT00488644|Cytomel|cytomel
4981260|NCT04109755|Short course radiotherapy|short course radiotherapy
4981261|NCT04109755|5x5Gy|5x5gy
4981262|NCT04109755|Pembrolizumab|pembrolizumab
4981263|NCT04109755|Localised rectal cancer|localised rectal cancer
4981264|NCT04109742|Pediatric|pediatric
4981265|NCT04109742|NAFLD - nonalcoholic fatty liver disease|nafld - nonalcoholic fatty liver disease
4981266|NCT04109742|Curcumin|curcumin
4981267|NCT04109742|Fatty liver|fatty liver
4981268|NCT04109703|chronic pain|chronic pain
4981269|NCT04109703|low back pain|low back pain
4981270|NCT04109703|heat|heat
4981271|NCT04109703|thermal|thermal
4981272|NCT04109703|analgesia|analgesia
4981273|NCT04109690|MDS|mds
4981274|NCT04109677|Handball, sport injuries, concussion, acute overload injury|handball, sport injuries, concussion, acute overload injury
4981275|NCT04109664|antral resection|antral resection
4981276|NCT04109664|sleeve gastrectomy|sleeve gastrectomy
4981277|NCT04109664|excess weight loss|excess weight loss
4981278|NCT04109664|total body weight loss|total body weight loss
4981279|NCT04109638|PEMF|pemf
4981280|NCT04109612|stroke|stroke
4981281|NCT04109612|stroke care|stroke care
4981282|NCT04109612|stroke units|stroke units
4981283|NCT04109612|value of stroke care|value of stroke care
4981284|NCT04109573|laser ablation|laser ablation
4981285|NCT04109573|anal intraepithelial neoplasia|anal intraepithelial neoplasia
4981287|NCT04109573|fecal incontinence|fecal incontinence
4981288|NCT04109573|anal function|anal function
4981289|NCT04109534|allergic asthma,|allergic asthma,
4981290|NCT04109534|house dust mite allergy|house dust mite allergy
4981291|NCT04109534|bronchial allergen provocation|bronchial allergen provocation
4981292|NCT04109534|LCPUFAs|lcpufas
4981293|NCT04109521|milk safety|milk safety
4981296|NCT04109521|informal sector|informal sector
4981297|NCT04109521|dairy|dairy
4981303|NCT04109456|uveal|uveal
4981304|NCT04109456|NRAS|nras
4981310|NCT04109430|PbtO2|pbto2
4981311|NCT04109430|hypothermia|hypothermia
4981312|NCT04109430|trauma brain injury|trauma brain injury
4981313|NCT04109430|targeted control temperature|targeted control temperature
4981314|NCT04109430|refractory brain hypertension|refractory brain hypertension
4981315|NCT04109404|meningioma,|meningioma,
4981316|NCT04109404|progestin,|progestin,
4981317|NCT04109404|cyproterone acetate|cyproterone acetate
4981318|NCT04109378|Fertility|fertility
4981319|NCT04109378|Colorectal endometriosis|colorectal endometriosis
4981320|NCT04109378|Surgery|surgery
4981723|NCT04107337|Dysodia|dysodia
4981333|NCT04109300|Pharmacogenomics|pharmacogenomics
4981341|NCT04109287|NMES|nmes
4981342|NCT04109287|Time-averaged mean velocity|time-averaged mean velocity
4981343|NCT04109287|Volume flow rate|volume flow rate
4981344|NCT04109287|Volume flow|volume flow
4981345|NCT04109287|TAMV|tamv
5305057|NCT02152319|Telehealth|telehealth
4981347|NCT04109287|Peak systolic velocity|peak systolic velocity
4981348|NCT04109287|PSV|psv
4981349|NCT04109287|Peak velocity|peak velocity
4981350|NCT04109287|PV|pv
4981351|NCT04109287|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4981352|NCT04109274|exercise|exercise
4981353|NCT04109274|physical activity|physical activity
4981354|NCT04109274|self-management|self-management
4981360|NCT04109209|Malignant Glioma|malignant glioma
4981361|NCT04109209|Caregiver Anxiety|caregiver anxiety
4981362|NCT04109209|Caregiver Burden|caregiver burden
4981363|NCT04109209|Psychological distress|psychological distress
4981364|NCT04109183|HIV/AIDS|hiv/aids
4981365|NCT04109170|Dry Eye|dry eye
4981366|NCT04109170|Bioinformatics|bioinformatics
4981367|NCT04109170|Data mining|data mining
4981368|NCT04109157|Pad test|pad test
4981369|NCT04109157|Test-retest reliability|test-retest reliability
4981370|NCT04109144|Paracentesis|paracentesis
4981371|NCT04109144|Albumin|albumin
4981372|NCT04109144|Plasma|plasma
4981373|NCT04109118|Opioid agonist therapy|opioid agonist therapy
4981374|NCT04109118|Benzodiazepine|benzodiazepine
4981375|NCT04109118|Distress tolerance|distress tolerance
4981376|NCT04109118|Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)|distress tolerance - benzodiazepine discontinuation (dt-bd)
4981377|NCT04109118|Relaxation Therapy (RT)|relaxation therapy (rt)
4981378|NCT04109105|Colon neoplasia|colon neoplasia
4981379|NCT04109105|Ascendant colon|ascendant colon
4981380|NCT04109105|Surgical anastomosis|surgical anastomosis
4981381|NCT04109105|Anastomotic leak|anastomotic leak
4981382|NCT04109105|Collagen|collagen
4981383|NCT04109105|Polyethylene glycol|polyethylene glycol
4981384|NCT04109105|Hemopatch|hemopatch
4981385|NCT04109092|E7766|e7766
4981386|NCT04109092|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
4981387|NCT04109092|Intravesical administration|intravesical administration
4981388|NCT04109092|Ta or T1 Papillary Disease|ta or t1 papillary disease
4981389|NCT04109092|Stimulator of Interferon Genes Agonist|stimulator of interferon genes agonist
4981390|NCT04109092|Carcinoma in situ|carcinoma in situ
4981391|NCT04109092|BCG Unresponsive|bcg unresponsive
4981392|NCT04109079|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4981393|NCT04109079|sentinel node biopsy|sentinel node biopsy
4981394|NCT04109079|breast cancer|breast cancer
4981395|NCT04109079|tattooing node|tattooing node
4981396|NCT04109079|marking node|marking node
4981397|NCT04109079|clip node|clip node
4981398|NCT04109079|axillary ultrasound|axillary ultrasound
4981399|NCT04109079|node positive|node positive
4981400|NCT04109079|axillary lymph node dissection|axillary lymph node dissection
4981401|NCT04109079|axillary radiotherapy|axillary radiotherapy
4981402|NCT04109079|axillary treatment|axillary treatment
4981411|NCT04109027|attention|attention
4981412|NCT04109027|working memory|working memory
4981413|NCT04109027|executive functioning|executive functioning
4981414|NCT04109014|Cognitive Behavioral|cognitive behavioral
4981415|NCT04109014|Qualitative Interviews|qualitative interviews
4981416|NCT04109014|Motivational Interviewing|motivational interviewing
4981417|NCT04108988|Black adolescent girls|black adolescent girls
4981419|NCT04108962|Benralizumab|benralizumab
4981420|NCT04108936|CRS|crs
4981421|NCT04108936|HIPEC|hipec
4981426|NCT04108923|Vessel ligation|vessel ligation
4981428|NCT04108910|Home Care|home care
4981429|NCT04108897|rosacea|rosacea
4981430|NCT04108897|skin microbiome|skin microbiome
4981431|NCT04108897|gut microbiome|gut microbiome
4981432|NCT04108897|antimicrobial therapy|antimicrobial therapy
4981433|NCT04108884|Atrial Fibrillation|atrial fibrillation
4981434|NCT04108884|Smartphone App|smartphone app
4981435|NCT04108884|CHA2DS2-VASc-Score|cha2ds2-vasc-score
4981436|NCT04108884|Screening|screening
4981437|NCT04108884|Cardiovascular risk factors|cardiovascular risk factors
4981438|NCT04108884|Outpatient setting|outpatient setting
4981439|NCT04108884|Congestive heart failure|congestive heart failure
4981440|NCT04108884|Stroke|stroke
4981441|NCT04108884|Diabetes|diabetes
4998697|NCT04002713|microsurgery|microsurgery
4981451|NCT04108689|internet intervention|internet intervention
4981452|NCT04108689|applied sport psychology|applied sport psychology
4981453|NCT04108689|performance enhancement|performance enhancement
4981454|NCT04108689|acceptance and commitment training|acceptance and commitment training
4981455|NCT04108689|elite ice hockey|elite ice hockey
4981456|NCT04108663|Brain stimulation|brain stimulation
4981457|NCT04108663|Cognitive training|cognitive training
4981458|NCT04108663|Cognition|cognition
4981459|NCT04108663|Cognitive enhancement|cognitive enhancement
4981460|NCT04108663|Transcranial direct current stimulation|transcranial direct current stimulation
4981461|NCT04108650|Physical Activity|physical activity
4981462|NCT04108650|Health Education|health education
4981463|NCT04108650|Fit & Strong!|fit & strong!
4981464|NCT04108637|penicillin|penicillin
4981466|NCT04108637|antimicrobial|antimicrobial
4981467|NCT04108637|resistance|resistance
4981468|NCT04108611|hemodiafiltration with endogenous re infusion|hemodiafiltration with endogenous re infusion
4981469|NCT04108611|immune adsorption In Lupus nephritis|immune adsorption in lupus nephritis
4981470|NCT04108598|Otolaryngology|otolaryngology
4981471|NCT04108598|Sudden onset sensorineural hearing loss|sudden onset sensorineural hearing loss
4981472|NCT04108598|Sensorineural hearing loss|sensorineural hearing loss
4981473|NCT04108572|Child Obesity|child obesity
4981474|NCT04108572|Infant Feeding|infant feeding
4981475|NCT04108572|Feasibility study|feasibility study
4981476|NCT04108559|Kinesiology tape|kinesiology tape
4981477|NCT04108559|Surgical drain|surgical drain
4981478|NCT04108559|Pain|pain
4981479|NCT04108559|Swelling|swelling
4981480|NCT04108559|Trismus|trismus
4981481|NCT04108507|Percutaneous kyphoplasty（PKP）|percutaneous kyphoplasty（pkp）
4981482|NCT04108507|nerve block|nerve block
4981483|NCT04108507|posterior branch of spinal nerve|posterior branch of spinal nerve
4981484|NCT04108494|Gastric Cancer|gastric cancer
4981485|NCT04108494|Omentectomy|omentectomy
4981486|NCT04108494|Prognosis|prognosis
4981487|NCT04108481|Y90|y90
4981488|NCT04108481|Y90-RE|y90-re
4981489|NCT04108481|Radioembolization|radioembolization
4981490|NCT04108481|Y90-Radioembolization|y90-radioembolization
4981491|NCT04108481|y-90|y-90
4981492|NCT04108481|Yttrium|yttrium
4981493|NCT04108481|Yttrium-90|yttrium-90
4981494|NCT04108481|Microsatellite Stable|microsatellite stable
4981495|NCT04108481|MSS|mss
4981496|NCT04108481|CRC|crc
4981497|NCT04108481|mCRC|mcrc
4981498|NCT04108481|Colorectal|colorectal
4981499|NCT04108481|Liver Metastases|liver metastases
4981500|NCT04108481|Liver Metastasis|liver metastasis
4981501|NCT04108481|Durvalumab|durvalumab
4981502|NCT04108481|Anti-PD1|anti-pd1
4981503|NCT04108481|Anti-PDL1|anti-pdl1
4981504|NCT04108481|Immunotherapy|immunotherapy
4981505|NCT04108481|Colorectal Cancer|colorectal cancer
4981506|NCT04108481|Mismatch repair proficient|mismatch repair proficient
4981507|NCT04108481|pMMR|pmmr
4981508|NCT04108481|KRAS|kras
4981509|NCT04108481|NRAS|nras
4981510|NCT04108481|BRAF|braf
4981511|NCT04108481|BRAF-V600E|braf-v600e
4981516|NCT04108416|cleft lip|cleft lip
4981517|NCT04108416|cleft palate|cleft palate
4981518|NCT04108416|cleft lip and palate|cleft lip and palate
4981519|NCT04108416|orofacial cleft|orofacial cleft
4981520|NCT04108390|ankle|ankle
4981521|NCT04108390|dry needling|dry needling
4981522|NCT04108390|trigger point|trigger point
4981523|NCT04108377|Hyperinsulinemia|hyperinsulinemia
4981724|NCT04107337|Singers|singers
4981531|NCT04108364|stroke|stroke
4981532|NCT04108364|stroke rehabilitation|stroke rehabilitation
4981533|NCT04108338|Clinical trial|clinical trial
4981534|NCT04108338|Real-world study|real-world study
4981535|NCT04108338|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
4981536|NCT04108338|Pragmatism|pragmatism
4981537|NCT04108338|Survival|survival
4981538|NCT04108338|Return to society|return to society
4981539|NCT04108299|Chinese Americans|chinese americans
4981540|NCT04108247|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4981541|NCT04108247|Abiraterone|abiraterone
4981542|NCT04108247|SHR3162|shr3162
4981543|NCT04108182|heart failure|heart failure
4981544|NCT04108169|Coronary artery bypass graft|coronary artery bypass graft
4981545|NCT04108169|Left Atrial Appendage Occlusion|left atrial appendage occlusion
4981546|NCT04108169|stroke|stroke
4981547|NCT04108169|prevention|prevention
4981548|NCT04108156|Port Delivery System|port delivery system
4981552|NCT04108117|Robotic mastectomy|robotic mastectomy
4981553|NCT04108117|Breast neoplasms|breast neoplasms
4981571|NCT04108065|gallbladder motility|gallbladder motility
4981573|NCT04108065|pregnancy|pregnancy
4981574|NCT04108052|HHT|hht
4981575|NCT04108052|diagnosis,|diagnosis,
4981576|NCT04108052|arteriovenous malformation|arteriovenous malformation
4981577|NCT04108052|interventional radiology|interventional radiology
4981578|NCT04108052|pulmonary arteriovenous fistulas|pulmonary arteriovenous fistulas
4981579|NCT04108052|embolization|embolization
4981580|NCT04108026|IFCT|ifct
4981581|NCT04108026|Savimmune|savimmune
4981582|NCT04108026|Non small cell Lung Cancer|non small cell lung cancer
4981583|NCT04108026|PS|ps
4981584|NCT04108026|Poor General condition|poor general condition
4981585|NCT04108026|Lung Cancer|lung cancer
4981586|NCT04108026|Durvalumab|durvalumab
4981587|NCT04108000|Dementia|dementia
4981588|NCT04108000|Nursing|nursing
4981589|NCT04108000|Nephrology|nephrology
4981590|NCT04108000|Behavioral research|behavioral research
4981591|NCT04108000|Social research|social research
4981592|NCT04107974|Gastropexy|gastropexy
4981593|NCT04107974|Percutaneous Radiologic Gastrostomy|percutaneous radiologic gastrostomy
4981594|NCT04107974|Interventional Radiology|interventional radiology
4981597|NCT04107935|Self management education and support|self management education and support
4981598|NCT04107935|Telemedicine|telemedicine
4981599|NCT04107935|Rural|rural
4981600|NCT04107883|endothelial|endothelial
4981601|NCT04107883|plasma|plasma
4981602|NCT04107870|ANOREXIA NERVOSA|anorexia nervosa
4981603|NCT04107870|FEMALE ADOLESCENTS|female adolescents
4981604|NCT04107870|BODY DYSMORPHIC DISORDER|body dysmorphic disorder
4981605|NCT04107870|VIRTUAL REALITY EXPOSURE THERAPY|virtual reality exposure therapy
4981606|NCT04107844|return to play|return to play
4981607|NCT04107844|pain catastrophizing|pain catastrophizing
4981608|NCT04107844|athletes|athletes
4981609|NCT04107831|Pulmonary rehabilitation|pulmonary rehabilitation
4981610|NCT04107831|Exercise|exercise
4981611|NCT04107831|Field walk test|field walk test
4981612|NCT04107831|Physical performance test|physical performance test
4981616|NCT04107792|parenting|parenting
5300947|NCT02172001|Iron deficiency|iron deficiency
4981617|NCT04107792|parental sense of competence|parental sense of competence
4981618|NCT04107792|children|children
4981619|NCT04107792|sensory processing issues|sensory processing issues
4981620|NCT04107779|Electronic Nicotine Delivery System|electronic nicotine delivery system
4981621|NCT04107779|Combustible Cigarettes|combustible cigarettes
4981622|NCT04107779|Nicotine|nicotine
4981627|NCT04107714|Parents of children with mental illness|parents of children with mental illness
4981628|NCT04107714|Disclosure|disclosure
4981629|NCT04107714|Secrecy|secrecy
4981630|NCT04107714|Group intervention|group intervention
4981631|NCT04107701|BPD|bpd
4981632|NCT04107701|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4981633|NCT04107701|children and environment|children and environment
4981634|NCT04107701|environment|environment
4981635|NCT04107701|bronchopulmonary dysplasia and environment|bronchopulmonary dysplasia and environment
4981636|NCT04107701|environment and children|environment and children
4981637|NCT04107701|chronic lung disease of newborn|chronic lung disease of newborn
4981638|NCT04107701|environment and chronic lung disease of the newborn|environment and chronic lung disease of the newborn
4981639|NCT04107688|Oral Microbiome|oral microbiome
4981640|NCT04107662|brain|brain
4981641|NCT04107662|injuries|injuries
4981642|NCT04107662|disease|disease
4981643|NCT04107662|trauma|trauma
4981644|NCT04107662|nervous system|nervous system
4981645|NCT04107662|wounds|wounds
4981646|NCT04107649|Physical Activity|physical activity
4981647|NCT04107649|Total Knee Replacement|total knee replacement
4981648|NCT04107649|Knee Osteoarthritis|knee osteoarthritis
4981649|NCT04107636|Minimal invasive|minimal invasive
4981650|NCT04107636|Biopsy|biopsy
4981651|NCT04107623|Gastric Conduit|gastric conduit
4981652|NCT04107623|Cardia resection|cardia resection
4981653|NCT04107623|Indocyanine Green|indocyanine green
4981654|NCT04107623|quantative perfusion|quantative perfusion
4981662|NCT04107597|Paced Breathing Training|paced breathing training
4981664|NCT04107597|Anxiety|anxiety
4981665|NCT04107597|Heart Rate Variability|heart rate variability
4981666|NCT04107571|Coronary artery bypass graft|coronary artery bypass graft
4981667|NCT04107571|Biomarker|biomarker
4981668|NCT04107571|Prognosis|prognosis
4985847|NCT04079673|microbiota|microbiota
4981672|NCT04107545|appetite|appetite
4981673|NCT04107545|energy metabolism|energy metabolism
4981674|NCT04107519|Chronic Pain|chronic pain
4981675|NCT04107519|Resilience|resilience
4981676|NCT04107519|Football Players|football players
4981677|NCT04107506|parent training|parent training
4981678|NCT04107506|early adversity|early adversity
4981679|NCT04107506|early intervention|early intervention
4981680|NCT04107506|manualized intervention|manualized intervention
4981681|NCT04107506|high-risk children|high-risk children
4981682|NCT04107506|parenting|parenting
4981683|NCT04107506|fMRI|fmri
4981684|NCT04107480|prolactinoma|prolactinoma
4981685|NCT04107480|dopamine agonist|dopamine agonist
4981686|NCT04107480|endoscopic trans-sphenoidal adenoma resection|endoscopic trans-sphenoidal adenoma resection
4981687|NCT04107480|remission rate|remission rate
4981688|NCT04107480|health-related quality of life|health-related quality of life
4981689|NCT04107454|Lichen sclerosus|lichen sclerosus
4981690|NCT04107441|open-label|open-label
4981691|NCT04107441|phase 1|phase 1
4981692|NCT04107441|safety|safety
4981693|NCT04107441|tolerability|tolerability
4981694|NCT04107441|pharmacokinetics|pharmacokinetics
4981695|NCT04107441|healthy volunteers|healthy volunteers
4981696|NCT04107441|AX-8|ax-8
4981697|NCT04107428|adult-to-adult living donor liver transplantation|adult-to-adult living donor liver transplantation
4981698|NCT04107428|small-for-size syndrome|small-for-size syndrome
4981699|NCT04107428|graft hyperperfusion|graft hyperperfusion
4981700|NCT04107415|Asthma|asthma
4981701|NCT04107415|nursing|nursing
4981702|NCT04107415|patient|patient
4981703|NCT04107415|yoga|yoga
4981704|NCT04107402|Septic shock|septic shock
4981705|NCT04107402|Platelets|platelets
4981706|NCT04107402|Acetyl CoA Carboxylase|acetyl coa carboxylase
4981707|NCT04107389|Art Psychotherapy|art psychotherapy
4981708|NCT04107389|Art Therapy|art therapy
4981709|NCT04107389|Perinatal Mental Health|perinatal mental health
4981710|NCT04107389|Mother and baby unit|mother and baby unit
4981711|NCT04107389|Mental health and wellbeing|mental health and wellbeing
4981712|NCT04107389|Pregnancy|pregnancy
4981713|NCT04107389|Post-Partum|post-partum
4981714|NCT04107389|Creative Intervention|creative intervention
4981715|NCT04107389|Randomised Control Trial|randomised control trial
4981716|NCT04107389|ReQol|reqol
4981717|NCT04107389|WEMWBS|wemwbs
4981718|NCT04107376|retroviewing|retroviewing
4981719|NCT04107376|endoscopy|endoscopy
4981720|NCT04107376|adenoma detection|adenoma detection
5703740|NCT00488319|Psychosis.|psychosis.
4981721|NCT04107376|polyp detection|polyp detection
4981722|NCT04107337|Nodules|nodules
4981732|NCT04107285|Neuroimaging Evaluations|neuroimaging evaluations
4981733|NCT04107285|19-268|19-268
4981734|NCT04107272|Oxaliplatin-induced peripheral neuropathy|oxaliplatin-induced peripheral neuropathy
4981735|NCT04107272|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4981736|NCT04107272|Pain|pain
4981737|NCT04107272|Feasibility|feasibility
4981738|NCT04107259|Type 2 diabetes mellitus|type 2 diabetes mellitus
4981739|NCT04107259|IL-34|il-34
4981740|NCT04107259|Irisin|irisin
4981741|NCT04107259|IRAPe|irape
4981742|NCT04107259|Visfatin|visfatin
4981743|NCT04107259|Insulin resistance|insulin resistance
4981744|NCT04107259|HOMA-IR|homa-ir
4981745|NCT04107220|BNP|bnp
4981746|NCT04107220|NT-proBNP|nt-probnp
4981747|NCT04107220|ARNI|arni
4981748|NCT04107220|Sacubitril/Valsartan|sacubitril/valsartan
4981749|NCT04107181|Pap smear|pap smear
4981750|NCT04107168|NSCLC|nsclc
4981751|NCT04107168|Advanced|advanced
4981752|NCT04107168|Unresectable|unresectable
4981753|NCT04107168|Microbiome|microbiome
4981754|NCT04107168|Adjuvant|adjuvant
4981755|NCT04107168|Resected|resected
4981756|NCT04107168|Immune checkpoint inhibitors|immune checkpoint inhibitors
4981757|NCT04107142|NKG2D|nkg2d
4981758|NCT04107142|gamma|gamma
4981759|NCT04107142|delta|delta
4981760|NCT04107142|T cell|t cell
4981761|NCT04107142|CAR|car
4981762|NCT04107142|chimeric antigen receptor|chimeric antigen receptor
4981763|NCT04107142|solid tumour|solid tumour
4981764|NCT04107142|cancer immunotherapy|cancer immunotherapy
4981765|NCT04107142|adoptive cell transfer|adoptive cell transfer
4981767|NCT04107129|Endometriosis|endometriosis
4981768|NCT04107129|BLC6|blc6
4981769|NCT04107129|SIRT1|sirt1
4981770|NCT04107129|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
4981771|NCT04107129|Embryo Transfer (ET)|embryo transfer (et)
4981772|NCT04107129|Frozen Embryo Transfer (FET)|frozen embryo transfer (fet)
4981773|NCT04107129|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
4981774|NCT04107116|cancer end of life patient-centered|cancer end of life patient-centered
4981786|NCT04106973|Pleural Mesothelioma|pleural mesothelioma
4981787|NCT04106973|Bilateral Pleural Plaques|bilateral pleural plaques
4981788|NCT04106973|Asbestos Exposure|asbestos exposure
4981789|NCT04106973|Exhaled breath analysis|exhaled breath analysis
4981790|NCT04106973|VOCs|vocs
4981791|NCT04106921|community health workers|community health workers
4981792|NCT04106921|primary health care|primary health care
4981793|NCT04106921|mobile applications|mobile applications
4981794|NCT04106882|insulin resistance|insulin resistance
4981795|NCT04106882|exogenous ketone|exogenous ketone
4981796|NCT04106882|glucose|glucose
4981797|NCT04106882|diet|diet
4981798|NCT04106882|aging|aging
4981799|NCT04106804|Psoriatic arthritis; Bone|psoriatic arthritis; bone
4981805|NCT04106726|Ivermectin|ivermectin
4981806|NCT04106713|Psychotherapy|psychotherapy
4981807|NCT04106713|Cognitive behavioural therapy|cognitive behavioural therapy
4981808|NCT04106713|Group psychotherapy|group psychotherapy
4981809|NCT04106713|Internet-based psychotherapy|internet-based psychotherapy
4981810|NCT04106700|Multiple Myeloma|multiple myeloma
4981811|NCT04106700|Venous Thromboembolism|venous thromboembolism
4981812|NCT04106674|Proximal humerus fracture|proximal humerus fracture
4981813|NCT04106674|Non-operative versus operative treatment|non-operative versus operative treatment
4981814|NCT04106674|Conservative versus surgical treatment|conservative versus surgical treatment
4981815|NCT04106674|Surgical versus non-surgical treatment|surgical versus non-surgical treatment
4981816|NCT04106661|Tai Chi|tai chi
4981817|NCT04106661|physical activity|physical activity
4981818|NCT04106661|morbid obesity|morbid obesity
4981944|NCT04105673|long-term outcome|long-term outcome
4981819|NCT04106648|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
4981821|NCT04106648|STEMI|stemi
4981822|NCT04106635|Laryngeal mask airway|laryngeal mask airway
4981823|NCT04106635|Paratracheal esophageal pressure|paratracheal esophageal pressure
4981824|NCT04106635|Cricoid pressure|cricoid pressure
4981825|NCT04106622|Wolff-Parkinson-White Syndrome|wolff-parkinson-white syndrome
4981826|NCT04106570|Obese|obese
4981827|NCT04106570|Torque production|torque production
4981828|NCT04106570|Neuromuscular fatigue|neuromuscular fatigue
4981829|NCT04106570|Electrical muscle stimulation|electrical muscle stimulation
4981830|NCT04106570|Knee extensors|knee extensors
4981831|NCT04106570|Metabolic disorders|metabolic disorders
4981832|NCT04106518|Cohort|cohort
4981833|NCT04106518|alcoholic hepatitis|alcoholic hepatitis
4981834|NCT04106518|alcoholic cirrhosis|alcoholic cirrhosis
4981835|NCT04106518|pathophysiology|pathophysiology
4981836|NCT04106518|bio bank|bio bank
4981837|NCT04106518|pan-genomic study|pan-genomic study
4981838|NCT04106505|Biofeedback|biofeedback
4981839|NCT04106505|smartphone app|smartphone app
4981840|NCT04106466|Deep Brain Stimulation|deep brain stimulation
5292468|NCT02213211|Malawi|malawi
4981841|NCT04106466|Major Depressive Disorder|major depressive disorder
4981842|NCT04106466|Treatment resistant depression|treatment resistant depression
4981843|NCT04106466|subcallosal cingulate white matter|subcallosal cingulate white matter
4981844|NCT04106466|Depression|depression
4981845|NCT04106453|laparoscopy|laparoscopy
4981846|NCT04106453|navigation|navigation
4981847|NCT04106453|microwave ablation|microwave ablation
4981848|NCT04106453|ultrasound guidance|ultrasound guidance
4981849|NCT04106427|gesture|gesture
4981850|NCT04106427|rTMS|rtms
4981851|NCT04106427|cognitive remediation|cognitive remediation
4981852|NCT04106427|social cognitive remediation therapy|social cognitive remediation therapy
4981853|NCT04106414|Nivolumab|nivolumab
4981854|NCT04106414|IDO-Inhibitor|ido-inhibitor
4981855|NCT04106414|BMS-986205|bms-986205
4981856|NCT04106401|total red blood cell volume|total red blood cell volume
4981857|NCT04106401|plasma volume|plasma volume
4981858|NCT04106401|total hemoglobin mass|total hemoglobin mass
4981859|NCT04106401|total blood volume|total blood volume
4981860|NCT04106375|major depression|major depression
4981861|NCT04106375|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
4981862|NCT04106375|MBCT|mbct
4981863|NCT04106375|fMRI|fmri
4981871|NCT04106271|older adults|older adults
4981872|NCT04106271|informal caregiver|informal caregiver
4981873|NCT04106219|aurora kinase A|aurora kinase a
4981875|NCT04106219|aurora A|aurora a
4981876|NCT04106219|aurora kinase inhibitor|aurora kinase inhibitor
4981877|NCT04106219|aurora kinase A inhibitor|aurora kinase a inhibitor
4981878|NCT04106219|kinase inhibitor|kinase inhibitor
4981879|NCT04106219|AURKA|aurka
4981880|NCT04106219|AurA|aura
4981881|NCT04106219|pediatric neuroblastoma|pediatric neuroblastoma
4981882|NCT04106219|children|children
4981883|NCT04106193|intimate partner violence|intimate partner violence
4981884|NCT04106193|women Veterans|women veterans
4981885|NCT04106193|screening|screening
4981886|NCT04106193|primary care|primary care
4981887|NCT04106154|Physical Activity|physical activity
4981888|NCT04106154|Activity Motivation|activity motivation
4981889|NCT04106154|Activity Confidence|activity confidence
4981890|NCT04106154|Children|children
4981891|NCT04106154|Adolescents|adolescents
4981892|NCT04106154|Sleep|sleep
4981893|NCT04106154|Screen Time|screen time
4981894|NCT04106115|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
4981895|NCT04106115|Durvalumab|durvalumab
4981896|NCT04106115|S-488210/S-488211|s-488210/s-488211
4981897|NCT04106115|Immunotherapy|immunotherapy
4981898|NCT04106115|Vaccine|vaccine
4981899|NCT04106115|PD-L1 Inhibitor|pd-l1 inhibitor
4981900|NCT04106115|BCG unresponsive|bcg unresponsive
4981901|NCT04106076|Acute Myeloid Leukaemia|acute myeloid leukaemia
4981902|NCT04106076|Newly diagnosed AML|newly diagnosed aml
4981903|NCT04106076|ELN adverse genetic risk group|eln adverse genetic risk group
4981904|NCT04106076|Chimeric Antigen Receptor T-Cell (CAR-T) therapy|chimeric antigen receptor t-cell (car-t) therapy
4981905|NCT04106076|Allogeneic|allogeneic
4981906|NCT04106076|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
4981907|NCT04105998|Healthy Volunteer|healthy volunteer
4981908|NCT04105998|Oxytocin|oxytocin
4981909|NCT04105998|Pupillometry|pupillometry
4981910|NCT04105985|Necrotic teeth, root canals|necrotic teeth, root canals
4981911|NCT04105946|FESS|fess
4981912|NCT04105946|Opioid Free Anesthesia|opioid free anesthesia
4981913|NCT04105946|Opioid Consumption|opioid consumption
4981914|NCT04105907|GentleWave|gentlewave
4981915|NCT04105907|Multisonication|multisonication
4981916|NCT04105907|Sonendo|sonendo
4981924|NCT04105816|ACL repair recovery|acl repair recovery
4981925|NCT04105816|musculoskeletal ultrasound|musculoskeletal ultrasound
4981926|NCT04105816|quadriceps atrophy|quadriceps atrophy
4981927|NCT04105816|validation|validation
4981928|NCT04105790|Stepped Model of Care|stepped model of care
4981929|NCT04105790|Class-Based Intervention|class-based intervention
4981930|NCT04105738|Difficult Intubation|difficult intubation
4981931|NCT04105738|Preoperative Surgical Assessment|preoperative surgical assessment
4981932|NCT04105738|Speech Dysfunction|speech dysfunction
4981933|NCT04105738|Difficult Airway|difficult airway
4981934|NCT04105712|withdrawal|withdrawal
4981935|NCT04105712|highly processed food|highly processed food
5703741|NCT00488306|Tigecycline|tigecycline
4981936|NCT04105712|food addiction|food addiction
4981937|NCT04105699|Sepsis|sepsis
4981938|NCT04105699|Pancreatic Stone Protein|pancreatic stone protein
4981939|NCT04105699|Point-of-care device|point-of-care device
4981940|NCT04105699|Immunoassay|immunoassay
4981941|NCT04105699|Intensive care unit|intensive care unit
4981942|NCT04105699|Abionic|abionic
4981943|NCT04105673|Shaken Baby Syndrome|shaken baby syndrome
4981945|NCT04105673|severity criteria in the admission to hospital for a Shaken Baby Syndrome|severity criteria in the admission to hospital for a shaken baby syndrome
4981946|NCT04105673|sequelae|sequelae
4981947|NCT04105673|brain injury|brain injury
4981948|NCT04105673|abusive head trauma|abusive head trauma
4981949|NCT04105647|Lifestyle modification|lifestyle modification
4981950|NCT04105647|physical activity|physical activity
4981951|NCT04105647|messages|messages
4981952|NCT04105621|Personalized nutrition|personalized nutrition
4981953|NCT04105621|Drug addicts|drug addicts
4981954|NCT04105621|Gut microbiota|gut microbiota
4981955|NCT04105608|Diabetes|diabetes
4981956|NCT04105608|GLP-1|glp-1
4981957|NCT04105608|Oxyntomodulin|oxyntomodulin
4981958|NCT04105608|Diet|diet
4981959|NCT04105608|Visual Analogue Scale|visual analogue scale
4981960|NCT04105582|Dendritic cells|dendritic cells
4981961|NCT04105582|Neo-antigen|neo-antigen
4981962|NCT04105582|Personalized medicine|personalized medicine
4981963|NCT04105582|immunotherapy|immunotherapy
4981964|NCT04105556|Male Child|male child
4981965|NCT04105556|Comfort Theory|comfort theory
4981966|NCT04105556|Fear|fear
4981971|NCT04105517|Propranolol|propranolol
4981972|NCT04105504|glutathione|glutathione
4981973|NCT04105504|whitening|whitening
4981974|NCT04105465|vulvar cancer|vulvar cancer
4981988|NCT04105335|CEBPA|cebpa
4981989|NCT04105322|Acute stroke|acute stroke
4981990|NCT04105322|Balance|balance
4981991|NCT04105322|Rehabilitation|rehabilitation
4981992|NCT04105322|Postural control|postural control
4981993|NCT04105309|Obesity|obesity
4981994|NCT04105309|College Students|college students
4981995|NCT04105309|Implementation Intentions|implementation intentions
4981996|NCT04105283|Lung Cancer|lung cancer
4981997|NCT04105244|Mental Health|mental health
4981998|NCT04105244|Physical Health|physical health
4981999|NCT04105244|Technology-Dependent Children|technology-dependent children
4982000|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents
4982001|NCT04105166|hemolytic anemia|hemolytic anemia
4982002|NCT04105166|anemia|anemia
4982003|NCT04105166|gene therapy|gene therapy
4982004|NCT04105153|Non-small cell lung carcinoma|non-small cell lung carcinoma
4982005|NCT04105153|EGFR mutation|egfr mutation
4982006|NCT04105153|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4982007|NCT04105153|Osimertinib|osimertinib
4982008|NCT04105153|EGFR T790M|egfr t790m
4982009|NCT04105140|oxytocin|oxytocin
4982010|NCT04105140|prosocial learning|prosocial learning
4982011|NCT04105114|Walking|walking
4982012|NCT04105114|Transcutaneous Stimulation|transcutaneous stimulation
4982013|NCT04105114|Locomotion|locomotion
4982014|NCT04105114|Paralysis|paralysis
4982015|NCT04105114|Buspirone|buspirone
4982016|NCT04105114|Motor Control|motor control
4982017|NCT04105114|Spinal Stimulation|spinal stimulation
4982018|NCT04105101|Human-centered robotics|human-centered robotics
4982019|NCT04105101|Prototype evaluation|prototype evaluation
4982020|NCT04105101|Industry|industry
4982021|NCT04105088|First Nations|first nations
4982022|NCT04105088|Indigenous|indigenous
4982023|NCT04105088|Epidemiology|epidemiology
4982024|NCT04105088|Risk Factors|risk factors
4982025|NCT04105088|Community-based Research|community-based research
4982026|NCT04105075|spirometry|spirometry
4982027|NCT04105075|inflammation|inflammation
4982029|NCT04105023|genistein|genistein
4982030|NCT04105023|gut microbiota|gut microbiota
4982031|NCT04105023|AMPK|ampk
4982032|NCT04105023|fatty acid oxidation|fatty acid oxidation
4982033|NCT04104932|surgical stabilization|surgical stabilization
4982034|NCT04104932|conservative treatment|conservative treatment
4982035|NCT04104919|Mastectomy|mastectomy
4982036|NCT04104906|Shoulder rehabilitation|shoulder rehabilitation
4982037|NCT04104906|Electromyography|electromyography
4982038|NCT04104906|Posture analysis|posture analysis
4982039|NCT04104893|Metastatic Prostate Cancer|metastatic prostate cancer
4982040|NCT04104893|Pembrolizumab|pembrolizumab
4982041|NCT04104893|Checkpoint Inhibitor|checkpoint inhibitor
4982042|NCT04104893|Mismatch Repair Deficiency|mismatch repair deficiency
4982043|NCT04104893|CDK12|cdk12
4982044|NCT04104880|obstructive sleep apnea|obstructive sleep apnea
4982045|NCT04104854|Quantitative flow ratio|quantitative flow ratio
4982046|NCT04104854|drug coated balloon|drug coated balloon
4982047|NCT04104854|Drug eluted stent|drug eluted stent
4982048|NCT04104854|percutaneous coronary intervention|percutaneous coronary intervention
4982049|NCT04104828|Allergy immunotherapy|allergy immunotherapy
4982050|NCT04104828|Adjuvant|adjuvant
4982051|NCT04104828|Innate immunity|innate immunity
4982052|NCT04104789|Cavities, crowns|cavities, crowns
4982053|NCT04104711|Diabetes|diabetes
4982054|NCT04104711|public health nursing|public health nursing
4982055|NCT04104711|randomized controlled trials|randomized controlled trials
4982056|NCT04104711|chronic illness|chronic illness
4982057|NCT04104711|Health Belief Model|health belief model
4982058|NCT04104698|Suicide, Major depression, quantitative EEG|suicide, major depression, quantitative eeg
4982059|NCT04104659|tau|tau
4982060|NCT04104659|PET|pet
4982061|NCT04104659|MK 6240|mk 6240
4982062|NCT04104659|ADAD|adad
4982063|NCT04104633|ctDNA|ctdna
4982064|NCT04104633|Molecular karyotype|molecular karyotype
4982065|NCT04104607|PSMA|psma
4982088|NCT04104464|VM|vm
4982089|NCT04104412|lumbar discogenic pain|lumbar discogenic pain
4982090|NCT04104412|mesenchymal stem cell|mesenchymal stem cell
4982091|NCT04104347|schizophrenia spectrum disorders|schizophrenia spectrum disorders
4982094|NCT04104347|ecological momentary assessment|ecological momentary assessment
4982095|NCT04104334|Cytoreduction|cytoreduction
4982096|NCT04104334|HIPEC|hipec
4982097|NCT04104334|Oxaliplatin|oxaliplatin
4982098|NCT04104334|Colorectal|colorectal
4982099|NCT04104334|Peritoneal|peritoneal
4982100|NCT04104334|Carcinomatosis|carcinomatosis
4982101|NCT04104334|Monitoring|monitoring
4982102|NCT04104334|Anesthesia|anesthesia
4982103|NCT04104321|fibrosis|fibrosis
4982104|NCT04104321|liver fibrosis|liver fibrosis
4982105|NCT04104321|diabetes|diabetes
4982106|NCT04104321|obesity|obesity
4982107|NCT04104295|nasogastric tube|nasogastric tube
4982108|NCT04104295|ultrasound|ultrasound
4982109|NCT04104282|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4982110|NCT04104282|Lipid droplets|lipid droplets
4982111|NCT04104282|Plin5|plin5
4982112|NCT04104269|Heart rupture|heart rupture
4982113|NCT04104269|Acute myocardial infarction|acute myocardial infarction
4982114|NCT04104256|Low Value Care|low value care
4982115|NCT04104256|Cataract Surgery|cataract surgery
4982116|NCT04104256|Behavioral Economics|behavioral economics
4982117|NCT04104243|Pre-Diabetes|pre-diabetes
4982118|NCT04104243|Men's Health|men's health
4982119|NCT04104243|Type 2 Diabetes|type 2 diabetes
4982120|NCT04104243|Racial Disparities|racial disparities
4982121|NCT04104230|Cancer Genetics|cancer genetics
4982122|NCT04104217|Music therapy|music therapy
4982129|NCT04104113|Cancer Related Fatigue|cancer related fatigue
4982130|NCT04104113|Cognitive Impairment|cognitive impairment
4982132|NCT04104113|Traditional Chinese Medicine|traditional chinese medicine
4982133|NCT04104100|Nocturnal polyuria|nocturnal polyuria
4982134|NCT04104100|Bladder diary|bladder diary
4982135|NCT04104087|tunneling technique, gingival recession, deepithelialized free gingival graft, sub epithelial connective tissue graft,|tunneling technique, gingival recession, deepithelialized free gingival graft, sub epithelial connective tissue graft,
4982136|NCT04104035|Chronic Myeloid Leukemia|chronic myeloid leukemia
4982137|NCT04104035|BCR-ABL|bcr-abl
4982138|NCT04104022|Post Traumatic Stress Disorder|post traumatic stress disorder
4982139|NCT04104022|Opioid-use Disorder|opioid-use disorder
4982140|NCT04104022|Prolonged Exposure Therapy|prolonged exposure therapy
4982141|NCT04104022|Opioid Agonist Therapy|opioid agonist therapy
4982142|NCT04104022|Financial Incentives|financial incentives
4982143|NCT04104022|Substance Use|substance use
4982144|NCT04104009|midwifery|midwifery
4982145|NCT04104009|education|education
4982146|NCT04104009|pregnancy|pregnancy
4982156|NCT04103970|Postoperative rehabilitation|postoperative rehabilitation
4982157|NCT04103970|Graded activity|graded activity
4982158|NCT04103970|Pain education|pain education
4982159|NCT04103970|Disability|disability
4982160|NCT04103970|Pain|pain
4982161|NCT04103970|Fear of movement|fear of movement
4982162|NCT04103970|Self-efficacy for exercise|self-efficacy for exercise
4982163|NCT04103970|Health related quality of life|health related quality of life
4982164|NCT04103970|Sedentary behavior|sedentary behavior
4982165|NCT04103957|Virtual reality|virtual reality
4982166|NCT04103944|osteonecrosis|osteonecrosis
4982167|NCT04103944|osteonecrotic repair device|osteonecrotic repair device
4982168|NCT04103931|Shared Decision Making|shared decision making
4982169|NCT04103905|1. CD20-positive 2. lymphomas 3. MIL62|1. cd20-positive 2. lymphomas 3. mil62
4982170|NCT04103892|MDD|mdd
4982171|NCT04103892|depression|depression
4982172|NCT04103892|depressive disorder|depressive disorder
4982173|NCT04103892|major depression|major depression
4982174|NCT04103892|adjunct therapy|adjunct therapy
4982175|NCT04103892|oral|oral
4982176|NCT04103853|AR-positive metastatic breast cancer|ar-positive metastatic breast cancer
4982177|NCT04103853|Proxalutamide|proxalutamide
4982178|NCT04103853|metastatic breast cancer|metastatic breast cancer
4982179|NCT04103853|GT0918|gt0918
4982185|NCT04103801|Sucrose,|sucrose,
4982186|NCT04103801|Substance P,|substance p,
4982187|NCT04103801|Pain,|pain,
4982188|NCT04103801|Immunization.|immunization.
4982189|NCT04103788|Bioavailability|bioavailability
4982190|NCT04103788|Absorption|absorption
4982191|NCT04103762|acute lithiasis cholecystitis|acute lithiasis cholecystitis
4982192|NCT04103762|intraoperative cholangiography|intraoperative cholangiography
4982193|NCT04103762|indocyanine green|indocyanine green
4982194|NCT04103762|cholecystectomy|cholecystectomy
4982195|NCT04103736|chronic kidney disease|chronic kidney disease
4982196|NCT04103736|dietary nitrates|dietary nitrates
4982197|NCT04103736|beetroot juice|beetroot juice
4982198|NCT04103736|endothelium, vascular|endothelium, vascular
4982199|NCT04103736|cardiovascular disease|cardiovascular disease
4982200|NCT04103736|exercise capacity|exercise capacity
4982201|NCT04103723|Midazolam|midazolam
4982202|NCT04103723|Premedication|premedication
4982203|NCT04103723|Preoperative anxiety|preoperative anxiety
4982205|NCT04103710|MIH|mih
4982206|NCT04103710|asthmatic drugs|asthmatic drugs
4986338|NCT04076943|Anemia|anemia
4982210|NCT04103671|NPDR|npdr
4982211|NCT04103671|Pars-plana vitrectomy|pars-plana vitrectomy
4982212|NCT04103671|panretinal photocoagulation|panretinal photocoagulation
4982213|NCT04103645|Anemia|anemia
4982214|NCT04103632|Athletes|athletes
4982222|NCT04103554|LVAD (Left Ventricular Assist Device)|lvad (left ventricular assist device)
4982228|NCT04103528|Early postoperative sleep|early postoperative sleep
5301440|NCT02169193|pepsin|pepsin
4982229|NCT04103528|Procedure started in the morning and afternoon|procedure started in the morning and afternoon
4982230|NCT04103463|square stepping exercise|square stepping exercise
4982231|NCT04103463|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
4982232|NCT04103463|Interactive stepping exercise|interactive stepping exercise
4982234|NCT04103463|cognitive function|cognitive function
4982235|NCT04103463|executive function|executive function
4982236|NCT04103450|Overactive Bladder|overactive bladder
4982237|NCT04103450|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4982238|NCT04103450|Vibegron|vibegron
4982239|NCT04103450|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
4982240|NCT04103450|β3-AR agonist|β3-ar agonist
4982241|NCT04103437|running harmonicity|running harmonicity
4982242|NCT04103437|running related injuries|running related injuries
4982249|NCT04103372|early stage|early stage
4982250|NCT04103372|early phase|early phase
4982251|NCT04103359|Myelodysplatic syndromes|myelodysplatic syndromes
4982252|NCT04103359|elderly|elderly
4982253|NCT04103359|fatigue|fatigue
4982254|NCT04103359|blood transfusion|blood transfusion
4982255|NCT04103359|physiopathology|physiopathology
4982256|NCT04103320|Infertility|infertility
4982257|NCT04103320|In Vitro Fertilization|in vitro fertilization
4982258|NCT04103320|Endometriosis|endometriosis
4982259|NCT04103320|pain evaluation|pain evaluation
4982262|NCT04103229|Urine Leakage|urine leakage
4982270|NCT04103216|Bangladesh|bangladesh
4982271|NCT04103216|Nitazoxanide|nitazoxanide
4982272|NCT04103112|Deep Vein Thrombosis|deep vein thrombosis
4982273|NCT04103086|Percutaneous Coronary Intervention|percutaneous coronary intervention
4982274|NCT04103086|Aromatherapy|aromatherapy
4982275|NCT04103086|Cognitive function|cognitive function
4982276|NCT04103086|Randomized Controlled Trial|randomized controlled trial
4982277|NCT04103073|obstructive sleep apnea|obstructive sleep apnea
4982278|NCT04103073|emg|emg
4982279|NCT04103073|inspiratory muscles|inspiratory muscles
4982280|NCT04103073|expiratory muscles|expiratory muscles
4982281|NCT04103047|Temporomandibular joint disorder|temporomandibular joint disorder
4982283|NCT04103008|Speckle tracking|speckle tracking
4982284|NCT04103008|2D echocardiography|2d echocardiography
4982285|NCT04103008|Left ventricle residual function|left ventricle residual function
4982286|NCT04103008|PCI, percutaneous coronary intervention|pci, percutaneous coronary intervention
4982287|NCT04103008|single coronary artery|single coronary artery
4982288|NCT04103008|multiple coronary arteries|multiple coronary arteries
4982289|NCT04102982|NSCLC|nsclc
4982290|NCT04102982|Camrelizumab|camrelizumab
4982291|NCT04102982|Microwave ablation|microwave ablation
4982292|NCT04102982|Overall survival|overall survival
4982293|NCT04102982|Progression free survival|progression free survival
4982294|NCT04102982|Objective response rate|objective response rate
4982295|NCT04102982|Safety|safety
4982296|NCT04102969|Benson relaxation|benson relaxation
4982297|NCT04102969|Benson response|benson response
4982298|NCT04102969|Relaxation response|relaxation response
4982299|NCT04102917|QFR|qfr
4982300|NCT04102917|quantitative flow ratio|quantitative flow ratio
4982301|NCT04102891|Metabolic syndrome|metabolic syndrome
4982302|NCT04102891|Gut microbiota|gut microbiota
4982303|NCT04102891|Personalized dietary advice|personalized dietary advice
4982304|NCT04102891|Food literacy|food literacy
4982305|NCT04102878|oculoplastic surgery|oculoplastic surgery
4982306|NCT04102865|surgical complication|surgical complication
4982307|NCT04102865|NPWT|npwt
4982308|NCT04102865|negative pressure|negative pressure
4982309|NCT04102865|knee arthroplasty|knee arthroplasty
4982310|NCT04102865|abdominal incision|abdominal incision
4982311|NCT04102852|probiotic|probiotic
4982312|NCT04102852|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
4982313|NCT04102852|ATCC 53103|atcc 53103
4982314|NCT04102852|cytokines|cytokines
4982315|NCT04102852|adhesion|adhesion
4982316|NCT04102839|Prader-Willi Syndrome|prader-willi syndrome
4982317|NCT04102839|PWS|pws
4982318|NCT04102813|deep diaphragmatic breathing|deep diaphragmatic breathing
4982319|NCT04102813|cortisol|cortisol
4983310|NCT04096339|Sedation|sedation
4982328|NCT04102774|airway warm humidification|airway warm humidification
4982330|NCT04102774|airway clearance|airway clearance
4982331|NCT04102735|facial pressure ulcers|facial pressure ulcers
4982332|NCT04102735|noninvasive ventilation|noninvasive ventilation
4982333|NCT04102735|acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
4982334|NCT04102722|tomography|tomography
4982335|NCT04102722|ultrasound|ultrasound
4982339|NCT04102696|Aromatherapy|aromatherapy
4982340|NCT04102696|Cognitive Function|cognitive function
5292900|NCT02211014|Btk|btk
4982341|NCT04102696|Randomized Controlled Trial|randomized controlled trial
4982342|NCT04102696|Myocardial Infarction|myocardial infarction
4982344|NCT04102683|Therapeutic Recreation|therapeutic recreation
4982345|NCT04102683|Intellectual Disability|intellectual disability
4982347|NCT04102657|Glucose Monitoring|glucose monitoring
4982348|NCT04102657|Intermittent Fasting|intermittent fasting
4982349|NCT04102657|Fasting|fasting
4982350|NCT04102657|Exercise|exercise
4982351|NCT04102644|Labor and Delivery|labor and delivery
4982352|NCT04102644|Childbirth in limited resource setting|childbirth in limited resource setting
4982353|NCT04102631|colonoscopy|colonoscopy
4982354|NCT04102631|computer vision|computer vision
4982355|NCT04102631|adenoma detection rate|adenoma detection rate
4982356|NCT04102631|Endo.Angel|endo.angel
4982357|NCT04102618|Breast|breast
4982358|NCT04102618|Breast Cancer|breast cancer
4982359|NCT04102618|Primary Breast|primary breast
4982360|NCT04102618|Primary Breast Cancer|primary breast cancer
4982361|NCT04102618|Pelareorep|pelareorep
4982362|NCT04102618|Atezolizumab|atezolizumab
4982363|NCT04102618|Reovirus|reovirus
4982364|NCT04102618|Oncolytic virus|oncolytic virus
4982369|NCT04102618|HER2+ breast cancer|her2+ breast cancer
4982370|NCT04102605|Visual field defect|visual field defect
4982371|NCT04102605|visual perceptual learning|visual perceptual learning
4982372|NCT04102605|Humphrey visual field|humphrey visual field
4982374|NCT04102592|P. Falciparum|p. falciparum
4982375|NCT04102592|Permethrin|permethrin
4982376|NCT04102592|Rapid diagnostic test|rapid diagnostic test
4982377|NCT04102566|postoperative pain|postoperative pain
4982378|NCT04102566|Transurethral resection of the prostate|transurethral resection of the prostate
4982379|NCT04102566|Multimodal pain control|multimodal pain control
4982380|NCT04102540|Information Visualization|information visualization
4982381|NCT04102514|Physical Activity|physical activity
4982382|NCT04102514|Exercise|exercise
4982383|NCT04102488|reduction of bacterial counts|reduction of bacterial counts
4982384|NCT04102488|hand hygiene technique|hand hygiene technique
4982397|NCT04102410|Cardiac rehabilitation|cardiac rehabilitation
4982398|NCT04102410|Physical activity|physical activity
4982399|NCT04102410|Force-velocity profile|force-velocity profile
4982400|NCT04102410|Autonomic nervous system|autonomic nervous system
4982401|NCT04102410|Coronary artery disease|coronary artery disease
4982402|NCT04102397|Subacromial Impingement Syndrome; Vojta therapy; pain|subacromial impingement syndrome; vojta therapy; pain
4982403|NCT04102384|Electronic Patient Reported Outcomes|electronic patient reported outcomes
4982404|NCT04102371|Sepsis|sepsis
4982405|NCT04102371|Septic Shock|septic shock
4982406|NCT04102371|Fluid resuscitation|fluid resuscitation
4982407|NCT04102371|Saline|saline
4982408|NCT04102371|Balanced Fluid|balanced fluid
4982409|NCT04102371|Mortality|mortality
4982410|NCT04102371|Feasibility|feasibility
4982411|NCT04102371|Crystalloid|crystalloid
4982412|NCT04102371|PlasmaLyte|plasmalyte
4982413|NCT04102371|Lactated Ringer's|lactated ringer's
4982414|NCT04102358|Vertical infraclavicular block|vertical infraclavicular block
4982415|NCT04102358|brachial plexus anatomy|brachial plexus anatomy
4982423|NCT04102332|Occupational Exposure|occupational exposure
4982424|NCT04102332|Nursing|nursing
4982425|NCT04102306|orofacial myotherapies;|orofacial myotherapies;
4982426|NCT04102306|physical therapy;|physical therapy;
4982427|NCT04102306|assessment;|assessment;
4982428|NCT04102306|questionnaire validation|questionnaire validation
4982429|NCT04102293|rotatry instrumentation|rotatry instrumentation
4982430|NCT04102280|Hemodialysis|hemodialysis
4982431|NCT04102280|Hemodiafiltration|hemodiafiltration
4982432|NCT04102280|Renal replacement therapy|renal replacement therapy
4982433|NCT04102267|herniorrhaphy|herniorrhaphy
4982434|NCT04102267|inguinal hernia|inguinal hernia
4982435|NCT04102267|hernia|hernia
4982436|NCT04102267|hernia surgery|hernia surgery
4982437|NCT04102267|postoperative pain|postoperative pain
4982438|NCT04102241|psoriasis|psoriasis
4982439|NCT04102241|PDE4|pde4
4982440|NCT04102228|Non-invasive brain stimulation|non-invasive brain stimulation
4982441|NCT04102228|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4982442|NCT04102228|Multi-modality aphasia therapy|multi-modality aphasia therapy
4982443|NCT04102228|Neuroimaging|neuroimaging
4982444|NCT04102176|chronic hepatitis B|chronic hepatitis b
4982445|NCT04102176|nucleoside analogues|nucleoside analogues
4982446|NCT04102176|stopping|stopping
4982447|NCT04102176|discontinuing|discontinuing
4982448|NCT04102163|Drug Therapy|drug therapy
4982449|NCT04102137|TDA202|tda202
4982450|NCT04102137|acellular pertussis vaccine|acellular pertussis vaccine
4982451|NCT04102137|antibody persistence at 3 years after vaccination|antibody persistence at 3 years after vaccination
4982452|NCT04102137|Pertagen|pertagen
4982453|NCT04102137|Boostagen|boostagen
4982474|NCT04101994|virtual cycling training|virtual cycling training
4982475|NCT04101994|Non-invasive brain stimulation|non-invasive brain stimulation
4982476|NCT04101994|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4982483|NCT04101929|irinotecan|irinotecan
4982484|NCT04101864|navigation|navigation
4982485|NCT04101864|hip arthroplasty|hip arthroplasty
4982486|NCT04101864|surgical time|surgical time
4982487|NCT04101864|landmark|landmark
4982488|NCT04101851|sentinel lymph node biopsy|sentinel lymph node biopsy
4982489|NCT04101851|neoadjuvant systemic therapy|neoadjuvant systemic therapy
4982490|NCT04101838|vaccine|vaccine
4982491|NCT04101799|Prison|prison
4982492|NCT04101799|Criminality|criminality
4982493|NCT04101799|Child|child
4982494|NCT04101786|sport|sport
4982495|NCT04101786|injury|injury
4982496|NCT04101786|prevention|prevention
4982497|NCT04101786|rehabilitation|rehabilitation
4982498|NCT04101786|groin pain|groin pain
4982499|NCT04101786|adductor strain|adductor strain
4982500|NCT04101773|hemorrhoids|hemorrhoids
4982501|NCT04101773|haemorrhoidal disease|haemorrhoidal disease
4982502|NCT04101773|recurrence|recurrence
4982503|NCT04101773|rubber band ligation|rubber band ligation
4982504|NCT04101773|haemorrhoidectomy|haemorrhoidectomy
4982505|NCT04101747|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4982506|NCT04101747|Combination of PD-1/PD-L1 Inhibitors and Targeted Drugs|combination of pd-1/pd-l1 inhibitors and targeted drugs
4982507|NCT04101747|Diversity of intestinal flora|diversity of intestinal flora
4982508|NCT04101747|Metabolites|metabolites
4982509|NCT04101734|Difficult Intubation|difficult intubation
4982510|NCT04101734|Thyromental Height Test|thyromental height test
4982511|NCT04101734|Double Lumen Video Tube|double lumen video tube
4982512|NCT04101708|elderly,helicobacter pylori eradication,dual therapy,half-dose clarithromycin|elderly,helicobacter pylori eradication,dual therapy,half-dose clarithromycin
4982515|NCT04101656|Breast Cancer|breast cancer
4982516|NCT04101656|Radiotherapy|radiotherapy
4982517|NCT04101656|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
4982518|NCT04101656|APBI|apbi
4982519|NCT04101656|Modulated Intensity Radiotherapy|modulated intensity radiotherapy
4982520|NCT04101656|IMRT|imrt
4982521|NCT04101656|Positive estrogen receptor|positive estrogen receptor
4982522|NCT04101630|Pulmonary Hypertension|pulmonary hypertension
4982523|NCT04101565|Fatherhood|fatherhood
4982524|NCT04101539|catheter ablation; atrial fibrillation|catheter ablation; atrial fibrillation
4982525|NCT04101487|Cash Transfers|cash transfers
4982526|NCT04101487|Liberia|liberia
4982527|NCT04101487|Stunting|stunting
4982528|NCT04101487|Dietary diversity|dietary diversity
4982529|NCT04101448|Bronchiectasis|bronchiectasis
4982530|NCT04101448|COPD|copd
4982531|NCT04101448|Prevalence|prevalence
4982532|NCT04101448|Prognosis|prognosis
4982533|NCT04101435|Influenza Vaccine|influenza vaccine
4982534|NCT04101435|Immunogenicity|immunogenicity
4982535|NCT04101422|Quit Smoking|quit smoking
4982536|NCT04101422|Augmented Reality|augmented reality
4982537|NCT04101422|Smoking|smoking
4982538|NCT04101409|decision aids|decision aids
4982539|NCT04101409|shared decision making|shared decision making
4982540|NCT04101396|diet modification, 4 and 7 points monitoring|diet modification, 4 and 7 points monitoring
4982541|NCT04101383|Pharmacokinetics|pharmacokinetics
4982542|NCT04101383|Pharmacodynamics|pharmacodynamics
4982543|NCT04101383|Insulin glargine|insulin glargine
4982545|NCT04101370|Cmax|cmax
4982546|NCT04101370|Pharmacokinetics|pharmacokinetics
4982547|NCT04101370|bosentan|bosentan
4982548|NCT04101370|fasting|fasting
4982549|NCT04101357|Solid Tumor|solid tumor
4982550|NCT04101357|Extensive-stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
4982551|NCT04101305|Prostate cancer, biomarker|prostate cancer, biomarker
4982552|NCT04101292|Fluorescence|fluorescence
4982553|NCT04101292|Antibody|antibody
4982554|NCT04101292|Bevacizumab|bevacizumab
4982555|NCT04101292|IRDye800|irdye800
4982556|NCT04101292|Hyperspectral imaging|hyperspectral imaging
4982557|NCT04101292|Light-CT Scanner|light-ct scanner
4982558|NCT04101292|Tumour detection|tumour detection
4982559|NCT04101292|Colorectal cancer|colorectal cancer
4982560|NCT04101279|stress urinary incontinence|stress urinary incontinence
4982561|NCT04101279|midurethral tension free tape|midurethral tension free tape
4982563|NCT04101279|bladder outlet obstruction|bladder outlet obstruction
4982564|NCT04101279|complications|complications
4982565|NCT04101279|tension control mechanism|tension control mechanism
4982566|NCT04101240|red blood cells transfusion|red blood cells transfusion
4982567|NCT04101214|Dry needling|dry needling
4982568|NCT04101214|Parkinson Disease|parkinson disease
4982572|NCT04101188|Vascular Health|vascular health
4982573|NCT04101175|First-trimester pregnancy|first-trimester pregnancy
4982574|NCT04101175|Abortions|abortions
4982575|NCT04101136|statin|statin
4982576|NCT04101136|atherosclerosis|atherosclerosis
4982577|NCT04101123|Social inequalities|social inequalities
4982578|NCT04101123|Social dimensions of health|social dimensions of health
4982579|NCT04101123|Brain tumors|brain tumors
4982580|NCT04101123|Leukemia|leukemia
4982581|NCT04101123|Sarcomas|sarcomas
4982582|NCT04101123|Childhood Cancer|childhood cancer
4982583|NCT04101123|Children and adolescents with cancer|children and adolescents with cancer
4982584|NCT04101097|factors;bowel preparation;colonoscopy|factors;bowel preparation;colonoscopy
4982585|NCT04101071|Critical care|critical care
4982586|NCT04101071|enteral feeding|enteral feeding
4982587|NCT04101071|nasogastric|nasogastric
4982588|NCT04101071|ketogenic feed|ketogenic feed
4982589|NCT04101071|feasibility|feasibility
4982590|NCT04101032|Mindfulness|mindfulness
4982591|NCT04101032|Self-compassion|self-compassion
4982592|NCT04101032|Values|values
4982593|NCT04101032|Binge Eating|binge eating
4982594|NCT04100967|sleep|sleep
4982595|NCT04100967|obesity|obesity
4982596|NCT04100967|body fat composition|body fat composition
4982597|NCT04100967|young adults|young adults
4982598|NCT04100967|diet|diet
4982599|NCT04100967|activity|activity
4982600|NCT04100967|Dual X-ray Absorptiometry|dual x-ray absorptiometry
4982601|NCT04100954|phonatory prosthesis|phonatory prosthesis
4982602|NCT04100954|voice rehabilitation|voice rehabilitation
4982603|NCT04100954|reinforced voice prosthesis|reinforced voice prosthesis
4982604|NCT04100954|laryngectomy|laryngectomy
4982605|NCT04100954|total pharyngolaryngectomy|total pharyngolaryngectomy
4982606|NCT04100954|total circular pharyngolaryngectomy|total circular pharyngolaryngectomy
4983309|NCT04096339|EGD|egd
4982614|NCT04100850|anxiety|anxiety
4982615|NCT04100772|PCV13i|pcv13i
4982616|NCT04100772|PCV13|pcv13
4982617|NCT04100772|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4982620|NCT04100707|Genicular nerve|genicular nerve
4982621|NCT04100707|Knee pain|knee pain
4982622|NCT04100707|Ultrasound|ultrasound
4982623|NCT04100694|Early Access|early access
4982624|NCT04100694|NRG1|nrg1
4982625|NCT04100694|Pancreas cancer|pancreas cancer
4982626|NCT04100694|Non Small Cell Lung Cancer|non small cell lung cancer
4982627|NCT04100694|Solid tumor|solid tumor
4982628|NCT04100694|Compassionate use|compassionate use
4982629|NCT04100694|Expanded access|expanded access
4982630|NCT04100655|GM-CSF|gm-csf
4982631|NCT04100655|frozen embryo transfer|frozen embryo transfer
4982632|NCT04100642|first in human|first in human
4982633|NCT04100642|atopic dermatitis|atopic dermatitis
4982634|NCT04100577|TNT-PISP|tnt-pisp
4982635|NCT04100564|intubation|intubation
4982636|NCT04100564|supraglottic airway|supraglottic airway
4982637|NCT04100538|Health coaching|health coaching
4982638|NCT04100538|Quality of Life|quality of life
4982639|NCT04100525|Employment|employment
4982640|NCT04100525|Vocational Rehabilitation|vocational rehabilitation
4982641|NCT04100499|Endoanchors|endoanchors
4982642|NCT04100499|EVAR|evar
4982643|NCT04100499|TEVAR|tevar
4982644|NCT04100486|Vagus Nerve Stimulation|vagus nerve stimulation
4982645|NCT04100486|Noninvasive|noninvasive
4982646|NCT04100486|Autonomic Nervous System|autonomic nervous system
4982647|NCT04100486|Biosensors|biosensors
4982648|NCT04100486|Vitals Monitoring|vitals monitoring
4982649|NCT04100486|Machine Learning|machine learning
4982650|NCT04100486|Deep Learning|deep learning
4982651|NCT04100473|Inhaled Insulin|inhaled insulin
4982652|NCT04100460|Fecal Microbiota|fecal microbiota
4982653|NCT04100460|Gastrointestinal tolerance|gastrointestinal tolerance
4982654|NCT04100460|Bowel habits|bowel habits
4982655|NCT04100447|post-operative|post-operative
4982656|NCT04100447|abdominal|abdominal
4982657|NCT04100434|Acute Coronary Syndrome|acute coronary syndrome
4982658|NCT04100434|Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor|proprotein convertase subtilisin/kexin type 9 inhibitor
4982659|NCT04100434|Lipid-lowering Drug|lipid-lowering drug
4982660|NCT04100434|Major Cardiovascular Adverse Events|major cardiovascular adverse events
4982661|NCT04100421|bisphenol|bisphenol
4982662|NCT04100421|human exposure|human exposure
4982663|NCT04100421|chronic kidney disease|chronic kidney disease
4982664|NCT04100421|blood purification|blood purification
4982665|NCT04100369|shock , poly trauma , serum lactate|shock , poly trauma , serum lactate
4982666|NCT04100356|Low-carbohydrate-high-fat diet (LCHF)|low-carbohydrate-high-fat diet (lchf)
4982667|NCT04100356|Low-density-lipoprotein (LDL)|low-density-lipoprotein (ldl)
4982668|NCT04100356|High-density-lipoprotein (HDL)|high-density-lipoprotein (hdl)
4982669|NCT04100356|Triglycerides (TG)|triglycerides (tg)
4982670|NCT04100356|Lipids|lipids
4982672|NCT04100356|Insulin resistance (IR)|insulin resistance (ir)
4982681|NCT04100239|mindfulness|mindfulness
4982682|NCT04100239|self-compassion|self-compassion
4982683|NCT04100239|young people|young people
4982684|NCT04100239|pilot study|pilot study
4982685|NCT04100226|Interstitial Lung Diseases|interstitial lung diseases
4982686|NCT04100226|Vitamin D Deficiency|vitamin d deficiency
4982687|NCT04100213|Stress, Stress Reaction, Trier Social Stress Test, Digital Phenotyping|stress, stress reaction, trier social stress test, digital phenotyping
4982688|NCT04100200|Strawberry|strawberry
4982689|NCT04100200|Raspberry|raspberry
4982690|NCT04100200|Metabolic responses|metabolic responses
4982691|NCT04100200|Gut microbiome|gut microbiome
4982692|NCT04100200|Inflammatory markers|inflammatory markers
4982693|NCT04100187|CAR-T|car-t
4982694|NCT04100187|Lymphoma|lymphoma
4982695|NCT04100161|muscle strain, atrophy, protein, rehabilitation|muscle strain, atrophy, protein, rehabilitation
4982696|NCT04100148|SyncAV feature|syncav feature
4982697|NCT04100148|CRT optimization|crt optimization
4982698|NCT04100148|CRT non-responders|crt non-responders
4982699|NCT04100148|ECG optimization|ecg optimization
4982700|NCT04100148|Cardiac remodeling|cardiac remodeling
4982701|NCT04100148|CRT with SyncAV|crt with syncav
4982702|NCT04100122|Major allergen|major allergen
4982703|NCT04099992|Mindfulness|mindfulness
4982704|NCT04099992|Transcutaneous Vagus Nerve Stimulation|transcutaneous vagus nerve stimulation
4982705|NCT04099992|tVNS|tvns
4982706|NCT04099992|Sympatho-inhibitory effects|sympatho-inhibitory effects
4982714|NCT04099953|physical function|physical function
5356778|NCT01918033|Histamine Agents|histamine agents
5356779|NCT01918020|Fruit|fruit
4982715|NCT04099940|Hearing Voices, Virtual Reality Avatar Therapy, Cognitive Behavioural Therapy|hearing voices, virtual reality avatar therapy, cognitive behavioural therapy
4982716|NCT04099914|Cerebellar ataxia|cerebellar ataxia
4982717|NCT04099914|Neurogenetics|neurogenetics
4982718|NCT04099914|Next generation sequence|next generation sequence
4982719|NCT04099914|Clinical algorithm|clinical algorithm
4982720|NCT04099901|Anakinra|anakinra
4982721|NCT04099901|Mucositis|mucositis
4982722|NCT04099901|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4982723|NCT04099901|Febrile neutropenia|febrile neutropenia
4982724|NCT04099888|Phase II|phase ii
4982725|NCT04099888|Safety|safety
4982726|NCT04099888|Tolerability|tolerability
4982727|NCT04099888|Efficacy|efficacy
4982728|NCT04099888|Amphinex-induced Photochemical Internalisation|amphinex-induced photochemical internalisation
4982729|NCT04099888|PCI|pci
4982730|NCT04099888|Amphinex|amphinex
4982731|NCT04099888|Gemcitabine|gemcitabine
4982732|NCT04099888|Cisplatin|cisplatin
4982733|NCT04099888|Inoperable|inoperable
4982734|NCT04099888|CCA|cca
4982735|NCT04099888|Cholangiocarcinoma|cholangiocarcinoma
4982736|NCT04099888|Bile duct cancer|bile duct cancer
4982737|NCT04099888|Photodynamic therapy|photodynamic therapy
4982738|NCT04099888|Extrahepatic|extrahepatic
4982739|NCT04099888|Perihilar|perihilar
4982740|NCT04099888|Distal|distal
4982741|NCT04099888|Fimaporfin|fimaporfin
4982742|NCT04099888|Pivotal|pivotal
4982743|NCT04099888|RELEASE|release
4982744|NCT04099888|PDT|pdt
4982745|NCT04099888|FimaChem|fimachem
4982746|NCT04099888|Klatskin|klatskin
4982747|NCT04099875|nutrition,cirrhosis|nutrition,cirrhosis
4982748|NCT04099849|Rice|rice
4982749|NCT04099849|biofortification,|biofortification,
4982750|NCT04099849|Bangladeshi children|bangladeshi children
4982751|NCT04099849|zinc|zinc
4982752|NCT04099836|EGFR Mutation|egfr mutation
4982753|NCT04099836|Atezolizumab|atezolizumab
4982754|NCT04099836|Bevacizumab|bevacizumab
4982755|NCT04099836|exon L858R|exon l858r
4982756|NCT04099836|exon 21 L858R|exon 21 l858r
4982757|NCT04099810|three-dimensional echocardiography|three-dimensional echocardiography
4982758|NCT04099810|right ventricular volumes|right ventricular volumes
4982759|NCT04099810|cardiac magnetic resonance|cardiac magnetic resonance
4982767|NCT04099784|Fresh transfer, freeze-only, ASQ-3, health of children|fresh transfer, freeze-only, asq-3, health of children
4982768|NCT04099745|FGM|fgm
4982769|NCT04099745|CGM|cgm
4982770|NCT04099706|Chronic pain|chronic pain
4982771|NCT04099706|Postherpetic Neuralgia|postherpetic neuralgia
4982772|NCT04099667|Stroke|stroke
4982773|NCT04099667|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
4982774|NCT04099667|Monoplegia|monoplegia
4982775|NCT04099667|Hemiplegia|hemiplegia
4982776|NCT04099667|Lower limb|lower limb
4982777|NCT04099654|obese|obese
4982778|NCT04099654|core stabilization|core stabilization
4982784|NCT04099628|rapid diagnostic test|rapid diagnostic test
4982785|NCT04099628|trypanolysis|trypanolysis
4982787|NCT04099628|ELISA|elisa
4982788|NCT04099628|molecular biology|molecular biology
4982789|NCT04099628|RT-PCR|rt-pcr
4982790|NCT04099628|serology|serology
4982791|NCT04099628|diagnosis|diagnosis
4982792|NCT04099628|specificity|specificity
4982793|NCT04099628|sensitivity|sensitivity
4982794|NCT04099615|Evoked Potentials, Somatosensory|evoked potentials, somatosensory
5863591|NCT00001245|Immediate Hypersensitivity|immediate hypersensitivity
5703850|NCT00487851|Duodenal|duodenal
4982797|NCT04099602|neonatal jaundice|neonatal jaundice
4982798|NCT04099602|baby massage|baby massage
4982799|NCT04099602|transcutaneous bilirubin level|transcutaneous bilirubin level
4982800|NCT04099602|premature infant|premature infant
4982801|NCT04099576|therapeutic neuroscience education|therapeutic neuroscience education
4982802|NCT04099576|chronic low back pain|chronic low back pain
4982803|NCT04099576|kinesiophobia|kinesiophobia
4982804|NCT04099576|pain|pain
4982805|NCT04099537|skin picking|skin picking
4982806|NCT04099537|cognitive training|cognitive training
4982807|NCT04099537|approach-avoidance|approach-avoidance
4982808|NCT04099511|Stroke|stroke
4982809|NCT04099511|Occupational therapy|occupational therapy
4982814|NCT04099498|Online|online
4982815|NCT04099498|Promotion|promotion
4982820|NCT04099472|delirium|delirium
4982821|NCT04099472|intensive care unit|intensive care unit
4982822|NCT04099472|critically ill|critically ill
4982823|NCT04099472|delirium detection|delirium detection
4982824|NCT04099472|delirium prevention|delirium prevention
4982825|NCT04099472|delirium education|delirium education
4982826|NCT04099472|delirium management|delirium management
4982827|NCT04099472|psychological distress|psychological distress
4982828|NCT04099472|post intensive care syndrome|post intensive care syndrome
4982829|NCT04099472|post intensive care syndrome family|post intensive care syndrome family
4982831|NCT04099433|HPV|hpv
4982832|NCT04099433|Probiotics|probiotics
4982833|NCT04099433|High Resolution Anoscopy|high resolution anoscopy
4982834|NCT04099433|Anal dysplasia|anal dysplasia
4982835|NCT04099420|Self-medication|self-medication
4982836|NCT04099420|Adherence to Mediterranean diet|adherence to mediterranean diet
4982837|NCT04099420|Orthorexia|orthorexia
5301941|NCT02166801|Early Intervention|early intervention
4982838|NCT04099420|Relationship lifestyle and metabolic status biomarkers|relationship lifestyle and metabolic status biomarkers
4982839|NCT04099420|Oral microbiota composition|oral microbiota composition
4982840|NCT04099420|Relationship lifestyle and immunological status biomarkers|relationship lifestyle and immunological status biomarkers
4982841|NCT04099407|Liver fibrosis|liver fibrosis
4982842|NCT04099407|Fibrosis treatment|fibrosis treatment
4982843|NCT04099407|Fibrosis reversibility|fibrosis reversibility
4982844|NCT04099407|Pirfenidone|pirfenidone
4982845|NCT04099394|Osteoarthritis|osteoarthritis
4982846|NCT04099394|chronic pain|chronic pain
4982847|NCT04099394|behavioral health|behavioral health
4982848|NCT04099394|exercise|exercise
4982849|NCT04099394|physical activity|physical activity
4982850|NCT04099394|older adults|older adults
4982851|NCT04099381|Autism, ASD, Cord blood, HLA|autism, asd, cord blood, hla
4982852|NCT04099329|Soccer|soccer
4982853|NCT04099329|Football|football
4982854|NCT04099329|Injury|injury
4982855|NCT04099329|Prevention|prevention
4982856|NCT04099329|Concussion|concussion
4982857|NCT04099329|Education|education
4982858|NCT04099329|Huddles|huddles
4982859|NCT04099329|Primary prevention|primary prevention
4982860|NCT04099329|Secondary prevention|secondary prevention
4982861|NCT04099329|Behavioral intervention|behavioral intervention
4982862|NCT04099316|Aging|aging
4982863|NCT04099316|Eccentric training|eccentric training
4982864|NCT04099316|Muscle strength|muscle strength
4982865|NCT04099316|Physical function|physical function
4982866|NCT04099316|Sarcopenia|sarcopenia
4982867|NCT04099303|Infection|infection
4982868|NCT04099303|DTcP|dtcp
4982869|NCT04099303|Whooping Cough|whooping cough
4982870|NCT04099290|Squamous Cell Carcinoma|squamous cell carcinoma
4982871|NCT04099290|Circulating Tumor DNA|circulating tumor dna
4982872|NCT04099277|immunotherapy|immunotherapy
4982873|NCT04099277|CD226 agonist|cd226 agonist
4982874|NCT04099264|personalized musical intervention|personalized musical intervention
4982875|NCT04099264|quasi-experimental study|quasi-experimental study
4982876|NCT04099264|dissatisfaction|dissatisfaction
4982877|NCT04099264|anxiety|anxiety
4982878|NCT04099264|surgical pain|surgical pain
4982879|NCT04099264|burden of care|burden of care
4982880|NCT04099238|Ischemic stroke|ischemic stroke
5006007|NCT03959176|Pupil Effects|pupil effects
4982881|NCT04099238|Non-valvular atrial fibrillation (NVAF)|non-valvular atrial fibrillation (nvaf)
4982882|NCT04099238|Oral anticoagulants (OAC)|oral anticoagulants (oac)
4982883|NCT04099238|Vitamin K antagonists (NKA)|vitamin k antagonists (nka)
4982884|NCT04099238|Non-vitamin K antagonist oral anticoagulants (NOAC)|non-vitamin k antagonist oral anticoagulants (noac)
4982885|NCT04099238|Discontinuation|discontinuation
4982886|NCT04099212|RESORCINOL|resorcinol
4982887|NCT04099212|HIDRADENITIS SUPPURATIVA|hidradenitis suppurativa
4982888|NCT04099173|mindfulness|mindfulness
4982889|NCT04099173|suicide related behavior|suicide related behavior
4982890|NCT04099173|Veterans|veterans
4982891|NCT04099173|Veterans' Affairs|veterans' affairs
4982892|NCT04099160|neurophysiology pain questionnaire|neurophysiology pain questionnaire
4982893|NCT04099160|reliability|reliability
4982894|NCT04099160|validity|validity
4982895|NCT04099160|pain|pain
4986974|NCT04072809|FAS|fas
4982937|NCT04098796|Gastric or gastroesophageal junction adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
5356780|NCT01918020|Vegetables|vegetables
4982940|NCT04098796|chemotherapy|chemotherapy
4982941|NCT04098796|first-line|first-line
4982942|NCT04098783|Breast Cancer|breast cancer
4982943|NCT04098783|Lymphedema|lymphedema
4982944|NCT04098783|Health Belief Model|health belief model
4982946|NCT04098783|Home Visit|home visit
4982947|NCT04098770|AIDS patients|aids patients
4982948|NCT04098770|Safety|safety
4982949|NCT04098770|Efficiency|efficiency
4982950|NCT04098770|Immune Therapy|immune therapy
4982951|NCT04098757|Fibromyalgia|fibromyalgia
4982952|NCT04098757|Fibromyalgic Sindrome (FMS)|fibromyalgic sindrome (fms)
4982953|NCT04098757|Pain|pain
4982954|NCT04098757|Acupuncture|acupuncture
4982955|NCT04098757|Nutraceutical products|nutraceutical products
4982956|NCT04098744|treatment study|treatment study
4982957|NCT04098744|cancer prevention|cancer prevention
4982958|NCT04098744|non-surgical|non-surgical
4982959|NCT04098744|HPV disease|hpv disease
4982960|NCT04098744|CIN|cin
4982961|NCT04098744|topical treatment|topical treatment
4982962|NCT04098744|vaginal inserts|vaginal inserts
4982963|NCT04098744|artesunate|artesunate
4982964|NCT04098744|artemisinin|artemisinin
4982965|NCT04098744|non-invasive|non-invasive
4982966|NCT04098744|high risk HPV|high risk hpv
4982967|NCT04098731|Fibromyalgia|fibromyalgia
4982968|NCT04098731|Respiratory function|respiratory function
4982969|NCT04098718|Exacerbations|exacerbations
4982970|NCT04098718|Interleukin 5|interleukin 5
4982971|NCT04098718|Prednisolone|prednisolone
4982972|NCT04098718|Randomised Clinical Trial|randomised clinical trial
4982989|NCT04098549|Hypoglycemia|hypoglycemia
4982990|NCT04098549|Glucagon|glucagon
4982991|NCT04098523|Carotid Artery Stenosis|carotid artery stenosis
4982992|NCT04098523|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
4982993|NCT04098523|Epidemiology|epidemiology
4982994|NCT04098523|Stenosis|stenosis
4982995|NCT04098523|Population screening|population screening
4982996|NCT04098510|Mitochondria-targeted antioxidant|mitochondria-targeted antioxidant
4982997|NCT04098510|Skeletal muscle biopsies|skeletal muscle biopsies
4982998|NCT04098497|mood|mood
4982999|NCT04098497|stress|stress
4983000|NCT04098497|sleep|sleep
4983001|NCT04098497|circadian rhythm|circadian rhythm
4983002|NCT04098497|medical adherence|medical adherence
4983003|NCT04098497|acceptance and commitment therapy|acceptance and commitment therapy
4983004|NCT04098497|microintervention|microintervention
4983005|NCT04098484|Obesity, strength training, cardiovascular training, inflammation, Liver, oxidative stress|obesity, strength training, cardiovascular training, inflammation, liver, oxidative stress
4983006|NCT04098471|transanal local excision|transanal local excision
4983007|NCT04098471|T2N0M0|t2n0m0
4983008|NCT04098432|Stereotactic radiotherapy|stereotactic radiotherapy
4983009|NCT04098432|Nivolumab|nivolumab
4983010|NCT04098432|Anti PD-1|anti pd-1
4983011|NCT04098432|Pancreatic cancer|pancreatic cancer
5026993|NCT03830073|IG4|ig4
4983025|NCT04098289|Metroplasty|metroplasty
4983026|NCT04098289|Primary infertility|primary infertility
4983027|NCT04098289|Preterm delivery|preterm delivery
4983028|NCT04098276|Intimate partner violence|intimate partner violence
4983029|NCT04098276|safety planning|safety planning
4983030|NCT04098276|immigrant|immigrant
4983031|NCT04098276|risk for future violence|risk for future violence
4983032|NCT04098276|risk for intimate partner homicide|risk for intimate partner homicide
4983033|NCT04098276|empowerment|empowerment
4983034|NCT04098276|mental health|mental health
4983035|NCT04098276|safety|safety
4983038|NCT04098211|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
4983039|NCT04098211|Atypical CLN2 Disease|atypical cln2 disease
4983040|NCT04098211|Natural History|natural history
4983043|NCT04098133|Carbapenemase-producing Klebsiella pneumoniae|carbapenemase-producing klebsiella pneumoniae
4983044|NCT04098133|antibiotic resistancy|antibiotic resistancy
4983045|NCT04098133|infections with Carbapenemase-producing Bacteria (CPB)|infections with carbapenemase-producing bacteria (cpb)
4983046|NCT04098133|Carbapenemase-producing Bacteria|carbapenemase-producing bacteria
4983047|NCT04098107|Healthy subjects|healthy subjects
4983048|NCT04098107|Athletes|athletes
4983049|NCT04098107|Baseball|baseball
4983050|NCT04098107|Sports research|sports research
4983051|NCT04098107|overuse injuries|overuse injuries
4983052|NCT04098081|pancreatic cancer|pancreatic cancer
4983053|NCT04098068|BRAF pv600E (human gene that encodes a protein called B-Raf)|braf pv600e (human gene that encodes a protein called b-raf)
4983054|NCT04098068|TGFBR2 (transforming growth factor-beta (TGF-β) receptor type 2)|tgfbr2 (transforming growth factor-beta (tgf-β) receptor type 2)
4983055|NCT04098068|Mutation load|mutation load
4983056|NCT04098068|Tumor mutation load|tumor mutation load
4983057|NCT04098068|Mutation burden|mutation burden
4983058|NCT04098068|Tumor mutation burden (TMB)|tumor mutation burden (tmb)
4983059|NCT04098068|Hypermutation|hypermutation
4983061|NCT04098068|MSI Negative with Mutator Phenotype (High Tumor Mutation Burden)|msi negative with mutator phenotype (high tumor mutation burden)
4983062|NCT04098068|TMB (Tumor Mutation Burden)|tmb (tumor mutation burden)
4983063|NCT04098055|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
4983064|NCT04098055|Foot Orthoses|foot orthoses
4983065|NCT04098055|Foot|foot
4983066|NCT04098055|Pain|pain
4983074|NCT04098029|Cerebral palsy|cerebral palsy
4983083|NCT04097977|Patient-reported outcomes|patient-reported outcomes
4983084|NCT04097977|Networked-based recovery|networked-based recovery
4983085|NCT04097964|SBIRT|sbirt
4983086|NCT04097925|Doravirine|doravirine
4983087|NCT04097886|circadian|circadian
4983088|NCT04097886|phase shift|phase shift
4983089|NCT04097886|exercise|exercise
4983090|NCT04097821|myelofibrosis|myelofibrosis
4983091|NCT04097821|ruxolitinib|ruxolitinib
4983092|NCT04097821|INC424|inc424
4983093|NCT04097821|siremadlin|siremadlin
4983094|NCT04097821|HDM201|hdm201
4983095|NCT04097821|crizanlizumab|crizanlizumab
4983096|NCT04097821|SEG101|seg101
4983097|NCT04097821|MBG453|mbg453
4983098|NCT04097821|platform study|platform study
4983099|NCT04097808|bioavailability|bioavailability
4983100|NCT04097808|collagen peptides|collagen peptides
4983101|NCT04097808|polyphenols|polyphenols
4983102|NCT04097782|antenatal education|antenatal education
4983103|NCT04097782|fear of childbirth|fear of childbirth
4983104|NCT04097782|depression|depression
4983105|NCT04097782|anxiety|anxiety
4983106|NCT04097782|stress|stress
4983107|NCT04097782|childbirth self-efficacy|childbirth self-efficacy
4983108|NCT04097782|mode of delivery|mode of delivery
4983118|NCT04097678|lumbar spine surgery|lumbar spine surgery
4983128|NCT04097613|Betadine|betadine
4983129|NCT04097613|Povidone Iodine|povidone iodine
4983130|NCT04097613|CRS|crs
4983131|NCT04097613|Biofilm|biofilm
4983132|NCT04097613|Recalcitrant|recalcitrant
4983133|NCT04097561|CD8 Counts|cd8 counts
4983134|NCT04097561|B-Cell Activating Factor (BAFF)|b-cell activating factor (baff)
4983135|NCT04097561|Heterogeneous Disorder|heterogeneous disorder
4983136|NCT04097561|Autoimmune Disease|autoimmune disease
4983137|NCT04097548|Pregnancy|pregnancy
4983138|NCT04097535|PET/MRI|pet/mri
4983139|NCT04097535|Fatty Acid Oxidation|fatty acid oxidation
4983140|NCT04097522|neurofeedback|neurofeedback
5903458|NCT00368446|Chronic Granulomatous Disease|chronic granulomatous disease
4983148|NCT04097444|Metastatic colorectal cancer|metastatic colorectal cancer
4983149|NCT04097444|bevacizumab|bevacizumab
4983150|NCT04097444|CAPOXIRI|capoxiri
4983151|NCT04097444|FOLFOXIRI|folfoxiri
4983152|NCT04097418|Multiple Sclerosis|multiple sclerosis
4983153|NCT04097418|Aerobic Training|aerobic training
4983154|NCT04097418|rehabilitation|rehabilitation
4983155|NCT04097379|Knee osteoarthritis|knee osteoarthritis
4983156|NCT04097379|Chondroanabolic drug|chondroanabolic drug
4983157|NCT04097379|Magnetic resonance imaging|magnetic resonance imaging
4983158|NCT04097379|Patient Reported Outcomes|patient reported outcomes
4983159|NCT04097379|Biosensors|biosensors
4983160|NCT04097353|Behavioral|behavioral
4983161|NCT04097353|Obesity|obesity
4983162|NCT04097353|Neoplasm|neoplasm
4983163|NCT04097327|Ectoin|ectoin
4983164|NCT04097327|Ectoin Dermatitis Cream|ectoin dermatitis cream
4983165|NCT04097327|Atopic dermatitis|atopic dermatitis
4983166|NCT04097314|Microvascular Angina|microvascular angina
4983167|NCT04097314|Angina|angina
4983168|NCT04097314|Endothelin|endothelin
4983169|NCT04097314|MVA|mva
4983170|NCT04097314|Impaired Exercise Intolerance|impaired exercise intolerance
4983171|NCT04097288|stress urinary incontinence|stress urinary incontinence
4983172|NCT04097288|pharmacologic treatment|pharmacologic treatment
4983173|NCT04097288|fecal incontinence|fecal incontinence
4983174|NCT04097249|Musculoskeletal pain|musculoskeletal pain
4983175|NCT04097249|Delayed Onset Muscle Soreness|delayed onset muscle soreness
4983176|NCT04097249|Pain sensitivity|pain sensitivity
4983177|NCT04097249|Infrared thermography|infrared thermography
4983178|NCT04097249|Referred pain|referred pain
4983179|NCT04097210|Q-CRP|q-crp
4983180|NCT04097210|lactate|lactate
4983181|NCT04097210|suPAR|supar
4983182|NCT04097210|POC|poc
4983183|NCT04097210|ambulance|ambulance
4983184|NCT04097197|Influenza Vaccines|influenza vaccines
4983185|NCT04097197|Influenza, Human|influenza, human
4983186|NCT04097197|Primary Health Care|primary health care
4983187|NCT04097119|HDL function|hdl function
4983188|NCT04097119|HDL dysfunction|hdl dysfunction
4983189|NCT04097119|nutritional supplement|nutritional supplement
4983190|NCT04097119|quality of life|quality of life
4983191|NCT04097119|dietary supplement|dietary supplement
4983192|NCT04097067|Lymphoma|lymphoma
4983193|NCT04097067|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
4983194|NCT04097067|Neoplasms by Histologic Type|neoplasms by histologic type
4983195|NCT04097067|Neoplasms|neoplasms
4983196|NCT04097067|Lymphoproliferative Disorders|lymphoproliferative disorders
4983200|NCT04097067|Lymphoma, B-Cell|lymphoma, b-cell
4983201|NCT04097067|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
4983202|NCT04097067|Lymphoma, follicular|lymphoma, follicular
4983203|NCT04097054|operative procedures|operative procedures
4983204|NCT04097054|intraoperative monitoring|intraoperative monitoring
4983205|NCT04097054|budgetary control|budgetary control
4983206|NCT04097015|Electrical Stimulation, Transcutaneous|electrical stimulation, transcutaneous
4983207|NCT04097015|Spinal Cord Injury|spinal cord injury
4983208|NCT04097015|Neutrophic Pain|neutrophic pain
4983209|NCT04097015|Functional Movements|functional movements
4983223|NCT04096937|Community-based participatory research|community-based participatory research
4983225|NCT04096924|Atrial septal defects|atrial septal defects
4983226|NCT04096924|amplatzer|amplatzer
4983227|NCT04096911|HPV vaccine|hpv vaccine
4983228|NCT04096911|PD-1 Monoclonal Antibody|pd-1 monoclonal antibody
4983239|NCT04096807|Atrial pressure|atrial pressure
4983240|NCT04096807|Left ventricle|left ventricle
4983241|NCT04096807|Left ventricular function|left ventricular function
4983242|NCT04096807|Left atrial function|left atrial function
4983243|NCT04096755|Deep Vein Thrombosis|deep vein thrombosis
4983244|NCT04096742|Skin|skin
4983245|NCT04096742|Chest|chest
4983246|NCT04096742|Photodamage|photodamage
4983247|NCT04096742|Sun Damage|sun damage
4983248|NCT04096729|commitment to treatment|commitment to treatment
4983249|NCT04096729|compression stockings|compression stockings
4983250|NCT04096729|varicose veins|varicose veins
4983251|NCT04096703|Idiopathic Esophagogastric Junction Outflow Obstruction|idiopathic esophagogastric junction outflow obstruction
4983252|NCT04096703|Esophageal Sphincter Function|esophageal sphincter function
4983253|NCT04096703|Esophagogastric Junction|esophagogastric junction
5401250|NCT01716299|HIV|hiv
4983254|NCT04096703|Pneumatic Dilation|pneumatic dilation
4983255|NCT04096690|Anti-PD-1 antibody|anti-pd-1 antibody
5703851|NCT00487851|Jaundice|jaundice
5027186|NCT03828760|IUD|iud
4983256|NCT04096690|Nasal Type Extranodal NK/T-Cell Lymphoma|nasal type extranodal nk/t-cell lymphoma
4983257|NCT04096690|Complete response rate|complete response rate
4983258|NCT04096690|Safety|safety
4983259|NCT04096677|post cesarean scar defect|post cesarean scar defect
4983260|NCT04096677|hysteroscopy|hysteroscopy
4983261|NCT04096677|transvaginal intervention|transvaginal intervention
4983262|NCT04096677|endometrial receptive|endometrial receptive
4983263|NCT04096664|bronchial clearance|bronchial clearance
4983264|NCT04096664|cystic fibrosis|cystic fibrosis
4983265|NCT04096651|progressive supranuclear palsy PSP|progressive supranuclear palsy psp
4983266|NCT04096651|atypical parkinsonism|atypical parkinsonism
4983267|NCT04096651|gait disorders|gait disorders
4983268|NCT04096651|neurophysiology|neurophysiology
4983269|NCT04096651|imaging|imaging
4983270|NCT04096625|Brain Stimulation, tDCS, Psychotherapy, Psychiatric Disorder|brain stimulation, tdcs, psychotherapy, psychiatric disorder
4983272|NCT04096534|partial nephrectomy|partial nephrectomy
4983273|NCT04096534|zero ischaemia|zero ischaemia
4983274|NCT04096534|renal function|renal function
4983275|NCT04096521|serum folic acid|serum folic acid
4983276|NCT04096521|genotyping|genotyping
4983277|NCT04096521|dna methylation of IGF2|dna methylation of igf2
4983278|NCT04096521|East Jakarta Cohort Study|east jakarta cohort study
4983279|NCT04096521|mother-children|mother-children
4983280|NCT04096482|Nasal endoscopy|nasal endoscopy
4983281|NCT04096469|breast cancer survivors|breast cancer survivors
4983282|NCT04096469|diet|diet
4983283|NCT04096469|physical activity|physical activity
4983284|NCT04096469|motivational interviewing|motivational interviewing
4983285|NCT04096469|body weight|body weight
4983286|NCT04096469|quality of life|quality of life
4983287|NCT04096469|biomarkers|biomarkers
4983288|NCT04096456|Gastropexy|gastropexy
4983289|NCT04096456|Endoscopic Gastropexy|endoscopic gastropexy
4983290|NCT04096456|Gastrostomy Tube|gastrostomy tube
4983291|NCT04096443|Fecal microbial transplant|fecal microbial transplant
4983292|NCT04096443|FMT|fmt
4983293|NCT04096443|Pilot study|pilot study
4983294|NCT04096391|Truncal Pain|truncal pain
4983295|NCT04096391|Lower Extremity Limb Pain|lower extremity limb pain
4983296|NCT04096391|Refractory Pain|refractory pain
4983297|NCT04096378|Racial Socialization|racial socialization
4983298|NCT04096378|Family Functioning|family functioning
4983299|NCT04096378|Stress and Coping|stress and coping
4983300|NCT04096365|Temporary|temporary
4983301|NCT04096365|Ventricular|ventricular
4983302|NCT04096365|Pacing|pacing
4983303|NCT04096352|Speech Therapy|speech therapy
4983304|NCT04096352|Virtual Reality|virtual reality
4983305|NCT04096352|Teacher's voice|teacher's voice
4983306|NCT04096352|Background Noise|background noise
4983307|NCT04096352|School Teachers|school teachers
4983308|NCT04096339|Colonoscopy|colonoscopy
4983319|NCT04096274|measurement based care|measurement based care
4987351|NCT04070196|Peritonitis|peritonitis
4983323|NCT04096274|leadership|leadership
4983324|NCT04096274|implementation science|implementation science
4983339|NCT04096144|sugammadex|sugammadex
4983340|NCT04096144|neostigmine|neostigmine
4983341|NCT04096144|neuromuscular reversal|neuromuscular reversal
4983342|NCT04096131|diabetic macular edema|diabetic macular edema
4983343|NCT04096131|cataract|cataract
4983344|NCT04096131|surgery|surgery
4983345|NCT04096118|Rectal cancer|rectal cancer
4983346|NCT04096118|Lymph node after neoadjuvant rectal cancer|lymph node after neoadjuvant rectal cancer
4983347|NCT04096105|Healthy subjects|healthy subjects
4983348|NCT04096105|CC-93538|cc-93538
4983349|NCT04096105|Japanese PK bridging|japanese pk bridging
4983350|NCT04096092|Teicoplanin|teicoplanin
4983351|NCT04096092|Pharmacokinetics|pharmacokinetics
4983352|NCT04096092|Critically ill|critically ill
4983353|NCT04096079|Out-Of-Hospital Cardiac Arrest, STEMI, coronary angiography, post-ROSC ECG|out-of-hospital cardiac arrest, stemi, coronary angiography, post-rosc ecg
4983354|NCT04096066|Multiple Myeloma|multiple myeloma
4983355|NCT04096066|AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE|autologous stem cell transplantation ineligible
4983356|NCT04096066|Proteasome inhibitor|proteasome inhibitor
4983357|NCT04096066|Immunomodulating agents|immunomodulating agents
4983358|NCT04095988|Allogeneic microbiota reconstitution|allogeneic microbiota reconstitution
4983359|NCT04095988|diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
4983360|NCT04095988|microbiome|microbiome
4983361|NCT04095962|Active Ageing|active ageing
4983362|NCT04095962|Exercise|exercise
4983363|NCT04095962|Health|health
4983364|NCT04095936|aplastic anemia|aplastic anemia
4983365|NCT04095936|romiplostim|romiplostim
4983366|NCT04095923|Physical activity|physical activity
4983367|NCT04095923|Social media|social media
4983368|NCT04095923|Wearable|wearable
5903459|NCT00368446|Mycobacterial Infection|mycobacterial infection
4983369|NCT04095923|Intrinsic motivation|intrinsic motivation
4983370|NCT04095923|Game|game
4983371|NCT04095923|Women's health|women's health
4983373|NCT04095910|Obesity|obesity
4983374|NCT04095910|Childhood|childhood
4983375|NCT04095910|School-based Program|school-based program
4983376|NCT04095910|Lifestyle|lifestyle
4983377|NCT04095910|Nutrition Education|nutrition education
4983378|NCT04095897|PMPS|pmps
4983379|NCT04095897|Pecs II|pecs ii
4983380|NCT04095897|Pectoral Nerve Block|pectoral nerve block
4983381|NCT04095897|CPSP|cpsp
4983382|NCT04095871|Intermittent urethral catheterization|intermittent urethral catheterization
4983383|NCT04095871|Treatment adherence and compliance|treatment adherence and compliance
4983384|NCT04095871|Lower urinary tract symptoms|lower urinary tract symptoms
4983385|NCT04095871|Urinary retention|urinary retention
4983386|NCT04095871|Patient satisfaction|patient satisfaction
4983387|NCT04095845|total hip arthroplasty|total hip arthroplasty
4983388|NCT04095845|total hip replacement|total hip replacement
4983389|NCT04095845|implant position|implant position
4983390|NCT04095845|computerised tomography|computerised tomography
4983391|NCT04095845|makoplasty|makoplasty
4983392|NCT04095845|robotic surgery|robotic surgery
4983393|NCT04095793|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
4983394|NCT04095793|snOH|snoh
4983395|NCT04095793|multiple symptom atrophy|multiple symptom atrophy
4983397|NCT04095793|Parkinson's disease|parkinson's disease
4983399|NCT04095793|pure autonomic failure|pure autonomic failure
4983400|NCT04095793|PAF|paf
4983401|NCT04095793|orthostatic hypotension|orthostatic hypotension
4983402|NCT04095793|OH|oh
4983403|NCT04095793|ampreloxetine|ampreloxetine
4983404|NCT04095793|171|171
4983405|NCT04095793|low blood pressure|low blood pressure
4983406|NCT04095793|dizziness|dizziness
4983407|NCT04095793|fainting|fainting
4983412|NCT04095793|OAK|oak
4983413|NCT04095780|Oral opportunistic pathogens|oral opportunistic pathogens
4983414|NCT04095780|Oral health promotion|oral health promotion
4983415|NCT04095780|Pneumonia complicating stroke|pneumonia complicating stroke
4983416|NCT04095780|Metagenome|metagenome
4983417|NCT04095767|Thrombectomy|thrombectomy
4983418|NCT04095728|Cognition|cognition
4983419|NCT04095728|Healthy|healthy
4983420|NCT04095728|Brain Octane Oil|brain octane oil
4983421|NCT04095728|Caprylic acid triglycerides|caprylic acid triglycerides
4983422|NCT04095728|Physical performance|physical performance
4983423|NCT04095715|Dense platelet granules|dense platelet granules
4983424|NCT04095715|Thrombopathy|thrombopathy
4983425|NCT04095715|Hemorrhagic symptomatology|hemorrhagic symptomatology
5023696|NCT03849521|MR|mr
4983426|NCT04095689|triple negative breast cancer, neoadjuvant, pembrolizumab|triple negative breast cancer, neoadjuvant, pembrolizumab
4983427|NCT04095637|alignment|alignment
4983428|NCT04095637|computer navigation|computer navigation
4983432|NCT04095637|unicondylar knee replacement|unicondylar knee replacement
4983434|NCT04095611|Hip fracture|hip fracture
4983438|NCT04095598|Syndesmotic instability|syndesmotic instability
4983439|NCT04095598|Computed Tomography|computed tomography
4983440|NCT04095598|Stress maneuver|stress maneuver
4983441|NCT04095585|Williams Beuren Syndrome|williams beuren syndrome
4983442|NCT04095585|Autism Spectrum Disorder|autism spectrum disorder
4983443|NCT04095572|Hyaluronic acid (HA)|hyaluronic acid (ha)
4983444|NCT04095572|Chondroitin sulphate (CS)|chondroitin sulphate (cs)
4983445|NCT04095572|antimicrobial resistance rates|antimicrobial resistance rates
4983446|NCT04095572|Intravesical instillation|intravesical instillation
4983447|NCT04095572|HA-CS instillations|ha-cs instillations
4983448|NCT04095572|Recurrent Urinary Tract Infection (rUTI)|recurrent urinary tract infection (ruti)
4983449|NCT04095559|left atrial (LA) substrate-based ablation|left atrial (la) substrate-based ablation
4983450|NCT04095559|focal ablation catheter|focal ablation catheter
4983451|NCT04095559|bipolar voltage amplitude|bipolar voltage amplitude
4983452|NCT04095559|micro-electrode catheter|micro-electrode catheter
4983453|NCT04095559|IntellaMap Orion|intellamap orion
4983454|NCT04095559|IntellaNav MIFI OI|intellanav mifi oi
4983455|NCT04095559|bipolar voltage maps|bipolar voltage maps
4983456|NCT04095559|irrigated-tip ablation catheter|irrigated-tip ablation catheter
4983457|NCT04095559|ring-electrode circular mapping catheter|ring-electrode circular mapping catheter
4983458|NCT04095559|microelectrode multipolar catheter|microelectrode multipolar catheter
4983459|NCT04095546|epigenetic changes|epigenetic changes
4983460|NCT04095546|Psychotherapy|psychotherapy
4983461|NCT04095546|epigenetic regulation|epigenetic regulation
4983462|NCT04095546|methylation patterns|methylation patterns
4983463|NCT04095546|change in methylation of genes|change in methylation of genes
4983464|NCT04095546|FKBP5 gene|fkbp5 gene
5703852|NCT00487851|obstruction|obstruction
4983465|NCT04095533|critical care|critical care
4983466|NCT04095494|EMONO|emono
4983467|NCT04095494|Health students|health students
4983468|NCT04095468|rectal cancer|rectal cancer
4983469|NCT04095468|preoperative radiotherapy|preoperative radiotherapy
4983470|NCT04095468|organ preservation|organ preservation
4983471|NCT04095468|watch-and-wait|watch-and-wait
4983472|NCT04095442|muscle power|muscle power
4983473|NCT04095442|nitric oxide|nitric oxide
4983474|NCT04095442|muscle speed|muscle speed
4983475|NCT04095442|oral microbiome|oral microbiome
4983476|NCT04095416|Compression wraps|compression wraps
4983477|NCT04095416|heart failure|heart failure
4983478|NCT04095416|systolic|systolic
4983479|NCT04095416|edema|edema
4983480|NCT04095416|wrap|wrap
4983481|NCT04095403|Heat|heat
4983482|NCT04095403|Cooling|cooling
4983483|NCT04095338|hip fracture|hip fracture
4983484|NCT04095338|rehabilitation|rehabilitation
4983485|NCT04095338|robotics|robotics
4983486|NCT04095286|Ambrisentan|ambrisentan
4983487|NCT04095286|Oral dosage forms|oral dosage forms
4983488|NCT04095286|Pulmonary arterial hypertension|pulmonary arterial hypertension
4983489|NCT04095286|Bioavailability|bioavailability
4983492|NCT04095234|acupuncture|acupuncture
4983493|NCT04095234|massage|massage
4983494|NCT04095234|IMPACT|impact
4983495|NCT04095234|19-341|19-341
4983496|NCT04095221|Prexasertib|prexasertib
4983497|NCT04095221|Irinotecan|irinotecan
4983498|NCT04095221|Temozolomide|temozolomide
4983499|NCT04095221|19-120|19-120
4983500|NCT04095208|soft-tissue sarcoma|soft-tissue sarcoma
4983501|NCT04095208|tertiary lymphoid structure|tertiary lymphoid structure
4983509|NCT04095195|Surveillance pancreatic cancer|surveillance pancreatic cancer
4983510|NCT04095156|Membranous nephropathy|membranous nephropathy
4983512|NCT04095156|Anti-PLA2R|anti-pla2r
4983513|NCT04095156|Anti-CD20 antibodies|anti-cd20 antibodies
4983514|NCT04095143|Point-Of-Care ultrasound|point-of-care ultrasound
4983515|NCT04095143|Doppler|doppler
4983516|NCT04095143|Major adverse kidney events|major adverse kidney events
4983517|NCT04095143|Portal flow pulsatility|portal flow pulsatility
4983518|NCT04095143|IVC ultrasound|ivc ultrasound
4983519|NCT04095143|Cardiac ultrasound|cardiac ultrasound
4983520|NCT04095143|Right ventricular failure|right ventricular failure
4983521|NCT04095143|Intensive care|intensive care
4983522|NCT04095130|Psoriasis|psoriasis
4983523|NCT04095130|Sodium|sodium
4983524|NCT04095130|Skin|skin
4983529|NCT04095091|Radiotherapy|radiotherapy
4983530|NCT04095078|bronchial clearance|bronchial clearance
4983531|NCT04095078|cystic fibrosis|cystic fibrosis
4983532|NCT04095065|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
5000692|NCT03990987|dexmedetomidine|dexmedetomidine
4983538|NCT04095026|Seizures|seizures
4983539|NCT04095026|Surgery|surgery
5023835|NCT03848858|HIV|hiv
4983540|NCT04095013|Elective low segment caesarean section|elective low segment caesarean section
4983541|NCT04095013|Intrathecal|intrathecal
4987557|NCT04069182|Anxiety|anxiety
4983555|NCT04094935|Fracture of the radius|fracture of the radius
4983556|NCT04094922|Posttraumatic Stress|posttraumatic stress
4983557|NCT04094909|rh-endostatin|rh-endostatin
4983558|NCT04094909|Pembrolizumab|pembrolizumab
4983559|NCT04094909|NSCLC|nsclc
4983560|NCT04094909|Chemotherapy|chemotherapy
4983561|NCT04094896|Neoadjuvant Treatment|neoadjuvant treatment
4983562|NCT04094896|HER2-Positive Breast Cancer|her2-positive breast cancer
4983563|NCT04094883|Neisseria gonorrhoeae|neisseria gonorrhoeae
4983564|NCT04094883|Cross-reactive|cross-reactive
4983565|NCT04094883|Immune|immune
4983566|NCT04094883|Responses|responses
4983567|NCT04094883|Neisseria meningitidis|neisseria meningitidis
4983569|NCT04094870|perinatal depression|perinatal depression
4983570|NCT04094870|HIV|hiv
4983571|NCT04094870|Antiretroviral Treatment|antiretroviral treatment
4983572|NCT04094870|Interpersonal psychotherapy|interpersonal psychotherapy
4983573|NCT04094857|therapeutic temperature management; therapeutic hypothermia|therapeutic temperature management; therapeutic hypothermia
4983574|NCT04094844|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
4983575|NCT04094844|Mobile Health Technology|mobile health technology
4983576|NCT04094818|Infection|infection
4983577|NCT04094818|mRNA|mrna
4983578|NCT04094818|Procalcitonin|procalcitonin
4983579|NCT04094818|C-Reactive Protein|c-reactive protein
4983580|NCT04094818|Lactate|lactate
4983581|NCT04094792|heart rate variability|heart rate variability
4983582|NCT04094792|autonomic function|autonomic function
4983583|NCT04094792|biofeedback|biofeedback
4983584|NCT04094792|mobile health|mobile health
4983585|NCT04094779|Agitation|agitation
4983586|NCT04094779|Flash activity|flash activity
4983587|NCT04094779|Breath of fresh air|breath of fresh air
4983588|NCT04094766|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
4983589|NCT04094766|CD19 and CD22|cd19 and cd22
4983590|NCT04094727|malaria|malaria
4983591|NCT04094727|Namibia|namibia
4983592|NCT04094675|PTEN|pten
4983593|NCT04094675|Cowden syndrome|cowden syndrome
4983594|NCT04094675|PHTS|phts
4983595|NCT04094675|Colon polyposis|colon polyposis
4983596|NCT04094675|sirolimus|sirolimus
4983597|NCT04094675|Rapamycin|rapamycin
4983598|NCT04094675|mTOR inhibitor|mtor inhibitor
4983599|NCT04094636|Physical training|physical training
4983600|NCT04094610|ALK|alk
4983601|NCT04094610|ROS1|ros1
4983602|NCT04094610|NTRK1-3|ntrk1-3
4983609|NCT04094610|glioblastoma|glioblastoma
4983610|NCT04094610|soft tissue schwannoma|soft tissue schwannoma
4983611|NCT04094610|solitary fibrous tumor|solitary fibrous tumor
4983612|NCT04094610|glioma|glioma
4983613|NCT04094610|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
4983614|NCT04094610|pediatric|pediatric
4983615|NCT04094597|lactoferrin|lactoferrin
4983616|NCT04094584|Emergency Department|emergency department
4983617|NCT04094584|Naltrexone|naltrexone
4983618|NCT04094571|functional electrical stimulation|functional electrical stimulation
4983619|NCT04094571|rehabilitation|rehabilitation
4983620|NCT04094545|Biomarker|biomarker
4983621|NCT04094545|nasopharyngeal carcinoma|nasopharyngeal carcinoma
4983622|NCT04094545|familial|familial
4983623|NCT04094545|sporadic|sporadic
4983624|NCT04094545|intestinal flora|intestinal flora
4983628|NCT04094506|safety|safety
4983629|NCT04094506|ASP1948|asp1948
4983630|NCT04094506|pharmacokinetics|pharmacokinetics
4983631|NCT04094493|thyroid - thyroidectomy - hypocalcemia - Vit D administiration|thyroid - thyroidectomy - hypocalcemia - vit d administiration
4983632|NCT04094454|female patients|female patients
4983633|NCT04094454|quality of life|quality of life
4983634|NCT04094454|vaginal dilator|vaginal dilator
4983635|NCT04094454|vaginal fibrosis|vaginal fibrosis
4983636|NCT04094428|burden|burden
4983637|NCT04094428|mortality|mortality
4983638|NCT04094428|end-of-life care|end-of-life care
4983639|NCT04094428|intensive care unit|intensive care unit
4983640|NCT04094428|critically ill patient|critically ill patient
4983641|NCT04094428|frailty|frailty
4983652|NCT04094350|Mass screening|mass screening
4987739|NCT04067921|Polymorphisms|polymorphisms
4983653|NCT04094350|Referral and consultation|referral and consultation
4983655|NCT04094337|non-cardiac chest pain|non-cardiac chest pain
4983656|NCT04094337|NCCP|nccp
4983657|NCT04094337|anxiety|anxiety
4983658|NCT04094337|internet-assisted treatment|internet-assisted treatment
4983659|NCT04094324|Mental health, pediatric medicine, obesity, IBD|mental health, pediatric medicine, obesity, ibd
4983660|NCT04094311|out of specification|out of specification
4983661|NCT04094311|tisagenlecleucel|tisagenlecleucel
4983662|NCT04094311|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4983663|NCT04094311|large B-cell lymphoma|large b-cell lymphoma
4983664|NCT04094311|relapsed/refractory|relapsed/refractory
4983665|NCT04094311|pediatric|pediatric
4983666|NCT04094311|young adult patients|young adult patients
4983667|NCT04094233|Beetroot|beetroot
4983668|NCT04094233|Heart rate variability|heart rate variability
4983669|NCT04094233|Blood pressure|blood pressure
4983670|NCT04094233|Strenght Exercise|strenght exercise
4983671|NCT04094220|indirect decompression|indirect decompression
4983672|NCT04094220|lateral interbody fusion|lateral interbody fusion
4983673|NCT04094220|lumbar|lumbar
4983674|NCT04094220|direct decompression|direct decompression
4983675|NCT04094194|Nordic diet|nordic diet
4983676|NCT04094194|Cardiometabolic risk factors|cardiometabolic risk factors
4983677|NCT04094194|Mortality|mortality
4983678|NCT04094194|Cardiovascular diseases|cardiovascular diseases
4983679|NCT04094194|Type 2 diabetes|type 2 diabetes
4983680|NCT04094194|Hypertension|hypertension
4983681|NCT04094194|Systematic review and meta-analysis|systematic review and meta-analysis
4983682|NCT04094194|Randomized controlled trials|randomized controlled trials
4983683|NCT04094194|Prospective cohort studies|prospective cohort studies
4983684|NCT04094168|Del Nido Cardioplegia|del nido cardioplegia
4983685|NCT04094168|Cardioplegia|cardioplegia
4983686|NCT04094168|Adult Cardiac Surgery|adult cardiac surgery
4983687|NCT04094168|Myocardial protection|myocardial protection
4983688|NCT04094168|Heart surgery|heart surgery
4983689|NCT04094129|Alzheimer's disease|alzheimer's disease
4983690|NCT04094129|Dementia|dementia
4983691|NCT04094129|Intestinal microbiota|intestinal microbiota
4983692|NCT04094129|Chronic inflammation|chronic inflammation
4983693|NCT04094129|Probiotics|probiotics
4983694|NCT04094077|Stereotactic Radiation|stereotactic radiation
4983695|NCT04094077|Nanoparticles|nanoparticles
4983715|NCT04093934|Early childhood development|early childhood development
4983716|NCT04093934|Psychosociaal stimulation|psychosociaal stimulation
4983717|NCT04093934|Bayley test|bayley test
4983718|NCT04093934|Bangladesh|bangladesh
4983719|NCT04093934|Undernutrition|undernutrition
4983720|NCT04093934|Stepped wedge design|stepped wedge design
4983721|NCT04093934|Cluster randomized controlled trial|cluster randomized controlled trial
4983722|NCT04093921|chronic pain|chronic pain
4983723|NCT04093921|pediatric|pediatric
4983729|NCT04093895|Periodontitis|periodontitis
4983730|NCT04093895|taurolidine|taurolidine
4983731|NCT04093895|PerioSept|periosept
4983732|NCT04093856|Advanced glycation end products|advanced glycation end products
4983733|NCT04093856|Advanced imaging|advanced imaging
4983734|NCT04093856|Mobility|mobility
4983735|NCT04093856|Strength|strength
4983736|NCT04093830|Hearing Loss|hearing loss
4983737|NCT04093791|postpartum|postpartum
4983738|NCT04093791|stress|stress
4983739|NCT04093791|depression|depression
4983740|NCT04093791|self efficacy|self efficacy
4983741|NCT04093791|Mother-Infant Relations|mother-infant relations
4983742|NCT04093765|Ultrasensitive Rapid Diagnostic Test|ultrasensitive rapid diagnostic test
5306947|NCT02143791|SCS|scs
4983743|NCT04093765|Mass Screening and Treatment|mass screening and treatment
4983744|NCT04093765|Greater Mekong Subregion|greater mekong subregion
4983745|NCT04093765|Malaria Elimination Task Force|malaria elimination task force
4983747|NCT04093713|Anaesthesia|anaesthesia
4983748|NCT04093713|Technique|technique
4983749|NCT04093713|extraoral|extraoral
4983750|NCT04093713|Landmarks|landmarks
4983751|NCT04093687|Colorectal Cancer Screening|colorectal cancer screening
4983752|NCT04093687|Screening Colonoscopy|screening colonoscopy
4983757|NCT04093674|patient outcome assessment|patient outcome assessment
4983758|NCT04093648|Hepatocellular Carcinoma|hepatocellular carcinoma
4983759|NCT04093648|Hepatoblastoma|hepatoblastoma
4983760|NCT04093648|GPC3-CAR T cells|gpc3-car t cells
4983761|NCT04093583|exodontia|exodontia
4983762|NCT04093583|PRGF|prgf
4983763|NCT04093583|alveolar ridge preservation|alveolar ridge preservation
4983764|NCT04093570|cedazuridine|cedazuridine
4983765|NCT04093570|decitabine|decitabine
4983767|NCT04093570|CMML|cmml
4983768|NCT04093570|AML|aml
4983769|NCT04093570|myelodysplastic syndromes|myelodysplastic syndromes
4983770|NCT04093570|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4983771|NCT04093570|acute myeloid leukemia|acute myeloid leukemia
4983772|NCT04093570|ASTX727|astx727
4983773|NCT04093557|colonoscopy|colonoscopy
4983774|NCT04093557|bowel prep|bowel prep
4983775|NCT04093557|screening|screening
4983776|NCT04093544|deep brain stimulation|deep brain stimulation
4983777|NCT04093531|primary sjogren syndrome|primary sjogren syndrome
4983778|NCT04093531|PSS|pss
4983779|NCT04093531|SjS|sjs
4980540|NCT04114500|IVF|ivf
4983796|NCT04093440|cardiometabolic clinic|cardiometabolic clinic
4983800|NCT04093388|Pap smear|pap smear
4983801|NCT04093388|Papanicolaou|papanicolaou
4984294|NCT04090268|balance|balance
4983805|NCT04093362|Advanced Cholangiocarcinoma|advanced cholangiocarcinoma
4983807|NCT04093362|Fusion|fusion
4983808|NCT04093362|Rearrangement|rearrangement
4983809|NCT04093362|TAS-120|tas-120
4983810|NCT04093336|Acute cerebral infarction ,Mesenchymal Stem Cells,prognosis|acute cerebral infarction ,mesenchymal stem cells,prognosis
4983811|NCT04093310|incision-drainage|incision-drainage
4983812|NCT04093310|Bartholin's abscess|bartholin's abscess
4983813|NCT04093310|Word catheter|word catheter
4983814|NCT04093310|Marsupialization|marsupialization
4983815|NCT04093310|Cost-utility analysis|cost-utility analysis
4983816|NCT04093284|Needle-free jet injection|needle-free jet injection
4983817|NCT04093284|Insulin glargine|insulin glargine
4983818|NCT04093284|Flash Glucose Monitoring|flash glucose monitoring
4983819|NCT04093271|Sleep|sleep
4983820|NCT04093271|Healthy|healthy
4983821|NCT04093271|Rest-ZZZ|rest-zzz
4983822|NCT04093271|randomized controlled trial|randomized controlled trial
4983823|NCT04093271|RCT|rct
4983824|NCT04093271|dietary supplement|dietary supplement
4983825|NCT04093271|natural health product|natural health product
4983826|NCT04093245|Emergency Department|emergency department
4983827|NCT04093245|Care Transition|care transition
4983828|NCT04093245|Elderly Frailty|elderly frailty
4983829|NCT04093219|Acetaminophen|acetaminophen
5704053|NCT00487305|K562|k562
4983830|NCT04093219|Postoperative|postoperative
4983831|NCT04093219|Delirium|delirium
4983832|NCT04093219|Cardiac Surgery|cardiac surgery
4983833|NCT04093193|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
4983834|NCT04093180|Rehabilitation|rehabilitation
4983835|NCT04093180|Motor skills|motor skills
4983836|NCT04093180|Activities of Daily living|activities of daily living
4983837|NCT04093141|locally advances pancreatic cancer|locally advances pancreatic cancer
4983838|NCT04093141|irreversible electroporation|irreversible electroporation
4983839|NCT04093141|nanoknife|nanoknife
4983840|NCT04093141|phase II|phase ii
4983841|NCT04093141|efficacy|efficacy
4983842|NCT04093128|herbal tea|herbal tea
4983843|NCT04093128|infusion|infusion
4983844|NCT04093128|carob|carob
4983845|NCT04093128|green tea|green tea
4983846|NCT04093128|anise|anise
4983847|NCT04093128|insulin resistance|insulin resistance
4983848|NCT04093128|inflammation|inflammation
4983849|NCT04093128|health|health
4983850|NCT04093128|lipid profile|lipid profile
4983851|NCT04093128|manuka honey|manuka honey
4983853|NCT04093063|microsurgery|microsurgery
4983854|NCT04093063|ophthalmology|ophthalmology
4983855|NCT04093063|medical education|medical education
4983856|NCT04093063|surgical skills|surgical skills
4983857|NCT04093063|surgical practice|surgical practice
4983858|NCT04093037|Dry eye|dry eye
4983859|NCT04093037|LacryDiag|lacrydiag
4983860|NCT04093037|Fluorescein|fluorescein
4983861|NCT04093037|Break-Up Time (BUT)|break-up time (but)
4983862|NCT04093037|Schirmer test|schirmer test
4983863|NCT04093037|Lacrimal film|lacrimal film
4983864|NCT04093037|Oxford score|oxford score
4983865|NCT04093037|Meibomian Gland|meibomian gland
4983869|NCT04092985|Cardiovascular App|cardiovascular app
4983870|NCT04092985|Rhythm monitoring|rhythm monitoring
4983871|NCT04092959|Hypertension|hypertension
5369128|NCT01861210|Homosexuality, Male|homosexuality, male
4983872|NCT04092959|Hypertension Complicated With Type 2 Diabetes|hypertension complicated with type 2 diabetes
4983873|NCT04092959|Walking|walking
4983874|NCT04092959|Chinese Square Dancing|chinese square dancing
4983875|NCT04092946|Home-based rehabilitation|home-based rehabilitation
4983876|NCT04092946|Biofeedback|biofeedback
4983877|NCT04092946|Telerehabilitation|telerehabilitation
4983878|NCT04092933|machine learning|machine learning
4983879|NCT04092933|decision support|decision support
4983880|NCT04092933|risk calculator|risk calculator
4983881|NCT04092933|anesthesia|anesthesia
4983886|NCT04092881|Striae Distensae|striae distensae
4983887|NCT04092881|Striae; Albicantes|striae; albicantes
4983888|NCT04092881|Striae Alba|striae alba
4983889|NCT04092881|Nd-YAG Laser|nd-yag laser
4983890|NCT04092881|Fractional CO2 Laser|fractional co2 laser
4983891|NCT04092881|High Frequency Skin Ultrasound|high frequency skin ultrasound
4983892|NCT04092881|Short Pulsed Nd-YAG|short pulsed nd-yag
4983893|NCT04092881|Carbon Dioxide Laser|carbon dioxide laser
4983894|NCT04092881|Neodymium-Doped Yttrium Aluminum Garnet Laser|neodymium-doped yttrium aluminum garnet laser
4983895|NCT04092855|Right Ventricular Pressure Waveform|right ventricular pressure waveform
4983918|NCT04092751|Healthy Subjects|healthy subjects
4983919|NCT04092751|Pharmacokinetics|pharmacokinetics
4983920|NCT04092738|mHealth|mhealth
4983921|NCT04092738|Physical Activity|physical activity
4983922|NCT04092738|Glucose, Blood|glucose, blood
4983923|NCT04092738|Glycated Hemoglobin A1c|glycated hemoglobin a1c
4983924|NCT04092738|Health-Related Quality Of Life|health-related quality of life
4983925|NCT04092738|Quality of Life|quality of life
4983926|NCT04092738|Triglycerides|triglycerides
4983927|NCT04092738|HDL Cholesterol|hdl cholesterol
4983928|NCT04092738|LDL Cholesterol|ldl cholesterol
4983929|NCT04092738|Blood Pressure, Arterial|blood pressure, arterial
4983930|NCT04092738|Presenteeism|presenteeism
4983931|NCT04092738|Sitting time|sitting time
4983932|NCT04092738|Sedentary Behaviour|sedentary behaviour
4983933|NCT04092738|Workplace|workplace
4983934|NCT04092725|SCY-078|scy-078
4983935|NCT04092725|Dabigatran|dabigatran
4983936|NCT04092725|Ibrexafungerp|ibrexafungerp
4983937|NCT04092725|Pharmacokinetics|pharmacokinetics
4983938|NCT04092725|Healthy Subjects|healthy subjects
4983939|NCT04092712|Mass Balance|mass balance
4983940|NCT04092712|Radiolabeled|radiolabeled
4983941|NCT04092712|Pharmacokinetics|pharmacokinetics
4983942|NCT04092699|CBCT|cbct
4983943|NCT04092699|maxillary sinus|maxillary sinus
4983944|NCT04092699|segmentation|segmentation
4983947|NCT04092647|ashwagandha|ashwagandha
4983948|NCT04092647|cognitive dysfunction|cognitive dysfunction
4983949|NCT04092647|breast cancer chemotherapy|breast cancer chemotherapy
4983950|NCT04092621|new onsent atrial fibrillation|new onsent atrial fibrillation
4983951|NCT04092621|sepsis|sepsis
4983952|NCT04092621|critical care|critical care
4983953|NCT04092621|direct current cardioversion|direct current cardioversion
4983954|NCT04092621|atrial fibrillation treatment|atrial fibrillation treatment
4983955|NCT04092595|pharmacokinetics (PK)|pharmacokinetics (pk)
4983956|NCT04092569|Pre-medical Consultation self-care education|pre-medical consultation self-care education
4983957|NCT04092569|Glycemic control|glycemic control
4983958|NCT04092556|Multiple System Atrophy|multiple system atrophy
4983959|NCT04092556|Cerebellar Ataxia|cerebellar ataxia
4983960|NCT04092556|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4983961|NCT04092543|CT-DRAGON score|ct-dragon score
4983962|NCT04092517|phytochemicals|phytochemicals
4983963|NCT04092517|systemic circulation|systemic circulation
4983964|NCT04092491|IgA nephropathy|iga nephropathy
4983965|NCT04092465|NSCLC|nsclc
4983966|NCT04092465|Locally Advanced NSCLC|locally advanced nsclc
4983967|NCT04092465|Induction treatment|induction treatment
4983968|NCT04092465|Induction chemotherapy|induction chemotherapy
5001089|NCT03988634|NYHA|nyha
4983979|NCT04092387|Compensatory Smoking|compensatory smoking
4983980|NCT04092387|Nicotine Dependence|nicotine dependence
4983981|NCT04092387|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
4983982|NCT04092387|Tobacco Withdrawal|tobacco withdrawal
4983983|NCT04092387|Women|women
4983984|NCT04092387|Health Disparities|health disparities
4983985|NCT04092387|Vulnerable Populations|vulnerable populations
4983986|NCT04092387|E-Cigarettes|e-cigarettes
4983987|NCT04092322|stroke|stroke
4983988|NCT04092322|physical activity|physical activity
4983989|NCT04092322|accelerometer|accelerometer
4983990|NCT04092322|physical activity scale for elderly|physical activity scale for elderly
4983991|NCT04092309|Cardio-oncology|cardio-oncology
4983992|NCT04092257|Visual inspection with acetic acid (VIA)|visual inspection with acetic acid (via)
4983994|NCT04092218|parenting style|parenting style
4984010|NCT04092127|Screening for Retinopathy of Prematurity|screening for retinopathy of prematurity
4984011|NCT04092114|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
4984012|NCT04092114|HIV prevention|hiv prevention
4984013|NCT04092114|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
4984014|NCT04092101|Biomarkers of Exposure|biomarkers of exposure
4984015|NCT04092101|Compensatory Smoking|compensatory smoking
4984016|NCT04092101|Nicotine Dependence|nicotine dependence
5369129|NCT01861197|Efficacy|efficacy
5294127|NCT02205242|Acute exacerbation|acute exacerbation
4984017|NCT04092101|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
4984018|NCT04092101|Affective Disorders|affective disorders
4984019|NCT04092101|Tobacco Withdrawal|tobacco withdrawal
4984020|NCT04092101|Vulnerable Populations|vulnerable populations
4984021|NCT04092101|E-Cigarettes|e-cigarettes
4984022|NCT04092088|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4984023|NCT04092088|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
4984024|NCT04092088|analgesic effect|analgesic effect
4984025|NCT04092088|functional disability|functional disability
4984026|NCT04092010|Stepped care intervention|stepped care intervention
4984027|NCT04092010|Problem solving education|problem solving education
4984028|NCT04092010|Engagement session|engagement session
4984029|NCT04092010|Head Start|head start
4984030|NCT04092010|Preschool children|preschool children
5342908|NCT01981538|Web-Based Survey|web-based survey
4984031|NCT04091997|Macrophage migration inhibitory factor|macrophage migration inhibitory factor
4984032|NCT04091997|Endometriosis|endometriosis
4984033|NCT04091997|Laparoscopy|laparoscopy
4984035|NCT04091958|Breast conserving surgery|breast conserving surgery
4984036|NCT04091958|Pectoralis major muscle|pectoralis major muscle
4984037|NCT04091932|PD-1 inhibitor|pd-1 inhibitor
4984038|NCT04091932|Pembrolizumab|pembrolizumab
4984039|NCT04091932|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
4984041|NCT04091919|Left and right ventricular global longitudinal strain|left and right ventricular global longitudinal strain
4984042|NCT04091919|ASD device closure|asd device closure
4984043|NCT04091880|EV71 vaccine|ev71 vaccine
4984044|NCT04091880|influenza vaccine|influenza vaccine
4984045|NCT04091880|simultaneously administration|simultaneously administration
4984046|NCT04091854|Glucokinase Activator|glucokinase activator
4984047|NCT04091854|Glucose control|glucose control
4984048|NCT04091841|Protein supplement|protein supplement
4984049|NCT04091841|Protein diet|protein diet
4984050|NCT04091841|Vertebral fusion|vertebral fusion
4984051|NCT04091841|Enhanced recovery after surgery|enhanced recovery after surgery
4984052|NCT04091841|Infection|infection
4984053|NCT04091841|Wound healing|wound healing
4984054|NCT04091841|Pain|pain
4984055|NCT04091815|Enhanced recovery|enhanced recovery
4984056|NCT04091815|Multimodal analgesia|multimodal analgesia
4984057|NCT04091815|Quality of life|quality of life
4984058|NCT04091802|interdental papilla reconstruction|interdental papilla reconstruction
4984059|NCT04091802|Leucocyte-Platelet Rich Fibrin (L-PRF)|leucocyte-platelet rich fibrin (l-prf)
4984060|NCT04091789|Pain Associated with Dysmenorrhea|pain associated with dysmenorrhea
4984061|NCT04091789|CBD|cbd
4984062|NCT04091789|Cannabidiol|cannabidiol
4984063|NCT04091763|Sclerotherapy|sclerotherapy
4984064|NCT04091763|Rubber band ligation|rubber band ligation
4984065|NCT04091763|Polidocanol foam|polidocanol foam
4984066|NCT04091763|Hemorrhoidal disease|hemorrhoidal disease
4984067|NCT04091750|melanoma|melanoma
4984068|NCT04091698|co enzymeQ10 - Antioxidant- Corticosteroids|co enzymeq10 - antioxidant- corticosteroids
4984069|NCT04091607|lumbar medial branch block|lumbar medial branch block
4984070|NCT04091607|chronic back pain|chronic back pain
4984076|NCT04091542|breath hold|breath hold
4984077|NCT04091542|hyperventilation|hyperventilation
4984078|NCT04091542|oxygenation|oxygenation
4984079|NCT04091516|weight loss|weight loss
4984080|NCT04091516|body composition|body composition
4984082|NCT04091516|hemoglobin A1c|hemoglobin a1c
4984083|NCT04091516|blood pressure|blood pressure
4984085|NCT04091503|Temozolomide|temozolomide
4984086|NCT04091503|Intranasal Administration|intranasal administration
4984087|NCT04091503|Nasal Spray|nasal spray
4984088|NCT04091503|Intranasal Modified Temozolomide|intranasal modified temozolomide
4984089|NCT04091477|Anorexia nervosa|anorexia nervosa
4984090|NCT04091477|Bulimia|bulimia
4984091|NCT04091477|Binge eating disorders|binge eating disorders
4984295|NCT04090268|flexibility|flexibility
4984101|NCT04091438|Drug therapy|drug therapy
4984102|NCT04091425|Drug therapy|drug therapy
4984103|NCT04091399|first-man-study|first-man-study
4984104|NCT04091399|alveolitis sicca dolorosa|alveolitis sicca dolorosa
4984105|NCT04091399|alveolar osteitis|alveolar osteitis
4984106|NCT04091399|alveolalgia|alveolalgia
4984107|NCT04091399|sodium hyaluronate|sodium hyaluronate
4984108|NCT04091399|octenidine hydrochlorid|octenidine hydrochlorid
4984109|NCT04091399|clinical study|clinical study
4984110|NCT04091386|Physical activity|physical activity
4984111|NCT04091386|Coagulation factor VIII|coagulation factor viii
4984112|NCT04091386|Joint health|joint health
4984118|NCT04091347|African American|african american
4984119|NCT04091347|Women's Health|women's health
4984120|NCT04091334|Dyspnea|dyspnea
4984121|NCT04091334|Ultrasound|ultrasound
4984122|NCT04091334|Point-of-care|point-of-care
4984123|NCT04091334|Focused|focused
4984124|NCT04091334|Serial|serial
4984125|NCT04091334|Monitoring|monitoring
4984126|NCT04091308|Exercise|exercise
4984127|NCT04091308|Protein supplementation|protein supplementation
4984128|NCT04091308|Physical exercise training|physical exercise training
4984133|NCT04091282|Metagenome|metagenome
4984134|NCT04091282|Infants|infants
4984135|NCT04091269|patient-ventilator interation|patient-ventilator interation
4984136|NCT04091269|automatic adjustmen of inspiratory triger and cycling-off|automatic adjustmen of inspiratory triger and cycling-off
4984137|NCT04091269|Neurally controlled PS|neurally controlled ps
4984138|NCT04091256|Biorepair sensitive toothpaste|biorepair sensitive toothpaste
5396845|NCT01736397|CKD|ckd
4984139|NCT04091256|Clinical trial|clinical trial
4984140|NCT04091256|Dentinal Hypersensitivity|dentinal hypersensitivity
4984141|NCT04091256|Schiff Sensitivity Scale|schiff sensitivity scale
4984142|NCT04091256|Zinc-carbonate hydroxyapatite nanocrystals|zinc-carbonate hydroxyapatite nanocrystals
4984143|NCT04091243|glucocorticoid|glucocorticoid
4984144|NCT04091243|osteoporosis|osteoporosis
4984145|NCT04091243|rheumatic diseases|rheumatic diseases
4984146|NCT04091230|biopsy quality|biopsy quality
4984147|NCT04091204|wild-type BRCA 1 and 2|wild-type brca 1 and 2
4984148|NCT04091204|platinum sensitive|platinum sensitive
4984149|NCT04091204|recurrent ovarian cancer|recurrent ovarian cancer
4984150|NCT04091204|olaparib|olaparib
4984151|NCT04091204|maintenance treatment|maintenance treatment
4984152|NCT04091165|food diary|food diary
4984153|NCT04091165|malnutrition|malnutrition
4984154|NCT04091152|old poeple|old poeple
4984156|NCT04091152|usability|usability
4984157|NCT04091152|ergonomy|ergonomy
4984158|NCT04091152|tablet PC|tablet pc
4984159|NCT04091139|Unified Protocol|unified protocol
4984160|NCT04091139|Cognitive Behavioural Therapy|cognitive behavioural therapy
4984161|NCT04091139|Depression|depression
4984162|NCT04091139|Anxiety|anxiety
4984163|NCT04091139|Adolescents|adolescents
4984172|NCT04091100|Tension-Type Headache|tension-type headache
4984173|NCT04091100|Myofascial Releasing|myofascial releasing
4984175|NCT04091087|Stasis Dermatitis|stasis dermatitis
4984176|NCT04091087|venous hypertension|venous hypertension
4984177|NCT04091087|venous insufficiency|venous insufficiency
4984178|NCT04091061|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
4984179|NCT04091061|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4984181|NCT04090957|Estetrol|estetrol
4984182|NCT04090957|Hot Flushes|hot flushes
4984183|NCT04090957|Vasomotor symptoms|vasomotor symptoms
4984184|NCT04090918|post-operative atrial fibrillation|post-operative atrial fibrillation
4984185|NCT04090918|abdominal surgery|abdominal surgery
4984186|NCT04090918|left atrial strain|left atrial strain
4984187|NCT04090918|atrial remodelling|atrial remodelling
4984188|NCT04090905|post-operative atrial fibrillation|post-operative atrial fibrillation
4984597|NCT04088474|probiotics|probiotics
4988300|NCT04064671|Zephyr|zephyr
4984207|NCT04090827|education|education
4984208|NCT04090827|adolescence|adolescence
4984209|NCT04090801|Female pattern hair loss|female pattern hair loss
4984210|NCT04090801|Minoxidil.|minoxidil.
4984211|NCT04090788|bitter gourd|bitter gourd
4984212|NCT04090788|pre-diabetics|pre-diabetics
4984213|NCT04090788|glucose response|glucose response
4984214|NCT04090749|coping|coping
4984215|NCT04090749|resilience|resilience
4984216|NCT04090749|quality of life|quality of life
4984224|NCT04090710|SBRT|sbrt
4984225|NCT04090710|Ipilimumab|ipilimumab
4984226|NCT04090710|Nivolumab|nivolumab
4984227|NCT04090671|Dyspnoea|dyspnoea
4984229|NCT04090632|CKCUEST|ckcuest
4984230|NCT04090632|Physical activity|physical activity
4984231|NCT04090632|rehabilitation|rehabilitation
4984238|NCT04090541|Kinesiology Tape|kinesiology tape
4984239|NCT04090541|Biomechanical Tape|biomechanical tape
4984240|NCT04090541|Performance|performance
4984241|NCT04090541|Muscle Strength|muscle strength
4984242|NCT04090541|Vertical Jump|vertical jump
4984243|NCT04090528|immunotherapy|immunotherapy
4984244|NCT04090528|prostate cancer|prostate cancer
4984245|NCT04090528|vaccine|vaccine
4984246|NCT04090528|DNA vaccine|dna vaccine
4984247|NCT04090528|pTVG-HP|ptvg-hp
4984248|NCT04090528|pTVG-AR|ptvg-ar
4984249|NCT04090528|androgen receptor|androgen receptor
4984250|NCT04090528|prostatic acid phosphatase|prostatic acid phosphatase
4984251|NCT04090528|pembrolizumab|pembrolizumab
4984252|NCT04090515|Obesity|obesity
4984253|NCT04090515|Eating|eating
4984254|NCT04090515|Physical Activity|physical activity
4984255|NCT04090515|Exercise|exercise
4984256|NCT04090502|pain|pain
4984257|NCT04090502|Back|back
4984258|NCT04090502|Hamstrings|hamstrings
4984259|NCT04090476|community exercise group|community exercise group
4984260|NCT04090463|Pancreatic cancer|pancreatic cancer
4984261|NCT04090463|Borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
4984262|NCT04090463|Intraoperative radiotherapy (IORT)|intraoperative radiotherapy (iort)
4984263|NCT04090463|Total neoadjuvant therapy|total neoadjuvant therapy
4984264|NCT04090372|Osteoarthritis|osteoarthritis
4984265|NCT04090372|Hip|hip
4984266|NCT04090372|Total hip arthroplasty|total hip arthroplasty
4984267|NCT04090372|leg discrepancy|leg discrepancy
4984268|NCT04090372|preoperative planning|preoperative planning
4984269|NCT04090346|CDiff|cdiff
4984270|NCT04090346|Fecal Microbiota Transplant|fecal microbiota transplant
4984271|NCT04090346|Infection Control|infection control
4984272|NCT04090346|Antibiotic Stewardship|antibiotic stewardship
5307365|NCT02141711|Drug therapy|drug therapy
4984273|NCT04090320|Arterial Embolization|arterial embolization
4984274|NCT04090320|Vascular Plug|vascular plug
4984275|NCT04090307|Group Prenatal Care|group prenatal care
4984276|NCT04090307|Diabetes|diabetes
4984277|NCT04090281|precision medicine|precision medicine
4984278|NCT04090281|antiplatelet|antiplatelet
4984279|NCT04090281|pharmacogenetics|pharmacogenetics
4984290|NCT04090268|hematopoietic stem cell transplant|hematopoietic stem cell transplant
4984291|NCT04090268|survivor|survivor
4984292|NCT04090268|oxidative metabolism|oxidative metabolism
4984293|NCT04090268|strength|strength
4984304|NCT04090164|Hepatitis C virus|hepatitis c virus
4984306|NCT04090164|Epidemiology|epidemiology
4984307|NCT04090151|HIV|hiv
4984308|NCT04090151|Prospective|prospective
4984309|NCT04090151|Cohort|cohort
4984310|NCT04090151|HCV|hcv
4984311|NCT04090138|endurance performance, l-citrulline, glutathione|endurance performance, l-citrulline, glutathione
4984312|NCT04090125|knee|knee
4984313|NCT04090125|total knee replacement|total knee replacement
4984314|NCT04090125|physical therapy|physical therapy
4984440|NCT04089293|GLENOID CAVITY|glenoid cavity
4984315|NCT04090099|Erector Spinae Block, Parasternal block, Cardiac surgery|erector spinae block, parasternal block, cardiac surgery
4984319|NCT04090021|H. pylori|h. pylori
4984320|NCT04090021|genotypic resistance|genotypic resistance
4984321|NCT04090021|tailored therapy|tailored therapy
4984322|NCT04090021|concomitant therapy|concomitant therapy
4984323|NCT04089995|Coats|coats
4984324|NCT04089995|leukencephalopathy with calcifications and cysts|leukencephalopathy with calcifications and cysts
4988398|NCT04064255|Adolescents|adolescents
4984335|NCT04089917|Mechanical thrombectomy|mechanical thrombectomy
4984336|NCT04089917|Acute ischemic stroke|acute ischemic stroke
4984337|NCT04089917|neurovascular intervention|neurovascular intervention
4984338|NCT04089787|Community-acquired pneumonia|community-acquired pneumonia
4984339|NCT04089787|Treatment duration|treatment duration
4984340|NCT04089787|Pneumonia|pneumonia
4984341|NCT04089787|Lung Diseases|lung diseases
4984342|NCT04089787|Respiratory Tract Diseases|respiratory tract diseases
4984343|NCT04089787|Respiratory Tract Infections|respiratory tract infections
4984344|NCT04089787|Bacterial Infections|bacterial infections
4984345|NCT04089787|Pneumonia, Bacterial|pneumonia, bacterial
4984346|NCT04089787|Anti-Infective Agents|anti-infective agents
4984347|NCT04089787|Anti-Bacterial Agents|anti-bacterial agents
4984349|NCT04089748|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4984350|NCT04089748|cisplatine|cisplatine
4984351|NCT04089709|Distal radius fracture|distal radius fracture
4984352|NCT04089709|cross-education|cross-education
4984353|NCT04089709|immobilization|immobilization
4984354|NCT04089696|ALS|als
4984355|NCT04089683|Operation Theatre|operation theatre
4984356|NCT04089683|Bacterial Contamination|bacterial contamination
4984357|NCT04089683|Web-space|web-space
4984358|NCT04089683|OT Dress|ot dress
4984359|NCT04089683|Anterior Nares|anterior nares
4984360|NCT04089670|Chronic Pain|chronic pain
4984361|NCT04089670|Acceptance and Commitment Therapy|acceptance and commitment therapy
4984362|NCT04089670|Sleep Dysfunction|sleep dysfunction
4984363|NCT04089670|Online Intervention|online intervention
4984364|NCT04089631|circulating tumour DNA|circulating tumour dna
4984365|NCT04089631|ctDNA|ctdna
4984366|NCT04089631|adjuvant chemotherapy|adjuvant chemotherapy
4984367|NCT04089618|Yoga|yoga
4984368|NCT04089618|Meditation|meditation
4984369|NCT04089618|Yoga Philosophy|yoga philosophy
4984370|NCT04089618|Mantra|mantra
4984371|NCT04089618|Mind-Body|mind-body
4984372|NCT04089605|dexamethasone implant|dexamethasone implant
4984373|NCT04089605|vitrectomized|vitrectomized
4984374|NCT04089605|diabetic macular edema|diabetic macular edema
4984375|NCT04089605|ranibizumab|ranibizumab
4984376|NCT04089592|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4984377|NCT04089592|Dexmedetomidine|dexmedetomidine
4984378|NCT04089592|Fentanyl|fentanyl
4984379|NCT04089592|Hemodynamics response|hemodynamics response
4984380|NCT04089592|Direct laryngoscopy|direct laryngoscopy
4984412|NCT04089423|tuberculosis, PLHIV|tuberculosis, plhiv
4984413|NCT04089410|Adaptation|adaptation
4984414|NCT04089410|Systemic hyperthermia|systemic hyperthermia
4984415|NCT04089410|Quality of life|quality of life
4984416|NCT04089410|Neuro-visceral interactions|neuro-visceral interactions
4984417|NCT04089410|Preventive medical technologies|preventive medical technologies
4984418|NCT04089410|Personalized approach|personalized approach
4984419|NCT04089410|Neuroplasticity|neuroplasticity
4984420|NCT04089410|Brain derived neurotrophic factor|brain derived neurotrophic factor
4984422|NCT04089410|Heat Shock proteins|heat shock proteins
4984423|NCT04089397|light therapy in sleep disorders of dialysis patients|light therapy in sleep disorders of dialysis patients
4984424|NCT04089384|Obesity|obesity
4984425|NCT04089384|Auriculotherapy|auriculotherapy
4984426|NCT04089384|Weight Loss|weight loss
4984427|NCT04089384|Nutrition Therapy|nutrition therapy
4984428|NCT04089371|Arthroplasty|arthroplasty
4984429|NCT04089371|Hemiarthroplasty|hemiarthroplasty
4984430|NCT04089371|Shoulder|shoulder
4984431|NCT04089371|Replacement|replacement
4984436|NCT04089306|Advanced Cancer|advanced cancer
4984437|NCT04089306|End of Life|end of life
4984438|NCT04089306|Agressiveness of Care|agressiveness of care
4984439|NCT04089306|Palliative Care integration|palliative care integration
4984441|NCT04089293|HUMERAL HEAD|humeral head
4984442|NCT04089293|SHOULDER JOINT|shoulder joint
4984443|NCT04089293|SUPRASPINATUS MUSCLE|supraspinatus muscle
4984444|NCT04089293|LABRUM|labrum
4984445|NCT04089293|ABER POSITION|aber position
4984446|NCT04089293|SCAPULOHUMERAL|scapulohumeral
4984447|NCT04089293|INTERNAL IMPINGEMENT|internal impingement
4984448|NCT04089293|ABDUCTED POSITION|abducted position
4984449|NCT04089293|SCAPULOHUMERAL JOINT|scapulohumeral joint
4984450|NCT04089280|diabetes type 2|diabetes type 2
4984456|NCT04089228|Myofascial trigger points|myofascial trigger points
4984457|NCT04089228|Kinesiotaping|kinesiotaping
4984458|NCT04089228|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
4984459|NCT04089215|JWCAR029|jwcar029
4984460|NCT04089215|B-Cell Malignancies|b-cell malignancies
4984461|NCT04089215|non-Hodgkin lymphoma|non-hodgkin lymphoma
4984462|NCT04089215|CAR T cells|car t cells
4984463|NCT04089215|Chimeric antigen receptor|chimeric antigen receptor
4984464|NCT04089215|Relapsed/Refractory|relapsed/refractory
4984465|NCT04089202|Diabetes specialty care|diabetes specialty care
4984466|NCT04089202|Flash glucose monitoring|flash glucose monitoring
4984467|NCT04089202|Clinical pharmacists|clinical pharmacists
4984468|NCT04089202|eConsults|econsults
4984469|NCT04089202|Freestyle Libre sensor|freestyle libre sensor
4984470|NCT04089163|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
4984471|NCT04089163|bladder cancer|bladder cancer
4984472|NCT04089163|high grade non-muscle invasive bladder cancer|high grade non-muscle invasive bladder cancer
4984473|NCT04089163|HG NMIBC|hg nmibc
4984474|NCT04089163|NMIBC|nmibc
4984475|NCT04089163|high grade NMIBC|high grade nmibc
4984476|NCT04089150|stereotactic body radiotherapy|stereotactic body radiotherapy
4984477|NCT04089150|SBRT|sbrt
4984478|NCT04089150|chemotherapy|chemotherapy
4984479|NCT04089150|radiotherapy|radiotherapy
4984480|NCT04089150|surgery|surgery
4984486|NCT04089098|fluid resuscitation|fluid resuscitation
4984487|NCT04089098|shock|shock
4984488|NCT04089098|volume challenge|volume challenge
4984489|NCT04089098|passive leg raising|passive leg raising
4984490|NCT04089098|renal perfusion|renal perfusion
4984491|NCT04089098|fluid responsiveness|fluid responsiveness
4984492|NCT04089085|Childhood Asthma|childhood asthma
4984493|NCT04089085|Childhood Anxiety/depression|childhood anxiety/depression
4984510|NCT04088994|Rehabilitation|rehabilitation
4984511|NCT04088994|fMRI|fmri
4984512|NCT04088981|insulin sensitivity|insulin sensitivity
4984513|NCT04088981|glycemic control|glycemic control
4984514|NCT04088981|intramyocellular|intramyocellular
4984515|NCT04088981|nutrition|nutrition
4984516|NCT04088955|DigiMeds|digimeds
5704054|NCT00487292|accidents|accidents
4984517|NCT04088955|Capecitabine|capecitabine
4984518|NCT04088955|Standard of Care|standard of care
4984519|NCT04088942|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4984520|NCT04088942|Randomized Controlled Trial|randomized controlled trial
4984521|NCT04088942|Smoking Cessation|smoking cessation
4984522|NCT04088942|Behavioural support|behavioural support
4984523|NCT04088942|varenicline|varenicline
4984524|NCT04088942|exacerbations|exacerbations
4984525|NCT04088929|Pain|pain
4984526|NCT04088929|Neuropathy|neuropathy
4984527|NCT04088929|Neuropathic Pain|neuropathic pain
4984528|NCT04088929|Diabetes|diabetes
4984529|NCT04088916|ADNproviral|adnproviral
4984531|NCT04088916|Resistance|resistance
4984532|NCT04088916|genotyping|genotyping
4984533|NCT04088903|Immunotherapy, anti-CD38 antibody|immunotherapy, anti-cd38 antibody
4984534|NCT04088890|CD22|cd22
4984535|NCT04088890|CAR T cells|car t cells
4984536|NCT04088877|Exercise|exercise
4984537|NCT04088877|Art sculpture|art sculpture
4984538|NCT04088877|Breast neoplasms|breast neoplasms
4984539|NCT04088877|Body Image|body image
4984540|NCT04088812|Satiety|satiety
4984541|NCT04088812|Meat derivative|meat derivative
4984542|NCT04088812|Fiber|fiber
4984543|NCT04088812|Visual Analogue Scale|visual analogue scale
4984544|NCT04088812|Parallel|parallel
4984545|NCT04088786|HIPEC|hipec
4984546|NCT04088786|nal-irinotecan|nal-irinotecan
4984547|NCT04088747|Fibromyalgia|fibromyalgia
4984548|NCT04088747|Ultrasound|ultrasound
4984549|NCT04088747|Regularization|regularization
4984550|NCT04088747|Logistic Regression|logistic regression
4984551|NCT04088747|Imaging|imaging
4984552|NCT04088734|MPS IIIA|mps iiia
4984553|NCT04088734|Sanfilippo|sanfilippo
4984554|NCT04088734|Gene therapy|gene therapy
4984555|NCT04088708|breast cancer|breast cancer
4984556|NCT04088708|fatigue|fatigue
4984557|NCT04088708|exercise|exercise
4984558|NCT04088708|psychosocial outcomes|psychosocial outcomes
4984559|NCT04088708|inflammation|inflammation
4984560|NCT04088708|gut microbiome|gut microbiome
4984561|NCT04088695|Blood|blood
4984562|NCT04088695|Donation|donation
4984563|NCT04088695|Voluntary|voluntary
4984564|NCT04088682|clinical performance|clinical performance
4984565|NCT04088682|quality measures|quality measures
4984566|NCT04088682|ST-Elevation myocardial infarction|st-elevation myocardial infarction
4984567|NCT04088669|asthma|asthma
4984568|NCT04088669|pulmonary rehabilitation|pulmonary rehabilitation
4988592|NCT04062838|steroids|steroids
4984574|NCT04088630|Stroke|stroke
4984575|NCT04088630|Intracerebral hemorrhage|intracerebral hemorrhage
4984576|NCT04088630|Neuroimmunomodulation|neuroimmunomodulation
4984577|NCT04088604|LY01610|ly01610
4984578|NCT04088604|5-Fu|5-fu
4984579|NCT04088604|Safety|safety
4984580|NCT04088604|Tolerability|tolerability
4984581|NCT04088604|Pharmacokinetics|pharmacokinetics
4984583|NCT04088565|Neuromodulation|neuromodulation
4984584|NCT04088565|Paresis|paresis
4984585|NCT04088565|Neurorehabilitation|neurorehabilitation
4984586|NCT04088539|Smoking cessation|smoking cessation
4984587|NCT04088539|Brief intervention|brief intervention
4984588|NCT04088539|Correctional institution|correctional institution
4984589|NCT04088513|G6PD Deficiency|g6pd deficiency
4984590|NCT04088513|Acute ischemic stroke|acute ischemic stroke
4984591|NCT04088513|Aspirin|aspirin
4984592|NCT04088513|Hemolysis|hemolysis
4984593|NCT04088513|Clopidogrel|clopidogrel
4984594|NCT04088513|Anti-platelet therapy|anti-platelet therapy
4984595|NCT04088474|gut microflora|gut microflora
4984596|NCT04088474|Lactobacillus paracasei subsp. paracasei NTU 101|lactobacillus paracasei subsp. paracasei ntu 101
4984612|NCT04088305|trough concentration|trough concentration
4984613|NCT04088305|elderly patients|elderly patients
4984615|NCT04088279|oxygen enhanced|oxygen enhanced
4984616|NCT04088279|fourier decomposition|fourier decomposition
4984617|NCT04088240|omega-3|omega-3
4984618|NCT04088214|Arthroscopy|arthroscopy
4984620|NCT04088136|everyday memory|everyday memory
4984621|NCT04088136|ecological momentary assessment|ecological momentary assessment
4984622|NCT04088136|memory complaint|memory complaint
4984623|NCT04088136|metacognition|metacognition
4984624|NCT04088136|mnemonics|mnemonics
4984625|NCT04088136|external aids|external aids
4984626|NCT04088097|adolescent|adolescent
4984627|NCT04088097|cognitive-behavioral therapy|cognitive-behavioral therapy
4984628|NCT04088097|loss of control eating|loss of control eating
4984629|NCT04088045|Osteoarthritis; Autologous Platelet Rich Plasma|osteoarthritis; autologous platelet rich plasma
4984630|NCT04088019|Idiopathic uveitis|idiopathic uveitis
4984631|NCT04088019|IGRA positive|igra positive
4984632|NCT04088019|Type 1 interferon|type 1 interferon
4984633|NCT04088019|Transcriptomic analysis|transcriptomic analysis
4984634|NCT04088019|Anti-Tuberculosis Therapy|anti-tuberculosis therapy
4984635|NCT04088006|Aging|aging
4984636|NCT04088006|Skin dryness|skin dryness
4984637|NCT04088006|Skin elasticity|skin elasticity
4984638|NCT04088006|Hyaluronic acid|hyaluronic acid
4984639|NCT04088006|Injection|injection
4984640|NCT04088006|Cheek|cheek
4984641|NCT04088006|Neckline area|neckline area
4984642|NCT04088006|Healthy subjects|healthy subjects
4984643|NCT04088006|Intra-individual|intra-individual
4984644|NCT04088006|Independent evaluators|independent evaluators
5024935|NCT03842176|CTC|ctc
4984645|NCT04088006|Prospective|prospective
4984646|NCT04088006|Randomized study|randomized study
4984647|NCT04087993|pre surgery iron treatment|pre surgery iron treatment
4984657|NCT04087915|Lowering cholesterol|lowering cholesterol
4984658|NCT04087915|Lowering high cholesterol|lowering high cholesterol
4984659|NCT04087915|Hypercholesterolemia|hypercholesterolemia
4984660|NCT04087902|Endoscopic Endonasal Approach Surgery|endoscopic endonasal approach surgery
4984661|NCT04087889|Cancer|cancer
4984662|NCT04087889|Pancreas|pancreas
4984663|NCT04087889|Adenocarcinoma|adenocarcinoma
4984664|NCT04087876|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4984665|NCT04087876|iCCA|icca
4984666|NCT04087876|Metastatic cholangiocarcinoma|metastatic cholangiocarcinoma
4984667|NCT04087876|FGFR genomic alteration|fgfr genomic alteration
4984668|NCT04087876|biliary cancer|biliary cancer
4984669|NCT04087876|bile duct cancer|bile duct cancer
4984670|NCT04087876|liver cancer|liver cancer
4984671|NCT04087850|peer relationships|peer relationships
4984672|NCT04087837|bougie, nasotracheal tube|bougie, nasotracheal tube
4984673|NCT04087837|Endotracheal Tube intubation General Anesthesia (ETGA)|endotracheal tube intubation general anesthesia (etga)
4984674|NCT04087824|Deep learning|deep learning
4984675|NCT04087824|Colonoscopy|colonoscopy
4984676|NCT04087824|Central Neural Networks|central neural networks
4984678|NCT04087785|miRNAs|mirnas
4984679|NCT04087785|cervical cancer|cervical cancer
4984680|NCT04087785|lymph node metastasis|lymph node metastasis
4984681|NCT04087694|Microdecompression|microdecompression
4984682|NCT04087694|laminectomy|laminectomy
4984683|NCT04087694|pain|pain
4984684|NCT04087694|stenosis|stenosis
4984688|NCT04087668|ERCP|ercp
4984689|NCT04087668|General anesthesia|general anesthesia
4984690|NCT04087668|Endoscopy|endoscopy
4984691|NCT04087668|MAC|mac
4984692|NCT04087629|CTCL|ctcl
4984694|NCT04087629|topical steroids|topical steroids
4984696|NCT04087629|cutaneous|cutaneous
5369130|NCT01861197|Dovitinib|dovitinib
4984697|NCT04087629|steroid sparing|steroid sparing
4984698|NCT04087616|tics|tics
4984699|NCT04087616|tourette Syndrome|tourette syndrome
4984700|NCT04087603|Circadian rhythms|circadian rhythms
4984701|NCT04087603|Sleep|sleep
4984707|NCT04087590|plethysmography|plethysmography
4984708|NCT04087590|dyspnea|dyspnea
4984709|NCT04087577|peripheral nerve injury|peripheral nerve injury
4984710|NCT04087577|motor learning|motor learning
4984711|NCT04087577|mirror therapy|mirror therapy
4984712|NCT04087577|physical therapy|physical therapy
4984713|NCT04087564|Music|music
4984714|NCT04087538|troponin|troponin
4984715|NCT04087512|perturbation-based balance training|perturbation-based balance training
4984716|NCT04087512|exercise|exercise
4984717|NCT04087486|Multiple errands tests|multiple errands tests
4984718|NCT04087473|ALK inhibitor (ALKi)|alk inhibitor (alki)
4984719|NCT04087473|NSCLC|nsclc
4984720|NCT04087473|Anaplastic lymphoma kinase (ALK) fusion oncogene NSCLC|anaplastic lymphoma kinase (alk) fusion oncogene nsclc
4984721|NCT04087473|Guardant360 assay|guardant360 assay
4984722|NCT04087473|Next-Generation Sequencing (NGS) DNA sequencing test|next-generation sequencing (ngs) dna sequencing test
4984723|NCT04087473|Cell-free circulating tumor DNA (ctDNA)|cell-free circulating tumor dna (ctdna)
4984724|NCT04087473|Plasma profiling|plasma profiling
4984725|NCT04087473|Blood-based assay|blood-based assay
4984726|NCT04087473|Mutational testing|mutational testing
4984727|NCT04087473|74 genetic alterations (point mutations, copy number variants, fusions, insertions, deletions)|74 genetic alterations (point mutations, copy number variants, fusions, insertions, deletions)
4984728|NCT04087473|ALK resistance mutations|alk resistance mutations
4984729|NCT04087460|Vaccnie|vaccnie
4984730|NCT04087460|PspA|pspa
4984731|NCT04087460|Pneomolysin|pneomolysin
4984732|NCT04087434|concussion|concussion
4984733|NCT04087421|Low Anterior Resection Syndrome|low anterior resection syndrome
4984734|NCT04087421|Transanal irrigation|transanal irrigation
4984735|NCT04087421|Glycerol suppositories|glycerol suppositories
4984736|NCT04087408|GnRHa , LPD, antagonist, progesterone and ART|gnrha , lpd, antagonist, progesterone and art
4984737|NCT04087369|implementation research|implementation research
4984738|NCT04087369|low- and middle-income countries|low- and middle-income countries
4984739|NCT04087369|Nepal|nepal
5342909|NCT01981538|Cancer Caregivers|cancer caregivers
4984740|NCT04087369|Package of Essential Noncommunicable disease interventions for primary care in low-resource settings|package of essential noncommunicable disease interventions for primary care in low-resource settings
4984741|NCT04087369|task-shifting|task-shifting
4984742|NCT04087369|non-physician health workers|non-physician health workers
4984750|NCT04087330|Whole body vibration|whole body vibration
4984751|NCT04087291|chronic|chronic
4984752|NCT04087291|pain management|pain management
4984753|NCT04087291|manipulation, chiropractic|manipulation, chiropractic
4984754|NCT04087278|Cardiovascular system|cardiovascular system
4984755|NCT04087278|Polyphenols|polyphenols
4984759|NCT04087239|HAART exposure|haart exposure
4984760|NCT04087239|infant immune/metabolic dyregulation,|infant immune/metabolic dyregulation,
4984761|NCT04087239|gut dysbiosis|gut dysbiosis
4981418|NCT04108962|ABPA|abpa
4984762|NCT04087239|breastfeeding|breastfeeding
4984765|NCT04087239|Syphilis|syphilis
4984766|NCT04087239|malnutrition|malnutrition
4984767|NCT04087226|Polytetrafluoroethylene|polytetrafluoroethylene
4984768|NCT04087226|Retraction|retraction
4984769|NCT04087226|Soft tissue Management|soft tissue management
4984770|NCT04087226|Retraction cord|retraction cord
4984771|NCT04087213|HemoCare™ Hemodialysis System|hemocare™ hemodialysis system
4984772|NCT04087213|Hemodialysis|hemodialysis
4984773|NCT04087200|STEMI|stemi
4984774|NCT04087200|NSTEMI|nstemi
4984775|NCT04087200|Acute kidney injury|acute kidney injury
4984776|NCT04087200|Renal function|renal function
4984777|NCT04087200|Statin therapy|statin therapy
4984778|NCT04087187|Pharmacokinetics|pharmacokinetics
4984782|NCT04087135|videolaryngoscopy|videolaryngoscopy
4984783|NCT04087135|Thiel's embalmed cadaver|thiel's embalmed cadaver
4984784|NCT04087083|stroke|stroke
4984785|NCT04087083|robotic rehabilitation|robotic rehabilitation
4984786|NCT04087083|frail elderly|frail elderly
4984787|NCT04087083|gait performance|gait performance
4984788|NCT04087083|balance|balance
4984789|NCT04087083|risk of falling|risk of falling
4984790|NCT04087083|quality of life|quality of life
4984791|NCT04087044|vestibular neuritis|vestibular neuritis
4984792|NCT04087044|vestibular migraine|vestibular migraine
4984793|NCT04087031|Parkinson disease|parkinson disease
4984794|NCT04087031|robotics|robotics
4984795|NCT04087031|elderly|elderly
4984796|NCT04087031|rehabilitation|rehabilitation
4984812|NCT04086901|Radiotherapy|radiotherapy
4984813|NCT04086901|Dose escalation|dose escalation
4984814|NCT04086901|Definitive chemo-radiotherapy|definitive chemo-radiotherapy
4984815|NCT04086888|Immune checkpoint inhibitors|immune checkpoint inhibitors
4984816|NCT04086862|temporomandibular disorders|temporomandibular disorders
4984817|NCT04086862|masseter myalgia|masseter myalgia
4984824|NCT04086849|artificial intelligence|artificial intelligence
4984825|NCT04086849|squamous cell carcinoma|squamous cell carcinoma
4984826|NCT04086836|TAVR|tavr
5307803|NCT02139657|Rabies|rabies
4984827|NCT04086836|Stroke|stroke
4984828|NCT04086810|PWS|pws
4984829|NCT04086810|Prader-Willi Syndrome|prader-willi syndrome
4984830|NCT04086797|IQP-AE-103|iqp-ae-103
4984831|NCT04086797|overweight treatment|overweight treatment
4984832|NCT04086797|obesity treatment|obesity treatment
4984833|NCT04086784|3D-printed Porous Titanium Alloy cage;PEEK cage;Osteoporosis|3d-printed porous titanium alloy cage;peek cage;osteoporosis
4984834|NCT04086758|Pharmacokinetic|pharmacokinetic
4984835|NCT04086758|MDV3100|mdv3100
4984836|NCT04086758|zolbetuximab|zolbetuximab
4984837|NCT04086732|central sensitization|central sensitization
4984838|NCT04086732|high-frequency stimulation|high-frequency stimulation
4984839|NCT04086706|Colonoscopy|colonoscopy
4984840|NCT04086706|Retroflexion|retroflexion
4984841|NCT04086706|Adenoma Detection Rate|adenoma detection rate
4984842|NCT04086706|Adenoma Miss Rate|adenoma miss rate
4984843|NCT04086693|intravenous access|intravenous access
4984844|NCT04086693|vascular access|vascular access
4984845|NCT04086693|IV survival|iv survival
4984846|NCT04086693|IV catheter complication|iv catheter complication
4984847|NCT04086667|LBP|lbp
4984848|NCT04086667|SMT|smt
4984849|NCT04086641|Ankle disarticulation|ankle disarticulation
4984850|NCT04086641|Syme|syme
4984851|NCT04086641|Amputation|amputation
4984852|NCT04086641|Prosthesis|prosthesis
4984853|NCT04086641|Prosthetic foot|prosthetic foot
4984854|NCT04086641|Crossover foot|crossover foot
4984855|NCT04086641|Biomechanics|biomechanics
4984856|NCT04086589|healthy, young, elderly|healthy, young, elderly
4984857|NCT04086537|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4984858|NCT04086537|BMPR2|bmpr2
4984860|NCT04086537|Hepcidin|hepcidin
4984861|NCT04086537|Mutations|mutations
4984862|NCT04086524|Amblyopia|amblyopia
4984863|NCT04086524|Binocular treatment|binocular treatment
4984864|NCT04086524|Visual acuity|visual acuity
4984865|NCT04086524|Stereopsis|stereopsis
4984866|NCT04086524|Motor function|motor function
4984867|NCT04086498|ketogenic diet|ketogenic diet
4984868|NCT04086498|Mediterranean diet|mediterranean diet
4984869|NCT04086498|ketones|ketones
4984870|NCT04086498|glycaemia|glycaemia
4984871|NCT04086498|executive functions|executive functions
4984875|NCT04086459|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4984876|NCT04086459|Functional magnetic resonance imaging|functional magnetic resonance imaging
4984877|NCT04086459|Positron emission tomography|positron emission tomography
4984881|NCT04086381|Brown adipose tissue|brown adipose tissue
4984882|NCT04086381|Creatine monohydrate|creatine monohydrate
4984883|NCT04086381|Diet-induced thermogenesis|diet-induced thermogenesis
4984884|NCT04086355|Dysphagia; electrical stimulation; cerebral palsy|dysphagia; electrical stimulation; cerebral palsy
4984885|NCT04086342|Anxiety|anxiety
4984886|NCT04086342|Cannabis|cannabis
4984887|NCT04086342|Cannabidiol|cannabidiol
4984888|NCT04086342|CBD|cbd
4984889|NCT04086316|Menstrual Cycle|menstrual cycle
4984890|NCT04086316|Major Depressive Disorder|major depressive disorder
4984891|NCT04086316|Stress|stress
4984892|NCT04086316|Sex hormones|sex hormones
4984893|NCT04086316|Depression|depression
4984894|NCT04086316|Female|female
4984895|NCT04086316|Ambulatory Assessment|ambulatory assessment
4984896|NCT04086290|radiotherapy|radiotherapy
4984897|NCT04086290|prostatectomy|prostatectomy
4984898|NCT04086290|androgen deprivation therapy|androgen deprivation therapy
4984902|NCT04086264|Acute Myeloid Leukemia|acute myeloid leukemia
4984904|NCT04086264|Minimal detectable disease|minimal detectable disease
4984905|NCT04086264|MRD|mrd
4984906|NCT04086264|CD123|cd123
4984907|NCT04086264|Relapsed/refractory|relapsed/refractory
4984908|NCT04086251|Neoplasm|neoplasm
4984909|NCT04086251|Malignancy|malignancy
4984910|NCT04086251|Oncology|oncology
4984911|NCT04086251|Remote patient monitoring|remote patient monitoring
4984912|NCT04086147|acute ischemic stroke|acute ischemic stroke
4984913|NCT04086147|large vessel occlusion|large vessel occlusion
4984914|NCT04086147|thrombolysis|thrombolysis
4984915|NCT04086147|tenecteplase|tenecteplase
4984916|NCT04086147|dosage|dosage
4984917|NCT04086147|computed tomography|computed tomography
4984918|NCT04086147|magnetic resonance imaging|magnetic resonance imaging
4984919|NCT04086147|diffusion weighted imaging|diffusion weighted imaging
4984920|NCT04086147|early combined imaging outcomes|early combined imaging outcomes
4984921|NCT04086147|modified Rankin scale|modified rankin scale
4984922|NCT04086147|time window beyond 4.5 hours|time window beyond 4.5 hours
4984934|NCT04086082|NSCLC|nsclc
4984935|NCT04086082|Oligometastases|oligometastases
4984936|NCT04086069|unilateral lower-lim amputation|unilateral lower-lim amputation
4984937|NCT04086069|sit-to-stand trainer device|sit-to-stand trainer device
4984938|NCT04086069|30-Second Chair Stand Test|30-second chair stand test
4984939|NCT04086069|kinesiological analysis|kinesiological analysis
4984940|NCT04086017|symptom management|symptom management
4984941|NCT04086017|Reiki therapy|reiki therapy
4984942|NCT04086017|self-care|self-care
4984943|NCT04086004|Motor Imagery practice|motor imagery practice
4984944|NCT04086004|Stroke|stroke
4984945|NCT04086004|Dual task training|dual task training
4984950|NCT04085965|Summer Camp|summer camp
4984951|NCT04085965|Child overweight / obesity|child overweight / obesity
4984952|NCT04085965|Diet|diet
4984953|NCT04085965|Physical Activity|physical activity
4984954|NCT04085952|pelvic organ prolapse, vaginal graft|pelvic organ prolapse, vaginal graft
4984955|NCT04085926|Wound Healing|wound healing
4984956|NCT04085926|Casts, Surgical|casts, surgical
4984957|NCT04085926|Shoes|shoes
4984958|NCT04085900|Screening|screening
4984959|NCT04085900|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4984960|NCT04085900|Biomarker|biomarker
4984961|NCT04085874|Nutrition intervention|nutrition intervention
4984962|NCT04085874|Food-Based Recommendations|food-based recommendations
4984963|NCT04085874|dietary practices|dietary practices
4984964|NCT04085874|women of reproductive age|women of reproductive age
4984965|NCT04085874|dyslipidemia|dyslipidemia
4984966|NCT04085861|Mental health|mental health
4984967|NCT04085861|Eating disorders|eating disorders
4984968|NCT04085861|Perfectionism|perfectionism
4984969|NCT04085861|Body image|body image
4984970|NCT04085861|Body dissatisfaction|body dissatisfaction
4984971|NCT04085861|Body appreciation|body appreciation
4984972|NCT04085861|Depression|depression
4984973|NCT04085861|Energy availability|energy availability
4984974|NCT04085835|endometrium|endometrium
4984975|NCT04085835|comparative genomics|comparative genomics
4984976|NCT04085783|Recurrent implantation failure|recurrent implantation failure
4984977|NCT04085783|implantation|implantation
4984979|NCT04085783|platelet rich plasma (PRP)|platelet rich plasma (prp)
4984980|NCT04085770|LOS|los
4984981|NCT04085770|mediastinitis|mediastinitis
4984982|NCT04085770|secondary myocardial infection|secondary myocardial infection
4984983|NCT04085744|intubation|intubation
4984984|NCT04085744|anesthesia|anesthesia
4984985|NCT04085744|corticosteroids|corticosteroids
4984986|NCT04085744|lidocaine|lidocaine
4984987|NCT04085744|complication of intubation|complication of intubation
4984988|NCT04085718|endomyocardial biopsy|endomyocardial biopsy
4984989|NCT04085718|myocarditis|myocarditis
4984990|NCT04085718|anti-heart autoantibodies|anti-heart autoantibodies
4984991|NCT04085718|biomarker|biomarker
4984992|NCT04085718|positron emission computed tomography|positron emission computed tomography
4984993|NCT04085718|heart failure|heart failure
4984994|NCT04085718|cardiomyopathy|cardiomyopathy
4984995|NCT04085718|magnetic resonance imaging|magnetic resonance imaging
4984996|NCT04085705|Wound Dressing|wound dressing
4984997|NCT04085679|Multidisciplinary care|multidisciplinary care
4984998|NCT04085679|Hospital-community care integration|hospital-community care integration
4985003|NCT04085640|Hip Arthroplasty|hip arthroplasty
4985004|NCT04085640|regional anesthesia|regional anesthesia
4985005|NCT04085640|obturator nerve block|obturator nerve block
4985006|NCT04085588|Pain|pain
4985007|NCT04085588|analgesia|analgesia
4985008|NCT04085588|Postoperative|postoperative
4985009|NCT04085588|Ketamine|ketamine
4985010|NCT04085588|Morphine|morphine
4985011|NCT04085523|Achondroplasia|achondroplasia
4985012|NCT04085523|Dwarfism|dwarfism
4985013|NCT04085510|breast cancer screening|breast cancer screening
4985014|NCT04085510|digital breast tomosynthesis|digital breast tomosynthesis
4985015|NCT04085510|contrast-enhanced mammogram|contrast-enhanced mammogram
4985016|NCT04085497|Medial Plica Syndrome|medial plica syndrome
4985017|NCT04085497|Kinesio Tape|kinesio tape
4985018|NCT04085484|preterm|preterm
4985019|NCT04085445|Agent DCB|agent dcb
4985020|NCT04085419|zoledronic acid|zoledronic acid
4985021|NCT04085419|denosumab|denosumab
4988991|NCT04060121|ptsd|ptsd
4985023|NCT04085419|osteoporosis|osteoporosis
4985024|NCT04085380|Clostridium difficile|clostridium difficile
4985025|NCT04085380|Multidrug resistant bacteria|multidrug resistant bacteria
4985026|NCT04085380|Risks factor|risks factor
4985027|NCT04085380|highly resistant bacteria|highly resistant bacteria
4985028|NCT04085380|eXDR|exdr
4985029|NCT04085380|ESBL|esbl
4985030|NCT04085354|Premature Ejaculation|premature ejaculation
4985031|NCT04085341|Macular Edema|macular edema
4985032|NCT04085263|Radical Mastectomy|radical mastectomy
4985033|NCT04085263|Postoperative pain|postoperative pain
4985034|NCT04085263|Morphine consumption|morphine consumption
4985035|NCT04085263|subserratus plane block|subserratus plane block
4985036|NCT04085250|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
4985037|NCT04085250|Neoadjuvant Chemotherapy plus nivolumab|neoadjuvant chemotherapy plus nivolumab
4985038|NCT04085250|Chemoradiotherapy|chemoradiotherapy
4985039|NCT04085250|Nivolumab consolidation|nivolumab consolidation
4985040|NCT04085211|endoscopy|endoscopy
4985041|NCT04085159|immunotherapy T cell cancer gene therapy|immunotherapy t cell cancer gene therapy
4985042|NCT04085146|robot-assisted surgery|robot-assisted surgery
4985043|NCT04085146|prostatectomy|prostatectomy
4985044|NCT04085146|laparoscopy|laparoscopy
4985045|NCT04085146|positive end-expiratory pressure|positive end-expiratory pressure
4985046|NCT04085146|individualized|individualized
4985047|NCT04085146|atelectasis|atelectasis
4985048|NCT04085146|general anesthesia|general anesthesia
4985049|NCT04085107|mild cognitive impairment|mild cognitive impairment
4985050|NCT04085107|neuropsychiatric symptoms|neuropsychiatric symptoms
4985051|NCT04085107|instrument validation|instrument validation
4985052|NCT04085107|coping styles|coping styles
4985053|NCT04085107|cognitive deficit|cognitive deficit
4985054|NCT04085107|neuroticism|neuroticism
4985055|NCT04085107|social support|social support
4985056|NCT04085094|BOLD-RMI|bold-rmi
4985057|NCT04085094|Contrast-enhanced ultrasound (CEUS)|contrast-enhanced ultrasound (ceus)
4985058|NCT04085094|Salt storage|salt storage
4985059|NCT04085094|Perfusion index|perfusion index
4985060|NCT04085094|Resistance index|resistance index
4985061|NCT04085094|Renal functional reserve|renal functional reserve
4985062|NCT04085094|Renal oxygenation|renal oxygenation
4985063|NCT04085081|Lung cancer|lung cancer
4985064|NCT04085081|geriatric oncology|geriatric oncology
4985065|NCT04085081|physical activity|physical activity
4985066|NCT04085081|family caregivers|family caregivers
4985067|NCT04085081|functional status|functional status
4985068|NCT04085055|pancreatic mass, pancreatic solid mass, pancreatic lesion|pancreatic mass, pancreatic solid mass, pancreatic lesion
4985069|NCT04085042|Catheterization, Peripheral|catheterization, peripheral
4985070|NCT04085029|Ablative radiotherapy|ablative radiotherapy
4985072|NCT04084990|OSA|osa
4985073|NCT04084990|FGR|fgr
4985074|NCT04084951|Solid tumors cancer|solid tumors cancer
4985075|NCT04084951|metastatic|metastatic
4985076|NCT04084951|locally advanced|locally advanced
4985077|NCT04084951|cancer|cancer
4985078|NCT04084951|cervical|cervical
4985079|NCT04084951|head and neck|head and neck
4985080|NCT04084951|anal|anal
4985081|NCT04084951|penile|penile
4985082|NCT04084951|SQZ-PBMC-HPV|sqz-pbmc-hpv
4985083|NCT04084951|atezolizumab|atezolizumab
4985084|NCT04084951|HPV16|hpv16
4985085|NCT04084951|APC|apc
4985086|NCT04084951|cell therapy|cell therapy
4985087|NCT04084938|Prostate|prostate
4985088|NCT04084938|Embolization|embolization
4985089|NCT04084938|Complication|complication
4985090|NCT04084938|Operation|operation
4985091|NCT04084938|Randomization|randomization
4985092|NCT04084899|Obstructive Sleep Apnea|obstructive sleep apnea
4985093|NCT04084899|Continuous Positive Airway Pressure|continuous positive airway pressure
4985094|NCT04084899|Lung hyperinflation|lung hyperinflation
4985095|NCT04084847|Barberry|barberry
4985104|NCT04084795|Major depressive disorder|major depressive disorder
4985106|NCT04084795|Eye Movement Desensitization and Reprocessing|eye movement desensitization and reprocessing
4985107|NCT04084795|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4985108|NCT04084782|Fungal Nail Infection|fungal nail infection
4985109|NCT04084782|Internet Mediated Research Study|internet mediated research study
4985110|NCT04084743|Virtual reality|virtual reality
4985111|NCT04084743|Targeted therapy|targeted therapy
4985112|NCT04084743|Computer game|computer game
4985113|NCT04084730|Unicentric pathological stage I breast invasive ductal breast cancer|unicentric pathological stage i breast invasive ductal breast cancer
4985114|NCT04084730|Breast Cancer|breast cancer
4985115|NCT04084730|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4985116|NCT04084730|19-300|19-300
4985117|NCT04084678|Prostacyclin|prostacyclin
4985118|NCT04084678|Connective Tissue Disease-Associated|connective tissue disease-associated
4985119|NCT04084678|Cardiopulmonary Exercise Capacity (CPET)|cardiopulmonary exercise capacity (cpet)
4985120|NCT04084678|IP Receptor Agonist|ip receptor agonist
4985121|NCT04084613|Severe Eosinophilic Asthma|severe eosinophilic asthma
4985122|NCT04084613|Mepolizumab|mepolizumab
4985123|NCT04084613|Anti-IL5 treatment|anti-il5 treatment
4985135|NCT04084574|Kidney disease|kidney disease
4985136|NCT04084548|Multimodal analgesia|multimodal analgesia
4985137|NCT04084548|Lidocaine|lidocaine
4985138|NCT04084548|Ketamine|ketamine
4985139|NCT04084548|Abdominal surgery|abdominal surgery
4985140|NCT04084522|Alcoholic Hepatitis|alcoholic hepatitis
4985141|NCT04084522|Gut Microbiota|gut microbiota
4985142|NCT04084522|Dysbiosis|dysbiosis
4985143|NCT04084522|Malnutrition|malnutrition
4985144|NCT04084522|Saturated Fat|saturated fat
4985145|NCT04084496|pancreatic cancer|pancreatic cancer
4985146|NCT04084496|adjuvant chemotherapy|adjuvant chemotherapy
4985147|NCT04084496|FOLFIRINOX|folfirinox
4985157|NCT04084457|polyphenols|polyphenols
4985158|NCT04084457|Blueberries|blueberries
4985159|NCT04084457|cognition|cognition
4985160|NCT04084457|vascular function|vascular function
4985161|NCT04084457|vascular health|vascular health
4985162|NCT04084457|cognitive function|cognitive function
4985163|NCT04084457|anthocyanins|anthocyanins
4985164|NCT04084457|flavonoids|flavonoids
4985165|NCT04084444|Chronic abnormal immune activation|chronic abnormal immune activation
4985166|NCT04084444|AIDS|aids
4985167|NCT04084444|T8|t8
4985168|NCT04084444|Efficacy|efficacy
4985169|NCT04084444|Safety|safety
4985170|NCT04084431|repeated whole brain radiation therapy|repeated whole brain radiation therapy
4985171|NCT04084405|COPD|copd
4985172|NCT04084405|IMT|imt
4985173|NCT04084405|ABC|abc
4985174|NCT04084405|BBS|bbs
4985175|NCT04084405|TUG|tug
4985176|NCT04084405|SLS|sls
4985177|NCT04084379|congenital chagas disease|congenital chagas disease
4985178|NCT04084379|congenital syphilis|congenital syphilis
4985179|NCT04084379|Chagas PCR diagnose|chagas pcr diagnose
4985180|NCT04084379|Syphilis PCR diagnose|syphilis pcr diagnose
4985181|NCT04084379|Children|children
4985182|NCT04084366|antibody drug conjugate (ADC)|antibody drug conjugate (adc)
4985183|NCT04084353|intra partum fetal monitoring|intra partum fetal monitoring
4985184|NCT04084353|training|training
4985185|NCT04084353|quality improvement|quality improvement
4985186|NCT04084353|intermittent cardiotocography (CTG)|intermittent cardiotocography (ctg)
5704055|NCT00487292|shift work|shift work
4985187|NCT04084353|intermittent auscultation|intermittent auscultation
4985188|NCT04084353|perinatal outcomes|perinatal outcomes
4985189|NCT04084353|caesarean section rate|caesarean section rate
4985190|NCT04084353|obstetric outcomes|obstetric outcomes
4985192|NCT04084314|migraine|migraine
4985210|NCT04084275|Levine's conservation model|levine's conservation model
4985211|NCT04084275|postpartum care|postpartum care
4985212|NCT04084275|postpartum quality of life|postpartum quality of life
4985213|NCT04084275|postpartum problems|postpartum problems
4985221|NCT04084223|JAK Inhibitors|jak inhibitors
4985223|NCT04084223|Patients Reported Outcomes (PROs)|patients reported outcomes (pros)
4985224|NCT04084223|Disease activity|disease activity
4985225|NCT04084223|Predictors|predictors
4985226|NCT04084223|Therapeutic response|therapeutic response
4985227|NCT04084171|Artificial Pancreas (AP)|artificial pancreas (ap)
4985228|NCT04084171|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
4985229|NCT04084171|Closed Loop Control (CLC)|closed loop control (clc)
4985230|NCT04084171|Insulin Pump|insulin pump
4985231|NCT04084158|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4985232|NCT04084158|PD-1 antibody|pd-1 antibody
4985233|NCT04084119|postpartum|postpartum
4985234|NCT04084119|inter-rectus distance|inter-rectus distance
4985235|NCT04084119|diastasis recti|diastasis recti
4985236|NCT04084119|Lumbar disability|lumbar disability
4985237|NCT04084119|urinary incontinence|urinary incontinence
4985238|NCT04084119|pelvic floor|pelvic floor
4985239|NCT04084119|quality of life|quality of life
4985240|NCT04084106|randomized trial|randomized trial
4985241|NCT04084106|antibiotic resistant genes|antibiotic resistant genes
4985242|NCT04084106|gut microbiota|gut microbiota
4985243|NCT04084106|healthy volunteers|healthy volunteers
4989215|NCT04058704|NSCLC|nsclc
4985245|NCT04084067|Ewing Sarcoma|ewing sarcoma
4985246|NCT04084067|Liver tumor|liver tumor
4985247|NCT04084067|Lymphoma|lymphoma
4985248|NCT04084067|Metastatic pulmonary deposits|metastatic pulmonary deposits
4985249|NCT04084067|Neoplastic Disease|neoplastic disease
4985250|NCT04084067|Neuroblastoma|neuroblastoma
4985251|NCT04084067|Non-Rhabdomyosarcoma Soft Tissue Sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
4985252|NCT04084067|Nodules of unknown etiology|nodules of unknown etiology
4985253|NCT04084067|Osteosarcoma|osteosarcoma
4985254|NCT04084067|Solid Tumor|solid tumor
4985255|NCT04084067|Rhabdomyosarcoma|rhabdomyosarcoma
4985256|NCT04084067|Renal tumors|renal tumors
4985257|NCT04084067|Rare tumors|rare tumors
4985258|NCT04084041|Airway clearance technique|airway clearance technique
4985259|NCT04084028|food agency|food agency
4985260|NCT04084028|cooking|cooking
4985261|NCT04084015|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4985262|NCT04084015|Left ventricular unloading|left ventricular unloading
4985263|NCT04084015|Impella®|impella®
4985264|NCT04084002|stroke|stroke
4985265|NCT04084002|physical activity|physical activity
4985266|NCT04083989|Anorexia nervosa|anorexia nervosa
4985267|NCT04083989|Eating disorder|eating disorder
4985268|NCT04083989|Adolescents|adolescents
4985269|NCT04083989|Inpatient treatment|inpatient treatment
4985270|NCT04083989|Integrative medicine|integrative medicine
4985271|NCT04083989|Anthroposophic medicine|anthroposophic medicine
4985272|NCT04083989|Heart rate variability|heart rate variability
4985273|NCT04083989|Thermography|thermography
4985274|NCT04083950|Gastrointestinal Health|gastrointestinal health
4985275|NCT04083950|Intestinal Permeability|intestinal permeability
4985276|NCT04083950|Inflammation|inflammation
4985277|NCT04083950|Vaccine Response|vaccine response
4985278|NCT04083950|Ty21a Typhoid Vaccine|ty21a typhoid vaccine
4985279|NCT04083950|Typhoid Fever|typhoid fever
4985289|NCT04083911|Decitabine, HAAG, AML|decitabine, haag, aml
4985290|NCT04083885|rehabilitation|rehabilitation
4985299|NCT04083807|haemostasis|haemostasis
4985300|NCT04083807|tissue glue|tissue glue
4985301|NCT04083807|tissue sealing|tissue sealing
4985302|NCT04083807|Ilio-femoral bypass|ilio-femoral bypass
4985303|NCT04083807|Femoro-femoral bypass|femoro-femoral bypass
4985304|NCT04083807|Ilio-popliteal bypass|ilio-popliteal bypass
4985305|NCT04083807|Femoro-popliteal bypass|femoro-popliteal bypass
4985306|NCT04083807|Femoro-tibial vessel bypass|femoro-tibial vessel bypass
4985307|NCT04083807|Arterio-arterial-bypass|arterio-arterial-bypass
4985308|NCT04083807|Arteriovenous shunting for dialysis|arteriovenous shunting for dialysis
4985309|NCT04083794|bone perfusion|bone perfusion
4985310|NCT04083794|bone blood flow regulation|bone blood flow regulation
4985311|NCT04083794|vascular sympathetic activity|vascular sympathetic activity
4985312|NCT04083794|skeletal loading|skeletal loading
4985313|NCT04083794|spinal cord injury|spinal cord injury
4985314|NCT04083768|Position|position
4985315|NCT04083755|anemia|anemia
4985316|NCT04083755|iron|iron
4985317|NCT04083755|surgery|surgery
4985319|NCT04083703|Interbody Cage|interbody cage
4985320|NCT04083690|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4985321|NCT04083690|Pacing|pacing
4985322|NCT04083690|Echocardiography|echocardiography
4985323|NCT04083690|Electrocardiography|electrocardiography
4985324|NCT04083690|Optimization|optimization
5002302|NCT03981289|LGMD|lgmd
4985332|NCT04083521|Gastrointestinal health|gastrointestinal health
4985333|NCT04083495|lymphoma|lymphoma
4985335|NCT04083495|peripheral T cell lymphoma|peripheral t cell lymphoma
4985336|NCT04083482|Mitochondrial DNA|mitochondrial dna
4985337|NCT04083482|Sepsis|sepsis
4985338|NCT04083482|Continous venovenous hemofiltation|continous venovenous hemofiltation
4985339|NCT04083482|Intensive Care Unit|intensive care unit
4985340|NCT04083456|Amputation|amputation
4985341|NCT04083456|Dysvascular Amputation|dysvascular amputation
4985342|NCT04083456|Diabetes|diabetes
4985343|NCT04083456|Peripheral Artery Disease|peripheral artery disease
4985344|NCT04083456|Physical Activity|physical activity
4985345|NCT04083417|sore throat|sore throat
4985346|NCT04083417|tonsillitis|tonsillitis
4985347|NCT04083417|randomized controlled trial|randomized controlled trial
4985348|NCT04083417|primary care|primary care
4985349|NCT04083417|phenoxymethylpenicillin|phenoxymethylpenicillin
4985350|NCT04083404|Complex mental health|complex mental health
4985351|NCT04083404|employment|employment
4985352|NCT04083404|Enhanced Individual Placement & Support|enhanced individual placement & support
5025792|NCT03837431|RDT|rdt
4985353|NCT04083404|Model of Human Occupation|model of human occupation
4985354|NCT04083404|Worker Role Interview|worker role interview
4985355|NCT04083391|chronic ankle instability|chronic ankle instability
4985356|NCT04083391|Hamstring|hamstring
4985357|NCT04083391|flexibility|flexibility
4985358|NCT04083339|Type 2 Diabetes|type 2 diabetes
4985359|NCT04083339|Aldose Reductase Inhibitor|aldose reductase inhibitor
4985360|NCT04083339|Stage B Heart Failure|stage b heart failure
4985361|NCT04083339|Stage C Heart Failure|stage c heart failure
4985362|NCT04083339|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
4985363|NCT04083313|Laparoscopic appendectomy|laparoscopic appendectomy
4985367|NCT04083287|Shoulder surgery|shoulder surgery
4985368|NCT04083287|Postoperative pain management|postoperative pain management
4985369|NCT04083287|Erector spina plane block|erector spina plane block
4985370|NCT04083274|Upper extremity surgery|upper extremity surgery
4985371|NCT04083274|Postoperative pain management|postoperative pain management
4985372|NCT04083274|Erector spina plane block|erector spina plane block
4985373|NCT04083261|Medical cannabis|medical cannabis
4985374|NCT04083261|Medical marijuana|medical marijuana
4985375|NCT04083222|Hypertension|hypertension
4985376|NCT04083222|Hypertensive|hypertensive
4985377|NCT04083222|AGT|agt
4985378|NCT04083222|Angiotensinogen|angiotensinogen
4985379|NCT04083222|Blood Pressure|blood pressure
4985380|NCT04083144|smoking cessation|smoking cessation
4985381|NCT04083144|varenicline|varenicline
4985382|NCT04083144|deep rTMS|deep rtms
4985383|NCT04083144|insula|insula
4985384|NCT04083144|addiction|addiction
4985385|NCT04083144|tobacco use disorder|tobacco use disorder
4985386|NCT04083131|Sens of coherence|sens of coherence
4985387|NCT04083131|Primary dysmenorrhea|primary dysmenorrhea
4985396|NCT04083105|intranasal midazolam|intranasal midazolam
4985397|NCT04083066|rituximab|rituximab
4985398|NCT04083066|fotemustine|fotemustine
4985399|NCT04083066|pemetrexed|pemetrexed
4985401|NCT04083066|OS|os
4985402|NCT04083066|PFS|pfs
4985403|NCT04083053|anoscopy|anoscopy
4985404|NCT04083053|screening|screening
4985405|NCT04083053|perianal examination|perianal examination
4985406|NCT04083014|warm autoimmune hemolytic anemia|warm autoimmune hemolytic anemia
4985407|NCT04083014|relapsed|relapsed
4985408|NCT04083014|refractory|refractory
4985409|NCT04083014|EVANS syndrome|evans syndrome
4985410|NCT04083014|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
4985411|NCT04083014|bortezomib|bortezomib
4985412|NCT04083001|Stroke|stroke
4985413|NCT04083001|FIM|fim
4985414|NCT04083001|OTR3|otr3
4985415|NCT04082988|PD-L1 expression|pd-l1 expression
4985416|NCT04082988|eligible for treatment with nivolumab|eligible for treatment with nivolumab
4985421|NCT04082949|Chronic Periodontitis|chronic periodontitis
4985422|NCT04082949|Autologous fibrin tissue adhesive|autologous fibrin tissue adhesive
4985423|NCT04082949|Blood Platelets|blood platelets
4985424|NCT04082949|Non-surgical periodontal therapy|non-surgical periodontal therapy
4985430|NCT04082910|Metoprolol|metoprolol
4985431|NCT04082910|cytokine release syndrome|cytokine release syndrome
4985432|NCT04082910|chimeric antigen receptor T cells|chimeric antigen receptor t cells
5369131|NCT01861197|Squamous NSCLC|squamous nsclc
4985440|NCT04082871|Medication management review service|medication management review service
4985441|NCT04082871|Pharmaceutical care|pharmaceutical care
4985442|NCT04082871|Clinical pharmacist|clinical pharmacist
4985443|NCT04082858|Ketamine|ketamine
5304004|NCT02157402|Adolescent|adolescent
4985444|NCT04082858|Electroconvulsive Therapy|electroconvulsive therapy
4985445|NCT04082858|Depression|depression
4985447|NCT04082793|Electrotherapy|electrotherapy
4985448|NCT04082793|Photobiomodulation|photobiomodulation
4985449|NCT04082793|Quality of life|quality of life
4985450|NCT04082780|brain MRI|brain mri
4985451|NCT04082780|cognitive testing|cognitive testing
4985452|NCT04082780|microbiota|microbiota
4985453|NCT04082780|metabolomics|metabolomics
4985454|NCT04082780|pharmacokinetics|pharmacokinetics
4985455|NCT04082767|sedation, delirium, pediatric, critical care|sedation, delirium, pediatric, critical care
4985456|NCT04082728|ambulant surgery|ambulant surgery
4985457|NCT04082728|post-operative medication|post-operative medication
4985458|NCT04082728|recovery|recovery
4985459|NCT04082715|Pain|pain
4985460|NCT04082702|CBPR|cbpr
4985461|NCT04082702|DPP|dpp
4985462|NCT04082702|African-American|african-american
4985463|NCT04082702|Women|women
4985464|NCT04082702|Obesity|obesity
4985465|NCT04082702|Pre-diabetes|pre-diabetes
4985466|NCT04082689|Colic|colic
4985467|NCT04082689|Constipation|constipation
4985468|NCT04082689|Bladder dysfunction|bladder dysfunction
4985469|NCT04082689|Toilet traning|toilet traning
4985470|NCT04082637|Buprenorphine|buprenorphine
4985471|NCT04082637|Medication-assisted treatment|medication-assisted treatment
4985472|NCT04082637|Mind-body therapies|mind-body therapies
4985473|NCT04082637|Mindfulness|mindfulness
4985474|NCT04082637|Interoception|interoception
4985475|NCT04082637|Mindful Awareness in Body-oriented Therapy|mindful awareness in body-oriented therapy
4985476|NCT04082611|Alzheimer Disease|alzheimer disease
4985477|NCT04082611|Mild Cognitive Impairment|mild cognitive impairment
4985478|NCT04082611|Precision Medicine|precision medicine
4985479|NCT04082611|Health Coaching|health coaching
4985480|NCT04082611|Multi-Modal Intervention|multi-modal intervention
4985481|NCT04082611|Personal, Dense, Dynamic Data (PD3) Clouds|personal, dense, dynamic data (pd3) clouds
4985482|NCT04082611|Cognitive decline|cognitive decline
4985483|NCT04082598|tooth extraction|tooth extraction
4985484|NCT04082598|antibiotics|antibiotics
4985485|NCT04082598|probiotics|probiotics
4989437|NCT04057495|Insulin|insulin
4985487|NCT04082598|complications|complications
4985488|NCT04082559|IBD|ibd
4985495|NCT04082533|hydrocortisone|hydrocortisone
4985496|NCT04082494|wellbeing|wellbeing
4985497|NCT04082494|Postoperative Pain|postoperative pain
4985498|NCT04082494|postoperative disturbances after anaesthesia|postoperative disturbances after anaesthesia
4985499|NCT04082481|Drug Therapy|drug therapy
4985500|NCT04082468|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
4985502|NCT04082364|gastric cancer|gastric cancer
4985503|NCT04082364|gastroesophageal junction cancer|gastroesophageal junction cancer
4985504|NCT04082364|HER2-positive gastroesophageal cancer|her2-positive gastroesophageal cancer
4985505|NCT04082364|anti-HER2 therapy|anti-her2 therapy
4985506|NCT04082364|checkpoint inhibitors|checkpoint inhibitors
4985508|NCT04082364|LAG-3|lag-3
4985509|NCT04082351|Nanotechnology water|nanotechnology water
4985510|NCT04082351|HbA1c|hba1c
4985511|NCT04082351|Type 2 Diabetes mellitus|type 2 diabetes mellitus
4985512|NCT04082312|Acute Kidney Injury|acute kidney injury
4985513|NCT04082312|ECMO|ecmo
4985514|NCT04082312|Post Cardiogenic Shock Syndrome|post cardiogenic shock syndrome
4985515|NCT04082273|Induced corneal Astigmatism|induced corneal astigmatism
4985516|NCT04082273|Clear corneal incisions|clear corneal incisions
4985517|NCT04082273|Femto-laser|femto-laser
4985518|NCT04082234|Behavior Therapy|behavior therapy
4985519|NCT04082234|Integrated Primary Care|integrated primary care
4985520|NCT04082234|Reducing Disparities|reducing disparities
4985521|NCT04082208|ERCP|ercp
4985522|NCT04082208|High Flow nasal cannula|high flow nasal cannula
4985523|NCT04082208|deep sedation|deep sedation
4985524|NCT04082182|dendritic cell|dendritic cell
4985525|NCT04082182|vaccine|vaccine
4985526|NCT04082182|immunotherapy|immunotherapy
4985527|NCT04082156|TENS, DOMS, soreness, fatigue|tens, doms, soreness, fatigue
4985528|NCT04082130|Xenogenic collagen matrix (XCM).|xenogenic collagen matrix (xcm).
4985529|NCT04082130|subepithelial connective tissue graft (SCGT).|subepithelial connective tissue graft (scgt).
4985530|NCT04082130|coronally advanced flap (CAF).|coronally advanced flap (caf).
4985537|NCT04082065|.Low back pain (LBP),|.low back pain (lbp),
4985538|NCT04082065|Oswestery disability index (ODI),|oswestery disability index (odi),
4985539|NCT04082065|Quality of life (QOL),|quality of life (qol),
4985540|NCT04082065|Range of motion (ROM)|range of motion (rom)
4985541|NCT04082065|Visual analogue scale (VAS)|visual analogue scale (vas)
4985543|NCT04082052|self-dislike|self-dislike
4985544|NCT04082052|self-compassion|self-compassion
4985545|NCT04082052|symptom level|symptom level
4985546|NCT04082052|single session|single session
4985547|NCT04081987|Arterial line|arterial line
4985548|NCT04081987|Non-invasive monitoring|non-invasive monitoring
4985549|NCT04081987|Vital signs|vital signs
4985550|NCT04081987|Blood pressure|blood pressure
4985551|NCT04081974|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
4985552|NCT04081974|Distal leg perfusion|distal leg perfusion
4985553|NCT04081974|Ischemia|ischemia
4985554|NCT04081948|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
4985555|NCT04081948|Postoperative pain management|postoperative pain management
4985556|NCT04081948|Erector spina plane block|erector spina plane block
4985557|NCT04081935|school-age children, emergency treatment, intravenous placement, virtual reality, pain, fear|school-age children, emergency treatment, intravenous placement, virtual reality, pain, fear
4985558|NCT04081909|Opioid|opioid
4985559|NCT04081909|Ketamine|ketamine
4985560|NCT04081909|Dexmedetomidine|dexmedetomidine
4985561|NCT04081909|Sevoflurane|sevoflurane
4985562|NCT04081909|Perioperative complications|perioperative complications
4985563|NCT04081883|Continuous Glucose Monitoring|continuous glucose monitoring
4985564|NCT04081883|Biosensor|biosensor
4985565|NCT04081870|doppler,endometrial,implantation|doppler,endometrial,implantation
4985569|NCT04081805|LASER|laser
4985570|NCT04081805|Radiofrequency|radiofrequency
4985571|NCT04081805|Vulvovaginal atrophy|vulvovaginal atrophy
4985572|NCT04081805|breast cancer|breast cancer
4985573|NCT04081805|treatment|treatment
4985574|NCT04081792|diabetic foot; osteomyelitis; amputation; antibiotics|diabetic foot; osteomyelitis; amputation; antibiotics
4985578|NCT04081766|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4985579|NCT04081766|Diabetes Mellitus|diabetes mellitus
4985580|NCT04081766|Hypoglycemia|hypoglycemia
4985581|NCT04081766|Counseling|counseling
4985582|NCT04081766|Older Adults|older adults
4985583|NCT04081753|HiDAC|hidac
4985584|NCT04081753|Neutropenia|neutropenia
4985585|NCT04081753|Fever|fever
4985587|NCT04081753|Leukemia|leukemia
4985588|NCT04081675|orthotics|orthotics
4985589|NCT04081675|gait analysis|gait analysis
4985590|NCT04081662|Acceptance and commitment therapy|acceptance and commitment therapy
4985591|NCT04081662|Micro-intervention|micro-intervention
4985592|NCT04081662|Mobile intervention|mobile intervention
4985593|NCT04081610|Dry eye|dry eye
4985594|NCT04081610|eye lubricant|eye lubricant
4985595|NCT04081610|sodium hyaluronate|sodium hyaluronate
4985596|NCT04081571|NAFLD|nafld
4985597|NCT04081571|Insulin Resistance|insulin resistance
4985598|NCT04081571|Hepatic Steatosis|hepatic steatosis
4985599|NCT04081571|EGYPTIAN|egyptian
4985614|NCT04081519|functional connectivity|functional connectivity
4985615|NCT04081493|Low-load blood flow restricted exercise|low-load blood flow restricted exercise
4985617|NCT04081493|Functional capacity|functional capacity
4985618|NCT04081441|gender-based violence|gender-based violence
4985619|NCT04081441|intimate-partner violence|intimate-partner violence
4985620|NCT04081441|empowerment|empowerment
4985621|NCT04081441|food insecurity|food insecurity
4985622|NCT04081441|humanitarian settings|humanitarian settings
4985623|NCT04081441|depression|depression
4985624|NCT04081441|fuel use|fuel use
4985625|NCT04081441|clean cookstoves|clean cookstoves
4985626|NCT04081428|Prostate cancer|prostate cancer
4985628|NCT04081428|Volatile organic compounds|volatile organic compounds
4985629|NCT04081428|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4985630|NCT04081428|Radiotherapy side effects|radiotherapy side effects
4985631|NCT04081428|Imaging biomarkers|imaging biomarkers
4985632|NCT04081415|FPIES|fpies
4985633|NCT04081415|microbiota|microbiota
4985634|NCT04081415|gut|gut
4985635|NCT04081415|stool|stool
4985636|NCT04081415|calprotectin saliva|calprotectin saliva
4985637|NCT04081415|skin|skin
4985638|NCT04081376|Hydromorphone|hydromorphone
4985639|NCT04081376|Opiates|opiates
4985640|NCT04081376|Anti-doping control|anti-doping control
4985642|NCT04081311|dental implants|dental implants
4985643|NCT04081311|water flosser|water flosser
4985644|NCT04081272|transfusion|transfusion
4985645|NCT04081272|post-transfusion recovery|post-transfusion recovery
4985646|NCT04081259|Acute Myeloid Leukemia|acute myeloid leukemia
4985647|NCT04081259|AML|aml
4985648|NCT04081259|ERK|erk
4985649|NCT04081259|Relapsed|relapsed
4985650|NCT04081259|Refractory|refractory
4985651|NCT04081259|LY3214996|ly3214996
4985652|NCT04081246|Bladder cancer, bladder tumour, en bloc resection|bladder cancer, bladder tumour, en bloc resection
4985653|NCT04081207|augmentative and alternative communication|augmentative and alternative communication
4985654|NCT04081207|aphasia|aphasia
4985655|NCT04081207|fMRI|fmri
4985656|NCT04081207|DTI|dti
4985657|NCT04081207|neuroimaging|neuroimaging
4985658|NCT04081155|EIT|eit
4985659|NCT04081155|pulmonary perfusion|pulmonary perfusion
4985660|NCT04081155|ventilation|ventilation
4985661|NCT04081142|EIT, pulmonary perfusion|eit, pulmonary perfusion
4985662|NCT04081129|EIT|eit
4985663|NCT04081129|early mobilization|early mobilization
4985664|NCT04081077|Pharmacokinetics|pharmacokinetics
4985665|NCT04081077|Pharmcogenomics|pharmcogenomics
4985666|NCT04081077|Pharmacodynamics|pharmacodynamics
4985667|NCT04081077|Bedaquiline|bedaquiline
4985668|NCT04081077|Pretomanid|pretomanid
4985670|NCT04081077|Clofazimine|clofazimine
4985671|NCT04081077|Moxifloxacin|moxifloxacin
4985672|NCT04081064|Obese|obese
4985673|NCT04081064|Non-obese|non-obese
4985674|NCT04081064|Qatar|qatar
4985675|NCT04081038|oral cancer screening|oral cancer screening
4985676|NCT04080999|r-TMS|r-tms
4985677|NCT04080999|Hemispatial Neglect|hemispatial neglect
4985678|NCT04080999|Visual Scanning|visual scanning
4985679|NCT04080986|Resuscitation|resuscitation
4985680|NCT04080986|Arrhythmia, Cardiac|arrhythmia, cardiac
4985681|NCT04080986|Heart Diseases|heart diseases
4985682|NCT04080986|Heart Arrest|heart arrest
4985683|NCT04080973|urolithiasis|urolithiasis
4985684|NCT04080973|metabolic abnormalities|metabolic abnormalities
4985685|NCT04080973|osteopenia|osteopenia
4985686|NCT04080973|hypercalcemia|hypercalcemia
4985687|NCT04080973|hypercalcuria|hypercalcuria
4985688|NCT04080973|bone density|bone density
4985689|NCT04080921|encephalitis|encephalitis
4985698|NCT04080856|Endometriosis|endometriosis
4985700|NCT04080856|Real-World|real-world
4985701|NCT04080856|Effectiveness|effectiveness
4985702|NCT04080830|Registration Study|registration study
4985703|NCT04080830|Acute Ischemic Stroke|acute ischemic stroke
4985704|NCT04080830|Atrial Fibrillation|atrial fibrillation
4985705|NCT04080817|Stroke|stroke
4985706|NCT04080817|Aphasia|aphasia
4985707|NCT04080817|Speech therapy|speech therapy
4985708|NCT04080817|Computer based|computer based
4985709|NCT04080804|anti-PD1 antibody|anti-pd1 antibody
4985710|NCT04080804|anti-CTLA4 antibody|anti-ctla4 antibody
4985711|NCT04080804|anti-LAG3 antibody|anti-lag3 antibody
4985712|NCT04080804|tumor infiltrating lymphocyte (TIL)|tumor infiltrating lymphocyte (til)
4985713|NCT04080791|Virtual Reality|virtual reality
4985714|NCT04080791|Stroke|stroke
4985715|NCT04080791|National Stroke Association|national stroke association
4985716|NCT04080791|Stroke Rehabilitation|stroke rehabilitation
4985717|NCT04080765|decision analysis|decision analysis
4985719|NCT04080765|education|education
4985720|NCT04080713|Budesonide|budesonide
4985721|NCT04080713|Healthy|healthy
4985722|NCT04080713|Pharmacokinetic|pharmacokinetic
4985723|NCT04080687|ankle-foot orthoses|ankle-foot orthoses
4985724|NCT04080687|lower limbs|lower limbs
4985725|NCT04080687|rehabilitation outpatients|rehabilitation outpatients
4985726|NCT04080687|balance confidence|balance confidence
4985727|NCT04080687|falls|falls
4985728|NCT04080661|Therapeutic drug monitoring|therapeutic drug monitoring
4985729|NCT04080661|Psoriasis|psoriasis
4985730|NCT04080661|Secukinumab|secukinumab
5002690|NCT03979118|Physical Activity|physical activity
4985736|NCT04080635|Brodalumab|brodalumab
4985737|NCT04080583|Physical activity|physical activity
4985738|NCT04080583|Health Status|health status
4985739|NCT04080570|home hospital|home hospital
4985740|NCT04080570|hospital at home|hospital at home
4985741|NCT04080570|hospital in the home|hospital in the home
4985742|NCT04080557|delirium|delirium
4985743|NCT04080557|intensive care unit|intensive care unit
4985744|NCT04080557|surgical ward|surgical ward
4985745|NCT04080557|abdominal aortic aneurysm surgery|abdominal aortic aneurysm surgery
4985746|NCT04080544|Positron Emission Tomography|positron emission tomography
4985747|NCT04080479|bolus enteral feeding|bolus enteral feeding
4985748|NCT04080479|continuous enteral feeding|continuous enteral feeding
4985749|NCT04080479|protein synthesis|protein synthesis
4985750|NCT04080479|nutritional parameters|nutritional parameters
4985752|NCT04080466|Cam deformity|cam deformity
4985753|NCT04080453|Blood platelets|blood platelets
4985754|NCT04080453|CD40 ligand|cd40 ligand
4985755|NCT04080453|Multiple Organ Failure|multiple organ failure
4985756|NCT04080440|Coma|coma
4985757|NCT04080440|Intensive care units|intensive care units
4985758|NCT04080440|Critical care|critical care
4985759|NCT04080440|Stroke|stroke
4985760|NCT04080440|Traumatic brain injury|traumatic brain injury
4985761|NCT04080440|Anoxic ischemic encephalopathy|anoxic ischemic encephalopathy
4985762|NCT04080440|Glasgow coma scale|glasgow coma scale
4985763|NCT04080401|Rehabilitation|rehabilitation
4985764|NCT04080401|Gaming|gaming
4985765|NCT04080401|Exercise|exercise
4985766|NCT04080401|Knee Arthroplasty|knee arthroplasty
4985770|NCT04080284|Niraparib|niraparib
4985771|NCT04080284|uterine Cancer|uterine cancer
4985772|NCT04080284|papillary serous uterine cancer|papillary serous uterine cancer
4985773|NCT04080284|endometrial cancer|endometrial cancer
4985774|NCT04080284|serous uterine cancer|serous uterine cancer
4985775|NCT04080284|Endometrial|endometrial
4985776|NCT04080284|Endometrial Carcinoma|endometrial carcinoma
4985777|NCT04080284|Recurrent Uterine Carcinoma|recurrent uterine carcinoma
4985778|NCT04080284|platinum-sensitive|platinum-sensitive
4985779|NCT04080258|Headache Disorders|headache disorders
4985780|NCT04080258|Primary Headache|primary headache
4985781|NCT04080245|Vaccine|vaccine
4985782|NCT04080245|Influenza|influenza
4985783|NCT04080245|Efficacy|efficacy
4985784|NCT04080232|lung MRI performance|lung mri performance
4985785|NCT04080232|UTE|ute
4985786|NCT04080232|quantification|quantification
4985787|NCT04080232|oxygen transfer|oxygen transfer
4985792|NCT04080193|Gender|gender
4985805|NCT04080167|health innovation|health innovation
4985806|NCT04080141|Therapeutic Abortion|therapeutic abortion
4985807|NCT04080141|Personality Disorders|personality disorders
4985808|NCT04080141|Childhood Trauma|childhood trauma
4985809|NCT04080141|Post Traumatic Stress Disorder|post traumatic stress disorder
4985811|NCT04080050|LDL Receptors|ldl receptors
4985812|NCT04080050|Gene Therapy|gene therapy
4985813|NCT04080050|Metabolic Diseases|metabolic diseases
4985814|NCT04080050|Rare Diseases|rare diseases
4985815|NCT04080050|Genetic Diseases|genetic diseases
4985816|NCT04080050|Atherosclerosis|atherosclerosis
4985818|NCT04079985|Animal-assisted therapy|animal-assisted therapy
4985819|NCT04079985|Chronic Pain|chronic pain
4985820|NCT04079985|Elderly|elderly
4985821|NCT04079985|Primary Health Care|primary health care
4985822|NCT04079946|cancer colon|cancer colon
4985823|NCT04079894|Accelerometry|accelerometry
4985824|NCT04079894|Walking|walking
4985825|NCT04079881|glucagon|glucagon
4985826|NCT04079881|post-prandial glucose|post-prandial glucose
4985827|NCT04079881|type 1 diabetes|type 1 diabetes
4985828|NCT04079868|Osteoporosis|osteoporosis
4985829|NCT04079868|Osteopenia|osteopenia
5002786|NCT03978429|Eclampsia|eclampsia
4985841|NCT04079777|Inflammatory necrosis;|inflammatory necrosis;
4985842|NCT04079764|bosniak classification|bosniak classification
4985843|NCT04079764|Bosniak III cyst|bosniak iii cyst
4985844|NCT04079764|Bosniak IV cyst|bosniak iv cyst
4985845|NCT04079764|complex renal mass|complex renal mass
4985846|NCT04079673|epidural anesthesia|epidural anesthesia
4985848|NCT04079660|hemoglobinA1c|hemoglobina1c
4985849|NCT04079660|serum fructosamine|serum fructosamine
4985850|NCT04079660|glycemic control|glycemic control
4985851|NCT04079608|Pregnancy|pregnancy
4985852|NCT04079608|Adolescents|adolescents
4985853|NCT04079608|STD|std
4985854|NCT04079608|Decision making|decision making
4985855|NCT04079608|Harm reduction|harm reduction
4985856|NCT04079608|Prevention education|prevention education
4985857|NCT04079582|Dialysate Magnesium|dialysate magnesium
4985858|NCT04079582|Kidney Disease|kidney disease
4985859|NCT04079582|Renal Insufficiency, Chronic|renal insufficiency, chronic
4985860|NCT04079582|Kidney Failure, Chronic|kidney failure, chronic
4985861|NCT04079582|Cluster Randomized Controlled Trial|cluster randomized controlled trial
4985862|NCT04079569|tobacco|tobacco
4985863|NCT04079569|smoking cessation|smoking cessation
4985864|NCT04079569|Asian Americans|asian americans
4985865|NCT04079543|Nil per os (NPO)|nil per os (npo)
4985866|NCT04079543|TAVR|tavr
4985867|NCT04079543|arrhythmia ablation|arrhythmia ablation
4985868|NCT04079517|Tamoxifen|tamoxifen
4985869|NCT04079517|Low-dose|low-dose
4985870|NCT04079517|Randomized Clinical Trial|randomized clinical trial
4985871|NCT04079504|Indirect inguinal hernia|indirect inguinal hernia
4985872|NCT04079504|Ligation of sac|ligation of sac
4985873|NCT04079504|Postoperative pain|postoperative pain
4985874|NCT04079491|oral mucosal lesions|oral mucosal lesions
4985875|NCT04079491|dental hygienist|dental hygienist
4985876|NCT04079478|Artificial Intelligence|artificial intelligence
4985877|NCT04079465|closed-loop|closed-loop
4985878|NCT04079465|oxygen treatment|oxygen treatment
4985879|NCT04079452|Doravirine|doravirine
4985880|NCT04079426|inflammasome|inflammasome
4985881|NCT04079426|Caspase|caspase
4985882|NCT04079426|NLRP3|nlrp3
4985883|NCT04079426|Antibiotics|antibiotics
4985884|NCT04079426|Tetracycline|tetracycline
4985885|NCT04079413|Insulin|insulin
4985886|NCT04079413|Insulin aspart|insulin aspart
4985887|NCT04079413|Aspart|aspart
4985888|NCT04079374|Etanercept|etanercept
4985889|NCT04079374|Enbrel|enbrel
4985893|NCT04079309|Orange Oil|orange oil
4985894|NCT04079309|Pediatric Dentistry|pediatric dentistry
4985895|NCT04079309|Deep Sedation|deep sedation
4985900|NCT04079283|Response Evaluation Criteria in Solid Tumors|response evaluation criteria in solid tumors
4985901|NCT04079283|Computed Tomography|computed tomography
4985914|NCT04079231|double-masked|double-masked
4985915|NCT04079218|HIV Infection|hiv infection
4985916|NCT04079218|Vaginal Atrophy|vaginal atrophy
4985917|NCT04079218|Menopause|menopause
4985918|NCT04079218|Vaginal Microbiome|vaginal microbiome
4985919|NCT04079218|Microbiome|microbiome
4985920|NCT04079218|Dysbiosis|dysbiosis
4985921|NCT04079218|Aging|aging
4985922|NCT04079218|Premature Aging|premature aging
4985923|NCT04079218|Atrophic Vaginitis|atrophic vaginitis
4985924|NCT04079205|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4985925|NCT04079205|Wearable device|wearable device
4985926|NCT04079205|Knee|knee
4985927|NCT04079205|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4985928|NCT04079205|Exercise|exercise
4985929|NCT04079192|Drug-Coated Balloon|drug-coated balloon
4985930|NCT04079179|Cobimetinib|cobimetinib
4985931|NCT04079179|Langerhans Cell Histiocytosis (LCH)|langerhans cell histiocytosis (lch)
4985932|NCT04079153|mandibular advancement appliance, protrusion|mandibular advancement appliance, protrusion
4985936|NCT04079075|Exercise Therapy|exercise therapy
5308702|NCT02135302|hepatic|hepatic
4985937|NCT04079075|Cognition Disorders|cognition disorders
4985938|NCT04079075|Neuropsychological Tests|neuropsychological tests
4985939|NCT04079075|Hearing Loss|hearing loss
4985940|NCT04079075|Memory Disorders|memory disorders
4985941|NCT04079075|Cognitive Remediation|cognitive remediation
4985942|NCT04079075|Non-Randomized Controlled Trials as Topic|non-randomized controlled trials as topic
4985943|NCT04079036|General Anesthesia|general anesthesia
4985944|NCT04079036|Anesthesia Awareness|anesthesia awareness
4985945|NCT04079036|Anesthesia overdose|anesthesia overdose
4985946|NCT04079010|blood flow restriction|blood flow restriction
4985947|NCT04079010|growth hormone|growth hormone
4985948|NCT04079010|strength outcomes|strength outcomes
4985949|NCT04079010|arginine|arginine
4985950|NCT04078997|Pneumococcal carriage|pneumococcal carriage
4985951|NCT04078997|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
4985952|NCT04078997|Vaccine schedule|vaccine schedule
4985953|NCT04078997|Evaluation|evaluation
4985954|NCT04078997|Children|children
4985955|NCT04078997|Herd immunity|herd immunity
4985956|NCT04078997|Malawi|malawi
4985957|NCT04078984|Pressure Support Ventilation|pressure support ventilation
4985958|NCT04078984|Mechanical Ventilation Weaning Time|mechanical ventilation weaning time
4985959|NCT04078984|Driving Pressure|driving pressure
4985960|NCT04078984|Respiratory Weaning|respiratory weaning
4985961|NCT04078984|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4985962|NCT04078984|Ventilation Induced Lung Injury|ventilation induced lung injury
4985963|NCT04078971|ketogenic diet|ketogenic diet
4985964|NCT04078971|western diet|western diet
4985966|NCT04078971|sport performance|sport performance
4985967|NCT04078971|muscle mass|muscle mass
4985968|NCT04078971|body composition|body composition
4985969|NCT04078945|strength|strength
4985970|NCT04078945|risk factors|risk factors
4985971|NCT04078945|youth volleyball players|youth volleyball players
4985972|NCT04078906|Intravenous lipid emulsions|intravenous lipid emulsions
4985973|NCT04078906|SMOF|smof
4985974|NCT04078906|Preterm Infants|preterm infants
4985975|NCT04078893|inactivated donors recruitment, on need ,communication|inactivated donors recruitment, on need ,communication
4985976|NCT04078867|Tricuspid valve|tricuspid valve
4985977|NCT04078867|Functional tricuspid regurgitation|functional tricuspid regurgitation
4985978|NCT04078867|Suture annuloplasty|suture annuloplasty
4985979|NCT04078867|Ring annuloplasty|ring annuloplasty
4985980|NCT04078854|Diabetic Foot|diabetic foot
4985981|NCT04078854|Sexual Dysfunction|sexual dysfunction
4985982|NCT04078854|Amputation|amputation
4985983|NCT04078828|minimally invasive surgical|minimally invasive surgical
4985984|NCT04078815|Advance Directive|advance directive
4985985|NCT04078815|Advance Care Planning|advance care planning
4985986|NCT04078815|Decision Making|decision making
4985987|NCT04078815|Autonomy|autonomy
4985988|NCT04078815|Justice|justice
4985989|NCT04078815|Emergency Care|emergency care
4985997|NCT04078763|Spatial hearing perception|spatial hearing perception
4985998|NCT04078763|cochlear prosthesis implantation users|cochlear prosthesis implantation users
4986000|NCT04078763|rehabilitation|rehabilitation
4986001|NCT04078737|stroke|stroke
4986002|NCT04078737|transient ischemic attack|transient ischemic attack
4986003|NCT04078737|acute treatment|acute treatment
4986004|NCT04078737|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
4986005|NCT04078737|clopidogrel|clopidogrel
4986006|NCT04078737|ticagrelor|ticagrelor
4986007|NCT04078737|clopidogrel combined with ASA|clopidogrel combined with asa
4986008|NCT04078737|ticagrelor combined with ASA|ticagrelor combined with asa
4986009|NCT04078737|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
4986010|NCT04078737|CYP2C19 loss-of-function allele(s) carrier|cyp2c19 loss-of-function allele(s) carrier
4986011|NCT04078724|Nutritional supplementation|nutritional supplementation
4986012|NCT04078724|Sleep quality|sleep quality
4986013|NCT04078724|Cognitive function|cognitive function
4986014|NCT04078724|Gut microbiome|gut microbiome
4986015|NCT04078711|hypertension|hypertension
4986016|NCT04078711|chronic kidney disease|chronic kidney disease
4986017|NCT04078711|traditional chinese medicine|traditional chinese medicine
4986018|NCT04078711|early renal injury|early renal injury
4986019|NCT04078711|albumin to creatinine ratio(UACR)|albumin to creatinine ratio(uacr)
4986020|NCT04078698|Therapeutic apheresis|therapeutic apheresis
4986021|NCT04078698|Immune apheresis|immune apheresis
4986022|NCT04078646|Carotenoids|carotenoids
4986034|NCT04078607|Ingestive behavior|ingestive behavior
4986035|NCT04078607|Rapid visual information processing|rapid visual information processing
4986037|NCT04078594|ward patients|ward patients
4986038|NCT04078594|Screening|screening
4986039|NCT04078594|qSOFA|qsofa
4986040|NCT04078581|Selection of healthy donors|selection of healthy donors
4986041|NCT04078581|Healthy volunteers|healthy volunteers
4986042|NCT04078581|Stool donors|stool donors
4986043|NCT04078581|Fecal microbiota transplantation|fecal microbiota transplantation
4986047|NCT04078516|diabetes|diabetes
4986048|NCT04078516|neuropathy|neuropathy
4986049|NCT04078516|early detection|early detection
5295744|NCT02197702|RCT|rct
4986050|NCT04078516|small nerve fibers|small nerve fibers
4986051|NCT04078503|neuroinflammation|neuroinflammation
4986052|NCT04078503|fMRI|fmri
4986053|NCT04078503|Functional MRI|functional mri
4986054|NCT04078503|ICU related delirium|icu related delirium
4986055|NCT04078477|Presure Ulcer|presure ulcer
4986056|NCT04078477|Neurocritical Care|neurocritical care
4986057|NCT04078477|Acute Brain Disease|acute brain disease
4986058|NCT04078477|Unconsciousness|unconsciousness
4986059|NCT04078477|Preventive Strategy|preventive strategy
4986060|NCT04078464|Mindfulness|mindfulness
4986061|NCT04078464|Physical Activity|physical activity
4986062|NCT04078451|cholecystectomy|cholecystectomy
4986063|NCT04078451|Laparoscopic|laparoscopic
4986064|NCT04078438|Treatment-resistant depression|treatment-resistant depression
4986065|NCT04078438|Neurofeedback|neurofeedback
4986066|NCT04078438|Functional recovery|functional recovery
4986067|NCT04078425|Heart failure|heart failure
4986068|NCT04078425|Echocardiography|echocardiography
4986069|NCT04078412|Nontuberculous mycobacteria|nontuberculous mycobacteria
4986070|NCT04078412|pulmonary|pulmonary
4986072|NCT04078399|azacitidine|azacitidine
4986073|NCT04078399|HSCT|hsct
4986074|NCT04078399|interferon|interferon
4986075|NCT04078399|safety|safety
4986076|NCT04078399|Efficacy|efficacy
4986077|NCT04078373|stroke|stroke
4986078|NCT04078373|inpatient rehabilitation|inpatient rehabilitation
4986079|NCT04078373|urinary disorders|urinary disorders
4986080|NCT04078373|treatment|treatment
4986081|NCT04078360|Hazardous Drinking, mHealth, India, Brief intervention|hazardous drinking, mhealth, india, brief intervention
4986082|NCT04078347|Peripheral nerve block|peripheral nerve block
4986083|NCT04078347|laser speckle contrast imaging|laser speckle contrast imaging
4986084|NCT04078347|thermography|thermography
4986089|NCT04078308|Diabetes Mellitus|diabetes mellitus
4986090|NCT04078308|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4986091|NCT04078308|Cell Transplantation|cell transplantation
4986092|NCT04078308|Autologous Transplantation|autologous transplantation
4986093|NCT04078308|Mesenchymal Stem Cell|mesenchymal stem cell
4986094|NCT04078295|E7389 liposomal formulation|e7389 liposomal formulation
4986095|NCT04078295|Nivolumab|nivolumab
4986096|NCT04078295|Neoplasms|neoplasms
4986097|NCT04078295|Solid Tumor|solid tumor
4986112|NCT04078204|Cerebral Small Vessel Diseases|cerebral small vessel diseases
4986113|NCT04078204|Clinical Study|clinical study
4986114|NCT04078191|tilmanocept|tilmanocept
4986115|NCT04078191|RA imaging|ra imaging
4986116|NCT04078191|synovial biopsy|synovial biopsy
4986117|NCT04078165|radiation protection|radiation protection
4986118|NCT04078165|EVAR|evar
4986121|NCT04078152|urothelial cancer|urothelial cancer
4986123|NCT04078152|long-term safety, efficacy|long-term safety, efficacy
4986124|NCT04078152|overall survival|overall survival
4986125|NCT04078152|immunotherapy|immunotherapy
4986126|NCT04078152|checkpoint inhibitor|checkpoint inhibitor
4986127|NCT04078152|PD-L1|pd-l1
4986128|NCT04078152|retreatment|retreatment
4986129|NCT04078152|Gastric adenocarcinoma|gastric adenocarcinoma
4986130|NCT04078139|Postoperative Pain;|postoperative pain;
4986131|NCT04078139|Post-Craniotomy;|post-craniotomy;
4986132|NCT04078139|Methylprednisolone|methylprednisolone
4986133|NCT04078139|Ropivacaine|ropivacaine
4986134|NCT04078139|Scalp Infiltration|scalp infiltration
4986136|NCT04078113|Pupillary dilation|pupillary dilation
4986137|NCT04078113|Analgosedated|analgosedated
4986138|NCT04078113|Mechanically ventilation|mechanically ventilation
4986139|NCT04078100|mitral valve replacement|mitral valve replacement
4986140|NCT04078100|transseptal approach|transseptal approach
4986141|NCT04078100|left atrial approach|left atrial approach
4986142|NCT04078100|mital valve repair|mital valve repair
4986143|NCT04078087|Body mass index|body mass index
4986144|NCT04078087|Follicular phase|follicular phase
4986145|NCT04078087|Injection pain|injection pain
4986146|NCT04078087|Luteal phase|luteal phase
4986147|NCT04078087|Menopause|menopause
4986148|NCT04078087|Menstrual cycle|menstrual cycle
4986149|NCT04078087|Visual analogue scale|visual analogue scale
4986153|NCT04078048|Positive and Negative syndrome scale (PANSS)|positive and negative syndrome scale (panss)
4986154|NCT04078048|Antioxidants|antioxidants
4986155|NCT04078048|Schizophrenia|schizophrenia
4986156|NCT04078009|Grass pollen allergy|grass pollen allergy
4986157|NCT04078009|Hayfever|hayfever
4986158|NCT04078009|Atopy|atopy
4986159|NCT04078009|Allergic rhinitis|allergic rhinitis
4986160|NCT04078009|Nasal allergen challenge|nasal allergen challenge
4986161|NCT04077996|PERITONITIS|peritonitis
4986162|NCT04077996|AUTOMATED PERITONEAL DIALYSIS|automated peritoneal dialysis
5704056|NCT00487292|sleepiness|sleepiness
4986163|NCT04077996|TREATMENT OF PERITONITIS|treatment of peritonitis
4986164|NCT04077983|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4986165|NCT04077983|nab-paclitaxel and gemcitabine chemotherapy|nab-paclitaxel and gemcitabine chemotherapy
4986166|NCT04077957|disease modifying anti-rheumatic drugs(DMARDs)|disease modifying anti-rheumatic drugs(dmards)
4986167|NCT04077957|etanercept|etanercept
4986168|NCT04077957|ankylosing spondylitis|ankylosing spondylitis
4986169|NCT04077957|spondyloarthritis|spondyloarthritis
4986170|NCT04077957|treat-to-target|treat-to-target
4986171|NCT04077931|Aerobic|aerobic
4986172|NCT04077931|Exercises|exercises
4986173|NCT04077931|Blood Oxygenation|blood oxygenation
4986174|NCT04077931|Pregnancy|pregnancy
4986175|NCT04077905|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
4986176|NCT04077892|budesonide|budesonide
4986177|NCT04077892|montelukast|montelukast
4986178|NCT04077892|combination therapy|combination therapy
4986179|NCT04077892|monotherapy|monotherapy
4986180|NCT04077879|ASP1617|asp1617
4986181|NCT04077879|Food Effect|food effect
4986182|NCT04077879|Pharmacokinetics|pharmacokinetics
4986183|NCT04077879|Healthy Volunteers|healthy volunteers
4986203|NCT04077697|Intensive Care Unit|intensive care unit
4986204|NCT04077697|mortality|mortality
4986205|NCT04077671|DFU|dfu
4986206|NCT04077671|Diabetic Foot Ulcers|diabetic foot ulcers
4986207|NCT04077671|Diabetic Neuropathic Foot Ulcers|diabetic neuropathic foot ulcers
4986208|NCT04077658|HeartMath app|heartmath app
4986209|NCT04077658|Inner Balance Sensor|inner balance sensor
4986210|NCT04077645|physical activity|physical activity
4986211|NCT04077645|walking|walking
4986212|NCT04077645|moderate intensity|moderate intensity
4986213|NCT04077645|acute intervention|acute intervention
4986214|NCT04077606|interleukin 1 beta, bacterial adhesion,monolithic zirconia|interleukin 1 beta, bacterial adhesion,monolithic zirconia
4986229|NCT04077541|experimental design|experimental design
4986230|NCT04077528|Severe asthma|severe asthma
4986231|NCT04077528|Adult|adult
4986232|NCT04077528|Respiratory disease|respiratory disease
4986233|NCT04077515|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
4986250|NCT04077411|Intracranial hypertension|intracranial hypertension
4986252|NCT04077411|Hypersmolar therapies|hypersmolar therapies
4986253|NCT04077411|Prophylactic hyperventilation|prophylactic hyperventilation
4986254|NCT04077411|Metabolism|metabolism
4986255|NCT04077411|Neuropsychology|neuropsychology
4986256|NCT04077346|Pediatric-onset|pediatric-onset
4986257|NCT04077346|Transcutaneous spinal stimulation|transcutaneous spinal stimulation
4986258|NCT04077346|Stepping|stepping
4986259|NCT04077320|memory|memory
4986260|NCT04077320|older adults|older adults
4986261|NCT04077320|randomized control trial|randomized control trial
4986262|NCT04077320|MRI|mri
4986263|NCT04077320|memory education|memory education
4986264|NCT04077307|AML|aml
4986265|NCT04077307|ALL|all
4986266|NCT04077307|MDS|mds
4986267|NCT04077294|Preoperative BNP|preoperative bnp
4986268|NCT04077294|Perioperative cardiac risk stratification|perioperative cardiac risk stratification
4986269|NCT04077294|Myocardial injury after non-cardiac surgery (MINS)|myocardial injury after non-cardiac surgery (mins)
4986270|NCT04077294|Canadian Cardiovascular Society (CCS) guidelines|canadian cardiovascular society (ccs) guidelines
4986271|NCT04077281|Polypharmacy|polypharmacy
4986273|NCT04077255|FGFR2|fgfr2
4986274|NCT04077242|hysteroscopy|hysteroscopy
4986275|NCT04077242|Parryscope|parryscope
4986276|NCT04077242|chromopertubation|chromopertubation
4986378|NCT04076748|analgesia|analgesia
4986281|NCT04077216|Diabetes Mellitus Type 2|diabetes mellitus type 2
4986282|NCT04077216|Diet therapy|diet therapy
4986283|NCT04077216|Extra virgin olive oil|extra virgin olive oil
4986284|NCT04077164|Couples|couples
4986285|NCT04077164|Relationships|relationships
4986286|NCT04077164|Physical Activity|physical activity
4986287|NCT04077151|Transgender|transgender
4986288|NCT04077151|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4986289|NCT04077151|HIV Prevention|hiv prevention
4986290|NCT04077151|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
4986291|NCT04077151|Cross-sex Hormone Therapy|cross-sex hormone therapy
4986292|NCT04077151|Adherence|adherence
4986293|NCT04077151|Behavior Change|behavior change
4986294|NCT04077151|Gender Affirmation|gender affirmation
4986295|NCT04077138|Transgender|transgender
4986296|NCT04077138|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
4986297|NCT04077138|HIV Prevention|hiv prevention
4986298|NCT04077138|Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC)|tenofovir disoproxil fumarate/emtricitabine (tdf/ftc)
4986299|NCT04077138|Cross-sex Hormone Therapy|cross-sex hormone therapy
4986300|NCT04077138|Adherence|adherence
4986301|NCT04077138|Behavior Change|behavior change
4986302|NCT04077138|Gender Affirmation|gender affirmation
4986303|NCT04077099|MET (mesenchymal-epithelial transition factor)|met (mesenchymal-epithelial transition factor)
4986304|NCT04077099|HGF (Hepatocyte Growth Factor)|hgf (hepatocyte growth factor)
4986305|NCT04077099|NSCLC (non-small cell lung cancer)|nsclc (non-small cell lung cancer)
4986306|NCT04077099|MET-altered advanced|met-altered advanced
4986307|NCT04077099|Unresectable|unresectable
4986308|NCT04077099|Metastatic disease|metastatic disease
4986309|NCT04077086|Refractive error|refractive error
4986310|NCT04077086|Myopia|myopia
4986311|NCT04077086|Academic high school attendance|academic high school attendance
4986312|NCT04077086|Education attainment|education attainment
4986313|NCT04077086|Spectacle wear compliance|spectacle wear compliance
4986321|NCT04077047|Adolescents|adolescents
4990309|NCT04052464|biopsy|biopsy
4986330|NCT04076969|Iron deficiency|iron deficiency
4986331|NCT04076969|Moderate anemia|moderate anemia
4986332|NCT04076969|Compliance|compliance
4986333|NCT04076956|Knee ligament injury|knee ligament injury
5003285|NCT03975751|intensive care unit|intensive care unit
4986334|NCT04076956|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
4986335|NCT04076956|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4986336|NCT04076956|Knee ligament rupture|knee ligament rupture
4986337|NCT04076956|Knee ligament reconstruction|knee ligament reconstruction
5304748|NCT02153814|Infertility|infertility
4986339|NCT04076943|Chemotherapy induced anemia|chemotherapy induced anemia
4986340|NCT04076943|Myelosuppressive chemotherapy|myelosuppressive chemotherapy
4986341|NCT04076943|Non-Myeloid malignances|non-myeloid malignances
4986342|NCT04076930|Cardiovascular|cardiovascular
4986343|NCT04076930|Hyperkalemia|hyperkalemia
4986344|NCT04076930|Mortality|mortality
4986345|NCT04076930|Peritoneal dialysis|peritoneal dialysis
4986346|NCT04076930|Renin-angiotensin system|renin-angiotensin system
4986347|NCT04076930|Retrospective cohort|retrospective cohort
4986348|NCT04076878|Spasticity|spasticity
4986349|NCT04076878|Stroke|stroke
4986350|NCT04076878|Functioning|functioning
4986351|NCT04076878|Disability|disability
4986352|NCT04076878|Intervention|intervention
4986353|NCT04076878|electrical stimulation therapy|electrical stimulation therapy
4986354|NCT04076839|cognitive remediation|cognitive remediation
4986355|NCT04076839|public safety personnel|public safety personnel
4986356|NCT04076839|Goal Management Training|goal management training
4986357|NCT04076839|Group therapy|group therapy
4986358|NCT04076839|first responders|first responders
4986359|NCT04076839|military|military
4986360|NCT04076826|Sepsis|sepsis
4986361|NCT04076826|Dexmedetomidine|dexmedetomidine
4986362|NCT04076826|Sedation|sedation
4986363|NCT04076826|S-100beta|s-100beta
4986364|NCT04076826|Encephalopathy|encephalopathy
4986365|NCT04076800|acupuncture|acupuncture
4986366|NCT04076800|insulin sensitivity|insulin sensitivity
4986367|NCT04076787|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
4986368|NCT04076787|Sunitinib|sunitinib
4986369|NCT04076774|female condom|female condom
4986370|NCT04076774|HIV and STI prevention|hiv and sti prevention
4986371|NCT04076774|Condom acceptability|condom acceptability
4986372|NCT04076774|Wondaleaf|wondaleaf
4986374|NCT04076761|Cholangiocarcinoma|cholangiocarcinoma
4986375|NCT04076761|Bile Duct Cancer|bile duct cancer
4986376|NCT04076761|FTD/TPI|ftd/tpi
4986377|NCT04076761|TRIFLURIDINE/TIPIRACIL|trifluridine/tipiracil
4986385|NCT04076722|Adverse childhood experiences|adverse childhood experiences
4986386|NCT04076722|Executive function|executive function
4986387|NCT04076722|Brain health|brain health
4986388|NCT04076696|Chest|chest
4986389|NCT04076696|Lung|lung
4986390|NCT04076696|Tomography|tomography
4986391|NCT04076696|Scatter|scatter
4986392|NCT04076683|Algorithm|algorithm
4986393|NCT04076683|Apherisis|apherisis
4986394|NCT04076683|Sickle cell patients|sickle cell patients
4986395|NCT04076670|Intervention study|intervention study
4986396|NCT04076670|Family caregiver|family caregiver
4986397|NCT04076670|Overburden|overburden
4986398|NCT04076670|Anxiety|anxiety
4986399|NCT04076670|Depression|depression
4986400|NCT04076657|brock string|brock string
4986401|NCT04076657|sport-concussion|sport-concussion
4986402|NCT04076657|concussion therapy|concussion therapy
4986403|NCT04076657|receded near point of convergence|receded near point of convergence
4986405|NCT04076618|nutrition|nutrition
4986406|NCT04076618|vest|vest
4986407|NCT04076605|Decompensated|decompensated
4986408|NCT04076605|Liver|liver
4986409|NCT04076605|Coagulopathy|coagulopathy
4986410|NCT04076605|ACLF|aclf
4986411|NCT04076592|Nutritional Intake,|nutritional intake,
4986412|NCT04076592|Child Growth and Development|child growth and development
4986413|NCT04076592|Bone Density|bone density
4986414|NCT04076592|Antibiotics|antibiotics
4986415|NCT04076566|OVARIAN|ovarian
4986416|NCT04076566|COLORECTAL|colorectal
4986417|NCT04076566|PARACENTESIS|paracentesis
4986422|NCT04076527|ursodeoxycholic acid|ursodeoxycholic acid
4986423|NCT04076527|UDCA|udca
4986424|NCT04076527|obeticholic acid|obeticholic acid
4986425|NCT04076527|OCALIVA|ocaliva
4986426|NCT04076527|Cohort|cohort
4986427|NCT04076527|observational study|observational study
4986428|NCT04076527|Bezafibrat|bezafibrat
4986429|NCT04076527|Budesonide|budesonide
4986430|NCT04076488|Telemedicine|telemedicine
4986431|NCT04076488|Exercise|exercise
4986433|NCT04076475|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4986434|NCT04076475|tissue oxygenation|tissue oxygenation
4986435|NCT04076475|prolonged mechanical ventilation|prolonged mechanical ventilation
4986436|NCT04076475|metabolic|metabolic
4986441|NCT04076449|Cerebral Cavernous Malformation|cerebral cavernous malformation
4986442|NCT04076449|Epilepsy|epilepsy
4986443|NCT04076449|Quantitative Susceptibility Mapping (QSM)|quantitative susceptibility mapping (qsm)
4986444|NCT04076449|Brain Connectome|brain connectome
4986445|NCT04076449|Cerebral Structure|cerebral structure
4986446|NCT04076436|Prospective follow-up study|prospective follow-up study
4986447|NCT04076436|Real-life conditions|real-life conditions
4986448|NCT04076436|Complicated urinary tract infection|complicated urinary tract infection
4986449|NCT04076436|Escherichia coli infection|escherichia coli infection
4986453|NCT04076436|Microbiological failure|microbiological failure
4986454|NCT04076436|Resistance development|resistance development
4986455|NCT04076410|photosensitivity|photosensitivity
4986456|NCT04076410|pattern sensitivity|pattern sensitivity
4986457|NCT04076410|Electroencephalography|electroencephalography
4986458|NCT04076410|Photic Stimulation|photic stimulation
5304852|NCT02153320|HBsAg|hbsag
4986459|NCT04076410|Pattern Stimulation|pattern stimulation
4986460|NCT04076410|photoparoxysmal response|photoparoxysmal response
4986461|NCT04076410|Light, Visible|light, visible
4986462|NCT04076410|Red Colour|red colour
4986463|NCT04076410|Blue Light|blue light
4986464|NCT04076410|Retina|retina
4986465|NCT04076410|Macular Degeneration|macular degeneration
4986466|NCT04076397|annoying pulpal dysesthesia|annoying pulpal dysesthesia
4986467|NCT04076397|lipofilling|lipofilling
4986468|NCT04076397|amputation|amputation
4986469|NCT04076397|sequelae|sequelae
4986470|NCT04076371|schizophrenia|schizophrenia
4986471|NCT04076371|sertraline|sertraline
4986472|NCT04076371|olanzapine|olanzapine
4986473|NCT04076371|risperidone|risperidone
4986474|NCT04076371|paliperidone|paliperidone
4986475|NCT04076371|ziprasidone|ziprasidone
4986476|NCT04076358|Rheumatoid Arthritis, fatigue|rheumatoid arthritis, fatigue
4986477|NCT04076345|presepsin|presepsin
4986478|NCT04076345|biomarker|biomarker
4986479|NCT04076345|newborns|newborns
4986480|NCT04076345|infants under 3 months of age|infants under 3 months of age
4986481|NCT04076345|fever|fever
4986583|NCT04075630|childbirth|childbirth
4986482|NCT04076345|paediatric emergency|paediatric emergency
4986483|NCT04076280|Hypertension|hypertension
4986484|NCT04076280|Low Sodium Diet|low sodium diet
4986485|NCT04076254|albumin 5%|albumin 5%
4986486|NCT04076254|resuscitation|resuscitation
4986487|NCT04076241|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
4986488|NCT04076241|Pranayama|pranayama
4986489|NCT04076241|Nitric Oxide|nitric oxide
4986490|NCT04076241|Cardiopulmonary|cardiopulmonary
4986491|NCT04076241|Complementary Therapy|complementary therapy
4986492|NCT04076228|NSCLC|nsclc
4986493|NCT04076228|PD-L1|pd-l1
4986494|NCT04076228|Biomarkers|biomarkers
4986495|NCT04076202|Knee replacement|knee replacement
4986496|NCT04076202|Knee Osteoarthritis|knee osteoarthritis
4986497|NCT04076189|Infant newborn|infant newborn
5030859|NCT03806426|EPA|epa
4986498|NCT04076189|Meconium Aspiration Syndrome|meconium aspiration syndrome
4986499|NCT04076189|Neonatal Resuscitation|neonatal resuscitation
4986500|NCT04076189|Positive Pressure Ventilation|positive pressure ventilation
4986501|NCT04076176|Phenylketonuria|phenylketonuria
4986502|NCT04076176|PKU|pku
4986503|NCT04076176|Child|child
4986504|NCT04076176|Adult|adult
4986505|NCT04076176|GMP|gmp
4986506|NCT04076176|Glycomacropeptide|glycomacropeptide
4986507|NCT04076137|Targeted T-cell|targeted t-cell
4986508|NCT04076137|HER2|her2
4986509|NCT04076137|MUC1|muc1
4986510|NCT04076137|CEA|cea
4986511|NCT04076137|EGFR|egfr
4986512|NCT04076137|GPC3|gpc3
4986513|NCT04076072|vitrectomy|vitrectomy
4986514|NCT04076059|Metastatic hormone sensitive prostate cancer|metastatic hormone sensitive prostate cancer
4986515|NCT04076059|Androgen Deprivation Therapy (ADT)|androgen deprivation therapy (adt)
4986516|NCT04076059|Xtandi|xtandi
4986517|NCT04076059|MDV3100|mdv3100
4986518|NCT04076059|Enzalutamide|enzalutamide
4986519|NCT04076046|pituitary adenoma endoscopic surgery zurich pituitary score|pituitary adenoma endoscopic surgery zurich pituitary score
4986520|NCT04076033|Functional Compressive Bandage|functional compressive bandage
4986521|NCT04076033|Lymphedema|lymphedema
4986522|NCT04076033|Physiotherapy|physiotherapy
4986523|NCT04076020|Adherence|adherence
4986524|NCT04076020|Health Literacy|health literacy
4986525|NCT04076020|quality of life|quality of life
4986526|NCT04076007|nitrate|nitrate
4986527|NCT04076007|nitrite|nitrite
4986528|NCT04076007|nitric oxide|nitric oxide
4986529|NCT04076007|diabetes|diabetes
4986530|NCT04076007|hypertension|hypertension
4986531|NCT04075994|Quality of Life (QoL)|quality of life (qol)
4986532|NCT04075994|Adherence|adherence
4986533|NCT04075994|Health Literacy|health literacy
4986534|NCT04075981|Xeomin®|xeomin®
4986535|NCT04075981|Botox|botox
4986536|NCT04075981|Botulinum|botulinum
4986537|NCT04075981|Atrial Fibrillation|atrial fibrillation
4986538|NCT04075981|Cardiac surgery|cardiac surgery
4986540|NCT04075929|endurance performance|endurance performance
4986541|NCT04075929|intermittent exercise|intermittent exercise
4986542|NCT04075929|maximal oxygen consumption|maximal oxygen consumption
4986543|NCT04075929|physiological adaptions|physiological adaptions
4986544|NCT04075929|well-trained athletes|well-trained athletes
4986545|NCT04075877|Pediatric cancer|pediatric cancer
4986546|NCT04075877|Pediatric Sickle Cell Disease|pediatric sickle cell disease
4986547|NCT04075877|Quality of Life|quality of life
4986548|NCT04075877|Randomized Controlled Trial|randomized controlled trial
4986551|NCT04075877|Narrative Psychology|narrative psychology
4986553|NCT04075851|Autoimmune thyroid disease|autoimmune thyroid disease
4986554|NCT04075851|Thyroid hormone autoantibodies|thyroid hormone autoantibodies
4986555|NCT04075851|Hashimoto's thyroiditis|hashimoto's thyroiditis
4986556|NCT04075851|Grave's disease|grave's disease
4986557|NCT04075825|Drug therapy|drug therapy
4986558|NCT04075812|reanimation|reanimation
4986559|NCT04075812|stimulation|stimulation
4986560|NCT04075799|obesity|obesity
4986561|NCT04075799|insulin resistance|insulin resistance
4986562|NCT04075799|high-intensity interval training|high-intensity interval training
4986563|NCT04075786|Uterine malformations|uterine malformations
4986564|NCT04075786|Hysteroscopy|hysteroscopy
4986565|NCT04075786|3D ultrasound|3d ultrasound
4986566|NCT04075786|Infertility|infertility
4986567|NCT04075721|M3258|m3258
4986568|NCT04075721|Dexamethasone|dexamethasone
4986569|NCT04075721|Pharmacokinetics|pharmacokinetics
4986570|NCT04075721|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
4986571|NCT04075695|ischemic index|ischemic index
4986572|NCT04075695|Ultra-wide field fundus fluorescein angiography|ultra-wide field fundus fluorescein angiography
4986573|NCT04075695|vascular leakage index|vascular leakage index
4986574|NCT04075669|Multiplex solid-phase strip PCR|multiplex solid-phase strip pcr
4986575|NCT04075669|Eye Infections|eye infections
4986576|NCT04075669|Endophthalmitis|endophthalmitis
4986577|NCT04075669|Corneal Ulcer|corneal ulcer
4986578|NCT04075669|Keratitis|keratitis
4986579|NCT04075669|Corneal Scraping Samples|corneal scraping samples
4986580|NCT04075656|Pediatrics|pediatrics
4986581|NCT04075656|mHealth|mhealth
4986582|NCT04075656|Behavioral intervention|behavioral intervention
4986600|NCT04075565|cognition|cognition
4986601|NCT04075539|Lumbar spinal stenosis|lumbar spinal stenosis
4986602|NCT04075539|Neurogenic claudication|neurogenic claudication
4986603|NCT04075539|Low back pain|low back pain
4986604|NCT04075539|Exercise therapy|exercise therapy
4986605|NCT04075539|Endurance training|endurance training
4986606|NCT04075539|Cycling|cycling
4986607|NCT04075539|Randomized trial|randomized trial
4986613|NCT04075448|Flavonoid|flavonoid
4986614|NCT04075448|Omega 3 Fatty Acid|omega 3 fatty acid
4986617|NCT04075409|Padsevonil|padsevonil
4986618|NCT04075409|CYP2C19|cyp2c19
4986619|NCT04075409|Healthy Japanese Participants|healthy japanese participants
5903460|NCT00368446|PCD|pcd
5903461|NCT00368446|CF|cf
4986620|NCT04075409|Pharmacokinetics|pharmacokinetics
4986621|NCT04075383|dental implant|dental implant
4986623|NCT04075383|quality of life|quality of life
4986624|NCT04075357|Amniotic membrane transplantation|amniotic membrane transplantation
4986625|NCT04075344|infection control ; bacterial contamination|infection control ; bacterial contamination
4986626|NCT04075331|COPD|copd
4986627|NCT04075331|eosinophilia|eosinophilia
4986628|NCT04075331|Chronic Obstructive Pulmonary Disorder|chronic obstructive pulmonary disorder
4986629|NCT04075331|Mepolizumab|mepolizumab
4986630|NCT04075292|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4986631|NCT04075292|Acalabrutinib|acalabrutinib
4986632|NCT04075292|Progression-free Survival|progression-free survival
4986633|NCT04075253|Exercise Training|exercise training
4986634|NCT04075240|total hip and knee arthroplasty|total hip and knee arthroplasty
4986635|NCT04075227|Impending recurrent pterygium|impending recurrent pterygium
4986636|NCT04075227|0.2% loteprednol etabonate|0.2% loteprednol etabonate
4986637|NCT04075227|0.1% dexamethasone|0.1% dexamethasone
4986638|NCT04075188|pachychoroid|pachychoroid
4986639|NCT04075188|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
4986640|NCT04075188|Aflibercept|aflibercept
4986641|NCT04075188|photodynamic therapy|photodynamic therapy
4986642|NCT04075188|Swept source OCT|swept source oct
4986643|NCT04075149|PCOS|pcos
4986644|NCT04075149|Polycystic Ovary Syndrome|polycystic ovary syndrome
4986645|NCT04075149|ovulation|ovulation
4986646|NCT04075149|puberty|puberty
4986647|NCT04075149|hyperandrogenemia|hyperandrogenemia
4986648|NCT04075149|androgen excess|androgen excess
4986649|NCT04075136|Macular degeneration|macular degeneration
4986650|NCT04075136|Lucentis|lucentis
4986651|NCT04075136|Triescense|triescense
4986652|NCT04075136|Photodynamic laser treatment|photodynamic laser treatment
4986653|NCT04075123|CPAP|cpap
4986654|NCT04075123|NIPPV|nippv
4986655|NCT04075123|INFANT, PREMATURE|infant, premature
4986656|NCT04075123|RESPIRATORY MANAGEMENT|respiratory management
4986657|NCT04075123|POST-ESTUBATION|post-estubation
4986658|NCT04075084|Implantable Cardiac Monitor|implantable cardiac monitor
4986659|NCT04075084|BIOMONITOR III|biomonitor iii
4986669|NCT04075058|Hypofractionated radiation|hypofractionated radiation
4986670|NCT04075045|High blood pressure|high blood pressure
4986671|NCT04075045|mobile health|mobile health
4986672|NCT04075045|behavioral economics|behavioral economics
4986673|NCT04075045|adherence|adherence
4986674|NCT04075045|non-compliance|non-compliance
4986675|NCT04075032|metabolic syndrome|metabolic syndrome
4986676|NCT04075032|pomegranate|pomegranate
4986677|NCT04075032|gut microbiota|gut microbiota
4986678|NCT04075032|polyphenol|polyphenol
4986679|NCT04075032|polymedication|polymedication
4986680|NCT04075032|inflammation|inflammation
4986682|NCT04075032|diabetes|diabetes
5404655|NCT01701414|Hip|hip
4986683|NCT04075032|hypertension|hypertension
4986684|NCT04075032|hyperlipidemia|hyperlipidemia
4986685|NCT04075032|urolithins|urolithins
4986686|NCT04075019|Proactive classroom management|proactive classroom management
4986687|NCT04075019|Interactive teaching|interactive teaching
4986688|NCT04075019|Cooperative learning|cooperative learning
4986689|NCT04075019|Interpersonal problem solving skills|interpersonal problem solving skills
4986690|NCT04075019|Refusal skills|refusal skills
4986691|NCT04075019|Behavior management skills|behavior management skills
4986692|NCT04075019|Academic support skills|academic support skills
4986693|NCT04075019|Skills to reduce risks for drug use|skills to reduce risks for drug use
4986694|NCT04075006|Ketamine, standard of care, critically ill, mechanically ventilation, ATTAINMENT, propofol, Fentanyl , midazolam , delirium, vasopressors|ketamine, standard of care, critically ill, mechanically ventilation, attainment, propofol, fentanyl , midazolam , delirium, vasopressors
4986695|NCT04074941|Sodium Intake|sodium intake
4986696|NCT04074941|Blood Pressure|blood pressure
4986697|NCT04074941|Hypertension|hypertension
4986698|NCT04074941|Physical Function|physical function
4986699|NCT04074941|Older Adults|older adults
4986700|NCT04074941|Randomized Controlled Trial|randomized controlled trial
4986701|NCT04074928|Influenza Vaccine|influenza vaccine
4986702|NCT04074889|Probiotics|probiotics
4986703|NCT04074889|Gut Liver Axis|gut liver axis
4986704|NCT04074876|pulmonary ultrasound|pulmonary ultrasound
4986705|NCT04074876|urgency orthopedic surgery|urgency orthopedic surgery
4986706|NCT04074876|major adverse cardiac events|major adverse cardiac events
4986707|NCT04074863|Distal radioulnar joint|distal radioulnar joint
4986708|NCT04074863|Darrach procedure|darrach procedure
4986709|NCT04074863|Ulnar head resection|ulnar head resection
5704057|NCT00487292|naps|naps
4986710|NCT04074863|Herbert prosthesis|herbert prosthesis
4986711|NCT04074863|Ulnar head replacement|ulnar head replacement
4986712|NCT04074850|Traumatic Brain Injury|traumatic brain injury
4986713|NCT04074850|Elderly|elderly
4986714|NCT04074850|Cognitive Impairment|cognitive impairment
4986715|NCT04074850|Quality of life|quality of life
4986716|NCT04074850|Impact|impact
4986717|NCT04074850|Health care economic costs|health care economic costs
4986718|NCT04074785|Abemaciclib|abemaciclib
4986719|NCT04074785|Bevacizumab|bevacizumab
4986720|NCT04074785|CDKN2A/B|cdkn2a/b
4986721|NCT04074785|CDK4/6|cdk4/6
4986722|NCT04074785|Verzenio|verzenio
4986723|NCT04074785|Avastin|avastin
4986725|NCT04074694|Parotitis|parotitis
4986726|NCT04074694|Juvenile|juvenile
4986727|NCT04074694|Sialoendoscopy|sialoendoscopy
4986728|NCT04074694|Watchfull waiting|watchfull waiting
4986729|NCT04074681|Gambling|gambling
4986730|NCT04074681|CBT|cbt
4986731|NCT04074681|Internet program|internet program
4986732|NCT04074681|Efficacy|efficacy
4986733|NCT04074655|Driving Simulator|driving simulator
4986734|NCT04074655|Virtual Reality|virtual reality
4986735|NCT04074642|macroadenoma|macroadenoma
4986736|NCT04074629|Multiple Sclerosis|multiple sclerosis
4986737|NCT04074629|Skin volatile organic compounds (VOCs)|skin volatile organic compounds (vocs)
4986738|NCT04074616|electric stimulation|electric stimulation
4986739|NCT04074603|Needle-free jet injection|needle-free jet injection
4986740|NCT04074603|Insulin glargine|insulin glargine
4986741|NCT04074590|ulcerative colitis, efficacy, safety|ulcerative colitis, efficacy, safety
4986742|NCT04074564|MASCT-I|masct-i
4986743|NCT04074564|the Efficacy|the efficacy
4986744|NCT04074564|Combined therapy|combined therapy
4990728|NCT04049890|adjustment|adjustment
4986755|NCT04074473|portal hypertension, esophageal varices, non-selective beta-blocker, acute kidney injury.|portal hypertension, esophageal varices, non-selective beta-blocker, acute kidney injury.
4986758|NCT04074421|Probiotics|probiotics
4986759|NCT04074421|IBS-D|ibs-d
4986760|NCT04074421|gut microbiota|gut microbiota
4986761|NCT04074395|oral pathology|oral pathology
4986762|NCT04074382|Patient Reported Outcome Measures|patient reported outcome measures
4986763|NCT04074382|Recovery of Function|recovery of function
4986764|NCT04074382|Rehabilitation|rehabilitation
4986765|NCT04074382|Disability Evaluation|disability evaluation
4986766|NCT04074382|Trauma Centers|trauma centers
4986767|NCT04074382|Trauma Severity Indices|trauma severity indices
4986768|NCT04074382|Advanced Trauma Life Support Care|advanced trauma life support care
4986769|NCT04074382|Multiple Trauma/Injuries|multiple trauma/injuries
4986770|NCT04074382|Wounds and Injuries|wounds and injuries
4986771|NCT04074382|Orthopedic Disorder|orthopedic disorder
4986772|NCT04074382|Surgery|surgery
4986773|NCT04074343|Gastric Adenocarcinoma|gastric adenocarcinoma
4986774|NCT04074343|TAS-102|tas-102
4986775|NCT04074343|Irinotecan|irinotecan
4986776|NCT04074343|Gastroesophageal Adenocarcinoma|gastroesophageal adenocarcinoma
4986777|NCT04074330|Drug Therapy|drug therapy
4986778|NCT04074278|mid-arm muscle circumference|mid-arm muscle circumference
4986789|NCT04074239|Fever|fever
4986790|NCT04074239|Pediatrics|pediatrics
4986791|NCT04074226|regional anesthesia|regional anesthesia
4986792|NCT04074226|postoperative pain|postoperative pain
4986793|NCT04074226|erector spinae plane block|erector spinae plane block
4986794|NCT04074226|quadratus lumborum block|quadratus lumborum block
4986795|NCT04074148|Patient Education|patient education
4986796|NCT04074148|Nepal|nepal
4986797|NCT04074148|Diabetes prevention|diabetes prevention
4986803|NCT04074122|Electromechanical Mapping|electromechanical mapping
4986804|NCT04074122|Risk Stratification|risk stratification
4986805|NCT04074109|telehealth|telehealth
4986806|NCT04074109|yoga|yoga
4986807|NCT04074083|Child health|child health
4986808|NCT04074083|Clinical guidelines|clinical guidelines
4986809|NCT04074083|South Africa|south africa
4986810|NCT04074083|Africa|africa
4986811|NCT04074083|electronic health intervention|electronic health intervention
4986812|NCT04074070|psoriasis|psoriasis
4986813|NCT04074070|psoriatic arthritis|psoriatic arthritis
4986814|NCT04074070|ultrasound|ultrasound
4986819|NCT04074005|Epidural analgesia|epidural analgesia
4986820|NCT04074005|Labor pain|labor pain
4986821|NCT04074005|Cesarean section rate|cesarean section rate
4986822|NCT04073953|G6PD|g6pd
4986823|NCT04073953|Hemolysis|hemolysis
4986824|NCT04073953|Primaquine|primaquine
4986825|NCT04073953|Pharmacokinetics|pharmacokinetics
4986826|NCT04073953|Malaria|malaria
5704852|NCT00483886|SCBM|scbm
4986827|NCT04073940|multiple sclerosis|multiple sclerosis
4986828|NCT04073940|ataxia|ataxia
4986829|NCT04073940|magnetic resonance imaging|magnetic resonance imaging
4986830|NCT04073940|structural connectivity|structural connectivity
4986831|NCT04073940|resting state functional connectivity|resting state functional connectivity
4986833|NCT04073940|wellness|wellness
4986834|NCT04073940|balance|balance
4986835|NCT04073940|mobility|mobility
4986836|NCT04073914|Diabetes|diabetes
4986837|NCT04073914|Adolescence|adolescence
4986838|NCT04073914|Parents|parents
4986839|NCT04073901|Aesthetic|aesthetic
4986840|NCT04073901|Endo-crowns|endo-crowns
4986841|NCT04073901|primary|primary
4986842|NCT04073901|molars|molars
4986843|NCT04073901|pulpotomy|pulpotomy
4986844|NCT04073901|zirconium|zirconium
4986845|NCT04073901|crowns|crowns
4986846|NCT04073862|Stepped-Care Trauma-Focused Cognitive Behavioral Therapy|stepped-care trauma-focused cognitive behavioral therapy
4986847|NCT04073784|Toripalimab|toripalimab
4986848|NCT04073784|Gemcitabine|gemcitabine
4986849|NCT04073784|Apatinib|apatinib
4986853|NCT04073758|Pectus Excavatum|pectus excavatum
4986854|NCT04073732|family physician contract services|family physician contract services
4986855|NCT04073732|physician agency theory|physician agency theory
4986856|NCT04073732|physician Behavior|physician behavior
4986857|NCT04073732|family physician|family physician
4986858|NCT04073732|health service supply|health service supply
4986859|NCT04073719|Kidney Stones, Urolithiasis, Hypocitraturia, Apple Cider Vinegar|kidney stones, urolithiasis, hypocitraturia, apple cider vinegar
4986860|NCT04073706|uterine cancer|uterine cancer
4986861|NCT04073706|sentinel node biopsy|sentinel node biopsy
4986862|NCT04073667|balance|balance
4986863|NCT04073667|proprioception|proprioception
4986864|NCT04073667|exercise|exercise
4986865|NCT04073667|cervical region|cervical region
4986866|NCT04073667|chiari malformation|chiari malformation
4986867|NCT04073667|rehabilitation|rehabilitation
4986868|NCT04073654|Dental implants|dental implants
4986869|NCT04073654|Implant surfaces|implant surfaces
4986870|NCT04073654|Marginal bone loss|marginal bone loss
4986872|NCT04073524|Supportive Environment Theory (SET)|supportive environment theory (set)
5006008|NCT03959137|Treatment choice|treatment choice
4986874|NCT04073524|Attention Restoration Theory (ART)|attention restoration theory (art)
4986875|NCT04073524|Nature-Body-Mind-Community (NBMC)|nature-body-mind-community (nbmc)
4986876|NCT04073511|Eungyosan|eungyosan
4986877|NCT04073511|Samsoeum|samsoeum
4986881|NCT04073446|Spinal Cord Stimulation|spinal cord stimulation
4986882|NCT04073446|Chronic Pain|chronic pain
4986886|NCT04073381|Blood Flow Restriction Training|blood flow restriction training
4986887|NCT04073381|Ergogenic Aids|ergogenic aids
4986888|NCT04073381|Abdominal Cancer|abdominal cancer
4986889|NCT04073355|exercise|exercise
4986890|NCT04073355|African American women|african american women
4986891|NCT04073355|mHealth|mhealth
4986892|NCT04073355|eHealth|ehealth
4986893|NCT04073355|smartphone|smartphone
4986894|NCT04073290|Rifaximin|rifaximin
4986895|NCT04073290|Lactulose|lactulose
4986896|NCT04073290|post-TIPS HE|post-tips he
4986897|NCT04073290|Prevention|prevention
4986898|NCT04073277|Acupuncture needle|acupuncture needle
4986899|NCT04073277|Supercritical fluid|supercritical fluid
4986900|NCT04073277|De-qi|de-qi
4986901|NCT04073277|Chinese medicine|chinese medicine
4986902|NCT04073251|Persistent cough|persistent cough
4986903|NCT04073251|Children|children
4986904|NCT04073212|dry needling|dry needling
4986905|NCT04073212|eccentric exercise|eccentric exercise
4986906|NCT04073212|concentric exercise|concentric exercise
4986907|NCT04073212|physical therapy|physical therapy
4986908|NCT04073212|heavy slow load exercise|heavy slow load exercise
4986909|NCT04073199|stretching,teres major, subacromial syndrome, manual therapy|stretching,teres major, subacromial syndrome, manual therapy
4986910|NCT04073173|RDS|rds
4986911|NCT04073173|Preterm Infants|preterm infants
4986912|NCT04073173|Surfactant|surfactant
5309526|NCT02131571|HIV|hiv
4986913|NCT04073173|LISA|lisa
4986914|NCT04073173|INSURE|insure
4986915|NCT04073173|Analgesia|analgesia
4986916|NCT04073173|Stress|stress
4986917|NCT04073160|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
4986918|NCT04073160|Decipher bladder test|decipher bladder test
4986919|NCT04073160|Durvalumab|durvalumab
4986920|NCT04073160|Tremelimumab|tremelimumab
4986921|NCT04073160|Bladder radiation|bladder radiation
4986922|NCT04073160|Urothelial carcinoma of the bladder|urothelial carcinoma of the bladder
4986923|NCT04073147|venetoclax|venetoclax
4986924|NCT04073147|obinutuzumab|obinutuzumab
4986925|NCT04073147|pharmacokinetics|pharmacokinetics
4986926|NCT04073134|Coronary Artery Disease|coronary artery disease
4986927|NCT04073134|Atherosclerosis|atherosclerosis
4986928|NCT04073121|Angioplasty|angioplasty
4986929|NCT04073121|Drug Coated Balloon|drug coated balloon
4986930|NCT04073121|Drug Coated Stents|drug coated stents
5704853|NCT00483886|PAC-SYM|pac-sym
4986931|NCT04073095|Lumbar spinal surgery|lumbar spinal surgery
4986932|NCT04073095|Postoperative pain management|postoperative pain management
4986933|NCT04073095|Erector spina plane block|erector spina plane block
4986934|NCT04073095|Modified thoracolumbar interfacial plane block|modified thoracolumbar interfacial plane block
4986935|NCT04073069|Postoperative Pain;|postoperative pain;
4986936|NCT04073069|Post-Craniotomy Headache|post-craniotomy headache
4986938|NCT04073069|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
4986939|NCT04073069|Diprospan|diprospan
4986940|NCT04073056|Sleeve gastrectomy|sleeve gastrectomy
4986941|NCT04073056|Quadratus lumborum block|quadratus lumborum block
4986942|NCT04073056|Bariatric surgery|bariatric surgery
4986943|NCT04073043|Support|support
4986944|NCT04073043|Self-management|self-management
4986945|NCT04073043|Resources|resources
4986946|NCT04073004|PTSD|ptsd
4986947|NCT04073004|Psychotherapy|psychotherapy
4986948|NCT04073004|Rape|rape
4986949|NCT04072952|Breast Cancer|breast cancer
4986950|NCT04072952|Metastatic Breast Cancer|metastatic breast cancer
4986955|NCT04072939|Phacoemulsification|phacoemulsification
4986956|NCT04072926|Biomaterials|biomaterials
4986957|NCT04072926|irrigation protocol|irrigation protocol
4986958|NCT04072926|pariapical healing|pariapical healing
4986959|NCT04072913|Matrix metalloproteinases|matrix metalloproteinases
4986960|NCT04072900|Melanoma, Metastasis|melanoma, metastasis
4986961|NCT04072887|COPD|copd
4986962|NCT04072874|Leishmaniasis|leishmaniasis
4986963|NCT04072874|Curaleish|curaleish
4986964|NCT04072835|PSVT|psvt
4986965|NCT04072809|Fetal Alcohol Syndrome|fetal alcohol syndrome
4986966|NCT04072809|Alcohol Related Neurodevelopmental Disorder|alcohol related neurodevelopmental disorder
4986967|NCT04072809|Alcohol-Related Birth Defects|alcohol-related birth defects
4986968|NCT04072809|FAE (Fetal Alcohol Effects)|fae (fetal alcohol effects)
4986969|NCT04072809|FASD|fasd
4986970|NCT04072809|Partial Fetal Alcohol Syndrome|partial fetal alcohol syndrome
4986971|NCT04072809|ND-PAE|nd-pae
4986972|NCT04072809|Prenatal Alcohol Exposure|prenatal alcohol exposure
4986973|NCT04072809|fetal exposure to ethanol during pregnancy|fetal exposure to ethanol during pregnancy
4987270|NCT04070690|dialysate|dialysate
4986979|NCT04072783|Craniosynostosis|craniosynostosis
4986980|NCT04072783|MRI|mri
4986981|NCT04072783|DTI|dti
4986982|NCT04072783|Neurodevelopment|neurodevelopment
4986983|NCT04072770|Pea protein|pea protein
4986984|NCT04072770|Casein|casein
4986985|NCT04072770|Amino acid bioavailability|amino acid bioavailability
4986986|NCT04072770|Protein digestibility|protein digestibility
4986987|NCT04072770|Isotopic tracers|isotopic tracers
4986988|NCT04072744|Peripheral oedema|peripheral oedema
4986989|NCT04072744|Peripheral edema|peripheral edema
4986990|NCT04072744|Heart failure|heart failure
4986991|NCT04072744|Decompensation|decompensation
4986992|NCT04072744|Weight|weight
4986993|NCT04072744|Hospital admissions|hospital admissions
4986994|NCT04072731|thyroid cancer|thyroid cancer
4986995|NCT04072731|SREBP1|srebp1
4986996|NCT04072718|Hypofractioned radiotherapy|hypofractioned radiotherapy
4986997|NCT04072718|Simultaneous integrated boost|simultaneous integrated boost
4986998|NCT04072705|Pharmacogenetics|pharmacogenetics
4986999|NCT04072705|Cytochrome P450 2C19|cytochrome p450 2c19
4987000|NCT04072705|Clopidogrel|clopidogrel
4987001|NCT04072705|Stroke|stroke
4987002|NCT04072679|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
4987003|NCT04072679|Sintilimab|sintilimab
4987004|NCT04072679|IBI305|ibi305
4987005|NCT04072666|Suicide Prevention|suicide prevention
4987006|NCT04072666|Suicide Attempt|suicide attempt
4987007|NCT04072666|Brief Intervention|brief intervention
4987008|NCT04072640|Voriconazole;amphotericin ;cryptococcal meningitis|voriconazole;amphotericin ;cryptococcal meningitis
4987009|NCT04072627|breast milk|breast milk
4987010|NCT04072627|microbiota|microbiota
4987011|NCT04072614|Spatial neglect|spatial neglect
4987012|NCT04072614|Perceptual disorders|perceptual disorders
4987013|NCT04072614|Diagnostic techniques and procedures|diagnostic techniques and procedures
4987014|NCT04072614|Symptom assessment|symptom assessment
4987015|NCT04072614|Rehabilitation|rehabilitation
5405030|NCT01699815|timing|timing
4987016|NCT04072614|Acute care|acute care
4987017|NCT04072562|Bioavailability|bioavailability
4987018|NCT04072562|Pharmacokinetics|pharmacokinetics
4987019|NCT04072562|Safety|safety
4987020|NCT04072562|Selective glucocorticoid receptor modulator|selective glucocorticoid receptor modulator
4987021|NCT04072523|Type 2 Diabetes, Heart Failure|type 2 diabetes, heart failure
4987022|NCT04072497|VZV|vzv
4987023|NCT04072419|esophageal atresia|esophageal atresia
4987024|NCT04072419|enhanced recovery after surgery|enhanced recovery after surgery
4987025|NCT04072419|perioperative management|perioperative management
4987026|NCT04072406|mindfulness|mindfulness
4987027|NCT04072406|meditation|meditation
4987028|NCT04072406|behavioral treatment|behavioral treatment
4987029|NCT04072380|SUVN-G3031|suvn-g3031
4987030|NCT04072380|Narcolepsy with and without cataplexy|narcolepsy with and without cataplexy
4987031|NCT04072380|Cataplexy|cataplexy
4987032|NCT04072380|Narcolepsy Type 1|narcolepsy type 1
4987033|NCT04072380|Narcolepsy Type 2|narcolepsy type 2
4987034|NCT04072380|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
4987035|NCT04072380|Histamine H3 receptor|histamine h3 receptor
4987038|NCT04072341|Inflammation|inflammation
4987039|NCT04072341|Propolis|propolis
4987040|NCT04072341|High-sensitivity C-reactive protein|high-sensitivity c-reactive protein
4987041|NCT04072341|Hemodialysis|hemodialysis
4987042|NCT04072328|Midazolam|midazolam
4987043|NCT04072328|Propofol|propofol
4987044|NCT04072328|Sedation|sedation
4987045|NCT04072302|Malaria|malaria
4987046|NCT04072302|KAF156|kaf156
4987047|NCT04072302|P. falciparum|p. falciparum
4987048|NCT04072289|refractive surgery|refractive surgery
4991077|NCT04047966|Inflammatory biomarkers|inflammatory biomarkers
4987050|NCT04072289|femtosecond laser|femtosecond laser
4987051|NCT04072289|myopia|myopia
4987052|NCT04072289|astigmatism|astigmatism
4987054|NCT04072250|Recurrent intrahepatic cholangiocarcinoma|recurrent intrahepatic cholangiocarcinoma
4987055|NCT04072250|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4987056|NCT04072250|Repeat hepatectomy|repeat hepatectomy
4987057|NCT04072250|Metastasectomy|metastasectomy
4987058|NCT04072211|Hepatitis B Virus|hepatitis b virus
4987059|NCT04072211|Vaccination|vaccination
4987060|NCT04072211|Health Personnel|health personnel
4987061|NCT04072185|Physical activity|physical activity
4987062|NCT04072185|Primary Care|primary care
4987063|NCT04072185|elderly people|elderly people
4987064|NCT04072185|anxiety|anxiety
4987065|NCT04072185|depression|depression
4987066|NCT04072185|social isolation|social isolation
4987067|NCT04072133|Midlife Women|midlife women
4987068|NCT04072133|Body Composition|body composition
4987069|NCT04072133|Meditative Movement|meditative movement
4987070|NCT04072133|Emotional Eating|emotional eating
4987071|NCT04072133|Sleep Quality|sleep quality
4987072|NCT04072133|Body Fat Percentage|body fat percentage
4987073|NCT04072133|Tai Chi Easy|tai chi easy
4987074|NCT04072120|Stroke|stroke
4987113|NCT04071730|Dietary supplementation|dietary supplementation
4987115|NCT04071717|fNIRS|fnirs
4987116|NCT04071717|Neurofeedback|neurofeedback
4987117|NCT04071717|Obesity|obesity
4987118|NCT04071704|health-related quality of life|health-related quality of life
4987119|NCT04071704|life satisfaction|life satisfaction
4987120|NCT04071704|treatment-related effects|treatment-related effects
4987121|NCT04071704|quality of life measure|quality of life measure
4987122|NCT04071626|ertugliflozin|ertugliflozin
4987123|NCT04071626|SGLT2 inhibtion|sglt2 inhibtion
4987124|NCT04071626|Cardiovascular Diseases|cardiovascular diseases
4987125|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
4987126|NCT04071626|Glucose Metabolism Disorders|glucose metabolism disorders
4987127|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs
4987128|NCT04071626|Diabetes Mellitus|diabetes mellitus
4987129|NCT04071626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4987130|NCT04071626|Endocrine System Diseases|endocrine system diseases
4987131|NCT04071600|neuropeptide Y|neuropeptide y
4987132|NCT04071600|intranasal|intranasal
4987133|NCT04071600|biomarkers|biomarkers
5031575|NCT03801811|CVC|cvc
4987134|NCT04071600|anxiety|anxiety
4987135|NCT04071587|BCI|bci
4987136|NCT04071587|upper limb|upper limb
4987137|NCT04071587|severe paresis|severe paresis
4987138|NCT04071587|subacute stroke|subacute stroke
4987139|NCT04071587|rehabilitation|rehabilitation
4987140|NCT04071574|Infertility; Ovarian; Ovulation; IVF; ICSI; Gonadotropin|infertility; ovarian; ovulation; ivf; icsi; gonadotropin
4987141|NCT04071561|Adrenalectomy|adrenalectomy
4987142|NCT04071561|Minimally invasive surgery|minimally invasive surgery
5004091|NCT03970551|Leg Crossing|leg crossing
4987155|NCT04071444|intestinal peristalsis|intestinal peristalsis
4987156|NCT04071444|schizophrenia spectrum|schizophrenia spectrum
4987157|NCT04071431|Early Detection of cancer|early detection of cancer
4987158|NCT04071431|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4987159|NCT04071431|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4987160|NCT04071418|recurrent lung cancer|recurrent lung cancer
4987161|NCT04071418|I-125 seeds implantation|i-125 seeds implantation
4987163|NCT04071405|Ulcerative colitis|ulcerative colitis
4987164|NCT04071405|Autoimmune Diseases|autoimmune diseases
4987165|NCT04071405|Immune System Diseases|immune system diseases
4987166|NCT04071405|Tofacitinib|tofacitinib
4987167|NCT04071405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
4987168|NCT04071405|Jak inhibitor|jak inhibitor
4987169|NCT04071405|safety|safety
4987176|NCT04071366|Janus kinase inhibitor|janus kinase inhibitor
4987177|NCT04071366|tisagenlecleucel|tisagenlecleucel
4987178|NCT04071366|axicabtagene ciloleucel|axicabtagene ciloleucel
4987179|NCT04071366|immune effector cell therapy|immune effector cell therapy
4987180|NCT04071353|chronic hepatitis C|chronic hepatitis c
4987181|NCT04071353|Interferon|interferon
4987182|NCT04071353|Ribavirin|ribavirin
4987183|NCT04071353|Clinical outcome|clinical outcome
4987184|NCT04071314|Microbiota|microbiota
4987185|NCT04071314|Gastrointestinal Microbiome|gastrointestinal microbiome
4987186|NCT04071314|Diet|diet
4987187|NCT04071314|Signs and Symptoms|signs and symptoms
4987188|NCT04071314|Quality of Life|quality of life
4987189|NCT04071314|Anxiety|anxiety
4987190|NCT04071314|Depression|depression
4987191|NCT04071249|Combined Symptom and Medication Score (CSMS)|combined symptom and medication score (csms)
4987192|NCT04071249|Validation|validation
4987193|NCT04071197|bile canalicular transport disorders|bile canalicular transport disorders
4987194|NCT04071184|gastric cancer|gastric cancer
4987195|NCT04071184|metastases|metastases
4987196|NCT04071184|patients with previous treatment failures|patients with previous treatment failures
4987197|NCT04071184|FGFR2 abnormalities|fgfr2 abnormalities
4987206|NCT04071119|oxytocin|oxytocin
4987207|NCT04071119|craving|craving
4991180|NCT04047303|CNS|cns
4987209|NCT04071119|smoking|smoking
4987210|NCT04071119|cigarettes|cigarettes
4987211|NCT04071119|drinking|drinking
4987212|NCT04071119|functional magnetic resonance imaging|functional magnetic resonance imaging
4987213|NCT04071119|cue-reactivity|cue-reactivity
4987214|NCT04071106|Psoriasis|psoriasis
4987215|NCT04071106|Turmeric|turmeric
4987216|NCT04071106|Curcumin|curcumin
4987217|NCT04071106|Olive oil|olive oil
4987218|NCT04071106|Dermoscopy|dermoscopy
4987219|NCT04071106|NFkB|nfkb
4987220|NCT04071041|Community-acquired Pneumonia|community-acquired pneumonia
4987221|NCT04071041|Albumin|albumin
4987222|NCT04071041|Inflammation|inflammation
4987223|NCT04071028|footbath|footbath
4987224|NCT04071028|parasympathetic activity|parasympathetic activity
4987225|NCT04071028|primary dysmenorrhea|primary dysmenorrhea
4987226|NCT04071028|sympathetic activity|sympathetic activity
4987227|NCT04071015|vital signs|vital signs
4987228|NCT04071015|blood pressure|blood pressure
4987229|NCT04071015|cardiac surgery|cardiac surgery
4987230|NCT04071015|non-invasive monitoring|non-invasive monitoring
4987231|NCT04071002|Distal radius fracture|distal radius fracture
4987232|NCT04071002|functional status|functional status
4987233|NCT04071002|activity participation|activity participation
4987234|NCT04071002|hand therapy|hand therapy
4987235|NCT04070976|hypofractionated radiotherapy|hypofractionated radiotherapy
4987236|NCT04070976|Brachytherapy|brachytherapy
4987237|NCT04070963|Incidence of Diabetes Mellitus|incidence of diabetes mellitus
4987244|NCT04070898|Laparoscopic colectomy|laparoscopic colectomy
4987245|NCT04070898|urinary catheter|urinary catheter
4987246|NCT04070898|acute urinary retention|acute urinary retention
4987247|NCT04070859|internal fixation|internal fixation
4987248|NCT04070833|stroke|stroke
4987249|NCT04070833|stroke outcomes|stroke outcomes
4987250|NCT04070833|vitamin D|vitamin d
4987251|NCT04070833|omega-3 fatty acid|omega-3 fatty acid
4987252|NCT04070820|Combination therapy|combination therapy
4987253|NCT04070820|Bloodstream Infection|bloodstream infection
4987254|NCT04070820|Enterococcus faecalis Infection|enterococcus faecalis infection
4987255|NCT04070820|Endocarditis|endocarditis
4987256|NCT04070807|AML|aml
4987257|NCT04070807|BCL-2|bcl-2
4987258|NCT04070807|anti BCL2 inhibitors|anti bcl2 inhibitors
4987259|NCT04070807|clinical practice|clinical practice
4987260|NCT04070781|Steroid Refractory GVHD|steroid refractory gvhd
4987261|NCT04070768|relapsed|relapsed
4987262|NCT04070768|refractory|refractory
4987263|NCT04070768|CD33+|cd33+
4987264|NCT04070703|Cognitive function|cognitive function
4987265|NCT04070703|mild cognitive impairment|mild cognitive impairment
4987266|NCT04070703|Tai Ji Quan|tai ji quan
4987267|NCT04070690|metabolic acidosis|metabolic acidosis
4987268|NCT04070690|sodium bicarbonate|sodium bicarbonate
4987269|NCT04070690|hemodialysis|hemodialysis
4987282|NCT04070664|Thiol/disulfide homeostasis|thiol/disulfide homeostasis
5305539|NCT02149914|GERD|gerd
4987283|NCT04070664|Ischemia modified albumin|ischemia modified albumin
4987284|NCT04070664|Differential diagnosis|differential diagnosis
4987286|NCT04070651|Fatigue|fatigue
4987287|NCT04070651|Depressive symptoms|depressive symptoms
4987288|NCT04070651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
4987289|NCT04070651|Lung Cancer|lung cancer
4987290|NCT04070651|Clinical response|clinical response
4987291|NCT04070612|Children|children
4987292|NCT04070586|Lung cancer|lung cancer
4987293|NCT04070586|Radiotherapy|radiotherapy
4987294|NCT04070586|4DCBCT|4dcbct
4987295|NCT04070573|Preterm preeclampsia|preterm preeclampsia
4987296|NCT04070573|Preeclampsia with severe features|preeclampsia with severe features
4987297|NCT04070573|High risk pregnancy|high risk pregnancy
4987298|NCT04070573|Low dose aspirin|low dose aspirin
4987299|NCT04070573|Cell free RNA|cell free rna
4987300|NCT04070560|umbilical cord|umbilical cord
4987301|NCT04070547|Cognitive function|cognitive function
4987302|NCT04070547|transcutaneous vagal nerve stimulation|transcutaneous vagal nerve stimulation
4987303|NCT04070547|autonomic nervous system|autonomic nervous system
4987304|NCT04070547|cognitive health/impairment|cognitive health/impairment
4987305|NCT04070521|Electroencephalogram|electroencephalogram
4987306|NCT04070521|Opioids|opioids
4987307|NCT04070521|Alcohol|alcohol
4987308|NCT04070521|Benzodiazepines|benzodiazepines
4987309|NCT04070521|Alpha-2 agonists|alpha-2 agonists
4987310|NCT04070521|Propofol|propofol
4987311|NCT04070521|Ketamine|ketamine
4987312|NCT04070521|Marijuana|marijuana
4987313|NCT04070521|Neuromechanisms of intoxicants|neuromechanisms of intoxicants
4987314|NCT04070508|early detection|early detection
4987315|NCT04070508|alcoholic liver disease|alcoholic liver disease
4987316|NCT04070508|alcohol|alcohol
4987317|NCT04070482|Tenofovir|tenofovir
4987318|NCT04070482|HIV-exposed infants|hiv-exposed infants
4987319|NCT04070482|renal injury|renal injury
4987320|NCT04070469|amoxycillin|amoxycillin
4987321|NCT04070469|drug kinetics|drug kinetics
4987322|NCT04070469|drug toxicity|drug toxicity
4987323|NCT04070469|crystalluria|crystalluria
4987324|NCT04070456|Physician Burnout|physician burnout
4987325|NCT04070456|social determinants of health|social determinants of health
4987329|NCT04070443|Induction phase|induction phase
4987330|NCT04070443|Consolidation phase|consolidation phase
4987331|NCT04070430|Arthroscopic hip surgery|arthroscopic hip surgery
4987332|NCT04070417|Depression|depression
4987333|NCT04070417|Lifestyle Medicine|lifestyle medicine
4987334|NCT04070404|Anaesthesia|anaesthesia
4987335|NCT04070404|Preoxygenation|preoxygenation
4987336|NCT04070391|vitamin B6|vitamin b6
4987337|NCT04070391|contraception|contraception
4987338|NCT04070391|depression|depression
4987339|NCT04070326|Lanadelumab|lanadelumab
4987340|NCT04070300|Exercise Training|exercise training
4987345|NCT04070248|Lung Microbiome|lung microbiome
4987346|NCT04070248|COPD|copd
4987347|NCT04070248|HIV/AIDS|hiv/aids
4987348|NCT04070235|Hepatitis C virus|hepatitis c virus
4987349|NCT04070235|SH229|sh229
5004285|NCT03969459|pesticide exposure|pesticide exposure
4987350|NCT04070222|Secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth|secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth
4987355|NCT04070170|Tooth Movement|tooth movement
4987356|NCT04070170|Bone Remodeling|bone remodeling
4987365|NCT04070144|Spinal puncture|spinal puncture
4987366|NCT04070144|Lumbar puncture|lumbar puncture
4987367|NCT04070131|Child Behavior|child behavior
4987368|NCT04070131|Neurologic Gait Disorder|neurologic gait disorder
4987369|NCT04070131|Cancer|cancer
4987372|NCT04070131|Physical and Rehabilitation Medicine|physical and rehabilitation medicine
4987373|NCT04070131|Rehabilitation|rehabilitation
4987374|NCT04070092|Traumatic Brain Injury|traumatic brain injury
4987376|NCT04070092|Cognitive Impairment|cognitive impairment
4987377|NCT04070092|Motor impairment|motor impairment
4987378|NCT04070092|Brain injury|brain injury
4987379|NCT04070092|Quality of life|quality of life
4987380|NCT04070092|Impact|impact
4987381|NCT04070092|Health care economic costs|health care economic costs
4987382|NCT04070066|Newborn, infant|newborn, infant
4987383|NCT04070066|exchange-transfusion|exchange-transfusion
4987384|NCT04070027|Total Hip Arthroplasty|total hip arthroplasty
4987385|NCT04070027|Total Hip Replacement|total hip replacement
4987386|NCT04070027|Exercise|exercise
4987387|NCT04070027|Progressive Resistance Training|progressive resistance training
4987388|NCT04070027|Strength Training|strength training
4987389|NCT04070027|Hip Joint|hip joint
4987390|NCT04070001|Pain|pain
4987391|NCT04070001|Elastomeric separator|elastomeric separator
4987392|NCT04070001|Laser|laser
4987393|NCT04070001|Ibuprofen|ibuprofen
4987394|NCT04070001|Gingival crevicular fluid|gingival crevicular fluid
4987395|NCT04069988|Baduanjin|baduanjin
4987396|NCT04069988|body mass index|body mass index
4987397|NCT04069988|metabolic parameters|metabolic parameters
4987398|NCT04069988|metabolic syndrome|metabolic syndrome
4987399|NCT04069988|schizophrenia|schizophrenia
4987400|NCT04069975|Early Detection of cancer|early detection of cancer
4987401|NCT04069975|Gastrointestinal Neoplasms|gastrointestinal neoplasms
4987402|NCT04069975|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
4987403|NCT04069962|cancer|cancer
4987404|NCT04069962|older persons|older persons
4987405|NCT04069962|comprehensive geriatric assessment|comprehensive geriatric assessment
4987406|NCT04069962|geriatric interventions|geriatric interventions
4987407|NCT04069962|patient compliance|patient compliance
4987408|NCT04069949|Sorafenib|sorafenib
4987409|NCT04069949|Toripalimab|toripalimab
4987410|NCT04069949|Unresectable|unresectable
5309943|NCT02129842|AFib|afib
4987411|NCT04069949|Hepatocellular Cancer|hepatocellular cancer
4987412|NCT04069949|Portal Vein Tumor Thrombus|portal vein tumor thrombus
4987413|NCT04069936|metastatic|metastatic
4987414|NCT04069936|locally advanced|locally advanced
4987415|NCT04069936|lung cancer|lung cancer
4987416|NCT04069936|non-small cell lung cancer|non-small cell lung cancer
4987417|NCT04069936|unresectable|unresectable
4987418|NCT04069936|NSCLC|nsclc
4987419|NCT04069936|cell therapy|cell therapy
4987420|NCT04069936|autologous cell therapy|autologous cell therapy
4987421|NCT04069936|adoptive cell therapy|adoptive cell therapy
4987422|NCT04069897|Botulinum Toxin Type A|botulinum toxin type a
4987423|NCT04069897|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
4987424|NCT04069897|Autonomic Nerve Block|autonomic nerve block
4987425|NCT04069897|Injections|injections
4987426|NCT04069806|Nausea|nausea
4987427|NCT04069806|Vomiting|vomiting
4987428|NCT04069806|Oral carbohydrate|oral carbohydrate
4987429|NCT04069806|Fasting|fasting
4987430|NCT04069793|Transradial Amputee|transradial amputee
4987431|NCT04069780|Suprachoroidal injection|suprachoroidal injection
4987432|NCT04069780|Diabetic macular edema|diabetic macular edema
4987433|NCT04069780|Tiamicinolone acetonide|tiamicinolone acetonide
4987434|NCT04069767|Physiotherapy|physiotherapy
4987435|NCT04069767|Rehabilitation|rehabilitation
4987436|NCT04069767|Trunk Stability|trunk stability
4987441|NCT04069767|Qualitative study|qualitative study
4987443|NCT04069767|Balance|balance
4987444|NCT04069754|trauma|trauma
4987445|NCT04069754|stress|stress
4987446|NCT04069754|depression|depression
4987447|NCT04069754|coping|coping
4987448|NCT04069754|mindfulness|mindfulness
4987449|NCT04069715|LDL-C|ldl-c
4987450|NCT04069715|Blood pressure|blood pressure
4987451|NCT04069715|triglycerides|triglycerides
4987452|NCT04069715|HDL-C|hdl-c
4987453|NCT04069715|total cholesterol|total cholesterol
5004393|NCT03968965|Spine|spine
4987456|NCT04069715|Hypertension|hypertension
4987458|NCT04069676|Autism Spectrum Condition|autism spectrum condition
4987459|NCT04069676|predictive coding|predictive coding
4987460|NCT04069676|visual perception|visual perception
4987461|NCT04069676|electroencephalography|electroencephalography
4987462|NCT04069676|autonomous nervous system|autonomous nervous system
4987463|NCT04069676|heart rate variability|heart rate variability
4987464|NCT04069676|electrodermal reactivity|electrodermal reactivity
4987465|NCT04069637|Titanium Levels|titanium levels
4987470|NCT04069559|Refugees health|refugees health
4987471|NCT04069559|Contact hypothesis|contact hypothesis
4987472|NCT04069559|Nursing students|nursing students
4987473|NCT04069559|Attitudes|attitudes
4987474|NCT04069559|Randomized controlled trial|randomized controlled trial
4987475|NCT04069546|Acute Ischemic Stroke|acute ischemic stroke
4987476|NCT04069546|Remote ischemic preconditioning|remote ischemic preconditioning
4987477|NCT04069546|Stroke-induced immunodeficiency|stroke-induced immunodeficiency
4987478|NCT04069546|Stroke-associated Pneumonia|stroke-associated pneumonia
4987479|NCT04069546|inflammation response|inflammation response
4987480|NCT04069533|anemia|anemia
4987481|NCT04069533|bone marrow failure|bone marrow failure
4987482|NCT04069533|gene therapy|gene therapy
4987483|NCT04069507|Biopsychosocial health|biopsychosocial health
4987484|NCT04069507|Clinical prediction tool|clinical prediction tool
4987485|NCT04069507|Patient-reported outcomes|patient-reported outcomes
4987486|NCT04069507|Movement pattern training|movement pattern training
4987487|NCT04069494|symptoms|symptoms
4987488|NCT04069494|predictor|predictor
4987489|NCT04069494|information needs|information needs
4987490|NCT04069494|self-management at home|self-management at home
4987491|NCT04069494|palliative radiotherapy|palliative radiotherapy
4987492|NCT04069481|Dance|dance
4987493|NCT04069481|Stroke|stroke
4987494|NCT04069481|Randomized Controlled Trial|randomized controlled trial
4987495|NCT04069481|Rehabilitation|rehabilitation
4987496|NCT04069481|Gait|gait
4987497|NCT04069481|Balance|balance
4987498|NCT04069468|Prospective Registry|prospective registry
4987499|NCT04069468|TheraSphere®|therasphere®
4987500|NCT04069468|France|france
4987501|NCT04069468|SIRT|sirt
4987502|NCT04069468|Liver Cancer, Adult|liver cancer, adult
4987503|NCT04069468|Liver Cell Carcinoma|liver cell carcinoma
4987504|NCT04069468|Hepatoma|hepatoma
4987505|NCT04069468|Intra arterial treatment|intra arterial treatment
4987506|NCT04069455|electronic patient reported outcomes|electronic patient reported outcomes
4987507|NCT04069455|gastric carcinoma|gastric carcinoma
5305717|NCT02149160|Granulin|granulin
4987508|NCT04069455|colorectal carcinoma|colorectal carcinoma
4987509|NCT04069455|adjuvant chemotherapy|adjuvant chemotherapy
4987510|NCT04069455|quality of life|quality of life
4987511|NCT04069416|liver transplant|liver transplant
4987513|NCT04069416|Extended milan|extended milan
4987514|NCT04069416|Living donor liver transplantation|living donor liver transplantation
4987515|NCT04069403|Opioids|opioids
4987516|NCT04069403|Prescription|prescription
4987517|NCT04069403|Patterns|patterns
4987518|NCT04069403|Nudge|nudge
4987519|NCT04069403|Practices|practices
4987520|NCT04069377|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4987521|NCT04069377|Chest compression|chest compression
4987522|NCT04069377|Manuel|manuel
4987523|NCT04069377|Mechanical|mechanical
4987524|NCT04069338|Lithotripsy|lithotripsy
4987525|NCT04069338|Extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
4987526|NCT04069325|gout|gout
4987527|NCT04069325|acute flares|acute flares
4987528|NCT04069325|prevention|prevention
4987529|NCT04069325|febuxostat|febuxostat
4987530|NCT04069312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4987531|NCT04069312|Chronic Bronchitis|chronic bronchitis
4987532|NCT04069312|COPD|copd
4987533|NCT04069312|Roflumilast|roflumilast
4987534|NCT04069312|Daliresp|daliresp
4987535|NCT04069312|Azithromycin|azithromycin
4987536|NCT04069260|aminoglycoside|aminoglycoside
4987537|NCT04069260|translational read-through|translational read-through
4987538|NCT04069260|cystinosis|cystinosis
4987539|NCT04069260|nonsense mutation|nonsense mutation
4987540|NCT04069247|cognitive behavioral therapy|cognitive behavioral therapy
4987570|NCT04069039|Trunk|trunk
4987571|NCT04069039|Lower Extremities|lower extremities
4987572|NCT04069039|Gait|gait
4987776|NCT04067726|Denosumab|denosumab
4987606|NCT04068857|schizoaffective disorder|schizoaffective disorder
4987607|NCT04068857|psychosis|psychosis
4987608|NCT04068857|early phase|early phase
4987609|NCT04068844|Exercise|exercise
4987610|NCT04068844|Hemodynamics,|hemodynamics,
4987611|NCT04068844|Heart failure|heart failure
4987612|NCT04068831|Talazoparib|talazoparib
4987613|NCT04068831|Avelumab|avelumab
4987614|NCT04068831|19-195|19-195
4987615|NCT04068753|Cervix Cancer|cervix cancer
4987616|NCT04068753|Niraparib|niraparib
4987617|NCT04068753|dostarlimab|dostarlimab
4987619|NCT04068701|Biofeedback|biofeedback
4987620|NCT04068701|Injury Prevention|injury prevention
4987621|NCT04068701|Virtual Reality|virtual reality
4987622|NCT04068688|NDBI|ndbi
4987623|NCT04068688|Autism|autism
4987624|NCT04068662|intimate partner violence|intimate partner violence
4987625|NCT04068662|resilience, psychological|resilience, psychological
4987626|NCT04068623|Triple negative breast cancer|triple negative breast cancer
4987627|NCT04068623|NLR (Neutrophil-to-Lymphocyte Ratio)|nlr (neutrophil-to-lymphocyte ratio)
4987628|NCT04068623|TILs (Tumor Infiltrating Lymphocytes)|tils (tumor infiltrating lymphocytes)
4987629|NCT04068623|Peripheral blood cells|peripheral blood cells
4987634|NCT04068558|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
4987635|NCT04068558|synchronized nasal intermittent positive pressure ventilation|synchronized nasal intermittent positive pressure ventilation
4987636|NCT04068480|capsule endoscopy|capsule endoscopy
4987637|NCT04068480|magnetically assisted capsule endoscopy|magnetically assisted capsule endoscopy
4987638|NCT04068480|MACE|mace
4987639|NCT04068480|Esophagus|esophagus
4987652|NCT04068428|Reproductive Health|reproductive health
4987653|NCT04068428|Time to Pregnancy|time to pregnancy
4987654|NCT04068428|Infertility|infertility
4987655|NCT04068428|Risk Factor|risk factor
4987656|NCT04068428|Assisted Reproductive Technology|assisted reproductive technology
4987657|NCT04068428|Prospective Cohort|prospective cohort
4987658|NCT04068415|Hospitalized patients|hospitalized patients
4987659|NCT04068389|Atmospheric particles|atmospheric particles
4987660|NCT04068376|cognitive decline|cognitive decline
4987661|NCT04068376|double task|double task
4987662|NCT04068376|older adults|older adults
4987663|NCT04068350|Pediatrics|pediatrics
4987664|NCT04068337|hemiarch replacement|hemiarch replacement
4987665|NCT04068337|cardiopulmonary bypass|cardiopulmonary bypass
4987666|NCT04068337|cannulation technique|cannulation technique
4991605|NCT04045119|Acne-prone skin|acne-prone skin
4987668|NCT04068311|Geriatrics|geriatrics
4987669|NCT04068311|Emergency Medicine|emergency medicine
4987670|NCT04068311|Implementation|implementation
4987706|NCT04068155|Brachytherapy|brachytherapy
4987707|NCT04068155|Radiotherapy|radiotherapy
4987708|NCT04068155|Lentigo maligna melanoma|lentigo maligna melanoma
4987709|NCT04068155|Carcinosarcom|carcinosarcom
4987710|NCT04068155|scalp cancer|scalp cancer
4987711|NCT04068155|Lip cancer|lip cancer
4987712|NCT04068155|Eyelid cancer|eyelid cancer
4987714|NCT04068142|Suicide|suicide
4987715|NCT04068142|Suicide Prevention|suicide prevention
4987716|NCT04068142|Safety Planning|safety planning
4984155|NCT04091152|elderly|elderly
4987717|NCT04068077|optical coherence tomography (OCT)|optical coherence tomography (oct)
4987718|NCT04068077|amyloidosis|amyloidosis
4987719|NCT04068077|pigmented diseases|pigmented diseases
4987720|NCT04068077|skin diseases|skin diseases
4987721|NCT04068077|dermatology|dermatology
4987722|NCT04068077|pathology|pathology
4987723|NCT04068077|H&E stain|h&e stain
4987724|NCT04068051|Axsome|axsome
4987725|NCT04068051|AXS-07|axs-07
4987726|NCT04068051|MoSEIC meloxicam|moseic meloxicam
4987727|NCT04068051|rizatriptan|rizatriptan
4987728|NCT04068025|incontinence|incontinence
4987729|NCT04068025|male|male
4987730|NCT04068025|overactive bladder|overactive bladder
4987731|NCT04068025|quality of life|quality of life
4987732|NCT04067973|optic nerve|optic nerve
5310132|NCT02129205|Phase 1|phase 1
4987733|NCT04067973|premature|premature
4987734|NCT04067934|Paediatrics|paediatrics
4987735|NCT04067934|Exercise|exercise
4987736|NCT04067921|Precision Nutrition|precision nutrition
4987737|NCT04067921|Nutritional Genetics|nutritional genetics
4987738|NCT04067921|Nutritional Genomics|nutritional genomics
4987753|NCT04067804|Restorative Practices|restorative practices
4987754|NCT04067791|Healthy|healthy
4987755|NCT04067791|Adult|adult
4987756|NCT04067791|Melatonin|melatonin
5705118|NCT00482885|Esophagus|esophagus
4987757|NCT04067791|Pharmacokinetic|pharmacokinetic
4987758|NCT04067791|Absorption|absorption
4987759|NCT04067791|prolonged-release|prolonged-release
4987760|NCT04067791|immediate-release|immediate-release
4987761|NCT04067778|IBD|ibd
4987762|NCT04067778|Dysplasia|dysplasia
4987763|NCT04067778|Biopsy|biopsy
4987764|NCT04067778|Colonoscopy|colonoscopy
4987765|NCT04067765|Alcohol|alcohol
4987766|NCT04067765|Neuroeconomics|neuroeconomics
4987767|NCT04067765|Demand|demand
4987768|NCT04067765|Cues|cues
4987769|NCT04067752|dialysis|dialysis
4987770|NCT04067752|ESRD|esrd
4987771|NCT04067752|hemodialysis|hemodialysis
4987772|NCT04067752|MRI|mri
4987773|NCT04067726|Mammographic density|mammographic density
4987774|NCT04067726|Breast cancer|breast cancer
4987782|NCT04067661|HIV Prevention|hiv prevention
4987783|NCT04067661|Transgender Women|transgender women
4987784|NCT04067661|Intervention|intervention
4987785|NCT04067648|Sufentanil|sufentanil
4987786|NCT04067648|perfusion index|perfusion index
4987787|NCT04067635|Mitral Valve Annuloplasty|mitral valve annuloplasty
4987788|NCT04067635|Mitral Regurgitation|mitral regurgitation
4987789|NCT04067635|Primary Mitral Regurgitation|primary mitral regurgitation
4987790|NCT04067635|Chronic Mitral Regurgitation|chronic mitral regurgitation
4987791|NCT04067635|Ventricular Reverse Remodeling|ventricular reverse remodeling
4987792|NCT04067635|Ventricular Recovery|ventricular recovery
4987793|NCT04067570|Prostate cancer|prostate cancer
4987794|NCT04067570|PSA|psa
4987795|NCT04067570|Radiation|radiation
4987796|NCT04067544|paclitaxel|paclitaxel
4987797|NCT04067544|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
4987798|NCT04067544|breast cancer|breast cancer
4987799|NCT04067544|gynecologic cancer|gynecologic cancer
4987801|NCT04067505|May-Thurner Syndrome|may-thurner syndrome
4987802|NCT04067505|warfarin|warfarin
4987803|NCT04067505|rivaroxaban|rivaroxaban
4987804|NCT04067505|stent implantation|stent implantation
4987805|NCT04067492|hyperuricemia|hyperuricemia
4987806|NCT04067492|acute arthritis|acute arthritis
4987807|NCT04067479|tendon|tendon
4987808|NCT04067479|amino acid|amino acid
4987809|NCT04067479|exercise|exercise
4987810|NCT04067453|Anal Canal|anal canal
4987811|NCT04067453|External Anal Sphincter|external anal sphincter
4987812|NCT04067453|Muscle fatigue|muscle fatigue
4987813|NCT04067453|Electromyography|electromyography
4987814|NCT04067453|Anorectal Manometry|anorectal manometry
4987815|NCT04067440|Microbiome|microbiome
4987816|NCT04067440|Obesity|obesity
4987817|NCT04067440|Chronic Liver Disease|chronic liver disease
4987818|NCT04067388|iKnife|iknife
4987819|NCT04067388|Mass sprectronomy|mass sprectronomy
4987820|NCT04067349|laparoscopic|laparoscopic
4987821|NCT04067349|minimal invasive|minimal invasive
4987822|NCT04067349|physical recovery|physical recovery
4987823|NCT04067349|liver surgery|liver surgery
4987828|NCT04067323|obesity|obesity
4987829|NCT04067323|medium chain triglycerides|medium chain triglycerides
4987830|NCT04067323|blood lipid profile|blood lipid profile
4987841|NCT04067258|beta-thalassemia|beta-thalassemia
4987842|NCT04067258|choroidal thickness|choroidal thickness
4987843|NCT04067258|enhanced depth imaging|enhanced depth imaging
4987844|NCT04067258|optical coherence tomography|optical coherence tomography
4987845|NCT04067245|Home Total Parenteral Nutrition|home total parenteral nutrition
4987846|NCT04067245|Tetrasodium EDTA catheter lock solution|tetrasodium edta catheter lock solution
4987847|NCT04067245|Catheter Complications|catheter complications
4987848|NCT04067245|Catheter-Related Thrombosis|catheter-related thrombosis
4987849|NCT04067245|Catheter-Related Infections|catheter-related infections
4987850|NCT04067232|Four Dimensional Computed Tomography (4D-CT)|four dimensional computed tomography (4d-ct)
4987852|NCT04067206|Premature|premature
4987853|NCT04067206|Pain|pain
4987854|NCT04067206|Comfort|comfort
4987855|NCT04067206|Auditory Interventions|auditory interventions
4987856|NCT04067193|old people|old people
4987857|NCT04067193|fall|fall
4987858|NCT04067193|elderly|elderly
4987859|NCT04067193|fall detection|fall detection
4987860|NCT04067193|usability|usability
4987861|NCT04067193|satisfaction|satisfaction
4987862|NCT04067193|ergonomy|ergonomy
4987863|NCT04067193|shoes|shoes
4987864|NCT04067180|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4987865|NCT04067180|Haplo-identical donors|haplo-identical donors
4987866|NCT04067180|Matched unrelated donors|matched unrelated donors
4987867|NCT04067180|Alternative stem cell donors|alternative stem cell donors
5705119|NCT00482885|Peristalsis|peristalsis
5903463|NCT00368446|Healthy Volunteer|healthy volunteer
4987868|NCT04067180|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
4987869|NCT04067180|Haplo-identical stem cell transplantation|haplo-identical stem cell transplantation
4987870|NCT04067167|Cancer|cancer
4987871|NCT04067167|Cachexia|cachexia
4987872|NCT04067167|Muscular strength|muscular strength
4987873|NCT04067167|Resistance training|resistance training
4987874|NCT04067167|Body composition|body composition
4987875|NCT04067167|Muscle mass|muscle mass
4987876|NCT04067167|Physical exercise|physical exercise
4987893|NCT04067037|Camrelizumab|camrelizumab
4987894|NCT04067024|regional anesthesia|regional anesthesia
4987905|NCT04066985|Depression|depression
4987906|NCT04066985|Adolescent|adolescent
4987907|NCT04066985|Therapeutics|therapeutics
4987908|NCT04066985|Mental Health|mental health
4987909|NCT04066959|emerging adults|emerging adults
4987910|NCT04066959|ehealth intervention|ehealth intervention
4987911|NCT04066959|diabetes|diabetes
4987912|NCT04066959|diabetes management|diabetes management
4987913|NCT04066959|adolescents|adolescents
4987914|NCT04066959|self-determination theory|self-determination theory
4987915|NCT04066946|scar|scar
4987917|NCT04066946|brachioplasty|brachioplasty
4987918|NCT04066946|microcurrent|microcurrent
4987919|NCT04066946|interventional study|interventional study
4987920|NCT04066933|Alpha 2 macroglobulin|alpha 2 macroglobulin
4987922|NCT04066881|Vaccine|vaccine
4987923|NCT04066881|Pre-exposure prophylaxis|pre-exposure prophylaxis
4987924|NCT04066881|Africa|africa
4987929|NCT04066829|Default settings|default settings
4987930|NCT04066829|Opioid prescribing|opioid prescribing
4987931|NCT04066829|Electronic Health Record|electronic health record
4987932|NCT04066829|Opioid|opioid
4987933|NCT04066829|Opioid Use|opioid use
4987934|NCT04066829|Behavioral intervention|behavioral intervention
4987935|NCT04066816|Colorectal cancer|colorectal cancer
4987936|NCT04066816|Microbiome|microbiome
4987937|NCT04066816|Urolithins|urolithins
4987938|NCT04066816|Walnuts|walnuts
4987939|NCT04066790|HER2-positive|her2-positive
4987940|NCT04066790|neoadjuvant|neoadjuvant
4987941|NCT04066764|venous thromboembolism|venous thromboembolism
4987942|NCT04066764|rivaroxaban|rivaroxaban
4987943|NCT04066764|vena cava filters|vena cava filters
4987944|NCT04066738|MultiPoint Pacing|multipoint pacing
4987945|NCT04066738|Acute Haemodynamic Response|acute haemodynamic response
4987946|NCT04066699|Surgical Lung Resection|surgical lung resection
4987947|NCT04066699|Percutaneous Localization|percutaneous localization
4987948|NCT04066699|Electromagnetic Navigation|electromagnetic navigation
4987949|NCT04066699|Transthoracic Localization|transthoracic localization
4987950|NCT04066699|Peripheral Pulmonary Nodule(s)|peripheral pulmonary nodule(s)
4987951|NCT04066686|Neck Injuries|neck injuries
4987952|NCT04066660|Oligo Fucoidan|oligo fucoidan
4987953|NCT04066608|Non-invasive Diagnostics|non-invasive diagnostics
4987954|NCT04066582|optical coherence tomography (OCT)|optical coherence tomography (oct)
4987955|NCT04066582|dermatology|dermatology
4987956|NCT04066582|skin diseases|skin diseases
4987957|NCT04066582|pathology|pathology
4987958|NCT04066582|H&E stain|h&e stain
4987959|NCT04066569|Diagnostic test|diagnostic test
4987960|NCT04066569|Growth hormone|growth hormone
4987961|NCT04066569|oral glucose tolerance test|oral glucose tolerance test
4987963|NCT04066556|Recanalization treatment|recanalization treatment
4987964|NCT04066556|Outcome|outcome
4987965|NCT04066556|Collateral|collateral
4987966|NCT04066556|Thrombus|thrombus
4987967|NCT04066556|CT|ct
4987968|NCT04066556|Comorbidity|comorbidity
4987971|NCT04066491|Metastatic Biliary Tract Cancer|metastatic biliary tract cancer
4987972|NCT04066491|Cholangiocarcinoma|cholangiocarcinoma
4987973|NCT04066491|Gallbladder Cancer|gallbladder cancer
4987974|NCT04066491|Ampullary cancer|ampullary cancer
4987975|NCT04066491|M7824|m7824
4987976|NCT04066491|Bintrafusp alfa|bintrafusp alfa
4987991|NCT04066426|codeine phosphate|codeine phosphate
4987992|NCT04066426|dexamethasone|dexamethasone
4987994|NCT04066426|trismus|trismus
4987995|NCT04066426|temporomandibular joint|temporomandibular joint
4987996|NCT04066413|infant formula|infant formula
4987997|NCT04066413|human milk oligosaccharide|human milk oligosaccharide
4987998|NCT04066413|HMO|hmo
4987999|NCT04066413|growth|growth
4988000|NCT04066400|hepatic inflammation|hepatic inflammation
4988001|NCT04066361|Other Cancer|other cancer
4988002|NCT04066348|tinnitus|tinnitus
4988003|NCT04066348|etanercept|etanercept
4988004|NCT04066348|tinnitus function index|tinnitus function index
4988005|NCT04066348|tinnitus primary function|tinnitus primary function
4988006|NCT04066348|functional MRI|functional mri
4988007|NCT04066348|audiological evaluation|audiological evaluation
5306031|NCT02147873|placebo|placebo
4988008|NCT04066335|Observational Study, Safety, Nanoxel M, Docetaxel|observational study, safety, nanoxel m, docetaxel
4988009|NCT04066309|Dental Implants|dental implants
5705177|NCT00482820|anxiety|anxiety
4988010|NCT04066309|Bone-Implant Interface|bone-implant interface
4988011|NCT04066309|Mouth Rehabilitation|mouth rehabilitation
4988012|NCT04066257|Drug-Drug interaction|drug-drug interaction
4988013|NCT04066257|pharmacokinetic|pharmacokinetic
4988014|NCT04066244|PET|pet
4988015|NCT04066244|ALS|als
4988016|NCT04066244|Microglia|microglia
4988017|NCT04066205|Sleep deficiency, self-management|sleep deficiency, self-management
4988018|NCT04066153|Palliative care|palliative care
4988019|NCT04066153|Physical functioning|physical functioning
4988020|NCT04066153|Unmet needs|unmet needs
4988021|NCT04066140|patient activation|patient activation
4988022|NCT04066140|self management|self management
4988023|NCT04066127|Heart preservation|heart preservation
4988024|NCT04066127|Ex-vivo perfusion|ex-vivo perfusion
4988025|NCT04066127|Heart transplantation|heart transplantation
4988026|NCT04066127|Acute cellular rejection|acute cellular rejection
4988027|NCT04066127|Survival|survival
4988034|NCT04066101|caries risk, gene polymorphisms|caries risk, gene polymorphisms
4988035|NCT04066062|CAD|cad
4988036|NCT04066049|Spanish-speaking|spanish-speaking
4988037|NCT04066049|caregiver-implemented intervention|caregiver-implemented intervention
4988038|NCT04066049|bilingual|bilingual
4988039|NCT04066036|HIV Integrase Inhibitors|hiv integrase inhibitors
4988040|NCT04066036|Sub-Saharan Africa|sub-saharan africa
4988041|NCT04066036|Anti-HIV Agents|anti-hiv agents
4988042|NCT04066036|Medication Adherence|medication adherence
4988043|NCT04066036|Virologic Failure|virologic failure
4988044|NCT04066036|Viral Drug Resistance|viral drug resistance
4988045|NCT04066036|South Africa|south africa
4988046|NCT04066036|Uganda|uganda
4988047|NCT04066036|HIV-1|hiv-1
4988050|NCT04065984|Rectal Cancer|rectal cancer
4988051|NCT04065984|Colorectal Cancer|colorectal cancer
4988052|NCT04065984|Recurrent Rectal Cancer|recurrent rectal cancer
4988053|NCT04065984|Advanced Rectal Cancer|advanced rectal cancer
4988054|NCT04065984|Myopenia|myopenia
4988055|NCT04065984|Sarcopenia|sarcopenia
4988056|NCT04065984|Myosteatosis|myosteatosis
4988057|NCT04065906|NIRS|nirs
4988058|NCT04065906|fNIRS|fnirs
4988059|NCT04065906|neurofeedback|neurofeedback
4988060|NCT04065906|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
4988061|NCT04065906|children|children
4988062|NCT04065880|lung resection|lung resection
4988063|NCT04065880|TachoSil®|tachosil®
4988064|NCT04065880|Neoveil®|neoveil®
4988065|NCT04065880|air leak closure|air leak closure
4988066|NCT04065880|drainage time|drainage time
4988067|NCT04065867|Family|family
4988068|NCT04065841|NASH|nash
4988069|NCT04065841|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
4988070|NCT04065841|Tropifexor (LJN452)|tropifexor (ljn452)
4988071|NCT04065841|Licogliflozin (LIK066)|licogliflozin (lik066)
4988072|NCT04065815|Cancer|cancer
4988073|NCT04065815|Cachexia|cachexia
4988371|NCT04064333|Geriatric|geriatric
4988074|NCT04065815|Cardiorespiratory Fitness|cardiorespiratory fitness
4988075|NCT04065815|Nutrition|nutrition
4988076|NCT04065815|Protein intake|protein intake
4988077|NCT04065815|Muscular strength|muscular strength
4988078|NCT04065815|Body composition|body composition
4988079|NCT04065815|High-intensity interval training|high-intensity interval training
4988080|NCT04065815|Physical exercise|physical exercise
4988081|NCT04065815|Resistance exercise|resistance exercise
4988109|NCT04065607|Open abdomen (OA)|open abdomen (oa)
4988110|NCT04065607|Temporary abdominal closure (TAC)|temporary abdominal closure (tac)
4988111|NCT04065607|Relook laparotomy|relook laparotomy
4988112|NCT04065594|ulcers|ulcers
4988113|NCT04065594|platelet rich plasma|platelet rich plasma
4988114|NCT04065594|ordinary dressing|ordinary dressing
4988115|NCT04065594|non-healing|non-healing
4988116|NCT04065568|Stroke|stroke
4988117|NCT04065568|Rehabilitation|rehabilitation
4988118|NCT04065568|Medical technology|medical technology
4988119|NCT04065555|precision oncology|precision oncology
4988120|NCT04065555|intratumoral microdosing|intratumoral microdosing
4988121|NCT04065555|microdose injection|microdose injection
4988122|NCT04065555|microinjection|microinjection
4988123|NCT04065555|microdosing|microdosing
4988124|NCT04065555|in vivo oncology|in vivo oncology
4988125|NCT04065555|in vivo drug sensitivity|in vivo drug sensitivity
4988126|NCT04065555|tumor microenvironment|tumor microenvironment
4988127|NCT04065555|multiplexed immunohistochemistry|multiplexed immunohistochemistry
4988128|NCT04065555|HNSCC|hnscc
4988129|NCT04065555|SCCHN|scchn
4988130|NCT04065542|Social behaviour|social behaviour
4988131|NCT04065542|Qualitative research|qualitative research
4988132|NCT04065542|Child|child
4988133|NCT04065542|Cancer|cancer
4988134|NCT04065529|Diarrhea; gastroenterology; acute gastroenteritis; gastroenteritis; acute; gelatin; tannate|diarrhea; gastroenterology; acute gastroenteritis; gastroenteritis; acute; gelatin; tannate
4988135|NCT04065516|Achalasia|achalasia
4988136|NCT04065516|Gastroesophageal Reflux|gastroesophageal reflux
4988137|NCT04065516|Argon Plasma Coagulation|argon plasma coagulation
4988138|NCT04065516|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
4988139|NCT04065503|probiotic|probiotic
4988140|NCT04065503|gut transit time|gut transit time
4988141|NCT04065490|Dry age-related macular degeneration|dry age-related macular degeneration
4988142|NCT04065490|Photobiomodulation|photobiomodulation
4988143|NCT04065490|Visual Acuity|visual acuity
4988144|NCT04065490|Contrast Sensitivity|contrast sensitivity
4988145|NCT04065490|Drusen|drusen
4988146|NCT04065490|Optical coherence tomography|optical coherence tomography
4988147|NCT04065477|Traumatic Brain Injury|traumatic brain injury
4988149|NCT04065477|Brain Injury|brain injury
4988150|NCT04065438|FSGS|fsgs
4988151|NCT04065438|Liposorber|liposorber
4988153|NCT04065399|ALL|all
4988154|NCT04065399|acute leukemia|acute leukemia
4988155|NCT04065399|MLLr|mllr
4988156|NCT04065399|KMT2A|kmt2a
4988157|NCT04065399|NPM1|npm1
4988158|NCT04065386|Vagus nerve stimulation|vagus nerve stimulation
4988159|NCT04065386|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4988160|NCT04065386|Non-invasive brain stimulation|non-invasive brain stimulation
4988161|NCT04065386|Neuromodulation|neuromodulation
4988162|NCT04065386|High-density EEG|high-density eeg
4988163|NCT04065386|Unresponsive wakefulness syndrome|unresponsive wakefulness syndrome
4988164|NCT04065386|Vegetative state|vegetative state
4988165|NCT04065386|Minimally Conscious state|minimally conscious state
4988166|NCT04065386|Consciousness disorder|consciousness disorder
4988167|NCT04065360|Schizophrenia|schizophrenia
4988168|NCT04065360|Psychosis|psychosis
4988169|NCT04065360|Family intervention|family intervention
4988192|NCT04065217|Diode laser|diode laser
4988193|NCT04065217|Histogram|histogram
4988194|NCT04065204|Pediatric Medulloblastoma|pediatric medulloblastoma
4988195|NCT04065204|Metabolomics|metabolomics
4988196|NCT04065204|Radiation Therapy|radiation therapy
4988197|NCT04065191|Aerobic exercise|aerobic exercise
4988198|NCT04065191|Cardiorespiratory Fitness|cardiorespiratory fitness
4988199|NCT04065191|High-intensity interval training (HIIT)|high-intensity interval training (hiit)
4988200|NCT04065191|Workability|workability
4988201|NCT04065191|Prevention|prevention
4988202|NCT04065165|intestinal NET|intestinal net
4992087|NCT04042402|PH1|ph1
4988222|NCT04065009|Anesthesia Local|anesthesia local
4988223|NCT04065009|Time to adjuvant chemotherapy|time to adjuvant chemotherapy
4988225|NCT04064996|foot exercise|foot exercise
4988226|NCT04064996|pain|pain
4988227|NCT04064983|movement disorders|movement disorders
4988228|NCT04064983|neurodegenerative|neurodegenerative
4988229|NCT04064983|MSCs|mscs
4988230|NCT04064983|stem cells|stem cells
4988231|NCT04064983|brain|brain
4988232|NCT04064957|spinal cord injury|spinal cord injury
4988233|NCT04064957|MSCs|mscs
4988234|NCT04064957|HB-adMSCs|hb-admscs
4988235|NCT04064957|chronic SCI|chronic sci
4988236|NCT04064957|stem cells|stem cells
4988237|NCT04064944|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
4988238|NCT04064944|immunoadsorption|immunoadsorption
4988239|NCT04064944|plasma exchange|plasma exchange
4988240|NCT04064944|acute attack|acute attack
4988241|NCT04064944|refractory|refractory
4988242|NCT04064931|recurrent miscarriage|recurrent miscarriage
4988243|NCT04064931|vitamins|vitamins
4988244|NCT04064905|mRNA-1893|mrna-1893
4988245|NCT04064905|zika vaccine|zika vaccine
4988246|NCT04064905|Moderna|moderna
4988247|NCT04064866|Lumbar Spine|lumbar spine
4988248|NCT04064866|Thoracic Spine|thoracic spine
4988249|NCT04064866|Cervical Spine|cervical spine
4988250|NCT04064853|grounded theory|grounded theory
4988251|NCT04064853|child|child
4988252|NCT04064853|adolescent|adolescent
4988253|NCT04064853|postoperative pain|postoperative pain
4988254|NCT04064853|procedural pain|procedural pain
4988255|NCT04064853|tooth extraction|tooth extraction
4988256|NCT04064840|subfertility|subfertility
4988257|NCT04064840|IVF|ivf
4988258|NCT04064840|FET|fet
4988259|NCT04064840|dual trigger|dual trigger
4988260|NCT04064840|luteal phase support|luteal phase support
4988261|NCT04064840|Gonadotrophin releasing hormone agonist|gonadotrophin releasing hormone agonist
4988262|NCT04064840|live birth rate|live birth rate
4988263|NCT04064827|Chronic Kidney Disease|chronic kidney disease
4988264|NCT04064827|Paricalcitol|paricalcitol
5005073|NCT03964662|stroke|stroke
4988265|NCT04064827|Hyperparathyroidism|hyperparathyroidism
4988266|NCT04064827|Pediatric Subjects|pediatric subjects
4988267|NCT04064827|Peritoneal Dialysis (PD)|peritoneal dialysis (pd)
4988268|NCT04064827|Hemodialysis (HD)|hemodialysis (hd)
4988269|NCT04064827|Intact parathyroid hormone (iPTH)|intact parathyroid hormone (ipth)
4988286|NCT04064723|Uncemented total hip arthroplasty|uncemented total hip arthroplasty
4988293|NCT04064684|Pediatric acute respiratory distress syndrome|pediatric acute respiratory distress syndrome
4988295|NCT04064684|Budesonide|budesonide
4988296|NCT04064684|inhaled steroids|inhaled steroids
4988297|NCT04064671|female-to-male|female-to-male
4988298|NCT04064671|transgender|transgender
4988299|NCT04064671|transsexual|transsexual
4988301|NCT04064671|erectile device|erectile device
4988302|NCT04064671|erectile implant|erectile implant
4988303|NCT04064671|neophallus|neophallus
4988304|NCT04064671|phalloplasty|phalloplasty
4988305|NCT04064671|gender reassignment surgery|gender reassignment surgery
4988306|NCT04064671|sex reassignment surgery|sex reassignment surgery
4988307|NCT04064658|Moyamoya Disease|moyamoya disease
4988308|NCT04064658|Cerebrovascular Disorders|cerebrovascular disorders
4988309|NCT04064658|Arterial Occlusive Diseases|arterial occlusive diseases
4988310|NCT04064658|Ischemia|ischemia
4988311|NCT04064632|Switch therapy|switch therapy
4988327|NCT04064554|Tuberculosis|tuberculosis
4988328|NCT04064554|BCG vaccination|bcg vaccination
4988329|NCT04064541|Heart Failure|heart failure
4988330|NCT04064541|Distance Health|distance health
4988331|NCT04064541|Virtual Visits|virtual visits
4988332|NCT04064541|Functional Assessment|functional assessment
4988333|NCT04064541|Quality of Life|quality of life
4988334|NCT04064541|Cognitive Assessment|cognitive assessment
4988335|NCT04064528|amino acid|amino acid
4988336|NCT04064528|tendon|tendon
4988337|NCT04064528|aging|aging
4988338|NCT04064502|Chronic Ankle Instability|chronic ankle instability
4988339|NCT04064502|Cumberland Ankle Instability Tool|cumberland ankle instability tool
4988340|NCT04064502|Pain|pain
4988344|NCT04064450|Heart Failure|heart failure
4988345|NCT04064411|Osteoporosis|osteoporosis
4988346|NCT04064411|transdermal delivery|transdermal delivery
4988347|NCT04064411|microneedle|microneedle
4988348|NCT04064411|solid microstructured transdermal system|solid microstructured transdermal system
4988349|NCT04064411|abaloparatide-sMTS|abaloparatide-smts
4988350|NCT04064411|patch|patch
4988351|NCT04064411|abaloparatide|abaloparatide
4988352|NCT04064411|fracture|fracture
4988353|NCT04064411|bone loss|bone loss
4988354|NCT04064411|TYMLOS®|tymlos®
4988355|NCT04064385|Functional Electrical Stimulation Cycling|functional electrical stimulation cycling
4988356|NCT04064385|Physical Therapy|physical therapy
4988357|NCT04064372|Mindfulness|mindfulness
4988358|NCT04064372|Resilience|resilience
4988359|NCT04064372|Equanimity|equanimity
4988360|NCT04064372|Inflammation|inflammation
4988361|NCT04064372|Wise Intervention|wise intervention
4988362|NCT04064333|EMST|emst
4988363|NCT04064333|RMST|rmst
4988364|NCT04064333|Expiratory Muscle Strength Training|expiratory muscle strength training
4988365|NCT04064333|Respiratory Muscle Strength Training|respiratory muscle strength training
4988366|NCT04064333|Videofluoroscopy|videofluoroscopy
4988367|NCT04064333|Aspiration Pneumonia|aspiration pneumonia
4988368|NCT04064333|Rehabilitation|rehabilitation
4988369|NCT04064333|Dysphagia|dysphagia
4988370|NCT04064333|Cough|cough
4988373|NCT04064333|Older Adults|older adults
4988374|NCT04064320|pregnancy|pregnancy
4988375|NCT04064320|high-risk|high-risk
4988376|NCT04064320|anxiety|anxiety
4988377|NCT04064320|prenatal attachment|prenatal attachment
4988378|NCT04064320|bonding|bonding
4988379|NCT04064320|lullaby|lullaby
4988380|NCT04064320|music|music
4988381|NCT04064307|Registry|registry
4988382|NCT04064307|Patient Registry|patient registry
4988383|NCT04064307|Myotubular|myotubular
4988384|NCT04064307|Centronuclear|centronuclear
4988385|NCT04064307|Myopathy|myopathy
4988386|NCT04064281|DASH|dash
4988387|NCT04064281|diet|diet
4988388|NCT04064281|trial|trial
4988389|NCT04064281|cardiovascular disease|cardiovascular disease
4988390|NCT04064281|blood pressure|blood pressure
4988391|NCT04064268|endotoxemia|endotoxemia
4988392|NCT04064268|muscle loss|muscle loss
4988393|NCT04064268|catabolic state|catabolic state
4988394|NCT04064268|whey protein|whey protein
4988395|NCT04064268|3-hydroxy butyrate|3-hydroxy butyrate
4988396|NCT04064255|Body Image|body image
4988397|NCT04064255|Anorexia Nervosa|anorexia nervosa
4988405|NCT04064216|Quality of life|quality of life
4988406|NCT04064203|glucagon|glucagon
4988407|NCT04064177|Blood Pressure|blood pressure
4988408|NCT04064164|Nursing home|nursing home
4988409|NCT04064164|Dementia|dementia
4988410|NCT04064164|Technology|technology
4988412|NCT04064151|Health Related Quality of Life|health related quality of life
4988413|NCT04064151|Symptom Burden|symptom burden
4988414|NCT04064151|Breast Cancer|breast cancer
4988415|NCT04064151|Hispanic|hispanic
4988416|NCT04064099|dental trauma|dental trauma
4988417|NCT04064099|rugby|rugby
4988418|NCT04064099|mouthguard|mouthguard
4988419|NCT04064099|speech|speech
4988434|NCT04063995|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4988435|NCT04063995|Premotor cortex|premotor cortex
4988436|NCT04063969|Radiation safety|radiation safety
4988437|NCT04063969|Radiation safety climate|radiation safety climate
4988438|NCT04063969|Radiation safety behavior|radiation safety behavior
4988439|NCT04063969|Quality improvement|quality improvement
4988440|NCT04063969|Patient safety|patient safety
4988441|NCT04063930|Hyperkalemia|hyperkalemia
4988442|NCT04063930|Renin angiotensin system|renin angiotensin system
4988443|NCT04063904|medical abortion|medical abortion
4988444|NCT04063904|mifepristone|mifepristone
4988445|NCT04063891|Fracture healing, Osteoporosis, Vibration treatment|fracture healing, osteoporosis, vibration treatment
4988446|NCT04063826|PET MR Imaging|pet mr imaging
4988447|NCT04063826|Steatohepatitis|steatohepatitis
4988448|NCT04063826|Chemotherapy associated steatohepatitis|chemotherapy associated steatohepatitis
4988449|NCT04063774|diagnostics|diagnostics
4988450|NCT04063774|sensitivity|sensitivity
4988451|NCT04063774|specificity|specificity
4988452|NCT04063774|clinical algorithm|clinical algorithm
4988453|NCT04063748|auditory rehabilitation|auditory rehabilitation
4988455|NCT04063735|Cordyceps cicadae mycelia|cordyceps cicadae mycelia
4988456|NCT04063696|tooth extraction|tooth extraction
4988457|NCT04063696|dental anxiety|dental anxiety
4988458|NCT04063696|antibiotic|antibiotic
4988459|NCT04063696|oral health|oral health
4988460|NCT04063670|Pain|pain
4988461|NCT04063670|Function|function
4988462|NCT04063670|Pediatric|pediatric
4988463|NCT04063670|Scoliosis|scoliosis
4988464|NCT04063670|Scoliosis Surgery|scoliosis surgery
4988465|NCT04063670|Spinal Fusion|spinal fusion
4988466|NCT04063670|Idiopathic Scoliosis|idiopathic scoliosis
4988467|NCT04063670|Coping|coping
4988468|NCT04063670|Coping Skills|coping skills
4988469|NCT04063670|Education|education
4988470|NCT04063670|Video Intervention|video intervention
4988471|NCT04063670|Randomized|randomized
4988472|NCT04063670|Prospective|prospective
4988473|NCT04063670|Satisfaction|satisfaction
4988474|NCT04063670|Adolescent|adolescent
4988475|NCT04063670|Opioid|opioid
4988476|NCT04063657|Staged External Fixation|staged external fixation
4988477|NCT04063657|Splinting|splinting
4988868|NCT04060940|Anxiety|anxiety
4988478|NCT04063657|Soft tissue complications|soft tissue complications
4988479|NCT04063644|Dry eye|dry eye
4988480|NCT04063644|Cataract|cataract
4988481|NCT04063644|Visual acuity|visual acuity
4988482|NCT04063644|Quality of life|quality of life
4988483|NCT04063644|Eye drops|eye drops
4988484|NCT04063644|Dry eye symptomatology|dry eye symptomatology
4988485|NCT04063644|N-acetylcarnosine|n-acetylcarnosine
4988486|NCT04063644|Vaccinium myrtillus|vaccinium myrtillus
4988487|NCT04063644|Chondroitin sulfate|chondroitin sulfate
4988488|NCT04063644|Chondroitin sulphate|chondroitin sulphate
4988489|NCT04063644|N-Acetylcharnosine|n-acetylcharnosine
4988490|NCT04063631|Asthma|asthma
4988491|NCT04063592|Amputation|amputation
4988492|NCT04063592|Residual limb pain|residual limb pain
4988493|NCT04063592|Phantom pain|phantom pain
4988494|NCT04063592|Residual limb atrophy|residual limb atrophy
4988495|NCT04063592|Prosthesis control|prosthesis control
4988496|NCT04063566|Prostate Cancer|prostate cancer
4988497|NCT04063566|MRI|mri
4988507|NCT04063449|Non-squamous NSCLC；endostar;PD-1 inhibitor;chemotherapy|non-squamous nsclc；endostar;pd-1 inhibitor;chemotherapy
4988510|NCT04063345|STEMI|stemi
4988511|NCT04063345|Intravascular ultrasound|intravascular ultrasound
4988512|NCT04063345|Angiography|angiography
4988513|NCT04063345|Primary percutaneous intervention|primary percutaneous intervention
4988514|NCT04063332|circadian|circadian
4988515|NCT04063332|sepsis|sepsis
4988516|NCT04063332|clock|clock
4988517|NCT04063332|melatonin|melatonin
4988518|NCT04063319|High-fidelity simulation|high-fidelity simulation
4988519|NCT04063319|Self-confidence|self-confidence
4988520|NCT04063319|Deteriorating patients|deteriorating patients
4988521|NCT04063319|Ordinal data|ordinal data
4988522|NCT04063319|Questionnaire|questionnaire
4988523|NCT04063293|fecal incontinence|fecal incontinence
4988524|NCT04063293|platelet rich plasma|platelet rich plasma
4988525|NCT04063293|PRP|prp
4988526|NCT04063293|injection|injection
4992381|NCT04040842|Rectal cancer|rectal cancer
4988541|NCT04063189|Treatment Response|treatment response
4988542|NCT04063189|Survival|survival
4988543|NCT04063176|myocardial infarction, registry|myocardial infarction, registry
4988544|NCT04063163|Extensive Stage|extensive stage
4988545|NCT04063163|Small Cell Lung Cancer|small cell lung cancer
4988546|NCT04063163|Anti-PD-1 Monoclonal Antibody|anti-pd-1 monoclonal antibody
4988555|NCT04063124|Dementia|dementia
4988556|NCT04063124|Alzheimer|alzheimer
4988557|NCT04063124|Cognitive decline|cognitive decline
4988558|NCT04063124|dasatinib|dasatinib
4988559|NCT04063085|Hyaluronan|hyaluronan
4988561|NCT04063085|adhesion agent|adhesion agent
4988562|NCT04063072|Hysterectomy|hysterectomy
4988563|NCT04063072|Uterine Cervical Neoplasms|uterine cervical neoplasms
4988564|NCT04063072|Endometrial Neoplasms|endometrial neoplasms
4988565|NCT04063072|Quality Improvement|quality improvement
4988566|NCT04063072|Perioperative Care|perioperative care
4988567|NCT04063072|Recovery of Function|recovery of function
4988568|NCT04063059|Weight Management|weight management
4988569|NCT04063059|Obesity|obesity
4988570|NCT04063059|African American|african american
4988571|NCT04063059|Women|women
4988572|NCT04063020|Ear aplasia|ear aplasia
4988573|NCT04063020|Reconstructive plastic surgery|reconstructive plastic surgery
4988574|NCT04063020|Subjective experience|subjective experience
4988575|NCT04063020|Psychic stakes|psychic stakes
4988576|NCT04063020|Psychodynamic evaluation|psychodynamic evaluation
4988577|NCT04062994|Hypotension|hypotension
4988578|NCT04062994|AKI|aki
4988579|NCT04062955|Breast - Female|breast - female
4988580|NCT04062916|endometriosis|endometriosis
4988581|NCT04062903|Waitlist|waitlist
4988582|NCT04062890|Type II Diabetes|type ii diabetes
4988584|NCT04062890|Insulin Resistance|insulin resistance
4988585|NCT04062890|Hypertension|hypertension
4988586|NCT04062877|Fluid biopsy|fluid biopsy
4988587|NCT04062877|lymphoma|lymphoma
4988588|NCT04062877|accurate diagnosis|accurate diagnosis
4988589|NCT04062851|gastric residuals, feeding, very low birth weight infants|gastric residuals, feeding, very low birth weight infants
4988590|NCT04062838|partial|partial
4988591|NCT04062838|prolotherapy|prolotherapy
4988597|NCT04062825|cART|cart
4988598|NCT04062825|InRs|inrs
4988599|NCT04062812|citrate anticoagulation|citrate anticoagulation
4988600|NCT04062812|calcemia control|calcemia control
4988601|NCT04062760|Acute Heart Failure|acute heart failure
4988602|NCT04062760|Diuretics|diuretics
4988603|NCT04062760|Sequential nephron blockade|sequential nephron blockade
4988604|NCT04062760|Fluid balance|fluid balance
4988605|NCT04062760|Worsening kidney failure|worsening kidney failure
4988606|NCT04062747|Laryngeal Mask|laryngeal mask
4988607|NCT04062747|I-gel|i-gel
4988608|NCT04062747|Ambu Aura i|ambu aura i
4988609|NCT04062747|Flexible bronchoscopy|flexible bronchoscopy
4988610|NCT04062747|Laryngopharyngeal damage|laryngopharyngeal damage
4988611|NCT04062747|Infant|infant
4988612|NCT04062734|Peripheral artery disease|peripheral artery disease
4988613|NCT04062734|abdominal aortic aneurysm|abdominal aortic aneurysm
4988614|NCT04062734|in situ fenestration|in situ fenestration
4988615|NCT04062734|endovascular treatment|endovascular treatment
4988616|NCT04062721|colorectal cancer|colorectal cancer
4988617|NCT04062721|liver metastases|liver metastases
4988618|NCT04062721|radiofrequency|radiofrequency
4988619|NCT04062721|immunotherapy|immunotherapy
4988620|NCT04062708|Stage IIIA/IIIB (T1-3,N2) Non-Small Cell Lung Cancer (NSCLC)|stage iiia/iiib (t1-3,n2) non-small cell lung cancer (nsclc)
4988621|NCT04062695|Psoriatic Arthritis|psoriatic arthritis
4988623|NCT04062695|Spondylitis|spondylitis
4988625|NCT04062669|First Time in Human|first time in human
4988626|NCT04062669|Vaccine|vaccine
4988627|NCT04062669|Healthy subjects|healthy subjects
4988628|NCT04062669|Rabies|rabies
4988629|NCT04062643|obesity|obesity
4988630|NCT04062643|recurrent stroke|recurrent stroke
4988631|NCT04062643|ischemic stroke|ischemic stroke
4988632|NCT04062643|hemorrhagic stroke|hemorrhagic stroke
4988633|NCT04062643|cardiovascular events|cardiovascular events
4988634|NCT04062643|vascular death|vascular death
4988635|NCT04062630|Adult Scoliotic Spinal Deformity|adult scoliotic spinal deformity
4988636|NCT04062630|Sacroiliac joint pain|sacroiliac joint pain
4988637|NCT04062630|multilevel lumbar surgery|multilevel lumbar surgery
4988638|NCT04062630|si joint pain|si joint pain
4988639|NCT04062591|piroxicam|piroxicam
4988641|NCT04062591|fractures|fractures
4988642|NCT04062578|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
4988643|NCT04062578|Injuries, Knee, Female Football|injuries, knee, female football
4988644|NCT04062578|Prevention & Control|prevention & control
4988645|NCT04062539|stroke|stroke
4988646|NCT04062539|cerebral embolic protection device|cerebral embolic protection device
4988647|NCT04062500|Heart Failure,prognostic, registry|heart failure,prognostic, registry
4988648|NCT04062435|Cross-linking, Riboflavin, Fluorophotometry, FluorotronTM Master|cross-linking, riboflavin, fluorophotometry, fluorotrontm master
4988649|NCT04062422|ulna; healthy children; height predicted|ulna; healthy children; height predicted
5343012|NCT01981135|Lung Function|lung function
4988650|NCT04062409|sickle cell disease; asthma; beta-agonist; hear rate variability|sickle cell disease; asthma; beta-agonist; hear rate variability
4988651|NCT04062383|ACS|acs
4988652|NCT04062383|Positive Psychology|positive psychology
4988653|NCT04062383|Motivational Interviewing|motivational interviewing
4988654|NCT04062383|Positive emotions|positive emotions
4988655|NCT04062357|Premature Ejaculation|premature ejaculation
4988656|NCT04062344|Betalactams hypersensitivity|betalactams hypersensitivity
4988657|NCT04062344|Children|children
4988658|NCT04062344|Drug provocation testing|drug provocation testing
4988659|NCT04062344|Bacterial resistances|bacterial resistances
4988660|NCT04062331|clinical trial|clinical trial
4988661|NCT04062331|multiple sclerosis|multiple sclerosis
4988662|NCT04062331|neurodegenerative diseases|neurodegenerative diseases
5306526|NCT02145481|patient-centered care|patient-centered care
4988663|NCT04062331|transcranial magnetic stimulation|transcranial magnetic stimulation
4988664|NCT04062331|deep brain stimulation|deep brain stimulation
4988665|NCT04062331|neurochemistry|neurochemistry
4988666|NCT04062318|somatosensory|somatosensory
4988667|NCT04062318|tactile|tactile
4988668|NCT04062318|perception|perception
4988669|NCT04062318|electroencephalography|electroencephalography
4988670|NCT04062318|transcranial magnetic stimulation|transcranial magnetic stimulation
4988671|NCT04062318|beta rhythm|beta rhythm
4988672|NCT04062292|balance|balance
4988673|NCT04062292|chronic obstructive diseases|chronic obstructive diseases
4988674|NCT04062279|Parkinson's disease|parkinson's disease
4988675|NCT04062279|cognitive dysfunction|cognitive dysfunction
4988676|NCT04062279|alpha synuclein|alpha synuclein
4988677|NCT04062279|autoantibodies|autoantibodies
4988678|NCT04062279|progression|progression
4988680|NCT04062253|HCV|hcv
4988681|NCT04062253|PWID (Persons who inject drugs)|pwid (persons who inject drugs)
4988682|NCT04062253|Screening|screening
4988689|NCT04062227|Mindfulness|mindfulness
4988690|NCT04062227|Dementia|dementia
4988691|NCT04062201|Tuberculosis|tuberculosis
4988692|NCT04062201|Drug-resistant Tuberculosis|drug-resistant tuberculosis
4988693|NCT04062201|Randomized Controlled Trial|randomized controlled trial
4988694|NCT04062201|Rifampicin Resistant Tuberculosis|rifampicin resistant tuberculosis
4989060|NCT04059653|incontinence|incontinence
4988695|NCT04062201|Multi Drug Resistant Tuberculosis|multi drug resistant tuberculosis
4988696|NCT04062201|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
4988697|NCT04062201|Pre-XDR-TB (fluoroquinolone resistant)|pre-xdr-tb (fluoroquinolone resistant)
4988698|NCT04062201|Open label|open label
4988699|NCT04062201|South Africa|south africa
4988700|NCT04062188|Barthel Index|barthel index
4988701|NCT04062188|modified Rankin Scale|modified rankin scale
4988702|NCT04062188|validity|validity
4988703|NCT04062188|reliability|reliability
4988704|NCT04062162|Prostate Cancer|prostate cancer
4988705|NCT04062162|Androgen Deprivation Therapy|androgen deprivation therapy
4988706|NCT04062162|Walking football|walking football
4988707|NCT04062136|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
4988708|NCT04062136|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
4988709|NCT04062123|propofol|propofol
4988710|NCT04062123|dexmedetomidine|dexmedetomidine
4988711|NCT04062123|fentanyl|fentanyl
4988712|NCT04062123|functional MRI|functional mri
4988713|NCT04062123|electric nerve stimulation|electric nerve stimulation
4988714|NCT04062123|sedation|sedation
4988715|NCT04062123|functional connectivity|functional connectivity
4992590|NCT04039789|Healthy Aging|healthy aging
4988721|NCT04062097|intracranial/intracerebral bleeding|intracranial/intracerebral bleeding
4988722|NCT04062097|stroke|stroke
4988723|NCT04062097|transient ischemic attack (TIA)|transient ischemic attack (tia)
4988724|NCT04062097|myocardial infarction|myocardial infarction
4988725|NCT04062097|anticoagulation|anticoagulation
4988726|NCT04062097|dabigatran|dabigatran
4988727|NCT04062097|idarucizumab|idarucizumab
4988728|NCT04062097|vitamin-k antagonists|vitamin-k antagonists
4988729|NCT04062071|anticoagulants|anticoagulants
4988730|NCT04062058|gastric cancer|gastric cancer
4988731|NCT04062058|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4988732|NCT04062058|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4988733|NCT04062045|Anesthesia, Conduction|anesthesia, conduction
4988734|NCT04061993|Total hip arthroplasty|total hip arthroplasty
4988735|NCT04061993|Early postoperative exercise|early postoperative exercise
4988736|NCT04061993|Home-based training|home-based training
4988737|NCT04061980|Encorafenib|encorafenib
4988738|NCT04061980|Binimetinib|binimetinib
4988739|NCT04061980|Nivolumab|nivolumab
4988740|NCT04061980|BRAF V600|braf v600
4988741|NCT04061980|Thyroid cancer|thyroid cancer
4988742|NCT04061980|Radiodine refractory Thyroid Cancer|radiodine refractory thyroid cancer
4988744|NCT04061980|IST-818-210X|ist-818-210x
4988745|NCT04061980|CA209-73R|ca209-73r
4988746|NCT04061967|participation|participation
4988747|NCT04061967|self sampling|self sampling
4988748|NCT04061967|screening|screening
4988749|NCT04061915|HIV Prevention|hiv prevention
4988750|NCT04061915|Sexual and Gender Minorities|sexual and gender minorities
4988751|NCT04061915|Consumer Health Informatics|consumer health informatics
4988752|NCT04061876|aGVHD|agvhd
4988753|NCT04061863|breast cancer|breast cancer
4988754|NCT04061863|eribulin|eribulin
4988755|NCT04061863|nivolumab|nivolumab
4988756|NCT04061863|immunotherapy|immunotherapy
4988757|NCT04061863|immune checkpoint inhibitor|immune checkpoint inhibitor
4988758|NCT04061863|metastatic breast cancer|metastatic breast cancer
4988759|NCT04061863|PD-1|pd-1
4988760|NCT04061811|congestive heart failure (HF)|congestive heart failure (hf)
4988761|NCT04061811|biomarker|biomarker
4988762|NCT04061811|chronic kidney disease (CKD)|chronic kidney disease (ckd)
4988763|NCT04061811|hemodialysis (HD)|hemodialysis (hd)
4988764|NCT04061811|peritoneal dialysis (PD)|peritoneal dialysis (pd)
4988765|NCT04061811|neprilysin (NEP)|neprilysin (nep)
4988766|NCT04061811|growth differentiation factor-15 (GDF15)|growth differentiation factor-15 (gdf15)
4988767|NCT04061798|ACT guided heparinization in open aortic surgery|act guided heparinization in open aortic surgery
4988768|NCT04061785|Fall prevention|fall prevention
4988771|NCT04061785|exercise|exercise
4988772|NCT04061785|Judo4Balance|judo4balance
4988773|NCT04061785|Break falls|break falls
5005589|NCT03961763|EPA|epa
4988774|NCT04061785|Preventive Exercise|preventive exercise
4988775|NCT04061772|Bortezomib|bortezomib
4988777|NCT04061746|mesenchymal stem cells|mesenchymal stem cells
4988778|NCT04061746|diabetes|diabetes
4988779|NCT04061746|autoantibodies|autoantibodies
4988780|NCT04061746|C-peptide|c-peptide
4988781|NCT04061746|Type 1 diabetes mellitus|type 1 diabetes mellitus
4988782|NCT04061733|osteoarthritis, pain, knee|osteoarthritis, pain, knee
4988783|NCT04061720|Tobacco dependence|tobacco dependence
4988784|NCT04061720|Clinical Trial|clinical trial
4988785|NCT04061720|Veterans|veterans
4988786|NCT04061707|Focal Epilepsy|focal epilepsy
4988787|NCT04061707|Longterm EEG Monitoring|longterm eeg monitoring
4988788|NCT04061707|Wearable Devices|wearable devices
4988789|NCT04061707|mHealth|mhealth
4988790|NCT04061707|Seizure Forecasting|seizure forecasting
4988791|NCT04061681|Physical Activity|physical activity
4988792|NCT04061668|PECS|pecs
4988793|NCT04061668|bupivacaine|bupivacaine
4988794|NCT04061655|CABG|cabg
4988795|NCT04061655|iron therapy|iron therapy
4988796|NCT04061655|blood transfusion|blood transfusion
4988797|NCT04061642|Artificial intelligence|artificial intelligence
4988798|NCT04061642|Deep learning|deep learning
4988799|NCT04061642|Clinical decision aid|clinical decision aid
4988800|NCT04061577|Transcranial direct current stimulation|transcranial direct current stimulation
4988801|NCT04061577|Bridging neuroprotection|bridging neuroprotection
4988802|NCT04061577|Adjunctive neuroprotection|adjunctive neuroprotection
4988803|NCT04061538|zinc sulfate|zinc sulfate
4988804|NCT04061538|Children|children
4988805|NCT04061538|acute diarrheal diseases|acute diarrheal diseases
4988806|NCT04061499|muscle|muscle
4988807|NCT04061499|ultrasound|ultrasound
4988809|NCT04061486|MACS|macs
4988810|NCT04061486|DNA fragmentation|dna fragmentation
4988816|NCT04061473|glucagon|glucagon
4988817|NCT04061460|smoking|smoking
4988818|NCT04061460|oral hygiene|oral hygiene
4988819|NCT04061447|gastric juice guided therapy|gastric juice guided therapy
4988820|NCT04061447|H.pylori eradication|h.pylori eradication
4988821|NCT04061434|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
4988822|NCT04061434|ECG Algorithms|ecg algorithms
4988823|NCT04061434|Machine based learning|machine based learning
4988824|NCT04061369|thermic effect of feeding|thermic effect of feeding
4988825|NCT04061369|thermogenesis|thermogenesis
4988826|NCT04061369|calorimeter|calorimeter
4988827|NCT04061369|fuel utilization|fuel utilization
4988828|NCT04061304|rTMS|rtms
4988829|NCT04061278|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
4988830|NCT04061278|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4988831|NCT04061278|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
4988833|NCT04061252|Palmoplantar Pustulosis|palmoplantar pustulosis
4988834|NCT04061252|brodalumab|brodalumab
4988835|NCT04061252|KHK4827|khk4827
4988836|NCT04061226|obstructive sleep apnea, normal weight obesity|obstructive sleep apnea, normal weight obesity
4988837|NCT04061187|Dispatcher|dispatcher
4988838|NCT04061187|Dispatcher-assisted cardiopulmonary resuscitation|dispatcher-assisted cardiopulmonary resuscitation
4988839|NCT04061187|Emergency call|emergency call
4988840|NCT04061187|Live video footage|live video footage
4988841|NCT04061174|shoulder|shoulder
4988842|NCT04061174|proprioception|proprioception
4988843|NCT04061174|vibration|vibration
4988844|NCT04061174|posture|posture
4988845|NCT04061174|stabilization|stabilization
4988846|NCT04061161|Tiotropium|tiotropium
4988847|NCT04061161|Anti-inflammatory effects|anti-inflammatory effects
4988848|NCT04061161|TNF-alpha mRNA in induced sputum|tnf-alpha mrna in induced sputum
4988849|NCT04061148|Near Infrared Spectroscopy|near infrared spectroscopy
4988850|NCT04061148|Depression|depression
4988851|NCT04061148|NIRS|nirs
4988852|NCT04061148|Major Depressive Disorder|major depressive disorder
4988853|NCT04061096|Anesthesia|anesthesia
4988854|NCT04061096|Cold test|cold test
4988855|NCT04061096|Electrical pulp test|electrical pulp test
4988856|NCT04061083|Intensive Care|intensive care
4988857|NCT04061031|Self-regulation, adoption, parent-child realtionship|self-regulation, adoption, parent-child realtionship
4988858|NCT04061018|HDL|hdl
4988859|NCT04061018|Atherosclerotic Cardiovascular Disease|atherosclerotic cardiovascular disease
4988860|NCT04061018|Cholesterol efflux|cholesterol efflux
4988861|NCT04061005|Cold snare polypectomy|cold snare polypectomy
4988862|NCT04061005|Hot snare polypectomy|hot snare polypectomy
4988863|NCT04061005|Colorectal polyps|colorectal polyps
4988864|NCT04061005|CARE Study|care study
4988865|NCT04061005|Complete resection rate|complete resection rate
4988866|NCT04060940|Emotion Regulation|emotion regulation
4988867|NCT04060940|Distress Disorders|distress disorders
4988883|NCT04060771|Anesthesia|anesthesia
4988884|NCT04060771|Strabismus|strabismus
4988885|NCT04060771|PONV|ponv
4988886|NCT04060745|brown adipose tissue|brown adipose tissue
4988887|NCT04060745|deuterium metabolic imaging|deuterium metabolic imaging
4988888|NCT04060745|FDG PET/CT|fdg pet/ct
4988896|NCT04060706|Brain|brain
4988897|NCT04060706|Lung|lung
4988898|NCT04060706|Prostate|prostate
4988899|NCT04060706|Adults|adults
4988900|NCT04060693|Non-invasive glucose monitoring|non-invasive glucose monitoring
4988908|NCT04060615|chronic total occlusion|chronic total occlusion
4988909|NCT04060615|coronary flow reserve|coronary flow reserve
4988910|NCT04060589|Prostate cancer|prostate cancer
4988911|NCT04060589|Magnetic resonance imaging-targeted biopsy|magnetic resonance imaging-targeted biopsy
4988912|NCT04060589|Biomarker|biomarker
4988913|NCT04060589|MRI-based diagnostic pathway|mri-based diagnostic pathway
4988914|NCT04060589|magnetic resonance imaging|magnetic resonance imaging
4988915|NCT04060589|targeted biopsy|targeted biopsy
4988916|NCT04060563|diastasis recti|diastasis recti
4988917|NCT04060563|postpartum|postpartum
4988918|NCT04060563|family medicine|family medicine
4988919|NCT04060563|microcurrent|microcurrent
4988924|NCT04060537|Cancer|cancer
4988925|NCT04060537|Renal|renal
4988926|NCT04060537|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
4988927|NCT04060537|Systemic Treatments|systemic treatments
4988928|NCT04060537|Biomarkers|biomarkers
4988929|NCT04060511|HS-10342; CDK4/6 inhibitor, advanced solid tumor|hs-10342; cdk4/6 inhibitor, advanced solid tumor
4988930|NCT04060498|Mindfulness, Prevention, Relapse, Psychosis, Schizophrenia, Psychotic Disorders, Mental Disorders, Schizophrenia and Disorders with Psychotic Features|mindfulness, prevention, relapse, psychosis, schizophrenia, psychotic disorders, mental disorders, schizophrenia and disorders with psychotic features
4988931|NCT04060485|Next generation sequencing|next generation sequencing
4988932|NCT04060485|Acute Myeloid Leukemia|acute myeloid leukemia
4988939|NCT04060433|Family Therapy|family therapy
4988940|NCT04060433|Health Plan Implementation|health plan implementation
4988941|NCT04060433|Outpatients|outpatients
4988942|NCT04060381|Speckle tracking echocardiography|speckle tracking echocardiography
4988943|NCT04060381|Tissue doppler|tissue doppler
4988944|NCT04060381|Neonates|neonates
4988946|NCT04060381|Maternal obesity|maternal obesity
4988947|NCT04060368|NASH|nash
4988948|NCT04060368|Obesity|obesity
4988949|NCT04060368|Endoscopic Sleeve Gastroplasty|endoscopic sleeve gastroplasty
4988950|NCT04060368|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
4988951|NCT04060355|People Living With Disability|people living with disability
4988952|NCT04060355|PLWD|plwd
4988953|NCT04060355|Caregiver|caregiver
4988954|NCT04060355|Interventionist|interventionist
4988955|NCT04060355|Distance education|distance education
4988956|NCT04060355|Savvy|savvy
4988957|NCT04060342|GEJ adenocarcinoma|gej adenocarcinoma
4988958|NCT04060342|TNBC|tnbc
4988959|NCT04060342|MSS mCRC|mss mcrc
4988960|NCT04060342|PD-L1 + gastric cancer|pd-l1 + gastric cancer
4989056|NCT04059692|neck pain|neck pain
4988961|NCT04060342|PD-L1 positive gastric cancer|pd-l1 positive gastric cancer
4988962|NCT04060316|Surgery|surgery
4988963|NCT04060303|Pediatric Surgery|pediatric surgery
4988964|NCT04060303|Implementation|implementation
4988965|NCT04060303|Quality Improvement|quality improvement
4988966|NCT04060303|Enhanced Recovery Protocols|enhanced recovery protocols
4988967|NCT04060251|Total knee arthroplasty|total knee arthroplasty
4988968|NCT04060251|Physical therapy|physical therapy
4988969|NCT04060251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4988970|NCT04060251|Telemedicine|telemedicine
4988971|NCT04060238|protanopia|protanopia
4988972|NCT04060238|taillight|taillight
4988973|NCT04060238|brake light|brake light
4988974|NCT04060238|differential luminance sensitivity|differential luminance sensitivity
4988975|NCT04060238|contrast sensitivity|contrast sensitivity
4988976|NCT04060238|colour vision|colour vision
4988977|NCT04060238|colour vision defect|colour vision defect
4988978|NCT04060238|perimetry|perimetry
4988979|NCT04060238|semi-automated kinetic perimetry|semi-automated kinetic perimetry
4988980|NCT04060238|traffic|traffic
4988981|NCT04060238|motorist|motorist
4988982|NCT04060238|reaction time|reaction time
4988983|NCT04060186|Recurrence rate of cSDH|recurrence rate of csdh
4988984|NCT04060186|Outcome|outcome
4988985|NCT04060173|Gout|gout
4988986|NCT04060173|Hyperuricemia|hyperuricemia
4988987|NCT04060160|machine learning|machine learning
4988988|NCT04060160|self-learning software|self-learning software
4988989|NCT04060160|image-detecting software|image-detecting software
5005759|NCT03960723|Informed consent|informed consent
4988999|NCT04060082|bvFTD|bvftd
4989000|NCT04060082|Chromosome 9 open reading frame 72 (C9ORF72)|chromosome 9 open reading frame 72 (c9orf72)
4989001|NCT04060082|Microtubule-associated protein tau (MAPT)|microtubule-associated protein tau (mapt)
4989002|NCT04060082|Progranulin (GRN)|progranulin (grn)
4989003|NCT04060082|TAR DNA-binding protein (TARDBP)|tar dna-binding protein (tardbp)
4989004|NCT04060082|Valosin-Containing Protein (VCP)|valosin-containing protein (vcp)
4989005|NCT04060082|Charged multivesicular body protein 2B (CHMP2B)|charged multivesicular body protein 2b (chmp2b)
4989006|NCT04060056|Precision Nutrition|precision nutrition
4989007|NCT04060056|Host and Microbiome|host and microbiome
4989008|NCT04060056|Birth Outcomes|birth outcomes
4989009|NCT04060043|goserelin|goserelin
4989010|NCT04060043|testosterone|testosterone
4989011|NCT04060004|physical therapy|physical therapy
4989012|NCT04059978|Cannabidiol|cannabidiol
5306814|NCT02144233|Therapy|therapy
4989013|NCT04059978|Remifentanil|remifentanil
4989014|NCT04059952|Electroconvulsive Therapy|electroconvulsive therapy
4989015|NCT04059952|Magnetic Resonance Imaging|magnetic resonance imaging
4989016|NCT04059913|Anemia|anemia
4989017|NCT04059913|Chronic Kidney Disease Dialysis|chronic kidney disease dialysis
4989018|NCT04059913|hemoglobin|hemoglobin
4989019|NCT04059913|End stage renal disease|end stage renal disease
4989020|NCT04059887|Non-small cell lung cancer|non-small cell lung cancer
4989021|NCT04059887|Immune checkpoint inhibitor|immune checkpoint inhibitor
4989022|NCT04059887|Tumor mutation burden|tumor mutation burden
4989023|NCT04059874|non-small cell lung cancer|non-small cell lung cancer
4989024|NCT04059861|ultrasound|ultrasound
4992912|NCT04038008|Diflucan®|diflucan®
4989033|NCT04059848|Transcranial direct current stimulation|transcranial direct current stimulation
4989034|NCT04059848|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
4989036|NCT04059848|Rehabilitation|rehabilitation
4989037|NCT04059822|Slow and deep breathing|slow and deep breathing
4989038|NCT04059822|Feasibility study|feasibility study
4989039|NCT04059809|Laser|laser
4989040|NCT04059809|Photobiomodulation|photobiomodulation
4989041|NCT04059809|Radiodermatitis|radiodermatitis
4989042|NCT04059809|Breast Cancer|breast cancer
4989043|NCT04059770|Histoplasmosis|histoplasmosis
4989044|NCT04059770|AIDS|aids
4989045|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b
4989046|NCT04059770|High dose therapy|high dose therapy
4989047|NCT04059757|Graft Versus Host Disease (GVHD)|graft versus host disease (gvhd)
4989048|NCT04059705|motor function|motor function
4989049|NCT04059705|cognitive|cognitive
4989050|NCT04059705|attention|attention
4989051|NCT04059705|dual-task|dual-task
4989052|NCT04059705|physical activity|physical activity
4989053|NCT04059705|cognition|cognition
4989054|NCT04059705|older adult|older adult
4989055|NCT04059705|mild cognitive impairment|mild cognitive impairment
4989080|NCT04059575|tennis|tennis
4989081|NCT04059575|vertical jump|vertical jump
4989082|NCT04059575|kinesio taping|kinesio taping
4989083|NCT04059575|thermography|thermography
4989084|NCT04059536|Stenotic Lesions|stenotic lesions
4989085|NCT04059510|Streptococcus agalactiae|streptococcus agalactiae
4989086|NCT04059510|GBS|gbs
4989094|NCT04059471|Yellow Fever vaccine|yellow fever vaccine
4989095|NCT04059471|Fractional doses|fractional doses
4989096|NCT04059471|Yellow Fever|yellow fever
4989097|NCT04059471|Vaccine dose|vaccine dose
4989098|NCT04059432|Tooth Wear|tooth wear
4989099|NCT04059432|Musculoskeletal Disorders|musculoskeletal disorders
4989100|NCT04059419|Osteoarthritis|osteoarthritis
4989101|NCT04059419|Quality of Life|quality of life
4989102|NCT04059419|Sleep disorder|sleep disorder
4989106|NCT04059380|parathormone|parathormone
4989108|NCT04059380|parathyroid|parathyroid
4989109|NCT04059380|hypocalcemia|hypocalcemia
4989110|NCT04059380|immunity|immunity
4989111|NCT04059380|immune function|immune function
4989112|NCT04059380|quality of life|quality of life
4989113|NCT04059380|sleep disturbances|sleep disturbances
4989114|NCT04059380|parathyroid hormone|parathyroid hormone
4989115|NCT04059354|Speech intelligibility|speech intelligibility
4989116|NCT04059341|Radical Prostatectomy|radical prostatectomy
4989117|NCT04059341|Prostatectomy|prostatectomy
4989118|NCT04059341|Nerve-sparing|nerve-sparing
4989119|NCT04059341|Non nerve-sparing|non nerve-sparing
4989120|NCT04059341|Erectile dysfunction|erectile dysfunction
4989121|NCT04059341|Erectile function|erectile function
4989122|NCT04059341|Shockwave|shockwave
4989123|NCT04059341|LI-ESWT|li-eswt
4989124|NCT04059341|ESWT|eswt
4989125|NCT04059341|Low intensity extracorporeal shockwave therapy|low intensity extracorporeal shockwave therapy
4989126|NCT04059341|extracorporeal shockwave therapy|extracorporeal shockwave therapy
4989127|NCT04059315|motor vehicle accident, epidemiology, facial fracture|motor vehicle accident, epidemiology, facial fracture
4989128|NCT04059289|glare|glare
4989129|NCT04059289|contrast sensitivity|contrast sensitivity
4989130|NCT04059289|driving simulator|driving simulator
4989131|NCT04059289|intermediate visual acuity|intermediate visual acuity
4989132|NCT04059289|pseudophakia|pseudophakia
4989133|NCT04059289|posterior chamber intraocular lenses|posterior chamber intraocular lenses
4989134|NCT04059289|benchmark|benchmark
4989135|NCT04059289|straylight|straylight
4989136|NCT04059289|nighttime driving|nighttime driving
4989137|NCT04059250|composite bactericidal|composite bactericidal
4989138|NCT04059250|caries prevention|caries prevention
4989139|NCT04059224|NRAS mutant|nras mutant
4989140|NCT04059224|NRAS wild-type|nras wild-type
4989141|NCT04059224|BRAF V600 wild-type|braf v600 wild-type
4989142|NCT04059224|Unresectable stage III melanoma|unresectable stage iii melanoma
4989143|NCT04059224|Stage IV melanoma|stage iv melanoma
4989144|NCT04059224|low-dose dabrafenib|low-dose dabrafenib
4989145|NCT04059224|dabrafenib|dabrafenib
4989146|NCT04059224|trametinib|trametinib
4989147|NCT04059224|Mekinist|mekinist
5306912|NCT02143908|adults|adults
4989148|NCT04059224|Tafinlar|tafinlar
4989149|NCT04059211|urinary dipstick|urinary dipstick
4989166|NCT04059068|RNA sequencing|rna sequencing
4989167|NCT04059042|Pain|pain
4989168|NCT04059042|Music|music
4989169|NCT04059042|Analgesia|analgesia
4989170|NCT04059029|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
4989171|NCT04059029|morbidly obese|morbidly obese
4989172|NCT04059029|Bariatric surgery|bariatric surgery
4989173|NCT04059016|opioid use disorder|opioid use disorder
4989174|NCT04059016|buprenorphine waiver training|buprenorphine waiver training
4989175|NCT04059016|VitalSign6|vitalsign6
4989176|NCT04059016|measurement based care|measurement based care
4989177|NCT04059016|primary care|primary care
4989178|NCT04059003|Biomarkers|biomarkers
4989179|NCT04059003|Tumor|tumor
4989180|NCT04059003|Positron Emission Tomography|positron emission tomography
4989181|NCT04059003|Computed Tomography|computed tomography
4989182|NCT04058938|opioid use|opioid use
4989183|NCT04058938|breast reconstruction|breast reconstruction
4989184|NCT04058938|pain control|pain control
4989185|NCT04058938|mastectomy|mastectomy
4989186|NCT04058925|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
4989187|NCT04058925|Near-infrared spectroscopy|near-infrared spectroscopy
4989188|NCT04058899|dexmedetomidine|dexmedetomidine
4989189|NCT04058899|emergence agitation|emergence agitation
5033822|NCT03787615|kidney|kidney
4989190|NCT04058899|adenotonsillectomy|adenotonsillectomy
4989191|NCT04058860|Microcirculation|microcirculation
4989192|NCT04058860|Cardiac Surgery|cardiac surgery
4989193|NCT04058847|Risk communication|risk communication
4989194|NCT04058847|CVD-risk|cvd-risk
4989195|NCT04058847|General practice|general practice
4989196|NCT04058847|Primary care|primary care
4989197|NCT04058847|Visual communication|visual communication
4989198|NCT04058847|Interactive communication|interactive communication
4989199|NCT04058847|Cardiovascular risk|cardiovascular risk
4989200|NCT04058795|PTSD|ptsd
4989201|NCT04058795|Depression|depression
4989202|NCT04058795|Anxiety|anxiety
4989203|NCT04058795|Distress|distress
4989204|NCT04058795|Digital Health|digital health
4989205|NCT04058795|mHealth|mhealth
4989206|NCT04058782|Prognosis|prognosis
4989207|NCT04058782|Vascular stiffness|vascular stiffness
4989208|NCT04058782|Heart failure|heart failure
5005964|NCT03959475|Hotline|hotline
4989226|NCT04058665|Blood loss|blood loss
4989227|NCT04058639|Bandages|bandages
4989228|NCT04058639|Wound Healing|wound healing
4989229|NCT04058639|Time|time
4989230|NCT04058639|Relief|relief
4989231|NCT04058626|Peripheral Vascular Diseases|peripheral vascular diseases
4989232|NCT04058626|Diabetic Foot|diabetic foot
4989233|NCT04058626|Critical Limb Ischemia|critical limb ischemia
4989239|NCT04058548|cystic fibrosis|cystic fibrosis
4989240|NCT04058548|walk test|walk test
4989241|NCT04058522|Physiotherapy|physiotherapy
4989242|NCT04058522|Group Treatment|group treatment
4989243|NCT04058509|Greater Trochanter Pain Syndrome|greater trochanter pain syndrome
4989244|NCT04058509|Lateral hip pain|lateral hip pain
4989245|NCT04058496|Cardia surgery|cardia surgery
4989246|NCT04058496|Cardio-pulmonary bypass|cardio-pulmonary bypass
4989247|NCT04058496|Inflammation|inflammation
4989249|NCT04058496|Cytokines|cytokines
4989250|NCT04058483|hypnosis|hypnosis
4989251|NCT04058483|hypnotizability|hypnotizability
4989252|NCT04058483|validation|validation
4989253|NCT04058483|remote|remote
4989254|NCT04058483|Hypnotic Induction Profile|hypnotic induction profile
4989255|NCT04058470|DLBCL,HGL|dlbcl,hgl
4989256|NCT04058457|Parkinson disease|parkinson disease
4989257|NCT04058457|movement disorder|movement disorder
4989258|NCT04058457|dyspnoea|dyspnoea
4989259|NCT04058457|dyspnea|dyspnea
4989260|NCT04058457|breathlessness|breathlessness
4989261|NCT04058457|respiratory|respiratory
4989262|NCT04058444|cesarean delivery|cesarean delivery
4989263|NCT04058444|ERAS protocol|eras protocol
4989274|NCT04058327|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
4989275|NCT04058327|early treatment|early treatment
4989288|NCT04058236|gelofusine|gelofusine
4989289|NCT04058236|pancreatic fistula|pancreatic fistula
4989290|NCT04058197|chronic sickle cell leg ulcer|chronic sickle cell leg ulcer
4989291|NCT04058184|Prepulse Inhibition|prepulse inhibition
4989292|NCT04058184|Startle Response|startle response
4989293|NCT04058171|Walking capacity|walking capacity
4989294|NCT04058171|Walking posture|walking posture
4989295|NCT04058171|Diagnostic test|diagnostic test
4989296|NCT04058145|Head and Neck Cancer|head and neck cancer
4989297|NCT04058132|traumatic cerebrovascular injury|traumatic cerebrovascular injury
4989298|NCT04058132|Functional Near Infrared Spectroscopy (fNIRS)|functional near infrared spectroscopy (fnirs)
4989299|NCT04058119|Mind-body therapies|mind-body therapies
4989300|NCT04058119|Yoga|yoga
4989301|NCT04058119|Qigong|qigong
4989302|NCT04058119|Pilates|pilates
4989303|NCT04058119|Primary health care|primary health care
4989304|NCT04058093|Exercise|exercise
4989305|NCT04058093|Physical activity|physical activity
4989306|NCT04058093|Nutrition|nutrition
4989307|NCT04058093|Counselling|counselling
4989308|NCT04058093|Primary health care|primary health care
4989309|NCT04058080|Major depression|major depression
4989310|NCT04058080|yoga|yoga
4989311|NCT04058080|Bikram yoga|bikram yoga
4989312|NCT04058080|aerobic exercise|aerobic exercise
4989313|NCT04058080|complementary and alternative treatment approaches|complementary and alternative treatment approaches
4989314|NCT04058080|nontraditional treatment approaches|nontraditional treatment approaches
4989315|NCT04058080|mindfulness|mindfulness
4989316|NCT04058080|rumination|rumination
4989317|NCT04058080|stress reactivity|stress reactivity
4989318|NCT04058080|cardiovascular functioning|cardiovascular functioning
4989319|NCT04058067|Diabetic Macular Edema|diabetic macular edema
4989320|NCT04058067|Intravitreal injection|intravitreal injection
4989321|NCT04058067|brolucizumab|brolucizumab
4989323|NCT04058041|Neural mobilization|neural mobilization
4989324|NCT04058041|Surgery|surgery
4989325|NCT04058041|Pain modulation|pain modulation
4989333|NCT04058015|admission hyperglycemia|admission hyperglycemia
4989334|NCT04058015|stress-induced hyperglycemia|stress-induced hyperglycemia
4989335|NCT04058015|diabetic hyperglycemia|diabetic hyperglycemia
4989336|NCT04058015|diabetes mellitus|diabetes mellitus
4989337|NCT04058015|thoracoabdominal trauma|thoracoabdominal trauma
4989338|NCT04058015|mortality|mortality
4989339|NCT04058002|Osteoarthritis|osteoarthritis
4989340|NCT04058002|Knee|knee
4989341|NCT04058002|Quality of Life|quality of life
4989342|NCT04058002|Sarcopenia|sarcopenia
4989343|NCT04057989|battlefield injury|battlefield injury
4989344|NCT04057989|ketamine infusion|ketamine infusion
4989345|NCT04057989|regional anesthesia|regional anesthesia
4989346|NCT04057989|opioids|opioids
4989347|NCT04057963|Inspiratory Muscle Training|inspiratory muscle training
4989348|NCT04057963|Exercise|exercise
4989349|NCT04057963|Cervical Posture|cervical posture
4989350|NCT04057950|seborrheic dermatitis|seborrheic dermatitis
4989351|NCT04057950|microbiota|microbiota
4989352|NCT04057950|malassezia|malassezia
4989353|NCT04057950|bacteria|bacteria
4989354|NCT04057950|diversity|diversity
4989355|NCT04057937|Palmoplantar Pustulosis|palmoplantar pustulosis
4989356|NCT04057937|CC-10004|cc-10004
4989357|NCT04057937|Apremilast|apremilast
4989358|NCT04057937|Only Japanese|only japanese
4989359|NCT04057937|Efficacy|efficacy
4989360|NCT04057937|Safety|safety
4989361|NCT04057937|Phase 2|phase 2
4989363|NCT04057924|alternative to surgery|alternative to surgery
4989364|NCT04057924|cervical cancer|cervical cancer
4989365|NCT04057911|Cervical dystonia|cervical dystonia
4989366|NCT04057911|Non-invasive stimulation|non-invasive stimulation
4989367|NCT04057898|ALS|als
4989368|NCT04057898|MN-166|mn-166
4989369|NCT04057898|ibudilast|ibudilast
4989370|NCT04057898|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4989371|NCT04057872|Therapeutic Plasma Exchange (TPE)|therapeutic plasma exchange (tpe)
4989372|NCT04057872|Septic Shock|septic shock
4989373|NCT04057872|Severe Sepsis|severe sepsis
4989374|NCT04057872|Albumin|albumin
4989375|NCT04057872|Fresh Frozen Plasma|fresh frozen plasma
4989376|NCT04057846|Walled of necrosis|walled of necrosis
4989377|NCT04057846|Endoscopic drainage|endoscopic drainage
4989378|NCT04057846|Lumen apposing metal stents|lumen apposing metal stents
4989379|NCT04057833|Cell Therapy|cell therapy
4989380|NCT04057833|Supraspinatus tendon|supraspinatus tendon
4989381|NCT04057833|Systemic safety and toxicity|systemic safety and toxicity
4989382|NCT04057833|Muscle and Tendon quality|muscle and tendon quality
4989383|NCT04057820|NOWS|nows
4989384|NCT04057794|Parkinson's|parkinson's
4989385|NCT04057794|Genetics|genetics
4989386|NCT04057794|PD Genetics|pd genetics
4989387|NCT04057768|acne scars|acne scars
4989388|NCT04057768|wrinkles|wrinkles
4989389|NCT04057768|rhytids|rhytids
4989390|NCT04057768|fractional RF|fractional rf
4989391|NCT04057755|botulinum toxin A|botulinum toxin a
4989411|NCT04057612|pediatric|pediatric
4989412|NCT04057612|temperature|temperature
4989413|NCT04057612|general anesthesia|general anesthesia
4989414|NCT04057599|post-operative ileus,lumbar spine surgery|post-operative ileus,lumbar spine surgery
4989415|NCT04057586|postoperative cognition|postoperative cognition
4989416|NCT04057586|nonintubated thoracic surgery|nonintubated thoracic surgery
4989417|NCT04057573|Vitiligo|vitiligo
4989418|NCT04057573|non-segmental|non-segmental
4989419|NCT04057573|JAK inhibitor|jak inhibitor
4989420|NCT04057534|Alcohol Dependence|alcohol dependence
4989421|NCT04057534|Alcoholism|alcoholism
4989422|NCT04057534|Craving|craving
4989423|NCT04057534|Cognitive Change|cognitive change
4989424|NCT04057534|cognitive remediation|cognitive remediation
4989425|NCT04057534|Chess based cognitive training|chess based cognitive training
4989426|NCT04057534|Working Memory|working memory
4989427|NCT04057534|Decision Making|decision making
4989428|NCT04057534|Executive Control|executive control
4989429|NCT04057534|Chess|chess
4989430|NCT04057534|fMRI|fmri
4989431|NCT04057521|care coordination|care coordination
4989432|NCT04057521|Children|children
4989433|NCT04057521|Young adults|young adults
4989434|NCT04057521|Chronic disease|chronic disease
4989435|NCT04057508|Heart rate variability, MSNA, vagus nerve, sympathetic nervous system|heart rate variability, msna, vagus nerve, sympathetic nervous system
4989436|NCT04057495|Blood glucose|blood glucose
4989438|NCT04057482|Bacterial vaginosis, polymerase chain reaction, molecular diagnostic|bacterial vaginosis, polymerase chain reaction, molecular diagnostic
4989439|NCT04057456|Cannabis|cannabis
4989440|NCT04057456|Spinal Cord Injury|spinal cord injury
4989442|NCT04057456|THC|thc
4989443|NCT04057456|Neuropathic pain|neuropathic pain
4989444|NCT04057456|Pain|pain
4989445|NCT04057456|Anti Inflammatory Diet|anti inflammatory diet
4989446|NCT04057443|older|older
4989447|NCT04057443|physical exercise|physical exercise
4989448|NCT04057443|nutrition support|nutrition support
4989449|NCT04057443|hematologic malignancies|hematologic malignancies
4989450|NCT04057443|geriatric assessment|geriatric assessment
4989451|NCT04057443|geriatric intervention|geriatric intervention
4989452|NCT04057430|Interdental plaque|interdental plaque
4989453|NCT04057430|Flossing aid|flossing aid
4989454|NCT04057430|Children|children
4989455|NCT04057430|Gingival inflammation|gingival inflammation
4989456|NCT04057417|physical activity|physical activity
4989457|NCT04057417|built environment|built environment
4989458|NCT04057365|Biliary Tract Cancer|biliary tract cancer
4989459|NCT04057339|Time Restricted Eating|time restricted eating
4989460|NCT04057339|Circadian Rhythm|circadian rhythm
4991052|NCT04048135|Fatty Liver|fatty liver
4989466|NCT04057313|Intra-dialytic hypotension|intra-dialytic hypotension
4989467|NCT04057300|Cardiovascular disease|cardiovascular disease
4989468|NCT04057300|Myocardial Infarction|myocardial infarction
4989470|NCT04057300|Clopidogrel|clopidogrel
4989471|NCT04057300|Ticagrelor|ticagrelor
4989472|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
4989473|NCT04057300|Pragmatic Trial|pragmatic trial
4989474|NCT04057274|Colon cancer|colon cancer
4989475|NCT04057274|Aerobic exercise|aerobic exercise
4989476|NCT04057261|Liraglutide|liraglutide
4989477|NCT04057261|Type 2 Diabetes|type 2 diabetes
4989478|NCT04057261|High Cardiovascular Risk|high cardiovascular risk
4989479|NCT04057261|Myocardial Infarction|myocardial infarction
4989480|NCT04057261|Metabolic Profile|metabolic profile
4989481|NCT04057222|Rectal sensory function|rectal sensory function
4989482|NCT04057222|Multiple sclerosis|multiple sclerosis
4989483|NCT04057222|anorectal disorders|anorectal disorders
4989484|NCT04057222|Fecal incontinence|fecal incontinence
4989485|NCT04057222|constipation|constipation
4989486|NCT04057222|bladder sensation|bladder sensation
4989487|NCT04057209|head and neck cancer|head and neck cancer
4989488|NCT04057209|squamous cell carcinoma|squamous cell carcinoma
4989489|NCT04057209|carcinoma in situ|carcinoma in situ
4989490|NCT04057209|radiotherapy|radiotherapy
4989492|NCT04057209|transoral laser microsurgery|transoral laser microsurgery
4989493|NCT04057209|patient reported outcome|patient reported outcome
4989494|NCT04057209|quality of life|quality of life
4989495|NCT04057209|voice|voice
4989496|NCT04057183|Carotid|carotid
4989497|NCT04057183|Stenosis|stenosis
4989498|NCT04057183|Noninvasive|noninvasive
4989499|NCT04057170|shoulder pain|shoulder pain
4989500|NCT04057157|dura mater repair|dura mater repair
4989501|NCT04057157|cerebrospinal fluid leak|cerebrospinal fluid leak
4989502|NCT04057157|CSF leak|csf leak
4989503|NCT04057157|Biodesign® Dural Repair Graft|biodesign® dural repair graft
4989504|NCT04057157|Biodesign® Duraplasty Repair Graft|biodesign® duraplasty repair graft
4989505|NCT04057144|Mindfulness|mindfulness
4989506|NCT04057144|Psychotherapy, Group|psychotherapy, group
4989507|NCT04057144|Behavior Therapy|behavior therapy
4989508|NCT04057092|perioperative immunonutrition|perioperative immunonutrition
4989509|NCT04057092|clinical nutrition|clinical nutrition
4989510|NCT04057092|infection prevention|infection prevention
4989511|NCT04057079|Hemoroidectomy|hemoroidectomy
4989512|NCT04057066|multiple sclerosis|multiple sclerosis
4989513|NCT04057066|e-health|e-health
4989514|NCT04057066|physical activity promotion|physical activity promotion
4989515|NCT04057066|exercise|exercise
4989516|NCT04057066|feasibility|feasibility
4989517|NCT04057066|online|online
4989518|NCT04057066|internet based|internet based
4989519|NCT04057053|DWEK, Netarsudil|dwek, netarsudil
4989520|NCT04057040|polycythemia vera|polycythemia vera
4989521|NCT04057014|Dentistry|dentistry
4989522|NCT04057014|Antibiotic|antibiotic
4989523|NCT04057014|Penicillin|penicillin
4989524|NCT04057014|pediatrics|pediatrics
4989525|NCT04056949|SCLC|sclc
4989526|NCT04056936|Breastfeeding|breastfeeding
4989527|NCT04056936|Lactational mastitis|lactational mastitis
4989528|NCT04056936|Infant nutrition|infant nutrition
4989529|NCT04056936|Infant growth|infant growth
4989530|NCT04056936|Speech development|speech development
4989531|NCT04056936|Frenotomy|frenotomy
4989532|NCT04056923|Pulmonary Nodules|pulmonary nodules
4989533|NCT04056923|Lung Neoplasms|lung neoplasms
4989534|NCT04056923|Computed Tomography|computed tomography
4989535|NCT04056923|Three-Dimensional Printing|three-dimensional printing
4989536|NCT04056871|post-operative delirium|post-operative delirium
4989537|NCT04056871|post-operative cognitive dysfunction|post-operative cognitive dysfunction
4989538|NCT04056871|frailty|frailty
4989539|NCT04056871|nutritional status|nutritional status
4989540|NCT04056871|depression|depression
4989541|NCT04056858|array-CGH|array-cgh
4989542|NCT04056858|exome sequencing|exome sequencing
4989543|NCT04056832|Aortic Stenosis|aortic stenosis
4989544|NCT04056832|Aortic Valve Replacement|aortic valve replacement
4989545|NCT04056832|Single Strip Pericardium|single strip pericardium
4989546|NCT04056832|Autologous Pericardium|autologous pericardium
4989547|NCT04056832|Mechanical Valve Replacement|mechanical valve replacement
4989548|NCT04056832|Comparison of Left Ventricle Remodeling|comparison of left ventricle remodeling
4989549|NCT04056793|Birthing position|birthing position
4989550|NCT04056793|Dystocia|dystocia
4989551|NCT04056741|Neonatal RDS|neonatal rds
4989553|NCT04056741|Surfactant Deficiency|surfactant deficiency
4989560|NCT04056702|Chronic Sinusitis|chronic sinusitis
4989584|NCT04056598|microbiome|microbiome
4989585|NCT04056598|SLST|slst
4989586|NCT04056585|brachial plexus block|brachial plexus block
4989587|NCT04056585|intermittent pneumatic compression maneuver|intermittent pneumatic compression maneuver
4989588|NCT04056559|Prototype|prototype
4989589|NCT04056559|Adaptable mouthguards|adaptable mouthguards
4989590|NCT04056546|Real-time Polymerase-Chain Reaction|real-time polymerase-chain reaction
4989591|NCT04056533|Citomegalovirus, Haploidentical, Hematopoietic Stem Cell Transplantation|citomegalovirus, haploidentical, hematopoietic stem cell transplantation
4989592|NCT04056507|Immunological parameters|immunological parameters
4989593|NCT04056507|Histological parameters|histological parameters
4989594|NCT04056481|Acute Hepatic Porphyria (AHP)|acute hepatic porphyria (ahp)
4989595|NCT04056481|Acute Intermittent Porphyria (AIP)|acute intermittent porphyria (aip)
4989596|NCT04056481|Porphyria|porphyria
4989597|NCT04056481|Acute Intermittent|acute intermittent
4989598|NCT04056481|Acute Porphyria|acute porphyria
4989599|NCT04056481|Hereditary Coproporphyria (HCP)|hereditary coproporphyria (hcp)
4989600|NCT04056481|Variegate Porphyria (VP)|variegate porphyria (vp)
4989601|NCT04056481|ALA Dehydratase Deficient Porphyria (ADP)|ala dehydratase deficient porphyria (adp)
4989602|NCT04056481|Givosiran|givosiran
4989603|NCT04056481|Expanded Access|expanded access
4989609|NCT04056390|catheter ablation|catheter ablation
4989610|NCT04056377|Hypertension|hypertension
4989612|NCT04056377|Obesity|obesity
4989613|NCT04056377|Arterial stiffness|arterial stiffness
4989614|NCT04056377|Physical inactivity|physical inactivity
4989615|NCT04056351|humerus|humerus
4989616|NCT04056351|fracture|fracture
4989617|NCT04056351|locking plate|locking plate
4989618|NCT04056351|PHILOS|philos
4989619|NCT04056351|fixation failure risk|fixation failure risk
4989620|NCT04056351|computer simulation|computer simulation
4989621|NCT04056351|patient activity tracking|patient activity tracking
4989622|NCT04056338|delirium|delirium
4989623|NCT04056312|memory|memory
4989624|NCT04056312|learning|learning
4989625|NCT04056312|cognition|cognition
4989626|NCT04056312|traumatic brain injury|traumatic brain injury
4989627|NCT04056312|treatment and therapy|treatment and therapy
4989638|NCT04056286|gastric emptying|gastric emptying
4985965|NCT04078971|soccer|soccer
4989639|NCT04056286|gastro-intestinal motility|gastro-intestinal motility
4989640|NCT04056286|endotoxemia|endotoxemia
4989641|NCT04056286|catabolism|catabolism
4989642|NCT04056286|GLP-1|glp-1
4989644|NCT04056273|guide sheath, bronchoscopic biopsy|guide sheath, bronchoscopic biopsy
4989645|NCT04056234|Translocation|translocation
4989646|NCT04056234|Synovial microbiota|synovial microbiota
4989647|NCT04056221|Sjogren`s syndrome|sjogren`s syndrome
4989648|NCT04056221|xerostomia|xerostomia
4989649|NCT04056221|xerophthalmia|xerophthalmia
4989650|NCT04056221|acupuncture|acupuncture
4989651|NCT04056182|opioid use disorder|opioid use disorder
4989652|NCT04056182|lofexidine|lofexidine
4989653|NCT04056182|naltrexon-xr|naltrexon-xr
4989654|NCT04056169|rosuvastatin|rosuvastatin
4989655|NCT04056169|ezetimibe/rosuvastatin|ezetimibe/rosuvastatin
5342918|NCT01981499|wheal|wheal
4989656|NCT04056169|carotid plaque inflammation|carotid plaque inflammation
4989657|NCT04056169|fluorodeoxyglucose F18|fluorodeoxyglucose f18
4989661|NCT04056156|Prevention|prevention
4989662|NCT04056156|Primary Care|primary care
4989663|NCT04056143|Thromboembolism|thromboembolism
4989664|NCT04056143|Oral anticoagulants|oral anticoagulants
4989665|NCT04056143|Adverse events|adverse events
4989666|NCT04056143|Pharmacogenomics|pharmacogenomics
4989667|NCT04056143|Precision Medicine|precision medicine
4989668|NCT04056091|Neonatal resuscitation|neonatal resuscitation
4989669|NCT04056091|Stimulation|stimulation
4989670|NCT04056091|Asphyxia|asphyxia
4989671|NCT04056065|Resuscitative agent|resuscitative agent
4989672|NCT04056065|Vasopressor|vasopressor
4989687|NCT04055974|postpartum period|postpartum period
4989691|NCT04055831|Gaucher disease|gaucher disease
4989692|NCT04055831|Osteoporosis|osteoporosis
4989696|NCT04055792|small cell lung cancer|small cell lung cancer
4989697|NCT04055792|PD-1 inhibitor|pd-1 inhibitor
4989698|NCT04055792|anti-angiogenesis|anti-angiogenesis
4989699|NCT04055792|third-line or beyond treatment|third-line or beyond treatment
4989700|NCT04055766|Artificial Intelligence|artificial intelligence
4989701|NCT04055740|CIED|cied
4989702|NCT04055727|treatment|treatment
4989703|NCT04055714|Eustachian tube dysfunction|eustachian tube dysfunction
4989704|NCT04055688|Orbeye Surgical Microscope|orbeye surgical microscope
4989705|NCT04055688|fluorescence-guided surgery|fluorescence-guided surgery
4989706|NCT04055688|5-ALA|5-ala
4989707|NCT04055623|Lou Gehrig's Disease|lou gehrig's disease
4989708|NCT04055610|H-MEX powered exoskeleton|h-mex powered exoskeleton
4989709|NCT04055610|Exoskeleton|exoskeleton
4989710|NCT04055597|cerebellar stroke|cerebellar stroke
4989711|NCT04055597|upper extremity rehabilitation robot|upper extremity rehabilitation robot
4989712|NCT04055597|transcranial direct current stimulation|transcranial direct current stimulation
4989713|NCT04055597|stroke rehabilitation|stroke rehabilitation
4989714|NCT04055558|childhood leukemia|childhood leukemia
4989715|NCT04055558|lymphoproliferative disorders|lymphoproliferative disorders
4989716|NCT04055558|EBV|ebv
4989717|NCT04055493|early breast cancer|early breast cancer
4989718|NCT04055493|ADAPT|adapt
4989719|NCT04055493|endocrine therapy|endocrine therapy
4989720|NCT04055493|ribociclib|ribociclib
4989721|NCT04055493|intermediate risk|intermediate risk
4989722|NCT04055493|HER2 negative|her2 negative
4989723|NCT04055493|HR positive|hr positive
4989724|NCT04055480|closed-loop|closed-loop
4989725|NCT04055480|artificial pancreas|artificial pancreas
4989726|NCT04055480|insulin|insulin
4989727|NCT04055467|smoking cessation|smoking cessation
4989728|NCT04055467|neuroimaging|neuroimaging
4989729|NCT04055467|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
4989730|NCT04055467|abstinence|abstinence
4989731|NCT04055454|Lassa Virus Infection|lassa virus infection
4989732|NCT04055454|Prevention|prevention
4989733|NCT04055454|Vaccine|vaccine
4989751|NCT04055363|Respiratory infection|respiratory infection
4989752|NCT04055363|Gastrointestinal infection|gastrointestinal infection
4989753|NCT04055350|National early warning score|national early warning score
4989754|NCT04055350|Prevention of serious adverse events|prevention of serious adverse events
4989755|NCT04055350|Patient deterioration|patient deterioration
4989855|NCT04054908|Oral Fluoropyrimidine|oral fluoropyrimidine
4989759|NCT04055311|recovery support|recovery support
4989760|NCT04055311|bladder cancer|bladder cancer
5034458|NCT03783884|VLT|vlt
4989767|NCT04055285|implantable loop recorder|implantable loop recorder
4989768|NCT04055285|continuous monitoring|continuous monitoring
4989769|NCT04055285|burden|burden
4989770|NCT04055285|insertable cardiac monitor|insertable cardiac monitor
4989771|NCT04055285|resistant hypertension|resistant hypertension
4989776|NCT04055259|Health and Wellness Coaching|health and wellness coaching
4989777|NCT04055220|Maintenance therapy|maintenance therapy
4989778|NCT04055220|First line therapy|first line therapy
4989779|NCT04055220|Regorafenib|regorafenib
4989780|NCT04055220|Randomization|randomization
4989781|NCT04055220|Double-blinded|double-blinded
4989782|NCT04055220|Placebo controlled|placebo controlled
4989783|NCT04055220|Relapse-free survival|relapse-free survival
4989784|NCT04055220|Time to treatment failure|time to treatment failure
4989785|NCT04055220|Overall survival|overall survival
4989786|NCT04055220|Quality of life|quality of life
4989787|NCT04055220|Tolerance|tolerance
4989788|NCT04055220|Compliance|compliance
4989789|NCT04055220|Bone sarcoma|bone sarcoma
4989790|NCT04055220|Osteosarcoma|osteosarcoma
4989791|NCT04055220|Efficacy|efficacy
4989792|NCT04055220|Complete response|complete response
4989793|NCT04055220|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4989794|NCT04055220|Multi-target inhibitor|multi-target inhibitor
4989795|NCT04055207|HIV|hiv
4989796|NCT04055207|Telemedicine|telemedicine
4989797|NCT04055181|schizophrenia|schizophrenia
4989798|NCT04055181|smoking|smoking
4989799|NCT04055181|rTMS|rtms
4989800|NCT04055181|major depressive disorder|major depressive disorder
4989801|NCT04055168|Dyslipidemia|dyslipidemia
4989802|NCT04055168|Single Ascending Dose|single ascending dose
4989803|NCT04055168|Safety|safety
4989804|NCT04055168|Tolerability|tolerability
4989805|NCT04055103|Total Hip/Knee Arthroplasty;Dutch Arthroplasty Register; Quality Improvement.|total hip/knee arthroplasty;dutch arthroplasty register; quality improvement.
4989806|NCT04055090|diabetic|diabetic
4989807|NCT04055090|neuropathy|neuropathy
4989808|NCT04055090|shooting pain|shooting pain
4989809|NCT04055090|burning pain|burning pain
4989810|NCT04055090|pins and needles pain|pins and needles pain
4989811|NCT04055090|foot pain|foot pain
4989812|NCT04055090|ViroMed|viromed
4989813|NCT04055077|Noninvasive Ventilation|noninvasive ventilation
4989814|NCT04055077|Airway management|airway management
4989815|NCT04055077|Vitrectomy|vitrectomy
4989816|NCT04055077|Adult|adult
4989817|NCT04055077|Moderate Sedation|moderate sedation
4989818|NCT04055077|Hypoxia|hypoxia
4989819|NCT04055064|DFU, wound healing, nutrition education,supplementation|dfu, wound healing, nutrition education,supplementation
4989820|NCT04055051|Hemophilia A|hemophilia a
4989821|NCT04055051|Hemophilia B|hemophilia b
4989822|NCT04055051|Liver Transplantation|liver transplantation
4989823|NCT04055051|Quality of Life|quality of life
4989824|NCT04055051|Hemophilia Treatment Centers (HTCs)|hemophilia treatment centers (htcs)
4989825|NCT04055025|Ghrelin|ghrelin
4989826|NCT04055025|Sleeve gastrectomy|sleeve gastrectomy
4989827|NCT04055025|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4989828|NCT04055012|Low Back Pain|low back pain
4989829|NCT04055012|Metformin|metformin
4989830|NCT04055012|Placebo|placebo
4989831|NCT04054999|hydroxocobalamin|hydroxocobalamin
4989832|NCT04054999|methylene blue|methylene blue
4989839|NCT04054973|psychosis|psychosis
4989847|NCT04054934|CORTICAL BRAIN|cortical brain
4989848|NCT04054934|Glucose variability|glucose variability
4989849|NCT04054934|Biological clock|biological clock
4989850|NCT04054934|Pediatrics|pediatrics
4989851|NCT04054921|Chronic anemia|chronic anemia
4989852|NCT04054921|β-thalassemia|β-thalassemia
4989853|NCT04054908|Gut Microbiome|gut microbiome
4989854|NCT04054908|Colorectal Cancer|colorectal cancer
4989868|NCT04054804|risk factor|risk factor
4989869|NCT04054804|software|software
4989870|NCT04054804|orthotics|orthotics
4989871|NCT04054778|Auditory verbal hallucinations|auditory verbal hallucinations
4989872|NCT04054778|Schizophrenia|schizophrenia
4989873|NCT04054778|Treatment-resistant|treatment-resistant
4989874|NCT04054778|Psychotherapy|psychotherapy
4989875|NCT04054778|Cognitive Behavioral Therapy|cognitive behavioral therapy
4989895|NCT04054713|Seattle protocol|seattle protocol
4989896|NCT04054713|Chromoendoscopy|chromoendoscopy
4989897|NCT04054700|upper limb rehabilitation|upper limb rehabilitation
4989898|NCT04054700|stroke|stroke
4989899|NCT04054700|proximal upper rehabilitation robot|proximal upper rehabilitation robot
4989900|NCT04054700|distal upper rehabilitation robot|distal upper rehabilitation robot
5356781|NCT01918020|Motor Activity|motor activity
4989901|NCT04054674|e.max, occlusal scheme, endodntically treated teeth,|e.max, occlusal scheme, endodntically treated teeth,
4989902|NCT04054661|G6PD Deficiency|g6pd deficiency
4989903|NCT04054648|Pragmatic|pragmatic
4989904|NCT04054648|Primary Care|primary care
4989905|NCT04054648|Chronotherapy|chronotherapy
4989906|NCT04054648|Administrative Data|administrative data
4989907|NCT04054648|Behaviourism|behaviourism
4989908|NCT04054648|Sundowning|sundowning
4989909|NCT04054648|Stroke|stroke
4989910|NCT04054648|Myocardial Infarction|myocardial infarction
4989911|NCT04054648|Heart Failure|heart failure
4989912|NCT04054648|Hip Fracture|hip fracture
4989913|NCT04054648|Nursing Home|nursing home
4989914|NCT04054648|Long Term Care|long term care
4989915|NCT04054635|silver diamine fluoride|silver diamine fluoride
4989916|NCT04054635|randomized clinical trial|randomized clinical trial
4989917|NCT04054635|early childhood caries|early childhood caries
4989918|NCT04054635|severe early childhood caries|severe early childhood caries
4989919|NCT04054635|oral microbiome|oral microbiome
4989920|NCT04054635|treatment|treatment
4989921|NCT04054635|arrest|arrest
4989922|NCT04054635|application|application
4989923|NCT04054635|frequency|frequency
4989924|NCT04054635|regimen|regimen
4989925|NCT04054635|cariogenic bacteria|cariogenic bacteria
4989926|NCT04054635|early childhood oral health impact scale|early childhood oral health impact scale
4989927|NCT04054635|oral health-related quality of of life|oral health-related quality of of life
4989928|NCT04054635|caries|caries
4989929|NCT04054635|oral bacteriome|oral bacteriome
4989930|NCT04054635|oral mycobiome|oral mycobiome
4989931|NCT04054635|cavitated lesions|cavitated lesions
4989932|NCT04054622|patient-ventilator asynchrony|patient-ventilator asynchrony
4989933|NCT04054596|Traumatic Brain Injury|traumatic brain injury
4989934|NCT04054596|Cognitive Impairment|cognitive impairment
4989935|NCT04054596|Intervention|intervention
4989936|NCT04054583|Long-term care|long-term care
4989937|NCT04054583|Renovations|renovations
4989938|NCT04054583|Residents|residents
4989939|NCT04054583|Family|family
4989940|NCT04054583|Staff|staff
4989942|NCT04054479|Penehyclidine|penehyclidine
4989943|NCT04054479|PONV|ponv
4989944|NCT04054466|HIV|hiv
4989945|NCT04054466|Counseling|counseling
4989946|NCT04054466|Antiretroviral Therapy|antiretroviral therapy
4989947|NCT04054466|Alcohol Drinking|alcohol drinking
4989948|NCT04054466|Nursing Care|nursing care
4989949|NCT04054440|office based angiosuite|office based angiosuite
4989950|NCT04054427|Intraocular Lens|intraocular lens
4989951|NCT04054427|Trifocal|trifocal
4989952|NCT04054427|hydrophobic|hydrophobic
4989953|NCT04054427|Post refractive surgery|post refractive surgery
4989954|NCT04054414|Endothelin|endothelin
4989964|NCT04054323|Transplant Waitlist|transplant waitlist
4989965|NCT04054297|NAFLD|nafld
4989966|NCT04054297|Diet|diet
4989967|NCT04054297|Glycemic index|glycemic index
4989968|NCT04054284|Type 2 Diabetes|type 2 diabetes
4989969|NCT04054284|Herbal Medicine|herbal medicine
4989970|NCT04054284|Safety|safety
4989971|NCT04054284|Glycaemia Control|glycaemia control
4989972|NCT04054284|Alternative Therapy|alternative therapy
4993723|NCT04033237|Health disparities|health disparities
4989988|NCT04054050|sleep disturbance|sleep disturbance
4989991|NCT04054037|APASL ACLF Research Consortium|apasl aclf research consortium
4989992|NCT04054037|Diagnosis and treatment standard|diagnosis and treatment standard
4989993|NCT04054037|HBV-ACLF|hbv-aclf
4989994|NCT04054037|acute on chronic liver failure|acute on chronic liver failure
4989995|NCT04053998|Pancreaticoduodenectomy|pancreaticoduodenectomy
4989996|NCT04053998|Portal vein resection|portal vein resection
4989997|NCT04053998|Benchmarks|benchmarks
4989998|NCT04053998|Outcomes|outcomes
4989999|NCT04053946|BKA|bka
4990000|NCT04053946|biofilm|biofilm
4990001|NCT04053946|Next Science|next science
4990002|NCT04053933|QUALMS|qualms
4990003|NCT04053933|MDS|mds
4990004|NCT04053933|Be-QUALMS|be-qualms
4990005|NCT04053933|Quality of life|quality of life
4990006|NCT04053933|QoL|qol
4990007|NCT04053907|falciparum|falciparum
4990008|NCT04053907|gametocyte|gametocyte
4990009|NCT04053907|elimination|elimination
4990010|NCT04053907|anopheles|anopheles
4990011|NCT04053907|transmission|transmission
4990012|NCT04053907|diagnostic|diagnostic
4990013|NCT04053894|vascular surgery|vascular surgery
4990014|NCT04053894|aspirin resistance|aspirin resistance
4990015|NCT04053894|MINS|mins
4990019|NCT04053855|Clear cell renal cell carcinoma|clear cell renal cell carcinoma
4990020|NCT04053855|Urinary exosomes|urinary exosomes
4990021|NCT04053855|Detection|detection
4990022|NCT04053855|Electron microscopy technique|electron microscopy technique
4990023|NCT04053855|Flow cytometry|flow cytometry
4990024|NCT04053855|RT-qPCR|rt-qpcr
4990031|NCT04053829|Rehabilitation|rehabilitation
4990032|NCT04053829|Tele-rehabilitation|tele-rehabilitation
4990033|NCT04053829|Physical Therapy|physical therapy
4990034|NCT04053829|Coaching|coaching
4990035|NCT04053829|Physical Activity|physical activity
4990036|NCT04053816|cardiovascular|cardiovascular
4990037|NCT04053816|potassium supplementation|potassium supplementation
4990038|NCT04053816|cardiac surgery|cardiac surgery
4990039|NCT04053816|atrial fibrillation|atrial fibrillation
4990040|NCT04053816|coronary artery bypass grafting|coronary artery bypass grafting
4990041|NCT04053816|potassium|potassium
4990042|NCT04053790|irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
4990043|NCT04053790|Lactobacillus LB|lactobacillus lb
4990044|NCT04053790|treatment|treatment
4990045|NCT04053790|safety|safety
4990046|NCT04053790|efficacy|efficacy
4990047|NCT04053764|SEG101|seg101
4990048|NCT04053764|SCD|scd
4990049|NCT04053764|Crizanlizumab|crizanlizumab
4990050|NCT04053764|Sickle cell nephropathy|sickle cell nephropathy
4990051|NCT04053764|chronic kidney disease|chronic kidney disease
4990052|NCT04053764|CKD|ckd
4990053|NCT04053764|albuminuria (ACR)|albuminuria (acr)
4990054|NCT04053764|renal function|renal function
4990055|NCT04053764|standard of care|standard of care
4990056|NCT04053751|intensive care unit|intensive care unit
4990061|NCT04053712|Closed-loop|closed-loop
4990062|NCT04053712|Dual-hormone|dual-hormone
4990063|NCT04053712|Glucagon|glucagon
4990064|NCT04053712|FiAsp|fiasp
4990065|NCT04053712|Artificial pancreas|artificial pancreas
4990066|NCT04053673|Phase 1|phase 1
4990067|NCT04053673|PARP7 inhibition|parp7 inhibition
4990068|NCT04053673|First in Human|first in human
4990069|NCT04053673|Solid Tumors|solid tumors
4990070|NCT04053673|Interferon|interferon
4990071|NCT04053660|Gingival Crevicular Fluid|gingival crevicular fluid
4990072|NCT04053660|Lipid Mediator|lipid mediator
4990073|NCT04053660|Periodontal Treatment|periodontal treatment
4990083|NCT04053621|metformin|metformin
4990090|NCT04053595|Postoperative complications|postoperative complications
4990091|NCT04053595|Mortality|mortality
4990097|NCT04053569|polyphenols|polyphenols
4990098|NCT04053569|diet|diet
4990099|NCT04053569|lipidomics|lipidomics
4990100|NCT04053569|metabolic syndrome|metabolic syndrome
4990101|NCT04053556|sleep deprivation|sleep deprivation
4990102|NCT04053556|internal medicine residency|internal medicine residency
4990103|NCT04053556|on call|on call
4990104|NCT04053556|cognitive impairment|cognitive impairment
4990105|NCT04053556|burn out|burn out
4990106|NCT04053556|safety|safety
4990107|NCT04053556|depression|depression
4990108|NCT04053543|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4990109|NCT04053543|Pulmonary Hypertension|pulmonary hypertension
4990110|NCT04053543|PAH|pah
4990111|NCT04053543|Connective Tissue Disease- Associated|connective tissue disease- associated
4990112|NCT04053543|6 Minute Walk Test|6 minute walk test
4990113|NCT04053543|6 Minute Walk Distance|6 minute walk distance
4990114|NCT04053543|Pulmonary Vascular Resistance|pulmonary vascular resistance
4990115|NCT04053543|Cardiac MRI|cardiac mri
4990116|NCT04053543|Right Ventricular Function|right ventricular function
4990117|NCT04053543|Hypertension|hypertension
4990118|NCT04053543|Familial Primary Pulmonary Hypertension|familial primary pulmonary hypertension
4990119|NCT04053543|Connective Tissue Diseases|connective tissue diseases
4990120|NCT04053543|Vascular Diseases|vascular diseases
4990121|NCT04053543|Hypertension, Pulmonary|hypertension, pulmonary
4990122|NCT04053543|Lung Diseases|lung diseases
4990123|NCT04053543|Cardiovascular Diseases|cardiovascular diseases
4990124|NCT04053504|Health disparities|health disparities
4990125|NCT04053504|Family teamwork|family teamwork
4990126|NCT04053504|Peer-delivered intervention|peer-delivered intervention
5307665|NCT02140268|Pharmacokinetics|pharmacokinetics
4990127|NCT04053504|Facilitators to diabetes management|facilitators to diabetes management
4990128|NCT04053504|Barriers to diabetes management|barriers to diabetes management
4990129|NCT04053504|Community-based intervention|community-based intervention
4990130|NCT04053491|Hand surgery|hand surgery
4990131|NCT04053491|Anesthesia, Regional|anesthesia, regional
4990132|NCT04053491|Brachial Plexus Block|brachial plexus block
4990133|NCT04053478|vasopressor|vasopressor
4990134|NCT04053478|ephedrine|ephedrine
4990135|NCT04053478|phenylephrine|phenylephrine
4990136|NCT04053478|norepinephrine|norepinephrine
4990137|NCT04053478|umbilical arteries|umbilical arteries
4990138|NCT04053478|uterine contraction|uterine contraction
4990139|NCT04053478|fetal acidosis|fetal acidosis
4990140|NCT04053439|Clonal Hematopoiesis of Indeterminate Significance|clonal hematopoiesis of indeterminate significance
4990141|NCT04053439|Chemotherapy|chemotherapy
4990142|NCT04053439|Lymphoma|lymphoma
4990143|NCT04053439|Chemotherapy complications|chemotherapy complications
4990144|NCT04053426|RASS|rass
4990145|NCT04053426|CAM-ICU|cam-icu
4990146|NCT04053387|Tapinarof|tapinarof
4990147|NCT04053387|plaque psoriasis,|plaque psoriasis,
4990148|NCT04053387|adult|adult
4990149|NCT04053387|phase 3|phase 3
4990150|NCT04053387|topical|topical
4990151|NCT04053387|open-label|open-label
4990152|NCT04053387|efficacy|efficacy
4990153|NCT04053387|safety|safety
4990154|NCT04053387|psoriasis|psoriasis
4990155|NCT04053387|long-term|long-term
4990156|NCT04053387|therapeutic aryl hydrocarbon receptor modulating agent|therapeutic aryl hydrocarbon receptor modulating agent
4990182|NCT04053192|Severe Aortic Valve Stenosis|severe aortic valve stenosis
4990183|NCT04053192|Surgical aortic valve replacement (SAVR)|surgical aortic valve replacement (savr)
4990184|NCT04053166|Intraplaque haemorrhage|intraplaque haemorrhage
4990186|NCT04053166|home-based Physical activity|home-based physical activity
4990187|NCT04053166|carotic plaque vulnerability|carotic plaque vulnerability
4990188|NCT04053140|Pharmacokinetics|pharmacokinetics
4990189|NCT04053140|Penicillin G|penicillin g
4990190|NCT04053140|Penicillins|penicillins
4990191|NCT04053140|Proof of Concept Study|proof of concept study
4990192|NCT04053140|Clinical Trial, Phase I|clinical trial, phase i
4990193|NCT04053140|Microneedle array|microneedle array
4990194|NCT04053127|vagus nerve stimulation|vagus nerve stimulation
4990195|NCT04053114|Ovarian teratoma|ovarian teratoma
4990196|NCT04053114|struma ovarii|struma ovarii
4990197|NCT04053114|thyroid carcinoma|thyroid carcinoma
4990198|NCT04053114|next generation sequencing|next generation sequencing
4990199|NCT04053101|Bladder cancer|bladder cancer
4990200|NCT04053101|PET CT|pet ct
4990201|NCT04053101|CT scan|ct scan
4990202|NCT04053101|Lymph node staging|lymph node staging
4990211|NCT04053075|Multidrug Resistant Organism|multidrug resistant organism
4990213|NCT04053075|Whole Genome Sequencing|whole genome sequencing
4990214|NCT04053062|Castrate-Resistant|castrate-resistant
4990215|NCT04053023|linerixibat (GSK2330672), obeticholic acid, drug interaction, primary biliary cholangitis, pharmacokinetics|linerixibat (gsk2330672), obeticholic acid, drug interaction, primary biliary cholangitis, pharmacokinetics
4990217|NCT04052984|Cesarean Section|cesarean section
4990218|NCT04052984|Umbilical cord|umbilical cord
4990219|NCT04052984|Breastfeeding|breastfeeding
4990226|NCT04052906|COPD|copd
4990227|NCT04052906|dyspnea|dyspnea
4990228|NCT04052906|self-efficacy|self-efficacy
4990229|NCT04052906|self-care|self-care
4990230|NCT04052893|Surgery|surgery
4990231|NCT04052893|Plastic|plastic
4990232|NCT04052880|Multiple myeloma|multiple myeloma
5342919|NCT01981499|flare|flare
4990233|NCT04052880|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
4990234|NCT04052880|Myeloma|myeloma
4990235|NCT04052880|Elderly|elderly
4990236|NCT04052880|Daratumumab|daratumumab
4990237|NCT04052867|Intravenous lignocaine|intravenous lignocaine
4990238|NCT04052867|Multimodal anagesic approach|multimodal anagesic approach
4990239|NCT04052867|Postoperative Pain|postoperative pain
4990240|NCT04052867|living related renal transplantation|living related renal transplantation
4990241|NCT04052867|Morphine|morphine
4990254|NCT04052776|Neuromodulation|neuromodulation
4990255|NCT04052776|Epidural electrical stimulation|epidural electrical stimulation
4990256|NCT04052763|NSTE-ACS|nste-acs
4990257|NCT04052763|FFR-CT|ffr-ct
4990258|NCT04052763|FFRangio™|ffrangio™
4990259|NCT04052750|Functional Gastrointestinal Disorders, Adherence|functional gastrointestinal disorders, adherence
4990260|NCT04052737|Endothelin|endothelin
4990261|NCT04052737|Neurogenesis|neurogenesis
4990262|NCT04052737|Neural progenitor cells|neural progenitor cells
4990263|NCT04052724|informal caregivers|informal caregivers
4990264|NCT04052724|internet-based cognitive behaviour therapy|internet-based cognitive behaviour therapy
4990265|NCT04052724|culturally adapted psychotherapy|culturally adapted psychotherapy
4990266|NCT04052724|eHealth|ehealth
4990267|NCT04052724|caregiver burden|caregiver burden
4990268|NCT04052672|Exercise|exercise
5307769|NCT02139800|Sustained inflation|sustained inflation
4990269|NCT04052672|Nutritional Supplement|nutritional supplement
4990270|NCT04052672|Physical Function|physical function
4990271|NCT04052672|Quality of Life|quality of life
4990272|NCT04052672|Cardiac Device|cardiac device
4990273|NCT04052672|Physical Activity|physical activity
4990274|NCT04052672|Defibrillators|defibrillators
4990275|NCT04052672|Pacemakers|pacemakers
4990276|NCT04052672|Biomarkers|biomarkers
4990277|NCT04052646|Subarachnoid hemorrhage|subarachnoid hemorrhage
4990278|NCT04052646|Emergency medical coordination center|emergency medical coordination center
4990279|NCT04052646|Emergency Medical Service|emergency medical service
4990280|NCT04052633|c arm cholangiography|c arm cholangiography
4990281|NCT04052633|cholecystectomy|cholecystectomy
4990282|NCT04052620|Ankle sprain|ankle sprain
4990283|NCT04052620|diclofenac diethylamine|diclofenac diethylamine
4990284|NCT04052581|Per oral Endoscopic Myotomy|per oral endoscopic myotomy
4990285|NCT04052581|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
4990286|NCT04052581|POEM|poem
4990287|NCT04052581|TIF|tif
4990288|NCT04052542|Noninvasive ventilation|noninvasive ventilation
4990289|NCT04052542|Education|education
4990290|NCT04052542|Intensive care unit|intensive care unit
4990291|NCT04052542|Mechanical ventilation|mechanical ventilation
4990292|NCT04052542|Evidence-based practice|evidence-based practice
4990293|NCT04052503|physical therapy|physical therapy
4990294|NCT04052503|knowledge translation|knowledge translation
4990295|NCT04052503|outcome measures|outcome measures
4990296|NCT04052503|knowledge brokering|knowledge brokering
4990297|NCT04052490|Zirconia,|zirconia,
4990298|NCT04052490|occlusal scheme,|occlusal scheme,
4990299|NCT04052490|endodontically treated teeth,|endodontically treated teeth,
4990300|NCT04052490|finishline designs.|finishline designs.
4990301|NCT04052477|Suicide|suicide
4990302|NCT04052477|Prevention|prevention
4990303|NCT04052477|Social network|social network
4990304|NCT04052464|gene expression|gene expression
4990305|NCT04052464|biomarkers|biomarkers
4990306|NCT04052464|implantation window|implantation window
4990322|NCT04052282|Technology|technology
4990323|NCT04052282|Physical Function|physical function
4990324|NCT04052269|Glaucoma|glaucoma
4990325|NCT04052256|Fractional flow reserve|fractional flow reserve
4990326|NCT04052256|Coronary computed tomography angiography|coronary computed tomography angiography
4990327|NCT04052256|Computational fluid dynamics|computational fluid dynamics
4990328|NCT04052256|Plaque characteristics|plaque characteristics
4990329|NCT04052230|diaphragm|diaphragm
4990330|NCT04052230|ECMO|ecmo
4990331|NCT04052230|ICU|icu
4990332|NCT04052178|Oropharyngeal dysphagia|oropharyngeal dysphagia
4990333|NCT04052178|Stroke|stroke
4990334|NCT04052178|Sensory stimulation|sensory stimulation
4990335|NCT04052165|Effectiveness|effectiveness
4990336|NCT04052165|Glaucoma Drainage Device|glaucoma drainage device
4990337|NCT04052165|Intraocular pressure|intraocular pressure
4990338|NCT04052165|Tissue Response|tissue response
4990339|NCT04052152|HCC|hcc
4990340|NCT04052152|Antiangiogenic agents combined with PD-1 antibody|antiangiogenic agents combined with pd-1 antibody
4990341|NCT04052139|Pain|pain
4990342|NCT04052139|Alcohol|alcohol
4990343|NCT04052139|HIV|hiv
4990344|NCT04052139|Inflammation|inflammation
4990345|NCT04052139|Low-dose naltrexone|low-dose naltrexone
4990346|NCT04052139|Gabapentin|gabapentin
4990347|NCT04052113|Real world, PD-L1, TMB, Stage IV, urothelial cancer, Japanese|real world, pd-l1, tmb, stage iv, urothelial cancer, japanese
4990348|NCT04052100|Prehabilitation|prehabilitation
4990349|NCT04052100|Exercise training|exercise training
4990357|NCT04052087|Mini-BESTest|mini-bestest
4990358|NCT04052087|Balance|balance
4990359|NCT04052087|Postural control|postural control
4990360|NCT04052087|Brain Stroke|brain stroke
4990361|NCT04052087|Stroke|stroke
4990362|NCT04052087|Cross-cultural adaptation|cross-cultural adaptation
4990372|NCT04052022|Auto-Antibody Production|auto-antibody production
4990373|NCT04052022|Host Genetic Predisposition|host genetic predisposition
4990374|NCT04052022|Immune Reconstitution Inflammatory Syndrome|immune reconstitution inflammatory syndrome
4990375|NCT04052022|Biomarkers|biomarkers
4990376|NCT04052022|Pathogenesis|pathogenesis
4990377|NCT04052009|Spinal cord injury|spinal cord injury
4990378|NCT04052009|Gait|gait
4990379|NCT04052009|Training|training
4990380|NCT04052009|Comparison|comparison
4990381|NCT04052009|Robotic-assisted|robotic-assisted
4990382|NCT04051957|Kidney Injury|kidney injury
4990383|NCT04051957|Proteinuria|proteinuria
4990384|NCT04051957|Hypertension|hypertension
4990385|NCT04051957|Anti-VEGF|anti-vegf
5863596|NCT00001243|AIDS|aids
4990391|NCT04051918|socially assistive robotics|socially assistive robotics
4990393|NCT04051905|Regeneration|regeneration
4990394|NCT04051866|Dentist|dentist
4990395|NCT04051866|Primary Health Care|primary health care
4990396|NCT04051866|Chronic Periodontitis|chronic periodontitis
4990397|NCT04051866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5307865|NCT02139345|AVN|avn
4990398|NCT04051866|Root planing|root planing
4990399|NCT04051866|Dental Scaling|dental scaling
4990400|NCT04051853|HCC|hcc
4990401|NCT04051853|Liver cirrhosis|liver cirrhosis
4990403|NCT04051788|Sedentary Lifestyle|sedentary lifestyle
4990404|NCT04051788|Step Aerobics|step aerobics
4990405|NCT04051788|Pulmonary Function|pulmonary function
4990406|NCT04051697|Head and Neck Cancer|head and neck cancer
4990407|NCT04051697|Self-management|self-management
4990414|NCT04051645|imposed WoB|imposed wob
4990415|NCT04051645|imposed PTP|imposed ptp
4990416|NCT04051645|flow resistance|flow resistance
4990417|NCT04051632|Medtronic 670G|medtronic 670g
4990418|NCT04051593|cervical stabilization exercise|cervical stabilization exercise
4990419|NCT04051580|myocardial protection|myocardial protection
4990420|NCT04051580|cardiac surgery|cardiac surgery
4990421|NCT04051580|del Nido cardioplegia|del nido cardioplegia
4990422|NCT04051554|ACL Injury|acl injury
4990423|NCT04051554|Landing Error Score System|landing error score system
4990424|NCT04051554|Neuromuscular Training|neuromuscular training
4990425|NCT04051554|Proprioceptive Training|proprioceptive training
4990426|NCT04051554|Soccer|soccer
5356782|NCT01918007|Apnea|apnea
4990427|NCT04051528|combinatorial training|combinatorial training
4990428|NCT04051515|Exercise|exercise
4990429|NCT04051515|Hemodialysis|hemodialysis
4990430|NCT04051502|Ovarian Cancer|ovarian cancer
4990431|NCT04051502|Adnexal Mass|adnexal mass
4990432|NCT04051502|Ovarian Sentinal Lymph Nodes|ovarian sentinal lymph nodes
4990433|NCT04051502|19-271|19-271
4990434|NCT04051502|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4990435|NCT04051502|Sentinal Lymph Nodes|sentinal lymph nodes
4990436|NCT04051502|indocyanine green dye|indocyanine green dye
4990437|NCT04051502|ICG Dye|icg dye
4990438|NCT04051489|Chronic Diseaase|chronic diseaase
4990439|NCT04051489|Technology|technology
4990440|NCT04051489|Pain|pain
4990441|NCT04051489|Function|function
4990442|NCT04051476|Ginger flour footbaths|ginger flour footbaths
4990443|NCT04051476|Dose-response relationship|dose-response relationship
4990444|NCT04051476|Thermogenesis|thermogenesis
4990445|NCT04051476|Infrared thermography|infrared thermography
4990446|NCT04051476|Heart rate variability|heart rate variability
4990447|NCT04051476|Healthy volunteers|healthy volunteers
4990448|NCT04051437|Plasma exchange|plasma exchange
4990749|NCT04049682|Sleep|sleep
4990451|NCT04051411|echocardiography|echocardiography
4990452|NCT04051411|MRI|mri
4990453|NCT04051398|Acupuncture|acupuncture
4990454|NCT04051398|Lung|lung
4990455|NCT04051385|periodontal disease|periodontal disease
4990456|NCT04051385|gingival crevicular fluid|gingival crevicular fluid
4990457|NCT04051385|macrophage|macrophage
4990458|NCT04051385|ErbB-4|erbb-4
4990459|NCT04051385|neuregulin-4|neuregulin-4
4990460|NCT04051372|Idiopathic Pneumonia Syndrome|idiopathic pneumonia syndrome
4990461|NCT04051372|CMV Pneumonia|cmv pneumonia
4990462|NCT04051372|Pneumocystis Jiroveci Pneumonia|pneumocystis jiroveci pneumonia
4990463|NCT04051372|Invasive Pulmonary Aspergillosis|invasive pulmonary aspergillosis
4990466|NCT04051320|Irritability|irritability
4990467|NCT04051320|Estrogen|estrogen
4990468|NCT04051320|Progesterone|progesterone
4990469|NCT04051320|Lupron Depot|lupron depot
4990470|NCT04051320|Mood Disorders|mood disorders
4990471|NCT04051320|Perinatal Depression|perinatal depression
4990472|NCT04051320|Postpartum|postpartum
4990473|NCT04051320|Hormones|hormones
4990474|NCT04051320|Physiological effects of drugs|physiological effects of drugs
4990475|NCT04051320|Reproductive Control Agents|reproductive control agents
4990476|NCT04051320|Mental Disorders|mental disorders
4990477|NCT04051320|Hormone Intervention|hormone intervention
4990478|NCT04051320|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4990479|NCT04051294|kombucha|kombucha
4990480|NCT04051294|kombucha tea|kombucha tea
4990481|NCT04051294|tea|tea
4990482|NCT04051294|fermented food|fermented food
4990483|NCT04051281|antimicrobial resistance|antimicrobial resistance
4990484|NCT04051281|social norms feedback|social norms feedback
4990485|NCT04051281|behavioural science|behavioural science
4990486|NCT04051281|feedback and monitoring|feedback and monitoring
4990487|NCT04051268|Vaccine|vaccine
4990490|NCT04051229|Exercise Induced Metabolic Flexibility|exercise induced metabolic flexibility
4990491|NCT04051216|caregivers|caregivers
4990492|NCT04051216|health information technology|health information technology
4990493|NCT04051216|patient-centered care|patient-centered care
4990495|NCT04051203|greater occipital neuralgia|greater occipital neuralgia
4990496|NCT04051203|post traumatic headache|post traumatic headache
4990497|NCT04051203|post concussive headache|post concussive headache
4990498|NCT04051190|diet|diet
4990499|NCT04051190|bariatric surgery|bariatric surgery
4990500|NCT04051190|appetite|appetite
4990501|NCT04051177|parental HIV disclosure|parental hiv disclosure
4990503|NCT04051177|intervention|intervention
4990504|NCT04051164|Amputation|amputation
4990505|NCT04051164|Progressive Muscle Relaxation Technique|progressive muscle relaxation technique
4990506|NCT04051164|Pulmonary Function|pulmonary function
4990507|NCT04051164|Stress|stress
4990508|NCT04051151|Physical Activity|physical activity
4990509|NCT04051151|Social Incentives|social incentives
4990510|NCT04051151|Behavioral Economics|behavioral economics
4990511|NCT04051151|Goal-Directed Behavior|goal-directed behavior
4990512|NCT04051151|Motivation|motivation
4990513|NCT04051099|bilateral superficial cervical plexus block|bilateral superficial cervical plexus block
4990514|NCT04051099|thyroid surgery|thyroid surgery
4990515|NCT04051099|parathyroid surgery|parathyroid surgery
4990516|NCT04051086|Williams-Beuren Syndrome|williams-beuren syndrome
4990517|NCT04051086|Micro-duplication 7q11.23 syndrome|micro-duplication 7q11.23 syndrome
4990518|NCT04051086|Vasculopathy|vasculopathy
4990519|NCT04051047|Glioma|glioma
4990520|NCT04051021|Surgery|surgery
4990521|NCT04051021|Cardiac|cardiac
4990522|NCT04051021|Opioids|opioids
4990523|NCT04051021|Anxiety|anxiety
4990524|NCT04051008|grocery shopping|grocery shopping
4990525|NCT04051008|online shopping|online shopping
4990526|NCT04051008|diabetes|diabetes
4990527|NCT04051008|behavioral economics|behavioral economics
4990528|NCT04051008|diet|diet
4990529|NCT04050982|Text Messaging|text messaging
4990530|NCT04050982|Patient Education|patient education
4990531|NCT04050982|Psychometric|psychometric
4990532|NCT04050956|Acute Myocardial Infarction|acute myocardial infarction
4990533|NCT04050956|Registry|registry
4990534|NCT04050956|Outcomes|outcomes
4990535|NCT04050956|Medico-economic evaluation|medico-economic evaluation
4990536|NCT04050956|Comorbidities|comorbidities
4990537|NCT04050930|mastication|mastication
4990538|NCT04050930|postprandial thermogenesis|postprandial thermogenesis
4990539|NCT04050930|autonomic nervous system|autonomic nervous system
4990540|NCT04050930|cephalic phase reflex|cephalic phase reflex
4990541|NCT04050930|food texture|food texture
4990542|NCT04050917|physical stimulation|physical stimulation
4990543|NCT04050917|Subliminal stimulation|subliminal stimulation
4990544|NCT04050917|stroke rehabilitation|stroke rehabilitation
4990545|NCT04050917|upper extremity|upper extremity
4990546|NCT04050917|paresis|paresis
4990558|NCT04050826|Dermal open flow microperfusion|dermal open flow microperfusion
4990559|NCT04050813|Hamstring Injury|hamstring injury
4990560|NCT04050813|Flywheel Inertial Resistance|flywheel inertial resistance
4990561|NCT04050813|Hamstring architecture|hamstring architecture
4990562|NCT04050813|Ultrasound|ultrasound
4990563|NCT04050813|Eccentric|eccentric
4990564|NCT04050696|chronic SCI|chronic sci
4990565|NCT04050696|incomplete SCI|incomplete sci
4990566|NCT04050696|central cord syndrome|central cord syndrome
4990567|NCT04050696|electromagnetic field|electromagnetic field
4990568|NCT04050696|physical therapy|physical therapy
4990569|NCT04050696|cervical SCI|cervical sci
4990570|NCT04050696|paraplegia|paraplegia
4990571|NCT04050696|tetraplegia|tetraplegia
4990572|NCT04050696|upper limb impairment|upper limb impairment
4990573|NCT04050696|GRASSP|grassp
4990574|NCT04050696|ISNCSCI|isncsci
4990575|NCT04050683|TIPS|tips
4990576|NCT04050683|Hemodynamic|hemodynamic
4990577|NCT04050683|Ascites|ascites
4990578|NCT04050683|Hepatic|hepatic
4990579|NCT04050683|Hydrothorax|hydrothorax
4990580|NCT04050657|orthodontic treatment|orthodontic treatment
4990581|NCT04050657|alignment|alignment
4990582|NCT04050657|rate of tooth movement|rate of tooth movement
4990583|NCT04050644|Preservative-free ocular drops|preservative-free ocular drops
4990584|NCT04050644|Preserved ocular drops|preserved ocular drops
4990585|NCT04050592|Randomized Controlled Trial|randomized controlled trial
4990586|NCT04050592|Menopause|menopause
4990587|NCT04050592|Hormone Therapy|hormone therapy
4990588|NCT04050592|Vasomotor symptoms|vasomotor symptoms
4990589|NCT04050592|Quality of Life|quality of life
4990590|NCT04050592|Cardiovascular diseases|cardiovascular diseases
4990591|NCT04050592|Endothelium|endothelium
4990592|NCT04050566|Malaria|malaria
4990593|NCT04050566|Immunity development|immunity development
4990594|NCT04050566|Plasmodium diversity|plasmodium diversity
4990595|NCT04050566|Microbiota|microbiota
4994242|NCT04030039|HBsAg|hbsag
4990610|NCT04050475|Functional Therapy|functional therapy
4990611|NCT04050475|Lifestyle Medicine|lifestyle medicine
4990612|NCT04050475|Health Psychology|health psychology
4990613|NCT04050475|Psychosomatic|psychosomatic
4990620|NCT04050423|Ultrasound|ultrasound
4990621|NCT04050423|Spectroscopy|spectroscopy
4990622|NCT04050423|Characterization|characterization
4990623|NCT04050410|postural tachycardia syndrome|postural tachycardia syndrome
4990624|NCT04050410|hyperadrenergic|hyperadrenergic
4990625|NCT04050410|moxonidine|moxonidine
4990626|NCT04050410|sympatholytic|sympatholytic
4990627|NCT04050410|orthostatic symptoms|orthostatic symptoms
4990628|NCT04050410|POTS|pots
4990629|NCT04050397|androgen deprivation therapy|androgen deprivation therapy
4990630|NCT04050397|exercise|exercise
4990631|NCT04050397|quality of life|quality of life
4990632|NCT04050397|blood glucose|blood glucose
4990633|NCT04050397|cholesterol|cholesterol
4990634|NCT04050397|prostate cancer|prostate cancer
4990635|NCT04050371|Pre Exposure Prophylaxis|pre exposure prophylaxis
4990636|NCT04050371|HIV prevention|hiv prevention
4990637|NCT04050371|Emtricitabine, Tenofovir Disoproxil Fumarate|emtricitabine, tenofovir disoproxil fumarate
4990638|NCT04050371|transgender health|transgender health
4990639|NCT04050371|transgender persons|transgender persons
4990640|NCT04050371|drug combination|drug combination
4990641|NCT04050371|androgens|androgens
4990642|NCT04050371|estrogens|estrogens
4990643|NCT04050371|drug combinations|drug combinations
4990644|NCT04050371|transmen|transmen
4990645|NCT04050371|non binary|non binary
4990646|NCT04050371|Truvada|truvada
4990650|NCT04050319|Fractures|fractures
4990651|NCT04050319|Instability|instability
4990652|NCT04050319|Sprains|sprains
4990653|NCT04050319|Strains|strains
4990654|NCT04050306|Quantitative Light-Induced Fluorescence|quantitative light-induced fluorescence
4990655|NCT04050306|Oral Health|oral health
4990656|NCT04050306|Dental Caries|dental caries
4990657|NCT04050306|Tooth Wear|tooth wear
5312322|NCT02119195|composite|composite
4990658|NCT04050306|Optical Imaging|optical imaging
4990659|NCT04050267|nitrous oxide|nitrous oxide
4990660|NCT04050267|tracing gas|tracing gas
4990661|NCT04050267|breathing experiments|breathing experiments
4990662|NCT04050267|cognitive tests|cognitive tests
4990663|NCT04050254|tDCS|tdcs
4990664|NCT04050254|Therapeutic exercise|therapeutic exercise
4990665|NCT04050254|Referred pain|referred pain
4990666|NCT04050254|Central sensitization|central sensitization
4990667|NCT04050241|Mental workload|mental workload
4990668|NCT04050241|Anesthesia|anesthesia
4990669|NCT04050241|Laryngoscopy|laryngoscopy
4990670|NCT04050241|Intubation|intubation
4990671|NCT04050241|Perceived workload|perceived workload
4990672|NCT04050228|Ultrasound, Chemotherapy|ultrasound, chemotherapy
4990673|NCT04050189|probiotic|probiotic
4990674|NCT04050189|in-utero transmission|in-utero transmission
4990675|NCT04050189|pilot study|pilot study
4990679|NCT04050163|Heart Attack|heart attack
4990680|NCT04050150|Rehabilitation|rehabilitation
4990681|NCT04050150|Upper Extremity|upper extremity
4990682|NCT04050137|Gaucher Disease|gaucher disease
4990683|NCT04050137|Exercise|exercise
4990684|NCT04050137|Terapheutic|terapheutic
4990685|NCT04050124|Donor site pain after skin graft harvesting|donor site pain after skin graft harvesting
4990686|NCT04050111|SVF|svf
4990687|NCT04050111|stromal-vascular fraction|stromal-vascular fraction
4990688|NCT04050111|Stem cell therapy|stem cell therapy
4990690|NCT04050046|non-invasive brain stimulation|non-invasive brain stimulation
4990691|NCT04050046|cognition|cognition
4990692|NCT04050046|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4990693|NCT04050020|PRP|prp
4990694|NCT04050020|Platelet-Rich Plasma|platelet-rich plasma
4990695|NCT04049994|spinal cord injury|spinal cord injury
4990696|NCT04049994|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
4990697|NCT04049994|urinary tract infection|urinary tract infection
4990698|NCT04049994|immunotherapy|immunotherapy
4990699|NCT04049994|immunomodulation|immunomodulation
4990700|NCT04049994|immunostimulation|immunostimulation
4990701|NCT04049994|E. coli|e. coli
4990702|NCT04049994|Uro-Vaxom|uro-vaxom
4990703|NCT04049981|digital|digital
4990704|NCT04049981|autism|autism
4990705|NCT04049981|mobile health|mobile health
4990706|NCT04049981|ASD|asd
4990707|NCT04049981|mobile therapy|mobile therapy
4990708|NCT04049981|Google Glass|google glass
4990709|NCT04049981|wearable computing|wearable computing
4990710|NCT04049981|technology|technology
4990711|NCT04049968|Oral cancer、Post-Operation Needs、Quality of Life、APP|oral cancer、post-operation needs、quality of life、app
4990712|NCT04049955|sleeve gastrostomy|sleeve gastrostomy
4990713|NCT04049955|endoscopy|endoscopy
4990714|NCT04049955|fistula|fistula
4990715|NCT04049955|double pig tail stents|double pig tail stents
4990716|NCT04049942|Perioperative|perioperative
4990717|NCT04049942|Functional capability|functional capability
4990718|NCT04049942|Prehabilitation|prehabilitation
4990719|NCT04049942|Thoracoscopic lobectomy|thoracoscopic lobectomy
4990720|NCT04049942|Lung Cancer|lung cancer
4990721|NCT04049929|YY-20394|yy-20394
4990722|NCT04049929|Advanced solid tumor|advanced solid tumor
4990723|NCT04049916|Primaquine|primaquine
4990724|NCT04049916|Pyramax|pyramax
4990725|NCT04049916|Euartesim|euartesim
4990726|NCT04049916|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
4990727|NCT04049916|Pyronaridine-artesunate|pyronaridine-artesunate
4990739|NCT04049786|simvastatin|simvastatin
4990740|NCT04049786|CYP3A4|cyp3a4
4990741|NCT04049786|P-glycoprotein|p-glycoprotein
4990742|NCT04049773|fatigue|fatigue
4990743|NCT04049773|haemodialysis|haemodialysis
4990744|NCT04049773|ecological momentary assessment|ecological momentary assessment
4990745|NCT04049760|Lysosomal storage disease|lysosomal storage disease
4990746|NCT04049760|migalastat|migalastat
4990747|NCT04049747|Prostate Cancer|prostate cancer
4990748|NCT04049747|prostate adenocarcinoma|prostate adenocarcinoma
4990788|NCT04049500|Practice assistants|practice assistants
4990789|NCT04049500|Health coaches|health coaches
4990790|NCT04049500|Population health managers|population health managers
4990791|NCT04049500|Patient navigators|patient navigators
4990792|NCT04049487|postpartum|postpartum
4990793|NCT04049487|diastasis recti|diastasis recti
4990794|NCT04049487|diastasis rectus|diastasis rectus
4990795|NCT04049461|Cancer of Pancreas|cancer of pancreas
4990796|NCT04049461|Ossification, Heterotopic|ossification, heterotopic
4990797|NCT04049461|Abdominal incision|abdominal incision
5308272|NCT02137486|DES|des
4990798|NCT04049448|moderate to severe Rheumatoid Arthritis|moderate to severe rheumatoid arthritis
4990799|NCT04049396|NAFLD, Berberine, ALP, AST, ALT, FBS, HDL,LDL|nafld, berberine, alp, ast, alt, fbs, hdl,ldl
4990801|NCT04049370|pulmonary embolism|pulmonary embolism
4990802|NCT04049370|clinical decision tool|clinical decision tool
4990803|NCT04049370|standard operating procedure|standard operating procedure
4990804|NCT04049357|Camera Capsule Endoscopy|camera capsule endoscopy
4990805|NCT04049357|Colorectal cancer screening|colorectal cancer screening
4990806|NCT04049357|Optical colonoscopy|optical colonoscopy
4990807|NCT04049357|Colorectal cancer|colorectal cancer
4990808|NCT04049344|renal cell carcinoma|renal cell carcinoma
4990809|NCT04049344|chemotherapy|chemotherapy
4990810|NCT04049344|decitabine|decitabine
4990811|NCT04049344|oxaliplatin|oxaliplatin
4990815|NCT04049318|Exercise|exercise
4990816|NCT04049318|Education|education
4990817|NCT04049318|Digital treatment|digital treatment
4990824|NCT04049292|anterior cruciate ligament|anterior cruciate ligament
4990825|NCT04049292|return to sport|return to sport
4990826|NCT04049292|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
4990827|NCT04049292|rehabilitation|rehabilitation
4990828|NCT04049279|primary total hip arthroplasty|primary total hip arthroplasty
4990829|NCT04049279|RSA|rsa
4990830|NCT04049279|cement|cement
4990831|NCT04049279|Dual mobility cup|dual mobility cup
4990832|NCT04049266|AMD|amd
4990833|NCT04049266|Wet AMD|wet amd
4990834|NCT04049266|choroidal neovascularization secondary to age-related macular degeneration|choroidal neovascularization secondary to age-related macular degeneration
4990835|NCT04049266|KSI-301|ksi-301
4990836|NCT04049266|Aflibercept|aflibercept
4990837|NCT04049266|Vascular endothelial growth factor|vascular endothelial growth factor
4990838|NCT04049266|VEGF|vegf
4990839|NCT04049266|Anti-VEGF|anti-vegf
4990840|NCT04049266|Antibody biopolymer conjugate|antibody biopolymer conjugate
4990841|NCT04049266|Macular Degeneration|macular degeneration
4990842|NCT04049266|Wet Macular Degeneration|wet macular degeneration
4990843|NCT04049266|Retinal Degeneration|retinal degeneration
4990844|NCT04049266|Retinal Diseases|retinal diseases
4990845|NCT04049266|Eye Diseases|eye diseases
4990846|NCT04049266|Vision Disorders|vision disorders
4990847|NCT04049266|Vision, low|vision, low
4990848|NCT04049266|Kodiak|kodiak
4990849|NCT04049253|sngceptin|sngceptin
4990850|NCT04049253|soreness|soreness
4990851|NCT04049253|muscle acidosis|muscle acidosis
4990852|NCT04049240|Noninvasive Ventilation|noninvasive ventilation
4990878|NCT04049006|Costs and Cost analysis|costs and cost analysis
4990879|NCT04049006|Primary Health Care|primary health care
4990880|NCT04048980|intervention|intervention
4990881|NCT04048980|elderly|elderly
4990882|NCT04048980|nursing care|nursing care
4990883|NCT04048967|Young children|young children
4990884|NCT04048967|Preschool|preschool
4990885|NCT04048967|Professional development|professional development
4990886|NCT04048967|Physical activity|physical activity
4990887|NCT04048967|Physical fitness|physical fitness
4990888|NCT04048967|Motor skills|motor skills
4990889|NCT04048967|Cognition|cognition
4990890|NCT04048954|Screening|screening
4990891|NCT04048954|Tabagism|tabagism
4990892|NCT04048954|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4990893|NCT04048954|Cancer|cancer
4990894|NCT04048954|Lung|lung
4990895|NCT04048915|Family well-being|family well-being
4990896|NCT04048915|Healthy Eating|healthy eating
4990897|NCT04048915|Physical activity|physical activity
4990898|NCT04048902|Exercise Therapy|exercise therapy
4990899|NCT04048902|Clinical Trial|clinical trial
4990900|NCT04048902|Diathermy|diathermy
4990901|NCT04048902|Physical Therapy Modalities|physical therapy modalities
4990907|NCT04048850|HCV|hcv
4990908|NCT04048850|HIV-HCV coinfection|hiv-hcv coinfection
4990909|NCT04048850|DAA|daa
4990910|NCT04048850|Elbasvir/grazoprevir|elbasvir/grazoprevir
4990911|NCT04048837|Dengue|dengue
4990912|NCT04048824|inhibitory learning|inhibitory learning
4990913|NCT04048824|exposure|exposure
4990914|NCT04048824|anxiety|anxiety
4990915|NCT04048824|habituation|habituation
4990916|NCT04048824|social anxiety|social anxiety
4990917|NCT04048824|panic|panic
4990918|NCT04048798|morbid obesity|morbid obesity
4990919|NCT04048798|bariatric surgery|bariatric surgery
4990920|NCT04048798|high frequency nasal cannula|high frequency nasal cannula
4990921|NCT04048798|oxygenation|oxygenation
4990922|NCT04048785|Child health care|child health care
4990923|NCT04048785|Behavior sleep intervention|behavior sleep intervention
4990924|NCT04048785|Mental health|mental health
4990925|NCT04048785|Social-emotional development|social-emotional development
4990926|NCT04048772|Relaxation|relaxation
4990928|NCT04048772|Support|support
4990929|NCT04048772|Group|group
4990930|NCT04048772|Knowledge|knowledge
4990931|NCT04048772|Therapy|therapy
4990932|NCT04048772|In vitro fertilization|in vitro fertilization
4990933|NCT04048772|Stress|stress
4990934|NCT04048772|Relationships|relationships
4990935|NCT04048772|IVF|ivf
4990936|NCT04048759|Physical Activity|physical activity
4990937|NCT04048759|Exercise|exercise
4990938|NCT04048733|Electrocardiography|electrocardiography
4990939|NCT04048733|Chest pain|chest pain
4990940|NCT04048733|Emergency Service,Hospital|emergency service,hospital
4990941|NCT04048733|Wireless Technology|wireless technology
4990942|NCT04048720|Family Nurture Intervention|family nurture intervention
4990943|NCT04048720|Martha G. Welch MD|martha g. welch md
4990944|NCT04048720|Feasibility Study|feasibility study
4990945|NCT04048720|Preschool intervention|preschool intervention
4990946|NCT04048720|Co-regulation|co-regulation
4990947|NCT04048720|Emotional Connection|emotional connection
4991051|NCT04048135|Liver diseases|liver diseases
4990955|NCT04048655|muscle relaxation|muscle relaxation
4990956|NCT04048655|train of four|train of four
4990957|NCT04048655|rocuronium|rocuronium
4990958|NCT04048629|Zimbabwe|zimbabwe
4990959|NCT04048629|HIV|hiv
4990960|NCT04048629|Viral load|viral load
4990964|NCT04048603|Neurodegeneration|neurodegeneration
4990965|NCT04048603|α-synucleinopathy|α-synucleinopathy
4990966|NCT04048603|Prodromal markers|prodromal markers
4990967|NCT04048590|Skilled Nursing Facilities|skilled nursing facilities
4990968|NCT04048590|Home-based care|home-based care
4990969|NCT04048590|Rehabilitation|rehabilitation
4990970|NCT04048577|Natalizumab|natalizumab
4990971|NCT04048577|Drug Holiday|drug holiday
4990972|NCT04048577|Alternative Dosing|alternative dosing
4990973|NCT04048577|Extended Dosing|extended dosing
4990974|NCT04048564|Chronic myeloid leukemia|chronic myeloid leukemia
4990975|NCT04048564|Iclusig|iclusig
4990976|NCT04048564|ponatinib|ponatinib
4990983|NCT04048538|patient education|patient education
4990984|NCT04048538|surgical education|surgical education
4990985|NCT04048538|multimedia|multimedia
4990986|NCT04048538|animation|animation
4990987|NCT04048538|guide|guide
4990988|NCT04048525|CRRT|crrt
4990989|NCT04048525|CVVHD|cvvhd
4990990|NCT04048525|CVVH|cvvh
4990991|NCT04048460|telehealth|telehealth
4990992|NCT04048460|eAudiology|eaudiology
4990993|NCT04048460|accessibility|accessibility
4990994|NCT04048460|Age-related hearing loss|age-related hearing loss
4990995|NCT04048382|HIV Seroprevalence|hiv seroprevalence
4990996|NCT04048382|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4990997|NCT04048382|Patient Navigation|patient navigation
4990998|NCT04048369|influenza|influenza
4990999|NCT04048369|point-of-care testing|point-of-care testing
4991000|NCT04048369|polymerase chain reaction|polymerase chain reaction
4991001|NCT04048369|emergency medicine|emergency medicine
4991002|NCT04048356|Urogynecology|urogynecology
4991003|NCT04048356|Surgery|surgery
4991004|NCT04048356|Antiseptic Preparation|antiseptic preparation
4991005|NCT04048343|Asthma|asthma
4991006|NCT04048343|Uncontrolled Asthma|uncontrolled asthma
4991007|NCT04048343|Severe Uncontrolled Asthma|severe uncontrolled asthma
4991008|NCT04048330|Anemia|anemia
4991009|NCT04048330|Periconceptional|periconceptional
4991010|NCT04048330|Vitamin B12|vitamin b12
4991011|NCT04048330|Folate|folate
4991012|NCT04048330|Surveillance|surveillance
4991013|NCT04048330|India|india
4991014|NCT04048291|rehabilitation|rehabilitation
4991015|NCT04048291|exercise|exercise
4991016|NCT04048291|postural balance|postural balance
4991017|NCT04048278|Pancreas|pancreas
4991018|NCT04048278|Pancreatic Cancer|pancreatic cancer
4991019|NCT04048278|Lidocaine|lidocaine
4991020|NCT04048278|Enzymatic Activity|enzymatic activity
4991021|NCT04048278|Cytokines|cytokines
4991022|NCT04048278|Chemokines|chemokines
4991023|NCT04048278|Gene Expression|gene expression
4991024|NCT04048265|TMS|tms
4991025|NCT04048265|Parkinson's disease|parkinson's disease
4991026|NCT04048265|pain|pain
4991027|NCT04048239|cochlear implant|cochlear implant
4991028|NCT04048239|robotic|robotic
4991029|NCT04048239|mini-invasive|mini-invasive
4991030|NCT04048226|Dexmedetomidine|dexmedetomidine
4991031|NCT04048226|Ketamine|ketamine
4991032|NCT04048226|Radical Mastectomy|radical mastectomy
4991033|NCT04048226|Chronic pain|chronic pain
4991034|NCT04048213|doose syndrome|doose syndrome
4991035|NCT04048213|Epileptic Syndromes|epileptic syndromes
4991036|NCT04048213|Learning Disabilities|learning disabilities
4991037|NCT04048200|Dexmedetomidine|dexmedetomidine
4991038|NCT04048200|Ketamine|ketamine
4991039|NCT04048200|Fentanyl|fentanyl
4991040|NCT04048200|Bariatric surgeries|bariatric surgeries
4991041|NCT04048174|Probiotics|probiotics
4991042|NCT04048174|Chronic rhinosinusitis|chronic rhinosinusitis
4991043|NCT04048174|Irrigation|irrigation
4991044|NCT04048174|Microbiome|microbiome
4991045|NCT04048161|Nephrotic Syndrome|nephrotic syndrome
4991046|NCT04048161|Frequently Relapsing Nephrotic Syndrome|frequently relapsing nephrotic syndrome
4991047|NCT04048161|Steroid Dependent Nephrotic Syndrome|steroid dependent nephrotic syndrome
4991049|NCT04048161|Mycophenolate mofetil|mycophenolate mofetil
4991050|NCT04048135|NASH, NAFLD|nash, nafld
4991057|NCT04048083|neuroplasticity|neuroplasticity
4991058|NCT04048083|sensorimotor cortex|sensorimotor cortex
4991059|NCT04048083|mental training|mental training
4991060|NCT04048083|virtual environment|virtual environment
4991061|NCT04048031|Hair thinning|hair thinning
4991062|NCT04048031|Hair Loss|hair loss
4991064|NCT04048031|Perimenopausal, Menopausal and Post Menopausal Women|perimenopausal, menopausal and post menopausal women
4991065|NCT04048031|Nutraceutical supplement|nutraceutical supplement
4991066|NCT04048018|Interferon Gamma Release Assay|interferon gamma release assay
4991067|NCT04048018|Tuberculosis|tuberculosis
4991068|NCT04047979|Zoster|zoster
4991069|NCT04047979|Immune responses|immune responses
4991070|NCT04047979|Vaccine|vaccine
4991071|NCT04047979|Vaccine Trials|vaccine trials
4991072|NCT04047979|Clinical Trials|clinical trials
4991073|NCT04047979|Chicken Pox|chicken pox
4991074|NCT04047979|Shingles|shingles
5312638|NCT02117765|T1D|t1d
4991078|NCT04047953|Paclitaxel (albumin-bound)|paclitaxel (albumin-bound)
4991080|NCT04047953|conversion therapy|conversion therapy
4991081|NCT04047914|photodynamic therapy|photodynamic therapy
4991082|NCT04047914|Staphylococcus aureus|staphylococcus aureus
4991083|NCT04047914|nasal decolonization|nasal decolonization
4991084|NCT04047914|hemodialysis|hemodialysis
4991085|NCT04047914|chronic kidney disease|chronic kidney disease
4991086|NCT04047914|mupirocin|mupirocin
4991087|NCT04047901|autonomic dysfunction|autonomic dysfunction
4991088|NCT04047901|baroreflex control|baroreflex control
4991089|NCT04047901|ergorreflex control|ergorreflex control
4991090|NCT04047901|muscle myopaty|muscle myopaty
4991091|NCT04047875|norethisterone|norethisterone
4991092|NCT04047875|uterine bleeding|uterine bleeding
4991096|NCT04047862|Anti-TIGIT antibody|anti-tigit antibody
4991097|NCT04047862|Tislelizumab|tislelizumab
4991098|NCT04047862|anti-PD-1|anti-pd-1
4991099|NCT04047849|Previable|previable
4991100|NCT04047849|PPROM|pprom
4991101|NCT04047849|Premature prelabor rupture of membranes|premature prelabor rupture of membranes
4991102|NCT04047849|Preterm|preterm
4991103|NCT04047849|Preterm birth|preterm birth
4991104|NCT04047849|Latency antibiotics|latency antibiotics
4991105|NCT04047836|E-Cigarettes|e-cigarettes
4991106|NCT04047836|Vaping|vaping
4991107|NCT04047836|E-Cig Mods|e-cig mods
4991108|NCT04047836|E-Liquid|e-liquid
4991109|NCT04047784|EBUS|ebus
4991110|NCT04047784|Acute Pulmonary Embolism|acute pulmonary embolism
4991111|NCT04047784|Endobronchial Ultrasound|endobronchial ultrasound
4991112|NCT04047784|Pilot|pilot
4991113|NCT04047758|palbociclib|palbociclib
4991114|NCT04047758|aromatase inhibitors|aromatase inhibitors
4991120|NCT04047693|dose dense MVAC|dose dense mvac
4991121|NCT04047693|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4991122|NCT04047693|Urothelial carcinoma|urothelial carcinoma
4991123|NCT04047680|Viral hepatitis C|viral hepatitis c
4991124|NCT04047680|Glomerular filtration rate|glomerular filtration rate
4991125|NCT04047680|Direct acting antiviral agent|direct acting antiviral agent
4991126|NCT04047680|Sofosbuvir|sofosbuvir
4991128|NCT04047628|Treatment-Resistant Relapsing Multiple Sclerosis (MS)|treatment-resistant relapsing multiple sclerosis (ms)
4991129|NCT04047628|Autologous Hematopoietic Stem Cell Transplantation (AHSCT)|autologous hematopoietic stem cell transplantation (ahsct)
4991130|NCT04047628|Autologous Peripheral Blood Stem Cells (PBMCs) Graft|autologous peripheral blood stem cells (pbmcs) graft
4991131|NCT04047628|Best Available Therapy (BAT)|best available therapy (bat)
4991132|NCT04047628|Disease-Modifying Therapy (DMT)|disease-modifying therapy (dmt)
4991133|NCT04047628|BAT DMT|bat dmt
4991134|NCT04047602|Radiation|radiation
4991135|NCT04047602|Immune therapy|immune therapy
4991136|NCT04047602|Stereotactic Radiosurgery|stereotactic radiosurgery
4991137|NCT04047589|solid tumor|solid tumor
4991138|NCT04047589|exercise|exercise
4991139|NCT04047576|mTOR inhibitor|mtor inhibitor
4991140|NCT04047576|Sirolimus|sirolimus
4991141|NCT04047576|Retroperitoneal Fibrosis|retroperitoneal fibrosis
4991142|NCT04047563|Endothelin|endothelin
4991143|NCT04047563|Neurogenesis|neurogenesis
4991144|NCT04047563|Neural progenitor cells|neural progenitor cells
4991145|NCT04047511|virtual reality|virtual reality
4991146|NCT04047511|depression|depression
4991147|NCT04047511|anxiety|anxiety
4991148|NCT04047511|mental health|mental health
4991157|NCT04047459|Organ specific endothelium|organ specific endothelium
5342920|NCT01981499|migraine|migraine
4991159|NCT04047459|Cancer cell extravasation|cancer cell extravasation
4991160|NCT04047407|Reffered pain|reffered pain
4991161|NCT04047407|Pain sensitivity|pain sensitivity
4991162|NCT04047407|Fibromyalgia|fibromyalgia
4991163|NCT04047407|Suprathreshold|suprathreshold
4991164|NCT04047407|Central sensitization|central sensitization
4991165|NCT04047381|Atrial fibrillation|atrial fibrillation
4991166|NCT04047381|Quality of life|quality of life
4991167|NCT04047368|Percutaneous coronary intervention|percutaneous coronary intervention
4991168|NCT04047368|Rotablation|rotablation
4991169|NCT04047368|Coronary lithoplasty|coronary lithoplasty
4991170|NCT04047368|Optical coherence tomography|optical coherence tomography
4991171|NCT04047355|Propranolol|propranolol
4991172|NCT04047355|Beta Blocker|beta blocker
4991173|NCT04047355|Psychopharmacology|psychopharmacology
4991174|NCT04047355|Inderal|inderal
4991175|NCT04047342|Prospect theory|prospect theory
4991176|NCT04047303|Diffuse Astrocytoma|diffuse astrocytoma
4991177|NCT04047303|Anaplastic Astrocytoma|anaplastic astrocytoma
4991178|NCT04047303|Glioblastoma|glioblastoma
4991179|NCT04047303|CC-90010|cc-90010
4991182|NCT04047290|anti-PD-1/VEGF bispecific antibody|anti-pd-1/vegf bispecific antibody
4991183|NCT04047290|immunotherapy|immunotherapy
4991184|NCT04047290|immuno-oncology|immuno-oncology
4991185|NCT04047290|advanced solid tumors|advanced solid tumors
4991186|NCT04047290|bispecific|bispecific
4991187|NCT04047290|PD-1/VEGF|pd-1/vegf
4991188|NCT04047277|Nightmares|nightmares
4991189|NCT04047277|Children|children
4991191|NCT04047277|CBT|cbt
4991192|NCT04047277|Exposure|exposure
4991193|NCT04047277|Relaxation|relaxation
4991194|NCT04047277|Rescripting|rescripting
4991195|NCT04047277|Cognitive|cognitive
4991196|NCT04047277|Behavioral|behavioral
4991197|NCT04047277|Therapy|therapy
4991208|NCT04047199|Percutaneous Coronary Intervention|percutaneous coronary intervention
4991209|NCT04047186|immunotherapy|immunotherapy
4991210|NCT04047186|Multiple Pulmonary Nodules|multiple pulmonary nodules
4991211|NCT04047186|Lung Neoplasms|lung neoplasms
4991212|NCT04047173|recurrent small hepatocellular carcinoma|recurrent small hepatocellular carcinoma
4991219|NCT04047160|Secondary Biliary Cholangitis|secondary biliary cholangitis
4991220|NCT04047160|Primary Biliary Cirrhosis|primary biliary cirrhosis
4991221|NCT04047160|Secondary Biliary Cirrhosis|secondary biliary cirrhosis
4991222|NCT04047134|Prevention and treatment of movement|prevention and treatment of movement
4991223|NCT04047134|Motor Function|motor function
4991224|NCT04047134|Action Observation Therapy|action observation therapy
4991225|NCT04047134|Mirror Neuron System|mirror neuron system
4991226|NCT04047134|Upper Limb Rehabilitation|upper limb rehabilitation
4991227|NCT04047095|Cardiac surgery|cardiac surgery
4991228|NCT04047095|Immunonutrition Glutamine Bioelectrical impedance|immunonutrition glutamine bioelectrical impedance
4991229|NCT04047095|Immunological status|immunological status
4991230|NCT04047056|physiotherapy|physiotherapy
4991231|NCT04047056|prevention|prevention
4991232|NCT04047056|pain|pain
4991233|NCT04047056|upper limb|upper limb
4991234|NCT04047056|exercises|exercises
4991235|NCT04047056|musculoskeletal disorders|musculoskeletal disorders
4991236|NCT04047043|Taurine/graft function/LDLT|taurine/graft function/ldlt
4991237|NCT04047004|Gastric adenocarcinoma|gastric adenocarcinoma
4991238|NCT04047004|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
4991239|NCT04047004|Laparoscopic gastrectomy|laparoscopic gastrectomy
4991240|NCT04047004|Gastric cancer|gastric cancer
4991241|NCT04047004|Surgery|surgery
4991242|NCT04046991|non-invasive brain stimulation|non-invasive brain stimulation
4991438|NCT04046120|heel|heel
4991244|NCT04046991|aphasia|aphasia
4991245|NCT04046978|Virus Diseases|virus diseases
4991246|NCT04046965|Alaska natives|alaska natives
4991247|NCT04046965|child care|child care
4991248|NCT04046965|child development|child development
4991249|NCT04046965|child health|child health
4991250|NCT04046965|child rearing|child rearing
4991251|NCT04046965|children|children
4991252|NCT04046965|curriculum|curriculum
4991253|NCT04046965|early childhood education|early childhood education
4991254|NCT04046965|families|families
4991255|NCT04046965|Head Start|head start
4991256|NCT04046965|Native Americans|native americans
4991257|NCT04046965|parenting skills|parenting skills
4991258|NCT04046965|parents|parents
4991259|NCT04046965|programs|programs
4991260|NCT04046965|school readiness|school readiness
4991261|NCT04046965|teachers|teachers
4991262|NCT04046952|Radial Artery Occlusion|radial artery occlusion
4991263|NCT04046952|Time to Hemostasis|time to hemostasis
4991264|NCT04046952|Statseal|statseal
4991265|NCT04046952|TR Band|tr band
4991266|NCT04046952|cardiac catheterization|cardiac catheterization
4991267|NCT04046952|transradial catheterization|transradial catheterization
4991268|NCT04046952|percutaneous coronary intervention|percutaneous coronary intervention
4991269|NCT04046939|Eosinophilic Asthma|eosinophilic asthma
4991270|NCT04046939|Asthma|asthma
4991271|NCT04046939|dexpramipexole|dexpramipexole
4991272|NCT04046926|anorexia nervosa|anorexia nervosa
4991273|NCT04046926|relapse|relapse
4991274|NCT04046926|inpatient|inpatient
4991275|NCT04046926|cognitive behavioral therapy|cognitive behavioral therapy
4991276|NCT04046926|prospective study|prospective study
4991278|NCT04046887|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
4991279|NCT04046887|Pancreatic Cancer|pancreatic cancer
4991280|NCT04046887|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4991281|NCT04046887|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
4991282|NCT04046874|Low Back Pain|low back pain
4991283|NCT04046874|Risk-stratification|risk-stratification
4991284|NCT04046874|STarT Back|start back
4991285|NCT04046874|Patient outcomes|patient outcomes
4991287|NCT04046874|Barriers and Facilitators|barriers and facilitators
4991288|NCT04046861|cardiac surgery|cardiac surgery
4991289|NCT04046861|cardiopulmonary bypass|cardiopulmonary bypass
4991290|NCT04046861|hyperlactatemia|hyperlactatemia
4991291|NCT04046861|vitamin C|vitamin c
4991292|NCT04046848|Hemophilia A|hemophilia a
4991293|NCT04046848|Blood Coagulation Disorders, Inherited|blood coagulation disorders, inherited
4991294|NCT04046848|Blood Coagulation Disorders|blood coagulation disorders
4991295|NCT04046848|Hematologic Diseases|hematologic diseases
4991296|NCT04046848|Coagulation Protein Disorders|coagulation protein disorders
4991297|NCT04046848|Hemorrhagic Disorders|hemorrhagic disorders
4991298|NCT04046848|Genetic Diseases, Inborn|genetic diseases, inborn
4991299|NCT04046848|Factor VIII|factor viii
4991309|NCT04046783|Natural products|natural products
4991310|NCT04046783|Wound healing|wound healing
4991311|NCT04046783|Cesarean delivery|cesarean delivery
4991312|NCT04046770|safety|safety
4991313|NCT04046770|Effectiveness|effectiveness
4991314|NCT04046770|Double-chamber syringe|double-chamber syringe
4991315|NCT04046770|Clinical research|clinical research
4991316|NCT04046770|medical devices|medical devices
4991317|NCT04046770|nurses|nurses
4991318|NCT04046770|hospital setting|hospital setting
4991319|NCT04046757|Ischemic stroke|ischemic stroke
4991320|NCT04046757|Mechanical Thrombectomy|mechanical thrombectomy
4991321|NCT04046744|Regional anesthesia|regional anesthesia
4991322|NCT04046744|Analgesia|analgesia
4991323|NCT04046744|Ultrasound|ultrasound
4991324|NCT04046692|hospital school|hospital school
4991325|NCT04046692|pain|pain
4991326|NCT04046692|distress|distress
4991327|NCT04046692|negative emotions|negative emotions
4991328|NCT04046692|school continuity|school continuity
4991329|NCT04046692|child|child
4991330|NCT04046679|MMP|mmp
4991331|NCT04046679|DRUG DELIVERY|drug delivery
4991332|NCT04046679|BLEOMYCIN|bleomycin
4991333|NCT04046679|PIGMENTATION DISORDERS|pigmentation disorders
4991334|NCT04046666|meridians|meridians
4991335|NCT04046666|acupuncture|acupuncture
4991336|NCT04046666|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4991337|NCT04046666|meridian phenomenon|meridian phenomenon
4991338|NCT04046666|near infrared spectroscopy|near infrared spectroscopy
4991339|NCT04046640|meridians|meridians
4991340|NCT04046640|acupuncture|acupuncture
4991439|NCT04046120|methods|methods
4991342|NCT04046640|meridian phenomenon|meridian phenomenon
4991343|NCT04046640|infrared thermography|infrared thermography
4991344|NCT04046601|impedance, Barrett´s cancer, early detection of cancer|impedance, barrett´s cancer, early detection of cancer
4991345|NCT04046588|meridians|meridians
4991346|NCT04046588|acupuncture|acupuncture
4991347|NCT04046588|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4991348|NCT04046588|meridian phenomenon|meridian phenomenon
4991349|NCT04046588|infrared thermography|infrared thermography
4991350|NCT04046549|Renal allograft dysfunction|renal allograft dysfunction
4991351|NCT04046549|Cell-mediated rejection|cell-mediated rejection
4991352|NCT04046549|Antibody mediated rejection|antibody mediated rejection
4991353|NCT04046549|Immunosuppression|immunosuppression
4991354|NCT04046549|Acute rejection|acute rejection
4991355|NCT04046549|VIB4920|vib4920
4991356|NCT04046549|MEDI4920|medi4920
4991357|NCT04046549|Belatacept|belatacept
4991358|NCT04046549|Thymoglobulin|thymoglobulin
4991359|NCT04046549|Methylprednisolone|methylprednisolone
4991360|NCT04046549|Corticosteroids|corticosteroids
4991361|NCT04046536|rTMS|rtms
4991362|NCT04046536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4991363|NCT04046536|Gulf War Illness|gulf war illness
4991364|NCT04046536|Depression|depression
4991365|NCT04046523|video ophthalmoscope|video ophthalmoscope
4991366|NCT04046523|intraocular pressure|intraocular pressure
4991367|NCT04046523|electrocardiogram|electrocardiogram
4991368|NCT04046523|photoplethysmography|photoplethysmography
4991369|NCT04046523|retinal pulsatility|retinal pulsatility
4991370|NCT04046523|spontaneous venous pulsation|spontaneous venous pulsation
4991371|NCT04046523|blind source separation|blind source separation
4991372|NCT04046510|Cesarean section, ocytocin, uterine tone, side effects|cesarean section, ocytocin, uterine tone, side effects
4991373|NCT04046471|Weight Loss|weight loss
4991374|NCT04046471|Physical Activity|physical activity
4991375|NCT04046471|Diet|diet
4991376|NCT04046445|CRC|crc
4991377|NCT04046445|Colorectal Cancer|colorectal cancer
4991378|NCT04046445|MSS|mss
4991379|NCT04046445|Metastatic Colorectal Cancer|metastatic colorectal cancer
4991380|NCT04046445|Liver Metastasis Colon Cancer|liver metastasis colon cancer
4991381|NCT04046445|Stage IV Colon Cancer|stage iv colon cancer
4991386|NCT04046445|MMRp|mmrp
4991387|NCT04046432|gut microflora|gut microflora
4991388|NCT04046432|immunity|immunity
4991389|NCT04046432|anti-oxidative capacity|anti-oxidative capacity
4991390|NCT04046432|Lactobacillus paracasei subsp. paracasei NTU 101|lactobacillus paracasei subsp. paracasei ntu 101
4994939|NCT04025502|ERP|erp
4991393|NCT04046393|rhinitis, sinusitis, nasal irrigation, TCM|rhinitis, sinusitis, nasal irrigation, tcm
4991395|NCT04046367|physical activity|physical activity
4991396|NCT04046367|prehabilitation|prehabilitation
4991397|NCT04046354|microwave|microwave
4991398|NCT04046354|thyroid|thyroid
4991399|NCT04046341|Difficulty falling asleep|difficulty falling asleep
4991400|NCT04046341|Difficulty staying asleep|difficulty staying asleep
4991401|NCT04046341|Not getting enough sleep|not getting enough sleep
4991402|NCT04046276|Parkinson's disease|parkinson's disease
4991403|NCT04046276|Aerobic Exercises|aerobic exercises
4991404|NCT04046276|High Intensity Training|high intensity training
4991405|NCT04046276|Neuroprotection|neuroprotection
4991406|NCT04046250|Mucositis|mucositis
4991407|NCT04046250|Methotrexate|methotrexate
4991408|NCT04046250|Uridine Phosphorylase Inhibitor|uridine phosphorylase inhibitor
4991409|NCT04046250|Head and Neck Cancer|head and neck cancer
4991410|NCT04046237|Acute Myocardial Infarction|acute myocardial infarction
4991411|NCT04046237|Severe Periodontitis|severe periodontitis
4991412|NCT04046237|FDG-PET|fdg-pet
4991413|NCT04046237|Carotid Atherosclerosis|carotid atherosclerosis
4991418|NCT04046198|Professional Values Model|professional values model
4991419|NCT04046198|professional values|professional values
4991420|NCT04046198|job satisfaction|job satisfaction
4991421|NCT04046198|pediatric nursing|pediatric nursing
4991422|NCT04046172|Periodontitis|periodontitis
4991423|NCT04046172|SLE|sle
4991424|NCT04046172|Lupus|lupus
4991425|NCT04046146|Healthy Volunteers|healthy volunteers
4991426|NCT04046146|Lymphatic Transport|lymphatic transport
4991427|NCT04046146|Imaging|imaging
4991428|NCT04046146|Indocyanine Green|indocyanine green
4991429|NCT04046146|Gadolinium|gadolinium
4991430|NCT04046146|ICG|icg
4991431|NCT04046146|GAD|gad
4991432|NCT04046146|NIR-ICG|nir-icg
4991433|NCT04046146|rhuematoid arthritis|rhuematoid arthritis
4991434|NCT04046146|NIR|nir
4991435|NCT04046120|varicose ulcer|varicose ulcer
4991436|NCT04046120|compression bandages|compression bandages
4991437|NCT04046120|patient compliance|patient compliance
4991452|NCT04046042|Virtual reality|virtual reality
4991453|NCT04046042|physical function|physical function
4991454|NCT04046042|health-related quality of life|health-related quality of life
4991455|NCT04046042|hemodynamic instability|hemodynamic instability
4991456|NCT04046029|Acute Coronary Syndrome|acute coronary syndrome
4991457|NCT04046029|Percutaneous Coronary Intervention|percutaneous coronary intervention
4991459|NCT04046029|Bivalirudin|bivalirudin
4991460|NCT04045977|virtual reality|virtual reality
4991461|NCT04045977|cardiac rehabilitation|cardiac rehabilitation
4991462|NCT04045977|psychotherapy|psychotherapy
4991463|NCT04045977|cardiac surgery|cardiac surgery
4991464|NCT04045977|depression|depression
4991465|NCT04045977|anxiety|anxiety
4991466|NCT04045977|stress|stress
4991467|NCT04045977|elderly|elderly
4991468|NCT04045977|Coronary Artery Disease|coronary artery disease
4991469|NCT04045977|Ischemic Heart Disease|ischemic heart disease
4991470|NCT04045951|Vision Disorders|vision disorders
4991471|NCT04045951|Artificial intelligence|artificial intelligence
4991472|NCT04045951|Myopia prediction|myopia prediction
4991473|NCT04045938|glycemic index|glycemic index
4991474|NCT04045938|glycemic load|glycemic load
4991475|NCT04045938|glycaemic index|glycaemic index
4991476|NCT04045938|glycaemic load|glycaemic load
4991477|NCT04045938|cardiovascular disease|cardiovascular disease
4991478|NCT04045938|cardiometabolic risk|cardiometabolic risk
4991479|NCT04045938|glycemic control|glycemic control
4991480|NCT04045925|Taïso|taïso
4991481|NCT04045925|Physical therapy|physical therapy
4991482|NCT04045925|Exercice therapy|exercice therapy
4991483|NCT04045925|Parkinson disease|parkinson disease
4991484|NCT04045912|HIV self-testing|hiv self-testing
4991485|NCT04045912|Accredited drug dispensing outlets|accredited drug dispensing outlets
4991486|NCT04045912|Adolescent girls and young women|adolescent girls and young women
4991487|NCT04045899|Comparison of device|comparison of device
4991488|NCT04045873|Complex high-risk patients|complex high-risk patients
4991489|NCT04045873|Percutaneous coronary intervention|percutaneous coronary intervention
4991490|NCT04045873|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4991491|NCT04045873|Intra-aortic balloon pump|intra-aortic balloon pump
4991492|NCT04045847|glioma|glioma
4991493|NCT04045847|CD147|cd147
4991494|NCT04045847|CAR-T|car-t
4991495|NCT04045808|coronary angiography|coronary angiography
4991496|NCT04045808|coronary artery disease|coronary artery disease
4991501|NCT04045782|biosimilar|biosimilar
4991502|NCT04045782|switch|switch
4991503|NCT04045782|IBD|ibd
4991504|NCT04045756|prostate cancer|prostate cancer
4991505|NCT04045756|laser ablation|laser ablation
4991506|NCT04045756|mpMRI|mpmri
4991507|NCT04045756|interventional radiology|interventional radiology
4991508|NCT04045717|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4991509|NCT04045691|BERING|bering
4991510|NCT04045691|Encorafenib|encorafenib
4991511|NCT04045691|Binimetinib|binimetinib
4991512|NCT04045678|parkinson disease|parkinson disease
4991526|NCT04045613|immune checkpoint blockade|immune checkpoint blockade
4991527|NCT04045613|atezolizumab|atezolizumab
4991528|NCT04045613|Tecentriq|tecentriq
4991529|NCT04045613|solid tumor|solid tumor
4991530|NCT04045574|CAD-CAM system|cad-cam system
4991531|NCT04045574|Immediate dental implant loading|immediate dental implant loading
4991533|NCT04045574|Comparative study|comparative study
4991534|NCT04045535|Primary Health Care|primary health care
4991535|NCT04045535|Nursing Intervention|nursing intervention
4991536|NCT04045535|Physical Activity|physical activity
4991537|NCT04045522|triple-negative breast cancer|triple-negative breast cancer
4991538|NCT04045522|zoledronic acid|zoledronic acid
4991546|NCT04045483|virtual reality|virtual reality
4991547|NCT04045470|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
4991548|NCT04045470|Peripheral T Cell Lymphoma|peripheral t cell lymphoma
4991549|NCT04045457|active trigger points|active trigger points
4991550|NCT04045444|physical activity|physical activity
4991551|NCT04045444|cognitive function|cognitive function
4991553|NCT04045444|parkinson|parkinson
4991554|NCT04045444|muscle oxygenation|muscle oxygenation
4991555|NCT04045444|gait parameters|gait parameters
4991556|NCT04045418|meridians|meridians
4991557|NCT04045418|acupuncture|acupuncture
4991558|NCT04045418|chronic stable angina pectoris|chronic stable angina pectoris
4991559|NCT04045418|meridian phenomenon|meridian phenomenon
4991560|NCT04045418|laser doppler|laser doppler
4991561|NCT04045379|postmenopause|postmenopause
4991562|NCT04045379|atrophic vaginitis|atrophic vaginitis
4991563|NCT04045379|vulvovaginal atrophy|vulvovaginal atrophy
4991564|NCT04045379|treatment|treatment
4991565|NCT04045379|LASER|laser
4991566|NCT04045379|Radiofrequency|radiofrequency
4991567|NCT04045379|estriol|estriol
4991568|NCT04045379|strogen therapy|strogen therapy
4991569|NCT04045366|Pharmacokinetics|pharmacokinetics
4991570|NCT04045366|Echinocandins|echinocandins
4991571|NCT04045366|Critically ill patients|critically ill patients
4991572|NCT04045353|Low carbohydrate diet|low carbohydrate diet
4991573|NCT04045314|CBD|cbd
4991574|NCT04045314|Cosmetics|cosmetics
4991575|NCT04045314|Dry skin|dry skin
4991576|NCT04045301|multi-food OIT|multi-food oit
4991577|NCT04045301|oral immunotherapy|oral immunotherapy
4991578|NCT04045301|omalizumab|omalizumab
4991579|NCT04045301|symptom-driven protocol|symptom-driven protocol
4991580|NCT04045301|double-Blind, randomized controlled trial|double-blind, randomized controlled trial
4991581|NCT04045288|School Wellness Policy|school wellness policy
4991582|NCT04045288|Professional Development|professional development
5342921|NCT01981499|PDE2|pde2
4991583|NCT04045288|Comprehensive School Physical Activity Programs|comprehensive school physical activity programs
4991584|NCT04045288|Whole-of-School Intervention|whole-of-school intervention
4991585|NCT04045288|Screen Time|screen time
4991586|NCT04045288|Physical Activity|physical activity
4991587|NCT04045249|Malnutrition|malnutrition
4991588|NCT04045249|RUTF|rutf
4991589|NCT04045249|Children|children
4991590|NCT04045249|Home base food|home base food
4991591|NCT04045197|Relaxation|relaxation
4991592|NCT04045171|Nephrotic Syndrome|nephrotic syndrome
4991593|NCT04045171|Tacrolimus|tacrolimus
4991594|NCT04045171|Population Pharmacokinetics|population pharmacokinetics
4991595|NCT04045158|diaphragm|diaphragm
4991596|NCT04045158|ultrasound|ultrasound
4991597|NCT04045158|echocardiography|echocardiography
4991598|NCT04045132|Social Media|social media
4991599|NCT04045132|Postpartum Depression|postpartum depression
4991600|NCT04045132|Parenting|parenting
4991601|NCT04045132|Infants|infants
4991602|NCT04045132|Mothers|mothers
4991603|NCT04045119|CBD|cbd
4991604|NCT04045119|Cosmetics|cosmetics
5008144|NCT03945487|safety|safety
4991686|NCT04044586|outbreak|outbreak
4991687|NCT04044586|prevalence|prevalence
4991688|NCT04044573|BPH|bph
4991689|NCT04044573|mpMRI|mpmri
4991690|NCT04044573|interventional radiology|interventional radiology
4991813|NCT04043897|Microscopic Colitis|microscopic colitis
4995123|NCT04024475|Oligometastatic prostate cancer|oligometastatic prostate cancer
4995129|NCT04024436|Futibatinib|futibatinib
4991696|NCT04044521|implementation|implementation
4991697|NCT04044521|primary care|primary care
4991698|NCT04044521|organizational change|organizational change
4991699|NCT04044521|Centers for Disease Control opioid prescribing guidelines|centers for disease control opioid prescribing guidelines
4991700|NCT04044521|clinical guidelines|clinical guidelines
4991701|NCT04044521|systems consultation|systems consultation
4991702|NCT04044495|Aging|aging
4991703|NCT04044495|Sleep/wake Cycle|sleep/wake cycle
4991704|NCT04044495|Hippocampal connectivity|hippocampal connectivity
4991705|NCT04044495|Hippocampal dependant Memory tests|hippocampal dependant memory tests
4991706|NCT04044495|Actigraphy|actigraphy
4991707|NCT04044495|Functional and structural MRI|functional and structural mri
4991708|NCT04044456|Brain Injury|brain injury
4991709|NCT04044456|Cognition|cognition
4991710|NCT04044456|Veteran|veteran
4991711|NCT04044456|Attention|attention
4991712|NCT04044456|Metacognition|metacognition
4991713|NCT04044430|BRAFV600E|brafv600e
4991714|NCT04044430|Metastatic Colorectal Cancer (mCRC)|metastatic colorectal cancer (mcrc)
4991715|NCT04044430|Microsatellite Status (MSS)|microsatellite status (mss)
4991716|NCT04044417|periodontitis|periodontitis
4991717|NCT04044417|curcumin|curcumin
4991718|NCT04044417|simvastatin|simvastatin
4991719|NCT04044417|EDTA|edta
4991720|NCT04044404|Ultrasound Elastography|ultrasound elastography
4991721|NCT04044404|Ultrasound Integrated Precision Diagnosis Technology|ultrasound integrated precision diagnosis technology
4991722|NCT04044404|Acute on Chronic Kidney Disease|acute on chronic kidney disease
4991723|NCT04044404|Kidney transplantation|kidney transplantation
4991724|NCT04044404|kidney fibrosis|kidney fibrosis
4991727|NCT04044378|famitinib|famitinib
4991728|NCT04044378|camrelizumab|camrelizumab
4991729|NCT04044378|advanced osteosarcoma|advanced osteosarcoma
4991730|NCT04044378|recommended phase 2 dose|recommended phase 2 dose
4991731|NCT04044378|efficacy|efficacy
4991753|NCT04044313|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
4991755|NCT04044313|Toripalimab|toripalimab
5300106|NCT02176980|HCV|hcv
4991756|NCT04044300|sacral fracture, function, pain|sacral fracture, function, pain
5342922|NCT01981486|PF-05180999|pf-05180999
4991757|NCT04044261|Emotional Response|emotional response
4991758|NCT04044248|Liver cirrhosis|liver cirrhosis
4991759|NCT04044248|Portal hypertension|portal hypertension
4991760|NCT04044248|Gastric varices|gastric varices
4991761|NCT04044248|Bleeding|bleeding
4991762|NCT04044248|Hepatic encephalopathy|hepatic encephalopathy
4991763|NCT04044248|Transjugular intrahepatic portosystemic shunt (TIPS)|transjugular intrahepatic portosystemic shunt (tips)
4991764|NCT04044248|Transvenous obliteration|transvenous obliteration
4991765|NCT04044183|Chronic Pain|chronic pain
4991766|NCT04044183|Mild Cognitive Impairment|mild cognitive impairment
4991767|NCT04044183|Older Adults|older adults
4991768|NCT04044183|Physical Activity|physical activity
4991769|NCT04044118|gut microbiota|gut microbiota
4991770|NCT04044118|calorie restrition dietary intervention|calorie restrition dietary intervention
4991771|NCT04044092|Cervical Disc Protrusion|cervical disc protrusion
4991772|NCT04044092|ELDOA,|eldoa,
4991773|NCT04044092|Neck Pain|neck pain
4991774|NCT04044092|Neck Disability|neck disability
4991775|NCT04044053|PF-06865571|pf-06865571
4991776|NCT04044053|Relative bioavailability|relative bioavailability
4991777|NCT04044053|Modified release|modified release
4991778|NCT04044053|Diacylglycerol acyltransferase|diacylglycerol acyltransferase
4991779|NCT04044053|DGAT2|dgat2
4991780|NCT04044053|Japanese|japanese
4991781|NCT04044040|Palliative care|palliative care
4991782|NCT04044040|Symptom control|symptom control
4991783|NCT04044040|Quality of life|quality of life
4991784|NCT04044040|Satisfaction with care|satisfaction with care
4991785|NCT04044040|Targeted referral|targeted referral
4991786|NCT04044014|Gellan, thermal injury, healthy volunteers, skin|gellan, thermal injury, healthy volunteers, skin
4991787|NCT04044001|Tuberculosis, Pulmonary|tuberculosis, pulmonary
4991788|NCT04044001|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
4991789|NCT04044001|BTZ-043|btz-043
4991790|NCT04044001|Tuberculosis|tuberculosis
4991791|NCT04044001|Antitubercular Agents|antitubercular agents
4991792|NCT04044001|Gram-positive Bacterial Infections|gram-positive bacterial infections
4991793|NCT04044001|Escalating dose|escalating dose
4991794|NCT04044001|Drug-sensitive TB|drug-sensitive tb
4991795|NCT04044001|Early Bactericidal Activity (EBA)|early bactericidal activity (eba)
4991796|NCT04044001|Drug-drug-interaction|drug-drug-interaction
4991797|NCT04044001|Pharmacokinetics (PK)|pharmacokinetics (pk)
4991798|NCT04044001|Safety|safety
4991802|NCT04043962|internet intervention|internet intervention
4991803|NCT04043962|pain management|pain management
4991805|NCT04043962|adolescent|adolescent
4991807|NCT04043936|suicide prevention|suicide prevention
4991808|NCT04043936|reducing stigma|reducing stigma
4991809|NCT04043910|Functional Neuroimaging|functional neuroimaging
4991810|NCT04043910|Pediatrics|pediatrics
4991811|NCT04043910|fNIRS|fnirs
4991812|NCT04043910|Single-sided deafness|single-sided deafness
4991814|NCT04043884|Shoulder rehabilitation|shoulder rehabilitation
4991815|NCT04043884|Electromyography|electromyography
4991816|NCT04043884|Posture analysis|posture analysis
4991817|NCT04043845|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4991818|NCT04043845|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
4991819|NCT04043845|Mantle Cell Lymphoma|mantle cell lymphoma
4991820|NCT04043845|Marginal Zone Lymphoma|marginal zone lymphoma
4991821|NCT04043845|CLL|cll
4991822|NCT04043845|WM|wm
4991823|NCT04043845|MCL|mcl
4991824|NCT04043845|MZL|mzl
4991825|NCT04043845|ERK|erk
4991826|NCT04043845|Ibrutinib|ibrutinib
4991827|NCT04043845|BTKCys481|btkcys481
4991828|NCT04043845|PLCG2|plcg2
4991829|NCT04043845|PLCγ2|plcγ2
4991830|NCT04043845|LY3214996|ly3214996
4991847|NCT04043741|Dry Needling|dry needling
4991848|NCT04043741|Oswestry disability index,|oswestry disability index,
4991849|NCT04043741|Paraspinal muscle length|paraspinal muscle length
4991850|NCT04043741|Pain pressure threshold|pain pressure threshold
4991851|NCT04043728|COPD|copd
4991852|NCT04043728|Smoking cessation|smoking cessation
4991853|NCT04043728|Nicotine dependence|nicotine dependence
4991854|NCT04043728|Tobacco use|tobacco use
4991855|NCT04043728|Cigarette smoking|cigarette smoking
4991856|NCT04043728|Behavioral treatment|behavioral treatment
4991857|NCT04043715|transcutaneous spinal stimulation|transcutaneous spinal stimulation
4991858|NCT04043715|epidural spinal stimulation|epidural spinal stimulation
4991859|NCT04043715|physical therapy|physical therapy
4991860|NCT04043715|lower extremity|lower extremity
4991861|NCT04043702|obesity|obesity
4991862|NCT04043702|drug combination|drug combination
4991863|NCT04043702|empagliflozin(jardiance)|empagliflozin(jardiance)
4991864|NCT04043702|topiramate(conviban)|topiramate(conviban)
4991865|NCT04043676|Leukemia|leukemia
4991866|NCT04043676|BCR-ABL positive|bcr-abl positive
4991867|NCT04043676|Myeloide|myeloide
4991868|NCT04043676|Philadelphia-positive|philadelphia-positive
4991869|NCT04043676|Chronic|chronic
4991870|NCT04043663|virtual reality|virtual reality
4991872|NCT04043650|Physical Activity|physical activity
5300211|NCT02176278|Asian|asian
5313214|NCT02115256|breech|breech
4991873|NCT04043650|Mobile Health|mobile health
4991874|NCT04043650|Self Monitoring|self monitoring
4991875|NCT04043650|Wearable Sensors|wearable sensors
4991876|NCT04043650|Tailored Health Communication|tailored health communication
4991877|NCT04043650|Implementation Intentions|implementation intentions
4991878|NCT04043650|Mobile Apps|mobile apps
4991879|NCT04043650|Anti-Sedentary Behavior|anti-sedentary behavior
4991880|NCT04043650|Opportunistic Physical Activity|opportunistic physical activity
4991881|NCT04043650|Health Belief Model|health belief model
4991882|NCT04043624|single-port thoracoscopic surgery|single-port thoracoscopic surgery
4991883|NCT04043624|lidocaine|lidocaine
4991884|NCT04043624|postoperative pain|postoperative pain
4991885|NCT04043624|opioid|opioid
4991886|NCT04043611|Lumbar Disc Protrusion|lumbar disc protrusion
4991887|NCT04043611|ELDOA|eldoa
4991888|NCT04043611|Oswestry Disability Index|oswestry disability index
4991889|NCT04043572|Fetus|fetus
4991890|NCT04043572|Neurological Development|neurological development
4991891|NCT04043572|Teratogenicity|teratogenicity
4991892|NCT04043572|Anti-Epileptic Drugs|anti-epileptic drugs
4991893|NCT04043572|Epilepsy|epilepsy
4991894|NCT04043507|Heme|heme
4991895|NCT04043507|Cardiac|cardiac
4991896|NCT04043507|Surgery|surgery
4991897|NCT04043481|Perfusion index|perfusion index
4991898|NCT04043481|modified Allen's test|modified allen's test
4991899|NCT04043468|audit and feedback|audit and feedback
4991900|NCT04043468|process indicators|process indicators
4991901|NCT04043468|quality|quality
4991902|NCT04043455|Abdominal pain|abdominal pain
4991903|NCT04043455|Olorinab|olorinab
4991904|NCT04043455|APD371|apd371
4991905|NCT04043455|IBS-C (predominant constipation)|ibs-c (predominant constipation)
4991906|NCT04043455|IBS-D (predominant diarrhea)|ibs-d (predominant diarrhea)
4991907|NCT04043455|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
4991908|NCT04043416|Long Term Care|long term care
4991909|NCT04043416|Motivating Reminiscence Technology|motivating reminiscence technology
4991910|NCT04043416|Feasibility|feasibility
4991911|NCT04043390|Xpert MTB/RIF|xpert mtb/rif
4991912|NCT04043390|tuberculosis|tuberculosis
4991913|NCT04043390|diagnostics|diagnostics
4991914|NCT04043390|Xpert Ultra|xpert ultra
4991915|NCT04043390|Truenat MTB|truenat mtb
4991916|NCT04043390|Truenat MTB RIF|truenat mtb rif
4991925|NCT04043364|Learning|learning
4991926|NCT04043364|Innovation|innovation
4991927|NCT04043364|Volunteers|volunteers
4991928|NCT04043364|Empowerment|empowerment
4991929|NCT04043299|Intrapartum oxygen administration|intrapartum oxygen administration
4991930|NCT04043299|first stage of labour|first stage of labour
4991931|NCT04043286|One abutment one time|one abutment one time
4991932|NCT04043286|Disconnection reconnection|disconnection reconnection
4991933|NCT04043286|Definitive abutment|definitive abutment
4991934|NCT04043260|Diabetes Type 1|diabetes type 1
4991935|NCT04043260|Multiple Daily Injections|multiple daily injections
4991936|NCT04043247|Postoperative Nausea and Vomiting;TEAS|postoperative nausea and vomiting;teas
4991937|NCT04043195|NSCLC|nsclc
4991938|NCT04043195|Ipilimumab|ipilimumab
4991939|NCT04043195|Nivolumab|nivolumab
4991940|NCT04043195|Oxaliplatin|oxaliplatin
4991941|NCT04043156|spinal cord compression, radiotherapy|spinal cord compression, radiotherapy
4991942|NCT04043143|opioids|opioids
4991943|NCT04043130|Reproductive and Sexual Health Care Utilization|reproductive and sexual health care utilization
4991944|NCT04043117|Dimorphism|dimorphism
4991945|NCT04043117|self-esteem|self-esteem
4991946|NCT04043117|oncological treatments|oncological treatments
4991947|NCT04043091|Type 2 myocardial infarction|type 2 myocardial infarction
4991948|NCT04043091|Percutaneous Coronary Intervention|percutaneous coronary intervention
4991949|NCT04043091|Critical Illness|critical illness
4991950|NCT04043052|Stroke|stroke
4991951|NCT04043052|e-health|e-health
4991952|NCT04043052|Depression|depression
4991953|NCT04043052|Anxiety|anxiety
4991954|NCT04043052|Prevention|prevention
4991955|NCT04043026|Warfarin|warfarin
4991956|NCT04043026|Fibrin clot structure and function|fibrin clot structure and function
4991957|NCT04043026|Lipids/lipoproteins|lipids/lipoproteins
4991958|NCT04043026|Statin|statin
4991959|NCT04043013|ARCH|arch
4991960|NCT04043013|TORQUE|torque
4991961|NCT04043013|BRACKET|bracket
4991962|NCT04043013|PRESCRIPTION|prescription
4991963|NCT04043000|Prebiotics|prebiotics
4991964|NCT04043000|Probiotics|probiotics
4991965|NCT04043000|Microbiota|microbiota
4991966|NCT04042948|lumbar spinal stenosis|lumbar spinal stenosis
4991967|NCT04042948|lumbar fusion surgery|lumbar fusion surgery
4991968|NCT04042948|drainage tube|drainage tube
5008441|NCT03943758|Polyp|polyp
4991969|NCT04042948|removal of drainage tube|removal of drainage tube
4991970|NCT04042948|fever|fever
4991971|NCT04042948|prevention of fever|prevention of fever
4991972|NCT04042948|preventive use of non-steroidal inflammatory drug|preventive use of non-steroidal inflammatory drug
4991973|NCT04042922|Alzheimer Disease|alzheimer disease
5309095|NCT02133638|Propofol|propofol
4991974|NCT04042922|Cognitive Impairment|cognitive impairment
4991975|NCT04042922|Non-invasive Sensory Stimulation|non-invasive sensory stimulation
4991976|NCT04042922|Light and Sound Stimulation|light and sound stimulation
4991978|NCT04042909|brief intervention|brief intervention
4991979|NCT04042909|college students|college students
4991980|NCT04042896|Aerobic exercise|aerobic exercise
4991981|NCT04042896|Exergame|exergame
4991982|NCT04042896|cardiorespiratory fitness|cardiorespiratory fitness
4991983|NCT04042896|endothelial function|endothelial function
4991984|NCT04042896|epicardial fat|epicardial fat
4991985|NCT04042883|Perfusion|perfusion
4991986|NCT04042870|Breast Cancer|breast cancer
4991987|NCT04042870|Yoga|yoga
4991988|NCT04042870|Aromatase Inhibitor|aromatase inhibitor
4991989|NCT04042870|Arthralgia|arthralgia
4991990|NCT04042870|Sukshma Vyayama|sukshma vyayama
4991991|NCT04042857|DSO|dso
4991992|NCT04042857|toenail|toenail
4991993|NCT04042857|onychomycosis|onychomycosis
4991994|NCT04042818|Sarcopenia|sarcopenia
4991995|NCT04042818|Stroke|stroke
4991996|NCT04042818|Quadriceps Muscle Atrophy|quadriceps muscle atrophy
4991997|NCT04042818|Hemiplegia|hemiplegia
4991998|NCT04042818|Ultrasonography|ultrasonography
4991999|NCT04042818|Hand Strength|hand strength
4992000|NCT04042792|pharmacokinetics|pharmacokinetics
4992001|NCT04042792|pharmacodynamics|pharmacodynamics
4992002|NCT04042792|Adalimumab|adalimumab
4992003|NCT04042792|methotrexate|methotrexate
4992004|NCT04042792|drug-drug interaction|drug-drug interaction
4992005|NCT04042792|trough ADA concentration|trough ada concentration
4995428|NCT04022447|dupilumab|dupilumab
4992010|NCT04042779|Model-based working memory training|model-based working memory training
4992011|NCT04042779|Cognitive training|cognitive training
4992012|NCT04042779|Long-term WM capacity|long-term wm capacity
5356783|NCT01918007|Sleep Apnea Syndromes|sleep apnea syndromes
4992013|NCT04042779|near transfer effects of the training|near transfer effects of the training
4992014|NCT04042779|far transfer effects of the training|far transfer effects of the training
4992015|NCT04042753|Pituitary tumor|pituitary tumor
4992016|NCT04042753|Nivolumab|nivolumab
4992017|NCT04042753|Ipilimumab|ipilimumab
4992018|NCT04042753|19-216|19-216
4992019|NCT04042740|Acute Hepatitis C Infection|acute hepatitis c infection
4992020|NCT04042740|Glecaprevir|glecaprevir
4992021|NCT04042740|Pibrentasvir|pibrentasvir
4992022|NCT04042740|4 weeks|4 weeks
4992023|NCT04042740|Direct-acting antivirals|direct-acting antivirals
4992024|NCT04042727|Dexmedetomidine|dexmedetomidine
4992025|NCT04042727|Critical Care|critical care
4992026|NCT04042727|Atrial Fibrillation|atrial fibrillation
4992027|NCT04042701|Human epidermal receptor 2 positive|human epidermal receptor 2 positive
4992028|NCT04042701|HER2|her2
4992029|NCT04042701|NSCLC|nsclc
4992030|NCT04042675|parkinson disease|parkinson disease
4992031|NCT04042675|respiratuary muscle strength|respiratuary muscle strength
4992032|NCT04042675|physical activity level|physical activity level
4992033|NCT04042675|fatigue|fatigue
4992039|NCT04042636|CLABSI|clabsi
4992040|NCT04042623|IgAN|igan
4992041|NCT04042623|AXL inhibitor|axl inhibitor
4992042|NCT04042623|Berger's Disease|berger's disease
4992043|NCT04042623|Proteinuria|proteinuria
4992044|NCT04042623|Kidney Disease|kidney disease
4992045|NCT04042597|chordoma|chordoma
4992046|NCT04042597|unresectable|unresectable
4992047|NCT04042597|anlotinib|anlotinib
4992048|NCT04042597|imatinib|imatinib
4992049|NCT04042597|survival|survival
4992050|NCT04042597|quality of life|quality of life
4992051|NCT04042584|Stroke|stroke
4992052|NCT04042584|Mechanical thrombectomy|mechanical thrombectomy
4992053|NCT04042584|Tele-evaluation|tele-evaluation
4992054|NCT04042584|Emergency medical service|emergency medical service
4992055|NCT04042584|Pre hospital|pre hospital
4992056|NCT04042571|Intracranial oxymetry|intracranial oxymetry
4992057|NCT04042571|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4992058|NCT04042571|Vasospasm|vasospasm
4992059|NCT04042532|Young-onset dementia|young-onset dementia
4992060|NCT04042532|Alzheimer's disease|alzheimer's disease
4992061|NCT04042532|rTMS|rtms
4992062|NCT04042532|TBS|tbs
4992063|NCT04042519|Metabolomics|metabolomics
4992064|NCT04042519|Omega 6|omega 6
4992065|NCT04042519|Omega 3|omega 3
4992066|NCT04042519|COPD|copd
4992067|NCT04042519|lung function tests|lung function tests
4992068|NCT04042506|immune checkpoint blockade|immune checkpoint blockade
4992070|NCT04042506|Nivolumab|nivolumab
4992077|NCT04042428|Somatropin|somatropin
4992078|NCT04042428|Growth hormone|growth hormone
4992079|NCT04042428|Anti-doping control|anti-doping control
4992080|NCT04042428|Athletic performance|athletic performance
4992081|NCT04042415|Multiple Sclerosis|multiple sclerosis
4992098|NCT04042389|Orthodontics|orthodontics
4992099|NCT04042389|Planimetry|planimetry
4992100|NCT04042389|Reminders|reminders
4992101|NCT04042363|multiple sclerosis|multiple sclerosis
4992102|NCT04042363|optic neuritis|optic neuritis
4992103|NCT04042363|transorbital stimulation|transorbital stimulation
4992104|NCT04042363|remyelination|remyelination
4992105|NCT04042363|nervous system disease|nervous system disease
4992106|NCT04042363|peripheral nervous system disease|peripheral nervous system disease
4992107|NCT04042363|optic nerve disease|optic nerve disease
4992108|NCT04042363|adaptive optic|adaptive optic
4992109|NCT04042350|AURORA|aurora
4992110|NCT04042350|Cardiovascular Events|cardiovascular events
4992111|NCT04042350|Chronic Kidney Disease|chronic kidney disease
4992112|NCT04042311|Exercise|exercise
4992113|NCT04042311|High-intensity interval training|high-intensity interval training
4992114|NCT04042311|interval training|interval training
4992115|NCT04042285|Diabetic Foot Wound|diabetic foot wound
4992116|NCT04042272|kidney transplantation|kidney transplantation
4992117|NCT04042272|s100β|s100β
4992118|NCT04042272|neuron specific enolase|neuron specific enolase
4992119|NCT04042272|glial fibrillary acidic protein|glial fibrillary acidic protein
4992120|NCT04042233|total hip arthroplasty|total hip arthroplasty
4992121|NCT04042233|vancomycin|vancomycin
4992122|NCT04042233|intraosseous vancomycin|intraosseous vancomycin
4992123|NCT04042207|Artificial pancreas|artificial pancreas
4992124|NCT04042207|Very Unstable Type 1 diabetes|very unstable type 1 diabetes
4992125|NCT04042194|clinical research|clinical research
4995530|NCT04021628|cmv|cmv
4992126|NCT04042194|Implant|implant
4992127|NCT04042194|Implantology|implantology
4992128|NCT04042194|Prospective|prospective
4992129|NCT04042194|Randomized controlled trial|randomized controlled trial
4992130|NCT04042194|Soft Tissue Grafting|soft tissue grafting
4992131|NCT04042194|Single-Tooth Implants|single-tooth implants
4992132|NCT04042168|COPD|copd
4992133|NCT04042168|Inhalers|inhalers
4992134|NCT04042155|dabigatran|dabigatran
4992135|NCT04042155|rivaroxaban|rivaroxaban
4992136|NCT04042155|apixaban|apixaban
4992137|NCT04042155|edoxaban|edoxaban
4992138|NCT04042116|lucitanib|lucitanib
4992139|NCT04042116|nivolumab|nivolumab
4992241|NCT04041466|Atrial Fibrillation|atrial fibrillation
4992142|NCT04042116|tyrosine kinase inhibitors|tyrosine kinase inhibitors
4992143|NCT04042116|gynecologic neoplasms|gynecologic neoplasms
4992144|NCT04042116|checkpoint inhibitor|checkpoint inhibitor
4992145|NCT04042090|Virtual reality|virtual reality
4992146|NCT04042090|Quality of life|quality of life
4992147|NCT04042090|Back pain|back pain
4992148|NCT04042077|Infection, Surgical Infection|infection, surgical infection
4992150|NCT04042064|Anesthesia for the elderly|anesthesia for the elderly
4992151|NCT04042051|HER2|her2
4992152|NCT04042051|HER2-positive|her2-positive
4992153|NCT04042051|Metastatic|metastatic
4992154|NCT04042051|Breast|breast
4992155|NCT04042051|Cancer|cancer
4992156|NCT04042038|Obsessive compulsive disorder|obsessive compulsive disorder
4992157|NCT04042038|Intensive cognitive-behavioral therapy|intensive cognitive-behavioral therapy
4992158|NCT04042038|Neuroimaging|neuroimaging
4992159|NCT04042038|Response prediction|response prediction
4992160|NCT04042038|Response mechanisms|response mechanisms
4992161|NCT04042038|Functional magnetic resonance imaging|functional magnetic resonance imaging
4992162|NCT04042025|Gene replacement|gene replacement
4992163|NCT04041999|Occupational therapy|occupational therapy
4992164|NCT04041999|cognition|cognition
4992165|NCT04041999|rehabilitation|rehabilitation
4992166|NCT04041986|stroke|stroke
4992167|NCT04041986|non-invasive brain stimulation|non-invasive brain stimulation
4992168|NCT04041986|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4992169|NCT04041947|Delirium|delirium
4992170|NCT04041947|Pediatric intensive care|pediatric intensive care
4992194|NCT04041817|Weaning of mechanical ventilation|weaning of mechanical ventilation
4992195|NCT04041804|Palatal Expansion Technique|palatal expansion technique
4992196|NCT04041804|Cone-Beam Computed Tomography|cone-beam computed tomography
4992197|NCT04041791|severe pneumonia|severe pneumonia
4992198|NCT04041791|supportive care|supportive care
4992199|NCT04041791|antibiotics|antibiotics
4992200|NCT04041791|World Health Organisation|world health organisation
4992201|NCT04041791|intravenous fluids|intravenous fluids
4992202|NCT04041791|nutrition|nutrition
4992203|NCT04041791|children|children
4992204|NCT04041765|IgM-enriched Intravenous Immunoglobulin|igm-enriched intravenous immunoglobulin
4992205|NCT04041752|Meal texture|meal texture
4992206|NCT04041752|Appetite|appetite
4992207|NCT04041752|Energy compensation|energy compensation
4992208|NCT04041752|Food reward|food reward
4992209|NCT04041739|fungal infection|fungal infection
4992210|NCT04041713|Rett Syndrome|rett syndrome
4992211|NCT04041713|Rett|rett
4992212|NCT04041713|RTT|rtt
4992213|NCT04041700|Hearing Loss, Conductive|hearing loss, conductive
4992214|NCT04041700|Hearing Loss, Mixed|hearing loss, mixed
4992215|NCT04041700|Deafness, sensorineural single-sided|deafness, sensorineural single-sided
4992216|NCT04041687|induction|induction
4992217|NCT04041661|Dual task performance|dual task performance
4992218|NCT04041661|Executive function|executive function
4992219|NCT04041661|Transcrainal direct current stimulation (tDCS)|transcrainal direct current stimulation (tdcs)
4992220|NCT04041635|Pain|pain
4992221|NCT04041635|Premature|premature
4992222|NCT04041635|Visual stimuli|visual stimuli
4992223|NCT04041635|Auditory stimuli|auditory stimuli
4992224|NCT04041622|Prevalence|prevalence
4992225|NCT04041622|General population|general population
4992226|NCT04041622|Diagnosis|diagnosis
4992227|NCT04041622|Prognosis|prognosis
4992228|NCT04041622|Etiology|etiology
4992229|NCT04041622|Genes|genes
4992230|NCT04041570|Ebola virus|ebola virus
4992231|NCT04041570|Ebola vaccine|ebola vaccine
4992232|NCT04041570|cAd3-EBO S|cad3-ebo s
4992233|NCT04041518|Autotransplantation|autotransplantation
4992234|NCT04041518|extraoral apicoectomy|extraoral apicoectomy
4992235|NCT04041518|revascularization|revascularization
4992236|NCT04041505|responsive feeding|responsive feeding
4992237|NCT04041505|expressing/pumping human milk|expressing/pumping human milk
4992238|NCT04041492|diabetes|diabetes
4992239|NCT04041492|osteocalcin|osteocalcin
4992240|NCT04041492|insulin|insulin
4992243|NCT04041466|Cardiovascular diseases|cardiovascular diseases
4992244|NCT04041466|Heart diseases|heart diseases
4992245|NCT04041466|Wearable Electronic Devices|wearable electronic devices
4992246|NCT04041466|Electrocardiography|electrocardiography
4992247|NCT04041453|TRICHURIS|trichuris
4992248|NCT04041453|STH|sth
4992249|NCT04041453|IVERMECTIN|ivermectin
4992250|NCT04041453|ALBENDAZOLE|albendazole
4992251|NCT04041440|Auditory training|auditory training
4992252|NCT04041440|Children with hearing loss|children with hearing loss
4992284|NCT04041297|Preoperative training|preoperative training
4992285|NCT04041297|Prehabilitation|prehabilitation
4992286|NCT04041297|oxygen-uptake kinetics|oxygen-uptake kinetics
4992293|NCT04041258|pseudoarthrosis|pseudoarthrosis
4992294|NCT04041258|clavicle|clavicle
4992295|NCT04041245|meridians|meridians
4992296|NCT04041245|acupuncture|acupuncture
4992297|NCT04041245|chronic stable angina pectoris|chronic stable angina pectoris
4992298|NCT04041245|meridian phenomenon|meridian phenomenon
4992299|NCT04041245|near infrared spectroscopy|near infrared spectroscopy
4992300|NCT04041232|achromatopsia|achromatopsia
4992301|NCT04041232|PBA|pba
4992302|NCT04041232|ATF6|atf6
4992303|NCT04041232|color blindness|color blindness
4992304|NCT04041206|meridians|meridians
4992305|NCT04041206|acupuncture|acupuncture
4992306|NCT04041206|chronic stable angina pectoris|chronic stable angina pectoris
4992307|NCT04041206|meridian phenomenon|meridian phenomenon
4992308|NCT04041206|laser doppler|laser doppler
4992309|NCT04041180|Sickle cell disease|sickle cell disease
4992310|NCT04041180|incentive spirometry|incentive spirometry
4992311|NCT04041180|pain|pain
4992312|NCT04041180|children|children
4992313|NCT04041167|Reperfusion|reperfusion
4992314|NCT04041167|Lipoic acid|lipoic acid
4992315|NCT04041167|Stroke|stroke
4992316|NCT04041141|tongue tumor|tongue tumor
4992317|NCT04041141|tongue cancer|tongue cancer
4992318|NCT04041141|oral cancer|oral cancer
4992319|NCT04041115|cirrhosis|cirrhosis
4992320|NCT04041115|nutrition|nutrition
4992321|NCT04041115|sarcopenia|sarcopenia
4992322|NCT04041115|non-alcoholic beer|non-alcoholic beer
4992323|NCT04041102|GM1|gm1
4992324|NCT04041102|GM1 gangliosidosis|gm1 gangliosidosis
4992325|NCT04041102|GM1 Type 1|gm1 type 1
4992326|NCT04041102|GM1 Type 2|gm1 type 2
4992327|NCT04041102|GM1 gangliosidosis Type 1|gm1 gangliosidosis type 1
4992328|NCT04041102|GM1 gangliosidosis Type 2|gm1 gangliosidosis type 2
4992329|NCT04041102|GM1 natural history study|gm1 natural history study
4992330|NCT04041102|GM1 gangliosidosis natural history study|gm1 gangliosidosis natural history study
4992331|NCT04041102|Lysosomal Storage Disorders|lysosomal storage disorders
4992332|NCT04041102|Lysosomal Disorders|lysosomal disorders
4992333|NCT04041076|preoperative parameters|preoperative parameters
4992334|NCT04041076|risk prediction|risk prediction
4992335|NCT04041076|postoperative mortality|postoperative mortality
4992336|NCT04041076|elective major general surgery|elective major general surgery
4992337|NCT04041063|robotics, hand function|robotics, hand function
4992338|NCT04041050|Myeloproliferative Neoplasm (MPN)|myeloproliferative neoplasm (mpn)
4992339|NCT04041050|Polycythemia Vera (PV)|polycythemia vera (pv)
4992340|NCT04041050|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
4992341|NCT04041050|Myelofibrosis (MF)|myelofibrosis (mf)
4992342|NCT04041050|cancer|cancer
4992359|NCT04040998|self-stigma|self-stigma
4992360|NCT04040985|Legion Primary|legion primary
4992361|NCT04040985|TKA|tka
4992362|NCT04040985|Osteoarthritis of Knee|osteoarthritis of knee
4992363|NCT04040959|stiffness|stiffness
4992364|NCT04040959|chronic kidney disease|chronic kidney disease
4992365|NCT04040959|Hypertension|hypertension
4992366|NCT04040920|Ozone|ozone
4992367|NCT04040920|Pits and fissures sealants|pits and fissures sealants
4992368|NCT04040920|Prevention|prevention
4992375|NCT04040881|Older adults|older adults
4992376|NCT04040881|Smartphones|smartphones
4992377|NCT04040881|eHealth|ehealth
4992378|NCT04040881|mHealth|mhealth
4992379|NCT04040881|Remote monitoring|remote monitoring
4992380|NCT04040855|medication reviews, elderly, primary care|medication reviews, elderly, primary care
4992389|NCT04040829|Photovoice|photovoice
4992396|NCT04040790|contrast sensitivity|contrast sensitivity
4992397|NCT04040790|scleral contact lens|scleral contact lens
4992398|NCT04040790|artificial iris|artificial iris
4992399|NCT04040777|Subclinical Atherosclerosis|subclinical atherosclerosis
4992400|NCT04040777|Metabolic Syndrome|metabolic syndrome
4992401|NCT04040777|Primary Prevention|primary prevention
4992402|NCT04040764|Knee replacement|knee replacement
4992409|NCT04040725|Bladder Cancer|bladder cancer
4992410|NCT04040712|fecal microbiota transplantation|fecal microbiota transplantation
4992411|NCT04040712|microbiota|microbiota
4992412|NCT04040712|chemotherapy|chemotherapy
4992413|NCT04040712|diarrhea|diarrhea
4992414|NCT04040712|renal cell carcinoma|renal cell carcinoma
4992416|NCT04040699|KN046|kn046
4992417|NCT04040699|HER2 Positive Solid Tumor|her2 positive solid tumor
4992418|NCT04040686|HER2|her2
4992419|NCT04040686|single domain antibody (sdAb)|single domain antibody (sdab)
4992420|NCT04040686|SPECT/CT imaging|spect/ct imaging
4992421|NCT04040673|cancer|cancer
4992422|NCT04040673|Raman|raman
4992423|NCT04040673|thyroid|thyroid
4992425|NCT04040608|visual analog scale|visual analog scale
4992426|NCT04040608|stress|stress
4992427|NCT04040595|Type 2 diabetes|type 2 diabetes
4992428|NCT04040595|adipocyte|adipocyte
4992429|NCT04040595|adipocyte tissue dysfunction|adipocyte tissue dysfunction
4992430|NCT04040595|adiposity|adiposity
4992431|NCT04040595|favourable adiposity|favourable adiposity
4992432|NCT04040595|gene expression|gene expression
4992433|NCT04040595|adipose tissue|adipose tissue
4992434|NCT04040582|Psychedelics, Wellness|psychedelics, wellness
4992435|NCT04040530|Renal Cell Carcinoma|renal cell carcinoma
4992436|NCT04040530|Nephron sparing treatment|nephron sparing treatment
4992437|NCT04040530|Quality of life|quality of life
4992438|NCT04040530|Patient Reported Outcome Measures|patient reported outcome measures
4992439|NCT04040530|Kidney Neoplasms|kidney neoplasms
4992440|NCT04040530|Cryosurgery|cryosurgery
4992453|NCT04040439|Precedex;|precedex;
4992454|NCT04040439|Dexmedetomidine Hydrochloride;|dexmedetomidine hydrochloride;
4992455|NCT04040439|Sedation;|sedation;
4992456|NCT04040439|intensive care;|intensive care;
4992457|NCT04040439|pediatric|pediatric
4992458|NCT04040426|Theraskin|theraskin
4992459|NCT04040426|Skin Graft|skin graft
4992460|NCT04040426|DFU|dfu
4992461|NCT04040426|Ulcer|ulcer
4992462|NCT04040387|PTSD|ptsd
4992463|NCT04040387|Nightmare|nightmare
4992464|NCT04040387|Nightmare Disorder|nightmare disorder
4992465|NCT04040387|Post-traumatic stress disorder|post-traumatic stress disorder
4992466|NCT04040387|Veteran|veteran
4992467|NCT04040387|Digital therapeutic|digital therapeutic
4992468|NCT04040387|Digital medicine|digital medicine
4992469|NCT04040374|artificial intelligence|artificial intelligence
4992470|NCT04040374|gastric cancer|gastric cancer
4992471|NCT04040348|Dementia|dementia
4992472|NCT04040348|Stem cells|stem cells
4992473|NCT04040348|Alzheimer's Disease|alzheimer's disease
4992480|NCT04040283|Growth factors|growth factors
4992481|NCT04040283|Meniscal injury|meniscal injury
4992482|NCT04040270|Family well-being|family well-being
4992483|NCT04040270|Healthy Eating|healthy eating
4992484|NCT04040270|Physical activity|physical activity
4992485|NCT04040231|Mesothelioma|mesothelioma
4992486|NCT04040231|Pleural Mesothelioma|pleural mesothelioma
4992487|NCT04040231|Wilms Tumor Protein 1|wilms tumor protein 1
4992488|NCT04040231|WT1|wt1
4992489|NCT04040231|galinpepimut-S|galinpepimut-s
4992490|NCT04040231|Montanide|montanide
4992507|NCT04040153|E-cigarette|e-cigarette
4992508|NCT04040153|Marijuana|marijuana
4992509|NCT04040153|Adolescent|adolescent
4992510|NCT04040140|Auricular Point Acupressure|auricular point acupressure
4992511|NCT04040140|Cancer-related Pain|cancer-related pain
4992512|NCT04040140|Acupressure|acupressure
4992513|NCT04040140|Nursing education|nursing education
4992514|NCT04040127|Pulpal regeneration|pulpal regeneration
4992515|NCT04040127|Stem cells|stem cells
4992516|NCT04040127|Residual Pulpal Tissue|residual pulpal tissue
4992517|NCT04040127|Irreversible Pulpitis|irreversible pulpitis
4992518|NCT04040114|Artificial Intelligence|artificial intelligence
4992519|NCT04040114|Surveillance|surveillance
4992520|NCT04040114|Melanoma|melanoma
4992521|NCT04040114|Skin Cancer|skin cancer
4992522|NCT04040114|photography|photography
4992523|NCT04040049|Gene Therapy|gene therapy
4992524|NCT04040036|blood draw|blood draw
4992533|NCT04040010|bovine colostrum|bovine colostrum
4992535|NCT04039997|cardiopulmonary resuscitation|cardiopulmonary resuscitation
4992536|NCT04039997|medical simulation|medical simulation
4992537|NCT04039997|basic life support|basic life support
4992538|NCT04039997|chest compression|chest compression
4992539|NCT04039997|feedback device|feedback device
4992540|NCT04039984|radiostereometric analysis|radiostereometric analysis
4992541|NCT04039984|implant migration|implant migration
4992542|NCT04039984|total hip replacement|total hip replacement
4992543|NCT04039984|arthroplasty|arthroplasty
4992545|NCT04039971|ACL Tear|acl tear
4992546|NCT04039971|ACL Injury|acl injury
4992550|NCT04039971|Anterior Cruciate Ligament Injuries|anterior cruciate ligament injuries
4992551|NCT04039971|Anterior Cruciate Ligament|anterior cruciate ligament
4992552|NCT04039971|ACL Repair|acl repair
4992553|NCT04039971|ACL Reconstruction|acl reconstruction
4992554|NCT04039971|ACL Surgery|acl surgery
4992555|NCT04039971|Anterior Cruciate Ligament Repair|anterior cruciate ligament repair
4992556|NCT04039971|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4992557|NCT04039971|Anterior Cruciate Ligament Surgery|anterior cruciate ligament surgery
4992558|NCT04039945|Fr1da|fr1da
4992559|NCT04039945|Fr1da-Plus|fr1da-plus
4992560|NCT04039945|type 1 diabetes|type 1 diabetes
4992561|NCT04039945|islet autoantibodies|islet autoantibodies
4992562|NCT04039919|Ethanol|ethanol
4992563|NCT04039919|Cannabidiol|cannabidiol
4992564|NCT04039919|Padsevonil|padsevonil
4992565|NCT04039906|Efficiency,Usability,Safety|efficiency,usability,safety
4992566|NCT04039893|axillary node clearance|axillary node clearance
4992567|NCT04039893|axillary ultrasound imaging|axillary ultrasound imaging
4992568|NCT04039893|sentinel node|sentinel node
4992569|NCT04039893|tumor load|tumor load
4992570|NCT04039867|Carcinoma, Transitional Cell|carcinoma, transitional cell
4992571|NCT04039867|Bladder Cancer|bladder cancer
4992572|NCT04039867|oxaliplatin|oxaliplatin
4992573|NCT04039867|Gemcitabine|gemcitabine
4992577|NCT04039828|Diarrhea|diarrhea
4992578|NCT04039828|3 to 59 months children|3 to 59 months children
4992579|NCT04039828|Zinc tablet|zinc tablet
4992580|NCT04039828|acceptability|acceptability
4992581|NCT04039828|adherence|adherence
4992582|NCT04039828|palatability|palatability
4992583|NCT04039802|Single-stage surgery|single-stage surgery
4992584|NCT04039802|Bone conduction devices|bone conduction devices
4992585|NCT04039802|Pediatric population|pediatric population
4992586|NCT04039802|Implant loss|implant loss
4992587|NCT04039789|Varicose ulcer|varicose ulcer
4992588|NCT04039789|Exercise|exercise
4992589|NCT04039789|Nurses|nurses
4992591|NCT04039776|CT|ct
4992592|NCT04039763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
4992593|NCT04039737|Qingpeng Ointment|qingpeng ointment
4992594|NCT04039737|Shoulder Syndrome|shoulder syndrome
4992595|NCT04039737|Rehabilitation Period of Cerebral Hemorrhage|rehabilitation period of cerebral hemorrhage
4992596|NCT04039711|Vaginal self-sampling|vaginal self-sampling
4992597|NCT04039711|STI|sti
4992598|NCT04039711|Genital infection|genital infection
4992599|NCT04039711|Group B streptococcus|group b streptococcus
4992600|NCT04039698|Hepatitis C|hepatitis c
4992601|NCT04039698|Telemedicine|telemedicine
4992602|NCT04039698|Direct acting antivirals|direct acting antivirals
4992603|NCT04039698|Public Health|public health
4992604|NCT04039685|uncoupling protein 1|uncoupling protein 1
4992605|NCT04039685|uncoupling protein one|uncoupling protein one
4992606|NCT04039685|resistance exercise|resistance exercise
4992607|NCT04039685|aerobic exercise|aerobic exercise
4992608|NCT04039685|browning formation|browning formation
4992609|NCT04039685|white fat|white fat
4992610|NCT04039672|Melanoma|melanoma
4992611|NCT04039672|Avian embryo|avian embryo
4992612|NCT04039659|wound complications|wound complications
4992613|NCT04039659|negative-pressure wound therapy|negative-pressure wound therapy
4992614|NCT04039646|Perforated peptic ulcer|perforated peptic ulcer
4992615|NCT04039646|Enhanced recovery after surgery|enhanced recovery after surgery
4992616|NCT04039646|Laparoscopic repair|laparoscopic repair
4992617|NCT04039646|Complications|complications
4992618|NCT04039633|Spinal Cord Stimulation|spinal cord stimulation
4992619|NCT04039620|Sarcopenia|sarcopenia
4992620|NCT04039620|Malnutrition|malnutrition
4992621|NCT04039620|EWGSOP2|ewgsop2
4992622|NCT04039620|Older people|older people
4992623|NCT04039620|Acute care|acute care
4992624|NCT04039620|Hospitalized|hospitalized
4992625|NCT04039594|extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest|extracorporeal life support, extracorporeal membrane oxygenation, cardiogenic shock, cardiac arrest
4992626|NCT04039581|Kinesio Tape|kinesio tape
4992627|NCT04039581|Pain|pain
4992628|NCT04039581|Functionality|functionality
4992629|NCT04039581|Cervical Spine Surgery|cervical spine surgery
4992630|NCT04039568|Opioid Therapy|opioid therapy
4992631|NCT04039568|Sahaj Samadhi Meditation|sahaj samadhi meditation
4992637|NCT04039529|kidney biopsy|kidney biopsy
4992638|NCT04039529|liver biopsy|liver biopsy
4992639|NCT04039529|image fusion|image fusion
4992640|NCT04039503|glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
4992641|NCT04039503|glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
4992669|NCT04039360|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4992671|NCT04039334|COPD|copd
4992672|NCT04039334|Creative Dance|creative dance
4992673|NCT04039334|Exercise Training|exercise training
4992674|NCT04039334|6 Minute Walk Test|6 minute walk test
4992675|NCT04039334|Pulmonary Function Test|pulmonary function test
4992676|NCT04039334|Postural Stability|postural stability
4992677|NCT04039334|Cognitive Functions|cognitive functions
4992678|NCT04039334|Muscle Strength|muscle strength
4992679|NCT04039321|Erector spina plane block|erector spina plane block
4992680|NCT04039321|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4992681|NCT04039321|Obesity|obesity
4992682|NCT04039321|Postoperative pain|postoperative pain
4992683|NCT04039321|Pulmonary functions|pulmonary functions
4992684|NCT04039282|nutrition|nutrition
4992685|NCT04039282|dietary recall|dietary recall
4992686|NCT04039269|Post operative Behavioral Changes|post operative behavioral changes
4992687|NCT04039269|Pediatric|pediatric
4992688|NCT04039269|Long term memory|long term memory
4992689|NCT04039269|video|video
4992690|NCT04039243|Anxiety disorders|anxiety disorders
4992691|NCT04039243|Toddlers|toddlers
4992692|NCT04039243|Preschoolers|preschoolers
4992693|NCT04039243|Cognitive-behavioral therapy|cognitive-behavioral therapy
4992694|NCT04039230|Breast Cancer|breast cancer
4992695|NCT04039217|PrEP|prep
4992696|NCT04039217|PEP|pep
4992697|NCT04039217|MSM|msm
4992698|NCT04039217|Short-course regimen|short-course regimen
4992699|NCT04039217|Pharmacokinetics|pharmacokinetics
4992700|NCT04039191|SMS|sms
4992701|NCT04039191|Education|education
4992702|NCT04039191|Opioid Use|opioid use
4992703|NCT04039191|Pain|pain
4992704|NCT04039191|postoperative|postoperative
4992705|NCT04039178|BCI|bci
4992706|NCT04039178|BQ|bq
4992707|NCT04039178|motor function|motor function
4992708|NCT04039178|acute stroke|acute stroke
4992709|NCT04039178|EMF|emf
4992710|NCT04039126|MALIGNANT PLEURAL EFFUSSION|malignant pleural effussion
4992715|NCT04039100|Peer to Peer|peer to peer
4992716|NCT04039100|Psychosocial Support|psychosocial support
4992717|NCT04039100|Caregivers|caregivers
4992718|NCT04039087|Exercise intolerance|exercise intolerance
4992719|NCT04039087|Quality of life|quality of life
4992731|NCT04039035|Body mass Index|body mass index
4992732|NCT04039035|Postoperative Complications|postoperative complications
4992733|NCT04039035|Length of Hospital Stay and Cost.|length of hospital stay and cost.
4992734|NCT04039022|Depression|depression
4992735|NCT04039022|AXS-05|axs-05
4992736|NCT04039022|Dextromethorphan|dextromethorphan
4992737|NCT04039022|Bupropion|bupropion
4992738|NCT04039022|Dopamine Reuptake Inhibitor|dopamine reuptake inhibitor
4992739|NCT04039022|NMDA Receptor Antagonist|nmda receptor antagonist
4992740|NCT04039022|Nicotinic Acetylcholine Receptor Antagonist|nicotinic acetylcholine receptor antagonist
4992741|NCT04039022|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
4992742|NCT04039022|Axsome Therapeutics|axsome therapeutics
4992743|NCT04039022|Norepinephrine Reuptake Inhibitor|norepinephrine reuptake inhibitor
4992744|NCT04039022|Sigma-1 Receptor Agonist|sigma-1 receptor agonist
4992745|NCT04039022|Glutamate Modulator|glutamate modulator
4992746|NCT04039022|Antidepressant|antidepressant
4992747|NCT04039009|Pelvic organ prolapse|pelvic organ prolapse
4992748|NCT04039009|Infertility|infertility
4992749|NCT04039009|Apical pelvic support|apical pelvic support
4992750|NCT04038996|immune checkpoint inhibitor|immune checkpoint inhibitor
4992751|NCT04038996|single nucleotide polymorphism|single nucleotide polymorphism
4992752|NCT04038996|microRNA|microrna
4992753|NCT04038983|Emergency, Old patients , Survey Questionnaire|emergency, old patients , survey questionnaire
4992754|NCT04038957|schizophrenia|schizophrenia
4992755|NCT04038918|Total knee arthroplasty|total knee arthroplasty
4992756|NCT04038918|progressive muscle relaxation exercise|progressive muscle relaxation exercise
4992757|NCT04038918|pain|pain
4992758|NCT04038918|functional outcomes|functional outcomes
4992759|NCT04038918|muscle strength|muscle strength
4992760|NCT04038892|Bronchiectasis|bronchiectasis
4992761|NCT04038892|Virtual Reality|virtual reality
4992762|NCT04038892|Exercise Training|exercise training
4992763|NCT04038892|Pulmonary Function|pulmonary function
4992764|NCT04038892|Functional Capacity|functional capacity
4992765|NCT04038892|6 Minute Walk Test|6 minute walk test
4992766|NCT04038892|Balance|balance
4992767|NCT04038892|Muscle Strength|muscle strength
4992768|NCT04038866|gait biomechanics|gait biomechanics
4992769|NCT04038866|physical rehabilitation|physical rehabilitation
4992770|NCT04038866|physical therapy|physical therapy
4992771|NCT04038866|dual task|dual task
4992772|NCT04038827|Circulating Endothelial Cells|circulating endothelial cells
4992773|NCT04038827|Graft versus Host Disease|graft versus host disease
4992774|NCT04038827|Neovascularization|neovascularization
4992775|NCT04038827|Allotransplantation|allotransplantation
4992777|NCT04038814|Evac Endotracheal Tube with TaperGuard Cuff|evac endotracheal tube with taperguard cuff
4992778|NCT04038814|MDR - multi drug resistant pathogens|mdr - multi drug resistant pathogens
4992779|NCT04038814|SSD - subglottic secretion drainage,|ssd - subglottic secretion drainage,
4992780|NCT04038775|medically uninsured|medically uninsured
4992781|NCT04038723|Fibrosis|fibrosis
4992782|NCT04038723|Ventricle Remodeling|ventricle remodeling
4992783|NCT04038723|Exercise Training|exercise training
4992784|NCT04038723|Proteomics|proteomics
4992785|NCT04038697|Stroke|stroke
4992786|NCT04038697|Rehabilitation|rehabilitation
4992787|NCT04038697|Ischemic Conditioning|ischemic conditioning
4992788|NCT04038697|Treadmill Training|treadmill training
4992789|NCT04038684|Emotional Eating|emotional eating
4992790|NCT04038684|Low-income|low-income
4992791|NCT04038684|Stress Biomarkers|stress biomarkers
4992792|NCT04038684|Mindfulness|mindfulness
4992793|NCT04038684|Adolescent|adolescent
4992794|NCT04038684|Obesity|obesity
4992795|NCT04038684|Weight Management|weight management
4992796|NCT04038684|Stress|stress
4992797|NCT04038684|Pediatric|pediatric
4992798|NCT04038658|exercise|exercise
4992799|NCT04038658|worksite|worksite
4992800|NCT04038658|digital|digital
4992801|NCT04038658|health promotion|health promotion
5300876|NCT02172703|TBI|tbi
5313882|NCT02112747|LS|ls
4992802|NCT04038645|Nasal Fracture|nasal fracture
4992803|NCT04038645|Photobiomodulation|photobiomodulation
4992804|NCT04038645|Laser|laser
4992805|NCT04038645|Edema|edema
4992806|NCT04038632|Childhood TB|childhood tb
4992807|NCT04038632|Decentralized Diagnosis approaches|decentralized diagnosis approaches
4992808|NCT04038632|Case detection|case detection
4992809|NCT04038593|Pain|pain
4992810|NCT04038593|Anxiety|anxiety
4992811|NCT04038593|Complex dressing|complex dressing
4992812|NCT04038593|Home hospitalization|home hospitalization
4992813|NCT04038593|Music|music
4992814|NCT04038580|Socket|socket
4992815|NCT04038580|Transfemoral|transfemoral
5009236|NCT03938636|healthy control|healthy control
4992820|NCT04038567|anxiety|anxiety
4992821|NCT04038567|post-traumatic stress disorder|post-traumatic stress disorder
4992822|NCT04038567|intensive care units|intensive care units
4992823|NCT04038567|adults|adults
4992824|NCT04038567|mechanical ventilation|mechanical ventilation
4992825|NCT04038541|Prebiotics|prebiotics
4992826|NCT04038541|Probiotics|probiotics
4992827|NCT04038541|Gut microbiome|gut microbiome
4992828|NCT04038541|Multiple Sclerosis|multiple sclerosis
4992829|NCT04038515|Menthol|menthol
4992830|NCT04038515|Electronic Nicotine Delivery Systems|electronic nicotine delivery systems
4992831|NCT04038502|metastatic prostate cancer|metastatic prostate cancer
4992832|NCT04038489|ER+/HER2- Breast Cancer|er+/her2- breast cancer
4992833|NCT04038476|electrophysiology|electrophysiology
4992834|NCT04038476|conscious sedation|conscious sedation
4992835|NCT04038476|transcutaneous CO2 measurement|transcutaneous co2 measurement
4992836|NCT04038476|sedation monitoring|sedation monitoring
4992837|NCT04038476|ablation of arrhythmia|ablation of arrhythmia
4992838|NCT04038463|Menstrual Cycle|menstrual cycle
4992839|NCT04038463|Resistance Training|resistance training
4992840|NCT04038463|Body Composition|body composition
4992841|NCT04038463|Intervention|intervention
4992842|NCT04038463|Exercise|exercise
4992843|NCT04038437|CPX-351|cpx-351
4992844|NCT04038437|Vyxeos|vyxeos
4992845|NCT04038437|Venetoclax|venetoclax
4992846|NCT04038437|Unfit|unfit
4992847|NCT04038411|PD-1 Antibody|pd-1 antibody
4992848|NCT04038411|chidamide|chidamide
4992849|NCT04038411|lenalidomide|lenalidomide
4992850|NCT04038411|etoposide|etoposide
4992851|NCT04038411|NK/T-cell Lymphoma|nk/t-cell lymphoma
4992853|NCT04038372|HBsAg|hbsag
4992854|NCT04038372|prevalence|prevalence
4992855|NCT04038372|Upper Egypt|upper egypt
4992856|NCT04038359|PI3K Inhibitor|pi3k inhibitor
4992857|NCT04038346|Lyme Arthritis|lyme arthritis
4992858|NCT04038346|Lyme|lyme
4992859|NCT04038346|Lyme Disease|lyme disease
4992860|NCT04038346|Arthritis|arthritis
4992861|NCT04038346|NSAID|nsaid
4992862|NCT04038320|Hepatitis C Virus|hepatitis c virus
4992863|NCT04038320|HIV|hiv
4992864|NCT04038320|Key Population|key population
4992865|NCT04038307|shoulder tip pain|shoulder tip pain
4992866|NCT04038294|Cardiac Surgery|cardiac surgery
4992867|NCT04038294|Protein supplementation|protein supplementation
4992868|NCT04038294|Pre-Frail and Frail older adults|pre-frail and frail older adults
4992869|NCT04038268|Immunotherapy|immunotherapy
4992870|NCT04038268|Real Clinical Practice|real clinical practice
4992871|NCT04038268|Respiratory disease|respiratory disease
4992872|NCT04038268|Aeroallergens|aeroallergens
4992873|NCT04038268|IgE-dependent hypersensitivity|ige-dependent hypersensitivity
4992874|NCT04038255|cancer|cancer
4992875|NCT04038255|nicotine replacement therapy|nicotine replacement therapy
4992876|NCT04038255|mindfulness|mindfulness
5342923|NCT01981486|safety|safety
4992877|NCT04038229|enhanced recovery pathway|enhanced recovery pathway
4992878|NCT04038229|analgesia|analgesia
4992879|NCT04038229|tele-monitoring|tele-monitoring
4992880|NCT04038229|biopsychosocial evaluation|biopsychosocial evaluation
4992881|NCT04038216|Single-stage surgery|single-stage surgery
4992882|NCT04038216|Bone conduction devices|bone conduction devices
4992883|NCT04038216|Pediatric population|pediatric population
4992884|NCT04038216|Implant loss|implant loss
4992885|NCT04038203|neonates|neonates
4992886|NCT04038203|low birth weight|low birth weight
4992887|NCT04038203|spectroscopy|spectroscopy
4992888|NCT04038203|Umbilical Artery Catheter (UAC)|umbilical artery catheter (uac)
4992889|NCT04038190|behavioral activation|behavioral activation
4992890|NCT04038190|prevention|prevention
4992891|NCT04038190|reinforcement|reinforcement
4992892|NCT04038190|college students|college students
4992893|NCT04038177|Resistance training|resistance training
4992894|NCT04038177|Muscle strength|muscle strength
4992895|NCT04038164|FASD|fasd
4992896|NCT04038164|animal-assisted therapy|animal-assisted therapy
4992897|NCT04038164|dog-assisted therapy|dog-assisted therapy
4992898|NCT04038151|Transfemoral Amputation|transfemoral amputation
4992899|NCT04038125|Diabetic Macula Edema|diabetic macula edema
5356784|NCT01918007|Snoring|snoring
4992900|NCT04038125|Diabetic Retinopathy|diabetic retinopathy
4992901|NCT04038125|Retina Ischemia|retina ischemia
4992902|NCT04038060|pre-exposure prophylaxis|pre-exposure prophylaxis
5313980|NCT02112383|Students|students
4992903|NCT04038060|young women|young women
4992904|NCT04038060|HIV infections/prevention|hiv infections/prevention
4992905|NCT04038060|SMART design|smart design
4992907|NCT04038047|CFTR modulator|cftr modulator
4992908|NCT04038047|triple combination therapy|triple combination therapy
4992909|NCT04038021|Unstably Housed|unstably housed
4992910|NCT04038021|Homeless|homeless
4992911|NCT04038008|fluconazole|fluconazole
4992920|NCT04037904|Gastric H+, K+- APTase|gastric h+, k+- aptase
4992921|NCT04037878|TAP block|tap block
4992922|NCT04037878|Local infiltration|local infiltration
4992923|NCT04037878|Tramadol|tramadol
4992924|NCT04037878|Gynecological surgery|gynecological surgery
4992925|NCT04037878|Pain control|pain control
4992926|NCT04037852|nipple sparing mastectomy|nipple sparing mastectomy
4992927|NCT04037852|robotic nipple sparing mastectomy (R-NSM)|robotic nipple sparing mastectomy (r-nsm)
4992928|NCT04037852|conventional nipple sparing mastectomy (C-NSM)|conventional nipple sparing mastectomy (c-nsm)
4992929|NCT04037852|endoscopic assisted nipple sparing mastectomy (E-NSM)|endoscopic assisted nipple sparing mastectomy (e-nsm)
4992930|NCT04037852|immediate breast reconstruction (IBR)|immediate breast reconstruction (ibr)
4992931|NCT04037852|immediate prothesis breast reconstruction (IPBR)|immediate prothesis breast reconstruction (ipbr)
4992932|NCT04037826|irritable bowel syndrome, adults, L. reuteri|irritable bowel syndrome, adults, l. reuteri
4992933|NCT04037813|Hysteroscopy|hysteroscopy
4992934|NCT04037813|Laparoscopy|laparoscopy
4992935|NCT04037813|Hydrosalpinx|hydrosalpinx
4992936|NCT04037800|Prostate cancer|prostate cancer
4992937|NCT04037800|Prostatectomy|prostatectomy
4992938|NCT04037800|Robotic surgery|robotic surgery
4992939|NCT04037800|Urinary incontinence|urinary incontinence
4993331|NCT04035564|Sodium|sodium
4992941|NCT04037774|analgesia,|analgesia,
4992942|NCT04037774|spinal block|spinal block
4992943|NCT04037774|dexmedetomidine|dexmedetomidine
4992944|NCT04037774|bupivacaine|bupivacaine
4992945|NCT04037774|selective spinal anesthesia|selective spinal anesthesia
4992946|NCT04037761|early child development|early child development
4992947|NCT04037761|cohort study|cohort study
4992948|NCT04037761|education|education
4992949|NCT04037748|Eutirox®|eutirox®
4992950|NCT04037748|Puran T4®|puran t4®
4992951|NCT04037748|Levothyroxine|levothyroxine
4992952|NCT04037735|Comparative Study|comparative study
4992953|NCT04037735|Knee Prosthesis|knee prosthesis
4992954|NCT04037735|Prosthesis Design|prosthesis design
4992955|NCT04037735|Treatment Outcome|treatment outcome
4992956|NCT04037735|Follow-Up Studies|follow-up studies
4992957|NCT04037722|Cardiac Output|cardiac output
4992958|NCT04037722|Endotoxemia|endotoxemia
4992959|NCT04037722|Ketone bodies|ketone bodies
4992960|NCT04037722|3-hydroxy butyrate|3-hydroxy butyrate
4992961|NCT04037722|Whey protein|whey protein
4992962|NCT04037722|Catabolic State|catabolic state
4992963|NCT04037683|induction of labour|induction of labour
4992964|NCT04037683|intrapartum fetal monitoring|intrapartum fetal monitoring
4992965|NCT04037683|qualitative|qualitative
4992966|NCT04037683|semi-structured interview|semi-structured interview
4992967|NCT04037683|focus groups|focus groups
4992970|NCT04037579|physical activity|physical activity
4992971|NCT04037579|self-determination|self-determination
4992972|NCT04037579|Social inclusion|social inclusion
4992973|NCT04037579|Well-being|well-being
4992974|NCT04037579|Rights|rights
4992975|NCT04037579|Interpersonal relations|interpersonal relations
4992976|NCT04037566|Leukemia Lymphocytic Acute|leukemia lymphocytic acute
4992977|NCT04037566|Lymphoma, B-Cell|lymphoma, b-cell
4992978|NCT04037553|Endotracheal tube cuff pressure|endotracheal tube cuff pressure
4992979|NCT04037553|Ear Surgery|ear surgery
4992980|NCT04037553|Head and Neck Surgery|head and neck surgery
4992981|NCT04037553|Position|position
4992982|NCT04037540|Jones fracture|jones fracture
4992983|NCT04037540|The American Orthopaedic Foot & Ankle Society (AOFAS)|the american orthopaedic foot & ankle society (aofas)
4992984|NCT04037540|Herbert screw|herbert screw
4992987|NCT04037501|Caregiver of people with dementia|caregiver of people with dementia
4992988|NCT04037501|Caregiver health|caregiver health
4992989|NCT04037501|Care management system|care management system
4992990|NCT04037501|Collaborative care|collaborative care
4992991|NCT04037501|Informal care coordination|informal care coordination
4992992|NCT04037501|Dementia|dementia
4992993|NCT04037501|Medical management|medical management
4992994|NCT04037501|Unmet needs|unmet needs
4992995|NCT04037488|Androgen deprivation therapy|androgen deprivation therapy
4992996|NCT04037488|Prostate cancer|prostate cancer
4992997|NCT04037488|Body composition|body composition
4992998|NCT04037488|Lean body mass|lean body mass
4992999|NCT04037475|photodynamic therapy|photodynamic therapy
4993000|NCT04037475|herpes labialis|herpes labialis
4993007|NCT04037436|Frailty|frailty
4993008|NCT04037436|Feasibility|feasibility
4993009|NCT04037397|Pulmonary Vein Isolation|pulmonary vein isolation
4993010|NCT04037371|Cold exposure|cold exposure
4993011|NCT04037371|white fat cells|white fat cells
4993012|NCT04037371|thermoregulation|thermoregulation
4993014|NCT04037345|human umbilical cord blood derived mesenchymal stem cells|human umbilical cord blood derived mesenchymal stem cells
4993016|NCT04037306|Fiber|fiber
4993017|NCT04037293|SLE|sle
4993018|NCT04037293|Atherosclerosis|atherosclerosis
4993019|NCT04037293|carotid intima media thickness|carotid intima media thickness
4993020|NCT04037293|brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
4993021|NCT04037293|risk factors|risk factors
4993022|NCT04037293|Cohort|cohort
4993023|NCT04037280|Urinary|urinary
4993024|NCT04037280|Exercise|exercise
4993025|NCT04037280|Posology|posology
4993026|NCT04037215|eye tracking|eye tracking
4993027|NCT04037215|cognitive processing|cognitive processing
4993028|NCT04037202|analgesia|analgesia
4993029|NCT04037202|massage|massage
4993030|NCT04037202|midwifery|midwifery
4993031|NCT04037202|pain|pain
4993032|NCT04037202|postpartum period|postpartum period
4993033|NCT04037176|Omalizumab|omalizumab
4993034|NCT04037176|Xolair|xolair
4993035|NCT04037163|Fractional flow reserve|fractional flow reserve
4993036|NCT04037163|Coronary CT angiography|coronary ct angiography
4993037|NCT04037163|Atherosclerosis|atherosclerosis
4993038|NCT04037150|NSCLC|nsclc
4993039|NCT04037150|cfDNA|cfdna
4993434|NCT04034771|melatonin|melatonin
4993047|NCT04037124|Radiotherapy|radiotherapy
4993049|NCT04037059|Activities of Daily Living (ADL)|activities of daily living (adl)
4993050|NCT04037059|Complex Spinal Fusion|complex spinal fusion
4993051|NCT04037007|Precut sphincterotomy|precut sphincterotomy
4993052|NCT04037007|Fistulotomy|fistulotomy
4993053|NCT04037007|Biliary cannulation|biliary cannulation
4993054|NCT04037007|Efficacy|efficacy
4993055|NCT04036994|photomodulation therapy|photomodulation therapy
4993056|NCT04036994|supportive cancer care|supportive cancer care
4993057|NCT04036994|epirubicin cyclophosphamide|epirubicin cyclophosphamide
4993058|NCT04036981|Stroke|stroke
4993059|NCT04036981|Muscle spasticity|muscle spasticity
4993060|NCT04036981|Botulinum toxin A|botulinum toxin a
4993064|NCT04036955|dementia|dementia
4993065|NCT04036955|Alzheimer's disease|alzheimer's disease
4993066|NCT04036955|patient care|patient care
4993067|NCT04036955|home care|home care
4993068|NCT04036942|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
4993069|NCT04036942|ARAT|arat
4993070|NCT04036942|ARMS|arms
4993071|NCT04036916|Concussion|concussion
4993072|NCT04036916|Injury prevention|injury prevention
4993073|NCT04036903|Lung nodules|lung nodules
4993074|NCT04036903|Deep learning|deep learning
4993075|NCT04036890|Recurrent periodontitis|recurrent periodontitis
4993076|NCT04036890|Periodontal therapy|periodontal therapy
4993077|NCT04036864|Singers|singers
4993078|NCT04036825|Liquid Nutritional Supplement|liquid nutritional supplement
4993079|NCT04036799|Pediatric|pediatric
4993080|NCT04036799|Risk Prediction|risk prediction
4993081|NCT04036786|pre-eclampsia|pre-eclampsia
4993082|NCT04036786|pregnancy|pregnancy
4993083|NCT04036786|healthy lifestyle|healthy lifestyle
4993084|NCT04036786|self efficacy|self efficacy
4993085|NCT04036773|diet|diet
4993086|NCT04036773|nutrition|nutrition
4993087|NCT04036773|hyperlipidemia|hyperlipidemia
4993088|NCT04036773|produce|produce
4993100|NCT04036669|rheumatoid arthritis, adipokines, foot function index, f-BMD|rheumatoid arthritis, adipokines, foot function index, f-bmd
4993101|NCT04036643|Rectal neoplasm|rectal neoplasm
4993102|NCT04036643|Imaging TEP/MRI|imaging tep/mri
4993103|NCT04036643|response assessement|response assessement
4993104|NCT04036604|Pelvic floor exercise|pelvic floor exercise
4993105|NCT04036604|Urinary incontinence|urinary incontinence
4993106|NCT04036604|Sexual dysfunction|sexual dysfunction
4993107|NCT04036591|Clinical scale|clinical scale
4993108|NCT04036591|infant|infant
4993109|NCT04036591|respiratory therapy|respiratory therapy
4993115|NCT04036565|depression|depression
4993116|NCT04036565|daily active function|daily active function
4993117|NCT04036565|stroke|stroke
4993128|NCT04036513|Periodontitis|periodontitis
4993129|NCT04036513|MINST|minst
4993130|NCT04036513|Scaling and root planing|scaling and root planing
4993131|NCT04036513|Split mouth|split mouth
4993132|NCT04036513|3D analysis|3d analysis
4993133|NCT04036461|Multiple Myeloma|multiple myeloma
4993134|NCT04036461|Relapsed and refractory|relapsed and refractory
4993135|NCT04036461|CC-99712|cc-99712
4993136|NCT04036461|BCMA|bcma
4993137|NCT04036461|Antibody drug conjugate|antibody drug conjugate
4993138|NCT04036448|REVLIMID®|revlimid®
4993139|NCT04036448|Lenalidomide|lenalidomide
4993140|NCT04036448|Observational|observational
4993141|NCT04036448|Korea|korea
4993142|NCT04036448|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
4993143|NCT04036448|Relapsed and Refractory Mantle cell lymphoma|relapsed and refractory mantle cell lymphoma
4993144|NCT04036448|IPSS Low- or intermediate-1-risk Myelodysplastic Syndromes Associated with a deletion 5q|ipss low- or intermediate-1-risk myelodysplastic syndromes associated with a deletion 5q
4993146|NCT04036422|neuronal plasticity|neuronal plasticity
4993147|NCT04036422|cognition|cognition
4993148|NCT04036422|hemiplegia|hemiplegia
4993149|NCT04036422|Remote rehabilitation|remote rehabilitation
4993150|NCT04036396|HIV prevention and testing|hiv prevention and testing
4993151|NCT04036396|sexually transmitted disease (STD) prevention and testing|sexually transmitted disease (std) prevention and testing
4993152|NCT04036396|HIV pre-exposure prophylaxis (PrEP)|hiv pre-exposure prophylaxis (prep)
4993153|NCT04036396|Incarceration|incarceration
4993154|NCT04036370|pectoral nerve block (pecs block)|pectoral nerve block (pecs block)
4993155|NCT04036370|breast cancer|breast cancer
4993156|NCT04036370|postoperative pain|postoperative pain
4993157|NCT04036370|numeric rating scale score (NRS score)|numeric rating scale score (nrs score)
4993159|NCT04036357|Liver fibrosis|liver fibrosis
4993160|NCT04036357|Cardiovascular|cardiovascular
4993161|NCT04036318|Sexually Transmitted Infections|sexually transmitted infections
4993162|NCT04036318|Periodic Presumptive Treatment|periodic presumptive treatment
4993163|NCT04036305|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
4993164|NCT04036305|Local Anesthesia Resistance|local anesthesia resistance
4993165|NCT04036279|NANOS|nanos
4993166|NCT04036279|Hip|hip
4993167|NCT04036279|Neck Preserving Stem|neck preserving stem
4993168|NCT04036253|epoetin|epoetin
4993169|NCT04036253|erythropoietin|erythropoietin
4993170|NCT04036253|Eprex|eprex
4993171|NCT04036253|Hemax|hemax
4993172|NCT04036253|Anemia|anemia
4993173|NCT04036253|Chronic Kidney Disease|chronic kidney disease
4993174|NCT04036253|pre-dialysis|pre-dialysis
4993175|NCT04036240|low birth weight infant|low birth weight infant
4993176|NCT04036240|breast milk supplementation|breast milk supplementation
4993177|NCT04036240|finger feeding|finger feeding
4993178|NCT04036201|Peribulbar block|peribulbar block
4993179|NCT04036201|minimum effective volume|minimum effective volume
4993180|NCT04036201|axial eye length|axial eye length
4993181|NCT04036162|Aging|aging
4993182|NCT04036162|Task-Positive Network (TPN)|task-positive network (tpn)
4993183|NCT04036162|Task-Negative Network (TNN)|task-negative network (tnn)
4993184|NCT04036162|MagnetoEncephaloGraphy (MEG)|magnetoencephalography (meg)
4993185|NCT04036162|Verticality|verticality
4993186|NCT04036162|Language|language
4993187|NCT04036162|Hemispheric asymmetry|hemispheric asymmetry
4993188|NCT04036123|Urodynamic investigation|urodynamic investigation
4993189|NCT04036123|Lower urinary tract dysfunction|lower urinary tract dysfunction
4993190|NCT04036123|Water-perfused catheter|water-perfused catheter
4993191|NCT04036123|Air-charged catheter|air-charged catheter
4993192|NCT04036110|Vitamin C supplementation|vitamin c supplementation
4993193|NCT04036097|secondary immunodeficiencies|secondary immunodeficiencies
4993194|NCT04036097|disease-modifying treatments (DMT)|disease-modifying treatments (dmt)
4993195|NCT04036097|immunosuppressive therapy|immunosuppressive therapy
4993196|NCT04036097|serious infection|serious infection
4993197|NCT04036097|respiratory tract infections (RTI)|respiratory tract infections (rti)
4993198|NCT04036097|urinary tract infections|urinary tract infections
4993200|NCT04036097|Swiss MS Cohort (SMSC)|swiss ms cohort (smsc)
4993201|NCT04036097|SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation) studies|summit (serially unified multicenter multiple sclerosis investigation) studies
4993202|NCT04036071|HA (hydroxylapatite) coated SL-PLUS™ MIA stem|ha (hydroxylapatite) coated sl-plus™ mia stem
4993203|NCT04036058|Clostridium difficile|clostridium difficile
4996535|NCT04015557|Cysteine|cysteine
4993209|NCT04035993|Automotive Technology|automotive technology
4993210|NCT04035993|Hypoglycemia|hypoglycemia
4993211|NCT04035993|Hypoglycaemia|hypoglycaemia
4993212|NCT04035993|Driving|driving
4993213|NCT04035993|Driving simulator|driving simulator
4993214|NCT04035980|Screening|screening
4993215|NCT04035980|Telemedicine|telemedicine
4993216|NCT04035980|Diagnosis|diagnosis
4993217|NCT04035967|Physical Disabilities|physical disabilities
4993218|NCT04035967|Anxiety Level|anxiety level
4993219|NCT04035967|Health Related Quality of Life|health related quality of life
4993220|NCT04035967|Parents'|parents'
4993221|NCT04035967|cerebral palsy|cerebral palsy
4993222|NCT04035954|Cerebral Palsy|cerebral palsy
4993223|NCT04035954|modified pilates|modified pilates
4993224|NCT04035954|trunk|trunk
4993225|NCT04035954|gait|gait
4993226|NCT04035954|function|function
4993227|NCT04035954|core stability|core stability
4993228|NCT04035941|physical activity|physical activity
4993229|NCT04035941|cycling|cycling
4993230|NCT04035928|prosthetic treatment|prosthetic treatment
4993231|NCT04035928|rhinectomy|rhinectomy
4993232|NCT04035915|Limited driving pressure|limited driving pressure
4993233|NCT04035915|Low tidal volume|low tidal volume
4993234|NCT04035915|Lung injury score|lung injury score
4993235|NCT04035902|iron|iron
4993236|NCT04035902|arthroplasty|arthroplasty
4993237|NCT04035902|red blood cell|red blood cell
4993238|NCT04035889|Sleep|sleep
4993239|NCT04035889|Melatonin|melatonin
4993240|NCT04035889|Sleep disturbance|sleep disturbance
4993241|NCT04035876|Camrelizumab|camrelizumab
4993242|NCT04035876|Apatinib|apatinib
4993244|NCT04035876|Liver transplantation|liver transplantation
4993245|NCT04035824|Gastrodia and Uncaria|gastrodia and uncaria
4993246|NCT04035824|Stage one Hypertension|stage one hypertension
4993247|NCT04035824|Liver yang hyperactivity|liver yang hyperactivity
4993248|NCT04035811|Skeletal dysplasia|skeletal dysplasia
4993249|NCT04035811|Endochondral ossification|endochondral ossification
4993251|NCT04035811|Shortened proximal limbs|shortened proximal limbs
4993252|NCT04035811|Fibroblast growth factor receptor 3|fibroblast growth factor receptor 3
4993253|NCT04035811|FGFR3|fgfr3
4993254|NCT04035811|Endochondral bone formation|endochondral bone formation
4993255|NCT04035811|Short-limb disproportionate dwarfism|short-limb disproportionate dwarfism
4993256|NCT04035811|Bone disease|bone disease
4993257|NCT04035811|Dwarfism|dwarfism
4993258|NCT04035811|Bone diseases|bone diseases
4993259|NCT04035811|Musculoskeletal diseases|musculoskeletal diseases
4993260|NCT04035811|Osteochondrodysplasia|osteochondrodysplasia
4993261|NCT04035811|Genetic diseases|genetic diseases
4993262|NCT04035811|Inborn|inborn
4993263|NCT04035785|Kangfu Anti-inflammatory Suppository|kangfu anti-inflammatory suppository
4993264|NCT04035785|efficacy and safety|efficacy and safety
4993265|NCT04035785|recurrence rate|recurrence rate
4993266|NCT04035785|randomized|randomized
4993267|NCT04035785|double blind|double blind
4993268|NCT04035785|parallel control|parallel control
4993269|NCT04035785|multi-center clinical study|multi-center clinical study
4993270|NCT04035772|interrupted time series|interrupted time series
4993271|NCT04035772|wiki|wiki
4993272|NCT04035772|quality improvement|quality improvement
4993273|NCT04035772|knowledge translation|knowledge translation
4993274|NCT04035772|trauma care|trauma care
4993275|NCT04035772|stakeholder engagement|stakeholder engagement
4993276|NCT04035772|adaptating knowledge tools|adaptating knowledge tools
4993277|NCT04035746|Microcirculation|microcirculation
4993278|NCT04035746|Plasticity|plasticity
4993279|NCT04035746|Cohort studies|cohort studies
4993280|NCT04035720|decision making|decision making
4993281|NCT04035720|therapeutic|therapeutic
4993282|NCT04035720|disease modifying agents|disease modifying agents
4993283|NCT04035720|monoclonal antobodies|monoclonal antobodies
4993284|NCT04035720|physicians|physicians
4993285|NCT04035720|neurologists|neurologists
4993286|NCT04035720|uncertainty|uncertainty
4993287|NCT04035720|neuroeconomics|neuroeconomics
4993288|NCT04035707|general anaesthesia|general anaesthesia
4993289|NCT04035707|mast cell|mast cell
4993290|NCT04035707|rocuronium|rocuronium
4993291|NCT04035707|tryptase|tryptase
4993292|NCT04035694|Adolescent sexual health|adolescent sexual health
4993293|NCT04035694|Media literacy education|media literacy education
4993294|NCT04035694|Web-based programming|web-based programming
4993295|NCT04035668|Sjogren Syndrome|sjogren syndrome
4993310|NCT04035668|Autoimmune Diseases|autoimmune diseases
4993315|NCT04035655|Electrophysiological signatures of consciousness|electrophysiological signatures of consciousness
4993317|NCT04035629|BPD|bpd
4993318|NCT04035616|microbial cell preparation|microbial cell preparation
4993319|NCT04035616|Hexbio®|hexbio®
4993320|NCT04035616|probiotics|probiotics
4993321|NCT04035616|elderly|elderly
4993322|NCT04035616|chronic medical conditions|chronic medical conditions
4993323|NCT04035616|constipation,|constipation,
4993324|NCT04035590|Mastectomy|mastectomy
4993326|NCT04035577|Mental health|mental health
4993327|NCT04035577|App|app
4993328|NCT04035577|Mobile phone|mobile phone
4993329|NCT04035577|Stress management|stress management
4993330|NCT04035564|Preterm infant|preterm infant
4993332|NCT04035564|Hyponatremia|hyponatremia
4993333|NCT04035551|Home|home
4993334|NCT04035551|HPN|hpn
4993335|NCT04035551|Homecare|homecare
4993336|NCT04035538|CKD-320|ckd-320
4993337|NCT04035512|Bariatric surgery|bariatric surgery
4993338|NCT04035512|Expressive writing|expressive writing
4993339|NCT04035512|Obesity|obesity
4993340|NCT04035512|Alexithymia|alexithymia
4993341|NCT04035512|Adherence|adherence
4993342|NCT04035486|Locally|locally
4993343|NCT04035486|Advanced|advanced
4993344|NCT04035486|Metastatic|metastatic
4993345|NCT04035486|Carcinoma|carcinoma
4993346|NCT04035486|Non-Small Cell Lung Cancer|non-small cell lung cancer
4993347|NCT04035486|Osimertinib|osimertinib
4989362|NCT04057924|HPV|hpv
4993348|NCT04035486|Tagrisso|tagrisso
4993349|NCT04035460|non-invasive ventilation|non-invasive ventilation
4993350|NCT04035447|Cancer|cancer
4993351|NCT04035447|Young Adult|young adult
4993352|NCT04035447|Behavioral Symptom Management|behavioral symptom management
4993353|NCT04035434|CAR T|car t
4993354|NCT04035434|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
4993355|NCT04035434|NHL|nhl
4993356|NCT04035434|Lymphoma|lymphoma
4993357|NCT04035434|Allogeneic|allogeneic
4993358|NCT04035421|Social Rhythm Metric|social rhythm metric
4993359|NCT04035421|Chronotype|chronotype
4993360|NCT04035421|Young adult|young adult
4993361|NCT04035395|Integrated Behavioral Health|integrated behavioral health
4993362|NCT04035395|Community Health Workers|community health workers
4993363|NCT04035382|BMI|bmi
4993364|NCT04035382|Obesity|obesity
4993365|NCT04035382|Labor induction|labor induction
4993366|NCT04035382|Cesarean section|cesarean section
4993367|NCT04035356|aortic valve repair|aortic valve repair
4993368|NCT04035356|aortic valve annuloplasty|aortic valve annuloplasty
4993369|NCT04035330|etidronate|etidronate
4993370|NCT04035330|postoperative pain|postoperative pain
4993371|NCT04035330|bacterial load reduction|bacterial load reduction
4993372|NCT04035330|sodium hypochlorite irrigation|sodium hypochlorite irrigation
4993373|NCT04035317|Fontan operation|fontan operation
4993374|NCT04035317|Aesculus hippocastanum|aesculus hippocastanum
4993375|NCT04035317|mesenteric artery resistance|mesenteric artery resistance
4993376|NCT04035291|Family Collaboration,|family collaboration,
4993377|NCT04035291|high risk of CP|high risk of cp
4993378|NCT04035291|physiotherapy|physiotherapy
4993379|NCT04035252|Functional response|functional response
4993380|NCT04035252|Abdominal aortic aneurysm|abdominal aortic aneurysm
4993381|NCT04035252|Carotid artery|carotid artery
4993382|NCT04035174|Health Public|health public
4993384|NCT04035109|nasal allergy|nasal allergy
4993385|NCT04035109|house dust mite|house dust mite
4993386|NCT04035109|cat|cat
4993387|NCT04035096|high dose vitamin C|high dose vitamin c
4993388|NCT04035096|very low carbohydrate diet|very low carbohydrate diet
4993389|NCT04035070|antibiotic-containg solution|antibiotic-containg solution
4993390|NCT04035070|co-amoxiclav-clindamycin solution|co-amoxiclav-clindamycin solution
4993391|NCT04035070|MTAD|mtad
4993392|NCT04035070|sodium hypochlorite|sodium hypochlorite
4993393|NCT04035070|postoperative pain|postoperative pain
4993394|NCT04035070|antimicrobial efficacy|antimicrobial efficacy
4993395|NCT04035070|root canal irrigation|root canal irrigation
4993396|NCT04035057|Therapist Training|therapist training
4993397|NCT04035057|Exposure Therapy|exposure therapy
4993398|NCT04035057|Experimental Therapeutics|experimental therapeutics
4993399|NCT04034992|Observational study|observational study
4993400|NCT04034992|Real-world data|real-world data
4993401|NCT04034992|Prospective and retrospective data capture|prospective and retrospective data capture
4993402|NCT04034992|DISCOVER CKD|discover ckd
4993403|NCT04034979|decision aid|decision aid
4993404|NCT04034979|ICU|icu
4993405|NCT04034979|goals-of-care|goals-of-care
4993406|NCT04034979|videotaping|videotaping
4993414|NCT04034953|Prostate Cancer|prostate cancer
4993415|NCT04034953|Obesity|obesity
4993416|NCT04034953|Obesity-related Cancer|obesity-related cancer
4993417|NCT04034953|Multi-Cancer Screening|multi-cancer screening
4993418|NCT04034875|Acquired cerebral lesion|acquired cerebral lesion
4993419|NCT04034875|Anger|anger
4993420|NCT04034875|Agression|agression
4993421|NCT04034849|Low-level Laser Therapy|low-level laser therapy
4993422|NCT04034849|Burning Mouth Syndrome|burning mouth syndrome
4993423|NCT04034849|Photobiomodulation|photobiomodulation
4993424|NCT04034849|Visual Analogue Scale|visual analogue scale
4993425|NCT04034849|Oral Health Impact Profile|oral health impact profile
4993426|NCT04034849|Clinical Trial|clinical trial
4993427|NCT04034836|Pain, Postoperative|pain, postoperative
4993428|NCT04034836|Parecoxib|parecoxib
4993429|NCT04034836|Ropivacaine|ropivacaine
4993430|NCT04034836|Scalp nerve blocks|scalp nerve blocks
4993431|NCT04034836|Craniotomy|craniotomy
4993432|NCT04034823|HER2-positive breast cancer|her2-positive breast cancer
4993433|NCT04034823|PD-L1 immune checkpoint|pd-l1 immune checkpoint
4993443|NCT04034719|Carrying|carrying
4993444|NCT04034719|Skin-to-skin|skin-to-skin
4993445|NCT04034719|Scarf|scarf
4993446|NCT04034680|Behavioral symptoms|behavioral symptoms
4993447|NCT04034680|Dementia|dementia
4993448|NCT04034680|Nevropsychiatric symptoms|nevropsychiatric symptoms
4993449|NCT04034680|Psychological symptoms|psychological symptoms
4993450|NCT04034680|The TIME model|the time model
4993451|NCT04034667|Lung Cancer|lung cancer
4993452|NCT04034667|Imaging features|imaging features
4993453|NCT04034667|Driving genes|driving genes
4993454|NCT04034667|Prediction|prediction
4993455|NCT04034667|Therapy response|therapy response
4993456|NCT04034654|preschool child|preschool child
4993457|NCT04034654|behavior|behavior
4993458|NCT04034654|anesthesia|anesthesia
4993459|NCT04034654|surgery|surgery
4993463|NCT04034602|stroke vibration fall risk postural stability|stroke vibration fall risk postural stability
4993464|NCT04034602|immediate effect|immediate effect
4993465|NCT04034602|fall risk|fall risk
4993466|NCT04034602|postural stability|postural stability
4993467|NCT04034576|Mindfulness-based intervention|mindfulness-based intervention
4993468|NCT04034576|Session-introducing interventions|session-introducing interventions
4993469|NCT04034576|Child and adolescent psychotherapy|child and adolescent psychotherapy
4993470|NCT04034576|Cognitive-behavioral therapy|cognitive-behavioral therapy
4993471|NCT04034576|Therapeutic alliance|therapeutic alliance
4993472|NCT04034576|Depressive disorder|depressive disorder
4993473|NCT04034576|Hyperkinetic disorder|hyperkinetic disorder
4993474|NCT04034576|Anxiety disorder|anxiety disorder
4993475|NCT04034550|leptospirosis|leptospirosis
4993476|NCT04034550|hospitalization|hospitalization
4993477|NCT04034537|Coronary Artery Disease|coronary artery disease
4993478|NCT04034537|cardiac Phase Space Tomography Analysis|cardiac phase space tomography analysis
4993479|NCT04034537|ischemia|ischemia
4993480|NCT04034511|nutrition|nutrition
4993481|NCT04034511|medically-tailored meals|medically-tailored meals
4993482|NCT04034485|LDL cholesterol|ldl cholesterol
5301453|NCT02169141|MDR-TB|mdr-tb
4993483|NCT04034485|PCSK9 inhibition|pcsk9 inhibition
4993484|NCT04034472|obesity|obesity
4993485|NCT04034472|comorbidities|comorbidities
4993486|NCT04034472|inflammation|inflammation
4993487|NCT04034472|digital technology|digital technology
4993488|NCT04034472|metabolic alterations|metabolic alterations
4993489|NCT04034459|FIRE|fire
4993490|NCT04034459|mCRC|mcrc
4993491|NCT04034459|AIO|aio
4993492|NCT04034459|BRAF|braf
4993493|NCT04034459|FOLFOXIRI|folfoxiri
4993498|NCT04034446|B-ALL|b-all
4993499|NCT04034433|Arteriovenous Fistula Diameter|arteriovenous fistula diameter
4993500|NCT04034433|Handgrip|handgrip
4993501|NCT04034433|Program exercise|program exercise
4993502|NCT04034433|Maturation|maturation
4993503|NCT04034420|Online platform|online platform
4993504|NCT04034420|ICT|ict
4993505|NCT04034420|Family services|family services
4993506|NCT04034394|Knee Osteoarthritis|knee osteoarthritis
4993507|NCT04034381|Micronutrient deficiency|micronutrient deficiency
4993508|NCT04034381|Dietary intake|dietary intake
4993509|NCT04034381|Food fortification|food fortification
4993510|NCT04034381|National survey|national survey
4993515|NCT04034342|RaceRunning;|racerunning;
4993516|NCT04034342|cardiometabolic health desease risk|cardiometabolic health desease risk
4993517|NCT04034342|functional mobility|functional mobility
4993518|NCT04034329|ASVAL|asval
4993519|NCT04034329|EVLA|evla
4993520|NCT04034329|GSV|gsv
4993530|NCT04034290|vector vaccines|vector vaccines
4993531|NCT04034277|Voice Disorders|voice disorders
4993532|NCT04034277|Speech and language therapy|speech and language therapy
4993533|NCT04034277|Lee Silverman voice treatment|lee silverman voice treatment
4993563|NCT04034147|objective cognition|objective cognition
4993564|NCT04034147|quality of life|quality of life
4993565|NCT04034147|medication adherence|medication adherence
4993566|NCT04034121|biorersorbable scaffold|biorersorbable scaffold
4993567|NCT04034121|drug eluting|drug eluting
4993568|NCT04034121|novolimus|novolimus
4993569|NCT04034108|surgical intervention|surgical intervention
4993570|NCT04034108|decompression|decompression
4993571|NCT04034108|walking training|walking training
4993572|NCT04034108|functional recovery|functional recovery
4993573|NCT04034108|spinal cord injury|spinal cord injury
4993574|NCT04034082|cardiovascular disease|cardiovascular disease
4993575|NCT04034082|rehabilitation|rehabilitation
4993576|NCT04034082|exercise|exercise
4993577|NCT04034069|stroke|stroke
4993578|NCT04034069|theta burst stimulation|theta burst stimulation
4993579|NCT04034069|upper limb|upper limb
4993580|NCT04034069|metaplasticity|metaplasticity
4993581|NCT04034069|priming|priming
4993582|NCT04034043|ceramic-on-ceramic|ceramic-on-ceramic
4993583|NCT04034043|total hip arthroplasty|total hip arthroplasty
4993584|NCT04034043|acetabular fracture|acetabular fracture
4993585|NCT04034043|post-traumatic hip osteoarthritis|post-traumatic hip osteoarthritis
4993586|NCT04034030|magnetic brain stimulation|magnetic brain stimulation
4993587|NCT04034017|College students|college students
4993588|NCT04034017|Gastroesophageal reflux disease|gastroesophageal reflux disease
4993589|NCT04034017|GERD|gerd
4993590|NCT04034017|Prevalence|prevalence
4993591|NCT04034017|Perceived stress|perceived stress
4993593|NCT04034004|Opioids|opioids
4993594|NCT04034004|Pain|pain
4993595|NCT04034004|Naloxone|naloxone
4993596|NCT04033991|Carcinoma;|carcinoma;
4993597|NCT04033991|renal cell;|renal cell;
4993598|NCT04033991|cancer;|cancer;
4993599|NCT04033991|kidney;|kidney;
4993600|NCT04033991|sunitinib;|sunitinib;
4993601|NCT04033991|axitinib|axitinib
4993602|NCT04033978|Schizophrenia|schizophrenia
4993603|NCT04033978|Cognitive remediation|cognitive remediation
4993604|NCT04033978|Jumping to Conclusion|jumping to conclusion
4993611|NCT04033900|Active preoperative warming|active preoperative warming
4993612|NCT04033900|Inadvertent hypothermia|inadvertent hypothermia
4993613|NCT04033900|Perioperative hypothermia|perioperative hypothermia
4993614|NCT04033900|Surgical prewarming|surgical prewarming
4993615|NCT04033900|Forced air warming|forced air warming
4993616|NCT04033887|Diagnosis|diagnosis
4993617|NCT04033887|HIV coinfection|hiv coinfection
4993618|NCT04033887|Rapid diagnostic test|rapid diagnostic test
4993619|NCT04033874|Heel stick|heel stick
4993620|NCT04033874|Newborn|newborn
4993621|NCT04033874|NIPS|nips
4993622|NCT04033874|Pain levels|pain levels
4993623|NCT04033874|Crying times|crying times
5705249|NCT00482690|reduction|reduction
4993624|NCT04033874|Voice decibels|voice decibels
4993625|NCT04033861|ST Segment Elevated Myocardial Infarction|st segment elevated myocardial infarction
4993626|NCT04033861|rhBNP|rhbnp
4993627|NCT04033861|cardiac magnetic resonance|cardiac magnetic resonance
4993628|NCT04033861|Microvascular disease|microvascular disease
4993629|NCT04033861|ventricular remodeling|ventricular remodeling
4993640|NCT04033783|Six minute walk test|six minute walk test
4993641|NCT04033783|Field test|field test
4993642|NCT04033783|Exercise capacity|exercise capacity
4993643|NCT04033783|Functional capacity|functional capacity
4993644|NCT04033770|Urodynamic investigation|urodynamic investigation
4993645|NCT04033770|Lower urinary tract dysfunction|lower urinary tract dysfunction
4993646|NCT04033770|Water-perfused catheter|water-perfused catheter
4993647|NCT04033770|Air-charged catheter|air-charged catheter
4993648|NCT04033757|osteoarthritis|osteoarthritis
4993649|NCT04033757|cohort study|cohort study
4993650|NCT04033757|population-based|population-based
4993651|NCT04033744|Molar, Third|molar, third
4993652|NCT04033744|Platelet-Rich Fibrin|platelet-rich fibrin
4993655|NCT04033705|Perioperative|perioperative
4993660|NCT04033679|Medication adherence|medication adherence
4993661|NCT04033666|asthma|asthma
4993662|NCT04033666|High flow nasal cannula|high flow nasal cannula
4993663|NCT04033666|Non invasive ventilation|non invasive ventilation
4993664|NCT04033640|G6PD deficiency|g6pd deficiency
4993665|NCT04033627|In Vitro T cell depletion|in vitro t cell depletion
4993666|NCT04033627|haploidentical transplantation|haploidentical transplantation
4993667|NCT04033627|GVHD|gvhd
4993668|NCT04033627|leukemia|leukemia
4993669|NCT04033627|TCRab|tcrab
4993670|NCT04033627|CD45RA|cd45ra
4993671|NCT04033627|CliniMACS|clinimacs
4993672|NCT04033614|Laparotomy, open abdomen, fascia, retraction, intraabdominal oedema|laparotomy, open abdomen, fascia, retraction, intraabdominal oedema
4993673|NCT04033601|latent class analysis|latent class analysis
4993674|NCT04033601|causal-pie analysis|causal-pie analysis
4993675|NCT04033601|sleep quality|sleep quality
4993676|NCT04033601|precision medicine|precision medicine
4993677|NCT04033601|older adults|older adults
4993678|NCT04033601|sleep medicine|sleep medicine
4993679|NCT04033549|Acute pancreatitis|acute pancreatitis
4993680|NCT04033549|Thoracic ultrasound|thoracic ultrasound
4993681|NCT04033536|Spine metastasis|spine metastasis
4993682|NCT04033536|Stereotactic spine radiosurgery|stereotactic spine radiosurgery
4993683|NCT04033536|Target definition|target definition
4993684|NCT04033523|heart failure|heart failure
4993685|NCT04033523|exercise|exercise
4993686|NCT04033523|microparticles|microparticles
4993687|NCT04033523|thrombin|thrombin
4993688|NCT04033510|atrial fibrillation|atrial fibrillation
4993689|NCT04033510|cognitive symptoms|cognitive symptoms
4993690|NCT04033510|executive dysfunction|executive dysfunction
4993691|NCT04033510|cognitive change|cognitive change
4993692|NCT04033510|cognitive impairment|cognitive impairment
4993693|NCT04033510|tablet-based cognitive evaluation|tablet-based cognitive evaluation
4993694|NCT04033510|Cambridge Cognition|cambridge cognition
4993695|NCT04033510|CANTAB|cantab
4993696|NCT04033510|Afib|afib
4993697|NCT04033497|Brain Tumor|brain tumor
4993698|NCT04033484|extralevator abdominoperineal excision|extralevator abdominoperineal excision
4993699|NCT04033484|Perineal wound healing|perineal wound healing
4993700|NCT04033484|negative pressure wound therapy|negative pressure wound therapy
4993701|NCT04033484|biological mesh|biological mesh
4993702|NCT04033471|epidural, morphine, midazolam, acute postoperative pain|epidural, morphine, midazolam, acute postoperative pain
4993703|NCT04033406|Influenza A|influenza a
4993704|NCT04033393|Executive function|executive function
4993705|NCT04033393|Dual-task performance|dual-task performance
4993706|NCT04033393|Dual-task training|dual-task training
4993707|NCT04033380|Ceramic, Resin Bloc, Endocrown , Root Canal Treatment, Molar|ceramic, resin bloc, endocrown , root canal treatment, molar
4993708|NCT04033354|Locally Advanced or Metastatic|locally advanced or metastatic
4993709|NCT04033354|Squamous Non Small Cell Lung Cancer|squamous non small cell lung cancer
4993710|NCT04033302|T-ALL|t-all
4993711|NCT04033302|TCL|tcl
4993712|NCT04033302|AML|aml
4993713|NCT04033302|NK lymphoma|nk lymphoma
4993714|NCT04033302|CAR T|car t
4993715|NCT04033302|CD7|cd7
4993716|NCT04033237|Biomarkers of exposure|biomarkers of exposure
4993717|NCT04033237|Compensatory smoking|compensatory smoking
4993718|NCT04033237|Nicotine dependence|nicotine dependence
4993719|NCT04033237|Reduced nicotine cigarettes|reduced nicotine cigarettes
4993720|NCT04033237|Tobacco withdrawal|tobacco withdrawal
4993721|NCT04033237|Women|women
4993722|NCT04033237|Pregnancy|pregnancy
4993734|NCT04033146|Walking|walking
4993735|NCT04033146|Aging|aging
4993736|NCT04033146|Exoskeleton Device|exoskeleton device
4993737|NCT04033133|Multiple Sclerosis|multiple sclerosis
4993738|NCT04033133|tDCS|tdcs
4993739|NCT04033133|Cerebral Blood Flow|cerebral blood flow
4993740|NCT04033120|HIV|hiv
4993741|NCT04033120|talaromycosis|talaromycosis
4993742|NCT04033120|endemic mycoses|endemic mycoses
4993743|NCT04033120|opportunistic infections|opportunistic infections
4993744|NCT04033120|penicilliosis|penicilliosis
4993745|NCT04033120|Southeast Asia|southeast asia
4993746|NCT04033094|Abuse|abuse
4993747|NCT04033094|Misuse|misuse
4993748|NCT04033094|Overdose|overdose
4993749|NCT04033081|CivaSheet|civasheet
4993750|NCT04033081|IORT|iort
4993751|NCT04033081|Intraoperative Radiation Therapy|intraoperative radiation therapy
4993752|NCT04033081|Brachytherapy|brachytherapy
4993753|NCT04033068|Zika virus|zika virus
4993754|NCT04033068|mosquito-borne pathogen|mosquito-borne pathogen
4993755|NCT04033068|Zika fever|zika fever
4993756|NCT04033042|Non-invasive glucose monitoring|non-invasive glucose monitoring
4993757|NCT04033042|Raman spectroscopy|raman spectroscopy
4993758|NCT04033029|Acute kidney Injury|acute kidney injury
4993759|NCT04033029|Sepsis|sepsis
4997068|NCT04012411|Huntington Disease|huntington disease
4993760|NCT04033029|Antibiotic plasma level|antibiotic plasma level
4993762|NCT04033029|oXiris®|oxiris®
4993763|NCT04033003|Antenatal care|antenatal care
4993764|NCT04033003|Sub-Saharan Africa|sub-saharan africa
4993765|NCT04033003|Ghana|ghana
4993769|NCT04032951|EUS-guided biopsy|eus-guided biopsy
4993770|NCT04032938|Cardiopulmonary Bypass|cardiopulmonary bypass
4993771|NCT04032938|Gastrointestinal Microbiome|gastrointestinal microbiome
4993772|NCT04032938|Thoracic Surgery|thoracic surgery
4993773|NCT04032938|Metagenomics|metagenomics
4993774|NCT04032938|Metabolomics|metabolomics
4993775|NCT04032938|sepsis|sepsis
4993776|NCT04032912|Polyp resection|polyp resection
4993777|NCT04032912|Colorectal cancer|colorectal cancer
4993778|NCT04032899|Probiotics|probiotics
4993779|NCT04032899|Gestation|gestation
4993780|NCT04032899|Lactation|lactation
4993781|NCT04032899|Mastitis|mastitis
4993782|NCT04032886|kinesio tape|kinesio tape
4993783|NCT04032886|posture|posture
4993784|NCT04032886|elastography|elastography
4993785|NCT04032873|Distal Radius Fracture|distal radius fracture
4993786|NCT04032873|Cost|cost
4993787|NCT04032873|Buckle Fracture|buckle fracture
4993788|NCT04032860|tenofovir, HBV, HCC, nucleo(t)side analogues, Entecavir|tenofovir, hbv, hcc, nucleo(t)side analogues, entecavir
4993789|NCT04032834|Asthma|asthma
4993790|NCT04032834|Budesonide|budesonide
4993791|NCT04032834|Nebulizer|nebulizer
4993792|NCT04032834|Pharmacokinetics|pharmacokinetics
4993793|NCT04032834|AKITA JET|akita jet
4993794|NCT04032821|Pharmacokinetics|pharmacokinetics
4993795|NCT04032821|Alkotinib|alkotinib
4993796|NCT04032795|Major Depressive Disorder|major depressive disorder
4993797|NCT04032795|Lycium barbarum polysaccharide|lycium barbarum polysaccharide
4993798|NCT04032795|depressive symptoms|depressive symptoms
4993799|NCT04032795|anxious symptoms|anxious symptoms
4993800|NCT04032769|Pulmonary embolism|pulmonary embolism
4993801|NCT04032769|PERC Rule|perc rule
4993802|NCT04032769|Years Rule|years rule
4993803|NCT04032769|Peps Rule|peps rule
4993804|NCT04032769|Emergency department|emergency department
4993805|NCT04032717|microbicide|microbicide
4993806|NCT04032717|enema|enema
4993807|NCT04032717|receptive anal intercourse|receptive anal intercourse
4993808|NCT04032717|HIV prevention|hiv prevention
4993809|NCT04032717|HIV transmission|hiv transmission
4993815|NCT04032678|Cardioversion|cardioversion
4993816|NCT04032678|Cardiac Arrythmias|cardiac arrythmias
4993817|NCT04032678|Myocardial Injury|myocardial injury
4993818|NCT04032678|Defibrillators|defibrillators
4993819|NCT04032678|Biomarkers|biomarkers
4993820|NCT04032652|Pharmacokinetics|pharmacokinetics
4993821|NCT04032652|Aminosalicylates|aminosalicylates
4993822|NCT04032652|Mucosal levels|mucosal levels
4993823|NCT04032652|Rectal dialysis|rectal dialysis
4993824|NCT04032639|Prader-Willi Syndrome|prader-willi syndrome
4993825|NCT04032639|Magnetoencephalography|magnetoencephalography
4993826|NCT04032639|Food Cue Reactivity|food cue reactivity
4993827|NCT04032639|Stress|stress
4993828|NCT04032626|Alzheimer's disease|alzheimer's disease
4993829|NCT04032626|Biomarkers|biomarkers
4993830|NCT04032626|Brain Amyloid|brain amyloid
4993831|NCT04032626|Brain Imaging|brain imaging
4993832|NCT04032626|Cognition|cognition
4994808|NCT04026256|denosumab|denosumab
4993833|NCT04032626|Immunomodulation|immunomodulation
4993834|NCT04032613|Hemodialysis|hemodialysis
4993835|NCT04032613|Vascular access|vascular access
4993836|NCT04032613|Arteriovenous|arteriovenous
4993837|NCT04032613|Dialysis|dialysis
4993838|NCT04032613|End Stage Renal Disease|end stage renal disease
4993839|NCT04032613|Patient-reported outcomes|patient-reported outcomes
4993840|NCT04032613|Feasibility|feasibility
4993841|NCT04032613|Care process|care process
4993842|NCT04032613|Patient education|patient education
4993843|NCT04032613|Health system navigation|health system navigation
4993844|NCT04032613|Chronic kidney disease|chronic kidney disease
4993845|NCT04032587|approach / avoidance|approach / avoidance
4993846|NCT04032587|alcohol use disorder|alcohol use disorder
4993848|NCT04032587|stress reduction|stress reduction
4993849|NCT04032587|goal-directed decision-making|goal-directed decision-making
4993850|NCT04032561|HbA1c|hba1c
4993851|NCT04032561|Sleep Quality|sleep quality
4993852|NCT04032561|Sleep Duration|sleep duration
4993853|NCT04032561|PSQI|psqi
4993854|NCT04032535|anti-inflamatory|anti-inflamatory
4993855|NCT04032535|PI3K|pi3k
4993856|NCT04032535|Sputum|sputum
4993857|NCT04032535|COPD|copd
4993858|NCT04032535|inhaled|inhaled
4993859|NCT04032470|Deep Brain Stimulation|deep brain stimulation
4993860|NCT04032470|Boston Scientific|boston scientific
4993861|NCT04032470|Essential Tremor|essential tremor
4993862|NCT04032457|Contact Lens|contact lens
4993863|NCT04032444|Orthopedic Surgery|orthopedic surgery
4993864|NCT04032431|Rehabilitation|rehabilitation
4993865|NCT04032431|Virtual Reality|virtual reality
4993866|NCT04032431|Upper limb|upper limb
4993867|NCT04032431|Neurorehabilitation|neurorehabilitation
4993868|NCT04032405|connective tissue graft|connective tissue graft
4993869|NCT04032392|Hepatocellular carcinoma|hepatocellular carcinoma
4993870|NCT04032392|Hepatitis B|hepatitis b
4993895|NCT04032301|central nervous system agents|central nervous system agents
4993896|NCT04032301|central nervous system depressants|central nervous system depressants
4993897|NCT04032301|depression|depression
4993898|NCT04032301|depressive disorder|depressive disorder
4993899|NCT04032301|depressive disorder, treatment-resistant|depressive disorder, treatment-resistant
4993900|NCT04032301|behavioral symptoms|behavioral symptoms
4993901|NCT04032301|mood disorders|mood disorders
4993902|NCT04032301|therapeutic uses|therapeutic uses
4993904|NCT04032288|Low tidal volume ventilation|low tidal volume ventilation
4993905|NCT04032288|Outcomes|outcomes
4993906|NCT04032275|chronic hepatitis B|chronic hepatitis b
4993907|NCT04032275|HBV|hbv
4993908|NCT04032275|HBsAg|hbsag
4993909|NCT04032275|HBeAg|hbeag
4993910|NCT04032275|HBV DNA|hbv dna
4993911|NCT04032275|histological examination|histological examination
4993912|NCT04032262|Brain-Gut Relationship|brain-gut relationship
4993913|NCT04032262|Anorectal Manometry|anorectal manometry
4993914|NCT04032249|Obesity|obesity
4993915|NCT04032249|Self-weighing|self-weighing
4993916|NCT04032249|Weight loss|weight loss
4993917|NCT04032249|Mobile health|mobile health
4993918|NCT04032236|caffeine|caffeine
4993919|NCT04032236|nicotin|nicotin
4993920|NCT04032236|pH|ph
4993921|NCT04032223|3D printed coping , overdenture, Implant , cast metal|3d printed coping , overdenture, implant , cast metal
4993922|NCT04032171|Evobrutinib|evobrutinib
4993923|NCT04032171|Avonex®|avonex®
4993924|NCT04032171|Interferon-beta 1a|interferon-beta 1a
4993925|NCT04032171|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4993926|NCT04032158|Evobrutinib|evobrutinib
4993927|NCT04032158|Avonex®|avonex®
4993928|NCT04032158|Interferon-beta 1a|interferon-beta 1a
4993929|NCT04032158|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
4993934|NCT04032132|periodontitis|periodontitis
4993935|NCT04032119|Gastric Endoscopic submucosal dissection|gastric endoscopic submucosal dissection
4993936|NCT04032119|Epinephrine|epinephrine
4993937|NCT04032106|HPV|hpv
4993938|NCT04032106|Men|men
4993939|NCT04032106|Vaccine|vaccine
4993940|NCT04032093|Respiratory tract infection|respiratory tract infection
4993946|NCT04032054|thoracolumbar fractures|thoracolumbar fractures
4993951|NCT04031963|Novel Biophotonic Methodology for Colon Cancer Screening.|novel biophotonic methodology for colon cancer screening.
4993952|NCT04031937|depression|depression
4993953|NCT04031937|psychomotor assessment|psychomotor assessment
4993954|NCT04031937|sensory profile|sensory profile
4993955|NCT04031937|perception|perception
4993956|NCT04031937|motricity|motricity
4993957|NCT04031924|liver transplantation|liver transplantation
4993958|NCT04031924|functional capacity|functional capacity
4993959|NCT04031924|kinesiophobia|kinesiophobia
4993960|NCT04031924|balance|balance
4993961|NCT04031924|physical fitness|physical fitness
4993962|NCT04031924|physical activity|physical activity
4993963|NCT04031924|muscle strength|muscle strength
4993964|NCT04031911|Urinary lithiasis|urinary lithiasis
4993965|NCT04031911|Urological treatments|urological treatments
4993966|NCT04031911|Spa treatment|spa treatment
4993967|NCT04031911|Posturotherapy|posturotherapy
4993968|NCT04031911|Lumbar percussions|lumbar percussions
4993969|NCT04031911|Hyperdiuresis|hyperdiuresis
4993970|NCT04031898|EGFR TKI|egfr tki
4993971|NCT04031898|retrospective|retrospective
4993972|NCT04031898|treatment patterns|treatment patterns
4993973|NCT04031898|real world evidence|real world evidence
4993974|NCT04031872|TGF- beta activated|tgf- beta activated
4993978|NCT04031820|Primary total hip arthroplasty|primary total hip arthroplasty
4993979|NCT04031820|Dual Mobility cup|dual mobility cup
4993980|NCT04031807|Single-Incision Sling|single-incision sling
4993981|NCT04031807|Stress Urinary Incontinence|stress urinary incontinence
4993982|NCT04031807|Failure|failure
4993983|NCT04031794|Veno-venous ECMO|veno-venous ecmo
4993984|NCT04031794|Severe ARDS|severe ards
4993985|NCT04031794|Refractory Hypoxemia|refractory hypoxemia
4993986|NCT04031781|rTMS = repetitive transcranial magnetic stimulation|rtms = repetitive transcranial magnetic stimulation
4993987|NCT04031781|LDLPFC = Left dorsolateral prefrontal cortex|ldlpfc = left dorsolateral prefrontal cortex
4993988|NCT04031781|HIT 6 = Headache Impact test|hit 6 = headache impact test
4993989|NCT04031781|NPRS = Numeric Pain Rating Scale|nprs = numeric pain rating scale
4993990|NCT04031781|ICHD = The international classfication of Headache disorder|ichd = the international classfication of headache disorder
4993991|NCT04031781|MT= Motor threshold|mt= motor threshold
4993992|NCT04031755|Autism|autism
4993993|NCT04031755|Autism Spectrum Disorder|autism spectrum disorder
4993994|NCT04031755|Minocycline|minocycline
4993995|NCT04031729|Aspirin|aspirin
4993996|NCT04031729|Liver Disease|liver disease
4993997|NCT04031729|Anti-inflammatory|anti-inflammatory
4993998|NCT04031716|Meditation|meditation
4993999|NCT04031716|Pectus Excavatum|pectus excavatum
4994000|NCT04031716|Scoliosis|scoliosis
4994001|NCT04031664|Qianjin Capsule of Gynaecology|qianjin capsule of gynaecology
4994002|NCT04031664|efficacy and safety|efficacy and safety
4994003|NCT04031664|recurrence rate|recurrence rate
4994004|NCT04031664|randomized|randomized
4994005|NCT04031664|double blind|double blind
4994006|NCT04031664|parallel control|parallel control
4994007|NCT04031664|multi-center clinical study|multi-center clinical study
4994008|NCT04031651|Pudilan Xiaoyan Oral Liquid|pudilan xiaoyan oral liquid
4994009|NCT04031651|Safety monitoring|safety monitoring
4994010|NCT04031638|Thyroid cancer, Iodine treatment|thyroid cancer, iodine treatment
4994011|NCT04031625|Metastatic Colorectal Cancer|metastatic colorectal cancer
4994012|NCT04031612|Cancer; Breast, Neoadjuvant|cancer; breast, neoadjuvant
4994013|NCT04031599|Type 1 diabetes|type 1 diabetes
4994014|NCT04031599|Artificial pancreas|artificial pancreas
4994015|NCT04031599|Closed-loop system|closed-loop system
4994016|NCT04031599|Insulin|insulin
4994017|NCT04031599|Postprandial glucose|postprandial glucose
4994018|NCT04031586|Malnutrition|malnutrition
4994019|NCT04031586|Childhood Cancer|childhood cancer
4994020|NCT04031586|Central America|central america
4994021|NCT04031586|Nicaragua|nicaragua
4994022|NCT04031573|Septic shock|septic shock
4994023|NCT04031573|Ivabradine|ivabradine
4994024|NCT04031560|mindfulness|mindfulness
4994025|NCT04031560|cognitive therapy|cognitive therapy
4994026|NCT04031560|psychoeducation|psychoeducation
4994027|NCT04031560|functional remediation|functional remediation
4994028|NCT04031534|F-Miso PET scan|f-miso pet scan
4994029|NCT04031534|Magnetic resonance imaging|magnetic resonance imaging
4994030|NCT04031534|immunohistochemistry|immunohistochemistry
4994031|NCT04031534|Head and neck cancer|head and neck cancer
4994032|NCT04031508|PPHN|pphn
4994033|NCT04031508|Diaphragmatic Hernia|diaphragmatic hernia
4994034|NCT04031508|omega 3|omega 3
4994035|NCT04031508|DHA and EPA|dha and epa
4994036|NCT04031469|Microbiome|microbiome
4994037|NCT04031443|prescription pattern|prescription pattern
4994038|NCT04031443|antibiotic prophylaxis|antibiotic prophylaxis
4994044|NCT04031391|fibromyalgia|fibromyalgia
4994045|NCT04031391|pain|pain
4994046|NCT04031391|exercice|exercice
4994047|NCT04031391|quality of live|quality of live
4994048|NCT04031378|Single Dose Radiotherapy|single dose radiotherapy
4994049|NCT04031378|Systemic Therapy|systemic therapy
4994050|NCT04031378|IGRT|igrt
4994051|NCT04031352|attitude|attitude
4994052|NCT04031352|CATCH|catch
4994053|NCT04031352|children|children
4994054|NCT04031352|disability|disability
4994055|NCT04031352|peers|peers
4994056|NCT04031339|papillary thyroid cancer|papillary thyroid cancer
4994057|NCT04031339|follicular thyroid cancer|follicular thyroid cancer
4994058|NCT04031339|poorly differentiated thyroid cancer|poorly differentiated thyroid cancer
4994059|NCT04031339|anaplastic thyroid cancer|anaplastic thyroid cancer
4994060|NCT04031339|medullary thyroid cancer|medullary thyroid cancer
4994061|NCT04031326|home visiting|home visiting
4994062|NCT04031326|LENA|lena
4994063|NCT04031326|infant language development|infant language development
4994064|NCT04031326|parenting|parenting
4994065|NCT04031300|Non-invasive glucose monitoring|non-invasive glucose monitoring
4994066|NCT04031300|Raman spectroscopy|raman spectroscopy
4994067|NCT04031261|Quality of Life|quality of life
4994068|NCT04031261|Patient Reported Outcomes|patient reported outcomes
4994069|NCT04031248|knee|knee
4994070|NCT04031248|whole body vibration|whole body vibration
4994071|NCT04031248|therapeutic exercise|therapeutic exercise
4994072|NCT04031196|Pediatric|pediatric
4994073|NCT04031196|Quadratus Lumborum|quadratus lumborum
4994074|NCT04031196|regional anesthesia|regional anesthesia
4994075|NCT04031170|Filipino Families|filipino families
4994076|NCT04031170|Incredible Years|incredible years
4994077|NCT04031157|MDD|mdd
4994078|NCT04031131|Haemorrhoid|haemorrhoid
4994079|NCT04031131|Banding|banding
4994080|NCT04031131|Topical Anaesthetic|topical anaesthetic
4994081|NCT04031092|Exercise|exercise
4994082|NCT04031092|Biomedical Technology|biomedical technology
4994083|NCT04031079|Weight Loss|weight loss
4994084|NCT04031079|Rehabilitation|rehabilitation
4994085|NCT04031079|Exercise|exercise
4994086|NCT04031079|Biomedical Technology|biomedical technology
4994087|NCT04031066|Alpha-Mannosidosis|alpha-mannosidosis
4994088|NCT04031066|velmanase alfa|velmanase alfa
4994089|NCT04031066|alpha-mann|alpha-mann
4994090|NCT04031066|shaman|shaman
4994091|NCT04031066|mannosidosis|mannosidosis
4994092|NCT04031066|alpha-mannosidasis|alpha-mannosidasis
4994093|NCT04031053|Pharmacokinetics|pharmacokinetics
4994094|NCT04031053|Efavirenz|efavirenz
4994095|NCT04031053|Penicilliosis|penicilliosis
4994096|NCT04031027|apremilast|apremilast
4994097|NCT04031027|DARWIN|darwin
4994098|NCT04031027|dermatology|dermatology
4994099|NCT04031027|retrospective|retrospective
4994100|NCT04031027|observational|observational
4994101|NCT04031027|psoriasis|psoriasis
4994102|NCT04031027|cross-sectional|cross-sectional
4994103|NCT04031014|Stress urinary incontinence, urge urinary incontinence, overactive bladder|stress urinary incontinence, urge urinary incontinence, overactive bladder
4994104|NCT04030988|Vitiligo|vitiligo
4994105|NCT04030988|Narrow-band UVB|narrow-band uvb
4994106|NCT04030988|Skin color|skin color
4994107|NCT04030988|Minipulse|minipulse
4994108|NCT04030975|diagnostic error|diagnostic error
4994109|NCT04030949|pediatric proctoscope|pediatric proctoscope
4994110|NCT04030949|oral sex,|oral sex,
4994111|NCT04030949|anal sex,|anal sex,
4994112|NCT04030949|MLST,|mlst,
4994113|NCT04030949|vPCR|vpcr
4994114|NCT04030949|discordance|discordance
4994115|NCT04030949|concordance|concordance
4994116|NCT04030936|MIH, knowledge , Molar Incisor Hypomineralization|mih, knowledge , molar incisor hypomineralization
4994117|NCT04030910|Life review|life review
4994118|NCT04030910|Reminiscence|reminiscence
4994119|NCT04030910|Technology|technology
4994120|NCT04030910|Existential distress|existential distress
4994121|NCT04030910|Virtual travel|virtual travel
4994122|NCT04030910|Well-being|well-being
4994123|NCT04030884|postoperative nausea and vomiting|postoperative nausea and vomiting
4994124|NCT04030884|nursing|nursing
4994125|NCT04030884|oral carbohydrate|oral carbohydrate
4994126|NCT04030884|honey|honey
4994127|NCT04030819|anxiety|anxiety
4994128|NCT04030819|multiple sclerosis|multiple sclerosis
4994136|NCT04030780|spore-forming probiotic|spore-forming probiotic
4994137|NCT04030780|sporebiotic|sporebiotic
4994138|NCT04030780|proton pump inhibitor|proton pump inhibitor
4994148|NCT04030728|human epidermal growth factor receptor 2 (HER2) negative|human epidermal growth factor receptor 2 (her2) negative
4994149|NCT04030715|Gastric Mucosal Pathology|gastric mucosal pathology
4994155|NCT04030689|Cost-effectiveness|cost-effectiveness
4994156|NCT04030676|Immune response against|immune response against
4994157|NCT04030676|QuantiFERON-CytoMegaloVirus (QF-CMV)|quantiferon-cytomegalovirus (qf-cmv)
4994158|NCT04030676|Ulcerative Colitis (UC)|ulcerative colitis (uc)
4994159|NCT04030676|CytoMegaloVirus (CMV)|cytomegalovirus (cmv)
4994160|NCT04030676|quantitative PolymeraseChainReaction (qPCR)|quantitative polymerasechainreaction (qpcr)
4994161|NCT04030676|ImmunoHistoChemistry (IHC)|immunohistochemistry (ihc)
4994162|NCT04030611|Diabetic retinopathy, traditional Chinese medicine(TCM), Diagnositic tools, sensitivity, Blood stasis|diabetic retinopathy, traditional chinese medicine(tcm), diagnositic tools, sensitivity, blood stasis
4994164|NCT04030546|anthracycline chemotherapy|anthracycline chemotherapy
4994165|NCT04030546|cardiotoxicity|cardiotoxicity
4994166|NCT04030546|heart failure|heart failure
4994167|NCT04030507|Breast Cancer|breast cancer
4994168|NCT04030507|HER2-positive Breast Cancer|her2-positive breast cancer
4994169|NCT04030507|Triple Negative Breast Cancer|triple negative breast cancer
4994170|NCT04030507|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
4994171|NCT04030507|Inflammatory Breast Cancer|inflammatory breast cancer
4994172|NCT04030507|Metastatic breast cancer|metastatic breast cancer
4994173|NCT04030494|blood pressure|blood pressure
4994174|NCT04030494|Arrhythmias, Cardiac|arrhythmias, cardiac
4994175|NCT04030494|atrial fibrillation|atrial fibrillation
4994176|NCT04030494|valvular disease|valvular disease
4994177|NCT04030494|blood pressure monitors|blood pressure monitors
4994178|NCT04030494|electrocardiography|electrocardiography
4994179|NCT04030494|Doppler echocardiography|doppler echocardiography
4994180|NCT04030494|Heart diseases|heart diseases
4994181|NCT04030494|Cardiovascular diseases|cardiovascular diseases
4994182|NCT04030481|propofol,sevoflurane|propofol,sevoflurane
4994183|NCT04030403|next-generation sequencing|next-generation sequencing
4994184|NCT04030403|metagenomics|metagenomics
4994185|NCT04030403|microorganism targeted polymerase chain reaction|microorganism targeted polymerase chain reaction
4994186|NCT04030403|conventional diagnostic culture|conventional diagnostic culture
4994187|NCT04030403|corneal impression membrane|corneal impression membrane
4994188|NCT04030338|prostate cancer|prostate cancer
4994189|NCT04030338|Metastatic Prostate Cancer|metastatic prostate cancer
4994191|NCT04030338|18 F-DCFPyL|18 f-dcfpyl
4994192|NCT04030338|68 Ga-PSMA|68 ga-psma
4994193|NCT04030338|19-170|19-170
4994194|NCT04030338|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4994195|NCT04030312|neonatal|neonatal
4994196|NCT04030312|newborn|newborn
4994197|NCT04030312|hypoglycemia|hypoglycemia
4994198|NCT04030312|human milk|human milk
4994199|NCT04030312|breastfed|breastfed
4994200|NCT04030312|donor milk|donor milk
4994201|NCT04030299|Presbycusis|presbycusis
4994202|NCT04030299|Hearing aid|hearing aid
4994203|NCT04030273|Intrauterine adhesions|intrauterine adhesions
4994204|NCT04030273|Abdominal myomectomy|abdominal myomectomy
4994205|NCT04030273|Hysteroscopy|hysteroscopy
4994206|NCT04030234|Hypertension|hypertension
4994207|NCT04030234|Blood pressure target|blood pressure target
4994208|NCT04030221|the pressure gradient for venous return|the pressure gradient for venous return
4994209|NCT04030221|fluid responsiveness|fluid responsiveness
4994210|NCT04030208|respiratory disease|respiratory disease
4994211|NCT04030208|low resource settings|low resource settings
4994212|NCT04030208|mechanical ventilation|mechanical ventilation
4994213|NCT04030208|ventilator performance|ventilator performance
4994214|NCT04030208|comparative study|comparative study
4994215|NCT04030208|patient safety|patient safety
4994216|NCT04030208|ease of use|ease of use
4994227|NCT04030143|Long Acting Injection|long acting injection
4994228|NCT04030078|PEEP|peep
4994229|NCT04030078|Alveolar Recruitment Manoeuvres|alveolar recruitment manoeuvres
4994230|NCT04030078|Survey|survey
4994231|NCT04030052|safety|safety
4994232|NCT04030052|immunogenicity|immunogenicity
4994233|NCT04030052|hemostatic efficacy|hemostatic efficacy
4994234|NCT04030052|prophylactic|prophylactic
4994235|NCT04030052|infants|infants
4994236|NCT04030052|children|children
4994237|NCT04030052|hemostasis|hemostasis
4994238|NCT04030039|Chronic hepatitis B|chronic hepatitis b
4994239|NCT04030039|interferon|interferon
4994245|NCT04030026|Cough|cough
4994246|NCT04030026|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4994247|NCT04030026|Pharmacokinetics|pharmacokinetics
4994249|NCT04030013|diabetes|diabetes
4994250|NCT04030013|outcome|outcome
4994251|NCT04030013|transplant|transplant
4994252|NCT04030013|Education|education
4994258|NCT04029961|Patient education|patient education
4994260|NCT04029896|stem cells|stem cells
4994261|NCT04029896|MSCs|mscs
4994263|NCT04029896|paralysis|paralysis
4994264|NCT04029896|cerebral palsy|cerebral palsy
4994265|NCT04029870|Osteoporosis|osteoporosis
4994266|NCT04029870|adherence to therapy|adherence to therapy
4994267|NCT04029870|psychological determinants|psychological determinants
4994268|NCT04029870|self regulation model|self regulation model
4994269|NCT04029818|LDL-cholesterol|ldl-cholesterol
4994270|NCT04029818|Probiotics|probiotics
4994271|NCT04029805|Polycystic ovarian syndrome|polycystic ovarian syndrome
4994272|NCT04029805|Extract plant|extract plant
4994273|NCT04029805|Probiotics|probiotics
4994274|NCT04029805|Insulin resistance|insulin resistance
4994275|NCT04029792|Plant extract|plant extract
4994276|NCT04029792|Joint Mobility|joint mobility
4994277|NCT04029792|Physical performance|physical performance
4994278|NCT04029792|Vitality|vitality
4994279|NCT04029779|Injectable platelet rich fibrin|injectable platelet rich fibrin
4994280|NCT04029779|Bone density|bone density
4994281|NCT04029779|Crestal bone loss|crestal bone loss
4994282|NCT04029779|Immediate implants|immediate implants
4994283|NCT04029753|Early Mobilization|early mobilization
4994284|NCT04029727|Plant extract|plant extract
4994285|NCT04029727|LDL cholesterol|ldl cholesterol
4994286|NCT04029727|Dietary supplement|dietary supplement
4994287|NCT04029714|Prostate Cancer|prostate cancer
4994288|NCT04029714|Active Surveillance|active surveillance
4994289|NCT04029714|MRI|mri
4994290|NCT04029714|standardised treatment triggers|standardised treatment triggers
4994291|NCT04029714|randomized|randomized
4994292|NCT04029701|Ruyizhenbao Pill|ruyizhenbao pill
4994293|NCT04029701|Post-stroke|post-stroke
4994294|NCT04029701|Motor dysfunction|motor dysfunction
4994295|NCT04029701|Sensory dysfunction|sensory dysfunction
4994296|NCT04029675|Vitamin C|vitamin c
4994297|NCT04029675|Sepsis|sepsis
4994298|NCT04029675|Intensive care unit|intensive care unit
4994299|NCT04029675|Mechanically ventilation|mechanically ventilation
4994300|NCT04029675|VAP|vap
4994301|NCT04029649|Beta-1,3/1,6-D-Glucan|beta-1,3/1,6-d-glucan
4994302|NCT04029649|Ganoderma lucidum|ganoderma lucidum
4994303|NCT04029649|Ulcerative colitis|ulcerative colitis
4994304|NCT04029584|drug-drug interaction|drug-drug interaction
4994305|NCT04029584|statin|statin
4994306|NCT04029584|rifampin|rifampin
4994307|NCT04029571|Obesity|obesity
4994308|NCT04029571|Fasting-mimicking diet|fasting-mimicking diet
4994309|NCT04029571|Traditional Chinese medicine|traditional chinese medicine
4994310|NCT04029558|Immune response|immune response
4994311|NCT04029558|Plant extracts|plant extracts
4994312|NCT04029558|Dietary supplement|dietary supplement
4994313|NCT04029532|Respiratory exchange ratio|respiratory exchange ratio
4994314|NCT04029532|Body image|body image
4994315|NCT04029532|Heart rate variability|heart rate variability
4994316|NCT04029493|Re-infection|re-infection
4994317|NCT04029467|ESP block|esp block
4994318|NCT04029467|erector spinae plane block|erector spinae plane block
4994319|NCT04029467|mastectomy|mastectomy
4994320|NCT04029467|ropivacaine|ropivacaine
4994321|NCT04029467|dexmedetomidine|dexmedetomidine
4994322|NCT04029467|pain|pain
4994323|NCT04029467|breast|breast
4994325|NCT04029454|immunization programs|immunization programs
4994326|NCT04029428|PRRT - Peptide Receptor Radionuclide Therapy,|prrt - peptide receptor radionuclide therapy,
4994327|NCT04029428|GEP-NET - Gastro-Entero-Pancreatic Neuroendocrine Tumours;|gep-net - gastro-entero-pancreatic neuroendocrine tumours;
4994328|NCT04029428|BPCs - Bronchopulmonary Carcinoids (Atypical & Typical)|bpcs - bronchopulmonary carcinoids (atypical & typical)
4994329|NCT04029428|PPGLs - Pheochromocytomas/Paragangliomas;|ppgls - pheochromocytomas/paragangliomas;
4994330|NCT04029428|NET-CUP - Neuroendocrine Tumours of unknown primary|net-cup - neuroendocrine tumours of unknown primary
4994331|NCT04029428|clinical efficacy|clinical efficacy
4994332|NCT04029428|toxcity - adverse events (AEs)|toxcity - adverse events (aes)
4994333|NCT04029428|OS - overall survival|os - overall survival
4994334|NCT04029428|PFS - progression free survival|pfs - progression free survival
4994335|NCT04029415|antimicrobial resistance|antimicrobial resistance
4994336|NCT04029389|Plantar Fascitis|plantar fascitis
4994338|NCT04029389|Injections|injections
4994339|NCT04029389|Ultrasonography|ultrasonography
4994340|NCT04029285|Exergaming|exergaming
4994341|NCT04029285|Exercise Therapy|exercise therapy
4994342|NCT04029285|Musculoskeletal Pain|musculoskeletal pain
5010718|NCT03929666|Capecitabine|capecitabine
4994359|NCT04029155|transbronchial needle aspiration|transbronchial needle aspiration
4994360|NCT04029142|thalassemia|thalassemia
4994361|NCT04029142|sickle cell anaemia|sickle cell anaemia
4994362|NCT04029142|molecular genetic analysis|molecular genetic analysis
4994363|NCT04029129|Traffic-related air pollution|traffic-related air pollution
4994364|NCT04029129|Air filtration|air filtration
4994365|NCT04029129|Blood pressure|blood pressure
4994366|NCT04029129|Controlled exposure|controlled exposure
4994367|NCT04029116|Recurrent yeast infection|recurrent yeast infection
4994368|NCT04029116|Recurrent yeast vaginitis|recurrent yeast vaginitis
4994369|NCT04029116|Chronic yeast vaginitis|chronic yeast vaginitis
4994370|NCT04029116|Ibrexafungerp|ibrexafungerp
4994373|NCT04029103|Diabetic foot|diabetic foot
4997679|NCT04008758|trauma|trauma
4994381|NCT04029025|conventional porcelain-fused-to metal iFDP|conventional porcelain-fused-to metal ifdp
4994383|NCT04029025|3Shape TRIOS Pod Intraoral Scan|3shape trios pod intraoral scan
4994384|NCT04029025|Dentalwings DWOS Implant Prosthetics Lab-Software|dentalwings dwos implant prosthetics lab-software
4994385|NCT04029025|Straumann CARES Lab-Software|straumann cares lab-software
4994386|NCT04029025|digital implant workflow|digital implant workflow
4994387|NCT04029025|CAD/CAM-technology|cad/cam-technology
4994388|NCT04028999|Cerebrovascular Accident|cerebrovascular accident
4994389|NCT04028999|sling|sling
4994390|NCT04028999|Upper limb impairment|upper limb impairment
4994391|NCT04028986|ulipristalacetate|ulipristalacetate
4994392|NCT04028986|fertility treatment|fertility treatment
4994393|NCT04028986|IVF/ICSI|ivf/icsi
4994394|NCT04028986|fibroid|fibroid
4994395|NCT04028973|COPD|copd
4994396|NCT04028973|Neuromuscular fatigue|neuromuscular fatigue
4994397|NCT04028973|Muscle|muscle
4994398|NCT04028973|Dual-task|dual-task
4994399|NCT04028973|Mental fatigue|mental fatigue
4994400|NCT04028908|ventral tilting of the tibial plateau|ventral tilting of the tibial plateau
4994401|NCT04028908|anterior tilt angle|anterior tilt angle
4994402|NCT04028908|proximal tibia epiphyseal plate|proximal tibia epiphyseal plate
4994403|NCT04028895|IRAP|irap
4994404|NCT04028895|Insulin Regulated Amino Peptidase|insulin regulated amino peptidase
4994405|NCT04028869|Autoimmune liver disease|autoimmune liver disease
4994406|NCT04028869|glycyrrhizic acid|glycyrrhizic acid
4994407|NCT04028869|liver function|liver function
4994408|NCT04028856|Chronic hepatitis B|chronic hepatitis b
4994409|NCT04028856|interferon|interferon
4994410|NCT04028856|intermittent|intermittent
4994411|NCT04028856|HBV|hbv
4994412|NCT04028856|HBsAg|hbsag
4994413|NCT04028856|HBV DNA|hbv dna
4994414|NCT04028817|parkinson's disease|parkinson's disease
4994415|NCT04028817|Photobiomodulation|photobiomodulation
4994416|NCT04028817|Inflammation|inflammation
4994417|NCT04028817|Oxidative stress|oxidative stress
4994418|NCT04028804|Hodgkin's Lymphoma|hodgkin's lymphoma
4994419|NCT04028804|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4994420|NCT04028804|Possitron Emission Therapy (PET)|possitron emission therapy (pet)
4994421|NCT04028804|FDG PET|fdg pet
4994422|NCT04028804|FLT PET|flt pet
4994423|NCT04028804|Pediatrics|pediatrics
4994424|NCT04028791|Exercise, sickling, rhamdomyolysis, oxidative stress|exercise, sickling, rhamdomyolysis, oxidative stress
4994425|NCT04028752|macrophage|macrophage
4994426|NCT04028752|microgravity|microgravity
4994427|NCT04028752|blood|blood
4994428|NCT04028752|cardiovascular disease|cardiovascular disease
4994429|NCT04028713|Therapeutic drug monitoring|therapeutic drug monitoring
4994430|NCT04028713|Psoriasis|psoriasis
4994431|NCT04028713|Adalimumab|adalimumab
4994432|NCT04028622|ambulatory|ambulatory
4994433|NCT04028622|anesthesia|anesthesia
4994434|NCT04028622|consultation|consultation
4994435|NCT04028622|telemedicine|telemedicine
4994436|NCT04028609|30-day readmission|30-day readmission
4994437|NCT04028609|primary care|primary care
4994438|NCT04028609|community health worker|community health worker
4994439|NCT04028609|health education|health education
4994440|NCT04028596|Epilepsy|epilepsy
4994441|NCT04028596|Depression|depression
4994442|NCT04028596|Electroconvulsive Therapy|electroconvulsive therapy
4994443|NCT04028596|Postictal|postictal
4994444|NCT04028596|Clinical Trial|clinical trial
4994445|NCT04028596|Postictal hypoperfusion/hypoxia|postictal hypoperfusion/hypoxia
4994446|NCT04028583|Inappropriate Prescribing|inappropriate prescribing
4994447|NCT04028583|Potentially Inappropriate Medication List|potentially inappropriate medication list
4994448|NCT04028583|Aged|aged
4994449|NCT04028583|Practice Guideline|practice guideline
4994450|NCT04028583|Education, Medical|education, medical
4994451|NCT04028570|Radiation|radiation
4994452|NCT04028570|Boost Radiation Therapy|boost radiation therapy
4994453|NCT04028570|Background Radiation Therapy|background radiation therapy
4994454|NCT04028570|Surgery|surgery
4994455|NCT04028570|Extensive Pleural Resection|extensive pleural resection
4994456|NCT04028544|heart failure|heart failure
4994457|NCT04028544|traditional Chinese medicine|traditional chinese medicine
4994458|NCT04028544|prognosis|prognosis
4994459|NCT04028544|Qishenyiqi|qishenyiqi
4994460|NCT04028531|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
4994461|NCT04028505|Terlipressin Drug|terlipressin drug
4994474|NCT04028492|neurokinin 1 receptor|neurokinin 1 receptor
4994475|NCT04028492|substance p|substance p
4994476|NCT04028479|Precision Medicine|precision medicine
4994477|NCT04028479|Molecular Sequence Data|molecular sequence data
4994478|NCT04028479|Databases, Genetic|databases, genetic
4994479|NCT04028479|High-Throughput Nucleotide Sequencing|high-throughput nucleotide sequencing
4994480|NCT04028479|Massively-Parallel Sequencing|massively-parallel sequencing
4994481|NCT04028479|Observational Study|observational study
4994482|NCT04028479|Treatment|treatment
4994483|NCT04028479|Patient Outcome Assessment|patient outcome assessment
4994484|NCT04028479|Adaptive clinical trial|adaptive clinical trial
4994485|NCT04028479|Molecular Typing|molecular typing
4994486|NCT04028479|Response Rate|response rate
4994487|NCT04028479|Progression Free Survival|progression free survival
4994488|NCT04028479|Overall Survival|overall survival
4994489|NCT04028466|GERD|gerd
4994490|NCT04028466|gastro esophageal reflux|gastro esophageal reflux
4994491|NCT04028466|proton pump inhibitor|proton pump inhibitor
4994492|NCT04028466|Potassium-Competitive Acid Blocker|potassium-competitive acid blocker
4994493|NCT04028466|H(+)-K(+)-Exchanging ATPase|h(+)-k(+)-exchanging atpase
4994494|NCT04028466|Randomized Controlled Trial|randomized controlled trial
4994495|NCT04028453|Increased nuchal translucency|increased nuchal translucency
4994496|NCT04028453|prenatal diagnosis|prenatal diagnosis
4994497|NCT04028453|karyotype analysis|karyotype analysis
4994498|NCT04028453|chromosome micro-array analysis|chromosome micro-array analysis
4994499|NCT04028453|neurodevelopmental disorders|neurodevelopmental disorders
4994500|NCT04028453|euploid children|euploid children
4994501|NCT04028375|Gastric Cancer|gastric cancer
4994502|NCT04028375|MRI|mri
4994503|NCT04028375|MSCT|msct
4994504|NCT04028375|Staging|staging
4994505|NCT04028375|Prediction and Prognosis|prediction and prognosis
4994506|NCT04028323|Functional MRI|functional mri
4994507|NCT04028323|Terlipressin|terlipressin
4994508|NCT04028323|Octreotide|octreotide
4994509|NCT04028323|Renal function disorder|renal function disorder
4994510|NCT04028323|Acute variceal bleeding|acute variceal bleeding
4994511|NCT04028297|Shock|shock
4994512|NCT04028297|emergency|emergency
4994522|NCT04028232|Multiple Sclerosis|multiple sclerosis
4994523|NCT04028232|Epidemiology|epidemiology
4994524|NCT04028232|Socio-Economic Status|socio-economic status
4994525|NCT04028232|Net Survival|net survival
4994526|NCT04028206|vibration treatment|vibration treatment
4994527|NCT04028206|sarcopenia|sarcopenia
4994528|NCT04028206|elastic-band resistance|elastic-band resistance
4994529|NCT04028206|hydroxylmethylbutyrate|hydroxylmethylbutyrate
4994530|NCT04028206|elderly|elderly
4994531|NCT04028206|randomized control trial|randomized control trial
4994532|NCT04028193|Dumping syndrome|dumping syndrome
4994533|NCT04028193|Fat supplement|fat supplement
4994547|NCT04028102|fluid challenge|fluid challenge
5705341|NCT00482248|Asthma|asthma
4994548|NCT04028076|Peer Support|peer support
4994549|NCT04028076|Type2 Diabetes|type2 diabetes
4994550|NCT04028076|African American|african american
4994551|NCT04027985|Kinesiotaping|kinesiotaping
4994552|NCT04027985|Spasticity|spasticity
4994553|NCT04027985|Elastosonography|elastosonography
4994554|NCT04027985|Stroke|stroke
4994555|NCT04027972|Neostigmine, Glycopyrrolate, Transdermal, Intravenous, Pharmacokinetic, Constipation, Bowel Control, Mass Spectroscopy, Stool Incontinence|neostigmine, glycopyrrolate, transdermal, intravenous, pharmacokinetic, constipation, bowel control, mass spectroscopy, stool incontinence
4994560|NCT04027933|Psychiatric nursing|psychiatric nursing
4994561|NCT04027933|Simulation|simulation
4994562|NCT04027933|Standardized patients|standardized patients
4994563|NCT04027920|postpartum hemorrhage|postpartum hemorrhage
4994564|NCT04027842|Perioperative hypothermia|perioperative hypothermia
4994565|NCT04027842|Core body temperature|core body temperature
4994566|NCT04027842|Prewarming|prewarming
4994567|NCT04027842|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
4994568|NCT04027829|dexmedetomidine|dexmedetomidine
4994569|NCT04027829|pediatric|pediatric
4994570|NCT04027829|sedation|sedation
4994571|NCT04027816|PLA2G6-related NBIA|pla2g6-related nbia
4994572|NCT04027816|INAD|inad
4994576|NCT04027790|DNA Methylation|dna methylation
4994577|NCT04027764|advanced biliary tract cancer|advanced biliary tract cancer
4994578|NCT04027764|Albumin Paclitaxel|albumin paclitaxel
4994580|NCT04027764|Toripalimab|toripalimab
4994584|NCT04027738|knee|knee
4994585|NCT04027738|Osteoarthritis|osteoarthritis
4994586|NCT04027738|Platelet rich plasma|platelet rich plasma
4994587|NCT04027725|Mild cognitive Impairment|mild cognitive impairment
4994588|NCT04027725|Neurofeedback|neurofeedback
4994589|NCT04027725|Electroencephalography|electroencephalography
4994590|NCT04027725|Memory|memory
4994591|NCT04027725|Attention|attention
4994592|NCT04027699|Mini-bolus challenge|mini-bolus challenge
4994593|NCT04027699|fluid responsiveness|fluid responsiveness
4994594|NCT04027699|volemic expansion|volemic expansion
4994595|NCT04027699|pediatric septic shock|pediatric septic shock
4994596|NCT04027699|severe sepsis|severe sepsis
4994597|NCT04027699|microcirculation|microcirculation
4994598|NCT04027686|Laser Therapy|laser therapy
4994599|NCT04027686|Non-surgical periodontal therapy|non-surgical periodontal therapy
4994600|NCT04027686|Scaling and root planing|scaling and root planing
4994601|NCT04027660|dentistry|dentistry
4994602|NCT04027660|zirconia|zirconia
4994603|NCT04027660|implants|implants
4994604|NCT04027647|Stage 3B NSCLC|stage 3b nsclc
4994605|NCT04027647|Stage 4 NSCLC|stage 4 nsclc
4994606|NCT04027647|Vizimpro|vizimpro
4994607|NCT04027647|EGFR TKI|egfr tki
4994608|NCT04027647|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
4994609|NCT04027634|Baduanjin program|baduanjin program
4994610|NCT04027634|body mass index|body mass index
4994611|NCT04027634|metabolic parameters|metabolic parameters
4994613|NCT04027608|adolescent, obesity, food reinforcement, sensitization|adolescent, obesity, food reinforcement, sensitization
4994614|NCT04027582|ORSIM|orsim
4994615|NCT04027582|Entrustable Professional Activity|entrustable professional activity
4994616|NCT04027543|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4994617|NCT04027543|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
4994618|NCT04027543|Resectable oesophageal carcinoma|resectable oesophageal carcinoma
4994619|NCT04027543|Effective|effective
4994620|NCT04027543|Safety|safety
4994621|NCT04027491|Rehabilitation|rehabilitation
4994622|NCT04027491|Upper limbs|upper limbs
4994623|NCT04027491|Virtual Reality|virtual reality
4994624|NCT04027478|fasting|fasting
4994625|NCT04027478|chemotherapy|chemotherapy
5011008|NCT03927599|PARP|parp
4994626|NCT04027452|electroconvulsive therapy|electroconvulsive therapy
4994627|NCT04027452|post traumatic stress disorder|post traumatic stress disorder
4994628|NCT04027426|Habituation|habituation
4994629|NCT04027413|Pulmonary Rehabilitation|pulmonary rehabilitation
4994630|NCT04027413|Nutrtional supplements|nutrtional supplements
4994631|NCT04027400|survivor|survivor
4994632|NCT04027400|cognitive rehabilitation|cognitive rehabilitation
4994634|NCT04027335|Fecal incontinence|fecal incontinence
4994635|NCT04027335|Women|women
4994636|NCT04027322|Pharyngitis|pharyngitis
4994637|NCT04027322|Sore Throat|sore throat
4994638|NCT04027322|Glucocorticoids|glucocorticoids
4994639|NCT04027322|Nebulizers|nebulizers
4994640|NCT04027244|Peripheral arterial disease|peripheral arterial disease
4994641|NCT04027244|Limb salvage|limb salvage
4994642|NCT04027244|Frailty|frailty
4994643|NCT04027244|Cognitive dysfunction|cognitive dysfunction
4994644|NCT04027244|Myocardial perfusion imaging|myocardial perfusion imaging
4994645|NCT04027244|Biomarkers|biomarkers
4994646|NCT04027218|venipuncture|venipuncture
4994647|NCT04027218|hemolysis|hemolysis
4994648|NCT04027218|heat|heat
4994649|NCT04027218|pressure|pressure
4994650|NCT04027218|safety|safety
4994651|NCT04027127|netrin-1|netrin-1
4994653|NCT04027127|reperfuzion|reperfuzion
4994654|NCT04027114|randomized controlled trial|randomized controlled trial
4994655|NCT04027114|multiple sclerosis|multiple sclerosis
4994656|NCT04027114|physiotherapy|physiotherapy
4994657|NCT04027114|behaviour change|behaviour change
4994658|NCT04027114|physical activity|physical activity
4994659|NCT04027114|exercise|exercise
4994660|NCT04027114|disability progression|disability progression
4994661|NCT04027114|walking function|walking function
4994662|NCT04027088|immunonutrition|immunonutrition
4994663|NCT04027088|surgery|surgery
4994664|NCT04027088|postoperative complications|postoperative complications
4994665|NCT04027088|length of hospital stay|length of hospital stay
4994666|NCT04027088|nutritional status|nutritional status
4994667|NCT04027075|Adolescent|adolescent
4994668|NCT04027075|Alcohol|alcohol
4994669|NCT04027075|Marijuana|marijuana
4994670|NCT04027075|Mindfulness|mindfulness
4994671|NCT04027062|Diabetes, Continuing education, Attitude, Practice, Health care physicians|diabetes, continuing education, attitude, practice, health care physicians
4994672|NCT04027049|rehabilitation|rehabilitation
4994673|NCT04027049|cycle ergometry|cycle ergometry
4994674|NCT04027036|Vaccine|vaccine
4994675|NCT04027036|Polio Virus|polio virus
4998008|NCT04006691|TC-3|tc-3
4994683|NCT04026958|Neurology|neurology
4994684|NCT04026945|chronic scrotal pain|chronic scrotal pain
4994685|NCT04026945|chronic testicular pain|chronic testicular pain
4994686|NCT04026945|spermatic cord|spermatic cord
4994687|NCT04026945|orchialgia|orchialgia
4994688|NCT04026945|chronic scrotal content pain|chronic scrotal content pain
4994689|NCT04026932|subjective tinnitus|subjective tinnitus
4994690|NCT04026932|tinnitus relieving sound|tinnitus relieving sound
4994691|NCT04026932|clinical effects|clinical effects
4994692|NCT04026906|skin glue|skin glue
4994693|NCT04026906|dermabond|dermabond
4994694|NCT04026906|randomized controlled trial|randomized controlled trial
4994695|NCT04026906|intravenous catheter|intravenous catheter
4994696|NCT04026893|AUFI|aufi
4994698|NCT04026880|Menopause|menopause
4994699|NCT04026880|Urinary Incontinence|urinary incontinence
4994700|NCT04026880|Pelvic Floor Muscles|pelvic floor muscles
4994701|NCT04026854|Quality of life at work;Nurse;Quality of care;psychiatric|quality of life at work;nurse;quality of care;psychiatric
4994702|NCT04026841|ground-glass nodule|ground-glass nodule
5311290|NCT02123576|Renal failure|renal failure
4994703|NCT04026841|ground-glass density|ground-glass density
4994704|NCT04026828|chronic periodontitis|chronic periodontitis
4994705|NCT04026828|aggressive periodontitis|aggressive periodontitis
4994706|NCT04026828|expression|expression
4994707|NCT04026828|polymorphism|polymorphism
4994708|NCT04026828|mutation|mutation
4994906|NCT04025658|oxytocin|oxytocin
4994711|NCT04026776|Uric Acid sensitivity|uric acid sensitivity
4994712|NCT04026776|Salt sensitivity|salt sensitivity
4994713|NCT04026776|Blood Pressure Influences|blood pressure influences
4994714|NCT04026763|Targeted Prostate Biopsy|targeted prostate biopsy
4994715|NCT04026737|Cardiotoxicity of Cancer Therapy|cardiotoxicity of cancer therapy
4994716|NCT04026737|Cardio-Oncology|cardio-oncology
4994717|NCT04026737|CART Cell Therapy|cart cell therapy
4994718|NCT04026685|caesarean delivery|caesarean delivery
4994719|NCT04026685|phenylephrine|phenylephrine
4994720|NCT04026685|spinal anaesthesia|spinal anaesthesia
4994721|NCT04026685|vasopressor administration|vasopressor administration
4994722|NCT04026685|pregnancy|pregnancy
4994723|NCT04026685|non invasive cardiac output (CO) monitoring (NICOM)|non invasive cardiac output (co) monitoring (nicom)
4994724|NCT04026659|Exercise|exercise
4994725|NCT04026659|Rehabilitation|rehabilitation
4994729|NCT04026633|Alcohol Intervention|alcohol intervention
4994730|NCT04026633|College Students|college students
4994731|NCT04026620|alcohol use and abuse|alcohol use and abuse
4994732|NCT04026620|prenatal alcohol use|prenatal alcohol use
4994735|NCT04026607|Aging|aging
4994736|NCT04026607|Muscle Protein Synthesis|muscle protein synthesis
4994737|NCT04026594|burnout prevention|burnout prevention
4994738|NCT04026594|emotional exhaustion|emotional exhaustion
4994739|NCT04026594|mindfulness|mindfulness
4994740|NCT04026594|medical students|medical students
4994741|NCT04026594|empathy|empathy
4994742|NCT04026568|Peripheral nerve trauma|peripheral nerve trauma
4994743|NCT04026568|laceration|laceration
4994744|NCT04026568|blast injury|blast injury
4994745|NCT04026568|mangled limb|mangled limb
4994746|NCT04026555|Medical Early Warning Systems|medical early warning systems
4994747|NCT04026555|Patient Monitoring|patient monitoring
4994748|NCT04026555|Electronic Health Record|electronic health record
4994749|NCT04026555|Big Data|big data
4994750|NCT04026555|Critical Care|critical care
4994751|NCT04026555|Machine Learning|machine learning
4994752|NCT04026542|VO2max|vo2max
4994753|NCT04026542|Fontan|fontan
4994754|NCT04026542|Congenital heart disease|congenital heart disease
4994755|NCT04026542|Single ventricle|single ventricle
4994756|NCT04026529|pulmonary rehabilitation|pulmonary rehabilitation
4994757|NCT04026516|eye movements|eye movements
4994758|NCT04026516|Electronystagmograpy|electronystagmograpy
4994759|NCT04026516|nystagmus|nystagmus
4994760|NCT04026516|electrooculogram|electrooculogram
4994761|NCT04026516|vestibular assessment|vestibular assessment
4994762|NCT04026516|ambulatory monitoring|ambulatory monitoring
4994763|NCT04026503|Rehabilitation|rehabilitation
4994764|NCT04026503|Aging|aging
4994765|NCT04026503|Mobility Skills|mobility skills
4994766|NCT04026451|Sedation|sedation
4994767|NCT04026451|EEG|eeg
4994768|NCT04026451|Mechanical Ventilation|mechanical ventilation
4994769|NCT04026451|Critical Care|critical care
4994770|NCT04026451|Propofol|propofol
4994785|NCT04026360|Airway growth|airway growth
4994786|NCT04026360|Airway development|airway development
4994787|NCT04026360|Genetic predisposition|genetic predisposition
4994789|NCT04026347|SUI|sui
4994790|NCT04026347|Women|women
4994791|NCT04026347|Incontinence|incontinence
4994796|NCT04026295|treadmill training|treadmill training
4994797|NCT04026295|gait|gait
4994798|NCT04026295|short burst interval locomotor training|short burst interval locomotor training
4994799|NCT04026295|spastic|spastic
4994800|NCT04026282|assisted reproductive technology|assisted reproductive technology
4994801|NCT04026282|live birth|live birth
4994802|NCT04026282|fertilization|fertilization
4994803|NCT04026269|MOAP; Relapsed/Refractory; Hodgkin Lymphoma; DP;|moap; relapsed/refractory; hodgkin lymphoma; dp;
4994804|NCT04026256|osteoporosis|osteoporosis
4994805|NCT04026256|histomorphometry|histomorphometry
4994806|NCT04026256|bone density|bone density
4994807|NCT04026256|teriparatide|teriparatide
4994813|NCT04026243|Pain management|pain management
4994814|NCT04026230|Prostate cancer|prostate cancer
4994815|NCT04026230|Castration resistance|castration resistance
4994816|NCT04026230|Cholesterol lowering drug|cholesterol lowering drug
4994817|NCT04026230|Cholesterol|cholesterol
4994818|NCT04026230|Atorvastatin|atorvastatin
4994819|NCT04026230|Survival|survival
4994820|NCT04026230|Mortality|mortality
4994824|NCT04026191|Hyaluronic Acid|hyaluronic acid
4994825|NCT04026191|Sodium Hyaluronate|sodium hyaluronate
4994826|NCT04026178|Immunogenicity|immunogenicity
4994827|NCT04026178|Antibodies|antibodies
4994828|NCT04026178|Lipodystrophy|lipodystrophy
4994829|NCT04026152|Anxiety-Related Disorder|anxiety-related disorder
4994830|NCT04026152|Exercise|exercise
4994831|NCT04026152|Resistance Training|resistance training
4994832|NCT04026152|Unified Protocol|unified protocol
4994833|NCT04026152|Adherence|adherence
4994834|NCT04026152|Randomized Controlled Trial|randomized controlled trial
5011216|NCT03926169|Risankizumab|risankizumab
4994843|NCT04026087|mass spectrometry technique|mass spectrometry technique
4994844|NCT04026061|Medical Research Framework|medical research framework
4994845|NCT04026061|Hand-held touchscreen devices|hand-held touchscreen devices
4994846|NCT04026061|Self-management|self-management
4994847|NCT04026061|Meaningful activities|meaningful activities
4994848|NCT04026048|Cognitive Behaviour Therapy for Insomnia|cognitive behaviour therapy for insomnia
4994849|NCT04026048|Actigraphy|actigraphy
4994850|NCT04026048|CBT-I|cbt-i
4994851|NCT04026048|Cancer|cancer
4994852|NCT04026048|Insomnia|insomnia
4994853|NCT04026048|Sleep|sleep
4994854|NCT04026048|Perceived Cognitive Impairment|perceived cognitive impairment
4994855|NCT04026035|PCR|pcr
4994856|NCT04026035|hemoculture|hemoculture
4994857|NCT04026035|septicemia|septicemia
4994858|NCT04025983|Helicobacter pylori|helicobacter pylori
4994859|NCT04025983|peptic ulcer|peptic ulcer
4994860|NCT04025983|Lactobacillus johnsonii|lactobacillus johnsonii
4994861|NCT04025983|immunoglobin Y|immunoglobin y
4994862|NCT04025970|Germ line DNA, gDNA|germ line dna, gdna
4994863|NCT04025970|Circulating tumor cell, CTC|circulating tumor cell, ctc
4994864|NCT04025970|Circulating cell free DNA, cfDNA, ctDNA|circulating cell free dna, cfdna, ctdna
4994865|NCT04025970|Screening|screening
4994866|NCT04025970|Diagnostic|diagnostic
4994867|NCT04025970|Predictive|predictive
4994868|NCT04025918|hypotension|hypotension
4994869|NCT04025918|spinal anesthesia|spinal anesthesia
4994870|NCT04025918|cesarean section|cesarean section
4994871|NCT04025918|phenylephrine|phenylephrine
4994872|NCT04025918|ephedrine|ephedrine
4994873|NCT04025918|closed-loop system|closed-loop system
4994874|NCT04025918|continuous non-invasive monitor|continuous non-invasive monitor
4994886|NCT04025840|Overall survival|overall survival
4994887|NCT04025801|confocal microscopy,cornea|confocal microscopy,cornea
4994888|NCT04025749|Cerebral Palsy|cerebral palsy
4994889|NCT04025749|Executive Functions|executive functions
4994890|NCT04025749|Cognitive Training|cognitive training
4994891|NCT04025749|Computerized Therapy|computerized therapy
4994892|NCT04025749|Quality of Life|quality of life
4994893|NCT04025749|Neuroimaging|neuroimaging
4994894|NCT04025749|Participation|participation
4994895|NCT04025736|Tranexamic Acid|tranexamic acid
4994896|NCT04025736|Shoulder Arthroscopy|shoulder arthroscopy
4994897|NCT04025736|Visual Clarity|visual clarity
4994898|NCT04025736|Hemostasis|hemostasis
4994899|NCT04025684|Oral Hygiene|oral hygiene
4994900|NCT04025671|naloxone|naloxone
4994901|NCT04025671|opioid use disorder|opioid use disorder
4994902|NCT04025671|harm reduction|harm reduction
4994903|NCT04025658|pregnancy|pregnancy
4994905|NCT04025658|postpartum hemorrhage|postpartum hemorrhage
4994909|NCT04025645|Common Bile Duct|common bile duct
4994910|NCT04025645|Sphincter of Oddi|sphincter of oddi
4994912|NCT04025645|Lipase|lipase
4994913|NCT04025606|Epidural analgesia|epidural analgesia
4994914|NCT04025606|Pneumonectomy|pneumonectomy
4994915|NCT04025580|Systems Biology|systems biology
4994916|NCT04025580|Immunology|immunology
4994920|NCT04025554|Chronic Active Lesions|chronic active lesions
4994921|NCT04025554|Ultra-high-field (7T) MRI|ultra-high-field (7t) mri
4994922|NCT04025554|Interleukin-1 (IL-1)|interleukin-1 (il-1)
4994923|NCT04025554|White Matter|white matter
4994924|NCT04025554|Paramagnetic Rim|paramagnetic rim
4994925|NCT04025515|Oncomine Focus Panel Assay|oncomine focus panel assay
4994926|NCT04025515|Molecular profiling|molecular profiling
4994927|NCT04025515|Targeted therapies|targeted therapies
4994928|NCT04025515|Driver oncogene|driver oncogene
4994929|NCT04025515|Next-Generation Sequencing (NGS)|next-generation sequencing (ngs)
4994930|NCT04025515|PD-L1 Immunohistochemistry (IHC, Dako 22C3)|pd-l1 immunohistochemistry (ihc, dako 22c3)
4994931|NCT04025515|Hotspots|hotspots
4994941|NCT04025502|Event-related potential|event-related potential
4994942|NCT04025502|MMN|mmn
4994943|NCT04025502|Schizophrenia|schizophrenia
4994944|NCT04025502|Electroencephalogram|electroencephalogram
4994945|NCT04025502|Mismatch Negativity|mismatch negativity
4994946|NCT04025502|N100|n100
4994947|NCT04025502|P3a|p3a
4994948|NCT04025502|P3b|p3b
4994949|NCT04025489|Pre-diabetes|pre-diabetes
4994950|NCT04025489|Type 2 Diabetes|type 2 diabetes
4994951|NCT04025489|Genes|genes
4994952|NCT04025489|Supplementation|supplementation
4994953|NCT04025476|VKH; immune profile;|vkh; immune profile;
4994954|NCT04025463|Implementation science|implementation science
4994955|NCT04025463|Organizational readiness|organizational readiness
4994956|NCT04025463|African American|african american
4994957|NCT04025463|Latino|latino
4994958|NCT04025411|Stroke|stroke
4994959|NCT04025411|Upper limb rehabilitation|upper limb rehabilitation
4994960|NCT04025411|Computerized mirror therapy|computerized mirror therapy
4994961|NCT04025411|Hemiparetic|hemiparetic
4994962|NCT04025411|Mirror therapy|mirror therapy
4994963|NCT04025372|Prostate Cancer|prostate cancer
4994964|NCT04025333|Smoking Cessation|smoking cessation
4994965|NCT04025255|Brain Health|brain health
4994966|NCT04025255|Cognitive Abilities|cognitive abilities
4994967|NCT04025255|Mental Orientation|mental orientation
5705948|NCT00479856|GW572016|gw572016
4994968|NCT04025255|Short-term Memory|short-term memory
4994969|NCT04025255|Executive Function|executive function
4994970|NCT04025216|Chimeric Antigen Receptor (CAR)|chimeric antigen receptor (car)
4994971|NCT04025216|T-cells|t-cells
4994972|NCT04025216|TnMUC1|tnmuc1
4994973|NCT04025203|Ibuprofen Arginine|ibuprofen arginine
4994974|NCT04025203|Gabapentin|gabapentin
4994975|NCT04025203|Median nerve neural mobilization|median nerve neural mobilization
4994976|NCT04025203|Physiotherapy|physiotherapy
4994977|NCT04025203|Pain management|pain management
4994978|NCT04025190|anxiety|anxiety
4994989|NCT04025151|chat-based IM|chat-based im
4994990|NCT04025151|alcohol brief intervention|alcohol brief intervention
4994991|NCT04025151|alcohol misuse|alcohol misuse
4994992|NCT04025151|university students|university students
4994993|NCT04025138|Sex differences|sex differences
4994994|NCT04025138|Ultra-endurance running|ultra-endurance running
4994995|NCT04025138|Mont Blanc Ultra Trail|mont blanc ultra trail
4994996|NCT04025138|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4994997|NCT04025138|Neuromuscular tests|neuromuscular tests
4994998|NCT04025138|Plantar flexors|plantar flexors
4994999|NCT04025138|Knee extensors|knee extensors
4995000|NCT04025138|Force/Velocity Profile (FVP)|force/velocity profile (fvp)
4995001|NCT04025112|Breast cancer|breast cancer
4995002|NCT04025112|Rehabilitation|rehabilitation
4995003|NCT04025112|Robotics|robotics
4995004|NCT04025099|intuitive eating|intuitive eating
4995005|NCT04025099|body positive yoga|body positive yoga
4995008|NCT04025099|interoceptive awareness|interoceptive awareness
4995009|NCT04025099|embodiment|embodiment
4995010|NCT04025099|internal cues|internal cues
4995011|NCT04025099|external cues|external cues
4995012|NCT04025086|Spinal Surgery|spinal surgery
4995013|NCT04025073|Metabolic syndrome|metabolic syndrome
4995014|NCT04025073|Schizophrenia|schizophrenia
4995015|NCT04025073|Nutrition Therapy|nutrition therapy
4995016|NCT04025060|sugar-sweetened beverages|sugar-sweetened beverages
4995017|NCT04025060|caffeine withdrawal|caffeine withdrawal
4995018|NCT04025060|beverages|beverages
4995020|NCT04025047|trans-vaginal mesh|trans-vaginal mesh
4995021|NCT04025047|pelvic reconstruction surgery|pelvic reconstruction surgery
4995022|NCT04025047|complications|complications
4995024|NCT04025034|Decompression|decompression
4995025|NCT04025034|Thyroid-related|thyroid-related
4995026|NCT04025034|Orbitopathy|orbitopathy
4995027|NCT04025021|Targeted Fortification|targeted fortification
4995028|NCT04025021|Human Milk Analysis|human milk analysis
4995029|NCT04025021|Neonatal Nutrition|neonatal nutrition
4995030|NCT04024995|Invasive Fungal Infections|invasive fungal infections
4995031|NCT04024995|EORTC/MSG criteria|eortc/msg criteria
4995032|NCT04024982|Transoesophageal Echocardiography (TEE)|transoesophageal echocardiography (tee)
4995033|NCT04024982|Learning|learning
4995034|NCT04024969|Central Vein Sign|central vein sign
4995035|NCT04024969|Translational Neuroimaging|translational neuroimaging
4995036|NCT04024969|Multiple Sclerosis|multiple sclerosis
4995037|NCT04024956|Hepatic resection|hepatic resection
4995038|NCT04024956|Distal pancreatectomy|distal pancreatectomy
4995039|NCT04024956|Sealant|sealant
4995040|NCT04024930|EUS guided biliairy drainage|eus guided biliairy drainage
4995041|NCT04024930|EUS Choledoco-duodenostomy|eus choledoco-duodenostomy
4995042|NCT04024930|Axios stent|axios stent
4995043|NCT04024930|Lumen Apposing Metal Stent|lumen apposing metal stent
4995044|NCT04024917|Colon|colon
4995045|NCT04024917|Rectum|rectum
4995046|NCT04024917|Stomach|stomach
4995047|NCT04024917|Ovary|ovary
4995048|NCT04024904|regional anesthesia|regional anesthesia
4995049|NCT04024904|virtual reality|virtual reality
4995050|NCT04024904|hypnosis|hypnosis
4995051|NCT04024904|distraction|distraction
4995052|NCT04024891|Nyxol|nyxol
4995053|NCT04024891|Pharmacologically Induced Mydriasis|pharmacologically induced mydriasis
4995054|NCT04024891|Dilation|dilation
4995055|NCT04024878|Ovarian Cancer|ovarian cancer
4995056|NCT04024865|Domperidone|domperidone
4995057|NCT04024865|Postpartum|postpartum
4995058|NCT04024865|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
4995059|NCT04024865|Sudden Cardiac Death|sudden cardiac death
4995060|NCT04024852|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
4995061|NCT04024852|physical activity|physical activity
4995062|NCT04024852|air pollution|air pollution
4995063|NCT04024839|Active isolated stretch|active isolated stretch
4995064|NCT04024839|Active knee extension|active knee extension
4995192|NCT04023864|Body Fat|body fat
4995065|NCT04024839|Post isometric relaxation|post isometric relaxation
4995066|NCT04024839|Sit and reach test|sit and reach test
4995071|NCT04024813|Cholangitis, Sclerosing|cholangitis, sclerosing
4998384|NCT04004455|cancer|cancer
4995074|NCT04024813|Biliary Tract Diseases|biliary tract diseases
4995075|NCT04024813|Digestive System Diseases|digestive system diseases
4995076|NCT04024800|Triple-negative Breast Cancer|triple-negative breast cancer
4995077|NCT04024800|Tumor-specific immune response|tumor-specific immune response
4995078|NCT04024800|Open-Label|open-label
4995079|NCT04024800|Pembrolizumab|pembrolizumab
4995080|NCT04024800|Peptide vaccine|peptide vaccine
4995081|NCT04024800|Metastatic Breast Cancer|metastatic breast cancer
4995082|NCT04024800|Dose limiting toxicity|dose limiting toxicity
4995083|NCT04024800|RECIST 1.1|recist 1.1
4995084|NCT04024800|AE37|ae37
4995085|NCT04024761|Leukemia|leukemia
4995086|NCT04024709|G-POEM|g-poem
4995087|NCT04024709|gastroparesis|gastroparesis
4995089|NCT04024709|oral endoscopic pyloromyotomy|oral endoscopic pyloromyotomy
4995090|NCT04024670|arts in medicine|arts in medicine
4995091|NCT04024670|sewing|sewing
4995092|NCT04024644|third molar|third molar
4995093|NCT04024644|dental caries|dental caries
4995094|NCT04024644|periodontal disease|periodontal disease
4995095|NCT04024644|quality of life|quality of life
4995096|NCT04024631|polygenic risk for type 2 diabetes|polygenic risk for type 2 diabetes
4995097|NCT04024618|Non- Hodgkin's Lymphoma|non- hodgkin's lymphoma
4995098|NCT04024618|Hodgkin's Lymphoma|hodgkin's lymphoma
4995099|NCT04024618|Multiple Myeloma|multiple myeloma
4995100|NCT04024618|AHSCT|ahsct
4995101|NCT04024592|child|child
4995102|NCT04024592|dynamometry|dynamometry
4995103|NCT04024592|knee joint|knee joint
4995400|NCT04022642|Motivation|motivation
4995104|NCT04024592|reproducability of results|reproducability of results
4995106|NCT04024566|echocardiography|echocardiography
4995107|NCT04024553|bipolar disorder|bipolar disorder
4995108|NCT04024553|family|family
4995109|NCT04024553|genetic|genetic
4995110|NCT04024514|CT|ct
4995111|NCT04024514|Spectral|spectral
4995112|NCT04024501|URAT1 inhibitor|urat1 inhibitor
4995113|NCT04024501|Uric acid transporter 1|uric acid transporter 1
4995114|NCT04024501|Verinurad|verinurad
4995115|NCT04024501|Crossover study|crossover study
4995116|NCT04024501|Relative bioavailability|relative bioavailability
4995117|NCT04024501|Pharmacokinetics|pharmacokinetics
4995118|NCT04024488|Mental Health|mental health
4995119|NCT04024488|Adherence|adherence
4995120|NCT04024488|Trauma-Informed Cognitive Behavioral Therapy|trauma-informed cognitive behavioral therapy
4995121|NCT04024475|Radical prostatectomy|radical prostatectomy
4995122|NCT04024475|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
4995134|NCT04024410|anesthesia, general|anesthesia, general
4995135|NCT04024410|end-expiratory pressure, positive|end-expiratory pressure, positive
4995136|NCT04024410|respiration, artificial|respiration, artificial
4995137|NCT04024384|Myeloma|myeloma
4995138|NCT04024358|neural invasion|neural invasion
4995139|NCT04024358|vascular invasion|vascular invasion
4995140|NCT04024319|Total Knee Replacement|total knee replacement
4995141|NCT04024319|Genicular nerves block|genicular nerves block
4995142|NCT04024319|Postoperative pain|postoperative pain
4995143|NCT04024254|ovarian cancer|ovarian cancer
4995144|NCT04024254|breast cancer|breast cancer
4995145|NCT04024254|olaparib|olaparib
4995146|NCT04024254|folic acid deficiency|folic acid deficiency
4995147|NCT04024241|AML HAM|aml ham
4995148|NCT04024215|intravascular ultrasound|intravascular ultrasound
4995149|NCT04024150|Anti-integrases treatment|anti-integrases treatment
4995150|NCT04024150|Antiretroviral treatment|antiretroviral treatment
4995151|NCT04024150|Pregnancy|pregnancy
4995152|NCT04024124|Atrial fibrillation|atrial fibrillation
4995153|NCT04024124|Deep learning|deep learning
4995154|NCT04024124|Diagnosis|diagnosis
4995155|NCT04024124|Photoplethysmography|photoplethysmography
4995156|NCT04024124|Wearable electronic devices|wearable electronic devices
4995157|NCT04024111|Social groups|social groups
4995158|NCT04024111|Active contol group|active contol group
4995159|NCT04024111|Children|children
4995160|NCT04024111|Australian|australian
4995161|NCT04024033|perennial allergic rhinitis|perennial allergic rhinitis
4995162|NCT04023981|Parafricta|parafricta
4995163|NCT04023981|Pressure ulcer|pressure ulcer
4995164|NCT04023955|vaccination|vaccination
4995165|NCT04023955|feasibility|feasibility
4995166|NCT04023955|public housing|public housing
4995167|NCT04023942|Obesity|obesity
4995168|NCT04023942|Weight loss|weight loss
4995169|NCT04023942|Weight maintenance|weight maintenance
4995170|NCT04023942|Lifestyle intervention|lifestyle intervention
4995171|NCT04023942|Dietary intervention|dietary intervention
4995172|NCT04023942|Formula diet|formula diet
4995173|NCT04023942|App|app
4995174|NCT04023942|Newsletter|newsletter
4995175|NCT04023942|Digital tool|digital tool
4995176|NCT04023942|Low carb|low carb
4995177|NCT04023942|Low fat|low fat
4995178|NCT04023942|Meal challenges|meal challenges
4995179|NCT04023916|DLBCL|dlbcl
4995180|NCT04023916|Sintilimab|sintilimab
4995181|NCT04023916|R-CHOP|r-chop
4995185|NCT04023903|Healthy subject|healthy subject
4995186|NCT04023903|Food effect|food effect
4995187|NCT04023877|E2027|e2027
4995188|NCT04023877|[14C]E2027|[14c]e2027
4995189|NCT04023877|Dementia with Lewy bodies|dementia with lewy bodies
4995190|NCT04023877|Dementia|dementia
4995191|NCT04023864|Platycodon Grandiflorus Extract|platycodon grandiflorus extract
4995193|NCT04023851|Epilepsy|epilepsy
4995194|NCT04023851|Seizure diary|seizure diary
4995195|NCT04023851|Mobile application|mobile application
4995196|NCT04023838|Radiation|radiation
4995197|NCT04023838|Snuffbox approach|snuffbox approach
4995198|NCT04023838|Radial approach|radial approach
4995199|NCT04023838|Vascular access|vascular access
4995200|NCT04023825|cleft palate|cleft palate
4995201|NCT04023825|surgery|surgery
4995202|NCT04023825|maxillary nerve block|maxillary nerve block
4995203|NCT04023825|local anesthetic|local anesthetic
4995204|NCT04023825|loco regional anesthesia|loco regional anesthesia
4995205|NCT04023825|face nerve block|face nerve block
4995227|NCT04023669|CHK1/2 Inhibitor|chk1/2 inhibitor
4995228|NCT04023669|Combination therapy|combination therapy
4995229|NCT04023669|Indeterminate molecular subgroup|indeterminate molecular subgroup
4995230|NCT04023669|Medulloblastoma, Group 3|medulloblastoma, group 3
4995231|NCT04023669|Medulloblastoma, Group 4|medulloblastoma, group 4
4995232|NCT04023669|Medulloblastoma, G3/G4|medulloblastoma, g3/g4
4995233|NCT04023669|Progressive brain tumor|progressive brain tumor
4995234|NCT04023669|Recurrent brain tumor|recurrent brain tumor
4995241|NCT04023669|Molecular|molecular
4995242|NCT04023669|Molecular therapy|molecular therapy
4995243|NCT04023656|paroxysmal kinesigenic choreoathetosis|paroxysmal kinesigenic choreoathetosis
4995244|NCT04023656|Prognosis|prognosis
4995245|NCT04023656|Korean population|korean population
4995246|NCT04023604|antibiotics|antibiotics
4995247|NCT04023604|gut microbiome|gut microbiome
4995248|NCT04023604|antimicrobial resistance|antimicrobial resistance
4995249|NCT04023604|beef|beef
4995250|NCT04023591|tetraplegia|tetraplegia
4995251|NCT04023591|spinal cord injury|spinal cord injury
4995252|NCT04023591|quadriplegia|quadriplegia
4995253|NCT04023591|nerve transfer|nerve transfer
4995254|NCT04023565|perindopril|perindopril
4995255|NCT04023565|moxonidine|moxonidine
4995257|NCT04023539|Cinnamon|cinnamon
4995258|NCT04023539|Type 2 diabetes|type 2 diabetes
4995259|NCT04023539|Diabetes|diabetes
4995260|NCT04023539|México|méxico
4995261|NCT04023539|Cinnamomum zeylanicum|cinnamomum zeylanicum
4995262|NCT04023539|Randomized Controlled Trial|randomized controlled trial
5036066|NCT03773770|TFP|tfp
4995263|NCT04023539|Glycated hemoglobin|glycated hemoglobin
4995264|NCT04023539|Glucose control|glucose control
4995265|NCT04023513|aging|aging
4995266|NCT04023513|protein intake|protein intake
4995267|NCT04023513|reistance training|reistance training
4995268|NCT04023487|Diabetes Mellitus, Type 1, randomized controlled trial|diabetes mellitus, type 1, randomized controlled trial
4995269|NCT04023474|Platelet-Rich Fibrin (PRF)|platelet-rich fibrin (prf)
4995270|NCT04023461|Radiofrequency Ablation|radiofrequency ablation
4995271|NCT04023461|Atrial Fibrilation|atrial fibrilation
4995272|NCT04023461|PVAC GOLD catheter|pvac gold catheter
4995273|NCT04023461|Elderly patients|elderly patients
4995274|NCT04023448|rectal cancer|rectal cancer
4995275|NCT04023435|chronic|chronic
4995276|NCT04023435|Low-Back Pain|low-back pain
4995277|NCT04023435|Depression|depression
4995278|NCT04023396|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
4995279|NCT04023344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
4995280|NCT04023344|Lispro Biphasic|lispro biphasic
4995281|NCT04023344|Insulin|insulin
4995282|NCT04023305|Nonfocal Acute respiratory distress syndrome|nonfocal acute respiratory distress syndrome
4995283|NCT04023305|Focal Acute respiratory distress syndrome|focal acute respiratory distress syndrome
4995284|NCT04023305|Sevoflurane|sevoflurane
4995285|NCT04023305|Pharmacokinetics|pharmacokinetics
5705949|NCT00479856|lapatinib|lapatinib
4995286|NCT04023305|Mechanical ventilation|mechanical ventilation
4995287|NCT04023292|Hormone receptors-positive breast neoplasms|hormone receptors-positive breast neoplasms
4995288|NCT04023292|preoperative endocrine therapy|preoperative endocrine therapy
4995289|NCT04023292|Ki-67|ki-67
4995290|NCT04023279|Manual therapy|manual therapy
4995291|NCT04023279|Myofascial release|myofascial release
4995292|NCT04023279|Lateral epicondylitis|lateral epicondylitis
4995293|NCT04023279|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
4995294|NCT04023279|Pain|pain
4995295|NCT04023279|Strength|strength
4995296|NCT04023279|Functionality|functionality
4995297|NCT04023266|STEMI|stemi
4995298|NCT04023227|Chagas' disease|chagas' disease
4995299|NCT04023227|heart failure|heart failure
4995300|NCT04023227|angiotensin receptor-neprilysin inhibitor|angiotensin receptor-neprilysin inhibitor
4995301|NCT04023227|ARNI|arni
4995303|NCT04023227|ACEI|acei
4995304|NCT04023227|sacubitril/valsartan|sacubitril/valsartan
4995305|NCT04023227|enalapril|enalapril
4995306|NCT04023188|atrial fibrillation|atrial fibrillation
4995309|NCT04023188|photoplethysmography|photoplethysmography
4995310|NCT04023188|wearable electronic devices|wearable electronic devices
4995311|NCT04023175|Virtual visit|virtual visit
4995312|NCT04023175|Preoperative counseling|preoperative counseling
4995313|NCT04023175|Preoperative preparedness|preoperative preparedness
4995314|NCT04023162|Low Back Pain|low back pain
4995315|NCT04023162|Exercise Therapy|exercise therapy
4995316|NCT04023162|Operant Conditioning|operant conditioning
4995317|NCT04023149|pemphigus vulgaris|pemphigus vulgaris
4995318|NCT04023149|oral mucosal lesion|oral mucosal lesion
4995319|NCT04023149|interleukin-2|interleukin-2
4995320|NCT04023110|Risk-Guided Intervention|risk-guided intervention
4995321|NCT04023110|Carvedilol|carvedilol
4995322|NCT04023110|Cardiotoxicity of Chemotherapy|cardiotoxicity of chemotherapy
4995323|NCT04023110|Cardio-Oncology|cardio-oncology
4995324|NCT04023110|Cardiomyopathy|cardiomyopathy
4995325|NCT04023084|dermatologic agents|dermatologic agents
4995330|NCT04023071|Lymphoma|lymphoma
4995331|NCT04023058|ischemic mitral regurgitation|ischemic mitral regurgitation
4995332|NCT04023058|mitral surgery|mitral surgery
4995333|NCT04023058|stress echo|stress echo
4995334|NCT04023019|Blood disorders|blood disorders
4995335|NCT04023006|Denture|denture
4995336|NCT04022993|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4995337|NCT04022993|Insulin|insulin
4995338|NCT04022993|Glargine|glargine
4995339|NCT04022967|Africa|africa
4995340|NCT04022967|Antiretroviral Treatment|antiretroviral treatment
4995341|NCT04022967|HIV-1|hiv-1
4995342|NCT04022967|Adults|adults
4995343|NCT04022967|Dual maintenance therapy|dual maintenance therapy
4995344|NCT04022967|Dolutegravir|dolutegravir
4995345|NCT04022967|Atazanavir|atazanavir
4995346|NCT04022928|Ankle joint|ankle joint
4995347|NCT04022928|Osteoarthritis|osteoarthritis
4995348|NCT04022928|Platelet rich plasma|platelet rich plasma
4995349|NCT04022902|Pneumoconiosis|pneumoconiosis
4995350|NCT04022902|Self-care|self-care
4995351|NCT04022902|Care-giving|care-giving
4995352|NCT04022889|INTERCEPT|intercept
4995353|NCT04022889|Recovery|recovery
4995354|NCT04022889|Survival|survival
4995355|NCT04022889|5 days|5 days
4995356|NCT04022889|6 days|6 days
4995357|NCT04022889|7 days|7 days
4995358|NCT04022889|Radiolabeled|radiolabeled
4995359|NCT04022889|Autologous|autologous
4995361|NCT04022863|ctDNA|ctdna
4995362|NCT04022863|ovarian cancer|ovarian cancer
4995363|NCT04022824|Coronary artery disease|coronary artery disease
4995364|NCT04022824|Obstructive sleep apnea|obstructive sleep apnea
4995365|NCT04022824|Optical coherence tomography|optical coherence tomography
4995366|NCT04022824|Vascular response|vascular response
4995367|NCT04022811|Pterygium|pterygium
4995368|NCT04022811|Bromofenac|bromofenac
4995369|NCT04022811|Pain|pain
4995370|NCT04022798|Low back pain|low back pain
4995371|NCT04022798|Neural mobilization|neural mobilization
4995372|NCT04022798|lumbar stabilization exercise|lumbar stabilization exercise
4995373|NCT04022798|Radial extracorporeal shock wave therapy|radial extracorporeal shock wave therapy
4995374|NCT04022759|Attachment|attachment
4995375|NCT04022759|Improving Access to Psychological Therapies|improving access to psychological therapies
4995376|NCT04022759|Security priming|security priming
4995377|NCT04022720|platelet rich fibrin (PRF)|platelet rich fibrin (prf)
4995378|NCT04022707|Elderly|elderly
4995379|NCT04022707|Circuit training|circuit training
4995380|NCT04022707|Cognitive ability|cognitive ability
4995381|NCT04022707|Cardiovascular condition|cardiovascular condition
4995382|NCT04022694|Food Labeling|food labeling
4995383|NCT04022694|Adolescents|adolescents
4995384|NCT04022668|Acute Coronary Occlusion|acute coronary occlusion
4995385|NCT04022668|Occlusive Myocardial Infarction|occlusive myocardial infarction
5706158|NCT00478959|Revlimid|revlimid
4995386|NCT04022668|Non-occlusive Myocardial Infarction|non-occlusive myocardial infarction
4995387|NCT04022668|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4995388|NCT04022668|Non-ST Elevated Myocardial Infarction|non-st elevated myocardial infarction
4995389|NCT04022668|Coronary Occlusion|coronary occlusion
4995390|NCT04022668|Coronary Thrombosis|coronary thrombosis
4995391|NCT04022668|Myocardial Ischemia|myocardial ischemia
4995392|NCT04022668|Coronary Disease|coronary disease
4995393|NCT04022655|Intensive Care Unit|intensive care unit
4995394|NCT04022655|Mortality|mortality
4995395|NCT04022655|Autoimmune Diseases|autoimmune diseases
4995396|NCT04022642|HIIT|hiit
4995397|NCT04022642|Adolescents|adolescents
4995398|NCT04022642|Physical Exercise|physical exercise
4995399|NCT04022642|Health|health
4995404|NCT04022577|Motivational Interviewing|motivational interviewing
4995405|NCT04022577|Schizophrenia Spectrum Disorder|schizophrenia spectrum disorder
4995406|NCT04022577|Symptom severity|symptom severity
4995407|NCT04022577|Randomized controlled trial|randomized controlled trial
4995408|NCT04022564|multiple sclerosis|multiple sclerosis
4995409|NCT04022564|Survival Analysis|survival analysis
4995410|NCT04022564|cause of death|cause of death
4995411|NCT04022564|medical resources|medical resources
4995415|NCT04022538|Sandwich Osteotomy|sandwich osteotomy
4995416|NCT04022512|Lung nodules|lung nodules
4995417|NCT04022512|Deep learning|deep learning
4995418|NCT04022512|Artificial intelligence|artificial intelligence
4995419|NCT04022512|Computer-aided diagnosis|computer-aided diagnosis
4995421|NCT04022473|Gastrointestinal|gastrointestinal
4995422|NCT04022460|Polysomnography|polysomnography
4995424|NCT04022460|Down syndrome|down syndrome
4995425|NCT04022460|Obstructive sleep apnea|obstructive sleep apnea
4995426|NCT04022460|Screening tool|screening tool
4995437|NCT04022369|Physical Activity|physical activity
4995438|NCT04022356|counting|counting
4995439|NCT04022356|steps|steps
4995440|NCT04022356|Connected Soles|connected soles
4995441|NCT04022330|Left Ventricular Hypertrophy|left ventricular hypertrophy
4995442|NCT04022330|Cardiac macrophages|cardiac macrophages
5311882|NCT02120950|PCV|pcv
4995443|NCT04022317|Recombinant Human Insulin R (rhi R)|recombinant human insulin r (rhi r)
4995444|NCT04022304|Recombinant Human Insulin N (rhi N)|recombinant human insulin n (rhi n)
4995445|NCT04022252|orthodontics|orthodontics
4995446|NCT04022252|tooth movement|tooth movement
4995447|NCT04022213|Solid Tumor|solid tumor
4995448|NCT04022213|Peritoneal Solid Tumor|peritoneal solid tumor
4995449|NCT04022213|DSRC|dsrc
4995450|NCT04022213|I131-Omburtamab|i131-omburtamab
4995451|NCT04022213|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4995452|NCT04022213|19-182|19-182
4995453|NCT04022200|drug-coated balloon|drug-coated balloon
4995454|NCT04022200|angioplasty|angioplasty
4995455|NCT04022200|de novo lesions|de novo lesions
4995456|NCT04022187|Bulbocavernosus reflex|bulbocavernosus reflex
4995457|NCT04022187|Spasticity assessment|spasticity assessment
4995458|NCT04022187|Motoneurone excitability|motoneurone excitability
4995459|NCT04022187|Stimulus-response curves|stimulus-response curves
4995460|NCT04022174|Motor Imagery|motor imagery
4995461|NCT04022174|Action observation|action observation
4995462|NCT04022161|Cardiac surgery|cardiac surgery
4995463|NCT04022161|Nitric oxide|nitric oxide
4995464|NCT04022161|Oxidative Stress|oxidative stress
4995465|NCT04022161|Redox Thiols couples|redox thiols couples
4995466|NCT04022161|Lipids peroxidation|lipids peroxidation
4995467|NCT04022161|Protein Oxidation|protein oxidation
4995468|NCT04022148|uterine cervical cancer|uterine cervical cancer
4995469|NCT04022148|HPV vaccine|hpv vaccine
4995470|NCT04022148|cancer screening|cancer screening
4995471|NCT04022135|folate|folate
4995472|NCT04022135|folic acid|folic acid
4995473|NCT04022135|nutrition|nutrition
4995474|NCT04022135|pregnancy|pregnancy
4995475|NCT04022122|Socioeconomic Level|socioeconomic level
4995476|NCT04022122|Disease Management|disease management
4995477|NCT04022122|Chronic Care Model|chronic care model
4995478|NCT04022122|Transitional Care|transitional care
4995479|NCT04022109|Volatile organic compounds|volatile organic compounds
4995480|NCT04022109|Breath testing|breath testing
4995481|NCT04022109|Gastric cancer|gastric cancer
4995482|NCT04022109|Atrophic gastritis|atrophic gastritis
4995483|NCT04022109|Precancerous lesions|precancerous lesions
4995484|NCT04022109|Screening|screening
4995485|NCT04022109|Nanosensor technology|nanosensor technology
4995486|NCT04022109|GC-MS|gc-ms
4995490|NCT04022018|cervical cancer|cervical cancer
4995491|NCT04022018|adaptive radiotherapy|adaptive radiotherapy
4995492|NCT04022018|side effects|side effects
4995493|NCT04021953|HIV Testing|hiv testing
4995494|NCT04021953|STI Testing|sti testing
4995495|NCT04021953|Homophobia|homophobia
4995496|NCT04021953|eHealth|ehealth
4995497|NCT04021953|Singapore|singapore
4995498|NCT04021914|CVD|cvd
4995499|NCT04021914|color vision deficiency|color vision deficiency
4995500|NCT04021914|healthcare providers|healthcare providers
4995501|NCT04021914|emergency department|emergency department
4995510|NCT04021823|Predictors of treatment response in DBS|predictors of treatment response in dbs
4995512|NCT04021810|CPAP|cpap
4995513|NCT04021810|Mandibular Advancement Device|mandibular advancement device
4995514|NCT04021810|Arterial Hypertension|arterial hypertension
4995515|NCT04021758|Suicide prevention|suicide prevention
4995516|NCT04021758|Peer mentoring|peer mentoring
4995517|NCT04021719|First Episode Psychosis|first episode psychosis
4995518|NCT04021719|Learning Healthcare system|learning healthcare system
4995519|NCT04021719|Stakeholders|stakeholders
4995520|NCT04021719|Data infrastructure|data infrastructure
4995521|NCT04021719|Psychotic disorders|psychotic disorders
4995522|NCT04021719|Mental disorders|mental disorders
4995523|NCT04021719|Schizophrenia Spectrum and Other Psychotic Disorders|schizophrenia spectrum and other psychotic disorders
4995524|NCT04021693|Medical Education|medical education
4995525|NCT04021667|Breastfeeding|breastfeeding
4995526|NCT04021667|Parents Training|parents training
4995527|NCT04021667|Self-Effıcacy|self-effıcacy
5011916|NCT03921801|Balance|balance
4995540|NCT04021615|difficult weaning|difficult weaning
4995541|NCT04021602|diabetes prevention program|diabetes prevention program
4995542|NCT04021602|breastfeeding|breastfeeding
4995543|NCT04021602|prediabetes|prediabetes
4995544|NCT04021550|Telmisartan|telmisartan
4995545|NCT04021550|Alpha-Lipoic Acid|alpha-lipoic acid
4995546|NCT04021550|Continuous Positive Airway Pressure|continuous positive airway pressure
4995547|NCT04021550|24-hour blood pressure|24-hour blood pressure
4995548|NCT04021511|overcrowding|overcrowding
4995549|NCT04021511|x rays|x rays
4995550|NCT04021511|emergency department|emergency department
4995551|NCT04021511|Ottawa Ankle Rules|ottawa ankle rules
4995552|NCT04021511|nurse practitioner|nurse practitioner
4995553|NCT04021498|Pancreatitis|pancreatitis
4995554|NCT04021498|Acute pancreatitis|acute pancreatitis
4995555|NCT04021498|Chronic pancreatitis|chronic pancreatitis
4995556|NCT04021498|Simvastatin|simvastatin
4995557|NCT04021498|Recurrent|recurrent
4995558|NCT04021472|Disease prevention|disease prevention
4995559|NCT04021472|Peer health coaching|peer health coaching
4995560|NCT04021472|Digital health|digital health
4995561|NCT04021472|Text messaging|text messaging
4995562|NCT04021459|endometrial cancer|endometrial cancer
4995563|NCT04021459|circulating tumor cells|circulating tumor cells
4995564|NCT04021459|laparoscopy|laparoscopy
4995565|NCT04021407|AirQ|airq
4995566|NCT04021407|LMA|lma
4995567|NCT04021407|dacrocystorhinostomy surgery|dacrocystorhinostomy surgery
4995568|NCT04021394|circulating tumor cell|circulating tumor cell
4995569|NCT04021394|epithelial-to-mesenchymal transition|epithelial-to-mesenchymal transition
4995570|NCT04021394|treatment response|treatment response
4995571|NCT04021394|phenotype|phenotype
4995572|NCT04021381|Urolithiasis|urolithiasis
4995573|NCT04021381|Urinary Calculi|urinary calculi
4995574|NCT04021381|Ureteroscopy|ureteroscopy
4995575|NCT04021381|Residual fragments|residual fragments
4995576|NCT04021381|Morphoconstitutional analysis|morphoconstitutional analysis
4995577|NCT04021381|Citrate|citrate
4995583|NCT04021342|Tart cherry|tart cherry
4995584|NCT04021342|Montmorency cherries|montmorency cherries
4995585|NCT04021342|Prunus Cerasus|prunus cerasus
4995586|NCT04021329|Post-traumatic Stress Disorder, Major Depressive Disorder, Comorbidity, Eye Movement Desensitization & Reprocessing, Cognitive Behavioral Therapy|post-traumatic stress disorder, major depressive disorder, comorbidity, eye movement desensitization & reprocessing, cognitive behavioral therapy
4995587|NCT04021316|Compression therapy|compression therapy
4995588|NCT04021316|Ulcer|ulcer
4995589|NCT04021303|Gluten|gluten
4995590|NCT04021303|Probiotic|probiotic
4995591|NCT04021303|Prebiotic|prebiotic
4995593|NCT04021264|Major abdominal surgery|major abdominal surgery
4995599|NCT04021225|Ectoin® Allergy Eye Drops 2%|ectoin® allergy eye drops 2%
4995600|NCT04021225|Ectoin® Eye Spray Colloidal|ectoin® eye spray colloidal
4995601|NCT04021225|Ectoin|ectoin
4995602|NCT04021212|Pituitary|pituitary
4995603|NCT04021212|Pituitary Adenoma|pituitary adenoma
4995604|NCT04021212|Serum Lipid Levels|serum lipid levels
4995605|NCT04021212|Resection|resection
4995606|NCT04021212|Recurrence|recurrence
4995607|NCT04021160|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4995608|NCT04021147|Motor Imagery|motor imagery
4995609|NCT04021147|Action observation|action observation
4995610|NCT04021147|Visual mirror feedback|visual mirror feedback
4995611|NCT04021147|Pain pressure thresholds|pain pressure thresholds
4995612|NCT04021082|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
4995613|NCT04021082|T-Cell Leukemia|t-cell leukemia
4995614|NCT04021082|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
4995615|NCT04021082|Nodal|nodal
4995616|NCT04021082|PTCL|ptcl
4995617|NCT04021082|Angioimmunoblastic|angioimmunoblastic
4995618|NCT04021082|AITL|aitl
4995619|NCT04021082|Anaplastic|anaplastic
4995620|NCT04021082|ALCL|alcl
4995621|NCT04021082|EATL|eatl
4995622|NCT04021082|Follicular|follicular
4995623|NCT04021082|FTCL|ftcl
4995624|NCT04021082|hepatosplenic|hepatosplenic
4995625|NCT04021082|HSTCL|hstcl
4995627|NCT04021082|SYK|syk
4995628|NCT04021082|JAK/STAT|jak/stat
4995629|NCT04021069|radiomics|radiomics
4995630|NCT04021069|pathomics|pathomics
4995631|NCT04021069|breast cancer|breast cancer
4995632|NCT04021069|machine learning|machine learning
4995633|NCT04021069|biomarkers|biomarkers
4995635|NCT04021017|estrogen|estrogen
4995636|NCT04021017|anorexia|anorexia
4995637|NCT04021017|bone health|bone health
4995638|NCT04021017|bone accrual|bone accrual
4995639|NCT04021017|IGF-1|igf-1
4995640|NCT04020978|Functional Imaging|functional imaging
4995641|NCT04020978|Dynamic PET|dynamic pet
4995642|NCT04020978|tracer kinetic modeling|tracer kinetic modeling
4995643|NCT04020978|treatment response|treatment response
4995644|NCT04020952|canine retraction|canine retraction
4995645|NCT04020952|archwire gauge|archwire gauge
4995654|NCT04020913|muscle strength|muscle strength
4995655|NCT04020913|prepubertal|prepubertal
4995656|NCT04020913|boys|boys
4995657|NCT04020913|short stature|short stature
4995658|NCT04020913|GH treatment|gh treatment
4995659|NCT04020913|muscle agility|muscle agility
4995660|NCT04020900|Children|children
4995661|NCT04020900|Respiratory|respiratory
4995664|NCT04020874|concussion|concussion
4995665|NCT04020874|tackle|tackle
4995666|NCT04020874|youth sports|youth sports
4995672|NCT04020822|Acetaminophen|acetaminophen
4995676|NCT04020783|Primary aldosteronism|primary aldosteronism
4995677|NCT04020783|Screening|screening
4995678|NCT04020731|Hypnosis|hypnosis
4995680|NCT04020731|Auditory Evoked Magnetic Fields|auditory evoked magnetic fields
4995681|NCT04020731|Oscillatory activity|oscillatory activity
4995682|NCT04020731|Networks|networks
4995683|NCT04020718|mobile health|mobile health
4995684|NCT04020705|Glaucoma|glaucoma
4995685|NCT04020705|Glaucoma Open Angle|glaucoma open angle
4995686|NCT04020705|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
4995687|NCT04020692|Multicenter study|multicenter study
4995688|NCT04020692|Before-and-after type study|before-and-after type study
4995689|NCT04020692|Minimal risks and constraints|minimal risks and constraints
4995690|NCT04020653|Uncomplicated malaria|uncomplicated malaria
4995691|NCT04020653|sodium ferrous citrate (SFC)|sodium ferrous citrate (sfc)
5312118|NCT02120001|Drug-Resistance|drug-resistance
4995692|NCT04020653|5-aminolevulinic acid hydrochloride (5-ALA HCl)|5-aminolevulinic acid hydrochloride (5-ala hcl)
4995693|NCT04020653|artemisinin-based combination therapy|artemisinin-based combination therapy
4995694|NCT04020640|human milk intake|human milk intake
4995695|NCT04020640|dose-to-mother deuterium oxide|dose-to-mother deuterium oxide
4995703|NCT04020627|Hemodynamics|hemodynamics
4995704|NCT04020614|Colorectal Cancer|colorectal cancer
4995706|NCT04020614|Screening|screening
4995707|NCT04020588|schizophrenia|schizophrenia
4995708|NCT04020588|adolescents|adolescents
4995709|NCT04020588|inflammation|inflammation
4995710|NCT04020588|anti-inflammatory|anti-inflammatory
4995711|NCT04020562|Pulmonary Function Test|pulmonary function test
4995712|NCT04020562|Spinal Cord|spinal cord
4991804|NCT04043962|CBT|cbt
4995713|NCT04020562|Breathing Exercise|breathing exercise
4995714|NCT04020562|Expiratory|expiratory
4995715|NCT04020536|real world study|real world study
4995716|NCT04020523|MRI|mri
4995717|NCT04020523|breast|breast
4995718|NCT04020523|cancer|cancer
4995719|NCT04020523|screening|screening
4995720|NCT04020523|innovative sequences|innovative sequences
4995721|NCT04020497|target support|target support
4995722|NCT04020497|informal caregiver|informal caregiver
4995723|NCT04020497|recovery|recovery
4995724|NCT04020497|well-being|well-being
4995725|NCT04020497|burden|burden
4995726|NCT04020497|quality of life|quality of life
4995727|NCT04020471|Pharmacogenomic Profile|pharmacogenomic profile
4995728|NCT04020471|Knee Osteoarthritis|knee osteoarthritis
4995729|NCT04020471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4995730|NCT04020471|Narcotic Use|narcotic use
4995731|NCT04020458|Kidney transplant, Immunoprofiling|kidney transplant, immunoprofiling
4995732|NCT04020445|iDegLira|ideglira
4995733|NCT04020445|deintensification|deintensification
4995734|NCT04020445|overtreatment|overtreatment
4995735|NCT04020445|simplification|simplification
4995736|NCT04020445|type 2 diabetes|type 2 diabetes
4995737|NCT04020432|knowledge|knowledge
4995738|NCT04020432|medicine|medicine
4995739|NCT04020432|pictogram|pictogram
4995740|NCT04020432|pregnant woman|pregnant woman
4995741|NCT04020432|childbearing age woman|childbearing age woman
4995742|NCT04020419|miR126|mir126
4995743|NCT04020419|Pediaberry|pediaberry
4995744|NCT04020393|septorhinoplasty|septorhinoplasty
4995745|NCT04020393|sphenopalatine ganglion|sphenopalatine ganglion
4995746|NCT04020393|postoperative pain|postoperative pain
4995747|NCT04020354|motor skill learning|motor skill learning
4995748|NCT04020354|functional changes|functional changes
4995749|NCT04020354|neuroplastic changes|neuroplastic changes
4995750|NCT04020354|biomechanical changes|biomechanical changes
4995757|NCT04020315|aggressive periodontitis|aggressive periodontitis
4995758|NCT04020315|gingival crevicular fluid|gingival crevicular fluid
4995775|NCT04020224|transfusion-transmitted infection|transfusion-transmitted infection
4995776|NCT04020224|whole blood|whole blood
4995777|NCT04020198|Alpha-synuclein|alpha-synuclein
4999073|NCT04000490|Assessment|assessment
4995784|NCT04020133|ACL|acl
4995785|NCT04020133|popliteal plexus block|popliteal plexus block
4995786|NCT04020133|saphenous nerve block|saphenous nerve block
4995787|NCT04020120|Prospective|prospective
4995788|NCT04020120|Descriptive|descriptive
4995789|NCT04020120|Non-interventional|non-interventional
4995790|NCT04020120|Monocentric|monocentric
4995791|NCT04020094|intermediate-risk prostate cancer|intermediate-risk prostate cancer
4995792|NCT04020094|high-risk prostate cancer|high-risk prostate cancer
4995793|NCT04020094|very high-risk prostate cancer|very high-risk prostate cancer
4995794|NCT04020081|Yoga|yoga
4995795|NCT04020081|Meditation|meditation
4995796|NCT04020081|COPD|copd
4995818|NCT04019886|Neonates|neonates
4995819|NCT04019886|Neurofacilitation Technique|neurofacilitation technique
4995820|NCT04019886|Respiration|respiration
4995822|NCT04019873|HIV|hiv
4995823|NCT04019873|Lamivudine|lamivudine
4995824|NCT04019873|COMBINE-2|combine-2
4995825|NCT04019873|Dolutegravir|dolutegravir
4995826|NCT04019860|Exercise|exercise
4995827|NCT04019860|Diet|diet
4995828|NCT04019860|Overweight|overweight
4995829|NCT04019860|Glycaemic control|glycaemic control
4995830|NCT04019860|Fitness|fitness
4995831|NCT04019860|Body composition|body composition
4995832|NCT04019821|super bolus|super bolus
4995833|NCT04019821|diabetes type 1|diabetes type 1
4995834|NCT04019821|insulin bolus|insulin bolus
4995835|NCT04019821|high glycemic index meal|high glycemic index meal
4995836|NCT04019821|prandial insulin requirement|prandial insulin requirement
4995837|NCT04019821|postprandial glycemia|postprandial glycemia
4995838|NCT04019821|insulin pump therapy|insulin pump therapy
4995844|NCT04019795|Hair Loss|hair loss
4995845|NCT04019795|Pattern Hair Loss|pattern hair loss
4995847|NCT04019795|Modulated Light Therapy|modulated light therapy
4995848|NCT04019795|Red Light|red light
4995849|NCT04019782|Osteoarthritis|osteoarthritis
4995850|NCT04019782|Intraarticular Injections|intraarticular injections
4995851|NCT04019782|Viscosupplementations|viscosupplementations
4995852|NCT04019782|Type I Collagen|type i collagen
4995853|NCT04019782|Patient Outcome Assessment|patient outcome assessment
4995854|NCT04019782|Patient Reported Outcome Measures|patient reported outcome measures
4995855|NCT04019769|Eczema|eczema
4995856|NCT04019769|MTORC1 Signaling|mtorc1 signaling
4995857|NCT04019769|CBM Complex|cbm complex
4995858|NCT04019704|Depressive Disorder|depressive disorder
5706159|NCT00478959|Hodgkin's|hodgkin's
4995859|NCT04019704|Depressive Disorder, Major|depressive disorder, major
4995860|NCT04019704|Bupropion|bupropion
4995861|NCT04019704|Dextromethorphan|dextromethorphan
4995863|NCT04019704|Dopamine Reuptake Inhibitor|dopamine reuptake inhibitor
4995864|NCT04019704|AXS-05|axs-05
4995865|NCT04019704|NMDA Receptor Antagonist|nmda receptor antagonist
4995866|NCT04019704|Central Nervous System|central nervous system
4995867|NCT04019704|CNS|cns
4995868|NCT04019704|Sigma-1 Receptor Agonist|sigma-1 receptor agonist
4995869|NCT04019704|Nicotinic Acetylcholine Receptor Antagonist|nicotinic acetylcholine receptor antagonist
4995870|NCT04019704|Norepinephrine Reuptake Inhibitor|norepinephrine reuptake inhibitor
4995873|NCT04019704|GEMINI|gemini
4995874|NCT04019704|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
4995875|NCT04019691|multifocal intraocular lens|multifocal intraocular lens
4995876|NCT04019665|Cognition Disorder|cognition disorder
4995877|NCT04019665|Alzheimer Disease|alzheimer disease
4995878|NCT04019665|MMSE|mmse
4995879|NCT04019665|SAGE|sage
4995880|NCT04019652|Hypertension|hypertension
4995881|NCT04019652|Mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
4995882|NCT04019639|ADM|adm
4995883|NCT04019639|acellular dermal matrix|acellular dermal matrix
4995884|NCT04019613|dyspnea|dyspnea
4995885|NCT04019613|heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
4995886|NCT04019613|pulmonary edema|pulmonary edema
4995887|NCT04019613|lung ultrasound|lung ultrasound
4995888|NCT04019613|extravascular lung water|extravascular lung water
4995893|NCT04019561|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4995894|NCT04019561|NAFLD|nafld
4995895|NCT04019561|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
4995896|NCT04019561|NASH|nash
4995897|NCT04019561|0382|0382
4995900|NCT04019496|electroencephalography|electroencephalography
4995901|NCT04019496|functional magnetic resonance imaging|functional magnetic resonance imaging
4995902|NCT04019496|evoked potentials|evoked potentials
4995904|NCT04019483|Infarct detection|infarct detection
4995905|NCT04019483|CT|ct
4995906|NCT04019483|MRI|mri
4995907|NCT04019483|Diagnosis|diagnosis
4995908|NCT04019483|Prognosis|prognosis
4995910|NCT04019444|ChAd155-RG|chad155-rg
4995911|NCT04019444|Dosage-Escalation|dosage-escalation
4995912|NCT04019444|Healthy|healthy
4995913|NCT04019444|Immunogenicity|immunogenicity
4995914|NCT04019444|RABAVERT|rabavert
4995915|NCT04019444|Rabies|rabies
4995916|NCT04019444|Safety|safety
4995917|NCT04019444|Vaccine|vaccine
4995918|NCT04019418|carbohydrate|carbohydrate
4995919|NCT04019418|exercise|exercise
4995920|NCT04019418|PYY|pyy
4995921|NCT04019418|GLP-1|glp-1
4995922|NCT04019418|ghrelin|ghrelin
4995923|NCT04019418|hormones|hormones
4995924|NCT04019405|coronary artery disease|coronary artery disease
4995925|NCT04019405|elderly|elderly
4995926|NCT04019405|revascularisation|revascularisation
4995927|NCT04019405|frailty|frailty
4995929|NCT04019379|Whole-body balance|whole-body balance
4995930|NCT04019379|Kinetic modeling|kinetic modeling
4995931|NCT04019379|Intestinal absorption|intestinal absorption
4995932|NCT04019366|Balance Training|balance training
4995933|NCT04019366|Biodex stability system|biodex stability system
4995934|NCT04019366|Osteoarthrosis|osteoarthrosis
4995935|NCT04019366|Degenerative|degenerative
4995936|NCT04019366|Stability exercises|stability exercises
4995937|NCT04019340|patient education|patient education
4995938|NCT04019327|talazoparib|talazoparib
4995939|NCT04019327|temozolomide|temozolomide
4995940|NCT04019327|Prostate cancer|prostate cancer
4995941|NCT04019327|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4995942|NCT04019327|19-041|19-041
4995943|NCT04019301|Cancer Caregiver|cancer caregiver
4995944|NCT04019301|Qigong|qigong
4995945|NCT04019301|Feasibility|feasibility
4995946|NCT04019301|Caregiver distress|caregiver distress
4995947|NCT04019275|disability, rehabilitation|disability, rehabilitation
4995948|NCT04019262|Chemo-Radiation Therapy|chemo-radiation therapy
4995949|NCT04019262|temozolomide|temozolomide
4995950|NCT04019262|lymphocytopenia|lymphocytopenia
4995951|NCT04019249|eHealth, web-based, internet-based, digital, body weight|ehealth, web-based, internet-based, digital, body weight
4995952|NCT04019197|HIV|hiv
4995953|NCT04019197|lipohypertrophy|lipohypertrophy
4995954|NCT04019197|semaglutide|semaglutide
4995955|NCT04019197|GLP-1 receptor agonist|glp-1 receptor agonist
4995956|NCT04019197|obesity|obesity
4995959|NCT04019158|Parkinson's Disease|parkinson's disease
4995960|NCT04019158|Virtual reality|virtual reality
4995961|NCT04019158|Gait|gait
4995962|NCT04019158|Variability|variability
4995963|NCT04019158|Fractal|fractal
4995964|NCT04019132|Muscle Power|muscle power
4995965|NCT04019132|Functional capacity|functional capacity
4995966|NCT04019106|Surfactant|surfactant
4995967|NCT04019106|Budesonide|budesonide
4995968|NCT04019106|Steroid|steroid
4995969|NCT04019106|Intratracheal|intratracheal
4995970|NCT04019106|Preterm|preterm
4995971|NCT04019106|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4995972|NCT04019106|Respiratory Distress Syndrome|respiratory distress syndrome
4995973|NCT04019106|Bovine Lipid Extract Surfactant|bovine lipid extract surfactant
4995974|NCT04019093|alcohol effects|alcohol effects
4995975|NCT04019067|magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
4995976|NCT04019067|detection algorithm|detection algorithm
4995977|NCT04019054|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
4995978|NCT04019054|Exposure Therapy|exposure therapy
4995980|NCT04019054|Intermittent Theta-Burst Stimulation (iTBS)|intermittent theta-burst stimulation (itbs)
4995988|NCT04019015|Wounds and Injuries|wounds and injuries
4995990|NCT04019002|Glioblastoma Multiforme|glioblastoma multiforme
4995991|NCT04019002|Hyperpolarized Pyruvate|hyperpolarized pyruvate
4995992|NCT04019002|Magnetic Resonance|magnetic resonance
4995993|NCT04019002|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
4995994|NCT04019002|Glioblastoma|glioblastoma
4995995|NCT04018963|Pituitary tumor|pituitary tumor
4995996|NCT04018963|Neuroendoscope|neuroendoscope
4995997|NCT04018963|Surgical approach|surgical approach
4995998|NCT04018963|Computational Fluid Dynamics|computational fluid dynamics
4995999|NCT04018963|Numerical simulation|numerical simulation
4996000|NCT04018950|Acinetobacter baumannii-calcoaceticus|acinetobacter baumannii-calcoaceticus
4996001|NCT04018950|complex infections|complex infections
4996002|NCT04018950|ETX2514|etx2514
4996003|NCT04018950|excretion|excretion
4996004|NCT04018950|metabolism|metabolism
4996005|NCT04018937|Pediatrics|pediatrics
4996006|NCT04018937|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4996007|NCT04018937|HLA matched sibling|hla matched sibling
4996008|NCT04018924|Blue Light|blue light
4996009|NCT04018924|Photo-bio-modulation|photo-bio-modulation
4996010|NCT04018924|ulcers|ulcers
4996011|NCT04018924|leg ulcers Venous|leg ulcers venous
4996012|NCT04018924|dehiscence surgical wound|dehiscence surgical wound
4996013|NCT04018924|non healing wound|non healing wound
4996014|NCT04018872|itraconazole|itraconazole
4996015|NCT04018872|esophageal neoplasms|esophageal neoplasms
4996016|NCT04018872|esophagus|esophagus
4996017|NCT04018872|esophagogastric junction|esophagogastric junction
4996018|NCT04018872|adenocarcinoma|adenocarcinoma
4996019|NCT04018872|squamous cell carcinoma|squamous cell carcinoma
4996029|NCT04018833|Ranibizumab|ranibizumab
4996030|NCT04018833|Aflibercept|aflibercept
4996031|NCT04018833|BCVA|bcva
4996033|NCT04018781|Medication reconciliation|medication reconciliation
4996034|NCT04018781|clinical pharmacy|clinical pharmacy
4996035|NCT04018716|deep dentin caries|deep dentin caries
4996036|NCT04018716|randomized clinical trial|randomized clinical trial
4996037|NCT04018716|mineral trioxide aggregate|mineral trioxide aggregate
4996038|NCT04018716|calcium hydroxide|calcium hydroxide
4996039|NCT04018716|total caries excavation|total caries excavation
4996040|NCT04018703|Monitored anesthesia care|monitored anesthesia care
4996041|NCT04018703|Ophthalmic surgery|ophthalmic surgery
4996042|NCT04018703|Dexmedetomidine|dexmedetomidine
4996043|NCT04018703|Midazolam|midazolam
4996044|NCT04018690|Hip Osteoarthritis|hip osteoarthritis
4996045|NCT04018690|Quality of Life|quality of life
4996046|NCT04018690|Function|function
4996047|NCT04018690|Viscosuplementação|viscosuplementação
4996048|NCT04018664|nalbuphine|nalbuphine
4996049|NCT04018664|abuse potential|abuse potential
4996050|NCT04018651|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
4996051|NCT04018651|PrEP|prep
4996052|NCT04018625|Prenatal Maternal Stress|prenatal maternal stress
4996053|NCT04018625|Perinatal Mental Health|perinatal mental health
4996054|NCT04018625|Pregnancy|pregnancy
4996055|NCT04018625|Perinatal Anxiety|perinatal anxiety
4996056|NCT04018625|Perinatal Depression|perinatal depression
4996057|NCT04018599|Biosimilar|biosimilar
4996058|NCT04018599|Adalimumab|adalimumab
4996059|NCT04018599|MSB11022|msb11022
4996060|NCT04018547|Screening, patient convenience|screening, patient convenience
4996061|NCT04018508|left ventricular assist device|left ventricular assist device
4996062|NCT04018508|massage|massage
4996063|NCT04018508|coping|coping
4996064|NCT04018508|self efficacy|self efficacy
4996065|NCT04018482|intravitreal|intravitreal
4996066|NCT04018482|injection|injection
4996067|NCT04018482|disinfectant|disinfectant
4996068|NCT04018482|comfort|comfort
4996069|NCT04018482|Povidone Iodine|povidone iodine
4996070|NCT04018482|Avenova|avenova
4996071|NCT04018469|PED Wound Dressing|ped wound dressing
4996072|NCT04018456|Necrotic pulp,|necrotic pulp,
4996073|NCT04018456|Apical periodontitis|apical periodontitis
4996074|NCT04018456|Regeneration|regeneration
4996075|NCT04018456|MTA|mta
4996076|NCT04018456|Biodentine|biodentine
4996077|NCT04018430|glucose, insulin, HbA1c|glucose, insulin, hba1c
4996078|NCT04018391|HIV treatment|hiv treatment
4996079|NCT04018391|Depression|depression
4996080|NCT04018391|Medication Adherence|medication adherence
4996081|NCT04018365|insulin resistance|insulin resistance
4996082|NCT04018365|refractory diabetes mellitus|refractory diabetes mellitus
5299401|NCT02180841|soy|soy
4996088|NCT04018326|proliferative diabetic retinopathy|proliferative diabetic retinopathy
4996089|NCT04018326|diabetic retinopathy|diabetic retinopathy
4996090|NCT04018326|panretinal photocoagulation|panretinal photocoagulation
4996091|NCT04018326|intravitreal injections|intravitreal injections
4996092|NCT04018300|ferrous sulfate|ferrous sulfate
4996093|NCT04018300|non-transferrin bound iron|non-transferrin bound iron
4996094|NCT04018300|oral iron supplement|oral iron supplement
4996095|NCT04018300|oral iron supplement side effects|oral iron supplement side effects
4996096|NCT04018287|microRNAs, bone microstructure|micrornas, bone microstructure
4996097|NCT04018261|CMV|cmv
4996098|NCT04018261|Bone marrow transplant|bone marrow transplant
4996099|NCT04018261|Activated T-Lymphocytes|activated t-lymphocytes
4996100|NCT04018261|Cell therapy|cell therapy
4996101|NCT04018261|Virus infection|virus infection
4996102|NCT04018261|immunosuppression|immunosuppression
4996103|NCT04018222|Systemic Lupus Erythematosus|systemic lupus erythematosus
4996104|NCT04018222|SLE|sle
4996105|NCT04018222|Lupus Flare|lupus flare
4996106|NCT04018222|Flare Prediction|flare prediction
4996107|NCT04018222|Lupus|lupus
4996108|NCT04018209|Pruritus|pruritus
4996109|NCT04018209|Myeloproliferative Neoplasms|myeloproliferative neoplasms
4996110|NCT04018196|Very old adults|very old adults
4996111|NCT04018196|Memorizing|memorizing
4996112|NCT04018196|Motor imagery|motor imagery
4996113|NCT04018196|Motor learning|motor learning
4996114|NCT04018196|Upper limb|upper limb
4996115|NCT04018196|Lower limb|lower limb
4996116|NCT04018196|Motor task|motor task
4996117|NCT04018196|Manual task|manual task
4996119|NCT04018183|epidermal growth factor receptor tyrosine inhibitor|epidermal growth factor receptor tyrosine inhibitor
4996121|NCT04018144|Periodontitis, PPAR-γ, RXR-α, VDR|periodontitis, ppar-γ, rxr-α, vdr
4996122|NCT04018131|Atopic Dermatitis|atopic dermatitis
4996123|NCT04018131|Cimetidine|cimetidine
4996124|NCT04018131|Immunoglobulin E|immunoglobulin e
4996125|NCT04018131|Interleukin-4|interleukin-4
4996126|NCT04018131|Interleukin-12|interleukin-12
4996127|NCT04018131|Interferon Gamma|interferon gamma
4996128|NCT04018131|SCORAD|scorad
4996129|NCT04018131|Treatment|treatment
4996130|NCT04018118|Eosinophilia|eosinophilia
4996131|NCT04018118|Hypereosinophilia|hypereosinophilia
4996132|NCT04018118|Hypereosinophilic Syndrome|hypereosinophilic syndrome
4996133|NCT04018105|Impaired glucose tolerance|impaired glucose tolerance
4996134|NCT04018105|type 2 diabetes|type 2 diabetes
4996135|NCT04018105|obesity|obesity
4996136|NCT04018105|carbohydrate absorption|carbohydrate absorption
4996137|NCT04018105|metformin|metformin
4996138|NCT04018079|PDA|pda
4996139|NCT04018079|Echo|echo
4996140|NCT04018066|gut microbiome|gut microbiome
4996141|NCT04018066|metabolome|metabolome
4996142|NCT04018066|dietary polyphenols|dietary polyphenols
4996143|NCT04018066|grape|grape
4996144|NCT04018066|nutrition|nutrition
4996145|NCT04018053|Bladder cancer|bladder cancer
4996146|NCT04018053|urothelial carcinoma|urothelial carcinoma
4996147|NCT04018053|cystectomy|cystectomy
4996148|NCT04018027|Atopic Dermatitis|atopic dermatitis
4996149|NCT04018027|Pruritus|pruritus
4996150|NCT04018027|CR845|cr845
4996151|NCT04018027|Chronic Itch|chronic itch
4996152|NCT04018027|difelikefalin|difelikefalin
4996153|NCT04018027|Itch|itch
4996154|NCT04018027|Itching|itching
4996155|NCT04018027|Generalized pruritus|generalized pruritus
4996156|NCT04018027|Eczema|eczema
4996157|NCT04018014|Pulmonary embolism|pulmonary embolism
4996158|NCT04018014|Obesity|obesity
4996159|NCT04018014|CT scanner|ct scanner
4996160|NCT04018014|Iterative reconstructions|iterative reconstructions
4996161|NCT04017988|Porphyra Tenera|porphyra tenera
4996162|NCT04017975|fiberoptic confocal microscopy|fiberoptic confocal microscopy
4996163|NCT04017975|cardiac surgery|cardiac surgery
4996164|NCT04017962|HCT|hct
4996165|NCT04017962|CMV infection|cmv infection
4996166|NCT04017962|Letermovir|letermovir
4996167|NCT04017962|LTV|ltv
4996168|NCT04017962|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4996169|NCT04017962|19-174|19-174
4996170|NCT04017949|viscosupplementation injection|viscosupplementation injection
4996171|NCT04017949|corticosteroid injection|corticosteroid injection
4996172|NCT04017923|Nasal tip|nasal tip
4996173|NCT04017923|Tip support|tip support
4996174|NCT04017923|Rhinoplasty|rhinoplasty
4996175|NCT04017923|Nasal cartilage|nasal cartilage
4996177|NCT04017884|Remineralization|remineralization
4996178|NCT04017884|caries regression|caries regression
4996179|NCT04017884|color improvement|color improvement
4996180|NCT04017871|Cerebral Palsy (CP)|cerebral palsy (cp)
4996181|NCT04017871|pre-school children with unilateral and bilateral CP|pre-school children with unilateral and bilateral cp
4996182|NCT04017858|Total knee arthroplasty|total knee arthroplasty
4996183|NCT04017858|Exercise|exercise
4996184|NCT04017858|Preoperative|preoperative
4996185|NCT04017858|Complications|complications
4996186|NCT04017845|Colorectal cancer|colorectal cancer
4996187|NCT04017845|Screening|screening
4996188|NCT04017845|Fecal Immunochemical Test|fecal immunochemical test
4996189|NCT04017806|arteriovenous fistula maturation|arteriovenous fistula maturation
4996190|NCT04017806|End stage renal disease|end stage renal disease
4996191|NCT04017806|luminal pressure|luminal pressure
4996192|NCT04017780|Noninvasive Ventilation|noninvasive ventilation
4996193|NCT04017780|Acute Respiratory Failure|acute respiratory failure
4996194|NCT04017780|Pediatrics|pediatrics
4996195|NCT04017767|Neuroplasticity|neuroplasticity
4996196|NCT04017767|Respiratory Function|respiratory function
4996197|NCT04017767|Motor Function|motor function
4996198|NCT04017754|Mannose binding lectin|mannose binding lectin
4996199|NCT04017754|Perinatal outcome|perinatal outcome
4996200|NCT04017754|Recurrent pregnancy loss|recurrent pregnancy loss
4996208|NCT04017637|Resistance Training|resistance training
4996209|NCT04017637|Lean Body Mass|lean body mass
4996210|NCT04017637|Pediatric|pediatric
4996211|NCT04017624|Mobile produce market|mobile produce market
4996212|NCT04017624|Boston Accountable Care Organization (BACO)|boston accountable care organization (baco)
4996213|NCT04017624|Medicaid ACO|medicaid aco
4996214|NCT04017624|Accountable Care Organization|accountable care organization
4996215|NCT04017624|ACO|aco
4996216|NCT04017624|Social determinants of health|social determinants of health
4996217|NCT04017624|THRIVE|thrive
4996218|NCT04017624|Healthcare utilization|healthcare utilization
4996219|NCT04017624|Cost of care|cost of care
4999531|NCT03997773|Type 2 Diabetes|type 2 diabetes
4996241|NCT04017546|MDS|mds
4996242|NCT04017533|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
4996243|NCT04017533|Total Knee Replacement (TKR)|total knee replacement (tkr)
4996244|NCT04017533|Radiostereometric Analysis|radiostereometric analysis
4996245|NCT04017533|RSA|rsa
4996246|NCT04017533|Medial Pivot|medial pivot
4996247|NCT04017533|Medially stabilized|medially stabilized
4996248|NCT04017533|Medial pivoting|medial pivoting
4996249|NCT04017533|GMK Sphere|gmk sphere
4996250|NCT04017533|Global Medacta Knee Sphere|global medacta knee sphere
4996251|NCT04017520|Atopy|atopy
4996252|NCT04017520|Wheezing|wheezing
4996253|NCT04017520|Eczema|eczema
4996254|NCT04017520|Allergy|allergy
4996255|NCT04017520|Food allergies|food allergies
4996256|NCT04017494|Fontan|fontan
4996257|NCT04017494|Congenital heart defects|congenital heart defects
4996258|NCT04017494|Non-invasive cardiac imaging|non-invasive cardiac imaging
4996259|NCT04017494|Biomarkers|biomarkers
4996260|NCT04017481|neuromodulation|neuromodulation
4996261|NCT04017481|TMS|tms
4996262|NCT04017481|NFB|nfb
4996263|NCT04017455|short term immunotherapy|short term immunotherapy
4996264|NCT04017455|atezolizumab|atezolizumab
4996265|NCT04017455|bevacizumab|bevacizumab
4996266|NCT04017455|radiotherapy|radiotherapy
4996267|NCT04017442|Postpartum depression|postpartum depression
4996268|NCT04017442|Postpartum anxiety|postpartum anxiety
4996269|NCT04017442|Postpartum opioids|postpartum opioids
4996270|NCT04017403|postoperative cognitive dysfunction|postoperative cognitive dysfunction
4996271|NCT04017403|postopeartive delirium|postopeartive delirium
4996272|NCT04017403|Probiotics|probiotics
4996273|NCT04017390|Hand Pain/Numbness|hand pain/numbness
4996274|NCT04017364|drug coated balloon|drug coated balloon
4996275|NCT04017364|Paclitaxel|paclitaxel
4996276|NCT04017364|sirolimus|sirolimus
4996279|NCT04017338|Organ Transplant|organ transplant
4996280|NCT04017338|Hepatitis C Virus|hepatitis c virus
4996281|NCT04017338|Direct-Acting Antivirals (DAAs)|direct-acting antivirals (daas)
4996289|NCT04017299|ICU|icu
4996290|NCT04017299|Pain|pain
4996291|NCT04017299|Anxiety|anxiety
4996292|NCT04017299|Thirst|thirst
4996293|NCT04017299|Dyspnea|dyspnea
4996294|NCT04017299|Sleep|sleep
4996295|NCT04017299|Discomfort|discomfort
4996296|NCT04017299|Distress|distress
4996297|NCT04017299|Virtual Reality|virtual reality
4996298|NCT04017299|Music Therapy|music therapy
4996299|NCT04017286|Developmental assessment|developmental assessment
4996300|NCT04017286|Homocysteine|homocysteine
4996301|NCT04017286|physique growth|physique growth
4996302|NCT04017286|nutrients|nutrients
4996311|NCT04017182|central venous catheter|central venous catheter
4996312|NCT04017182|external jugular vein|external jugular vein
4996313|NCT04017182|internal jugular vein|internal jugular vein
4996314|NCT04017182|superior vena cava oxygen saturation|superior vena cava oxygen saturation
4996316|NCT04017091|Virtual Reality Exposure Therapy|virtual reality exposure therapy
4996317|NCT04017091|Executive Function|executive function
4996318|NCT04017091|Rehabilitation|rehabilitation
4996319|NCT04017078|carotid artery calcification|carotid artery calcification
4996320|NCT04017078|panoramic radiography|panoramic radiography
4996321|NCT04017078|periodontitis|periodontitis
4996322|NCT04017078|periodontal disease|periodontal disease
4996323|NCT04017078|systemic diseases|systemic diseases
4996324|NCT04017065|limb deformity correction|limb deformity correction
4996325|NCT04017065|limb lengthening|limb lengthening
4996326|NCT04017065|MAXFRAME system|maxframe system
4996327|NCT04017026|Short dental implant|short dental implant
4996328|NCT04017026|Partially edentulous jaw|partially edentulous jaw
4996333|NCT04016948|Rectal cancer|rectal cancer
4996334|NCT04016948|distal margin|distal margin
4996335|NCT04016948|confocal laser endomicroscopy|confocal laser endomicroscopy
4996336|NCT04016948|real-time|real-time
4996337|NCT04016948|in vivo|in vivo
4996338|NCT04016948|optical biopsy|optical biopsy
4996339|NCT04016935|ER+ and HER2- Breast Cancer patients|er+ and her2- breast cancer patients
4996340|NCT04016935|Extended Endocrine Therapy|extended endocrine therapy
4996341|NCT04016935|EndoPredict|endopredict
4996342|NCT04016922|Fetal hemodynamics.|fetal hemodynamics.
4996343|NCT04016922|Intrauterine growth restriction|intrauterine growth restriction
4996344|NCT04016922|Amniotic fluid index|amniotic fluid index
4996345|NCT04016909|brain activity|brain activity
4996346|NCT04016909|cognitive function|cognitive function
4996347|NCT04016909|diet|diet
4996348|NCT04016909|exercise|exercise
4996349|NCT04016909|motor behavior|motor behavior
4996350|NCT04016909|psychosocial state|psychosocial state
4996351|NCT04016857|remote ischemic preconditioning|remote ischemic preconditioning
4996352|NCT04016857|lower limb revascularization|lower limb revascularization
4996353|NCT04016857|TIMP-2|timp-2
4996354|NCT04016857|IGFBP-7|igfbp-7
4996355|NCT04016844|Multiple Scerosis|multiple scerosis
4996356|NCT04016844|PET|pet
4996357|NCT04016844|tDCS|tdcs
4996358|NCT04016805|umbralisib|umbralisib
4996359|NCT04016805|ublituximab|ublituximab
4996360|NCT04016805|venetoclax|venetoclax
4996361|NCT04016805|ibrutinib|ibrutinib
4996362|NCT04016805|CLL|cll
4996363|NCT04016740|Cardiopulmonary Bypass|cardiopulmonary bypass
4996364|NCT04016740|Cardiac Surgery|cardiac surgery
4996365|NCT04016740|analgesics|analgesics
4996366|NCT04016727|tooth movement|tooth movement
4996367|NCT04016727|platelet rich plasma|platelet rich plasma
4996368|NCT04016597|diffusing capacity|diffusing capacity
4996369|NCT04016597|reliability|reliability
4996370|NCT04016597|healthy|healthy
4996371|NCT04016597|adults|adults
4996372|NCT04016597|nitric oxide|nitric oxide
4996373|NCT04016584|Type 2 Diabetes|type 2 diabetes
4996374|NCT04016584|Latino/Hispanic|latino/hispanic
4996375|NCT04016584|Promotore|promotore
4996376|NCT04016584|Community health worker|community health worker
4996377|NCT04016571|Cystic Fibrosis|cystic fibrosis
4996378|NCT04016571|Pulmonary Exacerbation|pulmonary exacerbation
4996379|NCT04016571|Antibiotics|antibiotics
4996380|NCT04016571|Outcome measures|outcome measures
4996381|NCT04016532|Elderly peopole|elderly peopole
4996382|NCT04016532|Undernutrition|undernutrition
4996383|NCT04016532|Acute Geriatric|acute geriatric
4996384|NCT04016506|Pancreas Injury|pancreas injury
4996385|NCT04016506|Child|child
4996386|NCT04016467|Spinal Manipulation|spinal manipulation
4996391|NCT04016441|sunscreen|sunscreen
4996392|NCT04016428|sleep|sleep
4996393|NCT04016428|pregnancy|pregnancy
4996394|NCT04016428|insomnia|insomnia
4996395|NCT04016428|depression|depression
4996396|NCT04016428|mindfulness|mindfulness
4996504|NCT04015674|Exercise|exercise
4996406|NCT04016376|Mastectomy with reconstruction|mastectomy with reconstruction
5706160|NCT00478959|Hodgkin|hodgkin
4996407|NCT04016376|Double mastectomy with reconstruction|double mastectomy with reconstruction
4996408|NCT04016376|Double mastectomy with immediate reconstruction|double mastectomy with immediate reconstruction
4996409|NCT04016376|Mastectomy with immediate reconstruction|mastectomy with immediate reconstruction
4996410|NCT04016376|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4996411|NCT04016376|19-238|19-238
4996412|NCT04016350|Exercise,|exercise,
4996413|NCT04016350|Inulin Propionate Ester|inulin propionate ester
4996414|NCT04016350|Gut hormones|gut hormones
4996415|NCT04016350|Body weigh|body weigh
4996416|NCT04016350|Fat oxidation|fat oxidation
4996417|NCT04016350|Overweight women|overweight women
4996418|NCT04016337|sweeteners|sweeteners
4996419|NCT04016337|stevia|stevia
4996420|NCT04016337|sucralose|sucralose
4996421|NCT04016337|polyphenols|polyphenols
4996422|NCT04016337|maqui|maqui
4996423|NCT04016337|bioavailability|bioavailability
4996424|NCT04016337|inflammation|inflammation
4996425|NCT04016337|gut hormones|gut hormones
4996426|NCT04016337|biomarkers|biomarkers
4996430|NCT04016298|Bladder Health|bladder health
4996431|NCT04016298|LUTS|luts
4996432|NCT04016298|PLUS|plus
4996433|NCT04016298|VIEW|view
4996434|NCT04016285|Tourniquet|tourniquet
4996435|NCT04016285|Aquamantys|aquamantys
4996436|NCT04016285|Arthroplasty|arthroplasty
4996437|NCT04016285|Total Knee|total knee
4996438|NCT04016285|Standard of Care Tourniquet|standard of care tourniquet
4996439|NCT04016246|LISA|lisa
4996440|NCT04016246|propofol|propofol
4996441|NCT04016246|medialipide|medialipide
4996442|NCT04016246|ketamin|ketamin
4996443|NCT04016246|sedation|sedation
4996457|NCT04016168|Biomarkers|biomarkers
4996458|NCT04016168|CD163|cd163
4996459|NCT04016142|Adjuvant Chemotherapy|adjuvant chemotherapy
4996460|NCT04016142|Cervical cancer|cervical cancer
4996461|NCT04016129|CD19- B-ALL|cd19- b-all
4996462|NCT04016129|CART|cart
4996463|NCT04016129|CD22, CD123, CD38, CD10, CD20, TSLPR|cd22, cd123, cd38, cd10, cd20, tslpr
4996465|NCT04016090|Postmenopausal women|postmenopausal women
4996466|NCT04016090|Vascular health|vascular health
4996467|NCT04016090|Folic acid|folic acid
4996468|NCT04016077|PF-06651600|pf-06651600
4996469|NCT04016077|Pharmacokinetics|pharmacokinetics
5312714|NCT02117453|Stroke|stroke
4996470|NCT04016077|Hepatic impairment|hepatic impairment
4996471|NCT04016064|gingival enlargement, Er:YAG, Nd:YAG, electrosurgery|gingival enlargement, er:yag, nd:yag, electrosurgery
4996472|NCT04015934|predictive factors|predictive factors
4996473|NCT04015921|self-concept|self-concept
4996474|NCT04015921|self referencing bias|self referencing bias
4996475|NCT04015895|Cancer|cancer
4996476|NCT04015895|Social fragilities|social fragilities
4996477|NCT04015895|Social inequalities|social inequalities
4996478|NCT04015895|DEFCO|defco
4996479|NCT04015895|machine learning|machine learning
4996480|NCT04015895|cancer care pathway|cancer care pathway
4996481|NCT04015882|acute lymphoblastic leukemia|acute lymphoblastic leukemia
4996482|NCT04015882|bone density|bone density
4996483|NCT04015882|total fat|total fat
4996484|NCT04015882|exercise|exercise
4996485|NCT04015856|Social research|social research
4996486|NCT04015830|Sleep|sleep
4996487|NCT04015830|Neurocognitive Disorders|neurocognitive disorders
4996488|NCT04015830|HIV/AIDS|hiv/aids
4996489|NCT04015830|Aging|aging
4996490|NCT04015817|Dyspnea|dyspnea
4996491|NCT04015817|Well being|well being
4996492|NCT04015817|respiratory care team non-specialized in palliative care|respiratory care team non-specialized in palliative care
4996493|NCT04015804|cancer|cancer
4996494|NCT04015804|rectum|rectum
4996495|NCT04015804|robot|robot
4996496|NCT04015791|lumbar disc disease|lumbar disc disease
4996497|NCT04015791|MR Spectroscopy|mr spectroscopy
4996498|NCT04015791|Nociscan|nociscan
4996499|NCT04015739|Bevacizumab|bevacizumab
4996500|NCT04015739|Olaparib|olaparib
4996501|NCT04015739|Durvalumab|durvalumab
4996502|NCT04015739|Tri association|tri association
4996503|NCT04015687|Pharmacokinetic study|pharmacokinetic study
4996505|NCT04015674|Vasodilation|vasodilation
4996506|NCT04015648|Vaccine|vaccine
4996507|NCT04015635|blood pressure|blood pressure
4996508|NCT04015635|hypertension|hypertension
4996509|NCT04015635|inflammation|inflammation
4996510|NCT04015635|immune dysfunction|immune dysfunction
4996511|NCT04015635|endothelial dysfunction|endothelial dysfunction
4996512|NCT04015622|circulating tumor DNA|circulating tumor dna
4996513|NCT04015622|Enzalutamide|enzalutamide
4996514|NCT04015622|Docetaxel|docetaxel
4996515|NCT04015609|Stage III solid tumor cancer|stage iii solid tumor cancer
4996516|NCT04015609|Stage IV solid tumor cancer|stage iv solid tumor cancer
4996517|NCT04015609|Stage III cancer|stage iii cancer
4996518|NCT04015609|Stage IV cancer|stage iv cancer
4996520|NCT04015609|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4996521|NCT04015609|15-076|15-076
4996522|NCT04015596|PANDAS|pandas
4996523|NCT04015596|Children|children
4996524|NCT04015596|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
4996525|NCT04015596|Anxiety|anxiety
4996526|NCT04015596|NSAID|nsaid
4996527|NCT04015583|exergaming|exergaming
4996528|NCT04015583|executive functions|executive functions
4996529|NCT04015583|event-related potential|event-related potential
4996530|NCT04015583|metabolic syndrome|metabolic syndrome
4996531|NCT04015557|Homocystinuria|homocystinuria
4996532|NCT04015557|Glutathione|glutathione
4996533|NCT04015557|Acetaminophen|acetaminophen
4996541|NCT04015544|watermelon|watermelon
4996542|NCT04015544|L-citrulline|l-citrulline
4999850|NCT03996057|UTI|uti
4996551|NCT04015479|skeletal muscle physiology|skeletal muscle physiology
4996552|NCT04015479|inflammatory cytokines|inflammatory cytokines
4996553|NCT04015479|fecal microbiome|fecal microbiome
4996554|NCT04015479|plant protein|plant protein
4996555|NCT04015466|Gastric Cancer|gastric cancer
4996556|NCT04015466|Personalized medicine|personalized medicine
4996557|NCT04015466|Oncology|oncology
4996558|NCT04015466|Solid tumor|solid tumor
4996559|NCT04015466|Primary Intervention|primary intervention
4996560|NCT04015440|attention bias|attention bias
4996561|NCT04015440|hostile attribution bias|hostile attribution bias
4996562|NCT04015440|hostile bias modification|hostile bias modification
4996563|NCT04015427|cement|cement
4996564|NCT04015427|dental|dental
4996565|NCT04015427|implant|implant
4996566|NCT04015427|implant prosthodontics|implant prosthodontics
4996567|NCT04015401|Quantitative sensory testing|quantitative sensory testing
4996568|NCT04015401|Jamaica|jamaica
4996569|NCT04015375|acne vulgaris|acne vulgaris
4996570|NCT04015362|Spasticity|spasticity
4996571|NCT04015349|grind|grind
4996572|NCT04015349|polysomnography|polysomnography
4996573|NCT04015349|rhythmic masticatory muscle activity|rhythmic masticatory muscle activity
4996574|NCT04015349|sleep bruxism|sleep bruxism
4996575|NCT04015336|T Cell Receptor|t cell receptor
4996576|NCT04015336|Fludarabine|fludarabine
4996577|NCT04015336|Cyclophosphamide|cyclophosphamide
4996578|NCT04015336|Immunotherapy|immunotherapy
4996579|NCT04015336|Aldesleukin|aldesleukin
4996580|NCT04015323|interferential current|interferential current
4996581|NCT04015323|knee osteoarthritis|knee osteoarthritis
4996582|NCT04015323|pain|pain
4996583|NCT04015310|MRCP|mrcp
4996584|NCT04015310|MRCP+|mrcp+
4996585|NCT04015310|PSC|psc
4996586|NCT04015310|Health economic|health economic
4996587|NCT04015297|endometriosis|endometriosis
4996588|NCT04015297|raman analaysis|raman analaysis
4996589|NCT04015284|NOL monitoring|nol monitoring
4996590|NCT04015284|regional anesthesia|regional anesthesia
4996591|NCT04015284|interscalene brachial plexus block|interscalene brachial plexus block
4996592|NCT04015284|shoulder arthroscopy|shoulder arthroscopy
4996593|NCT04015271|stroke|stroke
4996594|NCT04015271|hemiparesis|hemiparesis
4996595|NCT04015258|blueberry|blueberry
4996596|NCT04015258|intervention|intervention
4996597|NCT04015258|endothelial function|endothelial function
4996598|NCT04015258|cognition|cognition
4996599|NCT04015258|metabolomics|metabolomics
4996600|NCT04015258|genomics|genomics
4996601|NCT04015245|TACE|tace
4996602|NCT04015232|Pegfilgrastim|pegfilgrastim
4996603|NCT04015232|Biosimilar|biosimilar
4996604|NCT04015232|Immunogenicity|immunogenicity
4996605|NCT04015232|Pharmacokinetics|pharmacokinetics
4996606|NCT04015232|Pharmacodynamics|pharmacodynamics
4996607|NCT04015232|Safety|safety
4996608|NCT04015232|Healthy Volunteers|healthy volunteers
4996612|NCT04015141|Pediatric epileptic syndrome|pediatric epileptic syndrome
4996614|NCT04015141|Childhood epilepsy|childhood epilepsy
4996615|NCT04015141|Epilepsy in children|epilepsy in children
4996616|NCT04015141|Refractory seizures|refractory seizures
4996617|NCT04015141|Inadequately controlled seizures|inadequately controlled seizures
4996618|NCT04015141|E2007|e2007
4996619|NCT04015141|Fycompa|fycompa
4996620|NCT04015141|Perampanel|perampanel
4996621|NCT04015115|Buprenorphine|buprenorphine
4996622|NCT04015115|Central Nervous System Depressants|central nervous system depressants
4996623|NCT04015115|Chemically-Induced Disorders|chemically-induced disorders
4996624|NCT04015115|Community Mental Health Services|community mental health services
4996625|NCT04015115|Drug Partial Agonism|drug partial agonism
4996626|NCT04015115|Heroin Dependence|heroin dependence
4996627|NCT04015115|Medication Adherence|medication adherence
4996628|NCT04015115|Mental Disorders|mental disorders
4996629|NCT04015115|Naltrexone|naltrexone
4996630|NCT04015115|Narcotic Antagonists|narcotic antagonists
4996631|NCT04015115|Narcotics|narcotics
5012908|NCT03915925|prediction model|prediction model
4996639|NCT04015063|Dermatology|dermatology
4996640|NCT04015063|Skin Care|skin care
4996641|NCT04015024|Acute myeloid leukemia|acute myeloid leukemia
4996642|NCT04015024|monotherapy|monotherapy
4996643|NCT04015024|SKLB1028|sklb1028
4996644|NCT04014998|neck pain|neck pain
4996645|NCT04014998|virtual reality|virtual reality
4996651|NCT04014933|glaucoma|glaucoma
4996652|NCT04014933|retinal blood flow|retinal blood flow
4996653|NCT04014933|ocular perfusion pressure|ocular perfusion pressure
4996654|NCT04014868|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4996655|NCT04014868|Exercise|exercise
4996656|NCT04014868|Nasal high flow|nasal high flow
4996657|NCT04014868|Muscle|muscle
4996658|NCT04014829|Hysterectomy|hysterectomy
4996659|NCT04014829|Chronic Pain|chronic pain
4996660|NCT04014829|Fear-Avoidance|fear-avoidance
4996661|NCT04014829|Central Sensitization|central sensitization
4996662|NCT04014829|Pain-Pressure Threshold|pain-pressure threshold
4996663|NCT04014829|Mechanical Temporal Summation|mechanical temporal summation
4996664|NCT04014816|ICU|icu
4996665|NCT04014803|Percutaneous Coronary Intervention|percutaneous coronary intervention
4996666|NCT04014803|Dual Antiplatelet Therapy|dual antiplatelet therapy
4996667|NCT04014803|Complex Coronary Lesion|complex coronary lesion
4996668|NCT04014751|Symptom-monitoring|symptom-monitoring
4996669|NCT04014712|BH4|bh4
4996670|NCT04014712|Exercise|exercise
4996671|NCT04014712|Mitochondria|mitochondria
4996672|NCT04014712|Vascular function|vascular function
4996673|NCT04014686|postmenopausal|postmenopausal
4996674|NCT04014686|exercise|exercise
4996678|NCT04014660|celiac disease autoimmunity|celiac disease autoimmunity
4996679|NCT04014660|islet autoimmunity|islet autoimmunity
4996680|NCT04014660|auto-antibodies|auto-antibodies
4996681|NCT04014647|Vascular Surgical Procedure|vascular surgical procedure
4996682|NCT04014647|Pro-brain natriuretic peptide (1-76)|pro-brain natriuretic peptide (1-76)
4996683|NCT04014647|Natriuretic Peptide, Brain|natriuretic peptide, brain
4996684|NCT04014647|Troponin I|troponin i
4996685|NCT04014647|Galectin 3|galectin 3
4996686|NCT04014647|Biomarkers|biomarkers
4996688|NCT04014621|acute ischemic stroke|acute ischemic stroke
4996689|NCT04014621|randomized clinical trial|randomized clinical trial
4996690|NCT04014621|anterior circulation|anterior circulation
4996691|NCT04014621|penumbra|penumbra
4996692|NCT04014608|Clostridium difficile Infection|clostridium difficile infection
4996693|NCT04014608|Infection Control|infection control
4996694|NCT04014608|Quality Improvement|quality improvement
4996695|NCT04014608|Active Surveillance testing|active surveillance testing
4996696|NCT04014595|Calcified coronary lesions|calcified coronary lesions
4996697|NCT04014582|communal coping|communal coping
4996698|NCT04014582|couples coping|couples coping
4996699|NCT04014582|adjustment|adjustment
4996700|NCT04014530|Mismatch repair|mismatch repair
4996701|NCT04014530|Anti PD1|anti pd1
4996702|NCT04014530|Immunotherapy|immunotherapy
4996703|NCT04014530|Metastatic disease|metastatic disease
4996704|NCT04014517|Inflammatory Bowel Diseases|inflammatory bowel diseases
4997293|NCT04011254|Dialysis|dialysis
4996718|NCT04014465|esophageal cancer|esophageal cancer
4996719|NCT04014465|radiotherapy|radiotherapy
4996720|NCT04014465|ctDNA|ctdna
4996721|NCT04014452|Complicated Monochorionic Pregnancies|complicated monochorionic pregnancies
4996722|NCT04014452|Selective feticide|selective feticide
4996723|NCT04014439|diaphragm thickness|diaphragm thickness
4996724|NCT04014439|neutrophil to lymphocyte ratio|neutrophil to lymphocyte ratio
4996725|NCT04014439|mechanical ventilation|mechanical ventilation
4996726|NCT04014426|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4996727|NCT04014426|Healthcare Workers|healthcare workers
4996728|NCT04014426|Security|security
4996729|NCT04014426|Pressurized Intraperitoneal Aerosol Chemotherapy|pressurized intraperitoneal aerosol chemotherapy
4996730|NCT04014426|Aerosols/administration & dosage|aerosols/administration & dosage
4996731|NCT04014426|Oxaliplatin|oxaliplatin
4996732|NCT04014400|skin graft|skin graft
4996733|NCT04014400|suprathel|suprathel
4996734|NCT04014400|xeroform|xeroform
4996735|NCT04014400|burn|burn
4996736|NCT04014400|donor site|donor site
4996742|NCT04014322|electronic cigarette use|electronic cigarette use
4996743|NCT04014322|smoking behavior|smoking behavior
4996744|NCT04014309|distress screening|distress screening
5013014|NCT03915314|delirium|delirium
4996752|NCT04014296|dietary protein|dietary protein
4996753|NCT04014296|resistance training|resistance training
4996754|NCT04014283|Selenium|selenium
4996755|NCT04014283|Supplement|supplement
4996756|NCT04014283|Prevention|prevention
4996757|NCT04014283|Females|females
4996758|NCT04014283|Risk|risk
4996762|NCT04014257|tropomyosin receptor kinase|tropomyosin receptor kinase
4996763|NCT04014257|Solid organ malignancies|solid organ malignancies
4996764|NCT04014244|Carpal Tunnel Syndrome|carpal tunnel syndrome
4996765|NCT04014244|Electromyography|electromyography
4996766|NCT04014244|Ultrasonography|ultrasonography
4996767|NCT04014244|Surgery|surgery
4996768|NCT04014244|Dextrose|dextrose
4996769|NCT04014244|Corticosteroids|corticosteroids
4996770|NCT04014218|sedation|sedation
4996778|NCT04014166|Thrombocytopenia|thrombocytopenia
4996779|NCT04014153|acute kidney injury|acute kidney injury
4996780|NCT04014153|coronary artery disease|coronary artery disease
4996781|NCT04014153|contrast-induced acute kidney injury|contrast-induced acute kidney injury
4996782|NCT04014153|comorbidity|comorbidity
4996783|NCT04014153|CI-AKI|ci-aki
4996784|NCT04014153|stable CAD|stable cad
4996785|NCT04014140|Instantaneous wave-free ratio (iFR)|instantaneous wave-free ratio (ifr)
4996786|NCT04014140|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
4996787|NCT04014127|coronary flow reserve|coronary flow reserve
4996788|NCT04014127|living kidney donation|living kidney donation
4996789|NCT04014127|peritoneal dialysis|peritoneal dialysis
4996790|NCT04014088|helmet CPAP|helmet cpap
4996791|NCT04014088|facemask CPAP|facemask cpap
4996792|NCT04014088|pulmonary edema|pulmonary edema
4996793|NCT04014088|non invasive ventilation|non invasive ventilation
4996798|NCT04014062|Pegfilgrastim|pegfilgrastim
4996799|NCT04014062|Biosimilar|biosimilar
4996800|NCT04014062|Bioequivalence|bioequivalence
4996808|NCT04014036|chronic prostatitis/ pelvic pain syndrome|chronic prostatitis/ pelvic pain syndrome
4996809|NCT04014036|low-intensity extracorporeal shockwave therapy|low-intensity extracorporeal shockwave therapy
4996811|NCT04014010|Anesthesia|anesthesia
4996812|NCT04014010|Hemodynamics|hemodynamics
4996813|NCT04014010|Machine Learning|machine learning
4996814|NCT04014010|Non-cardiac Surgery|non-cardiac surgery
4996815|NCT04013997|Rehabilitation|rehabilitation
4996816|NCT04013997|Walking|walking
4996817|NCT04013997|Equipment and Supplies|equipment and supplies
4996818|NCT04013971|stroke|stroke
4996819|NCT04013971|gait rehabilitation|gait rehabilitation
4996820|NCT04013971|game|game
4996821|NCT04013958|Morphine|morphine
4996822|NCT04013958|Ketamine|ketamine
4996823|NCT04013958|Renal colic|renal colic
4996824|NCT04013932|Family Psychoeducation|family psychoeducation
4996825|NCT04013932|Schizophrenia|schizophrenia
4996826|NCT04013932|Tanzania|tanzania
4996827|NCT04013932|Severe and Persistent Mental Illness|severe and persistent mental illness
4996828|NCT04013932|Culturally tailored|culturally tailored
4996829|NCT04013906|coronary artery disease|coronary artery disease
4996830|NCT04013906|calcium|calcium
4996831|NCT04013906|percutaneous coronary intervention|percutaneous coronary intervention
4996832|NCT04013893|Enteral feeding|enteral feeding
4996833|NCT04013893|vasopressor|vasopressor
4996834|NCT04013893|lactate|lactate
4996835|NCT04013867|psoriasis|psoriasis
4996836|NCT04013867|depression|depression
4996837|NCT04013867|validation|validation
4996838|NCT04013867|self-questionnaire|self-questionnaire
4996844|NCT04013828|High-grade glioma|high-grade glioma
4996845|NCT04013828|Patient experiences|patient experiences
4996846|NCT04013828|Decision-making|decision-making
4996847|NCT04013828|Patient involvement|patient involvement
4996848|NCT04013815|erector spinae plane block|erector spinae plane block
4996849|NCT04013815|thoracotomy|thoracotomy
4996850|NCT04013815|ultrasound guided nerve block|ultrasound guided nerve block
4996851|NCT04013815|analgesia|analgesia
4996856|NCT04013789|eye strain|eye strain
4996857|NCT04013789|eye fatigue|eye fatigue
4996858|NCT04013763|wheat allergy|wheat allergy
4996863|NCT04013737|Antibiotic prescribing|antibiotic prescribing
4996864|NCT04013737|Clinical Decision Support Systems|clinical decision support systems
4996865|NCT04013724|Tobacco cessation, mental illness, tobacco dependence, Kenya|tobacco cessation, mental illness, tobacco dependence, kenya
4996866|NCT04013698|ventilation|ventilation
4996867|NCT04013698|brain injuries|brain injuries
4996868|NCT04013698|PEEP|peep
4996869|NCT04013698|esophageal pressure|esophageal pressure
4996870|NCT04013685|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4996871|NCT04013685|acute leukemia|acute leukemia
4996872|NCT04013685|Myelodysplastic syndromes|myelodysplastic syndromes
4996873|NCT04013685|matched related donor|matched related donor
4996874|NCT04013685|matched unrelated donor|matched unrelated donor
4996875|NCT04013633|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
4996876|NCT04013633|Basic life support (BLS)|basic life support (bls)
4996877|NCT04013633|Virtual reality (VR)|virtual reality (vr)
4996878|NCT04013633|Education|education
4996879|NCT04013633|Lay-person training|lay-person training
4996880|NCT04013607|short chain fatty acid|short chain fatty acid
4996881|NCT04013607|dietary fiber|dietary fiber
4996882|NCT04013516|Immunization|immunization
4996883|NCT04013516|Incentives|incentives
4996884|NCT04013503|NATURE-HTN|nature-htn
4996892|NCT04013451|mood|mood
4996893|NCT04013451|affect|affect
4996894|NCT04013451|resilience|resilience
4996895|NCT04013451|undergraduate students|undergraduate students
4996896|NCT04013451|graduate students|graduate students
4996897|NCT04013438|Ongoing pregnancy rate|ongoing pregnancy rate
4996898|NCT04013438|Estrogen|estrogen
4997294|NCT04011254|Salt taste|salt taste
4996909|NCT04013308|potassium iodine|potassium iodine
4996910|NCT04013308|thyroid|thyroid
4996912|NCT04013295|transactional sex|transactional sex
4996913|NCT04013295|prize-linked savings|prize-linked savings
4996914|NCT04013295|savings|savings
4996921|NCT04013243|Magnesium|magnesium
4996922|NCT04013230|Childhood obesity|childhood obesity
4996923|NCT04013230|BMI SDS|bmi sds
4996924|NCT04013204|non invasive endothelial function test|non invasive endothelial function test
4996925|NCT04013204|non-obstructive coronary artery disease|non-obstructive coronary artery disease
4996926|NCT04013204|Major Adverse Cardiovascular Events|major adverse cardiovascular events
4996927|NCT04013191|Padsevonil|padsevonil
4996928|NCT04013191|Phase 1|phase 1
4996929|NCT04013191|Pharmacokinetic|pharmacokinetic
4996930|NCT04013165|Old-aged|old-aged
4996931|NCT04013165|Community-based intervention|community-based intervention
4996932|NCT04013165|Late-life depression|late-life depression
4996933|NCT04013165|Suicide|suicide
4996934|NCT04013152|CROHN|crohn
4996935|NCT04013152|Diverticulitis|diverticulitis
4996936|NCT04013152|Rectal|rectal
4996937|NCT04013152|colorectal|colorectal
4996938|NCT04013152|ulcerative|ulcerative
4996939|NCT04013152|colitis|colitis
4996940|NCT04013152|polyposis|polyposis
4996941|NCT04013152|rectum|rectum
4996942|NCT04013152|prolapse|prolapse
4996943|NCT04013100|primary hyperparathyroidism|primary hyperparathyroidism
4996944|NCT04013100|parathyroidectomy|parathyroidectomy
4996945|NCT04013100|3D reconstruction|3d reconstruction
4996946|NCT04013100|Virtual neck exploration|virtual neck exploration
4996947|NCT04013048|Solid Tumor|solid tumor
4996948|NCT04013048|14C-Fluzoparib|14c-fluzoparib
4996949|NCT04013035|Cervix|cervix
4996950|NCT04013035|Length|length
4996951|NCT04013035|Viability|viability
4996952|NCT04013035|prostaglandin|prostaglandin
4996953|NCT04013035|Termination|termination
4996954|NCT04013022|Exercise Pressor Reflex|exercise pressor reflex
4996955|NCT04013022|Metaboreflex|metaboreflex
4996956|NCT04013022|Mechanoreflex|mechanoreflex
4996957|NCT04013022|Lifelong exercise training|lifelong exercise training
4996958|NCT04013009|incisional hernia|incisional hernia
4996959|NCT04013009|prevention|prevention
4996960|NCT04013009|laparotomy closure|laparotomy closure
4996961|NCT04013009|quality improvement|quality improvement
4996962|NCT04013009|survey|survey
4996963|NCT04013009|guideline|guideline
4996970|NCT04012970|lower back pain|lower back pain
4996971|NCT04012970|myometer|myometer
4996972|NCT04012970|muscle stiffness|muscle stiffness
4996973|NCT04012970|spinal mobilisations|spinal mobilisations
4996974|NCT04012957|DREAM-ND|dream-nd
4996975|NCT04012944|Heart Failure|heart failure
4996976|NCT04012944|Heart Diseases|heart diseases
4996977|NCT04012944|Cardiovascular Disease|cardiovascular disease
4996978|NCT04012918|chemotherapy|chemotherapy
4996979|NCT04012918|aromatase inhibitor|aromatase inhibitor
4996980|NCT04012918|capecitabine|capecitabine
4996990|NCT04012866|Computerized Cognitive Training|computerized cognitive training
4996992|NCT04012840|Fried's criteria|fried's criteria
4996993|NCT04012840|Rockwood's criteria|rockwood's criteria
4996994|NCT04012840|Loss of autonomy,|loss of autonomy,
4996995|NCT04012840|elderly|elderly
4996996|NCT04012814|fat|fat
4996997|NCT04012814|abdomen fat|abdomen fat
4996998|NCT04012814|flank fat|flank fat
4996999|NCT04012814|body contouring|body contouring
4997000|NCT04012788|probiotics|probiotics
4997001|NCT04012788|prebiotics|prebiotics
4997002|NCT04012788|synbiotics|synbiotics
4997004|NCT04012775|insulin|insulin
4997005|NCT04012762|Muscle Power, Muscle Flexibility, Muscle Tone, Whole-Body Vibration Training.|muscle power, muscle flexibility, muscle tone, whole-body vibration training.
4997006|NCT04012749|serious illness|serious illness
4997007|NCT04012749|POLST|polst
4997008|NCT04012749|population health|population health
4997009|NCT04012749|primary care|primary care
4997010|NCT04012736|gluten free diet|gluten free diet
4997011|NCT04012736|fitness|fitness
4997012|NCT04012736|pediatric|pediatric
4997014|NCT04012710|Transvaginal natural orifice transluminal endoscopic surgery|transvaginal natural orifice transluminal endoscopic surgery
4997015|NCT04012710|Salpingo-oophorectomy|salpingo-oophorectomy
4997016|NCT04012710|Laparoscopy|laparoscopy
4997017|NCT04012697|Survival analysis|survival analysis
4997018|NCT04012697|Quantitative analysis|quantitative analysis
4997019|NCT04012697|Patient-reported outcomes|patient-reported outcomes
4997020|NCT04012697|Randomized-controlled trial|randomized-controlled trial
4997021|NCT04012697|Homelessness|homelessness
4997022|NCT04012697|Health services research|health services research
5000249|NCT03993678|melanoma|melanoma
4997023|NCT04012697|Administrative health data|administrative health data
4997024|NCT04012697|Peer support|peer support
4997025|NCT04012684|Repetitive transcranial stimulation|repetitive transcranial stimulation
4997026|NCT04012684|Inferior frontal gyrus|inferior frontal gyrus
4997027|NCT04012658|Wilson's Disease|wilson's disease
4997028|NCT04012658|Nature history|nature history
4997029|NCT04012658|Genetics|genetics
4997030|NCT04012645|Rectal Neoplasms|rectal neoplasms
4997031|NCT04012645|Indocyanine Green|indocyanine green
4997032|NCT04012645|Anastomotic Leakage|anastomotic leakage
4997033|NCT04012632|SNP|snp
4997034|NCT04012632|kisspeptin|kisspeptin
4997035|NCT04012632|GPR54|gpr54
4997036|NCT04012580|postpartum|postpartum
4997037|NCT04012580|depression|depression
4997038|NCT04012580|anxiety|anxiety
4997039|NCT04012580|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
4997040|NCT04012580|randomized controlled trial|randomized controlled trial
4997041|NCT04012580|therapist-assistance|therapist-assistance
4997042|NCT04012567|Biosure Regenesorb|biosure regenesorb
4997043|NCT04012567|Chinese|chinese
4997044|NCT04012567|Cruciate ligaments reconstruction|cruciate ligaments reconstruction
4997045|NCT04012567|Prospective|prospective
4997046|NCT04012567|Randomize|randomize
4997047|NCT04012567|Evaluator-blinded|evaluator-blinded
4997048|NCT04012554|Postoperative pain|postoperative pain
4997049|NCT04012554|Avoiding chest drainage placement|avoiding chest drainage placement
4997050|NCT04012554|Hospital cost|hospital cost
4997051|NCT04012528|Pediatric|pediatric
4997052|NCT04012528|Surgery|surgery
4997053|NCT04012528|Rehabilitation|rehabilitation
4997054|NCT04012515|ECG Electrodes|ecg electrodes
4997055|NCT04012515|ambulatory monitoring|ambulatory monitoring
4997056|NCT04012515|dermatology|dermatology
4997057|NCT04012489|Physical Therapy Modalities|physical therapy modalities
4997058|NCT04012489|Respiratory Care Units|respiratory care units
4997059|NCT04012489|Respiratory Mechanics|respiratory mechanics
4997060|NCT04012476|Hypocalcemia post-thyroidectomy|hypocalcemia post-thyroidectomy
4997061|NCT04012476|Indocyanine green|indocyanine green
4997062|NCT04012476|Fluorescence guided surgery|fluorescence guided surgery
4997063|NCT04012476|Parathyroid fluorescence|parathyroid fluorescence
4997064|NCT04012437|Premature ejaculation|premature ejaculation
4997065|NCT04012437|IELT|ielt
4997066|NCT04012437|Medical device|medical device
4997067|NCT04012424|curcumin as premedication - root canal treatment|curcumin as premedication - root canal treatment
4997074|NCT04012385|Fertility|fertility
4997075|NCT04012385|Nutrition|nutrition
4997076|NCT04012385|Environmental Pollution|environmental pollution
4997077|NCT04012372|Infants|infants
4997078|NCT04012372|Water|water
4997079|NCT04012372|Safety|safety
4997080|NCT04012359|Lung ultrasound|lung ultrasound
4997081|NCT04012307|Candesartan Cilexetil|candesartan cilexetil
4997082|NCT04012307|Bioequivalence|bioequivalence
4997083|NCT04012307|Atacand PROTECT|atacand protect
4997084|NCT04012294|allopurinol|allopurinol
4997085|NCT04012294|ultrasound|ultrasound
4997086|NCT04012294|morphostructural changes|morphostructural changes
4997087|NCT04012281|drug eluting stent|drug eluting stent
4997088|NCT04012281|coronary atherosclerosis|coronary atherosclerosis
4997089|NCT04012268|moyamoya disease|moyamoya disease
4997090|NCT04012268|remote ischemic conditioning|remote ischemic conditioning
4997091|NCT04012268|cerebral blood flow|cerebral blood flow
4997092|NCT04012242|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
4997093|NCT04012242|Ultrasound|ultrasound
4997094|NCT04012242|Elastography|elastography
4997095|NCT04012242|Dispersion|dispersion
4997096|NCT04012229|Breast cancer|breast cancer
4997097|NCT04012229|BRCA1|brca1
4997098|NCT04012229|BRCA2|brca2
4997099|NCT04012229|Chemotherapy|chemotherapy
4997100|NCT04012203|Musculoskeletal pain|musculoskeletal pain
4997111|NCT04012190|Young infants|young infants
4997123|NCT04012138|hyperkaliema|hyperkaliema
4997124|NCT04012138|insulin|insulin
4997125|NCT04012138|salbutamol|salbutamol
4997126|NCT04012125|Cerebral palsy|cerebral palsy
4997127|NCT04012125|Brace|brace
4997128|NCT04012125|Scoliosis|scoliosis
4997129|NCT04012112|brace|brace
4997130|NCT04012112|neuromuscular disease|neuromuscular disease
4997131|NCT04012112|scoliosis|scoliosis
4997132|NCT04012099|scar prevention|scar prevention
4997133|NCT04012099|siRNA|sirna
4997134|NCT04012099|scar|scar
4997135|NCT04012086|Cognitive decline|cognitive decline
4997136|NCT04012086|Physical therapy|physical therapy
4997137|NCT04012086|Parkinson's Disease|parkinson's disease
4997138|NCT04012073|Positive end-expiratory pressure|positive end-expiratory pressure
4997139|NCT04012073|Ventilator-induced lung injury|ventilator-induced lung injury
4997140|NCT04012073|Mechanical ventilation|mechanical ventilation
4997141|NCT04012073|Respiratory mechanics|respiratory mechanics
4997142|NCT04012060|Limited access|limited access
4997143|NCT04012060|Aortic valve replacement|aortic valve replacement
4997144|NCT04012060|upper hemisternotomy|upper hemisternotomy
4997145|NCT04012060|patient reported outcomes|patient reported outcomes
4997146|NCT04012060|randomized clinical trial|randomized clinical trial
4997147|NCT04012047|Levcromakalim|levcromakalim
4997148|NCT04012021|liver|liver
4997151|NCT04012021|hepatocellular carcinoma|hepatocellular carcinoma
4997152|NCT04012021|pancreatic cancer|pancreatic cancer
4997154|NCT04012021|magnetic resonance imaging|magnetic resonance imaging
4997155|NCT04011995|Intermittent caloric restriction|intermittent caloric restriction
4997156|NCT04011995|Children|children
4997157|NCT04011995|Youth|youth
4997158|NCT04011982|Pancreatic cancer|pancreatic cancer
4997159|NCT04011982|Immune infiltrate|immune infiltrate
4997160|NCT04011982|Molecular alterations|molecular alterations
4997161|NCT04011982|Tumor stroma|tumor stroma
4997162|NCT04011969|chronic inflammation|chronic inflammation
4997163|NCT04011969|young-onset colorectal cancer|young-onset colorectal cancer
4997164|NCT04011969|gut microbiome|gut microbiome
4997166|NCT04011917|Minor Musculoskeletal Injuries|minor musculoskeletal injuries
4997167|NCT04011917|Emergency Department|emergency department
4997168|NCT04011917|Prediction outcome|prediction outcome
4997169|NCT04011917|Extended Scope Physiotherapists|extended scope physiotherapists
4997170|NCT04011904|Greenland Inuit|greenland inuit
4997171|NCT04011904|Traditional diet|traditional diet
4997172|NCT04011904|TBC1D4|tbc1d4
4997173|NCT04011891|Minimally Invasive Surgery|minimally invasive surgery
4997174|NCT04011891|Robotic Surgery|robotic surgery
4997175|NCT04011891|Partial Nephrectomy|partial nephrectomy
4997176|NCT04011891|Feasibility|feasibility
4997177|NCT04011865|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
4997178|NCT04011865|robotic-assisted laparoscopic radical prostatectomy|robotic-assisted laparoscopic radical prostatectomy
4997179|NCT04011865|prostate cancer|prostate cancer
4997180|NCT04011852|Ventilator Weaning|ventilator weaning
4997181|NCT04011852|Child|child
4997182|NCT04011852|Electrical Impedance Tomography|electrical impedance tomography
4997183|NCT04011852|Respiration, artificial|respiration, artificial
4997184|NCT04011852|Intensive Care units|intensive care units
4997185|NCT04011813|cryopreservation|cryopreservation
4997186|NCT04011813|density gradient centrifugation|density gradient centrifugation
4997187|NCT04011813|DNA fragmentation, oxidation, chromatin packaging|dna fragmentation, oxidation, chromatin packaging
4997188|NCT04011813|antioxidant hypotaurine supplementation|antioxidant hypotaurine supplementation
4997189|NCT04011813|cryo-capacitation|cryo-capacitation
4997190|NCT04011813|human spermatozoa fertilizing ability|human spermatozoa fertilizing ability
4997191|NCT04011800|atrial fibrillation|atrial fibrillation
4997192|NCT04011800|catheter ablation|catheter ablation
4997193|NCT04011800|risk factor modification|risk factor modification
4997194|NCT04011722|Aortic Stenosis|aortic stenosis
4997195|NCT04011722|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
4997295|NCT04011254|salt intake|salt intake
4997201|NCT04011709|Methodological study|methodological study
4997202|NCT04011696|pseudoaccommodation|pseudoaccommodation
4997203|NCT04011696|monofocal IOL|monofocal iol
4997204|NCT04011696|cataract surgery|cataract surgery
4997205|NCT04011670|Plasticity|plasticity
4997206|NCT04011670|Variability|variability
4997207|NCT04011670|Non-invasive brain stimulation|non-invasive brain stimulation
4997208|NCT04011670|Caffeine|caffeine
4997209|NCT04011657|computerized decision support|computerized decision support
4997210|NCT04011657|prospective review and feedback|prospective review and feedback
4997211|NCT04011657|antimicrobial stewardship|antimicrobial stewardship
4997212|NCT04011644|implementation|implementation
4997213|NCT04011644|alcohol drinking|alcohol drinking
4997215|NCT04011644|wellness|wellness
4997216|NCT04011618|ellagic acid|ellagic acid
4997217|NCT04011618|metabolic syndrome|metabolic syndrome
4997218|NCT04011618|insulin resistance|insulin resistance
4997219|NCT04011618|insulin secretion|insulin secretion
4997220|NCT04011579|Physical activity|physical activity
4997221|NCT04011579|Pilates|pilates
4997222|NCT04011579|Fitness|fitness
4997223|NCT04011566|Asymptomatic Normal Pressure Hydrocephalus|asymptomatic normal pressure hydrocephalus
4997224|NCT04011566|Ventriculoperitoneal Shunt|ventriculoperitoneal shunt
4997225|NCT04011553|Knee osteoarthritis|knee osteoarthritis
4997226|NCT04011553|Virtual reality|virtual reality
4997227|NCT04011553|Rehabilitation|rehabilitation
4997228|NCT04011553|Balance|balance
4997229|NCT04011553|Kinesiophobia|kinesiophobia
4997230|NCT04011527|Calcified coronary artery lesions|calcified coronary artery lesions
4997231|NCT04011501|erector spinae plane block|erector spinae plane block
4997232|NCT04011501|thoracic surgery|thoracic surgery
4997233|NCT04011501|cardiac surgical procedures|cardiac surgical procedures
4997234|NCT04011501|pain, postoperative|pain, postoperative
4997235|NCT04011488|shared decision making|shared decision making
4997236|NCT04011462|Nursing|nursing
4997237|NCT04011462|Hypothermia|hypothermia
4997238|NCT04011462|Perioperative Nursing|perioperative nursing
4997239|NCT04011436|anterior knee pain|anterior knee pain
4997240|NCT04011436|patellofemoral pain syndrome AND treatment|patellofemoral pain syndrome and treatment
4997241|NCT04011436|patellofemoral pain AND diagnosis|patellofemoral pain and diagnosis
4997242|NCT04011436|patellofemoral pain syndrome AND exercise|patellofemoral pain syndrome and exercise
4997251|NCT04011397|Exercise|exercise
4997252|NCT04011397|Feasibility|feasibility
4997253|NCT04011397|HbA1c|hba1c
4997254|NCT04011397|Interval training|interval training
4997255|NCT04011384|Food Assistance|food assistance
4997256|NCT04011384|Economics, Behavioral|economics, behavioral
4997257|NCT04011384|Food Labeling|food labeling
4997258|NCT04011384|Diet Records|diet records
4997259|NCT04011384|Biomarkers|biomarkers
4997260|NCT04011358|Retinal Vein Occlusion|retinal vein occlusion
4997261|NCT04011358|central retinal vein occlusion|central retinal vein occlusion
4997262|NCT04011358|branch retinal vein occlusion|branch retinal vein occlusion
4997263|NCT04011358|obstructive sleep apnea|obstructive sleep apnea
4997264|NCT04011358|sleep apnea|sleep apnea
4997265|NCT04011345|Folic Acid|folic acid
4997266|NCT04011345|Unmetabolized Folic Acid|unmetabolized folic acid
4997267|NCT04011345|Pediatrics|pediatrics
4997268|NCT04011332|integrated care|integrated care
4997269|NCT04011332|self-management|self-management
4997270|NCT04011319|Group culture|group culture
4997271|NCT04011319|Embryo quality|embryo quality
4997272|NCT04011319|Implantation rate|implantation rate
4997273|NCT04011319|Clinical pregnancy|clinical pregnancy
4997274|NCT04011293|Relapsed|relapsed
4997275|NCT04011293|Refractory|refractory
4997276|NCT04011293|Malignancy|malignancy
4997277|NCT04011280|nicotine|nicotine
4997278|NCT04011280|varenicline|varenicline
4997279|NCT04011280|Acceptance and Commitment Therapy|acceptance and commitment therapy
4997280|NCT04011280|schizophrenia|schizophrenia
4997281|NCT04011280|schizoaffective|schizoaffective
4997282|NCT04011280|bipolar|bipolar
4997283|NCT04011267|exercise therapy|exercise therapy
4997284|NCT04011267|diabetic foot|diabetic foot
4997285|NCT04011267|preventive care|preventive care
4997286|NCT04011267|foot-related exercises|foot-related exercises
4997287|NCT04011267|self-management|self-management
4997342|NCT04010981|exercise|exercise
4997343|NCT04010981|Nintendo wii|nintendo wii
4997344|NCT04010981|Video based exercise|video based exercise
4997345|NCT04010916|Postoperative analgesia|postoperative analgesia
4997346|NCT04010916|Adductor canal block|adductor canal block
4997347|NCT04010916|Knee arthroscopy|knee arthroscopy
4997348|NCT04010903|INSULIN RESISTANCE|insulin resistance
4997349|NCT04010890|culture|culture
4997350|NCT04010890|cognitive therapy|cognitive therapy
4997351|NCT04010890|Canada|canada
4997352|NCT04010877|AML|aml
4997353|NCT04010877|CAR T|car t
4997354|NCT04010877|CD33, CD123, CLL-1|cd33, cd123, cll-1
4997355|NCT04010851|Parental activation|parental activation
4997356|NCT04010851|Peer co-led education|peer co-led education
4997357|NCT04010838|disorders of consciousness|disorders of consciousness
4997358|NCT04010838|spinal cord stimulation|spinal cord stimulation
4997359|NCT04010838|DoC|doc
4997360|NCT04010838|SCS|scs
4997361|NCT04010825|Dyspnea|dyspnea
4997362|NCT04010825|Pulmonary rehabilitation|pulmonary rehabilitation
4997363|NCT04010825|Physical activity|physical activity
4997364|NCT04010825|Hypnosis|hypnosis
4997365|NCT04010825|Anxiety|anxiety
4997366|NCT04010825|COPD|copd
4997367|NCT04010773|Empowerment|empowerment
4997368|NCT04010773|leadership|leadership
4997369|NCT04010773|intervention|intervention
4997370|NCT04010773|psycho-social intervention|psycho-social intervention
4997371|NCT04010773|motivation|motivation
4997372|NCT04010773|working conditions|working conditions
4997373|NCT04010773|occupational health|occupational health
4997374|NCT04010734|suspected malignant biliary stricture|suspected malignant biliary stricture
4997375|NCT04010734|primary peroral cholangiscopy|primary peroral cholangiscopy
4997376|NCT04010734|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4997377|NCT04010734|fluorescence in situ hybridization|fluorescence in situ hybridization
4997378|NCT04010721|Cochlear implant|cochlear implant
4997379|NCT04010695|G6PD deficiency|g6pd deficiency
4997380|NCT04010669|Portal Hypertension|portal hypertension
4997381|NCT04010669|Liver resection|liver resection
5013627|NCT03911557|TMB|tmb
4997383|NCT04010656|Urogynecologic surgery|urogynecologic surgery
4997384|NCT04010656|Urinary retention postoperative|urinary retention postoperative
4997385|NCT04010643|online cognitive behavioural therapy|online cognitive behavioural therapy
4997386|NCT04010643|online neurocognitive remediation|online neurocognitive remediation
4997387|NCT04010643|memory|memory
4997388|NCT04010643|sustained attention|sustained attention
4997389|NCT04010643|everyday occupational function|everyday occupational function
4997390|NCT04010643|economic evaluation|economic evaluation
4997391|NCT04010617|Pharyngeal Electrical Stimulation|pharyngeal electrical stimulation
4997392|NCT04010617|Stroke|stroke
4997393|NCT04010617|Dysphagia|dysphagia
4997394|NCT04010617|Re-intubation|re-intubation
5000577|NCT03991650|depression|depression
4997400|NCT04010578|hybrid PET/MRI|hybrid pet/mri
4997401|NCT04010578|Coronary artery calcification score|coronary artery calcification score
4997402|NCT04010578|Menaquinone-7|menaquinone-7
4997403|NCT04010578|Carotid Artery Disease|carotid artery disease
4997404|NCT04010578|Coronary Artery Disease|coronary artery disease
4997405|NCT04010565|Cholesterol LDL|cholesterol ldl
4997406|NCT04010565|Black garlic extract|black garlic extract
4997407|NCT04010565|S-allyl cysteine|s-allyl cysteine
5356785|NCT01918007|Sleep Apnea, Obstructive|sleep apnea, obstructive
4997408|NCT04010539|Urogenital Gonorrhea, Gepotidacin, Neisseria gonorrhoeae, Efficacy, Phase 3|urogenital gonorrhea, gepotidacin, neisseria gonorrhoeae, efficacy, phase 3
4997409|NCT04010500|dental trauma|dental trauma
4997410|NCT04010500|rugby|rugby
4997411|NCT04010500|mouthguard|mouthguard
4997412|NCT04010500|speech|speech
4997413|NCT04010500|contact sports|contact sports
4997414|NCT04010474|Complication|complication
4997415|NCT04010474|Mortality|mortality
4997416|NCT04010474|Modified|modified
4997417|NCT04010474|Surgical Apgar Score|surgical apgar score
4997418|NCT04010461|functional magnetic resonance imaging|functional magnetic resonance imaging
4997419|NCT04010461|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4997420|NCT04010461|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4997421|NCT04010383|Perimetry|perimetry
4997422|NCT04010383|Virtual reality device|virtual reality device
4997423|NCT04010370|Insulin sensitivity|insulin sensitivity
4997424|NCT04010370|PREDIM|predim
4997425|NCT04010370|Correlation|correlation
4997426|NCT04010370|Healthy individuals|healthy individuals
4997427|NCT04010357|platinum refractory disease|platinum refractory disease
4997428|NCT04010357|Wild Type Rb Extensive Stage SCLC|wild type rb extensive stage sclc
4997429|NCT04010331|Nokyong|nokyong
4997430|NCT04010279|preoxygenation|preoxygenation
4997431|NCT04010279|CPAP(continuous positive airway pressure)|cpap(continuous positive airway pressure)
4997432|NCT04010279|APL (airway pressure release) valve|apl (airway pressure release) valve
4997433|NCT04010253|Cystic Fibrosis|cystic fibrosis
4997434|NCT04010253|Physiotherapy|physiotherapy
4997435|NCT04010253|Drainage|drainage
4997436|NCT04010240|Solid tumor|solid tumor
4997437|NCT04010240|Metastatic|metastatic
4997438|NCT04010240|NTRK|ntrk
4997439|NCT04010227|Acceptance and Commitment Therapy|acceptance and commitment therapy
4997440|NCT04010227|Fatigue|fatigue
4997441|NCT04010227|Family Caregivers|family caregivers
4997442|NCT04010227|Psychotherapy|psychotherapy
4997443|NCT04010201|brain calcification|brain calcification
4997444|NCT04010201|natural history|natural history
4997445|NCT04010201|genetics|genetics
4997446|NCT04010175|Cognitive training|cognitive training
4997447|NCT04010175|Distance training|distance training
4997448|NCT04010175|Alzheimer's disease|alzheimer's disease
4997449|NCT04010162|mesh complications|mesh complications
4997450|NCT04010162|social media awareness|social media awareness
4997451|NCT04010162|knowledge of doctors|knowledge of doctors
4997452|NCT04010149|Working memory|working memory
4997453|NCT04010149|cognitive training|cognitive training
4997454|NCT04010149|tDCS|tdcs
4997455|NCT04010136|Palliative care|palliative care
4997456|NCT04010136|Primary health care|primary health care
4997457|NCT04010136|Palliative care training|palliative care training
4997458|NCT04010136|Prevalence|prevalence
4997459|NCT04010136|Geriatrics|geriatrics
4997460|NCT04010110|Hydroxychloroquine|hydroxychloroquine
4997461|NCT04010110|Toxic retinopathy|toxic retinopathy
4997462|NCT04010110|Hydroxychloroquine screening|hydroxychloroquine screening
4997463|NCT04010084|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4997464|NCT04010084|Photobiomodulation|photobiomodulation
4997465|NCT04010071|Hepatobiliary Neoplasm|hepatobiliary neoplasm
4997466|NCT04010071|axitinib|axitinib
4997467|NCT04010071|toripalimab|toripalimab
4997468|NCT04010071|biomarker|biomarker
4997469|NCT04010045|lower extremity PAD|lower extremity pad
4997470|NCT04010006|Stomach Neoplasms|stomach neoplasms
4997471|NCT04010006|Laparoscopy|laparoscopy
4997472|NCT04009993|digital tool|digital tool
4997473|NCT04009993|decision making|decision making
4997474|NCT04009993|labour process|labour process
4997475|NCT04009993|birth results|birth results
4997476|NCT04009980|citicoline|citicoline
4997477|NCT04009980|neuropathy|neuropathy
4997483|NCT04009954|perioperative period|perioperative period
4997484|NCT04009837|older adult|older adult
4997485|NCT04009837|geriatrics|geriatrics
4997486|NCT04009837|chronic low back pain|chronic low back pain
4997487|NCT04009837|low back pain|low back pain
4997488|NCT04009837|hip-spine|hip-spine
4997489|NCT04009837|rehabilitation|rehabilitation
4997490|NCT04009837|physical therapy|physical therapy
4997491|NCT04009837|spine|spine
5000715|NCT03990792|App|app
4997501|NCT04009759|Ketamine|ketamine
4997502|NCT04009759|Survival rate|survival rate
4997503|NCT04009733|Osteogenesis imperfecta|osteogenesis imperfecta
4997504|NCT04009733|micro Ribonucleic acids|micro ribonucleic acids
4997505|NCT04009733|epigenetics|epigenetics
4997507|NCT04009707|BEARNI|bearni
4997508|NCT04009694|Pelvic floor muscle training|pelvic floor muscle training
4997509|NCT04009694|pelvic physiotherapy|pelvic physiotherapy
4997510|NCT04009694|pelvic floor exercises|pelvic floor exercises
4997511|NCT04009681|Synthorx|synthorx
4997512|NCT04009681|THOR-707|thor-707
4997513|NCT04009681|THOR 707|thor 707
4997514|NCT04009681|Interleukin 2|interleukin 2
4997515|NCT04009681|Interleukin-2|interleukin-2
4997517|NCT04009681|oncology|oncology
4997518|NCT04009681|immuno-oncology|immuno-oncology
4997519|NCT04009681|immunotherapy|immunotherapy
4997520|NCT04009681|IL-2|il-2
4997521|NCT04009668|Kidney Disease|kidney disease
4997522|NCT04009668|Minimal Change Disease|minimal change disease
4997523|NCT04009668|Nephrotic Syndrome|nephrotic syndrome
4997524|NCT04009668|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
4997525|NCT04009668|FSGS|fsgs
4997526|NCT04009616|Aloe vera mouthwash|aloe vera mouthwash
4997534|NCT04009551|meningitis|meningitis
4997535|NCT04009551|epidemiology|epidemiology
4997536|NCT04009551|neonate|neonate
4997537|NCT04009551|newborn|newborn
4997538|NCT04009538|copd|copd
4997539|NCT04009538|smoking|smoking
4997540|NCT04009538|Smoking Cessation|smoking cessation
4997541|NCT04009538|Rehabilitation; Tobacco Use|rehabilitation; tobacco use
4997542|NCT04009525|thalassemia major|thalassemia major
4997543|NCT04009525|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4997544|NCT04009499|Psoriatic Arthritis|psoriatic arthritis
4997545|NCT04009499|PsA|psa
4997546|NCT04009499|Bimekizumab|bimekizumab
4997547|NCT04009473|platelet rich plasma|platelet rich plasma
4997548|NCT04009473|growth factors|growth factors
4997549|NCT04009473|stem cells|stem cells
4997550|NCT04009473|bone marrow|bone marrow
4997551|NCT04009473|in vitro activation|in vitro activation
4997552|NCT04009473|ovarian cortex transplantation|ovarian cortex transplantation
4997553|NCT04009473|hippo signalling pathway|hippo signalling pathway
4997554|NCT04009460|ES101|es101
4997555|NCT04009460|solid tumor|solid tumor
4997556|NCT04009460|phase 1|phase 1
4997557|NCT04009460|PD-L1|pd-l1
4997558|NCT04009460|4-1BB|4-1bb
4997559|NCT04009460|INBRX-105|inbrx-105
4997560|NCT04009460|PD-L1×4-1BB|pd-l1×4-1bb
4997561|NCT04009460|41BB|41bb
4997562|NCT04009460|PDL1|pdl1
4997563|NCT04009434|Aortic Stenosis|aortic stenosis
4997564|NCT04009434|Aortic Disease|aortic disease
4997565|NCT04009434|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
4997566|NCT04009434|Mitral Regurgitation|mitral regurgitation
4997567|NCT04009434|Mitral Valve Regurgitation|mitral valve regurgitation
4997568|NCT04009434|Mitral Disease|mitral disease
4997569|NCT04009434|Mitral valve clipping|mitral valve clipping
4997570|NCT04009434|MitraClip|mitraclip
4997571|NCT04009434|Heart Valve Diseases|heart valve diseases
4997572|NCT04009421|coronary artery disease|coronary artery disease
4997573|NCT04009421|plaque burden|plaque burden
4997574|NCT04009421|prognosis|prognosis
4997575|NCT04009408|Dysphagia|dysphagia
4997576|NCT04009408|Myopathy|myopathy
4997582|NCT04009330|Phenotypes|phenotypes
4997583|NCT04009330|POC (point of care)|poc (point of care)
4997584|NCT04009304|Nutrition|nutrition
4997585|NCT04009304|Physical activity|physical activity
4997586|NCT04009291|Hypoparathyroidism|hypoparathyroidism
4997587|NCT04009291|Parathyroid Hormone|parathyroid hormone
4997589|NCT04009291|Prodrug|prodrug
4997590|NCT04009291|Sustained Release|sustained release
4997591|NCT04009291|TransCon PTH|transcon pth
4997592|NCT04009291|Parathyroid Hormone Replacement Therapy|parathyroid hormone replacement therapy
4997593|NCT04009278|Pain and discomfort|pain and discomfort
4997594|NCT04009265|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4997595|NCT04009265|adjuvant chemotherapy|adjuvant chemotherapy
4997601|NCT04009226|Neuromuscular Diseases|neuromuscular diseases
5000832|NCT03989947|ACH|ach
4997605|NCT04009213|Laparoacopic|laparoacopic
4997606|NCT04009213|Peritoneal Closure|peritoneal closure
4997607|NCT04009187|manual wheelchair|manual wheelchair
4997608|NCT04009187|wheelchair propulsion|wheelchair propulsion
4997609|NCT04009187|motor learning|motor learning
4997610|NCT04009174|Prostate Cancer|prostate cancer
4997611|NCT04009174|PET/CT|pet/ct
4997612|NCT04009174|PET/MRI|pet/mri
4997613|NCT04009174|Fluorocholine|fluorocholine
4997614|NCT04009174|PSMA|psma
4997615|NCT04009174|Sodium (Na) MRI|sodium (na) mri
4997616|NCT04009174|[18-F]-FCH|[18-f]-fch
4997617|NCT04009174|[18-F]-DCFPyL|[18-f]-dcfpyl
4997618|NCT04009174|Hybrid imaging|hybrid imaging
4997619|NCT04009174|Whole mount histopathology|whole mount histopathology
4997620|NCT04009135|Chronic non-cancer pain|chronic non-cancer pain
4997621|NCT04009135|Major depression|major depression
5313677|NCT02113475|CDT|cdt
4997622|NCT04009135|Internet therapies|internet therapies
4997623|NCT04009135|Cognitive behaviour therapy|cognitive behaviour therapy
4997624|NCT04009135|Acceptance and commitment therapy|acceptance and commitment therapy
4997625|NCT04009096|PvDBP|pvdbp
4997626|NCT04009096|efficacy|efficacy
4997627|NCT04009083|18F-Fluciclovine PET imaging|18f-fluciclovine pet imaging
4997628|NCT04009083|Focal Cryo Ablation|focal cryo ablation
4997629|NCT04009031|video games|video games
4997630|NCT04009031|upper extremity|upper extremity
4997631|NCT04009031|rehabilitation|rehabilitation
4997632|NCT04009031|cerebral palsy|cerebral palsy
4997636|NCT04008953|volume assessment|volume assessment
4997637|NCT04008940|VA-LCP DF|va-lcp df
4997638|NCT04008940|LCP DF|lcp df
4997639|NCT04008940|LISS DF|liss df
4997640|NCT04008940|various angle locking plate|various angle locking plate
4997641|NCT04008927|Hepatitis C|hepatitis c
4997642|NCT04008927|RDS survey|rds survey
4997643|NCT04008927|Communauty-based intervention|communauty-based intervention
4997644|NCT04008927|Viral hepatitis C|viral hepatitis c
4997645|NCT04008914|Heart Failure|heart failure
4997646|NCT04008914|Readmission Risks|readmission risks
4997647|NCT04008901|Functional dyspepsia|functional dyspepsia
4997648|NCT04008901|Irritable Bowel Syndrome|irritable bowel syndrome
4997649|NCT04008901|Lonicera Flos|lonicera flos
4997650|NCT04008901|GSRS|gsrs
4997651|NCT04008901|Antioxidant|antioxidant
4997652|NCT04008875|diaphragm ultrasound|diaphragm ultrasound
4997653|NCT04008875|mechanical ventilation|mechanical ventilation
4997654|NCT04008875|diaphragm function|diaphragm function
4997655|NCT04008862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
4997656|NCT04008862|Self-management|self-management
4997657|NCT04008862|Palliative care|palliative care
4997658|NCT04008862|Family|family
4997659|NCT04008862|Chronic Disease|chronic disease
4997660|NCT04008862|Nursing practice|nursing practice
4997661|NCT04008849|Inherited Metabolic Disorders|inherited metabolic disorders
4997662|NCT04008849|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4997663|NCT04008849|MGTA-456|mgta-456
4997664|NCT04008849|Umbilical Cord Blood Transplant|umbilical cord blood transplant
4997665|NCT04008849|Hurler Syndrome|hurler syndrome
4997666|NCT04008849|Cerebral Adrenoleukodystrophy|cerebral adrenoleukodystrophy
4997667|NCT04008849|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
4997668|NCT04008849|Metachromatic Leukodystrophy|metachromatic leukodystrophy
4997669|NCT04008810|renal insufficiency|renal insufficiency
4997670|NCT04008810|renal failure|renal failure
4997671|NCT04008810|acute kidney injury|acute kidney injury
4997677|NCT04008758|recruitment|recruitment
4997678|NCT04008758|ultrasound|ultrasound
4997680|NCT04008758|pulmonary contusion|pulmonary contusion
4997681|NCT04008745|exercise therapy|exercise therapy
4997682|NCT04008745|diabetic foot|diabetic foot
4997683|NCT04008745|preventive care|preventive care
4997684|NCT04008745|foot-related exercise|foot-related exercise
4997685|NCT04008745|self-management|self-management
4997686|NCT04008745|musculoskeletal function|musculoskeletal function
4997687|NCT04008745|Booklet|booklet
4997688|NCT04008745|Primary Health Care|primary health care
4997689|NCT04008719|Depression|depression
4997692|NCT04008693|Aging|aging
4997693|NCT04008693|Aged Garlic|aged garlic
4997694|NCT04008693|Functional Food|functional food
4997695|NCT04008693|Vascular Function|vascular function
4997696|NCT04008693|Muscle oxygenation|muscle oxygenation
4998294|NCT04005079|Eye Surgery|eye surgery
4997700|NCT04008680|burden|burden
4997701|NCT04008680|response|response
4997702|NCT04008680|methodology|methodology
4997703|NCT04008667|Postoperative ileus|postoperative ileus
4997704|NCT04008667|acupoint|acupoint
4997705|NCT04008667|ERAS|eras
4997706|NCT04008667|Chinese medicine|chinese medicine
4997707|NCT04008641|pediatric consultation|pediatric consultation
4997708|NCT04008641|psychological|psychological
4997709|NCT04008641|comprehension|comprehension
4997710|NCT04008628|Pain|pain
4997711|NCT04008628|nasogastric tube|nasogastric tube
4997721|NCT04008576|Internet-delivered CBT|internet-delivered cbt
4997722|NCT04008576|Blended CBT|blended cbt
4997723|NCT04008576|Group CBT|group cbt
4997724|NCT04008576|Negative affect|negative affect
4997725|NCT04008576|Positive affect|positive affect
4997726|NCT04008550|TAVI (Transcatheter Aortic Valve Implantation)|tavi (transcatheter aortic valve implantation)
4997727|NCT04008550|Aortic Stenosis|aortic stenosis
4997728|NCT04008550|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
4997729|NCT04008550|Right Heart Catheterization|right heart catheterization
4997730|NCT04008524|Relapsed|relapsed
4997731|NCT04008524|Refractory|refractory
4997732|NCT04008524|Hematological malignancy|hematological malignancy
4997733|NCT04008524|CAR-T cells|car-t cells
4997734|NCT04008511|Metastatic Colorectal Cancer|metastatic colorectal cancer
4997735|NCT04008511|Regorafenib|regorafenib
4997736|NCT04008511|Second line|second line
4997737|NCT04008511|XELOX|xelox
4997738|NCT04008472|Telemedecine|telemedecine
4997739|NCT04008394|CD-30 CART|cd-30 cart
5313699|NCT02113410|Balance|balance
4997740|NCT04008394|Refractory/Relapsed|refractory/relapsed
4997741|NCT04008394|lymphocyte malignancies|lymphocyte malignancies
4997742|NCT04008381|gamma-delta T|gamma-delta t
4997743|NCT04008381|Refractory/Relapsed|refractory/relapsed
4997747|NCT04008342|aged|aged
4997748|NCT04008342|nonpharmacological intervention|nonpharmacological intervention
4997749|NCT04008342|multisensory stimulation|multisensory stimulation
4997750|NCT04008342|neuropsychiatric symptoms|neuropsychiatric symptoms
4997751|NCT04008342|long-term care|long-term care
4997752|NCT04008329|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
4997753|NCT04008329|natural history|natural history
4997754|NCT04008329|genetics|genetics
4997755|NCT04008329|prognostic factors|prognostic factors
4997756|NCT04008290|Liraglutide|liraglutide
4997758|NCT04008290|Motilin|motilin
4997759|NCT04008290|Ghrelin|ghrelin
4997760|NCT04008290|Hunger|hunger
4997761|NCT04008290|glucose|glucose
4997762|NCT04008290|ad libitum food intake|ad libitum food intake
4997763|NCT04008238|Soft-tissue sarcoma|soft-tissue sarcoma
4997764|NCT04008238|Predictive biomarkers|predictive biomarkers
4997765|NCT04008238|Next-generation sequencing|next-generation sequencing
4997766|NCT04008225|Bronchoalveolar lavage|bronchoalveolar lavage
4997767|NCT04008186|RTA 408|rta 408
4997768|NCT04008186|RTA 408 capsules|rta 408 capsules
4997769|NCT04008186|omaveloxolone|omaveloxolone
4997770|NCT04008186|omaveloxolone capsules|omaveloxolone capsules
4997771|NCT04008186|DDI|ddi
4997772|NCT04008160|perfusion|perfusion
4997773|NCT04008160|oxygenation|oxygenation
4997774|NCT04008160|non invasive measurement|non invasive measurement
4997775|NCT04008134|handwashing with soap|handwashing with soap
4997776|NCT04008134|water treatment|water treatment
4997777|NCT04008134|behavior change|behavior change
4997778|NCT04008134|water, sanitation and hygiene|water, sanitation and hygiene
4997779|NCT04008121|Fluorescein angiography|fluorescein angiography
4997780|NCT04008108|urinary incontinence|urinary incontinence
4997781|NCT04008108|artificial urinary sphincter|artificial urinary sphincter
4997782|NCT04008108|physcial activity|physcial activity
4997783|NCT04008108|number of steps per day|number of steps per day
4997784|NCT04008108|activity tracker|activity tracker
4997785|NCT04008095|cervical cancer|cervical cancer
4997786|NCT04008095|pet/ct|pet/ct
4997787|NCT04008095|post-therapeutic|post-therapeutic
4997788|NCT04008095|advanced stage|advanced stage
4997798|NCT04008004|"First-in-Human"|"first-in-human"
4997799|NCT04008004|Single Ascending Dose|single ascending dose
4997809|NCT04007939|functional medicine|functional medicine
4997810|NCT04007939|4P medicine|4p medicine
4997811|NCT04007939|employee wellness program|employee wellness program
4997812|NCT04007939|functional capacity|functional capacity
4997813|NCT04007939|smart phone application|smart phone application
4997814|NCT04007926|insulin resistance|insulin resistance
4997815|NCT04007926|aerobic exercise|aerobic exercise
4997816|NCT04007926|resistance exercise|resistance exercise
4997817|NCT04007926|exercise training|exercise training
4997818|NCT04007926|South Asians|south asians
4997819|NCT04007900|positive affect treatment|positive affect treatment
4997820|NCT04007874|Migraine|migraine
4997821|NCT04007874|Women|women
4997822|NCT04007874|Hormones|hormones
4997823|NCT04007874|Oral contraceptive pill|oral contraceptive pill
4997824|NCT04007874|Vitamin E|vitamin e
4997825|NCT04007822|low back pain|low back pain
4997832|NCT04007796|Sleep Apnea Syndromes|sleep apnea syndromes
4997833|NCT04007796|Sleep Apnea, Central|sleep apnea, central
4997834|NCT04007796|Sleep Apnea, Obstructive|sleep apnea, obstructive
4997835|NCT04007796|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
4997836|NCT04007796|Insomnia|insomnia
5318070|NCT02094235|Dermatitis|dermatitis
4997837|NCT04007796|Insomnia Disorder|insomnia disorder
4997838|NCT04007796|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4997840|NCT04007796|Veterans|veterans
4997847|NCT04007757|Intracerebral Hemorrhage|intracerebral hemorrhage
4997848|NCT04007757|Hemorrhagic Stroke|hemorrhagic stroke
4997849|NCT04007757|Intracerebral Hematoma|intracerebral hematoma
4997850|NCT04007731|protein bar|protein bar
4997851|NCT04007731|physical activity|physical activity
4997852|NCT04007731|muscle|muscle
4997853|NCT04007705|Antiinflammatory diet|antiinflammatory diet
4997854|NCT04007705|Low FODMAPs diet|low fodmaps diet
4997855|NCT04007705|Gluten, casein, sugar and processed-foods free diet|gluten, casein, sugar and processed-foods free diet
4997856|NCT04007705|Nutrition|nutrition
4997857|NCT04007692|Esophageal stenosis|esophageal stenosis
4997858|NCT04007692|Endoscopic suturing|endoscopic suturing
4997859|NCT04007692|Esophageal stent fixation|esophageal stent fixation
4997860|NCT04007692|Stent migration|stent migration
4997861|NCT04007679|pain neuroscience education|pain neuroscience education
4997862|NCT04007679|chronic pain|chronic pain
4997863|NCT04007679|physiotherapy students|physiotherapy students
4997867|NCT04007653|Post thrombotic syndrome|post thrombotic syndrome
4997868|NCT04007653|Edoxaban|edoxaban
4997869|NCT04007653|Vitamin K antagonist|vitamin k antagonist
4997870|NCT04007653|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
4997871|NCT04007653|Quality of Life|quality of life
5426581|NCT01602159|SFA|sfa
4997872|NCT04007640|Obesity|obesity
4997873|NCT04007640|Diabetes|diabetes
4997874|NCT04007640|metabolic syndrome|metabolic syndrome
4997875|NCT04007640|Magnetic Resonance imaging,|magnetic resonance imaging,
4997876|NCT04007640|Pancreatic Cancer|pancreatic cancer
4997877|NCT04007640|preneoplastic lesions|preneoplastic lesions
4997878|NCT04007640|acino-ductal metaplasia,|acino-ductal metaplasia,
4997879|NCT04007627|ALADA|alada
4997880|NCT04007627|IQ|iq
4997881|NCT04007627|Pediatric Radiology|pediatric radiology
4997882|NCT04007614|Macro-progestins|macro-progestins
4997883|NCT04007614|Bone health|bone health
4997884|NCT04007601|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
4997885|NCT04007601|Neurocognitive impairment|neurocognitive impairment
4997886|NCT04007601|Executive dysfunction|executive dysfunction
4997887|NCT04007601|Survivorship|survivorship
4997888|NCT04007588|Melanoma|melanoma
4997889|NCT04007562|LIPIN1 deficiency|lipin1 deficiency
4997890|NCT04007562|Acute episodes of rhabdomyolysis|acute episodes of rhabdomyolysis
4997891|NCT04007562|Myoglobinuria|myoglobinuria
4997892|NCT04007562|Hydroxychloroquine Sulfate|hydroxychloroquine sulfate
4997893|NCT04007562|Orphan drug|orphan drug
4997894|NCT04007549|Breast cancer|breast cancer
4997895|NCT04007549|Smoking cessation|smoking cessation
4997921|NCT04007471|Primary dysmenorrhea|primary dysmenorrhea
4997922|NCT04007471|Secondary dysmenorrhea|secondary dysmenorrhea
4997923|NCT04007471|Pelvic pain|pelvic pain
4997924|NCT04007471|Menstrual pain|menstrual pain
4997925|NCT04007471|Adolescent|adolescent
4997926|NCT04007471|Endometriosis|endometriosis
4997928|NCT04007445|spinal cord injury|spinal cord injury
4997929|NCT04007445|exercise|exercise
4997930|NCT04007445|occupational therapy|occupational therapy
4997933|NCT04007419|Organ donation|organ donation
4997934|NCT04007419|Donor designation/registration|donor designation/registration
4997935|NCT04007419|Train-the-trainer|train-the-trainer
4997936|NCT04007419|Promotora|promotora
4997937|NCT04007419|Community health worker|community health worker
4997938|NCT04007419|Lay health educator|lay health educator
4997939|NCT04007419|Program development|program development
4997940|NCT04007419|Program evaluation|program evaluation
4997941|NCT04007380|Spinal cord injuries|spinal cord injuries
4997942|NCT04007380|Sleep-related breathing disorders|sleep-related breathing disorders
4997943|NCT04007328|sphingosine-1-phosphate|sphingosine-1-phosphate
4997944|NCT04007328|corticosteroids adjuvant therapy|corticosteroids adjuvant therapy
4997945|NCT04007315|rehabilitation|rehabilitation
4997946|NCT04007315|hand|hand
4997947|NCT04007263|NMDA|nmda
4997948|NCT04007263|GluN2B|glun2b
4997949|NCT04007250|Magnetic Anal Sphincter Augmentation|magnetic anal sphincter augmentation
4997950|NCT04007250|FENIX™ continence restoration system|fenix™ continence restoration system
5001122|NCT03988517|fasting|fasting
4997963|NCT04007172|lidocain injection|lidocain injection
4997964|NCT04007159|Skin Care, Cosmetic Facial Product|skin care, cosmetic facial product
4997965|NCT04007146|Cardiac Output|cardiac output
4997966|NCT04007146|vascular medicine|vascular medicine
4997967|NCT04007146|Transcutaneous Oxymetry|transcutaneous oxymetry
4997968|NCT04007133|Non-insulin-dependent diabetes|non-insulin-dependent diabetes
4997969|NCT04007133|Statins|statins
4997970|NCT04007133|Compliance|compliance
4997971|NCT04007081|Dry Mouth|dry mouth
4997972|NCT04007081|MSC|msc
4997973|NCT04007081|mesenchymal stem cells|mesenchymal stem cells
4997974|NCT04007081|adult stem cells|adult stem cells
4997975|NCT04007081|head and neck cancer|head and neck cancer
4997976|NCT04007081|salivary gland|salivary gland
5305108|NCT02152033|Parent|parent
5318164|NCT02093871|HEATT|heatt
4997977|NCT04007081|radiation|radiation
4997978|NCT04007081|HNC|hnc
4997979|NCT04006977|probiotics; psychological disorder;DSF|probiotics; psychological disorder;dsf
4997980|NCT04006951|Cancer|cancer
4997981|NCT04006951|Colorectal cancer|colorectal cancer
4997982|NCT04006951|Biological Specimen Banks|biological specimen banks
4997983|NCT04006925|sodium oxybate|sodium oxybate
4997984|NCT04006899|Bioelectrical Impedance spectroscopy|bioelectrical impedance spectroscopy
4997985|NCT04006899|Body compositions|body compositions
4997986|NCT04006899|Segmental Bioelectrical impedance spectroscopy|segmental bioelectrical impedance spectroscopy
4997993|NCT04006795|Skin Care, Cosmetic Facial Product|skin care, cosmetic facial product
4997994|NCT04006782|edentulous|edentulous
4997995|NCT04006782|narrow alveolar ridges|narrow alveolar ridges
4997996|NCT04006769|entacapone|entacapone
4997997|NCT04006769|Imatinib mesylate|imatinib mesylate
4997998|NCT04006769|GIST|gist
4997999|NCT04006769|treatment|treatment
4998000|NCT04006743|pain|pain
4998001|NCT04006743|preterm|preterm
4998002|NCT04006743|premature|premature
4998003|NCT04006743|orogastric tube|orogastric tube
4998004|NCT04006743|newborn nurse|newborn nurse
4998005|NCT04006717|Post-endodontic pain|post-endodontic pain
4998006|NCT04006717|Low-level laser|low-level laser
4998010|NCT04006691|UGN-101|ugn-101
4998011|NCT04006691|UTUC|utuc
4998012|NCT04006691|Ureteral|ureteral
4998013|NCT04006691|Upper Tract|upper tract
4998014|NCT04006691|Carcinoma|carcinoma
4998015|NCT04006691|Kidney|kidney
4998016|NCT04006691|Renal|renal
4998017|NCT04006691|Ureter|ureter
4998018|NCT04006691|Gel|gel
4998019|NCT04006691|Local|local
4998020|NCT04006691|Mitomycin C|mitomycin c
4998021|NCT04006691|Prolonged Release|prolonged release
4998022|NCT04006691|Slow Release|slow release
4998023|NCT04006691|Kidney Sparing|kidney sparing
4998024|NCT04006691|T1|t1
4998025|NCT04006691|T0|t0
4998026|NCT04006691|Low Grade|low grade
4998027|NCT04006691|Transitional Cell Carcinoma of Renal Pelvis|transitional cell carcinoma of renal pelvis
4998028|NCT04006691|TCC|tcc
4998029|NCT04006665|Lung Ultrasonography|lung ultrasonography
4998030|NCT04006665|Step Trendelenburg position|step trendelenburg position
4998031|NCT04006639|local infiltration|local infiltration
4998032|NCT04006639|bilateral superficial cervical plexus block|bilateral superficial cervical plexus block
4998033|NCT04006639|lidocaine|lidocaine
4998034|NCT04006639|bupivacaine|bupivacaine
4998035|NCT04006639|substance-p|substance-p
4998036|NCT04006613|Fatigue|fatigue
4998037|NCT04006613|Balance|balance
4998038|NCT04006613|Aerobic training|aerobic training
4998039|NCT04006587|incentive spirometer|incentive spirometer
4998040|NCT04006587|Hemothorax; Traumatic|hemothorax; traumatic
4998041|NCT04006587|trauma|trauma
4998042|NCT04006587|rib Fractures|rib fractures
4998043|NCT04006574|Developmental Hip Dysplasia|developmental hip dysplasia
4998044|NCT04006574|Physiotherapy|physiotherapy
4998045|NCT04006574|Gait|gait
4998046|NCT04006574|Core Stabilization|core stabilization
4998047|NCT04006574|Balance|balance
4998048|NCT04006561|Primary CNS Lymphoma|primary cns lymphoma
4998049|NCT04006561|Neurobehavioral Assessment|neurobehavioral assessment
4998073|NCT04006301|KRAS G12C|kras g12c
4998074|NCT04006288|dual antiplatelet therapy|dual antiplatelet therapy
4998075|NCT04006288|rivaroxaban|rivaroxaban
4998076|NCT04006288|pharmacodynamic|pharmacodynamic
4998077|NCT04006275|Hepatocellular Carcinoma|hepatocellular carcinoma
4998078|NCT04006275|cirhossi|cirhossi
4998079|NCT04006275|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
4998080|NCT04006275|LI-RADS|li-rads
4998081|NCT04006197|vocal folds dysplasia|vocal folds dysplasia
4998082|NCT04006184|Venaseal|venaseal
4998083|NCT04006184|Symptomatic Varicose Veins|symptomatic varicose veins
4998084|NCT04006171|c type natriuretic peptide|c type natriuretic peptide
4998085|NCT04006171|polycystic ovary syndrome|polycystic ovary syndrome
4998086|NCT04006171|menstrual cycle|menstrual cycle
4998087|NCT04006132|Bone anchored hearing systems|bone anchored hearing systems
4998088|NCT04006132|BAHS|bahs
4998089|NCT04006132|Bilateral benefit|bilateral benefit
4998090|NCT04006132|Ponto 3 SuperPower|ponto 3 superpower
4998091|NCT04006132|Minimum Audible Angle|minimum audible angle
4998092|NCT04006132|Auditory working memory|auditory working memory
4998093|NCT04006106|Drug hypersensitivity|drug hypersensitivity
4998094|NCT04006106|Endotypes|endotypes
4998095|NCT04006106|Anaphylaxis|anaphylaxis
4998096|NCT04006041|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4998097|NCT04006041|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
4998098|NCT04006041|Toripalimab|toripalimab
4998099|NCT04006041|Pathologic complete response|pathologic complete response
4998100|NCT04006028|Type 2 diabetes|type 2 diabetes
4998101|NCT04006028|renal biopsy|renal biopsy
4998102|NCT04006028|diabetic nephropathy|diabetic nephropathy
4998103|NCT04006028|proteinuria|proteinuria
4998104|NCT04006028|hematuria|hematuria
4998105|NCT04006015|COPD|copd
4998113|NCT04005937|H reflex|h reflex
5318258|NCT02093338|breast pain|breast pain
4998114|NCT04005937|spasticity|spasticity
4998115|NCT04005924|blood glucose|blood glucose
4998116|NCT04005924|blood insulin|blood insulin
4998117|NCT04005924|postprandial|postprandial
4998119|NCT04005911|Post-surgical|post-surgical
4998120|NCT04005833|Pulmonary disease|pulmonary disease
4998121|NCT04005833|chronic obstructive|chronic obstructive
4998122|NCT04005833|Primary Health Care|primary health care
4998123|NCT04005833|Fibrocyte|fibrocyte
4998124|NCT04005833|Respiratory Function Tests|respiratory function tests
4998125|NCT04005820|pediatric|pediatric
4998126|NCT04005794|schizophrenia|schizophrenia
4998127|NCT04005794|social skills training|social skills training
4998128|NCT04005794|social brain network|social brain network
4998129|NCT04005794|virtual reality|virtual reality
4998130|NCT04005794|simulation|simulation
4998131|NCT04005794|functional outcome|functional outcome
4998132|NCT04005781|bitter|bitter
4998133|NCT04005781|quinine|quinine
4998134|NCT04005781|ghrelin|ghrelin
4998135|NCT04005781|motilin|motilin
4998136|NCT04005781|food intake|food intake
4998137|NCT04005768|Bitter|bitter
4998138|NCT04005768|Quinine|quinine
4998139|NCT04005768|Motilin|motilin
4998140|NCT04005768|Ghrelin|ghrelin
4998141|NCT04005768|Food intake|food intake
4998142|NCT04005755|Analgesic|analgesic
4998143|NCT04005742|colorectal cancer|colorectal cancer
4998144|NCT04005742|biomarkers|biomarkers
4998145|NCT04005742|cancer risk|cancer risk
4998146|NCT04005742|cancer prevention|cancer prevention
4998147|NCT04005742|ageing|ageing
4998148|NCT04005742|diet|diet
4998149|NCT04005742|obesity|obesity
4998150|NCT04005742|physical activity|physical activity
4998151|NCT04005742|colorectal adenoma|colorectal adenoma
4998152|NCT04005729|cangrelor|cangrelor
4998156|NCT04005729|primary percutaneous coronary intervention|primary percutaneous coronary intervention
4998158|NCT04005703|Hodgkin's disease|hodgkin's disease
4998159|NCT04005703|Imaging|imaging
4998160|NCT04005703|Whole-Body MRI|whole-body mri
4998161|NCT04005703|PET/CT|pet/ct
4998162|NCT04005703|Radiation|radiation
4998163|NCT04005638|Biological collection|biological collection
4998164|NCT04005625|Crystal-Induced Arthritis|crystal-induced arthritis
4998165|NCT04005612|Vitamin D Deficiency|vitamin d deficiency
4998166|NCT04005612|plama osteocalcin|plama osteocalcin
4998167|NCT04005612|omega-3 fatty acids|omega-3 fatty acids
4998168|NCT04005599|Postoperative pain|postoperative pain
4998169|NCT04005599|opioid|opioid
4998170|NCT04005599|Postoperative analgesia|postoperative analgesia
4998171|NCT04005573|vitamin D3|vitamin d3
4998172|NCT04005573|Vitamin D Deficiency|vitamin d deficiency
4998173|NCT04005573|Lipid profile|lipid profile
4998174|NCT04005573|oxidized low density Lipoprotein|oxidized low density lipoprotein
4998175|NCT04005573|omega-3 fatty acids|omega-3 fatty acids
4998176|NCT04005560|severe bacterial infection|severe bacterial infection
4998177|NCT04005560|quality of life|quality of life
4998178|NCT04005560|long term sequela|long term sequela
4998179|NCT04005560|pediatric intensive care unit|pediatric intensive care unit
4998180|NCT04005560|children|children
4998181|NCT04005547|sexual health|sexual health
4998182|NCT04005547|Autism Spectrum Disorders|autism spectrum disorders
4998183|NCT04005534|Postoperative pain|postoperative pain
4998184|NCT04005534|Rotator cuff injuries|rotator cuff injuries
4998185|NCT04005534|Preemptive analgesia|preemptive analgesia
4998186|NCT04005508|sleep|sleep
4998187|NCT04005508|cardiovascular outcomes|cardiovascular outcomes
4998188|NCT04005508|high cardiovascular risk|high cardiovascular risk
4998189|NCT04005508|observational|observational
4998190|NCT04005495|Kitchen Collaborative|kitchen collaborative
4998191|NCT04005495|Healthful habits|healthful habits
4998192|NCT04005495|Worksite wellness program|worksite wellness program
4998193|NCT04005495|Mindfulness|mindfulness
4998194|NCT04005469|Ischemia-reperfusion injury|ischemia-reperfusion injury
4998195|NCT04005469|kidney transplantation|kidney transplantation
4998196|NCT04005469|prostacyclin|prostacyclin
4998197|NCT04005469|treprostinil|treprostinil
4998200|NCT04005456|n-of-1 trial|n-of-1 trial
4998201|NCT04005456|detoxification|detoxification
4998216|NCT04005404|Hip Fractures|hip fractures
4998217|NCT04005404|Lumbosacral Plexus|lumbosacral plexus
4998218|NCT04005391|postpartum contraception|postpartum contraception
4998219|NCT04005391|long-acting reversible contraceptives|long-acting reversible contraceptives
4998220|NCT04005391|implant|implant
4998221|NCT04005391|nursing|nursing
4998222|NCT04005391|community programming|community programming
4998223|NCT04005391|cluster-randomized trial|cluster-randomized trial
4998224|NCT04005365|propranolol|propranolol
4998225|NCT04005365|gastric cancer|gastric cancer
4998227|NCT04005339|Advanced Biliary Tract Cancer|advanced biliary tract cancer
4998228|NCT04005339|Biliary Tract Cancer|biliary tract cancer
4998229|NCT04005339|GI Cancer|gi cancer
4998230|NCT04005339|Biliary Cancer|biliary cancer
4998231|NCT04005339|NAPOLI-2|napoli-2
4998232|NCT04005313|Electromyographic activity|electromyographic activity
4998233|NCT04005313|Neck pain|neck pain
4998234|NCT04005313|Electroencephalographic activity|electroencephalographic activity
4998235|NCT04005313|dementia|dementia
4998236|NCT04005300|Refeeding syndrome|refeeding syndrome
4998237|NCT04005300|Enteral nutrition|enteral nutrition
4998238|NCT04005300|Critical illness|critical illness
4998239|NCT04005261|Type 2 diabetes|type 2 diabetes
4998240|NCT04005261|C-peptide|c-peptide
4998241|NCT04005261|beta-cell reserve|beta-cell reserve
4998242|NCT04005261|insulin use|insulin use
4998243|NCT04005235|phrenic nerve|phrenic nerve
4998244|NCT04005235|nerve block|nerve block
4998245|NCT04005235|ultrasonography|ultrasonography
4998246|NCT04005235|breath tests|breath tests
4998247|NCT04005235|oscillometry|oscillometry
4998248|NCT04005235|brachial plexus|brachial plexus
4998249|NCT04005222|Ocular ischemic syndrome|ocular ischemic syndrome
4998250|NCT04005222|selenium|selenium
4998251|NCT04005222|melatonin|melatonin
4998252|NCT04005222|MDA|mda
4998253|NCT04005222|GSH|gsh
4998254|NCT04005209|Ketamine|ketamine
4998255|NCT04005209|Intravenous Infusions|intravenous infusions
4998256|NCT04005209|Anemia; Sickle-Cell, with Crisis|anemia; sickle-cell, with crisis
4998257|NCT04005209|Acute Pain|acute pain
4998258|NCT04005183|Renal Cell Carcinoma|renal cell carcinoma
4998259|NCT04005183|Genomics|genomics
4998260|NCT04005183|Single-cell|single-cell
4998261|NCT04005183|Microenvironment|microenvironment
4998262|NCT04005183|Immunotherapy|immunotherapy
5001415|NCT03986411|pelvic floor|pelvic floor
4998272|NCT04005170|Definitive chemoradiotherapy|definitive chemoradiotherapy
4998273|NCT04005170|Toripalimab|toripalimab
5706364|NCT00478192|conivaptan|conivaptan
4998274|NCT04005170|Clinical complete response|clinical complete response
4998275|NCT04005157|Electromagnetic navigation bronchoscopy(ENB)|electromagnetic navigation bronchoscopy(enb)
4998276|NCT04005157|Microwave ablation|microwave ablation
4998277|NCT04005157|Peripheral lung cancer|peripheral lung cancer
4998278|NCT04005131|stroke|stroke
4998279|NCT04005131|transcranial direct current stimulation|transcranial direct current stimulation
4998280|NCT04005131|upper extremity rehabilitation robot|upper extremity rehabilitation robot
4998281|NCT04005118|Intestinal microbiome|intestinal microbiome
4998282|NCT04005118|colorectal cancer|colorectal cancer
4998283|NCT04005118|mechanical bowel preparation|mechanical bowel preparation
4998300|NCT04005027|Cardiac|cardiac
4998301|NCT04005027|Electrocardiogram|electrocardiogram
4998302|NCT04005001|Sepsis|sepsis
4998303|NCT04005001|Dascena|dascena
4998304|NCT04005001|Machine learning algorithm|machine learning algorithm
4998305|NCT04004975|anlotinib Recurrent Glioblastoma|anlotinib recurrent glioblastoma
4998306|NCT04004936|Emergency Department|emergency department
4998307|NCT04004936|Potentially Inappropriate Medications|potentially inappropriate medications
4998308|NCT04004936|Inappropriate Prescribing|inappropriate prescribing
4998309|NCT04004936|Quality Improvement|quality improvement
4998310|NCT04004936|Veteran Health|veteran health
4998311|NCT04004936|Older Adults|older adults
4998312|NCT04004910|Triple Negative Breast Cancer|triple negative breast cancer
4998313|NCT04004910|TNBC|tnbc
4998314|NCT04004884|Ulipristal Acetate|ulipristal acetate
4998315|NCT04004884|Selective Progesterone Receptor Modulators|selective progesterone receptor modulators
4998316|NCT04004884|Leiomyoma|leiomyoma
4998317|NCT04004884|Liver injury|liver injury
4998318|NCT04004858|Radiation toxicity|radiation toxicity
4998319|NCT04004858|Hypofractionation|hypofractionation
4998320|NCT04004858|Margin reduction|margin reduction
4998321|NCT04004780|Self-medication-drug interactions|self-medication-drug interactions
4998322|NCT04004767|Alzheimer's|alzheimer's
4998323|NCT04004767|Prevention|prevention
4998324|NCT04004767|Observational|observational
4998325|NCT04004767|Trial-Ready Cohort|trial-ready cohort
4998326|NCT04004741|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
4994190|NCT04030338|PCWG3|pcwg3
4998327|NCT04004728|laser|laser
4998328|NCT04004728|telangiectasias|telangiectasias
4998329|NCT04004728|leg veins|leg veins
4998330|NCT04004728|sclerotherapy|sclerotherapy
4998331|NCT04004702|neuro-psychiatric symptoms|neuro-psychiatric symptoms
4998332|NCT04004676|Ketones|ketones
4998333|NCT04004676|Glycogen replenishment|glycogen replenishment
4998334|NCT04004676|Exercise Performance|exercise performance
4998335|NCT04004663|pharmacokinetics|pharmacokinetics
4998336|NCT04004663|JAK inhibitor|jak inhibitor
4998337|NCT04004663|PF-06651600|pf-06651600
4998338|NCT04004637|NK/T cell lymphoma|nk/t cell lymphoma
4998339|NCT04004637|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
4998340|NCT04004637|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
4998344|NCT04004598|aging, exercise, golf, intervention|aging, exercise, golf, intervention
4998345|NCT04004585|Sedentary behaviour|sedentary behaviour
4998346|NCT04004585|Behaviour change|behaviour change
4998347|NCT04004585|Theoretical Domains Framework|theoretical domains framework
4998348|NCT04004572|Natural killer/T-cell lymphoma|natural killer/t-cell lymphoma
4998349|NCT04004572|Sintilimab|sintilimab
4998350|NCT04004572|Pegaspargase|pegaspargase
4998351|NCT04004572|Anlotinib|anlotinib
4998352|NCT04004559|Invasive Breast Cancer|invasive breast cancer
4998353|NCT04004559|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
4998354|NCT04004559|Radiomics|radiomics
4998355|NCT04004559|Axillary Lymph Node Metastasis|axillary lymph node metastasis
4998356|NCT04004559|Survival|survival
4998357|NCT04004559|Machine Learning Analysis|machine learning analysis
4998358|NCT04004533|duodenoscope|duodenoscope
4998359|NCT04004533|Endoscopic retrograded cholangiopancreatography|endoscopic retrograded cholangiopancreatography
4998360|NCT04004533|duodenoscope assessment tool|duodenoscope assessment tool
4998387|NCT04004455|pain catastrophizing|pain catastrophizing
4998388|NCT04004455|body composition|body composition
4998389|NCT04004442|avelumab|avelumab
4998390|NCT04004442|AVB-S6-500|avb-s6-500
4998391|NCT04004442|renal pelvis cancer|renal pelvis cancer
4998392|NCT04004442|ureter cancer|ureter cancer
4998396|NCT04004390|Data transcribed in the computerized patient file|data transcribed in the computerized patient file
4998397|NCT04004390|post-poliomyelitis syndrome|post-poliomyelitis syndrome
5314193|NCT02111499|atrophy measure|atrophy measure
4998398|NCT04004390|Intravenous immunoglobulins|intravenous immunoglobulins
4998399|NCT04004390|walking test|walking test
4998400|NCT04004390|isokinetics|isokinetics
4998401|NCT04004338|Carfilzomib|carfilzomib
4998402|NCT04004338|Multiple Myeloma|multiple myeloma
4998403|NCT04004312|single fraction|single fraction
4998404|NCT04004312|SBRT|sbrt
4998405|NCT04004312|Space OAR Gel|space oar gel
4998406|NCT04004299|Hepatitis C re-infection|hepatitis c re-infection
4998407|NCT04004286|Pain PASTOR Biobank|pain pastor biobank
4998408|NCT04004273|Type 2 diabetes|type 2 diabetes
4998409|NCT04004273|Non-alcohol fatty liver disease|non-alcohol fatty liver disease
4998410|NCT04004273|Exercise|exercise
4998411|NCT04004273|Saturated fat|saturated fat
4998412|NCT04004273|MRI|mri
4998413|NCT04004273|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
4998414|NCT04004247|High Flow Oxygenation|high flow oxygenation
4998415|NCT04004247|Electrical Impedance Tomography|electrical impedance tomography
4998416|NCT04004247|Non invasive ventilation|non invasive ventilation
4998417|NCT04004234|local advanced|local advanced
4998418|NCT04004234|metastatic|metastatic
4998419|NCT04004234|anti-PD-1 antibody|anti-pd-1 antibody
4998420|NCT04004234|Manganese|manganese
4998421|NCT04004234|gemcitabine|gemcitabine
4998422|NCT04004234|cisplatin|cisplatin
4998423|NCT04004169|Major Depressive Disorder|major depressive disorder
4998424|NCT04004169|Depression|depression
4998425|NCT04004169|Treatment-resistance|treatment-resistance
4998426|NCT04004169|Deep brain stimulation|deep brain stimulation
4998427|NCT04004169|Closed-loop|closed-loop
4998428|NCT04004169|Biomarker|biomarker
4998429|NCT04004169|Responsive neurostimulation|responsive neurostimulation
4998430|NCT04004169|Brain surgery|brain surgery
4998431|NCT04004156|Degenerative Disc Disease|degenerative disc disease
4998432|NCT04004156|DDD|ddd
4998433|NCT04004156|Chronic Low-back Pain|chronic low-back pain
4998434|NCT04004156|Low Back Pain|low back pain
4998435|NCT04004156|Nucleus Replacement Device|nucleus replacement device
4998436|NCT04004156|Nucleus Pulposus|nucleus pulposus
4998437|NCT04004156|Disc Replacement|disc replacement
4994241|NCT04030039|HBV|hbv
4998438|NCT04004156|Back pain|back pain
4998439|NCT04004156|Leg pain|leg pain
4998440|NCT04004156|Lumbar Spinal Fusion|lumbar spinal fusion
4998441|NCT04004104|Supine Exercise|supine exercise
4998442|NCT04004104|Orthodeoxia|orthodeoxia
4998443|NCT04004091|Premature Birth|premature birth
4998444|NCT04004091|Spermine|spermine
4998445|NCT04004091|Necrotizing Enterocolitis|necrotizing enterocolitis
4998446|NCT04004091|Tight Junction|tight junction
4998447|NCT04004065|DMD|dmd
4998448|NCT04004065|Duchenne|duchenne
4998449|NCT04004065|Dystrophy|dystrophy
4998450|NCT04004065|Dystrophin|dystrophin
4998451|NCT04004065|Exon Skipping|exon skipping
4998452|NCT04004065|Ambulatory|ambulatory
4998453|NCT04004065|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4998454|NCT04004065|Exon 51|exon 51
4998455|NCT04004065|Nonambulatory|nonambulatory
4998456|NCT04004065|Pediatric|pediatric
4998457|NCT04004065|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
4998458|NCT04004065|Momentum|momentum
4998462|NCT04004039|Satellite cells|satellite cells
4998463|NCT04004039|Therapeutic|therapeutic
4998464|NCT04004039|Aromatic plants|aromatic plants
4998465|NCT04004026|Multiple Sclerosis|multiple sclerosis
4998466|NCT04004026|3-m backwards walk|3-m backwards walk
4998467|NCT04004026|Balance|balance
4998468|NCT04004026|Fall risk|fall risk
4998469|NCT04004026|validity|validity
4998470|NCT04004026|reliability|reliability
4998471|NCT04004013|osteopenia|osteopenia
4998475|NCT04004000|FSHD, FSHD1|fshd, fshd1
4998476|NCT04004000|Muscular Dystrophies|muscular dystrophies
4998477|NCT04004000|Facioscapulohumeral Muscular Disorders|facioscapulohumeral muscular disorders
5001638|NCT03985267|breast cancer|breast cancer
4998485|NCT04003974|Musculoskeletal Diseases|musculoskeletal diseases
4998486|NCT04003974|Neuromuscular Diseases|neuromuscular diseases
4998488|NCT04003961|Obstructive Sleep Apnea|obstructive sleep apnea
4998489|NCT04003948|Ibogaine|ibogaine
4998490|NCT04003948|Methadone|methadone
4998517|NCT04003701|distraction|distraction
4998519|NCT04003701|pain memory|pain memory
4998529|NCT04003623|Advanced solid tumor|advanced solid tumor
4998530|NCT04003623|metastatic solid tumor|metastatic solid tumor
4998531|NCT04003623|FGFR inhibitor|fgfr inhibitor
4998532|NCT04003623|FGFR mutation|fgfr mutation
4998533|NCT04003623|FGFR translocation|fgfr translocation
4998541|NCT04003597|Low-salt bread|low-salt bread
4998542|NCT04003597|Dietary sodium restriction|dietary sodium restriction
4998543|NCT04003597|Pre-hypertension|pre-hypertension
4998544|NCT04003597|Hypertension stage 1|hypertension stage 1
4998545|NCT04003584|Minimally invasive|minimally invasive
4998546|NCT04003584|Cardiac Surgery|cardiac surgery
4998547|NCT04003584|Postoperative Pain|postoperative pain
4998548|NCT04003571|stroke|stroke
4998549|NCT04003571|augmented reality|augmented reality
4998550|NCT04003571|functional electrical stimulation|functional electrical stimulation
4998551|NCT04003558|Early-stage Breast Cancer|early-stage breast cancer
4998552|NCT04003558|Radiomics|radiomics
4998553|NCT04003558|Axillary lymph node metastasis|axillary lymph node metastasis
4998554|NCT04003558|Tumor microenvironment|tumor microenvironment
4998555|NCT04003558|Survival|survival
4998556|NCT04003558|Deep learning|deep learning
4998557|NCT04003532|Diagnosis|diagnosis
4998558|NCT04003532|Test-of-Cure|test-of-cure
4998559|NCT04003532|HIV co-infection|hiv co-infection
4998560|NCT04003532|Loop-mediated amplification assay|loop-mediated amplification assay
4998561|NCT04003532|PCR|pcr
4998562|NCT04003532|Nucleic-acid Lateral Flow Immunoassay|nucleic-acid lateral flow immunoassay
4998563|NCT04003506|bupivacaine|bupivacaine
4998564|NCT04003506|LIA|lia
4998565|NCT04003506|ACB|acb
4998566|NCT04003506|total knee replacement|total knee replacement
4998567|NCT04003506|post operative pain|post operative pain
4998568|NCT04003506|acute pain|acute pain
4998569|NCT04003506|anaesthesia|anaesthesia
4998570|NCT04003493|Nutrition|nutrition
4998571|NCT04003493|Oral health|oral health
4998572|NCT04003493|Care givers|care givers
4998573|NCT04003493|Home care clients|home care clients
4998574|NCT04003493|Quality of life|quality of life
4998575|NCT04003480|Saphenous vein graft|saphenous vein graft
4998576|NCT04003480|PAD|pad
4998577|NCT04003480|Peripheral bypass surgery|peripheral bypass surgery
4998578|NCT04003480|external support|external support
4998579|NCT04003467|Osteoporosis|osteoporosis
4998580|NCT04003467|hPTH(1-34)|hpth(1-34)
4998581|NCT04003454|Hepatitis C|hepatitis c
4998582|NCT04003454|Screening|screening
4998583|NCT04003454|Emergency Department|emergency department
4998584|NCT04003454|Risk|risk
4998585|NCT04003428|High Intensity Focused Ultrasound (HIFU)|high intensity focused ultrasound (hifu)
4998586|NCT04003428|Placenta accreta|placenta accreta
4998587|NCT04003428|Feasibility|feasibility
4998588|NCT04003428|Safety|safety
4998589|NCT04003402|alcohol effect|alcohol effect
4999082|NCT04000451|oxygen|oxygen
4998608|NCT04003259|Lifestyle|lifestyle
4998609|NCT04003259|Weight control|weight control
4998611|NCT04003233|Growth friendly system|growth friendly system
4998612|NCT04003233|Distraction system|distraction system
4998613|NCT04003233|Early Onset Scoliosis|early onset scoliosis
4998614|NCT04003233|Unilateral|unilateral
4998615|NCT04003207|Phelan McDermid Syndrome|phelan mcdermid syndrome
4998616|NCT04003207|22q13 deletion Syndrome|22q13 deletion syndrome
4998617|NCT04003207|Growth hormone|growth hormone
4998618|NCT04003207|Autism|autism
4998619|NCT04003207|Insulin like growth factor 1|insulin like growth factor 1
4998620|NCT04003194|pulses|pulses
4998621|NCT04003194|legumes|legumes
4998622|NCT04003194|Phaseolus vulgaris L.|phaseolus vulgaris l.
4998623|NCT04003194|glycemic response|glycemic response
4998624|NCT04003181|Bile acid malabsorption|bile acid malabsorption
4998625|NCT04003181|Bacterial overgrowth|bacterial overgrowth
4998626|NCT04003168|BCMA|bcma
4998627|NCT04003168|CAR-T|car-t
4998628|NCT04003168|multiple myeloma|multiple myeloma
4998629|NCT04003168|Relapsed/Refractory|relapsed/refractory
4998638|NCT04003129|paediatrician|paediatrician
4998639|NCT04003129|early childhood caries|early childhood caries
4998646|NCT04003077|methadone treatment|methadone treatment
5706545|NCT00477568|Back pain|back pain
4998648|NCT04003051|Head and neck cancer|head and neck cancer
4998649|NCT04003051|swallowing|swallowing
4998650|NCT04003051|trismus|trismus
4998651|NCT04003051|adherence|adherence
4998652|NCT04003051|coping|coping
4998653|NCT04003051|rural|rural
4998654|NCT04003051|website|website
4998655|NCT04003051|access|access
4998656|NCT04002999|3D printing|3d printing
4998657|NCT04002999|Virtual treatment planning|virtual treatment planning
4998664|NCT04002934|RRMS|rrms
4998665|NCT04002934|Remyelination|remyelination
4998666|NCT04002934|Repair|repair
4998667|NCT04002934|Multiple Sclerosis|multiple sclerosis
4998668|NCT04002934|SERM|serm
4998669|NCT04002934|Estrogen|estrogen
4998671|NCT04002934|Bazedoxifene|bazedoxifene
4998672|NCT04002934|Myelin Repair|myelin repair
4998673|NCT04002934|Conbriza|conbriza
4998674|NCT04002921|right colectomy|right colectomy
4998675|NCT04002921|calcification|calcification
4998676|NCT04002921|anastomotic leakage|anastomotic leakage
4998677|NCT04002908|Infant Health|infant health
4998678|NCT04002908|Low and Middle Income Countries [LMIC]|low and middle income countries [lmic]
4998679|NCT04002908|Maternal Health|maternal health
4998680|NCT04002908|Infant Feeding|infant feeding
4998681|NCT04002908|Low Birthweight|low birthweight
4998682|NCT04002843|jitter|jitter
4998683|NCT04002843|single fiber EMG|single fiber emg
4998684|NCT04002843|botulinum toxin|botulinum toxin
4998685|NCT04002778|EUS-FNA|eus-fna
4998686|NCT04002778|pancreatic solid lesions|pancreatic solid lesions
4998687|NCT04002778|sample adequacy|sample adequacy
4998688|NCT04002778|cytopathology|cytopathology
4998689|NCT04002778|endosonography|endosonography
4998690|NCT04002739|STEMI|stemi
4998691|NCT04002739|NSTEMI|nstemi
4998692|NCT04002739|Sleep Apnea|sleep apnea
4998693|NCT04002739|OSA|osa
4998694|NCT04002713|Anterolateral thigh (ALT)|anterolateral thigh (alt)
4998695|NCT04002713|anteromedial thigh (AMT)|anteromedial thigh (amt)
4998696|NCT04002713|free flap reconstruction|free flap reconstruction
4998706|NCT04002570|circulating bone marrow-derived cells|circulating bone marrow-derived cells
4998707|NCT04002570|circulating immune cells|circulating immune cells
4998708|NCT04002570|radiotherapy|radiotherapy
4998709|NCT04002570|conservative treatment|conservative treatment
4998710|NCT04002570|disease control|disease control
4998711|NCT04002557|diebetes|diebetes
4998712|NCT04002492|sarcopenia|sarcopenia
4998713|NCT04002492|osteopenia|osteopenia
4998714|NCT04002492|exercise|exercise
4998715|NCT04002492|body weight training|body weight training
4998716|NCT04002492|bone density|bone density
4998717|NCT04002492|demyelination|demyelination
4998718|NCT04002492|cognition|cognition
4998719|NCT04002479|pancreatic cancer|pancreatic cancer
4998720|NCT04002479|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
4998721|NCT04002479|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
4998722|NCT04002479|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4998723|NCT04002479|Pancreas Neoplasm|pancreas neoplasm
4998724|NCT04002479|Alpha radiation|alpha radiation
4998725|NCT04002479|Pancreas Cancer|pancreas cancer
4998726|NCT04002479|Pancreas Metastases|pancreas metastases
4998727|NCT04002453|OPAT|opat
4998728|NCT04002453|infectious diseases|infectious diseases
4998729|NCT04002453|implementation|implementation
4998730|NCT04002440|Estimated Dry Weight|estimated dry weight
4998731|NCT04002440|Peritoneal Dialysis|peritoneal dialysis
4998732|NCT04002440|AMIA|amia
4998733|NCT04002440|Sharesource|sharesource
4998734|NCT04002440|CCPD|ccpd
4998735|NCT04002440|Peritoneal Dialysis Cycler|peritoneal dialysis cycler
4998736|NCT04002440|HomeChoice PRO|homechoice pro
4998737|NCT04002414|Physical Activity|physical activity
4998738|NCT04002414|In Vitro Fertilization|in vitro fertilization
4998739|NCT04002414|Ovarian Stimulation|ovarian stimulation
4998740|NCT04002414|Exercise|exercise
4998741|NCT04002375|pectouteropexy|pectouteropexy
4998742|NCT04002362|Asthma|asthma
4998743|NCT04002362|Pediatrics|pediatrics
4998744|NCT04002336|adherence|adherence
4998745|NCT04002297|MCL, NHL|mcl, nhl
4998746|NCT04002271|TIVA|tiva
4998747|NCT04002271|total knee replacement|total knee replacement
4998748|NCT04002271|post operative pain|post operative pain
4998749|NCT04002271|acute pain|acute pain
4998750|NCT04002271|anaesthesia|anaesthesia
4998751|NCT04002245|vascular access|vascular access
4998752|NCT04002245|skin antisepsis|skin antisepsis
4998753|NCT04002245|cutaneous antisepsis|cutaneous antisepsis
4998754|NCT04002206|Muscle Energy Technique|muscle energy technique
4998755|NCT04002206|Post isometric relaxation technique.|post isometric relaxation technique.
4998756|NCT04002193|Pleth variability index|pleth variability index
4998757|NCT04002167|ADHD|adhd
4998758|NCT04002167|Working memory|working memory
4998759|NCT04002167|functional near infrared spectroscopy (fNIRS)|functional near infrared spectroscopy (fnirs)
4998760|NCT04002167|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
4998761|NCT04002167|Neurofeedback|neurofeedback
5706546|NCT00477568|Prevalence|prevalence
4998762|NCT04002167|Cognitive training|cognitive training
4998763|NCT04002167|Neuromonitoring|neuromonitoring
4998765|NCT04002141|Endometriosis|endometriosis
4998766|NCT04002141|Letrozole|letrozole
4998767|NCT04002128|tracheal colonization;|tracheal colonization;
4998768|NCT04002128|Bacteria;|bacteria;
4998769|NCT04002128|Survival|survival
4998770|NCT04002128|Anesthesia, General;|anesthesia, general;
4998774|NCT04002102|Placebo|placebo
4998775|NCT04002102|Open-Label|open-label
4998776|NCT04002076|stroke|stroke
4998777|NCT04002076|Robot-assisted Rehabilitation|robot-assisted rehabilitation
4998778|NCT04002063|Depression|depression
4998779|NCT04002063|OEF/OIF|oef/oif
4998780|NCT04002063|Mobile Apps|mobile apps
4998781|NCT04002063|Cognitive Behavioral Therapy|cognitive behavioral therapy
4998782|NCT04002050|Resilience|resilience
4998783|NCT04002050|Workplace Engagement|workplace engagement
4998784|NCT04002050|Public Safety Personnel|public safety personnel
4998785|NCT04002050|Stress Disorders|stress disorders
4998786|NCT04002037|Trigger Finger|trigger finger
4998787|NCT04002024|acne vulgaris|acne vulgaris
4998788|NCT04002024|acne|acne
4998789|NCT04002024|licochalcone A|licochalcone a
4998790|NCT04002024|decanediol|decanediol
4998791|NCT04002024|L-carnitine|l-carnitine
4998792|NCT04002024|salicylic acid|salicylic acid
4998793|NCT04002011|direct oral anticoagulant|direct oral anticoagulant
4998794|NCT04002011|vitamin K antagonist|vitamin k antagonist
4998795|NCT04002011|cardiac surgery|cardiac surgery
4998796|NCT04002011|perioperative care|perioperative care
4998797|NCT04001972|tobacco dependence treatment|tobacco dependence treatment
4998801|NCT04001972|nicotine replacement therapy|nicotine replacement therapy
4998802|NCT04001972|information and communication technologies|information and communication technologies
4998803|NCT04001959|Carostats|carostats
4998804|NCT04001959|Clinical trial|clinical trial
4998805|NCT04001959|Preventive dentistry|preventive dentistry
4998806|NCT04001959|Preschoolers|preschoolers
4998807|NCT04001946|Gastrostomy|gastrostomy
4998808|NCT04001933|Pregnancy|pregnancy
4998809|NCT04001933|Oral Health|oral health
5314489|NCT02110069|KHE|khe
4998810|NCT04001933|Maternal Oral Health|maternal oral health
4998811|NCT04001933|Infant Oral Health|infant oral health
4998812|NCT04001894|Ticagrelor|ticagrelor
4998813|NCT04001894|Clopidogrel|clopidogrel
4998814|NCT04001894|Coronary artery disease|coronary artery disease
4998815|NCT04001894|platelet function tests|platelet function tests
4998816|NCT04001881|inferior vena cava|inferior vena cava
4998817|NCT04001881|spinal anesthesia|spinal anesthesia
4998818|NCT04001881|echocardiography|echocardiography
4998819|NCT04001855|Atopic Dermatitis|atopic dermatitis
4998820|NCT04001855|Eczema|eczema
4998821|NCT04001842|Mandibular reconstruction|mandibular reconstruction
4998822|NCT04001842|Mandibular regeneration|mandibular regeneration
4998823|NCT04001842|Regenerative Medicine|regenerative medicine
4998824|NCT04001842|Tissue Engineering|tissue engineering
4998825|NCT04001842|Axial vascularization|axial vascularization
4998826|NCT04001842|Arterio-venous loop|arterio-venous loop
4998828|NCT04001790|Autism Spectrum Disorder|autism spectrum disorder
4998829|NCT04001790|Transition to Employment|transition to employment
4998830|NCT04001790|Employment|employment
4998831|NCT04001790|Project Search Plus ASD Supports|project search plus asd supports
4998832|NCT04001764|Arterial Catheterization|arterial catheterization
4998833|NCT04001764|Peripheral Ultrasonography|peripheral ultrasonography
4998834|NCT04001751|breast cancer|breast cancer
4998835|NCT04001751|hormonotherapy|hormonotherapy
4998836|NCT04001751|osteoarticular pain|osteoarticular pain
4998837|NCT04001751|yoga|yoga
4998838|NCT04001751|therapeutic patient education|therapeutic patient education
4998839|NCT04001738|Endovascular treatment|endovascular treatment
4998840|NCT04001738|Large Vessel Occlusion|large vessel occlusion
4998841|NCT04001725|Metformin|metformin
4998842|NCT04001725|Dexamethasone|dexamethasone
4998843|NCT04001725|Diabetes|diabetes
4998844|NCT04001725|Glucocorticoids|glucocorticoids
4998845|NCT04001725|Phase II|phase ii
4998846|NCT04001725|Tumor|tumor
4998847|NCT04001725|Immune system|immune system
4998848|NCT04001725|Immunological Effects|immunological effects
4998849|NCT04001725|Metabolic Effects|metabolic effects
4998850|NCT04001725|Anticancer Effects|anticancer effects
4998851|NCT04001725|Randomization|randomization
4998852|NCT04001725|Quality of Life|quality of life
4998853|NCT04001712|early caffeine preterm|early caffeine preterm
4998854|NCT04001699|preoperative|preoperative
4998855|NCT04001699|geriatric assessment|geriatric assessment
4998856|NCT04001699|interprofessional team|interprofessional team
4998857|NCT04001673|treatment knowledge|treatment knowledge
4998858|NCT04001647|ER stress|er stress
4998859|NCT04001647|Unfolded protein response|unfolded protein response
4998860|NCT04001647|Vascular function|vascular function
4998872|NCT04001582|Facioscapulohumeral Muscular Dystrophy|facioscapulohumeral muscular dystrophy
4998873|NCT04001582|Facioscapulohumeral Muscular Dystrophy Type 1|facioscapulohumeral muscular dystrophy type 1
4998874|NCT04001582|Facioscapulohumeral Muscular Dystrophy Type 2|facioscapulohumeral muscular dystrophy type 2
4998875|NCT04001582|Muscular Dystrophy|muscular dystrophy
4998876|NCT04001543|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
4998877|NCT04001543|immunomodulatory nutrient|immunomodulatory nutrient
4998878|NCT04001543|concomitant chemoradiotherapy|concomitant chemoradiotherapy
4998879|NCT04001543|survival|survival
4998880|NCT04001504|Unstable angina|unstable angina
4998881|NCT04001504|Non-ST-Elevation Myocardial Infarction - NSTEMI|non-st-elevation myocardial infarction - nstemi
4998882|NCT04001504|ST-Elevation Myocardial Infarction - STEMI|st-elevation myocardial infarction - stemi
4998883|NCT04001504|Quadrivalent Influenza Vaccine - QIV|quadrivalent influenza vaccine - qiv
4998884|NCT04001491|Inflammation|inflammation
4998885|NCT04001491|Inflammatory syndromes|inflammatory syndromes
4998886|NCT04001491|fever|fever
4998887|NCT04001491|Tomography|tomography
4998888|NCT04001491|Positron emission at 18F-FDG|positron emission at 18f-fdg
4999083|NCT04000451|oxyhydrogen|oxyhydrogen
4998898|NCT04001400|Gastroesophageal Reflux|gastroesophageal reflux
4998904|NCT04001348|lancet|lancet
4998905|NCT04001348|capillary blood|capillary blood
4998906|NCT04001348|capillary blood sampling|capillary blood sampling
4998907|NCT04001348|blood volume|blood volume
4998908|NCT04001348|pain|pain
4998909|NCT04001309|antimicrobial stewardship|antimicrobial stewardship
4998910|NCT04001309|prospective audit and feedback|prospective audit and feedback
4998911|NCT04001309|infectious diseases|infectious diseases
4998912|NCT04001309|randomized trial|randomized trial
4998913|NCT04001296|Behavior|behavior
4998914|NCT04001296|Toothbrushing|toothbrushing
4998915|NCT04001296|Toothpastes|toothpastes
4998916|NCT04001296|Dental Caries|dental caries
4998917|NCT04001296|Education, Dental|education, dental
4998918|NCT04001270|LGI1 encephalitis|lgi1 encephalitis
4998919|NCT04001270|Biomarkers|biomarkers
4998920|NCT04001270|Cerebrospinal Fluid (CSF)|cerebrospinal fluid (csf)
4998921|NCT04001270|Neurology|neurology
4998922|NCT04001257|18F-FET PET|18f-fet pet
4998923|NCT04001257|glioma|glioma
4998924|NCT04001257|grading|grading
4998925|NCT04001231|Pharmacokinetics|pharmacokinetics
4998926|NCT04001231|Safety|safety
4998927|NCT04001231|Tolerability|tolerability
4998928|NCT04001231|exenatide once weekly|exenatide once weekly
4998929|NCT04001231|Chinese|chinese
4998930|NCT04001192|exercise|exercise
4998931|NCT04001192|exercise therapy|exercise therapy
4998932|NCT04001192|treadmill|treadmill
4998933|NCT04001192|symptom threshold|symptom threshold
4998934|NCT04001192|Postconcussion symptoms|postconcussion symptoms
4998935|NCT04001179|Early diagnosis|early diagnosis
4998936|NCT04001179|Mass spectrometry|mass spectrometry
4998937|NCT04001179|Volatile Organic Compounds|volatile organic compounds
4998938|NCT04001179|Metabolomics|metabolomics
4998939|NCT04001179|Breath Tests|breath tests
4998940|NCT04001179|Biomarkers|biomarkers
4998944|NCT04001140|Emotion regulation|emotion regulation
4998945|NCT04001140|Prevention program|prevention program
4998946|NCT04001140|Adolescents|adolescents
4998947|NCT04001140|Physiological measurements|physiological measurements
4998948|NCT04001140|Internalizing problems|internalizing problems
4998949|NCT04001140|Externalizing problems|externalizing problems
4998950|NCT04001127|high intensity functional training|high intensity functional training
4998951|NCT04001127|crossfit|crossfit
4998952|NCT04001127|cancer survivors|cancer survivors
4998953|NCT04001101|Solid tumor|solid tumor
4998954|NCT04001101|Colorectal cancer|colorectal cancer
4998955|NCT04001101|Unresectable or metastatic|unresectable or metastatic
4998956|NCT04001088|Probiotics|probiotics
4998957|NCT04001088|Menopausal symptoms|menopausal symptoms
4998958|NCT04001088|Bone health|bone health
4998959|NCT04001088|Vulvar and vaginal atrophy|vulvar and vaginal atrophy
4998960|NCT04001088|Vaginal microflora|vaginal microflora
4998961|NCT04001088|Anxiety|anxiety
4998962|NCT04001088|Depression|depression
4998963|NCT04001088|Urinary incontinence|urinary incontinence
4998964|NCT04001088|Metabolic syndrome biomarkers|metabolic syndrome biomarkers
4998965|NCT04001088|Sleep quality|sleep quality
4998966|NCT04001088|Gut microflora|gut microflora
4998967|NCT04001088|Bone resorption markers|bone resorption markers
4998968|NCT04001088|Bone formation markers|bone formation markers
4998969|NCT04001088|Bone Mineral Density (BMD)|bone mineral density (bmd)
4998970|NCT04001088|Fracture risk assessment|fracture risk assessment
4998975|NCT04001010|cannabinoids|cannabinoids
4998976|NCT04001010|palliative care|palliative care
4998982|NCT04000984|Mindfulness|mindfulness
4998983|NCT04000984|Cognitive Rehabilitation|cognitive rehabilitation
4998984|NCT04000971|Technology-enabled|technology-enabled
4998985|NCT04000971|Engagement, caregiver|engagement, caregiver
4998986|NCT04000971|Team-based|team-based
4998987|NCT04000971|Integrated Care|integrated care
4998988|NCT04000932|Carpal tunnel syndrome|carpal tunnel syndrome
4998989|NCT04000932|Injection|injection
4999184|NCT03999905|Warfarin|warfarin
4998994|NCT04000906|primitive peritoneal mesothelioma|primitive peritoneal mesothelioma
4998995|NCT04000880|Cancer survivor|cancer survivor
4998996|NCT04000880|Lifestyle behaviors|lifestyle behaviors
4998997|NCT04000880|Web-based intervention|web-based intervention
4998998|NCT04000880|Diet|diet
4998999|NCT04000880|Exercise|exercise
4999000|NCT04000880|Weight Control|weight control
4999001|NCT04000880|Physical Activity|physical activity
4999002|NCT04000880|Distance Medicine|distance medicine
4999003|NCT04000880|Rural|rural
4999004|NCT04000880|Older|older
4999005|NCT04000880|Minority|minority
4999006|NCT04000880|African American|african american
4999007|NCT04000867|diabetic foot pain|diabetic foot pain
4999008|NCT04000867|diabetic foot neuropathy|diabetic foot neuropathy
4999009|NCT04000867|diabetic foot numbness|diabetic foot numbness
4999010|NCT04000854|Dental trauma|dental trauma
4999011|NCT04000854|pulp necrosis|pulp necrosis
4999012|NCT04000854|regenerative|regenerative
4999013|NCT04000854|endodontics|endodontics
4999014|NCT04000841|stress|stress
4999015|NCT04000841|emotion regulation|emotion regulation
4999016|NCT04000815|c type natriuretic peptide|c type natriuretic peptide
4999017|NCT04000815|duration of menopause|duration of menopause
4999018|NCT04000815|menstrual cycle|menstrual cycle
4999019|NCT04000789|Diabetes Mellitus|diabetes mellitus
4999020|NCT04000789|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
4999021|NCT04000789|Non-Proliferative Diabetic Retinopathy|non-proliferative diabetic retinopathy
4999022|NCT04000789|Dry Eye Syndromes|dry eye syndromes
4999023|NCT04000789|Sodium Hyaluronate|sodium hyaluronate
4999024|NCT04000789|Vitamin A|vitamin a
4999025|NCT04000789|Vitamin E|vitamin e
4999026|NCT04000763|Bladder|bladder
4999027|NCT04000750|Hypertrophy|hypertrophy
4999028|NCT04000750|Intermittent Fasting|intermittent fasting
4999029|NCT04000750|Time Restricted Eating|time restricted eating
4999030|NCT04000750|Protein Signaling|protein signaling
4999031|NCT04000750|Anabolic|anabolic
4999032|NCT04000737|Adult Primary Hepatocellular Carcinoma|adult primary hepatocellular carcinoma
4999033|NCT04000737|Advanced Adult Primary Liver Cancer|advanced adult primary liver cancer
4999034|NCT04000737|Advanced Adult Hepatocellular Carcinoma|advanced adult hepatocellular carcinoma
4999035|NCT04000737|BCLC Stage B Adult Hepatocellular Carcinoma|bclc stage b adult hepatocellular carcinoma
5314694|NCT02109185|rhinnorea|rhinnorea
4999036|NCT04000737|BCLC Stage C Adult Hepatocellular Carcinoma|bclc stage c adult hepatocellular carcinoma
4999037|NCT04000737|Hepatitis B (+) Associated Advanced Hepatocellular Carcinoma|hepatitis b (+) associated advanced hepatocellular carcinoma
4999038|NCT04000737|Child-Plough A Hepatocellular Carcinoma|child-plough a hepatocellular carcinoma
4999039|NCT04000724|Text Messaging|text messaging
4999040|NCT04000724|mHealth|mhealth
4999041|NCT04000724|HIV|hiv
4999042|NCT04000724|AIDS|aids
4999043|NCT04000724|PrEP|prep
4999044|NCT04000711|Fever and neutropenia|fever and neutropenia
4999045|NCT04000711|Febrile neutropenia|febrile neutropenia
4999046|NCT04000711|Cancer|cancer
4999047|NCT04000711|Outpatient treatment|outpatient treatment
4999048|NCT04000711|Children|children
4999054|NCT04000672|Patient Specific Instrumentation|patient specific instrumentation
4999055|NCT04000672|Randomized controlled trial|randomized controlled trial
4999056|NCT04000672|High Tibial Osteotomy|high tibial osteotomy
4999057|NCT04000659|Knee|knee
4999058|NCT04000659|Cartilage|cartilage
4999059|NCT04000646|anxiety, children|anxiety, children
4999060|NCT04000568|Preterm Infant|preterm infant
4999061|NCT04000568|Respiratory Distress Syndrome|respiratory distress syndrome
4999062|NCT04000568|Non-invasive respiratory Support|non-invasive respiratory support
4999063|NCT04000568|Neurally Adjust Respiratory Assist (NAVA)|neurally adjust respiratory assist (nava)
4999064|NCT04000568|Nasal Intermittent Positive Pressure Ventilation|nasal intermittent positive pressure ventilation
4999065|NCT04000555|prophylaxis|prophylaxis
4999066|NCT04000529|TNO155, spartalizumab, ribociclib, checkpoint inhibitor, SHP2, PD-1, CDK4/6, NSCLC, CRC, HNSCC, KRAS, esophageal SCC, GIST|tno155, spartalizumab, ribociclib, checkpoint inhibitor, shp2, pd-1, cdk4/6, nsclc, crc, hnscc, kras, esophageal scc, gist
4999067|NCT04000503|Human Papillomavirus DNA Tests|human papillomavirus dna tests
4999068|NCT04000503|Visual inspection with acetic acid|visual inspection with acetic acid
4999069|NCT04000503|Global Health|global health
4999070|NCT04000503|Developing Countries|developing countries
4999071|NCT04000503|Self-collection|self-collection
4999075|NCT04000490|ACS predictive score|acs predictive score
4999076|NCT04000490|physician's belief|physician's belief
4999079|NCT04000477|Cytobrush|cytobrush
4999080|NCT04000477|FCV|fcv
4999081|NCT04000451|Copd Exacerbation Acute|copd exacerbation acute
4999084|NCT04000438|labor induction|labor induction
4999085|NCT04000438|cervical ripening|cervical ripening
4999086|NCT04000425|Gastric Cancer|gastric cancer
4999087|NCT04000425|Circulating Tumor DNA|circulating tumor dna
4999088|NCT04000425|Minimal Residue Disease|minimal residue disease
4999089|NCT04000425|Chemotherapy Response|chemotherapy response
4999090|NCT04000412|electrical impedance|electrical impedance
4999091|NCT04000412|cardiac radiofrequency ablation|cardiac radiofrequency ablation
4999092|NCT04000386|Pitted keratolysis|pitted keratolysis
4999093|NCT04000386|zinc oxide|zinc oxide
4999094|NCT04000386|Foot Odor|foot odor
4999095|NCT04000386|preventsion|preventsion
4999096|NCT04000360|Exercise|exercise
4999097|NCT04000347|benzoyl peroxide|benzoyl peroxide
4999098|NCT04000347|Pitted keratolysis|pitted keratolysis
4999099|NCT04000347|Foot Odor|foot odor
4999100|NCT04000334|cardiac arrest|cardiac arrest
4999101|NCT04000334|cerebral blood flow|cerebral blood flow
4999102|NCT04000334|cerebral autoregulation|cerebral autoregulation
4999103|NCT04000334|transcranial doppler|transcranial doppler
4999104|NCT04000308|Analgesia|analgesia
4999105|NCT04000308|Cesarean Section|cesarean section
4999106|NCT04000308|Quadratus Lumborum Block type 2|quadratus lumborum block type 2
4999107|NCT04000308|Wound Infiltration|wound infiltration
4999108|NCT04000256|Spinal cord injuries|spinal cord injuries
4999109|NCT04000256|Telerehabilitation|telerehabilitation
4999110|NCT04000256|Qualitative|qualitative
4999111|NCT04000230|Early Education Program|early education program
4999112|NCT04000230|Developmental Delay|developmental delay
4999113|NCT04000230|Behavior Management|behavior management
4999114|NCT04000230|Social Emotional Development|social emotional development
4999115|NCT04000230|Special Education|special education
4999116|NCT04000204|Osteoarthritis|osteoarthritis
4999117|NCT04000204|synovial fluid supplement|synovial fluid supplement
4999118|NCT04000204|hyaluronic acid|hyaluronic acid
4999119|NCT04000191|ice|ice
4999120|NCT04000191|elective anorectal surgery|elective anorectal surgery
4999121|NCT04000191|anesthesia care|anesthesia care
4999122|NCT04000165|HbS polymerization|hbs polymerization
4999123|NCT04000165|pyruvate kinase|pyruvate kinase
4999124|NCT04000165|2,3- diphosphoglycerate|2,3- diphosphoglycerate
4999125|NCT04000165|ATP in red blood cells|atp in red blood cells
4999126|NCT04000165|acute sickle pain|acute sickle pain
4999127|NCT04000152|Blastocyst|blastocyst
4999128|NCT04000152|Non-invasive|non-invasive
4999129|NCT04000152|PGT-A|pgt-a
4999130|NCT04000152|Aneuploidy|aneuploidy
4999131|NCT04000152|Spent culture medium|spent culture medium
4999132|NCT04000152|Trophectoderm biopsy|trophectoderm biopsy
4999133|NCT04000152|Sustained implantation|sustained implantation
4999134|NCT04000152|Miscarriage|miscarriage
4999135|NCT04000152|Livebirth|livebirth
4999136|NCT04000139|bilberry|bilberry
4999137|NCT04000139|anthocyanin|anthocyanin
4999138|NCT04000139|anthocyanin-rich extract|anthocyanin-rich extract
4999139|NCT04000139|ulcerative colitis|ulcerative colitis
4999140|NCT04000126|lidocaine|lidocaine
4999141|NCT04000126|intubation|intubation
4999142|NCT04000126|pupillometry|pupillometry
4999143|NCT04000126|hemodynamic response|hemodynamic response
4999144|NCT04000126|pain|pain
4999145|NCT04000126|reflex|reflex
4999146|NCT04000126|pupillary monitoring|pupillary monitoring
4999147|NCT04000126|intraoperative|intraoperative
4999148|NCT04000126|analgesia|analgesia
4999149|NCT04000126|general anesthesia|general anesthesia
4999150|NCT04000113|menopause|menopause
4999151|NCT04000113|insomnia|insomnia
4999152|NCT04000113|sleep disorder|sleep disorder
4999153|NCT04000100|Neostigmine|neostigmine
4999154|NCT04000100|Bupivacaine|bupivacaine
4999155|NCT04000100|Supraclavicular brachial plexus block|supraclavicular brachial plexus block
4999156|NCT04000074|Social Determinants of Health|social determinants of health
4999157|NCT04000074|High-Needs, High-Cost Populations|high-needs, high-cost populations
4999158|NCT04000074|Case Management|case management
4999159|NCT04000074|Social Prescribing|social prescribing
4999160|NCT04000074|Linkage Services|linkage services
4999161|NCT04000048|Low-grade diffuse glioma|low-grade diffuse glioma
4999162|NCT04000048|DNA extraction|dna extraction
4999163|NCT04000048|sequencing|sequencing
4999164|NCT04000035|sickness absence|sickness absence
4999165|NCT04000035|psychosocial work environment|psychosocial work environment
4999166|NCT04000022|Major Depressive Disorder|major depressive disorder
4999167|NCT04000022|rTMS|rtms
4999169|NCT04000022|Theta Burst Stimulation|theta burst stimulation
4999170|NCT04000022|Neuronavigation|neuronavigation
4999174|NCT03999970|Cutaneous Leishmaniasis|cutaneous leishmaniasis
4999175|NCT03999970|Controlled Human Infection Model|controlled human infection model
4999177|NCT03999970|Human Challenge|human challenge
4999178|NCT03999957|hospice|hospice
4999179|NCT03999957|pediatric|pediatric
4999180|NCT03999905|Patient counseling|patient counseling
5002257|NCT03981562|Epistaxis|epistaxis
4999183|NCT03999905|Pharmacist|pharmacist
4999189|NCT03999866|c-mac|c-mac
4999190|NCT03999866|d-blade|d-blade
4999191|NCT03999866|mcgarth mac x-blade|mcgarth mac x-blade
4999192|NCT03999866|prediction|prediction
4999193|NCT03999866|difficult airway|difficult airway
4999194|NCT03999853|Butyrate|butyrate
4999195|NCT03999840|aHUS|ahus
4999196|NCT03999840|cemdisiran|cemdisiran
4999197|NCT03999840|synthetic RNA interference|synthetic rna interference
4999198|NCT03999814|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
4999199|NCT03999814|INAD|inad
4999200|NCT03999814|PLA2G6|pla2g6
4999201|NCT03999801|gene therapy|gene therapy
4999202|NCT03999801|wet AMD|wet amd
4999203|NCT03999801|nAMD|namd
4999204|NCT03999788|microRNA|microrna
4999205|NCT03999788|Multiple Sclerosis|multiple sclerosis
4999206|NCT03999788|synaptopathy|synaptopathy
4999207|NCT03999788|lower limb spasticity|lower limb spasticity
4999208|NCT03999788|transcranial magnetic stimulation|transcranial magnetic stimulation
4999209|NCT03999788|repetitive TMS stimulation protocol|repetitive tms stimulation protocol
4999210|NCT03999788|GLAST/EAAT1|glast/eaat1
4999211|NCT03999788|single nucleotide polymorphisms|single nucleotide polymorphisms
4999212|NCT03999788|Intermittent theta burst stimulation (iTBS)|intermittent theta burst stimulation (itbs)
4999213|NCT03999775|Collagen peptides|collagen peptides
4999214|NCT03999775|Bone turnover markers|bone turnover markers
4999215|NCT03999775|Calcium supplement|calcium supplement
4999216|NCT03999775|Postmenopausal women|postmenopausal women
4999222|NCT03999723|Vitamin C|vitamin c
4999223|NCT03999723|Ascorbic acid|ascorbic acid
4999224|NCT03999723|Azacitidine|azacitidine
4999225|NCT03999723|Hypomethylating agents|hypomethylating agents
4999226|NCT03999723|Randomized, Placebo-Controlled Trial|randomized, placebo-controlled trial
4999227|NCT03999710|Lung Cancer|lung cancer
4999228|NCT03999710|Non Small Cell Lung Cancer|non small cell lung cancer
4999229|NCT03999710|Radiation therapy|radiation therapy
4999230|NCT03999710|durvalumab|durvalumab
4999231|NCT03999710|19-218|19-218
4999232|NCT03999710|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4999233|NCT03999684|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
4999234|NCT03999671|Effect, Nursing, Process, Functional, Patterns,health|effect, nursing, process, functional, patterns,health
4999235|NCT03999658|ENKTL|enktl
4999236|NCT03999658|DLBCL|dlbcl
4999237|NCT03999658|PTCL|ptcl
4999238|NCT03999658|cholangiocarcinoma|cholangiocarcinoma
4999239|NCT03999658|gall bladder cancer|gall bladder cancer
4999240|NCT03999658|relapsed|relapsed
4999241|NCT03999658|refractory|refractory
4999242|NCT03999658|T/NK-cell|t/nk-cell
4999243|NCT03999658|NK/T-cell|nk/t-cell
4999244|NCT03999658|peripheral T-cell|peripheral t-cell
4999245|NCT03999658|PD-L1|pd-l1
4999246|NCT03999658|anti-PD-L1 antibody|anti-pd-l1 antibody
4999247|NCT03999645|Acute cholecystitis|acute cholecystitis
4999248|NCT03999645|Early laparoscopic cholecystectomy|early laparoscopic cholecystectomy
4999249|NCT03999645|Gallbladder disease|gallbladder disease
4999250|NCT03999645|Late laparoscopic cholecystectomy|late laparoscopic cholecystectomy
4999251|NCT03999632|Bariatric surgery|bariatric surgery
4999252|NCT03999632|Sleeve gastrectomy|sleeve gastrectomy
4999253|NCT03999632|Preoperative diet|preoperative diet
4999254|NCT03999632|Hepatic steatosis|hepatic steatosis
4999255|NCT03999632|Wolffia Globosa|wolffia globosa
4999256|NCT03999632|Hyperglycemia|hyperglycemia
4999257|NCT03999619|Pre-Literacy Skills|pre-literacy skills
4999258|NCT03999580|Crohn|crohn
4999259|NCT03999580|vitamin D|vitamin d
4999260|NCT03999580|remission|remission
4999261|NCT03999580|inflammation|inflammation
4999262|NCT03999580|tolerance|tolerance
4999263|NCT03999528|14-3-3η Protein|14-3-3η protein
4999265|NCT03999502|Endoscopy|endoscopy
4999266|NCT03999502|Mini invasive|mini invasive
4999267|NCT03999411|nicotine replacement therapy|nicotine replacement therapy
4999268|NCT03999411|antiretroviral|antiretroviral
4999269|NCT03999411|smartphone|smartphone
4999270|NCT03999398|Saphenous Vein|saphenous vein
4999271|NCT03999398|No-touch|no-touch
4999272|NCT03999398|Percutaneous Coronary Intervention|percutaneous coronary intervention
4999273|NCT03999385|Mindfulness|mindfulness
4999274|NCT03999385|Mindful Self-compassion|mindful self-compassion
4999275|NCT03999385|Self-compassion|self-compassion
4999276|NCT03999385|Diabetes|diabetes
4999277|NCT03999385|Self-care|self-care
4999278|NCT03999346|Swiss Polytrauma Registry|swiss polytrauma registry
4999279|NCT03999346|quality control|quality control
4999280|NCT03999346|standardized identification procedures|standardized identification procedures
4999281|NCT03999346|data capture|data capture
4999282|NCT03999307|Orthodontic Tooth Movement Acceleration|orthodontic tooth movement acceleration
4999283|NCT03999294|Music Therapy|music therapy
4999284|NCT03999268|Psychological insulin resistance|psychological insulin resistance
4999289|NCT03999242|Charcot Leyden Crystals|charcot leyden crystals
4999290|NCT03999242|Eosinophils|eosinophils
4999291|NCT03999229|S-Nitrosylation|s-nitrosylation
4999292|NCT03999229|Tissue Oxygenation|tissue oxygenation
4999305|NCT03999151|Digital|digital
4999306|NCT03999151|Text messaging|text messaging
4999307|NCT03999151|Coach|coach
4999308|NCT03999112|psychological therapy|psychological therapy
4999309|NCT03999112|metacognitive reflection|metacognitive reflection
4999310|NCT03999034|screening test|screening test
4999311|NCT03999034|XO test|xo test
4999312|NCT03998995|Immersive Virtual Reality (IVR)|immersive virtual reality (ivr)
4999313|NCT03998995|Patient-Centred Design|patient-centred design
4999314|NCT03998995|Upper Limb Injury|upper limb injury
4999315|NCT03998995|Children Rehabilitation|children rehabilitation
4999316|NCT03998982|ITP；glycyrrhetinic acid；dexamethasone|itp；glycyrrhetinic acid；dexamethasone
4999317|NCT03998969|Gastroesophageal Reflux|gastroesophageal reflux
4999318|NCT03998969|Esophagitis, Peptic|esophagitis, peptic
4999319|NCT03998956|catheter ablation|catheter ablation
4999320|NCT03998930|Disorders of consciousness,|disorders of consciousness,
4999321|NCT03998930|Brain Computer Interface|brain computer interface
4999322|NCT03998930|P300|p300
4999323|NCT03998930|Motor imagery|motor imagery
4999324|NCT03998917|Chronic Kidney Failure|chronic kidney failure
4999325|NCT03998917|Fatigue|fatigue
4999326|NCT03998917|Adapted Physical Activity|adapted physical activity
4999327|NCT03998878|Weight Loss|weight loss
4999328|NCT03998878|Diet Modification|diet modification
4999329|NCT03998878|Body Weight|body weight
4999330|NCT03998878|Body Weight Changes|body weight changes
4999331|NCT03998878|Ketogenic diet|ketogenic diet
4999332|NCT03998878|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
4999333|NCT03998878|Fasting|fasting
4999334|NCT03998878|Intermittent Fasting|intermittent fasting
4999335|NCT03998878|Hunger training|hunger training
4999336|NCT03998865|Implant-supported Provisional Abutment|implant-supported provisional abutment
4999337|NCT03998865|Poly-ether-ether-ketone|poly-ether-ether-ketone
4999338|NCT03998865|Titanium|titanium
4999339|NCT03998865|Bacterial Microbiota|bacterial microbiota
4999340|NCT03998865|Antimicrobial Resistance Genes|antimicrobial resistance genes
4999341|NCT03998852|Apathy|apathy
4999342|NCT03998852|Stroke|stroke
4999343|NCT03998852|Cholinergic neurotransmission|cholinergic neurotransmission
4999344|NCT03998852|Dopaminergic neurotransmission|dopaminergic neurotransmission
4999345|NCT03998839|drug resistance; Sulfadoxine-pyrimethamine|drug resistance; sulfadoxine-pyrimethamine
4999346|NCT03998826|Piroxicam|piroxicam
4999347|NCT03998826|Postendodontic pain|postendodontic pain
4999348|NCT03998826|analgesic intake|analgesic intake
4999349|NCT03998800|Endurance performance|endurance performance
4999350|NCT03998800|Mitochondrial function|mitochondrial function
4999351|NCT03998800|L-arginine|l-arginine
4999352|NCT03998800|L-citrulline|l-citrulline
4999353|NCT03998800|Healthy males|healthy males
4999356|NCT03998774|Nitrous oxide|nitrous oxide
4999357|NCT03998774|Conscious sedation|conscious sedation
4999358|NCT03998774|Paediatric dentistry|paediatric dentistry
4999360|NCT03998761|Micronized Progesterone|micronized progesterone
4999361|NCT03998761|Dydrogesterone|dydrogesterone
4999362|NCT03998696|Locally advanced|locally advanced
4999363|NCT03998696|Head and Neck Cancer|head and neck cancer
4999364|NCT03998696|Concurrent|concurrent
4999365|NCT03998696|Weekly Cisplatin|weekly cisplatin
4999366|NCT03998696|Three weekly Cisplatin|three weekly cisplatin
4999367|NCT03998696|Radiotherapy|radiotherapy
4999368|NCT03998670|Prism|prism
4999372|NCT03998605|intellectual disabilities|intellectual disabilities
4999373|NCT03998605|abuse|abuse
4999374|NCT03998605|abuse prevention|abuse prevention
4999375|NCT03998592|vaccine|vaccine
4999376|NCT03998592|peptide|peptide
4995070|NCT04024813|PSC|psc
4999377|NCT03998592|Streptococcus pyogenes|streptococcus pyogenes
4999378|NCT03998566|Radiotherapy|radiotherapy
4999379|NCT03998566|Radiation|radiation
4999380|NCT03998566|SBRT|sbrt
4999381|NCT03998553|OOCYTE ACTIVATION|oocyte activation
4999382|NCT03998553|IN VITRO MATURATION|in vitro maturation
5015614|NCT03899792|MTC|mtc
4999418|NCT03998319|STEMI|stemi
4999419|NCT03998319|IMR|imr
4999420|NCT03998319|microcirculation|microcirculation
4999421|NCT03998319|microvascular obstruction|microvascular obstruction
4999422|NCT03998319|myocardial infarction|myocardial infarction
4999423|NCT03998319|physiology|physiology
4999424|NCT03998319|angioplasty|angioplasty
4999425|NCT03998319|PCI|pci
4999426|NCT03998319|thrombolysis treatment|thrombolysis treatment
4999427|NCT03998319|thrombolysis|thrombolysis
4999428|NCT03998280|fatigue ,deep neck flexor|fatigue ,deep neck flexor
4999431|NCT03998241|patellofemoral pain|patellofemoral pain
4999432|NCT03998241|joint position sense|joint position sense
4999434|NCT03998202|Colorectal Cancer|colorectal cancer
4999436|NCT03998202|Sarcopenia|sarcopenia
4999437|NCT03998202|Chemotherapy|chemotherapy
4999438|NCT03998202|Geriatric-Oncology|geriatric-oncology
4999439|NCT03998176|Substance use|substance use
4999459|NCT03998150|enucleation|enucleation
4999460|NCT03998150|Prostate|prostate
4999461|NCT03998150|LUTS|luts
4999462|NCT03998150|IPSS|ipss
4999463|NCT03998150|quality of life|quality of life
4999464|NCT03998150|Large prostate|large prostate
4999465|NCT03998137|Ankle Fusions|ankle fusions
4999466|NCT03998137|AUGMENT® Injectable Bone Graft|augment® injectable bone graft
4999467|NCT03998137|Autologous Bone Graft|autologous bone graft
4999468|NCT03998137|arthritis|arthritis
4999469|NCT03998137|ankle pain|ankle pain
4999470|NCT03998137|foot pain|foot pain
4999471|NCT03998137|hindfoot fracture|hindfoot fracture
4999472|NCT03998137|ankle fracture|ankle fracture
4999473|NCT03998111|Glucose|glucose
4999474|NCT03998111|Genetic variation|genetic variation
4999475|NCT03998111|CHC22|chc22
4999476|NCT03998111|CLTCL1|cltcl1
4999477|NCT03998098|Blood Pressure|blood pressure
4999478|NCT03998098|SPO2|spo2
4999479|NCT03998098|Oxygen Saturation|oxygen saturation
4999480|NCT03998098|Respiratory Rate|respiratory rate
4999481|NCT03998098|Pulse|pulse
4999482|NCT03998098|Breathing Rate|breathing rate
4999483|NCT03998098|Heart Rate|heart rate
4999484|NCT03998072|psychology|psychology
4999485|NCT03998072|cognitive analytic therapy|cognitive analytic therapy
4999486|NCT03998059|Thrombocytopenia|thrombocytopenia
4999487|NCT03998059|splenectomy|splenectomy
4999488|NCT03998046|overweight|overweight
4999489|NCT03998046|obesity|obesity
4999490|NCT03998046|prediabetes|prediabetes
4999491|NCT03998046|type 2 diabetes|type 2 diabetes
4999492|NCT03998046|hypertension|hypertension
4999497|NCT03998033|Hepatocellular Carcinoma|hepatocellular carcinoma
4999498|NCT03998033|HCC|hcc
4999499|NCT03998033|Advanced HCC|advanced hcc
4999500|NCT03998033|Late-Stage HCC|late-stage hcc
4999501|NCT03998033|Liver Cancer|liver cancer
4999502|NCT03998033|Liver Neoplasm|liver neoplasm
4999503|NCT03998033|Metastatic Liver Cancer|metastatic liver cancer
4999504|NCT03998033|Metastatic HCC|metastatic hcc
4999505|NCT03998033|T-cell therapy|t-cell therapy
4999506|NCT03998033|Immunotherapy|immunotherapy
4999507|NCT03997981|CIPN|cipn
4999508|NCT03997968|Oral RAD51-inhibitor; refractory; B-cell; solid tumor|oral rad51-inhibitor; refractory; b-cell; solid tumor
4999509|NCT03997968|DNA Damage Repair inhibitor|dna damage repair inhibitor
4999510|NCT03997968|cancer|cancer
4999511|NCT03997942|burn, physiotherapy|burn, physiotherapy
4999512|NCT03997916|Belun Ring|belun ring
4999513|NCT03997916|pulse oximeter|pulse oximeter
4999514|NCT03997916|obstructive sleep apnea|obstructive sleep apnea
4999515|NCT03997890|Extended depth of focus|extended depth of focus
4999516|NCT03997890|Multifocal intraocular lens|multifocal intraocular lens
5306295|NCT02146560|Surgery|surgery
4999517|NCT03997890|Presbyopia|presbyopia
4999518|NCT03997890|Cataract surgery|cataract surgery
4999519|NCT03997877|sleep apnea syndrome|sleep apnea syndrome
4999520|NCT03997877|physical activity|physical activity
4999521|NCT03997877|mediterranean diet|mediterranean diet
4999522|NCT03997877|metabolism|metabolism
4999523|NCT03997877|impact on sleep|impact on sleep
4999524|NCT03997864|Sexual Assault|sexual assault
4999525|NCT03997864|Trauma|trauma
4999526|NCT03997864|prevention|prevention
4999527|NCT03997799|lung cancer|lung cancer
4999528|NCT03997799|mediastinum|mediastinum
4999529|NCT03997799|pulmonary resection|pulmonary resection
4999530|NCT03997773|Gestational Diabetes|gestational diabetes
4999534|NCT03997773|Health Promotion|health promotion
4999535|NCT03997773|Postpartum Intervention|postpartum intervention
4999536|NCT03997773|Quality of Life|quality of life
4999537|NCT03997773|Wellbeing|wellbeing
4999538|NCT03997747|genomic biomarkers|genomic biomarkers
4999539|NCT03997747|famitinib|famitinib
4999540|NCT03997747|camrelizumab|camrelizumab
4999541|NCT03997747|tumor mutation burden|tumor mutation burden
4999542|NCT03997747|PD-L1 expression|pd-l1 expression
4999543|NCT03997747|Tcell-inflamed gene expression profile (GEP)|tcell-inflamed gene expression profile (gep)
4999544|NCT03997721|emergency laparotomy|emergency laparotomy
4999545|NCT03997721|ileus|ileus
4999546|NCT03997721|perforated ulcer|perforated ulcer
4999547|NCT03997721|intestinal perforation|intestinal perforation
4999548|NCT03997721|perioperative fluid management|perioperative fluid management
4999549|NCT03997721|pathophysiology|pathophysiology
4999550|NCT03997721|fluid overload|fluid overload
4999552|NCT03997708|Quality of life|quality of life
4999553|NCT03997708|FODMAP|fodmap
4999554|NCT03997708|Mediterranean Diet|mediterranean diet
4999555|NCT03997708|Clinical Nutrition|clinical nutrition
4999556|NCT03997708|low FODMAP|low fodmap
4999557|NCT03997695|Fibromyalgia|fibromyalgia
4999558|NCT03997695|Exercise|exercise
4999559|NCT03997695|Kinesio Taping|kinesio taping
4999560|NCT03997643|Radiation Therapy|radiation therapy
4999561|NCT03997643|Oral Cavity Squamous Cell Carcinoma|oral cavity squamous cell carcinoma
4999563|NCT03997591|eating|eating
4999564|NCT03997591|upper limb|upper limb
4999565|NCT03997591|reeducation|reeducation
4999566|NCT03997526|3C Patch|3c patch
4999567|NCT03997526|Reapplix|reapplix
4999568|NCT03997526|LeucoPatch|leucopatch
4999569|NCT03997513|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
4999570|NCT03997513|pulmonary rehabilitation|pulmonary rehabilitation
4999571|NCT03997513|muscle atrophy|muscle atrophy
4999576|NCT03997461|Blood Pressure|blood pressure
4999577|NCT03997409|Low Carbohydrate Diet|low carbohydrate diet
4999578|NCT03997409|Standard Carbohydrate Diet|standard carbohydrate diet
4999579|NCT03997396|gestational diabetes mellitus|gestational diabetes mellitus
4999580|NCT03997396|children|children
4999581|NCT03997396|neuropsychological|neuropsychological
4999582|NCT03997396|physique growth|physique growth
4999583|NCT03997383|RNAi therapeutic|rnai therapeutic
4999584|NCT03997383|Transthyretin|transthyretin
4999586|NCT03997383|Amyloidosis|amyloidosis
4999587|NCT03997383|Cardiomyopathy|cardiomyopathy
4999588|NCT03997383|ATTR|attr
4999589|NCT03997344|posttraumatic stress disorders|posttraumatic stress disorders
4999590|NCT03997344|randomized controlled trial|randomized controlled trial
4999591|NCT03997344|pilot study|pilot study
4999592|NCT03997344|feasibility|feasibility
4999593|NCT03997344|nature|nature
4999594|NCT03997344|physical activity|physical activity
4999599|NCT03997318|Urinary Tract Diseases|urinary tract diseases
4999601|NCT03997318|Urinary Leak|urinary leak
4999602|NCT03997318|Urine Leak|urine leak
4999603|NCT03997318|Bladder Leak|bladder leak
4999604|NCT03997318|Urethra|urethra
4999605|NCT03997318|Urethral Spincter|urethral spincter
4999606|NCT03997305|Mitral Regurgitation|mitral regurgitation
4999607|NCT03997305|TMVR|tmvr
4999608|NCT03997305|Functional Regurgitation|functional regurgitation
4999609|NCT03997305|Degenerative Regurgitation|degenerative regurgitation
4999610|NCT03997305|Transcathether Mitral Valve Replacement|transcathether mitral valve replacement
4999611|NCT03997305|Primary Regurgitation|primary regurgitation
4999612|NCT03997305|Secondary Regurgitation|secondary regurgitation
4999613|NCT03997292|alteplase; urokinase; intravenous thrombolysis|alteplase; urokinase; intravenous thrombolysis
4999614|NCT03997279|Helicobacter Pylori|helicobacter pylori
4999615|NCT03997279|Saccharomyces boulardi|saccharomyces boulardi
4999616|NCT03997279|Eradication therapy|eradication therapy
4999620|NCT03997253|organ transplantation, graft, biological collection.|organ transplantation, graft, biological collection.
4999621|NCT03997201|Ventricular|ventricular
4999622|NCT03997201|Tachycardia|tachycardia
4999623|NCT03997201|Ischaemic|ischaemic
4999624|NCT03997201|Mapping|mapping
4999625|NCT03997201|Ablation|ablation
4999626|NCT03997175|biodiversity intervention|biodiversity intervention
4999627|NCT03997175|sand box|sand box
4999628|NCT03997175|guidance|guidance
4999629|NCT03997149|Trier Social Stress Test|trier social stress test
4999632|NCT03997110|Cervical Cancer|cervical cancer
4999633|NCT03997110|Palliative treatment|palliative treatment
5319462|NCT02087553|Iron|iron
4999634|NCT03997110|Radiation Therapy|radiation therapy
4999635|NCT03997097|Congenital heart defect|congenital heart defect
4999636|NCT03997097|single ventricle|single ventricle
4999637|NCT03997097|Pulmonary hypertension|pulmonary hypertension
4999638|NCT03997097|sildenafil|sildenafil
4999639|NCT03997097|pulmonary vasodilator|pulmonary vasodilator
4999640|NCT03997097|Eexercise capacity|eexercise capacity
4999641|NCT03997071|ACL repair|acl repair
4999660|NCT03996967|Biosignature proteins|biosignature proteins
4999661|NCT03996967|Luminex®-based immunoassays|luminex®-based immunoassays
4999662|NCT03996967|Point-of-care test|point-of-care test
4999664|NCT03996967|Sub-Saharan Africa|sub-saharan africa
4999665|NCT03996967|Diagnostic Biomarkers|diagnostic biomarkers
4999666|NCT03996967|Prognostic Biomarkers|prognostic biomarkers
4999667|NCT03996967|Mediators of Inflammation|mediators of inflammation
4999668|NCT03996941|PrEP|prep
4999669|NCT03996941|Community setting|community setting
4999670|NCT03996941|point of care|point of care
4999671|NCT03996928|Epicondylitis|epicondylitis
4999672|NCT03996928|Tennis elbow|tennis elbow
4999673|NCT03996928|Eccentric exercise|eccentric exercise
4999674|NCT03996915|photodynamic therapy|photodynamic therapy
4999675|NCT03996915|periodontal disease|periodontal disease
4999676|NCT03996915|randomized controlled clinical study|randomized controlled clinical study
4999677|NCT03996902|Chronic Pain|chronic pain
4999678|NCT03996902|Tobacco|tobacco
4999679|NCT03996902|Smoking|smoking
4999680|NCT03996902|Smoking cessation|smoking cessation
4999681|NCT03996902|Motivation|motivation
4999682|NCT03996876|Attention Bias Modification|attention bias modification
4999683|NCT03996876|PTSD|ptsd
4999684|NCT03996876|Digital Health|digital health
4999685|NCT03996876|Alcohol Use Disorder|alcohol use disorder
4999686|NCT03996863|Nausea|nausea
4999687|NCT03996863|Chemotherapy|chemotherapy
4999688|NCT03996863|cisplatin|cisplatin
4999689|NCT03996863|Emesis|emesis
4999690|NCT03996837|Platelet rich plasma|platelet rich plasma
4999691|NCT03996837|Recurrent implantation failure|recurrent implantation failure
5002693|NCT03979092|Emotion regulation|emotion regulation
4999701|NCT03996785|Walking condition (nature vs urban)|walking condition (nature vs urban)
4999702|NCT03996772|Atrial fibrillation|atrial fibrillation
4999703|NCT03996772|Arrhythmias|arrhythmias
4999704|NCT03996772|Cardiac|cardiac
4999705|NCT03996772|Cerebral Hemorrhage|cerebral hemorrhage
4999706|NCT03996772|Brain haemorrhage|brain haemorrhage
4999707|NCT03996772|Intracerebral hemorrhage|intracerebral hemorrhage
4999708|NCT03996772|Cerebral haemorrhage|cerebral haemorrhage
4999709|NCT03996772|Basal ganglia haemorrhage|basal ganglia haemorrhage
4999710|NCT03996772|Putaminal haemorrhage|putaminal haemorrhage
4999711|NCT03996772|Anticoagulants|anticoagulants
4999712|NCT03996772|Oral anticoagulant|oral anticoagulant
4999713|NCT03996772|Direct oral anticoagulant|direct oral anticoagulant
4999714|NCT03996772|New oral anticoagulant|new oral anticoagulant
4999715|NCT03996772|Factor Xa inhibitors|factor xa inhibitors
4999716|NCT03996772|Direct thrombin inhibitor|direct thrombin inhibitor
4999717|NCT03996772|Dabigatran|dabigatran
4999718|NCT03996772|Apixaban|apixaban
4999719|NCT03996772|Rivaroxaban|rivaroxaban
4999720|NCT03996772|Edoxaban|edoxaban
4999721|NCT03996772|DOAC|doac
4999722|NCT03996772|NOAC|noac
4999723|NCT03996772|Intracerebral haemorrhage|intracerebral haemorrhage
4999724|NCT03996772|Brain hemorrhage|brain hemorrhage
4999725|NCT03996759|Sepsis|sepsis
4999726|NCT03996759|metabolomics|metabolomics
4999727|NCT03996759|biomarker|biomarker
4999728|NCT03996759|prediction|prediction
4999729|NCT03996759|clinical data analysis|clinical data analysis
4999730|NCT03996746|Klotho|klotho
4999731|NCT03996746|Cardiovascular Calcification|cardiovascular calcification
4999732|NCT03996733|Training|training
4999733|NCT03996733|Education|education
4999734|NCT03996733|Homemade|homemade
4999735|NCT03996733|Model|model
4999736|NCT03996733|Central Venous Catheterization|central venous catheterization
4999737|NCT03996733|Ultrasound Guidance|ultrasound guidance
4999738|NCT03996720|metabolomics|metabolomics
4999739|NCT03996720|biomarkers|biomarkers
4999740|NCT03996720|inflammatory mediator profile|inflammatory mediator profile
4999741|NCT03996720|MODS|mods
4999742|NCT03996720|predictive model|predictive model
4999743|NCT03996707|Ankle surgery|ankle surgery
4999744|NCT03996707|Foot surgery|foot surgery
4999745|NCT03996694|Chronic Pain|chronic pain
4999746|NCT03996694|Ventilatory Response to Hypercapnia (VRH)|ventilatory response to hypercapnia (vrh)
4999747|NCT03996681|Transarterial Chemoembolization|transarterial chemoembolization
4999748|NCT03996681|Methylcantharidimide|methylcantharidimide
4999749|NCT03996681|Large and unresectable HCC|large and unresectable hcc
4999750|NCT03996642|active|active
4999751|NCT03996642|cancer|cancer
4999752|NCT03996642|avatar|avatar
4999753|NCT03996642|life-limiting|life-limiting
4999754|NCT03996642|palliative care|palliative care
4999755|NCT03996629|pharmacist-managed anticoagulation|pharmacist-managed anticoagulation
4999756|NCT03996629|warfarin|warfarin
4999757|NCT03996629|acenocoumarol|acenocoumarol
4999758|NCT03996616|Cardiac Arrest|cardiac arrest
5306491|NCT02145624|pertussis|pertussis
4999759|NCT03996616|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
4999760|NCT03996616|Head-up position|head-up position
4999761|NCT03996603|Genitourinary Syndrome of Menopause|genitourinary syndrome of menopause
4999762|NCT03996603|Vaginal Atrophy|vaginal atrophy
4999763|NCT03996603|Vaginal Estrogen Therapy|vaginal estrogen therapy
4999764|NCT03996603|Inflammatory Response|inflammatory response
4999765|NCT03996603|Microbial Colonization|microbial colonization
4999766|NCT03996603|Urinary Microbiome|urinary microbiome
4999767|NCT03996603|Vaginal Microbiome|vaginal microbiome
4999768|NCT03996603|Rectal Microbiome|rectal microbiome
4999769|NCT03996603|Conjugated Estrogen Cream|conjugated estrogen cream
4999770|NCT03996590|Difficult Asthma|difficult asthma
4999771|NCT03996590|Severe Asthma|severe asthma
4999772|NCT03996577|lidocaine propofol ercp|lidocaine propofol ercp
4999773|NCT03996564|Battlefield Acupuncture|battlefield acupuncture
4999774|NCT03996564|Auricular Acupuncture|auricular acupuncture
5040820|NCT03743779|vegan|vegan
4999775|NCT03996564|Complementary Alternative Medicine|complementary alternative medicine
4999776|NCT03996564|Military, Service Members|military, service members
4999777|NCT03996564|Emergency Medicine|emergency medicine
4999778|NCT03996564|Back Pain|back pain
4999779|NCT03996564|Acute Back Pain|acute back pain
4999780|NCT03996564|Chronic Back Pain|chronic back pain
4999781|NCT03996564|Alternative Medicine,|alternative medicine,
4999787|NCT03996525|unilateral facial nerve palsy|unilateral facial nerve palsy
4999794|NCT03996525|electrical stimulation|electrical stimulation
4999795|NCT03996525|e-stim|e-stim
4999796|NCT03996525|free muscle transfer|free muscle transfer
4999797|NCT03996525|FMT|fmt
4999798|NCT03996486|Coagulation Factor VIII (FVIII)|coagulation factor viii (fviii)
4999799|NCT03996486|Coagulation Factor IX (FIX)|coagulation factor ix (fix)
4999805|NCT03996421|Galacto-oligosaccharides|galacto-oligosaccharides
4999813|NCT03996369|Ulcerative Colitis|ulcerative colitis
4999814|NCT03996369|Etrasimod|etrasimod
4999816|NCT03996343|Laryngeal mask airway|laryngeal mask airway
4999817|NCT03996343|Endotracheal intubation|endotracheal intubation
4999818|NCT03996343|Obese|obese
4999819|NCT03996304|Birth cohort|birth cohort
4999820|NCT03996304|Intestinal microbiota|intestinal microbiota
4999821|NCT03996304|Child health|child health
4999822|NCT03996278|THYMOGLOBULINE®|thymoglobuline®
4999823|NCT03996278|GRAFALON®|grafalon®
4999824|NCT03996239|Aerobic Exercise|aerobic exercise
4999825|NCT03996239|19-126|19-126
4999826|NCT03996226|Healthy Participants|healthy participants
4999827|NCT03996226|E7386|e7386
4999828|NCT03996226|Bioavailability|bioavailability
4999829|NCT03996226|Food Effect|food effect
4999830|NCT03996200|glaucoma|glaucoma
4999831|NCT03996200|medical device|medical device
4999832|NCT03996200|MIGS|migs
4999833|NCT03996200|drainage device|drainage device
4999834|NCT03996200|eye|eye
4999835|NCT03996200|reduction IOP|reduction iop
4999836|NCT03996174|Palliative care|palliative care
4999837|NCT03996174|needs assessment|needs assessment
4999838|NCT03996174|Mayotte|mayotte
4999839|NCT03996174|terminal care|terminal care
4999840|NCT03996122|schizo-affective disorder|schizo-affective disorder
4999841|NCT03996122|utra-resistance|utra-resistance
4999842|NCT03996122|clozapine|clozapine
4999843|NCT03996122|biomarker|biomarker
4999844|NCT03996122|fMRI|fmri
4999858|NCT03995927|Difficult to treat cancers|difficult to treat cancers
4999860|NCT03995914|Major cardiac and cerebrovascular events|major cardiac and cerebrovascular events
4999861|NCT03995914|TAVI|tavi
4999862|NCT03995914|Older|older
4999863|NCT03995901|Kidney Transplant|kidney transplant
4999864|NCT03995901|Stem cell therapy|stem cell therapy
4999865|NCT03995901|Anti-rejection medications|anti-rejection medications
4999866|NCT03995901|Living donor kidney transplant|living donor kidney transplant
4999867|NCT03995875|NSCLC, stageIII, Durvalumab, Japanese, Real world|nsclc, stageiii, durvalumab, japanese, real world
4999868|NCT03995862|tenofovir disoproxil fumarate and emtricitabine combination|tenofovir disoproxil fumarate and emtricitabine combination
4999869|NCT03995836|Obstructive Sleep Apnea|obstructive sleep apnea
4999870|NCT03995836|Morbid Obesity|morbid obesity
4999871|NCT03995836|Epigenetics|epigenetics
4999872|NCT03995836|Bariatric Surgery|bariatric surgery
4999873|NCT03995823|arteriovenous malformation|arteriovenous malformation
4999874|NCT03995823|MRI|mri
4999875|NCT03995823|DSA|dsa
4999876|NCT03995823|Gamma Knife|gamma knife
4999877|NCT03995719|colostomy|colostomy
4999878|NCT03995719|education|education
4999879|NCT03995693|eccentric exercise|eccentric exercise
4999880|NCT03995693|13C-glucose|13c-glucose
4999881|NCT03995693|exercise mode|exercise mode
4999882|NCT03995680|Mebendazole|mebendazole
4999883|NCT03995680|Chewable tablet|chewable tablet
4999884|NCT03995680|Hookworm|hookworm
4999885|NCT03995680|Soil-transmitted helminths|soil-transmitted helminths
4999886|NCT03995680|Efficacy|efficacy
4999887|NCT03995680|Safety|safety
4999888|NCT03995680|Acceptability|acceptability
4999889|NCT03995654|Interstitial Lung Diseases|interstitial lung diseases
4999890|NCT03995654|Fibrotic Lung|fibrotic lung
4999894|NCT03995602|betalains|betalains
4999895|NCT03995602|dragon fruit|dragon fruit
4999896|NCT03995602|pitaya|pitaya
4999897|NCT03995537|liver transplantation|liver transplantation
4999898|NCT03995537|Liver Diseases|liver diseases
4999899|NCT03995511|Sensory deficit|sensory deficit
4999900|NCT03995511|Orthognathic surgery|orthognathic surgery
4999901|NCT03995511|Mandibular osteotomy|mandibular osteotomy
4999902|NCT03995511|Inferior alveolar nerve|inferior alveolar nerve
4999903|NCT03995498|Exercise|exercise
4999904|NCT03995498|Physical activity|physical activity
4999905|NCT03995498|Carbohydrates|carbohydrates
4999906|NCT03995498|Hypoglycemia|hypoglycemia
4999907|NCT03995485|Chronic hepatitis C|chronic hepatitis c
4999908|NCT03995485|Hepatitis C virus|hepatitis c virus
4999909|NCT03995485|Eradication|eradication
4999911|NCT03995485|Sofosbuvir|sofosbuvir
4999912|NCT03995485|Nonstructural protein 5A|nonstructural protein 5a
4999913|NCT03995485|Nonstructural protein 5B|nonstructural protein 5b
4999914|NCT03995485|Panogentypic regimen|panogentypic regimen
4999915|NCT03995485|Confirmatory study|confirmatory study
4999916|NCT03995446|Acupuncture points, low-level laser, postoperative pain, total knee arthroplasty|acupuncture points, low-level laser, postoperative pain, total knee arthroplasty
4999917|NCT03995407|Pressure ulcer|pressure ulcer
4999918|NCT03995407|Whey protein|whey protein
4999922|NCT03995368|Traumatic Brain Injury|traumatic brain injury
4999923|NCT03995368|Neuroplasticity|neuroplasticity
4999925|NCT03995342|frailty, flora|frailty, flora
4999926|NCT03995329|pulmonary function|pulmonary function
4999927|NCT03995329|heated tobacco|heated tobacco
4999928|NCT03995329|IQOS|iqos
4999929|NCT03995303|Malnutrition|malnutrition
4999930|NCT03995303|Old adults|old adults
4999931|NCT03995303|Home-delivered meals|home-delivered meals
4999932|NCT03995303|NCP - Nutrition Care Process|ncp - nutrition care process
4999933|NCT03995303|Food|food
4999934|NCT03995277|Biotin|biotin
4999935|NCT03995238|Amputation|amputation
4999943|NCT03995212|Chronic Itch|chronic itch
4999944|NCT03995212|difelikefalin|difelikefalin
4999945|NCT03995212|Itch|itch
4999946|NCT03995212|Itching|itching
4999947|NCT03995212|Generalized pruritus|generalized pruritus
4999948|NCT03995199|speech evaluation|speech evaluation
4999949|NCT03995199|modified Furlow palatoplasty|modified furlow palatoplasty
4999950|NCT03995199|Sommerlad intravelar veloplasty|sommerlad intravelar veloplasty
4999951|NCT03995186|behavioural activation|behavioural activation
4999952|NCT03995173|alcoholism|alcoholism
4999953|NCT03995173|brain concussion|brain concussion
4999954|NCT03995173|post-traumatic stress disorder|post-traumatic stress disorder
4999955|NCT03995160|total|total
4999956|NCT03995160|knee|knee
4999957|NCT03995160|arthroplasty|arthroplasty
4999958|NCT03995160|tkr|tkr
4999959|NCT03995160|drainage|drainage
4999960|NCT03995160|haematoma|haematoma
4999961|NCT03995134|Use of propofol and remifentanil administered with TCI pump|use of propofol and remifentanil administered with tci pump
4999962|NCT03995095|Spirituality|spirituality
4999963|NCT03995095|Intervention Study|intervention study
4999964|NCT03995069|Hand Strength|hand strength
4999965|NCT03995069|Electromyography|electromyography
4999966|NCT03995056|NAFLD|nafld
4999967|NCT03995056|Gut microbiota|gut microbiota
4999968|NCT03995056|high-intensity training|high-intensity training
4999969|NCT03995004|melatonin|melatonin
4999970|NCT03995004|orthognathic|orthognathic
4999971|NCT03995004|pain|pain
4999972|NCT03995004|surgery|surgery
4999973|NCT03994965|Pimavanserin|pimavanserin
4999974|NCT03994965|serotonin 2AR|serotonin 2ar
4999975|NCT03994965|MR|mr
4999976|NCT03994965|PET|pet
4999977|NCT03994952|Balance, postural|balance, postural
4999978|NCT03994952|Non-linear dynamics|non-linear dynamics
4999979|NCT03994939|Sexual and reproductive health|sexual and reproductive health
4999980|NCT03994939|Promotores de Salud|promotores de salud
4999981|NCT03994939|Parent-adolescent communication|parent-adolescent communication
4999982|NCT03994939|Health care insurance enrollment|health care insurance enrollment
4999984|NCT03994913|Relapsed and/or Refractory B-cell Non-Hodgkin Lymphoma|relapsed and/or refractory b-cell non-hodgkin lymphoma
4999985|NCT03994913|CAR T|car t
4999986|NCT03994900|cardiovascular nitric oxide erythrocyte|cardiovascular nitric oxide erythrocyte
4999990|NCT03994835|HIV|hiv
5000093|NCT03994367|Metabolism|metabolism
4999996|NCT03994822|Brain Clot|brain clot
4999997|NCT03994822|Brain Infarction|brain infarction
4999998|NCT03994822|Cerebral Ischemia|cerebral ischemia
4999999|NCT03994822|Cerebrovascular Disorders|cerebrovascular disorders
5000000|NCT03994822|Ischemia|ischemia
5000001|NCT03994822|Ischemic|ischemic
5000002|NCT03994822|Ischemic Stroke|ischemic stroke
5000003|NCT03994822|Mechanical Thrombectomy|mechanical thrombectomy
5000004|NCT03994822|Neurovascular Intervention|neurovascular intervention
5000006|NCT03994822|pRESET|preset
5000007|NCT03994822|pRESET Thrombectomy Device|preset thrombectomy device
5000008|NCT03994822|Revascularization|revascularization
5000009|NCT03994822|Randomized Control|randomized control
5000010|NCT03994822|Solitaire|solitaire
5000011|NCT03994822|Stent Retriever|stent retriever
5000012|NCT03994822|Stroke|stroke
5319753|NCT02085967|Healthy|healthy
5000013|NCT03994822|Vascular Diseases|vascular diseases
5000014|NCT03994809|biofield therapy|biofield therapy
5000015|NCT03994809|ethnic differences|ethnic differences
5000016|NCT03994809|Okada Purifying Therapy|okada purifying therapy
5000017|NCT03994809|effectiveness|effectiveness
5000018|NCT03994809|safety|safety
5000019|NCT03994783|Rituximab|rituximab
5000020|NCT03994783|AMR|amr
5000021|NCT03994770|Balance|balance
5000022|NCT03994757|Autism Spectrum Disorder|autism spectrum disorder
5000023|NCT03994757|Routine-Based Early Intervention|routine-based early intervention
5000024|NCT03994744|immunotherapy|immunotherapy
5000025|NCT03994744|metformin|metformin
5000026|NCT03994744|PD-L1|pd-l1
5000027|NCT03994744|PD-1 checkpoint inhibitor|pd-1 checkpoint inhibitor
5000030|NCT03994718|art|art
5000031|NCT03994718|music|music
5000032|NCT03994718|visual art|visual art
5000033|NCT03994718|writing|writing
5000034|NCT03994718|epilepsy|epilepsy
5000035|NCT03994705|CAR-T|car-t
5000036|NCT03994705|CART|cart
5000037|NCT03994705|CAR T Cell|car t cell
5000039|NCT03994705|Multiple Myeloma|multiple myeloma
5000040|NCT03994705|BCMA|bcma
5000041|NCT03994705|B cell maturation antigen|b cell maturation antigen
5016137|NCT03896165|Parent|parent
5000044|NCT03994692|PEEK eminoplasty ,autogenous inlay (sandwich) eminoplasty|peek eminoplasty ,autogenous inlay (sandwich) eminoplasty
5000046|NCT03994679|bone graft|bone graft
5000047|NCT03994653|Ovarian cancer|ovarian cancer
5000048|NCT03994653|Cancer of the ovary|cancer of the ovary
5000049|NCT03994653|Observational study|observational study
5000050|NCT03994653|Case-control study|case-control study
5000051|NCT03994653|Cancer Loyalty Card Study|cancer loyalty card study
5000052|NCT03994653|CLOCS|clocs
5000053|NCT03994640|temporomandibular disorder|temporomandibular disorder
5000054|NCT03994640|Cannabis|cannabis
5000055|NCT03994640|Electromyography|electromyography
5000056|NCT03994640|Masticatory muscles|masticatory muscles
5000057|NCT03994640|Topical application|topical application
5000058|NCT03994614|acupuncture|acupuncture
5000059|NCT03994614|quality|quality
5000060|NCT03994614|oocyte|oocyte
5000061|NCT03994614|poor ovarian response|poor ovarian response
5000062|NCT03994588|Complex ventral hernia|complex ventral hernia
5000063|NCT03994588|Polypropylene soft mesh|polypropylene soft mesh
5000064|NCT03994588|Intraperitoneal repair|intraperitoneal repair
5000065|NCT03994588|Recurrence|recurrence
5000066|NCT03994588|Loss of Domain|loss of domain
5000067|NCT03994562|Frailty|frailty
5000068|NCT03994562|Caregivers|caregivers
5000069|NCT03994562|Zarit scale|zarit scale
5000070|NCT03994549|Dual GLP-1R/GLP-2 Receptor agonist|dual glp-1r/glp-2 receptor agonist
5000071|NCT03994536|Transfer to adult care|transfer to adult care
5000072|NCT03994536|Continuity of patient care|continuity of patient care
5000073|NCT03994536|Transition program|transition program
5000074|NCT03994536|Empowerment|empowerment
5000075|NCT03994536|Adolescents|adolescents
5000076|NCT03994510|Psychiatry|psychiatry
5000077|NCT03994510|Suicidal Behavior|suicidal behavior
5000078|NCT03994510|Borderline Personality Disorder|borderline personality disorder
5000079|NCT03994510|Follow-Up Study|follow-up study
5000083|NCT03994432|mediterranean diet|mediterranean diet
5000084|NCT03994432|endometriosis|endometriosis
5000085|NCT03994432|physical activity|physical activity
5000086|NCT03994432|7 minutes work-out|7 minutes work-out
5000087|NCT03994419|Paediatric|paediatric
5000088|NCT03994419|Anaesthesia|anaesthesia
5000089|NCT03994406|contact lens|contact lens
5000090|NCT03994406|ocular erythema|ocular erythema
5000091|NCT03994406|contact lens discomfort|contact lens discomfort
5000092|NCT03994367|High Protein|high protein
5000100|NCT03994328|Rasagiline|rasagiline
5000101|NCT03994328|Levodopa|levodopa
5000102|NCT03994328|L-DOPA|l-dopa
5000103|NCT03994328|Fluctuating Patients|fluctuating patients
5000104|NCT03994328|Add-on Therapy|add-on therapy
5000105|NCT03994328|PDQ|pdq
5000106|NCT03994328|UPDRS|updrs
5000107|NCT03994328|NRS|nrs
5000108|NCT03994328|MMAS-8|mmas-8
5000109|NCT03994328|Morisky|morisky
5000110|NCT03994328|quality of life|quality of life
5000111|NCT03994328|observational|observational
5000112|NCT03994289|exercise|exercise
5000113|NCT03994289|FES|fes
5000120|NCT03994250|kinematic|kinematic
5000121|NCT03994250|mechanical|mechanical
5000122|NCT03994250|total knee replacement|total knee replacement
5000123|NCT03994185|PAOD|paod
5000124|NCT03994185|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5000125|NCT03994185|Iliac Artery Disease|iliac artery disease
5000126|NCT03994185|Stent Graft|stent graft
5000127|NCT03994172|male osteoporosis|male osteoporosis
5000128|NCT03994172|anabolic therapy|anabolic therapy
5000129|NCT03994172|teriparatide|teriparatide
5000130|NCT03994172|calcimimetic|calcimimetic
5000131|NCT03994172|calcium-sensing receptor|calcium-sensing receptor
5000132|NCT03994172|PTH receptor|pth receptor
5000133|NCT03994172|bone formation|bone formation
5000134|NCT03994133|Dialysis|dialysis
5000135|NCT03994133|BCM|bcm
5000136|NCT03994133|Daily Home Dialysis|daily home dialysis
5000137|NCT03994133|low-flow dialysate|low-flow dialysate
5000138|NCT03994133|Fluid Overload|fluid overload
5000140|NCT03994133|dialysis dose|dialysis dose
5000141|NCT03994133|Nutritional Status|nutritional status
5000142|NCT03994133|blood pressure|blood pressure
5000143|NCT03994120|Memory Systems|memory systems
5000144|NCT03994120|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5000145|NCT03994120|Behavioral Efficiency|behavioral efficiency
5000146|NCT03994120|Hippocampal and Striatal Memory Networks|hippocampal and striatal memory networks
5000147|NCT03994081|tACS|tacs
5000148|NCT03994081|Major Depressive Disorder|major depressive disorder
5000150|NCT03994081|mood symptoms|mood symptoms
5000151|NCT03994081|sham|sham
5000152|NCT03994055|Cancer|cancer
5000153|NCT03994055|Intestinal inflammation|intestinal inflammation
5000154|NCT03994055|Diet|diet
5000155|NCT03994016|Adolescent dating violence|adolescent dating violence
5000156|NCT03994016|Positive mental health|positive mental health
5000159|NCT03993977|ROTEM|rotem
5000160|NCT03993977|thromboelastometry|thromboelastometry
5000165|NCT03993977|oncological|oncological
5000166|NCT03993951|Family|family
5000167|NCT03993938|transcatheter mitral valve repair|transcatheter mitral valve repair
5000168|NCT03993938|pleth variability index|pleth variability index
5000169|NCT03993938|Mitraclip|mitraclip
5000170|NCT03993925|chronic hepatitis c|chronic hepatitis c
5000171|NCT03993925|people who inject drugs|people who inject drugs
5000172|NCT03993925|access to care|access to care
5000173|NCT03993912|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5000174|NCT03993912|Frail elderly patients|frail elderly patients
5000175|NCT03993912|Dexamethasone-sparing regimen|dexamethasone-sparing regimen
5000176|NCT03993912|Daratumumab|daratumumab
5000177|NCT03993912|Toxicity|toxicity
5000178|NCT03993899|cochlear implant stimulation strategy sound coding strategy|cochlear implant stimulation strategy sound coding strategy
5000179|NCT03993886|Hemodialysis|hemodialysis
5000180|NCT03993873|Non Small Cell Lung|non small cell lung
5000181|NCT03993873|Non Small Cell Lung Cancer|non small cell lung cancer
5000182|NCT03993873|Non-small cell lung cancer|non-small cell lung cancer
5000183|NCT03993873|NSCLC|nsclc
5000184|NCT03993873|TPX-0022|tpx-0022
5000185|NCT03993873|EGFR wild-type (wt)|egfr wild-type (wt)
5000186|NCT03993873|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5000187|NCT03993873|advanced/metastatic disease|advanced/metastatic disease
5000188|NCT03993873|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5000189|NCT03993873|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5000190|NCT03993873|treatment of gastric cancer after first metastasis|treatment of gastric cancer after first metastasis
5000191|NCT03993873|treatment of hepatocellular cancer after first metastasis|treatment of hepatocellular cancer after first metastasis
5000192|NCT03993873|lung cancer|lung cancer
5000193|NCT03993873|lung adenocarcinoma|lung adenocarcinoma
5000194|NCT03993873|Non small cell lung carcinoma|non small cell lung carcinoma
5000195|NCT03993873|MET exon 14 deletion|met exon 14 deletion
5000196|NCT03993873|MET exon 14 skipping|met exon 14 skipping
5000197|NCT03993873|MET exon 14 mutation|met exon 14 mutation
5000198|NCT03993873|MET mutation|met mutation
5000199|NCT03993873|MET amplification|met amplification
5000200|NCT03993873|MET inhibitor|met inhibitor
5000201|NCT03993873|MET dysregulation|met dysregulation
5000202|NCT03993873|MET activation|met activation
5000203|NCT03993873|MET signaling|met signaling
5000204|NCT03993873|MET pathway|met pathway
5000205|NCT03993873|MET fusion|met fusion
5000206|NCT03993873|gastric cancer|gastric cancer
5000207|NCT03993873|hepatocellular cancer|hepatocellular cancer
5000209|NCT03993873|CSF1R|csf1r
5000210|NCT03993873|cancer|cancer
5000211|NCT03993873|first in human|first in human
5000212|NCT03993860|Infants|infants
5000213|NCT03993860|Growth|growth
5000214|NCT03993860|Stunting|stunting
5000215|NCT03993860|Fish|fish
5000216|NCT03993860|Intervention|intervention
5000217|NCT03993847|Spondyloarthritis|spondyloarthritis
5000218|NCT03993847|SPARTAN|spartan
5000219|NCT03993847|ASAS|asas
5000221|NCT03993847|Undiagnosed Back Pain|undiagnosed back pain
5000222|NCT03993834|Transradial catheterization|transradial catheterization
5000223|NCT03993834|Transradial access|transradial access
5000224|NCT03993834|Radial artery occlusion|radial artery occlusion
5000225|NCT03993834|Palmar arch collateral circulation|palmar arch collateral circulation
5000226|NCT03993834|Collateral flow index|collateral flow index
5000227|NCT03993821|CSHS|cshs
5000228|NCT03993821|Cutaneous Skeletal Hypophosphatemia Syndrome|cutaneous skeletal hypophosphatemia syndrome
5000229|NCT03993821|Epidermal Nevus Syndrome|epidermal nevus syndrome
5000230|NCT03993808|Nutrition, micro-nutrients, implementation, food insecurity|nutrition, micro-nutrients, implementation, food insecurity
5000231|NCT03993743|liver cancer|liver cancer
5000232|NCT03993743|CD147|cd147
5000233|NCT03993743|CAR-T|car-t
5000234|NCT03993717|shingles vaccine|shingles vaccine
5000235|NCT03993717|immune responses|immune responses
5000236|NCT03993717|Clinical Trials|clinical trials
5000237|NCT03993717|Immunology|immunology
5000238|NCT03993717|Kidney Transplant|kidney transplant
5000239|NCT03993704|Lassa fever|lassa fever
5000240|NCT03993704|viral hemorrhagic fever|viral hemorrhagic fever
5000241|NCT03993691|Scaphoid Fracture|scaphoid fracture
5000242|NCT03993691|Wrist Fracture|wrist fracture
5000243|NCT03993691|Distal Radius Fracture|distal radius fracture
5000244|NCT03993678|advanced solid tumors|advanced solid tumors
5000245|NCT03993678|Intratumoral injection|intratumoral injection
5000246|NCT03993678|IP-001|ip-001
5000247|NCT03993678|thermal ablation|thermal ablation
5016337|NCT03894826|PEDIATRIC|pediatric
5000250|NCT03993678|soft tissue sarcoma|soft tissue sarcoma
5000251|NCT03993678|tumor ablation|tumor ablation
5000252|NCT03993678|systemic immune response|systemic immune response
5000253|NCT03993678|interventional immuno-oncology|interventional immuno-oncology
5000259|NCT03993639|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
5000260|NCT03993600|cystic fibrosis|cystic fibrosis
5000262|NCT03993600|sweat glands|sweat glands
5000263|NCT03993600|omics analysis|omics analysis
5000264|NCT03993561|treatment summary and survivorship care plan|treatment summary and survivorship care plan
5000265|NCT03993561|intervention|intervention
5000266|NCT03993561|head and neck cancer survivors|head and neck cancer survivors
5000267|NCT03993548|Wellness|wellness
5000268|NCT03993548|Mental Wellness|mental wellness
5000269|NCT03993548|Well-Being|well-being
5000270|NCT03993535|obsessive-compulsive disorder|obsessive-compulsive disorder
5000271|NCT03993535|predictors|predictors
5000272|NCT03993535|neuroimaging|neuroimaging
5315753|NCT02105090|Dyspepsia|dyspepsia
5000273|NCT03993522|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5000274|NCT03993496|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5000275|NCT03993496|Endovascular Abdominal Aortic Aneurysm Repair|endovascular abdominal aortic aneurysm repair
5000276|NCT03993496|Ultrasound|ultrasound
5000277|NCT03993496|M-mode|m-mode
5000278|NCT03993496|EVAR|evar
5000279|NCT03993470|pronation|pronation
5000280|NCT03993457|depression|depression
5000281|NCT03993457|mental health|mental health
5000282|NCT03993457|mood disorders|mood disorders
5000283|NCT03993457|major depressive episode|major depressive episode
5000284|NCT03993457|major depressive disorder|major depressive disorder
5000285|NCT03993457|antidepressants|antidepressants
5000286|NCT03993457|escitalopram|escitalopram
5000287|NCT03993457|bupropion|bupropion
5000288|NCT03993457|depression treatment|depression treatment
5000289|NCT03993431|Cementation|cementation
5000290|NCT03993431|Zirconia crowns|zirconia crowns
5000291|NCT03993405|older people|older people
5000292|NCT03993405|muscle|muscle
5000293|NCT03993405|ultrasound|ultrasound
5000294|NCT03993379|Combination|combination
5000295|NCT03993379|ipilimumab|ipilimumab
5000296|NCT03993379|Cancer|cancer
5000297|NCT03993379|checkpoint inhibitor|checkpoint inhibitor
5000298|NCT03993379|PD-L1|pd-l1
5000299|NCT03993379|CTLA-4|ctla-4
5000300|NCT03993379|PROCLAIM|proclaim
5000301|NCT03993379|PROCLAIM-CX-072|proclaim-cx-072
5000302|NCT03993366|type 1 diabetes|type 1 diabetes
5000303|NCT03993366|artificial pancreas|artificial pancreas
5000304|NCT03993366|pramlintide|pramlintide
5000305|NCT03993366|closed-loop|closed-loop
5000306|NCT03993353|cancer|cancer
5000307|NCT03993353|pembrolizumab|pembrolizumab
5000308|NCT03993353|tadalafil|tadalafil
5000309|NCT03993353|cialis|cialis
5000310|NCT03993353|opdivo|opdivo
5000311|NCT03993353|immunotherapy|immunotherapy
5000312|NCT03993353|metastatic|metastatic
5000313|NCT03993353|carcinoma|carcinoma
5000314|NCT03993353|pd-1|pd-1
5000315|NCT03993353|pde|pde
5000316|NCT03993301|Probiotics|probiotics
5000317|NCT03993301|Infant formula|infant formula
5000318|NCT03993301|Gastroenteritis|gastroenteritis
5000319|NCT03993301|Allergy|allergy
5000320|NCT03993301|Respiratory infection|respiratory infection
5000321|NCT03993288|Ferrum Lek® (iron (III) hydroxide polymaltosate), mild and moderate iron-deficiency anaemia|ferrum lek® (iron (iii) hydroxide polymaltosate), mild and moderate iron-deficiency anaemia
5000322|NCT03993275|Trunk Control|trunk control
5000323|NCT03993275|Exergames|exergames
5000324|NCT03993262|autoimmune disease|autoimmune disease
5000325|NCT03993262|autoimmune encephalitis|autoimmune encephalitis
5000326|NCT03993262|bortezomib|bortezomib
5000327|NCT03993262|NMDAR|nmdar
5000328|NCT03993262|LGI1|lgi1
5000329|NCT03993262|encephalitis|encephalitis
5000330|NCT03993236|Stroke, Ischemic|stroke, ischemic
5000331|NCT03993236|Rosuvastatin|rosuvastatin
5000332|NCT03993236|Ezetimibe|ezetimibe
5000333|NCT03993223|Upper trapezius|upper trapezius
5000334|NCT03993223|Myofascial Trigger Point|myofascial trigger point
5000335|NCT03993223|Muscle fatigue|muscle fatigue
5000336|NCT03993223|Overhead athlete|overhead athlete
5000337|NCT03993210|Gynecologic Tumor|gynecologic tumor
5000338|NCT03993197|Endometriosis|endometriosis
5000339|NCT03993197|Pain|pain
5000340|NCT03993197|group management|group management
5000341|NCT03993197|quality of life|quality of life
5000342|NCT03993171|neurodegeneration|neurodegeneration
5000343|NCT03993171|gold|gold
5000344|NCT03993171|nanoparticle|nanoparticle
5000345|NCT03993171|NAD+|nad+
5016435|NCT03894059|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
5000346|NCT03993171|redox|redox
5000347|NCT03993171|31P-MRS|31p-mrs
5000348|NCT03993171|multiple sclerosis|multiple sclerosis
5000349|NCT03993171|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5003338|NCT03975413|FMT|fmt
5000361|NCT03993015|Viable pregnancy|viable pregnancy
5000362|NCT03993015|miscarriage|miscarriage
5000363|NCT03993015|ectopic pregnancy|ectopic pregnancy
5000364|NCT03993015|early pregnancy|early pregnancy
5000365|NCT03993002|Mechanical Ventilation|mechanical ventilation
5000366|NCT03993002|Alevolar stretch|alevolar stretch
5000367|NCT03993002|Hyperoxia|hyperoxia
5000368|NCT03993002|Normoxia|normoxia
5000369|NCT03993002|Hypercarbia|hypercarbia
5000370|NCT03993002|Normocarbia|normocarbia
5000371|NCT03992976|Chronic Pain|chronic pain
5000372|NCT03992976|Paediatric Pain|paediatric pain
5000373|NCT03992976|Pain Management|pain management
5000374|NCT03992976|Qualitative Research|qualitative research
5000375|NCT03992911|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5000376|NCT03992911|Simmtecan|simmtecan
5000377|NCT03992911|Toripalimab|toripalimab
5000378|NCT03992885|the combination therapy of targeted therapy and chemotherapy|the combination therapy of targeted therapy and chemotherapy
5000379|NCT03992885|metastatic non-squamous non-small cell lung cancer with EGFR mutations|metastatic non-squamous non-small cell lung cancer with egfr mutations
5000380|NCT03992885|ectiecinib|ectiecinib
5000381|NCT03992859|regional anesthesia|regional anesthesia
5000382|NCT03992846|Dysmenorrhea|dysmenorrhea
5000383|NCT03992846|Dyspareunia|dyspareunia
5000384|NCT03992846|Dyschezia|dyschezia
5000385|NCT03992846|Non-menstrual pelvic pain|non-menstrual pelvic pain
5000386|NCT03992820|TENS|tens
5000387|NCT03992820|local anaesthetic cream|local anaesthetic cream
5000388|NCT03992820|skin graft donor site|skin graft donor site
5000389|NCT03992794|Sepsis|sepsis
5000390|NCT03992794|Emergency department|emergency department
5000391|NCT03992794|Sepsis biomarkers|sepsis biomarkers
5000392|NCT03992794|MR-proADM|mr-proadm
5000393|NCT03992755|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5000590|NCT03991585|Head Start|head start
5000399|NCT03992742|Smoking cessation|smoking cessation
5000400|NCT03992742|Quit to Win|quit to win
5000401|NCT03992742|Cocktail intervention|cocktail intervention
5000402|NCT03992742|SMART design|smart design
5000403|NCT03992703|Clinical impact|clinical impact
5000404|NCT03992703|Bacteremia|bacteremia
5000405|NCT03992703|Antibiotic|antibiotic
5000406|NCT03992703|Blood cultures|blood cultures
5000407|NCT03992703|Enterobacteriaceae|enterobacteriaceae
5000408|NCT03992703|Staphylococcus aureus|staphylococcus aureus
5000409|NCT03992677|Brugada Syndrome|brugada syndrome
5000410|NCT03992677|Ventricular Ectopic Beat|ventricular ectopic beat
5000411|NCT03992625|Deep brain stimulation|deep brain stimulation
5706748|NCT00476866|tetraplegia|tetraplegia
5000412|NCT03992612|Fibromyalgia|fibromyalgia
5000413|NCT03992612|Chronic Pain|chronic pain
5000414|NCT03992612|Psychological Treatment|psychological treatment
5000415|NCT03992612|Effectiveness|effectiveness
5000416|NCT03992612|CBT|cbt
5000417|NCT03992612|MBPM|mbpm
5000418|NCT03992599|Adenocarcinoma in right colon|adenocarcinoma in right colon
5000419|NCT03992599|mCME|mcme
5000420|NCT03992599|oncologic outcomes|oncologic outcomes
5000421|NCT03992599|right-sided colon cancer|right-sided colon cancer
5000422|NCT03992547|funcional near infrared spectroscopy|funcional near infrared spectroscopy
5000423|NCT03992547|Robot-assisted gait training|robot-assisted gait training
5000424|NCT03992534|Pregnancy|pregnancy
5000425|NCT03992534|Preterm labour|preterm labour
5000426|NCT03992534|Preterm delivery|preterm delivery
5000427|NCT03992534|Vaginal microbiome|vaginal microbiome
5000428|NCT03992534|Infection|infection
5000429|NCT03992534|Next generation sequencing|next generation sequencing
5000430|NCT03992534|Lactobacillus|lactobacillus
5000431|NCT03992495|Exercise|exercise
5000432|NCT03992495|Neck pain|neck pain
5000433|NCT03992495|Pain sensitivity|pain sensitivity
5000434|NCT03992482|Dry Eye|dry eye
5000435|NCT03992482|Intravenous Immunoglobulin (IVIG) Eye Drops|intravenous immunoglobulin (ivig) eye drops
5000436|NCT03992482|Treatment|treatment
5000437|NCT03992482|ocular Graft-vs-Host Disease (oGVHD)|ocular graft-vs-host disease (ogvhd)
5000443|NCT03992443|CVAD|cvad
5000444|NCT03992443|CUSA-081|cusa-081
5000445|NCT03992443|reteplase|reteplase
5000446|NCT03992430|Duchenne muscular dystrophy|duchenne muscular dystrophy
5000447|NCT03992430|Exon Skipping|exon skipping
5000448|NCT03992430|Exon 51|exon 51
5356786|NCT01918007|Respiration Disorders|respiration disorders
5000449|NCT03992430|North Star Ambulatory Assessment|north star ambulatory assessment
5000450|NCT03992430|Ambulatory|ambulatory
5000451|NCT03992430|DMD|dmd
5000464|NCT03992235|chest physiotherapy|chest physiotherapy
5000465|NCT03992235|physiotherapy|physiotherapy
5000466|NCT03992235|education|education
5000467|NCT03992235|educational material|educational material
5000468|NCT03992235|thoracotomy|thoracotomy
5000469|NCT03992235|chest|chest
5000470|NCT03992235|surgery|surgery
5000471|NCT03992235|lung|lung
5000472|NCT03992235|exercise|exercise
5418274|NCT01639677|VBG|vbg
5000473|NCT03992196|RLS|rls
5000474|NCT03992196|Neupro|neupro
5000475|NCT03992196|Rotigotine|rotigotine
5000476|NCT03992183|CAML|caml
5000477|NCT03992183|Early Detection|early detection
5000478|NCT03992170|Myeloma Multiple|myeloma multiple
5000479|NCT03992170|Daratumumab|daratumumab
5000480|NCT03992157|stroke|stroke
5000481|NCT03992157|ECG|ecg
5000482|NCT03992157|telemetry|telemetry
5000483|NCT03992157|atrial fibrillation|atrial fibrillation
5000484|NCT03992144|dry socket|dry socket
5000485|NCT03992144|metronidazole|metronidazole
5000486|NCT03992144|amoxicillin|amoxicillin
5000487|NCT03992144|lower 3rd molars|lower 3rd molars
5000489|NCT03992066|Anemia|anemia
5000490|NCT03992066|Chronic kidney disease|chronic kidney disease
5000491|NCT03992066|Vadadustat|vadadustat
5000492|NCT03992066|Hemodialysis|hemodialysis
5000504|NCT03992014|GSK2330672|gsk2330672
5000505|NCT03992014|Microtracer dose|microtracer dose
5000506|NCT03992001|Packed RBCs|packed rbcs
5000507|NCT03992001|leukodepletion|leukodepletion
5000508|NCT03992001|buffy-coat|buffy-coat
5000509|NCT03992001|transfusion|transfusion
5000510|NCT03991988|Alzheimer|alzheimer
5000515|NCT03991923|Non Ischemic Heart Preservation (NIHP)|non ischemic heart preservation (nihp)
5000516|NCT03991923|Ischemic cold static storage of donor hearts (ICSS)|ischemic cold static storage of donor hearts (icss)
5000517|NCT03991910|Rheumatic Heart Disease|rheumatic heart disease
5000518|NCT03991910|Mitral Stenosis|mitral stenosis
5000519|NCT03991910|Rheumatic Mitral Stenosis|rheumatic mitral stenosis
5000520|NCT03991910|Valve Fibrosis|valve fibrosis
5000521|NCT03991910|ramipril|ramipril
5000522|NCT03991910|ST2|st2
5000523|NCT03991871|Refractory Angina|refractory angina
5000524|NCT03991871|Angiogenesis|angiogenesis
5000525|NCT03991871|External Counterpulsation|external counterpulsation
5000526|NCT03991871|Angiopoietin|angiopoietin
5000531|NCT03991793|Granzyme A|granzyme a
5000532|NCT03991793|Sepsis|sepsis
5000533|NCT03991793|Pathogenesis|pathogenesis
5000534|NCT03991793|Escherichia coli Bloodstream Infection|escherichia coli bloodstream infection
5000535|NCT03991793|Immunopathology|immunopathology
5000536|NCT03991780|Renal transplant rejection|renal transplant rejection
5000537|NCT03991780|donor specific antibody|donor specific antibody
5000538|NCT03991780|antibody mediated rejection|antibody mediated rejection
5000539|NCT03991780|spleen tyrosine kinase|spleen tyrosine kinase
5000540|NCT03991780|fostamatinib|fostamatinib
5000541|NCT03991767|medical practices|medical practices
5000543|NCT03991767|Electronic Alert|electronic alert
5000544|NCT03991741|melanoma|melanoma
5000545|NCT03991741|metastatic|metastatic
5000546|NCT03991741|head and neck cancer|head and neck cancer
5000547|NCT03991741|solid tumor|solid tumor
5000548|NCT03991741|adoptive cell therapy|adoptive cell therapy
5000549|NCT03991741|autologous|autologous
5000550|NCT03991741|locally advanced refractory/recurrent melanoma|locally advanced refractory/recurrent melanoma
5000551|NCT03991741|locally advanced refractory/recurrent head and neck cancer|locally advanced refractory/recurrent head and neck cancer
5000552|NCT03991741|IL-2|il-2
5000553|NCT03991728|Temporomandibular joint|temporomandibular joint
5000554|NCT03991728|TMJ replacement|tmj replacement
5000555|NCT03991728|Trauma|trauma
5000556|NCT03991728|Ankylosis|ankylosis
5000557|NCT03991728|Degenerative joint disease|degenerative joint disease
5000558|NCT03991728|Registry|registry
5000559|NCT03991689|spinal cord injury|spinal cord injury
5000560|NCT03991689|pain management|pain management
5000561|NCT03991689|pain intensity|pain intensity
5000562|NCT03991689|pain self-efficacy|pain self-efficacy
5000563|NCT03991689|solution-focused group therapy|solution-focused group therapy
5000564|NCT03991676|Obesity|obesity
5000565|NCT03991676|Weight Loss|weight loss
5000566|NCT03991676|Behavioral treatment|behavioral treatment
5000567|NCT03991676|Values|values
5000568|NCT03991676|Values-based behavior change|values-based behavior change
5000569|NCT03991676|Autonomous motivation|autonomous motivation
5000570|NCT03991676|Acceptance and Commitment Therapy|acceptance and commitment therapy
5000571|NCT03991650|wearable|wearable
5000572|NCT03991650|sensor|sensor
5000573|NCT03991650|anxiety|anxiety
5000574|NCT03991650|monitoring|monitoring
5000575|NCT03991650|ehealth|ehealth
5000581|NCT03991611|Post-traumatic stress disorder|post-traumatic stress disorder
5000582|NCT03991611|Discomfort|discomfort
5000583|NCT03991611|Tailored program|tailored program
5000584|NCT03991611|Patient-reported outcome|patient-reported outcome
5000585|NCT03991611|ICU|icu
5000586|NCT03991598|Frail|frail
5000587|NCT03991598|Prefrail|prefrail
5000588|NCT03991598|Mobile decline|mobile decline
5000589|NCT03991585|At-risk preschoolers|at-risk preschoolers
5000596|NCT03991546|Opioid Pain Medication|opioid pain medication
5000598|NCT03991429|Voiding dysfunction|voiding dysfunction
5000599|NCT03991429|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5000600|NCT03991429|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5000601|NCT03991429|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5000602|NCT03991429|Urodynamic studies|urodynamic studies
5000603|NCT03991416|Universal|universal
5320249|NCT02083679|Sym004|sym004
5000604|NCT03991416|Prevention|prevention
5000605|NCT03991416|Parental competence|parental competence
5000606|NCT03991416|Socioemotional|socioemotional
5000607|NCT03991416|Public health nurses|public health nurses
5000608|NCT03991390|Pusher syndrome|pusher syndrome
5000609|NCT03991390|Core stability|core stability
5000610|NCT03991390|Visual feedback|visual feedback
5000611|NCT03991390|Postural control|postural control
5000612|NCT03991390|Balance|balance
5000613|NCT03991390|Rehabilitation stroke|rehabilitation stroke
5000614|NCT03991377|First psychotic episode, psychological trauma, EMDR therapy, Treatment as usual|first psychotic episode, psychological trauma, emdr therapy, treatment as usual
5000615|NCT03991364|Robot-assisted gait training|robot-assisted gait training
5000616|NCT03991364|stroke|stroke
5000617|NCT03991364|gait speed|gait speed
5000618|NCT03991351|Body Image|body image
5000619|NCT03991351|Mood, anxiety, depression|mood, anxiety, depression
5000620|NCT03991351|Self-esteem|self-esteem
5000621|NCT03991351|Body Dysmorphia|body dysmorphia
5000622|NCT03991351|Men|men
5000623|NCT03991351|Deit|deit
5000624|NCT03991351|Exercise|exercise
5000625|NCT03991286|PCOS|pcos
5000626|NCT03991286|Astaxanthin|astaxanthin
5000627|NCT03991286|ROS|ros
5000628|NCT03991273|disability|disability
5000629|NCT03991273|disabilities|disabilities
5000630|NCT03991273|teleexercise|teleexercise
5000631|NCT03991273|movement-to-music|movement-to-music
5000632|NCT03991273|physical activity|physical activity
5000633|NCT03991260|99mTc-ADAPT6|99mtc-adapt6
5000634|NCT03991260|Breast Cancer|breast cancer
5000635|NCT03991260|HER2 expression|her2 expression
5000636|NCT03991247|Spa treatment|spa treatment
5000637|NCT03991247|Cognitive Behavioral Therapy|cognitive behavioral therapy
5000638|NCT03991247|Internet delivered self-help program|internet delivered self-help program
5000639|NCT03991247|Insomnia|insomnia
5000640|NCT03991247|Sleep restriction|sleep restriction
5000641|NCT03991247|stimulus control|stimulus control
5000642|NCT03991247|crenotherapy|crenotherapy
5000643|NCT03991221|Prevention|prevention
5000644|NCT03991221|Early treatment|early treatment
5000645|NCT03991221|Skeletal discrepancy|skeletal discrepancy
5000646|NCT03991221|Malocclusion|malocclusion
5000647|NCT03991208|Pharmacokinetics|pharmacokinetics
5000648|NCT03991208|Exercise|exercise
5000649|NCT03991208|Malaria Prophylaxis|malaria prophylaxis
5000650|NCT03991208|Bioequivalence|bioequivalence
5000651|NCT03991208|Bioavailability|bioavailability
5000652|NCT03991195|mild cognitive impairment|mild cognitive impairment
5000653|NCT03991195|intestinal microorganism|intestinal microorganism
5000654|NCT03991195|regulation|regulation
5000655|NCT03991195|magnetic resonance imaging|magnetic resonance imaging
5000656|NCT03991182|Community based parenting|community based parenting
5000657|NCT03991182|Developmental outcomes|developmental outcomes
5000658|NCT03991182|Maternity waiting homes (MWHs)|maternity waiting homes (mwhs)
5000659|NCT03991182|Safe Motherhood Action Group leaders (SMAGs)|safe motherhood action group leaders (smags)
5000660|NCT03991182|Zambia|zambia
5000661|NCT03991169|Anemia|anemia
5000662|NCT03991169|Iron|iron
5000663|NCT03991169|Children|children
5000664|NCT03991169|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
5000665|NCT03991169|Appetite|appetite
5000666|NCT03991169|Physical activity|physical activity
5000667|NCT03991169|Muscle strength|muscle strength
5000669|NCT03991130|melanoma|melanoma
5000670|NCT03991130|renal cell carcinoma|renal cell carcinoma
5000671|NCT03991117|muscle fibre activation|muscle fibre activation
5000672|NCT03991117|electromyography|electromyography
5000673|NCT03991104|esophageal cancer|esophageal cancer
5000674|NCT03991104|chemoradiotherapy|chemoradiotherapy
5000675|NCT03991104|oxaliplatin|oxaliplatin
5000676|NCT03991104|S-1|s-1
5000682|NCT03991039|Trigeminal neuralgia, treatment|trigeminal neuralgia, treatment
5000687|NCT03991000|Acute myocardial infarction|acute myocardial infarction
5000688|NCT03991000|Systolic heart failure|systolic heart failure
5000693|NCT03990987|general anesthesia|general anesthesia
5000695|NCT03990883|nasolabial folds|nasolabial folds
5000696|NCT03990883|correction|correction
5000697|NCT03990857|comorbidities comprehensive care|comorbidities comprehensive care
5000703|NCT03990831|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5000704|NCT03990805|Stem Cell|stem cell
5000705|NCT03990805|Adipose tissue derived mesenchymal stem cell|adipose tissue derived mesenchymal stem cell
5000706|NCT03990805|osteoarthritis|osteoarthritis
5000707|NCT03990805|degenerative arthritis|degenerative arthritis
5000708|NCT03990805|biostar|biostar
5000709|NCT03990805|Rbio|rbio
5000710|NCT03990792|Depression|depression
5000711|NCT03990792|Primary Prevention|primary prevention
5000712|NCT03990792|Primary Health Care|primary health care
5000713|NCT03990792|Randomized controlled trial|randomized controlled trial
5000714|NCT03990792|mHealth|mhealth
5000716|NCT03990766|Olfactory dysfunction|olfactory dysfunction
5000718|NCT03990766|Hyposmia|hyposmia
5000719|NCT03990766|Post-viral|post-viral
5000720|NCT03990766|Theophylline|theophylline
5000721|NCT03990766|Adverse effects|adverse effects
5000722|NCT03990766|Smell|smell
5000723|NCT03990753|Microbiome/Peptidome|microbiome/peptidome
5000724|NCT03990753|High-risk Gastroesophageal Varices|high-risk gastroesophageal varices
5000725|NCT03990753|Compensated Cirrhosis|compensated cirrhosis
5000726|NCT03990740|Metalloproteinase|metalloproteinase
5000727|NCT03990740|Glycoprotein|glycoprotein
5000728|NCT03990740|Cornea|cornea
5000729|NCT03990740|Direct epithelial-stromal interactions|direct epithelial-stromal interactions
5000730|NCT03990740|Fibroblasts|fibroblasts
5000731|NCT03990740|Myofibroblasts|myofibroblasts
5000732|NCT03990714|Right hemicolectomy|right hemicolectomy
5000733|NCT03990714|Intracorporeal anastomosis|intracorporeal anastomosis
5000734|NCT03990714|Extracorporeal anastomosis|extracorporeal anastomosis
5000735|NCT03990714|Laparoscopy|laparoscopy
5000736|NCT03990701|11-C Metomidate PET/CT|11-c metomidate pet/ct
5000737|NCT03990701|Hypertension|hypertension
5000738|NCT03990701|Adrenalectomy|adrenalectomy
5000739|NCT03990701|Adrenal Vein Sampling|adrenal vein sampling
5000740|NCT03990701|Subtyping|subtyping
5000741|NCT03990662|Temporomandibular Joint Dysfunction Syndrome|temporomandibular joint dysfunction syndrome
5000742|NCT03990662|Manual Therapy|manual therapy
5000743|NCT03990662|Prediction|prediction
5000744|NCT03990662|Pain|pain
5000745|NCT03990649|Drug Therapy|drug therapy
5000746|NCT03990636|PDT|pdt
5000747|NCT03990636|Actinic Cheilitis|actinic cheilitis
5000748|NCT03990636|Phase 2 Clinical Trial|phase 2 clinical trial
5000749|NCT03990584|Chronic apical periodontitis|chronic apical periodontitis
5000750|NCT03990584|irrigation activation methods|irrigation activation methods
5000751|NCT03990584|periapical index|periapical index
5000752|NCT03990584|postoperative pain|postoperative pain
5000753|NCT03990584|treatment outcome|treatment outcome
5000754|NCT03990545|intracranial atherosclerotic disease|intracranial atherosclerotic disease
5000755|NCT03990545|acute stroke|acute stroke
5000756|NCT03990545|transient ischemic attack|transient ischemic attack
5000757|NCT03990545|vessel wall imaging|vessel wall imaging
5000758|NCT03990454|AXL Inhibitor|axl inhibitor
5000759|NCT03990454|Solid Tumor|solid tumor
5000760|NCT03990428|Supportive care|supportive care
5000761|NCT03990428|Erdheim-Chester Disease|erdheim-chester disease
5000762|NCT03990428|Other Histiocytic Diseases|other histiocytic diseases
5000763|NCT03990428|19-213|19-213
5000764|NCT03990415|Elderly|elderly
5000765|NCT03990415|Balance|balance
5000766|NCT03990415|Strength Training|strength training
5000767|NCT03990402|FeNO|feno
5000768|NCT03990402|Africa|africa
5000769|NCT03990402|Spirometry|spirometry
5000770|NCT03990402|Asthma Control|asthma control
5000771|NCT03990402|ACT|act
5000772|NCT03990402|Prevalence|prevalence
5000773|NCT03990376|Scoliosis|scoliosis
5000774|NCT03990376|Pediatric surgery|pediatric surgery
5000775|NCT03990376|Orthopedics|orthopedics
5000776|NCT03990376|Blood loss|blood loss
5000777|NCT03990363|Chronic Kidney Disease|chronic kidney disease
5000778|NCT03990350|Gut Microbiome|gut microbiome
5000779|NCT03990337|Ultrasound|ultrasound
5000780|NCT03990337|Cricoid Cartilage|cricoid cartilage
5000781|NCT03990337|Cricoid Pressure|cricoid pressure
5000782|NCT03990337|General Anesthesia|general anesthesia
5000783|NCT03990337|Endotracheal Intubation|endotracheal intubation
5000784|NCT03990324|range of motion|range of motion
5000785|NCT03990324|muscle sensitivity|muscle sensitivity
5000786|NCT03990324|muscle stretching|muscle stretching
5000787|NCT03990259|Ultraendurance|ultraendurance
5000791|NCT03990259|Physiological damage|physiological damage
5000992|NCT03989115|SHP2|shp2
5000797|NCT03990220|Lactobacillus rhamnosus yoba 2012|lactobacillus rhamnosus yoba 2012
5000798|NCT03990220|Skin diseases|skin diseases
5000799|NCT03990220|Respiratory Tract Infections|respiratory tract infections
5000800|NCT03990220|School absenteeism|school absenteeism
5000801|NCT03990220|Diarrhea|diarrhea
5000802|NCT03990220|Anthropometric indicators|anthropometric indicators
5000803|NCT03990129|Metamizole|metamizole
5000804|NCT03990129|Dipyrone|dipyrone
5000806|NCT03990129|Drug-Drug Interaction|drug-drug interaction
5000807|NCT03990129|Phenotyping|phenotyping
5000808|NCT03990116|Patient Positioning|patient positioning
5000809|NCT03990116|Kangaroo-Mother Care Method|kangaroo-mother care method
5000810|NCT03990116|skin to skin|skin to skin
5000811|NCT03990116|Extremely Premature infant|extremely premature infant
5000812|NCT03990103|Gastric Carcinoma|gastric carcinoma
5000813|NCT03990103|Malignant Ascites|malignant ascites
5000814|NCT03990103|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
5000815|NCT03990103|Bevacizumab|bevacizumab
5000816|NCT03990090|TG103|tg103
5000817|NCT03990090|Pharmacokinetic|pharmacokinetic
5000818|NCT03990090|Pharmacodynamic|pharmacodynamic
5000819|NCT03990090|Safety|safety
5000820|NCT03990090|Tolerability|tolerability
5000821|NCT03990064|effective connectomic neurological soft signs|effective connectomic neurological soft signs
5000823|NCT03989973|Liver cirrhosis|liver cirrhosis
5000824|NCT03989973|Esophageal Varices|esophageal varices
5000825|NCT03989973|Liver Stiffness|liver stiffness
5000826|NCT03989973|Spleen Stiffness|spleen stiffness
5000827|NCT03989960|InSurE|insure
5000828|NCT03989960|LISA|lisa
5000829|NCT03989960|SNIPPV|snippv
5000830|NCT03989947|Dwarfism|dwarfism
5000831|NCT03989947|Bone Disease|bone disease
5000833|NCT03989947|Natriuretic Peptide C-Type|natriuretic peptide c-type
5000834|NCT03989947|Musculoskeletal Diseases|musculoskeletal diseases
5000835|NCT03989947|Skeletal Dysplasias|skeletal dysplasias
5000836|NCT03989934|mindfulness; stress physiology; urban youth|mindfulness; stress physiology; urban youth
5000837|NCT03989908|microfludic|microfludic
5000838|NCT03989882|wheat germ|wheat germ
5000839|NCT03989882|overweight|overweight
5000840|NCT03989882|gut microbiome|gut microbiome
5000841|NCT03989882|inflammation|inflammation
5000842|NCT03989882|insulin resistance|insulin resistance
5000843|NCT03989843|ART|art
5000844|NCT03989843|Birthweight|birthweight
5000845|NCT03989843|Siblings|siblings
5000846|NCT03989843|Cryopreservation|cryopreservation
5000847|NCT03989843|Epigenetic|epigenetic
5000848|NCT03989843|Medical assistance to procreation|medical assistance to procreation
5000849|NCT03989830|Endostatins|endostatins
5000850|NCT03989830|Head and Neck Neoplasms|head and neck neoplasms
5000851|NCT03989804|Fitness center|fitness center
5000852|NCT03989804|Physical activity|physical activity
5000853|NCT03989804|Follow-up|follow-up
5000854|NCT03989804|Members|members
5000855|NCT03989804|Visits|visits
5000856|NCT03989804|Membership terminations|membership terminations
5000857|NCT03989804|Training advisors|training advisors
5000858|NCT03989752|Assistive Technology|assistive technology
5000859|NCT03989752|Locomotion|locomotion
5000860|NCT03989752|Rehabilitation|rehabilitation
5000861|NCT03989752|Robotics|robotics
5000862|NCT03989739|Cost-effectiveness|cost-effectiveness
5000863|NCT03989739|Pancreatectomy|pancreatectomy
5000864|NCT03989739|Willingness to pay|willingness to pay
5000865|NCT03989739|Robotic|robotic
5000866|NCT03989700|Diuretic drugs|diuretic drugs
5000867|NCT03989700|Thiamin deficiency|thiamin deficiency
5000872|NCT03989635|QAW039|qaw039
5000873|NCT03989635|Asthma|asthma
5000874|NCT03989635|Sputum|sputum
5000875|NCT03989635|Eosinophilia|eosinophilia
5000876|NCT03989635|eosinophillic|eosinophillic
5000877|NCT03989635|Prostaglandin D2 receptor|prostaglandin d2 receptor
5000878|NCT03989635|DP2|dp2
5000879|NCT03989635|Fevipiprant.|fevipiprant.
5000880|NCT03989622|Retinitis Pigmentosa|retinitis pigmentosa
5000881|NCT03989596|Dose Hypofractionation|dose hypofractionation
5000882|NCT03989596|Neoadjuvant Therapy|neoadjuvant therapy
5000883|NCT03989596|Sarcoma|sarcoma
5000884|NCT03989596|Hyperthermia|hyperthermia
5000885|NCT03989596|Dose Fractionation|dose fractionation
5000886|NCT03989583|Thermography|thermography
5000887|NCT03989583|Children|children
5000888|NCT03989583|Foot|foot
5000889|NCT03989583|Shoes|shoes
5000890|NCT03989570|Erector Spinae Plane Block|erector spinae plane block
5000891|NCT03989570|Transversus Abdominis Plane Block|transversus abdominis plane block
5000892|NCT03989557|Platelet function test|platelet function test
5000893|NCT03989557|high platelet reactivity|high platelet reactivity
5000993|NCT03989115|PTPN11|ptpn11
5000903|NCT03989531|Endothelial dysfunction|endothelial dysfunction
5016934|NCT03890484|Alcohol use|alcohol use
5000904|NCT03989518|Imaginal extinction, imaginal exposure, mental imagery|imaginal extinction, imaginal exposure, mental imagery
5000905|NCT03989505|CIN|cin
5000906|NCT03989505|Coronary Angiography|coronary angiography
5000907|NCT03989505|Contrast|contrast
5000908|NCT03989505|Angiography|angiography
5000909|NCT03989492|autonomic nervous system|autonomic nervous system
5000910|NCT03989492|skin blood flow|skin blood flow
5000911|NCT03989492|skin sympathetic nerve activity|skin sympathetic nerve activity
5000912|NCT03989479|toothbrush|toothbrush
5000913|NCT03989479|plaque removal|plaque removal
5000914|NCT03989479|gingival health|gingival health
5000915|NCT03989440|myelin-associated inhibitor|myelin-associated inhibitor
5000916|NCT03989440|Nogo-A|nogo-a
5000917|NCT03989440|MAG|mag
5000918|NCT03989440|OMgp|omgp
5000919|NCT03989440|Nogo Receptor|nogo receptor
5356787|NCT01918007|Respiratory Tract Diseases|respiratory tract diseases
5000932|NCT03989414|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5000933|NCT03989414|Multiple Myeloma|multiple myeloma
5000934|NCT03989414|CC-92480|cc-92480
5000935|NCT03989401|Nurse|nurse
5000936|NCT03989401|Workload|workload
5000937|NCT03989401|Multimedia|multimedia
5000938|NCT03989401|Patients Satisfaction|patients satisfaction
5000939|NCT03989401|Surgery|surgery
5000940|NCT03989401|Health Education|health education
5000941|NCT03989375|postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5000942|NCT03989375|hip- and knee arthroplasty|hip- and knee arthroplasty
5000943|NCT03989375|transcutaneous vagus nerve stimulation|transcutaneous vagus nerve stimulation
5000944|NCT03989362|ICOS|icos
5000945|NCT03989362|ICOS agonist monoclonal antibody|icos agonist monoclonal antibody
5000946|NCT03989362|JTX-2011|jtx-2011
5000947|NCT03989362|Vopratelimab|vopratelimab
5000948|NCT03989362|Anti-CTLA-4|anti-ctla-4
5000949|NCT03989362|Ipilimumab|ipilimumab
5000950|NCT03989362|EMERGE|emerge
5000951|NCT03989362|Immunotherapy|immunotherapy
5000952|NCT03989362|Immuno-Oncology|immuno-oncology
5000953|NCT03989362|Cancer|cancer
5000954|NCT03989362|Non-small Cell Lung Cancer|non-small cell lung cancer
5000955|NCT03989362|Urothelial Cancer|urothelial cancer
5000956|NCT03989336|relapsed|relapsed
5000957|NCT03989336|refractory|refractory
5000958|NCT03989336|anti-PD-1 antibody|anti-pd-1 antibody
5000959|NCT03989336|Manganese|manganese
5000960|NCT03989336|chemotherapy|chemotherapy
5000961|NCT03989310|local advanced|local advanced
5000962|NCT03989310|metastatic|metastatic
5000963|NCT03989310|anti-PD-1 antibody|anti-pd-1 antibody
5000964|NCT03989310|Manganese|manganese
5000965|NCT03989310|chemotherapy|chemotherapy
5000966|NCT03989297|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5000967|NCT03989297|programmed death-ligand 1|programmed death-ligand 1
5000968|NCT03989297|prognosis|prognosis
5000969|NCT03989271|Inflammation|inflammation
5000970|NCT03989271|Oxidative stress|oxidative stress
5000971|NCT03989271|Plant polyphenol|plant polyphenol
5000972|NCT03989271|Flavonols|flavonols
5000973|NCT03989258|Breast cancer|breast cancer
5000974|NCT03989258|Screening|screening
5000975|NCT03989258|Genetic risk|genetic risk
5000976|NCT03989258|Polygenic risk score|polygenic risk score
5000977|NCT03989245|Severe disruptive behaviour disorders|severe disruptive behaviour disorders
5000978|NCT03989245|Cognitive Behavioural Unit|cognitive behavioural unit
5000979|NCT03989245|Geriatric Follow-up and Rehabilitation Care Unit|geriatric follow-up and rehabilitation care unit
5000980|NCT03989219|cfDNA methylation|cfdna methylation
5000981|NCT03989219|CT follow-up|ct follow-up
5000982|NCT03989219|plasma|plasma
5000983|NCT03989219|pulmonary nodule|pulmonary nodule
5000984|NCT03989167|Hypercholesterolemia, Familial|hypercholesterolemia, familial
5000985|NCT03989167|Primary care|primary care
5000986|NCT03989167|Clinical decision support|clinical decision support
5000987|NCT03989141|Buttonhole cannulation|buttonhole cannulation
5000988|NCT03989141|Cannulation technique|cannulation technique
5000989|NCT03989141|Dialysis access|dialysis access
5000990|NCT03989141|Hemodialysis|hemodialysis
5000991|NCT03989141|Arterio venous fistula|arterio venous fistula
5000999|NCT03989115|KRAS mutations|kras mutations
5001000|NCT03989115|advanced solid tumor|advanced solid tumor
5001001|NCT03989115|advanced solid malignancies|advanced solid malignancies
5001002|NCT03989115|melanoma|melanoma
5001003|NCT03989115|skin cancer|skin cancer
5001004|NCT03989115|ovarian cancer|ovarian cancer
5001005|NCT03989115|pancreatic cancer|pancreatic cancer
5001006|NCT03989115|endometrium/uterus cancer|endometrium/uterus cancer
5001007|NCT03989115|bladder cancer|bladder cancer
5001008|NCT03989115|cervical cancer|cervical cancer
5001009|NCT03989115|carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
5001010|NCT03989115|neoplasm, squamous cell|neoplasm, squamous cell
5001011|NCT03989115|carcinoma, squamous cell|carcinoma, squamous cell
5001012|NCT03989115|esophageal neoplasms carcinoma, bronchogenic|esophageal neoplasms carcinoma, bronchogenic
5001013|NCT03989115|bronchial neoplasms|bronchial neoplasms
5001014|NCT03989115|lung neoplasms|lung neoplasms
5001015|NCT03989115|respiratory tract neoplasms|respiratory tract neoplasms
5001016|NCT03989115|thoracic neoplasms|thoracic neoplasms
5001017|NCT03989115|neoplasms by site|neoplasms by site
5001018|NCT03989115|neoplasms|neoplasms
5001031|NCT03989063|Diabetes|diabetes
5001033|NCT03989050|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5001034|NCT03989050|Pneumococcal Vaccination|pneumococcal vaccination
5001035|NCT03989011|Functional response|functional response
5001036|NCT03989011|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5001037|NCT03989011|Cardiovascular events|cardiovascular events
5001038|NCT03988985|Depression|depression
5001039|NCT03988985|Screening|screening
5001040|NCT03988985|Primary Care|primary care
5001041|NCT03988985|General Practice|general practice
5001042|NCT03988985|Feedback|feedback
5001048|NCT03988881|Dobutamine stress echocardiography|dobutamine stress echocardiography
5001049|NCT03988881|Fractional flow reserve|fractional flow reserve
5001050|NCT03988881|Computed tomography-fractional flow reserve|computed tomography-fractional flow reserve
5001051|NCT03988881|Non-culprit lesions|non-culprit lesions
5001052|NCT03988881|Myocardial infarction|myocardial infarction
5001053|NCT03988881|Lesion specific ischemia|lesion specific ischemia
5001054|NCT03988868|optic nerve sheath diameter|optic nerve sheath diameter
5001055|NCT03988868|end-tidal carbon dioxide|end-tidal carbon dioxide
5001056|NCT03988868|trans-orbital ultrasonography|trans-orbital ultrasonography
5001057|NCT03988829|randomized control trial|randomized control trial
5001058|NCT03988829|cognitive training|cognitive training
5001059|NCT03988829|simulation games|simulation games
5001060|NCT03988829|improving brain function|improving brain function
5001061|NCT03988829|improving cognition|improving cognition
5001062|NCT03988829|functional magnetic resonance imaging|functional magnetic resonance imaging
5001063|NCT03988816|bronchiectasis|bronchiectasis
5001064|NCT03988816|lung function|lung function
5001065|NCT03988816|quality of life|quality of life
5001066|NCT03988816|mucus properties|mucus properties
5001067|NCT03988777|Breast cancer|breast cancer
5001068|NCT03988777|Nonpalpable breast lesions|nonpalpable breast lesions
5001069|NCT03988777|Hooked-wire localisation|hooked-wire localisation
5001070|NCT03988777|Magnetic seed localisation|magnetic seed localisation
5001071|NCT03988738|Blood Donors|blood donors
5001072|NCT03988738|Social Media|social media
5001073|NCT03988738|Blood Donation|blood donation
5001074|NCT03988738|Facebook|facebook
5001075|NCT03988738|WhatsApp|whatsapp
5001077|NCT03988712|colorectal cancer|colorectal cancer
5001078|NCT03988712|Iron deficiency anaemia|iron deficiency anaemia
5001079|NCT03988686|oligometastasis|oligometastasis
5001080|NCT03988686|prostate cancer|prostate cancer
5001081|NCT03988686|radical prostatectomy|radical prostatectomy
5001082|NCT03988686|progression-free survival|progression-free survival
5001083|NCT03988686|quality of life|quality of life
5001084|NCT03988660|Appendicitis|appendicitis
5001085|NCT03988660|Fibrocytes|fibrocytes
5001086|NCT03988660|Biomarker|biomarker
5001087|NCT03988634|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5001088|NCT03988634|Heart failure hospitalization|heart failure hospitalization
5001093|NCT03988634|Global evaluation of treatment effectiveness (GETE)|global evaluation of treatment effectiveness (gete)
5001094|NCT03988621|Self-care|self-care
5001095|NCT03988621|Self-efficacy|self-efficacy
5001096|NCT03988621|Heart Failure|heart failure
5001097|NCT03988621|Stress|stress
5001098|NCT03988621|Support Systems|support systems
5001099|NCT03988608|Severe Aplastic Anemia|severe aplastic anemia
5001100|NCT03988608|Eltrombopag|eltrombopag
5001101|NCT03988608|ETB115|etb115
5001102|NCT03988608|Chinese subject|chinese subject
5001103|NCT03988608|Chinese refractory or relapsed SAA subjects|chinese refractory or relapsed saa subjects
5001104|NCT03988608|refractory severe aplastic anemia|refractory severe aplastic anemia
5001105|NCT03988608|relapsed severe aplastic anemia|relapsed severe aplastic anemia
5001111|NCT03988556|Photobiomodulation|photobiomodulation
5001112|NCT03988556|Oral Mucositis|oral mucositis
5001113|NCT03988556|Radiation Dermatitis|radiation dermatitis
5001114|NCT03988556|Radiotherapy|radiotherapy
5001115|NCT03988556|Head and neck cancer|head and neck cancer
5001116|NCT03988556|Breast cancer|breast cancer
5001117|NCT03988543|Curative Intent|curative intent
5001118|NCT03988543|Non-curative Intent|non-curative intent
5001126|NCT03988491|Observational Study|observational study
5001127|NCT03988491|Incidence|incidence
5001128|NCT03988491|Renal Dialysis|renal dialysis
5001129|NCT03988465|Viscoelastic testing|viscoelastic testing
5001130|NCT03988465|Coagulation|coagulation
5001131|NCT03988465|Quantra|quantra
5001132|NCT03988465|Hemostasis|hemostasis
5001133|NCT03988439|Plaque psoriasis|plaque psoriasis
5001134|NCT03988400|stroke|stroke
5001135|NCT03988400|gait|gait
5001136|NCT03988387|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5001137|NCT03988387|HIV prevention|hiv prevention
5001138|NCT03988387|Adherence|adherence
5001139|NCT03988335|PPP|ppp
5001140|NCT03988296|Monkey malaria|monkey malaria
5001141|NCT03988270|Hemodialysis|hemodialysis
5001142|NCT03988270|Fistula|fistula
5001143|NCT03988270|Access Failure|access failure
5001144|NCT03988270|Hemodialysis Fistula Creation|hemodialysis fistula creation
5001145|NCT03988257|Acute diarrhoea|acute diarrhoea
5001146|NCT03988257|Infectious diarrhoea|infectious diarrhoea
5001147|NCT03988257|Pleuran|pleuran
5001148|NCT03988257|Beta-glucan|beta-glucan
5001149|NCT03988257|Duration of diarrhoea|duration of diarrhoea
5001150|NCT03988257|Severity of diarrhoea|severity of diarrhoea
5001151|NCT03988257|Randomized Controlled Trails as Topic|randomized controlled trails as topic
5001153|NCT03988218|Interoceptive awareness|interoceptive awareness
5001154|NCT03988218|Anorexia Nervosa|anorexia nervosa
5042336|NCT03734562|ICD|icd
5001155|NCT03988218|Adolescent|adolescent
5001156|NCT03988218|Body image|body image
5001157|NCT03988205|Acute Myeloid Leukemia|acute myeloid leukemia
5001158|NCT03988205|Outpatient|outpatient
5001159|NCT03988205|CPX-351|cpx-351
5001160|NCT03988205|VYXEOS|vyxeos
5001161|NCT03988179|Attention|attention
5001162|NCT03988179|Attentional dysfunction|attentional dysfunction
5001163|NCT03988179|Delirium|delirium
5001164|NCT03988179|Preoperative|preoperative
5001165|NCT03988166|Chronic Total Occlusion|chronic total occlusion
5001166|NCT03988166|Percutaneous revascularization|percutaneous revascularization
5001167|NCT03988153|Probiotics|probiotics
5001168|NCT03988153|cholesterol|cholesterol
5001169|NCT03988153|LDL-c|ldl-c
5001170|NCT03988153|Hypercholesterolemic|hypercholesterolemic
5001171|NCT03988153|Fecal movement|fecal movement
5001172|NCT03988140|dental prosthesis|dental prosthesis
5001173|NCT03988140|biological markers|biological markers
5001174|NCT03988140|dental implants|dental implants
5001175|NCT03988036|HR positive|hr positive
5001176|NCT03988036|HER2 negative|her2 negative
5001177|NCT03988036|Early breast cancer|early breast cancer
5001178|NCT03988036|Neoadjuvant|neoadjuvant
5001179|NCT03988036|Anti-HER2 therapy|anti-her2 therapy
5001180|NCT03988036|Pertuzumab|pertuzumab
5001181|NCT03988036|Trastuzumab|trastuzumab
5001182|NCT03988036|Pembrolizumab|pembrolizumab
5001183|NCT03988036|Immune checkpoint inhibitor|immune checkpoint inhibitor
5001184|NCT03988036|PD-1|pd-1
5001185|NCT03988036|PDL-1|pdl-1
5001187|NCT03988036|Phase 2|phase 2
5001188|NCT03988010|amantadine sulphate|amantadine sulphate
5001189|NCT03988010|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5001190|NCT03988010|laparoscopic radical prostatectomy|laparoscopic radical prostatectomy
5001191|NCT03987997|Intensive Care Units|intensive care units
5001201|NCT03987945|atrial fibrillation; left atrial appendage occlusion|atrial fibrillation; left atrial appendage occlusion
5001208|NCT03987906|Symptom control|symptom control
5001209|NCT03987906|Quality of life|quality of life
5001210|NCT03987906|Satisfaction with care|satisfaction with care
5001211|NCT03987906|Targeted referral|targeted referral
5001212|NCT03987906|Randomized controlled trial|randomized controlled trial
5001213|NCT03987893|PEG3350|peg3350
5001214|NCT03987893|hepatic encephalopathy|hepatic encephalopathy
5001215|NCT03987893|acute on chronic liver failure|acute on chronic liver failure
5001216|NCT03987893|lactulose|lactulose
5001217|NCT03987893|rifaximin|rifaximin
5001218|NCT03987893|HESA|hesa
5001219|NCT03987854|nutrition|nutrition
5001220|NCT03987841|Diabetes distress|diabetes distress
5001221|NCT03987841|Mindfulness-based intervention|mindfulness-based intervention
5001222|NCT03987841|Diabetes self-management education|diabetes self-management education
5001223|NCT03987789|Mechanical Ventilation|mechanical ventilation
5001224|NCT03987789|Lung-Protective Ventilation|lung-protective ventilation
5001225|NCT03987789|Postoperative Pulmonary Complications|postoperative pulmonary complications
5001226|NCT03987789|Postoperative morbidity|postoperative morbidity
5001227|NCT03987776|anti-inflammatory diet|anti-inflammatory diet
5001240|NCT03987646|xenograft cortical flexible sheet|xenograft cortical flexible sheet
5001241|NCT03987646|fresh extraction socket|fresh extraction socket
5001242|NCT03987633|genetic disparity|genetic disparity
5001243|NCT03987633|health inequality|health inequality
5001244|NCT03987633|genetics|genetics
5316586|NCT02101099|Colonoscopy|colonoscopy
5001245|NCT03987633|health outcomes|health outcomes
5001246|NCT03987633|equality|equality
5001249|NCT03987607|neuromuscular monitoring|neuromuscular monitoring
5001250|NCT03987607|acceleromyography|acceleromyography
5001251|NCT03987607|electromyography|electromyography
5001252|NCT03987594|Interstitial Cystitis|interstitial cystitis
5001253|NCT03987594|Painful Bladder Syndrome|painful bladder syndrome
5001254|NCT03987594|Hydrodistension|hydrodistension
5001255|NCT03987594|Transurethral Fulguration|transurethral fulguration
5001256|NCT03987542|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5001257|NCT03987542|Asparaginase|asparaginase
5001258|NCT03987542|Truncation|truncation
5001259|NCT03987542|Toxicitities|toxicitities
5001260|NCT03987503|People who inject drugs|people who inject drugs
5001261|NCT03987503|Homeless|homeless
5001262|NCT03987503|Community-based testing and treatment|community-based testing and treatment
5001263|NCT03987490|vaccine|vaccine
5001264|NCT03987477|Cognitive Biases|cognitive biases
5001265|NCT03987477|Cognitive Bias Modification|cognitive bias modification
5001266|NCT03987477|Depression|depression
5001267|NCT03987477|Online intervention|online intervention
5001268|NCT03987477|Cognitive Bias Interpretation|cognitive bias interpretation
5001272|NCT03987438|Behavioral intervention|behavioral intervention
5001273|NCT03987438|Imparied glucose tolerance|imparied glucose tolerance
5001274|NCT03987438|Diabetes|diabetes
5004220|NCT03969823|NSCLC|nsclc
5001276|NCT03987412|First trimester|first trimester
5001277|NCT03987412|Gestational diabetes mellitus|gestational diabetes mellitus
5001278|NCT03987399|pediatric pain|pediatric pain
5001279|NCT03987399|postoperative pain|postoperative pain
5001280|NCT03987399|pain assessment|pain assessment
5001281|NCT03987399|pain management|pain management
5001282|NCT03987399|healthcare providers|healthcare providers
5001284|NCT03987399|nurses|nurses
5001285|NCT03987399|physicians|physicians
5001383|NCT03986632|Traditional Foods|traditional foods
5001286|NCT03987399|tailored educational intervention|tailored educational intervention
5001287|NCT03987399|surgical wards|surgical wards
5001288|NCT03987373|CABG|cabg
5001289|NCT03987373|Antiplatelet|antiplatelet
5001290|NCT03987373|MACE|mace
5001291|NCT03987373|grafts patency|grafts patency
5001292|NCT03987334|Virtual Reality|virtual reality
5001293|NCT03987334|Motor Control|motor control
5001294|NCT03987334|Augmented Feedback|augmented feedback
5001295|NCT03987334|Chronic Neck Pain|chronic neck pain
5001296|NCT03987334|Whiplash|whiplash
5001297|NCT03987321|Inferior vena cava|inferior vena cava
5001298|NCT03987321|filter|filter
5001299|NCT03987321|deep venous thrombosis|deep venous thrombosis
5001300|NCT03987321|pulmonary embolism|pulmonary embolism
5001301|NCT03987321|complex retrieval|complex retrieval
5001302|NCT03987308|Type 2 diabetic patients|type 2 diabetic patients
5001303|NCT03987308|Beinaglutide injection solution|beinaglutide injection solution
5001304|NCT03987308|Insulin aspart injection solution|insulin aspart injection solution
5001305|NCT03987256|tennis elbow|tennis elbow
5001306|NCT03987256|PRP|prp
5001307|NCT03987256|Focussed shockwave therapy|focussed shockwave therapy
5001308|NCT03987256|needling|needling
5001309|NCT03987256|tendinopathy|tendinopathy
5001310|NCT03987243|Spinal Cord Injury|spinal cord injury
5001311|NCT03987243|Seating Pressure Mapping|seating pressure mapping
5001312|NCT03987243|Pressure Injury Prevention|pressure injury prevention
5001313|NCT03987243|Seating Interface Pressure|seating interface pressure
5001315|NCT03987178|hot tub|hot tub
5001316|NCT03987178|conjunctival cultures|conjunctival cultures
5001323|NCT03987139|cerebral autoregulation|cerebral autoregulation
5001324|NCT03987022|Anti-inflammatory agents non-steroidal|anti-inflammatory agents non-steroidal
5001325|NCT03986996|Ulcerative Colitis|ulcerative colitis
5001326|NCT03986983|Gynoid Lipodystrophy|gynoid lipodystrophy
5001327|NCT03986983|Shock Wave Therapy|shock wave therapy
5001328|NCT03986983|Aerobic Exercise|aerobic exercise
5001329|NCT03986970|Pre-exposure prophylaxis|pre-exposure prophylaxis
5001330|NCT03986957|Vascular Cognitive Impairment|vascular cognitive impairment
5001331|NCT03986957|Magnetic Resonance Imaging|magnetic resonance imaging
5001332|NCT03986957|Blood Pressure Variability|blood pressure variability
5001333|NCT03986944|Dysmenorrhea|dysmenorrhea
5001334|NCT03986944|Dyspareunia|dyspareunia
5001335|NCT03986944|Dyschezia|dyschezia
5001336|NCT03986944|Non-menstrual pelvic pain|non-menstrual pelvic pain
5001337|NCT03986892|fitness|fitness
5001338|NCT03986892|exercise|exercise
5001339|NCT03986892|vascular function|vascular function
5001340|NCT03986879|Physical Activity|physical activity
5001341|NCT03986879|Cardiovascular Health|cardiovascular health
5001342|NCT03986879|Epidemiological|epidemiological
5001343|NCT03986840|Frailty|frailty
5001344|NCT03986840|Exercise|exercise
5001345|NCT03986840|Aging|aging
5001346|NCT03986827|Social anxiety disorder|social anxiety disorder
5001347|NCT03986827|Social phobia|social phobia
5001348|NCT03986827|Youth|youth
5001349|NCT03986827|Cognitive behavioral therapy|cognitive behavioral therapy
5001350|NCT03986827|Adolescents|adolescents
5001351|NCT03986775|Glycemic Index|glycemic index
5001352|NCT03986775|Overweight|overweight
5001353|NCT03986775|Endothelial function|endothelial function
5001354|NCT03986775|carbohydrate|carbohydrate
5001355|NCT03986749|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5001356|NCT03986749|bursa augmentation|bursa augmentation
5001357|NCT03986749|neovascularization|neovascularization
5001358|NCT03986749|Doppler ultrasonography|doppler ultrasonography
5001359|NCT03986736|rhabdomyolysis|rhabdomyolysis
5001360|NCT03986736|tissue injury|tissue injury
5001361|NCT03986736|alarmins|alarmins
5001362|NCT03986736|major trauma|major trauma
5001363|NCT03986736|acute kidney injury|acute kidney injury
5001364|NCT03986723|traditional plaster model|traditional plaster model
5001365|NCT03986723|3D printed model|3d printed model
5001366|NCT03986723|digital workflow|digital workflow
5001367|NCT03986723|reliability|reliability
5001368|NCT03986723|time efficiency|time efficiency
5001369|NCT03986710|3D virtual planning software|3d virtual planning software
5001370|NCT03986710|timing|timing
5001371|NCT03986697|HIV|hiv
5001372|NCT03986697|Coronary Artery Disease|coronary artery disease
5001373|NCT03986697|Atherosclerosis|atherosclerosis
5001374|NCT03986697|Antiretroviral therapy|antiretroviral therapy
5001375|NCT03986697|Computed tomography|computed tomography
5004336|NCT03969225|Hemodialysis|hemodialysis
5001381|NCT03986632|Healthy Eating|healthy eating
5001382|NCT03986632|Alaska Native|alaska native
5001391|NCT03986567|Contact Tracing|contact tracing
5001392|NCT03986567|Game Theory|game theory
5001393|NCT03986567|Adolescent|adolescent
5001394|NCT03986554|Swallowing|swallowing
5001395|NCT03986541|colorectal cancer|colorectal cancer
5001396|NCT03986541|anti-EGFR agents|anti-egfr agents
5001397|NCT03986541|cetuximab|cetuximab
5001398|NCT03986541|panitumumab|panitumumab
5001399|NCT03986541|amphiregulin|amphiregulin
5001400|NCT03986541|epiregulin|epiregulin
5001401|NCT03986541|EGFR|egfr
5001402|NCT03986528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5001403|NCT03986528|Kanglaite Injection|kanglaite injection
5001404|NCT03986489|Dance/movement therapy|dance/movement therapy
5001405|NCT03986489|Mindfulness-based dance/movement therapy|mindfulness-based dance/movement therapy
5001406|NCT03986489|Chronic pain management|chronic pain management
5001407|NCT03986489|Creative Arts Therapies|creative arts therapies
5001408|NCT03986489|Non-pharmacological intervention|non-pharmacological intervention
5001409|NCT03986450|Enhanced recovery after surgery|enhanced recovery after surgery
5001410|NCT03986450|Laparoscopic hysterectomy|laparoscopic hysterectomy
5001411|NCT03986437|Differentiated Thyroid Cancer|differentiated thyroid cancer
5001412|NCT03986437|Iodine-131|iodine-131
5001413|NCT03986437|Thyroidectomy|thyroidectomy
5706849|NCT00476567|prevention|prevention
5001421|NCT03986320|Keeogo™|keeogo™
5001422|NCT03986320|Dermoskeleton|dermoskeleton
5001423|NCT03986320|Powered dermoskeleton|powered dermoskeleton
5001424|NCT03986320|Lower limb dermoskeleton|lower limb dermoskeleton
5001425|NCT03986320|Assistive exoskeleton|assistive exoskeleton
5001426|NCT03986320|Orthotic dermoskeleton|orthotic dermoskeleton
5001427|NCT03986307|muscle metabolism|muscle metabolism
5001428|NCT03986307|inflammation|inflammation
5001429|NCT03986307|muscle molecular signaling|muscle molecular signaling
5001430|NCT03986307|muscle functioning|muscle functioning
5001431|NCT03986294|Liposomal irinotecan|liposomal irinotecan
5001433|NCT03986294|Pancreatic cancer|pancreatic cancer
5001434|NCT03986294|Second line|second line
5001435|NCT03986281|Wearable devices|wearable devices
5001436|NCT03986281|Blood pressure|blood pressure
5001437|NCT03986281|Arterial line|arterial line
5001438|NCT03986281|Hypertension|hypertension
5001439|NCT03986281|Post Operative|post operative
5001440|NCT03986281|Cardiac Surgery|cardiac surgery
5001441|NCT03986268|neoadjuvant treatment|neoadjuvant treatment
5001442|NCT03986268|Breast Cancer|breast cancer
5001443|NCT03986268|Vitamin D3|vitamin d3
5001444|NCT03986242|Delayed-onset muscle soreness|delayed-onset muscle soreness
5001445|NCT03986242|vibration therapy|vibration therapy
5001446|NCT03986242|foam roller|foam roller
5001447|NCT03986242|stretching exercise|stretching exercise
5001448|NCT03986242|recovery|recovery
5001449|NCT03986242|performance|performance
5001450|NCT03986229|ehlers-danlos syndrome|ehlers-danlos syndrome
5001451|NCT03986229|static balance|static balance
5001452|NCT03986229|custom compression garments|custom compression garments
5001459|NCT03986203|Low bone mass|low bone mass
5001460|NCT03986203|Osteoporosis|osteoporosis
5001461|NCT03986190|Hispanic|hispanic
5001462|NCT03986190|family|family
5001463|NCT03986190|digital health|digital health
5001464|NCT03986190|obesity prevention|obesity prevention
5001465|NCT03986190|physical activity|physical activity
5001466|NCT03986190|nutrition|nutrition
5001467|NCT03986177|Implementation Science|implementation science
5001468|NCT03986177|Global Health|global health
5001469|NCT03986177|Peru|peru
5001470|NCT03986164|Guided Surgery|guided surgery
5001471|NCT03986164|Linear Shifts|linear shifts
5001472|NCT03986164|Angular Shifts|angular shifts
5001473|NCT03986164|Satisfaction|satisfaction
5001474|NCT03986151|coronary angiography|coronary angiography
5001475|NCT03986151|radial access|radial access
5001476|NCT03986151|distal radial access|distal radial access
5001477|NCT03986151|anatomical snuffbox|anatomical snuffbox
5001478|NCT03986151|radial artery occlusion|radial artery occlusion
5001479|NCT03986125|college students|college students
5001480|NCT03986125|anxiety|anxiety
5001481|NCT03986125|somatic symptoms|somatic symptoms
5001482|NCT03986112|carotid sonography|carotid sonography
5001489|NCT03986099|Virologic suppression|virologic suppression
5001490|NCT03986099|Zimbabwe|zimbabwe
5001491|NCT03986099|Rural|rural
5001492|NCT03986099|GeneXpert|genexpert
5001493|NCT03986099|Point of care|point of care
5001494|NCT03986099|SAMBA|samba
5001498|NCT03986047|Disability|disability
5001499|NCT03986047|Acute pain|acute pain
5001505|NCT03986021|Menarche|menarche
5001506|NCT03986021|Adolescent|adolescent
5001507|NCT03986021|Physiology|physiology
5001508|NCT03986021|Hormones|hormones
5001509|NCT03985995|Cannabidiol (CBD)|cannabidiol (cbd)
5001510|NCT03985969|Healthy volunteers|healthy volunteers
5001511|NCT03985969|Elafibranor|elafibranor
5001512|NCT03985956|Daily Living Activities|daily living activities
5001513|NCT03985956|Exercise|exercise
5001514|NCT03985930|Infant|infant
5001515|NCT03985930|Child|child
5001516|NCT03985930|Virtual Reality|virtual reality
5001517|NCT03985930|Procedural Pain|procedural pain
5001518|NCT03985917|Singing Group|singing group
5001519|NCT03985917|Choir|choir
5001520|NCT03985917|Intervention|intervention
5001521|NCT03985917|Older Adults|older adults
5001522|NCT03985917|Well-Being|well-being
5001523|NCT03985917|Cognitive Function|cognitive function
5001524|NCT03985917|General Health|general health
5001525|NCT03985904|mental health recovery|mental health recovery
5001526|NCT03985904|art therapy|art therapy
5001527|NCT03985904|museum|museum
5001528|NCT03985891|Colon cancer|colon cancer
5001529|NCT03985891|PD-1|pd-1
5001530|NCT03985891|Chemotherapy|chemotherapy
5001531|NCT03985878|DMD|dmd
5001532|NCT03985878|Duchenne|duchenne
5001533|NCT03985878|Eteplirsen|eteplirsen
5017523|NCT03887169|MARS gene|mars gene
5001542|NCT03985865|Ghrelin|ghrelin
5001543|NCT03985865|CCK|cck
5001544|NCT03985865|GLP-1|glp-1
5001545|NCT03985865|SST|sst
5001546|NCT03985865|Denatonium benzoate|denatonium benzoate
5001547|NCT03985865|Quinine hydrochloride|quinine hydrochloride
5001548|NCT03985839|Microraptor, suture anchor, knotless, Smith and Nephew|microraptor, suture anchor, knotless, smith and nephew
5001549|NCT03985787|Resistance Exercise|resistance exercise
5001550|NCT03985787|Appetite Regulation|appetite regulation
5001551|NCT03985761|Stroke|stroke
5001552|NCT03985761|Upper extremity|upper extremity
5001553|NCT03985761|Hand|hand
5001554|NCT03985761|Arm|arm
5001555|NCT03985761|Virtual reality|virtual reality
5001556|NCT03985761|Telerehabilitation|telerehabilitation
5001557|NCT03985761|Gaming|gaming
5001558|NCT03985761|Hemiparesis|hemiparesis
5001559|NCT03985761|Dexterity|dexterity
5001560|NCT03985748|Nebulizer|nebulizer
5001561|NCT03985748|Breath Actuated Nebulizer|breath actuated nebulizer
5001562|NCT03985722|advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
5001563|NCT03985709|Osteoarthritis|osteoarthritis
5001565|NCT03985709|Probiotic|probiotic
5001566|NCT03985696|B cells|b cells
5001567|NCT03985696|exosomes|exosomes
5001568|NCT03985696|immunotherapy|immunotherapy
5001569|NCT03985696|Lymphomas|lymphomas
5001570|NCT03985696|DLBCL|dlbcl
5001571|NCT03985683|Agility training|agility training
5001572|NCT03985683|Carbohydrate loading|carbohydrate loading
5001573|NCT03985683|Effects on performance|effects on performance
5001577|NCT03985618|obesity|obesity
5001578|NCT03985618|pregnancy|pregnancy
5001579|NCT03985618|labour|labour
5001580|NCT03985618|labor|labor
5001581|NCT03985618|caesarean|caesarean
5001582|NCT03985618|cesarean|cesarean
5001583|NCT03985618|C-section|c-section
5001584|NCT03985618|induction|induction
5001585|NCT03985605|TDM|tdm
5001586|NCT03985605|Routine|routine
5001587|NCT03985605|intensive care patients|intensive care patients
5001588|NCT03985553|Parenting|parenting
5001589|NCT03985553|Spinal Cord Injuries|spinal cord injuries
5001590|NCT03985553|Self-Management|self-management
5001591|NCT03985553|Occupational Therapy|occupational therapy
5001592|NCT03985488|endoscopy|endoscopy
5001593|NCT03985488|fluoroscopy|fluoroscopy
5001594|NCT03985488|radiation exposure|radiation exposure
5001599|NCT03985449|Uterine Fibroids|uterine fibroids
5001600|NCT03985449|Normalization Process Theory|normalization process theory
5001601|NCT03985449|Consolidated Framework for Implementation Research|consolidated framework for implementation research
5001602|NCT03985449|Picture Superiority|picture superiority
5001603|NCT03985449|Electronic Health Record|electronic health record
5001604|NCT03985449|Coproduction|coproduction
5001605|NCT03985423|interferon gamma|interferon gamma
5001606|NCT03985423|emapalumab|emapalumab
5001607|NCT03985423|adult HLH|adult hlh
5001608|NCT03985423|malignancy-associated HLH|malignancy-associated hlh
5001609|NCT03985423|CXCL9|cxcl9
5001610|NCT03985410|Acinetobacter baumannii-calcoaceticus|acinetobacter baumannii-calcoaceticus
5001611|NCT03985410|complex infections|complex infections
5001612|NCT03985410|ETX2514|etx2514
5001613|NCT03985410|cardiac repolarization|cardiac repolarization
5001614|NCT03985410|heart rate-corrected QT interval (QTc)|heart rate-corrected qt interval (qtc)
5001615|NCT03985397|discharge training|discharge training
5001616|NCT03985397|acute myocardial infarction|acute myocardial infarction
5001617|NCT03985397|compliance to drug|compliance to drug
5001622|NCT03985358|bilateral reduction mammoplasty|bilateral reduction mammoplasty
5001623|NCT03985332|evolution of the rate|evolution of the rate
5001624|NCT03985332|causes of death in geriatric SSR|causes of death in geriatric ssr
5001626|NCT03985306|Wound treatment|wound treatment
5001627|NCT03985306|Inforatio technique|inforatio technique
5001628|NCT03985306|Diabetes|diabetes
5001629|NCT03985306|Foot ulcer|foot ulcer
5001630|NCT03985306|Outpatient clinic|outpatient clinic
5001631|NCT03985306|Feasibility trial|feasibility trial
5001632|NCT03985306|Punch biopsy|punch biopsy
5001633|NCT03985306|Foot ulcer treatment|foot ulcer treatment
5001634|NCT03985280|Cooled radiofrequency|cooled radiofrequency
5001635|NCT03985280|Radiofrequency|radiofrequency
5001636|NCT03985280|Hip pain|hip pain
5001637|NCT03985267|mindfulness|mindfulness
5001642|NCT03985267|swinging effect intervention|swinging effect intervention
5001643|NCT03985267|breathing technique|breathing technique
5001645|NCT03985267|cognitive behavioural therapy|cognitive behavioural therapy
5001646|NCT03985241|Intracoronary Electrocardiogram|intracoronary electrocardiogram
5001647|NCT03985241|Fractional Flow Reserve|fractional flow reserve
5001648|NCT03985241|Collateral Flow Index|collateral flow index
5001649|NCT03985241|Dobutamine|dobutamine
5001650|NCT03985228|golden milk, insomnia, gut-brain axis|golden milk, insomnia, gut-brain axis
5001651|NCT03985215|Aftercare|aftercare
5001652|NCT03985202|exercise programme|exercise programme
5001653|NCT03985176|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5001654|NCT03985176|delayed cerebral ischemia|delayed cerebral ischemia
5001655|NCT03985176|Intensive Care Unit|intensive care unit
5001656|NCT03985176|Neurosurgery|neurosurgery
5001657|NCT03985163|Patient Reported Outcomes|patient reported outcomes
5001658|NCT03985163|Clinical Data Research|clinical data research
5001659|NCT03985163|Electronic Health Records|electronic health records
5001660|NCT03985111|perioperative care|perioperative care
5001661|NCT03985111|perioperative blood pressure management|perioperative blood pressure management
5001662|NCT03985111|perioperative fluid management|perioperative fluid management
5001663|NCT03985098|Motivational interviewing|motivational interviewing
5001664|NCT03985098|trajectory modeling|trajectory modeling
5001665|NCT03985098|medication adherence|medication adherence
5001666|NCT03985085|female sex workers|female sex workers
5001667|NCT03985072|Neoplasm|neoplasm
5001668|NCT03985072|Solid Tumor|solid tumor
5001674|NCT03985007|chidamide|chidamide
5001675|NCT03985007|decitabine|decitabine
5001676|NCT03985007|priming regimen|priming regimen
5001677|NCT03984994|muscle|muscle
5001678|NCT03984994|capillary|capillary
5001679|NCT03984994|exercise|exercise
5001680|NCT03984981|diagnosis of brain death|diagnosis of brain death
5419488|NCT01633476|CMV|cmv
5321271|NCT02079064|TCI|tci
5001681|NCT03984968|feeding T cell|feeding t cell
5001682|NCT03984968|CD19 CAR-T therapy|cd19 car-t therapy
5001683|NCT03984942|Knee Arthroplasty|knee arthroplasty
5001684|NCT03984942|Hip Arthroplasty|hip arthroplasty
5001685|NCT03984942|Postoperative Anaesthesia Care Unit|postoperative anaesthesia care unit
5001686|NCT03984929|Conexion|conexion
5001687|NCT03984929|Diabetes|diabetes
5001688|NCT03984929|Depression|depression
5001689|NCT03984929|Low-income|low-income
5001690|NCT03984929|Hispanic|hispanic
5001691|NCT03984916|hesperidin|hesperidin
5001692|NCT03984916|orange extract|orange extract
5001693|NCT03984903|Back Pain without Radiation|back pain without radiation
5001694|NCT03984903|Low Back Pain, Mechanical|low back pain, mechanical
5001695|NCT03984877|TAVI|tavi
5001696|NCT03984877|Aortic Stenosis|aortic stenosis
5001697|NCT03984877|Cardiac amyloidosis|cardiac amyloidosis
5001698|NCT03984851|tonsillectomy|tonsillectomy
5001699|NCT03984851|primary hemostasis tonsillectomy|primary hemostasis tonsillectomy
5001700|NCT03984851|surgicel|surgicel
5001701|NCT03984838|Dolutegravir, Rilpivirine, HIV infection, Fixed-dose combination, Japanese, Pharmacokinetics|dolutegravir, rilpivirine, hiv infection, fixed-dose combination, japanese, pharmacokinetics
5001702|NCT03984825|GSK3640254|gsk3640254
5001703|NCT03984825|ethinyl estradiol|ethinyl estradiol
5001704|NCT03984825|levonorgestrel|levonorgestrel
5001705|NCT03984825|oral contraceptive|oral contraceptive
5001706|NCT03984825|drug-drug interaction|drug-drug interaction
5001707|NCT03984812|DAIDS, FTIH, HIV-1, MAD, SAD|daids, ftih, hiv-1, mad, sad
5001708|NCT03984786|alcohol misuse|alcohol misuse
5001709|NCT03984786|internet|internet
5001710|NCT03984786|guidance|guidance
5001711|NCT03984786|ICBT|icbt
5001712|NCT03984786|cognitive behaviour therapy|cognitive behaviour therapy
5001713|NCT03984786|assessment|assessment
5001714|NCT03984773|serious illness conversations|serious illness conversations
5001715|NCT03984773|advance care planning|advance care planning
5001716|NCT03984773|mortality estimates|mortality estimates
5001717|NCT03984773|nudge|nudge
5001718|NCT03984773|pre-commitment|pre-commitment
5001719|NCT03984773|opt-out|opt-out
5001720|NCT03984760|Kidney Diseases|kidney diseases
5001721|NCT03984760|Kidney Failure, Chronic|kidney failure, chronic
5001722|NCT03984760|Hyperphosphatemia|hyperphosphatemia
5001723|NCT03984760|Urologic Diseases|urologic diseases
5001724|NCT03984760|Renal Insufficiency, Chronic|renal insufficiency, chronic
5001725|NCT03984760|Renal Insufficiency|renal insufficiency
5001726|NCT03984760|Phosphorus Metabolism Disorder|phosphorus metabolism disorder
5001727|NCT03984747|transplant|transplant
5001728|NCT03984747|kidney|kidney
5001729|NCT03984747|renal|renal
5001730|NCT03984747|allograft|allograft
5001731|NCT03984747|cell-free DNA|cell-free dna
5001732|NCT03984734|Delayed Gastric Emptying|delayed gastric emptying
5017717|NCT03886090|balance|balance
5001738|NCT03984708|Metabolomics|metabolomics
5001739|NCT03984708|Transcriptomics|transcriptomics
5001742|NCT03984695|Jail|jail
5001743|NCT03984695|Vulnerable Populations|vulnerable populations
5001744|NCT03984695|STD Screening|std screening
5001745|NCT03984695|unintended pregnancy|unintended pregnancy
5001746|NCT03984682|Joint Crisis Plan|joint crisis plan
5001747|NCT03984682|Internalized Stigma of Mental Illness (ISMI)|internalized stigma of mental illness (ismi)
5001748|NCT03984682|Isolation|isolation
5001749|NCT03984682|physical restraint|physical restraint
5001750|NCT03984682|Psychiatry|psychiatry
5001751|NCT03984669|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5001752|NCT03984669|(1,3)-beta-D-glucan|(1,3)-beta-d-glucan
5001753|NCT03984669|children|children
5001754|NCT03984669|inflammatory status|inflammatory status
5001755|NCT03984669|intestinal microbiota|intestinal microbiota
5001756|NCT03984669|activity od the disease|activity od the disease
5001757|NCT03984656|serratus plane block|serratus plane block
5001758|NCT03984656|analgesia|analgesia
5001759|NCT03984656|pleural drainage|pleural drainage
5001760|NCT03984656|lidocaine|lidocaine
5001761|NCT03984656|intensive care unit|intensive care unit
5001762|NCT03984630|Dietary Fiber|dietary fiber
5001763|NCT03984630|Gestational weight gain|gestational weight gain
5001764|NCT03984604|sleep|sleep
5001765|NCT03984604|cannabis|cannabis
5001766|NCT03984604|primary insomnia|primary insomnia
5001767|NCT03984591|aldosterone antagonists|aldosterone antagonists
5001768|NCT03984591|spironolactone|spironolactone
5001769|NCT03984591|eplerenone|eplerenone
5001770|NCT03984591|mortality|mortality
5001774|NCT03984552|rapid test|rapid test
5001775|NCT03984552|HIV infection|hiv infection
5001776|NCT03984552|vertical transmission|vertical transmission
5001777|NCT03984500|Sickle Cell Trait|sickle cell trait
5001778|NCT03984500|Education|education
5001779|NCT03984474|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5001780|NCT03984474|Patient-reported outcome|patient-reported outcome
5001781|NCT03984474|Meniscus|meniscus
5001782|NCT03984474|Cartilage|cartilage
5001783|NCT03984461|Osteoarthritis|osteoarthritis
5001784|NCT03984461|Platelet Rich Plasma (PRP)|platelet rich plasma (prp)
5001785|NCT03984461|Micronized Lipoaspirate (MAT)|micronized lipoaspirate (mat)
5001793|NCT03984422|monitoring|monitoring
5001794|NCT03984396|dementia|dementia
5001795|NCT03984396|cognitive impairment|cognitive impairment
5001796|NCT03984396|multimorbidity/comorbidity|multimorbidity/comorbidity
5001797|NCT03984396|polypharmacy|polypharmacy
5001798|NCT03984396|deprescriptions|deprescriptions
5001799|NCT03984396|patient education|patient education
5001800|NCT03984383|Endothelial cells|endothelial cells
5001801|NCT03984383|inflammation|inflammation
5001802|NCT03984383|endothelial dysfunction|endothelial dysfunction
5001803|NCT03984383|IL-33|il-33
5001804|NCT03984383|Endocan|endocan
5001805|NCT03984357|PD-1 blockade|pd-1 blockade
5001806|NCT03984357|immune checkpoint inhibitor|immune checkpoint inhibitor
5001807|NCT03984357|induction chemotherapy|induction chemotherapy
5001808|NCT03984357|radiotherapy|radiotherapy
5001815|NCT03984331|Fish skin|fish skin
5001816|NCT03984331|Full thickness burn|full thickness burn
5001817|NCT03984331|Burns|burns
5001818|NCT03984331|Cadaver Skin|cadaver skin
5001819|NCT03984331|Split Thickness Skin Graft|split thickness skin graft
5001820|NCT03984331|Temporary Cover|temporary cover
5001821|NCT03984331|Blaze|blaze
5001822|NCT03984331|Kerecis|kerecis
5001823|NCT03984305|Personal KinetiGraph (PKG) Movement Recording System|personal kinetigraph (pkg) movement recording system
5001824|NCT03984305|Objective Measurement|objective measurement
5001825|NCT03984253|Asthma|asthma
5001826|NCT03984253|Severe|severe
5001827|NCT03984253|Register|register
5001828|NCT03984240|midazolam, dexmedetomidine, motor function|midazolam, dexmedetomidine, motor function
5001829|NCT03984214|Dronabinol|dronabinol
5001831|NCT03984214|Placebo|placebo
5001832|NCT03984214|Pancreatic Cancer|pancreatic cancer
5001833|NCT03984214|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5001834|NCT03984214|Tumor related symptoms|tumor related symptoms
5001835|NCT03984214|Quality of life|quality of life
5001836|NCT03984214|EORTC QLQ-C30|eortc qlq-c30
5001837|NCT03984214|FOLFIRINOX|folfirinox
5001838|NCT03984214|Abraxane|abraxane
5001839|NCT03984214|Gemcitabine|gemcitabine
5001846|NCT03984175|ARDS|ards
5001847|NCT03984175|Lung Protective Mechanical Ventilation|lung protective mechanical ventilation
5317102|NCT02098824|DTI|dti
5001848|NCT03984175|Clinical Decision Support|clinical decision support
5001849|NCT03984149|Atherosclerosis|atherosclerosis
5001850|NCT03984149|Familial hypercholesterolemia|familial hypercholesterolemia
5001851|NCT03984149|LIPA|lipa
5001852|NCT03984149|Lysosomal acid lipase deficiency|lysosomal acid lipase deficiency
5001853|NCT03984149|Wolman disease|wolman disease
5001854|NCT03984136|HIV testing|hiv testing
5043083|NCT03729752|MRI|mri
5001855|NCT03984136|Men who have sex with men|men who have sex with men
5001856|NCT03984123|Remote Ischemic Conditioning|remote ischemic conditioning
5001857|NCT03984123|Endothelial glycocalyx|endothelial glycocalyx
5001858|NCT03984123|Arterial stiffness|arterial stiffness
5001859|NCT03984123|micro RNA|micro rna
5001860|NCT03984123|NO pathway|no pathway
5001861|NCT03984097|Drug Therapy|drug therapy
5001862|NCT03984097|TAK-079|tak-079
5001863|NCT03984097|CD38|cd38
5001864|NCT03984097|Monoclonal Antibody|monoclonal antibody
5001865|NCT03984097|Lenalidomide|lenalidomide
5001866|NCT03984097|Bortezomib|bortezomib
5001867|NCT03984097|Velcade|velcade
5001868|NCT03984097|Stem Cell Transplant|stem cell transplant
5001869|NCT03984097|Neoplasms, Plasma Cell|neoplasms, plasma cell
5001870|NCT03984084|biomarkers|biomarkers
5001871|NCT03984084|translational medical research|translational medical research
5001872|NCT03984084|psychiatry|psychiatry
5001873|NCT03984084|Research Domain Criteria (RDoC)|research domain criteria (rdoc)
5001874|NCT03984084|omics|omics
5001875|NCT03984084|neuroimaging|neuroimaging
5001876|NCT03984084|taxonomy|taxonomy
5001877|NCT03984058|Pre-diabetes|pre-diabetes
5001878|NCT03984058|Sleep Apnea|sleep apnea
5001879|NCT03984058|PAP Therapy|pap therapy
5001880|NCT03984058|Obstructive Sleep Apnea|obstructive sleep apnea
5001881|NCT03984032|LMA Protector Cuff Pilot|lma protector cuff pilot
5001890|NCT03983980|phase 3|phase 3
5001891|NCT03983980|topical|topical
5001892|NCT03983980|double-blind|double-blind
5001893|NCT03983980|efficacy|efficacy
5001894|NCT03983980|safety|safety
5001895|NCT03983980|psoriasis|psoriasis
5001896|NCT03983902|stem cell|stem cell
5001897|NCT03983902|newborn|newborn
5001898|NCT03983902|endothelial progenitor cell|endothelial progenitor cell
5001899|NCT03983902|CD34+ hematopoietic stem cell|cd34+ hematopoietic stem cell
5001900|NCT03983902|delayed cord clamping|delayed cord clamping
5001901|NCT03983902|umbilical cord milking|umbilical cord milking
5001902|NCT03983902|immediate cord clamping|immediate cord clamping
5001906|NCT03983850|Human Leukocyte Antigen|human leukocyte antigen
5001907|NCT03983850|Busulfan|busulfan
5001908|NCT03983850|Fludarabine|fludarabine
5001909|NCT03983850|Mycophenolate Mofetil|mycophenolate mofetil
5001910|NCT03983850|Sirolimus|sirolimus
5001916|NCT03983798|Simulation training|simulation training
5001917|NCT03983798|Patient simulation|patient simulation
5001918|NCT03983798|Psychiatric|psychiatric
5321422|NCT02078440|Cycloset|cycloset
5001919|NCT03983798|Medical students|medical students
5001920|NCT03983798|Educational|educational
5001921|NCT03983798|Medical|medical
5001922|NCT03983785|Pilates|pilates
5001923|NCT03983785|Elastic Taping|elastic taping
5001924|NCT03983785|Balance|balance
5001925|NCT03983785|Postural control|postural control
5001926|NCT03983785|Early Parkinson`s Disease|early parkinson`s disease
5001927|NCT03983772|Prebiotics|prebiotics
5001928|NCT03983772|Resistant starch|resistant starch
5001929|NCT03983772|Gut microbiota|gut microbiota
5001930|NCT03983772|Microbial diversity|microbial diversity
5001931|NCT03983772|Dietary fiber|dietary fiber
5001932|NCT03983772|Short-chain fatty acid|short-chain fatty acid
5001933|NCT03983772|Gastrointestinal symptom|gastrointestinal symptom
5001934|NCT03983772|Dose-ramping design|dose-ramping design
5001935|NCT03983772|Resistant starch blend|resistant starch blend
5001936|NCT03983772|Fecal consistency|fecal consistency
5001937|NCT03983772|Fecal frequency|fecal frequency
5001938|NCT03983772|PROMIS|promis
5001939|NCT03983772|Microbiome analysis|microbiome analysis
5001940|NCT03983733|Gut microbiome|gut microbiome
5001941|NCT03983733|Personalised Nutrition|personalised nutrition
5001942|NCT03983733|Metabolic health|metabolic health
5001943|NCT03983733|Postprandial metabolism|postprandial metabolism
5001944|NCT03983720|Sleep assessment|sleep assessment
5001945|NCT03983720|Neuromuscular Fatigability|neuromuscular fatigability
5004853|NCT03966235|melatonin|melatonin
5001957|NCT03983681|Secondary Progressive|secondary progressive
5001959|NCT03983642|Static balance|static balance
5001960|NCT03983642|Wii Fit|wii fit
5001961|NCT03983642|Elderly|elderly
5001962|NCT03983629|Congenital Dyserythropoietic Anemia|congenital dyserythropoietic anemia
5001963|NCT03983629|French registry|french registry
5001964|NCT03983616|Pneumococcal Infections|pneumococcal infections
5001965|NCT03983603|Plant stanols|plant stanols
5001966|NCT03983603|Asthma|asthma
5001967|NCT03983603|Immune system|immune system
5001968|NCT03983603|Metabolic health|metabolic health
5001969|NCT03983590|pain|pain
5001970|NCT03983590|anxiety|anxiety
5001971|NCT03983590|communicative|communicative
5001973|NCT03983577|genetic counseling|genetic counseling
5001974|NCT03983551|Type 2 diabetes mellitus|type 2 diabetes mellitus
5001975|NCT03983551|dipeptidyl peptidase 4 inhibitors|dipeptidyl peptidase 4 inhibitors
5001976|NCT03983551|sulfonylureas|sulfonylureas
5001977|NCT03983551|proteinuria|proteinuria
5001978|NCT03983486|IS-FISH|is-fish
5001979|NCT03983486|Imaging flow cytometry|imaging flow cytometry
5001980|NCT03983486|Multiple Myeloma|multiple myeloma
5001981|NCT03983434|microbiome|microbiome
5001982|NCT03983434|microbiota|microbiota
5001983|NCT03983434|short chain fatty acids|short chain fatty acids
5001984|NCT03983434|prebiotic|prebiotic
5001985|NCT03983434|bile acids|bile acids
5001986|NCT03983408|Sjögren's Syndrome|sjögren's syndrome
5001987|NCT03983408|Korean Red Ginseng|korean red ginseng
5001988|NCT03983395|Breast Cancer|breast cancer
5001989|NCT03983395|GBR 1302|gbr 1302
5001990|NCT03983395|HER2|her2
5001991|NCT03983395|HER2 x CD3 bispecific antibody|her2 x cd3 bispecific antibody
5001992|NCT03983395|ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer|isb 1302 (cd3 bispecific ab) in her2-positive metastatic breast cancer
5001993|NCT03983382|non-anthracycline trastuzumab|non-anthracycline trastuzumab
5001994|NCT03983382|trastuzumab|trastuzumab
5001995|NCT03983382|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5001996|NCT03983382|19-045|19-045
5001997|NCT03983356|General Practitioner|general practitioner
5001998|NCT03983356|Training Program|training program
5001999|NCT03983343|Adhesive glue|adhesive glue
5002000|NCT03983343|Episiotomy|episiotomy
5002001|NCT03983343|Pain sensation|pain sensation
5002002|NCT03983343|Perineal tears|perineal tears
5002003|NCT03983343|Running sutures|running sutures
5002004|NCT03983343|Skin closure|skin closure
5002005|NCT03983343|Visual Analogue Scale|visual analogue scale
5002006|NCT03983278|Child|child
5002007|NCT03983278|Refractive Error|refractive error
5002008|NCT03983278|Myopia|myopia
5002009|NCT03983278|School screening|school screening
5002010|NCT03983278|Cost effectiveness|cost effectiveness
5002011|NCT03983278|India|india
5002012|NCT03983239|Healthy Subject|healthy subject
5002013|NCT03983239|Fedratinib|fedratinib
5002014|NCT03983239|Rifampin|rifampin
5002015|NCT03983239|Efavirenz|efavirenz
5002016|NCT03983239|Drug Interaction|drug interaction
5002017|NCT03983226|reurrent Ovarian Cancer|reurrent ovarian cancer
5002018|NCT03983226|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
5002019|NCT03983226|Chemotherapy|chemotherapy
5002020|NCT03983226|Niraparib maintenance|niraparib maintenance
5002021|NCT03983213|Patellar instability|patellar instability
5002022|NCT03983213|Recurrent patellar dislocation|recurrent patellar dislocation
5002023|NCT03983213|Isokinetics|isokinetics
5002024|NCT03983213|Children|children
5002025|NCT03983213|MPFL reconstruction|mpfl reconstruction
5002026|NCT03983161|Healthy Subjects|healthy subjects
5002027|NCT03983161|Fedratinib|fedratinib
5002028|NCT03983161|Hepatic impairment|hepatic impairment
5308421|NCT02136784|opioids|opioids
5002029|NCT03983161|Pharmacokinetics|pharmacokinetics
5002030|NCT03983148|Motivational Interviewing|motivational interviewing
5002031|NCT03983148|Parent|parent
5002032|NCT03983148|Children|children
5002033|NCT03983148|Cancer|cancer
5002034|NCT03983148|Physical activity|physical activity
5002035|NCT03983109|EpiFaith|epifaith
5002036|NCT03983109|Epidural localization|epidural localization
5002037|NCT03983096|invasive breast cancer|invasive breast cancer
5002038|NCT03983096|neoadjuvant|neoadjuvant
5002039|NCT03983096|adjuvant|adjuvant
5002040|NCT03983096|Anthracycline|anthracycline
5002041|NCT03983083|physical activity|physical activity
5002042|NCT03983083|sedentary behavior|sedentary behavior
5002043|NCT03983070|Strength|strength
5002044|NCT03983070|Hypertrophy|hypertrophy
5002045|NCT03983070|Oxygen consumption|oxygen consumption
5002046|NCT03983057|Pancreatic cancer|pancreatic cancer
5002047|NCT03983057|PD-1|pd-1
5002048|NCT03983057|FOLFIRINOX|folfirinox
5002049|NCT03983057|combination therapy|combination therapy
5002050|NCT03983044|cough evaluation|cough evaluation
5002051|NCT03983044|intensive care unit|intensive care unit
5002052|NCT03983044|utrasound evaluation|utrasound evaluation
5002053|NCT03983031|Immunopsychiatry|immunopsychiatry
5002059|NCT03983005|Endoscopic ultrasound|endoscopic ultrasound
5002060|NCT03983005|EUS-B-FNA|eus-b-fna
5002061|NCT03983005|Molecular analysis|molecular analysis
5002062|NCT03983005|Rapid on-site evaluation|rapid on-site evaluation
5002065|NCT03982992|combinatorial|combinatorial
5002066|NCT03982992|minimal residual disease|minimal residual disease
5002068|NCT03982992|mixed chimerism|mixed chimerism
5002070|NCT03982992|DLI-TARGET|dli-target
5002071|NCT03982992|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5002072|NCT03982914|biomarker|biomarker
5002073|NCT03982914|HE4|he4
5002074|NCT03982914|CA-125|ca-125
5002075|NCT03982914|IOTA|iota
5002076|NCT03982914|ROMA|roma
5002077|NCT03982914|RMI|rmi
5002078|NCT03982914|pelvic mass|pelvic mass
5317310|NCT02097862|ADSCs|adscs
5002079|NCT03982914|ovarian cancer|ovarian cancer
5002080|NCT03982901|Stress|stress
5002081|NCT03982901|Ischemia|ischemia
5002082|NCT03982901|PET-CT|pet-ct
5002083|NCT03982888|deep brain stimulation|deep brain stimulation
5002084|NCT03982875|remote monitoring|remote monitoring
5002085|NCT03982875|digital health|digital health
5002087|NCT03982862|Botulinum toxin type A|botulinum toxin type a
5002088|NCT03982862|Triamcinolone|triamcinolone
5002089|NCT03982862|scar pain|scar pain
5002090|NCT03982862|scar itch|scar itch
5002091|NCT03982849|melasma|melasma
5002092|NCT03982849|hydroquinone|hydroquinone
5002093|NCT03982849|silymarin|silymarin
5002094|NCT03982836|Gastric Emptying|gastric emptying
5002095|NCT03982836|Scintigraphy|scintigraphy
5002096|NCT03982836|Intestinal Transit Time|intestinal transit time
5002097|NCT03982836|Prebiotic|prebiotic
5002098|NCT03982836|Soluble Dietary Fiber|soluble dietary fiber
5002099|NCT03982836|Technetium-99m|technetium-99m
5002100|NCT03982823|morbid obesity|morbid obesity
5002101|NCT03982823|surgical stapling|surgical stapling
5002102|NCT03982823|suture techniques|suture techniques
5002103|NCT03982823|natural orifice surgery|natural orifice surgery
5002104|NCT03982823|transoral|transoral
5002105|NCT03982823|mini-laparoscopy|mini-laparoscopy
5002106|NCT03982797|non-muscle invasive bladder tumors|non-muscle invasive bladder tumors
5002107|NCT03982771|Idiopathic Multicentric Castleman's Disease|idiopathic multicentric castleman's disease
5002108|NCT03982771|BCD Regimen|bcd regimen
5002109|NCT03982771|Efficacy|efficacy
5002110|NCT03982771|Safety|safety
5002111|NCT03982745|bonfils fiberoptic stylet|bonfils fiberoptic stylet
5002112|NCT03982745|double lumen intubation|double lumen intubation
5002113|NCT03982745|thoracic surgery|thoracic surgery
5002114|NCT03982745|difficult intubation|difficult intubation
5002115|NCT03982745|difficult airway|difficult airway
5002116|NCT03982719|Dupuytren's disease|dupuytren's disease
5002117|NCT03982719|rehabilitation|rehabilitation
5002118|NCT03982719|fasciectomy|fasciectomy
5002119|NCT03982719|hand therapy|hand therapy
5002120|NCT03982706|MRI-targeted prostate biopsy|mri-targeted prostate biopsy
5002121|NCT03982706|focal treatment|focal treatment
5002122|NCT03982693|Chelation|chelation
5002123|NCT03982693|Critical Limb Ischemia|critical limb ischemia
5002124|NCT03982693|Diabetes|diabetes
5002125|NCT03982641|colorectal cancer surgery|colorectal cancer surgery
5002126|NCT03982641|auditing activity|auditing activity
5002127|NCT03982641|economical analysis|economical analysis
5002128|NCT03982641|surgical performance indicators|surgical performance indicators
5002129|NCT03982615|RNASeq|rnaseq
5002130|NCT03982615|mucosal integration|mucosal integration
5002132|NCT03982524|somatoform symptoms|somatoform symptoms
5002133|NCT03982524|somatic symptoms|somatic symptoms
5002134|NCT03982524|somatoform disorder|somatoform disorder
5002135|NCT03982524|somatic symptom disorder|somatic symptom disorder
5002136|NCT03982524|cognitive-behavioral therapy|cognitive-behavioral therapy
5002137|NCT03982524|emotion regulation training|emotion regulation training
5002138|NCT03982524|3-year follow-up|3-year follow-up
5002140|NCT03982485|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5002141|NCT03982485|Breast cancer|breast cancer
5002142|NCT03982472|heart rate|heart rate
5002143|NCT03982472|TENS|tens
5002144|NCT03982472|vagus nerve|vagus nerve
5002145|NCT03982433|HIV|hiv
5002146|NCT03982394|Chronic Plaque Psoriasis|chronic plaque psoriasis
5002147|NCT03982394|Risankizumab|risankizumab
5002152|NCT03982342|conservative treatment|conservative treatment
5002153|NCT03982342|percutaneous closure|percutaneous closure
5002155|NCT03982290|preschool children|preschool children
5002156|NCT03982277|High dose rifampicin|high dose rifampicin
5002157|NCT03982277|TB/HIV co-infected persons|tb/hiv co-infected persons
5002158|NCT03982277|safety|safety
5002159|NCT03982277|pharmacokinetics|pharmacokinetics
5002160|NCT03982277|efficacy|efficacy
5002161|NCT03982251|vibration|vibration
5002162|NCT03982251|bone|bone
5002163|NCT03982251|mucle|mucle
5002164|NCT03982251|cerebrovascular accident|cerebrovascular accident
5002165|NCT03982251|rehabilitation|rehabilitation
5002166|NCT03982225|Apoptosis|apoptosis
5002167|NCT03982225|Lipolysis|lipolysis
5002168|NCT03982225|Fat reduction|fat reduction
5002169|NCT03982225|Submental fat|submental fat
5002170|NCT03982225|Polyene Phosphatidylcholine|polyene phosphatidylcholine
5002171|NCT03982212|Copaxone|copaxone
5002172|NCT03982212|Window of Opportunity Trial|window of opportunity trial
5002173|NCT03982160|L-arginine|l-arginine
5002174|NCT03982160|blood pressure|blood pressure
5002175|NCT03982160|ADMA|adma
5002176|NCT03982147|Diffusion tensor imaging|diffusion tensor imaging
5002177|NCT03982108|shoulder|shoulder
5002178|NCT03982108|rotator cuff tear|rotator cuff tear
5002179|NCT03982108|arthroscopic repair|arthroscopic repair
5002180|NCT03982108|suture-bridge technique|suture-bridge technique
5002181|NCT03982108|retear|retear
5002182|NCT03982108|knotless|knotless
5317405|NCT02097381|CD4+|cd4+
5002183|NCT03982108|knot-tying|knot-tying
5002184|NCT03982095|Prostatic neoplasm|prostatic neoplasm
5002185|NCT03982095|Physical therapy modalities|physical therapy modalities
5002186|NCT03982095|Healthy lifestyle|healthy lifestyle
5002187|NCT03982095|Biobehavioral Sciences|biobehavioral sciences
5002188|NCT03982056|Floating|floating
5002189|NCT03982056|Sculling|sculling
5002190|NCT03982056|water safety|water safety
5002191|NCT03982030|Dalbavacin|dalbavacin
5002192|NCT03982017|readmission|readmission
5002193|NCT03982017|quality of life|quality of life
5002194|NCT03982017|self-care|self-care
5002195|NCT03981991|EHP 30|ehp 30
5002196|NCT03981991|Endometriosis|endometriosis
5002197|NCT03981991|Quality of Life|quality of life
5002198|NCT03981991|Uterosacral Ligament|uterosacral ligament
5002199|NCT03981978|physical activity|physical activity
5002200|NCT03981978|accelerometer|accelerometer
5002201|NCT03981978|bariatric surgery|bariatric surgery
5002202|NCT03981978|obesity|obesity
5002203|NCT03981965|physical activity|physical activity
5002204|NCT03981965|adherence|adherence
5002205|NCT03981965|Frailty|frailty
5002206|NCT03981965|Mood|mood
5002207|NCT03981965|Socialisation|socialisation
5002208|NCT03981965|Quality of life|quality of life
5002209|NCT03981965|Cognition|cognition
5002210|NCT03981939|Drug therapy|drug therapy
5002211|NCT03981926|Telemedicine|telemedicine
5002212|NCT03981926|Pragmatic|pragmatic
5002213|NCT03981926|Equivalency|equivalency
5002214|NCT03981926|Skin diseases|skin diseases
5002215|NCT03981913|Cognitive action control|cognitive action control
5002216|NCT03981913|Parkinson's disease|parkinson's disease
5002217|NCT03981913|high-density EEG|high-density eeg
5002218|NCT03981913|theta oscillations|theta oscillations
5002219|NCT03981913|medial frontal cortex|medial frontal cortex
5002220|NCT03981874|neuroborreliosis|neuroborreliosis
5002221|NCT03981874|facial palsy|facial palsy
5002222|NCT03981874|children|children
5002223|NCT03981822|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5002224|NCT03981822|Genital Warts|genital warts
5002225|NCT03981822|Sexually Transmitted Disease (STD)|sexually transmitted disease (std)
5002226|NCT03981822|Viral Disease|viral disease
5002227|NCT03981809|Pain|pain
5002228|NCT03981809|Cancer|cancer
5002229|NCT03981809|Chronic pain|chronic pain
5002230|NCT03981809|Persistent pain|persistent pain
5002231|NCT03981783|COPD|copd
5002232|NCT03981783|Pulmonary Rehabilitation|pulmonary rehabilitation
5002233|NCT03981783|Telerehabilitation|telerehabilitation
5002234|NCT03981783|Clinical Decision Support|clinical decision support
5002235|NCT03981783|Adherence|adherence
5002236|NCT03981757|carotid surgery|carotid surgery
5002237|NCT03981757|cerebral oxygenation|cerebral oxygenation
5002238|NCT03981757|brain blood volume|brain blood volume
5002239|NCT03981705|Breast Cancer|breast cancer
5002240|NCT03981692|Geriatrics|geriatrics
5002241|NCT03981692|quality of life|quality of life
5002242|NCT03981692|balance|balance
5002243|NCT03981692|fear of falling|fear of falling
5002244|NCT03981692|dual activity|dual activity
5002245|NCT03981679|colonoscopy|colonoscopy
5002246|NCT03981679|CRC screening|crc screening
5002251|NCT03981640|Cold stress|cold stress
5308620|NCT02135666|Twinrix|twinrix
5002252|NCT03981640|Mental stress|mental stress
5002253|NCT03981575|Myotonic Dystrophy|myotonic dystrophy
5002254|NCT03981575|END DM-1|end dm-1
5002255|NCT03981575|Muscular Dystophy|muscular dystophy
5002256|NCT03981575|DMCRN|dmcrn
5002259|NCT03981549|Retinal Vein Occlusion|retinal vein occlusion
5002260|NCT03981549|Retinal Diseases|retinal diseases
5002261|NCT03981549|Eye Diseases|eye diseases
5002262|NCT03981549|CD34+ Stem Cell Therapy|cd34+ stem cell therapy
5002263|NCT03981549|Autologous Bone Marrow Stem Cells|autologous bone marrow stem cells
5002264|NCT03981549|Stem Cells|stem cells
5002265|NCT03981536|Familial Amyotrophic Lateral Sclerosis|familial amyotrophic lateral sclerosis
5002266|NCT03981536|Sporadic Amyotrophic Lateral Sclerosis|sporadic amyotrophic lateral sclerosis
5002267|NCT03981523|Chagas disease|chagas disease
5002268|NCT03981523|Trypanosoma cruzi|trypanosoma cruzi
5002269|NCT03981523|Chemotherapy|chemotherapy
5002270|NCT03981523|Benznidazole|benznidazole
5002271|NCT03981523|Nifurtimox|nifurtimox
5002272|NCT03981523|Biomarkers|biomarkers
5002273|NCT03981523|Bolivia|bolivia
5002274|NCT03981523|Antiparasitic Agents|antiparasitic agents
5002275|NCT03981523|Parasitic Diseases|parasitic diseases
5002276|NCT03981497|MWA|mwa
5002277|NCT03981445|PrEP|prep
5002278|NCT03981445|HCV Treatment|hcv treatment
5002279|NCT03981445|Injection Drug Use|injection drug use
5002280|NCT03981432|appetite control|appetite control
5002281|NCT03981432|leanness|leanness
5002282|NCT03981432|physical fitness|physical fitness
5002283|NCT03981419|Total hip replacement|total hip replacement
5002284|NCT03981419|Total knee replacement|total knee replacement
5002285|NCT03981406|Palliative Care|palliative care
5002286|NCT03981380|Alzheimer Disease|alzheimer disease
5002287|NCT03981380|Cognitive Impairment|cognitive impairment
5002288|NCT03981380|11C-PiB|11c-pib
5002289|NCT03981380|Atherosclerosis|atherosclerosis
5002290|NCT03981367|External root resorption|external root resorption
5002291|NCT03981367|Distal caries|distal caries
5002292|NCT03981367|Mandibular third molar|mandibular third molar
5002293|NCT03981367|Mandibular second molar|mandibular second molar
5002689|NCT03979144|Prototype|prototype
5002294|NCT03981367|Cone beam computed tomography|cone beam computed tomography
5002295|NCT03981341|sleep apnea|sleep apnea
5002296|NCT03981341|post menopausal|post menopausal
5002297|NCT03981341|oxidative stress|oxidative stress
5002298|NCT03981302|Chronic Nonmalignant Pain|chronic nonmalignant pain
5002299|NCT03981302|Family Nursing|family nursing
5002300|NCT03981302|Multidisciplinary Pain Center|multidisciplinary pain center
5002301|NCT03981302|Quasi-Experimental Study|quasi-experimental study
5002303|NCT03981289|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
5002304|NCT03981289|CAPN3|capn3
5002305|NCT03981289|AN05|an05
5002306|NCT03981289|DYSF|dysf
5002307|NCT03981289|DNAJB6|dnajb6
5002308|NCT03981276|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5002309|NCT03981276|Biomarker|biomarker
5002310|NCT03981276|Genetic etiology|genetic etiology
5002311|NCT03981276|Molecular mechanisms|molecular mechanisms
5002312|NCT03981263|Prospective study|prospective study
5002313|NCT03981263|Cross over|cross over
5002314|NCT03981263|Quality of life|quality of life
5002315|NCT03981263|Breast|breast
5002316|NCT03981263|Mastectomy|mastectomy
5002317|NCT03981263|Breast external prothesis|breast external prothesis
5002318|NCT03981263|MEAVANTI prothesis|meavanti prothesis
5002319|NCT03981250|Resistance training|resistance training
5002320|NCT03981250|Strength Training|strength training
5002321|NCT03981250|Muscle Strength|muscle strength
5002322|NCT03981250|voluntary failure|voluntary failure
5002323|NCT03981237|root canal treatment|root canal treatment
5002324|NCT03981237|root canal irrigation|root canal irrigation
5002325|NCT03981224|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5002326|NCT03981224|Radiotherapy|radiotherapy
5002327|NCT03981224|Epstein-Barr virus|epstein-barr virus
5002328|NCT03981211|people who inject drugs|people who inject drugs
5002329|NCT03981211|injecting related infectious diseases|injecting related infectious diseases
5002330|NCT03981185|depression|depression
5002331|NCT03981185|TMS|tms
5002332|NCT03981185|transcranial magnetic stimulation|transcranial magnetic stimulation
5002333|NCT03981185|theta burst|theta burst
5002334|NCT03981185|alcohol use disorder|alcohol use disorder
5002335|NCT03981185|alcohol addiction|alcohol addiction
5002336|NCT03981172|food reinforcement|food reinforcement
5002337|NCT03981172|food liking|food liking
5002338|NCT03981172|motivation|motivation
5002339|NCT03981172|dopamine|dopamine
5002340|NCT03981172|obesity|obesity
5002341|NCT03981172|energy density|energy density
5002342|NCT03981172|snacks|snacks
5002343|NCT03981146|Strong Class II Microsatellite Status|strong class ii microsatellite status
5002344|NCT03981133|pacifier|pacifier
5002345|NCT03981133|breastfeeding|breastfeeding
5002356|NCT03981107|Cardiac Arrest|cardiac arrest
5002358|NCT03981081|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
5002360|NCT03981068|recurrent|recurrent
5002361|NCT03981068|reirradiation|reirradiation
5002362|NCT03981068|second primary|second primary
5002363|NCT03981042|laryngoscopy|laryngoscopy
5002364|NCT03981042|anesthesic aduction|anesthesic aduction
5002365|NCT03981042|neuromuscular blockade monitoring|neuromuscular blockade monitoring
5002366|NCT03981029|Folate|folate
5002367|NCT03981029|One Carbon Metabolism|one carbon metabolism
5002368|NCT03981029|Preeclampsia|preeclampsia
5002369|NCT03981029|Folic Acid|folic acid
5002370|NCT03981029|Pregnancy|pregnancy
5002371|NCT03981016|Nervous|nervous
5002372|NCT03981016|Central|central
5002373|NCT03981016|Tumor|tumor
5002374|NCT03981016|System|system
5002375|NCT03980990|metformin|metformin
5002376|NCT03980990|diabetes|diabetes
5002377|NCT03980990|pci|pci
5002378|NCT03980990|percutaneous coronary intervention|percutaneous coronary intervention
5002379|NCT03980990|unstable angina|unstable angina
5002380|NCT03980990|acute coronary syndrome|acute coronary syndrome
5002381|NCT03980977|unusual toxicity|unusual toxicity
5002382|NCT03980977|radiosensitivity|radiosensitivity
5002383|NCT03980977|radiotherapy|radiotherapy
5002384|NCT03980977|fibroblast cell|fibroblast cell
5356899|NCT01917578|Magnetic Resonance Imaging|magnetic resonance imaging
5002385|NCT03980977|indirect immunofluorescence test|indirect immunofluorescence test
5002386|NCT03980964|NMES|nmes
5002387|NCT03980964|arthritis|arthritis
5002388|NCT03980964|knee pain|knee pain
5002389|NCT03980964|osteoarthritis|osteoarthritis
5002390|NCT03980964|electrical stimulation therapy|electrical stimulation therapy
5002391|NCT03980912|LiverFASt|liverfast
5002392|NCT03980912|Fibrosis|fibrosis
5002393|NCT03980912|Steatosis|steatosis
5002394|NCT03980912|Activity|activity
5002403|NCT03980808|Diabetes|diabetes
5002404|NCT03980808|Deafness|deafness
5002405|NCT03980795|exercise|exercise
5002406|NCT03980795|physical function|physical function
5002407|NCT03980795|patient reported outcomes|patient reported outcomes
5002408|NCT03980782|Delirium elderly Music therapy|delirium elderly music therapy
5002409|NCT03980782|Elderly|elderly
5002410|NCT03980782|Music Therapy|music therapy
5002411|NCT03980743|Obesity|obesity
5002412|NCT03980743|Overweight|overweight
5002413|NCT03980743|Severe Mental illness|severe mental illness
5002417|NCT03980717|Fetal Tracheal Occlusion|fetal tracheal occlusion
5002418|NCT03980717|FETO plug-unplug|feto plug-unplug
5002419|NCT03980717|Goldvalve balloon|goldvalve balloon
5002420|NCT03980717|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
5002421|NCT03980717|Goldbal balloon|goldbal balloon
5002422|NCT03980717|FETO|feto
5002423|NCT03980704|immunonutrition|immunonutrition
5002424|NCT03980704|preoperative nutrition|preoperative nutrition
5002425|NCT03980691|Chidamide,CAR cell therapy,TCR cell therapy|chidamide,car cell therapy,tcr cell therapy
5002426|NCT03980678|Mineral Rich Algae|mineral rich algae
5002427|NCT03980678|Mineral Nutrition|mineral nutrition
5002428|NCT03980665|Arsenic Trioxide|arsenic trioxide
5002429|NCT03980665|cART|cart
5002430|NCT03980665|HIV-1 reservoir|hiv-1 reservoir
5002431|NCT03980665|functional cure|functional cure
5002437|NCT03980613|Emergency Medical Service|emergency medical service
5002438|NCT03980613|Triage|triage
5002439|NCT03980613|Telephone visitation|telephone visitation
5002440|NCT03980587|ctDNA|ctdna
5002441|NCT03980574|Diabetes Mellitus|diabetes mellitus
5002442|NCT03980561|marijuana|marijuana
5002443|NCT03980561|substance use|substance use
5002444|NCT03980496|CYP2C19|cyp2c19
5002445|NCT03980496|Helicobacter pylori|helicobacter pylori
5002446|NCT03980496|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
5002448|NCT03980496|proton pump inhibitor|proton pump inhibitor
5002449|NCT03980483|Rheumatoid arthritis|rheumatoid arthritis
5002450|NCT03980483|GSK3196165|gsk3196165
5002451|NCT03980483|Tofacitinib|tofacitinib
5002452|NCT03980483|Methotrexate|methotrexate
5002453|NCT03980483|Placebo|placebo
5002454|NCT03980457|Stroke|stroke
5002455|NCT03980457|leg weakness|leg weakness
5002456|NCT03980457|Exoskeleton|exoskeleton
5002457|NCT03980444|Ureterolithiasis|ureterolithiasis
5002458|NCT03980444|Manganese Poisoning|manganese poisoning
5002459|NCT03980444|Lithotripsy|lithotripsy
5002460|NCT03980444|Ureteroscopy|ureteroscopy
5002461|NCT03980444|stone baske|stone baske
5002462|NCT03980431|Brain Tumor|brain tumor
5002463|NCT03980431|FBY-Positron Emission Computed Tomography (FBY-PET)|fby-positron emission computed tomography (fby-pet)
5002464|NCT03980431|glioma|glioma
5002465|NCT03980431|brain metastasis|brain metastasis
5002466|NCT03980418|Parkinson Disease|parkinson disease
5002467|NCT03980418|DaTSCAN™ SPECT/CT scintigraphy|datscan™ spect/ct scintigraphy
5002468|NCT03980418|"Semiconductor CZT camera with large field"|"semiconductor czt camera with large field"
5002469|NCT03980392|prevention|prevention
5002470|NCT03980392|dementia|dementia
5002471|NCT03980392|intervention|intervention
5002472|NCT03980392|mild cognitive impairment|mild cognitive impairment
5002473|NCT03980366|Electroconvulsive Therapy|electroconvulsive therapy
5002474|NCT03980340|Sleep|sleep
5002475|NCT03980340|Circadian Rhythms|circadian rhythms
5002476|NCT03980340|Circadian Rhythm Disorder|circadian rhythm disorder
5002477|NCT03980288|Advanced hepatocellular Carcinoma|advanced hepatocellular carcinoma
5002478|NCT03980288|CAR-T|car-t
5002479|NCT03980288|GPC3|gpc3
5002480|NCT03980275|Bilateral vocal fold paralysis|bilateral vocal fold paralysis
5002481|NCT03980275|Tracheostomy dependency|tracheostomy dependency
5002482|NCT03980275|Glottic airway obstruction|glottic airway obstruction
5002483|NCT03980275|Stridor|stridor
5002484|NCT03980262|Obesity|obesity
5002485|NCT03980262|Self-efficacy|self-efficacy
5002486|NCT03980262|Nutrition|nutrition
5002487|NCT03980262|Physical Activity|physical activity
5002488|NCT03980262|Family-based|family-based
5002489|NCT03980262|Community-Based Participatory Research (CBPR)|community-based participatory research (cbpr)
5002490|NCT03980262|Faith-based organizations|faith-based organizations
5002502|NCT03980145|Robotics|robotics
5002503|NCT03980145|Gait Training|gait training
5002507|NCT03980106|Spinal Reflex Excitability|spinal reflex excitability
5002508|NCT03980106|Muscle Relaxation|muscle relaxation
5002509|NCT03980106|H reflex|h reflex
5002510|NCT03980080|CD127/IL-7Rα Antagonist|cd127/il-7rα antagonist
5002511|NCT03980080|Auto-Immune Diseases|auto-immune diseases
5002512|NCT03980080|inflammatory bowel diseases|inflammatory bowel diseases
5002513|NCT03980080|Ulcerative Colitis|ulcerative colitis
5002514|NCT03980067|Virtual Reality|virtual reality
5002515|NCT03980067|Procedural Sedation|procedural sedation
5002516|NCT03980067|Modified Yale Preoperative Anxiety Scale|modified yale preoperative anxiety scale
5002517|NCT03980067|Post-Hospitalization Behavior Questionnaire|post-hospitalization behavior questionnaire
5002518|NCT03980067|Pediatric|pediatric
5002519|NCT03980067|Emergency Department|emergency department
5002520|NCT03980067|Ketamine|ketamine
5002522|NCT03980028|cancer|cancer
5002523|NCT03980028|ovarian|ovarian
5002524|NCT03980028|advanced|advanced
5002525|NCT03980002|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5002526|NCT03980002|Therapeutics|therapeutics
5002527|NCT03980002|ibrutinib|ibrutinib
5002528|NCT03980002|fludarabine|fludarabine
5002529|NCT03980002|rituximab|rituximab
5002530|NCT03980002|bendamustine|bendamustine
5002531|NCT03980002|cyclophosphamide|cyclophosphamide
5002532|NCT03980002|treatment-naive|treatment-naive
5002533|NCT03979976|systemic lupus erythematosus|systemic lupus erythematosus
5002534|NCT03979976|endothelium|endothelium
5002535|NCT03979976|ramipril|ramipril
5002536|NCT03979963|Depression|depression
5002537|NCT03979963|Emotion Regulation|emotion regulation
5002538|NCT03979963|Cognitive Behavioral Therapy|cognitive behavioral therapy
5002539|NCT03979963|Ecological Momentary Assessment|ecological momentary assessment
5002540|NCT03979950|organ transplant|organ transplant
5002541|NCT03979924|Trismus|trismus
5002542|NCT03979924|prevention|prevention
5002543|NCT03979924|education|education
5002544|NCT03979924|nutrition|nutrition
5002545|NCT03979924|preventive rehabilitation|preventive rehabilitation
5002546|NCT03979924|mouth|mouth
5002547|NCT03979911|Pertuzumab|pertuzumab
5002548|NCT03979911|Breast Neoplasms/pathology|breast neoplasms/pathology
5002549|NCT03979911|Real life|real life
5002550|NCT03979911|Trastuzumab|trastuzumab
5002551|NCT03979911|Receptor, ErbB-2/antagonists & inhibitors*|receptor, erbb-2/antagonists & inhibitors*
5002552|NCT03979911|Breast Neoplasms/drug therapy*|breast neoplasms/drug therapy*
5002553|NCT03979911|Multicenter Study|multicenter study
5002554|NCT03979911|Taxoids|taxoids
5002555|NCT03979911|Antibodies, Monoclonal, Humanized|antibodies, monoclonal, humanized
5002556|NCT03979872|Education Prevention|education prevention
5002564|NCT03979703|Yoga|yoga
5002565|NCT03979690|Robotic Colonoscopy|robotic colonoscopy
5002566|NCT03979690|Tandem Colonoscopy|tandem colonoscopy
5002567|NCT03979690|NISInspire-C System|nisinspire-c system
5002568|NCT03979690|Single Use Colonoscope|single use colonoscope
5002569|NCT03979690|Colonoscopy|colonoscopy
5002570|NCT03979677|vestibular migraine, dizziness, vertigo|vestibular migraine, dizziness, vertigo
5002572|NCT03979651|MEK inhibitor|mek inhibitor
5002573|NCT03979651|Autophagy inhibition|autophagy inhibition
5002574|NCT03979651|Metastatic NRAs Melanoma|metastatic nras melanoma
5002575|NCT03979638|Unexplained or refractory chronic cough, P2X3 antagonists|unexplained or refractory chronic cough, p2x3 antagonists
5002576|NCT03979612|breast|breast
5002578|NCT03979612|cancer|cancer
5002579|NCT03979612|ovarian|ovarian
5002580|NCT03979612|predisposition|predisposition
5002581|NCT03979599|TAP, magnisum sulphate|tap, magnisum sulphate
5002582|NCT03979573|Prospective Study|prospective study
5002583|NCT03979573|Multiparametric MRI|multiparametric mri
5002584|NCT03979573|Radiomics|radiomics
5002585|NCT03979573|MR-guided Biopsy|mr-guided biopsy
5002586|NCT03979573|Molecular Markers|molecular markers
5002587|NCT03979573|Active Surveillance|active surveillance
5002588|NCT03979573|Prostate Cancer|prostate cancer
5002589|NCT03979560|Autonomy|autonomy
5002590|NCT03979560|Nutritional support|nutritional support
5002597|NCT03979534|low-protein diet|low-protein diet
5002598|NCT03979534|pre-dialysis|pre-dialysis
5002599|NCT03979534|chronic kidney disease|chronic kidney disease
5002600|NCT03979534|nutritional care|nutritional care
5002601|NCT03979534|start of dialysis|start of dialysis
5322016|NCT02075775|instability|instability
5002602|NCT03979534|incremental dialysis|incremental dialysis
5002603|NCT03979521|Myasthenia Gravis|myasthenia gravis
5002604|NCT03979521|Quality of life|quality of life
5002605|NCT03979521|Burden of disease|burden of disease
5002606|NCT03979521|Social support|social support
5002607|NCT03979495|Abnormal Screening Results|abnormal screening results
5002608|NCT03979482|skeletal muscle mitochondrial abnormalities|skeletal muscle mitochondrial abnormalities
5002609|NCT03979482|metabolic syndrome|metabolic syndrome
5002610|NCT03979482|insulin resistance|insulin resistance
5002611|NCT03979456|Multiple sclerosis|multiple sclerosis
5002612|NCT03979456|Relapsing-Remitting|relapsing-remitting
5002613|NCT03979456|Dosing protocols|dosing protocols
5002614|NCT03979456|Randomized trial|randomized trial
5002615|NCT03979443|Anterior cervical decompression and fusion|anterior cervical decompression and fusion
5002616|NCT03979443|cervical fusion|cervical fusion
5002617|NCT03979443|cervical spine|cervical spine
5002618|NCT03979443|spinal surgery|spinal surgery
5002619|NCT03979443|outpatient care|outpatient care
5002620|NCT03979443|randomized controlled trial|randomized controlled trial
5002622|NCT03979430|Acute Exacerbation|acute exacerbation
5002623|NCT03979430|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5002624|NCT03979430|Home Spirometry|home spirometry
5002625|NCT03979417|Biomarkers|biomarkers
5002632|NCT03979391|Clinically Isolated Syndrome|clinically isolated syndrome
5002633|NCT03979391|Radiologically Isolated Syndrome|radiologically isolated syndrome
5002634|NCT03979391|Multiple Sclerosis|multiple sclerosis
5002635|NCT03979391|Children|children
5002636|NCT03979391|Tear analysis|tear analysis
5002637|NCT03979365|tacrolimus|tacrolimus
5002638|NCT03979365|envarsus xr|envarsus xr
5002639|NCT03979365|renal transplant|renal transplant
5002640|NCT03979365|kidney transplant|kidney transplant
5002641|NCT03979352|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5002642|NCT03979352|Empagliflozin|empagliflozin
5002643|NCT03979352|Artificial Pancreas|artificial pancreas
5002644|NCT03979352|SGLT2 inhibitor|sglt2 inhibitor
5002645|NCT03979352|insulin pump|insulin pump
5002646|NCT03979352|closed loop|closed loop
5002647|NCT03979339|Circulating Tumour Cells|circulating tumour cells
5002648|NCT03979339|Selected cancer patients|selected cancer patients
5002649|NCT03979339|New technology|new technology
5002650|NCT03979313|Respiratory Syncytial Virus|respiratory syncytial virus
5002651|NCT03979313|RSV|rsv
5002652|NCT03979313|Late Preterm Infants|late preterm infants
5002653|NCT03979313|Healthy Infants|healthy infants
5002654|NCT03979313|Lower Respiratory Tract Infection|lower respiratory tract infection
5002655|NCT03979300|Simulation training|simulation training
5002656|NCT03979300|Role-play|role-play
5002657|NCT03979300|Psychiatry|psychiatry
5002658|NCT03979300|Students|students
5002668|NCT03979274|Levothyroxine|levothyroxine
5002669|NCT03979222|ECMO|ecmo
5002670|NCT03979222|ARDS|ards
5002671|NCT03979222|Acute respiratory failure|acute respiratory failure
5002672|NCT03979209|Cortisol Suppression|cortisol suppression
5002673|NCT03979209|Mometasone|mometasone
5002674|NCT03979209|Chronic Rhinosinusitis|chronic rhinosinusitis
5002675|NCT03979209|Steroid Irrigations|steroid irrigations
5002676|NCT03979196|Preterm Birth|preterm birth
5002677|NCT03979196|Pregnancy, High Risk|pregnancy, high risk
5002678|NCT03979196|Short Cervix|short cervix
5002679|NCT03979183|Pain|pain
5002680|NCT03979183|Therapeutic exercise|therapeutic exercise
5002681|NCT03979183|Physiotherapy|physiotherapy
5002682|NCT03979183|Rehabilitation|rehabilitation
5002683|NCT03979183|Quality of life|quality of life
5002684|NCT03979157|Muscular Diseases|muscular diseases
5002685|NCT03979157|Duchenne muscular disease|duchenne muscular disease
5002686|NCT03979157|MSOT|msot
5002687|NCT03979144|Usability|usability
5002688|NCT03979144|HIV self-test|hiv self-test
5002691|NCT03979118|Skeletal Related Events|skeletal related events
5002692|NCT03979092|Collaborative skills|collaborative skills
5002694|NCT03979092|Self-efficacy|self-efficacy
5002695|NCT03979092|Interprofessional education|interprofessional education
5002696|NCT03979092|Advanced Cardiac Life Support|advanced cardiac life support
5002697|NCT03979092|Nursing students|nursing students
5002698|NCT03979066|Neoadjuvant therapy|neoadjuvant therapy
5002699|NCT03979066|PEGPH20|pegph20
5002700|NCT03979066|Atezolizumab|atezolizumab
5002701|NCT03979066|Columbia|columbia
5002702|NCT03979066|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
5002703|NCT03979053|Auto Immune Hepatitis, Magnetic Resonance Imaging|auto immune hepatitis, magnetic resonance imaging
5002704|NCT03979027|Cognition|cognition
5002705|NCT03979014|neoplasia|neoplasia
5002706|NCT03979014|cervix cancer|cervix cancer
5002707|NCT03979014|vaccination|vaccination
5002708|NCT03978988|stroke|stroke
5002709|NCT03978988|tandem occlusion|tandem occlusion
5002710|NCT03978988|carotid stenting|carotid stenting
5002711|NCT03978988|thrombectomy|thrombectomy
5002712|NCT03978975|Energy expenditure|energy expenditure
5002713|NCT03978975|Food intake|food intake
5002714|NCT03978975|Women|women
5002715|NCT03978975|aquacycling|aquacycling
5002716|NCT03978962|Periodontal defects|periodontal defects
5002717|NCT03978962|Alveolar bone preservation|alveolar bone preservation
5002718|NCT03978962|Collagen membrane|collagen membrane
5002719|NCT03978962|Mucosa healing|mucosa healing
5002720|NCT03978936|Bronchial Diseases|bronchial diseases
5002721|NCT03978936|Respiratory Tract Diseases|respiratory tract diseases
5002722|NCT03978936|Lung Diseases|lung diseases
5002723|NCT03978936|Obstructive Lung Diseases|obstructive lung diseases
5002724|NCT03978923|ultrasonic surgery|ultrasonic surgery
5002725|NCT03978923|piezosurgery|piezosurgery
5002726|NCT03978923|implant bed preparation|implant bed preparation
5002727|NCT03978923|microcracks|microcracks
5002728|NCT03978923|pain|pain
5002729|NCT03978923|crestal bone resorption|crestal bone resorption
5002730|NCT03978897|lateral epicondylitis|lateral epicondylitis
5002731|NCT03978897|tennis elbow|tennis elbow
5002732|NCT03978897|blood flow restriction|blood flow restriction
5002733|NCT03978897|physical therapy|physical therapy
5002734|NCT03978871|Brain|brain
5002735|NCT03978871|Functional Neuroimaging|functional neuroimaging
5002736|NCT03978871|Stress, Psychological|stress, psychological
5002737|NCT03978871|Emotions|emotions
5002738|NCT03978871|Psychology, Developmental|psychology, developmental
5002739|NCT03978819|Analgesia nociception index|analgesia nociception index
5002740|NCT03978819|Parasympathetic nerve stimulation|parasympathetic nerve stimulation
5002741|NCT03978819|Excessive analgesia|excessive analgesia
5002742|NCT03978780|Spinae fascial plane block|spinae fascial plane block
5002743|NCT03978780|Serratus block|serratus block
5002744|NCT03978780|Breast surgery|breast surgery
5002745|NCT03978767|NSAIDs|nsaids
5002746|NCT03978767|Ibuprofen|ibuprofen
5002747|NCT03978754|Lymphedema of Upper Arm|lymphedema of upper arm
5002748|NCT03978754|Breast Neoplasms|breast neoplasms
5002749|NCT03978702|Pancreatectomy|pancreatectomy
5002750|NCT03978702|Immune system|immune system
5002751|NCT03978663|locally advanced breast cancer|locally advanced breast cancer
5002755|NCT03978663|radiotherapy|radiotherapy
5002756|NCT03978663|immuno-oncology|immuno-oncology
5002757|NCT03978637|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5002758|NCT03978637|lung transplant|lung transplant
5002759|NCT03978637|JAK1 inhibitor|jak1 inhibitor
5002760|NCT03978624|Muscle Invasive Bladder Cancer|muscle invasive bladder cancer
5002761|NCT03978624|MIBC|mibc
5002762|NCT03978624|pembrolizumab|pembrolizumab
5002763|NCT03978624|entinostat|entinostat
5002764|NCT03978585|HTEMS|htems
5002765|NCT03978585|peripheral neuropathy|peripheral neuropathy
5002766|NCT03978585|chemotherapy|chemotherapy
5002767|NCT03978585|TENS therapy|tens therapy
5002768|NCT03978572|Exercise|exercise
5002770|NCT03978520|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5002771|NCT03978520|ABBV-105|abbv-105
5002772|NCT03978520|Upadacitinib|upadacitinib
5002773|NCT03978520|ABBV-599|abbv-599
5002774|NCT03978507|Freezing of Gait, Intelligent cueing, Detection of freezing of gait, Home environment, Free-living gait monitoring|freezing of gait, intelligent cueing, detection of freezing of gait, home environment, free-living gait monitoring
5002775|NCT03978494|Kidney transplant; Renal transplant|kidney transplant; renal transplant
5002776|NCT03978481|Gastric cancer|gastric cancer
5002777|NCT03978481|Helicobacter pylori|helicobacter pylori
5002778|NCT03978481|Subtotal gastrectomy|subtotal gastrectomy
5002779|NCT03978481|Overall survival|overall survival
5002780|NCT03978481|Metachronous cancer|metachronous cancer
5002781|NCT03978468|Collaboration, Home Health Nurse, Providers|collaboration, home health nurse, providers
5002782|NCT03978455|Mobile app|mobile app
5002783|NCT03978442|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5002784|NCT03978442|Smoking|smoking
5002791|NCT03978416|Obesity|obesity
5002796|NCT03978403|Pharmacokinetics|pharmacokinetics
5002797|NCT03978403|Healthy|healthy
5002798|NCT03978403|Volunteer|volunteer
5002799|NCT03978390|Dental Injection|dental injection
5002800|NCT03978390|Behavioral Intervention|behavioral intervention
5002801|NCT03978390|Behavioral Priming|behavioral priming
5002802|NCT03978390|Endowment Effect|endowment effect
5002803|NCT03978390|Personality Traits|personality traits
5002804|NCT03978377|Radiotherapy|radiotherapy
5002805|NCT03978377|Pulmonary hypertension|pulmonary hypertension
5002806|NCT03978338|Alzheimer Disease|alzheimer disease
5002807|NCT03978338|Brain polypeptide|brain polypeptide
5002808|NCT03978325|Prehabilitation|prehabilitation
5002809|NCT03978325|Exercise|exercise
5002811|NCT03978312|Nutrition|nutrition
5002812|NCT03978312|Health|health
5002813|NCT03978312|Literacy|literacy
5002814|NCT03978312|Education|education
5002815|NCT03978312|Information|information
5002816|NCT03978312|Knowledge|knowledge
5002817|NCT03978299|Prostatic Neoplasms|prostatic neoplasms
5002818|NCT03978299|False Positive Reactions|false positive reactions
5002819|NCT03978299|False Negative Reactions|false negative reactions
5002820|NCT03978299|Disease Management|disease management
5002821|NCT03978286|depression|depression
5002822|NCT03978286|Type 2 diabetes Mellitus|type 2 diabetes mellitus
5002823|NCT03978286|vortioxetine|vortioxetine
5002824|NCT03978286|sertraline|sertraline
5002825|NCT03978273|Vertebral column|vertebral column
5309130|NCT02133521|NIHSS|nihss
5002826|NCT03978273|Rehabilitation|rehabilitation
5002827|NCT03978273|Virtual-brace|virtual-brace
5002828|NCT03978273|Posture|posture
5002829|NCT03978260|Anemia|anemia
5002830|NCT03978221|Diaphragmatic Tissue Doppler|diaphragmatic tissue doppler
5002831|NCT03978221|Non invasive ventilation|non invasive ventilation
5002832|NCT03978221|Spontaneous breathing|spontaneous breathing
5002833|NCT03978221|Post-extubation|post-extubation
5002834|NCT03978208|Knee|knee
5002835|NCT03978208|WOMAC|womac
5002836|NCT03978208|NSAID|nsaid
5002837|NCT03978208|Pain|pain
5002838|NCT03978182|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5002839|NCT03978169|anaesthetic modality|anaesthetic modality
5002840|NCT03978169|Lung|lung
5002841|NCT03978143|Adult|adult
5002842|NCT03978143|Bioavailability|bioavailability
5002843|NCT03978143|Crizotinib|crizotinib
5002844|NCT03978143|Drug Interactions|drug interactions
5002845|NCT03978143|Esomeprazole|esomeprazole
5002846|NCT03978143|Humans|humans
5002847|NCT03978143|Microsphere|microsphere
5002848|NCT03978143|Pharmacokinetics|pharmacokinetics
5002849|NCT03978143|Safety|safety
5002850|NCT03978143|Taste|taste
5002851|NCT03978104|Okara|okara
5002852|NCT03978104|Soybean pulp|soybean pulp
5002853|NCT03978104|Soybean|soybean
5002854|NCT03978104|Fibre|fibre
5002855|NCT03978104|Gut microbiome|gut microbiome
5002856|NCT03978104|Microbiota|microbiota
5002857|NCT03978104|Gastrointestinal microbiome|gastrointestinal microbiome
5002858|NCT03978104|Glycemic|glycemic
5002859|NCT03978104|Glycaemic|glycaemic
5002860|NCT03978104|Middle-aged and older adults|middle-aged and older adults
5003115|NCT03976700|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5003116|NCT03976700|Bufei Jianpi Granule|bufei jianpi granule
5003117|NCT03976700|Randomized Controlled Trial|randomized controlled trial
5003118|NCT03976674|Bariatric Surgery Candidate|bariatric surgery candidate
5003119|NCT03976674|Cognitive and Behavioural Emotional Therapies|cognitive and behavioural emotional therapies
5006011|NCT03959098|Effectiveness|effectiveness
5006012|NCT03959098|Neck Pain|neck pain
5006013|NCT03959033|PROMs|proms
5003121|NCT03976661|No severe behavioural disorders, EHPAD (retirement home), Older patients, loss of autonomy, Groupe-Iso-Ressources (GIR)|no severe behavioural disorders, ehpad (retirement home), older patients, loss of autonomy, groupe-iso-ressources (gir)
5003122|NCT03976635|Removable Mandibular Retractor|removable mandibular retractor
5003123|NCT03976635|Bone-anchored Intermaxillary Traction|bone-anchored intermaxillary traction
5003124|NCT03976622|Skin inflammation|skin inflammation
5003125|NCT03976622|Cytokines|cytokines
5003126|NCT03976609|Nasak Septum|nasak septum
5003127|NCT03976609|Cleft Lip|cleft lip
5003128|NCT03976609|Cleft palate|cleft palate
5003129|NCT03976609|Palatal expansion technique|palatal expansion technique
5003130|NCT03976596|neonates|neonates
5003131|NCT03976596|mitochondria|mitochondria
5003132|NCT03976596|MRI|mri
5003133|NCT03976544|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5003134|NCT03976544|FET|fet
5003135|NCT03976544|natural cycle|natural cycle
5003136|NCT03976544|hormone replacement therapy cycle|hormone replacement therapy cycle
5049574|NCT03688516|emotion|emotion
5003137|NCT03976544|miscarriage|miscarriage
5003138|NCT03976531|cancer|cancer
5003139|NCT03976531|elderly|elderly
5003140|NCT03976531|randomized trial|randomized trial
5003141|NCT03976531|consensus|consensus
5003142|NCT03976518|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5003143|NCT03976518|NSCLC Rare Histological Subtypes|nsclc rare histological subtypes
5003144|NCT03976505|medication prescriptions|medication prescriptions
5003145|NCT03976505|eye-tracking|eye-tracking
5003146|NCT03976505|non-adherence|non-adherence
5003147|NCT03976505|medication schedule|medication schedule
5003148|NCT03976479|Body composition|body composition
5003149|NCT03976479|Nutritional status|nutritional status
5003150|NCT03976479|Lipids|lipids
5003151|NCT03976479|Blood pressure|blood pressure
5003152|NCT03976479|Lifestyle factors|lifestyle factors
5003153|NCT03976466|periprosthetic joint infection|periprosthetic joint infection
5003154|NCT03976466|Prophylaxis|prophylaxis
5003155|NCT03976466|Joint Replacement|joint replacement
5003156|NCT03976466|calcium sulfate beds|calcium sulfate beds
5003157|NCT03976440|Acute kidney injury|acute kidney injury
5003158|NCT03976440|Regional citrate anticoagulation|regional citrate anticoagulation
5003159|NCT03976440|Continuous renal replacement therapy|continuous renal replacement therapy
5003160|NCT03976440|Prolonged intermittent renal replacement therapy|prolonged intermittent renal replacement therapy
5003161|NCT03976388|Virtual reality|virtual reality
5003162|NCT03976388|Clinical simulation|clinical simulation
5003163|NCT03976388|Adherence|adherence
5003164|NCT03976388|Guidelines|guidelines
5003175|NCT03976297|Machine learning|machine learning
5003176|NCT03976297|Artificial Intelligence|artificial intelligence
5003177|NCT03976297|Pragmatic Clinical Trial|pragmatic clinical trial
5003178|NCT03976297|Healthcare Delivery|healthcare delivery
5003179|NCT03976258|heroin|heroin
5003180|NCT03976258|HIV|hiv
5003181|NCT03976258|inflammation|inflammation
5003186|NCT03976193|Recent treatment|recent treatment
5003187|NCT03976180|Sickle Cell Disease|sickle cell disease
5003188|NCT03976180|vaso-occlusive pain crisis|vaso-occlusive pain crisis
5003189|NCT03976180|HFNO|hfno
5003191|NCT03976167|Children|children
5003192|NCT03976167|Desaturations|desaturations
5003193|NCT03976167|Bronchoscopy|bronchoscopy
5003194|NCT03976167|Oxygen|oxygen
5003195|NCT03976167|High flow oxygen|high flow oxygen
5003196|NCT03976128|endurance training|endurance training
5003197|NCT03976128|nordic walking|nordic walking
5003198|NCT03976128|walking ability|walking ability
5003199|NCT03976128|fatigue|fatigue
5003200|NCT03976102|Follicular Lymphoma|follicular lymphoma
5003201|NCT03976102|Dr. Reddy's Rituximab|dr. reddy's rituximab
5003202|NCT03976102|Biosimiliar (DRL_RI)|biosimiliar (drl_ri)
5003203|NCT03976102|FLINTER|flinter
5003204|NCT03976063|Preterm premature rupture of membranes|preterm premature rupture of membranes
5003205|NCT03976063|Tocolysis|tocolysis
5003211|NCT03976011|Postoperative dysphonia|postoperative dysphonia
5003212|NCT03976011|Thyroidectomy|thyroidectomy
5003213|NCT03976011|Parathyroidectomy|parathyroidectomy
5003214|NCT03976011|Inferior laryngeal nerve palsy|inferior laryngeal nerve palsy
5003215|NCT03976011|Trans laryngeal ultrasonography|trans laryngeal ultrasonography
5003216|NCT03976011|Quantitative vocal fold motion evaluation|quantitative vocal fold motion evaluation
5003217|NCT03976011|Postoperative recurrent Laryngeal Nerve Palsy|postoperative recurrent laryngeal nerve palsy
5003218|NCT03975998|Mitral regurgitation|mitral regurgitation
5003219|NCT03975998|Mitral repair|mitral repair
5003220|NCT03975998|Watchful waiting|watchful waiting
5003221|NCT03975998|Asymptomatic|asymptomatic
5003222|NCT03975985|stroke|stroke
5003223|NCT03975985|core stability|core stability
5003224|NCT03975985|trunk control|trunk control
5003225|NCT03975985|sitting balance|sitting balance
5003226|NCT03975985|gait|gait
5003227|NCT03975985|spasticity|spasticity
5003229|NCT03975985|activities of daily living|activities of daily living
5003230|NCT03975985|standing balance|standing balance
5003234|NCT03975933|Reproductive Health|reproductive health
5003236|NCT03975933|Randomization Trial|randomization trial
5003237|NCT03975933|Uganda|uganda
5003238|NCT03975920|jaw support device|jaw support device
5003239|NCT03975920|wisdom teeth|wisdom teeth
5003240|NCT03975920|impacted|impacted
5003241|NCT03975920|Temporomandibular Disorders|temporomandibular disorders
5003242|NCT03975907|multiple myeloma|multiple myeloma
5003243|NCT03975907|car-T|car-t
5003244|NCT03975894|pregnancy|pregnancy
5003245|NCT03975894|exchange transfusion|exchange transfusion
5003246|NCT03975894|perinatal complications|perinatal complications
5003247|NCT03975881|Suicide attempts|suicide attempts
5049706|NCT03687697|IVF|ivf
5003248|NCT03975881|digital device|digital device
5003249|NCT03975881|adolescent|adolescent
5003250|NCT03975881|adults|adults
5003251|NCT03975868|Cut-out|cut-out
5003252|NCT03975868|Gamma nail|gamma nail
5003253|NCT03975868|Lag-screw|lag-screw
5003254|NCT03975868|Tip-apex distance|tip-apex distance
5003255|NCT03975868|Trochanteric fracture|trochanteric fracture
5003256|NCT03975855|Breast Cancer|breast cancer
5003257|NCT03975855|Axillary Lymph Nodes|axillary lymph nodes
5003258|NCT03975855|Biopsy|biopsy
5003259|NCT03975842|otitis media with effusion (OME)|otitis media with effusion (ome)
5003260|NCT03975842|prevalence|prevalence
5003261|NCT03975842|risk factor|risk factor
5003262|NCT03975842|endoscopic nasal examination|endoscopic nasal examination
5003263|NCT03975842|otoscopic examination|otoscopic examination
5003264|NCT03975842|pure-tone audiometry|pure-tone audiometry
5003265|NCT03975842|tympanometry|tympanometry
5003266|NCT03975829|v600-mutation|v600-mutation
5003267|NCT03975829|neuroblastoma|neuroblastoma
5003268|NCT03975829|Trametinib|trametinib
5003269|NCT03975829|pediatrics|pediatrics
5003270|NCT03975829|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
5003271|NCT03975829|low grade glioma|low grade glioma
5003272|NCT03975829|plexiform neurofibromas|plexiform neurofibromas
5003273|NCT03975829|high grade glioma|high grade glioma
5003274|NCT03975829|dabrafenib|dabrafenib
5003275|NCT03975829|NF-1|nf-1
5044751|NCT03719482|HV|hv
5003276|NCT03975816|Analgesia nociception index|analgesia nociception index
5003277|NCT03975816|Painless labor|painless labor
5003278|NCT03975816|epidural analgesia|epidural analgesia
5003279|NCT03975803|return to work|return to work
5003280|NCT03975803|readiness for return to work|readiness for return to work
5003281|NCT03975803|occupational injury|occupational injury
5003282|NCT03975803|work hardening|work hardening
5003287|NCT03975699|paediatric-psychological partnership|paediatric-psychological partnership
5003288|NCT03975699|child|child
5003289|NCT03975699|mental health|mental health
5003290|NCT03975699|integrated care|integrated care
5003291|NCT03975699|well-being|well-being
5003292|NCT03975673|hip arthroplasty|hip arthroplasty
5003293|NCT03975673|spine hip relation|spine hip relation
5003294|NCT03975634|pediatric-onset|pediatric-onset
5003295|NCT03975634|transcutaneous spinal stimulation|transcutaneous spinal stimulation
5003296|NCT03975634|trunk control|trunk control
5003301|NCT03975569|vaginal, yeast infection, candida, candidosis|vaginal, yeast infection, candida, candidosis
5003302|NCT03975543|Retinitis Pigmentosa|retinitis pigmentosa
5003304|NCT03975543|PDE6A|pde6a
5003305|NCT03975543|PDE6B|pde6b
5003306|NCT03975543|Pathogenic mutation|pathogenic mutation
5003307|NCT03975543|Retrospective|retrospective
5003308|NCT03975543|Natural History|natural history
5003309|NCT03975543|Retinal Disease|retinal disease
5003310|NCT03975543|Eye Diseases|eye diseases
5003311|NCT03975543|Blindness|blindness
5003316|NCT03975530|Home visiting interventions|home visiting interventions
5003318|NCT03975530|Community based participatory research|community based participatory research
5003319|NCT03975530|Pregnancy|pregnancy
5003320|NCT03975517|Prep|prep
5003321|NCT03975517|Sexual behavior|sexual behavior
5003322|NCT03975517|HIV|hiv
5003323|NCT03975517|Syphilis|syphilis
5003324|NCT03975517|Chlamydia infection|chlamydia infection
5003325|NCT03975517|Hepatitis|hepatitis
5003326|NCT03975517|Gonococcus|gonococcus
5003327|NCT03975478|bariatric surgery|bariatric surgery
5003328|NCT03975478|gastric bypass|gastric bypass
5003329|NCT03975478|sleeve gastrectomy|sleeve gastrectomy
5003330|NCT03975478|LDL cholesterol|ldl cholesterol
5003331|NCT03975478|morbid obesity|morbid obesity
5003332|NCT03975465|oropharyngeal cancer|oropharyngeal cancer
5003333|NCT03975465|laryngeal cancer|laryngeal cancer
5003334|NCT03975465|swallow|swallow
5003335|NCT03975465|chemoradiation|chemoradiation
5003342|NCT03975413|Multiple Sclerosis|multiple sclerosis
5003343|NCT03975387|solid tumor|solid tumor
5003344|NCT03975387|mesothelioma|mesothelioma
5003345|NCT03975387|TP53|tp53
5003346|NCT03975361|Rituximab|rituximab
5003347|NCT03975348|High flow nasal cannula|high flow nasal cannula
5003348|NCT03975348|Bariatric surgery|bariatric surgery
5003349|NCT03975348|Postoperative atelectasis|postoperative atelectasis
5003350|NCT03975348|Electrical impedance tomography|electrical impedance tomography
5003351|NCT03975335|NCDs|ncds
5003352|NCT03975335|Risk behaviors|risk behaviors
5003353|NCT03975335|Adolescents|adolescents
5003354|NCT03975335|Health education intervention|health education intervention
5003355|NCT03975322|OLP|olp
5003356|NCT03975322|oral cancer|oral cancer
5003357|NCT03975322|OSCC|oscc
5003358|NCT03975322|oral squamous cell carcinoma|oral squamous cell carcinoma
5003359|NCT03975309|Cognition, Dementia, Mild Cognitive Impairment, European American, African American|cognition, dementia, mild cognitive impairment, european american, african american
5003360|NCT03975192|Opiate Withdrawal|opiate withdrawal
5003361|NCT03975192|Neurostimulation|neurostimulation
5003362|NCT03975192|Percutaneous Electric Nerve Field Stimulation|percutaneous electric nerve field stimulation
5003363|NCT03975192|Pediatrics|pediatrics
5003364|NCT03975192|Pediatric Intensive Care Unit|pediatric intensive care unit
5003365|NCT03975179|frozen section biopsy|frozen section biopsy
5003366|NCT03975179|resection margin|resection margin
5003367|NCT03975179|breast conserving surgery|breast conserving surgery
5003368|NCT03975166|bioequivalence|bioequivalence
5003369|NCT03975166|fluticasone propionate|fluticasone propionate
5003370|NCT03975166|salmeterol xinafoate|salmeterol xinafoate
5003371|NCT03975166|ADVAIR|advair
5003372|NCT03975153|Interleukin-23, IL-23, guselkumab, Tremfya|interleukin-23, il-23, guselkumab, tremfya
5003373|NCT03975127|population screening|population screening
5003374|NCT03975114|Eldelry|eldelry
5003375|NCT03975114|metastatic Non-Small-Cell Lung Cancer|metastatic non-small-cell lung cancer
5003376|NCT03975114|Durvalumab|durvalumab
5003377|NCT03975114|Immunotherapy|immunotherapy
5003378|NCT03975062|atrial fibrillation|atrial fibrillation
5003379|NCT03975062|cardioversion|cardioversion
5003380|NCT03975062|anticoagulation|anticoagulation
5003381|NCT03975062|dabigatran|dabigatran
5003382|NCT03975062|magnetic resonance imaging|magnetic resonance imaging
5003383|NCT03974945|Rehabilitation|rehabilitation
5003384|NCT03974932|total knee arthroplasty|total knee arthroplasty
5003385|NCT03974932|postoperative pain|postoperative pain
5003386|NCT03974932|multimodal analgesia|multimodal analgesia
5003387|NCT03974919|Pulmonary Hypertension, major cardiovascular event, non-cardiac surgery,threshold|pulmonary hypertension, major cardiovascular event, non-cardiac surgery,threshold
5003388|NCT03974906|goal-directed fluid therapy|goal-directed fluid therapy
5003389|NCT03974906|intraoperative hemodynamics|intraoperative hemodynamics
5003390|NCT03974906|postoperative complications|postoperative complications
5003391|NCT03974906|elderly patient|elderly patient
5003392|NCT03974906|prone position|prone position
5003393|NCT03974893|Dietary intake|dietary intake
5003395|NCT03974893|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5003396|NCT03974867|idiopathic sudden sensorineural hearing loss|idiopathic sudden sensorineural hearing loss
5003397|NCT03974867|vestibular dysfunction|vestibular dysfunction
5003398|NCT03974867|glucocorticoids|glucocorticoids
5003399|NCT03974828|Telemedicine|telemedicine
5003400|NCT03974828|Anesthesia Control Tower|anesthesia control tower
5003401|NCT03974828|Machine Learning|machine learning
5003402|NCT03974828|Forecasting Algorithms|forecasting algorithms
5309436|NCT02131961|foot wound|foot wound
5003403|NCT03974828|Randomized Controlled Trial|randomized controlled trial
5003404|NCT03974828|PACU|pacu
5003405|NCT03974815|tDCS|tdcs
5003406|NCT03974815|Bipolar disorder|bipolar disorder
5003407|NCT03974815|Depression|depression
5003408|NCT03974763|Facial Paralysis|facial paralysis
5003409|NCT03974763|Bell's Palsy|bell's palsy
5003410|NCT03974763|unilateral|unilateral
5003411|NCT03974763|3D|3d
5003412|NCT03974763|3D imaging|3d imaging
5003413|NCT03974763|Facial form|facial form
5003414|NCT03974763|Facial function|facial function
5003415|NCT03974737|POTS|pots
5003416|NCT03974737|Postural Orthostatic Tachycardia Syndrome|postural orthostatic tachycardia syndrome
5003417|NCT03974737|Dysautonomia|dysautonomia
5003418|NCT03974737|CRI|cri
5003419|NCT03974737|Compensatory Reserve Index|compensatory reserve index
5003420|NCT03974724|Preterm birth|preterm birth
5003421|NCT03974724|Prediction|prediction
5003422|NCT03974724|Cervical vaginal fluid|cervical vaginal fluid
5003423|NCT03974698|femoral offset|femoral offset
5003424|NCT03974698|leg length discrepancy|leg length discrepancy
5019311|NCT03876366|Decision Aid (DA)|decision aid (da)
5003429|NCT03974685|Integrin ανβ3|integrin ανβ3
5003430|NCT03974685|Dosimetry|dosimetry
5003431|NCT03974646|chronic kidney disease|chronic kidney disease
5003432|NCT03974646|health related quality of life|health related quality of life
5003433|NCT03974646|knowledge|knowledge
5003434|NCT03974646|randomized controlled trial|randomized controlled trial
5003435|NCT03974646|self-management|self-management
5003436|NCT03974646|self-efficacy|self-efficacy
5003437|NCT03974646|social cognitive theory|social cognitive theory
5003438|NCT03974633|Analgesia|analgesia
5003439|NCT03974633|Cryoanalgesia|cryoanalgesia
5318305|NCT02093130|Memory|memory
5003440|NCT03974633|Vibration analgesia|vibration analgesia
5003441|NCT03974633|Local anesthetic|local anesthetic
5003442|NCT03974581|pharmacoinvasive strategy|pharmacoinvasive strategy
5003443|NCT03974581|Mexico|mexico
5003444|NCT03974581|registry|registry
5003445|NCT03974529|Intensive running|intensive running
5003446|NCT03974529|Gait|gait
5003447|NCT03974529|Balance|balance
5342925|NCT01981486|pharmacokinetics|pharmacokinetics
5003448|NCT03974529|Motor symptoms of Parkinson's disease|motor symptoms of parkinson's disease
5003449|NCT03974529|Non-motor symptoms of Parkinson's disease|non-motor symptoms of parkinson's disease
5003450|NCT03974529|UPDRS score|updrs score
5003451|NCT03974529|Physiotherapy|physiotherapy
5003452|NCT03974529|Quality of life|quality of life
5003453|NCT03974503|Nightmares|nightmares
5003454|NCT03974503|Cognitive Behavioral Therapy|cognitive behavioral therapy
5003455|NCT03974503|PTSD|ptsd
5003456|NCT03974503|Veterans|veterans
5003457|NCT03974490|rhythm|rhythm
5003458|NCT03974490|musicotherapy|musicotherapy
5003459|NCT03974490|balance|balance
5003460|NCT03974490|gait|gait
5003461|NCT03974490|stroke|stroke
5003462|NCT03974490|physiotherapy|physiotherapy
5003463|NCT03974477|Dietary Salt|dietary salt
5003464|NCT03974477|Urinary sodium excretion|urinary sodium excretion
5003465|NCT03974477|Cooking|cooking
5003466|NCT03974477|Hypertension|hypertension
5003467|NCT03974477|Randomized Controlled Trial|randomized controlled trial
5003468|NCT03974477|Sodium|sodium
5003469|NCT03974477|Diet|diet
5003470|NCT03974477|Patient Education|patient education
5003471|NCT03974464|vertigo|vertigo
5003472|NCT03974464|stroke|stroke
5003473|NCT03974464|copeptin|copeptin
5003474|NCT03974464|S-100b protein|s-100b protein
5003475|NCT03974464|biomarkers|biomarkers
5003476|NCT03974451|Intraocular Lens|intraocular lens
5003477|NCT03974451|trifocal|trifocal
5003478|NCT03974451|extended range of vision|extended range of vision
5003479|NCT03974451|diffractive achromatic technology|diffractive achromatic technology
5003482|NCT03974438|post herpetic neuralgia|post herpetic neuralgia
5003484|NCT03974438|autologous fat grafting|autologous fat grafting
5003485|NCT03974438|autologous fat transplant|autologous fat transplant
5003486|NCT03974412|syncope|syncope
5003487|NCT03974412|head-up tilt table|head-up tilt table
5003488|NCT03974412|implantable loop recorder|implantable loop recorder
5003489|NCT03974412|pragmatic|pragmatic
5003490|NCT03974386|critical care|critical care
5003491|NCT03974386|septic shock|septic shock
5003492|NCT03974386|hemofiltration|hemofiltration
5003493|NCT03974386|endotoxin|endotoxin
5003494|NCT03974386|cytokine storm|cytokine storm
5003495|NCT03974386|prognosis|prognosis
5003496|NCT03974373|Buccal mucosa|buccal mucosa
5003497|NCT03974347|cardiac surgery|cardiac surgery
5003498|NCT03974347|renal resistive index|renal resistive index
5003499|NCT03974347|creatinine clearance|creatinine clearance
5003500|NCT03974334|Blood Pressure, High|blood pressure, high
5003501|NCT03974308|Balneotherapy|balneotherapy
5003502|NCT03974308|Health Resorts|health resorts
5003503|NCT03974308|Quality of life|quality of life
5003504|NCT03974269|Hypnosis|hypnosis
5003505|NCT03974269|Delirium|delirium
5003506|NCT03974269|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5003507|NCT03974256|Automaton|automaton
5003508|NCT03974256|Dosimetry|dosimetry
5003509|NCT03974256|Radiopharmaceutical|radiopharmaceutical
5003510|NCT03974256|Technetium-99m|technetium-99m
5003511|NCT03974230|Cornea|cornea
5003512|NCT03974230|Fuchs Endothelial Corneal Dystrophy (FECD)|fuchs endothelial corneal dystrophy (fecd)
5003513|NCT03974230|slit lamp|slit lamp
5003514|NCT03974230|Transcription Factor 4 (TCF4)|transcription factor 4 (tcf4)
5003518|NCT03974204|Cerebrospinal fluid|cerebrospinal fluid
5003519|NCT03974204|Proteomic profile|proteomic profile
5003520|NCT03974191|Low Back Pain|low back pain
5003521|NCT03974191|Pain|pain
5003522|NCT03974191|Physical Activity|physical activity
5003523|NCT03974191|Physical Capacity|physical capacity
5003524|NCT03974191|Work Ability|work ability
5003532|NCT03974165|postprandial hormone responses|postprandial hormone responses
5003534|NCT03974139|leptin|leptin
5003535|NCT03974139|cerebrospinal fluid|cerebrospinal fluid
5003538|NCT03974061|Brief Acceptance and Commitment Therapy|brief acceptance and commitment therapy
5003539|NCT03974061|HIV|hiv
5003540|NCT03974061|Alcohol|alcohol
5003541|NCT03974061|Randomized Controlled Trial|randomized controlled trial
5003542|NCT03974048|Epigenetics|epigenetics
5003543|NCT03974048|DNA methylation|dna methylation
5003544|NCT03974048|Trauma|trauma
5003545|NCT03974035|Local anesthesia|local anesthesia
5003546|NCT03974035|Ropivacaine|ropivacaine
5003547|NCT03974022|NonSmall Cell Lung Cancer|nonsmall cell lung cancer
5003548|NCT03974022|EGFR|egfr
5003549|NCT03974022|HER2|her2
5003550|NCT03974022|mutation|mutation
5003551|NCT03974009|Calcaneal taping|calcaneal taping
5003552|NCT03974009|Balance|balance
5003553|NCT03974009|Gait|gait
5003554|NCT03973996|Green tea|green tea
5003555|NCT03973996|Gut barrier function|gut barrier function
5003556|NCT03973996|Gut dysbiosis|gut dysbiosis
5003557|NCT03973996|Inflammation|inflammation
5003558|NCT03973996|Metabolic endotoxemia|metabolic endotoxemia
5003559|NCT03973996|Metabolic syndrome|metabolic syndrome
5003560|NCT03973996|Microbiome|microbiome
5003561|NCT03973983|neuralgia|neuralgia
5003562|NCT03973983|pudendal nerve|pudendal nerve
5003563|NCT03973983|pudendal nerve block|pudendal nerve block
5003564|NCT03973983|therapeutic local anaesthesia|therapeutic local anaesthesia
5003565|NCT03973983|transvaginal|transvaginal
5003566|NCT03973970|TB|tb
5003567|NCT03973957|Pleural effusion|pleural effusion
5003568|NCT03973957|Pleural diseases|pleural diseases
5003569|NCT03973957|Pleurodesis|pleurodesis
5003570|NCT03973957|Malignant pleural effusion|malignant pleural effusion
5003571|NCT03973931|cardiovascular disease|cardiovascular disease
5003572|NCT03973931|telemedicine|telemedicine
5003573|NCT03973931|medication adherence|medication adherence
5003574|NCT03973931|behavioral health|behavioral health
5003575|NCT03973918|BRAF V600E/K|braf v600e/k
5003576|NCT03973918|High Grade Primary Brain Tumor|high grade primary brain tumor
5003577|NCT03973918|High Grade Glioma|high grade glioma
5003578|NCT03973918|Glioblastoma|glioblastoma
5003579|NCT03973905|Whooping Cough|whooping cough
5003582|NCT03973905|effectiveness|effectiveness
5003584|NCT03973905|infants|infants
5003585|NCT03973879|PVSRIPO|pvsripo
5003586|NCT03973879|Atezolizumab|atezolizumab
5003587|NCT03973879|Glioblastoma|glioblastoma
5003588|NCT03973879|Glioma|glioma
5003589|NCT03973879|Bigner|bigner
5003590|NCT03973879|Randazzo|randazzo
5003591|NCT03973879|Brain tumor|brain tumor
5003592|NCT03973879|Duke|duke
5003593|NCT03973879|Istari|istari
5003594|NCT03973879|Pro00100677|pro00100677
5003595|NCT03973879|Genentech|genentech
5003596|NCT03973853|virtual reality|virtual reality
5003597|NCT03973853|social autonomy|social autonomy
5003598|NCT03973853|road safety|road safety
5003599|NCT03973853|driving abilities|driving abilities
5003600|NCT03973853|schizophrenia|schizophrenia
5003601|NCT03973853|cognitive functioning|cognitive functioning
5003602|NCT03973827|type 1 diabetes|type 1 diabetes
5003603|NCT03973827|diabetes|diabetes
5003604|NCT03973827|MSC's|msc's
5003605|NCT03973827|Mesenchymal|mesenchymal
5003606|NCT03973827|Stem Cells|stem cells
5003608|NCT03973827|Wharton´s Jelly|wharton´s jelly
5003610|NCT03973801|Acupressure|acupressure
5003611|NCT03973762|Diabetic Retinography, CAD|diabetic retinography, cad
5003612|NCT03973723|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5003614|NCT03973723|EBV|ebv
5003615|NCT03973723|Radiotherapy|radiotherapy
5003616|NCT03973723|Plasma Epstein-Barr virus DNA|plasma epstein-barr virus dna
5003617|NCT03973710|Probiotics|probiotics
5003618|NCT03973710|Prevention|prevention
5003619|NCT03973710|Hypertension|hypertension
5003620|NCT03973684|bronchiectasis:|bronchiectasis:
5003621|NCT03973684|photodynamic therapy|photodynamic therapy
5003622|NCT03973684|periodontal disease|periodontal disease
5003623|NCT03973684|randomized controlled clinical study|randomized controlled clinical study
5003624|NCT03973671|Risk stratification|risk stratification
5003625|NCT03973671|Recurrence|recurrence
5003626|NCT03973671|Progression|progression
5003627|NCT03973671|Non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
5003628|NCT03973671|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
5003629|NCT03973619|urethral stricture|urethral stricture
5003630|NCT03973619|mucosa graft|mucosa graft
5003631|NCT03973619|jugal graft,|jugal graft,
5003632|NCT03973619|labial graft|labial graft
5003633|NCT03973619|success rate|success rate
5003634|NCT03973606|Health literacy|health literacy
5003635|NCT03973606|East Jerusalem|east jerusalem
5003636|NCT03973606|Focus groups|focus groups
5003637|NCT03973606|Arabic Women|arabic women
5003638|NCT03973580|Attentional Bias|attentional bias
5003639|NCT03973580|Anxiety risk|anxiety risk
5003640|NCT03973580|Adolescence|adolescence
5003641|NCT03973580|Eye-tracking|eye-tracking
5003642|NCT03973580|Resting-state functional magnetic resonance imaging|resting-state functional magnetic resonance imaging
5003643|NCT03973567|antidepressants|antidepressants
5003644|NCT03973567|refractory functional dyspepsia|refractory functional dyspepsia
5003645|NCT03973567|resting fMRI|resting fmri
5003646|NCT03973554|white spot lesions,|white spot lesions,
5003647|NCT03973554|pearl powder|pearl powder
5003648|NCT03973554|CPP-ACP|cpp-acp
5003649|NCT03973541|Social Anxiety Disorder|social anxiety disorder
5003650|NCT03973541|Virtual Reality|virtual reality
5003651|NCT03973541|Exposure Therapy|exposure therapy
5003652|NCT03973541|Randomized Controlled Trial|randomized controlled trial
5003653|NCT03973528|anti-Mullerian hormone (AMH)|anti-mullerian hormone (amh)
5003654|NCT03973528|Traditional Chinese Medicine(TCM)|traditional chinese medicine(tcm)
5003655|NCT03973528|Infertility|infertility
5003656|NCT03973515|Glucokinase activator(GKA)|glucokinase activator(gka)
5003657|NCT03973515|hypoglycemia|hypoglycemia
5003658|NCT03973502|Hepatitis C|hepatitis c
5003659|NCT03973502|Hepatitis B|hepatitis b
5003660|NCT03973502|Parkinson's disease|parkinson's disease
5003661|NCT03973502|18F-FDOPA PET, MRS|18f-fdopa pet, mrs
5003662|NCT03973502|MRS|mrs
5003663|NCT03973489|Methamphetamine|methamphetamine
5003664|NCT03973476|phone support; midwife; early abandonment of breastfeeding|phone support; midwife; early abandonment of breastfeeding
5003665|NCT03973437|Ulcerative Colitis|ulcerative colitis
5003666|NCT03973437|Deep Learning|deep learning
5003667|NCT03973437|Convolutional Neural Network|convolutional neural network
5003668|NCT03973411|Ondansetron|ondansetron
5003669|NCT03973411|Hypotension|hypotension
5003670|NCT03973411|Spinal anesthesia|spinal anesthesia
5003671|NCT03973385|cryotherapy|cryotherapy
5003672|NCT03973385|vapocoolant spray|vapocoolant spray
5003673|NCT03973385|arterial puncture|arterial puncture
5003674|NCT03973385|intensive care unit|intensive care unit
5003676|NCT03973294|jet ventilation|jet ventilation
5003677|NCT03973294|electroimpedance tomography|electroimpedance tomography
5003678|NCT03973294|supraglottic jet ventilation|supraglottic jet ventilation
5003679|NCT03973294|subglottic jet ventilation|subglottic jet ventilation
5003782|NCT03972540|Postmenopausal breast cancer survivors|postmenopausal breast cancer survivors
5004582|NCT03967795|prediction|prediction
5003680|NCT03973281|Shorten Delivery Time, Pelvic Muscle Injury, Vaginal Delivery, Complications, Childbirth, prevention|shorten delivery time, pelvic muscle injury, vaginal delivery, complications, childbirth, prevention
5003683|NCT03973268|Magnetoenephalography|magnetoenephalography
5003684|NCT03973268|Neuropharmacology|neuropharmacology
5003685|NCT03973268|Neurobiology|neurobiology
5003686|NCT03973255|Vestibular rehabilitation|vestibular rehabilitation
5003687|NCT03973255|Vestibular weakness|vestibular weakness
5003688|NCT03973255|Whole Body Vibration|whole body vibration
5003689|NCT03973255|Biofeedback|biofeedback
5003690|NCT03973255|Posturography|posturography
5003691|NCT03973229|Estrogen|estrogen
5003692|NCT03973229|Stress Disorder|stress disorder
5003693|NCT03973216|Anxiety|anxiety
5003694|NCT03973216|Yoga|yoga
5003695|NCT03973216|Mindfulness|mindfulness
5003696|NCT03973216|Group-based therapy|group-based therapy
5003697|NCT03973203|vitamin B3|vitamin b3
5003698|NCT03973203|niacin|niacin
5003699|NCT03973203|mitochondrial myopathy|mitochondrial myopathy
5003700|NCT03973203|mitochondria|mitochondria
5003701|NCT03973203|muscle|muscle
5003702|NCT03973203|muscle strength|muscle strength
5003703|NCT03973203|NAD+ precursor|nad+ precursor
5003704|NCT03973203|NAD+|nad+
5003705|NCT03973203|NAD-booster|nad-booster
5003706|NCT03973177|Total knee arthroplasty|total knee arthroplasty
5003707|NCT03973177|Chronic Pain|chronic pain
5003708|NCT03973151|Melanoma|melanoma
5003709|NCT03973151|NRAS|nras
5003710|NCT03973138|Macular edema|macular edema
5003711|NCT03973138|ranibizumab|ranibizumab
5003712|NCT03973138|Mpredictive factor|mpredictive factor
5003713|NCT03973125|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
5003714|NCT03973125|conbercept|conbercept
5003715|NCT03973125|effectiveness|effectiveness
5003716|NCT03973125|safety|safety
5003717|NCT03973060|Jump test|jump test
5003718|NCT03973060|Genetic polymorphism|genetic polymorphism
5003719|NCT03973060|Muscle strength|muscle strength
5003720|NCT03973060|Physiotherapies techniques|physiotherapies techniques
5003721|NCT03973047|Nausea|nausea
5003722|NCT03973047|Bremelanotide|bremelanotide
5003723|NCT03973047|BMT|bmt
5003725|NCT03973047|ondansetron|ondansetron
5003726|NCT03973047|premenopausal|premenopausal
5003727|NCT03973047|healthy women|healthy women
5003728|NCT03973034|ctDNA|ctdna
5003729|NCT03973034|early screening|early screening
5003730|NCT03973034|Copy Number Variants (CNV)|copy number variants (cnv)
5003731|NCT03973034|Low Depth Whole Genome Sequencing (LDWGS)|low depth whole genome sequencing (ldwgs)
5003732|NCT03973021|erectile dysfunction|erectile dysfunction
5003737|NCT03972969|Exercise therapy|exercise therapy
5003738|NCT03972969|Accidental falls|accidental falls
5003739|NCT03972930|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5003741|NCT03972917|ulipristal acetate|ulipristal acetate
5003742|NCT03972917|myoma|myoma
5003743|NCT03972917|leiomyoma|leiomyoma
5003744|NCT03972917|endometrial patterns|endometrial patterns
5003745|NCT03972917|symptomatology|symptomatology
5003746|NCT03972904|Diabetes Mellitus,Type 2|diabetes mellitus,type 2
5003747|NCT03972904|Overweight|overweight
5003748|NCT03972904|Obesity|obesity
5003751|NCT03972839|Blood Coagulation|blood coagulation
5003752|NCT03972839|DDimers|ddimers
5003753|NCT03972826|hand hygiene|hand hygiene
5003754|NCT03972826|healthcare worker self-contamination|healthcare worker self-contamination
5003755|NCT03972813|HPV Vaccines|hpv vaccines
5003756|NCT03972813|China|china
5003757|NCT03972748|Itraconazole|itraconazole
5003758|NCT03972683|Exercise|exercise
5003759|NCT03972631|Lifestyle interventions|lifestyle interventions
5003760|NCT03972631|Low-carbohydrate diet|low-carbohydrate diet
5003761|NCT03972605|Breast Screening|breast screening
5003762|NCT03972605|Breast Imaging|breast imaging
5003763|NCT03972605|SoftVue|softvue
5003764|NCT03972605|Mammography|mammography
5003765|NCT03972605|Ultrasound|ultrasound
5003766|NCT03972605|Reader Study|reader study
5003767|NCT03972605|ROC AUC|roc auc
5003768|NCT03972605|Dense Breasts|dense breasts
5003769|NCT03972605|Breast Density|breast density
5003770|NCT03972605|Dense Breast Tissue|dense breast tissue
5003771|NCT03972605|Breast Neoplasms|breast neoplasms
5003772|NCT03972592|Cutaneous Microcystic Lymphatic Malformations|cutaneous microcystic lymphatic malformations
5003773|NCT03972566|Nitric Oxide|nitric oxide
5003774|NCT03972566|Photobiomodulation|photobiomodulation
5003775|NCT03972566|LLLT|lllt
5003776|NCT03972566|Photomedicine|photomedicine
5003777|NCT03972553|Sugarbaker|sugarbaker
5003778|NCT03972553|keyhole|keyhole
5003779|NCT03972553|Open parastomal hernia repair|open parastomal hernia repair
5003780|NCT03972540|Obesity|obesity
5003781|NCT03972540|Mindful eating|mindful eating
5003784|NCT03972540|Cardiovascular health|cardiovascular health
5003785|NCT03972527|photobiomodulation|photobiomodulation
5003786|NCT03972527|LLLT|lllt
5003787|NCT03972527|low-level laser therapy|low-level laser therapy
5003788|NCT03972527|oral mucositis|oral mucositis
5003789|NCT03972527|wound healing|wound healing
5003790|NCT03972527|radiation therapy|radiation therapy
5003791|NCT03972527|chemotherapy|chemotherapy
5003792|NCT03972527|antineoplastic therapy|antineoplastic therapy
5003793|NCT03972527|side effects|side effects
5003794|NCT03972527|phototherapy|phototherapy
5003795|NCT03972527|low-level light therapy|low-level light therapy
5003796|NCT03972514|brain|brain
5003797|NCT03972514|pediatrics brain cancer|pediatrics brain cancer
5003798|NCT03972514|pediatrics|pediatrics
5003799|NCT03972514|skull|skull
5003800|NCT03972423|checklist|checklist
5003801|NCT03972423|postoperative complication|postoperative complication
5003802|NCT03972423|anesthesia|anesthesia
5003803|NCT03972423|information transmission|information transmission
5003804|NCT03972423|care unit|care unit
5003805|NCT03972410|childbirth trauma|childbirth trauma
5003806|NCT03972410|post-traumatic stress|post-traumatic stress
5003807|NCT03972410|depression|depression
5003808|NCT03972410|post-partum PTSD|post-partum ptsd
5003809|NCT03972410|EMDR|emdr
5003810|NCT03972410|Supportive Expressive Dynamic Psychotherapy|supportive expressive dynamic psychotherapy
5003811|NCT03972397|Cryoablation|cryoablation
5003812|NCT03972384|Post-ICU Syndrome|post-icu syndrome
5003813|NCT03972384|Recovery|recovery
5003814|NCT03972384|Home Discharge|home discharge
5003815|NCT03972384|Problem Solving|problem solving
5003816|NCT03972384|Adaptation|adaptation
5003817|NCT03972332|Low Back Pain|low back pain
5003818|NCT03972332|Central Sensitisation|central sensitisation
5003819|NCT03972332|Hyperalgesia|hyperalgesia
5003820|NCT03972332|Hypersensitivity|hypersensitivity
5003821|NCT03972319|omega 3|omega 3
5003822|NCT03972319|bariatric surgery|bariatric surgery
5003823|NCT03972319|fatty liver|fatty liver
5003824|NCT03972319|vlcd|vlcd
5003825|NCT03972267|Wound Healing|wound healing
5003826|NCT03972267|Enamel Matrix Derivative|enamel matrix derivative
5003827|NCT03972267|Palatal|palatal
5003828|NCT03972254|Modified Interaction Guidance|modified interaction guidance
5003830|NCT03972241|Quality of life|quality of life
5003831|NCT03972241|Physical therapy|physical therapy
5003832|NCT03972241|tremor|tremor
5003833|NCT03972241|coordination|coordination
5003834|NCT03972241|gait analysis|gait analysis
5003835|NCT03972228|microdevice|microdevice
5003836|NCT03972228|chemotherapy|chemotherapy
5003837|NCT03972228|lung lesions|lung lesions
5003839|NCT03972202|dysarthria|dysarthria
5003840|NCT03972202|ataxia|ataxia
5003841|NCT03972202|cerebellum|cerebellum
5309832|NCT02130271|MRI|mri
5003842|NCT03972202|cerebellar|cerebellar
5003843|NCT03972202|adult|adult
5003844|NCT03972202|speaking|speaking
5003845|NCT03972202|language|language
5003847|NCT03972202|MRI|mri
5003848|NCT03972202|speech|speech
5003849|NCT03972176|non-caloric sweetener|non-caloric sweetener
5003850|NCT03972176|Amniotic liquid|amniotic liquid
5003851|NCT03972176|Breastmilk|breastmilk
5003852|NCT03972176|Infant gain weight|infant gain weight
5003853|NCT03972176|Sweet taste preferences|sweet taste preferences
5003854|NCT03972176|Taste receptor polymorphism|taste receptor polymorphism
5003855|NCT03972176|Breastmilk microbiota|breastmilk microbiota
5003856|NCT03972176|Infant gut microbiota|infant gut microbiota
5003857|NCT03972176|Salivary insulin|salivary insulin
5003858|NCT03972098|uromodulin|uromodulin
5003859|NCT03972085|Low Back Pain|low back pain
5003860|NCT03972085|Neurodynamics|neurodynamics
5003862|NCT03972046|BRAF/MEK inhibition|braf/mek inhibition
5003863|NCT03972046|Melanoma|melanoma
5003864|NCT03972046|Nodal metastasis|nodal metastasis
5003865|NCT03972046|Neoadjuvant treatment|neoadjuvant treatment
5003866|NCT03972046|BRAF mutant|braf mutant
5003867|NCT03972020|breast cancer|breast cancer
5003868|NCT03972020|mindfulness based intervention|mindfulness based intervention
5003869|NCT03972020|cognitive behavioral therapy|cognitive behavioral therapy
5003870|NCT03972020|depressive symptoms|depressive symptoms
5003871|NCT03972007|Physiotherapy|physiotherapy
5003872|NCT03972007|Muscle resistance|muscle resistance
5003873|NCT03972007|LED|led
5003874|NCT03972007|Athletic performance|athletic performance
5003875|NCT03971994|attention|attention
5003876|NCT03971994|emotion|emotion
5003877|NCT03971994|eye movements|eye movements
5003878|NCT03971994|amygdala|amygdala
5003879|NCT03971981|Xylitol|xylitol
5003880|NCT03971981|Saliva|saliva
5003881|NCT03971981|Bacteria|bacteria
5003882|NCT03971981|Dental Plaque|dental plaque
5003883|NCT03971981|Antimicrobial effect|antimicrobial effect
5003884|NCT03971981|Chewing gum|chewing gum
5003885|NCT03971968|Burn|burn
5003886|NCT03971968|Scar|scar
5003887|NCT03971968|Face|face
5003888|NCT03971968|Observational Study|observational study
5003889|NCT03971968|Integra Artificial Skin|integra artificial skin
5003890|NCT03971942|attention bias modification|attention bias modification
5003891|NCT03971942|positive attention bias|positive attention bias
5003892|NCT03971942|depressive symptoms|depressive symptoms
5003893|NCT03971942|prevention|prevention
5003894|NCT03971903|Attenion bias modification, major depression, treatment|attenion bias modification, major depression, treatment
5003895|NCT03971890|Balance|balance
5003896|NCT03971890|Pain|pain
5003897|NCT03971890|TUG|tug
5003898|NCT03971890|Dance|dance
5003899|NCT03971877|Colistin resistance in bacteria|colistin resistance in bacteria
5003900|NCT03971877|Rectal swab|rectal swab
5003901|NCT03971877|ICU|icu
5003902|NCT03971877|Oncohaematology|oncohaematology
5003903|NCT03971877|Gram negative bacteria|gram negative bacteria
5003904|NCT03971825|Psoriasis|psoriasis
5003905|NCT03971825|Healthy Volunteer|healthy volunteer
5003906|NCT03971825|Safety|safety
5003907|NCT03971825|CC-92252|cc-92252
5003908|NCT03971799|CD33CART cells|cd33cart cells
5003909|NCT03971799|Children/young adults|children/young adults
5003910|NCT03971747|Liver Cancer|liver cancer
5003911|NCT03971708|Lidocaine|lidocaine
5003912|NCT03971708|TAP block|tap block
5003913|NCT03971708|nephrectomy|nephrectomy
5003914|NCT03971708|acute pain|acute pain
5003915|NCT03971682|Conduct Disorder|conduct disorder
5003916|NCT03971682|Compassion Focused Therapy|compassion focused therapy
5003917|NCT03971682|Detained Youth|detained youth
5003918|NCT03971682|Psychopathic Traits|psychopathic traits
4999551|NCT03997708|IBS|ibs
5003919|NCT03971682|PSYCHOPATHY.COMP|psychopathy.comp
5003920|NCT03971669|Typhoid|typhoid
5003921|NCT03971656|Cancer|cancer
5003922|NCT03971656|Surgery|surgery
5003923|NCT03971656|Malnutrition|malnutrition
5003924|NCT03971656|Preoperative|preoperative
5003925|NCT03971656|Nutrition|nutrition
5003926|NCT03971630|HMV|hmv
5003927|NCT03971630|Tele-monitoring|tele-monitoring
5003928|NCT03971630|Telemedicine|telemedicine
5003929|NCT03971630|Chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
5003930|NCT03971578|Autism Spectrum Disorder|autism spectrum disorder
5003931|NCT03971552|Mechanical thrombectomy|mechanical thrombectomy
5003932|NCT03971552|Magnetic resonance angiography|magnetic resonance angiography
5003933|NCT03971552|Angiogram|angiogram
5003934|NCT03971552|Angiography|angiography
5003935|NCT03971552|Magnetic resonance imaging|magnetic resonance imaging
5003936|NCT03971552|Revascularization|revascularization
5003939|NCT03971526|Neuroimaging|neuroimaging
5003940|NCT03971526|Prognosis|prognosis
5003941|NCT03971526|Stroke|stroke
5003942|NCT03971513|Prospective randomized pilot study|prospective randomized pilot study
5003943|NCT03971513|Trans abdominal plane block|trans abdominal plane block
5003944|NCT03971513|Quo R 40 score|quo r 40 score
5003956|NCT03971435|child rearing|child rearing
5003958|NCT03971435|curriculum|curriculum
5309931|NCT02129907|Anemias|anemias
5003959|NCT03971435|early childhood education|early childhood education
5003960|NCT03971435|families|families
5003961|NCT03971435|Head Start|head start
5003962|NCT03971435|parenting skills|parenting skills
5003963|NCT03971435|parents|parents
5003964|NCT03971435|school readiness|school readiness
5003965|NCT03971422|UCB7665|ucb7665
5003966|NCT03971422|Myasthenia Gravis|myasthenia gravis
5003967|NCT03971422|Rozanolixizumab|rozanolixizumab
5342926|NCT01981486|migraine|migraine
5003968|NCT03971396|open cardiac surgery|open cardiac surgery
5003969|NCT03971396|breathing exercises|breathing exercises
5003970|NCT03971396|chest physiotherapy|chest physiotherapy
5003971|NCT03971331|acute respiratory distress syndrome|acute respiratory distress syndrome
5003972|NCT03971331|right ventricular dysfunction|right ventricular dysfunction
5003973|NCT03971331|critical care ultrasound|critical care ultrasound
5003974|NCT03971331|pulmonary artery catheter|pulmonary artery catheter
5003975|NCT03971279|dexamethasone;VKH|dexamethasone;vkh
5003976|NCT03971253|Post-Marketing Surveillance|post-marketing surveillance
5003977|NCT03971253|ASP015K|asp015k
5003978|NCT03971253|Smyraf|smyraf
5003979|NCT03971253|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5003980|NCT03971253|Peficitinib|peficitinib
5003981|NCT03971227|refractive|refractive
5003982|NCT03971227|permeable|permeable
5003983|NCT03971227|lens|lens
5003984|NCT03971227|rigid|rigid
5003985|NCT03971227|gas|gas
5003986|NCT03971227|myopia|myopia
5003987|NCT03971214|small cell lung cancer|small cell lung cancer
5003988|NCT03971214|radiotherapy|radiotherapy
5003989|NCT03971214|PD-1 inhibitor|pd-1 inhibitor
5003990|NCT03971201|portal vein invasion|portal vein invasion
5003991|NCT03971162|Choroidal Neovascularisation|choroidal neovascularisation
5003995|NCT03971097|Addiction|addiction
5003997|NCT03971097|Alcohol|alcohol
5003998|NCT03971097|Cocaine|cocaine
5003999|NCT03971097|Benzodiazepine|benzodiazepine
5004000|NCT03971097|Heroin|heroin
5004001|NCT03971097|Self-forgiveness|self-forgiveness
5004002|NCT03971097|Self-stigma|self-stigma
5004003|NCT03971084|casein phosphopeptide-amorphous calcium phosphate|casein phosphopeptide-amorphous calcium phosphate
5004004|NCT03971084|CPP-ACP|cpp-acp
5004005|NCT03971084|in situ appliance|in situ appliance
5004006|NCT03971084|Transverse Microradiography, TMR|transverse microradiography, tmr
5004007|NCT03971084|Recaldent|recaldent
5004008|NCT03971084|Tooth Remineralization|tooth remineralization
5004011|NCT03971058|Japanese Encephalitis vaccine|japanese encephalitis vaccine
5004012|NCT03971058|immune responses|immune responses
5004013|NCT03971045|Pembrolizumab|pembrolizumab
5004014|NCT03971045|Immunotherapy|immunotherapy
5004015|NCT03971019|breast cancer|breast cancer
5004016|NCT03971019|statins|statins
5004017|NCT03971019|abnormal lipid metabolism|abnormal lipid metabolism
5004018|NCT03971006|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5004019|NCT03971006|Pneumonia|pneumonia
5004020|NCT03971006|Septic Shock|septic shock
5004021|NCT03971006|bronchoalveolar lavage|bronchoalveolar lavage
5004022|NCT03970980|Fick Principle|fick principle
5004023|NCT03970967|Breast carcinoma|breast carcinoma
5004024|NCT03970967|Metastatic breast cancer|metastatic breast cancer
5004025|NCT03970967|Invasive breast cancer|invasive breast cancer
5004026|NCT03970967|Alpha radiation|alpha radiation
5004027|NCT03970967|Luminal A|luminal a
5004028|NCT03970967|Luminal B|luminal b
5004029|NCT03970967|Triple negative|triple negative
5004030|NCT03970967|HER2|her2
5004031|NCT03970967|Breast cancer|breast cancer
5004032|NCT03970967|Breast metastases|breast metastases
5004033|NCT03970954|Low-dose Interleukin-2|low-dose interleukin-2
5004034|NCT03970954|Miscarriage|miscarriage
5004035|NCT03970954|Regulatory T cells|regulatory t cells
5004036|NCT03970915|body warmer|body warmer
5004037|NCT03970915|pre-hospital|pre-hospital
5004038|NCT03970902|Integrated Care|integrated care
5004045|NCT03970837|Placebo|placebo
5004046|NCT03970837|DMARDs|dmards
5004047|NCT03970811|temporization immediate implants peri-implant soft tissue|temporization immediate implants peri-implant soft tissue
5004048|NCT03970785|fluorescein|fluorescein
5004049|NCT03970785|gangliogliomas|gangliogliomas
5004050|NCT03970785|glioneuronal|glioneuronal
5004051|NCT03970785|Dysembryoplastic Neuroepithelial Tumor|dysembryoplastic neuroepithelial tumor
5004052|NCT03970772|Type 1 diabetes mellitus|type 1 diabetes mellitus
5004053|NCT03970772|Fasting|fasting
5004054|NCT03970772|Ramadan|ramadan
5004055|NCT03970772|Glucagon|glucagon
5004056|NCT03970772|Mini-dose|mini-dose
5004057|NCT03970772|Hypoglycemia|hypoglycemia
5004058|NCT03970746|Anti-PD-1|anti-pd-1
5004059|NCT03970733|VLA15|vla15
5004060|NCT03970733|Lyme Borreliosis|lyme borreliosis
5004061|NCT03970733|Vaccine|vaccine
5004063|NCT03970694|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5004064|NCT03970694|Colon Cancer|colon cancer
5004065|NCT03970694|Initial Diagnosed Unresectable Locally Advanced Stage|initial diagnosed unresectable locally advanced stage
5004066|NCT03970694|Phase 3 Clinical Trial|phase 3 clinical trial
5004067|NCT03970681|Acoustic neuroma|acoustic neuroma
5004068|NCT03970681|Vestibular schwannoma|vestibular schwannoma
5004069|NCT03970681|Spontaneous shrinkage|spontaneous shrinkage
5004070|NCT03970681|Neoplasm regression|neoplasm regression
5342927|NCT01981486|PDE2|pde2
5004071|NCT03970681|Volume quantification|volume quantification
5004072|NCT03970681|Tridimensional measurements|tridimensional measurements
5004073|NCT03970681|Volumetric measurements|volumetric measurements
5004074|NCT03970642|video directly observed therapy|video directly observed therapy
5004075|NCT03970590|hypertension|hypertension
5004076|NCT03970590|Minority Health|minority health
5004077|NCT03970590|health behavior|health behavior
5004078|NCT03970590|text messaging|text messaging
5004079|NCT03970577|Minimal Change Nephrotic syndrome|minimal change nephrotic syndrome
5004080|NCT03970577|Rituximab|rituximab
5004081|NCT03970577|Relapse rate|relapse rate
5004082|NCT03970564|ultrasound|ultrasound
5004083|NCT03970564|lymphadenopathy|lymphadenopathy
5004084|NCT03970564|lung cancer|lung cancer
5004085|NCT03970551|Initial Orthostatic Hypotension|initial orthostatic hypotension
5004087|NCT03970551|Physical Counter-maneuver|physical counter-maneuver
5004088|NCT03970551|Refractory Period|refractory period
5004089|NCT03970551|Active Stand|active stand
5004090|NCT03970551|Muscle Tensing|muscle tensing
5004151|NCT03970330|endometriosis|endometriosis
5004152|NCT03970330|pelvic pain|pelvic pain
5004153|NCT03970330|opioid|opioid
5004154|NCT03970330|narcotic|narcotic
5004156|NCT03970278|gene therapy|gene therapy
5004157|NCT03970278|glucose metabolism disorder|glucose metabolism disorder
5004158|NCT03970278|carbohydrate metabolism, inborn errors|carbohydrate metabolism, inborn errors
5004159|NCT03970278|genetic diseases|genetic diseases
5004160|NCT03970278|Inborn Metabolic Diseases|inborn metabolic diseases
5004161|NCT03970265|Interstitial lung fluid|interstitial lung fluid
5004162|NCT03970265|Epithelial lining fluid|epithelial lining fluid
5004163|NCT03970265|Antibiotic concentration in the lung|antibiotic concentration in the lung
5004168|NCT03970226|Phase 0|phase 0
5004169|NCT03970226|Feasibility|feasibility
5004170|NCT03970226|Tocilizumab|tocilizumab
5004171|NCT03970213|Tranexamic acid|tranexamic acid
5004172|NCT03970213|Rhytidectomy|rhytidectomy
5004173|NCT03970213|Facelift|facelift
5004174|NCT03970174|Patient experience|patient experience
5004175|NCT03970122|Glomerulosclerosis|glomerulosclerosis
5004176|NCT03970122|proteinuria|proteinuria
5004177|NCT03970122|nephrotic syndrome|nephrotic syndrome
5004178|NCT03970122|nephrosis|nephrosis
5004179|NCT03970122|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5004180|NCT03970122|kidney diseases|kidney diseases
5004181|NCT03970122|urologic diseases|urologic diseases
5004182|NCT03970122|glomerulonephritis|glomerulonephritis
5004183|NCT03970122|nephritis|nephritis
5004184|NCT03970122|diabetic kidney disease|diabetic kidney disease
5004185|NCT03970122|diabetic nephropathies|diabetic nephropathies
5004186|NCT03970122|endocrine system diseases|endocrine system diseases
5004200|NCT03970005|clinical high-risk|clinical high-risk
5004201|NCT03969992|Respiratory Distress Syndrome|respiratory distress syndrome
5004202|NCT03969992|BPD|bpd
5004203|NCT03969992|surfactant|surfactant
5004204|NCT03969992|Preterm Infant|preterm infant
5004207|NCT03969953|Rivaroxaban|rivaroxaban
5004208|NCT03969927|Simulation|simulation
5004209|NCT03969927|Driving Simulation|driving simulation
5004210|NCT03969888|Cystic Fibrosis|cystic fibrosis
5004211|NCT03969888|ABBV-3067|abbv-3067
5004212|NCT03969888|ABBV-2222|abbv-2222
5004213|NCT03969888|F508del Mutation|f508del mutation
5004214|NCT03969862|Allergy diagnostic tool|allergy diagnostic tool
5004215|NCT03969862|Specific IgE assays|specific ige assays
5004216|NCT03969862|Allergens|allergens
5428214|NCT01595646|Alzheimer's disease|alzheimer's disease
5007648|NCT03948672|sensor|sensor
5004217|NCT03969836|cardiac surgery cerebral oxygenation, brain blood volume|cardiac surgery cerebral oxygenation, brain blood volume
5004219|NCT03969836|brain blood volume|brain blood volume
5004221|NCT03969823|Osimertinib|osimertinib
5004222|NCT03969823|EGFR exon 19 deletion or L858R mutation|egfr exon 19 deletion or l858r mutation
5004223|NCT03969771|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5004224|NCT03969771|Mindfulness|mindfulness
5004225|NCT03969745|chrononutrition|chrononutrition
5004226|NCT03969745|metabolism|metabolism
5004227|NCT03969745|body composition|body composition
5004229|NCT03969732|intracerebral hemorrhage|intracerebral hemorrhage
5004230|NCT03969732|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5004231|NCT03969732|amyloid PET|amyloid pet
5004232|NCT03969732|tau PET|tau pet
5004233|NCT03969732|MRI|mri
5004234|NCT03969732|Aβ|aβ
5004235|NCT03969732|ApoE|apoe
5004237|NCT03969693|Lymphoma|lymphoma
5004238|NCT03969693|Radiotherapy|radiotherapy
5004239|NCT03969693|Mediastinum|mediastinum
5004240|NCT03969693|Adverse effects|adverse effects
5004241|NCT03969693|Longitudinal|longitudinal
5004242|NCT03969693|Cardiac toxicities|cardiac toxicities
5004243|NCT03969693|Lung|lung
5004244|NCT03969693|Breast|breast
5004251|NCT03969641|Vaccination|vaccination
5004252|NCT03969641|Safety|safety
5004253|NCT03969641|Birth outcomes|birth outcomes
5004254|NCT03969641|Flublok|flublok
5004255|NCT03969641|Pregnant|pregnant
5004256|NCT03969641|Influenza|influenza
5342928|NCT01981486|cAMP|camp
5004264|NCT03969576|Conventional transarterial chemoembolization|conventional transarterial chemoembolization
5004265|NCT03969576|Objective response|objective response
5004266|NCT03969563|stroke|stroke
5004267|NCT03969563|MBSR|mbsr
5004268|NCT03969563|meditation|meditation
5004269|NCT03969563|mindfulness|mindfulness
5004270|NCT03969563|yoga|yoga
5004271|NCT03969550|Maraviroc|maraviroc
5004272|NCT03969550|John Cunningham virus (JCV)|john cunningham virus (jcv)
5004273|NCT03969550|Immune reconstitution inflammatory syndrome (IRIS)|immune reconstitution inflammatory syndrome (iris)
5004274|NCT03969550|Combined antiretroviral treatment (cART)|combined antiretroviral treatment (cart)
5004275|NCT03969550|Overall survival (OS)|overall survival (os)
5004276|NCT03969537|Cervical Dystonia|cervical dystonia
5004277|NCT03969537|Telemedicine|telemedicine
5004278|NCT03969537|Telehealth|telehealth
5004279|NCT03969511|large-vessel occlusion|large-vessel occlusion
5004280|NCT03969511|reperfusion therapy|reperfusion therapy
5004281|NCT03969472|probiotic|probiotic
5004282|NCT03969472|Electrophysiologic Therapy|electrophysiologic therapy
5004283|NCT03969472|uterine endometrial repair|uterine endometrial repair
5004284|NCT03969472|intrauterine adhesion|intrauterine adhesion
5004488|NCT03968419|CANOPY|canopy
5004291|NCT03969459|newborn|newborn
5004292|NCT03969420|Tolero, Phase 2, AML, Relapsed, Refractory, Alvocidib, Venetoclax|tolero, phase 2, aml, relapsed, refractory, alvocidib, venetoclax
5004293|NCT03969394|strain|strain
5004295|NCT03969394|echocardiography|echocardiography
5004299|NCT03969342|Pediatric|pediatric
5004300|NCT03969342|Pneumonia|pneumonia
5004301|NCT03969342|Ultrasound|ultrasound
5004302|NCT03969342|Point of Care Ultrasound|point of care ultrasound
5004303|NCT03969342|Diagnostic Imaging|diagnostic imaging
5004304|NCT03969342|Global Health|global health
5004305|NCT03969342|Uganda|uganda
5004306|NCT03969342|Rural Healthcare|rural healthcare
5004310|NCT03969316|quadratus lumborum block|quadratus lumborum block
5004311|NCT03969316|transversus abdominis plane block|transversus abdominis plane block
5004312|NCT03969316|pediatric patient|pediatric patient
5004313|NCT03969316|orchiopexy|orchiopexy
5004314|NCT03969316|regional anesthesia|regional anesthesia
5004315|NCT03969316|pain|pain
5004316|NCT03969290|Contact lens|contact lens
5004317|NCT03969290|Vision correction|vision correction
5004318|NCT03969290|Visual acuity|visual acuity
5004319|NCT03969290|Daily disposable contact lens|daily disposable contact lens
5004320|NCT03969277|Imagery|imagery
5004321|NCT03969277|Mirror Neurons|mirror neurons
5004322|NCT03969277|Immobilization|immobilization
5004323|NCT03969277|Exercise|exercise
5004324|NCT03969277|Rehabilitation|rehabilitation
5004325|NCT03969251|alcohol|alcohol
5004326|NCT03969251|alcohol dependence|alcohol dependence
5004327|NCT03969251|addiction|addiction
5004328|NCT03969251|alcohol use disorder|alcohol use disorder
5004329|NCT03969238|opioid dependence|opioid dependence
5004330|NCT03969238|pain management|pain management
5004331|NCT03969225|Haemodialysis vascular access|haemodialysis vascular access
5004332|NCT03969225|Core outcome|core outcome
5004333|NCT03969225|Vascular access function|vascular access function
5004334|NCT03969225|Validation|validation
5004335|NCT03969225|Haemodialysis|haemodialysis
5004337|NCT03969225|Vascular access intervention|vascular access intervention
5004338|NCT03969225|Vascular access procedure|vascular access procedure
5004339|NCT03969225|Standardised outcomes in nephrology (SONG)|standardised outcomes in nephrology (song)
5004340|NCT03969199|MANNA|manna
5004341|NCT03969199|Nutrition|nutrition
5004346|NCT03969199|Non-profit|non-profit
5004347|NCT03969199|Salt affinity|salt affinity
5004348|NCT03969199|Behavioral changes|behavioral changes
5004349|NCT03969186|Telehealth|telehealth
5004350|NCT03969186|Cirrhosis|cirrhosis
5004351|NCT03969186|Ascites|ascites
5004352|NCT03969186|Hepatic encephalopathy|hepatic encephalopathy
5004353|NCT03969186|Readmissions|readmissions
5004354|NCT03969186|Preventable readmissions|preventable readmissions
5004355|NCT03969186|Liver diseases|liver diseases
5004356|NCT03969186|Variceal bleeding|variceal bleeding
5004357|NCT03969173|Children undergoing pediatric general surgery or pediatric urology surgery|children undergoing pediatric general surgery or pediatric urology surgery
5004358|NCT03969160|Imaginal exposure|imaginal exposure
5004359|NCT03969160|brain imaging|brain imaging
5004360|NCT03969160|mental imagery|mental imagery
5004364|NCT03969108|Thyroid surgery|thyroid surgery
5004365|NCT03969108|Indocyanine green (ICG)|indocyanine green (icg)
5004366|NCT03969108|Hypoparathyroidism|hypoparathyroidism
5004367|NCT03969095|Stroke|stroke
5004368|NCT03969095|Dysphagia|dysphagia
5004369|NCT03969095|Rehabilitation|rehabilitation
5004370|NCT03969095|Videofluoroscopy|videofluoroscopy
5004371|NCT03969082|Bibliotherapy|bibliotherapy
5004372|NCT03969082|Cancer|cancer
5004373|NCT03969069|Adult|adult
5004374|NCT03969069|Human|human
5004375|NCT03969069|Cohort|cohort
5004377|NCT03969030|Sub-Sahara Africa|sub-sahara africa
5004378|NCT03969030|Lesotho|lesotho
5004379|NCT03969030|Differentiated Service Delivery|differentiated service delivery
5004380|NCT03969030|Adolescents and young adults living with HIV|adolescents and young adults living with hiv
5004381|NCT03969030|ART service|art service
5004382|NCT03969030|Preference-based|preference-based
5004383|NCT03969004|High risk|high risk
5004384|NCT03968991|Blinded population|blinded population
5004385|NCT03968991|Pain evaluation|pain evaluation
5004581|NCT03967795|tolerance|tolerance
5004389|NCT03968965|Computer-assisted surgery|computer-assisted surgery
5004390|NCT03968965|Machine vision|machine vision
5004391|NCT03968965|Navigation|navigation
5004392|NCT03968965|Image guidance|image guidance
5004394|NCT03968965|Lumbar spine|lumbar spine
5004395|NCT03968952|Digital health|digital health
5004396|NCT03968952|Gestational Diabetes|gestational diabetes
5004397|NCT03968952|Hypertension|hypertension
5004398|NCT03968952|Pre-Eclampsia|pre-eclampsia
5004399|NCT03968926|Cardiogenic shock|cardiogenic shock
5004400|NCT03968926|Temporary circulatory support|temporary circulatory support
5004401|NCT03968926|Vasoplegia|vasoplegia
5004402|NCT03968926|Inflammatory response|inflammatory response
5004403|NCT03968913|Osteoarthritis|osteoarthritis
5004404|NCT03968913|ACL|acl
5004405|NCT03968913|Anakinra|anakinra
5004410|NCT03968887|Postoperative Delirium|postoperative delirium
5004411|NCT03968874|Veterans|veterans
5004412|NCT03968848|Hepatic|hepatic
5004413|NCT03968848|Acalabrutinib|acalabrutinib
5004414|NCT03968809|Coronary Artery Disease|coronary artery disease
5004415|NCT03968809|Cardiac Imaging|cardiac imaging
5004416|NCT03968796|Kinesio Taping|kinesio taping
5004417|NCT03968796|Lateral epicondylitis|lateral epicondylitis
5004418|NCT03968796|Tennis elbow|tennis elbow
5004419|NCT03968796|TENS|tens
5319097|NCT02089412|Absorption|absorption
5004420|NCT03968783|cesarean section|cesarean section
5004421|NCT03968783|scar heal|scar heal
5004422|NCT03968783|isthmocele|isthmocele
5004423|NCT03968783|suture material|suture material
5004424|NCT03968783|saline infusion sonography|saline infusion sonography
5004425|NCT03968770|Osteoarthritis|osteoarthritis
5004426|NCT03968770|Pain|pain
5004427|NCT03968770|Microbiota|microbiota
5004428|NCT03968731|contact lens discomfort|contact lens discomfort
5004429|NCT03968718|Patient Reported Outcome Measures|patient reported outcome measures
5004430|NCT03968718|Feasibility study|feasibility study
5004431|NCT03968692|Prostatic Neoplasms|prostatic neoplasms
5004432|NCT03968692|Practice Guideline|practice guideline
5004433|NCT03968692|Early Detection of Cancer|early detection of cancer
5004434|NCT03968679|head and neck cancer|head and neck cancer
5004435|NCT03968679|lymph drainage mapping|lymph drainage mapping
5004436|NCT03968679|sentinel node procedure|sentinel node procedure
5004437|NCT03968679|radiotherapy|radiotherapy
5004438|NCT03968679|unilateral elective neck irradiation|unilateral elective neck irradiation
5004439|NCT03968640|MODS|mods
5004440|NCT03968627|Stroke|stroke
5004441|NCT03968627|Rehabilitation|rehabilitation
5004442|NCT03968627|Protocol|protocol
5004443|NCT03968627|Evidence-based|evidence-based
5004444|NCT03968601|Severe mitral regurgitation|severe mitral regurgitation
5020233|NCT03870672|CVA|cva
5004449|NCT03968601|Mitral surgery|mitral surgery
5004451|NCT03968549|Inflammation|inflammation
5004452|NCT03968549|Heart failure|heart failure
5007293|NCT03950934|Intubation|intubation
5004453|NCT03968549|Intestinal microbiota|intestinal microbiota
5004454|NCT03968523|Postoperative pain|postoperative pain
5004455|NCT03968523|Laparoscopic inguinal hernioplasty|laparoscopic inguinal hernioplasty
5004456|NCT03968523|TAP block|tap block
5004457|NCT03968497|pain|pain
5004458|NCT03968497|gender|gender
5004459|NCT03968497|visual analog scale|visual analog scale
5004460|NCT03968497|numeric rating scale|numeric rating scale
5004461|NCT03968458|appetite control|appetite control
5004462|NCT03968458|obesity|obesity
5004463|NCT03968458|Adolescents|adolescents
5004464|NCT03968458|exercise timing|exercise timing
5004465|NCT03968432|Childhood Vaccination,|childhood vaccination,
5004466|NCT03968432|Knowledge Translation,|knowledge translation,
5004467|NCT03968432|Pain management,|pain management,
5004468|NCT03968432|Parents.|parents.
5004469|NCT03968419|ACZ885|acz885
5004470|NCT03968419|canakinumab|canakinumab
5004471|NCT03968419|pembrolizumab|pembrolizumab
5004472|NCT03968419|NSCLC|nsclc
5004473|NCT03968419|non-small cell lung cancer|non-small cell lung cancer
5004474|NCT03968419|non small cell lung cancer|non small cell lung cancer
5004475|NCT03968419|early stage NSCLC|early stage nsclc
5004476|NCT03968419|squamous|squamous
5004477|NCT03968419|non-squamous,|non-squamous,
5004479|NCT03968419|major pathological response|major pathological response
5004480|NCT03968419|hs-CRP|hs-crp
5004481|NCT03968419|PD-L1|pd-l1
5004482|NCT03968419|hsCRP|hscrp
5004483|NCT03968419|surgery|surgery
5004484|NCT03968419|neo-adjuvant|neo-adjuvant
5004485|NCT03968419|neo adjuvant|neo adjuvant
5004487|NCT03968419|hs-IL-6|hs-il-6
5004490|NCT03968393|Perioperative Atrial Fibrillation|perioperative atrial fibrillation
5004491|NCT03968393|Non-vitamin K Oral Anticoagulation|non-vitamin k oral anticoagulation
5004492|NCT03968393|Noncardiac Surgery|noncardiac surgery
5004493|NCT03968393|PROBE Design|probe design
5004494|NCT03968380|Implementation science|implementation science
5004495|NCT03968380|Noncommunicable disease|noncommunicable disease
5004496|NCT03968380|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5004497|NCT03968380|Public Policy|public policy
5004498|NCT03968380|Delivery of Health Care|delivery of health care
5004499|NCT03968367|magnetic activated sperm sorting|magnetic activated sperm sorting
5004500|NCT03968367|DNA fragmentation index|dna fragmentation index
5004501|NCT03968367|sperm up|sperm up
5004502|NCT03968367|density differential centrifugation|density differential centrifugation
5004503|NCT03968367|clinical outcome|clinical outcome
5004505|NCT03968354|NASH|nash
5004506|NCT03968354|Diabetes type2|diabetes type2
5004507|NCT03968341|intraocular concentrations of antibiotics|intraocular concentrations of antibiotics
5004508|NCT03968302|H pylori; eradication; amoxicillin; clarithromycin; esomeprazole; colloidal bismuth subcitrate|h pylori; eradication; amoxicillin; clarithromycin; esomeprazole; colloidal bismuth subcitrate
5004509|NCT03968276|antithrombotic treatment|antithrombotic treatment
5004510|NCT03968276|digital therapeutic application assistance|digital therapeutic application assistance
5004511|NCT03968263|Vibration|vibration
5004512|NCT03968263|Tooth movement acceleration|tooth movement acceleration
5004513|NCT03968224|Metformin|metformin
5319186|NCT02089035|Total cholesterol|total cholesterol
5004514|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
5004515|NCT03968224|PreDiabetes|prediabetes
5004516|NCT03968224|Obesity, Morbid|obesity, morbid
5004517|NCT03968224|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5004520|NCT03968198|Cell therapy|cell therapy
5004521|NCT03968198|ASC autologous|asc autologous
5004522|NCT03968198|CLI|cli
5004523|NCT03968198|PAD|pad
5004524|NCT03968198|No option|no option
5004525|NCT03968185|Low back pain|low back pain
5004526|NCT03968185|Pain|pain
5004527|NCT03968185|Disability|disability
5004528|NCT03968185|Interfascial infiltration|interfascial infiltration
5004529|NCT03968185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5004530|NCT03968185|Analgesics|analgesics
5004531|NCT03968185|Emergency department / emergency room / emergency management|emergency department / emergency room / emergency management
5004532|NCT03968172|Multiple Sclerosis|multiple sclerosis
5004533|NCT03968172|Complex Intervention|complex intervention
5004534|NCT03968172|Lifestyle Intervention|lifestyle intervention
5004535|NCT03968172|Randomized Controlled Trial|randomized controlled trial
5004536|NCT03968172|Evidence-based Medicine|evidence-based medicine
5004537|NCT03968133|probiotic|probiotic
5004538|NCT03968133|mood|mood
5020414|NCT03869684|Wet|wet
5004542|NCT03968094|Respiratory Compromise|respiratory compromise
5004543|NCT03968081|theory of mind|theory of mind
5004544|NCT03968081|mentalisation|mentalisation
5004545|NCT03968081|ostracism|ostracism
5004546|NCT03968081|cyberball|cyberball
5004547|NCT03968055|pediatrics|pediatrics
5004548|NCT03968042|Alcohol-induced brain injury, atrophy, demyelination|alcohol-induced brain injury, atrophy, demyelination
5004549|NCT03968016|Acute Myocardial Infarction|acute myocardial infarction
5004550|NCT03968016|Cardiac marker|cardiac marker
5004551|NCT03968016|Troponin|troponin
5004552|NCT03968003|Prebiotics|prebiotics
5004553|NCT03968003|Intestinal Microbiota|intestinal microbiota
5004554|NCT03967990|cholesterol|cholesterol
5004555|NCT03967990|gut microbiome|gut microbiome
5004556|NCT03967990|gut microbiota|gut microbiota
5004568|NCT03967834|Clear Cell Sarcoma|clear cell sarcoma
5004569|NCT03967834|Epithelioid Sarcoma|epithelioid sarcoma
5004570|NCT03967834|Perivascular Epithelioid Cell Neoplasms|perivascular epithelioid cell neoplasms
5004571|NCT03967834|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5004572|NCT03967834|Solitary Fibrous Tumors|solitary fibrous tumors
5004573|NCT03967834|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5004574|NCT03967834|Epithelioid Hemangioendothelioma|epithelioid hemangioendothelioma
5004575|NCT03967834|Low Grade Fibromyxoid Sarcoma|low grade fibromyxoid sarcoma
5004576|NCT03967834|Sclerosing Epithelioid Fibrosarcoma|sclerosing epithelioid fibrosarcoma
5004578|NCT03967808|Renal replacement therapy|renal replacement therapy
5004579|NCT03967795|ICU|icu
5004580|NCT03967795|enteral nutrition|enteral nutrition
5004587|NCT03967769|Apnoeic oxygenation|apnoeic oxygenation
5004588|NCT03967769|Airway management|airway management
5004589|NCT03967769|Oxygen insufflation|oxygen insufflation
5004590|NCT03967769|Paediatric general anaesthesia|paediatric general anaesthesia
5004591|NCT03967743|Genetics|genetics
5004592|NCT03967743|Infant Development|infant development
5004593|NCT03967717|Edema|edema
5004594|NCT03967691|Interleukin-6|interleukin-6
5004595|NCT03967691|Tocilizumab|tocilizumab
5004596|NCT03967691|Exercise|exercise
5004597|NCT03967691|Substrate Metabolism|substrate metabolism
5004598|NCT03967691|Lipolysis|lipolysis
5004599|NCT03967678|enriched beef|enriched beef
5004600|NCT03967678|omega|omega
5004601|NCT03967678|poly unsaturated fatty acids (PUFA)|poly unsaturated fatty acids (pufa)
5004602|NCT03967678|cholesterol|cholesterol
5004603|NCT03967678|grass fed|grass fed
5004604|NCT03967665|N-acetyl-L-cysteine|n-acetyl-l-cysteine
5004605|NCT03967665|Poor hematopoietic reconstitution|poor hematopoietic reconstitution
5004606|NCT03967665|Unmanipulated Haploidentical stem cell Transplantation|unmanipulated haploidentical stem cell transplantation
5004607|NCT03967652|Volatile organic chemicals|volatile organic chemicals
5004608|NCT03967652|Cancer|cancer
5004609|NCT03967652|Diagnose Disease|diagnose disease
5004610|NCT03967652|Na-nose|na-nose
5004611|NCT03967652|breath diagnoses|breath diagnoses
5004612|NCT03967639|cardiac surgical procedures|cardiac surgical procedures
5004613|NCT03967639|respiratory mechanics|respiratory mechanics
5004614|NCT03967639|seasonal variation|seasonal variation
5004615|NCT03967626|Temperature targeted management (TTM)|temperature targeted management (ttm)
5004616|NCT03967626|close loop|close loop
5004617|NCT03967626|brain temperature|brain temperature
5004618|NCT03967626|cerebral temperature|cerebral temperature
5004619|NCT03967626|systemic temperature|systemic temperature
5004620|NCT03967626|neuroprotection|neuroprotection
5004621|NCT03967626|fever control|fever control
5004622|NCT03967613|Functional eletrical stimulation|functional eletrical stimulation
5004623|NCT03967613|Stroke|stroke
5004624|NCT03967613|Upper limb|upper limb
5004629|NCT03967574|transcranial direct current stimulation|transcranial direct current stimulation
5004630|NCT03967574|non invasive brain stimulation|non invasive brain stimulation
5004631|NCT03967574|tDCS|tdcs
5004632|NCT03967574|NIBS|nibs
5319282|NCT02088502|Prevention|prevention
5004633|NCT03967574|subacromial corticosteroid injection|subacromial corticosteroid injection
5004634|NCT03967561|Exercise|exercise
5004635|NCT03967561|Water-based exercise|water-based exercise
5004636|NCT03967561|Aerobic exercise|aerobic exercise
5004637|NCT03967561|Glucose control|glucose control
5004638|NCT03967561|Type 2 diabetes|type 2 diabetes
5004639|NCT03967522|mRCC|mrcc
5004640|NCT03967522|cabozantinib|cabozantinib
5020433|NCT03869619|PRO|pro
5004645|NCT03967509|Teacher management training|teacher management training
5004646|NCT03967509|Cluster randomized effectiveness trial|cluster randomized effectiveness trial
5004647|NCT03967496|delirium|delirium
5004648|NCT03967496|postoperative complications|postoperative complications
5004649|NCT03967496|anesthesia recovery period|anesthesia recovery period
5004650|NCT03967418|Behavioral addiction|behavioral addiction
5004651|NCT03967418|neurocognition|neurocognition
5004652|NCT03967418|neuropsychology|neuropsychology
5046193|NCT03710460|Obesity|obesity
5004665|NCT03967353|Infection Control|infection control
5004666|NCT03967340|chronic lung allograft dysfunction|chronic lung allograft dysfunction
5004667|NCT03967340|lung transplantation|lung transplantation
5004668|NCT03967340|biomarkers|biomarkers
5004669|NCT03967340|personalized medecine|personalized medecine
5004670|NCT03967314|Lumbar spinal surgery|lumbar spinal surgery
5004671|NCT03967314|Postoperative pain management|postoperative pain management
5004672|NCT03967314|Modified thoracolumbar interfacial plane block|modified thoracolumbar interfacial plane block
5004673|NCT03967301|Carbapenemase-producing Enterobacteriaceae|carbapenemase-producing enterobacteriaceae
5004674|NCT03967301|probiotics|probiotics
5004675|NCT03967288|Chloroprocaine|chloroprocaine
5004676|NCT03967288|Bupivacaine|bupivacaine
5004677|NCT03967288|Motor Block|motor block
5004697|NCT03967158|Percutaneous coronary intervention|percutaneous coronary intervention
5004698|NCT03967106|remote ischaemic preconditioning|remote ischaemic preconditioning
5004699|NCT03967106|gait analysis|gait analysis
5004700|NCT03967106|activity|activity
5004702|NCT03967093|solid tumor|solid tumor
5004703|NCT03967093|brain tumor|brain tumor
5004705|NCT03967093|ependymoma|ependymoma
5004706|NCT03967067|Audit|audit
5004707|NCT03967067|Liver resection|liver resection
5004708|NCT03967067|Surgical complications|surgical complications
5004709|NCT03967067|non-Eastern/non-Western|non-eastern/non-western
5004710|NCT03967067|Quality improvement|quality improvement
5004711|NCT03967054|mosquito|mosquito
5004712|NCT03967054|ivermectin|ivermectin
5004713|NCT03967054|Anopheles|anopheles
5004714|NCT03967054|Plasmodium|plasmodium
5004715|NCT03967041|splenic abscess|splenic abscess
5004716|NCT03967041|sarcopenia|sarcopenia
5004717|NCT03967041|surgical emergency|surgical emergency
5004718|NCT03967015|Mobile Health|mobile health
5004719|NCT03967015|Kenya|kenya
5004720|NCT03967015|Randomized Controlled Trial|randomized controlled trial
5004721|NCT03967002|Accelerated orthodontics|accelerated orthodontics
5004722|NCT03967002|Alveolar corticotomy|alveolar corticotomy
5004723|NCT03967002|Piezoelectric surgery|piezoelectric surgery
5004724|NCT03967002|Tooth movement|tooth movement
5004725|NCT03967002|Dental crowding|dental crowding
5004726|NCT03967002|Guided surgery|guided surgery
5004727|NCT03967002|Minimally invasive oral surgery|minimally invasive oral surgery
5004728|NCT03967002|Mandibular anterior alignment|mandibular anterior alignment
5004729|NCT03967002|Randomized prospective study|randomized prospective study
5004730|NCT03966989|Emergency Medicine|emergency medicine
5004731|NCT03966989|Behavioral Research|behavioral research
5004732|NCT03966963|Eye Movement Desensitization Reprocessing; EMDR|eye movement desensitization reprocessing; emdr
5004733|NCT03966963|childhood sexual abuse|childhood sexual abuse
5004734|NCT03966963|posttraumatic stress disorder|posttraumatic stress disorder
5004735|NCT03966963|PTSD|ptsd
5004736|NCT03966963|adults|adults
5323630|NCT02068326|Adolescence|adolescence
5004737|NCT03966950|Melatonin|melatonin
5004738|NCT03966950|Cognitive Dysfunction|cognitive dysfunction
5004739|NCT03966937|Anterior Knee Pain Syndrome|anterior knee pain syndrome
5004740|NCT03966937|Patellofemoral Syndrome|patellofemoral syndrome
5004741|NCT03966924|submental|submental
5004742|NCT03966924|laxity|laxity
5004743|NCT03966924|lipodystrophy|lipodystrophy
5004744|NCT03966872|integrated health|integrated health
5004745|NCT03966872|mental health|mental health
5004746|NCT03966872|illness management|illness management
5004747|NCT03966872|cardiovascular disease|cardiovascular disease
5004748|NCT03966872|physical health|physical health
5004749|NCT03966859|Atorvastatin|atorvastatin
5004750|NCT03966859|Emotional processing|emotional processing
5004751|NCT03966859|Reward processing|reward processing
5004752|NCT03966859|Inflammation (C-Reactive Protein)|inflammation (c-reactive protein)
5004753|NCT03966846|probiotics|probiotics
5004754|NCT03966846|dairy products|dairy products
5004756|NCT03966846|gut microbiota|gut microbiota
5004757|NCT03966820|Anxiety|anxiety
5319386|NCT02087904|Knee|knee
5004758|NCT03966820|Cognitive ageing|cognitive ageing
5004759|NCT03966820|Depression|depression
5004760|NCT03966820|Fatigue|fatigue
5004761|NCT03966820|Fibromyalgia|fibromyalgia
5004762|NCT03966820|Quality of life|quality of life
5004763|NCT03966820|Sleep|sleep
5004764|NCT03966807|lung cancer|lung cancer
5004765|NCT03966807|caregiver|caregiver
5004766|NCT03966755|Obesity|obesity
5004767|NCT03966755|Heart failure with Normal Ejection Fraction|heart failure with normal ejection fraction
5004768|NCT03966755|HFpEF|hfpef
5004769|NCT03966755|unsaturated fatty acids|unsaturated fatty acids
5004770|NCT03966755|cardiorespiratory fitness|cardiorespiratory fitness
5004771|NCT03966755|dietary intervention|dietary intervention
5004772|NCT03966729|HFmrEF|hfmref
5004773|NCT03966729|HFrEF|hfref
5004774|NCT03966729|HFpEF|hfpef
5004775|NCT03966729|Heart Failure|heart failure
5004776|NCT03966716|Internal Fixation|internal fixation
5004777|NCT03966716|Hip Arthroplasty|hip arthroplasty
5004778|NCT03966716|Reoperation Rate|reoperation rate
5004779|NCT03966716|Mortality|mortality
5004780|NCT03966716|Health Economy|health economy
5004781|NCT03966716|External validity|external validity
5004782|NCT03966716|Adverse events|adverse events
5004783|NCT03966703|complete denture|complete denture
5004784|NCT03966703|implant-fixed denture|implant-fixed denture
5004785|NCT03966703|masticatory efficiency|masticatory efficiency
5004786|NCT03966703|mixing ability test|mixing ability test
5004787|NCT03966677|Groin hernia repair|groin hernia repair
5004788|NCT03966677|Persistent postsurgical pain|persistent postsurgical pain
5004789|NCT03966677|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
5004790|NCT03966677|Normative data|normative data
5004791|NCT03966664|Acid-base equilibrium; pH; septic shock; critical illness|acid-base equilibrium; ph; septic shock; critical illness
5342929|NCT01981486|cGMP|cgmp
5342930|NCT01981486|cantharidin|cantharidin
5004792|NCT03966651|PRRT (Peptide Receptor Radionuclide Therapy)|prrt (peptide receptor radionuclide therapy)
5004793|NCT03966651|177Lu-DOTATATE|177lu-dotatate
5004794|NCT03966625|screening|screening
5004795|NCT03966599|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
5004796|NCT03966599|Analgesic|analgesic
5004797|NCT03966599|hemodynamic status|hemodynamic status
5004799|NCT03966586|India|india
5004800|NCT03966586|retention|retention
5004801|NCT03966586|continuum|continuum
5004802|NCT03966560|choroidal thickness|choroidal thickness
5004803|NCT03966560|multifocal electroretinography|multifocal electroretinography
5004804|NCT03966560|optic nerve head|optic nerve head
5004805|NCT03966560|optical coherence tomography|optical coherence tomography
5004806|NCT03966560|primer open-angle glaucoma|primer open-angle glaucoma
5004807|NCT03966521|Endovascular aneurysm repair|endovascular aneurysm repair
5004808|NCT03966508|central sensitization|central sensitization
5004809|NCT03966508|High-frequency electrical stimulation|high-frequency electrical stimulation
5004810|NCT03966482|cleft palate|cleft palate
5004811|NCT03966482|velopharyngeal sphincter|velopharyngeal sphincter
5004812|NCT03966482|velopharyngeal insufficiency|velopharyngeal insufficiency
5004813|NCT03966482|speech therapy|speech therapy
5004814|NCT03966482|rehabilitation|rehabilitation
5004815|NCT03966469|informed consent|informed consent
5004816|NCT03966469|support person|support person
5004817|NCT03966430|damage control surgery|damage control surgery
5004818|NCT03966430|acute mesenteric ischemia|acute mesenteric ischemia
5004819|NCT03966430|complication|complication
5004820|NCT03966417|exercise training|exercise training
5004821|NCT03966391|school vaccinations|school vaccinations
5004822|NCT03966391|pain management|pain management
5004823|NCT03966391|knowledge translation|knowledge translation
5004824|NCT03966391|cluster trial|cluster trial
5004825|NCT03966365|Glaucoma|glaucoma
5004826|NCT03966365|Krytantek|krytantek
5004827|NCT03966365|Krytantek PF|krytantek pf
5004828|NCT03966365|PRO-122|pro-122
5004829|NCT03966339|Infertility,Female|infertility,female
5004830|NCT03966339|Embryo Development|embryo development
5004831|NCT03966326|Mastectomy|mastectomy
5323757|NCT02067715|Tooth Discoloration|tooth discoloration
5004832|NCT03966326|(PECs) pectoral block|(pecs) pectoral block
5004833|NCT03966300|school vaccinations|school vaccinations
5004834|NCT03966300|pain management|pain management
5004835|NCT03966300|vaccination hesitancy|vaccination hesitancy
5004836|NCT03966300|knowledge translation|knowledge translation
5004837|NCT03966274|Electroencephalography|electroencephalography
5004838|NCT03966274|Acute Confusion|acute confusion
5004839|NCT03966274|Neurobehavioral Manifestations|neurobehavioral manifestations
5004840|NCT03966274|Encephalopathy|encephalopathy
5004841|NCT03966274|Neurocognitive Disorders|neurocognitive disorders
5004842|NCT03966274|Mental Disorders|mental disorders
5004843|NCT03966274|Acute Brain Failure|acute brain failure
5004844|NCT03966248|Arthritis|arthritis
5004846|NCT03966248|Tuina|tuina
5004854|NCT03966235|coronary artery calcification|coronary artery calcification
5004855|NCT03966235|adjuvant therapy|adjuvant therapy
5004856|NCT03966222|Vein graft|vein graft
5004857|NCT03966209|Checkpoint Inhibitor|checkpoint inhibitor
5004861|NCT03966131|swallowing|swallowing
5004862|NCT03966131|sensors|sensors
5004863|NCT03966131|complete denture|complete denture
5004864|NCT03966118|2nd line|2nd line
5004865|NCT03966118|Ramucirumab|ramucirumab
5004866|NCT03966118|Avelumab|avelumab
5004867|NCT03966118|Paclitaxel|paclitaxel
5004868|NCT03966118|gastric cancer|gastric cancer
5004869|NCT03966105|wild-type|wild-type
5004870|NCT03966105|carpal tunnel syndrome|carpal tunnel syndrome
5004871|NCT03966105|lumbar spinal stenosis|lumbar spinal stenosis
5004872|NCT03966105|prevalence|prevalence
5004873|NCT03966092|Prospective randomized pilot study|prospective randomized pilot study
5004874|NCT03966092|Quadratus lumborum block|quadratus lumborum block
5004879|NCT03966053|Diamond Blackfan Anemia|diamond blackfan anemia
5004880|NCT03966027|Diabetic Ankle Fractures|diabetic ankle fractures
5004881|NCT03966001|Cesarean scar pregnancy|cesarean scar pregnancy
5004882|NCT03966001|Isthmocele|isthmocele
5004883|NCT03966001|Uterine niche|uterine niche
5004884|NCT03966001|Cesarean scar defect|cesarean scar defect
5004885|NCT03965936|adipose tissue derived stem cells|adipose tissue derived stem cells
5004886|NCT03965936|lipofilling|lipofilling
5004887|NCT03965910|stroke|stroke
5004888|NCT03965910|rehabilitation|rehabilitation
5004889|NCT03965910|diffusion tensor imaging|diffusion tensor imaging
5004890|NCT03965845|Tumor Metabolism|tumor metabolism
5004891|NCT03965845|Glutaminase Inhibitor|glutaminase inhibitor
5004892|NCT03965845|CB-839|cb-839
5004893|NCT03965845|Palbociclib|palbociclib
5004894|NCT03965845|PALBO|palbo
5004895|NCT03965845|Telaglenestat|telaglenestat
5004896|NCT03965845|CDK4/6|cdk4/6
5004897|NCT03965845|CDK4|cdk4
5004898|NCT03965845|CDK6|cdk6
5004899|NCT03965832|high-flow nasal therapy|high-flow nasal therapy
5004900|NCT03965832|oxygen therapy|oxygen therapy
5004901|NCT03965832|Exercise-induced desaturation|exercise-induced desaturation
5004902|NCT03965819|Aches|aches
5004903|NCT03965819|Discomfort|discomfort
5004904|NCT03965819|Healthy|healthy
5004905|NCT03965819|Adults|adults
5004906|NCT03965819|Body aches|body aches
5004907|NCT03965780|Scleroderma|scleroderma
5004908|NCT03965780|Systemic Sclerosis|systemic sclerosis
5004909|NCT03965780|Peer Support Group|peer support group
5004910|NCT03965780|Training|training
5004911|NCT03965767|endoscopic sinus surgery- tranexamic acid|endoscopic sinus surgery- tranexamic acid
5004912|NCT03965754|Prospect theory|prospect theory
5004913|NCT03965715|3D printed technology|3d printed technology
5004914|NCT03965715|Ankle-Foot Orthosis (AFO)|ankle-foot orthosis (afo)
5004915|NCT03965715|Stroke|stroke
5004916|NCT03965715|Gait parameters|gait parameters
5004917|NCT03965715|Gait Analysis|gait analysis
5004918|NCT03965715|kinetics|kinetics
5004919|NCT03965715|kinematics|kinematics
5004920|NCT03965676|Gout,Dual-energy computed tomography,Tophus,Erosion|gout,dual-energy computed tomography,tophus,erosion
5004921|NCT03965650|axial spondyloarthritis|axial spondyloarthritis
5004922|NCT03965650|online video coaching|online video coaching
5004923|NCT03965650|physical activity|physical activity
5004924|NCT03965637|vitamin c|vitamin c
5004925|NCT03965637|Hysterectomy|hysterectomy
5004926|NCT03965637|bleeding|bleeding
5004927|NCT03965637|wound healing|wound healing
5004928|NCT03965637|abdominal surgeries|abdominal surgeries
5004929|NCT03965624|MCNS|mcns
5004930|NCT03965624|Rituximab|rituximab
5004931|NCT03965624|Complete remission|complete remission
5004932|NCT03965611|Traumatic brain injury|traumatic brain injury
5004933|NCT03965611|Multiple trauma|multiple trauma
5004934|NCT03965611|Microbiota|microbiota
5004935|NCT03965611|Intensive care unit|intensive care unit
5004936|NCT03965598|Schizophrenia; Ultra-high risk for psychosis; Predictors; Pathogenesis|schizophrenia; ultra-high risk for psychosis; predictors; pathogenesis
5004938|NCT03965533|Japanese, Caucasian, pharmacokinetics, pharmacodynamics, GSK2831781, lymphocyte activation gene-3|japanese, caucasian, pharmacokinetics, pharmacodynamics, gsk2831781, lymphocyte activation gene-3
5004939|NCT03965520|peripheral arterial disease|peripheral arterial disease
5004940|NCT03965520|exercise training|exercise training
5004941|NCT03965520|local aerobic training|local aerobic training
5004953|NCT03965442|Esmolol|esmolol
5004954|NCT03965442|Perioperative|perioperative
5004955|NCT03965429|malignant hemopathy|malignant hemopathy
5004956|NCT03965429|allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5004957|NCT03965429|blood collection|blood collection
5004958|NCT03965416|White Coat|white coat
5004959|NCT03965416|Communication|communication
5004960|NCT03965416|Physician - Patient Relationship|physician - patient relationship
5004961|NCT03965416|Satisfaction|satisfaction
5004962|NCT03965416|Trust|trust
5004963|NCT03965416|Competence|competence
5004964|NCT03965416|Empathy|empathy
5004965|NCT03965416|Knowledge|knowledge
5004969|NCT03965390|oral microbiota|oral microbiota
5004970|NCT03965390|parkinson|parkinson
5004971|NCT03965390|brain stimulation surgery|brain stimulation surgery
5004972|NCT03965390|oral therapeutic|oral therapeutic
5004985|NCT03965299|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5004986|NCT03965299|neuromodulation|neuromodulation
5004992|NCT03965273|CRCT|crct
5004993|NCT03965273|Impact|impact
5004994|NCT03965273|Bangladesh|bangladesh
5004995|NCT03965247|Lithium|lithium
5004996|NCT03965247|Reward|reward
5004997|NCT03965247|Caudate|caudate
5004998|NCT03965247|Reappraisal|reappraisal
5004999|NCT03965247|Prefrontal cortex|prefrontal cortex
5000542|NCT03991767|HIV|hiv
5005000|NCT03965247|Amygdala|amygdala
5005001|NCT03965221|PrEP|prep
5005002|NCT03965221|HIV Testing|hiv testing
5005003|NCT03965221|Sexually Transmitted Infections|sexually transmitted infections
5005004|NCT03965221|Mobile app|mobile app
5005005|NCT03965221|Young men who have sex with men|young men who have sex with men
5005006|NCT03965221|Technology|technology
5342931|NCT01981486|blister|blister
5005020|NCT03965130|Hepatic Mitochondrial Oxidation|hepatic mitochondrial oxidation
5005022|NCT03965130|Glucagon|glucagon
5005023|NCT03965117|hepatic blood flow|hepatic blood flow
5005024|NCT03965117|Norepinephrine|norepinephrine
5005025|NCT03965117|hepatic vascular pressure|hepatic vascular pressure
5005026|NCT03965078|cataract surgery|cataract surgery
5005032|NCT03965052|Travoprost|travoprost
5005033|NCT03965052|ophthalmic solution|ophthalmic solution
5005034|NCT03965052|Prostaglandin Analogues|prostaglandin analogues
5005035|NCT03965052|Antiglaucoma drugs|antiglaucoma drugs
5005036|NCT03965052|glaucoma|glaucoma
5005037|NCT03965000|SGLT2|sglt2
5005038|NCT03965000|SLC5A2|slc5a2
5005039|NCT03965000|glucose metabolism|glucose metabolism
5005040|NCT03965000|glucagon|glucagon
5005041|NCT03965000|incretin|incretin
5005042|NCT03964987|PDX-1|pdx-1
5005043|NCT03964987|NGN-3|ngn-3
5005044|NCT03964987|Glucose|glucose
5005045|NCT03964961|functional massage|functional massage
5005046|NCT03964961|conventional massage|conventional massage
5005047|NCT03964961|neuromuscular response|neuromuscular response
5005048|NCT03964870|Malignant Hyperthermia|malignant hyperthermia
5005049|NCT03964844|hematologic conditions|hematologic conditions
5005050|NCT03964844|recurrence|recurrence
5005051|NCT03964818|osteitis|osteitis
5005052|NCT03964818|flap surgery|flap surgery
5005053|NCT03964818|short-course antibiotics|short-course antibiotics
5005054|NCT03964805|Embryo culture|embryo culture
5005055|NCT03964805|oxygen tension,|oxygen tension,
5005056|NCT03964805|embryo quality,|embryo quality,
5005057|NCT03964805|extended culture|extended culture
5005058|NCT03964766|rotary files|rotary files
5005059|NCT03964766|Primary molar|primary molar
5005060|NCT03964766|Pulpectomy|pulpectomy
5005061|NCT03964714|Acutely hospitalised|acutely hospitalised
5005062|NCT03964714|Elderly|elderly
5005063|NCT03964714|Activity monitoring|activity monitoring
5005064|NCT03964701|children|children
5005065|NCT03964701|renal failure|renal failure
5005066|NCT03964701|dialysis|dialysis
5005067|NCT03964688|vitamin C|vitamin c
5005068|NCT03964688|ascorbate|ascorbate
5005069|NCT03964688|ascorbic acid|ascorbic acid
5005070|NCT03964688|autologous stem cell transplantation|autologous stem cell transplantation
5005558|NCT03961958|Propofol|propofol
5005097|NCT03964545|Borderline|borderline
5005098|NCT03964545|Post-traumatic stress|post-traumatic stress
5005099|NCT03964545|Neurofeedback|neurofeedback
5005100|NCT03964545|Amygdala|amygdala
5005101|NCT03964545|Emotion regulation|emotion regulation
5005106|NCT03964519|velocity loss|velocity loss
5005107|NCT03964519|Tensiomiography|tensiomiography
5005108|NCT03964519|resistance training|resistance training
5005109|NCT03964506|Allogeneic transplant|allogeneic transplant
5005110|NCT03964506|Hyperbaric Oxygen|hyperbaric oxygen
5005116|NCT03964480|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5005117|NCT03964480|Prognosis|prognosis
5005118|NCT03964480|Outcome|outcome
5005119|NCT03964480|Biological Characteristics|biological characteristics
5005120|NCT03964480|Heterogeneity|heterogeneity
5005121|NCT03964480|Rare Diseases|rare diseases
5005122|NCT03964467|stroke|stroke
5005123|NCT03964467|upper extremity|upper extremity
5005124|NCT03964467|intervention|intervention
5323972|NCT02066584|glucose|glucose
5005125|NCT03964467|transcranial direct current stimulation|transcranial direct current stimulation
5005126|NCT03964467|actigraph|actigraph
5005127|NCT03964467|fMRI|fmri
5005132|NCT03964428|periodontitis|periodontitis
5005133|NCT03964428|ferritin|ferritin
5005134|NCT03964428|hepicidin|hepicidin
5005135|NCT03964428|type 2 diabetes mellitus|type 2 diabetes mellitus
5005136|NCT03964428|non surgical perioontal therapy|non surgical perioontal therapy
5005137|NCT03964402|sample size, survival, randomized clinical trials, statistical test|sample size, survival, randomized clinical trials, statistical test
5005138|NCT03964389|Central Nervous System Sensitization|central nervous system sensitization
5005139|NCT03964389|kinesiophobia|kinesiophobia
5005140|NCT03964376|Sleep Apnea|sleep apnea
5005141|NCT03964363|Frailty|frailty
5005152|NCT03964363|perioperative care|perioperative care
5005153|NCT03964363|elderly|elderly
5005154|NCT03964363|prevention|prevention
5005155|NCT03964285|Rumination|rumination
5005156|NCT03964285|Fibromyalgia|fibromyalgia
5005157|NCT03964285|Chronic Pain|chronic pain
5005158|NCT03964285|affectivity|affectivity
5005159|NCT03964285|repetitive negative thinking|repetitive negative thinking
5005160|NCT03964272|MRgFUS|mrgfus
5005161|NCT03964272|ExAblate|exablate
5005162|NCT03964272|Parkinsons Disease|parkinsons disease
5005163|NCT03964272|Sub-Thalamotomy|sub-thalamotomy
5005164|NCT03964259|High Dose Methotrexate|high dose methotrexate
5005165|NCT03964259|HDMTX|hdmtx
5005166|NCT03964259|Intravenous Fluids|intravenous fluids
5005167|NCT03964246|Feasibility Studies|feasibility studies
5005168|NCT03964246|Meditation, psychology|meditation, psychology
5005169|NCT03964155|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5005170|NCT03964155|Inhaled Sedation with Sevoflurane|inhaled sedation with sevoflurane
5005171|NCT03964155|Biological collection|biological collection
5005172|NCT03964142|Chemotherapy|chemotherapy
5005173|NCT03964142|Anthracyclines|anthracyclines
5005174|NCT03964142|Trastuzumab|trastuzumab
5005175|NCT03964142|Pertuzumab|pertuzumab
5005176|NCT03964142|Antibodies, Monoclonal, Humanized|antibodies, monoclonal, humanized
5005177|NCT03964142|Breast Cancer|breast cancer
5005178|NCT03964142|Exercise therapy|exercise therapy
5005179|NCT03964090|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5005180|NCT03964090|Lymphoma in Brain and CNS|lymphoma in brain and cns
5005181|NCT03964090|ABC DLBCL|abc dlbcl
5005182|NCT03964090|Diffuse Large B-Cell Lymphomas in CNS|diffuse large b-cell lymphomas in cns
5005183|NCT03964077|Neurogenic Bladder|neurogenic bladder
5005184|NCT03964077|Quality of life|quality of life
5005185|NCT03964077|Spinal Cord Injury|spinal cord injury
5005186|NCT03964064|Pancreatic Cancer Non-resectable|pancreatic cancer non-resectable
5005187|NCT03964064|I125 seed implantation|i125 seed implantation
5005188|NCT03964064|Stereotactic radiotherapy|stereotactic radiotherapy
5005189|NCT03964051|Omalizumab|omalizumab
5005190|NCT03964051|Xolair|xolair
5005191|NCT03964051|Anaphylaxis|anaphylaxis
5005192|NCT03964038|gilteritinib|gilteritinib
5005193|NCT03964038|ASP2215|asp2215
5005194|NCT03964038|Healthy volunteer|healthy volunteer
5005195|NCT03964025|Holter Monitor|holter monitor
5005196|NCT03964025|ECG Monitor|ecg monitor
5005197|NCT03964025|Cardioskin|cardioskin
5005198|NCT03964012|Neisseria meningitidis|neisseria meningitidis
5005199|NCT03964012|conjugate meningococcal vaccine|conjugate meningococcal vaccine
5005200|NCT03964012|Meningococcal serogroup X|meningococcal serogroup x
5005201|NCT03963999|Ultrasound Elastography|ultrasound elastography
5005202|NCT03963986|Regular physical activity|regular physical activity
5005203|NCT03963934|Nurse-led management|nurse-led management
5005204|NCT03963934|Home blood pressure|home blood pressure
5005209|NCT03963908|pain self management|pain self management
5005211|NCT03963908|Transtheoretical Model|transtheoretical model
5005212|NCT03963895|Hemodialysis|hemodialysis
5005213|NCT03963843|spinal cord injuries|spinal cord injuries
5005214|NCT03963843|anxiety|anxiety
5005215|NCT03963843|depression|depression
5005216|NCT03963843|internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5005217|NCT03963817|Imaging|imaging
5005218|NCT03963817|Autofluorescence imaging|autofluorescence imaging
5005219|NCT03963817|Spectral domain optical coherence tomography|spectral domain optical coherence tomography
5005220|NCT03963817|Adaptive optics|adaptive optics
5005221|NCT03963817|Soft drusen|soft drusen
5005222|NCT03963817|Reticular pseudodrusen|reticular pseudodrusen
5005223|NCT03963804|Concussion|concussion
5005224|NCT03963804|Mild Traumatic Brain Injury|mild traumatic brain injury
5005225|NCT03963804|Sport Related Concussion|sport related concussion
5005226|NCT03963804|Non-Sport Related Concussion|non-sport related concussion
5005227|NCT03963778|Malnourishment|malnourishment
5005228|NCT03963778|Nutritional Deficiency|nutritional deficiency
5005229|NCT03963778|Undernutrition|undernutrition
5005230|NCT03963752|Idiopathic Precocious Puberty|idiopathic precocious puberty
5008025|NCT03946319|Wellness|wellness
5005237|NCT03963726|microwave ablation|microwave ablation
5005238|NCT03963726|Liver Metastases|liver metastases
5005239|NCT03963726|Colorectal Cancer|colorectal cancer
5324066|NCT02066220|PNET|pnet
5005240|NCT03963713|Stereotactic radiotherapy|stereotactic radiotherapy
5005241|NCT03963713|Intensity modulated radiotherapy|intensity modulated radiotherapy
5005242|NCT03963713|spinal metastatic tumors|spinal metastatic tumors
5005243|NCT03963687|genomics|genomics
5005244|NCT03963687|genetics|genetics
5005245|NCT03963687|nursing education|nursing education
5005246|NCT03963687|web-based|web-based
5005247|NCT03963674|Neuromuscular response|neuromuscular response
5005248|NCT03963674|diacutaneous fibrolysis|diacutaneous fibrolysis
5005249|NCT03963661|Telerehabilitation|telerehabilitation
5005250|NCT03963661|Spatial neglect|spatial neglect
5005252|NCT03963661|Computorized therapy|computorized therapy
5005254|NCT03963661|Innatention|innatention
5005255|NCT03963661|Self-admnistered therapy|self-admnistered therapy
5005256|NCT03963661|Usability|usability
5005257|NCT03963635|Lyme Disease|lyme disease
5005258|NCT03963635|Borrelia burgdorferi|borrelia burgdorferi
5005259|NCT03963635|Antibody Secreting Cells|antibody secreting cells
5005260|NCT03963635|Diagnostics|diagnostics
5005261|NCT03963635|Early Diagnosis|early diagnosis
5005262|NCT03963635|Treatment Outcome|treatment outcome
5005263|NCT03963635|Health Volunteers|health volunteers
5005264|NCT03963635|Adult|adult
5005265|NCT03963622|Ventilation|ventilation
5005266|NCT03963622|ARDS|ards
5005270|NCT03963609|chronic stable angina|chronic stable angina
5005271|NCT03963609|multislice CT|multislice ct
5005272|NCT03963609|remodeling index|remodeling index
5005273|NCT03963596|fundus diseases|fundus diseases
5005274|NCT03963596|antiangiogenic therapy|antiangiogenic therapy
5005275|NCT03963596|choroidal neovascularization|choroidal neovascularization
5005276|NCT03963596|pathologyc myopia|pathologyc myopia
5005277|NCT03963596|intravitreal injection|intravitreal injection
5005278|NCT03963596|anti-VEGF|anti-vegf
5005279|NCT03963583|Heart Failure|heart failure
5005280|NCT03963583|Caregivers|caregivers
5005281|NCT03963583|Resilience|resilience
5005282|NCT03963583|Preventive Health Behaviors|preventive health behaviors
5005283|NCT03963570|Accidental Falls|accidental falls
5005284|NCT03963570|Prevention and control|prevention and control
5005285|NCT03963570|Exercise|exercise
5005286|NCT03963570|Exercise therapy/methods*|exercise therapy/methods*
5005287|NCT03963570|Aged|aged
5005288|NCT03963570|Aged 80 and over|aged 80 and over
5005289|NCT03963570|Smartphone|smartphone
5005290|NCT03963570|Computers handheld|computers handheld
5005291|NCT03963570|Motivation|motivation
5005292|NCT03963570|Behaviour change|behaviour change
5005293|NCT03963570|Postural balance|postural balance
5005294|NCT03963570|Health behaviour|health behaviour
5005295|NCT03963570|mHealth|mhealth
5005296|NCT03963570|eHealth|ehealth
5005297|NCT03963570|Digital health|digital health
5005298|NCT03963570|Self-management|self-management
5005299|NCT03963518|cancer|cancer
5005300|NCT03963518|trial|trial
5005301|NCT03963518|immune-checkpoint inhibitors|immune-checkpoint inhibitors
5005305|NCT03963492|Fatigue|fatigue
5005306|NCT03963466|Melasma|melasma
5005307|NCT03963466|1064-nm Q-Switched Fractional Laser|1064-nm q-switched fractional laser
5005308|NCT03963466|Tranexamic acid (TA)|tranexamic acid (ta)
5005309|NCT03963466|Treatment|treatment
5005310|NCT03963453|Physical Therapy Modalities|physical therapy modalities
5005311|NCT03963453|Exercise|exercise
5005312|NCT03963453|Physical Activity|physical activity
5005313|NCT03963453|Exercise Program|exercise program
5005314|NCT03963453|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
5005315|NCT03963440|Chronic low back pain|chronic low back pain
5005316|NCT03963440|Physical activity|physical activity
5005317|NCT03963440|Questionnaire|questionnaire
5005318|NCT03963440|Adhesion|adhesion
5005319|NCT03963427|breast reconstruction|breast reconstruction
5005320|NCT03963427|plastic surgery|plastic surgery
5005321|NCT03963427|microsurgery|microsurgery
5005322|NCT03963414|Extensive stage small cell lung cancer|extensive stage small cell lung cancer
5005324|NCT03963388|Speech therapy|speech therapy
5005325|NCT03963388|Telerehabilitation|telerehabilitation
5005326|NCT03963388|Quality of life|quality of life
5005327|NCT03963362|GLA5PR|gla5pr
5005328|NCT03963362|Renal function|renal function
5005329|NCT03963362|Pharmacokinetics|pharmacokinetics
5005330|NCT03963362|Pregabalin|pregabalin
5005332|NCT03963336|D-dimer|d-dimer
5005336|NCT03963271|polymorphic ventricular tachycardia|polymorphic ventricular tachycardia
5005337|NCT03963271|body surface potential mapping|body surface potential mapping
5005338|NCT03963271|ECG Imaging|ecg imaging
5005339|NCT03963258|Whole-Body vibration|whole-body vibration
5005340|NCT03963258|Stroke|stroke
5005341|NCT03963258|Hemiplegia|hemiplegia
5005342|NCT03963258|upper extremity|upper extremity
5005343|NCT03963258|Rehabilitation training|rehabilitation training
5005344|NCT03963258|Muscular surface EMG|muscular surface emg
5005345|NCT03963258|Vibration training|vibration training
5005346|NCT03963245|Psychiatric Disabilities|psychiatric disabilities
5005347|NCT03963245|Rehabilitation|rehabilitation
5005348|NCT03963245|Recovery|recovery
5005349|NCT03963245|Occupational therapy|occupational therapy
5005350|NCT03963245|Peer-support|peer-support
5005351|NCT03963232|prevention|prevention
5005352|NCT03963232|prophylactic|prophylactic
5005353|NCT03963219|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5005354|NCT03963206|Hepatocellular carcinoma|hepatocellular carcinoma
5005355|NCT03963206|Cabozantinib|cabozantinib
5005357|NCT03963167|Adherence|adherence
5005358|NCT03963167|HRQoL determinants|hrqol determinants
5005359|NCT03963128|Vitamin D|vitamin d
5005360|NCT03963128|Royal Marines|royal marines
5005361|NCT03963128|Military Training|military training
5005362|NCT03963128|Illness|illness
5005365|NCT03963102|photodynamic therapy|photodynamic therapy
5005366|NCT03963089|Fluid Therapy|fluid therapy
5005367|NCT03963089|Hemodynamic Monitoring|hemodynamic monitoring
5005368|NCT03963050|Frailty phenotype|frailty phenotype
5005383|NCT03962998|Gut permeability|gut permeability
5005384|NCT03962998|Intestinal permeability|intestinal permeability
5005385|NCT03962998|MB-102|mb-102
5005386|NCT03962959|Mild Cognitive Impairment|mild cognitive impairment
5319864|NCT02085369|gene expression|gene expression
5005387|NCT03962959|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5005388|NCT03962946|Adolfsson-score|adolfsson-score
5005389|NCT03962946|Suhm Score|suhm score
5005390|NCT03962881|Hepatitis B Vaccine|hepatitis b vaccine
5005391|NCT03962881|Randomized Controlled Trial|randomized controlled trial
5005392|NCT03962881|Chronic Kidney Disease Population|chronic kidney disease population
5005393|NCT03962881|Immunogenicity|immunogenicity
5005394|NCT03962881|Long-term Immune Response|long-term immune response
5005395|NCT03962868|Colonic Polyp|colonic polyp
5005396|NCT03962868|large non pedunculated|large non pedunculated
5005397|NCT03962868|colonic adenoma|colonic adenoma
5005398|NCT03962868|Endoscopic submucosal dissection|endoscopic submucosal dissection
5005399|NCT03962868|Endoscopic Mucosal Resection|endoscopic mucosal resection
5005400|NCT03962842|spine|spine
5005401|NCT03962842|extensibility|extensibility
5005402|NCT03962842|children|children
5005403|NCT03962842|pilates|pilates
5005404|NCT03962842|exercise|exercise
5005405|NCT03962842|health|health
5005406|NCT03962842|physical activity|physical activity
5005407|NCT03962842|physical education|physical education
5005408|NCT03962816|Hepatitis B Vaccine|hepatitis b vaccine
5005409|NCT03962816|Randomized Controlled Trial|randomized controlled trial
5005410|NCT03962816|Methadone Maintenance Treatment Patients|methadone maintenance treatment patients
5005411|NCT03962816|Immunogenicity|immunogenicity
5005412|NCT03962816|Long-term Immune Response|long-term immune response
5005413|NCT03962803|Hepatitis B Vaccine|hepatitis b vaccine
5005414|NCT03962803|Randomized Controlled Trial|randomized controlled trial
5005426|NCT03962712|food insecurity|food insecurity
5005427|NCT03962712|food assistance program|food assistance program
5005428|NCT03962712|minimum wage|minimum wage
5005429|NCT03962699|sperm|sperm
5005430|NCT03962699|Epigenetic|epigenetic
5005432|NCT03962673|Phototherapy|phototherapy
5005433|NCT03962673|Microbiome|microbiome
5005434|NCT03962673|Vitamin D|vitamin d
5005435|NCT03962634|Cavities|cavities
5005436|NCT03962621|Facial rejuvenation, Erbium: YAG Laser, 1064 nm laser, skin aging|facial rejuvenation, erbium: yag laser, 1064 nm laser, skin aging
5005437|NCT03962569|Artificial Urinary Sphincter|artificial urinary sphincter
5005438|NCT03962556|trigger point,myofacial pain|trigger point,myofacial pain
5005439|NCT03962543|Neurofibromatoses|neurofibromatoses
5005440|NCT03962543|Neurofibromatosis 1|neurofibromatosis 1
5005441|NCT03962543|Plexiform Neurofibroma|plexiform neurofibroma
5005442|NCT03962543|PD-0325901|pd-0325901
5005443|NCT03962543|MEK Inhibitor|mek inhibitor
5005444|NCT03962543|Neurofibroma|neurofibroma
5005445|NCT03962504|PTSD|ptsd
5005446|NCT03962504|psychosocial treatment|psychosocial treatment
5005447|NCT03962504|cognitive behavioral treatment|cognitive behavioral treatment
5005448|NCT03962504|veterans|veterans
5005449|NCT03962504|quality of life|quality of life
5005450|NCT03962452|Rare Diseases|rare diseases
5005451|NCT03962452|Genetic Predisposition|genetic predisposition
5005452|NCT03962452|Epigenetic variation|epigenetic variation
5005453|NCT03962452|Omics|omics
5005454|NCT03962452|Genetic variation|genetic variation
5005466|NCT03962439|Active Learning|active learning
5005471|NCT03962361|Biomarkers|biomarkers
5005472|NCT03962361|Cell-Derived Microparticles|cell-derived microparticles
5005473|NCT03962335|Gut microbiota|gut microbiota
5005474|NCT03962335|Mediterranean diet|mediterranean diet
5005475|NCT03962335|Vegetarian diet|vegetarian diet
5005476|NCT03962335|Short chain fatty acids|short chain fatty acids
5005477|NCT03962322|Diaphragmatic Tissue Doppler|diaphragmatic tissue doppler
5005478|NCT03962322|Weaning|weaning
5005479|NCT03962322|Mechanical ventilation|mechanical ventilation
5005484|NCT03962296|Diabetic retinopathy, hard exudates|diabetic retinopathy, hard exudates
5005485|NCT03962270|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5005486|NCT03962270|Knee Osteoarthritis|knee osteoarthritis
5005487|NCT03962270|Cartilage Injury|cartilage injury
5005488|NCT03962257|Patient education|patient education
5005489|NCT03962244|Esophagectomy, Esophageal Cancer, Vacuum therapy, Stents|esophagectomy, esophageal cancer, vacuum therapy, stents
5005490|NCT03962231|Treatment|treatment
5005491|NCT03962231|Physiotherapy|physiotherapy
5005492|NCT03962231|Impingement Syndrome|impingement syndrome
5005493|NCT03962218|spinal cord injury|spinal cord injury
5005494|NCT03962218|Hydrotherapy|hydrotherapy
5005495|NCT03962218|Balance|balance
5005496|NCT03962218|Gait|gait
5005497|NCT03962205|obese patients|obese patients
5005498|NCT03962205|psychological well being|psychological well being
5005499|NCT03962205|weight loss|weight loss
5005500|NCT03962205|depression|depression
5005501|NCT03962205|psychological distress|psychological distress
5005502|NCT03962205|life-style intervention|life-style intervention
5005503|NCT03962205|demoralization|demoralization
5005504|NCT03962179|Perforation Esophagus, Esophageal Anastomotic Leak,|perforation esophagus, esophageal anastomotic leak,
5005505|NCT03962166|atrial fibrillation|atrial fibrillation
5021222|NCT03864211|Thermal ablation|thermal ablation
5005506|NCT03962166|left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5005507|NCT03962166|electrocardiogram|electrocardiogram
5319962|NCT02085044|children|children
5005508|NCT03962166|signal processed surface ECG|signal processed surface ecg
5005510|NCT03962166|transthoracic echocardiography|transthoracic echocardiography
5005511|NCT03962153|fetal growth|fetal growth
5005512|NCT03962153|ultrasonographic parameters|ultrasonographic parameters
5005513|NCT03962140|Endometrial Cancer|endometrial cancer
5005514|NCT03962140|CT-scan|ct-scan
5005515|NCT03962140|Fat distribution|fat distribution
5005516|NCT03962140|Obesity|obesity
5005517|NCT03962140|Sarcopenia|sarcopenia
5005518|NCT03962127|Cardiovascular risk factors|cardiovascular risk factors
5005519|NCT03962127|Risk Assessment|risk assessment
5005520|NCT03962127|Severity of Illness Index|severity of illness index
5005521|NCT03962127|Mortality|mortality
5005522|NCT03962127|Recurrent stroke|recurrent stroke
5005523|NCT03962127|Health-related quality of life|health-related quality of life
5005524|NCT03962127|modified Rankin scale|modified rankin scale
5005525|NCT03962127|NIHSS|nihss
5005526|NCT03962127|Fatigue severity score|fatigue severity score
5005527|NCT03962127|Hospital anxiety and depression scale|hospital anxiety and depression scale
5005528|NCT03962127|Montreal cognitive assessment|montreal cognitive assessment
5005529|NCT03962114|Ataxia Telangiectasia|ataxia telangiectasia
5005530|NCT03962114|ATM Gene Mutation|atm gene mutation
5005531|NCT03962114|ATM protein|atm protein
5005532|NCT03962114|Nicotinamide riboside|nicotinamide riboside
5005533|NCT03962049|Linzagolix|linzagolix
5005534|NCT03962049|OBE2109|obe2109
5005535|NCT03962049|Hepatic Impairment|hepatic impairment
5005536|NCT03962049|Hepatic Insufficiency|hepatic insufficiency
5005537|NCT03962049|Liver Diseases|liver diseases
5005538|NCT03962049|Clinical pharmacology study|clinical pharmacology study
5005539|NCT03962023|Mitral Valve Insufficiency|mitral valve insufficiency
5005540|NCT03962023|Imagery|imagery
5005541|NCT03962023|Prognosis|prognosis
5005542|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/metabolism|cytochrome p-450 cyp3a inhibitors/metabolism
5005543|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/adverse effects|cytochrome p-450 cyp3a inhibitors/adverse effects
5005544|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/pharmacokinetics|cytochrome p-450 cyp3a inhibitors/pharmacokinetics
5005545|NCT03961997|Cytochrome P-450 CYP3A Inhibitors/pharmacology|cytochrome p-450 cyp3a inhibitors/pharmacology
5005547|NCT03961997|Modafinil/pharmacokinetics|modafinil/pharmacokinetics
5005548|NCT03961997|Modafinil/pharmacology|modafinil/pharmacology
5005549|NCT03961984|anal fistula|anal fistula
5005550|NCT03961984|fistula-in-ano|fistula-in-ano
5005551|NCT03961984|surgical plug|surgical plug
5005552|NCT03961984|collagen plug|collagen plug
5005553|NCT03961984|complex anal fistula|complex anal fistula
5005554|NCT03961984|transsphincteric anal fistula|transsphincteric anal fistula
5005555|NCT03961971|Immunotherapy|immunotherapy
5005556|NCT03961958|Hemodynamics|hemodynamics
5005557|NCT03961958|Knee-Chest Position|knee-chest position
5005563|NCT03961945|Gastroesophageal Reflux|gastroesophageal reflux
5005564|NCT03961945|Reflux|reflux
5005565|NCT03961945|Esophageal Cancer|esophageal cancer
5005566|NCT03961945|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5005567|NCT03961932|Linzagolix|linzagolix
5005568|NCT03961932|OBE2109|obe2109
5005569|NCT03961932|Renal impairment|renal impairment
5005570|NCT03961932|Renal Insufficiency|renal insufficiency
5005571|NCT03961932|Kidney Diseases|kidney diseases
5005572|NCT03961932|Clinical pharmacology study|clinical pharmacology study
5005576|NCT03961854|probiotics|probiotics
5005577|NCT03961854|genetics|genetics
5005578|NCT03961802|Rehabilitation|rehabilitation
5005579|NCT03961802|shoulder dysfunction|shoulder dysfunction
5005580|NCT03961802|cervical lymph node dissection|cervical lymph node dissection
5005581|NCT03961802|head and neck cancer|head and neck cancer
5005582|NCT03961789|Opioid-Related Disorders|opioid-related disorders
5005583|NCT03961789|Opiate replacement therapy|opiate replacement therapy
5005584|NCT03961789|Community Pharmacy Services|community pharmacy services
5005585|NCT03961789|Patient Satisfaction|patient satisfaction
5005588|NCT03961763|omega-3|omega-3
5005591|NCT03961763|sdLDL|sdldl
5005592|NCT03961763|cardiovascular disease|cardiovascular disease
5005593|NCT03961763|hyperlipidemia|hyperlipidemia
5005594|NCT03961763|dyslipidemia|dyslipidemia
5005595|NCT03961750|Older Adult|older adult
5005596|NCT03961750|OTAGO|otago
5005597|NCT03961750|Student led|student led
5005598|NCT03961737|radiotherapy|radiotherapy
5005599|NCT03961737|explants|explants
5005600|NCT03961737|transcriptomic|transcriptomic
5005601|NCT03961737|immunohistochemistry|immunohistochemistry
5005602|NCT03961698|Phase 2|phase 2
5005603|NCT03961698|PI3K|pi3k
5005604|NCT03961698|IPI-549|ipi-549
5005605|NCT03961698|Advanced Solid Tumor|advanced solid tumor
5005606|NCT03961698|Triple Negative Breast Cancer (TNBC)|triple negative breast cancer (tnbc)
5005607|NCT03961698|Renal Cell Carcinoma (RCC)|renal cell carcinoma (rcc)
5005608|NCT03961698|PD-L1|pd-l1
5005609|NCT03961698|Myeloid-Derived Suppressor Cells (MDSCs)|myeloid-derived suppressor cells (mdscs)
5005610|NCT03961698|Front-Line Treatment|front-line treatment
5005619|NCT03961607|Photodynamic Therapy|photodynamic therapy
5005620|NCT03961607|Conventional|conventional
5005621|NCT03961607|Painless|painless
5005622|NCT03961607|Acne|acne
5005623|NCT03961568|Idiopathic Generalized Epilepsy|idiopathic generalized epilepsy
5005624|NCT03961555|Post-exposure prophylaxis of Rabies|post-exposure prophylaxis of rabies
5005625|NCT03961516|continuous glucose monitor|continuous glucose monitor
5005626|NCT03961516|cystic fibrosis|cystic fibrosis
5005627|NCT03961516|cystic fibrosis related diabetes|cystic fibrosis related diabetes
5005628|NCT03961503|Vancomycin|vancomycin
5005629|NCT03961503|Daptomycin|daptomycin
5005630|NCT03961503|Acute Kidney Injury|acute kidney injury
5005631|NCT03961503|Nephrotoxicity|nephrotoxicity
5005632|NCT03961503|Infective Endocarditis|infective endocarditis
5005633|NCT03961503|Foreign Body Associated Infection|foreign body associated infection
5005634|NCT03961503|Cardiovascular surgery|cardiovascular surgery
5005635|NCT03961477|Low Back Pain,|low back pain,
5005636|NCT03961477|Interferential Therapy|interferential therapy
5005637|NCT03961477|Quality of Life|quality of life
5005638|NCT03961464|Emotion processing|emotion processing
5005639|NCT03961464|Autobiographical memory|autobiographical memory
5005640|NCT03961464|Stress|stress
5005641|NCT03961451|pedometer|pedometer
5005642|NCT03961438|Neutralizing antibody responses|neutralizing antibody responses
5005643|NCT03961438|Antibodies|antibodies
5005644|NCT03961438|HIV-infection|hiv-infection
5005645|NCT03961438|Vaccine|vaccine
5005646|NCT03961386|prevention|prevention
5005647|NCT03961347|probiotics|probiotics
5005648|NCT03961347|genetics|genetics
5005649|NCT03961321|SMART|smart
5005650|NCT03961321|Prostate cancer|prostate cancer
5005651|NCT03961321|SBRT|sbrt
5005652|NCT03961321|MRgRT|mrgrt
5005653|NCT03961321|Toxicity|toxicity
5005654|NCT03961308|Drug therapy|drug therapy
5005655|NCT03961295|Drug therapy|drug therapy
5005656|NCT03961269|Breast cancer surgery|breast cancer surgery
5005657|NCT03961269|Persistent pain|persistent pain
5005658|NCT03961256|Kidney Transplant|kidney transplant
5005659|NCT03961243|Hemophilia B|hemophilia b
5005660|NCT03961243|factor IX|factor ix
5005661|NCT03961243|Gene therapylentiviral vector|gene therapylentiviral vector
5005662|NCT03961230|Psoriasis Vulgaris|psoriasis vulgaris
5005663|NCT03961230|Jueyin granules|jueyin granules
5005664|NCT03961230|Blood heat syndrome|blood heat syndrome
5005665|NCT03961230|Randomized controlled trial|randomized controlled trial
5005666|NCT03961217|Return to work|return to work
5005667|NCT03961217|Disability pension|disability pension
5005668|NCT03961217|Sickness Absence|sickness absence
5005669|NCT03961217|Employability|employability
5005670|NCT03961217|Fitness to work|fitness to work
5005671|NCT03961217|Wellbeing|wellbeing
5005672|NCT03961217|Radiotherapy Side Effect|radiotherapy side effect
5005673|NCT03961217|Cancer Survivors|cancer survivors
5005674|NCT03961204|Multiple Sclerosis|multiple sclerosis
5005675|NCT03961204|Cladribine|cladribine
5005676|NCT03961204|High Disease Activity|high disease activity
5005677|NCT03961139|Prematurity|prematurity
5005678|NCT03961139|Randomised control trial (RCT)|randomised control trial (rct)
5005679|NCT03961139|BPD|bpd
5005680|NCT03961139|CLD|cld
5005681|NCT03961139|continuous feeding|continuous feeding
5005682|NCT03961126|Vulvar Lichen Sclerosus|vulvar lichen sclerosus
5005683|NCT03961126|Autologous Platelet-rich Plasma (PRP)|autologous platelet-rich plasma (prp)
5005684|NCT03961113|Giant Cell Arteritis|giant cell arteritis
5005685|NCT03961113|Dependency|dependency
5005686|NCT03961113|Elderly|elderly
5005687|NCT03961074|Iron Deficiency Anemia|iron deficiency anemia
5005688|NCT03961074|iron supplements|iron supplements
5005689|NCT03961074|Chinese pregnant women|chinese pregnant women
5005690|NCT03961074|adverse maternal outcomes|adverse maternal outcomes
5005691|NCT03961074|adverse neonatal outcome|adverse neonatal outcome
5005692|NCT03961061|weight management|weight management
5005693|NCT03961061|pediatric weight management|pediatric weight management
5005694|NCT03961061|mHealth|mhealth
5005695|NCT03961061|mobile technology|mobile technology
5005696|NCT03961061|parent/child relations|parent/child relations
5005697|NCT03961061|dyad|dyad
5005698|NCT03961048|Erector Spinae|erector spinae
5005699|NCT03961048|Cardiac Surgery|cardiac surgery
5005700|NCT03961048|Regional Anesthesia|regional anesthesia
5005701|NCT03961022|DOMS|doms
5005702|NCT03961022|Fatigue rate|fatigue rate
5005712|NCT03960996|bicanalicular intubation|bicanalicular intubation
5005713|NCT03960996|dacryocystorinostomy|dacryocystorinostomy
5005714|NCT03960996|silicone stent|silicone stent
5005715|NCT03960983|Halitosis|halitosis
5005716|NCT03960983|photodynamic therapy|photodynamic therapy
5005717|NCT03960983|elderly|elderly
5005718|NCT03960983|denture|denture
5005719|NCT03960970|Cesarean Delivery|cesarean delivery
5005720|NCT03960970|Endometritis|endometritis
5005721|NCT03960970|Wound Infection|wound infection
5005722|NCT03960970|Azithromycin|azithromycin
5005723|NCT03960970|Antibiotic Prophylaxis|antibiotic prophylaxis
5005724|NCT03960931|Parkinson's disease|parkinson's disease
5005725|NCT03960931|Non motor signs|non motor signs
5005726|NCT03960931|Postural control|postural control
5005728|NCT03960931|Hydrophysiotherapy|hydrophysiotherapy
5005729|NCT03960918|stroke|stroke
5005730|NCT03960918|physical fitness|physical fitness
5005731|NCT03960918|oxygen uptake efficiency slope (OUES)|oxygen uptake efficiency slope (oues)
5005732|NCT03960892|Refugees|refugees
5005733|NCT03960892|Mental Health|mental health
5005734|NCT03960866|Open Angle Glaucoma|open angle glaucoma
5005735|NCT03960866|Ocular Hypertension|ocular hypertension
5005736|NCT03960853|aged|aged
5005737|NCT03960853|mechanical ventilation,|mechanical ventilation,
5005738|NCT03960840|CD19 CAR-T cells, CLL, SLL, ibrutinib, DLBCL|cd19 car-t cells, cll, sll, ibrutinib, dlbcl
5005739|NCT03960801|Intubation|intubation
5005740|NCT03960801|Remifentanil|remifentanil
5005741|NCT03960801|neuromuscular blockade|neuromuscular blockade
5005742|NCT03960801|succinylcholine|succinylcholine
5005743|NCT03960801|Rocuronium|rocuronium
5005744|NCT03960801|emergency anesthesia|emergency anesthesia
5005745|NCT03960801|rapid sequence induction|rapid sequence induction
5005746|NCT03960775|gastric cancer|gastric cancer
5005747|NCT03960775|laparoscopic gastrectomy|laparoscopic gastrectomy
5005748|NCT03960775|robotic gastrectomy|robotic gastrectomy
5005749|NCT03960762|Video assisted thoracic surgery|video assisted thoracic surgery
5005750|NCT03960762|Postoperative pain management|postoperative pain management
5005751|NCT03960762|Erector spina plane block|erector spina plane block
5005752|NCT03960762|Serratus anterior plane block|serratus anterior plane block
5005753|NCT03960749|Lumbar puncture|lumbar puncture
5005754|NCT03960749|Headache|headache
5005755|NCT03960736|Video assisted thoracic surgery|video assisted thoracic surgery
5005756|NCT03960736|Postoperative pain management|postoperative pain management
5005757|NCT03960736|Erector spina plane block|erector spina plane block
5005761|NCT03960606|Aspergillosis|aspergillosis
5005763|NCT03960567|Laryngeal view|laryngeal view
5005764|NCT03960567|Scoring systems|scoring systems
5005765|NCT03960567|Larynx|larynx
5005766|NCT03960554|Denosumab|denosumab
5005767|NCT03960554|Bone density|bone density
5005768|NCT03960554|Kidney transplant|kidney transplant
5005769|NCT03960554|Prolia|prolia
5005774|NCT03960528|spine surgery|spine surgery
5005775|NCT03960528|postoperative pain|postoperative pain
5005776|NCT03960528|perioperative analgesia|perioperative analgesia
5428215|NCT01595646|Mild Cognitive Impairment|mild cognitive impairment
5005779|NCT03960515|Heart disease|heart disease
5005780|NCT03960515|Cardiovascular Risk|cardiovascular risk
5005781|NCT03960502|Safety and tolerability|safety and tolerability
5005782|NCT03960502|Pharmacokinetic study|pharmacokinetic study
5005783|NCT03960489|Pharmacokinetics|pharmacokinetics
5005784|NCT03960489|Tolerability|tolerability
5005785|NCT03960489|Safety|safety
5005786|NCT03960489|ASP1517|asp1517
5005787|NCT03960489|Roxadustat|roxadustat
5005788|NCT03960463|Infection|infection
5005789|NCT03960463|Dehiscence|dehiscence
5005790|NCT03960463|Necrotic tissue|necrotic tissue
5005791|NCT03960463|Surgical Revision|surgical revision
5005792|NCT03960463|Scar tissue|scar tissue
5005793|NCT03960463|Wound Closure|wound closure
5005794|NCT03960450|Psoriasis|psoriasis
5005795|NCT03960450|BOS-475|bos-475
5005796|NCT03960437|Kidney disease|kidney disease
5005797|NCT03960437|Bone disease|bone disease
5005798|NCT03960437|Etelcalcetide|etelcalcetide
5005799|NCT03960437|Parsabiv|parsabiv
5005800|NCT03960411|Doxycycline|doxycycline
5005801|NCT03960411|Cardiac Remodelling|cardiac remodelling
5005806|NCT03960398|adverse drug reaction|adverse drug reaction
5005807|NCT03960385|Dengue|dengue
5005808|NCT03960385|Dengvaxia|dengvaxia
5005809|NCT03960385|Parana|parana
5005810|NCT03960385|Sanofi Pasteur|sanofi pasteur
5005811|NCT03960385|Vaccine Effectiveness|vaccine effectiveness
5005812|NCT03960385|Maringa|maringa
5005813|NCT03960385|Foz de Iguacu|foz de iguacu
5005814|NCT03960385|Paranagua|paranagua
5005815|NCT03960385|Brazil|brazil
5005816|NCT03960372|Family|family
5005817|NCT03960359|Asthma|asthma
5005818|NCT03960359|wheeze|wheeze
5005819|NCT03960359|preschool|preschool
5005820|NCT03960359|phenotype|phenotype
5005821|NCT03960333|Obesity|obesity
5005822|NCT03960333|Type2 Diabetes Mellitus|type2 diabetes mellitus
5005823|NCT03960333|Type2 Diabetes|type2 diabetes
5005824|NCT03960333|Insulin Resistance|insulin resistance
5005825|NCT03960333|Metformin|metformin
5005826|NCT03960333|Pediatric Health|pediatric health
5005827|NCT03960320|KINDL|kindl
5005829|NCT03960320|SF-36|sf-36
5005830|NCT03960307|Glycocalyx|glycocalyx
5005832|NCT03960307|microcirculation|microcirculation
5005833|NCT03960294|Insomnia|insomnia
5005834|NCT03960294|Adolescents|adolescents
5005835|NCT03960294|Young Adults|young adults
5005836|NCT03960268|Hidradenitis Suppurativa|hidradenitis suppurativa
5005837|NCT03960268|Acne Inversa|acne inversa
5005838|NCT03960268|Brodalumab|brodalumab
5005839|NCT03960255|Adiposity|adiposity
5005840|NCT03960255|Diabetic foot ulcer|diabetic foot ulcer
5005841|NCT03960255|Anti-microbial resistance|anti-microbial resistance
5005842|NCT03960229|microfluid chip|microfluid chip
5005843|NCT03960229|gradient-density|gradient-density
5005844|NCT03960229|IVF|ivf
5005845|NCT03960229|male factor|male factor
5005846|NCT03960203|Dascena|dascena
5005847|NCT03960203|Patient mortality|patient mortality
5005848|NCT03960203|Length of stay|length of stay
5005849|NCT03960203|Readmissions|readmissions
5005850|NCT03960203|Algorithm|algorithm
5005851|NCT03960203|Diagnostic|diagnostic
5005852|NCT03960203|Clinical outcomes|clinical outcomes
5005853|NCT03960164|Acute skin lesion|acute skin lesion
5005854|NCT03960164|Chronic skin ulcer|chronic skin ulcer
5005855|NCT03960164|Traumatic skin lesion|traumatic skin lesion
5005856|NCT03960164|Photosynthetic matrix|photosynthetic matrix
5005857|NCT03960164|Photosynthesis induced regeneration|photosynthesis induced regeneration
5005858|NCT03960164|Tissue regeneration|tissue regeneration
5005859|NCT03960112|multiparametric MRI|multiparametric mri
5005860|NCT03960112|cystoprostatectomy|cystoprostatectomy
5005861|NCT03960047|children|children
5005862|NCT03960047|crossing streets|crossing streets
5005863|NCT03960047|training|training
5005864|NCT03960034|Cachexia|cachexia
5005865|NCT03960034|Skeletal Muscle Atrophy|skeletal muscle atrophy
5005880|NCT03959956|Pneumonia|pneumonia
5005881|NCT03959956|Lung sounds|lung sounds
5005883|NCT03959956|LMIC|lmic
5005884|NCT03959943|Breast reconstruction|breast reconstruction
5005885|NCT03959943|LTP flap|ltp flap
5005886|NCT03959943|Sensory recovery|sensory recovery
5005887|NCT03959943|Breast sensation|breast sensation
5005888|NCT03959943|Nerve coaptation|nerve coaptation
5005889|NCT03959917|prostate|prostate
5005890|NCT03959917|resection|resection
5005891|NCT03959917|incontinence|incontinence
5005892|NCT03959917|erectile dysfunction|erectile dysfunction
5005893|NCT03959891|Breast Cancer|breast cancer
5005894|NCT03959878|Jejunostomy|jejunostomy
5005895|NCT03959852|Moderate|moderate
5005896|NCT03959852|Severe|severe
5005897|NCT03959852|Pain|pain
5005898|NCT03959839|Early Rectal Neoplasms|early rectal neoplasms
5005899|NCT03959839|ESD|esd
5005900|NCT03959839|TAMIS|tamis
5005901|NCT03959839|TEO|teo
5005905|NCT03959826|contingency management|contingency management
5005906|NCT03959800|Hepatoblastoma|hepatoblastoma
5005907|NCT03959800|Hepatocellular Carcinoma|hepatocellular carcinoma
5005908|NCT03959800|Pediatric Liver Cancer|pediatric liver cancer
5005909|NCT03959774|Elderly population|elderly population
5005910|NCT03959774|digital monitoring|digital monitoring
5005911|NCT03959761|Immunotherapy|immunotherapy
5005912|NCT03959761|Debulking surgery|debulking surgery
5005913|NCT03959761|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
5005914|NCT03959748|Pulmonary Hypertension,|pulmonary hypertension,
5005915|NCT03959748|CTEPH|cteph
5005916|NCT03959748|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5005917|NCT03959748|Registry|registry
5005918|NCT03959748|Data Base|data base
5005919|NCT03959748|Polish patients|polish patients
5005920|NCT03959735|inpatients|inpatients
5021619|NCT03862196|prevention|prevention
5006033|NCT03958864|Safety|safety
5006034|NCT03958864|Pharmacokinetics|pharmacokinetics
5006035|NCT03958851|renal resistive index|renal resistive index
5006036|NCT03958838|Peer Support|peer support
5006037|NCT03958838|Social Support|social support
5006038|NCT03958838|Primary Care|primary care
5006039|NCT03958838|Integrated Care|integrated care
5006040|NCT03958838|Community-Based|community-based
5006041|NCT03958838|Self-Management|self-management
5006042|NCT03958838|Diabetes Care|diabetes care
5006043|NCT03958812|CTCs|ctcs
5006044|NCT03958812|VOCs|vocs
5006045|NCT03958812|Breast cancer|breast cancer
5006046|NCT03958812|Gastric cancer|gastric cancer
5006047|NCT03958812|diagnoses|diagnoses
5006048|NCT03958773|Mitral valve|mitral valve
5006049|NCT03958773|Functional mitral regurgitation|functional mitral regurgitation
5006050|NCT03958773|Heart failure|heart failure
5006052|NCT03958708|gut microbiota|gut microbiota
5006053|NCT03958708|rifaximin|rifaximin
5006054|NCT03958695|midurethral sling|midurethral sling
5006055|NCT03958695|stress urinary incontinence|stress urinary incontinence
5006056|NCT03958695|urinary incontinence|urinary incontinence
5047601|NCT03701750|IVF|ivf
5001414|NCT03986411|urinary incontinence|urinary incontinence
5006057|NCT03958695|voiding dysfunction|voiding dysfunction
5006058|NCT03958682|air medical rescue|air medical rescue
5006059|NCT03958682|satellite information transmission|satellite information transmission
5006060|NCT03958682|Augmented Reality|augmented reality
5006061|NCT03958669|Sorafenib|sorafenib
5006062|NCT03958669|Liver Cancer|liver cancer
5006063|NCT03958669|Imaging|imaging
5006064|NCT03958669|Molecular Charakterization|molecular charakterization
5006065|NCT03958656|Chimeric Antigen Receptors|chimeric antigen receptors
5006073|NCT03958630|Amyloid|amyloid
5006074|NCT03958630|Neuroinflammation|neuroinflammation
5006075|NCT03958552|Palliative Care Consultation|palliative care consultation
5006076|NCT03958552|Medicare|medicare
5006077|NCT03958552|Skilled Nursing|skilled nursing
5006078|NCT03958526|transcranial direct current stimulation|transcranial direct current stimulation
5320369|NCT02083107|Intrapartum blood loss|intrapartum blood loss
5006079|NCT03958526|non-invasive brain stimulation|non-invasive brain stimulation
5006080|NCT03958526|neuromodulation|neuromodulation
5006081|NCT03958526|chronic pain|chronic pain
5006082|NCT03958526|neurogenic claudication|neurogenic claudication
5006083|NCT03958487|Activities of Daily Living|activities of daily living
5006084|NCT03958487|Brain Injuries/rehabilitation|brain injuries/rehabilitation
5006085|NCT03958487|Generalization (Psychology)|generalization (psychology)
5006086|NCT03958487|Brain Injuries/psychology|brain injuries/psychology
5006087|NCT03958487|Feedback, Psychological/physiology|feedback, psychological/physiology
5006094|NCT03958435|Current status|current status
5006095|NCT03958435|Chemotherapy regimen|chemotherapy regimen
5006096|NCT03958435|Chemotherapy time|chemotherapy time
5006097|NCT03958435|Efficacy|efficacy
5006098|NCT03958435|Safety|safety
5006099|NCT03958435|Adjuvant therapy|adjuvant therapy
5006100|NCT03958435|Stage II-III colon cancer|stage ii-iii colon cancer
5006101|NCT03958435|RWS(Real World Study)|rws(real world study)
5006102|NCT03958422|Acute myocardial infarction|acute myocardial infarction
5006103|NCT03958422|Nuclear magnetic image|nuclear magnetic image
5006104|NCT03958422|Survival myocardial area|survival myocardial area
5006105|NCT03958370|Fitbit|fitbit
5006106|NCT03958370|Activity Monitor|activity monitor
5006107|NCT03958370|Step Count|step count
5006108|NCT03958370|Total Knee Replacement|total knee replacement
5006109|NCT03958370|Arthroplasty|arthroplasty
5006110|NCT03958357|Cervix|cervix
5006111|NCT03958357|Uterus|uterus
5006112|NCT03958357|Vagina|vagina
5006113|NCT03958357|Cancer|cancer
5006114|NCT03958357|Gynecology|gynecology
5006115|NCT03958357|Cervical cancer|cervical cancer
5006116|NCT03958357|External beam radiation therapy|external beam radiation therapy
5006117|NCT03958357|Brachytherapy|brachytherapy
5006118|NCT03958331|adolescents, behavioral economics, mHealth|adolescents, behavioral economics, mhealth
5006119|NCT03958292|Cataract|cataract
5006120|NCT03958292|Endophthalmitis|endophthalmitis
5008799|NCT03941431|Jueyin granule|jueyin granule
5006129|NCT03958240|Non Small Cell Lung Cancer|non small cell lung cancer
5006130|NCT03958240|Anal Cancer|anal cancer
5006131|NCT03958227|Glenohumeral Arthritis|glenohumeral arthritis
5006132|NCT03958227|Pain|pain
5006133|NCT03958227|Mobilisation|mobilisation
5006138|NCT03958162|surgical lung biopsy|surgical lung biopsy
5006139|NCT03958162|transbronchial lung cryobiopsy|transbronchial lung cryobiopsy
5006140|NCT03958162|interstitial lung disease|interstitial lung disease
5006142|NCT03958136|Breast cancer|breast cancer
5006143|NCT03958136|first metastatic setting|first metastatic setting
5006144|NCT03958136|prospective clinico-biological database|prospective clinico-biological database
5006145|NCT03958136|multi omic analysis|multi omic analysis
5006146|NCT03958136|prediction in silico|prediction in silico
5006147|NCT03958136|overall survival|overall survival
5006148|NCT03958136|progression free survival|progression free survival
5006149|NCT03958136|predictive factors|predictive factors
5006150|NCT03958136|treatment response|treatment response
5006151|NCT03958136|resistance to cancer therapy|resistance to cancer therapy
5006152|NCT03958136|socio demographic profile|socio demographic profile
5006153|NCT03958123|QT/QTc Interval|qt/qtc interval
5006154|NCT03958110|Retinophotography|retinophotography
5006156|NCT03958110|Optical nerve|optical nerve
5006157|NCT03958084|Lower Extremity|lower extremity
5006158|NCT03958084|Musculoskeletal Manipulations|musculoskeletal manipulations
5006159|NCT03958084|Range of motion|range of motion
5006160|NCT03958084|Hamstring Muscles|hamstring muscles
5006161|NCT03958045|rucaparib|rucaparib
5006162|NCT03958045|nivolumab|nivolumab
5006163|NCT03958045|platinum-sensitive|platinum-sensitive
5006164|NCT03958045|maintenance|maintenance
5006166|NCT03958045|immune checkpoint|immune checkpoint
5006167|NCT03958045|PARP|parp
5006168|NCT03958032|sarcopenia|sarcopenia
5006169|NCT03958032|cancer|cancer
5006170|NCT03958032|gastrointestinal|gastrointestinal
5006171|NCT03958019|Rehabilitation|rehabilitation
5006172|NCT03958019|Exercise|exercise
5006173|NCT03958019|Diet|diet
5006174|NCT03958019|Education|education
5006175|NCT03958019|Survivor-ship|survivor-ship
5006176|NCT03957915|acute leukemia|acute leukemia
5006177|NCT03957915|refractory|refractory
5006178|NCT03957915|in relapse|in relapse
5006179|NCT03957915|antibody drug conjugate|antibody drug conjugate
5006180|NCT03957915|first in human|first in human
5006181|NCT03957915|escalating doses|escalating doses
5006182|NCT03957915|INA03|ina03
5006183|NCT03957850|Emotion Regulation Training|emotion regulation training
5006184|NCT03957850|LPP|lpp
5006185|NCT03957850|Adolescence|adolescence
5006186|NCT03957850|Major Depression|major depression
5006187|NCT03957850|Eye-tracking|eye-tracking
5006188|NCT03957850|Cognitive Reappraisal|cognitive reappraisal
5006189|NCT03957850|Event-related Potentials|event-related potentials
5006190|NCT03957824|Risk score|risk score
5006191|NCT03957824|Risk prediction|risk prediction
5006192|NCT03957824|Prevention|prevention
5006193|NCT03957772|upper extremity surgery|upper extremity surgery
5006194|NCT03957759|Altitude|altitude
5006195|NCT03957759|Hypobaric hypoxia|hypobaric hypoxia
5006196|NCT03957759|Altitude-related illness|altitude-related illness
5006197|NCT03957759|Prevention|prevention
5006198|NCT03957707|basal ganglion hemorrhage|basal ganglion hemorrhage
5006199|NCT03957707|stereotactic surgery|stereotactic surgery
5006200|NCT03957707|thrombolysis|thrombolysis
5006201|NCT03957694|aplastic anemia|aplastic anemia
5006202|NCT03957694|romiplostim|romiplostim
5006203|NCT03957681|systemic sclerosis|systemic sclerosis
5006204|NCT03957681|brodalumab|brodalumab
5006205|NCT03957681|KHK4827|khk4827
5006206|NCT03957668|PEG 3350|peg 3350
5006207|NCT03957668|Constipation|constipation
5006208|NCT03957655|Liver Cirrhosis|liver cirrhosis
5006209|NCT03957655|stem cell|stem cell
5006210|NCT03957655|therapy|therapy
5006211|NCT03957629|hepatitis b virus|hepatitis b virus
5006212|NCT03957629|liver fibrosis|liver fibrosis
5006213|NCT03957629|peg interferon alfa-2a|peg interferon alfa-2a
5006215|NCT03957577|ACOS, AECOPD, AERIS-J, CB, COPD, Exacerbation|acos, aecopd, aeris-j, cb, copd, exacerbation
5006216|NCT03957564|Gastric cancer|gastric cancer
5008912|NCT03940768|cancer|cancer
5006217|NCT03957564|Gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
5006218|NCT03957564|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5006220|NCT03957564|Circulating tumor cells|circulating tumor cells
5006221|NCT03957564|Circulating tumor DNA|circulating tumor dna
5006222|NCT03957564|Circulating cell free DNA|circulating cell free dna
5006223|NCT03957525|Virtual reality|virtual reality
5006224|NCT03957525|Pediatric|pediatric
5006225|NCT03957525|Anxiety|anxiety
5006226|NCT03957525|Surgery|surgery
5006227|NCT03957525|Anesthesia|anesthesia
5006228|NCT03957525|Intervention|intervention
5006229|NCT03957525|Exposure|exposure
5006230|NCT03957525|Randomized controlled trial|randomized controlled trial
5006231|NCT03957525|Pediatric urology|pediatric urology
5006232|NCT03957525|Orthopedic surgery|orthopedic surgery
5423180|NCT01616784|Adult|adult
5006236|NCT03957447|Ivory Coast community health services|ivory coast community health services
5006237|NCT03957447|prevalence study|prevalence study
5006238|NCT03957447|thermotherapy|thermotherapy
5006239|NCT03957434|Pilot study|pilot study
5006240|NCT03957434|Gynecological cancer survivors|gynecological cancer survivors
5006241|NCT03957434|Urinary Incontinence|urinary incontinence
5006242|NCT03957434|Physiotherapy|physiotherapy
5006244|NCT03957395|CRPS|crps
5006246|NCT03957395|Burst|burst
5006247|NCT03957395|Tonic|tonic
5006248|NCT03957395|High-frequency|high-frequency
5006249|NCT03957369|HIV infection|hiv infection
5006250|NCT03957369|Primary resistance|primary resistance
5006251|NCT03957369|Antiretroviral drugs|antiretroviral drugs
5006252|NCT03957369|Colombia|colombia
5006253|NCT03957369|Cross sectional study|cross sectional study
5006254|NCT03957356|Hemostatic|hemostatic
5006255|NCT03957356|Blood oozing|blood oozing
5006256|NCT03957356|Absorbent hemostatic|absorbent hemostatic
5006257|NCT03957356|Liver resection|liver resection
5006258|NCT03957356|Intraperitoneal surgery|intraperitoneal surgery
5006259|NCT03957343|acquired brain injury|acquired brain injury
5006260|NCT03957343|concussion|concussion
5006261|NCT03957330|Anxiety|anxiety
5006262|NCT03957330|Depression|depression
5006363|NCT03956732|Vitamin D|vitamin d
5006263|NCT03957330|Internet-delivered cognitive behaviour therapy|internet-delivered cognitive behaviour therapy
5006264|NCT03957330|Randomized controlled trial|randomized controlled trial
5006265|NCT03957330|Therapist contact|therapist contact
5006266|NCT03957330|Online therapy|online therapy
5006267|NCT03957330|Community mental health|community mental health
5006268|NCT03957317|Surgery|surgery
5006269|NCT03957317|Postoperative sleep deprivation|postoperative sleep deprivation
5006270|NCT03957278|Mechanical thrombectomy|mechanical thrombectomy
5001669|NCT03985072|Cancer|cancer
5006271|NCT03957278|Acute ischemic stroke|acute ischemic stroke
5006272|NCT03957278|neurovascular intervention|neurovascular intervention
5006273|NCT03957252|ClarityDX Prostate|claritydx prostate
5006274|NCT03957252|Diagnosis|diagnosis
5006275|NCT03957252|Reflex Test|reflex test
5006276|NCT03957252|Extracellular Vessicle|extracellular vessicle
5006277|NCT03957213|Intermittent Hypoxia|intermittent hypoxia
5006278|NCT03957213|Cognitive Training|cognitive training
5006279|NCT03957200|Ultrasound|ultrasound
5006280|NCT03957200|pregnancy|pregnancy
5006281|NCT03957200|first trimester|first trimester
5006282|NCT03957200|dating|dating
5006283|NCT03957187|iron deficiency|iron deficiency
5006284|NCT03957187|atrial fibrillation|atrial fibrillation
5006285|NCT03957148|Sugar sweetened beverages,|sugar sweetened beverages,
5006286|NCT03957148|childhood obesity|childhood obesity
5006287|NCT03957148|preschool children|preschool children
5006288|NCT03957135|pancreas neoplasms|pancreas neoplasms
5006289|NCT03957135|pancreatectomy|pancreatectomy
5006290|NCT03957122|tinnitus|tinnitus
5006291|NCT03957122|transcranial magnetic stimulation|transcranial magnetic stimulation
5006294|NCT03957083|pregnancy|pregnancy
5006295|NCT03957083|postpartum hemorrhage|postpartum hemorrhage
5006296|NCT03957083|Cesarean delivery|cesarean delivery
5006297|NCT03957083|oxytocin|oxytocin
5006298|NCT03957083|obesity|obesity
5006299|NCT03957070|liver|liver
5006300|NCT03957070|ultrasound elastography|ultrasound elastography
5320587|NCT02082327|migalastat|migalastat
5006301|NCT03957057|postpartum anemia|postpartum anemia
5006302|NCT03957057|iron deficiency|iron deficiency
5006303|NCT03957057|ferrous sulphate|ferrous sulphate
5006304|NCT03957057|ferric carboxymaltose|ferric carboxymaltose
5006305|NCT03957057|ferric isomaltoside|ferric isomaltoside
5006306|NCT03957031|Gastric Cancer|gastric cancer
5006307|NCT03957031|Personalized medicine|personalized medicine
5006308|NCT03957031|Oncology|oncology
5006309|NCT03957031|Solid tumor|solid tumor
5707173|NCT00475371|Healthy|healthy
5006310|NCT03957031|Primary Intervention|primary intervention
5006311|NCT03957005|Myocardial Infarction|myocardial infarction
5006312|NCT03957005|Major cardiovascular events|major cardiovascular events
5006313|NCT03957005|Risk assessment|risk assessment
5006314|NCT03956966|Quadratus Lumborum Block|quadratus lumborum block
5006315|NCT03956966|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5006316|NCT03956966|dexamethasone|dexamethasone
5006317|NCT03956940|Hepatocarcinoma|hepatocarcinoma
5006318|NCT03956940|cfDNA|cfdna
5006330|NCT03956823|obesity|obesity
5006331|NCT03956823|telmisartan|telmisartan
5006332|NCT03956823|metabolic abnormalities|metabolic abnormalities
5006333|NCT03956823|cardiac remodeling|cardiac remodeling
5006334|NCT03956810|transportation; prenatal care|transportation; prenatal care
5006335|NCT03956797|Intravitreal Injection|intravitreal injection
5006336|NCT03956797|Anesthesia|anesthesia
5006337|NCT03956797|Macular Degeneration|macular degeneration
5006338|NCT03956797|Diabetic Macular Edema|diabetic macular edema
5006339|NCT03956784|Bariatric surgery|bariatric surgery
5006340|NCT03956784|Colorectal surgery|colorectal surgery
5006341|NCT03956784|Gastric surgery|gastric surgery
5006342|NCT03956784|One day surgery|one day surgery
5006343|NCT03956784|Post-operative complications|post-operative complications
5006344|NCT03956784|Follow-up care via Mobile App|follow-up care via mobile app
5006345|NCT03956771|neurofeedback|neurofeedback
5006346|NCT03956771|biofeedback|biofeedback
5006347|NCT03956771|OCD|ocd
5006348|NCT03956771|obsessive-compulsive disorder|obsessive-compulsive disorder
5006349|NCT03956771|magnetic resonance imaging|magnetic resonance imaging
5006350|NCT03956771|functional magnetic resonance imaging|functional magnetic resonance imaging
5006351|NCT03956771|orbitofrontal cortex|orbitofrontal cortex
5006352|NCT03956758|MSM|msm
5006353|NCT03956758|Chemical sex|chemical sex
5006354|NCT03956758|HIV prevention|hiv prevention
5006355|NCT03956758|HIV pre-exposure prophylaxis|hiv pre-exposure prophylaxis
5006356|NCT03956745|Sleep|sleep
5006357|NCT03956745|Aging|aging
5006358|NCT03956745|Circadian Rhythms|circadian rhythms
5006359|NCT03956745|Circadian Rhythm Disorders|circadian rhythm disorders
5006360|NCT03956732|Child Nutrition|child nutrition
5006361|NCT03956732|Dietary recommendations|dietary recommendations
5006362|NCT03956732|Milk protein|milk protein
5006364|NCT03956732|Bone mineral density|bone mineral density
5006365|NCT03956732|Muscle strength|muscle strength
5006366|NCT03956732|Immune defence|immune defence
5006367|NCT03956719|Autologous adipose-derived mesenchymal stem cells|autologous adipose-derived mesenchymal stem cells
5006368|NCT03956719|Knee Osteoarthritis|knee osteoarthritis
5006369|NCT03956706|SRS|srs
5001740|NCT03984708|Biomarkers|biomarkers
5001741|NCT03984708|Fibroblast|fibroblast
5001773|NCT03984552|HIV|hiv
5006370|NCT03956706|Stereotactic Radiosurgery|stereotactic radiosurgery
5006371|NCT03956706|Glioblastoma|glioblastoma
5006372|NCT03956706|Astrocytoma|astrocytoma
5006373|NCT03956706|Grade III|grade iii
5006374|NCT03956706|Grade IV|grade iv
5006375|NCT03956706|Glioma|glioma
5006376|NCT03956706|Malignant Glioma|malignant glioma
5006377|NCT03956706|Gamma Knife|gamma knife
5006378|NCT03956693|Stroke|stroke
5006379|NCT03956693|CVA (cardiovascular accident)|cva (cardiovascular accident)
5006380|NCT03956693|Anxiety|anxiety
5006381|NCT03956693|Depression|depression
5006382|NCT03956693|Mindfulness|mindfulness
5006383|NCT03956693|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5006384|NCT03956693|Self-management|self-management
5006385|NCT03956667|Paediatric|paediatric
5006386|NCT03956667|distress|distress
5006387|NCT03956667|Paediatric Emergency Department|paediatric emergency department
5006388|NCT03956667|Music|music
5006389|NCT03956654|breast cancer|breast cancer
5006390|NCT03956654|elderly|elderly
5006391|NCT03956654|geriatric assessment|geriatric assessment
5006392|NCT03956654|geriatric oncology|geriatric oncology
5006393|NCT03956654|translational research|translational research
5006394|NCT03956654|biomarkers|biomarkers
5006395|NCT03956498|Cervix Cancer|cervix cancer
5006396|NCT03956498|Vaginal Cancer|vaginal cancer
5006397|NCT03956498|Sexual function|sexual function
5006398|NCT03956498|Brachytherapy|brachytherapy
5006399|NCT03956498|Radiotherapy|radiotherapy
5006400|NCT03956485|intracerebral hemorrhage|intracerebral hemorrhage
5006401|NCT03956485|outcome|outcome
5006402|NCT03956485|transportation|transportation
5006403|NCT03956485|transfer|transfer
5006404|NCT03956485|prognosis|prognosis
5006405|NCT03956472|Altitude|altitude
5006406|NCT03956472|Acute mountain sickness|acute mountain sickness
5006407|NCT03956472|Osteopathy|osteopathy
5006408|NCT03956472|End expiratory pressure|end expiratory pressure
5006409|NCT03956459|FDG-PET|fdg-pet
5428216|NCT01595633|nucleoside analogue|nucleoside analogue
5006413|NCT03956407|Peripheral stimulation|peripheral stimulation
5006414|NCT03956407|Motor function|motor function
5006415|NCT03956394|Cardiovascular Diseases|cardiovascular diseases
5006416|NCT03956394|Vascular Diseases|vascular diseases
5006417|NCT03956381|Femoral neck resection, offset, leg lenght, femoral anteversion|femoral neck resection, offset, leg lenght, femoral anteversion
5006418|NCT03956368|Chronic subdural haematoma|chronic subdural haematoma
5006419|NCT03956368|Medical treatment|medical treatment
5006420|NCT03956368|Atorvastatin|atorvastatin
5006421|NCT03956368|Clinical outcome|clinical outcome
5006422|NCT03956368|Surgical recurrence|surgical recurrence
5006423|NCT03956355|Tapinarof|tapinarof
5006424|NCT03956355|plaque psoriasis|plaque psoriasis
5006425|NCT03956355|adult|adult
5006426|NCT03956355|phase 3|phase 3
5006427|NCT03956355|topical|topical
5006428|NCT03956355|double-blind|double-blind
5006429|NCT03956355|efficacy|efficacy
5006430|NCT03956355|safety|safety
5006431|NCT03956355|psoriasis|psoriasis
5006432|NCT03956329|Positive Affect|positive affect
5006436|NCT03956329|Randomised Control Trial|randomised control trial
5006437|NCT03956303|Anesthesia, Spinal|anesthesia, spinal
5006438|NCT03956303|Cesarean Section|cesarean section
5006439|NCT03956303|Levobupivacaine|levobupivacaine
5006440|NCT03956290|Time restricted eating|time restricted eating
5006441|NCT03956290|Overweight|overweight
5006442|NCT03956290|Obesity|obesity
5006443|NCT03956290|Metabolic syndrome|metabolic syndrome
5006444|NCT03956290|Diabetes treated with metformin and/or diet and HbA1C< 7%|diabetes treated with metformin and/or diet and hba1c< 7%
5006445|NCT03956290|Pre Diabetes|pre diabetes
5006446|NCT03956290|Circadian rhythm|circadian rhythm
5006447|NCT03956264|Pain|pain
5006448|NCT03956264|Anxiety|anxiety
5006449|NCT03956264|Mediastinal drain removal|mediastinal drain removal
5006450|NCT03956238|Alcohol intoxication|alcohol intoxication
5006451|NCT03956238|Alcohol use|alcohol use
5006452|NCT03956238|Drinking|drinking
5006453|NCT03956238|Sexual assault|sexual assault
5006454|NCT03956238|Sexual violence|sexual violence
5006455|NCT03956238|Aggression|aggression
5006456|NCT03956238|Attention|attention
5006457|NCT03956238|Victimization|victimization
5006458|NCT03956238|Public health|public health
5006459|NCT03956225|Meibomian Gland Dysfunction|meibomian gland dysfunction
5006460|NCT03956225|Evaporative Dry Eye Disease|evaporative dry eye disease
5006461|NCT03956212|Lyme Borreliosis|lyme borreliosis
5006462|NCT03956212|Inflammation|inflammation
5006463|NCT03956212|Outcome|outcome
5006464|NCT03956160|Caregiver|caregiver
5006465|NCT03956160|Support|support
5006482|NCT03955991|Breast Cancer|breast cancer
5006484|NCT03955978|Immune checkpoint inhibition|immune checkpoint inhibition
5006485|NCT03955978|Radiation-induced immune response|radiation-induced immune response
5048104|NCT03698344|RME|rme
5006486|NCT03955978|CyTOF|cytof
5006495|NCT03955848|AML in Remission|aml in remission
5006496|NCT03955848|NK cells|nk cells
5006497|NCT03955848|Immunotherapy|immunotherapy
5006498|NCT03955822|effectiveness|effectiveness
5006499|NCT03955822|security|security
5006500|NCT03955822|adverse effects|adverse effects
5006501|NCT03955822|permanent birth control|permanent birth control
5006502|NCT03955809|Injection|injection
5006503|NCT03955809|Intra-Articular|intra-articular
5006504|NCT03955809|arthroscopy|arthroscopy
5006505|NCT03955809|ketamine|ketamine
5006506|NCT03955796|Cataract, cataract surgery, intraocular lens|cataract, cataract surgery, intraocular lens
5006507|NCT03955770|Exercise endurance|exercise endurance
5006508|NCT03955770|High-flow oxygen therapy|high-flow oxygen therapy
5006509|NCT03955770|Low-flow oxygen therapy|low-flow oxygen therapy
5006510|NCT03955757|Immunization|immunization
5006511|NCT03955757|Boot Camp Translation|boot camp translation
5006512|NCT03955757|Adolescent|adolescent
5006513|NCT03955679|Spinal Muscular Atrophy|spinal muscular atrophy
5006514|NCT03955679|SMA|sma
5006515|NCT03955679|Gene replacement therapy|gene replacement therapy
5006516|NCT03955679|AVXS-101|avxs-101
5006517|NCT03955679|Compassionate Use|compassionate use
5006518|NCT03955679|Managed Access Program|managed access program
5006519|NCT03955679|MAP|map
5006520|NCT03955627|Cancer Treatment Symptoms, Symptom Management|cancer treatment symptoms, symptom management
5006521|NCT03955614|Surgery|surgery
5006522|NCT03955601|haploidentical|haploidentical
5006523|NCT03955601|Aplastic anemia|aplastic anemia
5006524|NCT03955601|TBI|tbi
5006525|NCT03955588|Cytogenetics|cytogenetics
5006526|NCT03955588|aCGH|acgh
5006527|NCT03955588|Prenatal Diagnosis|prenatal diagnosis
5006528|NCT03955549|Insight Enhancement Program|insight enhancement program
5006529|NCT03955549|Insight Enhancement Therapy|insight enhancement therapy
5006530|NCT03955549|Metacognitive Training for Psychosis|metacognitive training for psychosis
5320845|NCT02081092|PAP|pap
5006531|NCT03955549|Psychotherapeutic Interventions for Schizophrenia|psychotherapeutic interventions for schizophrenia
5006547|NCT03955484|Medical Treatment|medical treatment
5006548|NCT03955484|Urine Marker|urine marker
5006549|NCT03955484|Glycosaminoglycan|glycosaminoglycan
5006550|NCT03955471|Open-label|open-label
5006551|NCT03955471|Single-arm|single-arm
5006552|NCT03955471|Efficacy and Safety|efficacy and safety
5006557|NCT03955445|C3G (C3 glomerulopathy)|c3g (c3 glomerulopathy)
5006558|NCT03955445|C3GN (C3 glomerulonephritis)|c3gn (c3 glomerulonephritis)
5006559|NCT03955445|DDD (dense deposit disease)|ddd (dense deposit disease)
5006560|NCT03955393|LYMPH NODE METASTASES|lymph node metastases
5006561|NCT03955393|18F-FAZA PET IMAGING TECHNIQUE|18f-faza pet imaging technique
5006562|NCT03955380|anti-prionic|anti-prionic
5006563|NCT03955380|anti-Abeta-pionic|anti-abeta-pionic
5006662|NCT03954847|Lung cancer|lung cancer
5006564|NCT03955380|treatment of cognition and memory deficits|treatment of cognition and memory deficits
5006565|NCT03955380|AD patients|ad patients
5006566|NCT03955380|AD stage-independent|ad stage-independent
5006567|NCT03955380|NOT anti-amyloid|not anti-amyloid
5006568|NCT03955380|neuron specific Ca-ion reduction|neuron specific ca-ion reduction
5006569|NCT03955367|Uterine Cervical Neoplasms|uterine cervical neoplasms
5006570|NCT03955367|Extended-field irradiation|extended-field irradiation
5006571|NCT03955302|Frailty|frailty
5006572|NCT03955302|Muscle Architecture|muscle architecture
5006573|NCT03955302|Ultrasound|ultrasound
5006574|NCT03955302|Exercise Regimen|exercise regimen
5006575|NCT03955302|Aqua-Aerobics|aqua-aerobics
5006576|NCT03955276|Hodgkin lymphoma|hodgkin lymphoma
5006577|NCT03955276|non-Hodgkin lymphoma|non-hodgkin lymphoma
5006578|NCT03955276|Acute leukemia|acute leukemia
5006579|NCT03955276|Chronic leukemia|chronic leukemia
5006580|NCT03955276|rare hematologic tumors|rare hematologic tumors
5006581|NCT03955276|Hematopoietic lymphoid/myeloid cancer|hematopoietic lymphoid/myeloid cancer
5006582|NCT03955263|asymptomatic|asymptomatic
5006583|NCT03955263|Malaria|malaria
5006584|NCT03955263|pregnancy|pregnancy
5006585|NCT03955263|prevalence|prevalence
5006586|NCT03955263|RT-PCR|rt-pcr
5006587|NCT03955250|schizophrenia|schizophrenia
5006588|NCT03955250|psychosis|psychosis
5006589|NCT03955250|mHealth|mhealth
5006590|NCT03955250|psychiatric hospitalization|psychiatric hospitalization
5006591|NCT03955250|treatment adherence|treatment adherence
5006592|NCT03955250|transitions of care|transitions of care
5006593|NCT03955250|coping skills|coping skills
5006594|NCT03955250|psychosocial intervention|psychosocial intervention
5006595|NCT03955224|Upper Aerodigestive Tract Neoplasms|upper aerodigestive tract neoplasms
5006596|NCT03955224|Low-Level Laser Therapy (LLLT)|low-level laser therapy (lllt)
5006597|NCT03955224|Mucositis|mucositis
5006598|NCT03955211|postoperative pain|postoperative pain
5006599|NCT03955211|caesarean section|caesarean section
5006600|NCT03955211|C-section|c-section
5006601|NCT03955198|Brain Metastases|brain metastases
5006602|NCT03955198|NSCLC|nsclc
5006603|NCT03955198|Anti-PD-L1|anti-pd-l1
5006604|NCT03955198|Durvalumab|durvalumab
5006605|NCT03955198|Radiation therapy|radiation therapy
5006606|NCT03955198|Hypo-fractionated stereotactic irradiation|hypo-fractionated stereotactic irradiation
5006607|NCT03955172|Missing self|missing self
5006608|NCT03955172|NK cells|nk cells
5006609|NCT03955172|Rejection|rejection
5006610|NCT03955172|mTOR inhibitors|mtor inhibitors
5006611|NCT03955172|Kidney transplanted patients|kidney transplanted patients
5006612|NCT03955146|Idiopathic Pulmonary Fibrosis, IPF, Idiopathic Interstitial Pneumonia, Interstitial Lung Disease, Lung Fibrosis|idiopathic pulmonary fibrosis, ipf, idiopathic interstitial pneumonia, interstitial lung disease, lung fibrosis
5006613|NCT03955133|medicines management|medicines management
5006614|NCT03955133|adverse drug reaction|adverse drug reaction
5006615|NCT03955133|care homes|care homes
5006616|NCT03955133|nurses|nurses
5006617|NCT03955120|sleep disorders|sleep disorders
5006618|NCT03955120|cognitive and behavioral treatment|cognitive and behavioral treatment
5006619|NCT03955120|digital treatment|digital treatment
5006620|NCT03955120|insomnia|insomnia
5006621|NCT03955120|sleep apnea|sleep apnea
5006622|NCT03955120|sleep|sleep
5006623|NCT03955107|gestational diabetes|gestational diabetes
5006624|NCT03955107|continuous glucose monitoring|continuous glucose monitoring
5006625|NCT03955107|glycemic Control|glycemic control
5006626|NCT03955094|AMBU® AURAGAIN™|ambu® auragain™
5006627|NCT03955094|intubation in paediatrics|intubation in paediatrics
5428217|NCT01595633|adefovir|adefovir
5006628|NCT03955094|flexible scope guided intubation|flexible scope guided intubation
5006629|NCT03955094|success rate of intubation|success rate of intubation
5006630|NCT03955094|glottic view|glottic view
5006631|NCT03955094|supraglottic airway intubation|supraglottic airway intubation
5006632|NCT03955094|efficacy safety|efficacy safety
5006633|NCT03955055|Gastro Intestinal Bleeding|gastro intestinal bleeding
5006634|NCT03955016|pulmonary rehabilitation|pulmonary rehabilitation
5006635|NCT03955016|physical activity|physical activity
5006636|NCT03954990|Bacterial Vaginoses in pregnancy|bacterial vaginoses in pregnancy
5006637|NCT03954977|PICC line|picc line
5006639|NCT03954951|hypertension|hypertension
5006640|NCT03954951|blood pressure|blood pressure
5006641|NCT03954951|clinical inertia|clinical inertia
5006642|NCT03954951|randomized clinical trial|randomized clinical trial
5006643|NCT03954951|uncontrolled hypertension|uncontrolled hypertension
5006645|NCT03954925|short hamstring graft|short hamstring graft
5006646|NCT03954925|standard hamstring graft|standard hamstring graft
5006647|NCT03954912|MAKO|mako
5006648|NCT03954912|NAVIO|navio
5006649|NCT03954912|robotic surgery|robotic surgery
5006650|NCT03954912|UKA|uka
5006651|NCT03954912|surgical time|surgical time
5006652|NCT03954912|KSS|kss
5006653|NCT03954912|KFS|kfs
5006654|NCT03954886|Myopia|myopia
5006655|NCT03954886|Choroid|choroid
5006656|NCT03954886|Retina|retina
5006657|NCT03954886|Blur|blur
5006658|NCT03954886|Defocus|defocus
5006659|NCT03954886|Eye growth|eye growth
5006660|NCT03954873|GLP-2|glp-2
5006661|NCT03954873|Glucagon|glucagon
5006681|NCT03954769|Proxy Test of Delirium|proxy test of delirium
5006683|NCT03954769|Hyperactive Delirium|hyperactive delirium
5006684|NCT03954769|Hypoactive Delirium|hypoactive delirium
5006685|NCT03954769|Mixed-type delirium|mixed-type delirium
5006694|NCT03954730|Eccentric training|eccentric training
5006695|NCT03954730|Active Release Technique|active release technique
5006696|NCT03954678|Exercise|exercise
5006697|NCT03954678|Nutrition supplement|nutrition supplement
5006698|NCT03954678|Surgery|surgery
5006699|NCT03954665|Ketones|ketones
5006700|NCT03954665|Supplementation|supplementation
5006701|NCT03954665|Exercise Performance|exercise performance
5006702|NCT03954652|Rare Diseases|rare diseases
5006703|NCT03954652|Genetic Predisposition|genetic predisposition
5006704|NCT03954652|Whole-exome sequencing|whole-exome sequencing
5006705|NCT03954652|WGS-trio analysis|wgs-trio analysis
5006706|NCT03954652|Whole Genome Sequencing (WGS)|whole genome sequencing (wgs)
5006707|NCT03954626|AMD, nAMD, wet AMD, RTH258, brolucizumab, ECG, open-label|amd, namd, wet amd, rth258, brolucizumab, ecg, open-label
5006708|NCT03954613|Alzheimer Disease|alzheimer disease
5006709|NCT03954613|Cognitive Exercises|cognitive exercises
5006710|NCT03954613|Internet|internet
5006711|NCT03954613|Donepezil|donepezil
5006712|NCT03954613|Memantin|memantin
5006713|NCT03954613|Combination|combination
5006714|NCT03954600|Phase 1|phase 1
5006715|NCT03954600|Safety|safety
5006716|NCT03954600|Tolerability|tolerability
5006717|NCT03954600|Pharmacokinetics|pharmacokinetics
5006718|NCT03954600|Parkinson's Disease|parkinson's disease
5006719|NCT03954600|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5006720|NCT03954587|Hormone replacement therapy|hormone replacement therapy
5006721|NCT03954587|Frozen thawed embryos|frozen thawed embryos
5006722|NCT03954587|Frozen embryo cycle|frozen embryo cycle
5002063|NCT03982992|donor lymphocyte infusion|donor lymphocyte infusion
5002064|NCT03982992|blinatumomab|blinatumomab
5006723|NCT03954561|colonoscopy|colonoscopy
5006724|NCT03954561|cecal intubation time|cecal intubation time
5006725|NCT03954535|sexual minorities|sexual minorities
5006726|NCT03954535|prevention|prevention
5006727|NCT03954535|web-based intervention|web-based intervention
5006728|NCT03954535|substance use|substance use
5006729|NCT03954535|longitudinal|longitudinal
5006730|NCT03954535|randomized controlled trial|randomized controlled trial
5006731|NCT03954535|adolescence|adolescence
5006733|NCT03954522|acute stress|acute stress
5006734|NCT03954522|PTSD|ptsd
5006735|NCT03954522|child|child
5006736|NCT03954522|parent hospitalized|parent hospitalized
5006737|NCT03954509|Complementary and Alternative Medicines|complementary and alternative medicines
5006738|NCT03954496|neuroplasticity|neuroplasticity
5006739|NCT03954496|rehabilitation|rehabilitation
5006740|NCT03954496|transcranial direct current stimulation|transcranial direct current stimulation
5006741|NCT03954496|transcranial magnetic stimulation|transcranial magnetic stimulation
5006742|NCT03954496|activities of daily living|activities of daily living
5006743|NCT03954496|motor training|motor training
5006744|NCT03954457|Suicide|suicide
5006745|NCT03954457|Aggression|aggression
5006746|NCT03954457|Prevention|prevention
5006747|NCT03954457|Culturally-Adapted|culturally-adapted
5006748|NCT03954457|African American Adolescents|african american adolescents
5006749|NCT03954418|Artificial sweeteners|artificial sweeteners
5006750|NCT03954418|Non-nutritive sweeteners|non-nutritive sweeteners
5006751|NCT03954418|Caesarean section|caesarean section
5006752|NCT03954392|Depression|depression
5006771|NCT03954249|erector spinae plane block|erector spinae plane block
5006772|NCT03954249|multimodal anesthesia|multimodal anesthesia
5006773|NCT03954236|Ruxolitinib Cream|ruxolitinib cream
5006810|NCT03953950|Spironolactone|spironolactone
5006811|NCT03953950|Losartan|losartan
5022313|NCT03858088|survival analysis|survival analysis
5006812|NCT03953950|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
5006813|NCT03953924|transtheoretical model|transtheoretical model
5006814|NCT03953924|motivational interviewing|motivational interviewing
5006815|NCT03953924|depression|depression
5006816|NCT03953924|coronary heart disease|coronary heart disease
5006817|NCT03953885|Plaque Psoriasis|plaque psoriasis
5006818|NCT03953885|Blood stasis syndrome|blood stasis syndrome
5006819|NCT03953885|Randomized controlled trial|randomized controlled trial
5006820|NCT03953885|Fire Needle Therapy|fire needle therapy
5006822|NCT03953833|MTD|mtd
5006823|NCT03953833|Safety|safety
5006824|NCT03953833|tolerability|tolerability
5006825|NCT03953833|HER2-positive|her2-positive
5006826|NCT03953833|Recombinant Humanized Anti-HER2 Monoclonal Antibody|recombinant humanized anti-her2 monoclonal antibody
5006827|NCT03953781|Epilepsy|epilepsy
5006828|NCT03953781|antiepileptic drugs|antiepileptic drugs
5006829|NCT03953781|males|males
5006830|NCT03953781|reproduction|reproduction
5006831|NCT03953768|epilepsy|epilepsy
5006832|NCT03953768|vagal|vagal
5006833|NCT03953768|autoimmune|autoimmune
5006834|NCT03953768|autonomic|autonomic
5006835|NCT03953768|inflammatory bowel disease|inflammatory bowel disease
5006836|NCT03953768|immune|immune
5006837|NCT03953755|tricuspid regurgitation|tricuspid regurgitation
5006838|NCT03953755|tricuspid surgery|tricuspid surgery
5006839|NCT03953755|moderate tricispid|moderate tricispid
5006840|NCT03953742|Intravenous infusion|intravenous infusion
5006841|NCT03953742|Phase 1|phase 1
5006842|NCT03953742|CPI-200|cpi-200
5006843|NCT03953716|Primary Dysmenorrhea|primary dysmenorrhea
5006844|NCT03953716|traditional Chinese medicine|traditional chinese medicine
5006845|NCT03953716|low-level light therapy|low-level light therapy
5006846|NCT03953703|Sjogren's syndrome, dry eye, sicca|sjogren's syndrome, dry eye, sicca
5006847|NCT03953625|Common Acute Low Back Pain|common acute low back pain
5006848|NCT03953625|Low Back Pain Booklet|low back pain booklet
5006849|NCT03953625|Health Insurance|health insurance
5006850|NCT03953586|laparoscopy|laparoscopy
5006851|NCT03953586|hysteroscopy,|hysteroscopy,
5006852|NCT03953586|tubal patency,|tubal patency,
5006853|NCT03953586|bubble test,|bubble test,
5006854|NCT03953586|peristalsis|peristalsis
5006855|NCT03953560|CTEPH|cteph
5006856|NCT03953560|Pulmonary Embolism|pulmonary embolism
5006857|NCT03953560|Symptoms and Signs|symptoms and signs
5006871|NCT03953469|passionflower|passionflower
5006872|NCT03953469|meditation|meditation
5006899|NCT03953248|phosphide; poisoning; L-carnitine; oxidative stress|phosphide; poisoning; l-carnitine; oxidative stress
5006910|NCT03953222|Real-time feedback|real-time feedback
5006912|NCT03953222|Posture|posture
5006913|NCT03953222|Rehabilitation|rehabilitation
5006914|NCT03953209|spironolactone|spironolactone
5006915|NCT03953183|Nicotine|nicotine
5006916|NCT03953144|Segmentectomy|segmentectomy
5006917|NCT03953144|Lung Cancer|lung cancer
5006918|NCT03953144|Robotic Surgery|robotic surgery
5006919|NCT03953144|3D Modelling|3d modelling
5006920|NCT03953144|CT Imaging|ct imaging
5006921|NCT03953144|Near-Infrared Fluorescence|near-infrared fluorescence
5006922|NCT03953144|IC-GREEN|ic-green
5006923|NCT03953144|Surgical Planning|surgical planning
5006924|NCT03953144|Indocyanine Green|indocyanine green
5006925|NCT03953144|Early-Stage Lung Cancer|early-stage lung cancer
5006926|NCT03953144|Surgical Mapping|surgical mapping
5006927|NCT03953144|Lung Preservation|lung preservation
5006928|NCT03953105|Weight estimation|weight estimation
5006929|NCT03953105|Patient safety|patient safety
5006930|NCT03953092|Diabetes|diabetes
5006931|NCT03953079|Age-related macular degeneration|age-related macular degeneration
5006932|NCT03953079|Choroidal neovascularization|choroidal neovascularization
5006933|NCT03953066|melatonin,colostral milk,IL-6, delivery, cesarean section|melatonin,colostral milk,il-6, delivery, cesarean section
5006934|NCT03953053|Femto Cataract Surgery|femto cataract surgery
5006935|NCT03953014|SSRI|ssri
5006936|NCT03953014|Depression|depression
5006937|NCT03953014|Children|children
5006938|NCT03953014|OCD|ocd
5006939|NCT03953014|Anxiety|anxiety
5006940|NCT03953014|Antidepressants|antidepressants
5006941|NCT03952975|Loop electrosurgical excision procedure|loop electrosurgical excision procedure
5006942|NCT03952949|Nutrition|nutrition
5006943|NCT03952949|Food Insecurity|food insecurity
5006944|NCT03952949|Choice Architecture|choice architecture
5006945|NCT03952949|Nudge|nudge
5006956|NCT03952884|Muscle Protein Synthesis|muscle protein synthesis
5006957|NCT03952884|Muscle Protein Breakdown|muscle protein breakdown
5006959|NCT03952871|Hemodynamic|hemodynamic
5006970|NCT03952780|stent graft|stent graft
5006971|NCT03952754|Nutrition|nutrition
5006973|NCT03952754|School Children|school children
5006974|NCT03952715|Focus analgesia selection test (FAST)|focus analgesia selection test (fast)
5006975|NCT03952715|Experimental pain variability|experimental pain variability
5006976|NCT03952715|Placebo effect|placebo effect
5006977|NCT03952715|Evoked pain training (EPT)|evoked pain training (ept)
5006978|NCT03952702|Intermittent exotropia|intermittent exotropia
5006979|NCT03952702|overminus lens therapy|overminus lens therapy
5006980|NCT03952702|myopic overcorrection|myopic overcorrection
5006981|NCT03952676|Plaque Psoriasis|plaque psoriasis
5006982|NCT03952676|Blood stasis syndrome|blood stasis syndrome
5006983|NCT03952676|Randomized controlled trial|randomized controlled trial
5006984|NCT03952676|Moving cupping|moving cupping
5006985|NCT03952663|inferior alveolar nerve lateralization|inferior alveolar nerve lateralization
5006986|NCT03952663|platelet rich fibrin|platelet rich fibrin
5006987|NCT03952663|posterior atrophic mandible|posterior atrophic mandible
5006993|NCT03952637|Lysosomal Diseases|lysosomal diseases
5006994|NCT03952624|Symptom Biology|symptom biology
5006995|NCT03952624|Symptom Phenotyping|symptom phenotyping
5007003|NCT03952546|Total Knee Arthroplasty|total knee arthroplasty
5007004|NCT03952546|Surgical Blood Loss|surgical blood loss
5007005|NCT03952546|Electrocautery|electrocautery
5007006|NCT03952546|Perioperative Blood Conservation|perioperative blood conservation
5007007|NCT03952533|alpha-lipoic Acid|alpha-lipoic acid
5007008|NCT03952533|vitamin D|vitamin d
5007009|NCT03952533|cervical shortening|cervical shortening
5007010|NCT03952533|pretermbirth|pretermbirth
5007011|NCT03952533|food supplement|food supplement
5007012|NCT03952520|Cluster randomized controlled implementation trial|cluster randomized controlled implementation trial
5007013|NCT03952520|Intervention mapping|intervention mapping
5007014|NCT03952520|People who inject drugs|people who inject drugs
5007015|NCT03952520|HIV/AIDS|hiv/aids
5007030|NCT03952429|alcohol dependence|alcohol dependence
5007032|NCT03952429|withdrawal|withdrawal
5007033|NCT03952416|Occupational Therapy|occupational therapy
5007034|NCT03952416|Spinal Cord Injury|spinal cord injury
5007035|NCT03952416|Rehabilitation|rehabilitation
5007036|NCT03952390|thrombocytopenia,Renin-Angiotensin System,platelet|thrombocytopenia,renin-angiotensin system,platelet
5007037|NCT03952377|Sciatica|sciatica
5007038|NCT03952377|Low Back Pain|low back pain
5007039|NCT03952377|Lumbosacral Radiculopathy|lumbosacral radiculopathy
5007040|NCT03952377|Leg Pain|leg pain
5007041|NCT03952364|Crohn's Disease|crohn's disease
5007042|NCT03952364|Ulcerative Colitis|ulcerative colitis
5007043|NCT03952364|IBD|ibd
5007044|NCT03952364|Inflammatory Bowel Disease|inflammatory bowel disease
5007045|NCT03952364|Precious|precious
5007046|NCT03952325|Tesetaxel|tesetaxel
5007047|NCT03952325|PD-(L)1 inhibitor|pd-(l)1 inhibitor
5007048|NCT03952325|Triple-negative breast cancer|triple-negative breast cancer
5007049|NCT03952325|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5007050|NCT03952325|Taxane|taxane
5007051|NCT03952325|Metastatic breast cancer|metastatic breast cancer
5022519|NCT03856801|hypoxia|hypoxia
5007052|NCT03952325|Breast cancer|breast cancer
5007053|NCT03952325|Combination of tesetaxel and PD-(L)1 inhibitors|combination of tesetaxel and pd-(l)1 inhibitors
5007054|NCT03952325|HER2 negative|her2 negative
5007055|NCT03952325|Oral chemotherapy|oral chemotherapy
5007071|NCT03952234|Encephalomyopathy|encephalomyopathy
5007072|NCT03952234|Metabolic strokes|metabolic strokes
5007073|NCT03952234|Stroke-like episodes|stroke-like episodes
5007074|NCT03952234|Citrulline|citrulline
5007075|NCT03952234|Nitric Oxide|nitric oxide
5007076|NCT03952221|hip osteoarthritis|hip osteoarthritis
5007077|NCT03952221|sonotens|sonotens
5007078|NCT03952221|pulsed ultrasound|pulsed ultrasound
5007079|NCT03952221|continuous ultrasound|continuous ultrasound
5007080|NCT03952195|IPAA|ipaa
5007082|NCT03952195|Ulcerative Colitis|ulcerative colitis
5007083|NCT03952195|Restorative Proctocolectomy|restorative proctocolectomy
5007084|NCT03952195|Ileal Pouch-Anal Anastomosis|ileal pouch-anal anastomosis
5007085|NCT03952195|Excisions|excisions
5007086|NCT03952195|Salvage|salvage
5007087|NCT03952195|Pouch|pouch
5007088|NCT03952169|Primary Hypercholesterolemia|primary hypercholesterolemia
5007089|NCT03952169|Probiotics|probiotics
5007090|NCT03952169|Cardiovascular risk|cardiovascular risk
5007091|NCT03952156|PKU|pku
5007092|NCT03952156|Phenylketonuria|phenylketonuria
5007093|NCT03952156|PAH Deficiency|pah deficiency
5007094|NCT03952156|Hyperphenylalaninemia|hyperphenylalaninemia
5007095|NCT03952156|Phenylalanine|phenylalanine
5007096|NCT03952156|Adeno Associated Virus|adeno associated virus
5007097|NCT03952156|AAVHSC15|aavhsc15
5007098|NCT03952117|primary motor cortex|primary motor cortex
5007099|NCT03952078|CTCL|ctcl
5007100|NCT03952078|PTCL|ptcl
5007101|NCT03952065|Head/Neck tumor|head/neck tumor
5007102|NCT03952065|PD1 antibody|pd1 antibody
5007103|NCT03952065|Artery infusion|artery infusion
5007104|NCT03952052|MRD|mrd
5007105|NCT03952052|Mutation|mutation
5007106|NCT03952052|Next Generation sequencing|next generation sequencing
5007107|NCT03952052|Digital Polymeras Chain Reaction|digital polymeras chain reaction
5007117|NCT03952026|Pelvic trauma|pelvic trauma
5007118|NCT03952026|Pelvic ring fracture|pelvic ring fracture
5007119|NCT03952026|Acetabular Fracture|acetabular fracture
5007120|NCT03952026|Abdominal Trauma|abdominal trauma
5007121|NCT03952026|Polytrauma|polytrauma
5007122|NCT03952026|Reduction quality|reduction quality
5007123|NCT03951974|emotion regulation|emotion regulation
5321228|NCT02079272|Tomotherapy|tomotherapy
5007124|NCT03951974|social regulation of emotion|social regulation of emotion
5007125|NCT03951948|total hip replacement|total hip replacement
5007126|NCT03951935|pelvic stability|pelvic stability
5007127|NCT03951935|lumbo- pelvic- hip complex|lumbo- pelvic- hip complex
5007128|NCT03951935|lumbo-pelvic-hip muscles|lumbo-pelvic-hip muscles
5007129|NCT03951870|mesolimbic reward system|mesolimbic reward system
5007141|NCT03951831|Prostate Cancer|prostate cancer
5007149|NCT03951740|Fitbit Charge 2|fitbit charge 2
5007151|NCT03951740|Validation study|validation study
5007152|NCT03951740|Energy expenditure|energy expenditure
5007153|NCT03951714|Post-market study|post-market study
5007154|NCT03951649|headache|headache
5007155|NCT03951649|Pregnancy|pregnancy
5007156|NCT03951649|Acute treatment|acute treatment
5007157|NCT03951649|Emergency department|emergency department
5007165|NCT03951623|ITP|itp
5007166|NCT03951597|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5007167|NCT03951597|oxaliplatin and gemcitabine chemotherapy|oxaliplatin and gemcitabine chemotherapy
5007168|NCT03951597|Lenvatinib|lenvatinib
5007169|NCT03951597|programmed cell death protein 1 antibody|programmed cell death protein 1 antibody
5007170|NCT03951584|idiopathic sudden sensorineural hearing loss|idiopathic sudden sensorineural hearing loss
5007171|NCT03951584|vestibular dysfunction|vestibular dysfunction
5007172|NCT03951558|diet|diet
5007173|NCT03951558|drinking water|drinking water
5007174|NCT03951558|salt|salt
5007175|NCT03951558|dietaryprotein|dietaryprotein
5007176|NCT03951545|Osteoarthritis Knee|osteoarthritis knee
5007177|NCT03951545|Knee prosthesis|knee prosthesis
5007178|NCT03951545|Patient satisfaction|patient satisfaction
5007179|NCT03951532|Hyperthyroidism|hyperthyroidism
5007180|NCT03951532|paediatrics|paediatrics
5007181|NCT03951532|health data base|health data base
5007182|NCT03951493|Hypo-fractured radiotherapy in stereotactic conditions (RSHF)|hypo-fractured radiotherapy in stereotactic conditions (rshf)
5007183|NCT03951493|zoledronic acid|zoledronic acid
5007184|NCT03951493|medico-economic|medico-economic
5007185|NCT03951493|vertebral compressive fracture|vertebral compressive fracture
5007186|NCT03951467|Literacy|literacy
5007187|NCT03951467|Cardiovascular Diseases|cardiovascular diseases
5007188|NCT03951467|Interventional study|interventional study
5007189|NCT03951467|Randomized Controlled Trial|randomized controlled trial
5007190|NCT03951467|Tertiary prevention|tertiary prevention
5007191|NCT03951467|Health promotion|health promotion
5007192|NCT03951454|maternal|maternal
5007193|NCT03951454|non-metastatic|non-metastatic
5007195|NCT03951454|depression|depression
5007196|NCT03951441|lower limb|lower limb
5007197|NCT03951415|Poly (ADP-ribose) Polymerase Inhibitors|poly (adp-ribose) polymerase inhibitors
5007198|NCT03951415|Antibodies, Monoclonal|antibodies, monoclonal
5007199|NCT03951415|Checkpoint Inhibitors|checkpoint inhibitors
5007200|NCT03951415|olaparib|olaparib
5007201|NCT03951415|durvalumab|durvalumab
5007202|NCT03951415|Anti-PD-L1|anti-pd-l1
5007203|NCT03951402|QT/QTc Interval|qt/qtc interval
5007204|NCT03951350|mediterranean lifestyles|mediterranean lifestyles
5007205|NCT03951350|depression|depression
5007206|NCT03951350|primary health care|primary health care
5007207|NCT03951350|adjuvant treatment|adjuvant treatment
5007215|NCT03951324|bile duct stricture|bile duct stricture
5007216|NCT03951324|bile duct neoplasm|bile duct neoplasm
5007217|NCT03951324|bile duct obstruction|bile duct obstruction
5007218|NCT03951324|bile duct lesion|bile duct lesion
5007219|NCT03951324|cholangiocarcinoma|cholangiocarcinoma
5007220|NCT03951324|pancreatic duct stricture|pancreatic duct stricture
5007221|NCT03951324|pancreatic duct obstruction|pancreatic duct obstruction
5007222|NCT03951324|pancreatic cancer|pancreatic cancer
5007223|NCT03951324|primary sclerosing cholangitis|primary sclerosing cholangitis
5007224|NCT03951298|Diabetes Mellitus|diabetes mellitus
5007225|NCT03951298|Diabetes Insipidus|diabetes insipidus
5007226|NCT03951298|Optic Atrophy|optic atrophy
5007227|NCT03951298|Deafness|deafness
5007228|NCT03951285|Obesity|obesity
5007229|NCT03951285|Metabolic syndrome|metabolic syndrome
5007230|NCT03951285|Vitamin B3|vitamin b3
5007231|NCT03951285|Nicotinamide riboside|nicotinamide riboside
5007232|NCT03951285|Mitochondrial dysfunction|mitochondrial dysfunction
5007233|NCT03951285|Mitochondria|mitochondria
5007234|NCT03951285|Adipose tissue|adipose tissue
5007235|NCT03951285|Skeletal muscle|skeletal muscle
5007236|NCT03951246|executive functions|executive functions
5007237|NCT03951246|motor skills|motor skills
5007241|NCT03951168|Diabetes Mellitus|diabetes mellitus
5007242|NCT03951168|Health education for diabetes|health education for diabetes
5007243|NCT03951155|ADHD|adhd
5007244|NCT03951155|behavioral management|behavioral management
5007245|NCT03951155|dental management|dental management
5007246|NCT03951142|Magnetic Resonance Imaging|magnetic resonance imaging
5007247|NCT03951142|Brain Cancer|brain cancer
5007248|NCT03951142|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5007249|NCT03951142|Losartan|losartan
5007250|NCT03951142|Perfusion|perfusion
5007251|NCT03951142|Solid stress|solid stress
5007252|NCT03951116|solid tumor|solid tumor
5007253|NCT03951103|Elocta|elocta
5007256|NCT03951077|Hormone|hormone
5007257|NCT03951077|Elagolix|elagolix
5007258|NCT03951064|Transpulmonary pressure|transpulmonary pressure
5007259|NCT03951064|Esophageal balloon|esophageal balloon
5007260|NCT03951064|Esophageal pressure monitoring|esophageal pressure monitoring
5007261|NCT03951064|Mechanical ventilation|mechanical ventilation
5007262|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil
5007263|NCT03951051|Bioequivalence|bioequivalence
5007264|NCT03951051|Olmetec|olmetec
5007265|NCT03951038|Lumbar disc herniation|lumbar disc herniation
5007266|NCT03951038|Postoperative analgesia|postoperative analgesia
5007267|NCT03951038|Patient controlled intravenous analgesia|patient controlled intravenous analgesia
5007268|NCT03951038|Nerve block|nerve block
5007269|NCT03951038|thoracolumbar|thoracolumbar
5007270|NCT03951025|melatonin|melatonin
5007271|NCT03951025|oral administration|oral administration
5007272|NCT03951025|sublingual administration|sublingual administration
5007273|NCT03950999|Focus analgesia selection test (FAST)|focus analgesia selection test (fast)
5007274|NCT03950999|Placebo effect|placebo effect
5007275|NCT03950999|Experimental pain variability|experimental pain variability
5007276|NCT03950986|Vaccination|vaccination
5007277|NCT03950986|EHR Reminders|ehr reminders
5007278|NCT03950986|Nudge|nudge
5007279|NCT03950986|Electronic Medical Records|electronic medical records
5007280|NCT03950986|Behavioral Economics|behavioral economics
5007281|NCT03950973|Diabetes|diabetes
5007282|NCT03950973|Self-management|self-management
5007283|NCT03950973|Adherence|adherence
5007284|NCT03950973|Social determinants of health|social determinants of health
5007285|NCT03950973|Social risk factors|social risk factors
5007287|NCT03950947|Circulation, Collateral|circulation, collateral
5007288|NCT03950947|Coronary Artery Disease|coronary artery disease
5007289|NCT03950947|Internal Mammary-Coronary Artery Anastomosis|internal mammary-coronary artery anastomosis
5007290|NCT03950947|Ischemia|ischemia
5007291|NCT03950934|Anesthesia|anesthesia
5007292|NCT03950934|Airway Management|airway management
5007297|NCT03950921|Catheter-Related Infections|catheter-related infections
5007298|NCT03950921|Pressure Injury|pressure injury
5007299|NCT03950921|Patient Safety|patient safety
5007300|NCT03950843|Atrial Fibrillation|atrial fibrillation
5007301|NCT03950804|Complement hyperactivation|complement hyperactivation
5007302|NCT03950804|CD55 deficiency|cd55 deficiency
5007303|NCT03950804|Complement C5|complement c5
5007304|NCT03950804|Eculizumab|eculizumab
5007305|NCT03950804|Multi-OMICs Analyses|multi-omics analyses
5007306|NCT03950804|Protein losing enteropathy|protein losing enteropathy
5007307|NCT03950765|ecological momentary assessment|ecological momentary assessment
5007308|NCT03950765|ecological momentary intervention|ecological momentary intervention
5007309|NCT03950765|distress|distress
5007310|NCT03950752|postprandial|postprandial
5007311|NCT03950752|cardiovascular disease|cardiovascular disease
5007312|NCT03950752|saturated fatty acids|saturated fatty acids
5007313|NCT03950752|monounsaturated fatty acids|monounsaturated fatty acids
5007314|NCT03950752|palm oil|palm oil
5007315|NCT03950739|prostacyclin|prostacyclin
5007316|NCT03950726|Crohn Disease|crohn disease
5007317|NCT03950726|Ileocolic resection|ileocolic resection
5007318|NCT03950726|Appendectomy|appendectomy
5007319|NCT03950726|Single-port incision|single-port incision
5007320|NCT03950726|McBurney|mcburney
5007321|NCT03950726|Laparoscopy|laparoscopy
5007322|NCT03950713|Mindfulness-based Program|mindfulness-based program
5007323|NCT03950713|Relocation stress|relocation stress
5007324|NCT03950713|Depression|depression
5007325|NCT03950713|Glycemic control|glycemic control
5007326|NCT03950700|Analgesia|analgesia
5007327|NCT03950700|Bupivacaine|bupivacaine
5007328|NCT03950700|Postoperative pain|postoperative pain
5007329|NCT03950700|Third molar|third molar
5007330|NCT03950700|Extraction|extraction
5007331|NCT03950674|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5007332|NCT03950674|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5007333|NCT03950674|Non-Small-Cell Lung Cancer (NSCLC)|non-small-cell lung cancer (nsclc)
5007335|NCT03950661|walk|walk
5007336|NCT03950661|stress|stress
5007337|NCT03950661|Green Walking|green walking
5007338|NCT03950661|Physical Activity|physical activity
5007341|NCT03950661|mood|mood
5007342|NCT03950583|interstitial lung disease|interstitial lung disease
5007343|NCT03950583|interstitial pneumonia|interstitial pneumonia
5007344|NCT03950583|connective tissue disease|connective tissue disease
5007345|NCT03950583|clinical course|clinical course
5007346|NCT03950557|Infusion pumps|infusion pumps
5007347|NCT03950557|Intraoperative brain monitoring|intraoperative brain monitoring
5007348|NCT03950531|Bronchiectasis|bronchiectasis
5007349|NCT03950531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5007350|NCT03950531|Exacerbation|exacerbation
5007351|NCT03950531|Computed Tomography|computed tomography
5007352|NCT03950518|treatment|treatment
5007353|NCT03950492|Deep Brain Stimulation|deep brain stimulation
5007354|NCT03950466|Sleep apnea|sleep apnea
5007355|NCT03950466|Children|children
5007356|NCT03950466|Neurocognitive|neurocognitive
5007357|NCT03950440|Transaortic valve replacement|transaortic valve replacement
5325865|NCT02058212|ROS|ros
5007358|NCT03950440|Surgical aortic valve replacement|surgical aortic valve replacement
5007359|NCT03950440|TAVR|tavr
5007360|NCT03950440|SAVR|savr
5007361|NCT03950427|smoking cessation|smoking cessation
5007362|NCT03950427|serious mental illness|serious mental illness
5007363|NCT03950414|T-cell|t-cell
5007364|NCT03950414|immunotherapy|immunotherapy
5007365|NCT03950401|skin closure|skin closure
5007366|NCT03950375|Sensorineural Hearing Loss|sensorineural hearing loss
5007367|NCT03950375|Round Window|round window
5007368|NCT03950375|ear surgery|ear surgery
5007369|NCT03950375|Cochlear implantation|cochlear implantation
5007370|NCT03950362|non-muscle-invasive bladder cancer|non-muscle-invasive bladder cancer
5007371|NCT03950362|radiotherapy|radiotherapy
5007372|NCT03950362|immunotherapy|immunotherapy
5007373|NCT03950362|quality of life|quality of life
5007374|NCT03950349|Radiculopathy|radiculopathy
5007375|NCT03950349|myelopathy|myelopathy
5007376|NCT03950349|anterior cervical fusion|anterior cervical fusion
5007377|NCT03950349|stand-alone cage|stand-alone cage
5007378|NCT03950349|pseudoarthrosis|pseudoarthrosis
5007379|NCT03950349|stabilization|stabilization
5007380|NCT03950349|HRCC|hrcc
5007381|NCT03950336|intestinal permeability|intestinal permeability
5007382|NCT03950336|Crohn's Disease (CD)|crohn's disease (cd)
5007383|NCT03950336|oligofructose-enriched inulin|oligofructose-enriched inulin
5007384|NCT03950336|prebiotics|prebiotics
5007385|NCT03950336|n-3 polyunsaturated fatty acids (n-3 PUFA)|n-3 polyunsaturated fatty acids (n-3 pufa)
5007386|NCT03950336|intestinal microbiota|intestinal microbiota
5007387|NCT03950323|Parotidetomy|parotidetomy
5007388|NCT03950323|Tractography|tractography
5007389|NCT03950323|Facial nerve|facial nerve
5007390|NCT03950323|Facial palsy|facial palsy
5007391|NCT03950323|Tumor of parotid gland|tumor of parotid gland
5007392|NCT03950310|ELCA|elca
5007393|NCT03950310|STEMI|stemi
5007394|NCT03950310|Myocardial Salvage|myocardial salvage
5007395|NCT03950245|glucagon-like peptide-1|glucagon-like peptide-1
5007396|NCT03950245|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5007397|NCT03950245|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5007398|NCT03950245|sleeve gastrectomy|sleeve gastrectomy
5007399|NCT03950245|gastric bypass|gastric bypass
5007400|NCT03950245|bariatric surgery|bariatric surgery
5007401|NCT03950245|glucose|glucose
5007402|NCT03950245|diabetes|diabetes
5007403|NCT03950245|exendin(9-39)|exendin(9-39)
5007404|NCT03950245|GIP(3-30)|gip(3-30)
5007405|NCT03950232|Ulcerative Colitis|ulcerative colitis
5007406|NCT03950232|Etrasimod|etrasimod
5007407|NCT03950232|APD334|apd334
5007408|NCT03950219|Diabetes self-management|diabetes self-management
5007409|NCT03950219|Diabetes Education|diabetes education
5007410|NCT03950219|Ethnic minorities|ethnic minorities
5007411|NCT03950219|Patient empowerment|patient empowerment
5007412|NCT03950206|Endometriosis|endometriosis
5007413|NCT03950206|Ureters|ureters
5007414|NCT03950206|Indocyanine green angiography|indocyanine green angiography
5007415|NCT03950193|Parental presence|parental presence
5007416|NCT03950193|parental involvement|parental involvement
5007417|NCT03950193|parental stress|parental stress
5007418|NCT03950193|development care|development care
5007419|NCT03950193|psychic development|psychic development
5007420|NCT03950167|gallbladder functions|gallbladder functions
5007421|NCT03950167|cholecystokinin|cholecystokinin
5007422|NCT03950167|hyperemesis gravidarum|hyperemesis gravidarum
5007423|NCT03950154|effcet|effcet
5007424|NCT03950154|safety|safety
5007425|NCT03950128|Dating aggression|dating aggression
5007426|NCT03950128|Emotion regulation|emotion regulation
5007427|NCT03950128|Mindfulness|mindfulness
5007428|NCT03950128|Mindfulness-based skills|mindfulness-based skills
5007429|NCT03950128|Romantic relationships|romantic relationships
5007430|NCT03950128|Dating relationships|dating relationships
5007431|NCT03950076|Edoxaban|edoxaban
5007432|NCT03950076|Intracranial Hemorrhage|intracranial hemorrhage
5007433|NCT03950076|Hemorrhagic Stroke|hemorrhagic stroke
5707747|NCT00473304|Efficacy|efficacy
5007434|NCT03950063|Cutibacterium acnes Prosthesis|cutibacterium acnes prosthesis
5007438|NCT03950024|functional brain MRI|functional brain mri
5007439|NCT03950024|Central nervous system|central nervous system
5007440|NCT03950024|Knee trauma|knee trauma
5007441|NCT03950011|Enhanced Recovery After Surgery Program (ERP)|enhanced recovery after surgery program (erp)
5007442|NCT03949998|Dry Needling|dry needling
5007443|NCT03949972|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
5007444|NCT03949972|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
5007445|NCT03949972|FSGS|fsgs
5007446|NCT03949972|Minimal change disease|minimal change disease
5007458|NCT03949881|Total bilateral limbal cell deficiency|total bilateral limbal cell deficiency
5007459|NCT03949881|Autologous jugal mucosa cell sheet|autologous jugal mucosa cell sheet
5007461|NCT03949868|mindfulness|mindfulness
5007462|NCT03949868|forgetfulness|forgetfulness
5007463|NCT03949868|Langerian mindfulness|langerian mindfulness
5007469|NCT03949842|Fluticasone furoate|fluticasone furoate
5007470|NCT03949842|Umeclidinium bromide|umeclidinium bromide
5007471|NCT03949842|Vilanterol|vilanterol
5007472|NCT03949842|COPD|copd
5007473|NCT03949842|ELLIPTA|ellipta
5007474|NCT03949842|TRELEGY|trelegy
5007475|NCT03949842|MITT|mitt
5007476|NCT03949842|SITT|sitt
5007477|NCT03949829|Pre- eclampsia|pre- eclampsia
5007478|NCT03949829|Heart disease in women|heart disease in women
5007479|NCT03949816|patient-centered communication|patient-centered communication
5007480|NCT03949816|doctor-centered communication|doctor-centered communication
5007481|NCT03949816|placebo|placebo
5007482|NCT03949816|nocebo|nocebo
5007483|NCT03949816|outcome expectation|outcome expectation
5007484|NCT03949816|blood pressure|blood pressure
5007485|NCT03949816|heart rate|heart rate
5007486|NCT03949816|patient-physician communication|patient-physician communication
5007487|NCT03949803|Chocolate|chocolate
5007488|NCT03949803|Timing|timing
5007489|NCT03949803|Menopause|menopause
5007490|NCT03949803|Calorimetry|calorimetry
5007491|NCT03949777|screening-colonoscopy|screening-colonoscopy
5007492|NCT03949777|diagnostic-colonoscopy|diagnostic-colonoscopy
5007493|NCT03949777|surveillance-colonoscopy|surveillance-colonoscopy
5007494|NCT03949751|gram positive bacteria|gram positive bacteria
5007495|NCT03949751|Benzoylperoxid and Miconazolnitrat|benzoylperoxid and miconazolnitrat
5007496|NCT03949738|Cerebral Autoregulation|cerebral autoregulation
5007497|NCT03949738|Cerebral Hemodynamics|cerebral hemodynamics
5007498|NCT03949738|Cognitive Impairment|cognitive impairment
5007499|NCT03949738|Near-infrared Spectroscopy|near-infrared spectroscopy
5007516|NCT03949595|Eating rate|eating rate
5007517|NCT03949582|Type 2 Diabetes|type 2 diabetes
5007518|NCT03949582|South Asian|south asian
5007519|NCT03949582|Guar gum|guar gum
5007520|NCT03949582|Mycoprotein|mycoprotein
5007521|NCT03949582|Caucasian|caucasian
5007522|NCT03949582|Glycaemic control|glycaemic control
5007523|NCT03949582|Appetite|appetite
5007524|NCT03949569|Children|children
5007525|NCT03949569|Human-Animal Interaction|human-animal interaction
5007526|NCT03949569|Stress|stress
5007527|NCT03949569|Cortisol|cortisol
5007528|NCT03949517|Prostate Cancer|prostate cancer
5007529|NCT03949504|Diabetes|diabetes
5007530|NCT03949504|neurological complications|neurological complications
5007531|NCT03949504|cardiovascular complications|cardiovascular complications
5007532|NCT03949478|Postictal|postictal
5007533|NCT03949478|Blood flow|blood flow
5007534|NCT03949439|Frailty|frailty
5007535|NCT03949439|Cardiac Suregry|cardiac suregry
5007536|NCT03949439|Adverse Events|adverse events
5007537|NCT03949387|exercise|exercise
5007538|NCT03949387|multiple sclerosis|multiple sclerosis
5007539|NCT03949387|mobility|mobility
5007540|NCT03949361|Glucocorticoids|glucocorticoids
5007541|NCT03949361|Brown Adipose tissue|brown adipose tissue
5007542|NCT03949361|Cold Induced Thermogenesis|cold induced thermogenesis
5007543|NCT03949361|Resting Metabolic Rate|resting metabolic rate
5007544|NCT03949348|midurethral sling placement|midurethral sling placement
5007545|NCT03949348|synthetic mesh|synthetic mesh
5007546|NCT03949348|autologous rectus fascia|autologous rectus fascia
5007547|NCT03949348|transobturator approach|transobturator approach
5007564|NCT03949218|bipolar disorder|bipolar disorder
5007565|NCT03949218|machine learning|machine learning
5007566|NCT03949179|Low back pain|low back pain
5007567|NCT03949179|Pain management|pain management
5007568|NCT03949179|Rehabilitation|rehabilitation
5007569|NCT03949179|Feasibility outcomes|feasibility outcomes
5007571|NCT03949166|delivery|delivery
5007572|NCT03949166|eating|eating
5007573|NCT03949127|non-surgical treatment|non-surgical treatment
5007574|NCT03949127|exercise|exercise
5007575|NCT03949114|neurosurgery|neurosurgery
5007576|NCT03949101|myopia progression|myopia progression
5007577|NCT03949101|atropine|atropine
5007578|NCT03949101|prospective study|prospective study
5007581|NCT03949088|Sodium (Na) profiling|sodium (na) profiling
5007583|NCT03949075|Adaptation, Physiological|adaptation, physiological
5007584|NCT03949075|Genotype|genotype
5007585|NCT03949075|Polymorphism, Genetic|polymorphism, genetic
5007586|NCT03949075|Enalapril|enalapril
5007587|NCT03949075|Physiological Effects of Drugs|physiological effects of drugs
5007589|NCT03949036|kidney transplantation|kidney transplantation
5007590|NCT03949036|preload index|preload index
5007591|NCT03949036|stroke volume variation|stroke volume variation
5007592|NCT03949036|goad-directed therapy|goad-directed therapy
5007593|NCT03949023|Neurovascular Condition|neurovascular condition
5007594|NCT03949023|Contrast Injections|contrast injections
5007595|NCT03949023|Brain|brain
5007596|NCT03949010|Myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program|myofascial pain syndrome, kinesiotaping, upper trapezius, home exercise program
5007597|NCT03948997|port wine stain, PI3K, vascular malformation,PDL|port wine stain, pi3k, vascular malformation,pdl
5007598|NCT03948971|cerebral arteriography|cerebral arteriography
5007599|NCT03948958|Vascular Access Devices|vascular access devices
5007600|NCT03948958|Implantable port|implantable port
5007601|NCT03948958|Flush interval|flush interval
5007602|NCT03948958|Catheter function|catheter function
5007603|NCT03948958|Catheter-related infection|catheter-related infection
5325998|NCT02057458|CF|cf
5007604|NCT03948958|Catheter tip location|catheter tip location
5007605|NCT03948958|Catheter tip thrombus|catheter tip thrombus
5007606|NCT03948958|Catheter sleeve|catheter sleeve
5007607|NCT03948958|Patient-reported outcome measure|patient-reported outcome measure
5007621|NCT03948815|Birthing room|birthing room
5007622|NCT03948815|labour|labour
5007623|NCT03948815|randomised controlled trial|randomised controlled trial
5007624|NCT03948802|Ischemic Stroke|ischemic stroke
5007625|NCT03948802|Interleukin 33|interleukin 33
5007626|NCT03948802|ASTRAL|astral
5007627|NCT03948802|DRAGON|dragon
5007628|NCT03948802|NIHSS|nihss
5007639|NCT03948737|Haptoglobin|haptoglobin
5007640|NCT03948737|Hemopexin|hemopexin
5007641|NCT03948737|Hemolysis|hemolysis
5007642|NCT03948737|Malondialdehyde|malondialdehyde
5007643|NCT03948737|Glutathione|glutathione
5007644|NCT03948737|Oxidative stress|oxidative stress
5007645|NCT03948737|Alpha-Tocopherol|alpha-tocopherol
5007646|NCT03948672|hand hygiene|hand hygiene
5007647|NCT03948672|infection|infection
5007651|NCT03948633|knowledge translation|knowledge translation
5007652|NCT03948607|Electroencephalography|electroencephalography
5007653|NCT03948607|Neurocognition|neurocognition
5007654|NCT03948607|Attention deficit|attention deficit
5007655|NCT03948607|Attention lapses|attention lapses
5007657|NCT03948594|gastric residual volume|gastric residual volume
5007658|NCT03948594|hunger score|hunger score
5007659|NCT03948581|Drug therapy|drug therapy
5007660|NCT03948568|Radiation Therapy|radiation therapy
5007661|NCT03948568|Endocrine Therapy|endocrine therapy
5007662|NCT03948542|Intramedullary nailing|intramedullary nailing
5007663|NCT03948542|ORIF|orif
5007664|NCT03948542|Humeral shaft fracture|humeral shaft fracture
5007665|NCT03948529|Poor Graft Function (PGF),|poor graft function (pgf),
5007666|NCT03948529|Allogeneic hematopoietic cell transplantation (Allo-HCT)|allogeneic hematopoietic cell transplantation (allo-hct)
5007667|NCT03948529|Eltrombopag.|eltrombopag.
5007668|NCT03948503|ankle sprain|ankle sprain
5007669|NCT03948503|Mulligan|mulligan
5007670|NCT03948503|manual therapy|manual therapy
5007671|NCT03948490|cognitive impairment|cognitive impairment
5007672|NCT03948490|quality of life|quality of life
5007673|NCT03948464|slow-release oral morphine|slow-release oral morphine
5007674|NCT03948464|methadone|methadone
5007675|NCT03948464|opioid use disorder|opioid use disorder
5007676|NCT03948464|fentanyl|fentanyl
5007677|NCT03948451|Coronary Artery Disease|coronary artery disease
5007678|NCT03948399|Ischemic Stroke|ischemic stroke
5007679|NCT03948399|TIA|tia
5007680|NCT03948399|ABI|abi
5007681|NCT03948399|LEAD|lead
5007682|NCT03948360|acute burn, thermal injury, wound, phototherapy, wound healing, antimicrobial|acute burn, thermal injury, wound, phototherapy, wound healing, antimicrobial
5007683|NCT03948347|ischemic stroke|ischemic stroke
5007684|NCT03948347|transient ischemic attack|transient ischemic attack
5007685|NCT03948347|glucagon-like peptide-1|glucagon-like peptide-1
5007686|NCT03948347|type 2 diabetes mellitus|type 2 diabetes mellitus
5007688|NCT03948321|Photodynamic Therapy，PDT|photodynamic therapy，pdt
5007689|NCT03948321|Conventional|conventional
5007690|NCT03948321|Painless|painless
5007691|NCT03948321|Genital Warts|genital warts
5007692|NCT03948269|menopause|menopause
5007693|NCT03948269|group treatment|group treatment
5007694|NCT03948269|mood swing|mood swing
5007695|NCT03948269|quality of life|quality of life
5007696|NCT03948256|External ventricular drain|external ventricular drain
5007697|NCT03948256|Weaning|weaning
5007698|NCT03948256|Closure|closure
5007699|NCT03948243|Licorice|licorice
5007700|NCT03948217|artificial lighting|artificial lighting
5007701|NCT03948191|99Tc-MDP|99tc-mdp
5007702|NCT03948191|TAO|tao
5007703|NCT03948191|efficacy|efficacy
5007704|NCT03948191|safety|safety
5007705|NCT03948165|dTRA|dtra
5007706|NCT03948165|transradial access|transradial access
5007707|NCT03948165|distal|distal
5007708|NCT03948165|coronary|coronary
5007710|NCT03948139|Pediatric|pediatric
5007711|NCT03948139|Fracture|fracture
5007712|NCT03948139|Functional Brace|functional brace
5007713|NCT03948139|Hip Spica Cast|hip spica cast
5007714|NCT03948126|geophagia|geophagia
5007715|NCT03948061|cherries|cherries
5007716|NCT03948061|inflammatory disease|inflammatory disease
5007717|NCT03948061|chronic stress|chronic stress
5007718|NCT03948048|septic shock|septic shock
5007719|NCT03948048|children|children
5007720|NCT03948048|ECMO|ecmo
5007721|NCT03948048|timing|timing
5007722|NCT03948035|multiple myeloma|multiple myeloma
5007723|NCT03948035|autologous stem cell transplant|autologous stem cell transplant
5007724|NCT03948035|Elotuzumab|elotuzumab
5007725|NCT03948035|Carfilzomib|carfilzomib
5007726|NCT03948035|Lenalidomide|lenalidomide
5007727|NCT03948022|progesterone|progesterone
5007728|NCT03948022|implantation|implantation
5007729|NCT03948022|pregnancy|pregnancy
5007730|NCT03948022|abortion|abortion
5007731|NCT03947983|self-management|self-management
5007732|NCT03947983|digital game|digital game
5007733|NCT03947983|sensor|sensor
5007734|NCT03947970|Hemodialysis|hemodialysis
5007735|NCT03947970|Difelikefalin|difelikefalin
5007736|NCT03947970|Dialysis|dialysis
5007737|NCT03947970|CR845|cr845
5007739|NCT03947970|ESRD (end stage renal disease)|esrd (end stage renal disease)
5007740|NCT03947944|Small incision lenticule extraction|small incision lenticule extraction
5007741|NCT03947944|astigmatism|astigmatism
5007742|NCT03947944|vector planning|vector planning
5007743|NCT03947931|ulcerative colitis, acute severe ulcerative colitis, predictors of colectomy|ulcerative colitis, acute severe ulcerative colitis, predictors of colectomy
5007744|NCT03947905|Vascular|vascular
5007745|NCT03947905|Clinic visit|clinic visit
5007746|NCT03947905|Tele-health|tele-health
5007747|NCT03947840|Colon cancer|colon cancer
5007748|NCT03947840|Physical activity|physical activity
5007749|NCT03947827|Treatment Resistant Depression|treatment resistant depression
5007750|NCT03947827|Minocycline|minocycline
5007755|NCT03947814|JNJ-63623872,|jnj-63623872,
5007756|NCT03947814|Pharmacokinetics,|pharmacokinetics,
5007757|NCT03947814|Renal impairment,|renal impairment,
5007758|NCT03947814|Kidney disease|kidney disease
5007759|NCT03947801|Bone Turnover|bone turnover
5007760|NCT03947801|Greek Yogurt|greek yogurt
5007761|NCT03947801|Adolescent Athletes|adolescent athletes
5007762|NCT03947775|Men who have sex with men|men who have sex with men
5007763|NCT03947775|Human immunodeficiency virus|human immunodeficiency virus
5007764|NCT03947775|Human papillomavirus|human papillomavirus
5007765|NCT03947775|Vaccine|vaccine
5007766|NCT03947775|Gardasil|gardasil
5007767|NCT03947775|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
5007768|NCT03947775|Anal Cancer|anal cancer
5007769|NCT03947775|9-valent|9-valent
5007770|NCT03947723|trichiasis|trichiasis
5007771|NCT03947723|radiofrequency ablation|radiofrequency ablation
5007772|NCT03947723|epilation|epilation
5007773|NCT03947723|histology|histology
5007774|NCT03947697|Obesity|obesity
5007775|NCT03947684|Sex Hormones|sex hormones
5007776|NCT03947671|temperature regulation|temperature regulation
5007777|NCT03947658|surgical|surgical
5007778|NCT03947658|prosthetic restoration|prosthetic restoration
5007779|NCT03947658|gingiva|gingiva
5007780|NCT03947658|surgical flaps|surgical flaps
5007781|NCT03947658|stents|stents
5007782|NCT03947619|Anterior STEMI|anterior stemi
5007783|NCT03947619|ST-Elevated MI|st-elevated mi
5007784|NCT03947619|Cardiac Unloading|cardiac unloading
5007785|NCT03947606|Decision-making|decision-making
5007786|NCT03947606|Decisions|decisions
5707748|NCT00473304|Adaptation|adaptation
5007788|NCT03947606|Factorial design|factorial design
5007789|NCT03947593|Early care and education|early care and education
5007791|NCT03947593|workforce|workforce
5007792|NCT03947593|child care|child care
5007793|NCT03947593|caregivers|caregivers
5007794|NCT03947593|home-based providers|home-based providers
5007795|NCT03947593|center-based providers|center-based providers
5007796|NCT03947554|Panax ginseng|panax ginseng
5007797|NCT03947554|Red ginseng|red ginseng
5007798|NCT03947554|Korean ginseng|korean ginseng
5007799|NCT03947554|Adaptogen|adaptogen
5007800|NCT03947541|Thoracolumbosacral (TLSO) brace|thoracolumbosacral (tlso) brace
5007801|NCT03947541|Lumbosacral orthotic (LSO) brace|lumbosacral orthotic (lso) brace
5007802|NCT03947541|Adult spinal deformity|adult spinal deformity
5007803|NCT03947541|Postoperative Brace|postoperative brace
5007804|NCT03947502|Fibromyalgia|fibromyalgia
5007805|NCT03947502|pain|pain
5007806|NCT03947502|neurobiology|neurobiology
5007807|NCT03947502|education|education
5007808|NCT03947502|movement|movement
5428218|NCT01595633|tenofovir|tenofovir
5428219|NCT01595633|hepatitis B|hepatitis b
5428220|NCT01595620|Cannabis|cannabis
5007814|NCT03947450|skin breakdown|skin breakdown
5007815|NCT03947424|laser|laser
5007816|NCT03947424|Er:YAG|er:yag
5007817|NCT03947424|NightLase|nightlase
5007818|NCT03947424|Fotona SMOOTH|fotona smooth
5007819|NCT03947411|severe Influenza|severe influenza
5007820|NCT03947372|Open Appendectomy|open appendectomy
5007821|NCT03947372|Laparoscopic Appendectomy|laparoscopic appendectomy
5007822|NCT03947372|post-operative pain|post-operative pain
5007823|NCT03947372|Hospital stay|hospital stay
5007824|NCT03947346|Kidney Function|kidney function
5007825|NCT03947346|Biomarkers|biomarkers
5007826|NCT03947346|19-160|19-160
5007831|NCT03947307|total knee replacement|total knee replacement
5007832|NCT03947307|Kinesiotape treatment|kinesiotape treatment
5007833|NCT03947307|manual lymphatic drainage|manual lymphatic drainage
5007834|NCT03947307|compressive bandages|compressive bandages
5007835|NCT03947307|Kinesiotaping|kinesiotaping
5007836|NCT03947294|Indirect calorimetry|indirect calorimetry
5007837|NCT03947294|Energy expenditure|energy expenditure
5007839|NCT03947294|VCO2|vco2
5007840|NCT03947281|satiety|satiety
5007841|NCT03947281|gastrointestinal hormones|gastrointestinal hormones
5007842|NCT03947281|appetite|appetite
5007843|NCT03947281|Dietary fiber|dietary fiber
5007844|NCT03947281|food cravings|food cravings
5007845|NCT03947268|palliative care|palliative care
5007846|NCT03947268|pelvic cancer|pelvic cancer
5007847|NCT03947268|radiotherapy|radiotherapy
5007848|NCT03947268|pain|pain
5007849|NCT03947268|Quality of life|quality of life
5445433|NCT01521819|Vascularized Pigment Epithelial Detachment|vascularized pigment epithelial detachment
5445434|NCT01521819|Iray|iray
5445435|NCT01521819|radiation|radiation
5007855|NCT03947229|Patients who underwent percutaneous coronary intervention with DES implantation carrying high risks for the recurrent major adverse events.|patients who underwent percutaneous coronary intervention with des implantation carrying high risks for the recurrent major adverse events.
5007856|NCT03947229|anti platelet therapy|anti platelet therapy
5007857|NCT03947229|bleeding|bleeding
5007858|NCT03947216|impulse control disorders|impulse control disorders
5007859|NCT03947216|pimavanserin|pimavanserin
5007860|NCT03947216|Serotoninergic 5-HT2A inverse agonist|serotoninergic 5-ht2a inverse agonist
5007861|NCT03947216|Dopamine agonist|dopamine agonist
5007862|NCT03947216|Behavior|behavior
5007863|NCT03947151|Fertility preservation|fertility preservation
5007864|NCT03947151|Controlled ovarian stimulation|controlled ovarian stimulation
5007865|NCT03947151|Oocyte vitrification|oocyte vitrification
5007866|NCT03947151|GnRH antagonist protocol|gnrh antagonist protocol
5007868|NCT03947099|ketamine|ketamine
5007869|NCT03947099|ptsd|ptsd
5007870|NCT03947099|depression|depression
5007871|NCT03947099|prehospital|prehospital
5007872|NCT03947086|Autistic disorder|autistic disorder
5007873|NCT03947086|Neuromodulation|neuromodulation
5007874|NCT03947086|Social cognition|social cognition
5007875|NCT03947086|Executive functions|executive functions
5007876|NCT03947086|Eye tracking|eye tracking
5007877|NCT03947073|Media|media
5007878|NCT03947073|Education|education
5007879|NCT03947073|Gestational diabetes|gestational diabetes
5007880|NCT03947073|Pregnancy|pregnancy
5007881|NCT03947060|Depth of anesthesia|depth of anesthesia
5007882|NCT03947060|SedLine® sensor|sedline® sensor
5007883|NCT03947060|Alternative position|alternative position
5007884|NCT03947047|Exhaled Women Breath|exhaled women breath
5007885|NCT03947047|Placenta Accreta|placenta accreta
5007886|NCT03947047|Ultrasound|ultrasound
5007887|NCT03947021|Electrocardiography|electrocardiography
5007888|NCT03947021|Body Surface Potential Mapping|body surface potential mapping
5007889|NCT03947021|Computational Biology|computational biology
5007890|NCT03947008|intuitive eating|intuitive eating
5007891|NCT03947008|dietary restraint|dietary restraint
5007892|NCT03946995|Trigger Area|trigger area
5007893|NCT03946995|Myofascial Pain Syndromes|myofascial pain syndromes
5007894|NCT03946995|Instrument assisted soft tissue tecnique|instrument assisted soft tissue tecnique
5007895|NCT03946982|Patient controlled epidural analgesia ,Cesarean delivery,pain management,epidural opioid|patient controlled epidural analgesia ,cesarean delivery,pain management,epidural opioid
5007896|NCT03946969|Neoadjuvant|neoadjuvant
5007897|NCT03946969|Esophageal Cancer|esophageal cancer
5007898|NCT03946969|PD-1|pd-1
5007899|NCT03946956|Screening|screening
5007900|NCT03946956|Prevention|prevention
5007901|NCT03946956|Cardiovascular|cardiovascular
5007902|NCT03946956|Public health|public health
5007903|NCT03946943|TKI|tki
5007904|NCT03946943|PD-1 inhibitor|pd-1 inhibitor
5007910|NCT03946852|abdominal regional perfusion|abdominal regional perfusion
5007911|NCT03946852|Donation after Cardiac Death|donation after cardiac death
5007912|NCT03946852|Liver Transplantation|liver transplantation
5007913|NCT03946852|Ischemia Reperfusion Injury|ischemia reperfusion injury
5007914|NCT03946826|nail psoriasis|nail psoriasis
5007915|NCT03946826|Pulsed dye laser (PDL)|pulsed dye laser (pdl)
5007916|NCT03946826|Halometasone Cream|halometasone cream
5007917|NCT03946826|Vaseline|vaseline
5007918|NCT03946813|Ovarian Rejuvenation , Infertility|ovarian rejuvenation , infertility
5007919|NCT03946800|MEDI1191|medi1191
5007920|NCT03946800|Durvalumab|durvalumab
5007921|NCT03946800|MEDI4736|medi4736
5007922|NCT03946800|Imfinzi|imfinzi
5007923|NCT03946774|Atherosclerosis|atherosclerosis
5007924|NCT03946774|Macrophage/monocyte|macrophage/monocyte
5007930|NCT03946735|Perfectionism|perfectionism
5007931|NCT03946735|Rumination|rumination
5007932|NCT03946735|Cognitive Behavioural Therapy|cognitive behavioural therapy
5007933|NCT03946722|In vitro fertilisation|in vitro fertilisation
5007934|NCT03946722|Assisted conception|assisted conception
5007935|NCT03946722|Randomised controlled trial|randomised controlled trial
5007936|NCT03946722|Down-regulation|down-regulation
5007937|NCT03946696|dementia|dementia
5007938|NCT03946696|Animal-Assisted Therapy|animal-assisted therapy
5007939|NCT03946696|ethnography|ethnography
5007940|NCT03946696|qualitative study|qualitative study
5007941|NCT03946670|Phase II,|phase ii,
5007942|NCT03946670|MBG453|mbg453
5007943|NCT03946670|TIM-3|tim-3
5007944|NCT03946670|decitabine|decitabine
5007945|NCT03946670|azacitidine|azacitidine
5007946|NCT03946670|myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5007947|NCT03946657|Bariatric|bariatric
5007948|NCT03946657|Surgery|surgery
5007949|NCT03946657|Sevoflurane|sevoflurane
5007950|NCT03946657|Propofol|propofol
5007951|NCT03946657|Oximetry|oximetry
5007952|NCT03946644|Safety distance|safety distance
5007953|NCT03946644|Laser ablation|laser ablation
5007954|NCT03946644|Great saphenous vein|great saphenous vein
5007955|NCT03946579|sexual health|sexual health
5007956|NCT03946579|quality of life|quality of life
5007957|NCT03946579|adjuvant chemotherapy|adjuvant chemotherapy
5007958|NCT03946553|intestinal microbiota|intestinal microbiota
5007959|NCT03946553|immunological markers|immunological markers
5007960|NCT03946527|advanced paraganglioma|advanced paraganglioma
5007961|NCT03946527|advanced pheochromocytoma|advanced pheochromocytoma
5007962|NCT03946527|metastatic paraganglioma|metastatic paraganglioma
5007963|NCT03946527|metastatic pheochromocytoma|metastatic pheochromocytoma
5007964|NCT03946527|lanreotide|lanreotide
5007965|NCT03946514|Blood pressure|blood pressure
5007966|NCT03946514|single-pill fixed combination|single-pill fixed combination
5007967|NCT03946514|losartan/hydrochlorothiazide|losartan/hydrochlorothiazide
5007968|NCT03946514|amlodipine/hydrochlorothiazide|amlodipine/hydrochlorothiazide
5007969|NCT03946501|missing data|missing data
5007970|NCT03946501|clinical research|clinical research
5007971|NCT03946501|clinical research assistant|clinical research assistant
5007972|NCT03946488|Hand function restoration|hand function restoration
5007973|NCT03946488|Prehension|prehension
5007974|NCT03946488|Closed-loop controlled neuroprosthesis|closed-loop controlled neuroprosthesis
5007976|NCT03946475|Linear programming|linear programming
5007977|NCT03946475|Optimized food based recommendations|optimized food based recommendations
5007978|NCT03946475|Nutrition knowledge|nutrition knowledge
5007979|NCT03946475|Dietary intake|dietary intake
5007980|NCT03946475|Dietary practices|dietary practices
5007981|NCT03946475|Adolescent girls|adolescent girls
5007982|NCT03946475|Nutrition education|nutrition education
5007983|NCT03946475|Indonesia|indonesia
5007984|NCT03946462|Congenital Heart Disease|congenital heart disease
5007985|NCT03946462|CHD|chd
5007986|NCT03946462|Acute Kidney Injury|acute kidney injury
5007990|NCT03946462|cardiac surgery|cardiac surgery
5007991|NCT03946462|neonate|neonate
5007992|NCT03946462|infant|infant
5007993|NCT03946462|nitric oxide|nitric oxide
5007994|NCT03946462|NO|no
5007995|NCT03946462|gestational age|gestational age
5007996|NCT03946436|stroke technique|stroke technique
5007997|NCT03946436|psychophysiological body responses|psychophysiological body responses
5007998|NCT03946436|visual perceptual skills|visual perceptual skills
5007999|NCT03946436|reaction time.|reaction time.
5008000|NCT03946410|screening|screening
5008001|NCT03946410|prevention|prevention
5008002|NCT03946410|cardiovascular|cardiovascular
5008003|NCT03946410|public health|public health
5008004|NCT03946410|cost effectiveness|cost effectiveness
5008005|NCT03946371|Sub glottic secretions|sub glottic secretions
5008006|NCT03946371|Failure Extubation|failure extubation
5008007|NCT03946371|endotracheal tube|endotracheal tube
5008009|NCT03946358|Atezolizumab|atezolizumab
5008010|NCT03946358|Cancer vaccine|cancer vaccine
5008011|NCT03946358|Cancer immunotherapy|cancer immunotherapy
5008012|NCT03946358|Telomerase|telomerase
5008013|NCT03946345|Iohexol|iohexol
5008014|NCT03946345|Glomerular Filtration Rate|glomerular filtration rate
5008015|NCT03946332|physical activity|physical activity
5008016|NCT03946332|multiple myeloma|multiple myeloma
5008017|NCT03946332|autologous stem cell transplantation|autologous stem cell transplantation
5008018|NCT03946332|quality of life|quality of life
5008019|NCT03946332|physical conditioning|physical conditioning
5008020|NCT03946319|Internet Interventions|internet interventions
5008021|NCT03946319|eMental Health|emental health
5008022|NCT03946319|mHealth|mhealth
5008023|NCT03946319|Transdiagnostic|transdiagnostic
5008032|NCT03946267|Large macular hole|large macular hole
5008033|NCT03946267|Inverted flap surgery|inverted flap surgery
5008034|NCT03946267|Infracyanine green|infracyanine green
5008035|NCT03946267|Brilliant blue G|brilliant blue g
5008036|NCT03946267|Swept source OCT|swept source oct
5008037|NCT03946241|School children|school children
5008038|NCT03946241|Physical Activity|physical activity
5008039|NCT03946241|Accelerometry|accelerometry
5008040|NCT03946241|Body mass index|body mass index
5008041|NCT03946241|Implementation|implementation
5008042|NCT03946241|Policy|policy
5008043|NCT03946228|blood pressure|blood pressure
5008044|NCT03946228|sedentary behavior|sedentary behavior
5008045|NCT03946228|physical activity|physical activity
5008046|NCT03946176|uremic toxins|uremic toxins
5008047|NCT03946176|gut microbiota dysbiosis|gut microbiota dysbiosis
5008048|NCT03946176|symbiotic|symbiotic
5008049|NCT03946176|divinylbenzene cartridge|divinylbenzene cartridge
5008050|NCT03946163|chronic prostatitis|chronic prostatitis
5008051|NCT03946163|chronic pelvic pain syndrome|chronic pelvic pain syndrome
5008052|NCT03946163|cinnamon|cinnamon
5008053|NCT03946163|herbal medicine|herbal medicine
5008054|NCT03946163|Traditional medicine|traditional medicine
5008055|NCT03946150|P/FP Ratio|p/fp ratio
5008056|NCT03946150|ARDS Definition|ards definition
5008057|NCT03946150|Severity of Oxygenation in ARDS|severity of oxygenation in ards
5008058|NCT03946137|Neurological chronic disorder|neurological chronic disorder
5008059|NCT03946137|Child|child
5008060|NCT03946137|Chest therapy|chest therapy
5008061|NCT03946137|Educational intervention|educational intervention
5008062|NCT03946137|Postural hygiene|postural hygiene
5008063|NCT03946098|Internet intervention|internet intervention
5008064|NCT03946098|Gambling Disorder|gambling disorder
5008065|NCT03946098|Cognitive-behavioral therapy|cognitive-behavioral therapy
5008066|NCT03946098|Psychiatric comorbidity|psychiatric comorbidity
5008067|NCT03946098|Regular addiction care|regular addiction care
5008068|NCT03946098|Problem gambling|problem gambling
5008069|NCT03946085|Lumega-Z|lumega-z
5008070|NCT03946085|Carotenoid supplement|carotenoid supplement
5008071|NCT03946046|Cervical dystonia|cervical dystonia
5008072|NCT03946046|Botulinum toxin|botulinum toxin
5008073|NCT03946046|Ultrasound-guided injection|ultrasound-guided injection
5008075|NCT03946046|TWSTRS-2|twstrs-2
5008076|NCT03946033|Immunoscore Adjuvant Prospective Colon|immunoscore adjuvant prospective colon
5008077|NCT03946020|implants; GBR; DBBM; grafts; bone|implants; gbr; dbbm; grafts; bone
5008078|NCT03945994|Improve Social Capital|improve social capital
5008079|NCT03945994|Improve mental health|improve mental health
5055263|NCT03653117|BPO|bpo
5008081|NCT03945968|anesthesia|anesthesia
5008082|NCT03945968|concomitant diseases|concomitant diseases
5008083|NCT03945968|risk stratification|risk stratification
5008084|NCT03945955|Melatonin, Sleep quality, DNA Damage, Lipid peroxidation, Nightshift worker|melatonin, sleep quality, dna damage, lipid peroxidation, nightshift worker
5008085|NCT03945890|quality improvement|quality improvement
5008086|NCT03945890|team resource management|team resource management
5008087|NCT03945890|bowel preparation|bowel preparation
5008088|NCT03945890|health screening colonoscopy|health screening colonoscopy
5008089|NCT03945851|vagal nerve stimulator|vagal nerve stimulator
5008090|NCT03945851|MRI|mri
5008091|NCT03945851|functional MRI|functional mri
5008092|NCT03945838|Lymphedema|lymphedema
5008093|NCT03945838|Hand grip strength|hand grip strength
5008094|NCT03945838|Breast cancer related lymphedema|breast cancer related lymphedema
5008095|NCT03945838|Complete decongestion therapy|complete decongestion therapy
5008096|NCT03945825|Immunogenicity|immunogenicity
5008097|NCT03945825|Influenza|influenza
5008098|NCT03945825|Influenza Vaccine|influenza vaccine
5008099|NCT03945825|Phase 1|phase 1
5008100|NCT03945825|Quadrivalent|quadrivalent
5008101|NCT03945825|Safety|safety
5008102|NCT03945812|GCSF|gcsf
5008103|NCT03945812|PRP|prp
5008104|NCT03945812|Pregnancy|pregnancy
5008105|NCT03945786|Hybrid PET/MRI|hybrid pet/mri
5008106|NCT03945747|Automated insulin delivery systems|automated insulin delivery systems
5008107|NCT03945747|Insulin sensitivity|insulin sensitivity
5023516|NCT03850509|intestine|intestine
5008115|NCT03945695|Vitreomacular Adhesion|vitreomacular adhesion
5010677|NCT03929991|Africa|africa
5008116|NCT03945695|Pneumatic Vitreolysis|pneumatic vitreolysis
5008118|NCT03945682|surgical resection|surgical resection
5008119|NCT03945669|External ring fixation|external ring fixation
5008120|NCT03945669|Intramedullary nailing|intramedullary nailing
5008121|NCT03945669|Tibial shaft fracture|tibial shaft fracture
5008122|NCT03945669|patient reported outcome|patient reported outcome
5008123|NCT03945630|Quadratus Lumborum Block|quadratus lumborum block
5008124|NCT03945617|anxiety|anxiety
5008125|NCT03945617|cognitive behavior therapy|cognitive behavior therapy
5008126|NCT03945617|transdiagnostic treatment|transdiagnostic treatment
5008127|NCT03945617|prediction|prediction
5008128|NCT03945591|Cyclophosphamide|cyclophosphamide
5008129|NCT03945591|Bortezomib|bortezomib
5008130|NCT03945552|Parenting Practices|parenting practices
5008131|NCT03945552|Parent-Child Relationships|parent-child relationships
5008132|NCT03945552|Child Development|child development
5008133|NCT03945526|Astaxanthin|astaxanthin
5008134|NCT03945526|Antioxidant|antioxidant
5008135|NCT03945526|Plasma Malondialdehyde|plasma malondialdehyde
5008136|NCT03945526|NIHSS score|nihss score
5008137|NCT03945526|Ischemic Stroke|ischemic stroke
5008138|NCT03945513|contraception|contraception
5008139|NCT03945513|hormonal oral contraceptive agents|hormonal oral contraceptive agents
5008140|NCT03945513|hormonal oral contraceptive|hormonal oral contraceptive
5008145|NCT03945487|liver function|liver function
5008146|NCT03945435|Exercise|exercise
5008147|NCT03945435|Cardiorespiratory Fitness|cardiorespiratory fitness
5008148|NCT03945435|Skeletal Muscle|skeletal muscle
5008149|NCT03945435|Angiogenesis|angiogenesis
5008150|NCT03945409|ARDS|ards
5008151|NCT03945409|Respiratory Mechanics|respiratory mechanics
5008152|NCT03945409|Transpulmonary pressure|transpulmonary pressure
5008153|NCT03945409|Pleural pressure|pleural pressure
5008154|NCT03945396|Obesity|obesity
5008155|NCT03945396|Overweight|overweight
5008156|NCT03945396|Homeopathy|homeopathy
5008157|NCT03945396|Calcarea carbonica ostrearum|calcarea carbonica ostrearum
5008158|NCT03945396|Mexico|mexico
5008159|NCT03945357|Infection|infection
5008160|NCT03945357|hernia repair|hernia repair
5008161|NCT03945305|Essential Hypertension, Remote Ischemic Conditioning|essential hypertension, remote ischemic conditioning
5008162|NCT03945266|gestational weight gain|gestational weight gain
5008163|NCT03945266|pregnancy weight regulation|pregnancy weight regulation
5008164|NCT03945266|individually tailored intervention|individually tailored intervention
5008165|NCT03945253|Pharmacokinetics|pharmacokinetics
5008166|NCT03945253|Tumors|tumors
5008167|NCT03945253|Oncology|oncology
5313218|NCT02115230|Renal Denervation|renal denervation
5008168|NCT03945253|Safety and tolerability|safety and tolerability
5008169|NCT03945253|Locally advanced or metastatic solid tumor|locally advanced or metastatic solid tumor
5008170|NCT03945253|ASP8374|asp8374
5008171|NCT03945227|Non small cell lung cancer|non small cell lung cancer
5008172|NCT03945227|Unresectable stage III NSCLC|unresectable stage iii nsclc
5008173|NCT03945214|Stress|stress
5008174|NCT03945214|Health|health
5008175|NCT03945214|Meditation|meditation
5008176|NCT03945214|Eating|eating
5008177|NCT03945214|Mindfulness|mindfulness
5008178|NCT03945214|Employees|employees
5008179|NCT03945214|Job strain|job strain
5008182|NCT03945214|Mood|mood
5008183|NCT03945214|Affect|affect
5008184|NCT03945214|Work related stress|work related stress
5008185|NCT03945214|Blood pressure|blood pressure
5008186|NCT03945214|Inflammation|inflammation
5008187|NCT03945201|cardiac rehabilitation|cardiac rehabilitation
5008188|NCT03945201|virtual reality|virtual reality
5008190|NCT03945201|treadmill|treadmill
5008191|NCT03945201|education retention|education retention
5008192|NCT03945201|patient education|patient education
5008193|NCT03945188|Ulcerative Colitis|ulcerative colitis
5008194|NCT03945188|Etrasimod|etrasimod
5008195|NCT03945188|APD334|apd334
5008196|NCT03945162|Photodynamic Therapy|photodynamic therapy
5008197|NCT03945162|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5008198|NCT03945162|Urothelial carcinoma|urothelial carcinoma
5008199|NCT03945162|Ta bladder cancer|ta bladder cancer
5008200|NCT03945162|T1 bladder cancer|t1 bladder cancer
5008201|NCT03945162|Refractory to BCG|refractory to bcg
5008202|NCT03945136|veterans|veterans
5008203|NCT03945136|depression|depression
5008204|NCT03945136|anxiety|anxiety
5008205|NCT03945136|psychodynamic|psychodynamic
5008206|NCT03945136|psychotherapy|psychotherapy
5008207|NCT03945136|treatment|treatment
5008211|NCT03945032|Parent of a childhood cancer survivor|parent of a childhood cancer survivor
5008213|NCT03945032|TICOP mobile App|ticop mobile app
5008214|NCT03945006|Multiple Sclerosis|multiple sclerosis
5008215|NCT03945006|Balance|balance
5008216|NCT03945006|Trunk impairment|trunk impairment
5008217|NCT03945006|Fear of falling|fear of falling
5008218|NCT03945006|Incontinence|incontinence
5008219|NCT03944993|PEMF|pemf
5008220|NCT03944993|Prefrontal cortex|prefrontal cortex
5008221|NCT03944993|Exercise mimetic|exercise mimetic
5008222|NCT03944993|Pulsed Electromagnetic Fields|pulsed electromagnetic fields
5008223|NCT03944980|Effect|effect
5008224|NCT03944980|Safety|safety
5008225|NCT03944928|Lung ultrasound|lung ultrasound
5008226|NCT03944928|B lines|b lines
5008296|NCT03944655|Post operative dysphagia|post operative dysphagia
5008297|NCT03944655|Post operative dysphonia|post operative dysphonia
5008299|NCT03944642|Pilot Study|pilot study
5008300|NCT03944642|Breastfeeding Support|breastfeeding support
5008301|NCT03944616|Diet beverages|diet beverages
5008302|NCT03944616|diet|diet
5008303|NCT03944616|diabetes control|diabetes control
5008304|NCT03944616|artificial sweeteners|artificial sweeteners
5008305|NCT03944616|continuous glucose monitor|continuous glucose monitor
5008306|NCT03944616|gut microbiome|gut microbiome
5008307|NCT03944616|metabolomics|metabolomics
5049975|NCT03685591|HR+|hr+
5008308|NCT03944603|Alzheimer's Disease|alzheimer's disease
5008309|NCT03944603|Dementia|dementia
5008310|NCT03944603|Older Adult|older adult
5008311|NCT03944590|screw osteosynthesis|screw osteosynthesis
5008312|NCT03944590|rupture of the interosseous membrane|rupture of the interosseous membrane
5008313|NCT03944590|collateral ligaments|collateral ligaments
5008314|NCT03944577|coronary allograft vasculopathy|coronary allograft vasculopathy
5008315|NCT03944577|lipid|lipid
5008316|NCT03944577|heart transplant|heart transplant
5008317|NCT03944564|cognition|cognition
5008318|NCT03944564|brain activity|brain activity
5008319|NCT03944564|cognitive reserve|cognitive reserve
5008320|NCT03944564|work productivity|work productivity
5008321|NCT03944564|musculoskeletal discomfort|musculoskeletal discomfort
5008322|NCT03944564|attention|attention
5008323|NCT03944538|Exercise|exercise
5008324|NCT03944538|Fitness|fitness
5008325|NCT03944538|Co-morbidity|co-morbidity
5008328|NCT03944486|Cerebrovascular Accident|cerebrovascular accident
5008329|NCT03944473|high risk|high risk
5008330|NCT03944473|chronic health condition|chronic health condition
5008331|NCT03944473|laparoscopic surgery|laparoscopic surgery
5008332|NCT03944460|anti-prionic|anti-prionic
5008333|NCT03944460|anti-Abeta-pionic|anti-abeta-pionic
5008334|NCT03944460|treatment of cognition and memory deficits|treatment of cognition and memory deficits
5008335|NCT03944460|AD patients|ad patients
5008336|NCT03944460|AD stage-independent|ad stage-independent
5008337|NCT03944460|NOT anti-amyloid|not anti-amyloid
5008338|NCT03944460|neuron specific Ca-ion reduction|neuron specific ca-ion reduction
5008339|NCT03944434|ribociclib|ribociclib
5008340|NCT03944434|hormone receptor positive|hormone receptor positive
5008341|NCT03944421|Genotoxicity|genotoxicity
5008342|NCT03944421|DNA damage|dna damage
5008343|NCT03944421|Gut Microbiota|gut microbiota
5008344|NCT03944421|Metabolites|metabolites
5445436|NCT01521819|retina|retina
5008345|NCT03944395|Active HIV Case finding|active hiv case finding
5008346|NCT03944395|Partner Notification Services|partner notification services
5008347|NCT03944369|Microbiome|microbiome
5008348|NCT03944369|Antibiotic resistance|antibiotic resistance
5008349|NCT03944369|Carbapenem-Resistant Enterobacteriaceae (CRE)|carbapenem-resistant enterobacteriaceae (cre)
5008350|NCT03944369|Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae (ESBLE)|extended-spectrum beta lactamase-producing enterobacteriaceae (esble)
5008351|NCT03944369|Vancomycin-resistant Enterococcus (VRE)|vancomycin-resistant enterococcus (vre)
5008352|NCT03944369|Multi Drug Resistant Organism (MDRO)|multi drug resistant organism (mdro)
5008353|NCT03944369|Drug resistant|drug resistant
5008354|NCT03944369|Kaleido|kaleido
5008366|NCT03944304|open-label|open-label
5008368|NCT03944226|Beetroot juice|beetroot juice
5008369|NCT03944226|Magnetic Resonance Imaging|magnetic resonance imaging
5008370|NCT03944226|Breast cancer|breast cancer
5008371|NCT03944213|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5008372|NCT03944213|Theta Burst Stimulation|theta burst stimulation
5008373|NCT03944213|rTMS|rtms
5008375|NCT03944213|resting-state fMRI|resting-state fmri
5008376|NCT03944161|nutritional supplement|nutritional supplement
5008377|NCT03944161|cost-effectiveness|cost-effectiveness
5008378|NCT03944161|cost-utility|cost-utility
5008379|NCT03944148|Upper Gastrointestinal Bleeding|upper gastrointestinal bleeding
5008380|NCT03944135|Cognition, Cognitive Dissonance, Geriatrics, Technology|cognition, cognitive dissonance, geriatrics, technology
5008381|NCT03944122|lateral epicondylitis, therapeutical ultrasound|lateral epicondylitis, therapeutical ultrasound
5008382|NCT03944096|fecal microbiota transplantation|fecal microbiota transplantation
5008383|NCT03944096|methotrexate|methotrexate
5008384|NCT03944096|rheumatoid arthritis|rheumatoid arthritis
5008385|NCT03944044|Paracetamol|paracetamol
5008386|NCT03944044|Acetaminophen|acetaminophen
5008387|NCT03944044|Palliative care|palliative care
5008388|NCT03944044|Subcutaneous administration|subcutaneous administration
5008389|NCT03944044|intravenous administration|intravenous administration
5008390|NCT03944044|pharmacokinetic|pharmacokinetic
5008391|NCT03944018|Back pain|back pain
5008392|NCT03944005|knee arthroplasty|knee arthroplasty
5008393|NCT03944005|discharge readiness|discharge readiness
5008394|NCT03944005|analgesia|analgesia
5008395|NCT03944005|adductor canal block|adductor canal block
5008396|NCT03944005|ipack|ipack
5008398|NCT03943927|Metoprolol|metoprolol
5008399|NCT03943927|Genotype|genotype
5008400|NCT03943927|Phenotype|phenotype
5008401|NCT03943927|CYP2D6|cyp2d6
5008402|NCT03943914|Chest trauma|chest trauma
5008403|NCT03943914|Respiratory failure|respiratory failure
5008404|NCT03943914|Noninvasive ventilation|noninvasive ventilation
5008405|NCT03943914|High-flow nasal oxygen therapy|high-flow nasal oxygen therapy
5008406|NCT03943901|chemotherapy|chemotherapy
5008407|NCT03943901|cancer|cancer
5008408|NCT03943901|elderly|elderly
5008409|NCT03943901|lymphoma|lymphoma
5008410|NCT03943888|sugammadex|sugammadex
5008411|NCT03943888|pharmacokinetics|pharmacokinetics
5008412|NCT03943888|pharmacodynamics|pharmacodynamics
5008413|NCT03943888|pediatric anesthesia|pediatric anesthesia
5008414|NCT03943875|HPV vaccination|hpv vaccination
5008415|NCT03943875|Gardasil 9|gardasil 9
5008416|NCT03943875|vaccine efficacy|vaccine efficacy
5008417|NCT03943862|Stigma|stigma
5008418|NCT03943862|Suicide attempt survivor|suicide attempt survivor
5008419|NCT03943862|Secrecy|secrecy
5008420|NCT03943862|Group intervention|group intervention
5008421|NCT03943862|Disclosure|disclosure
5008422|NCT03943849|Bone graft|bone graft
5008423|NCT03943849|Tooth extraction|tooth extraction
5008424|NCT03943849|Dental pulp|dental pulp
5008425|NCT03943836|Dental Anxiety|dental anxiety
5008426|NCT03943836|Pediatric dentistry|pediatric dentistry
5008427|NCT03943823|Pessary|pessary
5008428|NCT03943823|Vaginal pH|vaginal ph
5008429|NCT03943797|Oral mucosal epithelial cells|oral mucosal epithelial cells
5008430|NCT03943797|Cornea|cornea
5008431|NCT03943797|Amniotic membrane|amniotic membrane
5008432|NCT03943797|Collagenase|collagenase
5008433|NCT03943771|Kidney Neoplasms|kidney neoplasms
5008434|NCT03943771|Carcinoma, Renal Cell|carcinoma, renal cell
5008435|NCT03943771|Nephron-Sparing Surgery|nephron-sparing surgery
5008436|NCT03943771|3D Modeling|3d modeling
5008437|NCT03943771|3D Printing|3d printing
5008438|NCT03943771|Anxiety|anxiety
5008439|NCT03943771|Personalized Medicine|personalized medicine
5008440|NCT03943758|Bowel preparation|bowel preparation
5008442|NCT03943758|adenoma|adenoma
5008443|NCT03943745|EEG|eeg
5008444|NCT03943745|Propofol|propofol
5008445|NCT03943732|Pneumonia|pneumonia
5008446|NCT03943732|Molecular Testing|molecular testing
5008447|NCT03943732|Clinical impact|clinical impact
5008448|NCT03943732|FilmArray Pneumonia|filmarray pneumonia
5008449|NCT03943719|FilmArray|filmarray
5008451|NCT03943719|septicemia|septicemia
5008452|NCT03943719|clinical impact|clinical impact
5008453|NCT03943719|molecular testing|molecular testing
5008454|NCT03943719|identification|identification
5008455|NCT03943719|positive blood culture|positive blood culture
5008456|NCT03943719|optimal antimicrobial treatment|optimal antimicrobial treatment
5008457|NCT03943706|e-cigarettes|e-cigarettes
5008458|NCT03943706|JUUL brand e-cigarette|juul brand e-cigarette
5008459|NCT03943706|NJOY brand e-cigarette|njoy brand e-cigarette
5008460|NCT03943706|EVOLV brand mod e-cigarette|evolv brand mod e-cigarette
5008461|NCT03943706|Very Low Nicotine Cigarettes (VLNCs)|very low nicotine cigarettes (vlncs)
5008462|NCT03943693|Cardioversion|cardioversion
5008463|NCT03943680|Tooth extraction|tooth extraction
5008464|NCT03943680|Socket regeneration|socket regeneration
5008465|NCT03943680|Dental Implants|dental implants
5008466|NCT03943667|Metastatic Pancreas Ductal Adenocarcinoma|metastatic pancreas ductal adenocarcinoma
5008467|NCT03943654|Telemedicine|telemedicine
5008468|NCT03943654|Diarrhea|diarrhea
5008494|NCT03943472|multiple myeloma|multiple myeloma
5008495|NCT03943472|Relapsed /Refractory|relapsed /refractory
5008496|NCT03943459|coronary artery disease|coronary artery disease
5008497|NCT03943459|sirtuins|sirtuins
5008498|NCT03943459|Receptor for Advanced Glycation End Products|receptor for advanced glycation end products
5008499|NCT03943459|women|women
5008500|NCT03943459|quercetin|quercetin
5008501|NCT03943459|atorvastatin|atorvastatin
5008503|NCT03943433|Absorption atelectasis|absorption atelectasis
5008504|NCT03943433|Lung sono|lung sono
5008505|NCT03943433|Oxygen concentration|oxygen concentration
5008506|NCT03943420|Safety|safety
5008507|NCT03943420|Effectiveness|effectiveness
5008508|NCT03943420|Therapy|therapy
5008509|NCT03943420|Qianyang Yuyin Granules|qianyang yuyin granules
5008510|NCT03943420|Cognitive impairment|cognitive impairment
5008511|NCT03943420|Hypertension|hypertension
5008512|NCT03943407|Imiquimod|imiquimod
5008513|NCT03943407|Doxepin|doxepin
5008514|NCT03943407|Trans-cinnamaldehyde (CA)|trans-cinnamaldehyde (ca)
5008515|NCT03943407|L-menthol|l-menthol
5008516|NCT03943407|Histamine|histamine
5008517|NCT03943407|Cowhage|cowhage
5008518|NCT03943381|PCS|pcs
5008519|NCT03943316|Ovarian Cancer|ovarian cancer
5008521|NCT03943303|monazitc sands|monazitc sands
5008522|NCT03943303|radiation|radiation
5008523|NCT03943264|inflammation|inflammation
5008524|NCT03943264|Biomarker|biomarker
5008525|NCT03943264|TNF|tnf
5008526|NCT03943238|kidney transplant|kidney transplant
5008527|NCT03943238|Immunological Tolerance|immunological tolerance
5008528|NCT03943238|Tregs|tregs
5008529|NCT03943238|Stem cells|stem cells
5008530|NCT03943225|The do-not-resuscitate order, end of life, medical ethics|the do-not-resuscitate order, end of life, medical ethics
5008531|NCT03943212|Patient-Reported Outcomes|patient-reported outcomes
5008532|NCT03943212|Post-dialysis Fatigue|post-dialysis fatigue
5008533|NCT03943212|Dialysis Recovery Time|dialysis recovery time
5008534|NCT03943186|non-interventional study|non-interventional study
5008535|NCT03943186|Ectoin|ectoin
5008536|NCT03943186|Lozenges|lozenges
5008537|NCT03943186|Pharyngitis|pharyngitis
5008538|NCT03943134|Acute Trauma|acute trauma
5008539|NCT03943134|Upper Extremity Trauma|upper extremity trauma
5008540|NCT03943134|Acute Upper Extremity Trauma|acute upper extremity trauma
5008541|NCT03943134|Avive|avive
5008542|NCT03943134|Peripheral Nerve Injury|peripheral nerve injury
5008543|NCT03943134|Nerve Repair|nerve repair
5008544|NCT03943121|Endoscopic sinus surgery|endoscopic sinus surgery
5008545|NCT03943121|Eosinophilic sinusitis with nasal polyps|eosinophilic sinusitis with nasal polyps
5008546|NCT03943121|Steroid-eluting stent|steroid-eluting stent
5008547|NCT03943121|Randomized Trial|randomized trial
5008557|NCT03942952|anti-MOG|anti-mog
5008558|NCT03942952|Acute Disseminated Encephalolmyelitis|acute disseminated encephalolmyelitis
5008559|NCT03942926|plastic bronchitis|plastic bronchitis
5008560|NCT03942926|sirolimus|sirolimus
5008561|NCT03942900|locally advanced SCCA|locally advanced scca
5008562|NCT03942900|DCF|dcf
5008563|NCT03942900|radiotherapy|radiotherapy
5008564|NCT03942900|nivolumab|nivolumab
5008565|NCT03942900|biomarkers|biomarkers
5008566|NCT03942887|ANCA|anca
5008567|NCT03942887|Crescentic glomerulonephritis|crescentic glomerulonephritis
5008568|NCT03942887|systemic autoimmune disease|systemic autoimmune disease
5008569|NCT03942887|Renal failure|renal failure
5008570|NCT03942887|Renal insufficiency|renal insufficiency
5008571|NCT03942887|small vessel vasculitis|small vessel vasculitis
5008572|NCT03942887|GPA|gpa
5008573|NCT03942887|MPA|mpa
5008574|NCT03942874|reward|reward
5008575|NCT03942874|reward dysfunction|reward dysfunction
5008576|NCT03942874|group treatment|group treatment
5008577|NCT03942874|binge eating|binge eating
5008578|NCT03942861|Ultrasonography|ultrasonography
5008579|NCT03942861|Sonography|sonography
5008580|NCT03942861|Ulcerative Colitis|ulcerative colitis
5008581|NCT03942861|Inflammatory Bowel Disease|inflammatory bowel disease
5008582|NCT03942861|Severe Ulcerative colitis|severe ulcerative colitis
5008583|NCT03942861|Treatment response|treatment response
5008584|NCT03942861|Monitoring treatment|monitoring treatment
5008585|NCT03942848|Spinal cord lesion|spinal cord lesion
5008586|NCT03942848|intrathecal infusion|intrathecal infusion
5008587|NCT03942848|refractory neuropathic pain|refractory neuropathic pain
5008588|NCT03942848|ziconotide|ziconotide
5008589|NCT03942835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5008590|NCT03942835|attention|attention
5008591|NCT03942835|distraction|distraction
5008592|NCT03942835|psychometric test|psychometric test
5008593|NCT03942835|neuropsychological test validating procedure|neuropsychological test validating procedure
5008594|NCT03942835|psychostimulant|psychostimulant
5008595|NCT03942822|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5008596|NCT03942822|Milled chia seed suplementation|milled chia seed suplementation
5008597|NCT03942809|Airway Morbidity|airway morbidity
5008598|NCT03942783|work rehabilitation|work rehabilitation
5008599|NCT03942783|vocational rehabilitation|vocational rehabilitation
5008600|NCT03942783|occupational therapy|occupational therapy
5008601|NCT03942783|rehabilitation|rehabilitation
5008602|NCT03942783|presenteeism|presenteeism
5008603|NCT03942783|employment|employment
5008604|NCT03942757|preterm infant|preterm infant
5008605|NCT03942757|jaundice|jaundice
5008606|NCT03942757|bilirubin|bilirubin
5008607|NCT03942757|phototherapy|phototherapy
5008608|NCT03942757|educational program|educational program
5008609|NCT03942744|Hemodialysis|hemodialysis
5008610|NCT03942744|Endothelial dysfunction|endothelial dysfunction
5008611|NCT03942744|Atherogenesis|atherogenesis
5008612|NCT03942718|Exercise|exercise
5008613|NCT03942718|Aerobic training|aerobic training
5008614|NCT03942718|Anaerobic training|anaerobic training
5008615|NCT03942718|Internet-based exercise program|internet-based exercise program
5008616|NCT03942705|human papillomavirus (HPV)|human papillomavirus (hpv)
5008617|NCT03942705|cervical cancer|cervical cancer
5008618|NCT03942705|prevention|prevention
5008619|NCT03942705|Kenya|kenya
5008620|NCT03942627|mindfulness|mindfulness
5008621|NCT03942627|maternal depression|maternal depression
5008622|NCT03942614|Nordic Pole Walking|nordic pole walking
5008623|NCT03942614|Exercise|exercise
5008624|NCT03942614|Rehabilitation|rehabilitation
5008625|NCT03942575|Negative pressure wound therapy|negative pressure wound therapy
5008626|NCT03942562|DOMS|doms
5008627|NCT03942562|Healthy subjects|healthy subjects
5008628|NCT03942562|Pressure pain thresholds|pressure pain thresholds
5707849|NCT00472849|Fludarabine|fludarabine
5008629|NCT03942562|Active Knee Extension test|active knee extension test
5008630|NCT03942562|Maximal strength|maximal strength
5008631|NCT03942562|Electromyography|electromyography
5008632|NCT03942562|Plantar pressure measurement|plantar pressure measurement
5008654|NCT03942406|Bordetella infection|bordetella infection
5008655|NCT03942406|Gram-negative bacterial infection|gram-negative bacterial infection
5008656|NCT03942406|Respiratory tract infection|respiratory tract infection
5008657|NCT03942406|Whooping cough|whooping cough
5008658|NCT03942406|Infection|infection
5008659|NCT03942406|Respiratory tract disease|respiratory tract disease
5008663|NCT03942393|noise|noise
5008664|NCT03942393|sleep quality|sleep quality
5008665|NCT03942393|polysomnography|polysomnography
5008666|NCT03942393|cortical arousals|cortical arousals
5008667|NCT03942393|REM sleep|rem sleep
5008668|NCT03942393|Intensive Care Unit|intensive care unit
5008669|NCT03942367|Premature Ejaculation|premature ejaculation
5008670|NCT03942367|Sexual Medicine|sexual medicine
5008671|NCT03942367|Urology|urology
5008672|NCT03942367|Sexual Dysfunction|sexual dysfunction
5008673|NCT03942354|Quality of life, drug-resistant tuberculosis|quality of life, drug-resistant tuberculosis
5008674|NCT03942341|Down syndrome|down syndrome
5008675|NCT03942341|Alzheimer's disease|alzheimer's disease
5008676|NCT03942341|obstructive sleep apnea|obstructive sleep apnea
5008677|NCT03942341|Polysomnography|polysomnography
5008678|NCT03942289|Human|human
5008679|NCT03942289|Aging|aging
5008680|NCT03942289|Behavior|behavior
5008681|NCT03942289|Noradrenergic system|noradrenergic system
5008682|NCT03942289|Positron Emission Tomography|positron emission tomography
5008683|NCT03942289|Magnetic Resonance Imaging|magnetic resonance imaging
5008684|NCT03942276|Blood pressure|blood pressure
5008685|NCT03942276|Menopause|menopause
5008686|NCT03942276|Hypertension|hypertension
5008687|NCT03942276|Exercise|exercise
5008688|NCT03942276|Alternative training|alternative training
5008689|NCT03942263|Drug Therapy|drug therapy
5008690|NCT03942250|Epidermolysis Bullosa|epidermolysis bullosa
5008691|NCT03942250|Amniotic membrane|amniotic membrane
5008692|NCT03942237|transmuscular quadratus lumborum block|transmuscular quadratus lumborum block
5008693|NCT03942237|adrenalectomy|adrenalectomy
5008695|NCT03942198|Plaque psoriasis|plaque psoriasis
5008696|NCT03942198|Promoting blood circulation for removing blood stasis|promoting blood circulation for removing blood stasis
5008697|NCT03942198|Randomized controlled trial|randomized controlled trial
5008698|NCT03942198|Taodan Granules|taodan granules
5008699|NCT03942185|Psoriasis Vulgaris|psoriasis vulgaris
5008700|NCT03942185|Chinese Medicine|chinese medicine
5008701|NCT03942185|Real World Study|real world study
5008702|NCT03942185|Clearing heat and Cooling blood|clearing heat and cooling blood
5008703|NCT03942185|Promoting blood circulation and Removing blood stasis|promoting blood circulation and removing blood stasis
5008704|NCT03942159|Microbiome|microbiome
5008705|NCT03942159|stem cell transplantation|stem cell transplantation
5008706|NCT03942146|Randomised registry-based trial|randomised registry-based trial
5008707|NCT03942146|smoking cessation|smoking cessation
5008709|NCT03942146|complications|complications
5445437|NCT01521819|macula|macula
5008710|NCT03942133|adductor canal block|adductor canal block
5008711|NCT03942107|Dental posts|dental posts
5008712|NCT03942107|postoperative pain|postoperative pain
5008713|NCT03942107|single-visit root canal treatment|single-visit root canal treatment
5008714|NCT03942107|two-visit root canal treatment|two-visit root canal treatment
5008715|NCT03942107|vibration|vibration
5008717|NCT03942042|Generalized Pustular Psoriasis (GPP)|generalized pustular psoriasis (gpp)
5008718|NCT03942042|Erythrodermic Psoriasis (EP)|erythrodermic psoriasis (ep)
5008719|NCT03942042|Japan|japan
5008732|NCT03941951|Quasi-experimental study|quasi-experimental study
5008733|NCT03941951|Multidrug resistant bacteria|multidrug resistant bacteria
5008734|NCT03941951|Antimicrobial stewardship|antimicrobial stewardship
5008735|NCT03941951|Ceftaroline|ceftaroline
5008752|NCT03941795|the First Line Therapy|the first line therapy
5008754|NCT03941795|Mucosal Melanoma|mucosal melanoma
5008755|NCT03941795|Toripalimab|toripalimab
5008756|NCT03941795|JS001|js001
5008761|NCT03941691|VSD|vsd
5008762|NCT03941691|Ventriculai Septal Defects|ventriculai septal defects
5008763|NCT03941691|amplatzer|amplatzer
5008775|NCT03941639|breast cancer|breast cancer
5008776|NCT03941639|metastasis|metastasis
5008777|NCT03941639|prediction|prediction
5008778|NCT03941613|temporal lobe epilepsy; hippocampus sclerosis (HS); radiofrequency thermocoagulation (RF-TC); cognitive status|temporal lobe epilepsy; hippocampus sclerosis (hs); radiofrequency thermocoagulation (rf-tc); cognitive status
5008779|NCT03941600|occupational therapy|occupational therapy
5008780|NCT03941600|exercise|exercise
5008786|NCT03941522|ileostomy closure|ileostomy closure
5008787|NCT03941496|Tuberculosis|tuberculosis
5008788|NCT03941496|TB|tb
5008789|NCT03941496|Mycobacterium tuberculosis|mycobacterium tuberculosis
5008790|NCT03941496|Mtb|mtb
5008791|NCT03941496|anti-TB therapy|anti-tb therapy
5008792|NCT03941496|ATT|att
5008793|NCT03941496|rifampin (R), isoniazid (H) pyrazinamide (Z) ethambutol (E)|rifampin (r), isoniazid (h) pyrazinamide (z) ethambutol (e)
5008794|NCT03941496|RHZE|rhze
5008795|NCT03941496|rifampin (R), isoniazid (H)|rifampin (r), isoniazid (h)
5008796|NCT03941496|RH|rh
5008798|NCT03941431|Plaque Psoriasis|plaque psoriasis
5008800|NCT03941431|Moving cupping|moving cupping
5008801|NCT03941431|NB-UVB|nb-uvb
5008802|NCT03941431|combination of Chinese traditional and Western medicine|combination of chinese traditional and western medicine
5008803|NCT03941418|Saccharomyces boulardii|saccharomyces boulardii
5008804|NCT03941392|Nutrition|nutrition
5008805|NCT03941392|Pediatric age|pediatric age
5008806|NCT03941392|Physical activity|physical activity
5008807|NCT03941392|Dairy products|dairy products
5008808|NCT03941392|Dairy consumption|dairy consumption
5008809|NCT03941392|Sedentary habits|sedentary habits
5008810|NCT03941392|Diet quality|diet quality
5008811|NCT03941392|Children|children
5008812|NCT03941379|Choroidal Melanoma|choroidal melanoma
5008813|NCT03941379|Indeterminate Lesions of Eye|indeterminate lesions of eye
5008814|NCT03941249|Metabolomics|metabolomics
5008815|NCT03941249|Tau|tau
5008816|NCT03941249|Ischemic stroke|ischemic stroke
5008817|NCT03941249|Hemorrhagic stroke|hemorrhagic stroke
5008818|NCT03941223|breast cancer, regional anesthesia, cancer recurrence|breast cancer, regional anesthesia, cancer recurrence
5008819|NCT03941210|microRNA|microrna
5008820|NCT03941210|HIV|hiv
5008821|NCT03941210|Tuberculosis|tuberculosis
5008822|NCT03941210|IRIS|iris
5008823|NCT03941210|Biomarkers|biomarkers
5008827|NCT03941184|spontaneous coronary artery dissection|spontaneous coronary artery dissection
5008828|NCT03941184|autoimmune|autoimmune
5008829|NCT03941184|incidence|incidence
5008830|NCT03941171|Periacetabular Osteotomy|periacetabular osteotomy
5008831|NCT03941171|Progressive resistance training|progressive resistance training
5008832|NCT03941171|PAO|pao
5008833|NCT03941145|exercise|exercise
5008834|NCT03941132|T1D|t1d
5008835|NCT03941132|Ustekinumab|ustekinumab
5008836|NCT03941132|new-onset|new-onset
5008843|NCT03941119|Geriatric Nursing|geriatric nursing
5008844|NCT03941119|Health Services for the Aged|health services for the aged
5008845|NCT03941119|Hospitals, Community|hospitals, community
5008846|NCT03941119|Cognitive Dysfunction|cognitive dysfunction
5008847|NCT03941119|Dementia|dementia
5008848|NCT03941119|Delirium|delirium
5008849|NCT03941106|rTMS, depression, accelerated|rtms, depression, accelerated
5008852|NCT03941080|colorectal cancer|colorectal cancer
5008853|NCT03941080|gut microbiome|gut microbiome
5008854|NCT03941067|Neuromuscular response|neuromuscular response
5008855|NCT03941067|pre-competition massage|pre-competition massage
5008856|NCT03941067|pre-event massage|pre-event massage
5008857|NCT03941041|Yoga|yoga
5008858|NCT03941041|Caesarean Section|caesarean section
5008859|NCT03941041|Delivery Outcome|delivery outcome
5008860|NCT03941041|Labour Pain|labour pain
5008861|NCT03941015|Near infrared spectroscopy|near infrared spectroscopy
5008862|NCT03941015|S100B|s100b
5008863|NCT03941015|congenital heart disease|congenital heart disease
5008864|NCT03940976|afatinib|afatinib
5008865|NCT03940976|EGFR Overexpression|egfr overexpression
5008866|NCT03940976|EGFR Amplification|egfr amplification
5008867|NCT03940963|Peripheral Nerve Injuries|peripheral nerve injuries
5008868|NCT03940963|Peripheral Nervous System Disease|peripheral nervous system disease
5008869|NCT03940963|Foot Neuroma|foot neuroma
5008870|NCT03940963|Foot Pain|foot pain
5008871|NCT03940963|Nerve Foot Pain|nerve foot pain
5008872|NCT03940963|Nervous System Diseases|nervous system diseases
5008873|NCT03940963|Trauma - Nervous System|trauma - nervous system
5008874|NCT03940963|Wounds and Injuries|wounds and injuries
5008875|NCT03940963|Nerve Repair|nerve repair
5008876|NCT03940963|Surgical Treatment of Pain|surgical treatment of pain
5008877|NCT03940924|Interval Training|interval training
5008878|NCT03940924|Resistance Training|resistance training
5008879|NCT03940924|Overweight|overweight
5008880|NCT03940924|Postmenopausal women|postmenopausal women
5008881|NCT03940924|Body composition|body composition
5008882|NCT03940924|Gut microbiota|gut microbiota
5008883|NCT03940911|Axial spondylarthritis|axial spondylarthritis
5008884|NCT03940911|tired|tired
5008885|NCT03940911|Anti-TNF alpha|anti-tnf alpha
5008886|NCT03940911|exercises capacity|exercises capacity
5008887|NCT03940911|sacoprnia|sacoprnia
5707850|NCT00472849|Cytarabine|cytarabine
5428222|NCT01595620|Pain|pain
5008902|NCT03940859|prognosis|prognosis
5008903|NCT03940807|Infertility|infertility
5008904|NCT03940807|GnRH|gnrh
5008905|NCT03940794|Urinary incontinence|urinary incontinence
5008906|NCT03940794|Pelvic floor muscle contraction|pelvic floor muscle contraction
5008907|NCT03940794|Transabdominal ultrasound|transabdominal ultrasound
5024206|NCT03846713|thermosoftening|thermosoftening
5008914|NCT03940768|probiotic|probiotic
5008915|NCT03940768|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
5008917|NCT03940729|S aureus|s aureus
5008918|NCT03940729|colonization|colonization
5008919|NCT03940729|infection|infection
5008920|NCT03940729|chlorhexidine|chlorhexidine
5008925|NCT03940690|Retinal Telangiectasis|retinal telangiectasis
5008926|NCT03940690|Coats Disease|coats disease
5008927|NCT03940690|Anti-VEGF (Vascular Endothelial Growth Factor)|anti-vegf (vascular endothelial growth factor)
5008928|NCT03940677|Biomarkers|biomarkers
5008929|NCT03940677|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5008930|NCT03940677|Neuropsychology|neuropsychology
5008939|NCT03940625|echocardiography|echocardiography
5008941|NCT03940625|strain analysis|strain analysis
5008942|NCT03940612|candidiasis|candidiasis
5008943|NCT03940612|probiotic|probiotic
5008944|NCT03940612|STP4|stp4
5008945|NCT03940612|pregnant|pregnant
5008946|NCT03940560|suture|suture
5008947|NCT03940560|suture pull-through|suture pull-through
5008948|NCT03940560|suture sinus|suture sinus
5008949|NCT03940547|Aflatoxin ingestion|aflatoxin ingestion
5008950|NCT03940547|Growth|growth
5008951|NCT03940547|Stunting, nutritional|stunting, nutritional
5008952|NCT03940508|depression|depression
5008953|NCT03940508|treatment engagement|treatment engagement
5008954|NCT03940508|adolescents|adolescents
5008955|NCT03940508|Black youth|black youth
5008956|NCT03940508|Intervention|intervention
5008957|NCT03940482|TYPE 2 Diabetes Mellitus|type 2 diabetes mellitus
5008958|NCT03940482|Intermittent Fasting|intermittent fasting
5008959|NCT03940482|Time Restricted Eating as Treatment (TREAT)|time restricted eating as treatment (treat)
5008960|NCT03940469|Dexmedetomidine|dexmedetomidine
5008961|NCT03940469|Dexamethasone|dexamethasone
5008962|NCT03940469|Interscalene|interscalene
5008963|NCT03940456|Cohort|cohort
5008964|NCT03940456|Low Back Pain|low back pain
5008965|NCT03940456|Illness perception|illness perception
5008966|NCT03940456|Life Style|life style
5008967|NCT03940391|paradoxical reaction|paradoxical reaction
5008968|NCT03940391|midazolam|midazolam
5008981|NCT03940339|Hamstring muscles|hamstring muscles
5008982|NCT03940339|Pain measurement|pain measurement
5008983|NCT03940339|Low back pain|low back pain
5008984|NCT03940313|Chronic Low Back Pain|chronic low back pain
5008985|NCT03940313|Myofascial pain|myofascial pain
5008986|NCT03940313|Tensegrity|tensegrity
5008987|NCT03940313|Prolotherapy|prolotherapy
5008988|NCT03940313|Platelet-Rich Plasma|platelet-rich plasma
5008989|NCT03940300|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5008990|NCT03940300|food insecurity|food insecurity
5008991|NCT03940300|food prescriptions|food prescriptions
5008992|NCT03940300|minority|minority
5008993|NCT03940300|low-income|low-income
5008994|NCT03940287|Sacroiliac Joint pain|sacroiliac joint pain
5008995|NCT03940287|Low back pain|low back pain
5008996|NCT03940287|Pelvic girdle pain|pelvic girdle pain
5008997|NCT03940274|Cardiovascular health|cardiovascular health
5008998|NCT03940274|Walking training|walking training
5008999|NCT03940261|High intensity interval training|high intensity interval training
5009000|NCT03940248|Proton Therapy|proton therapy
5009001|NCT03940209|Low Income Population|low income population
5009002|NCT03940209|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5009003|NCT03940209|Pragmatic clinical trial|pragmatic clinical trial
5009012|NCT03940183|type 2 diabetes|type 2 diabetes
5009013|NCT03940183|monotherapy|monotherapy
5009014|NCT03940183|trelagliptin succinate|trelagliptin succinate
5009015|NCT03940131|re-challenge|re-challenge
5009016|NCT03940131|panitumumab|panitumumab
5009017|NCT03940118|respiratory secretion suctioning|respiratory secretion suctioning
5445438|NCT01521819|radiotherapy|radiotherapy
5009018|NCT03940118|mechanical insufflation exsufflation|mechanical insufflation exsufflation
5009019|NCT03940118|hypertonic saline|hypertonic saline
5009020|NCT03940118|hyaluronic acid|hyaluronic acid
5009021|NCT03940118|critically ill|critically ill
5009022|NCT03940118|artificial airway|artificial airway
5009023|NCT03940105|intuitive eating|intuitive eating
5009024|NCT03940105|package size|package size
5009025|NCT03940105|food variety|food variety
5009026|NCT03940066|Cardiac Monitor|cardiac monitor
5009027|NCT03940027|EUS-guided CPN|eus-guided cpn
5009028|NCT03939975|Hepatocellular carcinoma|hepatocellular carcinoma
5009029|NCT03939975|Immunotherapy|immunotherapy
5009030|NCT03939975|Nivolumab|nivolumab
5009031|NCT03939975|Pembrolizumab|pembrolizumab
5009033|NCT03939975|Microwave ablation|microwave ablation
5009034|NCT03939949|pain|pain
5009050|NCT03939819|suction calibration system|suction calibration system
5009051|NCT03939819|bariatric surgery|bariatric surgery
5009052|NCT03939793|Community Health Worker|community health worker
5009053|NCT03939793|Financial Incentives|financial incentives
5009054|NCT03939741|Chronic kidney disease|chronic kidney disease
5009055|NCT03939741|Stromal vascular fraction|stromal vascular fraction
5009056|NCT03939741|Adipose derived stem cell|adipose derived stem cell
5009067|NCT03939650|differential diagnosis|differential diagnosis
5009068|NCT03939650|hospital outpatient clinics|hospital outpatient clinics
5009069|NCT03939650|clinical applications software|clinical applications software
5009074|NCT03939624|Sodium-Glucose Cotransporter 2 Inhibitors|sodium-glucose cotransporter 2 inhibitors
5009075|NCT03939624|Type 2 Diabetes|type 2 diabetes
5009076|NCT03939624|Myocardial Infarction|myocardial infarction
5009077|NCT03939624|Ischemic Stroke|ischemic stroke
5009078|NCT03939624|Cardiovascular Death|cardiovascular death
5009079|NCT03939611|complementary therapies|complementary therapies
5009080|NCT03939611|infantile colic|infantile colic
5009081|NCT03939611|nurses|nurses
5009082|NCT03939611|reflexology|reflexology
5009083|NCT03939572|Psychological mindsets|psychological mindsets
5009084|NCT03939572|Physical activity|physical activity
5009085|NCT03939572|Wearable fitness trackers|wearable fitness trackers
5009086|NCT03939559|dual task|dual task
5009087|NCT03939559|balance|balance
5009088|NCT03939559|postural control|postural control
5009089|NCT03939559|rehabilitation|rehabilitation
5009090|NCT03939559|home-based exercise|home-based exercise
5009091|NCT03939520|Pneumology|pneumology
5009092|NCT03939520|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5009093|NCT03939520|progressive disease|progressive disease
5009094|NCT03939520|combined therapy|combined therapy
5009095|NCT03939520|pirfenidone|pirfenidone
5009096|NCT03939520|nintedanib|nintedanib
5009097|NCT03939507|epilepsy,|epilepsy,
5009098|NCT03939507|outcome|outcome
5009099|NCT03939507|antiepileptic drugs|antiepileptic drugs
5009100|NCT03939507|toxicity|toxicity
5009101|NCT03939468|Drug Coated Balloons|drug coated balloons
5009102|NCT03939468|Drug Eluting Stent|drug eluting stent
5009103|NCT03939468|Diffuse Disease|diffuse disease
5009104|NCT03939442|obesity, diabetes mellitus, bariatric surgery|obesity, diabetes mellitus, bariatric surgery
5009105|NCT03939429|beta-lactam antibiotic|beta-lactam antibiotic
5009106|NCT03939416|Fibromyalgia|fibromyalgia
5009107|NCT03939416|Chronic pain|chronic pain
5009108|NCT03939377|Palliative|palliative
5009109|NCT03939377|Osteopathy|osteopathy
5009110|NCT03939364|Erythroplakia, oral|erythroplakia, oral
5009111|NCT03939364|Erythro-leukoplakia, oral|erythro-leukoplakia, oral
5009114|NCT03939299|subintimal stenting|subintimal stenting
5009115|NCT03939299|vascular response and healing|vascular response and healing
5009116|NCT03939299|optical coherence tomography|optical coherence tomography
5009117|NCT03939273|Systemic Inflammation|systemic inflammation
5009118|NCT03939273|Microbiome|microbiome
5009119|NCT03939273|CABG|cabg
5009120|NCT03939273|Coronary Artery Bypass Graft|coronary artery bypass graft
5009121|NCT03939273|Innate Immunity|innate immunity
5009122|NCT03939273|Gut microbiota|gut microbiota
5009123|NCT03939247|elbow|elbow
5009124|NCT03939247|tendinopathy|tendinopathy
5009125|NCT03939247|physiotherapy|physiotherapy
5009126|NCT03939247|exercise|exercise
5009127|NCT03939247|electrotherapy|electrotherapy
5009128|NCT03939221|skin electric conductance|skin electric conductance
5009129|NCT03939221|survival period|survival period
5009130|NCT03939221|complementary and alternative medicine|complementary and alternative medicine
5009131|NCT03939208|children's mental health|children's mental health
5009132|NCT03939208|school mental health|school mental health
5009133|NCT03939208|evidence-based practice (EBP)|evidence-based practice (ebp)
5009134|NCT03939208|academic success|academic success
5009135|NCT03939182|Abexinostat|abexinostat
5009136|NCT03939182|Ibrutinib|ibrutinib
5009137|NCT03939182|19-080|19-080
5009138|NCT03939169|pain|pain
5009139|NCT03939169|naso-gastric tube|naso-gastric tube
5009140|NCT03939156|adjuvant endocrine therapy|adjuvant endocrine therapy
5009141|NCT03939156|patient's preferences|patient's preferences
5009142|NCT03939104|Artemether|artemether
5009143|NCT03939104|Lumefantrine|lumefantrine
5009144|NCT03939104|Amodiaquine|amodiaquine
5009145|NCT03939104|Piperaquine|piperaquine
5009146|NCT03939104|Artesunate|artesunate
5009147|NCT03939104|Mefloquine|mefloquine
5004262|NCT03969576|Hepatocellular Carcinoma|hepatocellular carcinoma
5428223|NCT01595594|Periodontal Diseases|periodontal diseases
5009183|NCT03938961|Metabolism, Energy,Glucose, Protein, Energy deficit|metabolism, energy,glucose, protein, energy deficit
5009185|NCT03938922|parkinson's disease-related dementia|parkinson's disease-related dementia
5009186|NCT03938883|Photorefractive Keratectomy, Corneal Defect|photorefractive keratectomy, corneal defect
5009188|NCT03938870|Alzheimer's|alzheimer's
5009189|NCT03938870|biomarker|biomarker
5009190|NCT03938870|dementia|dementia
5009191|NCT03938870|Tau|tau
5009192|NCT03938870|Tau Kinetics|tau kinetics
5009193|NCT03938870|Tauopathies|tauopathies
5009194|NCT03938844|hysterectomy|hysterectomy
5009195|NCT03938844|anti-incontinence surgery|anti-incontinence surgery
5009196|NCT03938844|Burch|burch
5009197|NCT03938844|Tot|tot
5009198|NCT03938844|stress incontinence|stress incontinence
5009199|NCT03938818|Gender-Based Violence|gender-based violence
5009200|NCT03938818|PrEP (Pre-exposure Prophylaxis)|prep (pre-exposure prophylaxis)
5009201|NCT03938818|AIDS Prevention|aids prevention
5009202|NCT03938818|HIV Prevention|hiv prevention
5009203|NCT03938792|Factor VIII|factor viii
5009204|NCT03938792|Factor IX|factor ix
5009205|NCT03938792|Inhibitors|inhibitors
5009206|NCT03938792|Anti-Tissue Factor Pathway Inhibitor (TFPI)|anti-tissue factor pathway inhibitor (tfpi)
5009207|NCT03938792|Subcutaneous (sc)|subcutaneous (sc)
5009208|NCT03938792|Prophylaxis|prophylaxis
5009209|NCT03938792|On-Demand|on-demand
5009210|NCT03938779|Elite Athletes|elite athletes
5009211|NCT03938779|Volleyball|volleyball
5009212|NCT03938779|Pelvic Floor Muscle Training|pelvic floor muscle training
5009213|NCT03938727|Dementia|dementia
5009214|NCT03938727|Aging|aging
5009215|NCT03938727|Alzheimer's Disease|alzheimer's disease
5009216|NCT03938727|Cognition|cognition
5009217|NCT03938727|Frailty|frailty
5009218|NCT03938727|Epidemiology|epidemiology
5009219|NCT03938727|Lifestyle|lifestyle
5009220|NCT03938727|Cardiovascula Risk Factors|cardiovascula risk factors
5009221|NCT03938714|VAS pain score|vas pain score
5009222|NCT03938714|Harmonic Scalpel Hemorrhoidectomy|harmonic scalpel hemorrhoidectomy
5009223|NCT03938714|Conventional Hemorrhoidectomy|conventional hemorrhoidectomy
5011747|NCT03922971|ASC|asc
5009244|NCT03938597|viscerotropic disease|viscerotropic disease
5009245|NCT03938597|neurological disease|neurological disease
5009246|NCT03938558|multiple sclerosis|multiple sclerosis
5009251|NCT03938519|survey|survey
5009252|NCT03938519|questionnaire|questionnaire
5009253|NCT03938519|radiation protection|radiation protection
5009254|NCT03938519|dental|dental
5009255|NCT03938506|Adult male patients who require endotracheal intubation using the endotracheal tube size of 6.0 or 8.0|adult male patients who require endotracheal intubation using the endotracheal tube size of 6.0 or 8.0
5009256|NCT03938506|endotracheal tube cuff|endotracheal tube cuff
5009257|NCT03938493|Adults who require endotracheal intubation for head and neck surgery under general anesthesia|adults who require endotracheal intubation for head and neck surgery under general anesthesia
5009258|NCT03938467|Shoulder Arthroplasty|shoulder arthroplasty
5009259|NCT03938467|C.acnes|c.acnes
5009260|NCT03938467|Cutibacterium acnes|cutibacterium acnes
5009262|NCT03938454|Priapism|priapism
5009263|NCT03938454|sickle cell disease|sickle cell disease
5009264|NCT03938454|crizanlizumab|crizanlizumab
5009265|NCT03938454|P-selectin|p-selectin
5009266|NCT03938454|SEG101|seg101
5009267|NCT03938454|monoclonal antibody|monoclonal antibody
5009268|NCT03938454|prolonged erection|prolonged erection
5009269|NCT03938454|painful erection|painful erection
5009270|NCT03938402|Intraocular pressure|intraocular pressure
5009271|NCT03938402|Optic nerve sheath diameter|optic nerve sheath diameter
5009272|NCT03938402|Positive end-expiratory pressure|positive end-expiratory pressure
5009277|NCT03938376|Prostatic Disease|prostatic disease
5009278|NCT03938376|Diagnostic Imaging|diagnostic imaging
5009279|NCT03938376|Micro-Ultrasound|micro-ultrasound
5009280|NCT03938363|cervical dystonia|cervical dystonia
5009281|NCT03938363|blepharospasm|blepharospasm
5009282|NCT03938363|gait parameters|gait parameters
5009283|NCT03938363|botulinum toxin|botulinum toxin
5009284|NCT03938350|Toxic stress|toxic stress
5009285|NCT03938350|Maternal PTSD|maternal ptsd
5009286|NCT03938350|Mindfulness-based intervention|mindfulness-based intervention
5009287|NCT03938350|Dialectical Behavior Therapy|dialectical behavior therapy
5009288|NCT03938350|Transgenerational transference of health disparities|transgenerational transference of health disparities
5009289|NCT03938337|immunotherapy|immunotherapy
5009290|NCT03938337|abemaciclib|abemaciclib
5009291|NCT03938337|pembrolizumab|pembrolizumab
5009292|NCT03938337|Cyclin-Dependent Kinase (CDK): CDK4|cyclin-dependent kinase (cdk): cdk4
5009293|NCT03938337|Cyclin-Dependent Kinase (CDK): CDK6|cyclin-dependent kinase (cdk): cdk6
5009294|NCT03938311|Acute ischemic stroke|acute ischemic stroke
5009295|NCT03938311|early rehabilitation|early rehabilitation
5009296|NCT03938311|early mobilization|early mobilization
5009297|NCT03938311|time window|time window
5009298|NCT03938311|multicenter randomized controlled trial|multicenter randomized controlled trial
5009299|NCT03938259|pediatrics|pediatrics
5009300|NCT03938259|opioids|opioids
5009301|NCT03938259|obstructive sleep apnea|obstructive sleep apnea
5009302|NCT03938246|NASH|nash
5009303|NCT03938246|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5009304|NCT03938246|Fatty Liver Disease|fatty liver disease
5009305|NCT03938246|Fatty Liver|fatty liver
5009306|NCT03938246|Liver Diseases|liver diseases
5009307|NCT03938246|FASN|fasn
5009308|NCT03938246|Fatty Acid Synthase Inhibitor|fatty acid synthase inhibitor
5009309|NCT03938233|Diabetes|diabetes
5009310|NCT03938233|Self-management|self-management
5009311|NCT03938233|Structured Education|structured education
5009312|NCT03938233|Thailand|thailand
5009313|NCT03938233|Peer Led|peer led
5009314|NCT03938207|Dry eye syndrome|dry eye syndrome
5009315|NCT03938207|Sjögren's syndrome|sjögren's syndrome
5009316|NCT03938207|Gene modulation|gene modulation
5009317|NCT03938207|Xerophthalmia|xerophthalmia
5009318|NCT03938207|TCM pattern|tcm pattern
5009326|NCT03938116|couple relationship|couple relationship
5009327|NCT03938116|heart disease|heart disease
5009329|NCT03938103|child care centers|child care centers
5009330|NCT03938103|nutrition|nutrition
5009331|NCT03938103|physical activity|physical activity
5009336|NCT03938090|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5009337|NCT03938090|MultiSite Pacing|multisite pacing
5009338|NCT03938077|mHealth|mhealth
5009339|NCT03938077|prevention intervention|prevention intervention
5009340|NCT03938077|primary health care|primary health care
5009341|NCT03938064|poor responders|poor responders
5009342|NCT03938064|IVF/ICSI|ivf/icsi
5009343|NCT03938064|Luteal Phase Support|luteal phase support
5009344|NCT03938064|GnRH Antagonist Protocol|gnrh antagonist protocol
5009345|NCT03938051|Exercise|exercise
5009346|NCT03938051|Mild Cognitive Impairment|mild cognitive impairment
5009347|NCT03938051|Elderly Population|elderly population
5009348|NCT03938025|Sleeve gastrectomy|sleeve gastrectomy
5009349|NCT03938025|Morbid obesity|morbid obesity
5009350|NCT03938025|Resected gastric volume|resected gastric volume
5009351|NCT03938012|mutations in MET and TP53|mutations in met and tp53
5009352|NCT03937999|clostridium difficile|clostridium difficile
5009353|NCT03937999|diarrhea|diarrhea
5009354|NCT03937973|sleep|sleep
5009355|NCT03937973|heart|heart
5009356|NCT03937973|stress|stress
5009357|NCT03937960|Dietary intervention|dietary intervention
5009358|NCT03937960|Anthropometric measure|anthropometric measure
5009359|NCT03937960|Lipid profile|lipid profile
5009360|NCT03937960|Augmentation Index|augmentation index
5009361|NCT03937960|Flow mediated dilation|flow mediated dilation
5009362|NCT03937960|DXA scan|dxa scan
5009363|NCT03937960|Nuclear magnetic resonance lipid profile|nuclear magnetic resonance lipid profile
5009364|NCT03937921|Signal intensity enhancement|signal intensity enhancement
5009365|NCT03937921|Relaxation rate enhancement|relaxation rate enhancement
5009374|NCT03937869|Vaginal itching|vaginal itching
5009375|NCT03937869|off-white milky vaginal discharge|off-white milky vaginal discharge
5009376|NCT03937843|Seminoma|seminoma
5009377|NCT03937843|Stage IIA/B seminoma|stage iia/b seminoma
5009378|NCT03937843|Radio-chemotherapy|radio-chemotherapy
5009379|NCT03937843|Phase II trial|phase ii trial
5009380|NCT03937843|Testicular Cancer|testicular cancer
5009385|NCT03937817|Assay Development|assay development
5009386|NCT03937817|Malaria|malaria
5009387|NCT03937817|Sickle Cell Disease|sickle cell disease
5009388|NCT03937817|Alpha Thalassemia|alpha thalassemia
5009389|NCT03937804|Trans-omics|trans-omics
5009390|NCT03937791|Human Papilloma Virus (HPV) Type 16|human papilloma virus (hpv) type 16
5009391|NCT03937791|Retroviral Vector Supernatant|retroviral vector supernatant
5009392|NCT03937791|Leukapheresis|leukapheresis
5009393|NCT03937791|T Cell Receptor|t cell receptor
5009394|NCT03937791|Premalignant Epithelial Lesion|premalignant epithelial lesion
5009395|NCT03937778|Somatosensory|somatosensory
5009396|NCT03937752|anal fistula|anal fistula
5009397|NCT03937752|fistula in ano|fistula in ano
5009398|NCT03937752|endoanal ultrasound|endoanal ultrasound
5009399|NCT03937752|3D ultrasound|3d ultrasound
5009400|NCT03937752|3D ultrasonography|3d ultrasonography
5009401|NCT03937752|endoanal ultrasonography|endoanal ultrasonography
5009402|NCT03937752|diagnostics|diagnostics
5009403|NCT03937739|Nutrition|nutrition
5009404|NCT03937739|Constipation|constipation
5009405|NCT03937739|Hernia|hernia
5009406|NCT03937726|Peanut allergy|peanut allergy
5009407|NCT03937726|Desensitisation|desensitisation
5009408|NCT03937726|Safety|safety
5009409|NCT03937713|post traumatic stress disorder|post traumatic stress disorder
5009410|NCT03937713|complex insomnia|complex insomnia
5009411|NCT03937713|cognitive behavioral therapy|cognitive behavioral therapy
5009412|NCT03937713|eszopiclone|eszopiclone
5009413|NCT03937674|Physical Activity|physical activity
5009414|NCT03937674|Mobile Health|mobile health
5009415|NCT03937674|Self Monitoring|self monitoring
5009416|NCT03937674|Wearable Sensors|wearable sensors
5009417|NCT03937674|Tailored Health Communication|tailored health communication
5009418|NCT03937674|Implementation Intentions|implementation intentions
5009419|NCT03937674|Mobile Apps|mobile apps
5009420|NCT03937674|Anti-Sedentary Behavior|anti-sedentary behavior
5009421|NCT03937674|Opportunistic Physical Activity|opportunistic physical activity
5009422|NCT03937674|Health Belief Model|health belief model
5009423|NCT03937609|infliximab|infliximab
5009424|NCT03937583|Venous Thromboembolic Disease|venous thromboembolic disease
5009440|NCT03937492|Distal radius fracture|distal radius fracture
5009442|NCT03937466|menopause|menopause
5009443|NCT03937466|cooling mattress pad|cooling mattress pad
5009444|NCT03937453|Pancreas|pancreas
5009445|NCT03937453|Cancer|cancer
5009446|NCT03937453|Diabetes Mellitus|diabetes mellitus
5009447|NCT03937453|MRI|mri
5009448|NCT03937453|Early Detection|early detection
5009449|NCT03937440|deep neuromuscular block|deep neuromuscular block
5009450|NCT03937440|robot-assisted surgery|robot-assisted surgery
5009451|NCT03937440|stress response|stress response
5009452|NCT03937440|stomach cancer|stomach cancer
5342932|NCT01981486|CYP3A induction|cyp3a induction
5009456|NCT03937401|fibroid|fibroid
5009457|NCT03937401|adenomyosis|adenomyosis
5009458|NCT03937388|cochlear implants|cochlear implants
5009459|NCT03937388|electrical stimulation|electrical stimulation
5009460|NCT03937388|processing strategy|processing strategy
5009461|NCT03937388|hearing quality|hearing quality
5009462|NCT03937388|speech recognition|speech recognition
5009463|NCT03937388|energy consumption|energy consumption
5009464|NCT03937375|Surgery|surgery
5009465|NCT03937375|Mechanical ventilation|mechanical ventilation
5009466|NCT03937375|PEEP|peep
5009467|NCT03937375|Postoperative pulmonary complications|postoperative pulmonary complications
5009468|NCT03937375|Individual patient data meta-analysis|individual patient data meta-analysis
5009469|NCT03937362|Esophagectomy|esophagectomy
5009470|NCT03937362|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5009471|NCT03937362|Esophageal cancer|esophageal cancer
5009472|NCT03937362|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5009473|NCT03937362|Active surveillance|active surveillance
5009474|NCT03937336|Active Commuting|active commuting
5009475|NCT03937336|Health behaviour|health behaviour
5009476|NCT03937336|Design|design
5009477|NCT03937336|Intervention|intervention
5009478|NCT03937336|Technology|technology
5009479|NCT03937336|Children|children
5009480|NCT03937336|Adolescents|adolescents
5009481|NCT03937336|Parents|parents
5009482|NCT03937336|Mobility|mobility
5009483|NCT03937323|Pancreatitis|pancreatitis
5009484|NCT03937323|Lymphocyte subtypes|lymphocyte subtypes
5009485|NCT03937323|Cytokine|cytokine
5009486|NCT03937297|non-pharmacological|non-pharmacological
5009487|NCT03937297|intervention|intervention
5009488|NCT03937297|culturally appropriate|culturally appropriate
5009489|NCT03937297|Chinese|chinese
5009490|NCT03937297|cognitive stimulation therapy|cognitive stimulation therapy
5009491|NCT03937297|Six Arts|six arts
5009492|NCT03937297|dementia|dementia
5009493|NCT03937297|CST|cst
5009494|NCT03937284|Lipoproteins|lipoproteins
5009495|NCT03937284|Lipopolysaccharide|lipopolysaccharide
5009496|NCT03937284|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
5009497|NCT03937284|Inflammation|inflammation
5009498|NCT03937271|Sjögren's syndrome|sjögren's syndrome
5009499|NCT03937271|Systemic lupus erythematosus|systemic lupus erythematosus
5009500|NCT03937271|Rheumatoid Arthritis|rheumatoid arthritis
5009501|NCT03937271|Systemic Sclerosis|systemic sclerosis
5009502|NCT03937271|Ankylosing spondylitis|ankylosing spondylitis
5009503|NCT03937271|Dry eye syndrome|dry eye syndrome
5009504|NCT03937258|healthy volunteers|healthy volunteers
5009505|NCT03937245|Hospital-acquired infection|hospital-acquired infection
5009506|NCT03937245|Blood stream infection|blood stream infection
5009507|NCT03937245|Bacteremia|bacteremia
5009508|NCT03937245|Intensive care|intensive care
5009512|NCT03937193|aortomesenteric angle|aortomesenteric angle
5009513|NCT03937193|aortomesenteric distance|aortomesenteric distance
5009514|NCT03937193|retroperitoneal adipose tissue|retroperitoneal adipose tissue
5009515|NCT03937193|computerized tomography|computerized tomography
5009516|NCT03937193|young Chinese population|young chinese population
5009517|NCT03937180|benzodiazepines|benzodiazepines
5009518|NCT03937180|blended care|blended care
5009519|NCT03937167|obesity|obesity
5009520|NCT03937167|Psychotherapy|psychotherapy
5009521|NCT03937167|Psychotherapy Group|psychotherapy group
5009526|NCT03937115|tDCS|tdcs
5009527|NCT03937115|Noninvasive brain stimulation|noninvasive brain stimulation
5009531|NCT03937102|trans thoracic echocardiography|trans thoracic echocardiography
5009532|NCT03937102|passive leg raising|passive leg raising
5009533|NCT03937102|volume expansion|volume expansion
5009534|NCT03937076|Intercostal block|intercostal block
5009535|NCT03937076|Pectoral nerve block II|pectoral nerve block ii
5009537|NCT03937050|gestational diabetes|gestational diabetes
5009538|NCT03937050|India|india
5009539|NCT03937050|Uganda|uganda
5009540|NCT03937050|cluster randomized trial|cluster randomized trial
5009541|NCT03937037|ERCP|ercp
5009542|NCT03937037|Common bile duct stone|common bile duct stone
5009543|NCT03937037|Cholangitis|cholangitis
5009544|NCT03937037|Residual stone|residual stone
5009545|NCT03937037|Irrigation|irrigation
5009546|NCT03937037|Recurrence|recurrence
5009547|NCT03937011|STRATAFIX SPIRAL PDS PLUS, ROBOTIC SUTURING,|stratafix spiral pds plus, robotic suturing,
5445439|NCT01521806|insulin sensitivity|insulin sensitivity
5323144|NCT02070588|NFL|nfl
5009548|NCT03936972|tibia fracture; ilizarov; open fracture; external fixator|tibia fracture; ilizarov; open fracture; external fixator
5009549|NCT03936959|PD-1|pd-1
5009550|NCT03936959|PD-L1|pd-l1
5009551|NCT03936894|Canakinumab|canakinumab
5009552|NCT03936894|Biomarker|biomarker
5009555|NCT03936790|cesarean section|cesarean section
5009556|NCT03936790|combined spinal epidural anaesthesia|combined spinal epidural anaesthesia
5009557|NCT03936790|tall parturients|tall parturients
5009558|NCT03936790|ropivacaine ED50 and MLAD|ropivacaine ed50 and mlad
5009559|NCT03936764|NSCLC|nsclc
5009560|NCT03936764|Preoperative pulmonary rehabilitation|preoperative pulmonary rehabilitation
5009561|NCT03936764|Preoperative training|preoperative training
5009562|NCT03936764|Prehabilitation|prehabilitation
5009563|NCT03936764|Lung resection|lung resection
5009564|NCT03936725|Rehabilitation program|rehabilitation program
5009565|NCT03936725|Non specific chronic low back pain|non specific chronic low back pain
5009566|NCT03936725|Return to work|return to work
5009567|NCT03936712|Energy drinks|energy drinks
5009568|NCT03936712|Exercise|exercise
5009569|NCT03936712|Physiological response|physiological response
5009570|NCT03936712|Mood State|mood state
5009571|NCT03936712|Fatigue|fatigue
5009572|NCT03936686|Education|education
5009573|NCT03936686|Knowledge level|knowledge level
5009574|NCT03936673|obstructive uropathy|obstructive uropathy
5009575|NCT03936673|relative renal function|relative renal function
5009576|NCT03936673|DMSA|dmsa
5009597|NCT03936621|CRP|crp
5009598|NCT03936608|CRT Programming|crt programming
5009599|NCT03936530|colon adenocarcinoma|colon adenocarcinoma
5009600|NCT03936530|lymph node metastasis|lymph node metastasis
5009601|NCT03936530|right hemi-colectomy|right hemi-colectomy
5009602|NCT03936517|Glucocorticoids|glucocorticoids
5009603|NCT03936517|Hydrocortisone|hydrocortisone
5009604|NCT03936517|Prednisolone|prednisolone
5009605|NCT03936517|Cortisol|cortisol
5009606|NCT03936504|Tai Chi|tai chi
5009607|NCT03936504|Cardiac rehabilitation|cardiac rehabilitation
5009608|NCT03936504|Coronary heart disease|coronary heart disease
5009609|NCT03936504|Safety|safety
5009610|NCT03936504|Effectiveness|effectiveness
5009611|NCT03936504|Randomized controlled trial|randomized controlled trial
5009612|NCT03936491|biomarker|biomarker
5009613|NCT03936491|ADHD|adhd
5009614|NCT03936478|cosmesis|cosmesis
5009615|NCT03936478|cosmetic|cosmetic
5009616|NCT03936478|breast-conserving therapy|breast-conserving therapy
5009617|NCT03936465|Solid Tumor|solid tumor
5009618|NCT03936465|Lymphoma|lymphoma
5009619|NCT03936465|Neuroblastoma|neuroblastoma
5009620|NCT03936465|Sarcoma|sarcoma
5009621|NCT03936465|Medulloblastoma|medulloblastoma
5009622|NCT03936465|MYC|myc
5009623|NCT03936465|MYCN|mycn
5009624|NCT03936465|BRD4|brd4
5009625|NCT03936465|BET inhibitor|bet inhibitor
5009626|NCT03936465|Bromodomain|bromodomain
5009638|NCT03936348|Pulmonary rehabilitation|pulmonary rehabilitation
5009640|NCT03936348|FeelBreathe|feelbreathe
5009641|NCT03936348|Exercise intervention|exercise intervention
5009642|NCT03936348|Equipment and Supplies|equipment and supplies
5009643|NCT03936296|multiparametric prostate magnetic resonance imaging|multiparametric prostate magnetic resonance imaging
5009644|NCT03936296|MR-US fusion|mr-us fusion
5009645|NCT03936296|MR guided prostate biopsy|mr guided prostate biopsy
5009646|NCT03936296|prostate cancer|prostate cancer
5009647|NCT03936283|lifestyle|lifestyle
5009648|NCT03936283|intervention|intervention
5009649|NCT03936283|body weight|body weight
5009650|NCT03936283|pregnancy|pregnancy
5009651|NCT03936283|Overweight|overweight
5009652|NCT03936283|Obesity|obesity
5009653|NCT03936283|Signs and Symptoms|signs and symptoms
5009654|NCT03936283|Body weight changes|body weight changes
5009658|NCT03936231|VILI|vili
5009659|NCT03936231|Mechanical Power|mechanical power
5009660|NCT03936231|Driving Pressure|driving pressure
5009661|NCT03936231|Strain|strain
5009662|NCT03936231|Stress|stress
5009669|NCT03936075|radiotherapy|radiotherapy
5009670|NCT03936075|breast cancer|breast cancer
5009671|NCT03936075|gynecologic cancer|gynecologic cancer
5009672|NCT03935997|Palliative care|palliative care
5009673|NCT03935997|End of life care|end of life care
5009681|NCT03935958|graft function|graft function
5009682|NCT03935945|Drinking|drinking
5009684|NCT03935945|HIV+|hiv+
5009685|NCT03935932|COPD|copd
5009686|NCT03935932|Chronic bronchitis|chronic bronchitis
5009694|NCT03935828|chronic rhinosinusitis|chronic rhinosinusitis
5009695|NCT03935828|topical sinonasal antibiotics|topical sinonasal antibiotics
5009696|NCT03935828|randomized controlled trial|randomized controlled trial
5009697|NCT03935802|Radiotherapy|radiotherapy
5009698|NCT03935802|CETC|cetc
5009699|NCT03935802|CTC|ctc
5009700|NCT03935802|breast cancer|breast cancer
5009701|NCT03935789|stroke|stroke
5009702|NCT03935789|occupational therapy|occupational therapy
5009703|NCT03935789|participation|participation
5009704|NCT03935776|Peripheral arterial disease|peripheral arterial disease
5009705|NCT03935776|Risk factor modifications|risk factor modifications
5009706|NCT03935776|Cardiovascular risk factors|cardiovascular risk factors
5009707|NCT03935763|Real Worl Evidence|real worl evidence
5009708|NCT03935750|Lateral extra-articular tenodesis|lateral extra-articular tenodesis
5009709|NCT03935750|Autografting|autografting
5009710|NCT03935750|Allografting|allografting
5009711|NCT03935750|Bone-Patellar Tendon-Bone Grafting|bone-patellar tendon-bone grafting
5009712|NCT03935711|cbct|cbct
5009713|NCT03935711|cbct dental|cbct dental
5009714|NCT03935711|mandibular anterior teeth|mandibular anterior teeth
5009715|NCT03935711|canal morphology|canal morphology
5009716|NCT03935698|Pilot study|pilot study
5009717|NCT03935698|Feasibility study|feasibility study
5009718|NCT03935698|Dyspareunia|dyspareunia
5009719|NCT03935698|Gynecological cancer survivors|gynecological cancer survivors
5009720|NCT03935698|Physiotherapy|physiotherapy
5009721|NCT03935672|Oropharyngeal Cancer|oropharyngeal cancer
5009722|NCT03935672|Radiotherapy|radiotherapy
5009723|NCT03935672|HPV positive|hpv positive
5009724|NCT03935672|Automated segmentation|automated segmentation
5009725|NCT03935672|Radiotherapy re-planning|radiotherapy re-planning
5009726|NCT03935659|Negative Pressure Wound Therapy|negative pressure wound therapy
5009727|NCT03935646|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5009728|NCT03935646|Stimulant Use|stimulant use
5009729|NCT03935646|Working Memory|working memory
5051534|NCT03676023|txa|txa
5009730|NCT03935646|Change in Sustained Attention|change in sustained attention
5009731|NCT03935646|Mood|mood
5009732|NCT03935594|platelet rich plasma (PRP)|platelet rich plasma (prp)
5009733|NCT03935594|hypertrophic scar|hypertrophic scar
5009734|NCT03935594|burn scar|burn scar
5009735|NCT03935594|tissue repair|tissue repair
5009736|NCT03935594|vancouver scar scale (VSS)|vancouver scar scale (vss)
5009737|NCT03935594|patient and observer scar assessment scale (POSAS)|patient and observer scar assessment scale (posas)
5009738|NCT03935581|MRgFUS|mrgfus
5009739|NCT03935581|ExAblate|exablate
5009740|NCT03935581|Essential Tremor|essential tremor
5009741|NCT03935581|Auto-Focusing Echo Imaging|auto-focusing echo imaging
5009742|NCT03935568|PU-AD|pu-ad
5009743|NCT03935555|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
5009744|NCT03935555|Post-Polycythemia Vera Myelofibrosis (Post-PV MF)|post-polycythemia vera myelofibrosis (post-pv mf)
5009745|NCT03935555|Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)|post-essential thrombocythemia myelofibrosis (post-et mf)
5009746|NCT03935542|Bifurcation|bifurcation
5009747|NCT03935542|Side branch|side branch
5009748|NCT03935542|Ischemia|ischemia
5009749|NCT03935542|Myocardium|myocardium
5009750|NCT03935542|Revascularization|revascularization
5009751|NCT03935516|cast|cast
5009752|NCT03935516|open growth plate|open growth plate
5009753|NCT03935516|pediatric|pediatric
5009754|NCT03935516|both bone|both bone
5009755|NCT03935503|Quality of life|quality of life
5009756|NCT03935503|Inguinal Hernia|inguinal hernia
5009757|NCT03935503|Lichtenstein repair|lichtenstein repair
5009758|NCT03935503|Sexual Function|sexual function
5009759|NCT03935503|Total Extraperitoneal Repair|total extraperitoneal repair
5009760|NCT03935490|Inguinal hernia|inguinal hernia
5009761|NCT03935490|Strangulated|strangulated
5009762|NCT03935490|TREPP|trepp
5009763|NCT03935490|Transrectus sheath pre-peritoneal|transrectus sheath pre-peritoneal
5009764|NCT03935464|PrEP, women, Kenya, adherence, POC monitoring, urine test, immunoassay, tenofovir|prep, women, kenya, adherence, poc monitoring, urine test, immunoassay, tenofovir
5009779|NCT03935373|Traditional Chinese Medicine tongue diagnosis|traditional chinese medicine tongue diagnosis
5009780|NCT03935373|Traditional Chinese Medicine pulse diagnosis|traditional chinese medicine pulse diagnosis
5009783|NCT03935360|lower gastrointestinal bleeding|lower gastrointestinal bleeding
5009785|NCT03935360|prognostic risk score|prognostic risk score
5009786|NCT03935360|safe discharge|safe discharge
5009787|NCT03935360|multi-centre cohort study|multi-centre cohort study
5009788|NCT03935360|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
5009789|NCT03935360|hospital presentation|hospital presentation
5009790|NCT03935321|Tetraplegia|tetraplegia
5009791|NCT03935321|Trauma|trauma
5009792|NCT03935321|Upper limbs function|upper limbs function
5009793|NCT03935308|prostate cancer, MRI, intraprostatic lesions|prostate cancer, mri, intraprostatic lesions
5009794|NCT03935295|AIS|ais
5009795|NCT03935295|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5009796|NCT03935282|Cardiovascular risk|cardiovascular risk
5327684|NCT02050152|Amnesia|amnesia
5009797|NCT03935282|Cardiovascular disease|cardiovascular disease
5009798|NCT03935282|Cancer|cancer
5009799|NCT03935282|Survivor|survivor
5009800|NCT03935282|Health Behaviors|health behaviors
5009801|NCT03935282|Oncology Providers|oncology providers
5009802|NCT03935282|EHR|ehr
5009803|NCT03935282|Informatics|informatics
5009807|NCT03935256|Cancer|cancer
5009808|NCT03935256|High Risk Endometrial Cancer|high risk endometrial cancer
5009809|NCT03935230|unexpected cardiopulmonary arrest|unexpected cardiopulmonary arrest
5009810|NCT03935230|potential organ donors|potential organ donors
5009811|NCT03935217|Vaginal Itching|vaginal itching
5009812|NCT03935217|Vaginal Discharge|vaginal discharge
5009813|NCT03935204|human papillomavirus vaccine|human papillomavirus vaccine
5009814|NCT03935165|indocyanine Green|indocyanine green
5009815|NCT03935165|deep Infiltrating Endometriosis|deep infiltrating endometriosis
5009816|NCT03935165|near-Infrared Vision|near-infrared vision
5009817|NCT03935165|occult endometriosis|occult endometriosis
5010317|NCT03932318|Venetoclax|venetoclax
5009833|NCT03935035|young people|young people
5009834|NCT03935035|trauma|trauma
5009835|NCT03935035|cognitive therapy|cognitive therapy
5009836|NCT03935009|Oral hygiene|oral hygiene
5009837|NCT03935009|Dental Plaque|dental plaque
5009838|NCT03935009|Brushing|brushing
5009839|NCT03935009|Flossing|flossing
5009840|NCT03935009|Gamification|gamification
5009841|NCT03935009|Game elements|game elements
5009842|NCT03935009|Motivation|motivation
5009843|NCT03935009|Education|education
5009844|NCT03935009|Children|children
5009845|NCT03935009|Parents|parents
5009846|NCT03934996|pelvic floor|pelvic floor
5009847|NCT03934996|athletes|athletes
5009848|NCT03934983|Viscoelastic testing|viscoelastic testing
5009849|NCT03934983|Coagulation|coagulation
5009850|NCT03934983|Quantra|quantra
5009851|NCT03934983|Hemostasis|hemostasis
5009852|NCT03934970|Diabetic Polyneuropathy|diabetic polyneuropathy
5009980|NCT03934229|Overweight|overweight
5009853|NCT03934970|Diffusion tensor imaging|diffusion tensor imaging
5009854|NCT03934970|Neuropathy scores|neuropathy scores
5009855|NCT03934957|Epidemiology|epidemiology
5009856|NCT03934957|prospective cohort study|prospective cohort study
5009857|NCT03934957|Nutrition|nutrition
5009858|NCT03934957|prevention|prevention
5009859|NCT03934957|psychiatric and psychosomatic disorders|psychiatric and psychosomatic disorders
5009860|NCT03934944|Patient education|patient education
5009861|NCT03934944|Prevention|prevention
5009862|NCT03934944|Smart phone application|smart phone application
5009863|NCT03934931|latent tuberculosis|latent tuberculosis
5009864|NCT03934931|tuberculosis|tuberculosis
5009865|NCT03934931|HIV/AIDS|hiv/aids
5009866|NCT03934931|implementation science|implementation science
5009867|NCT03934931|Uganda|uganda
5009869|NCT03934931|shared decision making|shared decision making
5009870|NCT03934931|rifapentine|rifapentine
5009875|NCT03934905|doxorubicin|doxorubicin
5009876|NCT03934905|sulforaphane|sulforaphane
5009888|NCT03934762|aseptic inflammation|aseptic inflammation
5009889|NCT03934762|muscle trauma|muscle trauma
5009890|NCT03934762|muscle strength|muscle strength
5009891|NCT03934762|aloe vera|aloe vera
5009892|NCT03934736|ESRD|esrd
5009893|NCT03934736|Hemodialysis|hemodialysis
5009894|NCT03934736|End Stage Renal Disease|end stage renal disease
5009895|NCT03934736|Hepatitis B|hepatitis b
5009896|NCT03934736|HEPLISAV-B|heplisav-b
5009897|NCT03934736|Prevention and Control|prevention and control
5009898|NCT03934736|HBV Vaccine|hbv vaccine
5009899|NCT03934736|Hepatitis B Vaccine|hepatitis b vaccine
5009900|NCT03934723|Exercise|exercise
5009901|NCT03934723|Antidepressants|antidepressants
5009922|NCT03934645|Delirium prediction model for ICU patients version 1|delirium prediction model for icu patients version 1
5009923|NCT03934645|Delirium prediction model for ICU patients version 2|delirium prediction model for icu patients version 2
5009924|NCT03934645|Early prediction model for delirium in ICU patients|early prediction model for delirium in icu patients
5009925|NCT03934645|sensitivity|sensitivity
5009926|NCT03934645|specificity|specificity
5009927|NCT03934593|diabetes|diabetes
5009928|NCT03934593|Hispanics|hispanics
5009929|NCT03934593|HbA1c|hba1c
5009930|NCT03934593|Self-Management Support Program|self-management support program
5009931|NCT03934567|refractory|refractory
5009932|NCT03934567|relapsed|relapsed
5009933|NCT03934567|lymph nodes|lymph nodes
5009934|NCT03934554|Nephrology|nephrology
5009935|NCT03934554|Kidney transplant|kidney transplant
5009936|NCT03934554|Registration|registration
5009937|NCT03934554|Transplant waiting list|transplant waiting list
5009938|NCT03934528|Phantom Limb Pain|phantom limb pain
5009939|NCT03934528|Virtual Reality|virtual reality
5009940|NCT03934528|Virtual Environment|virtual environment
5009941|NCT03934515|Gastric tube, capnometry, pHmetry|gastric tube, capnometry, phmetry
5009942|NCT03934502|Evobrutinib|evobrutinib
5009943|NCT03934502|Pharmacokinetics|pharmacokinetics
5009944|NCT03934476|ketogenic diet|ketogenic diet
5009945|NCT03934476|carbohydrates|carbohydrates
5009946|NCT03934476|chronic diseases|chronic diseases
5009947|NCT03934476|physical activity|physical activity
5009948|NCT03934476|fatigue|fatigue
5009949|NCT03934476|mood|mood
5009950|NCT03934476|wellbeing|wellbeing
5009951|NCT03934450|Hemolysis|hemolysis
5009952|NCT03934450|Primaquine|primaquine
5009953|NCT03934450|Pharmacokinetics|pharmacokinetics
5009954|NCT03934424|appetite|appetite
5009955|NCT03934424|fMRI|fmri
5009956|NCT03934424|overweight|overweight
5009957|NCT03934424|obese|obese
5009958|NCT03934424|weight stigma|weight stigma
5009959|NCT03934385|anxiety|anxiety
5009960|NCT03934385|consolidation|consolidation
5009961|NCT03934385|extinction|extinction
5009962|NCT03934385|mental rehearsal|mental rehearsal
5009963|NCT03934372|Leukemia|leukemia
5009964|NCT03934372|Solid tumors|solid tumors
5009965|NCT03934372|Pediatric|pediatric
5009966|NCT03934372|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5009967|NCT03934346|zinc|zinc
5009968|NCT03934346|absorption|absorption
5009969|NCT03934346|kinetics|kinetics
5009970|NCT03934346|amino acid chelate|amino acid chelate
5009971|NCT03934333|Pharmacokinetics|pharmacokinetics
5009972|NCT03934333|Inhaled corticosteroid|inhaled corticosteroid
5009973|NCT03934294|Critically ill|critically ill
5009974|NCT03934294|Intensive care|intensive care
5009975|NCT03934294|Oral cancer|oral cancer
5009976|NCT03934294|Hypo-pharyngeal cancer|hypo-pharyngeal cancer
5009977|NCT03934294|Acupuncture|acupuncture
5005016|NCT03965182|colon preparation, ,|colon preparation, ,
5005017|NCT03965182|polyethylene glycol|polyethylene glycol
5005018|NCT03965182|sodium picosulfate/magnesium citrate|sodium picosulfate/magnesium citrate
5005019|NCT03965130|Hepatic Glucose Metabolism|hepatic glucose metabolism
5005021|NCT03965130|PINTA|pinta
5009978|NCT03934294|Digestion|digestion
5009981|NCT03934229|Obesity|obesity
5009985|NCT03934190|internal limiting membrane peeling|internal limiting membrane peeling
5009986|NCT03934190|pars plana vitrectomy|pars plana vitrectomy
5009987|NCT03934177|Blueberry|blueberry
5009988|NCT03934177|Microbiota|microbiota
5009989|NCT03934177|Intestinal permeability|intestinal permeability
5009990|NCT03934164|prostate|prostate
5009991|NCT03934164|molecular stratification|molecular stratification
5009992|NCT03934151|laparoscopy|laparoscopy
5009993|NCT03934151|ileocolic anastomosis|ileocolic anastomosis
5009994|NCT03934151|right hemicolectomy|right hemicolectomy
5009995|NCT03934138|Placebo|placebo
5009996|NCT03934138|Experimental pain|experimental pain
5009997|NCT03934086|Migraine prevention, phonophobia, photophobia, nausea|migraine prevention, phonophobia, photophobia, nausea
5009998|NCT03934060|exercise|exercise
5009999|NCT03934060|strength training|strength training
5010000|NCT03934060|activities of daily living|activities of daily living
5010001|NCT03934060|childhood cancer|childhood cancer
5010002|NCT03934060|leukemia|leukemia
5027700|NCT03825562|ACT|act
5010012|NCT03934008|Pediatrics|pediatrics
5010013|NCT03933982|Breast cancer, Brain metastases, Pyrotinib, Vinorelbine, HER2|breast cancer, brain metastases, pyrotinib, vinorelbine, her2
5010014|NCT03933956|Diabetic nephropathy|diabetic nephropathy
5010015|NCT03933956|Sodium-glucose Cotransporter 2 Inhibitors|sodium-glucose cotransporter 2 inhibitors
5010016|NCT03933904|Castleman|castleman
5010017|NCT03933904|iMCD|imcd
5010018|NCT03933904|Castleman's Disease|castleman's disease
5010019|NCT03933904|multicentric Castleman's disease|multicentric castleman's disease
5010020|NCT03933904|multicentric Castleman disease|multicentric castleman disease
5010021|NCT03933904|idiopathic Castleman disease|idiopathic castleman disease
5010026|NCT03933891|TIPS|tips
5010027|NCT03933891|functional MRI|functional mri
5010028|NCT03933891|liver corrhosis|liver corrhosis
5010029|NCT03933891|portal hypertension|portal hypertension
5010030|NCT03933891|HVPG|hvpg
5010031|NCT03933865|buprenorphine|buprenorphine
5010032|NCT03933865|quantitative sensory testing|quantitative sensory testing
5010033|NCT03933865|cold pressor|cold pressor
5010034|NCT03933865|abuse liability|abuse liability
5010035|NCT03933865|ketamine|ketamine
5010036|NCT03933865|hydromorphone|hydromorphone
5010037|NCT03933839|Lupus|lupus
5010038|NCT03933839|Systemic Lupus Erythematosus|systemic lupus erythematosus
5010039|NCT03933826|pragmatic trial|pragmatic trial
5010040|NCT03933826|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
5010041|NCT03933826|urinary bladder neoplasms|urinary bladder neoplasms
5010042|NCT03933826|urogenital neoplasms|urogenital neoplasms
5010043|NCT03933826|radical cystectomy|radical cystectomy
5010044|NCT03933826|neoplasms by site|neoplasms by site
5010045|NCT03933826|neoplasms|neoplasms
5010046|NCT03933826|urinary bladder disease|urinary bladder disease
5010047|NCT03933826|immunologic factors|immunologic factors
5010048|NCT03933826|caregivers|caregivers
5010049|NCT03933826|physiological effects of drugs|physiological effects of drugs
5010050|NCT03933826|immunologic adjuvants|immunologic adjuvants
5010051|NCT03933826|urologic diseases|urologic diseases
5010052|NCT03933813|ovarian cancer|ovarian cancer
5010053|NCT03933813|anemia|anemia
5010054|NCT03933813|iron deficiency|iron deficiency
5010055|NCT03933813|blood transfusion|blood transfusion
5010056|NCT03933800|Therapy|therapy
5010057|NCT03933800|High flow nasal cannula|high flow nasal cannula
5010058|NCT03933800|Children|children
5010059|NCT03933800|Adolescents|adolescents
5010060|NCT03933787|neuropeptide Y,catecholamine, exercise|neuropeptide y,catecholamine, exercise
5010061|NCT03933761|High grade serous|high grade serous
5010062|NCT03933761|ABCB1 fusion|abcb1 fusion
5010063|NCT03933761|BRCA 1/2 reversion|brca 1/2 reversion
5010064|NCT03933683|fecal incontinence|fecal incontinence
5010065|NCT03933683|pudendal neuropthy|pudendal neuropthy
5010066|NCT03933683|pudendal nerve terminal motor latency|pudendal nerve terminal motor latency
5010067|NCT03933657|Chronic Total Occlusion|chronic total occlusion
5010068|NCT03933657|CTO|cto
5010069|NCT03933657|Crossing Device|crossing device
5010070|NCT03933657|Peripheral|peripheral
5010071|NCT03933657|SoundBite Crossing System|soundbite crossing system
5010072|NCT03933631|Cataract|cataract
5010073|NCT03933631|Glaucoma Surgery|glaucoma surgery
5010074|NCT03933631|Vision|vision
5010075|NCT03933631|Cataract Surgery|cataract surgery
5010076|NCT03933631|Eye surgery|eye surgery
5010077|NCT03933605|postoperative nausea and vomiting|postoperative nausea and vomiting
5010078|NCT03933605|midazolam|midazolam
5010079|NCT03933605|palonosetron|palonosetron
5010080|NCT03933566|Ultrasound-Guided Superficial Cervical Plexus Block|ultrasound-guided superficial cervical plexus block
5010081|NCT03933566|Landmark-Based Superficial Cervical Plexus Block|landmark-based superficial cervical plexus block
5010082|NCT03933553|aromatherapy essential oil|aromatherapy essential oil
5010083|NCT03933553|Easy Sleep complex essential oil|easy sleep complex essential oil
5010084|NCT03933553|Lavender essential oil|lavender essential oil
5010085|NCT03933553|sleep disorders|sleep disorders
5010086|NCT03933540|Patient Reported Outcome Measures|patient reported outcome measures
5010087|NCT03933540|Activity Monitors|activity monitors
5010088|NCT03933540|Pedometry|pedometry
5010090|NCT03933540|Health Measurement|health measurement
5010091|NCT03933527|tooth bleaching|tooth bleaching
5010092|NCT03933527|staining beverage|staining beverage
5010093|NCT03933514|Family|family
5010094|NCT03933514|Microbiome|microbiome
5010097|NCT03933501|Aggressive periodontitis|aggressive periodontitis
5010098|NCT03933501|anti-infective agents|anti-infective agents
5010099|NCT03933501|debridement|debridement
5010100|NCT03933501|randomized clinical trial|randomized clinical trial
5010101|NCT03933501|ultrasonic|ultrasonic
5010107|NCT03933410|Microbiome|microbiome
5010108|NCT03933410|Elevated Ammonia|elevated ammonia
5010109|NCT03933410|Disorder of the Urea Cycle Metabolism|disorder of the urea cycle metabolism
5010110|NCT03933410|Urea Cycle Disorder|urea cycle disorder
5010112|NCT03933410|Kaleido|kaleido
5010113|NCT03933410|UNLOCKED|unlocked
5010114|NCT03933410|Ornithine Transcarbamylase Deficiency (OTC)|ornithine transcarbamylase deficiency (otc)
5010115|NCT03933410|Carbamoyl Phosphatase Synthetase 1 (CPS1)|carbamoyl phosphatase synthetase 1 (cps1)
5010116|NCT03933410|Argininosuccinic Acid Synthetase (ASS1)|argininosuccinic acid synthetase (ass1)
5010117|NCT03933410|Argininosuccinic Acid Lyase (ASL)|argininosuccinic acid lyase (asl)
5010118|NCT03933410|Arginase (ARG 1)|arginase (arg 1)
5010125|NCT03933410|Oligosaccharide|oligosaccharide
5010126|NCT03933384|Hepatitis B|hepatitis b
5010127|NCT03933384|Viral Hepatitis|viral hepatitis
5010128|NCT03933384|Tenofovir alafenamide|tenofovir alafenamide
5010129|NCT03933384|Entecavir|entecavir
5010130|NCT03933371|colonoscopy|colonoscopy
5010131|NCT03933371|capsule|capsule
5010132|NCT03933371|Cleansing|cleansing
5010133|NCT03933345|Overdose Risk Behaviors|overdose risk behaviors
5010134|NCT03933345|Opioids|opioids
5010135|NCT03933345|Naloxone|naloxone
5010136|NCT03933345|Overdose|overdose
5010137|NCT03933306|blood pressure management|blood pressure management
5010138|NCT03933306|dexmedetomidine|dexmedetomidine
5010139|NCT03933306|high-risk patients|high-risk patients
5010140|NCT03933306|abdominal surgery|abdominal surgery
5010141|NCT03933306|postoperative organ injury|postoperative organ injury
5010142|NCT03933293|HoFH|hofh
5010143|NCT03933293|LDL-C|ldl-c
5010144|NCT03933267|Cervical Pain|cervical pain
5010145|NCT03933267|Kinesthesis|kinesthesis
5010146|NCT03933254|Intraocular pressure|intraocular pressure
5010147|NCT03933254|Optic nerve sheath diameter|optic nerve sheath diameter
5010148|NCT03933254|Pneumoperitoneum|pneumoperitoneum
5010149|NCT03933254|Laparoscopy|laparoscopy
5010150|NCT03933254|Laparoscopic surgery|laparoscopic surgery
5010151|NCT03933241|nasal irrigation|nasal irrigation
5010152|NCT03933228|Combined Interscalene-Cervical Plexus Block|combined interscalene-cervical plexus block
5010153|NCT03933228|Combined Supraclavicular-Cervical Plexus Block|combined supraclavicular-cervical plexus block
5010162|NCT03933189|chronic pain|chronic pain
5010163|NCT03933189|refugees|refugees
5010164|NCT03933189|torture|torture
5010165|NCT03933189|trauma|trauma
5010166|NCT03933189|rehabilitiation|rehabilitiation
5010167|NCT03933189|physical therapy|physical therapy
5010168|NCT03933189|musculoskeletal pain|musculoskeletal pain
5010169|NCT03933176|Glass ionomer|glass ionomer
5010170|NCT03933176|Bulk-Fill Composite|bulk-fill composite
5010171|NCT03933163|Resveratrol|resveratrol
5010172|NCT03933163|Frataxin|frataxin
5010173|NCT03933137|mortality|mortality
5010174|NCT03933137|morbidity|morbidity
5010175|NCT03933137|length of stay|length of stay
5010176|NCT03933137|kidney|kidney
5010177|NCT03933137|transplant|transplant
5010178|NCT03933124|Post-surgical pain|post-surgical pain
5010179|NCT03933124|Virtual Reality|virtual reality
5010180|NCT03933124|Distraction|distraction
5010181|NCT03933111|Endoscopic Ultrasound|endoscopic ultrasound
5010182|NCT03933111|Zone Sonography Technology|zone sonography technology
5010183|NCT03933098|Typhoid conjugate vaccine|typhoid conjugate vaccine
5010184|NCT03933098|Vi-DT|vi-dt
5010185|NCT03933098|Safety|safety
5010186|NCT03933098|Immunogenicity|immunogenicity
5010187|NCT03933085|Spanish-Speaking|spanish-speaking
5010188|NCT03933085|Hispanic|hispanic
5010189|NCT03933085|ages ≥50|ages ≥50
5445440|NCT01521806|resistant starch|resistant starch
5010190|NCT03933072|complete spinal cord injury, spinal cord transection, olfactory ensheathing cells, olfactory fibroblasts, Glial Neuropatch, nerve grafts|complete spinal cord injury, spinal cord transection, olfactory ensheathing cells, olfactory fibroblasts, glial neuropatch, nerve grafts
5010192|NCT03933046|proteinuria|proteinuria
5010193|NCT03933046|periodic limb movement disorder|periodic limb movement disorder
5010198|NCT03933020|Multiple Sclerosis|multiple sclerosis
5010199|NCT03933020|Cognitive Impairment|cognitive impairment
5010200|NCT03933020|Physical activity|physical activity
5010201|NCT03932981|Brainstem|brainstem
5010202|NCT03932981|Adult Glioma|adult glioma
5010203|NCT03932981|Chemotherapy|chemotherapy
5010204|NCT03932981|Temozolomide|temozolomide
5010205|NCT03932968|sleeve gastrectomy|sleeve gastrectomy
5010206|NCT03932968|clip ascent|clip ascent
5010207|NCT03932968|oesogastric reflux|oesogastric reflux
5010208|NCT03932968|sleeve gastrectomy follow-up|sleeve gastrectomy follow-up
5010209|NCT03932942|Anti-bacterial agents|anti-bacterial agents
5010210|NCT03932942|Emergency room|emergency room
5010211|NCT03932942|Respiratory pathogen|respiratory pathogen
5010212|NCT03932942|Point-of-care testing|point-of-care testing
5010213|NCT03932942|Patient admission|patient admission
5010220|NCT03932903|Adherence|adherence
5010221|NCT03932903|Adolescent|adolescent
5010222|NCT03932903|Young Adult|young adult
5010223|NCT03932903|Mobile Health|mobile health
5010224|NCT03932903|Oncology|oncology
5010225|NCT03932825|Nitrous Oxide|nitrous oxide
5010226|NCT03932825|Laughing Gas|laughing gas
5010227|NCT03932812|Alzheimer's disease|alzheimer's disease
5010228|NCT03932812|Dementia|dementia
5010229|NCT03932812|Caregiver|caregiver
5010230|NCT03932812|Bridging community|bridging community
5010231|NCT03932812|Bridging medical settings|bridging medical settings
5010232|NCT03932799|Workers' Compensation|workers' compensation
5010233|NCT03932799|Occupational Injuries|occupational injuries
5010234|NCT03932799|Drug Utilization Review|drug utilization review
5010235|NCT03932799|Humans|humans
5010236|NCT03932799|Adult|adult
5010237|NCT03932799|Cohort Studies|cohort studies
5010238|NCT03932799|Qualitative Research|qualitative research
5010239|NCT03932773|PTSD|ptsd
5010240|NCT03932773|post-traumatic stress disorder|post-traumatic stress disorder
5010241|NCT03932773|military-related PTSD|military-related ptsd
5010242|NCT03932773|CPT|cpt
5010243|NCT03932773|cognitive processing therapy|cognitive processing therapy
5010244|NCT03932773|rTMS|rtms
5010245|NCT03932773|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5010246|NCT03932773|combat|combat
5010247|NCT03932773|combat-related PTSD|combat-related ptsd
5010248|NCT03932747|Hydration|hydration
5010249|NCT03932747|UREA|urea
5010250|NCT03932734|Satisfaction|satisfaction
5010251|NCT03932734|Jawline augmentation|jawline augmentation
5010252|NCT03932734|Transgender|transgender
5010253|NCT03932734|Cosmetic jaw angle|cosmetic jaw angle
5010254|NCT03932721|Dyslipidemia|dyslipidemia
5010255|NCT03932721|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5010256|NCT03932721|Hypertension Arterial|hypertension arterial
5010257|NCT03932708|Antibiotic Stewardship|antibiotic stewardship
5010258|NCT03932708|Outpatient Antibiotic Stewardship|outpatient antibiotic stewardship
5010259|NCT03932708|Urgent Care|urgent care
5010260|NCT03932682|Influenza Vaccine|influenza vaccine
5010261|NCT03932669|spinocerebellar ataxia, treatment, nilotinib, bcr-abl inhibitor|spinocerebellar ataxia, treatment, nilotinib, bcr-abl inhibitor
5010262|NCT03932656|borderline personality disorder|borderline personality disorder
5010263|NCT03932656|latent toxoplasmosis|latent toxoplasmosis
5010264|NCT03932656|Toxoplasma gondii|toxoplasma gondii
5010265|NCT03932656|pharmacotherapy|pharmacotherapy
5010266|NCT03932656|psychotherapy|psychotherapy
5010267|NCT03932656|clinical features|clinical features
5010268|NCT03932630|artificial pancreas|artificial pancreas
5010269|NCT03932630|hybrid closed-loop|hybrid closed-loop
5010270|NCT03932630|low carbohydrate diet|low carbohydrate diet
5010271|NCT03932630|glucose control|glucose control
5010272|NCT03932591|Spasticity|spasticity
5010273|NCT03932591|kinesio tape|kinesio tape
5010274|NCT03932591|stretch reflex|stretch reflex
5010275|NCT03932591|H-reflex|h-reflex
5010276|NCT03932591|T-reflex|t-reflex
5010277|NCT03932578|Cesarean section|cesarean section
5010278|NCT03932578|Nausea and vomiting|nausea and vomiting
5010279|NCT03932578|Spinal Anesthesia|spinal anesthesia
5010280|NCT03932539|Immunosuppressive therapy|immunosuppressive therapy
5010281|NCT03932539|Tacrolimus|tacrolimus
5010282|NCT03932539|Heart transplantation|heart transplantation
5010283|NCT03932539|Pharmacokinetics|pharmacokinetics
5052082|NCT03672877|Walking|walking
5010284|NCT03932539|Pharmacogenetics|pharmacogenetics
5010285|NCT03932539|Acute rejection|acute rejection
5010286|NCT03932500|Validation|validation
5010290|NCT03932487|autoimmune thyroid disease|autoimmune thyroid disease
5010292|NCT03932474|probiotic|probiotic
5010293|NCT03932474|SAMe|same
5010294|NCT03932474|Lactobacillus plantarum 299v|lactobacillus plantarum 299v
5010295|NCT03932474|anxiety|anxiety
5010296|NCT03932474|insomnia|insomnia
5010297|NCT03932474|irritable bowel syndrome|irritable bowel syndrome
5010298|NCT03932474|randomized controlled study|randomized controlled study
5010299|NCT03932422|hypertension|hypertension
5010300|NCT03932422|resistant hypertension|resistant hypertension
5010301|NCT03932422|arterial stiffness|arterial stiffness
5010302|NCT03932422|sodium urine test|sodium urine test
5010303|NCT03932409|pembrolizumab|pembrolizumab
5010304|NCT03932409|radiation therapy|radiation therapy
5010305|NCT03932396|hepatitis C virus|hepatitis c virus
5010322|NCT03932292|Oral mucositis|oral mucositis
5010323|NCT03932292|Radiotherapy|radiotherapy
5010324|NCT03932292|Medical Device|medical device
5010325|NCT03932292|Non interventional study|non interventional study
5010326|NCT03932292|Mouth Wash|mouth wash
5010327|NCT03932292|§23b Medical Device Act|§23b medical device act
5010328|NCT03932266|Endostar|endostar
5010329|NCT03932266|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5010330|NCT03932266|Chemoradiotherapy|chemoradiotherapy
5010331|NCT03932266|Endostatin|endostatin
5010332|NCT03932240|Fibrinogen Concentrate|fibrinogen concentrate
5010334|NCT03932240|Cryoprecipitate|cryoprecipitate
5010335|NCT03932240|Transfusion|transfusion
5010336|NCT03932240|in vivo|in vivo
5010337|NCT03932240|Open-heart surgery|open-heart surgery
5010338|NCT03932240|Cardiopulmonary Bypass|cardiopulmonary bypass
5010339|NCT03932240|Fibrin Network Structure|fibrin network structure
5010340|NCT03932214|venous access|venous access
5010341|NCT03932214|illumination, infrared|illumination, infrared
5010342|NCT03932214|critically-ill|critically-ill
5010343|NCT03932214|catheterization|catheterization
5010344|NCT03932188|early psychosis|early psychosis
5010345|NCT03932188|prodrome|prodrome
5010346|NCT03932188|schizophrenia|schizophrenia
5010347|NCT03932188|psychosis|psychosis
5010348|NCT03932149|Alcohol Use Disorder|alcohol use disorder
5010349|NCT03932149|Intermittent Theta Burst Stimulation|intermittent theta burst stimulation
5010350|NCT03932149|Alcohol Dependence|alcohol dependence
5010351|NCT03932110|psoriasis vulgaris|psoriasis vulgaris
5010352|NCT03932110|psoriatic arthritis|psoriatic arthritis
5010353|NCT03932110|metabolic syndrome|metabolic syndrome
5010354|NCT03932110|omentin|omentin
5010355|NCT03932110|visfatin|visfatin
5010356|NCT03932084|Type 2 diabetes|type 2 diabetes
5010357|NCT03932084|Cerebral infarction|cerebral infarction
5010358|NCT03932084|Glucose fluctuation targeted intervention|glucose fluctuation targeted intervention
5010359|NCT03932019|Jitongning Tablet, Spondyloarthritis|jitongning tablet, spondyloarthritis
5010360|NCT03932006|ankylosing spondylitis|ankylosing spondylitis
5010361|NCT03932006|Fengshigutong Capsule|fengshigutong capsule
5010362|NCT03932006|imrecoxib|imrecoxib
5010363|NCT03931993|Grass MATA MPL|grass mata mpl
5010364|NCT03931993|Safety|safety
5010365|NCT03931980|rectal cancer|rectal cancer
5010366|NCT03931980|robotic surgery|robotic surgery
5010367|NCT03931980|laparoscopic surgery|laparoscopic surgery
5010368|NCT03931967|Sepsis|sepsis
5010369|NCT03931967|Septic shock|septic shock
5010370|NCT03931967|Microcirculation|microcirculation
5010371|NCT03931967|Glycocalix|glycocalix
5010372|NCT03931967|Proadrenomedullin|proadrenomedullin
5010373|NCT03931967|Organ dysfunction|organ dysfunction
5010374|NCT03931967|Critical Care|critical care
5010375|NCT03931967|Intensive Care|intensive care
5010376|NCT03931954|eosinophilic asthma|eosinophilic asthma
5010377|NCT03931954|severe asthma|severe asthma
5010378|NCT03931954|prevalence|prevalence
5010379|NCT03931954|phenotype|phenotype
5010380|NCT03931954|atopic phenotype|atopic phenotype
5010381|NCT03931954|eosinophilic phenotype|eosinophilic phenotype
5010382|NCT03931941|C. Difficile Diarrhea|c. difficile diarrhea
5010383|NCT03931941|Clostridium Difficile|clostridium difficile
5010384|NCT03931941|CDI|cdi
5010385|NCT03931941|FMT|fmt
5010386|NCT03931941|Fecal Microbiota Transplant|fecal microbiota transplant
5010387|NCT03931941|Microbiota Restoration Therapy|microbiota restoration therapy
5010388|NCT03931941|Diarrhea|diarrhea
5010389|NCT03931941|Microbial Suspension|microbial suspension
5010390|NCT03931941|Fecal Transplant|fecal transplant
5010391|NCT03931941|C Difficile Colitis|c difficile colitis
5010392|NCT03931941|Clostridium Difficile Associated Diarrhea|clostridium difficile associated diarrhea
5010393|NCT03931941|C diff diarrhea|c diff diarrhea
5010394|NCT03931941|C Difficile|c difficile
5010395|NCT03931941|C diff|c diff
5010396|NCT03931928|tamoxifen|tamoxifen
5010397|NCT03931928|endoxifen|endoxifen
5010398|NCT03931928|endocrine receptor positive breast cancer|endocrine receptor positive breast cancer
5010416|NCT03931811|Prolotherapy|prolotherapy
5010417|NCT03931811|Hypertonic dextrose solution injections|hypertonic dextrose solution injections
5010418|NCT03931811|Short-wave diathermy|short-wave diathermy
5010419|NCT03931798|Unilateral spatial neglect|unilateral spatial neglect
5010420|NCT03931798|Extrapersonal space|extrapersonal space
5010421|NCT03931798|Neuropsychology|neuropsychology
5010422|NCT03931785|Abdominal pain|abdominal pain
5010423|NCT03931785|Diarrhea|diarrhea
5010424|NCT03931785|Irritable Bowel Syndrome|irritable bowel syndrome
5010425|NCT03931759|diabetes mellitus|diabetes mellitus
5010426|NCT03931759|cardiac autonomic neuropathy|cardiac autonomic neuropathy
5010427|NCT03931759|laparoscopic surgery|laparoscopic surgery
5010428|NCT03931707|Newborn|newborn
5010429|NCT03931707|Hereditary Disease|hereditary disease
5010430|NCT03931707|Genetic Predisposition to Disease|genetic predisposition to disease
5010431|NCT03931707|Defect, Congenital|defect, congenital
5010432|NCT03931707|Genome Sequencing|genome sequencing
5010433|NCT03931707|Exome Sequencing|exome sequencing
5010434|NCT03931707|Newborn Screening|newborn screening
5010435|NCT03931707|Genetic Diseases, Inborn|genetic diseases, inborn
5010436|NCT03931694|Chronic pain|chronic pain
5010437|NCT03931694|e-Health|e-health
5010438|NCT03931668|tolerance|tolerance
5010439|NCT03931668|pharmacokinetics|pharmacokinetics
5010440|NCT03931668|pharmacodynamics|pharmacodynamics
5010441|NCT03931668|TPN-672|tpn-672
5010442|NCT03931655|Photoacoustic imaging|photoacoustic imaging
5010443|NCT03931655|Lymph nodes|lymph nodes
5010444|NCT03931655|micrometastases|micrometastases
5010445|NCT03931629|FEMTOSECOND LASER|femtosecond laser
5010446|NCT03931629|Femtosecond Laser-Assisted Cataract Surgery|femtosecond laser-assisted cataract surgery
5010447|NCT03931629|CATARACT SURGERY|cataract surgery
5010448|NCT03931629|phacoemulsification|phacoemulsification
5010449|NCT03931629|operation room workflow|operation room workflow
5010450|NCT03931629|public setting|public setting
5010451|NCT03931616|stroke|stroke
5010452|NCT03931616|prehospital|prehospital
5010453|NCT03931616|telemedicine|telemedicine
5010454|NCT03931616|thrombolysis|thrombolysis
5010455|NCT03931616|endovascular treatment|endovascular treatment
5010456|NCT03931616|functional outcome|functional outcome
5010457|NCT03931590|RTA 408|rta 408
5010458|NCT03931590|RTA 408 capsules|rta 408 capsules
5010459|NCT03931590|omaveloxolone|omaveloxolone
5010460|NCT03931590|omaveloxolone capsules|omaveloxolone capsules
5010461|NCT03931590|AME|ame
5010462|NCT03931590|mass balance|mass balance
5010463|NCT03931590|metabolite identification|metabolite identification
5010464|NCT03931577|Antimicrobial Stewardship|antimicrobial stewardship
5010465|NCT03931577|Cost-Benefit Analysis|cost-benefit analysis
5010466|NCT03931577|Anti-Bacterial Agents|anti-bacterial agents
5010467|NCT03931577|Primary Health Care|primary health care
5010468|NCT03931564|Glaucoma, Open-Angle|glaucoma, open-angle
5010469|NCT03931564|Trabeculectomy|trabeculectomy
5010470|NCT03931564|Intraocular Pressure|intraocular pressure
5010471|NCT03931564|Minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
5010472|NCT03931564|InnFocus Microshunt|innfocus microshunt
5010473|NCT03931564|PRESERFLO Microshunt|preserflo microshunt
5010474|NCT03931538|UTI|uti
5010475|NCT03931538|IC|ic
5010476|NCT03931525|Stretch Marks|stretch marks
5010477|NCT03931525|Skin Disease|skin disease
5010478|NCT03931525|Diathermy|diathermy
5010479|NCT03931525|Drug Delivery Systems|drug delivery systems
5428224|NCT01595594|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5010482|NCT03931434|coronary artery disease|coronary artery disease
5010483|NCT03931434|Endothelium|endothelium
5010484|NCT03931408|bladder|bladder
5010485|NCT03931408|spinal cord injury|spinal cord injury
5010486|NCT03931408|urinary tract infection|urinary tract infection
5010494|NCT03931330|Dysautonomia|dysautonomia
5010495|NCT03931226|drug consumption|drug consumption
5010496|NCT03931187|cognitive psychotherapy|cognitive psychotherapy
5010497|NCT03931187|progressive muscular relaxation|progressive muscular relaxation
5010498|NCT03931187|in vitro fertilization and embryo transfer(IVF-ET)|in vitro fertilization and embryo transfer(ivf-et)
5010499|NCT03931187|Couples Therapy|couples therapy
5010500|NCT03931174|implementation|implementation
5010501|NCT03931174|opioid use|opioid use
5010502|NCT03931161|carotid plaque morphology|carotid plaque morphology
5010503|NCT03931161|carotid plaque composition|carotid plaque composition
5010504|NCT03931161|evolocumab|evolocumab
5010505|NCT03931148|Neuroimaging|neuroimaging
5010506|NCT03931148|Dementia|dementia
5010507|NCT03931148|Decision making|decision making
5010508|NCT03931148|Neuropsychology|neuropsychology
5010509|NCT03931148|Aging|aging
5010510|NCT03931122|Ear Size|ear size
5010511|NCT03931109|Osteoporosis|osteoporosis
5010512|NCT03931109|primary hyperparathyroidism|primary hyperparathyroidism
5010513|NCT03931109|miRNA|mirna
5010514|NCT03931109|Bone remodeling|bone remodeling
5010515|NCT03931109|parathyroidectomy|parathyroidectomy
5010516|NCT03931109|Osteopenia|osteopenia
5010517|NCT03931109|postmenopausal|postmenopausal
5010518|NCT03931096|health related quality of life|health related quality of life
5010519|NCT03931096|congenital heart disease|congenital heart disease
5010520|NCT03931096|pediatrics|pediatrics
5010521|NCT03931096|cardiology|cardiology
5010522|NCT03931096|PedsQL 4.0|pedsql 4.0
5010523|NCT03931096|psychometric properties|psychometric properties
5010524|NCT03931044|Robotic surgery|robotic surgery
5010525|NCT03931044|fluorescence|fluorescence
5010526|NCT03931044|indocyanine green|indocyanine green
5010527|NCT03931044|lymphadenectomy|lymphadenectomy
5010528|NCT03931031|Viscoelastic testing|viscoelastic testing
5010529|NCT03931031|Coagulation|coagulation
5010530|NCT03931031|Quantra|quantra
5010531|NCT03931031|Hemostasis|hemostasis
5010532|NCT03931018|"binge drinking"|"binge drinking"
5010533|NCT03931018|"alcohol"|"alcohol"
5010534|NCT03931018|"pharmacokinetics"|"pharmacokinetics"
5010535|NCT03931018|"biomarkers"|"biomarkers"
5010536|NCT03930992|4 mg zoledronic acid|4 mg zoledronic acid
5010537|NCT03930992|Colaren|colaren
5010539|NCT03930992|Secondary Osteoporosis|secondary osteoporosis
5010540|NCT03930992|Man|man
5010541|NCT03930979|Procedural sedation|procedural sedation
5010542|NCT03930979|Cardiac output measurements non-invasive|cardiac output measurements non-invasive
5010543|NCT03930979|Emergency department|emergency department
5010544|NCT03930966|Severe trauma|severe trauma
5010545|NCT03930966|General anaesthesia|general anaesthesia
5010546|NCT03930966|Peri-traumatic dissociation state|peri-traumatic dissociation state
5010547|NCT03930966|Post-traumatic stress disorder|post-traumatic stress disorder
5010548|NCT03930953|Non-Hodgkin Lymphomas|non-hodgkin lymphomas
5010549|NCT03930953|Safety|safety
5010550|NCT03930953|Efficacy|efficacy
5010551|NCT03930953|CC-99282|cc-99282
5010552|NCT03930953|Rituximab|rituximab
5010553|NCT03930953|Relapsed|relapsed
5010554|NCT03930953|Refractory|refractory
5010555|NCT03930940|Spontenous intracerebral hemorrhage|spontenous intracerebral hemorrhage
5010556|NCT03930940|Hemorrhage resolution|hemorrhage resolution
5010557|NCT03930940|Remote ischemic conditioning|remote ischemic conditioning
5010558|NCT03930940|Neuroprotection|neuroprotection
5010559|NCT03930901|Intestinal Parasitic Infections|intestinal parasitic infections
5010560|NCT03930901|Soil-transmitted helminth infections|soil-transmitted helminth infections
5010561|NCT03930901|Health education|health education
5010562|NCT03930888|nutritional support|nutritional support
5010563|NCT03930888|colorectal cancer|colorectal cancer
5010564|NCT03930888|muscle strength|muscle strength
5010565|NCT03930888|muscle mass|muscle mass
5010566|NCT03930888|self-sufficiency|self-sufficiency
5010567|NCT03930849|Depression|depression
5010568|NCT03930849|Patient Participation|patient participation
5010569|NCT03930849|Text messaging|text messaging
5010570|NCT03930849|Patient Portals|patient portals
5010571|NCT03930836|motor function|motor function
5010572|NCT03930836|motor skill learning|motor skill learning
5010573|NCT03930784|physical function|physical function
5010574|NCT03930784|recovery|recovery
5010575|NCT03930784|abdominal|abdominal
5010576|NCT03930745|Bacterial vaginosis|bacterial vaginosis
5010577|NCT03930745|Candida albicans|candida albicans
5010583|NCT03930745|Suppression|suppression
5010584|NCT03930745|TOL-463 insert|tol-463 insert
5010585|NCT03930719|stroke|stroke
5010586|NCT03930719|delirium|delirium
5010587|NCT03930719|screening tool|screening tool
5010588|NCT03930693|Pregnancy|pregnancy
5010596|NCT03930641|neovascular age related macular degeneration intravitreal injection IVT|neovascular age related macular degeneration intravitreal injection ivt
5010597|NCT03930641|observation|observation
5010598|NCT03930563|inorganic nitrate|inorganic nitrate
5010599|NCT03930563|blood flow|blood flow
5010600|NCT03930563|Peripheral chemoreflex|peripheral chemoreflex
5010601|NCT03930563|Common carotid artery|common carotid artery
5010602|NCT03930511|Telemonitoring|telemonitoring
5010603|NCT03930511|Physical activity|physical activity
5010604|NCT03930511|Pulmonary Rehabilitation|pulmonary rehabilitation
5010605|NCT03930498|PD-1 antibody|pd-1 antibody
5010606|NCT03930498|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
5010607|NCT03930498|Chemotherapy|chemotherapy
5010608|NCT03930498|Efficacy|efficacy
5010609|NCT03930498|Adverse effects|adverse effects
5010610|NCT03930472|Farmers Markets|farmers markets
5010611|NCT03930472|Vouchers|vouchers
5010612|NCT03930433|Nebivolol|nebivolol
5010613|NCT03930420|evidence-based practice|evidence-based practice
5010717|NCT03929666|mFOLFOX6|mfolfox6
5010618|NCT03930407|Hayman uterine compression suture|hayman uterine compression suture
5010620|NCT03930407|Luteinizing hormone|luteinizing hormone
5010621|NCT03930407|Antral follicle count|antral follicle count
5010622|NCT03930381|Asthma|asthma
5010623|NCT03930355|Surgery|surgery
5010624|NCT03930355|Perioperative|perioperative
5010625|NCT03930355|Transfusion|transfusion
5010626|NCT03930355|Mortality|mortality
5010627|NCT03930303|dilatation and curettage|dilatation and curettage
5010628|NCT03930303|multimedia based education|multimedia based education
5010629|NCT03930303|anxiety|anxiety
5010630|NCT03930251|Cognitive Remediation|cognitive remediation
5010631|NCT03930238|Veterans|veterans
5010632|NCT03930225|Stigma|stigma
5010633|NCT03930225|Intervention program|intervention program
5010634|NCT03930225|Schizophrenia|schizophrenia
5010635|NCT03930199|Prosthesis|prosthesis
5010636|NCT03930199|Amputation|amputation
5010637|NCT03930199|Prosthetic|prosthetic
5010638|NCT03930199|Amputee|amputee
5010639|NCT03930199|Smartphone|smartphone
5010640|NCT03930199|Sensors|sensors
5010641|NCT03930199|Mobility|mobility
5010642|NCT03930160|Intensive care unit|intensive care unit
5010643|NCT03930160|Logistic Organ Dysfunction System|logistic organ dysfunction system
5324086|NCT02066064|Adenoma|adenoma
5010644|NCT03930160|30-day Mortality|30-day mortality
5010645|NCT03930160|Sepsis|sepsis
5010646|NCT03930160|Mortality prediction|mortality prediction
5010647|NCT03930147|Children|children
5010648|NCT03930147|Ventilation|ventilation
5010649|NCT03930147|Closed-loop mechanical ventilation|closed-loop mechanical ventilation
5010650|NCT03930147|Adaptive support ventilation|adaptive support ventilation
5010651|NCT03930134|caesarean|caesarean
5010652|NCT03930134|scar defect|scar defect
5010653|NCT03930134|sparse uterine suture|sparse uterine suture
5010654|NCT03930134|one layer uterine suture|one layer uterine suture
5010655|NCT03930134|blood loss|blood loss
5010656|NCT03930134|ultrasound|ultrasound
5010657|NCT03930121|Rehabilitation|rehabilitation
5010658|NCT03930121|Intensive speech-language therapy|intensive speech-language therapy
5010659|NCT03930121|Transcranial direct current stimulation|transcranial direct current stimulation
5010660|NCT03930108|Burn injury|burn injury
5010661|NCT03930108|Mortality prediction|mortality prediction
5010662|NCT03930108|SOFA score|sofa score
5010663|NCT03930108|Organ failure|organ failure
5010664|NCT03930082|Gastrointestinal surgery|gastrointestinal surgery
5010665|NCT03930082|Frailty|frailty
5010666|NCT03930082|Elder patient|elder patient
5010667|NCT03930082|Complication|complication
5010668|NCT03930056|Orthotic|orthotic
5010669|NCT03930056|C-Brace|c-brace
5010670|NCT03930017|Observational|observational
5010671|NCT03930017|Influenza|influenza
5010672|NCT03930017|Vaccine immunogenicity|vaccine immunogenicity
5010673|NCT03930017|Arsenic|arsenic
5010674|NCT03930017|Immunology|immunology
5010675|NCT03929991|Site infection|site infection
5010676|NCT03929991|Sierra Leone|sierra leone
5010679|NCT03929991|Maternal Mortality|maternal mortality
5010680|NCT03929965|Anlotinib|anlotinib
5010681|NCT03929965|FGFR|fgfr
5010682|NCT03929965|solid tumors|solid tumors
5010688|NCT03929900|Renal progression|renal progression
5010727|NCT03929614|Brace Treatment|brace treatment
5010728|NCT03929614|Health-related quality of life (HRQOL)|health-related quality of life (hrqol)
5010729|NCT03929614|Questionnaire development|questionnaire development
5010730|NCT03929588|myopia|myopia
5010731|NCT03929588|hyperopia|hyperopia
5010732|NCT03929562|Elective Surgery|elective surgery
5010733|NCT03929536|hip joint replacement|hip joint replacement
5010734|NCT03929536|hip joint preserving surgery|hip joint preserving surgery
5010735|NCT03929523|Liver Transplantation|liver transplantation
5010736|NCT03929523|Liver machine perfusion|liver machine perfusion
5010737|NCT03929523|extended criteria donor|extended criteria donor
5010738|NCT03929510|Phase 1|phase 1
5010739|NCT03929510|Male|male
5010740|NCT03929510|healthy|healthy
5010741|NCT03929484|Pneumonia|pneumonia
5010742|NCT03929484|Hypoxemia|hypoxemia
5010743|NCT03929484|Oxygen therapy|oxygen therapy
5010744|NCT03929484|Oxygen mask|oxygen mask
5010745|NCT03929458|oxidative stress|oxidative stress
5010746|NCT03929458|Sarcopenia|sarcopenia
5010747|NCT03929458|copy number of mitochondrial DNA (mtDNA)|copy number of mitochondrial dna (mtdna)
5010748|NCT03929445|Bougie|bougie
5010749|NCT03929445|Air Q|air q
5010750|NCT03929445|Fastrach|fastrach
5010751|NCT03929406|Deep Brain Stimulation|deep brain stimulation
5010752|NCT03929406|Tissue harvesting|tissue harvesting
5010753|NCT03929406|Molecular analysis - Proteomics|molecular analysis - proteomics
5010754|NCT03929393|Randomized controlled trial|randomized controlled trial
5010755|NCT03929393|Exercise|exercise
5010756|NCT03929393|Physical Activity|physical activity
5010757|NCT03929393|Behavior Change|behavior change
5010758|NCT03929393|Mindfulness|mindfulness
5010759|NCT03929393|Aging|aging
5010760|NCT03929380|Squat|squat
5010761|NCT03929380|Acute effect|acute effect
5010762|NCT03929380|Tendon thickness|tendon thickness
5010763|NCT03929380|Counter movement jump test|counter movement jump test
5010764|NCT03929380|Postural sway|postural sway
5010767|NCT03929354|Cardiovascular risk factors|cardiovascular risk factors
5010768|NCT03929354|Risk factor modification|risk factor modification
5010770|NCT03929315|one lung ventilation|one lung ventilation
5010771|NCT03929289|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5010772|NCT03929289|Healthy Subjects|healthy subjects
5010773|NCT03929276|adhesive capsulitis|adhesive capsulitis
5010774|NCT03929276|high-intensity laser therapy|high-intensity laser therapy
5010777|NCT03929198|metabolic syndrome|metabolic syndrome
5010778|NCT03929198|obesity|obesity
5010779|NCT03929185|Volatile organic compounds|volatile organic compounds
5010780|NCT03929185|colorectal cancer|colorectal cancer
5010781|NCT03929185|non invasive diagnostic tests|non invasive diagnostic tests
5010782|NCT03929185|medical device|medical device
5010783|NCT03929172|HPV-L2|hpv-l2
5324180|NCT02065648|MRA|mra
5010784|NCT03929133|fetal heart sounds|fetal heart sounds
5010785|NCT03929133|big data|big data
5010786|NCT03929133|cloud computing|cloud computing
5010787|NCT03929133|congenital heart disease|congenital heart disease
5010788|NCT03929133|data base|data base
5010789|NCT03929133|Acoustic structure design|acoustic structure design
5010790|NCT03929107|interleukin 7, Chemokine (C-C Motif) Ligand 19, CAR-T|interleukin 7, chemokine (c-c motif) ligand 19, car-t
5010791|NCT03929081|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5010792|NCT03929081|Inference Based Approach (IBA)|inference based approach (iba)
5010793|NCT03929081|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5010794|NCT03929081|Personalized care|personalized care
5010795|NCT03929081|Neurocognitive working mechanisms of treatment|neurocognitive working mechanisms of treatment
5010796|NCT03929081|Non-inferiority|non-inferiority
5010797|NCT03929081|Prediction of treatment efficiency|prediction of treatment efficiency
5010799|NCT03929068|PLS|pls
5010800|NCT03929068|Primary Lateral Sclerosis|primary lateral sclerosis
5010801|NCT03929042|AIS|ais
5010802|NCT03929029|Melanoma|melanoma
5010803|NCT03929016|First-in-human|first-in-human
5010804|NCT03929016|single ascending dose|single ascending dose
5010805|NCT03929016|healthy volunteer|healthy volunteer
5010806|NCT03928977|Transient Ischemic Attack|transient ischemic attack
5010807|NCT03928977|Stroke|stroke
5010808|NCT03928977|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5010809|NCT03928951|Urinary infections|urinary infections
5010810|NCT03928951|Antibiotherapy|antibiotherapy
5010811|NCT03928951|Emergency|emergency
5010812|NCT03928951|Reassessment|reassessment
5010830|NCT03928860|Peripheral arterial disease|peripheral arterial disease
5010831|NCT03928860|Osteopathic manual treatment|osteopathic manual treatment
5010832|NCT03928834|adolescence, HIV drug resistance mutations, genotyping, dried blood spots|adolescence, hiv drug resistance mutations, genotyping, dried blood spots
5010833|NCT03928808|Fecal Microbiota Transplantation|fecal microbiota transplantation
5010834|NCT03928795|neonatal ph|neonatal ph
5010835|NCT03928795|neonatal eucapnic ph|neonatal eucapnic ph
5010836|NCT03928795|fetal extraction|fetal extraction
5010837|NCT03928795|elective caesarean|elective caesarean
5010838|NCT03928795|apgar score|apgar score
5010839|NCT03928782|Radiation Injuries|radiation injuries
5010840|NCT03928782|microRNA|microrna
5010841|NCT03928769|Telomere length|telomere length
5010842|NCT03928769|Endothelial progenitor cell|endothelial progenitor cell
5010843|NCT03928769|Smooth muscle cell|smooth muscle cell
5010844|NCT03928769|Senescence|senescence
5010845|NCT03928756|substance use|substance use
5010846|NCT03928756|mobile health|mobile health
5010851|NCT03928717|adherence|adherence
5010852|NCT03928717|young adult|young adult
5010854|NCT03928717|mhealth|mhealth
5010855|NCT03928717|adolescent|adolescent
5010856|NCT03928717|viral load|viral load
5010865|NCT03928626|Binge Drinking|binge drinking
5010866|NCT03928626|Heavy Drinking|heavy drinking
5010867|NCT03928626|Young Adult|young adult
5010868|NCT03928626|Heavy Drinker|heavy drinker
5010869|NCT03928626|Regulation of craving|regulation of craving
5010870|NCT03928626|Cognitive behavioral therapy|cognitive behavioral therapy
5010871|NCT03928626|Neurocognitive training|neurocognitive training
5010872|NCT03928626|Emotion regulation|emotion regulation
5010873|NCT03928626|Alcohol|alcohol
5010874|NCT03928613|Cognitive training|cognitive training
5010875|NCT03928613|Cognitive intervention|cognitive intervention
5010876|NCT03928613|Cognitive rehabilitation|cognitive rehabilitation
5010877|NCT03928600|induction of labor|induction of labor
5010878|NCT03928600|cervical ripening|cervical ripening
5010879|NCT03928600|combined methods|combined methods
5010880|NCT03928574|Ultrasound-Guided Plane Block|ultrasound-guided plane block
5010881|NCT03928574|Conventional Block|conventional block
5010882|NCT03928561|Asthma|asthma
5010883|NCT03928561|Cat allergy|cat allergy
5010884|NCT03928561|Environmental Exposure Chamber|environmental exposure chamber
5010885|NCT03928561|Air cleaner|air cleaner
5010886|NCT03928457|preterm neonate|preterm neonate
5013349|NCT03913286|Utah array|utah array
5010888|NCT03928457|neurophysiological functions|neurophysiological functions
5010889|NCT03928444|Adipose tissue derived stem cells|adipose tissue derived stem cells
5010890|NCT03928444|Facial rejuvenation|facial rejuvenation
5010891|NCT03928431|microbiota|microbiota
5010892|NCT03928431|cesarean section|cesarean section
5010893|NCT03928431|vaginal delivery|vaginal delivery
5324281|NCT02065154|AML|aml
5010894|NCT03928431|allergy|allergy
5010895|NCT03928431|immunological programming|immunological programming
5010896|NCT03928405|Alzheimer's Dementia|alzheimer's dementia
5010897|NCT03928405|Balance|balance
5010898|NCT03928405|Gait Speed|gait speed
5010899|NCT03928405|Virtual Reality|virtual reality
5010900|NCT03928392|Post Traumatic Stress Disorder, Depression, Anxiety, Stress, SCUBA, Occupational therapy|post traumatic stress disorder, depression, anxiety, stress, scuba, occupational therapy
5010901|NCT03928366|Propofol, remifentanil, hypnosis, EEG, fMRI,|propofol, remifentanil, hypnosis, eeg, fmri,
5010902|NCT03928327|Drug Therapy|drug therapy
5010903|NCT03928314|GR antagonist|gr antagonist
5010904|NCT03928314|Glucocorticoid receptor antagonist|glucocorticoid receptor antagonist
5010905|NCT03928275|Interleukin-2|interleukin-2
5010906|NCT03928275|Bacillus Calmette Guerin|bacillus calmette guerin
5010907|NCT03928262|Pharmacokinetics|pharmacokinetics
5010908|NCT03928262|Safety|safety
5010909|NCT03928262|Tolerability|tolerability
5010928|NCT03928171|Pneumoperitoneum|pneumoperitoneum
5010929|NCT03928171|Peritoneal perfusion|peritoneal perfusion
5010930|NCT03928171|Intra-abdominal pressure|intra-abdominal pressure
5010931|NCT03928158|left ventricular hypertrophy|left ventricular hypertrophy
5010932|NCT03928158|diastolic dysfunction|diastolic dysfunction
5010933|NCT03928158|LCZ696|lcz696
5010934|NCT03928158|HFpEF|hfpef
5010936|NCT03928158|LV filling pressures|lv filling pressures
5010937|NCT03928145|Hypertension|hypertension
5010938|NCT03928145|Treatment|treatment
5010939|NCT03928145|Chlorthalidone|chlorthalidone
5010940|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide
5010941|NCT03928145|Amiloride|amiloride
5010942|NCT03928132|Diabetes and depression|diabetes and depression
5010943|NCT03928132|Continuing professional development|continuing professional development
5010944|NCT03928132|Continuing medical education|continuing medical education
5010945|NCT03928132|Sex and gender|sex and gender
5010946|NCT03928132|Minority languages|minority languages
5010947|NCT03928132|Knowledge translation|knowledge translation
5010948|NCT03928119|Acute myocardial infarction|acute myocardial infarction
5010949|NCT03928119|STEMI|stemi
5010950|NCT03928119|regional network|regional network
5010951|NCT03928106|Medication Reconciliation|medication reconciliation
5010952|NCT03928080|diagnostic accuracy|diagnostic accuracy
5010953|NCT03928080|early detection|early detection
5010954|NCT03928080|self-assessment|self-assessment
5010955|NCT03928080|periodontitis|periodontitis
5010956|NCT03928067|alcohol|alcohol
5010957|NCT03928067|sexual violence|sexual violence
5010958|NCT03928067|risky sex|risky sex
5010959|NCT03928067|college students|college students
5010960|NCT03928041|Lumbar Degenerative Disc Disease|lumbar degenerative disc disease
5010961|NCT03928041|Spondylolisthesis|spondylolisthesis
5010962|NCT03928015|marijuana|marijuana
5010963|NCT03928015|dronabinol|dronabinol
5010964|NCT03928015|morphine milligram equivalents|morphine milligram equivalents
5010965|NCT03928002|Eisenmenger|eisenmenger
5010966|NCT03928002|Pulmonary arterial hypertension|pulmonary arterial hypertension
5010967|NCT03928002|Magnetic resonance imaging|magnetic resonance imaging
5010968|NCT03928002|4Dflow imagery|4dflow imagery
5010969|NCT03928002|cardiac catheterization|cardiac catheterization
5010970|NCT03927950|Treatment efficacy|treatment efficacy
5010971|NCT03927950|Safety|safety
5010972|NCT03927924|Prostate Cancer|prostate cancer
5010973|NCT03927924|Focal Therapy|focal therapy
5010974|NCT03927924|High-intensity focused ultrasound|high-intensity focused ultrasound
5010975|NCT03927833|Infant, Newborn, Diseases|infant, newborn, diseases
5010976|NCT03927833|Phototherapy|phototherapy
5010977|NCT03927820|inhaler|inhaler
5010978|NCT03927820|pharmacy|pharmacy
5010979|NCT03927807|misoprostol|misoprostol
5010980|NCT03927794|Self-Assembling Peptide P11-4|self-assembling peptide p11-4
5010981|NCT03927794|Biomimetic Remineralization|biomimetic remineralization
5010982|NCT03927794|White spot lesions|white spot lesions
5010983|NCT03927794|Primary Anterior Teeth|primary anterior teeth
5010984|NCT03927794|Biomimetic Mineralization|biomimetic mineralization
5010985|NCT03927781|Pregabalin|pregabalin
5010986|NCT03927781|Perioperative medicine|perioperative medicine
5010987|NCT03927781|Opioid sparing|opioid sparing
5010988|NCT03927781|Urolithiasis|urolithiasis
5010989|NCT03927781|Ureteroscopy|ureteroscopy
5010990|NCT03927755|Bedside Ultrasound|bedside ultrasound
5010991|NCT03927742|sun protection|sun protection
5010992|NCT03927742|sunburn|sunburn
5010993|NCT03927729|Methoxyflurane|methoxyflurane
5010994|NCT03927729|Penthrox|penthrox
5010995|NCT03927729|non opioid analgesia|non opioid analgesia
5010996|NCT03927729|traumatic pain|traumatic pain
5010997|NCT03927729|pain|pain
5010998|NCT03927729|antalgic protocol|antalgic protocol
5010999|NCT03927729|emergency department|emergency department
5011024|NCT03927521|Local recurrence|local recurrence
5011025|NCT03927508|Pulmonary Embolism|pulmonary embolism
5011026|NCT03927417|oocyte yield|oocyte yield
5011027|NCT03927417|ethnicity|ethnicity
5011028|NCT03927417|ovarian stimulation|ovarian stimulation
5011032|NCT03927391|enzalutamide|enzalutamide
5011033|NCT03927391|cognitive side effects|cognitive side effects
5011034|NCT03927378|Perinatal Depression|perinatal depression
5011035|NCT03927378|Ketamine|ketamine
5011036|NCT03927378|Postpartum Depression|postpartum depression
5011037|NCT03927339|Osteoarthritis- Obesity- single aerobic exercise session|osteoarthritis- obesity- single aerobic exercise session
5011038|NCT03927313|TB meningitis, HIV|tb meningitis, hiv
5011039|NCT03927300|Home Peritoneal Dialysis|home peritoneal dialysis
5011040|NCT03927274|Glioma|glioma
5011041|NCT03927274|Brain Tumor|brain tumor
5011042|NCT03927274|High Grade Glioma|high grade glioma
5011043|NCT03927261|MDS|mds
5011044|NCT03927261|AML|aml
5011045|NCT03927235|Transbronchial Cryobiopsy|transbronchial cryobiopsy
5011046|NCT03927235|freezing time|freezing time
5011047|NCT03927235|Diagnostic Yield|diagnostic yield
5011048|NCT03927235|Safety|safety
5707851|NCT00472849|Ara-C|ara-c
5011049|NCT03927235|Diffuse Parenchymal Lung Disease|diffuse parenchymal lung disease
5011050|NCT03927222|Glioblastoma|glioblastoma
5011051|NCT03927222|Dendritic cells|dendritic cells
5011052|NCT03927222|Temozolomide|temozolomide
5011053|NCT03927222|Tetanus|tetanus
5011054|NCT03927222|David Ashley|david ashley
5011055|NCT03927222|Immunotherapy|immunotherapy
5011056|NCT03927222|Vaccine|vaccine
5011057|NCT03927196|primary prevention|primary prevention
5011058|NCT03927196|cardiovascular risk|cardiovascular risk
5011059|NCT03927196|hyperlipidaemia|hyperlipidaemia
5011060|NCT03927196|adherence|adherence
5011061|NCT03927183|Person-centred care|person-centred care
5011062|NCT03927183|Clinical pathway|clinical pathway
5006155|NCT03958110|OCT|oct
5011063|NCT03927183|Intervention|intervention
5011064|NCT03927183|Quasi-experimental|quasi-experimental
5011074|NCT03927131|Vaccine|vaccine
5011075|NCT03927118|Diabetic maculopathy|diabetic maculopathy
5011076|NCT03927118|dexamethasone implant|dexamethasone implant
5011077|NCT03927118|optic disc|optic disc
5011078|NCT03927118|vascular endothelial growth factor|vascular endothelial growth factor
5011079|NCT03927092|multiple sclerosis|multiple sclerosis
5011080|NCT03927092|surveys and questionnaires|surveys and questionnaires
5011081|NCT03927092|diagnostic self evaluation|diagnostic self evaluation
5011082|NCT03927079|Antibiotics|antibiotics
5011083|NCT03927079|Pneumonia|pneumonia
5011084|NCT03927079|broncho-alveolar lavage|broncho-alveolar lavage
5011085|NCT03927053|substance use|substance use
5011090|NCT03927014|oxidative stress|oxidative stress
5011091|NCT03927014|mercaptan|mercaptan
5011092|NCT03927014|severity|severity
5011093|NCT03926936|fulvestrant|fulvestrant
5011094|NCT03926936|low-grade gynecological cancer|low-grade gynecological cancer
5011095|NCT03926936|efficacy|efficacy
5011096|NCT03926923|stress response|stress response
5011097|NCT03926923|neurodevelopment|neurodevelopment
5011098|NCT03926923|newborn|newborn
5011099|NCT03926910|Preload-dependency|preload-dependency
5011100|NCT03926910|hypotension|hypotension
5011101|NCT03926910|cardiac surgery|cardiac surgery
5011102|NCT03926910|delta PP|delta pp
5011104|NCT03926910|Fluid responsiveness|fluid responsiveness
5011105|NCT03926858|post-surgical pain|post-surgical pain
5011106|NCT03926858|health-related quality of life|health-related quality of life
5011107|NCT03926845|Isobutylamido-thiazolyl-resorcinol|isobutylamido-thiazolyl-resorcinol
5011108|NCT03926832|CPAP|cpap
5011109|NCT03926819|Anemia, Sickle Cell|anemia, sickle cell
5011110|NCT03926819|Anemia, Hemolytic, Congenital|anemia, hemolytic, congenital
5011111|NCT03926819|Anemia, Hemolytic|anemia, hemolytic
5011112|NCT03926819|Anemia|anemia
5011113|NCT03926819|Hematologic Diseases|hematologic diseases
5011114|NCT03926819|Hemoglobinopathies|hemoglobinopathies
5011115|NCT03926819|Genetic Diseases, Inborn|genetic diseases, inborn
5011116|NCT03926819|Carbon Monoxide|carbon monoxide
5011142|NCT03926637|Clinically Isolated Syndrome|clinically isolated syndrome
5011145|NCT03926611|Angioedema Activity Score|angioedema activity score
5011146|NCT03926598|Observational|observational
5011147|NCT03926598|Mobile Applications|mobile applications
5011148|NCT03926533|Post-Intensive Care Syndrome|post-intensive care syndrome
5011149|NCT03926520|ECT|ect
5011150|NCT03926520|Agitation|agitation
5011151|NCT03926520|Alzheimer's|alzheimer's
5011152|NCT03926520|Dementia|dementia
5011153|NCT03926494|Carbon monoxide poisoning|carbon monoxide poisoning
5011154|NCT03926494|Oxygen|oxygen
5011155|NCT03926494|Coma|coma
5011156|NCT03926494|Hyperbaric oxygen|hyperbaric oxygen
5011157|NCT03926481|weight loss|weight loss
5011158|NCT03926481|cognition|cognition
5011159|NCT03926481|sarcopenia|sarcopenia
5011160|NCT03926481|obesity|obesity
5011161|NCT03926481|lifestyle|lifestyle
5011162|NCT03926468|Liquid biopsy|liquid biopsy
5011163|NCT03926468|FDG PET-CT|fdg pet-ct
5011164|NCT03926442|Spices|spices
5011165|NCT03926442|Herbs|herbs
5011166|NCT03926442|Metabolic responses|metabolic responses
5011167|NCT03926442|Endothelial function|endothelial function
5011168|NCT03926442|Inflammatory markers|inflammatory markers
5011169|NCT03926416|vaccines|vaccines
5011170|NCT03926416|live-attenuated vaccine|live-attenuated vaccine
5011171|NCT03926416|influenza vaccine|influenza vaccine
5011172|NCT03926403|hypnosis|hypnosis
5011173|NCT03926403|local anaesthesia|local anaesthesia
5011174|NCT03926403|outpatient surgery|outpatient surgery
5011175|NCT03926403|face surgery|face surgery
5324477|NCT02064452|online|online
5011176|NCT03926377|osteoporosis|osteoporosis
5011177|NCT03926377|dermocortocoids|dermocortocoids
5011178|NCT03926377|bullous pemphigoid|bullous pemphigoid
5011179|NCT03926377|pharmacoepidemiology|pharmacoepidemiology
5011180|NCT03926364|Pain drawings|pain drawings
5011181|NCT03926364|referred pain|referred pain
5011182|NCT03926364|somatic pain|somatic pain
5011183|NCT03926364|neuropathic pain|neuropathic pain
5011184|NCT03926364|e-health|e-health
5011185|NCT03926364|pain location|pain location
5011186|NCT03926364|biopsychosocial factors|biopsychosocial factors
5011187|NCT03926364|back pain|back pain
5011188|NCT03926364|neck pain|neck pain
5011189|NCT03926364|pain extent|pain extent
5011191|NCT03926312|myocardial infarction|myocardial infarction
5011192|NCT03926312|cardiac rehabilitation|cardiac rehabilitation
5011193|NCT03926312|smart device|smart device
5011194|NCT03926312|remote monitoring|remote monitoring
5011195|NCT03926312|telemonitoring|telemonitoring
5011206|NCT03926247|within-group longitudinal design|within-group longitudinal design
5011208|NCT03926208|Foot|foot
5011209|NCT03926208|Ankle|ankle
5011210|NCT03926208|Nail fold|nail fold
5011211|NCT03926208|Scrub|scrub
5011212|NCT03926208|Infection|infection
5053087|NCT03666793|Elderly|elderly
5006214|NCT03957629|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5011213|NCT03926208|Prevention|prevention
5011214|NCT03926208|Postoperative|postoperative
5011219|NCT03926143|Mesothelin|mesothelin
5011220|NCT03926143|Mesothelioma|mesothelioma
5011221|NCT03926117|IL-6|il-6
5011222|NCT03926117|CRP|crp
5011223|NCT03926117|Chronic Kidney Disease|chronic kidney disease
5011224|NCT03926117|Cardiovascular Disease|cardiovascular disease
5011225|NCT03926117|Inflammation|inflammation
5011226|NCT03926091|docetaxel|docetaxel
5011227|NCT03926091|cyclophosphamide|cyclophosphamide
5011228|NCT03926091|adjuvant chemotherapy|adjuvant chemotherapy
5011229|NCT03926078|Haller Index|haller index
5011230|NCT03926078|Optical Imaging|optical imaging
5011231|NCT03926078|Torso Topography|torso topography
5011232|NCT03926078|Three-dimensional Surface Scan|three-dimensional surface scan
5011233|NCT03926078|Diagnostic accuracy|diagnostic accuracy
5011238|NCT03925948|Type 2 diabetes|type 2 diabetes
5011239|NCT03925948|African American|african american
5011240|NCT03925948|numeracy|numeracy
5011241|NCT03925948|self-management|self-management
5011242|NCT03925948|glucose control|glucose control
5011243|NCT03925909|Eriocitrin|eriocitrin
5011244|NCT03925909|Citrus bioflavonoids|citrus bioflavonoids
5011245|NCT03925909|Flavanone|flavanone
5011246|NCT03925909|Pre-diabetes|pre-diabetes
5011247|NCT03925909|Blood glucose|blood glucose
5011248|NCT03925909|Microbiome|microbiome
5011249|NCT03925896|EBV TCR-T cells|ebv tcr-t cells
5011250|NCT03925896|recurrent|recurrent
5011251|NCT03925896|metastatic|metastatic
5011252|NCT03925883|Colorectal cancer screening|colorectal cancer screening
5011253|NCT03925883|Cancer screening|cancer screening
5011254|NCT03925883|Risk prediction model|risk prediction model
5011255|NCT03925883|Patient navigation|patient navigation
5011256|NCT03925883|Colonoscopy|colonoscopy
5011257|NCT03925857|Allocetra-OTS|allocetra-ots
5011258|NCT03925857|Cell based therapy|cell based therapy
5011259|NCT03925857|Apoptotic cells|apoptotic cells
5011260|NCT03925844|Cardiovascular risk prediction models|cardiovascular risk prediction models
5011261|NCT03925844|Framingham risk function|framingham risk function
5011272|NCT03925792|body-mind|body-mind
5011273|NCT03925792|resilience|resilience
5011274|NCT03925766|biliary disease|biliary disease
5011275|NCT03925766|gallstones|gallstones
5011276|NCT03925766|obesity|obesity
5011277|NCT03925753|autophagy|autophagy
5011278|NCT03925753|inflammatory markers|inflammatory markers
5011279|NCT03925740|caries|caries
5011280|NCT03925740|interproximal caries|interproximal caries
5011281|NCT03925740|MI varnish|mi varnish
5011282|NCT03925740|PreviDent varnish|prevident varnish
5011283|NCT03925740|Fluoride|fluoride
5011284|NCT03925740|1.23% ACP Fluoride|1.23% acp fluoride
5011285|NCT03925688|heterotopic ossification|heterotopic ossification
5011286|NCT03925688|serum uric acid，|serum uric acid，
5011287|NCT03925688|elbow joint|elbow joint
5011289|NCT03925649|stem cells|stem cells
5011290|NCT03925649|quadriplegia|quadriplegia
5011291|NCT03925649|spinal cord injury|spinal cord injury
5011292|NCT03925649|paralysis|paralysis
5011293|NCT03925649|MSCs|mscs
5011294|NCT03925636|Specific Carbohydrate Diet|specific carbohydrate diet
5011295|NCT03925636|Clostridium Difficile Infection|clostridium difficile infection
5026509|NCT03833063|botulinumtoxin|botulinumtoxin
5011303|NCT03925493|Graded exercise testing|graded exercise testing
5011304|NCT03925493|Cardiac rehab|cardiac rehab
5011305|NCT03925493|Exercise Prescription|exercise prescription
5011306|NCT03925493|Target heart rate range|target heart rate range
5011307|NCT03925493|RPE|rpe
5011308|NCT03925467|knee osteoarthritis|knee osteoarthritis
5011309|NCT03925467|acupuncture|acupuncture
5011310|NCT03925467|radial pressure pulse-wave|radial pressure pulse-wave
5011311|NCT03925467|spectral energy|spectral energy
5011312|NCT03925441|Post-marketing|post-marketing
5011313|NCT03925441|Adalimumab|adalimumab
5011314|NCT03925441|Humira|humira
5011315|NCT03925441|Pediatric|pediatric
5011316|NCT03925441|Chronic severe plaque psoriasis|chronic severe plaque psoriasis
5011317|NCT03925441|Psoriasis|psoriasis
5011326|NCT03925389|Peak Nasal Inspiratory Flow|peak nasal inspiratory flow
5011327|NCT03925389|Esthetics|esthetics
5011328|NCT03925376|Redo cardiac surgery|redo cardiac surgery
5011329|NCT03925376|Outcome|outcome
5011330|NCT03925350|Homologous recombination (HR)|homologous recombination (hr)
5011331|NCT03925350|Mutation|mutation
5011332|NCT03925350|Niraparib|niraparib
5011333|NCT03925350|PARP inhibitor|parp inhibitor
5011334|NCT03925311|Transcriptome|transcriptome
5011335|NCT03925311|endometrial receptivity|endometrial receptivity
5011336|NCT03925298|acute ischemic stroke|acute ischemic stroke
5011337|NCT03925298|troponin-I|troponin-i
5011339|NCT03925298|intravenous thrombolytic therapy|intravenous thrombolytic therapy
5011340|NCT03925272|immune system|immune system
5011341|NCT03925272|environmental interactions|environmental interactions
5011342|NCT03925272|genetic component|genetic component
5011344|NCT03925259|dismantling|dismantling
5011345|NCT03925259|long term conditions|long term conditions
5011346|NCT03925246|Recurrent high grade gliomas|recurrent high grade gliomas
5011347|NCT03925246|IDH mutation|idh mutation
5011348|NCT03925246|Immune Checkpoint inhibitor|immune checkpoint inhibitor
5011349|NCT03925246|Nivolumab|nivolumab
5011350|NCT03925233|Drug sensitivity experiment|drug sensitivity experiment
5011351|NCT03925233|Resistance mechanism research|resistance mechanism research
5011352|NCT03925220|Primary Prevention|primary prevention
5011353|NCT03925220|Adolescent Behavior|adolescent behavior
5011354|NCT03925220|Family|family
5011355|NCT03925220|Personal Communication|personal communication
5011356|NCT03925207|retrobulbar block|retrobulbar block
5011357|NCT03925207|general anesthesia|general anesthesia
5011358|NCT03925168|end stage kidney disease|end stage kidney disease
5011359|NCT03925168|depression|depression
5011360|NCT03925168|major depressive disorder|major depressive disorder
5011361|NCT03925168|anxiety|anxiety
5011362|NCT03925168|generalized anxiety disorder|generalized anxiety disorder
5011363|NCT03925168|music therapy|music therapy
5011364|NCT03925168|dialysis|dialysis
5011365|NCT03925168|quality of life|quality of life
5011366|NCT03925168|blood pressure|blood pressure
5011373|NCT03925155|vaginal prep|vaginal prep
5011374|NCT03925155|randomization|randomization
5011375|NCT03925155|chlorhexidine|chlorhexidine
5011376|NCT03925155|povidone iodine|povidone iodine
5011377|NCT03925142|beef|beef
5011378|NCT03925142|cardio-metabolic disease|cardio-metabolic disease
5011379|NCT03925116|contraceptive pathway|contraceptive pathway
5011380|NCT03925116|continuation|continuation
5011381|NCT03925103|VATS|vats
5011382|NCT03925103|Lobectomy|lobectomy
5011383|NCT03925103|3D VATS|3d vats
5011384|NCT03925103|VATS Ergonomics|vats ergonomics
5011385|NCT03925103|Non small cell lung cancer|non small cell lung cancer
5011386|NCT03925103|Three-dimensional thoracoscopy|three-dimensional thoracoscopy
5011387|NCT03924999|Lipedema|lipedema
5011388|NCT03924999|Combined decongestive treatment|combined decongestive treatment
5011389|NCT03924999|Intermittent pneumatic compression|intermittent pneumatic compression
5011390|NCT03924960|fibromyalgia|fibromyalgia
5011391|NCT03924960|functional capacity|functional capacity
5011392|NCT03924960|aerobic exercise|aerobic exercise
5011393|NCT03924947|Cystic Fibrosis|cystic fibrosis
5011394|NCT03924947|Creon|creon
5011395|NCT03924947|Pancrelipase|pancrelipase
5011396|NCT03924947|ABT-SLV-245|abt-slv-245
5423181|NCT01616784|Diabetes Mellitus|diabetes mellitus
5011401|NCT03924921|relaxation|relaxation
5011402|NCT03924921|quality of life|quality of life
5011403|NCT03924921|symptoms|symptoms
5011404|NCT03924921|pain|pain
5011405|NCT03924921|depression|depression
5011406|NCT03924921|anxiety|anxiety
5011407|NCT03924921|sleep problems|sleep problems
5011408|NCT03924921|fatigue|fatigue
5011412|NCT03924882|Anlotinib; Ovarian cancer|anlotinib; ovarian cancer
5011821|NCT03922568|MACS|macs
5011429|NCT03924791|Herniated intervertebral lumbar disk|herniated intervertebral lumbar disk
5011430|NCT03924791|Cost-effectiveness|cost-effectiveness
5011431|NCT03924765|Exoskeleton|exoskeleton
5011432|NCT03924752|Exoskeleton|exoskeleton
5011433|NCT03924739|Atrial fibrillation|atrial fibrillation
5011434|NCT03924739|Self-care|self-care
5011435|NCT03924739|Model of care|model of care
5011436|NCT03924739|Nurse-led|nurse-led
5011437|NCT03924739|Disease management|disease management
5011438|NCT03924739|Empowerment|empowerment
5011439|NCT03924713|Community health worker|community health worker
5011440|NCT03924713|health care utilization|health care utilization
5011441|NCT03924700|Herniated intervertebral disc|herniated intervertebral disc
5011442|NCT03924700|Discectomy|discectomy
5011443|NCT03924700|Microscope|microscope
5011444|NCT03924700|Biportal endoscopy|biportal endoscopy
5011445|NCT03924687|chronic pain|chronic pain
5445441|NCT01521780|hepatocellular carcinoma|hepatocellular carcinoma
5011446|NCT03924687|Acceptance or Commitment Therapy (ACT)|acceptance or commitment therapy (act)
5011447|NCT03924687|self-help|self-help
5011448|NCT03924687|pain-related disability|pain-related disability
5011449|NCT03924687|psychological inflexibility|psychological inflexibility
5011450|NCT03924687|depression|depression
5011451|NCT03924687|pain acceptance|pain acceptance
5011452|NCT03924687|bibliotherapy|bibliotherapy
5011453|NCT03924648|Premature menopause|premature menopause
5011454|NCT03924648|Premature ovarian insufficiency|premature ovarian insufficiency
5011461|NCT03924622|Pressure injury/prevention|pressure injury/prevention
5011462|NCT03924622|Military Nursing|military nursing
5011463|NCT03924622|Risk Reduction|risk reduction
5011464|NCT03924596|Renal Stones|renal stones
5011465|NCT03924596|Kidney Stones|kidney stones
5011466|NCT03924596|Renal Calculi|renal calculi
5011467|NCT03924596|Kidney Calculi|kidney calculi
5011468|NCT03924596|Urinary Calculi|urinary calculi
5011469|NCT03924596|Urolithiasis|urolithiasis
5011470|NCT03924596|Frankincense|frankincense
5011471|NCT03924596|Olibanum|olibanum
5011472|NCT03924596|Boswellia|boswellia
5011473|NCT03924596|Boswellic acid|boswellic acid
5011474|NCT03924596|Clinical Trial|clinical trial
5011475|NCT03924531|Hypertension|hypertension
5011476|NCT03924531|Health Behavior|health behavior
5011477|NCT03924531|Mindfulness|mindfulness
5011478|NCT03924531|Meditation|meditation
5011479|NCT03924518|sepsis|sepsis
5011480|NCT03924518|septic shock|septic shock
5011481|NCT03924518|granisetron|granisetron
5011482|NCT03924505|Opioid Overdose Prevention|opioid overdose prevention
5011483|NCT03924505|Naloxone Implementation|naloxone implementation
5011484|NCT03924505|Implementation Science|implementation science
5011485|NCT03924492|Expanded Access|expanded access
5011486|NCT03924479|heart failure preserved ejection fraction|heart failure preserved ejection fraction
5011487|NCT03924479|exercise|exercise
5011488|NCT03924479|respiratory muscle|respiratory muscle
5011489|NCT03924466|HER2|her2
5011490|NCT03924414|Parkinson Disease|parkinson disease
5013909|NCT03909997|Risk factors|risk factors
5011504|NCT03924401|Mismatched unrelated donor|mismatched unrelated donor
5342933|NCT01981473|rheumatoid arthritis|rheumatoid arthritis
5011508|NCT03924388|Autonomic Dysreflexia|autonomic dysreflexia
5011509|NCT03924388|Spinal Cord Stimulation|spinal cord stimulation
5011510|NCT03924336|stage 3 periodontitis|stage 3 periodontitis
5011511|NCT03924336|A-PRF|a-prf
5011512|NCT03924336|Advanced platelet rich fibrin|advanced platelet rich fibrin
5011515|NCT03924336|2-wall intraosseous defect|2-wall intraosseous defect
5011516|NCT03924336|3-wall intraosseous defect|3-wall intraosseous defect
5011517|NCT03924310|myoelectric prostheses|myoelectric prostheses
5011518|NCT03924310|closed-loop control|closed-loop control
5011530|NCT03924154|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
5011531|NCT03924154|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
5011532|NCT03924154|RVT-1201|rvt-1201
5011533|NCT03924154|Rodatristat ethyl|rodatristat ethyl
5011534|NCT03924154|Tryptophan hydroxylase (TPH)|tryptophan hydroxylase (tph)
5011535|NCT03924154|Serotonin reduction|serotonin reduction
5011536|NCT03924154|ELEVATE 1|elevate 1
5011538|NCT03924141|De-escalation|de-escalation
5011539|NCT03924141|Aggression|aggression
5011540|NCT03924141|Violence prevention|violence prevention
5011541|NCT03924115|Adherence, Hypertension, Mobil App, video|adherence, hypertension, mobil app, video
5011542|NCT03924063|total shoulder|total shoulder
5011543|NCT03924063|failure|failure
5011544|NCT03924063|salvage|salvage
5011545|NCT03924024|Depression|depression
5011546|NCT03924024|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5011547|NCT03924024|Theta Burst|theta burst
5011548|NCT03924024|Orthopaedic Trauma|orthopaedic trauma
5011549|NCT03924024|Pain|pain
5011550|NCT03924011|Radiodermatitis|radiodermatitis
5011551|NCT03924011|Breast cancer|breast cancer
5011552|NCT03924011|Radiotherapy|radiotherapy
5011553|NCT03924011|Photobiomodulation therapy|photobiomodulation therapy
5011554|NCT03924011|Low-level light therapy|low-level light therapy
5011555|NCT03924011|Skin diseases|skin diseases
5011556|NCT03924011|Radiation injuries|radiation injuries
5011557|NCT03924011|Wounds and injuries|wounds and injuries
5011558|NCT03924011|Oncology|oncology
5011559|NCT03923998|Oral neoplasms|oral neoplasms
5011560|NCT03923998|Mouth neoplasms|mouth neoplasms
5011561|NCT03923985|Vaginal Flora|vaginal flora
5011562|NCT03923985|Oral Probiotics|oral probiotics
5011563|NCT03923972|physical activity|physical activity
5011564|NCT03923972|exercise training|exercise training
5011565|NCT03923972|surveys and questionnaires|surveys and questionnaires
5011566|NCT03923972|chronic kidney disease|chronic kidney disease
5011567|NCT03923972|dialysis|dialysis
5011568|NCT03923972|kidney transplantation|kidney transplantation
5011569|NCT03923972|health care facilities|health care facilities
5011570|NCT03923959|Blood|blood
5011571|NCT03923959|Transfusion|transfusion
5011572|NCT03923959|Hip|hip
5006533|NCT03955536|Cardiac Rehabilitation|cardiac rehabilitation
5006534|NCT03955536|Virtual Reality|virtual reality
5006535|NCT03955536|Respiratory Muscle Training|respiratory muscle training
5011573|NCT03923959|Fracture|fracture
5011574|NCT03923959|Surgery|surgery
5011575|NCT03923959|Replacement|replacement
5011576|NCT03923959|Trauma|trauma
5011582|NCT03923933|Diuretics|diuretics
5011583|NCT03923933|Bumetanide|bumetanide
5011584|NCT03923933|Chlorthalidone|chlorthalidone
5011585|NCT03923933|Chronic Kidney Disease|chronic kidney disease
5011586|NCT03923933|Volume Overload|volume overload
5011587|NCT03923920|Biopsy|biopsy
5011588|NCT03923920|Surgery|surgery
5011589|NCT03923920|Screening|screening
5011590|NCT03923881|Multispectral Optoacoustic Tomography|multispectral optoacoustic tomography
5011591|NCT03923881|Molecular Imaging|molecular imaging
5011592|NCT03923881|Cetuximab-800CW|cetuximab-800cw
5011595|NCT03923829|zinc|zinc
5014012|NCT03909191|HBV RNA|hbv rna
5011605|NCT03923725|Amodiaquine|amodiaquine
5011606|NCT03923725|Artesunate|artesunate
5011607|NCT03923725|Piperaquine|piperaquine
5011608|NCT03923725|Mefloquine|mefloquine
5011609|NCT03923712|Physical exercise|physical exercise
5011610|NCT03923712|ageing|ageing
5011611|NCT03923712|dementia|dementia
5011612|NCT03923712|Alzheimer|alzheimer
5011613|NCT03923712|magnetic resonance image|magnetic resonance image
5011614|NCT03923712|cerebral|cerebral
5011615|NCT03923712|cognition|cognition
5011616|NCT03923712|metabolomic|metabolomic
5011617|NCT03923712|older people|older people
5011634|NCT03923660|concentric|concentric
5011635|NCT03923660|eccentric|eccentric
5423182|NCT01616784|Type 1|type 1
5011636|NCT03923621|Endoscopic Pilonidal Sinus Treatment (EPSiT)|endoscopic pilonidal sinus treatment (epsit)
5011637|NCT03923569|Alzheimer's disease|alzheimer's disease
5011638|NCT03923569|Rapid eye movement (REM) sleep|rapid eye movement (rem) sleep
5011639|NCT03923569|Memory consolidation|memory consolidation
5011640|NCT03923569|Epilepsy|epilepsy
5011641|NCT03923569|MRI|mri
5011642|NCT03923517|Young onset dementia|young onset dementia
5011643|NCT03923517|caregiver|caregiver
5011644|NCT03923517|online intervention|online intervention
5011645|NCT03923517|online communication technology|online communication technology
5011646|NCT03923504|Physical Activity Intervention|physical activity intervention
5011647|NCT03923504|Healthy Living Intervention|healthy living intervention
5011648|NCT03923504|Health-related Quality of Life|health-related quality of life
5011652|NCT03923452|mindfulness|mindfulness
5011653|NCT03923452|immigrant|immigrant
5011654|NCT03923452|stress|stress
5011655|NCT03923452|wellbeing|wellbeing
5011656|NCT03923439|Stroke|stroke
5011657|NCT03923439|High b-value diffusion MRI|high b-value diffusion mri
5011658|NCT03923439|Rescued penumbra|rescued penumbra
5011659|NCT03923439|Selective neuronal loss.|selective neuronal loss.
5011662|NCT03923413|circulating MP|circulating mp
5011663|NCT03923413|FMD|fmd
5011664|NCT03923413|LVAD|lvad
5011665|NCT03923413|endothelial function|endothelial function
5011666|NCT03923413|endothelial integrity|endothelial integrity
5011667|NCT03923400|GIST|gist
5011668|NCT03923400|small bowel|small bowel
5011669|NCT03923400|jejunum|jejunum
5011670|NCT03923400|ileum|ileum
5011671|NCT03923387|Vascular closure|vascular closure
5011672|NCT03923374|Pregnant with Opioid Use Disorder|pregnant with opioid use disorder
5011673|NCT03923374|Opioid Use Disorder ( OUD)|opioid use disorder ( oud)
5011674|NCT03923374|Subutex|subutex
5011675|NCT03923374|Buprenorphine|buprenorphine
5011676|NCT03923374|Pregnant taking buprenorphine/subutex|pregnant taking buprenorphine/subutex
5011677|NCT03923348|female urinary incontinence|female urinary incontinence
5011678|NCT03923348|urge urinary incontinence|urge urinary incontinence
5011679|NCT03923348|urgency|urgency
5011680|NCT03923348|frequency|frequency
5011681|NCT03923348|overactive bladder|overactive bladder
5011682|NCT03923348|pelvic floor muscle training|pelvic floor muscle training
5011683|NCT03923348|biofeedback|biofeedback
5011684|NCT03923335|colorectal cancer|colorectal cancer
5011685|NCT03923335|prognostic biomarkers|prognostic biomarkers
5011686|NCT03923335|DNA Methylation|dna methylation
5011687|NCT03923335|gene panel|gene panel
5011688|NCT03923335|recurrence|recurrence
5011689|NCT03923335|disease free survival|disease free survival
5011690|NCT03923309|Organ preservation|organ preservation
5011691|NCT03923309|Oncologic outcome|oncologic outcome
5011692|NCT03923296|point of care|point of care
5011693|NCT03923296|home monitoring|home monitoring
5011694|NCT03923296|device|device
5011695|NCT03923296|blood|blood
5011696|NCT03923283|End-tidal carbondioxide|end-tidal carbondioxide
5011697|NCT03923283|surgery drapes|surgery drapes
5011698|NCT03923283|carbondioxide accumulation|carbondioxide accumulation
5011699|NCT03923283|eye surgery|eye surgery
5011700|NCT03923270|lung cancer|lung cancer
5011701|NCT03923244|Dry Eye Syndrome|dry eye syndrome
5011702|NCT03923244|tear film analysis|tear film analysis
5011703|NCT03923244|ocular surface|ocular surface
5011704|NCT03923244|cataract surgery|cataract surgery
5011705|NCT03923218|Gingival crevicular fluid|gingival crevicular fluid
5011714|NCT03923153|quality of life|quality of life
5011715|NCT03923153|aerobic capacity|aerobic capacity
5011716|NCT03923153|depression|depression
5011717|NCT03923153|fatique|fatique
5011722|NCT03923114|exendin|exendin
5011723|NCT03923114|GLP-1 receptor agonist|glp-1 receptor agonist
5011724|NCT03923114|HPA-axis|hpa-axis
5011725|NCT03923114|Imaging|imaging
5011726|NCT03923101|Keratoconus|keratoconus
5011727|NCT03923101|Crosslinking|crosslinking
5011728|NCT03923101|Intracorneal ring segments|intracorneal ring segments
5011729|NCT03923101|Gas-permeable rigid contact-lenses|gas-permeable rigid contact-lenses
5011730|NCT03923101|Penetrating Keratoplasty|penetrating keratoplasty
5011731|NCT03923101|Deep anterior lamellar Keratoplasty|deep anterior lamellar keratoplasty
5011732|NCT03923101|ABCD Grading System|abcd grading system
5011733|NCT03923075|dexmedetomidine|dexmedetomidine
5011734|NCT03923075|propofol|propofol
5011735|NCT03923075|rocuronium|rocuronium
5011737|NCT03923075|children|children
5011738|NCT03923023|Facility delivery|facility delivery
5011739|NCT03923023|Neonatal mortality|neonatal mortality
5011740|NCT03923023|Preterm delivery|preterm delivery
5011741|NCT03923023|Preterm birth|preterm birth
5011742|NCT03923023|Perinatal mortality|perinatal mortality
5011743|NCT03922984|magnetic resonance imaging, arterial spin labeling|magnetic resonance imaging, arterial spin labeling
5011744|NCT03922971|colonoscopy|colonoscopy
5011746|NCT03922971|endoscopy|endoscopy
5011776|NCT03922802|Stimulation|stimulation
5011777|NCT03922802|Spinal Stimulation|spinal stimulation
5011778|NCT03922802|Noninvasive stimulation|noninvasive stimulation
5011779|NCT03922776|Ovarian cancer|ovarian cancer
5011780|NCT03922776|Tubal Cancer|tubal cancer
5011781|NCT03922776|Immunological profile|immunological profile
5011783|NCT03922776|TILs|tils
5011784|NCT03922776|Carcinomatosis|carcinomatosis
5011785|NCT03922776|HGSOC|hgsoc
5011790|NCT03922711|Levodopa|levodopa
5011791|NCT03922711|Dyskinesia|dyskinesia
5011792|NCT03922698|atherosclerotic plaque|atherosclerotic plaque
5011793|NCT03922698|autonomic nervous system|autonomic nervous system
5011794|NCT03922698|immune system|immune system
5011795|NCT03922698|autophagy|autophagy
5011796|NCT03922672|caregiver|caregiver
5011797|NCT03922672|Parkinson's disease|parkinson's disease
5011798|NCT03922672|group piano training|group piano training
5011799|NCT03922659|Heroin dependence, transcranial magnetic stimulation, cognitive behavioral therapy|heroin dependence, transcranial magnetic stimulation, cognitive behavioral therapy
5011800|NCT03922646|Cognitive Rehabilitation|cognitive rehabilitation
5011801|NCT03922646|Brain Rehabilitation|brain rehabilitation
5011802|NCT03922646|Treatment|treatment
5011803|NCT03922646|Addiction|addiction
5011804|NCT03922646|Heroin|heroin
5011805|NCT03922646|Opiates|opiates
5011806|NCT03922646|Meth|meth
5011807|NCT03922646|Methamphetamine|methamphetamine
5011808|NCT03922633|E3112|e3112
5011809|NCT03922633|Phase 1|phase 1
5011810|NCT03922633|Pharmacokinetics|pharmacokinetics
5011811|NCT03922633|Japanese|japanese
5011812|NCT03922607|Psoriasis|psoriasis
5011813|NCT03922607|Chronic Plaque Psoriasis|chronic plaque psoriasis
5011814|NCT03922607|ABBV-157|abbv-157
5011815|NCT03922607|Healthy Volunteers|healthy volunteers
5011816|NCT03922581|Anxiety disorders|anxiety disorders
5011817|NCT03922581|Behavioral intervention|behavioral intervention
5011818|NCT03922581|Psychology|psychology
5011819|NCT03922568|Gender Ratio|gender ratio
5011820|NCT03922568|PICSI|picsi
5011825|NCT03922503|APRF|aprf
5011826|NCT03922503|Advanced Platelet Rich Fibrin|advanced platelet rich fibrin
5011834|NCT03922438|Cleft lip|cleft lip
5011835|NCT03922438|Cleft alveolus|cleft alveolus
5011836|NCT03922438|Cheiloplasty|cheiloplasty
5011837|NCT03922438|Nasoalveolar fistula|nasoalveolar fistula
5011838|NCT03922425|Severe mental illnesses|severe mental illnesses
5011839|NCT03922412|Anesthesia|anesthesia
5011840|NCT03922412|plantar Block|plantar block
5011845|NCT03922360|Financial Incentives|financial incentives
5011846|NCT03922360|Pregnant Women|pregnant women
5011847|NCT03922360|Smoking Cessation|smoking cessation
5011848|NCT03922360|mHealth|mhealth
5053721|NCT03662750|MRI|mri
5006753|NCT03954392|Adolescents|adolescents
5006754|NCT03954392|Treatment|treatment
5006755|NCT03954366|rucaparib|rucaparib
5006756|NCT03954366|CO-338|co-338
5006757|NCT03954366|Clovis|clovis
5006758|NCT03954366|Clovis Oncology|clovis oncology
5006759|NCT03954366|PARP Inhibitor|parp inhibitor
5011859|NCT03922243|gender|gender
5011860|NCT03922243|age|age
5011861|NCT03922230|esophageal squamous cancer|esophageal squamous cancer
5011862|NCT03922230|DNA methylolation|dna methylolation
5011863|NCT03922230|early screening|early screening
5011868|NCT03922165|Pediatrics|pediatrics
5011869|NCT03922165|Adenotonsillectomy|adenotonsillectomy
5011870|NCT03922152|palliative care|palliative care
5011871|NCT03922152|radiotherapy|radiotherapy
5011872|NCT03922152|pain|pain
5011873|NCT03922152|quality of life|quality of life
5011874|NCT03922152|esophageal cancer|esophageal cancer
5011875|NCT03922074|ADR with Non-Anesthesiologist administered propofol (NAAP)|adr with non-anesthesiologist administered propofol (naap)
5011876|NCT03922061|inactivated polio vaccine (IPV)|inactivated polio vaccine (ipv)
5011877|NCT03922061|fractional-dose inactivated polio vaccine (fIPV)|fractional-dose inactivated polio vaccine (fipv)
5011878|NCT03922061|double mutant [LT(R192G/L211A)] Enterotoxigenic E coli heat toxin (dmLT)|double mutant [lt(r192g/l211a)] enterotoxigenic e coli heat toxin (dmlt)
5011879|NCT03922048|inguinal hernia|inguinal hernia
5011880|NCT03922048|postoperative pain|postoperative pain
5445442|NCT01521780|MRI|mri
5011881|NCT03922048|herniorrhaphy|herniorrhaphy
5011882|NCT03922048|pediatric|pediatric
5011883|NCT03922048|local anesthetic|local anesthetic
5011884|NCT03922009|Virtual Reality；Anxiety|virtual reality；anxiety
5011885|NCT03921996|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
5011886|NCT03921996|Pelvic lymph node dissection|pelvic lymph node dissection
5011887|NCT03921996|ePLND|eplnd
5011888|NCT03921996|Prostate Cancer|prostate cancer
5011889|NCT03921996|intermediate prostate cancer|intermediate prostate cancer
5011890|NCT03921996|High-risk prostate cancer|high-risk prostate cancer
5011891|NCT03921983|muscle oxygenation|muscle oxygenation
5011892|NCT03921983|hypoxia|hypoxia
5011893|NCT03921983|mitochondrial function|mitochondrial function
5011894|NCT03921983|non invasive|non invasive
5011895|NCT03921970|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5011896|NCT03921970|Postoperative pain management|postoperative pain management
5011897|NCT03921970|Erector spina plane block|erector spina plane block
5011901|NCT03921931|light stimulation|light stimulation
5011902|NCT03921931|retinal photoreceptors|retinal photoreceptors
5011903|NCT03921931|light adaptation|light adaptation
5011904|NCT03921931|functional optical coherence tomography|functional optical coherence tomography
5011905|NCT03921931|optophysiology|optophysiology
5011906|NCT03921931|intrinsic optical signals|intrinsic optical signals
5011907|NCT03921905|Peripheral Artery Disease|peripheral artery disease
5011908|NCT03921905|Coronary Artery Disease|coronary artery disease
5011909|NCT03921905|General Practice|general practice
5011910|NCT03921905|Ankle-brachial index (ABI)|ankle-brachial index (abi)
5011911|NCT03921827|MCA; ICA; vasodilatory reserve; EECP; intracranial stenosis|mca; ica; vasodilatory reserve; eecp; intracranial stenosis
5011912|NCT03921801|Osteoarthritis|osteoarthritis
5011913|NCT03921801|Knee|knee
5011914|NCT03921801|Achilles tendon|achilles tendon
5011925|NCT03921788|substance P|substance p
5011926|NCT03921762|Cataract surgery|cataract surgery
5011927|NCT03921762|Enhanced depth of focus (EDOF)|enhanced depth of focus (edof)
5011928|NCT03921762|Intraocular lens|intraocular lens
5423183|NCT01616784|Humans|humans
5011936|NCT03921736|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5011937|NCT03921723|Dolutegravir|dolutegravir
5011938|NCT03921723|Human immunodeficiency virus|human immunodeficiency virus
5011939|NCT03921723|Sequential study|sequential study
5011940|NCT03921723|Dispersible tablet|dispersible tablet
5011942|NCT03921723|Liquid solution|liquid solution
5011943|NCT03921697|Technological Rehabilitation; Digital Inclusion|technological rehabilitation; digital inclusion
5011944|NCT03921684|Nivolumab|nivolumab
5011945|NCT03921684|Chemoradiation|chemoradiation
5011946|NCT03921684|mFOLFOX6|mfolfox6
5011947|NCT03921684|rectal cancer|rectal cancer
5011950|NCT03921632|Anorexia nervosa|anorexia nervosa
5011951|NCT03921632|Bulimia|bulimia
5011952|NCT03921593|quality of life|quality of life
5011953|NCT03921593|pancreas transplant|pancreas transplant
5011954|NCT03921580|Satiety|satiety
5011955|NCT03921580|Polyphenols|polyphenols
5011956|NCT03921580|Fibre|fibre
5011957|NCT03921580|Visual Analogue Scale|visual analogue scale
5011958|NCT03921580|Cross-over|cross-over
5011959|NCT03921580|Tuna|tuna
5011960|NCT03921567|Analgesia|analgesia
5011961|NCT03921567|Perioperative periode|perioperative periode
5011962|NCT03921567|Postoperative periode|postoperative periode
5011963|NCT03921567|VAS scale|vas scale
5011970|NCT03921502|Choledocholithiasis|choledocholithiasis
5011971|NCT03921502|Gall Bladder drainage|gall bladder drainage
5011972|NCT03921502|LAMS|lams
5011973|NCT03921489|bone marrow edema|bone marrow edema
5011974|NCT03921489|subchondroplasty|subchondroplasty
5011975|NCT03921489|foot and ankle|foot and ankle
5011976|NCT03921450|motor behavior|motor behavior
5011977|NCT03921450|psychomotor slowing|psychomotor slowing
5011978|NCT03921450|psychosis|psychosis
5011982|NCT03921398|Lupus nephritis|lupus nephritis
5011983|NCT03921398|haemodialysis|haemodialysis
5011984|NCT03921372|Normal tension glaucoma|normal tension glaucoma
5011985|NCT03921359|Parkinson Disease|parkinson disease
5011986|NCT03921359|Exercise Training|exercise training
5011987|NCT03921359|Cognitive function|cognitive function
5011988|NCT03921346|Medication errors|medication errors
5011989|NCT03921346|Drugs|drugs
5011990|NCT03921346|Pediatrics|pediatrics
5011991|NCT03921346|Biomedical Technology|biomedical technology
5011992|NCT03921346|Mobile applications|mobile applications
5011993|NCT03921346|Emergency Medical Services|emergency medical services
5011994|NCT03921320|Hyperhidrosis|hyperhidrosis
5011995|NCT03921320|Sympathectomy|sympathectomy
5011996|NCT03921320|Sweating|sweating
5011997|NCT03921307|Computer-Aided Design|computer-aided design
5011998|NCT03921307|dental crowns|dental crowns
5011999|NCT03921307|survival|survival
5012000|NCT03921281|Cerebral palsy|cerebral palsy
5012001|NCT03921281|Motor dysfunction|motor dysfunction
5012002|NCT03921281|Scalp acupuncture treatment|scalp acupuncture treatment
5012003|NCT03921281|Safety/Efficacy assessment|safety/efficacy assessment
5012004|NCT03921255|Thought-Action Fusion|thought-action fusion
5012005|NCT03921255|Cognitive Bias Modification|cognitive bias modification
5012006|NCT03921255|Interpretation Training|interpretation training
5012007|NCT03921255|Stress Management Psychoeducation|stress management psychoeducation
5012008|NCT03921229|Patient Care|patient care
5012009|NCT03921229|Tele-health|tele-health
5012010|NCT03921229|Behavioral intervention|behavioral intervention
5012011|NCT03921190|Buccal infiltration anesthesia|buccal infiltration anesthesia
5012012|NCT03921190|Discomfort|discomfort
5012016|NCT03921177|adolescent pregnancy|adolescent pregnancy
5012018|NCT03921164|Cardiac after-load|cardiac after-load
5012019|NCT03921164|Pressure volume loop|pressure volume loop
5012020|NCT03921164|Perioperative risk|perioperative risk
5012021|NCT03921125|Living donors|living donors
5012022|NCT03921125|PVI|pvi
5012023|NCT03921125|PPV|ppv
5012024|NCT03921125|Fluids|fluids
5012025|NCT03921125|Response|response
5012026|NCT03921073|Cutaneous|cutaneous
5012027|NCT03921073|Angiosarcoma|angiosarcoma
5012028|NCT03921073|Skin|skin
5012029|NCT03920982|acute kidney injury|acute kidney injury
5012030|NCT03920982|septic shock|septic shock
5012031|NCT03920982|uremic toxins|uremic toxins
5012032|NCT03920982|indoxyl sulfate|indoxyl sulfate
5012033|NCT03920982|mortality|mortality
5012034|NCT03920969|Sport|sport
5012044|NCT03920917|Radiofrequency Pulmonary vein isolation|radiofrequency pulmonary vein isolation
5012045|NCT03920917|Cryoballoon Pulmonary Vein isolation|cryoballoon pulmonary vein isolation
5012047|NCT03920891|Radiofrequency Pulmonary vein isolation|radiofrequency pulmonary vein isolation
5012048|NCT03920891|Cryoballoon Pulmonary Vein isolation|cryoballoon pulmonary vein isolation
5012049|NCT03920878|anti-VEGF injections|anti-vegf injections
5012063|NCT03920787|children|children
5012064|NCT03920748|Difficult laryngoscopy, airway measurements, newborn, infant|difficult laryngoscopy, airway measurements, newborn, infant
5012066|NCT03920722|Rituximab|rituximab
5012067|NCT03920722|ANCA-associated vasculitis|anca-associated vasculitis
5012068|NCT03920696|Pityriasis Lichenoides;|pityriasis lichenoides;
5012069|NCT03920696|cutaneous lymphoma|cutaneous lymphoma
5012070|NCT03920696|lymphoproliferation|lymphoproliferation
5012071|NCT03920683|Prediction of coronary artery calcification score|prediction of coronary artery calcification score
5012072|NCT03920683|Diabetes mellitus|diabetes mellitus
5012073|NCT03920683|Toe-brachial index|toe-brachial index
5012074|NCT03920670|Neuromuscular Blockade|neuromuscular blockade
5012075|NCT03920670|ToFscan|tofscan
5012076|NCT03920670|Tetragraph|tetragraph
5012077|NCT03920670|AMG|amg
5012078|NCT03920670|EMG|emg
5012079|NCT03920657|MDS|mds
5012080|NCT03920644|Motion Sickness, INSCOP, Scopolamine, Defender, NAMRU|motion sickness, inscop, scopolamine, defender, namru
5012084|NCT03920618|hepatitis b virus|hepatitis b virus
5012085|NCT03920618|acute-on-chronic liver failure|acute-on-chronic liver failure
5012086|NCT03920618|nucleotide|nucleotide
5012087|NCT03920618|nucleoside|nucleoside
5012088|NCT03920605|hepatitis b virus|hepatitis b virus
5012089|NCT03920605|peginterferon alfa|peginterferon alfa
5012090|NCT03920605|liver fibrosis|liver fibrosis
5012091|NCT03920592|Virtual reality|virtual reality
5012092|NCT03920592|Psychophysiology|psychophysiology
5012093|NCT03920592|Empathy|empathy
5012094|NCT03920579|CKD-386|ckd-386
5012095|NCT03920579|Pharmacokinetics|pharmacokinetics
5012096|NCT03920579|D326|d326
5012097|NCT03920579|D337|d337
5012098|NCT03920579|D013|d013
5012099|NCT03920566|Enzalutamide|enzalutamide
5012100|NCT03920566|Anticoagulant Drugs|anticoagulant drugs
5012101|NCT03920566|P-glycoprotein|p-glycoprotein
5012102|NCT03920540|GC1111|gc1111
5012103|NCT03920540|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5012104|NCT03920540|MPS II|mps ii
5012105|NCT03920540|idursulfase-beta|idursulfase-beta
5012106|NCT03920540|IDS|ids
5012107|NCT03920527|CPA|cpa
5012108|NCT03920527|Aspergillosis|aspergillosis
5012109|NCT03920527|CCPA|ccpa
5012110|NCT03920527|CFPA|cfpa
5012111|NCT03920514|infertility|infertility
5012112|NCT03920501|Critical care|critical care
5012113|NCT03920501|Quality improvement|quality improvement
5012114|NCT03920501|Tele-critical care|tele-critical care
5012115|NCT03920501|Telemedicine|telemedicine
5012116|NCT03920488|genetic testing|genetic testing
5012117|NCT03920488|breast cancer|breast cancer
5012118|NCT03920462|Physical Activity|physical activity
5012119|NCT03920462|Connected bike|connected bike
5012120|NCT03920462|Connected vest|connected vest
5012121|NCT03920462|Rehabilitation|rehabilitation
5012122|NCT03920449|Chronic anal fissure|chronic anal fissure
5012123|NCT03920449|Botulinum toxin|botulinum toxin
5012124|NCT03920449|Sphincterotomy|sphincterotomy
5012125|NCT03920397|type 1 diabetes|type 1 diabetes
5012126|NCT03920397|pancreatic function|pancreatic function
5012127|NCT03920397|adipose tissue-derived stromal/stem cells|adipose tissue-derived stromal/stem cells
5012128|NCT03920371|small field of view|small field of view
5012129|NCT03920371|hybrid compact gamma camera|hybrid compact gamma camera
5012133|NCT03920332|miscarriage|miscarriage
5012134|NCT03920332|haemorrhage|haemorrhage
5012135|NCT03920332|fibrinogen|fibrinogen
5012136|NCT03920254|TD-1473|td-1473
5012137|NCT03920254|Janus kinase inhibitor|janus kinase inhibitor
5012139|NCT03920254|Inflammatory Bowel Disease|inflammatory bowel disease
5012140|NCT03920254|IBD|ibd
5012141|NCT03920254|Ulcerative colitis|ulcerative colitis
5012142|NCT03920254|UC|uc
5012143|NCT03920254|Intestinal restriction|intestinal restriction
5012144|NCT03920254|Gut-selective|gut-selective
5012145|NCT03920241|Mindfulness|mindfulness
5012146|NCT03920241|Compassion|compassion
5012147|NCT03920241|Well-being|well-being
5012148|NCT03920241|Network analysis|network analysis
5012149|NCT03920241|MBSR|mbsr
5012150|NCT03920241|CCT|cct
5012151|NCT03920241|Attentional blink|attentional blink
5012152|NCT03920241|Cognition|cognition
5012153|NCT03920228|PC|pc
5012155|NCT03920202|Bowel dysfunction|bowel dysfunction
5012156|NCT03920202|Low anterior resection syndrome|low anterior resection syndrome
5012157|NCT03920202|Low anterior resection syndrome score|low anterior resection syndrome score
5012158|NCT03920202|Quality of life|quality of life
5012159|NCT03920176|Cardiology|cardiology
5356900|NCT01917565|airway management|airway management
5007131|NCT03951857|Aging|aging
5012160|NCT03920176|Computed tomography coronary angiography|computed tomography coronary angiography
5012161|NCT03920150|optimal vitamin D value|optimal vitamin d value
5012162|NCT03920098|Breast densities|breast densities
5012163|NCT03920098|Breast neoplasms|breast neoplasms
5012164|NCT03920098|Glucose metabolism disorders|glucose metabolism disorders
5012165|NCT03920098|Diabetes, gestational|diabetes, gestational
5012166|NCT03920098|Glycated Hemoglobin A|glycated hemoglobin a
5012167|NCT03920098|Insulin-Like Growth Factor I|insulin-like growth factor i
5012168|NCT03920098|Pregnancy|pregnancy
5012169|NCT03920098|Gestation|gestation
5012170|NCT03920098|Primary Health Care|primary health care
5012171|NCT03920098|Dual-energy X-ray Absorptiometry|dual-energy x-ray absorptiometry
5012172|NCT03920098|Latin America|latin america
5012173|NCT03920098|Chile|chile
5012174|NCT03920046|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5012175|NCT03920046|laryngospasm|laryngospasm
5012176|NCT03920046|passive smoking|passive smoking
5012177|NCT03920046|sedation|sedation
5012178|NCT03920020|Concentric|concentric
5012179|NCT03920020|Eccentric|eccentric
5012180|NCT03920020|Muscle Architecture|muscle architecture
5012181|NCT03920020|Proprioception|proprioception
5012182|NCT03919994|Alkermes|alkermes
5012183|NCT03919994|Schizophrenia|schizophrenia
5012184|NCT03919994|ARISTADA|aristada
5012185|NCT03919994|Abilify Maintena|abilify maintena
5012186|NCT03919994|Invega Sustenna|invega sustenna
5012187|NCT03919994|Risperdal Consta|risperdal consta
5012188|NCT03919994|Cohort Study|cohort study
5012189|NCT03919994|Observational|observational
5012190|NCT03919994|Phase 4|phase 4
5012191|NCT03919968|Elderly|elderly
5012192|NCT03919968|Martial Arts|martial arts
5012193|NCT03919968|Functional Training|functional training
5012194|NCT03919968|Cardiovascular|cardiovascular
5012195|NCT03919968|Health|health
5012196|NCT03919942|Quality of life|quality of life
5012197|NCT03919942|Pericoronitis|pericoronitis
5012198|NCT03919942|Phytotherapy|phytotherapy
5012199|NCT03919929|Insulin Resistance|insulin resistance
5012200|NCT03919864|Lung cancer caregivers|lung cancer caregivers
5012201|NCT03919851|Prehospital recognition and treatment|prehospital recognition and treatment
5012202|NCT03919838|probiotic|probiotic
5012203|NCT03919838|oral health|oral health
5012204|NCT03919838|children|children
5012205|NCT03919786|postoperative atrial fibrillation|postoperative atrial fibrillation
5012206|NCT03919786|lobectomy|lobectomy
5012207|NCT03919786|thoracic surgery|thoracic surgery
5012208|NCT03919786|vagus nerve block|vagus nerve block
5012209|NCT03919786|pulmonary myocardial sleeve|pulmonary myocardial sleeve
5012210|NCT03919760|Implementation Science|implementation science
5012211|NCT03919760|Youth and Emerging Adults|youth and emerging adults
5012212|NCT03919760|First Episode Psychosis|first episode psychosis
5012213|NCT03919760|Schizophrenia|schizophrenia
5012228|NCT03919565|peginterferon alfa|peginterferon alfa
5012229|NCT03919565|liver fibrosis|liver fibrosis
5012230|NCT03919552|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5012231|NCT03919552|cisplatin|cisplatin
5012232|NCT03919552|carboplatin|carboplatin
5012233|NCT03919539|osteosarcoma|osteosarcoma
5012234|NCT03919539|5hmc|5hmc
5012235|NCT03919539|drug resistance|drug resistance
5012236|NCT03919539|famitinib|famitinib
5012237|NCT03919539|camrelizumab|camrelizumab
5012238|NCT03919526|CD19/CD22|cd19/cd22
5012239|NCT03919526|Bispecific CAR-T|bispecific car-t
5012240|NCT03919526|leukemia|leukemia
5012241|NCT03919526|MRD-positive|mrd-positive
5012242|NCT03919526|B-ALL|b-all
5012243|NCT03919513|IMT,NPPV,Pulmonary rehabilitation|imt,nppv,pulmonary rehabilitation
5012250|NCT03919474|serotonin|serotonin
5012251|NCT03919474|homocystein|homocystein
5012252|NCT03919474|antiphospholipid syndrom|antiphospholipid syndrom
5012253|NCT03919474|thrombophilia|thrombophilia
5012254|NCT03919461|Beta-blocker|beta-blocker
5012255|NCT03919461|Propranolol|propranolol
5012256|NCT03919461|COX-2 inhibitor|cox-2 inhibitor
5012257|NCT03919461|Etodolac|etodolac
5012279|NCT03919396|Multifocal Electroretinogram|multifocal electroretinogram
5012280|NCT03919383|Hepatocellular Carcinoma|hepatocellular carcinoma
5012281|NCT03919383|Lenvatinib|lenvatinib
5012282|NCT03919383|Toripalimab|toripalimab
5325369|NCT02060448|CBT|cbt
5012283|NCT03919331|High flow nasal canula / P-SILI/ AHRF / EIT|high flow nasal canula / p-sili/ ahrf / eit
5012284|NCT03919318|postoperative pain|postoperative pain
5012285|NCT03919318|Endoseal MTA|endoseal mta
5012286|NCT03919318|Endosequence BC|endosequence bc
5012288|NCT03919318|Root canal filling|root canal filling
5012289|NCT03919318|endodontic treatment|endodontic treatment
5012290|NCT03919305|Cerebral venous sinus thrombosis|cerebral venous sinus thrombosis
5012291|NCT03919305|Deep cerebral vein thrombosis|deep cerebral vein thrombosis
5012292|NCT03919305|Cortical vein thrombosis|cortical vein thrombosis
5012293|NCT03919305|Cohort study|cohort study
5012294|NCT03919305|Real world evidence|real world evidence
5012295|NCT03919305|Observational study|observational study
5012296|NCT03919305|China mainland|china mainland
5012297|NCT03919305|Cerebral venous system thrombosis|cerebral venous system thrombosis
5012303|NCT03919279|Erosive hand osteoarthritis|erosive hand osteoarthritis
5012305|NCT03919279|inflammation|inflammation
5012306|NCT03919279|vagus nerve stimulation|vagus nerve stimulation
5012311|NCT03919240|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5012312|NCT03919240|Refractory and relapsed|refractory and relapsed
5012313|NCT03919240|Chimeric antigen receptor T-cell therapy|chimeric antigen receptor t-cell therapy
5012315|NCT03919227|Upper urinary calculi|upper urinary calculi
5012316|NCT03919227|Ureteral access sheath|ureteral access sheath
5012317|NCT03919227|Bladder filling degree|bladder filling degree
5012318|NCT03919227|Ureteral injury|ureteral injury
5012319|NCT03919201|postmenopausal|postmenopausal
5012320|NCT03919201|exercise|exercise
5012321|NCT03919188|preterm neonates|preterm neonates
5012322|NCT03919188|incubator management|incubator management
5012323|NCT03919188|body temperature|body temperature
5012324|NCT03919188|relative air humidity|relative air humidity
5012325|NCT03919188|thermoneutrality|thermoneutrality
5012326|NCT03919175|Lymphoma|lymphoma
5012327|NCT03919175|Follicular Lymphoma|follicular lymphoma
5012328|NCT03919175|Marginal Zone Lymphoma|marginal zone lymphoma
5012329|NCT03919136|Heart Failure|heart failure
5012330|NCT03919136|Advanced Heart Failure|advanced heart failure
5012331|NCT03919136|Blood Pressure|blood pressure
5012332|NCT03919136|High Blood Pressure|high blood pressure
5012333|NCT03919136|Low Blood Pressure|low blood pressure
5012334|NCT03919123|Pelvic Organ Prolapse|pelvic organ prolapse
5012335|NCT03919123|laparoscopic promontofixation|laparoscopic promontofixation
5012336|NCT03919123|symptoms|symptoms
5012337|NCT03919123|Satisfaction|satisfaction
5012338|NCT03919123|Quality of Life|quality of life
5012339|NCT03919110|Inflammation|inflammation
5012340|NCT03919110|Rheumatology|rheumatology
5012341|NCT03919084|THRIVE|thrive
5012342|NCT03919084|Patient navigation|patient navigation
5012343|NCT03919084|Accountable Care Organization|accountable care organization
5012344|NCT03919084|Pharmacy liaison|pharmacy liaison
5012345|NCT03919084|Pharmacy services|pharmacy services
5012346|NCT03919084|Social determinants of health|social determinants of health
5012347|NCT03919084|health-related social needs|health-related social needs
5012348|NCT03919084|screening and referral|screening and referral
5012349|NCT03919084|Medicaid ACO|medicaid aco
5012355|NCT03919058|Comorbidities|comorbidities
5012356|NCT03919045|Chronic migraine|chronic migraine
5012357|NCT03919045|Saline injection|saline injection
5012358|NCT03919019|oral supplementation|oral supplementation
5012359|NCT03919019|mfERG|mferg
5012360|NCT03919019|OCT|oct
5012361|NCT03919006|periodontal diseases|periodontal diseases
5012362|NCT03919006|cytokines|cytokines
5012363|NCT03919006|gingival crevicular fluid|gingival crevicular fluid
5012364|NCT03919006|saliva|saliva
5012365|NCT03919006|serum|serum
5012366|NCT03918993|Erectile Dysfunction|erectile dysfunction
5014795|NCT03904251|AML, Leukemia|aml, leukemia
5012368|NCT03918993|monocyte to HDL ratio|monocyte to hdl ratio
5012369|NCT03918941|patients satisfaction|patients satisfaction
5012370|NCT03918941|Mobile application|mobile application
5012371|NCT03918941|orthognathic surgery|orthognathic surgery
5012372|NCT03918915|Children|children
5012373|NCT03918915|Myopia|myopia
5012374|NCT03918902|mortality|mortality
5012375|NCT03918902|oral hygiene|oral hygiene
5012376|NCT03918902|periodontitis|periodontitis
5012377|NCT03918902|smokeless tobacco|smokeless tobacco
5012378|NCT03918902|tobacco|tobacco
5012379|NCT03918889|dexmedetomidine|dexmedetomidine
5012380|NCT03918889|midazolam|midazolam
5012381|NCT03918889|cough|cough
5012382|NCT03918889|sedation|sedation
5012383|NCT03918889|pain|pain
5012384|NCT03918876|dance|dance
5012385|NCT03918876|health|health
5012386|NCT03918876|ballet|ballet
5012387|NCT03918876|musculoskeletal injury|musculoskeletal injury
5012388|NCT03918876|SF-36|sf-36
5012389|NCT03918876|wellness|wellness
5012390|NCT03918876|dance medicine|dance medicine
5342935|NCT01981473|adalimumab|adalimumab
5060132|NCT03623100|EEG|eeg
5012391|NCT03918863|electromyography|electromyography
5012392|NCT03918863|physiotherapy|physiotherapy
5012393|NCT03918863|knee|knee
5012394|NCT03918863|quadriceps muscle|quadriceps muscle
5012395|NCT03918850|CTN-0080|ctn-0080
5007339|NCT03950661|Environment|environment
5012396|NCT03918850|clinical trials network|clinical trials network
5012397|NCT03918850|medication assisted treatment|medication assisted treatment
5012398|NCT03918837|Arterial Spin Labeling|arterial spin labeling
5012399|NCT03918837|Obsessive Compulsive Disorder|obsessive compulsive disorder
5012400|NCT03918837|Magnetic Resonance Imaging|magnetic resonance imaging
5012401|NCT03918837|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5012402|NCT03918837|Double blinded|double blinded
5012403|NCT03918837|Sham|sham
5012404|NCT03918811|airway extubation|airway extubation
5012405|NCT03918811|extubation methods|extubation methods
5012406|NCT03918811|positive pressure|positive pressure
5012407|NCT03918811|positive-pressure extubation|positive-pressure extubation
5012408|NCT03918811|tracheal extubation|tracheal extubation
5012409|NCT03918811|positive-pressure ventilation|positive-pressure ventilation
5012410|NCT03918811|extubation complications|extubation complications
5012411|NCT03918798|Surgery|surgery
5012704|NCT03917121|Pulpotomy|pulpotomy
5012412|NCT03918798|Hernia, Inguinal|hernia, inguinal
5012414|NCT03918798|Pediatric population|pediatric population
5012415|NCT03918798|Peripheral nerve block|peripheral nerve block
5012416|NCT03918785|rice germ|rice germ
5012417|NCT03918785|swimmers|swimmers
5012418|NCT03918785|nutritional supplement|nutritional supplement
5012419|NCT03918785|lactic acid|lactic acid
5012420|NCT03918785|fat free mass|fat free mass
5012421|NCT03918772|Anaphylaxis|anaphylaxis
5012422|NCT03918772|Epinephrine|epinephrine
5012423|NCT03918772|Hypersensitivity, Immediate|hypersensitivity, immediate
5012424|NCT03918772|Morbidity|morbidity
5012425|NCT03918772|Mortality|mortality
5012426|NCT03918772|Perioperative Period|perioperative period
5012427|NCT03918772|Skin Tests|skin tests
5012428|NCT03918772|Tryptases|tryptases
5012429|NCT03918759|Lymph node metastases|lymph node metastases
5012430|NCT03918759|Diagnostic accuracy|diagnostic accuracy
5012431|NCT03918746|compassion|compassion
5012432|NCT03918746|internet-based Interventions|internet-based interventions
5012433|NCT03918746|feasibility|feasibility
5012434|NCT03918746|meditation|meditation
5012435|NCT03918746|attachment|attachment
5012436|NCT03918733|retreatment|retreatment
5012437|NCT03918733|endodontic surgery|endodontic surgery
5012438|NCT03918733|nonsurgical endodontic retreatment|nonsurgical endodontic retreatment
5012439|NCT03918720|Quality of Life|quality of life
5012440|NCT03918720|Empowerment|empowerment
5012441|NCT03918720|Low-income Families|low-income families
5012442|NCT03918720|Parent-child health relationship|parent-child health relationship
5012443|NCT03918681|Running|running
5012444|NCT03918681|Gait Retraining|gait retraining
5012445|NCT03918681|Return to Run|return to run
5012455|NCT03918642|Chronic Pain|chronic pain
5012456|NCT03918642|Psychotherapy|psychotherapy
5012457|NCT03918642|Musculoskeletal Disease|musculoskeletal disease
5012458|NCT03918629|Clostridium Difficile|clostridium difficile
5012459|NCT03918629|vaccine|vaccine
5012460|NCT03918616|Alzheimer disease|alzheimer disease
5012461|NCT03918616|Parkinson disease|parkinson disease
5012462|NCT03918616|P2X7 receptor|p2x7 receptor
5012463|NCT03918577|Caloric Vestibular Stimulation|caloric vestibular stimulation
5012464|NCT03918577|Insight|insight
5012466|NCT03918551|bioequivalence|bioequivalence
5012467|NCT03918551|febuxostat|febuxostat
5012468|NCT03918551|Adenuric|adenuric
5012469|NCT03918538|lung cancer|lung cancer
5012470|NCT03918538|early physical rehabilitation|early physical rehabilitation
5012471|NCT03918538|muscle endurance|muscle endurance
5012472|NCT03918538|aerobic capacity|aerobic capacity
5012473|NCT03918538|quality of life|quality of life
5012474|NCT03918512|Lumbar spinal stenosis|lumbar spinal stenosis
5012479|NCT03918447|Bardoxolone Methyl|bardoxolone methyl
5012481|NCT03918447|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5012482|NCT03918447|ADPKD|adpkd
5012483|NCT03918434|tibial nerve block|tibial nerve block
5012484|NCT03918382|Patient-Reported Outcome|patient-reported outcome
5012485|NCT03918382|Quality of life|quality of life
5012486|NCT03918382|Electronic reporting of symptoms|electronic reporting of symptoms
5012498|NCT03918265|Tacrolimus|tacrolimus
5012499|NCT03918265|Refractory autoimmune cytopenia|refractory autoimmune cytopenia
5012500|NCT03918265|Prospective study|prospective study
5012501|NCT03918252|malignant|malignant
5012502|NCT03918252|resectable|resectable
5012503|NCT03918213|high-resolution anorectal manometry|high-resolution anorectal manometry
5012504|NCT03918213|solid-state catheter|solid-state catheter
5012505|NCT03918213|healthy population|healthy population
5012506|NCT03918213|Russian population|russian population
5012507|NCT03918187|nalbuphine|nalbuphine
5012508|NCT03918187|midazolam|midazolam
5012509|NCT03918161|Interstitial fibrosis|interstitial fibrosis
5014112|NCT03908684|Ultrasound|ultrasound
5012513|NCT03918161|Elastography|elastography
5012514|NCT03918161|non-invasive diagnosis|non-invasive diagnosis
5012515|NCT03918135|fever, emergency department, paracetamol, ibuprofen, upper respiratory infection|fever, emergency department, paracetamol, ibuprofen, upper respiratory infection
5012516|NCT03918122|Preceptor|preceptor
5012517|NCT03918122|Physician Leadership|physician leadership
5012518|NCT03918122|Medical Education|medical education
5012519|NCT03918109|tinnitus, intratympanic injection, gacyclidine|tinnitus, intratympanic injection, gacyclidine
5012521|NCT03918044|Obesity|obesity
5012522|NCT03918044|Cesarean Section|cesarean section
5012523|NCT03918044|Vaginal Delivery|vaginal delivery
5012524|NCT03918044|Elective Cesarean Section|elective cesarean section
5012525|NCT03918044|Non-elective Cesarean Section|non-elective cesarean section
5012533|NCT03918018|Pulse oximetry|pulse oximetry
5012534|NCT03917992|Atrial fibrillation|atrial fibrillation
5012535|NCT03917979|Music Therapy|music therapy
5012536|NCT03917979|Guided Imagery|guided imagery
5012537|NCT03917979|Randomized Controlled Trial|randomized controlled trial
5012538|NCT03917940|Irisin|irisin
5012539|NCT03917940|sirtuin-1|sirtuin-1
5012540|NCT03917940|Omega 3 fatty acids|omega 3 fatty acids
5012541|NCT03917914|COPD|copd
5012549|NCT03917888|ventilator associated pneumonia|ventilator associated pneumonia
5012550|NCT03917888|lung ultrasound|lung ultrasound
5012551|NCT03917862|Ascending Aortic Surgery|ascending aortic surgery
5012552|NCT03917862|Hemostasis|hemostasis
5012553|NCT03917862|Ascending Aortic Dissection|ascending aortic dissection
5012554|NCT03917862|Ascending Aorta Aneurysm|ascending aorta aneurysm
5012555|NCT03917862|Bleeding|bleeding
5012556|NCT03917810|Nutrition|nutrition
5012557|NCT03917810|Carbohydrates|carbohydrates
5012558|NCT03917810|Ketogenic|ketogenic
5012559|NCT03917810|Metabolism|metabolism
5012560|NCT03917797|Systemic Lupus Erythematosus|systemic lupus erythematosus
5012561|NCT03917797|Mesenchymal Stromal Cells|mesenchymal stromal cells
5012562|NCT03917797|Lupus nephritis|lupus nephritis
5012564|NCT03917784|Insulin sensitivity|insulin sensitivity
5012565|NCT03917784|HOMA|homa
5012566|NCT03917771|physiotherapy|physiotherapy
5012567|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors
5012568|NCT03917758|Renin-Angiotensin System|renin-angiotensin system
5012569|NCT03917758|Vasopressin|vasopressin
5012570|NCT03917758|Natriuretic Peptide, Brain|natriuretic peptide, brain
5012571|NCT03917758|Blood Pressure|blood pressure
5012572|NCT03917758|Body Composition|body composition
5012573|NCT03917758|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5012574|NCT03917745|anxiety|anxiety
5012575|NCT03917745|depression|depression
5012576|NCT03917745|eHealth|ehealth
5012577|NCT03917745|mindfulness|mindfulness
5012578|NCT03917745|pregnancy distress|pregnancy distress
5012579|NCT03917719|Muscular Dystrophies|muscular dystrophies
5012580|NCT03917719|Musculoskeletal Diseases|musculoskeletal diseases
5012581|NCT03917719|Neuromuscular Diseases|neuromuscular diseases
5012583|NCT03917719|dystrophin|dystrophin
5012584|NCT03917719|dystrophy|dystrophy
5012585|NCT03917719|Duchenne|duchenne
5012586|NCT03917667|Sarcopenia|sarcopenia
5342936|NCT01981473|infliximab|infliximab
5012592|NCT03917641|Oculoplastic Surgery|oculoplastic surgery
5012593|NCT03917641|Khat leaves|khat leaves
5012594|NCT03917641|Post operative care|post operative care
5012595|NCT03917641|Edema|edema
5012596|NCT03917641|Hematoma|hematoma
5012597|NCT03917615|pelvic diaphragm, Physiotherapy students, education|pelvic diaphragm, physiotherapy students, education
5012598|NCT03917602|Human amniotic membrane; large macular holes|human amniotic membrane; large macular holes
5012599|NCT03917589|post-partum|post-partum
5012600|NCT03917589|corticosteroids|corticosteroids
5012601|NCT03917589|relapse|relapse
5012602|NCT03917589|disease modifying drugs (DMD)|disease modifying drugs (dmd)
5012603|NCT03917563|atrial fibrillation|atrial fibrillation
5012604|NCT03917550|Transdiagnostic|transdiagnostic
5012605|NCT03917550|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
5012606|NCT03917550|Depression|depression
5012607|NCT03917550|Anxiety|anxiety
5012608|NCT03917537|programmed death 1 (PD-1)|programmed death 1 (pd-1)
5012609|NCT03917537|programmed death ligand 1 (PD-1)|programmed death ligand 1 (pd-1)
5012610|NCT03917537|Nivolumab|nivolumab
5012611|NCT03917537|Pembrolizumab|pembrolizumab
5012612|NCT03917537|immune-related adverse events (irAEs)|immune-related adverse events (iraes)
5012613|NCT03917537|whole-genome sequencing (WGS)|whole-genome sequencing (wgs)
5012614|NCT03917537|Circulating tumor cells (CTCs)|circulating tumor cells (ctcs)
5012615|NCT03917537|Platinum-refractory|platinum-refractory
5012616|NCT03917524|Oral Cavity Cancer|oral cavity cancer
5012617|NCT03917524|Circulating Tumor Cells|circulating tumor cells
5012618|NCT03917524|Whole-genome analysis|whole-genome analysis
5012619|NCT03917524|transcriptomes|transcriptomes
5012620|NCT03917524|distant metastasis|distant metastasis
5012621|NCT03917524|locoregional recurrence|locoregional recurrence
5012622|NCT03917524|second primary tumor|second primary tumor
5012624|NCT03917511|Mirror therapy|mirror therapy
5012625|NCT03917511|Robotic Training|robotic training
5012626|NCT03917511|Neurorehabilitation|neurorehabilitation
5012627|NCT03917498|radiation therapy|radiation therapy
5012628|NCT03917472|Diabetic Macular Edema|diabetic macular edema
5012629|NCT03917472|intravitreal injection|intravitreal injection
5012630|NCT03917472|brolucizumab|brolucizumab
5012631|NCT03917472|aflibercept|aflibercept
5012632|NCT03917472|double-masked|double-masked
5012633|NCT03917459|heart failure|heart failure
5012634|NCT03917459|systolic heart failure|systolic heart failure
5012635|NCT03917459|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5012636|NCT03917459|erectile dysfunction|erectile dysfunction
5012637|NCT03917459|Enalapril|enalapril
5012638|NCT03917459|Enalaprilat|enalaprilat
5012639|NCT03917459|LCZ696|lcz696
5012640|NCT03917459|Sacubitril/valsartan|sacubitril/valsartan
5012641|NCT03917433|exposure therapy|exposure therapy
5012642|NCT03917433|virtual reality|virtual reality
5012643|NCT03917433|acrophobia|acrophobia
5012644|NCT03917433|fear of heights|fear of heights
5012645|NCT03917407|Alcoholic Hepatitis|alcoholic hepatitis
5012646|NCT03917407|Alcoholic Liver Disease|alcoholic liver disease
5012647|NCT03917394|THA/TKA|tha/tka
5012648|NCT03917394|Perioperative anemia|perioperative anemia
5012649|NCT03917394|rHuEPO|rhuepo
5012650|NCT03917394|iron sucrose|iron sucrose
5012651|NCT03917368|Jugular Venous Pulse|jugular venous pulse
5012652|NCT03917368|Central Venous Pressure|central venous pressure
5012653|NCT03917368|Ultrasounds|ultrasounds
5012654|NCT03917368|Validation Studies|validation studies
5012655|NCT03917368|Software Validation|software validation
5012656|NCT03917329|Parents|parents
5012657|NCT03917329|Education staff|education staff
5012658|NCT03917329|Teachers|teachers
5012659|NCT03917329|Intellectual Disability|intellectual disability
5012660|NCT03917329|Learning Disability|learning disability
5012661|NCT03917329|Positive Behaviour Support|positive behaviour support
5012663|NCT03917329|Group Therapy|group therapy
5012664|NCT03917329|Children|children
5012665|NCT03917329|Psychological Distress|psychological distress
5012666|NCT03917277|Erysipelas-like erythema|erysipelas-like erythema
5012667|NCT03917277|Familial Mediterranean Fever|familial mediterranean fever
5012668|NCT03917277|Musculoskeletal ultrasound|musculoskeletal ultrasound
5012669|NCT03917264|implant|implant
5012670|NCT03917264|titanium|titanium
5012671|NCT03917264|dental|dental
5012672|NCT03917251|coronary microvascular dysfunction|coronary microvascular dysfunction
5012673|NCT03917212|Organic acidemias|organic acidemias
5012674|NCT03917212|Mitochondria|mitochondria
5012675|NCT03917212|Oxidative stress|oxidative stress
5012676|NCT03917212|Fatty liver|fatty liver
5012677|NCT03917212|Dyslipidemia|dyslipidemia
5012678|NCT03917199|myocardial perfusion imaging|myocardial perfusion imaging
5012679|NCT03917199|computed tomography perfusion|computed tomography perfusion
5012680|NCT03917199|regadenoson|regadenoson
5012681|NCT03917199|dynamic perfusion|dynamic perfusion
5012682|NCT03917199|coronary artery disease|coronary artery disease
5012683|NCT03917186|Desflurane, Sevoflurane, Endovascular aortic repair|desflurane, sevoflurane, endovascular aortic repair
5012684|NCT03917173|gastric cancer|gastric cancer
5012685|NCT03917173|HIPEC CO2|hipec co2
5707852|NCT00472849|Rituximab|rituximab
5012686|NCT03917173|Prophylactic surgery|prophylactic surgery
5012687|NCT03917173|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5012688|NCT03917147|Endometrial Hyperplasia|endometrial hyperplasia
5012689|NCT03917147|Office Hysteroscopy|office hysteroscopy
5012690|NCT03917147|Predictive values|predictive values
5012691|NCT03917147|Sensitivity|sensitivity
5012692|NCT03917121|Jet anesthesia|jet anesthesia
5012693|NCT03917121|Pressure anesthesia|pressure anesthesia
5012709|NCT03917121|Children|children
5012710|NCT03917095|Inflammatory Bowel Disease|inflammatory bowel disease
5012711|NCT03917095|Transendoscopic Enteral Tubing|transendoscopic enteral tubing
5012712|NCT03917095|Mesalazine|mesalazine
5012713|NCT03917095|Compound Glutamine|compound glutamine
5012714|NCT03917082|endocrine therapy|endocrine therapy
5012715|NCT03917069|nab-paclitaxel|nab-paclitaxel
5012716|NCT03917069|carboplatin|carboplatin
5012717|NCT03917069|endostatin|endostatin
5012718|NCT03917069|melanoma|melanoma
5012719|NCT03917056|Cap-assisted endoscopic sclerotherapy|cap-assisted endoscopic sclerotherapy
5012720|NCT03917056|Internal Hemorrhoid|internal hemorrhoid
5012721|NCT03917056|Rectal Prolapse|rectal prolapse
5012722|NCT03917017|radiomics|radiomics
5012723|NCT03917017|Watson artificial intelligence|watson artificial intelligence
5012724|NCT03917017|hepatocellular carcinoma|hepatocellular carcinoma
5012725|NCT03917017|surgical decisions|surgical decisions
5012726|NCT03917017|prognosis|prognosis
5012727|NCT03917004|controlled hypotension|controlled hypotension
5012728|NCT03917004|cardiac output on|cardiac output on
5012729|NCT03917004|blood loss|blood loss
5012730|NCT03917004|surgical field|surgical field
5012731|NCT03917004|oxygen supply|oxygen supply
5012732|NCT03917004|oxygen consumption|oxygen consumption
5012733|NCT03916978|Ovarian rejuvenation|ovarian rejuvenation
5012734|NCT03916978|Ovarian reactivation; ovulation|ovarian reactivation; ovulation
5012735|NCT03916965|dissection of the superior mesenteric artery|dissection of the superior mesenteric artery
5012736|NCT03916965|patency of stents|patency of stents
5012737|NCT03916965|remodeling|remodeling
5012738|NCT03916926|Dental Caries|dental caries
5012739|NCT03916926|Oral Health Quality of Life|oral health quality of life
5012740|NCT03916913|Non small cell lung cancer|non small cell lung cancer
5012741|NCT03916913|Oligo-metastasis|oligo-metastasis
5012742|NCT03916913|EGFR activating mutation|egfr activating mutation
5012743|NCT03916913|Radiotherapy|radiotherapy
5012744|NCT03916900|Pulpotomy|pulpotomy
5012745|NCT03916900|Root canal treatment|root canal treatment
5012747|NCT03916900|Cariously exposed|cariously exposed
5012748|NCT03916900|Permanent molars|permanent molars
5012749|NCT03916900|Irreversible pulpitis|irreversible pulpitis
5012750|NCT03916887|aging, exercise golf senior intervention|aging, exercise golf senior intervention
5012751|NCT03916861|Hemodialysis|hemodialysis
5012752|NCT03916861|BIA|bia
5012753|NCT03916861|Acute Kidney Injury|acute kidney injury
5012761|NCT03916835|pain|pain
5012762|NCT03916822|Antibody mediated Rejection|antibody mediated rejection
5012763|NCT03916822|Renal Transplantation|renal transplantation
5012764|NCT03916822|Adults|adults
5012765|NCT03916822|CD154|cd154
5012766|NCT03916822|B-cells|b-cells
5012767|NCT03916822|B-cell subsets|b-cell subsets
5012768|NCT03916822|alloantigen-specific|alloantigen-specific
5012769|NCT03916809|oropharyngeal cancer|oropharyngeal cancer
5012770|NCT03916809|laryngeal cancer|laryngeal cancer
5012771|NCT03916809|swallow|swallow
5012772|NCT03916809|chemoradiation|chemoradiation
5012773|NCT03916809|expiratory muscle strength training|expiratory muscle strength training
5012774|NCT03916783|Suubi|suubi
5012775|NCT03916783|Youth|youth
5012776|NCT03916783|Poverty|poverty
5012777|NCT03916783|Economic Empowerment Interventions|economic empowerment interventions
5012778|NCT03916783|Epidemiology|epidemiology
5012779|NCT03916783|Access to Treatment Services|access to treatment services
5012780|NCT03916783|Treatment Adherence|treatment adherence
5012788|NCT03916731|Hemodialysis|hemodialysis
5012789|NCT03916731|Vascular Access|vascular access
5012790|NCT03916731|Arterio-Venous Grafts (AVG)|arterio-venous grafts (avg)
5012791|NCT03916705|Back Pain|back pain
5012792|NCT03916705|Ultrasound|ultrasound
5012793|NCT03916705|Fascia|fascia
5012794|NCT03916679|Ovarian Cancer|ovarian cancer
5012795|NCT03916679|CAR-T|car-t
5012796|NCT03916679|MESO|meso
5012797|NCT03916679|Relapsed and Refractory|relapsed and refractory
5012798|NCT03916627|NSCLC|nsclc
5012799|NCT03916627|HCC|hcc
5012800|NCT03916627|HNSCC|hnscc
5012801|NCT03916627|Resectable|resectable
5012802|NCT03916562|Walking|walking
5012803|NCT03916562|Gait|gait
5012804|NCT03916562|Stability|stability
5012805|NCT03916562|Energetic cost|energetic cost
5012806|NCT03916536|Holmium Laser|holmium laser
5012807|NCT03916536|Thulium Laser|thulium laser
5012808|NCT03916536|Bipolar diathermy|bipolar diathermy
5012809|NCT03916536|prostate enucleation|prostate enucleation
5012810|NCT03916523|Sustained lung inflation|sustained lung inflation
5012811|NCT03916523|Lung injury|lung injury
5012812|NCT03916523|Delivery room management|delivery room management
5012813|NCT03916523|CPAP|cpap
5012814|NCT03916510|locally advanced|locally advanced
5012815|NCT03916510|rectal cancer|rectal cancer
5012816|NCT03916510|Enadenotucirev|enadenotucirev
5012817|NCT03916510|oncolytic virus|oncolytic virus
5012818|NCT03916510|adenovirus|adenovirus
5012819|NCT03916510|dose escalation|dose escalation
5012820|NCT03916510|Time To Event Continual Reassessment Method|time to event continual reassessment method
5012821|NCT03916510|chemoradiotherapy|chemoradiotherapy
5012822|NCT03916510|phase 1|phase 1
5012823|NCT03916471|Stress Urinary Incontinence|stress urinary incontinence
5012824|NCT03916458|Carcinoma, Renal Cell|carcinoma, renal cell
5012825|NCT03916458|Disease-Free Survival|disease-free survival
5012826|NCT03916458|Sunitinib|sunitinib
5007787|NCT03947606|Multiphase Optimization Strategy|multiphase optimization strategy
5012827|NCT03916458|Protein Kinase Inhibitors|protein kinase inhibitors
5012828|NCT03916458|Angiogenesis Inhibitors|angiogenesis inhibitors
5012829|NCT03916458|Prognosis|prognosis
5012830|NCT03916393|PF-06651600|pf-06651600
5012831|NCT03916393|Palatability|palatability
5012832|NCT03916393|Bitrex|bitrex
5012833|NCT03916393|Taste Study|taste study
5012834|NCT03916380|Tacrolimus|tacrolimus
5012835|NCT03916380|Grapefruit Juice|grapefruit juice
5012836|NCT03916380|CYP3A4|cyp3a4
5012837|NCT03916380|Midazolam|midazolam
5012838|NCT03916380|Kidney Transplant|kidney transplant
5012839|NCT03916367|radioactive iodine-125 seeds implantation|radioactive iodine-125 seeds implantation
5012840|NCT03916367|non-small cell lung cancer|non-small cell lung cancer
5012841|NCT03916367|early stage|early stage
5012842|NCT03916341|e-cigarettes|e-cigarettes
5012843|NCT03916341|tobacco cigarettes|tobacco cigarettes
5012844|NCT03916341|nicotine|nicotine
5012845|NCT03916341|ventricular repolarization|ventricular repolarization
5012846|NCT03916315|General Anxiety Disorder|general anxiety disorder
5012847|NCT03916315|Social Anxiety Disorder|social anxiety disorder
5012848|NCT03916315|Specific Phobia|specific phobia
5012857|NCT03916276|Behavioral Activation|behavioral activation
5012859|NCT03916276|Telehealth|telehealth
5012860|NCT03916276|Opioid Misuse|opioid misuse
5012861|NCT03916276|Mechanisms|mechanisms
5012862|NCT03916263|PCOS|pcos
5012863|NCT03916263|Diet|diet
5012864|NCT03916263|Video Instruction|video instruction
5012865|NCT03916237|medical legal partnership|medical legal partnership
5012866|NCT03916237|urban health services|urban health services
5012867|NCT03916237|urban health|urban health
5012868|NCT03916224|Intubation|intubation
5012869|NCT03916224|Airway management|airway management
5012870|NCT03916211|stem cells|stem cells
5012871|NCT03916198|healing|healing
5012872|NCT03916198|fatty degeneration|fatty degeneration
5012873|NCT03916198|retear|retear
5012874|NCT03916172|Adolescence|adolescence
5012875|NCT03916172|Stress|stress
5012876|NCT03916172|Parent-adolescent relationship|parent-adolescent relationship
5012877|NCT03916159|extrauterine placental transfusion|extrauterine placental transfusion
5012878|NCT03916159|delayed cord clamping|delayed cord clamping
5012879|NCT03916159|neonatal resuscitation|neonatal resuscitation
5012880|NCT03916107|Ptosis|ptosis
5012881|NCT03916107|Frontalis flap|frontalis flap
5012882|NCT03916094|overexpressing HER2|overexpressing her2
5708780|NCT00469664|Attention|attention
5012883|NCT03916055|Tourette syndrome|tourette syndrome
5012884|NCT03916055|Tourette|tourette
5012885|NCT03916055|Tics|tics
5012886|NCT03916055|Behavior therapy|behavior therapy
5012897|NCT03916016|Volunteer Clinic|volunteer clinic
5012898|NCT03915990|diabetes|diabetes
5012899|NCT03915990|umbilical artery|umbilical artery
5012900|NCT03915990|middle cerebral artery|middle cerebral artery
5012901|NCT03915951|lung cancer|lung cancer
5012902|NCT03915951|cancer|cancer
5012903|NCT03915951|non-small cell lung cancer|non-small cell lung cancer
5012904|NCT03915938|Ketamine|ketamine
5012905|NCT03915938|ERP|erp
5012906|NCT03915938|Oddball|oddball
5012907|NCT03915925|right ventricle dysfunction|right ventricle dysfunction
5012915|NCT03915873|egyptian|egyptian
5012916|NCT03915873|questionnaire|questionnaire
5012917|NCT03915834|Biomarker|biomarker
5012918|NCT03915834|Mechanical thrombectomy|mechanical thrombectomy
5012919|NCT03915834|Intracerebral Hemorrhage|intracerebral hemorrhage
5012920|NCT03915834|Acute Ischemic stroke|acute ischemic stroke
5012921|NCT03915795|Kawasaki Disease|kawasaki disease
5012922|NCT03915795|coronary artery abnormalities|coronary artery abnormalities
5012923|NCT03915795|statins|statins
5012924|NCT03915782|Ischemic stroke|ischemic stroke
5012925|NCT03915782|Mechanical Thrombectomy|mechanical thrombectomy
5012926|NCT03915782|Ischemia/Reperfusion|ischemia/reperfusion
5012927|NCT03915782|Remote Ischemic Conditioning|remote ischemic conditioning
5012928|NCT03915782|Magnetic Resonance Imaging|magnetic resonance imaging
5012933|NCT03915756|Knee replacement|knee replacement
5012934|NCT03915756|Blood loss|blood loss
5012935|NCT03915756|Wound drainage|wound drainage
5012936|NCT03915743|Palliative care|palliative care
5012937|NCT03915743|Out-patient clinic|out-patient clinic
5012938|NCT03915743|COPD symptom burden|copd symptom burden
5012939|NCT03915730|Chronic periodontitis|chronic periodontitis
5012940|NCT03915730|gingival crevicular fluid|gingival crevicular fluid
5012941|NCT03915730|initial periodontal therapy|initial periodontal therapy
5356901|NCT01917565|laryngoscope|laryngoscope
5012942|NCT03915730|peptidoglycan recognition proteins|peptidoglycan recognition proteins
5012943|NCT03915730|smoking|smoking
5012944|NCT03915704|pain management|pain management
5012945|NCT03915704|intramuscular injection|intramuscular injection
5012946|NCT03915704|non-pharmacological method|non-pharmacological method
5012947|NCT03915691|Atrial Tachycardia|atrial tachycardia
5028122|NCT03823222|protein|protein
5012966|NCT03915639|Postoperative Pain|postoperative pain
5012967|NCT03915639|Cocktail|cocktail
5012968|NCT03915639|Analgesia|analgesia
5012969|NCT03915600|Metabolic Syndrome|metabolic syndrome
5012970|NCT03915600|Micronuceli|micronuceli
5012971|NCT03915600|Quinoa|quinoa
5012972|NCT03915600|Flaxseed|flaxseed
5012973|NCT03915600|Diet|diet
5012974|NCT03915561|postoperative sore throat|postoperative sore throat
5012975|NCT03915522|total kee arthroplasty|total kee arthroplasty
5012976|NCT03915522|adductor canal block|adductor canal block
5012977|NCT03915522|multimodal analgesia|multimodal analgesia
5012978|NCT03915509|nanotopography|nanotopography
5012979|NCT03915509|osseointegration|osseointegration
5012980|NCT03915509|resonance frequency analysis.|resonance frequency analysis.
5012986|NCT03915470|Post-operative|post-operative
5012987|NCT03915470|Post-surgical|post-surgical
5012988|NCT03915470|Infection prevention|infection prevention
5012989|NCT03915470|Staphylococcus aureus|staphylococcus aureus
5012990|NCT03915470|MSSA|mssa
5012991|NCT03915470|MRSA|mrsa
5012992|NCT03915457|Simulated Microgravity|simulated microgravity
5012993|NCT03915457|Weightlessness|weightlessness
5012994|NCT03915457|Countermeasure|countermeasure
5012995|NCT03915457|Dry immersion|dry immersion
5012996|NCT03915457|Supportlessness|supportlessness
5012997|NCT03915418|Screening|screening
5710631|NCT00462761|dysplasia|dysplasia
5012998|NCT03915418|sleep disorders|sleep disorders
5012999|NCT03915418|children|children
5013000|NCT03915418|cerebral palsy|cerebral palsy
5013001|NCT03915418|connected tools|connected tools
5013002|NCT03915392|Diffusion weighted MRI|diffusion weighted mri
5013003|NCT03915392|Cholesteatoma|cholesteatoma
5013004|NCT03915392|Localization|localization
5013005|NCT03915353|Noise|noise
5013006|NCT03915353|Balance|balance
5013007|NCT03915353|Quality of Life|quality of life
5013008|NCT03915340|propafenone|propafenone
5013009|NCT03915340|bioequivalence|bioequivalence
5013018|NCT03915288|Cancer|cancer
5013019|NCT03915288|Aerobic exercise|aerobic exercise
5013020|NCT03915288|High intensity training|high intensity training
5013022|NCT03915249|Energy metabolism|energy metabolism
5013023|NCT03915249|Exercise test|exercise test
5013024|NCT03915249|Leisure activities|leisure activities
5013025|NCT03915249|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5013026|NCT03915249|Muscle strength|muscle strength
5013027|NCT03915249|Respiratory function test|respiratory function test
5013028|NCT03915249|Exercise|exercise
5013035|NCT03915223|preoperative procedure|preoperative procedure
5013036|NCT03915223|leg fractures|leg fractures
5013037|NCT03915223|osteosynthesis|osteosynthesis
5013038|NCT03915223|corticosteroids|corticosteroids
5013039|NCT03915210|Energy metabolism|energy metabolism
5013040|NCT03915210|Exercise|exercise
5013041|NCT03915210|respiratory function test|respiratory function test
5013042|NCT03915210|quality of life|quality of life
5013043|NCT03915210|leisure activities|leisure activities
5013044|NCT03915210|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5013045|NCT03915197|allergic asthma|allergic asthma
5013046|NCT03915197|acute bronchiolitis|acute bronchiolitis
5013047|NCT03915197|allergic sensitization|allergic sensitization
5013048|NCT03915197|-risk factor|-risk factor
5013049|NCT03915184|CAR-T|car-t
5013050|NCT03915184|Carcinoma|carcinoma
5013053|NCT03915132|VMAT|vmat
5013054|NCT03915132|Nimotuzumab|nimotuzumab
5013055|NCT03915132|Elderly Patients|elderly patients
5013056|NCT03915132|efficacy|efficacy
5013057|NCT03915132|toxicity|toxicity
5013058|NCT03915106|scoliosis|scoliosis
5013059|NCT03915106|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5013060|NCT03915106|bracing|bracing
5013061|NCT03915106|surgery|surgery
5013062|NCT03915106|quality of life|quality of life
5013063|NCT03915106|questionnaire|questionnaire
5013064|NCT03915093|Thoracoscopy|thoracoscopy
5013065|NCT03915093|Educational nursing protocol|educational nursing protocol
5013066|NCT03915093|Quality of life|quality of life
5013067|NCT03915041|virtual reality|virtual reality
5013068|NCT03915041|brain stimulation|brain stimulation
5013069|NCT03915041|tDCS|tdcs
5013070|NCT03915041|phenomenology|phenomenology
5013071|NCT03915028|Multiple sclerosis|multiple sclerosis
5013072|NCT03915028|Spa treatment|spa treatment
5013073|NCT03915028|Crenotherapy|crenotherapy
5013074|NCT03915028|Balneotherapy|balneotherapy
5013075|NCT03915028|Physical exercise|physical exercise
5013076|NCT03914989|Memory preservation|memory preservation
5013077|NCT03914989|Age-related memory disorders|age-related memory disorders
5013078|NCT03914989|Intervention|intervention
5007987|NCT03946462|AKI|aki
5007988|NCT03946462|Cardiopulmonary bypass|cardiopulmonary bypass
5007989|NCT03946462|CPB|cpb
5013079|NCT03914989|Life quality|life quality
5013080|NCT03914989|Olfaction|olfaction
5013081|NCT03914976|high-risk digestive surgery|high-risk digestive surgery
5013082|NCT03914976|intensive care unit|intensive care unit
5013083|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive
5013084|NCT03914963|Lymph node dissection|lymph node dissection
5013085|NCT03914950|TOF-18F-FDG PET/CT|tof-18f-fdg pet/ct
5013086|NCT03914950|pancreatic lesions|pancreatic lesions
5013087|NCT03914924|Diabetes Mellitus|diabetes mellitus
5013088|NCT03914924|Exercise|exercise
5013089|NCT03914924|Health Education|health education
5013090|NCT03914924|Patient Education|patient education
5013091|NCT03914924|Randomized Controlled Trial|randomized controlled trial
5013092|NCT03914898|burnout|burnout
5013093|NCT03914898|compassion fatigue|compassion fatigue
5013094|NCT03914898|nursing|nursing
5013095|NCT03914898|psychological distress|psychological distress
5013096|NCT03914820|colorectal cancer, HIPEC CO2, prophylactic surgery , mitomycin|colorectal cancer, hipec co2, prophylactic surgery , mitomycin
5013097|NCT03914807|milk|milk
5013098|NCT03914807|fat|fat
5013099|NCT03914807|cohort-embedded|cohort-embedded
5013100|NCT03914794|Bladder Cancer|bladder cancer
5013101|NCT03914794|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5013102|NCT03914794|Non-Muscle Invasive Bladder Cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5013103|NCT03914794|NMIBC|nmibc
5013104|NCT03914794|Urothelial Carcinoma|urothelial carcinoma
5013105|NCT03914794|Urothelial Cancer|urothelial cancer
5013106|NCT03914794|Urinary Bladder Neoplasm|urinary bladder neoplasm
5013107|NCT03914794|Bladder Neoplasm|bladder neoplasm
5710632|NCT00462761|myeloid|myeloid
5013108|NCT03914794|Fibroblast inhibitors|fibroblast inhibitors
5013109|NCT03914794|Pemigatinib|pemigatinib
5013116|NCT03914768|DC vaccine therapy|dc vaccine therapy
5013118|NCT03914768|GBM|gbm
5013119|NCT03914768|neoantigen|neoantigen
5013120|NCT03914729|pilonidal sinus|pilonidal sinus
5013121|NCT03914729|plasty|plasty
5013122|NCT03914729|gluteus muscle fascia|gluteus muscle fascia
5013123|NCT03914729|ano-coccygeal plasty|ano-coccygeal plasty
5013124|NCT03914716|Hemophilia|hemophilia
5013134|NCT03914573|football|football
5013136|NCT03914573|obesity|obesity
5013137|NCT03914521|hip surgery|hip surgery
5013138|NCT03914521|bone mineral density|bone mineral density
5013139|NCT03914521|femoral head|femoral head
5013140|NCT03914521|Pre-surgical prognostic|pre-surgical prognostic
5013141|NCT03914508|Overweight|overweight
5013142|NCT03914508|Obesity|obesity
5013143|NCT03914508|Overeating|overeating
5013144|NCT03914508|Body Mass Index|body mass index
5013145|NCT03914508|Weight|weight
5013146|NCT03914508|Treatment|treatment
5013147|NCT03914508|Cravings|cravings
5013148|NCT03914508|Intervention|intervention
5013149|NCT03914508|Behavioral Treatment|behavioral treatment
5013150|NCT03914495|inulin|inulin
5013151|NCT03914495|microbiome|microbiome
5013152|NCT03914495|hepatic steatosis|hepatic steatosis
5013153|NCT03914495|obesity|obesity
5013154|NCT03914456|Spinal Cord Injury|spinal cord injury
5013155|NCT03914456|Motor rehabilitation|motor rehabilitation
5013156|NCT03914456|Sensorimotor reorganization|sensorimotor reorganization
5013165|NCT03914430|Food intake|food intake
5013166|NCT03914430|Satiety|satiety
5013167|NCT03914417|Actinic Keratosis|actinic keratosis
5013168|NCT03914378|Radiotherapy|radiotherapy
5013169|NCT03914365|Circumcision|circumcision
5013170|NCT03914365|Penile block|penile block
5013171|NCT03914365|Pudendal block|pudendal block
5013172|NCT03914365|Pediatric|pediatric
5013173|NCT03914352|Hepatocellular carcinoma|hepatocellular carcinoma
5013174|NCT03914352|Portal vein tumor thrombus|portal vein tumor thrombus
5013175|NCT03914352|Hepatic resection|hepatic resection
5013176|NCT03914352|Recurrence|recurrence
5013177|NCT03914352|PD-1 antibody|pd-1 antibody
5013178|NCT03914313|Lokomat|lokomat
5013179|NCT03914313|Robotic rehab|robotic rehab
5013180|NCT03914313|Executive function|executive function
5013181|NCT03914313|VR|vr
5013182|NCT03914274|Sport Injury; Technical socks; Temperature; Hiking|sport injury; technical socks; temperature; hiking
5013189|NCT03914235|Tumescent anesthesia|tumescent anesthesia
5013190|NCT03914235|tenosynovitis|tenosynovitis
5013191|NCT03914235|Visual Analog Scale|visual analog scale
5013192|NCT03914235|Tourniquets|tourniquets
5013193|NCT03914235|Epinephrine|epinephrine
5013194|NCT03914170|colorectal cancer|colorectal cancer
5013195|NCT03914170|first line|first line
5013196|NCT03914170|folfirinox + cetuximab|folfirinox + cetuximab
5013197|NCT03914144|catether|catether
5013198|NCT03914144|pregnancy|pregnancy
5013199|NCT03914144|postnatal infection|postnatal infection
5013200|NCT03914079|Coronary Artery Disease|coronary artery disease
5013201|NCT03914079|Cardiovascular Disease|cardiovascular disease
5013202|NCT03914079|Atherosclerosis|atherosclerosis
5013203|NCT03914079|Coronary Occlusion|coronary occlusion
5013204|NCT03914079|Non-Invasive Medical Device|non-invasive medical device
5013205|NCT03914079|Cardiac Diagnostics|cardiac diagnostics
5013206|NCT03914066|overweight|overweight
5013207|NCT03914066|obesity|obesity
5013208|NCT03914066|group treatment|group treatment
5013209|NCT03914066|primary care|primary care
5013210|NCT03914014|connective tissue massage|connective tissue massage
5013211|NCT03914014|massage|massage
5013212|NCT03914014|menstrual pain|menstrual pain
5013213|NCT03914014|treatment|treatment
5014207|NCT03908112|concussion|concussion
5013217|NCT03913988|Dreaming|dreaming
5013218|NCT03913988|Sleep|sleep
5013219|NCT03913988|Dream|dream
5013220|NCT03913962|Paediatric|paediatric
5013221|NCT03913962|Auto-immunity|auto-immunity
5013222|NCT03913962|Treatment|treatment
5013223|NCT03913962|Physical Activity|physical activity
5013224|NCT03913949|APG-2575|apg-2575
5013225|NCT03913949|B-cell lymphoma 2 (BCL-2)|b-cell lymphoma 2 (bcl-2)
5013226|NCT03913949|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5013227|NCT03913949|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5013228|NCT03913936|Breast Cancer|breast cancer
5013229|NCT03913910|Autologous micro-fragmented adipose tissue|autologous micro-fragmented adipose tissue
5013230|NCT03913910|Perianal fistula|perianal fistula
5013231|NCT03913910|Lipogems|lipogems
5013232|NCT03913910|Mesenchymal Stem Cells|mesenchymal stem cells
5013233|NCT03913897|acute pain|acute pain
5013234|NCT03913897|blood collection|blood collection
5013235|NCT03913897|nursing|nursing
5013239|NCT03913884|Clinical outcomes|clinical outcomes
5013240|NCT03913884|Concentrated growth factor|concentrated growth factor
5013241|NCT03913871|mHealth|mhealth
5013242|NCT03913871|African American|african american
5013243|NCT03913871|Women's Health|women's health
5013244|NCT03913871|Minority Health|minority health
5013245|NCT03913858|Morbid Obesity|morbid obesity
5013246|NCT03913858|Sleeve Gastrectomy|sleeve gastrectomy
5013247|NCT03913858|Low Flow Anesthesia|low flow anesthesia
5013248|NCT03913780|Exercise|exercise
5013249|NCT03913780|Force|force
5013250|NCT03913780|Cardiac Rehabilitation|cardiac rehabilitation
5013251|NCT03913780|Rehabilitation|rehabilitation
5013252|NCT03913780|Heart Failure|heart failure
5013253|NCT03913767|Chest pain|chest pain
5013254|NCT03913767|Acute coronary syndrom|acute coronary syndrom
5013255|NCT03913767|ED triage|ed triage
5013256|NCT03913741|tisotumab vedotin|tisotumab vedotin
5013257|NCT03913741|cervical cancer|cervical cancer
5013258|NCT03913702|Ketorolac|ketorolac
5013291|NCT03913533|Heart rate assessment|heart rate assessment
5013292|NCT03913533|Delivery Room|delivery room
5013293|NCT03913507|Cystic Fibrosis Children|cystic fibrosis children
5013294|NCT03913494|Upper Airway Conditioning|upper airway conditioning
5013295|NCT03913494|Snoring|snoring
5013296|NCT03913494|Snore|snore
5013297|NCT03913494|Sleep|sleep
5013298|NCT03913494|OSA|osa
5013299|NCT03913494|Sleep Apnea|sleep apnea
5013300|NCT03913494|Neurostimulation|neurostimulation
5013301|NCT03913481|tissue|tissue
5013302|NCT03913481|organ and systemic injury responses to surgery|organ and systemic injury responses to surgery
5013303|NCT03913481|trauma|trauma
5013304|NCT03913481|burn|burn
5013305|NCT03913481|sepsis|sepsis
5013306|NCT03913481|hemorrhage|hemorrhage
5013307|NCT03913481|ischemia- reperfusion|ischemia- reperfusion
5013308|NCT03913481|resuscitation|resuscitation
5013309|NCT03913481|including integrating pathways and signals|including integrating pathways and signals
5013310|NCT03913481|cardiac surgery|cardiac surgery
5013311|NCT03913481|transfusion|transfusion
5013312|NCT03913468|ascorbic acid|ascorbic acid
5013325|NCT03913390|guidelines|guidelines
5013326|NCT03913390|decision making|decision making
5013327|NCT03913390|bioethics|bioethics
5013328|NCT03913390|palliative care|palliative care
5013329|NCT03913390|end of life|end of life
5013330|NCT03913364|obesity|obesity
5013331|NCT03913364|breast milk|breast milk
5013332|NCT03913364|probiotic|probiotic
5013333|NCT03913364|IL-6|il-6
5013334|NCT03913364|CRP|crp
5013335|NCT03913364|Insulin|insulin
5013336|NCT03913364|Adiponectin|adiponectin
5013337|NCT03913364|Resistin|resistin
5013338|NCT03913364|breastmilk microbiota|breastmilk microbiota
5013339|NCT03913364|Bifidobacterium|bifidobacterium
5013340|NCT03913312|AML,Elderly patients,Decitabine,Unrelated cord blood|aml,elderly patients,decitabine,unrelated cord blood
5013341|NCT03913299|Frailty|frailty
5013342|NCT03913299|Cardiac surgery|cardiac surgery
5013343|NCT03913299|Vascular surgery|vascular surgery
5013347|NCT03913286|brain-machine|brain-machine
5008180|NCT03945214|Burnout|burnout
5008181|NCT03945214|Work|work
5008189|NCT03945201|VR|vr
5013348|NCT03913286|microelectrode|microelectrode
5013350|NCT03913286|orthosis|orthosis
5013351|NCT03913286|brain computer interface|brain computer interface
5013352|NCT03913286|assistive device|assistive device
5013353|NCT03913286|Neurorehabilitation|neurorehabilitation
5013354|NCT03913286|neurotechnology|neurotechnology
5013355|NCT03913273|Proprioception|proprioception
5013356|NCT03913273|Movement|movement
5013357|NCT03913273|Joint Prosthesis|joint prosthesis
5013358|NCT03913273|Feedback|feedback
5013359|NCT03913273|Rehabilitation|rehabilitation
5013360|NCT03913234|HR-positive|hr-positive
5013361|NCT03913234|HER2-positive|her2-positive
5013362|NCT03913234|Breast Cancer|breast cancer
5013363|NCT03913234|Hormone-positive|hormone-positive
5013364|NCT03913234|CDK4/6 inhibitor|cdk4/6 inhibitor
5013366|NCT03913195|ibalizumab|ibalizumab
5013367|NCT03913195|MDR HIV|mdr hiv
5013368|NCT03913182|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5013369|NCT03913182|apatinib|apatinib
5013370|NCT03913182|recurrence|recurrence
5013371|NCT03913182|metastasis|metastasis
5013372|NCT03913169|Interprofessional Education|interprofessional education
5013373|NCT03913169|Medical Education|medical education
5013374|NCT03913169|Interprofessional Practice|interprofessional practice
5013375|NCT03913169|Doctor of Osteopathic Medicine|doctor of osteopathic medicine
5013376|NCT03913169|Physician Assistant|physician assistant
5013386|NCT03913130|LCA10|lca10
5013387|NCT03913130|CEP290|cep290
5013388|NCT03913130|p.Cys998X|p.cys998x
5013389|NCT03913130|c.2991+1655A>G|c.2991+1655a>g
5013390|NCT03913130|Leber's Congenital Amaurosis|leber's congenital amaurosis
5013391|NCT03913130|Antisense oligonucleotide|antisense oligonucleotide
5013392|NCT03913130|RNA therapy|rna therapy
5013395|NCT03913091|Interscalene Nerve Block (ISB)|interscalene nerve block (isb)
5013396|NCT03913078|fitness|fitness
5013397|NCT03913078|exercise|exercise
5013398|NCT03913078|physical activity|physical activity
5013399|NCT03913065|Cardiac arrest|cardiac arrest
5013400|NCT03913065|Hypothermia|hypothermia
5013401|NCT03913065|Neurological function|neurological function
5013402|NCT03913065|Cardiovascular disease|cardiovascular disease
5013403|NCT03913065|Cerebral oedema|cerebral oedema
5013404|NCT03913065|Cerebral edema|cerebral edema
5013405|NCT03913065|Cerebral ischaemia|cerebral ischaemia
5013406|NCT03913065|Cerebral ischemia|cerebral ischemia
5013407|NCT03913065|Gray-white-matter differentiation|gray-white-matter differentiation
5013408|NCT03913065|Grey-white-matter differentiation|grey-white-matter differentiation
5013409|NCT03913065|ROI|roi
5013410|NCT03913065|Regions of interest|regions of interest
5013411|NCT03913065|CT|ct
5013412|NCT03913065|GWR|gwr
5013413|NCT03913065|Neurological prognostication|neurological prognostication
5013414|NCT03913026|UM171|um171
5013415|NCT03913026|Stem Cell Expansion|stem cell expansion
5326272|NCT02056496|Ellagic acid|ellagic acid
5013420|NCT03912935|Rapid sequence induction|rapid sequence induction
5013421|NCT03912935|Bed up head elevation|bed up head elevation
5013422|NCT03912935|sniffing position|sniffing position
5013423|NCT03912935|cricoid pressure|cricoid pressure
5013424|NCT03912935|time taken for intubation in seconds|time taken for intubation in seconds
5013425|NCT03912935|percentage of glottic opening|percentage of glottic opening
5013426|NCT03912922|insulin sensitivity|insulin sensitivity
5013427|NCT03912922|sitting time|sitting time
5013428|NCT03912909|Metabolic Syndrome|metabolic syndrome
5013429|NCT03912909|Central sympathetic nervous system|central sympathetic nervous system
5013430|NCT03912909|Sodium-glucose co-transporter-2 (SGLT2)|sodium-glucose co-transporter-2 (sglt2)
5013431|NCT03912909|Blood Pressure|blood pressure
5013432|NCT03912896|taekwondo|taekwondo
5013433|NCT03912896|Autism Spectrum Disorder|autism spectrum disorder
5013434|NCT03912896|occupational therapy|occupational therapy
5013435|NCT03912896|Social interaction skills|social interaction skills
5013436|NCT03912896|child participants|child participants
5013437|NCT03912883|biomarkers|biomarkers
5013438|NCT03912883|pathology|pathology
5013439|NCT03912883|tissue|tissue
5013440|NCT03912883|watchful waiting|watchful waiting
5013441|NCT03912883|active surveillance|active surveillance
5013442|NCT03912857|mCRC MSI-H|mcrc msi-h
5013443|NCT03912844|SIRT|sirt
5013444|NCT03912844|liver resection|liver resection
5013445|NCT03912844|hypertrophy|hypertrophy
5013446|NCT03912844|liver metastases|liver metastases
5013447|NCT03912844|liver transplantation|liver transplantation
5013448|NCT03912792|Natural History Study|natural history study
5013449|NCT03912792|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5013450|NCT03912779|First time hearing aid user|first time hearing aid user
5013451|NCT03912766|transurethral prostatectomy|transurethral prostatectomy
5013452|NCT03912766|copeptin|copeptin
5013453|NCT03912766|hyponatremia|hyponatremia
5013454|NCT03912766|risk prediction|risk prediction
5013455|NCT03912727|alpha-lipoic acid|alpha-lipoic acid
5013456|NCT03912727|Cardiovascular events|cardiovascular events
5013457|NCT03912727|Hemodialysis|hemodialysis
5013458|NCT03912714|Appendectomy, Ulcerative Colitis|appendectomy, ulcerative colitis
5013459|NCT03912675|Cell transplants|cell transplants
5013460|NCT03912675|Autografting|autografting
5013461|NCT03912636|cardiac vagal tone|cardiac vagal tone
5013462|NCT03912636|deep breathing|deep breathing
5013463|NCT03912636|diaphragmatic breathing|diaphragmatic breathing
5013465|NCT03912636|vagal tone|vagal tone
5013466|NCT03912636|cognitive behavioral therapy|cognitive behavioral therapy
5013467|NCT03912636|visceral hypersensitivity|visceral hypersensitivity
5013468|NCT03912623|HbA1c|hba1c
5013469|NCT03912623|Diabetes|diabetes
5013470|NCT03912623|Type 2|type 2
5013471|NCT03912610|Osteoarthritis of knee|osteoarthritis of knee
5013472|NCT03912610|Depressive Symptoms|depressive symptoms
5013473|NCT03912610|Anxiety State|anxiety state
5013474|NCT03912610|Brain Structure and Function|brain structure and function
5013475|NCT03912610|Multi-mode Magnetic Resonance Imaging|multi-mode magnetic resonance imaging
5013476|NCT03912597|virtual reality|virtual reality
5013477|NCT03912597|stigma reduction|stigma reduction
5013478|NCT03912597|depression|depression
5013479|NCT03912597|mental health campaigns|mental health campaigns
5013480|NCT03912597|user experience|user experience
5013481|NCT03912597|enjoyment|enjoyment
5013482|NCT03912597|presence|presence
5013483|NCT03912558|BPH|bph
5013484|NCT03912558|BOO|boo
5013485|NCT03912558|Enlarged prostate|enlarged prostate
5013486|NCT03912558|LUTS|luts
5013487|NCT03912558|Urinary obstruction|urinary obstruction
5013488|NCT03912558|Retrograde ejaculation|retrograde ejaculation
5013489|NCT03912545|Viscoelastic testing|viscoelastic testing
5013490|NCT03912545|Coagulation|coagulation
5013491|NCT03912545|Quantra|quantra
5013492|NCT03912545|Hemostasis|hemostasis
5013497|NCT03912428|Myositis|myositis
5013498|NCT03912428|PET Imaging|pet imaging
5013499|NCT03912376|Blood Flow|blood flow
5013500|NCT03912376|Healthy Participant|healthy participant
5013501|NCT03912376|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5013502|NCT03912376|19-098|19-098
5013503|NCT03912363|intrapartum|intrapartum
5013504|NCT03912363|glycemic control|glycemic control
5013505|NCT03912363|diabetes|diabetes
5013506|NCT03912363|insulin|insulin
5013507|NCT03912337|Episodic migraine|episodic migraine
5013508|NCT03912337|Disability|disability
5013509|NCT03912337|Migraine-related disability|migraine-related disability
5013510|NCT03912337|Work productivity|work productivity
5013511|NCT03912337|Erenumab|erenumab
5013512|NCT03912337|AIMOVIG|aimovig
5013513|NCT03912324|Atrial fibrillation|atrial fibrillation
5013514|NCT03912324|Pulmonary vein isolation|pulmonary vein isolation
5013515|NCT03912272|Long-Term Low-Frequency High-Intensity Interval Training|long-term low-frequency high-intensity interval training
5013516|NCT03912272|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5013517|NCT03912272|Central Obesity|central obesity
5013518|NCT03912272|Body Adiposity|body adiposity
5013519|NCT03912272|Liver Fat|liver fat
5013520|NCT03912246|sample|sample
5013521|NCT03912246|diagnostic|diagnostic
5013522|NCT03912207|BCG|bcg
5013523|NCT03912207|Aerosol|aerosol
5013524|NCT03912207|Tuberculosis|tuberculosis
5013525|NCT03912207|Challenge|challenge
5013526|NCT03912129|pediatric Evans Syndrome|pediatric evans syndrome
5013527|NCT03912129|genetic causes|genetic causes
5013528|NCT03912129|immunophenotyping immunologic explorations|immunophenotyping immunologic explorations
5013529|NCT03912103|Deprescibing|deprescibing
5013530|NCT03912103|Multimorbidity/comorbidity|multimorbidity/comorbidity
5013531|NCT03912103|Knowledge|knowledge
5013532|NCT03912103|Interdiciplinary intervention|interdiciplinary intervention
5013533|NCT03912103|Medication information|medication information
5013534|NCT03912103|Motivation|motivation
5013535|NCT03912090|pediatric|pediatric
5013536|NCT03912090|fentanyl|fentanyl
5013537|NCT03912090|intranasal|intranasal
5013538|NCT03912090|emergency|emergency
5013539|NCT03912077|Refugees|refugees
5013540|NCT03912077|Psychological distress|psychological distress
5013541|NCT03912077|Psychological trauma|psychological trauma
5013542|NCT03912077|Anxiety|anxiety
5013543|NCT03912077|CA-CBT|ca-cbt
5013544|NCT03912077|Depression|depression
5013545|NCT03912077|Post-traumatic stress disorder|post-traumatic stress disorder
5013546|NCT03912077|Intervention|intervention
5013547|NCT03912077|Turkey|turkey
5013548|NCT03912077|Migration|migration
5013549|NCT03912064|Myelofibrosis|myelofibrosis
5013550|NCT03912064|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5013551|NCT03912064|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5013552|NCT03912064|Myelodysplastic Syndromes|myelodysplastic syndromes
5013553|NCT03912064|Acute Myeloid Leukemia|acute myeloid leukemia
5013554|NCT03912038|Non-caloric sweeteners|non-caloric sweeteners
5013555|NCT03912038|microbiota|microbiota
5013556|NCT03912038|breast milk|breast milk
5061642|NCT03613649|TQT|tqt
5013564|NCT03912012|children|children
5013565|NCT03912012|adolescent|adolescent
5013566|NCT03911960|tobacco smoking|tobacco smoking
5356902|NCT01917565|Airtraq|airtraq
5013567|NCT03911960|psychiatric disorder|psychiatric disorder
5013568|NCT03911960|psychiatric hospitalization|psychiatric hospitalization
5013569|NCT03911960|acceptance and commitment therapy|acceptance and commitment therapy
5013570|NCT03911947|Vibroacoustic therapy, acute respiratory failure, pneumonia|vibroacoustic therapy, acute respiratory failure, pneumonia
5013571|NCT03911934|Polypharmacy|polypharmacy
5013572|NCT03911934|Medication review|medication review
5013573|NCT03911934|Randomized|randomized
5013574|NCT03911934|Deprescribing|deprescribing
5013575|NCT03911921|Fatigue, Cancer|fatigue, cancer
5013576|NCT03911908|near-infrared spectroscopy|near-infrared spectroscopy
5013577|NCT03911908|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5013578|NCT03911908|cardiac arrest|cardiac arrest
5013579|NCT03911908|cerebral oximetry|cerebral oximetry
5013580|NCT03911882|Fibromyalgia|fibromyalgia
5013581|NCT03911882|Cytokines|cytokines
5013582|NCT03911882|TNF|tnf
5013583|NCT03911882|Substance P|substance p
5013584|NCT03911882|Spermine|spermine
5013585|NCT03911882|Pain|pain
5013586|NCT03911882|Fatigue|fatigue
5013587|NCT03911869|BRAFV600-mutant|brafv600-mutant
5013588|NCT03911869|melanoma|melanoma
5013589|NCT03911869|brain metastasis|brain metastasis
5013590|NCT03911843|omega3|omega3
5013591|NCT03911843|T1D remission period|t1d remission period
5013592|NCT03911843|honeymoon period|honeymoon period
5013593|NCT03911843|AA/EPA ratio|aa/epa ratio
5013594|NCT03911830|Rheumatoid Arthritis|rheumatoid arthritis
5013595|NCT03911830|Physical exercise|physical exercise
5013596|NCT03911830|Cryotherapy|cryotherapy
5013597|NCT03911830|Pulse Wave Velocity|pulse wave velocity
5013598|NCT03911817|Midodrine|midodrine
5013599|NCT03911817|Septic shock|septic shock
5013600|NCT03911817|Norepinephrine|norepinephrine
5013601|NCT03911817|Weaning|weaning
5013602|NCT03911752|Occupational Therapy|occupational therapy
5013603|NCT03911752|Sexuality|sexuality
5013604|NCT03911752|Acquired Bain Injury|acquired bain injury
5013642|NCT03911518|loop drainage|loop drainage
5013643|NCT03911518|soft tissue infection|soft tissue infection
5013644|NCT03911518|abscess|abscess
5013645|NCT03911505|Pompe|pompe
5013646|NCT03911505|rhGAA|rhgaa
5013647|NCT03911492|SCI|sci
5013648|NCT03911492|Spinal Cord Injury|spinal cord injury
5013649|NCT03911492|CSF|csf
5013650|NCT03911492|Biomarker|biomarker
5013651|NCT03911492|CSF pressure|csf pressure
5013652|NCT03911492|Traumatic SCI|traumatic sci
5013653|NCT03911492|Perfusion pressure|perfusion pressure
5013654|NCT03911466|CTN-0080|ctn-0080
5013655|NCT03911466|clinical trials network|clinical trials network
5013656|NCT03911466|medication assisted treatment|medication assisted treatment
5013657|NCT03911466|pharmacokinetics|pharmacokinetics
5013658|NCT03911453|Breast Cancer|breast cancer
5013659|NCT03911453|Triple Negative|triple negative
5326479|NCT02055508|Exercise|exercise
5013660|NCT03911453|Breast Tumors|breast tumors
5013661|NCT03911453|PD-L1|pd-l1
5013662|NCT03911453|PARP|parp
5013663|NCT03911453|PARPi|parpi
5013664|NCT03911453|Rucaparib|rucaparib
5013665|NCT03911440|Mycoplasma pneumoniae, Macrolide-resistance, Children|mycoplasma pneumoniae, macrolide-resistance, children
5013666|NCT03911427|Beverage|beverage
5013667|NCT03911427|Beta glucan|beta glucan
5013668|NCT03911427|Fiber|fiber
5013669|NCT03911427|Oat|oat
5013670|NCT03911427|Hypercholesterolemia|hypercholesterolemia
5013671|NCT03911427|LDL|ldl
5013672|NCT03911427|Cholesterol|cholesterol
5028801|NCT03819452|vitamin D|vitamin d
5013703|NCT03911362|Lumbopelvic Stabilisation Exercises|lumbopelvic stabilisation exercises
5013704|NCT03911362|Pelvic Floor Exercises|pelvic floor exercises
5013705|NCT03911362|Stress Urinary Incontinence|stress urinary incontinence
5013706|NCT03911336|Chronotherapy|chronotherapy
5013707|NCT03911336|Chronomodulation|chronomodulation
5013709|NCT03911336|NSAID|nsaid
5013710|NCT03911310|prostate cancer|prostate cancer
5013711|NCT03911310|biochemical recurrence|biochemical recurrence
5013712|NCT03911310|18F-PSMA PET imaging|18f-psma pet imaging
5013713|NCT03911297|polycystic ovary syndrome|polycystic ovary syndrome
5013714|NCT03911297|androgens|androgens
5013715|NCT03911297|steroids|steroids
5013716|NCT03911297|metabolic risk|metabolic risk
5013717|NCT03911297|prediction|prediction
5013718|NCT03911297|stratified medicine|stratified medicine
5013719|NCT03911284|ASCVD|ascvd
5013720|NCT03911232|intraoperative neural monitoring|intraoperative neural monitoring
5013722|NCT03911180|Pertrochanteric fracture|pertrochanteric fracture
5013723|NCT03911180|Intertrochanteric fracture|intertrochanteric fracture
5013724|NCT03911180|subtrochanteric extension|subtrochanteric extension
5013725|NCT03911180|Proximal femoral nail|proximal femoral nail
5013726|NCT03911180|Proximal locking screw|proximal locking screw
5013727|NCT03911180|Distal locking screw|distal locking screw
5013728|NCT03911154|Sleep|sleep
5013729|NCT03911154|Sleep restriction|sleep restriction
5013730|NCT03911154|Cognitive performance|cognitive performance
5013731|NCT03911128|Leukemia|leukemia
5013732|NCT03911128|Acute Lymphoblastic|acute lymphoblastic
5013734|NCT03911128|ALLTogether|alltogether
5013735|NCT03911128|Leukaemia|leukaemia
5013736|NCT03911102|Lateral canthal wrinkle|lateral canthal wrinkle
5013737|NCT03911102|Crow's feet lines|crow's feet lines
5013738|NCT03911102|LCL|lcl
5013739|NCT03911063|Telemedicine|telemedicine
5013740|NCT03911050|endogenous reactive carbonyl species|endogenous reactive carbonyl species
5013741|NCT03911050|apple consumption|apple consumption
5013742|NCT03911050|formation of carbonyl species adducts of apple polyphenols|formation of carbonyl species adducts of apple polyphenols
5013743|NCT03911050|pharmacokinetics of adducts in human|pharmacokinetics of adducts in human
5013744|NCT03911050|intervention|intervention
5013745|NCT03911037|Regenerative medicine|regenerative medicine
5013746|NCT03911024|HIV prevention|hiv prevention
5013747|NCT03911024|homeless|homeless
5013748|NCT03911011|avalanche, survival, physiology|avalanche, survival, physiology
5013749|NCT03910998|neuromuscular blockade|neuromuscular blockade
5013750|NCT03910998|NOL monitoring|nol monitoring
5013751|NCT03910998|opioid consumption|opioid consumption
5013752|NCT03910998|intraoperative|intraoperative
5013761|NCT03910855|Mindfulness|mindfulness
5013762|NCT03910855|Stroke Survivors|stroke survivors
5013763|NCT03910855|Caregivers|caregivers
5013764|NCT03910842|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5013765|NCT03910842|Leukemia|leukemia
5013766|NCT03910842|children|children
5013767|NCT03910842|CD19|cd19
5013768|NCT03910842|CAR-T|car-t
5013769|NCT03910842|TriCAR-T|tricar-t
5013770|NCT03910842|TriCAR-SILK|tricar-silk
5013771|NCT03910829|Motor Imagery|motor imagery
5013772|NCT03910829|Action observation|action observation
5013773|NCT03910816|Surgery|surgery
5013774|NCT03910816|Eighteen|eighteen
5013775|NCT03910790|livery biopsy|livery biopsy
5013776|NCT03910790|fine needle biopsy|fine needle biopsy
5013777|NCT03910790|19-gauge needle|19-gauge needle
5013778|NCT03910751|TAVI|tavi
5013779|NCT03910751|TAVR|tavr
5013780|NCT03910751|Early discharge|early discharge
5013781|NCT03910751|ACURATE Neo|acurate neo
5013782|NCT03910738|Neuroprotection|neuroprotection
5013783|NCT03910738|Remyelination|remyelination
5013784|NCT03910738|Relapsing Remitting Multiple sclerosis|relapsing remitting multiple sclerosis
5013785|NCT03910738|Testosterone undecanoate|testosterone undecanoate
5013786|NCT03910738|Diffusion tensor Imaging|diffusion tensor imaging
5013787|NCT03910725|Arrhythmia|arrhythmia
5013788|NCT03910725|Cardiomyopathy, Dilated|cardiomyopathy, dilated
5013789|NCT03910725|Electrocardiographic imaging|electrocardiographic imaging
5013790|NCT03910712|MBC, Pyrotinib, Trastuzumab, First line, HER2|mbc, pyrotinib, trastuzumab, first line, her2
5013791|NCT03910699|Anastomosis|anastomosis
5013792|NCT03910699|Anastomotic leakage|anastomotic leakage
5013793|NCT03910699|Rectal cancer|rectal cancer
5326591|NCT02055105|Pediatric Sepsis|pediatric sepsis
5013794|NCT03910699|Total mesorectal excision|total mesorectal excision
5013795|NCT03910699|Low anterior resection|low anterior resection
5013796|NCT03910699|Anastomotic leak|anastomotic leak
5013797|NCT03910699|Colorectal anastomosis|colorectal anastomosis
5013798|NCT03910699|Three-row stapler|three-row stapler
5013799|NCT03910686|Alcohol Dependence, transcranial magnetic stimulation, cognitive behavioral therapy|alcohol dependence, transcranial magnetic stimulation, cognitive behavioral therapy
5013800|NCT03910673|Adults|adults
5013801|NCT03910673|Fosfomycin Disodium|fosfomycin disodium
5013802|NCT03910673|Healthy|healthy
5013803|NCT03910673|Intrapulmonary|intrapulmonary
5013804|NCT03910673|Intravenous|intravenous
5013805|NCT03910673|Pharmacokinetics|pharmacokinetics
5013806|NCT03910673|Phase 1|phase 1
5013807|NCT03910673|ZTI-01|zti-01
5013821|NCT03910569|Takotsubo|takotsubo
5013822|NCT03910556|re-craniotomy|re-craniotomy
5013823|NCT03910556|major non-neurological complications|major non-neurological complications
5013824|NCT03910556|neurosurgery|neurosurgery
5013825|NCT03910556|brain tumors|brain tumors
5013826|NCT03910530|Advanced solid tumors|advanced solid tumors
5013827|NCT03910530|metastatic solid tumors|metastatic solid tumors
5013828|NCT03910530|INCMGA00012|incmga00012
5013829|NCT03910530|INCB001158|incb001158
5013830|NCT03910530|Japan|japan
5013831|NCT03910530|PD-1 Inhibitor|pd-1 inhibitor
5013832|NCT03910530|Arginase Inhibitor|arginase inhibitor
5013833|NCT03910517|Musculoskeletal Pain|musculoskeletal pain
5013834|NCT03910517|Sleep|sleep
5013835|NCT03910517|Training load|training load
5013836|NCT03910517|E-sport|e-sport
5013837|NCT03910517|Physical activity|physical activity
5013838|NCT03910478|Allogeneic|allogeneic
5013839|NCT03910478|Cytomegalovirus|cytomegalovirus
5013840|NCT03910478|Dried Blood Spot|dried blood spot
5013841|NCT03910478|Hematopoietic cell transplantation|hematopoietic cell transplantation
5013842|NCT03910465|Rare Tumor|rare tumor
5013843|NCT03910465|Comprehensive Evaluation and Recommendations|comprehensive evaluation and recommendations
5013844|NCT03910465|Collecting Clinical, Epidemiologic and Biological Data|collecting clinical, epidemiologic and biological data
5013845|NCT03910452|Haploidentical|haploidentical
5013846|NCT03910452|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5013847|NCT03910452|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5013848|NCT03910452|Graft-Versus-Host Disease|graft-versus-host disease
5013849|NCT03910452|Non-Myeloablative Conditioning Regimen|non-myeloablative conditioning regimen
5013852|NCT03910400|STEMI|stemi
5013853|NCT03910400|Cardiac magnetic resonance|cardiac magnetic resonance
5013854|NCT03910400|balloon catheter|balloon catheter
5013855|NCT03910374|L-PRF|l-prf
5013856|NCT03910374|fibrin sealants|fibrin sealants
5013857|NCT03910374|endoscopic endonasal skull base reconstruction|endoscopic endonasal skull base reconstruction
5013858|NCT03910309|degenerative disc disease, spondylolisthesis|degenerative disc disease, spondylolisthesis
5013876|NCT03910153|Gut Health|gut health
5013877|NCT03910153|Microbiome|microbiome
5013878|NCT03910153|Glucose|glucose
5013879|NCT03910088|spinal|spinal
5013880|NCT03910088|cesarean|cesarean
5013881|NCT03910088|pregabalin|pregabalin
5013882|NCT03910075|P-CIMT|p-cimt
5013883|NCT03910075|Pediatric Constraint-Induced Movement Therapy|pediatric constraint-induced movement therapy
5013884|NCT03910075|Hemiparesis|hemiparesis
5013885|NCT03910075|Perinatal Stroke|perinatal stroke
5013886|NCT03910075|Neonatal Stroke|neonatal stroke
5013887|NCT03910075|Pediatric rehabilitation|pediatric rehabilitation
5013888|NCT03910075|Infant therapy|infant therapy
5013889|NCT03910075|Cerebral Palsy|cerebral palsy
5013890|NCT03910075|ACQUIRE|acquire
5013891|NCT03910075|I-ACQUIRE|i-acquire
5013895|NCT03910049|Indocyanine Green|indocyanine green
5013896|NCT03910049|Near Infrared Imaging|near infrared imaging
5013897|NCT03910049|Total Thyroidectomy|total thyroidectomy
5013899|NCT03910036|regeneration|regeneration
5013900|NCT03910036|ultrasound|ultrasound
5013901|NCT03910023|Low back pain|low back pain
5013902|NCT03910023|Crenobalneotherapy|crenobalneotherapy
5013903|NCT03910023|Spa therapy|spa therapy
5013904|NCT03910023|Mud application|mud application
5013905|NCT03910023|Water exercises|water exercises
5013906|NCT03910023|Underwater massages|underwater massages
5013907|NCT03909997|Stomach neoplasms|stomach neoplasms
5013908|NCT03909997|gastrectomy|gastrectomy
5013921|NCT03909945|Sub saharan Africa|sub saharan africa
5013922|NCT03909932|Physician attire|physician attire
5013923|NCT03909932|neuro-urology|neuro-urology
5013924|NCT03909932|urodynamic|urodynamic
5013925|NCT03909932|patient satisfaction|patient satisfaction
5013926|NCT03909919|Heart Failure|heart failure
5013927|NCT03909919|Kinematics|kinematics
5013928|NCT03909919|Validation|validation
5013929|NCT03909919|Functional task|functional task
5013930|NCT03909906|cognition|cognition
5013931|NCT03909906|anxiety|anxiety
5013932|NCT03909906|herbal supplements|herbal supplements
5013933|NCT03909893|Adaptive|adaptive
5013934|NCT03909893|Radiation Therapy|radiation therapy
5013935|NCT03909880|kinesio taping, sensorimotor control|kinesio taping, sensorimotor control
5013936|NCT03909815|total hip arthroplasty|total hip arthroplasty
5013937|NCT03909815|dual mobility cup|dual mobility cup
5013938|NCT03909815|dislocation|dislocation
5013939|NCT03909815|mortality|mortality
5013940|NCT03909815|periprosthetic joint infection|periprosthetic joint infection
5013941|NCT03909815|health economy|health economy
5013942|NCT03909789|Endothelium|endothelium
5013943|NCT03909776|osteosarcoma|osteosarcoma
5013944|NCT03909776|Intra-arterial chemotherapy|intra-arterial chemotherapy
5013945|NCT03909776|survival|survival
5013946|NCT03909776|Tumor neovascularity|tumor neovascularity
5013947|NCT03909776|telangiectatic subtype|telangiectatic subtype
5013948|NCT03909776|complications|complications
5013949|NCT03909763|corticosteroid-resistant or relapsed ITP|corticosteroid-resistant or relapsed itp
5013950|NCT03909763|Danazole|danazole
5013951|NCT03909763|berberine|berberine
5013952|NCT03909724|colorectal cancer|colorectal cancer
5013954|NCT03909724|Sunitinib|sunitinib
5013955|NCT03909711|Temperature|temperature
5013956|NCT03909711|Bleeding|bleeding
5013957|NCT03909711|Anemia|anemia
5013958|NCT03909711|Spine|spine
5013961|NCT03909620|lung cancer|lung cancer
5013962|NCT03909620|ldct|ldct
5013963|NCT03909620|low-dose CT|low-dose ct
5013964|NCT03909620|screening|screening
5013965|NCT03909620|lung nodule|lung nodule
5013966|NCT03909581|CABG|cabg
5013967|NCT03909581|EndoCAB|endocab
5013969|NCT03909555|Type 2 diabetes mellitus|type 2 diabetes mellitus
5013970|NCT03909555|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5013978|NCT03909464|neurosensory testing|neurosensory testing
5013979|NCT03909425|nAMD|namd
5013980|NCT03909425|Treat and Extend|treat and extend
5013981|NCT03909425|Aflibercept|aflibercept
5013982|NCT03909425|OCTA|octa
5013983|NCT03909425|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5013984|NCT03909347|Korean American elders|korean american elders
5013985|NCT03909347|Caregivers|caregivers
5013986|NCT03909347|dementia Literacy education And Navigation|dementia literacy education and navigation
5013987|NCT03909347|Community health workers|community health workers
5013988|NCT03909347|successful aging|successful aging
5013989|NCT03909347|PLAN|plan
5013990|NCT03909321|Exercise|exercise
5013991|NCT03909321|Beach Tennis|beach tennis
5013992|NCT03909321|Sport training|sport training
5013993|NCT03909321|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5013994|NCT03909308|Exercise|exercise
5013995|NCT03909308|Beach Tennis|beach tennis
5013996|NCT03909308|Sport training|sport training
5013997|NCT03909308|Post exercise hypotension|post exercise hypotension
5013998|NCT03909308|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5013999|NCT03909282|Ductal Breast Carcinoma|ductal breast carcinoma
5014000|NCT03909269|HbA1c|hba1c
5014001|NCT03909269|Glycated albumin|glycated albumin
5014002|NCT03909269|Fructosamine|fructosamine
5014003|NCT03909269|Continuous glucose monitoring|continuous glucose monitoring
5014004|NCT03909256|Rehabilitation|rehabilitation
5014005|NCT03909256|Nutrition impact symptoms|nutrition impact symptoms
5014006|NCT03909256|Quality of life|quality of life
5014007|NCT03909243|psychological attributes|psychological attributes
5014008|NCT03909243|child mental disorders|child mental disorders
5014009|NCT03909243|strength and difficulties questionnaire|strength and difficulties questionnaire
5014010|NCT03909243|child behavior|child behavior
5423184|NCT01616784|Hypoglycemic Agents|hypoglycemic agents
5029090|NCT03817489|Qigong|qigong
5014024|NCT03909178|HOS|hos
5014025|NCT03909178|NAHS|nahs
5014026|NCT03909178|LEFS|lefs
5014027|NCT03909178|iHOT-33|ihot-33
5014028|NCT03909178|RCT, Randomized Control Trial|rct, randomized control trial
5014029|NCT03909178|Physical Therapy, PT|physical therapy, pt
5014030|NCT03909178|Osteoarthritis, Hip|osteoarthritis, hip
5014032|NCT03909178|Outerbridge|outerbridge
5014033|NCT03909178|Older than 40 years old|older than 40 years old
5014034|NCT03909152|Onapristone ER (Apristor)|onapristone er (apristor)
5014035|NCT03909152|Oral Progesterone|oral progesterone
5014036|NCT03909152|Progesterone Receptor Positive (PR+)|progesterone receptor positive (pr+)
5014037|NCT03909152|19-061|19-061
5014038|NCT03909139|Acetabular Labrum Tear|acetabular labrum tear
5014039|NCT03909139|Pincer Lesion|pincer lesion
5014040|NCT03909139|Femoro Acetabular Impingement|femoro acetabular impingement
5014041|NCT03909139|Chondral Defect|chondral defect
5014042|NCT03909139|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
5014043|NCT03909139|Mesenchymal Stem Cell|mesenchymal stem cell
5014044|NCT03909139|Chondrolabral Junction|chondrolabral junction
5014045|NCT03909139|Osteoarthritis|osteoarthritis
5014046|NCT03909139|Acetabuloplasty|acetabuloplasty
5014047|NCT03909139|Hip Arthroscopy|hip arthroscopy
5014048|NCT03909139|BMAC|bmac
5014049|NCT03909139|Bone Marrow Cell Analysis|bone marrow cell analysis
5014050|NCT03909126|pertussis|pertussis
5014051|NCT03909126|immunization coverage|immunization coverage
5014052|NCT03909126|vaccination|vaccination
5014053|NCT03909126|pregnant women|pregnant women
5014054|NCT03909126|Quebec|quebec
5014055|NCT03909061|Wheelchair|wheelchair
5014056|NCT03909061|Participation|participation
5014057|NCT03909061|Training|training
5014058|NCT03909061|Maintenance|maintenance
5014059|NCT03909061|Breakdown|breakdown
5014060|NCT03909048|Chronic Pain|chronic pain
5014061|NCT03909048|Low Back Pain|low back pain
5014062|NCT03909035|Medication review polypharmacy|medication review polypharmacy
5014063|NCT03909035|clinical pharmacy|clinical pharmacy
5014064|NCT03909035|older people|older people
5008888|NCT03940898|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5008889|NCT03940898|Schizophrenia|schizophrenia
5008890|NCT03940898|Cerebellar vermis|cerebellar vermis
5008891|NCT03940898|Negative symptoms|negative symptoms
5008892|NCT03940898|Depressive symptoms|depressive symptoms
5008893|NCT03940898|Cognitive function|cognitive function
5008894|NCT03940898|Follow-up study|follow-up study
5016377|NCT03894566|Cohort Studies|cohort studies
5014080|NCT03908892|Paronychia|paronychia
5014081|NCT03908892|Zanthoxylum nitidum tincture|zanthoxylum nitidum tincture
5014082|NCT03908892|Afatinib|afatinib
5014083|NCT03908879|Intraosseous catheter|intraosseous catheter
5014084|NCT03908879|Intraosseous access|intraosseous access
5014085|NCT03908879|Resuscitation|resuscitation
5014086|NCT03908879|Diagnostic accuracy|diagnostic accuracy
5014087|NCT03908840|Hepatocellular|hepatocellular
5014088|NCT03908840|Carcinoma|carcinoma
5014090|NCT03908840|Cancer|cancer
5014091|NCT03908827|Randomized Clinical Trial|randomized clinical trial
5014092|NCT03908827|Osteoarthritis|osteoarthritis
5014093|NCT03908827|Hip|hip
5014094|NCT03908827|Knee|knee
5014095|NCT03908827|Bone Mineral Aspirate Concentrate|bone mineral aspirate concentrate
5014096|NCT03908788|Metastatic Colorectal Cancer|metastatic colorectal cancer
5014097|NCT03908788|Detection of the emergence of RAS mutations|detection of the emergence of ras mutations
5029193|NCT03816800|Allergy|allergy
5014103|NCT03908749|Pyrotinib Maleate Tablets|pyrotinib maleate tablets
5014104|NCT03908749|HER-2|her-2
5014105|NCT03908749|Real word study|real word study
5014106|NCT03908749|Efficacy|efficacy
5014107|NCT03908749|Safety|safety
5014108|NCT03908710|Home blood pressure monitor|home blood pressure monitor
5014109|NCT03908710|Telemedicine|telemedicine
5014110|NCT03908710|mHealth|mhealth
5014111|NCT03908710|eHealth|ehealth
5014121|NCT03908645|Bowel Preparation, Deep Learning, Central Neural Networks|bowel preparation, deep learning, central neural networks
5014122|NCT03908632|Community Acquired Pneumonia|community acquired pneumonia
5014123|NCT03908632|Endemic Areas|endemic areas
5014124|NCT03908632|Observational Study|observational study
5014125|NCT03908632|Primary Pulmonary Coccidioidomycosis|primary pulmonary coccidioidomycosis
5014126|NCT03908619|Helicobacter pylori eradication|helicobacter pylori eradication
5014127|NCT03908619|Triple therapy|triple therapy
5014128|NCT03908619|Proton pump inhibitor|proton pump inhibitor
5014129|NCT03908619|Vonoprazan|vonoprazan
5014130|NCT03908593|Gastrointestinal|gastrointestinal
5014131|NCT03908593|Mucosal injury|mucosal injury
5014132|NCT03908593|Antiplatelet|antiplatelet
5014133|NCT03908593|Coronary artery bypass grafting|coronary artery bypass grafting
5014134|NCT03908593|Prevention|prevention
5014135|NCT03908567|Vertigo|vertigo
5014136|NCT03908567|Balance|balance
5014137|NCT03908554|coping skill|coping skill
5014138|NCT03908554|quality of life|quality of life
5014139|NCT03908554|pain|pain
5014140|NCT03908554|fatigue|fatigue
5014141|NCT03908554|Workplace Health Promotion Program|workplace health promotion program
5014142|NCT03908541|Inflammatory markers|inflammatory markers
5014143|NCT03908541|Magnetic resonance imaging|magnetic resonance imaging
5014144|NCT03908541|disorder of consciousness|disorder of consciousness
5014145|NCT03908528|alpha-lipoic acid|alpha-lipoic acid
5014146|NCT03908528|taxol|taxol
5014147|NCT03908528|Adriamycin|adriamycin
5014148|NCT03908528|cyclophosphamide|cyclophosphamide
5014149|NCT03908528|breast cancer|breast cancer
5014150|NCT03908528|Brain Natriuretic Peptide (BNP).|brain natriuretic peptide (bnp).
5014151|NCT03908528|Neurotensin|neurotensin
5014152|NCT03908528|TNF-alpha|tnf-alpha
5014153|NCT03908515|Foldable Capsular Vitreous Body|foldable capsular vitreous body
5014154|NCT03908515|Retina detachment|retina detachment
5014155|NCT03908515|eye atrophy|eye atrophy
5014156|NCT03908502|Radiotherapy|radiotherapy
5014157|NCT03908502|Nervous System Complications|nervous system complications
5014158|NCT03908437|opiate use disorder|opiate use disorder
5014159|NCT03908437|overdose|overdose
5014160|NCT03908437|medication assisted treatment|medication assisted treatment
5014166|NCT03908398|Visual assessment|visual assessment
5014167|NCT03908359|Congenital Cataract|congenital cataract
5014168|NCT03908359|minimal invasive surgery|minimal invasive surgery
5014169|NCT03908359|secondary intraocular lens implantation|secondary intraocular lens implantation
5014170|NCT03908346|Neurologic Prognosis|neurologic prognosis
5014171|NCT03908346|Guideline Concordance|guideline concordance
5014172|NCT03908346|Surrogate Decision Makers|surrogate decision makers
5014173|NCT03908333|metastatic pancreatic cancer|metastatic pancreatic cancer
5014174|NCT03908333|cancer|cancer
5014175|NCT03908333|pancreatic|pancreatic
5014176|NCT03908333|Vitamin C|vitamin c
5014177|NCT03908333|Ascorbic Acid|ascorbic acid
5326877|NCT02053766|Sevoflurane|sevoflurane
5014178|NCT03908333|Nanoparticle Paclitaxel Protein Bound|nanoparticle paclitaxel protein bound
5014179|NCT03908333|cisplatin|cisplatin
5014180|NCT03908333|gemcitabine|gemcitabine
5014181|NCT03908333|pancreas|pancreas
5014182|NCT03908281|Exercise|exercise
5014183|NCT03908281|Glycated hemoglobin|glycated hemoglobin
5014184|NCT03908281|Liver fat|liver fat
5014185|NCT03908281|Continuous glucose monitoring|continuous glucose monitoring
5014193|NCT03908255|branch chain amino acid|branch chain amino acid
5014194|NCT03908255|nutritional supplement|nutritional supplement
5014195|NCT03908255|malnutrition|malnutrition
5014196|NCT03908255|decompensated liver failure|decompensated liver failure
5014197|NCT03908216|overweight,obesity,patients' survey,drug&non-drug treatment|overweight,obesity,patients' survey,drug&non-drug treatment
5014198|NCT03908190|Peer Support|peer support
5014199|NCT03908190|Patient Navigators|patient navigators
5014200|NCT03908164|Pregnancy|pregnancy
5014201|NCT03908164|Immunisation|immunisation
5014202|NCT03908164|Pertussis|pertussis
5014203|NCT03908151|hip prosthesis|hip prosthesis
5014220|NCT03908021|diabetes mellitus|diabetes mellitus
5014221|NCT03908021|children|children
5014222|NCT03908021|microbiome|microbiome
5014223|NCT03908008|Glabella line|glabella line
5014224|NCT03908008|Glabella lines|glabella lines
5014225|NCT03908008|Botulinum Toxin|botulinum toxin
5014226|NCT03907982|Cardiac ablation|cardiac ablation
5014227|NCT03907982|Cardioversion|cardioversion
5014228|NCT03907982|pacemaker|pacemaker
5014229|NCT03907982|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5014231|NCT03907969|Pharmacokinetics,|pharmacokinetics,
5014232|NCT03907969|Pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
5014233|NCT03907969|Olaparib,|olaparib,
5014234|NCT03907969|Dose finding|dose finding
5014239|NCT03907904|Intraoperative/methods* Oximetry/methods* Oxygen/metabolism|intraoperative/methods* oximetry/methods* oxygen/metabolism
5014240|NCT03907904|brain/metabolism|brain/metabolism
5014241|NCT03907904|brain chemistry|brain chemistry
5014242|NCT03907904|cerebrovascular circulation|cerebrovascular circulation
5014243|NCT03907904|humans|humans
5014244|NCT03907904|monitoring, intraoperative/methods|monitoring, intraoperative/methods
5014245|NCT03907904|oximetry/methods|oximetry/methods
5014246|NCT03907904|oxygen/metabolism|oxygen/metabolism
5014247|NCT03907878|CSU (chronic spontaneous urticaria)|csu (chronic spontaneous urticaria)
5014248|NCT03907878|Japanese|japanese
5014249|NCT03907878|QGE031|qge031
5014250|NCT03907878|Anti-IgE|anti-ige
5014251|NCT03907878|Ligelizumab|ligelizumab
5014252|NCT03907839|COPD|copd
5014253|NCT03907839|cognitive training|cognitive training
5014254|NCT03907839|cognitive impairment|cognitive impairment
5014255|NCT03907839|P300 test|p300 test
5014256|NCT03907839|MOCA|moca
5014257|NCT03907826|PD-1 antibody|pd-1 antibody
5014258|NCT03907826|Intensity-modulated Radiation Therapy|intensity-modulated radiation therapy
5014259|NCT03907826|Efficacy|efficacy
5014260|NCT03907826|Adverse effect|adverse effect
5014261|NCT03907761|thyroidectomy|thyroidectomy
5014262|NCT03907761|recurrent laryngeal nerve|recurrent laryngeal nerve
5014263|NCT03907761|hydrodissection|hydrodissection
5014264|NCT03907748|music therapy|music therapy
5014265|NCT03907748|music interventions|music interventions
5014266|NCT03907748|home-based interventions|home-based interventions
5014267|NCT03907748|Reading|reading
5014268|NCT03907748|dementia|dementia
5014269|NCT03907748|care giver|care giver
5014270|NCT03907735|Post-abortion hemorrhage|post-abortion hemorrhage
5014271|NCT03907735|Obstetric hemorrhage|obstetric hemorrhage
5014272|NCT03907735|Preterm labor|preterm labor
5014273|NCT03907735|Abnormal labor|abnormal labor
5014274|NCT03907735|Oxytocin|oxytocin
5014275|NCT03907735|Oxytocin receptor|oxytocin receptor
5014276|NCT03907670|chronic myeloid leukemia|chronic myeloid leukemia
5014277|NCT03907670|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5014278|NCT03907631|Rescue|rescue
5014287|NCT03907592|L-Carnitine|l-carnitine
5014288|NCT03907592|Resistance training|resistance training
5014289|NCT03907592|Magnetic resonance imaging|magnetic resonance imaging
5014290|NCT03907592|Muscle function|muscle function
5014291|NCT03907592|Aging|aging
5014292|NCT03907592|Leucine|leucine
5014293|NCT03907579|Knowledge|knowledge
5014294|NCT03907540|absorption|absorption
5014295|NCT03907540|metabolism|metabolism
5014296|NCT03907540|excretion|excretion
5014303|NCT03907501|Gastrointestinal System|gastrointestinal system
5014304|NCT03907501|Inflammatory Biomarkers|inflammatory biomarkers
5014305|NCT03907501|Psychological Health|psychological health
5014306|NCT03907462|young adult|young adult
5014307|NCT03907462|overweight|overweight
5014312|NCT03907462|social media|social media
5014313|NCT03907462|text message|text message
5014314|NCT03907462|health coach|health coach
5014315|NCT03907462|intervention|intervention
5014316|NCT03907462|weight loss|weight loss
5014317|NCT03907462|wellness|wellness
5014318|NCT03907462|physical activity|physical activity
5014319|NCT03907462|diet|diet
5014320|NCT03907462|sleep|sleep
5014321|NCT03907462|resilience|resilience
5014335|NCT03907345|Exposure Therapy|exposure therapy
5014336|NCT03907345|Fear of Spiders|fear of spiders
5014337|NCT03907345|Fear of Heights|fear of heights
5014338|NCT03907345|Anxiety Disorders|anxiety disorders
5014339|NCT03907345|Generalization|generalization
5014340|NCT03907345|Extinction|extinction
5014341|NCT03907345|Specific Phobias|specific phobias
5014342|NCT03907332|Home visits|home visits
5014343|NCT03907332|Community Health Nurse|community health nurse
5014344|NCT03907332|Community Health Workers|community health workers
5014345|NCT03907332|Pregnant women|pregnant women
5014346|NCT03907332|Effectiveness|effectiveness
5014348|NCT03907319|Parkinson's Disease|parkinson's disease
5014349|NCT03907319|Subthalamic Nucleus|subthalamic nucleus
5014350|NCT03907306|Cold argon plasma|cold argon plasma
5014351|NCT03907306|hemorrhoidectomy|hemorrhoidectomy
5014352|NCT03907306|wound healing|wound healing
5014353|NCT03907306|hemorrhoids|hemorrhoids
5014357|NCT03907202|Sub-cutaneous injection|sub-cutaneous injection
5014358|NCT03907202|Metformin|metformin
5014359|NCT03907202|KBP-089|kbp-089
5014360|NCT03907202|randomised|randomised
5014361|NCT03907202|placebo-controlled|placebo-controlled
5014362|NCT03907202|multiple-ascending dose|multiple-ascending dose
5014363|NCT03907176|inguinal hernia|inguinal hernia
5014364|NCT03907176|hernia|hernia
5014365|NCT03907176|hernia surgery|hernia surgery
5014366|NCT03907176|postoperative pain|postoperative pain
5014367|NCT03907176|herniorrhaphy|herniorrhaphy
5014368|NCT03907176|multimodal analgesia|multimodal analgesia
5014369|NCT03907150|Pont-of-Care Ultrasound|pont-of-care ultrasound
5014370|NCT03907124|Utility|utility
5014371|NCT03907124|Pharmacogenomics|pharmacogenomics
5014372|NCT03907124|Psychotropic|psychotropic
5014373|NCT03907124|Medications|medications
5014374|NCT03907111|bleeding wounds, hemostasis, open wounds, infection, antimicrobial|bleeding wounds, hemostasis, open wounds, infection, antimicrobial
5014375|NCT03907098|breast cancer|breast cancer
5014376|NCT03907098|endostar|endostar
5014377|NCT03907085|HILT|hilt
5014378|NCT03907085|calcaneal spur|calcaneal spur
5014379|NCT03907085|placebo|placebo
5014380|NCT03907059|protein source|protein source
5014381|NCT03907059|hypertrophy|hypertrophy
5014382|NCT03907059|resistance training|resistance training
5014383|NCT03907059|plant-based protein|plant-based protein
5014384|NCT03907059|omnivorous|omnivorous
5014385|NCT03907007|Neurostimulator|neurostimulator
5014386|NCT03906955|leisure-time physical activity|leisure-time physical activity
5014387|NCT03906955|adherence|adherence
5014388|NCT03906955|working adults|working adults
5014389|NCT03906955|motivation|motivation
5014390|NCT03906955|social cognitive theory|social cognitive theory
5014391|NCT03906955|telemedicine|telemedicine
5014392|NCT03906955|teleconference|teleconference
5014393|NCT03906955|self-perceptions|self-perceptions
5014394|NCT03906955|self-confidence|self-confidence
5014395|NCT03906903|Mild Cognitive Impairment|mild cognitive impairment
5014396|NCT03906864|Critical pathway, length of stay, recovery of function, subacute care|critical pathway, length of stay, recovery of function, subacute care
5014397|NCT03906851|School|school
5014398|NCT03906851|Health|health
5014399|NCT03906851|Academic performance|academic performance
5014404|NCT03906799|Dose-finding|dose-finding
5014405|NCT03906786|self-care|self-care
5014406|NCT03906786|motivational interviewing|motivational interviewing
5014407|NCT03906786|doctor-pacient relationship|doctor-pacient relationship
5014408|NCT03906734|septal myectomy|septal myectomy
5014409|NCT03906734|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5014410|NCT03906682|prevention|prevention
5014411|NCT03906682|urban youth|urban youth
5014412|NCT03906682|mindfulness|mindfulness
5014421|NCT03906552|acupressure|acupressure
5014422|NCT03906552|massage|massage
5014427|NCT03906539|Virgin coconut oil|virgin coconut oil
5014428|NCT03906539|Serum lipoprotein|serum lipoprotein
5014429|NCT03906539|Lipid peroxidation|lipid peroxidation
5014430|NCT03906539|Atorvastatin|atorvastatin
5014432|NCT03906526|Nivolumab|nivolumab
5014433|NCT03906526|Head and Neck Cancer|head and neck cancer
5014434|NCT03906526|Squamous Cell Carcinoma|squamous cell carcinoma
5014435|NCT03906526|Checkpoint inhibitor|checkpoint inhibitor
5014436|NCT03906526|anti-PD1 inhibitor|anti-pd1 inhibitor
5014437|NCT03906526|TLR 8 agonist|tlr 8 agonist
5014438|NCT03906513|Cornea|cornea
5014439|NCT03906513|Diabetes|diabetes
5014440|NCT03906513|Neural damage|neural damage
5014441|NCT03906500|Adolescence|adolescence
5014442|NCT03906500|Alcohol use|alcohol use
5014443|NCT03906500|High school|high school
5014444|NCT03906487|Intimate partner violence|intimate partner violence
5014445|NCT03906487|Self defining memories|self defining memories
5014446|NCT03906435|Vulnerable Child Syndrome|vulnerable child syndrome
5014447|NCT03906435|Neonatal Intensive Care Unit|neonatal intensive care unit
5014448|NCT03906435|Cognitive Behavioral Therapy|cognitive behavioral therapy
5014449|NCT03906435|Parental Perception of Child Vulnerability|parental perception of child vulnerability
5014450|NCT03906435|Child Developmental Outcomes|child developmental outcomes
5014451|NCT03906435|Parent Mental Health|parent mental health
5014452|NCT03906422|Orthodontic|orthodontic
5014453|NCT03906422|Pain|pain
5014454|NCT03906409|Feeding Patterns|feeding patterns
5014455|NCT03906409|Skeletal Muscle|skeletal muscle
5014456|NCT03906409|Metabolism|metabolism
5014457|NCT03906409|Circadian Rhythms|circadian rhythms
5014458|NCT03906409|Diurnal Rhythms|diurnal rhythms
5014467|NCT03906305|Muscle Spasticity|muscle spasticity
5014468|NCT03906305|Dry Needling|dry needling
5014469|NCT03906305|Stroke|stroke
5014470|NCT03906240|Web-Based Intervention|web-based intervention
5014471|NCT03906240|Pilot Study|pilot study
5014472|NCT03906240|Moral Elevation|moral elevation
5014473|NCT03906240|Veterans|veterans
5014474|NCT03906240|PTSD|ptsd
5014475|NCT03906240|Moral Injury|moral injury
5014476|NCT03906214|Porphyrias|porphyrias
5014477|NCT03906214|Variegate Porphyria|variegate porphyria
5014478|NCT03906214|Hereditary Coproporphyria|hereditary coproporphyria
5014479|NCT03906214|Acute Intermittent Porphyria|acute intermittent porphyria
5014480|NCT03906201|PreDiabetes|prediabetes
5014481|NCT03906201|Ecdysterone|ecdysterone
5014482|NCT03906201|Genotoxicity|genotoxicity
5014483|NCT03906201|Citotoxicity|citotoxicity
5014484|NCT03906201|Micronuclei|micronuclei
5014485|NCT03906201|Glycemic Control|glycemic control
5014486|NCT03906188|serious game|serious game
5014487|NCT03906188|videogame|videogame
5014488|NCT03906175|Depression|depression
5014489|NCT03906175|Hyperthermia|hyperthermia
5014490|NCT03906175|Randomized Controlled Trial|randomized controlled trial
5014491|NCT03906162|physical activity monitors|physical activity monitors
5014492|NCT03906162|motivational interviewing|motivational interviewing
5014493|NCT03906162|walking|walking
5014494|NCT03906162|fitness-tracker|fitness-tracker
5014495|NCT03906162|social cognitive theory|social cognitive theory
5014496|NCT03906162|older age|older age
5014497|NCT03906149|Depression|depression
5014498|NCT03906149|Hyperthermia|hyperthermia
5014499|NCT03906149|Randomized Controlled Trial|randomized controlled trial
5014500|NCT03906136|axial spondyloarthritis (axSpA)|axial spondyloarthritis (axspa)
5014501|NCT03906136|treat-to-target (T2T)|treat-to-target (t2t)
5014502|NCT03906136|secukinumab|secukinumab
5014503|NCT03906136|AIN457|ain457
5014504|NCT03906136|Non-Radiographic Axial Spondyloarthritis (nr-axSpA)|non-radiographic axial spondyloarthritis (nr-axspa)
5014505|NCT03906136|Radiographic Axial Spondyloarthritis (r-axSpA)|radiographic axial spondyloarthritis (r-axspa)
5014506|NCT03906123|DL-3-n-butylphthalide|dl-3-n-butylphthalide
5014507|NCT03906123|vascular dementia|vascular dementia
5014508|NCT03906123|cerebral small vessel disease|cerebral small vessel disease
5014509|NCT03906123|cognitive function|cognitive function
5014510|NCT03906123|cerebral blood flow|cerebral blood flow
5014511|NCT03906110|Colorectal Cancer Screening|colorectal cancer screening
5014512|NCT03906110|FIT test|fit test
5014538|NCT03905993|Immune response|immune response
5014540|NCT03905993|genotype-to-phenotype association|genotype-to-phenotype association
5014541|NCT03905993|genetic variability|genetic variability
5014542|NCT03905993|reference-based population|reference-based population
5014543|NCT03905967|Lenvatinib|lenvatinib
5014544|NCT03905967|Transarterial chemoembolisation|transarterial chemoembolisation
5014545|NCT03905954|employment|employment
5014547|NCT03905954|diagnosis|diagnosis
5014548|NCT03905954|early support|early support
5014549|NCT03905941|Polycystic Ovary Syndrome|polycystic ovary syndrome
5014560|NCT03905889|Abemaciclib|abemaciclib
5014561|NCT03905889|Sunitinib|sunitinib
5014562|NCT03905876|Psychological experience|psychological experience
5014563|NCT03905876|early clinical trial|early clinical trial
5014564|NCT03905876|initial predisposition|initial predisposition
5014565|NCT03905863|topical oxygen|topical oxygen
5014566|NCT03905863|topical oxygen treatment|topical oxygen treatment
5014567|NCT03905863|diabetic foot ulcer|diabetic foot ulcer
5014568|NCT03905863|non-healing wound|non-healing wound
5014569|NCT03905863|surgical site|surgical site
5014570|NCT03905863|pain|pain
5014571|NCT03905863|wound size|wound size
5014572|NCT03905863|healing|healing
5014573|NCT03905863|infection|infection
5014574|NCT03905837|lidocaine|lidocaine
5014575|NCT03905837|postoperative complications|postoperative complications
5014576|NCT03905837|thoracic surgery|thoracic surgery
5014577|NCT03905811|terazosin|terazosin
5014578|NCT03905798|Status Epilepticus;|status epilepticus;
5014579|NCT03905798|Lorazepam;|lorazepam;
5014580|NCT03905798|LORA-PITA;|lora-pita;
5014581|NCT03905798|Ativan|ativan
5014582|NCT03905772|Electrical stimulation|electrical stimulation
5014583|NCT03905772|M wave|m wave
5014584|NCT03905772|H reflex|h reflex
5014585|NCT03905772|Wide pulse|wide pulse
5014586|NCT03905720|cancer|cancer
5014587|NCT03905720|inpatient|inpatient
5014588|NCT03905720|non-pharmacologic approaches|non-pharmacologic approaches
5014589|NCT03905720|pain management|pain management
5014590|NCT03905720|acupuncture|acupuncture
5014591|NCT03905720|pain counseling|pain counseling
5014598|NCT03905681|Transcutaneous Electrical Nerve Stimulation, Acute back pain|transcutaneous electrical nerve stimulation, acute back pain
5014599|NCT03905642|Cystic Fibrosis|cystic fibrosis
5014600|NCT03905642|Respiratory Infections|respiratory infections
5014601|NCT03905642|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5014602|NCT03905642|CFTR|cftr
5014603|NCT03905616|Vision|vision
5014604|NCT03905616|perception|perception
5014605|NCT03905616|BOLD activity|bold activity
5014606|NCT03905603|Polycystic Ovary Syndrome|polycystic ovary syndrome
5014607|NCT03905577|Motor Imagery|motor imagery
5014608|NCT03905577|Action observation|action observation
5014609|NCT03905577|Pain perception|pain perception
5014610|NCT03905551|cold dialysis|cold dialysis
5710818|NCT00462111|indometacin|indometacin
5014611|NCT03905551|intradialytic exercise|intradialytic exercise
5014612|NCT03905551|insulin resistance|insulin resistance
5014613|NCT03905551|thermoregulation|thermoregulation
5014614|NCT03905551|muscle architecture|muscle architecture
5014615|NCT03905551|quality of life|quality of life
5014616|NCT03905551|fitness|fitness
5014637|NCT03905408|lung surgery|lung surgery
5014639|NCT03905408|postoperative|postoperative
5014640|NCT03905395|Meditation|meditation
5014641|NCT03905395|mindfulness|mindfulness
5014642|NCT03905395|pregnancy loss|pregnancy loss
5014643|NCT03905395|stress|stress
5014644|NCT03905382|Technology|technology
5014645|NCT03905382|Modems|modems
5014646|NCT03905382|Qualitative Research|qualitative research
5014647|NCT03905369|shared decision making|shared decision making
5014648|NCT03905369|quality of life|quality of life
5014649|NCT03905369|patient-doctor communication|patient-doctor communication
5014650|NCT03905369|patient treatment preferences|patient treatment preferences
5014651|NCT03905343|breast cancer|breast cancer
5014652|NCT03905343|Visceral metastatic breast cancer|visceral metastatic breast cancer
5014653|NCT03905343|Ribociclib|ribociclib
5014654|NCT03905343|Ribociclib-endocrine|ribociclib-endocrine
5014655|NCT03905330|Cholestasis|cholestasis
5014656|NCT03905330|Maralixibat|maralixibat
5014657|NCT03905330|Mutation|mutation
5014658|NCT03905330|PFIC|pfic
5014659|NCT03905330|PFIC2|pfic2
5014660|NCT03905330|Bile Duct Diseases|bile duct diseases
5014661|NCT03905330|Liver Diseases|liver diseases
5014662|NCT03905330|Biliary Tract Diseases|biliary tract diseases
5014663|NCT03905330|Digestive System Diseases|digestive system diseases
5014664|NCT03905330|Pediatric|pediatric
5014665|NCT03905317|bevacizumab|bevacizumab
5014666|NCT03905317|chemoradiotherapy|chemoradiotherapy
5029683|NCT03813654|sleep|sleep
5014667|NCT03905317|Oligometastasis of lung adenocarcinoma|oligometastasis of lung adenocarcinoma
5014668|NCT03905304|CD phase III|cd phase iii
5014669|NCT03905278|parental cancer|parental cancer
5014670|NCT03905278|parental guidance|parental guidance
5014671|NCT03905278|parent-child communication|parent-child communication
5014672|NCT03905265|moxidectin|moxidectin
5014673|NCT03905265|acaricide|acaricide
5014674|NCT03905265|oral|oral
5014677|NCT03905239|small bowel obstruction|small bowel obstruction
5014678|NCT03905174|revision surgery|revision surgery
5014679|NCT03905161|Fatigue|fatigue
5014680|NCT03905161|6-minute walk test|6-minute walk test
5014681|NCT03905161|Rhythmic Auditory Stimulation|rhythmic auditory stimulation
5014686|NCT03905109|Inflammatory Bowel Disorders|inflammatory bowel disorders
5014687|NCT03905109|ABX464|abx464
5014688|NCT03905070|bariatric surgery|bariatric surgery
5014689|NCT03905070|body awareness|body awareness
5014690|NCT03905070|physical therapy|physical therapy
5014691|NCT03905070|metabolic surgery|metabolic surgery
5014692|NCT03905031|Trauma|trauma
5009453|NCT03937414|Breast neoplasm; Molecular Diagnostic Techniques|breast neoplasm; molecular diagnostic techniques
5009454|NCT03937401|oxytocin|oxytocin
5009455|NCT03937401|MRI-HIFU|mri-hifu
5014693|NCT03905031|Traumatic Brain Injury|traumatic brain injury
5014694|NCT03905031|Infrascanner|infrascanner
5014695|NCT03905031|Near-Infrared Spectroscopy|near-infrared spectroscopy
5014696|NCT03905031|Pediatric|pediatric
5014697|NCT03904992|Nutrtition|nutrtition
5014698|NCT03904992|Physical activity|physical activity
5014699|NCT03904992|Preescholer|preescholer
5014700|NCT03904992|Informatics|informatics
5014701|NCT03904953|Ankylosing Spondylitis|ankylosing spondylitis
5014702|NCT03904953|Pilates|pilates
5014703|NCT03904953|Respiratory muscle strenght|respiratory muscle strenght
5014704|NCT03904940|Orthotic Devices|orthotic devices
5014705|NCT03904940|Insoles|insoles
5014706|NCT03904940|Quality of life|quality of life
5014707|NCT03904940|Function|function
5014708|NCT03904914|TOCI|toci
5014709|NCT03904914|scoliosis|scoliosis
5014710|NCT03904875|pollution|pollution
5014711|NCT03904875|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5014712|NCT03904875|ultrathin particles|ultrathin particles
5014713|NCT03904862|Medulloblastoma|medulloblastoma
5014714|NCT03904862|Sonic Hedgehog (SHH) positive|sonic hedgehog (shh) positive
5014715|NCT03904836|Chronic Renal Diseases|chronic renal diseases
5014716|NCT03904836|Kidney Failure, Chronic|kidney failure, chronic
5014717|NCT03904836|Renal Failure, Chronic|renal failure, chronic
5014718|NCT03904836|Tobramycin|tobramycin
5014719|NCT03904836|Aminoglycosides|aminoglycosides
5014731|NCT03904797|early intervention|early intervention
5014732|NCT03904758|extraesophageal reflux|extraesophageal reflux
5014733|NCT03904758|laryngopharyngeal reflux|laryngopharyngeal reflux
5014734|NCT03904758|pepsin|pepsin
5014735|NCT03904758|saliva|saliva
5014736|NCT03904758|oropharyngeal pH monitoring|oropharyngeal ph monitoring
5014737|NCT03904758|esophageal impedance|esophageal impedance
5014738|NCT03904745|in vitro fertilization|in vitro fertilization
5014739|NCT03904745|atosiban|atosiban
5014740|NCT03904745|embryo transfer|embryo transfer
5014741|NCT03904745|oxytocin antagonist|oxytocin antagonist
5014742|NCT03904706|Facility-based|facility-based
5014743|NCT03904706|Mortality|mortality
5014744|NCT03904706|Audits|audits
5014745|NCT03904706|Community engagement|community engagement
5014746|NCT03904706|Gilgit-Baltistan|gilgit-baltistan
5331669|NCT02032654|erysipelas|erysipelas
5014747|NCT03904706|Pakistan|pakistan
5014753|NCT03904680|Psoriasis|psoriasis
5014754|NCT03904680|Cardiovascular risk|cardiovascular risk
5014755|NCT03904680|Methotrexate|methotrexate
5014756|NCT03904680|Vitamin D|vitamin d
5014757|NCT03904667|Watson artificial intelligence|watson artificial intelligence
5014758|NCT03904667|hepatocellular carcinoma|hepatocellular carcinoma
5014759|NCT03904667|surgical decisions|surgical decisions
5014763|NCT03904602|Chronic Venous Insufficiency|chronic venous insufficiency
5014765|NCT03904563|bevacizumab|bevacizumab
5014766|NCT03904563|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5014767|NCT03904537|Colorectal Cancer|colorectal cancer
5014769|NCT03904537|immunotherapy|immunotherapy
5014770|NCT03904524|Intensive Care Unit|intensive care unit
5014771|NCT03904524|Serious Illness Communication|serious illness communication
5014772|NCT03904524|Clinician-Family Communication|clinician-family communication
5014773|NCT03904524|Family Support|family support
5014774|NCT03904485|SPK ,DCM,CMR|spk ,dcm,cmr
5014775|NCT03904472|cognitive behavioral therapy|cognitive behavioral therapy
5014776|NCT03904472|GERD|gerd
5014777|NCT03904459|Temporomandibular Joint|temporomandibular joint
5014778|NCT03904459|Oral Health|oral health
5014779|NCT03904459|Bone & Bones|bone & bones
5014780|NCT03904459|Bone Density|bone density
5014781|NCT03904459|Quality of Life|quality of life
5014782|NCT03904446|Methergine|methergine
5014783|NCT03904446|Uterine Atony|uterine atony
5014784|NCT03904407|overactive bladder|overactive bladder
5014785|NCT03904407|probiotic|probiotic
5014786|NCT03904407|anticholinergic|anticholinergic
5014787|NCT03904407|beta-3 agonist|beta-3 agonist
5014788|NCT03904342|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5014789|NCT03904342|Sophie CBT|sophie cbt
5014790|NCT03904342|iHope CBT|ihope cbt
5014801|NCT03904225|adjuvant chemotherapy|adjuvant chemotherapy
5014802|NCT03904225|Tegio|tegio
5014803|NCT03904199|High Blood Sugar|high blood sugar
5014814|NCT03904186|Cholinergic Agonists|cholinergic agonists
5014815|NCT03904186|Cholinergic Agents|cholinergic agents
5014816|NCT03904186|Neurotransmitter Agents|neurotransmitter agents
5015308|NCT03900858|isoniazid|isoniazid
5014819|NCT03904186|Anxious|anxious
5014820|NCT03904186|Anxiety Symptoms|anxiety symptoms
5014821|NCT03904186|Depressive Symptoms|depressive symptoms
5014822|NCT03904186|Quitting|quitting
5014823|NCT03904186|Cognitive Behavioral Therapy|cognitive behavioral therapy
5014824|NCT03904186|Anxiety Sensitivity|anxiety sensitivity
5014825|NCT03904186|Distress Intolerance|distress intolerance
5014826|NCT03904186|Anhedonia|anhedonia
5014827|NCT03904173|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
5014828|NCT03904173|human epidermal growth factor receptor 2 negative|human epidermal growth factor receptor 2 negative
5014829|NCT03904121|Colon cancer surgery octogenarian postoperative outcome|colon cancer surgery octogenarian postoperative outcome
5014830|NCT03904108|NSCLC|nsclc
5014831|NCT03904108|Immunotherapy|immunotherapy
5014832|NCT03904108|Ramucirumab|ramucirumab
5014833|NCT03904108|anti-PD-1|anti-pd-1
5014834|NCT03904095|Erector spinae block|erector spinae block
5014835|NCT03904095|hip arthroplasty|hip arthroplasty
5014836|NCT03904095|postoperative analgesia|postoperative analgesia
5014837|NCT03904095|psoas compartment block|psoas compartment block
5014838|NCT03904095|ultrasound|ultrasound
5014839|NCT03904082|dispne, pain|dispne, pain
5014840|NCT03904069|Relapsed/refractory acute myeloid leukemia|relapsed/refractory acute myeloid leukemia
5014841|NCT03904069|Acute myeloid leukemia|acute myeloid leukemia
5014842|NCT03904069|Oncology/hematology|oncology/hematology
5014843|NCT03904069|CAR T cell therapy|car t cell therapy
5014844|NCT03904056|Diabetic Retinopathy|diabetic retinopathy
5014845|NCT03904056|Macular Edema|macular edema
5014846|NCT03904030|knee arthroplasty|knee arthroplasty
5014847|NCT03904030|rehabilitation|rehabilitation
5014848|NCT03904030|anti-gravity treadmill|anti-gravity treadmill
5014849|NCT03904030|Randomized study|randomized study
5014850|NCT03904004|esophageal motility disorders|esophageal motility disorders
5014851|NCT03904004|laparoscopic Heller myotomy|laparoscopic heller myotomy
5710924|NCT00461643|Treatment|treatment
5014852|NCT03904004|peroral endoscopic myotomy|peroral endoscopic myotomy
5014853|NCT03904004|neumatic cilatation|neumatic cilatation
5014854|NCT03904004|botulinic toxin injection|botulinic toxin injection
5014855|NCT03904004|gastro esophageal reflux|gastro esophageal reflux
5014856|NCT03903991|Thoracic surgery|thoracic surgery
5014857|NCT03903991|Body temperature|body temperature
5014858|NCT03903978|Resilience|resilience
5014859|NCT03903978|University students|university students
5014860|NCT03903978|Prevention|prevention
5014861|NCT03903978|Online intervention|online intervention
5014862|NCT03903965|diabetes|diabetes
5014863|NCT03903965|OCT Angiography|oct angiography
5014864|NCT03903965|cataract surgery|cataract surgery
5014865|NCT03903952|ASCUS|ascus
5014866|NCT03903952|HPV|hpv
5014867|NCT03903952|Vitamine B12|vitamine b12
5014868|NCT03903952|Folate|folate
5014869|NCT03903939|Trauma patients|trauma patients
5014870|NCT03903939|Shock-induced endotheliopathy|shock-induced endotheliopathy
5014871|NCT03903926|EV71 vaccine; Efficacy; Seroprotective correlates|ev71 vaccine; efficacy; seroprotective correlates
5014872|NCT03903913|Asthma|asthma
5014873|NCT03903913|Carbon dioxide|carbon dioxide
5014874|NCT03903913|Perfluorocarbon|perfluorocarbon
5014875|NCT03903913|Mucolytic|mucolytic
5014876|NCT03903900|Activities of daily living|activities of daily living
5014877|NCT03903900|Occupational performance|occupational performance
5014878|NCT03903900|Quality of life|quality of life
5014879|NCT03903900|Health behaviour change|health behaviour change
5014881|NCT03903900|Physical activity|physical activity
5014882|NCT03903900|Occupational Therapy|occupational therapy
5014883|NCT03903887|Lung Cancer|lung cancer
5014885|NCT03903887|immunotherapy|immunotherapy
5014888|NCT03903796|HBeAg-positive or negative|hbeag-positive or negative
5014889|NCT03903757|Epigenetics|epigenetics
5014890|NCT03903757|Network medicine|network medicine
5014895|NCT03903718|Influenza|influenza
5014896|NCT03903718|Influenza A|influenza a
5014897|NCT03903718|Flu|flu
5014898|NCT03903718|Flu A|flu a
5014899|NCT03903705|Fruquintinib|fruquintinib
5014900|NCT03903705|Sintilimab|sintilimab
5014901|NCT03903705|VEGFR|vegfr
5014902|NCT03903705|PD-1|pd-1
5014903|NCT03903705|Solid Tumor|solid tumor
5014904|NCT03903679|Airway management|airway management
5014905|NCT03903679|Septal surgery|septal surgery
5014906|NCT03903679|Laryngeal mask airway|laryngeal mask airway
5014907|NCT03903679|Endotracheal tube|endotracheal tube
5014908|NCT03903679|Presence of tracheal blood|presence of tracheal blood
5014909|NCT03903666|Sleep Apnoa|sleep apnoa
5014910|NCT03903666|Down Syndrome|down syndrome
5014911|NCT03903666|Children|children
5014912|NCT03903666|OSA|osa
5014913|NCT03903627|verbal cue, pelvic diaphragm, stroke|verbal cue, pelvic diaphragm, stroke
5014914|NCT03903614|Developmental Dysgraphia|developmental dysgraphia
5014916|NCT03903614|Outcome study|outcome study
5014917|NCT03903601|trimethylamine-N-oxide|trimethylamine-n-oxide
5014918|NCT03903601|magnetic resonance imaging|magnetic resonance imaging
5014919|NCT03903601|cognitive functions|cognitive functions
5014920|NCT03903510|Virtual Reality|virtual reality
5014921|NCT03903510|Cast removal|cast removal
5014922|NCT03903510|Fracture|fracture
5014923|NCT03903497|Narrow band imaging|narrow band imaging
5014924|NCT03903497|WASP classification|wasp classification
5014925|NCT03903497|Diminutive colorectal polyps|diminutive colorectal polyps
5014926|NCT03903484|Frailty|frailty
5014927|NCT03903484|Deprescribing|deprescribing
5014928|NCT03903471|ProCore|procore
5014929|NCT03903471|Mediastinal and Hilar Lymphadenopathy|mediastinal and hilar lymphadenopathy
5014930|NCT03903471|EBUS-TBNA|ebus-tbna
5014931|NCT03903471|Diagnostic Yield|diagnostic yield
5014932|NCT03903471|Quality of Specimen|quality of specimen
5014933|NCT03903458|systemic anticancer treatment|systemic anticancer treatment
5014934|NCT03903458|immunotherapy|immunotherapy
5327470|NCT02051088|drug-elution|drug-elution
5014935|NCT03903458|epigenetic treatment|epigenetic treatment
5014937|NCT03903432|MRI|mri
5014938|NCT03903432|CT|ct
5014939|NCT03903432|Chronic Sinusitis|chronic sinusitis
5014940|NCT03903432|ESS|ess
5014941|NCT03903406|quality of life|quality of life
5014942|NCT03903380|Virtual reality|virtual reality
5014943|NCT03903380|Therapeuthic exercise|therapeuthic exercise
5014944|NCT03903380|Quantitative sensory testing|quantitative sensory testing
5014945|NCT03903341|Superior colliculus|superior colliculus
5014946|NCT03903341|fMRI|fmri
5014947|NCT03903328|muscle strength|muscle strength
5014948|NCT03903328|physical performance|physical performance
5014949|NCT03903328|Sarcopenia|sarcopenia
5014950|NCT03903302|tissue-plasminogen activator (t-PA)|tissue-plasminogen activator (t-pa)
5014951|NCT03903302|plasminogen-activator inhibitor 1 (PAI-1)|plasminogen-activator inhibitor 1 (pai-1)
5014952|NCT03903302|fibrinolysis|fibrinolysis
5014953|NCT03903302|thrombosis|thrombosis
5014954|NCT03903263|dermatologic disease|dermatologic disease
5014955|NCT03903250|A-GPC|a-gpc
5014956|NCT03903250|focus|focus
5014957|NCT03903250|non-resistance trained|non-resistance trained
5014958|NCT03903237|post-zoster neuralgia|post-zoster neuralgia
5014959|NCT03903237|Herpes Zoster-related complications|herpes zoster-related complications
5014960|NCT03903224|Breast Cancer|breast cancer
5014961|NCT03903224|Regional Anaesthesia|regional anaesthesia
5014962|NCT03903224|Morphine Consumption|morphine consumption
5014963|NCT03903211|[18F]PI-2620|[18f]pi-2620
5014964|NCT03903211|tauopathy|tauopathy
5014965|NCT03903211|positron emission computed tomography|positron emission computed tomography
5014966|NCT03903185|Hepatitis C virus|hepatitis c virus
5014967|NCT03903185|Pharmacokinetic Modeling|pharmacokinetic modeling
5014968|NCT03903185|Pharmacokinetics|pharmacokinetics
5014969|NCT03903185|Pediatrics|pediatrics
5014970|NCT03903185|Leukemia|leukemia
5014971|NCT03903185|Ledipasvir|ledipasvir
5014972|NCT03903185|Sofosbuvir|sofosbuvir
5014973|NCT03903185|Antiviral Drugs|antiviral drugs
5014974|NCT03903172|pain management|pain management
5014975|NCT03903172|vaginal delivery|vaginal delivery
5014976|NCT03903172|nonpharmacologic|nonpharmacologic
5014977|NCT03903172|abdominal binder|abdominal binder
5014978|NCT03903146|Breastfeeding|breastfeeding
5014979|NCT03903146|Exclusive breastfeeding|exclusive breastfeeding
5014980|NCT03903146|Hispanic Women|hispanic women
5014981|NCT03903146|Kentucky|kentucky
5014982|NCT03903094|anticholinergic burden|anticholinergic burden
5014983|NCT03903094|anticholinergic|anticholinergic
5014984|NCT03903094|overactive bladder|overactive bladder
5014989|NCT03903042|Artificial intelligence|artificial intelligence
5014990|NCT03903042|Diabetic retinopathy|diabetic retinopathy
5014991|NCT03903029|Cholesterol, LDL|cholesterol, ldl
5014992|NCT03903029|Asian|asian
5017207|NCT03888768|anaemia|anaemia
5015004|NCT03902912|prednisolone treatment|prednisolone treatment
5015006|NCT03902847|motor imagery|motor imagery
5015007|NCT03902847|action observation|action observation
5015008|NCT03902847|motor learning|motor learning
5015009|NCT03902795|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5015010|NCT03902795|Vitrectomy|vitrectomy
5015011|NCT03902795|Metamorphopsia|metamorphopsia
5015012|NCT03902795|M-charts|m-charts
5015013|NCT03902795|Microperimetry|microperimetry
5015014|NCT03902730|Electromyography|electromyography
5015015|NCT03902730|Resistance trained|resistance trained
5009771|NCT03935412|morphine|morphine
5009772|NCT03935412|cesarean section|cesarean section
5009781|NCT03935373|Proteomics|proteomics
5015016|NCT03902717|Minimally invasive cardiac surgery|minimally invasive cardiac surgery
5015017|NCT03902717|Endoscopic coronary artery bypass grafting|endoscopic coronary artery bypass grafting
5015018|NCT03902704|videolaryngoscopy|videolaryngoscopy
5015019|NCT03902704|tracheal intubation|tracheal intubation
5015020|NCT03902678|EUS|eus
5015021|NCT03902678|FNA|fna
5015022|NCT03902678|PVT|pvt
5015023|NCT03902652|Chest Compression|chest compression
5015024|NCT03902652|Newborn|newborn
5015025|NCT03902652|Infant|infant
5015026|NCT03902652|Sustained Inflation|sustained inflation
5015027|NCT03902639|High flow nasal cannual|high flow nasal cannual
5015028|NCT03902639|Airway pressure|airway pressure
5015029|NCT03902639|Lung volume|lung volume
5015030|NCT03902639|Non-invasive ventilation|non-invasive ventilation
5015031|NCT03902626|attitudes|attitudes
5015032|NCT03902626|chronic low back pain|chronic low back pain
5015033|NCT03902626|functionality|functionality
5015034|NCT03902626|healthcare professional students|healthcare professional students
5015035|NCT03902509|pirfenidone|pirfenidone
5015036|NCT03902418|Prevention in Pregnant and Breastfeeding Women|prevention in pregnant and breastfeeding women
5015037|NCT03902418|HIV Pre-Exposure Prophylaxis (PrEP)|hiv pre-exposure prophylaxis (prep)
5015038|NCT03902392|Allergic contact dermatitis|allergic contact dermatitis
5015039|NCT03902392|Cytokines|cytokines
5015040|NCT03902392|Cellular and molecular rehabilitation|cellular and molecular rehabilitation
5015041|NCT03902392|Immune response|immune response
5015042|NCT03902392|Nickel|nickel
5015043|NCT03902392|Polyphenols|polyphenols
5015044|NCT03902366|Hepatitis C|hepatitis c
5015045|NCT03902366|Direct-acting antiviral therapies|direct-acting antiviral therapies
5015046|NCT03902366|DAA|daa
5015047|NCT03902366|Chronic HCV infection|chronic hcv infection
5015048|NCT03902366|Alcohol Use Disorder|alcohol use disorder
5015049|NCT03902353|Pulmonary veino occlusive disease, pulmonary hypertension|pulmonary veino occlusive disease, pulmonary hypertension
5015050|NCT03902340|Pain|pain
5015051|NCT03902340|Knee osteoarthritis (KOA)|knee osteoarthritis (koa)
5015052|NCT03902340|Nociceptive pain|nociceptive pain
5015053|NCT03902340|TENS|tens
5015054|NCT03902340|Step 2 analgesics|step 2 analgesics
5015055|NCT03902327|N - acetylocysteine|n - acetylocysteine
5015056|NCT03902327|Obesity|obesity
5015057|NCT03902327|Insulin resistance|insulin resistance
5015058|NCT03902327|Nutrition intervention|nutrition intervention
5015059|NCT03902327|Carbohydrate Metabolism|carbohydrate metabolism
5015060|NCT03902314|Lidocaine|lidocaine
5015061|NCT03902314|Tonsillectomy and Adenoidectomy|tonsillectomy and adenoidectomy
5015062|NCT03902314|Pain|pain
5015063|NCT03902301|Lactobacillus rhamnosus|lactobacillus rhamnosus
5015064|NCT03902301|Polycystic Ovary Syndrome|polycystic ovary syndrome
5015065|NCT03902301|insulin resistance|insulin resistance
5015066|NCT03902301|nutrition intervention|nutrition intervention
5015067|NCT03902301|probiotic|probiotic
5015068|NCT03902288|Patients with type 2 diabetes|patients with type 2 diabetes
5015069|NCT03902288|Fresh pomegranate juice|fresh pomegranate juice
5015070|NCT03902288|Fasting serum glucose|fasting serum glucose
5015071|NCT03902275|cardiac surgery|cardiac surgery
5015072|NCT03902275|bleeding|bleeding
5015073|NCT03902275|point of care testing|point of care testing
5015074|NCT03902275|POCT|poct
5015078|NCT03902249|Analgesia|analgesia
5015079|NCT03902249|Postoperative pain|postoperative pain
5015080|NCT03902249|Children|children
5015081|NCT03902249|Hypospadias|hypospadias
5015082|NCT03902236|postural control|postural control
5015083|NCT03902236|reaction time|reaction time
5015084|NCT03902236|cystic fibrosis|cystic fibrosis
5015085|NCT03902236|Bronchiectasis|bronchiectasis
5015086|NCT03902223|sarcoidosis|sarcoidosis
5015087|NCT03902223|cardiac sarcoidosis|cardiac sarcoidosis
5015088|NCT03902223|cardiac sarcoidosis screening|cardiac sarcoidosis screening
5015089|NCT03902197|CD19 hsCAR-T|cd19 hscar-t
5015090|NCT03902197|B-ALL|b-all
5015091|NCT03902197|Humanized selective CAR|humanized selective car
5015092|NCT03902145|Complementary Feeding|complementary feeding
5015093|NCT03902145|Animal Source Foods|animal source foods
5015094|NCT03902145|Bone Age|bone age
5015095|NCT03902145|Stunting|stunting
5015096|NCT03902145|Ecuador|ecuador
5015097|NCT03902145|Follow Up Cohort|follow up cohort
5015098|NCT03902132|Backache|backache
5015099|NCT03902132|Core Stability exercises|core stability exercises
5015100|NCT03902132|Post menopausal|post menopausal
5015101|NCT03902119|neck pain|neck pain
5015102|NCT03902119|randomized control trial|randomized control trial
5015103|NCT03902119|manual therapy|manual therapy
5015104|NCT03902119|physical therapy|physical therapy
5015105|NCT03902119|suboccipital inhibition|suboccipital inhibition
5015106|NCT03902093|hearing loss, hearing aid|hearing loss, hearing aid
5015107|NCT03902080|Overactive Bladder|overactive bladder
5015108|NCT03902080|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5015109|NCT03902080|Vibegron|vibegron
5015110|NCT03902080|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
5015114|NCT03902028|pharmacist|pharmacist
5015115|NCT03902028|multidisciplinary team|multidisciplinary team
5015116|NCT03902028|readmission|readmission
5015117|NCT03902015|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5015119|NCT03902002|RTA 408 capsules|rta 408 capsules
5015120|NCT03902002|Omaveloxolone|omaveloxolone
5015121|NCT03902002|Omaveloxolone capsules|omaveloxolone capsules
5015122|NCT03902002|Hepatic impairment|hepatic impairment
5015123|NCT03901937|postoperative complications|postoperative complications
5015124|NCT03901924|Diaphragm Atrophy|diaphragm atrophy
5015125|NCT03901924|Ventilator Induced Diaphragm Dysfunction|ventilator induced diaphragm dysfunction
5015126|NCT03901924|Mechanical Ventilation|mechanical ventilation
5015127|NCT03901924|Volume Support Mode|volume support mode
5015128|NCT03901924|Assist Control Mode|assist control mode
5015129|NCT03901924|Diaphragm Thickening Fraction|diaphragm thickening fraction
5015130|NCT03901924|Intubation|intubation
5015131|NCT03901924|Delirium|delirium
5015132|NCT03901924|Ventilator-Free Days|ventilator-free days
5015133|NCT03901898|screening|screening
5015134|NCT03901898|primary care|primary care
5015135|NCT03901898|general practice|general practice
5015136|NCT03901898|feasibility|feasibility
5015137|NCT03901859|ADHD|adhd
5015138|NCT03901859|tryptophan|tryptophan
5015139|NCT03901859|executive function|executive function
5015140|NCT03901820|Electronic Record|electronic record
5015141|NCT03901820|Drug interaction|drug interaction
5015142|NCT03901820|Polypharmacy|polypharmacy
5015143|NCT03901820|Elderly|elderly
5015144|NCT03901820|Adverse Drug reaction|adverse drug reaction
5015145|NCT03901807|sepsis|sepsis
5015146|NCT03901807|septic shock|septic shock
5015147|NCT03901807|severe sepsis|severe sepsis
5015148|NCT03901807|endotoxemia|endotoxemia
5015149|NCT03901807|endotoxemic|endotoxemic
5015150|NCT03901807|TIGRIS|tigris
5015151|NCT03901807|PMX|pmx
5015152|NCT03901807|Toraymyxin|toraymyxin
5015153|NCT03901807|EAA|eaa
5015154|NCT03901755|Blood Coagulation Disorder|blood coagulation disorder
5015155|NCT03901755|Hematologic Diseases|hematologic diseases
5015156|NCT03901755|Coagulation Protein Disorder|coagulation protein disorder
5015157|NCT03901755|Hemorrhagic Disorder|hemorrhagic disorder
5015158|NCT03901755|Genetic Diseases, Inborn|genetic diseases, inborn
5015159|NCT03901742|Children|children
5015160|NCT03901742|Intensive Care|intensive care
5015161|NCT03901742|Nutrition|nutrition
5015162|NCT03901742|Enteral feeding|enteral feeding
5015163|NCT03901742|Protein intake|protein intake
5015164|NCT03901742|Protein balance.|protein balance.
5015165|NCT03901742|Lean Body Mass|lean body mass
5015166|NCT03901729|Chronic heart failure (CHF)|chronic heart failure (chf)
5015167|NCT03901729|Heart failure with reduced ejection fraction (HFrEF)|heart failure with reduced ejection fraction (hfref)
5015168|NCT03901729|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5015169|NCT03901729|Heart failure with mid-range ejection fraction (HFmrEF)|heart failure with mid-range ejection fraction (hfmref)
5015170|NCT03901690|Betaglucin soluble gel|betaglucin soluble gel
5015171|NCT03901690|Ano-genital warts|ano-genital warts
5015202|NCT03901469|poly ADP ribose polymerase|poly adp ribose polymerase
5015203|NCT03901469|bromodomain|bromodomain
5015204|NCT03901469|BETi|beti
5015205|NCT03901456|Caregiving|caregiving
5015206|NCT03901443|itchy skin diseases|itchy skin diseases
5015207|NCT03901443|itch treatments|itch treatments
5015208|NCT03901443|pruriception|pruriception
5015209|NCT03901404|Myomectomy|myomectomy
5015213|NCT03901378|Neuroendocrine carcinoma|neuroendocrine carcinoma
5015214|NCT03901378|Gastroenteropancreatic|gastroenteropancreatic
5015215|NCT03901378|Large cell neuroendocrine|large cell neuroendocrine
5015216|NCT03901365|Manual Therapy|manual therapy
5015217|NCT03901365|Neuroscience pain education|neuroscience pain education
5015218|NCT03901365|Quality of life|quality of life
5015219|NCT03901365|Chronic low back pain|chronic low back pain
5015220|NCT03901352|Central neuropathic pain|central neuropathic pain
5015221|NCT03901352|Developmental phase III|developmental phase iii
5015222|NCT03901339|Sacituzumab Govitecan|sacituzumab govitecan
5015223|NCT03901339|IMMU-132|immu-132
5015225|NCT03901339|estrogen receptor|estrogen receptor
5015226|NCT03901339|progesterone receptor|progesterone receptor
5015227|NCT03901339|hormonal receptor|hormonal receptor
5015228|NCT03901339|Anti-TROP2|anti-trop2
5015229|NCT03901339|Unresectable or Metastatic Breast Cancer|unresectable or metastatic breast cancer
5015230|NCT03901339|Human epidermal growth factor receptor 2 (HER2) Negative|human epidermal growth factor receptor 2 (her2) negative
5015232|NCT03901339|Antibody Drug Conjugate|antibody drug conjugate
5015233|NCT03901326|Coronary artery disease|coronary artery disease
5015234|NCT03901326|Coronary computed tomographic angiography|coronary computed tomographic angiography
5015235|NCT03901326|Fractional flow reserve|fractional flow reserve
5015236|NCT03901313|Pharmacokinetics|pharmacokinetics
5015237|NCT03901287|pulmonary hypertension|pulmonary hypertension
5015238|NCT03901287|dual energy CT|dual energy ct
5015239|NCT03901287|quantification|quantification
5015240|NCT03901287|lung perfusion|lung perfusion
5015241|NCT03901287|prediction|prediction
5015242|NCT03901274|School-based services|school-based services
5015243|NCT03901274|Stakeholder Engagement|stakeholder engagement
5015244|NCT03901274|Middle School|middle school
5015245|NCT03901261|Down Syndrome|down syndrome
5015246|NCT03901261|Alzheimer Disease|alzheimer disease
5015247|NCT03901261|Marker|marker
5015248|NCT03901261|Neuropsychological|neuropsychological
5015249|NCT03901261|Prodromal|prodromal
5015250|NCT03901261|Risk factors|risk factors
5015251|NCT03901222|tDCS|tdcs
5015252|NCT03901222|Athlete|athlete
5015253|NCT03901222|Endurance|endurance
5015254|NCT03901222|Fatigue|fatigue
5015255|NCT03901222|3D|3d
5015256|NCT03901196|Laser Induced Breakdown Spectroscopy|laser induced breakdown spectroscopy
5015257|NCT03901196|Multi elemental imaging|multi elemental imaging
5015258|NCT03901183|Metabolic Syndrom|metabolic syndrom
5015259|NCT03901183|Plant-based Diet|plant-based diet
5015260|NCT03901183|Nutrition|nutrition
5015261|NCT03901170|In Vitro Fertilization|in vitro fertilization
5015262|NCT03901170|letrozole|letrozole
5015263|NCT03901170|endometrial receptivity|endometrial receptivity
5015267|NCT03901144|atopic dermatitis|atopic dermatitis
5015268|NCT03901144|skin barrier|skin barrier
5015273|NCT03901092|flortaucipir F 18|flortaucipir f 18
5015274|NCT03901092|Positron Emission Tomography|positron emission tomography
5015275|NCT03901092|18F-AV-1451|18f-av-1451
5015276|NCT03901092|Diagnostic imaging|diagnostic imaging
5015277|NCT03901092|Tau imaging|tau imaging
5015285|NCT03901027|Parents|parents
5015286|NCT03901027|Children|children
5015287|NCT03901027|Chronic Illnesses|chronic illnesses
5015288|NCT03901014|ketogenic diet|ketogenic diet
5015289|NCT03901014|LDL cholesterol|ldl cholesterol
5015290|NCT03901014|carbohydrate|carbohydrate
5015291|NCT03901001|respiratory|respiratory
5015292|NCT03901001|Mortality|mortality
5015303|NCT03900949|FLT3|flt3
5015304|NCT03900949|FLT-3|flt-3
5015305|NCT03900923|cannabidiol (CBD)|cannabidiol (cbd)
5015306|NCT03900910|Cancer prevention; Antibiotics; Inequality|cancer prevention; antibiotics; inequality
5015307|NCT03900858|rifapentine|rifapentine
5015311|NCT03900845|transtibial amputation|transtibial amputation
5015312|NCT03900845|below knee amputation|below knee amputation
5015314|NCT03900845|perspiration|perspiration
5015315|NCT03900832|exercise|exercise
5015316|NCT03900832|blood pressure response|blood pressure response
5015317|NCT03900832|heating|heating
5015318|NCT03900806|Cancer, Cognitive rehabilitation, eHealth|cancer, cognitive rehabilitation, ehealth
5015319|NCT03900793|Pediatrics|pediatrics
5015320|NCT03900793|Adults|adults
5015321|NCT03900793|Phase 1|phase 1
5015322|NCT03900793|Losartan|losartan
5015323|NCT03900793|Sunitinib|sunitinib
5015324|NCT03900793|Maximum Tolerated Dose|maximum tolerated dose
5015325|NCT03900793|Recommended Phase 2 Dose|recommended phase 2 dose
5015326|NCT03900754|Oxytocin|oxytocin
5015327|NCT03900741|Peri-Implantitis|peri-implantitis
5015328|NCT03900741|Peri-Implant Diseases|peri-implant diseases
5015329|NCT03900741|Bone Regeneration|bone regeneration
5015330|NCT03900741|Submerged Healing|submerged healing
5015331|NCT03900741|Non-Submerged Healing|non-submerged healing
5015332|NCT03900741|Dental Implants|dental implants
5015333|NCT03900715|Myelodysplastic Syndromes|myelodysplastic syndromes
5015334|NCT03900715|MDS|mds
5015335|NCT03900715|ACE-536|ace-536
5015336|NCT03900715|Anemia|anemia
5015337|NCT03900650|Condom use resistance|condom use resistance
5015338|NCT03900650|Emotion dysregulation|emotion dysregulation
5015339|NCT03900572|Human Papilloma Virus|human papilloma virus
5015340|NCT03900572|Papillomavirus vaccines|papillomavirus vaccines
5015341|NCT03900572|Cervical Cancer|cervical cancer
5015342|NCT03900572|Genital Warts|genital warts
5015343|NCT03900559|Specific Phobia|specific phobia
5015344|NCT03900559|Computer-Assisted Exposure|computer-assisted exposure
5015345|NCT03900559|Self-help|self-help
5015346|NCT03900559|Internet-based Therapy|internet-based therapy
5015347|NCT03900559|Sense of presence|sense of presence
5015348|NCT03900533|child psychiatry|child psychiatry
5015349|NCT03900533|emotion regulation skills training|emotion regulation skills training
5015350|NCT03900520|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5015351|NCT03900520|vaccine impact|vaccine impact
5015352|NCT03900520|radiographic pneumonia|radiographic pneumonia
5015353|NCT03900520|hospitalization|hospitalization
5015354|NCT03900520|nasopharyngeal swab|nasopharyngeal swab
5015355|NCT03900520|India|india
5015356|NCT03900520|cost of illness|cost of illness
5015357|NCT03900520|pneumococcal carriage|pneumococcal carriage
5015358|NCT03900520|pneumococcal serotypes|pneumococcal serotypes
5015359|NCT03900520|pneumonia|pneumonia
5015360|NCT03900520|meningitis|meningitis
5015361|NCT03900520|sepsis|sepsis
5015362|NCT03900520|invasive pneumococcal disease|invasive pneumococcal disease
5015363|NCT03900507|incisional endometriosis|incisional endometriosis
5015364|NCT03900507|scar endometriosis|scar endometriosis
5015365|NCT03900494|salbutamol|salbutamol
5015366|NCT03900494|valved holding chamber|valved holding chamber
5015367|NCT03900494|pMDI|pmdi
5015380|NCT03900416|Mobile Intervention|mobile intervention
5015381|NCT03900416|Brief Intervention|brief intervention
5015382|NCT03900416|Adolescence|adolescence
5015383|NCT03900390|heart transplantation|heart transplantation
5015384|NCT03900390|ischemia-reperfusion injury|ischemia-reperfusion injury
5015385|NCT03900377|Lymphoma, B-cell, Diffuse, SyB L-0501RI|lymphoma, b-cell, diffuse, syb l-0501ri
5015386|NCT03900364|partial nephrectomy|partial nephrectomy
5015387|NCT03900364|robot-assisted partial nephrectomy|robot-assisted partial nephrectomy
5015388|NCT03900364|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
5015389|NCT03900338|pulse wave velocity|pulse wave velocity
5015390|NCT03900338|intestinal microbiota|intestinal microbiota
5015391|NCT03900338|cardiovascular disease|cardiovascular disease
5015392|NCT03900338|short chain fatty acids|short chain fatty acids
5015393|NCT03900338|multicentric study|multicentric study
5015397|NCT03900299|breast conservative surgery|breast conservative surgery
5015398|NCT03900299|oncoplastic breast surgery|oncoplastic breast surgery
5015399|NCT03900286|Familial Partial Lipodystrophy|familial partial lipodystrophy
5015400|NCT03900286|FPLD|fpld
5015401|NCT03900286|Diet|diet
5015402|NCT03900286|Total Diet Replacement|total diet replacement
5015403|NCT03900286|Diabetes|diabetes
5015404|NCT03900273|Alzheimer's disease|alzheimer's disease
5015405|NCT03900273|Neuropsychological Testing|neuropsychological testing
5015406|NCT03900273|Healthy Older Individuals|healthy older individuals
5015407|NCT03900273|Psychometrics|psychometrics
5015411|NCT03900234|chronic venous disease|chronic venous disease
5015412|NCT03900234|prevalence|prevalence
5015413|NCT03900234|risk factors|risk factors
5015414|NCT03900221|Multiple sclerosis|multiple sclerosis
5015415|NCT03900221|pregnancy|pregnancy
5015416|NCT03900221|disease modifying drugs|disease modifying drugs
5015417|NCT03900221|breastfeeding|breastfeeding
5015418|NCT03900221|loco-regional analgesia|loco-regional analgesia
5015419|NCT03900182|Traumatic brain injury|traumatic brain injury
5015420|NCT03900182|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5015421|NCT03900182|neuropsychological treatment|neuropsychological treatment
5015422|NCT03900182|cognitive function|cognitive function
5015423|NCT03900182|biomarkers.|biomarkers.
5015424|NCT03900130|hunger, satiety, satiety cascade, satiating capacity|hunger, satiety, satiety cascade, satiating capacity
5015425|NCT03900117|Non-small Cell Lung Cancer|non-small cell lung cancer
5015426|NCT03900117|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5015427|NCT03900117|Severe Impairment of Baseline Pulmonary Function|severe impairment of baseline pulmonary function
5015431|NCT03900091|Point of care|point of care
5015432|NCT03900091|Diagnostics|diagnostics
5015433|NCT03900091|Low-income countries|low-income countries
5015434|NCT03900091|Meningitis|meningitis
5015435|NCT03900091|Pediatrics|pediatrics
5015436|NCT03900091|MxA|mxa
5015437|NCT03900091|FilmArray|filmarray
5015438|NCT03900091|Low-cost diagnostics|low-cost diagnostics
5015439|NCT03900065|flap preconditioning|flap preconditioning
5015440|NCT03900052|Knee Osteoarthritis|knee osteoarthritis
5015441|NCT03900052|Knee adduction moment|knee adduction moment
5015442|NCT03900052|Knee loading|knee loading
5015443|NCT03900052|Walking cane|walking cane
5015444|NCT03900039|Hip arthroplasty|hip arthroplasty
5015445|NCT03900039|Tribology|tribology
5015446|NCT03900039|wear|wear
5015447|NCT03900026|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5015448|NCT03900026|CABG|cabg
5015449|NCT03900026|Saphenous Vein Graft|saphenous vein graft
5015450|NCT03900026|Evolocumab|evolocumab
5015451|NCT03900026|Repatha|repatha
5015452|NCT03900013|injectable platelet rich fibrin|injectable platelet rich fibrin
5015453|NCT03900013|Demineralized Freeze-Dried Bone Allograft|demineralized freeze-dried bone allograft
5015454|NCT03900013|Stage 3 periodontitis|stage 3 periodontitis
5015455|NCT03899961|cesarean delivery|cesarean delivery
5015456|NCT03899961|blood loss|blood loss
5015457|NCT03899961|troponin|troponin
5015458|NCT03899948|Excessive Anxiety|excessive anxiety
5015459|NCT03899948|Teacher Training|teacher training
5015460|NCT03899948|Elementary School|elementary school
5015461|NCT03899948|School-based|school-based
5332264|NCT02029729|RTA 408|rta 408
5015462|NCT03899948|Effectiveness Research|effectiveness research
5015463|NCT03899948|Randomized Controlled Trial|randomized controlled trial
5015464|NCT03899935|Endometriosis|endometriosis
5015468|NCT03899922|chemotherapies|chemotherapies
5015469|NCT03899922|drugs|drugs
5015470|NCT03899870|rectal adenocarcinoma|rectal adenocarcinoma
5015471|NCT03899870|recurrence|recurrence
5015472|NCT03899870|prognosis|prognosis
5015473|NCT03899831|Elopement|elopement
5015474|NCT03899818|small vessels|small vessels
5015475|NCT03899818|drug coated balloon|drug coated balloon
5015476|NCT03899805|Sarcoma|sarcoma
5015477|NCT03899792|Loxo|loxo
5015478|NCT03899792|LOXO-292|loxo-292
5015479|NCT03899792|KIF5B-RET|kif5b-ret
5015480|NCT03899792|M918T|m918t
5015481|NCT03899792|CCDC6-RET|ccdc6-ret
5015482|NCT03899792|RET-PTC1|ret-ptc1
5015483|NCT03899792|NCOA4-RET|ncoa4-ret
5015484|NCT03899792|RET-PTC|ret-ptc
5015485|NCT03899792|RET-PTC3|ret-ptc3
5015486|NCT03899792|RET-PTC4|ret-ptc4
5015487|NCT03899792|PRKAR1A-RET|prkar1a-ret
5015488|NCT03899792|RET-PTC2|ret-ptc2
5015489|NCT03899792|GOLGA5-RET|golga5-ret
5015490|NCT03899792|RET-PTC5|ret-ptc5
5015491|NCT03899792|ERC1-RET|erc1-ret
5015492|NCT03899792|KTN1-RET|ktn1-ret
5015493|NCT03899792|RET-PTC8|ret-ptc8
5015494|NCT03899792|HOOK3-RET|hook3-ret
5015495|NCT03899792|PCM1-RET|pcm1-ret
5015496|NCT03899792|TRIM24-RET|trim24-ret
5015497|NCT03899792|RET-PTC6|ret-ptc6
5015498|NCT03899792|TRIM27-RET|trim27-ret
5015499|NCT03899792|TRIM33-RET|trim33-ret
5015500|NCT03899792|RET-PTC7|ret-ptc7
5015501|NCT03899792|AKAP13-RET|akap13-ret
5015502|NCT03899792|FKBP15-RET|fkbp15-ret
5015510|NCT03899792|MYH13-RET|myh13-ret
5015511|NCT03899792|CUX1-RET|cux1-ret
5015512|NCT03899792|KIAA1468-RET|kiaa1468-ret
5015513|NCT03899792|FRMD4A-RET|frmd4a-ret
5015514|NCT03899792|SQSTM1-RET|sqstm1-ret
5015515|NCT03899792|AFAP1L2-RET|afap1l2-ret
5015516|NCT03899792|PPFIBP2-RET|ppfibp2-ret
5015517|NCT03899792|EML4-RET|eml4-ret
5015518|NCT03899792|PARD3-RET|pard3-ret
5015519|NCT03899792|G533C|g533c
5015520|NCT03899792|C609F|c609f
5015521|NCT03899792|C609G|c609g
5015522|NCT03899792|C609R|c609r
5015523|NCT03899792|C609S|c609s
5015524|NCT03899792|C609Y|c609y
5015525|NCT03899792|C611F|c611f
5015526|NCT03899792|C611G|c611g
5015527|NCT03899792|C611S|c611s
5015528|NCT03899792|C611Y|c611y
5015529|NCT03899792|C611W|c611w
5015530|NCT03899792|C618F|c618f
5015531|NCT03899792|C618R|c618r
5015532|NCT03899792|C618S|c618s
5015533|NCT03899792|C620F|c620f
5015534|NCT03899792|C620R|c620r
5015535|NCT03899792|C620S|c620s
5015536|NCT03899792|C630R|c630r
5015537|NCT03899792|C630Y|c630y
5015538|NCT03899792|D631Y|d631y
5015539|NCT03899792|C634F|c634f
5015540|NCT03899792|C634G|c634g
5015541|NCT03899792|C634R|c634r
5015542|NCT03899792|C634S|c634s
5015543|NCT03899792|C634W|c634w
5015544|NCT03899792|C634Y|c634y
5015545|NCT03899792|K666E|k666e
5015546|NCT03899792|E768D|e768d
5015547|NCT03899792|L790F|l790f
5015548|NCT03899792|V804L|v804l
5015549|NCT03899792|V804M|v804m
5015550|NCT03899792|A883F|a883f
5015551|NCT03899792|S891A|s891a
5015552|NCT03899792|R912P|r912p
5015553|NCT03899792|CLIP1-RET|clip1-ret
5015554|NCT03899792|Y806C|y806c
5015555|NCT03899792|RET fusion|ret fusion
5015556|NCT03899792|RET alteration|ret alteration
5015557|NCT03899792|RET mutation|ret mutation
5015558|NCT03899792|RET rearrangement|ret rearrangement
5015559|NCT03899792|RET translocation|ret translocation
5015560|NCT03899792|Neoplasms by Site|neoplasms by site
5015561|NCT03899792|Neoplasms|neoplasms
5015562|NCT03899792|Non-Small Cell Lung Cancer|non-small cell lung cancer
5015563|NCT03899792|Lung Neoplasms|lung neoplasms
5015564|NCT03899792|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5015565|NCT03899792|Cancer of Lung|cancer of lung
5015566|NCT03899792|Cancer of the Lung|cancer of the lung
5015567|NCT03899792|Lung Cancer|lung cancer
5015568|NCT03899792|Neoplasms, Lung|neoplasms, lung
5015569|NCT03899792|Neoplasms, Pulmonary|neoplasms, pulmonary
5015570|NCT03899792|Pulmonary Cancer|pulmonary cancer
5015571|NCT03899792|Pulmonary Neoplasms|pulmonary neoplasms
5015572|NCT03899792|Respiratory Tract Neoplasms|respiratory tract neoplasms
5015573|NCT03899792|Lung Diseases|lung diseases
5015574|NCT03899792|Respiratory Tract Diseases|respiratory tract diseases
5015575|NCT03899792|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5015576|NCT03899792|Bronchial Neoplasms|bronchial neoplasms
5015577|NCT03899792|Medullary Thyroid Cancer|medullary thyroid cancer
5015578|NCT03899792|Papillary Thyroid Cancer|papillary thyroid cancer
5015579|NCT03899792|Thyroid Diseases|thyroid diseases
5423186|NCT01616784|Insulin|insulin
5015586|NCT03899792|Thyroid Carcinoma|thyroid carcinoma
5015587|NCT03899792|Endocrine System Diseases|endocrine system diseases
5015588|NCT03899792|Endocrine Gland Neoplasms|endocrine gland neoplasms
5015589|NCT03899792|Head and Neck Neoplasms|head and neck neoplasms
5015590|NCT03899792|Thoracic Neoplasms|thoracic neoplasms
5015591|NCT03899792|CNS tumor|cns tumor
5015592|NCT03899792|Primary CNS tumor|primary cns tumor
5015593|NCT03899792|Colonic Neoplasms|colonic neoplasms
5015594|NCT03899792|Cancer of Colon|cancer of colon
5015595|NCT03899792|Cancer of the Colon|cancer of the colon
5015596|NCT03899792|Colon Cancer|colon cancer
5015597|NCT03899792|Colon Neoplasms|colon neoplasms
5015598|NCT03899792|Colonic Cancer|colonic cancer
5015599|NCT03899792|Neoplasms, Colonic|neoplasms, colonic
5015600|NCT03899792|Malignant tumor of Breast|malignant tumor of breast
5015601|NCT03899792|Mammary Cancer|mammary cancer
5015602|NCT03899792|Mammary Carcinoma, Human|mammary carcinoma, human
5015603|NCT03899792|Mammary Neoplasm, Human|mammary neoplasm, human
5015604|NCT03899792|Neoplasms, Breast|neoplasms, breast
5015605|NCT03899792|Tumors, Breast|tumors, breast
5015606|NCT03899792|Human Mammary Carcinoma|human mammary carcinoma
5015607|NCT03899792|Malignant Neoplasm of Breast|malignant neoplasm of breast
5015608|NCT03899792|Breast Carcinoma|breast carcinoma
5015609|NCT03899792|Breast Tumors|breast tumors
5015610|NCT03899792|Cancer of the Breast|cancer of the breast
5015611|NCT03899792|Breast Neoplasms|breast neoplasms
5015612|NCT03899792|Breast Cancer|breast cancer
5015613|NCT03899792|RET Inhibitor|ret inhibitor
5015615|NCT03899792|NSCLC|nsclc
5015616|NCT03899792|Soft tissue sarcoma|soft tissue sarcoma
5015617|NCT03899792|Infantile Myofibromatosis|infantile myofibromatosis
5015618|NCT03899792|Infantile Fibrosarcoma|infantile fibrosarcoma
5015619|NCT03899766|pain, procedural|pain, procedural
5015620|NCT03899766|child|child
5015630|NCT03899688|collagen membrane|collagen membrane
5015631|NCT03899688|biomaterial|biomaterial
5015632|NCT03899675|Caffeine|caffeine
5015633|NCT03899675|Exercise|exercise
5015634|NCT03899675|Heart Rate Variability|heart rate variability
5015635|NCT03899675|Autonomic Nervous System|autonomic nervous system
5015636|NCT03899675|Cardiovascular Risk Factor|cardiovascular risk factor
5015641|NCT03899623|Diabete Mellitus|diabete mellitus
5015642|NCT03899623|Diabetic Retinopathy|diabetic retinopathy
5015643|NCT03899623|Artificial Intelligence|artificial intelligence
5015644|NCT03899610|TRU-D|tru-d
5015645|NCT03899584|4-Aminopyridine|4-aminopyridine
5015646|NCT03899584|erectile function|erectile function
5015647|NCT03899584|tetraplegia|tetraplegia
5015648|NCT03899584|rehabilitation|rehabilitation
5015649|NCT03899584|questionnaires|questionnaires
5015650|NCT03899584|paraplegia|paraplegia
5015651|NCT03899558|Neural respiratory drive|neural respiratory drive
5015652|NCT03899558|Physiology|physiology
5015653|NCT03899558|Respiratory muscles|respiratory muscles
5015654|NCT03899558|COPD exacerbation|copd exacerbation
5015655|NCT03899558|Ventilation|ventilation
5015656|NCT03899558|Nasal high-flow|nasal high-flow
5015657|NCT03899558|High-flow nasal cannula|high-flow nasal cannula
5015662|NCT03899532|Remote Ischemic Conditioning|remote ischemic conditioning
5015663|NCT03899532|Traumatic Brain Injury|traumatic brain injury
5015665|NCT03899519|ultrasound|ultrasound
5015666|NCT03899519|airway|airway
5015667|NCT03899519|difficult intubation|difficult intubation
5015668|NCT03899493|Electroencephalography|electroencephalography
5015669|NCT03899493|Electromyography|electromyography
5015670|NCT03899493|Pelvic Floor|pelvic floor
5015671|NCT03899493|Labor curve|labor curve
5015672|NCT03899493|Intrauterine infection|intrauterine infection
5015673|NCT03899493|Hypertensive Disorders of Pregnancy|hypertensive disorders of pregnancy
5015674|NCT03899480|Suppressive Antiretroviral Therapy (ART)|suppressive antiretroviral therapy (art)
5015675|NCT03899454|exercise-induced oxidative-stress|exercise-induced oxidative-stress
5015676|NCT03899454|Garcinia mangostana L rind|garcinia mangostana l rind
5015677|NCT03899441|multimedia, video teaching|multimedia, video teaching
5015678|NCT03899389|trimethylamine-N-oxide|trimethylamine-n-oxide
5015679|NCT03899376|Gynecological Cancer|gynecological cancer
5015680|NCT03899376|Radiotherapy|radiotherapy
5015681|NCT03899376|VMAT|vmat
5015682|NCT03899376|Toxicity|toxicity
5015684|NCT03899350|Intracerebral Hemorrhage|intracerebral hemorrhage
5015685|NCT03899350|Surgery|surgery
5015686|NCT03899350|Outcome|outcome
5015687|NCT03899350|Prediction Model|prediction model
5015688|NCT03899337|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
5015692|NCT03899337|Acalabrutinib|acalabrutinib
5015693|NCT03899337|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5015694|NCT03899337|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5015695|NCT03899298|stem cell therapy|stem cell therapy
5015696|NCT03899298|umbilical stem cells|umbilical stem cells
5015697|NCT03899298|amniotic stem cells|amniotic stem cells
5015698|NCT03899298|stem cells|stem cells
5015699|NCT03899298|regenerative medicine|regenerative medicine
5015700|NCT03899298|r3 stem cell|r3 stem cell
5015701|NCT03899298|perinatal tissue|perinatal tissue
5015702|NCT03899298|placenta stem cell|placenta stem cell
5015703|NCT03899285|citalopram|citalopram
5015704|NCT03899285|major depressive disorder|major depressive disorder
5015705|NCT03899285|non responder|non responder
5015706|NCT03899285|MADRS|madrs
5015707|NCT03899272|osteoarthritis|osteoarthritis
5015708|NCT03899272|psychology|psychology
5015709|NCT03899246|Capsaicin|capsaicin
5015710|NCT03899246|Topical Analgesia|topical analgesia
5015711|NCT03899246|Quantitative Sensory Testing|quantitative sensory testing
5015712|NCT03899246|Pain|pain
5015713|NCT03899233|Melasma|melasma
5015714|NCT03899233|Tranexamic acid|tranexamic acid
5015715|NCT03899233|Fractional CO2 laser|fractional co2 laser
5015716|NCT03899194|major depressive disorder|major depressive disorder
5015717|NCT03899194|neuroimmunology|neuroimmunology
5015718|NCT03899194|PRKCB1 gene|prkcb1 gene
5015719|NCT03899194|modulation|modulation
5015723|NCT03899168|Information Search|information search
5015724|NCT03899168|Attitudes|attitudes
5015725|NCT03899168|Psychotherapy|psychotherapy
5015726|NCT03899168|Antidepressants|antidepressants
5015727|NCT03899051|interdental papilla reconstruction|interdental papilla reconstruction
5015728|NCT03899025|HRpQCT|hrpqct
5015729|NCT03899025|high resolution quantitative peripheral CT|high resolution quantitative peripheral ct
5015730|NCT03899025|Xtreme CT scan|xtreme ct scan
5015731|NCT03899025|CT scan|ct scan
5015732|NCT03899025|Diagnoses Disease|diagnoses disease
5015733|NCT03899025|Fracture healing|fracture healing
5015734|NCT03898999|Ankle|ankle
5015738|NCT03898947|Tamoxifen|tamoxifen
5015739|NCT03898947|Aromatase inhibitors|aromatase inhibitors
5015740|NCT03898947|Breast cancer|breast cancer
5015741|NCT03898947|Endometrial cancer|endometrial cancer
5015742|NCT03898947|Endometrial pathologies|endometrial pathologies
5015743|NCT03898934|Lean PCOS|lean pcos
5015744|NCT03898934|Vitamin D|vitamin d
5015745|NCT03898934|Supplementation|supplementation
5015746|NCT03898934|Ovulation|ovulation
5015747|NCT03898934|Pregnancy|pregnancy
5015748|NCT03898921|Small Hepatocellular Carcinoma|small hepatocellular carcinoma
5015749|NCT03898921|Radiofrequency Ablation|radiofrequency ablation
5015750|NCT03898921|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5015751|NCT03898908|metastases|metastases
5015752|NCT03898908|melanoma|melanoma
5015753|NCT03898908|encorafenib|encorafenib
5015754|NCT03898908|binimetinib|binimetinib
5015755|NCT03898856|diarrhea|diarrhea
5015756|NCT03898856|diagnosis|diagnosis
5015757|NCT03898856|crofelemer|crofelemer
5015758|NCT03898856|treatment|treatment
5015759|NCT03898843|Animal assisted therapy|animal assisted therapy
5015760|NCT03898843|Intensive Care Unit|intensive care unit
5015761|NCT03898843|Anxiety|anxiety
5015762|NCT03898817|helicase|helicase
5015763|NCT03898817|induced pluripotent stem cells|induced pluripotent stem cells
5015764|NCT03898791|aurora kinase A|aurora kinase a
5015766|NCT03898791|aurora A|aurora a
5015767|NCT03898791|aurora kinase inhibitor|aurora kinase inhibitor
5015768|NCT03898791|aurora kinase A inhibitor|aurora kinase a inhibitor
5015769|NCT03898791|kinase inhibitor|kinase inhibitor
5015770|NCT03898791|AURKA|aurka
5015771|NCT03898791|AurA|aura
5015772|NCT03898765|Dry blood spot test|dry blood spot test
5015773|NCT03898765|Biliary Atresia|biliary atresia
5015774|NCT03898739|Traction|traction
5015775|NCT03898739|Decompression angles|decompression angles
5015776|NCT03898713|IQ|iq
5015777|NCT03898713|Speech|speech
5015778|NCT03898713|VPI|vpi
5015779|NCT03898687|melanoma|melanoma
5015780|NCT03898687|Sentinel node|sentinel node
5015781|NCT03898687|SPIO-MRI|spio-mri
5015782|NCT03898661|Xiapex|xiapex
5015783|NCT03898661|esophageal stricture|esophageal stricture
5015784|NCT03898661|stricture|stricture
5015785|NCT03898661|collagenase|collagenase
5015786|NCT03898661|refractory|refractory
5015787|NCT03898661|anastomotic|anastomotic
5015788|NCT03898648|Depression|depression
5015789|NCT03898648|Suicide attempt|suicide attempt
5015790|NCT03898648|Neuropsychology|neuropsychology
5015791|NCT03898648|Decision- making|decision- making
5015792|NCT03898648|Social interaction|social interaction
5015793|NCT03898648|Implicit Emotional processing|implicit emotional processing
5015794|NCT03898635|linezolid|linezolid
5015798|NCT03898544|gait kinematics|gait kinematics
5015800|NCT03898531|hip arthroplasty|hip arthroplasty
5015801|NCT03898531|hip prosthesis resection|hip prosthesis resection
5015802|NCT03898531|first implantation|first implantation
5015803|NCT03898531|wear particles|wear particles
5015804|NCT03898518|adolescence|adolescence
5015805|NCT03898518|exercise|exercise
5015806|NCT03898518|body composition|body composition
5015807|NCT03898518|insulin sensitivity|insulin sensitivity
5015808|NCT03898518|obesity|obesity
5015809|NCT03898518|academic self-efficacy|academic self-efficacy
5015810|NCT03898505|Avocado|avocado
5015811|NCT03898505|Polyhydroxylated Fatty Alcohols|polyhydroxylated fatty alcohols
5015812|NCT03898505|Avocatin B|avocatin b
5015813|NCT03898453|Breast Cancer|breast cancer
5015814|NCT03898453|support psychotherapy|support psychotherapy
5015815|NCT03898453|EMDR therapy|emdr therapy
5015816|NCT03898453|anxiety disorders|anxiety disorders
5015817|NCT03898440|anogenital distance|anogenital distance
5015818|NCT03898440|prenatal|prenatal
5015819|NCT03898440|sex determination|sex determination
5015820|NCT03898440|androgen|androgen
5015821|NCT03898427|Wearable devices|wearable devices
5015822|NCT03898427|Scratch|scratch
5015823|NCT03898427|Sleep|sleep
5015824|NCT03898375|Virtual reality|virtual reality
5015825|NCT03898375|optic flow|optic flow
5015826|NCT03898375|gait|gait
5015827|NCT03898362|wheelchair|wheelchair
5015851|NCT03898271|virtual reality|virtual reality
5015852|NCT03898271|education|education
5015853|NCT03898271|training|training
5015854|NCT03898271|primary care|primary care
5015855|NCT03898271|mental health|mental health
5015856|NCT03898219|Hematogenous osteomyelitis|hematogenous osteomyelitis
5015857|NCT03898219|relapse|relapse
5015858|NCT03898219|adulthood|adulthood
5015859|NCT03898193|Bioequivalence|bioequivalence
5015860|NCT03898193|Montelukast|montelukast
5015861|NCT03898193|Singulair|singulair
5015870|NCT03898115|implementation science|implementation science
5015871|NCT03898115|chlorhexidine gluconate bathing|chlorhexidine gluconate bathing
5015872|NCT03898089|Myofascial Release Technique|myofascial release technique
5015873|NCT03898089|Core Stabilization Exercise|core stabilization exercise
5015874|NCT03898050|transcutaneous pacer pad|transcutaneous pacer pad
5015877|NCT03898011|Lamotrigine|lamotrigine
5015883|NCT03897972|Personalised nutrition|personalised nutrition
5015884|NCT03897959|suprapubic, urinary catheter|suprapubic, urinary catheter
5015885|NCT03897933|Erector spinae block|erector spinae block
5015886|NCT03897933|percutaneous|percutaneous
5015887|NCT03897933|nephrolithotomy|nephrolithotomy
5015888|NCT03897933|stone|stone
5015889|NCT03897933|ultrasound|ultrasound
5015890|NCT03897894|resilience|resilience
5015891|NCT03897894|child protection|child protection
5015892|NCT03897894|child development|child development
5015893|NCT03897881|mRNA-4157|mrna-4157
5015894|NCT03897881|Personalized cancer vaccine|personalized cancer vaccine
5015895|NCT03897881|PCV|pcv
5015896|NCT03897881|Pembrolizumab|pembrolizumab
5015897|NCT03897881|Moderna|moderna
5015898|NCT03897829|enthesitis|enthesitis
5015899|NCT03897829|osteoarthritis|osteoarthritis
5015900|NCT03897829|ultrasound|ultrasound
5015901|NCT03897816|personality disorders|personality disorders
5015902|NCT03897816|anxiety disorders|anxiety disorders
5015903|NCT03897816|mood disorders|mood disorders
5015904|NCT03897790|cerebral vasoreactivity|cerebral vasoreactivity
5015905|NCT03897790|transcranial doppler|transcranial doppler
5015906|NCT03897790|hypertensive disease|hypertensive disease
5015907|NCT03897790|elderly|elderly
5015908|NCT03897790|vasopressors|vasopressors
5015909|NCT03897790|general anesthesia|general anesthesia
5015910|NCT03897777|Blood pressure|blood pressure
5015911|NCT03897777|Gut dysbiosis|gut dysbiosis
5015912|NCT03897777|Exercise training|exercise training
5015913|NCT03897764|cesarean section|cesarean section
5015914|NCT03897764|postoperative pain|postoperative pain
5015915|NCT03897764|superior hypogastric block|superior hypogastric block
5015919|NCT03897686|intra-articular|intra-articular
5015920|NCT03897686|polyacrylamide hydrogel|polyacrylamide hydrogel
5015921|NCT03897660|Omega-3 fatty acids|omega-3 fatty acids
5015922|NCT03897660|Vitamin K2|vitamin k2
5015923|NCT03897660|Bioavailability|bioavailability
5015924|NCT03897660|Side effects|side effects
5015925|NCT03897660|Monoacylglyderols|monoacylglyderols
5015926|NCT03897647|echocardiography|echocardiography
5015927|NCT03897647|pulmonary artery catheter|pulmonary artery catheter
5016129|NCT03896230|ketamine|ketamine
5015928|NCT03897647|point of care ultrasound|point of care ultrasound
5015929|NCT03897634|Assistive Listening Device (ALD)|assistive listening device (ald)
5015930|NCT03897634|Hearing in Noise|hearing in noise
5015931|NCT03897621|tranexamic acid|tranexamic acid
5015932|NCT03897621|Rotational thromboelastometry|rotational thromboelastometry
5015933|NCT03897621|Fibrinolysis|fibrinolysis
5015934|NCT03897621|viscoelastic essay|viscoelastic essay
5015936|NCT03897582|amoxicillin-clavulanic acid|amoxicillin-clavulanic acid
5423187|NCT01616784|Self Care|self care
5015937|NCT03897582|piperacillin-tazobactam|piperacillin-tazobactam
5015938|NCT03897582|cefotaxime|cefotaxime
5015939|NCT03897582|ceftazidime|ceftazidime
5015940|NCT03897582|cefepime|cefepime
5015941|NCT03897582|meropenem|meropenem
5015942|NCT03897582|imipenem|imipenem
5015943|NCT03897582|multifiltrate|multifiltrate
5015944|NCT03897582|citrate|citrate
5015945|NCT03897582|CVVHD|cvvhd
5015946|NCT03897582|extended and continuous infusion|extended and continuous infusion
5015947|NCT03897582|TDM|tdm
5015948|NCT03897582|Therapeutic Drug Monitoring|therapeutic drug monitoring
5015949|NCT03897569|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5015950|NCT03897569|knee kinematics|knee kinematics
5015951|NCT03897569|frontal projection angle|frontal projection angle
5015952|NCT03897569|ankle motion|ankle motion
5015953|NCT03897543|HCC|hcc
5015954|NCT03897543|Nivolumab|nivolumab
5015955|NCT03897543|ABX196|abx196
5015956|NCT03897517|Glycemia|glycemia
5015957|NCT03897517|Carbohydrate blocker|carbohydrate blocker
5015958|NCT03897504|congenital adrenal hyperplasia|congenital adrenal hyperplasia
5015959|NCT03897504|Feminizing genitoplasty|feminizing genitoplasty
5015960|NCT03897504|Vaginal stenosis|vaginal stenosis
5015961|NCT03897478|Ischemic stroke|ischemic stroke
5015962|NCT03897478|Atrial fibrillation|atrial fibrillation
5015963|NCT03897478|Transient neurological event|transient neurological event
5015964|NCT03897478|Cryptogenic stroke|cryptogenic stroke
5015965|NCT03897478|Gene expression|gene expression
5015966|NCT03897478|RNA|rna
5015967|NCT03897478|Anticoagulant|anticoagulant
5015968|NCT03897478|NOAC|noac
5015969|NCT03897478|Implantable cardiac monitor|implantable cardiac monitor
5015970|NCT03897478|Point of care|point of care
5015971|NCT03897478|tPA|tpa
5015972|NCT03897478|Thrombectomy|thrombectomy
5015973|NCT03897478|Cardiac monitoring|cardiac monitoring
5015974|NCT03897452|analgesia|analgesia
5015975|NCT03897452|neonates|neonates
5015976|NCT03897452|procedural pain|procedural pain
5015977|NCT03897452|pain assessment|pain assessment
5015978|NCT03897452|physiological response|physiological response
5015979|NCT03897452|pharmacogenetics|pharmacogenetics
5015980|NCT03897348|alcohol craving|alcohol craving
5015981|NCT03897348|human laboratory|human laboratory
5015983|NCT03897348|non-treatment seeking|non-treatment seeking
5015984|NCT03897296|high-resolution anorectal manometry|high-resolution anorectal manometry
5015985|NCT03897296|healthy|healthy
5015986|NCT03897296|Russian population|russian population
5015987|NCT03897244|Helicobacter pylori|helicobacter pylori
5015988|NCT03897244|high dose dual therapy|high dose dual therapy
5015989|NCT03897244|bismuth high-dose dual therapy|bismuth high-dose dual therapy
5015990|NCT03897244|bismuth quadruple therapy|bismuth quadruple therapy
5015991|NCT03897218|Liver health|liver health
5015992|NCT03897218|Diet|diet
5015993|NCT03897218|Microbiom|microbiom
5015994|NCT03897192|punctate inner choroidopathy|punctate inner choroidopathy
5015995|NCT03897192|multifocal choroiditis|multifocal choroiditis
5015996|NCT03897192|zonal outer retinopathy|zonal outer retinopathy
5015997|NCT03897192|long-term outcome|long-term outcome
5015998|NCT03897153|Stroke, Acute|stroke, acute
5015999|NCT03897127|CPX-351|cpx-351
5016000|NCT03897127|Acute Myeloid Leukemia|acute myeloid leukemia
5016001|NCT03897114|Nutritional Supplement|nutritional supplement
5016002|NCT03897114|Cocoa|cocoa
5016003|NCT03897114|Prebiotic|prebiotic
5016004|NCT03897114|Physical Exercise|physical exercise
5016005|NCT03897114|Gut Microbiota|gut microbiota
5016006|NCT03897101|mild neonatal encephalopathy|mild neonatal encephalopathy
5016007|NCT03897101|birth asphyxia|birth asphyxia
5016008|NCT03897101|metabolic acidosis|metabolic acidosis
5016009|NCT03897101|Autophagy|autophagy
5016010|NCT03897101|Mitophagy|mitophagy
5016011|NCT03897101|inflammation|inflammation
5016012|NCT03897062|suvorexant|suvorexant
5016013|NCT03897062|insomnia|insomnia
5016014|NCT03897062|alcohol use disorder|alcohol use disorder
5016015|NCT03897062|craving|craving
5016016|NCT03897062|withdrawal|withdrawal
5016017|NCT03897049|Transgender Women|transgender women
5016018|NCT03897049|STI|sti
5016019|NCT03897049|Sexual Health|sexual health
5016020|NCT03897049|HIV/AIDS|hiv/aids
5016021|NCT03897036|Advanced Basal Cell Carcinoma|advanced basal cell carcinoma
5016022|NCT03897036|laBCC|labcc
5016023|NCT03897036|Locally Advanced Basal Cell Carcinoma|locally advanced basal cell carcinoma
5016024|NCT03897036|mBCC|mbcc
5016025|NCT03897036|Metastatic Basal Cell Carcinoma|metastatic basal cell carcinoma
5016026|NCT03897010|Silica-calcium phosphate composite|silica-calcium phosphate composite
5016027|NCT03897010|Socket augmentation|socket augmentation
5017037|NCT03889899|Lip cancer|lip cancer
5016039|NCT03896867|Pediatric perioperative temperature management|pediatric perioperative temperature management
5016040|NCT03896789|guideline adherence|guideline adherence
5016041|NCT03896789|implementation fidelity|implementation fidelity
5016042|NCT03896763|Pediatric Acute Respiratory Distress Syndrome (PARDS)|pediatric acute respiratory distress syndrome (pards)
5016043|NCT03896763|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5016044|NCT03896763|acute respiratory failure|acute respiratory failure
5016046|NCT03896763|pediatric intensive care unit|pediatric intensive care unit
5016057|NCT03896711|companion care|companion care
5016058|NCT03896711|activity|activity
5016059|NCT03896711|caregiver wellbeing|caregiver wellbeing
5016060|NCT03896711|caregiver respite|caregiver respite
5016061|NCT03896711|caregiver support|caregiver support
5016062|NCT03896711|home-based|home-based
5016063|NCT03896711|volunteer|volunteer
5016064|NCT03896698|Alzheimer's Disease|alzheimer's disease
5016065|NCT03896698|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
5016066|NCT03896685|bedaquiline|bedaquiline
5016067|NCT03896685|delamanid|delamanid
5016068|NCT03896685|linezolid|linezolid
5016069|NCT03896685|clofazimine|clofazimine
5016070|NCT03896685|tuberculosis|tuberculosis
5016071|NCT03896685|MDR-TB|mdr-tb
5016072|NCT03896685|XDR-TB|xdr-tb
5016073|NCT03896672|Clinical Practice Based on Scientific Evidence|clinical practice based on scientific evidence
5016074|NCT03896672|Non-Invasive Positive Airway Pressure|non-invasive positive airway pressure
5016075|NCT03896672|Pleural effusion|pleural effusion
5016076|NCT03896672|Chest drain|chest drain
5016077|NCT03896672|Physical therapy|physical therapy
5016078|NCT03896620|Sarcoma|sarcoma
5016079|NCT03896620|ctDNA|ctdna
5016080|NCT03896607|shear wave elastography|shear wave elastography
5016084|NCT03896529|Aging|aging
5016085|NCT03896529|Spatial Memory|spatial memory
5016086|NCT03896529|Stress|stress
5016087|NCT03896529|fMRI|fmri
5016093|NCT03896490|Learning|learning
5016094|NCT03896490|Memory|memory
5016095|NCT03896490|Memory Training|memory training
5016096|NCT03896490|Attention|attention
5016097|NCT03896490|Computerized Cognitive Training|computerized cognitive training
5016098|NCT03896464|Autograft|autograft
5016099|NCT03896464|Soft-tissue hamstring|soft-tissue hamstring
5016100|NCT03896464|Quadriceps Tendon|quadriceps tendon
5016101|NCT03896438|tDCS|tdcs
5016102|NCT03896438|cognitive training|cognitive training
5016103|NCT03896438|functional connectivity|functional connectivity
5016104|NCT03896425|tDCS|tdcs
5016105|NCT03896425|cognitive training|cognitive training
5016106|NCT03896425|functional connectivity|functional connectivity
5428225|NCT01595594|hemoglobin A1c protein|hemoglobin a1c protein
5016108|NCT03896412|circulating tumor DNA|circulating tumor dna
5016109|NCT03896412|Next Generation Sequencing|next generation sequencing
5016111|NCT03896399|Esophageal Cancer|esophageal cancer
5016112|NCT03896399|Esophagectomy|esophagectomy
5016113|NCT03896399|Ischemic conditioning|ischemic conditioning
5016114|NCT03896386|Epilepsy|epilepsy
5016115|NCT03896386|Seizures|seizures
5016116|NCT03896386|Seizure alert dogs|seizure alert dogs
5016117|NCT03896386|Seizure diary|seizure diary
5016125|NCT03896243|Uterine atony|uterine atony
5016126|NCT03896243|amh|amh
5016127|NCT03896230|moderate to severe pain|moderate to severe pain
5016128|NCT03896230|emergency department patient|emergency department patient
5016136|NCT03896165|Complementary Health Approach|complementary health approach
5016138|NCT03896165|Adolescent|adolescent
5016139|NCT03896152|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria, hemolysis|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria, hemolysis
5016140|NCT03896126|Healthy Control|healthy control
5016141|NCT03896126|Diabetic Gastroparesis|diabetic gastroparesis
5016142|NCT03896087|dried blood spots|dried blood spots
5016143|NCT03896087|plasma separation card|plasma separation card
5016144|NCT03896087|HCV RNA test|hcv rna test
5016145|NCT03896048|diaphragm ultrasound|diaphragm ultrasound
5016146|NCT03896048|mechanical ventilation|mechanical ventilation
5016147|NCT03896048|diaphragm function|diaphragm function
5016152|NCT03896022|auriculotherapy|auriculotherapy
5016153|NCT03896022|abortion|abortion
5016154|NCT03896022|pain management|pain management
5016155|NCT03896009|Migraine|migraine
5016156|NCT03896009|AXS-07|axs-07
5016157|NCT03896009|Meloxicam|meloxicam
5016158|NCT03896009|Rizatriptan|rizatriptan
5016159|NCT03896009|Axsome|axsome
5016160|NCT03896009|Axsome Therapeutics|axsome therapeutics
5016161|NCT03896009|MoSEIC meloxicam|moseic meloxicam
5016162|NCT03895970|Hepatobiliary Cancer|hepatobiliary cancer
5328526|NCT02046512|Probiotics|probiotics
5016163|NCT03895970|Pembrolizumab|pembrolizumab
5016164|NCT03895970|Lenvatinib|lenvatinib
5016165|NCT03895970|Biomarker|biomarker
5016170|NCT03895931|Frailty|frailty
5016171|NCT03895931|Lung transplant candidates|lung transplant candidates
5016172|NCT03895931|Rehabilitation|rehabilitation
5016173|NCT03895905|colposcopy|colposcopy
5016174|NCT03895905|High Risk HPV|high risk hpv
5016175|NCT03895879|Rheumatoid Arthritis|rheumatoid arthritis
5016176|NCT03895879|Tocilizumab|tocilizumab
5711231|NCT00460421|Kepivance|kepivance
5016182|NCT03895827|Medication Assisted Treatment|medication assisted treatment
5016183|NCT03895827|Treatment linkage|treatment linkage
5016184|NCT03895814|Balance|balance
5016185|NCT03895814|Falls|falls
5016186|NCT03895814|Posture|posture
5016187|NCT03895814|Cognition|cognition
5016188|NCT03895814|Training|training
5016189|NCT03895801|granulomatosis|granulomatosis
5016190|NCT03895801|polyangiitis|polyangiitis
5016191|NCT03895801|corticosteroid|corticosteroid
5016192|NCT03895801|replacement|replacement
5016193|NCT03895801|glucocorticoid|glucocorticoid
5016194|NCT03895775|obstructive sleep apnea|obstructive sleep apnea
5016195|NCT03895775|adolescents|adolescents
5016196|NCT03895775|prevalence|prevalence
5016197|NCT03895736|Transcriptome|transcriptome
5016198|NCT03895736|messenger ribonucleic acid (mRNA)|messenger ribonucleic acid (mrna)
5016199|NCT03895736|sequencing|sequencing
5016200|NCT03895736|biomarker|biomarker
5016201|NCT03895736|cardiac arrest|cardiac arrest
5016202|NCT03895736|prognostication|prognostication
5016203|NCT03895736|successful resuscitation|successful resuscitation
5016204|NCT03895723|Colorectal liver metastasis|colorectal liver metastasis
5016205|NCT03895723|Minimally invasive surgery|minimally invasive surgery
5016206|NCT03895723|Robotic surgery|robotic surgery
5016207|NCT03895723|Laparoscopic surgery|laparoscopic surgery
5016208|NCT03895710|sleep duration|sleep duration
5016209|NCT03895710|blood pressure|blood pressure
5016210|NCT03895710|adolescents|adolescents
5016211|NCT03895710|holiday|holiday
5016212|NCT03895697|glucagon|glucagon
5016217|NCT03895632|Extraocular muscle|extraocular muscle
5016218|NCT03895632|Electromyogram|electromyogram
5016219|NCT03895632|Monopolar|monopolar
5016220|NCT03895632|Needle guidance|needle guidance
5016221|NCT03895632|Botulinum toxin|botulinum toxin
5016222|NCT03895632|Strabismus|strabismus
5016223|NCT03895593|fecal microbiota transplantation|fecal microbiota transplantation
5016224|NCT03895593|intestinal infection|intestinal infection
5016225|NCT03895593|Clostridium Difficile Infection|clostridium difficile infection
5016226|NCT03895593|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
5016227|NCT03895541|heart failure|heart failure
5016228|NCT03895541|myocardial rigidity|myocardial rigidity
5016229|NCT03895541|new diagnosis|new diagnosis
5016230|NCT03895541|ultrasound imaging|ultrasound imaging
5016234|NCT03895437|Type 1 Diabetes|type 1 diabetes
5016235|NCT03895437|Diabetes|diabetes
5016236|NCT03895437|Diabetes Mellitus|diabetes mellitus
5016237|NCT03895424|Iron|iron
5016238|NCT03895424|Isotope study|isotope study
5016239|NCT03895424|Fatty Acid|fatty acid
5016247|NCT03895385|UCB4940|ucb4940
5016248|NCT03895385|Healthy Subjects|healthy subjects
5016249|NCT03895346|Mindfulness|mindfulness
5016250|NCT03895346|Meditation|meditation
5016251|NCT03895346|Imaging|imaging
5016252|NCT03895346|MRI|mri
5016253|NCT03895333|Bone mineral density|bone mineral density
5016254|NCT03895333|Postmenopause|postmenopause
5016255|NCT03895320|Native American|native american
5016256|NCT03895320|Youth|youth
5016257|NCT03895320|Young Adults|young adults
5016258|NCT03895320|STI Screening|sti screening
5016259|NCT03895320|Self Administered Sample Collection|self administered sample collection
5016260|NCT03895307|chronic low back pain|chronic low back pain
5016261|NCT03895307|kinesio taping|kinesio taping
5016262|NCT03895307|injection|injection
5016263|NCT03895307|local anesthetic|local anesthetic
5016264|NCT03895294|Direct-Acting Antivirals|direct-acting antivirals
5016265|NCT03895294|Health Services Accessibility|health services accessibility
5016271|NCT03895242|Preterm infant|preterm infant
5016272|NCT03895242|Mechanical ventilation|mechanical ventilation
5016273|NCT03895242|Position|position
5016274|NCT03895229|Diabetes|diabetes
5016275|NCT03895229|Empagliflozin|empagliflozin
5016276|NCT03895229|Circadian rythm|circadian rythm
5016277|NCT03895216|MicroRNAs|micrornas
5016278|NCT03895216|Bone Metastases|bone metastases
5016279|NCT03895216|Exosomes|exosomes
5016283|NCT03895190|well-being|well-being
5031167|NCT03804450|MRI|mri
5016299|NCT03895112|Phase 1|phase 1
5016300|NCT03895021|falls prevention|falls prevention
5016301|NCT03895021|Latino|latino
5016302|NCT03895021|Hispanic|hispanic
5016303|NCT03895021|Stepping On|stepping on
5016304|NCT03895008|Cardia gastric cancer|cardia gastric cancer
5016305|NCT03895008|Non-cardia gastric cancer|non-cardia gastric cancer
5016306|NCT03895008|Resection|resection
5016307|NCT03895008|Prognosis|prognosis
5016308|NCT03894995|Ventilation|ventilation
5016309|NCT03894969|Immunogenicity|immunogenicity
5016310|NCT03894969|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5016311|NCT03894969|Non-typeable Haemophilus influenza|non-typeable haemophilus influenza
5016312|NCT03894969|Moraxella catarrhalis|moraxella catarrhalis
5016313|NCT03894969|Shingrix|shingrix
5016314|NCT03894969|Herpes Zoster|herpes zoster
5016315|NCT03894969|Adjuvanted vaccines|adjuvanted vaccines
5016317|NCT03894956|Hidradenitis Suppurativa (HS)|hidradenitis suppurativa (hs)
5016318|NCT03894956|Humira|humira
5016319|NCT03894956|Adalimumab|adalimumab
5016320|NCT03894943|PET/CT|pet/ct
5016321|NCT03894930|healthy subjects|healthy subjects
5016322|NCT03894930|prosocial|prosocial
5016323|NCT03894930|metta meditation|metta meditation
5016324|NCT03894930|fMRI|fmri
5016325|NCT03894904|Heparin|heparin
5016326|NCT03894904|Papaverine|papaverine
5016327|NCT03894891|Head and Neck Cancer|head and neck cancer
5016328|NCT03894878|Warfarin|warfarin
5016329|NCT03894878|Coumadin|coumadin
5016330|NCT03894878|Pharmacogenomics|pharmacogenomics
5016331|NCT03894878|Pharmacogenetics|pharmacogenetics
5016332|NCT03894878|Adverse Drug Reactions|adverse drug reactions
5016333|NCT03894878|Bleeding/hemorrhaging|bleeding/hemorrhaging
5016334|NCT03894865|scoliosis, prevalence|scoliosis, prevalence
5016338|NCT03894800|metoxyflurane|metoxyflurane
5016339|NCT03894800|pain|pain
5016340|NCT03894800|fentanyl|fentanyl
5016341|NCT03894800|cold pressor test|cold pressor test
5016342|NCT03894787|Ross procedure|ross procedure
5016343|NCT03894787|Conventional aortic valve replacement|conventional aortic valve replacement
5016347|NCT03894761|Pain|pain
5016348|NCT03894761|Shoulder|shoulder
5016349|NCT03894761|Rotator Cuff|rotator cuff
5016350|NCT03894748|Glabella line|glabella line
5016351|NCT03894748|Glabella lines|glabella lines
5016352|NCT03894748|Botulinum Toxin|botulinum toxin
5016353|NCT03894735|Calcium|calcium
5016354|NCT03894735|Magnesium|magnesium
5016355|NCT03894735|Inflammation|inflammation
5016356|NCT03894722|third molar surgery|third molar surgery
5016357|NCT03894722|povidone iodine|povidone iodine
5016358|NCT03894709|older persons|older persons
5016359|NCT03894709|family-centered care model|family-centered care model
5016360|NCT03894709|family caregiver's competence|family caregiver's competence
5016361|NCT03894709|intervention protocol|intervention protocol
5319496|NCT02087358|genetic|genetic
5016362|NCT03894683|Heart failure|heart failure
5016363|NCT03894683|Melatonin|melatonin
5016364|NCT03894683|Muscle wasting|muscle wasting
5016373|NCT03894631|Intraocular Pressure|intraocular pressure
5016374|NCT03894579|natural killer cells|natural killer cells
5016375|NCT03894579|autologous|autologous
5016376|NCT03894566|Clinical Trial Protocol [Publication Type];|clinical trial protocol [publication type];
5031261|NCT03803839|RSA|rsa
5016385|NCT03894527|Endothelial Function|endothelial function
5016386|NCT03894527|Simple Obesity|simple obesity
5016387|NCT03894527|Metabolic Syndrome|metabolic syndrome
5016388|NCT03894501|opioid|opioid
5016389|NCT03894501|chronic pain|chronic pain
5016390|NCT03894501|methadone|methadone
5016391|NCT03894501|mindfulness|mindfulness
5016392|NCT03894475|Asthma|asthma
5016393|NCT03894475|COPD|copd
5016394|NCT03894475|Mobile Spirometry|mobile spirometry
5016395|NCT03894462|Zero Suicide|zero suicide
5016396|NCT03894462|Effectiveness|effectiveness
5016397|NCT03894462|Brief Treatment|brief treatment
5016399|NCT03894462|Cost-Effectiveness|cost-effectiveness
5016401|NCT03894410|Lapatinib|lapatinib
5016402|NCT03894397|(Unilateral) Deep brain stimulation|(unilateral) deep brain stimulation
5016403|NCT03894397|Anxiety|anxiety
5016404|NCT03894397|Mood|mood
5016405|NCT03894384|TFF3|tff3
5016407|NCT03894293|functional performance|functional performance
5016408|NCT03894293|respiratory failure|respiratory failure
5016409|NCT03894293|weaning|weaning
5016410|NCT03894293|mechanical ventilator|mechanical ventilator
5016411|NCT03894293|physical therapy|physical therapy
5016412|NCT03894293|cardiopulmonary physical therapy|cardiopulmonary physical therapy
5016413|NCT03894280|bioequivalence|bioequivalence
5016414|NCT03894280|fluticasone propionate|fluticasone propionate
5016415|NCT03894280|salmeterol xinafoate|salmeterol xinafoate
5016416|NCT03894280|SERETIDE|seretide
5016417|NCT03894280|charcoal blockade|charcoal blockade
5016418|NCT03894241|Sedentary lifestyle|sedentary lifestyle
5016419|NCT03894241|academic performance|academic performance
5016420|NCT03894241|aerobic fitness|aerobic fitness
5016421|NCT03894241|electroencephalogram|electroencephalogram
5016422|NCT03894137|Grains of Paradise|grains of paradise
5016423|NCT03894137|energy metabolism|energy metabolism
5016424|NCT03894137|substrate oxidation|substrate oxidation
5016425|NCT03894111|trauma, mortality|trauma, mortality
5016426|NCT03894098|nerve block|nerve block
5016427|NCT03894085|anxiety disorder|anxiety disorder
5016428|NCT03894085|obsessive-compulsive disorder|obsessive-compulsive disorder
5016429|NCT03894085|neuroimaging|neuroimaging
5016430|NCT03894085|biomarkers|biomarkers
5016431|NCT03894085|treatment response|treatment response
5016432|NCT03894072|High flow oxygen device, HFHO, CPAP, One-lung ventilation|high flow oxygen device, hfho, cpap, one-lung ventilation
5016433|NCT03894059|cardiac arrest|cardiac arrest
5016434|NCT03894059|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
5017818|NCT03885388|ACTD|actd
5016439|NCT03893981|Rehabilitation|rehabilitation
5016440|NCT03893981|Pain|pain
5016441|NCT03893981|Functionality|functionality
5016442|NCT03893981|Proprioception|proprioception
5016443|NCT03893955|Cancer|cancer
5016444|NCT03893955|Advanced Solid Tumors|advanced solid tumors
5016445|NCT03893955|Triple-Negative Breast Cancer (TNBC)|triple-negative breast cancer (tnbc)
5016446|NCT03893955|Non-small-cell-lung-cancer (NSCLC)|non-small-cell-lung-cancer (nsclc)
5016447|NCT03893955|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5016448|NCT03893955|ABBV-927|abbv-927
5016449|NCT03893955|ABBV-368|abbv-368
5016450|NCT03893955|ABBV-181|abbv-181
5016451|NCT03893955|metastatic solid tumors|metastatic solid tumors
5016452|NCT03893955|dose-escalation|dose-escalation
5016453|NCT03893955|recommended phase 2 dose|recommended phase 2 dose
5016454|NCT03893942|Inflammatory Bowel Diseases|inflammatory bowel diseases
5016455|NCT03893942|Mindfulness|mindfulness
5016456|NCT03893942|Psychological predictors|psychological predictors
5016457|NCT03893942|Colorectal surgery|colorectal surgery
5016458|NCT03893890|Edematous Fibrosclerotic Panniculopathy|edematous fibrosclerotic panniculopathy
5016459|NCT03893890|EFP|efp
5016460|NCT03893890|Cellulite|cellulite
5016461|NCT03893864|Coenzyme Q10|coenzyme q10
5016462|NCT03893864|Ubiquinone|ubiquinone
5016463|NCT03893864|Ubiquinol|ubiquinol
5016464|NCT03893864|Oxidative pattern|oxidative pattern
5016465|NCT03893864|Exercise|exercise
5016466|NCT03893851|violence|violence
5016467|NCT03893760|heart Failure|heart failure
5016468|NCT03893760|ventricular elastance|ventricular elastance
5031365|NCT03803254|Lenvatinib|lenvatinib
5016483|NCT03893682|MCL|mcl
5016484|NCT03893682|FL|fl
5016485|NCT03893682|MZL|mzl
5016486|NCT03893682|WM|wm
5016487|NCT03893682|LPL|lpl
5016488|NCT03893682|CLL|cll
5016489|NCT03893682|SLL|sll
5016490|NCT03893656|Living donor nephrectomy|living donor nephrectomy
5016491|NCT03893656|Kindey transplantation|kindey transplantation
5016492|NCT03893656|Retroperitoneoscopic donor nephrectomy|retroperitoneoscopic donor nephrectomy
5016493|NCT03893656|Hernia|hernia
5319605|NCT02086630|HIV|hiv
5333156|NCT02025660|Mw|mw
5016494|NCT03893630|aspirin|aspirin
5016495|NCT03893630|pulsatility index|pulsatility index
5016496|NCT03893630|doppler|doppler
5016497|NCT03893630|uterine|uterine
5016498|NCT03893630|acetylsalicylic acid|acetylsalicylic acid
5016499|NCT03893630|preeclampsia|preeclampsia
5016500|NCT03893630|blood pressure|blood pressure
5016501|NCT03893604|tDCS|tdcs
5016502|NCT03893604|Athlete|athlete
5016507|NCT03893578|Sapien 3|sapien 3
5016508|NCT03893578|cardiovascular disease|cardiovascular disease
5016509|NCT03893578|TMVR|tmvr
5016510|NCT03893578|failing valve|failing valve
5016511|NCT03893578|failing bioprosthetic valve|failing bioprosthetic valve
5016512|NCT03893565|GSK2831781, ulcerative colitis, anti-LAG3 cell|gsk2831781, ulcerative colitis, anti-lag3 cell
5016513|NCT03893565|depleting monoclonal antibody, dose-response|depleting monoclonal antibody, dose-response
5016514|NCT03893552|Negative expiratory pressure, sleep apnea, Snoring, Sleep-disordered breathing|negative expiratory pressure, sleep apnea, snoring, sleep-disordered breathing
5016515|NCT03893526|GLP-1|glp-1
5016516|NCT03893526|Neprilysin|neprilysin
5016517|NCT03893526|Diabetes|diabetes
5016518|NCT03893513|Bio-impedance|bio-impedance
5016519|NCT03893513|Haemodynamic monitoring|haemodynamic monitoring
5016520|NCT03893513|Pulse contour analysis|pulse contour analysis
5016521|NCT03893513|kidney transplantation|kidney transplantation
5016522|NCT03893500|Six minute walk test|six minute walk test
5016523|NCT03893500|Six minute walk distance|six minute walk distance
5016524|NCT03893500|Heart rate recovery|heart rate recovery
5016525|NCT03893500|Mobile health|mobile health
5016527|NCT03893474|nAMD|namd
5016532|NCT03893396|drug eluting stent|drug eluting stent
5016533|NCT03893396|Drug-coated balloon|drug-coated balloon
5016534|NCT03893396|Bare-Metal Stent|bare-metal stent
5016535|NCT03893396|Revascularization|revascularization
5016536|NCT03893383|knowledge attitude practice questionnaire post exposure prophylaxis|knowledge attitude practice questionnaire post exposure prophylaxis
5016537|NCT03893331|Arrhythmia's|arrhythmia's
5016538|NCT03893214|virtual reality exposure therapy|virtual reality exposure therapy
5016539|NCT03893214|waitlist control design|waitlist control design
5016540|NCT03893214|single session exposure|single session exposure
5016541|NCT03893214|emotion-driven behavior|emotion-driven behavior
5016542|NCT03893214|respiration|respiration
5016543|NCT03893201|Endovenous Ablation|endovenous ablation
5016544|NCT03893175|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5016545|NCT03893162|probiotic|probiotic
5016546|NCT03893162|depression|depression
5016547|NCT03893162|microbiome|microbiome
5016548|NCT03893162|bacteria|bacteria
5016549|NCT03893149|Exercise|exercise
5016550|NCT03893149|Prevention|prevention
5016551|NCT03893149|Attention capacity|attention capacity
5016552|NCT03893136|Takayasu arteritis|takayasu arteritis
5016553|NCT03893136|follow-up|follow-up
5016554|NCT03893136|treatment|treatment
5016555|NCT03893136|outcome|outcome
5016556|NCT03893136|pregnancy|pregnancy
5016557|NCT03893136|cohort|cohort
5016558|NCT03893097|Schistosoma|schistosoma
5016559|NCT03893097|Schistosomiasis|schistosomiasis
5016560|NCT03893097|Senegal|senegal
5016561|NCT03893097|Praziquantel|praziquantel
5016562|NCT03893097|Artesunate|artesunate
5016563|NCT03893097|Mefloquine|mefloquine
5016564|NCT03893084|preconception|preconception
5016565|NCT03893084|period|period
5016566|NCT03893084|education|education
5016567|NCT03893084|midwfiery|midwfiery
5016568|NCT03893058|Train-Of-Four|train-of-four
5016569|NCT03893058|Single Fiber Electromyography|single fiber electromyography
5016570|NCT03893058|NeuroMuscular Junction|neuromuscular junction
5016571|NCT03893058|Critical Illness|critical illness
5016572|NCT03893045|IDA|ida
5016573|NCT03893045|anemia|anemia
5016574|NCT03893045|pediatrics|pediatrics
5016575|NCT03893045|ferumoxytol|ferumoxytol
5016576|NCT03893045|iron sucrose|iron sucrose
5031463|NCT03802604|atezolizumab|atezolizumab
5031464|NCT03802604|T-vec|t-vec
5031465|NCT03802604|talimogene laherparepvec|talimogene laherparepvec
5016577|NCT03892980|breast cancer|breast cancer
5016578|NCT03892980|BRCA|brca
5016579|NCT03892980|NSM|nsm
5016580|NCT03892967|SPADE|spade
5016581|NCT03892967|Cancer Control|cancer control
5016588|NCT03892954|MicroRNAs|micrornas
5016589|NCT03892954|Chronic fatigue syndrome|chronic fatigue syndrome
5016590|NCT03892954|Pain intensity|pain intensity
5016591|NCT03892863|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5016592|NCT03892863|depression|depression
5016593|NCT03892863|rTMS|rtms
5016594|NCT03892850|Prescriptions|prescriptions
5016595|NCT03892850|Nurses|nurses
5016596|NCT03892850|Primary Health Care|primary health care
5016597|NCT03892850|Acute Disease|acute disease
5016598|NCT03892837|Platelet-rich plasma|platelet-rich plasma
5016599|NCT03892837|Refractory benign stenosis|refractory benign stenosis
5016601|NCT03892824|Stroke|stroke
5016602|NCT03892824|Filter|filter
5016603|NCT03892824|Emboli|emboli
5016604|NCT03892824|Carotid|carotid
5016605|NCT03892824|OAC|oac
5319698|NCT02086188|Voiding|voiding
5016606|NCT03892798|IRF2BPL|irf2bpl
5016607|NCT03892798|NEDAMSS|nedamss
5016608|NCT03892798|dystonia|dystonia
5016609|NCT03892798|movement disorder|movement disorder
5016610|NCT03892798|seizures|seizures
5016611|NCT03892759|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5016612|NCT03892746|Cervical Spinal Cord Injury|cervical spinal cord injury
5016613|NCT03892746|tDCS|tdcs
5016614|NCT03892746|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5016615|NCT03892746|Upper limb|upper limb
5016616|NCT03892746|Rehabilitation|rehabilitation
5016617|NCT03892746|Brain Stimulation|brain stimulation
5016618|NCT03892707|Low back pain|low back pain
5016619|NCT03892707|Milgamma|milgamma
5016620|NCT03892707|NSAIDs|nsaids
5016621|NCT03892681|HBsAg(+) with chronic hepatitis or cirrhosis|hbsag(+) with chronic hepatitis or cirrhosis
5016622|NCT03892681|anti-HCV(+) with cirrhosis|anti-hcv(+) with cirrhosis
5016623|NCT03892681|cirrhosis of any etiology|cirrhosis of any etiology
5016624|NCT03892655|breast carcinoma|breast carcinoma
5016625|NCT03892655|receptors 2 (HER2)|receptors 2 (her2)
5016626|NCT03892655|biosimilar|biosimilar
5016627|NCT03892655|trastuzumab|trastuzumab
5016628|NCT03892655|Zedora|zedora
5016629|NCT03892642|Intravesical BCG|intravesical bcg
5016630|NCT03892642|Bacille Calmette-Guerin|bacille calmette-guerin
5016631|NCT03892642|avelumab|avelumab
5016632|NCT03892551|risk prediction|risk prediction
5016633|NCT03892551|Electronic triage systems (ETS)|electronic triage systems (ets)
5016634|NCT03892551|undertriage|undertriage
5016635|NCT03892551|overtriage|overtriage
5016636|NCT03892538|Stress|stress
5016637|NCT03892538|Blood pressure|blood pressure
5016638|NCT03892538|Heart rate|heart rate
5016639|NCT03892538|Corticotropin|corticotropin
5016640|NCT03892538|Cortisol|cortisol
5016737|NCT03891875|elamipretide|elamipretide
5016641|NCT03892486|metabolomics, proteomics, PUFA, nutrition|metabolomics, proteomics, pufa, nutrition
5016643|NCT03892473|Community mental health teams|community mental health teams
5016644|NCT03892447|AKI|aki
5016645|NCT03892447|Child|child
5016646|NCT03892447|Alprostadil|alprostadil
5016647|NCT03892447|Sodium Ferulate|sodium ferulate
5016648|NCT03892447|Dopamine|dopamine
5016649|NCT03892395|Healthy ageing|healthy ageing
5016650|NCT03892395|B-vitamins|b-vitamins
5016651|NCT03892395|Bone health|bone health
5016652|NCT03892382|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5016653|NCT03892382|rTMS|rtms
5016654|NCT03892382|apathy|apathy
5016655|NCT03892382|depression|depression
5016656|NCT03892369|Alcohol|alcohol
5016658|NCT03892369|Alcohol dependence|alcohol dependence
5016659|NCT03892356|Concussion, Oculomotor function|concussion, oculomotor function
5016660|NCT03892330|Nephroblastoma|nephroblastoma
5016661|NCT03892330|Anthracycline|anthracycline
5016662|NCT03892330|Liposome doxorubicin|liposome doxorubicin
5016663|NCT03892330|Doxorubicin|doxorubicin
5016664|NCT03892330|Pharmorubicin|pharmorubicin
5016665|NCT03892330|Pirarubicin|pirarubicin
5016666|NCT03892291|mild traumatic brain injury|mild traumatic brain injury
5016667|NCT03892291|dual-task|dual-task
5016668|NCT03892291|veterans|veterans
5016669|NCT03892291|mobility|mobility
5016670|NCT03892278|combined training|combined training
5016671|NCT03892278|aerobic training|aerobic training
5016672|NCT03892278|aquatic exercises|aquatic exercises
5016673|NCT03892278|aging|aging
5016674|NCT03892226|stroke|stroke
5016675|NCT03892226|stroke-heart syndrome|stroke-heart syndrome
5016676|NCT03892226|troponin|troponin
5016677|NCT03892226|myocardial stunning|myocardial stunning
5016678|NCT03892226|acute coronary syndrome|acute coronary syndrome
5016679|NCT03892226|periodic repolarization dynamics|periodic repolarization dynamics
5016680|NCT03892226|cardiac complications|cardiac complications
5016690|NCT03892148|Diuretics|diuretics
5016691|NCT03892148|Diuretic resistance|diuretic resistance
5016692|NCT03892148|Loop diuretics|loop diuretics
5016693|NCT03892148|Furosemide|furosemide
5016694|NCT03892135|Role of parents, children and physician|role of parents, children and physician
5016695|NCT03892135|Qualitative|qualitative
5016696|NCT03892135|Interview|interview
5016697|NCT03892135|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5016698|NCT03892135|Adherence|adherence
5016699|NCT03892135|mechanisms of adherence in juvenile idiopathic arthritis|mechanisms of adherence in juvenile idiopathic arthritis
5016703|NCT03892122|Propofol|propofol
5016704|NCT03892083|Developmental coordination disorder|developmental coordination disorder
5712710|NCT00454662|Elderly|elderly
5016705|NCT03892083|Postural balance|postural balance
5016706|NCT03892083|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5016707|NCT03892083|Children|children
5016708|NCT03892083|Child Development|child development
5016709|NCT03892070|HMB|hmb
5016710|NCT03892070|Physical exercise|physical exercise
5016711|NCT03892057|Hispanics/Latinos|hispanics/latinos
5016712|NCT03892057|Underserved Population|underserved population
5016713|NCT03892057|Internet-based|internet-based
5016714|NCT03892031|brain natriuretic peptide|brain natriuretic peptide
5016715|NCT03892031|pneumoperitoneum|pneumoperitoneum
5016716|NCT03892031|Trendelenburg|trendelenburg
5016717|NCT03892031|circulatory function|circulatory function
5016718|NCT03892031|laparoscopic radical cystectomy for bladder cancer|laparoscopic radical cystectomy for bladder cancer
5016719|NCT03892031|central venous pressure|central venous pressure
5016720|NCT03892031|stroke volume variation|stroke volume variation
5016721|NCT03892031|transthoracic echocardiography|transthoracic echocardiography
5016723|NCT03891953|Non-small Cell Lung Cancer, melanoma, Nasopharyngeal Carcinoma, Microsatellite Stable Colorectal Cancer, Triple Negative Breast Cancer|non-small cell lung cancer, melanoma, nasopharyngeal carcinoma, microsatellite stable colorectal cancer, triple negative breast cancer
5016724|NCT03891927|olive oil|olive oil
5016725|NCT03891927|glycemic control|glycemic control
5016726|NCT03891914|Multiple Myeloma|multiple myeloma
5016727|NCT03891914|PET/CT|pet/ct
5016728|NCT03891914|18F-FDG|18f-fdg
5016729|NCT03891914|18F-FCH|18f-fch
5016730|NCT03891888|Tibial diaphyseal fracture|tibial diaphyseal fracture
5016731|NCT03891888|Nonunion|nonunion
5016732|NCT03891888|Delayed union|delayed union
5016733|NCT03891875|AMD|amd
5016734|NCT03891875|Macular degeneration|macular degeneration
5016735|NCT03891875|non-central geographic atrophy|non-central geographic atrophy
5016736|NCT03891875|MTP-131|mtp-131
5016742|NCT03891849|Haemorrhagic Shock|haemorrhagic shock
5016744|NCT03891771|Activities of daily living|activities of daily living
5016745|NCT03891771|Telemonitoring|telemonitoring
5016746|NCT03891758|Haemophilus influenza type b|haemophilus influenza type b
5016747|NCT03891758|Adsorbed Diphtheria-purified Pertussis-Tetanus- Inactivate poliovirus combined vaccine|adsorbed diphtheria-purified pertussis-tetanus- inactivate poliovirus combined vaccine
5016748|NCT03891758|Hib|hib
5016749|NCT03891758|DPT-IPV|dpt-ipv
5016750|NCT03891732|Prostate cancer|prostate cancer
5016751|NCT03891732|PSA|psa
5016752|NCT03891732|MRI|mri
5016753|NCT03891732|Biopsy|biopsy
5016754|NCT03891719|rhinoplasty|rhinoplasty
5016755|NCT03891719|cleft lip nose|cleft lip nose
5016756|NCT03891719|autologous cartilage graft|autologous cartilage graft
5016757|NCT03891719|asian nose|asian nose
5016758|NCT03891706|TCR-T|tcr-t
5016759|NCT03891693|Stenosis|stenosis
5016760|NCT03891693|Angioplasty|angioplasty
5016761|NCT03891693|Vascular Disease|vascular disease
5016762|NCT03891667|Lyme Disease|lyme disease
5016763|NCT03891667|Post-treatment Lyme Disease Syndrome|post-treatment lyme disease syndrome
5016764|NCT03891667|Disulfiram|disulfiram
5059013|NCT03630120|TKI|tki
5016765|NCT03891667|Chronic Lyme Disease|chronic lyme disease
5016770|NCT03891615|Lung Cancer|lung cancer
5016771|NCT03891602|Smoker|smoker
5016772|NCT03891602|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5016773|NCT03891589|Complementary feeding|complementary feeding
5016774|NCT03891589|Linear Programming|linear programming
5016775|NCT03891589|Nutritional status|nutritional status
5016780|NCT03891576|Primary Peritoneal Cancer|primary peritoneal cancer
5016782|NCT03891576|Recurrent Cancer|recurrent cancer
5016783|NCT03891576|Niraparib|niraparib
5016784|NCT03891576|Thrombocytopenia|thrombocytopenia
5016785|NCT03891576|Neutropenia|neutropenia
5016786|NCT03891576|Anemia|anemia
5016787|NCT03891576|RADAR dosing|radar dosing
5016788|NCT03891576|Maintenance Therapy|maintenance therapy
5016789|NCT03891576|PARP-inhibitor|parp-inhibitor
5016790|NCT03891550|HCV, micro-elimination, DAA|hcv, micro-elimination, daa
5016791|NCT03891537|Bilateral Tubal Ligation|bilateral tubal ligation
5016792|NCT03891537|Postoperative Discomforts|postoperative discomforts
5016793|NCT03891485|Nivolumab|nivolumab
5016794|NCT03891485|CXCR4 antagonist|cxcr4 antagonist
5016795|NCT03891485|mRCC|mrcc
5016796|NCT03891485|Tregs-NKs|tregs-nks
5016797|NCT03891472|mFOLFIRINOX|mfolfirinox
5016798|NCT03891472|SBRT|sbrt
5016799|NCT03891472|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
5016800|NCT03891459|social placebo effect|social placebo effect
5016801|NCT03891459|fMRI|fmri
5016802|NCT03891459|neural account|neural account
5016803|NCT03891433|adult|adult
5016804|NCT03891433|Equivalence Trial|equivalence trial
5016805|NCT03891433|Randomized Controlled Trial|randomized controlled trial
5016807|NCT03891433|Anti-Bacterial Agents/therapeutic use*|anti-bacterial agents/therapeutic use*
5016808|NCT03891433|Meropenem|meropenem
5016809|NCT03891433|Ertapenem|ertapenem
5712799|NCT00454376|insulinoma|insulinoma
5016810|NCT03891433|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination
5016811|NCT03891433|Escherichia coli Infections/drug therapy|escherichia coli infections/drug therapy
5016812|NCT03891433|Klebsiella Infections/drug therapy|klebsiella infections/drug therapy
5016813|NCT03891368|Learning collaborative|learning collaborative
5016814|NCT03891368|Technical assistance|technical assistance
5016815|NCT03891368|Serious mental illness|serious mental illness
5016816|NCT03891368|Organizational change|organizational change
5016817|NCT03891368|InSHAPE|inshape
5016818|NCT03891355|Carfilzomib|carfilzomib
5016819|NCT03891355|Lenalidomide|lenalidomide
5016820|NCT03891355|Dexamethasone|dexamethasone
5016821|NCT03891355|relapsed-refractory or intolerant mantle cell lymphomas|relapsed-refractory or intolerant mantle cell lymphomas
5016822|NCT03891303|Aorta, abdominal|aorta, abdominal
5333405|NCT02024711|IOL|iol
5016823|NCT03891303|Intraoperative blood salvage|intraoperative blood salvage
5016824|NCT03891303|Elective surgical procedures|elective surgical procedures
5016825|NCT03891303|Patient outcomes assessment|patient outcomes assessment
5016826|NCT03891277|Vascular Cognitive Impairment|vascular cognitive impairment
5016827|NCT03891277|dementia|dementia
5016828|NCT03891277|iron deficiency|iron deficiency
5016829|NCT03891277|cerebral infarction|cerebral infarction
5016831|NCT03891277|biological markers|biological markers
5016832|NCT03891277|Clinical Trial|clinical trial
5016833|NCT03891238|unfit for cisplatin|unfit for cisplatin
5016834|NCT03891238|PD-L1|pd-l1
5016839|NCT03891199|clinical trial|clinical trial
5016840|NCT03891199|randomization|randomization
5016841|NCT03891199|hip arthroplasty|hip arthroplasty
5016842|NCT03891186|schizophrenia|schizophrenia
5016843|NCT03891186|metacognitive training|metacognitive training
5016844|NCT03891186|insight|insight
5016845|NCT03891186|positive symptoms|positive symptoms
5016846|NCT03891186|functioning|functioning
5016847|NCT03891173|lung adenocarcinoma|lung adenocarcinoma
5016848|NCT03891173|immunoconjugate|immunoconjugate
5016849|NCT03891173|tumor microenvironment alkalinization|tumor microenvironment alkalinization
5016850|NCT03891147|symptomatic gallstone diseases|symptomatic gallstone diseases
5016851|NCT03891147|electro-acupuncture|electro-acupuncture
5016852|NCT03891121|Myofascial Pain|myofascial pain
5016853|NCT03891121|Botulinum Toxin|botulinum toxin
5016854|NCT03891095|intranasal oxytocin|intranasal oxytocin
5016855|NCT03891095|L-DOPA|l-dopa
5016856|NCT03891095|Vicarious optimism|vicarious optimism
5016857|NCT03891069|Parkinson's disease|parkinson's disease
5016858|NCT03891069|Exergames|exergames
5016859|NCT03891069|Virtual reality|virtual reality
5016860|NCT03891069|Exercise|exercise
5016861|NCT03891069|Feasibility study|feasibility study
5016862|NCT03891056|Diabetes Mellitus|diabetes mellitus
5016863|NCT03891056|Metabolic Surgery|metabolic surgery
5016864|NCT03891056|BMI 30-35|bmi 30-35
5016865|NCT03891056|BPGY|bpgy
5016866|NCT03891056|Vertical Gastrectomy|vertical gastrectomy
5016867|NCT03890991|Intervention|intervention
5016868|NCT03890991|Self-efficacy|self-efficacy
5016869|NCT03890991|Diabetes Self-care Activities|diabetes self-care activities
5016870|NCT03890991|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
5011505|NCT03924388|Transcutaneous Spinal Cord Stimulation|transcutaneous spinal cord stimulation
5011506|NCT03924388|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
5011507|NCT03924388|Orthostatic Hypotension|orthostatic hypotension
5016871|NCT03890991|Diabetes|diabetes
5016872|NCT03890991|Community|community
5016873|NCT03890991|Older people with diabetes|older people with diabetes
5016874|NCT03890978|exclusive, breastfeeding, text messages, Jordan|exclusive, breastfeeding, text messages, jordan
5016875|NCT03890965|stroke|stroke
5016876|NCT03890965|Physical therapy|physical therapy
5016877|NCT03890965|neurological hand|neurological hand
5016878|NCT03890965|Vojta therapy|vojta therapy
5016879|NCT03890939|Sleep Apnea, Mixed|sleep apnea, mixed
5016880|NCT03890939|Sleep Apnea Device|sleep apnea device
5016881|NCT03890939|BiPap device|bipap device
5016882|NCT03890939|Sleep Study|sleep study
5016883|NCT03890926|Three-Dimensional Printing|three-dimensional printing
5016884|NCT03890926|Rectum Cancer, Recurrent|rectum cancer, recurrent
5016885|NCT03890926|Radioactive Iodine-125 seed implantation|radioactive iodine-125 seed implantation
5016886|NCT03890874|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5016887|NCT03890874|Teaching techniques|teaching techniques
5016888|NCT03890874|Basic Life Support training|basic life support training
5016889|NCT03890874|Simulation|simulation
5016890|NCT03890861|African American|african american
5016891|NCT03890861|Aging|aging
5016892|NCT03890861|Physical activity|physical activity
5016893|NCT03890861|Cognition|cognition
5016894|NCT03890861|Prevention|prevention
5016895|NCT03890848|functional exercise|functional exercise
5016896|NCT03890848|health belief model|health belief model
5016897|NCT03890835|Pulpotomy|pulpotomy
5428226|NCT01595581|Testosterone|testosterone
5016908|NCT03890640|Thoracic epidural catheter insertion|thoracic epidural catheter insertion
5016910|NCT03890614|3D organoid technique|3d organoid technique
5016911|NCT03890588|Chronic Kidney Disease|chronic kidney disease
5016913|NCT03890588|Clinical Decision Support|clinical decision support
5016914|NCT03890588|Diabetes|diabetes
5016915|NCT03890588|Hypertension|hypertension
5016916|NCT03890575|3D printed|3d printed
5016917|NCT03890575|airway stent|airway stent
5016918|NCT03890575|carina|carina
5016919|NCT03890575|distal bronchi|distal bronchi
5016920|NCT03890562|acupressure|acupressure
5016921|NCT03890549|obstructive sleep apnea|obstructive sleep apnea
5016922|NCT03890549|polysomnography|polysomnography
5016923|NCT03890549|smart phone application|smart phone application
5016924|NCT03890536|Microbiome|microbiome
5016925|NCT03890523|3D printed|3d printed
5016926|NCT03890523|airway stent|airway stent
5016927|NCT03890523|carina|carina
5016928|NCT03890523|distal bronchi|distal bronchi
5016938|NCT03890484|Multimethod|multimethod
5016939|NCT03890458|vitamin D|vitamin d
5333507|NCT02024269|stem cells|stem cells
5016940|NCT03890458|vitamin D supplementation|vitamin d supplementation
5016941|NCT03890458|infertility|infertility
5016942|NCT03890458|D vitamin deficiency|d vitamin deficiency
5016943|NCT03890458|infertile women|infertile women
5016944|NCT03890458|embryo transfer|embryo transfer
5016945|NCT03890458|pregnancy rate|pregnancy rate
5016946|NCT03890445|Crohn´s Disease|crohn´s disease
5016947|NCT03890445|Inflammatory Bowel Disease|inflammatory bowel disease
5016948|NCT03890445|Adalimumab|adalimumab
5016949|NCT03890445|Infliximab|infliximab
5016950|NCT03890445|Biosimilar|biosimilar
5016951|NCT03890445|IBD-Index|ibd-index
5016952|NCT03890432|Nutrition management|nutrition management
5016953|NCT03890432|Glycaemia control|glycaemia control
5016954|NCT03890432|ICU|icu
5016955|NCT03890432|Software|software
5016956|NCT03890432|Critical illness|critical illness
5016957|NCT03890432|Insulin-therapy|insulin-therapy
5016958|NCT03890432|Critically ill patients|critically ill patients
5016959|NCT03890432|Blood glucose control|blood glucose control
5016960|NCT03890419|Acute Pain|acute pain
5016961|NCT03890419|Chronic Pain|chronic pain
5016962|NCT03890419|Opioid Use|opioid use
5016963|NCT03890419|Pain|pain
5016964|NCT03890406|Deep neuromuscular blockade|deep neuromuscular blockade
5016965|NCT03890289|Idelalisib|idelalisib
5016966|NCT03890289|Obinutuzumab|obinutuzumab
5016967|NCT03890289|Relapsed/Refractory Follicular Lymphoma|relapsed/refractory follicular lymphoma
5016968|NCT03890276|labor|labor
5016969|NCT03890276|birth|birth
5016970|NCT03890276|routine care|routine care
5016971|NCT03890276|midwifery|midwifery
5059277|NCT03628365|ICU|icu
5016972|NCT03890276|Zanzibar|zanzibar
5016973|NCT03890276|Sub-Saharan Africa|sub-saharan africa
5016974|NCT03890276|training|training
5016975|NCT03890276|skilled birth attendant|skilled birth attendant
5016976|NCT03890276|competency|competency
5016977|NCT03890276|simulation|simulation
5016978|NCT03890276|video|video
5016979|NCT03890250|pulmonary rehabilitation|pulmonary rehabilitation
5016980|NCT03890250|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5016982|NCT03890211|Hypothermia|hypothermia
5016983|NCT03890211|Infant Warmer|infant warmer
5016984|NCT03890198|Gastric cancer|gastric cancer
5016985|NCT03890198|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
5016986|NCT03890172|platelets rich plasma|platelets rich plasma
5016987|NCT03890146|intensive care|intensive care
5016988|NCT03890146|capillary sampling|capillary sampling
5016989|NCT03890146|veinous sampling|veinous sampling
5016990|NCT03890146|natremia|natremia
5016991|NCT03890146|kalaemia|kalaemia
5016992|NCT03890146|Chloremia|chloremia
5016993|NCT03890133|Fibromyalgia|fibromyalgia
5016994|NCT03890133|Ba-Duan-Jin|ba-duan-jin
5016995|NCT03890133|Gut microbiota|gut microbiota
5016996|NCT03890133|Mechanism|mechanism
5016997|NCT03890107|Ear Infection|ear infection
5017012|NCT03890029|Resilience|resilience
5017013|NCT03890016|Modified Lee and White Method|modified lee and white method
5017014|NCT03890016|20'WBCT|20'wbct
5017015|NCT03890016|Whole Blood Clotting Test|whole blood clotting test
5017016|NCT03889990|pulmonary function|pulmonary function
5017017|NCT03889990|IQOS|iqos
5017018|NCT03889990|heated tobacco|heated tobacco
5017019|NCT03889964|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5017020|NCT03889964|cardiovascular comorbidities|cardiovascular comorbidities
5017021|NCT03889964|cardiopulmonary interaction|cardiopulmonary interaction
5017024|NCT03889899|Squamous Cell Carcinoma|squamous cell carcinoma
5017026|NCT03889899|Skin Cancer|skin cancer
5017027|NCT03889899|Skin metastasis|skin metastasis
5017028|NCT03889899|HNSCC|hnscc
5017029|NCT03889899|Carcinoma, Squamous|carcinoma, squamous
5017031|NCT03889899|Basal cell carcinoma|basal cell carcinoma
5017032|NCT03889899|Superficial sarcoma|superficial sarcoma
5017033|NCT03889899|Kaposi sarcoma|kaposi sarcoma
5017034|NCT03889899|Alpha radiation|alpha radiation
5017035|NCT03889899|Cutaneous lesion|cutaneous lesion
5017036|NCT03889899|Tongue cancer|tongue cancer
5017038|NCT03889873|Drinking identity|drinking identity
5017039|NCT03889873|Hazardous drinking|hazardous drinking
5017040|NCT03889873|Social networks|social networks
5017041|NCT03889873|Self-efficacy|self-efficacy
5017042|NCT03889873|Alcohol craving|alcohol craving
5017043|NCT03889873|Cognitive control|cognitive control
5017044|NCT03889873|Narrative writing|narrative writing
5017045|NCT03889847|Fiberoptic intubation|fiberoptic intubation
5017046|NCT03889847|double lumen tube|double lumen tube
5017047|NCT03889834|autologous transfusion|autologous transfusion
5017048|NCT03889834|doping|doping
5017049|NCT03889834|blood markers|blood markers
5017050|NCT03889834|detection|detection
5017051|NCT03889795|Pancreatic|pancreatic
5017052|NCT03889795|Solid Tumor|solid tumor
5017053|NCT03889795|Advanced Pancreatic Cancer|advanced pancreatic cancer
5017054|NCT03889795|Dose Escalation|dose escalation
5017055|NCT03889795|Maximum Tolerated Dose|maximum tolerated dose
5017056|NCT03889756|depression, ketamine|depression, ketamine
5017057|NCT03889743|Respiratory Sounds|respiratory sounds
5017058|NCT03889743|Steroids|steroids
5017059|NCT03889743|Rhinovirus|rhinovirus
5017060|NCT03889730|Coronary Artery Bypass, Off-Pump|coronary artery bypass, off-pump
5017061|NCT03889730|Intraoperative Hypotension|intraoperative hypotension
5017062|NCT03889730|Acute Kidney Injury|acute kidney injury
5017063|NCT03889678|Color flow Doppler|color flow doppler
5017064|NCT03889678|infiltration|infiltration
5017065|NCT03889678|extravasation|extravasation
5017066|NCT03889678|peripheral intravenous catheters|peripheral intravenous catheters
5017067|NCT03889678|general anesthesia|general anesthesia
5017068|NCT03889652|Retinal nerve fiber layer (RNFL)|retinal nerve fiber layer (rnfl)
5017069|NCT03889652|Ganglion cell complex (GCC)|ganglion cell complex (gcc)
5017070|NCT03889652|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5017071|NCT03889652|Primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
5017072|NCT03889652|Cataract|cataract
5017073|NCT03889626|Capecitabine|capecitabine
5017074|NCT03889626|Apatinib|apatinib
5017075|NCT03889626|Maintenance Treatment|maintenance treatment
5017076|NCT03889626|Advance Gastric Cancer|advance gastric cancer
5017077|NCT03889600|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5017078|NCT03889600|Social determinants|social determinants
5017079|NCT03889600|Readmission|readmission
5017080|NCT03889587|Jaw reconstruction|jaw reconstruction
5017081|NCT03889587|Innervation|innervation
5017082|NCT03889587|Bone resorption|bone resorption
5017087|NCT03889561|Sugar-sweetened beverages|sugar-sweetened beverages
5017088|NCT03889535|primary maxillary incisors|primary maxillary incisors
5017090|NCT03889535|bonded composite resin strip crowns|bonded composite resin strip crowns
5017091|NCT03889535|zirconia crowns|zirconia crowns
5017092|NCT03889535|one-year survival|one-year survival
5017093|NCT03889509|systemic sclerosis|systemic sclerosis
5017094|NCT03889509|scleroderma|scleroderma
5017095|NCT03889509|pulmonary hypertension|pulmonary hypertension
5017096|NCT03889509|pulmonary arterial hypertension|pulmonary arterial hypertension
5329374|NCT02043080|UNC|unc
5017097|NCT03889496|exendin-4|exendin-4
5017098|NCT03889496|GLP-1 receptor imaging|glp-1 receptor imaging
5017099|NCT03889496|SPECT|spect
5017100|NCT03889496|pancreas|pancreas
5017101|NCT03889496|surgery|surgery
5017102|NCT03889496|quantification|quantification
5017103|NCT03889470|transradial catheterisation|transradial catheterisation
5017104|NCT03889470|radial artery spasm|radial artery spasm
5017105|NCT03889457|Deep Vein Thrombosis|deep vein thrombosis
5017106|NCT03889457|Superficial Vein Thrombosis|superficial vein thrombosis
5017107|NCT03889457|Anticoagulant|anticoagulant
5017108|NCT03889457|Patient Compliance|patient compliance
5017109|NCT03889457|Preference|preference
5017110|NCT03889457|Venous Thrombosis|venous thrombosis
5017111|NCT03889457|pulmonary embolism|pulmonary embolism
5017112|NCT03889379|albuterol|albuterol
5017113|NCT03889379|immune cells|immune cells
5017114|NCT03889379|immune cell composition|immune cell composition
5017115|NCT03889340|resuscitation|resuscitation
5017116|NCT03889340|cardiac arrest|cardiac arrest
5017117|NCT03889340|coma|coma
5017118|NCT03889327|Perceived Cognitive Impairment|perceived cognitive impairment
5017119|NCT03889327|Neuropsychology|neuropsychology
5017120|NCT03889314|Statin Therapy|statin therapy
5017121|NCT03889314|Prevention|prevention
5017122|NCT03889314|High ASCVD Risk|high ascvd risk
5017123|NCT03889288|pain treatment|pain treatment
5017124|NCT03889288|intensive care|intensive care
5017125|NCT03889288|cardiology|cardiology
5017126|NCT03889288|medical device|medical device
5017127|NCT03889275|solid tumors|solid tumors
5017128|NCT03889275|immunotherapy|immunotherapy
5017129|NCT03889275|oncolytic virus|oncolytic virus
5017130|NCT03889275|NDV-GMCSF|ndv-gmcsf
5017131|NCT03889262|Cerebral Palsy|cerebral palsy
5017132|NCT03889262|Physiotherapy and Rehabilitation|physiotherapy and rehabilitation
5017133|NCT03889262|Hippotherapy|hippotherapy
5017134|NCT03889262|Balance|balance
5017141|NCT03889197|Postnatal Growth Disorder|postnatal growth disorder
5017142|NCT03889197|Growth and development|growth and development
5017143|NCT03889184|meals-on-wheels|meals-on-wheels
5017144|NCT03889184|home-dwelling older people|home-dwelling older people
5017145|NCT03889171|genetic testing|genetic testing
5017147|NCT03889171|genes BRCA2|genes brca2
5017148|NCT03889171|mutation|mutation
5017149|NCT03889171|family|family
5017150|NCT03889171|disclosure|disclosure
5017151|NCT03889171|psychology|psychology
5017152|NCT03889171|DNA mismatch repair|dna mismatch repair
5017153|NCT03889171|genetic predisposition to disease|genetic predisposition to disease
5017154|NCT03889171|cancer|cancer
5017155|NCT03889171|oncology|oncology
5017156|NCT03889158|Cardiorespiratory Fitness|cardiorespiratory fitness
5017157|NCT03889158|Endothelial Function|endothelial function
5017158|NCT03889158|Oxidative Stress|oxidative stress
5017159|NCT03889132|Obesity|obesity
5017160|NCT03889132|Continous Glucose Monitoring|continous glucose monitoring
5017161|NCT03889132|Cognition|cognition
5017162|NCT03889132|Brain Iron content|brain iron content
5017163|NCT03889093|peripheral blood monocytes|peripheral blood monocytes
5017164|NCT03889093|cytokine|cytokine
5017165|NCT03889080|functional MRI|functional mri
5017166|NCT03889080|fMRI|fmri
5017167|NCT03889080|pain|pain
5017175|NCT03889002|Intellectual disabilities|intellectual disabilities
5017176|NCT03889002|Health indicators|health indicators
5017177|NCT03889002|Functioning|functioning
5017178|NCT03889002|Health care services|health care services
5017179|NCT03888989|Influenza|influenza
5017180|NCT03888989|Pregnancy|pregnancy
5017181|NCT03888989|Quadrivalent inactivated influenza vaccine (IIV).|quadrivalent inactivated influenza vaccine (iiv).
5017182|NCT03888976|Cholecystoduodenal fistula|cholecystoduodenal fistula
5017183|NCT03888976|Gallbladder|gallbladder
5017184|NCT03888924|BCG Vaccine|bcg vaccine
5017185|NCT03888924|Radiologically Isolated Syndrome|radiologically isolated syndrome
5017186|NCT03888911|Flaxseed mucilage|flaxseed mucilage
5017187|NCT03888911|Weight loss|weight loss
5017188|NCT03888911|Satiety|satiety
5017191|NCT03888898|public health emergency|public health emergency
5011841|NCT03922399|burn scar|burn scar
5011842|NCT03922399|laser|laser
5011843|NCT03922399|ultrapulse|ultrapulse
5011844|NCT03922360|Nicotine Dependence|nicotine dependence
5017192|NCT03888898|healthcare workers|healthcare workers
5017193|NCT03888898|occupational health|occupational health
5017194|NCT03888898|respiratory protection program|respiratory protection program
5017195|NCT03888898|personal protective equipment|personal protective equipment
5017196|NCT03888898|airborne transmissible pathogens|airborne transmissible pathogens
5017197|NCT03888898|reusable respirator|reusable respirator
5017198|NCT03888885|Physical Education|physical education
5017199|NCT03888885|Sport Education|sport education
5017200|NCT03888885|Physical Literacy|physical literacy
5017204|NCT03888807|Topical Analgesic|topical analgesic
5017205|NCT03888768|intravenous iron isomaltoside(monofer)|intravenous iron isomaltoside(monofer)
5017208|NCT03888768|patient blood management|patient blood management
5017209|NCT03888729|Hepatitis C|hepatitis c
5017210|NCT03888729|direct-acting antiviral|direct-acting antiviral
5017211|NCT03888729|Rwanda|rwanda
5017212|NCT03888716|Mitochondrial Diseases|mitochondrial diseases
5017213|NCT03888716|Mitochondrial Respiratory Chain Deficiencies|mitochondrial respiratory chain deficiencies
5017214|NCT03888716|MELAS Syndrome|melas syndrome
5017215|NCT03888716|Mitochondrial Myopathies|mitochondrial myopathies
5017216|NCT03888716|Kearns-Sayre Syndrome|kearns-sayre syndrome
5017217|NCT03888716|Ophthalmoplegia, Chronic Progressive External|ophthalmoplegia, chronic progressive external
5017218|NCT03888703|early laser intervention|early laser intervention
5017219|NCT03888703|scar prevention|scar prevention
5017220|NCT03888703|laser resurfacing|laser resurfacing
5017221|NCT03888703|wound healing|wound healing
5017222|NCT03888690|Children|children
5017223|NCT03888690|Adolescent|adolescent
5017224|NCT03888690|non pharmacological interventions|non pharmacological interventions
5017225|NCT03888690|onco-hematologic|onco-hematologic
5017226|NCT03888677|Breast Cancer|breast cancer
5017227|NCT03888625|macular holes|macular holes
5017228|NCT03888612|Metastatic Prostate Cancer|metastatic prostate cancer
5017234|NCT03888573|Stretching, Traction Decompression|stretching, traction decompression
5017235|NCT03888560|micro-osteperforation|micro-osteperforation
5017236|NCT03888560|orthodontic tooth movement|orthodontic tooth movement
5017237|NCT03888560|treatment duration|treatment duration
5017238|NCT03888547|occupational therapy|occupational therapy
5017240|NCT03888547|wellness|wellness
5017242|NCT03888521|Relief|relief
5017243|NCT03888482|Visual acuity|visual acuity
5017244|NCT03888482|VA|va
5017245|NCT03888482|Daily disposable contact lenses|daily disposable contact lenses
5017246|NCT03888469|Visual acuity|visual acuity
5017247|NCT03888469|VA|va
5017248|NCT03888469|Daily disposable contact lenses|daily disposable contact lenses
5017249|NCT03888443|Unilateral cerebral palsy|unilateral cerebral palsy
5017250|NCT03888443|three-dimensional movement analysis|three-dimensional movement analysis
5017251|NCT03888443|upper limb|upper limb
5017252|NCT03888443|bimanual task|bimanual task
5017253|NCT03888443|bimanual performance|bimanual performance
5017254|NCT03888430|Transcutaneous PCO2|transcutaneous pco2
5017255|NCT03888430|Preoxygenation|preoxygenation
5017256|NCT03888430|Post-intubation hypotension|post-intubation hypotension
5017257|NCT03888430|ICU|icu
5017258|NCT03888417|TPE|tpe
5017259|NCT03888417|therapeutic plasma exchange|therapeutic plasma exchange
5017260|NCT03888417|Side Effects|side effects
5017261|NCT03888404|Unintended Pregnancy|unintended pregnancy
5017262|NCT03888404|Unintended Birth|unintended birth
5017263|NCT03888404|Pregnancy Preferences|pregnancy preferences
5017264|NCT03888404|Pregnancy Desires|pregnancy desires
5017265|NCT03888404|Prenatal Care|prenatal care
5017266|NCT03888404|Abortion|abortion
5017267|NCT03888404|Adoption|adoption
5017268|NCT03888404|Pregnancy Decision-Making|pregnancy decision-making
5017269|NCT03888404|Mental Health|mental health
5017270|NCT03888404|Stress|stress
5017271|NCT03888404|Socioeconomic Status|socioeconomic status
5017272|NCT03888404|Education|education
5017273|NCT03888391|ADHD|adhd
5017274|NCT03888391|neuromodulation|neuromodulation
5017275|NCT03888391|trigeminal nerve stimulation|trigeminal nerve stimulation
5017276|NCT03888378|Minocycline Topical|minocycline topical
5017277|NCT03888378|Tetracycline|tetracycline
5017278|NCT03888378|Doxycycline|doxycycline
5017280|NCT03888378|Meibomian Gland Disorder|meibomian gland disorder
5017281|NCT03888378|Anti-Bacterial Agent|anti-bacterial agent
5017282|NCT03888378|Anti-imflammatory Agent|anti-imflammatory agent
5017283|NCT03888378|Minocycline|minocycline
5017284|NCT03888365|Hypertension|hypertension
5939748|NCT01005745|adoptive cell therapy|adoptive cell therapy
5939749|NCT01005745|tumor-infiltrating lymphocytes (TIL)|tumor-infiltrating lymphocytes (til)
5017285|NCT03888365|Treprostinil|treprostinil
5017286|NCT03888365|Pulmonary Hypertension|pulmonary hypertension
5017287|NCT03888365|Lung Diseases|lung diseases
5017288|NCT03888326|Robotic Rehabilitation|robotic rehabilitation
5017300|NCT03888235|Sacroiliac Instability|sacroiliac instability
5017301|NCT03888235|Sacroiliac Strain|sacroiliac strain
5017302|NCT03888235|Hypermobility|hypermobility
5017303|NCT03888235|sacroiliac sprain|sacroiliac sprain
5017304|NCT03888209|tDCS|tdcs
5017305|NCT03888209|WMFT|wmft
5017306|NCT03888209|Semmes Weinstein|semmes weinstein
5017307|NCT03888209|Acute stroke|acute stroke
5017308|NCT03888196|Panax|panax
5017309|NCT03888196|Lipid Metabolism|lipid metabolism
5017310|NCT03888196|Sport Performance|sport performance
5017317|NCT03888170|Myogenic Tone|myogenic tone
5017318|NCT03888170|Vascular Reactivity|vascular reactivity
5017319|NCT03888170|Vascular Remodeling|vascular remodeling
5017320|NCT03888131|Lung functions|lung functions
5017321|NCT03888131|COPD|copd
5017322|NCT03888118|Luna EMG|luna emg
5017323|NCT03888118|drop foot|drop foot
5017324|NCT03888118|chronic stroke|chronic stroke
5017345|NCT03888066|potassium|potassium
5017346|NCT03888066|spironolactone|spironolactone
5017347|NCT03888066|heart failure|heart failure
5017348|NCT03888066|Renin Angiotensin-Aldosterone System Inhibitor (RAASi)|renin angiotensin-aldosterone system inhibitor (raasi)
5017349|NCT03888066|RAASi|raasi
5017350|NCT03888066|high potassium|high potassium
5017351|NCT03888066|eplerenone|eplerenone
5017353|NCT03888040|Aging|aging
5017354|NCT03888040|Fatigue|fatigue
5017355|NCT03888040|Resistance training|resistance training
5017356|NCT03888040|Skeletal Muscle|skeletal muscle
5017357|NCT03888040|Knee extensor muscles|knee extensor muscles
5017358|NCT03888040|limb power|limb power
5017359|NCT03887988|Fracture fixation|fracture fixation
5017360|NCT03887988|Orbital implant|orbital implant
5017361|NCT03887988|Midface fracture|midface fracture
5017362|NCT03887988|Diplopia|diplopia
5017363|NCT03887962|Motor Neglect|motor neglect
5017368|NCT03887910|Postpartum Nurse Home Visitation|postpartum nurse home visitation
5017369|NCT03887910|Infant Emergency Medical Care Presentations|infant emergency medical care presentations
5017370|NCT03887910|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
5017371|NCT03887910|Parent-Child Relationship Quality|parent-child relationship quality
5017372|NCT03887910|Family Connections to Community Resources|family connections to community resources
5017373|NCT03887910|Child Development and Milestone Achievement|child development and milestone achievement
5017374|NCT03887910|Maternal Mental Health|maternal mental health
5017375|NCT03887910|Child Abuse|child abuse
5017376|NCT03887910|Child Neglect|child neglect
5017377|NCT03887910|Child Well-Care Compliance|child well-care compliance
5017378|NCT03887910|Mother Well-Care Compliance|mother well-care compliance
5017379|NCT03887897|First-pass; first attempt;intubation success|first-pass; first attempt;intubation success
5017380|NCT03887845|postoperative ileus|postoperative ileus
5017381|NCT03887845|prospective study|prospective study
5017382|NCT03887845|case-control|case-control
5017383|NCT03887845|open surgery|open surgery
5017384|NCT03887845|laparoscopic surgery|laparoscopic surgery
5017385|NCT03887845|bowel recovery|bowel recovery
5017386|NCT03887845|intestinal recovery|intestinal recovery
5017387|NCT03887845|gut recovery|gut recovery
5017388|NCT03887832|child development|child development
5017389|NCT03887832|maternal empathy|maternal empathy
5017390|NCT03887832|digital media-based pediatric intervention|digital media-based pediatric intervention
5017391|NCT03887832|small moments, big impact (SMBI)|small moments, big impact (smbi)
5017392|NCT03887806|Venous|venous
5017393|NCT03887806|Thromboembolic|thromboembolic
5017394|NCT03887806|Direct Oral Anticoagulants|direct oral anticoagulants
5017395|NCT03887806|AOD|aod
5017396|NCT03887806|Cost analysis|cost analysis
5017397|NCT03887806|REMOTEV|remotev
5017398|NCT03887806|AVK|avk
5032270|NCT03797404|Severe|severe
5017399|NCT03887806|Pulmonary embolism|pulmonary embolism
5017405|NCT03887754|Autism|autism
5017406|NCT03887754|Childhood Autism Rating Scale|childhood autism rating scale
5017407|NCT03887754|Hyperbaric oxygen|hyperbaric oxygen
5017408|NCT03887754|Risperidone|risperidone
5017409|NCT03887728|progesterone|progesterone
5017410|NCT03887728|endometrium|endometrium
5017411|NCT03887728|blood flow|blood flow
5017412|NCT03887728|estradiol|estradiol
5017416|NCT03887676|ASD|asd
5017417|NCT03887676|Autism|autism
5017418|NCT03887663|Motor symptoms|motor symptoms
5017419|NCT03887663|Nonmotor symptoms|nonmotor symptoms
5017420|NCT03887663|Chinese longitudinal cohort|chinese longitudinal cohort
5017421|NCT03887663|Natural history|natural history
5017422|NCT03887650|Brachial Plexus|brachial plexus
5017423|NCT03887650|Liposomal Bupivacaine|liposomal bupivacaine
5017424|NCT03887650|Dexamethasone|dexamethasone
5017425|NCT03887650|Interscalene|interscalene
5017426|NCT03887650|Bupivacaine|bupivacaine
5017427|NCT03887650|Shoulder Arthroplasty|shoulder arthroplasty
5017428|NCT03887650|Regional anesthesia|regional anesthesia
5012065|NCT03920722|MPA|mpa
5017429|NCT03887650|Exparel|exparel
5017433|NCT03887598|Artificial Intelligence; Ultrasound; Breast nodule; ECI|artificial intelligence; ultrasound; breast nodule; eci
5017435|NCT03887546|Multiple sclerosis|multiple sclerosis
5017437|NCT03887546|Respiration|respiration
5017438|NCT03887546|Breathing exercise|breathing exercise
5017439|NCT03887546|Fatigue|fatigue
5019456|NCT03875417|HCC|hcc
5017449|NCT03887481|working memory|working memory
5017450|NCT03887481|semantic short-term memory|semantic short-term memory
5017451|NCT03887481|non-fluent variant|non-fluent variant
5017452|NCT03887481|logopenic variant|logopenic variant
5017453|NCT03887481|semantic variant|semantic variant
5017454|NCT03887481|primary progressive aphasia|primary progressive aphasia
5017455|NCT03887468|dialysis adequacy|dialysis adequacy
5017456|NCT03887468|clotting|clotting
5017457|NCT03887455|BAN2401|ban2401
5017458|NCT03887455|Clinical Dementia Rating-Sum of Boxes|clinical dementia rating-sum of boxes
5017459|NCT03887455|Mild cognitive impairment|mild cognitive impairment
5017460|NCT03887455|Alzheimer's disease/prodromal Alzheimer's disease|alzheimer's disease/prodromal alzheimer's disease
5017461|NCT03887455|Mild Alzheimer's disease dementia|mild alzheimer's disease dementia
5017462|NCT03887455|Clarity AD|clarity ad
5017463|NCT03887442|Head and Neck Cancer|head and neck cancer
5017464|NCT03887442|Cetuximab|cetuximab
5017465|NCT03887442|Erbitux|erbitux
5017466|NCT03887442|Paclitaxel|paclitaxel
5017467|NCT03887442|Extreme|extreme
5017468|NCT03887442|Metastatic|metastatic
5017469|NCT03887442|Recurrent|recurrent
5017470|NCT03887429|Promentis Pharmaceuticals|promentis pharmaceuticals
5017471|NCT03887429|SXC-2023|sxc-2023
5017472|NCT03887416|Nighttime blood pressure|nighttime blood pressure
5017473|NCT03887416|Dapagliflozin|dapagliflozin
5017474|NCT03887390|Depression|depression
5017475|NCT03887390|Decision Aid|decision aid
5017476|NCT03887390|Shared Decision Making|shared decision making
5017477|NCT03887390|Primary Care|primary care
5017478|NCT03887390|Comparative Effectiveness Research|comparative effectiveness research
5017479|NCT03887377|macromastia|macromastia
5017480|NCT03887377|botulinum toxin|botulinum toxin
5017481|NCT03887377|scar prevention|scar prevention
5017482|NCT03887377|scar formation|scar formation
5017483|NCT03887364|Breathing Exercises|breathing exercises
5017484|NCT03887364|Icing and Airflow Stimulation|icing and airflow stimulation
5017485|NCT03887364|Chronic Obstructive Lung Diseases.|chronic obstructive lung diseases.
5017486|NCT03887351|frailty, heart failure, mortality, quality of life|frailty, heart failure, mortality, quality of life
5017487|NCT03887338|Noninvasive Ventilation|noninvasive ventilation
5017488|NCT03887338|Laryngoscopy|laryngoscopy
5017495|NCT03887299|Cesarean|cesarean
5017496|NCT03887299|Wound care|wound care
5017497|NCT03887299|Wound complication|wound complication
5017498|NCT03887299|Surgical site infection|surgical site infection
5017499|NCT03887247|Care coordination|care coordination
5017500|NCT03887247|Opioid|opioid
5017501|NCT03887247|Benzodiazepine|benzodiazepine
5017502|NCT03887247|Behavioral science|behavioral science
5017503|NCT03887247|Behavioral economics|behavioral economics
5017504|NCT03887247|Nudge|nudge
5017505|NCT03887247|Fragmentation of care|fragmentation of care
5017506|NCT03887247|Concurrent prescribing|concurrent prescribing
5017507|NCT03887221|Pharmacokinetic|pharmacokinetic
5017508|NCT03887221|Safety|safety
5017509|NCT03887221|Tolerability|tolerability
5017510|NCT03887221|Healthy Chinese subjects|healthy chinese subjects
5017511|NCT03887208|scar treatment|scar treatment
5017512|NCT03887208|cutis laxa treatment|cutis laxa treatment
5017513|NCT03887208|stromal vascular fraction|stromal vascular fraction
5017514|NCT03887208|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
5017521|NCT03887182|functional MRI|functional mri
5018105|NCT03883633|MCI|mci
5017526|NCT03887143|children|children
5017527|NCT03887143|recanalization treatment|recanalization treatment
5017528|NCT03887143|thrombolysis|thrombolysis
5017529|NCT03887143|thrombectomy|thrombectomy
5017530|NCT03887130|Breast cancer|breast cancer
5017532|NCT03887117|Heated Tobacco|heated tobacco
5017533|NCT03887091|Web Based Tools|web based tools
5017534|NCT03887091|Video Communication|video communication
5017535|NCT03887091|Web-based communication|web-based communication
5017536|NCT03887078|Obesity|obesity
5017537|NCT03887078|Bariatric Surgery|bariatric surgery
5017538|NCT03887078|mHealth|mhealth
5017539|NCT03887039|oral findings|oral findings
5017540|NCT03887039|oral characteristics|oral characteristics
5017541|NCT03887039|oral health|oral health
5017542|NCT03887039|caries|caries
5017552|NCT03886987|Skin Sensitisation|skin sensitisation
5017553|NCT03886987|Repeat Insult Patch Test|repeat insult patch test
5017555|NCT03886974|Support networks|support networks
5017556|NCT03886974|Adults with Type 1 diabetes|adults with type 1 diabetes
5017561|NCT03886896|systemic lidocaine|systemic lidocaine
5017563|NCT03886896|postoperative pain|postoperative pain
5017564|NCT03886896|multimodal analgesia|multimodal analgesia
5017565|NCT03886896|laparoscopic appendectomy|laparoscopic appendectomy
5017566|NCT03886896|laparoscopy|laparoscopy
5017567|NCT03886896|recovery|recovery
5017568|NCT03886883|Stretch tolerance|stretch tolerance
5017569|NCT03886883|Stretching Exercises|stretching exercises
5017570|NCT03886883|Exercise induced hypoalgesia|exercise induced hypoalgesia
5017571|NCT03886870|Obesity|obesity
5017572|NCT03886870|Work Focus|work focus
5017573|NCT03886870|Workability|workability
5017574|NCT03886870|Life-style treatment|life-style treatment
5017575|NCT03886844|Infant weight gain|infant weight gain
5017576|NCT03886844|Human milk fortifier|human milk fortifier
5017578|NCT03886844|ELBW infants|elbw infants
5017579|NCT03886779|Post-Ocular Inflammation|post-ocular inflammation
5017580|NCT03886779|Cataract Surgery|cataract surgery
5017581|NCT03886766|amorphous solid dispersion|amorphous solid dispersion
5017582|NCT03886766|Plasma concentration-time profile|plasma concentration-time profile
5017583|NCT03886766|Hot-Melt Extrusion|hot-melt extrusion
5017584|NCT03886740|Eustachian Tube Dysfunction|eustachian tube dysfunction
5017585|NCT03886740|Eustachian Tube balloon dilation|eustachian tube balloon dilation
5017586|NCT03886740|Eustachian Tube dilation|eustachian tube dilation
5017587|NCT03886740|Tympanostomy|tympanostomy
5017588|NCT03886714|Fabry disease|fabry disease
5017589|NCT03886714|Renal transplantation|renal transplantation
5017590|NCT03886714|Diabetic nephropathy|diabetic nephropathy
5017591|NCT03886714|Focal Segmental Hyalinosis (FSH)|focal segmental hyalinosis (fsh)
5017592|NCT03886714|Undetermined nephropathy|undetermined nephropathy
5017593|NCT03886701|Drug-drug interaction|drug-drug interaction
5017594|NCT03886701|Pharmacokinetics|pharmacokinetics
5017595|NCT03886701|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5017596|NCT03886701|NNRTI|nnrti
5017597|NCT03886701|LTBI|ltbi
5017598|NCT03886701|Antimycobacterial|antimycobacterial
5017599|NCT03886675|Stroke|stroke
5017600|NCT03886675|Silent cerebral infarction|silent cerebral infarction
5017601|NCT03886675|Carbon dioxide|carbon dioxide
5017602|NCT03886675|Thoracic endovascular aortic repair|thoracic endovascular aortic repair
5017603|NCT03886675|TEVAR|tevar
5017604|NCT03886675|DW-MRI|dw-mri
5017605|NCT03886675|Vascular brain infarction|vascular brain infarction
5017606|NCT03886649|Relapsed or refractory B-cell non-Hodgkin lymphoma|relapsed or refractory b-cell non-hodgkin lymphoma
5017607|NCT03886649|Copanlisib|copanlisib
5017608|NCT03886649|Venetoclax|venetoclax
5017609|NCT03886649|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5017610|NCT03886649|Splenic marginal zone lymphoma|splenic marginal zone lymphoma
5017611|NCT03886649|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (malt lymphoma)
5423188|NCT01616784|Health Education|health education
5017627|NCT03886558|longevity|longevity
5017628|NCT03886545|Assessment ; work-related musculoskeletal disorders of the shoulder|assessment ; work-related musculoskeletal disorders of the shoulder
5017633|NCT03886480|rehabilitation, upper extremity, virtual reality, SaeboVR|rehabilitation, upper extremity, virtual reality, saebovr
5017634|NCT03886467|Nepal|nepal
5017635|NCT03886467|ASF consumption|asf consumption
5017636|NCT03886454|Central apnea|central apnea
5017637|NCT03886454|Obstructive apnea|obstructive apnea
5017638|NCT03886454|Oxygen desaturation|oxygen desaturation
5017639|NCT03886454|Escalation of Care|escalation of care
5017640|NCT03886454|conscious sedation|conscious sedation
5017641|NCT03886454|Bronchoscopy|bronchoscopy
5017642|NCT03886454|Respiratory impairment|respiratory impairment
5017643|NCT03886441|beclomethasone propionate|beclomethasone propionate
5017644|NCT03886441|radiation pneumonitis|radiation pneumonitis
5017645|NCT03886441|NSCLC|nsclc
5017646|NCT03886441|radical radiotherapy|radical radiotherapy
5017647|NCT03886441|Preventive effect|preventive effect
5017648|NCT03886389|Breast Cancer|breast cancer
5017654|NCT03886389|RFS|rfs
5017655|NCT03886389|BCSS|bcss
5017656|NCT03886376|Athletes|athletes
5017657|NCT03886376|Swimming|swimming
5017658|NCT03886376|Performance|performance
5017659|NCT03886376|Massage|massage
5017660|NCT03886350|Unconventional T cells|unconventional t cells
5017661|NCT03886350|Cystic fibrosis|cystic fibrosis
5017662|NCT03886350|gamma delta T cell|gamma delta t cell
5017663|NCT03886350|Mucosal Associated Invariant T cell|mucosal associated invariant t cell
5017664|NCT03886350|Natural Killer T cell|natural killer t cell
5017665|NCT03886337|Germicidal lights|germicidal lights
5017666|NCT03886337|S. aureus|s. aureus
5017667|NCT03886337|Transmission|transmission
5017668|NCT03886337|Operating room S. aureus exposure|operating room s. aureus exposure
5017669|NCT03886311|marine derived alkaloid|marine derived alkaloid
5017670|NCT03886311|PD1 inhibitor|pd1 inhibitor
5017671|NCT03886311|CTLA4 inhibitor|ctla4 inhibitor
5713369|NCT00453037|life style|life style
5017676|NCT03886259|Total Knee Arthroplasty|total knee arthroplasty
5017677|NCT03886259|Pain Neuroscience Education|pain neuroscience education
5017678|NCT03886259|Neuromuscular exercise (NEMEX-TJR)|neuromuscular exercise (nemex-tjr)
5017681|NCT03886220|Uterine Fibroids|uterine fibroids
5017682|NCT03886220|Heavy Menstrual Bleeding (HMB)|heavy menstrual bleeding (hmb)
5017683|NCT03886207|Anorexia|anorexia
5017684|NCT03886207|Footbath|footbath
5017685|NCT03886207|Ginger powder|ginger powder
5017686|NCT03886207|Thermogenic substances|thermogenic substances
5017687|NCT03886207|Thermoregulation|thermoregulation
5017688|NCT03886207|External applications|external applications
5017689|NCT03886207|Anthroposophic medicine|anthroposophic medicine
5017690|NCT03886207|Eating disorders|eating disorders
5017691|NCT03886181|Squamous Cell Carcinoma|squamous cell carcinoma
5017692|NCT03886181|SCC|scc
5017693|NCT03886181|Skin Cancer|skin cancer
5017694|NCT03886181|Skin metastasis|skin metastasis
5017695|NCT03886181|HNSCC|hnscc
5017696|NCT03886181|Carcinoma, Squamous|carcinoma, squamous
5017697|NCT03886181|CMN|cmn
5017698|NCT03886181|Basal cell carcinoma|basal cell carcinoma
5017699|NCT03886181|Superficial sarcoma|superficial sarcoma
5017700|NCT03886181|Kaposi sarcoma|kaposi sarcoma
5017701|NCT03886181|Alpha radiation|alpha radiation
5017702|NCT03886181|Cutaneous lesion|cutaneous lesion
5017703|NCT03886181|Tongue cancer|tongue cancer
5017704|NCT03886181|Lip cancer|lip cancer
5017706|NCT03886155|Surgery|surgery
5017707|NCT03886155|Surgical release|surgical release
5017708|NCT03886155|Biopsy|biopsy
5017709|NCT03886116|Arteriovenous Fistula|arteriovenous fistula
5017710|NCT03886116|AVF Maturation|avf maturation
5329876|NCT02040909|hypotension|hypotension
5017711|NCT03886116|Pre Operative exercise|pre operative exercise
5017714|NCT03886090|neuroplasticity|neuroplasticity
5017715|NCT03886090|aerobic exercise|aerobic exercise
5017721|NCT03886025|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5017722|NCT03886025|Decision-making|decision-making
5017724|NCT03886025|Brain stimulation|brain stimulation
5017725|NCT03886012|Migraine Associated Vertigo|migraine associated vertigo
5017726|NCT03885973|SCFA|scfa
5017727|NCT03885973|Probiotic|probiotic
5017728|NCT03885973|Lactobacillus plantarum|lactobacillus plantarum
5017729|NCT03885973|Functional constipation|functional constipation
5017730|NCT03885960|Hip|hip
5017731|NCT03885960|function|function
5017732|NCT03885960|quality of life|quality of life
5017733|NCT03885960|osteoarthritis|osteoarthritis
5017734|NCT03885960|Perthes|perthes
5017735|NCT03885960|LCPD|lcpd
5017736|NCT03885947|Hematological Malignancies|hematological malignancies
5017737|NCT03885947|Expanded Umbilical Cord|expanded umbilical cord
5017738|NCT03885947|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5017739|NCT03885947|Leukemia|leukemia
5017740|NCT03885947|Lymphoma|lymphoma
5017746|NCT03885882|E0302|e0302
5017747|NCT03885882|Healthy Subjects|healthy subjects
5017748|NCT03885882|E0302 SR Tablet|e0302 sr tablet
5017749|NCT03885882|E0302 IR Tablet|e0302 ir tablet
5017750|NCT03885869|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5017751|NCT03885869|Joint Position Sense|joint position sense
5017752|NCT03885869|Plantar Sensation|plantar sensation
5017753|NCT03885869|Balance|balance
5017754|NCT03885869|Dual Task Performance|dual task performance
5017755|NCT03885856|rotator cuff repair|rotator cuff repair
5017756|NCT03885856|rotator cuff tear|rotator cuff tear
5017757|NCT03885856|single row repair technique|single row repair technique
5017758|NCT03885856|double row repair technique|double row repair technique
5017759|NCT03885830|Observational|observational
5017760|NCT03885830|Bosutinib|bosutinib
5017761|NCT03885830|Dasatinib|dasatinib
5017762|NCT03885830|Nilotinib|nilotinib
5017763|NCT03885830|Imatinib|imatinib
5017769|NCT03885817|Adjuvant chemotherapy|adjuvant chemotherapy
5017770|NCT03885817|Peripheral neuropathy, chemotherapy induced|peripheral neuropathy, chemotherapy induced
5017771|NCT03885817|Nutritional guide|nutritional guide
5017772|NCT03885804|quadratus - dexmedetomidine- bupivavaine- perineural|quadratus - dexmedetomidine- bupivavaine- perineural
5017773|NCT03885713|inflammatory bowel diseases|inflammatory bowel diseases
5017774|NCT03885713|Crohn Disease|crohn disease
5017775|NCT03885713|Ulcerative Colitis|ulcerative colitis
5017777|NCT03885713|Adalimumab|adalimumab
5017778|NCT03885713|Golimumab|golimumab
5017779|NCT03885713|Vedolizumab|vedolizumab
5017780|NCT03885713|Ustekinumab|ustekinumab
5017781|NCT03885713|Anti-TNF|anti-tnf
5017782|NCT03885687|Rehabilitation|rehabilitation
5017783|NCT03885687|Exercise|exercise
5017784|NCT03885687|Music Intervention|music intervention
5017785|NCT03885648|Breast cancer|breast cancer
5017786|NCT03885648|Microbiota|microbiota
5017787|NCT03885648|Endocrine disruptors|endocrine disruptors
5017788|NCT03885648|Estrogens|estrogens
5017790|NCT03885622|ANTHEM™ CR Total Knee System|anthem™ cr total knee system
5017791|NCT03885583|thoracotomy|thoracotomy
5017792|NCT03885583|thoracic epidural block|thoracic epidural block
5017793|NCT03885583|paravertebral block|paravertebral block
5017794|NCT03885570|mitral valve replacement|mitral valve replacement
5017795|NCT03885570|Predictive Model|predictive model
5017796|NCT03885570|Blood Transfusion|blood transfusion
5017797|NCT03885570|Perioperative period|perioperative period
5017798|NCT03885557|Flexibility|flexibility
5017799|NCT03885557|Extensibility|extensibility
5017800|NCT03885557|Static stretching|static stretching
5017801|NCT03885544|beef|beef
5017802|NCT03885544|pork|pork
5017803|NCT03885544|red meat|red meat
5017804|NCT03885544|gut microbiota|gut microbiota
5017805|NCT03885531|Journey II CR Total Knee System|journey ii cr total knee system
5017806|NCT03885479|Inflammatory bowel disease|inflammatory bowel disease
5017807|NCT03885479|Food specific IgGs|food specific iggs
5017808|NCT03885466|Nordic walking|nordic walking
5017809|NCT03885466|Osteoporosis|osteoporosis
5017810|NCT03885466|Hyperkyphosis|hyperkyphosis
5017811|NCT03885466|Vertebral Fracture|vertebral fracture
5017812|NCT03885427|sedation|sedation
5017813|NCT03885427|ketamine|ketamine
5017814|NCT03885427|analgesia|analgesia
5017815|NCT03885427|pre-schoolers|pre-schoolers
5017816|NCT03885388|GTN|gtn
5017817|NCT03885388|MTX|mtx
5017826|NCT03885297|metabolism|metabolism
5017827|NCT03885297|liraglutide|liraglutide
5017828|NCT03885297|saxenda|saxenda
5017829|NCT03885297|metabolomics|metabolomics
5017837|NCT03885258|Cardiac Autonomic System|cardiac autonomic system
5017838|NCT03885258|heart rate variability|heart rate variability
5017839|NCT03885232|Communication|communication
5017840|NCT03885232|Immunization|immunization
5017841|NCT03885193|anticoagulation|anticoagulation
5017842|NCT03885193|cardiopulmonary bypass|cardiopulmonary bypass
5017843|NCT03885193|heparin|heparin
5017844|NCT03885193|protamine|protamine
5017845|NCT03885193|postoperatively bleeding|postoperatively bleeding
5017846|NCT03885180|bioprosthetic heart valves|bioprosthetic heart valves
5017847|NCT03885180|oral anticoagulation|oral anticoagulation
5017848|NCT03885180|thrombotic events|thrombotic events
5017849|NCT03885154|Migraine|migraine
5017850|NCT03885154|Headache|headache
5017851|NCT03885154|Valproic acid|valproic acid
5017852|NCT03885154|Dihydroergotamine|dihydroergotamine
5017853|NCT03885154|Pediatric|pediatric
5017854|NCT03885141|Insomnia|insomnia
5017855|NCT03885141|Zolpidem|zolpidem
5017856|NCT03885102|chronic kidney disease|chronic kidney disease
5017857|NCT03885102|hemodialysis|hemodialysis
5017858|NCT03885102|intradialytic exercise|intradialytic exercise
5017859|NCT03885102|physical activity|physical activity
5017860|NCT03885102|safety|safety
5017861|NCT03885102|health economics|health economics
5017862|NCT03885102|health literacy|health literacy
5017863|NCT03885102|training therapy|training therapy
5017864|NCT03885089|Infliximab|infliximab
5017865|NCT03885089|biosimilar|biosimilar
5017866|NCT03885037|Rheumatoid Arthritis|rheumatoid arthritis
5017867|NCT03885037|Infliximab|infliximab
5017868|NCT03885037|biosimilar|biosimilar
5017872|NCT03884946|MSM|msm
5017873|NCT03884946|mHealth|mhealth
5017874|NCT03884946|App|app
5017875|NCT03884920|Impaired Fasting Glucose|impaired fasting glucose
5017876|NCT03884920|Impaired Glucose Tolerance|impaired glucose tolerance
5017877|NCT03884920|2hr -75gm Oral Glucose Tolerance Test|2hr -75gm oral glucose tolerance test
5017878|NCT03884920|Diabetes Mellitus Prevention|diabetes mellitus prevention
5019847|NCT03872908|Breast cancer|breast cancer
5017879|NCT03884907|human bone graft screw|human bone graft screw
5017880|NCT03884907|foot and ankle surgery|foot and ankle surgery
5017881|NCT03884907|hallux valgus deformity|hallux valgus deformity
5017882|NCT03884894|neonatal sepsis|neonatal sepsis
5017883|NCT03884894|Blood culture|blood culture
5017884|NCT03884894|molecular assay|molecular assay
5017885|NCT03884868|Colorectal cancer screening|colorectal cancer screening
5017886|NCT03884868|Iconographies|iconographies
5017887|NCT03884868|Risk communication|risk communication
5017888|NCT03884868|Patient medical knowledge|patient medical knowledge
5017889|NCT03884842|Airway hyperresponsivness|airway hyperresponsivness
5017890|NCT03884842|Ventilation heterogeneity|ventilation heterogeneity
5017891|NCT03884842|Hyperpolarized Xenon-129|hyperpolarized xenon-129
5017892|NCT03884842|Sputum eosinophils|sputum eosinophils
5012487|NCT03918382|Radiotherapy|radiotherapy
5012488|NCT03918369|Right Colon Cancer,|right colon cancer,
5012489|NCT03918369|Right hemicolectomy|right hemicolectomy
5012490|NCT03918369|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
5012491|NCT03918369|Intracorporeal anastomosis|intracorporeal anastomosis
5012492|NCT03918291|Muscle strength|muscle strength
5012493|NCT03918291|Squat|squat
5012494|NCT03918291|Brain derived neurotrophic factor|brain derived neurotrophic factor
5012495|NCT03918291|Osteoarthritis of knee|osteoarthritis of knee
5012496|NCT03918291|Whole-body vibration|whole-body vibration
5012497|NCT03918291|Elderly|elderly
5017893|NCT03884829|AML, ALL, CLL, CML, MDS, advanced leukemias, leukemia|aml, all, cll, cml, mds, advanced leukemias, leukemia
5017897|NCT03884790|Bone substitute|bone substitute
5017898|NCT03884790|Bone regeneration|bone regeneration
5017899|NCT03884777|Influenza A virus|influenza a virus
5017900|NCT03884777|myasthenia gravis|myasthenia gravis
5017901|NCT03884777|neurocritical care clinical|neurocritical care clinical
5017902|NCT03884777|neuromuscular disease|neuromuscular disease
5017903|NCT03884751|Hepatocellular Carcinoma|hepatocellular carcinoma
5017904|NCT03884751|CAR-T|car-t
5017905|NCT03884738|Muscle Tonus|muscle tonus
5017906|NCT03884738|Elasticity|elasticity
5017907|NCT03884738|Electric Stimulation Therapy|electric stimulation therapy
5017908|NCT03884738|Physical Conditioning, Human|physical conditioning, human
5017909|NCT03884725|Cardiac surgical procedures|cardiac surgical procedures
5017910|NCT03884725|Fibrinogen|fibrinogen
5017911|NCT03884725|Bleeding|bleeding
5017912|NCT03884712|anxiety symptoms|anxiety symptoms
5017913|NCT03884712|panic attack symptoms|panic attack symptoms
5017914|NCT03884712|emergency department|emergency department
5017915|NCT03884712|CalmiGo|calmigo
5017916|NCT03884699|Orthognathic Surgery|orthognathic surgery
5017920|NCT03884673|HIV-1-infected patients|hiv-1-infected patients
5017921|NCT03884621|continuity of patient care|continuity of patient care
5017922|NCT03884595|sepsis|sepsis
5017923|NCT03884595|septic shock|septic shock
5017924|NCT03884595|severe sepsis|severe sepsis
5017925|NCT03884595|SIRS|sirs
5017926|NCT03884595|children|children
5017927|NCT03884595|immature platelet fraction (IPF)|immature platelet fraction (ipf)
5017928|NCT03884595|immature granulocytes (IG)|immature granulocytes (ig)
5017929|NCT03884595|nucleated red blood cells (NRBC)|nucleated red blood cells (nrbc)
5017930|NCT03884582|Healthy volunteers|healthy volunteers
5017931|NCT03884569|limbal stem cell deficiency|limbal stem cell deficiency
5017932|NCT03884569|corneal failure|corneal failure
5017933|NCT03884569|limbal epithelial stem cells|limbal epithelial stem cells
5017934|NCT03884569|ocular surface|ocular surface
5017935|NCT03884569|corneal blindness|corneal blindness
5017936|NCT03884556|Cancer|cancer
5017937|NCT03884556|Metastatic Solid Tumors|metastatic solid tumors
5017938|NCT03884556|Advanced Solid Tumors|advanced solid tumors
5017939|NCT03884556|Relapsed/Refractory Lymphoma|relapsed/refractory lymphoma
5017940|NCT03884556|Prostrate Cancer|prostrate cancer
5017941|NCT03884556|Pancreatic Cancer|pancreatic cancer
5017942|NCT03884556|Monotherapy|monotherapy
5017943|NCT03884556|Combination Therapy|combination therapy
5017944|NCT03884556|CD39|cd39
5017945|NCT03884556|Adenosine Pathway|adenosine pathway
5017946|NCT03884556|Immunotherapy|immunotherapy
5017947|NCT03884556|Immuno-oncology|immuno-oncology
5017948|NCT03884556|PD-1|pd-1
5017949|NCT03884556|Checkpoint Inhibitor|checkpoint inhibitor
5017950|NCT03884556|Nab-paclitaxel|nab-paclitaxel
5017951|NCT03884556|Gemcitabine|gemcitabine
5017952|NCT03884556|Pembrolizumab|pembrolizumab
5017953|NCT03884556|Docetaxel|docetaxel
5017954|NCT03884556|Bladder Cancer|bladder cancer
5017955|NCT03884556|Lung Cancer|lung cancer
5017956|NCT03884543|Mechanical ventilation|mechanical ventilation
5017957|NCT03884543|Positive end-expiratory pressure|positive end-expiratory pressure
5017958|NCT03884543|Driving pressure|driving pressure
5017959|NCT03884543|Post-operative postoperative complications|post-operative postoperative complications
5017960|NCT03884543|Open abdominal surgery|open abdominal surgery
5017961|NCT03884543|Recruitment maneuver|recruitment maneuver
5017962|NCT03884543|PEEP|peep
5017963|NCT03884530|ticagrelol|ticagrelol
5017964|NCT03884530|aspirin|aspirin
5017965|NCT03884504|Advanced Heart Failure|advanced heart failure
5017966|NCT03884504|Ventricular Assist Device System|ventricular assist device system
5017967|NCT03884504|Destination Therapy|destination therapy
5017989|NCT03884465|Drug induced pulmonary arterial hypertension|drug induced pulmonary arterial hypertension
5017990|NCT03884465|Toxin induced pulmonary arterial hypertension|toxin induced pulmonary arterial hypertension
5017991|NCT03884465|Connective tissue disease|connective tissue disease
5017992|NCT03884439|Crohn's Disease|crohn's disease
5017993|NCT03884439|Ulcerative Colitis|ulcerative colitis
5017994|NCT03884439|Infliximab|infliximab
5017995|NCT03884439|biosimilar|biosimilar
5017996|NCT03884426|Mitral valve prolapse|mitral valve prolapse
5017997|NCT03884426|genetic|genetic
5017998|NCT03884426|echocardiography|echocardiography
5017999|NCT03884413|breast cancer survivors,|breast cancer survivors,
5018000|NCT03884413|spontaneous fertility rates,|spontaneous fertility rates,
5018001|NCT03884413|pregnancy,|pregnancy,
5018002|NCT03884413|birth rate,|birth rate,
5018003|NCT03884413|chemotherapy-induced infertility|chemotherapy-induced infertility
5018004|NCT03884387|Shared Decision Making, Lumbar Herniated Disk|shared decision making, lumbar herniated disk
5018005|NCT03884335|Epidural analgesia|epidural analgesia
5018006|NCT03884335|Transversus abdominis plane blockade|transversus abdominis plane blockade
5018007|NCT03884335|Laparoscopic prostatectomy|laparoscopic prostatectomy
5018008|NCT03884322|physical activity|physical activity
5018009|NCT03884322|prematurity|prematurity
5018010|NCT03884322|bone density|bone density
5018011|NCT03884322|length of stay|length of stay
5018012|NCT03884296|Obstructive sleep apnea|obstructive sleep apnea
5018013|NCT03884296|Quadrivalent live, attenuated influenza vaccine|quadrivalent live, attenuated influenza vaccine
5018014|NCT03884296|Flumist|flumist
5018015|NCT03884270|functional dyspepsia|functional dyspepsia
5018016|NCT03884270|hypnotherapy|hypnotherapy
5018141|NCT03883438|Tooth root|tooth root
5018017|NCT03884270|functional gastrointestinal disorders|functional gastrointestinal disorders
5320902|NCT02080910|stroke|stroke
5018018|NCT03884244|Laparoscopic Surgery|laparoscopic surgery
5018019|NCT03884244|Postoperative Bowel Function|postoperative bowel function
5018020|NCT03884218|Thermal Comfort|thermal comfort
5018021|NCT03884192|Locally advanced|locally advanced
5018022|NCT03884192|Stage III Non-Small Cell Lung Cancer|stage iii non-small cell lung cancer
5018023|NCT03884192|Unresectable Non-Small Cell Lung Cancer|unresectable non-small cell lung cancer
5018024|NCT03884192|Concurrent Chemoradiation|concurrent chemoradiation
5018026|NCT03884192|PD-1|pd-1
5018027|NCT03884192|Sintilimab|sintilimab
5018028|NCT03884192|IBI308|ibi308
5018029|NCT03884179|Endoscopic ultrasound|endoscopic ultrasound
5018030|NCT03884179|Radiology|radiology
5018031|NCT03884179|Accuracy|accuracy
5018032|NCT03884179|Pancreatic Cyst|pancreatic cyst
5018033|NCT03884179|Pancreatic Cystadenocarcinoma|pancreatic cystadenocarcinoma
5018034|NCT03884179|Pancreatic Mucinous Cystadenoma|pancreatic mucinous cystadenoma
5018035|NCT03884179|Pancreatic Intraductal Papillary-Mucinous Neoplasm|pancreatic intraductal papillary-mucinous neoplasm
5018036|NCT03884179|Pancreatic Serous Cystadenoma|pancreatic serous cystadenoma
5018037|NCT03884179|Pancreatic Pseudocyst|pancreatic pseudocyst
5018038|NCT03884179|Pancreatic Neuroendocrine Tumor|pancreatic neuroendocrine tumor
5018039|NCT03884179|Solid Pseudopapillary Tumor of the Pancreas|solid pseudopapillary tumor of the pancreas
5018040|NCT03884166|Acute Ischemic Stroke|acute ischemic stroke
5018041|NCT03884166|Bronchoscopy|bronchoscopy
5018057|NCT03884088|Postural Sway|postural sway
5018058|NCT03884075|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5018059|NCT03884075|Steatosis|steatosis
5018060|NCT03884075|Caloric Load|caloric load
5330215|NCT02039375|Ischemic|ischemic
5018061|NCT03884062|HCC, chronic hepatitis C, hepatitis C, liver fibrosis|hcc, chronic hepatitis c, hepatitis c, liver fibrosis
5018062|NCT03884049|ranscatheter|ranscatheter
5018063|NCT03884049|embolization|embolization
5018064|NCT03884049|osteoarthritis|osteoarthritis
5018065|NCT03884049|arterial|arterial
5018066|NCT03884023|Plasma REST|plasma rest
5018067|NCT03884023|REST gene polymorphism|rest gene polymorphism
5018068|NCT03884023|AD|ad
5018069|NCT03884010|DXA|dxa
5018070|NCT03884010|Soccer players|soccer players
5018071|NCT03884010|Skeletal muscle mass|skeletal muscle mass
5018072|NCT03883997|Body fat|body fat
5018073|NCT03883997|Soccer players|soccer players
5018074|NCT03883997|DXA|dxa
5018075|NCT03883945|rosacea|rosacea
5018076|NCT03883893|Tonsillectomy|tonsillectomy
5018077|NCT03883893|Intravenous Acetaminophen|intravenous acetaminophen
5018078|NCT03883893|Pediatric|pediatric
5018079|NCT03883880|diet|diet
5018080|NCT03883880|food choice|food choice
5018081|NCT03883880|taste|taste
5018082|NCT03883867|Pelvic Floor, Perineal Rapture, Obstetric Trauma|pelvic floor, perineal rapture, obstetric trauma
5018083|NCT03883815|cerebral palsy|cerebral palsy
5018084|NCT03883815|neurodevelopmental therapy|neurodevelopmental therapy
5018085|NCT03883815|active video games|active video games
5018086|NCT03883815|treatment intensity|treatment intensity
5018087|NCT03883815|energy consumption|energy consumption
5018088|NCT03883789|Fibrosis, FibroScan, Pregnancy, Trimesters, Liver disease|fibrosis, fibroscan, pregnancy, trimesters, liver disease
5018089|NCT03883776|PET/CT|pet/ct
5018090|NCT03883776|Somatostatin receptor imaging|somatostatin receptor imaging
5018091|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide
5018092|NCT03883724|Nocturia|nocturia
5018093|NCT03883724|Poor sleep|poor sleep
5018094|NCT03883711|Acute coronary syndrome|acute coronary syndrome
5018095|NCT03883711|Myocardial injury|myocardial injury
5018096|NCT03883711|ACS|acs
5018097|NCT03883711|MINOCA|minoca
5018098|NCT03883659|frozen shoulder|frozen shoulder
5018099|NCT03883659|smartphone|smartphone
5018100|NCT03883659|home exercise program|home exercise program
5018101|NCT03883659|range of motion|range of motion
5018102|NCT03883633|Dementia|dementia
5018103|NCT03883633|Alzheimer's Disease|alzheimer's disease
5018104|NCT03883633|Cognitive Decline|cognitive decline
5018113|NCT03883555|Respiratory failure|respiratory failure
5018114|NCT03883555|Hypercapnia|hypercapnia
5018115|NCT03883555|High flow nasal oxygen|high flow nasal oxygen
5018116|NCT03883555|Non invasive ventilation|non invasive ventilation
5018117|NCT03883555|Emergency department|emergency department
5018118|NCT03883542|low malignant potential|low malignant potential
5018120|NCT03883529|Birth experience|birth experience
5018121|NCT03883529|Midwifery|midwifery
5018122|NCT03883529|Feasibilty|feasibilty
5018123|NCT03883529|Intervention|intervention
5018124|NCT03883516|guideline for the treatment of Status Epilepticus|guideline for the treatment of status epilepticus
5018125|NCT03883516|antiseizure drugs (ASDs)|antiseizure drugs (asds)
5018126|NCT03883503|Copeptin|copeptin
5018127|NCT03883503|Salt-water homeostasis|salt-water homeostasis
5018128|NCT03883490|Magnetic Resonance Imaging|magnetic resonance imaging
5032967|NCT03792841|AMG 160|amg 160
5018131|NCT03883490|Bicuspid aortic valve|bicuspid aortic valve
5018132|NCT03883477|Tendinopathy|tendinopathy
5018133|NCT03883477|Trigger Finger|trigger finger
5018134|NCT03883464|Quality of live|quality of live
5018135|NCT03883464|Cholecystectomy|cholecystectomy
5018136|NCT03883464|Low fat diet|low fat diet
5018144|NCT03883425|Home Care Services|home care services
5018145|NCT03883425|Geriatric Assessment|geriatric assessment
5018146|NCT03883425|Aging|aging
5018147|NCT03883425|Frailty|frailty
5018148|NCT03883425|Complexity|complexity
5018149|NCT03883425|Nursing|nursing
5018150|NCT03883399|Surgical Site Infection|surgical site infection
5018151|NCT03883399|Prevention|prevention
5018152|NCT03883399|Survey|survey
5018153|NCT03883399|Colorectal surgery|colorectal surgery
5018154|NCT03883399|Guidelines|guidelines
5018155|NCT03883386|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5018156|NCT03883373|alveolar graft|alveolar graft
5018157|NCT03883373|cancellous bone|cancellous bone
5018158|NCT03883373|cortical block|cortical block
5018159|NCT03883373|nasal floor|nasal floor
5018160|NCT03883360|schizophrenia|schizophrenia
5018161|NCT03883360|cannabis|cannabis
5018162|NCT03883360|cannabidiol|cannabidiol
5018163|NCT03883360|psychosis|psychosis
5018164|NCT03883321|stress management|stress management
5018165|NCT03883321|CBSM|cbsm
5018166|NCT03883321|Chronic Pain|chronic pain
5018167|NCT03883321|Cancer|cancer
5018168|NCT03883282|patient adherence, randomized clinical trials|patient adherence, randomized clinical trials
5018169|NCT03883256|High flow nasal cannula oxygen|high flow nasal cannula oxygen
5018170|NCT03883256|exercise performance|exercise performance
5018171|NCT03883256|COPD|copd
5018172|NCT03883243|Telecoaching|telecoaching
5018173|NCT03883243|Physical activity|physical activity
5018174|NCT03883243|Lung cancer|lung cancer
5018177|NCT03883204|Cognition|cognition
5018178|NCT03883204|Antipsychotic Agents|antipsychotic agents
5018179|NCT03883204|Treatment|treatment
5018180|NCT03883204|Effectiveness|effectiveness
5018181|NCT03883204|Aripiprazole|aripiprazole
5018182|NCT03883204|Risperidone|risperidone
5018183|NCT03883191|Probiotics|probiotics
5018184|NCT03883191|Overweight|overweight
5018185|NCT03883191|Obese|obese
5018186|NCT03883191|Children|children
5018187|NCT03883191|Weight reduction|weight reduction
5018194|NCT03883152|Eating Difficulties|eating difficulties
5018195|NCT03883152|Chewing|chewing
5018196|NCT03883152|Swallowing|swallowing
5018197|NCT03883152|Head and neck cancer|head and neck cancer
5018198|NCT03883152|Depression|depression
5018199|NCT03883152|Physical function|physical function
5018200|NCT03883152|Nutrition|nutrition
5018201|NCT03883139|autism|autism
5018202|NCT03883139|JASPER|jasper
5018204|NCT03883139|ASD|asd
5018205|NCT03883139|Autism Spectrum Disorder|autism spectrum disorder
5717420|NCT00440843|attention|attention
5018206|NCT03883139|social and communication deficits|social and communication deficits
5018207|NCT03883100|Chronic Myeloid Leukemia,CML|chronic myeloid leukemia,cml
5018208|NCT03883100|T315I mutation|t315i mutation
5018209|NCT03883100|CML-AP|cml-ap
5018210|NCT03883100|HQP1351|hqp1351
5018211|NCT03883087|Chronic Myeloid Leukemia,CML|chronic myeloid leukemia,cml
5018212|NCT03883087|T315I mutation|t315i mutation
5018213|NCT03883087|TKI|tki
5018214|NCT03883087|CML-CP|cml-cp
5018215|NCT03883087|HQP1351|hqp1351
5018216|NCT03883035|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5018217|NCT03883035|gastric neoplasm|gastric neoplasm
5018218|NCT03883035|artificial intelligence|artificial intelligence
5018219|NCT03883035|quality control|quality control
5018220|NCT03883022|Deep surgical site infection|deep surgical site infection
5018221|NCT03883022|Vancomycin-impregnated bone graft|vancomycin-impregnated bone graft
5018222|NCT03883022|Spine surgery|spine surgery
5018223|NCT03883022|Degenerative lumbar disorder|degenerative lumbar disorder
5018224|NCT03883009|Epidemiology|epidemiology
5018225|NCT03883009|Modeling|modeling
5018226|NCT03883009|Risk factors|risk factors
5018227|NCT03883009|Surgical site infections|surgical site infections
5018228|NCT03882983|Autologous Adult Stem Cell|autologous adult stem cell
5018229|NCT03882983|Lipoaspirate|lipoaspirate
5018230|NCT03882983|Non-healing Wounds|non-healing wounds
5018231|NCT03882983|Stomal Vasular Fraction|stomal vasular fraction
5018232|NCT03882970|T2DM|t2dm
5018233|NCT03882957|Attention|attention
5018234|NCT03882957|Food cues|food cues
5018235|NCT03882957|Media multi-tasking|media multi-tasking
5018236|NCT03882931|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5018237|NCT03882931|Neuromodulation|neuromodulation
5018238|NCT03882931|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5018239|NCT03882931|Transcranial Ultrasound Stimulation|transcranial ultrasound stimulation
5018241|NCT03882879|exercise|exercise
5018242|NCT03882879|martial arts|martial arts
5018243|NCT03882879|Parkinson's Disease|parkinson's disease
5018244|NCT03882879|non-pharmacologic|non-pharmacologic
5020244|NCT03870646|Plug|plug
5018250|NCT03882866|Iodine-125|iodine-125
5018251|NCT03882866|Three-Dimensional Printing|three-dimensional printing
5018252|NCT03882866|Brachytherapy|brachytherapy
5018253|NCT03882866|template|template
5018254|NCT03882853|yoga|yoga
5018255|NCT03882853|osteoporosis|osteoporosis
5018256|NCT03882853|balance|balance
5018257|NCT03882853|tree pose|tree pose
5018258|NCT03882853|asana|asana
5018259|NCT03882814|Analgesia|analgesia
5018260|NCT03882814|labor|labor
5018261|NCT03882814|pethidine|pethidine
5018262|NCT03882814|Active Phase|active phase
5018263|NCT03882775|Major adverse cardiac events (MACEs)|major adverse cardiac events (maces)
5018264|NCT03882775|bivalirudin|bivalirudin
5018265|NCT03882749|Pain, WOMAC|pain, womac
5018266|NCT03882736|plastic and reconstructive surgery|plastic and reconstructive surgery
5018267|NCT03882736|gluteal ptosis|gluteal ptosis
5018268|NCT03882736|platipygia|platipygia
5018269|NCT03882710|heart failure, metoprolol, diastolic dysfunction|heart failure, metoprolol, diastolic dysfunction
5018270|NCT03882697|Robotic surgery|robotic surgery
5018271|NCT03882697|Position|position
5018272|NCT03882697|Cardio Q|cardio q
5018273|NCT03882697|hypotension|hypotension
5018274|NCT03882645|China Heart Diet|china heart diet
5018275|NCT03882645|Randomized Controlled Trial|randomized controlled trial
5018276|NCT03882645|Feeding Study|feeding study
5018277|NCT03882645|Blood Pressure|blood pressure
5018278|NCT03882645|Cholesterol|cholesterol
5018279|NCT03882645|Fasting Blood Glucose|fasting blood glucose
5018280|NCT03882645|Diet Modification|diet modification
5018281|NCT03882580|anticancer drugs|anticancer drugs
5018282|NCT03882580|cardiac toxicities|cardiac toxicities
5018283|NCT03882580|cardiovascular prevention|cardiovascular prevention
5018284|NCT03882580|vascular toxicities|vascular toxicities
5060764|NCT03619109|CRP|crp
5018285|NCT03882580|metabolic toxicities|metabolic toxicities
5018286|NCT03882580|adverse drug reactions|adverse drug reactions
5330417|NCT02038439|Medical Education|medical education
5018287|NCT03882567|visual analogue scale|visual analogue scale
5018288|NCT03882567|conditioned pain modulation|conditioned pain modulation
5018289|NCT03882567|disability|disability
5018290|NCT03882567|pressure pain threshold|pressure pain threshold
5018291|NCT03882567|temporal summation|temporal summation
5018292|NCT03882541|Anxiety|anxiety
5018293|NCT03882541|Pain|pain
5018294|NCT03882541|perioperative|perioperative
5018295|NCT03882541|Surgery|surgery
5018296|NCT03882541|Music Therapy|music therapy
5018297|NCT03882541|Drugs|drugs
5018298|NCT03882515|Neck Pain|neck pain
5018299|NCT03882515|Fascia|fascia
5018300|NCT03882515|Modalities of Physiotherapy|modalities of physiotherapy
5018301|NCT03882515|Oxygenation|oxygenation
5018302|NCT03882489|spinal anesthesia|spinal anesthesia
5018303|NCT03882489|Knee Arthroscopy|knee arthroscopy
5018304|NCT03882489|Chloroprocaine|chloroprocaine
5018305|NCT03882489|Height|height
5018307|NCT03882489|Continual Reassessment Method (CRM)|continual reassessment method (crm)
5018308|NCT03882476|Dascena|dascena
5018309|NCT03882476|patient mortality|patient mortality
5018310|NCT03882476|machine learning|machine learning
5018311|NCT03882476|algorithm|algorithm
5018312|NCT03882476|diagnostic|diagnostic
5018313|NCT03882437|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5018314|NCT03882437|HCM|hcm
5018316|NCT03882411|Stepped wedge design|stepped wedge design
5018317|NCT03882398|Neurodegenerative disorders|neurodegenerative disorders
5018318|NCT03882398|physical activity|physical activity
5018320|NCT03882398|endurance|endurance
5018321|NCT03882372|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5018322|NCT03882372|Pulmonary rehabilitation|pulmonary rehabilitation
5018323|NCT03882372|Nasal high flow|nasal high flow
5018324|NCT03882359|echo|echo
5018325|NCT03882359|echocardiogram|echocardiogram
5018326|NCT03882359|Healthy Volunteers|healthy volunteers
5018327|NCT03882359|Definity|definity
5018328|NCT03882346|Acute Liver Failure|acute liver failure
5018329|NCT03882346|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
5018330|NCT03882346|Artificial Liver|artificial liver
5018331|NCT03882346|Liver Transplantation|liver transplantation
5018332|NCT03882333|Chronic musculoskeletal pain|chronic musculoskeletal pain
5018333|NCT03882333|Acute exercise|acute exercise
5018334|NCT03882333|Movement control|movement control
5018335|NCT03882333|Muscle activity|muscle activity
5018336|NCT03882320|Sublingual Patient Controlled Analgesia (PCA)|sublingual patient controlled analgesia (pca)
5018337|NCT03882320|Intravenous Patient Controlled Analgesia (PCA)|intravenous patient controlled analgesia (pca)
5018338|NCT03882320|Patient Controlled Analgesia (PCA)|patient controlled analgesia (pca)
5018339|NCT03882307|hepatitis C virus therapy|hepatitis c virus therapy
5018340|NCT03882307|interleukin-6|interleukin-6
5018342|NCT03882307|sustained virological response|sustained virological response
5018360|NCT03882151|drug resistant epilepsy|drug resistant epilepsy
5018361|NCT03882151|electrical source imaging|electrical source imaging
5018362|NCT03882151|surgery|surgery
5018363|NCT03882125|mindfulness|mindfulness
5018364|NCT03882125|methadone maintenance|methadone maintenance
5018365|NCT03882125|relapse prevention|relapse prevention
5018366|NCT03882086|Foot reflexology|foot reflexology
5018367|NCT03882086|nursing|nursing
5018368|NCT03882086|postpartum period|postpartum period
5018369|NCT03882086|postpartum sleep quality|postpartum sleep quality
5018370|NCT03882034|Pediatric|pediatric
5018371|NCT03882034|Gigantism|gigantism
5018372|NCT03882034|Growth Hormone|growth hormone
5018373|NCT03881969|Trial Recruitment|trial recruitment
5018374|NCT03881969|Incentive Payment|incentive payment
5018375|NCT03881969|Patient Demographics|patient demographics
5018376|NCT03881956|gestational diabetes|gestational diabetes
5018377|NCT03881956|health-promoting lifestyle|health-promoting lifestyle
5018378|NCT03881956|maternal and neonatal health|maternal and neonatal health
5018379|NCT03881956|education|education
5018380|NCT03881930|Peripheral neuropathy|peripheral neuropathy
5018381|NCT03881930|Balance|balance
5018382|NCT03881930|Proprioceptive Disorders|proprioceptive disorders
5018383|NCT03881930|Visual dependence|visual dependence
5018384|NCT03881930|Rehabilitation|rehabilitation
5018385|NCT03881930|Physical Therapy|physical therapy
5018386|NCT03881917|renal impairment|renal impairment
5018387|NCT03881904|PCOS|pcos
5018388|NCT03881904|Anatgonist protocol|anatgonist protocol
5018389|NCT03881904|OCP pretreatment|ocp pretreatment
5018390|NCT03881865|Somatosensory Evoked Potential|somatosensory evoked potential
5018391|NCT03881865|cardiac arrest|cardiac arrest
5018392|NCT03881865|prognosis|prognosis
5018393|NCT03881865|P25/30|p25/30
5018394|NCT03881852|CONCERT|concert
5018395|NCT03881852|AXS-12|axs-12
5018397|NCT03881852|Cataplexy|cataplexy
5018398|NCT03881852|Narcolepsy|narcolepsy
5018399|NCT03881852|Axsome|axsome
5018400|NCT03881852|Reboxetine|reboxetine
5018401|NCT03881813|fixed retainers|fixed retainers
5018402|NCT03881813|alignment|alignment
5018403|NCT03881800|Ceftazidime|ceftazidime
5018404|NCT03881800|Burned Children|burned children
5067085|NCT03579576|MSM|msm
5018405|NCT03881800|Intensive care|intensive care
5018406|NCT03881800|Pharmacokinetic|pharmacokinetic
5330535|NCT02037828|EBC|ebc
5018407|NCT03881748|Acupuncture|acupuncture
5018408|NCT03881709|prostate biopsy|prostate biopsy
5018409|NCT03881709|E-Book|e-book
5018410|NCT03881709|decision support intervention|decision support intervention
5018411|NCT03881709|decision self-efficacy|decision self-efficacy
5018412|NCT03881709|decision conflict|decision conflict
5018413|NCT03881696|peanut allergic|peanut allergic
5018414|NCT03881696|multi-food allergic|multi-food allergic
5018415|NCT03881696|omalizumab|omalizumab
5018416|NCT03881696|placebo|placebo
5018417|NCT03881696|multi-allergen oral immunotherapy (OIT)|multi-allergen oral immunotherapy (oit)
5018418|NCT03881696|double-blind placebo-controlled food challenge (DBPCFC)|double-blind placebo-controlled food challenge (dbpcfc)
5018419|NCT03881683|BRCA 1/2 genes|brca 1/2 genes
5018420|NCT03881683|Circulating Tumor DNA/blood*|circulating tumor dna/blood*
5018421|NCT03881683|somatic tumor mutations|somatic tumor mutations
5018422|NCT03881683|HRD genes|hrd genes
5018423|NCT03881657|Integrated Behavioral Health|integrated behavioral health
5018424|NCT03881657|Reverse Colocation|reverse colocation
5018425|NCT03881657|Integrated Care|integrated care
5018427|NCT03881605|Screening|screening
5018439|NCT03881501|Hepatocellular Carcinoma|hepatocellular carcinoma
5018447|NCT03881436|Pelvic floor|pelvic floor
5018448|NCT03881436|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
5018449|NCT03881436|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5018450|NCT03881397|internet|internet
5018451|NCT03881397|social media|social media
5018452|NCT03881397|family rules|family rules
5018453|NCT03881384|ctDNA|ctdna
5018454|NCT03881358|Myopia control|myopia control
5018455|NCT03881358|Orthokeratology|orthokeratology
5018456|NCT03881358|Children|children
5018457|NCT03881319|Acupuncture|acupuncture
5018458|NCT03881319|Premenstrual Syndrome|premenstrual syndrome
5018459|NCT03881319|Dysmenorrhea|dysmenorrhea
5018460|NCT03881319|Autonomic nervous activity|autonomic nervous activity
5018461|NCT03881319|TCM syndrome|tcm syndrome
5018462|NCT03881319|Meridian|meridian
5018463|NCT03881306|TACE|tace
5018464|NCT03881306|Oxaliplatin|oxaliplatin
5018465|NCT03881293|urodynamics|urodynamics
5018466|NCT03881293|women|women
5018467|NCT03881293|lidocaine gel|lidocaine gel
5018468|NCT03881280|Childhood Obesity|childhood obesity
5018469|NCT03881280|Nutrition|nutrition
5018470|NCT03881280|mHealth|mhealth
5018471|NCT03881280|Parenting|parenting
5018473|NCT03881267|Ulcer|ulcer
5018474|NCT03881267|SkinTE™|skinte™
5018475|NCT03881254|DFU|dfu
5018476|NCT03881254|Ulcer|ulcer
5018477|NCT03881254|Skin TE|skin te
5018478|NCT03881241|Tibia|tibia
5018479|NCT03881241|fracture|fracture
5018480|NCT03881241|EVOS|evos
5018481|NCT03881241|EVOS SMALL|evos small
5018482|NCT03881241|plating system|plating system
5018483|NCT03881241|plates|plates
5018484|NCT03881241|tibial fracture|tibial fracture
5018485|NCT03881241|surgery|surgery
5018486|NCT03881241|open reduction|open reduction
5018487|NCT03881241|internal fixation|internal fixation
5018488|NCT03881150|Cardiac rehabilitation|cardiac rehabilitation
5018489|NCT03881150|Exercise|exercise
5018490|NCT03881150|Coronary Artery Disease|coronary artery disease
5018491|NCT03881150|Mobile technology|mobile technology
5018492|NCT03881137|older|older
5018493|NCT03881137|cancer|cancer
5018494|NCT03881137|radiotherapy|radiotherapy
5018495|NCT03881137|geriatric assessment|geriatric assessment
5018496|NCT03881137|quality of life|quality of life
5018497|NCT03881137|physical function|physical function
5018498|NCT03881124|Inguinal Herniorrhaphy|inguinal herniorrhaphy
5018499|NCT03881124|Hernia|hernia
5018500|NCT03881124|Persistent postsurgical pain|persistent postsurgical pain
5018501|NCT03881124|Long term follow up|long term follow up
5018502|NCT03881124|Quantitative sensory testing (QST)|quantitative sensory testing (qst)
5018503|NCT03881124|Pain trajectory|pain trajectory
5018504|NCT03881124|Explanatory variables|explanatory variables
5018505|NCT03881111|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
5018507|NCT03881111|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5018508|NCT03881111|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5018510|NCT03881098|Squamous Cell Carcinoma|squamous cell carcinoma
5018511|NCT03881098|Pre-Malignant Lesions|pre-malignant lesions
5018512|NCT03881098|Smoking|smoking
5018513|NCT03881098|Multi-site|multi-site
5018518|NCT03881072|Ultrasounicelastography|ultrasounicelastography
5018519|NCT03881072|Frozen embryo transplantation|frozen embryo transplantation
5018520|NCT03881072|Endometrial Receptivity|endometrial receptivity
5018521|NCT03881072|pregnancy outcome|pregnancy outcome
5018522|NCT03881007|Gonorrhea|gonorrhea
5018523|NCT03881007|Syphilis|syphilis
5018524|NCT03881007|Chlamydia|chlamydia
5018525|NCT03881007|Listerine|listerine
5018526|NCT03881007|STI|sti
5018527|NCT03880994|Sexual Health|sexual health
5018528|NCT03880994|Fatigue|fatigue
5018529|NCT03880994|Quality of Life|quality of life
5018530|NCT03880994|Depression|depression
5018531|NCT03880994|Anxiety|anxiety
5018534|NCT03880994|Erectile Function|erectile function
5018535|NCT03880994|Cognitive Impairment|cognitive impairment
5018536|NCT03880994|Testis Cancer|testis cancer
5018537|NCT03880981|fracture|fracture
5018538|NCT03880981|tendon rupture|tendon rupture
5018539|NCT03880981|NSAID|nsaid
5018540|NCT03880981|healing|healing
5018541|NCT03880929|kawasaki disease|kawasaki disease
5018542|NCT03880929|coronary artery lesion|coronary artery lesion
5018543|NCT03880929|epidemiology|epidemiology
5018552|NCT03880851|hypofractionation|hypofractionation
5018553|NCT03880851|MR-based IGRT|mr-based igrt
5018554|NCT03880851|Mbase HyPro|mbase hypro
5018555|NCT03880838|Plant-based diet|plant-based diet
5018556|NCT03880838|Behavioral nudge|behavioral nudge
5018557|NCT03880838|Mail distribution|mail distribution
5018558|NCT03880838|Randomized controlled trial|randomized controlled trial
5018559|NCT03880838|Insurance claims|insurance claims
5018560|NCT03880838|Chronic disease|chronic disease
5018561|NCT03880838|Letter-based intervention|letter-based intervention
5018562|NCT03880838|Health behaviors|health behaviors
5018563|NCT03880838|Prevention focus|prevention focus
5018564|NCT03880838|Loss framing|loss framing
5018565|NCT03880838|Commitment|commitment
5018566|NCT03880838|Provider testimonial|provider testimonial
5018567|NCT03880799|Mindfulness|mindfulness
5018568|NCT03880799|Surgical Decision Making|surgical decision making
5018569|NCT03880760|T1DM|t1dm
5018570|NCT03880760|Autoimmune diseases|autoimmune diseases
5018571|NCT03880760|Microbiota|microbiota
5018572|NCT03880760|Probiotics|probiotics
5018573|NCT03880721|radiomics|radiomics
5018574|NCT03880721|prognosis|prognosis
5018575|NCT03880708|brugada syndrome|brugada syndrome
5018576|NCT03880708|long QT syndrome|long qt syndrome
5018577|NCT03880708|short QT syndrome|short qt syndrome
5018578|NCT03880708|early repolarization syndrome|early repolarization syndrome
5018579|NCT03880708|catecholaminergic polymorphic ventricular tachycardia|catecholaminergic polymorphic ventricular tachycardia
5018580|NCT03880682|kidney transplant recipients|kidney transplant recipients
5018581|NCT03880682|chronic hepatitis c virus infection|chronic hepatitis c virus infection
5018582|NCT03880682|direct acting antivirals|direct acting antivirals
5018583|NCT03880682|sofosbuvir/ledipasvir|sofosbuvir/ledipasvir
5018584|NCT03880656|mononuclear cells|mononuclear cells
5018585|NCT03880643|membranous nephropathy|membranous nephropathy
5018586|NCT03880643|rituximab|rituximab
5018587|NCT03880617|Chronic myeloid leukemia|chronic myeloid leukemia
5018588|NCT03880617|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5018589|NCT03880617|Targeted therapy|targeted therapy
5018590|NCT03880617|Care needs|care needs
5018591|NCT03880617|Medication adherence|medication adherence
5018592|NCT03880604|Haemostatic tourniquets|haemostatic tourniquets
5018593|NCT03880604|tranexamic acid|tranexamic acid
5018594|NCT03880604|myomectomy|myomectomy
5018595|NCT03880578|LT4 treatment|lt4 treatment
5018596|NCT03880578|QoL|qol
5018597|NCT03880565|advanced reperfusion|advanced reperfusion
5018598|NCT03880565|mechanical cardiopulmonary resuscitation|mechanical cardiopulmonary resuscitation
5018599|NCT03880552|perineal laceration|perineal laceration
5018600|NCT03880552|obstetric trauma|obstetric trauma
5018601|NCT03880539|C.diff|c.diff
5018604|NCT03880539|Bezlotoxumab|bezlotoxumab
5018605|NCT03880539|CDI|cdi
5018608|NCT03880513|Endogenous Cushing's Syndrome|endogenous cushing's syndrome
5018609|NCT03880513|Cardiovascular status|cardiovascular status
5018610|NCT03880513|Metabolic profile|metabolic profile
5018611|NCT03880513|Endothelial function|endothelial function
5018612|NCT03880513|Quality of life|quality of life
5018613|NCT03880487|Phase I, Healthy Adult Participants|phase i, healthy adult participants
5018614|NCT03880461|Gestational weight gain|gestational weight gain
5018615|NCT03880461|Lifestyle|lifestyle
5018616|NCT03880461|Intervention|intervention
5018617|NCT03880461|Body weight|body weight
5018618|NCT03880461|Overweight|overweight
5018619|NCT03880461|Obesity|obesity
5018620|NCT03880461|Signs and Symptoms|signs and symptoms
5018621|NCT03880461|Body weight changes|body weight changes
5018622|NCT03880448|Disease Progression|disease progression
5018623|NCT03880448|Microbiota|microbiota
5018624|NCT03880448|Periodontitis/surgery|periodontitis/surgery
5018625|NCT03880448|Periodontitis/therapy|periodontitis/therapy
5018626|NCT03880448|Periodontitis/drug effect|periodontitis/drug effect
5018627|NCT03880448|Periodontitis/drug therapy|periodontitis/drug therapy
5018628|NCT03880448|Periodontal diseases/surgery|periodontal diseases/surgery
5018629|NCT03880448|Periodontal diseases/therapy|periodontal diseases/therapy
5018630|NCT03880448|Periodontal pocket/drug therapy|periodontal pocket/drug therapy
5018631|NCT03880448|Metronidazole/therapeutic use|metronidazole/therapeutic use
5018632|NCT03880448|Metronidazole|metronidazole
5018633|NCT03880448|Porphyromonas gingivalis|porphyromonas gingivalis
5018634|NCT03880448|Systemic antimicrobial/periodontal surgery|systemic antimicrobial/periodontal surgery
5018640|NCT03880383|child development|child development
5018641|NCT03880383|preschool skills and development|preschool skills and development
5018642|NCT03880383|parenting stress|parenting stress
5018643|NCT03880383|parenting mental health|parenting mental health
5018644|NCT03880383|coaching intervention|coaching intervention
5018645|NCT03880383|online education|online education
5018646|NCT03880383|parent peer support|parent peer support
5018647|NCT03880383|developmental delay|developmental delay
5018648|NCT03880370|ultrasound|ultrasound
5018649|NCT03880370|functional test|functional test
5018650|NCT03880370|herniated lumbar disk|herniated lumbar disk
5018651|NCT03880370|low back pain|low back pain
5018652|NCT03880344|vibration therapy|vibration therapy
5018653|NCT03880344|Knee Osteoarthritis|knee osteoarthritis
5018654|NCT03880344|Knee Arthropathy|knee arthropathy
5018655|NCT03880331|Secondary intention|secondary intention
5018656|NCT03880331|Wound care methods|wound care methods
5018657|NCT03880305|neonatal sepsis|neonatal sepsis
5018658|NCT03880305|white blood cells|white blood cells
5018659|NCT03880305|platelets|platelets
5018660|NCT03880240|Alzheimer Disease|alzheimer disease
5018661|NCT03880240|Mild Cognitive Impairment|mild cognitive impairment
5018662|NCT03880214|oral GVHD|oral gvhd
5018663|NCT03880214|Pediatric|pediatric
5018664|NCT03880201|perfusion index.ulnar nerve sparing. supraclavicular blocK|perfusion index.ulnar nerve sparing. supraclavicular block
5018665|NCT03880188|Autologous Transplantation|autologous transplantation
5018666|NCT03880188|Free Tissue Flaps|free tissue flaps
5018667|NCT03880188|Graft Survival|graft survival
5018668|NCT03880188|Reconstructive Surgical Procedures|reconstructive surgical procedures
5018669|NCT03880188|Patient Selection|patient selection
5018670|NCT03880188|Debridement|debridement
5018671|NCT03880188|Subcutaneous Fat|subcutaneous fat
5018672|NCT03880188|Surgical Flaps|surgical flaps
5018673|NCT03880188|Treatment Outcome|treatment outcome
5018674|NCT03880162|Prediabetes|prediabetes
5018675|NCT03880162|Bariatric Surgery|bariatric surgery
5018676|NCT03880162|Low-carb diet|low-carb diet
5018677|NCT03880149|Omega-3|omega-3
5018678|NCT03880149|Athletes|athletes
5018679|NCT03880149|Sports injuries|sports injuries
5018680|NCT03880149|Inflammatory markers|inflammatory markers
5018681|NCT03880149|Isokinetic muscle force|isokinetic muscle force
5018682|NCT03880136|Safety|safety
5018683|NCT03880136|Bioavailability|bioavailability
5018684|NCT03880136|Pharmacokinetics|pharmacokinetics
5018685|NCT03880123|Liposarcoma|liposarcoma
5018686|NCT03880123|Malignant Peripheral Nerve Sheath Tumors|malignant peripheral nerve sheath tumors
5018687|NCT03880123|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5018688|NCT03880123|Ewing Sarcoma|ewing sarcoma
5018689|NCT03880123|Selinexor|selinexor
5018690|NCT03880123|ixazomib|ixazomib
5018691|NCT03880123|sarcoma|sarcoma
5018692|NCT03880123|kpt-330|kpt-330
5018693|NCT03880110|Acute Kidney Injury|acute kidney injury
5018694|NCT03880110|Early prediction|early prediction
5018695|NCT03880110|Non cardiac surgery|non cardiac surgery
5018698|NCT03880110|Renal resistive index|renal resistive index
5018700|NCT03880071|Suicidal Behavior|suicidal behavior
5018701|NCT03880071|Borderline Personality Disorder|borderline personality disorder
5018702|NCT03880071|Prevention|prevention
5018703|NCT03880071|Dialectic Behavioral Therapy|dialectic behavioral therapy
5018704|NCT03880071|Acceptance Commitment Therapy|acceptance commitment therapy
5018705|NCT03880045|abdominal myomectomy|abdominal myomectomy
5018706|NCT03880045|tranexamic acid|tranexamic acid
5018707|NCT03880045|vasopressin|vasopressin
5018712|NCT03879993|Cognition|cognition
5018713|NCT03879993|Body composition|body composition
5018714|NCT03879993|Inflammatory biomarkers|inflammatory biomarkers
5013365|NCT03913195|HIV|hiv
5018716|NCT03879980|quadratus lumborum block|quadratus lumborum block
5018717|NCT03879980|pre-emptive analgesia|pre-emptive analgesia
5018718|NCT03879980|laparoscopic nephrectomy|laparoscopic nephrectomy
5018719|NCT03879967|Allograft block|allograft block
5018720|NCT03879967|guided bone regeneration|guided bone regeneration
5018721|NCT03879967|implants|implants
5018722|NCT03879941|Amputation|amputation
5018723|NCT03879941|thumb reconstruction|thumb reconstruction
5018724|NCT03879941|toe transfer|toe transfer
5018725|NCT03879941|foot morbidity|foot morbidity
5018726|NCT03879941|biomechanics|biomechanics
5018727|NCT03879915|hypophosphatemia|hypophosphatemia
5018728|NCT03879915|hypophosphatemic rickets|hypophosphatemic rickets
5018729|NCT03879915|dental implants|dental implants
5018730|NCT03879915|osseointegration|osseointegration
5018731|NCT03879902|fall|fall
5018732|NCT03879902|elderly|elderly
5018733|NCT03879889|Smoking reduction|smoking reduction
5018734|NCT03879889|Randomised controlled trial|randomised controlled trial
5018735|NCT03879889|Motivational interview|motivational interview
5018736|NCT03879889|Nicotine replacement therapy|nicotine replacement therapy
5018737|NCT03879889|Environmental tobacco smoke exposure|environmental tobacco smoke exposure
5018738|NCT03879889|Paediatrics|paediatrics
5018739|NCT03879889|Children|children
5018740|NCT03879876|SCID|scid
5018741|NCT03879876|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5018742|NCT03879876|Human T Lymphoid Progenitor|human t lymphoid progenitor
5018743|NCT03879837|Bioequivalence|bioequivalence
5018744|NCT03879811|MMR-Proficient Colorectal Cancer|mmr-proficient colorectal cancer
5018760|NCT03879733|quality|quality
5018761|NCT03879733|universal prevention|universal prevention
5018762|NCT03879733|mental health|mental health
5018763|NCT03879733|well-being|well-being
5018764|NCT03879720|ERCP|ercp
5018765|NCT03879720|Endoscopic Procedures|endoscopic procedures
5018766|NCT03879720|Anesthesia|anesthesia
5018767|NCT03879668|Advanced disease|advanced disease
5018768|NCT03879668|Specialised outpatient palliative care|specialised outpatient palliative care
5018769|NCT03879668|IPOS|ipos
5018770|NCT03879668|Electronical monitoring|electronical monitoring
5018771|NCT03879655|Niemann-Pick|niemann-pick
5018772|NCT03879655|NPC|npc
5018773|NCT03879603|Alphavirus|alphavirus
5018774|NCT03879603|VEE|vee
5018775|NCT03879603|WEE|wee
5018776|NCT03879603|EEE|eee
5018777|NCT03879603|Vaccine|vaccine
5018778|NCT03879603|Virus-like particles|virus-like particles
5018779|NCT03879590|doxophylline|doxophylline
5018780|NCT03879590|asthma|asthma
5018781|NCT03879590|steroid sparing|steroid sparing
5018782|NCT03879577|breast cancer|breast cancer
5018783|NCT03879577|breast cancer stage II|breast cancer stage ii
5018784|NCT03879577|Breast Cancer Stage III|breast cancer stage iii
5018785|NCT03879577|Docetaxel|docetaxel
5018786|NCT03879577|Herceptin|herceptin
5018787|NCT03879577|neoadjuvant treatment|neoadjuvant treatment
5018788|NCT03879577|nigeria|nigeria
5018789|NCT03879525|Electronic medical record|electronic medical record
5018790|NCT03879525|EMR|emr
5018791|NCT03879525|Patient Outcomes|patient outcomes
5018792|NCT03879512|cancer vaccine|cancer vaccine
5018793|NCT03879512|high-grade glioma|high-grade glioma
5018794|NCT03879512|immunomodulation|immunomodulation
5018795|NCT03879499|cuff hematoma|cuff hematoma
5018796|NCT03879499|CRP levels|crp levels
5018797|NCT03879447|Korean Medicine|korean medicine
5018798|NCT03879447|Effectiveness|effectiveness
5018799|NCT03879447|Numeric Rating Scale|numeric rating scale
5018800|NCT03879447|Safety|safety
5018801|NCT03879447|Walking ability|walking ability
5018802|NCT03879447|Disability|disability
5018803|NCT03879408|Analgesics|analgesics
5018804|NCT03879408|Dental Pain|dental pain
5018805|NCT03879408|Naproxen|naproxen
5018806|NCT03879408|Acetaminophen|acetaminophen
5018807|NCT03879408|Pain|pain
5018808|NCT03879395|melanoma|melanoma
5018809|NCT03879395|abdominal metastasis|abdominal metastasis
5018810|NCT03879395|metastasectomy|metastasectomy
5018811|NCT03879395|tumor resection|tumor resection
5018812|NCT03879395|M1c|m1c
5018813|NCT03879382|CD19/BCMA|cd19/bcma
5018814|NCT03879382|Bispecific CAR-T Cell|bispecific car-t cell
5018818|NCT03879356|N-acetylcystein|n-acetylcystein
5018819|NCT03879356|Assiut|assiut
5018820|NCT03879356|prognostic factors|prognostic factors
5018821|NCT03879304|Virtual Reality [L01.224.160.875], [L01.296.555]|virtual reality [l01.224.160.875], [l01.296.555]
5018822|NCT03879304|Physical Therapy Modalities [E02.779], [E02.831.535]|physical therapy modalities [e02.779], [e02.831.535]
5018823|NCT03879304|Respiratory Therapy [E02.880]|respiratory therapy [e02.880]
5018824|NCT03879304|Dystrophin [D12.776.210.500.250]|dystrophin [d12.776.210.500.250]
5018825|NCT03879304|Becker Muscular Dystrophy [C10.668.491.175.500.300]|becker muscular dystrophy [c10.668.491.175.500.300]
5018826|NCT03879304|Resistance training [E02.831.535.483.875]|resistance training [e02.831.535.483.875]
5018827|NCT03879304|Muscular Stretching Therapy [E02.831.535.483.750]|muscular stretching therapy [e02.831.535.483.750]
5018828|NCT03879265|Diagnosis|diagnosis
5018829|NCT03879265|Reproduction|reproduction
5018830|NCT03879265|Chromosomal Endowment|chromosomal endowment
5018831|NCT03879226|Photobiomodulation Therapy|photobiomodulation therapy
5018832|NCT03879226|Low-level Laser Therapy|low-level laser therapy
5020880|NCT03866356|Nursing|nursing
5018844|NCT03879174|HR Positive Breast Cancer|hr positive breast cancer
5018845|NCT03879161|Ultrasound|ultrasound
5018846|NCT03879161|Femoral Artery|femoral artery
5018847|NCT03879161|Intra-arterial|intra-arterial
5018848|NCT03879161|Catheterization|catheterization
5018849|NCT03879161|Liver Neoplasms|liver neoplasms
5018850|NCT03879148|Erector spinae plane block|erector spinae plane block
5018851|NCT03879148|Video assisted thoracic surgery|video assisted thoracic surgery
5018852|NCT03879148|Postoperative analgesia|postoperative analgesia
5018853|NCT03879122|prostate cancer|prostate cancer
5018854|NCT03879122|immunotherapy|immunotherapy
5018858|NCT03879096|cancer|cancer
5018859|NCT03879096|oncology|oncology
5018860|NCT03879096|Metastasis|metastasis
5018861|NCT03879096|survivors|survivors
5018862|NCT03879096|Exercise Therapy|exercise therapy
5018863|NCT03879096|Therapeutics|therapeutics
5018864|NCT03879096|Complementary Therapies|complementary therapies
5018865|NCT03879096|fatigue|fatigue
5018866|NCT03879096|assesment|assesment
5018867|NCT03879044|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5018868|NCT03879031|lumbar|lumbar
5018869|NCT03879031|physical endurance|physical endurance
5018870|NCT03879031|pain|pain
5018871|NCT03879031|disability|disability
5018872|NCT03879031|assessment|assessment
5018873|NCT03879018|Cerebellar Ataxia|cerebellar ataxia
5018874|NCT03878992|Growth hormone|growth hormone
5018875|NCT03878992|Satellite cells|satellite cells
5018876|NCT03878992|Metabolism|metabolism
5018877|NCT03878992|insulin-like effects|insulin-like effects
5018878|NCT03878927|AML|aml
5018879|NCT03878927|De novo AML|de novo aml
5018880|NCT03878927|Secondary AML|secondary aml
5018881|NCT03878927|Therapy-related AML|therapy-related aml
5018882|NCT03878914|Nephrotic sydrome|nephrotic sydrome
5018883|NCT03878914|Steroid sensitive nephrotic syndrome|steroid sensitive nephrotic syndrome
5018884|NCT03878901|hypothermia|hypothermia
5018885|NCT03878888|liposomal bupivacaine|liposomal bupivacaine
5018886|NCT03878888|TAP block|tap block
5018887|NCT03878888|pain control|pain control
5018888|NCT03878823|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5018889|NCT03878823|advanced hormone receptor positive breast cancer|advanced hormone receptor positive breast cancer
5018890|NCT03878797|Endotracheal tube|endotracheal tube
5018891|NCT03878797|Endobronchial intubation|endobronchial intubation
5018892|NCT03878797|Vocal cords|vocal cords
5018893|NCT03878797|Bronchoscopy|bronchoscopy
5018894|NCT03878771|Platelet rich fibrin, Oral Ulcer, Pain, Mucositis|platelet rich fibrin, oral ulcer, pain, mucositis
5018895|NCT03878719|Adolescent|adolescent
5018896|NCT03878719|BRAF V600K|braf v600k
5018897|NCT03878719|BRAF V600E|braf v600e
5019026|NCT03877757|Implementation science|implementation science
5018898|NCT03878706|Endothelial glycocalyx integrity|endothelial glycocalyx integrity
5018899|NCT03878706|Oxidative stress biomarkers|oxidative stress biomarkers
5018900|NCT03878706|Arterial stiffness|arterial stiffness
5018901|NCT03878706|GLS|gls
5018902|NCT03878667|Calcium Supplementation|calcium supplementation
5018903|NCT03878667|Exercise Intervention|exercise intervention
5018904|NCT03878615|liver surgery|liver surgery
5018905|NCT03878615|hepatic resection|hepatic resection
5018906|NCT03878615|inflammation|inflammation
5018907|NCT03878615|organ dysfunction|organ dysfunction
5018908|NCT03878615|blood loss|blood loss
5018914|NCT03878576|glycemic response|glycemic response
5018915|NCT03878576|bread|bread
5018916|NCT03878576|barley|barley
5018917|NCT03878576|beta-glucans|beta-glucans
5018918|NCT03878576|glucose level|glucose level
5018919|NCT03878576|continous glucose monitoring|continous glucose monitoring
5018920|NCT03878563|intestinal barrier dysfunction|intestinal barrier dysfunction
5018921|NCT03878498|Crohn disease|crohn disease
5018922|NCT03878498|anal fistula|anal fistula
5018923|NCT03878498|anal surgery|anal surgery
5356903|NCT01917565|Macintosh laryngoscope|macintosh laryngoscope
5018924|NCT03878459|T1DM,ketoacidosis, dapagliflozin, pioglitazone|t1dm,ketoacidosis, dapagliflozin, pioglitazone
5018925|NCT03878420|Dry AMD|dry amd
5018926|NCT03878420|Photobiomodulation|photobiomodulation
5018927|NCT03878420|Visual Acuity|visual acuity
5018928|NCT03878420|Contrast Sensitivity|contrast sensitivity
5018929|NCT03878420|Optical Coherence Tomography|optical coherence tomography
5018930|NCT03878420|Drusen|drusen
5018931|NCT03878407|ARCH|arch
5018932|NCT03878394|balance|balance
5018933|NCT03878394|cognitive function|cognitive function
5018934|NCT03878394|healthy individuals|healthy individuals
5018935|NCT03878394|quality of life|quality of life
5018961|NCT03878173|analgesic|analgesic
5018962|NCT03878173|paracetamol|paracetamol
5018963|NCT03878173|acetaminophen|acetaminophen
5018964|NCT03878160|Mindfulness|mindfulness
5018965|NCT03878160|Acute Coronary Syndrome|acute coronary syndrome
5018966|NCT03878160|Videoconferencing|videoconferencing
5018967|NCT03878160|Depression|depression
5018971|NCT03878121|Ad4-Env150KN|ad4-env150kn
5018972|NCT03878121|Ad4-Env145NFL|ad4-env145nfl
5018973|NCT03878121|VRC-HIVRGP096-00-VP (Trimer 4571) with alum|vrc-hivrgp096-00-vp (trimer 4571) with alum
5018974|NCT03878121|Adenovirus|adenovirus
5018975|NCT03878121|HIV Vaccine|hiv vaccine
5018976|NCT03878108|Accelerometry|accelerometry
5018977|NCT03878108|Body Composition|body composition
5018978|NCT03878108|Body Weight Regulation|body weight regulation
5018979|NCT03878108|Calories|calories
5018980|NCT03878108|Energy Expenditure|energy expenditure
5018981|NCT03878082|cesarean section|cesarean section
5018982|NCT03878082|uterine contraction pain|uterine contraction pain
5018983|NCT03878082|propacetamol|propacetamol
5018984|NCT03878043|subdural hematoma|subdural hematoma
5018985|NCT03878043|readmission|readmission
5018986|NCT03878043|risk factors|risk factors
5018987|NCT03878004|Tuberculosis|tuberculosis
5018988|NCT03878004|Mycobacterium tuberculosis|mycobacterium tuberculosis
5018989|NCT03878004|Recombinant vaccine|recombinant vaccine
5018990|NCT03878004|Mycobacterium Infections|mycobacterium infections
5018991|NCT03878004|Vaccines|vaccines
5018992|NCT03877991|Bioavailability|bioavailability
5018993|NCT03877991|Pharmacokinetics|pharmacokinetics
5018994|NCT03877939|Ectopic pregnancy|ectopic pregnancy
5018995|NCT03877939|non-viable pregnancy|non-viable pregnancy
5018997|NCT03877939|Kisspeptin|kisspeptin
5018998|NCT03877939|β-HCG|β-hcg
5018999|NCT03877939|biomarkers|biomarkers
5019000|NCT03877926|Anthrax|anthrax
5019001|NCT03877926|AV7909|av7909
5019002|NCT03877926|BioThrax|biothrax
5019003|NCT03877926|Bacillus anthracis|bacillus anthracis
5019004|NCT03877926|Anthrax Vaccine Adsorbed|anthrax vaccine adsorbed
5331040|NCT02035527|head and neck|head and neck
5019005|NCT03877926|Post-exposure Prophylaxis|post-exposure prophylaxis
5019006|NCT03877926|Vaccine|vaccine
5019007|NCT03877926|CPG 7909|cpg 7909
5019008|NCT03877926|Adjuvant|adjuvant
5019009|NCT03877913|atrial fibrillation|atrial fibrillation
5019010|NCT03877913|ablation|ablation
5019011|NCT03877913|electrocardiographic monitoring|electrocardiographic monitoring
5019803|NCT03873285|children|children
5019014|NCT03877900|fetal death|fetal death
5019015|NCT03877900|neonatal death|neonatal death
5019016|NCT03877900|Minimally Invasive Autopsy|minimally invasive autopsy
5019017|NCT03877900|Tissue samplings|tissue samplings
5019018|NCT03877848|bleeding|bleeding
5019019|NCT03877848|PCI|pci
5019020|NCT03877809|Fetal hemoglobin|fetal hemoglobin
5019021|NCT03877809|Sirolimus|sirolimus
5019022|NCT03877809|Red Blood Cells|red blood cells
5019025|NCT03877757|Family Planning|family planning
5019027|NCT03877757|Evaluation|evaluation
5019028|NCT03877757|Contraceptive initiative|contraceptive initiative
5019029|NCT03877731|hypertrophic cardiomyopathy, mitral valve, echocardiography|hypertrophic cardiomyopathy, mitral valve, echocardiography
5019030|NCT03877718|Acute Migraine Pain|acute migraine pain
5019031|NCT03877718|Acute Migraine Pain, With or Without Aura|acute migraine pain, with or without aura
5019032|NCT03877718|Prevention of Migraine Associated Nausea and Vomiting (MANV)|prevention of migraine associated nausea and vomiting (manv)
5019033|NCT03877705|Dental Plaque , salivary pH|dental plaque , salivary ph
5019034|NCT03877692|Hypertension|hypertension
5019035|NCT03877692|Labetalol|labetalol
5019036|NCT03877679|oral lichen planus|oral lichen planus
5019037|NCT03877679|curcumin|curcumin
5019039|NCT03877679|corticosteroids|corticosteroids
5019041|NCT03877653|Chronic|chronic
5019042|NCT03877653|Pain|pain
5019043|NCT03877653|Wireless|wireless
5019044|NCT03877653|Neuromodulation|neuromodulation
5019045|NCT03877640|incontinence|incontinence
5019046|NCT03877640|stress urgency incontinence|stress urgency incontinence
5019047|NCT03877640|urge incontinence|urge incontinence
5019048|NCT03877640|EMSELLA|emsella
5019049|NCT03877601|Fluorescence|fluorescence
5019050|NCT03877601|Endoscopy|endoscopy
5019060|NCT03877484|chronic and acute wounds|chronic and acute wounds
5019061|NCT03877484|full-thickness|full-thickness
5019062|NCT03877484|partial thickness|partial thickness
5019063|NCT03877484|shadow granulating|shadow granulating
5019064|NCT03877484|exuding wounds|exuding wounds
5019065|NCT03877484|including pressure ulcers|including pressure ulcers
5019066|NCT03877484|leg ulcers|leg ulcers
5019067|NCT03877484|diabetic foot ulcers|diabetic foot ulcers
5019068|NCT03877484|dehisced surgical wounds|dehisced surgical wounds
5019069|NCT03877471|Mesenchymal stem cell|mesenchymal stem cell
5019070|NCT03877471|Transplantation|transplantation
5019071|NCT03877471|Human embryonic stem cell|human embryonic stem cell
5019072|NCT03877471|Premature ovarian failure|premature ovarian failure
5019073|NCT03877458|Infantile Colic|infantile colic
5019074|NCT03877458|Bifidobacteria and Lactobacilli|bifidobacteria and lactobacilli
5019075|NCT03877458|Intestinal Microbiome|intestinal microbiome
5019076|NCT03877458|Probiotics|probiotics
5019077|NCT03877419|dental implant|dental implant
5019078|NCT03877419|bone quality|bone quality
5019079|NCT03877419|tactile sensation|tactile sensation
5019080|NCT03877419|drilling speed|drilling speed
5019081|NCT03877406|Sodium-glucose transporter 2 inhibitor|sodium-glucose transporter 2 inhibitor
5019082|NCT03877393|Probiotics; dietary supplements|probiotics; dietary supplements
5019083|NCT03877393|Diet, Gluten-Free|diet, gluten-free
5019084|NCT03877393|Inflammation|inflammation
5019085|NCT03877393|Gastrointestinal Microbiome|gastrointestinal microbiome
5019086|NCT03877393|Intestinal mucosal permeability|intestinal mucosal permeability
5019087|NCT03877393|Gut-brain axis|gut-brain axis
5019088|NCT03877393|Gut permeability|gut permeability
5019089|NCT03877393|EEG functional connectivity|eeg functional connectivity
5019090|NCT03877393|Cortisol|cortisol
5019091|NCT03877393|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
5019092|NCT03877393|Cognitive function|cognitive function
5019093|NCT03877380|personalised autonomy allowance|personalised autonomy allowance
5019094|NCT03877380|difficulties|difficulties
5019095|NCT03877380|physician's role|physician's role
5019096|NCT03877367|Chiropractic manipulation|chiropractic manipulation
5019097|NCT03877367|Extremity manipulation|extremity manipulation
5019098|NCT03877367|Balance task|balance task
5019099|NCT03877354|ventilation|ventilation
5019100|NCT03877354|paediatric patient|paediatric patient
5019101|NCT03877354|mechanical ventilation|mechanical ventilation
5019105|NCT03877302|Birth|birth
5019106|NCT03877302|Reflexology|reflexology
5019107|NCT03877302|Pain|pain
5019108|NCT03877289|pediatrics|pediatrics
5019109|NCT03877289|cystitis|cystitis
5019110|NCT03877289|UTI|uti
5019111|NCT03877289|oxybutynin|oxybutynin
5019112|NCT03877276|dietary oxalate|dietary oxalate
5019113|NCT03877276|diet therapy|diet therapy
5019114|NCT03877263|Chlamydia Trachomatis|chlamydia trachomatis
5019115|NCT03877263|Neisseria gonorrhoeae|neisseria gonorrhoeae
5019116|NCT03877250|PD-L1 High|pd-l1 high
5019117|NCT03877250|19-030|19-030
5019118|NCT03877250|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5019119|NCT03877211|speech audiometry|speech audiometry
5019120|NCT03877211|psychophysical tuning curve|psychophysical tuning curve
5019121|NCT03877211|electrophysiology|electrophysiology
5019122|NCT03877211|auditory brainstem response|auditory brainstem response
5019123|NCT03877185|IVF|ivf
5019124|NCT03877185|infertility|infertility
5019125|NCT03877185|long antagonist|long antagonist
5019126|NCT03877185|long acting gonadotropin|long acting gonadotropin
5019127|NCT03877185|corifollitropin alfa|corifollitropin alfa
5019128|NCT03877185|ovarian stimulation|ovarian stimulation
5019129|NCT03877146|Controlled Breathing|controlled breathing
5019130|NCT03877146|MRI-Guided Breast Biopsy|mri-guided breast biopsy
5019141|NCT03877120|Dexmedetomidine|dexmedetomidine
5019142|NCT03877120|Diazepam|diazepam
5033946|NCT03786874|teamwork|teamwork
5019157|NCT03877081|Acute kidney injury|acute kidney injury
5019158|NCT03877081|Probiotics|probiotics
5019160|NCT03877081|Shock|shock
5019161|NCT03877068|Glycemic control|glycemic control
5019162|NCT03877068|Bedside point-of-care capillary glucose monitoring|bedside point-of-care capillary glucose monitoring
5019163|NCT03877068|POC|poc
5019164|NCT03877068|Dexcom|dexcom
5019165|NCT03877068|Continuous glucose monitoring|continuous glucose monitoring
5019166|NCT03877068|Hyperglycemia|hyperglycemia
5019167|NCT03877068|Inpatient|inpatient
5019168|NCT03877055|Copanlisib|copanlisib
5019169|NCT03877055|Ibrutinib|ibrutinib
5019170|NCT03877055|18-450|18-450
5019171|NCT03877042|Total Knee Arthroplasty|total knee arthroplasty
5019172|NCT03877042|CR|cr
5019173|NCT03877042|PS|ps
5019174|NCT03877029|Mammography|mammography
5019175|NCT03877029|Breast cancer screening|breast cancer screening
5019176|NCT03877029|Health related quality of life|health related quality of life
5019177|NCT03877029|Long-term effects of breast cancer treatment|long-term effects of breast cancer treatment
5019178|NCT03877029|Screen-detected breast cancer|screen-detected breast cancer
5019179|NCT03877029|Symptomatic breast cancer|symptomatic breast cancer
5019180|NCT03877029|Tumor characteristics|tumor characteristics
5019181|NCT03877029|Interval breast cancer|interval breast cancer
5019182|NCT03877016|neuropathic pain|neuropathic pain
5019183|NCT03877016|electrical nerve stimulation therapy|electrical nerve stimulation therapy
5019184|NCT03877016|patient report outcomes|patient report outcomes
5019185|NCT03877016|non-pharmalogical treatment|non-pharmalogical treatment
5019186|NCT03877003|eggs,|eggs,
5019187|NCT03877003|choline|choline
5019188|NCT03877003|metabolic syndrome|metabolic syndrome
5019189|NCT03877003|TMAO|tmao
5019190|NCT03876990|multiplex PCR|multiplex pcr
5019191|NCT03876990|blood culture|blood culture
5019192|NCT03876990|rapid diagnosis|rapid diagnosis
5019193|NCT03876951|breast cancer|breast cancer
5019194|NCT03876951|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5019195|NCT03876951|vacuum-assisted biopsy|vacuum-assisted biopsy
5019196|NCT03876951|pathological complete response|pathological complete response
5019197|NCT03876925|RCC|rcc
5019198|NCT03876912|Prostate Specific Membrane Antigen|prostate specific membrane antigen
5019199|NCT03876912|GnRH antagonist|gnrh antagonist
5019200|NCT03876912|Positron Emission Tomography|positron emission tomography
5019201|NCT03876912|PSMA-PET/CT|psma-pet/ct
5436726|NCT01558934|ECG|ecg
5335541|NCT02014896|tPA|tpa
5019202|NCT03876886|homologous recombination deficiency;adjuvant chemotherapy;anthracycline;taxanes;platinum|homologous recombination deficiency;adjuvant chemotherapy;anthracycline;taxanes;platinum
5019203|NCT03876873|Face Mask|face mask
5019204|NCT03876873|Obesity|obesity
5019205|NCT03876873|Anesthetized Adult|anesthetized adult
5019206|NCT03876873|Ventilation|ventilation
5019207|NCT03876873|Head Rotation|head rotation
5019208|NCT03876860|Vaginal dilator|vaginal dilator
5019211|NCT03876834|chemotherapy|chemotherapy
5019212|NCT03876834|respiratory training|respiratory training
5019213|NCT03876808|temperature|temperature
5019214|NCT03876808|prewarming|prewarming
5019215|NCT03876808|convective warming|convective warming
5019216|NCT03876808|thermoregulation|thermoregulation
5019217|NCT03876808|gastrointestinal surgery|gastrointestinal surgery
5019218|NCT03876808|genitourinary surgery|genitourinary surgery
5019219|NCT03876795|Bone Marrow Comcentrate|bone marrow comcentrate
5019220|NCT03876795|intra-articular|intra-articular
5019221|NCT03876795|intra-osseus|intra-osseus
5019222|NCT03876782|cataract surgery|cataract surgery
5019223|NCT03876782|Verion Image-Guided System|verion image-guided system
5019224|NCT03876782|IOLMaster|iolmaster
5019225|NCT03876782|IOL calculation|iol calculation
5019226|NCT03876782|keratometry|keratometry
5034040|NCT03786315|Older age|older age
5019227|NCT03876782|corneal power|corneal power
5019228|NCT03876782|toric IOL|toric iol
5019230|NCT03876769|Kymriah|kymriah
5019231|NCT03876769|B-Cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
5019232|NCT03876769|ALL|all
5019240|NCT03876678|Hyperbilirubinemia|hyperbilirubinemia
5019241|NCT03876678|Jaundice|jaundice
5019242|NCT03876678|Probiotics|probiotics
5019243|NCT03876678|Intestinal microbial flora|intestinal microbial flora
5019244|NCT03876665|Polycystic Ovary Syndrome|polycystic ovary syndrome
5019245|NCT03876665|Military|military
5019246|NCT03876665|Service Women|service women
5019247|NCT03876665|Active Duty|active duty
5019248|NCT03876652|Syncope|syncope
5019249|NCT03876652|Presyncope|presyncope
5019250|NCT03876652|Time|time
5019251|NCT03876652|Vasovagal|vasovagal
5019252|NCT03876652|Unconsciousness|unconsciousness
5019253|NCT03876639|Water-in-oil emulsion|water-in-oil emulsion
5019254|NCT03876639|Confocal Raman spectroscopy|confocal raman spectroscopy
5019255|NCT03876639|Skin parameters|skin parameters
5019256|NCT03876639|Tape stripping|tape stripping
5019257|NCT03876600|pacemaker|pacemaker
5019258|NCT03876600|replace for elective wear|replace for elective wear
5019259|NCT03876600|french context|french context
5019260|NCT03876600|cost-utility analysis|cost-utility analysis
5019261|NCT03876600|prospective|prospective
5019262|NCT03876600|multicentric|multicentric
5019263|NCT03876600|randomized study|randomized study
5019264|NCT03876587|Metastatic Breast Cancer|metastatic breast cancer
5019265|NCT03876587|Pyrotinib Maleate|pyrotinib maleate
5019266|NCT03876587|HER2 Targeted Therapy|her2 targeted therapy
5019267|NCT03876574|Hepatic artery infusion pump|hepatic artery infusion pump
5019268|NCT03876574|Gemcitabine|gemcitabine
5019269|NCT03876574|Floxuridine|floxuridine
5019270|NCT03876548|keloid|keloid
5019271|NCT03876522|Lafora Disease|lafora disease
5019272|NCT03876522|EPM2A|epm2a
5019273|NCT03876522|EPM2B|epm2b
5019274|NCT03876522|Myoclonus epilepsy|myoclonus epilepsy
5019275|NCT03876522|Myoclonic seizures|myoclonic seizures
5019276|NCT03876522|Glycogen storage disease|glycogen storage disease
5019277|NCT03876509|impedance cardiography|impedance cardiography
5019278|NCT03876496|fall prevention|fall prevention
5019279|NCT03876496|bed fall|bed fall
5019280|NCT03876496|acute care|acute care
5019281|NCT03876496|patient safety|patient safety
5019282|NCT03876496|patient monitoring|patient monitoring
5019283|NCT03876496|health technology assessment|health technology assessment
5019284|NCT03876496|sensor devices and platforms|sensor devices and platforms
5019285|NCT03876496|nursing|nursing
5019286|NCT03876483|HIV|hiv
5019287|NCT03876483|Adolescents|adolescents
5019288|NCT03876483|ART|art
5019289|NCT03876470|Hepatitis C|hepatitis c
5019290|NCT03876470|Telehealth|telehealth
5019291|NCT03876470|Injection Drug Use|injection drug use
5019292|NCT03876457|Ischemic stroke|ischemic stroke
5019293|NCT03876457|Large vessel occlusion|large vessel occlusion
5019294|NCT03876457|Endovascular thrombectomy|endovascular thrombectomy
5019295|NCT03876444|Hypsarrythmia|hypsarrythmia
5019296|NCT03876444|Methylprednisolone|methylprednisolone
5019297|NCT03876444|Prednisolone|prednisolone
5019301|NCT03876405|hand prosthesis|hand prosthesis
5019302|NCT03876405|sensory feedback|sensory feedback
5019303|NCT03876405|amputation|amputation
5019304|NCT03876405|upper limb|upper limb
5019305|NCT03876379|Depth of anesthesia|depth of anesthesia
5019306|NCT03876379|brain fragility|brain fragility
5019307|NCT03876379|electrographic suppression|electrographic suppression
5019308|NCT03876379|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5019309|NCT03876366|cancer patients|cancer patients
5019310|NCT03876366|male cancer patients|male cancer patients
5019315|NCT03876340|Clinical decision rule|clinical decision rule
5019316|NCT03876340|Length of stay|length of stay
5019317|NCT03876340|Cost of treatment|cost of treatment
5019323|NCT03876236|Reproducibility of Results|reproducibility of results
5019325|NCT03876236|Healthy Volunteers|healthy volunteers
5019326|NCT03876223|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
5019327|NCT03876223|Coronary Vascular Dysfunction (CVD)|coronary vascular dysfunction (cvd)
5019328|NCT03876223|Coronary angiography|coronary angiography
5019329|NCT03876223|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5019330|NCT03876197|Xerostomia Due to Radiotherapy|xerostomia due to radiotherapy
5019331|NCT03876184|tooth alignment|tooth alignment
5019332|NCT03876184|coating loss|coating loss
5019333|NCT03876184|color change|color change
5019334|NCT03876184|patient perception|patient perception
5019335|NCT03876184|aesthetic archwire|aesthetic archwire
5019348|NCT03876028|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5019349|NCT03876028|DLBCL|dlbcl
5019350|NCT03876028|r/r Diffuse Large B-cell Lymphoma|r/r diffuse large b-cell lymphoma
5019351|NCT03876028|relapsed/refractory DLBCL|relapsed/refractory dlbcl
5019352|NCT03876028|CTL019|ctl019
5019353|NCT03876028|Tisagenlecleucel|tisagenlecleucel
5019354|NCT03876028|Ibrutinib|ibrutinib
5019355|NCT03876002|HV|hv
5019356|NCT03876002|ALS|als
5019357|NCT03875989|Prolapse|prolapse
5019358|NCT03875989|Vaginal native tissues repair|vaginal native tissues repair
5019359|NCT03875989|Pelvic organ|pelvic organ
5019360|NCT03875976|fast track care|fast track care
5019361|NCT03875976|total hip arthroplasty|total hip arthroplasty
5019362|NCT03875963|Infection|infection
5019363|NCT03875963|Antibiotic bone cement|antibiotic bone cement
5019364|NCT03875963|Tibia nonunion|tibia nonunion
5019365|NCT03875950|Adolescents|adolescents
5019366|NCT03875950|Young women|young women
5014031|NCT03909178|Tonnis|tonnis
5019367|NCT03875950|HIV care and treatment|hiv care and treatment
5019368|NCT03875950|Clinical training|clinical training
5019369|NCT03875950|Africa|africa
5019370|NCT03875950|Kenya|kenya
5019374|NCT03875911|Trabeculectomy|trabeculectomy
5019375|NCT03875911|Mitomycin-C|mitomycin-c
5019376|NCT03875911|Glaucoma|glaucoma
5019378|NCT03875872|propofol, inhalation anaesthetics, postoperative outcomes, regression control|propofol, inhalation anaesthetics, postoperative outcomes, regression control
5019379|NCT03875846|Intraoperative Decision Making|intraoperative decision making
5019380|NCT03875846|Revascularization|revascularization
5019381|NCT03875846|Physiologic Monitoring Feedback|physiologic monitoring feedback
5019384|NCT03875807|ACL|acl
5019385|NCT03875807|ACL reconstruction|acl reconstruction
5019386|NCT03875807|Knee Flexion Angle|knee flexion angle
5019387|NCT03875807|Bone Patellar Tendon Bone|bone patellar tendon bone
5019388|NCT03875794|Lactation; Insufficient, Partial|lactation; insufficient, partial
5019389|NCT03875794|Lactating Female|lactating female
5019390|NCT03875781|Rectal cancer|rectal cancer
5019391|NCT03875781|FOLFIRINOX,|folfirinox,
5019392|NCT03875781|chemotherapy|chemotherapy
5019393|NCT03875781|radiochemotherapy|radiochemotherapy
5019394|NCT03875781|surgery|surgery
5019395|NCT03875768|Digital Health|digital health
5019396|NCT03875768|Dash Diet|dash diet
5019397|NCT03875755|Diabetes|diabetes
5019398|NCT03875755|Pregnancy|pregnancy
5019399|NCT03875755|MYO-INOSITOL|myo-inositol
5019400|NCT03875755|Oral supplementation|oral supplementation
5019401|NCT03875742|simulation|simulation
5019402|NCT03875742|interfascial blocks|interfascial blocks
5019403|NCT03875742|TAP block|tap block
5019404|NCT03875742|needles|needles
5019406|NCT03875703|Biological Collection|biological collection
5019407|NCT03875703|Vaccination|vaccination
5019413|NCT03875625|Dietitian Lifestyle intervention|dietitian lifestyle intervention
5019414|NCT03875625|Bariatric surgery|bariatric surgery
5019415|NCT03875625|Brown adipose tissue|brown adipose tissue
5019416|NCT03875625|White adipose tissue|white adipose tissue
5019417|NCT03875625|no alcoholic fatty liver disease|no alcoholic fatty liver disease
5019418|NCT03875625|diabetes mellitus type 2|diabetes mellitus type 2
5019419|NCT03875625|Pancreatic fat|pancreatic fat
5019420|NCT03875612|Inferior Mesenteric Artery|inferior mesenteric artery
5019421|NCT03875612|Computerized Tomography|computerized tomography
5717544|NCT00440388|AT-101|at-101
5019424|NCT03875599|PRAISE|praise
5019425|NCT03875586|Reasons for consultation|reasons for consultation
5019426|NCT03875586|Family Medicine|family medicine
5019427|NCT03875573|Breast Cancer|breast cancer
5019428|NCT03875534|Achondroplasia|achondroplasia
5019429|NCT03875534|Dwarfism|dwarfism
5019430|NCT03875521|Work Schedule Tolerance|work schedule tolerance
5019431|NCT03875521|Observational Study|observational study
5019432|NCT03875521|Intensive Care Units/manpower|intensive care units/manpower
5019433|NCT03875521|Job Satisfaction|job satisfaction
5019434|NCT03875508|Psoriasis|psoriasis
5019435|NCT03875508|Risankizumab|risankizumab
5019436|NCT03875508|Plaque Psoriasis|plaque psoriasis
5019437|NCT03875495|Temferon|temferon
5019438|NCT03875495|Gene Therapy|gene therapy
5019439|NCT03875495|Immunotherapy|immunotherapy
5019440|NCT03875495|Hematological malignancy|hematological malignancy
5019441|NCT03875482|Risankizumab|risankizumab
5019442|NCT03875482|Psoriasis|psoriasis
5019443|NCT03875482|Plaque Psoriasis|plaque psoriasis
5019444|NCT03875469|Contrast-enhanced computed tomography (CECT)|contrast-enhanced computed tomography (cect)
5019445|NCT03875469|Injector|injector
5019463|NCT03875417|TACE|tace
5019464|NCT03875404|Deep Brain Stimulation|deep brain stimulation
5019468|NCT03875352|central venous catheter|central venous catheter
5019469|NCT03875352|reddening|reddening
5019470|NCT03875352|dressing|dressing
5019471|NCT03875352|hydrophilic methacrylate gel|hydrophilic methacrylate gel
5019472|NCT03875352|chlorhexidine gluconate|chlorhexidine gluconate
5019475|NCT03875326|Dementia|dementia
5019476|NCT03875326|Memory|memory
5019477|NCT03875326|Cognitive Rehabilitation|cognitive rehabilitation
5019478|NCT03875326|PET scan|pet scan
5019479|NCT03875326|fMRI|fmri
5019480|NCT03875326|Brain Stimulation|brain stimulation
5019481|NCT03875313|Tumor Metabolism|tumor metabolism
5019482|NCT03875313|Glutaminase Inhibitor|glutaminase inhibitor
5019483|NCT03875313|CB-839|cb-839
5019484|NCT03875313|telaglenastat|telaglenastat
5019485|NCT03875313|talazoparib|talazoparib
5019486|NCT03875313|PARP Inhibitor|parp inhibitor
5019487|NCT03875313|DNA Damage|dna damage
5019488|NCT03875313|DNA Repair|dna repair
5019489|NCT03875313|Homologous recombination deficiency|homologous recombination deficiency
5019490|NCT03875313|HRD|hrd
5019491|NCT03875313|BRCA 1|brca 1
5019492|NCT03875313|BRCA 2|brca 2
5019497|NCT03875196|Stress urinary incontinence|stress urinary incontinence
5019498|NCT03875196|quality of life|quality of life
5019499|NCT03875196|sexual function|sexual function
5019500|NCT03875183|Heart failure|heart failure
5019501|NCT03875170|Proprioceptive Neuromuscular Facilitation|proprioceptive neuromuscular facilitation
5019502|NCT03875170|Range of motion|range of motion
5019503|NCT03875170|Stretching|stretching
5019504|NCT03875170|Muscle strength|muscle strength
5019505|NCT03875170|Randomized clinical trial|randomized clinical trial
5019506|NCT03875144|Peritoneal mesothelioma|peritoneal mesothelioma
5019507|NCT03875144|PIPAC|pipac
5019519|NCT03875066|Neurological condition|neurological condition
5019520|NCT03875066|Walking ability|walking ability
5019521|NCT03875066|Feedback|feedback
5019522|NCT03875066|External information|external information
5019523|NCT03875040|kinesiophobia|kinesiophobia
5019524|NCT03875040|osteoarthritis|osteoarthritis
5019525|NCT03875040|fear of movement|fear of movement
5019526|NCT03875040|tampa|tampa
5019527|NCT03875040|physical inactivity|physical inactivity
5019528|NCT03875027|proximal femur|proximal femur
5019529|NCT03875027|functional outcome|functional outcome
5019530|NCT03875027|fracture|fracture
5019531|NCT03875027|failed hip surgery|failed hip surgery
5019532|NCT03875014|dual mobility cup|dual mobility cup
5019533|NCT03875014|total hip repcament|total hip repcament
5019534|NCT03875014|bipolar hemiarthroplasty|bipolar hemiarthroplasty
5019535|NCT03875014|dislocation|dislocation
5717545|NCT00440388|AT101|at101
5019536|NCT03874962|Oral care intervention|oral care intervention
5019537|NCT03874962|Nursing home residents|nursing home residents
5019538|NCT03874936|postoperative pain|postoperative pain
5019539|NCT03874936|dexamethasone|dexamethasone
5019540|NCT03874936|pain management|pain management
5019541|NCT03874923|fluid expansion|fluid expansion
5019542|NCT03874923|oxygen delivery|oxygen delivery
5019543|NCT03874923|tissue perfusion|tissue perfusion
5019544|NCT03874923|cardiac output|cardiac output
5019545|NCT03874897|Advanced solid tumor|advanced solid tumor
5019546|NCT03874897|claudin18.2|claudin18.2
5019547|NCT03874897|CAR-T cell therapy|car-t cell therapy
5019548|NCT03874871|gastric cancer|gastric cancer
5019549|NCT03874871|function preserving gastrectomy|function preserving gastrectomy
5019551|NCT03874858|CML-CP|cml-cp
5019552|NCT03874858|TFR|tfr
5019553|NCT03874858|nilotinib|nilotinib
5019554|NCT03874858|AMN107|amn107
5019555|NCT03874858|Tasigna|tasigna
5019556|NCT03874858|DMR|dmr
5019557|NCT03874858|sustained deep molecular response|sustained deep molecular response
5019558|NCT03874858|full treatment-free remission|full treatment-free remission
5019559|NCT03874858|TKI|tki
5019560|NCT03874858|qPCR|qpcr
5019561|NCT03874858|adult|adult
5019566|NCT03874832|dihydroergotamine|dihydroergotamine
5019567|NCT03874832|dihydroergotamine mesylate|dihydroergotamine mesylate
5019568|NCT03874832|migraine|migraine
5019579|NCT03874728|Falls|falls
5019580|NCT03874728|Gait|gait
5019581|NCT03874728|Stability|stability
5019582|NCT03874728|Muscle activity|muscle activity
5019583|NCT03874728|Footwear|footwear
5019584|NCT03874728|Minimal shoes|minimal shoes
5019585|NCT03874728|Smart shoe insoles|smart shoe insoles
5019586|NCT03874702|stroke|stroke
5019587|NCT03874702|artificial intelligence|artificial intelligence
5019588|NCT03874702|ischemic stroke|ischemic stroke
5019589|NCT03874689|Neurocysticercosis|neurocysticercosis
5019594|NCT03874650|acquired brain injury|acquired brain injury
5019595|NCT03874650|traumatic brain injury|traumatic brain injury
5019596|NCT03874650|depression|depression
5019597|NCT03874650|rehabilitation|rehabilitation
5019598|NCT03874650|executive function|executive function
5019599|NCT03874637|Overactive Bladder|overactive bladder
5019600|NCT03874637|Women|women
5019601|NCT03874637|Neuromodulation|neuromodulation
5019602|NCT03874637|Bioelectronic Medicine|bioelectronic medicine
5019603|NCT03874637|Non-significant Risk|non-significant risk
5019604|NCT03874598|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5019605|NCT03874598|Acupuncture, Ear|acupuncture, ear
5019606|NCT03874598|Cytokines|cytokines
5019607|NCT03874598|Breast Neoplasm|breast neoplasm
5019608|NCT03874572|Xerostomia Due to Radiotherapy|xerostomia due to radiotherapy
5019609|NCT03874559|neoadjuvant chemoradiation therapy|neoadjuvant chemoradiation therapy
5019610|NCT03874559|Low anterior resection|low anterior resection
5019611|NCT03874559|abdominoperineal resection|abdominoperineal resection
5019612|NCT03874559|exosomes|exosomes
5019613|NCT03874559|biomarkers|biomarkers
5019614|NCT03874559|external beam radiation|external beam radiation
5019615|NCT03874546|Severe and moderate traumatic brain injury|severe and moderate traumatic brain injury
5019616|NCT03874546|Prognosis|prognosis
5019617|NCT03874546|IMPACT score|impact score
5019618|NCT03874533|Cochlear Implantation|cochlear implantation
5019619|NCT03874533|telemonitoring|telemonitoring
5019620|NCT03874533|training workshop|training workshop
5019621|NCT03874520|Telemedicine|telemedicine
5019622|NCT03874520|Triage|triage
5019623|NCT03874520|Call Centers|call centers
5019624|NCT03874520|Respiratory Tract Diseases|respiratory tract diseases
5019625|NCT03874520|Pediatrics|pediatrics
5019626|NCT03874507|virtual reality|virtual reality
5019627|NCT03874507|augmented reality|augmented reality
5019628|NCT03874507|physical therapy|physical therapy
5019629|NCT03874507|deconditioning|deconditioning
5019630|NCT03874494|Schizophrenia|schizophrenia
5019631|NCT03874494|Brexpiprazole|brexpiprazole
5019632|NCT03874494|Non-inferiority|non-inferiority
5019633|NCT03874481|sleep duration|sleep duration
5019634|NCT03874481|sleep quality|sleep quality
5019635|NCT03874481|coronary artery disease|coronary artery disease
5019636|NCT03874481|in stent restenosis|in stent restenosis
5019637|NCT03874442|postoperative pain in children|postoperative pain in children
5019638|NCT03874442|preoperative anxiety in children|preoperative anxiety in children
5019639|NCT03874416|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
5019640|NCT03874416|cognitive rehabilitation|cognitive rehabilitation
5019641|NCT03874416|working memory|working memory
5019642|NCT03874416|daily life function|daily life function
5019643|NCT03874416|Working Memory Questionnaire, WMQ|working memory questionnaire, wmq
5019644|NCT03874416|Brown-Peterson test|brown-peterson test
5019645|NCT03874351|Migraine;|migraine;
5019646|NCT03874351|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5019647|NCT03874351|tDCS-Telehealth intervention|tdcs-telehealth intervention
5019648|NCT03874325|HR+|hr+
5019649|NCT03874312|right heart catheterization|right heart catheterization
5019650|NCT03874312|Peripheral congestion|peripheral congestion
5019651|NCT03874312|Right atrial pressure|right atrial pressure
5019652|NCT03874312|Internal jugular vein distention ratio|internal jugular vein distention ratio
5019653|NCT03874312|ultrasound of jugular vein|ultrasound of jugular vein
5019654|NCT03874312|chronic heart failure|chronic heart failure
5019655|NCT03874286|Liver Transplant|liver transplant
5019656|NCT03874273|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
5019665|NCT03874208|Disorders of Consciousness|disorders of consciousness
5019667|NCT03874208|MRI|mri
5019668|NCT03874208|Brain injury|brain injury
5019669|NCT03874182|Prevalence|prevalence
5019670|NCT03874182|Dental trauma|dental trauma
5019671|NCT03874182|Special health care needs children|special health care needs children
5019672|NCT03874169|Biosensor watch|biosensor watch
5019673|NCT03874169|E4 Wristband|e4 wristband
5019674|NCT03874169|Intensive Care Unit|intensive care unit
5019675|NCT03874169|GI bleeding|gi bleeding
5019676|NCT03874091|Erector Spinae Plane block|erector spinae plane block
5019677|NCT03874091|ESP block|esp block
5019678|NCT03874091|Laparoscopic Nephrectomy|laparoscopic nephrectomy
5019679|NCT03874078|school children|school children
5019680|NCT03874078|balance|balance
5019681|NCT03874000|Sintilimab|sintilimab
5019682|NCT03874000|Metformin Hydrochloride|metformin hydrochloride
5021690|NCT03861689|MRI|mri
5019691|NCT03873961|Low-level Laser Therapy|low-level laser therapy
5019692|NCT03873922|Ketogenic diet|ketogenic diet
5019693|NCT03873922|Intervention|intervention
5019695|NCT03873922|Feasibility|feasibility
5019696|NCT03873922|Psychosis|psychosis
5019697|NCT03873922|Psychotic symptoms|psychotic symptoms
5019698|NCT03873922|Schizophrenia|schizophrenia
5019699|NCT03873922|Dietary intervention|dietary intervention
5019700|NCT03873909|Ketocarotenoids|ketocarotenoids
5019701|NCT03873909|Mamey sapote|mamey sapote
5019702|NCT03873909|Sapotexanthin|sapotexanthin
5019703|NCT03873909|Cryptocapsin|cryptocapsin
5019704|NCT03873909|Vitamin A|vitamin a
5019705|NCT03873870|PET scans|pet scans
5019706|NCT03873857|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5019708|NCT03873857|Observational Study|observational study
5019709|NCT03873857|Venetoclax|venetoclax
5019710|NCT03873857|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5019711|NCT03873857|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5019712|NCT03873844|cognitive processing, transfer package|cognitive processing, transfer package
5019713|NCT03873831|Therapy dog|therapy dog
5019714|NCT03873831|Autism Spectrum Disorder|autism spectrum disorder
5019715|NCT03873831|Social skills|social skills
5019716|NCT03873831|Group therapy|group therapy
5019717|NCT03873792|Allergic diseases|allergic diseases
5019718|NCT03873792|Probiotics|probiotics
5019719|NCT03873792|Immunoglobulin E|immunoglobulin e
5019720|NCT03873792|Intestinal microbiota|intestinal microbiota
5019721|NCT03873753|Pediatric dentistry|pediatric dentistry
5019722|NCT03873753|Mouth, Edentulous|mouth, edentulous
5019723|NCT03873740|Inactivated Enterovirus Type 71 (EV71) Vaccine|inactivated enterovirus type 71 (ev71) vaccine
5019724|NCT03873740|Sequential vaccination|sequential vaccination
5019725|NCT03873740|Immunity|immunity
5019726|NCT03873740|Safety|safety
5019727|NCT03873727|Vaccination / Re-vaccination|vaccination / re-vaccination
5019728|NCT03873727|Asplenic patient|asplenic patient
5019729|NCT03873727|Splenectomy|splenectomy
5019730|NCT03873727|Pneumococcal infections|pneumococcal infections
5019731|NCT03873727|immunological response|immunological response
5019732|NCT03873727|Pneumovax|pneumovax
5019733|NCT03873727|Prevenar13|prevenar13
5019734|NCT03873701|bedside ultrasonography|bedside ultrasonography
5019735|NCT03873701|emergency department|emergency department
5019736|NCT03873688|expiratory muscle training|expiratory muscle training
5019738|NCT03873688|respiratory muscle strength|respiratory muscle strength
5019739|NCT03873688|exercise capacity|exercise capacity
5019740|NCT03873675|acute kidney injury|acute kidney injury
5019741|NCT03873675|parathyroid hormone|parathyroid hormone
5019742|NCT03873675|continuous renal replacement therapy|continuous renal replacement therapy
5019743|NCT03873675|citrate anticoagulation|citrate anticoagulation
5019744|NCT03873675|intensive care|intensive care
5019745|NCT03873662|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5019746|NCT03873662|Pediatric patient|pediatric patient
5019750|NCT03873623|Kidney transplant|kidney transplant
5019751|NCT03873597|tele-coaching|tele-coaching
5331620|NCT02032966|ankle|ankle
5019752|NCT03873597|physical activity|physical activity
5019753|NCT03873597|lung transplant|lung transplant
5019754|NCT03873545|Cartilage|cartilage
5019755|NCT03873545|Cartilage Injury|cartilage injury
5019756|NCT03873545|Cartilage Repair|cartilage repair
5019757|NCT03873545|Cartilage Damage|cartilage damage
5019758|NCT03873545|Cartilage Lesion|cartilage lesion
5019759|NCT03873545|Cartilage Defect|cartilage defect
5019760|NCT03873519|chemotherapy|chemotherapy
5019761|NCT03873519|vital signs|vital signs
5019763|NCT03873519|health status|health status
5019764|NCT03873519|healing environment|healing environment
5019765|NCT03873506|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5019766|NCT03873506|human umbilical cord -derived mesenchymal stem cells|human umbilical cord -derived mesenchymal stem cells
5019767|NCT03873493|T-cell Prolymphocytic Leukemia (T-PLL)|t-cell prolymphocytic leukemia (t-pll)
5019768|NCT03873493|Cancer|cancer
5019769|NCT03873493|venetoclax|venetoclax
5019770|NCT03873493|ibrutinib|ibrutinib
5019771|NCT03873493|Relapsed or Refractory T-lymphoid malignancy|relapsed or refractory t-lymphoid malignancy
5019772|NCT03873467|Group Lifestyle Balance|group lifestyle balance
5019773|NCT03873467|Physical Activity|physical activity
5019775|NCT03873467|Weight-loss|weight-loss
5019776|NCT03873467|Dietary Behaviors|dietary behaviors
5019777|NCT03873454|cataract surgery|cataract surgery
5019778|NCT03873454|music|music
5019779|NCT03873454|salivary cortisol|salivary cortisol
5019780|NCT03873441|Cerebral Palsy|cerebral palsy
5019781|NCT03873441|Balance|balance
5019782|NCT03873441|Rehabilitation|rehabilitation
5019783|NCT03873428|breast cancer|breast cancer
5019784|NCT03873428|first metastatic relapse|first metastatic relapse
5019785|NCT03873428|PET|pet
5019786|NCT03873376|mass screening|mass screening
5019787|NCT03873376|non-attendance|non-attendance
5019788|NCT03873376|self-sampling|self-sampling
5019789|NCT03873376|HPV|hpv
5019790|NCT03873363|Total Knee Arthroplasty|total knee arthroplasty
5019791|NCT03873363|Total Knee Replacement|total knee replacement
5019792|NCT03873363|Outcome|outcome
5019793|NCT03873363|Implant Design|implant design
5019794|NCT03873350|Microbiota colonization kombucha bacteria yeast|microbiota colonization kombucha bacteria yeast
5019795|NCT03873337|tobacco|tobacco
5019796|NCT03873337|cigarette|cigarette
5019797|NCT03873337|schizophrenia|schizophrenia
5019798|NCT03873337|schizoaffective disorders|schizoaffective disorders
5019799|NCT03873337|smoking cessation|smoking cessation
5019800|NCT03873311|Azacytidine; HAG regimen|azacytidine; hag regimen
5019801|NCT03873285|Genodermatosis|genodermatosis
5019802|NCT03873285|genetic|genetic
5019804|NCT03873272|Neuropathy|neuropathy
5019805|NCT03873272|CIPN|cipn
5019806|NCT03873272|Cryotherapy|cryotherapy
5019807|NCT03873272|Compression therapy|compression therapy
5019808|NCT03873220|Wearable devices|wearable devices
5019809|NCT03873220|Scratch|scratch
5019810|NCT03873220|Sleep|sleep
5019811|NCT03873194|systemic arterial hypertension|systemic arterial hypertension
5019812|NCT03873194|hypertension|hypertension
5019813|NCT03873194|hypertension, pregnancy-induced|hypertension, pregnancy-induced
5019814|NCT03873194|pre-eclampsia|pre-eclampsia
5019815|NCT03873194|meditation|meditation
5019816|NCT03873194|randomized clinical Trial|randomized clinical trial
5019817|NCT03873129|antiretroviral therapy|antiretroviral therapy
5019818|NCT03873129|HIV transmission|hiv transmission
5019820|NCT03873077|local infiltration analgesia|local infiltration analgesia
5019821|NCT03873077|postoperative analgesia|postoperative analgesia
5019823|NCT03873064|EORTC QLQ-C30|eortc qlq-c30
5019824|NCT03873064|metastatic cancer|metastatic cancer
5019825|NCT03873064|localized cancer|localized cancer
5019826|NCT03873051|Community-based intervention|community-based intervention
5019827|NCT03873051|Motivation|motivation
5019828|NCT03873025|Relapsed|relapsed
5019829|NCT03873025|Refractory|refractory
5019830|NCT03873012|Dual antiplatelet therapy duration|dual antiplatelet therapy duration
5019831|NCT03873012|Optical coherence tomography|optical coherence tomography
5019832|NCT03872999|Attention|attention
5019833|NCT03872999|Control|control
5019834|NCT03872999|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5019835|NCT03872999|Parietal|parietal
5019836|NCT03872999|Space|space
5019837|NCT03872986|primary teeth|primary teeth
5019838|NCT03872986|silver diamine fluoride|silver diamine fluoride
5019839|NCT03872986|caries sealing|caries sealing
5019840|NCT03872973|balance|balance
5019841|NCT03872973|chronic ankle instability|chronic ankle instability
5019842|NCT03872973|function|function
5019843|NCT03872973|running|running
5019844|NCT03872960|cardiac arrest|cardiac arrest
5019845|NCT03872960|pre-hospital care|pre-hospital care
5019846|NCT03872960|strategy trial|strategy trial
5019852|NCT03872869|osteoarthritis|osteoarthritis
5019853|NCT03872869|patient education|patient education
5019854|NCT03872869|Tai Chi|tai chi
5019855|NCT03872869|physical function|physical function
5019856|NCT03872856|High Blood Pressure|high blood pressure
5019857|NCT03872856|Alaska Native and American Indian|alaska native and american indian
5019858|NCT03872856|Home Blood Pressure Monitoring|home blood pressure monitoring
5019859|NCT03872856|Self-efficacy|self-efficacy
5019860|NCT03872856|Primary Care|primary care
5019861|NCT03872843|Ureteroscopy|ureteroscopy
5019862|NCT03872843|Opioid|opioid
5019863|NCT03872843|Non-Opioid|non-opioid
5019864|NCT03872843|Stent Placement|stent placement
5019865|NCT03872843|Nephrolithiasis|nephrolithiasis
5019866|NCT03872817|Mental Health|mental health
5019867|NCT03872817|Health Literacy|health literacy
5019868|NCT03872817|Adolescent|adolescent
5019869|NCT03872817|Schools|schools
5019870|NCT03872804|Vitiligo|vitiligo
5019871|NCT03872804|Punch graft|punch graft
5019872|NCT03872804|Oral pulse steroid|oral pulse steroid
5019873|NCT03872804|Transverse needling|transverse needling
5019875|NCT03872739|Hydration|hydration
5019876|NCT03872739|enhanced computed tomography|enhanced computed tomography
5019877|NCT03872726|disability|disability
5019878|NCT03872726|Inflammatory Bowel Diseases|inflammatory bowel diseases
5019879|NCT03872726|Ulcerative Colitis|ulcerative colitis
5019880|NCT03872726|Crohn Disease|crohn disease
5019881|NCT03872687|dental implants, tufted brush, IDB, mucositis, gingivitis|dental implants, tufted brush, idb, mucositis, gingivitis
5019882|NCT03872596|Seroquel|seroquel
5019883|NCT03872596|Digital Medicine Quetiapine|digital medicine quetiapine
5019884|NCT03872596|Pharmacokinetics|pharmacokinetics
5019885|NCT03872596|Bioavailability|bioavailability
5019886|NCT03872583|Patient education|patient education
5019887|NCT03872583|Disease-specific knowledge|disease-specific knowledge
5019888|NCT03872583|Shared decision making|shared decision making
5019889|NCT03872570|cardiac output|cardiac output
5019890|NCT03872570|pulse pressure variation|pulse pressure variation
5019891|NCT03872570|fluid responsiveness|fluid responsiveness
5019892|NCT03872570|hemodynamic monitoring|hemodynamic monitoring
5019893|NCT03872557|Glucose tolerance|glucose tolerance
5019894|NCT03872557|Tyrosine|tyrosine
5019895|NCT03872544|Autologous Transplantation|autologous transplantation
5019896|NCT03872544|Free Tissue Flaps|free tissue flaps
5019897|NCT03872544|Graft Survival|graft survival
5019898|NCT03872544|Reconstructive Surgical Procedures|reconstructive surgical procedures
5019899|NCT03872544|Patient Selection|patient selection
5019900|NCT03872544|Debridement|debridement
5019901|NCT03872544|Subcutaneous Fat|subcutaneous fat
5019902|NCT03872544|Surgical Flaps|surgical flaps
5019905|NCT03872505|durvalumab|durvalumab
5019906|NCT03872505|immunotherapy|immunotherapy
5019907|NCT03872505|triple negative|triple negative
5019908|NCT03872505|HER2 negative|her2 negative
5019909|NCT03872505|ER/PR negative|er/pr negative
5019910|NCT03872505|carboplatin|carboplatin
5019911|NCT03872505|radiation therapy|radiation therapy
5019912|NCT03872505|paclitaxel|paclitaxel
5019913|NCT03872505|neoadjuvant|neoadjuvant
5019914|NCT03872505|stage II breast cancer|stage ii breast cancer
5019915|NCT03872505|stage III breast cancer|stage iii breast cancer
5019921|NCT03872479|LCA10|lca10
5019922|NCT03872479|Retinal degenerative diseases (RDD)|retinal degenerative diseases (rdd)
5019923|NCT03872479|Leber congenital amaurosis (LCA)|leber congenital amaurosis (lca)
5019924|NCT03872479|Congenital Retinal Blindness|congenital retinal blindness
5019926|NCT03872479|c.2991+1655A>G|c.2991+1655a>g
5019927|NCT03872479|CRISPR Treatment|crispr treatment
5019928|NCT03872479|Cas9 Protein|cas9 protein
5019929|NCT03872479|Eye Diseases Signs and Symptoms|eye diseases signs and symptoms
5019930|NCT03872479|Genetic Diseases, Inborn|genetic diseases, inborn
5019931|NCT03872479|Congenital Abnormalities|congenital abnormalities
5019932|NCT03872479|Eye Abnormalities|eye abnormalities
5019933|NCT03872479|CRISPR-Cas9|crispr-cas9
5019934|NCT03872479|CRISPR Associated Protein 9|crispr associated protein 9
5019935|NCT03872479|Cas9 Enzyme|cas9 enzyme
5019936|NCT03872453|Acute Migraine|acute migraine
5019937|NCT03872453|phonophobia|phonophobia
5019938|NCT03872453|photophobia|photophobia
5019939|NCT03872453|nausea|nausea
5019940|NCT03872440|EGFR mutant cancer|egfr mutant cancer
5019941|NCT03872414|Emotional Aging|emotional aging
5019942|NCT03872414|Neurofeedback|neurofeedback
5019943|NCT03872401|High Cardiovascular Risk|high cardiovascular risk
5019944|NCT03872401|No prior Myocardial Infarction stroke|no prior myocardial infarction stroke
5034749|NCT03781999|Performance|performance
5019945|NCT03872401|>= 50 years of age (men)|>= 50 years of age (men)
5019946|NCT03872401|>= 55 years of age (women)|>= 55 years of age (women)
5019947|NCT03872401|lipid-lowering therapy|lipid-lowering therapy
5019948|NCT03872375|Executive function|executive function
5019949|NCT03872375|MRI|mri
5019950|NCT03872375|Memory|memory
5019951|NCT03872375|5-2 CR|5-2 cr
5019952|NCT03872362|Lung cancer|lung cancer
5019953|NCT03872362|CT|ct
5019954|NCT03872362|Frozen sections|frozen sections
5019955|NCT03872362|Radiomics|radiomics
5019956|NCT03872362|Lung adenocarcinoma|lung adenocarcinoma
5019957|NCT03872336|Hypertension|hypertension
5019958|NCT03872336|Labetalol|labetalol
5019959|NCT03872336|Obesity|obesity
5019960|NCT03872323|Artery Injury|artery injury
5019961|NCT03872323|Surgery|surgery
5019962|NCT03872323|Endovascular Repair|endovascular repair
5019963|NCT03872323|Peripheral Arteries|peripheral arteries
5019964|NCT03872310|Schizephrenia|schizephrenia
5019965|NCT03872310|Cognitive enhancement|cognitive enhancement
5445443|NCT01521780|pharmacogenomics|pharmacogenomics
5019966|NCT03872310|Transcranial direct current stimulation|transcranial direct current stimulation
5019967|NCT03872310|Non-invasive brain stimulation|non-invasive brain stimulation
5019968|NCT03872310|Working memory|working memory
5019969|NCT03872258|Physical activity|physical activity
5019970|NCT03872258|Postmenopause|postmenopause
5019971|NCT03872258|Body composition|body composition
5019972|NCT03872258|Health education|health education
5019973|NCT03872258|Information and Communication Technologies|information and communication technologies
5019974|NCT03872219|biodiversity intervention|biodiversity intervention
5019975|NCT03872219|IgE|ige
5019976|NCT03872219|atopy|atopy
5019977|NCT03872193|Amputation|amputation
5019978|NCT03872193|Virtual Reality|virtual reality
5019979|NCT03872193|Rehabilitation|rehabilitation
5019980|NCT03872167|NIV|niv
5019981|NCT03872167|hypoxemia|hypoxemia
5019982|NCT03872167|hypercapnia|hypercapnia
5019983|NCT03872154|code status discussion|code status discussion
5019984|NCT03872154|resuscitation|resuscitation
5019985|NCT03872154|hospitalized patient|hospitalized patient
5019986|NCT03872154|cardiac arrest|cardiac arrest
5019987|NCT03872141|neuropathy|neuropathy
5019988|NCT03872141|taxane|taxane
5019989|NCT03872141|docetaxel|docetaxel
5019990|NCT03872115|Gait|gait
5019991|NCT03872115|Balance|balance
5019992|NCT03872089|Infrared Thermography|infrared thermography
5019993|NCT03872089|Diabetic foot|diabetic foot
5019994|NCT03872089|Six minutes walking test|six minutes walking test
5019995|NCT03872089|Microcirculation|microcirculation
5019996|NCT03872076|Strengthening|strengthening
5019997|NCT03872076|Stability|stability
5019998|NCT03872076|Muscle Volume|muscle volume
5019999|NCT03872076|Physical Effort|physical effort
5020000|NCT03872076|Randomized clinical trial|randomized clinical trial
5020001|NCT03872063|Volleyball|volleyball
5020002|NCT03872063|Range of motion|range of motion
5020003|NCT03872063|Myofascial|myofascial
5020004|NCT03872063|Eccentric|eccentric
5020005|NCT03872063|Pain|pain
5020006|NCT03872037|minimally invasive dentistry|minimally invasive dentistry
5020012|NCT03872011|hydrocortisone|hydrocortisone
5020013|NCT03872011|mortality|mortality
5020014|NCT03871998|Eczema|eczema
5020015|NCT03871998|Atopic dermatitis|atopic dermatitis
5020016|NCT03871998|Food allergy|food allergy
5020017|NCT03871998|Skin barrier|skin barrier
5020018|NCT03871998|Filaggrin|filaggrin
5020019|NCT03871998|Natural moisturizing factor|natural moisturizing factor
5020020|NCT03871998|TEWL|tewl
5020021|NCT03871998|Skin microbiome|skin microbiome
5020022|NCT03871998|Prevention|prevention
5020023|NCT03871998|Moisturizer|moisturizer
5020024|NCT03871985|ventilator-associated pneumonia|ventilator-associated pneumonia
5020025|NCT03871985|subglottic secretion drainage|subglottic secretion drainage
5020026|NCT03871985|endotracheal tube|endotracheal tube
5020027|NCT03871985|length of mechanical ventilation|length of mechanical ventilation
5020028|NCT03871959|PD1 Monoclonal Antibody|pd1 monoclonal antibody
5020029|NCT03871959|IAP Antagonist|iap antagonist
5020030|NCT03871959|phase I|phase i
5020032|NCT03871933|atrial fibrillation|atrial fibrillation
5020033|NCT03871933|autonomic function|autonomic function
5020034|NCT03871933|cardiopulmonary interaction|cardiopulmonary interaction
5020035|NCT03871920|Physiotherapy|physiotherapy
5020036|NCT03871920|outcomes|outcomes
5020037|NCT03871920|therapy quality|therapy quality
5020038|NCT03871894|Indirect calorimeter|indirect calorimeter
5020039|NCT03871894|Resting energy expenditure|resting energy expenditure
5020040|NCT03871894|substrate utilization|substrate utilization
5020041|NCT03871894|nitrogen balance|nitrogen balance
5020042|NCT03871881|Magnetic resonance imaging|magnetic resonance imaging
5020043|NCT03871881|Brain|brain
5020044|NCT03871881|Neuropsychology|neuropsychology
5020045|NCT03871881|Heart Defects, Congenital|heart defects, congenital
5020046|NCT03871881|Follow-Up Studies|follow-up studies
5020047|NCT03871868|25-hydroxyvitamin D|25-hydroxyvitamin d
5717546|NCT00440388|Rituxan|rituxan
5020048|NCT03871803|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5020049|NCT03871803|Chronotropic incompetence|chronotropic incompetence
5020050|NCT03871803|Functional capacity|functional capacity
5020051|NCT03871803|Quality of life|quality of life
5020056|NCT03871777|nitrate|nitrate
5020057|NCT03871777|vegetarian|vegetarian
5020058|NCT03871777|nitrite|nitrite
5020059|NCT03871777|oral microbiome|oral microbiome
5020060|NCT03871751|Polyvagal Theory|polyvagal theory
5020061|NCT03871751|Social Behavior|social behavior
5020062|NCT03871751|Hyperacusis|hyperacusis
5020063|NCT03871751|Prosody|prosody
5020064|NCT03871751|Auditory intervention|auditory intervention
5020065|NCT03871738|Proprioception|proprioception
5020066|NCT03871738|Sports performance|sports performance
5020067|NCT03871738|Long jump|long jump
5020068|NCT03871738|Physiotherapy|physiotherapy
5020069|NCT03871738|Randomized clinical trial.|randomized clinical trial.
5020070|NCT03871699|Heart|heart
5020071|NCT03871699|Failure|failure
5020072|NCT03871699|Iron|iron
5020073|NCT03871699|Deficiency|deficiency
5020074|NCT03871699|Systolic|systolic
5020075|NCT03871699|Reduced|reduced
5020076|NCT03871699|Ejection|ejection
5020082|NCT03871660|Total Parenteral Nutrition|total parenteral nutrition
5020083|NCT03871608|temporomandibular joint disorders|temporomandibular joint disorders
5020084|NCT03871608|rehabilitation|rehabilitation
5020085|NCT03871608|assessment|assessment
5020086|NCT03871582|Protein intake|protein intake
5020087|NCT03871582|Older adults|older adults
5020088|NCT03871582|Mexican adults|mexican adults
5020089|NCT03871582|Functionality|functionality
5020090|NCT03871569|Telemedicine|telemedicine
5020091|NCT03871569|dentistry|dentistry
5020092|NCT03871569|long-term-care-home|long-term-care-home
5020093|NCT03871530|Analgesia|analgesia
5020094|NCT03871530|Epidural|epidural
5020095|NCT03871530|Labor|labor
5020096|NCT03871530|Obstetric Analgesia|obstetric analgesia
5020097|NCT03871530|Obstetrical|obstetrical
5020098|NCT03871504|exercise|exercise
5020099|NCT03871504|hypoalgesia|hypoalgesia
5020100|NCT03871504|pain|pain
5020101|NCT03871504|expectation|expectation
5020102|NCT03871491|maternal sepsis|maternal sepsis
5020103|NCT03871491|maternal death|maternal death
5020104|NCT03871491|neonatal sepsis|neonatal sepsis
5020105|NCT03871491|neonatal death|neonatal death
5020106|NCT03871491|azithromycin|azithromycin
5020107|NCT03871491|Democratic Republic of Congo|democratic republic of congo
5020108|NCT03871491|Zambia|zambia
5020109|NCT03871491|Guatemala|guatemala
5020114|NCT03871465|subacromial bursitis|subacromial bursitis
5020115|NCT03871465|subacromial impingement syndrome|subacromial impingement syndrome
5020117|NCT03871465|physical therapy|physical therapy
5020118|NCT03871465|therapeutic exercise|therapeutic exercise
5020119|NCT03871465|rehabilitation|rehabilitation
5020120|NCT03871452|Ankaferd BloodStopper, laceration, bleeding|ankaferd bloodstopper, laceration, bleeding
5020121|NCT03871426|High resolution manometry|high resolution manometry
5020122|NCT03871426|globus pharyngeus|globus pharyngeus
5020123|NCT03871426|gastroesophageal reflux disease|gastroesophageal reflux disease
5020124|NCT03871426|manual cervical traction|manual cervical traction
5020125|NCT03871426|trunk stabilization maneuver|trunk stabilization maneuver
5020126|NCT03871413|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5020127|NCT03871413|Vertigo|vertigo
5020128|NCT03871413|Dizziness|dizziness
5020129|NCT03871413|Vestibular Diseases|vestibular diseases
5020130|NCT03871413|Epley Maneuver|epley maneuver
5020131|NCT03871413|TRV-chair|trv-chair
5020132|NCT03871413|Repositioning chair|repositioning chair
5020133|NCT03871361|Birdshot Uveitis|birdshot uveitis
5020134|NCT03871361|HLA A29|hla a29
5020135|NCT03871361|Abatacept|abatacept
5020136|NCT03871335|work-related musculoskeletal disorders|work-related musculoskeletal disorders
5020137|NCT03871335|hazelnut factory|hazelnut factory
5020138|NCT03871335|low back pain|low back pain
5020139|NCT03871335|neck pain|neck pain
5020140|NCT03871322|vitamin D|vitamin d
5020141|NCT03871322|vitamin K2|vitamin k2
5020142|NCT03871322|low-energy fractures|low-energy fractures
5020143|NCT03871322|fracture healing|fracture healing
5020144|NCT03871322|children|children
5020145|NCT03871296|DNA-methylation|dna-methylation
5020146|NCT03871296|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5020147|NCT03871270|healing|healing
5020148|NCT03871270|spiritual|spiritual
5020149|NCT03871270|psycho-social-spiritual|psycho-social-spiritual
5020150|NCT03871270|growth|growth
5020151|NCT03871270|chronic illness|chronic illness
5020152|NCT03871270|patient care|patient care
5020153|NCT03871244|hemoglobin threshold|hemoglobin threshold
5717547|NCT00440388|Rituximab|rituximab
5020154|NCT03871244|critically ill children|critically ill children
5034944|NCT03780855|scaffold|scaffold
5020171|NCT03871101|STAI|stai
5020172|NCT03871101|Er,Cr:YSGG|er,cr:ysgg
5020173|NCT03871101|oral surgery|oral surgery
5020174|NCT03871088|Depression, omega-3 fatty acids, nutritional intervention|depression, omega-3 fatty acids, nutritional intervention
5020175|NCT03871075|peripheral arterial disease|peripheral arterial disease
5020176|NCT03871075|Peripheral Artery Disease|peripheral artery disease
5020178|NCT03871075|exercise|exercise
5020179|NCT03871075|Intermittent claudication|intermittent claudication
5020180|NCT03871062|intravitreal injection|intravitreal injection
5020181|NCT03871062|pain|pain
5020182|NCT03871062|anesthesia|anesthesia
5020183|NCT03871036|Advanced urothelial carcinoma|advanced urothelial carcinoma
5020184|NCT03871036|Checkpoint inhibition|checkpoint inhibition
5020185|NCT03871036|Tremelimumab|tremelimumab
5020186|NCT03871036|Durvalumab|durvalumab
5020187|NCT03871036|Paclitaxel|paclitaxel
5020188|NCT03871010|Midline catheter|midline catheter
5020189|NCT03871010|Vascular nursing team|vascular nursing team
5020190|NCT03870984|obesity, children, nuts,|obesity, children, nuts,
5020191|NCT03870932|Fibromyalgia|fibromyalgia
5020192|NCT03870932|Pain|pain
5020193|NCT03870932|Imagery|imagery
5020194|NCT03870919|therapies combination|therapies combination
5020195|NCT03870893|cerebral palsy|cerebral palsy
5020196|NCT03870893|hippotherapy|hippotherapy
5020197|NCT03870893|cardiopulmonary fitness|cardiopulmonary fitness
5020198|NCT03870893|physical activity|physical activity
5020199|NCT03870893|attention|attention
5020200|NCT03870867|seniors|seniors
5020201|NCT03870867|falls|falls
5020202|NCT03870867|imaging|imaging
5020203|NCT03870867|emergency department|emergency department
5020204|NCT03870867|CT head|ct head
5020205|NCT03870867|intracranial hemorrhages|intracranial hemorrhages
5020206|NCT03870828|IPAF|ipaf
5020207|NCT03870828|CTD-ILD|ctd-ild
5020208|NCT03870828|ILD|ild
5020209|NCT03870828|diagnostic markers|diagnostic markers
5020210|NCT03870828|progression markers|progression markers
5020211|NCT03870815|Ischemic heart disease|ischemic heart disease
5020212|NCT03870815|Coronary artery bypass grafting|coronary artery bypass grafting
5020213|NCT03870815|Percutaneous coronary intervention|percutaneous coronary intervention
5020214|NCT03870802|Breast cancer|breast cancer
5020215|NCT03870802|Stem cells|stem cells
5020216|NCT03870802|Immune cells|immune cells
5020217|NCT03870789|sepsis, septic shock, early warning scores, infecion|sepsis, septic shock, early warning scores, infecion
5020218|NCT03870776|Depression|depression
5022213|NCT03858764|restenosis|restenosis
5020219|NCT03870776|Resistant depression|resistant depression
5020220|NCT03870763|Pediatric, Multiple Sclerosis|pediatric, multiple sclerosis
5020221|NCT03870737|ADHD|adhd
5020222|NCT03870737|neuromodulation|neuromodulation
5020223|NCT03870737|trigeminal nerve stimulation|trigeminal nerve stimulation
5020224|NCT03870724|Prevention|prevention
5020225|NCT03870724|Cardiovascular diseases|cardiovascular diseases
5020226|NCT03870724|Physical activity|physical activity
5020227|NCT03870724|Ethnic differences in health|ethnic differences in health
5020228|NCT03870724|Risk factors|risk factors
5020229|NCT03870711|Intrauterine device|intrauterine device
5020230|NCT03870711|lidocaine spray|lidocaine spray
5020231|NCT03870672|Upper limb|upper limb
5020232|NCT03870672|Stroke|stroke
5020234|NCT03870672|Rehabilitation|rehabilitation
5020235|NCT03870672|Brain Stimulation|brain stimulation
5020236|NCT03870672|CCFES|ccfes
5020237|NCT03870672|Motor Cortex|motor cortex
5020238|NCT03870672|TMS|tms
5020239|NCT03870672|Motor Recovery|motor recovery
5020240|NCT03870646|Critical Illness|critical illness
5020241|NCT03870646|Tracheostomy|tracheostomy
5020242|NCT03870646|Mechanical Ventilation|mechanical ventilation
5020243|NCT03870646|Complication|complication
5020250|NCT03870581|social software|social software
5020251|NCT03870581|warfarin|warfarin
5020252|NCT03870581|anticoagulation therapy|anticoagulation therapy
5020253|NCT03870581|INR|inr
5020254|NCT03870568|frailty|frailty
5020255|NCT03870568|liver transplantation|liver transplantation
5020256|NCT03870568|functional status|functional status
5020257|NCT03870555|Drug Therapy|drug therapy
5020258|NCT03870516|mitral|mitral
5020259|NCT03870516|regurgitation|regurgitation
5020260|NCT03870516|speckle|speckle
5020261|NCT03870516|echocardiography|echocardiography
5020262|NCT03870516|replacement|replacement
5020263|NCT03870503|Postpartum Hemorrhage|postpartum hemorrhage
5020264|NCT03870503|vaginal delivery|vaginal delivery
5020265|NCT03870503|carbetocin|carbetocin
5020266|NCT03870503|misoprostol|misoprostol
5020267|NCT03870503|oxytocin|oxytocin
5020268|NCT03870477|Cannulated Screws|cannulated screws
5020269|NCT03870477|Lag Screws|lag screws
5020270|NCT03870477|Compression Screws|compression screws
5020271|NCT03870477|Telescoping Lag Screws|telescoping lag screws
5020272|NCT03870477|Cortical Screws|cortical screws
5020273|NCT03870477|Hip Fracture Plate|hip fracture plate
5020274|NCT03870464|non-small cell lung cancer|non-small cell lung cancer
5020275|NCT03870464|immunotherapy|immunotherapy
5020276|NCT03870464|checkpoint inhibition|checkpoint inhibition
5020277|NCT03870464|biomarkers|biomarkers
5020278|NCT03870464|quality of life|quality of life
5020279|NCT03870464|real life patients|real life patients
5020280|NCT03870438|HIV-1|hiv-1
5020281|NCT03870438|PMTCT|pmtct
5020282|NCT03870438|Point of Care|point of care
5020283|NCT03870438|PrEP|prep
5020284|NCT03870438|Zambia|zambia
5020285|NCT03870438|Burkina Faso|burkina faso
5020286|NCT03870438|Expanded Program of Immunization (EPI)|expanded program of immunization (epi)
5020287|NCT03870425|Dietary protein|dietary protein
5020288|NCT03870425|Sarcopenia|sarcopenia
5020289|NCT03870425|Protein turnover|protein turnover
5020290|NCT03870425|Muscle protein|muscle protein
5020291|NCT03870412|PEG-rhG-CSF|peg-rhg-csf
5020292|NCT03870399|neuroendocrine tumor|neuroendocrine tumor
5020293|NCT03870399|tamoxifen|tamoxifen
5020294|NCT03870399|Progesterone Receptor|progesterone receptor
5020295|NCT03870399|Estrogen Receptor|estrogen receptor
5020296|NCT03870386|EUS|eus
5020297|NCT03870386|ERCP|ercp
5020298|NCT03870386|Lumen apposing metal stent|lumen apposing metal stent
5020299|NCT03870386|Biliary drainage|biliary drainage
5020300|NCT03870386|Biliary obstruction|biliary obstruction
5020301|NCT03870386|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5020302|NCT03870321|Core|core
5020303|NCT03870321|Strength|strength
5020304|NCT03870321|Proprioception|proprioception
5020305|NCT03870321|Ankle|ankle
5020306|NCT03870321|Basketball|basketball
5020307|NCT03870308|Deep Brain Stimulation|deep brain stimulation
5020308|NCT03870295|Type C nerve fibres|type c nerve fibres
5020309|NCT03870295|Conduction velocity|conduction velocity
5020310|NCT03870295|Polyneuropathy|polyneuropathy
5020311|NCT03870282|Childhood sleep promotion|childhood sleep promotion
5020312|NCT03870282|Sleep promotion|sleep promotion
5020313|NCT03870282|Sleep|sleep
5020314|NCT03870256|Postpartum Hemorrhage|postpartum hemorrhage
5020315|NCT03870256|vaginal delivery|vaginal delivery
5020316|NCT03870256|tranexamic acid|tranexamic acid
5020323|NCT03870126|phytochemicals|phytochemicals
5020324|NCT03870126|caffeine|caffeine
5020325|NCT03870126|polyphenol|polyphenol
5020326|NCT03870126|beverage|beverage
5020327|NCT03870126|exercise|exercise
5020328|NCT03870126|mental performance|mental performance
5020329|NCT03870126|physical performance|physical performance
5020330|NCT03870126|vigilance|vigilance
5020331|NCT03870126|vigor|vigor
5020332|NCT03870126|energy|energy
5020333|NCT03870126|vitality|vitality
5020334|NCT03870126|fatigue|fatigue
5020335|NCT03870126|sports performance|sports performance
5020336|NCT03870126|high-intensity intermittent exercise|high-intensity intermittent exercise
5020352|NCT03870061|Infants|infants
5020353|NCT03870061|Impact Evaluation|impact evaluation
5020354|NCT03870061|Immunization|immunization
5020355|NCT03870009|ARDS|ards
5020356|NCT03870009|computed tomography|computed tomography
5020357|NCT03870009|cyclic hyperinflation|cyclic hyperinflation
5020358|NCT03870009|mechanical ventilation|mechanical ventilation
5020359|NCT03869996|fast track care|fast track care
5020360|NCT03869996|total knee arthroplasty|total knee arthroplasty
5020361|NCT03869983|Iohexol|iohexol
5020362|NCT03869983|Captisol®|captisol®
5020363|NCT03869983|cyclodextrin|cyclodextrin
5020364|NCT03869983|radiographic|radiographic
5020365|NCT03869983|iodinated contrast medium|iodinated contrast medium
5020366|NCT03869983|Omnipaque™|omnipaque™
5020367|NCT03869970|Concussion|concussion
5020371|NCT03869944|HIV-1|hiv-1
5020372|NCT03869944|PMTCT|pmtct
5020373|NCT03869944|Point of Care|point of care
5020374|NCT03869944|PrEP|prep
5020375|NCT03869944|Burkina Faso|burkina faso
5020376|NCT03869944|Expanded Program of Immunization (EPI)|expanded program of immunization (epi)
5020377|NCT03869931|Fenofibrate|fenofibrate
5020378|NCT03869931|Diabetic Nephropathy|diabetic nephropathy
5020379|NCT03869931|Metabolomics|metabolomics
5020381|NCT03869892|Metastatic|metastatic
5020382|NCT03869892|Cancer|cancer
5020383|NCT03869892|Colorectal|colorectal
5020384|NCT03869892|Colorectal Cancer|colorectal cancer
5020385|NCT03869892|Colon|colon
5020386|NCT03869892|Rectum|rectum
5020387|NCT03869892|Metastasis|metastasis
5020388|NCT03869879|gait|gait
5020389|NCT03869879|balance|balance
5020391|NCT03869879|mobility|mobility
5020392|NCT03869879|feedback|feedback
5020396|NCT03869762|Castration-resistant|castration-resistant
5020397|NCT03869762|Progressive|progressive
5020398|NCT03869762|Metastatic|metastatic
5020399|NCT03869762|Prostate Cancer|prostate cancer
5020400|NCT03869762|Bone Metastases|bone metastases
5020401|NCT03869736|Depression|depression
5020402|NCT03869736|Depressive Disorder, Major|depressive disorder, major
5020403|NCT03869736|Mood Disorders|mood disorders
5020404|NCT03869736|Mental Disorders|mental disorders
5020405|NCT03869736|Nitrous Oxide|nitrous oxide
5020406|NCT03869736|Anesthetics, Inhalational|anesthetics, inhalational
5020407|NCT03869736|Anesthetics|anesthetics
5020408|NCT03869736|Anesthetics, General|anesthetics, general
5020409|NCT03869736|Physiologic Effects of Drugs|physiologic effects of drugs
5020410|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic
5020411|NCT03869736|Analgesics|analgesics
5020412|NCT03869710|Pain|pain
5020413|NCT03869684|Exudative|exudative
5020416|NCT03869684|Age-related macular degeneration|age-related macular degeneration
5020417|NCT03869684|Age related macular degeneration|age related macular degeneration
5020418|NCT03869671|Antiretroviral pre-exposure prophylaxis (PrEP)|antiretroviral pre-exposure prophylaxis (prep)
5020719|NCT03867279|Squat|squat
5020421|NCT03869671|Adherence intervention|adherence intervention
5020422|NCT03869671|People who inject drugs (PWID)|people who inject drugs (pwid)
5020423|NCT03869658|Voice recognition|voice recognition
5020424|NCT03869658|24-hr diet recall|24-hr diet recall
5020425|NCT03869658|Mobile application|mobile application
5020426|NCT03869658|Self-report|self-report
5020427|NCT03869632|YL-13027|yl-13027
5020428|NCT03869632|Advanced Solid Tumors|advanced solid tumors
5020429|NCT03869619|lymphoma|lymphoma
5020430|NCT03869619|real life|real life
5020431|NCT03869619|cohort|cohort
5020432|NCT03869619|epidemiology|epidemiology
5020434|NCT03869567|thrombectomy|thrombectomy
5020435|NCT03869567|flat panel Computed tomography|flat panel computed tomography
5020436|NCT03869567|cone beam computed tomography|cone beam computed tomography
5020437|NCT03869567|hemorrhage|hemorrhage
5020438|NCT03869567|stroke|stroke
5020440|NCT03869541|Critical Illness|critical illness
5020441|NCT03869541|Physical rehabilitation|physical rehabilitation
5020442|NCT03869528|bronchoscopy|bronchoscopy
5020443|NCT03869528|lignocaine|lignocaine
5020444|NCT03869515|chILD|child
5020445|NCT03869515|clinic features|clinic features
5020446|NCT03869515|genetic backgrounds|genetic backgrounds
5020447|NCT03869515|outcomes|outcomes
5020448|NCT03869489|approach motivation|approach motivation
5020449|NCT03869489|avoidance motivation|avoidance motivation
5020450|NCT03869489|transcranial direct current stimulation|transcranial direct current stimulation
5020451|NCT03869411|diabetes|diabetes
5020452|NCT03869411|muscle quality|muscle quality
5020453|NCT03869411|aerobic exercise|aerobic exercise
5020454|NCT03869411|FTO gene|fto gene
5020455|NCT03869385|Human albumin|human albumin
5020473|NCT03869229|osteoarthritis|osteoarthritis
5020474|NCT03869229|Adipose-derived Mesenchymal Stem Cells|adipose-derived mesenchymal stem cells
5020475|NCT03869216|Prostate cancer|prostate cancer
5020476|NCT03869216|Primary Care|primary care
5020477|NCT03869216|PSA-screening|psa-screening
5020478|NCT03869216|African American males|african american males
5020479|NCT03869177|Family psychoeducation|family psychoeducation
5020480|NCT03869177|Schizophrenia|schizophrenia
5020481|NCT03869177|Implementation science|implementation science
5020482|NCT03869177|Mental health care services|mental health care services
5020483|NCT03869177|Clinical ethics|clinical ethics
5020484|NCT03869177|Family involvement|family involvement
5020485|NCT03869177|Family intervention|family intervention
5020486|NCT03869112|COPD|copd
5020487|NCT03869112|Physical activity|physical activity
5020488|NCT03869112|pulmonary rehabilitation|pulmonary rehabilitation
5020489|NCT03869112|COPD physical activity level|copd physical activity level
5020490|NCT03869112|COPD comorbidities|copd comorbidities
5020494|NCT03869086|Blueberry|blueberry
5020495|NCT03869086|Metabolism|metabolism
5020496|NCT03869086|Anthocyanins|anthocyanins
5020497|NCT03869086|Inter-individual variation|inter-individual variation
5020498|NCT03869086|Cardiometabolic health|cardiometabolic health
5020499|NCT03869073|Bacterial|bacterial
5020500|NCT03869073|Infection|infection
5020501|NCT03869073|Blood|blood
5020502|NCT03869073|Systemic|systemic
5020503|NCT03869073|ICU|icu
5020504|NCT03869060|Dengue|dengue
5020505|NCT03869060|Flavivirus Infections|flavivirus infections
5020506|NCT03869060|Virus Diseases|virus diseases
5020507|NCT03869034|Transarterial Infusion Chemotherapy|transarterial infusion chemotherapy
5020509|NCT03869034|Hepatocellular Carcinoma|hepatocellular carcinoma
5020510|NCT03869021|Computer guided surgery|computer guided surgery
5020511|NCT03869021|Hemifacial Microsomia|hemifacial microsomia
5020512|NCT03868982|acute respiratory distress syndrome|acute respiratory distress syndrome
5020513|NCT03868982|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5020514|NCT03868982|lung protective strategy|lung protective strategy
5020515|NCT03868956|Deep vein thrombosis|deep vein thrombosis
5020516|NCT03868956|Recurrence|recurrence
5020517|NCT03868956|Diagnostic strategy|diagnostic strategy
5020523|NCT03868891|Eustachian tube|eustachian tube
5020524|NCT03868891|Eustachian tube dysfunction|eustachian tube dysfunction
5020525|NCT03868891|Eustachian tube function testing|eustachian tube function testing
5020526|NCT03868891|Middle ear ventilation|middle ear ventilation
5020527|NCT03868878|Capoeira Training (martial arts)|capoeira training (martial arts)
5020528|NCT03868878|Triglycerides|triglycerides
5020529|NCT03868878|Aging|aging
5020530|NCT03868852|Radiation Therapy|radiation therapy
5020531|NCT03868852|Rhabdomyosarcoma in Children|rhabdomyosarcoma in children
5020532|NCT03868774|treatment|treatment
5020533|NCT03868761|Mobile app|mobile app
5020534|NCT03868761|Disaster|disaster
5020535|NCT03868761|Digital Medicine|digital medicine
5020536|NCT03868761|Teens|teens
5020537|NCT03868709|Postoperative pulmonary complications|postoperative pulmonary complications
5020538|NCT03868709|Penehyclidine Hydrochloride|penehyclidine hydrochloride
5020539|NCT03868709|High risk patients|high risk patients
5020540|NCT03868709|Postoperative period|postoperative period
5020541|NCT03868709|Long-term outcome|long-term outcome
5020542|NCT03868696|Ultrasound|ultrasound
5020543|NCT03868696|Manipulation under anaesthesia|manipulation under anaesthesia
5035341|NCT03778593|5-FU|5-fu
5020555|NCT03868475|Vacuum-assisted biopsy|vacuum-assisted biopsy
5020556|NCT03868475|Surgical excisional biopsy|surgical excisional biopsy
5020557|NCT03868475|Complete removal|complete removal
5020558|NCT03868475|Patient satisfaction|patient satisfaction
5020559|NCT03868475|Cosmesis|cosmesis
5020560|NCT03868410|stroke|stroke
5020561|NCT03868410|brain stimulation|brain stimulation
5020563|NCT03868410|Upper Limb|upper limb
5020564|NCT03868410|MRI|mri
5020565|NCT03868410|CVA|cva
5020566|NCT03868410|Rehabilitation|rehabilitation
5020567|NCT03868397|MRI|mri
5020568|NCT03868397|cirrhosis|cirrhosis
5020569|NCT03868345|ALS|als
5020570|NCT03868345|Cognitive dysfunction|cognitive dysfunction
5020571|NCT03868345|Speech|speech
5020572|NCT03868319|lung-protective ventilation strategy|lung-protective ventilation strategy
5020579|NCT03868267|Microbiome|microbiome
5020580|NCT03868267|Upper GI|upper gi
5020581|NCT03868267|Dyspepsia|dyspepsia
5020582|NCT03868267|Nitrates|nitrates
5020583|NCT03868267|Gastrointestinal symptoms|gastrointestinal symptoms
5020588|NCT03868228|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5020590|NCT03868228|pressurised|pressurised
5020591|NCT03868228|colorectal cancer|colorectal cancer
5020592|NCT03868228|peritoneal metastases|peritoneal metastases
5020593|NCT03868215|Colorectal Cancer|colorectal cancer
5020594|NCT03868215|Lymph Node Metastases|lymph node metastases
5020595|NCT03868215|Local Residual|local residual
5020596|NCT03868176|surveillance|surveillance
5020597|NCT03868176|compliance|compliance
5020598|NCT03868176|germ cell tumors|germ cell tumors
5020599|NCT03868176|short message service|short message service
5020600|NCT03868163|Chronic Hepatitis C|chronic hepatitis c
5020601|NCT03868163|Hepatitis C|hepatitis c
5020602|NCT03868163|Hepatitis|hepatitis
5020603|NCT03868163|glecaprevir|glecaprevir
5020604|NCT03868163|pibrentasvir|pibrentasvir
5020605|NCT03868163|real world setting|real world setting
5020606|NCT03868163|Observational Study|observational study
5020607|NCT03868137|NSAID|nsaid
5020608|NCT03868137|Intrauterine Devices|intrauterine devices
5020609|NCT03868137|Ibuprofen|ibuprofen
5020610|NCT03868137|Pelvic pain|pelvic pain
5020611|NCT03868046|Immune-related Adverse Events|immune-related adverse events
5020612|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors
5020613|NCT03868046|Biomarkers|biomarkers
5020614|NCT03868046|Autoantibodies|autoantibodies
5020615|NCT03868033|Osteoporosis|osteoporosis
5020616|NCT03868033|Denosumab|denosumab
5020617|NCT03868033|Zoledronate|zoledronate
5020618|NCT03868033|Bone mineral density|bone mineral density
5020619|NCT03868007|remote ischemic conditioning|remote ischemic conditioning
5020620|NCT03868007|elderly|elderly
5020621|NCT03868007|acute ischemic stroke|acute ischemic stroke
5020622|NCT03868007|Acute Coronary Syndrome|acute coronary syndrome
5020623|NCT03867994|Cardiac catheterization, carvedilol, atorvastatin.|cardiac catheterization, carvedilol, atorvastatin.
5020624|NCT03867981|Obesity|obesity
5020625|NCT03867981|weight loss|weight loss
5020626|NCT03867981|exercise|exercise
5020627|NCT03867981|diet|diet
5020628|NCT03867981|phone coaching|phone coaching
5020629|NCT03867955|photomotor reflex|photomotor reflex
5020630|NCT03867955|depth of anesthesia|depth of anesthesia
5020631|NCT03867955|AlgiScan™|algiscan™
5020632|NCT03867955|pupil diameter|pupil diameter
5020633|NCT03867929|Erectile dysfunction|erectile dysfunction
5020634|NCT03867929|Vitamin-D|vitamin-d
5020635|NCT03867929|Hypogonadism|hypogonadism
5020636|NCT03867929|Endothelial Dysfunction|endothelial dysfunction
5020637|NCT03867929|Nitric Oxide|nitric oxide
5020639|NCT03867864|Migraine|migraine
5020640|NCT03867864|Disability|disability
5020641|NCT03867864|Quality of life|quality of life
5020642|NCT03867864|Nurse|nurse
5020643|NCT03867864|Aromatherapy|aromatherapy
5020644|NCT03867864|Essential oils|essential oils
5020645|NCT03867864|Missed care|missed care
5020646|NCT03867786|Resistance Exercise Neurobiological Mechanisms|resistance exercise neurobiological mechanisms
5020647|NCT03867747|Ventricular Tachycardia|ventricular tachycardia
5020648|NCT03867747|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5020649|NCT03867747|Radiosurgery|radiosurgery
5020650|NCT03867734|aztreonam|aztreonam
5020651|NCT03867734|treatment study|treatment study
5020652|NCT03867721|noninvasive ventilation|noninvasive ventilation
5020653|NCT03867695|Serratus plane block|serratus plane block
5020654|NCT03867695|Analgesia after VATS|analgesia after vats
5020655|NCT03867695|Lobectomy VATS|lobectomy vats
5020656|NCT03867682|Lintuzumab-Ac225|lintuzumab-ac225
5020657|NCT03867682|Venetoclax|venetoclax
5020658|NCT03867682|Lintuzumab|lintuzumab
5020659|NCT03867682|Refractory AML|refractory aml
5020660|NCT03867669|Developmental Disabilities|developmental disabilities
5020661|NCT03867669|Follow-Up Studies|follow-up studies
5020662|NCT03867669|Infant, Premature|infant, premature
5020663|NCT03867669|Intensive Care Units, Neonatal|intensive care units, neonatal
5020664|NCT03867669|randomized controlled trial|randomized controlled trial
5020665|NCT03867656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5020666|NCT03867656|Bone resorption|bone resorption
5020667|NCT03867656|Bone formation|bone formation
5020669|NCT03867656|P1NP|p1np
5020670|NCT03867656|GLP-2|glp-2
5020671|NCT03867656|GIP|gip
5020677|NCT03867565|Minor burns|minor burns
5020678|NCT03867565|Nutrition|nutrition
5020679|NCT03867552|post-operative pain|post-operative pain
5020680|NCT03867552|recovery|recovery
5020681|NCT03867552|laparoscopy|laparoscopy
5020682|NCT03867552|nitrous oxide|nitrous oxide
5020683|NCT03867539|hand|hand
5020684|NCT03867539|exparel|exparel
5020685|NCT03867539|opioid crisis|opioid crisis
5020686|NCT03867513|Magnetoencephalography|magnetoencephalography
5020687|NCT03867513|Magnetic Resonance Imaging|magnetic resonance imaging
5020688|NCT03867513|Mild traumatic brain injury|mild traumatic brain injury
5020689|NCT03867474|Mindfulness, Primary Care, MBSR, Cognitive Impairment|mindfulness, primary care, mbsr, cognitive impairment
5020690|NCT03867461|End-Tidal Carbon Dioxide|end-tidal carbon dioxide
5020691|NCT03867461|Venous Sinus Stenting|venous sinus stenting
5020692|NCT03867461|Venous Sinus Caliber and Pressures|venous sinus caliber and pressures
5020693|NCT03867448|Adrenal Gland|adrenal gland
5020694|NCT03867448|Pituitary|pituitary
5020695|NCT03867435|Muscle Weakness|muscle weakness
5020696|NCT03867435|Muscular Dystrophy|muscular dystrophy
5020697|NCT03867435|Neuromuscular Disease|neuromuscular disease
5020698|NCT03867435|Myotonia|myotonia
5020699|NCT03867396|Cochlear Implant|cochlear implant
5020700|NCT03867396|Hearing Loss|hearing loss
5020701|NCT03867396|Hearing Aids|hearing aids
5020702|NCT03867396|Hearing Tests|hearing tests
5020703|NCT03867357|Androgen deprivation therapy|androgen deprivation therapy
5020704|NCT03867357|Prostate cancer|prostate cancer
5020705|NCT03867357|Sarcopenia|sarcopenia
5020706|NCT03867344|Hypoglycemia|hypoglycemia
5020707|NCT03867344|Stress|stress
5020708|NCT03867344|Brain|brain
5020709|NCT03867292|Paddle-tennis|paddle-tennis
5020710|NCT03867292|Myofascial release|myofascial release
5020711|NCT03867292|Electrotherapy|electrotherapy
5020712|NCT03867292|Physiotherapy|physiotherapy
5020713|NCT03867292|Low back|low back
5020714|NCT03867292|Randomized clinical trial|randomized clinical trial
5020715|NCT03867279|Weightlifters|weightlifters
5020716|NCT03867279|Flossbands|flossbands
5020717|NCT03867279|Clinical Trial|clinical trial
5020718|NCT03867279|Physical Therapy|physical therapy
5020727|NCT03867240|Idiopathic scoliosis surgery|idiopathic scoliosis surgery
5020728|NCT03867227|left atrial appendage|left atrial appendage
5020729|NCT03867227|LAA occluder|laa occluder
5020730|NCT03867227|thromboembolic prophylaxis|thromboembolic prophylaxis
5020731|NCT03867227|atrial fibrillation|atrial fibrillation
5020733|NCT03867201|erenumab|erenumab
5020734|NCT03867201|migraine|migraine
5020735|NCT03867201|chronic|chronic
5020736|NCT03867201|headache|headache
5020737|NCT03867201|Chinese|chinese
5020738|NCT03867188|Exparel|exparel
5020739|NCT03867188|Liposomal Bupivacaine|liposomal bupivacaine
5020740|NCT03867188|Removal by Surgery|removal by surgery
5020741|NCT03867188|Pain Reduction|pain reduction
5020742|NCT03867149|Mediodorsal nucleus|mediodorsal nucleus
5020743|NCT03867149|higher order cognition|higher order cognition
5020744|NCT03867136|Multidrug resistant tuberculosis|multidrug resistant tuberculosis
5020745|NCT03867136|shorter treatment|shorter treatment
5020746|NCT03867136|all-oral regimen|all-oral regimen
5020747|NCT03867110|Hypercholesterolemia|hypercholesterolemia
5020748|NCT03867110|Ezetimibe|ezetimibe
5020749|NCT03867110|Atorvastatin|atorvastatin
5020750|NCT03867110|Low density lipoprotein-cholesterol|low density lipoprotein-cholesterol
5020758|NCT03867019|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5020759|NCT03867019|BPPV|bppv
5020760|NCT03867019|Vertigo|vertigo
5020761|NCT03867019|Autonomic Nervous System|autonomic nervous system
5020762|NCT03867019|Heart Rate Variability|heart rate variability
5020763|NCT03867019|Vestibulo Sympathetic Response|vestibulo sympathetic response
5020764|NCT03867019|Vestibulo Sympathetic Reflex|vestibulo sympathetic reflex
5020765|NCT03867006|Malnutrition|malnutrition
5020766|NCT03867006|Undernutrition|undernutrition
5020767|NCT03867006|Elderly|elderly
5020768|NCT03867006|Protein|protein
5020769|NCT03867006|Carbohydrate|carbohydrate
5020770|NCT03866993|immuno-oncology|immuno-oncology
5020771|NCT03866993|NSCLC|nsclc
5020772|NCT03866993|Anti-PD-1 Antibody|anti-pd-1 antibody
5020773|NCT03866993|immunotherapy|immunotherapy
5020774|NCT03866980|immunotherapy,immuno-oncology, non-small cell lung cancer|immunotherapy,immuno-oncology, non-small cell lung cancer
5020775|NCT03866980|Anti-PD-1 antibody|anti-pd-1 antibody
5020776|NCT03866967|immunotherapy|immunotherapy
5020777|NCT03866967|Anti-PD-1 antibody|anti-pd-1 antibody
5020778|NCT03866967|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5020779|NCT03866967|immuno-oncology|immuno-oncology
5020780|NCT03866954|neuropathy|neuropathy
5020781|NCT03866954|gastrointestinal disease|gastrointestinal disease
5020787|NCT03866902|adiposity|adiposity
5020788|NCT03866902|nutrition|nutrition
5020789|NCT03866902|physical activity|physical activity
5020790|NCT03866902|Hispanic|hispanic
5020791|NCT03866889|Strength|strength
5020792|NCT03866889|Military|military
5020793|NCT03866889|Functionality|functionality
5020794|NCT03866889|Physiotherapy|physiotherapy
5020795|NCT03866889|Randomized clinical trial|randomized clinical trial
5020796|NCT03866837|Iron-deficiency|iron-deficiency
5020797|NCT03866837|Iron supplementation|iron supplementation
5020798|NCT03866837|Galacto-oligosaccharides|galacto-oligosaccharides
5020802|NCT03866837|Microbiome|microbiome
5020803|NCT03866837|PolyFermS|polyferms
5020804|NCT03866837|Polyfermenter intestinal model|polyfermenter intestinal model
5020805|NCT03866811|emergency medicine|emergency medicine
5020806|NCT03866811|reproductive health|reproductive health
5020807|NCT03866811|sexual health|sexual health
5020808|NCT03866811|adolescent health|adolescent health
5020809|NCT03866811|emergency department|emergency department
5020810|NCT03866811|text messaging|text messaging
5020811|NCT03866811|mobile health|mobile health
5020812|NCT03866811|digital health|digital health
5020813|NCT03866785|Prostate cancer|prostate cancer
5020814|NCT03866785|Physical activity|physical activity
5020815|NCT03866785|Activity actigraph|activity actigraph
5020816|NCT03866785|Peer|peer
5020817|NCT03866785|Program|program
5020831|NCT03866746|subthreshold|subthreshold
5020832|NCT03866733|erector spinea block, open heart surgeries,analgesia|erector spinea block, open heart surgeries,analgesia
5020833|NCT03866694|maternal opioid use|maternal opioid use
5020834|NCT03866694|substance use|substance use
5020835|NCT03866694|parent-child relationship|parent-child relationship
5020837|NCT03866694|social and emotional development|social and emotional development
5020838|NCT03866694|mental health and well-being|mental health and well-being
5020839|NCT03866694|perinatal|perinatal
5020840|NCT03866694|postpartum|postpartum
5020841|NCT03866694|health disparities|health disparities
5020842|NCT03866668|Esomeprazole|esomeprazole
5020843|NCT03866655|Breast Cancer|breast cancer
5020844|NCT03866655|Digital|digital
5020845|NCT03866655|eHealth|ehealth
5020846|NCT03866655|Supportive Care|supportive care
5020847|NCT03866655|Patient Activation|patient activation
5020848|NCT03866655|Resource Utilisation|resource utilisation
5020858|NCT03866551|Acute Heart Failure|acute heart failure
5020859|NCT03866551|Decompensated Heart Failure|decompensated heart failure
5020860|NCT03866551|Heart Failure Treatment|heart failure treatment
5015465|NCT03899935|Obesity|obesity
5020861|NCT03866551|Heart Failure Management Fluid Overload|heart failure management fluid overload
5020862|NCT03866551|Diuresis|diuresis
5020863|NCT03866525|Oncolytic Virus|oncolytic virus
5020864|NCT03866499|EGFR|egfr
5020865|NCT03866499|T790M|t790m
5020866|NCT03866499|NSCLC|nsclc
5020867|NCT03866486|Clinical outcome; IVUS; Stent|clinical outcome; ivus; stent
5020868|NCT03866460|Hearing Status|hearing status
5020869|NCT03866460|18-529|18-529
5020870|NCT03866408|adipose tissue|adipose tissue
5020871|NCT03866395|Stable angina|stable angina
5020872|NCT03866395|coronary artery diseases|coronary artery diseases
5020873|NCT03866395|heart rate|heart rate
5020874|NCT03866395|exercise tolerability|exercise tolerability
5020875|NCT03866395|diastolic function|diastolic function
5020876|NCT03866395|ivabradine|ivabradine
5020877|NCT03866369|healthy male volunteers|healthy male volunteers
5020892|NCT03866265|Salmon Polar Lipids|salmon polar lipids
5020893|NCT03866265|anti-inflammatory|anti-inflammatory
5020894|NCT03866265|anti-coagulant|anti-coagulant
5020895|NCT03866265|platelet aggregation|platelet aggregation
5020896|NCT03866226|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5020897|NCT03866226|sleep|sleep
5020898|NCT03866213|Diagnostic|diagnostic
5020899|NCT03866213|Point-of-Care|point-of-care
5020900|NCT03866213|Low-Resource Setting|low-resource setting
5020901|NCT03866200|resveratrol|resveratrol
5020902|NCT03866200|joint pain|joint pain
5020903|NCT03866174|Psilocybin, Psychedelics, Depression, MDD|psilocybin, psychedelics, depression, mdd
5020904|NCT03866148|Atrial Fibrillation|atrial fibrillation
5020905|NCT03866148|Obstructive Sleep Apnea|obstructive sleep apnea
5020906|NCT03866148|Implantable Loop Recorder|implantable loop recorder
5020907|NCT03866148|Extended Cardiac Monitoring|extended cardiac monitoring
5020908|NCT03866148|Matrix Metalloproteinase-9|matrix metalloproteinase-9
5020909|NCT03866148|Interleukin-6|interleukin-6
5020910|NCT03866148|Tumour Necrosis Factor-Alpha|tumour necrosis factor-alpha
5021034|NCT03865498|Family Caregivers|family caregivers
5022804|NCT03855098|Metabolomics|metabolomics
5020914|NCT03866148|Heart Rate Variability|heart rate variability
5020915|NCT03866148|N-Terminal pro B-type Natriuretic Peptide|n-terminal pro b-type natriuretic peptide
5020916|NCT03866109|Temferon|temferon
5020917|NCT03866109|Gene Therapy|gene therapy
5020918|NCT03866109|Immunotherapy|immunotherapy
5020919|NCT03866109|Solid tumor|solid tumor
5020920|NCT03866070|Handball|handball
5020921|NCT03866070|Physiotherapy|physiotherapy
5020922|NCT03866070|Shoulder instability|shoulder instability
5020923|NCT03866070|Scapular dyskinesia|scapular dyskinesia
5020925|NCT03866057|Stroke|stroke
5020926|NCT03866057|Predictors of recovery|predictors of recovery
5020927|NCT03866057|Neurological Rehabilitation|neurological rehabilitation
5020928|NCT03866057|Genetic|genetic
5020929|NCT03866057|Epigenetic|epigenetic
5020930|NCT03866057|Mirror Therapy|mirror therapy
5020931|NCT03866057|Neurophysiopathology|neurophysiopathology
5020932|NCT03866031|Implant, overdenture, Immediate loading|implant, overdenture, immediate loading
5020933|NCT03866005|diabetes, retina, diabetic retinopathy, diabetic macular edema, anti-VEGF therapy|diabetes, retina, diabetic retinopathy, diabetic macular edema, anti-vegf therapy
5020934|NCT03865992|Breast cancer|breast cancer
5020935|NCT03865992|curcumin|curcumin
5020936|NCT03865992|aromatase inhibitor|aromatase inhibitor
5020937|NCT03865992|joint pain|joint pain
5020938|NCT03865992|arthropathy|arthropathy
5020939|NCT03865979|Artificial Intelligence|artificial intelligence
5020941|NCT03865927|Reactive oxygen species (ROS)|reactive oxygen species (ros)
5020942|NCT03865927|nicotinamide adenine dinucleotide phosphate (NADPH) oxidase|nicotinamide adenine dinucleotide phosphate (nadph) oxidase
5020943|NCT03865914|Diabetic kidney disease (DKD)|diabetic kidney disease (dkd)
5020944|NCT03865914|Diabetic nephropathy（DN)|diabetic nephropathy（dn)
5020945|NCT03865914|non-diabetic renal diseases（ NDRD)|non-diabetic renal diseases（ ndrd)
5020946|NCT03865914|Clinical-pathological correlations|clinical-pathological correlations
5020947|NCT03865914|differential diagnosis|differential diagnosis
5020948|NCT03865901|in vitro diagnostic|in vitro diagnostic
5020949|NCT03865901|GDM|gdm
5020950|NCT03865901|gestational diabetes mellitus|gestational diabetes mellitus
5020951|NCT03865901|screening|screening
5020952|NCT03865901|pregnancy|pregnancy
5020953|NCT03865901|prenatal care|prenatal care
5020954|NCT03865901|women's health|women's health
5020955|NCT03865888|Sjogren Syndrome|sjogren syndrome
5020956|NCT03865888|Dry eye|dry eye
5020962|NCT03865875|Exercise|exercise
5020963|NCT03865875|Nutrition|nutrition
5020964|NCT03865875|Optimization|optimization
5020965|NCT03865875|Surgery|surgery
5020966|NCT03865862|Eccentric|eccentric
5020967|NCT03865862|Load control|load control
5020968|NCT03865862|Volleyball|volleyball
5020969|NCT03865862|Physiotherapy|physiotherapy
5020970|NCT03865862|Patellar tendon|patellar tendon
5020971|NCT03865862|Randomized clinical trial|randomized clinical trial
5020972|NCT03865836|expanded access|expanded access
5020973|NCT03865836|compassionate use|compassionate use
5020974|NCT03865823|anal fistula|anal fistula
5020975|NCT03865823|anal infection|anal infection
5020976|NCT03865784|Boxing|boxing
5020977|NCT03865784|Injuries|injuries
5020978|NCT03865784|Physiotherapy|physiotherapy
5020979|NCT03865784|Kinesiotape|kinesiotape
5020980|NCT03865784|Core|core
5020981|NCT03865784|Low back pain|low back pain
5020982|NCT03865771|Memory consolidation|memory consolidation
5020983|NCT03865771|Epilepsy|epilepsy
5020984|NCT03865771|Childhood|childhood
5020985|NCT03865771|Benign epilepsy with centro temporal spikes (BECTS)|benign epilepsy with centro temporal spikes (bects)
5020986|NCT03865771|Epileptic encephalopathy with continuous spike and waves during sleep (ECSWS)|epileptic encephalopathy with continuous spike and waves during sleep (ecsws)
5020987|NCT03865758|Dementia|dementia
5020988|NCT03865758|Rehabilitation|rehabilitation
5020989|NCT03865732|refractory seizures|refractory seizures
5020990|NCT03865732|epilepsy in children|epilepsy in children
5020991|NCT03865732|seizure disorder|seizure disorder
5020992|NCT03865719|Second Generation Antipsychotics|second generation antipsychotics
5020993|NCT03865719|Weight Management|weight management
5020994|NCT03865706|Microbiome|microbiome
5020995|NCT03865706|Antibiotic resistance|antibiotic resistance
5020996|NCT03865706|Intensive care unit|intensive care unit
5020997|NCT03865706|Sepsis|sepsis
5020998|NCT03865706|Nutrition|nutrition
5020999|NCT03865706|Pathogen colonization|pathogen colonization
5021000|NCT03865693|Burn|burn
5021001|NCT03865693|pain scrambler|pain scrambler
5021002|NCT03865680|Fluoride varnish|fluoride varnish
5021003|NCT03865680|Casein|casein
5021004|NCT03865680|MI varnish|mi varnish
5021005|NCT03865654|Breast Cancer|breast cancer
5021006|NCT03865641|burn|burn
5021007|NCT03865641|virtual reality|virtual reality
5021008|NCT03865628|Doppler|doppler
5021026|NCT03865563|retrograde venous infusion|retrograde venous infusion
5021028|NCT03865563|gemcitabine|gemcitabine
5021029|NCT03865563|lipiodol|lipiodol
5021030|NCT03865524|Osteoarthritis, Knee|osteoarthritis, knee
5021031|NCT03865524|Obesity|obesity
5021032|NCT03865524|Knee replacement|knee replacement
5021033|NCT03865524|Arthroplasty|arthroplasty
5021035|NCT03865498|Dementia|dementia
5021036|NCT03865485|Parenting Program|parenting program
5021037|NCT03865459|anxiety|anxiety
5021038|NCT03865459|cystoscopy|cystoscopy
5021039|NCT03865459|female|female
5021040|NCT03865459|nursing|nursing
5021041|NCT03865459|pain|pain
5021042|NCT03865459|video|video
5021043|NCT03865446|Pharmacokinetics|pharmacokinetics
5021044|NCT03865446|Dacomitinib|dacomitinib
5021045|NCT03865446|Hepatic Impairment|hepatic impairment
5021046|NCT03865420|Pre-symptomatic|pre-symptomatic
5021047|NCT03865420|Familial|familial
5021048|NCT03865420|FALS|fals
5021049|NCT03865420|Genetic testing|genetic testing
5021050|NCT03865420|C9orf72|c9orf72
5021051|NCT03865420|SOD1|sod1
5021052|NCT03865420|TARDBP|tardbp
5021054|NCT03865420|VCP|vcp
5021055|NCT03865420|PFN1|pfn1
5021056|NCT03865394|stromal vascular fraction|stromal vascular fraction
5021057|NCT03865394|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
5021058|NCT03865394|chronic wounds|chronic wounds
5021059|NCT03865394|diabetes|diabetes
5021081|NCT03865225|Heart Rate Variability|heart rate variability
5021082|NCT03865225|Autonomic Nervous System|autonomic nervous system
5021083|NCT03865225|cardiac autonomic dysfunction|cardiac autonomic dysfunction
5021084|NCT03865225|sudomotor function|sudomotor function
5021085|NCT03865225|vasomotor function|vasomotor function
5021087|NCT03865186|facial expression|facial expression
5021088|NCT03865186|facial recognition|facial recognition
5021089|NCT03865186|psychiatric nursing|psychiatric nursing
5021090|NCT03865186|psychoeducation|psychoeducation
5021091|NCT03865186|schizophrenia|schizophrenia
5021092|NCT03865173|Stroke|stroke
5021093|NCT03865173|Pathways|pathways
5021094|NCT03865173|Sequelae|sequelae
5021095|NCT03865173|Health services research|health services research
5021096|NCT03865160|Myopia|myopia
5021097|NCT03865160|Children|children
5021098|NCT03865160|Atropine|atropine
5021099|NCT03865160|Low-dose|low-dose
5021100|NCT03865160|0.01|0.01
5021101|NCT03865121|Parkinson Disease|parkinson disease
5021102|NCT03865121|Nicotine|nicotine
5063956|NCT03599583|HPV|hpv
5021103|NCT03865121|Transnasal|transnasal
5021104|NCT03865108|Pessary|pessary
5021105|NCT03865108|Cervix|cervix
5021106|NCT03865108|Biomechanical environment|biomechanical environment
5021107|NCT03865108|Aspiration|aspiration
5021108|NCT03865108|Computer simulation models|computer simulation models
5021113|NCT03865069|automated oxygen control|automated oxygen control
5021114|NCT03865069|automated pressure control|automated pressure control
5021115|NCT03865069|CLIO|clio
5021119|NCT03865043|TAVI|tavi
5021120|NCT03865043|preclosing|preclosing
5021121|NCT03865017|Regulatory T cell|regulatory t cell
5021122|NCT03865017|Treg|treg
5021123|NCT03865017|cell therapy|cell therapy
5021124|NCT03865017|autologous|autologous
5021125|NCT03864991|Log book|log book
5021126|NCT03864991|Step count|step count
5021127|NCT03864991|Diet|diet
5021128|NCT03864991|Physical activity|physical activity
5021129|NCT03864991|HbA1c|hba1c
5021130|NCT03864991|Blood sugar|blood sugar
5021131|NCT03864965|Alzheimer's disease|alzheimer's disease
5021132|NCT03864965|Dementia|dementia
5023023|NCT03853694|TAP|tap
5021144|NCT03864887|Near infrared spectroscopy|near infrared spectroscopy
5021145|NCT03864874|Pulmonary metastases|pulmonary metastases
5021146|NCT03864874|Intraoperative ultrasonography|intraoperative ultrasonography
5021148|NCT03864874|Lung|lung
5021149|NCT03864835|fatty liver|fatty liver
5021150|NCT03864835|NASH|nash
5021151|NCT03864835|NAFLD|nafld
5021152|NCT03864770|myofascial trigger points|myofascial trigger points
5021153|NCT03864770|nocturnal leg cramps|nocturnal leg cramps
5021154|NCT03864770|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5021155|NCT03864757|unilateral vocal fold paralysis|unilateral vocal fold paralysis
5021156|NCT03864757|type I thyroplasty|type i thyroplasty
5021157|NCT03864744|liver biopsy|liver biopsy
5021158|NCT03864744|Lipid metabolism|lipid metabolism
5021159|NCT03864744|Glucose metabolism|glucose metabolism
5021160|NCT03864744|Postoperative complications|postoperative complications
5021161|NCT03864744|Pancreatic surgery|pancreatic surgery
5021162|NCT03864679|exercise|exercise
5021164|NCT03864679|fasted|fasted
5021166|NCT03864679|carbohydrate|carbohydrate
5021167|NCT03864666|Peripheral Artery Disease|peripheral artery disease
5021168|NCT03864666|Cilostazol|cilostazol
5021169|NCT03864666|PMR|pmr
5021170|NCT03864666|Extended-Release Tablet of Cilostazol|extended-release tablet of cilostazol
5323510|NCT02068846|HIV|hiv
5337148|NCT02007863|ALL|all
5021171|NCT03864653|MSM|msm
5021172|NCT03864653|PrEP|prep
5021173|NCT03864653|ART|art
5021174|NCT03864653|Sexual Risk Behavior|sexual risk behavior
5021175|NCT03864575|Nivolumab|nivolumab
5021176|NCT03864575|Celecoxib|celecoxib
5021177|NCT03864562|gastric emptying|gastric emptying
5021178|NCT03864562|oral glucose tolerance test|oral glucose tolerance test
5021179|NCT03864562|Ethnicity|ethnicity
5021180|NCT03864562|Diabetes risk|diabetes risk
5021181|NCT03864523|AMN|amn
5021182|NCT03864523|pioglitazone|pioglitazone
5021183|NCT03864458|Tenapanor|tenapanor
5021184|NCT03864458|Hyperphosphatemia|hyperphosphatemia
5021185|NCT03864458|Hemodialysis|hemodialysis
5021186|NCT03864445|Tenapanor|tenapanor
5021187|NCT03864445|Hyperphosphatemia|hyperphosphatemia
5021188|NCT03864445|Hemodialysis|hemodialysis
5021189|NCT03864406|Antiretroviral Therapy|antiretroviral therapy
5021190|NCT03864406|Human Immunodeficiency Disease|human immunodeficiency disease
5021191|NCT03864406|Drug-Drug Interactions|drug-drug interactions
5021192|NCT03864406|Thrombosis|thrombosis
5021193|NCT03864406|Bleeding|bleeding
5021197|NCT03864380|Retinal Vascularization|retinal vascularization
5021198|NCT03864380|Intense effort|intense effort
5021199|NCT03864380|OCT-A|oct-a
5021200|NCT03864354|osteopathic manipulative medicine|osteopathic manipulative medicine
5021201|NCT03864354|Spirometry|spirometry
5021202|NCT03864354|Respiratory|respiratory
5021203|NCT03864354|OMM|omm
5021204|NCT03864354|OMT|omt
5021205|NCT03864354|osteopathic manual medicine|osteopathic manual medicine
5021206|NCT03864354|osteopathic manipulative treatment|osteopathic manipulative treatment
5021207|NCT03864354|osteopathic manual treatment|osteopathic manual treatment
5021208|NCT03864328|Cough|cough
5021209|NCT03864328|Chronic Cough|chronic cough
5021210|NCT03864328|IPF|ipf
5021211|NCT03864328|IPF Cough|ipf cough
5021212|NCT03864315|Vitiligo|vitiligo
5021213|NCT03864315|Harmonic Generation Microscopy|harmonic generation microscopy
5021214|NCT03864315|In Vivo|in vivo
5021215|NCT03864237|alcohol abuse|alcohol abuse
5021216|NCT03864237|college students|college students
5021217|NCT03864237|preventive programs|preventive programs
5021218|NCT03864237|text messages|text messages
5021219|NCT03864224|Low Back Pain|low back pain
5021220|NCT03864211|Hepatocellular Carcinoma|hepatocellular carcinoma
5021221|NCT03864211|Immunotherapy|immunotherapy
5021236|NCT03864159|Hamstring|hamstring
5021237|NCT03864146|Alcohol Use Disorder|alcohol use disorder
5021238|NCT03864146|Alcohol dependence|alcohol dependence
5021239|NCT03864146|Craving|craving
5021240|NCT03864107|Glycaemic Control|glycaemic control
5021241|NCT03864107|Gut Permeability|gut permeability
5021242|NCT03864107|Gut Microbiota|gut microbiota
5021244|NCT03864107|Metabolic Health|metabolic health
5021245|NCT03864094|Cardiac Output (CO)|cardiac output (co)
5021246|NCT03864094|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
5717549|NCT00440362|Flu|flu
5021247|NCT03864094|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
5021248|NCT03864094|Heart Rate (HR)|heart rate (hr)
5021249|NCT03864094|Stroke Volume (SV)|stroke volume (sv)
5021250|NCT03864094|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
5021251|NCT03864094|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
5021252|NCT03864094|Propofol|propofol
5021253|NCT03864094|Remifentanil|remifentanil
5021254|NCT03864094|Ephedrine|ephedrine
5021255|NCT03864094|Phenylephrine|phenylephrine
5021256|NCT03864094|Norepinephrine|norepinephrine
5021263|NCT03864055|otitis media|otitis media
5021264|NCT03864055|mastoiditis|mastoiditis
5021265|NCT03864055|Lateral Sinus Thrombosis|lateral sinus thrombosis
5021266|NCT03864055|subperiosteal abscess|subperiosteal abscess
5021267|NCT03864055|sigmoid sinus|sigmoid sinus
5021268|NCT03864055|mastoid|mastoid
5021269|NCT03864055|mastoidectomy|mastoidectomy
5021270|NCT03864055|ventilation tube|ventilation tube
5021271|NCT03864042|solid tumor|solid tumor
5021272|NCT03864042|melanoma|melanoma
5021289|NCT03863925|Target controlled infusion|target controlled infusion
5021290|NCT03863899|Ilioinguinal Iliohypogastric nerve block|ilioinguinal iliohypogastric nerve block
5021291|NCT03863899|local anaesthesia infiltration|local anaesthesia infiltration
5021292|NCT03863899|ultrasound-guided|ultrasound-guided
5021293|NCT03863899|pain control|pain control
5021294|NCT03863886|crohn's disease|crohn's disease
5021295|NCT03863886|ulcerative colitis|ulcerative colitis
5021296|NCT03863886|endoscopic ultrasound|endoscopic ultrasound
5021297|NCT03863886|inflammatory bowel disease|inflammatory bowel disease
5021300|NCT03863847|Pain|pain
5021301|NCT03863847|Chronic Pain|chronic pain
5021302|NCT03863847|Musculoskeletal Pain|musculoskeletal pain
5021303|NCT03863847|Treatment|treatment
5021304|NCT03863847|Neurofeedback|neurofeedback
5021305|NCT03863847|Brain Activity|brain activity
5021306|NCT03863847|Brain Oscillation|brain oscillation
5021307|NCT03863847|Brain Computer Interface|brain computer interface
5021308|NCT03863821|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5021309|NCT03863821|heated humidified high-flow nasal cannula|heated humidified high-flow nasal cannula
5021310|NCT03863821|pulmonary rehabilitation|pulmonary rehabilitation
5021311|NCT03863821|six-minute walking test|six-minute walking test
5021312|NCT03863808|Cognitive Behavioural Therapy|cognitive behavioural therapy
5021313|NCT03863808|Flexion Relaxation Phenomenon|flexion relaxation phenomenon
5021314|NCT03863808|Electromyography|electromyography
5021315|NCT03863808|Biofeedback|biofeedback
5021316|NCT03863808|Functional Training|functional training
5021317|NCT03863769|Chiropractic manipulation|chiropractic manipulation
5021318|NCT03863769|postural sway|postural sway
5021520|NCT03862651|randomized|randomized
5021319|NCT03863769|distraction manipulation|distraction manipulation
5021320|NCT03863769|performance-based mobility|performance-based mobility
5021321|NCT03863756|spondyloarthritis|spondyloarthritis
5021322|NCT03863756|spine|spine
5021323|NCT03863756|syndesmophyte|syndesmophyte
5021324|NCT03863756|radiography|radiography
5021325|NCT03863756|EOS|eos
5021326|NCT03863730|Food for special medical purposes|food for special medical purposes
5021327|NCT03863730|Gut and liver axis|gut and liver axis
5021328|NCT03863691|dopamine antagonists|dopamine antagonists
5021329|NCT03863691|dopamine blockade|dopamine blockade
5021330|NCT03863691|psychophysiological stress response|psychophysiological stress response
5021331|NCT03863691|Maastricht acute stress test (MAST)|maastricht acute stress test (mast)
5021332|NCT03863691|effort based paradigms|effort based paradigms
5021333|NCT03863691|positivity offset theory|positivity offset theory
5021334|NCT03863691|international affective picture system (IAPS)|international affective picture system (iaps)
5021335|NCT03863678|dry needling|dry needling
5021336|NCT03863678|neurodevelopmental therapy|neurodevelopmental therapy
5021337|NCT03863678|spasticity|spasticity
5021338|NCT03863678|balance|balance
5021339|NCT03863678|functions|functions
5021340|NCT03863678|independence|independence
5021341|NCT03863652|snuffbox approach|snuffbox approach
5021342|NCT03863652|distal radial approach|distal radial approach
5021343|NCT03863652|hemostasis|hemostasis
5021344|NCT03863639|Pre-Eclampsia|pre-eclampsia
5021345|NCT03863639|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5021346|NCT03863639|Neurocognitive Function|neurocognitive function
5021347|NCT03863613|Pessary, Cerclage, Progesterone, Twins, Preterm birth|pessary, cerclage, progesterone, twins, preterm birth
5021348|NCT03863600|Satisfaction with care|satisfaction with care
5717653|NCT00439972|Metabolism|metabolism
5021349|NCT03863600|Low-middle income country|low-middle income country
5021350|NCT03863600|Continuity of care|continuity of care
5021351|NCT03863600|Maternal care|maternal care
5021352|NCT03863574|NASH|nash
5021353|NCT03863561|self-management|self-management
5021354|NCT03863561|questionnaire|questionnaire
5021355|NCT03863561|diabetes education|diabetes education
5021356|NCT03863535|Conbercept|conbercept
5021357|NCT03863535|Panretinal photocoagulation|panretinal photocoagulation
5021358|NCT03863535|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
5021359|NCT03863535|diabetic macular edema|diabetic macular edema
5021368|NCT03863470|Early ICU mobility|early icu mobility
5021369|NCT03863457|breast cancer|breast cancer
5021370|NCT03863444|First-time Parents|first-time parents
5021371|NCT03863444|Prenatal Preparation Education|prenatal preparation education
5021372|NCT03863444|Partner Support|partner support
5021373|NCT03863431|High-fat diets|high-fat diets
5021374|NCT03863431|High-carbohydrate diets|high-carbohydrate diets
5021375|NCT03863431|Glycaemic control|glycaemic control
5021376|NCT03863379|Sarcopenia|sarcopenia
5021377|NCT03863379|sarcopenic obesity|sarcopenic obesity
5021378|NCT03863379|stroke|stroke
5021380|NCT03863379|TBI|tbi
5021381|NCT03863379|MS|ms
5021382|NCT03863366|5-HT4|5-ht4
5021383|NCT03863366|Prucalopride|prucalopride
5021384|NCT03863366|Resolor|resolor
5021385|NCT03863366|Emotional Processing|emotional processing
5021386|NCT03863366|Healthy Volunteers|healthy volunteers
5021387|NCT03863340|muscle fatigue|muscle fatigue
5021388|NCT03863340|work-related disorders|work-related disorders
5021389|NCT03863340|trapezius myalgia|trapezius myalgia
5021390|NCT03863340|sustained working task|sustained working task
5021391|NCT03863340|high-density EMG|high-density emg
5021392|NCT03863327|Acute Coronary Occlusion|acute coronary occlusion
5021393|NCT03863327|ACO|aco
5021394|NCT03863327|Occlusive Myocardial Infarction|occlusive myocardial infarction
5021395|NCT03863327|OMI|omi
5021396|NCT03863327|Non-occlusive Myocardial Infarction|non-occlusive myocardial infarction
5021397|NCT03863327|NOMI|nomi
5021398|NCT03863314|Virtual Reality|virtual reality
5021399|NCT03863314|Augmented Reality|augmented reality
5021400|NCT03863314|Simulation|simulation
5021401|NCT03863314|Workplace|workplace
5021402|NCT03863301|Radiotherapy|radiotherapy
5021403|NCT03863288|oxytocin|oxytocin
5021404|NCT03863288|neuroimaging|neuroimaging
5021405|NCT03863288|irritability|irritability
5021406|NCT03863288|fMRI|fmri
5021407|NCT03863288|pharmacokinetics|pharmacokinetics
5021408|NCT03863262|cardiovascular|cardiovascular
5021409|NCT03863249|Periodontitis|periodontitis
5021410|NCT03863249|Microbiome|microbiome
5021411|NCT03863249|Dysbiosis|dysbiosis
5021412|NCT03863249|Homeostasis|homeostasis
5021413|NCT03863249|Dental plaque|dental plaque
5021414|NCT03863249|Antibiotics|antibiotics
5021415|NCT03863236|colon cancer, nutritional support, complications, mortality,|colon cancer, nutritional support, complications, mortality,
5021416|NCT03863210|cardiovascular risk|cardiovascular risk
5021425|NCT03863184|MRD|mrd
5021426|NCT03863184|Minimal-residual-disease|minimal-residual-disease
5021427|NCT03863184|Treatment naive|treatment naive
5021428|NCT03863184|Untreated|untreated
5021429|NCT03863184|Frontline|frontline
5021430|NCT03863184|Acalabrutinib|acalabrutinib
5021431|NCT03863184|Lenalidomide|lenalidomide
5021432|NCT03863184|Rituximab|rituximab
5021433|NCT03863132|Aortic stenosis|aortic stenosis
5021434|NCT03863132|Low flow|low flow
5021435|NCT03863132|Low gradient|low gradient
5021436|NCT03863132|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5021437|NCT03863119|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5021438|NCT03863119|Vamorolone|vamorolone
5021439|NCT03863119|VBP-15|vbp-15
5021440|NCT03863119|DMD|dmd
5021442|NCT03863067|Lumbosacral epiduroscopy|lumbosacral epiduroscopy
5021443|NCT03863067|spinal stenosis|spinal stenosis
5021444|NCT03863067|magnetic resonance imaging|magnetic resonance imaging
5021445|NCT03863067|intraoperative neurophysiological monitoring|intraoperative neurophysiological monitoring
5021446|NCT03863067|neurogenic claudication|neurogenic claudication
5021447|NCT03863054|Topical Oxygen|topical oxygen
5021448|NCT03863054|Wound Management|wound management
5021449|NCT03863028|Validity-evidence|validity-evidence
5021450|NCT03863028|TURB|turb
5021451|NCT03863028|Mastery Learning|mastery learning
5021452|NCT03863028|Bladder Cancer|bladder cancer
5021453|NCT03863015|OHCA|ohca
5021454|NCT03863015|PCAS|pcas
5021455|NCT03863015|SIRS|sirs
5021456|NCT03863015|Inflammation|inflammation
5021457|NCT03863015|RoActemra|roactemra
5021458|NCT03863015|Tociluzumab|tociluzumab
5021459|NCT03863002|mesenchymal stem cell|mesenchymal stem cell
5021460|NCT03862950|Congenital Abnormalities|congenital abnormalities
5021461|NCT03862950|Metformin|metformin
5021462|NCT03862950|Nervous System Diseases|nervous system diseases
5021463|NCT03862950|Chromosome Disorders|chromosome disorders
5021467|NCT03862937|Functional Capacity|functional capacity
5021468|NCT03862937|Muscle Strength|muscle strength
5021470|NCT03862924|smoking|smoking
5021471|NCT03862872|Inflammation|inflammation
5021472|NCT03862872|Skin|skin
5021473|NCT03862872|UV-light|uv-light
5021474|NCT03862872|Inflammatory markers|inflammatory markers
5021475|NCT03862872|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5021476|NCT03862872|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5021477|NCT03862872|Fish Oil|fish oil
5021478|NCT03862872|Gamma-linolenic acid (GLA)|gamma-linolenic acid (gla)
5021486|NCT03862872|8-hydroxy-2' -deoxyguanosine (8- OHdG)|8-hydroxy-2' -deoxyguanosine (8- ohdg)
5021487|NCT03862872|8-isoprostane|8-isoprostane
5021488|NCT03862833|Haplo-SCT|haplo-sct
5021489|NCT03862833|Phase 1|phase 1
5021490|NCT03862833|Zoledronic acid|zoledronic acid
5021491|NCT03862833|IL-2|il-2
5021492|NCT03862833|g/d T cells|g/d t cells
5021493|NCT03862768|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5021494|NCT03862768|imatinib-resistant|imatinib-resistant
5021495|NCT03862768|focal progression|focal progression
5021496|NCT03862755|Pulmonary embolism|pulmonary embolism
5021497|NCT03862755|Thoracic surgery|thoracic surgery
5021498|NCT03862755|Thromboprophylaxis|thromboprophylaxis
5021499|NCT03862729|Risk stratification|risk stratification
5021500|NCT03862729|minimally invasive surgery|minimally invasive surgery
5021501|NCT03862729|early-stage ICH patient|early-stage ich patient
5021502|NCT03862729|prospective cohort study|prospective cohort study
5021503|NCT03862716|Diabetes|diabetes
5021504|NCT03862716|IDegLira|ideglira
5021505|NCT03862716|Metformin|metformin
5021506|NCT03862716|Insulin|insulin
5021507|NCT03862716|Diet|diet
5021508|NCT03862716|Excercise|excercise
5021509|NCT03862716|Lifestyle|lifestyle
5021518|NCT03862651|aNtiplatElet Therapy|antiplatelet therapy
5021519|NCT03862651|cangrelor|cangrelor
5021531|NCT03862599|prostatectomy|prostatectomy
5021532|NCT03862586|Implantation|implantation
5021533|NCT03862586|Recurrent implantation failure|recurrent implantation failure
5021534|NCT03862586|N-acetyl cysteine|n-acetyl cysteine
5021535|NCT03862586|HOXA cluster genes|hoxa cluster genes
5021536|NCT03862586|Window of implantation|window of implantation
5021537|NCT03862573|Virtual Reality|virtual reality
5021538|NCT03862573|Pain|pain
5021539|NCT03862573|Anxiety|anxiety
5021540|NCT03862560|Soccer|soccer
5021541|NCT03862560|Female|female
5021542|NCT03862560|Lower limb asymmetries|lower limb asymmetries
5021543|NCT03862560|Strength|strength
5021544|NCT03862547|Erectile Dysfunction|erectile dysfunction
5021545|NCT03862547|NGF|ngf
5021546|NCT03862547|TrKA|trka
5021547|NCT03862547|p75NTR|p75ntr
5021548|NCT03862534|Gingival recession|gingival recession
5021549|NCT03862534|Non-carious cervical lesion|non-carious cervical lesion
5323796|NCT02067481|Diet|diet
5021550|NCT03862534|Connective tissue graft|connective tissue graft
5021551|NCT03862521|type 1 diabetes|type 1 diabetes
5021552|NCT03862521|low carbohydrate diets|low carbohydrate diets
5021553|NCT03862521|insulin pump therapy|insulin pump therapy
5021554|NCT03862521|continuous glucose monitoring|continuous glucose monitoring
5021555|NCT03862508|Jump|jump
5021556|NCT03862508|Plyometrics|plyometrics
5021557|NCT03862508|Training|training
5021558|NCT03862508|Performance|performance
5021559|NCT03862508|Powerinstep|powerinstep
5021560|NCT03862508|Non-randomized clinical trial|non-randomized clinical trial
5021561|NCT03862482|Dental implant|dental implant
5021562|NCT03862456|Disease Progression|disease progression
5021563|NCT03862456|Microbiota|microbiota
5021564|NCT03862456|Periodontitis/surgery|periodontitis/surgery
5021565|NCT03862456|Periodontitis/therapy|periodontitis/therapy
5021566|NCT03862456|Periodontitis/drug effect|periodontitis/drug effect
5021567|NCT03862456|Periodontitis/drug therapy|periodontitis/drug therapy
5021568|NCT03862456|Periodontal diseases/surgery|periodontal diseases/surgery
5021569|NCT03862456|Periodontal diseases/therapy|periodontal diseases/therapy
5021570|NCT03862456|Periodontal pocket/surgery|periodontal pocket/surgery
5021571|NCT03862456|Periodontal pocket/therapy|periodontal pocket/therapy
5021572|NCT03862456|Periodontal pocket/drug therapy|periodontal pocket/drug therapy
5021573|NCT03862456|Azithromycin/therapeutic use|azithromycin/therapeutic use
5021574|NCT03862456|Metronidazole/therapeutic use|metronidazole/therapeutic use
5021575|NCT03862456|Azithromycin|azithromycin
5021576|NCT03862456|Metronidazole|metronidazole
5021577|NCT03862456|Porphyromonas gingivalis|porphyromonas gingivalis
5021578|NCT03862443|Preventive Dentistry|preventive dentistry
5021579|NCT03862443|Health Disparities|health disparities
5021585|NCT03862417|Pain|pain
5021586|NCT03862417|Posture|posture
5021587|NCT03862417|Quality of life|quality of life
5016177|NCT03895879|Therapeutic Drug Monitoring|therapeutic drug monitoring
5016178|NCT03895879|Drug level|drug level
5016179|NCT03895879|Dose reduction|dose reduction
5016180|NCT03895827|Opioid Overdose|opioid overdose
5016181|NCT03895827|First responders|first responders
5021588|NCT03862417|Disability|disability
5021589|NCT03862391|postanesthesia agitation|postanesthesia agitation
5023425|NCT03851107|youth|youth
5021610|NCT03862222|preclinical Alzheimer's disease|preclinical alzheimer's disease
5021612|NCT03862222|neurology|neurology
5021613|NCT03862209|Community implementation|community implementation
5021614|NCT03862209|Community engagement|community engagement
5021615|NCT03862209|patient centerednessP|patient centerednessp
5021616|NCT03862209|Implementation science|implementation science
5021617|NCT03862209|Co-creation|co-creation
5021618|NCT03862209|Iterative learning processes|iterative learning processes
5021623|NCT03862170|prophylactic antibiotics|prophylactic antibiotics
5021624|NCT03862170|ciprofloxacin|ciprofloxacin
5021625|NCT03862170|ancef|ancef
5021626|NCT03862170|RCT|rct
5021627|NCT03862144|nausea|nausea
5021628|NCT03862144|vomiting|vomiting
5021629|NCT03862144|breast cancer|breast cancer
5021630|NCT03862144|AC-based chemotherapy|ac-based chemotherapy
5021631|NCT03862092|Enteric zoster|enteric zoster
5021632|NCT03862092|Salivary VZV DNA PCR|salivary vzv dna pcr
5021633|NCT03862066|head and neck cancer|head and neck cancer
5021634|NCT03862053|ocular allergy|ocular allergy
5021635|NCT03862053|allergy|allergy
5021636|NCT03862053|manuka honey|manuka honey
5021637|NCT03862053|anti-inflammatory|anti-inflammatory
5021638|NCT03862014|molar incisor hypomineralization|molar incisor hypomineralization
5021639|NCT03862014|silver diamine flouride|silver diamine flouride
5021640|NCT03862001|randomized control trial|randomized control trial
5021641|NCT03862001|lung cancer risk assessment|lung cancer risk assessment
5021642|NCT03862001|shared decision making|shared decision making
5021643|NCT03861988|depression|depression
5021644|NCT03861988|ketamine|ketamine
5021645|NCT03861988|anesthesia|anesthesia
5021646|NCT03861988|total joint arthroplasty|total joint arthroplasty
5021647|NCT03861975|Breast Cancer|breast cancer
5021648|NCT03861962|serum-specific donor antibodies (DSA)|serum-specific donor antibodies (dsa)
5021649|NCT03861962|human leukocyte antigens (HLA)|human leukocyte antigens (hla)
5021650|NCT03861962|organ allocation|organ allocation
5021651|NCT03861962|epitope level|epitope level
5021652|NCT03861949|apnea|apnea
5021653|NCT03861949|CPAP|cpap
5021654|NCT03861949|Preoxygenation|preoxygenation
5021655|NCT03861923|dry needling|dry needling
5021656|NCT03861923|physical therapy|physical therapy
5021657|NCT03861923|trigger point|trigger point
5021658|NCT03861897|Non instrumental physiotherapy|non instrumental physiotherapy
5021659|NCT03861897|Physiotherapy|physiotherapy
5021660|NCT03861871|CKDL5 Deficiency Disorder|ckdl5 deficiency disorder
5021661|NCT03861858|borderline personality disorder|borderline personality disorder
5021662|NCT03861858|adolescence|adolescence
5021663|NCT03861858|suicide|suicide
5021664|NCT03861858|substance use|substance use
5021665|NCT03861845|Assistive Technology|assistive technology
5021666|NCT03861793|Alkermes|alkermes
5021667|NCT03861793|IL-2|il-2
5021668|NCT03861793|Interleukin-2|interleukin-2
5021669|NCT03861793|Oncology|oncology
5021670|NCT03861793|Immuno-oncology|immuno-oncology
5021671|NCT03861793|Cytokine|cytokine
5021672|NCT03861793|ALKS 4230|alks 4230
5021673|NCT03861793|Pembrolizumab|pembrolizumab
5021674|NCT03861793|Keytruda|keytruda
5021675|NCT03861793|PD-L1|pd-l1
5021676|NCT03861793|Solid tumors|solid tumors
5021677|NCT03861793|Immunotherapy|immunotherapy
5021678|NCT03861767|Prehabilitation|prehabilitation
5021679|NCT03861754|Obesity|obesity
5021680|NCT03861754|Weight loss|weight loss
5021681|NCT03861754|Weight maintenance|weight maintenance
5021682|NCT03861754|Physical activity|physical activity
5021683|NCT03861754|Fitness|fitness
5021684|NCT03861741|screening, aortic disease, mortality, genetic testing, imaging|screening, aortic disease, mortality, genetic testing, imaging
5021685|NCT03861715|antagonist protocol|antagonist protocol
5021686|NCT03861715|degarelix antagonist protocol|degarelix antagonist protocol
5021687|NCT03861715|degarelix|degarelix
5021688|NCT03861715|IVF|ivf
5021691|NCT03861676|focal therapy|focal therapy
5016293|NCT03895125|EEG|eeg
5023540|NCT03850444|PD1|pd1
5021696|NCT03861650|Hemifacial Microsomia|hemifacial microsomia
5021697|NCT03861650|Distraction osteogenesis|distraction osteogenesis
5021698|NCT03861624|Tibia|tibia
5021699|NCT03861624|Intramedullary nailing|intramedullary nailing
5021700|NCT03861624|External fixation|external fixation
5021701|NCT03861624|Trauma|trauma
5021702|NCT03861611|ketorolac|ketorolac
5021703|NCT03861611|diclofenac|diclofenac
5021704|NCT03861611|ibuprofen|ibuprofen
5021705|NCT03861611|low back pain|low back pain
5021706|NCT03861611|back pain|back pain
5021707|NCT03861572|Achilles tendon|achilles tendon
5021708|NCT03861572|physical therapy|physical therapy
5021709|NCT03861572|eccentric training|eccentric training
5021710|NCT03861572|Achilles tendon rupture|achilles tendon rupture
5021711|NCT03861572|rehabilitation|rehabilitation
5021712|NCT03861546|South Asian adults|south asian adults
5021713|NCT03861546|Patient-centered approach|patient-centered approach
5021714|NCT03861546|Intensive lifestyle interventions|intensive lifestyle interventions
5021715|NCT03861546|Diabetes|diabetes
5021716|NCT03861520|Anomaly scan|anomaly scan
5021717|NCT03861520|Anuploidy|anuploidy
5021726|NCT03861455|Chronic Hand Eczema|chronic hand eczema
5021727|NCT03861442|front-end features|front-end features
5021728|NCT03861442|speech perception|speech perception
5021729|NCT03861442|patient reported outcome|patient reported outcome
5021730|NCT03861416|Peripheral Arterial Disease|peripheral arterial disease
5021731|NCT03861416|Arterial Occlusive Disease|arterial occlusive disease
5021732|NCT03861416|intermittent claudication|intermittent claudication
5021733|NCT03861403|Metastatic|metastatic
5021734|NCT03861403|Stage III or IV|stage iii or iv
5021735|NCT03861403|Recurrent|recurrent
5021736|NCT03861403|Refractory|refractory
5021737|NCT03861403|Solid tumors|solid tumors
5021738|NCT03861403|Breast cancer|breast cancer
5021739|NCT03861403|Prostate cancer|prostate cancer
5021740|NCT03861403|Ovarian cancer|ovarian cancer
5021741|NCT03861377|Cardiac Output (CO)|cardiac output (co)
5021742|NCT03861377|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
5021743|NCT03861377|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
5021744|NCT03861377|Heart Rate (HR)|heart rate (hr)
5021745|NCT03861377|Stroke Volume (SV)|stroke volume (sv)
5021746|NCT03861377|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
5021747|NCT03861377|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
5021748|NCT03861377|Remifentanil|remifentanil
5021749|NCT03861364|Cardiac Output (CO)|cardiac output (co)
5021750|NCT03861364|Systolic Blood Pressure (SBP)|systolic blood pressure (sbp)
5021751|NCT03861364|Systemic Vascular Resistance (SVR)|systemic vascular resistance (svr)
5021752|NCT03861364|Heart Rate (HR)|heart rate (hr)
5021753|NCT03861364|Stroke Volume (SV)|stroke volume (sv)
5021754|NCT03861364|Lithium Dilutional Cardiac Output (LiDCO)|lithium dilutional cardiac output (lidco)
5021755|NCT03861364|Minimal Invasive Hemodynamic Monitor|minimal invasive hemodynamic monitor
5021756|NCT03861364|Propofol|propofol
5021757|NCT03861364|Propolipid|propolipid
5021758|NCT03861351|Cataract|cataract
5021759|NCT03861351|Astigmatism|astigmatism
5021760|NCT03861338|opioid use disorder, sublocade, buprenorphine|opioid use disorder, sublocade, buprenorphine
5021761|NCT03861325|acute gut failure|acute gut failure
5021762|NCT03861312|Laterality task, neck pain|laterality task, neck pain
5021763|NCT03861299|Glioblastoma|glioblastoma
5021764|NCT03861299|Neurological morbidity|neurological morbidity
5021765|NCT03861299|Postoperative complications|postoperative complications
5021766|NCT03861299|Extent of resection|extent of resection
5021767|NCT03861299|Gross-total resection|gross-total resection
5021768|NCT03861299|Health-related quality of life|health-related quality of life
5021769|NCT03861299|Progression-free survival|progression-free survival
5021770|NCT03861299|Overall survival|overall survival
5021771|NCT03861286|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
5021772|NCT03861286|Unfractionated Heparin|unfractionated heparin
5021773|NCT03861273|PF 06838435|pf 06838435
5021774|NCT03861273|Hemophilia|hemophilia
5021775|NCT03861273|Factor IX|factor ix
5021777|NCT03861273|Gene Therapy|gene therapy
5021778|NCT03861273|Infusion|infusion
5021779|NCT03861273|rAAV Spark100 hFIX Padua|raav spark100 hfix padua
5021780|NCT03861273|BeneGene 2|benegene 2
5021781|NCT03861273|Hematological Diseases|hematological diseases
5021782|NCT03861273|Annualized bleeding rate (ABR)|annualized bleeding rate (abr)
5021783|NCT03861130|Kawasaki Disease|kawasaki disease
5021784|NCT03861117|Critical care|critical care
5021785|NCT03861117|spontaneous breathing trial|spontaneous breathing trial
5021786|NCT03861117|T-piece|t-piece
5021787|NCT03861117|positive end-expiratory pressure|positive end-expiratory pressure
5021788|NCT03861117|difficult weaning|difficult weaning
5717654|NCT00439959|GSK625433,|gsk625433,
5036535|NCT03770741|NIRS|nirs
5023648|NCT03849820|RAS|ras
5021824|NCT03860896|Ulcerative Colitis|ulcerative colitis
5021825|NCT03860883|Malignant|malignant
5021826|NCT03860883|Melanoma|melanoma
5021827|NCT03860883|Cancer|cancer
5021828|NCT03860883|Surgery|surgery
5021829|NCT03860870|dried blood spots|dried blood spots
5021830|NCT03860870|skeletal muscle biopsies|skeletal muscle biopsies
5021831|NCT03860870|muscle strength|muscle strength
5021832|NCT03860870|muscle signaling|muscle signaling
5021833|NCT03860857|Alzheimer disease|alzheimer disease
5021834|NCT03860857|cognitive impairment|cognitive impairment
5021835|NCT03860857|mild cognitive impairment|mild cognitive impairment
5021836|NCT03860857|biomarker|biomarker
5021839|NCT03860831|nasal|nasal
5021840|NCT03860831|sedation|sedation
5021841|NCT03860831|developmental delay|developmental delay
5021842|NCT03860818|medication safety|medication safety
5021843|NCT03860805|Sterilization Tubal|sterilization tubal
5021844|NCT03860805|Salpingectomy|salpingectomy
5021845|NCT03860805|Laparoscopy|laparoscopy
5021846|NCT03860805|Ovarian Reserve|ovarian reserve
5021847|NCT03860779|colonoscopy|colonoscopy
5021848|NCT03860779|biosignals|biosignals
5021849|NCT03860779|pain|pain
5021850|NCT03860779|sedation|sedation
5021851|NCT03860766|Isokinetic|isokinetic
5021852|NCT03860766|Electromyography|electromyography
5021853|NCT03860766|Physiotherapy|physiotherapy
5021854|NCT03860766|Handball|handball
5021855|NCT03860753|Alcohol|alcohol
5021856|NCT03860753|Pioglitazone|pioglitazone
5021857|NCT03860753|Stress|stress
5021858|NCT03860753|Anxiety|anxiety
5021859|NCT03860740|Physical exercise|physical exercise
5021860|NCT03860740|Breast Cancer|breast cancer
5021861|NCT03860714|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5021862|NCT03860714|Delirium|delirium
5021863|NCT03860714|UACR|uacr
5021864|NCT03860688|Intestinal lipoprotein|intestinal lipoprotein
5021865|NCT03860688|Gut peptide|gut peptide
5021866|NCT03860688|Chylomicrons|chylomicrons
5021867|NCT03860688|Glucose|glucose
5021868|NCT03860662|Antispastic drugs|antispastic drugs
5021869|NCT03860662|Nociceptive flexor reflex|nociceptive flexor reflex
5021870|NCT03860662|Baclofen|baclofen
5021871|NCT03860662|Botulinum toxin|botulinum toxin
5021872|NCT03860649|Mobility|mobility
5021873|NCT03860649|Functionality|functionality
5021874|NCT03860649|Movement disorders|movement disorders
5021875|NCT03860649|Rehabilitation|rehabilitation
5021876|NCT03860649|Locomotion|locomotion
5021877|NCT03860636|In Vitro Fertilisation (IVF)|in vitro fertilisation (ivf)
5021878|NCT03860636|Intra Cytoplasmic Injection (ICSI)|intra cytoplasmic injection (icsi)
5021879|NCT03860636|Endometrial Pattern|endometrial pattern
5021880|NCT03860636|Ultrasound|ultrasound
5021881|NCT03860623|satiety|satiety
5021882|NCT03860623|gut blood flow|gut blood flow
5021883|NCT03860623|gastric emptying|gastric emptying
5021884|NCT03860623|obesity|obesity
5021885|NCT03860623|incretin hormones|incretin hormones
5021891|NCT03860584|metabolic endotoxemia|metabolic endotoxemia
5021892|NCT03860584|milk fat globule membrane|milk fat globule membrane
5021893|NCT03860584|gut health|gut health
5021894|NCT03860584|endotoxin|endotoxin
5021895|NCT03860584|inflammation|inflammation
5021896|NCT03860584|obesity|obesity
5021897|NCT03860545|Acute Kidney Injury, cardiopulmonary bypass|acute kidney injury, cardiopulmonary bypass
5021898|NCT03860545|brush-border enzymes of the proximal renal tubules|brush-border enzymes of the proximal renal tubules
5021899|NCT03860545|ischemia modified albumin|ischemia modified albumin
5021900|NCT03860519|asthma|asthma
5021905|NCT03860506|healthy subjects who smoke|healthy subjects who smoke
5021906|NCT03860506|healthy subjects|healthy subjects
5021907|NCT03860493|organ perfusion|organ perfusion
5021908|NCT03860493|Fluorescence|fluorescence
5021909|NCT03860493|icg|icg
5016503|NCT03893604|Isokinetic|isokinetic
5016504|NCT03893604|Endurance|endurance
5016505|NCT03893604|Fatigue|fatigue
5016506|NCT03893578|Conveyor System|conveyor system
5016526|NCT03893474|AMD|amd
5021910|NCT03860480|Post-operative analgesia|post-operative analgesia
5021911|NCT03860480|VATS|vats
5021912|NCT03860480|Thoracoscopic surgery|thoracoscopic surgery
5021913|NCT03860480|Erector spinae plane block|erector spinae plane block
5021914|NCT03860480|Regional anesthesia|regional anesthesia
5021915|NCT03860467|Status epilepticus|status epilepticus
5021917|NCT03860467|Intensive Care Unit|intensive care unit
5021918|NCT03860454|Dilated Cardiomyopathy|dilated cardiomyopathy
5021923|NCT03860441|cognitive reserve|cognitive reserve
5021924|NCT03860441|EEG/ERP|eeg/erp
5021925|NCT03860428|PDA|pda
5021926|NCT03860428|Ibuprofen|ibuprofen
5021927|NCT03860428|Paracetamol|paracetamol
5021928|NCT03860428|Expectant management|expectant management
5021929|NCT03860402|pre-warmed epiural anesthetics|pre-warmed epiural anesthetics
5021930|NCT03860402|epidural anesthesia|epidural anesthesia
5021931|NCT03860389|Autism|autism
5021932|NCT03860389|Anxiety|anxiety
5021933|NCT03860389|Exercise|exercise
5021934|NCT03860389|Behaviour|behaviour
5021935|NCT03860376|ex vivo drug sensitivity assay|ex vivo drug sensitivity assay
5021936|NCT03860376|genomic profiling|genomic profiling
5021937|NCT03860350|garlic|garlic
5021938|NCT03860337|fat digestion|fat digestion
5021939|NCT03860337|alginate|alginate
5021940|NCT03860337|sausages|sausages
5021941|NCT03860324|Hip Arthroplasty|hip arthroplasty
5021942|NCT03860324|Erector Spinae Plane Block|erector spinae plane block
5021943|NCT03860311|Ovarian Torsion|ovarian torsion
5021944|NCT03860311|Point-of-Care|point-of-care
5021945|NCT03860311|Pelvic pain|pelvic pain
5021946|NCT03860311|Bedside Ultrasound|bedside ultrasound
5021947|NCT03860298|NaviFUS System|navifus system
5021948|NCT03860298|Focused Ultrasound|focused ultrasound
5021949|NCT03860298|Drug Resistant Epilepsy|drug resistant epilepsy
5021950|NCT03860298|Intracranial Electroencephalography|intracranial electroencephalography
5021951|NCT03860285|inguinal hernia|inguinal hernia
5021952|NCT03860285|quality of life|quality of life
5021953|NCT03860285|survey|survey
5021954|NCT03860285|surgery|surgery
5021955|NCT03860285|pamplona|pamplona
5021956|NCT03860285|prospective|prospective
5021957|NCT03860285|observational|observational
5021958|NCT03860285|cohorts|cohorts
5021959|NCT03860272|Solid Tumors|solid tumors
5021960|NCT03860272|Advanced Cancer|advanced cancer
5021961|NCT03860272|Open-Label|open-label
5021962|NCT03860272|Dose Escalation|dose escalation
5021963|NCT03860272|Monotherapy|monotherapy
5021964|NCT03860272|Combination Therapy|combination therapy
5021965|NCT03860272|Anti-CTLA-4|anti-ctla-4
5021966|NCT03860272|Anti-PD-1|anti-pd-1
5021967|NCT03860233|Continuous Positive Airway Pressure|continuous positive airway pressure
5021968|NCT03860233|CPAP|cpap
5021969|NCT03860233|Oxytocin|oxytocin
5021970|NCT03860207|Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb)|humanized 3f8 bispecific antibody (hu3f8-bsab)
5021971|NCT03860207|18-034|18-034
5021977|NCT03860155|Acute-on-Chronic Liver Failure|acute-on-chronic liver failure
5021978|NCT03860155|ACLF|aclf
5021979|NCT03860155|ABCB5|abcb5
5021980|NCT03860155|ATP Binding Cassette Subfamily B Member 5|atp binding cassette subfamily b member 5
5021981|NCT03860155|allogeneic|allogeneic
5021982|NCT03860155|mesenchymal stem cells|mesenchymal stem cells
5021983|NCT03860155|advanced therapy medicinal product|advanced therapy medicinal product
5021984|NCT03860155|somatic cell therapy|somatic cell therapy
5021985|NCT03860155|phase I/IIa|phase i/iia
5021986|NCT03860129|inhalational Sedation|inhalational sedation
5021987|NCT03860116|case management|case management
5021988|NCT03860116|men who have sex with men|men who have sex with men
5021989|NCT03860116|mhealth|mhealth
5021990|NCT03860103|microDoppler|microdoppler
5021991|NCT03860103|placenta|placenta
5021992|NCT03860103|preeclampsia|preeclampsia
5021993|NCT03860103|intrauterine growth restriction|intrauterine growth restriction
5021994|NCT03860090|Cephalic Vein|cephalic vein
5021995|NCT03860090|Axillary Vein|axillary vein
5021996|NCT03860012|methotrexate|methotrexate
5021997|NCT03860012|folic|folic
5021998|NCT03860012|acid|acid
5021999|NCT03859999|Colles' Fracture|colles' fracture
5022000|NCT03859999|Distal radial fracture|distal radial fracture
5022001|NCT03859999|Manipulation under anaesthesia (MUA)|manipulation under anaesthesia (mua)
5022002|NCT03859999|Emergency Department|emergency department
5022015|NCT03859882|cognition|cognition
5022016|NCT03859882|attention|attention
5022017|NCT03859869|Exocrine Pancreatic Insufficiency (EPI)|exocrine pancreatic insufficiency (epi)
5022018|NCT03859869|Pancreatic Cancer|pancreatic cancer
5022019|NCT03859869|Creon|creon
5022020|NCT03859869|Pancrelipase|pancrelipase
5022021|NCT03859804|fusion|fusion
5022022|NCT03859804|prostate|prostate
5022023|NCT03859804|biopsy|biopsy
5022024|NCT03859804|pain|pain
5022025|NCT03859778|Opioid-Related Disorders|opioid-related disorders
5022026|NCT03859778|student|student
5022027|NCT03859778|Community Pharmacy Services|community pharmacy services
5022028|NCT03859765|physical disability|physical disability
5022029|NCT03859765|pain|pain
5022030|NCT03859765|fatigue|fatigue
5022031|NCT03859765|distress|distress
5022032|NCT03859765|physical activity|physical activity
5022033|NCT03859765|coping|coping
5022034|NCT03859765|mHealth|mhealth
5022035|NCT03859765|cancer|cancer
5022036|NCT03859765|symptom management|symptom management
5022037|NCT03859752|antibody-drug conjugate|antibody-drug conjugate
5022038|NCT03859752|c-Met|c-met
5022039|NCT03859752|solid tumors|solid tumors
5337791|NCT02004951|restenosis|restenosis
5022040|NCT03859752|Phase 1|phase 1
5022041|NCT03859726|Sepsis, NIRS, sublingual microcirculation|sepsis, nirs, sublingual microcirculation
5022042|NCT03859713|Physical Therapy|physical therapy
5022043|NCT03859713|Cognitive Behavioral Therapy|cognitive behavioral therapy
5022044|NCT03859713|Mindfulness|mindfulness
5022045|NCT03859713|Adaptive Treatment Regimens|adaptive treatment regimens
5022046|NCT03859700|EPIT|epit
5022047|NCT03859700|Epicutaneous|epicutaneous
5022048|NCT03859700|Immunotherapy|immunotherapy
5022049|NCT03859700|Viaskin|viaskin
5022050|NCT03859687|Children|children
5022051|NCT03859687|Vitamin Supplements|vitamin supplements
5022052|NCT03859687|PCV13|pcv13
5022053|NCT03859687|Hepatitis A vaccine|hepatitis a vaccine
5022054|NCT03859635|acute pain|acute pain
5022055|NCT03859635|VATS|vats
5022056|NCT03859622|Cytochrome P 450 CYP2D6 Variants|cytochrome p 450 cyp2d6 variants
5022057|NCT03859622|Genetic polymorphism|genetic polymorphism
5022058|NCT03859622|Practice, Family|practice, family
5022059|NCT03859622|Drug metabolism|drug metabolism
5022060|NCT03859609|GAP-score|gap-score
5022061|NCT03859609|Schwab score|schwab score
5022062|NCT03859609|Proximal Junctional Failure|proximal junctional failure
5022063|NCT03859609|Spinal Fusion|spinal fusion
5022064|NCT03859583|capsaicin|capsaicin
5022065|NCT03859583|resting metabolic rate|resting metabolic rate
5022066|NCT03859583|glucose|glucose
5022067|NCT03859505|Low Back Pain|low back pain
5022068|NCT03859505|Photobiomodulation Therapy|photobiomodulation therapy
5022069|NCT03859505|PBMT|pbmt
5022070|NCT03859505|Low-Level Laser Therapy|low-level laser therapy
5022071|NCT03859505|LLLT|lllt
5022072|NCT03859479|Cold snare polypectomy|cold snare polypectomy
5022073|NCT03859479|Hot snare polypectomy|hot snare polypectomy
5022074|NCT03859479|Сolorectal polyps|сolorectal polyps
5022075|NCT03859479|Endoscopic treatment|endoscopic treatment
5022077|NCT03859401|Artificial Pancreas|artificial pancreas
5022078|NCT03859401|Continuous Glucose Monitor|continuous glucose monitor
5022079|NCT03859401|Exercise|exercise
5022080|NCT03859401|Exercise-Induced Hypoglycemia|exercise-induced hypoglycemia
5022081|NCT03859375|Colony forming units|colony forming units
5022082|NCT03859375|preoperative skin disinfection|preoperative skin disinfection
5022083|NCT03859375|microbial skin counts|microbial skin counts
5022084|NCT03859362|pharmacokinetic, pharmacodynamic, ertapenem, urosepsis|pharmacokinetic, pharmacodynamic, ertapenem, urosepsis
5022085|NCT03859349|Endobronchial Ultrasound|endobronchial ultrasound
5022086|NCT03859349|Diagnostic Imaging|diagnostic imaging
5022087|NCT03859349|Feasibility|feasibility
5022088|NCT03859349|Randomized Controlled Trial|randomized controlled trial
5022089|NCT03859349|Clinical N0 Disease|clinical n0 disease
5022090|NCT03859336|Anxiety|anxiety
5022091|NCT03859336|Sleep Issues|sleep issues
5022092|NCT03859297|rumination|rumination
5022093|NCT03859297|depression|depression
5022094|NCT03859297|brain imaging|brain imaging
5022095|NCT03859297|cognitive behavioral therapy|cognitive behavioral therapy
5022108|NCT03859219|Japanese healthy-volunteers|japanese healthy-volunteers
5022109|NCT03859219|Phase 1|phase 1
5022110|NCT03859219|UCB7665|ucb7665
5022111|NCT03859219|Chinese healthy-volunteers|chinese healthy-volunteers
5022113|NCT03859206|Thoracoscopy|thoracoscopy
5022114|NCT03859206|loculated|loculated
5022115|NCT03859206|empyema|empyema
5022116|NCT03859180|Anxiety|anxiety
5022117|NCT03859180|Self-managed Intervention|self-managed intervention
5022118|NCT03859180|Focused Breathing|focused breathing
5022119|NCT03859141|Influenza Vaccine|influenza vaccine
5022120|NCT03859141|Quadrivalent|quadrivalent
5022121|NCT03859141|Trivalent|trivalent
5022125|NCT03859115|propofol|propofol
5022126|NCT03859115|anesthesia|anesthesia
5022127|NCT03859115|myocardial protection|myocardial protection
5022128|NCT03859102|Enhanced recovery after Surgery|enhanced recovery after surgery
5022129|NCT03859102|ERAS|eras
5022130|NCT03859102|Enhanced Recovery after Cardiac Surgery|enhanced recovery after cardiac surgery
5022131|NCT03859102|Cardiac Surgery|cardiac surgery
5022132|NCT03859102|Coronary Artery Bypass graft|coronary artery bypass graft
5022133|NCT03859102|Aortic Valve Surgery|aortic valve surgery
5022134|NCT03859102|Mitral Valve Surgery|mitral valve surgery
5022135|NCT03859102|Aortic Root Surgery|aortic root surgery
5022136|NCT03859089|medical cannabis|medical cannabis
5022137|NCT03859089|opioids|opioids
5022138|NCT03859089|pain|pain
5022139|NCT03859089|substitution|substitution
5022140|NCT03859089|alternative|alternative
5022141|NCT03859076|mindfulness|mindfulness
5022142|NCT03859076|blood pressure|blood pressure
5022143|NCT03859076|hypertension|hypertension
5022144|NCT03859076|prehypertension|prehypertension
5022145|NCT03859076|self regulation|self regulation
5022146|NCT03859076|Science of Behavior Change|science of behavior change
5022147|NCT03859076|attention control|attention control
5022148|NCT03859076|self awareness|self awareness
5022149|NCT03859076|emotion regulation|emotion regulation
5022150|NCT03859063|Rehabilitation|rehabilitation
5022151|NCT03859063|Cognition|cognition
5022152|NCT03859063|Physical Fitness|physical fitness
5337887|NCT02004470|right shoulder pain|right shoulder pain
5022153|NCT03859063|Case Managers|case managers
5022154|NCT03859063|Secondary prevention|secondary prevention
5022159|NCT03859011|acupuncture|acupuncture
5022160|NCT03859011|pain|pain
5022161|NCT03859011|disability|disability
5022162|NCT03858972|Tesetaxel|tesetaxel
5022163|NCT03858972|Capecitabine|capecitabine
5022164|NCT03858972|HER2 negative|her2 negative
5022165|NCT03858972|Combination of tesetaxel and capecitabine|combination of tesetaxel and capecitabine
5022166|NCT03858972|Taxane-naive|taxane-naive
5022167|NCT03858972|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5333642|NCT02023684|ropivacaine|ropivacaine
5022168|NCT03858972|Hormone receptor positive|hormone receptor positive
5022169|NCT03858972|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
5022170|NCT03858972|Breast cancer|breast cancer
5022171|NCT03858972|Central nervous system (CNS) metastases|central nervous system (cns) metastases
5022172|NCT03858972|de novo metastatic breast cancer|de novo metastatic breast cancer
5022173|NCT03858972|Oral chemotherapy|oral chemotherapy
5022174|NCT03858972|Taxane|taxane
5022175|NCT03858933|PTSD|ptsd
5022176|NCT03858933|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5022177|NCT03858933|Acute Stress Syndrome|acute stress syndrome
5022178|NCT03858933|Emotion Regulation|emotion regulation
5022179|NCT03858933|Depression|depression
5022180|NCT03858933|Anxiety|anxiety
5022181|NCT03858933|Sexual Assault|sexual assault
5022182|NCT03858933|Combat PTSD|combat ptsd
5022183|NCT03858868|physical activity|physical activity
5022184|NCT03858868|community-based health promotion|community-based health promotion
5022191|NCT03858855|Melanoma|melanoma
5022192|NCT03858842|Progressive fibrosing interstitial lung disease|progressive fibrosing interstitial lung disease
5022193|NCT03858842|Systemic Sclerosis-Associated Interstitial Lung Disease|systemic sclerosis-associated interstitial lung disease
5022194|NCT03858829|coronary artery disease|coronary artery disease
5022195|NCT03858829|physical activity|physical activity
5022196|NCT03858829|cardiac rehabilitation|cardiac rehabilitation
5022197|NCT03858829|validation studies|validation studies
5022198|NCT03858829|psychometrics|psychometrics
5022199|NCT03858816|probiotics|probiotics
5022200|NCT03858816|neuropsychiatric disorder|neuropsychiatric disorder
5022201|NCT03858816|very low birth weight infants|very low birth weight infants
5022202|NCT03858816|attention deficit and hyperactivity disorder (ADHD)|attention deficit and hyperactivity disorder (adhd)
5022203|NCT03858816|autism spectrum disorder (ASD)|autism spectrum disorder (asd)
5022205|NCT03858803|STI|sti
5022206|NCT03858803|Unplanned pregnancy|unplanned pregnancy
5022207|NCT03858803|Reproductive health of families|reproductive health of families
5022208|NCT03858803|Adolescents|adolescents
5022209|NCT03858790|Pain|pain
5022210|NCT03858777|sarcoidosis|sarcoidosis
5022211|NCT03858764|Paclitaxel|paclitaxel
5022216|NCT03858738|malignancy|malignancy
5022217|NCT03858738|artificial intelligence|artificial intelligence
5022218|NCT03858738|liquid crystal contact thermography|liquid crystal contact thermography
5022219|NCT03858738|automatic algorithms|automatic algorithms
5022220|NCT03858738|efficacy|efficacy
5022221|NCT03858738|sensitivity|sensitivity
5022222|NCT03858738|specificity|specificity
5022223|NCT03858712|Oral Cancer Directed Therapy|oral cancer directed therapy
5022224|NCT03858712|Breast Cancer|breast cancer
5022225|NCT03858712|Gastrointestinal Cancer|gastrointestinal cancer
5022226|NCT03858712|oral chemotherapy|oral chemotherapy
5022227|NCT03858673|Vault prolapse|vault prolapse
5022228|NCT03858673|Vaginal total hysterectomy|vaginal total hysterectomy
5022229|NCT03858621|pain|pain
5022230|NCT03858621|Postoperative Pain|postoperative pain
5022231|NCT03858621|fentanyl|fentanyl
5022232|NCT03858621|Nociceptive monitoring index|nociceptive monitoring index
5022233|NCT03858608|Weight loss|weight loss
5022234|NCT03858608|Counterweight Plus|counterweight plus
5022235|NCT03858595|Eclampsia,|eclampsia,
5022236|NCT03858595|Pre-Eclampsia|pre-eclampsia
5022237|NCT03858595|Low birthweight|low birthweight
5022238|NCT03858595|Wearable|wearable
5022239|NCT03858595|continuous monitoring|continuous monitoring
5022240|NCT03858556|gait|gait
5022241|NCT03858556|effectiveness|effectiveness
5022242|NCT03858556|treatment|treatment
5022243|NCT03858556|Lumbar intervertebral disc herniation|lumbar intervertebral disc herniation
5022244|NCT03858556|Chuna|chuna
5022245|NCT03858543|Stretch marks|stretch marks
5022246|NCT03858543|Fractional laser therapy|fractional laser therapy
5022247|NCT03858543|Poly-L lactic acid|poly-l lactic acid
5022248|NCT03858543|Sculptra|sculptra
5022249|NCT03858530|Ultrasound elastography|ultrasound elastography
5022250|NCT03858504|yoga, home exercises, juvenile idiopathic arthritis|yoga, home exercises, juvenile idiopathic arthritis
5022251|NCT03858491|Osimertinib|osimertinib
5022252|NCT03858491|Cobicistat|cobicistat
5022253|NCT03858491|Pharmacokinetic boosting|pharmacokinetic boosting
5022254|NCT03858478|HIV, new diagnosis, Biktarvy|hiv, new diagnosis, biktarvy
5022255|NCT03858465|Hypotension|hypotension
5022256|NCT03858465|Phenylephrine|phenylephrine
5022257|NCT03858465|Ephedryne|ephedryne
5022258|NCT03858452|Prostatectomy|prostatectomy
5022259|NCT03858452|Rehabilitation|rehabilitation
5022260|NCT03858452|Incontinence|incontinence
5445444|NCT01521780|beta-catenin|beta-catenin
5333766|NCT02022995|EGFR|egfr
5022261|NCT03858426|Eosinophilic Esophagitis; PPIs, children, elimination diet, topical steroids|eosinophilic esophagitis; ppis, children, elimination diet, topical steroids
5022262|NCT03858400|Unconscious patient|unconscious patient
5022263|NCT03858400|critical care unit|critical care unit
5022264|NCT03858400|electrophysiological test|electrophysiological test
5022265|NCT03858387|pharmacokinetic, betalactams, ICU|pharmacokinetic, betalactams, icu
5022266|NCT03858335|constraint-induced movement therapy|constraint-induced movement therapy
5022267|NCT03858335|hemiplegia|hemiplegia
5022268|NCT03858335|hand function|hand function
5022269|NCT03858335|gross motor|gross motor
5022270|NCT03858322|Breast Cancer|breast cancer
5022271|NCT03858309|Cerebrospinal Fluid|cerebrospinal fluid
5022272|NCT03858309|Cerebrospinal Fluid Flow|cerebrospinal fluid flow
5022273|NCT03858309|Cerebrospinal Fluid Circulation|cerebrospinal fluid circulation
5022274|NCT03858309|Yoga|yoga
5022275|NCT03858309|Yogic Breathwork|yogic breathwork
5022276|NCT03858309|Magnetic Resonance Imaging|magnetic resonance imaging
5022277|NCT03858309|Breathing|breathing
5022279|NCT03858309|RT-PCMRI|rt-pcmri
5022280|NCT03858309|CSF Flow|csf flow
5022281|NCT03858309|Slow Breathing|slow breathing
5022282|NCT03858309|Respiration|respiration
5022283|NCT03858283|Mindfulness|mindfulness
5022284|NCT03858283|Anxiety and depression symptoms|anxiety and depression symptoms
5022285|NCT03858283|Caregivers|caregivers
5022286|NCT03858283|Alzheimer|alzheimer
5022287|NCT03858283|neuropsychiatric disorders|neuropsychiatric disorders
5022288|NCT03858257|Oxygen|oxygen
5022289|NCT03858257|Ventilation|ventilation
5022290|NCT03858257|High-flow nasal oxygen|high-flow nasal oxygen
5022291|NCT03858257|Hypercapnia|hypercapnia
5022292|NCT03858257|Respiratory depression|respiratory depression
5022293|NCT03858257|Respiratory compromise|respiratory compromise
5022294|NCT03858257|Carbon dioxide|carbon dioxide
5022295|NCT03858257|Transcutaneous carbon dioxide|transcutaneous carbon dioxide
5022296|NCT03858218|Psychometric properties|psychometric properties
5022297|NCT03858218|Sleep disturbance|sleep disturbance
5022298|NCT03858218|Childhood cancer survivors|childhood cancer survivors
5022299|NCT03858218|Quality of life,|quality of life,
5022300|NCT03858218|Confirmatory factor analysis|confirmatory factor analysis
5022301|NCT03858192|Acute sarcopenia, muscle, physical function, older adults|acute sarcopenia, muscle, physical function, older adults
5022302|NCT03858179|Photobiomodulation Therapy|photobiomodulation therapy
5022303|NCT03858179|Low-level Laser Therapy|low-level laser therapy
5022304|NCT03858179|Skeletal Muscle Strenght|skeletal muscle strenght
5022305|NCT03858179|Strength Training|strength training
5022306|NCT03858166|PEG-rhG-CSF|peg-rhg-csf
5022307|NCT03858166|secondary prophylaxis|secondary prophylaxis
5022308|NCT03858153|chemotherapy|chemotherapy
5022309|NCT03858088|liver transplant|liver transplant
5022310|NCT03858088|allograft failure|allograft failure
5022311|NCT03858088|primary dysfunction|primary dysfunction
5022312|NCT03858088|early outcome|early outcome
5022323|NCT03858023|hippotherapy|hippotherapy
5022324|NCT03858023|gross motor|gross motor
5022326|NCT03858023|behavior|behavior
5022327|NCT03858010|asthma|asthma
5022328|NCT03857971|Vulnerable plaque|vulnerable plaque
5022329|NCT03857971|Optical coherence Tomography|optical coherence tomography
5022330|NCT03857971|OCT|oct
5022331|NCT03857945|preoperative mobility device training|preoperative mobility device training
5022332|NCT03857906|intra-aortic balloon pump|intra-aortic balloon pump
5022333|NCT03857906|coronary artery bypass graft|coronary artery bypass graft
5022334|NCT03857906|preoperative|preoperative
5022335|NCT03857893|Vulvo-vaginal atrophy|vulvo-vaginal atrophy
5022336|NCT03857893|Dynamic Quadripolar Radio-Frequency|dynamic quadripolar radio-frequency
5022337|NCT03857893|Menopause|menopause
5022338|NCT03857893|Genitourinary syndrome of menopause|genitourinary syndrome of menopause
5022339|NCT03857802|diabetes mellitus type 2|diabetes mellitus type 2
5022340|NCT03857802|prediabetic state|prediabetic state
5022341|NCT03857802|sleep hygiene|sleep hygiene
5022342|NCT03857802|haemoglobin A glycosylated|haemoglobin a glycosylated
5022343|NCT03857802|clinical nursing research|clinical nursing research
5022344|NCT03857776|Randomized controlled trial|randomized controlled trial
5022345|NCT03857776|Neoplasm|neoplasm
5022346|NCT03857776|Communication|communication
5022347|NCT03857776|Complementary medicine|complementary medicine
5022348|NCT03857776|Integrative care|integrative care
5022349|NCT03857776|Integrative medicine|integrative medicine
5022350|NCT03857737|early gastric cancer|early gastric cancer
5022351|NCT03857737|endoscopic submucosal dissection|endoscopic submucosal dissection
5022352|NCT03857737|surgery|surgery
5022353|NCT03857711|Bipolar radiofrequency ablation|bipolar radiofrequency ablation
5022354|NCT03857711|Atrial Fibrillation New Onset|atrial fibrillation new onset
5022355|NCT03857711|CABG|cabg
5022356|NCT03857711|Coronary artery disease|coronary artery disease
5022357|NCT03857711|Postoperative atrial fibrillation|postoperative atrial fibrillation
5022358|NCT03857698|Total Knee Prosthesis|total knee prosthesis
5022359|NCT03857698|Stabilization Exercise|stabilization exercise
5022360|NCT03857698|Balance|balance
5022361|NCT03857698|Functional Performance|functional performance
5022362|NCT03857698|Lumbar Lordosis Angle|lumbar lordosis angle
5022363|NCT03857685|Lens capsule|lens capsule
5022364|NCT03857685|Proliferation|proliferation
5022365|NCT03857672|Behavioral|behavioral
5022366|NCT03857672|Cognitive Therapy|cognitive therapy
5022367|NCT03857672|Self-Hypnosis|self-hypnosis
5022368|NCT03857659|Pregnancy|pregnancy
5022369|NCT03857659|Ultrasound|ultrasound
5022370|NCT03857659|neonatal morbidity|neonatal morbidity
5022371|NCT03857646|parenteral nutrition|parenteral nutrition
5022372|NCT03857646|lipid emulsion|lipid emulsion
5022373|NCT03857646|free bilirubin|free bilirubin
5022374|NCT03857646|free fatty acids|free fatty acids
5022375|NCT03857633|Cardiac MRI|cardiac mri
5022376|NCT03857633|Myocardial Fibrosis|myocardial fibrosis
5022377|NCT03857633|End Stage Renal Failure|end stage renal failure
5022378|NCT03857633|Monocyte Subsets|monocyte subsets
5022379|NCT03857633|Renal Replacement Therapy|renal replacement therapy
5022380|NCT03857594|Hereditary Cancer Syndrome|hereditary cancer syndrome
5022382|NCT03857594|Mutation|mutation
5022383|NCT03857594|Germline Mutation|germline mutation
5022384|NCT03857594|Rare Cancer Histology|rare cancer histology
5022385|NCT03857594|Whole Genome Sequencing (WGS)|whole genome sequencing (wgs)
5022386|NCT03857594|Whole Exome Sequencing (WES)|whole exome sequencing (wes)
5022387|NCT03857581|Schizophrenia|schizophrenia
5022388|NCT03857581|Schizoaffective disorder|schizoaffective disorder
5022389|NCT03857581|Bipolar disorder|bipolar disorder
5022390|NCT03857581|Major depressive disorder|major depressive disorder
5022391|NCT03857581|Psychosis|psychosis
5022392|NCT03857581|Substance abuse|substance abuse
5022393|NCT03857581|Clozapine|clozapine
5022394|NCT03857581|Olanzapine|olanzapine
5022395|NCT03857490|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5022396|NCT03857490|Sympathetic Neural Control|sympathetic neural control
5022397|NCT03857490|Vascular Function|vascular function
5022399|NCT03857464|Near-Patient Testing|near-patient testing
5022400|NCT03857464|Clostridioides difficile|clostridioides difficile
5022401|NCT03857464|nosocomial infections|nosocomial infections
5022402|NCT03857464|Clostridium difficile Infection|clostridium difficile infection
5022403|NCT03857451|Dravet syndrome|dravet syndrome
5022404|NCT03857451|severe myoclonic epilepsy of infancy|severe myoclonic epilepsy of infancy
5022405|NCT03857451|intellectual disabilities|intellectual disabilities
5022406|NCT03857451|movement disorders|movement disorders
5022419|NCT03857386|pectoral nerve block (PECS block)|pectoral nerve block (pecs block)
5022420|NCT03857386|breast reduction surgery|breast reduction surgery
5022422|NCT03857386|postoperative pain|postoperative pain
5022423|NCT03857386|VAS score|vas score
5022424|NCT03857373|Renal Cancer|renal cancer
5022425|NCT03857373|Machine Learning|machine learning
5022426|NCT03857360|Gluten|gluten
5022427|NCT03857360|Probiotic|probiotic
5022428|NCT03857360|Microbiota|microbiota
5022429|NCT03857360|Dysbiosis|dysbiosis
5022430|NCT03857347|FND|fnd
5022431|NCT03857347|Functional Neurological Disorder|functional neurological disorder
5022432|NCT03857347|Psychoeducation|psychoeducation
5022433|NCT03857321|Intranasal Delivery of Insulin|intranasal delivery of insulin
5022434|NCT03857321|Cognitive Testing|cognitive testing
5022435|NCT03857321|Nasal Insulin|nasal insulin
5022436|NCT03857308|well-being|well-being
5022437|NCT03857308|sleep|sleep
5022438|NCT03857308|caregiver|caregiver
5022439|NCT03857295|infections|infections
5022440|NCT03857295|neurosurgery|neurosurgery
5022441|NCT03857295|multi drug resistance|multi drug resistance
5022442|NCT03857295|spondylodiscitis|spondylodiscitis
5022443|NCT03857295|sepsis|sepsis
5022444|NCT03857282|Bicycling|bicycling
5022445|NCT03857282|Coronary Artery Disease|coronary artery disease
5022446|NCT03857282|Pulmonary Function|pulmonary function
5022447|NCT03857282|Tai Chi|tai chi
5022448|NCT03857269|acupressure|acupressure
5022449|NCT03857269|Aromatherapy|aromatherapy
5022450|NCT03857269|Nursing Homes|nursing homes
5022451|NCT03857269|china|china
5022452|NCT03857230|follitropin alfa|follitropin alfa
5022453|NCT03857230|follicle stimulating hormone|follicle stimulating hormone
5022454|NCT03857230|hormones, hormone substitutes, and hormone antagonists|hormones, hormone substitutes, and hormone antagonists
5022455|NCT03857230|physiological effects of drugs|physiological effects of drugs
5022456|NCT03857230|biosimilar|biosimilar
5022457|NCT03857230|bioequivalence|bioequivalence
5022458|NCT03857191|obesity|obesity
5022459|NCT03857191|sleep apnea|sleep apnea
5022460|NCT03857191|hypertension|hypertension
5022461|NCT03857191|type 2 diabetes|type 2 diabetes
5022462|NCT03857191|CPAP|cpap
5022463|NCT03857126|Signal Database|signal database
5022464|NCT03857126|Pregnancy|pregnancy
5022465|NCT03857126|Electrocardiogram|electrocardiogram
5022466|NCT03857126|Phonocardiogram|phonocardiogram
5022467|NCT03857126|Cardiotocography|cardiotocography
5022468|NCT03857126|Usability|usability
5022469|NCT03857074|Refractory Epilepsy|refractory epilepsy
5022470|NCT03857074|Green Light Exposure|green light exposure
5338183|NCT02003053|intubated|intubated
5022471|NCT03857074|Epileptic Spikes|epileptic spikes
5022472|NCT03857061|wearables|wearables
5022473|NCT03857061|self-monitoring|self-monitoring
5022474|NCT03857035|Trismus|trismus
5022475|NCT03857035|piezosurgery|piezosurgery
5022476|NCT03857035|pain|pain
5022477|NCT03857035|swelling|swelling
5022478|NCT03857022|EECP, Heart Failure, NT-proBNP, Inotropic Agents|eecp, heart failure, nt-probnp, inotropic agents
5022479|NCT03856957|Serrated Lesion|serrated lesion
5022480|NCT03856957|Endocuff|endocuff
5022481|NCT03856957|Detection|detection
5022482|NCT03856944|Astigmatism|astigmatism
5022483|NCT03856944|intraocular lens|intraocular lens
5022484|NCT03856944|multifocal|multifocal
5022485|NCT03856931|mental health|mental health
5022486|NCT03856931|preschool|preschool
5022487|NCT03856931|SDQ|sdq
5022488|NCT03856931|parental depression|parental depression
5022489|NCT03856918|Protective ventilation|protective ventilation
5022490|NCT03856918|One-lung ventilation|one-lung ventilation
5022491|NCT03856905|Cerebral palsy|cerebral palsy
5022492|NCT03856905|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5022493|NCT03856905|Functional Electrical Stimulation|functional electrical stimulation
5022494|NCT03856905|Function|function
5022496|NCT03856905|Spasticity|spasticity
5022497|NCT03856892|Yoga|yoga
5022498|NCT03856892|Breath-based yoga|breath-based yoga
5022499|NCT03856892|Stress management|stress management
5022500|NCT03856892|Meditation|meditation
5022501|NCT03856892|Hatha yoga|hatha yoga
5022502|NCT03856879|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5022503|NCT03856879|intervention studies|intervention studies
5022504|NCT03856879|randomized controlled trial|randomized controlled trial
5022505|NCT03856879|provider satisfaction|provider satisfaction
5022506|NCT03856879|patient satisfaction|patient satisfaction
5022507|NCT03856879|E-consult|e-consult
5022508|NCT03856866|PBD, Zellweger spectrum, PBD-ZSD|pbd, zellweger spectrum, pbd-zsd
5022509|NCT03856840|Pemphigoid, Bullous|pemphigoid, bullous
5022520|NCT03856801|strength|strength
5022521|NCT03856788|Randomized control trial|randomized control trial
5022522|NCT03856788|Subcostal transversus abdominis plane block|subcostal transversus abdominis plane block
5022523|NCT03856788|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5022524|NCT03856788|Regional anesthesia|regional anesthesia
5022525|NCT03856788|Opioid consumption|opioid consumption
5022526|NCT03856788|Bariatrics|bariatrics
5022527|NCT03856736|Heart Failure|heart failure
5022528|NCT03856736|Telomere Length|telomere length
5022529|NCT03856736|Aerobic Exercise|aerobic exercise
5022530|NCT03856723|Acute Kidney Injury|acute kidney injury
5022531|NCT03856723|Renal Replacement Treatment|renal replacement treatment
5022532|NCT03856723|Biomarker|biomarker
5022533|NCT03856710|Inguinal hernia|inguinal hernia
5022534|NCT03856710|Groin hernia|groin hernia
5022535|NCT03856710|Laparoscopy|laparoscopy
5022537|NCT03856684|vaginal|vaginal
5022538|NCT03856684|self-sampling|self-sampling
5022539|NCT03856684|cervical cancer screening|cervical cancer screening
5022540|NCT03856684|Papillomavirus|papillomavirus
5022542|NCT03856684|High Risk Human papillomavirus Infection|high risk human papillomavirus infection
5022543|NCT03856684|pap smear|pap smear
5022544|NCT03856671|Surgical Site Infection|surgical site infection
5022545|NCT03856671|oral antibiotics|oral antibiotics
5022546|NCT03856671|mechanical bowel preparation|mechanical bowel preparation
5022547|NCT03856671|laparoscopic surgery|laparoscopic surgery
5022548|NCT03856658|pancreatic cancer, liver metastases, HAI, hepatic artery infusion pump|pancreatic cancer, liver metastases, hai, hepatic artery infusion pump
5022549|NCT03856593|Opioids|opioids
5022550|NCT03856593|Safe prescribing|safe prescribing
5022563|NCT03856541|advanced solid tumor|advanced solid tumor
5022564|NCT03856541|C-Met antibody drug conjugate|c-met antibody drug conjugate
5022565|NCT03856541|Safety|safety
5022566|NCT03856541|Pharmacokinetics|pharmacokinetics
5022567|NCT03856528|meningitis|meningitis
5022568|NCT03856528|encephalitis|encephalitis
5022569|NCT03856515|Cigarette|cigarette
5022570|NCT03856515|Smoker|smoker
5022571|NCT03856502|spinal anesthesia|spinal anesthesia
5022572|NCT03856502|femoral fracture|femoral fracture
5022573|NCT03856502|dexamethasone|dexamethasone
5022574|NCT03856489|sleep|sleep
5022575|NCT03856489|intensive care unit|intensive care unit
5022576|NCT03856489|patient|patient
5022577|NCT03856489|nurse|nurse
5022578|NCT03856489|inter-rater reliability|inter-rater reliability
5022579|NCT03856489|Richards-Campbell sleeping questionnaire|richards-campbell sleeping questionnaire
5022580|NCT03856463|end of life|end of life
5022581|NCT03856463|quality of care|quality of care
5022582|NCT03856463|cancer care delivery|cancer care delivery
5022583|NCT03856424|Ventilation|ventilation
5022584|NCT03856424|Tracheotomy|tracheotomy
5022585|NCT03856424|Difficult weaning|difficult weaning
5022586|NCT03856424|Spontaneous Breathing Test|spontaneous breathing test
5022587|NCT03856424|Esophageal pressure|esophageal pressure
5022588|NCT03856424|Work of breathing|work of breathing
5022589|NCT03856424|Esophageal pressure time-product|esophageal pressure time-product
5338310|NCT02002429|Low back pain|low back pain
5022590|NCT03856424|Difficult weaning from mechanical ventilation|difficult weaning from mechanical ventilation
5022591|NCT03856424|Ventilation weaning|ventilation weaning
5022592|NCT03856372|Postmastectomy Hypofractionated Adjuvant Radiotherapy|postmastectomy hypofractionated adjuvant radiotherapy
5022593|NCT03856346|Vitrectomy|vitrectomy
5022594|NCT03856346|Phacoemulsification|phacoemulsification
5022595|NCT03856346|Biometry|biometry
5022596|NCT03856346|IOL calculation|iol calculation
5022597|NCT03856346|Cataract|cataract
5022598|NCT03856333|Cognitive Exercise Therapy Approach Scale|cognitive exercise therapy approach scale
5022599|NCT03856333|validity|validity
5022600|NCT03856333|reliability|reliability
5022601|NCT03856333|responsiveness|responsiveness
5022602|NCT03856333|neck pain|neck pain
5022603|NCT03856320|Obesity|obesity
5022604|NCT03856320|Patient Education|patient education
5022605|NCT03856320|Weight Loss|weight loss
5022606|NCT03856294|gastric motility|gastric motility
5022607|NCT03856294|functional dyspepsia|functional dyspepsia
5022608|NCT03856294|functional dyspepsia symptoms|functional dyspepsia symptoms
5022609|NCT03856229|HIV/AIDS|hiv/aids
5022610|NCT03856229|PCP treatment|pcp treatment
5022623|NCT03856151|Intra-dialytic Hypotension|intra-dialytic hypotension
5022624|NCT03856151|heating device|heating device
5022625|NCT03856125|Tennis elbow|tennis elbow
5022626|NCT03856125|Lateral epicondylalgia|lateral epicondylalgia
5072080|NCT03548753|Angina|angina
5022627|NCT03856125|Lateral elbow tendinopathy|lateral elbow tendinopathy
5022628|NCT03856125|Lateral elbow pain|lateral elbow pain
5022629|NCT03856125|Percutaneous electrical stimulation|percutaneous electrical stimulation
5022630|NCT03856086|Comparing Distress Screening|comparing distress screening
5022631|NCT03856086|Consultation With Enhanced Usual Care|consultation with enhanced usual care
5022632|NCT03856086|Supportive care|supportive care
5022633|NCT03856086|18-539|18-539
5022634|NCT03856034|spina bifida|spina bifida
5022635|NCT03856034|myelomeningocele|myelomeningocele
5022636|NCT03856034|neural tube defect|neural tube defect
5022637|NCT03856034|chiari malformation|chiari malformation
5022638|NCT03856034|fetoscopy|fetoscopy
5022639|NCT03856034|percutaneous|percutaneous
5022640|NCT03856034|fetus|fetus
5022641|NCT03856008|cervical spinal stabilisation exercises|cervical spinal stabilisation exercises
5022642|NCT03856008|muscle cross sectional area|muscle cross sectional area
5022643|NCT03856008|muscle t2 relaxation time|muscle t2 relaxation time
5022644|NCT03855995|Malaria|malaria
5022645|NCT03855995|Plasmodium falciparum|plasmodium falciparum
5022646|NCT03855995|Vaccine effectiveness|vaccine effectiveness
5022647|NCT03855995|Sub-Saharan Africa|sub-saharan africa
5022648|NCT03855995|Active surveillance|active surveillance
5022649|NCT03855982|myocardial toxicity|myocardial toxicity
5022650|NCT03855982|chemotherapies|chemotherapies
5022651|NCT03855982|drugs|drugs
5022652|NCT03855969|PAC infections|pac infections
5022653|NCT03855969|oncology|oncology
5022654|NCT03855904|GI bleeding|gi bleeding
5022655|NCT03855904|Hemospray|hemospray
5022656|NCT03855904|TC-325|tc-325
5022657|NCT03855904|malignancy|malignancy
5022658|NCT03855904|tumor|tumor
5022659|NCT03855891|Ischemic Heart Disease|ischemic heart disease
5022660|NCT03855891|Atherosclerosis|atherosclerosis
5022661|NCT03855891|micro-RNA|micro-rna
5022662|NCT03855891|multislice spiral computed tomography|multislice spiral computed tomography
5022663|NCT03855891|coronary angiography|coronary angiography
5022664|NCT03855852|vertical bone defect|vertical bone defect
5022665|NCT03855852|Ridge augmentation|ridge augmentation
5022666|NCT03855852|One stage|one stage
5022667|NCT03855852|Xenograft|xenograft
5022668|NCT03855852|Collagen membrane|collagen membrane
5022669|NCT03855852|Advanced platelet rich fibrin|advanced platelet rich fibrin
5022670|NCT03855852|Guided bone regeneration|guided bone regeneration
5022671|NCT03855852|Surgical template|surgical template
5022672|NCT03855852|Implant|implant
5022673|NCT03855852|horizontal bone defect|horizontal bone defect
5022674|NCT03855839|Posture|posture
5022675|NCT03855839|Muscle activity|muscle activity
5022676|NCT03855839|Posture corrective shirts|posture corrective shirts
5022677|NCT03855813|30 seconds chair stand test|30 seconds chair stand test
5022678|NCT03855813|Performance test|performance test
5022679|NCT03855813|Reliability|reliability
5022680|NCT03855774|healthy subject|healthy subject
5022681|NCT03855774|epidemiological|epidemiological
5022682|NCT03855735|Preventable adverse events|preventable adverse events
5022683|NCT03855735|Patient safety|patient safety
5022684|NCT03855735|Core communication competences|core communication competences
5022685|NCT03855735|Different communication models|different communication models
5022686|NCT03855735|HAPA|hapa
5022687|NCT03855735|Participatory intervention development|participatory intervention development
5022688|NCT03855735|Digitization|digitization
5022690|NCT03855735|eHealth|ehealth
5022691|NCT03855735|Health services research|health services research
5022692|NCT03855696|MG1113|mg1113
5022693|NCT03855696|Hemophilia|hemophilia
5022694|NCT03855683|depression|depression
5022695|NCT03855683|anxiety|anxiety
5022696|NCT03855657|Biobank|biobank
5022697|NCT03855644|Pelvic Fracture|pelvic fracture
5022698|NCT03855644|Predictive Model|predictive model
5022699|NCT03855644|Blood Transfusion|blood transfusion
5022700|NCT03855644|Perioperative period|perioperative period
5022701|NCT03855631|Kabuki syndrome CRIPSR/Cas9 KMT2D|kabuki syndrome cripsr/cas9 kmt2d
5022702|NCT03855618|Translation.|translation.
5022703|NCT03855618|Transcultural validation.|transcultural validation.
5022709|NCT03855553|Anorexia Nervosa|anorexia nervosa
5022710|NCT03855553|Bulimia Nervosa|bulimia nervosa
5022711|NCT03855553|Eating Disorders|eating disorders
5022712|NCT03855553|Adolescence|adolescence
5022713|NCT03855553|Clinical Training|clinical training
5022714|NCT03855553|Community Outreach|community outreach
5022715|NCT03855553|Family Based Treatment|family based treatment
5022716|NCT03855553|Enhanced Cognitive Behavioral Therapy|enhanced cognitive behavioral therapy
5022717|NCT03855540|Atrial fibrillation|atrial fibrillation
5022727|NCT03855514|Non-healing DFU|non-healing dfu
5022728|NCT03855501|apexification treatment|apexification treatment
5022729|NCT03855501|calcium hydroxide|calcium hydroxide
5022730|NCT03855501|mineral trioxide aggregate|mineral trioxide aggregate
5022731|NCT03855488|Worry|worry
5022732|NCT03855488|Anxiety|anxiety
5022733|NCT03855488|Imagery|imagery
5022734|NCT03855488|Cognitive bias modification|cognitive bias modification
5022735|NCT03855475|Exercise|exercise
5022736|NCT03855475|Memory|memory
5022737|NCT03855475|Brain|brain
5022738|NCT03855462|endotamponade|endotamponade
5022739|NCT03855462|retinal detachment|retinal detachment
5022740|NCT03855462|vitreoretinal proliferation|vitreoretinal proliferation
5022741|NCT03855449|Problem solving|problem solving
5022742|NCT03855449|Self-management|self-management
5022743|NCT03855449|Education|education
5022744|NCT03855436|coronary intermediate lesions|coronary intermediate lesions
5022745|NCT03855436|quantitative flow reserve|quantitative flow reserve
5022746|NCT03855436|serum biomarker|serum biomarker
5022747|NCT03855436|risk score|risk score
5022748|NCT03855423|MTD|mtd
5022749|NCT03855423|TRF|trf
5022750|NCT03855423|Pharmacology|pharmacology
5022751|NCT03855410|mHealth|mhealth
5022752|NCT03855410|preventive intervention|preventive intervention
5017352|NCT03888066|reduced ejection fraction|reduced ejection fraction
5022753|NCT03855410|substance use|substance use
5022755|NCT03855410|eHealth|ehealth
5022756|NCT03855410|technology-based|technology-based
5022757|NCT03855410|HIV/STI|hiv/sti
5022758|NCT03855397|Microneedles|microneedles
5022759|NCT03855397|Buccal mucosa|buccal mucosa
5022760|NCT03855397|Transbuccal administration|transbuccal administration
5022761|NCT03855371|p53 mutation|p53 mutation
5022762|NCT03855371|personalized treatment|personalized treatment
5022763|NCT03855371|Decitabine|decitabine
5022764|NCT03855371|Arsenic Trioxide|arsenic trioxide
5022765|NCT03855371|AML|aml
5022766|NCT03855371|MDS|mds
5022767|NCT03855319|Neurofeedback|neurofeedback
5022768|NCT03855319|Electroencephalography|electroencephalography
5022769|NCT03855319|MCI|mci
5022770|NCT03855319|Alzheimer|alzheimer
5022771|NCT03855267|propofol|propofol
5022772|NCT03855267|etomidate|etomidate
5022773|NCT03855267|General anesthesia|general anesthesia
5022774|NCT03855267|mixture|mixture
5022775|NCT03855254|Contextual effects|contextual effects
5022776|NCT03855241|Leftover opioids|leftover opioids
5022777|NCT03855241|Unused opioids|unused opioids
5022778|NCT03855241|Safe prescription opioid disposal|safe prescription opioid disposal
5022779|NCT03855241|Drug disposal|drug disposal
5022780|NCT03855215|acute respiratory infection|acute respiratory infection
5022781|NCT03855215|ARI|ari
5022782|NCT03855215|antibiotic|antibiotic
5022783|NCT03855215|Antimicrobial resistance|antimicrobial resistance
5022784|NCT03855215|AMR|amr
5022785|NCT03855215|primary health care|primary health care
5022786|NCT03855215|CRP|crp
5022787|NCT03855202|PS|ps
5022788|NCT03855202|cord blood mononuclaer Cells|cord blood mononuclaer cells
5022789|NCT03855202|preterm|preterm
5022790|NCT03855163|Mental Distress|mental distress
5022791|NCT03855163|Musculoskeletal Pain|musculoskeletal pain
5022792|NCT03855163|Work-related|work-related
5022793|NCT03855163|Cluster Randomized Trial|cluster randomized trial
5022794|NCT03855163|Effect Evaluation|effect evaluation
5022795|NCT03855124|Electromyography|electromyography
5022796|NCT03855124|Musculoskeletal|musculoskeletal
5022797|NCT03855111|Neuropathic pain|neuropathic pain
5022798|NCT03855111|HIV Neuropathy|hiv neuropathy
5022799|NCT03855111|HIV/AIDS|hiv/aids
5022800|NCT03855111|Symptom Management|symptom management
5022801|NCT03855111|Acupuncture|acupuncture
5022802|NCT03855111|Pain|pain
5022803|NCT03855111|Pain Syndrome|pain syndrome
5022810|NCT03855072|Mandibular Prognanthism,customized plate|mandibular prognanthism,customized plate
5022811|NCT03855046|Internal sphincterotomy|internal sphincterotomy
5022815|NCT03855046|proctologic diseases|proctologic diseases
5022816|NCT03855046|surgical treatment|surgical treatment
5334263|NCT02020538|cardiac surgery|cardiac surgery
5022817|NCT03855046|Chronic anal pain|chronic anal pain
5022818|NCT03855046|Fecal incontinence|fecal incontinence
5022828|NCT03854981|Inflammation|inflammation
5022829|NCT03854981|Exercise|exercise
5022830|NCT03854981|Diet|diet
5022831|NCT03854968|Mechanical ventilation|mechanical ventilation
5022832|NCT03854968|Performance|performance
5022833|NCT03854955|iScribes|iscribes
5022834|NCT03854955|patient satisfaction|patient satisfaction
5022835|NCT03854955|device based scribe|device based scribe
5022836|NCT03854929|Azithromycin|azithromycin
5022837|NCT03854929|Ciprofloxacin|ciprofloxacin
5022838|NCT03854929|Children|children
5022839|NCT03854929|Dysentery|dysentery
5022840|NCT03854929|Vietnam|vietnam
5022841|NCT03854916|Physical Activity|physical activity
5022842|NCT03854916|Latina|latina
5022843|NCT03854916|Hispanic|hispanic
5022844|NCT03854916|Women|women
5022845|NCT03854916|Minority Health|minority health
5022846|NCT03854916|Mobile Technology|mobile technology
5022847|NCT03854916|Social Support|social support
5022848|NCT03854916|mHealth|mhealth
5022849|NCT03854916|Location-based Services|location-based services
5022850|NCT03854916|Walking|walking
5022851|NCT03854903|breast cancer|breast cancer
5022853|NCT03854903|HER2-|her2-
5022854|NCT03854903|HR positive|hr positive
5022855|NCT03854903|HER2 negative|her2 negative
5022856|NCT03854903|metastatic|metastatic
5022857|NCT03854903|aromatase inhibitor|aromatase inhibitor
5022858|NCT03854903|CDK4/6 inhibitor|cdk4/6 inhibitor
5022859|NCT03854903|palbociclib|palbociclib
5022860|NCT03854903|bosutinib|bosutinib
5022861|NCT03854903|fulvestrant|fulvestrant
5022862|NCT03854903|Faslodex|faslodex
5022863|NCT03854877|Health behaviour|health behaviour
5022864|NCT03854877|Work place intervention|work place intervention
5022865|NCT03854877|Stress|stress
5022866|NCT03854877|Physical activity|physical activity
5022867|NCT03854877|Nutrition|nutrition
5022868|NCT03854877|e-health|e-health
5022869|NCT03854877|Mindfulness|mindfulness
5022870|NCT03854864|Peripheral Nervous System Diseases|peripheral nervous system diseases
5022871|NCT03854864|Oncologists|oncologists
5022872|NCT03854851|Naldebain|naldebain
5022873|NCT03854851|long-term analgesia|long-term analgesia
5022874|NCT03854851|take down of anastomosis|take down of anastomosis
5022875|NCT03854838|toripalimab|toripalimab
5022876|NCT03854838|IMRT|imrt
5022877|NCT03854838|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
5022878|NCT03854838|PD-1|pd-1
5022879|NCT03854812|magnesium sulphate|magnesium sulphate
5022880|NCT03854812|fentanyl|fentanyl
5022881|NCT03854812|propofol|propofol
5022882|NCT03854812|monitored anesthesia care|monitored anesthesia care
5022883|NCT03854812|burr-hole evacuation|burr-hole evacuation
5022884|NCT03854812|chronic subdural hematoma|chronic subdural hematoma
5022888|NCT03854734|Vaccinations|vaccinations
5022889|NCT03854734|Vaccine hesitancy|vaccine hesitancy
5022890|NCT03854734|School-based research|school-based research
5022891|NCT03854721|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5022892|NCT03854708|gastric accommodation|gastric accommodation
5022893|NCT03854708|gastric emptying|gastric emptying
5022894|NCT03854708|hunger|hunger
5022895|NCT03854708|satiety|satiety
5022896|NCT03854708|nutrient tolerance|nutrient tolerance
5022897|NCT03854669|Acute post-operative pain|acute post-operative pain
5022898|NCT03854669|Clinical pain variability|clinical pain variability
5022899|NCT03854669|Experimental pain variability|experimental pain variability
5022900|NCT03854669|FAST|fast
5022901|NCT03854669|pain reporting accuracy|pain reporting accuracy
5022902|NCT03854656|Overweight|overweight
5022903|NCT03854656|Obesity|obesity
5022904|NCT03854656|Time-restricted eating|time-restricted eating
5022905|NCT03854656|Prediabetes|prediabetes
5022909|NCT03854617|metronomic chemotherapy|metronomic chemotherapy
5022910|NCT03854591|GLOBAL SURGERY|global surgery
5022911|NCT03854591|COLLABORATIVE RESEARCH|collaborative research
5022912|NCT03854591|GUNSHOT IN JURY|gunshot in jury
5022913|NCT03854591|EPIDEMIOLOGY|epidemiology
5022914|NCT03854565|ARDS|ards
5022918|NCT03854565|pulmonary fibrosis|pulmonary fibrosis
5022919|NCT03854565|mortality|mortality
5022920|NCT03854500|Tenecteplase|tenecteplase
5022921|NCT03854500|Thrombolysis|thrombolysis
5022922|NCT03854500|Alteplase|alteplase
5022923|NCT03854487|stroke; unilateral neglect; mirror therapy; mirror visual feedback|stroke; unilateral neglect; mirror therapy; mirror visual feedback
5022924|NCT03854461|individualised dietary advice|individualised dietary advice
5022925|NCT03854461|biomarkers|biomarkers
5022926|NCT03854461|diet quality|diet quality
5022927|NCT03854461|cardiometabolic health|cardiometabolic health
5022928|NCT03854448|inferior STEMI|inferior stemi
5022929|NCT03854422|Colonoscopy|colonoscopy
5022930|NCT03854422|Insertıon tecnique|insertıon tecnique
5022931|NCT03854422|Prone|prone
5022932|NCT03854422|Left Supine|left supine
5022933|NCT03854422|Dynamic|dynamic
5022934|NCT03854396|recurrent urinary tract infection|recurrent urinary tract infection
5022935|NCT03854396|genitourinary syndrome of menopause|genitourinary syndrome of menopause
5022936|NCT03854396|prasterone|prasterone
5022937|NCT03854370|surgical prep|surgical prep
5022938|NCT03854370|vaginal prep|vaginal prep
5022939|NCT03854370|baby shampoo|baby shampoo
5022940|NCT03854357|Subscapularis|subscapularis
5022941|NCT03854357|Total Shoulder Arthroplasty|total shoulder arthroplasty
5022942|NCT03854357|Subscapularis Rehabilitation|subscapularis rehabilitation
5022943|NCT03854357|Subscapularis strength|subscapularis strength
5022944|NCT03854331|Resilience|resilience
5022945|NCT03854331|Cortisol|cortisol
5022946|NCT03854331|Feasibility|feasibility
5022947|NCT03854331|Healthy lifestyle|healthy lifestyle
5022948|NCT03854331|Sleep|sleep
5022949|NCT03854318|inherited hematological diseases|inherited hematological diseases
5022950|NCT03854318|Rare Diseases|rare diseases
5022951|NCT03854318|Hematological Malignancies|hematological malignancies
5022952|NCT03854318|Cancer|cancer
5022953|NCT03854318|Acute Myeloid Leukemia|acute myeloid leukemia
5022954|NCT03854305|Crohn's Disease|crohn's disease
5022955|NCT03854240|Thoracolumbar Interfascial Plane Block|thoracolumbar interfascial plane block
5022956|NCT03854240|Pain Management|pain management
5022957|NCT03854240|Lumbar Laminectomy Surgery|lumbar laminectomy surgery
5022958|NCT03854214|Spinal Cord Injuries|spinal cord injuries
5022959|NCT03854214|MRI, Functional|mri, functional
5022960|NCT03854214|Rehabilitation|rehabilitation
5022961|NCT03854214|Neuronal Plasticity|neuronal plasticity
5022962|NCT03854201|workability, sickness absence, health promotion, costs|workability, sickness absence, health promotion, costs
5022963|NCT03854188|acupuncture|acupuncture
5022964|NCT03854149|Congenital Heart Disease|congenital heart disease
5022965|NCT03854149|Atrial Fibrillation|atrial fibrillation
5017577|NCT03886844|Preterm infants|preterm infants
5022966|NCT03854149|Thromboembolism|thromboembolism
5022967|NCT03854149|NOAC|noac
5022968|NCT03854149|Apixaban|apixaban
5022969|NCT03854149|Atrial arrhythmias|atrial arrhythmias
5022970|NCT03854123|Geriatric population|geriatric population
5022971|NCT03854123|EDMUS|edmus
5022972|NCT03854123|OFSEP|ofsep
5022973|NCT03854110|Disease progression on Folfirinox|disease progression on folfirinox
5022974|NCT03854097|PAD|pad
5022975|NCT03854045|telepsychiatry|telepsychiatry
5022976|NCT03854045|telemedicine|telemedicine
5022977|NCT03854045|home-based care|home-based care
5022978|NCT03854019|Irritability|irritability
5022979|NCT03854006|Atrial Fibrillation|atrial fibrillation
5022980|NCT03853993|Influenza Vaccine|influenza vaccine
5022981|NCT03853993|Quadrivalent|quadrivalent
5022982|NCT03853993|Trivalent|trivalent
5022983|NCT03853980|submental|submental
5022984|NCT03853980|laxity|laxity
5022985|NCT03853967|low dose CT scan|low dose ct scan
5022986|NCT03853941|Motivation|motivation
5022987|NCT03853941|Communication|communication
5022988|NCT03853941|Healthcare Professional|healthcare professional
5022989|NCT03853941|Training|training
5022990|NCT03853941|Adherence|adherence
5022991|NCT03853941|Diabetes|diabetes
5022992|NCT03853941|Foot Ulcer|foot ulcer
5022993|NCT03853928|Hepatocellular carcinoma|hepatocellular carcinoma
5022994|NCT03853928|prevention|prevention
5022995|NCT03853928|microbiome|microbiome
5022996|NCT03853915|Cervical Cancer|cervical cancer
5022997|NCT03853915|PET Scan|pet scan
5022998|NCT03853915|HPV DNA|hpv dna
5022999|NCT03853902|prostate cancer|prostate cancer
5023000|NCT03853902|mindfulness|mindfulness
5023001|NCT03853902|MBSR|mbsr
5023002|NCT03853902|online course|online course
5037721|NCT03762902|HFHS|hfhs
5023025|NCT03853668|aerobic and resisted exercises|aerobic and resisted exercises
5023026|NCT03853668|CABG|cabg
5023027|NCT03853655|Cancer of the Mouth|cancer of the mouth
5023028|NCT03853655|Tongue cancer|tongue cancer
5023029|NCT03853655|Buccal Mucosa cancer|buccal mucosa cancer
5023030|NCT03853655|Head and Neck|head and neck
5023031|NCT03853655|Oral Cancer|oral cancer
5074741|NCT03531593|MTX|mtx
5023048|NCT03853538|Skin hydration|skin hydration
5023049|NCT03853538|Consumer satisfaction|consumer satisfaction
5023050|NCT03853538|Sensorial perception|sensorial perception
5023051|NCT03853525|Dermal spray|dermal spray
5023052|NCT03853525|Laser depilation|laser depilation
5023053|NCT03853525|Skin hydration|skin hydration
5023054|NCT03853525|Consumer satisfaction|consumer satisfaction
5023055|NCT03853525|Sensorial perception|sensorial perception
5023056|NCT03853512|Dermal spray|dermal spray
5023057|NCT03853512|Peeling|peeling
5023058|NCT03853512|Skin hydration|skin hydration
5023059|NCT03853512|Consumer satisfaction|consumer satisfaction
5023060|NCT03853512|Sensorial perception|sensorial perception
5023061|NCT03853499|Failure|failure
5023062|NCT03853499|Forceps Delivery|forceps delivery
5023063|NCT03853499|Cesarean Section|cesarean section
5023064|NCT03853499|Affecting Fetus or Newborn|affecting fetus or newborn
5023065|NCT03853499|Vacuum Extraction|vacuum extraction
5023067|NCT03853486|von Willebrand Disease|von willebrand disease
5023069|NCT03853486|Factor|factor
5023070|NCT03853486|ATHN 9|athn 9
5023071|NCT03853434|embolization|embolization
5023072|NCT03853434|blood loss|blood loss
5023073|NCT03853434|Early Goal Directed Therapy|early goal directed therapy
5023074|NCT03853434|spine metastasis|spine metastasis
5023075|NCT03853408|Acute cholecystitis|acute cholecystitis
5325112|NCT02061527|Strattice|strattice
5023076|NCT03853408|Cholecystectomy|cholecystectomy
5023077|NCT03853408|overweight|overweight
5023078|NCT03853408|BMI|bmi
5023079|NCT03853408|early|early
5023080|NCT03853408|delayed|delayed
5023081|NCT03853369|ventricular tachycardia|ventricular tachycardia
5023082|NCT03853369|ventricular fibrillation|ventricular fibrillation
5023083|NCT03853278|Colorectal Neoplasms|colorectal neoplasms
5023084|NCT03853278|self-management support|self-management support
5023085|NCT03853278|cancer survivor|cancer survivor
5023086|NCT03853278|healthy life styles|healthy life styles
5023087|NCT03853239|face mask|face mask
5023088|NCT03853239|nasal ventilation|nasal ventilation
5023089|NCT03853226|After-load cardiac performance|after-load cardiac performance
5023090|NCT03853226|high cardiovascular risk|high cardiovascular risk
5023091|NCT03853226|surgical patient|surgical patient
5023092|NCT03853213|Fear of Recurrence|fear of recurrence
5023093|NCT03853213|Acute Coronary Syndrome|acute coronary syndrome
5023094|NCT03853213|Intervention|intervention
5023095|NCT03853213|Cognitive Bias Modification Training|cognitive bias modification training
5023096|NCT03853213|Attentional Bias|attentional bias
5023097|NCT03853213|Interpretation Bias|interpretation bias
5066165|NCT03585231|Smoking|smoking
5017675|NCT03886259|Chronic Pain|chronic pain
5017679|NCT03886220|Elagolix|elagolix
5023098|NCT03853213|Medication Adherence|medication adherence
5023099|NCT03853200|Final irrigation|final irrigation
5023100|NCT03853200|Irrigation in Endodontics|irrigation in endodontics
5023101|NCT03853200|QMix|qmix
5023102|NCT03853200|CFU|cfu
5023103|NCT03853200|Colony forming unit|colony forming unit
5023104|NCT03853200|MRS|mrs
5037826|NCT03762369|CKD-351|ckd-351
5023133|NCT03852953|False negative|false negative
5023134|NCT03852953|Quantitative methods|quantitative methods
5023135|NCT03852953|Survival|survival
5023136|NCT03852940|vasoactive drug|vasoactive drug
5023137|NCT03852940|mechanical ventilation|mechanical ventilation
5023138|NCT03852940|early enteral nutrition|early enteral nutrition
5023139|NCT03852940|intensive care unit|intensive care unit
5023140|NCT03852940|early parenteral nutrition|early parenteral nutrition
5023141|NCT03852940|critical care medicine|critical care medicine
5023142|NCT03852940|nosocomial infection|nosocomial infection
5023143|NCT03852940|mortality|mortality
5023144|NCT03852940|shock|shock
5023145|NCT03852901|Ketones|ketones
5023146|NCT03852901|Metabolism|metabolism
5023147|NCT03852901|Hormones|hormones
5023148|NCT03852901|Alzheimer's Disease|alzheimer's disease
5023152|NCT03852836|Cholangiopancreatography by MRI|cholangiopancreatography by mri
5023153|NCT03852836|Compressed Sensing|compressed sensing
5023154|NCT03852797|uterine contraction|uterine contraction
5023155|NCT03852797|oxytocin|oxytocin
5023156|NCT03852797|ketamine|ketamine
5023157|NCT03852797|propofol|propofol
5023158|NCT03852797|etomidate|etomidate
5023159|NCT03852784|Bone and Joint Infection|bone and joint infection
5023160|NCT03852784|Streptococcus peumoniae|streptococcus peumoniae
5023161|NCT03852758|exercise|exercise
5023162|NCT03852745|cognitive behavioral therapy, online intervention|cognitive behavioral therapy, online intervention
5023163|NCT03852706|Hallucinations|hallucinations
5023170|NCT03852667|exercise therapy|exercise therapy
5023171|NCT03852654|Prostate Cancer, PET CT scan, 18F-DCFPyL|prostate cancer, pet ct scan, 18f-dcfpyl
5023172|NCT03852628|Alcohol Use Disorder (AUD)|alcohol use disorder (aud)
5023173|NCT03852628|Alcoholism|alcoholism
5023174|NCT03852628|Alcohol Abuse|alcohol abuse
5023175|NCT03852628|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5023176|NCT03852628|Military|military
5023177|NCT03852628|Veteran|veteran
5023178|NCT03852615|Ovarian Torsion|ovarian torsion
5023179|NCT03852615|Laparoscopy|laparoscopy
5023180|NCT03852615|Anti Mullarian Hormone (AMH)|anti mullarian hormone (amh)
5023181|NCT03852589|Airway management|airway management
5023182|NCT03852589|Videolaryngoscopy|videolaryngoscopy
5023183|NCT03852589|General anesthesia|general anesthesia
5023184|NCT03852563|Skin cream|skin cream
5023185|NCT03852563|Ablative lasering|ablative lasering
5023186|NCT03852563|Skin hydration|skin hydration
5023187|NCT03852563|Consumer satisfaction|consumer satisfaction
5023188|NCT03852563|Sensorial perception|sensorial perception
5023194|NCT03852537|Pneumonia, steroid|pneumonia, steroid
5023195|NCT03852524|Spinal Arthrodesis|spinal arthrodesis
5023196|NCT03852524|Ileus|ileus
5023197|NCT03852524|Postoperative Ileus|postoperative ileus
5023198|NCT03852524|Adult Spinal Deformity|adult spinal deformity
5023199|NCT03852511|metastatic; epithelial; virus; advanced|metastatic; epithelial; virus; advanced
5023204|NCT03852472|Avacopan|avacopan
5023205|NCT03852472|ChemoCentryx|chemocentryx
5023206|NCT03852472|Skin Disease|skin disease
5023207|NCT03852472|Inflammatory nodule|inflammatory nodule
5023208|NCT03852472|Abscess|abscess
5023209|NCT03852472|Sinus formation|sinus formation
5023210|NCT03852472|Fistula formation|fistula formation
5023211|NCT03852446|Indoximod|indoximod
5023212|NCT03852407|hematological malignancies|hematological malignancies
5023213|NCT03852407|Graft versus host disease|graft versus host disease
5023214|NCT03852407|GVHD|gvhd
5023215|NCT03852407|Progression free survival|progression free survival
5023216|NCT03852407|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
5023217|NCT03852407|HLA-matched donor|hla-matched donor
5023218|NCT03852407|reduced intensity conditioning|reduced intensity conditioning
5023219|NCT03852407|Overall survival|overall survival
5023220|NCT03852407|ATG PK|atg pk
5037928|NCT03761901|EGFRm|egfrm
5023221|NCT03852407|Immunosuppressive regimen|immunosuppressive regimen
5023223|NCT03852381|Spinal Cord Stimulation|spinal cord stimulation
5023224|NCT03852381|Burst Stimulation|burst stimulation
5023225|NCT03852381|High Frequency Stimulation|high frequency stimulation
5023226|NCT03852381|High Density Stimulation|high density stimulation
5023227|NCT03852381|fMRI|fmri
5023228|NCT03852381|MEG|meg
5023229|NCT03852381|QST|qst
5023230|NCT03852342|Anaphylaxis|anaphylaxis
5023231|NCT03852342|Oral Food Challenge|oral food challenge
5023232|NCT03852342|Hypersensitivity|hypersensitivity
5023233|NCT03852342|Food Allergy|food allergy
5023234|NCT03852342|Peanut|peanut
5023235|NCT03852329|Image-guidance|image-guidance
5023236|NCT03852329|Lateral skull base surgery|lateral skull base surgery
5023237|NCT03852316|Chlamydia trachomatis|chlamydia trachomatis
5023238|NCT03852316|Device|device
5023239|NCT03852316|Diagnostic|diagnostic
5023240|NCT03852316|Neisseria gonorrohoeae|neisseria gonorrohoeae
5023241|NCT03852316|Trichomonas vaginalis|trichomonas vaginalis
5023242|NCT03852290|Colon cancer|colon cancer
5023243|NCT03852290|Fluoropyrimidine|fluoropyrimidine
5023244|NCT03852264|Oxytocin|oxytocin
5023245|NCT03852264|Vasopressin|vasopressin
5023246|NCT03852264|Cortisol|cortisol
5023247|NCT03852264|Human-animal interaction|human-animal interaction
5023248|NCT03852251|immuno-oncology|immuno-oncology
5023249|NCT03852251|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
5023250|NCT03852251|gastric or GEJ adenocarcinoma|gastric or gej adenocarcinoma
5023251|NCT03852251|PD-1|pd-1
5023252|NCT03852251|CTLA-4|ctla-4
5023253|NCT03852238|hepatocellular carcinoma|hepatocellular carcinoma
5023254|NCT03852238|Non-cirrhotic liver|non-cirrhotic liver
5023255|NCT03852238|Risk factors|risk factors
5023256|NCT03852212|Thrust technique|thrust technique
5023257|NCT03852212|Blood levels|blood levels
5023258|NCT03852212|Pancreas|pancreas
5023259|NCT03852212|Ninth vertebra|ninth vertebra
5023260|NCT03852212|Manipulation|manipulation
5023261|NCT03852199|force sense|force sense
5023262|NCT03852199|knee joint|knee joint
5025116|NCT03841240|catheter|catheter
5023266|NCT03852173|Child|child
5023267|NCT03852173|Health promotion|health promotion
5023268|NCT03852173|longitudinal studies|longitudinal studies
5023269|NCT03852173|Surveys and Questionnaires|surveys and questionnaires
5023270|NCT03852173|beverages|beverages
5023271|NCT03852173|Water/administration & dosage|water/administration & dosage
5023272|NCT03852173|Austria|austria
5023273|NCT03852173|Program evaluation|program evaluation
5023274|NCT03852173|Students/statistics & numerical data|students/statistics & numerical data
5718523|NCT00436670|IL-13|il-13
5023275|NCT03852173|Food Preferences|food preferences
5023276|NCT03852173|Follow-Up Studies|follow-up studies
5023277|NCT03852173|school setting|school setting
5023278|NCT03852173|behavioural change|behavioural change
5023279|NCT03852147|respiratory quotient, post operative complications, anaerobic metabolism.|respiratory quotient, post operative complications, anaerobic metabolism.
5023280|NCT03852134|preterm infant|preterm infant
5023281|NCT03852134|delayed cord clamping|delayed cord clamping
5023282|NCT03852134|cord milking|cord milking
5023283|NCT03852134|resuscitation|resuscitation
5023284|NCT03852121|caregiving appraisal|caregiving appraisal
5023285|NCT03852121|bibliotherapy|bibliotherapy
5023286|NCT03852121|psychological wellbeing|psychological wellbeing
5023287|NCT03852121|informal caregiver|informal caregiver
5023288|NCT03852095|Pediatric, traumatology, hemarthrosis, ankle, knee,|pediatric, traumatology, hemarthrosis, ankle, knee,
5023289|NCT03852095|buckle fracture, clavicle, sprains|buckle fracture, clavicle, sprains
5023290|NCT03852030|prostate cancer|prostate cancer
5023291|NCT03852030|mindfulness|mindfulness
5023292|NCT03852030|eHealth|ehealth
5023293|NCT03852030|kidney cancer|kidney cancer
5023294|NCT03852030|bladder cancer|bladder cancer
5023295|NCT03852030|caregiver|caregiver
5023296|NCT03852017|prostate cancer|prostate cancer
5023297|NCT03852017|mindfulness|mindfulness
5023298|NCT03852017|music|music
5023299|NCT03852004|osteopathy|osteopathy
5023300|NCT03852004|hypotonia|hypotonia
5023301|NCT03852004|children|children
5023302|NCT03851991|AECOPD|aecopd
5023303|NCT03851991|Arbidol|arbidol
5023304|NCT03851978|vaccination|vaccination
5023305|NCT03851965|Soluble urokinase plasminogen activator receptor|soluble urokinase plasminogen activator receptor
5023306|NCT03851965|Major non-cardiac surgery|major non-cardiac surgery
5023307|NCT03851965|Outcome|outcome
5023308|NCT03851965|Perioperative|perioperative
5023309|NCT03851926|HYPOFRACTIONED|hypofractioned
5023310|NCT03851900|Dentin hypersensitivity|dentin hypersensitivity
5023311|NCT03851900|Randomized clinical trial|randomized clinical trial
5023312|NCT03851900|Calcium phosphate desensitizer|calcium phosphate desensitizer
5023313|NCT03851900|Adhesive resin|adhesive resin
5023315|NCT03851874|Bariatric surgery, gut peptides, weight loss, glycemia|bariatric surgery, gut peptides, weight loss, glycemia
5023316|NCT03851861|Intestinal Permeability|intestinal permeability
5023317|NCT03851861|Mediterranean Diet|mediterranean diet
5023318|NCT03851861|Leaky Gut|leaky gut
5023319|NCT03851861|Intestinal Barrier Function|intestinal barrier function
5023320|NCT03851848|Myofascial release|myofascial release
5023321|NCT03851848|Ankle and foot mobilization|ankle and foot mobilization
5023322|NCT03851848|Diabetic patients|diabetic patients
5023323|NCT03851848|plantar heel pain|plantar heel pain
5023324|NCT03851835|Vomiting|vomiting
5023325|NCT03851835|Zofran|zofran
5023326|NCT03851835|Ondansetron|ondansetron
5023327|NCT03851835|Gastroenteritis|gastroenteritis
5023328|NCT03851835|Pediatrics|pediatrics
5023329|NCT03851835|DOSE-AGE|dose-age
5023330|NCT03851809|traditional chinese medicine combination treatment|traditional chinese medicine combination treatment
5023331|NCT03851796|Pediatric Obesity|pediatric obesity
5023332|NCT03851796|Lifestyle Intervention|lifestyle intervention
5023333|NCT03851796|Family-based Intervention|family-based intervention
5023334|NCT03851796|Motivational Interviewing|motivational interviewing
5023335|NCT03851783|solar|solar
5023336|NCT03851783|oxygen|oxygen
5023337|NCT03851770|Epilepsy|epilepsy
5023338|NCT03851757|biofilm|biofilm
5023339|NCT03851757|interdental brushes|interdental brushes
5023340|NCT03851757|interproximal|interproximal
5023341|NCT03851757|oral hygiene|oral hygiene
5023342|NCT03851757|periodontal disease(s)/periodontitis|periodontal disease(s)/periodontitis
5023343|NCT03851718|Acupuncture|acupuncture
5023344|NCT03851718|Hypogalactia|hypogalactia
5023345|NCT03851718|Power Pumping|power pumping
5023346|NCT03851718|Brest Milk Production|brest milk production
5023347|NCT03851692|Sevoflurane|sevoflurane
5023348|NCT03851692|Intravenous Cannulation|intravenous cannulation
5023349|NCT03851692|anesthesia|anesthesia
5023350|NCT03851692|child|child
5023351|NCT03851679|pulmonary echography|pulmonary echography
5023352|NCT03851679|B-Type natriuretic peptide|b-type natriuretic peptide
5023353|NCT03851679|Spinal anesthesia|spinal anesthesia
5023354|NCT03851653|obstructive sleep apnea|obstructive sleep apnea
5023355|NCT03851653|weight loss|weight loss
5023356|NCT03851653|lifestyle intervention|lifestyle intervention
5023373|NCT03851458|15-088|15-088
5023374|NCT03851393|Cough|cough
5023375|NCT03851393|Reflux|reflux
5023376|NCT03851393|Pepsin|pepsin
5023377|NCT03851393|Peptest|peptest
5023378|NCT03851380|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5023379|NCT03851380|Magnetic Resonance Imaging|magnetic resonance imaging
5023380|NCT03851380|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5023381|NCT03851380|fMRI|fmri
5023382|NCT03851380|TMS|tms
5023383|NCT03851380|Neuronavigation|neuronavigation
5023384|NCT03851380|MRI|mri
5023385|NCT03851367|back pain|back pain
5023386|NCT03851367|suspension therapy|suspension therapy
5023387|NCT03851367|Gymball|gymball
5023388|NCT03851367|standing posture|standing posture
5023389|NCT03851367|muscle endurance|muscle endurance
5023390|NCT03851354|enteral feeding|enteral feeding
5023391|NCT03851354|gastric ultrasound|gastric ultrasound
5023392|NCT03851328|Adverse Drug Events (ADEs)|adverse drug events (ades)
5023393|NCT03851328|Medication Accuracy|medication accuracy
5023394|NCT03851328|Medication Discrepancy|medication discrepancy
5023395|NCT03851315|Atrioventricular Block|atrioventricular block
5023396|NCT03851315|left bundle branch area pacing|left bundle branch area pacing
5023397|NCT03851302|Remote ischemic conditioning|remote ischemic conditioning
5023398|NCT03851302|Neuroplasticity|neuroplasticity
5023399|NCT03851302|transcranial magnetic stimulation|transcranial magnetic stimulation
5023400|NCT03851289|socket augmentation|socket augmentation
5023401|NCT03851289|platelet-rich fibrin|platelet-rich fibrin
5023402|NCT03851289|calcium sulfate|calcium sulfate
5023403|NCT03851289|xenograft|xenograft
5023404|NCT03851250|MRx-4DP0004|mrx-4dp0004
5023405|NCT03851250|Asthma|asthma
5023406|NCT03851250|Live Biotherapeutic Product|live biotherapeutic product
5023407|NCT03851198|Mild Cognitive Impairment|mild cognitive impairment
5023408|NCT03851198|Diagnosis|diagnosis
5023409|NCT03851198|Functional tests|functional tests
5023410|NCT03851198|Kinematics|kinematics
5023411|NCT03851198|Validation|validation
5023416|NCT03851172|Nepafenac eye drops|nepafenac eye drops
5023417|NCT03851159|Microbiome|microbiome
5023418|NCT03851133|pancreas|pancreas
5023419|NCT03851133|biobank|biobank
5023420|NCT03851133|quantitative imaging|quantitative imaging
5023421|NCT03851133|biomarkers|biomarkers
5023422|NCT03851133|health disparities|health disparities
5023423|NCT03851107|participation|participation
5023431|NCT03851055|beta thalassemia|beta thalassemia
5023432|NCT03851029|Aerobic Exercise|aerobic exercise
5023434|NCT03851029|Tai Chi Exercise|tai chi exercise
5023435|NCT03851029|University Student|university student
5023436|NCT03851003|cesarean section|cesarean section
5023437|NCT03851003|niche|niche
5023438|NCT03851003|uterine scar defect|uterine scar defect
5023439|NCT03850964|Osler-Weber-Rendu|osler-weber-rendu
5445445|NCT01521767|pharmacokinetics|pharmacokinetics
5023440|NCT03850964|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5023441|NCT03850964|Patient Reported Outcome|patient reported outcome
5023442|NCT03850951|Fixed appliances|fixed appliances
5023443|NCT03850951|labial appliances|labial appliances
5023444|NCT03850951|lingual appliances|lingual appliances
5023445|NCT03850938|fractures, compression|fractures, compression
5023446|NCT03850938|back pain|back pain
5023447|NCT03850938|bone cements|bone cements
5023448|NCT03850938|kyphoplasty|kyphoplasty
5023449|NCT03850912|Other Cancer|other cancer
5023450|NCT03850912|Digital health|digital health
5023451|NCT03850912|Patient reported outcomes|patient reported outcomes
5023452|NCT03850912|Symptom management|symptom management
5023466|NCT03850808|permanent pacemaker|permanent pacemaker
5023467|NCT03850808|AV node dysfunction|av node dysfunction
5023468|NCT03850795|HC-1119|hc-1119
5023469|NCT03850795|enzalutamide|enzalutamide
5023470|NCT03850756|Biomarker|biomarker
5023471|NCT03850756|Tobacco|tobacco
5023472|NCT03850756|Nephrotoxicity|nephrotoxicity
5023473|NCT03850756|Prevention|prevention
5023474|NCT03850756|Diagnosis|diagnosis
5023475|NCT03850730|osler-weber-rendu|osler-weber-rendu
5023476|NCT03850730|nose bleeds|nose bleeds
5023477|NCT03850730|open label|open label
5023479|NCT03850730|Pazopanib|pazopanib
5023481|NCT03850691|MM|mm
5023482|NCT03850665|total|total
5023483|NCT03850665|hip|hip
5023484|NCT03850665|arthroplasty|arthroplasty
5023485|NCT03850665|surgical|surgical
5023486|NCT03850665|approach|approach
5023487|NCT03850652|Iron Supplementation|iron supplementation
5023488|NCT03850652|Prebiotics|prebiotics
5023489|NCT03850652|Microbiota|microbiota
5023490|NCT03850626|Allergy|allergy
5023491|NCT03850626|Rhinoconjuctivitis|rhinoconjuctivitis
5023492|NCT03850626|Combined Symptom and Medication Score|combined symptom and medication score
5023493|NCT03850626|Allergic Asthma|allergic asthma
5023494|NCT03850626|Pollen|pollen
5023495|NCT03850626|Mites|mites
5023496|NCT03850613|caregivers, stress, anxiety|caregivers, stress, anxiety
5023497|NCT03850600|Microbiota|microbiota
5023498|NCT03850600|Diet|diet
5023499|NCT03850600|Immune System|immune system
5023500|NCT03850561|Male infertility|male infertility
5023501|NCT03850561|Coenzyme Q10|coenzyme q10
5023502|NCT03850561|Antioxidants|antioxidants
5023503|NCT03850548|bone and joint infection|bone and joint infection
5023504|NCT03850548|Propionibacterium acnes|propionibacterium acnes
5023505|NCT03850548|Cutibacterium acnes|cutibacterium acnes
5023506|NCT03850535|AML|aml
5023512|NCT03850509|Crohn's Disease|crohn's disease
5023513|NCT03850509|inflammatory bowel disease|inflammatory bowel disease
5023514|NCT03850509|fluoroquinolones|fluoroquinolones
5023515|NCT03850509|inflammation|inflammation
5023530|NCT03850470|foot|foot
5023531|NCT03850470|ankle|ankle
5023532|NCT03850470|stress fracture|stress fracture
5023533|NCT03850457|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5023534|NCT03850457|preterm infants|preterm infants
5023535|NCT03850457|epidemiologic characteristics|epidemiologic characteristics
5023536|NCT03850457|risk factors|risk factors
5023537|NCT03850457|mortality|mortality
5023538|NCT03850444|Programmed Cell Death-1 (PD-1)|programmed cell death-1 (pd-1)
5023543|NCT03850431|Behavioral Economics|behavioral economics
5023545|NCT03850431|Veterans|veterans
5023546|NCT03850431|Veterans Health|veterans health
5023547|NCT03850431|Primary Care|primary care
5023548|NCT03850431|Appointments and Schedules|appointments and schedules
5023549|NCT03850392|cryotherapy|cryotherapy
5023550|NCT03850392|knee arthritis|knee arthritis
5023551|NCT03850392|cytokines|cytokines
5023552|NCT03850340|Ventilator Associated Conditions|ventilator associated conditions
5023553|NCT03850340|Infection Related Ventilator Associated Conditions|infection related ventilator associated conditions
5023554|NCT03850340|Probable Ventilator Associated Pneumonia|probable ventilator associated pneumonia
5023555|NCT03850327|Implantable Cardiac Monitor|implantable cardiac monitor
5023556|NCT03850249|Radioscapholunate|radioscapholunate
5023557|NCT03850249|Fusion|fusion
5023558|NCT03850249|Arthrodesis|arthrodesis
5023559|NCT03850249|Radiocarpal osteoarthritis|radiocarpal osteoarthritis
5023560|NCT03850249|Partial radiocarpal fusion|partial radiocarpal fusion
5023561|NCT03850236|pancreatic fistula|pancreatic fistula
5025436|NCT03839433|Asthma|asthma
5023577|NCT03850145|inhaled therapy|inhaled therapy
5023578|NCT03850145|physiotherapist|physiotherapist
5023579|NCT03850145|educational program|educational program
5023582|NCT03850132|Palliative care|palliative care
5023583|NCT03850119|adipose derived stem cells|adipose derived stem cells
5023584|NCT03850119|stromal vascular fraction|stromal vascular fraction
5023585|NCT03850119|wound healing|wound healing
5023586|NCT03850119|scar formation|scar formation
5023587|NCT03850119|donor site morbidity|donor site morbidity
5023588|NCT03850119|nanofat|nanofat
5023589|NCT03850093|gabapentin|gabapentin
5023590|NCT03850093|bisoprolol|bisoprolol
5023591|NCT03850093|hemodynamic|hemodynamic
5023592|NCT03850093|surgical field|surgical field
5023593|NCT03850080|Knee|knee
5023594|NCT03850080|Osteoarthritis|osteoarthritis
5023595|NCT03850080|Inflammation|inflammation
5334891|NCT02017574|Stroke|stroke
5023597|NCT03850080|Autologous Conditioned Serum|autologous conditioned serum
5023598|NCT03850067|Safety|safety
5023599|NCT03850067|CC-90011|cc-90011
5023600|NCT03850067|Extensive stage small cell lung cancer|extensive stage small cell lung cancer
5023601|NCT03850054|AADI; glaucoma tube shunt|aadi; glaucoma tube shunt
5023602|NCT03850028|high risk DLBCL|high risk dlbcl
5023603|NCT03850028|molecular imaging|molecular imaging
5023604|NCT03850028|89Zr-atezolizumab-PET|89zr-atezolizumab-pet
5023605|NCT03850028|PDL1 imaging|pdl1 imaging
5023606|NCT03850015|echocardiography|echocardiography
5023607|NCT03849976|Therapeutic communication|therapeutic communication
5023608|NCT03849976|Anxiety|anxiety
5023609|NCT03849976|Endoscopic examination under general anesthesia|endoscopic examination under general anesthesia
5023610|NCT03849976|Operating room|operating room
5023611|NCT03849976|Stretcher bearer|stretcher bearer
5023612|NCT03849950|self-management support|self-management support
5023613|NCT03849950|health coaching|health coaching
5023614|NCT03849950|patient education|patient education
5023615|NCT03849950|treatment-related toxicities|treatment-related toxicities
5023620|NCT03849937|Staff Communication|staff communication
5023621|NCT03849937|Nonpharmacological treatment for Dementia|nonpharmacological treatment for dementia
5023623|NCT03849924|randomised controlled trial|randomised controlled trial
5023624|NCT03849924|intervention|intervention
5023628|NCT03849859|Plastic stent|plastic stent
5023629|NCT03849859|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5023630|NCT03849846|Low socioeconomic status population|low socioeconomic status population
5023631|NCT03849846|Web-based prospective cohort study|web-based prospective cohort study
5023632|NCT03849846|Focus groups|focus groups
5023633|NCT03849846|Recruitment|recruitment
5023634|NCT03849846|Behavioural beliefs|behavioural beliefs
5023635|NCT03849846|Normative beliefs|normative beliefs
5023636|NCT03849846|Control beliefs|control beliefs
5023637|NCT03849846|Security of data|security of data
5023638|NCT03849846|Use of data|use of data
5023639|NCT03849846|Share of data|share of data
5023640|NCT03849833|Vitamin D|vitamin d
5023641|NCT03849833|25(OH)D|25(oh)d
5023642|NCT03849833|vitamin D3 supplementation|vitamin d3 supplementation
5023643|NCT03849833|pigment genes|pigment genes
5023644|NCT03849820|Robotic-assisted Surgery|robotic-assisted surgery
5023645|NCT03849820|Open Surgery|open surgery
5023646|NCT03849820|Partial Nephrectomy|partial nephrectomy
5023651|NCT03849807|Children|children
5023652|NCT03849807|Chiropractic|chiropractic
5023653|NCT03849807|Neurological function|neurological function
5023654|NCT03849807|Quality of life|quality of life
5023655|NCT03849794|Chronic Stroke|chronic stroke
5023656|NCT03849794|Chiropractic Care|chiropractic care
5023657|NCT03849794|Physiotherapy|physiotherapy
5023658|NCT03849755|bolus advisor|bolus advisor
5023659|NCT03849729|Obesity|obesity
5023660|NCT03849729|Obesity treatment|obesity treatment
5023661|NCT03849729|Non-alcoholic Fatty Liver|non-alcoholic fatty liver
5023662|NCT03849729|Weight Loss|weight loss
5023663|NCT03849703|Adolescent parents|adolescent parents
5023664|NCT03849703|coparenting|coparenting
5023665|NCT03849703|romantic relationships|romantic relationships
5023666|NCT03849690|Drug Therapy|drug therapy
5023667|NCT03849677|uric acid|uric acid
5023668|NCT03849677|hemodynamic parameters|hemodynamic parameters
5023669|NCT03849677|endothelial function|endothelial function
5023670|NCT03849677|oxidative stress and inflammation|oxidative stress and inflammation
5023671|NCT03849677|vegan|vegan
5023672|NCT03849677|omnivore|omnivore
5023673|NCT03849664|postoperative cognitive decline|postoperative cognitive decline
5023674|NCT03849638|gait analysis|gait analysis
5023687|NCT03849534|Mixed dentition|mixed dentition
5023688|NCT03849534|Primary dentition|primary dentition
5023689|NCT03849534|Adolescents|adolescents
5023690|NCT03849534|Myalgia|myalgia
5023691|NCT03849534|Arthralgia of TMJ|arthralgia of tmj
5023692|NCT03849534|Treatment|treatment
5023693|NCT03849534|Side-effects|side-effects
5023694|NCT03849521|Atherosclerosis|atherosclerosis
5023695|NCT03849521|Calcium|calcium
5023697|NCT03849508|cesarean section complications|cesarean section complications
5023698|NCT03849508|spinal anesthesia|spinal anesthesia
5023699|NCT03849508|norepinephrine|norepinephrine
5023700|NCT03849508|maternal hemodynamic and cardiac output|maternal hemodynamic and cardiac output
5023701|NCT03849482|Fine Needle Aspiration Cytology|fine needle aspiration cytology
5023702|NCT03849482|Multiparametric Magnetic Resonance Imaging|multiparametric magnetic resonance imaging
5023703|NCT03849482|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5023704|NCT03849482|Dynamic Contrast-Enhanced Magnetic Resonance Imaging|dynamic contrast-enhanced magnetic resonance imaging
5023705|NCT03849469|DUET-4|duet-4
5023706|NCT03849469|Advanced solid tumors|advanced solid tumors
5718524|NCT00436670|IL-4|il-4
5023707|NCT03849469|Metastatic solid tumors|metastatic solid tumors
5023708|NCT03849469|Melanoma|melanoma
5023709|NCT03849469|Cervical Cancer|cervical cancer
5023710|NCT03849469|Pancreatic Cancer|pancreatic cancer
5023711|NCT03849469|Triple Negative Breast Cancer|triple negative breast cancer
5023714|NCT03849469|Renal Cell Cancer|renal cell cancer
5023715|NCT03849469|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5023716|NCT03849469|Non-small Cell Lung Cancer|non-small cell lung cancer
5023717|NCT03849469|Small Cell Lung Cancer|small cell lung cancer
5023719|NCT03849469|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5023720|NCT03849469|Lymphocyte-activation gene 3 (LAG3)|lymphocyte-activation gene 3 (lag3)
5023721|NCT03849469|Cytotoxic T-lymphocyte-associated protein 4 (CTLA4)|cytotoxic t-lymphocyte-associated protein 4 (ctla4)
5023722|NCT03849469|Prostate Cancer|prostate cancer
5023723|NCT03849469|MSI (microsatellite instability)-high tumors|msi (microsatellite instability)-high tumors
5023724|NCT03849469|MMR (mismatch repair)-deficient tumors|mmr (mismatch repair)-deficient tumors
5023725|NCT03849469|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5023726|NCT03849469|Epithelial ovarian cancer|epithelial ovarian cancer
5023727|NCT03849469|Fallopian tube cancer|fallopian tube cancer
5023728|NCT03849469|Primary peritoneal carcinoma|primary peritoneal carcinoma
5023729|NCT03849469|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5023730|NCT03849456|Cannabidivarin|cannabidivarin
5023731|NCT03849456|CBDV|cbdv
5023732|NCT03849456|GWP42006|gwp42006
5023733|NCT03849430|Low grade glioma|low grade glioma
5023734|NCT03849430|High grade glioma|high grade glioma
5023735|NCT03849430|HRQOL|hrqol
5023736|NCT03849417|Late-life depression|late-life depression
5023737|NCT03849417|Electroconvulsive therapy|electroconvulsive therapy
5023738|NCT03849417|Neuroimaging|neuroimaging
5023739|NCT03849417|Aging|aging
5023749|NCT03849274|Pressure Garment|pressure garment
5023750|NCT03849248|maternal scent|maternal scent
5023751|NCT03849248|infant behavior|infant behavior
5023752|NCT03849248|feeding patterns|feeding patterns
5023753|NCT03849248|stress levels|stress levels
5023754|NCT03849222|Open apex|open apex
5023755|NCT03849222|Immature teeth|immature teeth
5023756|NCT03849222|Non vital pulp|non vital pulp
5023757|NCT03849222|Apical plug|apical plug
5023758|NCT03849222|Internal matrix|internal matrix
5023759|NCT03849209|Pancreatic Solid Lesions|pancreatic solid lesions
5023760|NCT03849209|Fine-Needle Biopsy|fine-needle biopsy
5023761|NCT03849209|Stylet Slow-Pull Technique|stylet slow-pull technique
5023762|NCT03849209|Standard Suction|standard suction
5023763|NCT03849209|Endoscopic Ultrasound|endoscopic ultrasound
5023764|NCT03849183|Radial Artery|radial artery
5023765|NCT03849183|Vascular Catheters|vascular catheters
5023766|NCT03849170|cheerleading|cheerleading
5023767|NCT03849170|stress management|stress management
5023768|NCT03849170|injury prevention|injury prevention
5023769|NCT03849170|psychosocial factors|psychosocial factors
5023770|NCT03849170|stress-injury|stress-injury
5023771|NCT03849170|performance|performance
5023780|NCT03849131|patient reported outcome|patient reported outcome
5023781|NCT03849131|oncology|oncology
5023785|NCT03849105|glioblastoma multiforme (GBM),|glioblastoma multiforme (gbm),
5023786|NCT03849105|External Radiotherapy|external radiotherapy
5023787|NCT03849105|131I-IPA|131i-ipa
5023788|NCT03849079|Peanut Allergy|peanut allergy
5023789|NCT03849079|Skin Prick Test|skin prick test
5023790|NCT03849079|Oral Food Challenge|oral food challenge
5023791|NCT03849079|Hyponut|hyponut
5023792|NCT03849066|Neurological Impairment|neurological impairment
5023793|NCT03849066|Pediatric Complex Chronic Condition|pediatric complex chronic condition
5023794|NCT03849066|Children with Medical Complexity|children with medical complexity
5023795|NCT03849066|Pediatric Polypharmacy|pediatric polypharmacy
5023796|NCT03849053|Low back pain|low back pain
5023797|NCT03849053|Mézières method|mézières method
5023798|NCT03849053|Postural treatment|postural treatment
5023799|NCT03849053|Athletes|athletes
5023800|NCT03849040|endobronchial ultrasound|endobronchial ultrasound
5023801|NCT03849040|ultrasonographic features|ultrasonographic features
5023802|NCT03849040|artificial intelligence|artificial intelligence
5023906|NCT03848364|Community|community
5023812|NCT03849014|Comparative study|comparative study
5023813|NCT03849001|Exercise|exercise
5023814|NCT03848988|Chiropractic|chiropractic
5023815|NCT03848988|Screening tool|screening tool
5023816|NCT03848988|Teaching|teaching
5023817|NCT03848975|Simulation training|simulation training
5023818|NCT03848975|Obstetrics|obstetrics
5023819|NCT03848975|External cephalic version|external cephalic version
5023820|NCT03848975|Vacuum assisted delivery|vacuum assisted delivery
5023821|NCT03848936|adult cerebral palsy|adult cerebral palsy
5023822|NCT03848936|cerebral palsy|cerebral palsy
5023823|NCT03848936|functional status|functional status
5023824|NCT03848936|mental function|mental function
5023825|NCT03848923|Thrombocytopenia|thrombocytopenia
5023826|NCT03848923|Neonates|neonates
5023827|NCT03848923|Platelets|platelets
5023828|NCT03848923|NET Formation|net formation
5023829|NCT03848897|Virtual reality|virtual reality
5023830|NCT03848897|Human metrology|human metrology
5023831|NCT03848897|Motor behavior|motor behavior
5023832|NCT03848897|Modeling|modeling
5023834|NCT03848897|Parkinson's disease|parkinson's disease
5023836|NCT03848858|Psychological Trauma|psychological trauma
5023837|NCT03848858|Eye Movement Desensitization and Reprocessing Therapy|eye movement desensitization and reprocessing therapy
5423190|NCT01616784|Randomised controlled trial|randomised controlled trial
5023841|NCT03848832|Epidiolex|epidiolex
5023842|NCT03848832|GWP42003-P|gwp42003-p
5023845|NCT03848806|Psoriasis|psoriasis
5023846|NCT03848780|preconditioning|preconditioning
5023847|NCT03848780|hepatectomy|hepatectomy
5023848|NCT03848780|ischemia reperfusion injury|ischemia reperfusion injury
5023849|NCT03848728|HIV|hiv
5023850|NCT03848728|Adolescent|adolescent
5023851|NCT03848728|Young Adult|young adult
5023852|NCT03848728|Viral Load|viral load
5023853|NCT03848728|Counseling|counseling
5023854|NCT03848728|Costs and Cost Analysis|costs and cost analysis
5023855|NCT03848676|Multiple Myeloma|multiple myeloma
5023856|NCT03848676|Immunotherapies|immunotherapies
5023857|NCT03848676|Genomic|genomic
5023858|NCT03848676|Resistance|resistance
5023859|NCT03848663|Scotoma|scotoma
5023860|NCT03848663|Remapping|remapping
5023861|NCT03848663|Reading|reading
5023862|NCT03848663|Low vision|low vision
5023863|NCT03848663|Visual aid|visual aid
5023864|NCT03848650|FFR OCT LAD|ffr oct lad
5023865|NCT03848598|patellar|patellar
5023866|NCT03848598|ultrasound|ultrasound
5023867|NCT03848598|speckle|speckle
5023868|NCT03848598|isometric|isometric
5023869|NCT03848585|Immunosuppressants|immunosuppressants
5023870|NCT03848585|Treatment adherence|treatment adherence
5023871|NCT03848572|Dual Anti-platelet Therapy|dual anti-platelet therapy
5023872|NCT03848572|Bleeding|bleeding
5023873|NCT03848546|fiber intake|fiber intake
5023874|NCT03848546|personalized dietary advice|personalized dietary advice
5023875|NCT03848546|stool pattern|stool pattern
5023879|NCT03848533|Pre Diabetes|pre diabetes
5023880|NCT03848533|PreDiabetes|prediabetes
5023881|NCT03848533|Micronuclei|micronuclei
5023882|NCT03848533|Genotoxicity Markers|genotoxicity markers
5023883|NCT03848533|Cytotoxicity Markers|cytotoxicity markers
5023885|NCT03848494|gastroesophageal reflux disease|gastroesophageal reflux disease
5023886|NCT03848494|hiatus hernia|hiatus hernia
5023892|NCT03848468|Visual Analogue pain score|visual analogue pain score
5023893|NCT03848468|conventional Hemorrhoidectomy|conventional hemorrhoidectomy
5023894|NCT03848468|Ligasure Hemorrhoidectomy|ligasure hemorrhoidectomy
5023895|NCT03848455|Parkinson's disease|parkinson's disease
5023896|NCT03848455|synaptic correlation function|synaptic correlation function
5023897|NCT03848455|key gene|key gene
5023898|NCT03848377|Spine surgery|spine surgery
5023899|NCT03848377|Neuromonitoring|neuromonitoring
5023900|NCT03848377|Evoked potential|evoked potential
5023901|NCT03848377|electromyography|electromyography
5023902|NCT03848377|neurological injury|neurological injury
5023903|NCT03848364|Stroke|stroke
5023904|NCT03848364|Education|education
5023905|NCT03848364|Hip Hop Stroke|hip hop stroke
5023907|NCT03848364|Nutrition|nutrition
5023908|NCT03848364|Schools|schools
5023909|NCT03848364|Stroke Centers|stroke centers
5023910|NCT03848338|Cochlear Implant|cochlear implant
5023911|NCT03848338|Electrocochleography|electrocochleography
5023912|NCT03848325|adenosine|adenosine
5023913|NCT03848299|Glycemic responses|glycemic responses
5023914|NCT03848299|Microbiota|microbiota
5023915|NCT03848299|Personalized nutrition|personalized nutrition
5023916|NCT03848299|Digital cohort|digital cohort
5023917|NCT03848299|Citizen Science|citizen science
5023918|NCT03848286|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5023919|NCT03848273|stroke|stroke
5023920|NCT03848273|epilepsy|epilepsy
5023921|NCT03848273|seizure|seizure
5023923|NCT03848260|Lagophthalmos|lagophthalmos
5718525|NCT00436670|IL-4R|il-4r
5023924|NCT03848260|Incomplete eye closure|incomplete eye closure
5023925|NCT03848260|Magnetic device|magnetic device
5023926|NCT03848260|Blink restoration|blink restoration
5023927|NCT03848260|Facial nerve palsy|facial nerve palsy
5023928|NCT03848221|Systane Complete|systane complete
5023929|NCT03848221|Dry Eye|dry eye
5023930|NCT03848221|Contact Lens Discomfort|contact lens discomfort
5023931|NCT03848221|Artificial Tears|artificial tears
5023932|NCT03848221|Rewetting Drops|rewetting drops
5023933|NCT03848195|hip fractures|hip fractures
5023934|NCT03848195|adult|adult
5023935|NCT03848195|middle-aged|middle-aged
5023936|NCT03848195|DXA-scan|dxa-scan
5023937|NCT03848195|osteoporosis|osteoporosis
5023938|NCT03848182|T-cell responses|t-cell responses
5023939|NCT03848182|Pancreatic cancer|pancreatic cancer
5023940|NCT03848182|Gemcitabine|gemcitabine
5023941|NCT03848182|Perforin|perforin
5023942|NCT03848182|Granzyme-B|granzyme-b
5023943|NCT03848182|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
5023944|NCT03848130|Knee osteoarthritis|knee osteoarthritis
5023945|NCT03848130|Knee injury and Osteoarthritis Outcome Score|knee injury and osteoarthritis outcome score
5023946|NCT03848130|Rapid assessment of physical activity|rapid assessment of physical activity
5038619|NCT03757273|CAD/CAM|cad/cam
5023951|NCT03848117|Deep Transverse friction massage|deep transverse friction massage
5023952|NCT03848104|cefoxitin|cefoxitin
5023953|NCT03848104|Bone and Joint Infection|bone and joint infection
5023954|NCT03848091|bone and joint infection|bone and joint infection
5023955|NCT03848091|Antibiotic pretreatment|antibiotic pretreatment
5023956|NCT03848078|Basal Cell Carcinoma|basal cell carcinoma
5023957|NCT03848078|Optical Coherence Tomography|optical coherence tomography
5023958|NCT03848078|Punch biopsy|punch biopsy
5023959|NCT03848065|Pneumococcal Vaccines|pneumococcal vaccines
5023960|NCT03848052|lung cancer|lung cancer
5023961|NCT03848052|observational study|observational study
5023962|NCT03848052|survival|survival
5023963|NCT03848052|real world data|real world data
5023964|NCT03848052|real life setting|real life setting
5023965|NCT03848039|Cervical Cancer|cervical cancer
5023966|NCT03848039|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5023967|NCT03848039|Papillomavirus Vaccines|papillomavirus vaccines
5023968|NCT03848026|Otitis media|otitis media
5023969|NCT03848026|tympanostomy tube|tympanostomy tube
5023970|NCT03848026|viscosity|viscosity
5023971|NCT03848026|middle ear fluid|middle ear fluid
5023972|NCT03848000|Alcohol abuse|alcohol abuse
5023973|NCT03848000|Exercise|exercise
5023974|NCT03848000|Alcohol consumption|alcohol consumption
5023975|NCT03848000|Depression|depression
5023976|NCT03848000|Anxiety|anxiety
5023977|NCT03847961|sepsis|sepsis
5023978|NCT03847961|IL-6|il-6
5023979|NCT03847961|hemoperfusion|hemoperfusion
5023980|NCT03847935|treatment outcome|treatment outcome
5023981|NCT03847935|hand therapy|hand therapy
5023982|NCT03847935|physical therapy|physical therapy
5025804|NCT03837327|InterVenn|intervenn
5023988|NCT03847909|RNAi therapeutic|rnai therapeutic
5023989|NCT03847909|GalNAc|galnac
5023990|NCT03847909|LDHA gene|ldha gene
5023991|NCT03847909|LDH|ldh
5023992|NCT03847909|siRNA|sirna
5023993|NCT03847883|Ateplase|ateplase
5023994|NCT03847883|Intravenous recombinant tissue plasminogen activator|intravenous recombinant tissue plasminogen activator
5023995|NCT03847883|Acute is hemic stroke|acute is hemic stroke
5023996|NCT03847883|Low-dose Ateplase|low-dose ateplase
5023997|NCT03847883|rtPa|rtpa
5023998|NCT03847883|Modified Rankin 's Scale|modified rankin 's scale
5023999|NCT03847870|rickettsiae|rickettsiae
5024000|NCT03847870|seroprevalence|seroprevalence
5024001|NCT03847857|Esophageal Cancer|esophageal cancer
5024002|NCT03847857|Anastomotic Leak|anastomotic leak
5024003|NCT03847831|whole-school|whole-school
5024004|NCT03847831|health promotion|health promotion
5067182|NCT03578835|BSI|bsi
5018506|NCT03881111|Programmed Cell Death 1 (PD1)|programmed cell death 1 (pd1)
5018509|NCT03881098|Bronchoscopy|bronchoscopy
5024005|NCT03847805|Bouldering|bouldering
5024006|NCT03847805|Exercise|exercise
5024007|NCT03847805|Shoulder|shoulder
5024008|NCT03847805|Stability|stability
5024009|NCT03847805|Performance|performance
5024010|NCT03847779|vasomotion|vasomotion
5024011|NCT03847766|PRO-based follow-up, TelePRO|pro-based follow-up, telepro
5024012|NCT03847766|Outpatients, Chronic Kidney Disease|outpatients, chronic kidney disease
5024013|NCT03847753|Comorbidity|comorbidity
5024014|NCT03847727|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5024015|NCT03847727|Bendamustine Hydrochloride|bendamustine hydrochloride
5024016|NCT03847727|Rituximab|rituximab
5024017|NCT03847727|Maintenance|maintenance
5024018|NCT03847701|Slowly Digestible Starch|slowly digestible starch
5024019|NCT03847701|SDS|sds
5024020|NCT03847701|Type 2 diabetes|type 2 diabetes
5024021|NCT03847701|T2D|t2d
5024022|NCT03847701|Glycemic response|glycemic response
5024023|NCT03847701|Continuous Glucose Monitoring System|continuous glucose monitoring system
5024024|NCT03847701|CGMS|cgms
5024025|NCT03847701|Diet|diet
5024026|NCT03847701|MAGE|mage
5024027|NCT03847701|Mean Amplitude of Glucose Excursion|mean amplitude of glucose excursion
5024028|NCT03847688|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5024029|NCT03847688|Electroencephalography|electroencephalography
5024030|NCT03847688|Machine Learning|machine learning
5024031|NCT03847675|Reach out and Read|reach out and read
5024032|NCT03847675|Arabic literacy|arabic literacy
5024033|NCT03847675|Child development|child development
5024034|NCT03847662|Food Insecurity|food insecurity
5024035|NCT03847662|Stunting|stunting
5024036|NCT03847662|Wasting|wasting
5024037|NCT03847662|Underweight|underweight
5024038|NCT03847662|Anemia|anemia
5024039|NCT03847662|Complimentary Foods|complimentary foods
5024040|NCT03847662|Food Fortification|food fortification
5024041|NCT03847662|Complimentary Feeding|complimentary feeding
5024056|NCT03847571|Acetazolamide|acetazolamide
5024057|NCT03847571|Hypokalemic metabolic alkalosis|hypokalemic metabolic alkalosis
5024058|NCT03847571|Bartter syndrome|bartter syndrome
5024059|NCT03847545|Speckle tracking ultrasonography|speckle tracking ultrasonography
5024060|NCT03847545|Muscle strain|muscle strain
5024061|NCT03847545|Fampridine|fampridine
5024062|NCT03847545|Multiple Sclerosis|multiple sclerosis
5024063|NCT03847545|Neurological diseases|neurological diseases
5024064|NCT03847545|Biomarkers|biomarkers
5024065|NCT03847545|muscle contractility|muscle contractility
5024066|NCT03847532|MutYH-associated polyposis|mutyh-associated polyposis
5024067|NCT03847532|familial adenomatous polyposis|familial adenomatous polyposis
5024068|NCT03847532|biallelic mutation|biallelic mutation
5024069|NCT03847532|monoallelic mutation|monoallelic mutation
5024070|NCT03847532|colproctectomy|colproctectomy
5024071|NCT03847519|NSCLC Lung Cancer|nsclc lung cancer
5024072|NCT03847519|Metastatic Squamous Non-Small Cell Lung Cancer|metastatic squamous non-small cell lung cancer
5024073|NCT03847519|Metastatic Non-Squamous Cell Lung Cancer|metastatic non-squamous cell lung cancer
5024074|NCT03847493|perfused boundary region|perfused boundary region
5024075|NCT03847493|PBR|pbr
5024076|NCT03847493|Sepsis|sepsis
5024077|NCT03847493|endothelial glycocalyx|endothelial glycocalyx
5024078|NCT03847493|ICU|icu
5024079|NCT03847480|Dose painting|dose painting
5024080|NCT03847480|18F-FDG|18f-fdg
5024081|NCT03847480|Positron emission tomography|positron emission tomography
5024082|NCT03847480|Radiotherapy|radiotherapy
5024083|NCT03847441|Alopecia Areata|alopecia areata
5024084|NCT03847441|Calcipotriol|calcipotriol
5024085|NCT03847441|Narrow Band-UVB|narrow band-uvb
5024086|NCT03847441|Vitamin D3|vitamin d3
5024087|NCT03847428|Early stage HCC|early stage hcc
5024088|NCT03847428|Durvalumab|durvalumab
5024089|NCT03847428|Bevacizumab|bevacizumab
5024099|NCT03847298|physical activity|physical activity
5024100|NCT03847298|physical fitness|physical fitness
5024101|NCT03847285|Transplant|transplant
5024102|NCT03847285|Infection|infection
5024103|NCT03847285|rejection|rejection
5024104|NCT03847285|immunology|immunology
5024105|NCT03847233|Superficial Femoral Artery|superficial femoral artery
5024412|NCT03845413|women|women
5024108|NCT03847233|Atherectomy|atherectomy
5024109|NCT03847220|metastatic breast cancer|metastatic breast cancer
5024110|NCT03847220|bone metastasis|bone metastasis
5024111|NCT03847220|quality of life|quality of life
5024112|NCT03847220|psychometric|psychometric
5018602|NCT03880539|Clostridium Difficile|clostridium difficile
5018603|NCT03880539|recurrence|recurrence
5024113|NCT03847220|treatment|treatment
5024114|NCT03847220|assessments|assessments
5024115|NCT03847207|First in Human|first in human
5024116|NCT03847207|Single Ascending Dose|single ascending dose
5024117|NCT03847181|Oral anticoagulants|oral anticoagulants
5024118|NCT03847181|Under-dosing|under-dosing
5024119|NCT03847181|Stroke prevention in atrial fibrillation|stroke prevention in atrial fibrillation
5024121|NCT03847181|Effectiveness|effectiveness
5718526|NCT00436657|Children|children
5024128|NCT03847142|asthma|asthma
5024129|NCT03847103|Stroke|stroke
5024130|NCT03847103|Robotic-Assisted Therapy|robotic-assisted therapy
5024131|NCT03847103|Bilateral Practice|bilateral practice
5038816|NCT03755869|Non-squamous NSCLC|non-squamous nsclc
5024142|NCT03847051|Multicontrast EPI (echo planar imaging)|multicontrast epi (echo planar imaging)
5024143|NCT03847051|Clinical validation|clinical validation
5024145|NCT03847025|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5024146|NCT03847025|Lead extraction|lead extraction
5024147|NCT03847012|coronary artery disease|coronary artery disease
5024148|NCT03847012|blood pressure|blood pressure
5024149|NCT03847012|rehabilitation|rehabilitation
5024150|NCT03847012|exercise mode|exercise mode
5024151|NCT03846999|breast cancer|breast cancer
5024152|NCT03846999|comorbidities|comorbidities
5024153|NCT03846999|healthcare services research|healthcare services research
5024154|NCT03846999|survival|survival
5024155|NCT03846986|Apple pomace fiber|apple pomace fiber
5024156|NCT03846986|Glycemic response|glycemic response
5024157|NCT03846986|Apple|apple
5024158|NCT03846973|Trauma, Mortality, Tranexamic , Prehospital|trauma, mortality, tranexamic , prehospital
5024161|NCT03846934|Pleural Effusion|pleural effusion
5024162|NCT03846934|Ultrasonography|ultrasonography
5024163|NCT03846934|Thoracic|thoracic
5024164|NCT03846934|Acute Respiratory Failure|acute respiratory failure
5024165|NCT03846934|Emergencies|emergencies
5024166|NCT03846882|PET/MR|pet/mr
5024167|NCT03846882|PET/CT|pet/ct
5024168|NCT03846882|FDG|fdg
5024169|NCT03846882|Staging|staging
5024170|NCT03846869|Fluid Therapy|fluid therapy
5024171|NCT03846869|Anesthesia|anesthesia
5024172|NCT03846869|Renal Transplantation|renal transplantation
5024173|NCT03846843|Cirrhosis|cirrhosis
5024174|NCT03846843|Ornithine phenylacetate|ornithine phenylacetate
5024175|NCT03846843|OCR-002|ocr-002
5024176|NCT03846830|gaze stability|gaze stability
5024177|NCT03846830|balance|balance
5024178|NCT03846830|vestibulo-ocular reflex (VOR) gain|vestibulo-ocular reflex (vor) gain
5024179|NCT03846830|dizzy|dizzy
5024180|NCT03846804|infection|infection
5024181|NCT03846804|plasma based next generation sequencing|plasma based next generation sequencing
5024182|NCT03846804|blood culture|blood culture
5024183|NCT03846804|tissue culture|tissue culture
5024184|NCT03846804|joint fluid culture|joint fluid culture
5024185|NCT03846804|pathogen identification|pathogen identification
5024186|NCT03846778|Postoperative outcomes|postoperative outcomes
5024187|NCT03846778|Laparoscopy|laparoscopy
5024188|NCT03846778|Comprehensive complication index|comprehensive complication index
5024189|NCT03846778|Postoperative complications|postoperative complications
5024190|NCT03846765|spinal oxygenation|spinal oxygenation
5024191|NCT03846765|NIRS|nirs
5024192|NCT03846752|Transradial Intervention|transradial intervention
5024193|NCT03846752|transfemoral intervention|transfemoral intervention
5024194|NCT03846752|PCI for complex coronary lesions|pci for complex coronary lesions
5024195|NCT03846739|amygdala|amygdala
5024196|NCT03846739|reward|reward
5024197|NCT03846739|oxytocin|oxytocin
5024201|NCT03846726|Rectal Cancer|rectal cancer
5024202|NCT03846726|clinical complete response|clinical complete response
5024203|NCT03846713|double-lumen tube|double-lumen tube
5024204|NCT03846713|intubation|intubation
5024207|NCT03846635|Cellulitis|cellulitis
5024208|NCT03846635|Temperature|temperature
5024209|NCT03846635|Venous Stasis|venous stasis
5024210|NCT03846635|Lymphedema|lymphedema
5024211|NCT03846609|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5024212|NCT03846596|Sepsis|sepsis
5024213|NCT03846596|reactive oxygen species|reactive oxygen species
5024214|NCT03846596|immature neutrophils|immature neutrophils
5024215|NCT03846583|Breast Cancer|breast cancer
5024216|NCT03846570|Randomized Controlled Trial|randomized controlled trial
5024217|NCT03846570|Inhaled corticosteroids|inhaled corticosteroids
5024218|NCT03846570|Placebo|placebo
5024219|NCT03846570|Cough|cough
5024220|NCT03846557|TAVI|tavi
5024221|NCT03846557|Valve|valve
5024222|NCT03846531|Nano-Pulse Stimulation|nano-pulse stimulation
5024223|NCT03846531|Seborrheic Keratosis|seborrheic keratosis
5024224|NCT03846518|palatal expansion technique|palatal expansion technique
5024225|NCT03846518|adolescent|adolescent
5024226|NCT03846518|quality of life|quality of life
5024227|NCT03846505|Couple|couple
5024228|NCT03846505|Alcohol|alcohol
5018696|NCT03880110|Biomarker|biomarker
5018697|NCT03880110|Urine sedimentation|urine sedimentation
5018699|NCT03880071|Psychiatry|psychiatry
5024229|NCT03846505|Therapy|therapy
5024230|NCT03846492|Dementia|dementia
5024231|NCT03846492|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5024232|NCT03846492|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5024233|NCT03846492|tDCS|tdcs
5024235|NCT03846492|TMS-EEG|tms-eeg
5024236|NCT03846492|MRI|mri
5024237|NCT03846492|Agitation|agitation
5024238|NCT03846492|Alzheimer's disease|alzheimer's disease
5024239|NCT03846492|Neuropsychiatric symptoms|neuropsychiatric symptoms
5024240|NCT03846492|Agitation in dementia|agitation in dementia
5024241|NCT03846492|Mixed dementia|mixed dementia
5024242|NCT03846492|Non-invasive brain stimulation|non-invasive brain stimulation
5024243|NCT03846479|Graft-versus-host disease|graft-versus-host disease
5024244|NCT03846479|Itacitinib|itacitinib
5024245|NCT03846440|Protein intake|protein intake
5024246|NCT03846440|Older adults|older adults
5024247|NCT03846440|Mexican adults|mexican adults
5024248|NCT03846440|Functionality|functionality
5024251|NCT03846414|PEG-rhG-CSF|peg-rhg-csf
5024252|NCT03846414|Pegfilgrastim|pegfilgrastim
5024253|NCT03846375|Emotional Dysregulation|emotional dysregulation
5024254|NCT03846375|Emotional regulation|emotional regulation
5024255|NCT03846375|Dialectical Behavioral Therapy|dialectical behavioral therapy
5024256|NCT03846375|para-suicidal behavior|para-suicidal behavior
5024257|NCT03846362|AML|aml
5024258|NCT03846362|MRD|mrd
5024259|NCT03846362|stem cell transplantation|stem cell transplantation
5024260|NCT03846362|pediatric|pediatric
5024261|NCT03846362|leukemia|leukemia
5024262|NCT03846362|haploidentical|haploidentical
5024263|NCT03846362|TcRab-depletion|tcrab-depletion
5024264|NCT03846362|young adult|young adult
5024265|NCT03846336|Multiple Sclerosis|multiple sclerosis
5024266|NCT03846336|Upper Extremity Function|upper extremity function
5024267|NCT03846336|Position Sense|position sense
5024268|NCT03846323|Posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5024269|NCT03846323|ICU|icu
5024270|NCT03846323|visiting hours policies|visiting hours policies
5024271|NCT03846297|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5024272|NCT03846297|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5024273|NCT03846284|Sevoflurane-|sevoflurane-
5024274|NCT03846284|Emergence agitation|emergence agitation
5024275|NCT03846284|Magnesium sulfate|magnesium sulfate
5024276|NCT03846284|Children|children
5024277|NCT03846271|Oxytocin|oxytocin
5024278|NCT03846271|performance monitoring|performance monitoring
5024279|NCT03846271|reinforcement learning|reinforcement learning
5024280|NCT03846219|RRMS|rrms
5024281|NCT03846219|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5024282|NCT03846206|Microbiota.|microbiota.
5024283|NCT03846206|Mediterranean Diet|mediterranean diet
5024284|NCT03846206|Bacterial Traslocation|bacterial traslocation
5024285|NCT03846193|Dry AMD|dry amd
5024286|NCT03846193|AMD|amd
5024287|NCT03846193|Atrophic AMD|atrophic amd
5024288|NCT03846193|Geographic Atrophy (GA)|geographic atrophy (ga)
5024289|NCT03846102|Fascia Iliaca Compartment Block|fascia iliaca compartment block
5024290|NCT03846102|Peripheral Nerve Block|peripheral nerve block
5024291|NCT03846102|Elderly|elderly
5024292|NCT03846102|Hip fracture|hip fracture
5024293|NCT03846102|Levobupivacaïne|levobupivacaïne
5024294|NCT03846102|Morphine|morphine
5024295|NCT03846102|Emergency Physician|emergency physician
5024296|NCT03846102|Emergency department|emergency department
5024297|NCT03846102|Ultrasound|ultrasound
5024298|NCT03846102|Pain score|pain score
5024304|NCT03846063|Home-based rehabilitation program|home-based rehabilitation program
5024305|NCT03846050|alcohol impaired driving|alcohol impaired driving
5024314|NCT03846024|PelvicBinder|pelvicbinder
5024315|NCT03846024|Rib Fractures|rib fractures
5024317|NCT03846024|Pulmonary toilet|pulmonary toilet
5335545|NCT02014870|Virus|virus
5024318|NCT03846024|Incentive Spirometry|incentive spirometry
5024319|NCT03846011|urolithiasis|urolithiasis
5024320|NCT03846011|24-h urine composition|24-h urine composition
5024325|NCT03845985|psychotherapy|psychotherapy
5024327|NCT03845985|addiction|addiction
5024328|NCT03845985|Deaf|deaf
5024329|NCT03845894|Shoulder Surgery|shoulder surgery
5024330|NCT03845894|Interscalene Nerve Block|interscalene nerve block
5024331|NCT03845894|Liposomal Bupivacaine|liposomal bupivacaine
5024332|NCT03845894|Shoulder pain|shoulder pain
5024333|NCT03845894|Regional anesthesia|regional anesthesia
5024334|NCT03845894|Brachial plexus blockade|brachial plexus blockade
5024335|NCT03845855|virtual reality|virtual reality
5024336|NCT03845855|stroke|stroke
5024337|NCT03845855|dual task|dual task
5024338|NCT03845842|Cannabis|cannabis
5024339|NCT03845842|Risk reduction|risk reduction
5074080|NCT03536143|DEB|deb
5024340|NCT03845803|Sit/stand workstation|sit/stand workstation
5024341|NCT03845803|Office workers|office workers
5024342|NCT03845803|Sedentary behaviour|sedentary behaviour
5024343|NCT03845803|Sitting time|sitting time
5024344|NCT03845803|Musculoskeletal disorder|musculoskeletal disorder
5024345|NCT03845777|Iodine|iodine
5024346|NCT03845777|Surgical|surgical
5024347|NCT03845777|Staff|staff
5024348|NCT03845777|Antiseptic|antiseptic
5024349|NCT03845751|HIFU|hifu
5024351|NCT03845751|focal therapy|focal therapy
5024352|NCT03845738|OsseoSpeed|osseospeed
5024353|NCT03845738|EV|ev
5024354|NCT03845699|Opioid Overdose|opioid overdose
5024355|NCT03845699|Diagnostic Algorithm|diagnostic algorithm
5024356|NCT03845699|Wearable Trachea Sound Sensor|wearable trachea sound sensor
5024357|NCT03845699|Respiratory Depression|respiratory depression
5024358|NCT03845699|Hypoventilation|hypoventilation
5024359|NCT03845686|stroke|stroke
5024360|NCT03845686|reading|reading
5024361|NCT03845686|fMRI|fmri
5024362|NCT03845686|perfusion|perfusion
5024363|NCT03845686|activation|activation
5024364|NCT03845686|BOLD|bold
5024365|NCT03845686|recovery|recovery
5024366|NCT03845686|subacute|subacute
5024367|NCT03845686|chronic|chronic
5024368|NCT03845673|Bowel recipe|bowel recipe
5024369|NCT03845673|Bristol stool form scale|bristol stool form scale
5024370|NCT03845673|Konsyl|konsyl
5024371|NCT03845673|psyllium|psyllium
5024372|NCT03845673|wheat bran|wheat bran
5024373|NCT03845660|Heart Failure|heart failure
5024374|NCT03845660|Prognosis|prognosis
5024375|NCT03845660|Electronic Alerts|electronic alerts
5024376|NCT03845647|lymph node dissection|lymph node dissection
5024377|NCT03845647|differentiated thyroid carcinoma|differentiated thyroid carcinoma
5024378|NCT03845634|Non-motor fluctuation|non-motor fluctuation
5024379|NCT03845595|Cortical excitability sequential change|cortical excitability sequential change
5024380|NCT03845595|Transcranial Magnetic stimulation|transcranial magnetic stimulation
5024381|NCT03845595|Recommended number of sessions|recommended number of sessions
5024382|NCT03845595|Upper limb motor performance|upper limb motor performance
5024383|NCT03845569|Amino acids|amino acids
5024384|NCT03845569|Protein|protein
5024385|NCT03845569|metabolism|metabolism
5024386|NCT03845569|IAAO|iaao
5024387|NCT03845569|Tracer|tracer
5024388|NCT03845569|Indicator amino acid|indicator amino acid
5024389|NCT03845569|Resistance trained|resistance trained
5024394|NCT03845478|Obesity|obesity
5024395|NCT03845478|Physical Activity|physical activity
5024396|NCT03845478|Fat mass|fat mass
5024397|NCT03845478|Fat free mass|fat free mass
5024398|NCT03845478|Pedometer|pedometer
5024399|NCT03845478|mHealth|mhealth
5024400|NCT03845452|chronic kidney disease|chronic kidney disease
5024401|NCT03845452|muscle strength|muscle strength
5024402|NCT03845452|muscle mass|muscle mass
5024403|NCT03845452|lean body mass|lean body mass
5024404|NCT03845452|physical activity|physical activity
5024405|NCT03845439|tau|tau
5024406|NCT03845439|post mortem interval|post mortem interval
5024407|NCT03845439|cerebrospinal fluid|cerebrospinal fluid
5024408|NCT03845439|immunoassay|immunoassay
5024409|NCT03845439|biomarker|biomarker
5024410|NCT03845439|forensic medicine|forensic medicine
5024411|NCT03845413|tobacco cessation|tobacco cessation
5024413|NCT03845413|capacity building|capacity building
5024414|NCT03845361|Perfusion index|perfusion index
5024424|NCT03845309|Nutritional intervention|nutritional intervention
5024426|NCT03845309|Self-Care Behavior|self-care behavior
5024427|NCT03845283|Cardiovascular Diseases|cardiovascular diseases
5024428|NCT03845283|Obesity|obesity
5024429|NCT03845283|Multiphase Optimization Strategy|multiphase optimization strategy
5024430|NCT03845283|Technology|technology
5024431|NCT03845283|Weight Loss|weight loss
5024432|NCT03845283|Cardiac Rehabilitation|cardiac rehabilitation
5024434|NCT03845270|NSCLC|nsclc
5024435|NCT03845270|HER2|her2
5024436|NCT03845244|high flow nasal cannula|high flow nasal cannula
5024437|NCT03845244|weaning|weaning
5024438|NCT03845244|adult|adult
5024439|NCT03845231|Intranasal Vaccination|intranasal vaccination
5024440|NCT03845231|Influenza Vaccination|influenza vaccination
5024441|NCT03845231|Human Challenge|human challenge
5024442|NCT03845231|Vaccine|vaccine
5024443|NCT03845231|Mucosal IgA|mucosal iga
5024444|NCT03845231|Antibody|antibody
5024445|NCT03845231|Systemic IgG|systemic igg
5024446|NCT03845231|Challenge Study|challenge study
5024447|NCT03845231|Healthy Volunteer|healthy volunteer
5024448|NCT03845231|Immune Response|immune response
5024449|NCT03845218|Retina|retina
5024450|NCT03845218|Imaging|imaging
5024451|NCT03845218|Psychophysics|psychophysics
5024452|NCT03845218|Functional Outcome Measures|functional outcome measures
5024453|NCT03845205|Alcohol treatment|alcohol treatment
5024454|NCT03845205|Liver transplant|liver transplant
5024455|NCT03845205|Motivational intervention|motivational intervention
5024456|NCT03845205|Cognitive-behavioral therapy|cognitive-behavioral therapy
5024457|NCT03845153|Bone Fracture|bone fracture
5024458|NCT03845153|Post-Menopausal Women|post-menopausal women
5024459|NCT03845153|Metformin|metformin
5024460|NCT03845153|Irisin|irisin
5024461|NCT03845140|Schistosomiasis|schistosomiasis
5024462|NCT03845140|Children|children
5024463|NCT03845140|L-praziquantel|l-praziquantel
5024464|NCT03845140|Biltricide®|biltricide®
5024465|NCT03845127|Ischemic Cardiomyopathy, Heart Failure, Revivent TC System|ischemic cardiomyopathy, heart failure, revivent tc system
5024466|NCT03845114|Type 1 diabetes|type 1 diabetes
5024467|NCT03845114|Exercise|exercise
5024468|NCT03845114|Hypoglycemia|hypoglycemia
5024469|NCT03845101|Social anxiety|social anxiety
5024470|NCT03845101|Virtual Reality|virtual reality
5024471|NCT03845101|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5024473|NCT03845101|Social Phobia|social phobia
5024474|NCT03845088|Virtual mandibular position; temporomandibular joint reconstruction; Jaw deformity;Costochondral graft|virtual mandibular position; temporomandibular joint reconstruction; jaw deformity;costochondral graft
5024475|NCT03845062|drug-induced sleep endoscopy|drug-induced sleep endoscopy
5024476|NCT03845062|pediatric obstructive sleep apnea hypopnea syndrome|pediatric obstructive sleep apnea hypopnea syndrome
5024477|NCT03845062|tongue base|tongue base
5024478|NCT03845062|epiglottis|epiglottis
5024479|NCT03845062|occult laryngomalacia|occult laryngomalacia
5024480|NCT03845062|lingual tonsillectomy|lingual tonsillectomy
5024481|NCT03845062|epiglottopexy|epiglottopexy
5024482|NCT03845062|aryepiglottic folds division|aryepiglottic folds division
5024483|NCT03844971|Arthrocentesis|arthrocentesis
5024484|NCT03844971|Computer assisted surgery|computer assisted surgery
5024485|NCT03844971|Anterior disc displacement with reduction|anterior disc displacement with reduction
5024486|NCT03844958|Red furu|red furu
5024487|NCT03844958|Metabolism|metabolism
5024488|NCT03844958|Randomized|randomized
5024489|NCT03844945|Glaucoma|glaucoma
5024490|NCT03844945|Ocular Hypertension|ocular hypertension
5024491|NCT03844945|Open-Angle Glaucoma|open-angle glaucoma
5024492|NCT03844919|Children|children
5024493|NCT03844919|Adolescent|adolescent
5024494|NCT03844919|CBIT|cbit
5024495|NCT03844919|Transcranial magnetic stimulation|transcranial magnetic stimulation
5024496|NCT03844919|Comprehensive Behavioral Intervention for Tics|comprehensive behavioral intervention for tics
5024497|NCT03844919|rTMS|rtms
5024499|NCT03844919|MRI|mri
5024500|NCT03844919|Tourette's Syndrome|tourette's syndrome
5024501|NCT03844880|Chronic Pain|chronic pain
5024502|NCT03844880|Psychotherapy|psychotherapy
5024503|NCT03844880|Musculoskeletal Disease|musculoskeletal disease
5024504|NCT03844854|Sonoelastography|sonoelastography
5024505|NCT03844854|Elastography|elastography
5024506|NCT03844854|Shear-wave|shear-wave
5024507|NCT03844854|Masseter muscle|masseter muscle
5024508|NCT03844854|Temporomandibular disorders|temporomandibular disorders
5024509|NCT03844841|Atrial Fibrillation|atrial fibrillation
5024510|NCT03844841|Ablation|ablation
5024511|NCT03844841|Sedation|sedation
5024512|NCT03844841|Anesthesia|anesthesia
5024520|NCT03844802|trigger points|trigger points
5024521|NCT03844802|dry needling|dry needling
5024522|NCT03844802|physical therapy|physical therapy
5024529|NCT03844776|dry socket|dry socket
5024530|NCT03844776|bleeding|bleeding
5024531|NCT03844776|swelling|swelling
5024532|NCT03844763|Immunotherapy|immunotherapy
5024533|NCT03844763|Avelumab|avelumab
5024534|NCT03844763|Head and neck cancer|head and neck cancer
5024535|NCT03844763|Radiotherapy|radiotherapy
5024536|NCT03844763|Cyclophosphamide|cyclophosphamide
5024537|NCT03844724|Peripheral Arterial Disease|peripheral arterial disease
5024538|NCT03844724|Drug-eluting PTA Balloon Dilatation Catheter|drug-eluting pta balloon dilatation catheter
5024539|NCT03844724|Late Lumen Loss（6 months）|late lumen loss（6 months）
5024540|NCT03844711|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5024541|NCT03844711|Electrical Stimulation|electrical stimulation
5024542|NCT03844711|Respiratory Muscle Training|respiratory muscle training
5024543|NCT03844698|sarcoidosis, cancer, paraneoplastic, treatment, outcome|sarcoidosis, cancer, paraneoplastic, treatment, outcome
5024544|NCT03844633|lactation|lactation
5024545|NCT03844633|Depo Provera|depo provera
5024546|NCT03844633|contraception|contraception
5024547|NCT03844594|Acute Ischemic Stroke|acute ischemic stroke
5024548|NCT03844594|Eptifibatide|eptifibatide
5024549|NCT03844594|Endovascular Treatment|endovascular treatment
5024550|NCT03844594|Recovery of Dysfunction|recovery of dysfunction
5024551|NCT03844568|aspiration pneumonia|aspiration pneumonia
5024552|NCT03844568|continuous positive airway pressure, CPAP|continuous positive airway pressure, cpap
5024553|NCT03844516|Chronotropic incompetence|chronotropic incompetence
5024555|NCT03844516|heart rate|heart rate
5024556|NCT03844516|exercise|exercise
5024557|NCT03844516|peak oxygen uptake|peak oxygen uptake
5024558|NCT03844503|Cereal bar|cereal bar
5024559|NCT03844503|Fiber|fiber
5024560|NCT03844503|Resistant Starch|resistant starch
5024561|NCT03844503|Glycemic Response|glycemic response
5024562|NCT03844503|Insulin Response|insulin response
5024563|NCT03844490|Postpartum Hemorrhage|postpartum hemorrhage
5024564|NCT03844490|Neonatal jaundice|neonatal jaundice
5024565|NCT03844490|Umbilical cord|umbilical cord
5024566|NCT03844451|Exparel, liposomal bupivacaine, postoperative, pain control|exparel, liposomal bupivacaine, postoperative, pain control
5024569|NCT03844425|Colony Count, Microbial|colony count, microbial
5024571|NCT03844412|Lidocaine|lidocaine
5024572|NCT03844412|Estradiol|estradiol
5024573|NCT03844412|Nortriptyline|nortriptyline
5024574|NCT03844412|Chronic pain|chronic pain
5024575|NCT03844399|Diagnostic|diagnostic
5024576|NCT03844399|Intervention|intervention
5024577|NCT03844399|3D Ultrasound|3d ultrasound
5024578|NCT03844386|HIV-1|hiv-1
5024579|NCT03844386|Infection|infection
5024580|NCT03844386|Suppressed|suppressed
5024582|NCT03844386|Vaccines|vaccines
5024583|NCT03844386|Alone|alone
5024584|NCT03844386|Combination|combination
5024585|NCT03844386|Immunogenicity|immunogenicity
5024586|NCT03844347|Colorectal cancer|colorectal cancer
5024587|NCT03844347|Well-being|well-being
5024588|NCT03844347|Stress|stress
5024589|NCT03844347|Recovery|recovery
5024590|NCT03844295|stimulation|stimulation
5024591|NCT03844295|hypoglossal nerve|hypoglossal nerve
5024592|NCT03844295|Upper-airway|upper-airway
5024593|NCT03844282|Concussion|concussion
5024594|NCT03844282|mTBI|mtbi
5024595|NCT03844282|mild traumatic brain injury|mild traumatic brain injury
5024596|NCT03844282|motorsport|motorsport
5024597|NCT03844282|motor sport|motor sport
5024598|NCT03844282|racing|racing
5024599|NCT03844269|ADHD|adhd
5024600|NCT03844269|Inattention|inattention
5024601|NCT03844256|Immunotherapy|immunotherapy
5024602|NCT03844256|Chemoradiotherapy|chemoradiotherapy
5024603|NCT03844256|Nivolumab|nivolumab
5024604|NCT03844256|Ipilimumab|ipilimumab
5024605|NCT03844256|bladder sparing treatment|bladder sparing treatment
5024606|NCT03844243|NGF-induced hyperalgesia|ngf-induced hyperalgesia
5024607|NCT03844243|Exercise-induced ischemic pain|exercise-induced ischemic pain
5024608|NCT03844243|Pain modulation|pain modulation
5024609|NCT03844243|NGF pain model|ngf pain model
5024610|NCT03844230|sweeteners|sweeteners
5024611|NCT03844230|glucose metabolism|glucose metabolism
5024612|NCT03844230|taste receptors|taste receptors
5024613|NCT03844230|sucralose|sucralose
5024614|NCT03844217|Copeptin|copeptin
5024615|NCT03844217|Macimorelin|macimorelin
5024616|NCT03844217|Ghrelin receptor agonist|ghrelin receptor agonist
5024617|NCT03844217|posterior pituitary gland|posterior pituitary gland
5024618|NCT03844217|polyuria-polydipsia syndrome|polyuria-polydipsia syndrome
5024619|NCT03844217|hypothalamo-pituitary-adrenal axis|hypothalamo-pituitary-adrenal axis
5024620|NCT03844152|fermented whey|fermented whey
5024621|NCT03844152|microbiota|microbiota
5024637|NCT03844035|periimplant mucositis|periimplant mucositis
5024638|NCT03843996|Stratamed|stratamed
5024639|NCT03843996|wound healing|wound healing
5024640|NCT03843996|follicular unit extraction hair transplantation|follicular unit extraction hair transplantation
5024641|NCT03843983|Meibomian gland dysfunction|meibomian gland dysfunction
5024642|NCT03843983|Lipiflow|lipiflow
5024643|NCT03843983|Meibum composition|meibum composition
5024644|NCT03843983|Adverse environmental conditions|adverse environmental conditions
5024645|NCT03843983|Dry eye disease|dry eye disease
5024646|NCT03843970|Hip fracture, Subarachnoid block|hip fracture, subarachnoid block
5024647|NCT03843957|Mortality|mortality
5024648|NCT03843957|Cancer Screening|cancer screening
5024649|NCT03843957|Cancer Intervention|cancer intervention
5024650|NCT03843957|Mobile Health|mobile health
5024651|NCT03843957|Implementation Science|implementation science
5024652|NCT03843944|IMAO-B|imao-b
5024653|NCT03843944|Safinamide|safinamide
5024658|NCT03843918|Prostate Cancer|prostate cancer
5024659|NCT03843905|Gut microbiota|gut microbiota
5024660|NCT03843905|Colorectal cancer|colorectal cancer
5024662|NCT03843905|Metabolic syndrome|metabolic syndrome
5024663|NCT03843905|Prognostic factors|prognostic factors
5024664|NCT03843905|Pathogenic E.coli|pathogenic e.coli
5024665|NCT03843814|MRI (Magnetic Resonance Imaging) of the brain|mri (magnetic resonance imaging) of the brain
5024666|NCT03843814|Amide Proton Transfer (APT)|amide proton transfer (apt)
5039302|NCT03752788|Stroke|stroke
5024677|NCT03843762|Actigraphy|actigraphy
5024678|NCT03843762|Psychiatric Health|psychiatric health
5024680|NCT03843749|Pyrotinib|pyrotinib
5024681|NCT03843749|Trastuzumab|trastuzumab
5024682|NCT03843749|Metastatic Colorectal Cancar|metastatic colorectal cancar
5024683|NCT03843736|Polycystic Ovary Syndrome|polycystic ovary syndrome
5024684|NCT03843736|Metagenomics|metagenomics
5024685|NCT03843736|Metabonomics|metabonomics
5024686|NCT03843723|Pre-flight evaluation|pre-flight evaluation
5024687|NCT03843723|Air travel|air travel
5024688|NCT03843723|Pulseoximetry|pulseoximetry
5024689|NCT03843723|Exercise desaturation|exercise desaturation
5024690|NCT03843723|Hypobaria|hypobaria
5024691|NCT03843723|Hypoxemia|hypoxemia
5024692|NCT03843710|Neurodegeneration|neurodegeneration
5024693|NCT03843710|gold|gold
5024694|NCT03843710|nanocrystal|nanocrystal
5024695|NCT03843710|NAD+|nad+
5024696|NCT03843710|NADH|nadh
5024697|NCT03843710|Redox|redox
5024698|NCT03843710|Redox Ratio|redox ratio
5024699|NCT03843710|ALS|als
5024700|NCT03843710|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5024701|NCT03843710|31P-MRS|31p-mrs
5024702|NCT03843710|MRS|mrs
5024703|NCT03843710|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5024704|NCT03843710|nanoparticle|nanoparticle
5024705|NCT03843710|nanomedicine|nanomedicine
5024706|NCT03843671|Hyperbaric oxygen; HNSCC; Radiotherapy; Chemotherapy|hyperbaric oxygen; hnscc; radiotherapy; chemotherapy
5024707|NCT03843645|anesthesia, general|anesthesia, general
5024708|NCT03843645|anesthesia, regional|anesthesia, regional
5024709|NCT03843645|sleep disorder|sleep disorder
5024710|NCT03843645|REM stage|rem stage
5024717|NCT03843580|Apnea oxygenation|apnea oxygenation
5024718|NCT03843580|Suspension laryngoscopy|suspension laryngoscopy
5024719|NCT03843580|General Anesthesia|general anesthesia
5024720|NCT03843580|Oxygenation apnea|oxygenation apnea
5024732|NCT03843541|ambroxol hydrochloride|ambroxol hydrochloride
5024733|NCT03843541|bronchitis|bronchitis
5024734|NCT03843541|cystic fibrosis|cystic fibrosis
5024735|NCT03843541|fibrosis bronchiectasis|fibrosis bronchiectasis
5024736|NCT03843541|increased sputum viscosity|increased sputum viscosity
5024737|NCT03843541|cough|cough
5024738|NCT03843541|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5024739|NCT03843515|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5024740|NCT03843515|nivolumab|nivolumab
5024741|NCT03843515|PD-L1|pd-l1
5024742|NCT03843515|PET/CT|pet/ct
5024743|NCT03843515|neoadjuvant|neoadjuvant
5024748|NCT03843450|circulating tumor cells,WBCs adhesion, biomedical materials|circulating tumor cells,wbcs adhesion, biomedical materials
5024752|NCT03843411|mini-fluid challenge|mini-fluid challenge
5024753|NCT03843398|Colorectal Cancer|colorectal cancer
5024754|NCT03843398|Minilaparotomy|minilaparotomy
5024755|NCT03843398|Survival|survival
5024756|NCT03843385|fecal transplantation|fecal transplantation
5024757|NCT03843385|multidonor fecal transplantation|multidonor fecal transplantation
5024758|NCT03843372|Continuous Positive Airway pressure|continuous positive airway pressure
5718527|NCT00436657|Pediatric|pediatric
5024759|NCT03843372|Transnasal High Flow|transnasal high flow
5024761|NCT03843333|Functional decline|functional decline
5024762|NCT03843333|Older adult|older adult
5024763|NCT03843333|Community health workers|community health workers
5024764|NCT03843333|Cognitive impairment|cognitive impairment
5024765|NCT03843333|Mobility limitation|mobility limitation
5024766|NCT03843333|Depressive symptoms|depressive symptoms
5024778|NCT03843307|Foot wound|foot wound
5024779|NCT03843307|Foot pain|foot pain
5024780|NCT03843281|Paracetamol|paracetamol
5024781|NCT03843281|Morphine|morphine
5024784|NCT03843229|Cinobufacini|cinobufacini
5024786|NCT03843203|Brain derived neurotrophic factor|brain derived neurotrophic factor
5024787|NCT03843203|functional capacity|functional capacity
5024788|NCT03843190|weight loss|weight loss
5024789|NCT03843190|african american women|african american women
5024790|NCT03843190|physical function|physical function
5024791|NCT03843164|Solitary Pulmonary Nodule|solitary pulmonary nodule
5356904|NCT01917565|fiberoptic bronchoscope|fiberoptic bronchoscope
5024792|NCT03843164|Multidetector Computed Tomography|multidetector computed tomography
5024793|NCT03843164|Artificial Intelligence|artificial intelligence
5024794|NCT03843138|3D virtual planning software|3d virtual planning software
5024795|NCT03843138|Individual Patient Solutions Case Designer (IPSCD)|individual patient solutions case designer (ipscd)
5024796|NCT03843138|timing|timing
5024797|NCT03843138|international|international
5024798|NCT03843138|multicenter|multicenter
5024800|NCT03843112|Infertility, female|infertility, female
5024801|NCT03843112|Vaginal microbiome|vaginal microbiome
5024802|NCT03843073|Spinal Cord Injury (SCI),|spinal cord injury (sci),
5024803|NCT03843073|Neurogenic Lower Urinary Tract Dysfunction (NLUTD)|neurogenic lower urinary tract dysfunction (nlutd)
5024902|NCT03842319|Atherosclerosis|atherosclerosis
5024804|NCT03843073|Catheter associated Urinary Tract Infection (CAUTI)|catheter associated urinary tract infection (cauti)
5024805|NCT03843073|Urinary Catheters|urinary catheters
5024806|NCT03843073|Urinary Retention|urinary retention
5024807|NCT03843073|Enlarged Prostate|enlarged prostate
5024809|NCT03843060|Congestive heart failure|congestive heart failure
5024810|NCT03843060|Healthy volunteers|healthy volunteers
5024811|NCT03843060|Itraconazole|itraconazole
5024812|NCT03843060|Drug-drug interaction|drug-drug interaction
5024813|NCT03843060|Pharmacokinetics|pharmacokinetics
5024814|NCT03843060|Open-label non-randomized|open-label non-randomized
5024815|NCT03842995|Genetic Counseling|genetic counseling
5024816|NCT03842995|NICU|nicu
5024817|NCT03842982|Ovarian cancer|ovarian cancer
5024818|NCT03842982|Hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5024819|NCT03842982|HIPEC|hipec
5024820|NCT03842982|Primary Debulking Surgery|primary debulking surgery
5024821|NCT03842982|Interval Debulking Surgery|interval debulking surgery
5024822|NCT03842956|Fixator extern|fixator extern
5024823|NCT03842956|Fixateur externe|fixateur externe
5024824|NCT03842956|External fixator|external fixator
5026726|NCT03831841|elderly|elderly
5024829|NCT03842956|Infection|infection
5024830|NCT03842917|Cancer|cancer
5024831|NCT03842917|bevacizumab|bevacizumab
5024832|NCT03842917|blood pressure|blood pressure
5024833|NCT03842917|proteinuria|proteinuria
5024834|NCT03842865|Immunotherapy|immunotherapy
5024835|NCT03842852|inguinal hernia|inguinal hernia
5024836|NCT03842852|laparoscopy reapir|laparoscopy reapir
5024837|NCT03842852|open repair|open repair
5024838|NCT03842826|Clinical examination|clinical examination
5024839|NCT03842826|Groin|groin
5024840|NCT03842826|Reproducibility|reproducibility
5024841|NCT03842787|systemic lupus erythematosus|systemic lupus erythematosus
5024842|NCT03842787|lupus nephritis|lupus nephritis
5024843|NCT03842787|complement|complement
5024844|NCT03842787|ficolin-3|ficolin-3
5024845|NCT03842787|anti-ficolin-3 autoantibodies|anti-ficolin-3 autoantibodies
5024846|NCT03842748|Nonalcoholic|nonalcoholic
5024847|NCT03842748|fatty liver|fatty liver
5024848|NCT03842748|hepatitis|hepatitis
5024849|NCT03842748|liver fibrosis|liver fibrosis
5024850|NCT03842735|Physiotherapy|physiotherapy
5024851|NCT03842735|Rehabilitation|rehabilitation
5024852|NCT03842735|Exercise|exercise
5024853|NCT03842696|GVHD|gvhd
5024854|NCT03842670|Alcohol Use Disorder|alcohol use disorder
5024855|NCT03842670|Behavioral Treatment|behavioral treatment
5024856|NCT03842670|Mechanisms of behavior change|mechanisms of behavior change
5024859|NCT03842657|hemodialysis|hemodialysis
5024861|NCT03842644|Tension Reduction|tension reduction
5024862|NCT03842631|Timolol Maleate|timolol maleate
5024863|NCT03842631|Doppler Ultrasound Examination|doppler ultrasound examination
5024864|NCT03842618|asthma- obstructive sleep apnea-adenotonsillectomy|asthma- obstructive sleep apnea-adenotonsillectomy
5024865|NCT03842579|Frailty|frailty
5024866|NCT03842579|Ageing|ageing
5024867|NCT03842579|High-Protein diet|high-protein diet
5024868|NCT03842579|Protein Supplementation|protein supplementation
5024869|NCT03842579|Resistance Training|resistance training
5024870|NCT03842579|Strength Training|strength training
5024871|NCT03842579|Muscle Power|muscle power
5024872|NCT03842579|Muscle Strength|muscle strength
5024873|NCT03842579|Muscle Mass|muscle mass
5024874|NCT03842579|Functional Performance|functional performance
5024875|NCT03842579|Nutritional Status|nutritional status
5024876|NCT03842553|PTSD|ptsd
5024877|NCT03842553|Trauma|trauma
5024878|NCT03842553|Coping|coping
5024879|NCT03842553|Self Efficacy|self efficacy
5024880|NCT03842540|LARC|larc
5024881|NCT03842540|Contraceptive decision-making|contraceptive decision-making
5024882|NCT03842540|Diffusion of Innovations|diffusion of innovations
5024883|NCT03842527|Gastric Ultrasound|gastric ultrasound
5024884|NCT03842527|Carbohydrate Loading|carbohydrate loading
5024885|NCT03842462|Preterm Infant|preterm infant
5024886|NCT03842462|Respiratory distress syndrome|respiratory distress syndrome
5024887|NCT03842462|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5024888|NCT03842462|noninvasive intermittent positive airway pressure|noninvasive intermittent positive airway pressure
5356905|NCT01917565|intubation|intubation
5019320|NCT03876301|Recombinant|recombinant
5019321|NCT03876236|Magnetic Resonance Imaging|magnetic resonance imaging
5019322|NCT03876236|Diffusion Tensor Imaging|diffusion tensor imaging
5019324|NCT03876236|Feasibility Study|feasibility study
5024889|NCT03842462|noninvasive high-frequency oscillatory ventilation|noninvasive high-frequency oscillatory ventilation
5024890|NCT03842449|Tobacco|tobacco
5024891|NCT03842449|Pregnancy Addictive|pregnancy addictive
5024892|NCT03842449|Pregnant Women|pregnant women
5024893|NCT03842449|Stop smoking|stop smoking
5024894|NCT03842436|PrEP|prep
5024895|NCT03842436|Substance Use Disorder|substance use disorder
5024896|NCT03842436|Digital Pills|digital pills
5024897|NCT03842436|Medication Adherence|medication adherence
5024898|NCT03842397|Mitral regurgitation|mitral regurgitation
5024899|NCT03842397|Mitral valve repair|mitral valve repair
5024900|NCT03842397|Mitral annuloplasty|mitral annuloplasty
5024901|NCT03842397|Adjustable annuloplasty|adjustable annuloplasty
5024942|NCT03842163|Hipertrophic cardiomyopathy (HCM)|hipertrophic cardiomyopathy (hcm)
5024944|NCT03842124|infection|infection
5024945|NCT03842124|pacemaker|pacemaker
5024946|NCT03842124|ICD|icd
5024947|NCT03842124|CRT|crt
5024948|NCT03842111|Alaska natives|alaska natives
5024949|NCT03842111|child care|child care
5024950|NCT03842111|child development|child development
5024951|NCT03842111|child health|child health
5024952|NCT03842111|child rearing|child rearing
5024953|NCT03842111|children|children
5024954|NCT03842111|curriculum|curriculum
5024955|NCT03842111|early childhood education|early childhood education
5024956|NCT03842111|families|families
5024957|NCT03842111|Head Start|head start
5024958|NCT03842111|Native Americans|native americans
5024959|NCT03842111|parenting skills|parenting skills
5024960|NCT03842111|parents|parents
5024968|NCT03842085|solid tumor|solid tumor
5024969|NCT03842085|MBS301|mbs301
5024970|NCT03842046|hypotension|hypotension
5024971|NCT03842046|phenylephrine|phenylephrine
5024972|NCT03842046|noradrenaline|noradrenaline
5024973|NCT03842046|cardiac output|cardiac output
5024974|NCT03842046|fetal|fetal
5024975|NCT03842046|maternal hemodynamics|maternal hemodynamics
5024976|NCT03842046|cesarean section|cesarean section
5024977|NCT03842033|Asthma Action Plan|asthma action plan
5024978|NCT03842033|Smartphone App|smartphone app
5024979|NCT03842020|heart rhythm disorder|heart rhythm disorder
5024980|NCT03842020|Amiodarone|amiodarone
5024981|NCT03842020|Cardiac arrhythmias|cardiac arrhythmias
5024982|NCT03842020|Pediatric|pediatric
5024983|NCT03842020|Population pharmacokinetic (Pop PK)|population pharmacokinetic (pop pk)
5024984|NCT03842020|Modeling|modeling
5024985|NCT03841994|microbiome|microbiome
5024986|NCT03841981|Exercise|exercise
5024987|NCT03841981|Sex steroids|sex steroids
5024988|NCT03841981|Hyperandrogenism|hyperandrogenism
5024989|NCT03841981|Adipose tissue|adipose tissue
5024990|NCT03841981|Muscle|muscle
5024991|NCT03841981|Proteome|proteome
5024992|NCT03841981|Gene expression|gene expression
5024993|NCT03841981|Adipokine|adipokine
5024998|NCT03841903|Spinal cord atrophy|spinal cord atrophy
5024999|NCT03841903|Cerebrospinal Fluid|cerebrospinal fluid
5025000|NCT03841903|Swiss Multiple Sclerosis Cohort|swiss multiple sclerosis cohort
5025001|NCT03841838|Energy drink|energy drink
5025002|NCT03841838|Heart rhythm|heart rhythm
5025011|NCT03841773|PTSD|ptsd
5025012|NCT03841747|ER-positive|er-positive
5025013|NCT03841747|Metastatic|metastatic
5025014|NCT03841747|Locally Advanced|locally advanced
5025015|NCT03841747|Ki67|ki67
5025016|NCT03841747|PAM50|pam50
5025017|NCT03841747|Pembrolizumab|pembrolizumab
5025018|NCT03841747|Paclitaxel|paclitaxel
5025019|NCT03841747|HER2-negative|her2-negative
5025020|NCT03841721|pharmacokinetic|pharmacokinetic
5025021|NCT03841721|linezolid|linezolid
5025022|NCT03841721|healthy volunteers|healthy volunteers
5025023|NCT03841708|Cardiac arrest|cardiac arrest
5025024|NCT03841708|Hemodynamic monitoring|hemodynamic monitoring
5025025|NCT03841708|Non invasive monitoring|non invasive monitoring
5025026|NCT03841708|Pleth Variability Index|pleth variability index
5025027|NCT03841708|Adult cardiac arrest|adult cardiac arrest
5025028|NCT03841669|Brain|brain
5025029|NCT03841669|Cardiovascular Disease|cardiovascular disease
5025030|NCT03841669|Exercise|exercise
5025031|NCT03841669|Brain Health|brain health
5025032|NCT03841643|cranial reconstruction|cranial reconstruction
5019422|NCT03875599|self-efficacy|self-efficacy
5019423|NCT03875599|instrument validity|instrument validity
5025033|NCT03841643|cement|cement
5025034|NCT03841643|patient-specific implant|patient-specific implant
5025035|NCT03841643|preprothetic surgery|preprothetic surgery
5025036|NCT03841643|atrophic jaw|atrophic jaw
5025037|NCT03841617|Thyroid Cancer|thyroid cancer
5025038|NCT03841617|PET/CT|pet/ct
5025039|NCT03841617|124-I|124-i
5025040|NCT03841617|Radioiodine|radioiodine
5025041|NCT03841617|Metastases|metastases
5025042|NCT03841578|Dark chocolate, gastrointestinal motility|dark chocolate, gastrointestinal motility
5025043|NCT03841552|Low Back Pain|low back pain
5025044|NCT03841539|Cognitive Impairment|cognitive impairment
5025045|NCT03841539|Dementia|dementia
5025046|NCT03841539|Alzheimer Disease|alzheimer disease
5025047|NCT03841539|Mediterranean Diet|mediterranean diet
5025048|NCT03841539|Low Fat Diet|low fat diet
5025052|NCT03841513|Burch Colposuspension|burch colposuspension
5025053|NCT03841513|Sacrocolpopexy|sacrocolpopexy
5025054|NCT03841513|Laparoscopy|laparoscopy
5025055|NCT03841513|Robotic Surgery|robotic surgery
5025056|NCT03841487|ST-elevation myocardial infarction|st-elevation myocardial infarction
5025057|NCT03841487|Thrombectomy|thrombectomy
5025058|NCT03841487|Mortality|mortality
5025059|NCT03841487|Stroke|stroke
5025060|NCT03841487|Physician volume|physician volume
5025066|NCT03841461|Academician|academician
5025067|NCT03841461|Physical Activity Level|physical activity level
5025068|NCT03841461|Sleep Quality|sleep quality
5025069|NCT03841461|Fatigue|fatigue
5025070|NCT03841422|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5025071|NCT03841422|video-assisted teaching|video-assisted teaching
5025072|NCT03841422|nasal self-packing|nasal self-packing
5025073|NCT03841357|Polyarthritis|polyarthritis
5025081|NCT03841305|Interventional radiology|interventional radiology
5025082|NCT03841305|Portal vein embolization|portal vein embolization
5025083|NCT03841305|Portal and hepatic vein embolization|portal and hepatic vein embolization
5025084|NCT03841305|Future liver remnant|future liver remnant
5025085|NCT03841305|Surgery|surgery
5025086|NCT03841305|Non-cirrhotic liver|non-cirrhotic liver
5025087|NCT03841305|Liver metastases|liver metastases
5025088|NCT03841305|Colorectal cancer|colorectal cancer
5025089|NCT03841305|Liver Regeneration|liver regeneration
5025090|NCT03841305|Liver resection|liver resection
5025091|NCT03841292|Smoking Cessation Medication|smoking cessation medication
5025092|NCT03841292|Smoking Treatment|smoking treatment
5025093|NCT03841292|Tobacco Treatment|tobacco treatment
5025094|NCT03841292|Quitting Smoking|quitting smoking
5025095|NCT03841292|Varenicline|varenicline
5025096|NCT03841292|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5025097|NCT03841292|Neuroimaging|neuroimaging
5025098|NCT03841292|fMRI|fmri
5025099|NCT03841292|Attentional Bias|attentional bias
5025100|NCT03841292|Eye-tracking|eye-tracking
5025101|NCT03841292|Dependence|dependence
5025102|NCT03841292|Addiction|addiction
5025103|NCT03841292|Cigarettes|cigarettes
5025104|NCT03841292|Biochemical Confirmation|biochemical confirmation
5025115|NCT03841253|Excimer laser|excimer laser
5025121|NCT03841227|fibromyalgia|fibromyalgia
5025122|NCT03841227|tDCS|tdcs
5025123|NCT03841227|fMRI|fmri
5025124|NCT03841227|rs-fMRI|rs-fmri
5025125|NCT03841201|hepatocellular carcinoma|hepatocellular carcinoma
5025126|NCT03841188|osteogenesis imperfecta|osteogenesis imperfecta
5025127|NCT03841188|Nutritional intervention|nutritional intervention
5025128|NCT03841188|calcium intake|calcium intake
5025129|NCT03841175|Squamous cell carcinoma|squamous cell carcinoma
5025130|NCT03841175|FDG PET/CT|fdg pet/ct
5025131|NCT03841175|Initial staging|initial staging
5025132|NCT03841175|Clinical management|clinical management
5025133|NCT03841175|Prognosis|prognosis
5025134|NCT03841162|Blood Cultures|blood cultures
5025135|NCT03841149|3D Ultrasound volume measurements|3d ultrasound volume measurements
5025136|NCT03841149|Renal volume|renal volume
5025137|NCT03841149|Tumour Volume|tumour volume
5025138|NCT03841123|complementary feeding|complementary feeding
5025139|NCT03841123|added sugar|added sugar
5025140|NCT03841123|ultra-processed foods|ultra-processed foods
5025141|NCT03841123|intervention|intervention
5025142|NCT03841123|infants|infants
5025143|NCT03841110|Advanced Solid Tumor|advanced solid tumor
5025144|NCT03841110|Lymphoma|lymphoma
5025145|NCT03841110|Breast Cancer|breast cancer
5025146|NCT03841110|Head and Neck Cancer|head and neck cancer
5025147|NCT03841110|Head and Neck|head and neck
5025148|NCT03841110|Squamous Cell Carcinoma|squamous cell carcinoma
5025149|NCT03841110|Gastric Cancer|gastric cancer
5025150|NCT03841110|Colorectal Cancer|colorectal cancer
5019550|NCT03874858|CML|cml
5025151|NCT03841110|Immunotherapy|immunotherapy
5025152|NCT03841110|NK cell therapy|nk cell therapy
5025153|NCT03841110|Melanoma|melanoma
5025154|NCT03841110|Checkpoint Inhibitor|checkpoint inhibitor
5025155|NCT03841110|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5025156|NCT03841110|Monoclonal Antibody|monoclonal antibody
5025157|NCT03841110|Cell therapy|cell therapy
5025158|NCT03841110|Cellular therapy|cellular therapy
5025159|NCT03841110|nivolumab|nivolumab
5025160|NCT03841110|pembrolizumab|pembrolizumab
5025161|NCT03841110|atezolizumab|atezolizumab
5025162|NCT03841097|Renal|renal
5025163|NCT03841097|Transplant|transplant
5025164|NCT03841097|Pulse wave velocity|pulse wave velocity
5025165|NCT03841084|ECMO|ecmo
5025166|NCT03841084|V-A ECMO|v-a ecmo
5025167|NCT03841084|Oxygen|oxygen
5025168|NCT03841084|Hyperoxia|hyperoxia
5025169|NCT03841058|abalopartide|abalopartide
5025170|NCT03841058|pain|pain
5025171|NCT03841058|surgical outcome|surgical outcome
5025172|NCT03841032|Facial redness|facial redness
5025173|NCT03841032|Skin sensitivity|skin sensitivity
5025174|NCT03840993|Endometriosis|endometriosis
5025175|NCT03840941|COPD|copd
5025176|NCT03840941|Frailty|frailty
5025177|NCT03840941|Balance|balance
5025178|NCT03840941|Cognition|cognition
5025179|NCT03840941|Activities of Daily Living|activities of daily living
5025191|NCT03840889|Prospective cohort|prospective cohort
5025192|NCT03840889|Population-based study|population-based study
5025193|NCT03840889|Multicenter study|multicenter study
5025194|NCT03840889|Maternity|maternity
5025195|NCT03840876|Jet Ventilation|jet ventilation
5025204|NCT03840837|Parkinson disease dementia|parkinson disease dementia
5025205|NCT03840837|wearable sensor|wearable sensor
5025206|NCT03840837|gait analysis|gait analysis
5025207|NCT03840837|rivastigmine|rivastigmine
5025219|NCT03840811|ciprofloxacin|ciprofloxacin
5025220|NCT03840811|males|males
5025221|NCT03840811|Neisseria gonorrhoeae|neisseria gonorrhoeae
5025222|NCT03840785|Chronic inflammatory arthritis|chronic inflammatory arthritis
5025223|NCT03840785|argentine tango|argentine tango
5025224|NCT03840785|physical activity|physical activity
5025225|NCT03840772|Solitary Fibrous Tumor|solitary fibrous tumor
5025226|NCT03840772|soft tissue sarcoma|soft tissue sarcoma
5025227|NCT03840772|rare sarcoma|rare sarcoma
5025228|NCT03840746|self-reported healthy adults|self-reported healthy adults
5025229|NCT03840746|age 40-70|age 40-70
5025230|NCT03840746|BMI > 25|bmi > 25
5025235|NCT03840668|USB eyemask|usb eyemask
5025236|NCT03840603|Respiratory Tract Infections|respiratory tract infections
5025237|NCT03840603|Emergency Department|emergency department
5025238|NCT03840603|Procalcitonin|procalcitonin
5025239|NCT03840590|adenoma detection rate|adenoma detection rate
5025240|NCT03840577|Deep Sedation|deep sedation
5025244|NCT03840577|sedatives|sedatives
5025245|NCT03840551|injury prevention|injury prevention
5025246|NCT03840551|biomechanical indices|biomechanical indices
5025247|NCT03840551|inertial sensors|inertial sensors
5025250|NCT03840473|Neck pain|neck pain
5025251|NCT03840473|Upper trapezius muscle|upper trapezius muscle
5025252|NCT03840473|Myofascial trigger points|myofascial trigger points
5025253|NCT03840473|Muscle tenderness|muscle tenderness
5025254|NCT03840473|Pain pressure threshold|pain pressure threshold
5025255|NCT03840447|Chronic Disease|chronic disease
5025256|NCT03840447|Prevention and control|prevention and control
5025257|NCT03840447|Patient Education as Topic|patient education as topic
5025258|NCT03840447|Health Services/utilization|health services/utilization
5025259|NCT03840447|Program Evaluation|program evaluation
5025260|NCT03840447|Cost-Benefit Analysis|cost-benefit analysis
5025261|NCT03840447|Self-Efficacy|self-efficacy
5025262|NCT03840447|Disease Management|disease management
5025263|NCT03840447|Health Status|health status
5025264|NCT03840447|Outcome Assessment (Health Care)|outcome assessment (health care)
5025265|NCT03840447|Self Care|self care
5025266|NCT03840447|Socioeconomic Factors|socioeconomic factors
5025267|NCT03840447|Poverty Areas|poverty areas
5025268|NCT03840447|Chronic Disease Self-Management Programme|chronic disease self-management programme
5025269|NCT03840434|compartment syndrome|compartment syndrome
5025270|NCT03840434|intramuscular punction Versus non invasive assessment|intramuscular punction versus non invasive assessment
5025271|NCT03840421|gemcitabine|gemcitabine
5025272|NCT03840421|cisplatin|cisplatin
5025273|NCT03840421|fluorouracil|fluorouracil
5025274|NCT03840395|Dysphagia|dysphagia
5025275|NCT03840395|Extubation|extubation
5025276|NCT03840395|Intensive Care Unit|intensive care unit
5025277|NCT03840395|Pharyngeal Electrical Stimulation|pharyngeal electrical stimulation
5025278|NCT03840395|Oropharyngeal Dysphagia|oropharyngeal dysphagia
5025279|NCT03840395|Mechanical Ventilation|mechanical ventilation
5025280|NCT03840395|Critically ill patients|critically ill patients
5025281|NCT03840395|Post-Extubation Dysphagia|post-extubation dysphagia
5025288|NCT03840330|High-intensity interval training|high-intensity interval training
5025289|NCT03840330|Circuit training|circuit training
5025290|NCT03840330|Elderly|elderly
5025291|NCT03840330|Functional capacity|functional capacity
5025292|NCT03840330|VO2 max|vo2 max
5025293|NCT03840330|Cardiovascular parameters|cardiovascular parameters
5025294|NCT03840278|bionic pancreas|bionic pancreas
5025295|NCT03840278|closed loop|closed loop
5025296|NCT03840278|glucagon|glucagon
5025297|NCT03840278|insulin|insulin
5025298|NCT03840252|3D-gait analysis|3d-gait analysis
5025299|NCT03840252|Magnetic Resonance Imaging|magnetic resonance imaging
5025300|NCT03840239|rectal cancer|rectal cancer
5025301|NCT03840239|chemoradiation|chemoradiation
5025302|NCT03840239|total neoadjuvant treatment|total neoadjuvant treatment
5025303|NCT03840226|magnesium|magnesium
5025304|NCT03840226|heart failure|heart failure
5025305|NCT03840213|Chemotherapy|chemotherapy
5025310|NCT03840187|digital cervicography|digital cervicography
5025311|NCT03840187|Gynescope system|gynescope system
5025312|NCT03840161|Diabetes mellitus Type 1|diabetes mellitus type 1
5718616|NCT00436501|TXT|txt
5025314|NCT03840161|blood glucose self-testing|blood glucose self-testing
5025315|NCT03840161|non-invasive tissue glucose prediction|non-invasive tissue glucose prediction
5025316|NCT03840161|optical pain-free glucose testing|optical pain-free glucose testing
5025317|NCT03840148|Bacterial Infections|bacterial infections
5025318|NCT03840148|Cefepime|cefepime
5025319|NCT03840148|Meropenem|meropenem
5025320|NCT03840148|Complicated Urinary Tract Infections|complicated urinary tract infections
5025321|NCT03840148|Anti-Infective Agents|anti-infective agents
5025322|NCT03840148|β-Lactamase Inhibitors|β-lactamase inhibitors
5025323|NCT03840148|VNRX-5133 (taniborbactam)|vnrx-5133 (taniborbactam)
5025324|NCT03840135|ARI, acute respiratory infection|ari, acute respiratory infection
5025325|NCT03840109|emotional support|emotional support
5025326|NCT03840109|cancer|cancer
5025327|NCT03840057|GIB|gib
5025328|NCT03840057|UGIB|ugib
5025329|NCT03840044|Asthma|asthma
5025330|NCT03840044|Exercise|exercise
5025331|NCT03840044|Cold air exposure|cold air exposure
5025332|NCT03840031|Biofortification|biofortification
5025333|NCT03840031|Orange fleshed sweet potato|orange fleshed sweet potato
5025334|NCT03840031|Stable isotope studies|stable isotope studies
5025335|NCT03839992|abnormal FEF75|abnormal fef75
5025336|NCT03839992|bronchiectasis|bronchiectasis
5025337|NCT03839992|lung CT|lung ct
5025338|NCT03839953|Rehabilitation|rehabilitation
5025339|NCT03839953|Exercise|exercise
5025340|NCT03839953|Revascularization|revascularization
5025341|NCT03839953|Endovascular|endovascular
5025342|NCT03839953|Vascular Surgery|vascular surgery
5025343|NCT03839927|Life Space Assesment|life space assesment
5025344|NCT03839927|Daily Life Activity|daily life activity
5025361|NCT03839823|HR-positive|hr-positive
5025362|NCT03839823|HER2-negative|her2-negative
5025363|NCT03839823|advanced breast cancer|advanced breast cancer
5025364|NCT03839823|Ribociclib|ribociclib
5025365|NCT03839823|NSAI|nsai
5025366|NCT03839823|Goserelin|goserelin
5025367|NCT03839823|Docetaxel / capecitabine|docetaxel / capecitabine
5025368|NCT03839823|Paclitaxel/gemcitabine|paclitaxel/gemcitabine
5025369|NCT03839823|Capecitabine/vinorelbine|capecitabine/vinorelbine
5025370|NCT03839823|CDK4/6|cdk4/6
5025371|NCT03839823|Phase II|phase ii
5025372|NCT03839823|ER-positive|er-positive
5025373|NCT03839823|PR-positive|pr-positive
5025374|NCT03839823|Premenopausal|premenopausal
5025375|NCT03839823|Perimenopausal.|perimenopausal.
5025376|NCT03839810|stochastic resonance|stochastic resonance
5025377|NCT03839810|proprioception|proprioception
5025378|NCT03839810|motor control|motor control
5025379|NCT03839810|motor recovery|motor recovery
5025380|NCT03839758|Prothesis|prothesis
5025381|NCT03839758|Glenoid implantation|glenoid implantation
5025382|NCT03839745|E-Cigarettes|e-cigarettes
5025383|NCT03839745|Vaping|vaping
5025384|NCT03839745|E-Cig Mods|e-cig mods
5025385|NCT03839732|observer variability|observer variability
5025386|NCT03839732|kauppila score|kauppila score
5025387|NCT03839732|quantitative vertebral morphometry|quantitative vertebral morphometry
5025388|NCT03839732|computer assisted procedure|computer assisted procedure
5025389|NCT03839732|abdominal aorta|abdominal aorta
5025390|NCT03839732|lumbar spine|lumbar spine
5025391|NCT03839719|Gingivitis|gingivitis
5025392|NCT03839719|Aerosol|aerosol
5025393|NCT03839719|Ocimum sanctum|ocimum sanctum
5025394|NCT03839719|Mouth rinse|mouth rinse
5025395|NCT03839719|SRP|srp
5025396|NCT03839719|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
5025397|NCT03839719|Periodontitis|periodontitis
5025398|NCT03839680|ulcerative colitis, endoscopic activity, mucosal healing, vedolizumab|ulcerative colitis, endoscopic activity, mucosal healing, vedolizumab
5025403|NCT03839602|Locoregional Failure Pattern|locoregional failure pattern
5025404|NCT03839602|Toxicity|toxicity
5025405|NCT03839589|Hispanics|hispanics
5019737|NCT03873688|cough|cough
5025406|NCT03839589|Mindfulness|mindfulness
5025407|NCT03839589|Emotional well-being|emotional well-being
5025408|NCT03839576|gait|gait
5025409|NCT03839576|computerized cognitive training|computerized cognitive training
5025410|NCT03839576|falls|falls
5025411|NCT03839576|mild cognitive impairment|mild cognitive impairment
5025412|NCT03839576|mobility|mobility
5025413|NCT03839576|physical exercise|physical exercise
5025414|NCT03839576|tai chi chuan|tai chi chuan
5025415|NCT03839563|Biomarker|biomarker
5025416|NCT03839563|Cognitive impairment|cognitive impairment
5025417|NCT03839563|Gait abnormality|gait abnormality
5025418|NCT03839563|Older Adults|older adults
5025419|NCT03839563|Exercise|exercise
5025420|NCT03839537|Ultrafine particles|ultrafine particles
5025421|NCT03839537|black carbon|black carbon
5025422|NCT03839537|taxi drivers|taxi drivers
5025423|NCT03839537|respiratory function test|respiratory function test
5025424|NCT03839537|occupational exposure|occupational exposure
5025425|NCT03839498|Axitinib|axitinib
5025426|NCT03839485|pulpectomy|pulpectomy
5025427|NCT03839485|primary teeth|primary teeth
5025428|NCT03839485|root canal filling materials|root canal filling materials
5025429|NCT03839459|Smoldering Multiple Myeloma|smoldering multiple myeloma
5025458|NCT03839290|3D geometric morphometrics|3d geometric morphometrics
5025459|NCT03839290|upper dental arch|upper dental arch
5025460|NCT03839290|classical morphometrics|classical morphometrics
5025461|NCT03839290|early neonatal cheiloplasty|early neonatal cheiloplasty
5025462|NCT03839277|adenoma detection rate|adenoma detection rate
5025463|NCT03839264|diagnostic accuracy|diagnostic accuracy
5025464|NCT03839264|screening|screening
5025465|NCT03839251|aripiprazole|aripiprazole
5025466|NCT03839251|long-acting injection|long-acting injection
5025467|NCT03839186|personalized medicine|personalized medicine
5025468|NCT03839186|genetic polymorphism|genetic polymorphism
5025469|NCT03839186|pharmacogenetics|pharmacogenetics
5025470|NCT03839186|hemodynamic change|hemodynamic change
5025471|NCT03839173|premature infant|premature infant
5025472|NCT03839173|breast milk|breast milk
5025473|NCT03839173|breastmilk|breastmilk
5025474|NCT03839173|human milk|human milk
5025475|NCT03839173|human milk fortifier|human milk fortifier
5025476|NCT03839147|hysterosalpingography|hysterosalpingography
5025477|NCT03839147|anxiety|anxiety
5340585|NCT01992094|Adults|adults
5025478|NCT03839147|pain|pain
5025479|NCT03839147|education|education
5025480|NCT03839147|counseling|counseling
5025481|NCT03839121|Heart Diseases|heart diseases
5025482|NCT03839121|CRT-D|crt-d
5025483|NCT03839108|paraffin|paraffin
5025484|NCT03839108|prolotherapy|prolotherapy
5025485|NCT03839108|hand osteoarthritis|hand osteoarthritis
5025486|NCT03839095|Nonmetastatic Osteosarcoma|nonmetastatic osteosarcoma
5025487|NCT03839095|Pediatric Cancer|pediatric cancer
5025488|NCT03839095|Limb Salvage|limb salvage
5025489|NCT03839095|Prediction Model|prediction model
5025490|NCT03839082|Mobile Technology|mobile technology
5025491|NCT03839082|Weight|weight
5025492|NCT03839082|Nutrition|nutrition
5025493|NCT03839056|epidural local anesthetic|epidural local anesthetic
5025494|NCT03839056|epidural analgesia|epidural analgesia
5025495|NCT03839056|analgesia labor|analgesia labor
5025496|NCT03839043|Tobacco|tobacco
5025497|NCT03839043|Cigarettes|cigarettes
5025498|NCT03839043|Surgery|surgery
5025499|NCT03839043|Text Message|text message
5025500|NCT03839043|SMS|sms
5025501|NCT03839017|War Injury Combat Casualty Care Cognitive Aid|war injury combat casualty care cognitive aid
5025502|NCT03838952|Chinese Herbal Medicine|chinese herbal medicine
5025503|NCT03838952|Herbal treatment|herbal treatment
5025504|NCT03838939|chronic inflammatory rheumatism|chronic inflammatory rheumatism
5025505|NCT03838939|biotherapies|biotherapies
5025510|NCT03838926|Cancer|cancer
5025511|NCT03838926|Blood|blood
5025512|NCT03838913|Whole-exome Sequencing|whole-exome sequencing
5025513|NCT03838913|intraductal papillary neoplasms of the bile duct|intraductal papillary neoplasms of the bile duct
5025514|NCT03838913|mutation characteristics|mutation characteristics
5025515|NCT03838900|Loop|loop
5025516|NCT03838900|RileyLink|rileylink
5025517|NCT03838900|Type 1 Diabetes|type 1 diabetes
5025518|NCT03838822|nicotinamid riboside|nicotinamid riboside
5025519|NCT03838822|L-carnitine|l-carnitine
5025520|NCT03838822|L-serine|l-serine
5025521|NCT03838822|N-acetylcystein|n-acetylcystein
5025527|NCT03838757|Exercise capacity|exercise capacity
5025528|NCT03838757|Cardiopulmonary exercise test|cardiopulmonary exercise test
5025529|NCT03838757|Respiratory muscle strength|respiratory muscle strength
5025530|NCT03838757|Physical activity|physical activity
5025531|NCT03838757|Pulmonary functions|pulmonary functions
5025532|NCT03838757|Peripheral Muscle Strength|peripheral muscle strength
5025533|NCT03838757|Quality of life|quality of life
5025534|NCT03838757|Sleep of quality|sleep of quality
5025535|NCT03838757|Dyspnea|dyspnea
5025536|NCT03838757|Depression|depression
5025537|NCT03838757|Fatigue|fatigue
5025538|NCT03838757|Cough|cough
5025539|NCT03838744|Soft tissue sarcoma|soft tissue sarcoma
5025546|NCT03838705|stop-bang, bariatric surgery, obesity, hypoxia|stop-bang, bariatric surgery, obesity, hypoxia
5025547|NCT03838692|Ponatinib|ponatinib
5025548|NCT03838692|Metastatic Medullary|metastatic medullary
5025549|NCT03838692|Advanced Medullary|advanced medullary
5025550|NCT03838653|Double-lumen endotracheal tube|double-lumen endotracheal tube
5025551|NCT03838653|Multidetector Computed Tomography|multidetector computed tomography
5025553|NCT03838575|Surgical Site Infection|surgical site infection
5025554|NCT03838575|Infection Prevention|infection prevention
5025555|NCT03838575|MAMS|mams
5025556|NCT03838575|Multi-arm, Multi-stage|multi-arm, multi-stage
5025557|NCT03838575|Pragmatic|pragmatic
5025558|NCT03838575|Abdominal Surgery|abdominal surgery
5025559|NCT03838575|Multicentre|multicentre
5025561|NCT03838575|Pilot|pilot
5025562|NCT03838575|Chlorhexidine|chlorhexidine
5025563|NCT03838575|Skin Prep|skin prep
5025564|NCT03838575|Iodophor|iodophor
5025565|NCT03838575|Drape|drape
5025566|NCT03838575|Gentamicin|gentamicin
5025567|NCT03838575|Sponge|sponge
5025568|NCT03838562|virtual reality|virtual reality
5025569|NCT03838562|vestibular|vestibular
5025570|NCT03838562|balance|balance
5025571|NCT03838562|rehabilitation|rehabilitation
5025572|NCT03838549|Prophylactic Surgical Procedure|prophylactic surgical procedure
5025573|NCT03838549|Subcutaneous Mastectomy|subcutaneous mastectomy
5025574|NCT03838549|Endoscopy|endoscopy
5025575|NCT03838549|Breast Reconstruction|breast reconstruction
5025576|NCT03838549|Breast Implants|breast implants
5025577|NCT03838536|Breastfeeding|breastfeeding
5025578|NCT03838536|Eggs|eggs
5025579|NCT03838536|Baby|baby
5025580|NCT03838484|Nicotine|nicotine
5025581|NCT03838484|Nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
5025582|NCT03838484|Schizophrenia|schizophrenia
5025583|NCT03838484|Schizoaffective disorder|schizoaffective disorder
5025584|NCT03838484|Healthy control|healthy control
5025585|NCT03838484|Impulsive behavior|impulsive behavior
5025586|NCT03838484|Aggression|aggression
5025587|NCT03838484|Urgency|urgency
5025588|NCT03838471|CSI|csi
5025589|NCT03838471|kinesiophobia|kinesiophobia
5025590|NCT03838471|Central Nervous System Sensitization|central nervous system sensitization
5025591|NCT03838471|Catastrophizing|catastrophizing
5025592|NCT03838471|Illness Behavior|illness behavior
5025598|NCT03838445|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5025599|NCT03838445|PAH|pah
5025600|NCT03838445|Interatrial Shunt|interatrial shunt
5025601|NCT03838445|Interatrial Shunting|interatrial shunting
5025602|NCT03838445|Atrial Septostomy|atrial septostomy
5025603|NCT03838432|focal therapy|focal therapy
5025604|NCT03838432|IRE|ire
5025605|NCT03838432|Composite Steep-pulse Treatment Apparatus|composite steep-pulse treatment apparatus
5025606|NCT03838432|prostate cancer|prostate cancer
5025607|NCT03838432|Multi-center|multi-center
5025611|NCT03838406|Capecitabine plus Oxalipatin (CAPOX)|capecitabine plus oxalipatin (capox)
5025612|NCT03838393|multidisciplinary management|multidisciplinary management
5025613|NCT03838393|real-life study|real-life study
5025616|NCT03838354|ITP|itp
5025617|NCT03838354|Chidamide|chidamide
5025618|NCT03838341|Stroke prevention|stroke prevention
5025619|NCT03838341|Atrial fibrillation|atrial fibrillation
5025620|NCT03838341|Totally thoracoscopic|totally thoracoscopic
5025621|NCT03838341|LAAO|laao
5025622|NCT03838341|AtriClip®|atriclip®
5025623|NCT03838328|dose effect|dose effect
5025624|NCT03838328|tranexamic acid|tranexamic acid
5025625|NCT03838328|deep vein thromboses|deep vein thromboses
5025636|NCT03838263|HPV-driven oropharynx cancer|hpv-driven oropharynx cancer
5025637|NCT03838250|Alcoholic|alcoholic
5025638|NCT03838250|Liver|liver
5025639|NCT03838250|Cirrhosis|cirrhosis
5025640|NCT03838250|Liver Disease|liver disease
5025641|NCT03838237|Fabry Disease|fabry disease
5025642|NCT03838237|Migalastat|migalastat
5025643|NCT03838237|Cardiomyopathy|cardiomyopathy
5025644|NCT03838237|Cardiac Magnetic Resonance|cardiac magnetic resonance
5025645|NCT03838237|T1 mapping|t1 mapping
5025646|NCT03838211|memory|memory
5025647|NCT03838211|brain stimulation|brain stimulation
5025648|NCT03838198|Adaptive Intervention|adaptive intervention
5025649|NCT03838198|Sequential, Multiple Assignment, Randomized Trial (SMART)|sequential, multiple assignment, randomized trial (smart)
5025650|NCT03838198|Adolescent|adolescent
5025651|NCT03838198|Motivational Interviewing|motivational interviewing
5025652|NCT03838198|Suicide attempt|suicide attempt
5025653|NCT03838198|Safety planning|safety planning
5025654|NCT03838198|mobile technology|mobile technology
5025655|NCT03838185|Dementia|dementia
5025662|NCT03838120|Infraclavicular block|infraclavicular block
5025663|NCT03838107|pediatric complex regional pain syndrome|pediatric complex regional pain syndrome
5025664|NCT03838107|fMRI|fmri
5025665|NCT03838107|psychosocial|psychosocial
5025666|NCT03838107|quantitative sensory testing|quantitative sensory testing
5025667|NCT03838107|markers|markers
5025668|NCT03838094|pulp exposure|pulp exposure
5025669|NCT03838094|vital immature|vital immature
5025670|NCT03838094|MTA|mta
5025671|NCT03838094|Biodentine|biodentine
5025672|NCT03838081|third molar extraction|third molar extraction
5025673|NCT03838081|Preoperative anxiety|preoperative anxiety
5025674|NCT03838081|Dental Anxiety|dental anxiety
5025675|NCT03838068|trauma|trauma
5025676|NCT03838068|vital immature|vital immature
5025677|NCT03838068|MTA|mta
5025678|NCT03838068|Biodentine|biodentine
5025679|NCT03838042|high-risk solid tumors|high-risk solid tumors
5025680|NCT03838042|high-risk CNS tumors|high-risk cns tumors
5025681|NCT03838029|Beta-blocker|beta-blocker
5025682|NCT03838029|Propranolol|propranolol
5025683|NCT03838029|COX-2 inhibitor|cox-2 inhibitor
5025684|NCT03838029|Etodolac|etodolac
5025685|NCT03838003|Exercise|exercise
5025686|NCT03838003|Rehabilitation Nursing|rehabilitation nursing
5025687|NCT03838003|Functional capacity|functional capacity
5025688|NCT03838003|Heart failure|heart failure
5025689|NCT03837990|Whole genome sequencing|whole genome sequencing
5025690|NCT03837990|Polymorphism|polymorphism
5025691|NCT03837951|reliability|reliability
5025692|NCT03837951|edema|edema
5025693|NCT03837951|physical therapy|physical therapy
5025694|NCT03837951|occupational therapy|occupational therapy
5025695|NCT03837951|figure-of-eight|figure-of-eight
5025696|NCT03837925|Statins|statins
5025697|NCT03837925|cardiovascular risk|cardiovascular risk
5025698|NCT03837925|primary prevention microbiota|primary prevention microbiota
5025699|NCT03837925|metabolomics|metabolomics
5025700|NCT03837912|cluster randomized controlled trial|cluster randomized controlled trial
5025701|NCT03837912|primary health care|primary health care
5025702|NCT03837912|patient safety|patient safety
5025703|NCT03837912|patient-centred care|patient-centred care
5025704|NCT03837912|patient-reported experiences and outcomes measures|patient-reported experiences and outcomes measures
5025705|NCT03837912|audit and feedback interventions.|audit and feedback interventions.
5025707|NCT03837847|Health coaching|health coaching
5025708|NCT03837834|HIGH INTENSITY INTERVAL TRAINING|high intensity interval training
5025709|NCT03837834|INCOMPLETE SPINAL CORD INJURY|incomplete spinal cord injury
5025710|NCT03837834|MUSCLE STRENGTH|muscle strength
5025711|NCT03837834|CARDIO-RESPIRATORY FITNESS|cardio-respiratory fitness
5025712|NCT03837808|nimotuzumab|nimotuzumab
5025713|NCT03837795|Neurofeedback|neurofeedback
5025714|NCT03837795|Sensory Modulation Disorder|sensory modulation disorder
5040285|NCT03747120|Trastuzumab|trastuzumab
5025725|NCT03837717|Oxytocin|oxytocin
5025726|NCT03837717|Stress|stress
5327217|NCT02052206|3D|3d
5025727|NCT03837717|Cortisol|cortisol
5025728|NCT03837665|Platelet Rich Plasma|platelet rich plasma
5025729|NCT03837665|TM perforations|tm perforations
5025730|NCT03837665|Hearing loss|hearing loss
5025731|NCT03837665|Hole in the eardrum|hole in the eardrum
5025732|NCT03837652|Cleft palate|cleft palate
5025733|NCT03837652|transverse discrepancy|transverse discrepancy
5025734|NCT03837652|palatal expansion|palatal expansion
5025735|NCT03837652|bone-borne|bone-borne
5025736|NCT03837639|arm-crank|arm-crank
5025737|NCT03837639|exercise training|exercise training
5025738|NCT03837639|cardiovascular function|cardiovascular function
5025739|NCT03837613|cancer|cancer
5025740|NCT03837613|squamous cell carcinoma|squamous cell carcinoma
5025741|NCT03837613|ultrasound|ultrasound
5025742|NCT03837613|tumor thickness|tumor thickness
5025743|NCT03837600|LDCT|ldct
5025744|NCT03837600|Sputum|sputum
5025745|NCT03837600|High-risk Smoker|high-risk smoker
5025746|NCT03837600|Porphyrin|porphyrin
5025747|NCT03837600|Early detection|early detection
5025748|NCT03837587|Validity|validity
5025749|NCT03837587|Reliability|reliability
5025750|NCT03837587|Temporomandibular Joint Disorders|temporomandibular joint disorders
5025751|NCT03837574|tretalogy of fallot|tretalogy of fallot
5025752|NCT03837574|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5025753|NCT03837574|congenital heart disease|congenital heart disease
5025754|NCT03837574|sudden cardiac death|sudden cardiac death
5025755|NCT03837574|ventricular arrhythmia|ventricular arrhythmia
5025756|NCT03837548|Parkinson's Disease|parkinson's disease
5025757|NCT03837548|Magnetoencephalography|magnetoencephalography
5025758|NCT03837548|Neurofeedback|neurofeedback
5025759|NCT03837522|Biopsy|biopsy
5027615|NCT03826095|Multiple Sclerosis|multiple sclerosis
5025762|NCT03837509|Arginase inhibitor|arginase inhibitor
5025763|NCT03837509|multiple myeloma|multiple myeloma
5025764|NCT03837509|recombinant human immunoglobulin G monoclonal antibody|recombinant human immunoglobulin g monoclonal antibody
5025765|NCT03837496|Breast Cancer|breast cancer
5025766|NCT03837496|Endocrine Therapy|endocrine therapy
5025767|NCT03837496|Hormonal Therapy|hormonal therapy
5025768|NCT03837496|Symptoms|symptoms
5025769|NCT03837496|Distress|distress
5025770|NCT03837496|Survivors|survivors
5025771|NCT03837457|PRISM|prism
5025772|NCT03837457|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5025773|NCT03837457|CTCL|ctcl
5025774|NCT03837457|Mycosis Fungoides|mycosis fungoides
5025775|NCT03837457|Lymphoma|lymphoma
5025776|NCT03837457|Lymphoma, T-cell|lymphoma, t-cell
5025777|NCT03837457|Lymphoma, T-cell, cutaneous|lymphoma, t-cell, cutaneous
5025778|NCT03837457|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5025779|NCT03837457|Lymphoproliferative Disorders|lymphoproliferative disorders
5025780|NCT03837457|Lymphatic Diseases|lymphatic diseases
5025781|NCT03837457|Immunoproliferative Disorders|immunoproliferative disorders
5025782|NCT03837457|Immune System Diseases|immune system diseases
5025783|NCT03837457|Neoplasms|neoplasms
5025784|NCT03837457|MicroRNAs|micrornas
5025785|NCT03837444|Cirrhosis|cirrhosis
5025786|NCT03837444|Outcome prognostication|outcome prognostication
5025787|NCT03837444|Microvesicle|microvesicle
5025788|NCT03837444|Monocyte|monocyte
5025789|NCT03837431|Cutaneous|cutaneous
5025790|NCT03837431|Leishmaniasis|leishmaniasis
5025791|NCT03837431|Ethiopia|ethiopia
5025793|NCT03837418|Patient-Oriented|patient-oriented
5025794|NCT03837418|Designing|designing
5025795|NCT03837418|Prescriptions|prescriptions
5025796|NCT03837392|Pregnancy|pregnancy
5025797|NCT03837392|Mental Health|mental health
5025798|NCT03837366|Activity tracker|activity tracker
5025799|NCT03837366|Physical Activity|physical activity
5025800|NCT03837366|mHealth|mhealth
5025801|NCT03837366|habit|habit
5025802|NCT03837366|Motivational Interviewing|motivational interviewing
5040390|NCT03746470|arthroscopy|arthroscopy
5025803|NCT03837340|Community mental health teams|community mental health teams
5025805|NCT03837327|Ovarian Cancer|ovarian cancer
5025806|NCT03837327|Liquid Biopsy|liquid biopsy
5025814|NCT03837288|preterm labor|preterm labor
5025815|NCT03837288|cerclage|cerclage
5025816|NCT03837275|intralift|intralift
5025817|NCT03837275|maxillery sinus lift|maxillery sinus lift
5025818|NCT03837275|hydrodynamic ultrasonic|hydrodynamic ultrasonic
5025819|NCT03837262|Flash Glucose Monitoring|flash glucose monitoring
5025826|NCT03837236|Behçet disease|behçet disease
5025827|NCT03837236|Physical activity level|physical activity level
5025828|NCT03837236|Exercise barriers|exercise barriers
5025829|NCT03837197|donors and donation|donors and donation
5025830|NCT03837197|Extended criteria donor|extended criteria donor
5025831|NCT03837197|Organ perfusion and preservation|organ perfusion and preservation
5025832|NCT03837197|Liver transplantation|liver transplantation
5025833|NCT03837197|Kidney transplantation|kidney transplantation
5025834|NCT03837197|Preservation injury|preservation injury
5025835|NCT03837197|Ischemia reperfusion injury|ischemia reperfusion injury
5025836|NCT03837184|Spinal Muscular Atrophy|spinal muscular atrophy
5025837|NCT03837184|SMN2|smn2
5025838|NCT03837184|Onasemnogene Abeparvovec-xioi|onasemnogene abeparvovec-xioi
5025839|NCT03837184|Gene replacement therapy|gene replacement therapy
5025840|NCT03837171|Septic Shock|septic shock
5025841|NCT03837171|Anemia|anemia
5025842|NCT03837171|cancer|cancer
5025843|NCT03837171|erythrocyte transfusion|erythrocyte transfusion
5025844|NCT03837132|Advanced Pancreatic Cancer|advanced pancreatic cancer
5025845|NCT03837132|Early Palliative Care|early palliative care
5025846|NCT03837132|Quality of Life|quality of life
5025847|NCT03837119|pregnancy|pregnancy
5025848|NCT03837119|gestational diabetes|gestational diabetes
5025849|NCT03837119|cholestasis in pregnancy|cholestasis in pregnancy
5025850|NCT03837119|urinary tract infection in pregnancy|urinary tract infection in pregnancy
5025851|NCT03837093|Low dose of IL-2|low dose of il-2
5025852|NCT03837093|Healthy volunteers|healthy volunteers
5025853|NCT03837093|Kinetic study|kinetic study
5025854|NCT03837080|chronic pain|chronic pain
5025855|NCT03837080|nutrition education|nutrition education
5025856|NCT03837080|inflammatory biomarkers|inflammatory biomarkers
5025857|NCT03837067|Domperidone|domperidone
5025858|NCT03837041|total knee arthroplasty|total knee arthroplasty
5025859|NCT03837041|Proprioception|proprioception
5025860|NCT03837041|osteoarthritis|osteoarthritis
5025861|NCT03837002|Foot Disease|foot disease
5025862|NCT03837002|Foot Care Protocol|foot care protocol
5025863|NCT03837002|Nursing Care|nursing care
5025864|NCT03836989|Facial Paralysis|facial paralysis
5025865|NCT03836989|Bell Palsy|bell palsy
5025866|NCT03836989|Electrical Stimulation|electrical stimulation
5020177|NCT03871075|PAD|pad
5025867|NCT03836976|mild traumatic brain injury|mild traumatic brain injury
5025871|NCT03836963|Parkinson's disease|parkinson's disease
5025872|NCT03836963|cognition|cognition
5025873|NCT03836963|cognitive training|cognitive training
5025874|NCT03836963|prospective memory|prospective memory
5025875|NCT03836963|executive function|executive function
5025876|NCT03836950|rTMS|rtms
5025877|NCT03836950|Parkinson's disease|parkinson's disease
5025878|NCT03836950|mild cognitive impairment|mild cognitive impairment
5025879|NCT03836950|executive function|executive function
5025880|NCT03836950|neuromodulation|neuromodulation
5025881|NCT03836950|functional connectivity|functional connectivity
5025882|NCT03836924|E2007|e2007
5025883|NCT03836924|Fycompa|fycompa
5025884|NCT03836924|Perampanel|perampanel
5025885|NCT03836924|Prospective|prospective
5025886|NCT03836924|Partial onset seizures|partial onset seizures
5025887|NCT03836924|Epilepsy|epilepsy
5025888|NCT03836924|Seizures|seizures
5025889|NCT03836911|Institutionalized olders adults|institutionalized olders adults
5025890|NCT03836911|SERIOUS GAME|serious game
5025891|NCT03836820|Rheumatoid Arhritis|rheumatoid arhritis
5025892|NCT03836820|Pilates exercises|pilates exercises
5025893|NCT03836820|Fatigue|fatigue
5025894|NCT03836755|osseointegration|osseointegration
5025895|NCT03836755|implant migration|implant migration
5025896|NCT03836755|amputee|amputee
5025897|NCT03836729|Human immunodeficiency virus|human immunodeficiency virus
5025898|NCT03836729|Sequential|sequential
5025899|NCT03836729|Tenofovir alafenamide|tenofovir alafenamide
5025900|NCT03836729|Emtricitabine|emtricitabine
5025901|NCT03836729|GSK3640254|gsk3640254
5025904|NCT03836703|Pregnancy, Twins , Iron Deficiency Anaemia|pregnancy, twins , iron deficiency anaemia
5025905|NCT03836677|COPD|copd
5025909|NCT03836651|metabolic syndrome|metabolic syndrome
5025911|NCT03836638|Botulinum Toxin|botulinum toxin
5025912|NCT03836638|Rejuvenation|rejuvenation
5025913|NCT03836638|Age|age
5025914|NCT03836638|Wrinkles|wrinkles
5025915|NCT03836638|Rhytidis|rhytidis
5025916|NCT03836599|Uric acid transporter 1 (URAT1) Inhibitor|uric acid transporter 1 (urat1) inhibitor
5025917|NCT03836599|Xantine oxidoreductase inhibitor|xantine oxidoreductase inhibitor
5025918|NCT03836599|Pharmacokinetics|pharmacokinetics
5025919|NCT03836599|Verinurad|verinurad
5025925|NCT03836560|nicotine replacement therapy|nicotine replacement therapy
5025926|NCT03836560|smoking cessation|smoking cessation
5026053|NCT03835832|Sensitivity|sensitivity
5025928|NCT03836482|Awaiting Left ventricular assist device implantation|awaiting left ventricular assist device implantation
5025929|NCT03836482|Hospitalized|hospitalized
5025932|NCT03836443|NAFLD, toxic lipids, postprandial lipotoxicity|nafld, toxic lipids, postprandial lipotoxicity
5025933|NCT03836430|newborn behavioral observation|newborn behavioral observation
5025934|NCT03836430|late preterm|late preterm
5025935|NCT03836430|postpartum depression|postpartum depression
5025936|NCT03836404|Bone substitute|bone substitute
5025937|NCT03836404|Bone regeneration|bone regeneration
5025938|NCT03836391|Mobile health|mobile health
5025939|NCT03836391|Physical activity|physical activity
5025940|NCT03836391|Nutrition|nutrition
5025941|NCT03836391|Self-monitoring|self-monitoring
5025942|NCT03836391|Smartphone app|smartphone app
5025943|NCT03836391|Digital health tools|digital health tools
5025944|NCT03836365|Pelvic organ prolapse|pelvic organ prolapse
5025945|NCT03836365|Patient preparedness|patient preparedness
5025946|NCT03836365|Randomized controlled trial|randomized controlled trial
5340967|NCT01990235|vulnerable population|vulnerable population
5025947|NCT03836352|T cell activation|t cell activation
5025948|NCT03836352|Immunotherapy|immunotherapy
5025949|NCT03836352|Ovarian|ovarian
5025950|NCT03836352|Hepatocellular Carcinoma|hepatocellular carcinoma
5025951|NCT03836352|Non-small Cell Lung|non-small cell lung
5025952|NCT03836352|Bladder|bladder
5025953|NCT03836352|Microsatellite Instability-High|microsatellite instability-high
5025954|NCT03836352|Survivin|survivin
5025955|NCT03836352|Anti-PD-1|anti-pd-1
5025956|NCT03836352|MK-3475|mk-3475
5025957|NCT03836339|emergency department|emergency department
5025958|NCT03836339|pathway of care|pathway of care
5025959|NCT03836339|assessment|assessment
5025960|NCT03836339|anticoagulants|anticoagulants
5025961|NCT03836326|Prematurity|prematurity
5025962|NCT03836326|Development|development
5025963|NCT03836326|Parental engagement|parental engagement
5025964|NCT03836326|Parental satisfaction|parental satisfaction
5025965|NCT03836300|Early intervention|early intervention
5025966|NCT03836300|Fragile X Syndrome|fragile x syndrome
5025967|NCT03836300|Parent-Child interaction|parent-child interaction
5025968|NCT03836261|CLL|cll
5025969|NCT03836261|Chronic Leukemia Lymphocytic|chronic leukemia lymphocytic
5025970|NCT03836261|Leukemia|leukemia
5025971|NCT03836248|Osteopathic treatment|osteopathic treatment
5025972|NCT03836248|Sham osteopathic treatment|sham osteopathic treatment
5025973|NCT03836248|Low back pain|low back pain
5025974|NCT03836235|older adults|older adults
5025975|NCT03836235|quality of life|quality of life
5025976|NCT03836235|adverse events|adverse events
5026000|NCT03836157|gynecologic cancer|gynecologic cancer
5026001|NCT03836144|Mass spectrometry|mass spectrometry
5026002|NCT03836144|Cystinuria|cystinuria
5026005|NCT03836066|NSCLC, Atezolizumab, Bevacizumab|nsclc, atezolizumab, bevacizumab
5026006|NCT03836040|Migraine|migraine
5026007|NCT03836040|Headache|headache
5026008|NCT03836040|Prevention|prevention
5026009|NCT03836040|Pediatric|pediatric
5026010|NCT03836040|Episodic Migraine|episodic migraine
5026011|NCT03836014|Multiple myeloma|multiple myeloma
5026013|NCT03836014|daratumumab,|daratumumab,
5026014|NCT03836014|lenalidomide|lenalidomide
5026015|NCT03836014|dexamethasone|dexamethasone
5026016|NCT03835988|Embolization|embolization
5026017|NCT03835936|Physical Therapy|physical therapy
5026018|NCT03835936|Respiratory|respiratory
5026023|NCT03835923|cardiovascular risk factors|cardiovascular risk factors
5026024|NCT03835923|health literacy|health literacy
5026025|NCT03835923|telemedicine|telemedicine
5026026|NCT03835923|cross-sectoral care|cross-sectoral care
5026027|NCT03835923|HbA1c|hba1c
5026028|NCT03835923|individual exercise training|individual exercise training
5026029|NCT03835923|dietary change|dietary change
5026030|NCT03835923|sustainability|sustainability
5026031|NCT03835923|heart disease|heart disease
5026032|NCT03835923|nutrition|nutrition
5026033|NCT03835923|exercise|exercise
5026034|NCT03835923|physical activity|physical activity
5026035|NCT03835923|coronary artery disease|coronary artery disease
5026036|NCT03835923|coronary heart disease|coronary heart disease
5026037|NCT03835910|corticosteroid injection|corticosteroid injection
5026038|NCT03835910|physical activity|physical activity
5026039|NCT03835910|pain|pain
5026040|NCT03835910|disability|disability
5026041|NCT03835910|behavioral incentives|behavioral incentives
5026042|NCT03835884|Neovascular AMD|neovascular amd
5026043|NCT03835884|Diabetic macular edema|diabetic macular edema
5026044|NCT03835884|Diabetic retinopathy|diabetic retinopathy
5026045|NCT03835884|Vascular endothelial growth factor|vascular endothelial growth factor
5026046|NCT03835884|Intravitreal injection|intravitreal injection
5026047|NCT03835858|Physical Therapy|physical therapy
5026048|NCT03835858|Respiratory|respiratory
5026049|NCT03835858|Pediatric|pediatric
5026050|NCT03835832|Tuberculin skin test|tuberculin skin test
5026051|NCT03835832|latent TB infection|latent tb infection
5026052|NCT03835832|HIV/TB co-infected participants|hiv/tb co-infected participants
5026054|NCT03835832|Specificity|specificity
5026055|NCT03835832|positive predictive value (PPV)|positive predictive value (ppv)
5026056|NCT03835832|negative predictive value (NPV)|negative predictive value (npv)
5026057|NCT03835819|Endometrial Cancer|endometrial cancer
5026058|NCT03835793|long-term|long-term
5026059|NCT03835793|premature ovarian insufficiency|premature ovarian insufficiency
5026060|NCT03835767|Oral Food Challenge|oral food challenge
5026061|NCT03835767|Atopic Dermatitis|atopic dermatitis
5026062|NCT03835767|Milk|milk
5026063|NCT03835767|Peanut|peanut
5026064|NCT03835767|Food Allergy|food allergy
5026067|NCT03835702|PAP|pap
5026068|NCT03835702|Group|group
5026069|NCT03835702|PAP adherence|pap adherence
5026070|NCT03835689|Behavioural intervention|behavioural intervention
5026071|NCT03835689|E-health intervention|e-health intervention
5026072|NCT03835689|Parenting intervention|parenting intervention
5026073|NCT03835676|Pulmonary hypertension|pulmonary hypertension
5026074|NCT03835676|Right ventricular function|right ventricular function
5026075|NCT03835624|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5327536|NCT02050763|HIV|hiv
5341065|NCT01989624|diagnosis|diagnosis
5026076|NCT03835624|Interleukin 33|interleukin 33
5026077|NCT03835611|Parkinson Disease,|parkinson disease,
5026078|NCT03835611|Balance|balance
5026094|NCT03835533|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5026096|NCT03835533|Platform study|platform study
5026097|NCT03835533|NKTR-214|nktr-214
5026098|NCT03835533|Nivolumab|nivolumab
5026100|NCT03835533|Poly-ICLC|poly-iclc
5026101|NCT03835533|INO-5151|ino-5151
5026102|NCT03835520|Immunotherapy|immunotherapy
5026103|NCT03835520|Molecular Targeted Therapies|molecular targeted therapies
5026104|NCT03835520|Tumor Biopsy|tumor biopsy
5026105|NCT03835520|Plasma Samples|plasma samples
5026106|NCT03835494|Tetralogy of Fallot|tetralogy of fallot
5026107|NCT03835494|Tissue Doppler Imaging|tissue doppler imaging
5026108|NCT03835494|Exercise testing|exercise testing
5026109|NCT03835455|Finger food|finger food
5026110|NCT03835429|oral appliance|oral appliance
5026111|NCT03835429|atrial fibrillation|atrial fibrillation
5026112|NCT03835429|sleep apnea|sleep apnea
5026113|NCT03835429|mouth shield|mouth shield
5026114|NCT03835429|snoring|snoring
5026115|NCT03835416|obesity|obesity
5026116|NCT03835416|prediabetic state|prediabetic state
5026117|NCT03835416|older person|older person
5026118|NCT03835416|diet, reducing|diet, reducing
5026119|NCT03835416|protein|protein
5026120|NCT03835416|muscle function|muscle function
5026121|NCT03835390|Anxiety|anxiety
5026122|NCT03835390|Preparedness|preparedness
5026123|NCT03835390|Spinal Fusion|spinal fusion
5026124|NCT03835377|Iron|iron
5026125|NCT03835377|Biofortification|biofortification
5026126|NCT03835377|Iron deficiency|iron deficiency
5026127|NCT03835377|Anemia|anemia
5026128|NCT03835377|Children|children
5026129|NCT03835377|Mexico|mexico
5026130|NCT03835351|Urinary catheter|urinary catheter
5026131|NCT03835351|Urinary retention|urinary retention
5026132|NCT03835351|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5026133|NCT03835325|Postmenopausal Symptoms, Memory Disorders|postmenopausal symptoms, memory disorders
5026134|NCT03835312|Islets of Langerhans Transplantation|islets of langerhans transplantation
5026135|NCT03835312|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5026136|NCT03835299|blood donor, fear, vasovagal reaction|blood donor, fear, vasovagal reaction
5026137|NCT03835286|critical care|critical care
5026138|NCT03835286|vitamin C|vitamin c
5026139|NCT03835286|vasopressor|vasopressor
5026140|NCT03835286|intensive care unit|intensive care unit
5026141|NCT03835273|Esophagectomy|esophagectomy
5026142|NCT03835273|Motion capture|motion capture
5026143|NCT03835273|Respiratory|respiratory
5026144|NCT03835273|Oesophageal cancer|oesophageal cancer
5026145|NCT03835247|physician-nurse collaboration|physician-nurse collaboration
5026146|NCT03835247|nurse-nurse collaboration|nurse-nurse collaboration
5026147|NCT03835208|gestational diabetes|gestational diabetes
5026148|NCT03835208|carbohydrate distribution|carbohydrate distribution
5026149|NCT03835208|high/low carbohydrate|high/low carbohydrate
5026150|NCT03835208|glycemic variability|glycemic variability
5026151|NCT03835208|MAGE|mage
5026152|NCT03835208|continuous glucose monitoring|continuous glucose monitoring
5026153|NCT03835208|Pregnancy in Diabetics|pregnancy in diabetics
5026154|NCT03835182|lumbar vertebrae|lumbar vertebrae
5026155|NCT03835182|herniated disc|herniated disc
5026156|NCT03835182|radiculopathy|radiculopathy
5026157|NCT03835182|low back pain|low back pain
5026158|NCT03835182|short wave therapy|short wave therapy
5026159|NCT03835182|diathermy|diathermy
5026160|NCT03835182|ultrasonic waves|ultrasonic waves
5026161|NCT03835169|Cardiac intensive care unit|cardiac intensive care unit
5026162|NCT03835169|Organization|organization
5026163|NCT03835169|Prognostic score|prognostic score
5026164|NCT03835117|Mitochondrial Dysfunction|mitochondrial dysfunction
5026165|NCT03835104|diagnosis|diagnosis
5026166|NCT03835104|sensitivity and specificity|sensitivity and specificity
5026167|NCT03835104|serious infections|serious infections
5026168|NCT03835065|Displaced distal third forearm|displaced distal third forearm
5026169|NCT03835065|Pediatric Patients|pediatric patients
5026170|NCT03835065|Closed reduction|closed reduction
5026171|NCT03835065|Cast|cast
5026172|NCT03835065|Patient centered outcome data|patient centered outcome data
5026173|NCT03835065|RCT|rct
5026174|NCT03835052|Survivorship|survivorship
5026175|NCT03835000|virtual patient|virtual patient
5026176|NCT03835000|joint modeling|joint modeling
5026177|NCT03835000|biomechanical simulation|biomechanical simulation
5026178|NCT03835000|surgery mechanical results|surgery mechanical results
5026179|NCT03834987|NGLY1 Deficiency|ngly1 deficiency
5026180|NCT03834961|Larotrectinib|larotrectinib
5026181|NCT03834961|TRK fusion|trk fusion
5026182|NCT03834961|NTRK fusion|ntrk fusion
5026183|NCT03834961|Infantile fibrosarcoma|infantile fibrosarcoma
5026184|NCT03834948|CD47|cd47
5026185|NCT03834948|AO-176|ao-176
5026186|NCT03834948|Immunotherapy|immunotherapy
5026187|NCT03834935|pityriasis alba|pityriasis alba
5341198|NCT01989052|CTO|cto
5026188|NCT03834935|treatment|treatment
5718613|NCT00436501|docetaxel|docetaxel
5026189|NCT03834935|topical calcineurin inhibitor|topical calcineurin inhibitor
5026190|NCT03834922|Acute pain|acute pain
5026191|NCT03834922|Chronification of pain|chronification of pain
5026192|NCT03834922|Pain treatment|pain treatment
5026193|NCT03834922|Pain management|pain management
5026194|NCT03834922|Postoperative pain|postoperative pain
5026195|NCT03834909|HIV Prevention|hiv prevention
5026196|NCT03834909|Healthy Volunteer|healthy volunteer
5026197|NCT03834844|Symptom Management|symptom management
5026198|NCT03834844|Quality of Life|quality of life
5026199|NCT03834844|Anxiety|anxiety
5026200|NCT03834831|Male infertility|male infertility
5026201|NCT03834831|Coenzyme Q10|coenzyme q10
5026202|NCT03834831|Selenium|selenium
5026203|NCT03834831|Antioxidants|antioxidants
5026204|NCT03834818|opioid use|opioid use
5026231|NCT03834675|cardiac output|cardiac output
5026232|NCT03834662|Solid tumors|solid tumors
5026233|NCT03834623|melanoma|melanoma
5026234|NCT03834623|skin|skin
5026235|NCT03834610|Erectile dysfunction|erectile dysfunction
5026236|NCT03834610|Diabetes|diabetes
5026237|NCT03834610|Tadaladil|tadaladil
5026238|NCT03834610|L-arginine|l-arginine
5026244|NCT03834571|Cervical Cancer|cervical cancer
5026245|NCT03834571|HIV Infection|hiv infection
5026246|NCT03834558|Sarcopenia|sarcopenia
5026247|NCT03834558|Frailty|frailty
5026248|NCT03834558|Strength|strength
5026250|NCT03834558|image biomarkers|image biomarkers
5026257|NCT03834480|Platelet reach plasma|platelet reach plasma
5026258|NCT03834480|sacroiliac|sacroiliac
5026259|NCT03834480|Ultrasound|ultrasound
5026260|NCT03834480|Steroid|steroid
5026261|NCT03834480|Chronic low back Pain|chronic low back pain
5026262|NCT03834467|psychopathic traits|psychopathic traits
5026263|NCT03834467|moral elevation|moral elevation
5026264|NCT03834467|prosocial behavior|prosocial behavior
5026265|NCT03834454|pregnancy|pregnancy
5026266|NCT03834454|caesarean section|caesarean section
5026267|NCT03834454|spinal anesthesia|spinal anesthesia
5026268|NCT03834454|bupivacaine|bupivacaine
5026269|NCT03834454|opioid|opioid
5026270|NCT03834454|hypotension|hypotension
5026271|NCT03834454|intraoperative|intraoperative
5026272|NCT03834454|postoperative|postoperative
5026273|NCT03834441|social needs|social needs
5026274|NCT03834428|Text message reminder|text message reminder
5026275|NCT03834428|ICOUGH protocol|icough protocol
5026276|NCT03834428|IText|itext
5026277|NCT03834428|Safety net hospital|safety net hospital
5026278|NCT03834428|Inpatient|inpatient
5026279|NCT03834402|Mild Cognitive Impairment|mild cognitive impairment
5026280|NCT03834402|Alzheimer Disease|alzheimer disease
5026281|NCT03834389|case- based learning|case- based learning
5026282|NCT03834389|critical thinking|critical thinking
5026283|NCT03834389|self-efficacy|self-efficacy
5026284|NCT03834389|nursing education|nursing education
5026285|NCT03834389|nursing|nursing
5026286|NCT03834363|COPD|copd
5026287|NCT03834363|Refractory Dyspnea|refractory dyspnea
5026288|NCT03834363|Morphine|morphine
5026289|NCT03834363|Fentanyl|fentanyl
5026290|NCT03834324|Functional Electrical Stimulation|functional electrical stimulation
5026291|NCT03834324|Cycling|cycling
5026292|NCT03834324|Virtual Reality|virtual reality
5026293|NCT03834272|Gastrointestinal Cancer|gastrointestinal cancer
5026294|NCT03834272|Ovarian Cancer|ovarian cancer
5026295|NCT03834272|Mesothelioma|mesothelioma
5026296|NCT03834272|Peritoneal surface malignancies|peritoneal surface malignancies
5026297|NCT03834259|spinal anaesthesia|spinal anaesthesia
5026298|NCT03834259|ephedrine|ephedrine
5026299|NCT03834246|Prognostic Factors|prognostic factors
5026300|NCT03834246|intensive care unit|intensive care unit
5026301|NCT03834207|C3-Cloud|c3-cloud
5026302|NCT03834207|Multimorbidity|multimorbidity
5026303|NCT03834207|Diabetes Type 2|diabetes type 2
5026304|NCT03834207|Heart Failure|heart failure
5026305|NCT03834207|Cardiac Failure|cardiac failure
5026314|NCT03834207|Polypharmacy|polypharmacy
5026315|NCT03834207|Integrated Care|integrated care
5026316|NCT03834207|Clinical Decision Support|clinical decision support
5026317|NCT03834194|excessive weight gain|excessive weight gain
5026318|NCT03834194|pregnancy|pregnancy
5026319|NCT03834181|Connected devices|connected devices
5026320|NCT03834181|Telemetry|telemetry
5026321|NCT03834181|Obesity surgery|obesity surgery
5026322|NCT03834168|Diurnal Rhythm|diurnal rhythm
5026324|NCT03834142|Auriculotherapy|auriculotherapy
5026325|NCT03834142|Pain Therapy|pain therapy
5026326|NCT03834077|physiotherapy|physiotherapy
5026327|NCT03834025|Opioid Abuse Disorder|opioid abuse disorder
5026328|NCT03833999|ondansetron|ondansetron
5718614|NCT00436501|RP 56976|rp 56976
5026329|NCT03833999|small bowel water|small bowel water
5026330|NCT03833973|Training|training
5026331|NCT03833973|Cell free plasma DNA|cell free plasma dna
5026332|NCT03833973|Oxidative stress|oxidative stress
5026333|NCT03833973|Performance|performance
5026334|NCT03833960|breast cancer|breast cancer
5341260|NCT01988831|betablocker|betablocker
5026335|NCT03833960|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5026336|NCT03833960|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5026337|NCT03833960|locoregional recurrence|locoregional recurrence
5026338|NCT03833960|distant recurrence|distant recurrence
5026339|NCT03833947|Intracuff Dexamethasone|intracuff dexamethasone
5026340|NCT03833947|Intracuff Alkalinized lignocaine|intracuff alkalinized lignocaine
5026341|NCT03833947|General anesthesia|general anesthesia
5026342|NCT03833934|ALK positive|alk positive
5026343|NCT03833921|Abiraterone acetate|abiraterone acetate
5026344|NCT03833921|hormone naive prostate cancer|hormone naive prostate cancer
5026345|NCT03833895|Cesarean delivery|cesarean delivery
5026346|NCT03833817|advance care planning|advance care planning
5026347|NCT03833817|prognostic understanding|prognostic understanding
5026348|NCT03833817|communication|communication
5026349|NCT03833804|natural language processing|natural language processing
5026350|NCT03833804|machine learning|machine learning
5026351|NCT03833804|artificial intelligence|artificial intelligence
5026352|NCT03833804|clinical decision support|clinical decision support
5026364|NCT03833752|BPH|bph
5026365|NCT03833739|Class II division 2|class ii division 2
5026366|NCT03833739|Alignment|alignment
5026367|NCT03833739|Leveling|leveling
5026368|NCT03833726|Vaginal Atrophy|vaginal atrophy
5026369|NCT03833726|Breast Cancer|breast cancer
5026370|NCT03833726|Hormonal Therapy|hormonal therapy
5026371|NCT03833726|Photodynamic Therapy|photodynamic therapy
5026372|NCT03833726|Light Emitting Diode|light emitting diode
5026373|NCT03833713|text message|text message
5026374|NCT03833713|behavioral intervention|behavioral intervention
5026375|NCT03833713|motor vehicle|motor vehicle
5026379|NCT03833674|acute intermittent hypoxia (AIH)|acute intermittent hypoxia (aih)
5026380|NCT03833674|spinal neuroplasticity|spinal neuroplasticity
5026381|NCT03833674|motor function|motor function
5026382|NCT03833674|respiratory strength training|respiratory strength training
5026383|NCT03833674|respiration|respiration
5026384|NCT03833674|breathing|breathing
5026385|NCT03833674|plasticity|plasticity
5026386|NCT03833661|M7824|m7824
5026387|NCT03833661|Bintrafusp alfa (proposed INN)|bintrafusp alfa (proposed inn)
5026388|NCT03833661|Transforming growth factor-beta|transforming growth factor-beta
5026389|NCT03833661|First-line Platinum-Based Chemotherapy|first-line platinum-based chemotherapy
5026390|NCT03833661|Programmed death-ligand 1|programmed death-ligand 1
5026391|NCT03833661|Metastatic Biliary Tract Cancer|metastatic biliary tract cancer
5026392|NCT03833661|Cholangiocarcinoma|cholangiocarcinoma
5026393|NCT03833661|Gallbladder cancer|gallbladder cancer
5026394|NCT03833661|INTR@PID BTC 047|intr@pid btc 047
5026395|NCT03833596|Corticosteroids|corticosteroids
5026396|NCT03833596|Exclusive Enteral Nutrition|exclusive enteral nutrition
5026397|NCT03833583|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5026398|NCT03833583|tDCS|tdcs
5026399|NCT03833583|Brain Stimulation|brain stimulation
5026400|NCT03833583|Cocaine Addiction|cocaine addiction
5026401|NCT03833583|Drug Craving|drug craving
5026402|NCT03833570|Melatonin|melatonin
5026403|NCT03833557|Formocresol|formocresol
5026404|NCT03833557|MTA|mta
5026405|NCT03833557|Nanohydroxyapatite|nanohydroxyapatite
5026406|NCT03833557|Pulpotomy|pulpotomy
5026430|NCT03833427|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5428227|NCT01595581|ACL Reconstruction|acl reconstruction
5026431|NCT03833427|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5026432|NCT03833414|intra-articular fractures; distal humerus; osteotomy; elbow joint|intra-articular fractures; distal humerus; osteotomy; elbow joint
5026433|NCT03833375|TBI|tbi
5026434|NCT03833375|stroke|stroke
5026435|NCT03833375|ICH|ich
5026436|NCT03833375|AIS|ais
5026437|NCT03833375|decision aid|decision aid
5026438|NCT03833375|shared decision making|shared decision making
5026439|NCT03833375|neurocritical care|neurocritical care
5026440|NCT03833375|SABI|sabi
5026441|NCT03833375|surrogate|surrogate
5026442|NCT03833349|Parkinson's disease|parkinson's disease
5026443|NCT03833349|fatigue|fatigue
5026444|NCT03833349|anxiety|anxiety
5026445|NCT03833349|depression|depression
5026446|NCT03833349|exercise|exercise
5026447|NCT03833336|heart failure|heart failure
5026448|NCT03833336|preserved ejection fraction|preserved ejection fraction
5026449|NCT03833336|ferropenic anemia|ferropenic anemia
5026451|NCT03833323|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5026452|NCT03833323|Pulmonary Hypertension|pulmonary hypertension
5026453|NCT03833323|Remodulin|remodulin
5026454|NCT03833323|treprostinil|treprostinil
5026455|NCT03833323|DelIVery for PAH|delivery for pah
5026456|NCT03833323|Implantable Pump|implantable pump
5026457|NCT03833323|Drug Pump|drug pump
5026458|NCT03833323|Intrathecal Catheter|intrathecal catheter
5026459|NCT03833323|Targeted Drug Delivery|targeted drug delivery
5026460|NCT03833323|Programmable Pump|programmable pump
5026461|NCT03833297|hepatological disease|hepatological disease
5026462|NCT03833297|hepatotoxicity|hepatotoxicity
5026463|NCT03833297|chemotherapies|chemotherapies
5026464|NCT03833297|drugs|drugs
5026465|NCT03833284|Transvaginal Ultrasound|transvaginal ultrasound
5026466|NCT03833284|Telemedicine|telemedicine
5026467|NCT03833258|THR|thr
5026469|NCT03833258|Total Hip Arthroplasty|total hip arthroplasty
5026470|NCT03833258|Total Hip Replacement|total hip replacement
5026471|NCT03833219|distracted driving automobile|distracted driving automobile
5026472|NCT03833219|behavioral economics|behavioral economics
5026473|NCT03833219|usage-based insurance|usage-based insurance
5026474|NCT03833219|auto insurance|auto insurance
5026475|NCT03833219|automobile|automobile
5026476|NCT03833219|smartphone application|smartphone application
5026477|NCT03833193|Hypofractionated radiotherapy;|hypofractionated radiotherapy;
5026478|NCT03833193|Radiation-reduced esophagitis;|radiation-reduced esophagitis;
5026479|NCT03833193|Radiation-reduced pneumonitis;Predictor|radiation-reduced pneumonitis;predictor
5026519|NCT03833024|chronic venous insufficiency|chronic venous insufficiency
5026520|NCT03833024|venoactive drug|venoactive drug
5026521|NCT03833024|Micronized Purified Flavonoid Fraction|micronized purified flavonoid fraction
5026522|NCT03833024|DVT|dvt
5026523|NCT03833024|post thrombotic syndrome|post thrombotic syndrome
5026524|NCT03832998|Migraine|migraine
5026525|NCT03832998|Headache|headache
5026526|NCT03832998|Prevention|prevention
5026527|NCT03832998|Pediatric|pediatric
5026528|NCT03832998|Chronic Migraine|chronic migraine
5026529|NCT03832985|adult-onset|adult-onset
5026530|NCT03832985|pediatric|pediatric
5026531|NCT03832985|genomic|genomic
5026532|NCT03832985|genetic|genetic
5026533|NCT03832972|menstrual cycle|menstrual cycle
5026534|NCT03832972|Estrogen|estrogen
5026535|NCT03832972|performance|performance
5026536|NCT03832972|variation|variation
5026540|NCT03832933|weight loss|weight loss
5026541|NCT03832933|dietary protein|dietary protein
5026542|NCT03832920|general anesthesia|general anesthesia
5026543|NCT03832920|paravertebral Block|paravertebral block
5026544|NCT03832920|analgesia nociception index|analgesia nociception index
5026545|NCT03832907|Glucose monitoring|glucose monitoring
5026546|NCT03832907|POC BG|poc bg
5026547|NCT03832907|DexcomG6 CGM|dexcomg6 cgm
5026548|NCT03832894|IVF|ivf
5026549|NCT03832894|ICSI|icsi
5026550|NCT03832894|oestradiol|oestradiol
5026551|NCT03832894|long protocol|long protocol
5026552|NCT03832868|Decision aid|decision aid
5026553|NCT03832842|ECMO|ecmo
5026554|NCT03832842|thrombin generation test|thrombin generation test
5026555|NCT03832842|hemostasis|hemostasis
5026556|NCT03832842|bleeding events|bleeding events
5026557|NCT03832842|thrombotic events|thrombotic events
5026558|NCT03832816|cortisol|cortisol
5026560|NCT03832816|Heart rate|heart rate
5026561|NCT03832816|delta9-Tetrahydrocannabinol|delta9-tetrahydrocannabinol
5026562|NCT03832816|cannabidiol|cannabidiol
5026563|NCT03832777|Borderline Personality Disorder|borderline personality disorder
5026564|NCT03832777|Personality Disorders|personality disorders
5026565|NCT03832764|skin impedance|skin impedance
5026566|NCT03832764|pain monitoring|pain monitoring
5026567|NCT03832764|observational study|observational study
5026568|NCT03832764|PACU/ICU|pacu/icu
5026569|NCT03832738|JTE-451|jte-451
5026570|NCT03832738|Psoriasis|psoriasis
5026571|NCT03832738|Plaque psoriasis|plaque psoriasis
5026572|NCT03832738|IMPACT-PS|impact-ps
5026573|NCT03832725|Type 2 Diabetes|type 2 diabetes
5026574|NCT03832725|obesity|obesity
5026575|NCT03832725|pathobiology|pathobiology
5026576|NCT03832712|Deep Brain Stimulation|deep brain stimulation
5026585|NCT03832621|temozolomide|temozolomide
5026586|NCT03832621|microsatellite stable|microsatellite stable
5026587|NCT03832621|MSS|mss
5026588|NCT03832621|MGMT|mgmt
5026589|NCT03832608|Older adult|older adult
5026590|NCT03832608|Sarcopenia|sarcopenia
5026591|NCT03832608|Frailty|frailty
5026592|NCT03832608|Functionality|functionality
5026593|NCT03832608|Muscle strength|muscle strength
5026594|NCT03832608|Muscle mass|muscle mass
5026595|NCT03832608|Walk speed|walk speed
5026596|NCT03832595|electronic health record|electronic health record
5026597|NCT03832595|population health management|population health management
5026598|NCT03832595|patient education|patient education
5020799|NCT03866837|Lactoferrin|lactoferrin
5020800|NCT03866837|Ferrous fumarate|ferrous fumarate
5020801|NCT03866837|Clinical trial|clinical trial
5026599|NCT03832595|medication therapy management|medication therapy management
5026600|NCT03832595|electronic consultation|electronic consultation
5026601|NCT03832595|randomized controlled trial|randomized controlled trial
5026602|NCT03832595|pragmatic trial|pragmatic trial
5026603|NCT03832582|Aorta|aorta
5026604|NCT03832582|Type B dissection|type b dissection
5026605|NCT03832582|Descending aorta dissection|descending aorta dissection
5026606|NCT03832582|Annexin|annexin
5026616|NCT03832530|conception|conception
5026617|NCT03832530|prevention|prevention
5026624|NCT03832478|Virtual Reality|virtual reality
5026625|NCT03832478|Meditation|meditation
5026626|NCT03832478|Mindfulness Meditation|mindfulness meditation
5026627|NCT03832478|Guided Mindfulness Meditation|guided mindfulness meditation
5026628|NCT03832478|Anxiety|anxiety
5026629|NCT03832478|Pain|pain
5026647|NCT03832244|sub-mental ultrasonography|sub-mental ultrasonography
5026648|NCT03832244|obstructive sleep apnea|obstructive sleep apnea
5026649|NCT03832231|Shear wave elastography|shear wave elastography
5026650|NCT03832231|Ultrasonography|ultrasonography
5026651|NCT03832231|Transdiaphragmatic pressure|transdiaphragmatic pressure
5026652|NCT03832231|Diaphragmatic function|diaphragmatic function
5026653|NCT03832231|Mechanical ventilation|mechanical ventilation
5026654|NCT03832192|patient satisfaction|patient satisfaction
5026655|NCT03832192|HCAHPS|hcahps
5026656|NCT03832192|loneliness|loneliness
5026657|NCT03832192|delirium|delirium
5026658|NCT03832192|falls|falls
5026659|NCT03832192|HELP|help
5026660|NCT03832192|hospitals|hospitals
5026661|NCT03832192|geriatrics|geriatrics
5026662|NCT03832192|elder care|elder care
5026663|NCT03832166|CKD|ckd
5026664|NCT03832166|Low Income|low income
5026665|NCT03832166|Diet|diet
5026666|NCT03832166|Fruits and Vegetables|fruits and vegetables
5026667|NCT03832153|Bioprinting|bioprinting
5026668|NCT03832153|thrombus aspiration|thrombus aspiration
5026669|NCT03832153|micro-CT|micro-ct
5026670|NCT03832088|osteoporosis|osteoporosis
5026671|NCT03832088|sarcopenia|sarcopenia
5026672|NCT03832088|balance disorder|balance disorder
5026673|NCT03832075|osteoporosis|osteoporosis
5026674|NCT03832075|balance|balance
5026675|NCT03832075|berg balance scale|berg balance scale
5026676|NCT03832075|korebalance balance system|korebalance balance system
5026677|NCT03832049|HPV vaccination in healthy females|hpv vaccination in healthy females
5026678|NCT03832036|Electromyography|electromyography
5026679|NCT03832036|Paraspinal Mapping|paraspinal mapping
5026680|NCT03832036|Quantitative clinical tests|quantitative clinical tests
5026681|NCT03832036|Conditioned pain modulation|conditioned pain modulation
5026682|NCT03832036|Temporal pain summation|temporal pain summation
5026683|NCT03832036|Pain threshold|pain threshold
5026684|NCT03832036|Pain tolerance|pain tolerance
5026685|NCT03832023|Children|children
5026686|NCT03832023|Contact tracing|contact tracing
5026687|NCT03832023|Preventive therapy|preventive therapy
5026688|NCT03832023|Prophylaxis|prophylaxis
5026689|NCT03832023|Community health workers|community health workers
5026690|NCT03832023|Community-based distribution|community-based distribution
5026691|NCT03832023|Standard of care|standard of care
5026692|NCT03832023|Screening|screening
5026693|NCT03832023|Randomized controlled trial|randomized controlled trial
5026694|NCT03832023|Cameroon|cameroon
5026695|NCT03832023|Uganda|uganda
5026696|NCT03832023|Patient outcome assessment|patient outcome assessment
5026697|NCT03832010|Topical steroid|topical steroid
5026698|NCT03832010|Crisaborole|crisaborole
5026699|NCT03832010|Topical calcineurin inhibitor|topical calcineurin inhibitor
5026700|NCT03831984|Phacoemulsification|phacoemulsification
5026701|NCT03831984|femtosecond laser|femtosecond laser
5026732|NCT03831802|mhealth|mhealth
5026733|NCT03831802|quality of life|quality of life
5026734|NCT03831776|Bosupeg|bosupeg
5026735|NCT03831776|Ropeginterferon|ropeginterferon
5026736|NCT03831750|ulcerative colitis|ulcerative colitis
5026737|NCT03831750|remission|remission
5026738|NCT03831750|perceived stress|perceived stress
5026739|NCT03831750|fecal calprotectin|fecal calprotectin
5026740|NCT03831750|salivary stress biomarker|salivary stress biomarker
5026741|NCT03831750|psychological stress|psychological stress
5026742|NCT03831750|stress reduction|stress reduction
5026743|NCT03831750|Crohn's disease|crohn's disease
5026744|NCT03831750|Inflammatory bowel diseases|inflammatory bowel diseases
5026745|NCT03831698|Omega 3|omega 3
5026746|NCT03831685|sepsis|sepsis
5026747|NCT03831685|lactate|lactate
5026748|NCT03831685|prehospital|prehospital
5026749|NCT03831685|prediction|prediction
5026750|NCT03831685|mortality|mortality
5026751|NCT03831672|intracranial aneurysm|intracranial aneurysm
5026752|NCT03831672|outcome|outcome
5026753|NCT03831672|occlusion|occlusion
5026754|NCT03831672|Pipeline embolization device|pipeline embolization device
5026755|NCT03831672|endovascular treatment|endovascular treatment
5026756|NCT03831672|flow diversion|flow diversion
5026757|NCT03831659|migraine|migraine
5026758|NCT03831659|in vitro fertilization|in vitro fertilization
5026759|NCT03831659|infertility|infertility
5026760|NCT03831646|atopic dermatitis|atopic dermatitis
5026761|NCT03831646|psoriasis|psoriasis
5026762|NCT03831646|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5026763|NCT03831646|depression|depression
5026764|NCT03831646|gender|gender
5026765|NCT03831646|immunoglobulin E|immunoglobulin e
5026766|NCT03831646|cortisol|cortisol
5026767|NCT03831646|testosterone|testosterone
5026768|NCT03831607|Tenapanor|tenapanor
5026769|NCT03831607|Hyperphosphatemia|hyperphosphatemia
5026770|NCT03831607|Hemodialysis|hemodialysis
5026771|NCT03831594|stroke|stroke
5026772|NCT03831594|galvanic vestibular stimulation|galvanic vestibular stimulation
5026773|NCT03831581|Erector Spinae Plane|erector spinae plane
5026774|NCT03831581|Erector Spinae Plane Block|erector spinae plane block
5026775|NCT03831568|Airway management|airway management
5026776|NCT03831568|Cough|cough
5026777|NCT03831568|Neuromuscular diseases|neuromuscular diseases
5026778|NCT03831568|Pediatrics|pediatrics
5026779|NCT03831568|Mechanical insufflation-exsufflation|mechanical insufflation-exsufflation
5026780|NCT03831555|Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment tool|psychosocial readiness evaluation and preparation for hepatitis c treatment tool
5026781|NCT03831542|follicular flushing|follicular flushing
5026782|NCT03831542|double lumen needle|double lumen needle
5026783|NCT03831529|critically ill|critically ill
5026784|NCT03831529|mortality|mortality
5026785|NCT03831529|outcome|outcome
5026786|NCT03831529|treatment intensity level|treatment intensity level
5026787|NCT03831516|Ablation|ablation
5026788|NCT03831516|Ventricular Tachycardia|ventricular tachycardia
5026789|NCT03831516|Mapping|mapping
5026790|NCT03831490|screening|screening
5026791|NCT03831490|biomarkers|biomarkers
5026792|NCT03831490|prediction|prediction
5026793|NCT03831477|fractional radiofrequency|fractional radiofrequency
5026794|NCT03831477|fractional RF|fractional rf
5026795|NCT03831477|wrinkles|wrinkles
5026796|NCT03831477|facial wrinkles|facial wrinkles
5026797|NCT03831451|stroke preparedness|stroke preparedness
5026798|NCT03831451|behavioral intervention|behavioral intervention
5026799|NCT03831425|CoQ10|coq10
5026800|NCT03831425|muscle function|muscle function
5026801|NCT03831425|attention span|attention span
5026802|NCT03831425|quality of life|quality of life
5026803|NCT03831399|Frailty|frailty
5026804|NCT03831399|Aged|aged
5026805|NCT03831399|Leucine|leucine
5026806|NCT03831399|Sarcopenia|sarcopenia
5026807|NCT03831373|Exercise|exercise
5026808|NCT03831308|Breast cancer|breast cancer
5026809|NCT03831308|Physical exercise and Breast Cancer|physical exercise and breast cancer
5026810|NCT03831308|Cognitive status and Breast Cancer|cognitive status and breast cancer
5028651|NCT03820479|Quality of recovery|quality of recovery
5026821|NCT03831230|predictive tests|predictive tests
5026822|NCT03831230|tumor models|tumor models
5026823|NCT03831217|Trans-Obturator Tape|trans-obturator tape
5041295|NCT03740750|heat|heat
5026826|NCT03831204|impedance|impedance
5026827|NCT03831204|dyspnea|dyspnea
5026829|NCT03831204|BNP|bnp
5026830|NCT03831204|EFFECT|effect
5026831|NCT03831204|GWTG-HF|gwtg-hf
5026834|NCT03831165|acyclovir|acyclovir
5026835|NCT03831165|melatonin|melatonin
5026838|NCT03831061|Mild Cognitive Impairment|mild cognitive impairment
5026839|NCT03831061|Elderly|elderly
5026840|NCT03831061|Randomized Controlled Trial|randomized controlled trial
5026841|NCT03831061|Cognitive Stimulation|cognitive stimulation
5026842|NCT03831061|Cognitive Intervention|cognitive intervention
5026845|NCT03831035|Fast trio exome|fast trio exome
5026846|NCT03831035|Multiple congenital malformation|multiple congenital malformation
5026847|NCT03831035|Intensive care unit|intensive care unit
5026848|NCT03831035|Neurological distress|neurological distress
5026849|NCT03831022|shock|shock
5026850|NCT03831022|sepsis|sepsis
5026851|NCT03831022|haemoragy|haemoragy
5026852|NCT03831022|intensive care unit|intensive care unit
5026853|NCT03831022|prediction|prediction
5026854|NCT03830983|Cardioembolic stroke|cardioembolic stroke
5026855|NCT03830983|Cardiac MRI|cardiac mri
5026856|NCT03830983|Heart disease|heart disease
5026857|NCT03830983|Vascular disease|vascular disease
5026858|NCT03830970|Mixed Beans|mixed beans
5026859|NCT03830944|ST elevation myocardial infarction|st elevation myocardial infarction
5026860|NCT03830944|Inflammatory Response|inflammatory response
5026861|NCT03830944|Coronary plaque vulnerability|coronary plaque vulnerability
5026862|NCT03830944|myocardial viability|myocardial viability
5026863|NCT03830931|Hyperglycemia, arthroplasty , complication|hyperglycemia, arthroplasty , complication
5026864|NCT03830918|Small Cell Lung Cancer|small cell lung cancer
5026866|NCT03830918|PARP Inhibitor|parp inhibitor
5026867|NCT03830918|Maintenance Therapy|maintenance therapy
5026871|NCT03830853|CTO - chronic total occlusion|cto - chronic total occlusion
5026872|NCT03830853|OCT - optical coherence tomography|oct - optical coherence tomography
5026873|NCT03830853|coronary physiology|coronary physiology
5026874|NCT03830853|absolute flow|absolute flow
5026875|NCT03830840|Type 2 diabetes|type 2 diabetes
5026876|NCT03830840|Cardio-metabolic disease|cardio-metabolic disease
5026877|NCT03830840|Latino/Hispanic|latino/hispanic
5026878|NCT03830840|Especialista|especialista
5026879|NCT03830840|Community health worker|community health worker
5026880|NCT03830840|Social determinants of health|social determinants of health
5026881|NCT03830840|LatinX|latinx
5026882|NCT03830814|Sacubitril/Valsartan|sacubitril/valsartan
5026883|NCT03830814|Heart Failure|heart failure
5026884|NCT03830814|Ejection Fraction|ejection fraction
5026885|NCT03830801|Barrett's Esophagus|barrett's esophagus
5026886|NCT03830801|EGD|egd
5026887|NCT03830801|Endoscopy|endoscopy
5026888|NCT03830801|Biopsy|biopsy
5026889|NCT03830801|Tethered Capulse Endomicroscopy|tethered capulse endomicroscopy
5026890|NCT03830801|OCT|oct
5026891|NCT03830788|SBRT|sbrt
5026892|NCT03830788|brachytherapy|brachytherapy
5026893|NCT03830788|localized low-risk and favorable intermediate risk prostate cancer|localized low-risk and favorable intermediate risk prostate cancer
5026894|NCT03830775|TFCC|tfcc
5026896|NCT03830762|Actinogen|actinogen
5026897|NCT03830762|Xanamem|xanamem
5026898|NCT03830762|UE2343|ue2343
5026899|NCT03830762|Cortisol|cortisol
5026900|NCT03830762|11β-HSD1|11β-hsd1
5026901|NCT03830762|11-beta-Hydroxysteroid Dehydrogenase Type 1|11-beta-hydroxysteroid dehydrogenase type 1
5026902|NCT03830762|Healthy Ageing|healthy ageing
5026903|NCT03830762|Peripheral Neuropathy|peripheral neuropathy
5026904|NCT03830762|Safety|safety
5026905|NCT03830762|Dose Escalation|dose escalation
5026906|NCT03830762|Elderly|elderly
5026907|NCT03830762|XanaHES|xanahes
5026908|NCT03830710|Squamous cell carcinoma|squamous cell carcinoma
5026909|NCT03830710|8-hydroxy-2- deoxyguanosine|8-hydroxy-2- deoxyguanosine
5026910|NCT03830710|Antioxidant|antioxidant
5026911|NCT03830619|exosomes；lncRNA； lung cancer；|exosomes；lncrna； lung cancer；
5026912|NCT03830606|Nab-paclitaxel, S-1, Advanced Biliary Tract Adenocarcinoma|nab-paclitaxel, s-1, advanced biliary tract adenocarcinoma
5026913|NCT03830593|endocrine surgery; laparoscopic adrenalectomy;|endocrine surgery; laparoscopic adrenalectomy;
5026914|NCT03830567|Hormonal Contraception|hormonal contraception
5026915|NCT03830567|Birth Control|birth control
5026916|NCT03830567|Pharmacists|pharmacists
5026917|NCT03830554|sleep disturbances|sleep disturbances
5026918|NCT03830554|Aromatherapy|aromatherapy
5026919|NCT03830554|sleep quality|sleep quality
5026920|NCT03830554|Atlas cedar wood essential oil|atlas cedar wood essential oil
5026921|NCT03830541|oral health|oral health
5026922|NCT03830541|dental care|dental care
5026923|NCT03830541|general anaesthesia|general anaesthesia
5026930|NCT03830489|Cleansing quality score|cleansing quality score
5342937|NCT01981473|anti-drug antibody|anti-drug antibody
5026932|NCT03830476|Acceptance- and Commitment Therapy, Parenting stress, depression, anxiety, parenting, children with disabilities|acceptance- and commitment therapy, parenting stress, depression, anxiety, parenting, children with disabilities
5026933|NCT03830450|Acute kidney injury|acute kidney injury
5026934|NCT03830450|Cardiac surgery|cardiac surgery
5026935|NCT03830450|NGAL|ngal
5026936|NCT03830450|GDF-15|gdf-15
5026937|NCT03830437|Newborn|newborn
5026938|NCT03830437|Salivary Cortisol Level|salivary cortisol level
5026939|NCT03830437|Double Weghing|double weghing
5026940|NCT03830437|Physiological weight loss|physiological weight loss
5026941|NCT03830437|Breastfeeding|breastfeeding
5026942|NCT03830437|Stress marker|stress marker
5026943|NCT03830411|Sintilimab|sintilimab
5026944|NCT03830411|docetaxel|docetaxel
5026945|NCT03830411|pemetrexed|pemetrexed
5026946|NCT03830411|nonsquamous non-small-cell lung cancer|nonsquamous non-small-cell lung cancer
5026947|NCT03830411|wild-type EGFR|wild-type egfr
5026948|NCT03830411|second-line treatment|second-line treatment
5026949|NCT03830372|stroke|stroke
5026950|NCT03830372|post-stroke rehabilitation|post-stroke rehabilitation
5026951|NCT03830372|virtual reality|virtual reality
5026952|NCT03830372|depression|depression
5026953|NCT03830372|mental health|mental health
5026954|NCT03830346|Instrument Assisted Soft Tissue Mobilization|instrument assisted soft tissue mobilization
5026955|NCT03830346|Manual Therapy|manual therapy
5026956|NCT03830346|Muscle Stretching Exercises|muscle stretching exercises
5026957|NCT03830346|Range of motion|range of motion
5026958|NCT03830346|Shoulder Joint|shoulder joint
5026959|NCT03830346|CrossFit|crossfit
5026960|NCT03830320|PET-MRI|pet-mri
5026961|NCT03830307|Pain Therapy|pain therapy
5026962|NCT03830307|Auriculotherapy|auriculotherapy
5026963|NCT03830307|Cesarean Delivery|cesarean delivery
5026964|NCT03830294|breast prostheses, physical, psychological, breast cancer,|breast prostheses, physical, psychological, breast cancer,
5026965|NCT03830268|Ketones|ketones
5026966|NCT03830268|Medium Chain Triglycerides|medium chain triglycerides
5026967|NCT03830268|Glucose|glucose
5026968|NCT03830268|Insulin|insulin
5026969|NCT03830268|Free fatty acids|free fatty acids
5026970|NCT03830255|Renal Transplantation|renal transplantation
5026971|NCT03830255|Genetic Polymorphism|genetic polymorphism
5026972|NCT03830255|CP3A5|cp3a5
5026973|NCT03830255|CYP3A4|cyp3a4
5026974|NCT03830229|DNA Repair Genes|dna repair genes
5026975|NCT03830190|Parkinson's disease|parkinson's disease
5026976|NCT03830190|Parkinson's disease nurse specialist|parkinson's disease nurse specialist
5026977|NCT03830190|Nursing|nursing
5026978|NCT03830190|Quality of life|quality of life
5026979|NCT03830190|Cost-effectiveness|cost-effectiveness
5026980|NCT03830190|Multidisciplinary care|multidisciplinary care
5026981|NCT03830138|Oxidized-LDL|oxidized-ldl
5026982|NCT03830138|OLR1 gene|olr1 gene
5026983|NCT03830138|Single nucleotide polymorphism|single nucleotide polymorphism
5026984|NCT03830138|Oxygen therapy|oxygen therapy
5026985|NCT03830125|Autotaxin|autotaxin
5026986|NCT03830086|postoperative pain|postoperative pain
5026987|NCT03830086|regional anesthesia|regional anesthesia
5026988|NCT03830086|general anesthesia|general anesthesia
5026989|NCT03830086|gynecological laparoscopy|gynecological laparoscopy
5026990|NCT03830073|Cytomegalovirus|cytomegalovirus
5026991|NCT03830073|Coxsackie- virus|coxsackie- virus
5026992|NCT03830073|Vitamin D receptor gene|vitamin d receptor gene
5026994|NCT03830073|Autoimmune pancreatitis|autoimmune pancreatitis
5026995|NCT03830060|Marker of inflammation|marker of inflammation
5026996|NCT03830060|high-sensitivity CRP|high-sensitivity crp
5026997|NCT03830060|Antinuclear antibodies|antinuclear antibodies
5026998|NCT03830060|Cortisol|cortisol
5026999|NCT03830008|Problem Management Plus|problem management plus
5027000|NCT03830008|Distress|distress
5027001|NCT03830008|Mental Health Care|mental health care
5027002|NCT03830008|Low-intensity|low-intensity
5027003|NCT03830008|Refugees|refugees
5027004|NCT03829982|Circadian Rhythm|circadian rhythm
5027005|NCT03829956|snoring|snoring
5027006|NCT03829956|obstructive sleep apnoea|obstructive sleep apnoea
5027060|NCT03829553|IMRT|imrt
5027061|NCT03829553|Hypofractionated radiotherapy|hypofractionated radiotherapy
5027062|NCT03829540|CD4; T-cell; lymphoma; leukemia; chimeric antigen; CAR-T|cd4; t-cell; lymphoma; leukemia; chimeric antigen; car-t
5027063|NCT03829475|Crohn's DIsease|crohn's disease
5027064|NCT03829475|Ulcerative Colitis|ulcerative colitis
5027065|NCT03829462|REGIRI|regiri
5027066|NCT03829462|regorafenib|regorafenib
5027067|NCT03829462|irinotecan|irinotecan
5027068|NCT03829423|artificial intelligence|artificial intelligence
5027087|NCT03829371|STANDARD TREATMENTS|standard treatments
5027088|NCT03829358|Constipation|constipation
5027089|NCT03829358|Quality of Life|quality of life
5027090|NCT03829358|Probiotic|probiotic
5027098|NCT03829306|HER2-positive|her2-positive
5027099|NCT03829293|High-flow nasal cannula oxygenation|high-flow nasal cannula oxygenation
5027100|NCT03829293|gastrointestinal endoscopy|gastrointestinal endoscopy
5027101|NCT03829293|upper gasatrointestinal endoscopy|upper gasatrointestinal endoscopy
5027112|NCT03829254|Cordycepin|cordycepin
5027113|NCT03829241|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
5027114|NCT03829228|Protective Qi|protective qi
5027115|NCT03829228|Immunity|immunity
5027122|NCT03829189|microbiome|microbiome
5027123|NCT03829189|food wanting|food wanting
5027124|NCT03829189|memory|memory
5027125|NCT03829189|fiber|fiber
5027126|NCT03829176|Whole Genome Sequencing|whole genome sequencing
5027127|NCT03829150|non-bismuth containing quadruple therapy|non-bismuth containing quadruple therapy
5027128|NCT03829124|Electroconvulsive therapy|electroconvulsive therapy
5027129|NCT03829124|ketamine|ketamine
5027130|NCT03829098|Anastomotic leakage|anastomotic leakage
5027131|NCT03829085|Acute Pancreatitis|acute pancreatitis
5027132|NCT03829085|Oral refeeding|oral refeeding
5027133|NCT03829085|Nutrition|nutrition
5027134|NCT03829085|Length hospitalization|length hospitalization
5027135|NCT03829072|Allo Stem Cell Transplantation|allo stem cell transplantation
5027136|NCT03829072|Cooking|cooking
5027137|NCT03829072|Physical activity|physical activity
5027138|NCT03829046|PCSK9 inhibition|pcsk9 inhibition
5027139|NCT03829046|Evolocumab|evolocumab
5027140|NCT03829046|Inflammatory Signals|inflammatory signals
5027141|NCT03829046|Circulating monocyte subsets|circulating monocyte subsets
5027153|NCT03829007|durvalumab|durvalumab
5027154|NCT03829007|PD-L1 imaging|pd-l1 imaging
5027155|NCT03828994|Pelvic Inflammatory Disease(PID)|pelvic inflammatory disease(pid)
5027156|NCT03828994|Community Health Nursing|community health nursing
5027157|NCT03828994|Adolescents|adolescents
5027158|NCT03828994|Text Messaging|text messaging
5027159|NCT03828994|mobile health (mhealth)|mobile health (mhealth)
5027160|NCT03828968|urinary retention|urinary retention
5027161|NCT03828968|chronic disease|chronic disease
5027162|NCT03828968|aged|aged
5027163|NCT03828968|homes for the aged|homes for the aged
5027164|NCT03828955|soybean peptides|soybean peptides
5027165|NCT03828955|clinical trial|clinical trial
5027166|NCT03828955|blood preesure|blood preesure
5027167|NCT03828955|SBP|sbp
5027168|NCT03828955|DBP|dbp
5027173|NCT03828916|Tendon Surgery|tendon surgery
5027174|NCT03828916|NuShield|nushield
5027175|NCT03828903|Cryobiopsy|cryobiopsy
5027176|NCT03828877|Acupuncture, Pain , IL 17, IL 23 and Vessel|acupuncture, pain , il 17, il 23 and vessel
5027177|NCT03828799|Metastatic colorectal cancer|metastatic colorectal cancer
5027178|NCT03828799|Colorectal cancer|colorectal cancer
5027179|NCT03828799|Folfirinox|folfirinox
5027180|NCT03828799|Regorafenib|regorafenib
5027181|NCT03828799|RAS mutated|ras mutated
5027182|NCT03828786|intra-uterine insemination|intra-uterine insemination
5027183|NCT03828786|endometrial injury|endometrial injury
5027184|NCT03828786|scratching|scratching
5027185|NCT03828760|Intrauterine Device|intrauterine device
5027187|NCT03828760|Anxiety|anxiety
5027188|NCT03828760|Pain|pain
5027189|NCT03828760|Music|music
5027190|NCT03828760|Contraception|contraception
5027191|NCT03828760|Visual analog scale|visual analog scale
5027192|NCT03828760|VAS|vas
5027193|NCT03828682|tacrolimus|tacrolimus
5027194|NCT03828682|extended release|extended release
5027204|NCT03828669|post-operative pain|post-operative pain
5027205|NCT03828669|opioid|opioid
5027214|NCT03828643|Secukinumab|secukinumab
5027215|NCT03828643|loading dose|loading dose
5027216|NCT03828643|chronic plaque psoriasis|chronic plaque psoriasis
5027217|NCT03828643|no loading dose|no loading dose
5027218|NCT03828604|reward processing|reward processing
5027219|NCT03828591|Endometriosis|endometriosis
5027220|NCT03828591|Psychological support|psychological support
5027227|NCT03828526|Patient Safety|patient safety
5027228|NCT03828526|Medication Errors|medication errors
5027229|NCT03828526|Critical Care|critical care
5027230|NCT03828526|Nursing Education|nursing education
5027231|NCT03828526|High Fidelity Simulation Training|high fidelity simulation training
5027232|NCT03828500|Cataract|cataract
5027233|NCT03828500|Cataract Extraction|cataract extraction
5027234|NCT03828500|Fasting|fasting
5027235|NCT03828500|Preoperative Period|preoperative period
5027236|NCT03828500|Interrupted Time Series Analysis|interrupted time series analysis
5027237|NCT03828500|Guideline|guideline
5027238|NCT03828500|Patient Care|patient care
5027239|NCT03828474|acetazolamide|acetazolamide
5027240|NCT03828474|chemoprophylaxis|chemoprophylaxis
5027241|NCT03828474|altitude|altitude
5027242|NCT03828461|hoarding disorder|hoarding disorder
5027243|NCT03828461|hoarding|hoarding
5027244|NCT03828461|clutter|clutter
5027245|NCT03828448|Treatment naïve|treatment naïve
5027246|NCT03828435|patient|patient
5027247|NCT03828422|essential thrombocythaemia|essential thrombocythaemia
5027248|NCT03828422|JAK2 V617F mutation burden|jak2 v617f mutation burden
5027249|NCT03828422|preclinical atherosclerosis|preclinical atherosclerosis
5027250|NCT03828422|arterial stiffness|arterial stiffness
5027251|NCT03828422|endothelial function|endothelial function
5027252|NCT03828422|coronary artery calcium score|coronary artery calcium score
5027253|NCT03828409|short stitch|short stitch
5027254|NCT03828409|post-operative pain|post-operative pain
5027255|NCT03828409|PCA morphine usage|pca morphine usage
5027256|NCT03828409|elective midline laparotomy|elective midline laparotomy
5027257|NCT03828396|DNA methylation|dna methylation
5027258|NCT03828396|Next generation sequencing|next generation sequencing
5027259|NCT03828383|Caregivers|caregivers
5027260|NCT03828383|Dementia|dementia
5027261|NCT03828383|In-Home Assistive Technology|in-home assistive technology
5027262|NCT03828344|rheumatoid arthritis|rheumatoid arthritis
5027263|NCT03828344|mesenchymal stem cell|mesenchymal stem cell
5027264|NCT03828344|autoimmune|autoimmune
5027266|NCT03828305|Out of hospital cardiac arrest|out of hospital cardiac arrest
5027267|NCT03828305|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5027268|NCT03828305|automated external defibrillators|automated external defibrillators
5027269|NCT03828305|emergency medical system services|emergency medical system services
5027270|NCT03828305|mobile phone|mobile phone
5027271|NCT03828305|Primary healt-care|primary healt-care
5027272|NCT03828305|Technology|technology
5027273|NCT03828292|Japanese|japanese
5027274|NCT03828292|GSK2857916|gsk2857916
5027275|NCT03828292|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5027276|NCT03828292|dose-escalation|dose-escalation
5027277|NCT03828292|antibody drug conjugate|antibody drug conjugate
5027278|NCT03828279|angioedema|angioedema
5027279|NCT03828279|disease registry|disease registry
5027280|NCT03828279|C1 inhibitor|c1 inhibitor
5027281|NCT03828279|anti bradykinin treatments|anti bradykinin treatments
5027282|NCT03828227|chemotherapy|chemotherapy
5027283|NCT03828214|exoskeleton|exoskeleton
5027284|NCT03828214|gait|gait
5027285|NCT03828214|kinematics|kinematics
5027287|NCT03828214|stair climbing|stair climbing
5027288|NCT03828201|WHO 9-11-month regimen for MDR-TB|who 9-11-month regimen for mdr-tb
5027289|NCT03828201|bedaquiline (BDQ)|bedaquiline (bdq)
5027290|NCT03828201|delamanid (DLM)|delamanid (dlm)
5027291|NCT03828201|linezolid (LZD)|linezolid (lzd)
5027292|NCT03828201|levofloxacin (LFX)|levofloxacin (lfx)
5027293|NCT03828201|clofazimine (CF)|clofazimine (cf)
5027294|NCT03828188|Red Ginseng Concentrated Powder|red ginseng concentrated powder
5027295|NCT03828188|Hyperlipidemias|hyperlipidemias
5027296|NCT03828188|Clinical Trial|clinical trial
5027297|NCT03828175|Cardiac output, Hemodynamic, Monitoring, Percutaneous.|cardiac output, hemodynamic, monitoring, percutaneous.
5027298|NCT03828136|Cervical Disc Disease|cervical disc disease
5027299|NCT03828136|ACDF|acdf
5027300|NCT03828136|Single-level|single-level
5041690|NCT03738670|Pain|pain
5027313|NCT03827980|Osteoarticular Infections|osteoarticular infections
5027314|NCT03827980|Follow-up|follow-up
5027315|NCT03827954|Heart failure|heart failure
5027316|NCT03827954|cognitive impairment|cognitive impairment
5027317|NCT03827954|HeartMapp Mobile app|heartmapp mobile app
5027318|NCT03827954|Self-care|self-care
5027319|NCT03827928|Multiple Sclerosis|multiple sclerosis
5027320|NCT03827928|Fatigue|fatigue
5027321|NCT03827928|Anxiety|anxiety
5027329|NCT03827850|sqNSCLC|sqnsclc
5027330|NCT03827850|FGFR Mutations|fgfr mutations
5027331|NCT03827824|Virtual Reality|virtual reality
5027332|NCT03827824|Hysteroscopy|hysteroscopy
5027333|NCT03827824|Pain|pain
5027334|NCT03827824|Anxiety|anxiety
5027335|NCT03827811|MDR|mdr
5027336|NCT03827798|Hidradenitis suppurativa|hidradenitis suppurativa
5027337|NCT03827785|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5027338|NCT03827785|randomized clinical trials|randomized clinical trials
5027339|NCT03827785|treatment|treatment
5027340|NCT03827785|craving|craving
5027341|NCT03827785|cognitive function|cognitive function
5027342|NCT03827759|idiopathic juvenile arthritis, septic arthritis, biomarkers|idiopathic juvenile arthritis, septic arthritis, biomarkers
5342020|NCT01985256|recurrent glioblastoma|recurrent glioblastoma
5027343|NCT03827746|Parkinson's Disease, Kinesiophobia, Physical Activity, Balance, Falling|parkinson's disease, kinesiophobia, physical activity, balance, falling
5027344|NCT03827733|Gut Microbiota|gut microbiota
5027345|NCT03827733|Alzheimer's Diseases|alzheimer's diseases
5027346|NCT03827707|meal ingestion|meal ingestion
5027347|NCT03827707|postprandial responses|postprandial responses
5027348|NCT03827707|hedonic sensations|hedonic sensations
5027349|NCT03827707|homeostatic sensations|homeostatic sensations
5027350|NCT03827707|ambient noise|ambient noise
5027351|NCT03827668|Drug-Drug Interaction|drug-drug interaction
5027352|NCT03827655|Drug Therapy|drug therapy
5027353|NCT03827616|Prostate cancer|prostate cancer
5027354|NCT03827616|Radiation therapy|radiation therapy
5021469|NCT03862924|HIV|hiv
5027355|NCT03827616|Hypofractionated radiotherapy|hypofractionated radiotherapy
5027356|NCT03827564|Dry Eye Disease|dry eye disease
5027357|NCT03827551|Oral Health|oral health
5027358|NCT03827551|Parkinson Disease|parkinson disease
5027359|NCT03827551|Tooth cavities|tooth cavities
5027360|NCT03827551|Saliva|saliva
5027361|NCT03827551|Mucosa|mucosa
5027362|NCT03827525|Williams Syndrome|williams syndrome
5027363|NCT03827525|Anxiety|anxiety
5027364|NCT03827525|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
5027365|NCT03827525|Intellectual Disability|intellectual disability
5027366|NCT03827512|Vascular physicians|vascular physicians
5027367|NCT03827512|Peripheral artery disease|peripheral artery disease
5027368|NCT03827512|classification|classification
5027369|NCT03827512|doppler waveforms|doppler waveforms
5027370|NCT03827512|Saint-Bonnet|saint-bonnet
5027371|NCT03827460|Alcohol|alcohol
5027372|NCT03827460|Alcoholism|alcoholism
5027373|NCT03827460|Sex Differences|sex differences
5027374|NCT03827460|Abstinence|abstinence
5027375|NCT03827460|Alcohol Deprivation Effect|alcohol deprivation effect
5027376|NCT03827447|Clostridium Difficile|clostridium difficile
5027377|NCT03827447|Metabolomics|metabolomics
5027378|NCT03827447|Vancomycin|vancomycin
5027379|NCT03827447|Microbiome|microbiome
5027380|NCT03827421|transcranial doppler|transcranial doppler
5027381|NCT03827421|learning curve|learning curve
5027382|NCT03827421|emergency|emergency
5027383|NCT03827421|traumatic brain injury|traumatic brain injury
5027384|NCT03827408|Nebulized Dexmedetomidine|nebulized dexmedetomidine
5027385|NCT03827408|Nebulized Midazolam|nebulized midazolam
5027386|NCT03827408|Moderate sedation|moderate sedation
5027387|NCT03827408|Dental procedural sedation|dental procedural sedation
5027388|NCT03827408|Pediatric dentistry|pediatric dentistry
5027401|NCT03827382|Life Style Intervention|life style intervention
5027402|NCT03827382|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5027403|NCT03827369|Blood pressure|blood pressure
5027406|NCT03827356|REHABILITATION|rehabilitation
5027407|NCT03827356|RESPIRATION|respiration
5027408|NCT03827356|BREATHING EXERCISE|breathing exercise
5027409|NCT03827356|FATIGUE|fatigue
5027410|NCT03827356|PHYSICAL CAPACITY|physical capacity
5027411|NCT03827343|CAR-T Cell Therapy|car-t cell therapy
5027412|NCT03827343|Macrophage Activation Syndrome (MAS)|macrophage activation syndrome (mas)
5027413|NCT03827343|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5027419|NCT03827317|HER2|her2
5027420|NCT03827317|imaging|imaging
5027421|NCT03827317|PET|pet
5027433|NCT03827200|Ambrisentan|ambrisentan
5027435|NCT03827200|Hepatic Vein Pressure Gradient|hepatic vein pressure gradient
5027436|NCT03827200|HVPG|hvpg
5027437|NCT03827200|Refractory Ascites|refractory ascites
5027438|NCT03827200|Varices, Esophageal|varices, esophageal
5027439|NCT03827200|Variceal Hemorrhage|variceal hemorrhage
5027440|NCT03827200|Hepatitis B|hepatitis b
5027441|NCT03827200|Hepatitis C|hepatitis c
5027445|NCT03827174|Chronic pain|chronic pain
5027446|NCT03827174|Endometriosis|endometriosis
5027447|NCT03827174|Opioid therapy|opioid therapy
5027448|NCT03827174|Return to work|return to work
5027449|NCT03827174|Vocational rehabilitation|vocational rehabilitation
5027450|NCT03827174|Behavioural medicine|behavioural medicine
5027451|NCT03827148|Pharmacist intervention|pharmacist intervention
5027452|NCT03827148|Disease knowledge|disease knowledge
5027453|NCT03827148|Medication adherence|medication adherence
5027454|NCT03827148|Rehabilitation|rehabilitation
5027455|NCT03827148|Physical therapy|physical therapy
5027456|NCT03827148|Health related quality of life|health related quality of life
5027457|NCT03827148|Direct cost of treatment|direct cost of treatment
5027458|NCT03827148|Rheumatoid arthritis|rheumatoid arthritis
5027459|NCT03827148|Pakistan|pakistan
5027460|NCT03827148|Out-patients|out-patients
5027461|NCT03827135|Cervical Discogenic pain|cervical discogenic pain
5027462|NCT03827135|Cyriax manipulation|cyriax manipulation
5027463|NCT03827135|Neck Pain Disability index|neck pain disability index
5027464|NCT03827122|Bruxism|bruxism
5027465|NCT03827083|spinal and general anesthesia|spinal and general anesthesia
5027466|NCT03827083|cerebral pulse oxymetry|cerebral pulse oxymetry
5027467|NCT03827083|cognitive dysfunction|cognitive dysfunction
5027468|NCT03827070|Afatinib|afatinib
5027469|NCT03827070|Talcum powder|talcum powder
5027470|NCT03827070|Thoracoscopy|thoracoscopy
5027471|NCT03827070|Pleurodesis|pleurodesis
5027472|NCT03827070|BIBW2992|bibw2992
5027473|NCT03827057|posttraumatic stress disorder|posttraumatic stress disorder
5027474|NCT03827057|traumatic brain injury|traumatic brain injury
5027475|NCT03827057|cognitive behavioral therapy|cognitive behavioral therapy
5027476|NCT03827057|exposure therapy|exposure therapy
5027477|NCT03827057|reconsolidation|reconsolidation
5027481|NCT03827018|GCA|gca
5027482|NCT03827018|temporal arteritis|temporal arteritis
5027483|NCT03827018|Horton's disease|horton's disease
5027484|NCT03827005|L-arginine|l-arginine
5027485|NCT03827005|flow mediated dilation|flow mediated dilation
5027486|NCT03827005|resistance exercise|resistance exercise
5027487|NCT03826992|relapsed|relapsed
5027488|NCT03826992|refractory|refractory
5027489|NCT03826992|Vyxeos|vyxeos
5027490|NCT03826992|Venetoclax|venetoclax
5027491|NCT03826992|acute myeloid leukemia|acute myeloid leukemia
5027492|NCT03826992|acute myeloid leukemia, childhood|acute myeloid leukemia, childhood
5027493|NCT03826992|mixed-lineage leukemia (MLL)|mixed-lineage leukemia (mll)
5027494|NCT03826992|AML|aml
5027495|NCT03826992|CPX-351|cpx-351
5027496|NCT03826992|Venclexta|venclexta
5027497|NCT03826992|Histone-lysine N-methyltransferase 2A (KmT2A)|histone-lysine n-methyltransferase 2a (kmt2a)
5027498|NCT03826979|Breast cancer.|breast cancer.
5027499|NCT03826979|Exercise Therapy|exercise therapy
5027694|NCT03825601|Patients,|patients,
5027506|NCT03826940|Autism Spectrum Disorder|autism spectrum disorder
5027507|NCT03826940|Neurofibromatosis 1|neurofibromatosis 1
5027508|NCT03826927|New oral Anticoagulants (NOAC)|new oral anticoagulants (noac)
5027509|NCT03826927|vitamin K antagonists (VKA)|vitamin k antagonists (vka)
5027510|NCT03826927|cerebrovascular disease|cerebrovascular disease
5027511|NCT03826914|dietary supplements|dietary supplements
5027512|NCT03826914|cardiovascular diseases|cardiovascular diseases
5027519|NCT03826901|adults, pediatric|adults, pediatric
5027520|NCT03826888|IVF|ivf
5027521|NCT03826888|AMH isoforms|amh isoforms
5027522|NCT03826888|ovarian reserve test|ovarian reserve test
5027523|NCT03826888|poor response|poor response
5027524|NCT03826875|stroke|stroke
5027525|NCT03826875|hemorrhagic stroke|hemorrhagic stroke
5027526|NCT03826875|subarachnoid hemorrhage|subarachnoid hemorrhage
5027527|NCT03826875|depression|depression
5027528|NCT03826862|lateral lymph node dissection|lateral lymph node dissection
5027529|NCT03826862|node-by-node|node-by-node
5027530|NCT03826862|rectal cancer|rectal cancer
5027531|NCT03826862|CT three-dimensional reconstruction|ct three-dimensional reconstruction
5027532|NCT03826862|internal iliac vessels dissection|internal iliac vessels dissection
5027533|NCT03826849|mobile app|mobile app
5027534|NCT03826849|Veteran|veteran
5027535|NCT03826849|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5342938|NCT01981473|immunogenicity|immunogenicity
5718617|NCT00436488|ICAM-1|icam-1
5027536|NCT03826823|hysterosalpingography, catheter, pain, visual analogue scale|hysterosalpingography, catheter, pain, visual analogue scale
5027537|NCT03826797|Non invasive ventilation|non invasive ventilation
5027538|NCT03826797|Esophageal pressure|esophageal pressure
5027539|NCT03826797|Transpulmonary pressure|transpulmonary pressure
5027540|NCT03826771|stroke|stroke
5027541|NCT03826771|rehabilitation|rehabilitation
5027542|NCT03826771|depression|depression
5027543|NCT03826771|exercise|exercise
5027548|NCT03826706|Videolaryngoscopy|videolaryngoscopy
5027549|NCT03826706|Double lumen tube|double lumen tube
5027560|NCT03826576|restaurant-based intervention|restaurant-based intervention
5027561|NCT03826524|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5027562|NCT03826524|sudden cardiac arrest|sudden cardiac arrest
5027563|NCT03826524|epinephrine|epinephrine
5027564|NCT03826524|randomized controlled trial|randomized controlled trial
5027565|NCT03826511|mud-pack therapy|mud-pack therapy
5027566|NCT03826511|osteoarthritis of the knee|osteoarthritis of the knee
5027567|NCT03826511|hot-pack therapy|hot-pack therapy
5027568|NCT03826511|non-inferiority study|non-inferiority study
5027569|NCT03826498|Cerebral palsy|cerebral palsy
5027571|NCT03826498|Cord Blood|cord blood
5027572|NCT03826498|Stem cells|stem cells
5027573|NCT03826485|Pranlukast hydrate|pranlukast hydrate
5027574|NCT03826446|Right colon cancer|right colon cancer
5027575|NCT03826446|Mesocolic excision|mesocolic excision
5027576|NCT03826433|Hepatitis B Cirrhosis, mesenchymal stem cell|hepatitis b cirrhosis, mesenchymal stem cell
5027577|NCT03826407|Coma|coma
5027578|NCT03826407|Machine Learning|machine learning
5027579|NCT03826407|Prognosis|prognosis
5027580|NCT03826407|Electrophysiology|electrophysiology
5027581|NCT03826407|Event-related potentials|event-related potentials
5027582|NCT03826407|Electroencephalography|electroencephalography
5027583|NCT03826407|Mismatch Negativity|mismatch negativity
5027584|NCT03826407|Auditory Brainstem Response|auditory brainstem response
5027585|NCT03826407|Disorders of Consciousness|disorders of consciousness
5027586|NCT03826394|Postpartum, Overweight, Obesity, Exercise, Diet, Lifestyle|postpartum, overweight, obesity, exercise, diet, lifestyle
5027587|NCT03826368|Cannabinoid|cannabinoid
5027588|NCT03826368|CBD|cbd
5027589|NCT03826329|Adjacent segment disease (ASD)|adjacent segment disease (asd)
5027590|NCT03826329|Second surgery|second surgery
5027591|NCT03826329|Anterior cervical discectomy and fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5027592|NCT03826329|Risk factors|risk factors
5027593|NCT03826329|Cohort study|cohort study
5027594|NCT03826316|Pharmacokinetic|pharmacokinetic
5027600|NCT03826264|real-world|real-world
5027601|NCT03826238|alcohol-related brain damage|alcohol-related brain damage
5027602|NCT03826238|depression|depression
5027603|NCT03826238|attention|attention
5027604|NCT03826238|eeg|eeg
5027605|NCT03826199|pre-exposure prophylaxis|pre-exposure prophylaxis
5027606|NCT03826199|PrEP|prep
5027607|NCT03826199|pregnancy|pregnancy
5027608|NCT03826199|prevention of mother to child transmission|prevention of mother to child transmission
5027609|NCT03826199|PMTCT|pmtct
5027610|NCT03826186|CompuFlo; dynamic pressure sensing|compuflo; dynamic pressure sensing
5027611|NCT03826173|Positive Psychology|positive psychology
5027612|NCT03826173|Affect|affect
5027613|NCT03826121|Cognitive Function|cognitive function
5027618|NCT03826095|Trunk control|trunk control
5027619|NCT03826095|Functional mobility|functional mobility
5027620|NCT03826069|Augmented reality|augmented reality
5027621|NCT03826069|Endoscopy|endoscopy
5027622|NCT03826069|Polypectomy|polypectomy
5027623|NCT03826069|Simulation training|simulation training
5027624|NCT03826056|clinical education|clinical education
5027625|NCT03826043|Neoplasms, Thrombosis, hypocoagulability|neoplasms, thrombosis, hypocoagulability
5027627|NCT03826030|stroke recovery|stroke recovery
5027628|NCT03826030|brain stimulation|brain stimulation
5027629|NCT03826030|transcranial direct current stimulation|transcranial direct current stimulation
5027630|NCT03826017|Catechin high contain greentea extract|catechin high contain greentea extract
5027631|NCT03826017|Cognitive Function|cognitive function
5027632|NCT03826004|Cardiovascular Surgery|cardiovascular surgery
5027633|NCT03826004|Histamine H1 Receptor Antagonist|histamine h1 receptor antagonist
5027634|NCT03826004|Anaphylaxis|anaphylaxis
5027635|NCT03825991|Pharmacoepidemiology|pharmacoepidemiology
5027636|NCT03825991|Back pain|back pain
5027637|NCT03825991|Psychiatric disorder|psychiatric disorder
5027638|NCT03825991|Psychiatric comorbidity|psychiatric comorbidity
5027639|NCT03825991|Comorbidity|comorbidity
5027640|NCT03825978|prenatal genetic screening|prenatal genetic screening
5027641|NCT03825978|prenatal diagnosis|prenatal diagnosis
5027642|NCT03825978|counseling|counseling
5027643|NCT03825978|decision|decision
5027644|NCT03825978|anxiety|anxiety
5027645|NCT03825978|nursing|nursing
5027650|NCT03825952|adherence|adherence
5027651|NCT03825939|Total hip arthroplasty|total hip arthroplasty
5027652|NCT03825939|Total knee arthroplasty|total knee arthroplasty
5027653|NCT03825913|Melanoma|melanoma
5027654|NCT03825861|Gastric Cancer|gastric cancer
5027655|NCT03825861|FOLFIRINOX|folfirinox
5027656|NCT03825835|Delivery Room|delivery room
5027661|NCT03825822|Procedures|procedures
5027663|NCT03825822|Assessment|assessment
5027664|NCT03825822|Management|management
5027665|NCT03825822|Knowledge translation|knowledge translation
5027666|NCT03825822|Context|context
5027667|NCT03825822|Implementation|implementation
5027668|NCT03825783|Leukocyte Adhesion Deficiency- Type I|leukocyte adhesion deficiency- type i
5027669|NCT03825783|LAD-I|lad-i
5027670|NCT03825770|Fatigue|fatigue
5027671|NCT03825770|Energy conservation|energy conservation
5027672|NCT03825770|Rehabilitation|rehabilitation
5027673|NCT03825770|Occupational therapy|occupational therapy
5027674|NCT03825770|End-stage renal disease|end-stage renal disease
5027675|NCT03825770|Chronic kidney disease|chronic kidney disease
5027676|NCT03825770|Hemodialysis|hemodialysis
5027677|NCT03825770|Disability|disability
5027678|NCT03825770|Quality of life|quality of life
5027679|NCT03825757|chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
5027680|NCT03825757|Acetyl salicylic acid exacerbated respiratory disease|acetyl salicylic acid exacerbated respiratory disease
5027682|NCT03825692|Functional Dyspepsia|functional dyspepsia
5027683|NCT03825692|Postprandial Distress Syndrome|postprandial distress syndrome
5027684|NCT03825692|Traditional Chinese Medicine|traditional chinese medicine
5027685|NCT03825692|efficacy|efficacy
5027686|NCT03825692|safety|safety
5027687|NCT03825692|clinical evaluation|clinical evaluation
5027688|NCT03825666|quality of recovery|quality of recovery
5027689|NCT03825666|PONV|ponv
5027690|NCT03825666|PDNV|pdnv
5027691|NCT03825653|stress urinary incontinence|stress urinary incontinence
5027692|NCT03825653|pelvic tilt|pelvic tilt
5027693|NCT03825653|ankle position|ankle position
5027706|NCT03825549|Emergency Medicine|emergency medicine
5027707|NCT03825549|Urgent Care|urgent care
5027708|NCT03825549|Feedback|feedback
5027710|NCT03825536|methamphetamine|methamphetamine
5027711|NCT03825536|viral transcription|viral transcription
5027712|NCT03825536|inflammation|inflammation
5027713|NCT03825523|HIV/AIDS|hiv/aids
5027714|NCT03825523|ART|art
5027715|NCT03825510|Opdivo, Keytruda, Cyberknife|opdivo, keytruda, cyberknife
5027716|NCT03825497|older medical patient|older medical patient
5027717|NCT03825497|mobility|mobility
5027718|NCT03825497|hospitalization|hospitalization
5027719|NCT03825497|activity monitoring|activity monitoring
5027720|NCT03825497|cross sectoral|cross sectoral
5027721|NCT03825471|Cranial electrotherapy stimulation (CES)|cranial electrotherapy stimulation (ces)
5027722|NCT03825471|Autonomic nervous system|autonomic nervous system
5027723|NCT03825471|acute postoperative pain|acute postoperative pain
5027724|NCT03825471|colon cancer surgery|colon cancer surgery
5027726|NCT03825445|GnRH agonist trigger|gnrh agonist trigger
5027727|NCT03825445|hCG trigger|hcg trigger
5027728|NCT03825445|ovulation induction|ovulation induction
5027729|NCT03825432|Physical activity|physical activity
5027730|NCT03825432|Prosthesis|prosthesis
5027731|NCT03825419|Stroke, Acute, Neurocritical Care, Nutrition, Sarcopenia|stroke, acute, neurocritical care, nutrition, sarcopenia
5027732|NCT03825393|Fibromyalgia Syndrome, Ferritin, Sleep|fibromyalgia syndrome, ferritin, sleep
5027733|NCT03825367|Relapse|relapse
5027734|NCT03825367|Refractory|refractory
5027735|NCT03825367|Leukemia|leukemia
5027736|NCT03825367|Acute|acute
5027737|NCT03825367|Pediatric|pediatric
5027738|NCT03825367|nivolumab|nivolumab
5027739|NCT03825367|azacytidine|azacytidine
5027740|NCT03825354|suicide|suicide
5027741|NCT03825354|thoughts|thoughts
5027742|NCT03825354|attempts|attempts
5027743|NCT03825354|death|death
5027744|NCT03825354|brief intervention|brief intervention
5027745|NCT03825354|contact|contact
5027746|NCT03825315|DAXI for injection,|daxi for injection,
5027747|NCT03825315|Plantar Fasciitis,|plantar fasciitis,
5027748|NCT03825315|Heel Pain,|heel pain,
5027749|NCT03825315|BotulinumtoxinA|botulinumtoxina
5027750|NCT03825276|Mango|mango
5027751|NCT03825276|Polyphenols|polyphenols
5027752|NCT03825276|Inflammation|inflammation
5027753|NCT03825276|Insulin resistance|insulin resistance
5027754|NCT03825276|Transcriptomic|transcriptomic
5027755|NCT03825276|Metabolomic|metabolomic
5027756|NCT03825276|Metagenomic|metagenomic
5027757|NCT03825250|Sodium Valproate|sodium valproate
5077850|NCT03513029|PAF|paf
5027758|NCT03825250|Cardiac Surgery|cardiac surgery
5027759|NCT03825250|Organ Injury Prevention|organ injury prevention
5027760|NCT03825237|diagnostic|diagnostic
5027761|NCT03825237|polysomnography|polysomnography
5027762|NCT03825237|sleep architecture|sleep architecture
5027763|NCT03825237|sleep bruxism|sleep bruxism
5027764|NCT03825224|MRI|mri
5027765|NCT03825224|SENC MyoStrain|senc myostrain
5027772|NCT03825120|reproductive health|reproductive health
5027773|NCT03825120|fertility|fertility
5027774|NCT03825120|infertility|infertility
5027775|NCT03825120|aging|aging
5027783|NCT03825055|quality of life|quality of life
5027784|NCT03825055|well-being|well-being
5027785|NCT03825055|young adults|young adults
5027786|NCT03825003|Basketball|basketball
5027787|NCT03825003|Sedentary|sedentary
5027788|NCT03825003|Joint Mobility|joint mobility
5027789|NCT03825003|Performance|performance
5027790|NCT03824990|Quality improvement|quality improvement
5027791|NCT03824990|Hyperbilirubinemia|hyperbilirubinemia
5027792|NCT03824990|screening|screening
5027793|NCT03824990|follow-up|follow-up
5027794|NCT03824977|lung resection|lung resection
5027795|NCT03824977|low technology|low technology
5027796|NCT03824977|six minutes stepper test|six minutes stepper test
5027797|NCT03824977|sit to stand test|sit to stand test
5027798|NCT03824977|physiotherapy|physiotherapy
5027799|NCT03824977|lung surgery|lung surgery
5027800|NCT03824938|exercise|exercise
5027801|NCT03824938|aspirin|aspirin
5027802|NCT03824938|cooling|cooling
5027803|NCT03824938|antipyretic|antipyretic
5027804|NCT03824925|Taste alterations|taste alterations
5027805|NCT03824925|zinc sulfate|zinc sulfate
5027806|NCT03824925|oral cancer|oral cancer
5027807|NCT03824925|taste acuity|taste acuity
5027808|NCT03824899|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5027809|NCT03824899|irinotecan|irinotecan
5027810|NCT03824899|SN-38|sn-38
5027811|NCT03824886|Skin Integrity|skin integrity
5027812|NCT03824886|Aged Care Receivers|aged care receivers
5027813|NCT03824886|Care Dependent|care dependent
5027814|NCT03824886|Geriatric Patients|geriatric patients
5027815|NCT03824886|Prevention|prevention
5027816|NCT03824886|Skin Protection|skin protection
5027817|NCT03824873|Internal iliac artery|internal iliac artery
5027818|NCT03824873|Internal iliac artery ligation|internal iliac artery ligation
5027819|NCT03824873|Placenta previa|placenta previa
5027820|NCT03824873|Placenta accreta|placenta accreta
5027821|NCT03824873|cesarean hysterectomy|cesarean hysterectomy
5027822|NCT03824860|Chemotherapy-induced Peripheral Neuropathy|chemotherapy-induced peripheral neuropathy
5027823|NCT03824860|Yoga|yoga
5027824|NCT03824860|Chronic Pain|chronic pain
5027825|NCT03824860|Neuropathic Pain|neuropathic pain
5027826|NCT03824847|Macrolides|macrolides
5027827|NCT03824847|Immunomodulation|immunomodulation
5027828|NCT03824834|Breathlessness|breathlessness
5027829|NCT03824834|Dyspnea|dyspnea
5027830|NCT03824834|Exercise|exercise
5027831|NCT03824834|Opioids|opioids
5027832|NCT03824834|Morphine|morphine
5027833|NCT03824834|Exercise tolerance|exercise tolerance
5027834|NCT03824821|Nutrition|nutrition
5027835|NCT03824821|Irritable Bowel Syndrome|irritable bowel syndrome
5027836|NCT03824821|Quality of Life|quality of life
5027837|NCT03824808|prostatectomy|prostatectomy
5027838|NCT03824808|partial nephrectomy|partial nephrectomy
5027839|NCT03824808|robotic surgery|robotic surgery
5027840|NCT03824808|intravenous lidocaine|intravenous lidocaine
5027841|NCT03824808|lidocaine hydrochloride|lidocaine hydrochloride
5027842|NCT03824795|Clostridium difficile|clostridium difficile
5027843|NCT03824795|CDAD|cdad
5027844|NCT03824795|MGB-BP-3|mgb-bp-3
5027845|NCT03824795|Novel anti-infective|novel anti-infective
5027846|NCT03824795|Efficacy|efficacy
5027847|NCT03824795|Tolerability|tolerability
5027848|NCT03824795|Safety|safety
5027849|NCT03824795|Phase IIa|phase iia
5027850|NCT03824782|Retinopathy of Prematurity|retinopathy of prematurity
5027852|NCT03824782|Screening|screening
5027853|NCT03824782|Stress|stress
5027854|NCT03824782|Pain|pain
5027855|NCT03824782|Photophobia|photophobia
5027856|NCT03824782|Neonate|neonate
5027857|NCT03824782|Light Sensitivity|light sensitivity
5027858|NCT03824782|Desaturation|desaturation
5027859|NCT03824782|Bradycardia|bradycardia
5027860|NCT03824782|Apnea|apnea
5027861|NCT03824769|Weight Loss Maintenance|weight loss maintenance
5027862|NCT03824756|Growth monitoring and promotion|growth monitoring and promotion
5027863|NCT03824756|child growth|child growth
5027864|NCT03824756|Infant and young child feeding practices|infant and young child feeding practices
5027865|NCT03824756|program|program
5027866|NCT03824756|Bangladesh|bangladesh
5027867|NCT03824730|endovascular|endovascular
5027868|NCT03824730|stent|stent
5027869|NCT03824730|aorto-iliac|aorto-iliac
5027870|NCT03824730|occlusions|occlusions
5027871|NCT03824730|iliac|iliac
5027872|NCT03824717|Ropivacaine|ropivacaine
5027873|NCT03824717|Brachial plexus block|brachial plexus block
5027891|NCT03824678|Hepatic impairment|hepatic impairment
5027892|NCT03824678|Healthy Subjects|healthy subjects
5027893|NCT03824678|CC-220|cc-220
5027894|NCT03824678|Pharmacokinetics|pharmacokinetics
5027895|NCT03824652|prostate cancer|prostate cancer
5027896|NCT03824652|prostate adenocarcinoma|prostate adenocarcinoma
5027897|NCT03824652|diet|diet
5027898|NCT03824652|walnuts|walnuts
5027899|NCT03824652|radical prostatectomy|radical prostatectomy
5027900|NCT03824652|omega-3 fatty acids|omega-3 fatty acids
5027901|NCT03824652|polyphenols|polyphenols
5027902|NCT03824639|Mild cognitive impairment|mild cognitive impairment
5027903|NCT03824639|exercise therapy|exercise therapy
5027904|NCT03824639|patient adherence|patient adherence
5027905|NCT03824626|thoracic endovascular aortic repair|thoracic endovascular aortic repair
5028009|NCT03823924|ustekinumab|ustekinumab
5027906|NCT03824626|computational fluid dynamics|computational fluid dynamics
5027907|NCT03824626|preoperative planning|preoperative planning
5027908|NCT03824574|Functional appliance|functional appliance
5027910|NCT03824574|mandibular deficiency|mandibular deficiency
5027911|NCT03824574|twin-block|twin-block
5027912|NCT03824574|Growing patients|growing patients
5027913|NCT03824574|Clear appliance|clear appliance
5027914|NCT03824574|Aligner|aligner
5027915|NCT03824509|risk|risk
5027916|NCT03824509|CHA2DS-VASc score|cha2ds-vasc score
5027917|NCT03824483|Zanubrutinib|zanubrutinib
5027918|NCT03824483|Obinutuzumab|obinutuzumab
5027919|NCT03824483|Venetoclax|venetoclax
5027920|NCT03824483|18-427|18-427
5027921|NCT03824470|stop bang|stop bang
5027922|NCT03824470|Intubation Without Muscle Relaxation|intubation without muscle relaxation
5027923|NCT03824470|Post Operative Recovery|post operative recovery
5027924|NCT03824470|TOF|tof
5027926|NCT03824444|humerus|humerus
5027927|NCT03824444|amputee|amputee
5027928|NCT03824444|Amputation|amputation
5027929|NCT03824431|Gastroesophageal reflux disease|gastroesophageal reflux disease
5027930|NCT03824431|Narrow Band Imaging|narrow band imaging
5022014|NCT03859882|sleep deprivation|sleep deprivation
5027931|NCT03824431|High definition endoscopy|high definition endoscopy
5027932|NCT03824431|Microerosions|microerosions
5027933|NCT03824431|Esophageal biopsy|esophageal biopsy
5027934|NCT03824431|Immunohistochemistry.|immunohistochemistry.
5027935|NCT03824418|Surveillance|surveillance
5027936|NCT03824418|Chromoendoscopy|chromoendoscopy
5027938|NCT03824418|Ulcerative Colitis|ulcerative colitis
5027939|NCT03824405|CBD|cbd
5027940|NCT03824405|Synthetic CBD|synthetic cbd
5027941|NCT03824405|Cannabidiol|cannabidiol
5027948|NCT03824392|Interstitial Lung Disease|interstitial lung disease
5027949|NCT03824392|Neuropilin-2|neuropilin-2
5027950|NCT03824392|Steroids|steroids
5027951|NCT03824392|Oral corticosteroids|oral corticosteroids
5027952|NCT03824392|Immunomodulatory|immunomodulatory
5027953|NCT03824392|tRNA Synthetase|trna synthetase
5027954|NCT03824392|ATYR1923|atyr1923
5027955|NCT03824379|magnesium|magnesium
5027956|NCT03824379|diabetic nephropathy|diabetic nephropathy
5027957|NCT03824379|osteocalcin|osteocalcin
5027958|NCT03824301|cardiopulmonary bypass|cardiopulmonary bypass
5027959|NCT03824301|pressure-controlled ventilation|pressure-controlled ventilation
5027960|NCT03824301|volume-controlled ventilation|volume-controlled ventilation
5027961|NCT03824301|atelectasis|atelectasis
5027962|NCT03824301|pleural effusion|pleural effusion
5027963|NCT03824301|lung compliance|lung compliance
5027964|NCT03824249|Energy Expenditure|energy expenditure
5027965|NCT03824249|Ventilator Weaning|ventilator weaning
5027966|NCT03824249|Calorimetry, indirect|calorimetry, indirect
5027967|NCT03824236|Malaria|malaria
5027968|NCT03824236|RTS,S/AS01E vaccine|rts,s/as01e vaccine
5027969|NCT03824236|Fractional dose|fractional dose
5027971|NCT03824158|cancer, advance care planning|cancer, advance care planning
5027972|NCT03824093|Adolescent Vaccines|adolescent vaccines
5027973|NCT03824067|HIV/AIDS|hiv/aids
5027974|NCT03824067|Point of Care|point of care
5027975|NCT03824067|Early infant diagnosis|early infant diagnosis
5027976|NCT03824067|Health systems|health systems
5027977|NCT03824067|Diagnostic tools|diagnostic tools
5027979|NCT03824054|deep infiltrating endometriosis|deep infiltrating endometriosis
5027980|NCT03824054|colorectal resection|colorectal resection
5027981|NCT03824054|quality of life|quality of life
5027982|NCT03824041|Polyphenols|polyphenols
5027983|NCT03824041|Anthocyanins|anthocyanins
5027984|NCT03824041|Vascular function|vascular function
5027985|NCT03824041|Gut microbiome|gut microbiome
5027986|NCT03824041|Gut health|gut health
5027987|NCT03824041|Berries|berries
5027988|NCT03824028|Cataract surgery|cataract surgery
5027989|NCT03824028|Intraocular lens|intraocular lens
5027990|NCT03824028|IOL|iol
5027991|NCT03824028|Clareon|clareon
5027992|NCT03824028|AutonoMe|autonome
5027993|NCT03824015|Physical Activity|physical activity
5027994|NCT03824015|Older Adults|older adults
5027995|NCT03824015|Behaviour maintenance|behaviour maintenance
5027996|NCT03824015|feasibility study|feasibility study
5027997|NCT03824015|falls prevention|falls prevention
5027998|NCT03824002|diabetes mellitus|diabetes mellitus
5027999|NCT03824002|dulaglutide|dulaglutide
5028000|NCT03824002|endothelial function|endothelial function
5028001|NCT03823976|dental care|dental care
5028002|NCT03823976|oral rehabilitation|oral rehabilitation
5028003|NCT03823976|general anaesthesia|general anaesthesia
5028004|NCT03823976|tooth loss|tooth loss
5028005|NCT03823937|fibromyalgia|fibromyalgia
5028006|NCT03823937|smell|smell
5028007|NCT03823937|taste|taste
5028008|NCT03823924|Psoriatic arthritis|psoriatic arthritis
5028017|NCT03823898|cardiovascular and metabolic markers|cardiovascular and metabolic markers
5028019|NCT03823898|Exercise|exercise
5028020|NCT03823859|Hypothyroidism|hypothyroidism
5028021|NCT03823859|Metabolomics|metabolomics
5028022|NCT03823859|Thyroid Hormones|thyroid hormones
5028023|NCT03823859|Hyperthyroidism|hyperthyroidism
5028024|NCT03823846|movement evoked pain|movement evoked pain
5028025|NCT03823846|analgesia|analgesia
5028026|NCT03823846|general surgery|general surgery
5028027|NCT03823846|hepatobiliary and pancreatic disease|hepatobiliary and pancreatic disease
5028028|NCT03823833|Oocyte freezing|oocyte freezing
5028029|NCT03823833|fertility preservation|fertility preservation
5028030|NCT03823833|ovarian cysts|ovarian cysts
5028031|NCT03823833|benign ovarian tumor|benign ovarian tumor
5028032|NCT03823833|endometrioma|endometrioma
5028033|NCT03823703|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5028034|NCT03823703|NASH|nash
5028035|NCT03823703|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5028036|NCT03823664|prediabetes|prediabetes
5028037|NCT03823664|type 2 diabetes|type 2 diabetes
5028038|NCT03823664|cardiorespiratory fitness|cardiorespiratory fitness
5028039|NCT03823664|pulmonary functions|pulmonary functions
5028040|NCT03823664|functional capacity|functional capacity
5028041|NCT03823664|exercise capacity|exercise capacity
5028042|NCT03823625|SqLC|sqlc
5028043|NCT03823599|chat-based intervention|chat-based intervention
5028044|NCT03823599|alcohol brief intervention|alcohol brief intervention
5042398|NCT03734107|adherence|adherence
5028059|NCT03823547|Clopidogrel|clopidogrel
5028060|NCT03823547|Thrombosis|thrombosis
5028061|NCT03823547|Myocardial Ischemia|myocardial ischemia
5028062|NCT03823547|Platelet aggregation inhibitors|platelet aggregation inhibitors
5028063|NCT03823547|Risk scores|risk scores
5028064|NCT03823547|Cardiovascular diseases|cardiovascular diseases
5028071|NCT03823521|Cardioplegic Solutions|cardioplegic solutions
5028072|NCT03823508|Vegetative state|vegetative state
5028073|NCT03823508|Minimally Conscious State|minimally conscious state
5028074|NCT03823508|Disorders of consciousness|disorders of consciousness
5028075|NCT03823508|Transcranial direct current stimulation|transcranial direct current stimulation
5028076|NCT03823508|Non invasive brain stimulation|non invasive brain stimulation
5028077|NCT03823508|Neuromodulation|neuromodulation
5028078|NCT03823508|High density electroencephalography|high density electroencephalography
5028079|NCT03823495|pain management|pain management
5028080|NCT03823495|nursing home|nursing home
5028082|NCT03823495|non-drug|non-drug
5028083|NCT03823482|aneurysm, cerebral|aneurysm, cerebral
5028084|NCT03823482|inflammation mediators|inflammation mediators
5028085|NCT03823482|lidocaine, hydrochloride|lidocaine, hydrochloride
5028086|NCT03823469|Home cooking|home cooking
5028087|NCT03823469|Telemedicine|telemedicine
5028088|NCT03823469|Nutrition|nutrition
5028089|NCT03823469|Health coaching|health coaching
5028090|NCT03823456|acupressure|acupressure
5028091|NCT03823456|insomnia|insomnia
5028092|NCT03823456|anxiety|anxiety
5028093|NCT03823456|depression|depression
5028094|NCT03823456|symptom cluster|symptom cluster
5028095|NCT03823443|exacerbation|exacerbation
5028096|NCT03823443|cough|cough
5028097|NCT03823443|sputum|sputum
5028098|NCT03823417|Tranexamic Acid|tranexamic acid
5028108|NCT03823378|Long-term extension (LTE)|long-term extension (lte)
5028499|NCT03821389|Secretion|secretion
5028127|NCT03823183|Video-game cognitive training|video-game cognitive training
5028128|NCT03823183|Dance|dance
5028129|NCT03823183|Physical exercise|physical exercise
5028130|NCT03823183|Multi-domain training|multi-domain training
5028131|NCT03823183|Executive functions|executive functions
5028132|NCT03823183|Memory functions|memory functions
5028133|NCT03823183|Plasticity|plasticity
5028134|NCT03823183|Transfer|transfer
5028135|NCT03823183|Follow-up intervention|follow-up intervention
5028136|NCT03823183|Randomized controlled trial|randomized controlled trial
5028137|NCT03823170|hypomineralization molar incisor|hypomineralization molar incisor
5028138|NCT03823170|Child|child
5028139|NCT03823170|Laser Therapy|laser therapy
5028140|NCT03823170|Tooth Sensitivity|tooth sensitivity
5028141|NCT03823105|Sleep apnea|sleep apnea
5028142|NCT03823105|Hypersomnia|hypersomnia
5028143|NCT03823105|Parasomnia|parasomnia
5028144|NCT03823092|macular function|macular function
5338435|NCT02001909|Safety|safety
5028145|NCT03823092|polarization perception|polarization perception
5028146|NCT03823092|Haidinger's brush|haidinger's brush
5028147|NCT03823092|vision testing|vision testing
5028148|NCT03823092|cataract|cataract
5028149|NCT03823092|age related macular degeneration|age related macular degeneration
5028150|NCT03823092|pseudophakia|pseudophakia
5028151|NCT03823092|macular disease|macular disease
5028152|NCT03823092|retinal disease|retinal disease
5028153|NCT03823079|Recombinant human interleukin-11|recombinant human interleukin-11
5028154|NCT03823079|Recombinant human thrombopoietin|recombinant human thrombopoietin
5028155|NCT03823066|acceptance|acceptance
5028156|NCT03823066|usability|usability
5028157|NCT03823066|home care|home care
5028158|NCT03823066|socially assistive robot|socially assistive robot
5028159|NCT03823066|humanoid robot|humanoid robot
5028160|NCT03823066|caregivers|caregivers
5028161|NCT03823066|dementia trainers|dementia trainers
5028162|NCT03823066|cognitive training|cognitive training
5028163|NCT03823066|physical training|physical training
5028164|NCT03823053|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5028165|NCT03823053|Scoliosis|scoliosis
5028166|NCT03823053|Core Stabilization Training|core stabilization training
5028167|NCT03823053|Exercise Training|exercise training
5028168|NCT03823053|Pulmonary Function Test|pulmonary function test
5028169|NCT03823053|6 - Minute Walk Test|6 - minute walk test
5028170|NCT03823053|Peripheral Muscle Strength|peripheral muscle strength
5028171|NCT03823053|Balance with Biodex|balance with biodex
5028172|NCT03823053|Quality of Life|quality of life
5028173|NCT03823027|Medical Device|medical device
5028174|NCT03823027|Prediabetes|prediabetes
5028175|NCT03823027|Type2 Diabetes|type2 diabetes
5028176|NCT03823027|Silica|silica
5028177|NCT03823027|Metabolic risk factors|metabolic risk factors
5028178|NCT03823014|transgender|transgender
5028179|NCT03823014|transmasculine|transmasculine
5028180|NCT03823014|ftm|ftm
5028181|NCT03823014|phalloplasty|phalloplasty
5028182|NCT03823014|penile prosthesis|penile prosthesis
5028183|NCT03823001|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5028184|NCT03822988|advance directives|advance directives
5028185|NCT03822988|Advance care planning|advance care planning
5028186|NCT03822988|Patient's informed|patient's informed
5028187|NCT03822988|treatment preferences|treatment preferences
5028188|NCT03822988|skin cancer|skin cancer
5028189|NCT03822988|dermatology|dermatology
5028190|NCT03822975|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5028191|NCT03822975|anticoagulant agents|anticoagulant agents
5028192|NCT03822975|bivalirudin|bivalirudin
5028193|NCT03822975|heparin|heparin
5028194|NCT03822962|NSAIDs|nsaids
5028195|NCT03822962|post-operative pain|post-operative pain
5028196|NCT03822962|post-operative hemorrhage|post-operative hemorrhage
5028197|NCT03822962|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5028198|NCT03822936|carbon ion radiation therapy|carbon ion radiation therapy
5028199|NCT03822936|exocrine pancreas|exocrine pancreas
5028200|NCT03822936|pancreas tumour|pancreas tumour
5028201|NCT03822923|Neurodynamics|neurodynamics
5028202|NCT03822923|Spasticity|spasticity
5028203|NCT03822923|Stroke|stroke
5028204|NCT03822871|prostate cancer|prostate cancer
5028221|NCT03822845|PET imaging|pet imaging
5028222|NCT03822845|prostate cancer|prostate cancer
5028223|NCT03822793|tranexamic acid (TXA)|tranexamic acid (txa)
5028224|NCT03822793|arthroplasty|arthroplasty
5028226|NCT03822793|Exacyl|exacyl
5028229|NCT03822767|Sabin strain|sabin strain
5028230|NCT03822767|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
5028236|NCT03822754|Sabin strain|sabin strain
5028237|NCT03822754|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
5028238|NCT03822754|poliomyelitis|poliomyelitis
5028239|NCT03822754|safety|safety
5028240|NCT03822754|immunogenicity|immunogenicity
5028241|NCT03822754|infant|infant
5028242|NCT03822754|sequential schedule|sequential schedule
5028244|NCT03822715|aromatase inhibitor|aromatase inhibitor
5028245|NCT03822715|carbohydrate restricted diet|carbohydrate restricted diet
5028246|NCT03822702|handwriting|handwriting
5028247|NCT03822702|kinetics|kinetics
5028248|NCT03822702|kinematics|kinematics
5028249|NCT03822702|handwriting difficulty|handwriting difficulty
5028250|NCT03822689|pediatric|pediatric
5028251|NCT03822689|Ventilation breathing tube|ventilation breathing tube
5028252|NCT03822689|End-Tidal Carbon Dioxide|end-tidal carbon dioxide
5028253|NCT03822689|Heart rate|heart rate
5028254|NCT03822689|tidal volume|tidal volume
5028255|NCT03822689|blood temperature|blood temperature
5028256|NCT03822663|Sports nutrition|sports nutrition
5028257|NCT03822663|Caffeine|caffeine
5028258|NCT03822663|Physical capacity|physical capacity
5028259|NCT03822663|Exercise performance|exercise performance
5028260|NCT03822624|Probiotic|probiotic
5028261|NCT03822598|Teaching Recovery Techniques|teaching recovery techniques
5028262|NCT03822598|Asylum-seeking children|asylum-seeking children
5028263|NCT03822598|Refugee children|refugee children
5028264|NCT03822598|Low-threshold intervention|low-threshold intervention
5028265|NCT03822585|HbA2, HPLC|hba2, hplc
5028266|NCT03822572|endurance exercise|endurance exercise
5028267|NCT03822559|Glaucoma|glaucoma
5028268|NCT03822533|Primary assessor|primary assessor
5028269|NCT03822533|cost efficiency|cost efficiency
5028270|NCT03822533|physiotherapist|physiotherapist
5028271|NCT03822533|quality of life|quality of life
5028272|NCT03822494|radiation therapy|radiation therapy
5028273|NCT03822494|Cyberknife|cyberknife
5028274|NCT03822494|SBRT|sbrt
5028275|NCT03822494|Protons|protons
5423191|NCT01616784|Patient Education as Topic|patient education as topic
5028289|NCT03822429|CLBR|clbr
5028290|NCT03822416|mental illness|mental illness
5028291|NCT03822416|tobacco treatment|tobacco treatment
5028292|NCT03822403|glass ionomer|glass ionomer
5028293|NCT03822403|composite resin|composite resin
5028294|NCT03822390|Artificial Intelligence|artificial intelligence
5028295|NCT03822390|Computer aided diagnosis|computer aided diagnosis
5028296|NCT03822390|Diminutive colorectal polyps|diminutive colorectal polyps
5028297|NCT03822390|Optical diagnosis|optical diagnosis
5028298|NCT03822364|apomorphine|apomorphine
5028299|NCT03822364|aerosol|aerosol
5028306|NCT03822338|Renal ischemia reperfusion injury|renal ischemia reperfusion injury
5028309|NCT03822312|Breast Cancer|breast cancer
5028310|NCT03822312|Optical imaging|optical imaging
5028311|NCT03822312|neoadjuvant therapy|neoadjuvant therapy
5028312|NCT03822286|home-care worker|home-care worker
5028313|NCT03822286|e-training|e-training
5028314|NCT03822286|mentoring support|mentoring support
5028315|NCT03822273|Traumatic rib fractures|traumatic rib fractures
5028316|NCT03822273|Acupuncture|acupuncture
5028317|NCT03822273|Analgesia|analgesia
5028318|NCT03822247|Recovery|recovery
5028319|NCT03822247|Patient reported outcome measures|patient reported outcome measures
5028320|NCT03822247|Hip fracture|hip fracture
5028321|NCT03822247|Hip arthritis|hip arthritis
5028322|NCT03822247|Knee fracture|knee fracture
5028323|NCT03822247|Knee arthritis|knee arthritis
5028324|NCT03822221|Quadriceps muscle|quadriceps muscle
5028325|NCT03822221|Electrical Stimulation|electrical stimulation
5028326|NCT03822221|Patellar Tendon|patellar tendon
5028327|NCT03822221|Ultrasonography|ultrasonography
5028328|NCT03822221|Electromyography|electromyography
5028329|NCT03822195|carotid artery atherosclerosis|carotid artery atherosclerosis
5028330|NCT03822195|alternative complement pathway|alternative complement pathway
5028331|NCT03822182|liposomal bupivicaine|liposomal bupivicaine
5028332|NCT03822182|interscalene block|interscalene block
5028333|NCT03822156|Cavitary Pulmonary Tuberculosis|cavitary pulmonary tuberculosis
5028334|NCT03822156|Acid fast bacilli (AFB)|acid fast bacilli (afb)
5028335|NCT03822156|Isolation|isolation
5028336|NCT03822156|Endobronchial Tuberculosis|endobronchial tuberculosis
5028337|NCT03822156|Transmission|transmission
5028338|NCT03822156|Drug susceptible test (DST)|drug susceptible test (dst)
5028339|NCT03822156|Ant-tuberculous agent|ant-tuberculous agent
5028340|NCT03822117|Fibroblast growth factor receptor (FGFR) inhibitor|fibroblast growth factor receptor (fgfr) inhibitor
5028341|NCT03822117|FGFR mutations|fgfr mutations
5028342|NCT03822117|FGFR translocations|fgfr translocations
5028343|NCT03822117|solid tumor malignancy|solid tumor malignancy
5028344|NCT03822104|Very Preterm Infants|very preterm infants
5028345|NCT03822104|Human Milk Fortifier|human milk fortifier
5028356|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate
5028357|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
5028358|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
5028359|NCT03822065|Membrane Transport Modulators|membrane transport modulators
5028360|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5028361|NCT03822065|Neurotransmitter Agents|neurotransmitter agents
5028362|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs
5028363|NCT03822065|Antidepressive Agents|antidepressive agents
5028364|NCT03822065|Psychotropic Drugs|psychotropic drugs
5028365|NCT03822026|intracranial pressure|intracranial pressure
5028366|NCT03822026|cerebral metabolism|cerebral metabolism
5028367|NCT03822026|cerebral oxygenation|cerebral oxygenation
5028368|NCT03822013|Sandhoff Disease|sandhoff disease
5028369|NCT03822013|Tay-Sachs Disease|tay-sachs disease
5028370|NCT03822013|Miglustat|miglustat
5028371|NCT03822000|femur fracture|femur fracture
5028373|NCT03822000|fall|fall
5028374|NCT03822000|elderly|elderly
5028375|NCT03822000|mortality|mortality
5028376|NCT03822000|respiratory complication|respiratory complication
5028377|NCT03821987|haploidentical transplantation|haploidentical transplantation
5028378|NCT03821987|aplastic anemia|aplastic anemia
5028379|NCT03821974|Pancreatic solid lesions|pancreatic solid lesions
5028380|NCT03821974|wet suction technique|wet suction technique
5028381|NCT03821974|dry suction technique|dry suction technique
5028385|NCT03821948|Blood Draw|blood draw
5028386|NCT03821948|Sample Collection|sample collection
5028387|NCT03821948|Stool DNA|stool dna
5028388|NCT03821935|Advanced Solid Tumors Cancer|advanced solid tumors cancer
5028389|NCT03821935|cancer|cancer
5028390|NCT03821935|Solid Tumors|solid tumors
5028391|NCT03821935|metastatic|metastatic
5028392|NCT03821935|monotherapy|monotherapy
5028393|NCT03821935|combination therapy|combination therapy
5028394|NCT03821935|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5028395|NCT03821935|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5028396|NCT03821935|urothelial cancer|urothelial cancer
5028397|NCT03821935|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5028398|NCT03821935|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5028500|NCT03821363|Neoplasms|neoplasms
5028406|NCT03821883|atrial fibrillation|atrial fibrillation
5028407|NCT03821883|stroke|stroke
5028408|NCT03821883|left atrial appendage closure|left atrial appendage closure
5028409|NCT03821883|aspirin|aspirin
5028410|NCT03821831|Obstructive sleep apnea|obstructive sleep apnea
5028411|NCT03821831|Children|children
5028412|NCT03821831|Orthodontic intervention|orthodontic intervention
5028413|NCT03821831|Nutrition|nutrition
5028414|NCT03821831|Metabolomic markers|metabolomic markers
5028415|NCT03821818|Food Hypersensitivity|food hypersensitivity
5028416|NCT03821818|Exercise|exercise
5028417|NCT03821805|Heart rate variability|heart rate variability
5028418|NCT03821805|Arterial pulse waveform|arterial pulse waveform
5028419|NCT03821766|Intracavitary pressure|intracavitary pressure
5028420|NCT03821766|Ballistocardiography|ballistocardiography
5028421|NCT03821766|Seismocardiography|seismocardiography
5028422|NCT03821766|Microaccelerations|microaccelerations
5028423|NCT03821766|Kinetic energy|kinetic energy
5028424|NCT03821753|Diabetic retinopathy|diabetic retinopathy
5028425|NCT03821753|Glycemic variability|glycemic variability
5028426|NCT03821753|Diabetes|diabetes
5028427|NCT03821753|Macular retinal microcirculation|macular retinal microcirculation
5028428|NCT03821753|Microangiopathy|microangiopathy
5028429|NCT03821753|Cognitive dysfunction|cognitive dysfunction
5028430|NCT03821714|septic shock|septic shock
5028431|NCT03821714|glucocorticoid|glucocorticoid
5028432|NCT03821714|vitamin C|vitamin c
5028433|NCT03821714|microcirculation|microcirculation
5028434|NCT03821701|Shakurba valsartan|shakurba valsartan
5028435|NCT03821701|Heart failure|heart failure
5028436|NCT03821701|ACEI/ARB|acei/arb
5028443|NCT03821662|Diabetes|diabetes
5028444|NCT03821662|Occupational Therapy|occupational therapy
5028445|NCT03821662|Interdisciplinary Teams|interdisciplinary teams
5428228|NCT01595581|Clinical outcomes|clinical outcomes
5028446|NCT03821662|Diabetes Self-Management Education (DSME)|diabetes self-management education (dsme)
5028447|NCT03821662|Diabetes Self-Management|diabetes self-management
5028448|NCT03821649|Education|education
5028449|NCT03821649|Naloxone|naloxone
5028450|NCT03821649|Opioid|opioid
5028451|NCT03821649|Overdose|overdose
5028452|NCT03821649|Resusitation|resusitation
5028453|NCT03821636|Obesity|obesity
5028454|NCT03821636|Diabetes Mellitus Type 2|diabetes mellitus type 2
5028455|NCT03821636|Bariatric Surgery|bariatric surgery
5028456|NCT03821636|Roux-en-Y|roux-en-y
5028457|NCT03821636|gastric bypass|gastric bypass
5028458|NCT03821597|Fibrinolysis, sequential compression devices|fibrinolysis, sequential compression devices
5028459|NCT03821584|migraine|migraine
5028460|NCT03821584|perfusion arterial|perfusion arterial
5028461|NCT03821584|aura brain|aura brain
5028462|NCT03821571|Hypertension,primary aldosteronism|hypertension,primary aldosteronism
5028463|NCT03821558|exercise|exercise
5028464|NCT03821558|interval training|interval training
5028465|NCT03821558|continuous training|continuous training
5028466|NCT03821558|endothelial dysfunction|endothelial dysfunction
5028467|NCT03821545|Anti-Inflammatory Effect|anti-inflammatory effect
5028468|NCT03821545|Surgical Stress|surgical stress
5028469|NCT03821545|Lidocaine|lidocaine
5028470|NCT03821545|Ketamine|ketamine
5329421|NCT02042950|MCL|mcl
5343175|NCT01980238|LAR|lar
5028471|NCT03821545|Abdominal Surgery|abdominal surgery
5028472|NCT03821532|Action Plan|action plan
5028473|NCT03821532|Adherence|adherence
5028474|NCT03821532|Pediatrics|pediatrics
5028475|NCT03821493|PF-06651600|pf-06651600
5028476|NCT03821493|Itraconazole|itraconazole
5028477|NCT03821493|CYP3A4|cyp3a4
5028478|NCT03821493|Drug-Drug Interaction|drug-drug interaction
5028479|NCT03821480|Fluconazole|fluconazole
5028482|NCT03821441|bOPV|bopv
5028484|NCT03821441|Sequential immunization|sequential immunization
5028485|NCT03821441|Immunity Duration|immunity duration
5028486|NCT03821441|Booster Immunization|booster immunization
5028487|NCT03821415|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
5028488|NCT03821415|Dry Eye Disease|dry eye disease
5028489|NCT03821415|Slow-release|slow-release
5028490|NCT03821415|Ophthalmology|ophthalmology
5028491|NCT03821415|Topical Eye Disease|topical eye disease
5028492|NCT03821402|ULS|uls
5028493|NCT03821402|JUNIPER|juniper
5028494|NCT03821402|DAXI for injection|daxi for injection
5028495|NCT03821402|Botulinum toxin|botulinum toxin
5028496|NCT03821389|Chest Physiotherapy|chest physiotherapy
5028497|NCT03821389|Non-invasive|non-invasive
5028498|NCT03821389|Oscillation|oscillation
5028547|NCT03821155|Vestibular Neuronitis|vestibular neuronitis
5028548|NCT03821142|pelvic organ prolapse|pelvic organ prolapse
5028550|NCT03821142|Calistar|calistar
5028551|NCT03821142|Transvaginal repair|transvaginal repair
5028552|NCT03821142|Transvaginal mesh repair|transvaginal mesh repair
5028553|NCT03821142|anterior prolapse|anterior prolapse
5028554|NCT03821129|Occluder|occluder
5028555|NCT03821129|Patent Foramen Ovale|patent foramen ovale
5028557|NCT03821129|Stroke|stroke
5028558|NCT03821129|Gore Septal Occluder|gore septal occluder
5028559|NCT03821077|Allergen immunotherapy (AIT)|allergen immunotherapy (ait)
5028560|NCT03821077|Rhinitis|rhinitis
5028561|NCT03821077|Rhinoconjunctivitis|rhinoconjunctivitis
5028562|NCT03821077|Subcutaneous Immunotherapy (SCIT)|subcutaneous immunotherapy (scit)
5028563|NCT03821077|Allergovac Poliplus|allergovac poliplus
5028564|NCT03821064|Cancer|cancer
5028565|NCT03821064|Patient Navigation|patient navigation
5028566|NCT03821051|structural ventricular arrythmia|structural ventricular arrythmia
5028567|NCT03821051|ischemic cardiomyopathy|ischemic cardiomyopathy
5028568|NCT03821051|arrhythmogenic right ventricular cardiomyopathy|arrhythmogenic right ventricular cardiomyopathy
5028569|NCT03821051|dilated cardiomyopathy|dilated cardiomyopathy
5028570|NCT03821051|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5028571|NCT03821051|risk stratification|risk stratification
5028572|NCT03821038|Sepsis|sepsis
5028573|NCT03821038|IL-7|il-7
5028574|NCT03821038|lymphocytopenia|lymphocytopenia
5028575|NCT03820999|treatment delay|treatment delay
5028576|NCT03820999|primary health care|primary health care
5028582|NCT03820960|Thrombosis|thrombosis
5029084|NCT03817567|EGFR|egfr
5028599|NCT03820934|Fibrosis|fibrosis
5028600|NCT03820921|EUS-FNB, PDL1, MMR|eus-fnb, pdl1, mmr
5028601|NCT03820908|relapsed AML|relapsed aml
5028602|NCT03820908|refractory AML|refractory aml
5028603|NCT03820895|vitamin D|vitamin d
5028604|NCT03820895|Cobb angle|cobb angle
5028605|NCT03820895|alkaline phosphatase|alkaline phosphatase
5028606|NCT03820856|Lateral Epicondylitis|lateral epicondylitis
5028607|NCT03820856|Tennis Elbow|tennis elbow
5028608|NCT03820856|Acupuncture|acupuncture
5078726|NCT03507413|placebo|placebo
5028609|NCT03820856|Fire needle|fire needle
5028610|NCT03820843|brain connectivity|brain connectivity
5028611|NCT03820843|aphasia|aphasia
5028612|NCT03820843|art therapy|art therapy
5028613|NCT03820843|rehabilitation|rehabilitation
5028614|NCT03820830|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5028615|NCT03820830|HER2 receptor negative|her2 receptor negative
5028616|NCT03820830|CDK4/6 inhibitor|cdk4/6 inhibitor
5428229|NCT01595581|Lean mass|lean mass
5428230|NCT01595581|Strength|strength
5028623|NCT03820700|Pain|pain
5028624|NCT03820700|Cognition and perception|cognition and perception
5028625|NCT03820700|Recovery|recovery
5028626|NCT03820674|Heart Failure|heart failure
5028627|NCT03820674|Fatigue|fatigue
5028628|NCT03820674|Rehabilitation|rehabilitation
5028629|NCT03820674|Occupational Therapy|occupational therapy
5028630|NCT03820622|coronary artery stenosis|coronary artery stenosis
5028631|NCT03820622|drug eluting balloon|drug eluting balloon
5028632|NCT03820622|bifurcation|bifurcation
5028633|NCT03820609|Sexual Assault|sexual assault
5028634|NCT03820609|Digital Intervention|digital intervention
5028635|NCT03820596|Sintilimab|sintilimab
5028636|NCT03820596|Chidamide|chidamide
5028637|NCT03820596|refractory and relapsed|refractory and relapsed
5028638|NCT03820596|Extranodal natural killer cell/T-cell lymphoma|extranodal natural killer cell/t-cell lymphoma
5028639|NCT03820583|Whipple procedure, pancreatic carcinoma, biliary stenting,|whipple procedure, pancreatic carcinoma, biliary stenting,
5028640|NCT03820531|DNA Mutational Analysis|dna mutational analysis
5028641|NCT03820531|Cyst Fluid|cyst fluid
5028642|NCT03820531|Pancreas|pancreas
5028643|NCT03820505|obstetrics|obstetrics
5343330|NCT01979341|hCG|hcg
5028644|NCT03820505|pre-hospital emergencies unannounced delivery outside maternity,|pre-hospital emergencies unannounced delivery outside maternity,
5028645|NCT03820505|mortality-morbidity|mortality-morbidity
5028646|NCT03820505|reinforcement midwife in pre-hospital|reinforcement midwife in pre-hospital
5028647|NCT03820492|Coronary artery disease|coronary artery disease
5028648|NCT03820492|Fractional flow reserve|fractional flow reserve
5028658|NCT03820440|Lung Recruitment Manovre|lung recruitment manovre
5028659|NCT03820440|Fluid responsiveness|fluid responsiveness
5028660|NCT03820440|Functional Hemodynamic Test|functional hemodynamic test
5028661|NCT03820414|VZV, Vaccine, Shingles|vzv, vaccine, shingles
5028662|NCT03820401|hemodialyzer|hemodialyzer
5028663|NCT03820401|fibre clotting|fibre clotting
5028664|NCT03820388|Etomidate|etomidate
5028665|NCT03820388|Propofol|propofol
5028666|NCT03820375|Stroke|stroke
5028667|NCT03820375|ESUS|esus
5028668|NCT03820375|PFO|pfo
5028669|NCT03820375|PFO closure|pfo closure
5028670|NCT03820375|ICM|icm
5028671|NCT03820362|personal identity|personal identity
5028672|NCT03820362|personal constructs|personal constructs
5028673|NCT03820349|CFRD|cfrd
5028674|NCT03820349|Cystic fibrosis|cystic fibrosis
5028675|NCT03820310|malignancy|malignancy
5028676|NCT03820310|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5028677|NCT03820271|Liver transplantation|liver transplantation
5028678|NCT03820271|Predictive prognostic models|predictive prognostic models
5028679|NCT03820271|Decompensated cirrhosis|decompensated cirrhosis
5028680|NCT03820245|Carotenoid|carotenoid
5028681|NCT03820245|LDL oxidation|ldl oxidation
5028682|NCT03820245|Cardiovascular disease|cardiovascular disease
5028683|NCT03820245|Antioxidant|antioxidant
5028684|NCT03820232|Intraoperative, Hypothermia|intraoperative, hypothermia
5028685|NCT03820219|spine|spine
5028686|NCT03820219|surgical dressing|surgical dressing
5028687|NCT03820219|negative pressure therapy|negative pressure therapy
5028688|NCT03820219|surgical infection|surgical infection
5028689|NCT03820180|bioequivalence|bioequivalence
5028690|NCT03820180|fluticasone propionate|fluticasone propionate
5029085|NCT03817567|SCT200|sct200
5028691|NCT03820180|salmeterol xinafoate|salmeterol xinafoate
5028693|NCT03820063|neo adjuvant|neo adjuvant
5028694|NCT03820063|HER2 positive|her2 positive
5028695|NCT03820063|de-escalation|de-escalation
5028696|NCT03820011|participation|participation
5028697|NCT03820011|environment|environment
5028698|NCT03820011|goal setting|goal setting
5028699|NCT03819959|Pilot Trial|pilot trial
5028700|NCT03819959|Muscle Biopsy|muscle biopsy
5028701|NCT03819959|Blood Metabolome|blood metabolome
5028702|NCT03819946|Esophageal protection|esophageal protection
5028703|NCT03819946|Ablation-related thermal injury|ablation-related thermal injury
5028704|NCT03819946|Catheter ablation for AF|catheter ablation for af
5028708|NCT03819920|cancer screening beliefs|cancer screening beliefs
5028709|NCT03819920|colorectal cancer screening|colorectal cancer screening
5028710|NCT03819894|myocardial infarction|myocardial infarction
5028712|NCT03819894|high-sensitivity cardiac troponin|high-sensitivity cardiac troponin
5028713|NCT03819894|biomarkers|biomarkers
5028714|NCT03819894|heart attack|heart attack
5028715|NCT03819894|emergency department|emergency department
5028716|NCT03819894|acute coronary syndrome|acute coronary syndrome
5028717|NCT03819868|dental caries|dental caries
5028718|NCT03819868|molars|molars
5028728|NCT03819790|Insulin glargine|insulin glargine
5028729|NCT03819790|Glucose variability|glucose variability
5028730|NCT03819790|Insulin Titration|insulin titration
5028731|NCT03819790|South Asians|south asians
5028732|NCT03819764|stroke|stroke
5028733|NCT03819764|aerobic exercise|aerobic exercise
5028734|NCT03819764|forced exercise|forced exercise
5028735|NCT03819764|repetitive task practice|repetitive task practice
5028736|NCT03819764|arm function|arm function
5028737|NCT03819764|upper extremity|upper extremity
5028738|NCT03819751|prostatic neoplasms|prostatic neoplasms
5028739|NCT03819751|biopsy|biopsy
5028740|NCT03819751|Multimodal Imaging|multimodal imaging
5028741|NCT03819751|prostate|prostate
5028742|NCT03819738|fMRI|fmri
5028743|NCT03819738|epilepsy|epilepsy
5028744|NCT03819738|pain|pain
5028745|NCT03819738|electrode|electrode
5028746|NCT03819738|brain|brain
5028747|NCT03819738|neuromodulation|neuromodulation
5028748|NCT03819738|DBS|dbs
5028749|NCT03819725|Glucose variation|glucose variation
5028753|NCT03819686|end stage renal disease|end stage renal disease
5028754|NCT03819686|ESRD|esrd
5028755|NCT03819686|living donor kidney transplantation|living donor kidney transplantation
5028756|NCT03819686|LDKT|ldkt
5028757|NCT03819686|African American|african american
5028758|NCT03819673|Personalised|personalised
5028759|NCT03819673|Nutrition|nutrition
5028760|NCT03819673|Intervention|intervention
5028761|NCT03819673|Children|children
5028762|NCT03819673|Obesity|obesity
5028763|NCT03819673|Health professionals|health professionals
5028764|NCT03819660|Type 3|type 3
5028765|NCT03819621|Prosthetic|prosthetic
5343371|NCT01979055|asthma|asthma
5028766|NCT03819621|Eye|eye
5028767|NCT03819621|Enucleation|enucleation
5028768|NCT03819608|mTBI|mtbi
5028769|NCT03819608|PTSD|ptsd
5028770|NCT03819608|intermittent theta burst stimulation|intermittent theta burst stimulation
5028771|NCT03819608|cognitive training|cognitive training
5028772|NCT03819608|neuroimaging|neuroimaging
5028773|NCT03819569|genomic risk assessment|genomic risk assessment
5028774|NCT03819569|small renal mass|small renal mass
5028775|NCT03819556|Cow milk allergy|cow milk allergy
5028776|NCT03819556|Oral immune therapy|oral immune therapy
5028777|NCT03819556|Basophil activation test|basophil activation test
5028778|NCT03819556|IgE|ige
5028779|NCT03819556|Microbiome|microbiome
5028780|NCT03819556|Quality of life|quality of life
5028782|NCT03819504|Structural Heart Disease|structural heart disease
5028783|NCT03819504|Ventricular Tachycardia|ventricular tachycardia
5028784|NCT03819504|Substrate Ablation|substrate ablation
5028785|NCT03819504|Stereotactic Radiosurgery|stereotactic radiosurgery
5028786|NCT03819504|Functional Radiosurgery|functional radiosurgery
5028787|NCT03819504|4D navigation|4d navigation
5028788|NCT03819491|COQUN|coqun
5028789|NCT03819491|antioxidant|antioxidant
5028790|NCT03819491|Bioavailability|bioavailability
5028791|NCT03819491|CoQ10|coq10
5028792|NCT03819491|Healthy|healthy
5028802|NCT03819452|Ischemic Stroke|ischemic stroke
5028803|NCT03819439|autism|autism
5028804|NCT03819439|microbiome|microbiome
5028805|NCT03819439|mycobiome|mycobiome
5028806|NCT03819439|bacteria|bacteria
5028807|NCT03819439|fungi|fungi
5028808|NCT03819413|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5028809|NCT03819413|prevalence|prevalence
5028810|NCT03819413|anti-AQP4|anti-aqp4
5028811|NCT03819413|anti-MOG|anti-mog
5028812|NCT03819400|kidney graft|kidney graft
5028813|NCT03819400|fibrosis|fibrosis
5028814|NCT03819400|elastography|elastography
5028815|NCT03819361|Night-to-night variability|night-to-night variability
5028816|NCT03819361|Apnoea-Hypopnoea Index|apnoea-hypopnoea index
5028817|NCT03819361|Oxygen Desaturation Index|oxygen desaturation index
5028818|NCT03819361|Pulse-oximetry|pulse-oximetry
5028819|NCT03819335|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5028820|NCT03819335|Mobile Applications|mobile applications
5028821|NCT03819335|Telemedicine|telemedicine
5028822|NCT03819309|tubo ovarian abscess|tubo ovarian abscess
5028823|NCT03819309|transvaginal aspiration|transvaginal aspiration
5028824|NCT03819309|laparoscopy|laparoscopy
5028825|NCT03819283|fatty liver, coronary artery disease, atherosclerosis|fatty liver, coronary artery disease, atherosclerosis
5028829|NCT03819231|Mindfulness|mindfulness
5028830|NCT03819231|Oxytocin|oxytocin
5028831|NCT03819205|cerebral palsy|cerebral palsy
5028832|NCT03819205|upper extremity kinesiotaping|upper extremity kinesiotaping
5028833|NCT03819205|modified house|modified house
5028834|NCT03819140|Hyperandrogenism|hyperandrogenism
5028835|NCT03819140|Oral Contraceptive Pills|oral contraceptive pills
5028836|NCT03819114|Levonorgestrel|levonorgestrel
5028837|NCT03819114|Pharmacokinetics|pharmacokinetics
5028838|NCT03819114|Efavirenz|efavirenz
5028839|NCT03819114|Dolutegravir|dolutegravir
5028840|NCT03819114|Rifampin|rifampin
5028841|NCT03819075|laser|laser
5028842|NCT03819075|Er:YAG|er:yag
5028843|NCT03819075|Nd:YAG|nd:yag
5028844|NCT03819075|periimplantitis|periimplantitis
5028845|NCT03819075|randomized controlled trial|randomized controlled trial
5028851|NCT03819036|Dental emergency|dental emergency
5028852|NCT03819036|Toothache|toothache
5028853|NCT03819036|Tooth pain|tooth pain
5028854|NCT03818971|retina AND electroretinogram|retina and electroretinogram
5028855|NCT03818906|Photochemotherapy|photochemotherapy
5028856|NCT03818893|Cancer immunotherapy|cancer immunotherapy
5028857|NCT03818880|Myopia|myopia
5028858|NCT03818880|Myopia control|myopia control
5028859|NCT03818867|cervical cerclage|cervical cerclage
5028860|NCT03818867|Preterm Birth|preterm birth
5028861|NCT03818867|Twin pregnancy|twin pregnancy
5028862|NCT03818867|Twin to Twin Transfusion Syndrome|twin to twin transfusion syndrome
5028863|NCT03818854|Human Mesenchymal Stromal Cells|human mesenchymal stromal cells
5028869|NCT03818802|NAD precursors|nad precursors
5028870|NCT03818802|Aging|aging
5028871|NCT03818776|Durvalumab|durvalumab
5028872|NCT03818776|PARTICLE-D|particle-d
5028873|NCT03818737|mesenchymal stem cells|mesenchymal stem cells
5028874|NCT03818737|corticosteroids|corticosteroids
5028875|NCT03818737|bone marrow aspiration|bone marrow aspiration
5028876|NCT03818737|adipose-derived stromal vascular fraction|adipose-derived stromal vascular fraction
5028877|NCT03818724|Atrial Fibrillation|atrial fibrillation
5028878|NCT03818724|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5028879|NCT03818724|Persistent Atrial Fibrillation|persistent atrial fibrillation
5028880|NCT03818724|Cryoablation|cryoablation
5028881|NCT03818724|Cryosurgery|cryosurgery
5028882|NCT03818685|Residual disease with RCB of Class III|residual disease with rcb of class iii
5028883|NCT03818646|Exacerbation|exacerbation
5028884|NCT03818646|Functional respiratory imaging|functional respiratory imaging
5028887|NCT03818568|chronic kidney disease|chronic kidney disease
5028888|NCT03818568|ketoanalogue|ketoanalogue
5028889|NCT03818568|diabetes|diabetes
5028890|NCT03818542|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5028891|NCT03818542|Cancer|cancer
5028892|NCT03818542|ABBV-927|abbv-927
5028893|NCT03818542|ABBV-368|abbv-368
5028894|NCT03818542|ABBV-181|abbv-181
5028895|NCT03818542|tumor resection|tumor resection
5028896|NCT03818542|immunotherapeutic drug|immunotherapeutic drug
5028897|NCT03818529|Hemophilia|hemophilia
5028898|NCT03818529|Previously Untreated Patients (PUPs)|previously untreated patients (pups)
5028899|NCT03818529|Clotting Factor Replacement Products|clotting factor replacement products
5028900|NCT03818529|Haemophilia|haemophilia
5028901|NCT03818516|Inflammation|inflammation
5028902|NCT03818516|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5028903|NCT03818516|Negative Symptoms|negative symptoms
5028904|NCT03818490|Aromatherapy|aromatherapy
5028905|NCT03818490|Essential Oils|essential oils
5028906|NCT03818490|Children|children
5028907|NCT03818464|pre-operative assessment|pre-operative assessment
5028908|NCT03818464|postoperative pain|postoperative pain
5028909|NCT03818464|biological complications|biological complications
5028910|NCT03818451|Moderate brain trauma|moderate brain trauma
5028911|NCT03818451|Glialia|glialia
5028912|NCT03818451|Neuroinflammation|neuroinflammation
5028913|NCT03818451|Neuroprotection|neuroprotection
5028914|NCT03818438|Chronic instability|chronic instability
5028915|NCT03818438|Strength|strength
5028916|NCT03818438|Proprioception|proprioception
5028919|NCT03818438|Balance|balance
5028920|NCT03818425|Anxiety|anxiety
5028921|NCT03818425|Posttraumatic Stress Disorder|posttraumatic stress disorder
5028922|NCT03818412|Circulating tumor DNA|circulating tumor dna
5028923|NCT03818386|gadolinium nanoparticles|gadolinium nanoparticles
5028924|NCT03818386|AGuIX|aguix
5028925|NCT03818373|Univentricular congenital heart|univentricular congenital heart
5028926|NCT03818373|Sleep apnea|sleep apnea
5028927|NCT03818373|Polysomnography|polysomnography
5028928|NCT03818373|Respiratory drive|respiratory drive
5028929|NCT03818373|VE/VCO2 slope|ve/vco2 slope
5028930|NCT03818360|Smoking cessation intervention|smoking cessation intervention
5028931|NCT03818360|Evidence-based|evidence-based
5028932|NCT03818360|Brief advice|brief advice
5028933|NCT03818360|Active referrals|active referrals
5030637|NCT03807752|Fish Proteins|fish proteins
5028945|NCT03818256|Schizophrenia|schizophrenia
5028946|NCT03818256|Risperidone|risperidone
5028947|NCT03818256|Quetiapine|quetiapine
5028948|NCT03818256|Olanzapine|olanzapine
5028949|NCT03818243|Parkinson disease|parkinson disease
5028950|NCT03818243|Restless Leg Syndrome|restless leg syndrome
5028951|NCT03818243|Impulse control disorders|impulse control disorders
5028952|NCT03818243|circadian rhythm|circadian rhythm
5028953|NCT03818230|Clinical trials|clinical trials
5028954|NCT03818230|Early phase clinical trials|early phase clinical trials
5028955|NCT03818230|Experimental cancer medicine|experimental cancer medicine
5028956|NCT03818217|socially assistive robot|socially assistive robot
5028957|NCT03818217|humanoid robot|humanoid robot
5028958|NCT03818217|motivation|motivation
5028959|NCT03818217|home care|home care
5028960|NCT03818217|cognitive training|cognitive training
5028961|NCT03818217|physical training|physical training
5028962|NCT03818217|caregivers|caregivers
5028963|NCT03818217|dementia trainers|dementia trainers
5028964|NCT03818217|Computers, handheld|computers, handheld
5028965|NCT03818165|pancreatic carcinoma|pancreatic carcinoma
5028966|NCT03818165|Cacinomaembryonic antigen postive (CEA +)|cacinomaembryonic antigen postive (cea +)
5028967|NCT03818165|liver metastases|liver metastases
5028968|NCT03818165|pancreatic cancer|pancreatic cancer
5028970|NCT03818165|metastatic pancreatic carcinoma|metastatic pancreatic carcinoma
5028971|NCT03818165|metastatic pancreatic cancer|metastatic pancreatic cancer
5028972|NCT03818165|phase 1|phase 1
5028973|NCT03818152|Cerebral palsy|cerebral palsy
5028974|NCT03818152|Children|children
5028975|NCT03818152|Functional strength measurement|functional strength measurement
5028976|NCT03818152|Lower limbs|lower limbs
5028977|NCT03818152|Reproducability|reproducability
5028978|NCT03818139|diagnostic imaging, Newborn, Intubation, Ultrasonography methods|diagnostic imaging, newborn, intubation, ultrasonography methods
5028979|NCT03818126|del Nido|del nido
5028980|NCT03818126|cardioplegia|cardioplegia
5028981|NCT03818126|aortic valve|aortic valve
5028982|NCT03818113|mitral valve insufficiency|mitral valve insufficiency
5028983|NCT03818113|cardioplegia|cardioplegia
5028984|NCT03818113|cardioplegia Solution|cardioplegia solution
5028985|NCT03818113|HTK-Bretschneider (Custidiol®) solution|htk-bretschneider (custidiol®) solution
5028994|NCT03818022|knee|knee
5028995|NCT03818022|joint replacement|joint replacement
5028996|NCT03818022|total knee|total knee
5028997|NCT03818022|cryoneurolysis|cryoneurolysis
5028998|NCT03818022|Iovera|iovera
5028999|NCT03818022|TKA|tka
5029000|NCT03818022|pain|pain
5029002|NCT03817996|High flow nasal cannula|high flow nasal cannula
5029003|NCT03817996|Nasal high flow|nasal high flow
5029004|NCT03817996|Plethysmographic variation index|plethysmographic variation index
5029005|NCT03817996|Fluid responsiveness|fluid responsiveness
5029006|NCT03817970|Nephrotoxicity|nephrotoxicity
5029007|NCT03817970|Cisplatin|cisplatin
5029008|NCT03817970|Kidney Injury|kidney injury
5029009|NCT03817970|anti-emetics|anti-emetics
5029010|NCT03817957|post surgery anemia treatment,|post surgery anemia treatment,
5029011|NCT03817944|potato consumption|potato consumption
5029012|NCT03817944|CHNS|chns
5029013|NCT03817944|mortality|mortality
5029014|NCT03817944|fried potato|fried potato
5029015|NCT03817944|sweet potato|sweet potato
5029016|NCT03817905|Colonoscopy|colonoscopy
5029017|NCT03817905|Fecal Immunochemical Testing|fecal immunochemical testing
5029025|NCT03817866|Endocrine tumors|endocrine tumors
5029026|NCT03817866|Carcinoids|carcinoids
5029027|NCT03817866|Functional NETs|functional nets
5029032|NCT03817827|female athlete triad|female athlete triad
5029034|NCT03817814|Quality of Life|quality of life
5029035|NCT03817814|Web-based questionnaire|web-based questionnaire
5029036|NCT03817814|18-461|18-461
5029037|NCT03817775|Music therapy|music therapy
5029038|NCT03817775|sedation|sedation
5029039|NCT03817775|coronary angioplasty|coronary angioplasty
5029040|NCT03817762|pediatric obstructive sleep apnea hypopnea syndrome|pediatric obstructive sleep apnea hypopnea syndrome
5029042|NCT03817762|device acceptance|device acceptance
5339129|NCT01998724|Pulmonary|pulmonary
5029043|NCT03817762|signal quality|signal quality
5029044|NCT03817762|automatic detection of respiratory events|automatic detection of respiratory events
5029045|NCT03817749|Flow mediated dilation|flow mediated dilation
5029046|NCT03817749|Glucose control|glucose control
5029047|NCT03817749|Inflammation|inflammation
5029048|NCT03817749|Immune cell function|immune cell function
5029049|NCT03817749|Cognition|cognition
5029050|NCT03817749|Oxidative stress|oxidative stress
5029051|NCT03817749|Cardiovascular function|cardiovascular function
5029052|NCT03817736|HCC|hcc
5029053|NCT03817736|START-FIT|start-fit
5029054|NCT03817736|TACE|tace
5029055|NCT03817736|SBRT|sbrt
5029056|NCT03817736|immunotherapy|immunotherapy
5029057|NCT03817736|hepatectomy|hepatectomy
5029058|NCT03817736|hepatocellular carcinoma|hepatocellular carcinoma
5029059|NCT03817736|liver cancer|liver cancer
5029060|NCT03817723|Radiation dose|radiation dose
5029061|NCT03817723|cholangiography|cholangiography
5029062|NCT03817723|Cholecystectomy|cholecystectomy
5029063|NCT03817710|tics disorder in childern with acute deficit hyper activity syndrom|tics disorder in childern with acute deficit hyper activity syndrom
5029064|NCT03817671|Thawed blastocyst|thawed blastocyst
5029065|NCT03817671|ultra low oxygen tension|ultra low oxygen tension
5029066|NCT03817671|2%O2|2%o2
5029067|NCT03817671|Degree of expansion|degree of expansion
5029068|NCT03817645|Zeolite|zeolite
5029073|NCT03817593|meditation|meditation
5029074|NCT03817593|heart rate variability|heart rate variability
5029075|NCT03817593|ADD|add
5029076|NCT03817593|ADHD|adhd
5029077|NCT03817593|children|children
5029078|NCT03817567|Carcinoma|carcinoma
5029079|NCT03817567|Carcinoma, Squamous Cell|carcinoma, squamous cell
5029080|NCT03817567|Esophageal Neoplasms|esophageal neoplasms
5029081|NCT03817567|Neoplasms, Squamous Cell|neoplasms, squamous cell
5029091|NCT03817489|Mindfulness meditation|mindfulness meditation
5029092|NCT03817489|Randomized controlled trial|randomized controlled trial
5029093|NCT03817489|Cortisol|cortisol
5029094|NCT03817450|Mouth Care|mouth care
5029095|NCT03817437|Oral health|oral health
5029096|NCT03817437|Odontology|odontology
5029097|NCT03817437|Epidemiology|epidemiology
5029098|NCT03817437|Public health|public health
5029099|NCT03817437|Deprivation|deprivation
5029100|NCT03817385|Transcranial magnetic stimulation|transcranial magnetic stimulation
5029101|NCT03817385|Robotic gait training|robotic gait training
5029102|NCT03817385|Gait|gait
5029103|NCT03817385|Spasticity|spasticity
5029104|NCT03817372|Cardioversion|cardioversion
5029105|NCT03817372|Electrode position|electrode position
5029106|NCT03817359|propofol|propofol
5029107|NCT03817359|remifentanil|remifentanil
5029108|NCT03817359|total intravenous anesthesia|total intravenous anesthesia
5029109|NCT03817359|breast surgery|breast surgery
5029110|NCT03817346|Safety|safety
5029111|NCT03817346|Tolerability|tolerability
5029112|NCT03817346|Pharmacokinetics|pharmacokinetics
5029113|NCT03817333|phenotype|phenotype
5029114|NCT03817333|inflammation|inflammation
5029115|NCT03817333|pulmonary function|pulmonary function
5029116|NCT03817333|comorbidities|comorbidities
5029117|NCT03817242|Cartilage|cartilage
5029118|NCT03817242|Hearing loss|hearing loss
5029119|NCT03817242|Tympanoplasty|tympanoplasty
5029120|NCT03817229|adherence|adherence
5029121|NCT03817229|mHealth|mhealth
5029122|NCT03817229|eHealth|ehealth
5029123|NCT03817229|children|children
5029124|NCT03817229|caregivers|caregivers
5029125|NCT03817229|compliance|compliance
5029126|NCT03817216|Prostatic Urethral Lift (PUL)|prostatic urethral lift (pul)
5029132|NCT03817125|Metastatic Melanoma|metastatic melanoma
5029133|NCT03817125|anti-PD1|anti-pd1
5029134|NCT03817125|Nivolumab|nivolumab
5029135|NCT03817125|Microbiome|microbiome
5029136|NCT03817125|SER-401|ser-401
5029137|NCT03817112|cerebral oxygen saturation|cerebral oxygen saturation
5029138|NCT03817112|cardiopulmonary bypass|cardiopulmonary bypass
5029139|NCT03817112|dexmedetomidine|dexmedetomidine
5029140|NCT03817112|propofol|propofol
5029141|NCT03817060|OHSS|ohss
5029142|NCT03817060|Agonist trigger|agonist trigger
5029143|NCT03817060|freeze-all|freeze-all
5029144|NCT03817060|blastocyst|blastocyst
5029145|NCT03817060|cleavage|cleavage
5029146|NCT03817047|Adolescents|adolescents
5029147|NCT03817047|Physical activity|physical activity
5029148|NCT03817047|Physical fitness|physical fitness
5029149|NCT03817047|Academic performance|academic performance
5029150|NCT03817047|Cluster RCT|cluster rct
5029151|NCT03817047|Mental health|mental health
5029152|NCT03817047|Secondary school|secondary school
5029153|NCT03817047|Physical education|physical education
5029154|NCT03817047|Physical active educational lessons|physical active educational lessons
5029155|NCT03817047|Accelerometer|accelerometer
5029156|NCT03817034|multimodal|multimodal
5029157|NCT03817034|dexmedetomidine|dexmedetomidine
5029158|NCT03817034|ropivacaine|ropivacaine
5029164|NCT03817021|Children's Appetite Self-Regulation|children's appetite self-regulation
5029165|NCT03817021|Early Childhood Education|early childhood education
5029166|NCT03816995|wound irrigation|wound irrigation
5029168|NCT03816995|colorectal surgery|colorectal surgery
5339312|NCT01997983|IC|ic
5029169|NCT03816969|Self-pressurized Air Q|self-pressurized air q
5029170|NCT03816956|Staphylococcus aureus|staphylococcus aureus
5029171|NCT03816956|S. aureus|s. aureus
5029172|NCT03816956|monoclonal antibody|monoclonal antibody
5029173|NCT03816956|Aridis|aridis
5029175|NCT03816956|ventilator acquired pneumonia|ventilator acquired pneumonia
5029176|NCT03816956|infection|infection
5029177|NCT03816956|pneumonia|pneumonia
5029178|NCT03816956|AR301|ar301
5029179|NCT03816943|fixed appliances|fixed appliances
5029180|NCT03816943|orthodontics|orthodontics
5029181|NCT03816943|quality of life|quality of life
5029182|NCT03816943|anxiety|anxiety
5029183|NCT03816943|pain|pain
5029184|NCT03816943|instant messaging|instant messaging
5029185|NCT03816943|telephone call|telephone call
5029186|NCT03816930|CAD/CAM|cad/cam
5029187|NCT03816930|Gingival retraction|gingival retraction
5029188|NCT03816917|Screening|screening
5029189|NCT03816917|Prediction Model|prediction model
5029190|NCT03816852|Premature Ovarian Failure|premature ovarian failure
5029203|NCT03816774|adequate bowel preparation|adequate bowel preparation
5029204|NCT03816748|Minimally invasive surgery, High flow nasal cannula|minimally invasive surgery, high flow nasal cannula
5029205|NCT03816709|heating rates|heating rates
5029206|NCT03816709|therapeutic ultrasound|therapeutic ultrasound
5029208|NCT03816683|Mantle Cell Lymphoma|mantle cell lymphoma
5029210|NCT03816644|Cognitive screening|cognitive screening
5029211|NCT03816644|Primary care|primary care
5029212|NCT03816644|Dementia|dementia
5029213|NCT03816644|Cognitive Impairment|cognitive impairment
5029214|NCT03816644|Mild Cognitive Impairment|mild cognitive impairment
5029215|NCT03816618|purilon gel|purilon gel
5029216|NCT03816618|medihoney|medihoney
5029217|NCT03816618|fucidine|fucidine
5029218|NCT03816605|GDM|gdm
5029219|NCT03816605|IRS-1|irs-1
5029220|NCT03816605|GLUT-1|glut-1
5029221|NCT03816501|postoperative anxiety|postoperative anxiety
5029222|NCT03816501|State - Trait Anxiety Inventory|state - trait anxiety inventory
5029223|NCT03816488|Metformin|metformin
5029224|NCT03816488|Salsalate|salsalate
5029225|NCT03816475|Dose Hypofractionation|dose hypofractionation
5029226|NCT03816475|Neoadjuvant Therapy|neoadjuvant therapy
5029227|NCT03816475|Sarcoma|sarcoma
5029228|NCT03816475|Dose Fractionation|dose fractionation
5029229|NCT03816475|Dose-Response Relationship|dose-response relationship
5029230|NCT03816436|clavicle non-unions|clavicle non-unions
5029231|NCT03816436|plate treatment of clavicular fractures|plate treatment of clavicular fractures
5029232|NCT03816436|cortical bone grafting of clavicular fractures|cortical bone grafting of clavicular fractures
5029233|NCT03816436|clavicular midshaft non- union|clavicular midshaft non- union
5029234|NCT03816436|clavicular lateral non- union|clavicular lateral non- union
5029235|NCT03816436|clavicular shortening|clavicular shortening
5029236|NCT03816423|patient education|patient education
5029237|NCT03816423|genetic counseling|genetic counseling
5029238|NCT03816384|urinary catheter|urinary catheter
5029239|NCT03816371|thyroidectomy|thyroidectomy
5029240|NCT03816371|head-of-bed elevation|head-of-bed elevation
5029241|NCT03816371|supine position|supine position
5029242|NCT03816371|respiratory pattern|respiratory pattern
5029243|NCT03816371|amount of drainage|amount of drainage
5029244|NCT03816371|peripheral oxygen saturation|peripheral oxygen saturation
5029245|NCT03816293|colon surgery|colon surgery
5029246|NCT03816293|abdominal hysterectomy|abdominal hysterectomy
5029247|NCT03816280|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5029253|NCT03816215|Adolescents|adolescents
5029254|NCT03816215|FMRI|fmri
5029255|NCT03816215|volunteerism|volunteerism
5029256|NCT03816189|Eosinophil|eosinophil
5029257|NCT03816189|Fibrosis|fibrosis
5029258|NCT03816189|Systemic Scleroderma|systemic scleroderma
5029259|NCT03816176|ASP9766|asp9766
5029260|NCT03816176|Cresemba|cresemba
5029261|NCT03816176|BAL8557|bal8557
5029262|NCT03816176|isavuconazonium sulfate|isavuconazonium sulfate
5029271|NCT03816137|Antibody|antibody
5029272|NCT03816137|Antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
5029273|NCT03816137|Neuralizing antibody responses|neuralizing antibody responses
5029274|NCT03816124|osteoarthritis|osteoarthritis
5029275|NCT03816124|radiofrequency ablation|radiofrequency ablation
5029276|NCT03816111|Training|training
5029277|NCT03816098|elderly|elderly
5029278|NCT03816098|screening|screening
5029279|NCT03816085|women|women
5029280|NCT03816085|shoes|shoes
5029281|NCT03816085|balance|balance
5029294|NCT03816033|catheter ablation techniques|catheter ablation techniques
5029295|NCT03816020|clinical pilot, Nicotamide Riboside, Parkinson's Disease|clinical pilot, nicotamide riboside, parkinson's disease
5029297|NCT03816007|chronic pain|chronic pain
5029298|NCT03816007|yoga|yoga
5029299|NCT03816007|mantram repetition|mantram repetition
5029300|NCT03816007|mind-body interventions|mind-body interventions
5029301|NCT03816007|complementary and integrative medicine|complementary and integrative medicine
5029302|NCT03815994|Physical therapy modalities,|physical therapy modalities,
5029303|NCT03815994|Electric stimulation therapy|electric stimulation therapy
5029304|NCT03815994|Indirect calorimetry|indirect calorimetry
5029305|NCT03815981|iron|iron
5029306|NCT03815981|siderophores|siderophores
5029307|NCT03815981|allergy|allergy
5029308|NCT03815981|allergic sensitisation|allergic sensitisation
5029309|NCT03815981|trace elements|trace elements
5029310|NCT03815968|oligohydroamnios|oligohydroamnios
5029311|NCT03815968|low salt diet|low salt diet
5029312|NCT03815929|Hormone therapy|hormone therapy
5029313|NCT03815929|Pre-menopausal Oophorectomy|pre-menopausal oophorectomy
5029314|NCT03815929|Cardiovascular Disease|cardiovascular disease
5029315|NCT03815916|neurodegeneration|neurodegeneration
5029316|NCT03815916|gold|gold
5029317|NCT03815916|nanocrystal|nanocrystal
5029318|NCT03815916|NAD+|nad+
5029319|NCT03815916|redox|redox
5029320|NCT03815916|31P-MRS|31p-mrs
5029323|NCT03815916|nanoparticle|nanoparticle
5029324|NCT03815916|nanomedicine|nanomedicine
5029325|NCT03815916|NADH|nadh
5029326|NCT03815890|pre-operative|pre-operative
5029327|NCT03815890|triple negative and Luminal B|triple negative and luminal b
5029328|NCT03815890|resectable, stage I-III|resectable, stage i-iii
5029329|NCT03815877|Caffeine|caffeine
5029330|NCT03815877|Postoperative Ileus|postoperative ileus
5029331|NCT03815877|Caesarean Section|caesarean section
5029332|NCT03815864|donor specific antibody|donor specific antibody
5029333|NCT03815864|autoantibody|autoantibody
5029334|NCT03815864|human leucocyte antigen|human leucocyte antigen
5029335|NCT03815799|Erector Spinae Block|erector spinae block
5029336|NCT03815799|Laparoscopy|laparoscopy
5029337|NCT03815799|Respiratory Function|respiratory function
5029338|NCT03815786|gut microbiota dysbiosis|gut microbiota dysbiosis
5029339|NCT03815786|uremic toxins|uremic toxins
5029340|NCT03815786|symbiotic|symbiotic
5029341|NCT03815773|ECMO|ecmo
5029342|NCT03815773|PRBC|prbc
5029343|NCT03815773|Fresh frozen Plasma|fresh frozen plasma
5029344|NCT03815773|Fibrinogen|fibrinogen
5029345|NCT03815773|Antithrombin III|antithrombin iii
5029346|NCT03815773|Bleeding|bleeding
5029347|NCT03815773|Anticoagulation|anticoagulation
5029348|NCT03815760|infraspinatus, external rotators, blood flow restriction|infraspinatus, external rotators, blood flow restriction
5029349|NCT03815734|Mental practice|mental practice
5029350|NCT03815734|motor imagery|motor imagery
5029351|NCT03815734|trapeziometacarpal osteoarthritis|trapeziometacarpal osteoarthritis
5029352|NCT03815669|arthroscopic subacromial decompression|arthroscopic subacromial decompression
5029353|NCT03815669|shoulder impingement syndrome|shoulder impingement syndrome
5029354|NCT03815669|effect|effect
5029355|NCT03815669|surgery|surgery
5029356|NCT03815656|Deep Brain Stimulation|deep brain stimulation
5029357|NCT03815643|Avelumab|avelumab
5029358|NCT03815643|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5029359|NCT03815643|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5029360|NCT03815643|Urothelial carcinoma (UC)|urothelial carcinoma (uc)
5029361|NCT03815643|Ovarian cancer|ovarian cancer
5029363|NCT03815604|Psychiatric Rehabilitation|psychiatric rehabilitation
5029364|NCT03815604|Supported Housing|supported housing
5029365|NCT03815604|Residential Care|residential care
5029366|NCT03815591|smoking|smoking
5029367|NCT03815591|tobacco|tobacco
5029368|NCT03815591|e-cigarettes|e-cigarettes
5029369|NCT03815591|flavored tobacco|flavored tobacco
5029370|NCT03815578|pain sensitization|pain sensitization
5029371|NCT03815578|Tofacitinib|tofacitinib
5029372|NCT03815578|miRNA|mirna
5029379|NCT03815539|dry eye|dry eye
5029380|NCT03815539|noninvasive tear breakup time|noninvasive tear breakup time
5029381|NCT03815539|tear film related optical quality|tear film related optical quality
5029382|NCT03815539|correlation analysis|correlation analysis
5029383|NCT03815526|DynamicTape|dynamictape
5029384|NCT03815526|Sport Tape|sport tape
5029385|NCT03815526|Kinesio Tape|kinesio tape
5029394|NCT03815448|knee osteoarthritis|knee osteoarthritis
5029395|NCT03815448|Magnetic Resonance imaging|magnetic resonance imaging
5029396|NCT03815448|pain|pain
5029397|NCT03815448|synovitis|synovitis
5029398|NCT03815435|Surgical field clarity|surgical field clarity
5029399|NCT03815435|Endonasal surgery|endonasal surgery
5029400|NCT03815435|Intraoperative bleeding|intraoperative bleeding
5029401|NCT03815422|Early ambulation|early ambulation
5029402|NCT03815422|Plantar block|plantar block
5029403|NCT03815396|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5029404|NCT03815396|AATD|aatd
5029405|NCT03815396|alpha-1 disease|alpha-1 disease
5029407|NCT03815370|Abdominal trauma/injury|abdominal trauma/injury
5029408|NCT03815370|Abdominal sepsis/infection|abdominal sepsis/infection
5029409|NCT03815370|Open Abdomen|open abdomen
5029410|NCT03815370|Abdominal binder|abdominal binder
5029411|NCT03815370|Abthera|abthera
5029412|NCT03815370|VAC|vac
5029413|NCT03815370|ABRO|abro
5029414|NCT03815357|streptococcus pneumoniae|streptococcus pneumoniae
5029415|NCT03815357|invasive pneumococcal disease|invasive pneumococcal disease
5029416|NCT03815357|primary immunodeficiency|primary immunodeficiency
5029417|NCT03815344|Robot-assisted|robot-assisted
5029418|NCT03815344|Laparoscopic|laparoscopic
5029419|NCT03815344|vasopressin|vasopressin
5029420|NCT03815344|misoprostol|misoprostol
5029421|NCT03815344|blood loss|blood loss
5029422|NCT03815331|Peyronie's disease|peyronie's disease
5029423|NCT03815331|Hypogonadism|hypogonadism
5029424|NCT03815305|dry skin|dry skin
5029425|NCT03815305|dm type 2|dm type 2
5029426|NCT03815305|centella asiatica|centella asiatica
5029427|NCT03815305|superoxide dismutase|superoxide dismutase
5029428|NCT03815305|AGEs CML|ages cml
5029429|NCT03815305|IL-1α|il-1α
5029430|NCT03815279|Multiple Myeloma|multiple myeloma
5029431|NCT03815279|Smoldering Multiple Myeloma|smoldering multiple myeloma
5029437|NCT03815266|hemiparetic|hemiparetic
5029438|NCT03815266|Ischemic|ischemic
5029439|NCT03815266|stroke|stroke
5029440|NCT03815266|Intensive Visual Simulation3 (IVS3)|intensive visual simulation3 (ivs3)
5029441|NCT03815240|Pressure Ulcer Prevention|pressure ulcer prevention
5029442|NCT03815240|Preventive Dressings|preventive dressings
5029443|NCT03815201|muscle mass|muscle mass
5029444|NCT03815201|protein supplementation|protein supplementation
5029445|NCT03815201|leucine|leucine
5029446|NCT03815201|elderly|elderly
5029447|NCT03815201|exercise training|exercise training
5029454|NCT03815162|cocoa flavanols|cocoa flavanols
5029455|NCT03815149|Interventional Neuroradiology|interventional neuroradiology
5029456|NCT03815149|Diagnostic neuroradiology|diagnostic neuroradiology
5029457|NCT03815149|Neurosurgery|neurosurgery
5029458|NCT03815149|Neurovascular Devices|neurovascular devices
5029459|NCT03815149|Flow Diversion Device|flow diversion device
5029460|NCT03815019|Gastrostomy Tube|gastrostomy tube
5029461|NCT03815019|G-Tube|g-tube
5029462|NCT03815019|Oral Food Refusal|oral food refusal
5029463|NCT03815019|Behavioral Intervention|behavioral intervention
5029464|NCT03815019|Megestrol|megestrol
5029465|NCT03815019|Transition to Oral Feedings|transition to oral feedings
5029466|NCT03815019|Weaning|weaning
5029467|NCT03814967|schizophrenia|schizophrenia
5029469|NCT03814967|tDCS|tdcs
5029470|NCT03814967|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5029471|NCT03814967|cognitive control|cognitive control
5029472|NCT03814967|language|language
5029473|NCT03814967|transcranial direct current stimulation|transcranial direct current stimulation
5029474|NCT03814941|Artifacts|artifacts
5029475|NCT03814941|anesthesia information management system|anesthesia information management system
5029476|NCT03814928|education|education
5029477|NCT03814928|online|online
5029478|NCT03814928|skill development|skill development
5029479|NCT03814928|e-learning|e-learning
5029480|NCT03814928|caregivers|caregivers
5029481|NCT03814915|Gene-environment interaction|gene-environment interaction
5029482|NCT03814915|Genome|genome
5029483|NCT03814915|Glycaemic control|glycaemic control
5029484|NCT03814915|Lifestyle|lifestyle
5029485|NCT03814915|Microbiome|microbiome
5029500|NCT03814850|endovascular repair|endovascular repair
5029501|NCT03814850|ischemic stroke|ischemic stroke
5029502|NCT03814824|VLE|vle
5029503|NCT03814824|Volumetric laser endomicroscopy|volumetric laser endomicroscopy
5029504|NCT03814824|IRIS|iris
5029505|NCT03814824|Intelligent real-time image segmentation|intelligent real-time image segmentation
5029506|NCT03814824|Barrett's Esophagus|barrett's esophagus
5029507|NCT03814811|Breast Cancer|breast cancer
5029508|NCT03814811|Bone|bone
5029509|NCT03814811|Metastasis|metastasis
5029510|NCT03814811|Osteoblast|osteoblast
5029511|NCT03814772|liver transplantation|liver transplantation
5029512|NCT03814772|blood transfusion|blood transfusion
5029513|NCT03814772|Patient blood management|patient blood management
5029527|NCT03814720|Flu|flu
5029528|NCT03814720|Seasonal Allergy|seasonal allergy
5029529|NCT03814720|Respiratory Illness|respiratory illness
5029530|NCT03814720|Flu Virus|flu virus
5029531|NCT03814720|Viral Infection|viral infection
5029532|NCT03814707|gingival recession|gingival recession
5029533|NCT03814707|gingival augmentation|gingival augmentation
5029534|NCT03814707|free gingival graft|free gingival graft
5029536|NCT03814707|2 steps free gingival graft|2 steps free gingival graft
5029537|NCT03814707|hyaluronic acid in wound healing|hyaluronic acid in wound healing
5029538|NCT03814694|Weight Loss|weight loss
5029539|NCT03814694|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5029540|NCT03814694|Diet, High-Protein|diet, high-protein
5029541|NCT03814694|Insulin Resistance|insulin resistance
5029542|NCT03814694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5029543|NCT03814694|Metabolic Syndrome|metabolic syndrome
5029545|NCT03814655|digital workflow|digital workflow
5029546|NCT03814655|guided surgery|guided surgery
5029547|NCT03814629|chronic atrophic gastritis|chronic atrophic gastritis
5029548|NCT03814629|precancerous lesions of gastric cancer|precancerous lesions of gastric cancer
5029549|NCT03814629|Weifuchun|weifuchun
5029550|NCT03814629|randomized clinical trial|randomized clinical trial
5029551|NCT03814629|mechanism|mechanism
5029552|NCT03814616|Asymptomatic malaria|asymptomatic malaria
5029553|NCT03814590|Respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5029554|NCT03814590|Vaccine|vaccine
5029555|NCT03814590|Safety|safety
5029559|NCT03814577|Inhalation anesthetics|inhalation anesthetics
5029560|NCT03814577|Total Intravenous anesthesia|total intravenous anesthesia
5029561|NCT03814577|Oxidative Stress|oxidative stress
5029562|NCT03814577|Morbid Obesity|morbid obesity
5029563|NCT03814538|Postoperative pulmonary complications|postoperative pulmonary complications
5029564|NCT03814538|Incidence of EFL|incidence of efl
5029565|NCT03814486|platelet transfusion|platelet transfusion
5029566|NCT03814486|palliative care|palliative care
5029567|NCT03814460|Topographical mapping|topographical mapping
5029568|NCT03814460|Muscle state of tension|muscle state of tension
5029569|NCT03814460|Myotonometer|myotonometer
5029570|NCT03814460|Pressure Pain Threshold|pressure pain threshold
5029571|NCT03814460|Muscle Thickness|muscle thickness
5029573|NCT03814447|CAR-T|car-t
5029574|NCT03814447|Ovarian cancer|ovarian cancer
5029575|NCT03814447|Refractory-Relapsed|refractory-relapsed
5029576|NCT03814434|peri-implantitis|peri-implantitis
5029577|NCT03814434|inflammation|inflammation
5029578|NCT03814434|Therapy|therapy
5029579|NCT03814408|FANCA, FA-A, Fanconi Anemia Subtype A|fanca, fa-a, fanconi anemia subtype a
5029580|NCT03814369|colonoscopy|colonoscopy
5029581|NCT03814369|adenoma detection rate|adenoma detection rate
5029582|NCT03814369|colorectal cancer screening|colorectal cancer screening
5029583|NCT03814369|new technology|new technology
5029584|NCT03814343|fungal infection|fungal infection
5029589|NCT03814343|randomized double blind controlled trial|randomized double blind controlled trial
5029590|NCT03814330|Anesthesia management|anesthesia management
5029591|NCT03814330|In-vitro Fertilization|in-vitro fertilization
5029592|NCT03814330|Sedation-Analgesia|sedation-analgesia
5029593|NCT03814317|right heart catheterization (RHC)|right heart catheterization (rhc)
5029594|NCT03814317|pulmonary vascular resistance (PVR)|pulmonary vascular resistance (pvr)
5029595|NCT03814317|mean pulmonary arterial pressure (mPAP)|mean pulmonary arterial pressure (mpap)
5029596|NCT03814317|pulmonary hypertension (PH)|pulmonary hypertension (ph)
5029597|NCT03814317|Inhaled treprostinil|inhaled treprostinil
5029598|NCT03814317|Sarcoidosis|sarcoidosis
5029599|NCT03814265|Cortisol|cortisol
5029600|NCT03814265|Laughter Yoga|laughter yoga
5029601|NCT03814265|Mental Symptom|mental symptom
5029602|NCT03814265|Nursing|nursing
5029603|NCT03814265|Student|student
5029604|NCT03814252|Localized prostate cancer|localized prostate cancer
5029605|NCT03814252|Transurethral ultrasound ablation|transurethral ultrasound ablation
5029606|NCT03814252|Image guided|image guided
5029607|NCT03814252|Magnetic resonance imaging guided|magnetic resonance imaging guided
5029608|NCT03814252|Lesion-targeted|lesion-targeted
5029609|NCT03814252|Focal therapy|focal therapy
5029610|NCT03814239|transfusion|transfusion
5029611|NCT03814239|goal directed fluid therapy|goal directed fluid therapy
5029612|NCT03814213|Comprehensive geriatric assessment|comprehensive geriatric assessment
5029613|NCT03814213|Cancer|cancer
5029614|NCT03814213|Short time mortality|short time mortality
5029620|NCT03814174|Childhood Epilepsy|childhood epilepsy
5029621|NCT03814174|Physical Fitness|physical fitness
5029622|NCT03814174|Physical Activity|physical activity
5029623|NCT03814174|Use of Pedometer|use of pedometer
5029624|NCT03814135|insomnia|insomnia
5029625|NCT03814109|Hypertension|hypertension
5029626|NCT03814096|Syphilis, prenatal screening, SHC, point-of-care test|syphilis, prenatal screening, shc, point-of-care test
5029627|NCT03814057|Anthropometric measurements,|anthropometric measurements,
5029628|NCT03814057|creatinine height index|creatinine height index
5029629|NCT03814057|lean body mass|lean body mass
5029630|NCT03814057|Mini- nutritional assessment|mini- nutritional assessment
5029631|NCT03814057|Hand Grip strength|hand grip strength
5029632|NCT03814031|TEE|tee
5029633|NCT03814031|orthotopic liver transplant|orthotopic liver transplant
5029634|NCT03814031|postoperative graft function|postoperative graft function
5029635|NCT03814018|Bronchodilation test|bronchodilation test
5029636|NCT03814018|GINA|gina
5029637|NCT03814018|Reversibility criteria|reversibility criteria
5029644|NCT03813836|Head and Neck Cancer|head and neck cancer
5029645|NCT03813836|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
5029646|NCT03813836|Recurrent Head and Neck Squamous Cell Carcinoma|recurrent head and neck squamous cell carcinoma
5029647|NCT03813836|Pembrolizumab|pembrolizumab
5029648|NCT03813797|Low Pressure|low pressure
5029649|NCT03813797|Laparoscopy|laparoscopy
5029650|NCT03813797|Colectomy|colectomy
5029651|NCT03813797|Pneumoperitoneum|pneumoperitoneum
5029652|NCT03813797|AirSeal|airseal
5029653|NCT03813784|PD-1|pd-1
5029663|NCT03813732|trans-conjunctival approach|trans-conjunctival approach
5029664|NCT03813719|endometrial cancer|endometrial cancer
5029665|NCT03813719|cancer|cancer
5029666|NCT03813719|uterine cancer|uterine cancer
5029667|NCT03813719|anxiety|anxiety
5029668|NCT03813719|stress|stress
5029669|NCT03813719|psychological|psychological
5029670|NCT03813719|survey|survey
5029671|NCT03813719|point-of-care|point-of-care
5029672|NCT03813680|Mechanical Neck Pain|mechanical neck pain
5029673|NCT03813680|Passive Vertebral Mobilization|passive vertebral mobilization
5029674|NCT03813680|Proprioceptive Neuromuscular Techniques (PNF)|proprioceptive neuromuscular techniques (pnf)
5029675|NCT03813680|Quality of Life|quality of life
5029676|NCT03813680|Disability|disability
5029677|NCT03813680|Pain|pain
5029678|NCT03813667|advanced lung diseases|advanced lung diseases
5029679|NCT03813667|Palliative Care|palliative care
5029680|NCT03813667|Dyspnea|dyspnea
5029681|NCT03813667|pilot projects|pilot projects
5029694|NCT03813615|18-534|18-534
5029695|NCT03813576|screening|screening
5029696|NCT03813576|cervical cancer|cervical cancer
5029697|NCT03813576|primary prevention|primary prevention
5029698|NCT03813576|human papillomavirus infection|human papillomavirus infection
5029699|NCT03813576|acceptability|acceptability
5029700|NCT03813576|feasibility|feasibility
5029702|NCT03813550|calcification|calcification
5029703|NCT03813550|Gla proteins|gla proteins
5029704|NCT03813550|gut microbiota|gut microbiota
5029705|NCT03813550|vitamin K2|vitamin k2
5029706|NCT03813550|menaquinones|menaquinones
5029707|NCT03813550|taxonomic meta-sequencing|taxonomic meta-sequencing
5029708|NCT03813511|Minimally invasive surgery|minimally invasive surgery
5029709|NCT03813511|Clip procedure|clip procedure
5029710|NCT03813485|surface electromyographic|surface electromyographic
5029711|NCT03813485|dry needling|dry needling
5029712|NCT03813459|Delirium|delirium
5029713|NCT03813459|Subsyndromal delirium|subsyndromal delirium
5029714|NCT03813459|Intensive Care Unit|intensive care unit
5029715|NCT03813420|Sleep quality|sleep quality
5029716|NCT03813420|Body mass index|body mass index
5029717|NCT03813420|Active life|active life
5029718|NCT03813420|Academic performance|academic performance
5029719|NCT03813407|sodium zirconium cyclosilicate|sodium zirconium cyclosilicate
5029720|NCT03813407|Hyperkalaemia in children|hyperkalaemia in children
5029721|NCT03813394|Immunotherapy|immunotherapy
5029722|NCT03813394|Epstein Barr virus|epstein barr virus
5718902|NCT00435357|patella|patella
5029726|NCT03813381|Esophageal adenocarcinoma|esophageal adenocarcinoma
5029728|NCT03813381|Physical activity|physical activity
5029729|NCT03813381|Microbiota|microbiota
5029730|NCT03813355|brain stimulation|brain stimulation
5029731|NCT03813355|Body Mass Index|body mass index
5029735|NCT03813316|Diabetes|diabetes
5029736|NCT03813316|Type 2|type 2
5029737|NCT03813316|T2D|t2d
5029738|NCT03813303|Colonoscopy|colonoscopy
5029739|NCT03813303|Anesthesia|anesthesia
5029740|NCT03813303|Fentanyl|fentanyl
5029741|NCT03813303|Midazolam|midazolam
5029742|NCT03813303|Propofol|propofol
5029746|NCT03813264|MATRIX|matrix
5029747|NCT03813264|ROM (Routine Outcome Measures)|rom (routine outcome measures)
5029748|NCT03813264|mobile-assisted PROMS|mobile-assisted proms
5029749|NCT03813264|managed care|managed care
5029751|NCT03813225|Analgesia, patient- controlled, Block , Pain Postoperative|analgesia, patient- controlled, block , pain postoperative
5029761|NCT03813134|Cardiogenic Shock|cardiogenic shock
5029762|NCT03813134|Acute Myocardial Infarction|acute myocardial infarction
5029763|NCT03813134|Acute Coronary Syndrome|acute coronary syndrome
5029764|NCT03813108|Mosquito bites|mosquito bites
5029765|NCT03813108|Sporozoite|sporozoite
5029766|NCT03813108|Immunization|immunization
5029767|NCT03813108|Malaria|malaria
5029768|NCT03813108|Falciparum|falciparum
5029769|NCT03813095|Addiction|addiction
5029770|NCT03813095|Cannabis|cannabis
5029771|NCT03813095|Substance Use|substance use
5029799|NCT03812861|failure to rescue|failure to rescue
5029800|NCT03812861|postoperative complications|postoperative complications
5029801|NCT03812861|adherence to best practice|adherence to best practice
5029802|NCT03812848|anticoagulation|anticoagulation
5029803|NCT03812848|stewardship program|stewardship program
5029804|NCT03812848|anticoagulants|anticoagulants
5029805|NCT03812848|clinical pharmacist|clinical pharmacist
5029806|NCT03812848|heparin|heparin
5029807|NCT03812848|warfarin|warfarin
5029808|NCT03812822|Femoral anteversion, flat foot, insole, gait|femoral anteversion, flat foot, insole, gait
5029810|NCT03812809|T790M|t790m
5029811|NCT03812809|NSCLC|nsclc
5029812|NCT03812783|Hepatocellular Carcinoma|hepatocellular carcinoma
5029813|NCT03812783|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
5029814|NCT03812783|Oxaliplatin, 5-Fluorouracil and Leucovorin (FOLFOX)|oxaliplatin, 5-fluorouracil and leucovorin (folfox)
5029815|NCT03812783|Irinotecan, Oxaliplatin, 5-Fluorouracil and Leucovorin (FOLFIRINOX)|irinotecan, oxaliplatin, 5-fluorouracil and leucovorin (folfirinox)
5029816|NCT03812783|sorafenib|sorafenib
5029817|NCT03812770|Hepatocellular Carcinoma|hepatocellular carcinoma
5029818|NCT03812770|Sorafenib|sorafenib
5029819|NCT03812770|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
5029820|NCT03812770|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
5029821|NCT03812770|Oxaliplatin|oxaliplatin
5029822|NCT03812757|Central venous catheter|central venous catheter
5029823|NCT03812757|Subclavian vein|subclavian vein
5029824|NCT03812757|Supraclavicular fossa ultrasound view|supraclavicular fossa ultrasound view
5029825|NCT03812705|allogeneic hematopoeitic stem cell transplantation|allogeneic hematopoeitic stem cell transplantation
5029826|NCT03812705|acute gastrointestinal graft versus host disease|acute gastrointestinal graft versus host disease
5029827|NCT03812705|fecal microbiome transplantation|fecal microbiome transplantation
5029828|NCT03812692|Oral appliance therapy|oral appliance therapy
5029833|NCT03812640|pediatric|pediatric
5029834|NCT03812640|cataract|cataract
5029835|NCT03812640|suture|suture
5029836|NCT03812640|poliglactin|poliglactin
5029837|NCT03812640|nylon|nylon
5029838|NCT03812627|Implantable medical devices|implantable medical devices
5029839|NCT03812627|Biomarker|biomarker
5029840|NCT03812627|Systemic inflammation|systemic inflammation
5029841|NCT03812614|Diabetes|diabetes
5029842|NCT03812614|Patient Activation|patient activation
5029843|NCT03812614|Self Management Education|self management education
5029844|NCT03812614|Self Management Behavior|self management behavior
5029845|NCT03812614|Autonomy Support|autonomy support
5029846|NCT03812614|Social Support|social support
5029847|NCT03812614|Caregiver|caregiver
5029848|NCT03812614|Family Support|family support
5029849|NCT03812614|Glycemic Control|glycemic control
5029850|NCT03812549|Immunotherapy;SBRT; PD-L1 positive; LDRT|immunotherapy;sbrt; pd-l1 positive; ldrt
5029851|NCT03812510|common warts|common warts
5029852|NCT03812497|Microbiome|microbiome
5029853|NCT03812497|Metabolome|metabolome
5029854|NCT03812458|resilience|resilience
5029855|NCT03812458|anxiety|anxiety
5029856|NCT03812458|acute stress|acute stress
5029857|NCT03812458|relatives|relatives
5029858|NCT03812458|critical ill patients|critical ill patients
5029859|NCT03812445|Probiotics|probiotics
5029860|NCT03812445|Gut microbiota|gut microbiota
5029861|NCT03812445|ischemic stroke|ischemic stroke
5029862|NCT03812419|Allograft rejection|allograft rejection
5029863|NCT03812419|cyclosporine|cyclosporine
5029864|NCT03812419|kidney transplantation|kidney transplantation
5043983|NCT03724383|Nutrition|nutrition
5029865|NCT03812419|proton pump inhibitors|proton pump inhibitors
5029866|NCT03812419|gastric complications.|gastric complications.
5029867|NCT03812406|cesarean|cesarean
5029868|NCT03812380|Bone mineral density|bone mineral density
5029872|NCT03812328|venous thromboembolism|venous thromboembolism
5029873|NCT03812328|adhesion molecule|adhesion molecule
5029874|NCT03812328|P-selectin glycoprotein ligand 1|p-selectin glycoprotein ligand 1
5029876|NCT03812328|venous thrombosis|venous thrombosis
5029877|NCT03812315|Propoplis|propoplis
5029878|NCT03812315|chewing gum|chewing gum
5029879|NCT03812315|mouthwash|mouthwash
5029880|NCT03812315|high caries risk children|high caries risk children
5029881|NCT03812315|antimicrobial|antimicrobial
5029895|NCT03812159|Shape analysis|shape analysis
5029896|NCT03812159|Computer-assited surgical plan|computer-assited surgical plan
5029897|NCT03812159|Surgical planning|surgical planning
5029898|NCT03812159|Computational anatomy|computational anatomy
5029899|NCT03812120|L-PRF|l-prf
5029900|NCT03812120|CSF leakage|csf leakage
5029901|NCT03812120|fibrin sealants|fibrin sealants
5029902|NCT03812107|Opioid-use Disorder (OUD)|opioid-use disorder (oud)
5029903|NCT03812107|Medication for OUD (MOUD)|medication for oud (moud)
5029904|NCT03812107|Co-occurring opioid use disorder and mental disorders|co-occurring opioid use disorder and mental disorders
5029905|NCT03812107|Office-based Addiction Treatment|office-based addiction treatment
5029906|NCT03812094|paediatric, children, treatment, intervention|paediatric, children, treatment, intervention
5029907|NCT03812068|ASD|asd
5029908|NCT03812068|Early intervention|early intervention
5029910|NCT03812042|Gaucher disease|gaucher disease
5029911|NCT03812042|Fabry disease|fabry disease
5029912|NCT03812042|Pompe disease|pompe disease
5029913|NCT03812042|Gangliosidoses|gangliosidoses
5029914|NCT03812029|EYP001|eyp001
5029915|NCT03812029|Liver Diseases|liver diseases
5029916|NCT03812029|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5029917|NCT03812029|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5029918|NCT03812029|NASH|nash
5029919|NCT03812016|Blepharoptosis|blepharoptosis
5029920|NCT03812016|Blink restoration|blink restoration
5029921|NCT03812016|Magnetic device|magnetic device
5029922|NCT03812016|Oculomotor nerve palsy|oculomotor nerve palsy
5029923|NCT03812016|Ptosis|ptosis
5029924|NCT03812003|opioid-induced hyperalgesia, remifentanil|opioid-induced hyperalgesia, remifentanil
5029925|NCT03811951|Tobacco|tobacco
5029926|NCT03811951|Cigarettes|cigarettes
5029927|NCT03811951|Nicotine|nicotine
5029928|NCT03811951|Insulin|insulin
5029929|NCT03811951|Electroencephalogram|electroencephalogram
5029930|NCT03811951|EEG|eeg
5029931|NCT03811951|Event-Related Potential|event-related potential
5029932|NCT03811951|ERP (Event-Related Potential)|erp (event-related potential)
5029933|NCT03811938|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5029934|NCT03811886|Natalizumab|natalizumab
5029935|NCT03811873|transplant related disorders|transplant related disorders
5029936|NCT03811873|liver transplant|liver transplant
5029937|NCT03811873|transplant related bone disease|transplant related bone disease
5029938|NCT03811860|lithium|lithium
5029939|NCT03811860|pharmacokinetics|pharmacokinetics
5029940|NCT03811860|renal|renal
5029941|NCT03811860|kidney|kidney
5029942|NCT03811834|Drug Therapy|drug therapy
5029943|NCT03811821|Accidental Bowel Leakage|accidental bowel leakage
5029944|NCT03811821|Fecal Incontinence|fecal incontinence
5029945|NCT03811821|Biofeedback|biofeedback
5029946|NCT03811821|Sacral Nerve Stimulation|sacral nerve stimulation
5029947|NCT03811821|Injectable Bulking Agents|injectable bulking agents
5029948|NCT03811821|Enhanced Medical Management|enhanced medical management
5029949|NCT03811782|conscious motor processing|conscious motor processing
5029950|NCT03811782|single-task training|single-task training
5029951|NCT03811782|dual-task training|dual-task training
5029952|NCT03811782|analogy training|analogy training
5029953|NCT03811782|gait rehabilitation|gait rehabilitation
5029954|NCT03811782|reinvestment propensity|reinvestment propensity
5029955|NCT03811782|balance|balance
5029956|NCT03811782|fear of falling|fear of falling
5029957|NCT03811782|older adults|older adults
5029958|NCT03811782|Hong Kong|hong kong
5029959|NCT03811769|Mechanical thrombectomy|mechanical thrombectomy
5029960|NCT03811769|Stroke|stroke
5029961|NCT03811769|Proximal intracranial arterial occlusions|proximal intracranial arterial occlusions
5029962|NCT03811769|Large vessel occlusion|large vessel occlusion
5029967|NCT03811730|transesophageal echocardiography|transesophageal echocardiography
5029968|NCT03811730|intensive care unit|intensive care unit
5029969|NCT03811704|three-dimensional reconstruction|three-dimensional reconstruction
5029970|NCT03811704|fluorescence|fluorescence
5029971|NCT03811704|indocyanine green|indocyanine green
5029972|NCT03811704|liver resection|liver resection
5029973|NCT03811704|navigation surgery|navigation surgery
5029974|NCT03811652|Medi7247|medi7247
5029975|NCT03811652|non small cell lung cancer|non small cell lung cancer
5029976|NCT03811652|head and neck cancer|head and neck cancer
5029977|NCT03811652|small cell lung cancer|small cell lung cancer
5029978|NCT03811652|colorectal cancer|colorectal cancer
5029980|NCT03811652|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5029986|NCT03811626|neuropsychological tests|neuropsychological tests
5029987|NCT03811626|pain|pain
5029988|NCT03811626|memory reactive|memory reactive
5029990|NCT03811613|movement disorders|movement disorders
5029991|NCT03811613|light therapy|light therapy
5029992|NCT03811613|motor aspects|motor aspects
5029995|NCT03811509|osteoporosis|osteoporosis
5029996|NCT03811509|aromatase inhibitors|aromatase inhibitors
5029997|NCT03811509|breast cancer|breast cancer
5029998|NCT03811509|microindentation|microindentation
5029999|NCT03811509|arthralgia|arthralgia
5030000|NCT03811509|musculoskeletal pain|musculoskeletal pain
5030001|NCT03811496|Parkinson disease|parkinson disease
5030002|NCT03811496|Gaucher disease|gaucher disease
5030003|NCT03811496|GBA gene|gba gene
5030004|NCT03811496|alpha-synuclein|alpha-synuclein
5030005|NCT03811483|Fluid Therapy|fluid therapy
5030006|NCT03811483|Gender difference|gender difference
5030007|NCT03811457|CAR-T cell, CD19, Lymphoma, Leukemia|car-t cell, cd19, lymphoma, leukemia
5030008|NCT03811444|needlestick|needlestick
5030009|NCT03811444|needlestick injury|needlestick injury
5030010|NCT03811444|safety lancet|safety lancet
5030011|NCT03811444|sharps injury prevention|sharps injury prevention
5030012|NCT03811444|capillary blood sampling|capillary blood sampling
5030013|NCT03811431|contrast enhanced ultrasound guided liver biopsy|contrast enhanced ultrasound guided liver biopsy
5030014|NCT03811431|ultrasound guided liver biopsy|ultrasound guided liver biopsy
5030015|NCT03811431|focal liver lesions|focal liver lesions
5030016|NCT03811431|hepatocellular carcinoma|hepatocellular carcinoma
5030017|NCT03811431|advanced chronic liver disease|advanced chronic liver disease
5030018|NCT03811418|advanced breast cancer|advanced breast cancer
5030019|NCT03811418|HER2-positive|her2-positive
5030020|NCT03811418|metastatic|metastatic
5030021|NCT03811418|inoperable|inoperable
5030022|NCT03811418|female|female
5030023|NCT03811418|quality of life|quality of life
5030024|NCT03811405|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5030025|NCT03811405|ventralis intermedius nucleus (VIN)|ventralis intermedius nucleus (vin)
5344394|NCT01974596|Dental implants|dental implants
5030026|NCT03811405|implantable pulse generator (IPG)|implantable pulse generator (ipg)
5030027|NCT03811405|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
5030028|NCT03811379|Immunotherapy|immunotherapy
5030029|NCT03811327|Zero-time Exercise|zero-time exercise
5030030|NCT03811327|Depression|depression
5030031|NCT03811327|Lifestyle|lifestyle
5030032|NCT03811327|Behavioural Activation|behavioural activation
5030033|NCT03811314|Dementia|dementia
5030034|NCT03811275|upper extremity recovery of function|upper extremity recovery of function
5030035|NCT03811275|action observation|action observation
5030036|NCT03811275|virtual reality|virtual reality
5030037|NCT03811275|task-based intervention|task-based intervention
5030038|NCT03811262|PECS|pecs
5030039|NCT03811262|ESP|esp
5030040|NCT03811262|RCT|rct
5030041|NCT03811249|Near Vision|near vision
5030042|NCT03811249|Reading Vision|reading vision
5030043|NCT03811249|Reading Glasses|reading glasses
5030044|NCT03811249|Reading|reading
5030045|NCT03811249|Readers|readers
5030046|NCT03811249|Presbyopic|presbyopic
5030047|NCT03811223|Postprandial hyperlipidemia|postprandial hyperlipidemia
5030048|NCT03811223|Evolocumab|evolocumab
5030049|NCT03811223|PCSK9 monoclonal antibody|pcsk9 monoclonal antibody
5030050|NCT03811197|Obesity|obesity
5030051|NCT03811197|Weight Loss|weight loss
5030052|NCT03811197|Telemedicine|telemedicine
5030053|NCT03811197|Hypnotic Suggestions|hypnotic suggestions
5030054|NCT03811171|Stone|stone
5030055|NCT03811171|Lithotripsy|lithotripsy
5030056|NCT03811171|Calculi|calculi
5030057|NCT03811145|Topical|topical
5030058|NCT03811145|Gel|gel
5030059|NCT03811145|Platelet|platelet
5030060|NCT03811145|Growth factor|growth factor
5030061|NCT03811145|Regenerative|regenerative
5030062|NCT03811119|Vascular Closure Devices|vascular closure devices
5030063|NCT03811119|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5030064|NCT03811106|Electrotherapy, Neuromuscular Electrical Stimulation, Stroke|electrotherapy, neuromuscular electrical stimulation, stroke
5030189|NCT03810391|Butorphanol|butorphanol
5030065|NCT03811093|Adipose, Fat, Aesthetics, Skin, Weight Reduction,|adipose, fat, aesthetics, skin, weight reduction,
5030066|NCT03811067|Postoperative pain|postoperative pain
5030067|NCT03811067|Transversus abdominis plane block|transversus abdominis plane block
5030068|NCT03811067|Rectus sheath block|rectus sheath block
5030069|NCT03811067|Cesarean delivery|cesarean delivery
5030070|NCT03811054|Apatinib|apatinib
5030071|NCT03811054|Non Small Cell Lung Cancer|non small cell lung cancer
5030072|NCT03811054|EGFR TKI|egfr tki
5030078|NCT03810963|cardiometabolic disease risk|cardiometabolic disease risk
5030080|NCT03810963|body fat percentage|body fat percentage
5030081|NCT03810963|nutritional counseling|nutritional counseling
5030082|NCT03810911|Forearm blood flow|forearm blood flow
5030083|NCT03810911|Flow mediated dilatation|flow mediated dilatation
5030084|NCT03810898|Huntington Disease|huntington disease
5030085|NCT03810898|Huntington's Disease|huntington's disease
5030086|NCT03810898|HD|hd
5030087|NCT03810898|HDGEC|hdgec
5030088|NCT03810898|Gene Expansion Carrier|gene expansion carrier
5030089|NCT03810898|PET|pet
5030090|NCT03810898|Tracer|tracer
5030091|NCT03810898|Positron Emission Tomography|positron emission tomography
5030093|NCT03810898|imaging|imaging
5030094|NCT03810898|mHTT|mhtt
5030095|NCT03810898|huntingtin|huntingtin
5030096|NCT03810898|iMagemHTT|imagemhtt
5030097|NCT03810885|24hr urine collection|24hr urine collection
5030098|NCT03810859|Amelogenesis imperfecta|amelogenesis imperfecta
5030099|NCT03810859|Dentinogenesis imperfecta|dentinogenesis imperfecta
5030100|NCT03810859|Dentin anomalies|dentin anomalies
5030101|NCT03810859|Whole Exome Study|whole exome study
5030102|NCT03810846|Exercise|exercise
5030103|NCT03810846|Physical Activity|physical activity
5030104|NCT03810846|Football|football
5030105|NCT03810846|Walking Football|walking football
5030106|NCT03810846|Type 2 Diabetes|type 2 diabetes
5030107|NCT03810846|Primary Health Care|primary health care
5030108|NCT03810846|Feasibility|feasibility
5030109|NCT03810846|Safety|safety
5030110|NCT03810833|Glomerular Filtration Rate|glomerular filtration rate
5030111|NCT03810820|TAVR|tavr
5030112|NCT03810820|TAVI|tavi
5030113|NCT03810820|Heart block|heart block
5030114|NCT03810820|Atrial fibrillation|atrial fibrillation
5030115|NCT03810820|Cardiac arrhythmias|cardiac arrhythmias
5030116|NCT03810820|Permanent pacemaker|permanent pacemaker
5030117|NCT03810820|Remote cardiac monitoring|remote cardiac monitoring
5030118|NCT03810820|Loop monitor|loop monitor
5030123|NCT03810794|Acupuncture Treatment|acupuncture treatment
5030124|NCT03810794|Alzheimer's Disease|alzheimer's disease
5030125|NCT03810781|Posturography|posturography
5030126|NCT03810781|Spinal Cord Injury|spinal cord injury
5030127|NCT03810768|pilot trial|pilot trial
5030128|NCT03810768|muscle biopsy|muscle biopsy
5030129|NCT03810768|blood metabolome|blood metabolome
5030130|NCT03810729|Smartphone|smartphone
5030131|NCT03810729|Coronary artery bypass grafting|coronary artery bypass grafting
5030132|NCT03810729|Modified Allen's Test|modified allen's test
5030133|NCT03810716|interactive platform|interactive platform
5030134|NCT03810716|family planning|family planning
5030135|NCT03810716|contraception|contraception
5030136|NCT03810638|Heart Failure|heart failure
5030137|NCT03810638|Heart Transplant|heart transplant
5030138|NCT03810638|Left Ventricular Assist Device|left ventricular assist device
5030139|NCT03810612|Adherence to treatment|adherence to treatment
5030140|NCT03810612|Continuity of care|continuity of care
5030141|NCT03810612|Health literacy|health literacy
5030142|NCT03810612|Patient involvement|patient involvement
5030143|NCT03810612|Patient preferences|patient preferences
5719214|NCT00434291|Nemonoxacin|nemonoxacin
5030152|NCT03810599|Lifestyle|lifestyle
5030153|NCT03810599|Self-reported health|self-reported health
5030154|NCT03810586|Hypertension|hypertension
5030155|NCT03810586|Continuous Monitoring|continuous monitoring
5030156|NCT03810586|Non-invasive Blood Pressure|non-invasive blood pressure
5030157|NCT03810586|Non-invasive Monitoring|non-invasive monitoring
5030158|NCT03810547|Abdominoplasty|abdominoplasty
5030159|NCT03810547|spinal anesthesia|spinal anesthesia
5030160|NCT03810547|general anesthesia|general anesthesia
5030161|NCT03810547|postoperative pain|postoperative pain
5030162|NCT03810534|Transitional Care|transitional care
5030163|NCT03810534|Skilled Nursing Facilities|skilled nursing facilities
5030164|NCT03810521|mesenchymal stromal cells|mesenchymal stromal cells
5030165|NCT03810508|CMT4J|cmt4j
5030166|NCT03810495|naltrexone|naltrexone
5030167|NCT03810495|opioids|opioids
5030168|NCT03810495|opioid use disorder|opioid use disorder
5030169|NCT03810495|OLANI implant|olani implant
5030170|NCT03810482|health related quality of life|health related quality of life
5030171|NCT03810482|anxiety|anxiety
5030172|NCT03810482|depression|depression
5030173|NCT03810482|coping|coping
5030175|NCT03810469|limb salvage|limb salvage
5030176|NCT03810469|foot perfusion|foot perfusion
5030177|NCT03810469|hybrid room|hybrid room
5030178|NCT03810456|Cognitive Behavior Therapy|cognitive behavior therapy
5030179|NCT03810443|Hyperventilation|hyperventilation
5030180|NCT03810417|coronary artery bypass surgery|coronary artery bypass surgery
5030181|NCT03810417|ouabain|ouabain
5030182|NCT03810417|acute kidney injury|acute kidney injury
5044275|NCT03722355|Astrocytoma|astrocytoma
5030193|NCT03810378|Ketogenic diet|ketogenic diet
5030194|NCT03810378|Mediterranean diet|mediterranean diet
5030195|NCT03810378|Diabetes|diabetes
5030196|NCT03810378|Prediabetes|prediabetes
5030197|NCT03810365|Cancer Survivors|cancer survivors
5030198|NCT03810365|Brief Behavioral Treatment|brief behavioral treatment
5030199|NCT03810365|Older Adults|older adults
5030200|NCT03810365|Attention Control|attention control
5030201|NCT03810365|Intervention|intervention
5030202|NCT03810352|ITP|itp
5030203|NCT03810352|platelet function|platelet function
5030204|NCT03810352|Sysmex|sysmex
5030205|NCT03810339|Immune checkpoint inhibitor|immune checkpoint inhibitor
5030206|NCT03810339|POLE/POLD mutation|pole/pold mutation
5030207|NCT03810339|non-MSI-H|non-msi-h
5030217|NCT03810300|Cash transfers|cash transfers
5030218|NCT03810300|Food transfers|food transfers
5030219|NCT03810300|Behavior change communication|behavior change communication
5030220|NCT03810300|Sustainability|sustainability
5030221|NCT03810300|Social protection|social protection
5030222|NCT03810300|Nutrition|nutrition
5030233|NCT03810183|eosinophilia,|eosinophilia,
5030234|NCT03810183|prostaglandin D2 receptor,|prostaglandin d2 receptor,
5030235|NCT03810183|DP2,|dp2,
5030236|NCT03810183|CRTh2,|crth2,
5030237|NCT03810183|fevipiprant|fevipiprant
5030238|NCT03810157|laser-assisted hatching (LAH)|laser-assisted hatching (lah)
5030239|NCT03810157|zona pellucida|zona pellucida
5030240|NCT03810157|cryopreservation|cryopreservation
5030241|NCT03810157|pregnancy outcomes|pregnancy outcomes
5030242|NCT03810131|Acceptance and Commitment Therapy|acceptance and commitment therapy
5030243|NCT03810105|radical prostatectomy|radical prostatectomy
5030244|NCT03810105|Olaparib|olaparib
5030250|NCT03810079|minimally conscious state|minimally conscious state
5030251|NCT03810079|disorders of consciousness|disorders of consciousness
5030252|NCT03810079|non invasive brain stimulation|non invasive brain stimulation
5030254|NCT03810040|Embryos quality|embryos quality
5030255|NCT03810040|In vitro fertilization|in vitro fertilization
5030256|NCT03810040|Denuding pipette|denuding pipette
5030257|NCT03810027|Nocturnal polyuria|nocturnal polyuria
5030258|NCT03810027|Overactive bladder|overactive bladder
5030259|NCT03810014|rapid diagnostic test (RDT)|rapid diagnostic test (rdt)
5030260|NCT03810014|Artemisinin combination therapy (ACT)|artemisinin combination therapy (act)
5030261|NCT03810014|Conditional subsidy|conditional subsidy
5030262|NCT03810014|Private retail sector|private retail sector
5030263|NCT03810001|oocyte activation|oocyte activation
5030264|NCT03810001|intracytoplasmic sperm injection(ICSI)|intracytoplasmic sperm injection(icsi)
5030265|NCT03810001|mechanical stimulation|mechanical stimulation
5030266|NCT03810001|2PN rate|2pn rate
5030268|NCT03809988|breast cancer|breast cancer
5030269|NCT03809988|ABC|abc
5030270|NCT03809988|progesterone receptor|progesterone receptor
5030271|NCT03809988|HER2|her2
5030272|NCT03809988|advanced|advanced
5030863|NCT03806426|polyp|polyp
5330876|NCT02036411|amh|amh
5344618|NCT01973543|PD|pd
5030289|NCT03809884|Hypertension|hypertension
5030290|NCT03809871|exercise training|exercise training
5030291|NCT03809871|weight management|weight management
5030292|NCT03809871|biomarkers|biomarkers
5030293|NCT03809858|Klue|klue
5030294|NCT03809858|Meal bolus|meal bolus
5030295|NCT03809858|Bolus reminder|bolus reminder
5030296|NCT03809819|Laparoscopic Vecchietti vaginoplasty|laparoscopic vecchietti vaginoplasty
5030297|NCT03809819|sexual function|sexual function
5030298|NCT03809819|urinary incontinence|urinary incontinence
5030299|NCT03809806|vaginal stump prolapse|vaginal stump prolapse
5030300|NCT03809806|sexual function|sexual function
5030301|NCT03809806|quality of life|quality of life
5030302|NCT03809741|Infection prevention and control|infection prevention and control
5044370|NCT03721835|Hip|hip
5030303|NCT03809741|Alcoholic hand rubs|alcoholic hand rubs
5030304|NCT03809741|Intrapartum care|intrapartum care
5030305|NCT03809741|Postpartum care|postpartum care
5030306|NCT03809741|Infection Control Assessment Tool (ICAT)|infection control assessment tool (icat)
5030307|NCT03809741|Rural Zambia|rural zambia
5030308|NCT03809702|Herpes Zoster|herpes zoster
5030309|NCT03809702|Herpetic neuralgia|herpetic neuralgia
5030310|NCT03809702|Pregabalin|pregabalin
5030311|NCT03809689|Acute myocardial infarction|acute myocardial infarction
5030312|NCT03809689|Myocardial reperfusion treatment|myocardial reperfusion treatment
5030313|NCT03809689|Chronic ischemic occlusion|chronic ischemic occlusion
5030314|NCT03809689|68Ga-NODAGA-RGD|68ga-nodaga-rgd
5030324|NCT03809650|CTEPH|cteph
5030325|NCT03809650|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5030326|NCT03809650|macitentan|macitentan
5445446|NCT01521767|relative bioavailability|relative bioavailability
5030345|NCT03809611|Presbyopia, adults, randomized study, placebo|presbyopia, adults, randomized study, placebo
5030346|NCT03809598|Infant MRI|infant mri
5030347|NCT03809598|Brain Development|brain development
5030348|NCT03809598|MBCT|mbct
5030349|NCT03809598|Mindfulness|mindfulness
5030350|NCT03809585|Iris|iris
5030351|NCT03809585|Tumor|tumor
5030352|NCT03809585|Melanoma|melanoma
5030353|NCT03809585|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
5030354|NCT03809585|Angiography|angiography
5030355|NCT03809572|fMRI|fmri
5030356|NCT03809572|pregnancy|pregnancy
5030357|NCT03809572|postpartum|postpartum
5030366|NCT03809494|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5030367|NCT03809494|Leukocytes, Mononuclear|leukocytes, mononuclear
5030368|NCT03809494|Transplantation, Autologous|transplantation, autologous
5030369|NCT03809468|patient satisfaction, hysterectomy, follow up|patient satisfaction, hysterectomy, follow up
5030370|NCT03809455|Breakthrough Pain|breakthrough pain
5030371|NCT03809416|Acne scars|acne scars
5030376|NCT03809403|No touch technic|no touch technic
5030377|NCT03809403|Circulating Tumor DNA|circulating tumor dna
5030378|NCT03809403|Circulating Tumor Cells|circulating tumor cells
5030380|NCT03809390|Allergic risk|allergic risk
5030381|NCT03809390|Vaginal seeding|vaginal seeding
5030382|NCT03809390|Randomized controlled study|randomized controlled study
5030383|NCT03809390|Caesarean delivery|caesarean delivery
5030384|NCT03809390|Overweight and obesity|overweight and obesity
5030385|NCT03809364|Couple-based intervention|couple-based intervention
5030386|NCT03809364|Antiretroviral therapy|antiretroviral therapy
5030387|NCT03809364|South Africa|south africa
5030388|NCT03809312|ESS|ess
5030389|NCT03809312|Prophylactic antibiotics|prophylactic antibiotics
5030390|NCT03809312|Chronic sinus infection|chronic sinus infection
5030391|NCT03809299|Caloric restriction|caloric restriction
5030392|NCT03809299|Fasting|fasting
5024122|NCT03847155|nicotine patch|nicotine patch
5024123|NCT03847155|placebo|placebo
5024124|NCT03847155|critically ill patients|critically ill patients
5024125|NCT03847155|delirium|delirium
5024126|NCT03847155|prevention|prevention
5024127|NCT03847142|informatics|informatics
5030393|NCT03809299|intermittent fasting|intermittent fasting
5030394|NCT03809299|isocaloric ad lib meal timing|isocaloric ad lib meal timing
5030395|NCT03809299|Twice-a-day feeding|twice-a-day feeding
5030396|NCT03809299|insulin|insulin
5030397|NCT03809299|glucose metabolism|glucose metabolism
5030398|NCT03809299|normoglycemia|normoglycemia
5030399|NCT03809299|hyperglycemia|hyperglycemia
5030400|NCT03809286|rTMS|rtms
5030401|NCT03809286|alcohol use disorder|alcohol use disorder
5030402|NCT03809273|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5030403|NCT03809221|down-regulation|down-regulation
5030404|NCT03809221|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5030405|NCT03809221|IVF/ICSI|ivf/icsi
5030406|NCT03809195|hypnosis|hypnosis
5030407|NCT03809195|inflammatory bowel disease|inflammatory bowel disease
5030408|NCT03809195|mind-body|mind-body
5030409|NCT03809195|brain-gut|brain-gut
5030410|NCT03809195|hypnotherapy|hypnotherapy
5030411|NCT03809195|quality of life|quality of life
5030412|NCT03809195|psychosocial|psychosocial
5030413|NCT03809182|Impaired Glucose Tolerance|impaired glucose tolerance
5030414|NCT03809182|Obese patients|obese patients
5030415|NCT03809182|Dexmedetomidine|dexmedetomidine
5030416|NCT03809169|peripheral endobronchial ultrasound|peripheral endobronchial ultrasound
5030417|NCT03809169|radial endobronchial ultrasound|radial endobronchial ultrasound
5030418|NCT03809169|guide sheath|guide sheath
5030419|NCT03809169|ultrathin bronchoscope|ultrathin bronchoscope
5030420|NCT03809169|peripheral pulmonary lesion|peripheral pulmonary lesion
5030421|NCT03809156|Pulmonary Hypertension|pulmonary hypertension
5030422|NCT03809104|virtual reality|virtual reality
5030423|NCT03809104|sarcopenia|sarcopenia
5030424|NCT03809104|elderly|elderly
5030425|NCT03809078|Prostate Cancer|prostate cancer
5030426|NCT03809065|Deliberate hypotension|deliberate hypotension
5030427|NCT03809065|Nitroglycerin|nitroglycerin
5030428|NCT03809065|Labetalol|labetalol
5030429|NCT03809065|Peripheral perfusion|peripheral perfusion
5030430|NCT03809052|GB1211|gb1211
5030437|NCT03809052|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5030439|NCT03809052|Nonalcoholic Steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5030440|NCT03809052|Liver Fibrosis|liver fibrosis
5030441|NCT03809026|Azoospermia|azoospermia
5030442|NCT03809026|micro-TESE|micro-tese
5030443|NCT03809026|Klinefelter's syndrome|klinefelter's syndrome
5030444|NCT03809026|Cryptorchidism|cryptorchidism
5030445|NCT03809026|Vitrified oocytes|vitrified oocytes
5030446|NCT03809000|Post-prostatectomy|post-prostatectomy
5030447|NCT03809000|Enzalutamide|enzalutamide
5030448|NCT03809000|STEEL|steel
5030449|NCT03808961|Parkinson's disease, Niacin, Niacinamide|parkinson's disease, niacin, niacinamide
5030450|NCT03808961|Niacin|niacin
5030451|NCT03808961|Niacinamide|niacinamide
5030487|NCT03808753|Functional Hemodynamic Test|functional hemodynamic test
5030488|NCT03808727|cognitive processing therapy|cognitive processing therapy
5030490|NCT03808727|PTSD|ptsd
5030491|NCT03808727|military|military
5030492|NCT03808714|african american, smoking cessation, rural, young adults|african american, smoking cessation, rural, young adults
5030493|NCT03808701|SCT200|sct200
5030494|NCT03808701|Squamous non-small cell Lung cancer|squamous non-small cell lung cancer
5030495|NCT03808701|NSCLC|nsclc
5030509|NCT03808662|SBRT|sbrt
5030510|NCT03808662|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5030511|NCT03808662|Non-hematology metatstatic cancer|non-hematology metatstatic cancer
5030512|NCT03808662|non-CNS oligo-progressive disease|non-cns oligo-progressive disease
5030513|NCT03808662|intracranial metastatic disease|intracranial metastatic disease
5030514|NCT03808662|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5030515|NCT03808662|18-431|18-431
5030516|NCT03808623|cartilage defect|cartilage defect
5030517|NCT03808623|knee|knee
5030518|NCT03808623|AMIC|amic
5030519|NCT03808597|digital health|digital health
5030520|NCT03808597|digital health promotion|digital health promotion
5030521|NCT03808597|health promotion|health promotion
5030522|NCT03808597|disease prevention|disease prevention
5030523|NCT03808597|HIV|hiv
5030524|NCT03808597|Tuberculosis|tuberculosis
5030525|NCT03808597|Cysticercosis|cysticercosis
5030526|NCT03808584|Core muscle exercise|core muscle exercise
5030527|NCT03808584|rehabilitation|rehabilitation
5030528|NCT03808584|Incisional hernia|incisional hernia
5030535|NCT03808467|Cognitive Remediation|cognitive remediation
5030536|NCT03808467|Neuropsychology|neuropsychology
5030537|NCT03808467|Neuropsychological Tests|neuropsychological tests
5030539|NCT03808441|Circulating tumour DNA|circulating tumour dna
5030540|NCT03808441|targeted therapy|targeted therapy
5030541|NCT03808441|immune therapy|immune therapy
5030542|NCT03808441|dabrafenib|dabrafenib
5044570|NCT03720496|CAR-T|car-t
5030552|NCT03808389|Gut-brain axis|gut-brain axis
5030553|NCT03808363|Metabolic Syndrome|metabolic syndrome
5030554|NCT03808363|Spinal Cord Injury|spinal cord injury
5030555|NCT03808363|Cardiovascular Disease|cardiovascular disease
5030556|NCT03808363|High Intensity Interval Training|high intensity interval training
5030557|NCT03808337|Stereotactic body radiotherapy|stereotactic body radiotherapy
5030558|NCT03808337|SBRT|sbrt
5030559|NCT03808337|18-486|18-486
5030560|NCT03808337|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5030561|NCT03808285|bone and joint infection|bone and joint infection
5030562|NCT03808285|osteomyelitis|osteomyelitis
5030563|NCT03808285|mandibular|mandibular
5030564|NCT03808285|denosumab|denosumab
5030565|NCT03808207|Docosahexaenoic acid|docosahexaenoic acid
5030566|NCT03808207|LcPufas|lcpufas
5030567|NCT03808207|Diet|diet
5030568|NCT03808207|Human milk|human milk
5030589|NCT03808051|Preterm infant|preterm infant
5030590|NCT03808051|Cord clamping|cord clamping
5030591|NCT03808051|Resuscitation|resuscitation
5030592|NCT03808038|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5030593|NCT03808038|Bladder Symptoms|bladder symptoms
5030594|NCT03808038|Recall|recall
5720180|NCT00431015|Lung Cancer|lung cancer
5030595|NCT03808038|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
5030596|NCT03807986|Striae Distensae|striae distensae
5030597|NCT03807986|Platelet-Rich Plasma (PRP)|platelet-rich plasma (prp)
5030598|NCT03807986|Nanofat Graft|nanofat graft
5030599|NCT03807986|Microfat Graft|microfat graft
5030600|NCT03807986|Combination Therapy|combination therapy
5030601|NCT03807947|embolisation, therapeutic|embolisation, therapeutic
5030602|NCT03807947|Embolization, Therapeutic|embolization, therapeutic
5030603|NCT03807947|Hepatocellular Carcinoma|hepatocellular carcinoma
5030604|NCT03807947|HCC|hcc
5030605|NCT03807947|TAE|tae
5030606|NCT03807934|transcranial direct current stimulation|transcranial direct current stimulation
5030607|NCT03807934|cognitive psychology|cognitive psychology
5030608|NCT03807934|noninvasive brain stimulation|noninvasive brain stimulation
5030609|NCT03807934|electrical brain stimulation|electrical brain stimulation
5030610|NCT03807921|aortic valve replacement|aortic valve replacement
5030611|NCT03807921|bioprosthesis|bioprosthesis
5030612|NCT03807921|anticoagulation|anticoagulation
5030613|NCT03807908|Pregnancy|pregnancy
5030614|NCT03807908|Low back pain|low back pain
5030615|NCT03807908|Pelvic girdle pain|pelvic girdle pain
5030616|NCT03807908|Kinesiotape|kinesiotape
5030617|NCT03807895|career indecision|career indecision
5030618|NCT03807895|career decision-making difficulties|career decision-making difficulties
5030619|NCT03807895|worry|worry
5030620|NCT03807895|psychological distress|psychological distress
5030621|NCT03807882|M-ECT|m-ect
5030622|NCT03807882|Clozapine|clozapine
5030623|NCT03807882|Psychopathology|psychopathology
5030624|NCT03807882|Cerebral hemodynamics|cerebral hemodynamics
5030625|NCT03807869|I-stent|i-stent
5030626|NCT03807869|glaucoma surgery|glaucoma surgery
5030627|NCT03807869|minimally invasive glaucoma surgery|minimally invasive glaucoma surgery
5030628|NCT03807791|Vitamine C deficiency|vitamine c deficiency
5030629|NCT03807791|skin rash|skin rash
5030630|NCT03807791|scurvy|scurvy
5030631|NCT03807791|food texture|food texture
5030632|NCT03807791|geriatric institution|geriatric institution
5030633|NCT03807791|Unit Of Long Term Care|unit of long term care
5030634|NCT03807765|breast cancer|breast cancer
5030636|NCT03807752|Dietary Supplements|dietary supplements
5030638|NCT03807752|Protein Hydrolysates|protein hydrolysates
5030639|NCT03807726|Breastfeeding, self-efficacy, education, intervention|breastfeeding, self-efficacy, education, intervention
5030640|NCT03807700|Denture, Adhesive, Gum-Health, Lifestyle|denture, adhesive, gum-health, lifestyle
5030641|NCT03807674|Calcium-silicate, coronal pulpotomy, MMP-9, symptomatic pulpitis.|calcium-silicate, coronal pulpotomy, mmp-9, symptomatic pulpitis.
5030642|NCT03807661|Desert foot|desert foot
5030643|NCT03807661|No-option patients|no-option patients
5030644|NCT03807661|Venous arterialization|venous arterialization
5030645|NCT03807635|needlestick|needlestick
5030646|NCT03807635|needlestick injury|needlestick injury
5030647|NCT03807635|safety lancet|safety lancet
5030648|NCT03807635|sharps injury prevention|sharps injury prevention
5030649|NCT03807635|capillary blood sampling|capillary blood sampling
5030650|NCT03807622|Elective Major Cardiothoracic|elective major cardiothoracic
5030651|NCT03807622|Mitral Valve Surgery|mitral valve surgery
5030652|NCT03807622|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5030653|NCT03807609|appetite control|appetite control
5030654|NCT03807609|obesity|obesity
5030655|NCT03807609|Adolescents|adolescents
5030656|NCT03807609|exercise timing|exercise timing
5030657|NCT03807570|Morus Alba L. Extract|morus alba l. extract
5030658|NCT03807570|Clinical Trial|clinical trial
5030659|NCT03807557|Stroke rehabilitation|stroke rehabilitation
5030660|NCT03807557|Botulinum toxin type A injection|botulinum toxin type a injection
5030661|NCT03807557|robot-assisted therapy|robot-assisted therapy
5030662|NCT03807557|Constraint-induced movement therapy|constraint-induced movement therapy
5030663|NCT03807557|spasticity|spasticity
5032244|NCT03797521|TTM|ttm
5030674|NCT03807453|Seborrheic Dermatitis|seborrheic dermatitis
5030676|NCT03807453|Microbiome|microbiome
5030677|NCT03807427|Adolescents|adolescents
5030678|NCT03807427|Mental Health|mental health
5030679|NCT03807427|Prevention|prevention
5030680|NCT03807427|Emotion Regulation|emotion regulation
5030681|NCT03807427|Global Mental Health|global mental health
5030682|NCT03807414|intensive care unit|intensive care unit
5030683|NCT03807414|regisrty|regisrty
5030684|NCT03807414|endotoxin|endotoxin
5030685|NCT03807414|heparin|heparin
5030686|NCT03807401|Virtual Reality|virtual reality
5030687|NCT03807401|prismatic adaptation|prismatic adaptation
5030688|NCT03807401|motor imagery|motor imagery
5030689|NCT03807388|eHealth|ehealth
5030690|NCT03807388|mHealth|mhealth
5030691|NCT03807388|smartphone|smartphone
5030692|NCT03807388|app|app
5030693|NCT03807388|psychosis|psychosis
5030694|NCT03807388|adherence|adherence
5030695|NCT03807388|early intervention|early intervention
5030696|NCT03807375|CPAP(Continuous Positive Airway Pressure)|cpap(continuous positive airway pressure)
5030697|NCT03807375|Standard preoxygenation|standard preoxygenation
5030698|NCT03807349|Cannulated Screws|cannulated screws
5030699|NCT03807349|Augmentation|augmentation
5030700|NCT03807323|Primary intervention|primary intervention
5030706|NCT03807284|Feasibility|feasibility
5030707|NCT03807284|Confidence|confidence
5030708|NCT03807284|group intervention|group intervention
5030709|NCT03807284|Psycho-social intervention|psycho-social intervention
5030710|NCT03807284|Stroke recovery|stroke recovery
5030711|NCT03807271|Anesthesia, Methods|anesthesia, methods
5030712|NCT03807271|Anesthesia, Analysis|anesthesia, analysis
5030713|NCT03807271|Patient Safety|patient safety
5030714|NCT03807271|Anesthetics/administration and dosage|anesthetics/administration and dosage
5030715|NCT03807258|COPD|copd
5030716|NCT03807258|Transcranial magnetic stimulation|transcranial magnetic stimulation
5030717|NCT03807258|Motor-evoked potentials|motor-evoked potentials
5030718|NCT03807258|Muscle weakness|muscle weakness
5030719|NCT03807258|Interhemispheric|interhemispheric
5030720|NCT03807258|Inhibition|inhibition
5030721|NCT03807232|ARDS, Human|ards, human
5030722|NCT03807232|Burns|burns
5030723|NCT03807232|Lung Diseases|lung diseases
5030724|NCT03807232|Risk Factors|risk factors
5030725|NCT03807232|Retrospective Studies|retrospective studies
5030726|NCT03807232|Decision Support Techniques|decision support techniques
5030727|NCT03807219|nocturnal legs cramps|nocturnal legs cramps
5030728|NCT03807219|legs cramps|legs cramps
5030730|NCT03807193|Worry|worry
5030731|NCT03807180|Tai Chi|tai chi
5030732|NCT03807180|ankylosing spondylitis|ankylosing spondylitis
5030733|NCT03807180|functionality|functionality
5030734|NCT03807154|Loneliness|loneliness
5030735|NCT03807154|ICBT|icbt
5030736|NCT03807154|Internet-based psychotherapy|internet-based psychotherapy
5030737|NCT03807154|Cognitive behavioral therapy|cognitive behavioral therapy
5030738|NCT03807154|Interpersonal psychotherapy|interpersonal psychotherapy
5030739|NCT03807128|Myeloma|myeloma
5030740|NCT03807128|Cohort|cohort
5030752|NCT03807024|Overactive bladder|overactive bladder
5030753|NCT03807024|Bladder diary|bladder diary
5030754|NCT03807011|Emergence Agitation|emergence agitation
5030755|NCT03807011|fentanyl|fentanyl
5030756|NCT03807011|remifentanil|remifentanil
5030757|NCT03807011|children|children
5030758|NCT03806985|psilocybin|psilocybin
5030759|NCT03806972|acute heart failure prognosis|acute heart failure prognosis
5030760|NCT03806920|Isomaltulose|isomaltulose
5030761|NCT03806920|Palatinose|palatinose
5030762|NCT03806920|second meal effect|second meal effect
5030763|NCT03806920|incretin|incretin
5030765|NCT03806920|GLP-1|glp-1
5031867|NCT03800004|Bone Health|bone health
5030768|NCT03806907|Pulmonary Hypertension|pulmonary hypertension
5030769|NCT03806907|Pulmonary embolism|pulmonary embolism
5030770|NCT03806907|Chronic Thromboembolism|chronic thromboembolism
5030771|NCT03806907|Iodine Subtraction|iodine subtraction
5030773|NCT03806855|Health Related Quality of Life|health related quality of life
5030774|NCT03806855|Overactive Bladder|overactive bladder
5030775|NCT03806855|Bladder Diary|bladder diary
5030778|NCT03806829|antioxidants|antioxidants
5030779|NCT03806829|polyphenols|polyphenols
5030780|NCT03806829|flow-mediated dilatation|flow-mediated dilatation
5030781|NCT03806816|autophagy|autophagy
5030782|NCT03806816|neuroprotection|neuroprotection
5030783|NCT03806816|melatonin|melatonin
5030784|NCT03806816|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
5030785|NCT03806816|hypothermia|hypothermia
5030786|NCT03806816|newborn|newborn
5030787|NCT03806816|neurological outcome|neurological outcome
5032565|NCT03795545|SWL|swl
5030788|NCT03806816|perinatal asphyxia|perinatal asphyxia
5030789|NCT03806777|dexmedetomidine|dexmedetomidine
5030790|NCT03806764|Cytomegalovirus|cytomegalovirus
5030792|NCT03806764|Reactivation|reactivation
5030793|NCT03806764|HSCT|hsct
5030794|NCT03806764|Stem cell transplant|stem cell transplant
5030795|NCT03806764|allogeneic|allogeneic
5030796|NCT03806764|immunosuppression|immunosuppression
5030797|NCT03806764|viral infection|viral infection
5030798|NCT03806738|Metastatic Breast Cancer|metastatic breast cancer
5030799|NCT03806738|Treatment Decision Making|treatment decision making
5030800|NCT03806738|Shared Decision Making|shared decision making
5030801|NCT03806725|Contrast-induced Nephropathy|contrast-induced nephropathy
5722354|NCT00423605|Body Pain|body pain
5081247|NCT03491176|MRI|mri
5030802|NCT03806725|Contrast-induced acute kidney injury|contrast-induced acute kidney injury
5030803|NCT03806725|Coronary computed tomography angiography|coronary computed tomography angiography
5030804|NCT03806712|social representation|social representation
5030805|NCT03806699|Tuberculosis, TB, vaccine, adjuvant|tuberculosis, tb, vaccine, adjuvant
5030806|NCT03806686|Tuberculosis, TB, vaccine, adjuvant|tuberculosis, tb, vaccine, adjuvant
5030807|NCT03806673|unilateral, ,|unilateral, ,
5030808|NCT03806673|epidural block|epidural block
5030809|NCT03806673|repeated epidural|repeated epidural
5030810|NCT03806660|Cardiac Arrest|cardiac arrest
5030811|NCT03806660|Coma|coma
5030812|NCT03806660|hypoxic brain damage|hypoxic brain damage
5030813|NCT03806660|prognosis|prognosis
5030814|NCT03806660|neurological examination|neurological examination
5030815|NCT03806660|pupillary reflex|pupillary reflex
5030816|NCT03806660|electroencephalography|electroencephalography
5030817|NCT03806660|targeted temperature management|targeted temperature management
5030818|NCT03806660|biomarkers|biomarkers
5030819|NCT03806660|clinical score|clinical score
5030820|NCT03806660|evoked potentials|evoked potentials
5030821|NCT03806647|Amyotrophic lateral sclerosis, ALS, communication, needs|amyotrophic lateral sclerosis, als, communication, needs
5030822|NCT03806634|Amyotrophic lateral sclerosis, ALS, communication, needs|amyotrophic lateral sclerosis, als, communication, needs
5448242|NCT01510132|OAG|oag
5030823|NCT03806621|coronary artery disease|coronary artery disease
5030824|NCT03806621|percutaneous coronary intervention|percutaneous coronary intervention
5044866|NCT03718702|Chronic pain|chronic pain
5030826|NCT03806608|Marginal Bone Loss|marginal bone loss
5030827|NCT03806608|Implant depth|implant depth
5030828|NCT03806608|Crestal or Subcrestal|crestal or subcrestal
5030829|NCT03806569|cognitive behavioral therapy|cognitive behavioral therapy
5030830|NCT03806569|mindfulness|mindfulness
5030831|NCT03806569|acceptance|acceptance
5030832|NCT03806569|commitment|commitment
5030833|NCT03806569|adult ADHD|adult adhd
5030834|NCT03806556|tranexamic acid|tranexamic acid
5030835|NCT03806556|anti-fibrinolytic agents|anti-fibrinolytic agents
5030836|NCT03806556|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
5030837|NCT03806517|bone mineral density|bone mineral density
5030838|NCT03806517|Parkinson's disease|parkinson's disease
5030839|NCT03806517|tremor|tremor
5030840|NCT03806517|postural instability and gait difficulty|postural instability and gait difficulty
5030841|NCT03806517|akinetic-rigid|akinetic-rigid
5030842|NCT03806504|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5030843|NCT03806504|PEEP|peep
5030844|NCT03806504|reperfusion injury|reperfusion injury
5030845|NCT03806491|veteran|veteran
5030846|NCT03806491|alcohol|alcohol
5030847|NCT03806491|insomnia|insomnia
5030848|NCT03806491|sleep|sleep
5030849|NCT03806491|drinking|drinking
5030850|NCT03806478|Alzheimer's Disease|alzheimer's disease
5030851|NCT03806478|Dementia|dementia
5030852|NCT03806465|Vaccine|vaccine
5030853|NCT03806465|Malaria|malaria
5030854|NCT03806465|Africa|africa
5030855|NCT03806465|Child|child
5030856|NCT03806452|albuminuria|albuminuria
5030857|NCT03806452|hydroxycarbamide|hydroxycarbamide
5030858|NCT03806426|Eicosapentaenoic Acid|eicosapentaenoic acid
5030860|NCT03806426|EPA 99%|epa 99%
5030861|NCT03806426|Fatty Acid|fatty acid
5030862|NCT03806426|omega-3|omega-3
5030864|NCT03806426|Familial Adenomatous Polyposis|familial adenomatous polyposis
5030866|NCT03806426|IRA (Ileo-rectal anastomosis)|ira (ileo-rectal anastomosis)
5030867|NCT03806426|PUFA (polyunsaturated fatty acid)|pufa (polyunsaturated fatty acid)
5030868|NCT03806426|Endoscopy|endoscopy
5030869|NCT03806400|Postoperative nausea and vomiting|postoperative nausea and vomiting
5030870|NCT03806400|strabismus surgery|strabismus surgery
5030871|NCT03806400|oculocardiac reflex|oculocardiac reflex
5030872|NCT03806374|fentanyl|fentanyl
5030873|NCT03806374|lidocaine|lidocaine
5030874|NCT03806374|ketamine|ketamine
5030875|NCT03806374|induction of anesthesia|induction of anesthesia
5030876|NCT03806374|intubation|intubation
5030877|NCT03806309|Immunotherapy|immunotherapy
5030878|NCT03806309|Chemotherapy|chemotherapy
5030879|NCT03806296|sleep|sleep
5030880|NCT03806296|circadian|circadian
5030881|NCT03806296|adolescence|adolescence
5030882|NCT03806296|substance use|substance use
5030883|NCT03806296|reward|reward
5030884|NCT03806296|impulse control|impulse control
5030885|NCT03806270|Strabismus surgery|strabismus surgery
5030893|NCT03806244|laparoscopy|laparoscopy
5030894|NCT03806244|transanal surgery|transanal surgery
5030895|NCT03806231|Cervical Ripening|cervical ripening
5030896|NCT03806218|RFA|rfa
5030897|NCT03806205|Knee osteoarthritis pain; Adherence; Diclofenac; Follow up|knee osteoarthritis pain; adherence; diclofenac; follow up
5030898|NCT03806192|Caregiver|caregiver
5030899|NCT03806179|Radioimmunotherapy|radioimmunotherapy
5030900|NCT03806179|Lu-177|lu-177
5030901|NCT03806179|Betalutin|betalutin
5030902|NCT03806179|Phase 1b|phase 1b
5030903|NCT03806179|Combination|combination
5030904|NCT03806179|Rituximab|rituximab
5030905|NCT03806140|Texting|texting
5030906|NCT03806140|mHealth|mhealth
5030907|NCT03806140|Adolescents and young adults transitioning of treatment|adolescents and young adults transitioning of treatment
5030908|NCT03806127|Irritable Bowel Syndrome|irritable bowel syndrome
5030909|NCT03806127|Irritable Bowel Syndrome with predominantly diarrhea (IBS-D)|irritable bowel syndrome with predominantly diarrhea (ibs-d)
5030910|NCT03806127|Irritable Bowel Syndrome with mixed episodes of diarrhea and constipation (IBS-M)|irritable bowel syndrome with mixed episodes of diarrhea and constipation (ibs-m)
5030911|NCT03806127|Vibegron|vibegron
5030912|NCT03806127|Beta-3 adrenergic receptor (β3-AR)|beta-3 adrenergic receptor (β3-ar)
5030913|NCT03806088|CKD|ckd
5030914|NCT03806075|Second generation gene sequencing, gut microbiota, Gastrointestinal polyp syndrome|second generation gene sequencing, gut microbiota, gastrointestinal polyp syndrome
5030915|NCT03806049|chemotherapy-free regimen|chemotherapy-free regimen
5030916|NCT03806049|niraparib|niraparib
5030917|NCT03806049|bevacizumab|bevacizumab
5030918|NCT03806049|TSR042|tsr042
5030919|NCT03806049|recurrent ovarian cancer|recurrent ovarian cancer
5030920|NCT03806023|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5030921|NCT03806023|transcranial magnetic stimulation|transcranial magnetic stimulation
5030926|NCT03805971|pleural carcinomatosis|pleural carcinomatosis
5030927|NCT03805971|mesothelioma|mesothelioma
5030928|NCT03805971|optical biopsies|optical biopsies
5030929|NCT03805945|Cesarean Section|cesarean section
5030930|NCT03805945|Dexmedetomidine|dexmedetomidine
5030931|NCT03805945|Breast Feeding|breast feeding
5030932|NCT03805945|Recovery quality|recovery quality
5024654|NCT03843944|Rasagiline|rasagiline
5024655|NCT03843931|Exercise|exercise
5024656|NCT03843931|Placebo|placebo
5024657|NCT03843931|Injection|injection
5024661|NCT03843905|Sarcopenia|sarcopenia
5030933|NCT03805932|HCL Variant|hcl variant
5030934|NCT03805932|Recombinant Immunotoxin|recombinant immunotoxin
5030935|NCT03805932|Monoclonal Antibody|monoclonal antibody
5030936|NCT03805932|Targeted Therapy|targeted therapy
5030937|NCT03805932|Biologic Therapy|biologic therapy
5030938|NCT03805919|BRCA1|brca1
5030939|NCT03805919|BRCA2|brca2
5030940|NCT03805919|MMR genes|mmr genes
5030941|NCT03805919|Lynch Syndrome|lynch syndrome
5030942|NCT03805854|pain|pain
5030943|NCT03805854|tACS|tacs
5030944|NCT03805854|alpha|alpha
5030945|NCT03805854|gamma|gamma
5030946|NCT03805854|neural oscillations|neural oscillations
5030947|NCT03805854|brain|brain
5030948|NCT03805828|Autism spectrum disorder|autism spectrum disorder
5030949|NCT03805828|parenting stress|parenting stress
5030950|NCT03805828|coping mechanism|coping mechanism
5030951|NCT03805828|coping strategies|coping strategies
5030952|NCT03805828|education program|education program
5030953|NCT03805828|educational intervention|educational intervention
5030954|NCT03805815|blood pressure|blood pressure
5030955|NCT03805815|crack sensor|crack sensor
5030956|NCT03805802|fiber|fiber
5030957|NCT03805802|type 2 diabetes|type 2 diabetes
5030958|NCT03805802|dietary intervention|dietary intervention
5030959|NCT03805802|weight loss|weight loss
5031868|NCT03799952|Older adult|older adult
5030960|NCT03805802|glucose control|glucose control
5030961|NCT03805802|obesity|obesity
5030962|NCT03805802|overweight|overweight
5030963|NCT03805802|metabolic syndrome|metabolic syndrome
5030964|NCT03805802|oats|oats
5030965|NCT03805776|Intermittent fasting|intermittent fasting
5030966|NCT03805776|Fasting|fasting
5030967|NCT03805776|Cholesterol|cholesterol
5030968|NCT03805711|Aortic Stenosis|aortic stenosis
5030969|NCT03805711|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5030970|NCT03805711|TAVR|tavr
5030971|NCT03805711|TAVI|tavi
5030972|NCT03805711|Aortic Valve|aortic valve
5030973|NCT03805698|Platelet-rich Plasma|platelet-rich plasma
5030974|NCT03805672|Lovenox|lovenox
5030988|NCT03805659|Aphasia|aphasia
5030989|NCT03805646|Aftercare|aftercare
5030990|NCT03805646|Telemedicine|telemedicine
5030991|NCT03805646|Africa South of the Sahara|africa south of the sahara
5030992|NCT03805620|mild cognitive impairment|mild cognitive impairment
5030993|NCT03805620|combined physical-cognitive training|combined physical-cognitive training
5030995|NCT03805620|mitochondrial function|mitochondrial function
5030996|NCT03805620|cognitive function|cognitive function
5030997|NCT03805607|Cesarean Section Complications|cesarean section complications
5030998|NCT03805607|Postoperative Pain|postoperative pain
5030999|NCT03805607|Coagulation Defect; Postpartum|coagulation defect; postpartum
5031000|NCT03805607|Nonsteroidals (NSAIDs)Toxicity|nonsteroidals (nsaids)toxicity
5031001|NCT03805607|Postpartum Hemorrhage|postpartum hemorrhage
5031002|NCT03805607|Ketorolac|ketorolac
5031003|NCT03805607|Cesarean Delivery|cesarean delivery
5031004|NCT03805607|Platelet Function|platelet function
5031005|NCT03805568|postoperative sore throat|postoperative sore throat
5031006|NCT03805568|dexmedetomidine|dexmedetomidine
5031007|NCT03805568|remifentanil|remifentanil
5031008|NCT03805568|thyroidectomy|thyroidectomy
5031009|NCT03805555|ablation|ablation
5031010|NCT03805542|calculous pyonephrosis|calculous pyonephrosis
5031011|NCT03805542|I-stage PCNL|i-stage pcnl
5031012|NCT03805542|iodophors|iodophors
5031013|NCT03805503|Chloroprocaine|chloroprocaine
5031014|NCT03805503|spinal anesthesia|spinal anesthesia
5031015|NCT03805503|one-day clinic|one-day clinic
5031016|NCT03805477|allogeneic hematopoietic cell transplantation.|allogeneic hematopoietic cell transplantation.
5031017|NCT03805477|chronic graft-versus-host disease (cGvHD)|chronic graft-versus-host disease (cgvhd)
5031018|NCT03805477|Nintedanib|nintedanib
5031024|NCT03805425|PiXL|pixl
5031025|NCT03805399|TNBC|tnbc
5031026|NCT03805399|Molecular Subtype|molecular subtype
5031027|NCT03805399|Precision Treatment|precision treatment
5031028|NCT03805399|Umbrella|umbrella
5031029|NCT03805386|patient directed postoperative opioid prescribing|patient directed postoperative opioid prescribing
5031030|NCT03805347|Ankle fracture|ankle fracture
5031031|NCT03805347|Helminthostachys zeylanica(L.)Hook|helminthostachys zeylanica(l.)hook
5031032|NCT03805347|Clinical trials|clinical trials
5031033|NCT03805347|Functional recovery|functional recovery
5031035|NCT03805334|sensory over-responsiveness|sensory over-responsiveness
5031036|NCT03805334|hypersensitivity|hypersensitivity
5031040|NCT03805282|general anesthesia|general anesthesia
5031041|NCT03805282|cough|cough
5031042|NCT03805282|anesthesia emergence|anesthesia emergence
5031043|NCT03805282|lidocaine|lidocaine
5031044|NCT03805230|anaesthesia|anaesthesia
5031045|NCT03805230|Intensive Care|intensive care
5345218|NCT01970995|HPHCs|hphcs
5031046|NCT03805230|vasopressor|vasopressor
5031047|NCT03805191|Glycemic excursions|glycemic excursions
5031048|NCT03805191|Acarbose|acarbose
5031049|NCT03805191|Continuous glucose monitoring|continuous glucose monitoring
5031050|NCT03805139|Ajwa (Pheonix Dactylfera) Derived polyphenol|ajwa (pheonix dactylfera) derived polyphenol
5031051|NCT03805139|Dyslipidemia|dyslipidemia
5031052|NCT03805139|Cardioprotection|cardioprotection
5031053|NCT03805139|HDL|hdl
5031054|NCT03805139|Transferulic Acid|transferulic acid
5031055|NCT03805139|Gallic Acid|gallic acid
5031056|NCT03805113|Erosive arthritis|erosive arthritis
5031057|NCT03805113|Hands arthritis|hands arthritis
5031058|NCT03805113|Magnetotherapy|magnetotherapy
5031059|NCT03805087|Hemorrhoids|hemorrhoids
5031074|NCT03805022|Soft-tissue sarcoma|soft-tissue sarcoma
5031075|NCT03805022|Resectable|resectable
5031076|NCT03805022|Non-metastatic|non-metastatic
5031077|NCT03805009|Stroke|stroke
5031078|NCT03805009|Robot|robot
5031079|NCT03805009|Hemiparesis|hemiparesis
5031080|NCT03805009|Gait Training|gait training
5031081|NCT03805009|Rehabilitation|rehabilitation
5031082|NCT03805009|Functional Recovery|functional recovery
5031083|NCT03805009|Robot-Assisted Gait Training|robot-assisted gait training
5032695|NCT03794869|physical therapy|physical therapy
5031089|NCT03804983|Hybrid Closed Loop (HCL)|hybrid closed loop (hcl)
5031090|NCT03804983|Total Daily Insulin (TDI)|total daily insulin (tdi)
5031092|NCT03804970|follow-up|follow-up
5031093|NCT03804970|Diabetic retinopathy|diabetic retinopathy
5031094|NCT03804970|Diabetic teaching|diabetic teaching
5031095|NCT03804970|SMS|sms
5031096|NCT03804970|rewards|rewards
5031097|NCT03804957|biopsy|biopsy
5031098|NCT03804957|pneumothorax|pneumothorax
5031099|NCT03804918|Healthcare education|healthcare education
5031100|NCT03804918|Breaking bad news|breaking bad news
5031101|NCT03804918|Digital learning|digital learning
5031102|NCT03804905|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5031103|NCT03804905|Medication Compliance|medication compliance
5031104|NCT03804905|Medication Insurance|medication insurance
5031109|NCT03804866|Platinum-resistant|platinum-resistant
5031110|NCT03804866|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
5031111|NCT03804866|Ovarian Cancer|ovarian cancer
5031112|NCT03804866|Advanced or metastatic|advanced or metastatic
5031115|NCT03804827|Sleep|sleep
5031116|NCT03804827|OSA|osa
5031117|NCT03804827|CSA|csa
5031118|NCT03804827|CHF|chf
5031119|NCT03804827|Heart Failure|heart failure
5031120|NCT03804827|Troponin|troponin
5031121|NCT03804814|Motivational Interviewing|motivational interviewing
5031122|NCT03804814|Healthcare delivery|healthcare delivery
5031128|NCT03804749|suramin sodium|suramin sodium
5031129|NCT03804710|Skin care, Moisturizing Cream|skin care, moisturizing cream
5031130|NCT03804684|open angle glaucoma|open angle glaucoma
5031131|NCT03804684|visual field|visual field
5031132|NCT03804684|Standard Automatic Perimetry|standard automatic perimetry
5031133|NCT03804658|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5031134|NCT03804658|Vascular cell adhesion molecule 1|vascular cell adhesion molecule 1
5031135|NCT03804658|Renalase|renalase
5031136|NCT03804658|Orexin|orexin
5031137|NCT03804658|Continue glucose monitor|continue glucose monitor
5045164|NCT03716921|native joint|native joint
5031138|NCT03804645|Mineralocorticoid receptor|mineralocorticoid receptor
5031139|NCT03804645|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5031140|NCT03804645|Safety|safety
5031141|NCT03804645|Pharmacokinetics|pharmacokinetics
5031142|NCT03804645|Influence of Food|influence of food
5031143|NCT03804645|Bioavailability|bioavailability
5031144|NCT03804606|Heart Failure|heart failure
5031145|NCT03804606|Machine Learning|machine learning
5031146|NCT03804606|Medication Therapy Management|medication therapy management
5031147|NCT03804606|Supervised Machine Learning|supervised machine learning
5031148|NCT03804606|Population Health Management|population health management
5031149|NCT03804580|Targeted therapy|targeted therapy
5031150|NCT03804580|EGFR|egfr
5031151|NCT03804567|Oldpain2go®|oldpain2go®
5031152|NCT03804567|Feasibility|feasibility
5031156|NCT03804489|Decision Aids; Shared decision making; Rotavirus Vaccines|decision aids; shared decision making; rotavirus vaccines
5031157|NCT03804476|stroke|stroke
5031158|NCT03804476|acute ischemic stroke|acute ischemic stroke
5031162|NCT03804463|endometrial cancer|endometrial cancer
5031163|NCT03804450|Mature teeth|mature teeth
5031164|NCT03804450|Necrotic teeth|necrotic teeth
5031165|NCT03804450|REPs|reps
5031166|NCT03804450|Biodentine|biodentine
5031168|NCT03804450|CBCT|cbct
5031169|NCT03804437|Mandibular canals|mandibular canals
5031170|NCT03804437|bifid canal|bifid canal
5031171|NCT03804437|cbct|cbct
5031172|NCT03804437|cbct dental.|cbct dental.
5031173|NCT03804372|diffuse Large B‑Cell Lymphoma|diffuse large b‑cell lymphoma
5031174|NCT03804372|chronic Lymphoid Leukemia HBsAg-positive|chronic lymphoid leukemia hbsag-positive
5031175|NCT03804372|Rituximab|rituximab
5031176|NCT03804372|chemotherapy|chemotherapy
5031177|NCT03804372|alafenamide|alafenamide
5031178|NCT03804372|hepatitis B virus reactivation|hepatitis b virus reactivation
5031179|NCT03804359|Nephrotic Syndrome|nephrotic syndrome
5031180|NCT03804359|PLA2R1-antibodies|pla2r1-antibodies
5031181|NCT03804359|Epitope spreading|epitope spreading
5031182|NCT03804359|Rituximab|rituximab
5031183|NCT03804333|short course radiotherapy|short course radiotherapy
5031184|NCT03804333|symptomatic pelvic lesions|symptomatic pelvic lesions
5031185|NCT03804320|Kidney cancer|kidney cancer
5031186|NCT03804320|Active surveillance|active surveillance
5031187|NCT03804320|Small renal masses|small renal masses
5031188|NCT03804320|Partial nephrectomy|partial nephrectomy
5031189|NCT03804307|Short Course Radiotherapy|short course radiotherapy
5032793|NCT03794375|Follow-up|follow-up
5031194|NCT03804242|help-seeking|help-seeking
5031195|NCT03804242|identity|identity
5031196|NCT03804229|Vascular Dementia|vascular dementia
5031197|NCT03804229|cognition|cognition
5031198|NCT03804203|Short Course Radiotherapy|short course radiotherapy
5031199|NCT03804203|Symptomatic esophageal lesions|symptomatic esophageal lesions
5031200|NCT03804177|immediate implant|immediate implant
5031201|NCT03804177|hyaluronic acid|hyaluronic acid
5031202|NCT03804177|melatonin|melatonin
5031203|NCT03804177|vitamin C|vitamin c
5031204|NCT03804151|Exercise|exercise
5031205|NCT03804073|Short Course Radiotherapy|short course radiotherapy
5031206|NCT03804073|Symptomatic head and neck lesions|symptomatic head and neck lesions
5031207|NCT03804060|Therapeutic Hypothermia|therapeutic hypothermia
5031209|NCT03804060|Stroke|stroke
5031210|NCT03804060|Neurological Acute Care|neurological acute care
5031211|NCT03804047|Kinesio Tape|kinesio tape
5031212|NCT03804047|Physical functioning|physical functioning
5031213|NCT03804047|Disability|disability
5031214|NCT03804034|Neurogenic inflammation|neurogenic inflammation
5031215|NCT03804034|Dental Pulp|dental pulp
5031216|NCT03804034|Occlusal trauma|occlusal trauma
5031217|NCT03804034|Orthodontics forces|orthodontics forces
5031219|NCT03804034|CGRP|cgrp
5031220|NCT03804034|VEGF|vegf
5031221|NCT03804021|alpha1-antitrypsin deficiency|alpha1-antitrypsin deficiency
5031222|NCT03804021|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
5031223|NCT03804021|alpha1AT|alpha1at
5031224|NCT03804021|A1AT|a1at
5031225|NCT03804021|ADVM-043|advm-043
5031226|NCT03804021|AAVrh.10halpha1AT|aavrh.10halpha1at
5031227|NCT03804021|AAVrh.10hA1AT|aavrh.10ha1at
5031228|NCT03804021|Gene transfer vector|gene transfer vector
5031229|NCT03804021|Gene therapy|gene therapy
5031230|NCT03804021|Lung disease|lung disease
5031231|NCT03804021|Emphysema|emphysema
5031232|NCT03804021|COPD|copd
5031233|NCT03804021|ADVANCE study|advance study
5031234|NCT03804021|Long Term Follow Up|long term follow up
5031235|NCT03803969|Syncope|syncope
5031236|NCT03803969|Cryptogenic Stroke|cryptogenic stroke
5031237|NCT03803969|Physical activity|physical activity
5031238|NCT03803969|Posture|posture
5031239|NCT03803956|Photobiomodulation therapy|photobiomodulation therapy
5031240|NCT03803956|Low-level laser therapy|low-level laser therapy
5031241|NCT03803956|Performance|performance
5031242|NCT03803956|Skeletal muscle recovery|skeletal muscle recovery
5031244|NCT03803956|Intense progressive running test|intense progressive running test
5031249|NCT03803930|EUS-FNB|eus-fnb
5031250|NCT03803930|slow pull|slow pull
5031251|NCT03803930|modified wet suction technique|modified wet suction technique
5031252|NCT03803904|exercise|exercise
5031253|NCT03803904|brain health|brain health
5031254|NCT03803891|Endoscopic resection|endoscopic resection
5031255|NCT03803891|Colonoscopy|colonoscopy
5031256|NCT03803891|Full-thickness resection|full-thickness resection
5031257|NCT03803865|Job Stress|job stress
5031258|NCT03803865|Mindfulness|mindfulness
5031278|NCT03803787|Lung cancer treatment|lung cancer treatment
5031279|NCT03803787|Respiratory Tract Neoplasms|respiratory tract neoplasms
5031280|NCT03803787|Radiation fibrosis|radiation fibrosis
5031281|NCT03803787|Thoracic Neoplasms|thoracic neoplasms
5031282|NCT03803787|Lung Diseases|lung diseases
5031283|NCT03803787|Radiation Injury with Fibrosis|radiation injury with fibrosis
5031284|NCT03803787|Radiation Fibrosis of Lung|radiation fibrosis of lung
5031285|NCT03803787|Lung Injury|lung injury
5031286|NCT03803709|dietary fibers|dietary fibers
5031287|NCT03803709|alcohol-dependent|alcohol-dependent
5031288|NCT03803696|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5031289|NCT03803696|Hematologic Diseases|hematologic diseases
5031290|NCT03803696|Sexual Dysfunction|sexual dysfunction
5031291|NCT03803683|mLab|mlab
5031292|NCT03803683|HIV prevention|hiv prevention
5031293|NCT03803670|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5031294|NCT03803670|flow cytometry|flow cytometry
5031295|NCT03803644|Healthy Subjects|healthy subjects
5031296|NCT03803644|CC-92480|cc-92480
5031297|NCT03803644|Food Effect|food effect
5031298|NCT03803605|VRC07-523LS|vrc07-523ls
5031299|NCT03803605|Vorinostat|vorinostat
5031300|NCT03803605|HIV-1|hiv-1
5031301|NCT03803605|Suppressed|suppressed
5031302|NCT03803605|Latency|latency
5031303|NCT03803605|Reversal|reversal
5031304|NCT03803605|Novel|novel
5031305|NCT03803605|Monoclonal|monoclonal
5031307|NCT03803605|Antibody|antibody
5031308|NCT03803605|Frequency|frequency
5031309|NCT03803605|T Cell|t cell
5031310|NCT03803605|Infection|infection
5031311|NCT03803605|ART|art
5031314|NCT03803579|Bleeding event|bleeding event
5031315|NCT03803579|Thromboembolic event|thromboembolic event
5031316|NCT03803579|Plasma concentration of drug|plasma concentration of drug
5031317|NCT03803566|Manual dexterity|manual dexterity
5031318|NCT03803553|Metastatic colorectal cancer|metastatic colorectal cancer
5031319|NCT03803553|Stage III Colorectal Cancer|stage iii colorectal cancer
5031320|NCT03803540|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5031321|NCT03803540|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
5031323|NCT03803540|NASH|nash
5031324|NCT03803540|Fecal Microbiota Transplantation|fecal microbiota transplantation
5031325|NCT03803540|FMT|fmt
5031326|NCT03803488|needlestick|needlestick
5031327|NCT03803488|needlestick injury|needlestick injury
5031328|NCT03803488|pen needle|pen needle
5031329|NCT03803488|sharps injury prevention|sharps injury prevention
5031330|NCT03803462|Damage|damage
5031331|NCT03803462|Outcome measure|outcome measure
5031332|NCT03803449|propofol|propofol
5031333|NCT03803449|fentanyl|fentanyl
5722355|NCT00423605|Tenderness|tenderness
5031335|NCT03803436|Liver Transplant|liver transplant
5031336|NCT03803436|Colorectal Cancer|colorectal cancer
5031337|NCT03803436|Chemotherapy|chemotherapy
5031338|NCT03803436|Metastasis|metastasis
5031339|NCT03803423|Live Donor Transplant|live donor transplant
5031340|NCT03803423|Social Media|social media
5031341|NCT03803423|Advocacy|advocacy
5031342|NCT03803423|Education|education
5031343|NCT03803423|Living Donation|living donation
5031344|NCT03803423|The Donor App|the donor app
5031345|NCT03803384|hypoxemia, exercise, oxygen, automatic oxygen-titration|hypoxemia, exercise, oxygen, automatic oxygen-titration
5031347|NCT03803358|NIV|niv
5031348|NCT03803358|exercise training|exercise training
5031360|NCT03803319|dietary fibre|dietary fibre
5031367|NCT03803254|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
5031368|NCT03803254|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5031370|NCT03803215|asystole|asystole
5031371|NCT03803215|implantable loop recorder|implantable loop recorder
5031372|NCT03803202|Pneumococcal vaccine|pneumococcal vaccine
5031373|NCT03803202|Vaccine|vaccine
5031374|NCT03803202|Pneumococccal Disease|pneumococccal disease
5031375|NCT03803202|ASP3772|asp3772
5031376|NCT03803124|CYSTS, KIDNEYS|cysts, kidneys
5031380|NCT03803072|Exercise therapy|exercise therapy
5031381|NCT03803072|Diet|diet
5031382|NCT03803072|Prevention and control|prevention and control
5031383|NCT03803046|Benzodiazepin|benzodiazepin
5031384|NCT03803046|Children|children
5031385|NCT03803046|Epilepsy|epilepsy
5031386|NCT03803033|Treatment-related problems|treatment-related problems
5031387|NCT03803033|Cost saving|cost saving
5031393|NCT03803007|Haemorrhages|haemorrhages
5031394|NCT03803007|Thrombolysis|thrombolysis
5031395|NCT03803007|Thrombectomy|thrombectomy
5031396|NCT03803007|Anti-platelet|anti-platelet
5031397|NCT03803007|Dose-escalation|dose-escalation
5031398|NCT03802994|Prevnar|prevnar
5031399|NCT03802994|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5031400|NCT03802994|aging|aging
5031401|NCT03802994|renal transplant recipient|renal transplant recipient
5031402|NCT03802955|Solid Tumor|solid tumor
5031403|NCT03802955|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5031404|NCT03802942|hypoglycemia|hypoglycemia
5031405|NCT03802942|diabetes mellitus|diabetes mellitus
5031406|NCT03802942|malnutrition|malnutrition
5031411|NCT03802890|microbial dysbiosis|microbial dysbiosis
5031412|NCT03802890|rheumatoid arthritis|rheumatoid arthritis
5031413|NCT03802890|dietary factors|dietary factors
5031414|NCT03802877|gestational weight gain|gestational weight gain
5031415|NCT03802877|large for gestational age status|large for gestational age status
5031416|NCT03802877|step counts|step counts
5031417|NCT03802877|physical activity|physical activity
5031418|NCT03802877|health coaching|health coaching
5031419|NCT03802877|ePlatform|eplatform
5031420|NCT03802877|pedometer|pedometer
5031421|NCT03802838|Schizophrenia ，acupuncture，Amisulpride|schizophrenia ，acupuncture，amisulpride
5031422|NCT03802786|pharmacokinetics|pharmacokinetics
5031423|NCT03802747|Liver Metastases|liver metastases
5031424|NCT03802747|Phase 1|phase 1
5031425|NCT03802747|Durvalumab|durvalumab
5031426|NCT03802747|Tremelimumab|tremelimumab
5031427|NCT03802747|Yttrium-90|yttrium-90
5031428|NCT03802747|Radioembolization|radioembolization
5031429|NCT03802747|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5031430|NCT03802721|Benzo[a]pyrene|benzo[a]pyrene
5031431|NCT03802721|Accelerator Mass Spectrometry|accelerator mass spectrometry
5031432|NCT03802721|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
5031433|NCT03802721|cruciferous vegetable|cruciferous vegetable
5031434|NCT03802721|Brussels sprouts|brussels sprouts
5031435|NCT03802721|3,3'-diindolylmethane|3,3'-diindolylmethane
5031436|NCT03802721|DIM|dim
5448863|NCT01507376|hCG|hcg
5031437|NCT03802721|indole-3-carbinol|indole-3-carbinol
5031438|NCT03802721|I3C|i3c
5031439|NCT03802721|PAH|pah
5031440|NCT03802669|human saliva|human saliva
5031441|NCT03802669|mutans streptococcus|mutans streptococcus
5031443|NCT03802669|caries activity|caries activity
5031444|NCT03802656|Scoliosis|scoliosis
5031445|NCT03802656|Idiopathic Scoliosis|idiopathic scoliosis
5031446|NCT03802656|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5031447|NCT03802656|Vertebral Body Tethering|vertebral body tethering
5031448|NCT03802656|growth modulation spine|growth modulation spine
5031449|NCT03802656|spine|spine
5031450|NCT03802656|juvenile scoliosis|juvenile scoliosis
5031451|NCT03802643|Oximetry|oximetry
5031452|NCT03802643|Desaturation of Blood|desaturation of blood
5031453|NCT03802643|Postoperative pulmonary complications|postoperative pulmonary complications
5031472|NCT03802539|Self-etch adhesive|self-etch adhesive
5031473|NCT03802513|tinnitus|tinnitus
5031474|NCT03802461|Fecal Microbiota Transplantation|fecal microbiota transplantation
5031475|NCT03802461|Gut Microbiome|gut microbiome
5031476|NCT03802461|Carbapenemase-producing Enterobacteriaceae (CPE)|carbapenemase-producing enterobacteriaceae (cpe)
5031477|NCT03802435|perineural injection therapy|perineural injection therapy
5031478|NCT03802435|nerve hydrodissection|nerve hydrodissection
5031479|NCT03802422|Hydrodissection|hydrodissection
5031480|NCT03802422|Vitamin B12|vitamin b12
5031481|NCT03802409|Albumin-binding taxol|albumin-binding taxol
5031487|NCT03802357|Pulmonary rehabilitation|pulmonary rehabilitation
5031488|NCT03802357|Exercise training|exercise training
5031489|NCT03802357|Alpha-1 Antitrypsin deficiency|alpha-1 antitrypsin deficiency
5031490|NCT03802318|Helicobacter pylori|helicobacter pylori
5031491|NCT03802318|Proton pump inhibitor|proton pump inhibitor
5031492|NCT03802318|Amoxicillin|amoxicillin
5031493|NCT03802318|Urea breath test|urea breath test
5031494|NCT03802318|Levofloxacin|levofloxacin
5031495|NCT03802318|Clarithromycin|clarithromycin
5031496|NCT03802279|Rhabdomyolysis linked to a hereditary disease of metabolism|rhabdomyolysis linked to a hereditary disease of metabolism
5341086|NCT01989468|PsA|psa
5031497|NCT03802279|Correlation between the effort test and the severity of the disease and biochemical flux on myoblasts|correlation between the effort test and the severity of the disease and biochemical flux on myoblasts
5031498|NCT03802201|chronic anemia|chronic anemia
5031499|NCT03802201|β-thalassemia|β-thalassemia
5031500|NCT03802188|Retinal toxicity|retinal toxicity
5031501|NCT03802162|Alzheimer's disease|alzheimer's disease
5031517|NCT03802097|Laparoscopic gastrectomy|laparoscopic gastrectomy
5031518|NCT03802097|Prophylactic antibiotics|prophylactic antibiotics
5031519|NCT03802097|Infectious complications|infectious complications
5031520|NCT03802045|Acupuncture|acupuncture
5031521|NCT03802045|Electroacupuncture|electroacupuncture
5031522|NCT03802045|Low back pain|low back pain
5031523|NCT03802045|Aged|aged
5031524|NCT03802045|Clinical trial|clinical trial
5031528|NCT03802019|Smoking Behavior|smoking behavior
5031529|NCT03801993|Cystic Fibrosis|cystic fibrosis
5031530|NCT03801993|CF|cf
5031531|NCT03801993|GI|gi
5031532|NCT03801993|nutrition|nutrition
5031533|NCT03801993|quality of life|quality of life
5031534|NCT03801993|bowel|bowel
5031535|NCT03801993|constipation|constipation
5031536|NCT03801993|gastrointestinal|gastrointestinal
5031537|NCT03801967|Mineralocorticoid receptor|mineralocorticoid receptor
5031538|NCT03801967|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5031539|NCT03801967|Safety|safety
5031540|NCT03801967|Pharmacokinetics|pharmacokinetics
5031541|NCT03801967|Single Ascending Dose|single ascending dose
5031542|NCT03801967|Multiple Ascending Dose|multiple ascending dose
5031543|NCT03801954|Nutrition|nutrition
5031544|NCT03801954|Diet|diet
5031545|NCT03801954|Radical cystectomy|radical cystectomy
5031547|NCT03801941|Medical device|medical device
5031548|NCT03801941|Spine|spine
5031549|NCT03801941|Rehabilitation|rehabilitation
5031550|NCT03801941|Traction|traction
5031551|NCT03801928|Inflectra|inflectra
5031552|NCT03801928|Remicade|remicade
5031562|NCT03801850|repositioning|repositioning
5031563|NCT03801850|dosimetric quality|dosimetric quality
5031564|NCT03801850|3D scan|3d scan
5031565|NCT03801837|Macadamia Nuts|macadamia nuts
5031566|NCT03801837|Cardiovascular Disease|cardiovascular disease
5031567|NCT03801837|Inflammation|inflammation
5031568|NCT03801824|Gestational Diabetes Mellitus|gestational diabetes mellitus
5031569|NCT03801824|Glycemic index|glycemic index
5031570|NCT03801824|Metabolic Response|metabolic response
5031571|NCT03801824|Pregnancy Outcomes|pregnancy outcomes
5031572|NCT03801824|Glycemic control|glycemic control
5031573|NCT03801811|Port|port
5031574|NCT03801811|Glue|glue
5031576|NCT03801798|GC1102|gc1102
5031577|NCT03801798|GC1102B|gc1102b
5031578|NCT03801798|Chronic Hepatitis B virus|chronic hepatitis b virus
5031579|NCT03801798|CHB|chb
5031580|NCT03801798|NAs|nas
5031581|NCT03801798|NUC|nuc
5031582|NCT03801785|Proprioceptive and exteroceptive development|proprioceptive and exteroceptive development
5031583|NCT03801785|Non-nutritive habit benefits|non-nutritive habit benefits
5031584|NCT03801785|Thumb sucking|thumb sucking
5031585|NCT03801785|Pacifiers|pacifiers
5031586|NCT03801785|Appropriate age to stop non-nutritive sucking|appropriate age to stop non-nutritive sucking
5033105|NCT03791918|TACE|tace
5031592|NCT03801759|vadadustat|vadadustat
5031593|NCT03801759|drug interactions|drug interactions
5031594|NCT03801759|healthy volunteers|healthy volunteers
5031595|NCT03801746|Healthy volunteers|healthy volunteers
5031596|NCT03801746|vadadustat|vadadustat
5031597|NCT03801746|drug interactions|drug interactions
5031598|NCT03801733|Vadadustat|vadadustat
5031599|NCT03801733|Normal Healthy volunteers|normal healthy volunteers
5031600|NCT03801733|Pharmacokinetics|pharmacokinetics
5031601|NCT03801733|Rosuvastatin|rosuvastatin
5031602|NCT03801733|Sulfasalazine|sulfasalazine
5031603|NCT03801733|Pravastatin|pravastatin
5031604|NCT03801733|Atrovastatin|atrovastatin
5031605|NCT03801733|Simvastatin|simvastatin
5031606|NCT03801720|Clean Catch Urine (CCU)|clean catch urine (ccu)
5031607|NCT03801720|Catherterization|catherterization
5031608|NCT03801720|Ultrasound|ultrasound
5031609|NCT03801720|Micturition|micturition
5031610|NCT03801720|Urine Collection|urine collection
5031611|NCT03801720|Pre-Continent Children|pre-continent children
5031612|NCT03801720|Pediatrics|pediatrics
5031613|NCT03801681|myocarditis|myocarditis
5031614|NCT03801681|heart failure|heart failure
5031615|NCT03801681|endomyocardial biopsy|endomyocardial biopsy
5031616|NCT03801681|arrythmia|arrythmia
5031617|NCT03801681|sudden cardiac death|sudden cardiac death
5031618|NCT03801681|biomarker|biomarker
5031619|NCT03801681|cardiomyopathy|cardiomyopathy
5031620|NCT03801681|high-sensitive troponin|high-sensitive troponin
5031621|NCT03801681|galectin-3|galectin-3
5031622|NCT03801681|st-2|st-2
5031623|NCT03801681|NT-proBNP|nt-probnp
5031624|NCT03801668|Gastric Cancer|gastric cancer
5031625|NCT03801668|Albumin-bound Paclitaxel|albumin-bound paclitaxel
5031626|NCT03801629|Neuroimmune System|neuroimmune system
5031627|NCT03801629|Morphine|morphine
5031628|NCT03801629|PET Imaging|pet imaging
5031629|NCT03801629|TSPO|tspo
5031630|NCT03801577|omega-3|omega-3
5031631|NCT03801577|nafld|nafld
5031632|NCT03801577|nafl|nafl
5031633|NCT03801577|nash|nash
5031634|NCT03801577|medical food|medical food
5031635|NCT03801564|Knee Osteoarthritis|knee osteoarthritis
5031636|NCT03801564|Hyaluronic Acid|hyaluronic acid
5031637|NCT03801564|Platelet Rich Plasma|platelet rich plasma
5031638|NCT03801551|apathy|apathy
5031639|NCT03801551|schizophrenia|schizophrenia
5031640|NCT03801525|CLL|cll
5031641|NCT03801499|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5031642|NCT03801499|Lenvatinib|lenvatinib
5031643|NCT03801473|rehabilitation|rehabilitation
5031644|NCT03801473|robot assisted gait training|robot assisted gait training
5031645|NCT03801421|Surgical Wound|surgical wound
5031646|NCT03801421|Suture, Complication|suture, complication
5031652|NCT03801356|back pain|back pain
5031653|NCT03801356|lumbar spine pain|lumbar spine pain
5031654|NCT03801356|nerve root block|nerve root block
5031655|NCT03801356|foraminotomy|foraminotomy
5031656|NCT03801356|radiculopathy|radiculopathy
5031657|NCT03801356|lumbar|lumbar
5031658|NCT03801356|foraminal stenosis|foraminal stenosis
5031659|NCT03801330|pulmonary rehabilitation|pulmonary rehabilitation
5031660|NCT03801330|digital|digital
5031661|NCT03801330|telehealth|telehealth
5031671|NCT03801213|Urine Specimen Collection/methods|urine specimen collection/methods
5031672|NCT03801213|Infant|infant
5031673|NCT03801213|Newborn|newborn
5031674|NCT03801213|Feasibility Studies|feasibility studies
5031675|NCT03801213|Bladder stimulation|bladder stimulation
5031676|NCT03801200|Brain metastasis|brain metastasis
5031677|NCT03801200|Apatinib|apatinib
5031678|NCT03801200|Radiotherapy|radiotherapy
5031679|NCT03801200|NSCLC|nsclc
5031680|NCT03801200|Drive gene negative|drive gene negative
5031681|NCT03801187|peri-implantitis|peri-implantitis
5031682|NCT03801187|surgical treatment|surgical treatment
5031683|NCT03801187|Er:Yag laser|er:yag laser
5031684|NCT03801187|Air-flow|air-flow
5031685|NCT03801187|chlorhexidine|chlorhexidine
5031686|NCT03801161|vitamin A|vitamin a
5031687|NCT03801161|vitamin A isotope|vitamin a isotope
5031688|NCT03801161|vitamin D|vitamin d
5031689|NCT03801161|ferritin|ferritin
5031690|NCT03801161|transferrin receptor|transferrin receptor
5031691|NCT03801161|folate|folate
5031692|NCT03801161|cobalamin|cobalamin
5031693|NCT03801161|beta-carotene|beta-carotene
5031694|NCT03801161|Inflammation|inflammation
5031695|NCT03801148|Drug therapy|drug therapy
5031696|NCT03801135|Fibrinogen concentrate|fibrinogen concentrate
5031697|NCT03801135|Fresh frozen plasma|fresh frozen plasma
5031698|NCT03801135|ROTEM|rotem
5031699|NCT03801135|Fibrinogen|fibrinogen
5031700|NCT03801135|Overall coagulation potential|overall coagulation potential
5031701|NCT03801122|Tranexamic acid|tranexamic acid
5031702|NCT03801122|bleeding|bleeding
5031703|NCT03801122|hematological malignancies|hematological malignancies
5031704|NCT03801122|thrombocytopenia|thrombocytopenia
5345733|NCT01968759|Sevelamer carbonate|sevelamer carbonate
5031705|NCT03801109|transcranial magnetic stimulation|transcranial magnetic stimulation
5031706|NCT03801109|hyperbaric chamber|hyperbaric chamber
5031707|NCT03801109|pain|pain
5031708|NCT03801109|endorphins|endorphins
5031711|NCT03801057|Dietary Supplements|dietary supplements
5031712|NCT03801057|Fish Proteins|fish proteins
5031713|NCT03801057|Protein Hydrolysates|protein hydrolysates
5031714|NCT03800992|SPIKES - a Six-Step Protocol for Delivering Bad News|spikes - a six-step protocol for delivering bad news
5031715|NCT03800992|advisory skills|advisory skills
5031716|NCT03800979|Alopecia areata|alopecia areata
5031717|NCT03800979|Alopecia universalis|alopecia universalis
5031718|NCT03800979|Alopecia totalis|alopecia totalis
5031719|NCT03800979|Tofacitinib|tofacitinib
5031720|NCT03800979|JAK inhibitor|jak inhibitor
5031721|NCT03800888|Real-time|real-time
5031722|NCT03800888|Medication Adherence|medication adherence
5031723|NCT03800888|Tuberculosis|tuberculosis
5031724|NCT03800875|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5031725|NCT03800875|Pramlintide|pramlintide
5031726|NCT03800875|Glucagon|glucagon
5031728|NCT03800875|Triple-Hormone|triple-hormone
5031729|NCT03800875|Closed-Loop|closed-loop
5031730|NCT03800875|Artificial Pancreas|artificial pancreas
5031738|NCT03800823|Children|children
5031739|NCT03800823|Obesity|obesity
5031740|NCT03800823|Treatment|treatment
5031741|NCT03800823|Family|family
5031742|NCT03800823|mHealth|mhealth
5031743|NCT03800810|Osteoarthritis|osteoarthritis
5031744|NCT03800810|Mesenchymal Stem Cells|mesenchymal stem cells
5031745|NCT03800810|Umbilical Cord|umbilical cord
5031746|NCT03800797|ankylosing spondylitis|ankylosing spondylitis
5031747|NCT03800797|loxoprofen|loxoprofen
5031748|NCT03800797|patch|patch
5031749|NCT03800784|18F-DCFPyL PET/CT PyL|18f-dcfpyl pet/ct pyl
5031750|NCT03800784|PSMA|psma
5031751|NCT03800771|geriatric|geriatric
5031752|NCT03800771|dual-task|dual-task
5031753|NCT03800771|ergometer|ergometer
5031754|NCT03800719|smoking cessation|smoking cessation
5031755|NCT03800719|active referral|active referral
5031757|NCT03800680|Diabetes|diabetes
5031758|NCT03800680|Smartphone application|smartphone application
5031759|NCT03800680|Behavior change|behavior change
5031760|NCT03800680|Weight monitoring|weight monitoring
5031761|NCT03800680|Physical activity|physical activity
5031762|NCT03800680|Blood glucose monitoring|blood glucose monitoring
5031763|NCT03800680|Medication adherence|medication adherence
5031764|NCT03800680|Financial incentive|financial incentive
5031765|NCT03800680|Cost-effectiveness analysis|cost-effectiveness analysis
5031769|NCT03800654|Mindfulness Meditation|mindfulness meditation
5031770|NCT03800641|Dexmedetomidine|dexmedetomidine
5031773|NCT03800628|resources|resources
5031778|NCT03800511|sliding test , ceaserean section|sliding test , ceaserean section
5031779|NCT03800485|stroke|stroke
5031780|NCT03800485|respiratory muscles|respiratory muscles
5031781|NCT03800485|lung|lung
5031782|NCT03800485|stroke rehabilitation|stroke rehabilitation
5031783|NCT03800459|Children with Cystic Fibrosis|children with cystic fibrosis
5031784|NCT03800459|Parents|parents
5031785|NCT03800459|Quality of Life|quality of life
5031786|NCT03800459|Coping with Stress|coping with stress
5031787|NCT03800459|Problem Solving|problem solving
5031788|NCT03800459|family empowerment program|family empowerment program
5031789|NCT03800459|Nursing|nursing
5031790|NCT03800433|pentoxifylline|pentoxifylline
5031791|NCT03800420|Pellino-1|pellino-1
5031792|NCT03800407|Pharmacokinetic|pharmacokinetic
5031793|NCT03800407|Concurrent antituberculosis therapy|concurrent antituberculosis therapy
5031794|NCT03800407|Efavirenz|efavirenz
5031795|NCT03800407|Virologic response|virologic response
5031796|NCT03800407|Children|children
5031797|NCT03800394|Pharmacokinetic|pharmacokinetic
5031798|NCT03800394|Pharmacogenomic|pharmacogenomic
5031799|NCT03800394|Tenofovir diphosphate|tenofovir diphosphate
5031800|NCT03800394|Emtricitabine triphosphate|emtricitabine triphosphate
5031801|NCT03800394|Adolescents|adolescents
5031802|NCT03800381|Pharmacokinetic|pharmacokinetic
5031803|NCT03800381|Pharmacogenomic|pharmacogenomic
5031804|NCT03800381|Antituberculosis drugs|antituberculosis drugs
5031805|NCT03800381|Children|children
5031806|NCT03800381|Tuberculosis|tuberculosis
5031807|NCT03800381|TB/HIV coinfection|tb/hiv coinfection
5031808|NCT03800368|Exercise|exercise
5031809|NCT03800368|Sleep-dependent memory consolidation|sleep-dependent memory consolidation
5031811|NCT03800368|Anaerobic|anaerobic
5031812|NCT03800355|Breast Cancer in males|breast cancer in males
5031813|NCT03800355|Observational|observational
5031814|NCT03800355|Gene Sequencing|gene sequencing
5031815|NCT03800342|recovery|recovery
5031816|NCT03800342|proteomics|proteomics
5031817|NCT03800342|cardiorespiratory fitness|cardiorespiratory fitness
5031818|NCT03800342|exercise|exercise
5031819|NCT03800342|aerobic exercise training|aerobic exercise training
5031820|NCT03800303|depression|depression
5031821|NCT03800303|bipolar|bipolar
5031822|NCT03800303|caregivers|caregivers
5031823|NCT03800303|children|children
5031824|NCT03800303|adolescents|adolescents
5345888|NCT01967940|HIV|hiv
5031832|NCT03800264|corticosteroid,|corticosteroid,
5031833|NCT03800264|atrial fibrillation|atrial fibrillation
5031834|NCT03800264|cardiac surgery|cardiac surgery
5031835|NCT03800251|Gastric Emptying|gastric emptying
5031836|NCT03800251|Pregnancy|pregnancy
5031837|NCT03800251|Elective Cesarean section|elective cesarean section
5031838|NCT03800251|Fasting|fasting
5031839|NCT03800238|caregiver|caregiver
5031840|NCT03800238|wellness|wellness
5031841|NCT03800238|telehealth|telehealth
5031842|NCT03800199|health statues|health statues
5031843|NCT03800199|observational study|observational study
5031844|NCT03800199|questionnaire|questionnaire
5031845|NCT03800160|metabolic surgery|metabolic surgery
5031846|NCT03800160|metabolic disease|metabolic disease
5031847|NCT03800160|multicenter|multicenter
5031848|NCT03800134|Resectable Non-small Cell Lung Cancer, NSCLC, Carcinoma, Non-small Cell Lung Cancer|resectable non-small cell lung cancer, nsclc, carcinoma, non-small cell lung cancer
5031849|NCT03800121|exosomes|exosomes
5031850|NCT03800095|Supportive care|supportive care
5031851|NCT03800095|Early palliative care|early palliative care
5031852|NCT03800095|Quality of life|quality of life
5031853|NCT03800095|Symptoms management|symptoms management
5031854|NCT03800095|Haematological malignancy|haematological malignancy
5031855|NCT03800082|Women, Self-Management, Cardiac Pain|women, self-management, cardiac pain
5031856|NCT03800056|APECED syndrome|apeced syndrome
5031857|NCT03800056|autoimmune polyendocrinopathy|autoimmune polyendocrinopathy
5031858|NCT03800056|chronic mucocutaneous candidiasis|chronic mucocutaneous candidiasis
5031859|NCT03800043|Early Childhood Caries|early childhood caries
5031860|NCT03800043|children|children
5031861|NCT03800043|dentistry|dentistry
5031862|NCT03800043|face perception|face perception
5031863|NCT03800043|dental appearance|dental appearance
5031865|NCT03800030|Cognitive Control|cognitive control
5031866|NCT03800030|Executive Function|executive function
5031869|NCT03799952|Peer-led exercise program|peer-led exercise program
5031870|NCT03799952|Risk of falling|risk of falling
5031871|NCT03799913|CAR-T|car-t
5031872|NCT03799913|MESO|meso
5031873|NCT03799913|Ovarian Cancer|ovarian cancer
5031874|NCT03799913|Relapsed and Refractory|relapsed and refractory
5341341|NCT01988441|autophagy|autophagy
5031875|NCT03799887|Parkinson's disease|parkinson's disease
5031876|NCT03799887|gait|gait
5031877|NCT03799887|balance|balance
5031878|NCT03799887|treadmill training|treadmill training
5031879|NCT03799887|fatigue|fatigue
5031880|NCT03799861|Neonatal Resuscitation|neonatal resuscitation
5031881|NCT03799861|Stillbirth|stillbirth
5031882|NCT03799861|Neonatal Respiratory Depression|neonatal respiratory depression
5031883|NCT03799861|Neonatal Bradycardia|neonatal bradycardia
5031884|NCT03799848|Hepatic impairment|hepatic impairment
5031885|NCT03799848|Healthy subjects|healthy subjects
5031886|NCT03799848|Child-pugh|child-pugh
5031887|NCT03799848|Vadadustat|vadadustat
5031888|NCT03799822|hemodialysis|hemodialysis
5031889|NCT03799822|rivaroxaban|rivaroxaban
5031890|NCT03799822|vitamin K2|vitamin k2
5031891|NCT03799796|flash glucose monitoring|flash glucose monitoring
5031892|NCT03799796|online peer support|online peer support
5031893|NCT03799796|Hispanic|hispanic
5031894|NCT03799796|Spanish-Speaking|spanish-speaking
5031895|NCT03799783|dexmedetomidine|dexmedetomidine
5031896|NCT03799783|sedation|sedation
5031897|NCT03799757|bupivacaine|bupivacaine
5031898|NCT03799757|Post-mastectomy acute pain|post-mastectomy acute pain
5031899|NCT03799757|Wound instillation|wound instillation
5031900|NCT03799692|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5031901|NCT03799679|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5031902|NCT03799666|Pulmonary rehabilitation|pulmonary rehabilitation
5031903|NCT03799666|Community-based|community-based
5031904|NCT03799666|Chronic Respiratory Diseases|chronic respiratory diseases
5031905|NCT03799666|Cost-benefit analysis|cost-benefit analysis
5031906|NCT03799627|Vadadustat|vadadustat
5031907|NCT03799627|AKB-6548|akb-6548
5031908|NCT03799627|Anemia|anemia
5031909|NCT03799627|Chronic kidney disease (CKD)|chronic kidney disease (ckd)
5031910|NCT03799627|erythropoietin|erythropoietin
5031911|NCT03799601|Anlotinib|anlotinib
5031912|NCT03799601|Docetaxel|docetaxel
5031913|NCT03799601|Carboplatin|carboplatin
5031915|NCT03799588|Pediatrics|pediatrics
5031916|NCT03799588|biphasic chest cuirass|biphasic chest cuirass
5031917|NCT03799588|transpulmonary pressure|transpulmonary pressure
5031918|NCT03799562|Depression|depression
5031919|NCT03799562|Pain|pain
5031920|NCT03799562|Clinical Trial|clinical trial
5031921|NCT03799562|Veteran|veteran
5031922|NCT03799562|Supplement|supplement
5031929|NCT03799510|GLA-SE|gla-se
5031930|NCT03799510|Fatty acid-binding protein (FABP)|fatty acid-binding protein (fabp)
5031931|NCT03799510|Phase II Clinical Trial|phase ii clinical trial
5031932|NCT03799510|Senegal|senegal
5031933|NCT03799497|Anorexia nervosa|anorexia nervosa
5031934|NCT03799497|functional MRI (fMRI)|functional mri (fmri)
5031935|NCT03799497|self body-shape recognition|self body-shape recognition
5031936|NCT03799484|Rhytides|rhytides
5031937|NCT03799484|Forehead Wrinkles|forehead wrinkles
5031938|NCT03799471|chronic musculoskeletal pain|chronic musculoskeletal pain
5332105|NCT02030301|Herpes|herpes
5031939|NCT03799471|central hypersensitivity|central hypersensitivity
5031940|NCT03799432|Implementation Science|implementation science
5031941|NCT03799432|Cognitive Behavioral Therapy|cognitive behavioral therapy
5031942|NCT03799432|Children|children
5031943|NCT03799432|Youth|youth
5031944|NCT03799419|cognitive bias modification|cognitive bias modification
5031945|NCT03799419|interpretation bias|interpretation bias
5031946|NCT03799419|approach avoidance|approach avoidance
5031947|NCT03799406|Acute bronchiolitis|acute bronchiolitis
5031948|NCT03799406|Vitamin D|vitamin d
5031957|NCT03799354|rehabilitation|rehabilitation
5031958|NCT03799354|resistive training|resistive training
5031960|NCT03799341|Cocaine-Related Disorders|cocaine-related disorders
5031961|NCT03799341|Contingency Management|contingency management
5031962|NCT03799341|Reward|reward
5031963|NCT03799341|Choice Behavior|choice behavior
5031964|NCT03799341|Executive Function|executive function
5031965|NCT03799341|Precision Medicine|precision medicine
5031966|NCT03799341|Evidence-Based Practice|evidence-based practice
5031967|NCT03799341|Prospective Thinking|prospective thinking
5031968|NCT03799341|Electroencephalography|electroencephalography
5031969|NCT03799341|Event-Related Potentials|event-related potentials
5031970|NCT03799341|Functional Connectivity|functional connectivity
5031972|NCT03799315|Smoking|smoking
5031973|NCT03799315|Counseling|counseling
5031974|NCT03799315|Nicotine Replacement|nicotine replacement
5031975|NCT03799315|Disparities|disparities
5031981|NCT03799237|Dengue|dengue
5031982|NCT03799237|Adult Aedes|adult aedes
5031983|NCT03799237|GOS trap|gos trap
5031984|NCT03799237|Dengue NS1 antigen test|dengue ns1 antigen test
5031985|NCT03799237|Early dengue detection and surveillance|early dengue detection and surveillance
5031986|NCT03799224|recurrent acute leukemia|recurrent acute leukemia
5031987|NCT03799224|refractory acute leukemia|refractory acute leukemia
5031988|NCT03799224|preconditioning regimen|preconditioning regimen
5031989|NCT03799224|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5341451|NCT01987986|dimple|dimple
5031990|NCT03799185|Coronary Heart Disease|coronary heart disease
5031991|NCT03799185|Hypercholesterolemia|hypercholesterolemia
5031992|NCT03799185|Triglycerides High|triglycerides high
5031993|NCT03799185|LDL Hyperlipoproteinemia|ldl hyperlipoproteinemia
5031994|NCT03799185|HDL Low|hdl low
5031995|NCT03799185|Diabetes|diabetes
5031996|NCT03799185|Cardiovascular Diseases|cardiovascular diseases
5031997|NCT03799185|Hypertension|hypertension
5031998|NCT03799185|Risk Factor, Cardiovascular|risk factor, cardiovascular
5031999|NCT03799185|Diet Habit|diet habit
5032000|NCT03799185|Smoking|smoking
5032001|NCT03799159|Sepsis|sepsis
5032002|NCT03799159|Acute Kidney Injury|acute kidney injury
5032003|NCT03799159|Ultrasound|ultrasound
5032004|NCT03799159|Resistive Index|resistive index
5032005|NCT03799159|Biomarkers|biomarkers
5032006|NCT03799146|physical activity|physical activity
5032007|NCT03799146|sedentary behaviour|sedentary behaviour
5032009|NCT03799146|mHealth|mhealth
5032010|NCT03799146|self-regulation|self-regulation
5032011|NCT03799146|behaviour change techniques|behaviour change techniques
5032012|NCT03799133|gastric reactance|gastric reactance
5032013|NCT03799133|elective cardiac surgery|elective cardiac surgery
5032014|NCT03799133|morbimortality|morbimortality
5032015|NCT03799133|APACHE II|apache ii
5032016|NCT03799133|STS|sts
5032017|NCT03799133|SOFA|sofa
5032018|NCT03799133|EUROSCORE II|euroscore ii
5032019|NCT03799094|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5032020|NCT03799094|Vitamin C|vitamin c
5032021|NCT03799094|non-small cell lung cancer|non-small cell lung cancer
5032022|NCT03799094|progression-free survival|progression-free survival
5032023|NCT03799094|overall survival|overall survival
5032024|NCT03799068|bupivacaine|bupivacaine
5032025|NCT03799068|suprazygomatic nerve block|suprazygomatic nerve block
5032026|NCT03799029|Cognitive training|cognitive training
5032027|NCT03799029|treatment|treatment
5032028|NCT03799029|ADHD|adhd
5032029|NCT03799003|ASP1951|asp1951
5032030|NCT03799003|cervical cancer|cervical cancer
5032031|NCT03799003|Oncology|oncology
5428231|NCT01595581|Muscle atrophy|muscle atrophy
5428232|NCT01595568|Adolescents|adolescents
5032038|NCT03799003|Advanced (unresectable) or metastatic solid tumor malignancies|advanced (unresectable) or metastatic solid tumor malignancies
5032040|NCT03798990|Speed|speed
5032048|NCT03798951|Enhanced recovery after surgery|enhanced recovery after surgery
5032049|NCT03798912|RaniPill capsule, drug delivery, octreotide, pharmacokinetic|ranipill capsule, drug delivery, octreotide, pharmacokinetic
5032050|NCT03798886|Frozen embryo replacement, IVF success, ovarian stimulation|frozen embryo replacement, ivf success, ovarian stimulation
5032051|NCT03798873|Compression garment|compression garment
5032052|NCT03798873|Physical therapy|physical therapy
5032054|NCT03798873|Movement|movement
5032055|NCT03798873|Abdominal binder|abdominal binder
5032056|NCT03798847|Journey II XR Total Knee System|journey ii xr total knee system
5032057|NCT03798808|vegetables, fruits, dairy, children, habits|vegetables, fruits, dairy, children, habits
5032058|NCT03798782|Cardiac surgery|cardiac surgery
5032059|NCT03798782|Aortic valve replacement|aortic valve replacement
5032060|NCT03798782|Ross procedure|ross procedure
5032062|NCT03798743|Non-small Cell Lung Cancer|non-small cell lung cancer
5032063|NCT03798743|Sintilimab|sintilimab
5032064|NCT03798743|Docetaxel|docetaxel
5032065|NCT03798730|Older Adults|older adults
5032066|NCT03798730|Oral Nutritional Supplements|oral nutritional supplements
5032067|NCT03798730|Saliva Flow|saliva flow
5032075|NCT03798652|Perfusion|perfusion
5032076|NCT03798652|Viability|viability
5032077|NCT03798626|colorectal cancer|colorectal cancer
5032078|NCT03798626|gastroesophageal cancer|gastroesophageal cancer
5032079|NCT03798626|renal cell carcinoma|renal cell carcinoma
5032080|NCT03798626|gevokizumab|gevokizumab
5032081|NCT03798626|bevacizumab|bevacizumab
5032082|NCT03798626|modified FOLFOX6|modified folfox6
5032083|NCT03798626|FOLFIRI|folfiri
5032084|NCT03798626|ramucirumab|ramucirumab
5032085|NCT03798626|paclitaxel|paclitaxel
5032086|NCT03798626|cabozantinib|cabozantinib
5032088|NCT03798626|GEC|gec
5032089|NCT03798626|RCC|rcc
5032090|NCT03798626|VPM087|vpm087
5032091|NCT03798613|Post-op Atrial Fibrillation|post-op atrial fibrillation
5032092|NCT03798613|Heart Rhythm|heart rhythm
5032093|NCT03798613|Accuracy|accuracy
5032094|NCT03798613|Apple Watch|apple watch
5032095|NCT03798600|Caspofungin|caspofungin
5032096|NCT03798600|pharmacokinetic|pharmacokinetic
5032097|NCT03798600|pharmacodynamic|pharmacodynamic
5032098|NCT03798548|CBT|cbt
5032099|NCT03798548|Brief Therapy|brief therapy
5032100|NCT03798548|Bedside Intervention|bedside intervention
5032101|NCT03798522|ultrasound guided regional blocks|ultrasound guided regional blocks
5032102|NCT03798522|laparoscopic surgery|laparoscopic surgery
5032103|NCT03798522|erector spinae plane block|erector spinae plane block
5032104|NCT03798509|CD19|cd19
5032105|NCT03798509|CAR-T|car-t
5032106|NCT03798509|leukemia|leukemia
5032107|NCT03798509|Relapsed /Refractory|relapsed /refractory
5032108|NCT03798509|B-ALL|b-all
5032109|NCT03798470|opioid|opioid
5032110|NCT03798470|overdose|overdose
5032111|NCT03798457|Community-acquired pneumonia (CAP)|community-acquired pneumonia (cap)
5341650|NCT01986894|TQT|tqt
5032112|NCT03798444|Height loss, Kyphosis|height loss, kyphosis
5032113|NCT03798444|Osteoporosis, Vertebral fracture|osteoporosis, vertebral fracture
5032114|NCT03798444|Postmenopausal women|postmenopausal women
5032122|NCT03798405|Pain|pain
5032123|NCT03798405|Inflammatory Bowel Disease|inflammatory bowel disease
5032124|NCT03798405|Opioids|opioids
5032125|NCT03798379|cancer|cancer
5032126|NCT03798379|chemotherapy|chemotherapy
5032127|NCT03798379|peripheral neuropathy|peripheral neuropathy
5032129|NCT03798353|Cardiac repair|cardiac repair
5032130|NCT03798353|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
5032131|NCT03798353|Chronic myocardial infarction|chronic myocardial infarction
5032132|NCT03798353|Tissue engineering|tissue engineering
5032133|NCT03798353|Cell therapy|cell therapy
5032134|NCT03798353|Clinical trial|clinical trial
5032136|NCT03798340|perturbation-based training|perturbation-based training
5032137|NCT03798340|task-specific motor training|task-specific motor training
5032138|NCT03798340|recovery of function|recovery of function
5032139|NCT03798327|Palliative Care|palliative care
5032140|NCT03798327|Home-Based Care|home-based care
5032141|NCT03798301|Immunocompromised|immunocompromised
5032142|NCT03798301|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5033601|NCT03789123|Dienogest|dienogest
5032154|NCT03798236|Immune modulator|immune modulator
5032155|NCT03798223|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5032156|NCT03798210|ulcerative colitis|ulcerative colitis
5032157|NCT03798210|prevention|prevention
5032158|NCT03798210|microbiota|microbiota
5032159|NCT03798210|Lactobacillus|lactobacillus
5032160|NCT03798197|Estetrol|estetrol
5032161|NCT03798197|Menopausal hormone therapy|menopausal hormone therapy
5032162|NCT03798184|Prime&Bond Active|prime&bond active
5032163|NCT03798184|Bioactive glass|bioactive glass
5032164|NCT03798184|non-carious cervical lesion|non-carious cervical lesion
5032165|NCT03798184|direct resin composite|direct resin composite
5032166|NCT03798171|peritoneal dialysis|peritoneal dialysis
5032167|NCT03798171|exit site|exit site
5032168|NCT03798171|infection|infection
5032169|NCT03798171|peritonitis|peritonitis
5032266|NCT03797417|Metabolic Pathways|metabolic pathways
5032172|NCT03798119|advanced fibrosis|advanced fibrosis
5032173|NCT03798119|Cirrhosis|cirrhosis
5032175|NCT03798119|Tenofovir alafenamide|tenofovir alafenamide
5032176|NCT03798093|Umbilical Cord Milking|umbilical cord milking
5032177|NCT03798093|Immediate Cord Clamping|immediate cord clamping
5032178|NCT03798093|Resuscitation|resuscitation
5032179|NCT03798041|Surgical Wound|surgical wound
5032180|NCT03798041|Suture, Complication|suture, complication
5032181|NCT03798028|anemia|anemia
5032182|NCT03798028|Interstitial pulmonary disease|interstitial pulmonary disease
5032183|NCT03798015|mitral valve surgery|mitral valve surgery
5032184|NCT03798015|mitral valve stenosis|mitral valve stenosis
5032185|NCT03798015|mitral valve insufficiency|mitral valve insufficiency
5032186|NCT03798015|minimal invasive mitral valve surgery|minimal invasive mitral valve surgery
5032187|NCT03798015|neurological outcome|neurological outcome
5032188|NCT03798002|isolated quadriceps training|isolated quadriceps training
5032189|NCT03798002|Neuro-muscular exercise training|neuro-muscular exercise training
5032190|NCT03798002|knee Osteoarthritis|knee osteoarthritis
5032191|NCT03797963|Maxillary sinus augmentation|maxillary sinus augmentation
5032192|NCT03797963|Sinus lift|sinus lift
5032193|NCT03797963|Biomaterial|biomaterial
5032194|NCT03797963|Anorganic bovine bone|anorganic bovine bone
5032195|NCT03797963|Porcine bone mineral|porcine bone mineral
5032196|NCT03797963|Implant dentistry|implant dentistry
5032198|NCT03797950|BCG|bcg
5032199|NCT03797950|vaccine delivery|vaccine delivery
5032200|NCT03797950|mhealth|mhealth
5032201|NCT03797950|incentives|incentives
5032205|NCT03797846|ptosis|ptosis
5032206|NCT03797846|combined procedures|combined procedures
5032207|NCT03797846|glaucoma|glaucoma
5032208|NCT03797846|post-surgery complication|post-surgery complication
5032209|NCT03797833|breech presentation, external version, spinal anaesthesia|breech presentation, external version, spinal anaesthesia
5032210|NCT03797755|survival|survival
5032211|NCT03797755|cancer|cancer
5032212|NCT03797755|palliative|palliative
5032213|NCT03797755|radiotherapy|radiotherapy
5032214|NCT03797755|prognosis|prognosis
5032215|NCT03797729|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5032216|NCT03797729|Tirofiban|tirofiban
5032217|NCT03797729|Percutaneous Coronary Intervention|percutaneous coronary intervention
5032218|NCT03797716|Anxiety, peri-operative, preparation, app|anxiety, peri-operative, preparation, app
5032219|NCT03797690|Dupuytren's disease|dupuytren's disease
5032220|NCT03797690|Percutaneous needle aponeurotomy|percutaneous needle aponeurotomy
5032221|NCT03797690|Limited aponeurectomy|limited aponeurectomy
5032222|NCT03797690|Randomized trial|randomized trial
5032223|NCT03797677|Airway Clearance|airway clearance
5032224|NCT03797677|Cystic Fibrosis|cystic fibrosis
5032225|NCT03797677|Motor Neuron Disease|motor neuron disease
5032226|NCT03797677|Home care|home care
5032227|NCT03797638|Dystonic Disorder|dystonic disorder
5032228|NCT03797638|Focal Dystonia|focal dystonia
5032229|NCT03797638|Writer's Cramp|writer's cramp
5341763|NCT01986452|OSA|osa
5032230|NCT03797612|Knee replacement|knee replacement
5032232|NCT03797612|Total Knee Arthroplasty|total knee arthroplasty
5032233|NCT03797586|electroacupuncture；opioid-induced constipation ,cancer|electroacupuncture；opioid-induced constipation ,cancer
5032234|NCT03797573|transcranial direct current stimulation|transcranial direct current stimulation
5032235|NCT03797573|disorder of consciousness|disorder of consciousness
5032236|NCT03797573|muscle hypertonia|muscle hypertonia
5032237|NCT03797573|spasticity|spasticity
5032254|NCT03797443|Pancreatic|pancreatic
5032255|NCT03797443|Vitamin C|vitamin c
5032256|NCT03797443|Ascorbic Acid|ascorbic acid
5032257|NCT03797443|Paclitaxel Protein Bound|paclitaxel protein bound
5032258|NCT03797443|Cisplatin|cisplatin
5032259|NCT03797443|Gemcitabine|gemcitabine
5032260|NCT03797430|hand ball|hand ball
5032261|NCT03797430|evaluation|evaluation
5032262|NCT03797430|risk of injury|risk of injury
5032263|NCT03797430|women|women
5032264|NCT03797417|Gut Microbiome|gut microbiome
5032265|NCT03797417|Vitiligo|vitiligo
5032267|NCT03797404|Eosinophil|eosinophil
5032276|NCT03797391|EMB-01, Tyrosine Kinase Inhibitor (TKI) Resistant|emb-01, tyrosine kinase inhibitor (tki) resistant
5032278|NCT03797352|Cognitive Decline|cognitive decline
5032279|NCT03797352|Health Education|health education
5032280|NCT03797352|Mobility Decline|mobility decline
5032281|NCT03797339|epigenome|epigenome
5032282|NCT03797339|metabolome|metabolome
5032283|NCT03797339|microbiome|microbiome
5032284|NCT03797339|genome|genome
5032285|NCT03797339|multi-omics targets|multi-omics targets
5032286|NCT03797339|individual drug use|individual drug use
5032295|NCT03797261|Acute Myeloid Leukemia|acute myeloid leukemia
5032296|NCT03797261|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5032297|NCT03797261|Cancer|cancer
5032298|NCT03797261|Venetoclax|venetoclax
5032299|NCT03797261|AMG 176|amg 176
5032300|NCT03797261|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5032301|NCT03797248|traditional Chinese medicine|traditional chinese medicine
5032302|NCT03797248|quality of life|quality of life
5032303|NCT03797248|disease-free survival|disease-free survival
5032304|NCT03797248|adjuvant chemotherapy|adjuvant chemotherapy
5032305|NCT03797248|breast cancer|breast cancer
5032306|NCT03797235|Ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5032307|NCT03797222|hyperinsulinism|hyperinsulinism
5032308|NCT03797222|hyperammonemia|hyperammonemia
5032309|NCT03797222|hypoglycemia|hypoglycemia
5032310|NCT03797222|vitamin e|vitamin e
5032312|NCT03797209|WON|won
5032313|NCT03797170|RCHOP|rchop
5032314|NCT03797170|first line|first line
5032315|NCT03797170|microbiota|microbiota
5032316|NCT03797170|response|response
5032317|NCT03797170|disease control|disease control
5032318|NCT03797170|therapy toxicity|therapy toxicity
5032319|NCT03797131|KB195|kb195
5032320|NCT03797131|Urea Cycle Disorders|urea cycle disorders
5032321|NCT03797131|UCD|ucd
5032322|NCT03797131|microbiome|microbiome
5032323|NCT03797131|Kaleido|kaleido
5032324|NCT03797131|ammonia|ammonia
5032325|NCT03797118|noninvasive assessment of the fractional flow reserve|noninvasive assessment of the fractional flow reserve
5032326|NCT03797118|coronary computed tomography angiography|coronary computed tomography angiography
5032327|NCT03797092|Stem cell therapy|stem cell therapy
5032328|NCT03797092|Heart failure|heart failure
5032329|NCT03797092|Clinical trial|clinical trial
5032330|NCT03797092|Allogeneic|allogeneic
5032331|NCT03797079|Erector spinae plane block|erector spinae plane block
5032332|NCT03797066|hepatitis C virus|hepatitis c virus
5032333|NCT03797066|homeless|homeless
5032334|NCT03797027|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5032335|NCT03797027|cushion|cushion
5032336|NCT03797014|HIV-1|hiv-1
5032337|NCT03797014|Hepatitis B|hepatitis b
5032338|NCT03797014|HIV-HBV coinfection|hiv-hbv coinfection
5032339|NCT03797014|Bictegravir|bictegravir
5032340|NCT03797014|B/F/TAF|b/f/taf
5032341|NCT03797014|Tenofovir alafenamide|tenofovir alafenamide
5032342|NCT03797014|Biktarvy|biktarvy
5032343|NCT03797001|heart failure|heart failure
5032344|NCT03797001|inflammation|inflammation
5032345|NCT03797001|anakinra|anakinra
5032346|NCT03797001|exercise capacity|exercise capacity
5032347|NCT03796962|Epilepsy|epilepsy
5032348|NCT03796936|posttraumatic stress disorder|posttraumatic stress disorder
5032349|NCT03796936|traumatic brain injury|traumatic brain injury
5032371|NCT03796819|prognosis|prognosis
5032372|NCT03796806|lichen planus|lichen planus
5032373|NCT03796806|proteomics|proteomics
5032374|NCT03796806|xenograft model for lichen planus|xenograft model for lichen planus
5032375|NCT03796715|sepsis|sepsis
5032376|NCT03796715|presepsin|presepsin
5032377|NCT03796715|red cell distribution width|red cell distribution width
5032378|NCT03796676|Atopic Dermatitis, JAK1 inhibitor|atopic dermatitis, jak1 inhibitor
5032386|NCT03796650|Clostridium difficile|clostridium difficile
5032387|NCT03796650|Intestinal microbiota therapy|intestinal microbiota therapy
5032388|NCT03796650|Fecal microbiota transplantation|fecal microbiota transplantation
5032389|NCT03796650|Investigator-initiated|investigator-initiated
5032390|NCT03796650|Antibiotics|antibiotics
5032391|NCT03796650|Diarrhea|diarrhea
5341769|NCT01986413|COPD|copd
5032392|NCT03796624|Intraocular lens|intraocular lens
5032393|NCT03796624|Monofocal|monofocal
5032394|NCT03796624|Hydrophobic|hydrophobic
5032395|NCT03796611|immunology|immunology
5032396|NCT03796611|B cells|b cells
5032397|NCT03796598|fecal microbial transplant|fecal microbial transplant
5032398|NCT03796598|cirrhosis|cirrhosis
5032399|NCT03796598|hepatic encephalopathy|hepatic encephalopathy
5032400|NCT03796572|lateral condyle|lateral condyle
5032401|NCT03796572|infraclavicular|infraclavicular
5032402|NCT03796572|regional block|regional block
5032403|NCT03796559|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5032404|NCT03796546|Pediatric|pediatric
5032405|NCT03796533|AML-PCZ-UGT1A4 gene|aml-pcz-ugt1a4 gene
5032406|NCT03796494|dental implant|dental implant
5032407|NCT03796494|periimplant tissues|periimplant tissues
5032408|NCT03796468|Mechanical thrombectomy|mechanical thrombectomy
5032409|NCT03796468|stroke|stroke
5032410|NCT03796468|Proximal intracranial arterial occlusions|proximal intracranial arterial occlusions
5032411|NCT03796468|Large vessel occlusion|large vessel occlusion
5032412|NCT03796455|Fish Oil supplement|fish oil supplement
5032413|NCT03796455|HMB supplement|hmb supplement
5032414|NCT03796442|aortic valve replacement|aortic valve replacement
5032415|NCT03796442|bioprosthesis|bioprosthesis
5032416|NCT03796429|Advanced Biliary Tract Cancer|advanced biliary tract cancer
5032417|NCT03796429|PD-1 antibody(Toripalimab)|pd-1 antibody(toripalimab)
5032418|NCT03796429|first-line chemotherapy|first-line chemotherapy
5032419|NCT03796390|AML，CD123|aml，cd123
5032420|NCT03796364|endostatin|endostatin
5032421|NCT03796364|Radiotherapy|radiotherapy
5032422|NCT03796364|Radiation pneumonitis|radiation pneumonitis
5032423|NCT03796364|Radiation fibrosis|radiation fibrosis
5032424|NCT03796338|intensive care unit|intensive care unit
5032425|NCT03796338|Sleep interruption|sleep interruption
5032426|NCT03796338|Sleep phases|sleep phases
5032427|NCT03796312|Bathing|bathing
5032428|NCT03796312|Comfort|comfort
5032429|NCT03796312|Neonatal intensive care unit|neonatal intensive care unit
5032430|NCT03796312|Nursing care|nursing care
5032431|NCT03796312|Premature infant|premature infant
5032432|NCT03796312|Skin care|skin care
5032433|NCT03796299|bladder cancer|bladder cancer
5032434|NCT03796299|biomarker|biomarker
5032435|NCT03796299|urothelial cancer|urothelial cancer
5032436|NCT03796299|cystoscopy|cystoscopy
5032437|NCT03796286|Postprandial glucose|postprandial glucose
5032438|NCT03796286|Meal tolerance test|meal tolerance test
5032439|NCT03796247|cognition|cognition
5032440|NCT03796247|alexithymia|alexithymia
5032441|NCT03796221|Childhood obesity|childhood obesity
5032442|NCT03796221|Parenting intervention|parenting intervention
5032443|NCT03796221|Video intervention|video intervention
5032444|NCT03796221|Healthcare delivery|healthcare delivery
5032445|NCT03796208|Opioid Use Disorder|opioid use disorder
5032456|NCT03796117|Electric Stimulation|electric stimulation
5032457|NCT03796104|Bone and Joint Infection|bone and joint infection
5032458|NCT03796104|Staphylococcus Aureus|staphylococcus aureus
5032459|NCT03796104|chronic infection|chronic infection
5032460|NCT03796078|OSA|osa
5032461|NCT03796078|orthognathic surgery|orthognathic surgery
5032462|NCT03796065|refugees|refugees
5032469|NCT03796052|Pruritis|pruritis
5032470|NCT03796052|Itching|itching
5032471|NCT03796052|Dryness|dryness
5032472|NCT03796052|Xerosis|xerosis
5032473|NCT03796039|Long Term Care Residents|long term care residents
5032474|NCT03796039|Sedentary|sedentary
5032482|NCT03795974|Quadriparetic CP, Diparetic CP, Spastic|quadriparetic cp, diparetic cp, spastic
5032483|NCT03795948|Stoke|stoke
5032484|NCT03795948|Patient-reported outcomes (PROs)|patient-reported outcomes (pros)
5032485|NCT03795948|Quality of life|quality of life
5032486|NCT03795948|Morbidity|morbidity
5032487|NCT03795948|Mortality|mortality
5032488|NCT03795948|Functional status|functional status
5032489|NCT03795948|Patient-centered care|patient-centered care
5032490|NCT03795948|ICHOM|ichom
5032491|NCT03795948|Treatment quality|treatment quality
5032492|NCT03795935|Deep Brain Stimulation|deep brain stimulation
5032493|NCT03795935|Directional Lead|directional lead
5032494|NCT03795935|Essential Tremor|essential tremor
5032495|NCT03795883|Thrombin generation|thrombin generation
5032496|NCT03795883|Calibrated automated thrombogram|calibrated automated thrombogram
5032497|NCT03795883|Atrial fibrillation|atrial fibrillation
5032498|NCT03795870|Home Enteral Nutrition|home enteral nutrition
5032499|NCT03795870|Gut Microbiome|gut microbiome
5032500|NCT03795870|Blenderized Tube Feeds|blenderized tube feeds
5032501|NCT03795779|CLL1|cll1
5032502|NCT03795779|CD33|cd33
5032503|NCT03795779|CLL1-CD33 cCAR|cll1-cd33 ccar
5032504|NCT03795779|Leukemia|leukemia
5032505|NCT03795779|Hematologic Malignancies|hematologic malignancies
5032506|NCT03795753|Emphysema|emphysema
5032507|NCT03795753|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5032508|NCT03795753|Obstructive sleep apnea|obstructive sleep apnea
5032509|NCT03795740|computed tomography|computed tomography
5032510|NCT03795740|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5032511|NCT03795740|pulmonary endarterectomy|pulmonary endarterectomy
5032512|NCT03795740|result|result
5032513|NCT03795740|randomized controlled trial|randomized controlled trial
5032514|NCT03795714|Intravascular Ultrasound|intravascular ultrasound
5032515|NCT03795714|Optical Coherence Tomography|optical coherence tomography
5032516|NCT03795714|Fractional Flow Reserve|fractional flow reserve
5032517|NCT03795714|Diastolic Pressure Ratio|diastolic pressure ratio
5032518|NCT03795714|Resting Full-Cycle Ratio|resting full-cycle ratio
5032519|NCT03795714|Ischemic Heart Disease|ischemic heart disease
5032520|NCT03795714|Instantaneous Wave-free Ratio|instantaneous wave-free ratio
5032521|NCT03795701|Neuroimaging|neuroimaging
5032522|NCT03795701|Hormones|hormones
5032523|NCT03795675|Cochlear implants|cochlear implants
5032524|NCT03795662|Community-acquired pneumonia|community-acquired pneumonia
5032525|NCT03795662|Diabetes|diabetes
5032526|NCT03795662|Immune status|immune status
5032527|NCT03795662|Nutritional status|nutritional status
5032528|NCT03795662|Physical inactivity|physical inactivity
5032529|NCT03795662|Risk factors|risk factors
5032530|NCT03795636|Primary molars|primary molars
5032531|NCT03795636|Garlic extract|garlic extract
5032532|NCT03795636|Sodium hypochlorite|sodium hypochlorite
5032533|NCT03795636|Pulpectomy|pulpectomy
5032534|NCT03795623|Critical Illness|critical illness
5032535|NCT03795623|Respiration Disorder|respiration disorder
5032536|NCT03795623|Neurology|neurology
5032537|NCT03795610|HPV positive|hpv positive
5032538|NCT03795610|HPV negative|hpv negative
5032539|NCT03795610|HPV-|hpv-
5032540|NCT03795610|HPV+|hpv+
5032541|NCT03795610|PI3K-γ|pi3k-γ
5032542|NCT03795610|microenvironment|microenvironment
5032543|NCT03795610|immunotherapy|immunotherapy
5032544|NCT03795610|tumor|tumor
5032545|NCT03795610|resection|resection
5032546|NCT03795610|PI3K|pi3k
5032547|NCT03795610|cancer|cancer
5032548|NCT03795610|carcinoma|carcinoma
5033964|NCT03786757|STEMI|stemi
5032549|NCT03795610|malignancy|malignancy
5032550|NCT03795610|head|head
5032551|NCT03795610|neck|neck
5032552|NCT03795610|throat|throat
5032553|NCT03795610|esophageal|esophageal
5032554|NCT03795610|nasopharyngeal|nasopharyngeal
5032555|NCT03795610|nasopharynx|nasopharynx
5032556|NCT03795597|Multiple Myeloma|multiple myeloma
5032557|NCT03795597|Autologous|autologous
5032558|NCT03795597|Stem Cell Transplantation|stem cell transplantation
5032559|NCT03795597|Bone Marrow Transplant|bone marrow transplant
5032560|NCT03795597|Carfilzomib|carfilzomib
5032561|NCT03795571|lenalidomide|lenalidomide
5032562|NCT03795571|R-GOD|r-god
5032563|NCT03795571|DLBCL|dlbcl
5032564|NCT03795545|ureteric stone|ureteric stone
5032578|NCT03795506|Atopic Dermatitis Eczema|atopic dermatitis eczema
5032580|NCT03795493|Nutrition|nutrition
5032581|NCT03795493|Caloric Restriction|caloric restriction
5032582|NCT03795493|Chemotherapy|chemotherapy
5032583|NCT03795454|Kangaroo care|kangaroo care
5032585|NCT03795454|AERP|aerp
5032595|NCT03795363|Cystic Fibrosis|cystic fibrosis
5032596|NCT03795350|Lung deposition|lung deposition
5032597|NCT03795350|Gamma scintigraphy|gamma scintigraphy
5032598|NCT03795337|Hypofractionation|hypofractionation
5032599|NCT03795337|Prostate Cancer|prostate cancer
5032600|NCT03795337|Radiotherapy|radiotherapy
5032601|NCT03795337|long-term toxicity|long-term toxicity
5032602|NCT03795324|Anthocyanins|anthocyanins
5032603|NCT03795324|apple|apple
5032604|NCT03795324|biofortification|biofortification
5032605|NCT03795324|cardiometabolic|cardiometabolic
5032606|NCT03795324|LDL cholesterol|ldl cholesterol
5032607|NCT03795324|polyphenols|polyphenols
5032608|NCT03795311|FOLFIRINOX3 Bevacizumab|folfirinox3 bevacizumab
5032612|NCT03795285|Early onset sepsis|early onset sepsis
5032613|NCT03795285|sTREM-1|strem-1
5032614|NCT03795285|Neutrophil CD64|neutrophil cd64
5032615|NCT03795272|Cervical cancer|cervical cancer
5032616|NCT03795272|rucaparib|rucaparib
5032617|NCT03795272|maintenance therapy|maintenance therapy
5032618|NCT03795272|placebo-controlled|placebo-controlled
5032619|NCT03795259|Sugammadex|sugammadex
5032620|NCT03795259|Sevoflurane|sevoflurane
5032621|NCT03795259|Desflurane|desflurane
5032622|NCT03795259|Rocuronium|rocuronium
5032623|NCT03795259|TOF|tof
5032624|NCT03795259|Child|child
5032625|NCT03795259|Train-of-four|train-of-four
5032631|NCT03795207|Node; Prostate|node; prostate
5032632|NCT03795207|Bone Metastases|bone metastases
5032633|NCT03795207|Prostate cancer patients|prostate cancer patients
5032634|NCT03795207|SBRT (Stereotactic body radiation therapy)|sbrt (stereotactic body radiation therapy)
5032635|NCT03795207|Durvalumab|durvalumab
5032636|NCT03795207|TEP-FCH|tep-fch
5032637|NCT03795207|TEP-PSMA|tep-psma
5032638|NCT03795181|multiple pulmonary nodules; predictive model|multiple pulmonary nodules; predictive model
5032639|NCT03795168|Vestibular physical therapy|vestibular physical therapy
5032640|NCT03795168|Positional vertigo|positional vertigo
5032641|NCT03795168|Ménière's disease|ménière's disease
5032642|NCT03795129|Early awakening|early awakening
5032643|NCT03795116|Light emitting diode|light emitting diode
5032644|NCT03795116|Light emitting diode-red light|light emitting diode-red light
5032645|NCT03795116|Visible red light|visible red light
5032646|NCT03795116|Skin fibrosis|skin fibrosis
5032647|NCT03795116|Wound healing|wound healing
5032648|NCT03795116|Scarring|scarring
5032649|NCT03795103|Lower Extremity Peripheral Arterial Disease|lower extremity peripheral arterial disease
5032650|NCT03795090|Antimicrobial coating, MDRO, MRSA, Patient Privacy Curtains|antimicrobial coating, mdro, mrsa, patient privacy curtains
5032651|NCT03795064|Venous Ulcer|venous ulcer
5032652|NCT03795064|Venous Insufficiency of Leg|venous insufficiency of leg
5032653|NCT03795064|Varicose Veins|varicose veins
5032654|NCT03795051|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5032655|NCT03795051|Navigated Transcranial Magnetic Stimulation|navigated transcranial magnetic stimulation
5032656|NCT03795038|Lipoprotein apheresis|lipoprotein apheresis
5032657|NCT03795025|Contralateral|contralateral
5032658|NCT03795025|Strength training|strength training
5032659|NCT03795025|Muscle|muscle
5032660|NCT03795012|breast cancer|breast cancer
5032661|NCT03795012|Unresectable|unresectable
5032662|NCT03795012|ER|er
5032663|NCT03795012|PR|pr
5032664|NCT03795012|Her2|her2
5032665|NCT03795012|recurrent|recurrent
5032666|NCT03795012|metastatic|metastatic
5032673|NCT03794973|Diabetes|diabetes
5032674|NCT03794973|Diabetes Mellitus|diabetes mellitus
5032675|NCT03794960|Diabetes|diabetes
5032676|NCT03794960|Type 1 Diabetes|type 1 diabetes
5032677|NCT03794960|Diabetes Mellitus|diabetes mellitus
5032678|NCT03794947|remote ischaemic conditioning|remote ischaemic conditioning
5032679|NCT03794934|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5032680|NCT03794934|Continuous Glucose Monitoring|continuous glucose monitoring
5032681|NCT03794934|Insulin pump|insulin pump
5032682|NCT03794934|Structured Education|structured education
5032683|NCT03794921|Pulmonary Rehabilitation|pulmonary rehabilitation
5032684|NCT03794921|Technology-Mediated|technology-mediated
5032685|NCT03794921|Web-Based Intervention|web-based intervention
5032686|NCT03794921|Physical Activity|physical activity
5032687|NCT03794908|Circadian timing|circadian timing
5032700|NCT03794856|Cognitive functioning|cognitive functioning
5032701|NCT03794856|MRI|mri
5032702|NCT03794843|Nimodipine|nimodipine
5032703|NCT03794843|bioavailability|bioavailability
5032704|NCT03794843|Safety|safety
5032705|NCT03794843|ischemic cerebrovascular disease|ischemic cerebrovascular disease
5032706|NCT03794830|sacroiliac joint|sacroiliac joint
5032707|NCT03794830|low back pain|low back pain
5032708|NCT03794830|Osteopathic manipulation|osteopathic manipulation
5026356|NCT03833791|obesity|obesity
5032709|NCT03794817|Kidney transplant recipient|kidney transplant recipient
5032711|NCT03794791|HCV|hcv
5032712|NCT03794791|Co-infection|co-infection
5032713|NCT03794778|PEGylated Doxorubicin Hydrochloride Liposome Injection|pegylated doxorubicin hydrochloride liposome injection
5032714|NCT03794778|Duomeisu|duomeisu
5032715|NCT03794778|First-line treatment|first-line treatment
5032716|NCT03794778|Epithelial Ovarian Cancer|epithelial ovarian cancer
5032717|NCT03794765|Antibiotics|antibiotics
5032718|NCT03794765|Ceftriaxone|ceftriaxone
5032719|NCT03794765|Metronidazole|metronidazole
5032720|NCT03794739|Diabetes mellitus|diabetes mellitus
5032721|NCT03794739|Beta cell loss|beta cell loss
5032722|NCT03794739|Beta cell apoptosis|beta cell apoptosis
5032723|NCT03794726|Orthodontic tooth movement|orthodontic tooth movement
5032724|NCT03794726|Molar protraction|molar protraction
5032725|NCT03794726|Periodontally accelerated osteogenic orthodontics|periodontally accelerated osteogenic orthodontics
5032726|NCT03794726|Patient-centered outcomes|patient-centered outcomes
5032727|NCT03794713|beta-blocker|beta-blocker
5032728|NCT03794713|Stable Angina Pectoris|stable angina pectoris
5032729|NCT03794713|Patient support tool|patient support tool
5032730|NCT03794713|Adherence|adherence
5032731|NCT03794700|Hospice|hospice
5032732|NCT03794700|End-of-life|end-of-life
5032733|NCT03794700|Patient decision aid|patient decision aid
5032734|NCT03794700|Shared decision making|shared decision making
5032735|NCT03794687|Left heart catheterizations|left heart catheterizations
5032736|NCT03794674|Multidimensional Prognostic Index|multidimensional prognostic index
5032737|NCT03794674|Frailty|frailty
5032738|NCT03794674|Geriatric|geriatric
5032739|NCT03794674|Elderly|elderly
5032740|NCT03794674|Aged|aged
5032741|NCT03794674|+75|+75
5032742|NCT03794674|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5032743|NCT03794648|mobile app|mobile app
5032744|NCT03794648|HIV-infections|hiv-infections
5032745|NCT03794648|medication adherence|medication adherence
5032746|NCT03794635|Latina|latina
5032747|NCT03794635|Latino|latino
5032748|NCT03794635|Spanish|spanish
5032749|NCT03794635|Caregiver|caregiver
5032750|NCT03794635|18-530|18-530
5032751|NCT03794635|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5032752|NCT03794622|Bone Marrow|bone marrow
5032753|NCT03794622|Mesenchymal Stromal Cells|mesenchymal stromal cells
5032754|NCT03794622|Femoral Shaft Fracture|femoral shaft fracture
5032755|NCT03794583|Treprostinil|treprostinil
5032756|NCT03794583|Lung Diseases|lung diseases
5032757|NCT03794583|Hypertension|hypertension
5032758|NCT03794583|Vascular Diseases|vascular diseases
5032759|NCT03794544|Neoadjuvant|neoadjuvant
5032760|NCT03794544|Non-small Cell Lung Cancer|non-small cell lung cancer
5032761|NCT03794544|Cancer|cancer
5032762|NCT03794544|Lung|lung
5032763|NCT03794544|Resectable|resectable
5032764|NCT03794544|Early-stage|early-stage
5032765|NCT03794544|Stage I|stage i
5032766|NCT03794544|Stage II|stage ii
5032767|NCT03794544|Stage IIIA|stage iiia
5032768|NCT03794544|Durvalumab|durvalumab
5032769|NCT03794531|Hispanics/Latinos|hispanics/latinos
5032770|NCT03794531|Minority health|minority health
5032771|NCT03794531|Puerto Rico|puerto rico
5032776|NCT03794531|Caribbean and Latin America|caribbean and latin america
5032778|NCT03794531|Prospective study|prospective study
5032779|NCT03794531|Allostatic load|allostatic load
5032780|NCT03794479|Intestinal microbiota|intestinal microbiota
5032781|NCT03794479|Antimicrobial resistance|antimicrobial resistance
5032782|NCT03794466|gonadal vein embolization|gonadal vein embolization
5032783|NCT03794453|Stroke|stroke
5032784|NCT03794453|Intestinal microbiota|intestinal microbiota
5032785|NCT03794453|Antimicrobial resistance|antimicrobial resistance
5032786|NCT03794401|body composition|body composition
5722356|NCT00423605|Joint pain|joint pain
5032787|NCT03794401|chronic kidney disease|chronic kidney disease
5032788|NCT03794401|dietary pattern|dietary pattern
5032789|NCT03794401|gut microbiot|gut microbiot
5032790|NCT03794388|Breast cancer patient|breast cancer patient
5032792|NCT03794388|Inter Costobrachial Neuralgia|inter costobrachial neuralgia
5032801|NCT03794245|Prevention|prevention
5032804|NCT03794232|Inulin|inulin
5032805|NCT03794232|Soluble dietary fiber|soluble dietary fiber
5032806|NCT03794232|Prediabetes|prediabetes
5032807|NCT03794180|Anti-GM-CSF agents|anti-gm-csf agents
5032808|NCT03794180|GM-CSF/GM-CSFR (GM-CSF receptor) antibody|gm-csf/gm-csfr (gm-csf receptor) antibody
5032809|NCT03794180|colony-stimulating factor 2|colony-stimulating factor 2
5032810|NCT03794180|monoclonal antibody|monoclonal antibody
5032811|NCT03794128|neoantigen cancer vaccine|neoantigen cancer vaccine
5032812|NCT03794128|personalized neoantigen cancer vaccine|personalized neoantigen cancer vaccine
5032813|NCT03794089|anxiety|anxiety
5032814|NCT03794089|primary health care|primary health care
5032815|NCT03794089|Veterans|veterans
5032816|NCT03794076|schizophrenia|schizophrenia
5032817|NCT03794076|schizoaffective disorder|schizoaffective disorder
5032818|NCT03794076|cromoglicate|cromoglicate
5032819|NCT03794063|Robson classification|robson classification
5032820|NCT03794037|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5032821|NCT03794037|Montelukast|montelukast
5032822|NCT03794011|myelomeningocele|myelomeningocele
5032823|NCT03794011|MMC|mmc
5032824|NCT03794011|NTD|ntd
5032825|NCT03794011|neural|neural
5032826|NCT03794011|defect|defect
5032827|NCT03794011|Spinal Bifida|spinal bifida
5032828|NCT03794011|Neural Tube Defect|neural tube defect
5032829|NCT03793998|Cardiac Catheter Ablation|cardiac catheter ablation
5032830|NCT03793998|Cardiac Arrhythmias|cardiac arrhythmias
5032831|NCT03793998|Mapping System|mapping system
5346652|NCT01964846|gene expression|gene expression
5032832|NCT03793972|Triage|triage
5032833|NCT03793972|Primary Health Care|primary health care
5032834|NCT03793972|Emergency Service, Hospital|emergency service, hospital
5032835|NCT03793959|female athletes|female athletes
5032836|NCT03793959|iron supplementation|iron supplementation
5032837|NCT03793959|prebiotic|prebiotic
5032838|NCT03793959|probiotic|probiotic
5032839|NCT03793959|synbiotic|synbiotic
5032840|NCT03793959|serum ferritin|serum ferritin
5032841|NCT03793946|Drug Resistance, Microbial|drug resistance, microbial
5032842|NCT03793946|Multicenter Study|multicenter study
5032843|NCT03793946|Decision Support Systems, Clinical|decision support systems, clinical
5032844|NCT03793920|Prenatal alcohol exposure|prenatal alcohol exposure
5032845|NCT03793920|Emotional|emotional
5032846|NCT03793920|Cognition|cognition
5032847|NCT03793920|Addiction|addiction
5032848|NCT03793920|Fetal Alcohol Syndrome|fetal alcohol syndrome
5032852|NCT03793842|Electrical Impedance Tomography|electrical impedance tomography
5032853|NCT03793842|Ventilator|ventilator
5032854|NCT03793842|Lung|lung
5032855|NCT03793842|Respiration|respiration
5032856|NCT03793829|HER2-expressing ductal carcinoma in situ (DCIS).|her2-expressing ductal carcinoma in situ (dcis).
5032859|NCT03793790|Nocebo|nocebo
5032860|NCT03793790|Pain|pain
5032861|NCT03793790|Conditioning|conditioning
5032862|NCT03793790|Counterconditioning|counterconditioning
5032863|NCT03793790|Partial reinforcement|partial reinforcement
5032864|NCT03793790|Learning|learning
5032865|NCT03793738|anterior component separation, posterior component separation, transversus abdominis muscle release|anterior component separation, posterior component separation, transversus abdominis muscle release
5032866|NCT03793699|Suicide|suicide
5032867|NCT03793699|Suicidal ideation|suicidal ideation
5032868|NCT03793699|Sleep disorder|sleep disorder
5032869|NCT03793673|Adolescents and Young Adults(AYA)|adolescents and young adults(aya)
5032870|NCT03793660|Biologic|biologic
5032871|NCT03793660|Safety|safety
5032872|NCT03793660|LITAR|litar
5032873|NCT03793660|DACIMA|dacima
5032874|NCT03793660|Tunisia|tunisia
5032875|NCT03793582|OSA|osa
5032876|NCT03793582|ACS (Acute Coronary Syndrome)|acs (acute coronary syndrome)
5032877|NCT03793582|MACE (Major Adverse Cardiac Events)|mace (major adverse cardiac events)
5032878|NCT03793543|J18127 PSMA PyL 18F-DCFPyL PET/CT|j18127 psma pyl 18f-dcfpyl pet/ct
5032879|NCT03793530|Bone Marrow|bone marrow
5032880|NCT03793530|Mesenchymal Stromal Cells|mesenchymal stromal cells
5032881|NCT03793530|spine fusion surgery|spine fusion surgery
5032882|NCT03793517|high risk acute myeloid leukemia|high risk acute myeloid leukemia
5032883|NCT03793517|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5032884|NCT03793517|leukemia relapse|leukemia relapse
5032885|NCT03793517|preparation regimen|preparation regimen
5032886|NCT03793517|decitabine|decitabine
5032887|NCT03793504|pulmonary rehabilitation|pulmonary rehabilitation
5032888|NCT03793504|exercise|exercise
5032893|NCT03793478|Relapsed or refractory|relapsed or refractory
5032894|NCT03793478|FMS-like tyrosine kinase 3 positive|fms-like tyrosine kinase 3 positive
5032895|NCT03793478|Cancer of the blood|cancer of the blood
5032896|NCT03793478|AML|aml
5032897|NCT03793478|FLT3-ITD mutation|flt3-itd mutation
5032898|NCT03793452|COPD, pulmonary rehabilitation, fear of falling, evaluation|copd, pulmonary rehabilitation, fear of falling, evaluation
5032899|NCT03793439|Sarcoidosis|sarcoidosis
5032900|NCT03793439|Corticosteroid dependent sarcoidosis|corticosteroid dependent sarcoidosis
5032901|NCT03793413|tongue tie|tongue tie
5032902|NCT03793413|ankyloglossia|ankyloglossia
5032906|NCT03793400|multifocal choroidits|multifocal choroidits
5032907|NCT03793400|choroidal neovascularization|choroidal neovascularization
5032908|NCT03793400|anti-VEGF|anti-vegf
5032909|NCT03793400|long-term outcome|long-term outcome
5032910|NCT03793374|Axillary osmidrosis|axillary osmidrosis
5032911|NCT03793374|Surgery|surgery
5032912|NCT03793374|Cartilage shaver|cartilage shaver
5032913|NCT03793348|facial wrinkles|facial wrinkles
5032914|NCT03793348|skin laxity|skin laxity
5032915|NCT03793348|sagging skin|sagging skin
5032916|NCT03793322|Hepatocellular Carcinoma|hepatocellular carcinoma
5032917|NCT03793322|Indocyanine-Green(ICG)|indocyanine-green(icg)
5032918|NCT03793296|Paravalvular leak|paravalvular leak
5032919|NCT03793270|Rheumatoid arthritis RA - B cells (B Lymphocyte).|rheumatoid arthritis ra - b cells (b lymphocyte).
5032920|NCT03793257|Intensive Care|intensive care
5032921|NCT03793257|Critical Care|critical care
5032922|NCT03793257|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5032923|NCT03793257|Extracorporeal Life Support|extracorporeal life support
5032924|NCT03793231|Fungal infections|fungal infections
5032925|NCT03793231|Deep learning|deep learning
5032926|NCT03793231|Electronic surveillance|electronic surveillance
5032927|NCT03793231|Antifungal stewardship|antifungal stewardship
5032928|NCT03793231|Image classification|image classification
5032929|NCT03793140|Burkitt Lymphoma/Leukemia|burkitt lymphoma/leukemia
5032930|NCT03793140|high-grade B-cell lymphoma|high-grade b-cell lymphoma
5032931|NCT03793140|CPI-613|cpi-613
5032932|NCT03793101|BiMICS, biaxial cataract surgery, SIA,diabetes mellitus,|bimics, biaxial cataract surgery, sia,diabetes mellitus,
5450344|NCT01501435|Safety|safety
5032933|NCT03793088|Glioblastoma|glioblastoma
5032934|NCT03793088|Glioma|glioma
5032935|NCT03793088|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5032936|NCT03793062|genome|genome
5032937|NCT03793062|epigenome|epigenome
5032938|NCT03793062|chronic wounds|chronic wounds
5032939|NCT03793062|genetics|genetics
5032940|NCT03793049|acoustic|acoustic
5032941|NCT03793049|ECG|ecg
5032942|NCT03793036|fasting|fasting
5032943|NCT03793036|carbohydrate|carbohydrate
5032944|NCT03793036|insulin resistance|insulin resistance
5032945|NCT03793010|Osteoarthritis|osteoarthritis
5032946|NCT03793010|Hip|hip
5032947|NCT03793010|Pain|pain
5032948|NCT03793010|Intra-articular|intra-articular
5032949|NCT03793010|Injection|injection
5032950|NCT03792984|Polycystic Ovary Syndrome|polycystic ovary syndrome
5032951|NCT03792984|Calcium|calcium
5032952|NCT03792984|Vitamin D|vitamin d
5032953|NCT03792984|Metformin|metformin
5032954|NCT03792945|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5032955|NCT03792945|corticosteroid injection|corticosteroid injection
5032956|NCT03792893|Cardiovascular parameters|cardiovascular parameters
5032957|NCT03792893|Blood Pressure|blood pressure
5032958|NCT03792893|Pulse Wave|pulse wave
5032959|NCT03792893|Ergometry|ergometry
5032960|NCT03792893|Somnotouch|somnotouch
5032961|NCT03792893|BOSO-TM-2430|boso-tm-2430
5032962|NCT03792880|CPAP treatment|cpap treatment
5032963|NCT03792880|Self-management|self-management
5032964|NCT03792854|anal cancer|anal cancer
5032965|NCT03792854|quality of life|quality of life
5032968|NCT03792841|HLE-BiTE®|hle-bite®
5032969|NCT03792841|mCRPC|mcrpc
5032970|NCT03792841|Metastatic Castration-resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5032971|NCT03792841|Prostate cancer|prostate cancer
5032972|NCT03792841|PSMA|psma
5032973|NCT03792841|BiTE®|bite®
5032974|NCT03792841|Bispecific T-Cell engager|bispecific t-cell engager
5032975|NCT03792841|Immunotherapy|immunotherapy
5032976|NCT03792841|Immuno-oncology|immuno-oncology
5032977|NCT03792841|Immunooncology|immunooncology
5032978|NCT03792841|Solid tumor|solid tumor
5032979|NCT03792841|PSMA Targeted Therapy|psma targeted therapy
5032980|NCT03792828|total knee replacement arthroplasty|total knee replacement arthroplasty
5032981|NCT03792828|total knee arthroplasty|total knee arthroplasty
5032982|NCT03792828|central censitization|central censitization
5032983|NCT03792828|duloxetine|duloxetine
5032985|NCT03792828|pre-emptive effect|pre-emptive effect
5032986|NCT03792815|Transplantation Conditioning|transplantation conditioning
5032987|NCT03792802|dermatome|dermatome
5032988|NCT03792802|laparoscopic appendectomy|laparoscopic appendectomy
5032989|NCT03792789|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5032990|NCT03792789|modified Constraint Induced Movement Therapy (mCIMT)|modified constraint induced movement therapy (mcimt)
5032991|NCT03792776|Lidocaine 1%|lidocaine 1%
5032992|NCT03792776|Lidocaine 2%|lidocaine 2%
5032993|NCT03792776|Endotracheal tube cuff|endotracheal tube cuff
5032994|NCT03792776|Cuff inflation|cuff inflation
5032995|NCT03792776|Postoperative sore throat|postoperative sore throat
5032996|NCT03792776|Postoperative cough|postoperative cough
5032997|NCT03792776|General anesthesia|general anesthesia
5032998|NCT03792776|Endotracheal intubation|endotracheal intubation
5032999|NCT03792763|early multiple myeloma|early multiple myeloma
5033005|NCT03792698|Lung Transplantation|lung transplantation
5033007|NCT03792698|Readmisson|readmisson
5033008|NCT03792698|Physical Therapy|physical therapy
5033009|NCT03792698|Personalized|personalized
5033010|NCT03792672|Drug Therapy|drug therapy
5033011|NCT03792646|Supplementary Feeding|supplementary feeding
5033012|NCT03792646|Protein|protein
5033013|NCT03792646|Muscle strenght|muscle strenght
5033014|NCT03792646|Exercise|exercise
5033015|NCT03792646|Aged|aged
5033016|NCT03792620|multiple myeloma|multiple myeloma
5033017|NCT03792607|Network medicine|network medicine
5033018|NCT03792607|Epigenetics|epigenetics
5033019|NCT03792607|Diabetes|diabetes
5033020|NCT03792607|Cardiovascular risk|cardiovascular risk
5033021|NCT03792594|Bone Marrow|bone marrow
5033022|NCT03792594|Mesenchymal Stromal Cells|mesenchymal stromal cells
5033023|NCT03792594|Rotator Cuff Tear|rotator cuff tear
5033024|NCT03792568|ALK mutation|alk mutation
5033025|NCT03792568|ALK inhibitor|alk inhibitor
5033026|NCT03792568|Metastatic Colorectal Cancer|metastatic colorectal cancer
5033030|NCT03792529|Targeted Therapy|targeted therapy
5033031|NCT03792529|Molecular Screening|molecular screening
5033032|NCT03792516|artesunate|artesunate
5033033|NCT03792516|pre-invasive disease|pre-invasive disease
5033034|NCT03792516|treatment|treatment
5033035|NCT03792516|alternative|alternative
5033036|NCT03792516|non-surgical|non-surgical
5033037|NCT03792516|cancer prevention|cancer prevention
5033038|NCT03792490|Motor neuron disease|motor neuron disease
5033039|NCT03792490|Neurodegenerative disease|neurodegenerative disease
5033040|NCT03792412|bariatric surgery|bariatric surgery
5033041|NCT03792412|lifelong follow-up|lifelong follow-up
5033042|NCT03792412|primary care|primary care
5450486|NCT01500824|ALK|alk
5033044|NCT03792412|health care study|health care study
5033045|NCT03792399|continuous glucose monitoring|continuous glucose monitoring
5033046|NCT03792399|immediate feedback counseling|immediate feedback counseling
5033047|NCT03792399|delayed feedback counseling|delayed feedback counseling
5033048|NCT03792347|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5033049|NCT03792347|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5033050|NCT03792347|pembrolizumab|pembrolizumab
5033051|NCT03792347|immune therapy|immune therapy
5033052|NCT03792347|checkpoint inhibitor|checkpoint inhibitor
5033053|NCT03792321|testosterone|testosterone
5033054|NCT03792321|hypogonadism|hypogonadism
5033055|NCT03792321|diabetes mellitus|diabetes mellitus
5033056|NCT03792321|visceral obesity|visceral obesity
5033057|NCT03792321|insulin resistance|insulin resistance
5033058|NCT03792321|metabolic syndrome|metabolic syndrome
5033059|NCT03792321|NAFLD|nafld
5033060|NCT03792321|endothelial function|endothelial function
5033061|NCT03792308|Safety|safety
5033556|NCT03789357|Arrhythmia|arrhythmia
5033065|NCT03792282|Polycystic Ovary Syndrome|polycystic ovary syndrome
5033066|NCT03792282|Overweight and Obesity|overweight and obesity
5033067|NCT03792282|Time-Restricted Feeding|time-restricted feeding
5033068|NCT03792282|Intermittent fasting regimens|intermittent fasting regimens
5033069|NCT03792230|Lumbar disc hernia surgery|lumbar disc hernia surgery
5033070|NCT03792230|Body mechanics|body mechanics
5033071|NCT03792230|Patient education|patient education
5033072|NCT03792230|Quality of life|quality of life
5033073|NCT03792230|Disability|disability
5033074|NCT03792230|Pain|pain
5033075|NCT03792230|Nursing|nursing
5033076|NCT03792204|wearing off|wearing off
5033077|NCT03792204|wearing-off 9 questionnaire|wearing-off 9 questionnaire
5033078|NCT03792204|prevalence|prevalence
5033079|NCT03792204|sensitivity|sensitivity
5033080|NCT03792204|specificity|specificity
5033081|NCT03792178|Post operative sensitivity|post operative sensitivity
5342389|NCT01983735|Hypertension|hypertension
5033082|NCT03792152|Atrial Fibrillation|atrial fibrillation
5033083|NCT03792152|Left Atrial Appendage Thrombosis|left atrial appendage thrombosis
5033084|NCT03792152|rivaroxaban|rivaroxaban
5033085|NCT03792100|SmofKabiven|smofkabiven
5033086|NCT03792100|Abdominal surgery|abdominal surgery
5033087|NCT03792100|Parenteral|parenteral
5033088|NCT03792100|Nutrition|nutrition
5033089|NCT03792087|SmofKabiven|smofkabiven
5033090|NCT03792087|Nutrition|nutrition
5033091|NCT03792087|Parenteral|parenteral
5033092|NCT03792087|Abdominal surgery|abdominal surgery
5033093|NCT03792048|bilioenteric anastomosis|bilioenteric anastomosis
5033094|NCT03792048|pancreaticojejunostomy|pancreaticojejunostomy
5033095|NCT03792048|Magnetic Compressive|magnetic compressive
5033096|NCT03791996|Cranioplasty|cranioplasty
5033097|NCT03791996|Craniectomy|craniectomy
5033120|NCT03791853|Dynamic cell imaging|dynamic cell imaging
5033121|NCT03791840|breast neoplasms|breast neoplasms
5033122|NCT03791840|Ultrasonography, Interventional|ultrasonography, interventional
5033123|NCT03791840|Biopsy, Large-Core Needle|biopsy, large-core needle
5033124|NCT03791840|Biopsy, Fine-Needle|biopsy, fine-needle
5033128|NCT03791801|sugammadex|sugammadex
5033129|NCT03791801|rocuronium|rocuronium
5033130|NCT03791801|critically ill|critically ill
5033131|NCT03791788|Stable angina|stable angina
5033132|NCT03791788|Acute Myocardial Infarction|acute myocardial infarction
5033133|NCT03791788|Fractional Flow Reserve|fractional flow reserve
5033134|NCT03791788|Quantitative Flow Ratio|quantitative flow ratio
5033135|NCT03791775|Hemorrhoids|hemorrhoids
5033136|NCT03791775|Sclerotherapy|sclerotherapy
5033137|NCT03791775|Polidocanol 3%|polidocanol 3%
5033138|NCT03791775|Non-surgical treatments|non-surgical treatments
5033139|NCT03791762|postoperative pain|postoperative pain
5033140|NCT03791762|WaveOne Gold|waveone gold
5033141|NCT03791762|Reciproc Blue|reciproc blue
5033142|NCT03791762|ProTaper Next|protaper next
5033143|NCT03791749|breastfeeding|breastfeeding
5033144|NCT03791749|postnatal mental health|postnatal mental health
5033145|NCT03791749|breastfeeding support|breastfeeding support
5033146|NCT03791749|stress|stress
5033147|NCT03791749|late preterm infant|late preterm infant
5033148|NCT03791749|breast milk|breast milk
5033149|NCT03791736|breast cancer|breast cancer
5033150|NCT03791736|axillary clearance|axillary clearance
5033151|NCT03791736|lymphocele|lymphocele
5033152|NCT03791723|Atrial Fibrillation|atrial fibrillation
5033153|NCT03791723|Cardiac Remodeling|cardiac remodeling
5033154|NCT03791723|Sacubitril/Valsartan|sacubitril/valsartan
5033155|NCT03791697|Postoperative patient satisfaction|postoperative patient satisfaction
5033156|NCT03791671|Balance training|balance training
5033157|NCT03791671|Gait Speed|gait speed
5033158|NCT03791658|TAI|tai
5033159|NCT03791658|Test for the Adherence to Inhalers|test for the adherence to inhalers
5033160|NCT03791580|Polypharmacy|polypharmacy
5033161|NCT03791580|Primary Health Care|primary health care
5033162|NCT03791580|Economics, Behavioral|economics, behavioral
5033163|NCT03791580|Deprescriptions|deprescriptions
5033164|NCT03791580|Decision Support Systems, Clinical|decision support systems, clinical
5033165|NCT03791580|Electronic Health Records|electronic health records
5346968|NCT01963611|Copaxone|copaxone
5033166|NCT03791580|Geriatrics|geriatrics
5033167|NCT03791567|Type 1|type 1
5033168|NCT03791567|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5033169|NCT03791567|Islets of Langerhans Transplantation|islets of langerhans transplantation
5033170|NCT03791567|Allogeneic Islet transplantation|allogeneic islet transplantation
5033171|NCT03791554|tunneling|tunneling
5033172|NCT03791554|laterally closed tunnel|laterally closed tunnel
5033173|NCT03791554|gingival recession|gingival recession
5033174|NCT03791554|recession type 2|recession type 2
5033175|NCT03791541|Readmissions|readmissions
5033178|NCT03791528|Kinesio Taping Treatment|kinesio taping treatment
5033179|NCT03791502|Exercise Movement Techniques|exercise movement techniques
5033181|NCT03791502|Muscular Strength|muscular strength
5033182|NCT03791502|Postural Balance|postural balance
5033186|NCT03791437|digital chest tube system, shorten hospital stay|digital chest tube system, shorten hospital stay
5033188|NCT03791424|midazolam|midazolam
5033189|NCT03791424|skin resistance|skin resistance
5033190|NCT03791424|measurements|measurements
5033191|NCT03791411|Clinical Narratives|clinical narratives
5033192|NCT03791411|Respect|respect
5033193|NCT03791411|Intentional presence|intentional presence
5033194|NCT03791411|knowing the person|knowing the person
5033195|NCT03791411|Professional development|professional development
5033196|NCT03791398|Metastatic|metastatic
5033197|NCT03791398|colorectal cancer|colorectal cancer
5033198|NCT03791398|colon cancer|colon cancer
5033199|NCT03791398|microsatellite stable|microsatellite stable
5033200|NCT03791385|Autism Spectrum Disorder|autism spectrum disorder
5033201|NCT03791385|Picture Exchange Communication System (PECS)|picture exchange communication system (pecs)
5033202|NCT03791385|Tooth-brushing program|tooth-brushing program
5033203|NCT03791385|Gingival index|gingival index
5033204|NCT03791385|Plaque index|plaque index
5033205|NCT03791372|Cerebral palsy|cerebral palsy
5033206|NCT03791372|Autologous Umbilical Cord Blood|autologous umbilical cord blood
5033207|NCT03791372|safety|safety
5033208|NCT03791372|effect|effect
5033209|NCT03791359|Out- of- Hospital Cardiac Arrest|out- of- hospital cardiac arrest
5033210|NCT03791346|neuroendocrine tumor|neuroendocrine tumor
5033211|NCT03791346|Survival|survival
5033212|NCT03791346|WHO 2017 grading system|who 2017 grading system
5033213|NCT03791346|pancreatectomy|pancreatectomy
5033214|NCT03791346|Laparoscopy|laparoscopy
5033215|NCT03791346|Postoperative outcomes|postoperative outcomes
5033216|NCT03791320|Fractional Flow Reserve|fractional flow reserve
5033217|NCT03791320|Coronary Physiology|coronary physiology
5033218|NCT03791320|3D-QCA|3d-qca
5033219|NCT03791320|Percutaneous coronary intervention|percutaneous coronary intervention
5033220|NCT03791307|Pilates method|pilates method
5033221|NCT03791307|Blood pressure|blood pressure
5033222|NCT03791307|Autonomic heart rate modulation|autonomic heart rate modulation
5033223|NCT03791281|pre-implementation intervention|pre-implementation intervention
5033224|NCT03791281|implementation strategy|implementation strategy
5033225|NCT03791281|individual-level barriers|individual-level barriers
5033226|NCT03791268|Stomach Adenocarcinoma|stomach adenocarcinoma
5033227|NCT03791268|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5033228|NCT03791255|resin modified calcium silicate|resin modified calcium silicate
5033229|NCT03791255|indirect pulp treatment|indirect pulp treatment
5033230|NCT03791255|primary molars|primary molars
5033231|NCT03791229|Appendectomy|appendectomy
5033232|NCT03791229|Chronic abdominal pain|chronic abdominal pain
5033233|NCT03791229|Discomfort|discomfort
5033234|NCT03791229|Numerical rating scale|numerical rating scale
5033235|NCT03791229|Pediatric quality of life inventory|pediatric quality of life inventory
5033236|NCT03791203|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5033237|NCT03791190|CRRT|crrt
5033238|NCT03791190|liver failure|liver failure
5033239|NCT03791190|filter lifespan|filter lifespan
5033240|NCT03791190|bleeding|bleeding
5033241|NCT03791177|Music|music
5033242|NCT03791151|Pharmacogenetics|pharmacogenetics
5033243|NCT03791151|Lung cancer|lung cancer
5033244|NCT03791151|Cisplatin|cisplatin
5033245|NCT03791138|breast reconstruction|breast reconstruction
5033246|NCT03791138|patient decision aid|patient decision aid
5033247|NCT03791138|decisional conflict|decisional conflict
5033248|NCT03791138|randomized controlled trial|randomized controlled trial
5033249|NCT03791099|Periodontitis treatment|periodontitis treatment
5033250|NCT03791099|Periodonal pockets|periodonal pockets
5033251|NCT03791099|local delivery drugs|local delivery drugs
5033252|NCT03791073|Biomarker discovery|biomarker discovery
5033253|NCT03791073|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5033254|NCT03791073|Bioinformatics|bioinformatics
5033255|NCT03791073|pancreatic cancer|pancreatic cancer
5033258|NCT03791073|transcriptomics|transcriptomics
5033259|NCT03791073|metabolomics|metabolomics
5033260|NCT03791073|diagnosis|diagnosis
5033261|NCT03791073|Prognosis|prognosis
5033262|NCT03791060|Necrobiosis lipoidica|necrobiosis lipoidica
5033264|NCT03791047|Balance|balance
5033265|NCT03791047|Postural control|postural control
5033266|NCT03791047|Muscle|muscle
5033267|NCT03791047|Older adults|older adults
5347068|NCT01963065|NICU|nicu
5033268|NCT03791034|Non-small cell lung cancer|non-small cell lung cancer
5033269|NCT03791034|Recurrence|recurrence
5033270|NCT03791034|cfDNA|cfdna
5033271|NCT03791021|postpartum, depression, self portraits|postpartum, depression, self portraits
5033272|NCT03791008|Personalized|personalized
5033273|NCT03791008|Early detection|early detection
5033274|NCT03791008|Screening|screening
5033275|NCT03791008|Feasibility|feasibility
5033276|NCT03791008|Acceptability|acceptability
5033277|NCT03790995|Prostate cancer|prostate cancer
5033278|NCT03790995|Robot assisted radical prostatectomy|robot assisted radical prostatectomy
5033279|NCT03790995|RALP|ralp
5033280|NCT03790995|RARP|rarp
5033281|NCT03790995|High risk|high risk
5033282|NCT03790995|Intermediate risk|intermediate risk
5033283|NCT03790995|Low risk|low risk
5033284|NCT03790995|Urinary|urinary
5033285|NCT03790995|Erectile|erectile
5033286|NCT03790995|Quality of life|quality of life
5033288|NCT03790995|Post operation|post operation
5033289|NCT03790995|functional outcomes|functional outcomes
5033290|NCT03790995|follow-up|follow-up
5033291|NCT03790982|AD-35 tablet|ad-35 tablet
5033292|NCT03790982|Alzheimer's Disease|alzheimer's disease
5033293|NCT03790982|Phase II study|phase ii study
5033294|NCT03790969|steroid injection|steroid injection
5033295|NCT03790969|pain|pain
5033296|NCT03790969|needle gauge|needle gauge
5033297|NCT03790969|trigger finger|trigger finger
5033298|NCT03790956|vocal fold paralysis|vocal fold paralysis
5033299|NCT03790956|glottal insufficiency|glottal insufficiency
5033300|NCT03790956|vocal fold injection|vocal fold injection
5033301|NCT03790956|augmentation|augmentation
5033302|NCT03790956|medialization|medialization
5033303|NCT03790956|laryngoplasty|laryngoplasty
5033304|NCT03790956|silk|silk
5033305|NCT03790943|Childhood cancer survivors|childhood cancer survivors
5033306|NCT03790943|Late effects|late effects
5033307|NCT03790943|Cardiotoxicity|cardiotoxicity
5033308|NCT03790943|Chemotherapy|chemotherapy
5033309|NCT03790943|Anthracyclines|anthracyclines
5033310|NCT03790943|Radiation|radiation
5033311|NCT03790917|adherence|adherence
5033312|NCT03790917|new oral anticoagulants (NOACs)|new oral anticoagulants (noacs)
5033314|NCT03790904|Dental plaque,|dental plaque,
5033315|NCT03790904|Tea|tea
5033316|NCT03790904|Salvadora|salvadora
5033317|NCT03790904|Mouthwash|mouthwash
5033318|NCT03790904|Clinical trial|clinical trial
5033319|NCT03790891|CAR-T|car-t
5033320|NCT03790891|TriCAR-T|tricar-t
5033321|NCT03790891|CD19-TriCAR-T|cd19-tricar-t
5033322|NCT03790891|CD19-TriCAR-SILK|cd19-tricar-silk
5033323|NCT03790891|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5033324|NCT03790878|Emotion Dysregulation|emotion dysregulation
5033325|NCT03790878|Empathy|empathy
5033326|NCT03790878|Emotion Perception|emotion perception
5033329|NCT03790852|DME|dme
5033330|NCT03790852|wAMD|wamd
5033331|NCT03790852|RVO|rvo
5033332|NCT03790852|KSI-301|ksi-301
5033333|NCT03790852|Kodiak|kodiak
5033334|NCT03790826|bladder mucosal trauma|bladder mucosal trauma
5033335|NCT03790800|stroke|stroke
5033336|NCT03790800|blood pressure control|blood pressure control
5033337|NCT03790800|hypertension|hypertension
5033338|NCT03790800|clinical trial|clinical trial
5033339|NCT03790800|ambulances|ambulances
5033340|NCT03790761|Guam|guam
5033341|NCT03790761|healthy relationships|healthy relationships
5033342|NCT03790761|non-profit organization|non-profit organization
5033343|NCT03790761|PREP 8.0 curriculum|prep 8.0 curriculum
5033344|NCT03790735|pulmonary nodule|pulmonary nodule
5033345|NCT03790722|Cardiovascular parameters|cardiovascular parameters
5033346|NCT03790722|Blood Pressure|blood pressure
5033347|NCT03790722|Pulse Wave|pulse wave
5033348|NCT03790722|Ergometry|ergometry
5033349|NCT03790722|MobiloGraph|mobilograph
5033350|NCT03790722|Somnotouch|somnotouch
5033351|NCT03790683|intraoperative hypothermia|intraoperative hypothermia
5033352|NCT03790683|inadvertent hypothermia|inadvertent hypothermia
5033353|NCT03790683|perioperative hypothermia|perioperative hypothermia
5033354|NCT03790657|aging|aging
5033355|NCT03790657|walking|walking
5033356|NCT03790657|brain|brain
5033357|NCT03790657|electrical stimulation|electrical stimulation
5033358|NCT03790644|Walking|walking
5033359|NCT03790644|Exoskeleton Device|exoskeleton device
5033360|NCT03790605|periodontitis, 1% curcumin chips, host modulation therapy, anti inflammatory effect, interleukin 1 beta|periodontitis, 1% curcumin chips, host modulation therapy, anti inflammatory effect, interleukin 1 beta
5033361|NCT03790579|Gestational diabetes mellitus|gestational diabetes mellitus
5033368|NCT03790566|transversus abdominus plane block|transversus abdominus plane block
5033369|NCT03790566|flank incision|flank incision
5033370|NCT03790566|post-op analgesia|post-op analgesia
5033371|NCT03790566|peri-op analgesia|peri-op analgesia
5033372|NCT03790553|chemoradiotherapy|chemoradiotherapy
5033373|NCT03790553|esophageal cancer|esophageal cancer
5033374|NCT03790553|PET/CT|pet/ct
5033375|NCT03790540|DentalVibe|dentalvibe
5033376|NCT03790540|Mandibular nerve block injection|mandibular nerve block injection
5033377|NCT03790540|Consolability Scale|consolability scale
5033378|NCT03790514|Heat wrap|heat wrap
5033379|NCT03790488|Solid Tumor Malignancies|solid tumor malignancies
5033380|NCT03790488|JTX-4014|jtx-4014
5033381|NCT03790488|Monoclonal Antibody (mAb)|monoclonal antibody (mab)
5033382|NCT03790488|Programmed Cell Death Receptor-1 (PD-1)|programmed cell death receptor-1 (pd-1)
5033383|NCT03790488|Immunotherapy|immunotherapy
5033384|NCT03790488|Immuno-oncology|immuno-oncology
5033385|NCT03790488|Dose Escalation|dose escalation
5033386|NCT03790475|Colorectal Cancer Screening|colorectal cancer screening
5033409|NCT03790332|Imbruvica|imbruvica
5033410|NCT03790332|Ibrutinib|ibrutinib
5033411|NCT03790332|Immunology|immunology
5033412|NCT03790332|graft versus host disease|graft versus host disease
5033413|NCT03790332|corticosteroids|corticosteroids
5033414|NCT03790332|prednisone|prednisone
5033415|NCT03790332|PCI32765|pci32765
5033416|NCT03790332|PCYC1146|pcyc1146
5033417|NCT03790332|refractory|refractory
5033418|NCT03790332|new onset graft versus host disease|new onset graft versus host disease
5033419|NCT03790332|refractory graft versus host disease|refractory graft versus host disease
5033420|NCT03790332|moderate cGVHD|moderate cgvhd
5033421|NCT03790332|severe cGVHD|severe cgvhd
5033422|NCT03790332|moderate chronic graft versus host disease|moderate chronic graft versus host disease
5033423|NCT03790332|severe chronic graft versus host disease|severe chronic graft versus host disease
5033424|NCT03790319|Stress|stress
5033425|NCT03790319|Emotion|emotion
5033426|NCT03790254|recurrent urinary tract infections|recurrent urinary tract infections
5033427|NCT03790254|d mannose prophylaxis|d mannose prophylaxis
5033428|NCT03790254|antibiotic prophylaxis|antibiotic prophylaxis
5033429|NCT03790241|catheter insertion|catheter insertion
5033430|NCT03790241|puncture|puncture
5033431|NCT03790241|skin|skin
5033432|NCT03790241|vein|vein
5033433|NCT03790241|palpation|palpation
5033434|NCT03790241|motion tracking|motion tracking
5033435|NCT03790228|Advanced nonsquamous Non-Small Cell Lung Cancer|advanced nonsquamous non-small cell lung cancer
5356788|NCT01918007|Signs and Symptoms, Respiratory Signs and Symptoms|signs and symptoms, respiratory signs and symptoms
5033436|NCT03790228|Anlotinib Combined With Pemetrexed and Carboplatin as the First-line|anlotinib combined with pemetrexed and carboplatin as the first-line
5033437|NCT03790202|wound|wound
5033438|NCT03790202|VistaCare|vistacare
5033439|NCT03790202|wound healing|wound healing
5033440|NCT03790202|controlled atmosphere|controlled atmosphere
5033441|NCT03790189|knee|knee
5033442|NCT03790189|unicompartmental osteoarthritis|unicompartmental osteoarthritis
5033443|NCT03790189|injection|injection
5033444|NCT03790189|subchondroplasty|subchondroplasty
5033445|NCT03790189|bone marrow concentrate|bone marrow concentrate
5033446|NCT03790189|mesenchymal stem cells|mesenchymal stem cells
5033447|NCT03790163|levobupivacaine,spinal anesthesia ,temperature|levobupivacaine,spinal anesthesia ,temperature
5033453|NCT03790137|Sunflower Syndrome|sunflower syndrome
5033454|NCT03790137|Epilepsy|epilepsy
5033455|NCT03790085|Precision medicine|precision medicine
5033456|NCT03790085|Bio-marker|bio-marker
5033457|NCT03790085|Neuroimaging|neuroimaging
5033464|NCT03790059|hepatocellular carcinoma|hepatocellular carcinoma
5033465|NCT03790059|recombinant human adenovirus type 5 injection|recombinant human adenovirus type 5 injection
5033466|NCT03790033|Cold Hypersensitivity|cold hypersensitivity
5033467|NCT03790033|Korean medicine|korean medicine
5033468|NCT03790033|Ucha-Shinki-Hwan|ucha-shinki-hwan
5033469|NCT03790020|acute appendicitis|acute appendicitis
5033470|NCT03790020|postoperative pain relief|postoperative pain relief
5033471|NCT03790020|local anesthetic|local anesthetic
5033472|NCT03790020|laparoscopic appendectomy|laparoscopic appendectomy
5033473|NCT03790007|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5033474|NCT03790007|postoperative pain relief|postoperative pain relief
5033475|NCT03790007|local anesthetic|local anesthetic
5033476|NCT03789994|Family caregiver|family caregiver
5033477|NCT03789994|attachment security|attachment security
5033478|NCT03789994|affective touch|affective touch
5033479|NCT03789994|self-esteem|self-esteem
5033480|NCT03789994|family harmony|family harmony
5033482|NCT03789981|Acute Myeloid Leukemia|acute myeloid leukemia
5033483|NCT03789981|Immunogenic profile|immunogenic profile
5033484|NCT03789981|transcriptome analysis|transcriptome analysis
5033485|NCT03789955|Fluoroscopy|fluoroscopy
5033486|NCT03789955|Contralateral Oblique View|contralateral oblique view
5033487|NCT03789955|Thoracic epidural block|thoracic epidural block
5047324|NCT03703635|Ischemic Stroke|ischemic stroke
5033489|NCT03789929|Stress|stress
5033490|NCT03789929|Emotion|emotion
5033491|NCT03789916|coronary artery bypass grafting|coronary artery bypass grafting
5033492|NCT03789916|incomplete revascularization|incomplete revascularization
5033493|NCT03789916|coronary artery disease|coronary artery disease
5033494|NCT03789916|dual antiplatelet therapy|dual antiplatelet therapy
5033495|NCT03789890|Drug-drug interaction|drug-drug interaction
5033496|NCT03789890|Itraconazole (ITZ)|itraconazole (itz)
5033497|NCT03789890|Cytochrom P450 3A4 (CYP3A4) metabolism|cytochrom p450 3a4 (cyp3a4) metabolism
5033498|NCT03789890|P2X3-inhibitor|p2x3-inhibitor
5033499|NCT03789864|Lymphoma|lymphoma
5033500|NCT03789786|Selective Dorsal Rhizotomy|selective dorsal rhizotomy
5033502|NCT03789760|Vascular Dementia|vascular dementia
5033503|NCT03789760|cognitive|cognitive
5033508|NCT03789656|Acromegaly|acromegaly
5033509|NCT03789656|ACROBAT|acrobat
5033510|NCT03789656|EDGE|edge
5033511|NCT03789643|JTT-251|jtt-251
5033512|NCT03789643|Pulmonary arterial hypertension|pulmonary arterial hypertension
5033513|NCT03789643|RELIEF-PAH|relief-pah
5033514|NCT03789643|Six-minute walk distance (6MWD)|six-minute walk distance (6mwd)
5033515|NCT03789630|Knee Replacement|knee replacement
5033516|NCT03789630|Wearable|wearable
5033517|NCT03789630|Pain Score Quantification|pain score quantification
5033518|NCT03789617|Cytotoxic T cell|cytotoxic t cell
5033519|NCT03789617|Lymphoma|lymphoma
5033520|NCT03789617|Immuno-oncology|immuno-oncology
5033521|NCT03789617|ENKTL|enktl
5033522|NCT03789617|EBViNT|ebvint
5033527|NCT03789565|periodontal diseases|periodontal diseases
5033528|NCT03789565|hepcidin|hepcidin
5033529|NCT03789565|elisa|elisa
5033530|NCT03789565|interleukin 6|interleukin 6
5033531|NCT03789565|interleukin 10|interleukin 10
5033532|NCT03789552|angina pectoris|angina pectoris
5033533|NCT03789539|Safety|safety
5033534|NCT03789539|Reactogenicity|reactogenicity
5033535|NCT03789539|Universal Influenza Vaccine|universal influenza vaccine
5033536|NCT03789526|Tenosynovitis|tenosynovitis
5033537|NCT03789526|ultrasound|ultrasound
5033538|NCT03789526|diabetes mellitus|diabetes mellitus
5033539|NCT03789513|HIV infection, HPV infection, cervical cancer, screening algorithms|hiv infection, hpv infection, cervical cancer, screening algorithms
5033540|NCT03789487|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5033541|NCT03789487|Non-responders|non-responders
5033542|NCT03789487|Pacing vector optimization|pacing vector optimization
5033543|NCT03789487|Atrioventricular delay optimization|atrioventricular delay optimization
5033544|NCT03789487|Non invasive hemodynamic optimization|non invasive hemodynamic optimization
5033545|NCT03789487|Heart Failure|heart failure
5033546|NCT03789461|Fecal Microbiota Transplantation|fecal microbiota transplantation
5033547|NCT03789461|FMT|fmt
5033548|NCT03789448|Antiretroviral Treatment|antiretroviral treatment
5033549|NCT03789396|Oxygenation|oxygenation
5033550|NCT03789396|Hypoxia|hypoxia
5033551|NCT03789396|Normoxia|normoxia
5033552|NCT03789396|Hyperoxia|hyperoxia
5033553|NCT03789396|Trauma|trauma
5033554|NCT03789396|Critical Illness|critical illness
5033555|NCT03789357|Hypertension|hypertension
5033561|NCT03789331|anogenital distance|anogenital distance
5033562|NCT03789305|Early Mobilization|early mobilization
5033563|NCT03789305|Early Rehabilitation|early rehabilitation
5033564|NCT03789305|Functional Status|functional status
5033565|NCT03789305|Functional Outcome|functional outcome
5033566|NCT03789305|Patient Outcome|patient outcome
5033567|NCT03789305|Intensive Care|intensive care
5033568|NCT03789305|Critical Care Outcomes|critical care outcomes
5033569|NCT03789279|Invasive coronary angiography|invasive coronary angiography
5033570|NCT03789279|Distal transradial arterial access|distal transradial arterial access
5033571|NCT03789279|Anatomical snuffbox|anatomical snuffbox
5033572|NCT03789279|dTRA|dtra
5033573|NCT03789279|dRA|dra
5033574|NCT03789279|Distal radial|distal radial
5033575|NCT03789279|Radial artery occlusion|radial artery occlusion
5033576|NCT03789253|active surveillance, microarray, latent, GSEA, latent|active surveillance, microarray, latent, gsea, latent
5033577|NCT03789240|BAY 80-6946|bay 80-6946
5033578|NCT03789240|PI3K Target|pi3k target
5033579|NCT03789240|Aliqopa|aliqopa
5033580|NCT03789240|Monoclonal Antibody|monoclonal antibody
5033586|NCT03789188|Inflammation|inflammation
5033587|NCT03789188|Nutrition|nutrition
5033588|NCT03789188|Shift Work|shift work
5033589|NCT03789188|Sleep|sleep
5033590|NCT03789188|Cognitive Performance|cognitive performance
5033591|NCT03789175|Oxidative Phosphorylation Capacity|oxidative phosphorylation capacity
5033592|NCT03789175|Increased Oxidative Metabolism|increased oxidative metabolism
5033593|NCT03789175|Regeneration of Phosphocreatine( PCr)|regeneration of phosphocreatine( pcr)
5033594|NCT03789175|Inherited Mutation of TP53 Tumor Supressor Gene|inherited mutation of tp53 tumor supressor gene
5033617|NCT03789019|Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic acids derived from lignin|cis-coordinated complexes of platinum(ii) with polymer of benzene polycarboxylic acids derived from lignin
5033618|NCT03789019|Benzene polycarboxylic acids complex with cis-diammineplatinum( II)|benzene polycarboxylic acids complex with cis-diammineplatinum( ii)
5033619|NCT03789019|Metastatic Breast Cancer|metastatic breast cancer
5033620|NCT03789019|Platinum analogue|platinum analogue
5033621|NCT03789019|Metronomic chemotherapy|metronomic chemotherapy
5033622|NCT03789019|Breast cancer|breast cancer
5033623|NCT03789019|Cisplatin|cisplatin
5033624|NCT03789019|cis-diammineplatinum(II) complexed with a polymer containing benzene polycarboxylic acids derived from lignin|cis-diammineplatinum(ii) complexed with a polymer containing benzene polycarboxylic acids derived from lignin
5033625|NCT03788993|Phototherapy|phototherapy
5033626|NCT03788993|Hospitals, psychiatric|hospitals, psychiatric
5033627|NCT03788993|Emergency Services, Psychiatric|emergency services, psychiatric
5033628|NCT03788980|Endarterectomy|endarterectomy
5347342|NCT01962155|Fibrosis|fibrosis
5033629|NCT03788967|Complicated Urinary Tract Infection|complicated urinary tract infection
5033630|NCT03788967|Acute Pyelonephritis|acute pyelonephritis
5033631|NCT03788954|Range of motion|range of motion
5033632|NCT03788954|Hand injuries|hand injuries
5033633|NCT03788954|Biomechanics|biomechanics
5033634|NCT03788954|Rehabilitation|rehabilitation
5033635|NCT03788915|obesity|obesity
5033636|NCT03788915|internet community|internet community
5033637|NCT03788915|treatment; preventive medicine|treatment; preventive medicine
5033638|NCT03788915|risk perception|risk perception
5033639|NCT03788915|lifestyle counseling|lifestyle counseling
5033640|NCT03788889|Lorazepam|lorazepam
5033641|NCT03788889|Ketamine|ketamine
5033642|NCT03788889|Phenobarbital|phenobarbital
5033643|NCT03788850|residual disease|residual disease
5033644|NCT03788850|central cone|central cone
5033645|NCT03788850|predictive model|predictive model
5033646|NCT03788837|Microcirculatory defects|microcirculatory defects
5033647|NCT03788837|hemodynamic macroparameters|hemodynamic macroparameters
5033648|NCT03788837|mottling|mottling
5033649|NCT03788837|Septic shock|septic shock
5033650|NCT03788837|SOFA score|sofa score
5033651|NCT03788824|Ulcerative Colitis|ulcerative colitis
5033652|NCT03788824|probe-based Confocal Laser Endoscopy|probe-based confocal laser endoscopy
5033653|NCT03788824|Inflammation Activity|inflammation activity
5033654|NCT03788824|Histology|histology
5033655|NCT03788811|Retinal Signal|retinal signal
5033656|NCT03788811|Schizophrenia|schizophrenia
5033657|NCT03788811|Bipolar I Disorder|bipolar i disorder
5033658|NCT03788811|Support to diagnostic|support to diagnostic
5033660|NCT03788811|Mental Disorder|mental disorder
5033661|NCT03788772|dendritic cell|dendritic cell
5033662|NCT03788772|sepsis|sepsis
5033663|NCT03788759|Schizophrenia|schizophrenia
5033664|NCT03788759|Drug repurposing|drug repurposing
5033665|NCT03788759|Alpha-lipoic acid|alpha-lipoic acid
5033666|NCT03788759|Adjuvant treatment|adjuvant treatment
5033669|NCT03788733|Burning mouth syndrome,|burning mouth syndrome,
5033670|NCT03788733|melatonin|melatonin
5033671|NCT03788733|pain|pain
5033672|NCT03788733|sleep|sleep
5033673|NCT03788720|Endometrioma|endometrioma
5033674|NCT03788720|Laparoscopy|laparoscopy
5033675|NCT03788720|Suture|suture
5033676|NCT03788720|Ovary|ovary
5033677|NCT03788694|Ketamine|ketamine
5033678|NCT03788694|Veteran|veteran
5033679|NCT03788694|Suicide|suicide
5033680|NCT03788694|Suicidal Ideation|suicidal ideation
5033681|NCT03788668|Hyoid suspension|hyoid suspension
5033682|NCT03788668|Barbed reposition pharyngoplasty|barbed reposition pharyngoplasty
5033683|NCT03788655|metal stent|metal stent
5033684|NCT03788655|biliary stricture|biliary stricture
5033685|NCT03788655|stenting|stenting
5033686|NCT03788642|Diabetic Foot Ulcer|diabetic foot ulcer
5033687|NCT03788642|Low Level Laser Therapy|low level laser therapy
5033698|NCT03788499|Maxillofacial and Oral Cavity|maxillofacial and oral cavity
5033699|NCT03788499|Radioactive Oral Mucositis|radioactive oral mucositis
5033700|NCT03788499|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5033701|NCT03788486|dry eye|dry eye
5033702|NCT03788434|Clostridium Difficile Infection Recurrence|clostridium difficile infection recurrence
5723469|NCT00418899|Glioma|glioma
5033703|NCT03788434|Clostridium Difficile Infection|clostridium difficile infection
5033704|NCT03788434|Clostridium Difficile|clostridium difficile
5033705|NCT03788434|VE303|ve303
5033706|NCT03788434|Consortium|consortium
5033707|NCT03788434|Vedanta|vedanta
5033709|NCT03788434|C. Diff|c. diff
5033710|NCT03788434|CDiff|cdiff
5033711|NCT03788434|Clostridiodes Difficile Infection|clostridiodes difficile infection
5033712|NCT03788434|Clostridiodes Difficile|clostridiodes difficile
5033713|NCT03788382|Failure Adjuvant Therapy|failure adjuvant therapy
5033714|NCT03788369|Hybrid coronary revascularization|hybrid coronary revascularization
5033715|NCT03788343|Phenylketonuria|phenylketonuria
5033716|NCT03788343|PKU|pku
5033717|NCT03788343|Phenylalanine|phenylalanine
5033718|NCT03788343|Diet|diet
5033719|NCT03788343|Neuropsychology|neuropsychology
5033720|NCT03788343|Working Memory|working memory
5033721|NCT03788343|Neuroimaging|neuroimaging
5033722|NCT03788330|exhaled nitric oxide|exhaled nitric oxide
5033723|NCT03788330|Sick building syndrome|sick building syndrome
5033724|NCT03788330|indoor air|indoor air
5033725|NCT03788317|Cerebral Palsy, Botulinum Toxin A, Participation|cerebral palsy, botulinum toxin a, participation
5033726|NCT03788291|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5033727|NCT03788291|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5033728|NCT03788291|Phase II|phase ii
5033729|NCT03788291|Acalabrutinib|acalabrutinib
5033730|NCT03788291|Rituximab|rituximab
5033731|NCT03788278|Digital psychiatry|digital psychiatry
5033732|NCT03788252|Sarcopenia|sarcopenia
5033733|NCT03788252|AST-120|ast-120
5033734|NCT03788252|Indoxyl sulfate|indoxyl sulfate
5033735|NCT03788213|Hypo-fractionated Radiotherapy,|hypo-fractionated radiotherapy,
5033736|NCT03788213|One week Radiotherapy|one week radiotherapy
5033737|NCT03788213|Simultaneous integrated boost|simultaneous integrated boost
5033738|NCT03788213|Breast Cancer|breast cancer
5033739|NCT03788161|trigger points|trigger points
5033740|NCT03788161|virtual reality|virtual reality
5033741|NCT03788161|Dry needling|dry needling
5033742|NCT03788148|transfusion, PCI, DES, BMS|transfusion, pci, des, bms
5033743|NCT03788122|Acceptability|acceptability
5033744|NCT03788122|Qualitative research|qualitative research
5033745|NCT03788122|Patient Perspectives|patient perspectives
5033746|NCT03788096|Post-Intensive Care Syndrome (PICS)|post-intensive care syndrome (pics)
5033747|NCT03788096|Chronic Critical Illness|chronic critical illness
5033752|NCT03788044|Application|application
5033753|NCT03788044|Adherence|adherence
5033754|NCT03788018|Lidocaine|lidocaine
5033755|NCT03788018|Dexmedetomidine|dexmedetomidine
5033756|NCT03788018|Postoperative nausea and vomiting|postoperative nausea and vomiting
5033757|NCT03788018|laparoscopic hysterectomy|laparoscopic hysterectomy
5033758|NCT03788005|Chronic Subdural Hematoma|chronic subdural hematoma
5033759|NCT03788005|Bed rest|bed rest
5033760|NCT03788005|Early mobilization|early mobilization
5033761|NCT03787979|History of low back pain|history of low back pain
5033762|NCT03787979|Clinical lumbar instability|clinical lumbar instability
5033763|NCT03787979|Stretching exercise|stretching exercise
5033764|NCT03787966|Breast neoplasm|breast neoplasm
5033765|NCT03787966|Breast cancer|breast cancer
5027551|NCT03826693|OCD|ocd
5033766|NCT03787966|therapeutic exercise|therapeutic exercise
5033767|NCT03787966|cardiotoxicity|cardiotoxicity
5033768|NCT03787966|muscle toxicity|muscle toxicity
5033769|NCT03787953|anti-PD-1/PD-L1 antibodies|anti-pd-1/pd-l1 antibodies
5033770|NCT03787953|Efficacy|efficacy
5033771|NCT03787953|Safety|safety
5033772|NCT03787953|Real world study|real world study
5033773|NCT03787940|N-Acetyltransferase Type 2 Genotype|n-acetyltransferase type 2 genotype
5033774|NCT03787940|treatment|treatment
5033775|NCT03787940|Tuberculous Meningitis|tuberculous meningitis
5033776|NCT03787875|RANKL|rankl
5033777|NCT03787875|OPG|opg
5033778|NCT03787875|periodontal biomarkers|periodontal biomarkers
5033779|NCT03787875|alveolar bone loss|alveolar bone loss
5047628|NCT03701542|m-charts|m-charts
5033792|NCT03787797|Chest pain|chest pain
5033793|NCT03787797|Echocardiography|echocardiography
5033794|NCT03787797|Coronary artery disease|coronary artery disease
5033795|NCT03787771|Fecal Microbiota Transplantation|fecal microbiota transplantation
5033796|NCT03787745|Primary PCI|primary pci
5033797|NCT03787745|Ischemic postconditioning|ischemic postconditioning
5033798|NCT03787745|Clinical outcome|clinical outcome
5033799|NCT03787732|Intubation|intubation
5033800|NCT03787719|Twice weekly dialysis|twice weekly dialysis
5033801|NCT03787719|Thrice weekly dialysis|thrice weekly dialysis
5723662|NCT00417963|Artery|artery
5033804|NCT03787706|Trigger points|trigger points
5033805|NCT03787706|Dry needling|dry needling
5033806|NCT03787706|Cranio-cervical flexion test|cranio-cervical flexion test
5033807|NCT03787693|hemiparesis|hemiparesis
5033808|NCT03787693|gait|gait
5033809|NCT03787693|perception|perception
5033810|NCT03787693|sensory|sensory
5033811|NCT03787693|vision|vision
5033812|NCT03787693|coordination|coordination
5033813|NCT03787641|cardiopulmonary bypass|cardiopulmonary bypass
5033814|NCT03787641|heparin|heparin
5033815|NCT03787641|protamine|protamine
5033816|NCT03787641|anti-IIa assay|anti-iia assay
5033817|NCT03787641|anti-Xa assay|anti-xa assay
5033818|NCT03787641|activated clotting time|activated clotting time
5033819|NCT03787628|Buprenorphine|buprenorphine
5033820|NCT03787628|Cannabidiol|cannabidiol
5033821|NCT03787628|Opioid Use disorder|opioid use disorder
5033823|NCT03787589|Renal Failure|renal failure
5033824|NCT03787589|Hemodialysis|hemodialysis
5033825|NCT03787589|Peritoneal Dialysis|peritoneal dialysis
5033826|NCT03787589|Exercise|exercise
5033827|NCT03787576|Multifocal intraocular lens|multifocal intraocular lens
5033828|NCT03787576|Trifocal intraocular lens|trifocal intraocular lens
5033829|NCT03787576|Extended Depth of Focus Lens|extended depth of focus lens
5033830|NCT03787563|Herbal Tea|herbal tea
5033831|NCT03787563|Diabetes|diabetes
5033836|NCT03787537|Nutrition|nutrition
5033837|NCT03787537|Surgery|surgery
5033838|NCT03787511|cough|cough
5033839|NCT03787511|diabetes|diabetes
5033840|NCT03787511|small fiber neuropathy|small fiber neuropathy
5033841|NCT03787498|PLX2853|plx2853
5033842|NCT03787498|Acute Myeloid Leukemia|acute myeloid leukemia
5033844|NCT03787498|Myelodysplastic Syndrome|myelodysplastic syndrome
5033845|NCT03787498|MDS|mds
5033846|NCT03787498|Hematologic Malignancy|hematologic malignancy
5033847|NCT03787498|Blood Cancer|blood cancer
5033848|NCT03787485|Community Health Worker|community health worker
5033849|NCT03787485|Community Clinical Linkage|community clinical linkage
5033944|NCT03786874|health & safety|health & safety
5033850|NCT03787459|severe influenza, arbidol, oseltamivir, ordinal scale|severe influenza, arbidol, oseltamivir, ordinal scale
5033851|NCT03787433|Rehabilitation|rehabilitation
5033852|NCT03787433|Accelerometers|accelerometers
5033853|NCT03787433|Wearable sensors|wearable sensors
5033854|NCT03787433|Artificial Intelligence|artificial intelligence
5033855|NCT03787433|Stroke|stroke
5033856|NCT03787433|Home-based Rehabilitation|home-based rehabilitation
5033857|NCT03787433|Activities of Daily Living|activities of daily living
5033858|NCT03787433|Post-stroke rehabilitation|post-stroke rehabilitation
5033859|NCT03787407|resilience|resilience
5033860|NCT03787407|emotional labor|emotional labor
5033861|NCT03787407|mindfulness|mindfulness
5033862|NCT03787407|neurofeedback|neurofeedback
5033863|NCT03787394|taste enhancers|taste enhancers
5033864|NCT03787381|cesarean section, niche, uterine scar defect|cesarean section, niche, uterine scar defect
5033865|NCT03787368|End-stage renal disease patients undergoing hemodialysis|end-stage renal disease patients undergoing hemodialysis
5423192|NCT01616784|Hemoglobin A|hemoglobin a
5423193|NCT01616784|Glycosylated|glycosylated
5423194|NCT01616771|laryngoscopes|laryngoscopes
5047731|NCT03700710|DASH diet|dash diet
5033871|NCT03787316|sever's|sever's
5033872|NCT03787277|Aortic Dissection Type A|aortic dissection type a
5033873|NCT03787277|Post operative residual aortic dissection|post operative residual aortic dissection
5033874|NCT03787277|Aneurysmal progression of the dissected aorta|aneurysmal progression of the dissected aorta
5033875|NCT03787277|Intimal flap mobility|intimal flap mobility
5033876|NCT03787199|Andago|andago
5033877|NCT03787199|Feasibility|feasibility
5027681|NCT03825744|SAA|saa
5033878|NCT03787199|Pediatric Neurorehabilitation|pediatric neurorehabilitation
5033879|NCT03787173|non invasive ventilation|non invasive ventilation
5033880|NCT03787173|patient ventilator synchrony|patient ventilator synchrony
5033881|NCT03787173|acute respiratory failure|acute respiratory failure
5033882|NCT03787173|closed loop ventilation|closed loop ventilation
5033883|NCT03787160|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5033884|NCT03787160|volatile organic compounds|volatile organic compounds
5033885|NCT03787160|microbiome|microbiome
5033886|NCT03787160|pulmonary function|pulmonary function
5033887|NCT03787160|multiple breath washout|multiple breath washout
5033888|NCT03787147|Virtual Reality|virtual reality
5033889|NCT03787147|Spinal Injection|spinal injection
5033890|NCT03787147|Adult|adult
5033891|NCT03787147|Analgesia|analgesia
5033892|NCT03787147|Google cardboard|google cardboard
5033893|NCT03787147|Oculus|oculus
5033894|NCT03787121|health economics|health economics
5033895|NCT03787121|care management pathways|care management pathways
5033896|NCT03787121|overtreatment|overtreatment
5033897|NCT03787108|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5033898|NCT03787108|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5033899|NCT03787108|Ultrasonographic hepatorenal index|ultrasonographic hepatorenal index
5033900|NCT03787056|dd|dd
5033901|NCT03787056|TUMOR MARKER|tumor marker
5033912|NCT03786965|Valve Disease|valve disease
5033913|NCT03786965|Septal Defect|septal defect
5033914|NCT03786965|Myeloperoxidase|myeloperoxidase
5033915|NCT03786965|Molecular biology|molecular biology
5033916|NCT03786965|Gene analysis|gene analysis
5033917|NCT03786952|stress|stress
5033918|NCT03786952|sex|sex
5033919|NCT03786952|fear|fear
5033920|NCT03786952|generalization|generalization
5033921|NCT03786952|cortisol|cortisol
5033922|NCT03786952|alpha-amylase|alpha-amylase
5033923|NCT03786952|estradiol|estradiol
5033924|NCT03786952|progesterone|progesterone
5033925|NCT03786939|Ischemic Heart Disease|ischemic heart disease
5033926|NCT03786939|coronary artery bypass grafting|coronary artery bypass grafting
5033927|NCT03786939|on-pump CABG|on-pump cabg
5033928|NCT03786939|off-pump CABG|off-pump cabg
5033929|NCT03786939|pump - assisted CABG|pump - assisted cabg
5033930|NCT03786939|myeloperoxidase after CABG|myeloperoxidase after cabg
5033931|NCT03786926|CLL|cll
5033932|NCT03786926|SLL|sll
5033933|NCT03786926|FL|fl
5033934|NCT03786926|MZL|mzl
5033935|NCT03786926|LPL|lpl
5033936|NCT03786926|WM|wm
5033937|NCT03786926|MCL|mcl
5033938|NCT03786913|Inflammatory myositis|inflammatory myositis
5033939|NCT03786913|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5033940|NCT03786913|Musculoskeletal ultrasound|musculoskeletal ultrasound
5033941|NCT03786887|mechanical ventilation|mechanical ventilation
5033942|NCT03786887|nalbuphine|nalbuphine
5033943|NCT03786874|Risk management|risk management
5033950|NCT03786861|photorefractive keratectomy.|photorefractive keratectomy.
5033952|NCT03786848|Patient Derived Xenograft|patient derived xenograft
5033953|NCT03786848|CRPC|crpc
5033954|NCT03786822|cryoballoon|cryoballoon
5033955|NCT03786822|Atrial fibrillation|atrial fibrillation
5033956|NCT03786822|pulmonary vein isolation|pulmonary vein isolation
5033957|NCT03786809|postmenopause|postmenopause
5033958|NCT03786809|vascular effects|vascular effects
5033959|NCT03786809|CIMICIFUGA RACEMOSA|cimicifuga racemosa
5033960|NCT03786796|Olaparib|olaparib
5033970|NCT03786731|Transdiagnostic Sleep and Circadian Treatment|transdiagnostic sleep and circadian treatment
5033972|NCT03786718|Patient Web Portals|patient web portals
5033973|NCT03786718|Usability|usability
5033974|NCT03786718|Health Information Technology|health information technology
5033975|NCT03786679|Non-operative treatment, orthosis, healing, rehabilitation|non-operative treatment, orthosis, healing, rehabilitation
5033976|NCT03786666|Stroke|stroke
5033977|NCT03786666|Ischemia|ischemia
5033978|NCT03786666|Carotid artery Stenosis|carotid artery stenosis
5033979|NCT03786666|CEA|cea
5347676|NCT01960517|Urinary|urinary
5033980|NCT03786666|Stenting|stenting
5033981|NCT03786666|Ultrasound|ultrasound
5033982|NCT03786666|Vulnerable plaque|vulnerable plaque
5033983|NCT03786653|Immunotherapy, bronchial cancer, home-based hospitalization|immunotherapy, bronchial cancer, home-based hospitalization
5033984|NCT03786640|3 Tesla MRI|3 tesla mri
5033990|NCT03786614|treatment resistant depression|treatment resistant depression
5033991|NCT03786614|serotonergic antidepressants|serotonergic antidepressants
5033992|NCT03786614|short form of serotonin transporter|short form of serotonin transporter
5033993|NCT03786575|Breast Neoplasm|breast neoplasm
5033994|NCT03786575|Next Generation Sequencing|next generation sequencing
5033995|NCT03786575|Endocrine Therapy|endocrine therapy
5033996|NCT03786549|sickle cell disease (SDC)|sickle cell disease (sdc)
5033997|NCT03786549|Pediatric-adult care transition|pediatric-adult care transition
5033998|NCT03786523|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5033999|NCT03786523|Obesity|obesity
5034000|NCT03786523|Time restricted feeding|time restricted feeding
5034001|NCT03786523|Calorie restriction|calorie restriction
5034002|NCT03786510|Risk reduction|risk reduction
5034003|NCT03786510|Community|community
5034004|NCT03786510|Older adults|older adults
5034005|NCT03786510|Lifestyle modification|lifestyle modification
5034006|NCT03786484|solid tumors|solid tumors
5034007|NCT03786484|PDE10 inhibitors|pde10 inhibitors
5034008|NCT03786484|Immunoncology|immunoncology
5034009|NCT03786471|dementia|dementia
5034010|NCT03786471|pragmatic clinical trial|pragmatic clinical trial
5034011|NCT03786471|effectiveness|effectiveness
5034013|NCT03786471|Alzheimer's disease|alzheimer's disease
5034014|NCT03786458|Infertility|infertility
5034015|NCT03786458|young female cancer patients|young female cancer patients
5034016|NCT03786458|decision aids|decision aids
5034017|NCT03786458|fertility concerns|fertility concerns
5034018|NCT03786419|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5034019|NCT03786419|Atezolizumab|atezolizumab
5034020|NCT03786419|Thoracic neoplasms|thoracic neoplasms
5034021|NCT03786419|Antibodies, monoclonal|antibodies, monoclonal
5034022|NCT03786419|Antineoplasic, agents|antineoplasic, agents
5034023|NCT03786393|Fibromyalgia|fibromyalgia
5034024|NCT03786393|Migraine|migraine
5034025|NCT03786393|estrogen receptor alpha|estrogen receptor alpha
5034026|NCT03786393|polymorphism|polymorphism
5034027|NCT03786380|Diabetic Gastroparesis|diabetic gastroparesis
5034028|NCT03786367|Dyspnea|dyspnea
5034029|NCT03786367|Exertional Dyspnea|exertional dyspnea
5034030|NCT03786367|Pulmonary Hypertension|pulmonary hypertension
5034031|NCT03786367|Exercise|exercise
5034032|NCT03786341|Gait|gait
5034033|NCT03786341|Stroke|stroke
5034034|NCT03786341|Walking assist device|walking assist device
5034035|NCT03786341|Auxiliary illuminator|auxiliary illuminator
5034036|NCT03786341|visual feedback|visual feedback
5034037|NCT03786328|Early detection and treatment|early detection and treatment
5034038|NCT03786315|Primary care|primary care
5034039|NCT03786315|Elderly|elderly
5034054|NCT03786250|Emergency department|emergency department
5034055|NCT03786250|Older|older
5034056|NCT03786250|Frailty|frailty
5034057|NCT03786211|Mandible|mandible
5034058|NCT03786211|Anesthesia|anesthesia
5034070|NCT03786172|Smoking cessation|smoking cessation
5034071|NCT03786172|Intervention|intervention
5034072|NCT03786172|Head and Neck neoplasms|head and neck neoplasms
5034073|NCT03786172|Cognitive therapy|cognitive therapy
5034074|NCT03786133|Subgingival analysis|subgingival analysis
5034075|NCT03786133|Real-time PCR|real-time pcr
5034076|NCT03786133|Comparative study|comparative study
5034077|NCT03786133|Chronic Periodontitis|chronic periodontitis
5034078|NCT03786133|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5034079|NCT03786107|Circulating Tumor DNA|circulating tumor dna
5034080|NCT03786107|HER2|her2
5034081|NCT03786107|Genomic Screening|genomic screening
5034082|NCT03786107|Metastatic|metastatic
5034083|NCT03786107|Breast|breast
5034084|NCT03786107|Cervical|cervical
5034085|NCT03786107|ERBB2|erbb2
5034086|NCT03786107|Mutation|mutation
5034087|NCT03786081|cervical carcinoma|cervical carcinoma
5034088|NCT03786068|Emergency Medical Services|emergency medical services
5034089|NCT03786068|Prehospital|prehospital
5034090|NCT03786068|Time to admission|time to admission
5034091|NCT03786068|Time to neurosurgery|time to neurosurgery
5034092|NCT03786068|Treatment delay|treatment delay
5034093|NCT03786055|cancer survivor|cancer survivor
5034094|NCT03786055|pain|pain
5034095|NCT03786055|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5034096|NCT03786055|fall risk|fall risk
5034097|NCT03786055|quality of life|quality of life
5034098|NCT03786055|somatic yoga|somatic yoga
5034099|NCT03786055|meditation|meditation
5034100|NCT03786042|Positive Smoking expectancies|positive smoking expectancies
5034101|NCT03786042|e-cigarette advertising|e-cigarette advertising
5034102|NCT03786042|adolescents|adolescents
5034103|NCT03786029|Pre-emptive administration|pre-emptive administration
5034104|NCT03786029|Analgesic|analgesic
5034105|NCT03786029|Tooth extraction|tooth extraction
5034106|NCT03786003|Video-Assisted Thoracic Surgery|video-assisted thoracic surgery
5034107|NCT03786003|Thoracotomy|thoracotomy
5034108|NCT03786003|Early-stage NSCLC|early-stage nsclc
5034109|NCT03786003|Consolidation-predominant|consolidation-predominant
5034110|NCT03785990|preterm|preterm
5034111|NCT03785990|fatty acid|fatty acid
5034112|NCT03785990|docosahexaenoic acid|docosahexaenoic acid
5034113|NCT03785990|arachidonic acid|arachidonic acid
5034114|NCT03785990|infant|infant
5034115|NCT03785990|adipose tissue|adipose tissue
5034116|NCT03785990|subcutaneous adipose tissue|subcutaneous adipose tissue
5034117|NCT03785977|Ventilation|ventilation
5034118|NCT03785977|pediatrics|pediatrics
5034119|NCT03785977|airway management|airway management
5034120|NCT03785977|respiration|respiration
5034125|NCT03785951|HbA1c|hba1c
5034126|NCT03785951|whey|whey
5034127|NCT03785951|postprandial glycaemia|postprandial glycaemia
5034128|NCT03785951|cardiometabolic|cardiometabolic
5034129|NCT03785951|vascular|vascular
5034130|NCT03785951|leucine|leucine
5034131|NCT03785951|branched chain amino acids (BCAA)|branched chain amino acids (bcaa)
5034132|NCT03785951|glucose control|glucose control
5034133|NCT03785951|Milk protein|milk protein
5034134|NCT03785938|pediatric|pediatric
5034135|NCT03785938|cancer|cancer
5034136|NCT03785938|malignant haematology|malignant haematology
5034137|NCT03785938|transplant|transplant
5034138|NCT03785938|probiotics|probiotics
5034139|NCT03785938|mucositis|mucositis
5034140|NCT03785938|infection|infection
5034141|NCT03785938|supportive care|supportive care
5034142|NCT03785925|Bladder|bladder
5034151|NCT03785925|Natural Killer Cells|natural killer cells
5034152|NCT03785925|Nivolumab|nivolumab
5034153|NCT03785925|NKTR-214|nktr-214
5034154|NCT03785925|Opdivo®|opdivo®
5034155|NCT03785925|PD-L1|pd-l1
5034156|NCT03785925|Urothelial Cancer|urothelial cancer
5034157|NCT03785925|Urothelial|urothelial
5034158|NCT03785925|Metastatic Urothelial Carcinoma|metastatic urothelial carcinoma
5034159|NCT03785925|Urothelial Carcinoma|urothelial carcinoma
5034160|NCT03785925|Bempegaldesleukin|bempegaldesleukin
5034161|NCT03785886|hypertension|hypertension
5034162|NCT03785886|hypertension complicated with type diabetes|hypertension complicated with type diabetes
5034163|NCT03785886|walking|walking
5034164|NCT03785886|Chinese square dancing|chinese square dancing
5034165|NCT03785821|Bitter melon seed oil|bitter melon seed oil
5034166|NCT03785821|Olive oil|olive oil
5034167|NCT03785821|Weight control|weight control
5034168|NCT03785821|UCP1 polymorphism|ucp1 polymorphism
5034169|NCT03785808|ketogenic diet|ketogenic diet
5034170|NCT03785808|low-fat diet|low-fat diet
5034171|NCT03785795|Preterm labor detection|preterm labor detection
5034172|NCT03785795|Labor detection|labor detection
5034173|NCT03785795|False labor|false labor
5034174|NCT03785782|Screening|screening
5034175|NCT03785743|Pancreatic Carcinoma|pancreatic carcinoma
5034176|NCT03785743|Laparoscopic|laparoscopic
5034177|NCT03785743|Pancreaticoduodenectomy|pancreaticoduodenectomy
5034178|NCT03785743|Survival|survival
5034179|NCT03785717|shock wave therapy (SWT or ESWT)|shock wave therapy (swt or eswt)
5034180|NCT03785717|Guided bone regeneration (GBR)|guided bone regeneration (gbr)
5034181|NCT03785717|horizontal ridge augmentation|horizontal ridge augmentation
5034182|NCT03785704|Xinmailong injection|xinmailong injection
5034183|NCT03785704|anthracycline induced cardiac toxicity|anthracycline induced cardiac toxicity
5034189|NCT03785691|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5034190|NCT03785639|balance|balance
5034191|NCT03785639|dual task|dual task
5034192|NCT03785639|Four Square Step Test|four square step test
5034193|NCT03785626|Ultrasound|ultrasound
5034194|NCT03785626|Carotid Endarterectomy|carotid endarterectomy
5034195|NCT03785626|Risk Prediction Model|risk prediction model
5034196|NCT03785600|traumatic brain injury|traumatic brain injury
5034197|NCT03785600|sleep-wake disturbances|sleep-wake disturbances
5034198|NCT03785600|Veterans|veterans
5034199|NCT03785600|chronic pain|chronic pain
5034200|NCT03785574|Pulmonary Nodule|pulmonary nodule
5034201|NCT03785574|Chemotherapy|chemotherapy
5034202|NCT03785574|Chorionic Gonadotrophin|chorionic gonadotrophin
5034203|NCT03785561|Musculoskeletal Diseases|musculoskeletal diseases
5034204|NCT03785561|Osteoarthritis, Knee|osteoarthritis, knee
5034205|NCT03785561|cohort study|cohort study
5034206|NCT03785561|illness perceptions|illness perceptions
5034207|NCT03785509|DAPT, Statin, Compliance, Persistence, Adherence, PCI|dapt, statin, compliance, persistence, adherence, pci
5034208|NCT03785483|Physical activity|physical activity
5034209|NCT03785483|Multiple sclerosis|multiple sclerosis
5034210|NCT03785483|Motivation|motivation
5034211|NCT03785483|Intention|intention
5034212|NCT03785483|Mindfulness|mindfulness
5034213|NCT03785470|arterial stiffness|arterial stiffness
5034214|NCT03785470|endothelial dysfunction|endothelial dysfunction
5034215|NCT03785470|fructose|fructose
5034216|NCT03785470|physical inactivity|physical inactivity
5034217|NCT03785457|Low Back Pain|low back pain
5034218|NCT03785457|Extension|extension
5034219|NCT03785457|Posture|posture
5034220|NCT03785457|Physical Therapy|physical therapy
5034221|NCT03785444|Assessment by others|assessment by others
5034222|NCT03785444|Self-Assessment|self-assessment
5034223|NCT03785444|Critically ill|critically ill
5034224|NCT03785444|Intensive care|intensive care
5034225|NCT03785444|standardized questionnaire|standardized questionnaire
5034226|NCT03785444|functional status|functional status
5034227|NCT03785444|WHODAS|whodas
5034228|NCT03785444|EQ5D|eq5d
5034229|NCT03785444|IADL|iadl
5034230|NCT03785444|Barthel Score|barthel score
5034231|NCT03785444|SF-36|sf-36
5034232|NCT03785444|MoCA Blind|moca blind
5034233|NCT03785431|STEMI|stemi
5034234|NCT03785431|cardiovascular disease|cardiovascular disease
5034235|NCT03785431|bioresorbable scaffold|bioresorbable scaffold
5034236|NCT03785418|Atrial Fibrillation|atrial fibrillation
5034243|NCT03785379|Obesity|obesity
5034244|NCT03785379|Lifestyle intervention|lifestyle intervention
5035754|NCT03775460|ENL|enl
5034252|NCT03785249|Colorectal Cancer|colorectal cancer
5034253|NCT03785249|Colon Cancer|colon cancer
5034254|NCT03785249|Metastatic Cancer|metastatic cancer
5034255|NCT03785223|ADHD|adhd
5034256|NCT03785223|Anxiety Disorders|anxiety disorders
5034257|NCT03785223|Stimulants|stimulants
5034258|NCT03785223|Methylphenidate|methylphenidate
5034259|NCT03785210|Anticancer Activities|anticancer activities
5034260|NCT03785210|Altering Gut Commensual Bacteria|altering gut commensual bacteria
5034261|NCT03785210|Immunodulatory Effect|immunodulatory effect
5034262|NCT03785210|Checkpoint Inhibition|checkpoint inhibition
5034263|NCT03785197|fasting|fasting
5034264|NCT03785197|natural therapies|natural therapies
5034265|NCT03785197|prolonged fasting|prolonged fasting
5034266|NCT03785184|Multiple Myeloma|multiple myeloma
5034267|NCT03785184|Cancer|cancer
5034268|NCT03785184|t(11;14)-Positive Multiple Myeloma|t(11;14)-positive multiple myeloma
5034269|NCT03785184|Venetoclax|venetoclax
5034270|NCT03785184|Lenalidomide|lenalidomide
5034271|NCT03785158|Delirium|delirium
5034272|NCT03785158|Elderly patients having non-cardiac surgery|elderly patients having non-cardiac surgery
5034273|NCT03785158|Melatonin|melatonin
5034274|NCT03785158|sleep quality|sleep quality
5034275|NCT03785158|sleep deprivation|sleep deprivation
5034276|NCT03785158|sleep-wake cycle|sleep-wake cycle
5034277|NCT03785132|blood pressure|blood pressure
5034278|NCT03785132|performance measurement|performance measurement
5034279|NCT03785132|cardiac surgery|cardiac surgery
5034280|NCT03785132|mortality|mortality
5034281|NCT03785106|people living with HIV (PLHIV)|people living with hiv (plhiv)
5034282|NCT03785093|Microbiota, Allergy, Growth, Development, offspring|microbiota, allergy, growth, development, offspring
5034283|NCT03785080|gastrointestinal bleeding|gastrointestinal bleeding
5034284|NCT03785080|stroke|stroke
5034286|NCT03785080|atrial fibrillation|atrial fibrillation
5034287|NCT03785080|NOAC|noac
5034288|NCT03785067|TRIDENT|trident
5034289|NCT03785041|Tramadol|tramadol
5034290|NCT03785041|Intra-articular injection|intra-articular injection
5034291|NCT03785041|Preemptive|preemptive
5034292|NCT03785041|post-arthroscopy pain|post-arthroscopy pain
5034293|NCT03785041|Levobupivacaine|levobupivacaine
5034294|NCT03784963|Angiogenesis|angiogenesis
5034295|NCT03784963|Inflammation|inflammation
5034296|NCT03784963|Microbiome|microbiome
5034297|NCT03784937|Wells Clinical score|wells clinical score
5034298|NCT03784937|Thromboprophylaxis|thromboprophylaxis
5034299|NCT03784924|Prostate cancer|prostate cancer
5034300|NCT03784924|psa|psa
5034301|NCT03784924|early detection|early detection
5034302|NCT03784924|MRI|mri
5034303|NCT03784911|Body Composition|body composition
5034304|NCT03784911|SOZO|sozo
5034305|NCT03784911|Cancer|cancer
5034306|NCT03784911|Cancer Treatment|cancer treatment
5034307|NCT03784911|Impedimed|impedimed
5034308|NCT03784885|adjuvant|adjuvant
5034309|NCT03784885|vaccine|vaccine
5034310|NCT03784885|mucosa|mucosa
5034311|NCT03784885|IgA|iga
5034312|NCT03784885|Escherichia coli Enterotoxin|escherichia coli enterotoxin
5034313|NCT03784833|heart failure|heart failure
5034314|NCT03784820|Binge-Eating Disorder|binge-eating disorder
5034315|NCT03784820|Eating disorders|eating disorders
5034316|NCT03784820|Couple therapy|couple therapy
5034317|NCT03784820|CBT|cbt
5034318|NCT03784807|synovial fluid analysis|synovial fluid analysis
5034319|NCT03784794|Post Partum Hemorrhage|post partum hemorrhage
5034320|NCT03784794|Massive tranfusion|massive tranfusion
5034321|NCT03784794|Thromboelastometry|thromboelastometry
5034322|NCT03784781|Severe asthma in children|severe asthma in children
5034323|NCT03784781|Type 2 innate lymphoid cells (ILC2)|type 2 innate lymphoid cells (ilc2)
5034324|NCT03784781|bronchial mucosa|bronchial mucosa
5034325|NCT03784781|bronchoalveolar lavages|bronchoalveolar lavages
5034326|NCT03784768|Static balanced|static balanced
5034327|NCT03784768|Dynamic balanced|dynamic balanced
5034328|NCT03784768|Stroke|stroke
5034329|NCT03784768|Rehabilitation|rehabilitation
5034330|NCT03784768|Vibration|vibration
5034331|NCT03784755|Oligometastatic Hormone|oligometastatic hormone
5034332|NCT03784716|Fatty Liver|fatty liver
5034333|NCT03784716|Liver Disease|liver disease
5034334|NCT03784716|Ketogenic diet|ketogenic diet
5034335|NCT03784716|Keto diet|keto diet
5034336|NCT03784703|Adiponectin|adiponectin
5034337|NCT03784703|Sortilin|sortilin
5034338|NCT03784703|Leptin|leptin
5034339|NCT03784703|Atherosclerosis|atherosclerosis
5034340|NCT03784703|Diabetes type II|diabetes type ii
5034341|NCT03784703|Rosuvastatin|rosuvastatin
5034342|NCT03784703|Atorvastatin|atorvastatin
5034343|NCT03784690|Hypotension|hypotension
5034360|NCT03784586|primary prevention|primary prevention
5034361|NCT03784547|multiple sclerosis|multiple sclerosis
5034362|NCT03784547|Latin america|latin america
5034363|NCT03784534|EEG|eeg
5034364|NCT03784534|Recovery|recovery
5034365|NCT03784534|Motor|motor
5034366|NCT03784521|SIRS|sirs
5034367|NCT03784521|In-line filtration|in-line filtration
5034368|NCT03784521|Cardiac surgery|cardiac surgery
5034369|NCT03784508|morbid obesity|morbid obesity
5034370|NCT03784508|bariatric surgery|bariatric surgery
5034371|NCT03784508|psychological profile|psychological profile
5034372|NCT03784482|Multiple Drug Hypersensitivity|multiple drug hypersensitivity
5034373|NCT03784482|drug hypersensitivity|drug hypersensitivity
5034374|NCT03784482|antibiotics|antibiotics
5034375|NCT03784482|drug provocation tests|drug provocation tests
5034376|NCT03784482|skin tests|skin tests
5034377|NCT03784469|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5034378|NCT03784469|position change|position change
5034379|NCT03784469|back pain|back pain
5034380|NCT03784443|Diabetes|diabetes
5034381|NCT03784443|Eye|eye
5034382|NCT03784443|Macular Oedema|macular oedema
5034383|NCT03784443|Intravitreal Injection|intravitreal injection
5034384|NCT03784443|Ranibizumab|ranibizumab
5034385|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide
5034386|NCT03784378|RXDX-105|rxdx-105
5034387|NCT03784378|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5034388|NCT03784378|18-487|18-487
5034389|NCT03784365|oesophageal aperistalsis|oesophageal aperistalsis
5034392|NCT03784313|Axillary Hidradenitis Suppurativa|axillary hidradenitis suppurativa
5034393|NCT03784313|Perforator flaps|perforator flaps
5034394|NCT03784313|Secondary intention wound healing|secondary intention wound healing
5034395|NCT03784287|Sanfilippo Syndrome Type B|sanfilippo syndrome type b
5034396|NCT03784196|WAD|wad
5034397|NCT03784196|rehabilitation|rehabilitation
5034398|NCT03784196|whiplash|whiplash
5034400|NCT03784196|pain sensitivity|pain sensitivity
5034401|NCT03784183|Alzheimer's Disease|alzheimer's disease
5034402|NCT03784183|Mild Cognitive Stimulation|mild cognitive stimulation
5343747|NCT01977573|GSK1278863|gsk1278863
5034403|NCT03784183|Non Pharmacological Intervention|non pharmacological intervention
5034404|NCT03784183|Cognitive Stimulation|cognitive stimulation
5034405|NCT03784183|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5034406|NCT03784183|Blink Reflex|blink reflex
5034407|NCT03784183|Neuropsychological Evaluation|neuropsychological evaluation
5034408|NCT03784183|Randomized Controlled Trial|randomized controlled trial
5034409|NCT03784170|Overactive Bladder|overactive bladder
5034410|NCT03784170|OAB|oab
5034411|NCT03784170|Women|women
5034412|NCT03784170|Neuromodulation|neuromodulation
5034413|NCT03784170|Bioelectronic Medicine|bioelectronic medicine
5034414|NCT03784157|Hysterotomy|hysterotomy
5034415|NCT03784157|UTERINE MUSCLE CELLS|uterine muscle cells
5034416|NCT03784157|ISCHEMIA|ischemia
5034417|NCT03784157|COLD ISCHEMIA|cold ischemia
5034418|NCT03784144|Muscle endurance|muscle endurance
5034419|NCT03784144|Biering-Sorensen Test|biering-sorensen test
5034420|NCT03784144|Prone Plank Test.|prone plank test.
5034421|NCT03784144|Dual task|dual task
5034422|NCT03784144|time to failure|time to failure
5034423|NCT03784131|CVI|cvi
5034424|NCT03784131|Leg Ulcer|leg ulcer
5034425|NCT03784131|Tissue Engineering|tissue engineering
5034426|NCT03784131|Personalized Vascular Graft|personalized vascular graft
5034427|NCT03784131|Chronic Venous Insufficiency|chronic venous insufficiency
5034428|NCT03784131|ATMP|atmp
5034429|NCT03784105|codeine|codeine
5034430|NCT03784105|Esophageal motility|esophageal motility
5034431|NCT03784105|Pharyngeal motility|pharyngeal motility
5034432|NCT03784079|HIV-1, Antiviral Effect, GSK3640254, Proof of Concept|hiv-1, antiviral effect, gsk3640254, proof of concept
5034433|NCT03784066|squamous cell carcinoma|squamous cell carcinoma
5034434|NCT03784053|Older adults|older adults
5034435|NCT03784053|Virtual reality|virtual reality
5034436|NCT03784053|Quality of life|quality of life
5034437|NCT03784053|Occupation|occupation
5034438|NCT03784040|Nivolumab|nivolumab
5034439|NCT03784040|Ipilimumab|ipilimumab
5034440|NCT03784040|OTSGC-A24|otsgc-a24
5034441|NCT03784014|advanced disease|advanced disease
5034442|NCT03784014|metastatic disease|metastatic disease
5034848|NCT03781479|Type 3|type 3
5034453|NCT03783910|Chronic pain|chronic pain
5034454|NCT03783897|OC DDI, drug-drug interaction, oral contraceptive|oc ddi, drug-drug interaction, oral contraceptive
5034455|NCT03783884|VIDD|vidd
5028225|NCT03822793|hip|hip
5035909|NCT03774654|CD19|cd19
5034461|NCT03783884|Phrenic nerve stimulation|phrenic nerve stimulation
5034462|NCT03783884|Maximal Inspiratory Pressure|maximal inspiratory pressure
5034467|NCT03783806|hip, postural control, degenerative, inflammation|hip, postural control, degenerative, inflammation
5034468|NCT03783793|mindfulness|mindfulness
5034469|NCT03783793|attention|attention
5034470|NCT03783793|mobile health|mobile health
5034471|NCT03783793|interoception|interoception
5034472|NCT03783793|mood|mood
5034473|NCT03783767|school|school
5034474|NCT03783767|intervention|intervention
5034475|NCT03783767|physical literacy|physical literacy
5034476|NCT03783767|peer mentor|peer mentor
5034477|NCT03783767|leadership|leadership
5034478|NCT03783767|motor skills|motor skills
5034479|NCT03783767|physical activity|physical activity
5034480|NCT03783741|Prostate cancer|prostate cancer
5034481|NCT03783741|Biopsy|biopsy
5034482|NCT03783676|extubation|extubation
5034483|NCT03783624|hypnosis|hypnosis
5034484|NCT03783624|open label placebo|open label placebo
5034485|NCT03783624|neurocognitive measures|neurocognitive measures
5034486|NCT03783624|stress|stress
5034487|NCT03783624|induced pain|induced pain
5034488|NCT03783624|HRV|hrv
5034496|NCT03783572|Botulinum toxin|botulinum toxin
5034497|NCT03783572|Cerebrovascular Accident|cerebrovascular accident
5034498|NCT03783572|upper-limb movement|upper-limb movement
5034499|NCT03783572|spastic cocontraction|spastic cocontraction
5034500|NCT03783572|electromyography|electromyography
5034501|NCT03783572|electroencephalography|electroencephalography
5034502|NCT03783559|colorectal cancer liver metastasis|colorectal cancer liver metastasis
5034503|NCT03783559|Transarterial chemoembolization|transarterial chemoembolization
5034504|NCT03783559|conversion resection rates|conversion resection rates
5034505|NCT03783559|chemotherapy|chemotherapy
5034506|NCT03783546|Breast Cancer|breast cancer
5034507|NCT03783520|root canal treatment|root canal treatment
5034508|NCT03783520|intracanal irrigation|intracanal irrigation
5034509|NCT03783520|Laser|laser
5034510|NCT03783507|Energy Density|energy density
5034511|NCT03783494|ED|ed
5034512|NCT03783494|dislocation reduction|dislocation reduction
5034513|NCT03783494|emergency department|emergency department
5034514|NCT03783494|TCI|tci
5034515|NCT03783494|Target-controlled infusion|target-controlled infusion
5034516|NCT03783494|sedation|sedation
5034517|NCT03783494|fracture reduction|fracture reduction
5034525|NCT03783429|Digoxin|digoxin
5034526|NCT03783429|Atrial fibrillation|atrial fibrillation
5034532|NCT03783338|Aerobic exercises|aerobic exercises
5034533|NCT03783338|Balance|balance
5034534|NCT03783338|Down syndrome|down syndrome
5034535|NCT03783338|Physical performance|physical performance
5034536|NCT03783338|Vitamin D|vitamin d
5034537|NCT03783325|Sun Exposure|sun exposure
5034538|NCT03783325|UV Dosimetry|uv dosimetry
5034539|NCT03783325|Biomarkers|biomarkers
5034540|NCT03783325|Behaviors|behaviors
5034541|NCT03783325|Genetics|genetics
5034542|NCT03783312|Electroconvulsive therapy|electroconvulsive therapy
5034543|NCT03783312|Intravenous paracetamol|intravenous paracetamol
5034544|NCT03783312|Intravenous ibuprofen|intravenous ibuprofen
5034545|NCT03783312|Postoperative pain|postoperative pain
5034558|NCT03783221|diet|diet
5034559|NCT03783221|postprandial responses|postprandial responses
5034560|NCT03783221|hedonic sensations|hedonic sensations
5034561|NCT03783221|homeostatic sensations|homeostatic sensations
5034562|NCT03783221|intestinal gas production|intestinal gas production
5034563|NCT03783208|Endometrium|endometrium
5034564|NCT03783208|G-CSF|g-csf
5034565|NCT03783208|Recurrent implantation failure|recurrent implantation failure
5034566|NCT03783195|Glucose|glucose
5034567|NCT03783195|Fructose|fructose
5034568|NCT03783195|Fatty-liver|fatty-liver
5034569|NCT03783195|Polymorphisms|polymorphisms
5034570|NCT03783195|Imaging|imaging
5034571|NCT03783195|Fibroscan|fibroscan
5034572|NCT03783156|polypectomy snare|polypectomy snare
5034573|NCT03783156|polypectomy complications|polypectomy complications
5034578|NCT03783130|Human Immunodeficiency Virus|human immunodeficiency virus
5034579|NCT03783130|Immune Response|immune response
5034580|NCT03783130|Neutralizing Antibodies|neutralizing antibodies
5034581|NCT03783130|HIV Prevention|hiv prevention
5034582|NCT03783130|Cellular Immunogenicity|cellular immunogenicity
5034583|NCT03783117|Hypertension|hypertension
5034584|NCT03783104|Vitamin B12|vitamin b12
5034585|NCT03783104|Maternal nutrition|maternal nutrition
5034586|NCT03783104|Neurodevelopment|neurodevelopment
5034587|NCT03783104|Supplementation|supplementation
5034588|NCT03783078|programmed cell death receptor 1 (PD-1)|programmed cell death receptor 1 (pd-1)
5034589|NCT03783078|programmed cell death ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
5036041|NCT03773900|biomarkers|biomarkers
5034595|NCT03783065|Laparoscopic Therapy|laparoscopic therapy
5034596|NCT03783065|Endoscopic Therapy|endoscopic therapy
5034598|NCT03783039|broad area oozing bleeding|broad area oozing bleeding
5034599|NCT03783039|hemostat|hemostat
5034600|NCT03783039|topical hemostatic agents|topical hemostatic agents
5034601|NCT03783039|adjunctive hemostats|adjunctive hemostats
5034606|NCT03782974|Protective Qi|protective qi
5034607|NCT03782974|Immunity|immunity
5034608|NCT03782948|gait training|gait training
5034609|NCT03782948|dynamic balance|dynamic balance
5034610|NCT03782948|gait symmetry|gait symmetry
5034611|NCT03782948|rehabilitation robotics|rehabilitation robotics
5034612|NCT03782935|alcohol|alcohol
5034613|NCT03782935|pregnancy|pregnancy
5034614|NCT03782935|infant|infant
5348174|NCT01957917|HIV|hiv
5034615|NCT03782922|exercise|exercise
5034616|NCT03782922|anatomical|anatomical
5034617|NCT03782922|mental|mental
5034618|NCT03782922|training program|training program
5034619|NCT03782909|Nutrition|nutrition
5034620|NCT03782909|Weight|weight
5034622|NCT03782909|Behaviour change|behaviour change
5034623|NCT03782870|granulomatosis with polyangitis, cardiac involvement|granulomatosis with polyangitis, cardiac involvement
5034624|NCT03782831|Hepatocellular carcinoma|hepatocellular carcinoma
5034625|NCT03782831|Programmed cell death protein-1 antibody|programmed cell death protein-1 antibody
5034626|NCT03782831|Transarterial chemoembolization|transarterial chemoembolization
5034627|NCT03782818|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5034628|NCT03782818|PAH|pah
5034629|NCT03782818|poly (ADP-ribose) polymerases inhibition|poly (adp-ribose) polymerases inhibition
5034630|NCT03782818|PARP-1 inhibition|parp-1 inhibition
5034631|NCT03782818|DNA damage|dna damage
5034632|NCT03782818|Multicenter study|multicenter study
5034633|NCT03782818|Olaparib|olaparib
5034634|NCT03782818|Safety and efficacy|safety and efficacy
5423195|NCT01616745|NTM Lung disease|ntm lung disease
5034658|NCT03782597|Radicalization|radicalization
5034659|NCT03782584|exercise|exercise
5034660|NCT03782584|pilates|pilates
5034661|NCT03782584|modified pilates|modified pilates
5034662|NCT03782584|chronic neck pain|chronic neck pain
5034663|NCT03782558|carpal tunnel syndrome|carpal tunnel syndrome
5034664|NCT03782558|pBCTQ|pbctq
5034665|NCT03782558|validation|validation
5034666|NCT03782558|nerve conduction study|nerve conduction study
5034667|NCT03782519|Incremental Hemodialysis|incremental hemodialysis
5034668|NCT03782519|Nephrology|nephrology
5034669|NCT03782506|music therapy|music therapy
5034670|NCT03782506|pain management|pain management
5034671|NCT03782506|opioid use|opioid use
5034672|NCT03782506|cancer survivors|cancer survivors
5034673|NCT03782454|Bacterial DNA clearance|bacterial dna clearance
5034674|NCT03782454|Droplet digital PCR|droplet digital pcr
5034675|NCT03782454|Betalactam antibiotics|betalactam antibiotics
5034676|NCT03782454|Acute gastrointestinal index|acute gastrointestinal index
5034677|NCT03782454|Cytokines|cytokines
5034678|NCT03782441|Non-invasive glucose monitoring|non-invasive glucose monitoring
5034679|NCT03782441|Raman spectroscopy|raman spectroscopy
5034680|NCT03782415|ibudilast|ibudilast
5034681|NCT03782415|MN-166|mn-166
5034682|NCT03782415|GBM|gbm
5034683|NCT03782415|glioblastoma|glioblastoma
5034684|NCT03782415|recurrent GBM|recurrent gbm
5034685|NCT03782415|temozolomide|temozolomide
5034686|NCT03782389|Athlete|athlete
5034687|NCT03782389|injury prevention|injury prevention
5034688|NCT03782389|muscle strain|muscle strain
5034689|NCT03782389|prediction|prediction
5034690|NCT03782389|prognosis|prognosis
5034691|NCT03782389|screening|screening
5034692|NCT03782389|sport|sport
5034696|NCT03782350|Tranexamic Acid|tranexamic acid
5034697|NCT03782350|Antifibrinolytics|antifibrinolytics
5034698|NCT03782350|Mortality and Morbidity|mortality and morbidity
5034699|NCT03782350|Cardiac Surgery|cardiac surgery
5034700|NCT03782350|Cardiopulmonary Bypass|cardiopulmonary bypass
5034701|NCT03782337|Heart failure,|heart failure,
5034702|NCT03782337|Cardiac biomarker|cardiac biomarker
5034703|NCT03782337|Cardiopulmonary exercise test|cardiopulmonary exercise test
5034704|NCT03782337|Multi-discipline disease management program|multi-discipline disease management program
5034705|NCT03782337|Reverse remodeling|reverse remodeling
5034706|NCT03782298|Dynomite|dynomite
5034707|NCT03782298|Spyromite|spyromite
5034708|NCT03782298|Raptormite|raptormite
5034709|NCT03782298|Foot|foot
5034710|NCT03782298|Ankle|ankle
5034711|NCT03782298|Wrist|wrist
5034712|NCT03782298|Hand|hand
5034713|NCT03782298|Elbow|elbow
5034722|NCT03782233|Gastrointestinal Barrier Function|gastrointestinal barrier function
5034723|NCT03782220|somatosensory tinnitus|somatosensory tinnitus
5034725|NCT03782220|kinesio taping|kinesio taping
5034726|NCT03782194|Ultrasound|ultrasound
5034727|NCT03782194|MRI|mri
5034728|NCT03782194|Emotion|emotion
5034729|NCT03782194|Reactivity|reactivity
5034730|NCT03782194|Reappraisal|reappraisal
5034731|NCT03782194|Cognitive Neural Prosthetic|cognitive neural prosthetic
5034732|NCT03782155|wound healing, diabetes wound healing|wound healing, diabetes wound healing
5034733|NCT03782129|diabetes mellitus|diabetes mellitus
5034734|NCT03782129|diabetic foot|diabetic foot
5034735|NCT03782129|mortality rate|mortality rate
5034736|NCT03782129|diabetes complications|diabetes complications
5034737|NCT03782064|Multiple Myeloma|multiple myeloma
5034738|NCT03782051|Viscocanalostomy|viscocanalostomy
5034739|NCT03782051|Ologen|ologen
5034740|NCT03782051|glaucoma|glaucoma
5034741|NCT03782051|phacoemulsification|phacoemulsification
5034742|NCT03782038|Acne Scars|acne scars
5034743|NCT03782038|Stretchmarks|stretchmarks
5034744|NCT03782038|Surgical Scars|surgical scars
5034745|NCT03782012|Reading Comprehension|reading comprehension
5034746|NCT03782012|Adolescents|adolescents
5035239|NCT03779048|Incretins|incretins
5034753|NCT03781973|Transition to adult care|transition to adult care
5034754|NCT03781973|Glycemic control|glycemic control
5034755|NCT03781921|eating disorder|eating disorder
5034756|NCT03781921|Electroencephalography|electroencephalography
5034757|NCT03781921|emotion regulation|emotion regulation
5034758|NCT03781921|emotion processing|emotion processing
5034759|NCT03781921|negative urgency|negative urgency
5034761|NCT03781895|VitaminD3|vitamind3
5034762|NCT03781895|6 Minute Walk Distance|6 minute walk distance
5034763|NCT03781895|Modified BORG scale|modified borg scale
5034764|NCT03781882|Platelet rich plasma|platelet rich plasma
5034765|NCT03781882|disrupted wounds|disrupted wounds
5034766|NCT03781882|Obstetrics and Gynecology|obstetrics and gynecology
5034767|NCT03781869|Small Cell Lung Cancer; Anlotinib; Maintenance therapy|small cell lung cancer; anlotinib; maintenance therapy
5034768|NCT03781856|childhood obesity|childhood obesity
5034769|NCT03781856|intervention|intervention
5034770|NCT03781856|community health workers|community health workers
5034771|NCT03781856|community-based|community-based
5034772|NCT03781843|Neuropathic Pain|neuropathic pain
5034773|NCT03781843|Nerve block|nerve block
5034774|NCT03781843|Knee osteoarthritis|knee osteoarthritis
5034775|NCT03781830|mHealth|mhealth
5034776|NCT03781830|liver transplantation|liver transplantation
5034777|NCT03781830|medication adherence|medication adherence
5034778|NCT03781830|video directly observed therapy|video directly observed therapy
5034786|NCT03781778|Resistant Starch|resistant starch
5034787|NCT03781778|Colorectal Cancer|colorectal cancer
5034788|NCT03781778|Recurrence|recurrence
5034789|NCT03781765|fMRI Study|fmri study
5034790|NCT03781765|MPH|mph
5034791|NCT03781765|Methylphenidate|methylphenidate
5034792|NCT03781765|ATX|atx
5034793|NCT03781765|Atomoxetine|atomoxetine
5034794|NCT03781765|Reward System|reward system
5034795|NCT03781765|Substance Abuse Risk|substance abuse risk
5034796|NCT03781752|PK Study|pk study
5034797|NCT03781752|PD Study|pd study
5034798|NCT03781752|Pharmacokinetics|pharmacokinetics
5034799|NCT03781752|Pharmacodynamics|pharmacodynamics
5034800|NCT03781752|Methylphenidate|methylphenidate
5034801|NCT03781752|MPH|mph
5034802|NCT03781726|hemodialysis|hemodialysis
5034803|NCT03781726|renal failure|renal failure
5034804|NCT03781726|kidney transplant|kidney transplant
5034805|NCT03781713|prospective|prospective
5034806|NCT03781713|surveillance|surveillance
5034807|NCT03781713|trigger|trigger
5034808|NCT03781713|stabilization|stabilization
5034809|NCT03781700|Children|children
5034810|NCT03781700|Paediatric|paediatric
5034811|NCT03781687|erector spinae plane block|erector spinae plane block
5034812|NCT03781687|postoperative pain|postoperative pain
5034813|NCT03781687|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5034814|NCT03781674|Preterm birth|preterm birth
5034815|NCT03781674|Twin gestation|twin gestation
5034816|NCT03781674|Vaginal progesterone|vaginal progesterone
5034817|NCT03781661|Non coronary Chest Pain|non coronary chest pain
5034818|NCT03781661|Extended Information|extended information
5034819|NCT03781661|Normal Examination Result|normal examination result
5035068|NCT03780218|Burn Injury|burn injury
5428233|NCT01595568|Dual Diagnosis|dual diagnosis
5034831|NCT03781609|manual wheelchair|manual wheelchair
5034832|NCT03781609|wheelchair propulsion|wheelchair propulsion
5034833|NCT03781609|occupational therapy|occupational therapy
5034834|NCT03781609|motor learning|motor learning
5034835|NCT03781557|Omega-3|omega-3
5034836|NCT03781557|DHA fatty acids|dha fatty acids
5034837|NCT03781557|EPA fatty acids|epa fatty acids
5034838|NCT03781557|Cognition|cognition
5034839|NCT03781557|Brain|brain
5034840|NCT03781557|Healthy Adult|healthy adult
5034841|NCT03781557|Fish Oil|fish oil
5034842|NCT03781557|Human|human
5034843|NCT03781531|Occult cancer|occult cancer
5034844|NCT03781531|Venous thromboembolism|venous thromboembolism
5034845|NCT03781531|Biomarkers|biomarkers
5034846|NCT03781531|Early diagnosis|early diagnosis
5034847|NCT03781531|Neutrophil extracellular traps|neutrophil extracellular traps
5034849|NCT03781466|Preterm birth|preterm birth
5034850|NCT03781466|Twin gestation|twin gestation
5034851|NCT03781466|Vaginal progesterone|vaginal progesterone
5034852|NCT03781466|cervical cerclage|cervical cerclage
5034853|NCT03781427|Pacemaker|pacemaker
5034854|NCT03781427|Cardiac resynchronization therapy|cardiac resynchronization therapy
5034855|NCT03781414|Liver transplantation|liver transplantation
5034856|NCT03781414|de novo recipients|de novo recipients
5034857|NCT03781414|deceased donor|deceased donor
5034858|NCT03781414|CFZ533|cfz533
5034859|NCT03781414|CNI-free immunosuppression|cni-free immunosuppression
5034860|NCT03781414|Transplant rejection|transplant rejection
5034861|NCT03781388|Bupivacaine ED90|bupivacaine ed90
5034862|NCT03781388|Cesarean Delivery|cesarean delivery
5034863|NCT03781388|Obesity|obesity
5034864|NCT03781388|Spinal Anesthesia|spinal anesthesia
5034865|NCT03781362|Intravenous infusion|intravenous infusion
5034866|NCT03781336|mindfulness|mindfulness
5034867|NCT03781336|stress|stress
5034868|NCT03781336|resilience building|resilience building
5034869|NCT03781336|meditation|meditation
5034870|NCT03781336|healthcare professionals|healthcare professionals
5034871|NCT03781336|trainees|trainees
5034872|NCT03781336|physicians|physicians
5034873|NCT03781336|nurses|nurses
5034874|NCT03781323|Advanced rectal cancer|advanced rectal cancer
5034875|NCT03781323|FOLFOX (fluorouracil, leucovorin, oxaliplatin)|folfox (fluorouracil, leucovorin, oxaliplatin)
5034876|NCT03781297|Homeless Populations|homeless populations
5034877|NCT03781297|PTSD|ptsd
5034878|NCT03781297|Narrative Exposure Therapy|narrative exposure therapy
5034879|NCT03781297|Individual Therapy|individual therapy
5034880|NCT03781297|Genealogy|genealogy
5034881|NCT03781284|[18F]-FDG PET/MR enterography|[18f]-fdg pet/mr enterography
5034882|NCT03781284|Diagnosis|diagnosis
5034883|NCT03781271|Interstitial Brachytherapy|interstitial brachytherapy
5034884|NCT03781271|Electromagnetic tracking|electromagnetic tracking
5034885|NCT03781271|Implant quality|implant quality
5034886|NCT03781271|Image guidance|image guidance
5034887|NCT03781258|Mechanical circulatory support|mechanical circulatory support
5034888|NCT03781258|Anti-thrombotic monotherapy|anti-thrombotic monotherapy
5034889|NCT03781232|Non-invasive glucose monitoring|non-invasive glucose monitoring
5034890|NCT03781232|Raman spectroscopy|raman spectroscopy
5034891|NCT03781206|Stoma|stoma
5034892|NCT03781206|Surgical Site Infection|surgical site infection
5034893|NCT03781206|Negative Pressure Wound Therapy|negative pressure wound therapy
5034894|NCT03781193|mindfulness|mindfulness
5034895|NCT03781193|Psychological predictors|psychological predictors
5034896|NCT03781193|Colorectal surgery|colorectal surgery
5034897|NCT03781193|ERAS|eras
5034898|NCT03781180|SIPT|sipt
5034899|NCT03781180|Motor Accuracy|motor accuracy
5034900|NCT03781180|Validity|validity
5034901|NCT03781180|Reliability|reliability
5034902|NCT03781154|Physical activity|physical activity
5034903|NCT03781154|Survivors|survivors
5034904|NCT03781154|Maintenance|maintenance
5034905|NCT03781154|Personal Training|personal training
5034906|NCT03781154|Group Mediated Cognitive Behavior|group mediated cognitive behavior
5034907|NCT03781154|Randomized|randomized
5036358|NCT03771729|Heart Failure|heart failure
5034909|NCT03781128|serotonin|serotonin
5034910|NCT03781128|hallucinogen|hallucinogen
5034911|NCT03781128|cluster headache|cluster headache
5034912|NCT03781115|schizophrenia, psychosis, ziprasidone, olanzapine|schizophrenia, psychosis, ziprasidone, olanzapine
5034913|NCT03781102|Type 2 Diabetes|type 2 diabetes
5034914|NCT03781102|Diabetes Prevention|diabetes prevention
5034915|NCT03781102|Prediabetes Intervention|prediabetes intervention
5034916|NCT03781102|Mothers|mothers
5034917|NCT03781102|Children|children
5034918|NCT03781102|Federally Qualified Health Center (FQHC) Program|federally qualified health center (fqhc) program
5034919|NCT03781089|Hemodialysis|hemodialysis
5034920|NCT03781076|Adolescence, Sleep|adolescence, sleep
5034921|NCT03781063|Locally Advanced Breast Cancer|locally advanced breast cancer
5034922|NCT03781063|Metastatic Breast Cancer|metastatic breast cancer
5034923|NCT03781063|Lasofoxifene|lasofoxifene
5034924|NCT03781063|Fulvestrant|fulvestrant
5034939|NCT03780907|generalized seizures|generalized seizures
5034940|NCT03780894|Polytrauma|polytrauma
5034941|NCT03780894|Red blood cells transfusion|red blood cells transfusion
5034942|NCT03780894|Acute traumatic hemorrhage|acute traumatic hemorrhage
5035240|NCT03779048|Hormones|hormones
5034946|NCT03780855|repair|repair
5034947|NCT03780855|safety|safety
5028705|NCT03819946|Persistent AF ablation|persistent af ablation
5028706|NCT03819933|Counseling|counseling
5028707|NCT03819933|Extreme Prematurity|extreme prematurity
5028711|NCT03819894|sex differences|sex differences
5034948|NCT03780855|effectiveness|effectiveness
5034949|NCT03780829|spinal cord injury|spinal cord injury
5034950|NCT03780829|hypoxia|hypoxia
5034951|NCT03780829|plasticity|plasticity
5034952|NCT03780803|cardiac rehabilitation|cardiac rehabilitation
5034953|NCT03780803|pulmonary rehabilitation|pulmonary rehabilitation
5034954|NCT03780790|quadratus lumborum block|quadratus lumborum block
5034955|NCT03780790|transversus abdominis plane block|transversus abdominis plane block
5034956|NCT03780790|caudal block|caudal block
5034957|NCT03780790|ultrasound-guided|ultrasound-guided
5034958|NCT03780777|older adult falls|older adult falls
5034959|NCT03780777|home hazards|home hazards
5034960|NCT03780777|home barriers|home barriers
5034961|NCT03780764|Pulpal blood flow|pulpal blood flow
5034962|NCT03780764|self ligating brackets|self ligating brackets
5034963|NCT03780764|orthodontics|orthodontics
5034964|NCT03780751|Sexual dysfunction|sexual dysfunction
5034965|NCT03780751|Female Sexual Interest/Arousal Disorder|female sexual interest/arousal disorder
5034966|NCT03780751|Internet-based intervention|internet-based intervention
5034967|NCT03780751|Mindfulness|mindfulness
5034968|NCT03780751|Cognitive-behavioral therapy|cognitive-behavioral therapy
5034969|NCT03780738|Aortic dissection|aortic dissection
5034970|NCT03780738|Aldehyde dehydrogenase 2 polymorphism|aldehyde dehydrogenase 2 polymorphism
5034971|NCT03780686|Restrictive hydration,|restrictive hydration,
5034972|NCT03780686|Dopamine,|dopamine,
5034973|NCT03780686|Norepinephrine,|norepinephrine,
5034974|NCT03780686|Serum lactate,|serum lactate,
5034975|NCT03780686|Standard hydration|standard hydration
5034976|NCT03780660|Volume expansion|volume expansion
5034977|NCT03780660|fluid responsiveness|fluid responsiveness
5034978|NCT03780660|critically ill patient|critically ill patient
5034979|NCT03780660|spontaneously breathing patient|spontaneously breathing patient
5034980|NCT03780660|central venous pressure variation|central venous pressure variation
5034981|NCT03780647|Thoracic outlet syndrome|thoracic outlet syndrome
5034982|NCT03780647|Performance at work|performance at work
5034983|NCT03780634|Hepatocellular Carcinoma|hepatocellular carcinoma
5034984|NCT03780634|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5034985|NCT03780634|Programmed cell death protein-1 antibody|programmed cell death protein-1 antibody
5034986|NCT03780634|Oxaliplatin, 5-Fluorouracil and Leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
5034987|NCT03780621|Electroencephalography|electroencephalography
5034988|NCT03780621|Andrographis|andrographis
5034989|NCT03780621|Ashwagandha|ashwagandha
5034990|NCT03780595|Benzodiazepine|benzodiazepine
5034991|NCT03780595|Withdrawal|withdrawal
5034992|NCT03780595|passiflora|passiflora
5034994|NCT03780569|TTFields|ttfields
5034995|NCT03780569|Tumor Treating Fields|tumor treating fields
5034996|NCT03780569|Glioblastoma|glioblastoma
5034997|NCT03780569|Glioblastoma Multiforme|glioblastoma multiforme
5034998|NCT03780556|Renal pain|renal pain
5034999|NCT03780556|lornoxicam|lornoxicam
5035000|NCT03780556|pethidine|pethidine
5035001|NCT03780556|emergency room|emergency room
5035002|NCT03780556|ketamine|ketamine
5035004|NCT03780543|HBV|hbv
5035005|NCT03780543|HBeAg positive|hbeag positive
5048830|NCT03693716|LHBT|lhbt
5035006|NCT03780543|HBeAg negative|hbeag negative
5035008|NCT03780543|hepatitis B virus|hepatitis b virus
5035009|NCT03780543|SVR|svr
5035014|NCT03780452|intramedullary nail|intramedullary nail
5035015|NCT03780452|arthrodesis|arthrodesis
5035016|NCT03780452|subtalar|subtalar
5035017|NCT03780452|tibiotalar|tibiotalar
5035018|NCT03780439|procalcitonin|procalcitonin
5035019|NCT03780439|infection|infection
5035031|NCT03780361|visual acuity|visual acuity
5035032|NCT03780361|optical coherence tomography|optical coherence tomography
5035033|NCT03780361|macular thickness|macular thickness
5035034|NCT03780361|hyperreflective foci|hyperreflective foci
5035035|NCT03780348|Weigh-for-Height/Length|weigh-for-height/length
5035037|NCT03780335|STEMI|stemi
5035038|NCT03780335|Cardiac magnetic resonance|cardiac magnetic resonance
5035039|NCT03780322|brachial plexus birth palsy|brachial plexus birth palsy
5035040|NCT03780322|Armeo®Spring Pediatric|armeo®spring pediatric
5035055|NCT03780257|USH2A|ush2a
5035056|NCT03780257|RP|rp
5035057|NCT03780257|exon 13|exon 13
5035058|NCT03780257|RNA therapies|rna therapies
5035059|NCT03780257|antisense oligonucleotide|antisense oligonucleotide
5035060|NCT03780257|exon skipping|exon skipping
5035061|NCT03780257|STELLAR|stellar
5035062|NCT03780257|IVT|ivt
5035063|NCT03780257|mutations in exon 13 of the USH2A gene|mutations in exon 13 of the ush2a gene
5035064|NCT03780257|NSRP|nsrp
5035065|NCT03780231|Athletes|athletes
5035066|NCT03780231|Late gadolinium enhancement|late gadolinium enhancement
5035067|NCT03780231|fibrosis|fibrosis
5035069|NCT03780218|Pulmonary function|pulmonary function
5035070|NCT03780218|Respiratory muscle|respiratory muscle
5035071|NCT03780218|Peripheral muscle|peripheral muscle
5035072|NCT03780205|Amblyopia|amblyopia
5035073|NCT03780179|measles-mumps-rubella vaccine|measles-mumps-rubella vaccine
5035074|NCT03780166|Pemphigus vulgaris|pemphigus vulgaris
5035075|NCT03780166|phosphatidylinositol 3-kinase delta|phosphatidylinositol 3-kinase delta
5035076|NCT03780166|immunoglobulin G autoantibodies|immunoglobulin g autoantibodies
5035080|NCT03780062|S100B protein|s100b protein
5035081|NCT03780062|minor traumatic brain injuries|minor traumatic brain injuries
5035082|NCT03780062|antiplatelet therapy|antiplatelet therapy
5035083|NCT03780049|Hepatocellular Carcinoma|hepatocellular carcinoma
5035084|NCT03780049|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
5035085|NCT03780049|Oxaliplatin, 5-fluorouracil and leucovorin|oxaliplatin, 5-fluorouracil and leucovorin
5035086|NCT03780049|Recombinant Human Type-5 Adenovirus|recombinant human type-5 adenovirus
5035091|NCT03779945|PRP|prp
5035092|NCT03779906|hypothyroidism|hypothyroidism
5035093|NCT03779906|ISOVUE|isovue
5035094|NCT03779906|Iodinated Contrast Agent|iodinated contrast agent
5035095|NCT03779880|Parkinson Disease, Early Retirement,|parkinson disease, early retirement,
5035096|NCT03779828|CIDP|cidp
5035097|NCT03779828|Telemonitoring|telemonitoring
5035098|NCT03779828|Telemedicine|telemedicine
5035099|NCT03779815|multiple myeloma|multiple myeloma
5035100|NCT03779815|amyloidosis|amyloidosis
5035101|NCT03779815|Florbetaben|florbetaben
5035102|NCT03779802|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5035103|NCT03779802|Atrioventricular delay optimization|atrioventricular delay optimization
5035104|NCT03779802|Multipoint pacing|multipoint pacing
5334810|NCT02017938|Fatigue|fatigue
5035105|NCT03779802|Negative atrioventricular hysteresis|negative atrioventricular hysteresis
5035106|NCT03779802|Non invasive hemodynamic optimization|non invasive hemodynamic optimization
5035107|NCT03779802|Heart Failure|heart failure
5035108|NCT03779789|vortioxetine|vortioxetine
5035109|NCT03779789|SSRI|ssri
5035110|NCT03779789|depression|depression
5035111|NCT03779789|elderly|elderly
5035112|NCT03779724|multiple sclerosis|multiple sclerosis
5035113|NCT03779724|isokinetic|isokinetic
5035114|NCT03779724|exercises|exercises
5035115|NCT03779724|joint position sense|joint position sense
5035116|NCT03779724|kinesiophobia|kinesiophobia
5035128|NCT03779698|BiodentineTM|biodentinetm
5035129|NCT03779698|Formocresol|formocresol
5035130|NCT03779698|Primary molars|primary molars
5035131|NCT03779698|Pulpotomy|pulpotomy
5036573|NCT03770442|FES|fes
5035157|NCT03779490|Edwards Cardioband TR|edwards cardioband tr
5035159|NCT03779490|Tricuspid Repair|tricuspid repair
5035160|NCT03779490|Tricuspid Valve|tricuspid valve
5035161|NCT03779477|Depression|depression
5035162|NCT03779477|High-Risk|high-risk
5035163|NCT03779477|Adolescent|adolescent
5035164|NCT03779477|fMRI|fmri
5035165|NCT03779464|pancreatic cancer|pancreatic cancer
5035166|NCT03779464|nab-paclitaxel|nab-paclitaxel
5035167|NCT03779464|gemcitabine|gemcitabine
5035168|NCT03779464|S1|s1
5035169|NCT03779451|cesarean section|cesarean section
5035170|NCT03779451|placenta previa|placenta previa
5035171|NCT03779451|antepartum hemorrhage|antepartum hemorrhage
5035172|NCT03779451|vaginal progesterone|vaginal progesterone
5035173|NCT03779451|17-Alpha-Hydroxyprogesterone Caproate|17-alpha-hydroxyprogesterone caproate
5035174|NCT03779438|cesarean section|cesarean section
5035175|NCT03779438|placenta previa|placenta previa
5035176|NCT03779438|antepartum hemorrhage|antepartum hemorrhage
5035177|NCT03779438|17-alpha-Hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
5035178|NCT03779399|Ovarian Cancer|ovarian cancer
5035179|NCT03779399|Borderline Ovarian Tumor|borderline ovarian tumor
5035180|NCT03779399|Benign Ovarian Tumor|benign ovarian tumor
5035181|NCT03779399|lymphocyte T regulatory|lymphocyte t regulatory
5035182|NCT03779399|Natural Killer T cell|natural killer t cell
5035183|NCT03779399|ROMA|roma
5035184|NCT03779399|HE4|he4
5028917|NCT03818438|Rehabilitation|rehabilitation
5028918|NCT03818438|Ankle|ankle
5035185|NCT03779347|pregnancy, UPC-LF CAA, Schistosomiasis, children|pregnancy, upc-lf caa, schistosomiasis, children
5035186|NCT03779321|food, acceptability, appetite, hormones, ghrelin, GLP-1|food, acceptability, appetite, hormones, ghrelin, glp-1
5035192|NCT03779295|perioral dermatitis|perioral dermatitis
5035193|NCT03779295|laser therapy|laser therapy
5035194|NCT03779256|Deep infiltrating endometriosis|deep infiltrating endometriosis
5035195|NCT03779256|Transvaginal ultrasound|transvaginal ultrasound
5035196|NCT03779256|Endometriosis rectum|endometriosis rectum
5035197|NCT03779256|Conservative surgery|conservative surgery
5035198|NCT03779256|Radical surgery|radical surgery
5035199|NCT03779256|Quality of life|quality of life
5035200|NCT03779204|Social Isolation|social isolation
5035201|NCT03779204|Self-Esteem|self-esteem
5035203|NCT03779204|Psychiatric Problem|psychiatric problem
5035204|NCT03779204|Education|education
5035205|NCT03779204|Employment|employment
5035206|NCT03779204|Income|income
5035207|NCT03779204|Housing Problems|housing problems
5035208|NCT03779204|Identity, Social|identity, social
5035209|NCT03779204|Youth|youth
5035210|NCT03779204|Rent Subsidy|rent subsidy
5035211|NCT03779204|Mentorship|mentorship
5035212|NCT03779178|landiolol|landiolol
5035213|NCT03779178|microcirculation|microcirculation
5035214|NCT03779178|cardiac surgery|cardiac surgery
5035215|NCT03779178|atrial fibrillation|atrial fibrillation
5035216|NCT03779165|ventricular tachycardia|ventricular tachycardia
5035217|NCT03779165|R wave; sensing|r wave; sensing
5035218|NCT03779165|radiofrequency ablation|radiofrequency ablation
5035219|NCT03779165|follow-up|follow-up
5035220|NCT03779139|total pancreatectomy with islet autotransplant|total pancreatectomy with islet autotransplant
5035221|NCT03779126|Chronic Kidney Disease|chronic kidney disease
5035222|NCT03779126|Electrical stimulation|electrical stimulation
5035223|NCT03779113|lymphoma|lymphoma
5035224|NCT03779113|mantle cell|mantle cell
5035225|NCT03779113|marginal zone|marginal zone
5035226|NCT03779113|waldenstrom|waldenstrom
5035227|NCT03779113|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5035228|NCT03779113|follicular|follicular
5035229|NCT03779100|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5035230|NCT03779100|Lenvatinib|lenvatinib
5035231|NCT03779100|PD-1 Antibody|pd-1 antibody
5035232|NCT03779087|Helicobacter pylori|helicobacter pylori
5035233|NCT03779087|Eradication rate|eradication rate
5723664|NCT00417950|diabetes|diabetes
5035236|NCT03779074|Eradication rate|eradication rate
5035237|NCT03779048|phentermine|phentermine
5035238|NCT03779048|Hypoglycemic agents|hypoglycemic agents
5035245|NCT03779048|Body Weight|body weight
5036666|NCT03769844|pediatric|pediatric
5035266|NCT03778983|Pediatric Live Transplantation|pediatric live transplantation
5035267|NCT03778957|Hepatocellular Carcinoma|hepatocellular carcinoma
5035268|NCT03778957|TACE|tace
5035269|NCT03778957|Durvalumab|durvalumab
5035270|NCT03778957|Bevacizumab|bevacizumab
5035271|NCT03778957|Liver Cancer|liver cancer
5035272|NCT03778944|Mannitol|mannitol
5035273|NCT03778944|Dopamine|dopamine
5035274|NCT03778944|Perfusion|perfusion
5035275|NCT03778944|Renal graft donor|renal graft donor
5035276|NCT03778944|Anesthesia|anesthesia
5035277|NCT03778918|REG3 alpha|reg3 alpha
5035279|NCT03778918|biomarker|biomarker
5035280|NCT03778918|ulcerative colitis|ulcerative colitis
5035281|NCT03778918|serum calprotectin|serum calprotectin
5035282|NCT03778892|PrEP adherence|prep adherence
5035283|NCT03778892|Youth|youth
5035284|NCT03778892|Adolescents|adolescents
5035286|NCT03778892|HIV Prevention|hiv prevention
5035287|NCT03778892|Mobile Health|mobile health
5035288|NCT03778879|Adenocarcinoma|adenocarcinoma
5035289|NCT03778879|Pancreas|pancreas
5035290|NCT03778879|Radiation Therapy|radiation therapy
5035291|NCT03778879|CCX872-B|ccx872-b
5035292|NCT03778853|Non-squamous NSCLC|non-squamous nsclc
5035293|NCT03778840|Infections|infections
5035294|NCT03778840|immunoglobulins|immunoglobulins
5029028|NCT03817866|Non-functional NETs|non-functional nets
5029029|NCT03817866|Immunoassay|immunoassay
5029030|NCT03817840|Glucocorticoids|glucocorticoids
5029031|NCT03817827|sports injury|sports injury
5029033|NCT03817827|acupuncture|acupuncture
5035295|NCT03778840|secondary immunodeficiency|secondary immunodeficiency
5035296|NCT03778840|rituximab|rituximab
5035297|NCT03778827|Pivotal Response Treatment|pivotal response treatment
5035298|NCT03778814|Lung Cancer; Solid Tumor|lung cancer; solid tumor
5035299|NCT03778814|Immunotherapy|immunotherapy
5035300|NCT03778814|TCR-T Cell Therapy|tcr-t cell therapy
5035301|NCT03778801|kinesiophobia|kinesiophobia
5035302|NCT03778801|physical activity|physical activity
5035303|NCT03778801|disability|disability
5035304|NCT03778788|life style modification program|life style modification program
5035305|NCT03778788|mobile application|mobile application
5035306|NCT03778788|booklet|booklet
5035307|NCT03778788|exercise|exercise
5035308|NCT03778788|body weight|body weight
5035309|NCT03778788|randomized control trial|randomized control trial
5035310|NCT03778788|metabolic syndrome|metabolic syndrome
5035311|NCT03778788|adult|adult
5035312|NCT03778775|Transient elastography|transient elastography
5035313|NCT03778775|Gastroesophageal varices bleeding|gastroesophageal varices bleeding
5035314|NCT03778775|Varices needing treatment|varices needing treatment
5035315|NCT03778762|air-Q, blind intubation, correction maneuvers, fiberoptic guided intubation|air-q, blind intubation, correction maneuvers, fiberoptic guided intubation
5035316|NCT03778749|train-of-four monitoring|train-of-four monitoring
5035317|NCT03778749|acceleromyography|acceleromyography
5035318|NCT03778749|electromyography|electromyography
5035336|NCT03778606|Clostridium difficile|clostridium difficile
5035337|NCT03778606|Asymptomatic carrier|asymptomatic carrier
5035338|NCT03778606|Potato starch|potato starch
5035339|NCT03778606|Non digestable oligosaccharide|non digestable oligosaccharide
5035357|NCT03778476|fibromyalgia|fibromyalgia
5035365|NCT03778398|cerebral palsy|cerebral palsy
5035366|NCT03778398|piano training|piano training
5035367|NCT03778385|Fibromyalgia|fibromyalgia
5035368|NCT03778385|Exercise|exercise
5035369|NCT03778385|Pain|pain
5035370|NCT03778385|Physical Activity|physical activity
5035371|NCT03778385|Body Composition|body composition
5035372|NCT03778333|Mesenchymal Stem Cells|mesenchymal stem cells
5035373|NCT03778333|Multiple Sclerosis|multiple sclerosis
5035374|NCT03778307|Trauma|trauma
5035375|NCT03778307|PTSD|ptsd
5035376|NCT03778307|Endothelial Dysfunction|endothelial dysfunction
5035377|NCT03778281|Baclofen|baclofen
5035378|NCT03778281|Chemotheropy|chemotheropy
5035379|NCT03778268|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5035380|NCT03778255|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5035381|NCT03778242|cesarean section|cesarean section
5035382|NCT03778242|tranexamic acid|tranexamic acid
5035383|NCT03778242|postpartum hemorrhage|postpartum hemorrhage
5035384|NCT03778242|oxytocin|oxytocin
5035393|NCT03778203|Immunology|immunology
5035394|NCT03778203|Inactivated influenza vaccine|inactivated influenza vaccine
5035395|NCT03778203|Influenza infection|influenza infection
5035396|NCT03778203|Host response|host response
5035397|NCT03778203|Pediatrics|pediatrics
5035398|NCT03778177|transcranial electrical stimulation (tES)|transcranial electrical stimulation (tes)
5035399|NCT03778138|Advanced nonsquamous Non-Small Cell Lung Cancer|advanced nonsquamous non-small cell lung cancer
5035400|NCT03778138|Anlotinib Combined With Pemetrexed|anlotinib combined with pemetrexed
5035401|NCT03778125|multidrug resistant|multidrug resistant
5035402|NCT03778112|Prostate Cancer|prostate cancer
5035403|NCT03778112|Radiotherapy|radiotherapy
5035404|NCT03778112|SBRT|sbrt
5035405|NCT03778112|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5035407|NCT03778099|PCOS|pcos
5035408|NCT03778099|Ovulation|ovulation
5035409|NCT03778099|Cinnamon|cinnamon
5035410|NCT03778073|relapsed or refractory|relapsed or refractory
5348752|NCT01954914|poor donors|poor donors
5035413|NCT03778008|Radiation therapy|radiation therapy
5035414|NCT03778008|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5035415|NCT03777995|Balance|balance
5035416|NCT03777982|Prostate Cancer|prostate cancer
5035417|NCT03777969|Chronic Hepatitis B|chronic hepatitis b
5035418|NCT03777969|Liver fibrosis/cirrhosis|liver fibrosis/cirrhosis
5035419|NCT03777969|HBV-related endpoint events|hbv-related endpoint events
5035420|NCT03777969|Precise prediction model|precise prediction model
5035421|NCT03777930|thalidomide|thalidomide
5035422|NCT03777930|megestrol acetate|megestrol acetate
5035423|NCT03777930|tumor|tumor
5035424|NCT03777930|lymphocyte|lymphocyte
5035425|NCT03777930|inflammatory cytokines|inflammatory cytokines
5035426|NCT03777930|nutritional|nutritional
5035427|NCT03777878|cesarean section|cesarean section
5035428|NCT03777878|tranexamic acid|tranexamic acid
5035429|NCT03777878|oxytocin|oxytocin
5035430|NCT03777878|carbetocin|carbetocin
5035431|NCT03777852|breast cancer, breast surgery, breast reconstruction,|breast cancer, breast surgery, breast reconstruction,
5035432|NCT03777813|oesophagus|oesophagus
5035433|NCT03777813|localised unresectable|localised unresectable
5035434|NCT03777813|adenocarcinoma or squamous cell carcinoma|adenocarcinoma or squamous cell carcinoma
5035435|NCT03777813|durvalumab|durvalumab
5035436|NCT03777813|FOLFOX 4 simplified|folfox 4 simplified
5035437|NCT03777813|Definitive modulated-intensity radiotherapy|definitive modulated-intensity radiotherapy
5035438|NCT03777800|Veterans|veterans
5035450|NCT03777787|TLESRs|tlesrs
5035451|NCT03777787|Gastric tone|gastric tone
5035455|NCT03777774|Post craniectomy hydrocephalus|post craniectomy hydrocephalus
5035457|NCT03777774|Bradycardia|bradycardia
5035458|NCT03777774|Hypotension|hypotension
5035459|NCT03777774|Wound breakdown|wound breakdown
5035460|NCT03777748|Oral Health Impact Factor|oral health impact factor
5035461|NCT03777748|Survival rate|survival rate
5035462|NCT03777748|Maxillary overdenture|maxillary overdenture
5035463|NCT03777748|Implant-Supported|implant-supported
5035464|NCT03777748|Bone Resorption|bone resorption
5035465|NCT03777748|Titanium-Zirconium|titanium-zirconium
5035466|NCT03777748|Anchor System|anchor system
5035467|NCT03777735|human bone graft screw|human bone graft screw
5035468|NCT03777735|osteochondral defect|osteochondral defect
5035469|NCT03777735|knee|knee
5035470|NCT03777696|cesarean section|cesarean section
5035471|NCT03777696|tranexamic acid|tranexamic acid
5035472|NCT03777696|postpartum hemorrhage|postpartum hemorrhage
5035473|NCT03777696|misoprostol|misoprostol
5035474|NCT03777670|Newborn|newborn
5035475|NCT03777631|anticoagulation treatment|anticoagulation treatment
5035476|NCT03777631|catheter ablation|catheter ablation
5035477|NCT03777618|plastic and reconstructive surgery|plastic and reconstructive surgery
5035478|NCT03777618|gluteal ptosis|gluteal ptosis
5035479|NCT03777618|platipygia|platipygia
5035480|NCT03777553|posttraumatic stress disorder|posttraumatic stress disorder
5035481|NCT03777553|criminal justice|criminal justice
5035501|NCT03777306|Educational intervention|educational intervention
5035503|NCT03777267|Neurotechnology|neurotechnology
5035504|NCT03777267|Autonomic Dysregulation|autonomic dysregulation
5035505|NCT03777267|Hyperarousal|hyperarousal
5035506|NCT03777267|Brain electrical activity|brain electrical activity
5035507|NCT03777267|Allostasis|allostasis
5035508|NCT03777267|HIRREM|hirrem
5035509|NCT03777267|Cereset Research|cereset research
5035510|NCT03777267|Insomnia|insomnia
5035511|NCT03777267|Anxiety|anxiety
5035512|NCT03777228|Traumatic brain injury, concussion, eye tracking, EEG, fMRI, DTI, Neurocognition|traumatic brain injury, concussion, eye tracking, eeg, fmri, dti, neurocognition
5035513|NCT03777163|Vaccine|vaccine
5035514|NCT03777163|Immunization|immunization
5035515|NCT03777163|Safety|safety
5035516|NCT03777163|Immunogenicity|immunogenicity
5035517|NCT03777150|Intensive care|intensive care
5035518|NCT03777150|postoperative care|postoperative care
5035519|NCT03777150|elective surgery|elective surgery
5035520|NCT03777137|Brain network for pain|brain network for pain
5035521|NCT03777111|Aging|aging
5035522|NCT03777111|gait|gait
5035523|NCT03777111|balance|balance
5035524|NCT03777111|functional mobility|functional mobility
5035525|NCT03777111|dual task training|dual task training
5035526|NCT03777072|Total Ankle Replacement|total ankle replacement
5035527|NCT03777072|Pain Measurement|pain measurement
5035528|NCT03777059|Migraine|migraine
5035529|NCT03777059|Aura|aura
5035533|NCT03777020|human-animal interaction|human-animal interaction
5035534|NCT03777020|service dog|service dog
5035535|NCT03777020|stress|stress
5035536|NCT03776994|Venezuelan Equine Encephalitis, vaccine|venezuelan equine encephalitis, vaccine
5035537|NCT03776994|Intramuscular|intramuscular
5035538|NCT03776994|Phase 1 clinical study|phase 1 clinical study
5035636|NCT03776188|Bariatric Revision|bariatric revision
5035539|NCT03776929|Dialectical Behavioral Therapy|dialectical behavioral therapy
5035540|NCT03776929|Orthopaedic|orthopaedic
5035542|NCT03776929|Pain Catastrophizing Scale|pain catastrophizing scale
5035543|NCT03776890|stress reduction|stress reduction
5035544|NCT03776890|rural|rural
5035545|NCT03776890|health behaviors|health behaviors
5035546|NCT03776890|north carolina|north carolina
5035547|NCT03776851|Hemolytic-Uremic Syndrome|hemolytic-uremic syndrome
5035548|NCT03776851|erythropoietin|erythropoietin
5035549|NCT03776851|RBC transfusion|rbc transfusion
5035550|NCT03776838|NOL monitoring|nol monitoring
5035551|NCT03776838|anesthesia|anesthesia
5035552|NCT03776838|fentanyl consumption|fentanyl consumption
5035553|NCT03776838|intraoperative|intraoperative
5035554|NCT03776812|Glucocorticoid Receptor|glucocorticoid receptor
5035555|NCT03776812|Ovarian Cancer|ovarian cancer
5035556|NCT03776812|Fallopian Tube Cancer|fallopian tube cancer
5035557|NCT03776812|Primary Peritoneal Cancer|primary peritoneal cancer
5035558|NCT03776812|Nab-paclitaxel|nab-paclitaxel
5035559|NCT03776812|GR Antagonist|gr antagonist
5035560|NCT03776812|Relacorilant|relacorilant
5035561|NCT03776734|precooling|precooling
5035562|NCT03776734|exercise|exercise
5035563|NCT03776734|pulmonary function|pulmonary function
5035564|NCT03776734|isokinetic|isokinetic
5035565|NCT03776734|lactate|lactate
5035566|NCT03776708|pressure pain threshold|pressure pain threshold
5035567|NCT03776708|asymptomatic subjects|asymptomatic subjects
5035568|NCT03776708|duration|duration
5036948|NCT03768310|ALL|all
5035572|NCT03776669|High resolution impedance manometry|high resolution impedance manometry
5035573|NCT03776656|Adenylosuccinate lyase|adenylosuccinate lyase
5035574|NCT03776656|Deficit|deficit
5035575|NCT03776656|Allopurinol|allopurinol
5035576|NCT03776656|Autism|autism
5035577|NCT03776656|Epilepsy|epilepsy
5035578|NCT03776630|Ovarian cancer|ovarian cancer
5035579|NCT03776630|endometrial cancer|endometrial cancer
5035581|NCT03776630|diagnostic|diagnostic
5035582|NCT03776617|scalp block|scalp block
5035583|NCT03776617|craniotomy|craniotomy
5035584|NCT03776617|dexmedetomidine|dexmedetomidine
5035585|NCT03776617|ropivacaine|ropivacaine
5035586|NCT03776591|D3 lymphadenectomy|d3 lymphadenectomy
5035587|NCT03776591|Right-sided|right-sided
5035589|NCT03776591|Complications|complications
5035590|NCT03776591|Circulating tumor cells|circulating tumor cells
5035591|NCT03776591|Circulating DNA (cDNA)|circulating dna (cdna)
5035592|NCT03776591|Laparoscopy|laparoscopy
5035593|NCT03776591|Complete mesocolic excision|complete mesocolic excision
5035594|NCT03776539|Impaired Renal Function|impaired renal function
5035595|NCT03776539|PK|pk
5035596|NCT03776526|Hip fractures|hip fractures
5035597|NCT03776513|obesity, teenagers, emotional memory, brain networks|obesity, teenagers, emotional memory, brain networks
5035598|NCT03776474|Food allergy in children|food allergy in children
5035599|NCT03776474|Immunoglobulin E|immunoglobulin e
5035600|NCT03776474|Immunoglobulin G4|immunoglobulin g4
5035601|NCT03776474|Oral food challenge|oral food challenge
5035602|NCT03776474|Plasma metabolomic analysis|plasma metabolomic analysis
5035603|NCT03776461|fractional radiofrequency|fractional radiofrequency
5035604|NCT03776461|fractional RF|fractional rf
5035605|NCT03776461|facial wrinkles|facial wrinkles
5035606|NCT03776461|wrinkles|wrinkles
5035607|NCT03776396|Perioperative Goal Directed Therapy|perioperative goal directed therapy
5035608|NCT03776396|Minimally invasive hemodynamic monitoring|minimally invasive hemodynamic monitoring
5035609|NCT03776396|Kidney transplantation|kidney transplantation
5035610|NCT03776383|Antibiotic use|antibiotic use
5035611|NCT03776383|Audit and feedback|audit and feedback
5035612|NCT03776383|implementation science|implementation science
5035613|NCT03776383|Antimicrobial stewardship|antimicrobial stewardship
5035614|NCT03776370|rectal cancer|rectal cancer
5035615|NCT03776370|Postoperative Complications|postoperative complications
5035616|NCT03776370|Preserve the left colonic artery|preserve the left colonic artery
5035617|NCT03776331|Myeloma|myeloma
5035618|NCT03776331|Flow mediated dilation|flow mediated dilation
5035619|NCT03776331|Endothelial Dysfunction|endothelial dysfunction
5035620|NCT03776331|Proteasome inhibitors|proteasome inhibitors
5035621|NCT03776305|pharmacokinetic|pharmacokinetic
5035622|NCT03776305|imipenem|imipenem
5035623|NCT03776305|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5035624|NCT03776292|cardiac, output, pulmonary, compliance, bladder, Retractor.|cardiac, output, pulmonary, compliance, bladder, retractor.
5035625|NCT03776266|Transfusion|transfusion
5035626|NCT03776266|PCI|pci
5035627|NCT03776266|Percutaneous Coronary Intervention|percutaneous coronary intervention
5035628|NCT03776240|randomized|randomized
5035629|NCT03776240|double-blind|double-blind
5035630|NCT03776214|No pitting edema|no pitting edema
5035631|NCT03776214|After medical and surgical evaluation|after medical and surgical evaluation
5035632|NCT03776214|Microlipoaspiration|microlipoaspiration
5035633|NCT03776214|surgery|surgery
5035634|NCT03776214|lymphedema|lymphedema
5035635|NCT03776188|Endoscopic Suturing|endoscopic suturing
5035637|NCT03776188|Stent Fixation|stent fixation
5035638|NCT03776188|Bariatric Surgery|bariatric surgery
5035639|NCT03776162|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
5035640|NCT03776162|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5035641|NCT03776162|Anterior Cruciate Ligament Repair|anterior cruciate ligament repair
5035642|NCT03776162|Knee Surgery|knee surgery
5035643|NCT03776136|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5356789|NCT01918007|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5035644|NCT03776136|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5035645|NCT03776136|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5035646|NCT03776110|Dose escalation|dose escalation
5035647|NCT03776084|treatment adherence and compliance|treatment adherence and compliance
5035648|NCT03776084|attitudes|attitudes
5035649|NCT03776084|Continuous Positive Airway Pressure|continuous positive airway pressure
5035650|NCT03776084|cross-cultural validation|cross-cultural validation
5035651|NCT03776045|Prostate Cancer|prostate cancer
5035652|NCT03776045|Androgen deprivation therapy|androgen deprivation therapy
5035653|NCT03776045|Exercise|exercise
5035654|NCT03776032|Lung cancer|lung cancer
5035655|NCT03776019|Pain|pain
5035656|NCT03776019|Stress|stress
5035657|NCT03776019|AVWF|avwf
5035658|NCT03776019|Audio-Visual-Perception-Enhancement|audio-visual-perception-enhancement
5035659|NCT03776006|Transperineal laser ablation|transperineal laser ablation
5035660|NCT03776006|LUTS|luts
5035661|NCT03775993|Growth Hormone|growth hormone
5035662|NCT03775993|Placebo|placebo
5035663|NCT03775993|Exercise capacity|exercise capacity
5035664|NCT03775993|Vascular reactivity|vascular reactivity
5035665|NCT03775993|LV function|lv function
5035666|NCT03775993|Prognosis|prognosis
5035667|NCT03775967|sialic acid|sialic acid
5035668|NCT03775967|IL10|il10
5035669|NCT03775967|stage 1 periodontal disease|stage 1 periodontal disease
5035670|NCT03775967|stage 2 periodontal disease|stage 2 periodontal disease
5035671|NCT03775954|Fetal Magnetocardiography|fetal magnetocardiography
5035672|NCT03775954|Stillbirth|stillbirth
5035673|NCT03775954|Intrauterine Fetal Demise|intrauterine fetal demise
5035674|NCT03775954|Mobile Medical Technologies|mobile medical technologies
5035675|NCT03775954|Fetal Heart Rate Variability|fetal heart rate variability
5035676|NCT03775954|Fetal Arrhythmias|fetal arrhythmias
5035677|NCT03775954|High Risk Pregnancy|high risk pregnancy
5035678|NCT03775954|Pregnancy|pregnancy
5035686|NCT03775941|White matter|white matter
5035687|NCT03775941|Cardiorespiratory fitness|cardiorespiratory fitness
5035688|NCT03775941|Physical activity|physical activity
5035689|NCT03775941|Cognitive aging|cognitive aging
5035690|NCT03775941|Executive function|executive function
5035691|NCT03775941|Cognitive reserve|cognitive reserve
5035692|NCT03775915|Motor function|motor function
5035693|NCT03775915|Brain activity|brain activity
5035694|NCT03775876|Propofol|propofol
5035695|NCT03775876|Dexmedetomidine|dexmedetomidine
5035696|NCT03775876|Regional anesthesia|regional anesthesia
5035697|NCT03775876|Satisfaction|satisfaction
5035698|NCT03775876|Shoulder arthroscopy|shoulder arthroscopy
5035699|NCT03775863|Hepatocellular carcinoma|hepatocellular carcinoma
5035700|NCT03775863|models|models
5035701|NCT03775863|allocation|allocation
5035702|NCT03775863|selection|selection
5035703|NCT03775824|microbiome|microbiome
5035704|NCT03775824|methotrexate|methotrexate
5035705|NCT03775824|tnf-inhibitor|tnf-inhibitor
5035706|NCT03775824|dysbiosis|dysbiosis
5035707|NCT03775798|direct acting antivirals|direct acting antivirals
5035708|NCT03775798|hepatitis c|hepatitis c
5035709|NCT03775798|hepatocellular carcinoma|hepatocellular carcinoma
5035710|NCT03775785|enteral nutrition|enteral nutrition
5035711|NCT03775785|fortification|fortification
5035712|NCT03775785|tailored enteral nutrition|tailored enteral nutrition
5035713|NCT03775772|oral health|oral health
5035714|NCT03775772|bite force|bite force
5035715|NCT03775772|chewing efficiency|chewing efficiency
5035716|NCT03775772|dementia|dementia
5035717|NCT03775772|elderly|elderly
5035718|NCT03775772|aged|aged
5035719|NCT03775759|Left ventricular assist device|left ventricular assist device
5035720|NCT03775759|Tricuspid regurgitation|tricuspid regurgitation
5035721|NCT03775759|Right heart failure|right heart failure
5035722|NCT03775733|Hydrolysed red ginseng extract|hydrolysed red ginseng extract
5035723|NCT03775733|Glucose|glucose
5035724|NCT03775733|Clinical Trial|clinical trial
5035725|NCT03775707|Hepatocellular Carcinoma|hepatocellular carcinoma
5035726|NCT03775707|Lenvatinib|lenvatinib
5035727|NCT03775707|PD-1 Antibody|pd-1 antibody
5035728|NCT03775707|BCLC B stage|bclc b stage
5035729|NCT03775707|Beyond up-to-seven criteria|beyond up-to-seven criteria
5035730|NCT03775655|Cesarean Section|cesarean section
5035731|NCT03775655|Intrathecal Dexmedetomidine|intrathecal dexmedetomidine
5035732|NCT03775590|Atopic Dermatitis|atopic dermatitis
5035733|NCT03775590|Eczema|eczema
5035748|NCT03775473|progastrin|progastrin
5035749|NCT03775473|screening|screening
5035750|NCT03775473|bio-marker|bio-marker
5035751|NCT03775473|healthy person|healthy person
5035752|NCT03775473|early stage|early stage
5035753|NCT03775460|Erythema Nodosum Leprosum|erythema nodosum leprosum
5035755|NCT03775460|corticosteroids|corticosteroids
5035756|NCT03775460|Methotrexate|methotrexate
5035757|NCT03775460|ENL severity scale|enl severity scale
5035758|NCT03775460|quality of life|quality of life
5035759|NCT03775460|Leprosy|leprosy
5035760|NCT03775447|Parkinson's Disease|parkinson's disease
5035761|NCT03775447|Biomarker|biomarker
5035762|NCT03775447|LRRK2|lrrk2
5035763|NCT03775447|CSF|csf
5035769|NCT03775395|Hepatocellular carcinoma|hepatocellular carcinoma
5035770|NCT03775395|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
5035771|NCT03775395|Sorafenib|sorafenib
5035772|NCT03775395|Lenvatinib|lenvatinib
5035773|NCT03775369|interventions of physical activity and exercising (PAE)|interventions of physical activity and exercising (pae)
5035774|NCT03775369|resistance training|resistance training
5035775|NCT03775369|endurance training|endurance training
5035776|NCT03775356|Intraoperative EEG based monitoring|intraoperative eeg based monitoring
5035777|NCT03775356|Level of hypnosis|level of hypnosis
5035778|NCT03775356|Burst suppression|burst suppression
5035779|NCT03775356|Postoperative delirium|postoperative delirium
5035780|NCT03775356|EEG-signal characteristics|eeg-signal characteristics
5035781|NCT03775356|Entropy|entropy
5035782|NCT03775343|Anesthesia|anesthesia
5035783|NCT03775343|Postoperative cognitive decline|postoperative cognitive decline
5035784|NCT03775317|Video laryngoscopy|video laryngoscopy
5035785|NCT03775317|Nasal intubation|nasal intubation
5035788|NCT03775239|Erectile dysfunction|erectile dysfunction
5035789|NCT03775239|Orgasm dysfunction|orgasm dysfunction
5035796|NCT03775213|Overtreatment|overtreatment
5035797|NCT03775213|Active surveillance|active surveillance
5035798|NCT03775187|Expanded Access|expanded access
5035799|NCT03775187|Compassionate Use|compassionate use
5035800|NCT03775187|XLH|xlh
5035801|NCT03775187|TIO|tio
5035802|NCT03775174|Expanded Access|expanded access
5035803|NCT03775174|Compassionate Use|compassionate use
5035804|NCT03775148|Depression|depression
5035805|NCT03775148|Insomnia|insomnia
5035806|NCT03775148|Transdiagnostic Sleep and Circadian Treatment|transdiagnostic sleep and circadian treatment
5035807|NCT03775135|Identity|identity
5035815|NCT03775096|Early Parkinson Disease|early parkinson disease
5035816|NCT03775096|REM Sleep Behaviour Disorder (RBD)|rem sleep behaviour disorder (rbd)
5035817|NCT03775096|carvedilol|carvedilol
5035818|NCT03775096|Autonomic dysfunction|autonomic dysfunction
5035819|NCT03775096|Neurodegeneration|neurodegeneration
5035821|NCT03775083|nPEP|npep
5035822|NCT03775083|Post Exposure Prophylaxis|post exposure prophylaxis
5035823|NCT03775083|non occupational exposure to HIV|non occupational exposure to hiv
5035827|NCT03775005|Short Course Radiotherapy|short course radiotherapy
5035828|NCT03775005|Symptomatic abdomen lesions|symptomatic abdomen lesions
5035829|NCT03774992|Orthokeratology lenses|orthokeratology lenses
5035830|NCT03774992|Myopia|myopia
5035831|NCT03774992|Children|children
5035832|NCT03774979|SHR-1701|shr-1701
5035833|NCT03774979|Solid tumor|solid tumor
5035841|NCT03774953|weight loss|weight loss
5035842|NCT03774953|readmission|readmission
5035843|NCT03774953|infection|infection
5035844|NCT03774940|fever|fever
5035845|NCT03774940|bacteremia|bacteremia
5035846|NCT03774940|lymphocytes|lymphocytes
5035847|NCT03774940|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5035848|NCT03774940|neutrophil-lymphocyte ratio|neutrophil-lymphocyte ratio
5035849|NCT03774927|schizophrenia|schizophrenia
5035850|NCT03774927|rTMS|rtms
5035851|NCT03774901|Immunotherapy|immunotherapy
5035852|NCT03774901|Penile Cancer|penile cancer
5035853|NCT03774901|Penile Squamous Cell Carcinoma|penile squamous cell carcinoma
5035854|NCT03774901|Avelumab|avelumab
5035855|NCT03774901|maintenance|maintenance
5035856|NCT03774888|Keratinized Tissue|keratinized tissue
5035857|NCT03774888|Keratinized mucosa|keratinized mucosa
5035858|NCT03774888|attached mucosa|attached mucosa
5035859|NCT03774888|dental implants|dental implants
5035860|NCT03774888|ridge augmentation|ridge augmentation
5035861|NCT03774888|guided bone regeneration|guided bone regeneration
5035862|NCT03774888|connective tissue graft|connective tissue graft
5035863|NCT03774888|acellular demral matrix|acellular demral matrix
5035864|NCT03774875|Apremilast|apremilast
5035865|NCT03774875|CC-10004|cc-10004
5035866|NCT03774875|Quality of life|quality of life
5035867|NCT03774875|Safety|safety
5035868|NCT03774875|Efficacy|efficacy
5035869|NCT03774875|Psoriasis manifestations|psoriasis manifestations
5035870|NCT03774862|Medullary carcinoma|medullary carcinoma
5035871|NCT03774862|Colorectal cancer|colorectal cancer
5035872|NCT03774862|Microsatellite instability|microsatellite instability
5035873|NCT03774823|RF/PEMF|rf/pemf
5035874|NCT03774823|Ultrasound|ultrasound
5035875|NCT03774810|insomnia|insomnia
5035876|NCT03774810|sleep|sleep
5035877|NCT03774810|chronic insomnia|chronic insomnia
5035878|NCT03774810|zolpidem|zolpidem
5035879|NCT03774810|ambien|ambien
5035880|NCT03774797|contraception|contraception
5035881|NCT03774797|long-acting reversible contraception|long-acting reversible contraception
5035882|NCT03774797|postpartum|postpartum
5035883|NCT03774797|toolkit|toolkit
5035884|NCT03774797|implementation|implementation
5035885|NCT03774797|feasibility|feasibility
5035886|NCT03774758|Lung cancer screening|lung cancer screening
5035887|NCT03774758|Biomarkers of lung cancer|biomarkers of lung cancer
5035888|NCT03774758|Circulating tumor DNA|circulating tumor dna
5035889|NCT03774758|Low dose computed tomography of lung|low dose computed tomography of lung
5035890|NCT03774758|Pulmonary nodule|pulmonary nodule
5035891|NCT03774745|mifepristone|mifepristone
5035892|NCT03774745|progesterone|progesterone
5035893|NCT03774745|abortion|abortion
5035894|NCT03774732|NSCLC|nsclc
5035895|NCT03774732|radiotherapy|radiotherapy
5035896|NCT03774732|immunotherapy|immunotherapy
5035897|NCT03774732|PD(L)-1blockage|pd(l)-1blockage
5035898|NCT03774706|cesarean section|cesarean section
5035899|NCT03774706|tranexamic acid|tranexamic acid
5035900|NCT03774706|misoprostol|misoprostol
5035905|NCT03774654|Gene Therapy|gene therapy
5035906|NCT03774654|CAR T-cells|car t-cells
5035907|NCT03774654|chimeric antigen receptor|chimeric antigen receptor
5035908|NCT03774654|B-Cell Malignancies|b-cell malignancies
5035915|NCT03774589|bilioenteric anastomosis|bilioenteric anastomosis
5035916|NCT03774589|magnetic compressive technique|magnetic compressive technique
5035918|NCT03774563|weight loss|weight loss
5035921|NCT03774550|Catheter ablation|catheter ablation
5035922|NCT03774550|Radiofrequency|radiofrequency
5035923|NCT03774550|Contact-force|contact-force
5035924|NCT03774550|Cryoablation|cryoablation
5342939|NCT01981473|drug concentration|drug concentration
5035925|NCT03774537|high risk； Bronchopulmonary Dysplasia；hUC-MSCs|high risk； bronchopulmonary dysplasia；huc-mscs
5035926|NCT03774524|cesarean section|cesarean section
5035927|NCT03774524|tranexamic acid|tranexamic acid
5035928|NCT03774524|postpartum hemorrhage|postpartum hemorrhage
5035929|NCT03774524|misoprostol|misoprostol
5035930|NCT03774446|Cushing disease|cushing disease
5035931|NCT03774446|R-roscovitine|r-roscovitine
5035932|NCT03774446|Seliciclib|seliciclib
5035933|NCT03774433|self-regulation|self-regulation
5035934|NCT03774433|binge eating|binge eating
5035935|NCT03774433|smoking|smoking
5035959|NCT03774316|Intensive care|intensive care
5035960|NCT03774277|Hypertension|hypertension
5035961|NCT03774277|Blood Pressure|blood pressure
5035963|NCT03774277|BMI|bmi
5035964|NCT03774277|American Indian|american indian
5035965|NCT03774277|Food Environment|food environment
5035966|NCT03774277|CBPR|cbpr
5035967|NCT03774277|CHEERS|cheers
5035968|NCT03774277|Native American|native american
5035975|NCT03774225|Virtual Reality|virtual reality
5035976|NCT03774225|International Classification of Functioning|international classification of functioning
5035977|NCT03774225|Disability and Health|disability and health
5035978|NCT03774225|Rehabilitation|rehabilitation
5035979|NCT03774225|Gait|gait
5035980|NCT03774225|Balance|balance
5035981|NCT03774212|Critical care patients|critical care patients
5035982|NCT03774212|High dependency unit|high dependency unit
5035983|NCT03774212|Intensive care unit|intensive care unit
5035984|NCT03774186|type 1 diabetes mellitus|type 1 diabetes mellitus
5035985|NCT03774186|pregnancy|pregnancy
5035986|NCT03774186|hybrid closed-loop therapy|hybrid closed-loop therapy
5035987|NCT03774186|artificial pancreas therapy|artificial pancreas therapy
5035988|NCT03774186|sensor-augmented pump therapy|sensor-augmented pump therapy
5035989|NCT03774134|Colon cancer|colon cancer
5035990|NCT03774134|Surgery|surgery
5035991|NCT03774134|Oncological outcome|oncological outcome
5035992|NCT03774134|Survival|survival
5035993|NCT03774121|Cryoneurolysis|cryoneurolysis
5035994|NCT03774121|Exercise|exercise
5035995|NCT03774121|Pain|pain
5035996|NCT03774121|Physical capacity|physical capacity
5035997|NCT03774095|incretins|incretins
5035998|NCT03774095|Fat metabolites|fat metabolites
5035999|NCT03774095|Free fatty acid receptors|free fatty acid receptors
5036000|NCT03774095|G-protein-coupled receptors|g-protein-coupled receptors
5036001|NCT03774082|INC424|inc424
5036002|NCT03774082|pediatric|pediatric
5036003|NCT03774082|Chronic Graft versus Host Disease|chronic graft versus host disease
5036004|NCT03774082|moderate and severe chronic graft vs. host disease|moderate and severe chronic graft vs. host disease
5036005|NCT03774082|allogeneic stem cell transplant|allogeneic stem cell transplant
5036006|NCT03774082|ruxolitinib|ruxolitinib
5036007|NCT03774082|corticosteroids|corticosteroids
5036008|NCT03774069|Insulin pump treatment|insulin pump treatment
5036009|NCT03774069|Type 1 diabetes|type 1 diabetes
5036010|NCT03774069|Pump setting advisor|pump setting advisor
5036011|NCT03774017|brain arteriovenous malformations|brain arteriovenous malformations
5036012|NCT03774017|one-staged hybrid operation|one-staged hybrid operation
5036013|NCT03773991|Dyspnea|dyspnea
5036014|NCT03773991|Hemodialysis|hemodialysis
5036015|NCT03773991|End Stage Renal Disease|end stage renal disease
5036025|NCT03773926|Tinnitus|tinnitus
5036026|NCT03773926|Neuro-feedback|neuro-feedback
5036027|NCT03773926|Male|male
5036028|NCT03773926|Female|female
5036029|NCT03773926|Tinnitus Handicap Inventory|tinnitus handicap inventory
5036030|NCT03773913|Child Mortality|child mortality
5036031|NCT03773913|Reproductive, Maternal, Newborn, and Child Health|reproductive, maternal, newborn, and child health
5036032|NCT03773913|Community Health Workers|community health workers
5036033|NCT03773913|Implementation Research|implementation research
5036034|NCT03773913|Preliminary Research|preliminary research
5036035|NCT03773913|Health Systems Strengthening|health systems strengthening
5036036|NCT03773900|chitin-glucan|chitin-glucan
5036037|NCT03773900|gut microbiota|gut microbiota
5029723|NCT03813394|Nasopharyngeal cancer|nasopharyngeal cancer
5029724|NCT03813394|Anti-PD1|anti-pd1
5029725|NCT03813394|Tumor neoantigens|tumor neoantigens
5036042|NCT03773822|Cardiogenic Shock|cardiogenic shock
5036043|NCT03773822|Steroids|steroids
5036044|NCT03773822|Hydrocortisone|hydrocortisone
5036045|NCT03773822|Fludrocortisone|fludrocortisone
5036046|NCT03773822|Reversal of shock|reversal of shock
5036047|NCT03773822|Mortality|mortality
5036048|NCT03773822|Adrenal insufficiency|adrenal insufficiency
5036049|NCT03773809|ACO|aco
5036050|NCT03773809|HRV|hrv
5036051|NCT03773809|Vitamin D deficiency|vitamin d deficiency
5036052|NCT03773796|Parkinson´s Disease|parkinson´s disease
5036053|NCT03773796|cannabinoids|cannabinoids
5036054|NCT03773796|non-motor symptoms|non-motor symptoms
5036063|NCT03773770|Long Chain 3-hydroxy-acyl-CoA Dehydrogenase Deficiency|long chain 3-hydroxy-acyl-coa dehydrogenase deficiency
5036065|NCT03773770|Trifunctional Protein Deficiency|trifunctional protein deficiency
5036067|NCT03773770|Carnitine-acylcarnitine Translocase Deficiency|carnitine-acylcarnitine translocase deficiency
5036068|NCT03773770|CACT|cact
5036069|NCT03773718|metabolic syndrome|metabolic syndrome
5036070|NCT03773718|children|children
5036071|NCT03773718|cancer|cancer
5036072|NCT03773718|survivors|survivors
5036073|NCT03773718|genetic|genetic
5036074|NCT03773692|Spinal Cord Injuries|spinal cord injuries
5036075|NCT03773692|Physical Activity|physical activity
5036076|NCT03773692|Mobile-health|mobile-health
5036077|NCT03773692|Just-in-time-adaptive intervention|just-in-time-adaptive intervention
5036078|NCT03773692|Real-time feedback|real-time feedback
5036079|NCT03773679|Preterm infants with very low birth weight (VLBW)|preterm infants with very low birth weight (vlbw)
5036080|NCT03773679|bone mineral density|bone mineral density
5036081|NCT03773679|cortisol|cortisol
5036082|NCT03773679|exercise|exercise
5036083|NCT03773666|Bladder Cancer|bladder cancer
5036084|NCT03773653|stroke, robot-assisted therapy, mirror therapy|stroke, robot-assisted therapy, mirror therapy
5036085|NCT03773640|temporomandibular joint dysfunction,|temporomandibular joint dysfunction,
5036086|NCT03773640|supportive treatment,|supportive treatment,
5036087|NCT03773640|occlusal splint,|occlusal splint,
5036088|NCT03773640|radiofreqency,|radiofreqency,
5036089|NCT03773640|physiotherapy|physiotherapy
5036090|NCT03773601|Sleep|sleep
5036091|NCT03773601|Athlete|athlete
5036092|NCT03773601|Sleep Profiler|sleep profiler
5036093|NCT03773588|Closed loop|closed loop
5036094|NCT03773588|Entropy|entropy
5036095|NCT03773588|Surgical pleth index|surgical pleth index
5036096|NCT03773588|Adequacy of Anesthesia|adequacy of anesthesia
5036097|NCT03773588|Target controlled infusion|target controlled infusion
5036098|NCT03773562|Migraine|migraine
5036099|NCT03773562|Magnetic Resonance Imaging|magnetic resonance imaging
5036100|NCT03773562|Brain Structure|brain structure
5036101|NCT03773562|Brain Function|brain function
5036102|NCT03773536|Artesunate-amodiaquine|artesunate-amodiaquine
5036103|NCT03773536|Single Low Dose Primaquine|single low dose primaquine
5036104|NCT03773536|Zanzibar|zanzibar
5036105|NCT03773523|tDCS|tdcs
5036106|NCT03773523|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5036108|NCT03773523|Opioid dependence|opioid dependence
5036109|NCT03773523|Opioids|opioids
5036110|NCT03773523|Buprenorphine|buprenorphine
5036111|NCT03773523|Suboxone|suboxone
5036112|NCT03773523|Lodging Plus|lodging plus
5036113|NCT03773523|Fairview Lodging Plus|fairview lodging plus
5036114|NCT03773510|trabectedin|trabectedin
5036115|NCT03773510|soft tissue sarcoma|soft tissue sarcoma
5036116|NCT03773484|Opioids|opioids
5036117|NCT03773484|Behavioral Research|behavioral research
5036118|NCT03773458|Orthopedic Disorder of Spine|orthopedic disorder of spine
5036119|NCT03773445|ulcerative colitis|ulcerative colitis
5036120|NCT03773445|golimumab|golimumab
5036121|NCT03773445|simponi|simponi
5036122|NCT03773445|therapeutic drug monitoring|therapeutic drug monitoring
5036123|NCT03773445|endoscopic healing|endoscopic healing
5036124|NCT03773445|histologic remission|histologic remission
5036125|NCT03773432|meal ingestion|meal ingestion
5036126|NCT03773432|meal schedule|meal schedule
5036136|NCT03773367|Gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
5939877|NCT00903994|Acute Pain|acute pain
5036137|NCT03773367|Chemotherapy|chemotherapy
5036138|NCT03773367|Fluorouracil|fluorouracil
5049819|NCT03686748|Pain|pain
5356790|NCT01918007|Dyssomnias|dyssomnias
5029829|NCT03812666|Stroke|stroke
5029830|NCT03812666|Pneumonia|pneumonia
5029831|NCT03812666|Biomarkers|biomarkers
5029832|NCT03812666|Infection|infection
5036143|NCT03773367|Histopathological response|histopathological response
5036144|NCT03773367|Rate of R0-resection|rate of r0-resection
5036145|NCT03773341|ACL injury|acl injury
5036146|NCT03773341|non sport causes|non sport causes
5036147|NCT03773341|Egyptians|egyptians
5036148|NCT03773302|cholangiocarcinoma|cholangiocarcinoma
5036154|NCT03773302|BGJ398|bgj398
5036155|NCT03773289|Infants, neonates|infants, neonates
5036156|NCT03773289|rational drug use|rational drug use
5036157|NCT03773263|sequential IVM system|sequential ivm system
5036158|NCT03773263|PCOS|pcos
5036159|NCT03773263|infertility|infertility
5036160|NCT03773237|SMOF|smof
5036161|NCT03773237|Intralipid|intralipid
5036162|NCT03773237|Mixed oil emulsion|mixed oil emulsion
5036163|NCT03773237|Intestinal failure|intestinal failure
5036164|NCT03773237|HPN|hpn
5036165|NCT03773172|Lipid and Lipoprotein Metabolism|lipid and lipoprotein metabolism
5036166|NCT03773146|mobile phone surveys|mobile phone surveys
5036167|NCT03773146|interactive voice response|interactive voice response
5036168|NCT03773146|incentive|incentive
5036169|NCT03773120|superior laryngeal nerve|superior laryngeal nerve
5036170|NCT03773081|Acute Coronary Syndrome|acute coronary syndrome
5036171|NCT03773081|STE-ACS|ste-acs
5036172|NCT03773081|NSTE-ACS|nste-acs
5036173|NCT03773081|Magmaris|magmaris
5036174|NCT03773068|Endometriosis|endometriosis
5036175|NCT03773068|Refractory chronic cough|refractory chronic cough
5036176|NCT03773016|care home|care home
5036177|NCT03773016|visual art|visual art
5036178|NCT03773016|app|app
5036179|NCT03773016|touchscreen technology|touchscreen technology
5036180|NCT03773016|dementia|dementia
5036181|NCT03773003|Cancer Fatigue, Chronic Fatigue|cancer fatigue, chronic fatigue
5036186|NCT03772977|mild cognitive impairment|mild cognitive impairment
5036187|NCT03772977|dementia risk reduction|dementia risk reduction
5036188|NCT03772964|prefrail|prefrail
5036189|NCT03772964|non-diabetic|non-diabetic
5036190|NCT03772964|metformin|metformin
5036191|NCT03772964|thrombosis|thrombosis
5036192|NCT03772964|microbiome|microbiome
5036193|NCT03772964|cellular respiration|cellular respiration
5036194|NCT03772964|short physical performance batter|short physical performance batter
5036195|NCT03772938|stem cells|stem cells
5036196|NCT03772938|Retinitis Pigmentosa|retinitis pigmentosa
5036197|NCT03772938|Age Related Macular Degeneration|age related macular degeneration
5036198|NCT03772938|Stargardt Disease|stargardt disease
5036199|NCT03772938|electroretinography|electroretinography
5036200|NCT03772912|Hemostatics|hemostatics
5036201|NCT03772912|Coagulants|coagulants
5036202|NCT03772886|Peanut Ball|peanut ball
5036203|NCT03772795|Pulpal blood flow|pulpal blood flow
5036204|NCT03772795|clear aligners|clear aligners
5036205|NCT03772795|orthodontics|orthodontics
5036206|NCT03772756|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5036207|NCT03772756|radiofrequency ablation|radiofrequency ablation
5036208|NCT03772756|Endoscopic ultrasound|endoscopic ultrasound
5036215|NCT03772665|Stargardt Disease|stargardt disease
5036216|NCT03772665|STGD|stgd
5036217|NCT03772665|ABCA4|abca4
5036218|NCT03772626|COPD|copd
5036219|NCT03772626|Heated humidified high-flow nasal cannula|heated humidified high-flow nasal cannula
5036220|NCT03772626|Exacerbation of COPD|exacerbation of copd
5036221|NCT03772613|activated clotting time|activated clotting time
5036222|NCT03772613|outcomes|outcomes
5036223|NCT03772613|bleeding|bleeding
5036233|NCT03772561|Durvalumab|durvalumab
5036234|NCT03772561|Solid Tumor|solid tumor
5036235|NCT03772522|Hopelessness|hopelessness
5036236|NCT03772522|Self Esteem|self esteem
5036237|NCT03772522|Social Isolation|social isolation
5036238|NCT03772522|Employment Status|employment status
5036239|NCT03772522|Education|education
5036240|NCT03772522|Housing Problems|housing problems
5036241|NCT03772522|Identity, Social|identity, social
5036242|NCT03772522|Self Efficacy|self efficacy
5036243|NCT03772522|Control Locus|control locus
5036244|NCT03772522|Poverty|poverty
5036245|NCT03772522|Youth|youth
5036246|NCT03772522|Homelessness|homelessness
5036247|NCT03772522|Homeless Youth|homeless youth
5036248|NCT03772509|mobile phone surveys|mobile phone surveys
5036249|NCT03772509|interactive voice response|interactive voice response
5036250|NCT03772509|computer-assisted telephone interviews|computer-assisted telephone interviews
5036251|NCT03772509|introduction mode|introduction mode
5049916|NCT03685838|compression stockings|compression stockings
5036258|NCT03772483|pediatric dental patients|pediatric dental patients
5036259|NCT03772483|pediatric pain management|pediatric pain management
5036260|NCT03772483|local anesthesia children|local anesthesia children
5036261|NCT03772470|mobile phone surveys|mobile phone surveys
5036262|NCT03772470|interactive voice response|interactive voice response
5036263|NCT03772470|incentive|incentive
5036264|NCT03772431|mobile phone surveys|mobile phone surveys
5036265|NCT03772431|interactive voice response|interactive voice response
5036266|NCT03772431|narration|narration
5036267|NCT03772288|Drug Therapy|drug therapy
5036268|NCT03772262|Pharmacokinetics|pharmacokinetics
5036269|NCT03772262|Goldenseal|goldenseal
5036270|NCT03772262|Metformin|metformin
5036271|NCT03772262|Furosemide|furosemide
5036272|NCT03772262|Rosuvastatin|rosuvastatin
5036273|NCT03772262|Midazolam|midazolam
5036274|NCT03772262|Natural product|natural product
5036281|NCT03772236|Total Ankle Replacement; Pain Measurement|total ankle replacement; pain measurement
5036282|NCT03772223|Pharmacokinectics|pharmacokinectics
5036283|NCT03772223|Inhaled corticosteroid|inhaled corticosteroid
5036285|NCT03772210|mechanism|mechanism
5036287|NCT03772210|neuromodulation|neuromodulation
5036288|NCT03772197|Breast cancer|breast cancer
5036289|NCT03772197|Distant recurrence|distant recurrence
5036290|NCT03772197|NanoString|nanostring
5036291|NCT03772197|Gene-expression profiling|gene-expression profiling
5036292|NCT03772197|Prognosis|prognosis
5036293|NCT03772197|Locoreginal recurrence|locoreginal recurrence
5036294|NCT03772158|Bioequivalence study|bioequivalence study
5036295|NCT03772158|Healthy volunteers|healthy volunteers
5036296|NCT03772158|Cetirizine|cetirizine
5036297|NCT03772158|Tablet|tablet
5036298|NCT03772145|Ulcerative colitis|ulcerative colitis
5036299|NCT03772145|Inflammatory bowel diseases|inflammatory bowel diseases
5036300|NCT03772145|Tofacitinib|tofacitinib
5036301|NCT03772119|Vertebral Malformation|vertebral malformation
5036302|NCT03772119|Hemivertebra|hemivertebra
5036303|NCT03772119|Surgical resection|surgical resection
5036304|NCT03772119|SOFOP|sofop
5036305|NCT03772106|hepato-splanchnic blood flow|hepato-splanchnic blood flow
5036306|NCT03772093|massage|massage
5036307|NCT03772093|low back pain|low back pain
5036308|NCT03772093|Trabert current|trabert current
5036309|NCT03772093|Ultra-Reiz current|ultra-reiz current
5036310|NCT03772080|Antenatal Counseling|antenatal counseling
5036311|NCT03772080|Education|education
5036313|NCT03772054|Heparan sulfate|heparan sulfate
5036314|NCT03772054|Thrombomodulin|thrombomodulin
5036315|NCT03772054|Ischemia Reperfusion|ischemia reperfusion
5036316|NCT03772054|Anesthesia|anesthesia
5036317|NCT03772028|ovarian cancer|ovarian cancer
5036318|NCT03772028|HIPEC|hipec
5036319|NCT03772028|OVHIPEC|ovhipec
5036320|NCT03772028|primary debulking|primary debulking
5036321|NCT03772015|laparoscopic lateral mesh suspension|laparoscopic lateral mesh suspension
5036322|NCT03772015|lateral abdominocervicopexy|lateral abdominocervicopexy
5036323|NCT03772015|apical prolapse|apical prolapse
5036324|NCT03772015|anterior prolapse|anterior prolapse
5036325|NCT03772015|vaginal axis|vaginal axis
5036531|NCT03770754|clean|clean
5036328|NCT03771976|Primipara|primipara
5036329|NCT03771976|Cesarean section|cesarean section
5036330|NCT03771963|Vaccine|vaccine
5036331|NCT03771950|rehabilitation|rehabilitation
5036332|NCT03771937|lifestyle change|lifestyle change
5036333|NCT03771937|telephone follow-up|telephone follow-up
5036334|NCT03771937|Roy Adaptation Model|roy adaptation model
5036335|NCT03771924|inorganic phosphate|inorganic phosphate
5036336|NCT03771924|postprandial response|postprandial response
5036337|NCT03771924|fibroblast growth factor-23|fibroblast growth factor-23
5036338|NCT03771924|health individuals|health individuals
5036339|NCT03771846|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5036340|NCT03771846|systemic chemotherapy|systemic chemotherapy
5036341|NCT03771846|hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
5036346|NCT03771794|HRV|hrv
5036347|NCT03771794|Peripheral neuromodulation|peripheral neuromodulation
5036348|NCT03771794|Autonomic balance|autonomic balance
5036349|NCT03771768|Oral ulcers|oral ulcers
5036350|NCT03771755|ibuprofen|ibuprofen
5036351|NCT03771755|acetaminophen|acetaminophen
5036352|NCT03771755|orthopedic|orthopedic
5036353|NCT03771755|VAS|vas
5036354|NCT03771755|morphine|morphine
5036355|NCT03771755|opioid|opioid
5036356|NCT03771729|Sacubitril/Valsartan|sacubitril/valsartan
5036357|NCT03771729|Advanced CKD Patients|advanced ckd patients
5036371|NCT03771638|HIV Risk Reduction|hiv risk reduction
5036372|NCT03771638|Mobile App|mobile app
5036373|NCT03771625|fMRI|fmri
5036374|NCT03771625|DTI|dti
5036375|NCT03771625|Intracranial Germ cell tumor|intracranial germ cell tumor
5036376|NCT03771625|Basal ganglia|basal ganglia
5036377|NCT03771612|Immune system|immune system
5036378|NCT03771612|Social psychology|social psychology
5036379|NCT03771612|Health psychology|health psychology
5036380|NCT03771599|cerebral palsy, traditional massage, spasticity, children|cerebral palsy, traditional massage, spasticity, children
5036381|NCT03771573|REHABILITATION|rehabilitation
5036382|NCT03771573|PHYSICAL THERAPY|physical therapy
5036383|NCT03771573|CARDIOVASCULAR DISEASE|cardiovascular disease
5036385|NCT03771547|Elderly|elderly
5036386|NCT03771547|Difficult cannulation|difficult cannulation
5036387|NCT03771534|maternal hyperoxygenation|maternal hyperoxygenation
5036388|NCT03771534|fetal echocardiography|fetal echocardiography
5036389|NCT03771534|fetal MRI|fetal mri
5036390|NCT03771495|mobilization|mobilization
5036391|NCT03771495|muscle strength|muscle strength
5036392|NCT03771495|hip abductors|hip abductors
5087660|NCT03450252|HCM|hcm
5036402|NCT03771430|Cognitive behavioral therapy|cognitive behavioral therapy
5036403|NCT03771430|e-therapy|e-therapy
5036404|NCT03771404|NSCLC|nsclc
5036405|NCT03771404|Tumor heterogeneity|tumor heterogeneity
5036406|NCT03771404|liquid biopsy|liquid biopsy
5036407|NCT03771404|CTCs|ctcs
5036408|NCT03771404|ctDNA|ctdna
5036409|NCT03771404|NGS|ngs
5036410|NCT03771391|Phenylketonuria|phenylketonuria
5036411|NCT03771391|PKU|pku
5036412|NCT03771391|Child|child
5036413|NCT03771391|Children|children
5036414|NCT03771391|Adult|adult
5036415|NCT03771391|Adults|adults
5036416|NCT03771391|GMP|gmp
5036417|NCT03771391|Glycomacropeptide|glycomacropeptide
5036418|NCT03771391|Amino acid mixture|amino acid mixture
5036419|NCT03771391|Amino acid|amino acid
5036420|NCT03771391|Protein supplement|protein supplement
5036421|NCT03771391|Protein substitute|protein substitute
5036422|NCT03771378|ITP|itp
5036423|NCT03771378|rhTPO|rhtpo
5036424|NCT03771378|Eltrombopag|eltrombopag
5036425|NCT03771378|platelets|platelets
5036426|NCT03771365|percutaneous nephrostolithotomy|percutaneous nephrostolithotomy
5036427|NCT03771365|renal stone|renal stone
5036428|NCT03771365|safety|safety
5036429|NCT03771365|efficacy|efficacy
5036430|NCT03771339|quadratus lumborum block|quadratus lumborum block
5036435|NCT03771300|University students|university students
5036436|NCT03771300|Mindfulness|mindfulness
5036437|NCT03771300|Virtual Reality (VR)|virtual reality (vr)
5036439|NCT03771261|Protein|protein
5036440|NCT03771261|Aging|aging
5036441|NCT03771261|Health Disparities|health disparities
5036442|NCT03771261|Weight Loss|weight loss
5036443|NCT03771235|Tourette Syndrome|tourette syndrome
5036444|NCT03771235|Tic Disorder|tic disorder
5036445|NCT03771235|Online|online
5036446|NCT03771235|Adults|adults
5036447|NCT03771235|Mindfulness|mindfulness
5036448|NCT03771235|Therapy|therapy
5036449|NCT03771209|ultrasound assessment|ultrasound assessment
5036450|NCT03771209|ankle brachial index|ankle brachial index
5036451|NCT03771209|lung ultrasound|lung ultrasound
5036452|NCT03771209|carotid intima media thickness|carotid intima media thickness
5036453|NCT03771209|vascular ultrasound (abdominal aorta and cave vein)|vascular ultrasound (abdominal aorta and cave vein)
5036454|NCT03771209|echocardiographic ejection fraction|echocardiographic ejection fraction
5036456|NCT03771196|ACTIVA Restorative|activa restorative
5036457|NCT03771196|Resin Modified Glass Ionomer (RMGI)|resin modified glass ionomer (rmgi)
5036458|NCT03771196|class V|class v
5036459|NCT03771196|Clinical perfomance|clinical perfomance
5036460|NCT03771157|shingles vaccine (Shingrix)|shingles vaccine (shingrix)
5036461|NCT03771157|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5036462|NCT03771157|Waldenstrom macroglobulinemia (WM)|waldenstrom macroglobulinemia (wm)
5036463|NCT03771157|Pilot Study|pilot study
5036464|NCT03771144|Brachial obstetrical palsy|brachial obstetrical palsy
5036465|NCT03771131|healthy cognitive ageing|healthy cognitive ageing
5036466|NCT03771131|multi-domain cognitive training|multi-domain cognitive training
5036467|NCT03771118|Drug Hypersensitivity Reaction|drug hypersensitivity reaction
5036468|NCT03771118|Drug Provocation Test|drug provocation test
5036469|NCT03771118|Paracetamol|paracetamol
5036470|NCT03771118|Reactive Doses|reactive doses
5036471|NCT03771118|Reactive Times|reactive times
5036472|NCT03771118|Acetaminophen|acetaminophen
5036473|NCT03771092|Iron|iron
5036474|NCT03771092|Iron Deficiency Anemia|iron deficiency anemia
5036475|NCT03771092|Anemia|anemia
5036476|NCT03771079|Hematological Malignancy|hematological malignancy
5036477|NCT03771079|mutations|mutations
5036478|NCT03771079|NGS sequencing|ngs sequencing
5036479|NCT03771079|mass spectrometry|mass spectrometry
5036480|NCT03771066|bisphenol A|bisphenol a
5036481|NCT03771066|diet|diet
5036482|NCT03771053|Coronary heart disease|coronary heart disease
5036483|NCT03771053|Atherosclerosis|atherosclerosis
5036484|NCT03771053|Acute myocardial infarction|acute myocardial infarction
5036485|NCT03771053|Coronary intervention|coronary intervention
5036486|NCT03771040|Severe persistent asthma|severe persistent asthma
5030144|NCT03810612|Percutaneous coronary intervention|percutaneous coronary intervention
5030145|NCT03810612|Rehabilitation|rehabilitation
5036494|NCT03771014|rehabilitation|rehabilitation
5036495|NCT03771001|Wellness|wellness
5036496|NCT03771001|Caregivers|caregivers
5036497|NCT03771001|Lifestyle|lifestyle
5036498|NCT03771001|Stressor|stressor
5036499|NCT03770988|esophageal squamous carcinoma|esophageal squamous carcinoma
5036500|NCT03770988|poziotinib|poziotinib
5036501|NCT03770988|pan-HER inhibitor|pan-her inhibitor
5036506|NCT03770949|3-D printing|3-d printing
5036507|NCT03770949|Children|children
5036508|NCT03770949|Adolescents|adolescents
5036510|NCT03770910|Insulin secretin|insulin secretin
5036511|NCT03770910|Incretin hormone|incretin hormone
5036512|NCT03770897|3d Laparoscopy|3d laparoscopy
5036513|NCT03770884|rheumatoid arthritis|rheumatoid arthritis
5036514|NCT03770884|Axial spondyloarthritis|axial spondyloarthritis
5036515|NCT03770884|hand osteoarthritis|hand osteoarthritis
5036517|NCT03770884|beliefs|beliefs
5036518|NCT03770871|indirect pulp|indirect pulp
5036519|NCT03770871|primary|primary
5036520|NCT03770871|calcium hydroxide|calcium hydroxide
5036521|NCT03770871|resin modified glass ionomer|resin modified glass ionomer
5036522|NCT03770871|Children|children
5036523|NCT03770858|Wearables|wearables
5036524|NCT03770858|Atopic Dermatitis|atopic dermatitis
5036525|NCT03770858|Scratch sensor|scratch sensor
5036526|NCT03770845|nutritional status|nutritional status
5036527|NCT03770845|vitamin D|vitamin d
5036528|NCT03770793|One lung ventilation|one lung ventilation
5036529|NCT03770793|Lung ultrasound|lung ultrasound
5036530|NCT03770793|Alveolar recruitment|alveolar recruitment
5036533|NCT03770754|rotary instrumentation|rotary instrumentation
5036534|NCT03770741|Near-infrared spectroscopy|near-infrared spectroscopy
5036536|NCT03770741|Cerebral oximetry|cerebral oximetry
5036537|NCT03770741|Extremely preterm|extremely preterm
5036538|NCT03770741|Brain injury|brain injury
5036539|NCT03770741|Mortality|mortality
5036540|NCT03770741|Treatment guideline|treatment guideline
5036541|NCT03770715|Sleep Apnea|sleep apnea
5036542|NCT03770715|Respiratory polygraphy|respiratory polygraphy
5036543|NCT03770715|Extubation|extubation
5036544|NCT03770689|DNA-PK inhibitor|dna-pk inhibitor
5036545|NCT03770689|M3814|m3814
5036546|NCT03770689|capecitabine|capecitabine
5036547|NCT03770676|Food sensory perception|food sensory perception
5036548|NCT03770676|Selenium|selenium
5036551|NCT03770611|dialysis|dialysis
5036552|NCT03770611|uremic toxin|uremic toxin
5036553|NCT03770611|inflammation|inflammation
5036554|NCT03770611|prebiotics|prebiotics
5036555|NCT03770611|probiotics|probiotics
5036556|NCT03770598|Psychosocial Care|psychosocial care
5036557|NCT03770598|Wellness|wellness
5036558|NCT03770572|CLN3|cln3
5036559|NCT03770572|Neuronal ceroid lipofuscinosis|neuronal ceroid lipofuscinosis
5036560|NCT03770572|NCL|ncl
5036561|NCT03770572|Gene Transfer|gene transfer
5036562|NCT03770559|Radical Antegrade Modular Pancreatosplenectomy|radical antegrade modular pancreatosplenectomy
5036563|NCT03770559|Pancreatic cancer|pancreatic cancer
5036574|NCT03770442|Functional Electrical Stimulation|functional electrical stimulation
5036575|NCT03770442|Rehabilitation|rehabilitation
5036577|NCT03770429|Myelodysplastic Syndrome|myelodysplastic syndrome
5036578|NCT03770377|speech|speech
5036579|NCT03770377|swallowing|swallowing
5036580|NCT03770377|rehabilitation|rehabilitation
5036581|NCT03770377|stroke|stroke
5036582|NCT03770377|deglutition|deglutition
5036583|NCT03770377|dysphagia|dysphagia
5036584|NCT03770377|dysarthria|dysarthria
5036585|NCT03770377|laryngeal|laryngeal
5036586|NCT03770377|ataxia|ataxia
5036587|NCT03770351|genomics|genomics
5036588|NCT03770351|racial disparities|racial disparities
5036589|NCT03770351|patient reported outcomes|patient reported outcomes
5036590|NCT03770338|osteoporosis, teriparatide, insertional torque|osteoporosis, teriparatide, insertional torque
5036591|NCT03770273|Cytokine|cytokine
5036595|NCT03770273|Bone Marrow|bone marrow
5036596|NCT03770208|Lidocaine Infusions|lidocaine infusions
5036597|NCT03770208|Thoracic trauma|thoracic trauma
5036598|NCT03770208|Analgesic Management|analgesic management
5036599|NCT03770208|Rib Fractures|rib fractures
5036600|NCT03770208|Pain|pain
5036601|NCT03770195|Hemostatics|hemostatics
5036602|NCT03770195|Coagulants|coagulants
5036603|NCT03770156|Terrorist attack|terrorist attack
5036604|NCT03770156|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5036605|NCT03770156|Depression|depression
5036606|NCT03770156|Psychotherapy|psychotherapy
5036607|NCT03770156|Mental health|mental health
5036608|NCT03770156|Victimology|victimology
5036609|NCT03770156|Mourning|mourning
5036610|NCT03770117|Pancreas|pancreas
5036611|NCT03770117|Cancer|cancer
5036612|NCT03770117|Sarcopenia|sarcopenia
5036613|NCT03770117|Cachexia|cachexia
5036614|NCT03770117|Prehabilitation|prehabilitation
5036615|NCT03770117|Pancreatoduodenectomy|pancreatoduodenectomy
5036616|NCT03770104|Intubation|intubation
5036617|NCT03770104|Newborn|newborn
5036618|NCT03770104|Delivery room|delivery room
5036619|NCT03770104|Complications|complications
5036620|NCT03770039|PF-06700841|pf-06700841
5036621|NCT03770039|mass balance|mass balance
5036622|NCT03770039|metabolites|metabolites
5036623|NCT03770039|absolute bioavailability|absolute bioavailability
5036624|NCT03770013|Bupivacaine|bupivacaine
5036625|NCT03770013|Dexmedetomidine|dexmedetomidine
5036626|NCT03770013|Clonidine|clonidine
5036627|NCT03770013|Transversus Abdominis Plane Block|transversus abdominis plane block
5036628|NCT03770000|T cell Lymphoma|t cell lymphoma
5036629|NCT03770000|RP6530|rp6530
5036630|NCT03770000|Tenalisib|tenalisib
5036631|NCT03770000|Romidepsin|romidepsin
5036632|NCT03769987|neurosarcoidosis, pulmonary hyeprtension, infliximab, repository corticotropin|neurosarcoidosis, pulmonary hyeprtension, infliximab, repository corticotropin
5036633|NCT03769974|motor imagery|motor imagery
5036634|NCT03769974|action observation|action observation
5036929|NCT03768518|Exendin|exendin
5036644|NCT03769909|Inflammation|inflammation
5036645|NCT03769909|Pro-inflammatory|pro-inflammatory
5036646|NCT03769909|Cartilage|cartilage
5036647|NCT03769909|Fracture|fracture
5036648|NCT03769909|Joint Injury|joint injury
5036649|NCT03769896|Parkinson´s Disease|parkinson´s disease
5036650|NCT03769896|cannabinoids|cannabinoids
5036651|NCT03769896|non-motor symptoms|non-motor symptoms
5036652|NCT03769883|Exercise|exercise
5036653|NCT03769883|Physical Activity|physical activity
5036654|NCT03769883|Type 2 diabetes|type 2 diabetes
5036655|NCT03769883|Pancreatic beta-cell function|pancreatic beta-cell function
5036656|NCT03769883|Insulin sensitivity|insulin sensitivity
5036657|NCT03769883|Dose finding|dose finding
5036658|NCT03769883|lifestyle|lifestyle
5036659|NCT03769857|exercise-induced|exercise-induced
5036660|NCT03769857|joint pain|joint pain
5036661|NCT03769857|joint stiffness|joint stiffness
5036662|NCT03769857|cartilage turnover|cartilage turnover
5036664|NCT03769844|sepsis|sepsis
5036665|NCT03769844|MODS|mods
5036679|NCT03769753|intraoperative use of IRE|intraoperative use of ire
5036680|NCT03769753|18-489|18-489
5036681|NCT03769740|cardiac arrest, cardiac death, CPR, neurologic prognostication, emergency medicine,|cardiac arrest, cardiac death, cpr, neurologic prognostication, emergency medicine,
5036682|NCT03769714|laparoscopy|laparoscopy
5036683|NCT03769714|supracervical hysterectomy|supracervical hysterectomy
5036684|NCT03769714|Multimodal pain management|multimodal pain management
5036685|NCT03769714|bupivacaine liposome|bupivacaine liposome
5036686|NCT03769714|Exparel|exparel
5036687|NCT03769688|bacterial vaginosis|bacterial vaginosis
5036688|NCT03769688|cervicovaginal secretions|cervicovaginal secretions
5036689|NCT03769688|vaginal microbiota|vaginal microbiota
5036692|NCT03769662|Cytokines|cytokines
5036693|NCT03769662|Anti-inflammatory|anti-inflammatory
5036694|NCT03769662|Pain|pain
5036695|NCT03769662|Inflammation|inflammation
5036696|NCT03769636|Multiple Sclerosis|multiple sclerosis
5036697|NCT03769636|In-patient rehabilitation|in-patient rehabilitation
5036720|NCT03769519|health disparities|health disparities
5036721|NCT03769519|african american|african american
5036723|NCT03769506|Rakuten Medical|rakuten medical
5036724|NCT03769506|ASP-1929|asp-1929
5036725|NCT03769506|PIT|pit
5036726|NCT03769506|photoimmunotherapy|photoimmunotherapy
5036727|NCT03769506|HNC|hnc
5036728|NCT03769506|HNSCC|hnscc
5036729|NCT03769506|head and neck|head and neck
5036730|NCT03769493|Medication adherence|medication adherence
5036731|NCT03769493|Treatment adherence|treatment adherence
5036732|NCT03769493|Ecological momentary assessment|ecological momentary assessment
5036733|NCT03769493|Ecological momentary intervention|ecological momentary intervention
5036734|NCT03769493|Coping skills|coping skills
5036735|NCT03769493|Psychiatric Hospitalization|psychiatric hospitalization
5036736|NCT03769480|Athletes|athletes
5036737|NCT03769480|Disability|disability
5036738|NCT03769480|Respiratory Function|respiratory function
5036739|NCT03769480|Core Muscles|core muscles
5036740|NCT03769480|Sport|sport
5036741|NCT03769467|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5036742|NCT03769467|NPC|npc
5036743|NCT03769467|Nasopharyngeal Cancer|nasopharyngeal cancer
5036744|NCT03769467|Nose Cancer|nose cancer
5036745|NCT03769467|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5036746|NCT03769467|Epstein-Barr Virus Viremia|epstein-barr virus viremia
5036747|NCT03769467|EBV-associated NPC|ebv-associated npc
5036748|NCT03769467|Allogeneic, off-the-shelf T-cell|allogeneic, off-the-shelf t-cell
5036749|NCT03769467|immunotherapy|immunotherapy
5036750|NCT03769467|Head and Neck Cancer|head and neck cancer
5036751|NCT03769467|Carcinoma|carcinoma
5036752|NCT03769467|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
5036753|NCT03769467|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5036754|NCT03769467|Neoplasms by Histologic Type|neoplasms by histologic type
5036755|NCT03769467|Neoplasms|neoplasms
5036756|NCT03769467|Pharyngeal Neoplasms|pharyngeal neoplasms
5036757|NCT03769467|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
5036758|NCT03769467|Head and Neck Neoplasms|head and neck neoplasms
5036759|NCT03769467|Neoplasms by Site|neoplasms by site
5036760|NCT03769467|Nasopharyngeal Diseases|nasopharyngeal diseases
5036761|NCT03769467|Pharyngeal Diseases|pharyngeal diseases
5050422|NCT03682757|Trauma|trauma
5036781|NCT03769259|suicidal ideation|suicidal ideation
5036782|NCT03769259|ambivalence|ambivalence
5036783|NCT03769259|suicide ambivalence|suicide ambivalence
5036784|NCT03769259|reasons for living|reasons for living
5036785|NCT03769259|reasons for dying|reasons for dying
5036786|NCT03769259|military|military
5036787|NCT03769259|clinical trial|clinical trial
5036788|NCT03769259|cognitive behavioral therapy|cognitive behavioral therapy
5036789|NCT03769259|psychotherapy|psychotherapy
5036790|NCT03769259|crisis|crisis
5036791|NCT03769259|Crisis Response Plan (CRP)|crisis response plan (crp)
5036792|NCT03769259|Present Centered Therapy (PCT)|present centered therapy (pct)
5036793|NCT03769259|Brief Cognitive-Behavioral Therapy (BCBT)|brief cognitive-behavioral therapy (bcbt)
5036794|NCT03769246|Upright|upright
5036795|NCT03769246|Back|back
5036796|NCT03769246|Posture|posture
5036797|NCT03769246|Back pain|back pain
5036799|NCT03769233|Well-being|well-being
5036800|NCT03769233|Emotion Regulation|emotion regulation
5036801|NCT03769233|Perceived Stress|perceived stress
5036802|NCT03769233|Self-Compassion|self-compassion
5036803|NCT03769220|Time up and Go Test|time up and go test
5036804|NCT03769194|VLA15, Lyme Borreliosis, Vaccine|vla15, lyme borreliosis, vaccine
5036805|NCT03769168|JIA|jia
5036806|NCT03769168|JPsA|jpsa
5036807|NCT03769168|ERA|era
5036808|NCT03769168|Secukinumab|secukinumab
5036809|NCT03769168|ILAR|ilar
5036810|NCT03769168|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
5036811|NCT03769168|Enthesitis Related Arthritis|enthesitis related arthritis
5036812|NCT03769168|cain457|cain457
5036813|NCT03769168|cain457f|cain457f
5036814|NCT03769142|cerebral perfusion|cerebral perfusion
5036815|NCT03769142|hypotension|hypotension
5036816|NCT03769142|transcranial Doppler|transcranial doppler
5036817|NCT03769142|general anesthesia|general anesthesia
5036818|NCT03769142|Bispectral Index|bispectral index
5036819|NCT03769142|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5036820|NCT03769129|Microwave ablation|microwave ablation
5036821|NCT03769129|Pembrolizumab|pembrolizumab
5036822|NCT03769129|NSCLC|nsclc
5036823|NCT03769116|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5088148|NCT03447002|pvc|pvc
5036824|NCT03769116|Gene-Delivery|gene-delivery
5036825|NCT03769116|DMD|dmd
5036826|NCT03769116|Ambulatory|ambulatory
5036827|NCT03769116|Pediatric|pediatric
5036828|NCT03769116|North Star Ambulatory Assessment (NSAA)|north star ambulatory assessment (nsaa)
5036829|NCT03769116|Percent Dystrophin Positive Fibers (PDPF)|percent dystrophin positive fibers (pdpf)
5036830|NCT03769103|EGFR positive|egfr positive
5036831|NCT03769103|Osimertinib|osimertinib
5036832|NCT03769103|SRS|srs
5036833|NCT03769077|Cerebral Palsy|cerebral palsy
5036834|NCT03769077|Orthopedic Surgery|orthopedic surgery
5036835|NCT03769077|Exergames|exergames
5036836|NCT03769077|Motor Function|motor function
5036837|NCT03769077|Rehabilitation|rehabilitation
5036838|NCT03769077|GMFCS|gmfcs
5036839|NCT03769077|Pain Reduction|pain reduction
5036840|NCT03769077|Cycling|cycling
5036848|NCT03769025|remote observed dosing|remote observed dosing
5036849|NCT03768947|Chronic Pain|chronic pain
5036850|NCT03768934|mobile phone surveys|mobile phone surveys
5036851|NCT03768934|short message service|short message service
5036852|NCT03768934|incentive|incentive
5036853|NCT03768921|Dyspnea|dyspnea
5036854|NCT03768921|Respiration, Artificial|respiration, artificial
5036855|NCT03768921|Intensive Care Units|intensive care units
5036856|NCT03768908|Artemether-Lumefantrine|artemether-lumefantrine
5036857|NCT03768908|Coartem|coartem
5036858|NCT03768908|Artesunate|artesunate
5036859|NCT03768908|Amodiaquine|amodiaquine
5036860|NCT03768908|Zanzibar|zanzibar
5036861|NCT03768882|paracetamol,dexketoprofen,emergency department,sore throat|paracetamol,dexketoprofen,emergency department,sore throat
5036862|NCT03768869|Pediatrics|pediatrics
5036863|NCT03768869|Oncology|oncology
5036864|NCT03768869|Outpatient therapy|outpatient therapy
5036865|NCT03768856|Radiation|radiation
5036866|NCT03768830|Quality of life|quality of life
5036867|NCT03768830|Multiple Sclerosis|multiple sclerosis
5036868|NCT03768830|Pain|pain
5036869|NCT03768830|Headache|headache
5036870|NCT03768830|Anxiety Disorders|anxiety disorders
5036871|NCT03768830|Depressive Disorder|depressive disorder
5036872|NCT03768830|Sleep Disorder|sleep disorder
5036873|NCT03768830|Fatigue|fatigue
5036874|NCT03768817|Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)|long-chain fatty acid oxidation disorders (lc-faod)
5036875|NCT03768817|Triheptanoin|triheptanoin
5036876|NCT03768804|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5036877|NCT03768804|Fusion pacing|fusion pacing
5036878|NCT03768804|SyncAV|syncav
5036879|NCT03768791|Spinal Cord Stimulation|spinal cord stimulation
5036880|NCT03768791|Heart rate variability|heart rate variability
5036881|NCT03768778|Penetrating brain trauma (PBT),Traumatic brain injury (TBI), Intensive care unit, non missile.|penetrating brain trauma (pbt),traumatic brain injury (tbi), intensive care unit, non missile.
5036882|NCT03768752|intensive care unit|intensive care unit
5036883|NCT03768752|echocardiography|echocardiography
5036884|NCT03768739|Dysphagia|dysphagia
5036885|NCT03768739|Extubation|extubation
5036886|NCT03768739|Cardiac Intensive Care Unit (CICU)|cardiac intensive care unit (cicu)
5036887|NCT03768739|Forced Expiratory Volume in One second (FEV1)|forced expiratory volume in one second (fev1)
5036888|NCT03768739|Peak Expiratory Flow (PEF)|peak expiratory flow (pef)
5036889|NCT03768687|pancreatic cancer|pancreatic cancer
5036890|NCT03768687|albumin-bound paclitaxel|albumin-bound paclitaxel
5036891|NCT03768674|Selfharming behaviors|selfharming behaviors
5036892|NCT03768661|cholecystectomy|cholecystectomy
5036893|NCT03768661|laparoscopy|laparoscopy
5036894|NCT03768661|single-incision laparoscopic surgery|single-incision laparoscopic surgery
5036895|NCT03768661|incisional hernia|incisional hernia
5036896|NCT03768661|trocar-site hernia|trocar-site hernia
5036897|NCT03768648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5036898|NCT03768648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5038188|NCT03760445|midostaurin|midostaurin
5036901|NCT03768648|Nervous System Diseases|nervous system diseases
5036902|NCT03768648|Pathologic Processes|pathologic processes
5036903|NCT03768648|cognitive impairment|cognitive impairment
5036904|NCT03768648|ecological assessment|ecological assessment
5036906|NCT03768635|otitis|otitis
5036907|NCT03768622|femoral neck fracture|femoral neck fracture
5036908|NCT03768622|pertrochanteric femoral fracture|pertrochanteric femoral fracture
5036909|NCT03768622|risk factor for proximal femoral fracture|risk factor for proximal femoral fracture
5036910|NCT03768596|Nudge|nudge
5036911|NCT03768596|acceptability|acceptability
5036912|NCT03768583|Postural Balace|postural balace
5036913|NCT03768583|Physioteraphy|physioteraphy
5036914|NCT03768583|Ankle Injuries|ankle injuries
5036915|NCT03768583|Electromyography|electromyography
5036916|NCT03768544|generalized anxiety disorder|generalized anxiety disorder
5036917|NCT03768544|older adult|older adult
5036918|NCT03768544|psychological treatment|psychological treatment
5036919|NCT03768544|randomized controlled trial|randomized controlled trial
5036920|NCT03768531|Nivolumab|nivolumab
5036921|NCT03768531|Cabiralizumab|cabiralizumab
5036922|NCT03768531|Immunotherapy|immunotherapy
5036923|NCT03768531|Anti-PD-1|anti-pd-1
5036924|NCT03768531|Anti-CSF-1R|anti-csf-1r
5050622|NCT03681847|colloids|colloids
5036928|NCT03768531|Tumor microenvironment|tumor microenvironment
5036930|NCT03768518|GLP-1|glp-1
5036931|NCT03768518|PET/CT|pet/ct
5036932|NCT03768492|Masectomy|masectomy
5036933|NCT03768440|ropivacaine infusion|ropivacaine infusion
5036934|NCT03768440|regional anesthesia|regional anesthesia
5036935|NCT03768440|paravertebral block|paravertebral block
5036936|NCT03768440|erector spinae block|erector spinae block
5036937|NCT03768349|Prostate Cancer|prostate cancer
5036938|NCT03768349|PET/CT|pet/ct
5036939|NCT03768349|PSMA|psma
5036940|NCT03768349|C-11 Choline|c-11 choline
5036941|NCT03768336|Cancer|cancer
5036942|NCT03768336|Behavioral Intervention|behavioral intervention
5036943|NCT03768336|Adolescent|adolescent
5036944|NCT03768336|Young Adult|young adult
5036945|NCT03768323|mobile phone surveys|mobile phone surveys
5036946|NCT03768323|interactive voice response|interactive voice response
5036947|NCT03768323|incentive|incentive
5036949|NCT03768310|NHL|nhl
5036950|NCT03768310|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5036951|NCT03768245|Body Mass Index|body mass index
5036952|NCT03768245|Glucose|glucose
5036953|NCT03768245|Haemoglobin glycosylated|haemoglobin glycosylated
5036954|NCT03768245|Blood Lipids|blood lipids
5036955|NCT03768245|Liver Function|liver function
5036956|NCT03768245|Kidney Function|kidney function
5036957|NCT03768245|Exercise|exercise
5036958|NCT03768245|Physical activity|physical activity
5036959|NCT03768232|ultrasound assessment|ultrasound assessment
5036960|NCT03768232|diaphragm disfuncion|diaphragm disfuncion
5036961|NCT03768206|knee arthroplasty|knee arthroplasty
5036962|NCT03768206|behavioral intervention|behavioral intervention
5036963|NCT03768206|physical activity|physical activity
5036964|NCT03768167|Corpectomy|corpectomy
5036965|NCT03768167|Pyramesh|pyramesh
5036966|NCT03768167|Posterolateral|posterolateral
5036967|NCT03768167|Pediculectomy|pediculectomy
5036968|NCT03768167|Facetectomies|facetectomies
5036969|NCT03768154|spontaneous breathing|spontaneous breathing
5036970|NCT03768154|prone position|prone position
5036971|NCT03768154|muscle paralysis|muscle paralysis
5036972|NCT03768141|Liver|liver
5036973|NCT03768141|Surgery|surgery
5036974|NCT03768141|Outcomes|outcomes
5036975|NCT03768141|Snapshot|snapshot
5036976|NCT03768141|Collaborative|collaborative
5036977|NCT03768141|International|international
5036978|NCT03768050|integrated care|integrated care
5036979|NCT03767998|Respiratory muscle training|respiratory muscle training
5036980|NCT03767998|Spirometry|spirometry
5036981|NCT03767998|Maximal Inspiratory Pressure|maximal inspiratory pressure
5036982|NCT03767998|Maximal Expiratory pressure|maximal expiratory pressure
5036983|NCT03767998|Surface electromyography|surface electromyography
5036984|NCT03767946|Tuberculosis|tuberculosis
5036985|NCT03767946|Quantiferon Gold Plus test|quantiferon gold plus test
5036986|NCT03767946|Tuberculosis in children|tuberculosis in children
5036987|NCT03767946|SENEGAL|senegal
5036988|NCT03767946|MTBVAC|mtbvac
5036989|NCT03767933|Pediatrics|pediatrics
5036990|NCT03767933|Emergency|emergency
5036991|NCT03767933|Analgesia|analgesia
5036992|NCT03767933|Opioids|opioids
5036993|NCT03767933|Combination therapy|combination therapy
5036994|NCT03767933|Ibuprofen|ibuprofen
5036995|NCT03767933|Acetaminophen|acetaminophen
5036996|NCT03767933|Hydromorphone|hydromorphone
5036997|NCT03767920|dexamethasone|dexamethasone
5036998|NCT03767920|transversus abdominis plane block|transversus abdominis plane block
5036999|NCT03767920|cesarean section|cesarean section
5037000|NCT03767907|cognitive behavioural therapy|cognitive behavioural therapy
5037014|NCT03767816|erector spinae plane block|erector spinae plane block
5037015|NCT03767816|visceral pain|visceral pain
5037016|NCT03767803|Hypertension|hypertension
5037017|NCT03767803|Proteinuria|proteinuria
5037018|NCT03767803|Thrombocytopenia|thrombocytopenia
5037019|NCT03767803|Renal Insufficiency|renal insufficiency
5037020|NCT03767803|Impaired Liver Function|impaired liver function
5037021|NCT03767803|Pulmonary Edema|pulmonary edema
5037022|NCT03767803|Cerebral Symptoms|cerebral symptoms
5037027|NCT03767790|Nutrition|nutrition
5037128|NCT03767270|OTC|otc
5037036|NCT03767764|Alpha fetoprotein|alpha fetoprotein
5037037|NCT03767725|Anti-BCMA, Anti-CD19, CART cell, treatment, Multiple Myeloma|anti-bcma, anti-cd19, cart cell, treatment, multiple myeloma
5037038|NCT03767712|trauma|trauma
5037039|NCT03767712|immunological reaction to trauma|immunological reaction to trauma
5037040|NCT03767712|pertrochanteric femoral fracture|pertrochanteric femoral fracture
5037041|NCT03767712|antinuclear antibodies|antinuclear antibodies
5037042|NCT03767712|activation of innate immunity|activation of innate immunity
5037043|NCT03767712|adaptive immunity|adaptive immunity
5037044|NCT03767699|Medical nutrition therapy|medical nutrition therapy
5037045|NCT03767699|Eating behavior|eating behavior
5037046|NCT03767699|Type 2 diabetes mellitus|type 2 diabetes mellitus
5037047|NCT03767699|Gestational Diabetes|gestational diabetes
5037048|NCT03767660|Blue Rubber Bleb Nevus Syndrome|blue rubber bleb nevus syndrome
5037049|NCT03767660|Venous Malformation|venous malformation
5037050|NCT03767660|Rapamycin (sirolimus)|rapamycin (sirolimus)
5037051|NCT03767660|Mammalian target of rapamycin (mTOR) inhibitor|mammalian target of rapamycin (mtor) inhibitor
5037052|NCT03767660|Treatment|treatment
5037053|NCT03767647|emotional intelligence|emotional intelligence
5037054|NCT03767647|students|students
5037055|NCT03767647|randomized clinical trial|randomized clinical trial
5037056|NCT03767647|schools|schools
5037057|NCT03767634|Preterm neonate|preterm neonate
5037058|NCT03767634|Parenteral nutrition|parenteral nutrition
5037064|NCT03767582|GVAX|gvax
5037065|NCT03767582|Nivolumab|nivolumab
5037066|NCT03767582|CCR2/CCR5 dual antagonist|ccr2/ccr5 dual antagonist
5037067|NCT03767582|Anti-PD-1|anti-pd-1
5037068|NCT03767582|Cancer vaccine|cancer vaccine
5037069|NCT03767582|Monoclonal antibody|monoclonal antibody
5037070|NCT03767582|Checkpoint inhibitor|checkpoint inhibitor
5037071|NCT03767582|Myeloid modulating agent|myeloid modulating agent
5037072|NCT03767582|Immunotherapy|immunotherapy
5037073|NCT03767582|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5037074|NCT03767582|Stereotactic body radiation therapy|stereotactic body radiation therapy
5037075|NCT03767582|SBRT|sbrt
5037076|NCT03767582|Pancreatic cancer|pancreatic cancer
5037077|NCT03767582|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
5037078|NCT03767582|PDAC|pdac
5037079|NCT03767582|Locally advanced pancreatic ductal adenocarcinoma|locally advanced pancreatic ductal adenocarcinoma
5037080|NCT03767582|LAPC|lapc
5037081|NCT03767556|physical tests|physical tests
5037082|NCT03767556|functional capacity|functional capacity
5037083|NCT03767556|spirometry|spirometry
5037084|NCT03767556|travelled distance|travelled distance
5037085|NCT03767556|cardiorespiratory fitness|cardiorespiratory fitness
5037086|NCT03767556|flexibility|flexibility
5037087|NCT03767556|respiratory pressures|respiratory pressures
5037088|NCT03767556|dyspnea|dyspnea
5345983|NCT01967563|Fat|fat
5037089|NCT03767530|Meibomian gland dysfunction|meibomian gland dysfunction
5037090|NCT03767530|Mibo|mibo
5037091|NCT03767530|MGD|mgd
5037092|NCT03767530|Dry eye disease|dry eye disease
5037093|NCT03767530|Thermic devices|thermic devices
5037094|NCT03767478|neuromuscular stimulation|neuromuscular stimulation
5037095|NCT03767465|HIV|hiv
5037096|NCT03767465|Cancer|cancer
5037097|NCT03767465|Checkpoint inhibitors|checkpoint inhibitors
5037098|NCT03767465|HIV reservoir|hiv reservoir
5037099|NCT03767465|Immunity|immunity
5037108|NCT03767426|Emotion|emotion
5037109|NCT03767426|Memory|memory
5037110|NCT03767426|Sleep|sleep
5037111|NCT03767426|Sleep Deprivation|sleep deprivation
5037112|NCT03767387|Prehabilitation|prehabilitation
5037113|NCT03767387|Physical Activity|physical activity
5037114|NCT03767387|Integrated Care|integrated care
5037115|NCT03767387|Collaborative Self-management|collaborative self-management
5037116|NCT03767374|MDR, XDR, ESBL, ESBL, MRSA, CRE|mdr, xdr, esbl, esbl, mrsa, cre
5037117|NCT03767374|HIV, PrEP, CeGIDD, STI, bacteria colonization|hiv, prep, cegidd, sti, bacteria colonization
5037122|NCT03767322|contrast induced acute kidney injury|contrast induced acute kidney injury
5037123|NCT03767322|contrast induced nephropathy|contrast induced nephropathy
5037124|NCT03767322|allopurinol|allopurinol
5037125|NCT03767322|febuxostat|febuxostat
5037126|NCT03767296|spinal oxygenation|spinal oxygenation
5037127|NCT03767296|NIRS|nirs
5037129|NCT03767270|Urea Cycle Disorder|urea cycle disorder
5037130|NCT03767270|UCD|ucd
5037131|NCT03767257|Lenalidomide Associated Diarrhea|lenalidomide associated diarrhea
5037132|NCT03767257|Colesevelam|colesevelam
5037133|NCT03767257|18-421|18-421
5037134|NCT03767257|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5037135|NCT03767231|viral load testing|viral load testing
5037136|NCT03767231|point of care|point of care
5037137|NCT03767218|Oocyte donor|oocyte donor
5037138|NCT03767218|Ovarian stimulation|ovarian stimulation
5037139|NCT03767205|gait function|gait function
5037140|NCT03767205|Metabolic energy expenditure|metabolic energy expenditure
5037141|NCT03767205|ankle assist robot|ankle assist robot
5037142|NCT03767192|acute ischemic stroke|acute ischemic stroke
5037143|NCT03767192|randomized clinical trial|randomized clinical trial
5037144|NCT03767192|effectiveness|effectiveness
5037145|NCT03767192|safety|safety
5037146|NCT03767179|Missed abortion|missed abortion
5037147|NCT03767179|Procalcitonin|procalcitonin
5037148|NCT03767179|Erythrocyte sedimentation rate (ESR)|erythrocyte sedimentation rate (esr)
5037149|NCT03767179|C-reactive protein (CRP)|c-reactive protein (crp)
5037150|NCT03767179|Leukocyte (WBC)|leukocyte (wbc)
5037151|NCT03767153|acne scarring|acne scarring
5037152|NCT03767153|acne scar|acne scar
5037153|NCT03767153|fractional radiofrequency|fractional radiofrequency
5037154|NCT03767153|fractional RF|fractional rf
5037155|NCT03767127|transfusion|transfusion
5037156|NCT03767127|intensive care medicine|intensive care medicine
5037157|NCT03767127|90-day mortality|90-day mortality
5037158|NCT03767101|Positive Affect|positive affect
5037159|NCT03767101|Mental Imagery|mental imagery
5037160|NCT03767101|Cognitive Behavioral Therapy|cognitive behavioral therapy
5037161|NCT03767101|Psychotherapy process|psychotherapy process
5037162|NCT03767101|Micro-Intervention|micro-intervention
5037163|NCT03767088|WB-EMS|wb-ems
5037164|NCT03767088|rehabilitation|rehabilitation
5037165|NCT03767088|sarcopenia|sarcopenia
5037166|NCT03767075|Advanced Solid Tumor|advanced solid tumor
5037167|NCT03767075|Cancer|cancer
5037168|NCT03767075|Atezolizumab|atezolizumab
5037169|NCT03767075|Immunotherapy|immunotherapy
5037170|NCT03767062|Medication overuse headache; Greater occipital nerve block; supratrochlear nerve block; topiramate.|medication overuse headache; greater occipital nerve block; supratrochlear nerve block; topiramate.
5037171|NCT03767036|tramadol|tramadol
5037172|NCT03767036|ketorolac|ketorolac
5037173|NCT03767036|interaction|interaction
5037174|NCT03766997|Granulomatous Mastitis|granulomatous mastitis
5037175|NCT03766997|local injection|local injection
5037176|NCT03766997|topical steroids|topical steroids
5037177|NCT03766984|fixed-dose combination|fixed-dose combination
5037178|NCT03766984|diclofenac|diclofenac
5037179|NCT03766984|tramadol|tramadol
5037180|NCT03766984|interaction|interaction
5037181|NCT03766945|Gastric Cancer|gastric cancer
5037182|NCT03766945|Surgery|surgery
5037183|NCT03766945|Fatigue|fatigue
5037184|NCT03766945|Quality of Life|quality of life
5037185|NCT03766919|INVICTA|invicta
5037186|NCT03766919|Lead|lead
5037187|NCT03766919|ICD|icd
5037188|NCT03766919|CRT-D|crt-d
5037189|NCT03766919|MicroPort|microport
5037190|NCT03766880|clinically significant portal hypertension, hepatic venous pressure gradient, MR imaging|clinically significant portal hypertension, hepatic venous pressure gradient, mr imaging
5037191|NCT03766841|consumer informatics|consumer informatics
5037192|NCT03766841|communication|communication
5037193|NCT03766841|patient engagement|patient engagement
5037194|NCT03766828|thoracic central venous occlusion|thoracic central venous occlusion
5037204|NCT03766789|Adherence, Medication, Therapy|adherence, medication, therapy
5037206|NCT03766711|Bimanual Task|bimanual task
5037207|NCT03766711|Motor Adaptation|motor adaptation
5037208|NCT03766698|Multiple Sclerosis|multiple sclerosis
5037209|NCT03766698|Muscle Architecture|muscle architecture
5037210|NCT03766698|Lower extremity|lower extremity
5037211|NCT03766685|Bimekizumab|bimekizumab
5037212|NCT03766685|PSO|pso
5037213|NCT03766685|Psoriasis|psoriasis
5037214|NCT03766685|Auto-Injector|auto-injector
5037215|NCT03766672|Endometrial carcinoma|endometrial carcinoma
5037216|NCT03766646|Optiflow|optiflow
5342940|NCT01981447|epilepsy|epilepsy
5037217|NCT03766646|High Flow Nasal Oxygen|high flow nasal oxygen
5037218|NCT03766646|Preoxygenation|preoxygenation
5037219|NCT03766646|Speech|speech
5037220|NCT03766633|LiverVision|livervision
5037221|NCT03766633|Liver|liver
5037222|NCT03766633|Volumetry|volumetry
5037223|NCT03766633|Semi-automated|semi-automated
5037224|NCT03766633|Living donor liver transplantation|living donor liver transplantation
5037225|NCT03766633|Surgery|surgery
5037226|NCT03766568|Rhinosinusitis|rhinosinusitis
5037242|NCT03766464|polisomnography|polisomnography
5037243|NCT03766464|sleep wake disorders|sleep wake disorders
5037244|NCT03766425|aflibercept|aflibercept
5037245|NCT03766425|glaucoma|glaucoma
5037246|NCT03766425|mitomycin|mitomycin
5037247|NCT03766425|trabeculectomy|trabeculectomy
5037248|NCT03766399|Inhaled JAK inhibitor|inhaled jak inhibitor
5037249|NCT03766347|Pediatric|pediatric
5037250|NCT03766347|Aquaporin-4|aquaporin-4
5037251|NCT03766347|AQP4|aqp4
5037253|NCT03766347|NMO|nmo
5037254|NCT03766347|Neuromyelitis Optica|neuromyelitis optica
5037255|NCT03766334|Highland Barley Diet|highland barley diet
5037256|NCT03766334|Glucose variability|glucose variability
5037257|NCT03766321|microbiota|microbiota
5037258|NCT03766321|fecal transplantation|fecal transplantation
5037259|NCT03766321|adaptive immunity|adaptive immunity
5037260|NCT03766321|T regulatory lymphocytes|t regulatory lymphocytes
5037262|NCT03766295|Pancreatic cancer|pancreatic cancer
5037263|NCT03766295|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5037264|NCT03766282|Pharmacokinetics|pharmacokinetics
5037265|NCT03766282|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5037266|NCT03766243|Microstomia|microstomia
5037267|NCT03766243|Rehabilitation|rehabilitation
5037268|NCT03766243|Self-Management|self-management
5037269|NCT03766204|circRNAs|circrnas
5037270|NCT03766204|microRNAs|micrornas
5037271|NCT03766191|Obesity|obesity
5037272|NCT03766191|Cue Reactivity|cue reactivity
5037273|NCT03766191|Genetics|genetics
5037274|NCT03766191|Self Regulation|self regulation
5037275|NCT03766191|fMRI|fmri
5037276|NCT03766191|Children|children
5037277|NCT03766191|Eating in the Absence of Hunger|eating in the absence of hunger
5037278|NCT03766152|Hearing aid|hearing aid
5037285|NCT03766113|Neurofeedback ; fMRI ; EEG ; BCI ; Motor imagery|neurofeedback ; fmri ; eeg ; bci ; motor imagery
5037286|NCT03766100|Rheumatoid Arthritis|rheumatoid arthritis
5037287|NCT03766100|Insomnia|insomnia
5037288|NCT03766100|Sleep|sleep
5037289|NCT03766100|Cognitive Behavioural Therapy for Insomnia|cognitive behavioural therapy for insomnia
5037290|NCT03766100|CBT-I|cbt-i
5037291|NCT03766100|Non-pharmacological treatment|non-pharmacological treatment
5037292|NCT03766100|Polysomnography|polysomnography
5037293|NCT03766100|Actigraphy|actigraphy
5037294|NCT03766100|Patient reported outcomes|patient reported outcomes
5037295|NCT03766074|vitamin D- Depression- Cholecalciferol-|vitamin d- depression- cholecalciferol-
5037296|NCT03766048|Urogenital prolapse|urogenital prolapse
5037297|NCT03766048|laparoscopic sacropexy|laparoscopic sacropexy
5037298|NCT03766048|mesh|mesh
5037299|NCT03766048|medico-economic study|medico-economic study
5037300|NCT03766035|per oral cholangioscopy|per oral cholangioscopy
5037302|NCT03766035|cholangiocarcinoma|cholangiocarcinoma
5037303|NCT03766035|primary sclerosing cholangitis|primary sclerosing cholangitis
5037304|NCT03766035|ERCP|ercp
5037305|NCT03765983|Breast Cancer|breast cancer
5037306|NCT03765970|Tumor resection|tumor resection
5037307|NCT03765970|MSTS|msts
5037328|NCT03765814|organ donation|organ donation
5037329|NCT03765814|serious brain-injured patient|serious brain-injured patient
5037330|NCT03765814|anticipated approach|anticipated approach
5037331|NCT03765788|Giant Cell Arteritis|giant cell arteritis
5037332|NCT03765788|Secukinumab|secukinumab
5037333|NCT03765788|Subcutaneous|subcutaneous
5037334|NCT03765788|Vessel Inflammation|vessel inflammation
5037335|NCT03765775|Non-small Cell Lung Cancer|non-small cell lung cancer
5037336|NCT03765775|Anlotinib|anlotinib
5037337|NCT03765775|Sintilimab|sintilimab
5037338|NCT03765762|Brain Diseases|brain diseases
5037339|NCT03765762|Nervous System Diseases|nervous system diseases
5037340|NCT03765762|Central Nervous System Diseases|central nervous system diseases
5037341|NCT03765762|Neurodegenerative Diseases|neurodegenerative diseases
5037342|NCT03765762|Neurocognitive Disorders|neurocognitive disorders
5037343|NCT03765762|Mental Disorders|mental disorders
5037344|NCT03765762|Dementia|dementia
5037345|NCT03765762|Tauopathy|tauopathy
5037346|NCT03765723|TKRA|tkra
5037347|NCT03765723|Postoperative pain|postoperative pain
5037348|NCT03765697|post-herpetic neuralgia|post-herpetic neuralgia
5037349|NCT03765697|lidocaine|lidocaine
5037350|NCT03765645|Liver Transplant|liver transplant
5037351|NCT03765645|Donor Hepatectomy|donor hepatectomy
5346137|NCT01966939|TMJ|tmj
5037352|NCT03765645|Antibiotic prophylaxis|antibiotic prophylaxis
5037354|NCT03765606|methylaxanthin|methylaxanthin
5037355|NCT03765606|theobromine|theobromine
5037356|NCT03765606|Ileostomists|ileostomists
5037357|NCT03765606|bioavailability|bioavailability
5037358|NCT03765606|randomised controlled trial|randomised controlled trial
5037359|NCT03765593|Primary Sjogren Syndrome|primary sjogren syndrome
5037360|NCT03765593|Lymphoma|lymphoma
5037361|NCT03765593|Biomarker|biomarker
5037362|NCT03765580|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
5037363|NCT03765580|fish|fish
5037364|NCT03765580|fish consumption|fish consumption
5037365|NCT03765580|women|women
5037366|NCT03765580|childbearing age|childbearing age
5037367|NCT03765567|infection|infection
5037368|NCT03765567|vancomycin|vancomycin
5037369|NCT03765567|topical antibiotic|topical antibiotic
5037370|NCT03765567|antibiotic prophylaxis|antibiotic prophylaxis
5037371|NCT03765541|dexamethasone|dexamethasone
5037372|NCT03765541|acute myeloid leukemia|acute myeloid leukemia
5037373|NCT03765541|relapse|relapse
5037374|NCT03765541|refractory|refractory
5037375|NCT03765541|azacitidine|azacitidine
5037376|NCT03765541|amsacrine|amsacrine
5037377|NCT03765541|cytarabine|cytarabine
5037378|NCT03765541|randomized controlled trial|randomized controlled trial
5037379|NCT03765528|Clostridium difficile|clostridium difficile
5037380|NCT03765528|Extended-Spectrum β-Lactamase producing Enterobacteriaceae|extended-spectrum β-lactamase producing enterobacteriaceae
5037381|NCT03765528|Vancomycin-resistant enterococci|vancomycin-resistant enterococci
5037382|NCT03765528|Antimicrobial resistance|antimicrobial resistance
5037383|NCT03765528|Microbiome|microbiome
5037384|NCT03765528|Nosocomial infection|nosocomial infection
5037385|NCT03765528|Antimicrobial Stewardship|antimicrobial stewardship
5037386|NCT03765528|Infection Control|infection control
5037387|NCT03765489|polyneuropathies|polyneuropathies
5037388|NCT03765489|muscle weakness|muscle weakness
5037389|NCT03765489|sepsis|sepsis
5037390|NCT03765489|septic shock|septic shock
5037391|NCT03765489|electrical stimulation|electrical stimulation
5037392|NCT03765489|intensive care unit|intensive care unit
5037393|NCT03765463|Extinction learning|extinction learning
5037394|NCT03765463|Behavior Therapy|behavior therapy
5037395|NCT03765463|Tourette's Disorder|tourette's disorder
5037396|NCT03765463|Habit Reversal Training|habit reversal training
5037397|NCT03765463|Comprehensive Behavioral Intervention for Tics|comprehensive behavioral intervention for tics
5037398|NCT03765450|ASUC|asuc
5037399|NCT03765450|Infliximab|infliximab
5037400|NCT03765450|Optimal Dose|optimal dose
5454852|NCT01482351|apnea|apnea
5350433|NCT01947075|Fever|fever
5037401|NCT03765450|Optimal Frequency|optimal frequency
5037402|NCT03765450|Theraputic Drug Monitoring|theraputic drug monitoring
5038723|NCT03756519|acute|acute
5037419|NCT03765359|metformin|metformin
5037420|NCT03765346|intranasal abuse|intranasal abuse
5037421|NCT03765346|abuse-deterrent|abuse-deterrent
5037422|NCT03765307|Asthma|asthma
5037423|NCT03765307|Bronchial Ablation|bronchial ablation
5037424|NCT03765307|Bronchial Thermoplasty|bronchial thermoplasty
5037425|NCT03765255|youth|youth
5037426|NCT03765255|adolescent|adolescent
5037427|NCT03765229|PD-1|pd-1
5037434|NCT03765125|gingivitis|gingivitis
5037435|NCT03765125|collagen peptide|collagen peptide
5037436|NCT03765125|plaque|plaque
5037437|NCT03765047|Standardized Test Score|standardized test score
5037438|NCT03765047|Academic Achievement|academic achievement
5037439|NCT03765008|water|water
5037440|NCT03765008|vasopressin|vasopressin
5037441|NCT03764995|massage|massage
5037442|NCT03764995|abdominal massage|abdominal massage
5037443|NCT03764995|chronic constipation|chronic constipation
5037444|NCT03764995|primary constipation|primary constipation
5037445|NCT03764995|functional constipation|functional constipation
5037446|NCT03764995|defecation|defecation
5037447|NCT03764982|Rehabilitation|rehabilitation
5037448|NCT03764982|Multidisciplinary|multidisciplinary
5037449|NCT03764982|Health care|health care
5037450|NCT03764969|Addiction|addiction
5037451|NCT03764969|Nicotine|nicotine
5037452|NCT03764969|Smoking Cessation|smoking cessation
5037453|NCT03764969|Relapse|relapse
5037454|NCT03764969|Craving|craving
5037455|NCT03764969|habitual behavior|habitual behavior
5037456|NCT03764969|cognitive remediation|cognitive remediation
5037457|NCT03764969|implicit priming|implicit priming
5037466|NCT03764865|in vitro fertilization|in vitro fertilization
5037468|NCT03764839|pain|pain
5037469|NCT03764839|treatment|treatment
5037470|NCT03764839|opioid cessation|opioid cessation
5037471|NCT03764748|Tic Disorders|tic disorders
5037472|NCT03764748|Gut microbiota|gut microbiota
5037473|NCT03764748|Brain-gut axis|brain-gut axis
5037474|NCT03764748|Microbiota Transplantation|microbiota transplantation
5037475|NCT03764748|Tourette syndrome|tourette syndrome
5037476|NCT03764735|Dry Eye|dry eye
5037477|NCT03764735|Dry Eye Syndrome|dry eye syndrome
5037478|NCT03764735|SkQ1|skq1
5037479|NCT03764735|KCS|kcs
5031105|NCT03804879|diabetes|diabetes
5031106|NCT03804866|NGR-hTNF|ngr-htnf
5346237|NCT01966809|malignant gliomas|malignant gliomas
5031107|NCT03804866|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5031108|NCT03804866|Doxorubicin|doxorubicin
5037480|NCT03764735|Keratoconjunctivitis|keratoconjunctivitis
5037481|NCT03764722|Levosimendan|levosimendan
5037482|NCT03764722|Rehospitalisation|rehospitalisation
5037483|NCT03764722|Heart failure|heart failure
5037484|NCT03764709|Wireless monitoring, hospital-territory integration|wireless monitoring, hospital-territory integration
5037489|NCT03764657|Pilonidal sinus disease|pilonidal sinus disease
5037490|NCT03764657|wound deiscence|wound deiscence
5037491|NCT03764618|wAIHA|waiha
5037492|NCT03764618|Warm Antibody Autoimmune Hemolytic Anemia|warm antibody autoimmune hemolytic anemia
5037493|NCT03764618|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
5037500|NCT03764553|palliative chemotherapy|palliative chemotherapy
5037501|NCT03764553|metastatic esophagogastric cancer|metastatic esophagogastric cancer
5037502|NCT03764553|Efficacy|efficacy
5037503|NCT03764553|toxicity|toxicity
5038812|NCT03755908|Asthma|asthma
5037511|NCT03764436|Early Childhood Education|early childhood education
5037512|NCT03764436|Youth Development|youth development
5037513|NCT03764410|Diabetes mellitus, periodontal diseases, periodontal index|diabetes mellitus, periodontal diseases, periodontal index
5037514|NCT03764397|Lifestyle|lifestyle
5037515|NCT03764397|Education|education
5037516|NCT03764397|Self-management|self-management
5037517|NCT03764397|Physical Activity|physical activity
5037518|NCT03764397|Proof-of-concept study|proof-of-concept study
5037520|NCT03764384|N-Tidal C Device|n-tidal c device
5037521|NCT03764384|Self-monitoring|self-monitoring
5037522|NCT03764384|CO2 waveforms|co2 waveforms
5037523|NCT03764332|Footwear|footwear
5037524|NCT03764332|Barefoot|barefoot
5037526|NCT03764306|carotid angioplaty|carotid angioplaty
5037527|NCT03764306|MRI DWI|mri dwi
5037528|NCT03764280|Multiple Daily Injections|multiple daily injections
5037533|NCT03764241|left ventricular thrombus|left ventricular thrombus
5037534|NCT03764241|rivaroxaban|rivaroxaban
5037535|NCT03764228|human amniotic epithelial cells(hAECs)|human amniotic epithelial cells(haecs)
5037536|NCT03764228|Acute-graft-versus-host disease（aGVHD）|acute-graft-versus-host disease（agvhd）
5037537|NCT03764189|Accelerated tooth movement AND anterior segment retraction AND miniscrews AND microosteoperforation|accelerated tooth movement and anterior segment retraction and miniscrews and microosteoperforation
5037538|NCT03764150|Sleep Apnea Syndrome|sleep apnea syndrome
5037539|NCT03764150|Muscular Diseases|muscular diseases
5037540|NCT03764150|non invasive ventilation|non invasive ventilation
5037541|NCT03764150|Diaphragmatic Disorder|diaphragmatic disorder
5037542|NCT03764124|Allograft survival|allograft survival
5037543|NCT03764124|PET/CT imaging|pet/ct imaging
5037544|NCT03764124|Corticoids withdrawal|corticoids withdrawal
5037545|NCT03764124|Bone mineral Density|bone mineral density
5037548|NCT03764046|Pain Measurement|pain measurement
5037549|NCT03764046|Acute Postoperative Pain|acute postoperative pain
5037550|NCT03764033|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5037551|NCT03764033|Moral Injury|moral injury
5037552|NCT03764033|Treatment|treatment
5037553|NCT03764020|melatonin|melatonin
5037554|NCT03764020|inflammatory biomarkers|inflammatory biomarkers
5037555|NCT03764007|Positron emission tomography|positron emission tomography
5037556|NCT03763942|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5723665|NCT00417950|acarbose|acarbose
5089036|NCT03441776|TBI|tbi
5037557|NCT03763942|Men who have sex with men (MSM)|men who have sex with men (msm)
5037558|NCT03763942|Pre-Exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5037560|NCT03763903|skills training|skills training
5037561|NCT03763903|laparoscopic surgery|laparoscopic surgery
5037562|NCT03763890|ARDS（Acute respiratory syndrome）;|ards（acute respiratory syndrome）;
5037563|NCT03763890|stress;|stress;
5037564|NCT03763890|strain;|strain;
5037565|NCT03763890|Trans-pulmonary pressure;|trans-pulmonary pressure;
5037566|NCT03763890|FRC(functional residual capacity )|frc(functional residual capacity )
5037567|NCT03763890|PEEP（post end-expiratory pressure）;|peep（post end-expiratory pressure）;
5037568|NCT03763890|EIT（Electronic impedance tomography）;|eit（electronic impedance tomography）;
5037569|NCT03763890|RVD(region ventilation delay)|rvd(region ventilation delay)
5037570|NCT03763838|Acupressure|acupressure
5037571|NCT03763825|fear of recurrence|fear of recurrence
5037572|NCT03763825|cancer|cancer
5037573|NCT03763825|brief intervention|brief intervention
5037574|NCT03763825|telephone counselling|telephone counselling
5037575|NCT03763825|following primary cancer treatment|following primary cancer treatment
5037576|NCT03763812|EVAR|evar
5037577|NCT03763812|EVAS|evas
5037578|NCT03763812|Post implant syndrome|post implant syndrome
5037579|NCT03763812|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5037580|NCT03763799|Aspiration pneumonia|aspiration pneumonia
5037581|NCT03763799|Invasive ventilation|invasive ventilation
5037582|NCT03763799|PCR|pcr
5037583|NCT03763799|Antibiotics|antibiotics
5037584|NCT03763799|Tracheal aspirate|tracheal aspirate
5037585|NCT03763773|respiratory variations,|respiratory variations,
5037586|NCT03763773|superior vena cava|superior vena cava
5037587|NCT03763773|prognosis.|prognosis.
5037588|NCT03763760|Hip Arthroplasty|hip arthroplasty
5037589|NCT03763760|Hip Replacement|hip replacement
5037590|NCT03763760|Perioperative Medicine|perioperative medicine
5037591|NCT03763747|Coronary Artery Disease|coronary artery disease
5037592|NCT03763747|Coronary Disease|coronary disease
5037593|NCT03763747|Myocardial Ischemia|myocardial ischemia
5037594|NCT03763747|Heart Diseases|heart diseases
5037595|NCT03763747|Arteriosclerosis|arteriosclerosis
5037596|NCT03763747|Cardiovascular Diseases|cardiovascular diseases
5037597|NCT03763734|Knee Arthroplasty|knee arthroplasty
5037598|NCT03763734|Knee Replacement|knee replacement
5037599|NCT03763734|Perioperative Medicine|perioperative medicine
5037600|NCT03763695|Pediatric intensive care unit|pediatric intensive care unit
5037601|NCT03763695|Oral Hygiene Care|oral hygiene care
5037602|NCT03763695|Chlorhexidine|chlorhexidine
5037603|NCT03763695|Broncho-alveolar lavage|broncho-alveolar lavage
5037604|NCT03763695|Pharyngeal swab|pharyngeal swab
5037605|NCT03763669|Insulin resistance|insulin resistance
5037606|NCT03763669|Fetal sonographic parameter|fetal sonographic parameter
5037607|NCT03763669|Myoinositol|myoinositol
5037608|NCT03763656|Hydroxyurea|hydroxyurea
5037609|NCT03763656|Hydroxycarbomide|hydroxycarbomide
5037611|NCT03763630|Atopy|atopy
5037612|NCT03763630|Early childhood|early childhood
5037613|NCT03763630|House Dust-mite|house dust-mite
5037614|NCT03763630|Sublingual immunotherapy|sublingual immunotherapy
5037615|NCT03763617|Socket preservation|socket preservation
5037616|NCT03763552|arthroscopy|arthroscopy
5037617|NCT03763552|wrist osteoarthrosis|wrist osteoarthrosis
5037618|NCT03763539|renal stones|renal stones
5037619|NCT03763539|SWL|swl
5037620|NCT03763539|High density stones|high density stones
5037621|NCT03763539|Ultraslow SWL|ultraslow swl
5037627|NCT03763513|Tennis Elbow|tennis elbow
5037628|NCT03763513|Taping|taping
5037629|NCT03763513|Grip Strength|grip strength
5037630|NCT03763513|Pain|pain
5037631|NCT03763500|Atrial fibrillation|atrial fibrillation
5037632|NCT03763500|Symptom burden|symptom burden
5037633|NCT03763500|Health-related quality of life|health-related quality of life
5037634|NCT03763500|Health economy|health economy
5037635|NCT03763487|celiac sprue, celiac, hyposplenism, IgM memory, B lymphocytes|celiac sprue, celiac, hyposplenism, igm memory, b lymphocytes
5037636|NCT03763474|Diabetes|diabetes
5037637|NCT03763461|Awake Craniotomy|awake craniotomy
5037638|NCT03763461|HFNC|hfnc
5037639|NCT03763461|Oxygen Therapy|oxygen therapy
5037640|NCT03763461|Atelectasis|atelectasis
5037641|NCT03763461|Ultrasound|ultrasound
5037642|NCT03763461|Patient Comfort|patient comfort
5037647|NCT03763435|postpartum depression|postpartum depression
5037648|NCT03763435|sleep disorder|sleep disorder
5037649|NCT03763435|genital self-image|genital self-image
5037650|NCT03763435|breast-feeding|breast-feeding
5037651|NCT03763435|prevalence|prevalence
5037652|NCT03763409|anxiety|anxiety
5037653|NCT03763409|losartan|losartan
5037654|NCT03763409|appetitive learning|appetitive learning
5037655|NCT03763409|aversive learning|aversive learning
5037656|NCT03763396|recurrent high grade glioma, posaconazole, ketoconazole, hexokinase 2 (HK2)|recurrent high grade glioma, posaconazole, ketoconazole, hexokinase 2 (hk2)
5037657|NCT03763344|memory|memory
5037658|NCT03763344|visual spatial training|visual spatial training
5037659|NCT03763344|multiple object tracking|multiple object tracking
5037660|NCT03763344|Elderly|elderly
5037661|NCT03763305|skin sympathetic nerve activity, anesthetics|skin sympathetic nerve activity, anesthetics
5037662|NCT03763292|Parents|parents
5037663|NCT03763292|Patient Education as Topic|patient education as topic
5037664|NCT03763292|Preoperative Care|preoperative care
5037665|NCT03763292|Pamphlets|pamphlets
5037666|NCT03763266|bowel preparation|bowel preparation
5037667|NCT03763266|low residue diet|low residue diet
5037668|NCT03763266|colonoscopy|colonoscopy
5037669|NCT03763214|metal stent|metal stent
5037670|NCT03763214|biliary stricture|biliary stricture
5037671|NCT03763214|stenting|stenting
5037672|NCT03763201|Rheumatoid arthritis|rheumatoid arthritis
5037673|NCT03763201|glucocorticoid-induced tumour necrosis factor receptor related protein|glucocorticoid-induced tumour necrosis factor receptor related protein
5037674|NCT03763175|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
5037675|NCT03763175|Lovastatin|lovastatin
5037676|NCT03763175|SYN-010|syn-010
5037677|NCT03763097|pelvic floor ultrasonography|pelvic floor ultrasonography
5031334|NCT03803449|gastrointestinal endoscopy|gastrointestinal endoscopy
5031346|NCT03803358|CHRF|chrf
5037678|NCT03763097|transperineal ultrasound|transperineal ultrasound
5037679|NCT03763097|introital ultrasound|introital ultrasound
5037680|NCT03763097|mini-sling|mini-sling
5037681|NCT03763097|needleless|needleless
5037682|NCT03763097|Urinary Incontinence,Stress|urinary incontinence,stress
5037683|NCT03763084|acetaminophen|acetaminophen
5037684|NCT03763084|analgesia|analgesia
5037685|NCT03763084|delirium|delirium
5037686|NCT03763058|Migraine|migraine
5037687|NCT03763058|Headache|headache
5037688|NCT03763058|Music intervention|music intervention
5037689|NCT03763058|Pain|pain
5037690|NCT03763058|Smartphone application|smartphone application
5037691|NCT03763032|Palliative Care|palliative care
5037692|NCT03763032|Latino|latino
5037693|NCT03763032|Psychosocial Intervention|psychosocial intervention
5037694|NCT03763032|Patient Navigation|patient navigation
5037695|NCT03763019|hemiplegia|hemiplegia
5037696|NCT03763019|respiratory function tests|respiratory function tests
5037697|NCT03763019|respiratory exercises|respiratory exercises
5037698|NCT03763019|diaphragm ultrasonography|diaphragm ultrasonography
5037703|NCT03762967|Oligospermia|oligospermia
5037704|NCT03762941|Elderly patients|elderly patients
5037705|NCT03762941|Emergency Department|emergency department
5037706|NCT03762941|Homecare|homecare
5037707|NCT03762928|PK|pk
5037708|NCT03762928|Phase 1|phase 1
5037709|NCT03762902|Migraine|migraine
5037710|NCT03762902|Smartphone|smartphone
5037711|NCT03762902|App|app
5037712|NCT03762902|Prediction|prediction
5037713|NCT03762902|Forecast|forecast
5037714|NCT03762902|Detection|detection
5037715|NCT03762902|Individual|individual
5037716|NCT03762902|Machine Learning|machine learning
5037717|NCT03762902|Data Science|data science
5037718|NCT03762902|Algorithm|algorithm
5037719|NCT03762902|Behavior|behavior
5037723|NCT03762876|Hepatectomy|hepatectomy
5037724|NCT03762876|Trans-hepatic flow|trans-hepatic flow
5037725|NCT03762876|Post-hepatectomy liver failure|post-hepatectomy liver failure
5037726|NCT03762876|Mortality|mortality
5037727|NCT03762837|Gallbladder cancer|gallbladder cancer
5037728|NCT03762824|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5037729|NCT03762824|Pneumococcal Disease|pneumococcal disease
5037730|NCT03762824|Immune Response|immune response
5037731|NCT03762824|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
5037732|NCT03762824|Pneumococcal Polysaccharide Vaccine|pneumococcal polysaccharide vaccine
5037733|NCT03762824|Immunosuppression|immunosuppression
5037734|NCT03762811|Demineralized Bone Matrix|demineralized bone matrix
5037735|NCT03762811|Bone Graft|bone graft
5037736|NCT03762811|Fusion|fusion
5037737|NCT03762798|substance abuse|substance abuse
5037738|NCT03762798|the bridge|the bridge
5037739|NCT03762785|pharmacokinitics|pharmacokinitics
5037740|NCT03762785|nebulized|nebulized
5037741|NCT03762785|dexmedetomidine|dexmedetomidine
5037742|NCT03762785|preschool children|preschool children
5037743|NCT03762772|HIV|hiv
5037744|NCT03762772|TAF|taf
5037745|NCT03762772|EVG|evg
5037746|NCT03762772|Prevention|prevention
5037747|NCT03762772|Vaginal Insert|vaginal insert
5037751|NCT03762720|Manual Therapy|manual therapy
5037752|NCT03762720|Massage|massage
5037753|NCT03762720|physium|physium
5037754|NCT03762720|pain|pain
5037755|NCT03762720|range of motion|range of motion
5037756|NCT03762720|quality of life|quality of life
5037757|NCT03762720|muscle injuries|muscle injuries
5037758|NCT03762707|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
5037759|NCT03762707|Kidney biopsy|kidney biopsy
5037760|NCT03762707|Bleeding Complications|bleeding complications
5037761|NCT03762694|Acupuncture|acupuncture
5037762|NCT03762694|Insomnia|insomnia
5037763|NCT03762694|Breast cancer|breast cancer
5037764|NCT03762694|Chemotherapy|chemotherapy
5037765|NCT03762668|Contact lens|contact lens
5037766|NCT03762668|Vision correction|vision correction
5089258|NCT03440346|ADHD|adhd
5037767|NCT03762668|Visual acuity|visual acuity
5037768|NCT03762642|Breast Cancer Surgery|breast cancer surgery
5037769|NCT03762642|Lumpectomy|lumpectomy
5037770|NCT03762642|Surgery Choice|surgery choice
5037780|NCT03762577|Walking Training|walking training
5037781|NCT03762577|Exercise|exercise
5037782|NCT03762577|Balance|balance
5037783|NCT03762577|Quality of Life|quality of life
5037784|NCT03762564|Squamous Cell Carcinoma of the Esophagus|squamous cell carcinoma of the esophagus
5037785|NCT03762564|Ramucirumab|ramucirumab
5037786|NCT03762564|Paclitaxel|paclitaxel
5037787|NCT03762538|propofol|propofol
5037788|NCT03762538|ALDH2|aldh2
5037789|NCT03762538|potency|potency
5037790|NCT03762499|Young adults|young adults
5037791|NCT03762499|Echocardiography|echocardiography
5031466|NCT03802578|Exercise|exercise
5031467|NCT03802578|Hand function|hand function
5031468|NCT03802578|Quality of Life|quality of life
5031469|NCT03802539|Root caries|root caries
5031470|NCT03802539|Cavity lining|cavity lining
5031471|NCT03802539|Composite resin restorations|composite resin restorations
5037792|NCT03762486|Postoperative pain|postoperative pain
5037793|NCT03762486|Alternative therapy|alternative therapy
5037794|NCT03762486|Acupuncture|acupuncture
5037795|NCT03762486|TENS|tens
5037796|NCT03762486|Surgical nursing|surgical nursing
5037797|NCT03762486|Randomised controlled trial|randomised controlled trial
5037798|NCT03762473|Envarsus|envarsus
5037799|NCT03762460|Measurement-Based Care|measurement-based care
5037800|NCT03762460|e-Mental Health|e-mental health
5037801|NCT03762460|Functional Outcomes|functional outcomes
5037802|NCT03762460|Occupational Functioning|occupational functioning
5037803|NCT03762460|Cognition|cognition
5037804|NCT03762460|Mobile Technology|mobile technology
5037805|NCT03762447|solid tumors|solid tumors
5037806|NCT03762434|life style modification program|life style modification program
5037807|NCT03762434|mobile application|mobile application
5037818|NCT03762408|Biomarkers|biomarkers
5037819|NCT03762382|Intravaginal Ring|intravaginal ring
5037820|NCT03762382|HIV Prevention|hiv prevention
5037821|NCT03762382|Tenofovir|tenofovir
5037822|NCT03762382|Levonorgestrel|levonorgestrel
5037839|NCT03762330|structured plan|structured plan
5037840|NCT03762330|COPD|copd
5037841|NCT03762304|Causal inference|causal inference
5037842|NCT03762304|Regression discontinuity|regression discontinuity
5037843|NCT03762291|hematologic malignancy|hematologic malignancy
5037844|NCT03762291|malignant proliferation of plasma cells|malignant proliferation of plasma cells
5037845|NCT03762291|MM|mm
5037846|NCT03762278|Unilateral Immobilisation|unilateral immobilisation
5037847|NCT03762278|Leucine|leucine
5037848|NCT03762278|Muscle Wasting|muscle wasting
5037849|NCT03762278|Nutritional Intervention|nutritional intervention
5037850|NCT03762265|Pemphigus Vulgaris (PV)|pemphigus vulgaris (pv)
5037851|NCT03762265|Pemphigus Foliaceus (PF)|pemphigus foliaceus (pf)
5037852|NCT03762239|Attention|attention
5037853|NCT03762239|Air pollution|air pollution
5037854|NCT03762239|Black carbon|black carbon
5037855|NCT03762239|Particulate matter|particulate matter
5037856|NCT03762239|Risk behavior|risk behavior
5037857|NCT03762239|Social preferences|social preferences
5037858|NCT03762239|Decision making|decision making
5037859|NCT03762239|Air purifier|air purifier
5037860|NCT03762239|Air cleaner|air cleaner
5037866|NCT03762174|Emergency Medical Services|emergency medical services
5037867|NCT03762174|Emergency Department|emergency department
5037868|NCT03762174|Back Pain|back pain
5037869|NCT03762148|iron-deficiency|iron-deficiency
5037870|NCT03762148|prebiotics|prebiotics
5037871|NCT03762148|galacto-oligosaccharides|galacto-oligosaccharides
5037872|NCT03762122|Fibroblast growth factor receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5037873|NCT03762122|Rogaratinib|rogaratinib
5037874|NCT03762122|Advanced pretreated squamous-cell non-small cell lung cancer|advanced pretreated squamous-cell non-small cell lung cancer
5037875|NCT03762122|SQCLC|sqclc
5037876|NCT03762122|FGFR mRNA|fgfr mrna
5037877|NCT03762109|Surgery|surgery
5037878|NCT03762109|Dantrolene|dantrolene
5037879|NCT03762109|Anesthesia|anesthesia
5037880|NCT03762083|vaginitis|vaginitis
5037881|NCT03762083|vaginal disease|vaginal disease
5037886|NCT03762057|Abdominal Compartment Syndrome|abdominal compartment syndrome
5037887|NCT03762057|Prevalence|prevalence
5037888|NCT03762057|Risk factors|risk factors
5037889|NCT03762057|ICU|icu
5037890|NCT03762057|Surgical|surgical
5037891|NCT03762044|Breast Cancer|breast cancer
5037892|NCT03762044|Breast Cancer Lymphedema|breast cancer lymphedema
5037893|NCT03762044|Post-Mastectomy Secondary Lymphedema|post-mastectomy secondary lymphedema
5037894|NCT03762044|Occupational Therapy|occupational therapy
5037895|NCT03762044|Proprioceptive Neuromuscular Facilitation|proprioceptive neuromuscular facilitation
5037896|NCT03762044|Neural Mobilization|neural mobilization
5037897|NCT03762018|MPM|mpm
5037898|NCT03762005|Septic Shock|septic shock
5037899|NCT03762005|Lactate|lactate
5037900|NCT03762005|Capillary refill time|capillary refill time
5037901|NCT03762005|Fluid Responsiveness|fluid responsiveness
5037902|NCT03762005|Mortality|mortality
5037903|NCT03761979|Bone density|bone density
5037905|NCT03761979|Osteoporosis|osteoporosis
5037906|NCT03761979|Bone health|bone health
5037907|NCT03761979|Pharmacokinetics|pharmacokinetics
5037908|NCT03761966|IL-10|il-10
5037909|NCT03761966|IL-4|il-4
5037910|NCT03761966|IFN-γ|ifn-γ
5037911|NCT03761966|TNF-α|tnf-α
5037912|NCT03761966|Pregnancy|pregnancy
5037937|NCT03761823|Electromyography|electromyography
5037938|NCT03761823|Intensive Care Unit|intensive care unit
5037939|NCT03761784|Acne Vulgaris|acne vulgaris
5037941|NCT03761745|Postoperative Care|postoperative care
5037942|NCT03761706|breast cancer|breast cancer
5037943|NCT03761706|exercise|exercise
5037944|NCT03761706|chemotherapy and aging|chemotherapy and aging
5037945|NCT03761693|Mcad deficiency|mcad deficiency
5037946|NCT03761693|Phenotypic Variation|phenotypic variation
5037947|NCT03761693|Biomarkers|biomarkers
5037948|NCT03761693|Diet Therapy|diet therapy
5037949|NCT03761680|Malnutrition|malnutrition
5037950|NCT03761654|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
5037951|NCT03761654|Left Ventricular Dysfunction|left ventricular dysfunction
5037952|NCT03761654|Intensive Care Unit|intensive care unit
5037953|NCT03761654|Speckle-tracking|speckle-tracking
5037954|NCT03761654|STRAIN|strain
5037955|NCT03761628|Vaginal Yeast Infection|vaginal yeast infection
5037956|NCT03761628|Candidiasis, vulvovaginal|candidiasis, vulvovaginal
5037957|NCT03761628|Genital diseases, female|genital diseases, female
5037958|NCT03761628|Vaginitis|vaginitis
5037959|NCT03761628|Vulvovaginitis|vulvovaginitis
5037960|NCT03761628|Vaginal diseases|vaginal diseases
5037961|NCT03761615|type 1 diabetes|type 1 diabetes
5037962|NCT03761615|pregnancy|pregnancy
5037963|NCT03761615|continues glucose monitoring|continues glucose monitoring
5037964|NCT03761615|artificial pancreas|artificial pancreas
5037965|NCT03761589|Cardiovascular fitness|cardiovascular fitness
5037966|NCT03761589|Physical Activity|physical activity
5037967|NCT03761589|Obesity|obesity
5037968|NCT03761589|Children|children
5037969|NCT03761589|Adults|adults
5037970|NCT03761550|pMDT|pmdt
5037971|NCT03761550|Pain|pain
5037972|NCT03761550|Thoracic surgery|thoracic surgery
5037973|NCT03761524|Angle fracture|angle fracture
5037974|NCT03761524|superior-inferior plate fixation|superior-inferior plate fixation
5037975|NCT03761524|custom made plate fixation|custom made plate fixation
5037976|NCT03761524|postoperative complications|postoperative complications
5037977|NCT03761511|Friedreich Ataxia|friedreich ataxia
5037978|NCT03761511|Nicotinamide|nicotinamide
5037979|NCT03761511|Rare disease|rare disease
5037980|NCT03761511|ZSEA|zsea
5037981|NCT03761511|SARA|sara
5037982|NCT03761472|Osteoarthritis|osteoarthritis
5037983|NCT03761472|Hyaluronic acid|hyaluronic acid
5037984|NCT03761472|Platelet-rich plasma|platelet-rich plasma
5037985|NCT03761472|Injection|injection
5037986|NCT03761459|Surgical site infection|surgical site infection
5037987|NCT03761459|low and middle income country|low and middle income country
5037988|NCT03761459|low resource setting|low resource setting
5037989|NCT03761459|Africa|africa
5037990|NCT03761459|Ethiopia|ethiopia
5037995|NCT03761394|Cardiac Arrhythmias|cardiac arrhythmias
5037997|NCT03761381|OCT|oct
5037998|NCT03761381|Angiography|angiography
5037999|NCT03761381|Alzheimer's|alzheimer's
5038000|NCT03761381|Dementia|dementia
5038001|NCT03761368|remote ischemic preconditioning|remote ischemic preconditioning
5038002|NCT03761368|contrast induced-acute kidney injury|contrast induced-acute kidney injury
5038003|NCT03761368|neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5038004|NCT03761368|percutaneous coronary intervention|percutaneous coronary intervention
5038005|NCT03761355|mindfulness|mindfulness
5038008|NCT03761355|medical students|medical students
5038009|NCT03761355|pediatrics|pediatrics
5038010|NCT03761342|Front-of-pack label|front-of-pack label
5038011|NCT03761342|Nutrition label|nutrition label
5038012|NCT03761342|Diet Quality|diet quality
5038013|NCT03761342|Online grocery store|online grocery store
5038014|NCT03761342|Diet|diet
5038015|NCT03761329|Anesthesia|anesthesia
5038016|NCT03761329|Bier's block|bier's block
5038017|NCT03761329|Mini-Bier's block|mini-bier's block
5038018|NCT03761329|Hand surgery|hand surgery
5038019|NCT03761316|Spinal cord stimulation|spinal cord stimulation
5038020|NCT03761316|interview|interview
5038021|NCT03761303|rTMS|rtms
5038022|NCT03761303|Escitalopram|escitalopram
5038023|NCT03761303|add-on therapy|add-on therapy
5038024|NCT03761277|Pain|pain
5038025|NCT03761277|Intrathecal|intrathecal
5038026|NCT03761277|Targeted Drug Delivery (TDD)|targeted drug delivery (tdd)
5038027|NCT03761277|Non-Malignant Pain|non-malignant pain
5038028|NCT03761277|Systemic Opioids|systemic opioids
5038029|NCT03761277|Opioid Weaning|opioid weaning
5038030|NCT03761277|Pain Pump|pain pump
5038031|NCT03761277|Drug Pump|drug pump
5038032|NCT03761277|Medtronic Pump|medtronic pump
5038033|NCT03761264|Odontogenic Infections|odontogenic infections
5038034|NCT03761264|Paediatric Patients|paediatric patients
5038035|NCT03761264|Local Antimicrobials|local antimicrobials
5038036|NCT03761264|Systemic Antimicrobials|systemic antimicrobials
5038037|NCT03761264|Dentoalveolar Abscess|dentoalveolar abscess
5038038|NCT03761264|Apical Dentoalveolar Abscess|apical dentoalveolar abscess
5038039|NCT03761264|Periapical Abscess|periapical abscess
5038040|NCT03761264|Suppurative Periapical Periodontitis|suppurative periapical periodontitis
5038041|NCT03761238|Molecular Adsorbent Recirculating System|molecular adsorbent recirculating system
5038042|NCT03761238|post-hepatectomy liver failure|post-hepatectomy liver failure
5038043|NCT03761238|liver dialysis|liver dialysis
5038044|NCT03761238|post-hepatectomy liver dysfunction|post-hepatectomy liver dysfunction
5038045|NCT03761225|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5038046|NCT03761225|metastatic hormone-resistant prostate cancer|metastatic hormone-resistant prostate cancer
5038047|NCT03761225|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5038048|NCT03761225|mCRPC|mcrpc
5038049|NCT03761225|mHRPC|mhrpc
5038050|NCT03761212|Ankylosing spondylitis|ankylosing spondylitis
5038051|NCT03761212|Gait|gait
5038052|NCT03761212|BASFI|basfi
5038053|NCT03761212|BASDAI|basdai
5038054|NCT03761212|6MWT|6mwt
5038055|NCT03761199|AD patients|ad patients
5038060|NCT03761186|adults|adults
5038061|NCT03761186|insulin|insulin
5038062|NCT03761186|metabolic control|metabolic control
5038064|NCT03761173|pulmonary embolism|pulmonary embolism
5038065|NCT03761173|thromboembolism|thromboembolism
5038066|NCT03761173|thrombectomy|thrombectomy
5038067|NCT03761173|FlowTriever|flowtriever
5038068|NCT03761160|Prostate Cancer|prostate cancer
5038069|NCT03761121|Neuro Oncology|neuro oncology
5038070|NCT03761108|Relapsed, Refractory|relapsed, refractory
5038071|NCT03761069|Leukemia, Myeloid|leukemia, myeloid
5038072|NCT03761069|Neoplasms by Histologic Type|neoplasms by histologic type
5038073|NCT03761069|Neoplasms|neoplasms
5038074|NCT03761069|Dihydroorotate dehydrogenase (DHODH) inhibitor|dihydroorotate dehydrogenase (dhodh) inhibitor
5038075|NCT03761043|Nurse|nurse
5038076|NCT03761043|Antibiotic step-down|antibiotic step-down
5038077|NCT03761030|Depressive symptoms|depressive symptoms
5038078|NCT03761030|Cognitive problems|cognitive problems
5038079|NCT03761030|Antidepressant non-response|antidepressant non-response
5038080|NCT03761030|Dopamine system|dopamine system
5038081|NCT03761030|Older Adults|older adults
5038082|NCT03761030|Motor slowing|motor slowing
5038083|NCT03761017|Checkpoint blockade|checkpoint blockade
5038084|NCT03760978|sedation|sedation
5038085|NCT03760978|dexmedetomidine|dexmedetomidine
5038086|NCT03760952|T-cell therapy|t-cell therapy
5038087|NCT03760952|Immunotherapy|immunotherapy
5038088|NCT03760952|Screening|screening
5038089|NCT03760952|Metastatic|metastatic
5038090|NCT03760952|Previously Treated|previously treated
5038091|NCT03760939|Colorectal surgery|colorectal surgery
5038092|NCT03760939|Ambulatory care|ambulatory care
5038093|NCT03760939|Medical and economic evaluation|medical and economic evaluation
5038094|NCT03760926|Anovulatory infertility|anovulatory infertility
5038095|NCT03760913|Pain|pain
5038096|NCT03760913|Pain Injection|pain injection
5038097|NCT03760900|Autologous Umbilical Cord Blood Stem Cells|autologous umbilical cord blood stem cells
5038098|NCT03760900|Safety|safety
5038099|NCT03760900|Effect|effect
5038100|NCT03760900|neonates|neonates
5038101|NCT03760900|Mechanism|mechanism
5051728|NCT03674931|well-being|well-being
5038116|NCT03760796|cardiovascular disease prevention|cardiovascular disease prevention
5038117|NCT03760796|cardiovascular disease risk factors|cardiovascular disease risk factors
5038119|NCT03760796|heart attack|heart attack
5038120|NCT03760796|acute myocardial infarction|acute myocardial infarction
5038514|NCT03758144|rifaximin|rifaximin
5038121|NCT03760796|secondary prevention|secondary prevention
5038122|NCT03760796|digital health|digital health
5038123|NCT03760796|smartphone app|smartphone app
5038124|NCT03760796|self-management|self-management
5038125|NCT03760796|guideline adherence|guideline adherence
5038126|NCT03760796|behavior modification|behavior modification
5038127|NCT03760770|Crosslinking|crosslinking
5038128|NCT03760770|Keratoconus|keratoconus
5038129|NCT03760770|Cold|cold
5038130|NCT03760770|Pain|pain
5038131|NCT03760757|krill oil|krill oil
5038132|NCT03760757|DOMS|doms
5038133|NCT03760757|EIMD (exercise induced muscle damage)|eimd (exercise induced muscle damage)
5038134|NCT03760744|lymphedema|lymphedema
5038135|NCT03760744|therapy|therapy
5038136|NCT03760744|swelling|swelling
5038137|NCT03760744|graded negative pressure|graded negative pressure
5038138|NCT03760744|complete decongestive therapy|complete decongestive therapy
5038139|NCT03760731|Psychosocial Rehabilitation|psychosocial rehabilitation
5038140|NCT03760731|Acceptance and Commitment Therapy|acceptance and commitment therapy
5038141|NCT03760718|chloroprocaine|chloroprocaine
5038142|NCT03760718|cesarean delivery|cesarean delivery
5038143|NCT03760718|lavage|lavage
5038144|NCT03760705|CAD|cad
5038146|NCT03760705|AF|af
5038147|NCT03760705|SingCLOUD|singcloud
5038148|NCT03760705|Cardiovascular|cardiovascular
5038149|NCT03760705|Retrospective|retrospective
5038150|NCT03760705|BRAIN|brain
5038151|NCT03760705|HDG|hdg
5038152|NCT03760705|Database|database
5038153|NCT03760692|supraglottic airway device|supraglottic airway device
5038154|NCT03760692|laparoscopic gynecological surgery|laparoscopic gynecological surgery
5038155|NCT03760679|laryngeal mask|laryngeal mask
5038156|NCT03760679|geriatric|geriatric
5038157|NCT03760679|patient|patient
5038158|NCT03760666|DHODH|dhodh
5038159|NCT03760666|Brequinar|brequinar
5038160|NCT03760666|Differentiation|differentiation
5038161|NCT03760653|Breast Cancer Survivor|breast cancer survivor
5038162|NCT03760653|Probiotic|probiotic
5038163|NCT03760653|Immune System|immune system
5038164|NCT03760653|Physical Exercise|physical exercise
5038165|NCT03760653|Quality of Life|quality of life
5038166|NCT03760653|Gut Microbiota|gut microbiota
5038167|NCT03760588|LCZ696|lcz696
5038168|NCT03760588|CMR|cmr
5038172|NCT03760588|Breast Cancer|breast cancer
5038173|NCT03760588|Anthracyclines|anthracyclines
5038174|NCT03760523|leukemia|leukemia
5038175|NCT03760523|myeloid leukemia|myeloid leukemia
5038176|NCT03760510|endotracheal tube|endotracheal tube
5038177|NCT03760510|tube fastener|tube fastener
5038178|NCT03760510|facial skin tear|facial skin tear
5038179|NCT03760510|lip ulcer|lip ulcer
5038180|NCT03760510|endotracheal tube dislodgement|endotracheal tube dislodgement
5038181|NCT03760497|Lasers|lasers
5038182|NCT03760497|Hipomineralization of dental enamel|hipomineralization of dental enamel
5038183|NCT03760497|Preventive dentistry|preventive dentistry
5038184|NCT03760497|Glass ionomer cement|glass ionomer cement
5038185|NCT03760484|Fecal microbiota transplantation|fecal microbiota transplantation
5038186|NCT03760484|Fidaxomicin|fidaxomicin
5038187|NCT03760445|HDM201|hdm201
5038189|NCT03760445|cytarabine|cytarabine
5038190|NCT03760445|daunorubicin|daunorubicin
5038191|NCT03760445|idarubicin|idarubicin
5038192|NCT03760445|liposomal cytarabine/daunorubicin|liposomal cytarabine/daunorubicin
5038193|NCT03760445|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5038194|NCT03760445|1L newly diagnosed AML|1l newly diagnosed aml
5038195|NCT03760445|relapsed/refractory AML|relapsed/refractory aml
5038196|NCT03760445|FLT3-mutation|flt3-mutation
5038197|NCT03760445|combination treatment|combination treatment
5038198|NCT03760445|dose escalation|dose escalation
5038199|NCT03760445|CR/CRi|cr/cri
5038200|NCT03760445|minimal residual disease|minimal residual disease
5038201|NCT03760445|DDI with CYP3A4 inhibitors|ddi with cyp3a4 inhibitors
5038202|NCT03760445|DDI with sensitive CYP3A4 substrate|ddi with sensitive cyp3a4 substrate
5038203|NCT03760432|Keratoconus (KCN)|keratoconus (kcn)
5038204|NCT03760432|Optical Coherence Tomography (OCT)|optical coherence tomography (oct)
5038205|NCT03760432|Collagen Cross-linking (CXL)|collagen cross-linking (cxl)
5038206|NCT03760406|Essential Tremor|essential tremor
5038207|NCT03760406|Deep brain stimulation|deep brain stimulation
5038208|NCT03760406|Ventro-intermediate nucleus of the thalamus|ventro-intermediate nucleus of the thalamus
5038209|NCT03760406|Targeting|targeting
5038210|NCT03760406|Asleep surgery|asleep surgery
5038211|NCT03760393|Sedentary Behaviour|sedentary behaviour
5038212|NCT03760393|Health Behaviour Change|health behaviour change
5038213|NCT03760393|Health Action Process Approach|health action process approach
5038214|NCT03760393|mHealth|mhealth
5038215|NCT03760393|Intervention|intervention
5038216|NCT03760393|Non-Sedentary Behaviours|non-sedentary behaviours
5038217|NCT03760393|Break Frequency|break frequency
5038218|NCT03760393|Break Duration|break duration
5038219|NCT03760393|Action Planning|action planning
5038220|NCT03760393|Coping Planning|coping planning
5039301|NCT03752801|family|family
5038228|NCT03760367|tooth bleaching|tooth bleaching
5038229|NCT03760354|Caustic|caustic
5038230|NCT03760354|Esophageal Stenosis|esophageal stenosis
5038231|NCT03760354|Pharyngeal Stenosis|pharyngeal stenosis
5038232|NCT03760354|Corticosteroid treatment|corticosteroid treatment
5038233|NCT03760315|next- generation sequencing； microbe|next- generation sequencing； microbe
5038234|NCT03760224|Intervention|intervention
5038235|NCT03760224|WhatsApp|whatsapp
5038236|NCT03760224|Smoking Cessation|smoking cessation
5038237|NCT03760224|Relapse Prevention|relapse prevention
5038238|NCT03760224|Group Disscussion|group disscussion
5038243|NCT03760120|physiotherapy|physiotherapy
5038244|NCT03760120|pulmonary function|pulmonary function
5038245|NCT03760081|Incurable Platinum Refractory Germ Cell Tumors|incurable platinum refractory germ cell tumors
5038246|NCT03760081|ASP1650|asp1650
5038247|NCT03760016|Rehabilitation|rehabilitation
5038248|NCT03760016|Locomotion|locomotion
5038249|NCT03760016|Aerobic|aerobic
5038250|NCT03760016|Intensity|intensity
5038251|NCT03760016|Dosing|dosing
5038256|NCT03759990|videolaryngoscope|videolaryngoscope
5038257|NCT03759990|Airtraq|airtraq
5038258|NCT03759990|McGrath MAC|mcgrath mac
5031914|NCT03799601|NSCLC|nsclc
5038259|NCT03759990|Morbid obesity|morbid obesity
5038260|NCT03759990|intubation|intubation
5038261|NCT03759977|adapted physical activity|adapted physical activity
5038262|NCT03759977|nursing home|nursing home
5038263|NCT03759977|elderly|elderly
5038264|NCT03759977|postural control|postural control
5038265|NCT03759964|cardiac surgery|cardiac surgery
5038266|NCT03759964|ferric carboxymaltose|ferric carboxymaltose
5038267|NCT03759964|anemia|anemia
5038268|NCT03759964|transfusion|transfusion
5038269|NCT03759951|functional fitness|functional fitness
5038270|NCT03759951|circuit training|circuit training
5038271|NCT03759951|bodyweight training|bodyweight training
5038272|NCT03759938|ischaemic stroke, atrial fibrilation|ischaemic stroke, atrial fibrilation
5038273|NCT03759912|Atrial fibrillation ablation|atrial fibrillation ablation
5038274|NCT03759912|Pulmonary vein|pulmonary vein
5038275|NCT03759912|Ultra high resolution mapping|ultra high resolution mapping
5038276|NCT03759873|Incentives|incentives
5038285|NCT03759821|Parenting|parenting
5038286|NCT03759821|Early childhood development|early childhood development
5038287|NCT03759821|Social and behavior change|social and behavior change
5038288|NCT03759821|Father involvement|father involvement
5038289|NCT03759821|Male engagement|male engagement
5038290|NCT03759821|Household decision-making|household decision-making
5038291|NCT03759821|Community health workers|community health workers
5038292|NCT03759821|Peer groups|peer groups
5038293|NCT03759821|Integrated interventions|integrated interventions
5038294|NCT03759808|post-concussion syndrome|post-concussion syndrome
5038295|NCT03759808|mild traumatic brain injury|mild traumatic brain injury
5038296|NCT03759808|autonomic dysfunction|autonomic dysfunction
5038299|NCT03759808|cognitive behavioral therapy|cognitive behavioral therapy
5038300|NCT03759795|Resilience|resilience
5038301|NCT03759795|Psychological flexibility|psychological flexibility
5038302|NCT03759795|Acceptance and Commitment Training|acceptance and commitment training
5038303|NCT03759769|power wheelchair|power wheelchair
5038304|NCT03759769|virtual reality|virtual reality
5038305|NCT03759769|skills|skills
5038306|NCT03759704|Musculoskeletal Sarcoma|musculoskeletal sarcoma
5038307|NCT03759691|prehospital delay|prehospital delay
5038308|NCT03759691|help-seeking behaviour|help-seeking behaviour
5038309|NCT03759652|neurosurgery|neurosurgery
5038310|NCT03759652|surgical site infections|surgical site infections
5038311|NCT03759652|spinal surgery|spinal surgery
5038312|NCT03759652|craniotomy|craniotomy
5038313|NCT03759652|laminectomy|laminectomy
5038314|NCT03759626|alcohol|alcohol
5038315|NCT03759626|youth|youth
5038316|NCT03759626|prevention|prevention
5038317|NCT03759626|comparative study|comparative study
5038318|NCT03759626|reflexive model|reflexive model
5038319|NCT03759626|impulsive model|impulsive model
5726098|NCT00410384|Antibodies|antibodies
5038325|NCT03759574|Orthostatic Hypotension|orthostatic hypotension
5038326|NCT03759548|Nutritional Status|nutritional status
5038327|NCT03759548|Colorectal Cancer|colorectal cancer
5038328|NCT03759548|Breast Cancer|breast cancer
5038329|NCT03759548|Pharmacological Treatment|pharmacological treatment
5038330|NCT03759548|Toxicity|toxicity
5038331|NCT03759548|Quality of Life|quality of life
5038332|NCT03759535|DNA acute rejection kidney transplantation|dna acute rejection kidney transplantation
5038333|NCT03759496|bladder|bladder
5038334|NCT03759496|durvalumab|durvalumab
5038335|NCT03759496|cancer|cancer
5038336|NCT03759483|Deep convolutional neural network|deep convolutional neural network
5038337|NCT03759483|Visual field|visual field
5038338|NCT03759483|Glaucoma|glaucoma
5038339|NCT03759444|Perception of time|perception of time
5038340|NCT03759444|Eating disorders|eating disorders
5038341|NCT03759444|Ego-syntonicity|ego-syntonicity
5038342|NCT03759444|Existential suffering|existential suffering
5038343|NCT03759444|Psychotherapy|psychotherapy
5038344|NCT03759418|Left Atrial Appendage Ligation|left atrial appendage ligation
5038345|NCT03759418|Atriclip|atriclip
5038346|NCT03759418|atrial fibrillation|atrial fibrillation
5038347|NCT03759366|Myasthenia Gravis|myasthenia gravis
5038348|NCT03759366|Myasthenia Gravis, Generalized|myasthenia gravis, generalized
5038349|NCT03759314|EMS, elderly, inadequate nutrition, falling, cognitive functioning|ems, elderly, inadequate nutrition, falling, cognitive functioning
5038350|NCT03759301|Growth Hormone|growth hormone
5038351|NCT03759301|IVF/ICSI|ivf/icsi
5038352|NCT03759301|Poor Responders|poor responders
5038353|NCT03759275|pMDT|pmdt
5038354|NCT03759275|Pain|pain
5038355|NCT03759275|Thoracic surgery|thoracic surgery
5038356|NCT03759262|vitamin D|vitamin d
5038357|NCT03759262|cytokines|cytokines
5038358|NCT03759249|multiple sclerosis|multiple sclerosis
5038359|NCT03759249|polysomnography|polysomnography
5038364|NCT03759223|Mild Traumatic Brain Injury|mild traumatic brain injury
5038365|NCT03759223|Concussion, Mild|concussion, mild
5038366|NCT03759223|Veterans|veterans
5038367|NCT03759223|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5038372|NCT03759145|virtual reality|virtual reality
5038373|NCT03759145|exergame|exergame
5038374|NCT03759145|stroke rehabilitation|stroke rehabilitation
5038375|NCT03759106|Virtual reality|virtual reality
5038376|NCT03759106|telerehabilitation|telerehabilitation
5038377|NCT03759106|Stroke rehabilitation|stroke rehabilitation
5038378|NCT03759067|clopidogrel loading|clopidogrel loading
5039663|NCT03750617|Screening|screening
5038396|NCT03758911|bone marrow|bone marrow
5038397|NCT03758911|stem cell|stem cell
5038410|NCT03758846|Cognitive-motor training|cognitive-motor training
5038411|NCT03758846|Conventional training|conventional training
5038412|NCT03758846|Virtual-reality exergaming|virtual-reality exergaming
5038413|NCT03758846|Dance Therapy|dance therapy
5038414|NCT03758833|in vitro fertilization|in vitro fertilization
5038415|NCT03758833|single embryo transfer|single embryo transfer
5038515|NCT03758144|insulin resistance|insulin resistance
5038420|NCT03758807|Education|education
5038421|NCT03758807|Neuroplasticiy|neuroplasticiy
5038422|NCT03758768|Circadian rhythm|circadian rhythm
5038423|NCT03758768|Sleep|sleep
5038424|NCT03758768|evening-type individuals|evening-type individuals
5038425|NCT03758768|morningness-eveningness|morningness-eveningness
5038426|NCT03758768|blue light|blue light
5038427|NCT03758768|monochromatic light|monochromatic light
5726294|NCT00409448|head injury|head injury
5038428|NCT03758768|randomized controlled trial|randomized controlled trial
5038429|NCT03758755|BFR|bfr
5038430|NCT03758755|ACL|acl
5038431|NCT03758755|rehabilitation|rehabilitation
5038432|NCT03758742|diabetes|diabetes
5038433|NCT03758742|whole fruit|whole fruit
5038434|NCT03758742|diabetes remission|diabetes remission
5038435|NCT03758742|glycemic control|glycemic control
5038436|NCT03758742|liver fat|liver fat
5038437|NCT03758742|intrahepatic lipid|intrahepatic lipid
5038438|NCT03758742|controlled feeding trial|controlled feeding trial
5038439|NCT03758651|Williams Syndrome|williams syndrome
5038440|NCT03758651|Lipedema|lipedema
5038441|NCT03758651|Body Composition|body composition
5038442|NCT03758651|Glucose|glucose
5038443|NCT03758651|Bone Density|bone density
5038444|NCT03758625|dendritic cell|dendritic cell
5038445|NCT03758625|vaccine|vaccine
5038446|NCT03758625|immunogenicity|immunogenicity
5038447|NCT03758625|HIV|hiv
5038448|NCT03758625|vaccination|vaccination
5038449|NCT03758625|immune system|immune system
5038454|NCT03758599|Anxiety Disorder|anxiety disorder
5038455|NCT03758599|Posttraumatic Stress Disorder|posttraumatic stress disorder
5038456|NCT03758599|Sports intervention|sports intervention
5038457|NCT03758573|Breathing Exercises|breathing exercises
5038458|NCT03758573|Respiratory Muscles|respiratory muscles
5038459|NCT03758573|Respiration Artificial|respiration artificial
5038460|NCT03758573|Weaning|weaning
5038461|NCT03758521|SSADHD|ssadhd
5038462|NCT03758521|SSADH deficiency|ssadh deficiency
5038463|NCT03758508|Noninvasive ventilation|noninvasive ventilation
5038464|NCT03758508|High flow oxygen nasal cannula|high flow oxygen nasal cannula
5038465|NCT03758508|Pneumonia|pneumonia
5038466|NCT03758508|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5038467|NCT03758482|meal ingestion|meal ingestion
5038468|NCT03758482|metabolomic responses|metabolomic responses
5038469|NCT03758482|hedonic sensations|hedonic sensations
5038470|NCT03758482|homeostatic sensations|homeostatic sensations
5038471|NCT03758456|Subcutaneous immunotherapy|subcutaneous immunotherapy
5038472|NCT03758456|Ragweed pollen|ragweed pollen
5038473|NCT03758456|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
5038474|NCT03758456|Safety|safety
5038475|NCT03758456|Tolerability|tolerability
5038476|NCT03758443|TD-1473|td-1473
5038477|NCT03758443|Janus kinase inhibitor|janus kinase inhibitor
5038478|NCT03758443|JAK inhibitor|jak inhibitor
5038479|NCT03758443|Inflammatory Bowel Disease|inflammatory bowel disease
5038480|NCT03758443|IBD|ibd
5038481|NCT03758443|Ulcerative colitis|ulcerative colitis
5038482|NCT03758443|UC|uc
5038483|NCT03758443|Gut selective|gut selective
5038484|NCT03758391|Neonatal-Perinatal Medicine|neonatal-perinatal medicine
5038485|NCT03758391|Andragogy|andragogy
5038486|NCT03758391|Flipped Classroom|flipped classroom
5039770|NCT03750032|laparoscopy|laparoscopy
5038495|NCT03758261|Erector Spinae nerve block|erector spinae nerve block
5038496|NCT03758261|Video assisted thoracoscopic surgery|video assisted thoracoscopic surgery
5038497|NCT03758248|Genotype-guided therapy|genotype-guided therapy
5038498|NCT03758248|CYP2C19 Polymorphism|cyp2c19 polymorphism
5038505|NCT03758196|renal sympathetic denervation|renal sympathetic denervation
5038506|NCT03758196|resistant hypertension|resistant hypertension
5038507|NCT03758183|Arthroplasty|arthroplasty
5038508|NCT03758183|Prolotherapy|prolotherapy
5038509|NCT03758183|Osteoarthritis|osteoarthritis
5038510|NCT03758170|Knee Arthroplasty|knee arthroplasty
5038511|NCT03758170|Knee Replacement|knee replacement
5038512|NCT03758170|Perioperative Medicine|perioperative medicine
5038513|NCT03758144|gut dysbiosis|gut dysbiosis
5038524|NCT03758105|Neurostimulation|neurostimulation
5038526|NCT03758066|youth|youth
5038527|NCT03758066|young adults|young adults
5038528|NCT03758066|digital health|digital health
5038529|NCT03758066|mobile application|mobile application
5038530|NCT03758066|case management|case management
5038531|NCT03758027|emotional regulation|emotional regulation
5038532|NCT03758027|drug taking refusal skills|drug taking refusal skills
5038533|NCT03758027|physiological responses|physiological responses
5038534|NCT03757988|Walking|walking
5038535|NCT03757988|Exercise|exercise
5038536|NCT03757988|Physical Health|physical health
5038540|NCT03757962|dietary modification|dietary modification
5038542|NCT03757923|Metformin|metformin
5038543|NCT03757910|Metformin|metformin
5038544|NCT03757910|Pre-diabetes|pre-diabetes
5038545|NCT03757910|Type 2 diabetes|type 2 diabetes
5038546|NCT03757910|DPPOS|dppos
5038547|NCT03757897|dexmedetomidine|dexmedetomidine
5038548|NCT03757884|Diagnostic Errors|diagnostic errors
5038549|NCT03757884|Hospital Medicine|hospital medicine
5038550|NCT03757819|Multiple Scerosis|multiple scerosis
5038551|NCT03757806|Dementia|dementia
5038552|NCT03757806|Physical activity|physical activity
5038553|NCT03757806|Home-based|home-based
5038554|NCT03757806|Lifestyle|lifestyle
5038555|NCT03757793|Near infrared spectroscopy|near infrared spectroscopy
5038556|NCT03757767|Physiology|physiology
5038557|NCT03757767|Humans|humans
5038558|NCT03757754|PHHP|phhp
5038559|NCT03757754|Esophageal cancer|esophageal cancer
5038560|NCT03757754|Phase I study|phase i study
5038561|NCT03757741|atrial fibrillation recurrence|atrial fibrillation recurrence
5038562|NCT03757741|atrial volume|atrial volume
5038563|NCT03757741|atrial fibrosis|atrial fibrosis
5038564|NCT03757741|epicardial adipose tissue|epicardial adipose tissue
5038565|NCT03757741|inflammatory biomarkers|inflammatory biomarkers
5038566|NCT03757741|late gadolinium-enhancement cardiac magnetic resonance|late gadolinium-enhancement cardiac magnetic resonance
5038567|NCT03757741|pulmonary vein isolation|pulmonary vein isolation
5038568|NCT03757689|Stage IIB/C|stage iib/c
5038569|NCT03757676|Physical Activity|physical activity
5038570|NCT03757676|Mobile Games|mobile games
5038571|NCT03757663|UV Dosimetry|uv dosimetry
5038572|NCT03757663|UV Exposure|uv exposure
5038573|NCT03757663|Behavioral|behavioral
5038574|NCT03757663|Social Cognitive Theory|social cognitive theory
5038575|NCT03757663|Self-Regulation|self-regulation
5038576|NCT03757663|Self-Efficacy|self-efficacy
5038577|NCT03757650|obesity|obesity
5038578|NCT03757650|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5038579|NCT03757650|helicobacter pylori|helicobacter pylori
5038580|NCT03757650|gastric wall thickness|gastric wall thickness
5038581|NCT03757637|Thyroid cancer|thyroid cancer
5038582|NCT03757637|Survivorship Care|survivorship care
5038583|NCT03757637|Mobile applications|mobile applications
5038584|NCT03757637|Mobile phone|mobile phone
5038585|NCT03757624|shrinkage|shrinkage
5038586|NCT03757624|formol|formol
5038587|NCT03757624|stomach|stomach
5038588|NCT03757624|gastric wall|gastric wall
5038589|NCT03757598|partograph, labor, birth, complications, newborn, Kenya|partograph, labor, birth, complications, newborn, kenya
5038590|NCT03757585|autism|autism
5038591|NCT03757585|learning disorder|learning disorder
5038592|NCT03757585|natural supplements|natural supplements
5038593|NCT03757585|NAC|nac
5038594|NCT03757585|omega-3|omega-3
5038603|NCT03757559|Cebranopadol|cebranopadol
5038604|NCT03757559|Hydromorphone|hydromorphone
5038605|NCT03757559|Drug liking|drug liking
5032231|NCT03797612|TKA|tka
5038606|NCT03757416|recurrent|recurrent
5038607|NCT03757416|carpal tunnel release|carpal tunnel release
5038608|NCT03757416|flexor tenosynovectomy|flexor tenosynovectomy
5038609|NCT03757364|Distal Interphalangeal Joint Extensor Tendon Enthesopathy|distal interphalangeal joint extensor tendon enthesopathy
5038624|NCT03757221|Multiple Myeloma|multiple myeloma
5038625|NCT03757208|Carbohydrate loading, oral carbohydrate beverage|carbohydrate loading, oral carbohydrate beverage
5038626|NCT03757195|Mineralized plasmatic matrix|mineralized plasmatic matrix
5038628|NCT03757195|plasma|plasma
5038629|NCT03757195|autogeous fibrin glue|autogeous fibrin glue
5038630|NCT03757182|Wearable device|wearable device
5038631|NCT03757182|Fitness tracker|fitness tracker
5038632|NCT03757182|Wearable activity monitor|wearable activity monitor
5038633|NCT03757182|Biosensor|biosensor
5038634|NCT03757182|Performance Status|performance status
5038635|NCT03757182|Activity Monitoring|activity monitoring
5038636|NCT03757169|training|training
5038637|NCT03757169|hand grip|hand grip
5038638|NCT03757169|exercise|exercise
5038639|NCT03757143|Skin antisepsis|skin antisepsis
5038640|NCT03757143|Chlorhexidine|chlorhexidine
5038641|NCT03757143|Povidone Iodine|povidone iodine
5038642|NCT03757143|Intravascular-catheter colonization|intravascular-catheter colonization
5038643|NCT03757143|Catheter failure|catheter failure
5038644|NCT03757143|Bundle of new devices|bundle of new devices
5038645|NCT03757117|Peru|peru
5038646|NCT03757117|Health services|health services
5038647|NCT03757117|Transgender women|transgender women
5038648|NCT03757117|Patient navigation|patient navigation
5038649|NCT03757117|Implementation science|implementation science
5038650|NCT03757117|Gender affirming care|gender affirming care
5038651|NCT03757117|HIV prevention|hiv prevention
5038652|NCT03757117|HIV treatment|hiv treatment
5038653|NCT03757117|HIV care cascade|hiv care cascade
5038654|NCT03757039|contact lenses|contact lenses
5038655|NCT03757039|multifocal|multifocal
5038656|NCT03757039|spectacles|spectacles
5038658|NCT03757039|progressive|progressive
5038659|NCT03757039|vision|vision
5038660|NCT03757039|eyes|eyes
5038661|NCT03757026|Balance Training|balance training
5038662|NCT03757026|Multidirectional harness|multidirectional harness
5038663|NCT03757026|Conventional balance training|conventional balance training
5038664|NCT03757026|Reactive Slip Training|reactive slip training
5038665|NCT03757026|Stroke|stroke
5038666|NCT03757026|Independent ambulation|independent ambulation
5038667|NCT03757026|Physical therapy|physical therapy
5038672|NCT03757000|YY-20394|yy-20394
5038673|NCT03757000|B-cell Lymphoma Recurrent|b-cell lymphoma recurrent
5038674|NCT03756987|ultrasound-guided|ultrasound-guided
5038675|NCT03756987|erector spinae plane block|erector spinae plane block
5038676|NCT03756987|quality of recovery|quality of recovery
5038677|NCT03756974|cannabinoid|cannabinoid
5038678|NCT03756974|dronabinol|dronabinol
5038679|NCT03756961|opioids|opioids
5038680|NCT03756961|bariatric surgery|bariatric surgery
5038681|NCT03756961|anesthesia|anesthesia
5038682|NCT03756961|opioid-free|opioid-free
5038683|NCT03756961|person-centred care|person-centred care
5038684|NCT03756961|recovery|recovery
5038685|NCT03756961|TENS|tens
5038686|NCT03756961|pain|pain
5038687|NCT03756948|Liver Transplantation|liver transplantation
5038688|NCT03756948|Blood Coagulation Disorders|blood coagulation disorders
5038689|NCT03756948|Blood Transfusion|blood transfusion
5038690|NCT03756948|Hemostasis|hemostasis
5038691|NCT03756948|Thromboelastometry|thromboelastometry
5038692|NCT03756922|Cystic Fibrosis|cystic fibrosis
5038693|NCT03756870|Chronic total coronary occlusion|chronic total coronary occlusion
5038694|NCT03756870|Percutaneous coronary intervention|percutaneous coronary intervention
5038695|NCT03756870|Optimal medical therapy|optimal medical therapy
5038696|NCT03756870|Myocardial ischemia|myocardial ischemia
5038697|NCT03756844|Avoidant Restrictive Food Intake Disorder|avoidant restrictive food intake disorder
5038698|NCT03756831|BMI, Core Stability, Healthy Adult|bmi, core stability, healthy adult
5038699|NCT03756805|obstructive sleep apnea|obstructive sleep apnea
5038700|NCT03756805|hypoglossal nerve stimulation|hypoglossal nerve stimulation
5038701|NCT03756805|upper airway stimulation|upper airway stimulation
5038702|NCT03756805|surgical treatment sleep apnea|surgical treatment sleep apnea
5038703|NCT03756792|Mohs Micographic Surgery|mohs micographic surgery
5038704|NCT03756792|skin cancer|skin cancer
5038705|NCT03756792|melanoma|melanoma
5038724|NCT03756519|exercise|exercise
5038725|NCT03756519|emergency department|emergency department
5038726|NCT03756493|Platlet rich fibrin|platlet rich fibrin
5038727|NCT03756493|Bone graft|bone graft
5038728|NCT03756493|Furcation defects|furcation defects
5038729|NCT03756480|Endometriosis|endometriosis
5038730|NCT03756467|Adolescent Behavior|adolescent behavior
5038731|NCT03756467|Sexual Violence|sexual violence
5038732|NCT03756402|Acute Kidney Injury|acute kidney injury
5038733|NCT03756402|ColorDoppler|colordoppler
5083027|NCT03479372|AMD|amd
5038734|NCT03756402|IRRIV test|irriv test
5038735|NCT03756402|Renal functional reserve|renal functional reserve
5038736|NCT03756402|Renal resistive index|renal resistive index
5038737|NCT03756402|Ultrasound|ultrasound
5038738|NCT03756363|Postoperative pain|postoperative pain
5038742|NCT03756350|abdomen|abdomen
5038743|NCT03756350|adipose|adipose
5038744|NCT03756350|fat|fat
5038745|NCT03756337|cochlear implant|cochlear implant
5038746|NCT03756337|sound processor|sound processor
5038747|NCT03756337|upgrade|upgrade
5038748|NCT03756324|Pugongying|pugongying
5038749|NCT03756324|Herba Taraxaci|herba taraxaci
5038750|NCT03756324|Acute Mastitis|acute mastitis
5038751|NCT03756324|Cefdinir|cefdinir
5038752|NCT03756324|Randomized controlled trial|randomized controlled trial
5038753|NCT03756324|Postpartum|postpartum
5038754|NCT03756324|Breastfeeding|breastfeeding
5038755|NCT03756324|Lactation|lactation
5038756|NCT03756324|multicenter|multicenter
5038757|NCT03756324|Chinese herb|chinese herb
5038758|NCT03756324|Traditional Chinese medicine|traditional chinese medicine
5038759|NCT03756324|Cephalosporin|cephalosporin
5038760|NCT03756324|Antibiotics|antibiotics
5038761|NCT03756285|Heart Failure with Ejection Fraction|heart failure with ejection fraction
5038762|NCT03756246|depression|depression
5038763|NCT03756246|Major Depressive Disorder|major depressive disorder
5038764|NCT03756246|depressive|depressive
5038765|NCT03756220|Septic shock|septic shock
5038767|NCT03756220|Vitamin C|vitamin c
5038768|NCT03756220|Thiamine|thiamine
5038769|NCT03756207|multidisciplinary; bladder cancer; bladder-preservation|multidisciplinary; bladder cancer; bladder-preservation
5038770|NCT03756194|Aged|aged
5038771|NCT03756194|Elders|elders
5038772|NCT03756194|Robotics|robotics
5038773|NCT03756194|Cultural competence|cultural competence
5038774|NCT03756194|Quality of life|quality of life
5038775|NCT03756194|Loneliness|loneliness
5038776|NCT03756194|Technology acceptance|technology acceptance
5038777|NCT03756194|Social robotics|social robotics
5038778|NCT03756194|Informal caregiver|informal caregiver
5038779|NCT03756194|Homes for the aged|homes for the aged
5038780|NCT03756142|3D analysis|3d analysis
5038781|NCT03756142|Biomarkers|biomarkers
5038782|NCT03756142|Rehabilition|rehabilition
5038783|NCT03756142|Locomotion|locomotion
5038785|NCT03756103|mild-moderate essential hypertension|mild-moderate essential hypertension
5038786|NCT03756103|SPH3127 tablet|sph3127 tablet
5038787|NCT03756103|renin inhibitor|renin inhibitor
5038788|NCT03756103|efficacy|efficacy
5038789|NCT03756103|safety|safety
5038790|NCT03756051|Physical Harms|physical harms
5038791|NCT03756051|Financial Harms|financial harms
5038792|NCT03756051|Overdiagnosis|overdiagnosis
5038793|NCT03756051|Psychosocial Harms|psychosocial harms
5038794|NCT03756025|Early Childhood Caries|early childhood caries
5038795|NCT03756025|Atraumatic Restorative Treatment|atraumatic restorative treatment
5038796|NCT03756025|Glass Ionomer Cement|glass ionomer cement
5038797|NCT03756025|Deciduous Tooth|deciduous tooth
5038798|NCT03756025|Odontopediatrics|odontopediatrics
5038799|NCT03755999|preterm infants|preterm infants
5038800|NCT03755999|transitional feeding period|transitional feeding period
5038801|NCT03755999|cue-based care|cue-based care
5038802|NCT03755999|clinical guidelines|clinical guidelines
5038803|NCT03755973|Endometrial receptivity|endometrial receptivity
5038804|NCT03755973|Ovarian stimulation|ovarian stimulation
5038846|NCT03755674|Diet|diet
5038847|NCT03755648|Delorme resistance exercises|delorme resistance exercises
5038848|NCT03755648|treadmill training|treadmill training
5038849|NCT03755648|locomotor abilities|locomotor abilities
5038850|NCT03755648|tendon of achilles lengthening|tendon of achilles lengthening
5038851|NCT03755635|Neonatal sepsis|neonatal sepsis
5038852|NCT03755635|Infection control|infection control
5038853|NCT03755635|Hand hygiene|hand hygiene
5038854|NCT03755635|WHO multi modal|who multi modal
5038855|NCT03755609|Endoscopic Retrograde Choledochopancreatography|endoscopic retrograde choledochopancreatography
5038856|NCT03755609|sedation|sedation
5038857|NCT03755609|fentanyl|fentanyl
5038858|NCT03755609|oxycodonel|oxycodonel
5038859|NCT03755596|Zingiber officinale|zingiber officinale
5038860|NCT03755596|Motion sickness|motion sickness
5038861|NCT03755596|Motion sickness assessment questionnaire|motion sickness assessment questionnaire
5038862|NCT03755583|Exclusive enteral nutrition|exclusive enteral nutrition
5347324|NCT01962220|PMTCT|pmtct
5038863|NCT03755570|Cognitive Impairment|cognitive impairment
5038864|NCT03755570|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
5038865|NCT03755570|Heart Failure|heart failure
5038866|NCT03755570|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5038867|NCT03755570|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5038868|NCT03755570|Pacemaker|pacemaker
5038869|NCT03755570|CRT|crt
5038870|NCT03755570|ICD|icd
5038871|NCT03755570|PPM|ppm
5038872|NCT03755557|budesonide|budesonide
5038873|NCT03755557|allergic rhinitis|allergic rhinitis
5038874|NCT03755557|allergic rhinoconjuntivitis|allergic rhinoconjuntivitis
5038875|NCT03755557|allergen exposure chamber|allergen exposure chamber
5038876|NCT03755557|onset of action|onset of action
5038877|NCT03755557|therapeutic equivalence|therapeutic equivalence
5038878|NCT03755557|total nasal symptom score|total nasal symptom score
5038892|NCT03755505|Microbiome|microbiome
5038893|NCT03755479|Diabetes Mellitus Type 1|diabetes mellitus type 1
5038894|NCT03755479|Insulin Pump|insulin pump
5038895|NCT03755479|Hybrid closed Loop System|hybrid closed loop system
5038896|NCT03755479|Minimed 670G|minimed 670g
5038897|NCT03755440|EBV|ebv
5038898|NCT03755440|Gatric cancer|gatric cancer
5038899|NCT03755440|Check point inhibitor|check point inhibitor
5038900|NCT03755427|H7N9|h7n9
5038901|NCT03755401|psychotherapy|psychotherapy
5038902|NCT03755401|psychodynamic psychotherapy|psychodynamic psychotherapy
5038903|NCT03755375|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
5038904|NCT03755375|Physiotherapy|physiotherapy
5038905|NCT03755375|Biofeedback|biofeedback
5038906|NCT03755375|Interventions|interventions
5038907|NCT03755362|carotid stenosis cognitive function periodontitis|carotid stenosis cognitive function periodontitis
5038908|NCT03755349|Burr hole cover|burr hole cover
5038909|NCT03755349|Chronic subdural hematoma|chronic subdural hematoma
5038910|NCT03755349|Trepanation|trepanation
5038911|NCT03755349|Aesthetic outcome|aesthetic outcome
5039208|NCT03753360|Online|online
5038919|NCT03755297|Rheumatoid arthritis|rheumatoid arthritis
5052521|NCT03670433|Care path|care path
5038921|NCT03755297|JAK/STAT inhibitors|jak/stat inhibitors
5038922|NCT03755284|anxiety|anxiety
5038923|NCT03755284|labor pain|labor pain
5038924|NCT03755284|massage|massage
5038925|NCT03755284|surveys and questionnaires|surveys and questionnaires
5038926|NCT03755284|visual analog scale|visual analog scale
5038927|NCT03755271|Intraoperative hypotension|intraoperative hypotension
5038928|NCT03755271|Caesarean section|caesarean section
5038929|NCT03755271|Spinal anesthesia|spinal anesthesia
5038930|NCT03755258|Ginsenoside compound K tablet|ginsenoside compound k tablet
5038931|NCT03755258|Rheumatoid Arthritis|rheumatoid arthritis
5038932|NCT03755258|Phase Ib study|phase ib study
5038933|NCT03755232|dietary fibre|dietary fibre
5038934|NCT03755232|fructo-oligosaccharide|fructo-oligosaccharide
5038935|NCT03755232|prebiotic|prebiotic
5038936|NCT03755232|glucose metabolism|glucose metabolism
5038937|NCT03755232|insulin metabolism|insulin metabolism
5038938|NCT03755219|Totally extraperitoneal|totally extraperitoneal
5038939|NCT03755219|Transabdominal preperitoneal|transabdominal preperitoneal
5038940|NCT03755219|Fibrin glue|fibrin glue
5038941|NCT03755219|Fibrin sealant|fibrin sealant
5038942|NCT03755219|Mesh fixation|mesh fixation
5038943|NCT03755219|Fixation devices|fixation devices
5038944|NCT03755180|Venous Insufficiency|venous insufficiency
5038945|NCT03755180|Exercise|exercise
5038946|NCT03755180|Compression Bandages|compression bandages
5038947|NCT03755180|Duplex Doppler Ultrasonography|duplex doppler ultrasonography
5038948|NCT03755154|Leukemia|leukemia
5038949|NCT03755154|Lymphoma|lymphoma
5038950|NCT03755154|Myeloma|myeloma
5038951|NCT03755154|Dose-escalation|dose-escalation
5038958|NCT03755115|PD1|pd1
5038959|NCT03755115|ED-SCLC|ed-sclc
5038960|NCT03755102|EGFR C797S|egfr c797s
5038961|NCT03755102|EGFR mutant lung cancer|egfr mutant lung cancer
5038962|NCT03755102|dacomitinib|dacomitinib
5038963|NCT03755102|osimertinib|osimertinib
5038964|NCT03755102|18-341|18-341
5038965|NCT03755102|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5038966|NCT03754946|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5038967|NCT03754946|pulse oximetry plethysmographic waveform|pulse oximetry plethysmographic waveform
5038968|NCT03754946|quality monitor|quality monitor
5038969|NCT03754946|partial pressure of end-tidal carbon dioxide|partial pressure of end-tidal carbon dioxide
5038970|NCT03754933|Fludarabine|fludarabine
5038971|NCT03754933|Adenovirus|adenovirus
5038972|NCT03754933|Head & neck squamous cell carcinoma|head & neck squamous cell carcinoma
5038973|NCT03754920|prolonged fasting|prolonged fasting
5038974|NCT03754920|meditation|meditation
5038975|NCT03754920|physical exercise|physical exercise
5351328|NCT01942889|COPD|copd
5038976|NCT03754907|stapled anastomosis|stapled anastomosis
5038977|NCT03754907|hand-sewn anastomosis|hand-sewn anastomosis
5038978|NCT03754907|intestinal atresia|intestinal atresia
5038979|NCT03754907|neonate|neonate
5038980|NCT03754894|dental implants|dental implants
5038981|NCT03754868|ECMO|ecmo
5038982|NCT03754868|Coagulation monitoring|coagulation monitoring
5038983|NCT03754868|point-of-care|point-of-care
5038984|NCT03754855|Rheumatoid arthritis|rheumatoid arthritis
5038985|NCT03754855|medication adherence|medication adherence
5038996|NCT03754803|Human Immunodeficiency Virus|human immunodeficiency virus
5038997|NCT03754803|HIV Symptom Distress Module|hiv symptom distress module
5038999|NCT03754803|HIV treatment satisfaction questionnaire|hiv treatment satisfaction questionnaire
5039000|NCT03754777|enhanced recovery|enhanced recovery
5039001|NCT03754777|fast-track|fast-track
5039002|NCT03754777|appendectomy|appendectomy
5039003|NCT03754777|intraperitoneal anesthesia|intraperitoneal anesthesia
5039004|NCT03754777|low pressure pneumoperitoneum|low pressure pneumoperitoneum
5039005|NCT03754751|enhanced recovery|enhanced recovery
5039006|NCT03754751|intraperitoneal anesthesia|intraperitoneal anesthesia
5039007|NCT03754751|low pressure pneumoperitoneum|low pressure pneumoperitoneum
5039008|NCT03754751|cholecystitis|cholecystitis
5039009|NCT03754751|in-hospital stay|in-hospital stay
5039010|NCT03754751|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5039011|NCT03754725|Deferiprone|deferiprone
5039012|NCT03754699|Pain|pain
5039013|NCT03754699|Surgery|surgery
5039014|NCT03754699|Preoperative Education|preoperative education
5039015|NCT03754699|Outpatient|outpatient
5039016|NCT03754660|PAH|pah
5039017|NCT03754660|CTEPH|cteph
5039018|NCT03754660|pulmonary arterial hypertension|pulmonary arterial hypertension
5052617|NCT03669744|regional anesthesia|regional anesthesia
5039019|NCT03754660|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5039020|NCT03754647|Vitamin C|vitamin c
5039022|NCT03754647|MDA|mda
5039023|NCT03754647|RBC Glutathione|rbc glutathione
5039024|NCT03754634|ITP|itp
5039025|NCT03754634|Eltrombopag|eltrombopag
5039026|NCT03754634|Diacerein|diacerein
5039027|NCT03754621|TSH|tsh
5039028|NCT03754595|2D and 3D Laparoscopic pancreatoduodenectomy|2d and 3d laparoscopic pancreatoduodenectomy
5039029|NCT03754582|Partial Onset Seizures|partial onset seizures
5039030|NCT03754582|Secondarily Generalized Seizures|secondarily generalized seizures
5039031|NCT03754582|Primary Generalized Tonic-Clonic Seizures|primary generalized tonic-clonic seizures
5039032|NCT03754569|ovarian|ovarian
5039033|NCT03754569|peritoneal|peritoneal
5039034|NCT03754569|recurrences|recurrences
5039035|NCT03754569|surgery|surgery
5039036|NCT03754569|cancer|cancer
5039037|NCT03754569|metastases|metastases
5039038|NCT03754556|Contraception|contraception
5039039|NCT03754556|Breast-feeding|breast-feeding
5039040|NCT03754556|Electronic medical records|electronic medical records
5039041|NCT03754556|Uterine perforation|uterine perforation
5039042|NCT03754556|Expulsion of intrauterine device|expulsion of intrauterine device
5039043|NCT03754530|NSCLC brain metastases|nsclc brain metastases
5039044|NCT03754517|syphilis|syphilis
5039045|NCT03754517|serofast|serofast
5039046|NCT03754491|Acute cholangitis|acute cholangitis
5039047|NCT03754491|choledocholithiasis|choledocholithiasis
5039048|NCT03754491|ERCP|ercp
5039049|NCT03754491|One-stage treatment|one-stage treatment
5039050|NCT03754387|children|children
5039051|NCT03754387|antibiotic therapy|antibiotic therapy
5039052|NCT03754387|laparoscopic appendectomy|laparoscopic appendectomy
5039053|NCT03754387|randomized clinical trial(RCT)|randomized clinical trial(rct)
5039054|NCT03754387|Chronic appendicitis|chronic appendicitis
5039055|NCT03754374|Primary health|primary health
5039056|NCT03754374|migrants|migrants
5039057|NCT03754374|health care utilization|health care utilization
5039058|NCT03754374|access to healthcare|access to healthcare
5039059|NCT03754361|urgent start dialysis|urgent start dialysis
5039060|NCT03754361|automated PD|automated pd
5039061|NCT03754348|narcolepsy type 1|narcolepsy type 1
5039062|NCT03754348|orexin|orexin
5039063|NCT03754348|hypocretin|hypocretin
5039064|NCT03754348|[18F] DPA-714|[18f] dpa-714
5039065|NCT03754348|biomarker|biomarker
5039066|NCT03754348|auto immunity|auto immunity
5039067|NCT03754335|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5039068|NCT03754335|lumbar puncture|lumbar puncture
5039069|NCT03754335|headache|headache
5040326|NCT03746860|Allergy|allergy
5039070|NCT03754283|Indirect bonding|indirect bonding
5039071|NCT03754283|Accuracy|accuracy
5039072|NCT03754270|Apnea/hypopnea index|apnea/hypopnea index
5039073|NCT03754257|sepsis|sepsis
5039074|NCT03754257|septic shock|septic shock
5039075|NCT03754257|electrical stimulation|electrical stimulation
5039076|NCT03754231|Vital sign monitoring|vital sign monitoring
5039077|NCT03754231|Heart rate|heart rate
5039078|NCT03754231|Respiratory rate|respiratory rate
5039079|NCT03754218|Human amnion membrane|human amnion membrane
5039080|NCT03754218|Autologous skin graft|autologous skin graft
5039081|NCT03754218|Scar Formation|scar formation
5039082|NCT03754192|Perfusion computer tomography|perfusion computer tomography
5039083|NCT03754192|dual-energy computer tomography|dual-energy computer tomography
5039084|NCT03754179|autophagy|autophagy
5039085|NCT03754179|dabrafenib|dabrafenib
5039086|NCT03754179|hydroxychloroquine|hydroxychloroquine
5039087|NCT03754179|trametinib|trametinib
5039088|NCT03754179|melanoma|melanoma
5039089|NCT03754179|rechallenge|rechallenge
5039090|NCT03754140|Sclerosant|sclerosant
5039091|NCT03754140|Polidocanol|polidocanol
5039092|NCT03754127|tinnitus|tinnitus
5039093|NCT03754127|tdcs|tdcs
5039094|NCT03754127|neuromodulation|neuromodulation
5039096|NCT03754114|intracranial pressure|intracranial pressure
5039097|NCT03754114|hypoxia, brain|hypoxia, brain
5039098|NCT03754114|critical care|critical care
5039099|NCT03754114|emergency treatment|emergency treatment
5039100|NCT03754114|monitoring, physiologic|monitoring, physiologic
5039101|NCT03754075|Colon cancer|colon cancer
5039102|NCT03754075|Surgery|surgery
5039103|NCT03754075|Oncological outcome|oncological outcome
5039104|NCT03754075|Survival|survival
5039106|NCT03754023|Biomarkers|biomarkers
5039107|NCT03754023|Urine TIMP-IGFBP7|urine timp-igfbp7
5039108|NCT03754023|Emergency Department|emergency department
5039109|NCT03754010|periodontitis|periodontitis
5039110|NCT03754010|hyaluronic acid|hyaluronic acid
5039111|NCT03754010|scaling and root planning|scaling and root planning
5039112|NCT03754010|adenosione deaminase|adenosione deaminase
5039113|NCT03754010|catalase|catalase
5039114|NCT03754010|glutathione|glutathione
5039115|NCT03753984|Fatigue|fatigue
5039116|NCT03753984|Low-level Laser Therapy|low-level laser therapy
5039117|NCT03753984|Stroke|stroke
5039118|NCT03753984|Infrared thermograpy|infrared thermograpy
5039119|NCT03753945|deep brain stimulation|deep brain stimulation
5039120|NCT03753880|Liver resection|liver resection
5039121|NCT03753880|Bile leaks|bile leaks
5039122|NCT03753880|Outcome|outcome
5039123|NCT03753854|sickle cell disease|sickle cell disease
5039124|NCT03753854|obstructive sleep apnoea|obstructive sleep apnoea
5039125|NCT03753854|vaso-occlusive crisis|vaso-occlusive crisis
5039126|NCT03753841|Dysphagia|dysphagia
5039127|NCT03753841|Aspiration|aspiration
5039128|NCT03753841|Management of Dysphagia|management of dysphagia
5039129|NCT03753841|Deglutition Disorders|deglutition disorders
5039130|NCT03753841|Deglutition|deglutition
5039131|NCT03753841|FEES|fees
5039132|NCT03753841|Intensive Care Neurological Disorder|intensive care neurological disorder
5039133|NCT03753802|Bronchiolitis|bronchiolitis
5039134|NCT03753802|Chest physiotherapy|chest physiotherapy
5039135|NCT03753802|Infants|infants
5039136|NCT03753776|Homeopathy|homeopathy
5039137|NCT03753776|Radium bromatum|radium bromatum
5039138|NCT03753776|Apis mellifica|apis mellifica
5039139|NCT03753776|Belladonna|belladonna
5039140|NCT03753776|Radiodermatitis|radiodermatitis
5039141|NCT03753776|Radiotherapy|radiotherapy
5039142|NCT03753776|Prevention|prevention
5351798|NCT01940666|FAI/|fai/
5039143|NCT03753776|Treatment|treatment
5039144|NCT03753776|Breast cancer|breast cancer
5039145|NCT03753724|pulmonary nodules|pulmonary nodules
5039146|NCT03753724|lung cancer|lung cancer
5039147|NCT03753724|artificial intelligence|artificial intelligence
5039148|NCT03753724|CAP model|cap model
5039149|NCT03753711|lumbar disc herniation|lumbar disc herniation
5039150|NCT03753711|hernia|hernia
5039151|NCT03753698|Multiple Sclerosis|multiple sclerosis
5039152|NCT03753698|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5039153|NCT03753698|Posterior tibial nerve stimulation|posterior tibial nerve stimulation
5039154|NCT03753698|Neuromodulation|neuromodulation
5039155|NCT03753685|NSCLC|nsclc
5039156|NCT03753685|Brain metastases|brain metastases
5039157|NCT03753685|ALK mutations|alk mutations
5039158|NCT03753685|X-396 (Ensartinib)|x-396 (ensartinib)
5039159|NCT03753659|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5039160|NCT03753646|Bangladesh|bangladesh
5039161|NCT03753646|Cognitive development|cognitive development
5039162|NCT03753646|behavior|behavior
5039163|NCT03753646|quality of life|quality of life
5039164|NCT03753646|psycho social stimulation|psycho social stimulation
5039165|NCT03753646|lactating allowance|lactating allowance
5039166|NCT03753633|speech therapy|speech therapy
5039167|NCT03753633|sleep apnea|sleep apnea
5039168|NCT03753633|resistant hypertension|resistant hypertension
5039169|NCT03753633|quality of life|quality of life
5039170|NCT03753633|quality of sleep|quality of sleep
5039171|NCT03753594|Peripheral nerve block|peripheral nerve block
5039172|NCT03753581|Electric Stimulation Therapy|electric stimulation therapy
5039173|NCT03753581|Pressure Ulcer|pressure ulcer
5039174|NCT03753581|Aged|aged
5039175|NCT03753568|medicine reminder|medicine reminder
5039176|NCT03753568|diabetes mellitus, type 2|diabetes mellitus, type 2
5039177|NCT03753568|direct oral anticoagulants|direct oral anticoagulants
5039178|NCT03753542|chemotherapy, side effects, parents, anxiety, depression|chemotherapy, side effects, parents, anxiety, depression
5039179|NCT03753503|Parkinson's disease|parkinson's disease
5039180|NCT03753503|intensive interval training|intensive interval training
5039181|NCT03753503|motor function|motor function
5039182|NCT03753503|executive function|executive function
5032791|NCT03794388|Surgery|surgery
5039183|NCT03753503|neuroplasticity|neuroplasticity
5039184|NCT03753451|periodontal diseases|periodontal diseases
5039185|NCT03753451|atherosclerosis|atherosclerosis
5039186|NCT03753451|mannose binding protein|mannose binding protein
5039187|NCT03753451|sirtuins|sirtuins
5039188|NCT03753451|inflammation|inflammation
5039189|NCT03753425|Inflammatory bowel disease|inflammatory bowel disease
5039190|NCT03753425|colonoscopy|colonoscopy
5039191|NCT03753425|bowel preparations|bowel preparations
5039192|NCT03753412|Extra Corporeal Membrane Oxygenation (ECMO)|extra corporeal membrane oxygenation (ecmo)
5039193|NCT03753412|Intensive Care Unit Acquired Weakness (ICUAW)|intensive care unit acquired weakness (icuaw)
5039194|NCT03753412|Critical Illness Polyneuromyopathy (CIPM)|critical illness polyneuromyopathy (cipm)
5039195|NCT03753412|Ultrasound (US)|ultrasound (us)
5039196|NCT03753412|Health Related Quality of Life (HRQoL)|health related quality of life (hrqol)
5039197|NCT03753399|Gastric cancer|gastric cancer
5039198|NCT03753399|Acupuncture|acupuncture
5039199|NCT03753399|Quality of life|quality of life
5039200|NCT03753399|Adjuvant chemotherapy|adjuvant chemotherapy
5039201|NCT03753373|acupuncture|acupuncture
5039202|NCT03753373|Medial Tibial Stress Syndrome|medial tibial stress syndrome
5039203|NCT03753360|Stress|stress
5039204|NCT03753360|Mindfulness|mindfulness
5039205|NCT03753360|Meditation|meditation
5039206|NCT03753360|Gene expression|gene expression
5039207|NCT03753360|Immune|immune
5039209|NCT03753360|Healthcare workers|healthcare workers
5039210|NCT03753360|Burnout|burnout
5039211|NCT03753360|Cytokines|cytokines
5039212|NCT03753360|Cortisol|cortisol
5039213|NCT03753334|Biochemical recurrence (BCR)|biochemical recurrence (bcr)
5039214|NCT03753334|Androgen-deprivation therapy (ADT)|androgen-deprivation therapy (adt)
5039215|NCT03753334|PSA doubling time|psa doubling time
5039216|NCT03753334|Quality of life|quality of life
5039217|NCT03753334|Omega-3 fatty acids|omega-3 fatty acids
5039218|NCT03753334|Biomarkers|biomarkers
5039219|NCT03753334|Prostate cancer progression|prostate cancer progression
5039220|NCT03753334|PSA kinetics|psa kinetics
5039221|NCT03753308|Dendritic cells|dendritic cells
5039222|NCT03753308|C-type lectins (CLR)|c-type lectins (clr)
5039223|NCT03753308|mDCs BDCA1+ and BDCA3+ circulating and hepatic|mdcs bdca1+ and bdca3+ circulating and hepatic
5039224|NCT03753295|BMI, Hand Grip, Healthy Adults|bmi, hand grip, healthy adults
5039225|NCT03753282|Total hip arthroplasty|total hip arthroplasty
5039226|NCT03753282|Total hip replacement|total hip replacement
5039227|NCT03753269|myocardial infarction|myocardial infarction
5039228|NCT03753269|reperfusion therapy|reperfusion therapy
5039229|NCT03753269|microvascular dysfunction|microvascular dysfunction
5039230|NCT03753269|Fasudil Hydrochloride|fasudil hydrochloride
5039231|NCT03753269|myocardial perfusion|myocardial perfusion
5039232|NCT03753243|Neoadjuvant|neoadjuvant
5039233|NCT03753243|Programmed cell death protein 1 (PD-1)|programmed cell death protein 1 (pd-1)
5351890|NCT01940250|Magnesium sulphate|magnesium sulphate
5039234|NCT03753217|Anesthesia Monitoring|anesthesia monitoring
5039235|NCT03753178|ultrasonography|ultrasonography
5039236|NCT03753178|Common peroneal electrophysiological evaluations|common peroneal electrophysiological evaluations
5039237|NCT03753178|Common peroneal neuropathy|common peroneal neuropathy
5039238|NCT03753165|Chronic low back pain, Heart rate variability|chronic low back pain, heart rate variability
5039239|NCT03753139|Atrial fibrillation; detection; portable device; algorithms|atrial fibrillation; detection; portable device; algorithms
5039240|NCT03753113|Androgenic Alopecia|androgenic alopecia
5039241|NCT03753113|Hair Diseases|hair diseases
5039242|NCT03753113|Skin Diseases|skin diseases
5039244|NCT03753113|Alopecia|alopecia
5039245|NCT03753113|Hair Loss|hair loss
5039246|NCT03753087|HF|hf
5039247|NCT03753087|HFpEF|hfpef
5039248|NCT03753087|DM|dm
5039249|NCT03753087|Empagliflozin|empagliflozin
5039250|NCT03753087|Jardiance|jardiance
5039251|NCT03753061|Large vessel occlusion|large vessel occlusion
5039252|NCT03753061|Acute ischemic stroke|acute ischemic stroke
5039253|NCT03753061|Endovascular treatment|endovascular treatment
5039254|NCT03753061|Mechanical thrombectomy|mechanical thrombectomy
5039255|NCT03753061|Aspiration Catheter|aspiration catheter
5039256|NCT03753048|Total Arterial Revascularization|total arterial revascularization
5039257|NCT03753048|Y-Graft|y-graft
5039258|NCT03753048|In-Situ|in-situ
5039259|NCT03753048|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5039260|NCT03753035|epilepsy|epilepsy
5039261|NCT03753035|children|children
5039262|NCT03753035|seizures|seizures
5039263|NCT03753035|patient compliance|patient compliance
5039264|NCT03753035|quality of life|quality of life
5039265|NCT03753022|Acute Lung Injury|acute lung injury
5039266|NCT03753022|postoperative of cardiac surgery|postoperative of cardiac surgery
5039267|NCT03752957|Wide-Awake Local Anesthesia|wide-awake local anesthesia
5039268|NCT03752931|Pneumonectomy Thoracic surgery Celiprolol Diltiazem|pneumonectomy thoracic surgery celiprolol diltiazem
5039269|NCT03752918|MDMA|mdma
5039270|NCT03752905|RDEB|rdeb
5039271|NCT03752892|pulmonary rehabilitation|pulmonary rehabilitation
5039272|NCT03752892|exercise training|exercise training
5356791|NCT01918007|Sleep Disorders|sleep disorders
5039273|NCT03752879|Kristeller maneuver,LAM avulsion,3D transperineal ultrasoun|kristeller maneuver,lam avulsion,3d transperineal ultrasoun
5039274|NCT03752866|Portico™ valve|portico™ valve
5039275|NCT03752866|Portico™ valve delivery system|portico™ valve delivery system
5039276|NCT03752866|Portico™ valve loading system|portico™ valve loading system
5039277|NCT03752866|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5039278|NCT03752866|Aortic Stenosis|aortic stenosis
5039279|NCT03752866|Heart Valve Prosthesis|heart valve prosthesis
5039280|NCT03752866|TAVR|tavr
5039281|NCT03752866|TAVR Registry|tavr registry
5039282|NCT03752866|Transcatheter Aortic Valve Implant|transcatheter aortic valve implant
5039283|NCT03752866|TAVI|tavi
5039284|NCT03752866|TAVI Registry|tavi registry
5039285|NCT03752853|major depressive episode|major depressive episode
5039286|NCT03752853|cortisol|cortisol
5039287|NCT03752853|alpha-amylase|alpha-amylase
5039288|NCT03752853|psychotherapy|psychotherapy
5039289|NCT03752827|rotator cuff tear|rotator cuff tear
5039290|NCT03752827|adipose-derived regenerative cells|adipose-derived regenerative cells
5039291|NCT03752827|adipose-derived stem cells|adipose-derived stem cells
5039292|NCT03752827|partial rotator cuff tears|partial rotator cuff tears
5039293|NCT03752827|corticosteroid|corticosteroid
5039294|NCT03752814|distraction osteogenesis|distraction osteogenesis
5039295|NCT03752814|bone lengthening|bone lengthening
5039296|NCT03752814|leg length discrepancy|leg length discrepancy
5039297|NCT03752814|callotasis|callotasis
5039298|NCT03752814|Intramedullary distraction nail|intramedullary distraction nail
5039299|NCT03752801|education|education
5039300|NCT03752801|pediatric|pediatric
5039305|NCT03752788|Step length|step length
5039306|NCT03752788|Balance training|balance training
5039307|NCT03752788|Dual task|dual task
5039308|NCT03752788|Institutional priority sets|institutional priority sets
5039312|NCT03752762|Stunting|stunting
5039313|NCT03752762|Obesity|obesity
5039314|NCT03752762|Lipid-based Nutrient Supplements (LNS)|lipid-based nutrient supplements (lns)
5039315|NCT03752762|Latin America|latin america
5039316|NCT03752762|Child nutrition|child nutrition
5039317|NCT03752762|Feeding practices|feeding practices
5039318|NCT03752736|Sunscreen|sunscreen
5039319|NCT03752736|Sun protection|sun protection
5039320|NCT03752736|Education|education
5039321|NCT03752736|skin cancer|skin cancer
5039322|NCT03752736|school-aged children|school-aged children
5039323|NCT03752736|prevention|prevention
5039324|NCT03752697|metacognition|metacognition
5039325|NCT03752697|self-assessment|self-assessment
5039326|NCT03752684|Oxalobacter formigenes|oxalobacter formigenes
5039327|NCT03752684|oxalate|oxalate
5039328|NCT03752684|kidney stones|kidney stones
5039329|NCT03752645|acoustic rhinometry|acoustic rhinometry
5039330|NCT03752645|active anterior rhinomanometry|active anterior rhinomanometry
5039331|NCT03752645|allergic rhinitis|allergic rhinitis
5039332|NCT03752645|red light rhinophototherapy|red light rhinophototherapy
5039333|NCT03752632|intravenous|intravenous
5039334|NCT03752632|peripheral vein|peripheral vein
5039335|NCT03752632|cannulation|cannulation
5039336|NCT03752632|IV access|iv access
5039337|NCT03752619|peripheral nerve stimulation|peripheral nerve stimulation
5039338|NCT03752619|Sprint|sprint
5039339|NCT03752619|stimulation|stimulation
5039340|NCT03752606|lymphadenectomy|lymphadenectomy
5039341|NCT03752606|lymphocele|lymphocele
5039342|NCT03752606|endometrial cancer|endometrial cancer
5039343|NCT03752606|cervical cancer|cervical cancer
5039344|NCT03752567|adherence|adherence
5039345|NCT03752567|terapy|terapy
5039346|NCT03752567|follow up|follow up
5039347|NCT03752567|community pharmacy|community pharmacy
5039348|NCT03752567|pharmacist|pharmacist
5039349|NCT03752567|case manager|case manager
5039350|NCT03752567|telemedicine|telemedicine
5039351|NCT03752567|pharmacy of service|pharmacy of service
5039352|NCT03752567|fundus camera|fundus camera
5039354|NCT03752567|local pharmacist|local pharmacist
5039355|NCT03752567|general physician|general physician
5039356|NCT03752554|segmental mandibular resection-IAN|segmental mandibular resection-ian
5039357|NCT03752489|Dascena|dascena
5039358|NCT03752489|machine learning|machine learning
5039359|NCT03752489|fluid administration|fluid administration
5039360|NCT03752489|clustering algorithm|clustering algorithm
5039361|NCT03752489|mortality|mortality
5039362|NCT03752489|diagnostic|diagnostic
5039363|NCT03752476|antibiotic resistant|antibiotic resistant
5039364|NCT03752476|multidrug resistant|multidrug resistant
5039365|NCT03752476|Beta lactam|beta lactam
5039366|NCT03752450|Water-electrolyte imbalance|water-electrolyte imbalance
5039367|NCT03752398|DUET-3|duet-3
5039368|NCT03752398|Advanced solid tumors|advanced solid tumors
5039369|NCT03752398|Melanoma|melanoma
5039370|NCT03752398|Cervical Cancer|cervical cancer
5039380|NCT03752398|Non-small Cell Lung Cancer|non-small cell lung cancer
5039382|NCT03752398|Gastric Cancer|gastric cancer
5039383|NCT03752398|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5039384|NCT03752385|smartphone|smartphone
5039385|NCT03752385|screen time|screen time
5039386|NCT03752385|sedentary behaviour|sedentary behaviour
5039387|NCT03752385|physical activity|physical activity
5039388|NCT03752385|mental health|mental health
5039389|NCT03752385|sleep|sleep
5039390|NCT03752385|adolescents|adolescents
5039391|NCT03752385|young adults|young adults
5039392|NCT03752372|interleukin 10 receptor alpha gene|interleukin 10 receptor alpha gene
5039393|NCT03752359|sarcopenia|sarcopenia
5039395|NCT03752359|protein intake|protein intake
5039396|NCT03752359|IL-6|il-6
5039397|NCT03752359|lean tissue|lean tissue
5039398|NCT03752346|Parkinson's Disease|parkinson's disease
5039399|NCT03752346|A Multimodal Exercise Program|a multimodal exercise program
5039400|NCT03752346|Aerobic Exercise|aerobic exercise
5039401|NCT03752346|Depression|depression
5039402|NCT03752346|Health Related Quality of Life|health related quality of life
5039403|NCT03752320|Postoperative pneumonia|postoperative pneumonia
5039414|NCT03752255|Video|video
5039415|NCT03752255|Anxiety|anxiety
5039416|NCT03752229|safety lancets|safety lancets
5039417|NCT03752229|lancet|lancet
5039418|NCT03752229|capillary blood|capillary blood
5039419|NCT03752229|capillary blood sampling|capillary blood sampling
5039420|NCT03752229|blood volume|blood volume
5039421|NCT03752229|pain|pain
5039422|NCT03752216|Ovarian Cancer|ovarian cancer
5039423|NCT03752216|Anti-PARP (poly-ADP ribose polymerase)|anti-parp (poly-adp ribose polymerase)
5039424|NCT03752216|Late Relapse|late relapse
5039425|NCT03752203|Sodium Fluorescein|sodium fluorescein
5039426|NCT03752203|Surgical Microscope|surgical microscope
5039427|NCT03752203|Central Nervous System|central nervous system
5039428|NCT03752203|Tumors|tumors
5039429|NCT03752177|TIM-3|tim-3
5039430|NCT03752177|PD-L1|pd-l1
5039431|NCT03752125|energy expenditure|energy expenditure
5039432|NCT03752125|caffeine|caffeine
5039439|NCT03752112|Sexually Transmitted Infection|sexually transmitted infection
5039440|NCT03752112|STI|sti
5039441|NCT03752060|post-menopause|post-menopause
5039442|NCT03752060|women|women
5039443|NCT03752060|post-prandial|post-prandial
5039444|NCT03752060|metabolic function|metabolic function
5039445|NCT03752060|cardiovascular function|cardiovascular function
5039446|NCT03752060|muscle|muscle
5039447|NCT03752060|body composition|body composition
5039448|NCT03752060|angiogenesis|angiogenesis
5039449|NCT03752034|Muscle Fiber Fragments|muscle fiber fragments
5039450|NCT03752034|Rotator Cuff Musculature|rotator cuff musculature
5039451|NCT03752034|Rotator Cuff Repair|rotator cuff repair
5039452|NCT03752021|Endocannabinoid System|endocannabinoid system
5039453|NCT03752021|Human Gestational Tissues|human gestational tissues
5039454|NCT03752021|Labor|labor
5039455|NCT03752021|Cesarean Section|cesarean section
5039456|NCT03751982|transcranial electrical stimulation|transcranial electrical stimulation
5039457|NCT03751943|Demineralized Bone Matrix|demineralized bone matrix
5039458|NCT03751943|Primary Lumbar Fusion|primary lumbar fusion
5039459|NCT03751943|Autograft Lumbar Fusion|autograft lumbar fusion
5039460|NCT03751930|Autism Spectrum Disorder|autism spectrum disorder
5039461|NCT03751930|Tryptophan metabolism|tryptophan metabolism
5039462|NCT03751930|Gut microbiota|gut microbiota
5039463|NCT03751917|Acute promyelocytic leukemia|acute promyelocytic leukemia
5039464|NCT03751917|Adults|adults
5039465|NCT03751917|Arsenic trioxide|arsenic trioxide
5039466|NCT03751878|Reporting guidelines|reporting guidelines
5039467|NCT03751878|CONSORT|consort
5039468|NCT03751878|Adherence|adherence
5039469|NCT03751878|Completeness of reporting|completeness of reporting
5039470|NCT03751878|Quality of reporting|quality of reporting
5039471|NCT03751878|Peer review|peer review
5039473|NCT03751787|osteopathy|osteopathy
5039474|NCT03751787|cranial|cranial
5039475|NCT03751735|Diabetes|diabetes
5039476|NCT03751735|Wharton jelly mesenchymal stem cells|wharton jelly mesenchymal stem cells
5039481|NCT03751722|cytokines|cytokines
5039492|NCT03751670|Acute exacerbation of chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
5039493|NCT03751670|Pulmonary rehabilitation|pulmonary rehabilitation
5039494|NCT03751670|Community|community
5039495|NCT03751670|Home|home
5039496|NCT03751644|systemic autoimmune myopathies|systemic autoimmune myopathies
5039497|NCT03751644|Peripherical neuromuscular electrical stimulation|peripherical neuromuscular electrical stimulation
5039498|NCT03751644|myositis|myositis
5039499|NCT03751618|Hip arthroscopy|hip arthroscopy
5039500|NCT03751618|capsular suture|capsular suture
5039501|NCT03751618|Femoral Acetabular Impingement|femoral acetabular impingement
5039600|NCT03751137|Hormone|hormone
5039601|NCT03751137|Obesity|obesity
5039511|NCT03751475|Child Malnutrition|child malnutrition
5039512|NCT03751475|Congo, The Democratic Republic of the|congo, the democratic republic of the
5039513|NCT03751475|Randomized Clinical Trial|randomized clinical trial
5039514|NCT03751475|Africa|africa
5039515|NCT03751462|Cataract|cataract
5039516|NCT03751462|Pseudoexfoliation|pseudoexfoliation
5039517|NCT03751462|Traumatic cataract|traumatic cataract
5039518|NCT03751423|procedural sedation|procedural sedation
5039519|NCT03751423|ketamine|ketamine
5039520|NCT03751423|fentanyl|fentanyl
5039521|NCT03751423|morphine|morphine
5039522|NCT03751410|ibrutinib|ibrutinib
5039523|NCT03751410|echocardiography|echocardiography
5039524|NCT03751410|left atrium|left atrium
5039525|NCT03751410|function|function
5039526|NCT03751410|long-term|long-term
5039527|NCT03751397|Creatinine|creatinine
5039528|NCT03751397|Albumin|albumin
5039529|NCT03751397|Cystatin C|cystatin c
5039530|NCT03751397|Neutrophil gelatinase-associated lipocalin (NGAL)|neutrophil gelatinase-associated lipocalin (ngal)
5039531|NCT03751397|beta-trace Protein|beta-trace protein
5039532|NCT03751397|beta-2 Microglobulin|beta-2 microglobulin
5039533|NCT03751397|Uromodulin|uromodulin
5039534|NCT03751371|Parkinson|parkinson
5039535|NCT03751371|Exoskeleton|exoskeleton
5039536|NCT03751371|Honda|honda
5039537|NCT03751371|Walking Assist|walking assist
5039538|NCT03751371|Walking|walking
5039539|NCT03751371|Gait|gait
5039540|NCT03751371|Mobility|mobility
5039541|NCT03751371|Rehabilitation|rehabilitation
5039542|NCT03751371|Physical Therapy|physical therapy
5039543|NCT03751358|ESP Thoracic|esp thoracic
5039544|NCT03751358|Spread Local anesthetic|spread local anesthetic
5039545|NCT03751358|Volunteer|volunteer
5053115|NCT03666598|Muscle strength|muscle strength
5039548|NCT03751345|Computer-based parenting program|computer-based parenting program
5039549|NCT03751345|Parenting Wisely|parenting wisely
5039550|NCT03751345|Adolescent disruptive behavior disorders|adolescent disruptive behavior disorders
5039551|NCT03751332|Calcineurin inhibitors|calcineurin inhibitors
5039552|NCT03751332|Tacrolimus modified release|tacrolimus modified release
5039554|NCT03751332|Trough levels|trough levels
5039555|NCT03751332|MDR-1|mdr-1
5039556|NCT03751306|Neurological Diseases|neurological diseases
5039557|NCT03751306|Cardiorespiratory Rehabilitation|cardiorespiratory rehabilitation
5039558|NCT03751306|Aerobic exercise|aerobic exercise
5039559|NCT03751306|Fotobiomodulação Transcraniana|fotobiomodulação transcraniana
5039560|NCT03751280|Schizophrenia|schizophrenia
5039561|NCT03751280|Digital Therapeutic|digital therapeutic
5039563|NCT03751280|smartphone app|smartphone app
5039564|NCT03751267|Paediatric Massage, Constipation, Pre-school Children|paediatric massage, constipation, pre-school children
5039565|NCT03751254|Cataract|cataract
5039566|NCT03751254|Cataract surgery|cataract surgery
5039567|NCT03751254|Phacoemulsification platform|phacoemulsification platform
5039568|NCT03751241|Pseudophakia|pseudophakia
5039569|NCT03751241|Reading speed|reading speed
5039570|NCT03751215|Cataract|cataract
5039571|NCT03751215|Cataract surgery|cataract surgery
5039572|NCT03751215|Intraocular lens|intraocular lens
5039573|NCT03751202|inhaler|inhaler
5039574|NCT03751202|fluticasone proprionate|fluticasone proprionate
5039575|NCT03751202|salmeterol xinafoate|salmeterol xinafoate
5039576|NCT03751202|ADVAIR DISKUS|advair diskus
5039577|NCT03751189|trauma|trauma
5039578|NCT03751189|overjet|overjet
5039579|NCT03751189|libya|libya
5039580|NCT03751189|schoolchildren|schoolchildren
5039591|NCT03751163|melasma|melasma
5039592|NCT03751163|tranexamic acid|tranexamic acid
5039593|NCT03751163|hydroquinone|hydroquinone
5039594|NCT03751163|mMASI|mmasi
5039595|NCT03751163|mexameter|mexameter
5039596|NCT03751150|Running-related injury|running-related injury
5039597|NCT03751137|Microbiome|microbiome
5039598|NCT03751137|Gut-brain axis|gut-brain axis
5039599|NCT03751137|Satiety|satiety
5039610|NCT03751111|single-blind randomized trial|single-blind randomized trial
5039611|NCT03751085|AW frame|aw frame
5039612|NCT03751085|biopsy|biopsy
5039614|NCT03751085|accuracy|accuracy
5039615|NCT03751085|safety|safety
5039616|NCT03751046|HIV|hiv
5039617|NCT03751046|Cognitive therapy|cognitive therapy
5039618|NCT03751046|Treatment|treatment
5039619|NCT03751046|HAART|haart
5039620|NCT03751046|Treatment adherence and compliance|treatment adherence and compliance
5039621|NCT03751033|Cataract Extraction|cataract extraction
5039622|NCT03751020|Expressive Writing|expressive writing
5039623|NCT03751020|Minority Stress|minority stress
5039624|NCT03751020|Lesbian Gay Bisexual|lesbian gay bisexual
5039625|NCT03750929|Takayasus's arteritis|takayasus's arteritis
5039626|NCT03750929|Physical exercises|physical exercises
5039627|NCT03750929|Rheumatic diseases|rheumatic diseases
5039628|NCT03750929|Systemic vasculitis|systemic vasculitis
5039629|NCT03750916|NSCLC Anlotinib Docetaxel|nsclc anlotinib docetaxel
5039631|NCT03750877|median approach|median approach
5039632|NCT03750877|paramedian approach|paramedian approach
5039633|NCT03750877|geriatric patient|geriatric patient
5039634|NCT03750877|spinal anesthesia|spinal anesthesia
5039635|NCT03750864|Lung cancer|lung cancer
5039637|NCT03750864|Lung cancer stigma|lung cancer stigma
5726399|NCT00409123|controls|controls
5039638|NCT03750864|Acceptance and commitment therapy|acceptance and commitment therapy
5039639|NCT03750851|desensitizing treatment|desensitizing treatment
5039640|NCT03750851|dental hypersensitivity|dental hypersensitivity
5039641|NCT03750851|CPPACPF|cppacpf
5039642|NCT03750851|Low level laser therapy|low level laser therapy
5039643|NCT03750825|Electronic Nicotine Delivery System|electronic nicotine delivery system
5039644|NCT03750747|IMCI services|imci services
5039645|NCT03750747|Pulse Oximeter|pulse oximeter
5039646|NCT03750747|Acute respiratory infections|acute respiratory infections
5039647|NCT03750747|Implementation research|implementation research
5039648|NCT03750747|Hypoxaemia|hypoxaemia
5039649|NCT03750747|Childhood Pneumonia|childhood pneumonia
5039650|NCT03750747|Resource poor settings|resource poor settings
5039651|NCT03750708|Alveolar bone graft complications, oral hygiene, cleft lip and palate, connected health|alveolar bone graft complications, oral hygiene, cleft lip and palate, connected health
5039652|NCT03750695|exercise|exercise
5039653|NCT03750695|glucose|glucose
5039654|NCT03750695|vascular|vascular
5039655|NCT03750669|Pancreatic Cancer|pancreatic cancer
5039656|NCT03750669|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5039657|NCT03750669|Gemcitabine|gemcitabine
5039658|NCT03750669|Nab-paclitaxel|nab-paclitaxel
5039659|NCT03750669|Modified Folfirinox|modified folfirinox
5039660|NCT03750669|Sequential treatment|sequential treatment
5039661|NCT03750630|vision, children, adolescent|vision, children, adolescent
5039662|NCT03750617|Colorectal Polyp|colorectal polyp
5039664|NCT03750617|Risk assessment|risk assessment
5039665|NCT03750604|abdominal obesity|abdominal obesity
5039666|NCT03750604|OAB|oab
5039667|NCT03750591|Integrative Korean medicine|integrative korean medicine
5039668|NCT03750591|treatment|treatment
5039669|NCT03750591|effectiveness|effectiveness
5039670|NCT03750591|safety|safety
5039671|NCT03750591|Lumbar intervertebral disc herniation|lumbar intervertebral disc herniation
5039672|NCT03750578|virtual reality|virtual reality
5039673|NCT03750578|procedural pain|procedural pain
5039674|NCT03750578|pediatric emergency department|pediatric emergency department
5039675|NCT03750578|procedural anxiety|procedural anxiety
5039676|NCT03750565|Healthy Japanese Subjects|healthy japanese subjects
5039677|NCT03750565|Healthy Caucasian Subjects|healthy caucasian subjects
5039678|NCT03750565|Ethnobridging|ethnobridging
5039679|NCT03750552|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
5039680|NCT03750552|snOH|snoh
5039681|NCT03750552|multiple system atrophy|multiple system atrophy
5039682|NCT03750552|MSA|msa
5039683|NCT03750552|Parkinson's disease|parkinson's disease
5039684|NCT03750552|PD|pd
5039685|NCT03750552|pure autonomic failure|pure autonomic failure
5039686|NCT03750552|PAF|paf
5039687|NCT03750552|primary autonomic failure|primary autonomic failure
5039688|NCT03750552|SEQUOIA|sequoia
5039689|NCT03750552|ampreloxetine|ampreloxetine
5039690|NCT03750552|low blood pressure|low blood pressure
5039691|NCT03750552|dizziness|dizziness
5039692|NCT03750552|fainting|fainting
5039693|NCT03750552|blacking out|blacking out
5039694|NCT03750552|lightheadedness|lightheadedness
5039695|NCT03750552|norepinephrine|norepinephrine
5039696|NCT03750552|hypotension|hypotension
5039697|NCT03750552|Parkinsonism|parkinsonism
5039698|NCT03750552|TD-9855|td-9855
5039699|NCT03750552|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5039700|NCT03750552|nOH|noh
5039701|NCT03750552|0145|0145
5338504|NCT02001597|surgery|surgery
5039706|NCT03750526|Repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5039707|NCT03750526|Augmented reality (AR)|augmented reality (ar)
5039709|NCT03750474|elastography; magnetic resonance imaging|elastography; magnetic resonance imaging
5039710|NCT03750461|ileostomy|ileostomy
5039711|NCT03750461|hernia|hernia
5039712|NCT03750461|rectal cancer|rectal cancer
5039713|NCT03750461|colon cancer|colon cancer
5039714|NCT03750448|Total knee arthroplasty|total knee arthroplasty
5039715|NCT03750448|Total hip arthroplasty|total hip arthroplasty
5039719|NCT03750409|dementia|dementia
5039720|NCT03750396|Oligometastasis|oligometastasis
5039721|NCT03750396|Local treatments|local treatments
5039722|NCT03750383|drug drug interaction study|drug drug interaction study
5039723|NCT03750357|Cardiac surgery pain reduction|cardiac surgery pain reduction
5039724|NCT03750357|Post operative pain|post operative pain
5039725|NCT03750357|PENS|pens
5039726|NCT03750357|Neurostimulation|neurostimulation
5039727|NCT03750344|Respiratory Rate|respiratory rate
5039728|NCT03750331|telemedicine|telemedicine
5039732|NCT03750279|Knee osteoarthritis|knee osteoarthritis
5039733|NCT03750279|Inflammation|inflammation
5039734|NCT03750279|Photobiomodulation|photobiomodulation
5039735|NCT03750279|Low-level laser therapy|low-level laser therapy
5039736|NCT03750279|Double-blind|double-blind
5039737|NCT03750279|Randomized clinical trial|randomized clinical trial
5039739|NCT03750253|Extracorporeal Shock Wave Therapy|extracorporeal shock wave therapy
5039740|NCT03750253|Osteochondral Lesions of Talus|osteochondral lesions of talus
5039741|NCT03750253|Arthroscopy|arthroscopy
5039742|NCT03750253|Pain-relief|pain-relief
5039743|NCT03750188|CNS|cns
5039744|NCT03750188|MRI|mri
5039745|NCT03750188|ProHance|prohance
5039746|NCT03750188|Gadoteridol|gadoteridol
5039747|NCT03750162|photodynamic therapy|photodynamic therapy
5039748|NCT03750162|diode laser|diode laser
5039749|NCT03750149|Diabetic Maculopathy|diabetic maculopathy
5039750|NCT03750149|Age Related Macular Degeneration|age related macular degeneration
5039751|NCT03750149|Glaucoma|glaucoma
5039752|NCT03750149|Epiretinal membrane|epiretinal membrane
5039753|NCT03750149|Reading analysis|reading analysis
5039754|NCT03750136|diuretics|diuretics
5039755|NCT03750123|kawasaki|kawasaki
5039756|NCT03750123|arterial stiffness|arterial stiffness
5039757|NCT03750123|PWV|pwv
5039758|NCT03750123|cIMT|cimt
5039759|NCT03750097|Multiple Sclerosis|multiple sclerosis
5039760|NCT03750097|Motion sensors|motion sensors
5039761|NCT03750097|Smartwatch|smartwatch
5039762|NCT03750097|Steps|steps
5039763|NCT03750097|Walking|walking
5039764|NCT03750097|Validation|validation
5039765|NCT03750084|Anesthesia|anesthesia
5039766|NCT03750084|Cell Phone|cell phone
5039767|NCT03750084|Mobile Applications|mobile applications
5039768|NCT03750058|quadripolar LV leads|quadripolar lv leads
5039777|NCT03750019|satiety|satiety
5039778|NCT03750019|eating behavior|eating behavior
5039779|NCT03750006|frailty|frailty
5039780|NCT03750006|sarcopenia|sarcopenia
5039781|NCT03750006|exercise|exercise
5039782|NCT03750006|high intensity|high intensity
5039783|NCT03750006|older adults|older adults
5039784|NCT03750006|microRNA|microrna
5039786|NCT03749980|BHD|bhd
5039787|NCT03749980|HLRCC|hlrcc
5039788|NCT03749980|SDHB|sdhb
5039789|NCT03749980|MyVHL|myvhl
5039791|NCT03749954|Magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
5039792|NCT03749954|Gastroesophageal varices bleeding|gastroesophageal varices bleeding
5039793|NCT03749954|Varices needing treatment|varices needing treatment
5039794|NCT03749941|EUS-FNA|eus-fna
5039795|NCT03749928|night guard|night guard
5039796|NCT03749928|biofeedback|biofeedback
5039797|NCT03749928|biosensor|biosensor
5039798|NCT03749915|Pain Ease|pain ease
5039799|NCT03749915|Ametop Gel|ametop gel
5039800|NCT03749902|preeclampsia|preeclampsia
5039801|NCT03749902|misoprostol|misoprostol
5039802|NCT03749902|oxytocin|oxytocin
5039803|NCT03749876|Cigarette filters|cigarette filters
5039804|NCT03749876|Cigarette smoking|cigarette smoking
5039805|NCT03749876|Unfiltered cigarettes|unfiltered cigarettes
5039806|NCT03749863|presbyphonia|presbyphonia
5039810|NCT03749863|platelet rich plasma|platelet rich plasma
5039812|NCT03749850|High Intensity Focused Ultrasound|high intensity focused ultrasound
5039813|NCT03749850|lyso-thermosensitive liposomal doxorubicin|lyso-thermosensitive liposomal doxorubicin
5039814|NCT03749850|ThermoDox|thermodox
5039815|NCT03749850|MR-HIFU|mr-hifu
5039816|NCT03749850|mild local hyperthermia|mild local hyperthermia
5039817|NCT03749850|local drug delivery|local drug delivery
5039818|NCT03749850|image-guided therapy|image-guided therapy
5039819|NCT03749850|nanomedicine|nanomedicine
5039820|NCT03749850|liposome|liposome
5039821|NCT03749850|doxorubicin|doxorubicin
5039822|NCT03749850|adriamycin|adriamycin
5039823|NCT03749850|cyclophosphamide|cyclophosphamide
5039824|NCT03749850|HIFU|hifu
5039825|NCT03749850|LTLD|ltld
5039826|NCT03749850|hyperthermia|hyperthermia
5039827|NCT03749850|de novo stage IV|de novo stage iv
5039828|NCT03749850|metastatic breast cancer|metastatic breast cancer
5039829|NCT03749811|Pupil dilatory reflex|pupil dilatory reflex
5039830|NCT03749811|Remifentanil|remifentanil
5039831|NCT03749811|Analgesia|analgesia
5039832|NCT03749798|Cataract|cataract
5729117|NCT00397852|Distal|distal
5039837|NCT03749759|Biofeedback|biofeedback
5039838|NCT03749733|Bioequivalence|bioequivalence
5039839|NCT03749733|Estradiol|estradiol
5039840|NCT03749733|Nomegestrol acetate|nomegestrol acetate
5039841|NCT03749720|Cervical Cancer|cervical cancer
5039842|NCT03749720|HPV|hpv
5039843|NCT03749720|Pathology|pathology
5039844|NCT03749720|ddPCR|ddpcr
5039845|NCT03749707|HPV|hpv
5039846|NCT03749707|Cervical cancer|cervical cancer
5039847|NCT03749707|SLN|sln
5039848|NCT03749694|Acute Myocardial Infarction|acute myocardial infarction
5039849|NCT03749694|mortality|mortality
5039850|NCT03749694|evidence-based care|evidence-based care
5039851|NCT03749694|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5039852|NCT03749694|ST-elevation myocardial infarction|st-elevation myocardial infarction
5039853|NCT03749681|Neuroendocrine Tumors|neuroendocrine tumors
5039854|NCT03749681|75 y and over patients|75 y and over patients
5039855|NCT03749681|Oncogeriatric follow-up|oncogeriatric follow-up
5039856|NCT03749681|Oncologic care|oncologic care
5039857|NCT03749668|surgery: colorectal|surgery: colorectal
5039858|NCT03749668|enhanced recovery|enhanced recovery
5039859|NCT03749668|caloric intake|caloric intake
5039860|NCT03749668|protein intake|protein intake
5039861|NCT03749655|Pulmonary Rehabilitation|pulmonary rehabilitation
5039862|NCT03749655|Physical activity|physical activity
5039863|NCT03749655|Anxiety and depression|anxiety and depression
5039864|NCT03749642|Trazodone|trazodone
5039865|NCT03749642|Gabapentin|gabapentin
5039866|NCT03749642|Neuropathic pain|neuropathic pain
5039875|NCT03749564|Spinal Manipulative Therapy|spinal manipulative therapy
5039876|NCT03749564|Optimization|optimization
5039877|NCT03749512|NLCR, The neutrophil-lymphocyte count ratio, Lung Neoplasm|nlcr, the neutrophil-lymphocyte count ratio, lung neoplasm
5039878|NCT03749499|Emergency Department|emergency department
5039879|NCT03749499|Minorities|minorities
5039880|NCT03749486|Cataract surgery|cataract surgery
5039881|NCT03749486|High resolution immersion ultrasound|high resolution immersion ultrasound
5039882|NCT03749473|Physical Activity|physical activity
5039883|NCT03749473|Goal-Setting|goal-setting
5039884|NCT03749473|Gamification|gamification
5348221|NCT01957748|Care|care
5039885|NCT03749460|Metastatic Malignant Neoplasm in the Bone|metastatic malignant neoplasm in the bone
5039886|NCT03749460|Metastatic Malignant Neoplasm in the Lung|metastatic malignant neoplasm in the lung
5039887|NCT03749460|Salivary Gland Carcinoma|salivary gland carcinoma
5039888|NCT03749460|Stage IV Major Salivary Gland Cancer AJCC v8|stage iv major salivary gland cancer ajcc v8
5039889|NCT03749460|Stage IVA Major Salivary Gland Cancer AJCC v8|stage iva major salivary gland cancer ajcc v8
5039890|NCT03749460|Stage IVB Major Salivary Gland Cancer AJCC v8|stage ivb major salivary gland cancer ajcc v8
5039891|NCT03749460|Stage IVC Major Salivary Gland Cancer AJCC v8|stage ivc major salivary gland cancer ajcc v8
5039892|NCT03749447|Bardoxolone methyl|bardoxolone methyl
5039893|NCT03749447|CDDO-ME|cddo-me
5039894|NCT03749447|RTA 402|rta 402
5039895|NCT03749447|Alport Syndrome|alport syndrome
5039896|NCT03749434|Infections|infections
5039897|NCT03749434|Ventricular Assist Device Therapy|ventricular assist device therapy
5039898|NCT03749421|Breast Cancer|breast cancer
5039899|NCT03749408|inferior alveolar nerve block|inferior alveolar nerve block
5039997|NCT03748784|ADVM-022-01|advm-022-01
5039903|NCT03749408|symptomatic irreversible pulpitits|symptomatic irreversible pulpitits
5039904|NCT03749382|Smoking|smoking
5039905|NCT03749382|Tobacco|tobacco
5039906|NCT03749382|Cessation|cessation
5039907|NCT03749382|Intervention|intervention
5039908|NCT03749343|T1 mapping|t1 mapping
5039909|NCT03749343|native T1|native t1
5039910|NCT03749343|native T2|native t2
5039911|NCT03749343|accuracy|accuracy
5039912|NCT03749343|prognosis|prognosis
5039913|NCT03749330|cardiac intensive care unit|cardiac intensive care unit
5039914|NCT03749330|pediatrics|pediatrics
5039915|NCT03749330|medical communication|medical communication
5039916|NCT03749317|IVIEW-1201|iview-1201
5039917|NCT03749317|Adenoviral Conjunctivitis|adenoviral conjunctivitis
5039918|NCT03749291|Childhood Obesity|childhood obesity
5039919|NCT03749291|Motivational therapy|motivational therapy
5039920|NCT03749291|Dietary Patterns|dietary patterns
5039921|NCT03749291|Cardiovascular disease risk|cardiovascular disease risk
5039922|NCT03749278|Mental Health|mental health
5039923|NCT03749278|Minority Health|minority health
5039924|NCT03749278|Latina|latina
5039925|NCT03749265|Peroneus Tertius Muscle|peroneus tertius muscle
5039926|NCT03749226|Nebulized antibiotic|nebulized antibiotic
5039927|NCT03749226|Ventilator associated pneumonia|ventilator associated pneumonia
5039928|NCT03749226|Ventilated associated tracheobronchitis|ventilated associated tracheobronchitis
5039929|NCT03749226|Aztreonam lysine|aztreonam lysine
5039930|NCT03749200|Childhood Obesity|childhood obesity
5039937|NCT03749161|Low-add intraocular lens|low-add intraocular lens
5039938|NCT03749148|hives|hives
5039939|NCT03749148|itch|itch
5039941|NCT03749135|hives|hives
5039942|NCT03749135|itch|itch
5039943|NCT03749109|Endometrioma|endometrioma
5039944|NCT03749109|Adenomyosis|adenomyosis
5039945|NCT03749109|Deep infiltrating endometriosis|deep infiltrating endometriosis
5039946|NCT03749096|IVIG|ivig
5039947|NCT03749096|stiff-person syndrome|stiff-person syndrome
5039948|NCT03749096|SPS|sps
5039949|NCT03749096|glycine receptor antibody|glycine receptor antibody
5039950|NCT03749096|intravenous immunoglobulin|intravenous immunoglobulin
5039951|NCT03749096|GlyRα1|glyrα1
5039952|NCT03749083|Gastrointestinal Malignancies|gastrointestinal malignancies
5039953|NCT03749070|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5039954|NCT03749070|sylimarin|sylimarin
5039955|NCT03749057|rivaroxaban|rivaroxaban
5039959|NCT03749005|Pancreatic Cancer|pancreatic cancer
5039960|NCT03749005|Three-dimensional Visualization|three-dimensional visualization
5039962|NCT03748966|calcitriol|calcitriol
5039963|NCT03748966|x-linked hypophosphatemia|x-linked hypophosphatemia
5039965|NCT03748966|1,25 dihydroxyvitamin D|1,25 dihydroxyvitamin d
5039966|NCT03748966|bone disorder|bone disorder
5039967|NCT03748966|rare bone disease|rare bone disease
5039968|NCT03748966|vitamin D|vitamin d
5039969|NCT03748966|hypophosphatemic rickets|hypophosphatemic rickets
5039970|NCT03748953|Drug Therapy|drug therapy
5039971|NCT03748927|Clinical Outcome|clinical outcome
5039972|NCT03748927|Advice in the Management of Cancer|advice in the management of cancer
5039973|NCT03748927|Patterns of Disease Progression|patterns of disease progression
5039974|NCT03748927|Response or Lack of Response to Therapeutic Interventions|response or lack of response to therapeutic interventions
5039975|NCT03748888|Cardiovascular system|cardiovascular system
5039976|NCT03748888|Antenatal physical activity|antenatal physical activity
5039977|NCT03748888|Maternal heart rate|maternal heart rate
5039978|NCT03748888|Foetal heart rate|foetal heart rate
5039979|NCT03748875|Mindfulness-based relapse prevention|mindfulness-based relapse prevention
5039980|NCT03748875|methamphetamine|methamphetamine
5039981|NCT03748875|Prefrontal-striatal circuit|prefrontal-striatal circuit
5039982|NCT03748875|impulsive|impulsive
5039983|NCT03748875|mechanism|mechanism
5039984|NCT03748862|Opioids|opioids
5039985|NCT03748862|Chronic Pain|chronic pain
5039986|NCT03748862|Opioid Therapy|opioid therapy
5039987|NCT03748862|Opioid Taper|opioid taper
5039988|NCT03748836|Healthy Volunteers|healthy volunteers
5039989|NCT03748810|Empagliflozin|empagliflozin
5039990|NCT03748810|Dapagliflozin|dapagliflozin
5039991|NCT03748810|Sodium-glucose cotransporter 2 inhibitors|sodium-glucose cotransporter 2 inhibitors
5039992|NCT03748810|Quadruple combination antidiabetic drugs|quadruple combination antidiabetic drugs
5039993|NCT03748797|HIV, exercise, aging, physical health, quality of life|hiv, exercise, aging, physical health, quality of life
5039994|NCT03748784|Choroidal Neovascularizatio|choroidal neovascularizatio
5039995|NCT03748784|ADVM-022|advm-022
5039996|NCT03748784|CNV|cnv
5040015|NCT03748732|uveal effusion|uveal effusion
5040016|NCT03748719|High Risk Prostate Cancer|high risk prostate cancer
5040017|NCT03748719|prostate|prostate
5040018|NCT03748719|radiation therapy|radiation therapy
5040019|NCT03748667|Endoscopy|endoscopy
5040020|NCT03748667|Colonoscopy|colonoscopy
5040021|NCT03748667|Invasive pattern|invasive pattern
5040022|NCT03748667|Polypectomy|polypectomy
5040023|NCT03748667|NBI|nbi
5040024|NCT03748667|BLI|bli
5040025|NCT03748667|Deep submucosal invasion|deep submucosal invasion
5040026|NCT03748667|JNET|jnet
5040027|NCT03748667|Kudo pit pattern|kudo pit pattern
5040028|NCT03748628|AME Study|ame study
5040029|NCT03748602|thoracic outlet decompression (TOD)|thoracic outlet decompression (tod)
5040030|NCT03748589|i-gel|i-gel
5040031|NCT03748589|pediatric|pediatric
5040032|NCT03748589|laryngeal mask airway|laryngeal mask airway
5040033|NCT03748589|children|children
5040034|NCT03748563|Capsule Endoscopy|capsule endoscopy
5040035|NCT03748563|Portal Hypertension|portal hypertension
5040036|NCT03748563|Cirrhosis|cirrhosis
5040037|NCT03748550|Anthracyclines|anthracyclines
5040038|NCT03748550|Cardiotoxic|cardiotoxic
5040039|NCT03748550|Breast cancer|breast cancer
5040040|NCT03748550|Aerobic exercise|aerobic exercise
5040041|NCT03748550|Cardiac structure|cardiac structure
5040042|NCT03748550|Cardiac function|cardiac function
5040043|NCT03748550|CVD risk|cvd risk
5040044|NCT03748524|Influenza, B cells, Antibodies, Vaccination|influenza, b cells, antibodies, vaccination
5040045|NCT03748498|laser|laser
5040046|NCT03748498|pulpitis|pulpitis
5040049|NCT03748485|adjuvant chemotherapy|adjuvant chemotherapy
5040065|NCT03748433|Real time continuous glucose monitoring|real time continuous glucose monitoring
5040066|NCT03748433|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5040067|NCT03748433|self monitoring blood glucose|self monitoring blood glucose
5040068|NCT03748433|sensor augmented pump|sensor augmented pump
5040069|NCT03748433|severe hypoglycaemia|severe hypoglycaemia
5040070|NCT03748433|hypounaware|hypounaware
5040071|NCT03748420|Decision Support Systems, Clinical|decision support systems, clinical
5040072|NCT03748420|Cardiovascular Diseases|cardiovascular diseases
5040073|NCT03748420|Cardiovascular Risk Factor|cardiovascular risk factor
5040074|NCT03748420|Medication Non-adherence|medication non-adherence
5726498|NCT00408759|dry mouth|dry mouth
5040075|NCT03748394|Work capacity evaluation|work capacity evaluation
5040076|NCT03748394|Common mental disorders|common mental disorders
5040077|NCT03748394|Occupational therapy|occupational therapy
5040078|NCT03748394|Physical Therapy Modalities|physical therapy modalities
5040079|NCT03748381|Cataract surgery|cataract surgery
5040080|NCT03748381|Trifocal IOL|trifocal iol
5040081|NCT03748368|Cataract surgery|cataract surgery
5040082|NCT03748368|Informed Consent Process|informed consent process
5040083|NCT03748355|Polypharmacy|polypharmacy
5040084|NCT03748303|Alzheimer's disease|alzheimer's disease
5040085|NCT03748303|Mild cognitive impairment|mild cognitive impairment
5040086|NCT03748303|Dementia|dementia
5040087|NCT03748303|Regenerative therapeutic|regenerative therapeutic
5040088|NCT03748303|Drug development|drug development
5040089|NCT03748277|intraoperative procedures|intraoperative procedures
5040090|NCT03748251|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5040092|NCT03748251|postprandial glucose|postprandial glucose
5040093|NCT03748251|postprandial hypoglycemia|postprandial hypoglycemia
5040094|NCT03748251|postprandial hyperglycemia|postprandial hyperglycemia
5040118|NCT03748082|Cardiac Surgery|cardiac surgery
5040119|NCT03748082|Cardiopulmonary Bypass|cardiopulmonary bypass
5040120|NCT03748082|Reactive Hyperemia Index|reactive hyperemia index
5040121|NCT03748082|Nitric Oxide|nitric oxide
5040122|NCT03748069|Influenza|influenza
5040124|NCT03748069|ICU|icu
5040125|NCT03748069|Immunology|immunology
5040126|NCT03748004|Homeless|homeless
5040127|NCT03748004|Employment|employment
5040128|NCT03747991|Infant GERD|infant gerd
5040129|NCT03747991|H2RA medication|h2ra medication
5040130|NCT03747978|diabetes|diabetes
5040131|NCT03747978|hypertension|hypertension
5040132|NCT03747978|blacks|blacks
5040133|NCT03747978|Africa|africa
5040134|NCT03747978|ACE inhibitor|ace inhibitor
5040135|NCT03747978|Calcium channel blocker|calcium channel blocker
5040136|NCT03747978|Diuretic|diuretic
5040137|NCT03747952|Tibiotalocalcaneal arthrodesis|tibiotalocalcaneal arthrodesis
5040138|NCT03747952|Intramedullary Nail|intramedullary nail
5040139|NCT03747952|Sustained Compression|sustained compression
5040146|NCT03747900|Needling, botulinum, toxin, spasticity, stroke|needling, botulinum, toxin, spasticity, stroke
5040150|NCT03747848|fatigue|fatigue
5040151|NCT03747848|cognitive behavioral therapy|cognitive behavioral therapy
5040152|NCT03747809|Remote Monitoring|remote monitoring
5040153|NCT03747783|Survival|survival
5040154|NCT03747783|Nomograms|nomograms
5040155|NCT03747783|Laryngeal cancer|laryngeal cancer
5040156|NCT03747770|CERVARIX|cervarix
5040157|NCT03747770|Urine|urine
5040158|NCT03747770|DNA PCR|dna pcr
5040159|NCT03747770|HPV infection|hpv infection
5040160|NCT03747770|HPV genotyping|hpv genotyping
5040161|NCT03747770|Effectiveness|effectiveness
5040162|NCT03747731|Renal blood perfusion|renal blood perfusion
5040163|NCT03747731|Mechanical ventilation|mechanical ventilation
5040164|NCT03747718|Crohn's|crohn's
5040165|NCT03747718|Pediatric|pediatric
5040166|NCT03747718|IBD|ibd
5040167|NCT03747718|Fecal|fecal
5040168|NCT03747692|intracervical anasthesia , outpatient hystroscopy ,|intracervical anasthesia , outpatient hystroscopy ,
5040169|NCT03747679|CML; palatability; taste; pediatric formulation|cml; palatability; taste; pediatric formulation
5040170|NCT03747653|Hemophilia A|hemophilia a
5040171|NCT03747653|Pharmacokinetics|pharmacokinetics
5040172|NCT03747653|Factor VIII-Fc Fusion Protein|factor viii-fc fusion protein
5040173|NCT03747653|Adolescent and Adult Patients|adolescent and adult patients
5040174|NCT03747653|Phase I|phase i
5040175|NCT03747653|Safety and Tolerability|safety and tolerability
5040176|NCT03747627|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
5040177|NCT03747627|Hypersensitivity Pneumonitis|hypersensitivity pneumonitis
5040178|NCT03747627|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5040179|NCT03747627|Extrinsic Allergic Alveolitis (EAA)|extrinsic allergic alveolitis (eaa)
5040180|NCT03747627|Bird Fancier's Lung|bird fancier's lung
5040181|NCT03747627|Genetics|genetics
5040182|NCT03747588|laparoscopic pancreaticoduodenectomy|laparoscopic pancreaticoduodenectomy
5040183|NCT03747588|open pancreaticoduodenectomy|open pancreaticoduodenectomy
5040200|NCT03747484|Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8|pathologic stage iiia merkel cell carcinoma ajcc v8
5342941|NCT01981421|Liver fibrosis|liver fibrosis
5728841|NCT00399035|RECENTIN|recentin
5040201|NCT03747484|Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8|pathologic stage iiib merkel cell carcinoma ajcc v8
5040202|NCT03747484|Pathologic Stage IV Merkel Cell Carcinoma AJCC v8|pathologic stage iv merkel cell carcinoma ajcc v8
5040204|NCT03747484|Merkel cell carcinoma, unresectable|merkel cell carcinoma, unresectable
5040205|NCT03747484|Metastatic Merkel Cell Carcinoma|metastatic merkel cell carcinoma
5040206|NCT03747484|Unresectable Merkel Cell Carcinoma|unresectable merkel cell carcinoma
5040207|NCT03747471|Diabetes|diabetes
5040208|NCT03747471|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5040209|NCT03747471|Health Education|health education
5040210|NCT03747471|Conversation Map|conversation map
5040211|NCT03747471|Developing countries|developing countries
5040212|NCT03747432|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5040221|NCT03747419|Muscle Invasive Bladder Cancer|muscle invasive bladder cancer
5040222|NCT03747419|Muscle-Invasive Urothelial Carcinoma of the Bladder|muscle-invasive urothelial carcinoma of the bladder
5040223|NCT03747419|Immunotherapy|immunotherapy
5040224|NCT03747419|Avelumab|avelumab
5040225|NCT03747419|Radiation and Immunotherapy|radiation and immunotherapy
5040226|NCT03747419|No cisplatin|no cisplatin
5040227|NCT03747419|Cisplatin Ineligible|cisplatin ineligible
5040228|NCT03747419|Cisplatin-Ineligible|cisplatin-ineligible
5040229|NCT03747419|T2 Disease|t2 disease
5040230|NCT03747419|T3 Disease|t3 disease
5040231|NCT03747419|T4 Disease|t4 disease
5040232|NCT03747419|squamous bladder cancer|squamous bladder cancer
5040233|NCT03747419|adenocarcinoma bladder cancer|adenocarcinoma bladder cancer
5040234|NCT03747419|micropapillary bladder cancer|micropapillary bladder cancer
5040235|NCT03747419|Inability to receive cisplatin-based chemotherapy|inability to receive cisplatin-based chemotherapy
5040236|NCT03747393|knee osteoarthritis|knee osteoarthritis
5040237|NCT03747393|physical therapy|physical therapy
5040238|NCT03747393|clinical practice guidelines|clinical practice guidelines
5040239|NCT03747393|military service members|military service members
5040240|NCT03747393|self-management|self-management
5040241|NCT03747367|Microbiome|microbiome
5040243|NCT03747367|Sleep|sleep
5040244|NCT03747367|Circadian|circadian
5040245|NCT03747302|Adolescence|adolescence
5040246|NCT03747302|Attitudes|attitudes
5040247|NCT03747302|Parents|parents
5040248|NCT03747302|Vaccination|vaccination
5040249|NCT03747276|clinical trial|clinical trial
5040250|NCT03747276|accrual|accrual
5040255|NCT03747237|edema|edema
5040256|NCT03747237|third molar|third molar
5040262|NCT03747172|complementary alternative medicine|complementary alternative medicine
5040263|NCT03747172|cancer|cancer
5040264|NCT03747172|complementary alternative therapy|complementary alternative therapy
5040265|NCT03747172|hospice care|hospice care
5040266|NCT03747172|palliative care|palliative care
5040267|NCT03747159|systemic lupus erythematosus|systemic lupus erythematosus
5040268|NCT03747159|lupus nephritis|lupus nephritis
5040269|NCT03747159|systemic autoimmune disease|systemic autoimmune disease
5040270|NCT03747159|glomerulonephritis|glomerulonephritis
5040271|NCT03747159|autoimmune glomerulonephritis|autoimmune glomerulonephritis
5040272|NCT03747159|membranoproliferative glomerulonephritis|membranoproliferative glomerulonephritis
5040273|NCT03747159|renal insufficiency|renal insufficiency
5040274|NCT03747159|renal failure|renal failure
5040275|NCT03747133|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5040276|NCT03747133|SABR|sabr
5040277|NCT03747133|Radiation Therapy|radiation therapy
5040278|NCT03747133|Renal Cell Carcinoma|renal cell carcinoma
5040300|NCT03747042|invasive mammary carcinoma|invasive mammary carcinoma
5040301|NCT03746990|fluoride|fluoride
5040302|NCT03746990|mottling|mottling
5040303|NCT03746990|libya|libya
5040304|NCT03746990|fluorosis|fluorosis
5040305|NCT03746977|exercise|exercise
5040306|NCT03746977|electromyostimulation|electromyostimulation
5040307|NCT03746977|protein|protein
5040308|NCT03746977|weight reduction|weight reduction
5040309|NCT03746925|DAA|daa
5040310|NCT03746925|SuperPATH|superpath
5040311|NCT03746925|Direct Anterior Approach|direct anterior approach
5040312|NCT03746925|THA|tha
5040313|NCT03746912|Refractory or Relapsed|refractory or relapsed
5040314|NCT03746912|FLT3- internal tandem duplication (ITD) positive|flt3- internal tandem duplication (itd) positive
5040315|NCT03746912|FLT3-ITD positive refractory or relapsed acute myeloid leukemia|flt3-itd positive refractory or relapsed acute myeloid leukemia
5040316|NCT03746899|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5040317|NCT03746886|breast milk|breast milk
5040318|NCT03746886|lipids|lipids
5040319|NCT03746886|bioactive compounds|bioactive compounds
5040320|NCT03746886|infant formula|infant formula
5040333|NCT03746795|electrical impedance tomography|electrical impedance tomography
5040334|NCT03746795|spirometric examination|spirometric examination
5040335|NCT03746795|bioimpedance|bioimpedance
5040336|NCT03746795|FVC|fvc
5040337|NCT03746795|FEV1|fev1
5040338|NCT03746795|Tiffeneau index|tiffeneau index
5040339|NCT03746782|Dual Anti-Platelet Therapy|dual anti-platelet therapy
5040346|NCT03746678|Cesarean delivery|cesarean delivery
5040347|NCT03746678|Perioperative medicine|perioperative medicine
5040348|NCT03746678|Mobile health|mobile health
5040349|NCT03746665|Men A|men a
5040350|NCT03746665|Maternal|maternal
5040351|NCT03746665|Systems Immunology|systems immunology
5040352|NCT03746665|Vaccination|vaccination
5040353|NCT03746652|Second line treatment; Daratumumab; Ixazomib; Dexamethasone;|second line treatment; daratumumab; ixazomib; dexamethasone;
5040354|NCT03746639|Chronic Pain|chronic pain
5040355|NCT03746639|physiotherapy|physiotherapy
5040356|NCT03746639|renal function|renal function
5040357|NCT03746626|Spiritual care|spiritual care
5040358|NCT03746626|Palliative care|palliative care
5040359|NCT03746626|Chaplain|chaplain
5040360|NCT03746626|Day care|day care
5040361|NCT03746613|robot|robot
5040362|NCT03746613|Image guidance|image guidance
5040363|NCT03746613|Cochlear implantation|cochlear implantation
5040364|NCT03746613|navigation|navigation
5040365|NCT03746613|HEARO procedure|hearo procedure
5040366|NCT03746613|sensorineural hearing loss|sensorineural hearing loss
5040367|NCT03746613|inner ear access|inner ear access
5040368|NCT03746600|HIV/AIDS|hiv/aids
5040369|NCT03746600|Alcohol Drinking|alcohol drinking
5040370|NCT03746600|Medication Adherence|medication adherence
5040371|NCT03746587|Gaucher Disease|gaucher disease
5040376|NCT03746509|Dystonia|dystonia
5040377|NCT03746509|Spasmodic dysphonia|spasmodic dysphonia
5040378|NCT03746509|Laryngeal dystonia|laryngeal dystonia
5040379|NCT03746496|intraosseous|intraosseous
5040380|NCT03746496|blood gas analysis|blood gas analysis
5040381|NCT03746496|emergency medicine|emergency medicine
5040382|NCT03746496|critically ill|critically ill
5040383|NCT03746496|point-of-care|point-of-care
5040401|NCT03746379|sensory processing|sensory processing
5040402|NCT03746379|fybromyalgia|fybromyalgia
5040403|NCT03746340|sevoflurane|sevoflurane
5040404|NCT03746340|propofol|propofol
5040405|NCT03746340|Folic Acid|folic acid
5040406|NCT03746314|Caregivers|caregivers
5040407|NCT03746314|Oncology|oncology
5040408|NCT03746314|Cancer|cancer
5040409|NCT03746301|Non-valvular Atrial fibrillation (NVAF), Stroke; Non-Central Nervous Systemic (CNS) embolism|non-valvular atrial fibrillation (nvaf), stroke; non-central nervous systemic (cns) embolism
5040410|NCT03746275|Coronary artery disease (CAD)|coronary artery disease (cad)
5040411|NCT03746275|Peripheral artery disease (PAD)|peripheral artery disease (pad)
5040412|NCT03746275|Major adverse limb events (MALE)|major adverse limb events (male)
5040413|NCT03746275|Major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5040414|NCT03746275|Atherosclerosis|atherosclerosis
5040415|NCT03746275|Atherothrombosis|atherothrombosis
5040416|NCT03746275|Thrombosis|thrombosis
5040419|NCT03746262|Non-Metastatic Non-Small Cell Lung Cancer|non-metastatic non-small cell lung cancer
5040421|NCT03746262|Lung Cancer|lung cancer
5040422|NCT03746262|circulating tumor-specific DNA (ctDNA)|circulating tumor-specific dna (ctdna)
5040423|NCT03746262|non-invasive diagnostic|non-invasive diagnostic
5040424|NCT03746249|Hepatocellular Carcinoma|hepatocellular carcinoma
5040425|NCT03746249|Lenvatinib|lenvatinib
5040426|NCT03746249|PD-1 Antibody|pd-1 antibody
5040427|NCT03746223|intravitreal methotrexate injection|intravitreal methotrexate injection
5040428|NCT03746223|rituximab|rituximab
5040429|NCT03746223|lenalidomide|lenalidomide
5040430|NCT03746223|Primary vitreoretinal lymphoma|primary vitreoretinal lymphoma
5040431|NCT03746197|Lupus|lupus
5040433|NCT03746197|Cognition|cognition
5040434|NCT03746197|Cognitive Assessment|cognitive assessment
5040435|NCT03746197|Videogames|videogames
5040436|NCT03746184|precision medicine|precision medicine
5040437|NCT03746184|Patient-Specific Modeling|patient-specific modeling
5040438|NCT03746145|probiotics|probiotics
5040439|NCT03746145|microbiota|microbiota
5040440|NCT03746145|gastrointestinal|gastrointestinal
5040441|NCT03746145|immune system|immune system
5040442|NCT03746145|immunology|immunology
5040443|NCT03746145|stress|stress
5040444|NCT03746145|Bifidobacterium|bifidobacterium
5040445|NCT03746145|hypoxia|hypoxia
5040446|NCT03746145|confinement|confinement
5040447|NCT03746145|isolation|isolation
5040448|NCT03746132|Vascular|vascular
5040449|NCT03746132|Surgery|surgery
5040450|NCT03746132|groin|groin
5040451|NCT03746132|incision|incision
5040452|NCT03746132|oxygen|oxygen
5040453|NCT03746132|infection|infection
5040454|NCT03746132|wound healing|wound healing
5040455|NCT03746132|Transdermal Continuos|transdermal continuos
5040456|NCT03746119|Nicotine|nicotine
5040457|NCT03746119|Electronic cigarette|electronic cigarette
5040458|NCT03746119|E-cigarrette|e-cigarrette
5040459|NCT03746119|Forearm Plethysmography|forearm plethysmography
5040460|NCT03746106|Drug-induced vitamin deficiency|drug-induced vitamin deficiency
5040461|NCT03746067|TS-134, CSF|ts-134, csf
5040462|NCT03746054|Blood|blood
5040463|NCT03746054|Chronic Myeloid Leukemia|chronic myeloid leukemia
5040464|NCT03746054|Vascular medicine|vascular medicine
5040474|NCT03746015|Vaccine|vaccine
5040475|NCT03746002|diuretic|diuretic
5040476|NCT03746002|metolazone|metolazone
5040477|NCT03746002|furosemide|furosemide
5040478|NCT03745989|advanced/metastatic|advanced/metastatic
5040479|NCT03745989|solid tumors|solid tumors
5040480|NCT03745989|Selumetinib|selumetinib
5040481|NCT03745976|follow-up|follow-up
5040482|NCT03745976|total knee arthroplasty|total knee arthroplasty
5040483|NCT03745976|total hip arthroplasty|total hip arthroplasty
5040484|NCT03745963|Neonate|neonate
5040485|NCT03745963|Pain|pain
5040486|NCT03745963|Sucrose|sucrose
5040487|NCT03745963|Skin-to-skin contact|skin-to-skin contact
5040490|NCT03745963|RCT|rct
5040491|NCT03745963|Bio behavioural|bio behavioural
5040492|NCT03745950|Maintenance therapy|maintenance therapy
5040493|NCT03745950|Olaparib|olaparib
5040494|NCT03745950|Randomized, double blinded|randomized, double blinded
5040495|NCT03745950|P53 and MMR Immunohistochemistry|p53 and mmr immunohistochemistry
5040496|NCT03745950|Phase II|phase ii
5040497|NCT03745950|progression-free survival|progression-free survival
5040498|NCT03745937|MEDI0382, diabetes, obesity, overweight, type 2 diabetes mellitus|medi0382, diabetes, obesity, overweight, type 2 diabetes mellitus
5040499|NCT03745911|Urothelial carcinoma|urothelial carcinoma
5040500|NCT03745872|Sunscreen|sunscreen
5040501|NCT03745872|Sun Exposure|sun exposure
5040502|NCT03745872|Behaviors|behaviors
5040503|NCT03745872|Baseline Assessments|baseline assessments
5040504|NCT03745872|Follow-up Assessments|follow-up assessments
5040505|NCT03745872|Knowledge|knowledge
5040506|NCT03745859|Bronchoscopy|bronchoscopy
5040507|NCT03745859|Navigation|navigation
5040508|NCT03745859|Feasibility Studies|feasibility studies
5040509|NCT03745768|depression|depression
5040510|NCT03745768|executive dysfunction|executive dysfunction
5040511|NCT03745768|transcranial magnetic stimulation|transcranial magnetic stimulation
5040512|NCT03745768|intermittent theta burst stimulation|intermittent theta burst stimulation
5040513|NCT03745768|neuromodulation|neuromodulation
5040514|NCT03745768|older adults|older adults
5040515|NCT03745768|geriatrics|geriatrics
5040516|NCT03745755|elderly|elderly
5040517|NCT03745755|clinical decision rule|clinical decision rule
5040518|NCT03745755|emergency department|emergency department
5040519|NCT03745755|CT scan|ct scan
5040520|NCT03745755|bleeding|bleeding
5040521|NCT03745742|Cardiac rehabilitation|cardiac rehabilitation
5040522|NCT03745742|myocardial infarction|myocardial infarction
5040523|NCT03745742|heart rate variability|heart rate variability
5040524|NCT03745742|physical fitness|physical fitness
5040525|NCT03745664|corticosteroids|corticosteroids
5040526|NCT03745651|Atopic dermatitis|atopic dermatitis
5040527|NCT03745651|pruritus|pruritus
5040537|NCT03745599|Analgesics|analgesics
5040538|NCT03745599|Non steroid anti-inflammatory drugs|non steroid anti-inflammatory drugs
5040539|NCT03745599|Benzydamine|benzydamine
5040540|NCT03745599|Quality of life|quality of life
5040541|NCT03745573|corporal punishment, teacher violence, school violence, sexual violence|corporal punishment, teacher violence, school violence, sexual violence
5040542|NCT03745560|Cochlear implant|cochlear implant
5040544|NCT03745469|Smartphone|smartphone
5040546|NCT03745469|proprioception|proprioception
5040547|NCT03745469|Deep cervical fatigue|deep cervical fatigue
5040548|NCT03745469|neck pain|neck pain
5040549|NCT03745456|Rotational Thromboelstrometry|rotational thromboelstrometry
5040550|NCT03745417|Psoriasis|psoriasis
5040551|NCT03745417|Umbilical cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5040552|NCT03745404|Post herpetic neuralgia|post herpetic neuralgia
5040553|NCT03745404|Lidocaine|lidocaine
5040554|NCT03745404|Herpes zoster|herpes zoster
5040555|NCT03745378|Myeloproliferative neoplasms|myeloproliferative neoplasms
5040556|NCT03745378|Secondary cancer|secondary cancer
5040557|NCT03745378|JAK2V617F mutation|jak2v617f mutation
5040558|NCT03745339|Addiction|addiction
5040559|NCT03745339|Orbitofrontal Cortex|orbitofrontal cortex
5040560|NCT03745339|Associative Learning|associative learning
5040561|NCT03745339|Implicit Learning|implicit learning
5040562|NCT03745326|Immunotherapy|immunotherapy
5040563|NCT03745326|Cell Therapy|cell therapy
5040564|NCT03745326|KRAS|kras
5040565|NCT03745326|HRAS|hras
5040566|NCT03745326|NRAS|nras
5040567|NCT03745313|Functional|functional
5040568|NCT03745313|TR|tr
5040569|NCT03745313|FTR|ftr
5040570|NCT03745313|Transcatheter|transcatheter
5040571|NCT03745313|Repair|repair
5040572|NCT03745313|Regurgitation|regurgitation
5040573|NCT03745313|Degenerative|degenerative
5040574|NCT03745261|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5040575|NCT03745261|mild, moderate, severe|mild, moderate, severe
5040576|NCT03745261|Medicine, Chinese Traditional|medicine, chinese traditional
5040577|NCT03745261|Cordyceps sinensis|cordyceps sinensis
5040578|NCT03745248|Degenerative cerebellar disease|degenerative cerebellar disease
5040579|NCT03745248|Ataxia|ataxia
5040580|NCT03745248|Aerobic Exercise|aerobic exercise
5040581|NCT03745222|Locally Advanced, Unresectable Non-Small Cell Lung Cancer|locally advanced, unresectable non-small cell lung cancer
5040582|NCT03745222|Non-Small Cell Lung Cancer|non-small cell lung cancer
5040583|NCT03745222|NSCLC|nsclc
5040584|NCT03745222|Randomized|randomized
5040585|NCT03745222|BGB-A317|bgb-a317
5040586|NCT03745222|Tislelizumab|tislelizumab
5040587|NCT03745222|PD-1|pd-1
5040592|NCT03745183|Senna alata|senna alata
5040593|NCT03745144|Multiple Sclerosis|multiple sclerosis
5040594|NCT03745144|Cladribine|cladribine
5040595|NCT03745144|Microgynon®|microgynon®
5040596|NCT03745131|Immunisation|immunisation
5040597|NCT03745131|Modified Vaccinia Ankara|modified vaccinia ankara
5040598|NCT03745131|Imvanex|imvanex
5040599|NCT03745131|Imvamune|imvamune
5040600|NCT03745131|Vaccine|vaccine
5040601|NCT03745118|Seizure|seizure
5040602|NCT03745092|normobaric oxygen|normobaric oxygen
5040603|NCT03745092|chronic cerebral ischemia|chronic cerebral ischemia
5040604|NCT03745066|coronary artery disease|coronary artery disease
5040605|NCT03745027|in vitro fertilization|in vitro fertilization
5040606|NCT03745027|sialic acid|sialic acid
5040607|NCT03744949|Tracheal intubation|tracheal intubation
5040608|NCT03744949|Remifentanil|remifentanil
5040609|NCT03744949|Pain|pain
5040610|NCT03744949|NOL index|nol index
5040611|NCT03744949|Anesthesia|anesthesia
5040612|NCT03744949|Analgesia|analgesia
5040615|NCT03744897|pain perception|pain perception
5040616|NCT03744897|tDCS|tdcs
5040617|NCT03744897|Hypnosis|hypnosis
5040618|NCT03744897|cortical activity|cortical activity
5040619|NCT03744884|Virtual reality|virtual reality
5040620|NCT03744884|Haptic feedback|haptic feedback
5040621|NCT03744884|Robotic|robotic
5040622|NCT03744858|chronic vein disease|chronic vein disease
5040623|NCT03744858|inflammation|inflammation
5040624|NCT03744858|pyroptosis|pyroptosis
5040625|NCT03744845|Pain|pain
5040626|NCT03744845|Anxiety|anxiety
5040627|NCT03744845|Intraoperative Care|intraoperative care
5040628|NCT03744832|Pediatrics|pediatrics
5040633|NCT03744754|Endometriosis|endometriosis
5040634|NCT03744754|Endometriomas|endometriomas
5040635|NCT03744754|Ovarian stimulation|ovarian stimulation
5040636|NCT03744754|Oocyte vitrification|oocyte vitrification
5040637|NCT03744741|Acute Infections|acute infections
5040638|NCT03744741|Host response|host response
5040639|NCT03744741|mRNA|mrna
5040640|NCT03744741|diagnosis|diagnosis
5040641|NCT03744741|prognosis|prognosis
5040642|NCT03744741|procalcitonin|procalcitonin
5040643|NCT03744741|c-reactive protein|c-reactive protein
5040644|NCT03744741|molecular respiratory panel|molecular respiratory panel
5040645|NCT03744741|adults|adults
5040646|NCT03744715|EGFR|egfr
5040647|NCT03744715|HER2|her2
5040648|NCT03744715|Exon 20 insertion mutation|exon 20 insertion mutation
5040649|NCT03744715|Poziotinib|poziotinib
5040650|NCT03744702|vasoplegia|vasoplegia
5040651|NCT03744702|cardiac surgery|cardiac surgery
5040652|NCT03744702|ascorbic acid|ascorbic acid
5040653|NCT03744689|Lomber disc hernia|lomber disc hernia
5040654|NCT03744689|Erector spinae plane block|erector spinae plane block
5040655|NCT03744689|Postoperative pain|postoperative pain
5040656|NCT03744676|Lisocabtagene maraleucel|lisocabtagene maraleucel
5040657|NCT03744676|liso-cel|liso-cel
5040658|NCT03744676|JCAR017|jcar017
5040659|NCT03744676|relapse|relapse
5040660|NCT03744676|refractory|refractory
5040661|NCT03744676|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
5040663|NCT03744676|chimeric antigen receptor|chimeric antigen receptor
5040664|NCT03744676|CAR|car
5040665|NCT03744676|CAR T cell|car t cell
5040666|NCT03744676|autologous T cell therapy|autologous t cell therapy
5040667|NCT03744676|immunotherapy|immunotherapy
5040668|NCT03744676|cell therapy|cell therapy
5040669|NCT03744676|B-cell malignancies|b-cell malignancies
5040670|NCT03744663|opioid|opioid
5040671|NCT03744663|Opioid Agonist Treatment|opioid agonist treatment
5040672|NCT03744663|buprenorphine|buprenorphine
5040673|NCT03744663|substance abuse|substance abuse
5040674|NCT03744663|drug|drug
5040675|NCT03744663|abstinence|abstinence
5040676|NCT03744650|Pirmary prevention|pirmary prevention
5040677|NCT03744650|Coronary Heart Disease|coronary heart disease
5040678|NCT03744650|mHealth|mhealth
5040679|NCT03744624|3D printing|3d printing
5040680|NCT03744624|Liver cancer|liver cancer
5040681|NCT03744624|Laparoscopic surgery|laparoscopic surgery
5040682|NCT03744611|Cortex Eucommiae (CE: Eucommia ulmoides Oliver extract), mild OA|cortex eucommiae (ce: eucommia ulmoides oliver extract), mild oa
5040685|NCT03744546|Expanded Access, Pre-approval Access, Compassionate Use, Special Access Program, Named Patient Basis, Special Access Scheme.|expanded access, pre-approval access, compassionate use, special access program, named patient basis, special access scheme.
5040686|NCT03744533|head-down position|head-down position
5040687|NCT03744533|Large Artery Atherosclerosis|large artery atherosclerosis
5040688|NCT03744520|regional anesthesia|regional anesthesia
5040993|NCT03742700|e-cigarette|e-cigarette
5040693|NCT03744507|Endometriosis|endometriosis
5040694|NCT03744494|orchidectomy|orchidectomy
5040695|NCT03744494|pseudotesticle|pseudotesticle
5040696|NCT03744442|CALM Therapy|calm therapy
5040697|NCT03744442|Dignity Therapy|dignity therapy
5040698|NCT03744442|Mindfulness-based intervention|mindfulness-based intervention
5040699|NCT03744442|Personalized Modular Intervention|personalized modular intervention
5040700|NCT03744429|Breast Milk|breast milk
5040701|NCT03744429|Mediterranean Diet|mediterranean diet
5040707|NCT03744364|Dinoprostone|dinoprostone
5040708|NCT03744364|Misoprostol|misoprostol
5040709|NCT03744351|Follicular helper T cells|follicular helper t cells
5040710|NCT03744351|B cells|b cells
5040711|NCT03744351|Differentiation|differentiation
5040712|NCT03744325|Food allergy|food allergy
5040713|NCT03744325|Hen's egg allergy|hen's egg allergy
5040714|NCT03744325|Desensitization|desensitization
5040715|NCT03744325|Oral immunotherapy (OIT)|oral immunotherapy (oit)
5040716|NCT03744325|Systems biology|systems biology
5040717|NCT03744312|Inflammation|inflammation
5040718|NCT03744312|PET scans|pet scans
5040719|NCT03744299|acupuncture|acupuncture
5040720|NCT03744299|surveys and questionnaires|surveys and questionnaires
5040721|NCT03744299|patient|patient
5040722|NCT03744299|caregiver|caregiver
5040723|NCT03744260|Lower back pain|lower back pain
5040724|NCT03744260|Radiofrequency ablation|radiofrequency ablation
5040725|NCT03744260|Spine|spine
5040726|NCT03744247|Hepatocellular Carcinoma|hepatocellular carcinoma
5040727|NCT03744247|Lenvatinib|lenvatinib
5040728|NCT03744247|PD-1 Antibody|pd-1 antibody
5040729|NCT03744234|PRP|prp
5040730|NCT03744234|Platelet-Rich Plasma|platelet-rich plasma
5040731|NCT03744234|Sacroiliac Joint Pain|sacroiliac joint pain
5040732|NCT03744234|SIJ Pain|sij pain
5040733|NCT03744234|Osteoarthritis|osteoarthritis
5041921|NCT03737305|TMJ|tmj
5040740|NCT03744195|Kinesotaping|kinesotaping
5040741|NCT03744143|Vaginal endometriosis|vaginal endometriosis
5040742|NCT03744143|Deep infiltrating endometriosis|deep infiltrating endometriosis
5040743|NCT03744130|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
5040744|NCT03744130|Inflammatory Bowel Disease|inflammatory bowel disease
5040745|NCT03744130|CD|cd
5040746|NCT03744130|UC|uc
5040747|NCT03744130|SonoVue|sonovue
5040748|NCT03744130|Endoscopic activity|endoscopic activity
5040749|NCT03744117|dialysis|dialysis
5040750|NCT03744117|end-stage kidney disease|end-stage kidney disease
5040751|NCT03744117|supportive care|supportive care
5040752|NCT03744117|palliative care|palliative care
5040753|NCT03744117|rural health|rural health
5040754|NCT03744091|cannabis|cannabis
5040755|NCT03744065|nerve block|nerve block
5040756|NCT03744065|fascia iliaca|fascia iliaca
5040757|NCT03744065|hip replacement|hip replacement
5040758|NCT03744065|lumbar plexus|lumbar plexus
5040759|NCT03744026|Recurrent Glioblastoma|recurrent glioblastoma
5040760|NCT03744026|Carboplatin|carboplatin
5040761|NCT03744026|Ultrasound|ultrasound
5040762|NCT03744026|Blood-brain barrier|blood-brain barrier
5040763|NCT03744026|Glioblastoma|glioblastoma
5040764|NCT03744026|SonoCloud|sonocloud
5040765|NCT03744026|Low Intensity Pulsed Ultrasound (LIPU)|low intensity pulsed ultrasound (lipu)
5040775|NCT03743961|metastatic neoplasia|metastatic neoplasia
5040776|NCT03743961|systemic therapies|systemic therapies
5040777|NCT03743948|Non Invasive Prenatal Diagnosis|non invasive prenatal diagnosis
5040778|NCT03743948|Circulating Fetal Trophoblastic Cells|circulating fetal trophoblastic cells
5040779|NCT03743948|monogenic disease|monogenic disease
5040781|NCT03743935|MRI|mri
5040782|NCT03743935|ICD|icd
5040783|NCT03743935|Sudden death|sudden death
5040784|NCT03743896|Transdermal Delivery|transdermal delivery
5040785|NCT03743896|Glucosamine|glucosamine
5040786|NCT03743896|Synovial Fluid|synovial fluid
5040787|NCT03743896|Osteoarthritis|osteoarthritis
5040788|NCT03743896|Knee|knee
5040789|NCT03743896|Human|human
5040790|NCT03743896|Arthrocentesis|arthrocentesis
5040791|NCT03743870|intraoperative hypotension|intraoperative hypotension
5040792|NCT03743870|bupivacaine|bupivacaine
5040793|NCT03743870|levobupivacaine|levobupivacaine
5040794|NCT03743870|cesarean section|cesarean section
5040795|NCT03743870|spinal anaesthesia|spinal anaesthesia
5040796|NCT03743870|intraoperative bradycardia|intraoperative bradycardia
5040797|NCT03743857|Ankle|ankle
5040798|NCT03743857|Balance|balance
5040799|NCT03743857|Manual Therapy|manual therapy
5040800|NCT03743857|Older Adult|older adult
5040801|NCT03743844|weight management|weight management
5040802|NCT03743844|compassion-focused treatment|compassion-focused treatment
5040803|NCT03743844|internalized weight bias|internalized weight bias
5040804|NCT03743844|depressive symptoms|depressive symptoms
5040805|NCT03743831|Laryngoscopy direct|laryngoscopy direct
5040806|NCT03743831|Laryngoscopy indirect by Airtraq|laryngoscopy indirect by airtraq
5040807|NCT03743831|hemodynamic changes|hemodynamic changes
5040808|NCT03743831|side effects|side effects
5040809|NCT03743805|brain|brain
5040810|NCT03743805|death|death
5040811|NCT03743805|sedative|sedative
5040812|NCT03743805|narcotic|narcotic
5040813|NCT03743792|Raspberry|raspberry
5040814|NCT03743792|Cognition|cognition
5040815|NCT03743792|Vascular function|vascular function
5040816|NCT03743779|diabetes|diabetes
5040817|NCT03743779|lifestyle|lifestyle
5040818|NCT03743779|plant-based, whole food|plant-based, whole food
5040819|NCT03743779|vegetarian|vegetarian
5040821|NCT03743779|exercise|exercise
5040822|NCT03743766|Stage IIIB|stage iiib
5040823|NCT03743766|Stage IIIC|stage iiic
5040824|NCT03743766|Stage IIID|stage iiid
5040825|NCT03743766|Stage IV|stage iv
5040826|NCT03743766|immune checkpoint blockade (ICB)|immune checkpoint blockade (icb)
5040827|NCT03743766|Lymphocyte activation gene-3 (LAG3; CD223)|lymphocyte activation gene-3 (lag3; cd223)
5040828|NCT03743766|immunotherapy|immunotherapy
5040829|NCT03743753|Patient education|patient education
5040830|NCT03743753|Satisfaction|satisfaction
5040831|NCT03743753|Anxiety|anxiety
5040832|NCT03743753|Quality of life|quality of life
5040833|NCT03743753|Implant|implant
5040834|NCT03743753|Autologous|autologous
5040835|NCT03743753|Breast reconstruction|breast reconstruction
5040836|NCT03743753|Alloplastic|alloplastic
5040837|NCT03743688|Influenza Vaccine|influenza vaccine
5040838|NCT03743688|Influenza|influenza
5040840|NCT03743675|Exercise Training|exercise training
5040841|NCT03743675|Older Adults|older adults
5040848|NCT03743662|recurrent glioblastoma|recurrent glioblastoma
5040849|NCT03743662|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5040856|NCT03743584|cardiac arrest|cardiac arrest
5040857|NCT03743584|hypothermia, therapeutic|hypothermia, therapeutic
5040858|NCT03743584|ischemia reperfusion injury|ischemia reperfusion injury
5040859|NCT03743584|Innate Immune system|innate immune system
5040860|NCT03743571|social anxiety|social anxiety
5342942|NCT01981421|Elastography|elastography
5054317|NCT03658798|Neuroprosthesis|neuroprosthesis
5040864|NCT03743558|Adeno-amygdala hypertrophy|adeno-amygdala hypertrophy
5040865|NCT03743558|Tonsillectomy|tonsillectomy
5040866|NCT03743558|Video|video
5040867|NCT03743558|Smartphone|smartphone
5040868|NCT03743558|Ventilatory polygraphy|ventilatory polygraphy
5040869|NCT03743532|smoking cessation|smoking cessation
5040870|NCT03743532|contingency management|contingency management
5040871|NCT03743532|financial incentives|financial incentives
5040872|NCT03743532|JUUL|juul
5040873|NCT03743506|Wobble board|wobble board
5040874|NCT03743506|center of pressure|center of pressure
5040875|NCT03743506|dynamic balance|dynamic balance
5040876|NCT03743506|force platform|force platform
5040877|NCT03743480|palliative care|palliative care
5040878|NCT03743480|cancer|cancer
5040879|NCT03743480|hematologic malignancies|hematologic malignancies
5040880|NCT03743467|Parkinson's disease|parkinson's disease
5040881|NCT03743467|vision|vision
5040882|NCT03743467|quality of life|quality of life
5040883|NCT03743454|physical activity level|physical activity level
5040884|NCT03743454|physical activity awareness|physical activity awareness
5040885|NCT03743441|Chronic tendinopathy|chronic tendinopathy
5040886|NCT03743441|Low-level Laser Therapy|low-level laser therapy
5040887|NCT03743441|LLLT|lllt
5040888|NCT03743441|Photobiomodulation|photobiomodulation
5040889|NCT03743441|Cryotherapy|cryotherapy
5040890|NCT03743441|Exercise therapy|exercise therapy
5040891|NCT03743441|Randomized Clinical Trial|randomized clinical trial
5040892|NCT03743441|RCT|rct
5040894|NCT03743428|apatinib,bevacizumab,FOLFIRI,colorectal cancer|apatinib,bevacizumab,folfiri,colorectal cancer
5040895|NCT03743415|psychosocial oncology|psychosocial oncology
5040896|NCT03743415|symptom management|symptom management
5040897|NCT03743402|long-term opioid therapy|long-term opioid therapy
5040898|NCT03743402|chronic pain self-management|chronic pain self-management
5040899|NCT03743402|primary care prescribing guidance|primary care prescribing guidance
5040900|NCT03743389|uniportal video-assisted thoracoscopic surgery|uniportal video-assisted thoracoscopic surgery
5040901|NCT03743389|mediastinal nodes|mediastinal nodes
5040902|NCT03743389|chest drainage|chest drainage
5040903|NCT03743389|pigtail catheter|pigtail catheter
5040905|NCT03743363|movement|movement
5040906|NCT03743363|exergaming|exergaming
5040907|NCT03743363|work performance|work performance
5040908|NCT03743337|Infant-toddler care|infant-toddler care
5040909|NCT03743337|Early child development|early child development
5040910|NCT03743337|Professional development|professional development
5040911|NCT03743324|breast reconstruction|breast reconstruction
5040912|NCT03743324|Chinese|chinese
5040913|NCT03743324|radiation|radiation
5040914|NCT03743324|timing|timing
5040915|NCT03743272|Multiparametric MRI|multiparametric mri
5040916|NCT03743272|LiverMultiScan|livermultiscan
5040917|NCT03743272|Repeatability|repeatability
5040918|NCT03743272|Reproducibility|reproducibility
5040919|NCT03743272|Liver MRI|liver mri
5040920|NCT03743259|Nonpalpable Breast Lesions|nonpalpable breast lesions
5040921|NCT03743246|Pediatric|pediatric
5040922|NCT03743246|JCAR017|jcar017
5040923|NCT03743246|CAR-T|car-t
5040924|NCT03743246|CART|cart
5040925|NCT03743246|CD19|cd19
5040926|NCT03743246|ALL|all
5040927|NCT03743246|NHL|nhl
5040928|NCT03743246|DLBCL|dlbcl
5040929|NCT03743246|BL|bl
5040930|NCT03743246|PMBCL|pmbcl
5040931|NCT03743246|Cell Therapy|cell therapy
5040932|NCT03743246|LisoCell|lisocell
5040933|NCT03743246|Young Adults|young adults
5040934|NCT03743246|Lymphoproliferative disorders|lymphoproliferative disorders
5040935|NCT03743246|Immune system diseases|immune system diseases
5040936|NCT03743246|Leukemia|leukemia
5040937|NCT03743246|Lymphoma|lymphoma
5040938|NCT03743246|lymphatic diseases|lymphatic diseases
5040939|NCT03743220|Drug Hypersensitivity Reaction|drug hypersensitivity reaction
5040940|NCT03743220|Drug Provocation Test|drug provocation test
5040941|NCT03743220|Non steroidal Anti Inflammatory drugs|non steroidal anti inflammatory drugs
5040942|NCT03743220|Reactive Doses|reactive doses
5040943|NCT03743220|Reactive Times|reactive times
5040944|NCT03743207|Prematurity|prematurity
5040945|NCT03743207|Enteral nutrition|enteral nutrition
5040968|NCT03742947|tranexamic acid|tranexamic acid
5040969|NCT03742947|post-partum haemorrhage|post-partum haemorrhage
5040971|NCT03742921|Istodax|istodax
5040972|NCT03742921|Survey|survey
5040973|NCT03742921|Relapsed or refractory|relapsed or refractory
5040974|NCT03742921|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5040975|NCT03742908|Implant-based breast reconstruction|implant-based breast reconstruction
5040976|NCT03742908|intraoperative antibiotics/antiseptics|intraoperative antibiotics/antiseptics
5040977|NCT03742908|Chinese|chinese
5040978|NCT03742882|CC-90001|cc-90001
5040979|NCT03742882|Pharmacokinetics|pharmacokinetics
5040980|NCT03742882|Hepatic Impairment|hepatic impairment
5040981|NCT03742882|Healthy subjects|healthy subjects
5040982|NCT03742791|TS-134, multiple dose, titration|ts-134, multiple dose, titration
5040983|NCT03742778|exercise|exercise
5040984|NCT03742778|Incentives|incentives
5040985|NCT03742778|reflection|reflection
5040986|NCT03742778|output|output
5040987|NCT03742765|Exercise|exercise
5040988|NCT03742765|Incentives|incentives
5040989|NCT03742765|Planning|planning
5040990|NCT03742752|enteral nutrition|enteral nutrition
5040991|NCT03742752|parenteral nutrition|parenteral nutrition
5040992|NCT03742752|gastrointestinal fistula|gastrointestinal fistula
5041004|NCT03742648|Rhonchi|rhonchi
5041005|NCT03742648|Wheeze|wheeze
5041006|NCT03742648|Crackles|crackles
5041007|NCT03742648|ISM|ism
5041008|NCT03742648|DBE|dbe
5041009|NCT03742622|appetite control|appetite control
5041010|NCT03742622|obesity|obesity
5041011|NCT03742622|Adolescents|adolescents
5041012|NCT03742622|exercise|exercise
5041013|NCT03742622|Energy replacement|energy replacement
5041014|NCT03742596|Colorectal cancer|colorectal cancer
5041015|NCT03742596|Radiotherapy|radiotherapy
5041016|NCT03742596|immune system|immune system
5041017|NCT03742596|Inflammatory markers|inflammatory markers
5041018|NCT03742596|Life quality|life quality
5041019|NCT03742570|Childhood Bladder and Bowel Dysfunction Questionnaire|childhood bladder and bowel dysfunction questionnaire
5041020|NCT03742570|Reliability|reliability
5041021|NCT03742570|Turkish|turkish
5041022|NCT03742557|Depression|depression
5041023|NCT03742557|Ketamine|ketamine
5041024|NCT03742557|Treatment-Resistant|treatment-resistant
5041025|NCT03742557|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5041026|NCT03742518|male pattern baldness|male pattern baldness
5041027|NCT03742518|SM04554|sm04554
5041028|NCT03742518|AGA|aga
5041029|NCT03742492|Omega-3 fatty acids|omega-3 fatty acids
5041030|NCT03742492|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5041031|NCT03742492|Docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5041032|NCT03742492|Bioavailability|bioavailability
5041033|NCT03742492|Blood pressure|blood pressure
5041034|NCT03742492|Lipid absorption|lipid absorption
5041035|NCT03742492|Canned tuna|canned tuna
5041036|NCT03742453|CEUS|ceus
5041037|NCT03742453|gadoxetic acid|gadoxetic acid
5041038|NCT03742453|MRI|mri
5041042|NCT03742414|Dermatitis|dermatitis
5041043|NCT03742401|Breast Fibroadenoma|breast fibroadenoma
5041044|NCT03742375|Human Papilloma Virus|human papilloma virus
5041045|NCT03742375|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
5041046|NCT03742362|Osteoporosis|osteoporosis
5041047|NCT03742362|MRI|mri
5041048|NCT03742362|distal radius|distal radius
5041049|NCT03742362|postmenopausal|postmenopausal
5041050|NCT03742349|Phase Ib, TNBC, advanced, metastatic, immunotherapy, PDR001,|phase ib, tnbc, advanced, metastatic, immunotherapy, pdr001,
5041051|NCT03742349|LAG525, NIR178, INC280, MCS110, ACZ885|lag525, nir178, inc280, mcs110, acz885
5041052|NCT03742310|Vitamin D Receptor gene|vitamin d receptor gene
5041053|NCT03742310|physical development|physical development
5041054|NCT03742310|intelligent development|intelligent development
5041055|NCT03742245|breast cancer|breast cancer
5041056|NCT03742245|relapsed|relapsed
5041057|NCT03742245|refractory|refractory
5041058|NCT03742245|metastatic|metastatic
5041059|NCT03742167|Prehospital emergency care|prehospital emergency care
5041060|NCT03742167|Paramedic performance|paramedic performance
5041061|NCT03742167|Telemedicine|telemedicine
5041062|NCT03742167|Medical control physician|medical control physician
5041063|NCT03742167|Infant mannequin smulation|infant mannequin smulation
5041064|NCT03742167|Pediatric life threatening illness|pediatric life threatening illness
5041065|NCT03742141|Thyroidectomy|thyroidectomy
5041066|NCT03742141|Neck Procedures|neck procedures
5041067|NCT03742141|Nerve Monitoring|nerve monitoring
5041324|NCT03740529|Acalabrutinib|acalabrutinib
5041076|NCT03742063|osteosarcoma|osteosarcoma
5054571|NCT03656965|EBV|ebv
5041080|NCT03742063|chemotherapy|chemotherapy
5041081|NCT03742063|targeted therapy|targeted therapy
5041082|NCT03742050|Stable Angina|stable angina
5041083|NCT03742037|Musculoskeletal and connective tissue disorders|musculoskeletal and connective tissue disorders
5041084|NCT03742011|PCOS|pcos
5041085|NCT03742011|Hyperandrogenism|hyperandrogenism
5041086|NCT03742011|Epigenetics|epigenetics
5041087|NCT03742011|Glucolipid metabolism disorder|glucolipid metabolism disorder
5041088|NCT03741972|Heart failure|heart failure
5041089|NCT03741972|Diabetes|diabetes
5041090|NCT03741972|iSGLT2|isglt2
5041589|NCT03739372|genomics|genomics
5041091|NCT03741959|postural defect|postural defect
5041092|NCT03741946|carotid arteries|carotid arteries
5041093|NCT03741946|central venous catheterization|central venous catheterization
5041094|NCT03741946|jugular veins|jugular veins
5041095|NCT03741946|Malay race|malay race
5041096|NCT03741946|ultrasonography|ultrasonography
5041097|NCT03741920|Personal KinetiGraph (PKG) Movement Recording System|personal kinetigraph (pkg) movement recording system
5041098|NCT03741907|Cesarean|cesarean
5041099|NCT03741907|Surgery|surgery
5041100|NCT03741907|Birth|birth
5041101|NCT03741907|Recovery|recovery
5041102|NCT03741907|Outcomes|outcomes
5041103|NCT03741894|alveolitis|alveolitis
5041104|NCT03741894|iodoform|iodoform
5041105|NCT03741894|chlorhexidine|chlorhexidine
5041106|NCT03741894|minor complications|minor complications
5041107|NCT03741868|Lung Cancer|lung cancer
5041108|NCT03741868|Immunotherapy|immunotherapy
5041109|NCT03741868|Stage IV cancer|stage iv cancer
5041110|NCT03741855|COPD|copd
5041111|NCT03741855|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5041112|NCT03741855|Self-Management|self-management
5041113|NCT03741829|Thymidylate Synthase|thymidylate synthase
5041114|NCT03741829|Cancer|cancer
5041115|NCT03741829|Cancer Treatments|cancer treatments
5041116|NCT03741816|permanent molars|permanent molars
5041117|NCT03741816|indirect pulp capping|indirect pulp capping
5041118|NCT03741816|reversible pulpitis|reversible pulpitis
5041119|NCT03741816|deep carious lesions|deep carious lesions
5041120|NCT03741816|Biodentine|biodentine
5041121|NCT03741816|TheraCal LC|theracal lc
5041122|NCT03741790|airway|airway
5041123|NCT03741790|intubation|intubation
5041124|NCT03741777|NPO time|npo time
5041125|NCT03741777|Gastric content|gastric content
5041126|NCT03741751|cognition|cognition
5041127|NCT03741751|schizophrenia|schizophrenia
5041128|NCT03741751|schizoaffective disorder|schizoaffective disorder
5041129|NCT03741712|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
5041130|NCT03741712|SHR2554|shr2554
5041131|NCT03741712|SHR3680|shr3680
5041132|NCT03741699|Poor ovarian response|poor ovarian response
5041133|NCT03741699|Recombinant LH|recombinant lh
5041134|NCT03741699|Advanced maternal age|advanced maternal age
5041135|NCT03741699|Oocyte retrieved|oocyte retrieved
5041136|NCT03741686|insulin resistance syndrome|insulin resistance syndrome
5041137|NCT03741686|fiber|fiber
5041138|NCT03741686|konjac|konjac
5041139|NCT03741660|konjac|konjac
5041140|NCT03741660|type2 diabetes|type2 diabetes
5041141|NCT03741660|fiber|fiber
5041142|NCT03741660|coronary heart disease|coronary heart disease
5042319|NCT03734627|GLP-1|glp-1
5041156|NCT03741582|Respiratory Diseases|respiratory diseases
5041157|NCT03741569|Fetal heart rate|fetal heart rate
5041158|NCT03741569|Multiple sensors|multiple sensors
5041159|NCT03741543|health promotion|health promotion
5041160|NCT03741543|early-stage dementia|early-stage dementia
5041161|NCT03741543|psychosocial|psychosocial
5041162|NCT03741530|Intracerebral hemorrhage|intracerebral hemorrhage
5041163|NCT03741530|Perihematomal edema|perihematomal edema
5041164|NCT03741530|Disability|disability
5041165|NCT03741530|Clinical trial|clinical trial
5041166|NCT03741465|neuraxial anesthesia positioning technique|neuraxial anesthesia positioning technique
5041167|NCT03741465|Anatolian sitting position|anatolian sitting position
5041168|NCT03741465|sitting cross-legged position|sitting cross-legged position
5041169|NCT03741465|sitting fetal position|sitting fetal position
5041170|NCT03741465|ultrasonography|ultrasonography
5041171|NCT03741465|numerical rating scale|numerical rating scale
5041172|NCT03741426|Olaparib|olaparib
5041178|NCT03741361|Prospective Studies|prospective studies
5041179|NCT03741361|Anesthetics, Intravenous|anesthetics, intravenous
5041180|NCT03741361|Propofol|propofol
5041181|NCT03741361|Anxiety/*psychology|anxiety/*psychology
5041182|NCT03741361|Depression/*psychology|depression/*psychology
5041183|NCT03741348|Erector Spinae Plane Block|erector spinae plane block
5041184|NCT03741348|Postoperative Analgesia|postoperative analgesia
5041185|NCT03741348|Total Abdominal Hysterectomy|total abdominal hysterectomy
5041186|NCT03741348|fentanyl consumption|fentanyl consumption
5041187|NCT03741309|dentinal hypersensitivity|dentinal hypersensitivity
5041188|NCT03741309|visual analog scale|visual analog scale
5041189|NCT03741296|Hip replacement|hip replacement
5041190|NCT03741296|periprosthetic hip infection|periprosthetic hip infection
5041191|NCT03741296|single stage revision|single stage revision
5041217|NCT03741179|pre-eclampsia|pre-eclampsia
5041218|NCT03741179|pregnant|pregnant
5041219|NCT03741179|sFlt-1/PlGF ratio|sflt-1/plgf ratio
5041220|NCT03741179|ASA treatment|asa treatment
5041221|NCT03741166|Blood Draw|blood draw
5041222|NCT03741127|CAR-T cells|car-t cells
5041223|NCT03741114|placenta previa|placenta previa
5041224|NCT03741114|tranexamic acid|tranexamic acid
5041225|NCT03741114|cesarean section|cesarean section
5041226|NCT03741114|Foley's Catheter Balloon|foley's catheter balloon
5041227|NCT03741075|placenta previa|placenta previa
5041228|NCT03741075|tranexamic acid|tranexamic acid
5041229|NCT03741075|uterine artery ligation|uterine artery ligation
5041230|NCT03741062|Laser Therapy|laser therapy
5041231|NCT03741062|Low-Level Light Therapy|low-level light therapy
5041232|NCT03741062|Periodontics|periodontics
5041233|NCT03741062|Oral Surgery|oral surgery
5041235|NCT03741062|Palate, Hard|palate, hard
5041237|NCT03741049|Emergency medicine|emergency medicine
5041238|NCT03741049|Airway management|airway management
5041239|NCT03741049|Cricothyroidotomy|cricothyroidotomy
5041240|NCT03741036|immidiate|immidiate
5041241|NCT03741036|dental implant|dental implant
5041242|NCT03741036|immidiate provisionalization|immidiate provisionalization
5041243|NCT03741036|bone graft|bone graft
5041250|NCT03740984|Chemotherapy|chemotherapy
5041251|NCT03740984|Side effects of chemotherapy|side effects of chemotherapy
5041252|NCT03740945|Vulvovaginal atrophy (VVA)|vulvovaginal atrophy (vva)
5041253|NCT03740945|Vaginal atrophy|vaginal atrophy
5041254|NCT03740945|Atrophic vaginitis|atrophic vaginitis
5041255|NCT03740945|Prasterone|prasterone
5041256|NCT03740945|DHEA|dhea
5041257|NCT03740945|Intrarosa|intrarosa
5041258|NCT03740945|Breast cancer|breast cancer
5041259|NCT03740945|Aromatase inhibitor|aromatase inhibitor
5041274|NCT03740867|Cognitive Impairment|cognitive impairment
5085769|NCT03462446|VKA|vka
5041275|NCT03740867|pulmonary rehabilitation|pulmonary rehabilitation
5041276|NCT03740867|exercise|exercise
5041277|NCT03740867|MOCA|moca
5041278|NCT03740867|aerobic training|aerobic training
5041279|NCT03740854|lung ultrasonography|lung ultrasonography
5041280|NCT03740854|mechanical ventilation|mechanical ventilation
5041283|NCT03740841|Per-operative stress|per-operative stress
5041284|NCT03740841|per-operative anxiety|per-operative anxiety
5041285|NCT03740841|pediatric surgery|pediatric surgery
5041286|NCT03740828|In vitro fertilization|in vitro fertilization
5041287|NCT03740828|Time-lapse|time-lapse
5041288|NCT03740828|Assisted Reproduction|assisted reproduction
5041289|NCT03740789|Hepatitis B|hepatitis b
5041291|NCT03740763|Pain|pain
5041292|NCT03740763|Quality of Life|quality of life
5041299|NCT03740711|Cardiogenic shock|cardiogenic shock
5041300|NCT03740711|Extracorporeal Membrane Oxygenation Support|extracorporeal membrane oxygenation support
5041301|NCT03740711|Left atrial venting|left atrial venting
5041302|NCT03740646|Bronchiolitis|bronchiolitis
5041303|NCT03740646|Nasopharyngeal aspirates|nasopharyngeal aspirates
5041304|NCT03740620|epistaxis|epistaxis
5041305|NCT03740607|Adult|adult
5041306|NCT03740607|Peripheral IV|peripheral iv
5041307|NCT03740607|procedural pain|procedural pain
5041308|NCT03740607|procedural anxiety|procedural anxiety
5041309|NCT03740607|virtual reality|virtual reality
5041314|NCT03740529|LOXO-305|loxo-305
5041316|NCT03740529|Bruton's tyrosine kinase|bruton's tyrosine kinase
5041318|NCT03740529|SLL|sll
5041319|NCT03740529|NHL|nhl
5342943|NCT01981421|MR Elastography|mr elastography
5041320|NCT03740529|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5041321|NCT03740529|C481S|c481s
5041322|NCT03740529|C481|c481
5041323|NCT03740529|Ibrutinib|ibrutinib
5041325|NCT03740529|Zanubrutinib|zanubrutinib
5041326|NCT03740529|BGB-3111|bgb-3111
5041327|NCT03740529|GS-4059|gs-4059
5041328|NCT03740529|ONO-4059|ono-4059
5041329|NCT03740529|Tirabrutinib|tirabrutinib
5041330|NCT03740529|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5041331|NCT03740529|Mantle Cell Lymphoma|mantle cell lymphoma
5041332|NCT03740529|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5041333|NCT03740529|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5041334|NCT03740529|BTK Intolerant|btk intolerant
5041335|NCT03740529|C481S Mutation|c481s mutation
5041336|NCT03740529|Marginal zone lymphoma|marginal zone lymphoma
5041337|NCT03740529|DLBCL (Diffuse Large B-cell lymphoma)|dlbcl (diffuse large b-cell lymphoma)
5041338|NCT03740529|Follicular Lymphoma|follicular lymphoma
5041339|NCT03740516|Expanded Access|expanded access
5041340|NCT03740516|Compassionate Use|compassionate use
5041341|NCT03740503|Cancer|cancer
5041342|NCT03740503|Breast Cancer|breast cancer
5041343|NCT03740503|Non- small Cell Lung Cancer|non- small cell lung cancer
5041344|NCT03740503|Colorectal Cancer|colorectal cancer
5041345|NCT03740503|Genitourinary Cancer|genitourinary cancer
5041346|NCT03740503|Gynecological Cancer|gynecological cancer
5041347|NCT03740503|Upper Aerodigestive Tract Cancer|upper aerodigestive tract cancer
5041348|NCT03740503|Pancreatobiliary Gastrointestinal Cancer|pancreatobiliary gastrointestinal cancer
5041349|NCT03740503|Melanoma Cancer|melanoma cancer
5041350|NCT03740503|Rare Cancer|rare cancer
5041351|NCT03740503|Unknown Primary Cancer|unknown primary cancer
5041352|NCT03740490|Smoking Cessation|smoking cessation
5041353|NCT03740490|Smartphone Based Smoking Cessation|smartphone based smoking cessation
5041354|NCT03740451|Fibromyalgia, Manual Therapy, Autonomic Nervous System, Pain, Psychological well-being|fibromyalgia, manual therapy, autonomic nervous system, pain, psychological well-being
5041355|NCT03740438|Hemoglobin|hemoglobin
5041356|NCT03740438|Hemoglobin drop|hemoglobin drop
5041357|NCT03740438|Surgical Blood loss|surgical blood loss
5041358|NCT03740412|sedentary|sedentary
5041359|NCT03740412|arthroplasty|arthroplasty
5041360|NCT03740412|osteoarthritis|osteoarthritis
5041361|NCT03740412|older adults|older adults
5041362|NCT03740412|elderly|elderly
5041364|NCT03740412|elders|elders
5041365|NCT03740412|sitting|sitting
5041366|NCT03740412|intervention|intervention
5041367|NCT03740399|sitting position|sitting position
5041368|NCT03740399|lateral decubitus position|lateral decubitus position
5041369|NCT03740399|spinal block|spinal block
5041370|NCT03740386|phentolamine mesylate|phentolamine mesylate
5041371|NCT03740386|reverse local anesthesia|reverse local anesthesia
5041377|NCT03740347|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5041378|NCT03740347|chronic pain|chronic pain
5041379|NCT03740347|anxiety|anxiety
5041380|NCT03740347|depression|depression
5041381|NCT03740347|sleepiness|sleepiness
5041382|NCT03740347|quality of life|quality of life
5041383|NCT03740334|ALL|all
5041384|NCT03740321|Hemorrhoids|hemorrhoids
5041385|NCT03740321|Superior rectal artery|superior rectal artery
5041386|NCT03740321|embolization|embolization
5041387|NCT03740321|microspheric particles|microspheric particles
5041388|NCT03740308|Primary posterior teeth|primary posterior teeth
5041389|NCT03740308|zirconia crown|zirconia crown
5041390|NCT03740282|arthrodesis|arthrodesis
5041391|NCT03740282|bunion|bunion
5041394|NCT03740282|hallux valgus|hallux valgus
5041395|NCT03740269|oral health education|oral health education
5041399|NCT03740269|knowledge,attitude,practice|knowledge,attitude,practice
5041400|NCT03740269|oral health knowledge,attitude,practice|oral health knowledge,attitude,practice
5041401|NCT03740269|oral hygiene knowledge,attitude,practice|oral hygiene knowledge,attitude,practice
5041402|NCT03740269|knowledge,attitude,practice oral health|knowledge,attitude,practice oral health
5041403|NCT03740269|knowledge,attitude,practice oral hygiene|knowledge,attitude,practice oral hygiene
5041405|NCT03740256|HER2|her2
5041406|NCT03740256|Human Epidermal Growth Factor Receptor 2|human epidermal growth factor receptor 2
5041407|NCT03740256|Bladder|bladder
5041408|NCT03740256|Squamous Cell Carcinoma|squamous cell carcinoma
5041409|NCT03740256|Salivary Gland|salivary gland
5041410|NCT03740256|Lung|lung
5041414|NCT03740256|Colorectal|colorectal
5041415|NCT03740256|Pancreatic|pancreatic
5041416|NCT03740243|opioid use disorder|opioid use disorder
5041417|NCT03740243|Buprenorphine/naloxone|buprenorphine/naloxone
5041418|NCT03740243|Buprenorphine|buprenorphine
5041419|NCT03740230|Hepatitis C|hepatitis c
5041420|NCT03740230|Chronic Hepatitis C|chronic hepatitis c
5041421|NCT03740230|Genotypes|genotypes
5041422|NCT03740230|Genotypes 1 to 6|genotypes 1 to 6
5041423|NCT03740230|Maviret|maviret
5041424|NCT03740230|Glecaprevir|glecaprevir
5041425|NCT03740230|Pibrentasvir|pibrentasvir
5041426|NCT03740204|Adolescent|adolescent
5041427|NCT03740204|Amenorrhea|amenorrhea
5041428|NCT03740204|Anorexia Nervosa|anorexia nervosa
5041429|NCT03740204|Cognitive Flexibility|cognitive flexibility
5041430|NCT03740204|Dietary Restriction|dietary restriction
5041431|NCT03740204|Eating Disorders|eating disorders
5041432|NCT03740204|Estrogen|estrogen
5041433|NCT03740204|Excessive Exercise|excessive exercise
5041434|NCT03740204|Females|females
5041435|NCT03740204|Hypoestrogenemia|hypoestrogenemia
5041436|NCT03740204|Reward|reward
5041437|NCT03740139|Serious mental illnesses|serious mental illnesses
5041438|NCT03740139|Pre-arrest jail diversion|pre-arrest jail diversion
5041439|NCT03740139|Police|police
5041440|NCT03740126|Positron Emission Tomography Computed Tomography|positron emission tomography computed tomography
5041441|NCT03740126|X-Ray Computed Tomography|x-ray computed tomography
5041442|NCT03740126|Liquid Biopsy|liquid biopsy
5041443|NCT03740126|Quality of Life|quality of life
5041444|NCT03740126|Medical Oncology|medical oncology
5041445|NCT03740126|Radiation Oncology|radiation oncology
5041446|NCT03740126|Follow-up|follow-up
5041447|NCT03740113|Sugar sweetened beverages|sugar sweetened beverages
5041448|NCT03740113|health disparities|health disparities
5041449|NCT03740113|Appalachia|appalachia
5041450|NCT03740100|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5041451|NCT03740100|Notch 1 loss of function mutation|notch 1 loss of function mutation
5041452|NCT03740100|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
5041453|NCT03740100|Refractory metastatic|refractory metastatic
5041454|NCT03740087|miRNA|mirna
5041455|NCT03740087|Xenomirs|xenomirs
5041456|NCT03740087|Diet|diet
5041457|NCT03740087|Vegan|vegan
5041458|NCT03740061|Ultrasound|ultrasound
5041459|NCT03740061|Assessment|assessment
5041460|NCT03740061|Acute sarcopenia|acute sarcopenia
5041461|NCT03740061|Hospitalized older people|hospitalized older people
5041462|NCT03740048|Hemodialysis|hemodialysis
5041463|NCT03740048|Kidney Disease|kidney disease
5041464|NCT03740048|Kidney Function|kidney function
5041468|NCT03740009|Hormone Replacement Therapy|hormone replacement therapy
5041469|NCT03740009|Estrogen|estrogen
5041470|NCT03740009|Depression|depression
5041471|NCT03740009|Mood Disorders|mood disorders
5041472|NCT03740009|Estrogen Replacement Therapy|estrogen replacement therapy
5041473|NCT03740009|Depressive Disorder|depressive disorder
5041474|NCT03740009|Mental Disorders|mental disorders
5041475|NCT03740009|Hormones|hormones
5041476|NCT03740009|Physiological effects of drugs|physiological effects of drugs
5041477|NCT03740009|Reproductive Control Agents|reproductive control agents
5041478|NCT03740009|Tissue Selective Estrogen Complex|tissue selective estrogen complex
5041481|NCT03739931|mRNA-2752|mrna-2752
5041482|NCT03739931|OX40L|ox40l
5041483|NCT03739931|IL-23|il-23
5339886|NCT01995643|Insulin|insulin
5353734|NCT01931722|sarcopenia|sarcopenia
5041484|NCT03739931|IL-36γ|il-36γ
5041485|NCT03739931|Intratumoral injection|intratumoral injection
5041486|NCT03739918|Cystic|cystic
5041487|NCT03739918|Adrenal|adrenal
5041488|NCT03739918|Incidentaloma|incidentaloma
5041489|NCT03739918|Vascular|vascular
5041490|NCT03739918|Benign|benign
5041590|NCT03739372|RNA sequencing|rna sequencing
5041491|NCT03739905|Magnetic Resonance guided Focal Ultrasound (MRgFUS)|magnetic resonance guided focal ultrasound (mrgfus)
5041493|NCT03739905|ExAblate|exablate
5041494|NCT03739905|Blood Brain Barrier|blood brain barrier
5041495|NCT03739879|Inspiratory muscle trainer|inspiratory muscle trainer
5041496|NCT03739879|Pulmonary rehabilitation|pulmonary rehabilitation
5041497|NCT03739879|COPD|copd
5349560|NCT01951209|Human|human
5041498|NCT03739879|St George Respiratory Questionnaire|st george respiratory questionnaire
5041510|NCT03739749|Autograft|autograft
5041511|NCT03739749|Xenograft|xenograft
5041533|NCT03739658|Exercise|exercise
5041534|NCT03739645|fear|fear
5041535|NCT03739645|pain|pain
5041536|NCT03739645|conditioning|conditioning
5041537|NCT03739645|skin conductance response|skin conductance response
5041538|NCT03739645|Ratings of Pain and Conditioning|ratings of pain and conditioning
5041539|NCT03739645|Intracranial Electrophysiology|intracranial electrophysiology
5041540|NCT03739593|Macular Edema|macular edema
5041541|NCT03739593|Retinal Vein Occlusion|retinal vein occlusion
5041542|NCT03739593|Dexamethasone Intravitreal Implant|dexamethasone intravitreal implant
5041543|NCT03739580|drug-coating balloon|drug-coating balloon
5041544|NCT03739580|stent|stent
5041545|NCT03739580|popliteal artery|popliteal artery
5041546|NCT03739580|atherosclerotic occlusion|atherosclerotic occlusion
5041547|NCT03739567|General anesthesia, clinical manifestations. .|general anesthesia, clinical manifestations. .
5041548|NCT03739554|CYC065|cyc065
5041549|NCT03739554|CDK2/9|cdk2/9
5041550|NCT03739554|venetoclax|venetoclax
5041551|NCT03739554|BCL-2|bcl-2
5041552|NCT03739554|MCL-1|mcl-1
5041553|NCT03739554|Relapsed|relapsed
5041554|NCT03739554|Refractory|refractory
5041555|NCT03739554|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5041556|NCT03739554|small lymphocytic lymphoma|small lymphocytic lymphoma
5041557|NCT03739515|Emergency department|emergency department
5041558|NCT03739515|Health and Social Care Professional|health and social care professional
5041559|NCT03739515|Team care|team care
5041560|NCT03739515|Older patients|older patients
5041561|NCT03739515|Effectiveness|effectiveness
5041562|NCT03739489|healthy subjects|healthy subjects
5041563|NCT03739489|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5041564|NCT03739489|heart rate variability|heart rate variability
5041565|NCT03739476|Postoperative|postoperative
5041566|NCT03739476|Delirium|delirium
5041567|NCT03739476|Quetiapine|quetiapine
5041568|NCT03739476|Prophylaxis|prophylaxis
5041569|NCT03739463|Pro-omega-3|pro-omega-3
5041570|NCT03739463|Inflammation|inflammation
5041571|NCT03739463|Prematurity|prematurity
5041572|NCT03739437|automated|automated
5041573|NCT03739437|smoking cessation|smoking cessation
5041574|NCT03739437|socioeconomic disadvantage|socioeconomic disadvantage
5041575|NCT03739437|contingency management|contingency management
5041576|NCT03739437|financial incentives|financial incentives
5041577|NCT03739437|mobile health|mobile health
5041578|NCT03739437|biochemical verification|biochemical verification
5041579|NCT03739424|Bone|bone
5041580|NCT03739424|Cognition|cognition
5041582|NCT03739424|Protein|protein
5041583|NCT03739385|Intergenerational|intergenerational
5041584|NCT03739385|Exercise|exercise
5041585|NCT03739385|Health|health
5041586|NCT03739372|High-grade glioma|high-grade glioma
5041587|NCT03739372|whole exome sequencing|whole exome sequencing
5041593|NCT03739359|Gas flow|gas flow
5041594|NCT03739346|Dental anxiety|dental anxiety
5041595|NCT03739346|Pain|pain
5041596|NCT03739346|Child|child
5041597|NCT03739346|Pediatric dentistry|pediatric dentistry
5041598|NCT03739346|Hypnosis|hypnosis
5041599|NCT03739333|glioblastoma|glioblastoma
5041600|NCT03739333|11C-Methionine PET-MRI|11c-methionine pet-mri
5041601|NCT03739333|sensitivity|sensitivity
5041602|NCT03739333|temozolomide|temozolomide
5041603|NCT03739333|radiotherapy|radiotherapy
5041604|NCT03739320|severe asthma|severe asthma
5041605|NCT03739320|biologic therapy|biologic therapy
5041606|NCT03739320|physical activity monitoring|physical activity monitoring
5041607|NCT03739268|bile acid|bile acid
5041608|NCT03739242|Lipids|lipids
5041618|NCT03739242|Nutriceuticals|nutriceuticals
5041619|NCT03739229|pandemic|pandemic
5041620|NCT03739229|influenza|influenza
5041621|NCT03739229|vaccine|vaccine
5041622|NCT03739229|H7N9|h7n9
5041624|NCT03739177|Neoadjuvant Chemotherapy, Muscle Invasive Bladder Cancer|neoadjuvant chemotherapy, muscle invasive bladder cancer
5041629|NCT03739151|passive sensing|passive sensing
5041630|NCT03739151|dietary assessment|dietary assessment
5041631|NCT03739138|Programmed Death-1 (PD-1, PD1),|programmed death-1 (pd-1, pd1),
5041632|NCT03739138|Programmed Death-Ligand 1 (PD-L1, PDL1)|programmed death-ligand 1 (pd-l1, pdl1)
5041633|NCT03739099|Type 1 diabetes|type 1 diabetes
5041634|NCT03739099|Prepubertal children|prepubertal children
5041635|NCT03739099|Closed-loop insulin infusion|closed-loop insulin infusion
5041636|NCT03739060|Inguinal hernia|inguinal hernia
5041637|NCT03739060|Transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5041638|NCT03739060|Postoperative pain|postoperative pain
5041639|NCT03739060|Quality of life|quality of life
5041640|NCT03739060|Pain threshold|pain threshold
5041641|NCT03739060|Algometry|algometry
5041642|NCT03739047|Children with feeding disorders|children with feeding disorders
5041643|NCT03739021|replacement|replacement
5041644|NCT03739021|shoulder|shoulder
5041645|NCT03739008|Thunderclap headache|thunderclap headache
5041646|NCT03738995|Red cell transfusion|red cell transfusion
5041647|NCT03738995|Obstetric transfusion|obstetric transfusion
5041648|NCT03738995|anaemia in pregnancy|anaemia in pregnancy
5041649|NCT03738982|Type1 Diabetes Mellitus|type1 diabetes mellitus
5041650|NCT03738982|PEPPER safety system|pepper safety system
5041651|NCT03738956|Axial spondyloarthritis|axial spondyloarthritis
5041652|NCT03738943|Adenosine Triphosphate|adenosine triphosphate
5041653|NCT03738943|Pyridoxine|pyridoxine
5041654|NCT03738943|Cardiovascular|cardiovascular
5041656|NCT03738943|P5P|p5p
5041657|NCT03738930|Acute Coronary Syndrome|acute coronary syndrome
5041658|NCT03738930|Percutaneous coronary intervention|percutaneous coronary intervention
5041659|NCT03738930|Bleeding|bleeding
5041660|NCT03738917|Cough; Dextromethorphan; Ipratropium; Honey.|cough; dextromethorphan; ipratropium; honey.
5041663|NCT03738839|White Spot Lesions|white spot lesions
5041664|NCT03738839|Direct Bonding|direct bonding
5041665|NCT03738839|Indirect Bonding|indirect bonding
5041666|NCT03738839|Quantitative Light-Induced Fluorescence|quantitative light-induced fluorescence
5041667|NCT03738826|medication adherence|medication adherence
5041668|NCT03738774|Post intensive care syndrome|post intensive care syndrome
5041669|NCT03738761|Hypertension|hypertension
5041670|NCT03738761|Blood pressure control|blood pressure control
5041671|NCT03738761|Fixed-dose combination antihypertensives|fixed-dose combination antihypertensives
5041672|NCT03738761|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5041673|NCT03738748|Neuromodulation|neuromodulation
5041674|NCT03738748|Low back pain|low back pain
5041675|NCT03738748|Ultrasound-guied percutaneous|ultrasound-guied percutaneous
5041676|NCT03738748|TENS|tens
5041677|NCT03738748|Randomized Controlled Trial|randomized controlled trial
5041678|NCT03738748|Percutaneous stimulation|percutaneous stimulation
5041679|NCT03738709|Prevention|prevention
5041680|NCT03738709|Group|group
5041681|NCT03738709|Technical assistance|technical assistance
5041682|NCT03738709|Fall|fall
5041683|NCT03738709|Occupational therapy|occupational therapy
5041684|NCT03738709|Hospitalization discharge|hospitalization discharge
5041685|NCT03738683|Pharmacokinetics|pharmacokinetics
5041686|NCT03738683|Piperacillin-tazobactam|piperacillin-tazobactam
5041694|NCT03738670|Bone metastases|bone metastases
5041695|NCT03738644|Endovascular treatment|endovascular treatment
5041696|NCT03738644|Near-infrared spectroscopy|near-infrared spectroscopy
5041697|NCT03738644|Intra-operational monitoring|intra-operational monitoring
5041698|NCT03738592|spatial hearing perception|spatial hearing perception
5041699|NCT03738592|cochlear implant|cochlear implant
5041701|NCT03738592|virtual reality|virtual reality
5055132|NCT03653585|7T|7t
5041705|NCT03738540|Weight loss|weight loss
5041706|NCT03738540|Nutrition|nutrition
5041707|NCT03738540|Exercise|exercise
5041708|NCT03738540|Diet|diet
5041709|NCT03738540|Telephone coaching|telephone coaching
5041710|NCT03738527|tranexamic acid|tranexamic acid
5041711|NCT03738527|mastectomy|mastectomy
5041712|NCT03738527|topical|topical
5041713|NCT03738527|breast cancer|breast cancer
5041714|NCT03738527|seroma|seroma
5041715|NCT03738527|hematoma|hematoma
5041716|NCT03738514|Dentinal Hypersensitivity|dentinal hypersensitivity
5041717|NCT03738514|Visual Analogue Score|visual analogue score
5041718|NCT03738501|Food intake|food intake
5041719|NCT03738501|Chest physiotherapy|chest physiotherapy
5041720|NCT03738501|Sleep|sleep
5041721|NCT03738501|Respiratory Distress|respiratory distress
5041722|NCT03738436|Visual feedback|visual feedback
5041723|NCT03738436|Proprioception|proprioception
5041724|NCT03738423|Moderate|moderate
5041725|NCT03738423|Severe|severe
5041726|NCT03738410|mHealth|mhealth
5041727|NCT03738410|mobile applications|mobile applications
5041728|NCT03738410|culturally-competent|culturally-competent
5041730|NCT03738410|Resilience|resilience
5041731|NCT03738397|Upadacitinib|upadacitinib
5041732|NCT03738397|ABT-494|abt-494
5041733|NCT03738397|Dupilumab|dupilumab
5041734|NCT03738397|Atopic Dermatitis|atopic dermatitis
5041735|NCT03738384|Rehabilitation, Visual, Feedback|rehabilitation, visual, feedback
5729118|NCT00397852|Child|child
5041736|NCT03738345|High flow nasal cannula|high flow nasal cannula
5041737|NCT03738345|Hypoxemia|hypoxemia
5041738|NCT03738345|Flow setting|flow setting
5041739|NCT03738293|Steroid|steroid
5041740|NCT03738293|Corticosteroid|corticosteroid
5041741|NCT03738293|Betamethasone|betamethasone
5041742|NCT03738293|Preterm Birth|preterm birth
5041751|NCT03738215|MDD|mdd
5041752|NCT03738202|Randomized controlled trial|randomized controlled trial
5041753|NCT03738202|Textile industry|textile industry
5041754|NCT03738202|Cotton fiber|cotton fiber
5041755|NCT03738202|Byssinosis|byssinosis
5041756|NCT03738189|Dental Prosthesis Designs|dental prosthesis designs
5041757|NCT03738189|Dentures|dentures
5041758|NCT03738189|Denture Design|denture design
5041759|NCT03738189|Denture, Complete, Upper|denture, complete, upper
5041760|NCT03738189|Technology, Dental|technology, dental
5041761|NCT03738189|Aesthetics, Dental|aesthetics, dental
5041762|NCT03738176|Oral lichen planus|oral lichen planus
5041763|NCT03738176|sesame oil|sesame oil
5041764|NCT03738176|corticosteroid|corticosteroid
5041765|NCT03738176|MDA|mda
5041766|NCT03738150|PAH|pah
5041767|NCT03738137|Narcotrend|narcotrend
5041768|NCT03738137|Bispectral index|bispectral index
5041769|NCT03738137|Bronchoscopy|bronchoscopy
5041770|NCT03738137|Conscious Sedation|conscious sedation
5041771|NCT03738124|stent graft|stent graft
5041772|NCT03738124|branch stent graft|branch stent graft
5041773|NCT03738124|thoracic aneurysm|thoracic aneurysm
5041774|NCT03738124|endovascular aortic repair|endovascular aortic repair
5041775|NCT03738124|aortic dissection|aortic dissection
5041776|NCT03738124|Valiant Mona LSA Thoracic Stent Graft System|valiant mona lsa thoracic stent graft system
5041777|NCT03738098|Whole Genome Sequencing|whole genome sequencing
5041778|NCT03738098|Genetic Counseling|genetic counseling
5041779|NCT03738098|Hereditary Childhood Disease|hereditary childhood disease
5041780|NCT03738098|Genomic Medicine|genomic medicine
5041781|NCT03738085|Complication|complication
5041782|NCT03738085|Previous surgery|previous surgery
5041783|NCT03738085|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
5041784|NCT03738085|Obesity|obesity
5041785|NCT03738072|Epilepsy|epilepsy
5041786|NCT03738072|Electrical Brain stimulation|electrical brain stimulation
5041787|NCT03738072|Neurosurgery|neurosurgery
5041788|NCT03738072|stereo-electro-encephalography (SEEG)|stereo-electro-encephalography (seeg)
5041789|NCT03738059|Skull Pin Insertion|skull pin insertion
5042295|NCT03734757|trimodality|trimodality
5041790|NCT03738059|Dexmedetomidine|dexmedetomidine
5041791|NCT03738059|Hemodynamic Responses|hemodynamic responses
5041792|NCT03738033|emergency medicine ,emergency ultrasound|emergency medicine ,emergency ultrasound
5041793|NCT03737968|oral cavity|oral cavity
5041794|NCT03737968|hypopharynx|hypopharynx
5041795|NCT03737968|oropharynx|oropharynx
5041796|NCT03737968|larynx|larynx
5041797|NCT03737968|medi4736|medi4736
5041798|NCT03737968|tremelimumab|tremelimumab
5041799|NCT03737942|diabetes mellitus|diabetes mellitus
5041800|NCT03737942|Neuromuscular Transmission|neuromuscular transmission
5041801|NCT03737929|Epicardial surgical ablation|epicardial surgical ablation
5041802|NCT03737929|Percutaneous endocardial catheter ablation|percutaneous endocardial catheter ablation
5041803|NCT03737903|Frail elderly|frail elderly
5041804|NCT03737903|Accelerometer|accelerometer
5041805|NCT03737903|Preoperative assessment|preoperative assessment
5041806|NCT03737877|ADHD|adhd
5041807|NCT03737877|Diet Modification|diet modification
5041816|NCT03737838|Ventricular|ventricular
5041817|NCT03737838|Tachycardia|tachycardia
5041818|NCT03737825|MS|ms
5041819|NCT03737825|Multiple Sclerosis|multiple sclerosis
5041820|NCT03737825|Cognitive remediation|cognitive remediation
5041821|NCT03737825|Brain training|brain training
5041822|NCT03737825|Physical Therapy|physical therapy
5041823|NCT03737812|Progressive multiple sclerosis|progressive multiple sclerosis
5041824|NCT03737799|Diabetes|diabetes
5041825|NCT03737799|C-peptide|c-peptide
5041826|NCT03737799|Insulin|insulin
5041827|NCT03737799|Classification|classification
5041828|NCT03737786|large vessel occlusion|large vessel occlusion
5041829|NCT03737786|anesthesia|anesthesia
5041830|NCT03737786|thrombectomy|thrombectomy
5041831|NCT03737786|acute ischemic stroke|acute ischemic stroke
5041832|NCT03737760|walking|walking
5041833|NCT03737760|aging|aging
5041834|NCT03737760|brain|brain
5041835|NCT03737747|Synek score|synek score
5041836|NCT03737747|electroencephalography|electroencephalography
5041837|NCT03737747|cardiac arrest|cardiac arrest
5041838|NCT03737734|Squamous Cell Carcinoma|squamous cell carcinoma
5041840|NCT03737734|Skin Cancer|skin cancer
5041841|NCT03737734|Skin metastasis|skin metastasis
5041842|NCT03737734|HNSCC|hnscc
5041843|NCT03737734|Carcinoma, Squamous|carcinoma, squamous
5041853|NCT03737708|abatacept|abatacept
5041854|NCT03737708|Prograf|prograf
5041855|NCT03737708|adalimumab|adalimumab
5041856|NCT03737708|methotrexate|methotrexate
5041857|NCT03737708|tocilizumab|tocilizumab
5041858|NCT03737708|FK506|fk506
5041859|NCT03737669|transfusion|transfusion
5041860|NCT03737669|pathogen reduction technology|pathogen reduction technology
5041861|NCT03737669|Uganda|uganda
5041862|NCT03737669|tranfusion transmitted infections|tranfusion transmitted infections
5041863|NCT03737669|Mirasol|mirasol
5041864|NCT03737669|blood|blood
5041865|NCT03737656|Progesterone|progesterone
5041866|NCT03737656|Vaginal ring|vaginal ring
5041867|NCT03737643|Advanced Ovarian Cancer|advanced ovarian cancer
5041868|NCT03737643|Ovarian neoplasms|ovarian neoplasms
5041869|NCT03737630|cystic fibrosis|cystic fibrosis
5041870|NCT03737630|quality of life|quality of life
5041871|NCT03737630|posture|posture
5041872|NCT03737617|Replacement therapy|replacement therapy
5041873|NCT03737617|Microbiology|microbiology
5041874|NCT03737617|Exacerbations|exacerbations
5041875|NCT03737617|Bronchiectasis|bronchiectasis
5041876|NCT03737617|Immunoglobulin G subclass 2|immunoglobulin g subclass 2
5041877|NCT03737604|Transversus Abdominis Plane Block|transversus abdominis plane block
5041878|NCT03737604|Ropivacaine|ropivacaine
5041879|NCT03737604|Liposomal bupivacaine|liposomal bupivacaine
5041880|NCT03737591|Colorectal Cancer|colorectal cancer
5041881|NCT03737591|Adenomas|adenomas
5041882|NCT03737591|ctDNA Methylation Haplotypes|ctdna methylation haplotypes
5041883|NCT03737578|Home hemodialysis|home hemodialysis
5041884|NCT03737578|Daily hemodialysis|daily hemodialysis
5041885|NCT03737578|Frequent hemodialysis|frequent hemodialysis
5041886|NCT03737565|Cobalt-chromium|cobalt-chromium
5041887|NCT03737552|Sleep|sleep
5041888|NCT03737552|ADHD|adhd
5041889|NCT03737552|Children|children
5041890|NCT03737552|Cognition|cognition
5041891|NCT03737539|Colorectal Cancer|colorectal cancer
5041892|NCT03737539|Circulating tumor DNA|circulating tumor dna
5041893|NCT03737539|Surveillance|surveillance
5041894|NCT03737539|ctDNA Methylation|ctdna methylation
5041908|NCT03737357|SLActive® surface|slactive® surface
5041910|NCT03737357|BLT implant|blt implant
5041911|NCT03737344|haemorrhage|haemorrhage
5041912|NCT03737344|Stroke|stroke
5041913|NCT03737344|Bleeding|bleeding
5041914|NCT03737331|Visual|visual
5041915|NCT03737331|Variability|variability
5041916|NCT03737331|Gait|gait
5041917|NCT03737331|Fractals|fractals
5041918|NCT03737331|Rehabilitation|rehabilitation
5041919|NCT03737331|Brain|brain
5055323|NCT03652727|ECG|ecg
5041924|NCT03737305|TMJ Distraction Device|tmj distraction device
5041925|NCT03737305|TMJ Pain|tmj pain
5041926|NCT03737279|Pregnancy|pregnancy
5041927|NCT03737279|Meditation|meditation
5041928|NCT03737253|gonadotropin|gonadotropin
5041929|NCT03737253|receptor|receptor
5041930|NCT03737253|assisted reproduction|assisted reproduction
5041931|NCT03737240|Type 2 Diabetes|type 2 diabetes
5041932|NCT03737227|Lumbar intervertebral motion|lumbar intervertebral motion
5041933|NCT03737227|Flexion|flexion
5041934|NCT03737227|Extension|extension
5041935|NCT03737227|Cinematographic recording|cinematographic recording
5041936|NCT03737227|Segmental rotations|segmental rotations
5041937|NCT03737227|Segmental translation|segmental translation
5041938|NCT03737227|lumbar spine|lumbar spine
5041939|NCT03737227|asymptomatic participants|asymptomatic participants
5041940|NCT03737201|ozone|ozone
5041941|NCT03737201|Deep Carious Lesion|deep carious lesion
5041942|NCT03737201|Primary Molars|primary molars
5041952|NCT03737136|transplantation|transplantation
5041953|NCT03737136|plasmapheresis|plasmapheresis
5041954|NCT03737097|Fall|fall
5041955|NCT03737097|Multiple Sclerosis|multiple sclerosis
5041956|NCT03737084|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5041957|NCT03737084|cancer|cancer
5041958|NCT03737084|compassion|compassion
5041959|NCT03737084|meditation|meditation
5041960|NCT03737084|depression|depression
5041961|NCT03737084|anxiety|anxiety
5041962|NCT03737084|heart rate variability|heart rate variability
5041963|NCT03737084|resilience|resilience
5041964|NCT03737045|Decision Aid|decision aid
5041965|NCT03737045|Shared Decision-Making|shared decision-making
5041966|NCT03736967|Moderate|moderate
5043071|NCT03729778|HIV|hiv
5041979|NCT03736876|Teens|teens
5041980|NCT03736876|Healthy Relationships|healthy relationships
5035406|NCT03778112|MRI|mri
5041981|NCT03736876|Unintended Pregnancy|unintended pregnancy
5041982|NCT03736876|Teen Pregnancy|teen pregnancy
5041983|NCT03736876|Sexually Transmitted Infections|sexually transmitted infections
5041984|NCT03736876|Sexually Transmitted Diseases|sexually transmitted diseases
5041985|NCT03736876|Sexual Health Education|sexual health education
5041986|NCT03736876|School-Based Health Center|school-based health center
5041987|NCT03736876|Randomized Controlled Trial|randomized controlled trial
5041988|NCT03736837|sensitive EGFR mutations|sensitive egfr mutations
5041989|NCT03736837|anlotinib|anlotinib
5041990|NCT03736837|icotinib|icotinib
5041991|NCT03736837|first line|first line
5041992|NCT03736837|cancer|cancer
5041993|NCT03736837|non-squamous NSCLC|non-squamous nsclc
5041994|NCT03736759|exercise|exercise
5041995|NCT03736759|vaccine|vaccine
5041996|NCT03736759|older adults|older adults
5042002|NCT03736642|stool|stool
5042003|NCT03736642|constitutional thinness|constitutional thinness
5042004|NCT03736629|Asthma|asthma
5042005|NCT03736629|Azithromycin|azithromycin
5042006|NCT03736629|Microbiome|microbiome
5042007|NCT03736629|Sputum|sputum
5042008|NCT03736564|FGF 23|fgf 23
5042009|NCT03736564|oncogenic|oncogenic
5042010|NCT03736564|tumor induced|tumor induced
5042011|NCT03736551|intermittent fasting|intermittent fasting
5354122|NCT01930006|Ron|ron
5042012|NCT03736551|weight loss|weight loss
5042013|NCT03736538|Nitrous Oxide|nitrous oxide
5042014|NCT03736538|Anesthetics|anesthetics
5042015|NCT03736525|Wellness|wellness
5042016|NCT03736525|Home environment|home environment
5042017|NCT03736525|Design|design
5042018|NCT03736525|Online intervention|online intervention
5042019|NCT03736525|Randomized Controlled Trail (RCT)|randomized controlled trail (rct)
5042020|NCT03736525|Nudge theory|nudge theory
5042021|NCT03736525|Mothers|mothers
5042022|NCT03736486|Type 2 diabetes|type 2 diabetes
5042023|NCT03736486|Cardio-metabolic disease|cardio-metabolic disease
5042024|NCT03736486|Latino|latino
5042025|NCT03736486|Hispanic|hispanic
5042026|NCT03736486|Especialista|especialista
5042027|NCT03736447|CODIT™ (characterized oral desensitization immunotherapy™)|codit™ (characterized oral desensitization immunotherapy™)
5042028|NCT03736447|Peanut-Allergic Children|peanut-allergic children
5349982|NCT01949090|H7N1|h7n1
5042029|NCT03736447|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5042030|NCT03736447|Desensitization|desensitization
5042031|NCT03736447|AR101|ar101
5042038|NCT03736434|Hypertension|hypertension
5042039|NCT03736434|Mild Cognitive impairment (MCI)|mild cognitive impairment (mci)
5042040|NCT03736434|functional Magnetic resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5042041|NCT03736434|Hair cortisol|hair cortisol
5042042|NCT03736408|temporomandibular joint dysfunction|temporomandibular joint dysfunction
5042043|NCT03736408|pain form|pain form
5042044|NCT03736408|treatment|treatment
5042045|NCT03736408|epidemiologcal assessment|epidemiologcal assessment
5042046|NCT03736395|Behavioral Symptoms|behavioral symptoms
5042047|NCT03736395|Disruptive Behavior|disruptive behavior
5042048|NCT03736395|Schools|schools
5042049|NCT03736395|School Teachers|school teachers
5042050|NCT03736382|Mild Intermittent hypoxia|mild intermittent hypoxia
5042051|NCT03736382|Continuous positive airway pressure therapy|continuous positive airway pressure therapy
5042052|NCT03736356|Aeromedical Evacuation|aeromedical evacuation
5042053|NCT03736356|Combat Injury|combat injury
5042059|NCT03736330|Ranal Carcinoma|ranal carcinoma
5042060|NCT03736330|Immunotherapy|immunotherapy
5042061|NCT03736330|Axitinib|axitinib
5042062|NCT03736317|Amphetamine-type stimulants|amphetamine-type stimulants
5042063|NCT03736317|prefrontal-striatal circuits|prefrontal-striatal circuits
5042064|NCT03736317|rTMS|rtms
5042065|NCT03736317|individualized therapy|individualized therapy
5042066|NCT03736317|craving|craving
5042067|NCT03736317|relapse|relapse
5042068|NCT03736265|Portal Hypertension|portal hypertension
5042069|NCT03736265|Esophageal varices|esophageal varices
5042070|NCT03736265|Carvedilol|carvedilol
5042077|NCT03736239|Ventilator Weaning|ventilator weaning
5042078|NCT03736239|Diaphragm|diaphragm
5042079|NCT03736239|Ultrasonography|ultrasonography
5042080|NCT03736213|speech|speech
5042081|NCT03736213|articulation|articulation
5042082|NCT03736213|motor development|motor development
5042083|NCT03736200|balance|balance
5042084|NCT03736200|movement|movement
5042085|NCT03736200|exergaming|exergaming
5042086|NCT03736200|posture|posture
5042087|NCT03736200|quality of life|quality of life
5042088|NCT03736200|gait|gait
5042089|NCT03736174|CECS|cecs
5042090|NCT03736161|PsA|psa
5042091|NCT03736148|manipulation|manipulation
5042092|NCT03736148|electromyography|electromyography
5042093|NCT03736148|sympathetic nervous system|sympathetic nervous system
5042094|NCT03736135|Cortisol|cortisol
5042095|NCT03736135|Post-ICU syndrome|post-icu syndrome
5042096|NCT03736135|Cognitive impairment|cognitive impairment
5042097|NCT03736135|Anxiety and depressive symptoms|anxiety and depressive symptoms
5042103|NCT03736109|hyaluronic acid|hyaluronic acid
5042104|NCT03736109|Insulin like growth factor|insulin like growth factor
5042105|NCT03736109|Nitric oxide|nitric oxide
5042106|NCT03736096|cystic fibrosis|cystic fibrosis
5042107|NCT03736096|sputum|sputum
5042108|NCT03736096|nasopharyngeal swab|nasopharyngeal swab
5042109|NCT03736096|viral molecular diagnosis|viral molecular diagnosis
5042110|NCT03736096|respiratory infection|respiratory infection
5042111|NCT03736096|expectoration|expectoration
5042112|NCT03736083|glucose monitoring|glucose monitoring
5042113|NCT03736083|glycemic control|glycemic control
5042114|NCT03736044|Rheumatoid arthritis|rheumatoid arthritis
5042115|NCT03736044|Remission|remission
5042116|NCT03736044|T regulatory lymphocytes|t regulatory lymphocytes
5042117|NCT03736044|Tumor Necrosis Factor-blocker therapy|tumor necrosis factor-blocker therapy
5042118|NCT03736031|cancer|cancer
5042119|NCT03736018|Coronary Artery Bypass Grafts|coronary artery bypass grafts
5042120|NCT03736018|Computed Tomography Cardiac Angiography|computed tomography cardiac angiography
5042121|NCT03736018|Invasive Coronary Angiogram|invasive coronary angiogram
5042127|NCT03735940|Electroencephalography|electroencephalography
5042128|NCT03735940|Intensive Care|intensive care
5042129|NCT03735940|Brain disease|brain disease
5042130|NCT03735940|Confusion|confusion
5042131|NCT03735940|Neurobehavioral Manifestations|neurobehavioral manifestations
5042132|NCT03735940|Nervous System Diseases|nervous system diseases
5042133|NCT03735940|Signs and Symptoms|signs and symptoms
5042134|NCT03735940|Neurocognitive Disorders|neurocognitive disorders
5042135|NCT03735940|Mental Disorders|mental disorders
5042136|NCT03735927|Electroencephalography|electroencephalography
5042137|NCT03735927|Brain diseases|brain diseases
5042138|NCT03735927|Confusion|confusion
5042143|NCT03735927|Mental Disorders|mental disorders
5042144|NCT03735901|Levodopa/ Carbidopa|levodopa/ carbidopa
5042145|NCT03735901|Fugl-Meyer-Motor-Assessment (FMMA)|fugl-meyer-motor-assessment (fmma)
5042146|NCT03735823|IL-11 T cell migration|il-11 t cell migration
5042147|NCT03735771|Epidural|epidural
5042148|NCT03735771|Labor analgesia|labor analgesia
5042149|NCT03735771|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5042150|NCT03735758|in-label prescription|in-label prescription
5042151|NCT03735758|Quality of Life|quality of life
5042152|NCT03735758|pazopanib|pazopanib
5042153|NCT03735758|chemotherapy|chemotherapy
5042154|NCT03735719|soluble ST2|soluble st2
5042155|NCT03735719|galectin-3|galectin-3
5042156|NCT03735719|prognosis|prognosis
5042157|NCT03735719|STEMI|stemi
5042158|NCT03735719|primary PCI|primary pci
5042159|NCT03735706|Radiation|radiation
5042160|NCT03735706|Contrast media|contrast media
5042161|NCT03735706|Liver|liver
5042162|NCT03735706|Body Weight|body weight
5042163|NCT03735693|ultrasound|ultrasound
5042164|NCT03735693|intensive care|intensive care
5042165|NCT03735641|Expanded Pedicled Deltopectoral Flap|expanded pedicled deltopectoral flap
5042166|NCT03735641|skin color|skin color
5042167|NCT03735641|Sensory recovery|sensory recovery
5042168|NCT03735615|Exercise therapy|exercise therapy
5042169|NCT03735615|High-Intensity Interval Training|high-intensity interval training
5042170|NCT03735576|Late-life depression|late-life depression
5042171|NCT03735576|Psychotherapy|psychotherapy
5042172|NCT03735576|Major depression|major depression
5042173|NCT03735576|Randomized controlled trial|randomized controlled trial
5042174|NCT03735576|Treatment|treatment
5042175|NCT03735563|less invasive surfactant administration|less invasive surfactant administration
5042176|NCT03735563|premedication|premedication
5042177|NCT03735550|breast cancer|breast cancer
5042178|NCT03735550|contact thermography|contact thermography
5042185|NCT03735524|exercise, synaptopathy, inflammation|exercise, synaptopathy, inflammation
5729119|NCT00397852|Treatment|treatment
5042186|NCT03735498|Malignant Gliomas|malignant gliomas
5042187|NCT03735485|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
5042188|NCT03735485|functionality|functionality
5042189|NCT03735485|mobilization|mobilization
5042191|NCT03735459|Treatment adherence and compliance|treatment adherence and compliance
5042192|NCT03735446|Acute Myeloid Leukemia|acute myeloid leukemia
5042194|NCT03735446|AML|aml
5042195|NCT03735446|MDS|mds
5042196|NCT03735446|CHK1|chk1
5042197|NCT03735446|MEC|mec
5042198|NCT03735446|Prexasertib|prexasertib
5042201|NCT03735420|xanthohumol|xanthohumol
5042202|NCT03735420|gut microbiome|gut microbiome
5042203|NCT03735420|inflammation|inflammation
5042204|NCT03735394|Gingival thickness|gingival thickness
5042205|NCT03735394|gingival biotype|gingival biotype
5042206|NCT03735394|gingival recession|gingival recession
5042207|NCT03735394|maxilla|maxilla
5042208|NCT03735394|mandible|mandible
5042209|NCT03735381|Pedometer watch, walking, pregnancy, insomnia|pedometer watch, walking, pregnancy, insomnia
5042214|NCT03735316|Vitamin B12a|vitamin b12a
5042215|NCT03735316|Hypotension|hypotension
5042216|NCT03735316|Cardiopulmonary Bypass|cardiopulmonary bypass
5042217|NCT03735303|vitamin D3|vitamin d3
5042218|NCT03735303|vitamin D deficiency|vitamin d deficiency
5042219|NCT03735303|leptin|leptin
5042220|NCT03735303|A1C|a1c
5042221|NCT03735303|omega-3 fatty acid|omega-3 fatty acid
5042222|NCT03735290|immunotherapy|immunotherapy
5042223|NCT03735290|ilixadencel|ilixadencel
5042224|NCT03735290|checkpoint inhibitor|checkpoint inhibitor
5042225|NCT03735290|allogeneic|allogeneic
5042226|NCT03735290|somatic cell therapy|somatic cell therapy
5042227|NCT03735290|dendritic cell|dendritic cell
5042228|NCT03735290|intratumoral|intratumoral
5042229|NCT03735290|in situ|in situ
5042230|NCT03735277|Human Umbilical Cord Blood|human umbilical cord blood
5042231|NCT03735277|Hematopoietic stem cells|hematopoietic stem cells
5042232|NCT03735264|NSCLC Anlotinib Docetaxel|nsclc anlotinib docetaxel
5042233|NCT03735251|Left Ventricular Diastoic Dysfunction Cohort study|left ventricular diastoic dysfunction cohort study
5042234|NCT03735238|lupus|lupus
5042235|NCT03735238|decision making|decision making
5042236|NCT03735238|implementation|implementation
5042237|NCT03735238|SLE|sle
5042238|NCT03735238|decision-aid|decision-aid
5042239|NCT03735238|decision conflict|decision conflict
5042260|NCT03735043|cardiac output|cardiac output
5042261|NCT03735043|hemodynamic|hemodynamic
5042262|NCT03735043|non-invasive monitoring|non-invasive monitoring
5042264|NCT03735004|electrical stimulation|electrical stimulation
5042265|NCT03735004|electric anesthesia|electric anesthesia
5042266|NCT03734978|Blood group|blood group
5042267|NCT03734978|sepsis|sepsis
5042268|NCT03734978|preterms|preterms
5042269|NCT03734965|aweken intubation|aweken intubation
5354337|NCT01928823|DCS|dcs
5042270|NCT03734965|fiberoptic|fiberoptic
5042271|NCT03734965|videolaryngoscopy|videolaryngoscopy
5042272|NCT03734939|cardiovascular risk factor|cardiovascular risk factor
5042273|NCT03734939|Slums|slums
5042274|NCT03734939|survey|survey
5042275|NCT03734939|cardiovascular disease|cardiovascular disease
5042276|NCT03734861|Asthma|asthma
5042277|NCT03734848|Pectoralis block|pectoralis block
5042278|NCT03734848|Opioids Consumption|opioids consumption
5042279|NCT03734848|off-pump|off-pump
5042280|NCT03734796|High-sensitive cardiac troponin|high-sensitive cardiac troponin
5042281|NCT03734796|Non-ST-elevation Myocardial Infarction (NSTEMI)|non-st-elevation myocardial infarction (nstemi)
5042282|NCT03734796|Chinese|chinese
5042283|NCT03734796|Acute chest pain|acute chest pain
5042284|NCT03734783|chronic hepatitis B|chronic hepatitis b
5042285|NCT03734783|regulating B cells|regulating b cells
5042286|NCT03734783|T help 17 cells|t help 17 cells
5042287|NCT03734783|Interleukin 35|interleukin 35
5042288|NCT03734770|progesterone|progesterone
5042289|NCT03734770|subcutaneous|subcutaneous
5042290|NCT03734770|vaginal|vaginal
5042291|NCT03734770|luteal phase support|luteal phase support
5042292|NCT03734770|in vitro fertilization|in vitro fertilization
5042293|NCT03734757|prostate cancer|prostate cancer
5042294|NCT03734757|Imaging|imaging
5042296|NCT03734744|Pharmacokinetics|pharmacokinetics
5042297|NCT03734744|Pharmacodynamics|pharmacodynamics
5042298|NCT03734718|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5042299|NCT03734718|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5042300|NCT03734718|Hypoglycemia|hypoglycemia
5043364|NCT03728062|Mindfulness|mindfulness
5042311|NCT03734705|attachment|attachment
5042312|NCT03734666|alcohol drinking|alcohol drinking
5042313|NCT03734666|quit smoking|quit smoking
5042314|NCT03734653|Square Wave Testosterone Therapy|square wave testosterone therapy
5042315|NCT03734653|Androgen Deprivation Therapy|androgen deprivation therapy
5042316|NCT03734653|Transdermal Testosterone|transdermal testosterone
5042320|NCT03734627|Enteroendocrine L-cell|enteroendocrine l-cell
5042321|NCT03734627|Early satiety|early satiety
5042322|NCT03734627|Dumping syndrome|dumping syndrome
5042323|NCT03734627|Gastrointestinal transit|gastrointestinal transit
5042324|NCT03734627|Insulin|insulin
5042325|NCT03734627|Octreotide|octreotide
5042326|NCT03734627|Somatostatin|somatostatin
5042327|NCT03734627|Esophagectomy|esophagectomy
5042328|NCT03734614|asprin|asprin
5042329|NCT03734614|locally advanced|locally advanced
5042330|NCT03734614|renal cell carcinoma|renal cell carcinoma
5042331|NCT03734614|adjuvant therapy|adjuvant therapy
5042332|NCT03734562|Ventricular tachycardia|ventricular tachycardia
5042333|NCT03734562|Ischemic cardiomyopathy|ischemic cardiomyopathy
5042334|NCT03734562|Catheter Ablation|catheter ablation
5042335|NCT03734562|Antiarrhythmic drug therapy|antiarrhythmic drug therapy
5042337|NCT03734536|REGENETEN|regeneten
5042338|NCT03734536|REGENETEN Bioinductive Implant|regeneten bioinductive implant
5042339|NCT03734536|highgrade partial thickness tear|highgrade partial thickness tear
5042340|NCT03734536|rotator cuff tear|rotator cuff tear
5042341|NCT03734536|rotator cuff repair|rotator cuff repair
5042342|NCT03734484|Dascena|dascena
5042343|NCT03734484|Gram infection|gram infection
5042344|NCT03734484|antibiotic administration|antibiotic administration
5042345|NCT03734484|machine learning|machine learning
5042346|NCT03734484|algorithm|algorithm
5042347|NCT03734484|diagnostic|diagnostic
5042348|NCT03734445|Diabetes Mellitus type 2|diabetes mellitus type 2
5042349|NCT03734445|Vitamin C|vitamin c
5042350|NCT03734445|Vitamin D|vitamin d
5042351|NCT03734445|Cinc|cinc
5042352|NCT03734432|Diagnostic, Imaging, MRI|diagnostic, imaging, mri
5042353|NCT03734419|epiaging|epiaging
5042354|NCT03734419|biological age|biological age
5042355|NCT03734419|chronological age|chronological age
5042356|NCT03734419|DNA methylation|dna methylation
5042357|NCT03734419|ELOVL2-AS1|elovl2-as1
5042358|NCT03734419|ELOVL2|elovl2
5042359|NCT03734380|Gait retraining|gait retraining
5042360|NCT03734380|Knee adduction moment|knee adduction moment
5042361|NCT03734380|Wearable technology|wearable technology
5042362|NCT03734380|Knee osteoarthritis|knee osteoarthritis
5042363|NCT03734367|Emotional Intelligence|emotional intelligence
5042364|NCT03734367|HbA1c|hba1c
5042365|NCT03734367|Healthy habits|healthy habits
5042366|NCT03734367|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5042367|NCT03734341|CPAP|cpap
5042368|NCT03734341|Titration|titration
5042369|NCT03734341|Obstructive Sleep Apnea|obstructive sleep apnea
5042370|NCT03734341|Telemonitoring|telemonitoring
5042371|NCT03734341|Telemedicine|telemedicine
5042372|NCT03734328|connective tissue graft|connective tissue graft
5042373|NCT03734328|platelet rich fibrin|platelet rich fibrin
5042374|NCT03734328|patient perceptions|patient perceptions
5042376|NCT03734250|Sugammadex|sugammadex
5042377|NCT03734250|Neostigmine|neostigmine
5042378|NCT03734250|Anesthesia|anesthesia
5042379|NCT03734250|Neuromuscular blockers|neuromuscular blockers
5042380|NCT03734250|Reverse time|reverse time
5042381|NCT03734250|Vitamin D|vitamin d
5042382|NCT03734237|Influenza vaccine|influenza vaccine
5042383|NCT03734211|Evolocumab|evolocumab
5042384|NCT03734211|Heart Transplantation|heart transplantation
5042385|NCT03734211|Vasculopathy|vasculopathy
5042386|NCT03734198|p53 dysfunction|p53 dysfunction
5042387|NCT03734185|Cardiac Rehabilitation|cardiac rehabilitation
5042388|NCT03734172|Tuberculosis|tuberculosis
5042389|NCT03734172|Paediatrics|paediatrics
5042390|NCT03734172|Diagnostics|diagnostics
5042391|NCT03734159|Regional Anesthesia|regional anesthesia
5042392|NCT03734159|Sternotomy|sternotomy
5042393|NCT03734120|Cryo preservation|cryo preservation
5042402|NCT03734068|Tumor response|tumor response
5042403|NCT03734068|Lifepearls|lifepearls
5042404|NCT03734042|Platelet rich plasma|platelet rich plasma
5042405|NCT03734042|Intrauterine infusion|intrauterine infusion
5042406|NCT03734042|Thawed embryos|thawed embryos
5042407|NCT03734042|IVF/ICSI cycles|ivf/icsi cycles
5042408|NCT03734029|Anti-HER2-Antibody Drug Conjugate (ADC)|anti-her2-antibody drug conjugate (adc)
5042409|NCT03734029|Unresectable or Metastatic|unresectable or metastatic
5042410|NCT03734029|Human epidermal growth factor receptor 2 (HER2)-low|human epidermal growth factor receptor 2 (her2)-low
5042411|NCT03734029|DESTINY - Breast 04|destiny - breast 04
5042412|NCT03734016|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5042413|NCT03734016|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5042415|NCT03734016|SLL|sll
5042416|NCT03734016|relapsed|relapsed
5042417|NCT03734016|refractory|refractory
5042418|NCT03734003|hyperthermia|hyperthermia
5055823|NCT03649958|mTBI|mtbi
5042419|NCT03734003|human papilloma virus|human papilloma virus
5042420|NCT03734003|cutaneous warts|cutaneous warts
5042421|NCT03733977|Family|family
5042422|NCT03733977|Intensive Care Unit|intensive care unit
5042423|NCT03733977|Quality Of Care|quality of care
5042424|NCT03733977|Satisfaction|satisfaction
5042425|NCT03733964|manual therapy|manual therapy
5042426|NCT03733964|kinesiotherapy|kinesiotherapy
5042427|NCT03733964|pnf|pnf
5042428|NCT03733964|back pain|back pain
5042429|NCT03733938|rarifaction|rarifaction
5042430|NCT03733938|root end filling|root end filling
5042431|NCT03733938|bioceramic|bioceramic
5042432|NCT03733938|outcome|outcome
5042433|NCT03733873|nocturnal enuresischildren|nocturnal enuresischildren
5042434|NCT03733873|Chinsese medicine|chinsese medicine
5042435|NCT03733873|children|children
5042436|NCT03733873|relapse rate|relapse rate
5042437|NCT03733860|erectile dysfunction|erectile dysfunction
5042438|NCT03733860|penile tumescence|penile tumescence
5042439|NCT03733860|cavernous tissue|cavernous tissue
5042440|NCT03733821|rTMS|rtms
5042441|NCT03733808|rTMS|rtms
5042442|NCT03733743|Circadian Rhythm|circadian rhythm
5042443|NCT03733691|Multiple Myeloma|multiple myeloma
5042444|NCT03733691|Front-line|front-line
5042445|NCT03733691|Maintenance therapy|maintenance therapy
5042446|NCT03733678|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, LARCs, family planning counseling|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, larcs, family planning counseling
5042452|NCT03733652|Chronic Hepatitis B|chronic hepatitis b
5042453|NCT03733652|entecavir|entecavir
5042454|NCT03733613|Kinect|kinect
5042455|NCT03733613|somatosensory detector|somatosensory detector
5042456|NCT03733613|physical fitness|physical fitness
5042457|NCT03733613|gait analysis|gait analysis
5042458|NCT03733574|Depressive Disorder, Major|depressive disorder, major
5042459|NCT03733574|Depressive Disorder|depressive disorder
5042460|NCT03733574|Mood Disorders|mood disorders
5042461|NCT03733574|Mental Disorders|mental disorders
5042462|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate
5042463|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
5042464|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
5042465|NCT03733574|Membrane Transport Modulators|membrane transport modulators
5042466|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5042467|NCT03733574|Neurotransmitter Agents|neurotransmitter agents
5042468|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs
5042469|NCT03733574|Antidepressive Agents|antidepressive agents
5042470|NCT03733574|Psychotropic Drugs|psychotropic drugs
5042471|NCT03733535|Benralizumab|benralizumab
5042472|NCT03733535|Xenon|xenon
5042473|NCT03733496|PD|pd
5042474|NCT03733496|Parkinson's Disease|parkinson's disease
5042475|NCT03733496|Aromatic L-Amino Acid Decarboxylase|aromatic l-amino acid decarboxylase
5042476|NCT03733496|AADC|aadc
5042477|NCT03733496|AAV2|aav2
5042478|NCT03733496|AAV2-AADC|aav2-aadc
5042479|NCT03733496|VY-AADC|vy-aadc
5042480|NCT03733483|Bone|bone
5042481|NCT03733483|Sleep Restriction|sleep restriction
5042482|NCT03733431|vagal nerve stimulation|vagal nerve stimulation
5042483|NCT03733418|vitamin D|vitamin d
5042484|NCT03733418|cognitive decline|cognitive decline
5042485|NCT03733418|dementia|dementia
5042486|NCT03733418|critical care|critical care
5042487|NCT03733405|Breastfeeding|breastfeeding
5042488|NCT03733405|Contraception|contraception
5042489|NCT03733405|Emergency|emergency
5042490|NCT03733405|Department|department
5042491|NCT03733379|Periodontitis|periodontitis
5042508|NCT03733288|Intervention|intervention
5042509|NCT03733288|Workplace|workplace
5042510|NCT03733288|Sedentary behaviour|sedentary behaviour
5042523|NCT03733262|chronic kidney disease|chronic kidney disease
5042524|NCT03733262|end-stage renal disease|end-stage renal disease
5042525|NCT03733249|Long term follow up|long term follow up
5042526|NCT03733249|Gene-modified cells|gene-modified cells
5042528|NCT03733249|AML|aml
5042529|NCT03733249|hematologic neoplasms|hematologic neoplasms
5042530|NCT03733249|hematologic malignancies|hematologic malignancies
5042531|NCT03733249|anemia|anemia
5042532|NCT03733249|congenital cytopenia|congenital cytopenia
5042533|NCT03733249|primary immune deficiencies|primary immune deficiencies
5042534|NCT03733249|hemoglobinopathy|hemoglobinopathy
5042535|NCT03733236|Ischemic Stroke|ischemic stroke
5042536|NCT03733236|Treatment|treatment
5042537|NCT03733236|ISS|iss
5042538|NCT03733236|ImpACT|impact
5042539|NCT03733236|clinical trial|clinical trial
5042541|NCT03733223|MMP-9|mmp-9
5042542|NCT03733223|FVIII|fviii
5042543|NCT03733223|Alteplase|alteplase
5042544|NCT03733223|intracranial haemorrhage|intracranial haemorrhage
5042545|NCT03733223|Ischemic stroke|ischemic stroke
5350371|NCT01947270|Elderly|elderly
5042547|NCT03733184|Colorectal|colorectal
5042548|NCT03733184|Cancer|cancer
5042549|NCT03733184|Peritoneal Metastasis|peritoneal metastasis
5042550|NCT03733184|IDEAL|ideal
5042551|NCT03733184|PCI|pci
5042552|NCT03733184|CRPM|crpm
5042553|NCT03733184|Colorectal Peritoneal Metastasis|colorectal peritoneal metastasis
5042554|NCT03733171|platelet rich plasma|platelet rich plasma
5042555|NCT03733158|endotracheal intubation|endotracheal intubation
5042556|NCT03733158|emergency medicine|emergency medicine
5042557|NCT03733158|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5042558|NCT03733158|physician|physician
5042559|NCT03733145|Angiotensin II|angiotensin ii
5042560|NCT03733145|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
5042561|NCT03733145|Angiotensin Receptor Blockers|angiotensin receptor blockers
5042562|NCT03733145|Anesthesia-Mediated Hypotension|anesthesia-mediated hypotension
5042563|NCT03733132|Insulin Resistance|insulin resistance
5042564|NCT03733132|Cognition|cognition
5042565|NCT03733132|Cognitive Impairment|cognitive impairment
5042566|NCT03733132|Brain Function|brain function
5042567|NCT03733106|screening|screening
5042568|NCT03733106|tomosynthesis|tomosynthesis
5042574|NCT03733080|Motor Behavior|motor behavior
5042575|NCT03733080|Healthy Volunteers|healthy volunteers
5042581|NCT03733054|female|female
5042582|NCT03733054|Veterans|veterans
5042583|NCT03733054|Quality of life|quality of life
5042584|NCT03733054|Prostheses|prostheses
5042585|NCT03733054|Lower extremity amputation|lower extremity amputation
5042586|NCT03733054|Surveys and questionnaires|surveys and questionnaires
5042587|NCT03733054|electronic health records|electronic health records
5042588|NCT03733041|exercise adherence|exercise adherence
5042589|NCT03733041|Older veterans|older veterans
5042590|NCT03733041|home based exercise|home based exercise
5042595|NCT03733015|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5042596|NCT03733015|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5042597|NCT03733015|pain thresholds|pain thresholds
5042598|NCT03733002|acute ischemic stroke|acute ischemic stroke
5042599|NCT03733002|AngongNiuhuang pill|angongniuhuang pill
5042600|NCT03732963|Oral Melatonin Premedication|oral melatonin premedication
5042601|NCT03732911|Child Development|child development
5042602|NCT03732911|Cognitive Home Environment|cognitive home environment
5042603|NCT03732911|Literacy promotion|literacy promotion
5042604|NCT03732911|Text Messages|text messages
5042605|NCT03732885|Sinus|sinus
5042606|NCT03732885|Stability|stability
5042607|NCT03732885|Bone gain|bone gain
5042608|NCT03732885|Osseodensification|osseodensification
5042609|NCT03732872|OSMF|osmf
5042611|NCT03732872|miRNA 21|mirna 21
5042612|NCT03732872|vimentin|vimentin
5042613|NCT03732872|e-cadherin|e-cadherin
5042615|NCT03732820|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5042629|NCT03732703|Relapsed Refractory|relapsed refractory
5042630|NCT03732703|Multiple Myeloma Research Consortium (MMRC)|multiple myeloma research consortium (mmrc)
5042631|NCT03732703|Genomic Profile|genomic profile
5042632|NCT03732703|My Drug|my drug
5042633|NCT03732703|Multiple Myeloma Research Foundation|multiple myeloma research foundation
5042634|NCT03732690|Type 2 diabetes|type 2 diabetes
5042635|NCT03732690|Diet|diet
5042636|NCT03732690|Protein|protein
5042637|NCT03732690|Gut microbiota|gut microbiota
5042638|NCT03732690|Metabolites|metabolites
5042639|NCT03732677|Bladder Cancer|bladder cancer
5042640|NCT03732677|Immunotherapy|immunotherapy
5042641|NCT03732677|PD-L1|pd-l1
5042642|NCT03732677|Durvalumab (MEDI4736)|durvalumab (medi4736)
5042643|NCT03732638|Migraine Prevention|migraine prevention
5042644|NCT03732638|phonophobia|phonophobia
5042645|NCT03732638|photophobia|photophobia
5042646|NCT03732638|nausea|nausea
5042647|NCT03732625|HIV infection|hiv infection
5042648|NCT03732625|neuropsychological adverse effects|neuropsychological adverse effects
5042650|NCT03732586|Severe Alcoholic Hepatitis treatment|severe alcoholic hepatitis treatment
5042651|NCT03732573|Physical Activity|physical activity
5042652|NCT03732573|Cycling|cycling
5042653|NCT03732573|Behaviour Change Techniques|behaviour change techniques
5042654|NCT03732547|Hepatocellular carcinoma|hepatocellular carcinoma
5042655|NCT03732547|Polyinosinic-polycytidylic acid|polyinosinic-polycytidylic acid
5042656|NCT03732547|PD-1 mAb|pd-1 mab
5042657|NCT03732521|Dementia|dementia
5042658|NCT03732521|family caregiver|family caregiver
5042659|NCT03732521|Zarit scale|zarit scale
5042660|NCT03732521|NPI-10|npi-10
5042661|NCT03732521|psychological and behavioral symptoms|psychological and behavioral symptoms
5042662|NCT03732469|egg retrieval|egg retrieval
5042663|NCT03732469|oocyte retrieval|oocyte retrieval
5042664|NCT03732469|opioid dependence|opioid dependence
5042665|NCT03732469|rectal acetaminophen|rectal acetaminophen
5042666|NCT03732469|rectal tylenol|rectal tylenol
5042667|NCT03732469|pain|pain
5042668|NCT03732469|opioid use|opioid use
5042669|NCT03732469|opioid abuse|opioid abuse
5042670|NCT03732443|Delirium|delirium
5042671|NCT03732443|Family Members|family members
5042672|NCT03732443|Critical Illness|critical illness
5042673|NCT03732443|ABCDEF|abcdef
5042674|NCT03732443|Validation|validation
5042675|NCT03732443|Translation|translation
5042676|NCT03732443|FAMCAM|famcam
5042677|NCT03732443|CAM-ICU|cam-icu
5042678|NCT03732417|Nurse's Role|nurse's role
5042679|NCT03732417|quality of life|quality of life
5042680|NCT03732417|adherence|adherence
5042681|NCT03732417|risk factors|risk factors
5042682|NCT03732417|stroke|stroke
5042683|NCT03732417|secondary prevention|secondary prevention
5042684|NCT03732404|Enhanced recovery after surgery|enhanced recovery after surgery
5042685|NCT03732404|Preoperative carbohydrate drink|preoperative carbohydrate drink
5042686|NCT03732404|cesarean section|cesarean section
5042687|NCT03732326|Cardiac and Vascular Structure and Function|cardiac and vascular structure and function
5042688|NCT03732313|Ingrown toenail|ingrown toenail
5042689|NCT03732313|Biomechanic|biomechanic
5042690|NCT03732313|Central resection|central resection
5042691|NCT03732313|Recurrence|recurrence
5042692|NCT03732287|intravitreal injection|intravitreal injection
5042693|NCT03732287|anesthesia|anesthesia
5042694|NCT03732287|macular degeneration|macular degeneration
5042695|NCT03732287|diabetic macular edema|diabetic macular edema
5042794|NCT03731637|Diabetes|diabetes
5042702|NCT03732235|Embolics|embolics
5042703|NCT03732235|FOLFIRI|folfiri
5042704|NCT03732222|Diaphragm|diaphragm
5042705|NCT03732222|Neck|neck
5042706|NCT03732222|Frenic Nerve|frenic nerve
5042707|NCT03732183|Stress|stress
5042708|NCT03732183|Military Caregiver|military caregiver
5042709|NCT03732183|Caregiver|caregiver
5042710|NCT03732183|Online|online
5042711|NCT03732183|Podcast|podcast
5042712|NCT03732183|Mind-Body|mind-body
5042713|NCT03732183|Wellness|wellness
5042714|NCT03732157|Primary Hyperparathyroidism|primary hyperparathyroidism
5042715|NCT03732157|Parathyroidectomy|parathyroidectomy
5042716|NCT03732157|Outpatient management|outpatient management
5042717|NCT03732144|Physical Activity|physical activity
5042718|NCT03732144|Community-based Intervention|community-based intervention
5042719|NCT03732144|Social Motivational Theories|social motivational theories
5042720|NCT03732144|Behavioral Change|behavioral change
5042721|NCT03732144|Agents of Change|agents of change
5042722|NCT03732144|Social Mechanisms|social mechanisms
5042723|NCT03732092|disorders of consciousness|disorders of consciousness
5042724|NCT03732092|prognosis prediction|prognosis prediction
5042725|NCT03732092|minimally conscious state|minimally conscious state
5043751|NCT03725956|sleep|sleep
5042736|NCT03732014|AFB Culture|afb culture
5042737|NCT03732014|AFB microscopy|afb microscopy
5042738|NCT03732014|Bronchoscopy|bronchoscopy
5042739|NCT03731988|actinic keratosis|actinic keratosis
5042740|NCT03731988|ablative fractional laser|ablative fractional laser
5042741|NCT03731988|photodynamic therapy|photodynamic therapy
5042742|NCT03731988|ablative density|ablative density
5042743|NCT03731988|protoporphyrin IX|protoporphyrin ix
5042744|NCT03731975|Tooth, deciduous|tooth, deciduous
5042745|NCT03731975|Pulp Capping and Pulpectomy Agents|pulp capping and pulpectomy agents
5042746|NCT03731975|Pulpectomy|pulpectomy
5042747|NCT03731962|Urine Metabolomics|urine metabolomics
5042748|NCT03731962|Contrast Induced Nephropathy|contrast induced nephropathy
5042749|NCT03731936|artificial intelligence|artificial intelligence
5042750|NCT03731936|facial characteristics|facial characteristics
5042752|NCT03731923|ultrasonography|ultrasonography
5042753|NCT03731910|MRI|mri
5042754|NCT03731884|Coronary thrombus|coronary thrombus
5042755|NCT03731884|Proteomics|proteomics
5042756|NCT03731884|Lipidomics|lipidomics
5042757|NCT03731884|Thrombus aspiration|thrombus aspiration
5042758|NCT03731845|Breast Cancer|breast cancer
5042759|NCT03731845|ovarian reserve|ovarian reserve
5042760|NCT03731845|primary ovarian insufficiency|primary ovarian insufficiency
5042772|NCT03731767|Ankle|ankle
5042773|NCT03731767|Ligaments|ligaments
5042775|NCT03731754|"Cross closure"|"cross closure"
5042776|NCT03731754|Rectal cancer|rectal cancer
5042777|NCT03731754|Anal canal cancer|anal canal cancer
5042778|NCT03731754|Abdominoperineal resection|abdominoperineal resection
5042779|NCT03731715|LGS|lgs
5042783|NCT03731689|intrauterine lavage therapy|intrauterine lavage therapy
5042784|NCT03731689|hysteroscopy|hysteroscopy
5042785|NCT03731689|microbiome|microbiome
5042786|NCT03731689|uterine endometrial repair|uterine endometrial repair
5042787|NCT03731689|intrauterine gel-injection therapy|intrauterine gel-injection therapy
5042788|NCT03731663|foodporn|foodporn
5042789|NCT03731663|food craving|food craving
5042790|NCT03731663|external eating|external eating
5042791|NCT03731663|disordered eating|disordered eating
5042792|NCT03731663|social networks|social networks
5042793|NCT03731637|New Onset Diabetes|new onset diabetes
5042795|NCT03731637|Type 2 Diabetes|type 2 diabetes
5042796|NCT03731611|Umbilical cord milking|umbilical cord milking
5042797|NCT03731572|Falls|falls
5042798|NCT03731572|Balance|balance
5042799|NCT03731572|Protective Stepping|protective stepping
5042800|NCT03731572|Lateral Balance|lateral balance
5042801|NCT03731572|Elderly|elderly
5042802|NCT03731572|Power training|power training
5042803|NCT03731559|Efficacy|efficacy
5042804|NCT03731559|safety|safety
5042805|NCT03731559|pharmacokinetics|pharmacokinetics
5042806|NCT03731559|Dolutegravir|dolutegravir
5350613|NCT01946282|FIT|fit
5042807|NCT03731559|HIV/TB co-infected patients|hiv/tb co-infected patients
5042808|NCT03731559|rifampin-based antituberculosis therapy|rifampin-based antituberculosis therapy
5042809|NCT03731546|Delayed cord clamping|delayed cord clamping
5042810|NCT03731546|Preterm Infant|preterm infant
5042811|NCT03731546|Placental Insufficiency|placental insufficiency
5042812|NCT03731546|Intrauterine growth restriction|intrauterine growth restriction
5042813|NCT03731533|diabetes|diabetes
5042814|NCT03731533|lifestyle|lifestyle
5042815|NCT03731533|nutrition|nutrition
5042816|NCT03731533|exercise|exercise
5042817|NCT03731520|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5042818|NCT03731520|exercise|exercise
5042819|NCT03731520|behavior|behavior
5042820|NCT03731507|range of motion|range of motion
5042821|NCT03731507|upper extremity|upper extremity
5042822|NCT03731507|lower extremity|lower extremity
5042823|NCT03731494|Nickel allergy|nickel allergy
5042824|NCT03731494|Systemic nickel allergy syndrome|systemic nickel allergy syndrome
5042825|NCT03731494|Health-related quality of life|health-related quality of life
5042826|NCT03731494|Nickel oral hyposensitizing treatment|nickel oral hyposensitizing treatment
5042827|NCT03731494|Diet|diet
5043847|NCT03725280|Testosterone|testosterone
5042838|NCT03731429|Hemodynamic changes|hemodynamic changes
5042839|NCT03731429|Extubation|extubation
5042840|NCT03731429|Lidocaine|lidocaine
5042841|NCT03731429|Double blind|double blind
5042842|NCT03731416|GBR, autogenous bone, xenograft|gbr, autogenous bone, xenograft
5042843|NCT03731403|Early childhood caries|early childhood caries
5042844|NCT03731403|Casein phosphopeptides‑amorphous calcium phosphate|casein phosphopeptides‑amorphous calcium phosphate
5042845|NCT03731403|fluoride|fluoride
5042846|NCT03731403|remineralization potential|remineralization potential
5042847|NCT03731403|varnish|varnish
5042848|NCT03731390|programmed death ligand-1 (PD-L1)|programmed death ligand-1 (pd-l1)
5042849|NCT03731351|Large Vessel Occlusion|large vessel occlusion
5042850|NCT03731351|mechanical thrombectomy|mechanical thrombectomy
5042856|NCT03731299|functional ability|functional ability
5042857|NCT03731247|Optical biopsy|optical biopsy
5042858|NCT03731247|Skin cancer|skin cancer
5042859|NCT03731247|Diagnostic performance|diagnostic performance
5042860|NCT03731234|DLBCL|dlbcl
5042861|NCT03731234|Activated-B-Cell DLBCL|activated-b-cell dlbcl
5042862|NCT03731234|Ibrutinib|ibrutinib
5042863|NCT03731234|Phase II|phase ii
5042864|NCT03731208|Quality of life|quality of life
5042865|NCT03731208|Telerehabilitation|telerehabilitation
5042866|NCT03731208|Knee rehabilitation|knee rehabilitation
5042867|NCT03731208|Knee Osteoarthritis|knee osteoarthritis
5042868|NCT03731208|Total Knee Replacement|total knee replacement
5042869|NCT03731195|Baby Massage|baby massage
5042870|NCT03731195|SSEP|ssep
5042871|NCT03731156|Granulomatous Pneumocystis Pneumonia|granulomatous pneumocystis pneumonia
5042872|NCT03731156|PCR Pneumocystis jirovecii|pcr pneumocystis jirovecii
5042873|NCT03731143|pigtail|pigtail
5042874|NCT03731143|punctal stenosis|punctal stenosis
5042875|NCT03731143|bicanalicular|bicanalicular
5042876|NCT03731130|rectal cancer|rectal cancer
5042877|NCT03731130|quality of life|quality of life
5042878|NCT03731130|neoadjuvant|neoadjuvant
5042879|NCT03731130|radiation therapy|radiation therapy
5042880|NCT03731130|chemoradiation|chemoradiation
5042881|NCT03731117|Ischemic Acute Kidney Injury|ischemic acute kidney injury
5042882|NCT03731117|Intensive care units|intensive care units
5042883|NCT03731117|AKI|aki
5042884|NCT03731117|ICU|icu
5042885|NCT03731117|FST|fst
5042886|NCT03731117|FUROSEMIDE STRESS TEST|furosemide stress test
5042887|NCT03731117|RRT|rrt
5042888|NCT03731117|Renal Replacement Therapy|renal replacement therapy
5042889|NCT03731117|sepsis|sepsis
5341005|NCT01990040|SBS|sbs
5042890|NCT03731117|Cardio-pulmonary bypass|cardio-pulmonary bypass
5042891|NCT03731104|Near InfraRed Spectroscopy|near infrared spectroscopy
5042892|NCT03731104|Brain perfusion|brain perfusion
5042893|NCT03731104|Pediatric shock|pediatric shock
5042901|NCT03731039|Adult|adult
5042902|NCT03731000|Pediatric|pediatric
5042903|NCT03730987|Family Violence|family violence
5042904|NCT03730987|Hispanic/Latino|hispanic/latino
5042905|NCT03730987|Health Disparities|health disparities
5042906|NCT03730987|Migrant farmworkers|migrant farmworkers
5042907|NCT03730948|colorectal cancer|colorectal cancer
5042908|NCT03730948|cancer vaccine|cancer vaccine
5042909|NCT03730948|dendritic cell vaccine|dendritic cell vaccine
5042910|NCT03730922|Breast cancer|breast cancer
5042911|NCT03730922|Reconstruction|reconstruction
5042912|NCT03730922|Post mastectomy radiotherapy|post mastectomy radiotherapy
5042913|NCT03730896|Dry needling|dry needling
5042914|NCT03730896|Cervicogenic headache|cervicogenic headache
5042915|NCT03730896|Manual therapy|manual therapy
5042916|NCT03730870|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5042917|NCT03730870|ADHD|adhd
5042918|NCT03730870|Pharmacogenomics|pharmacogenomics
5042919|NCT03730870|Pediatric ADHD|pediatric adhd
5042920|NCT03730870|ADHD medications|adhd medications
5042921|NCT03730857|schizophrenia|schizophrenia
5042922|NCT03730857|PANSS|panss
5042923|NCT03730857|positive predictive value|positive predictive value
5042924|NCT03730857|negative predictive value|negative predictive value
5042927|NCT03730831|Course|course
5042928|NCT03730831|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
5042934|NCT03730818|Cancer-related Fatigue|cancer-related fatigue
5042935|NCT03730818|Exercise Tolerance|exercise tolerance
5042936|NCT03730818|Physical Activity|physical activity
5042937|NCT03730805|Catha Edulis|catha edulis
5042938|NCT03730805|Khat|khat
5042940|NCT03730805|Khat Use Disorder|khat use disorder
5042941|NCT03730805|Screening and Brief Intervention|screening and brief intervention
5042942|NCT03730805|ASSIST|assist
5042943|NCT03730792|Body Weight|body weight
5042944|NCT03730792|Nutrition|nutrition
5042945|NCT03730792|Physical Activity|physical activity
5042946|NCT03730792|Sleep|sleep
5042947|NCT03730792|Stress|stress
5042948|NCT03730792|Occupational Health|occupational health
5042949|NCT03730792|Working Conditions|working conditions
5042950|NCT03730766|helicobacter pylori, saliva microbiota|helicobacter pylori, saliva microbiota
5042951|NCT03730727|Exercise|exercise
5042952|NCT03730727|Type 2 diabetes|type 2 diabetes
5042953|NCT03730727|Walking|walking
5042954|NCT03730727|Standing|standing
5042955|NCT03730727|Circuit exercises|circuit exercises
5042956|NCT03730727|Inactivity|inactivity
5042957|NCT03730727|Blood glucose control|blood glucose control
5042958|NCT03730727|Continuous glucose monitoring|continuous glucose monitoring
5042960|NCT03730701|Primary prevention|primary prevention
5042961|NCT03730701|Modifiable risk factors|modifiable risk factors
5042962|NCT03730688|compartment syndrome|compartment syndrome
5042963|NCT03730688|compartment pressure|compartment pressure
5042964|NCT03730688|polytrauma|polytrauma
5042965|NCT03730688|burn injury|burn injury
5042966|NCT03730688|limb ischemia|limb ischemia
5042967|NCT03730688|fasciotomy|fasciotomy
5042974|NCT03730636|Late Onset Sepsis (LOS)|late onset sepsis (los)
5042975|NCT03730636|antibiotic therapy duration|antibiotic therapy duration
5042976|NCT03730636|procalcitonin (PCTR)|procalcitonin (pctr)
5042977|NCT03730623|Supervised exercise training|supervised exercise training
5042978|NCT03730623|community based intervention|community based intervention
5042979|NCT03730623|Rehabilitation Program|rehabilitation program
5042980|NCT03730623|Cross-sectoral intervention|cross-sectoral intervention
5042981|NCT03730623|Interdisciplinary|interdisciplinary
5042982|NCT03730623|Mixed Methods Research|mixed methods research
5042983|NCT03730584|Hereditary Epidermolysis Bullosa|hereditary epidermolysis bullosa
5042984|NCT03730584|pain|pain
5042985|NCT03730584|bath|bath
5042986|NCT03730584|dressing change|dressing change
5042987|NCT03730584|Ropivacaine|ropivacaine
5042988|NCT03730584|topical application|topical application
5042989|NCT03730558|metastatic|metastatic
5042990|NCT03730558|colon cancer|colon cancer
5042991|NCT03730545|gastric cancer|gastric cancer
5042992|NCT03730545|enteral nutrition|enteral nutrition
5042998|NCT03730532|Cognitive Behavioral Therapy|cognitive behavioral therapy
5042999|NCT03730519|Refractory Hypertension|refractory hypertension
5043000|NCT03730467|Breast feeding|breast feeding
5043001|NCT03730467|breast abscess|breast abscess
5043002|NCT03730467|ultrasound-guide|ultrasound-guide
5043003|NCT03730467|puncture|puncture
5043005|NCT03730402|post-operative analgesia|post-operative analgesia
5043006|NCT03730389|Ureteral Calculi|ureteral calculi
5043007|NCT03730389|External Physical Vibration Lithecbole (EPVL)|external physical vibration lithecbole (epvl)
5043008|NCT03730389|Efficacy|efficacy
5043009|NCT03730389|Safety|safety
5043010|NCT03730363|Pentamidine|pentamidine
5043011|NCT03730363|Salvage Chemotherapy|salvage chemotherapy
5043012|NCT03730324|Biomarkers|biomarkers
5460479|NCT01459406|stomach|stomach
5043013|NCT03730324|Magnetic Resonance Imaging|magnetic resonance imaging
5043014|NCT03730324|Diagnostic|diagnostic
5043015|NCT03730298|American Ginseng|american ginseng
5043016|NCT03730298|Cancer related fatigue|cancer related fatigue
5043017|NCT03730298|Breast Cancer Female|breast cancer female
5043018|NCT03730285|telemedicine, patient satisfaction, randomization|telemedicine, patient satisfaction, randomization
5043019|NCT03730259|Pediatric|pediatric
5043020|NCT03730259|Pain|pain
5043021|NCT03730259|Postoperative|postoperative
5043022|NCT03730259|General Anesthesia|general anesthesia
5043023|NCT03730259|Anesthesia Recovery Period|anesthesia recovery period
5043024|NCT03730259|Patient Satisfaction|patient satisfaction
5043025|NCT03730259|mobile health|mobile health
5043026|NCT03730194|Autism Spectrum Disorder|autism spectrum disorder
5043027|NCT03730194|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5043028|NCT03730194|Sleep Disturbance|sleep disturbance
5043029|NCT03730194|Melatonin|melatonin
5043030|NCT03730194|ASD|asd
5043031|NCT03730194|ADHD|adhd
5043032|NCT03730168|Diabetes mellitus.|diabetes mellitus.
5043033|NCT03730168|Inflammatory markers|inflammatory markers
5043037|NCT03730129|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5043039|NCT03730064|NAC|nac
5043040|NCT03730064|N-acetyl cysteine|n-acetyl cysteine
5043047|NCT03730038|Dyslipidemia|dyslipidemia
5043048|NCT03730025|Heart rate|heart rate
5043049|NCT03730025|Assessment|assessment
5043050|NCT03730025|Time|time
5043051|NCT03730025|Resuscitation intervention|resuscitation intervention
5043052|NCT03730012|AML|aml
5043053|NCT03730012|gilteritinib|gilteritinib
5043054|NCT03730012|ASP2215|asp2215
5043055|NCT03730012|Acute Myeloid Leukemia|acute myeloid leukemia
5043056|NCT03730012|FLT3|flt3
5043057|NCT03729895|Orthodontic Appliances|orthodontic appliances
5043058|NCT03729895|Cone-Beam Computed Tomography|cone-beam computed tomography
5043059|NCT03729882|endoscopic ultrasound|endoscopic ultrasound
5043060|NCT03729882|acute cholecystitis|acute cholecystitis
5043061|NCT03729882|cholangiocarcinoma|cholangiocarcinoma
5043062|NCT03729882|gallbladder drainage|gallbladder drainage
5043063|NCT03729882|metallic stents|metallic stents
5043064|NCT03729817|Vertebrobasilar stenosis|vertebrobasilar stenosis
5043065|NCT03729817|Stenosis|stenosis
5043066|NCT03729817|Angioplasty|angioplasty
5043067|NCT03729817|Blood Flow|blood flow
5043068|NCT03729791|Schizophrenia|schizophrenia
5043069|NCT03729791|tDCS|tdcs
5043070|NCT03729791|negative symptoms|negative symptoms
5043078|NCT03729765|veno-arterial extracorporeal membrane oxygenation (VA-ECMO)|veno-arterial extracorporeal membrane oxygenation (va-ecmo)
5043080|NCT03729765|inflammatory factor|inflammatory factor
5043081|NCT03729752|HIV-1-infection|hiv-1-infection
5043082|NCT03729752|PET scan|pet scan
5043084|NCT03729752|Viremia|viremia
5043085|NCT03729752|Antiretroviral therapy|antiretroviral therapy
5043086|NCT03729739|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5043087|NCT03729739|Quantitative Flow Ratio (QFR)|quantitative flow ratio (qfr)
5043088|NCT03729739|Stable coronary artery disease|stable coronary artery disease
5043089|NCT03729739|Angina pectoris|angina pectoris
5043092|NCT03729687|high risk|high risk
5043093|NCT03729687|total neoadjuvant treatment|total neoadjuvant treatment
5043094|NCT03729674|Inflammatory rheumatic diseases Inflammatory Bowel Diseases|inflammatory rheumatic diseases inflammatory bowel diseases
5043095|NCT03729648|Younger Stroke survivors|younger stroke survivors
5043096|NCT03729648|Expressive Arts Therapy|expressive arts therapy
5043097|NCT03729648|Rehabilitation|rehabilitation
5043098|NCT03729648|Randomized Controlled Trial|randomized controlled trial
5043099|NCT03729648|Salivary Cortisol|salivary cortisol
5043100|NCT03729622|FODMAPs|fodmaps
5043101|NCT03729622|Low FODMAP Diet|low fodmap diet
5043102|NCT03729596|antibody-drug conjugate (ADC)|antibody-drug conjugate (adc)
5043103|NCT03729596|B7-H3|b7-h3
5043104|NCT03729596|anti-PD-1|anti-pd-1
5043105|NCT03729570|PrEP|prep
5043106|NCT03729570|MSM|msm
5043107|NCT03729570|HIV|hiv
5043108|NCT03729570|telemedicine|telemedicine
5043109|NCT03729570|randomized controlled trial|randomized controlled trial
5043110|NCT03729557|Kidney donor|kidney donor
5043111|NCT03729544|echocardiography|echocardiography
5043112|NCT03729544|pulmonary embolism|pulmonary embolism
5043113|NCT03729544|pulmonary hypertension|pulmonary hypertension
5043114|NCT03729544|screening|screening
5043115|NCT03729531|Coronary Artery Disease|coronary artery disease
5043116|NCT03729531|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5043117|NCT03729531|Vein Graft Failure|vein graft failure
5043118|NCT03729531|Endothelial dysfunction|endothelial dysfunction
5043119|NCT03729479|dietary intervention|dietary intervention
5043120|NCT03729466|clinical pilates|clinical pilates
5043121|NCT03729453|IPMN|ipmn
5036516|NCT03770884|diet|diet
5043122|NCT03729453|SpyGlass|spyglass
5043123|NCT03729453|Pancreatoscopy|pancreatoscopy
5043124|NCT03729453|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5043125|NCT03729453|Intraoperative|intraoperative
5043126|NCT03729453|Surgical|surgical
5043127|NCT03729427|Erector Spinae Plane|erector spinae plane
5043128|NCT03729427|Erector Spiane Plane Block|erector spiane plane block
5043129|NCT03729427|Rib Cartilage|rib cartilage
5043130|NCT03729414|Hemorrhoid|hemorrhoid
5043131|NCT03729414|Doppler|doppler
5043132|NCT03729414|Mucopexy|mucopexy
5043133|NCT03729401|1-year post myocardial infarction|1-year post myocardial infarction
5043134|NCT03729401|P2Y12 inhibitor|p2y12 inhibitor
5043135|NCT03729401|antiplatelet regimen|antiplatelet regimen
5043136|NCT03729388|Opiate substitution treatment|opiate substitution treatment
5043137|NCT03729388|Opioid-related disorder|opioid-related disorder
5043138|NCT03729388|Behavior|behavior
5043139|NCT03729388|Addictive|addictive
5043140|NCT03729388|Substance-related disorder|substance-related disorder
5043141|NCT03729388|Methadone|methadone
5043157|NCT03729297|adenoid cystic carcinoma|adenoid cystic carcinoma
5043158|NCT03729297|salivary duct carcinoma|salivary duct carcinoma
5043159|NCT03729297|cabozantinib|cabozantinib
5043160|NCT03729297|progression free survival|progression free survival
5043161|NCT03729297|overall survival|overall survival
5043162|NCT03729297|phase 2 clinical trial|phase 2 clinical trial
5043163|NCT03729271|IBS|ibs
5043174|NCT03729245|NKTR-214|nktr-214
5043175|NCT03729245|Nivolumab|nivolumab
5043176|NCT03729245|Opdivo®|opdivo®
5043178|NCT03729245|PD-1|pd-1
5043179|NCT03729245|Bempegaldesleukin|bempegaldesleukin
5043180|NCT03729245|IL-2|il-2
5043186|NCT03729193|musculoskeletal system pain|musculoskeletal system pain
5043187|NCT03729193|athlete|athlete
5043188|NCT03729193|psychosocial problems|psychosocial problems
5043189|NCT03729193|algometer|algometer
5043194|NCT03729141|Cholesterol|cholesterol
5043195|NCT03729141|Adipocyte|adipocyte
5043196|NCT03729141|Macrophage|macrophage
5043197|NCT03729128|amphetamine-type stimulants use disorder|amphetamine-type stimulants use disorder
5043198|NCT03729128|dextromethorphan|dextromethorphan
5043199|NCT03729128|memantine|memantine
5043200|NCT03729128|inflammation|inflammation
5043201|NCT03729128|neurodegeneration|neurodegeneration
5043202|NCT03729102|rabies vaccination|rabies vaccination
5043203|NCT03729050|Mental Disorder|mental disorder
5043204|NCT03729050|Rehabilitation|rehabilitation
5043205|NCT03729037|Virtual learning|virtual learning
5043206|NCT03729037|Educational technology|educational technology
5043207|NCT03729037|Medical education|medical education
5043208|NCT03729011|delirium|delirium
5043209|NCT03729011|Cardiac surgery|cardiac surgery
5043210|NCT03729011|Cardiopulmonary bypass|cardiopulmonary bypass
5043211|NCT03729011|Cognitive dysfunction|cognitive dysfunction
5043212|NCT03728998|Passive leg raise|passive leg raise
5043213|NCT03728998|Fluid responsiveness|fluid responsiveness
5043214|NCT03728998|Cardiac output, non-invasive|cardiac output, non-invasive
5043215|NCT03728998|Emergency Department|emergency department
5043216|NCT03728972|Pembrolizumab|pembrolizumab
5043217|NCT03728972|Early stage NK/T-Cell Lymphoma|early stage nk/t-cell lymphoma
5043218|NCT03728972|18-393|18-393
5043219|NCT03728972|Memorial Sloan kettering Cancer Center|memorial sloan kettering cancer center
5043220|NCT03728959|hypoparathyroidism|hypoparathyroidism
5043221|NCT03728959|Glucose-dependent insulinotropic polypeptide (GIP)|glucose-dependent insulinotropic polypeptide (gip)
5043222|NCT03728959|Glucagon-like peptide-2 (GLP-2)|glucagon-like peptide-2 (glp-2)
5043223|NCT03728959|Bone remodeling|bone remodeling
5043224|NCT03728959|Bone resorption|bone resorption
5043225|NCT03728959|Bone formation|bone formation
5043226|NCT03728959|C-terminal telopeptide (CTX)|c-terminal telopeptide (ctx)
5043227|NCT03728959|N-terminal propeptide of type 1 procollagen (P1NP)|n-terminal propeptide of type 1 procollagen (p1np)
5043229|NCT03728933|Rotigotine|rotigotine
5043230|NCT03728933|Neupro|neupro
5043231|NCT03728907|hearing aid|hearing aid
5043232|NCT03728907|self-fitting|self-fitting
5043233|NCT03728894|Midazolam|midazolam
5043234|NCT03728894|hydroxyzine|hydroxyzine
5043235|NCT03728894|oxygen|oxygen
5043236|NCT03728894|behavior|behavior
5043237|NCT03728894|child|child
5043238|NCT03728894|tooth|tooth
5043248|NCT03728855|Self-administration of medication|self-administration of medication
5043249|NCT03728855|SAM|sam
5043250|NCT03728855|Medication Safety|medication safety
5043251|NCT03728855|Patient Empowerment|patient empowerment
5043252|NCT03728855|Patient Satisfaction|patient satisfaction
5043253|NCT03728855|Staff Satisfaction|staff satisfaction
5043254|NCT03728842|metastatic disease|metastatic disease
5043255|NCT03728842|spontaneous regression|spontaneous regression
5043256|NCT03728829|breast cancer|breast cancer
5043257|NCT03728829|HER2 positive|her2 positive
5043258|NCT03728829|next generation sequencing|next generation sequencing
5043259|NCT03728829|trastuzumab|trastuzumab
5043260|NCT03728829|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5095545|NCT03401203|ISR|isr
5043261|NCT03728816|Community Acquired Pneumonia|community acquired pneumonia
5043262|NCT03728816|Epidemiology|epidemiology
5043263|NCT03728816|Multicenter study|multicenter study
5056627|NCT03645213|venipuncture|venipuncture
5043266|NCT03728790|gestational hypertension|gestational hypertension
5043267|NCT03728790|HELLP|hellp
5043268|NCT03728751|Dry needling|dry needling
5043269|NCT03728751|Autonomic nervous system|autonomic nervous system
5043270|NCT03728751|pupillometry|pupillometry
5043272|NCT03728686|Intubation, Intratracheal|intubation, intratracheal
5043273|NCT03728673|serotonin selective reuptake inhibitor|serotonin selective reuptake inhibitor
5043274|NCT03728673|cognition|cognition
5043275|NCT03728673|escitalopram|escitalopram
5043276|NCT03728660|age related macular degeneration|age related macular degeneration
5043277|NCT03728660|visual impairment|visual impairment
5043278|NCT03728660|virtual reality|virtual reality
5043279|NCT03728621|obesity|obesity
5043280|NCT03728621|child|child
5043282|NCT03728621|lifestyle intervention|lifestyle intervention
5043283|NCT03728608|neonatal intensive care unit (NICU)|neonatal intensive care unit (nicu)
5043284|NCT03728608|feeding tube contamination|feeding tube contamination
5043285|NCT03728595|gas exchange|gas exchange
5043286|NCT03728595|in-flight hypoxia|in-flight hypoxia
5043287|NCT03728595|hypoxic altitude simulation test|hypoxic altitude simulation test
5043288|NCT03728595|blood gas response|blood gas response
5043289|NCT03728582|Aphasia|aphasia
5043290|NCT03728582|Language therapy|language therapy
5043291|NCT03728582|Neurocognitive Disorders|neurocognitive disorders
5043292|NCT03728582|Frontotemporal Dementia|frontotemporal dementia
5043293|NCT03728582|Dementia|dementia
5043294|NCT03728582|Anomia|anomia
5043295|NCT03728543|Anesthesia|anesthesia
5043296|NCT03728543|Pediatrics|pediatrics
5043297|NCT03728543|Pediatric oncology|pediatric oncology
5043298|NCT03728543|MRI anesthesia|mri anesthesia
5043299|NCT03728530|Deep breathing exercises, smokers, lung function|deep breathing exercises, smokers, lung function
5043300|NCT03728517|Narcotic|narcotic
5043301|NCT03728517|Inpatient|inpatient
5043302|NCT03728517|Outpatient|outpatient
5043303|NCT03728517|Comparison|comparison
5043304|NCT03728504|eczema|eczema
5043305|NCT03728504|hand eczema|hand eczema
5043306|NCT03728504|hand dermatitis|hand dermatitis
5043307|NCT03728491|Medical Education|medical education
5043308|NCT03728491|Simulation-based training|simulation-based training
5043309|NCT03728491|Ultrasonography|ultrasonography
5043310|NCT03728491|Thoracic imaging|thoracic imaging
5043311|NCT03728478|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5043312|NCT03728478|treatment|treatment
5043313|NCT03728478|treat to target|treat to target
5043314|NCT03728452|Trophic nutrition|trophic nutrition
5043315|NCT03728452|high flow ventilation|high flow ventilation
5043316|NCT03728452|noninvasive ventilation|noninvasive ventilation
5043317|NCT03728452|mortality|mortality
5043318|NCT03728452|complications|complications
5043319|NCT03728439|Recovery|recovery
5043320|NCT03728439|Rugby|rugby
5043321|NCT03728439|Phototherapy|phototherapy
5043322|NCT03728426|Cytomegalovirus Infections|cytomegalovirus infections
5043323|NCT03728426|CMV|cmv
5043324|NCT03728413|Elderly|elderly
5043325|NCT03728413|Human|human
5043326|NCT03728413|Respiratory Syncytial Infections|respiratory syncytial infections
5043327|NCT03728413|RNA Virus Infections|rna virus infections
5043328|NCT03728387|osteoarthritis|osteoarthritis
5043329|NCT03728387|exercise|exercise
5043330|NCT03728387|balance|balance
5043331|NCT03728348|Sample Collection|sample collection
5043332|NCT03728348|Stool DNA|stool dna
5043333|NCT03728348|Colonoscopy|colonoscopy
5043334|NCT03728283|connective tissue graft|connective tissue graft
5043335|NCT03728283|implant surgery|implant surgery
5043336|NCT03728283|two-stage implants|two-stage implants
5043337|NCT03728283|mucosa thickness|mucosa thickness
5043338|NCT03728283|crestal bone|crestal bone
5043339|NCT03728244|mucoginival defects|mucoginival defects
5043340|NCT03728244|Free gingival graft|free gingival graft
5043341|NCT03728244|palatal donor site|palatal donor site
5043342|NCT03728244|pain|pain
5043343|NCT03728166|venous thromboembolism|venous thromboembolism
5043344|NCT03728166|prevention|prevention
5043345|NCT03728166|medical patients|medical patients
5043346|NCT03728166|hospital discharge|hospital discharge
5043347|NCT03728153|Motor recovery|motor recovery
5043348|NCT03728140|Embryo Transfer|embryo transfer
5043349|NCT03728114|adult|adult
5043350|NCT03728114|remote ischemic conditioning|remote ischemic conditioning
5043351|NCT03728114|high altitude condition|high altitude condition
5043352|NCT03728114|cognitive function|cognitive function
5043353|NCT03728114|blood oxygen levels|blood oxygen levels
5043354|NCT03728088|Non-technical attributes|non-technical attributes
5043355|NCT03728088|Surgical training|surgical training
5043356|NCT03728088|Communication style|communication style
5043357|NCT03728088|Risk aversion|risk aversion
5043358|NCT03728088|Reaction to uncertainty|reaction to uncertainty
5043359|NCT03728088|Self-assessment|self-assessment
5043360|NCT03728075|NMES|nmes
5043361|NCT03728075|IL-6|il-6
5043362|NCT03728075|IL-15|il-15
5043383|NCT03727997|Intensive Care Unit|intensive care unit
5043384|NCT03727984|Myocardial infarction|myocardial infarction
5043385|NCT03727984|Hospitalization|hospitalization
5043386|NCT03727984|Coronary artery disease|coronary artery disease
5043389|NCT03727945|stress urinary incontinence|stress urinary incontinence
5043390|NCT03727945|abdominopelvic exercise|abdominopelvic exercise
5043391|NCT03727945|quality of life|quality of life
5043393|NCT03727919|rehabilitation|rehabilitation
5043394|NCT03727919|robotics|robotics
5043395|NCT03727906|Cardiovascular|cardiovascular
5043396|NCT03727906|Blood Pressure|blood pressure
5043397|NCT03727906|ECG|ecg
5043398|NCT03727906|EEG|eeg
5043399|NCT03727893|manual wheelchairs|manual wheelchairs
5043400|NCT03727893|wheelchair propulsion|wheelchair propulsion
5043401|NCT03727893|high intensity exercise training|high intensity exercise training
5043402|NCT03727880|Pembrolizumab|pembrolizumab
5043403|NCT03727880|Defactinib|defactinib
5043404|NCT03727880|Immunotherapy|immunotherapy
5043405|NCT03727880|Anti-PD-1|anti-pd-1
5043406|NCT03727880|Antibody|antibody
5043407|NCT03727880|PD-L1|pd-l1
5043408|NCT03727880|Pancreatic cancer|pancreatic cancer
5043409|NCT03727880|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5043410|NCT03727880|Adjuvant chemotherapy|adjuvant chemotherapy
5043411|NCT03727880|PDAC - Pancreatic Ductal Adenocarcinoma|pdac - pancreatic ductal adenocarcinoma
5043412|NCT03727880|FAK (focal adhesion kinase) inhibitor|fak (focal adhesion kinase) inhibitor
5043413|NCT03727880|Resectable Pancreatic Adenocarcinoma|resectable pancreatic adenocarcinoma
5043414|NCT03727880|High Risk Resectable Pancreatic Cancer|high risk resectable pancreatic cancer
5043415|NCT03727880|Tumor microenvironment|tumor microenvironment
5043416|NCT03727880|CA 19-9|ca 19-9
5043417|NCT03727880|Surgery|surgery
5043418|NCT03727880|Pancreatectomy|pancreatectomy
5043419|NCT03727854|protein-enriched bar|protein-enriched bar
5043420|NCT03727854|glycemic control|glycemic control
5043421|NCT03727854|type 2 diabetes|type 2 diabetes
5043422|NCT03727854|long term|long term
5043423|NCT03727841|Proteasome Inhibitor|proteasome inhibitor
5043424|NCT03727841|Penetration Across the Blood-Brain-Barrier (BBB)|penetration across the blood-brain-barrier (bbb)
5043425|NCT03727841|Apoptosis Induction|apoptosis induction
5043426|NCT03727841|Targeted Therapeutic Effect|targeted therapeutic effect
5043427|NCT03727841|Tumor Progression|tumor progression
5043428|NCT03727815|mindfulness|mindfulness
5043429|NCT03727815|meditation|meditation
5043430|NCT03727815|patient satisfaction|patient satisfaction
5043431|NCT03727815|rhinoplasty|rhinoplasty
5043432|NCT03727815|pain control|pain control
5043433|NCT03727815|quality of life|quality of life
5043436|NCT03727776|Post-operative Intraocular Inflammation|post-operative intraocular inflammation
5043437|NCT03727763|FLOFIRI|flofiri
5043438|NCT03727763|vemurafenib|vemurafenib
5043439|NCT03727763|cetuximab|cetuximab
5043440|NCT03727763|BRAF V600E mutation|braf v600e mutation
5043441|NCT03727763|Advanced Colorectal Cancer|advanced colorectal cancer
5043442|NCT03727750|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5043443|NCT03727750|Mylotarg|mylotarg
5043444|NCT03727750|QT interval prolongation|qt interval prolongation
5043445|NCT03727750|Pharmacokinetics|pharmacokinetics
5043446|NCT03727750|Safety|safety
5043447|NCT03727750|Veno-occlusive disease|veno-occlusive disease
5043448|NCT03727750|Anti-drug antibody|anti-drug antibody
5043449|NCT03727737|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5043450|NCT03727737|Brain Injuries, Traumatic|brain injuries, traumatic
5043451|NCT03727711|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
5043476|NCT03727464|Anesthesia|anesthesia
5043477|NCT03727464|Language processing|language processing
5043478|NCT03727464|Abstract and Concrete words|abstract and concrete words
5043479|NCT03727464|Neural correlates|neural correlates
5043480|NCT03727451|Pulmonary Hypertension|pulmonary hypertension
5043481|NCT03727451|Pulmonary Fibrosis|pulmonary fibrosis
5043482|NCT03727451|Sarcoidosis|sarcoidosis
5043483|NCT03727438|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
5043487|NCT03727425|Robotic bronchoscopy|robotic bronchoscopy
5043488|NCT03727425|Lung cancer|lung cancer
5043489|NCT03727425|Peripheral lesions|peripheral lesions
5043490|NCT03727412|post implantation syndrome|post implantation syndrome
5043492|NCT03727412|cardiovascular outcome|cardiovascular outcome
5043493|NCT03727412|NSAIDs|nsaids
5043494|NCT03727373|Pain measurement|pain measurement
5043495|NCT03727373|Pain, Chronic or acute|pain, chronic or acute
5043496|NCT03727373|Pain, Cancer|pain, cancer
5043497|NCT03727373|Health technology|health technology
5043498|NCT03727360|Walking Exercise|walking exercise
5043499|NCT03727360|Flexibility Exercise|flexibility exercise
5043500|NCT03727360|Cognition|cognition
5043501|NCT03727360|Memory|memory
5043502|NCT03727360|Magnetic Resonance Imaging|magnetic resonance imaging
5043503|NCT03727321|Fecal microbial transplant|fecal microbial transplant
5043504|NCT03727321|obesity|obesity
5043505|NCT03727321|metabolic syndrome|metabolic syndrome
5043506|NCT03727308|medical abortion|medical abortion
5043507|NCT03727308|self-use|self-use
5043508|NCT03727269|Wii Fit|wii fit
5043509|NCT03727269|Urinary Incontinence|urinary incontinence
5043510|NCT03727269|Females|females
5043511|NCT03727269|Abdomino-Pelvic Training|abdomino-pelvic training
5043512|NCT03727256|knee osteoarthritis|knee osteoarthritis
5043513|NCT03727256|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5043514|NCT03727256|ultrasound therapy|ultrasound therapy
5043515|NCT03727243|Pneumonia|pneumonia
5043516|NCT03727243|Infection|infection
5043517|NCT03727243|Tropical Infection|tropical infection
5043518|NCT03727243|Endotypes|endotypes
5043519|NCT03727243|Biomarkers|biomarkers
5043520|NCT03727243|Immunephenotyping|immunephenotyping
5043521|NCT03727243|Lower middle-income countries (LMIC)|lower middle-income countries (lmic)
5043522|NCT03727243|Microbiome|microbiome
5043523|NCT03727243|Post-sepsis survival|post-sepsis survival
5043524|NCT03727243|Multi-omics|multi-omics
5043528|NCT03727204|Ultrasound|ultrasound
5043529|NCT03727204|Ultrasonographic flow measures|ultrasonographic flow measures
5043530|NCT03727204|Fluid treatment|fluid treatment
5043531|NCT03727191|Deglutition disorders|deglutition disorders
5043532|NCT03727191|Nutritional deficiency|nutritional deficiency
5043533|NCT03727191|Chew problems|chew problems
5043534|NCT03727191|Swallowing disorder|swallowing disorder
5043535|NCT03727191|Nutritional formula|nutritional formula
5043536|NCT03727191|Nutritional oral supplement|nutritional oral supplement
5043537|NCT03727178|Acromioclavicular Joint Dislocation|acromioclavicular joint dislocation
5043538|NCT03727178|AC joint dislocation|ac joint dislocation
5043539|NCT03727178|Treatment|treatment
5043540|NCT03727178|Conservative treatment|conservative treatment
5043541|NCT03727178|Type III AC dislocation|type iii ac dislocation
5043542|NCT03727178|Grade III AC dislocation|grade iii ac dislocation
5043543|NCT03727178|AC joint|ac joint
5043544|NCT03727178|Rockwood|rockwood
5043545|NCT03727178|Rockwood type III|rockwood type iii
5043546|NCT03727178|Rockwood grade III|rockwood grade iii
5043547|NCT03727165|enteral nutrition|enteral nutrition
5043548|NCT03727165|critically ill|critically ill
5056919|NCT03643328|vaccine|vaccine
5043553|NCT03727152|pharmacokinetics (PK) parameters of DTG|pharmacokinetics (pk) parameters of dtg
5043554|NCT03727152|psychiatric symptoms|psychiatric symptoms
5043555|NCT03727152|metabolic syndrome|metabolic syndrome
5043556|NCT03727152|ASCVD risk|ascvd risk
5043557|NCT03727152|liver fibrosis|liver fibrosis
5043558|NCT03727126|Esophagectomy|esophagectomy
5043559|NCT03727126|Robotic esophagectomy|robotic esophagectomy
5043560|NCT03727126|Laparoscopic esophagectomy|laparoscopic esophagectomy
5043561|NCT03727126|Minimally invasive esophagectomy|minimally invasive esophagectomy
5043562|NCT03727126|Ivor Lewis esophagectomy|ivor lewis esophagectomy
5043563|NCT03727126|McKeown's esophagectomy|mckeown's esophagectomy
5043564|NCT03727113|microbiota|microbiota
5043565|NCT03727113|microbiome|microbiome
5043566|NCT03727113|graft versus host disease|graft versus host disease
5043567|NCT03727113|infection|infection
5043568|NCT03727113|antibiotics|antibiotics
5043569|NCT03727074|Actinic Keratosis ,AK|actinic keratosis ,ak
5043570|NCT03727035|CD163, Chronic periodontitis|cd163, chronic periodontitis
5043571|NCT03727022|SM04690|sm04690
5043572|NCT03727022|Wnt pathway inhibitor|wnt pathway inhibitor
5043573|NCT03727022|osteoarthritis|osteoarthritis
5043574|NCT03727022|Samumed|samumed
5043575|NCT03727009|blood draw|blood draw
5043576|NCT03727009|sample collections|sample collections
5043577|NCT03726996|Pediatric genetic disorder|pediatric genetic disorder
5043578|NCT03726996|cognitive function|cognitive function
5043579|NCT03726996|neuro-muscular disorder|neuro-muscular disorder
5043580|NCT03726996|PLA2G6|pla2g6
5044173|NCT03723421|Aspiration|aspiration
5043583|NCT03726983|e-health management|e-health management
5043584|NCT03726983|metabolic syndrome|metabolic syndrome
5043585|NCT03726905|CHF|chf
5043586|NCT03726905|exercise|exercise
5043587|NCT03726905|aerobic|aerobic
5043588|NCT03726905|respiratory muscle training|respiratory muscle training
5043589|NCT03726866|dyslipidemias|dyslipidemias
5043590|NCT03726866|hypertension|hypertension
5043591|NCT03726866|Drug-Drug interaction|drug-drug interaction
5043592|NCT03726853|Acute upper respiratory infection|acute upper respiratory infection
5043593|NCT03726853|Acute bronchitis|acute bronchitis
5043594|NCT03726827|NAFLD|nafld
5043595|NCT03726827|NASH|nash
5043596|NCT03726827|cirrhosis|cirrhosis
5043597|NCT03726827|fatty liver|fatty liver
5043598|NCT03726827|incidence|incidence
5043599|NCT03726827|fibroscan|fibroscan
5043600|NCT03726801|Body image|body image
5043601|NCT03726801|Conservative surgery|conservative surgery
5043602|NCT03726801|Quality of life|quality of life
5043603|NCT03726801|Breast cancer|breast cancer
5043604|NCT03726801|Mastectomy|mastectomy
5043605|NCT03726801|Ostomy|ostomy
5043606|NCT03726801|Colon cancer|colon cancer
5043607|NCT03726801|Self esteem|self esteem
5043608|NCT03726788|knee|knee
5043609|NCT03726788|Arthrosis|arthrosis
5043610|NCT03726788|Botulinum toxin|botulinum toxin
5043611|NCT03726788|Magnetic Resonance Imaging|magnetic resonance imaging
5043612|NCT03726775|durvalumab|durvalumab
5043613|NCT03726775|without prophylactic|without prophylactic
5043614|NCT03726762|diet beverages|diet beverages
5043615|NCT03726762|water|water
5043616|NCT03726762|diabetes|diabetes
5043617|NCT03726762|weight loss|weight loss
5043618|NCT03726762|insulin sensitivity|insulin sensitivity
5043622|NCT03726697|Tahneek|tahneek
5043623|NCT03726697|Neonatal; Hypoglycemia, Diabetes, Maternal|neonatal; hypoglycemia, diabetes, maternal
5043624|NCT03726697|Neonatal Hypoglycemia|neonatal hypoglycemia
5043625|NCT03726697|late preterm infants|late preterm infants
5043626|NCT03726697|Prevention|prevention
5043627|NCT03726697|IUGR|iugr
5043628|NCT03726684|cochlear implant|cochlear implant
5043629|NCT03726684|coding strategy|coding strategy
5043630|NCT03726684|objective measures|objective measures
5043631|NCT03726645|ankylosing spondylitis|ankylosing spondylitis
5043632|NCT03726645|fecal microbiota transplantation|fecal microbiota transplantation
5043633|NCT03726645|intestinal mucosal immunity|intestinal mucosal immunity
5043634|NCT03726645|dysbiosis|dysbiosis
5043635|NCT03726645|microbiome|microbiome
5043636|NCT03726632|Elderly|elderly
5043637|NCT03726632|Intoxication|intoxication
5043638|NCT03726632|Poison Control centre|poison control centre
5043639|NCT03726632|Poisoning|poisoning
5043640|NCT03726632|Accidental exposure|accidental exposure
5043641|NCT03726632|Prevention|prevention
5043642|NCT03726606|Cataract|cataract
5043643|NCT03726606|Intraocular lenses|intraocular lenses
5043644|NCT03726606|Trifocal intraocular lenses|trifocal intraocular lenses
5043645|NCT03726606|Extended depth of focus intraocular lenses|extended depth of focus intraocular lenses
5043646|NCT03726606|Presbyopia|presbyopia
5043647|NCT03726593|malaria|malaria
5043648|NCT03726593|plasmodium falciparum|plasmodium falciparum
5043654|NCT03726593|combination treatment|combination treatment
5043655|NCT03726593|triple therapy|triple therapy
5043656|NCT03726593|multidrug resistant malaria|multidrug resistant malaria
5043657|NCT03726580|General anesthesia.|general anesthesia.
5043658|NCT03726580|neurotoxicity,|neurotoxicity,
5043659|NCT03726580|olfaction,|olfaction,
5043660|NCT03726580|olfactory identification.|olfactory identification.
5351266|NCT01943305|vaccination|vaccination
5043661|NCT03726580|sevoflurane.|sevoflurane.
5043662|NCT03726554|Reverse Shoulder Arthroplasty|reverse shoulder arthroplasty
5043663|NCT03726554|Medical Device|medical device
5043664|NCT03726554|Performance|performance
5043665|NCT03726554|Safety|safety
5043666|NCT03726554|Shoulder Prosthesis|shoulder prosthesis
5043667|NCT03726554|Glenoid Erosion|glenoid erosion
5043668|NCT03726502|Ureteral Calculi|ureteral calculi
5043669|NCT03726502|safety guide-wire|safety guide-wire
5043670|NCT03726502|ureteroscopy|ureteroscopy
5043671|NCT03726450|myo-inositol|myo-inositol
5043672|NCT03726450|N-acetyl-cysteine|n-acetyl-cysteine
5043673|NCT03726450|semen hyperviscosity|semen hyperviscosity
5043674|NCT03726450|idiopathic male infertility|idiopathic male infertility
5043675|NCT03726424|pathogenic mutations|pathogenic mutations
5043676|NCT03726424|clinical phenotype|clinical phenotype
5043677|NCT03726424|prognosis|prognosis
5043678|NCT03726411|periodontitis|periodontitis
5043679|NCT03726411|Prolactin|prolactin
5043681|NCT03726411|non-surgical periodontal treatment|non-surgical periodontal treatment
5043682|NCT03726385|cerebral palsy|cerebral palsy
5043683|NCT03726385|upper extremity rehabilitation|upper extremity rehabilitation
5043689|NCT03726372|neuromuscular blockade|neuromuscular blockade
5043690|NCT03726372|postoperative complication|postoperative complication
5043691|NCT03726333|hepatic impairment|hepatic impairment
5043692|NCT03726333|lorlatinib|lorlatinib
5043693|NCT03726333|cancer|cancer
5043694|NCT03726333|pharmacokinetic|pharmacokinetic
5043695|NCT03726307|allogeneic regulatory dendritic cell therapy (DCreg)|allogeneic regulatory dendritic cell therapy (dcreg)
5043696|NCT03726307|DCreg therapy|dcreg therapy
5043697|NCT03726307|de novo live-donor renal transplant recipients|de novo live-donor renal transplant recipients
5043698|NCT03726255|Perianal fistula|perianal fistula
5043699|NCT03726255|compassionate use|compassionate use
5043700|NCT03726255|mesenchymal stem cells|mesenchymal stem cells
5043701|NCT03726229|liver disease|liver disease
5043702|NCT03726203|Laparoscopy|laparoscopy
5043703|NCT03726203|Trocar|trocar
5043704|NCT03726203|MiniLap|minilap
5043705|NCT03726203|surgery|surgery
5043706|NCT03726203|gynecology|gynecology
5043707|NCT03726203|pain, scars|pain, scars
5043708|NCT03726203|scars|scars
5043709|NCT03726190|Degenerative Disk Disease|degenerative disk disease
5043710|NCT03726190|Lumbar Fusion|lumbar fusion
5043711|NCT03726190|Minimally Invasive Surgery|minimally invasive surgery
5043712|NCT03726190|Lumbar Disk Disease|lumbar disk disease
5043713|NCT03726177|preeclampsia|preeclampsia
5043714|NCT03726177|low dose aspirin|low dose aspirin
5043715|NCT03726177|high risk pregnancy|high risk pregnancy
5043716|NCT03726151|Human Papillomavirus|human papillomavirus
5043717|NCT03726151|Immunization|immunization
5043718|NCT03726151|Oncogenic viruses|oncogenic viruses
5043719|NCT03726151|Cervical Cancer|cervical cancer
5043720|NCT03726151|Health Disparities|health disparities
5043721|NCT03726151|Comparative effectiveness|comparative effectiveness
5043722|NCT03726151|System-level Intervention|system-level intervention
5043723|NCT03726151|Federally Qualified Health Centers|federally qualified health centers
5043726|NCT03726086|larynx|larynx
5043727|NCT03726086|injury|injury
5043728|NCT03726086|voice|voice
5043729|NCT03726086|trachea|trachea
5043730|NCT03726073|cognitive function|cognitive function
5043731|NCT03726073|elderly patients|elderly patients
5043732|NCT03726073|acupoint stimulation|acupoint stimulation
5043733|NCT03726034|Caregiver relationship|caregiver relationship
5043734|NCT03726034|Life story book|life story book
5043735|NCT03726034|migrant caregivers|migrant caregivers
5043736|NCT03726034|older adults|older adults
5043737|NCT03726034|randomized controlled trial|randomized controlled trial
5043738|NCT03726021|overall survival; Irinotecan; Oxaliplatin; S1; Chemotherapy|overall survival; irinotecan; oxaliplatin; s1; chemotherapy
5043739|NCT03725995|midazolam|midazolam
5043740|NCT03725995|Lidocaine|lidocaine
5043741|NCT03725995|Intranasal|intranasal
5043742|NCT03725995|Burning|burning
5043743|NCT03725995|Children|children
5043744|NCT03725982|passive exoskeleton|passive exoskeleton
5043745|NCT03725982|forward trunk flexion|forward trunk flexion
5043746|NCT03725982|trunk rotation|trunk rotation
5043747|NCT03725982|muscle activity|muscle activity
5043748|NCT03725982|inverse dynamics|inverse dynamics
5043749|NCT03725982|modelling|modelling
5057121|NCT03642002|song of kin|song of kin
5043754|NCT03725956|quality of life|quality of life
5043755|NCT03725943|Automated Sleep Staging|automated sleep staging
5043756|NCT03725930|paediatric|paediatric
5043757|NCT03725930|premedication|premedication
5043758|NCT03725930|clonidine|clonidine
5043759|NCT03725930|intranasal|intranasal
5043760|NCT03725917|Prevention|prevention
5043761|NCT03725917|Physiotherapy|physiotherapy
5043762|NCT03725917|Diabetic Foot Ulcer|diabetic foot ulcer
5043763|NCT03725917|Exercise Therapy|exercise therapy
5043764|NCT03725917|Manual Therapy|manual therapy
5043765|NCT03725904|Progesterone|progesterone
5043768|NCT03725904|Frozen embryo transfer|frozen embryo transfer
5043769|NCT03725891|preeclampsia|preeclampsia
5043770|NCT03725891|low dose aspirin|low dose aspirin
5043771|NCT03725891|high risk pregnancy|high risk pregnancy
5729415|NCT00396669|Genetics|genetics
5043776|NCT03725826|Sudden Cardiac Death|sudden cardiac death
5043777|NCT03725826|Acute Myocardial Infarction|acute myocardial infarction
5043778|NCT03725826|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5043779|NCT03725826|Cardiac Magnetic Resonance|cardiac magnetic resonance
5043780|NCT03725813|Person-centred care|person-centred care
5043781|NCT03725813|Intervention|intervention
5043782|NCT03725813|Inpatient care|inpatient care
5043786|NCT03725800|coronary heart disease|coronary heart disease
5043787|NCT03725800|mono-antiplatelet drug|mono-antiplatelet drug
5043788|NCT03725800|antiplatelet-induced gastrointestinal injury symptom|antiplatelet-induced gastrointestinal injury symptom
5043789|NCT03725800|medication adherence|medication adherence
5043790|NCT03725800|prospective observational study|prospective observational study
5043791|NCT03725787|Static air support surface|static air support surface
5043792|NCT03725787|Support device|support device
5043793|NCT03725787|Elderly|elderly
5043794|NCT03725787|Prevention|prevention
5043795|NCT03725774|pain|pain
5043796|NCT03725774|accidental falls|accidental falls
5043797|NCT03725774|urinary incontinence|urinary incontinence
5043798|NCT03725774|clinical audit|clinical audit
5043799|NCT03725761|Prostate|prostate
5043800|NCT03725748|saline, betadine, cesarean scar infection|saline, betadine, cesarean scar infection
5043801|NCT03725735|Gambling disorder|gambling disorder
5043802|NCT03725735|psychiatric comorbidities|psychiatric comorbidities
5043803|NCT03725735|emotion regulation|emotion regulation
5043804|NCT03725670|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5043805|NCT03725670|lentiviral vector|lentiviral vector
5043806|NCT03725631|Magnetic resonance imager(MRI)|magnetic resonance imager(mri)
5043807|NCT03725631|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
5043808|NCT03725631|Biomarker|biomarker
5043809|NCT03725592|arsenic|arsenic
5043810|NCT03725592|drinking water|drinking water
5043811|NCT03725579|Anesthetic efficacy|anesthetic efficacy
5043812|NCT03725579|Inferior alveolar nerve blocks|inferior alveolar nerve blocks
5043813|NCT03725566|New vascular macular degeneration|new vascular macular degeneration
5043814|NCT03725553|vasopressin|vasopressin
5043815|NCT03725553|placenta previa|placenta previa
5043816|NCT03725553|postpartum hemorrhage|postpartum hemorrhage
5043817|NCT03725540|Laryngeal Masks|laryngeal masks
5043818|NCT03725540|Oropharyngeal leak pressure|oropharyngeal leak pressure
5043819|NCT03725540|I-gel laryngeal mask airway|i-gel laryngeal mask airway
5043820|NCT03725488|Dental labs|dental labs
5043821|NCT03725488|genre|genre
5043822|NCT03725488|music|music
5043823|NCT03725488|perceived stress scale|perceived stress scale
5043824|NCT03725488|stress|stress
5043825|NCT03725475|Lung Cancer|lung cancer
5043826|NCT03725384|Anemia|anemia
5043827|NCT03725384|Iron deficiency|iron deficiency
5043828|NCT03725384|hemoglobin|hemoglobin
5043829|NCT03725384|oral iron|oral iron
5043830|NCT03725384|Ferrous sulfate|ferrous sulfate
5043831|NCT03725358|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, LARCs|adolescent sexual and reproductive health, maternal mortality, teen pregnancy, larcs
5043832|NCT03725319|Endoscopic Biliary Sphincterotomy|endoscopic biliary sphincterotomy
5043833|NCT03725319|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5043834|NCT03725319|Bleeding|bleeding
5043835|NCT03725319|Epinephrine|epinephrine
5043836|NCT03725319|Stent|stent
5043837|NCT03725306|Heavy Menstrual Bleeding|heavy menstrual bleeding
5043838|NCT03725306|Endometrial Ablation|endometrial ablation
5043839|NCT03725293|thrombosis|thrombosis
5043840|NCT03725293|superficial venous thrombosis|superficial venous thrombosis
5043841|NCT03725293|deep venous thrombosis|deep venous thrombosis
5043842|NCT03725293|line related infection|line related infection
5043843|NCT03725293|catheter survival|catheter survival
5043844|NCT03725280|Micro RNA|micro rna
5043845|NCT03725280|Ovarian Follicular fluid|ovarian follicular fluid
5043846|NCT03725280|Transgender men|transgender men
5043859|NCT03725202|ABT-494|abt-494
5043860|NCT03725202|Upadacitinib|upadacitinib
5043861|NCT03725189|Photophlethysmograph|photophlethysmograph
5043862|NCT03725189|device|device
5043863|NCT03725189|pulse waveform|pulse waveform
5043864|NCT03725163|Trichotillomania|trichotillomania
5043865|NCT03725163|Adolescents|adolescents
5043866|NCT03725163|Telepsychotherapy|telepsychotherapy
5043867|NCT03725163|AEBT|aebt
5043869|NCT03725072|[14C]-evobrutinib|[14c]-evobrutinib
5043870|NCT03725072|Healthy|healthy
5043871|NCT03725072|Pharmacokinetics|pharmacokinetics
5043872|NCT03725072|Metabolism|metabolism
5043873|NCT03725072|Excretion|excretion
5043878|NCT03725020|Orthodontics|orthodontics
5043879|NCT03725020|Fixed appliance|fixed appliance
5043880|NCT03725020|White Spot Lesions|white spot lesions
5043888|NCT03724994|prognostic|prognostic
5043889|NCT03724994|predictive|predictive
5043890|NCT03724994|immune response|immune response
5043891|NCT03724994|biomarkers|biomarkers
5043892|NCT03724994|mutations|mutations
5043893|NCT03724994|cytokines|cytokines
5043894|NCT03724994|immune cell signatures|immune cell signatures
5043895|NCT03724955|Hypogonadism|hypogonadism
5043896|NCT03724955|Estrogen Supplement|estrogen supplement
5043897|NCT03724929|Ulcerative Colitis|ulcerative colitis
5043898|NCT03724929|Vedolizumab|vedolizumab
5043899|NCT03724929|anti-vedolizumab|anti-vedolizumab
5043900|NCT03724916|Drug therapy|drug therapy
5043901|NCT03724890|Palliative Radiotherapy|palliative radiotherapy
5043902|NCT03724890|Advanced solid tumors|advanced solid tumors
5043904|NCT03724890|Avelumab|avelumab
5043905|NCT03724838|Esomeprazole|esomeprazole
5043906|NCT03724838|Sildenafil Citrate|sildenafil citrate
5043907|NCT03724838|preterm preeclampsia|preterm preeclampsia
5043916|NCT03724812|Heart Valve Disease|heart valve disease
5043917|NCT03724812|High surgical risk|high surgical risk
5043918|NCT03724773|Closed Reduction|closed reduction
5043919|NCT03724773|Sugar-Tong Splint|sugar-tong splint
5043920|NCT03724773|Long-Arm Cast|long-arm cast
5043922|NCT03724734|subthalamic nucleus|subthalamic nucleus
5043923|NCT03724734|deep brain stimulation|deep brain stimulation
5043924|NCT03724734|closed-loop|closed-loop
5043925|NCT03724721|Pneumothorax/therapy|pneumothorax/therapy
5043926|NCT03724721|Drainage|drainage
5043927|NCT03724708|IUD expulsion|iud expulsion
5043928|NCT03724708|hang up technique|hang up technique
5043929|NCT03724708|postpartum insertion|postpartum insertion
5043930|NCT03724656|Transcutaneous Acupoint Electrical Stimulation|transcutaneous acupoint electrical stimulation
5043931|NCT03724656|non-gastrointestinal abdominal surgery|non-gastrointestinal abdominal surgery
5043932|NCT03724656|gastrointestinal motility|gastrointestinal motility
5043933|NCT03724643|Mechanical ventilation|mechanical ventilation
5043934|NCT03724643|Ventilator weaning|ventilator weaning
5043935|NCT03724643|Extubation|extubation
5043936|NCT03724617|thin endometrium|thin endometrium
5043937|NCT03724617|Intrauterine Adhesion|intrauterine adhesion
5043938|NCT03724617|stem cell|stem cell
5043939|NCT03724617|Collagen scaffold|collagen scaffold
5043940|NCT03724604|Neuron-Specific Enolase|neuron-specific enolase
5043941|NCT03724604|Albumin|albumin
5043942|NCT03724604|Prognostic Biomarker|prognostic biomarker
5043943|NCT03724591|left colic artery|left colic artery
5043944|NCT03724591|rectal cancer|rectal cancer
5043945|NCT03724565|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5043946|NCT03724565|air pollution, indoor|air pollution, indoor
5043947|NCT03724565|Respiratory Protective Devices|respiratory protective devices
5043948|NCT03724552|photobiomodulation|photobiomodulation
5043964|NCT03724474|Smart Coaches|smart coaches
5043965|NCT03724461|resistance training|resistance training
5043966|NCT03724461|sarcopenia|sarcopenia
5043967|NCT03724461|hypertrophy|hypertrophy
5043968|NCT03724461|tendon|tendon
5043969|NCT03724461|frailty|frailty
5043970|NCT03724461|ageing|ageing
5043971|NCT03724435|pancreatic cancer|pancreatic cancer
5043972|NCT03724435|focused ultrasound|focused ultrasound
5043973|NCT03724422|Herteropic Ossification|herteropic ossification
5043974|NCT03724409|PRRT|prrt
5043975|NCT03724409|Radionuclide|radionuclide
5043976|NCT03724409|DOTATOC|dotatoc
5043977|NCT03724409|intra-arterial|intra-arterial
5044368|NCT03721861|grasping|grasping
5043993|NCT03724331|Cancer-Related Fatigue|cancer-related fatigue
5043994|NCT03724331|Fatigue|fatigue
5043995|NCT03724331|Symptoms|symptoms
5043996|NCT03724331|Functional Status|functional status
5043997|NCT03724331|Quality of Life|quality of life
5043998|NCT03724331|Lung Cancer|lung cancer
5043999|NCT03724331|Rehabilitation|rehabilitation
5044000|NCT03724331|Exercise|exercise
5044001|NCT03724331|Physical Activity|physical activity
5044002|NCT03724331|Self-Efficacy|self-efficacy
5044003|NCT03724331|Self-Management|self-management
5044004|NCT03724318|Left Atrium Appendage|left atrium appendage
5044005|NCT03724318|Atrial Fibrillation|atrial fibrillation
5044006|NCT03724318|Stroke|stroke
5044007|NCT03724318|Heart Surgery|heart surgery
5044012|NCT03724292|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5044013|NCT03724227|Expanded Access|expanded access
5044014|NCT03724227|Compassionate Use|compassionate use
5044023|NCT03724201|Delirium|delirium
5044024|NCT03724201|Confusion|confusion
5044025|NCT03724201|Neurobehavioral Manifestations|neurobehavioral manifestations
5044026|NCT03724201|Neurologic Manifestations|neurologic manifestations
5044027|NCT03724201|Nervous System Diseases|nervous system diseases
5044028|NCT03724201|Signs and Symptoms|signs and symptoms
5044029|NCT03724201|Neurocognitive Disorders|neurocognitive disorders
5044030|NCT03724201|Mental Disorders|mental disorders
5044031|NCT03724201|Biomarkers|biomarkers
5044032|NCT03724201|Pathophysiology|pathophysiology
5044033|NCT03724175|Ulcerative Colitis|ulcerative colitis
5044034|NCT03724175|Pouchitis|pouchitis
5044035|NCT03724162|cancer oesophagus|cancer oesophagus
5044036|NCT03724149|Lung Disease|lung disease
5044037|NCT03724136|Dementia|dementia
5044038|NCT03724136|Alzheimer's Disease|alzheimer's disease
5044039|NCT03724136|CADASIL|cadasil
5044040|NCT03724136|Autism Spectrum Disorder|autism spectrum disorder
5044041|NCT03724136|Adult Autism|adult autism
5044042|NCT03724136|High Functioning Autism|high functioning autism
5044043|NCT03724136|Asperger's Syndrome|asperger's syndrome
5044044|NCT03724136|CTE Chronic Traumatic Encephalopathy|cte chronic traumatic encephalopathy
5044045|NCT03724136|TBI Traumatic Brain Injury|tbi traumatic brain injury
5044046|NCT03724136|LATE Limbic-predominant Age-related TDP-43 Encephalopathy|late limbic-predominant age-related tdp-43 encephalopathy
5044047|NCT03724123|random forests|random forests
5044048|NCT03724123|heart valve surgery|heart valve surgery
5044049|NCT03724123|support vector machines|support vector machines
5044050|NCT03724123|artificial neural networks|artificial neural networks
5044051|NCT03724110|Telestroke|telestroke
5044052|NCT03724110|Telemedicine|telemedicine
5044053|NCT03724110|Secondary stroke prevention|secondary stroke prevention
5044054|NCT03724097|biomarkers|biomarkers
5044055|NCT03724097|target therapy|target therapy
5044057|NCT03724097|RNAseq|rnaseq
5044058|NCT03724097|mRNA|mrna
5044059|NCT03724097|transcriptome analysis|transcriptome analysis
5044060|NCT03724097|signaling pathway|signaling pathway
5044061|NCT03724097|intracellular molecular pathway|intracellular molecular pathway
5044062|NCT03724097|Oncobox|oncobox
5044063|NCT03724097|Next generation sequencing|next generation sequencing
5044064|NCT03724097|RNA sequencing|rna sequencing
5044065|NCT03724019|Ketamine|ketamine
5044066|NCT03724019|QoR-15|qor-15
5044067|NCT03724019|Laparoscopic surgery|laparoscopic surgery
5044068|NCT03724006|Congenital Heart Defects|congenital heart defects
5057430|NCT03639987|BIIB037|biib037
5044074|NCT03723993|Lactate level|lactate level
5044075|NCT03723993|Cardiopulmonary bypass|cardiopulmonary bypass
5044077|NCT03723967|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5044078|NCT03723967|Recurrent / metastatic SCCHN|recurrent / metastatic scchn
5044079|NCT03723967|Frail patients|frail patients
5044080|NCT03723967|GORTEC|gortec
5044081|NCT03723941|Adrenocortical Carcinoma|adrenocortical carcinoma
5044082|NCT03723941|Adjuvant Chemotherapy|adjuvant chemotherapy
5044083|NCT03723902|Strength training|strength training
5044084|NCT03723902|Pre-frail|pre-frail
5044085|NCT03723889|Near Infrared Spectroscopy|near infrared spectroscopy
5044086|NCT03723889|preterm infants|preterm infants
5044087|NCT03723889|intestinal complications|intestinal complications
5044088|NCT03723876|Autism|autism
5044089|NCT03723876|Movement|movement
5044090|NCT03723876|Body-mind therapy|body-mind therapy
5044091|NCT03723876|Physiotherapy|physiotherapy
5044092|NCT03723850|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5044093|NCT03723850|Memory|memory
5044094|NCT03723850|Prefrontal Cortex|prefrontal cortex
5044096|NCT03723837|Routine immunization|routine immunization
5044097|NCT03723837|Single dose|single dose
5044098|NCT03723837|Persistence of immunity|persistence of immunity
5044099|NCT03723733|amygdala|amygdala
5044100|NCT03723733|mirror neuron system|mirror neuron system
5044101|NCT03723733|brain network|brain network
5044102|NCT03723668|kidney transplantation|kidney transplantation
5044103|NCT03723668|allograft survival|allograft survival
5044104|NCT03723655|Symptomatic, left ventricular outflow tract gradient|symptomatic, left ventricular outflow tract gradient
5044105|NCT03723642|acute appendicitis|acute appendicitis
5044106|NCT03723642|volatile organic compounds|volatile organic compounds
5044107|NCT03723642|oxidative stress|oxidative stress
5044108|NCT03723642|laparoscopic appendectomy|laparoscopic appendectomy
5044109|NCT03723642|open appendectomy|open appendectomy
5044110|NCT03723629|Ground glass opacity|ground glass opacity
5044111|NCT03723616|Hookah|hookah
5044112|NCT03723616|Shisha|shisha
5044113|NCT03723616|Tobacco|tobacco
5044114|NCT03723616|Narghile|narghile
5044115|NCT03723564|bilateral renal agenesis|bilateral renal agenesis
5044116|NCT03723564|lower urinary tract obstruction|lower urinary tract obstruction
5044117|NCT03723564|congenital renal anomalies|congenital renal anomalies
5044118|NCT03723564|fetal surgery|fetal surgery
5044119|NCT03723564|amnioinfusion|amnioinfusion
5044120|NCT03723564|fetus|fetus
5044121|NCT03723525|Package of care|package of care
5044122|NCT03723525|Rapid Initiation of antiretroviral therapy|rapid initiation of antiretroviral therapy
5044123|NCT03723525|Advanced HIV disease|advanced hiv disease
5044124|NCT03723525|mHealth|mhealth
5044125|NCT03723525|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5044126|NCT03723525|Management of advance HIV disease|management of advance hiv disease
5044127|NCT03723512|Non-contrast enhanced MRI|non-contrast enhanced mri
5044128|NCT03723512|Diffusivity|diffusivity
5044129|NCT03723512|Renal microstructure|renal microstructure
5044130|NCT03723512|Renal function|renal function
5044131|NCT03723512|C3G|c3g
5044132|NCT03723512|IC-MPGN|ic-mpgn
5044133|NCT03723499|Carcinoid tumors|carcinoid tumors
5044134|NCT03723499|Endoscopic treatment|endoscopic treatment
5044135|NCT03723499|Recurrence|recurrence
5044136|NCT03723486|Morbidly obese|morbidly obese
5044137|NCT03723486|Insulin resistance|insulin resistance
5044138|NCT03723486|Metabolic syndrome|metabolic syndrome
5044139|NCT03723486|Intestinal microbiome|intestinal microbiome
5044140|NCT03723486|Gastric bypass|gastric bypass
5044141|NCT03723486|Oral microbiome|oral microbiome
5428234|NCT01595568|Mental Disorders|mental disorders
5044144|NCT03723473|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5044145|NCT03723473|Spectroscopy|spectroscopy
5044146|NCT03723473|Revascularization|revascularization
5351658|NCT01941329|Diabetes|diabetes
5044147|NCT03723473|Claudication with surgical planning|claudication with surgical planning
5044148|NCT03723460|Dietary Intake Assessment|dietary intake assessment
5044149|NCT03723460|Malnutrition|malnutrition
5044150|NCT03723447|transversus abdominis plane block|transversus abdominis plane block
5044151|NCT03723447|tap block|tap block
5044152|NCT03723447|liposomal bupivacaine|liposomal bupivacaine
5044153|NCT03723447|exparel|exparel
5044154|NCT03723447|dexamethasone|dexamethasone
5044155|NCT03723447|colorectal surgery|colorectal surgery
5044156|NCT03723447|regional anesthesia|regional anesthesia
5044157|NCT03723447|bupivacaine|bupivacaine
5044158|NCT03723447|surgery|surgery
5044159|NCT03723447|postoperative pain|postoperative pain
5044166|NCT03723434|Multiple sclerosis|multiple sclerosis
5044167|NCT03723434|Transcranial magnetic stimulation|transcranial magnetic stimulation
5044168|NCT03723434|Paired associative stimulation|paired associative stimulation
5044169|NCT03723434|Electroencephalography|electroencephalography
5044170|NCT03723434|Magnetic resonance imaging|magnetic resonance imaging
5044171|NCT03723421|pain management|pain management
5044172|NCT03723421|Vaccination|vaccination
5044180|NCT03723252|SGLT-2 inhibitor|sglt-2 inhibitor
5044181|NCT03723239|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
5044182|NCT03723239|Heart Valve Diseases|heart valve diseases
5044183|NCT03723239|Heart Diseases|heart diseases
5044184|NCT03723239|Cardiovascular Diseases|cardiovascular diseases
5044185|NCT03723213|stroke|stroke
5044186|NCT03723213|occupational therapy|occupational therapy
5044187|NCT03723213|activity daily living|activity daily living
5044188|NCT03723200|Hemorrhagic|hemorrhagic
5044189|NCT03723200|Obstetric|obstetric
5044190|NCT03723200|Fibrinogen|fibrinogen
5044191|NCT03723187|intravenous port|intravenous port
5044192|NCT03723187|port maintenancem|port maintenancem
5044193|NCT03723148|Expanded Access|expanded access
5044194|NCT03723148|Compassionate Use|compassionate use
5044195|NCT03723135|Expanded Access|expanded access
5044196|NCT03723135|Compassionate Use|compassionate use
5044197|NCT03723122|Psychological intervention|psychological intervention
5044198|NCT03723122|Dyadic communication|dyadic communication
5044199|NCT03723122|Dyadic adaptation to cancer|dyadic adaptation to cancer
5044200|NCT03723096|Expanded Access|expanded access
5044201|NCT03723096|Compassionate Use|compassionate use
5044202|NCT03723083|Expanded Access|expanded access
5044203|NCT03723083|Compassionate Use|compassionate use
5044204|NCT03723057|Expanded Access|expanded access
5044205|NCT03723057|Compassionate Use|compassionate use
5044206|NCT03723044|Multistable Perception|multistable perception
5044207|NCT03723044|Micro eye movement|micro eye movement
5044208|NCT03723044|Electroencephalography|electroencephalography
5044209|NCT03723031|hemorrhage|hemorrhage
5044210|NCT03723031|misopristol|misopristol
5044211|NCT03723031|Cesarean section|cesarean section
5044212|NCT03722966|smoking cessation|smoking cessation
5044213|NCT03722966|varenicline|varenicline
5044214|NCT03722966|nicotine gum|nicotine gum
5044215|NCT03722966|nicotine lozenges|nicotine lozenges
5044216|NCT03722966|nicotine replacement therapy|nicotine replacement therapy
5044217|NCT03722966|adherence|adherence
5044218|NCT03722966|mHealth|mhealth
5044219|NCT03722953|Exercise|exercise
5044220|NCT03722953|Treadmill|treadmill
5044221|NCT03722953|Vascular Function|vascular function
5044222|NCT03722953|Intensity|intensity
5044223|NCT03722927|Bupivacaine|bupivacaine
5044224|NCT03722927|Liposomal Bupivacaine|liposomal bupivacaine
5044225|NCT03722927|Mastectomy|mastectomy
5044226|NCT03722927|Breast Reconstruction|breast reconstruction
5044227|NCT03722927|Pain Control|pain control
5044228|NCT03722849|functional brain imaging|functional brain imaging
5044230|NCT03722849|Capsaicin|capsaicin
5044231|NCT03722849|Refractory cough|refractory cough
5044232|NCT03722810|Medical Professionalism|medical professionalism
5044233|NCT03722810|Professionalism Education|professionalism education
5044237|NCT03722771|Lavandula|lavandula
5044238|NCT03722771|phytotherapy|phytotherapy
5044239|NCT03722771|aromatherapy|aromatherapy
5044240|NCT03722771|dental anxiety|dental anxiety
5044241|NCT03722771|anaesthesia|anaesthesia
5044242|NCT03722758|micro hybrid resin composite|micro hybrid resin composite
5044243|NCT03722758|resin-modified glass ionomer|resin-modified glass ionomer
5044244|NCT03722758|split-mouth randomized clinical trial|split-mouth randomized clinical trial
5044247|NCT03722680|Riluzole|riluzole
5044248|NCT03722680|oxaliplatin|oxaliplatin
5044249|NCT03722680|colorectal cancer|colorectal cancer
5044250|NCT03722680|neuropathy|neuropathy
5044251|NCT03722654|Adolescents|adolescents
5044252|NCT03722654|Conduct problems|conduct problems
5044253|NCT03722654|Delinquency|delinquency
5044254|NCT03722654|Substance misuse|substance misuse
5044255|NCT03722602|stroke|stroke
5044280|NCT03722303|lipografting|lipografting
5044281|NCT03722303|numbness|numbness
5044282|NCT03722303|tingling|tingling
5044283|NCT03722303|median nerve|median nerve
5044284|NCT03722290|Metformin|metformin
5044285|NCT03722290|Insulin signalisation|insulin signalisation
5044286|NCT03722251|appetite, food intake, active gaming|appetite, food intake, active gaming
5044287|NCT03722199|flavanols|flavanols
5044288|NCT03722199|diabetes type 2|diabetes type 2
5044289|NCT03722199|essential hypertension|essential hypertension
5044290|NCT03722199|vascular function (peripheral and cerebral)|vascular function (peripheral and cerebral)
5044291|NCT03722186|advanced solid tumor|advanced solid tumor
5044292|NCT03722186|R/R lymphoma|r/r lymphoma
5044293|NCT03722147|immunotherapy|immunotherapy
5044294|NCT03722147|immuno-oncology|immuno-oncology
5044295|NCT03722147|Classic Hodgkin Lymphoma|classic hodgkin lymphoma
5044296|NCT03722134|Great saphenous vein|great saphenous vein
5044297|NCT03722134|Thermal ablation|thermal ablation
5044298|NCT03722134|Mechanochemical ablation|mechanochemical ablation
5044299|NCT03722134|Randomized controlled trial|randomized controlled trial
5044300|NCT03722121|distance|distance
5044301|NCT03722108|adenocarcinoma|adenocarcinoma
5044302|NCT03722108|gastro-oesophageal|gastro-oesophageal
5044303|NCT03722108|regorafenib|regorafenib
5044304|NCT03722095|Non-invasive Brain Stimulation|non-invasive brain stimulation
5044305|NCT03722095|intermittent Theta Burst Stimulation (iTBS)|intermittent theta burst stimulation (itbs)
5044306|NCT03722095|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5044307|NCT03722095|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5044308|NCT03722095|Stress reactivity|stress reactivity
5044309|NCT03722095|Stress-related Disorders|stress-related disorders
5044310|NCT03722095|Major Depressive Disorder|major depressive disorder
5044311|NCT03722082|bipolar disorder|bipolar disorder
5044312|NCT03722082|schizophrenia|schizophrenia
5044313|NCT03722082|offsprings|offsprings
5044314|NCT03722069|Hyponatremia|hyponatremia
5044315|NCT03722069|Sodium Intake|sodium intake
5044316|NCT03722069|Blood Pressure|blood pressure
5044317|NCT03722069|Sodium Chloride|sodium chloride
5044318|NCT03722056|Gastric GISTs|gastric gists
5729513|NCT00396318|CVAD|cvad
5044319|NCT03722056|Submucosal tumours|submucosal tumours
5044320|NCT03722056|Benign gastric lesions|benign gastric lesions
5044321|NCT03722056|Laparoscopic wedge resection|laparoscopic wedge resection
5044322|NCT03722030|Strength Training|strength training
5044323|NCT03722030|Resistance Training|resistance training
5044324|NCT03722030|Obesity|obesity
5044325|NCT03722030|Sedentary|sedentary
5044326|NCT03722017|deprescriptions|deprescriptions
5044327|NCT03722017|polypharmacy|polypharmacy
5044328|NCT03722017|potentially inappropriate medication|potentially inappropriate medication
5044329|NCT03722017|medication adherence|medication adherence
5044330|NCT03722004|monovalent oral poliovirus vaccine type 1|monovalent oral poliovirus vaccine type 1
5044331|NCT03722004|bivalent oral poliovirus vaccine|bivalent oral poliovirus vaccine
5044332|NCT03722004|inactivated poliovirus vaccine|inactivated poliovirus vaccine
5044333|NCT03722004|fractional inactivated poliovirus vaccine|fractional inactivated poliovirus vaccine
5044334|NCT03722004|humoral immunity|humoral immunity
5044335|NCT03722004|intestinal immunity|intestinal immunity
5044336|NCT03722004|Bangladesh|bangladesh
5044337|NCT03721991|beta cell|beta cell
5044338|NCT03721978|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5044340|NCT03721978|CIN 3|cin 3
5044341|NCT03721978|Human papillomavirus (HPV)|human papillomavirus (hpv)
5044342|NCT03721978|HPV-16|hpv-16
5044343|NCT03721978|HPV-18|hpv-18
5044344|NCT03721978|High Grade Squamous Intraepithelial Lesion (HSIL)|high grade squamous intraepithelial lesion (hsil)
5044345|NCT03721978|papillomavirus|papillomavirus
5044351|NCT03721926|Other Cancer|other cancer
5044352|NCT03721913|Autism|autism
5044353|NCT03721913|participation-based intervention|participation-based intervention
5045315|NCT03715894|PPI|ppi
5044356|NCT03721913|randomized controlled trial|randomized controlled trial
5044357|NCT03721900|Depression|depression
5044358|NCT03721887|Parkinson's disease|parkinson's disease
5044359|NCT03721887|Multiple system atrophy|multiple system atrophy
5044360|NCT03721887|Freezing of gait|freezing of gait
5044361|NCT03721887|Transcranial direct current stimulation|transcranial direct current stimulation
5044362|NCT03721874|Dapagliflozin|dapagliflozin
5044363|NCT03721874|Disrupted glucose homeostasis|disrupted glucose homeostasis
5044364|NCT03721874|Nocturnal substrate oxidation|nocturnal substrate oxidation
5044365|NCT03721874|Glucose metabolism|glucose metabolism
5044366|NCT03721861|neural stimulation|neural stimulation
5044367|NCT03721861|quadriplegia|quadriplegia
5351851|NCT01940393|desloratadine|desloratadine
5044379|NCT03721770|Post Traumatic Stress Disorder|post traumatic stress disorder
5044381|NCT03721757|Head and Neck cancer|head and neck cancer
5044382|NCT03721757|Squamous cell carcinoma|squamous cell carcinoma
5044383|NCT03721744|Pancreatic Cancer|pancreatic cancer
5044384|NCT03721718|MERS CoV|mers cov
5044385|NCT03721718|MERS-CoV|mers-cov
5044386|NCT03721718|Middle East Respiratory Syndrome|middle east respiratory syndrome
5044387|NCT03721718|MERS|mers
5044388|NCT03721718|DNA Vaccine|dna vaccine
5044389|NCT03721679|Immunotherapy|immunotherapy
5044390|NCT03721679|Vaccine Therapy|vaccine therapy
5044391|NCT03721666|Dispatcher-assisted cardiopulmonary resuscitation|dispatcher-assisted cardiopulmonary resuscitation
5044392|NCT03721666|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5044393|NCT03721666|Emergency Medical dispatcher|emergency medical dispatcher
5044394|NCT03721653|FOLFOXIRI|folfoxiri
5044395|NCT03721653|Bevacizumab|bevacizumab
5044396|NCT03721653|Atezolizumab|atezolizumab
5044397|NCT03721640|INSURE (Intubation / surfactant / extubation)|insure (intubation / surfactant / extubation)
5044398|NCT03721640|LISA (Less-invasive surfactant administration)|lisa (less-invasive surfactant administration)
5044399|NCT03721640|surfactant|surfactant
5044400|NCT03721640|propofol|propofol
5044401|NCT03721627|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
5044402|NCT03721627|Gaucher disease|gaucher disease
5044404|NCT03721601|atrial fibrillation|atrial fibrillation
5044405|NCT03721601|stroke|stroke
5044406|NCT03721601|atrial fibrillation screening|atrial fibrillation screening
5044407|NCT03721601|heart rate monitoring|heart rate monitoring
5044408|NCT03721562|Antibiotic Resistance|antibiotic resistance
5044409|NCT03721562|Gram Negative Bacteria|gram negative bacteria
5044410|NCT03721562|Pediatric Patients|pediatric patients
5044411|NCT03721536|Morbidly obese patients|morbidly obese patients
5044412|NCT03721536|Bariatric surgery|bariatric surgery
5044413|NCT03721536|Arterial blood analysis|arterial blood analysis
5044415|NCT03721510|AIDS|aids
5044416|NCT03721510|Monoclonal antibodies|monoclonal antibodies
5044417|NCT03721510|Neutralizing antibodies|neutralizing antibodies
5044418|NCT03721510|Analytical treatment interruption|analytical treatment interruption
5044419|NCT03721406|ropivacaine|ropivacaine
5044420|NCT03721406|undergoing ultrasound guided thoracic paravertebral block|undergoing ultrasound guided thoracic paravertebral block
5044421|NCT03721393|tilt table test, valsalva|tilt table test, valsalva
5044422|NCT03721380|Behavior drug and risk reduction counseling|behavior drug and risk reduction counseling
5044423|NCT03721380|Heroin|heroin
5044424|NCT03721380|Addiction treatment|addiction treatment
5044425|NCT03721380|Randomization|randomization
5044426|NCT03721380|Treatment effect|treatment effect
5044428|NCT03721328|Knee|knee
5044429|NCT03721328|Biofilm|biofilm
5044430|NCT03721328|Minimum-biofilm-eradication-concentration|minimum-biofilm-eradication-concentration
5044431|NCT03721263|Allergic disorder|allergic disorder
5044432|NCT03721237|Esophageal catheter calibration|esophageal catheter calibration
5044433|NCT03721237|Assisted mechanical ventilation|assisted mechanical ventilation
5044434|NCT03721224|psychiatry, children, habit cough|psychiatry, children, habit cough
5044435|NCT03721211|Breast Cancer|breast cancer
5044436|NCT03721185|obesity|obesity
5044437|NCT03721185|overweight|overweight
5044438|NCT03721185|fat percentage|fat percentage
5044439|NCT03721185|body fat|body fat
5044440|NCT03721185|lipolytic cream|lipolytic cream
5044454|NCT03721159|Micro-RNA|micro-rna
5044455|NCT03721159|Chronic periodontitis|chronic periodontitis
5044456|NCT03721146|Encapsulated bacterial Infection|encapsulated bacterial infection
5044457|NCT03721146|Primary immune deficiency|primary immune deficiency
5044458|NCT03721146|Secondary immune deficiency|secondary immune deficiency
5044459|NCT03721146|Adult|adult
5044460|NCT03721107|constipation|constipation
5044461|NCT03721107|diarrhea|diarrhea
5044462|NCT03721068|Autologous Chimeric Antigen Receptor (CAR) T Cells|autologous chimeric antigen receptor (car) t cells
5356174|NCT01920477|autoimmune disorder|autoimmune disorder
5044463|NCT03721068|Interleukin (IL)-15|interleukin (il)-15
5044464|NCT03721068|Disialoganglioside (GD2)|disialoganglioside (gd2)
5044465|NCT03721068|Caspase 9|caspase 9
5044466|NCT03721068|Pediatric|pediatric
5044467|NCT03721068|Rimiducid|rimiducid
5044468|NCT03721068|AP1903|ap1903
5044469|NCT03721068|modified T cells|modified t cells
5044470|NCT03721068|CAR T|car t
5044475|NCT03721029|Robotic prostatectomy|robotic prostatectomy
5044477|NCT03721029|Urethral sphincter|urethral sphincter
5044478|NCT03720990|7-Dehydrocholesterol reductase deficiency|7-dehydrocholesterol reductase deficiency
5044479|NCT03720951|Pulsed Radiofrequency|pulsed radiofrequency
5044480|NCT03720951|chronic Prostatitis|chronic prostatitis
5044481|NCT03720938|inactive children|inactive children
5044499|NCT03720808|venous blood sample|venous blood sample
5044500|NCT03720808|non-pharmacological method|non-pharmacological method
5044501|NCT03720782|Legion|legion
5044502|NCT03720756|nickel-free|nickel-free
5044503|NCT03720756|diet|diet
5044504|NCT03720756|GERD|gerd
5044505|NCT03720756|Gastroesophageal Reflux|gastroesophageal reflux
5044506|NCT03720743|Biodanza|biodanza
5044507|NCT03720743|libido|libido
5044508|NCT03720743|sexual excitement|sexual excitement
5044509|NCT03720743|sexual inhibition|sexual inhibition
5044510|NCT03720743|young adults|young adults
5044511|NCT03720743|dance therapy|dance therapy
5044512|NCT03720743|complementary therapies|complementary therapies
5044513|NCT03720730|Suicidal crisis|suicidal crisis
5044514|NCT03720730|Suicidal behaviour|suicidal behaviour
5044515|NCT03720730|Prevention|prevention
5044516|NCT03720730|Smartphone application|smartphone application
5044517|NCT03720730|Ecological momentary assessment|ecological momentary assessment
5044518|NCT03720730|Psychiatry|psychiatry
5044519|NCT03720730|Follow-up|follow-up
5044520|NCT03720704|Lesion-exclusion|lesion-exclusion
5044521|NCT03720704|Visceral Perfusion|visceral perfusion
5044522|NCT03720704|Luminal Reconstruction|luminal reconstruction
5044523|NCT03720704|Occlusive Disease|occlusive disease
5044524|NCT03720691|parkinsonism|parkinsonism
5044525|NCT03720691|vascular parkinsonism|vascular parkinsonism
5044526|NCT03720691|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5044527|NCT03720691|brain stimulation|brain stimulation
5044528|NCT03720652|Stress Reduction|stress reduction
5044529|NCT03720652|Certified Nursing Assistants|certified nursing assistants
5044530|NCT03720652|Long-Term Care|long-term care
5044531|NCT03720652|Staff Turnover|staff turnover
5044532|NCT03720652|Mindful Self-Compassion|mindful self-compassion
5044533|NCT03720639|Implantable Loop Recorder|implantable loop recorder
5044534|NCT03720639|Implantable Cardiac Monitor|implantable cardiac monitor
5044535|NCT03720639|Cryptogenic Stroke|cryptogenic stroke
5044536|NCT03720626|Sickle cell disease|sickle cell disease
5044537|NCT03720626|sickle cell anemia|sickle cell anemia
5044538|NCT03720626|vaso-occlusive crisis|vaso-occlusive crisis
5044539|NCT03720626|P-selectin|p-selectin
5044540|NCT03720626|SEG101|seg101
5044541|NCT03720626|crizanlizumab|crizanlizumab
5044542|NCT03720626|monoclonal antibody|monoclonal antibody
5044543|NCT03720626|Anemia, Sickle Cell|anemia, sickle cell
5044544|NCT03720626|HbS Disease|hbs disease
5044545|NCT03720626|Hemoglobin SC Disease|hemoglobin sc disease
5044546|NCT03720626|Sickle Cell Disorders|sickle cell disorders
5044547|NCT03720626|Sickling Disorder Due to Hemoglobin S|sickling disorder due to hemoglobin s
5044548|NCT03720626|Adult|adult
5044549|NCT03720626|Hb SS|hb ss
5044550|NCT03720626|Hb SC|hb sc
5044551|NCT03720626|Hb Sβ+-thalassemia|hb sβ+-thalassemia
5044552|NCT03720626|Hb Sβ0-thalassemia|hb sβ0-thalassemia
5044553|NCT03720626|Expanded Access Use|expanded access use
5044554|NCT03720626|Pain Crisis|pain crisis
5044555|NCT03720626|Compassionate Use|compassionate use
5044556|NCT03720613|naloxegol|naloxegol
5044557|NCT03720613|major adverse cardiovascular event (MACE)|major adverse cardiovascular event (mace)
5044558|NCT03720613|opioid induced constipation (OIC)|opioid induced constipation (oic)
5044559|NCT03720613|lubiprostone|lubiprostone
5044560|NCT03720613|naldemedine|naldemedine
5044561|NCT03720600|mindfulness|mindfulness
5044562|NCT03720600|acceptance|acceptance
5044563|NCT03720600|racism|racism
5044564|NCT03720587|GTPS|gtps
5044565|NCT03720587|Gluteal tendinopathy|gluteal tendinopathy
5044566|NCT03720587|Lateral hip pain|lateral hip pain
5057939|NCT03636594|Dance|dance
5044591|NCT03720405|Esophageal segmentation|esophageal segmentation
5044592|NCT03720405|Regression equation|regression equation
5044593|NCT03720392|Allogeneic Hematopoietic Cell Transplantation (HCT)|allogeneic hematopoietic cell transplantation (hct)
5044594|NCT03720379|fluoride varnish|fluoride varnish
5044595|NCT03720379|dental caries|dental caries
5044596|NCT03720379|ADOLESCENTS|adolescents
5044597|NCT03720366|Enasidenib|enasidenib
5044598|NCT03720366|CC-90007|cc-90007
5044599|NCT03720366|Acute Myeloid Leukemia|acute myeloid leukemia
5044600|NCT03720340|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5044601|NCT03720340|Acute Radiation Oral Mucositis|acute radiation oral mucositis
5044602|NCT03720340|Recombinant human interleukin-11|recombinant human interleukin-11
5044603|NCT03720340|oral microflora|oral microflora
5044604|NCT03720301|Sore Throat|sore throat
5044605|NCT03720301|Osteopathic Manipulation|osteopathic manipulation
5044606|NCT03720301|Post operative sore throat|post operative sore throat
5044607|NCT03720301|Endotracheal tube|endotracheal tube
5044608|NCT03720275|proportion, TTR-FAP, study, neuropathy|proportion, ttr-fap, study, neuropathy
5044609|NCT03720236|dental implant|dental implant
5044610|NCT03720236|immediate loading|immediate loading
5044611|NCT03720236|periimplant tissues|periimplant tissues
5044612|NCT03720223|Buccal mucosal graft|buccal mucosal graft
5044613|NCT03720210|Hyperthyroidism|hyperthyroidism
5044614|NCT03720210|RFA|rfa
5044615|NCT03720184|Retrograde autologous priming|retrograde autologous priming
5044616|NCT03720184|RAP|rap
5044617|NCT03720184|HAR|har
5044618|NCT03720184|cardiopulmonary bypass|cardiopulmonary bypass
5044619|NCT03720184|Extracorporeal circulation|extracorporeal circulation
5044620|NCT03720184|Gaseous microemboli|gaseous microemboli
5044621|NCT03720184|perfusion|perfusion
5044625|NCT03720158|Head and Neck Neoplasms|head and neck neoplasms
5044626|NCT03720158|Omega 3 PolyUnsaturated Fatty Acid (PUFA)|omega 3 polyunsaturated fatty acid (pufa)
5044627|NCT03720158|Quality of Life|quality of life
5044628|NCT03720158|Radiotherapy|radiotherapy
5044629|NCT03720158|Cancer Cachexia|cancer cachexia
5044630|NCT03720145|Depression|depression
5044631|NCT03720145|Lifestyle Medicine|lifestyle medicine
5044632|NCT03720132|Vancomycin|vancomycin
5044633|NCT03720132|Therapeutic drug monitoring|therapeutic drug monitoring
5044634|NCT03720132|Catheter related blood stream infections|catheter related blood stream infections
5044635|NCT03720119|wound healing|wound healing
5044636|NCT03720119|pain|pain
5044637|NCT03720119|lidocaine|lidocaine
5044638|NCT03720106|interdisciplinarity|interdisciplinarity
5044639|NCT03720106|therapy planning|therapy planning
5044640|NCT03720106|assessment|assessment
5044641|NCT03720106|stroke|stroke
5044642|NCT03720106|neurorehabilitation|neurorehabilitation
5044643|NCT03720106|physical therapy|physical therapy
5044644|NCT03720106|occupational therapy|occupational therapy
5044645|NCT03720106|neuropsychology|neuropsychology
5044646|NCT03720106|logopedia|logopedia
5044647|NCT03720093|ventilation|ventilation
5044648|NCT03720093|intubation|intubation
5044649|NCT03720093|pulmonary microbiome|pulmonary microbiome
5044650|NCT03720080|Type 1 Diabetes|type 1 diabetes
5044651|NCT03720080|Artificial Pancreas|artificial pancreas
5044652|NCT03720080|Medtronic 670G|medtronic 670g
5044654|NCT03720041|Multiple Myeloma|multiple myeloma
5044655|NCT03720041|Lenalidomide|lenalidomide
5044656|NCT03720041|Ixazomib|ixazomib
5044657|NCT03720041|Dexamethasone|dexamethasone
5044658|NCT03720041|Revlimid|revlimid
5044659|NCT03720041|Ninlaro|ninlaro
5044660|NCT03720041|Non-transplant eligible myeloma patients|non-transplant eligible myeloma patients
5044661|NCT03720041|Newly diagnosed myeloma|newly diagnosed myeloma
5044662|NCT03720041|Double blind|double blind
5044663|NCT03720041|Placebo|placebo
5044664|NCT03720041|Frailty scoring|frailty scoring
5044665|NCT03720041|Frailty score-adjusted dosing|frailty score-adjusted dosing
5044666|NCT03719976|Refugee Health|refugee health
5044667|NCT03719976|Immigrant Health|immigrant health
5044677|NCT03719859|reverse total shoulder arthroplasty|reverse total shoulder arthroplasty
5044678|NCT03719859|physical therapy|physical therapy
5044679|NCT03719833|Breast Cancer|breast cancer
5044680|NCT03719833|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5044681|NCT03719833|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5044682|NCT03719820|Acute Ischemic Stroke|acute ischemic stroke
5044683|NCT03719820|Intracranial Atherosclerosis ICAS|intracranial atherosclerosis icas
5044684|NCT03719820|HRMRI|hrmri
5044685|NCT03719807|rehabilitation|rehabilitation
5044686|NCT03719807|post-operative|post-operative
5044687|NCT03719807|scoliosis correction|scoliosis correction
5044688|NCT03719768|Whole Brain Radiotherapy|whole brain radiotherapy
5044689|NCT03719768|meningeal|meningeal
5044690|NCT03719768|LMDz|lmdz
5044691|NCT03719768|brain metastases|brain metastases
5044692|NCT03719768|Immunotherapy|immunotherapy
5044693|NCT03719716|Oncology|oncology
5044694|NCT03719716|Palliative Care|palliative care
5044695|NCT03719716|Primary care|primary care
5044696|NCT03719716|Care planning|care planning
5044697|NCT03719703|Frozen embryo transfer; cardiovascular; metabolic; IVF|frozen embryo transfer; cardiovascular; metabolic; ivf
5044698|NCT03719690|TIPIFARNIB|tipifarnib
5044699|NCT03719690|HEAD AND NECK CANCER|head and neck cancer
5044700|NCT03719664|HIV-1|hiv-1
5044701|NCT03719664|3BNC117|3bnc117
5044702|NCT03719664|Albuvirtide|albuvirtide
5044703|NCT03719664|Broadly neutralizing antibody|broadly neutralizing antibody
5044704|NCT03719664|Long-Acting HIV-1 Fusion Inhibitor|long-acting hiv-1 fusion inhibitor
5044705|NCT03719651|Implementation|implementation
5044706|NCT03719651|Implementation strategy|implementation strategy
5044707|NCT03719651|Leadership|leadership
5044708|NCT03719651|Organizational climate|organizational climate
5044709|NCT03719651|Fidelity|fidelity
5044710|NCT03719651|PTSD treatment|ptsd treatment
5044711|NCT03719638|D-Blade|d-blade
5044712|NCT03719638|Macintosh videolaryngoscope blade|macintosh videolaryngoscope blade
5044713|NCT03719638|Simulated difficult intubation|simulated difficult intubation
5044731|NCT03719573|perioperative care|perioperative care
5044733|NCT03719573|quality of recovery|quality of recovery
5044734|NCT03719573|colorectal|colorectal
5044735|NCT03719547|Cervical cancer|cervical cancer
5044736|NCT03719547|Robot-assisted surgery|robot-assisted surgery
5044737|NCT03719547|Sentinel node biopsy|sentinel node biopsy
5044738|NCT03719547|Laparotomy|laparotomy
5044739|NCT03719547|Recurrence|recurrence
5044740|NCT03719547|Survival|survival
5044746|NCT03719508|Nutritional assesment|nutritional assesment
5044747|NCT03719508|Nutritional screening tools|nutritional screening tools
5044748|NCT03719508|Abdominal Surgery|abdominal surgery
5044749|NCT03719508|Stomach Neoplasms|stomach neoplasms
5044750|NCT03719508|Colorectal Surgery|colorectal surgery
5044752|NCT03719456|Renal stone|renal stone
5044754|NCT03719456|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
5044755|NCT03719456|Flexible ureteroscope|flexible ureteroscope
5044756|NCT03719443|chronic glomerular disease|chronic glomerular disease
5044757|NCT03719443|autoimmune glomerulonephritis|autoimmune glomerulonephritis
5044758|NCT03719430|Leiomyosarcoma|leiomyosarcoma
5044759|NCT03719430|Liposarcoma|liposarcoma
5044760|NCT03719430|Pleomorphic sarcoma|pleomorphic sarcoma
5044761|NCT03719430|Synovial sarcoma|synovial sarcoma
5044762|NCT03719430|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
5352169|NCT01939106|Stoma|stoma
5044763|NCT03719430|Spindle cell sarcoma|spindle cell sarcoma
5044764|NCT03719417|Knee Pain|knee pain
5044765|NCT03719404|Retreatment|retreatment
5044766|NCT03719404|Irrigants|irrigants
5044768|NCT03719391|Electronic Nicotine Delivery System|electronic nicotine delivery system
5044769|NCT03719391|Combustible Cigarettes|combustible cigarettes
5044770|NCT03719391|Nicotine|nicotine
5044771|NCT03719378|Fluid Management|fluid management
5044773|NCT03719365|NAVA|nava
5044774|NCT03719365|Driving Pressure|driving pressure
5044775|NCT03719365|Mechanical Assisted Ventilation|mechanical assisted ventilation
5044776|NCT03719339|Kidney disease|kidney disease
5044777|NCT03719339|Kidney allograph|kidney allograph
5044778|NCT03719300|BCG-unresponsive|bcg-unresponsive
5044779|NCT03719248|Epidural.|epidural.
5044780|NCT03719248|ventricular mass|ventricular mass
5044781|NCT03719248|Aortic valve|aortic valve
5044782|NCT03719248|coronary bypass|coronary bypass
5044783|NCT03719222|Genomic profiling assay|genomic profiling assay
5044784|NCT03719209|Crohns disease|crohns disease
5044785|NCT03719209|Patient Education|patient education
5044786|NCT03719209|Ulcerative Colitis|ulcerative colitis
5044787|NCT03719209|Celiac|celiac
5044788|NCT03719209|Ulcer|ulcer
5044789|NCT03719209|Polyp|polyp
5044790|NCT03719209|Gastrointestinal bleeding|gastrointestinal bleeding
5044791|NCT03719209|Inflammatory Bowel Disease|inflammatory bowel disease
5044792|NCT03719209|Virtual Reality|virtual reality
5044793|NCT03719196|Presbyopia|presbyopia
5044794|NCT03719196|Quality of life|quality of life
5044795|NCT03719196|Reading glass|reading glass
5044796|NCT03719196|Productivity|productivity
5044798|NCT03719170|proton pump inhibitors|proton pump inhibitors
5044799|NCT03719170|program evaluation|program evaluation
5044800|NCT03719170|low-value care|low-value care
5044801|NCT03719170|de-implementation|de-implementation
5044802|NCT03719170|patient safety|patient safety
5044803|NCT03719079|Fluid decompensation|fluid decompensation
5044804|NCT03719079|Non-invasive Multi-parameter monitoring|non-invasive multi-parameter monitoring
5044805|NCT03719079|Multi-parameter algorithm|multi-parameter algorithm
5044806|NCT03719079|Heart Rate Variability|heart rate variability
5044807|NCT03719079|Thoracic impedance|thoracic impedance
5044808|NCT03719079|Heart Sounds|heart sounds
5044809|NCT03719079|Respiration|respiration
5044810|NCT03719079|Posture|posture
5044811|NCT03719079|Activity|activity
5044812|NCT03719079|Tidal Volume|tidal volume
5044813|NCT03719079|Stroke Volume|stroke volume
5044822|NCT03718949|general anesthesia|general anesthesia
5044823|NCT03718949|cardiac output,Ultrasonography|cardiac output,ultrasonography
5044824|NCT03718949|Ultrasonography|ultrasonography
5044825|NCT03718936|ADNP|adnp
5044826|NCT03718936|Intellectual Disability|intellectual disability
5044827|NCT03718936|Autism Spectrum Disorder|autism spectrum disorder
5044828|NCT03718936|Global Developmental Delay|global developmental delay
5044829|NCT03718936|Neurodevelopmental Deficits|neurodevelopmental deficits
5044830|NCT03718936|Developmental Disability|developmental disability
5044831|NCT03718923|FOXP1|foxp1
5044832|NCT03718923|Intellectual Disability|intellectual disability
5044833|NCT03718923|Autism Spectrum Disorder|autism spectrum disorder
5044834|NCT03718923|Global Developmental Delay|global developmental delay
5044835|NCT03718923|Neurodevelopmental Deficits|neurodevelopmental deficits
5044836|NCT03718923|Developmental Disability|developmental disability
5044837|NCT03718910|DDX3X|ddx3x
5044838|NCT03718910|Intellectual Disability|intellectual disability
5044839|NCT03718910|Global Developmental Delay|global developmental delay
5044840|NCT03718910|Neurodevelopmental Deficits|neurodevelopmental deficits
5044841|NCT03718910|Developmental Disability|developmental disability
5044842|NCT03718845|Empathy|empathy
5044843|NCT03718845|Hope|hope
5044844|NCT03718832|Diabetes|diabetes
5044845|NCT03718819|multiple sclerosis|multiple sclerosis
5044846|NCT03718819|pilates|pilates
5044847|NCT03718819|aquatherapy|aquatherapy
5044848|NCT03718819|postural control|postural control
5044849|NCT03718819|dual task|dual task
5044850|NCT03718780|transcutaneous PtCO2|transcutaneous ptco2
5044851|NCT03718780|dead space|dead space
5044852|NCT03718780|exercise test|exercise test
5044853|NCT03718767|PD 1 Pathway|pd 1 pathway
5044854|NCT03718767|High Tumor Mutational Load|high tumor mutational load
5044855|NCT03718767|Immune Checkpoint|immune checkpoint
5044856|NCT03718767|Quality of Life|quality of life
5044857|NCT03718728|Overweight|overweight
5044858|NCT03718728|Obesity|obesity
5044859|NCT03718728|Adults|adults
5044860|NCT03718728|Mindfulness|mindfulness
5044861|NCT03718728|Acceptance|acceptance
5044862|NCT03718728|Emotional eating|emotional eating
5044863|NCT03718715|Metformin|metformin
5044864|NCT03718715|Gastrointestinal side effects|gastrointestinal side effects
5044879|NCT03718585|Chronic Kidney Disease|chronic kidney disease
5044880|NCT03718585|Whole Exome Sequencing|whole exome sequencing
5044881|NCT03718559|Edoxaban|edoxaban
5044882|NCT03718559|antiplatelet|antiplatelet
5044883|NCT03718559|anticoagulant|anticoagulant
5044885|NCT03718520|cannabis|cannabis
5044886|NCT03718520|fetal programming|fetal programming
5044887|NCT03718520|pregnancy|pregnancy
5352278|NCT01938625|RBV|rbv
5044888|NCT03718520|infant neuroimaging|infant neuroimaging
5044889|NCT03718481|ARCP|arcp
5044890|NCT03718481|Surgical Training|surgical training
5044891|NCT03718481|Assessment|assessment
5044892|NCT03718481|Qualitative|qualitative
5044898|NCT03718416|observational|observational
5044899|NCT03718416|non-interventional|non-interventional
5044900|NCT03718416|Prader-Willi syndrome|prader-willi syndrome
5044901|NCT03718416|PWS|pws
5044902|NCT03718403|PHP|php
5044903|NCT03718364|atrial fibrillation|atrial fibrillation
5044904|NCT03718364|pulmonary vein isolation|pulmonary vein isolation
5044905|NCT03718351|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5044906|NCT03718351|Endoscopic submucosal dissection|endoscopic submucosal dissection
5044907|NCT03718351|Minimally invasive surgery|minimally invasive surgery
5044908|NCT03718325|Burst-SCS|burst-scs
5044909|NCT03718325|Chronic pain|chronic pain
5044910|NCT03718325|Spinal cord stimulation|spinal cord stimulation
5044911|NCT03718312|Clamping|clamping
5044912|NCT03718312|pre-conditioning|pre-conditioning
5044913|NCT03718273|Ivabradine|ivabradine
5044914|NCT03718273|Digoxin|digoxin
5044915|NCT03718273|Atrial Fibrillation|atrial fibrillation
5044916|NCT03718273|Heart rate control|heart rate control
5044917|NCT03718260|Prostate Cancer|prostate cancer
5044918|NCT03718260|Biochemical Failure|biochemical failure
5044919|NCT03718260|Node positive|node positive
5044920|NCT03718260|PSMA-PET|psma-pet
5044921|NCT03718260|[18F]DCFPyL PET/CT imaging|[18f]dcfpyl pet/ct imaging
5044924|NCT03718247|Ketogenic diet|ketogenic diet
5044925|NCT03718234|adrenal gland diseases|adrenal gland diseases
5044926|NCT03718234|cortisol succinate|cortisol succinate
5044927|NCT03718234|hydrocortisone|hydrocortisone
5044929|NCT03718182|vitamin D supplementation|vitamin d supplementation
5044930|NCT03718182|quality of life|quality of life
5044931|NCT03718182|Inflammatory Bowel Disease Questionnaire IBDQ|inflammatory bowel disease questionnaire ibdq
5044932|NCT03718182|Hepcidin|hepcidin
5044933|NCT03718169|women|women
5044940|NCT03718117|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5044941|NCT03718117|crizotinib|crizotinib
5044942|NCT03718117|ALK gene rearrangement or ROS1 gene rearrangement|alk gene rearrangement or ros1 gene rearrangement
5044943|NCT03718104|naltrexone|naltrexone
5044944|NCT03718104|buprenorphine/naloxone|buprenorphine/naloxone
5044945|NCT03718104|maternal relapse|maternal relapse
5044946|NCT03718104|retention in care|retention in care
5044947|NCT03718104|pharmacokinetics|pharmacokinetics
5044948|NCT03718104|pharmacogenetics|pharmacogenetics
5044949|NCT03718091|Solid Tumor|solid tumor
5044950|NCT03718091|leiomyosarcoma|leiomyosarcoma
5044951|NCT03718091|Osteosarcoma|osteosarcoma
5044952|NCT03718039|bunion|bunion
5044953|NCT03718039|bunionectomy|bunionectomy
5044954|NCT03718039|bunion surgery|bunion surgery
5044955|NCT03718039|postoperative pain|postoperative pain
5044956|NCT03718026|The timed 360° turn test|the timed 360° turn test
5044957|NCT03718026|Multiple sclerosis|multiple sclerosis
5044958|NCT03718026|reliability|reliability
5044959|NCT03718026|validity|validity
5044960|NCT03718000|Holiday weight gain|holiday weight gain
5044961|NCT03718000|Daily self-weighing|daily self-weighing
5044962|NCT03718000|Weight maintenance|weight maintenance
5044963|NCT03718000|Caloric titration method|caloric titration method
5044964|NCT03718000|Obesity|obesity
5044965|NCT03718000|Overweight|overweight
5044966|NCT03718000|Holiday season|holiday season
5044967|NCT03717987|gummy smile|gummy smile
5044968|NCT03717987|Botulinum toxin type A|botulinum toxin type a
5044969|NCT03717987|excessive gingival display|excessive gingival display
5044971|NCT03717974|medico-economic|medico-economic
5044972|NCT03717974|neurological disability|neurological disability
5044973|NCT03717961|Raynaud Phenomenon|raynaud phenomenon
5044974|NCT03717961|Systemic Sclerosis|systemic sclerosis
5044975|NCT03717961|Botulinum toxin A|botulinum toxin a
5044976|NCT03717948|Acute Exercise|acute exercise
5044977|NCT03717948|Mitochondria|mitochondria
5044978|NCT03717948|Skeletal Muscle|skeletal muscle
5044979|NCT03717948|PGC1α|pgc1α
5044980|NCT03717948|Mitochondrial Biogenesis|mitochondrial biogenesis
5044981|NCT03717948|Intracellular Signalling|intracellular signalling
5044982|NCT03717935|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5044983|NCT03717922|Ultrasound|ultrasound
5044984|NCT03717922|MRI|mri
5044985|NCT03717922|Learning|learning
5044986|NCT03717922|Memory|memory
5044987|NCT03717922|Cognitive Neural Prosthetic|cognitive neural prosthetic
5044988|NCT03717909|Wolfram Syndrome|wolfram syndrome
5044989|NCT03717909|Treat Wolfram|treat wolfram
5044990|NCT03717909|Sodium valproate|sodium valproate
5044991|NCT03717896|diabetic ketoacidosis|diabetic ketoacidosis
5044992|NCT03717896|DKA|dka
5044993|NCT03717896|thiamine|thiamine
5044994|NCT03717896|acidosis|acidosis
5044995|NCT03717896|oxygen consumption|oxygen consumption
5044996|NCT03717896|lactate|lactate
5044997|NCT03717883|hepatic transporters|hepatic transporters
5044998|NCT03717870|Endometrioma|endometrioma
5044999|NCT03717870|Infertility|infertility
5045000|NCT03717870|Laparoscopy|laparoscopy
5045001|NCT03717870|GnRH-a|gnrh-a
5045002|NCT03717870|Assisted Reproduction Technology|assisted reproduction technology
5045003|NCT03717870|Reproductive outcomes|reproductive outcomes
5045004|NCT03717857|Latino children|latino children
5045005|NCT03717857|middles school|middles school
5045006|NCT03717857|sleep hygiene|sleep hygiene
5045007|NCT03717857|educational intervention|educational intervention
5045008|NCT03717831|muscle ultrasound|muscle ultrasound
5045009|NCT03717831|post-intensive care syndrome|post-intensive care syndrome
5045010|NCT03717831|physical function|physical function
5045011|NCT03717831|muscle tissue analysis|muscle tissue analysis
5045012|NCT03717805|Patient-centered care|patient-centered care
5045021|NCT03717727|Total knee replacement|total knee replacement
5045022|NCT03717727|Exergame|exergame
5045023|NCT03717727|Total knee arthroplasty|total knee arthroplasty
5045024|NCT03717727|Exercise|exercise
5045025|NCT03717727|Physiotherapy|physiotherapy
5045026|NCT03717727|Physical functioning|physical functioning
5045027|NCT03717701|preeclampsia|preeclampsia
5045028|NCT03717701|esomeprazole|esomeprazole
5045029|NCT03717701|metformin|metformin
5045030|NCT03717688|GLP-1|glp-1
5045031|NCT03717688|Neprilysin|neprilysin
5045032|NCT03717688|DPP-4|dpp-4
5045033|NCT03717662|women|women
5045034|NCT03717584|microbiota|microbiota
5045043|NCT03717493|Binge-Eating Disorder|binge-eating disorder
5045044|NCT03717493|Affect Regulation Training|affect regulation training
5045045|NCT03717493|Emotion Regulation|emotion regulation
5045046|NCT03717493|Transdiagnostic|transdiagnostic
5045047|NCT03717480|Graft vs. Host Disease|graft vs. host disease
5045048|NCT03717480|Hematologic Malignancy|hematologic malignancy
5045049|NCT03717467|Magnesium sulfate|magnesium sulfate
5045050|NCT03717467|Morphine requirement|morphine requirement
5045051|NCT03717467|Hepatotomy|hepatotomy
5045052|NCT03717467|Orthotopic liver transplantation|orthotopic liver transplantation
5045053|NCT03717454|Dopamine agonist|dopamine agonist
5045054|NCT03717454|Dopamine D2 receptors|dopamine d2 receptors
5045055|NCT03717454|PET-MR|pet-mr
5045056|NCT03717415|rebastinib|rebastinib
5045057|NCT03717415|breast cancer|breast cancer
5045058|NCT03717415|ovarian cancer|ovarian cancer
5045059|NCT03717415|mesothelioma|mesothelioma
5045060|NCT03717402|Cancer|cancer
5045061|NCT03717402|Pain management|pain management
5045062|NCT03717402|Opioid use|opioid use
5045063|NCT03717402|Health app|health app
5045064|NCT03717402|Gastrointestinal cancer|gastrointestinal cancer
5045065|NCT03717402|Breast cancer|breast cancer
5045066|NCT03717402|Lung cancer|lung cancer
5045067|NCT03717389|prevalence|prevalence
5045257|NCT03716206|Stroke|stroke
5045071|NCT03717376|Early Maladaptive Scheme|early maladaptive scheme
5045072|NCT03717376|Parkinson|parkinson
5045073|NCT03717376|Dystonia|dystonia
5045074|NCT03717363|Training Programme|training programme
5045075|NCT03717363|Physical Activity|physical activity
5045076|NCT03717363|cardiovascular primary prevention|cardiovascular primary prevention
5045077|NCT03717350|biomarkers|biomarkers
5045078|NCT03717350|suPAR|supar
5045079|NCT03717350|outcome|outcome
5045080|NCT03717350|antibiotics|antibiotics
5045081|NCT03717337|Regeneration, mature teeth, regenerative procedures|regeneration, mature teeth, regenerative procedures
5045082|NCT03717324|Emergency Department|emergency department
5045083|NCT03717324|Geriatrics|geriatrics
5045085|NCT03717311|biomarkers|biomarkers
5045086|NCT03717311|fermentation|fermentation
5045087|NCT03717311|labeled wheat bran|labeled wheat bran
5045088|NCT03717298|Nutritional supplement|nutritional supplement
5369184|NCT01860937|Chimeric Antigen Receptor (CAR) Modified T cells|chimeric antigen receptor (car) modified t cells
5369185|NCT01860937|Conditioning Chemotherapy|conditioning chemotherapy
5369187|NCT01860924|exercise|exercise
5369188|NCT01860924|depression|depression
5369189|NCT01860924|smoking|smoking
5369190|NCT01860898|lung|lung
5369191|NCT01860898|cancer|cancer
5369192|NCT01860898|thoracic|thoracic
5369193|NCT01860898|chest|chest
5369194|NCT01860898|pulmonary|pulmonary
5369195|NCT01860885|naloxone|naloxone
5369196|NCT01860885|children|children
5369197|NCT01860885|opioid|opioid
5369198|NCT01860885|respiratory depression|respiratory depression
5369199|NCT01860885|safety|safety
5369200|NCT01860872|Cystic Fibrosis|cystic fibrosis
5369201|NCT01860872|Pulmonary perfusion|pulmonary perfusion
5369202|NCT01860872|Inflammatory markers|inflammatory markers
5369203|NCT01860872|MRI|mri
5369204|NCT01860872|CT of chest|ct of chest
5369205|NCT01860872|Lung Clearance Index|lung clearance index
5369206|NCT01860859|cesarean|cesarean
5369207|NCT01860859|ultrasound|ultrasound
5369208|NCT01860859|hysterotomy|hysterotomy
5369209|NCT01860859|uterus|uterus
5369210|NCT01860859|suture|suture
5369211|NCT01860846|Crohn's Disease|crohn's disease
5369212|NCT01860833|Knee Osteoarthritis|knee osteoarthritis
5369213|NCT01860820|IPC/TEDS|ipc/teds
5369214|NCT01860820|Geko device|geko device
5369215|NCT01860807|methamphetamine|methamphetamine
5369216|NCT01860807|ibudilast|ibudilast
5369217|NCT01860807|HIV|hiv
5369218|NCT01860781|Schizophrenia|schizophrenia
5369219|NCT01860781|Injection|injection
5369220|NCT01860781|Switch|switch
5369221|NCT01860781|Paliperidone|paliperidone
5369222|NCT01860781|refractory, chronic akathisia, poor complianc|refractory, chronic akathisia, poor complianc
5369223|NCT01860768|Acute aortic dissection|acute aortic dissection
5369224|NCT01860768|Serum biomarkers|serum biomarkers
5369225|NCT01860768|Early diagnosis|early diagnosis
5369226|NCT01860755|Sport-related concussion|sport-related concussion
5369227|NCT01860755|Dizziness|dizziness
5369228|NCT01860755|Neck pain|neck pain
5369229|NCT01860755|Headaches|headaches
5369230|NCT01860755|Physiotherapy|physiotherapy
5369231|NCT01860755|Treatment|treatment
5369232|NCT01860742|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
5369233|NCT01860742|Neuroendocrine Tumors|neuroendocrine tumors
5369234|NCT01860742|Interferon alpha|interferon alpha
5369235|NCT01860716|Melatonin, liver transplant, oxidative stress|melatonin, liver transplant, oxidative stress
5369236|NCT01860703|Ferriprox®|ferriprox®
5369237|NCT01860703|LI|li
5369238|NCT01860703|DFP|dfp
5369239|NCT01860703|Deferiprone|deferiprone
5369240|NCT01860703|Healthy Volunteers|healthy volunteers
5369241|NCT01860690|MTX|mtx
5369242|NCT01860690|Ectopic pregnancy|ectopic pregnancy
5369243|NCT01860690|medical treatment|medical treatment
5369244|NCT01860677|cranial stimulation|cranial stimulation
5369252|NCT01860664|hydrocortisone|hydrocortisone
5369253|NCT01860664|ophthalmic|ophthalmic
5369254|NCT01860664|ointment|ointment
5369255|NCT01860651|Inflammatory Bowel Disease|inflammatory bowel disease
5369256|NCT01860651|Ulcerative Colitis|ulcerative colitis
5369257|NCT01860651|Crohn´s Disease|crohn´s disease
5369258|NCT01860651|Children|children
5369259|NCT01860651|Adolescence|adolescence
5369260|NCT01860651|E-health web-monitoring|e-health web-monitoring
5369261|NCT01860651|Adherence|adherence
5369262|NCT01860651|Disease activity|disease activity
5369263|NCT01860651|Fecal Calprotectin|fecal calprotectin
5369264|NCT01860599|prediabetes|prediabetes
5369266|NCT01860599|vascular reactivity|vascular reactivity
5369269|NCT01860586|Proliferative Vitreoretinopathy|proliferative vitreoretinopathy
5369270|NCT01860586|retinal detachment|retinal detachment
5369271|NCT01860586|detachment|detachment
5369272|NCT01860573|Amino acids|amino acids
5369273|NCT01860573|Protein|protein
5369274|NCT01860560|OSA|osa
5369275|NCT01860560|Obstructive Sleep Apnea|obstructive sleep apnea
5369276|NCT01860560|High Flow Therapy|high flow therapy
5369277|NCT01860560|CPAP|cpap
5369278|NCT01860560|HFT|hft
5369279|NCT01860560|Continuous Positive Airway Pressure|continuous positive airway pressure
5369280|NCT01860560|Mild OSA|mild osa
5369281|NCT01860560|Moderate OSA|moderate osa
5369282|NCT01860534|pain|pain
5369283|NCT01860534|mydriasis|mydriasis
5369284|NCT01860534|light|light
5369285|NCT01860521|Termination of pregnancy|termination of pregnancy
5369286|NCT01860521|Second trimester|second trimester
5369287|NCT01860521|Programmed intermittent epidural bolus|programmed intermittent epidural bolus
5369288|NCT01860521|Continuous epidural infusion|continuous epidural infusion
5369289|NCT01860521|Epidural analgesia|epidural analgesia
5369290|NCT01860521|Legally Induced Abortion|legally induced abortion
5369291|NCT01860508|Progression free Survival|progression free survival
5369292|NCT01860495|growth factors|growth factors
5369293|NCT01860495|periodontal pockets|periodontal pockets
5369294|NCT01860482|Refractory Reflux Esophagitis|refractory reflux esophagitis
5369295|NCT01860482|GERD|gerd
5369296|NCT01860482|Phase 4|phase 4
5369297|NCT01860456|Chronic myeloid leukemia|chronic myeloid leukemia
5357006|NCT01917136|FDG|fdg
5369298|NCT01860456|Imatinib|imatinib
5369299|NCT01860456|Nilotinib|nilotinib
5369303|NCT01860456|SLC Transporters|slc transporters
5369304|NCT01860456|Treatment outcome|treatment outcome
5369306|NCT01860443|depression|depression
5369307|NCT01860443|adolescents|adolescents
5369308|NCT01860417|Degenerative Disc Disease,|degenerative disc disease,
5369309|NCT01860417|Intervertebral Disc Disease|intervertebral disc disease
5369310|NCT01860417|Low Back Pain|low back pain
5369311|NCT01860417|Nucleus pulposus|nucleus pulposus
5369312|NCT01860417|Stem cell|stem cell
5369313|NCT01860417|Cellular therapy|cellular therapy
5369314|NCT01860417|Regenerative therapy|regenerative therapy
5369315|NCT01860417|Mesenchymal stem cells|mesenchymal stem cells
5369316|NCT01860417|Bone marrow|bone marrow
5369317|NCT01860417|Musculoskeletal Diseases|musculoskeletal diseases
5369318|NCT01860417|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
5369323|NCT01860391|Silver|silver
5369324|NCT01860391|Fluoride|fluoride
5369325|NCT01860391|Diammine Silver Fluoride|diammine silver fluoride
5369326|NCT01860391|Saliva|saliva
5369327|NCT01860378|Whooping Cough|whooping cough
5369328|NCT01860378|Pertussis|pertussis
5369329|NCT01860378|Tdap vaccination|tdap vaccination
5369330|NCT01860378|Randomized placebo controlled factorial trial|randomized placebo controlled factorial trial
5369336|NCT01860352|Fish Oil|fish oil
5369337|NCT01860352|colon health|colon health
5369338|NCT01860352|fatty acid metabolism|fatty acid metabolism
5369339|NCT01860339|Huntington's Disease|huntington's disease
5369340|NCT01860339|HD|hd
5369341|NCT01860339|Huntington Disease|huntington disease
5369342|NCT01860326|hepatic impairment|hepatic impairment
5369343|NCT01860326|mild and moderate hepatic impairment|mild and moderate hepatic impairment
5369344|NCT01860326|Alisporivir|alisporivir
5369345|NCT01860313|effectiveness|effectiveness
5369346|NCT01860313|distance learning|distance learning
5369347|NCT01860313|mental health|mental health
5369348|NCT01860300|Tic Disorders|tic disorders
5369349|NCT01860300|Tourette Syndrome|tourette syndrome
5369350|NCT01860287|opioid|opioid
5369351|NCT01860287|subjective|subjective
5369352|NCT01860287|stress|stress
5369353|NCT01860287|buprenorphine|buprenorphine
5369354|NCT01860274|Mesh|mesh
5369355|NCT01860274|Graft|graft
5369356|NCT01860274|Patency|patency
5369358|NCT01860261|AIDS|aids
5369359|NCT01860261|sedentary|sedentary
5369360|NCT01860261|fitness|fitness
5369361|NCT01860261|aging|aging
5369362|NCT01860261|V02max|v02max
5369363|NCT01860261|d-dimer|d-dimer
5369364|NCT01860261|IL-6|il-6
5369365|NCT01860261|CRP|crp
5369366|NCT01860261|ChiWalking|chiwalking
5355306|NCT01924585|Surgery|surgery
5369367|NCT01860261|ChiRunning|chirunning
5369368|NCT01860261|aerobic exercise|aerobic exercise
5369369|NCT01860261|strength training|strength training
5369370|NCT01860248|vapocoolant effectiveness|vapocoolant effectiveness
5369371|NCT01860248|arterial puncture|arterial puncture
5369372|NCT01860235|Local anesthesia|local anesthesia
5369373|NCT01860235|Pain measurement|pain measurement
5373078|NCT01844557|Surveys|surveys
5369374|NCT01860235|Pain perception|pain perception
5369375|NCT01860235|Dental anesthesia|dental anesthesia
5369376|NCT01860235|Root planing|root planing
5369377|NCT01860222|Hepatocellular carcinoma|hepatocellular carcinoma
5369378|NCT01860222|CSPH|csph
5369379|NCT01860222|Hepatectomy|hepatectomy
5369380|NCT01860222|percutaneous local ablative|percutaneous local ablative
5369381|NCT01860222|therapy (PLAT)|therapy (plat)
5369382|NCT01860222|randomized controlled trials(RCTs)|randomized controlled trials(rcts)
5369383|NCT01860209|obstructive sleep apnea|obstructive sleep apnea
5369384|NCT01860209|overhydration|overhydration
5369385|NCT01860209|end stage renal disease|end stage renal disease
5369386|NCT01860209|intermittent ambulatory hemodialysis|intermittent ambulatory hemodialysis
5369387|NCT01860209|polysomnography|polysomnography
5369388|NCT01860209|bioimpedance|bioimpedance
5369389|NCT01860209|leg fluid shift|leg fluid shift
5369390|NCT01860209|neck circumference|neck circumference
5369391|NCT01860183|kidney transplantation|kidney transplantation
5369392|NCT01860183|chronic allograft dysfunction|chronic allograft dysfunction
5369393|NCT01860183|mycophenolate mofetil|mycophenolate mofetil
5369394|NCT01860183|Chronic|chronic
5369395|NCT01860170|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
5369396|NCT01860170|MRD|mrd
5369397|NCT01860170|MUD|mud
5369398|NCT01860170|GVHD|gvhd
5369399|NCT01860157|rTMS|rtms
5369400|NCT01860157|depression|depression
5369401|NCT01860157|magnetic|magnetic
5369402|NCT01860144|bevacizumab|bevacizumab
5369403|NCT01860144|overall survival|overall survival
5369404|NCT01860144|adverse events|adverse events
5369405|NCT01860144|tumor resection rate|tumor resection rate
5369410|NCT01860066|COPD|copd
5369411|NCT01860014|Pulmonary hemorrhage|pulmonary hemorrhage
5369412|NCT01860014|Mortality|mortality
5369413|NCT01860014|Newborn|newborn
5369414|NCT01860001|cancer|cancer
5369415|NCT01860001|metabolic acidosis|metabolic acidosis
5369416|NCT01859988|Eczema|eczema
5369417|NCT01859962|Liver diseases|liver diseases
5369418|NCT01859962|Virus diseases|virus diseases
5369419|NCT01859962|Ribavirin|ribavirin
5369420|NCT01859962|protease inhibitor|protease inhibitor
5369421|NCT01859962|NS5B polymerase inhibitor|ns5b polymerase inhibitor
5369422|NCT01859962|NS5A inhibitor|ns5a inhibitor
5369423|NCT01859949|Genotropin(somatropin)|genotropin(somatropin)
5369424|NCT01859949|SGA|sga
5369425|NCT01859949|Short Stature|short stature
5369426|NCT01859949|Long-term|long-term
5369427|NCT01859949|Safety|safety
5369428|NCT01859923|Tuberculosis|tuberculosis
5369429|NCT01859923|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
5369430|NCT01859923|Mycobacterium Infections|mycobacterium infections
5369431|NCT01859923|Actinomycetales Infections|actinomycetales infections
5369432|NCT01859923|Gram-Positive Infections|gram-positive infections
5369433|NCT01859923|Bacterial Infections|bacterial infections
5369434|NCT01859923|Pediatric|pediatric
5369435|NCT01859884|Kidney transplantation|kidney transplantation
5369436|NCT01859884|Increased risk donor kidneys|increased risk donor kidneys
5369437|NCT01859884|Kidney donation|kidney donation
5369438|NCT01859884|Organ donation|organ donation
5369439|NCT01859884|Human Immunodeficiency Virus|human immunodeficiency virus
5369440|NCT01859884|Hepatitis B|hepatitis b
5369441|NCT01859884|Hepatitis C|hepatitis c
5369442|NCT01859884|Infectious disease|infectious disease
5369443|NCT01859884|Disease transmission|disease transmission
5369444|NCT01859884|Centers for Disease Control (CDC)|centers for disease control (cdc)
5352701|NCT01936467|FNA|fna
5369445|NCT01859884|Web-based intervention|web-based intervention
5369446|NCT01859871|Living kidney donation|living kidney donation
5369447|NCT01859871|End-stage renal disease|end-stage renal disease
5369448|NCT01859871|Latinos|latinos
5369449|NCT01859871|Undocumented Immigrants|undocumented immigrants
5369450|NCT01859871|Bilingual|bilingual
5369451|NCT01859871|Spanish|spanish
5369452|NCT01859871|Website|website
5369453|NCT01859871|Dialysis|dialysis
5369454|NCT01859871|Hispanics|hispanics
5369455|NCT01859871|Transplantation|transplantation
5369456|NCT01859858|mCRC (metastatic colorectal cancer)|mcrc (metastatic colorectal cancer)
5369457|NCT01859858|CRC (colorectal cancer)|crc (colorectal cancer)
5369458|NCT01859858|Advanced colorectal cancer|advanced colorectal cancer
5369459|NCT01859858|Metastatic colorectal cancer|metastatic colorectal cancer
5369460|NCT01859858|Colon cancer|colon cancer
5369461|NCT01859845|Melanoma|melanoma
5369462|NCT01859845|Opportunistic surveillance|opportunistic surveillance
5369463|NCT01859845|Melanoma simulation model|melanoma simulation model
5369464|NCT01859845|Smartphone devices|smartphone devices
5369465|NCT01859832|renal transplant|renal transplant
5369466|NCT01859832|kidney transplantation|kidney transplantation
5369467|NCT01859832|immune status|immune status
5369468|NCT01859832|immunosuppressive medications|immunosuppressive medications
5369469|NCT01859819|Pediatric|pediatric
5369470|NCT01859819|Lymphoma (NOT primary mediastinal B-cell lymphoma)|lymphoma (not primary mediastinal b-cell lymphoma)
5369471|NCT01859819|B-Cell---Burkitt's like|b-cell---burkitt's like
5369473|NCT01859819|Liposomal ARA-C|liposomal ara-c
5369474|NCT01859806|periampullary tumour|periampullary tumour
5369475|NCT01859806|isolated Roux loop PJ|isolated roux loop pj
5369476|NCT01859806|PG|pg
5369477|NCT01859793|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
5369478|NCT01859793|endothelium, vascular|endothelium, vascular
5369479|NCT01859793|diabetes type 2|diabetes type 2
5369480|NCT01859793|nitric oxide|nitric oxide
5369481|NCT01859793|inflammation|inflammation
5369482|NCT01859780|Poison control|poison control
5369483|NCT01859780|Child resistant packaging|child resistant packaging
5369484|NCT01859780|prescription vials|prescription vials
5369485|NCT01859780|prescription blisters|prescription blisters
5369486|NCT01859780|drug packaging|drug packaging
5369487|NCT01859767|Alzheimer's disease|alzheimer's disease
5369488|NCT01859767|SPECT|spect
5369489|NCT01859754|Primary Immune Deficiency Syndrome|primary immune deficiency syndrome
5369490|NCT01859754|Primary immunodeficiency Disease (PIDD)|primary immunodeficiency disease (pidd)
5369491|NCT01859754|PID|pid
5369492|NCT01859741|Newly diagnosed Stage IV Small Cell Lung Cancer|newly diagnosed stage iv small cell lung cancer
5369493|NCT01859728|biliary cancer|biliary cancer
5369494|NCT01859728|irinotecan|irinotecan
5369495|NCT01859728|cisplatin|cisplatin
5369496|NCT01859728|gemcitabine|gemcitabine
5369497|NCT01859715|Drug Interactions|drug interactions
5369499|NCT01859715|opioid efficacy|opioid efficacy
5369501|NCT01859715|nausea|nausea
5369502|NCT01859702|Aqueous Humor|aqueous humor
5369503|NCT01859702|Moxifloxacin|moxifloxacin
5369504|NCT01859702|Vigadexa|vigadexa
5369505|NCT01859663|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5369506|NCT01859663|Diet|diet
5369507|NCT01859663|Exercise|exercise
5369508|NCT01859663|Questionnaires|questionnaires
5369509|NCT01859663|Health Beliefs|health beliefs
5369510|NCT01859637|Filgrastim, immunogenicity, severe chronic neutropenia|filgrastim, immunogenicity, severe chronic neutropenia
5369511|NCT01859624|LOPD|lopd
5369512|NCT01859624|Pompe Disease|pompe disease
5369513|NCT01859598|diabetes|diabetes
5002861|NCT03978104|Singapore|singapore
5357286|NCT01915628|TVR|tvr
5369514|NCT01859598|basal insulin|basal insulin
5369515|NCT01859598|effectiveness and safety|effectiveness and safety
5369516|NCT01859598|oral antidiabetic drugs|oral antidiabetic drugs
5369517|NCT01859598|real world clinical practice|real world clinical practice
5369518|NCT01859585|preemptive analgesia|preemptive analgesia
5369519|NCT01859585|lumbar fusion|lumbar fusion
5369520|NCT01859585|Parecoxib|parecoxib
5369521|NCT01859585|Ketorolac|ketorolac
5369522|NCT01859572|Stroke|stroke
5369523|NCT01859572|Cerebral Infarction|cerebral infarction
5369524|NCT01859572|Brain Disorders|brain disorders
5369525|NCT01859572|Central Nervous System Diseases|central nervous system diseases
5369526|NCT01859572|Nervous System Diseases|nervous system diseases
5369527|NCT01859572|Vascular Diseases|vascular diseases
5369528|NCT01859572|Cardiovascular Diseases|cardiovascular diseases
5369529|NCT01859572|Brain Infarction|brain infarction
5369530|NCT01859572|Brain Ischaemia|brain ischaemia
5369531|NCT01859559|ultrasound|ultrasound
5369532|NCT01859559|peripheral intravenous access|peripheral intravenous access
5369533|NCT01859559|operator experience|operator experience
5369534|NCT01859546|SMS|sms
5369535|NCT01859520|Spermatozoa|spermatozoa
5369536|NCT01859520|DNA fragmentation|dna fragmentation
5369537|NCT01859520|Swim-up|swim-up
5369538|NCT01859520|Density gradient|density gradient
5369539|NCT01859507|Vaginismus|vaginismus
5369540|NCT01859507|Botox|botox
5369541|NCT01859507|Sex|sex
5369542|NCT01859507|Clostridium|clostridium
5369543|NCT01859507|Botulinum|botulinum
5369544|NCT01859507|Neurotoxin|neurotoxin
5369545|NCT01859507|Perineal|perineal
5369546|NCT01859507|Muscles|muscles
5369547|NCT01859455|Hypercholesterolemia,|hypercholesterolemia,
5369548|NCT01859455|LDL cholesterol lowering,|ldl cholesterol lowering,
5369549|NCT01859455|proprotein convertase subtilisin/kexin type 9 (PCSK9),|proprotein convertase subtilisin/kexin type 9 (pcsk9),
5369550|NCT01859455|LGT209,|lgt209,
5369551|NCT01859455|drug safety,|drug safety,
5369552|NCT01859455|pharmacokinetics,|pharmacokinetics,
5369553|NCT01859455|pharmacodynamics|pharmacodynamics
5369554|NCT01859429|Cancer patients|cancer patients
5369555|NCT01859429|Psycho-oncological Care Provision|psycho-oncological care provision
5369556|NCT01859429|Structured Screening|structured screening
5369557|NCT01859429|Stepped care|stepped care
5369558|NCT01859403|veteran|veteran
5369559|NCT01859403|obesity|obesity
5369560|NCT01859403|personalized genomics|personalized genomics
5369561|NCT01859390|Antioxidants|antioxidants
5369562|NCT01859390|Vitamins|vitamins
5369563|NCT01859390|Inflammation|inflammation
5369564|NCT01859390|Oxidative stress|oxidative stress
5369565|NCT01859364|Tobacco|tobacco
5369566|NCT01859364|Smoking|smoking
5369567|NCT01859364|Smoking Cessation|smoking cessation
5369568|NCT01859364|Outcome|outcome
5369569|NCT01859364|Nicotine Dependence|nicotine dependence
5369570|NCT01859325|HIV-MAG pDNA Prime|hiv-mag pdna prime
5369571|NCT01859325|HIV Therapy|hiv therapy
5369572|NCT01859325|Therapeutic Vaccine|therapeutic vaccine
5369573|NCT01859312|Glucocorticoids|glucocorticoids
5369574|NCT01859312|Adrenal Insufficiency|adrenal insufficiency
5369575|NCT01859312|Congenital Adrenal Hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5369576|NCT01859312|Adrenal|adrenal
5369577|NCT01859299|Oral Tolerance|oral tolerance
5369578|NCT01859299|Uveitis|uveitis
5369579|NCT01859299|AMD|amd
5369580|NCT01859273|renal failure|renal failure
5369581|NCT01859273|medication adherence|medication adherence
5369582|NCT01859273|hypertension|hypertension
5369583|NCT01859260|chronic kidney disease, acute kidney injury, obstructive sleep apnea|chronic kidney disease, acute kidney injury, obstructive sleep apnea
5369584|NCT01859247|cervical dystonia|cervical dystonia
5369585|NCT01859247|torticollis|torticollis
5369586|NCT01859247|rTMS|rtms
5369587|NCT01859234|multiple myeloma|multiple myeloma
5369588|NCT01859234|PET scan|pet scan
5369589|NCT01859221|Prostate cancer|prostate cancer
5369590|NCT01859221|Oligometastatic prostate cancer|oligometastatic prostate cancer
5369591|NCT01859221|Proton radiation|proton radiation
5369592|NCT01859195|HIV/STI|hiv/sti
5369593|NCT01859195|Prevention|prevention
5369594|NCT01859195|Microbicides, Topical|microbicides, topical
5369595|NCT01859169|bili duct neoplasms|bili duct neoplasms
5369596|NCT01859169|bile duct cancer|bile duct cancer
5369597|NCT01859169|photodynamic therapy|photodynamic therapy
5369598|NCT01859169|biliary drainage|biliary drainage
5369599|NCT01859156|Carbon Monoxide|carbon monoxide
5365049|NCT01879917|Type 1|type 1
5369600|NCT01859156|Carboxyhemoglobin|carboxyhemoglobin
5369601|NCT01859156|End-tidal carbon dioxide|end-tidal carbon dioxide
5369602|NCT01859156|Capnography|capnography
5369603|NCT01859143|Trivalent|trivalent
5369604|NCT01859143|Influenza|influenza
5369605|NCT01859143|FluMist Quadrivalent|flumist quadrivalent
5369607|NCT01859143|Prevention|prevention
5369608|NCT01859143|Healthy|healthy
5369609|NCT01859117|Peripheral arterial disease|peripheral arterial disease
5369610|NCT01859117|diabetic foot|diabetic foot
5369611|NCT01859091|Lipolysis|lipolysis
5002869|NCT03978078|colorectal|colorectal
5369612|NCT01859091|Cryolipolysis|cryolipolysis
5369613|NCT01859091|Fat Reduction|fat reduction
5369614|NCT01859065|Non-urgent ED visits|non-urgent ed visits
5369615|NCT01859065|Neonates|neonates
5369616|NCT01859065|Newborn care|newborn care
5369617|NCT01859052|migraine|migraine
5369619|NCT01859052|low fat diet|low fat diet
5369620|NCT01859052|low carbohydrate diet|low carbohydrate diet
5369621|NCT01859039|Egg allergy|egg allergy
5369622|NCT01859039|Anaphylaxis|anaphylaxis
5369623|NCT01859039|Children|children
5369624|NCT01859039|Influenza vaccine|influenza vaccine
5369625|NCT01859026|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5369626|NCT01859026|EGFR mutation|egfr mutation
5369627|NCT01859026|Kirsten rat sarcoma 2 viral oncogene homolog(KRAS)|kirsten rat sarcoma 2 viral oncogene homolog(kras)
5369628|NCT01859026|KRAS mutation|kras mutation
5369629|NCT01859026|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5369630|NCT01859026|Advanced-stage IV|advanced-stage iv
5369631|NCT01859000|Adolescents|adolescents
5369632|NCT01859000|Hurricane Katrina|hurricane katrina
5369633|NCT01859000|Family-based treatment|family-based treatment
5369634|NCT01859000|Multidimensional Family Therapy|multidimensional family therapy
5369635|NCT01859000|Group CBT|group cbt
5369636|NCT01858974|multiplex PCR|multiplex pcr
5369637|NCT01858974|MALDI-TOF|maldi-tof
5369638|NCT01858974|pneumonia|pneumonia
5369639|NCT01858974|microbiological investigation|microbiological investigation
5369640|NCT01858974|intensive care|intensive care
5369641|NCT01858948|Bipolar disorder|bipolar disorder
5352881|NCT01935505|Chinese|chinese
5369642|NCT01858948|Second-generation antipsychotics|second-generation antipsychotics
5369643|NCT01858948|Obesity|obesity
5369644|NCT01858948|Cardiometabolic risk|cardiometabolic risk
5369645|NCT01858922|Hodgkin's Lymphoma|hodgkin's lymphoma
5369646|NCT01858922|ABVE-PC|abve-pc
5369647|NCT01858922|doxorubicin|doxorubicin
5369648|NCT01858922|bleomycin|bleomycin
5369649|NCT01858922|vincristine|vincristine
5369650|NCT01858922|etoposide|etoposide
5369651|NCT01858922|prednisone|prednisone
5369652|NCT01858922|cyclophosphamide|cyclophosphamide
5369654|NCT01858922|decadron|decadron
5369655|NCT01858922|cisplatin|cisplatin
5369656|NCT01858922|cytarabine|cytarabine
5369657|NCT01858922|Radiation|radiation
5369658|NCT01858909|Sepsis|sepsis
5369659|NCT01858896|hypoglycemia|hypoglycemia
5369660|NCT01858896|GLP-1|glp-1
5369661|NCT01858896|Type 2 diabetes|type 2 diabetes
5369662|NCT01858896|endothelial function|endothelial function
5369663|NCT01858870|Lacosamide|lacosamide
5369664|NCT01858870|Partial Crisis|partial crisis
5369665|NCT01858857|geriatric psychiatry|geriatric psychiatry
5369666|NCT01858857|pharmacovigilance|pharmacovigilance
5369667|NCT01858818|CAIS Computer Assisted Infusion System|cais computer assisted infusion system
5369668|NCT01858818|real life drinking behavior|real life drinking behavior
5369669|NCT01858818|family history of alcoholism|family history of alcoholism
5369670|NCT01858818|conditioning|conditioning
5369671|NCT01858818|instrumental learning|instrumental learning
5369672|NCT01858818|habitization|habitization
5369673|NCT01858805|esophagus carcinoma|esophagus carcinoma
5369674|NCT01858805|surgery|surgery
5369675|NCT01858805|circulating tumor cells|circulating tumor cells
5369685|NCT01858766|HCV Genotype 5|hcv genotype 5
5369686|NCT01858766|HCV Genotype 6|hcv genotype 6
5369687|NCT01858766|treatment naive|treatment naive
5369688|NCT01858753|burn scars|burn scars
5369689|NCT01858753|restrictive|restrictive
5369690|NCT01858753|contractures|contractures
5369691|NCT01858753|autologous fibroblasts|autologous fibroblasts
5369692|NCT01858727|forced-air|forced-air
5369693|NCT01858727|hypothermia|hypothermia
5369694|NCT01858727|TUR-P surgery|tur-p surgery
5369695|NCT01858727|core temperatures|core temperatures
5369696|NCT01858727|prewarming|prewarming
5369697|NCT01858727|general anaesthesia|general anaesthesia
5369699|NCT01858714|overweight|overweight
5369700|NCT01858714|weight loss|weight loss
5369701|NCT01858701|myopia|myopia
5369702|NCT01858701|hyperopia|hyperopia
5369703|NCT01858701|astigmatism|astigmatism
5369704|NCT01858701|contact lenses|contact lenses
5369705|NCT01858688|Prostate Cancer|prostate cancer
5369706|NCT01858688|MRI|mri
5369707|NCT01858688|Active surveillance in prostate cancer|active surveillance in prostate cancer
5369708|NCT01858675|ProADM|proadm
5369709|NCT01858675|ProANP|proanp
5369710|NCT01858675|proendothelin|proendothelin
5369711|NCT01858675|proAVP|proavp
5369712|NCT01858675|Cr 51|cr 51
5369713|NCT01858675|Volemia|volemia
5369714|NCT01858675|fluid management|fluid management
5369715|NCT01858675|ICU patients|icu patients
5369716|NCT01858675|poly trauma patients|poly trauma patients
5369717|NCT01858662|metastatic colorectal cancer|metastatic colorectal cancer
5369719|NCT01858662|cetuximab|cetuximab
5369720|NCT01858662|Pathological response|pathological response
5369721|NCT01858649|metastatic|metastatic
5369722|NCT01858649|colorectal|colorectal
5369723|NCT01858649|cancer|cancer
5369724|NCT01858649|liver|liver
5002870|NCT03978078|pancreas|pancreas
5369725|NCT01858649|Bevacizumab|bevacizumab
5369726|NCT01858649|Pathological response|pathological response
5369727|NCT01858623|Healthy Normotensive Participants|healthy normotensive participants
5369728|NCT01858623|Fixed dose combination|fixed dose combination
5369729|NCT01858623|Pharmacokinetics|pharmacokinetics
5369730|NCT01858623|Losartan|losartan
5369731|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide
5369732|NCT01858610|Fixed dose combination|fixed dose combination
5369733|NCT01858610|Pharmacokinetics|pharmacokinetics
5369734|NCT01858610|Irbesartan|irbesartan
5369735|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide
5369736|NCT01858610|Pharmacodynamics|pharmacodynamics
5369737|NCT01858610|Normotensive Participants|normotensive participants
5369738|NCT01858597|GDM, FGF|gdm, fgf
5369739|NCT01858584|GER|ger
5369740|NCT01858584|Alginate|alginate
5369741|NCT01858584|Regurgitation|regurgitation
5369742|NCT01858584|questionnaire|questionnaire
5369743|NCT01858571|Childhood Cancer|childhood cancer
5369744|NCT01858532|Diabetes|diabetes
5369745|NCT01858532|Nephropathy|nephropathy
5369746|NCT01858519|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5369747|NCT01858519|antibodies|antibodies
5369748|NCT01858519|porcine viruses|porcine viruses
5369749|NCT01858519|epidemiology|epidemiology
5369750|NCT01858519|prospective|prospective
5369751|NCT01858506|Type 2 diabetes mellitus|type 2 diabetes mellitus
5369752|NCT01858506|Lifestyle counselling|lifestyle counselling
5369753|NCT01858506|Lifestyle assessment|lifestyle assessment
5369754|NCT01858506|Randomized controlled trial|randomized controlled trial
5369755|NCT01858506|Diabetes education|diabetes education
5352975|NCT01935128|Kidney|kidney
5369756|NCT01858493|Urinary incontinence|urinary incontinence
5369757|NCT01858493|Falls|falls
5369758|NCT01858493|Quality of life|quality of life
5369759|NCT01858493|Stigma|stigma
5369760|NCT01858493|Community-dwelling older women|community-dwelling older women
5369761|NCT01858493|Continence promotion|continence promotion
5369762|NCT01858480|CHF|chf
5369763|NCT01858467|Airway, Cesarean|airway, cesarean
5369764|NCT01858402|Pediatric spinal anesthesia, paracetamol, dipyrone|pediatric spinal anesthesia, paracetamol, dipyrone
5369765|NCT01858389|Non-small cell lung cancer|non-small cell lung cancer
5369766|NCT01858389|T790M mutation. dacomitinib|t790m mutation. dacomitinib
5369767|NCT01858376|LDL cholesterol|ldl cholesterol
5373460|NCT01842581|Brain Diseases|brain diseases
5369768|NCT01858376|anti-hyperlipidemic|anti-hyperlipidemic
5369769|NCT01858376|hyperlipidemic|hyperlipidemic
5369770|NCT01858376|Capros|capros
5369771|NCT01858376|Natural Supplement|natural supplement
5369772|NCT01858363|Peripheral arterial disease|peripheral arterial disease
5369773|NCT01858363|claudication|claudication
5369774|NCT01858363|drug-coated balloon|drug-coated balloon
5369775|NCT01858363|drug-eluting balloon|drug-eluting balloon
5369776|NCT01858350|CAM|cam
5369777|NCT01858350|Sedation|sedation
5369778|NCT01858350|MRI|mri
5369779|NCT01858350|Music Therapy|music therapy
5369780|NCT01858337|weaning|weaning
5369781|NCT01858337|infants|infants
5369782|NCT01858337|vegetables|vegetables
5369783|NCT01858337|repeated-exposure|repeated-exposure
5369784|NCT01858324|Preeclampsia|preeclampsia
5369785|NCT01858324|Hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
5369786|NCT01858324|Patient education|patient education
5369787|NCT01858324|Educationnal tools|educationnal tools
5369788|NCT01858324|Pamphlet|pamphlet
5369789|NCT01858324|Video|video
5369790|NCT01858324|Knowledge|knowledge
5369791|NCT01858324|Anxiety|anxiety
5369792|NCT01858324|Satisfaction|satisfaction
5369793|NCT01858311|Stroke survivors|stroke survivors
5369794|NCT01858311|TIA survivors|tia survivors
5369795|NCT01858311|Vitamin E|vitamin e
5369796|NCT01858311|Carotech|carotech
5369797|NCT01858311|Tocotrienol|tocotrienol
5369798|NCT01858298|Dental caries|dental caries
5369799|NCT01858298|Quality of Life|quality of life
5369800|NCT01858298|Pulpectomy|pulpectomy
5369801|NCT01858298|Tooth extraction|tooth extraction
5369802|NCT01858285|Epilepsy|epilepsy
5369803|NCT01858285|Ohtahara|ohtahara
5369804|NCT01858285|Dravet|dravet
5369805|NCT01858285|MMPEI|mmpei
5369806|NCT01858285|EMEE|emee
5369807|NCT01858285|EIEE|eiee
5369808|NCT01858246|Hearing Loss, Conductive|hearing loss, conductive
5369809|NCT01858246|Bone Conduction|bone conduction
5369810|NCT01858246|bone conduction thresholds better than 45 dBHL|bone conduction thresholds better than 45 dbhl
5369811|NCT01858233|Gestational diabetes|gestational diabetes
5369812|NCT01858220|Gastroparesis|gastroparesis
5369813|NCT01858220|Small bowel video capsule|small bowel video capsule
5369814|NCT01858220|gastric retention|gastric retention
5369815|NCT01858207|HCC|hcc
5369816|NCT01858207|hepatocellular carcinoma|hepatocellular carcinoma
5369824|NCT01858142|children|children
5369825|NCT01858142|elective surgical procedures|elective surgical procedures
5369826|NCT01858142|mask induction|mask induction
5369828|NCT01858103|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
5369829|NCT01858103|MPS IVA Type A|mps iva type a
5343643|NCT01977976|IVF|ivf
5369830|NCT01858103|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5369831|NCT01858103|MPS IVA|mps iva
5369832|NCT01858103|Morquio A Syndrome|morquio a syndrome
5369833|NCT01858103|Lysosomal Storage Disorder|lysosomal storage disorder
5369834|NCT01858103|LSD|lsd
5369835|NCT01858103|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5369836|NCT01858103|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5369837|NCT01858090|spinal anesthesia|spinal anesthesia
5369838|NCT01858090|caesarean section|caesarean section
5369839|NCT01858090|local anesthetics|local anesthetics
5369840|NCT01858090|levobupivacaine|levobupivacaine
5369841|NCT01858090|sufentanil|sufentanil
5369842|NCT01858090|fentanyl|fentanyl
5369843|NCT01858090|above 18 years of age|above 18 years of age
5369844|NCT01858090|pregnant women|pregnant women
5369845|NCT01858090|multiparous|multiparous
5369846|NCT01858090|nulliparous|nulliparous
5369847|NCT01858064|ADHD|adhd
5369848|NCT01858064|OROS-MPH|oros-mph
5369849|NCT01858064|Adults|adults
5369850|NCT01858064|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5369851|NCT01858051|Vitamin D|vitamin d
5369852|NCT01858051|Perioperative immune regulation|perioperative immune regulation
5369853|NCT01858051|LL-37|ll-37
5369854|NCT01858051|Hospital-acquired infection|hospital-acquired infection
5369855|NCT01858051|Surgical site infections|surgical site infections
5369856|NCT01858038|Scar|scar
5369857|NCT01858012|insulin resistance|insulin resistance
5369858|NCT01857999|Renin-aldosterone system|renin-aldosterone system
5369859|NCT01857999|Hemodynamic|hemodynamic
5369860|NCT01857999|Low cardiac output|low cardiac output
5369861|NCT01857999|Vasodilation|vasodilation
5369862|NCT01857999|Natriuretic peptide|natriuretic peptide
5369863|NCT01857986|Endotracheal intubation|endotracheal intubation
5369864|NCT01857986|Mechanical ventilation|mechanical ventilation
5369865|NCT01857986|Critical care|critical care
5369866|NCT01857973|HCL|hcl
5369867|NCT01857973|Type 1 Diabetes|type 1 diabetes
5369868|NCT01857973|Sensor|sensor
5369869|NCT01857960|Acne|acne
5369870|NCT01857960|Treatment|treatment
5369872|NCT01857960|Behavior|behavior
5369873|NCT01857947|AECOPD Mr ProADM Biomarkers ER Outcome|aecopd mr proadm biomarkers er outcome
5369874|NCT01857934|Anti-GD2 monoclonal antibody|anti-gd2 monoclonal antibody
5369875|NCT01857934|hu14.18K322A|hu14.18k322a
5369876|NCT01857934|High-risk neuroblastoma|high-risk neuroblastoma
5369877|NCT01857934|Phase II|phase ii
5369878|NCT01857934|Allogeneic NK cells|allogeneic nk cells
5369879|NCT01857908|Adenocarcinoma|adenocarcinoma
5369880|NCT01857908|Abiraterone|abiraterone
5369881|NCT01857908|Abiraterone Acetate|abiraterone acetate
5369882|NCT01857908|Zytiga|zytiga
5369883|NCT01857908|Correlative study|correlative study
5369884|NCT01857908|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5369885|NCT01857908|Abiraterone Correlative study|abiraterone correlative study
5369886|NCT01857895|Nausea|nausea
5369887|NCT01857895|subcutaneous infusion|subcutaneous infusion
5369888|NCT01857895|exenatide|exenatide
5369889|NCT01857882|breast cancer|breast cancer
5369890|NCT01857882|breast reconstruction|breast reconstruction
5369891|NCT01857882|shared decision making|shared decision making
5369892|NCT01857882|decision support intervention|decision support intervention
5369893|NCT01857869|Efficacy|efficacy
5369894|NCT01857869|Sporozoite challenge model|sporozoite challenge model
5369895|NCT01857869|Malaria|malaria
5369896|NCT01857869|Immunogenicity|immunogenicity
5369897|NCT01857869|Malaria- naïve adults|malaria- naïve adults
5369899|NCT01857856|Phospholamban|phospholamban
5369900|NCT01857856|cardiomyopathy|cardiomyopathy
5369901|NCT01857856|Eplerenone|eplerenone
5369902|NCT01857856|presymptomatic|presymptomatic
5369903|NCT01857830|Telomerase|telomerase
5369904|NCT01857830|Telomere Length|telomere length
5369905|NCT01857830|Psychological Stress|psychological stress
5369906|NCT01857830|Amyloid beta proteins|amyloid beta proteins
5369907|NCT01857830|Meditation|meditation
5369908|NCT01857804|peri-implantitis|peri-implantitis
5369909|NCT01857804|surgical therapy|surgical therapy
5369910|NCT01857804|systemic antibiotics|systemic antibiotics
5369911|NCT01857804|local antiseptics|local antiseptics
5369912|NCT01857778|Breastfeeding|breastfeeding
5369913|NCT01857778|Breast tissue|breast tissue
5369914|NCT01857778|Breast pump|breast pump
5369915|NCT01857765|rehabilitation|rehabilitation
5369916|NCT01857765|reconstructive surgery|reconstructive surgery
5369917|NCT01857752|Retinoblastoma|retinoblastoma
5369918|NCT01857726|hepatocellular carcinoma|hepatocellular carcinoma
5369919|NCT01857726|portal vein invasion|portal vein invasion
5369920|NCT01857726|transarterial chemoembolization|transarterial chemoembolization
5369921|NCT01857726|transarterial chemoinfusion|transarterial chemoinfusion
5369922|NCT01857674|Laryngeal edema|laryngeal edema
5369923|NCT01857674|Post-extubation|post-extubation
5369924|NCT01857674|Acute respiratory distress|acute respiratory distress
5369925|NCT01857674|Ultrasonography|ultrasonography
5369926|NCT01857674|Intensive care unit|intensive care unit
5369927|NCT01857661|tinnitus|tinnitus
5369928|NCT01857661|hearing loss|hearing loss
5369929|NCT01857661|hearing devices|hearing devices
5369930|NCT01857648|Physical Activity|physical activity
5369931|NCT01857648|Health Promotion|health promotion
5369932|NCT01857648|Primary Health Care|primary health care
5369933|NCT01857648|Intervention Studies|intervention studies
5369934|NCT01857648|Public health Practice|public health practice
5369935|NCT01857635|Acute respiratory failure|acute respiratory failure
5369936|NCT01857635|Hypercapnia|hypercapnia
5369937|NCT01857635|Non invasive ventilation|non invasive ventilation
5369938|NCT01857635|Transcutaneous CO2 measurement|transcutaneous co2 measurement
5369939|NCT01857622|anticoagulant|anticoagulant
5369941|NCT01857622|edoxaban|edoxaban
5369942|NCT01857622|factor Xa|factor xa
5369944|NCT01857622|atrial fibrillation|atrial fibrillation
5369945|NCT01857622|severe renal impairment|severe renal impairment
5369946|NCT01857609|Metformin|metformin
5369947|NCT01857609|Proton pump inhibitor|proton pump inhibitor
5369948|NCT01857609|Drug interaction|drug interaction
5369949|NCT01857596|Female Sexual Dysfunction|female sexual dysfunction
5369950|NCT01857596|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5369951|NCT01857596|Sexual Interest/Arousal Disorder|sexual interest/arousal disorder
5369952|NCT01857596|Lorexys|lorexys
5369953|NCT01857596|Premenopausal female health|premenopausal female health
5369954|NCT01857583|anticoagulant|anticoagulant
5369955|NCT01857583|DU-176b|du-176b
5369956|NCT01857583|edoxaban|edoxaban
5369957|NCT01857583|factor Xa|factor xa
5369958|NCT01857583|oral|oral
5369959|NCT01857583|orthopedic surgery of lower limbs|orthopedic surgery of lower limbs
5369960|NCT01857583|severe renal impairment|severe renal impairment
5369961|NCT01857570|Radius fracture|radius fracture
5369962|NCT01857570|Scaphoid fracture|scaphoid fracture
5369963|NCT01857570|Tomography, x-ray computed|tomography, x-ray computed
5369964|NCT01857557|Exercise|exercise
5369965|NCT01857557|Fitness program|fitness program
5369966|NCT01857544|Retinal Vein Occlusion|retinal vein occlusion
5369967|NCT01857544|Central Retinal Vein Occlusion|central retinal vein occlusion
5369968|NCT01857544|Macular Edema|macular edema
5355879|NCT01921790|Avastin+ GemAOD|avastin+ gemaod
5369969|NCT01857531|Smoking Cessation|smoking cessation
5369970|NCT01857531|Quit Smoking|quit smoking
5369971|NCT01857531|Ganaxolone|ganaxolone
5369972|NCT01857531|Nicotine Patch|nicotine patch
5369973|NCT01857505|Total Hip replacement|total hip replacement
5369974|NCT01857505|Fracture table|fracture table
5369975|NCT01857505|DePuySynthes|depuysynthes
5369976|NCT01857505|Direct anterior approach hip replacement|direct anterior approach hip replacement
5369977|NCT01857505|Posterior approach hip replacement|posterior approach hip replacement
5369978|NCT01857492|abdominal pain|abdominal pain
5369979|NCT01857492|pancreatitis|pancreatitis
5369980|NCT01857492|chronic abdominal pain|chronic abdominal pain
5369981|NCT01857492|visceral pain|visceral pain
5369982|NCT01857492|meditation|meditation
5369983|NCT01857492|tDCS|tdcs
5369984|NCT01857492|noninvasive brain stimulation|noninvasive brain stimulation
5369985|NCT01857492|EEG|eeg
5369986|NCT01857492|Kirtan Kriya|kirtan kriya
5369987|NCT01857479|ABPA|abpa
5369988|NCT01857453|Adult Patients Medulloblatoma Standard risk group Chemotherapy Radiotherapy Quality of Life|adult patients medulloblatoma standard risk group chemotherapy radiotherapy quality of life
5369989|NCT01857440|Glaucoma|glaucoma
5369990|NCT01857440|Pupil|pupil
5369991|NCT01857440|Melanopsin|melanopsin
5369992|NCT01857388|school-based program, mental health, implementation|school-based program, mental health, implementation
5369993|NCT01857375|Diabetes - insulin administration|diabetes - insulin administration
5369994|NCT01857362|Orfadin|orfadin
5369995|NCT01857362|Nitisinone|nitisinone
5369996|NCT01857362|Bioequivalence|bioequivalence
5369997|NCT01857349|Efficacy|efficacy
5369998|NCT01857349|surgical scrubs|surgical scrubs
5369999|NCT01857349|Total Knee Arthroplasty|total knee arthroplasty
5370000|NCT01857323|asthma|asthma
5370001|NCT01857323|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5370002|NCT01857323|COPD|copd
5365527|NCT01877746|ICM|icm
5370003|NCT01857323|Albuterol Spiromax®|albuterol spiromax®
5370004|NCT01857310|Folic Acid|folic acid
5370005|NCT01857310|Zinc|zinc
5370006|NCT01857310|Semen|semen
5370007|NCT01857310|In vitro fertilization|in vitro fertilization
5370008|NCT01857310|Assisted reproductive technology|assisted reproductive technology
5370009|NCT01857310|Ovulation induction|ovulation induction
5370010|NCT01857310|Intrauterine insemination|intrauterine insemination
5370011|NCT01857310|Pregnancy|pregnancy
5370012|NCT01857310|Live Birth|live birth
5370013|NCT01857310|Abortion, spontaneous|abortion, spontaneous
5370014|NCT01857284|Tauroursodeoxycholic Acid|tauroursodeoxycholic acid
5370015|NCT01857284|Primary Biliary Cirrhosis|primary biliary cirrhosis
5370016|NCT01857284|Safety|safety
5370017|NCT01857284|Efficacy|efficacy
5370018|NCT01857258|green tea|green tea
5370019|NCT01857258|catechins|catechins
5370020|NCT01857258|vascular endothelial function|vascular endothelial function
5370021|NCT01857258|postprandial hyperglycemia|postprandial hyperglycemia
5370022|NCT01857258|oxidative stress|oxidative stress
5370023|NCT01857245|addiction|addiction
5370024|NCT01857245|Adherence (attribute)|adherence (attribute)
5370025|NCT01857245|Adverse effects|adverse effects
5370026|NCT01857245|Agonist|agonist
5370027|NCT01857245|Antiviral Agents|antiviral agents
5370029|NCT01857245|base|base
5370030|NCT01857245|care delivery|care delivery
5370031|NCT01857245|Caring|caring
5370032|NCT01857245|Chronic Hepatitis C|chronic hepatitis c
5370033|NCT01857245|Clinic|clinic
5370034|NCT01857245|Clinical Trials|clinical trials
5370035|NCT01857245|Complex|complex
5370036|NCT01857245|Computer Simulation|computer simulation
5370037|NCT01857245|cost|cost
5370038|NCT01857245|cost effective|cost effective
5370039|NCT01857245|cost effectiveness|cost effectiveness
5370040|NCT01857245|Data|data
5370041|NCT01857245|Development|development
5370042|NCT01857245|Directly Observed Therapy|directly observed therapy
5370043|NCT01857245|Disease|disease
5370044|NCT01857245|Dose|dose
5370045|NCT01857245|Drug resistance|drug resistance
5370046|NCT01857245|drug resistant virus|drug resistant virus
5370047|NCT01857245|Educational aspects|educational aspects
5370048|NCT01857245|Epidemic|epidemic
5370049|NCT01857245|experience|experience
5370050|NCT01857245|Frequencies (time pattern)|frequencies (time pattern)
5370051|NCT01857245|Fright|fright
5370052|NCT01857245|Genotype|genotype
5370053|NCT01857245|Group Therapy|group therapy
5370055|NCT01857245|Health Personnel|health personnel
5370056|NCT01857245|Healthcare Systems|healthcare systems
5370057|NCT01857245|Hepatitis C|hepatitis c
5370058|NCT01857245|Hepatitis C Prevalence|hepatitis c prevalence
5370059|NCT01857245|Hepatitis C Transmission|hepatitis c transmission
5370060|NCT01857245|Hepatitis C virus|hepatitis c virus
5370061|NCT01857245|HIV|hiv
5370062|NCT01857245|Homelessness|homelessness
5370063|NCT01857245|improved|improved
5370064|NCT01857245|Incidence|incidence
5370065|NCT01857245|Infection|infection
5370066|NCT01857245|Injecting drug user|injecting drug user
5370067|NCT01857245|Injection of therapeutic agent|injection of therapeutic agent
5370068|NCT01857245|Intensive Care|intensive care
5370069|NCT01857245|Interferons|interferons
5370070|NCT01857245|Intervention|intervention
5370071|NCT01857245|Knowledge|knowledge
5370072|NCT01857245|Life|life
5370073|NCT01857245|Liver diseases|liver diseases
5370074|NCT01857245|Liver Failure|liver failure
5370075|NCT01857245|liver transplantation|liver transplantation
5370076|NCT01857245|Living Costs|living costs
5370077|NCT01857245|Mental disorders|mental disorders
5370078|NCT01857245|Methadone|methadone
5370079|NCT01857245|methadone clinic/center|methadone clinic/center
5370080|NCT01857245|Modeling|modeling
5370081|NCT01857245|Mortality Vital Statistics|mortality vital statistics
5370082|NCT01857245|Motivation|motivation
5370083|NCT01857245|multidisciplinary|multidisciplinary
5370084|NCT01857245|Opiates|opiates
5370085|NCT01857245|Oral|oral
5370086|NCT01857245|Outcome|outcome
5370087|NCT01857245|Patients|patients
5370088|NCT01857245|Persons|persons
5370089|NCT01857245|Pharmaceutical Preparations|pharmaceutical preparations
5370090|NCT01857245|Physicians|physicians
5370091|NCT01857245|pill (pharmacologic)|pill (pharmacologic)
5370092|NCT01857245|Play|play
5370093|NCT01857245|Poverty|poverty
5370094|NCT01857245|Primary Health Care|primary health care
5370095|NCT01857245|programs|programs
5370096|NCT01857245|Psychiatric therapeutic procedure|psychiatric therapeutic procedure
5370097|NCT01857245|psychosocial|psychosocial
5370098|NCT01857245|Publishing|publishing
5370099|NCT01857245|Quality-Adjusted Life Years|quality-adjusted life years
5370100|NCT01857245|Randomized|randomized
5370101|NCT01857245|Randomized Controlled Trials|randomized controlled trials
5370102|NCT01857245|randomized trial|randomized trial
5370103|NCT01857245|Recruitment Activity|recruitment activity
5370104|NCT01857245|Regimen|regimen
5370105|NCT01857245|Resistance|resistance
5370106|NCT01857245|Resistance development|resistance development
5370107|NCT01857245|response|response
5370108|NCT01857245|Risk|risk
5370109|NCT01857245|risk perception|risk perception
5370110|NCT01857245|Role|role
5370111|NCT01857245|Site|site
5370112|NCT01857245|skills|skills
5370113|NCT01857245|Social support|social support
5370114|NCT01857245|standard care|standard care
5370115|NCT01857245|substance abuse treatment|substance abuse treatment
5370116|NCT01857245|success|success
5370117|NCT01857245|Time|time
5370118|NCT01857245|Treatment outcome|treatment outcome
5370119|NCT01857245|Treatment Protocols|treatment protocols
5370120|NCT01857245|treatment site|treatment site
5370121|NCT01857245|Trust|trust
5370122|NCT01857245|United States|united states
5370123|NCT01857245|Viral|viral
5370124|NCT01857245|Virus|virus
5370126|NCT01857206|Influenza|influenza
5370127|NCT01857206|children and adolescents|children and adolescents
5370128|NCT01857206|trivalent vaccine|trivalent vaccine
5370129|NCT01857206|cell culture|cell culture
5370130|NCT01857206|embryonated chicken eggs|embryonated chicken eggs
5370131|NCT01857193|Open label|open label
5370132|NCT01857193|dose escalation|dose escalation
5370134|NCT01857193|LEE011|lee011
5370135|NCT01857193|CDK4/6|cdk4/6
5370136|NCT01857193|everolimus|everolimus
5370137|NCT01857193|advanced breast cancer|advanced breast cancer
5370138|NCT01857193|mTOR|mtor
5370139|NCT01857193|HR positive|hr positive
5370140|NCT01857193|HER2 negative|her2 negative
5370141|NCT01857167|omega-3 fatty acids|omega-3 fatty acids
5370142|NCT01857167|randomized controlled trial|randomized controlled trial
5370143|NCT01857154|Bone mineral density|bone mineral density
5370144|NCT01857154|Bone mineral content|bone mineral content
5370145|NCT01857154|Bone density|bone density
5370146|NCT01857154|Bone health|bone health
5370147|NCT01857154|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5370148|NCT01857141|dexmedetomidine|dexmedetomidine
5370149|NCT01857141|heart rate variability|heart rate variability
5370150|NCT01857141|preemptive epidural|preemptive epidural
5370151|NCT01857141|gastrectomy|gastrectomy
5370152|NCT01857115|Multiple myeloma|multiple myeloma
5370153|NCT01857115|Diagnosis|diagnosis
5370154|NCT01857115|Weekly|weekly
5370155|NCT01857115|CCyd|ccyd
5370156|NCT01857089|Pressure Ulcer|pressure ulcer
5370157|NCT01857089|prevention|prevention
5370158|NCT01857076|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5370159|NCT01857076|Grade I obesity|grade i obesity
5370160|NCT01857076|Inadequate glycemic control|inadequate glycemic control
5370161|NCT01857011|Anemia, Iron-Deficiency|anemia, iron-deficiency
5370162|NCT01857011|bariatric surgery|bariatric surgery
5370163|NCT01857011|abdominoplasty|abdominoplasty
5370164|NCT01857011|surgery, plastic|surgery, plastic
5370166|NCT01856998|Therapeutic Equivalence|therapeutic equivalence
5370167|NCT01856998|Propofol|propofol
5370168|NCT01856985|Medical abortion|medical abortion
5370169|NCT01856985|Misoprostol|misoprostol
5370170|NCT01856985|Mifepristone|mifepristone
5370171|NCT01856972|Limited Dorsiflexion Range of Motion|limited dorsiflexion range of motion
5370172|NCT01856972|Gastrocnemius tightness|gastrocnemius tightness
5370173|NCT01856972|Soleus tightness|soleus tightness
5370174|NCT01856959|magnesium sulfate|magnesium sulfate
5370175|NCT01856959|nebulized|nebulized
5370176|NCT01856959|lung function|lung function
5370177|NCT01856933|GBM|gbm
5370178|NCT01856933|Glioblastoma Multiforme|glioblastoma multiforme
5370179|NCT01856933|Gliosarcoma|gliosarcoma
5370185|NCT01856907|prediabetes|prediabetes
5370186|NCT01856907|impaired fasting/impaired glucose tolerance|impaired fasting/impaired glucose tolerance
5370187|NCT01856907|post gestational diabetes|post gestational diabetes
5370188|NCT01856907|diabetes prevention|diabetes prevention
5370189|NCT01856894|polycystic ovary syndrome|polycystic ovary syndrome
5370190|NCT01856894|Anti-Mullerian Hormone|anti-mullerian hormone
5370191|NCT01856894|obesity|obesity
5370192|NCT01856881|Type 2 diabetes|type 2 diabetes
5370193|NCT01856868|BMD|bmd
5370194|NCT01856868|Becker muscular dystrophy|becker muscular dystrophy
5370195|NCT01856868|epicatechin|epicatechin
5370196|NCT01856868|clinical trial|clinical trial
5370197|NCT01856868|neuromuscular disease|neuromuscular disease
5370198|NCT01856855|Prostate Cancer|prostate cancer
5370199|NCT01856855|Prostate Adenocarcinoma|prostate adenocarcinoma
5370200|NCT01856855|Radiation|radiation
5370201|NCT01856855|SBRT|sbrt
5671945|NCT00613496|Atrial Fibrillation|atrial fibrillation
5370202|NCT01856855|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5370203|NCT01856842|Pulmonary Arteriovenous Malformations|pulmonary arteriovenous malformations
5370204|NCT01856842|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5370205|NCT01856842|Embolization|embolization
5370206|NCT01856842|reperfusion rates|reperfusion rates
5370207|NCT01856777|Medical Abortion|medical abortion
5370208|NCT01856777|Pregnancy Test|pregnancy test
5370209|NCT01856777|continuing pregnancy|continuing pregnancy
5370210|NCT01856764|Atopic dermatitis|atopic dermatitis
5370211|NCT01856751|Haemophilia|haemophilia
5370213|NCT01856751|TEM|tem
5370214|NCT01856738|Parkinson's disease|parkinson's disease
5370215|NCT01856738|Visual hallucinations|visual hallucinations
5370216|NCT01856738|Rivastigmine|rivastigmine
5370217|NCT01856738|Cholinesterase inhibitor|cholinesterase inhibitor
5370218|NCT01856738|Randomized controlled trial|randomized controlled trial
5370220|NCT01856712|alcohol|alcohol
5370221|NCT01856712|veterans|veterans
5370222|NCT01856699|supratentorial superficial siderosis|supratentorial superficial siderosis
5370223|NCT01856699|intracerebral hemorrhage|intracerebral hemorrhage
5370224|NCT01856699|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5370225|NCT01856686|ADD|add
5370226|NCT01856686|ADHD|adhd
5370227|NCT01856686|Proteins|proteins
5370228|NCT01856686|Dietary|dietary
5370229|NCT01856686|Nutrition|nutrition
5370230|NCT01856686|QEEG|qeeg
5370231|NCT01856686|ERP|erp
5370232|NCT01856686|ICA|ica
5370233|NCT01856673|Mental Health|mental health
5370234|NCT01856673|Displacement|displacement
5370235|NCT01856673|Torture|torture
5370236|NCT01856673|Violence|violence
5370237|NCT01856673|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5370238|NCT01856673|Depression|depression
5370239|NCT01856673|Anxiety|anxiety
5370240|NCT01856673|Community-based intervention|community-based intervention
5370241|NCT01856673|Prevention trial|prevention trial
5370242|NCT01856673|Disabled Persons|disabled persons
5370243|NCT01856660|Obesity|obesity
5370244|NCT01856660|Weight Loss|weight loss
5370245|NCT01856660|Body Weight Change|body weight change
5370246|NCT01856660|Taste|taste
5370247|NCT01856660|Taste Phenotype|taste phenotype
5370248|NCT01856660|Lifestyle Intervention|lifestyle intervention
5370249|NCT01856647|Psoriasis|psoriasis
5370250|NCT01856647|Obesity|obesity
5370251|NCT01856634|Tuberculosis|tuberculosis
5370252|NCT01856634|Tuberculosis, Multidrug-Resistant|tuberculosis, multidrug-resistant
5370253|NCT01856634|Mycobacterium Infections|mycobacterium infections
5370254|NCT01856634|Actinomycetales Infections|actinomycetales infections
5370255|NCT01856634|Gram-Positive Infections|gram-positive infections
5370256|NCT01856634|Bacterial Infections|bacterial infections
5370257|NCT01856634|Pediatric|pediatric
5370258|NCT01856582|Primary Immunodeficiency Disease(s)|primary immunodeficiency disease(s)
5370259|NCT01856582|Mixed Donor Chimerism|mixed donor chimerism
5370260|NCT01856582|bone marrow failure syndromes|bone marrow failure syndromes
5370261|NCT01856582|allogeneic hematopoietic stem cell transplant (HSCT)|allogeneic hematopoietic stem cell transplant (hsct)
5370262|NCT01856582|children|children
5370263|NCT01856556|safety|safety
5370264|NCT01856556|tolerability|tolerability
5370265|NCT01856556|pharmacokinetics|pharmacokinetics
5370266|NCT01856543|Breast cancer|breast cancer
5370267|NCT01856543|Status post mastectomy|status post mastectomy
5370268|NCT01856543|plan to receive PMRT|plan to receive pmrt
5370269|NCT01856543|Topical|topical
5370270|NCT01856543|steroid cream|steroid cream
5370271|NCT01856543|emollient skin care|emollient skin care
5370272|NCT01856543|Eucerin|eucerin
5370273|NCT01856543|Mometasone Furoate 0.1%|mometasone furoate 0.1%
5373969|NCT01840111|fMRI|fmri
5370274|NCT01856517|pressor response|pressor response
5370275|NCT01856517|chronotropic response|chronotropic response
5370276|NCT01856504|Heart Disease|heart disease
5356177|NCT01920477|vulgaris|vulgaris
5370277|NCT01856504|Coronary Artery Disease|coronary artery disease
5370278|NCT01856504|Coronary Arteriosclerosis|coronary arteriosclerosis
5370279|NCT01856491|RELIANCE 4-FRONT|reliance 4-front
5370280|NCT01856491|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5370281|NCT01856491|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
5370282|NCT01856465|Bariatric surgery|bariatric surgery
5370283|NCT01856465|NAFLD|nafld
5370284|NCT01856465|Steatohepatitis|steatohepatitis
5370285|NCT01856465|Simple Steatosis|simple steatosis
5370286|NCT01856465|Intestinal Microbiota|intestinal microbiota
5370287|NCT01856452|Sentinel lymph node|sentinel lymph node
5370288|NCT01856452|multimodal|multimodal
5370289|NCT01856452|breast cancer|breast cancer
5370290|NCT01856439|ProSavin|prosavin
5370291|NCT01856439|Gene therapy|gene therapy
5370292|NCT01856426|Hepatitis C infected subjects|hepatitis c infected subjects
5370293|NCT01856413|Prevention|prevention
5370294|NCT01856413|Hepatitis B virus re-infection|hepatitis b virus re-infection
5370295|NCT01856413|HBV-DNA negative|hbv-dna negative
5370296|NCT01856413|Liver transplantation|liver transplantation
5370297|NCT01856400|ventricular arrythmias|ventricular arrythmias
5370298|NCT01856400|SERCA2a|serca2a
5370299|NCT01856400|Chronic Kidney Disease|chronic kidney disease
5370300|NCT01856400|microvolt T wave alternans|microvolt t wave alternans
5370301|NCT01856387|preeclampsia|preeclampsia
5370302|NCT01856387|eclampsia|eclampsia
5370303|NCT01856387|prediction|prediction
5370304|NCT01856387|neutrophil-to Lymphocyte ratio|neutrophil-to lymphocyte ratio
5370305|NCT01856361|Male infertility|male infertility
5370306|NCT01856361|Low sperm count|low sperm count
5370307|NCT01856361|Poor sperm motility|poor sperm motility
5370308|NCT01856361|Poor Sperm shape and morphology|poor sperm shape and morphology
5370309|NCT01856335|Seizures|seizures
5370310|NCT01856335|Epilepsy|epilepsy
5370311|NCT01856322|Colorectal Cancer|colorectal cancer
5370312|NCT01856322|Liver Metastasis|liver metastasis
5370313|NCT01856322|Sulindac|sulindac
5370314|NCT01856309|Rheumatoid Arthritis|rheumatoid arthritis
5370316|NCT01856309|CNTO 136|cnto 136
5370317|NCT01856309|CNTO136ARA3002|cnto136ara3002
5370318|NCT01856309|SIRROUND-D|sirround-d
5370319|NCT01856309|CNTO136ARA3003|cnto136ara3003
5370320|NCT01856309|SIRROUND-T|sirround-t
5370321|NCT01856309|SIRROUND-LTE|sirround-lte
5370322|NCT01856270|Traumatic brain injury|traumatic brain injury
5370323|NCT01856270|Post-traumatic headache|post-traumatic headache
5370324|NCT01856270|Drug therapy|drug therapy
5370325|NCT01856257|Kidney Transplantation|kidney transplantation
5370326|NCT01856257|Transplantation|transplantation
5370327|NCT01856257|NULOJIX|nulojix
5370328|NCT01856257|belatacept|belatacept
5370329|NCT01856257|chronic immunosuppression|chronic immunosuppression
5370330|NCT01856244|Parkinson's Disease|parkinson's disease
5370331|NCT01856244|treadmill training|treadmill training
5370332|NCT01856244|gait|gait
5370333|NCT01856244|balance|balance
5370334|NCT01856244|mobility|mobility
5370335|NCT01856231|COPD|copd
5370336|NCT01856231|Physical activity|physical activity
5370337|NCT01856218|Mucopolysaccharidosis type 7, MPS 7, Sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder|mucopolysaccharidosis type 7, mps 7, sly syndrome, enzyme replacement therapy, rare disease, lysosomal storage disease, metabolic disorder
5370338|NCT01856205|Japanese Encephalitis, Randomized Controlled Trial, intravenous immunoglobulin, safety, efficacy, Nepal|japanese encephalitis, randomized controlled trial, intravenous immunoglobulin, safety, efficacy, nepal
5370339|NCT01856179|Conversion of ALA and SDA|conversion of ala and sda
5370340|NCT01856179|Metabolism of n-3 fatty acids|metabolism of n-3 fatty acids
5370341|NCT01856166|Nulliparous|nulliparous
5370342|NCT01856166|Singleton|singleton
5370343|NCT01856166|delivery|delivery
5370344|NCT01856166|pregnancy|pregnancy
5370345|NCT01856153|Bioavailability|bioavailability
5370346|NCT01856153|Strawberry polyphenols|strawberry polyphenols
5370347|NCT01856153|Time Influence|time influence
5370348|NCT01856140|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
5370349|NCT01856140|allogeneic stem cell|allogeneic stem cell
5370350|NCT01856127|Sexual Dysfunction|sexual dysfunction
5370351|NCT01856127|Antidepressant|antidepressant
5370352|NCT01856127|Major Depressant|major depressant
5370353|NCT01856127|SSRI|ssri
5370354|NCT01856127|SNRI|snri
5370355|NCT01856127|Vilazodone|vilazodone
5370356|NCT01856127|Sertraline|sertraline
5370357|NCT01856114|Advanced Cancers|advanced cancers
5370358|NCT01856114|Cancer with evidence of active disease|cancer with evidence of active disease
5370359|NCT01856114|Exercise induced breakthrough dyspnea|exercise induced breakthrough dyspnea
5370360|NCT01856114|Shortness of breath|shortness of breath
5370361|NCT01856114|Fentanyl Buccal Tablets|fentanyl buccal tablets
5370363|NCT01856114|Placebo|placebo
5370364|NCT01856114|Walk tests|walk tests
5370365|NCT01856114|Questionnaires|questionnaires
5370366|NCT01856114|Surveys|surveys
5370367|NCT01856101|TCC|tcc
5423322|NCT01616199|BRAF-mutant cancers|braf-mutant cancers
5356280|NCT01920113|propofol|propofol
5370368|NCT01856101|Failure of platinum based chemotherapy|failure of platinum based chemotherapy
5370369|NCT01856088|Coronary artery|coronary artery
5370370|NCT01856088|Drug eluting stent|drug eluting stent
5370371|NCT01856088|thrombosis|thrombosis
5370372|NCT01856075|Atrial Fibrillation|atrial fibrillation
5370373|NCT01856075|Dronedarone|dronedarone
5370374|NCT01856075|Cohort|cohort
5370375|NCT01856075|Effectiveness|effectiveness
5370376|NCT01856062|ovulation induction|ovulation induction
5370377|NCT01856062|dexamethasone|dexamethasone
5370378|NCT01856049|HLHS|hlhs
5370379|NCT01856049|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5370380|NCT01856049|UCB (umbilical cord blood)|ucb (umbilical cord blood)
5370381|NCT01856049|Umbilical cord blood|umbilical cord blood
5370382|NCT01856049|Cord blood|cord blood
5370383|NCT01856049|Cardiac regeneration|cardiac regeneration
5370384|NCT01856036|Ductal Histology|ductal histology
5370385|NCT01856036|Unifocal|unifocal
5370386|NCT01856036|Estrogen Receptor Positive|estrogen receptor positive
5370387|NCT01856036|her2neu negative|her2neu negative
5370388|NCT01856023|melanoma|melanoma
5370389|NCT01856023|metastatic|metastatic
5370390|NCT01856023|skin cancer|skin cancer
5370391|NCT01856023|Stage IV|stage iv
5370392|NCT01856023|interleukin-2|interleukin-2
5370393|NCT01856010|Dementia|dementia
5370394|NCT01856010|Aggression|aggression
5370395|NCT01856010|Agitation|agitation
5370396|NCT01855984|ADHD|adhd
5370397|NCT01855984|Children|children
5370398|NCT01855984|Tocotrienol|tocotrienol
5370399|NCT01855958|Osteoarthritis|osteoarthritis
5370400|NCT01855958|Electro acupuncture|electro acupuncture
5370401|NCT01855958|Deep intramuscular stimulation|deep intramuscular stimulation
5370402|NCT01855958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5370403|NCT01855958|Pain pressure threshold|pain pressure threshold
5370404|NCT01855958|Conditioned pain modulation|conditioned pain modulation
5370405|NCT01855958|Clinical trial|clinical trial
5370406|NCT01855945|Influenza|influenza
5370407|NCT01855919|Chronic Low Back Pain|chronic low back pain
5370408|NCT01855919|CLBP|clbp
5365930|NCT01875874|ALF|alf
5370409|NCT01855906|Total knee replacement|total knee replacement
5370410|NCT01855906|Gap balanced|gap balanced
5370411|NCT01855906|Measured resection|measured resection
5370412|NCT01855893|Neck pain|neck pain
5370413|NCT01855880|psoriasis|psoriasis
5370414|NCT01855880|dermatology|dermatology
5370415|NCT01855880|monoclonal antibody|monoclonal antibody
5370418|NCT01855867|nPEP|npep
5370419|NCT01855867|Prophylaxis|prophylaxis
5370420|NCT01855867|Post Exposure Prophylaxis|post exposure prophylaxis
5370421|NCT01855867|exposure to HIV|exposure to hiv
5370422|NCT01855867|HIV prevention|hiv prevention
5370423|NCT01855841|ERCP|ercp
5370424|NCT01855841|virgin papilla|virgin papilla
5370425|NCT01855841|risk of post-ERCP acute pancreatitis|risk of post-ercp acute pancreatitis
5370426|NCT01855802|Greece|greece
5370427|NCT01855802|Ophthalmology|ophthalmology
5370428|NCT01855802|Glaucoma|glaucoma
5370429|NCT01855802|Generics|generics
5370430|NCT01855802|Perception|perception
5370431|NCT01855776|Physical Activity/Walking|physical activity/walking
5370432|NCT01855776|Full-time employees|full-time employees
5370433|NCT01855776|RCT|rct
5370434|NCT01855776|Incentives|incentives
5370435|NCT01855776|Wireless pedometer|wireless pedometer
5370436|NCT01855763|gestational diabetes|gestational diabetes
5370437|NCT01855763|type 2 diabetes|type 2 diabetes
5370438|NCT01855763|pregnancy|pregnancy
5370439|NCT01855763|metformin|metformin
5370440|NCT01855763|insulin|insulin
5370441|NCT01855750|Lymphoma|lymphoma
5370442|NCT01855750|B-cell lymphoma|b-cell lymphoma
5370443|NCT01855750|Non-germinal center B-cell subtype|non-germinal center b-cell subtype
5370444|NCT01855750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5370445|NCT01855750|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5370446|NCT01855750|PCI-32765|pci-32765
5370447|NCT01855750|JNJ-54179060|jnj-54179060
5370448|NCT01855750|Ibrutinib|ibrutinib
5370449|NCT01855750|Rituximab|rituximab
5370450|NCT01855750|Cyclophosphamide|cyclophosphamide
5370451|NCT01855750|Doxorubicin|doxorubicin
5370452|NCT01855750|Vincristine|vincristine
5370453|NCT01855750|Prednisone|prednisone
5370454|NCT01855737|gene guided|gene guided
5370455|NCT01855737|warfarin dose|warfarin dose
5370456|NCT01855737|Chinese|chinese
5370457|NCT01855711|Alosetron hydrochloride|alosetron hydrochloride
5370458|NCT01855711|Global Improvement Scale(GIS)|global improvement scale(gis)
5370459|NCT01855711|Diarrhea-predominant IBS|diarrhea-predominant ibs
5370460|NCT01855698|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism|hematologic neoplasm, profhylaxis, arterial and venous thromboembolism
5370461|NCT01855685|XCGD, lentivirus, cellular therapy|xcgd, lentivirus, cellular therapy
5370462|NCT01855672|Migraine, occipital nerve, stimulation|migraine, occipital nerve, stimulation
5370463|NCT01855659|Lung diseases,|lung diseases,
5370464|NCT01855659|Obstructive,|obstructive,
5370465|NCT01855659|Peak Inspiratory Flow|peak inspiratory flow
5370466|NCT01855659|[C08.381.495.389]|[c08.381.495.389]
5370467|NCT01855620|Contraception|contraception
5370468|NCT01855620|Implant|implant
5370469|NCT01855620|Obesity|obesity
5370472|NCT01855529|ropivacaine, pain, mastectomy|ropivacaine, pain, mastectomy
5370473|NCT01855516|Antithrombotic prophylaxis|antithrombotic prophylaxis
5370475|NCT01855503|Breast Cancer|breast cancer
5370476|NCT01855503|Metastatic Breast Cancer|metastatic breast cancer
5370477|NCT01855503|Breast|breast
5370478|NCT01855503|Biopsy|biopsy
5370479|NCT01855503|Molecular|molecular
5370480|NCT01855503|Genetic|genetic
5370481|NCT01855464|pneumothorax|pneumothorax
5370482|NCT01855464|primary pneumothorax|primary pneumothorax
5370483|NCT01855464|lung collapse|lung collapse
5370484|NCT01855451|Human Papilloma Virus|human papilloma virus
5370485|NCT01855451|HPV|hpv
5370486|NCT01855451|Oropharyngeal|oropharyngeal
5370487|NCT01855451|Squamous Cell|squamous cell
5370488|NCT01855451|Carcinoma|carcinoma
5370489|NCT01855438|Live donor kidney transplantation|live donor kidney transplantation
5370490|NCT01855438|Living donation|living donation
5370491|NCT01855438|Patient education|patient education
5370492|NCT01855438|Kidney transplant candidates|kidney transplant candidates
5370493|NCT01855412|PAD|pad
5370494|NCT01855412|LIBERTY|liberty
5370495|NCT01855412|Observational|observational
5370496|NCT01855399|Peer Support|peer support
5370497|NCT01855399|Self Management|self management
5370498|NCT01855399|Health Disparities|health disparities
5370499|NCT01855373|Blood Sugar|blood sugar
5370500|NCT01855373|Endothelial Function|endothelial function
5370501|NCT01855373|Blood Vessel Health|blood vessel health
5370502|NCT01855360|amyloid|amyloid
5370503|NCT01855360|amyloidosis|amyloidosis
5370504|NCT01855360|cardiac amyloidosis|cardiac amyloidosis
5370505|NCT01855360|senile amyloidosis|senile amyloidosis
5370506|NCT01855360|familial amyloidosis|familial amyloidosis
5370507|NCT01855360|transthyretin amyloidosis|transthyretin amyloidosis
5370508|NCT01855347|Prematurity|prematurity
5370509|NCT01855347|Hypoxia|hypoxia
5370510|NCT01855347|Necrotizing Enterocolitis|necrotizing enterocolitis
5370511|NCT01855347|Near Infrared Spectroscopy|near infrared spectroscopy
5370512|NCT01855347|Abdominal tissue oxygenation|abdominal tissue oxygenation
5370513|NCT01855347|NICU|nicu
5370514|NCT01855334|Dialysis|dialysis
5370515|NCT01855334|ESRD|esrd
5370516|NCT01855334|Cardiovascular disease|cardiovascular disease
5370517|NCT01855334|spironolactone|spironolactone
5370518|NCT01855334|L-arginine|l-arginine
5370519|NCT01855334|myocardial perfusion|myocardial perfusion
5370520|NCT01855334|coronary flow reserve|coronary flow reserve
5370521|NCT01855334|diastolic function|diastolic function
5370522|NCT01855321|uncontrolled diabetes|uncontrolled diabetes
5370523|NCT01855321|vitamin D deficiency|vitamin d deficiency
5370524|NCT01855295|Dialysis|dialysis
5370525|NCT01855295|End Stage Renal Disease|end stage renal disease
5370526|NCT01855295|Protein supplementation|protein supplementation
5370527|NCT01855295|Inflammation|inflammation
5370528|NCT01855295|Quality of Life|quality of life
5370529|NCT01855282|Diabetes Type II,|diabetes type ii,
5370531|NCT01855282|Obesity,|obesity,
5370532|NCT01855282|Behavioral Intervention,|behavioral intervention,
5370533|NCT01855282|Latino, farm worker|latino, farm worker
5370534|NCT01855282|randomized controlled intervention|randomized controlled intervention
5370535|NCT01855269|probiotic|probiotic
5370536|NCT01855269|infantile colic|infantile colic
5370537|NCT01855256|hyperhidrosis|hyperhidrosis
5370538|NCT01855256|oxybutynin|oxybutynin
5370539|NCT01855243|Type 2 D M|type 2 d m
5370540|NCT01855243|sliding scale insulin|sliding scale insulin
5370541|NCT01855243|70/30 insulin|70/30 insulin
5370542|NCT01855243|basals insulin|basals insulin
5370543|NCT01855243|supplemental insulin|supplemental insulin
5370544|NCT01855217|morbid|morbid
5370545|NCT01855217|obesity|obesity
5370546|NCT01855217|sugammadex|sugammadex
5370547|NCT01855217|pharmacodynamics|pharmacodynamics
5370548|NCT01855204|Computed Tomography, Spiral|computed tomography, spiral
5370549|NCT01855204|Urography|urography
5370550|NCT01855204|Radiation dosage|radiation dosage
5370551|NCT01855204|Contrast media|contrast media
5370552|NCT01855178|nocturnal|nocturnal
5370553|NCT01855178|epilepsy|epilepsy
5353816|NCT01931618|alcohol|alcohol
5370554|NCT01855165|chronic heart failure|chronic heart failure
5370555|NCT01855165|drug-drug interactions|drug-drug interactions
5370556|NCT01855165|pharmacist's intervention|pharmacist's intervention
5370557|NCT01855152|Dementia|dementia
5370558|NCT01855152|Care Homes|care homes
5370559|NCT01855152|Quality of life|quality of life
5370560|NCT01855152|Antipsychotic medication|antipsychotic medication
5370561|NCT01855152|Behavioural symptoms|behavioural symptoms
5370562|NCT01855152|Cost effectiveness|cost effectiveness
5370563|NCT01855152|Implementation|implementation
5370564|NCT01855152|Person centred care|person centred care
5370565|NCT01855152|Social interaction|social interaction
5370566|NCT01855139|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5370567|NCT01855139|Stroke|stroke
5370568|NCT01855139|Systemic embolism|systemic embolism
5370569|NCT01855139|Oral anticoagulation|oral anticoagulation
5370570|NCT01855139|Real-life setting|real-life setting
5370571|NCT01855139|Preventive measure|preventive measure
5370572|NCT01855126|light|light
5370573|NCT01855126|circadian rhythms|circadian rhythms
5370574|NCT01855126|dim light melatonin onset|dim light melatonin onset
5370575|NCT01855126|sleep|sleep
5370576|NCT01855113|PAIN|pain
5370577|NCT01855113|ORTHODONTIC TREATMENT|orthodontic treatment
5370578|NCT01855113|INVISALIGN|invisalign
5370579|NCT01855100|Treatment of acute deep vein thrombosis|treatment of acute deep vein thrombosis
5370580|NCT01855100|Prevention of recurrence|prevention of recurrence
5370581|NCT01855100|Oral anticoagulation|oral anticoagulation
5370582|NCT01855100|Real-life setting|real-life setting
5370583|NCT01855074|Schizophrenia|schizophrenia
5370584|NCT01855074|Schizophreniform Disorder|schizophreniform disorder
5370585|NCT01855074|Schizoaffective Disorder|schizoaffective disorder
5370586|NCT01855074|Risperidone|risperidone
5370587|NCT01855074|Risperdal consta|risperdal consta
5370588|NCT01855061|Feasibility studies|feasibility studies
5370589|NCT01855061|Sequence analysis, DNA|sequence analysis, dna
5370590|NCT01855061|Biological markers|biological markers
5370591|NCT01855061|Solid tumors|solid tumors
5370592|NCT01855061|Neoplasm metastasis|neoplasm metastasis
5370593|NCT01855061|Irinotecan|irinotecan
5370594|NCT01855061|Pharmacokinetics SN-38|pharmacokinetics sn-38
5370595|NCT01855061|Carboxylesterase activity within metastasis|carboxylesterase activity within metastasis
5370596|NCT01855048|N-Rephasin® SAL200|n-rephasin® sal200
5370597|NCT01855048|endolysin|endolysin
5370598|NCT01855048|Placebo|placebo
5370599|NCT01855035|ischemic stroke|ischemic stroke
5370600|NCT01855035|ECG monitoring|ecg monitoring
5370601|NCT01855035|atrial fibrillation (/flutter)|atrial fibrillation (/flutter)
5370602|NCT01855022|Motivational interviewing|motivational interviewing
5370603|NCT01855022|Interactive voice response|interactive voice response
5370604|NCT01855022|Hospital readmission|hospital readmission
5370605|NCT01855009|Quality of Life|quality of life
5370606|NCT01855009|Body Weight and Measures|body weight and measures
5370607|NCT01855009|Malnutrition|malnutrition
5370608|NCT01855009|Adolescent Nutrition Sciences|adolescent nutrition sciences
5370609|NCT01855009|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5370610|NCT01855009|Motor Activity|motor activity
5370613|NCT01854983|cervical cancer|cervical cancer
5370614|NCT01854957|Multiple sclerosis|multiple sclerosis
5370615|NCT01854957|Mesenchymal stem cells|mesenchymal stem cells
5370616|NCT01854931|Tai Ji Quan|tai ji quan
5370617|NCT01854931|fall prevention|fall prevention
5370618|NCT01854931|community dissemination|community dissemination
5370619|NCT01854918|High cholesterol|high cholesterol
5370620|NCT01854918|Raised cholesterol|raised cholesterol
5370621|NCT01854918|Cholesterol|cholesterol
5370622|NCT01854918|Elevated Cholesterol|elevated cholesterol
5370623|NCT01854892|low back pain|low back pain
5370624|NCT01854892|manipulation|manipulation
5370625|NCT01854892|laser therapy|laser therapy
5370626|NCT01854892|osteopathic|osteopathic
5370627|NCT01854892|chiropractic|chiropractic
5370628|NCT01854892|mobilization|mobilization
5370629|NCT01854892|muscle energy|muscle energy
5370630|NCT01854892|physical therapy|physical therapy
5370632|NCT01854892|spine|spine
5370633|NCT01854892|adjustment|adjustment
5370634|NCT01854892|rehabilitation|rehabilitation
5370635|NCT01854866|Pleural Effusion|pleural effusion
5370636|NCT01854866|ascites|ascites
5370637|NCT01854866|Malignant|malignant
5370638|NCT01854853|unsafe sex|unsafe sex
5370639|NCT01854853|safer sex|safer sex
5370640|NCT01854853|HIV|hiv
5370641|NCT01854853|STI|sti
5370642|NCT01854853|Pregnancy|pregnancy
5370643|NCT01854840|hyaline membrane disease|hyaline membrane disease
5370644|NCT01854840|placenta|placenta
5370645|NCT01854840|betamethasone|betamethasone
5370646|NCT01854827|Biliary atresia|biliary atresia
5370647|NCT01854827|Hepatic portoenterostomy|hepatic portoenterostomy
5370648|NCT01854827|Intravenous immunoglobulin|intravenous immunoglobulin
5370649|NCT01854801|IEI-EMF|iei-emf
5370650|NCT01854801|WI-FI|wi-fi
5370651|NCT01854801|DECT|dect
5370652|NCT01854801|Electro-sensitivity|electro-sensitivity
5370653|NCT01854801|Radiofrequency|radiofrequency
5370654|NCT01854801|EHS|ehs
5370655|NCT01854801|Idiopathic|idiopathic
5370656|NCT01854801|Environmental|environmental
5370657|NCT01854801|Intolerance fields|intolerance fields
5370658|NCT01854801|Mobile phone|mobile phone
5370762|NCT01854476|Bleeding|bleeding
5370663|NCT01854788|Slow expiration with glottis opened in lateral posture(ELTGOL)|slow expiration with glottis opened in lateral posture(eltgol)
5370664|NCT01854788|Temporary-positive expiratory pressure (T-PEP)|temporary-positive expiratory pressure (t-pep)
5370665|NCT01854788|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5370671|NCT01854762|HIV|hiv
5370672|NCT01854762|Treatment|treatment
5370673|NCT01854762|Pregnancy|pregnancy
5370674|NCT01854749|ESCC|escc
5370675|NCT01854736|Allergy|allergy
5370676|NCT01854736|Phleum pratense|phleum pratense
5370677|NCT01854736|Rhinoconjunctivitis|rhinoconjunctivitis
5370678|NCT01854736|asthma|asthma
5370679|NCT01854736|positive SPT to Phleum pratense|positive spt to phleum pratense
5370680|NCT01854723|Diabetes|diabetes
5370681|NCT01854723|Insulin glargine|insulin glargine
5370682|NCT01854723|NPH insulin|nph insulin
5370683|NCT01854710|ADASUVE|adasuve
5370684|NCT01854710|inhaled loxapine|inhaled loxapine
5370685|NCT01854710|thorough QT/QTc study|thorough qt/qtc study
5370686|NCT01854697|Chronic Hepatitis C|chronic hepatitis c
5370687|NCT01854697|Interferon Free|interferon free
5370688|NCT01854697|Hepatitis C Treatment Naive|hepatitis c treatment naive
5370689|NCT01854697|Hepatitis C Virus|hepatitis c virus
5370690|NCT01854697|Hepatitis C Genotype 1|hepatitis c genotype 1
5370691|NCT01854671|postpartum contraception|postpartum contraception
5370692|NCT01854671|contraceptive counseling|contraceptive counseling
5370693|NCT01854632|influenza vaccine|influenza vaccine
5370694|NCT01854632|trivalent live-attenuated influenza vaccine|trivalent live-attenuated influenza vaccine
5370695|NCT01854632|efficacy|efficacy
5370696|NCT01854632|Africa|africa
5370697|NCT01854632|Senegal|senegal
5370698|NCT01854619|chronic rhinosinusitis|chronic rhinosinusitis
5370699|NCT01854619|sinusitis|sinusitis
5370700|NCT01854619|photodisinfection|photodisinfection
5370701|NCT01854619|photodynamic therapy|photodynamic therapy
5370702|NCT01854619|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
5370703|NCT01854619|aPDT|apdt
5370705|NCT01854619|paranasal sinus diseases|paranasal sinus diseases
5370706|NCT01854619|respiratory tract infections|respiratory tract infections
5370707|NCT01854619|respiratory tract diseases|respiratory tract diseases
5370708|NCT01854606|Diffuse Large B-Cell Lymphoma, DBCL, AEB071, Everolimus|diffuse large b-cell lymphoma, dbcl, aeb071, everolimus
5370709|NCT01854580|Comparative effectiveness research|comparative effectiveness research
5370710|NCT01854580|health economic evaluation|health economic evaluation
5370711|NCT01854567|Cord Blood|cord blood
5370712|NCT01854567|Stem Cells|stem cells
5370713|NCT01854567|MPC|mpc
5370714|NCT01854567|Mesoblast|mesoblast
5370715|NCT01854567|Expanded|expanded
5370716|NCT01854567|AML|aml
5370717|NCT01854567|ALL|all
5370718|NCT01854567|NHL|nhl
5370719|NCT01854567|Leukemia|leukemia
5370721|NCT01854554|Brain cancer|brain cancer
5370722|NCT01854554|Glioblastoma|glioblastoma
5370723|NCT01854554|Glioblastoma Multiforme|glioblastoma multiforme
5370724|NCT01854554|GBM|gbm
5370725|NCT01854554|Intensity Modulated Proton Radiotherapy|intensity modulated proton radiotherapy
5370726|NCT01854554|IMPT|impt
5370727|NCT01854554|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5370728|NCT01854554|IMRT|imrt
5370729|NCT01854554|Radiotherapy|radiotherapy
5370730|NCT01854554|XRT|xrt
5370731|NCT01854554|Cognitive tests|cognitive tests
5370732|NCT01854554|Thinking skills tests|thinking skills tests
5370733|NCT01854554|Questionnaires|questionnaires
5370734|NCT01854554|Surveys|surveys
5370735|NCT01854554|Quality of life|quality of life
5370736|NCT01854554|QOL|qol
5370737|NCT01854541|Cancer|cancer
5370738|NCT01854541|Radiotherapy|radiotherapy
5370739|NCT01854528|Partial responder|partial responder
5370740|NCT01854528|Interferon free|interferon free
5370741|NCT01854528|Treatment-experienced|treatment-experienced
5370742|NCT01854528|Relapser|relapser
5370743|NCT01854528|Hepatitis C Virus|hepatitis c virus
5370744|NCT01854528|Null responder|null responder
5370745|NCT01854528|Hepatitis C Genotype 1|hepatitis c genotype 1
5370746|NCT01854528|paritaprevir|paritaprevir
5370747|NCT01854528|ombitasvir|ombitasvir
5370748|NCT01854528|dasabuvir|dasabuvir
5370749|NCT01854528|ribavirin|ribavirin
5370750|NCT01854528|Viekira PAK|viekira pak
5370751|NCT01854528|Chronic hepatitis C|chronic hepatitis c
5370752|NCT01854502|Young children|young children
5370753|NCT01854502|counseling|counseling
5370754|NCT01854502|fluoride|fluoride
5370756|NCT01854489|Buprenorphine|buprenorphine
5370757|NCT01854489|Rifampicin|rifampicin
5370758|NCT01854489|Interactions|interactions
5370759|NCT01854489|Pharmakokinetics|pharmakokinetics
5370760|NCT01854489|Pharmakodynamics|pharmakodynamics
5370761|NCT01854476|Hemodialysis|hemodialysis
5370763|NCT01854476|Hemostatic dressing|hemostatic dressing
5370764|NCT01854476|Tranexamic Acid|tranexamic acid
5370765|NCT01854463|DIABETES MELLITUS|diabetes mellitus
5370766|NCT01854463|VITAMIN D|vitamin d
5370767|NCT01854463|ARTERIAL STIFFNESS|arterial stiffness
5370768|NCT01854463|FATTY LIVER|fatty liver
5370769|NCT01854463|BONE TURNOVER|bone turnover
5370770|NCT01854450|Occipitoposterior position|occipitoposterior position
5370771|NCT01854450|Maternal posturing|maternal posturing
5370772|NCT01854450|Labor|labor
5370773|NCT01854437|mg oxide|mg oxide
5370774|NCT01854437|hyperphosphatemia|hyperphosphatemia
5370775|NCT01854437|plasma phosphor level|plasma phosphor level
5370776|NCT01854424|Fibrocyte|fibrocyte
5370777|NCT01854424|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5370779|NCT01854424|Fibrosis|fibrosis
5370780|NCT01854424|Mortality|mortality
5356683|NCT01918449|CPAP treatment|cpap treatment
5370781|NCT01854411|Analgesics|analgesics
5370782|NCT01854411|Ibuprofene|ibuprofene
5370783|NCT01854411|Ketoprofene|ketoprofene
5370784|NCT01854411|Breastmilk|breastmilk
5370785|NCT01854411|Relative Infant Dose|relative infant dose
5370786|NCT01854411|Theoric Infant Dose|theoric infant dose
5370787|NCT01854398|Obstructive sleep apnea|obstructive sleep apnea
5370788|NCT01854398|Continuous positive airway pressure|continuous positive airway pressure
5370789|NCT01854398|diastolic function|diastolic function
5370790|NCT01854385|Post-traumatic headache|post-traumatic headache
5370791|NCT01854385|Traumatic brain injury|traumatic brain injury
5370792|NCT01854385|Sumatriptan|sumatriptan
5370793|NCT01854359|Multiple Sclerosis|multiple sclerosis
5370794|NCT01854359|Extension Trial|extension trial
5370795|NCT01854346|Autism spectrum disorder|autism spectrum disorder
5370796|NCT01854346|Social skills training|social skills training
5370797|NCT01854346|Group training|group training
5370798|NCT01854346|Comorbidity|comorbidity
5370799|NCT01854346|Intervention|intervention
5370800|NCT01854346|Evidence-based|evidence-based
5370801|NCT01854333|Diagnostics|diagnostics
5370802|NCT01854333|ADOS|ados
5370803|NCT01854333|ADI-R|adi-r
5370804|NCT01854333|Psychometrics|psychometrics
5370805|NCT01854333|Autism spectrum disorders|autism spectrum disorders
5370806|NCT01854333|Autism|autism
5370807|NCT01854307|Difference of|difference of
5370808|NCT01854307|measurements|measurements
5370809|NCT01854307|before and after|before and after
5370810|NCT01854294|ALS|als
5370811|NCT01854294|motorneuron disease|motorneuron disease
5370812|NCT01854294|Central Nervous System (CNS) disease|central nervous system (cns) disease
5370813|NCT01854294|neurodegeneration|neurodegeneration
5370814|NCT01854294|neuroprotective|neuroprotective
5370815|NCT01854294|mechanisms of action|mechanisms of action
5370816|NCT01854294|pathways|pathways
5370817|NCT01854294|biomarkers|biomarkers
5370818|NCT01854294|Cerebral Spinal Fluid (CSF)|cerebral spinal fluid (csf)
5370819|NCT01854294|blood biomarkers|blood biomarkers
5370820|NCT01854294|multi-factorial|multi-factorial
5370821|NCT01854294|multisystem|multisystem
5370822|NCT01854294|single target|single target
5370823|NCT01854294|pathogenic mechanisms|pathogenic mechanisms
5370824|NCT01854294|Protein Bands Selection by Function|protein bands selection by function
5370825|NCT01854294|in silico analysis|in silico analysis
5370826|NCT01854294|active site|active site
5370828|NCT01854294|peptide|peptide
5370829|NCT01854294|embryonic stage|embryonic stage
5370830|NCT01854294|endogenous|endogenous
5370831|NCT01854294|master regulators|master regulators
5370832|NCT01854294|fetal development|fetal development
5370833|NCT01854294|embryonic development|embryonic development
5370834|NCT01854294|common pathways|common pathways
5370835|NCT01854294|Blood Brain Barrier (BBB)|blood brain barrier (bbb)
5370836|NCT01854294|anti-inflammatory|anti-inflammatory
5370837|NCT01854294|anti-apoptotic|anti-apoptotic
5370838|NCT01854294|anti-oxidative|anti-oxidative
5370839|NCT01854294|regenerative|regenerative
5370840|NCT01854294|distress signals|distress signals
5370841|NCT01854294|neurotrophin|neurotrophin
5370842|NCT01854294|Motoneuronotrophic factor (MNTF)|motoneuronotrophic factor (mntf)
5370843|NCT01854294|ALS model|als model
5370844|NCT01854294|life span|life span
5370845|NCT01854294|disease onset|disease onset
5370846|NCT01854294|grip strength|grip strength
5370847|NCT01854294|protein expression|protein expression
5370848|NCT01854294|DNA microarray|dna microarray
5370849|NCT01854294|differential expression|differential expression
5370850|NCT01854294|Phase 1 clinical trial|phase 1 clinical trial
5370851|NCT01854294|rare disease|rare disease
5370852|NCT01854294|common underlying pathogenic mechanisms|common underlying pathogenic mechanisms
5370853|NCT01854294|neurological deficits|neurological deficits
5370854|NCT01854294|gene mutation|gene mutation
5370855|NCT01854294|misfolded proteins|misfolded proteins
5370856|NCT01854294|inadvertent errors|inadvertent errors
5370857|NCT01854294|modulation of genes|modulation of genes
5370858|NCT01854294|master regulator peptide drug|master regulator peptide drug
5370859|NCT01854294|ALS related genes|als related genes
5370860|NCT01854294|mitochondria dysfunction|mitochondria dysfunction
5370861|NCT01854294|excitotoxicity|excitotoxicity
5370862|NCT01854294|axonal transport|axonal transport
5370863|NCT01854294|oxidative stress|oxidative stress
5370864|NCT01854294|protein aggregation|protein aggregation
5370865|NCT01854294|pathogenesis|pathogenesis
5370866|NCT01854294|target biomarkers|target biomarkers
5370867|NCT01854294|efficacy biomarkers|efficacy biomarkers
5370868|NCT01854281|Patent foramen ovale|patent foramen ovale
5370869|NCT01854281|Catheter-based closure|catheter-based closure
5370870|NCT01854281|Nitrogen bubbles|nitrogen bubbles
5370871|NCT01854281|Decompression sickness|decompression sickness
5370872|NCT01854268|cough|cough
5370873|NCT01854255|Gastric|gastric
5370874|NCT01854255|Cancer|cancer
5370875|NCT01854255|Chemotherapy|chemotherapy
5370876|NCT01854255|Intraperitoneal|intraperitoneal
5370877|NCT01854229|Morphine|morphine
5370878|NCT01854229|Implantable Infusion Pumps|implantable infusion pumps
5370879|NCT01854229|Intrathecal Pump|intrathecal pump
5370880|NCT01854216|Rotigotine|rotigotine
5370881|NCT01854216|Neupro|neupro
5370882|NCT01854216|Japanese|japanese
5370883|NCT01854216|Caucasian|caucasian
5370884|NCT01854216|Male|male
5370885|NCT01854216|Female|female
5370886|NCT01854216|Single dose|single dose
5370887|NCT01854216|Pharmacokinetics|pharmacokinetics
5370888|NCT01854203|Cisplatin|cisplatin
5370889|NCT01854203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5370890|NCT01854203|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5370891|NCT01854203|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5370892|NCT01854190|Obstructive sleep apnea|obstructive sleep apnea
5370893|NCT01854190|Resistent hypertension|resistent hypertension
5370894|NCT01854190|Endothelial function|endothelial function
5370895|NCT01854190|Blood pressure|blood pressure
5370896|NCT01854177|breathlessness; substance P; beta-endorphin|breathlessness; substance p; beta-endorphin
5370897|NCT01854164|HGE, impaired fasting glucose, clinical trial|hge, impaired fasting glucose, clinical trial
5370898|NCT01854151|Medication errors|medication errors
5370899|NCT01854151|Medication dosing|medication dosing
5370900|NCT01854138|primary knee arthroplasty|primary knee arthroplasty
5370901|NCT01854138|primary hip arthroplasty|primary hip arthroplasty
5370902|NCT01854138|negative pressure wound therapy|negative pressure wound therapy
5370903|NCT01854125|immun function|immun function
5370904|NCT01854125|liver function|liver function
5370905|NCT01854125|ascites|ascites
5370906|NCT01854125|quality of life|quality of life
5370907|NCT01854125|Child-Pugh score|child-pugh score
5370908|NCT01854112|Helical tomotherapy|helical tomotherapy
5370909|NCT01854112|total skin electron therapy|total skin electron therapy
5370910|NCT01854112|TSEB|tseb
5370911|NCT01854112|irradiation 5.|irradiation 5.
5370912|NCT01854099|Brain Tumor|brain tumor
5370913|NCT01854086|osteoporosis|osteoporosis
5370914|NCT01854086|postmenopausal|postmenopausal
5370915|NCT01854086|patient compliance|patient compliance
5370916|NCT01854086|compliance|compliance
5370917|NCT01854086|diphosphonates|diphosphonates
5370918|NCT01854086|bisphosphonates|bisphosphonates
5370919|NCT01854060|Irritable bowel syndrome|irritable bowel syndrome
5370920|NCT01854060|Epidimiology|epidimiology
5370921|NCT01854060|Deterioration in the severity of irritable bowel syndrome|deterioration in the severity of irritable bowel syndrome
5370922|NCT01854034|Advanced disease|advanced disease
5370923|NCT01854034|EGFR mutation|egfr mutation
5370924|NCT01854021|Anesthesia|anesthesia
5370925|NCT01854021|general|general
5370926|NCT01854021|Immunity|immunity
5370927|NCT01854021|Tongue neoplasms|tongue neoplasms
5370928|NCT01854021|immune|immune
5370929|NCT01854021|general anesthesia|general anesthesia
5370930|NCT01854008|Exercise, Physical activity, Rehabilitation, COPD.|exercise, physical activity, rehabilitation, copd.
5370931|NCT01853995|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
5370932|NCT01853995|Class II division 1 malocclusion|class ii division 1 malocclusion
5370933|NCT01853995|Sagittal Occlusal Correction|sagittal occlusal correction
5370934|NCT01853995|Skeletal changes|skeletal changes
5370935|NCT01853995|Dental changes|dental changes
5370936|NCT01853956|Mexico|mexico
5370937|NCT01853956|Bioequivalence|bioequivalence
5370938|NCT01853956|Alprazolam|alprazolam
5370939|NCT01853956|Pharmacokinetics|pharmacokinetics
5370940|NCT01853943|Transradial approach|transradial approach
5370941|NCT01853943|radial occlusion|radial occlusion
5370942|NCT01853943|hand grip|hand grip
5370943|NCT01853943|coronary angiography|coronary angiography
5370944|NCT01853930|reading rehabilitation|reading rehabilitation
5370945|NCT01853930|macular degeneration|macular degeneration
5370946|NCT01853930|eccentric viewing|eccentric viewing
5370947|NCT01853904|Bronchoscopy|bronchoscopy
5370949|NCT01853904|Suction|suction
5370950|NCT01853878|Non-Small Cell Lung Cancer|non-small cell lung cancer
5370951|NCT01853878|Immunotherapy|immunotherapy
5370952|NCT01853878|Antigen-Specific|antigen-specific
5370953|NCT01853865|Endometrial cancer|endometrial cancer
5370954|NCT01853865|Follow-up examination|follow-up examination
5370955|NCT01853813|colorectal cancer|colorectal cancer
5370956|NCT01853813|advanced disease|advanced disease
5370957|NCT01853813|LDH|ldh
5370958|NCT01853800|Relative bioavailability|relative bioavailability
5370959|NCT01853800|Rivaroxaban|rivaroxaban
5370960|NCT01853787|COPD|copd
5370961|NCT01853787|bronchial inflammation|bronchial inflammation
5370962|NCT01853787|NO concentration|no concentration
5370963|NCT01853787|small airways|small airways
5370964|NCT01853787|LABA|laba
5354163|NCT01929720|fatigue|fatigue
5370965|NCT01853787|Small Airways Stretching|small airways stretching
5370966|NCT01853787|Stretch and strain of small airways in COPD|stretch and strain of small airways in copd
5370967|NCT01853787|Acute LABA effect on NO production|acute laba effect on no production
5370968|NCT01853787|Pulmonary desufflation|pulmonary desufflation
5370969|NCT01853774|Tailored navigation|tailored navigation
5370970|NCT01853774|Tailored messages|tailored messages
5370971|NCT01853761|abdominal fat|abdominal fat
5370972|NCT01853761|metabolic syndrome|metabolic syndrome
5370973|NCT01853761|microcurrent|microcurrent
5370992|NCT01853631|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5370993|NCT01853631|CD28|cd28
5370994|NCT01853631|CD137|cd137
5370995|NCT01853631|4-1BB|4-1bb
5671946|NCT00613496|irbesartan|irbesartan
5370996|NCT01853631|acute lymphocytic leukemia|acute lymphocytic leukemia
5370997|NCT01853618|Blocking of Immune Suppression|blocking of immune suppression
5370998|NCT01853618|Monoclonal Antibody|monoclonal antibody
5370999|NCT01853618|Immunotherapy|immunotherapy
5371000|NCT01853618|Ablative Therapy|ablative therapy
5371001|NCT01853592|Gadolinium Contrast|gadolinium contrast
5371002|NCT01853592|Cardiac MRI|cardiac mri
5371003|NCT01853592|MRA|mra
5371004|NCT01853592|MRI|mri
5371005|NCT01853592|MRI Safety|mri safety
5371006|NCT01853579|Randomized controlled trial|randomized controlled trial
5371007|NCT01853579|Subclinical hypothyroidism|subclinical hypothyroidism
5371008|NCT01853579|Levothyroxine|levothyroxine
5371009|NCT01853579|Depression|depression
5371010|NCT01853566|Muscle Strength|muscle strength
5371011|NCT01853566|Growth Hormone|growth hormone
5371012|NCT01853566|men|men
5371013|NCT01853540|Ciliary Beat Frequency (CBF)|ciliary beat frequency (cbf)
5371014|NCT01853540|Nasal Nitric Oxide (nNO)|nasal nitric oxide (nno)
5371015|NCT01853540|Mucociliary Dysfunction|mucociliary dysfunction
5371016|NCT01853527|CT coronary angiography|ct coronary angiography
5371017|NCT01853527|Contrast stress echocardiography|contrast stress echocardiography
5371018|NCT01853527|Arterial stiffness|arterial stiffness
5371019|NCT01853527|Quality of life|quality of life
5371020|NCT01853527|Biochemical and genetic markers|biochemical and genetic markers
5371021|NCT01853514|Low income|low income
5371022|NCT01853514|Fruit and vegetables|fruit and vegetables
5371023|NCT01853514|Conventional produce|conventional produce
5371024|NCT01853514|Organic produce|organic produce
5371025|NCT01853514|Pesticide|pesticide
5371026|NCT01853514|Purchasing behavior|purchasing behavior
5371027|NCT01853514|Message framing|message framing
5371028|NCT01853501|POF|pof
5371029|NCT01853488|Osteoporosis|osteoporosis
5371030|NCT01853488|BMD|bmd
5371031|NCT01853488|SCI|sci
5371032|NCT01853488|DXA|dxa
5371033|NCT01853488|pQCT|pqct
5371034|NCT01853475|pharmacokinetics|pharmacokinetics
5371035|NCT01853475|safety|safety
5371036|NCT01853475|tolerability|tolerability
5371037|NCT01853475|bioavailability|bioavailability
5371038|NCT01853449|Fentanyl Citrate|fentanyl citrate
5371039|NCT01853449|Opioids|opioids
5371040|NCT01853449|Exercise|exercise
5371041|NCT01853436|Breast Cancer|breast cancer
5371042|NCT01853436|Reconstructive Tissue Matrix|reconstructive tissue matrix
5371043|NCT01853436|Acellular Dermal Matrices (ADM)|acellular dermal matrices (adm)
5371044|NCT01853423|Rapamune|rapamune
5371045|NCT01853423|Topical|topical
5371046|NCT01853423|Pediatric|pediatric
5371047|NCT01853423|Safety|safety
5371048|NCT01853423|Efficiency|efficiency
5371049|NCT01853423|Angiofibroma|angiofibroma
5371050|NCT01853423|Skin Cream|skin cream
5371051|NCT01853410|coronary artery disease|coronary artery disease
5371052|NCT01853410|coronary flow reserve|coronary flow reserve
5371053|NCT01853410|endothelial function|endothelial function
5371054|NCT01853384|Venous leg ulcer|venous leg ulcer
5371055|NCT01853384|ulcer|ulcer
5371056|NCT01853384|venous stasis|venous stasis
5371057|NCT01853384|compression|compression
5371058|NCT01853384|venous|venous
5371059|NCT01853384|venous stasis ulcer|venous stasis ulcer
5371061|NCT01853384|wound|wound
5371062|NCT01853384|varicose veins|varicose veins
5371063|NCT01853384|venous insufficiency|venous insufficiency
5371064|NCT01853384|dvt|dvt
5371065|NCT01853384|deep vein thrombosis|deep vein thrombosis
5371066|NCT01853358|hematological malignancy|hematological malignancy
5371067|NCT01853358|stem cell transplantation|stem cell transplantation
5371068|NCT01853345|Refractory|refractory
5371069|NCT01853345|Recurrent|recurrent
5371070|NCT01853345|High Risk|high risk
5371071|NCT01853332|Cardiovascular Disease|cardiovascular disease
5371072|NCT01853332|Diabetes|diabetes
5371074|NCT01853332|Adversity|adversity
5371075|NCT01853332|Psychology|psychology
5371076|NCT01853332|Midlife|midlife
5371077|NCT01853332|Functioning|functioning
5371078|NCT01853332|Socioeconomic|socioeconomic
5371079|NCT01853332|Psychosocial outcomes|psychosocial outcomes
5371080|NCT01853319|Regorafenib|regorafenib
5371081|NCT01853319|Metastatic colorectal cancer|metastatic colorectal cancer
5371082|NCT01853306|High grade serous ovarian cancer|high grade serous ovarian cancer
5371083|NCT01853306|BRCA mutated breast cancer|brca mutated breast cancer
5371084|NCT01853306|BRCA mutated|brca mutated
5371085|NCT01853306|Oncology|oncology
5371086|NCT01853293|Alcohol Abuse|alcohol abuse
5371087|NCT01853293|Alcohol Dependence|alcohol dependence
5371088|NCT01853293|Heavy drinking days|heavy drinking days
5371089|NCT01853293|Kudzu|kudzu
5371090|NCT01853280|ADHD|adhd
5371091|NCT01853280|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5371092|NCT01853280|Deplin|deplin
5371093|NCT01853280|L-methylfolate|l-methylfolate
5371094|NCT01853280|Natural Treatments|natural treatments
5371095|NCT01853280|Medical Food|medical food
5371096|NCT01853267|Colorectal|colorectal
5371098|NCT01853267|Perianal|perianal
5371099|NCT01853267|Abscess|abscess
5371100|NCT01853241|small intestine|small intestine
5371101|NCT01853241|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5371102|NCT01853228|Acute myeloid leukemia|acute myeloid leukemia
5371103|NCT01853228|Relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
5371104|NCT01853228|Children|children
5371105|NCT01853228|Decitabine|decitabine
5371106|NCT01853228|DACOGEN|dacogen
5371107|NCT01853228|Cytarabine|cytarabine
5371108|NCT01853215|sternal intraosseous infusion study|sternal intraosseous infusion study
5371109|NCT01853202|Cancer|cancer
5371110|NCT01853202|Chemotherapy|chemotherapy
5371111|NCT01853202|Thrombosis|thrombosis
5371112|NCT01853202|Prevention|prevention
5371113|NCT01853202|Exercise|exercise
5371114|NCT01853189|pediatrics|pediatrics
5371115|NCT01853189|asthma|asthma
5371116|NCT01853189|osteopathic manipulative treatment|osteopathic manipulative treatment
5371117|NCT01853176|Pain, Postoperative|pain, postoperative
5371118|NCT01853176|Analgesia|analgesia
5371119|NCT01853176|Anesthesia, local|anesthesia, local
5371120|NCT01853176|Abdominoplasty|abdominoplasty
5371121|NCT01853163|Gadolinium|gadolinium
5371122|NCT01853163|Contrast Agent|contrast agent
5371123|NCT01853163|Long-term retention|long-term retention
5371124|NCT01853137|Class II division 1 malocclusion|class ii division 1 malocclusion
5371125|NCT01853137|Dentofacial orthopedics|dentofacial orthopedics
5371126|NCT01853137|Fixed Lingual Mandibular Growth Modificator (FLMGM)|fixed lingual mandibular growth modificator (flmgm)
5371127|NCT01853124|Diarrhea|diarrhea
5371128|NCT01853098|loving-kindness meditation|loving-kindness meditation
5371129|NCT01853098|mindfulness meditation|mindfulness meditation
5371130|NCT01853098|compassion|compassion
5371131|NCT01853072|Diabetes Type I|diabetes type i
5371132|NCT01853072|Diabetes Type II|diabetes type ii
5371133|NCT01853072|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy
5371134|NCT01853072|macular edema|macular edema
5371135|NCT01853072|Cataract|cataract
5371136|NCT01853059|Anal cancer|anal cancer
5371137|NCT01853059|Squamous cell cancer|squamous cell cancer
5371138|NCT01853059|Radiotherapy|radiotherapy
5371139|NCT01853059|Chemoradiotherapy|chemoradiotherapy
5371140|NCT01853059|Conformational radiotherapy|conformational radiotherapy
5371141|NCT01853059|Intensity modulated radiation therapy|intensity modulated radiation therapy
5371142|NCT01853059|IMRT|imrt
5371143|NCT01853046|Regorafenib|regorafenib
5371144|NCT01853046|pharmacokinetics|pharmacokinetics
5371145|NCT01853046|safety|safety
5371146|NCT01853046|severe renal impairment|severe renal impairment
5371147|NCT01853046|Solid tumors|solid tumors
5371148|NCT01853033|Tolerability|tolerability
5371149|NCT01853033|Immunogenicity|immunogenicity
5371150|NCT01853033|Safety|safety
5371151|NCT01853033|Rheumatoid Arthritis|rheumatoid arthritis
5371152|NCT01853033|Pharmacokinetics|pharmacokinetics
5371153|NCT01853020|Cannabinoids|cannabinoids
5371154|NCT01853020|Eyeblink Conditioning|eyeblink conditioning
5371155|NCT01853020|EBC|ebc
5371156|NCT01853007|End stage renal disease|end stage renal disease
5371157|NCT01853007|Kidney transplantation|kidney transplantation
5371158|NCT01853007|Transplant options (living and deceased donor)|transplant options (living and deceased donor)
5371159|NCT01853007|Patient education|patient education
5371160|NCT01853007|Communication skills training|communication skills training
5371161|NCT01852981|Physical activity promotion|physical activity promotion
5371162|NCT01852981|Intervention|intervention
5371369|NCT01852214|prasugrel|prasugrel
5371163|NCT01852981|Public Health|public health
5371164|NCT01852968|hypoglycemia|hypoglycemia
5371165|NCT01852968|hypoglycemia unawareness|hypoglycemia unawareness
5371166|NCT01852968|type 1 diabetes, hippocampus|type 1 diabetes, hippocampus
5371167|NCT01852968|glucose transport|glucose transport
5371168|NCT01852968|cognitive dysfunction|cognitive dysfunction
5371169|NCT01852955|Outpatient|outpatient
5371172|NCT01852955|Pain|pain
5371173|NCT01852942|Infection|infection
5371174|NCT01852942|HIV 1|hiv 1
5371175|NCT01852942|HIV|hiv
5371176|NCT01852942|Losartan|losartan
5371177|NCT01852942|Fibrosis|fibrosis
5371178|NCT01852942|Immune Activation|immune activation
5371179|NCT01852942|Immune Reconstitution|immune reconstitution
5371180|NCT01852929|Memory|memory
5371181|NCT01852916|RDS|rds
5371182|NCT01852903|vitamin C|vitamin c
5371183|NCT01852903|calcium ascorbate|calcium ascorbate
5371184|NCT01852903|ascorbic acid|ascorbic acid
5371185|NCT01852903|bioavailability|bioavailability
5371186|NCT01852890|Ascorbate|ascorbate
5371187|NCT01852890|Vitamin C|vitamin c
5371188|NCT01852890|Radiation|radiation
5371189|NCT01852890|Gemcitabine|gemcitabine
5371190|NCT01852890|Ascorbic Acid|ascorbic acid
5371191|NCT01852877|HIV Diagnosis|hiv diagnosis
5371192|NCT01852877|Case Management|case management
5371193|NCT01852877|Telemedicine|telemedicine
5371194|NCT01852877|Patient Compliance|patient compliance
5371195|NCT01852877|Prisoners|prisoners
5371196|NCT01852864|Prostate cancer|prostate cancer
5371197|NCT01852864|testosterone|testosterone
5371198|NCT01852864|castration|castration
5371199|NCT01852864|degarelix|degarelix
5371200|NCT01852864|proliferation|proliferation
5371201|NCT01852838|lung cancer|lung cancer
5371202|NCT01852838|volatile organic compounds|volatile organic compounds
5371203|NCT01852838|Warburg effect|warburg effect
5371204|NCT01852838|early detection|early detection
5371205|NCT01852799|Multiple myeloma|multiple myeloma
5371207|NCT01852799|ASCT|asct
5371208|NCT01852799|Bone metabolites|bone metabolites
5371209|NCT01852799|Bone marker|bone marker
5371210|NCT01852786|Contraception|contraception
5371211|NCT01852786|Hyperandrogenism|hyperandrogenism
5371212|NCT01852786|Female sexual function|female sexual function
5371213|NCT01852773|blunt|blunt
5371214|NCT01852773|injury|injury
5371215|NCT01852773|aorta|aorta
5371216|NCT01852773|endovascular|endovascular
5371217|NCT01852760|endoscopic ultrasound|endoscopic ultrasound
5371218|NCT01852760|ulcerative colitis|ulcerative colitis
5371219|NCT01852760|inflammatory bowel disease|inflammatory bowel disease
5371220|NCT01852747|Spinal Deformity|spinal deformity
5371221|NCT01852747|Multilevel|multilevel
5371222|NCT01852747|Posterior|posterior
5371223|NCT01852747|Lumbar|lumbar
5371224|NCT01852747|Fusion|fusion
5371225|NCT01852747|Levoscoliosis|levoscoliosis
5371226|NCT01852747|Dextroscoliosis|dextroscoliosis
5371227|NCT01852747|Graft|graft
5371228|NCT01852721|Cardiovascular diseases|cardiovascular diseases
5371229|NCT01852721|Nutritional intervention program|nutritional intervention program
5371230|NCT01852721|Self-Determination Theory|self-determination theory
5371231|NCT01852721|Motivational interviewing|motivational interviewing
5371232|NCT01852721|Gender differences|gender differences
5371233|NCT01852721|Women|women
5371234|NCT01852721|Men|men
5371235|NCT01852721|Motivation|motivation
5371236|NCT01852721|Dietary intakes|dietary intakes
5371237|NCT01852721|Mediterranean diet|mediterranean diet
5371238|NCT01852721|Eating behaviors|eating behaviors
5371239|NCT01852721|Lipid profile|lipid profile
5371240|NCT01852708|22q|22q
5371241|NCT01852708|1p36|1p36
5371242|NCT01852708|Angelman|angelman
5371243|NCT01852708|Cri-du-chat|cri-du-chat
5371244|NCT01852708|Prader-Willi|prader-willi
5371245|NCT01852708|DiGeorge|digeorge
5371246|NCT01852708|Turner syndrome|turner syndrome
5371247|NCT01852708|Patau syndrome|patau syndrome
5371248|NCT01852708|Edwards syndrome|edwards syndrome
5371249|NCT01852708|Down syndrome|down syndrome
5371250|NCT01852695|Family integrated Care|family integrated care
5371255|NCT01852682|Hyperphosphatemia|hyperphosphatemia
5371256|NCT01852656|Influenza, Human|influenza, human
5371257|NCT01852656|Immunization|immunization
5371258|NCT01852643|Rhinoplasty|rhinoplasty
5371259|NCT01852643|Spreader graft technique|spreader graft technique
5371260|NCT01852643|Lateral crural overlay technique|lateral crural overlay technique
5371261|NCT01852643|Rhinomanometry|rhinomanometry
5371262|NCT01852617|Smoking Cessation|smoking cessation
5371263|NCT01852617|Pregnancy|pregnancy
5371264|NCT01852617|Implementation|implementation
5371265|NCT01852617|Knowledge translation|knowledge translation
5371267|NCT01852604|Hepatitis C|hepatitis c
5371268|NCT01852604|chronic hepatitis C|chronic hepatitis c
5371269|NCT01852604|antiviral|antiviral
5371270|NCT01852591|autologous transplant|autologous transplant
5371271|NCT01852591|multiple myeloma|multiple myeloma
5371272|NCT01852578|Metastatic NSCLC|metastatic nsclc
5371273|NCT01852578|2nd Line|2nd line
5371274|NCT01852578|Docetaxel-based treatment|docetaxel-based treatment
5371275|NCT01852578|Progressed|progressed
5371277|NCT01852565|CYP3A4|cyp3a4
5371278|NCT01852565|Lp-PLA2|lp-pla2
5371279|NCT01852565|Atherosclerosis|atherosclerosis
5371280|NCT01852565|healthy volunteer|healthy volunteer
5371281|NCT01852565|Drug interaction|drug interaction
5371282|NCT01852552|Aortic stenosis|aortic stenosis
5371283|NCT01852552|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5371284|NCT01852552|Aortic valve replacement|aortic valve replacement
5371285|NCT01852552|Costs|costs
5371286|NCT01852552|Cognitive function|cognitive function
5371287|NCT01852552|Quality of life|quality of life
5371288|NCT01852539|LMA insertion|lma insertion
5371289|NCT01852539|dexmedetomidine|dexmedetomidine
5371290|NCT01852539|propofol|propofol
5371291|NCT01852526|degenerative disc disease|degenerative disc disease
5371292|NCT01852526|spondylolisthesis|spondylolisthesis
5371293|NCT01852526|Lumbar spine|lumbar spine
5371294|NCT01852526|fusion|fusion
5371295|NCT01852526|adjacent instability|adjacent instability
5371296|NCT01852487|Pumpkin seed oil|pumpkin seed oil
5371297|NCT01852487|Hair growth|hair growth
5371298|NCT01852487|Men|men
5371299|NCT01852474|motor learning|motor learning
5371300|NCT01852474|cortical plasticity|cortical plasticity
5371301|NCT01852474|direct current stimulation|direct current stimulation
5371302|NCT01852461|natural surfactants; perfusion index|natural surfactants; perfusion index
5371303|NCT01852435|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5371304|NCT01852435|follicular lymphoma grade 3B|follicular lymphoma grade 3b
5371305|NCT01852409|refractory malignant ascites|refractory malignant ascites
5371307|NCT01852409|intraperitoneal|intraperitoneal
5371308|NCT01852409|phase I|phase i
5371309|NCT01852396|Infraclavicular block|infraclavicular block
5371310|NCT01852396|Brachial Plexus|brachial plexus
5371311|NCT01852396|Retroclavicular Approach|retroclavicular approach
5371312|NCT01852396|Complications of retroclavicular approach|complications of retroclavicular approach
5371313|NCT01852396|Success of retroclavicular approach|success of retroclavicular approach
5371314|NCT01852383|Duloxetine|duloxetine
5371315|NCT01852383|Antidepressant|antidepressant
5371316|NCT01852383|Depression|depression
5371317|NCT01852383|Dysthymic Disorder|dysthymic disorder
5371318|NCT01852383|Side Effects|side effects
5371319|NCT01852383|Elderly|elderly
5371320|NCT01852370|Lung transplantation|lung transplantation
5371321|NCT01852370|Bone Marrow Transplantation|bone marrow transplantation
5371322|NCT01852370|Unrelated Donor|unrelated donor
5371323|NCT01852370|Cadaveric Donor|cadaveric donor
5371324|NCT01852370|Deceased Donor|deceased donor
5371325|NCT01852370|HLA-mismatch|hla-mismatch
5371326|NCT01852370|BOLT|bolt
5371327|NCT01852370|BMT|bmt
5371328|NCT01852370|HSCT|hsct
5371329|NCT01852344|Methylphenidate|methylphenidate
5371330|NCT01852344|Effortful Control|effortful control
5371331|NCT01852344|Attention Control|attention control
5371332|NCT01852344|Cognitive functions|cognitive functions
5371333|NCT01852331|Schizophrenia|schizophrenia
5371334|NCT01852331|Schizophrenic Disorder|schizophrenic disorder
5371335|NCT01852331|Hyperprolactinemia|hyperprolactinemia
5371336|NCT01852331|Hyperprolactinaemia|hyperprolactinaemia
5371337|NCT01852331|Chinese herbal medicine|chinese herbal medicine
5371338|NCT01852331|Traditional Chinese medicine|traditional chinese medicine
5371339|NCT01852331|Peony-Glycyrrhiza Decoction|peony-glycyrrhiza decoction
5371340|NCT01852331|PGD|pgd
5371341|NCT01852331|Glycyrrhiza Radix|glycyrrhiza radix
5371342|NCT01852331|Liquorice Root|liquorice root
5371343|NCT01852331|Gancao|gancao
5371344|NCT01852331|Paeoniae Alba Radix|paeoniae alba radix
5371345|NCT01852331|White Peony Root|white peony root
5371346|NCT01852331|Baishao|baishao
5371347|NCT01852318|uremic pruritus|uremic pruritus
5371349|NCT01852318|gabapentin|gabapentin
5371350|NCT01852318|fexofenadine|fexofenadine
5371351|NCT01852305|Obstructive sleep apnea|obstructive sleep apnea
5371352|NCT01852305|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5371353|NCT01852305|Oximetry|oximetry
5371354|NCT01852305|Bariatric Surgery|bariatric surgery
5371355|NCT01852305|Anesthesia|anesthesia
5371356|NCT01852305|Oxygen desaturation index (ODI)|oxygen desaturation index (odi)
5371357|NCT01852292|platinum pre-treated recurrent or metastatic|platinum pre-treated recurrent or metastatic
5371358|NCT01852292|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5371359|NCT01852292|recurrent|recurrent
5371360|NCT01852292|metastatic|metastatic
5371361|NCT01852292|BKM120|bkm120
5371362|NCT01852253|Dental implants|dental implants
5371363|NCT01852253|Periodontal diseases|periodontal diseases
5371364|NCT01852253|Peri-implantitis|peri-implantitis
5371365|NCT01852253|Chlorhexidine|chlorhexidine
5371366|NCT01852253|Microbiology|microbiology
5371367|NCT01852214|Diabetes mellitus|diabetes mellitus
5371368|NCT01852214|Coronary artery disease|coronary artery disease
5371373|NCT01852188|Chorioamnionitis|chorioamnionitis
5371374|NCT01852175|Coronary artery disease|coronary artery disease
5371375|NCT01852175|Dual antiplatelet therapy|dual antiplatelet therapy
5371376|NCT01852175|prasugrel|prasugrel
5371377|NCT01852175|ticagrelor|ticagrelor
5371378|NCT01852162|Coronary artery disease|coronary artery disease
5371379|NCT01852162|antiplatelet therapy|antiplatelet therapy
5371380|NCT01852162|anticoagulant therapy|anticoagulant therapy
5371381|NCT01852149|Mitral Valve Regurgitation|mitral valve regurgitation
5371382|NCT01852149|Coaptation|coaptation
5371383|NCT01852149|Mitral Valve Repair|mitral valve repair
5371384|NCT01852149|Plication|plication
5371385|NCT01852149|Leaflet|leaflet
5371386|NCT01852149|Annulus|annulus
5371387|NCT01852149|Mitral Annuloplasty|mitral annuloplasty
5371388|NCT01852136|pen needle|pen needle
5371389|NCT01852136|insulin|insulin
5371390|NCT01852123|High-sensitivity troponin assay|high-sensitivity troponin assay
5371391|NCT01852123|Myocardial infarction|myocardial infarction
5371392|NCT01852123|Unstable angina|unstable angina
5371393|NCT01852123|Myocardial injury|myocardial injury
5371394|NCT01852123|Cluster randomized trial|cluster randomized trial
5371395|NCT01852097|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5371396|NCT01852097|Crohn's disease|crohn's disease
5371397|NCT01852097|Ulcerative colitis|ulcerative colitis
5371398|NCT01852097|Cognitive Behavioural Therapy (CBT)|cognitive behavioural therapy (cbt)
5371399|NCT01852097|Medication adherence|medication adherence
5371402|NCT01852019|CAD|cad
5371403|NCT01851993|Ondansetron|ondansetron
5371404|NCT01851993|Exercise|exercise
5371405|NCT01851980|Furosemide|furosemide
5371406|NCT01851980|Exercise|exercise
5371407|NCT01851980|Restrictive pulmonary disorder|restrictive pulmonary disorder
5371408|NCT01851967|Major depressive disorder|major depressive disorder
5371409|NCT01851967|Cognitive behavioral therapy|cognitive behavioral therapy
5371410|NCT01851967|Computerized CBT|computerized cbt
5371411|NCT01851967|Online CBT|online cbt
5371412|NCT01851915|Major depression|major depression
5371413|NCT01851915|Interpersonal psychotherapy|interpersonal psychotherapy
5371414|NCT01851915|Cognitive Behavioral Therapy|cognitive behavioral therapy
5371415|NCT01851915|Alliance|alliance
5371416|NCT01851915|Return to Work|return to work
5371417|NCT01851902|Atrial Fibrillation|atrial fibrillation
5371418|NCT01851902|Atrial Flutter|atrial flutter
5371419|NCT01851902|Arrhythmia|arrhythmia
5371420|NCT01851863|functional dyspepsia|functional dyspepsia
5371421|NCT01851863|depression|depression
5371422|NCT01851863|compliance|compliance
5371423|NCT01851850|PD|pd
5371424|NCT01851850|Off periods|off periods
5371425|NCT01851850|quality of life|quality of life
5371426|NCT01851850|dyskinesia|dyskinesia
5371427|NCT01851850|end-off-dose motor fluctuations|end-off-dose motor fluctuations
5371428|NCT01851811|OSA|osa
5371429|NCT01851798|OSA|osa
5371430|NCT01851798|Sleep disordered breathing|sleep disordered breathing
5371431|NCT01851798|anesthesia|anesthesia
5371432|NCT01851798|ambulatory orthopedic surgery|ambulatory orthopedic surgery
5371433|NCT01851785|Knee Arthroplasty|knee arthroplasty
5371434|NCT01851785|Knee Osteoarthritis|knee osteoarthritis
5371435|NCT01851785|Osteoarthritis|osteoarthritis
5371436|NCT01851785|disparity|disparity
5371437|NCT01851785|joint replacement|joint replacement
5371438|NCT01851772|cervical|cervical
5371439|NCT01851772|cancer|cancer
5371440|NCT01851772|brachytherapy|brachytherapy
5371441|NCT01851772|electronic|electronic
5371442|NCT01851772|device|device
5371443|NCT01851772|applicator|applicator
5371444|NCT01851772|toxicity|toxicity
5371445|NCT01851772|gynecologic|gynecologic
5371446|NCT01851772|high-dose-rate (HDR)|high-dose-rate (hdr)
5371447|NCT01851772|x-ray|x-ray
5371448|NCT01851772|safety|safety
5371449|NCT01851772|external beam radiation therapy (EBRT)|external beam radiation therapy (ebrt)
5371450|NCT01851746|recurrent ovarian cancer|recurrent ovarian cancer
5371451|NCT01851746|lobaplatin|lobaplatin
5371452|NCT01851746|docetaxel|docetaxel
5371453|NCT01851746|carboplatin|carboplatin
5371454|NCT01851694|Cystic Fibrosis|cystic fibrosis
5371455|NCT01851694|Diabetes|diabetes
5371456|NCT01851694|Pancreatic insufficiency|pancreatic insufficiency
5371457|NCT01851694|Cystic Fibrosis with Normal Glucose Tolerance|cystic fibrosis with normal glucose tolerance
5371458|NCT01851694|Non-Cystic Fibrosis control group|non-cystic fibrosis control group
5371459|NCT01851681|dental implants|dental implants
5371460|NCT01851681|wound healing|wound healing
5371461|NCT01851681|amoxicillin|amoxicillin
5371462|NCT01851681|pain|pain
5371463|NCT01851668|vibration|vibration
5371464|NCT01851668|noise|noise
5371465|NCT01851668|transfer|transfer
5371466|NCT01851668|intraventricular hemorrhage|intraventricular hemorrhage
5371467|NCT01851655|rehabilitation|rehabilitation
5002875|NCT03978078|cancer|cancer
5465400|NCT01439308|NAR|nar
5371468|NCT01851655|plyometric|plyometric
5371469|NCT01851642|Macrophage|macrophage
5371470|NCT01851642|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5371479|NCT01851590|Resin Lacquer|resin lacquer
5371480|NCT01851590|Amorolfine|amorolfine
5371481|NCT01851590|Terbinafine|terbinafine
5371486|NCT01851564|Gastrointestinal Haemorrhage|gastrointestinal haemorrhage
5371487|NCT01851564|Varices|varices
5371488|NCT01851564|Liver Cirrhosis|liver cirrhosis
5371489|NCT01851564|Stent|stent
5371491|NCT01851551|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5371492|NCT01851551|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5371493|NCT01851551|mantle cell lymphoma|mantle cell lymphoma
5371494|NCT01851538|Heart failure|heart failure
5371495|NCT01851538|Biomarkers|biomarkers
5371496|NCT01851538|Echocardiography|echocardiography
5371497|NCT01851525|Atrial fibrillation|atrial fibrillation
5371498|NCT01851525|Ablation|ablation
5371499|NCT01851499|Neuropathic pain following spinal cord injury|neuropathic pain following spinal cord injury
5371500|NCT01851473|Cocaine|cocaine
5371501|NCT01851473|Pharmacokinetics|pharmacokinetics
5371502|NCT01851473|Pharmacodynamics|pharmacodynamics
5371503|NCT01851473|Drug Interactions|drug interactions
5371504|NCT01851473|Acetazolamide|acetazolamide
5371505|NCT01851460|Non-surgical Liver Lesions|non-surgical liver lesions
5371506|NCT01851460|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
5371507|NCT01851460|Microorganisms|microorganisms
5371508|NCT01851460|Bacteria|bacteria
5371509|NCT01851460|Liver Lesions|liver lesions
5371515|NCT01851434|OCT|oct
5371516|NCT01851434|Multiple Sclerosis|multiple sclerosis
5371517|NCT01851434|Optic Neuritis|optic neuritis
5371518|NCT01851434|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5371519|NCT01851421|Lipogenesis|lipogenesis
5371520|NCT01851421|Adult|adult
5371521|NCT01851421|Obesity|obesity
5371522|NCT01851421|LIPOLYSIS|lipolysis
5371523|NCT01851421|Melanocortin-3 Receptor|melanocortin-3 receptor
5371524|NCT01851408|Sorafenib|sorafenib
5371525|NCT01851408|Temsirolimus|temsirolimus
5371526|NCT01851408|Stage IV|stage iv
5371527|NCT01851408|recurrent|recurrent
5371528|NCT01851408|unresectable|unresectable
5371529|NCT01851408|non-choroidal origin|non-choroidal origin
5371530|NCT01851408|CCI-779|cci-779
5371531|NCT01851408|BAY43-9006|bay43-9006
5371532|NCT01851408|metastatic melanoma|metastatic melanoma
5371533|NCT01851395|Palliative|palliative
5371534|NCT01851395|Tumor Heterogeneity|tumor heterogeneity
5371535|NCT01851395|Genomic and Proteomic Alterations|genomic and proteomic alterations
5371536|NCT01851395|Deep Sequencing and Global Analysis|deep sequencing and global analysis
5371537|NCT01851395|Clonal Evolution|clonal evolution
5371538|NCT01851382|ELISA|elisa
5371539|NCT01851382|Spectrometry|spectrometry
5371540|NCT01851382|Protein Biomarkers|protein biomarkers
5371541|NCT01851382|Proteomic Analyses|proteomic analyses
5371542|NCT01851369|Solid Tumors|solid tumors
5371543|NCT01851369|Lymphomas|lymphomas
5371544|NCT01851369|DNA Damage|dna damage
5371545|NCT01851369|Pharmacodynamics|pharmacodynamics
5371546|NCT01851369|Pharmacokinetics|pharmacokinetics
5371547|NCT01851356|PBR28|pbr28
5371548|NCT01851356|Depression|depression
5371549|NCT01851356|PET Imaging|pet imaging
5371550|NCT01851356|Neuroinflammation|neuroinflammation
5371551|NCT01851343|Stem Cell Infusion|stem cell infusion
5371552|NCT01851343|Crohns|crohns
5371553|NCT01851343|Ulcerative Colitis|ulcerative colitis
5371554|NCT01851343|Inflammation|inflammation
5371555|NCT01851343|Diarrhea|diarrhea
5371556|NCT01851330|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5371558|NCT01851330|Sustained Virologic Response|sustained virologic response
5371559|NCT01851330|Direct Acting Antiviral|direct acting antiviral
5371560|NCT01851330|Combination Therapy|combination therapy
5371561|NCT01851330|GS-7977|gs-7977
5371562|NCT01851330|GS-5885|gs-5885
5371563|NCT01851330|Ribavirin|ribavirin
5371564|NCT01851330|Open Label|open label
5371565|NCT01851330|Sofosbuvir|sofosbuvir
5371566|NCT01851330|Additional relevant MeSH terms:|additional relevant mesh terms:
5371567|NCT01851330|Hepatitis|hepatitis
5371568|NCT01851330|Hepatitis, Chronic|hepatitis, chronic
5371569|NCT01851330|Hepatitis C|hepatitis c
5371570|NCT01851330|Hepatitis C, Chronic|hepatitis c, chronic
5371571|NCT01851330|Liver Diseases|liver diseases
5371572|NCT01851330|Digestive System Diseases|digestive system diseases
5371765|NCT01850498|Motor|motor
5371573|NCT01851330|Hepatitis, Viral, Human|hepatitis, viral, human
5371574|NCT01851330|Virus Diseases|virus diseases
5371575|NCT01851330|Enterovirus Infections|enterovirus infections
5371576|NCT01851330|Picornaviridae Infections|picornaviridae infections
5371577|NCT01851330|RNA Virus Infections|rna virus infections
5371578|NCT01851330|Flaviviridae Infections|flaviviridae infections
5371579|NCT01851330|Antiviral Agents|antiviral agents
5371580|NCT01851330|Anti-Infective Agents|anti-infective agents
5371581|NCT01851330|Therapeutic Uses|therapeutic uses
5371582|NCT01851330|Pharmacologic Actions|pharmacologic actions
5345308|NCT01970553|tumors|tumors
5371583|NCT01851330|Antimetabolites|antimetabolites
5371584|NCT01851330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5371585|NCT01851304|beta-Glucans|beta-glucans
5371587|NCT01851304|Bread|bread
5371588|NCT01851304|Coffee|coffee
5371589|NCT01851304|Gentiana lutea|gentiana lutea
5371590|NCT01851304|Melanoidins|melanoidins
5371591|NCT01851304|Microencapsulation|microencapsulation
5371592|NCT01851278|injection|injection
5371593|NCT01851278|arthritis|arthritis
5371594|NCT01851278|corticosteroid|corticosteroid
5371595|NCT01851265|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability|oncology, cancer, tumour, neoplasm, anticancer drug, food effect, area under the curve, pharmacokinetics, olaparib, solid tumour, metabolites, drug availability
5371596|NCT01851252|Cirrhotics|cirrhotics
5371597|NCT01851252|Esophageal varices|esophageal varices
5371598|NCT01851252|Portal Hypertension|portal hypertension
5371599|NCT01851239|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
5371600|NCT01851239|ICU|icu
5371601|NCT01851213|genomics|genomics
5371602|NCT01851213|cancer|cancer
5371603|NCT01851213|registry|registry
5371604|NCT01851213|neoplasm metastasis|neoplasm metastasis
5371605|NCT01851200|Testicular neoplasms|testicular neoplasms
5371606|NCT01851200|Germ Cell cancers|germ cell cancers
5371607|NCT01851200|Embryonal Carcinoma|embryonal carcinoma
5371608|NCT01851200|Metastatic|metastatic
5371609|NCT01851200|Brentuximab Vedotin|brentuximab vedotin
5371610|NCT01851187|Psychological intervention,|psychological intervention,
5371611|NCT01851187|prenatal period,|prenatal period,
5371612|NCT01851187|cesarean section rate,|cesarean section rate,
5371613|NCT01851187|stage of labor|stage of labor
5371614|NCT01851148|osteopathic manipulative treatment|osteopathic manipulative treatment
5371616|NCT01851135|Quality of life|quality of life
5371617|NCT01851135|Neuropsychological disorders|neuropsychological disorders
5371618|NCT01851135|Neurofibromatosis type 1|neurofibromatosis type 1
5371619|NCT01851122|l-theanine|l-theanine
5371620|NCT01851122|alertness|alertness
5371621|NCT01851122|well-being|well-being
5371622|NCT01851109|ovarian cancer|ovarian cancer
5371623|NCT01851109|prevention|prevention
5371624|NCT01851109|prophylactic surgery|prophylactic surgery
5371625|NCT01851109|risk|risk
5371626|NCT01851109|biomarkers|biomarkers
5371627|NCT01851109|screening|screening
5371628|NCT01851109|symptoms|symptoms
5371629|NCT01851096|Hsp90|hsp90
5371630|NCT01851096|SNX-5422|snx-5422
5371631|NCT01851096|Erlotinib|erlotinib
5371632|NCT01851096|Lung adenocarcinoma|lung adenocarcinoma
5371633|NCT01851083|Traumatic Brain Injury|traumatic brain injury
5371635|NCT01851083|pediatric|pediatric
5371636|NCT01851083|acute|acute
5371637|NCT01851083|stem cells|stem cells
5371638|NCT01851057|Epilepsy|epilepsy
5371639|NCT01851044|Platelet Rich Plasma|platelet rich plasma
5371640|NCT01851044|Whole Blood Injection|whole blood injection
5371641|NCT01851044|Lateral Epicondylitis|lateral epicondylitis
5371642|NCT01851044|Tennis Elbow|tennis elbow
5371643|NCT01851031|medial or low condylar fractures|medial or low condylar fractures
5371644|NCT01851031|the minor parotid anterior approach|the minor parotid anterior approach
5371645|NCT01851031|the retromandibular approach|the retromandibular approach
5371646|NCT01851018|Prostate cancer|prostate cancer
5371647|NCT01851018|brachytherapy|brachytherapy
5371648|NCT01851018|hypofractionated radiation therapy|hypofractionated radiation therapy
5371649|NCT01851018|hormonal therapy|hormonal therapy
5371650|NCT01851005|Dexmedetomidine|dexmedetomidine
5371651|NCT01851005|Anesthesia|anesthesia
5371652|NCT01851005|Recovery profile|recovery profile
5371653|NCT01850992|Obstructive sleep apnea.|obstructive sleep apnea.
5371654|NCT01850992|sleep|sleep
5371655|NCT01850992|male hormones|male hormones
5371656|NCT01850979|CYCLOSPORINE/TACROLIMUS [VA Drug Interaction]|cyclosporine/tacrolimus [va drug interaction]
5371657|NCT01850966|Arthritis, Rheumatoid, Iguratimod|arthritis, rheumatoid, iguratimod
5371658|NCT01850953|Varenicline|varenicline
5371659|NCT01850953|Schizophrenia|schizophrenia
5371660|NCT01850953|smoking|smoking
5371661|NCT01850953|Lapse|lapse
5371662|NCT01850940|Cirrhotic Patients|cirrhotic patients
5371663|NCT01850940|Hyponatremia|hyponatremia
5371664|NCT01850940|tolvaptan|tolvaptan
5371665|NCT01850914|Normal pressure hydrocephalus|normal pressure hydrocephalus
5371666|NCT01850914|Vascular risk factors|vascular risk factors
5371667|NCT01850901|Hypertension|hypertension
5371668|NCT01850901|Renal denervation|renal denervation
5371669|NCT01850901|Sympathetic denervation|sympathetic denervation
5371670|NCT01850888|neuroblastoma|neuroblastoma
5371671|NCT01850888|pheochromocytoma|pheochromocytoma
5371672|NCT01850875|Eye-Movement-Desensitization and Reprocessing|eye-movement-desensitization and reprocessing
5371674|NCT01850875|Chronic back pain|chronic back pain
5371675|NCT01850875|CBP|cbp
5371676|NCT01850875|treatment|treatment
5371677|NCT01850836|Aphasia, Stroke, repetitive transcranial magnetic stimulation.|aphasia, stroke, repetitive transcranial magnetic stimulation.
5371678|NCT01850797|oral anticoagulants|oral anticoagulants
5371679|NCT01850797|ischemic stroke|ischemic stroke
5371680|NCT01850797|blood thinner|blood thinner
5371681|NCT01850797|intracranial hemorrhage|intracranial hemorrhage
5371682|NCT01850784|Congenital heart disease, Growth,Neurodevelopment|congenital heart disease, growth,neurodevelopment
5371683|NCT01850771|Lumbar Radiculopathy|lumbar radiculopathy
5371684|NCT01850771|Disc bulge|disc bulge
5371685|NCT01850771|Disc herniation|disc herniation
5371686|NCT01850771|Disc degeneration|disc degeneration
5371687|NCT01850758|ACL|acl
5371688|NCT01850758|Anterior Cruciate Ligament|anterior cruciate ligament
5371689|NCT01850758|ACL Tear|acl tear
5371690|NCT01850758|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
5371691|NCT01850758|Partial ACL Tear|partial acl tear
5371692|NCT01850745|Chronic hepatitis C virus infection (CHC)|chronic hepatitis c virus infection (chc)
5371693|NCT01850719|Tibial meniscus|tibial meniscus
5371694|NCT01850719|Arthroscopy|arthroscopy
5371695|NCT01850719|Meniscectomy|meniscectomy
5371696|NCT01850719|Conservative treatment|conservative treatment
5371697|NCT01850719|Physical therapy|physical therapy
5371698|NCT01850719|Osteoarthritis knee joint|osteoarthritis knee joint
5371700|NCT01850706|urinary nerve growth factor|urinary nerve growth factor
5371701|NCT01850706|detrusor overactivity|detrusor overactivity
5371702|NCT01850706|InterStim|interstim
5371703|NCT01850706|sacral neuromodulation|sacral neuromodulation
5371704|NCT01850706|sacral nerve stimulation|sacral nerve stimulation
5371705|NCT01850706|quality of life|quality of life
5371706|NCT01850706|questionnaire|questionnaire
5371707|NCT01850706|urodynamic detrusor overactivity|urodynamic detrusor overactivity
5371708|NCT01850706|overactive bladder|overactive bladder
5371709|NCT01850693|coronary artery disease|coronary artery disease
5371710|NCT01850693|stroke|stroke
5371711|NCT01850693|coronary CT angiography|coronary ct angiography
5371712|NCT01850667|Hepatocellular carcinoma|hepatocellular carcinoma
5371713|NCT01850667|Stereotactic body radiotherapy|stereotactic body radiotherapy
5371714|NCT01850667|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5371715|NCT01850654|colorectal cancer|colorectal cancer
5371716|NCT01850654|colon cancer|colon cancer
5371717|NCT01850654|rectal cancer|rectal cancer
5371718|NCT01850654|endometrial cancer|endometrial cancer
5371719|NCT01850654|Lynch syndrome|lynch syndrome
5371720|NCT01850654|Ohio colon cancer study|ohio colon cancer study
5371721|NCT01850654|OSU colon study|osu colon study
5371722|NCT01850641|Hemodialysis|hemodialysis
5371723|NCT01850641|Hyperphosphatemia|hyperphosphatemia
5371724|NCT01850628|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
5371725|NCT01850628|paclitaxel|paclitaxel
5371726|NCT01850628|trastuzumab|trastuzumab
5371727|NCT01850628|pertuzumab|pertuzumab
5371728|NCT01850628|HER2 positive (human epidermal growth factor receptor 2)|her2 positive (human epidermal growth factor receptor 2)
5371729|NCT01850628|Proteomics|proteomics
5371730|NCT01850628|Neoadjuvant Therapy|neoadjuvant therapy
5371731|NCT01850628|Anthracycline therapy|anthracycline therapy
5371732|NCT01850628|Locally advanced|locally advanced
5371733|NCT01850628|Operable|operable
5371734|NCT01850628|Biomarkers|biomarkers
5371735|NCT01850602|Hemodialysis|hemodialysis
5371736|NCT01850602|Hyperphosphatemia|hyperphosphatemia
5371737|NCT01850576|prevention|prevention
5371738|NCT01850576|testing|testing
5371739|NCT01850576|counseling|counseling
5371740|NCT01850576|linkage|linkage
5371741|NCT01850563|Demonstrate coordination of HBO with SRS treatments is feasible.|demonstrate coordination of hbo with srs treatments is feasible.
5371742|NCT01850563|Demonstrate outcomes for patients treated with combination of HBO and SRS are non-inferior .|demonstrate outcomes for patients treated with combination of hbo and srs are non-inferior .
5371743|NCT01850550|Weight loss|weight loss
5371744|NCT01850537|DDD|ddd
5371745|NCT01850537|PROW|prow
5371746|NCT01850537|FUSION|fusion
5371747|NCT01850537|eSPIN|espin
5371748|NCT01850537|Cage|cage
5371749|NCT01850537|IBF|ibf
5371750|NCT01850537|Discectomy|discectomy
5371751|NCT01850537|Lumbar Fusion|lumbar fusion
5371752|NCT01850537|TLIF|tlif
5371753|NCT01850537|MIS|mis
5371754|NCT01850524|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
5371755|NCT01850524|multiple myeloma|multiple myeloma
5371756|NCT01850524|MLN9708|mln9708
5371757|NCT01850524|IXAZOMIB|ixazomib
5371758|NCT01850524|Proteasome inhibitor|proteasome inhibitor
5371759|NCT01850524|Tourmaline MM2|tourmaline mm2
5371760|NCT01850511|Nasal obstruction|nasal obstruction
5371761|NCT01850511|Vibrissae|vibrissae
5371762|NCT01850511|Nasal hair|nasal hair
5371763|NCT01850498|Epilepsy|epilepsy
5371764|NCT01850498|Seizure|seizure
5371766|NCT01850498|Motion|motion
5371767|NCT01850498|Accelerometer|accelerometer
5371768|NCT01850485|cardiac arrest|cardiac arrest
5371769|NCT01850485|therapeutic hypothermia|therapeutic hypothermia
5371770|NCT01850485|microcirculation|microcirculation
5371771|NCT01850472|Anhedonia|anhedonia
5371772|NCT01850472|Depression|depression
5371773|NCT01850472|Stress|stress
5371774|NCT01850472|Cortisol|cortisol
5371775|NCT01850472|Inflammatory cytokines|inflammatory cytokines
5371776|NCT01850472|Learning|learning
5371777|NCT01850472|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5371780|NCT01850420|fibromyalgia|fibromyalgia
5371781|NCT01850420|Myofascial|myofascial
5371782|NCT01850407|Lack of Preparation for Abused Children during Medical Examination|lack of preparation for abused children during medical examination
5371783|NCT01850381|Parkinson Disease|parkinson disease
5371784|NCT01850381|Efficacy|efficacy
5371785|NCT01850381|Safety|safety
5371786|NCT01850381|Tolerability|tolerability
5371787|NCT01850381|Phase 2A|phase 2a
5371788|NCT01850381|Pilot trial|pilot trial
5371789|NCT01850381|human Motoneuronotrophic Factor|human motoneuronotrophic factor
5371790|NCT01850381|neuroprotective agent|neuroprotective agent
5371791|NCT01850381|neurodegenerative diseases|neurodegenerative diseases
5371792|NCT01850381|rate of clinical progression of PD|rate of clinical progression of pd
5371793|NCT01850381|UPDRS|updrs
5375484|NCT01833169|AML|aml
5371794|NCT01850381|Proof of principle|proof of principle
5371795|NCT01850368|Hepatocellular carcinoma|hepatocellular carcinoma
5371796|NCT01850368|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5371797|NCT01850368|Stereotactic body radiotherapy|stereotactic body radiotherapy
5371798|NCT01850368|Portal vein tumor thrombus|portal vein tumor thrombus
5371799|NCT01850355|Autism Spectrum Disorders|autism spectrum disorders
5371801|NCT01850355|Children|children
5371802|NCT01850355|Adolescents|adolescents
5371803|NCT01850355|Buspar|buspar
5371804|NCT01850355|Buspirone|buspirone
5371805|NCT01850355|Pervasive Developmental Disorders|pervasive developmental disorders
5371806|NCT01850342|Male stress urinary incontinence|male stress urinary incontinence
5357650|NCT01914133|Elderly|elderly
5371807|NCT01850342|Cell-assisted lipotransfer|cell-assisted lipotransfer
5371808|NCT01850342|Adipose-derived regenerative cells|adipose-derived regenerative cells
5371809|NCT01850342|ADRC|adrc
5371810|NCT01850342|Micrograft|micrograft
5371811|NCT01850342|Fat tissue|fat tissue
5371812|NCT01850342|Stem cells|stem cells
5371813|NCT01850303|Elderly|elderly
5371814|NCT01850303|lung cancer|lung cancer
5371815|NCT01850303|switch|switch
5371816|NCT01850303|maintenance|maintenance
5371817|NCT01850303|Elderly patients (between 70 and 89 years)|elderly patients (between 70 and 89 years)
5371818|NCT01850303|NSCLC|nsclc
5371819|NCT01850290|TBI|tbi
5371820|NCT01850277|Atrial fibrillation|atrial fibrillation
5371821|NCT01850277|Cardiac resynchronization therapy|cardiac resynchronization therapy
5371822|NCT01850277|Heart failure|heart failure
5371823|NCT01850277|Rhythm control strategy|rhythm control strategy
5371824|NCT01850264|cardiac resynchronization therapy; heart failure, congestive|cardiac resynchronization therapy; heart failure, congestive
5371825|NCT01850251|Hip fractures|hip fractures
5371826|NCT01850251|Ageing|ageing
5371827|NCT01850251|Sarcopenia|sarcopenia
5371828|NCT01850251|Function|function
5371829|NCT01850238|Alzheimer disease|alzheimer disease
5371830|NCT01850238|tau protein|tau protein
5371831|NCT01850238|neurofibrillary degeneration|neurofibrillary degeneration
5371832|NCT01850238|disease-modifying|disease-modifying
5371833|NCT01850212|Treatment Experienced|treatment experienced
5371834|NCT01850212|Male greater than or equal to 50 years|male greater than or equal to 50 years
5371835|NCT01850212|Female postmenopausal|female postmenopausal
5371836|NCT01850199|Gestational diabetes|gestational diabetes
5371837|NCT01850199|Telemedicine|telemedicine
5371838|NCT01850199|Artificial Intelligence|artificial intelligence
5371839|NCT01850160|Hypertension|hypertension
5371840|NCT01850160|High blood pressure|high blood pressure
5371841|NCT01850160|Drug therapy combination|drug therapy combination
5371842|NCT01850160|Valsartan|valsartan
5371843|NCT01850160|Chlorthalidone|chlorthalidone
5371844|NCT01850160|Safety|safety
5371845|NCT01850160|Efficacy|efficacy
5371846|NCT01850147|sunitinib|sunitinib
5371847|NCT01850147|chemotherapy|chemotherapy
5371848|NCT01850147|non-small cell lung cancer|non-small cell lung cancer
5371849|NCT01850147|NSCLC|nsclc
5371850|NCT01850121|Ankylosing Spondylitis|ankylosing spondylitis
5371851|NCT01850121|infiximab|infiximab
5371852|NCT01850121|single armed trial|single armed trial
5371853|NCT01850095|acne|acne
5371854|NCT01850095|adult|adult
5371855|NCT01850095|women|women
5371856|NCT01850095|TLR|tlr
5371857|NCT01850095|CD1d|cd1d
5371858|NCT01850095|androgens|androgens
5371859|NCT01850082|Coronary artery disease|coronary artery disease
5371860|NCT01850082|CABG|cabg
5371861|NCT01850082|Coronary revascularization|coronary revascularization
5371862|NCT01850082|Endoscopic vein harvest|endoscopic vein harvest
5371863|NCT01850082|Saphenous vein graft|saphenous vein graft
5371864|NCT01850082|Graft failure|graft failure
5372675|NCT01846442|Menopause|menopause
5371865|NCT01850069|Intracranial hypertension|intracranial hypertension
5371866|NCT01850069|intracranial elastance|intracranial elastance
5371867|NCT01850056|drug eluting balloon catheter|drug eluting balloon catheter
5371868|NCT01850017|Opiate consumption|opiate consumption
5371869|NCT01850017|Visual Analogue Scale|visual analogue scale
5371870|NCT01849991|Crying|crying
5371871|NCT01849991|Fussiness|fussiness
5359490|NCT01904669|Internet|internet
5371873|NCT01849991|Hydrogen Breath|hydrogen breath
5371874|NCT01849991|Fecal Calprotectin|fecal calprotectin
5371875|NCT01849978|breast cancer|breast cancer
5371876|NCT01849978|survivor|survivor
5371877|NCT01849978|exercise|exercise
5371878|NCT01849978|physical activity|physical activity
5371879|NCT01849978|strenuous exercise|strenuous exercise
5371880|NCT01849978|moderate exercise|moderate exercise
5371881|NCT01849978|enjoyable exercise|enjoyable exercise
5371882|NCT01849978|enjoy exercise|enjoy exercise
5371883|NCT01849978|breast cancer survivor|breast cancer survivor
5371884|NCT01849965|diabetic foot ulcers|diabetic foot ulcers
5371885|NCT01849965|Wagner Grade 1 or 2 ulcers|wagner grade 1 or 2 ulcers
5371886|NCT01849952|glioblastoma|glioblastoma
5371887|NCT01849952|miRNA|mirna
5371888|NCT01849952|GBM|gbm
5371889|NCT01849952|astrocytoma|astrocytoma
5371890|NCT01849939|Allogeneic transplantation of hematopoietic stem cells transplantation|allogeneic transplantation of hematopoietic stem cells transplantation
5371891|NCT01849939|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5371892|NCT01849939|Donor Lymphocyte Injection|donor lymphocyte injection
5371893|NCT01849939|Preemptive immunointervention|preemptive immunointervention
5371895|NCT01849913|hydrocortisone|hydrocortisone
5371896|NCT01849913|stress|stress
5371897|NCT01849913|electromyography|electromyography
5371898|NCT01849913|adolescent|adolescent
5371899|NCT01849913|low-level laser therapy|low-level laser therapy
5371900|NCT01849900|Menstrual cycle|menstrual cycle
5371901|NCT01849900|Ovulation time|ovulation time
5371902|NCT01849900|pregnancy recognition|pregnancy recognition
5371903|NCT01849900|Community-based participatory research|community-based participatory research
5371904|NCT01849900|Unintended pregnancy|unintended pregnancy
5371905|NCT01849861|Cardiopulmonary Capacity|cardiopulmonary capacity
5371906|NCT01849861|Ranges of TSH|ranges of tsh
5371907|NCT01849861|Elderly Population|elderly population
5371908|NCT01849835|rate of positive detection|rate of positive detection
5371909|NCT01849822|neural|neural
5371910|NCT01849822|prosthetic|prosthetic
5371911|NCT01849822|brain machine interface|brain machine interface
5371912|NCT01849822|brain computer interface|brain computer interface
5371913|NCT01849822|brain control|brain control
5371914|NCT01849822|paralysis|paralysis
5371915|NCT01849822|tetraplegia|tetraplegia
5371916|NCT01849822|quadriplegia|quadriplegia
5371917|NCT01849822|spinal cord injury|spinal cord injury
5371918|NCT01849796|tDCS|tdcs
5371919|NCT01849796|Neuropathic|neuropathic
5371920|NCT01849796|Facial|facial
5371921|NCT01849796|Pain|pain
5371922|NCT01849796|Neuralgia|neuralgia
5371923|NCT01849796|deafferentation|deafferentation
5371924|NCT01849796|Trigeminal|trigeminal
5371925|NCT01849770|SALS|sals
5371926|NCT01849770|Mexiletine|mexiletine
5371927|NCT01849770|Safety|safety
5371928|NCT01849757|Cardiopulmonary bypass|cardiopulmonary bypass
5371929|NCT01849757|prime|prime
5371930|NCT01849757|crystalloid|crystalloid
5371931|NCT01849757|albumin|albumin
5371932|NCT01849757|HES 130/0.4|hes 130/0.4
5371933|NCT01849744|Focal Adhesion Kinase inhibitor|focal adhesion kinase inhibitor
5371934|NCT01849744|FAK inhibitor|fak inhibitor
5371935|NCT01849744|Cancer Stem Cells|cancer stem cells
5371936|NCT01849744|CSC|csc
5371937|NCT01849731|Diabetes Mellitus type 2;|diabetes mellitus type 2;
5371938|NCT01849731|Primary Care, healthcare inequalities;|primary care, healthcare inequalities;
5371939|NCT01849731|Diabetes self-management,|diabetes self-management,
5371940|NCT01849731|Quality of diabetes care|quality of diabetes care
5371941|NCT01849705|Obesity|obesity
5371942|NCT01849705|MC4R|mc4r
5371943|NCT01849705|Blood pressure|blood pressure
5371944|NCT01849705|Blood glucose|blood glucose
5371945|NCT01849692|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
5371946|NCT01849692|Wet AMD|wet amd
5371947|NCT01849692|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5371948|NCT01849692|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5371949|NCT01849679|Dysphagia|dysphagia
5371950|NCT01849679|extubation|extubation
5371951|NCT01849679|aspiration|aspiration
5371952|NCT01849653|vaginal swabs|vaginal swabs
5371953|NCT01849653|diagnosis|diagnosis
5371954|NCT01849640|Malaria|malaria
5371955|NCT01849640|Drug resistance|drug resistance
5371956|NCT01849640|DHA-piperaquine|dha-piperaquine
5371957|NCT01849640|Cambodia|cambodia
5371958|NCT01849640|Transmission Blocking|transmission blocking
5371959|NCT01849627|weight loss maintenance|weight loss maintenance
5371960|NCT01849588|Hepatitis C positive|hepatitis c positive
5371961|NCT01849575|Ultrasonography|ultrasonography
5371962|NCT01849575|Cardiovascular diseases|cardiovascular diseases
5371963|NCT01849575|Prevention|prevention
5371964|NCT01849575|Risk communication|risk communication
5371967|NCT01849562|Hepatitis C, Chronic|hepatitis c, chronic
5371968|NCT01849562|Genotype 1|genotype 1
5371972|NCT01849562|ribavirin|ribavirin
5371973|NCT01849562|antiviral agents|antiviral agents
5371974|NCT01849562|anti-infective agents|anti-infective agents
5371975|NCT01849562|protease inhibitors|protease inhibitors
5371976|NCT01849562|NS5a inhibitors|ns5a inhibitors
5371977|NCT01849549|neuropsychological Study|neuropsychological study
5371978|NCT01849549|brain Imaging|brain imaging
5371979|NCT01849536|Open angle glaucoma|open angle glaucoma
5371980|NCT01849536|Corneal biomechanics|corneal biomechanics
5371981|NCT01849536|Intra ocular pressure|intra ocular pressure
5371982|NCT01849536|IOP|iop
5371983|NCT01849536|IOP fluctuation|iop fluctuation
5371984|NCT01849536|Continuous IOP monitoring|continuous iop monitoring
5371985|NCT01849536|SENSIMED Triggerfish®|sensimed triggerfish®
5371986|NCT01849523|Neuroendocrine tumor|neuroendocrine tumor
5371987|NCT01849523|Website|website
5371988|NCT01849523|Information|information
5371989|NCT01849523|Psychosocial support|psychosocial support
5371990|NCT01849510|spinal metastases|spinal metastases
5371991|NCT01849510|vertebral body|vertebral body
5371992|NCT01849510|stereotaxis|stereotaxis
5371993|NCT01849510|image-guided radiotherapy|image-guided radiotherapy
5371994|NCT01849510|hypofractionated|hypofractionated
5371995|NCT01849510|dose intensified|dose intensified
5371996|NCT01849510|dose elevation|dose elevation
5371997|NCT01849497|LDL-C, triglycerides, high cholesterol|ldl-c, triglycerides, high cholesterol
5371998|NCT01849484|meningioma|meningioma
5371999|NCT01849484|skull base meningioma|skull base meningioma
5372000|NCT01849484|pituitary adenoma|pituitary adenoma
5372001|NCT01849484|brain metastases|brain metastases
5372002|NCT01849484|small cell lung carcinoma|small cell lung carcinoma
5372003|NCT01849471|socioeconomic aspects|socioeconomic aspects
5372004|NCT01849471|costs of therapy|costs of therapy
5372005|NCT01849471|follow-up costs|follow-up costs
5372006|NCT01849471|primary radiation|primary radiation
5372007|NCT01849471|percutaneous|percutaneous
5372008|NCT01849471|interstitial|interstitial
5372009|NCT01849393|Adolescents|adolescents
5372010|NCT01849393|Medication Compliance|medication compliance
5372011|NCT01849393|Rewards-Based Incentive Programs|rewards-based incentive programs
5372012|NCT01849380|Local Advanced Breast Neoplasms|local advanced breast neoplasms
5372013|NCT01849380|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5372014|NCT01849380|S-1|s-1
5372015|NCT01849341|COPD|copd
5372016|NCT01849302|Appetite|appetite
5372017|NCT01849302|Satiety hormones|satiety hormones
5372018|NCT01849302|Dietary Protein|dietary protein
5372019|NCT01849237|Mesenchymal Stromal Cells|mesenchymal stromal cells
5372020|NCT01849237|Septic Shock|septic shock
5372021|NCT01849237|Neutropenia|neutropenia
5372022|NCT01849237|Procalcitonin|procalcitonin
5372023|NCT01849237|Interleukin-6|interleukin-6
5372024|NCT01849237|Interleukin-10|interleukin-10
5372025|NCT01849237|C-reactive protein|c-reactive protein
5372026|NCT01849237|Survival|survival
5372027|NCT01849237|Organ dysfunction|organ dysfunction
5372028|NCT01849224|Lower extremity edema|lower extremity edema
5372029|NCT01849224|Lower leg lymphedema|lower leg lymphedema
5372030|NCT01849224|Lower leg edema|lower leg edema
5372031|NCT01849224|Lymphedema|lymphedema
5372032|NCT01849224|Pelvic lymphadenectomy|pelvic lymphadenectomy
5372033|NCT01849224|Exercise|exercise
5372037|NCT01849198|accelerometry|accelerometry
5372038|NCT01849198|neuromuscular block|neuromuscular block
5372039|NCT01849198|m. trapezius|m. trapezius
5372040|NCT01849185|Hypercholesterolemia|hypercholesterolemia
5372041|NCT01849159|Mesenchymal stem cells|mesenchymal stem cells
5372042|NCT01849159|Hypoxia|hypoxia
5372043|NCT01849159|Emphysema|emphysema
5372044|NCT01849133|Breast cancer|breast cancer
5372045|NCT01849133|conservative surgery|conservative surgery
5372046|NCT01849133|intraoperative radiation therapy|intraoperative radiation therapy
5372047|NCT01849133|mobile linear accelerator|mobile linear accelerator
5372048|NCT01849120|near infrared spectroscopy (NIRS)|near infrared spectroscopy (nirs)
5372049|NCT01849120|EQUANOX Advance 8004CB probes|equanox advance 8004cb probes
5372050|NCT01849120|cerebral vascular circulation|cerebral vascular circulation
5372051|NCT01849120|peripheral perfusion|peripheral perfusion
5372052|NCT01849107|Radiation-induced small bowel toxicity|radiation-induced small bowel toxicity
5372053|NCT01849107|Plasma citrulline|plasma citrulline
5372054|NCT01849081|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5372055|NCT01849081|Obstructive sleep apnea|obstructive sleep apnea
5372056|NCT01849029|Post traumatic Stress Disorders|post traumatic stress disorders
5372057|NCT01849029|PTSD|ptsd
5372058|NCT01849029|HIV risk|hiv risk
5372059|NCT01849029|sexual risk|sexual risk
5372060|NCT01849029|substance use|substance use
5372061|NCT01849029|alcohol misuse|alcohol misuse
5372062|NCT01849029|Substance Abuse|substance abuse
5372063|NCT01849029|Substance Addiction|substance addiction
5372064|NCT01849029|Substance Dependence|substance dependence
5367522|NCT01868490|Th17|th17
5372074|NCT01849016|N-Acetylcysteine|n-acetylcysteine
5372075|NCT01849016|Acetylcysteine|acetylcysteine
5372076|NCT01849016|Oxidative stress|oxidative stress
5372077|NCT01849003|Long QT Syndrome|long qt syndrome
5372078|NCT01849003|LQTS|lqts
5372079|NCT01849003|Long QT-3 Syndrome|long qt-3 syndrome
5372080|NCT01849003|LQT-3|lqt-3
5372081|NCT01849003|prolonged QT interval|prolonged qt interval
5372082|NCT01849003|GS-6615|gs-6615
5372083|NCT01849003|late sodium current inhibitor|late sodium current inhibitor
5372084|NCT01848990|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5372085|NCT01848990|Sub Cutaneous Insulin Infusion|sub cutaneous insulin infusion
5372086|NCT01848990|Rapid Acting Analog Insulin|rapid acting analog insulin
5372087|NCT01848990|Hylenex|hylenex
5372088|NCT01848990|Halozyme|halozyme
5372089|NCT01848990|Phase 4|phase 4
5372090|NCT01848977|Measures|measures
5372091|NCT01848977|near-Infrared spectroscopy|near-infrared spectroscopy
5372092|NCT01848977|ischemia|ischemia
5372094|NCT01848964|amputation|amputation
5372095|NCT01848964|prosthesis|prosthesis
5372096|NCT01848964|stump|stump
5372097|NCT01848964|socket|socket
5372098|NCT01848964|pressure|pressure
5372099|NCT01848964|gait|gait
5372100|NCT01848964|posture|posture
5372101|NCT01848938|female|female
5372102|NCT01848938|stress urinary incontinence|stress urinary incontinence
5372103|NCT01848938|treatment|treatment
5372104|NCT01848938|pelvic floor muscle training|pelvic floor muscle training
5372105|NCT01848938|smartphone|smartphone
5372106|NCT01848938|internet|internet
5357961|NCT01912287|GAD|gad
5372107|NCT01848938|life style|life style
5372108|NCT01848938|eHealth|ehealth
5372109|NCT01848925|SANGUINATE|sanguinate
5372110|NCT01848899|Coronary angiography|coronary angiography
5372111|NCT01848899|Percutaneous coronary intervention|percutaneous coronary intervention
5372112|NCT01848899|Contrast media|contrast media
5372113|NCT01848899|Platelet activity|platelet activity
5372114|NCT01848899|Thrombin generation|thrombin generation
5372115|NCT01848899|Fibrinolysis|fibrinolysis
5372117|NCT01848886|Endoscopic Radial Artery Harvest|endoscopic radial artery harvest
5372118|NCT01848886|Y-graft|y-graft
5372119|NCT01848886|Radial Artery Harvest|radial artery harvest
5372120|NCT01848886|Total Arterial Revascularisation|total arterial revascularisation
5372121|NCT01848886|CABG|cabg
5372122|NCT01848886|Radial Artery Conduit|radial artery conduit
5372123|NCT01848873|Hyperhomocysteinemia|hyperhomocysteinemia
5372124|NCT01848873|Amlodipine-folic acid tablets|amlodipine-folic acid tablets
5372125|NCT01848873|Hypertension|hypertension
5372126|NCT01848873|MTHFR C677T|mthfr c677t
5372127|NCT01848860|Pneumothorax|pneumothorax
5372128|NCT01848860|thoracoscopy|thoracoscopy
5372129|NCT01848860|mesh|mesh
5372130|NCT01848860|pleurodesis|pleurodesis
5372131|NCT01848860|treatment|treatment
5372132|NCT01848847|Hysteroscopy|hysteroscopy
5372133|NCT01848847|Bladder|bladder
5372134|NCT01848847|Pain|pain
5372135|NCT01848847|Feasibility|feasibility
5372136|NCT01848847|Duration|duration
5372137|NCT01848834|PD-1|pd-1
5372138|NCT01848834|PD1|pd1
5372139|NCT01848834|PD-L1|pd-l1
5372140|NCT01848834|PDL1|pdl1
5372141|NCT01848821|OASIS ultra|oasis ultra
5372142|NCT01848821|faster healing time|faster healing time
5372143|NCT01848821|better healing quality|better healing quality
5372144|NCT01848821|standard of care|standard of care
5372145|NCT01848795|Type 2 Diabetes|type 2 diabetes
5372146|NCT01848795|Obesity|obesity
5372147|NCT01848795|gastrointestinal hormones|gastrointestinal hormones
5372148|NCT01848795|intestinal bypass|intestinal bypass
5372149|NCT01848795|endoscopy|endoscopy
5372150|NCT01848782|abstract|abstract
5372151|NCT01848782|meta-analysis|meta-analysis
5372152|NCT01848782|systematic review|systematic review
5372153|NCT01848782|interpretation|interpretation
5372154|NCT01848782|results|results
5372155|NCT01848782|quality|quality
5372156|NCT01848782|bias|bias
5372157|NCT01848782|spin|spin
5372158|NCT01848782|limits|limits
5372159|NCT01848782|limitation|limitation
5372160|NCT01848782|risk of bias|risk of bias
5372161|NCT01848769|Asthma|asthma
5372162|NCT01848769|ICS+LABA|ics+laba
5372163|NCT01848769|Children|children
5372166|NCT01848756|SNX-5422|snx-5422
5372167|NCT01848756|HER2 positive cancer|her2 positive cancer
5372168|NCT01848743|tenofovir, lamivudine, hepatitis B, acute exacerbation|tenofovir, lamivudine, hepatitis b, acute exacerbation
5372169|NCT01848704|spin|spin
5372170|NCT01848704|interpretation|interpretation
5372171|NCT01848704|bias|bias
5372172|NCT01848652|cerebral lymphoma B cell refractory|cerebral lymphoma b cell refractory
5372173|NCT01848652|Myocet|myocet
5372174|NCT01848652|efficacy|efficacy
5372175|NCT01848652|safety|safety
5372176|NCT01848639|chronic kidney disease|chronic kidney disease
5372177|NCT01848639|end-stage renal disease|end-stage renal disease
5372178|NCT01848639|hemodialysis (ESRD)|hemodialysis (esrd)
5372179|NCT01848639|cardiovascular morbimortality|cardiovascular morbimortality
5372180|NCT01848639|aldosterone antagonist|aldosterone antagonist
5372181|NCT01848639|spironolactone|spironolactone
5372182|NCT01848600|limitation|limitation
5372183|NCT01848600|quality|quality
5372184|NCT01848600|bias|bias
5372185|NCT01848600|meta-analysis|meta-analysis
5372186|NCT01848600|interpretation|interpretation
5372187|NCT01848600|abstract|abstract
5372188|NCT01848587|Pregnancy|pregnancy
5372189|NCT01848587|Acupuncture|acupuncture
5372190|NCT01848587|Pelvic and low back pain|pelvic and low back pain
5372191|NCT01848587|Impairment|impairment
5372192|NCT01848587|Economic evaluation|economic evaluation
5372193|NCT01848574|Understanding|understanding
5372194|NCT01848574|Patients|patients
5372195|NCT01848574|Emergency|emergency
5372196|NCT01848574|Information|information
5372197|NCT01848561|Ulcerative Colitis|ulcerative colitis
5372198|NCT01848561|Registry|registry
5372199|NCT01848561|Adalimumab|adalimumab
5372200|NCT01848561|Colitis|colitis
5372201|NCT01848561|Gastroenteritis|gastroenteritis
5372202|NCT01848561|Inflammatory Bowel Diseases|inflammatory bowel diseases
5372203|NCT01848561|Gastrointestinal Diseases|gastrointestinal diseases
5372204|NCT01848535|intestinal microbiota composition|intestinal microbiota composition
5372205|NCT01848535|intestinal microbiota activity|intestinal microbiota activity
5372206|NCT01848535|gastro-intestinal complains|gastro-intestinal complains
5372207|NCT01848522|qualitative study|qualitative study
5372208|NCT01848522|rehabilitation|rehabilitation
5372209|NCT01848522|physical therapy|physical therapy
5372210|NCT01848522|patient education|patient education
5372211|NCT01848522|health care|health care
5372212|NCT01848522|administration|administration
5372213|NCT01848522|patient satisfaction|patient satisfaction
5372214|NCT01848522|handicap|handicap
5372215|NCT01848509|CPAP|cpap
5372216|NCT01848509|adherence|adherence
5372217|NCT01848509|SAOS|saos
5372218|NCT01848509|telemedicine|telemedicine
5372219|NCT01848483|Early Palliative Care|early palliative care
5372220|NCT01848483|Motivational Interviewing|motivational interviewing
5372221|NCT01848483|Persons Living With Human immunodeficiency virus(HIV)|persons living with human immunodeficiency virus(hiv)
5372222|NCT01848483|Acquired Immunodeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
5372223|NCT01848457|Osteosarcoma|osteosarcoma
5372225|NCT01848457|Nephrotoxicity|nephrotoxicity
5372226|NCT01848457|Ototoxicity|ototoxicity
5372227|NCT01848457|Cisplatin|cisplatin
5372228|NCT01848457|High-dose methotrexate|high-dose methotrexate
5372229|NCT01848457|Biomarkers|biomarkers
5372230|NCT01848457|Patient reported outcomes|patient reported outcomes
5372231|NCT01848444|Public Health|public health
5372232|NCT01848444|Epidemiology|epidemiology
5372233|NCT01848444|Pharmacy Toxicology|pharmacy toxicology
5372234|NCT01848444|Perinatal period|perinatal period
5372236|NCT01848418|Core sets|core sets
5372237|NCT01848418|Systemic sclerosis|systemic sclerosis
5372238|NCT01848418|Function|function
5372239|NCT01848418|Evaluation|evaluation
5372240|NCT01848392|Cystic fibrosis|cystic fibrosis
5372241|NCT01848392|Adults|adults
5372242|NCT01848392|Physical activity|physical activity
5372243|NCT01848366|Frequency|frequency
5372244|NCT01848366|urgency|urgency
5372245|NCT01848366|incontinence|incontinence
5372246|NCT01848340|mass balance|mass balance
5372247|NCT01848340|GSK1265744|gsk1265744
5372248|NCT01848340|supratherapeutic|supratherapeutic
5372249|NCT01848340|integrase inhibitor|integrase inhibitor
5372250|NCT01848340|healthy volunteer|healthy volunteer
5372251|NCT01848327|Cognition|cognition
5372252|NCT01848327|Neuropsychology|neuropsychology
5372253|NCT01848327|Multiple Sclerosis|multiple sclerosis
5372254|NCT01848301|Optical Coherence Tomography|optical coherence tomography
5372255|NCT01848301|OCT|oct
5372508|NCT01847209|lung nodule|lung nodule
5372256|NCT01848301|Coronary Allograft Vasculopathy|coronary allograft vasculopathy
5372257|NCT01848301|Donor Specific Antibodies|donor specific antibodies
5372258|NCT01848301|Acetylcholine|acetylcholine
5372259|NCT01848301|Coronary endothelial function|coronary endothelial function
5372260|NCT01848301|Brachial Artery Flow Mediated Dilation|brachial artery flow mediated dilation
5372261|NCT01848301|Heart transplantation|heart transplantation
5372262|NCT01848288|Cataract|cataract
5372263|NCT01848288|Phacoemulsification|phacoemulsification
5372264|NCT01848288|Cumulative Dissipated Energy (CDE)|cumulative dissipated energy (cde)
5372265|NCT01848262|ECALMIST|ecalmist
5372267|NCT01848262|CPAP|cpap
5372268|NCT01848262|Ventilation|ventilation
5372269|NCT01848262|Vascular Catheter|vascular catheter
5372270|NCT01848249|deceased donors|deceased donors
5372271|NCT01848249|kidney donor|kidney donor
5372272|NCT01848249|transplant recipients|transplant recipients
5372273|NCT01848249|kidney transplant|kidney transplant
5372274|NCT01848249|delayed graft function|delayed graft function
5372275|NCT01848249|biomarkers|biomarkers
5372276|NCT01848249|end stage renal disease|end stage renal disease
5372277|NCT01848249|graft failure|graft failure
5372278|NCT01848223|quality of life|quality of life
5372280|NCT01848223|late menopause|late menopause
5372281|NCT01848210|Drug therapy|drug therapy
5372282|NCT01848184|PARIETEX Composite Ventral Patch|parietex composite ventral patch
5372283|NCT01848184|PCO VP OR PCOVP|pco vp or pcovp
5372284|NCT01848184|Primary ventral hernia repair|primary ventral hernia repair
5372285|NCT01848184|Panacea|panacea
5372286|NCT01848171|Hypothyroidism|hypothyroidism
5372287|NCT01848171|Lipid|lipid
5372288|NCT01848171|Atherosclerosis|atherosclerosis
5372289|NCT01848171|Oxidative Stress|oxidative stress
5372290|NCT01848171|Chronic Inflammation|chronic inflammation
5372291|NCT01848171|Endothelial Function|endothelial function
5372292|NCT01848171|Adipocytokine|adipocytokine
5372293|NCT01848171|L-thyroxine|l-thyroxine
5372294|NCT01848158|acupuncture|acupuncture
5372295|NCT01848158|pediatric|pediatric
5372296|NCT01848158|critical care|critical care
5372297|NCT01848158|mechanical ventilation|mechanical ventilation
5372298|NCT01848158|sedation|sedation
5372299|NCT01848158|comfort|comfort
5372300|NCT01848145|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5372301|NCT01848145|Ofatumumab|ofatumumab
5372302|NCT01848145|Rapid Infusion|rapid infusion
5372303|NCT01848132|Lymphoma|lymphoma
5372304|NCT01848132|Large B-Cell|large b-cell
5372305|NCT01848119|Gabapentin|gabapentin
5372306|NCT01848119|Cesarean section|cesarean section
5372307|NCT01848106|Percutaneous Coronary Intervention|percutaneous coronary intervention
5372308|NCT01848106|Coronary Artery Disease|coronary artery disease
5372309|NCT01848106|Acute Coronary Syndrome|acute coronary syndrome
5372311|NCT01848106|Reg 1|reg 1
5372312|NCT01848106|bivalirudin|bivalirudin
5358151|NCT01911325|Stage IV|stage iv
5372313|NCT01848093|lung|lung
5372314|NCT01848093|airway|airway
5372315|NCT01848093|pulmonary exacerbation|pulmonary exacerbation
5372316|NCT01848093|mucus|mucus
5372317|NCT01848080|Telemedicine|telemedicine
5372318|NCT01848080|Telerehabilitation|telerehabilitation
5372319|NCT01848080|Acute Stroke|acute stroke
5372320|NCT01848080|Tai Chi|tai chi
5372321|NCT01848080|Tai Ji|tai ji
5372322|NCT01848080|Rehabilitation|rehabilitation
5372323|NCT01848080|Home care services|home care services
5372324|NCT01848080|Single blind method|single blind method
5372325|NCT01848080|Randomized controlled trial|randomized controlled trial
5372326|NCT01848054|opioid dependence, buprenorphine/naloxone, sublingual|opioid dependence, buprenorphine/naloxone, sublingual
5372327|NCT01848041|Blepharoptosis|blepharoptosis
5372328|NCT01848041|Ptosis|ptosis
5372329|NCT01848028|Patient registry|patient registry
5372330|NCT01848028|Germany|germany
5372331|NCT01848028|Psoriasis|psoriasis
5372332|NCT01848028|psoriatic-arthritis|psoriatic-arthritis
5372333|NCT01848028|Efalizumab|efalizumab
5372334|NCT01848028|Psonet|psonet
5372335|NCT01848028|Effectiveness|effectiveness
5372336|NCT01848028|Safety|safety
5372337|NCT01848015|CTCs before and after gastrectomy|ctcs before and after gastrectomy
5372338|NCT01847976|breast|breast
5372339|NCT01847976|bone pain|bone pain
5372340|NCT01847963|Urolithiasis|urolithiasis
5372341|NCT01847963|Kalladaippu Kudineer|kalladaippu kudineer
5372342|NCT01847963|Siddha|siddha
5372343|NCT01847963|Sindhuvallathy|sindhuvallathy
5372344|NCT01847963|Kidney stones|kidney stones
5372345|NCT01847911|self instructed resuscitation training|self instructed resuscitation training
5372346|NCT01847898|Osteoporosis|osteoporosis
5372347|NCT01847898|Vertebral Body|vertebral body
5372348|NCT01847898|Compression Fracture|compression fracture
5372349|NCT01847898|Kyphoplasty|kyphoplasty
5372350|NCT01847885|electrical stimulation|electrical stimulation
5372351|NCT01847885|neurostimulation|neurostimulation
5372352|NCT01847885|neuromodulation|neuromodulation
5372353|NCT01847885|post-stroke shoulder pain|post-stroke shoulder pain
5372354|NCT01847885|hemiplegic shoulder pain|hemiplegic shoulder pain
5372355|NCT01847872|Inactivated Poliovirus Vaccine|inactivated poliovirus vaccine
5372356|NCT01847872|Randomised Control Phase IV Study|randomised control phase iv study
5372357|NCT01847872|Gambia|gambia
5372358|NCT01847872|IPV|ipv
5372359|NCT01847872|Safety and Immunogenicity|safety and immunogenicity
5372360|NCT01847872|Non-interference study|non-interference study
5372361|NCT01847872|IM Jet injector|im jet injector
5372362|NCT01847872|ID Jet Injector|id jet injector
5372363|NCT01847859|Cardiothoracic surgery|cardiothoracic surgery
5372364|NCT01847859|Post-operative|post-operative
5372365|NCT01847859|Nurses|nurses
5372366|NCT01847859|Cardiac|cardiac
5372367|NCT01847859|Echocardiography|echocardiography
5372368|NCT01847859|Pocket-size|pocket-size
5372369|NCT01847859|Hand-held|hand-held
5372370|NCT01847820|ROM|rom
5372371|NCT01847820|PROM|prom
5372372|NCT01847820|PPROM (preterm premature rupture of membranes)|pprom (preterm premature rupture of membranes)
5372373|NCT01847807|5-10 gram astragalus per day|5-10 gram astragalus per day
5372374|NCT01847781|Opsonophagocytic antibodies|opsonophagocytic antibodies
5372375|NCT01847781|Cellular immunity|cellular immunity
5372376|NCT01847781|Vaccine immunity|vaccine immunity
5372377|NCT01847781|Antimicrobial peptides|antimicrobial peptides
5372378|NCT01847768|asthma|asthma
5372379|NCT01847768|rhinovirus|rhinovirus
5372380|NCT01847768|remodeling mediators|remodeling mediators
5372381|NCT01847768|human rhinovirus infection|human rhinovirus infection
5372382|NCT01847729|Opiate dependence|opiate dependence
5372383|NCT01847729|Opiate substitution treatment|opiate substitution treatment
5372384|NCT01847729|co-addictions|co-addictions
5372385|NCT01847729|Patients addicted to opiates|patients addicted to opiates
5372386|NCT01847729|methadone|methadone
5372387|NCT01847729|buprenorhine|buprenorhine
5372388|NCT01847729|morphine|morphine
5372389|NCT01847729|OST in place|ost in place
5372390|NCT01847729|pathological gambling|pathological gambling
5372391|NCT01847729|pharmacokinetic|pharmacokinetic
5372392|NCT01847729|pharmacogenetic|pharmacogenetic
5372393|NCT01847729|polymorphism|polymorphism
5372394|NCT01847729|cytochrome P450 2D6|cytochrome p450 2d6
5372395|NCT01847729|Therapeutic Drug Monitoring|therapeutic drug monitoring
5372396|NCT01847716|Muscle weakness|muscle weakness
5372397|NCT01847716|Pulmonary arterial hypertension|pulmonary arterial hypertension
5372398|NCT01847716|Transforming growth factor beta|transforming growth factor beta
5372399|NCT01847716|Growth and differentiation factor 15|growth and differentiation factor 15
5372400|NCT01847690|Addison Disease|addison disease
5372401|NCT01847677|ovarian cancer|ovarian cancer
5372402|NCT01847677|neoadyuvant|neoadyuvant
5372403|NCT01847677|bevacizumab|bevacizumab
5372404|NCT01847651|hepatic encephalopathy|hepatic encephalopathy
5372405|NCT01847651|minimal hepatic encephalopathy|minimal hepatic encephalopathy
5372406|NCT01847651|cirrhosis|cirrhosis
5372407|NCT01847651|lateral vastus|lateral vastus
5372408|NCT01847651|muscle biopsy|muscle biopsy
5372409|NCT01847651|L ornithine L aspartate|l ornithine l aspartate
5372410|NCT01847651|functional magnetic resonance imaging|functional magnetic resonance imaging
5372411|NCT01847651|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5372412|NCT01847651|cognitive testing|cognitive testing
5372413|NCT01847651|Paper and pencil Hepatic Encephalopathy score (PHES)|paper and pencil hepatic encephalopathy score (phes)
5372415|NCT01847651|urine metabonomics|urine metabonomics
5372416|NCT01847651|plasma metabonomics|plasma metabonomics
5372417|NCT01847651|muscle metabonomics|muscle metabonomics
5372418|NCT01847638|Retinal edema|retinal edema
5372419|NCT01847638|Cataract|cataract
5372420|NCT01847638|inflammation|inflammation
5372421|NCT01847612|per operative cholangiography|per operative cholangiography
5372422|NCT01847612|liver resection|liver resection
5372423|NCT01847612|biliary fistula|biliary fistula
5372424|NCT01847599|educational intervention|educational intervention
5372425|NCT01847599|adherence|adherence
5372426|NCT01847599|capecitabine|capecitabine
5372427|NCT01847599|lapatinib|lapatinib
5372428|NCT01847586|Alzheimer's Disease|alzheimer's disease
5372429|NCT01847586|Brain stimulation|brain stimulation
5355628|NCT01923233|HCC|hcc
5372430|NCT01847586|transcranial magnetic stimulation|transcranial magnetic stimulation
5372431|NCT01847573|halofuginone hydrobromide|halofuginone hydrobromide
5372432|NCT01847573|anti-fibrotic|anti-fibrotic
5372433|NCT01847573|anti-inflammatory|anti-inflammatory
5372434|NCT01847573|muscle regeneration|muscle regeneration
5372435|NCT01847573|protein synthesis inhibitor|protein synthesis inhibitor
5372436|NCT01847495|Stage IV Colorectal Carcinoma|stage iv colorectal carcinoma
5372437|NCT01847495|Liver metastasis|liver metastasis
5372438|NCT01847495|Cyberknife|cyberknife
5372439|NCT01847495|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5372440|NCT01847495|SBRT|sbrt
5372441|NCT01847495|Irinotecan HCl|irinotecan hcl
5372442|NCT01847495|CPT-11|cpt-11
5372443|NCT01847482|Cardiac arrest|cardiac arrest
5372444|NCT01847482|Return of Spontaneous Circulation (ROSC)|return of spontaneous circulation (rosc)
5372445|NCT01847482|IntraVascular Temperature Management (IVTM)|intravascular temperature management (ivtm)
5372446|NCT01847482|Therapeutic Hypothermia|therapeutic hypothermia
5372447|NCT01847482|Japan|japan
5372448|NCT01847469|Alcohol Dependence|alcohol dependence
5372449|NCT01847469|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5372450|NCT01847469|Zonisamide|zonisamide
5372451|NCT01847469|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
5372452|NCT01847456|whole body insulin sensitivity|whole body insulin sensitivity
5372453|NCT01847456|insulin action in the brain|insulin action in the brain
5372454|NCT01847443|nicotine|nicotine
5372455|NCT01847443|nicotine replacement therapy|nicotine replacement therapy
5372456|NCT01847443|nicotine gum|nicotine gum
5372457|NCT01847430|Healthy|healthy
5372458|NCT01847430|Hepatitis B|hepatitis b
5372459|NCT01847430|Adolescents|adolescents
5372460|NCT01847430|Engerix™-B Kinder|engerix™-b kinder
5372461|NCT01847417|Acetylsalicylic acid|acetylsalicylic acid
5372462|NCT01847417|Pantoprazole|pantoprazole
5372463|NCT01847417|Fixed dose combination|fixed dose combination
5372464|NCT01847404|Fixed dose combination|fixed dose combination
5372465|NCT01847404|Acetylsalicylic acid|acetylsalicylic acid
5372466|NCT01847404|Pantoprazole|pantoprazole
5372676|NCT01846442|Intrarosa|intrarosa
5372467|NCT01847391|Ischemic Heart Disease|ischemic heart disease
5372468|NCT01847391|Heart Disease|heart disease
5372469|NCT01847378|ventricular tachycardia|ventricular tachycardia
5372470|NCT01847378|catheter ablation|catheter ablation
5372471|NCT01847378|chagas disease|chagas disease
5372472|NCT01847378|epicardial mapping|epicardial mapping
5372473|NCT01847378|magnetic resonance imaging|magnetic resonance imaging
5372474|NCT01847365|Retinitis Pigmentosa|retinitis pigmentosa
5372475|NCT01847365|Transcorneal electrical stimulation|transcorneal electrical stimulation
5372477|NCT01847352|Hypoxia|hypoxia
5372478|NCT01847352|Pulmonary hypertension|pulmonary hypertension
5372479|NCT01847352|Iron deficiency|iron deficiency
5372480|NCT01847352|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5372481|NCT01847313|kidney|kidney
5372482|NCT01847313|diabetes|diabetes
5372483|NCT01847313|glp-1|glp-1
5372484|NCT01847300|alcohol abuse|alcohol abuse
5360078|NCT01901978|Obesity|obesity
5372485|NCT01847300|tobacco dependence|tobacco dependence
5372486|NCT01847300|substance abuse|substance abuse
5372487|NCT01847300|SBIRT|sbirt
5372488|NCT01847287|Multiple sclerosis|multiple sclerosis
5372489|NCT01847287|Tysabri|tysabri
5372490|NCT01847287|MRI|mri
5372491|NCT01847287|Natalizumab|natalizumab
5372492|NCT01847274|ovarian cancer|ovarian cancer
5372493|NCT01847274|platinum sensitive|platinum sensitive
5372494|NCT01847274|gBRCAmut|gbrcamut
5372495|NCT01847274|BRCA|brca
5372496|NCT01847274|high-grade serous histology|high-grade serous histology
5372497|NCT01847274|PARP inhibitor|parp inhibitor
5372498|NCT01847261|soy|soy
5372499|NCT01847261|whey|whey
5372500|NCT01847261|muscle|muscle
5372501|NCT01847261|older|older
5372502|NCT01847261|mTOR|mtor
5372503|NCT01847261|sarcopenia|sarcopenia
5372504|NCT01847248|sepsis|sepsis
5372505|NCT01847248|biomarker|biomarker
5372506|NCT01847248|HSPA12B|hspa12b
5372507|NCT01847235|Temozolomide|temozolomide
5372509|NCT01847209|lung cancer|lung cancer
5372510|NCT01847209|lung mass|lung mass
5372511|NCT01847196|Pulmonary Embolism|pulmonary embolism
5372512|NCT01847196|PE|pe
5372513|NCT01847196|DVT|dvt
5372514|NCT01847196|Deep Vein Thrombosis|deep vein thrombosis
5372516|NCT01847196|Venous Thromboembolism|venous thromboembolism
5372517|NCT01847196|prophylaxis|prophylaxis
5372518|NCT01847196|thromboprophylaxis|thromboprophylaxis
5372519|NCT01847196|contraindications to thromboprophylaxis|contraindications to thromboprophylaxis
5372520|NCT01847196|prophylactic|prophylactic
5372521|NCT01847196|prevention|prevention
5372522|NCT01847196|Inferior vena cava filter|inferior vena cava filter
5372523|NCT01847196|IVC filter|ivc filter
5372524|NCT01847196|filter|filter
5372525|NCT01847196|prevention of pulmonary embolism|prevention of pulmonary embolism
5372526|NCT01847196|trauma|trauma
5372527|NCT01847196|critically-ill|critically-ill
5372528|NCT01847183|heavy drinking|heavy drinking
5372529|NCT01847183|prevention|prevention
5372530|NCT01847183|high school|high school
5372531|NCT01847183|adolescence|adolescence
5372532|NCT01847157|recovery of function|recovery of function
5372533|NCT01847157|stroke|stroke
5372534|NCT01847157|Upper extremity|upper extremity
5372535|NCT01847157|Motor|motor
5372536|NCT01847157|transcranial direct current stimulation|transcranial direct current stimulation
5372537|NCT01847131|Rhinitis|rhinitis
5372538|NCT01847131|Oxymetazoline|oxymetazoline
5372539|NCT01847092|albuminuria|albuminuria
5372540|NCT01847066|wrinkles|wrinkles
5372541|NCT01847066|acne scars|acne scars
5372542|NCT01847066|pigmentation|pigmentation
5372543|NCT01847053|Cinnamon|cinnamon
5372544|NCT01847053|Bioavailability|bioavailability
5372545|NCT01847053|Glucose|glucose
5372546|NCT01847053|Proanthocyanidins|proanthocyanidins
5372547|NCT01847040|Traumatic Brain Injury|traumatic brain injury
5372548|NCT01847040|Epidemiology|epidemiology
5372549|NCT01847040|Concussion|concussion
5372550|NCT01847040|Outcomes|outcomes
5372551|NCT01847040|PTSD|ptsd
5372552|NCT01847040|Prospective|prospective
5372553|NCT01847040|Longitudinal|longitudinal
5372554|NCT01847040|Military|military
5372555|NCT01847040|Symptoms|symptoms
5372556|NCT01847040|Validation|validation
5372557|NCT01847040|Screening|screening
5372558|NCT01847040|Mild Traumatic Brain Injury|mild traumatic brain injury
5372559|NCT01847027|Healthy|healthy
5372560|NCT01847027|Stem cells|stem cells
5372561|NCT01847027|Aging|aging
5372562|NCT01847027|Increase stem cell replacement|increase stem cell replacement
5372563|NCT01847027|decreased stem cell proliferation|decreased stem cell proliferation
5372564|NCT01847014|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5372565|NCT01847014|psychometric instrument|psychometric instrument
5372566|NCT01847014|PAH-SYMPACT|pah-sympact
5372567|NCT01847001|Breast Cancer|breast cancer
5372570|NCT01847001|Biomarker|biomarker
5372571|NCT01847001|Breast imaging|breast imaging
5372572|NCT01846988|Obstructive Sleep Apnea|obstructive sleep apnea
5372573|NCT01846988|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
5372574|NCT01846988|Auto PAP|auto pap
5372575|NCT01846988|Auto-adjustable Positive Airway Pressure|auto-adjustable positive airway pressure
5372576|NCT01846988|APAP|apap
5372577|NCT01846988|CPAP|cpap
5372578|NCT01846975|Abatacept|abatacept
5372579|NCT01846975|Low disease activity|low disease activity
5372580|NCT01846975|Intravenous|intravenous
5372581|NCT01846975|Subcutaneous|subcutaneous
5372582|NCT01846975|Rheumatoid arthritis|rheumatoid arthritis
5372583|NCT01846962|Eosinophilic esophagitis (EoE)|eosinophilic esophagitis (eoe)
5372584|NCT01846962|budesonide|budesonide
5372585|NCT01846962|fluticasione|fluticasione
5372586|NCT01846962|six-foods elimination diet|six-foods elimination diet
5372587|NCT01846936|one lung ventilation|one lung ventilation
5372588|NCT01846936|efficacy|efficacy
5372589|NCT01846936|bronchial blocker|bronchial blocker
5372590|NCT01846910|Cessation|cessation
5372591|NCT01846845|Amputee|amputee
5372592|NCT01846832|Hepatitis C, Chronic|hepatitis c, chronic
5372593|NCT01846832|Infection|infection
5372594|NCT01846832|Triple therapy|triple therapy
5372595|NCT01846832|TMC435|tmc435
5372596|NCT01846832|simeprevir|simeprevir
5372597|NCT01846832|Pegylated interferon alfa-2a (PegIFNα-2a)|pegylated interferon alfa-2a (pegifnα-2a)
5372598|NCT01846832|ribavirin (RBV)|ribavirin (rbv)
5372599|NCT01846832|PEGASYS|pegasys
5372600|NCT01846832|COPEGUS|copegus
5372601|NCT01846806|Hepatic Encephalopathy|hepatic encephalopathy
5372602|NCT01846793|Benign prostatic hyperplasia|benign prostatic hyperplasia
5372604|NCT01846793|Lower urinary tract symptoms|lower urinary tract symptoms
5372605|NCT01846793|LUTS|luts
5372606|NCT01846793|LUTS secondary to BPH|luts secondary to bph
5372607|NCT01846793|LUTS/BPH|luts/bph
5372608|NCT01846793|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
5372610|NCT01846793|Bladder outlet obstruction|bladder outlet obstruction
5372611|NCT01846793|BOO|boo
5372612|NCT01846767|13CO2|13co2
5372613|NCT01846767|Breath test|breath test
5372614|NCT01846767|Glucose oxidation|glucose oxidation
5372615|NCT01846767|Diabetes mellitus|diabetes mellitus
5372616|NCT01846754|Hemodialysis|hemodialysis
5372617|NCT01846754|Fatigue|fatigue
5372618|NCT01846754|Muscle strength|muscle strength
5372619|NCT01846754|Metabolomics|metabolomics
5372620|NCT01846741|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
5372621|NCT01846741|Vagus Nerve Stimulation (VNS)|vagus nerve stimulation (vns)
5372622|NCT01846715|Kidney disease|kidney disease
5372623|NCT01846715|Renal insufficiency|renal insufficiency
5372624|NCT01846715|CKD|ckd
5372625|NCT01846715|Autologous cell therapy|autologous cell therapy
5372626|NCT01846676|Hearing loss, rehabilitation programs, adherence to hearing aids.|hearing loss, rehabilitation programs, adherence to hearing aids.
5372627|NCT01846663|Hepatic Encephalopathy|hepatic encephalopathy
5372628|NCT01846663|Liver Failure|liver failure
5372629|NCT01846663|Hepatic Insufficiency|hepatic insufficiency
5372630|NCT01846663|Liver Diseases|liver diseases
5372631|NCT01846663|Brain Diseases|brain diseases
5372632|NCT01846663|Rifaximin|rifaximin
5372633|NCT01846663|Cirrhosis|cirrhosis
5372634|NCT01846611|Ovarian neoplasms|ovarian neoplasms
5372635|NCT01846611|Peritoneal neoplasms|peritoneal neoplasms
5372636|NCT01846611|Fallopian tube neoplasms|fallopian tube neoplasms
5372637|NCT01846611|Advanced-relapsed epithelial ovarian cancer|advanced-relapsed epithelial ovarian cancer
5372638|NCT01846611|Advanced-relapsed primary peritoneal cancer|advanced-relapsed primary peritoneal cancer
5372639|NCT01846611|Advanced-relapsed fallopian tube cancer|advanced-relapsed fallopian tube cancer
5372640|NCT01846611|Trabectedin|trabectedin
5372641|NCT01846611|Yondelis|yondelis
5372642|NCT01846611|Doxil|doxil
5372643|NCT01846611|Caelyx|caelyx
5372644|NCT01846611|Platinum sensitive|platinum sensitive
5372645|NCT01846611|Tthird-line|tthird-line
5372646|NCT01846611|BRCA|brca
5372647|NCT01846611|Patient related outcome|patient related outcome
5372648|NCT01846572|Stroke|stroke
5372649|NCT01846572|Clopidogrel|clopidogrel
5372650|NCT01846572|Aggregometry|aggregometry
5372651|NCT01846572|Antiplatelet therapy|antiplatelet therapy
5372652|NCT01846572|Platelet function tests|platelet function tests
5372653|NCT01846559|Immune system processes|immune system processes
5372654|NCT01846546|Traumatic brain injury;|traumatic brain injury;
5372655|NCT01846546|Endostatin/collagen XVIII;|endostatin/collagen xviii;
5372656|NCT01846546|Cerebrospinal fluid;|cerebrospinal fluid;
5372657|NCT01846546|Prognosis|prognosis
5372658|NCT01846507|Heavy Menstrual Bleeding|heavy menstrual bleeding
5372659|NCT01846507|HMB|hmb
5372660|NCT01846507|Lysteda|lysteda
5372661|NCT01846481|Cocaine|cocaine
5372662|NCT01846468|Healthy volunteers and patients,|healthy volunteers and patients,
5372663|NCT01846468|renal insufficiency,|renal insufficiency,
5372664|NCT01846455|Hepatic|hepatic
5368144|NCT01865565|GIST|gist
5372665|NCT01846455|Hepatitis C Virus|hepatitis c virus
5372667|NCT01846455|Buprenorphine|buprenorphine
5372668|NCT01846455|Naloxone|naloxone
5372669|NCT01846442|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
5372670|NCT01846442|Atrophic Vaginitis|atrophic vaginitis
5372671|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone
5372672|NCT01846442|DHEA|dhea
5372673|NCT01846442|Prasterone|prasterone
5372674|NCT01846442|Vaginorm|vaginorm
5372677|NCT01846429|cancer|cancer
5372678|NCT01846429|pain fibers|pain fibers
5372679|NCT01846429|acid levels|acid levels
5372680|NCT01846429|tumor related pain|tumor related pain
5372681|NCT01846429|cancer related pain|cancer related pain
5372682|NCT01846429|sodium bicarbonate|sodium bicarbonate
5372683|NCT01846429|pain reliever|pain reliever
5372684|NCT01846429|metastatic|metastatic
5372685|NCT01846429|unresectable|unresectable
5372686|NCT01846429|solid malignancy|solid malignancy
5372687|NCT01846429|hematologic malignancy|hematologic malignancy
5372688|NCT01846429|multiple myeloma|multiple myeloma
5372689|NCT01846429|lymphoma|lymphoma
5372690|NCT01846377|video game|video game
5372691|NCT01846377|diet|diet
5372692|NCT01846377|physical activity|physical activity
5372693|NCT01846377|sedentary behavior|sedentary behavior
5372694|NCT01846377|obesity|obesity
5372695|NCT01846377|diabetes|diabetes
5372696|NCT01846364|Thyroid|thyroid
5346423|NCT01965990|weight loss|weight loss
5360276|NCT01901107|ASP1585|asp1585
5372697|NCT01846364|DIM|dim
5372698|NCT01846351|choroidal neovascularization|choroidal neovascularization
5372699|NCT01846351|epiretinal membrane|epiretinal membrane
5372700|NCT01846351|anti-VEGF|anti-vegf
5372701|NCT01846338|acne, EGCG, green tea|acne, egcg, green tea
5372702|NCT01846299|Vision Impairment|vision impairment
5372703|NCT01846286|Neuropathic Pain|neuropathic pain
5372704|NCT01846286|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
5372705|NCT01846286|acute pain|acute pain
5372706|NCT01846286|pain management|pain management
5372707|NCT01846286|genome-wide analyses|genome-wide analyses
5372708|NCT01846286|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5372709|NCT01846286|chronic pain|chronic pain
5372710|NCT01846286|neuropathic|neuropathic
5372711|NCT01846286|locoregional squamous cell carcinoma of the head and neck|locoregional squamous cell carcinoma of the head and neck
5372712|NCT01846273|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5372713|NCT01846273|Visual acuity|visual acuity
5372714|NCT01846273|Ranibizumab|ranibizumab
5372715|NCT01846273|Verteporfin PDT|verteporfin pdt
5372717|NCT01846234|Multiple Sclerosis|multiple sclerosis
5372719|NCT01846221|Analgesia|analgesia
5372720|NCT01846221|Epidural|epidural
5372721|NCT01846221|Pregnancy|pregnancy
5372722|NCT01846221|Labor|labor
5372723|NCT01846221|Clonidine|clonidine
5372724|NCT01846221|Fentanyl|fentanyl
5372725|NCT01846221|Bupivacaine|bupivacaine
5372726|NCT01846221|Childbirth|childbirth
5372727|NCT01846208|Egg Allergy|egg allergy
5372728|NCT01846208|Egg Oral Immunotherapy|egg oral immunotherapy
5372729|NCT01846208|Food Allergy|food allergy
5372730|NCT01846195|blood loss|blood loss
5372731|NCT01846182|Gulf War Illness|gulf war illness
5372732|NCT01846182|Pregabalin|pregabalin
5372733|NCT01846182|Duloxetine|duloxetine
5372734|NCT01846182|Gulf War Veterans|gulf war veterans
5372735|NCT01846182|Cymbalta|cymbalta
5372736|NCT01846182|Lyrica|lyrica
5372737|NCT01846169|food insecurity|food insecurity
5372738|NCT01846169|older adults|older adults
5372739|NCT01846169|nutrition|nutrition
5372740|NCT01846169|food deliveries|food deliveries
5372741|NCT01846156|convulsion rate|convulsion rate
5372742|NCT01846130|Bed rest,|bed rest,
5372743|NCT01846117|lignans|lignans
5372744|NCT01846117|oxidative stress|oxidative stress
5372745|NCT01846117|inflammation|inflammation
5372746|NCT01846117|aging|aging
5372747|NCT01846117|muscle weakness|muscle weakness
5372748|NCT01846117|pain|pain
5372749|NCT01846052|achromatopsia, CNGB3|achromatopsia, cngb3
5372750|NCT01846013|Sit-Stand Workstations|sit-stand workstations
5372751|NCT01846013|Increase Workplace Physical Activity|increase workplace physical activity
5372752|NCT01846000|temporomandibular joint|temporomandibular joint
5372753|NCT01846000|temporomandibular disorder|temporomandibular disorder
5372754|NCT01846000|electromyography|electromyography
5372755|NCT01846000|low-level laser therapy|low-level laser therapy
5372756|NCT01845987|Palmoplantaris Pustulosis|palmoplantaris pustulosis
5372757|NCT01845987|CNTO 1959|cnto 1959
5372758|NCT01845987|Psoriasis|psoriasis
5372759|NCT01845987|Anti-IL 23 Monoclonal Antibody|anti-il 23 monoclonal antibody
5372760|NCT01845974|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5372761|NCT01845974|Atrial Fibrillation|atrial fibrillation
5372762|NCT01845948|parents|parents
5372763|NCT01845948|school transition|school transition
5372764|NCT01845948|parental-child relationship|parental-child relationship
5372765|NCT01845935|Cryoablation|cryoablation
5372766|NCT01845935|Venous vascular malformation|venous vascular malformation
5372767|NCT01845935|MRI|mri
5372768|NCT01845935|safety|safety
5372769|NCT01845935|pain|pain
5368240|NCT01865071|rectal cancer|rectal cancer
5372770|NCT01845922|Refeeding Syndrome|refeeding syndrome
5372771|NCT01845922|low sodium|low sodium
5372772|NCT01845922|slowly absorbed carbohydrates|slowly absorbed carbohydrates
5372773|NCT01845922|hypopotassemia|hypopotassemia
5372774|NCT01845922|hypophosphatemia|hypophosphatemia
5372775|NCT01845909|Sudden cardiac death|sudden cardiac death
5372776|NCT01845909|Young adults|young adults
5372777|NCT01845909|Cardiac Disease|cardiac disease
5372778|NCT01845909|Arrhythmia|arrhythmia
5372779|NCT01845909|Sports|sports
5372780|NCT01845896|high intensity interval training|high intensity interval training
5372781|NCT01845896|combined training|combined training
5372782|NCT01845896|insulin resistance|insulin resistance
5372783|NCT01845896|muscle contractile properties|muscle contractile properties
5372784|NCT01845857|Long term health problems|long term health problems
5372785|NCT01845857|chronic disease|chronic disease
5372786|NCT01845831|Diabetes|diabetes
5372787|NCT01845831|DPP4 inhibitors|dpp4 inhibitors
5372788|NCT01845831|Sitagliptin|sitagliptin
5372789|NCT01845831|Glargine|glargine
5372790|NCT01845831|RCT|rct
5372791|NCT01845831|basal insulin|basal insulin
5372792|NCT01845831|hospital hyperglycemia|hospital hyperglycemia
5372793|NCT01845831|inpatient diabetes|inpatient diabetes
5346525|NCT01965405|HIV|hiv
5372794|NCT01845818|work productivity|work productivity
5372795|NCT01845818|multicenter study|multicenter study
5372796|NCT01845792|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
5372797|NCT01845766|sepsis, septic shock, rehabilitation, exercise|sepsis, septic shock, rehabilitation, exercise
5372798|NCT01845740|systemic lupus erythematoses|systemic lupus erythematoses
5372799|NCT01845740|lupus|lupus
5372800|NCT01845740|SLE|sle
5372801|NCT01845727|Cutaneous leishmaniasis|cutaneous leishmaniasis
5372802|NCT01845727|Topical treatment|topical treatment
5372803|NCT01845727|Colombia|colombia
5372804|NCT01845714|Keratoconus|keratoconus
5372805|NCT01845714|Corneal cross Linking|corneal cross linking
5372806|NCT01845714|Topo guided PRK|topo guided prk
5372807|NCT01845714|Quality of Life|quality of life
5372808|NCT01845701|malaria, cure rate, efficacy, safety|malaria, cure rate, efficacy, safety
5372809|NCT01845688|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5372810|NCT01845688|Traditional Chinese Medicine|traditional chinese medicine
5372811|NCT01845688|Randomized Control Trial|randomized control trial
5372812|NCT01845675|temozolomide|temozolomide
5372813|NCT01845675|endostatin|endostatin
5372814|NCT01845675|advanced|advanced
5372815|NCT01845675|well-differentiated|well-differentiated
5372816|NCT01845675|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5372817|NCT01845662|splenectomy|splenectomy
5372818|NCT01845662|embolization|embolization
5372819|NCT01845662|observation|observation
5372820|NCT01845662|blood transfusion|blood transfusion
5372821|NCT01845649|Vulvovaginal Atrophy|vulvovaginal atrophy
5372822|NCT01845649|Dyspareunia|dyspareunia
5372823|NCT01845649|Postmenopausal|postmenopausal
5372824|NCT01845636|Olfaction|olfaction
5372825|NCT01845636|Donepezil|donepezil
5372826|NCT01845636|Alzheimer's Disease|alzheimer's disease
5372827|NCT01845636|Mild Cognitive Impairment|mild cognitive impairment
5372828|NCT01845636|Memory|memory
5372829|NCT01845623|Asthma|asthma
5372830|NCT01845623|Indacaterol|indacaterol
5372831|NCT01845623|QAB149|qab149
5372832|NCT01845584|IVIG in Neuromyelitis Optica spectrum disorder|ivig in neuromyelitis optica spectrum disorder
5372833|NCT01845584|Patients with Neuromyelitis Optica spectrum disorder|patients with neuromyelitis optica spectrum disorder
5372834|NCT01845558|Muscle soreness|muscle soreness
5372835|NCT01845558|Exercise induced muscle damage|exercise induced muscle damage
5372836|NCT01845558|Inflammation|inflammation
5372837|NCT01845558|Proteolytic enzymes|proteolytic enzymes
5372838|NCT01845558|Muscle strength Dynamometer|muscle strength dynamometer
5372839|NCT01845545|microfinance|microfinance
5372840|NCT01845545|under five mortality|under five mortality
5372841|NCT01845545|underweight|underweight
5372842|NCT01845545|malnutrition|malnutrition
5372843|NCT01845506|wireless pressure sensor|wireless pressure sensor
5372844|NCT01845506|Elderly|elderly
5372845|NCT01845493|asthma|asthma
5372846|NCT01845493|Asthmatics|asthmatics
5372847|NCT01845493|allergic|allergic
5372848|NCT01845493|allergies|allergies
5372849|NCT01845480|health promotion|health promotion
5372850|NCT01845480|obesity prevention|obesity prevention
5372851|NCT01845480|Childhood obesity|childhood obesity
5372852|NCT01845480|home-based|home-based
5372853|NCT01845480|Lifestyle intervention|lifestyle intervention
5372854|NCT01845480|Body composition|body composition
5372855|NCT01845480|quality of life|quality of life
5372856|NCT01845480|physical activity|physical activity
5372857|NCT01845480|nutrition|nutrition
5372858|NCT01845467|Secretin MRCP, diagnosis, Autoimmune pancreatitis|secretin mrcp, diagnosis, autoimmune pancreatitis
5372859|NCT01845454|Barrett's Esophagus|barrett's esophagus
5372860|NCT01845454|Spray cryotherapy|spray cryotherapy
5372861|NCT01845441|Dexmedetomidine|dexmedetomidine
5372862|NCT01845441|Endovascular procedure|endovascular procedure
5372863|NCT01845441|Stroke|stroke
5372864|NCT01845441|Vasospasm, intracranial|vasospasm, intracranial
5372865|NCT01845441|Conscious sedation|conscious sedation
5372866|NCT01845428|nephrotic|nephrotic
5372867|NCT01845428|hyperlipidemia|hyperlipidemia
5372868|NCT01845428|oxLDL|oxldl
5372869|NCT01845428|kidney|kidney
5372870|NCT01845402|Kidney Failure, Chronic|kidney failure, chronic
5372871|NCT01845402|Adolescent|adolescent
5372872|NCT01845402|Heart Defects, Congenital|heart defects, congenital
5372873|NCT01845389|Anesthesia|anesthesia
5372874|NCT01845389|Regional|regional
5372875|NCT01845389|Epidural|epidural
5372876|NCT01845389|Continuous spinal|continuous spinal
5372877|NCT01845389|Wiley Catheter|wiley catheter
5372878|NCT01845389|Geriatric|geriatric
5372880|NCT01845376|Inflammatory Markers after Inguinal Hernia Repair|inflammatory markers after inguinal hernia repair
5372881|NCT01845376|Anesthetic technique for hernia repair|anesthetic technique for hernia repair
5372882|NCT01845363|Obesity|obesity
5372883|NCT01845363|Bariatric surgery|bariatric surgery
5372884|NCT01845363|Cefazolin|cefazolin
5372885|NCT01845363|antimicrobial prophylaxis|antimicrobial prophylaxis
5372886|NCT01845363|administration and dosage|administration and dosage
5372887|NCT01845324|Pregnancy|pregnancy
5372888|NCT01845324|Diabetes Mellitus|diabetes mellitus
5467207|NCT01432002|FDG|fdg
5372889|NCT01845285|transcatheter valve replacement|transcatheter valve replacement
5372890|NCT01845285|aortic valve disease|aortic valve disease
5372891|NCT01845285|aortic stenosis|aortic stenosis
5372892|NCT01845285|Aortic regurgitation,catheter|aortic regurgitation,catheter
5372893|NCT01845285|Effective orifice area|effective orifice area
5372894|NCT01845246|Colistin|colistin
5372895|NCT01845246|Polymyxins|polymyxins
5372896|NCT01845246|Therapeutic drug monitoring|therapeutic drug monitoring
5372897|NCT01845246|Multi Drug resistant Gram negative bacterial infections|multi drug resistant gram negative bacterial infections
5372898|NCT01845220|Broccoli sprouts|broccoli sprouts
5372899|NCT01845220|alcohol sensitivity|alcohol sensitivity
5372900|NCT01845220|sulforaphane|sulforaphane
5372901|NCT01845220|alcohol metabolism|alcohol metabolism
5372902|NCT01845220|in the Asian Community|in the asian community
5372903|NCT01845207|Aortic stenosis|aortic stenosis
5372904|NCT01845207|Aortic valve replacement|aortic valve replacement
5372905|NCT01845207|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5372906|NCT01845207|Outcomes|outcomes
5372908|NCT01845207|Elderly|elderly
5372909|NCT01845194|pharmacokinetic|pharmacokinetic
5372910|NCT01845194|heritability|heritability
5372911|NCT01845194|drug membrane transport|drug membrane transport
5372912|NCT01845194|drug biotransformation|drug biotransformation
5372913|NCT01845181|Adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
5372914|NCT01845181|Asthma|asthma
5372915|NCT01845181|adenosine receptor modulator|adenosine receptor modulator
5372916|NCT01845181|COPD|copd
5372917|NCT01845168|Bleeding peptic ulcer|bleeding peptic ulcer
5372918|NCT01845168|NSAID and Aspirin|nsaid and aspirin
5372919|NCT01845168|Computer-alert|computer-alert
5372920|NCT01845168|General practitioner|general practitioner
5372921|NCT01845155|Tinnitus|tinnitus
5372922|NCT01845155|music therapy|music therapy
5372923|NCT01845155|directive counselling|directive counselling
5372924|NCT01845155|acoustic stimulation|acoustic stimulation
5372925|NCT01845155|group comparison|group comparison
5372926|NCT01845155|subjective evaluation|subjective evaluation
5372927|NCT01845155|pitch|pitch
5372928|NCT01845142|vitamin D|vitamin d
5372929|NCT01845142|vitamin D deficiency|vitamin d deficiency
5372930|NCT01845142|immune cells|immune cells
5372931|NCT01845142|pharmacokinetic|pharmacokinetic
5372932|NCT01845142|< 50 nmol/L 25(OH)D serum concentration|< 50 nmol/l 25(oh)d serum concentration
5372933|NCT01845116|PNALD|pnald
5372934|NCT01845116|Cholestasis|cholestasis
5372935|NCT01845116|Omegaven®|omegaven®
5372936|NCT01845116|Short Bowel Syndrome|short bowel syndrome
5372937|NCT01845103|ANGINA|angina
5372938|NCT01845103|Thoracoscopic|thoracoscopic
5372939|NCT01845064|type 2 diabetes|type 2 diabetes
5372940|NCT01845064|diabetes mellitus|diabetes mellitus
5372941|NCT01845064|type 2 diabetes mellitus|type 2 diabetes mellitus
5372942|NCT01845064|HbA1c|hba1c
5372943|NCT01845064|blood glucose|blood glucose
5372944|NCT01845064|glucose control|glucose control
5372945|NCT01845064|DiaMedica|diamedica
5372946|NCT01845064|DM-199|dm-199
5372947|NCT01845064|DM199|dm199
5372948|NCT01845064|recombinant human tissue kallikrein-1|recombinant human tissue kallikrein-1
5372949|NCT01845064|tissue kallikrein-1|tissue kallikrein-1
5372950|NCT01845051|Migraine|migraine
5372951|NCT01845051|allergic rhinitis|allergic rhinitis
5372952|NCT01845051|Specific Immunoglobulin E (IgE)|specific immunoglobulin e (ige)
5372953|NCT01845051|nasal symptoms|nasal symptoms
5372954|NCT01845051|signs of allergy.|signs of allergy.
5372955|NCT01845025|Asthma|asthma
5372956|NCT01845025|formoterol fumarate|formoterol fumarate
5372957|NCT01845025|Foradil|foradil
5372958|NCT01845025|inhaled corticosteroid|inhaled corticosteroid
5372959|NCT01845025|fluticasone propionate|fluticasone propionate
5372960|NCT01845025|safety|safety
5372961|NCT01845012|Short daily hemodialysis|short daily hemodialysis
5372962|NCT01845012|Low dialysate flow|low dialysate flow
5372963|NCT01845012|End stage renal disease|end stage renal disease
5372964|NCT01844999|Prostate cancer|prostate cancer
5372965|NCT01844999|Decision|decision
5372966|NCT01844986|BRCA|brca
5372967|NCT01844986|Ovarian Cancer|ovarian cancer
5372968|NCT01844986|Chemotherapy|chemotherapy
5372969|NCT01844986|PARP inhibitor|parp inhibitor
5372970|NCT01844986|First Line|first line
5372971|NCT01844986|FIGO Stage III|figo stage iii
5372972|NCT01844986|FIGO Stage IV|figo stage iv
5372973|NCT01844960|Single Incision Surgery|single incision surgery
5372974|NCT01844960|SILS|sils
5372975|NCT01844960|Laparoscopic Gastric Band|laparoscopic gastric band
5372976|NCT01844960|Morbid Obesity|morbid obesity
5372977|NCT01844960|Bariatric Surgery|bariatric surgery
5372978|NCT01844934|Knee Arthroplasty|knee arthroplasty
5372979|NCT01844934|Knee Replacement|knee replacement
5372980|NCT01844934|Prehabilitation|prehabilitation
5372981|NCT01844882|The effects|the effects
5372982|NCT01844882|dietary|dietary
5372983|NCT01844882|fiber|fiber
5372984|NCT01844882|kidney function|kidney function
5372985|NCT01844882|CKD patients|ckd patients
5372986|NCT01844869|omacetaxine|omacetaxine
5372987|NCT01844869|omacetaxine mepesuccinate|omacetaxine mepesuccinate
5372988|NCT01844869|pharmacokinetics|pharmacokinetics
5372989|NCT01844869|hematologic malignancies|hematologic malignancies
5372990|NCT01844869|advanced solid tumors|advanced solid tumors
5372991|NCT01844843|Drug eluting stents|drug eluting stents
5372992|NCT01844843|coronary artery disease|coronary artery disease
5372993|NCT01844843|Percutaneous Coronary Intervention|percutaneous coronary intervention
5372994|NCT01844843|Tomography, Optical Coherence|tomography, optical coherence
5372995|NCT01844830|operative|operative
5372996|NCT01844830|dental procedure|dental procedure
5372997|NCT01844817|untreated|untreated
5372998|NCT01844817|metastatic|metastatic
5372999|NCT01844817|OGX-427|ogx-427
5373000|NCT01844804|Bioequivalence|bioequivalence
5373001|NCT01844804|Biosimilarity|biosimilarity
5373002|NCT01844804|Similarity|similarity
5373004|NCT01844804|Phase 1|phase 1
5373005|NCT01844804|Infliximab|infliximab
5373006|NCT01844804|Healthy Volunteers|healthy volunteers
5376718|NCT01827722|RVO|rvo
5373007|NCT01844804|Single-dose|single-dose
5373008|NCT01844804|Immunology|immunology
5373009|NCT01844791|Non-small cell lung cancer|non-small cell lung cancer
5373010|NCT01844791|OCZ103-OS|ocz103-os
5373011|NCT01844791|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
5373012|NCT01844791|platinum-gemcitabine based doublet first line therapy|platinum-gemcitabine based doublet first line therapy
5373136|NCT01844284|Coronary Artery Disease|coronary artery disease
5373013|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI,|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi,
5373014|NCT01844778|colistimethate|colistimethate
5373015|NCT01844778|Cystic Fibrosis, Pseudomonas aeruginosa, FEV1, tobramycin inhalation powder, TOBI, colistimethate|cystic fibrosis, pseudomonas aeruginosa, fev1, tobramycin inhalation powder, tobi, colistimethate
5373017|NCT01844765|nilotinib treatment|nilotinib treatment
5373018|NCT01844765|chronic phase|chronic phase
5373019|NCT01844765|Ph+ CML|ph+ cml
5373020|NCT01844765|accelerated phase|accelerated phase
5373021|NCT01844765|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
5373022|NCT01844765|pediatric|pediatric
5373023|NCT01844765|24 month treatment|24 month treatment
5373024|NCT01844752|acne|acne
5373025|NCT01844739|Propionibacterium acnes|propionibacterium acnes
5373026|NCT01844739|acne|acne
5373027|NCT01844726|healthy individuals|healthy individuals
5373028|NCT01844726|schizophrenia|schizophrenia
5373029|NCT01844726|schizoaffective disorder|schizoaffective disorder
5373030|NCT01844726|learning|learning
5373031|NCT01844726|memory|memory
5373032|NCT01844726|cognitive enhancement|cognitive enhancement
5373033|NCT01844726|fMRI|fmri
5373034|NCT01844713|Kidney transplant|kidney transplant
5373035|NCT01844713|Renal transplant|renal transplant
5373036|NCT01844713|Sun protection|sun protection
5373037|NCT01844713|Skin cancer|skin cancer
5373038|NCT01844700|MC4R genotype|mc4r genotype
5373039|NCT01844700|antipsychotic induced weight gain|antipsychotic induced weight gain
5373040|NCT01844700|pediatric population|pediatric population
5373041|NCT01844687|reinforcement, good drug effect, high, mood, cannabidiol|reinforcement, good drug effect, high, mood, cannabidiol
5373042|NCT01844661|Mesenchymal stem cells|mesenchymal stem cells
5373043|NCT01844661|Oncolytic adenovirus|oncolytic adenovirus
5373044|NCT01844648|Parkinson's disease|parkinson's disease
5373045|NCT01844648|Sialorrhea|sialorrhea
5373046|NCT01844648|Tropicamide|tropicamide
5373047|NCT01844648|Non-motor symptoms|non-motor symptoms
5373048|NCT01844648|Thin strip delivery|thin strip delivery
5373049|NCT01844622|Digestive System Diseases Disease|digestive system diseases disease
5373050|NCT01844609|Comprehension|comprehension
5373051|NCT01844609|Verbal Learning|verbal learning
5373052|NCT01844609|Writing|writing
5373053|NCT01844609|Testing|testing
5373054|NCT01844596|linkage to care|linkage to care
5373055|NCT01844596|hypertension management|hypertension management
5373056|NCT01844596|behavioral science|behavioral science
5373057|NCT01844596|cardiovascular health|cardiovascular health
5373058|NCT01844596|global health|global health
5373059|NCT01844596|multi-disciplinary implementation research approach|multi-disciplinary implementation research approach
5373060|NCT01844596|linking and retaining|linking and retaining
5373061|NCT01844596|community health workers|community health workers
5373063|NCT01844596|behavioral communication strategy|behavioral communication strategy
5373064|NCT01844596|smartphone-based tool|smartphone-based tool
5373065|NCT01844596|electronic health record|electronic health record
5373066|NCT01844596|retention to care|retention to care
5373067|NCT01844557|Head And Neck Cancer|head and neck cancer
5373068|NCT01844557|Nasopharyngeal cancer|nasopharyngeal cancer
5373069|NCT01844557|Oropharyngeal cancer|oropharyngeal cancer
5373070|NCT01844557|Hypopharyngeal cancer|hypopharyngeal cancer
5373071|NCT01844557|Laryngeal cancer|laryngeal cancer
5373072|NCT01844557|Primary cancer with cervical metastases|primary cancer with cervical metastases
5373073|NCT01844557|Swallowing exercises|swallowing exercises
5373074|NCT01844557|Videotape|videotape
5373075|NCT01844557|Videocamera|videocamera
5373076|NCT01844557|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5346831|NCT01964131|safety|safety
5360695|NCT01899170|PET-imaging|pet-imaging
5373077|NCT01844557|Questionnaires|questionnaires
5373079|NCT01844544|drug related problems|drug related problems
5373080|NCT01844544|clinical pharmacist|clinical pharmacist
5373081|NCT01844544|femoral neck fractures|femoral neck fractures
5373082|NCT01844544|orthopedic patients|orthopedic patients
5373083|NCT01844492|decision making for incapacitated patients|decision making for incapacitated patients
5373084|NCT01844492|intensive care|intensive care
5373085|NCT01844492|surrogate decision making|surrogate decision making
5373086|NCT01844492|patient centered care|patient centered care
5373087|NCT01844492|Palliative Care|palliative care
5373088|NCT01844492|End of Life|end of life
5373089|NCT01844492|Quality of Communication|quality of communication
5373090|NCT01844479|diabetic foot ulcer|diabetic foot ulcer
5373091|NCT01844479|diabetic foot|diabetic foot
5373092|NCT01844466|course of motor and visual rehabilitation|course of motor and visual rehabilitation
5373093|NCT01844466|improvement of deficits|improvement of deficits
5373094|NCT01844466|stroke patients|stroke patients
5373095|NCT01844453|Subfertility|subfertility
5423323|NCT01616199|Advanced melanoma|advanced melanoma
5373096|NCT01844453|Recurrent Implantation Failure|recurrent implantation failure
5373098|NCT01844440|tLESR|tlesr
5373099|NCT01844440|impedance|impedance
5373100|NCT01844440|manometry|manometry
5373101|NCT01844427|ADHD|adhd
5373102|NCT01844427|Executive function deficits|executive function deficits
5373103|NCT01844427|Psychiatry|psychiatry
5373104|NCT01844427|Psychopharmacology|psychopharmacology
5373105|NCT01844427|Namenda|namenda
5373106|NCT01844414|Homeless Men|homeless men
5373107|NCT01844414|Parolees|parolees
5373108|NCT01844414|Hepatitis B|hepatitis b
5373109|NCT01844414|Hepatitis C|hepatitis c
5373111|NCT01844414|Community Drug Treatment|community drug treatment
5373112|NCT01844414|Recidivism|recidivism
5373113|NCT01844401|persistent asthma|persistent asthma
5373114|NCT01844401|Albuterol Spiromax®|albuterol spiromax®
5373115|NCT01844401|ProAir® HFA|proair® hfa
5373116|NCT01844401|Pediatric Patients|pediatric patients
5373117|NCT01844401|Phase 1|phase 1
5373118|NCT01844375|oral carbohydrate loading|oral carbohydrate loading
5373119|NCT01844375|walking capacity|walking capacity
5373120|NCT01844362|uterus|uterus
5373121|NCT01844362|transplantation|transplantation
5373122|NCT01844362|infertility|infertility
5373123|NCT01844349|North Africa|north africa
5373124|NCT01844349|Urban women|urban women
5373125|NCT01844349|Double burden of malnutrition|double burden of malnutrition
5373126|NCT01844349|Iron depletion|iron depletion
5373127|NCT01844349|Overweight/obesity|overweight/obesity
5373128|NCT01844349|Metabolic syndrome|metabolic syndrome
5373129|NCT01844349|Abdominal obesity|abdominal obesity
5373130|NCT01844349|Excess body fat|excess body fat
5373131|NCT01844284|Absorb™ BVS|absorb™ bvs
5373132|NCT01844284|Angioplasty|angioplasty
5373133|NCT01844284|Bioabsorbable|bioabsorbable
5373134|NCT01844284|Bioreabsorbable|bioreabsorbable
5373135|NCT01844284|BVS|bvs
5373137|NCT01844284|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5373138|NCT01844284|Coronary artery restenosis|coronary artery restenosis
5373139|NCT01844284|Coronary artery stenosis|coronary artery stenosis
5373140|NCT01844284|Coronary scaffold|coronary scaffold
5373141|NCT01844284|Coronary Stent|coronary stent
5373142|NCT01844284|Drug eluting stents|drug eluting stents
5373143|NCT01844284|Everolimus|everolimus
5373144|NCT01844284|Myocardial ischemia|myocardial ischemia
5373145|NCT01844284|Stent thrombosis|stent thrombosis
5373146|NCT01844284|Stents|stents
5373147|NCT01844271|LLLT|lllt
5373148|NCT01844271|muscle fatigue and recovery|muscle fatigue and recovery
5373149|NCT01844271|phototherapy parameter|phototherapy parameter
5373150|NCT01844258|pediatric cataract|pediatric cataract
5373151|NCT01844258|lens regeneration|lens regeneration
5373152|NCT01844258|endogenous lens epithelial stem cells|endogenous lens epithelial stem cells
5373153|NCT01844258|visual axis opacification|visual axis opacification
5373154|NCT01844258|visual function|visual function
5373155|NCT01844245|Cholangiocarcinoma|cholangiocarcinoma
5373156|NCT01844245|Ampullary carcinoma|ampullary carcinoma
5373157|NCT01844245|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5373158|NCT01844245|Radiofrequency ablation|radiofrequency ablation
5373159|NCT01844232|Multiple sclerosis|multiple sclerosis
5373161|NCT01844232|arbaclofen|arbaclofen
5373162|NCT01844219|aortic surgery|aortic surgery
5373163|NCT01844219|acute kidney injury|acute kidney injury
5373164|NCT01844219|gray zone approach|gray zone approach
5373165|NCT01844206|Post-cesarean analgesia|post-cesarean analgesia
5373166|NCT01844206|Second dose of epidural morphine after surgery|second dose of epidural morphine after surgery
5373167|NCT01844206|Post-operative analgesia|post-operative analgesia
5373168|NCT01844206|Self-administered epidural morphine|self-administered epidural morphine
5373169|NCT01844206|Pain management after cesarean|pain management after cesarean
5373170|NCT01844180|Irritable Bowel Syndrome|irritable bowel syndrome
5373172|NCT01844180|ONO-2952|ono-2952
5373173|NCT01844167|noxipoint|noxipoint
5373174|NCT01844167|physical therapy|physical therapy
5373175|NCT01844167|cervical pain|cervical pain
5373176|NCT01844167|trigger point|trigger point
5373177|NCT01844167|neck pain|neck pain
5373178|NCT01844167|TENS|tens
5373179|NCT01844167|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5373180|NCT01844141|phenol|phenol
5373181|NCT01844141|ingrown toenail|ingrown toenail
5373182|NCT01844141|chemical matricectomy|chemical matricectomy
5373183|NCT01844128|MMA, AFC, Ovarian reserve|mma, afc, ovarian reserve
5373184|NCT01844115|Generalized Anxiety Disorder, GAD|generalized anxiety disorder, gad
5373185|NCT01844102|HIV Prevention, PrePex, voluntary medical circumcision, non-surgical,|hiv prevention, prepex, voluntary medical circumcision, non-surgical,
5373186|NCT01844102|medical device, wound healing, Zambia|medical device, wound healing, zambia
5373187|NCT01844089|Postpartum hemorrhage|postpartum hemorrhage
5373188|NCT01844089|Bakri Postpartum Balloon|bakri postpartum balloon
5373189|NCT01844076|advanced stage colorectal adenocarcinoma|advanced stage colorectal adenocarcinoma
5373190|NCT01844050|Chinese herbal medicine|chinese herbal medicine
5373191|NCT01844050|diabetes symptoms|diabetes symptoms
5373192|NCT01844011|fetal movement|fetal movement
5373194|NCT01843998|Early stage|early stage
5373195|NCT01843998|Stage 1A|stage 1a
5373196|NCT01843998|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5373197|NCT01843998|CTCL|ctcl
5373198|NCT01843985|Stage IV cancer|stage iv cancer
5373199|NCT01843985|Survival|survival
5373200|NCT01843959|adenovirus-36|adenovirus-36
5373201|NCT01843959|Emirati population|emirati population
5373203|NCT01843920|pneumatic retinopexy|pneumatic retinopexy
5373204|NCT01843920|topical|topical
5373205|NCT01843894|sever dry eye,keratoconjunctivitis sicca|sever dry eye,keratoconjunctivitis sicca
5373206|NCT01843881|Gastric Bypass|gastric bypass
5373207|NCT01843881|bariatric surgery|bariatric surgery
5373208|NCT01843881|carbohydrate metabolism|carbohydrate metabolism
5373209|NCT01843868|Lymphoma|lymphoma
5373210|NCT01843868|Non-Hodgkin|non-hodgkin
5373211|NCT01843868|Emesis|emesis
5373212|NCT01843868|Chemotherapy|chemotherapy
5373213|NCT01843868|Nausea|nausea
5373214|NCT01843868|Vomiting|vomiting
5373215|NCT01843868|Aprepitant|aprepitant
5373216|NCT01843855|Gastric Bypass|gastric bypass
5373217|NCT01843855|bariatric surgery|bariatric surgery
5373218|NCT01843855|glucose metabolism|glucose metabolism
5373219|NCT01843829|Oesophageal cancer|oesophageal cancer
5373220|NCT01843816|Tragus-to-wall distance|tragus-to-wall distance
5373221|NCT01843816|obesity|obesity
5373222|NCT01843816|body shape|body shape
5373223|NCT01843816|height|height
5373224|NCT01843816|weight|weight
5373225|NCT01843803|patient centered care|patient centered care
5373226|NCT01843803|collaborative decision making|collaborative decision making
5373227|NCT01843803|cost impact|cost impact
5373228|NCT01843777|hearing loss|hearing loss
5373229|NCT01843777|hearing aids|hearing aids
5373230|NCT01843777|motivational interviewing|motivational interviewing
5373231|NCT01843777|counseling|counseling
5373232|NCT01843777|rehabilitation|rehabilitation
5373233|NCT01843764|RDT|rdt
5373234|NCT01843764|malaria|malaria
5373235|NCT01843764|treatment follow up|treatment follow up
5373236|NCT01843764|diagnosis|diagnosis
5373237|NCT01843725|breast cancer|breast cancer
5373238|NCT01843725|digestive cancer|digestive cancer
5373239|NCT01843712|Caloric compensation|caloric compensation
5373240|NCT01843712|Eating in the absence of hunger|eating in the absence of hunger
5373241|NCT01843712|Children|children
5373242|NCT01843712|Parental feeding practices|parental feeding practices
5373243|NCT01843686|Acute 2nd and 3rd Degree Burns|acute 2nd and 3rd degree burns
5373244|NCT01843686|Autologous Platelet Rich Plasma (PRP)|autologous platelet rich plasma (prp)
5373245|NCT01843686|Skin Grafting|skin grafting
5373246|NCT01843686|Magellan® System|magellan® system
5373247|NCT01843686|Wounds|wounds
5373248|NCT01843673|Lip, Oral Cavity and Pharynx|lip, oral cavity and pharynx
5373249|NCT01843673|Larynx|larynx
5373250|NCT01843660|Low back pain|low back pain
5373251|NCT01843660|Shoulder pain|shoulder pain
5373252|NCT01843660|Neck pain|neck pain
5373253|NCT01843660|Tramadol hydrochloride|tramadol hydrochloride
5373254|NCT01843660|Paracetamol|paracetamol
5373255|NCT01843621|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
5373256|NCT01843608|Physical treatment|physical treatment
5368812|NCT01862744|MRI|mri
5373257|NCT01843608|Exercise prescription to breast cancer survival|exercise prescription to breast cancer survival
5373258|NCT01843608|Side cancer effect treatment|side cancer effect treatment
5373259|NCT01843582|Keyword: blind spot|keyword: blind spot
5373260|NCT01843569|In Vitro Maturation|in vitro maturation
5373262|NCT01843569|Natural cycle IVF|natural cycle ivf
5373263|NCT01843569|PCOS|pcos
5373360|NCT01843101|Imaging|imaging
5373264|NCT01843543|Functional MRI (fMRI)|functional mri (fmri)
5373265|NCT01843543|Resting state functional connectivity MRI (rs-fcMRI)|resting state functional connectivity mri (rs-fcmri)
5373266|NCT01843543|Diffusion Tensor Imaging (DTI)|diffusion tensor imaging (dti)
5373267|NCT01843517|Pain|pain
5373268|NCT01843517|Facilitation|facilitation
5373269|NCT01843517|Inhibition|inhibition
5373270|NCT01843517|Oxytocin|oxytocin
5467652|NCT01430481|RCT|rct
5373271|NCT01843517|Postpartum|postpartum
5373272|NCT01843504|platelet rich plasma|platelet rich plasma
5373273|NCT01843504|PRP|prp
5373274|NCT01843504|plasma|plasma
5373275|NCT01843504|plasma injection|plasma injection
5373276|NCT01843504|patellar tendinopathy|patellar tendinopathy
5373277|NCT01843504|patella tendon|patella tendon
5373278|NCT01843504|patella|patella
5373279|NCT01843504|ultrasound|ultrasound
5373280|NCT01843504|shear wave ultrasound|shear wave ultrasound
5373281|NCT01843504|tendinosis|tendinosis
5373282|NCT01843504|tendinopathy|tendinopathy
5373283|NCT01843504|tendinitis|tendinitis
5373284|NCT01843504|jumper's knee|jumper's knee
5373285|NCT01843478|women|women
5373286|NCT01843478|human immunodeficiency virus|human immunodeficiency virus
5373287|NCT01843478|cervical cancer screening|cervical cancer screening
5373288|NCT01843478|Pap testing|pap testing
5373289|NCT01843478|human papillomavirus|human papillomavirus
5373290|NCT01843465|atrial fibrillation|atrial fibrillation
5373291|NCT01843465|balloon cryoablation|balloon cryoablation
5373292|NCT01843465|pulmonary veins|pulmonary veins
5377003|NCT01826565|success|success
5373293|NCT01843439|Acute exacerbation|acute exacerbation
5373294|NCT01843439|Quality of life|quality of life
5373295|NCT01843439|Magnesium deficiency|magnesium deficiency
5373296|NCT01843439|Multidisciplinary intervention|multidisciplinary intervention
5373297|NCT01843426|Comorbidity|comorbidity
5373298|NCT01843413|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5373299|NCT01843400|Regorafenib|regorafenib
5373300|NCT01843400|Colorectal Neoplasms|colorectal neoplasms
5373301|NCT01843387|Diabetic nephropathy|diabetic nephropathy
5373302|NCT01843387|Chronic kidney disease|chronic kidney disease
5373303|NCT01843387|Metabolic disease|metabolic disease
5373304|NCT01843387|Diabetes mellitus, type 2|diabetes mellitus, type 2
5373305|NCT01843374|tremelimumab|tremelimumab
5373306|NCT01843374|pleural, peritoneal|pleural, peritoneal
5373307|NCT01843374|malignant mesothelioma|malignant mesothelioma
5373308|NCT01843374|CTLA-4|ctla-4
5373309|NCT01843361|Stroke|stroke
5373310|NCT01843361|Clopidogrel|clopidogrel
5373311|NCT01843361|Aggregometry|aggregometry
5373312|NCT01843361|Antiplatelet therapy|antiplatelet therapy
5373313|NCT01843361|Platelet function tests|platelet function tests
5373314|NCT01843348|Transplant|transplant
5373315|NCT01843348|Renal transplant|renal transplant
5373316|NCT01843348|Rejection,allograf|rejection,allograf
5373317|NCT01843348|Rejection|rejection
5373318|NCT01843348|Xenograft rejection|xenograft rejection
5373319|NCT01843348|Host vs graft disease|host vs graft disease
5373320|NCT01843348|Kidney Transplant|kidney transplant
5373321|NCT01843335|Cardiovascular Diagnostic Technique|cardiovascular diagnostic technique
5373322|NCT01843335|Ultrasound|ultrasound
5373323|NCT01843322|Image guided therapy|image guided therapy
5373324|NCT01843322|Endovascular procedures|endovascular procedures
5373325|NCT01843322|Angiography|angiography
5373326|NCT01843322|Vascular surgical procedures|vascular surgical procedures
5373327|NCT01843296|Spinal Anesthesia|spinal anesthesia
5373328|NCT01843296|Bupivacaine|bupivacaine
5373329|NCT01843296|Fentanyl|fentanyl
5373330|NCT01843296|Magnesium sulfate|magnesium sulfate
5373331|NCT01843296|Postoperative Pain|postoperative pain
5373332|NCT01843283|Mild Cognitive Impairment|mild cognitive impairment
5373333|NCT01843283|Family Caregivers|family caregivers
5373334|NCT01843283|Intervention studies|intervention studies
5373335|NCT01843270|general anesthesia|general anesthesia
5373336|NCT01843270|body weight|body weight
5373337|NCT01843270|laryngeal mask airway size|laryngeal mask airway size
5373338|NCT01843257|Alcohol intake after bariatric surgery|alcohol intake after bariatric surgery
5373339|NCT01843257|Alcohol and bariatric surgery|alcohol and bariatric surgery
5373340|NCT01843244|plethysmography|plethysmography
5373341|NCT01843231|g-Cath EZ Suture Anchor Delivery Catheter|g-cath ez suture anchor delivery catheter
5373342|NCT01843231|Weight Loss Intervention|weight loss intervention
5373343|NCT01843218|Localized rectal cancer in a male patient|localized rectal cancer in a male patient
5373344|NCT01843179|Newly diagnosed|newly diagnosed
5373345|NCT01843179|Complete Remission|complete remission
5373346|NCT01843166|Pessary|pessary
5373347|NCT01843166|Patient Satisfaction|patient satisfaction
5373348|NCT01843166|Estrogen Cream|estrogen cream
5373349|NCT01843153|pain score|pain score
5373350|NCT01843140|cancer|cancer
5373351|NCT01843140|fertility preservation|fertility preservation
5373352|NCT01843140|infertility|infertility
5373353|NCT01843140|pregnancy|pregnancy
5373354|NCT01843114|Retinal blood flow|retinal blood flow
5373355|NCT01843114|Retinal vessel diameter|retinal vessel diameter
5373356|NCT01843114|Fourier Domain Optical Coherence Tomography|fourier domain optical coherence tomography
5373357|NCT01843114|Retinal blood velocities|retinal blood velocities
5373358|NCT01843101|Optical Coherence Tomography|optical coherence tomography
5373359|NCT01843101|Cornea|cornea
5373361|NCT01843088|Pain|pain
5373362|NCT01843088|exercise|exercise
5373363|NCT01843088|muscle|muscle
5373364|NCT01843062|Selumetinib, Differentiated Thyroid Cancer , AZD6244|selumetinib, differentiated thyroid cancer , azd6244
5373365|NCT01843036|Child Abuse|child abuse
5373366|NCT01843036|Child Neglect|child neglect
5373367|NCT01843036|Child Emergency Medical Care Presentations|child emergency medical care presentations
5373368|NCT01843036|Child Well-Care Compliance|child well-care compliance
5373369|NCT01843036|Mother Well-Care Compliance|mother well-care compliance
5373370|NCT01843036|Mother Emergency Medical Care Presentations|mother emergency medical care presentations
5373371|NCT01843036|Mother Mental Health|mother mental health
5373372|NCT01843036|Family Connections to Community Resources|family connections to community resources
5373373|NCT01843036|Parent-Child Relationship Quality|parent-child relationship quality
5373374|NCT01843023|opioid dependence|opioid dependence
5373375|NCT01843010|NSAIDs|nsaids
5373376|NCT01843010|Hyperalgesia|hyperalgesia
5373377|NCT01843010|Postlaparoscopic shoulder pain|postlaparoscopic shoulder pain
5373378|NCT01842997|Flu|flu
5373379|NCT01842997|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
5373380|NCT01842997|Safety|safety
5373381|NCT01842997|pregnant women|pregnant women
5373382|NCT01842984|Loneliness|loneliness
5373383|NCT01842984|Social isolation|social isolation
5373384|NCT01842984|Depression|depression
5373385|NCT01842984|Older adults|older adults
5373386|NCT01842984|Social competence|social competence
5373387|NCT01842984|Social integration|social integration
5373388|NCT01842971|two stage hepatectomy|two stage hepatectomy
5373389|NCT01842971|liver metastasis|liver metastasis
5373390|NCT01842971|colorectal cancer|colorectal cancer
5373391|NCT01842958|Dental Implant|dental implant
5373392|NCT01842945|Procrastination|procrastination
5373393|NCT01842945|internet based cognitive behavior therapy|internet based cognitive behavior therapy
5373394|NCT01842945|randomized controlled trial|randomized controlled trial
5373395|NCT01842932|Colonoscopy|colonoscopy
5373396|NCT01842932|Anticholinergics|anticholinergics
5373397|NCT01842906|positive end expiratory pressure|positive end expiratory pressure
5373398|NCT01842906|acute mountain sickness|acute mountain sickness
5373399|NCT01842906|prevention|prevention
5373400|NCT01842906|high altitude|high altitude
5373401|NCT01842893|fentanyl|fentanyl
5373402|NCT01842893|breakthrough pain|breakthrough pain
5373403|NCT01842893|opioid treated cancer patients|opioid treated cancer patients
5373404|NCT01842880|MicroRNAs|micrornas
5373405|NCT01842880|Chagas disease|chagas disease
5373406|NCT01842880|Biomarkers|biomarkers
5373407|NCT01842867|Syndecan-4|syndecan-4
5373408|NCT01842867|Chagas disease|chagas disease
5373409|NCT01842867|Biomarkers|biomarkers
5373410|NCT01842854|Galectin-3|galectin-3
5373411|NCT01842854|Chagas disease|chagas disease
5373412|NCT01842854|Biomarkers|biomarkers
5373413|NCT01842789|Acessa|acessa
5373414|NCT01842789|Fibroids|fibroids
5373415|NCT01842789|Halt|halt
5373416|NCT01842789|Targeting Animation|targeting animation
5373417|NCT01842789|Image Overlay|image overlay
5373418|NCT01842789|Radiofrequency Ablation|radiofrequency ablation
5373419|NCT01842789|RFA|rfa
5373420|NCT01842763|Chronic daily headache|chronic daily headache
5373421|NCT01842763|treated by occipital nerves stimulation|treated by occipital nerves stimulation
5373422|NCT01842763|peripheral neuromodulation|peripheral neuromodulation
5373423|NCT01842763|occipital nerves|occipital nerves
5373424|NCT01842763|network|network
5373425|NCT01842763|database|database
5373426|NCT01842737|Low Back Pain|low back pain
5373427|NCT01842737|Chiropractic|chiropractic
5373428|NCT01842737|Spinal Manipulation|spinal manipulation
5373429|NCT01842737|Massage|massage
5373430|NCT01842698|Thoracotomy surgery|thoracotomy surgery
5373431|NCT01842698|Anesthesia|anesthesia
5373432|NCT01842698|Ultrasound-guided PVB|ultrasound-guided pvb
5373433|NCT01842698|Post-operative pain|post-operative pain
5373434|NCT01842685|Overactive Bladder|overactive bladder
5373435|NCT01842685|Bladder Distention|bladder distention
5373436|NCT01842672|pediatric non-hodgkins lymphoma|pediatric non-hodgkins lymphoma
5373437|NCT01842672|pediatric acute leukemia|pediatric acute leukemia
5373438|NCT01842672|clofarabine|clofarabine
5373439|NCT01842672|mitoxantrone|mitoxantrone
5373440|NCT01842659|MI|mi
5373441|NCT01842659|amniocentesis|amniocentesis
5373442|NCT01842659|cord blood|cord blood
5373443|NCT01842659|placenta|placenta
5373444|NCT01842659|Silver Russell Syndrome|silver russell syndrome
5373445|NCT01842659|Beckwith Wiedemann Syndrome|beckwith wiedemann syndrome
5373446|NCT01842646|Leukemia|leukemia
5373447|NCT01842646|Myeloid Malignancies|myeloid malignancies
5373448|NCT01842620|Metformin|metformin
5373449|NCT01842620|Bioequivalence|bioequivalence
5373451|NCT01842607|mepolizumab|mepolizumab
5373452|NCT01842607|SB-240563|sb-240563
5373453|NCT01842607|safety|safety
5373454|NCT01842607|extension study|extension study
5373455|NCT01842607|Severe refractory asthma|severe refractory asthma
5373456|NCT01842594|Sarcoma, Hydroxychloroquine, Sirolimus, PET|sarcoma, hydroxychloroquine, sirolimus, pet
5373457|NCT01842581|Liver Failure|liver failure
5373458|NCT01842581|Hepatic Insufficiency|hepatic insufficiency
5373459|NCT01842581|Liver Diseases|liver diseases
5373470|NCT01842555|Photodynamic therapy|photodynamic therapy
5373471|NCT01842542|Postpartum Depression, NeuroStar TMS Therapy, TMS|postpartum depression, neurostar tms therapy, tms
5373472|NCT01842503|alcohol dependence|alcohol dependence
5373473|NCT01842503|cue reactivity|cue reactivity
5373474|NCT01842503|alcohol self administration|alcohol self administration
5373475|NCT01842490|Biomarker|biomarker
5373476|NCT01842490|Carotid enhanced ultrasound|carotid enhanced ultrasound
5373477|NCT01842490|Intraplaque neovascularization|intraplaque neovascularization
5373478|NCT01842438|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
5373479|NCT01842425|Liver volume|liver volume
5373480|NCT01842425|Gastric bypass|gastric bypass
5373481|NCT01842425|Magnetic resonance imaging|magnetic resonance imaging
5373482|NCT01842412|Mitochondria, Muscle|mitochondria, muscle
5373483|NCT01842412|Exercise|exercise
5373489|NCT01842386|Pulmonary Alveolar Proteinosis|pulmonary alveolar proteinosis
5373490|NCT01842386|Autoantibodies|autoantibodies
5373491|NCT01842386|Mucocutaneous Candidiasis|mucocutaneous candidiasis
5373492|NCT01842386|Anti-Granuloctye|anti-granuloctye
5373493|NCT01842386|Macrophage|macrophage
5373494|NCT01842373|topical anesthetics|topical anesthetics
5373495|NCT01842373|laser resurfacing|laser resurfacing
5373496|NCT01842360|Vaccine|vaccine
5373497|NCT01842360|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5373498|NCT01842334|Nicotine Dependence|nicotine dependence
5373499|NCT01842334|Smoking Cessation|smoking cessation
5373500|NCT01842334|D-cycloserine|d-cycloserine
5373508|NCT01842295|Bariatric surgery|bariatric surgery
5373509|NCT01842295|Sperm quality|sperm quality
5373510|NCT01842295|Fertility|fertility
5373511|NCT01842282|diabetes mellitus type 2|diabetes mellitus type 2
5373512|NCT01842282|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5373513|NCT01842282|obesity|obesity
5373514|NCT01842282|amlexanox|amlexanox
5373515|NCT01842269|Mycophenolate Mofetil|mycophenolate mofetil
5373517|NCT01842256|Telminouveau|telminouveau
5373518|NCT01842256|Atorvastatin|atorvastatin
5373519|NCT01842256|Pharmacokinetic|pharmacokinetic
5373520|NCT01842256|Healthy volunteers|healthy volunteers
5373521|NCT01842243|Ventricular dysfunction|ventricular dysfunction
5373523|NCT01842243|Echocardiography|echocardiography
5373524|NCT01842243|Pacemakers|pacemakers
5373525|NCT01842230|Telminuvo|telminuvo
5373526|NCT01842230|Telmisartan|telmisartan
5373527|NCT01842230|S-amlodipine|s-amlodipine
5373528|NCT01842230|Atorvastatin|atorvastatin
5373529|NCT01842230|pharmacokinetics|pharmacokinetics
5373530|NCT01842230|Healthy volunteers|healthy volunteers
5373531|NCT01842217|18F-FES PET|18f-fes pet
5373532|NCT01842217|Nuclear Medicine|nuclear medicine
5373533|NCT01842217|Premenopausal|premenopausal
5373534|NCT01842217|Postmenopausal|postmenopausal
5373535|NCT01842217|Estrogen receptor|estrogen receptor
5373536|NCT01842217|Anxiety|anxiety
5373537|NCT01842217|Depression|depression
5373538|NCT01842217|Cognition|cognition
5373539|NCT01842204|inguinal hernia|inguinal hernia
5373540|NCT01842191|R-R MS|r-r ms
5373541|NCT01842165|Peptide Receptor Radionuclide Therapy (PRRT)|peptide receptor radionuclide therapy (prrt)
5373542|NCT01842165|Neuroendocrine Tumors|neuroendocrine tumors
5373543|NCT01842126|Sciatica|sciatica
5373544|NCT01842100|Induced abortion|induced abortion
5373545|NCT01842100|Postaboral pelvic inflammatory disease|postaboral pelvic inflammatory disease
5373546|NCT01842100|Sexually transmitted infections|sexually transmitted infections
5373547|NCT01842100|Universal antibiotic prophylaxis|universal antibiotic prophylaxis
5373548|NCT01842100|Screen-and-treat approach|screen-and-treat approach
5373549|NCT01842087|Chronic Kidney Disease|chronic kidney disease
5373550|NCT01842087|Fiber|fiber
5373552|NCT01842087|Serum Creatinine|serum creatinine
5373553|NCT01842087|Uremic Symptoms|uremic symptoms
5373554|NCT01842087|Quality of Life|quality of life
5373555|NCT01842074|bortezomib|bortezomib
5373556|NCT01842074|desensitization|desensitization
5373557|NCT01842074|living kidney transplantation|living kidney transplantation
5373558|NCT01842061|active living|active living
5373559|NCT01842061|retirement|retirement
5373560|NCT01842048|External-beam radiotherapy|external-beam radiotherapy
5373561|NCT01842048|Hyperthermia|hyperthermia
5373562|NCT01842035|Implantable cardiac defibrillator|implantable cardiac defibrillator
5373563|NCT01842035|regadenoson|regadenoson
5373564|NCT01842035|sudden cardiac death|sudden cardiac death
5373565|NCT01842035|heart rate response|heart rate response
5373566|NCT01842022|Glycemic load|glycemic load
5373567|NCT01842022|memory|memory
5373568|NCT01842022|mood|mood
5373569|NCT01842009|transcranial stimulation|transcranial stimulation
5373570|NCT01842009|direct current|direct current
5373571|NCT01841983|Total worker health|total worker health
5373572|NCT01841983|Sleep|sleep
5373573|NCT01841983|MSDs|msds
5373574|NCT01841983|Diet|diet
5373575|NCT01841983|Physical Activity|physical activity
5373576|NCT01841957|Bilateral Cataract|bilateral cataract
5373577|NCT01841957|Simultaneous Cataract Surgery|simultaneous cataract surgery
5373578|NCT01841957|ISBCS|isbcs
5373579|NCT01841944|Fatty Acids, Omega-3|fatty acids, omega-3
5373580|NCT01841944|Aged|aged
5373581|NCT01841944|Myocardial Infarction|myocardial infarction
5373582|NCT01841931|Opioids|opioids
5373583|NCT01841931|Dependence|dependence
5373584|NCT01841931|Buprenorphine|buprenorphine
5373585|NCT01841931|Pain|pain
5373586|NCT01841905|Alzheimer's Disease|alzheimer's disease
5373587|NCT01841905|Family History|family history
5373588|NCT01841905|Memory Concerns|memory concerns
5373589|NCT01841866|post operative sore throat|post operative sore throat
5373590|NCT01841866|laryngeal mask airway|laryngeal mask airway
5373591|NCT01841866|children|children
5373592|NCT01841853|Elderly|elderly
5373593|NCT01841853|Health promotion|health promotion
5373594|NCT01841853|Randomized controlled study|randomized controlled study
5373595|NCT01841853|Immigrant|immigrant
5373596|NCT01841853|Vulnerable population|vulnerable population
5373598|NCT01841853|KASAM|kasam
5373599|NCT01841853|Implementation|implementation
5373601|NCT01841840|Hemiparetic|hemiparetic
5373602|NCT01841840|Passive Vibration|passive vibration
5373603|NCT01841840|Arterial Stiffness|arterial stiffness
5373604|NCT01841840|Pulse Wave Velocity|pulse wave velocity
5373605|NCT01841840|Wave Reflection|wave reflection
5373606|NCT01841840|Body Composition|body composition
5373607|NCT01841840|Autonomic Function|autonomic function
5373608|NCT01841814|Lymphoma|lymphoma
5377313|NCT01825044|TBI|tbi
5373614|NCT01841775|Interferon α 2b|interferon α 2b
5373615|NCT01841775|Ribavirin|ribavirin
5373616|NCT01841775|Pharmacovigilance|pharmacovigilance
5373617|NCT01841762|PAH-SYMPACT|pah-sympact
5373618|NCT01841762|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5373619|NCT01841762|psychometric instrument|psychometric instrument
5373620|NCT01841749|Breast cancer|breast cancer
5373621|NCT01841710|Bitter Taste|bitter taste
5373622|NCT01841710|Pediatric Medications|pediatric medications
5373623|NCT01841697|Diabetes Mellitus|diabetes mellitus
5373624|NCT01841697|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5373625|NCT01841697|Glucose Metabolism Disorders|glucose metabolism disorders
5373626|NCT01841697|Metabolic Diseases|metabolic diseases
5373627|NCT01841697|Endocrine System Diseases|endocrine system diseases
5373628|NCT01841697|Glimepiride|glimepiride
5373629|NCT01841697|Metformin|metformin
5373630|NCT01841697|Hypoglycemic Agents|hypoglycemic agents
5373631|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs
5373632|NCT01841697|Pharmacologic Actions|pharmacologic actions
5373633|NCT01841684|HoFH|hofh
5373634|NCT01841671|Polio|polio
5373635|NCT01841671|IPV|ipv
5373636|NCT01841671|bOPV|bopv
5373637|NCT01841671|mOPV|mopv
5373638|NCT01841671|vaccination|vaccination
5373639|NCT01841658|Folate Status|folate status
5373640|NCT01841658|Folate Biomarkers|folate biomarkers
5373641|NCT01841645|CLA-enriched butter|cla-enriched butter
5373642|NCT01841645|CLA metabolism|cla metabolism
5373643|NCT01841645|inflammation|inflammation
5373644|NCT01841632|Liver transplantation|liver transplantation
5373645|NCT01841632|Allogeneic liver transplantation|allogeneic liver transplantation
5373646|NCT01841632|Solid organ transplantation|solid organ transplantation
5373647|NCT01841619|skin, lupus, intravenous immunoglobulin, ivig|skin, lupus, intravenous immunoglobulin, ivig
5373648|NCT01841606|Spinal anesthesia|spinal anesthesia
5373649|NCT01841606|Elective cesarean deliveries|elective cesarean deliveries
5373650|NCT01841606|Ondansetron|ondansetron
5373651|NCT01841580|Tear proteins profiles|tear proteins profiles
5373652|NCT01841580|Longitudinal|longitudinal
5373653|NCT01841580|Ocular surface damage|ocular surface damage
5373654|NCT01841580|Trabeculectomy|trabeculectomy
5373655|NCT01841567|hip|hip
5373656|NCT01841567|knee|knee
5373657|NCT01841554|Mitral Valve|mitral valve
5373658|NCT01841554|Annuloplasty|annuloplasty
5373659|NCT01841541|Tuberculosis|tuberculosis
5373660|NCT01841541|Informal providers|informal providers
5373661|NCT01841541|Informal carers|informal carers
5373662|NCT01841541|Barriers to health system|barriers to health system
5373663|NCT01841528|Polycystic Ovary Syndrome|polycystic ovary syndrome
5373664|NCT01841528|Infertility|infertility
5373665|NCT01841528|In-vitro fertilization|in-vitro fertilization
5373666|NCT01841528|fresh embryo transfer|fresh embryo transfer
5373667|NCT01841528|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5373668|NCT01841502|telaprevir|telaprevir
5373669|NCT01841502|paroxetine|paroxetine
5373670|NCT01841502|interaction|interaction
5373671|NCT01841502|pharmacokinetics|pharmacokinetics
5373672|NCT01841489|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5373673|NCT01841489|CLL|cll
5373674|NCT01841476|Peripheral blood|peripheral blood
5373675|NCT01841476|HSC|hsc
5369172|NCT01861002|AML|aml
5373677|NCT01841476|CXCR4|cxcr4
5373678|NCT01841476|volunteers|volunteers
5373679|NCT01841463|Malignant Melanoma|malignant melanoma
5373680|NCT01841450|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
5373681|NCT01841450|Trabecular meshwork|trabecular meshwork
5373682|NCT01841450|iStent|istent
5373683|NCT01841437|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
5373684|NCT01841437|Trabecular meshwork|trabecular meshwork
5373686|NCT01841424|dietary counseling|dietary counseling
5373687|NCT01841424|food diary|food diary
5373688|NCT01841424|obesity|obesity
5373689|NCT01841424|pregnancy|pregnancy
5373690|NCT01841424|weight gain|weight gain
5373691|NCT01841411|bacterial vaginosis, recurrence, N-Acetyl cysteine|bacterial vaginosis, recurrence, n-acetyl cysteine
5373692|NCT01841398|Cardiovascular|cardiovascular
5373693|NCT01841398|Prevention|prevention
5373694|NCT01841398|Ethnicity|ethnicity
5373695|NCT01841398|Culture|culture
5373696|NCT01841398|Internet|internet
5373697|NCT01841398|Text Message|text message
5373698|NCT01841385|Exercise|exercise
5373699|NCT01841385|spirometry|spirometry
5373700|NCT01841385|muscle strength|muscle strength
5373701|NCT01841385|physical therapy modalities|physical therapy modalities
5373702|NCT01841372|Obesity|obesity
5373703|NCT01841372|Overweight|overweight
5373704|NCT01841372|Weight Maintenance|weight maintenance
5373705|NCT01841359|Hypoglycemia|hypoglycemia
5373706|NCT01841359|Gastric bypass surgery|gastric bypass surgery
5373707|NCT01841346|Outcome after PCI|outcome after pci
5373708|NCT01841346|Middle Eastern Patients|middle eastern patients
5373709|NCT01841333|Myeloid leukemia in remission|myeloid leukemia in remission
5373710|NCT01841333|Recurrent myeloid leukemia|recurrent myeloid leukemia
5373712|NCT01841281|Severe Asthma|severe asthma
5373713|NCT01841268|premature, preterm, premie, skin|premature, preterm, premie, skin
5373714|NCT01841255|Preoxygenation|preoxygenation
5373715|NCT01841255|Device|device
5373716|NCT01841255|Tolerability|tolerability
5373717|NCT01841255|Efficacy|efficacy
5373718|NCT01841242|Infection|infection
5373719|NCT01841242|Cardiac Resynchronization Device|cardiac resynchronization device
5373720|NCT01841242|Heart Failure|heart failure
5373721|NCT01841216|Gluteus Maximus|gluteus maximus
5373722|NCT01841216|Gluteus Medius|gluteus medius
5373723|NCT01841216|TFL|tfl
5373724|NCT01841216|EMG|emg
5373725|NCT01841216|Perceived Exertion|perceived exertion
5373726|NCT01841216|Thera-Band|thera-band
5373727|NCT01841203|Diagnosis|diagnosis
5373728|NCT01841203|Rapid tests|rapid tests
5373729|NCT01841203|non-treponemal serology|non-treponemal serology
5373730|NCT01841203|eradication|eradication
5373731|NCT01841190|Prognosis|prognosis
5373732|NCT01841190|Sepsis|sepsis
5373733|NCT01841190|Septic shock|septic shock
5373734|NCT01841190|Procalcitonin|procalcitonin
5373735|NCT01841190|SOFA|sofa
5373736|NCT01841177|Congenital Heart Disease|congenital heart disease
5373737|NCT01841177|Pediatrics|pediatrics
5373738|NCT01841177|Milrinone|milrinone
5373739|NCT01841177|Cardiopulmonary Bypass|cardiopulmonary bypass
5373740|NCT01841177|Therapeutic Drug Monitoring|therapeutic drug monitoring
5373741|NCT01841164|Leukotriene responsiveness|leukotriene responsiveness
5373742|NCT01841164|LTE4|lte4
5373743|NCT01841164|asthma|asthma
5373744|NCT01841164|airway hyperresponsiveness|airway hyperresponsiveness
5373745|NCT01841164|bronchoprovocation|bronchoprovocation
5373746|NCT01841164|anti-asthmatic agents|anti-asthmatic agents
5373747|NCT01841164|human|human
5373748|NCT01841151|AD/HD in Children and Adolescents|ad/hd in children and adolescents
5373749|NCT01841138|colonoscopy|colonoscopy
5373750|NCT01841138|bowel preparation|bowel preparation
5373751|NCT01841138|electrolytes|electrolytes
5373752|NCT01841138|osmolality|osmolality
5373753|NCT01841138|water|water
5373754|NCT01841125|Alzheimer's Disease|alzheimer's disease
5373755|NCT01841125|depressive disorder|depressive disorder
5373756|NCT01841073|Prediabetes|prediabetes
5373757|NCT01841073|Fermentable carbohydrate|fermentable carbohydrate
5373758|NCT01841073|Appetite|appetite
5373759|NCT01841073|Glucose homeostasis|glucose homeostasis
5373760|NCT01841073|Weight management|weight management
5373884|NCT01840618|insulin action|insulin action
5373761|NCT01841060|Malignant Non-small Cell Neoplasm of Lung|malignant non-small cell neoplasm of lung
5373762|NCT01841047|Retroperitoneal liposarcoma operable|retroperitoneal liposarcoma operable
5373763|NCT01841034|Male|male
5373764|NCT01841021|Peripheral T-Cell Lymphoma (PTCL)|peripheral t-cell lymphoma (ptcl)
5373765|NCT01841021|Relapsed|relapsed
5373766|NCT01841021|Refractory|refractory
5373767|NCT01841021|CD30 Receptor|cd30 receptor
5373768|NCT01841021|Large B-Cell Lymphoma|large b-cell lymphoma
5373769|NCT01841008|[C17.800.621]|[c17.800.621]
5373770|NCT01840995|stellate ganglion block|stellate ganglion block
5373771|NCT01840982|Mixed grains|mixed grains
5373772|NCT01840982|Glycemic index|glycemic index
5373773|NCT01840982|Giant embryonic brown rice|giant embryonic brown rice
5373774|NCT01840982|Giant embryonic rice|giant embryonic rice
5373775|NCT01840982|diabetes|diabetes
5369265|NCT01860599|EPC's|epc's
5373776|NCT01840969|off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
5373777|NCT01840969|common carotid artery|common carotid artery
5373778|NCT01840969|speckle tracking analysis|speckle tracking analysis
5373780|NCT01840956|End-stage Renal Disease|end-stage renal disease
5373781|NCT01840956|Hemodialysis|hemodialysis
5373782|NCT01840956|Chronic Renal Insufficiency|chronic renal insufficiency
5373783|NCT01840956|Renal Dialysis|renal dialysis
5373784|NCT01840956|Hemodiafiltration|hemodiafiltration
5373785|NCT01840956|Blood Vessel Prosthesis|blood vessel prosthesis
5373786|NCT01840956|Tissue-Engineered Vascular Graft|tissue-engineered vascular graft
5373787|NCT01840956|Vascular Prosthesis Implantation|vascular prosthesis implantation
5373788|NCT01840956|Kidney Diseases|kidney diseases
5373789|NCT01840956|Kidney Failure, Chronic|kidney failure, chronic
5373790|NCT01840956|Renal Insufficiency|renal insufficiency
5373791|NCT01840956|Urologic Diseases|urologic diseases
5373792|NCT01840943|Epithelial ovarian cancer|epithelial ovarian cancer
5373793|NCT01840943|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
5373794|NCT01840943|Carcinoma|carcinoma
5373795|NCT01840943|Malignancy|malignancy
5373796|NCT01840943|Ovarian carcinoma|ovarian carcinoma
5373797|NCT01840943|CAELYX|caelyx
5373798|NCT01840943|Topotecan hydrochloride|topotecan hydrochloride
5373799|NCT01840943|Topotecan|topotecan
5359637|NCT01903967|Tumor|tumor
5373800|NCT01840943|Platinum-based regimen chemotherapy|platinum-based regimen chemotherapy
5373801|NCT01840943|Chinese patients|chinese patients
5373802|NCT01840930|Cohort|cohort
5373803|NCT01840930|Cerebral Palsy|cerebral palsy
5373804|NCT01840930|Children|children
5373806|NCT01840930|Orthopedic complications|orthopedic complications
5373807|NCT01840930|Epidemiology|epidemiology
5373808|NCT01840865|young healthy subjects|young healthy subjects
5373809|NCT01840865|brain stimulation|brain stimulation
5373810|NCT01840865|tSOS|tsos
5373811|NCT01840865|tDCS|tdcs
5373812|NCT01840865|sleep|sleep
5373813|NCT01840865|daytime sleep|daytime sleep
5373814|NCT01840865|nap|nap
5373815|NCT01840865|memory|memory
5373816|NCT01840865|memory consolidation|memory consolidation
5373817|NCT01840839|aging|aging
5373818|NCT01840839|cognitive decline|cognitive decline
5373819|NCT01840839|brain stimulation|brain stimulation
5373820|NCT01840839|tSOS|tsos
5373821|NCT01840839|tDCS|tdcs
5373822|NCT01840839|sleep|sleep
5373823|NCT01840839|nap|nap
5373824|NCT01840839|daytime sleep|daytime sleep
5373825|NCT01840839|memory|memory
5373826|NCT01840839|memory consolidation|memory consolidation
5373827|NCT01840826|Rehospitalization|rehospitalization
5373828|NCT01840826|Reutilization|reutilization
5373829|NCT01840826|Depressive Symptoms|depressive symptoms
5373830|NCT01840826|Pharmacotherapy|pharmacotherapy
5373831|NCT01840826|Cognitive Therapy|cognitive therapy
5373832|NCT01840826|Self-help|self-help
5373833|NCT01840826|Complementary Therapies|complementary therapies
5373834|NCT01840813|Intraumbilical misoprostol|intraumbilical misoprostol
5373835|NCT01840813|Retained placenta|retained placenta
5373836|NCT01840813|Active management of third stage of labour|active management of third stage of labour
5373837|NCT01840800|Postoperative pain|postoperative pain
5373838|NCT01840800|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5373839|NCT01840800|ultrasound guided nerve blocks|ultrasound guided nerve blocks
5373840|NCT01840800|opioid consumption|opioid consumption
5373841|NCT01840761|delayed vasospasm,|delayed vasospasm,
5373842|NCT01840761|medicine,|medicine,
5373843|NCT01840761|standardization|standardization
5373844|NCT01840735|CF|cf
5373845|NCT01840735|Cystic Fibrosis|cystic fibrosis
5373846|NCT01840735|PK|pk
5373847|NCT01840722|HIV|hiv
5373848|NCT01840722|HCV|hcv
5373849|NCT01840722|Substance abuse|substance abuse
5373850|NCT01840722|women|women
5373851|NCT01840709|Systemic lupus erythematosus|systemic lupus erythematosus
5373852|NCT01840709|Psychotherapy|psychotherapy
5373853|NCT01840683|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5373854|NCT01840683|Age Related Eye Disease Study (AREDS)|age related eye disease study (areds)
5373855|NCT01840683|Best-Corrected Visual Acuity (BCVA)|best-corrected visual acuity (bcva)
5373856|NCT01840683|Early Treatment Diabetic Retinopathy Study (ETDRS)|early treatment diabetic retinopathy study (etdrs)
5373857|NCT01840683|Heparin-Induced Extracorporeal LDL-Cholesterol Precipitation (HELP)|heparin-induced extracorporeal ldl-cholesterol precipitation (help)
5373858|NCT01840683|Visual Function Questionnaire (VFQ)|visual function questionnaire (vfq)
5374761|NCT01836783|Allograft|allograft
5373859|NCT01840670|Inferior Vena Cava|inferior vena cava
5373860|NCT01840670|Central Venous Pressure|central venous pressure
5373861|NCT01840670|Abdominal Pressure|abdominal pressure
5373862|NCT01840657|CMDIR (Congenital Muscle Disease International Registry)|cmdir (congenital muscle disease international registry)
5373863|NCT01840657|X-linked myotubular myopathy|x-linked myotubular myopathy
5373864|NCT01840657|centronuclear myopathy|centronuclear myopathy
5373865|NCT01840657|myotubularin|myotubularin
5373866|NCT01840657|MTM1 gene|mtm1 gene
5373867|NCT01840657|mutation|mutation
5373868|NCT01840657|survival|survival
5373869|NCT01840657|adverse event|adverse event
5373870|NCT01840657|disease complication|disease complication
5373871|NCT01840657|hospital admission|hospital admission
5373872|NCT01840657|emergency room visit|emergency room visit
5373874|NCT01840657|respiratory function|respiratory function
5373875|NCT01840657|natural history study|natural history study
5373876|NCT01840631|Obesity|obesity
5373877|NCT01840631|Nutritional counseling|nutritional counseling
5373878|NCT01840631|Physical activity|physical activity
5373879|NCT01840631|Food diary|food diary
5373880|NCT01840618|insulin function|insulin function
5373881|NCT01840618|sleep apnea|sleep apnea
5373882|NCT01840618|girls|girls
5373883|NCT01840618|PCOS|pcos
5373885|NCT01840592|Liver|liver
5373886|NCT01840592|Sorafenib|sorafenib
5373887|NCT01840592|Doxorubicin|doxorubicin
5373888|NCT01840592|12-259|12-259
5373889|NCT01840566|Relapsed|relapsed
5373890|NCT01840566|Refractory|refractory
5373891|NCT01840566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5373892|NCT01840566|HIGH DOSE CHEMOTHERAPY|high dose chemotherapy
5373893|NCT01840566|19-28z T cells/kg|19-28z t cells/kg
5373894|NCT01840566|12-117|12-117
5373895|NCT01840540|renal artery stenosis|renal artery stenosis
5373896|NCT01840540|renovascular hypertension|renovascular hypertension
5373897|NCT01840540|ischemic nephropathy|ischemic nephropathy
5373898|NCT01840540|chronic kidney disease|chronic kidney disease
5373899|NCT01840527|Biomarker|biomarker
5373900|NCT01840527|BRAF|braf
5373901|NCT01840527|blood-based|blood-based
5373902|NCT01840514|recipient|recipient
5373903|NCT01840501|Healthy|healthy
5373904|NCT01840501|JNJ-42721458|jnj-42721458
5373906|NCT01840501|Safety|safety
5373907|NCT01840501|Tolerability|tolerability
5373908|NCT01840501|Pharmacokinetics|pharmacokinetics
5373909|NCT01840501|Pharmacodynamics|pharmacodynamics
5373910|NCT01840501|Immunogenicity|immunogenicity
5373911|NCT01840436|MUCIPLIQ|mucipliq
5373912|NCT01840436|Matrix therapy|matrix therapy
5373913|NCT01840436|RGTA|rgta
5373914|NCT01840436|Oral mucositis|oral mucositis
5373915|NCT01840423|First in man study|first in man study
5373916|NCT01840423|Volunteer study|volunteer study
5373917|NCT01840410|Vision Impairment|vision impairment
5373918|NCT01840410|Abnormal growth of blood vessels|abnormal growth of blood vessels
5373919|NCT01840397|S-100B|s-100b
5373921|NCT01840384|Healthy infants|healthy infants
5373922|NCT01840384|Anemia, iron-deficiency|anemia, iron-deficiency
5373923|NCT01840371|ERCP|ercp
5373924|NCT01840371|Sedation|sedation
5373925|NCT01840371|Fentanyl|fentanyl
5373926|NCT01840371|Propofol|propofol
5373927|NCT01840358|Hypoglycemias|hypoglycemias
5373928|NCT01840358|Insulin pump|insulin pump
5373929|NCT01840358|Children|children
5373930|NCT01840345|uncontrolled|uncontrolled
5373931|NCT01840345|neuropathic pain|neuropathic pain
5373932|NCT01840332|thyroid cancer|thyroid cancer
5373933|NCT01840280|carcinoma|carcinoma
5373934|NCT01840280|colorectal cancer|colorectal cancer
5373935|NCT01840280|ambulant chemotherapy|ambulant chemotherapy
5373936|NCT01840280|treatment cycles|treatment cycles
5373937|NCT01840280|Irinotecan|irinotecan
5373938|NCT01840280|Irinotecan onkovis|irinotecan onkovis
5373939|NCT01840280|Quantity of Irinotecan|quantity of irinotecan
5373940|NCT01840280|Packaging Sizes|packaging sizes
5373941|NCT01840267|pneumoperitoneum|pneumoperitoneum
5373942|NCT01840267|pediatric laparoscopy|pediatric laparoscopy
5373943|NCT01840267|optic nerve sheath diameter|optic nerve sheath diameter
5373944|NCT01840267|intracranial pressure|intracranial pressure
5373945|NCT01840254|PONV|ponv
5373946|NCT01840254|IV PCA|iv pca
5373947|NCT01840254|dexmedetomidine|dexmedetomidine
5373948|NCT01840254|Female|female
5373949|NCT01840254|non-smoking|non-smoking
5373950|NCT01840254|lumbar spine surgery|lumbar spine surgery
5373951|NCT01840241|sodium bicarbonate|sodium bicarbonate
5373952|NCT01840241|acute kidney injury|acute kidney injury
5373953|NCT01840241|OPCAB|opcab
5373954|NCT01840228|Preterm|preterm
5373955|NCT01840228|Progesterone|progesterone
5373956|NCT01840189|Addison disease|addison disease
5373957|NCT01840189|Type 1 diabetes|type 1 diabetes
5373958|NCT01840189|treatment|treatment
5373959|NCT01840176|McCall culdoplasty|mccall culdoplasty
5373960|NCT01840176|Total laparoscopic hysterectomy|total laparoscopic hysterectomy
5373961|NCT01840176|Vaginal vault prolapse|vaginal vault prolapse
5373962|NCT01840176|Sexual function|sexual function
5373963|NCT01840124|Fibroids|fibroids
5373968|NCT01840111|nicotine|nicotine
5373970|NCT01840085|Diabetic foot ulcer|diabetic foot ulcer
5373971|NCT01840085|plantar neuropathic ulcer|plantar neuropathic ulcer
5373972|NCT01840085|plantar neuroischemic ulcer|plantar neuroischemic ulcer
5373973|NCT01840085|Wagner Grade 1 or Grade 2 DFU|wagner grade 1 or grade 2 dfu
5373974|NCT01840072|Ischemic stroke|ischemic stroke
5373975|NCT01840072|Hypertension|hypertension
5373976|NCT01840072|Antihypertensive Agents|antihypertensive agents
5373977|NCT01840072|Randomized Controlled Trial|randomized controlled trial
5373978|NCT01840059|Cardiac Failure|cardiac failure
5373979|NCT01840059|Autonomic Denervation|autonomic denervation
5369472|NCT01859819|Rituximab|rituximab
5373985|NCT01839994|prostate cancer,|prostate cancer,
5373986|NCT01839994|high-dose-rate brachytherapy boost,|high-dose-rate brachytherapy boost,
5373987|NCT01839994|stereotactic body radiotherapy boost,|stereotactic body radiotherapy boost,
5373988|NCT01839994|conformal radiotherapy,|conformal radiotherapy,
5373989|NCT01839994|randomized trial|randomized trial
5373990|NCT01839942|Hernia, Ventral|hernia, ventral
5373991|NCT01839929|tacrolimus|tacrolimus
5373992|NCT01839929|immunosuppressant|immunosuppressant
5373994|NCT01839903|Smoking|smoking
5373995|NCT01839903|Tobacco|tobacco
5373996|NCT01839903|Emergency Department|emergency department
5373997|NCT01839890|Paclitaxel|paclitaxel
5373998|NCT01839890|stent|stent
5373999|NCT01839890|Acute infarction|acute infarction
5374000|NCT01839890|Systolic time elevation|systolic time elevation
5374001|NCT01839877|Metastatic colorectal Cancer|metastatic colorectal cancer
5374002|NCT01839864|Promotoras|promotoras
5374003|NCT01839864|Hispanic Adults|hispanic adults
5374004|NCT01839864|metabolic syndrome|metabolic syndrome
5374005|NCT01839864|rural|rural
5374006|NCT01839864|patient attitudes|patient attitudes
5374007|NCT01839864|provider cultural competency|provider cultural competency
5374008|NCT01839864|patient activation measure|patient activation measure
5374009|NCT01839851|Hair cortisol|hair cortisol
5374010|NCT01839851|asthma|asthma
5374011|NCT01839851|allergic rhinitis|allergic rhinitis
5374012|NCT01839851|inhaled corticosteroids|inhaled corticosteroids
5374013|NCT01839851|intranasal glucocorticoids|intranasal glucocorticoids
5374015|NCT01839838|age 50 and above|age 50 and above
5374025|NCT01839812|Dexamethasone|dexamethasone
5374026|NCT01839799|Patients|patients
5374027|NCT01839799|with|with
5374028|NCT01839799|resected|resected
5374029|NCT01839786|Pulmonary Hypertension|pulmonary hypertension
5374030|NCT01839786|Doppler|doppler
5374031|NCT01839786|Valsalva|valsalva
5374032|NCT01839773|Stomach Neoplasms|stomach neoplasms
5374033|NCT01839773|Cancer of Stomach|cancer of stomach
5374034|NCT01839773|Gastric Cancer|gastric cancer
5374035|NCT01839773|Gastric Neoplasms|gastric neoplasms
5374036|NCT01839773|Neoplasms, Gastric|neoplasms, gastric
5374037|NCT01839773|Neoplasms, Stomach|neoplasms, stomach
5374038|NCT01839773|Stomach Cancer|stomach cancer
5374039|NCT01839773|paclitaxel|paclitaxel
5374040|NCT01839773|Taxol|taxol
5374041|NCT01839760|Influenza|influenza
5374042|NCT01839760|Virus|virus
5374043|NCT01839760|Viral shedding|viral shedding
5374044|NCT01839760|Epidemiology|epidemiology
5374045|NCT01839747|Pediatric|pediatric
5374046|NCT01839734|CD4+|cd4+
5374047|NCT01839721|Probiotics|probiotics
5374048|NCT01839721|radiation-induced enteritis|radiation-induced enteritis
5374049|NCT01839721|radiation-induced diarrhea|radiation-induced diarrhea
5374050|NCT01839721|radiation, diarrhea, enteritis|radiation, diarrhea, enteritis
5374051|NCT01839721|diet|diet
5374052|NCT01839721|nutrition|nutrition
5374053|NCT01839708|Intervention|intervention
5374054|NCT01839695|Thoracic Aneurysm|thoracic aneurysm
5374055|NCT01839695|Endovascular Aortic Repair|endovascular aortic repair
5374056|NCT01839695|TEVAR|tevar
5374057|NCT01839682|StabiliT|stabilit
5374058|NCT01839682|Kyphoplasty|kyphoplasty
5374059|NCT01839682|Vertebral|vertebral
5374060|NCT01839682|Compression|compression
5374061|NCT01839682|Fracture|fracture
5374062|NCT01839682|Osteoporosis|osteoporosis
5374063|NCT01839669|conservative therapy|conservative therapy
5374064|NCT01839669|Foot-Function-Index|foot-function-index
5374065|NCT01839669|functional movement changes|functional movement changes
5374066|NCT01839669|non-surgical treatment|non-surgical treatment
5374067|NCT01839669|pes planovalgus|pes planovalgus
5374068|NCT01839669|posterior tibial tendon dysfunction|posterior tibial tendon dysfunction
5374069|NCT01839656|Spinal Muscular Atrophy|spinal muscular atrophy
5374070|NCT01839656|SMA|sma
5374071|NCT01839656|SMN|smn
5374072|NCT01839656|SMNRx|smnrx
5374073|NCT01839656|ISIS-SMNRx|isis-smnrx
5374074|NCT01839656|ISIS 396443|isis 396443
5374075|NCT01839656|IONIS-SMNRx|ionis-smnrx
5374076|NCT01839656|Spinraza|spinraza
5374077|NCT01839656|Nusinersen|nusinersen
5374078|NCT01839643|pharmacokinetic|pharmacokinetic
5374079|NCT01839630|Sorafenib|sorafenib
5374080|NCT01839630|Hepatocellular cancer|hepatocellular cancer
5374081|NCT01839630|TACE combination|tace combination
5374082|NCT01839630|Treatment pattern|treatment pattern
5374083|NCT01839630|Safety|safety
5374084|NCT01839630|Effectiveness|effectiveness
5374085|NCT01839617|parenteral nutrition|parenteral nutrition
5374086|NCT01839617|early nutrition|early nutrition
5374087|NCT01839617|abdominal surgery|abdominal surgery
5374088|NCT01839617|cancer|cancer
5374089|NCT01839604|Child-Pugh A to B7,|child-pugh a to b7,
5374090|NCT01839604|Advanced/Metastatic Hepatocellular Carcinoma,|advanced/metastatic hepatocellular carcinoma,
5374091|NCT01839604|AZD9150,|azd9150,
5374092|NCT01839604|Antisense Oligonucleotide Inhibitor of STAT3|antisense oligonucleotide inhibitor of stat3
5374093|NCT01839578|cytokines|cytokines
5374094|NCT01839578|blood purification|blood purification
5374095|NCT01839578|super high flux hemodialysis|super high flux hemodialysis
5374096|NCT01839565|Adverse events|adverse events
5374106|NCT01839513|Analgesia/nociception index|analgesia/nociception index
5374108|NCT01839513|Remifentanil|remifentanil
5374109|NCT01839513|Orthopedic surgery|orthopedic surgery
5374110|NCT01839513|Ear-nose-throat surgery|ear-nose-throat surgery
5374111|NCT01839513|Hemodynamic reactivity|hemodynamic reactivity
5374112|NCT01839487|pancreatic ductal carcinoma(PDA)|pancreatic ductal carcinoma(pda)
5374113|NCT01839487|Pancreatic ductal carcinoma|pancreatic ductal carcinoma
5374115|NCT01839487|Gemcitabine|gemcitabine
5374116|NCT01839487|Nab-paclitaxel|nab-paclitaxel
5374117|NCT01839474|Continuous Positive Airway Pressure|continuous positive airway pressure
5374118|NCT01839474|Controlled trial|controlled trial
5374119|NCT01839474|Pneumonia|pneumonia
5374120|NCT01839474|Children|children
5374121|NCT01839461|Pharmacogenetics|pharmacogenetics
5374122|NCT01839461|postoperative|postoperative
5374123|NCT01839461|pediatric|pediatric
5374124|NCT01839461|opioid|opioid
5374125|NCT01839461|perioperative|perioperative
5374126|NCT01839461|respiratory depression|respiratory depression
5374127|NCT01839461|chronic pain|chronic pain
5374128|NCT01839448|post partum diabetes|post partum diabetes
5374129|NCT01839448|impaired fasting glucose|impaired fasting glucose
5374130|NCT01839435|appendectomy|appendectomy
5374131|NCT01839435|acute appendicitis|acute appendicitis
5374132|NCT01839435|outpatient|outpatient
5374133|NCT01839409|Circadian Rhythm|circadian rhythm
5374134|NCT01839409|Exercise|exercise
5374135|NCT01839409|Reflex, Vestibular Ocular|reflex, vestibular ocular
5374136|NCT01839409|Postural Balance|postural balance
5374137|NCT01839396|Intrepid, Vercise, PD, DBS, Boston Scientific|intrepid, vercise, pd, dbs, boston scientific
5374138|NCT01839370|Pramlintide|pramlintide
5374139|NCT01839370|Closed Loop|closed loop
5374140|NCT01839370|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5374141|NCT01839370|Diabetes Assistant (DiAs)|diabetes assistant (dias)
5374142|NCT01839357|Rivaroxaban|rivaroxaban
5374143|NCT01839357|Oral anticoagulant|oral anticoagulant
5374144|NCT01839357|Nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5374145|NCT01839357|Left atrial thrombus|left atrial thrombus
5374146|NCT01839357|Transesophageal echocardiography|transesophageal echocardiography
5374147|NCT01839357|Thrombus resolution|thrombus resolution
5374148|NCT01839357|Stroke|stroke
5374149|NCT01839357|Thromboembolism|thromboembolism
5374150|NCT01839344|hyperglycemia|hyperglycemia
5374151|NCT01839344|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5374152|NCT01839344|endothelial dysfunction|endothelial dysfunction
5374153|NCT01839344|quercetin|quercetin
5374154|NCT01839344|Acarbose|acarbose
5374155|NCT01839344|glucose tolerance|glucose tolerance
5374156|NCT01839344|maltose|maltose
5374157|NCT01839331|osteoarthritis|osteoarthritis
5374158|NCT01839331|osteoarthrisis of the knee|osteoarthrisis of the knee
5374159|NCT01839318|Soft contact lenses|soft contact lenses
5374160|NCT01839318|Daily disposable contact lenses|daily disposable contact lenses
5374161|NCT01839318|Tear Film Break Up Time|tear film break up time
5374162|NCT01839318|Contact lens wettability|contact lens wettability
5374163|NCT01839305|Kinematics|kinematics
5374164|NCT01839305|Fibromyalgia|fibromyalgia
5374165|NCT01839305|Physical Therapy|physical therapy
5374166|NCT01839305|3D Kinematics|3d kinematics
5374167|NCT01839305|Heart Rate Frequency|heart rate frequency
5374168|NCT01839305|Hydrotherapy|hydrotherapy
5374169|NCT01839292|gastric outlet obstruction|gastric outlet obstruction
5374170|NCT01839292|palliative treatment|palliative treatment
5374171|NCT01839292|stent|stent
5374172|NCT01839266|acute PTE, prognostic factors|acute pte, prognostic factors
5374173|NCT01839253|antihypertensive agents|antihypertensive agents
5374174|NCT01839253|hemodynamic|hemodynamic
5374175|NCT01839253|anesthetics reduction|anesthetics reduction
5374176|NCT01839253|orthognathic surgery|orthognathic surgery
5374177|NCT01839227|Post-operative cognitive dysfunction|post-operative cognitive dysfunction
5374178|NCT01839227|regional cerebral oxygen saturation|regional cerebral oxygen saturation
5374179|NCT01839227|elderly|elderly
5374180|NCT01839201|anesthesia|anesthesia
5374181|NCT01839201|modification of dreaming|modification of dreaming
5374182|NCT01839201|suggestions|suggestions
5369676|NCT01858779|stroke|stroke
5374183|NCT01839162|Transradial approach|transradial approach
5374184|NCT01839162|shield drape|shield drape
5374185|NCT01839162|radiation|radiation
5374186|NCT01839162|PTCA|ptca
5374187|NCT01839149|Refractory Chronic Migraine|refractory chronic migraine
5374188|NCT01839149|Medically Intractable Chronic Migraine|medically intractable chronic migraine
5374189|NCT01839149|Oxytocin|oxytocin
5374190|NCT01839149|Intranasal oxytocin|intranasal oxytocin
5374191|NCT01839136|Assisted Reproductive Techniques|assisted reproductive techniques
5374192|NCT01839136|Health Services Accessibility|health services accessibility
5374193|NCT01839136|Ovulation Induction|ovulation induction
5374194|NCT01839136|Embryo Transfer|embryo transfer
5374195|NCT01839123|Amputee|amputee
5374196|NCT01839110|pulmonary hypertension|pulmonary hypertension
5374197|NCT01839110|right ventricular function|right ventricular function
5374198|NCT01839110|ranolazine|ranolazine
5374199|NCT01839097|PTCL|ptcl
5374200|NCT01839097|Maximum Tolerated Dose|maximum tolerated dose
5374201|NCT01839097|Belinostat|belinostat
5374202|NCT01839084|Xenon|xenon
5374203|NCT01839084|Isoflurane|isoflurane
5374204|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation
5374205|NCT01839084|Nephroprotection|nephroprotection
5374206|NCT01839084|Partial nephrectomy|partial nephrectomy
5377883|NCT01822366|Kenya|kenya
5374207|NCT01839084|Xenon versus Isoflurane anesthesia|xenon versus isoflurane anesthesia
5374209|NCT01839045|Woman|woman
5374210|NCT01839045|Breast Cancer|breast cancer
5374211|NCT01839045|Cancer|cancer
5374212|NCT01839045|Mammogram|mammogram
5374213|NCT01839045|Ultrasound|ultrasound
5360015|NCT01902186|HIV|hiv
5374214|NCT01839045|Imaging|imaging
5374215|NCT01839045|Biomarkers|biomarkers
5374216|NCT01839045|ACR BI RAD Category 3|acr bi rad category 3
5374217|NCT01839045|ACR BI RAD Category 4|acr bi rad category 4
5374218|NCT01839019|Healthy volunteers|healthy volunteers
5374219|NCT01839006|hydronephrosis|hydronephrosis
5374220|NCT01839006|ultrasonography|ultrasonography
5374221|NCT01839006|Kidney Function Test|kidney function test
5374222|NCT01839006|Patients with unilateral UPJO and patients with preop HN in USG and supranormal renal function in DTPA renography|patients with unilateral upjo and patients with preop hn in usg and supranormal renal function in dtpa renography
5374223|NCT01838993|anesthetics,|anesthetics,
5374224|NCT01838993|local,|local,
5374225|NCT01838993|lidocaine;|lidocaine;
5374226|NCT01838993|nebulizers and vaporizers;|nebulizers and vaporizers;
5374227|NCT01838993|complications,|complications,
5374228|NCT01838993|intubation,|intubation,
5374229|NCT01838993|intratracheal.|intratracheal.
5374230|NCT01838980|Colonoscopy Cleaning|colonoscopy cleaning
5374231|NCT01838967|cilnidipin and valsartn|cilnidipin and valsartn
5374232|NCT01838967|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
5374233|NCT01838967|oral administration|oral administration
5374234|NCT01838967|healthy male subjects|healthy male subjects
5374235|NCT01838954|hand osteoarthritis|hand osteoarthritis
5374236|NCT01838954|short-wave diathermy|short-wave diathermy
5374237|NCT01838941|Peroxisome Biogenesis Disorder|peroxisome biogenesis disorder
5374239|NCT01838941|neonatal adrenoleukodystrophy|neonatal adrenoleukodystrophy
5374240|NCT01838941|infantile Refsum disease|infantile refsum disease
5374241|NCT01838941|PEX1 mutation|pex1 mutation
5374242|NCT01838941|Betaine|betaine
5374243|NCT01838928|Axillary brachial plexus block|axillary brachial plexus block
5374244|NCT01838928|Ultrasound|ultrasound
5374245|NCT01838928|Minimum effective concentration|minimum effective concentration
5374246|NCT01838928|Bupivacaine|bupivacaine
5374247|NCT01838928|ultrasound-guided axillary brachial plexus block|ultrasound-guided axillary brachial plexus block
5374248|NCT01838915|HIV|hiv
5374249|NCT01838915|immunoactivation|immunoactivation
5374250|NCT01838915|bacterial translocation|bacterial translocation
5374251|NCT01838915|prebiotics|prebiotics
5374252|NCT01838915|glutamine|glutamine
5374253|NCT01838915|microbiota|microbiota
5374254|NCT01838902|Malaria|malaria
5374255|NCT01838902|Falciparum|falciparum
5374256|NCT01838902|Direct membrane feeding|direct membrane feeding
5374257|NCT01838902|QT-NASBA|qt-nasba
5374258|NCT01838902|Asexual parasite|asexual parasite
5374259|NCT01838902|Asymptomatic carrier|asymptomatic carrier
5374260|NCT01838902|Gametocytocidal, Gametocyte|gametocytocidal, gametocyte
5374261|NCT01838902|Transmission blocking|transmission blocking
5374266|NCT01838902|Gambia|gambia
5374267|NCT01838902|Africa|africa
5374268|NCT01838889|Culturally adapted|culturally adapted
5374269|NCT01838889|Group psychological intervention|group psychological intervention
5374270|NCT01838889|British South Asian women|british south asian women
5374272|NCT01838876|Major Depressive Disorder|major depressive disorder
5374273|NCT01838876|MDD|mdd
5374274|NCT01838876|Depression|depression
5374275|NCT01838863|coagulopathy|coagulopathy
5374276|NCT01838863|hemorrhagic shock|hemorrhagic shock
5374277|NCT01838863|plasma|plasma
5374278|NCT01838863|blood product transfusion|blood product transfusion
5374283|NCT01838811|Processing Speed|processing speed
5374284|NCT01838811|Intervention|intervention
5374285|NCT01838811|Traumatic Brain Injury|traumatic brain injury
5374286|NCT01838811|Cognition|cognition
5374287|NCT01838798|cognitive disorders|cognitive disorders
5374288|NCT01838798|quality of life|quality of life
5374290|NCT01838785|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
5374291|NCT01838772|HCV and HIV co-infection|hcv and hiv co-infection
5374292|NCT01838759|Bioimpedance spectroscopy|bioimpedance spectroscopy
5374293|NCT01838759|Hypervolemia|hypervolemia
5374294|NCT01838759|Hypovolemia|hypovolemia
5374295|NCT01838746|Percutaneous coronary intervention|percutaneous coronary intervention
5374296|NCT01838746|Coronary artery bypass grafting|coronary artery bypass grafting
5374297|NCT01838746|Coronary artery bypass surgery|coronary artery bypass surgery
5374298|NCT01838746|Survival|survival
5374299|NCT01838746|Acute coronary syndrome|acute coronary syndrome
5374300|NCT01838746|ST segment elevation myocardial infarction|st segment elevation myocardial infarction
5374301|NCT01838746|Non-ST segment elevation myocardial infarction|non-st segment elevation myocardial infarction
5374302|NCT01838746|Younge patient|younge patient
5374303|NCT01838720|renal cell carcinoma|renal cell carcinoma
5374304|NCT01838720|ischemia|ischemia
5374305|NCT01838720|radio frequency ablation|radio frequency ablation
5374306|NCT01838707|postoperative|postoperative
5374307|NCT01838707|spine surgery|spine surgery
5374308|NCT01838655|Albinism|albinism
5374309|NCT01838655|Nitisinone|nitisinone
5374311|NCT01838655|Vision Loss|vision loss
5374312|NCT01838642|Monoclonal Antibody|monoclonal antibody
5374313|NCT01838642|AP24534|ap24534
5374314|NCT01838642|RET Mutation Positive|ret mutation positive
5374315|NCT01838642|RET Mutation Negative|ret mutation negative
5374316|NCT01838642|RET Inhibitor|ret inhibitor
5374317|NCT01838616|Severe chronic low back pain|severe chronic low back pain
5374318|NCT01838616|Neuropathic pain|neuropathic pain
5374319|NCT01838616|Constipation|constipation
5374320|NCT01838590|Liver Diseases|liver diseases
5374321|NCT01838590|Digestive System Diseases|digestive system diseases
5374322|NCT01838590|Hepatitis, Viral, Human|hepatitis, viral, human
5374323|NCT01838590|Virus Diseases|virus diseases
5374324|NCT01838590|Enterovirus Infections|enterovirus infections
5374325|NCT01838590|Picornaviridae Infections|picornaviridae infections
5374326|NCT01838590|RNA Virus Infections|rna virus infections
5374327|NCT01838590|Flaviviridae Infections|flaviviridae infections
5374328|NCT01838590|Antiviral Agents|antiviral agents
5374329|NCT01838590|Anti-Infective Agents|anti-infective agents
5374330|NCT01838590|Therapeutic Uses|therapeutic uses
5374331|NCT01838590|Pharmacologic Actions|pharmacologic actions
5374332|NCT01838590|Antimetabolites|antimetabolites
5374333|NCT01838590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5374334|NCT01838590|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
5374336|NCT01838590|Sustained Virologic Response|sustained virologic response
5374337|NCT01838590|Direct Acting Antiviral|direct acting antiviral
5374338|NCT01838590|Combination Therapy|combination therapy
5374339|NCT01838590|GS-7977|gs-7977
5374340|NCT01838590|Ribavirin|ribavirin
5374341|NCT01838590|Open Label|open label
5374342|NCT01838590|Sofosbuvir|sofosbuvir
5374343|NCT01838590|Additional relevant MeSH terms:|additional relevant mesh terms:
5374344|NCT01838590|Hepatitis|hepatitis
5374345|NCT01838590|Hepatitis, Chronic|hepatitis, chronic
5374346|NCT01838590|Hepatitis C|hepatitis c
5374347|NCT01838590|Hepatitis C, Chronic|hepatitis c, chronic
5374348|NCT01838564|Pediatric Advanced Cancer|pediatric advanced cancer
5374349|NCT01838564|Children|children
5374350|NCT01838564|Quality of Life|quality of life
5374351|NCT01838564|Health Information technology|health information technology
5374352|NCT01838564|Patient reported outcomes|patient reported outcomes
5374353|NCT01838525|sepsis|sepsis
5374354|NCT01838525|alpha-1-acid glycoprotein (AGP)|alpha-1-acid glycoprotein (agp)
5374355|NCT01838525|diagnosis|diagnosis
5374356|NCT01838525|prognosis|prognosis
5374357|NCT01838525|SIRS|sirs
5374358|NCT01838486|Interstitial cystitis|interstitial cystitis
5374359|NCT01838486|painful bladder syndrome|painful bladder syndrome
5374360|NCT01838486|bladder hydrodistention|bladder hydrodistention
5374361|NCT01838486|hyperthermia|hyperthermia
5374362|NCT01838473|smokeless tobacco|smokeless tobacco
5374363|NCT01838473|Nicotine|nicotine
5374364|NCT01838473|Cadmium|cadmium
5374365|NCT01838473|lead|lead
5374366|NCT01838473|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
5374367|NCT01838447|Vitamin D|vitamin d
5374368|NCT01838447|Congenital Heart Disease|congenital heart disease
5374369|NCT01838447|Cardiac Surgery|cardiac surgery
5374370|NCT01838447|Pediatrics|pediatrics
5374371|NCT01838447|Phase II Clinical Trial|phase ii clinical trial
5374372|NCT01838408|screening colonoscopy|screening colonoscopy
5374373|NCT01838408|surveillance colonoscopy|surveillance colonoscopy
5374374|NCT01838408|colonoscopy|colonoscopy
5374375|NCT01838395|AML|aml
5374376|NCT01838395|Acute Myeloid Leukemia|acute myeloid leukemia
5374377|NCT01838395|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5374378|NCT01838395|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5374379|NCT01838382|pain|pain
5374380|NCT01838382|total laparoscopic hysterectomy|total laparoscopic hysterectomy
5374381|NCT01838356|Depression|depression
5374382|NCT01838356|Vascular depression|vascular depression
5374383|NCT01838356|Intracranial atherosclerosis|intracranial atherosclerosis
5374384|NCT01838356|Coronary artery disease|coronary artery disease
5374385|NCT01838356|Coronary artery bypass graft|coronary artery bypass graft
5374386|NCT01838356|Cognitive impairment|cognitive impairment
5374387|NCT01838330|Kidney Disease|kidney disease
5374388|NCT01838330|Fiber|fiber
5374389|NCT01838330|Dietary Intervention|dietary intervention
5374390|NCT01838304|propofol sedation endoscopy|propofol sedation endoscopy
5374391|NCT01838291|Ferriprox|ferriprox
5374392|NCT01838291|Deferiprone|deferiprone
5374393|NCT01838291|DFP|dfp
5374394|NCT01838291|L1|l1
5374395|NCT01838278|Vojta therapy|vojta therapy
5374396|NCT01838278|Exercise Movement Technique|exercise movement technique
5374397|NCT01838278|Early intervention|early intervention
5374398|NCT01838252|Ectropion|ectropion
5374399|NCT01838252|Hyaluronic Acid|hyaluronic acid
5374400|NCT01838252|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5374401|NCT01838252|Lower eyelid retraction|lower eyelid retraction
5374402|NCT01838239|Fish oil|fish oil
5374403|NCT01838239|Omega-3 fatty acids|omega-3 fatty acids
5374404|NCT01838226|Chronic Disease|chronic disease
5374405|NCT01838226|Prevention|prevention
5374406|NCT01838226|cardiovascular disease|cardiovascular disease
5374407|NCT01838213|Urinary tract infection|urinary tract infection
5374408|NCT01838213|ESBL|esbl
5374409|NCT01838213|treatment|treatment
5374410|NCT01838213|carriage|carriage
5348101|NCT01958333|Flexibility|flexibility
5374411|NCT01838213|risk factors|risk factors
5374412|NCT01838213|water contamination|water contamination
5374414|NCT01838200|Bacillus Calmette-Guérin|bacillus calmette-guérin
5374415|NCT01838200|Ipilimumab|ipilimumab
5374416|NCT01838200|YERVOY|yervoy
5374417|NCT01838200|Advanced Metastatic Melanoma|advanced metastatic melanoma
5374418|NCT01838200|Metastatic Melanoma|metastatic melanoma
5374419|NCT01838174|Optic Neuritis|optic neuritis
5374420|NCT01838161|adolescents|adolescents
5374421|NCT01838161|immunizations|immunizations
5374422|NCT01838148|coronary artery disease|coronary artery disease
5374423|NCT01838148|angina, stable|angina, stable
5374424|NCT01838148|exercise test|exercise test
5374425|NCT01838148|biological Markers|biological markers
5374426|NCT01838148|SPECT|spect
5374427|NCT01838135|wheelchair|wheelchair
5374428|NCT01838135|manual wheelchair|manual wheelchair
5374429|NCT01838135|rehabilitation|rehabilitation
5374430|NCT01838135|self-efficacy|self-efficacy
5374431|NCT01838135|older adults|older adults
5374432|NCT01838135|feasibility|feasibility
5374433|NCT01838135|intervention|intervention
5374434|NCT01838135|training|training
5374435|NCT01838122|PCOS|pcos
5374436|NCT01838122|HbA1C|hba1c
5374437|NCT01838122|Insulin resistance|insulin resistance
5374438|NCT01838122|OGTT|ogtt
5374439|NCT01838122|HOMA-IR|homa-ir
5374440|NCT01838122|HOMA-B-cell|homa-b-cell
5374441|NCT01838070|Hepatitis A|hepatitis a
5374442|NCT01838070|Hepatitis A vaccine|hepatitis a vaccine
5374443|NCT01838070|AVAXIM 160U|avaxim 160u
5374444|NCT01838031|antenatal thyroid screening|antenatal thyroid screening
5374445|NCT01838031|subclinical hypothyroidism|subclinical hypothyroidism
5374446|NCT01838031|thyroid function|thyroid function
5374447|NCT01838031|thyroid antibody|thyroid antibody
5374448|NCT01838031|pregnancy outcome|pregnancy outcome
5374449|NCT01838031|childhood cognitive function|childhood cognitive function
5374450|NCT01838018|PKAN|pkan
5374451|NCT01838018|brain iron|brain iron
5374452|NCT01838018|NBIA|nbia
5374453|NCT01838018|neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
5374454|NCT01838018|Hallervorden Spatz Syndrome|hallervorden spatz syndrome
5374455|NCT01838005|Contingency management|contingency management
5374456|NCT01838005|conditional cash transfer|conditional cash transfer
5374457|NCT01838005|PMTCT|pmtct
5374458|NCT01838005|Retention|retention
5374459|NCT01838005|HIV|hiv
5374460|NCT01837979|prenatal testing for fetal aneuploidy|prenatal testing for fetal aneuploidy
5374461|NCT01837979|dried blood spots|dried blood spots
5374462|NCT01837979|cell-free fetal DNA|cell-free fetal dna
5374463|NCT01837979|detection rate|detection rate
5374464|NCT01837979|cost-effectiveness|cost-effectiveness
5374465|NCT01837966|re-operative anxiety|re-operative anxiety
5374466|NCT01837966|breast surgery|breast surgery
5374467|NCT01837966|lavender oil|lavender oil
5374468|NCT01837966|aromatherapy|aromatherapy
5374469|NCT01837927|Efficacy, NVA237, Tiotropium, Chronic Obstructive Pulmonary Disease, COPD|efficacy, nva237, tiotropium, chronic obstructive pulmonary disease, copd
5374470|NCT01837901|transcorneal electrostimulation|transcorneal electrostimulation
5374471|NCT01837888|wheelchair|wheelchair
5374472|NCT01837888|manual wheelchair|manual wheelchair
5374473|NCT01837888|rehabilitation|rehabilitation
5374474|NCT01837888|self-efficacy|self-efficacy
5374475|NCT01837888|older adults|older adults
5374476|NCT01837888|feasibility|feasibility
5374477|NCT01837888|intervention|intervention
5374478|NCT01837888|training|training
5374479|NCT01837888|Wheelchair mobility|wheelchair mobility
5374480|NCT01837875|Intervention|intervention
5374481|NCT01837875|Quality of life|quality of life
5374482|NCT01837875|African American|african american
5374483|NCT01837875|Stress|stress
5374484|NCT01837862|pilomyxoid astrocytoma|pilomyxoid astrocytoma
5374485|NCT01837862|Pilocytic Astrocytoma|pilocytic astrocytoma
5374486|NCT01837862|Glioma|glioma
5374487|NCT01837862|Optic Nerve Glioma|optic nerve glioma
5374488|NCT01837862|mebendazole|mebendazole
5374489|NCT01837862|Pleomorphic Xanthoastrocytoma|pleomorphic xanthoastrocytoma
5374490|NCT01837862|glioblastoma multiforme|glioblastoma multiforme
5374491|NCT01837862|anaplastic astrocytoma|anaplastic astrocytoma
5374492|NCT01837862|gliosarcoma|gliosarcoma
5374493|NCT01837862|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5374494|NCT01837862|DIPG|dipg
5374495|NCT01837862|low-grade glioma|low-grade glioma
5374496|NCT01837862|high-grade glioma|high-grade glioma
5374497|NCT01837862|brainstem glioma|brainstem glioma
5374498|NCT01837862|pediatric|pediatric
5374499|NCT01837849|heart failure|heart failure
5374500|NCT01837849|rhBNP|rhbnp
5374501|NCT01837849|Dobutamine|dobutamine
5374502|NCT01837836|Health education|health education
5374503|NCT01837836|water handling practices|water handling practices
5374504|NCT01837836|Bacteriological quality of water|bacteriological quality of water
5374505|NCT01837823|Coronary artery disease|coronary artery disease
5374506|NCT01837823|Lipid|lipid
5374507|NCT01837823|Regression|regression
5374508|NCT01837823|Plaque|plaque
5374509|NCT01837810|Post tonsillectomy hemorrhage|post tonsillectomy hemorrhage
5374510|NCT01837810|post operative hemorrhage|post operative hemorrhage
5374511|NCT01837810|complications|complications
5374512|NCT01837810|tonsillectomy|tonsillectomy
5374513|NCT01837758|Platelet function|platelet function
5374514|NCT01837758|hemofiltration|hemofiltration
5374515|NCT01837758|Multiplate|multiplate
5374516|NCT01837732|Chronic pain|chronic pain
5374518|NCT01837732|relational touch|relational touch
5374519|NCT01837706|Empathy|empathy
5374520|NCT01837706|Communication|communication
5374521|NCT01837706|Physician litigation|physician litigation
5374522|NCT01837693|cervical cancer screening|cervical cancer screening
5374524|NCT01837693|cervical cancer|cervical cancer
5374525|NCT01837693|biomarkers|biomarkers
5374526|NCT01837693|sensitivity and specificity|sensitivity and specificity
5374527|NCT01837680|Insulin, Long-Acting|insulin, long-acting
5374528|NCT01837654|Detrusor Overactivity|detrusor overactivity
5374529|NCT01837654|Plantarflexion|plantarflexion
5374530|NCT01837654|Urgency|urgency
5374531|NCT01837628|Urodynamic|urodynamic
5374532|NCT01837628|Paraffin oil|paraffin oil
5374533|NCT01837628|Lidocaine gel|lidocaine gel
5374534|NCT01837628|Pain|pain
5374535|NCT01837615|Ulcerative Colitis|ulcerative colitis
5374536|NCT01837615|Ulcerative Proctitis|ulcerative proctitis
5374537|NCT01837615|Low Level Light Therapy|low level light therapy
5374538|NCT01837615|Safety|safety
5374539|NCT01837615|Efficacy|efficacy
5374540|NCT01837602|refractory to at least one standard therapy|refractory to at least one standard therapy
5374541|NCT01837602|newly diagnosed|newly diagnosed
5374542|NCT01837602|with operable triple negative breast cancer|with operable triple negative breast cancer
5374543|NCT01837589|Cystic fibrosis-DXA-QCT-Osteopenia- Osteoporosis|cystic fibrosis-dxa-qct-osteopenia- osteoporosis
5374544|NCT01837576|Psoriasis Vulgaris|psoriasis vulgaris
5374545|NCT01837576|Calcipotriol|calcipotriol
5374546|NCT01837576|Betamethasone Dipropionate|betamethasone dipropionate
5374547|NCT01837550|audiologic rehabilitation|audiologic rehabilitation
5374548|NCT01837550|hearing loss|hearing loss
5374549|NCT01837550|patient education|patient education
5374550|NCT01837550|patient participation|patient participation
5374551|NCT01837550|structured rehabilitation|structured rehabilitation
5374552|NCT01837550|counseling|counseling
5374553|NCT01837550|Internet|internet
5374554|NCT01837524|Dietary advice|dietary advice
5374555|NCT01837524|Nutritional knowledge|nutritional knowledge
5374556|NCT01837524|Self-efficacy|self-efficacy
5374557|NCT01837524|Nutrition|nutrition
5374558|NCT01837511|Tumor antigens|tumor antigens
5374559|NCT01837511|Asiatic patients|asiatic patients
5374660|NCT01837147|breast cancer|breast cancer
5374560|NCT01837511|Reverse Transciptase-Polymerase chain reaction (RT-PCR)|reverse transciptase-polymerase chain reaction (rt-pcr)
5374561|NCT01837511|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5374562|NCT01837498|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery|residual neuromuscular blockade, sugammadex, neostigmine, thoracic surgery
5374563|NCT01837485|Irritable bowel syndrome|irritable bowel syndrome
5374564|NCT01837485|Functional gastrointestinal disorders|functional gastrointestinal disorders
5374565|NCT01837485|Gut flora|gut flora
5374566|NCT01837485|Probiotics|probiotics
5374567|NCT01837472|Irritable bowel syndrome|irritable bowel syndrome
5374568|NCT01837472|Functional gastrointestinal disorders|functional gastrointestinal disorders
5374569|NCT01837472|Gut flora|gut flora
5374570|NCT01837472|Probiotics|probiotics
5374571|NCT01837459|Obstructive Sleep Apnea|obstructive sleep apnea
5374572|NCT01837459|Sleep Disordered Breathing|sleep disordered breathing
5374573|NCT01837459|Vascular function|vascular function
5374574|NCT01837459|Arterial stiffness|arterial stiffness
5374575|NCT01837459|Polysomnography|polysomnography
5374576|NCT01837459|Cytokines|cytokines
5374577|NCT01837446|mucositis|mucositis
5374578|NCT01837446|topical morphine|topical morphine
5374579|NCT01837446|pain|pain
5374580|NCT01837446|head and neck carcinoma|head and neck carcinoma
5374581|NCT01837433|Efficacy|efficacy
5374587|NCT01837407|nerve defect|nerve defect
5374588|NCT01837407|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5374589|NCT01837407|heterodigital arterialized nerve pedicle flap|heterodigital arterialized nerve pedicle flap
5374590|NCT01837407|Composite Flap|composite flap
5374591|NCT01837407|nerve flap|nerve flap
5374592|NCT01837407|nerve transfer|nerve transfer
5374593|NCT01837394|Nerve block|nerve block
5374594|NCT01837394|Ultrasound|ultrasound
5374595|NCT01837394|postoperative pain|postoperative pain
5374596|NCT01837394|Saphenous nerve|saphenous nerve
5374597|NCT01837394|Obturator nerve|obturator nerve
5374598|NCT01837329|Non-Squamous|non-squamous
5374599|NCT01837329|NSCLC|nsclc
5374600|NCT01837329|Adenocarcinoma|adenocarcinoma
5374601|NCT01837329|Lung Cancer|lung cancer
5374602|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate
5374603|NCT01837329|Copper|copper
5374604|NCT01837329|Carboplatin|carboplatin
5374606|NCT01837329|Newly Diagnosed|newly diagnosed
5374607|NCT01837329|Chemo-naive|chemo-naive
5374608|NCT01837316|pharmacodynamics|pharmacodynamics
5374609|NCT01837316|FF/VI|ff/vi
5348340|NCT01957072|BMI|bmi
5374610|NCT01837316|asthma|asthma
5374611|NCT01837316|duration of action|duration of action
5374612|NCT01837303|Cervical dysplasia|cervical dysplasia
5374613|NCT01837303|Cervical cancer|cervical cancer
5374614|NCT01837290|Renal failure,|renal failure,
5374615|NCT01837290|hip fracture,|hip fracture,
5374616|NCT01837290|spinal anesthesia,|spinal anesthesia,
5374617|NCT01837290|dexmedetomidine|dexmedetomidine
5374618|NCT01837290|patient|patient
5374619|NCT01837264|Magellan MAR01|magellan mar01
5374620|NCT01837264|Autologous Platelet Rich Plasma|autologous platelet rich plasma
5374621|NCT01837264|Compartment Syndrome|compartment syndrome
5374622|NCT01837264|Battlefield Trauma|battlefield trauma
5374623|NCT01837264|Fasciotomy|fasciotomy
5374624|NCT01837251|Ovarian Carcinoma|ovarian carcinoma
5374625|NCT01837251|Bevacizumab|bevacizumab
5374626|NCT01837251|Gemcitabine|gemcitabine
5374628|NCT01837251|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5374629|NCT01837251|Carboplatin|carboplatin
5374630|NCT01837251|best therapeutic index|best therapeutic index
5374631|NCT01837251|progression-free survival|progression-free survival
5374632|NCT01837238|hemodialysis|hemodialysis
5374633|NCT01837238|physical function|physical function
5374634|NCT01837225|Fluorescence Imaging|fluorescence imaging
5374635|NCT01837225|Breast Tumor Margins|breast tumor margins
5374636|NCT01837225|Real-time Assessment|real-time assessment
5374637|NCT01837199|Periodontal disease|periodontal disease
5374638|NCT01837199|Scaling and root planing|scaling and root planing
5374639|NCT01837199|Metronidazole|metronidazole
5374640|NCT01837199|Amoxicillin|amoxicillin
5374641|NCT01837199|Generalized chronic periodontitis|generalized chronic periodontitis
5374642|NCT01837199|Periodontal treatment|periodontal treatment
5374643|NCT01837186|Surgery|surgery
5374644|NCT01837186|NSCLC|nsclc
5374645|NCT01837173|Adenocarcinoma|adenocarcinoma
5374646|NCT01837173|Squamous Cell Carcinoma|squamous cell carcinoma
5374647|NCT01837173|Neoadjuvant treatment|neoadjuvant treatment
5374648|NCT01837173|Esophagectomy|esophagectomy
5374649|NCT01837160|Angiogenesis|angiogenesis
5374650|NCT01837160|Fibrosis|fibrosis
5374651|NCT01837160|Aortic Stenosis|aortic stenosis
5374652|NCT01837160|Imaging|imaging
5374653|NCT01837160|CT-PET|ct-pet
5374654|NCT01837160|PET-CT|pet-ct
5374655|NCT01837160|Cardiac MRI|cardiac mri
5374656|NCT01837147|primary prevention|primary prevention
5374657|NCT01837147|sedentary|sedentary
5374658|NCT01837147|overweight|overweight
5374659|NCT01837147|obesity|obesity
5374661|NCT01837147|post-menopausal|post-menopausal
5374662|NCT01837147|women|women
5374663|NCT01837134|telemedicine|telemedicine
5374664|NCT01837134|overweight|overweight
5374665|NCT01837134|obesity|obesity
5374666|NCT01837121|not-attended rate|not-attended rate
5374667|NCT01837121|re-visit|re-visit
5374668|NCT01837121|vision|vision
5374669|NCT01837121|knowledge|knowledge
5374670|NCT01837121|satisfaction|satisfaction
5374671|NCT01837108|healthy|healthy
5374672|NCT01837095|Overall survival|overall survival
5374673|NCT01837095|Progression free survival|progression free survival
5374674|NCT01837082|Heart Failure|heart failure
5374675|NCT01837082|Iron Deficiency|iron deficiency
5374676|NCT01837082|Anemia|anemia
5374677|NCT01837082|Ferric Carboxymaltose|ferric carboxymaltose
5374678|NCT01837069|Hypertension|hypertension
5374679|NCT01837069|Diabetes|diabetes
5374680|NCT01837069|Coronary Artery Disease|coronary artery disease
5374681|NCT01837069|Peripheral Vascular Disease|peripheral vascular disease
5374682|NCT01837056|Toxoplasma gondii|toxoplasma gondii
5374683|NCT01837056|Toxocara canis|toxocara canis
5374684|NCT01837043|Delayed Graft Function|delayed graft function
5374685|NCT01837043|Renal Transplantation|renal transplantation
5374686|NCT01837043|Kidney Transplant|kidney transplant
5374687|NCT01837017|Falls,|falls,
5374688|NCT01837017|Balance,|balance,
5374689|NCT01837017|Gait,|gait,
5374690|NCT01837017|Older adults|older adults
5374691|NCT01837004|adherence|adherence
5374692|NCT01837004|cognition|cognition
5374693|NCT01837004|exercise|exercise
5374694|NCT01837004|aging|aging
5374695|NCT01836991|gastric cancer|gastric cancer
5374696|NCT01836991|surgery|surgery
5374697|NCT01836991|surgery safety|surgery safety
5374698|NCT01836991|effect|effect
5374699|NCT01836965|Aspergers|aspergers
5374700|NCT01836965|Social Skills|social skills
5374701|NCT01836965|Adolescents|adolescents
5374702|NCT01836965|High-functioning Autism|high-functioning autism
5374703|NCT01836939|psoriasis, oral therapy|psoriasis, oral therapy
5374704|NCT01836939|ova|ova
5374705|NCT01836939|Trichuris suis ova|trichuris suis ova
5374706|NCT01836939|TSO|tso
5374707|NCT01836939|CNDO 201 Trichuris suis ova|cndo 201 trichuris suis ova
5374708|NCT01836926|sphincter sparing procedures|sphincter sparing procedures
5374709|NCT01836926|intersphincteric resection|intersphincteric resection
5374710|NCT01836926|rectal cancer|rectal cancer
5374711|NCT01836926|low rectal cancer|low rectal cancer
5374712|NCT01836926|sphincter preserving procedures|sphincter preserving procedures
5374713|NCT01836926|Abdominoperineal resection|abdominoperineal resection
5374714|NCT01836926|laparoscopic resection of rectal cancer|laparoscopic resection of rectal cancer
5374715|NCT01836926|laparoscopic versus open colorectal resection|laparoscopic versus open colorectal resection
5374716|NCT01836926|laparoscopic versus open rectal surgery|laparoscopic versus open rectal surgery
5374717|NCT01836926|neoadjuvant chemo-radiotherapy for rectal cancer|neoadjuvant chemo-radiotherapy for rectal cancer
5374719|NCT01836913|Esophageal cancer|esophageal cancer
5374720|NCT01836913|Radiotherapy|radiotherapy
5374721|NCT01836900|OTSC|otsc
5374722|NCT01836900|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5374723|NCT01836887|Polyphenol|polyphenol
5374724|NCT01836887|Fruit|fruit
5374725|NCT01836887|Metabolic|metabolic
5374726|NCT01836887|Healthy|healthy
5374727|NCT01836874|Migraine|migraine
5374728|NCT01836874|Indian|indian
5374729|NCT01836874|Topiramate|topiramate
5374730|NCT01836861|Phase I|phase i
5374731|NCT01836861|healthy male volunteers|healthy male volunteers
5374732|NCT01836861|ADME|adme
5374733|NCT01836861|Bioavailability|bioavailability
5374734|NCT01836861|PI3K inhibitor|pi3k inhibitor
5374735|NCT01836861|Absorption|absorption
5374736|NCT01836861|Distribution|distribution
5374737|NCT01836861|Metabolism|metabolism
5374738|NCT01836861|Excretion|excretion
5374739|NCT01836861|safety|safety
5374740|NCT01836848|subarachnoid hemorrhage|subarachnoid hemorrhage
5374741|NCT01836848|near-infrared-spectroscopy|near-infrared-spectroscopy
5374742|NCT01836848|indocyanine green|indocyanine green
5374743|NCT01836848|secondary ischemia|secondary ischemia
5374744|NCT01836835|Hyperemesis gravidarum|hyperemesis gravidarum
5374745|NCT01836835|Pregnancy|pregnancy
5374746|NCT01836835|Nausea|nausea
5374747|NCT01836835|Nutritional status|nutritional status
5374748|NCT01836835|Questionnaire|questionnaire
5374749|NCT01836835|Case-control|case-control
5374750|NCT01836822|mediastinal lymph node enlargement|mediastinal lymph node enlargement
5374751|NCT01836822|sarcoidosis|sarcoidosis
5374752|NCT01836822|bronchoscopy|bronchoscopy
5374753|NCT01836822|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
5374754|NCT01836822|transbronchial needle aspiration (EBUS-TBNA)|transbronchial needle aspiration (ebus-tbna)
5374755|NCT01836822|EBUS guided transbronchial forceps biopsy EBUS-TBFB)|ebus guided transbronchial forceps biopsy ebus-tbfb)
5374756|NCT01836809|Total Artificial Heart|total artificial heart
5374757|NCT01836809|Left Ventricular Assist Device|left ventricular assist device
5374758|NCT01836809|Natriuretic peptides|natriuretic peptides
5374759|NCT01836809|Heart Failure|heart failure
5374760|NCT01836809|Cardiorenal Syndrome|cardiorenal syndrome
5374767|NCT01836731|weight-for age|weight-for age
5374768|NCT01836731|height-for-age|height-for-age
5374769|NCT01836731|water sanitation facilities|water sanitation facilities
5374770|NCT01836731|hygiene behavior|hygiene behavior
5374771|NCT01836718|Hepatitis C Virus|hepatitis c virus
5374772|NCT01836718|Liver Transplantation|liver transplantation
5374773|NCT01836718|Antiviral Therapy|antiviral therapy
5374774|NCT01836718|HCV|hcv
5374775|NCT01836679|Chidamide,lung cancer|chidamide,lung cancer
5374776|NCT01836653|Bevacizumab|bevacizumab
5374777|NCT01836653|Cetuximab|cetuximab
5374778|NCT01836653|KRAS wild type colorectal cancer|kras wild type colorectal cancer
5374779|NCT01836653|RAS wild type colorectal cancer|ras wild type colorectal cancer
5374780|NCT01836653|liver metastasis|liver metastasis
5374781|NCT01836627|Congenital Muscular Dystrophy|congenital muscular dystrophy
5374782|NCT01836627|Collagen VI Deficiency|collagen vi deficiency
5374783|NCT01836627|Hyperinsufflation|hyperinsufflation
5374784|NCT01836627|Cough Assist|cough assist
5374785|NCT01836627|LAMA2- Muscular Dystrophy|lama2- muscular dystrophy
5374786|NCT01836601|safety|safety
5374787|NCT01836601|patient experience|patient experience
5374788|NCT01836601|family-centered rounds|family-centered rounds
5374790|NCT01836575|PS2|ps2
5374791|NCT01836575|Pemetrexed|pemetrexed
5374792|NCT01836575|First line|first line
5374793|NCT01836575|non squamous|non squamous
5374794|NCT01836562|Autism stem cell MNCs|autism stem cell mncs
5374795|NCT01836536|High grade glioma|high grade glioma
5374796|NCT01836536|Bevacizumab|bevacizumab
5374797|NCT01836536|Chemotherapy|chemotherapy
5374798|NCT01836536|Myeloid Cells|myeloid cells
5374799|NCT01836536|Treg|treg
5374800|NCT01836510|Heart Failure|heart failure
5374801|NCT01836510|Remote Monitoring|remote monitoring
5374802|NCT01836510|Lung Edema|lung edema
5374803|NCT01836510|Patient Monitoring|patient monitoring
5374804|NCT01836510|Prediction|prediction
5374805|NCT01836484|Surgically staged endometrial carcinoma|surgically staged endometrial carcinoma
5374806|NCT01836484|Surgically staged cervical carcinoma|surgically staged cervical carcinoma
5374807|NCT01836458|Malaria, KAE609|malaria, kae609
5374808|NCT01836432|Pancreatic Cancer|pancreatic cancer
5374809|NCT01836432|Immunotherapy|immunotherapy
5374810|NCT01836432|Vaccine Therapy|vaccine therapy
5374811|NCT01836419|classic laryngeal mask airway|classic laryngeal mask airway
5374822|NCT01836367|Scalp|scalp
5374823|NCT01836367|Ingenol Mebutate|ingenol mebutate
5374828|NCT01836341|Afatinib|afatinib
5360637|NCT01899521|zinc|zinc
5374829|NCT01836341|Cisplatin|cisplatin
5374830|NCT01836341|Carboplatin|carboplatin
5374831|NCT01836341|Pemetrexed|pemetrexed
5374832|NCT01836341|Radiation therapy|radiation therapy
5374833|NCT01836341|EGFR mutation|egfr mutation
5374834|NCT01836341|12-279|12-279
5374835|NCT01836328|Methadone|methadone
5374836|NCT01836328|Pain|pain
5374837|NCT01836328|Neoplasms|neoplasms
5374838|NCT01836328|Ratio|ratio
5374839|NCT01836237|Surgical site infection rate|surgical site infection rate
5374840|NCT01836237|Wound protector use|wound protector use
5374841|NCT01836237|Whipple|whipple
5374842|NCT01836211|Chest pain|chest pain
5374843|NCT01836211|Acute coronary syndrome|acute coronary syndrome
5374844|NCT01836211|Cardiac biomarkers|cardiac biomarkers
5374845|NCT01836211|Computed coronary tomography angiography|computed coronary tomography angiography
5374846|NCT01836211|Emergency department|emergency department
5374847|NCT01836172|The treatment of diabetic complication|the treatment of diabetic complication
5374848|NCT01836159|Stroke Rehabilitation|stroke rehabilitation
5374849|NCT01836159|iPad|ipad
5374850|NCT01836159|Fine Motor Function|fine motor function
5374851|NCT01836159|Ischemic Stroke|ischemic stroke
5374852|NCT01836159|Visual Neglect|visual neglect
5374853|NCT01836120|second-line chemotherapy|second-line chemotherapy
5374854|NCT01836120|Raltitrexed|raltitrexed
5374855|NCT01836107|Clinical notes|clinical notes
5374856|NCT01836107|Communication between physicians|communication between physicians
5374857|NCT01836107|Quality|quality
5374858|NCT01836107|Cross-cultural adaptation|cross-cultural adaptation
5374859|NCT01836094|Methylene Blue|methylene blue
5374860|NCT01836094|Memory|memory
5374861|NCT01836094|Mental Fatigue|mental fatigue
5374862|NCT01836094|Brain metabolism|brain metabolism
5374863|NCT01836094|fMRI|fmri
5374864|NCT01836094|psychomotor vigilance task (PVT)|psychomotor vigilance task (pvt)
5374865|NCT01836094|delayed match-to-sample memory task|delayed match-to-sample memory task
5374867|NCT01836094|DMS|dms
5374868|NCT01836081|fluid responsiveness|fluid responsiveness
5374869|NCT01836081|carotid artery peak velocity variation|carotid artery peak velocity variation
5374870|NCT01836081|coronary disease|coronary disease
5374871|NCT01836068|HIV positive|hiv positive
5374872|NCT01836068|HIV-1|hiv-1
5374873|NCT01836068|Bone Marrow Transplant|bone marrow transplant
5374874|NCT01836068|Allogeneic BMT|allogeneic bmt
5374875|NCT01836068|BMT|bmt
5374876|NCT01836055|Multiple Sclerosis|multiple sclerosis
5374877|NCT01836055|White Matter Lesions|white matter lesions
5374878|NCT01836055|Contrast Agent|contrast agent
5374879|NCT01836055|Magnetic Resonance Imaging|magnetic resonance imaging
5374880|NCT01836042|Primary open-angle glaucoma (POAG)|primary open-angle glaucoma (poag)
5374881|NCT01836042|Trabecular meshwork|trabecular meshwork
5362115|NCT01892566|HIV|hiv
5374882|NCT01836042|iStent|istent
5374883|NCT01836029|SCCHN|scchn
5374884|NCT01836029|HNSCC|hnscc
5374885|NCT01836016|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5374886|NCT01836016|Comparative effectiveness research|comparative effectiveness research
5374887|NCT01836016|Medicine, Chinese Traditional|medicine, chinese traditional
5374888|NCT01836016|Humans|humans
5374889|NCT01836016|Treatment Outcome|treatment outcome
5374890|NCT01836003|Pregnancy|pregnancy
5374891|NCT01836003|Prevention of Mother to Child Transmission|prevention of mother to child transmission
5374892|NCT01836003|Short Message Service (SMS)|short message service (sms)
5374893|NCT01836003|HIV infection|hiv infection
5374894|NCT01836003|CD4 testing|cd4 testing
5374895|NCT01836003|Antiretroviral therapy|antiretroviral therapy
5374896|NCT01835990|venous thromboembolism|venous thromboembolism
5374897|NCT01835990|trauma|trauma
5374898|NCT01835990|mechanical methods of prophylaxis|mechanical methods of prophylaxis
5374899|NCT01835977|Focal therapy|focal therapy
5374900|NCT01835977|Irreversible electroporation|irreversible electroporation
5374905|NCT01835951|Debriefing|debriefing
5374906|NCT01835951|Anaesthesia Crisis Management|anaesthesia crisis management
5374907|NCT01835951|Cardiac Arrest|cardiac arrest
5374908|NCT01835951|Pregnancy|pregnancy
5374909|NCT01835938|Hepatitis C Virus infection|hepatitis c virus infection
5374910|NCT01835938|entry inhibitor|entry inhibitor
5374911|NCT01835938|kinase inhibitor|kinase inhibitor
5374912|NCT01835925|adenocarcinoma of rectum|adenocarcinoma of rectum
5374913|NCT01835925|rectal cancer|rectal cancer
5374914|NCT01835925|stage II|stage ii
5374915|NCT01835925|stage III|stage iii
5374916|NCT01835912|performance|performance
5374917|NCT01835912|speed|speed
5374918|NCT01835912|exertion|exertion
5374919|NCT01835860|BPH|bph
5374920|NCT01835834|zirconia crown|zirconia crown
5374921|NCT01835821|zirconia|zirconia
5374922|NCT01835821|crown|crown
5374923|NCT01835821|IPS e.max CAD|ips e.max cad
5374924|NCT01835808|Fractional flow reserve|fractional flow reserve
5374925|NCT01835795|Myofascial Pain Syndromes|myofascial pain syndromes
5374926|NCT01835795|Myofascial Trigger Point|myofascial trigger point
5374927|NCT01835795|Low Back Pain|low back pain
5374928|NCT01835795|Lumbago|lumbago
5374929|NCT01835795|Shock Waves, High-Energy|shock waves, high-energy
5374930|NCT01835795|High-Energy Shock Waves|high-energy shock waves
5374931|NCT01835795|Interdisciplinary Health Team|interdisciplinary health team
5374932|NCT01835795|Multidisciplinary Pain Centers|multidisciplinary pain centers
5374933|NCT01835782|ALS|als
5374934|NCT01835782|L-Serine|l-serine
5374935|NCT01835782|BMAA|bmaa
5374936|NCT01835717|Preclinical phase of Alzheimer's disease|preclinical phase of alzheimer's disease
5374937|NCT01835717|Asymptomatic phase of Alzheimer's disease|asymptomatic phase of alzheimer's disease
5374938|NCT01835717|Cognitive normal|cognitive normal
5374939|NCT01835717|Exogenous factors|exogenous factors
5374940|NCT01835717|Endogenous factors|endogenous factors
5374941|NCT01835717|Episodic memory test|episodic memory test
5374942|NCT01835717|Executive function test|executive function test
5374943|NCT01835717|Memory binding test validation into Spanish|memory binding test validation into spanish
5374944|NCT01835717|Memory binding test validation into Catalan|memory binding test validation into catalan
5374945|NCT01835691|Chronic Kidney Disease|chronic kidney disease
5374946|NCT01835691|Vitamin D|vitamin d
5374947|NCT01835691|Vitamin D2|vitamin d2
5374948|NCT01835691|Vitamin D3|vitamin d3
5374949|NCT01835652|Exercise|exercise
5374950|NCT01835652|Parkinson's Disease|parkinson's disease
5374951|NCT01835652|Positron Emission Tomography|positron emission tomography
5374952|NCT01835652|fMRI|fmri
5374953|NCT01835639|Glomerular Disease|glomerular disease
5374954|NCT01835639|Vitamin D|vitamin d
5374955|NCT01835639|Steroid-resistant nephrotic syndrome|steroid-resistant nephrotic syndrome
5374956|NCT01835639|Minimal change disease|minimal change disease
5374957|NCT01835639|Focal segmental glomerulosclerosis (FSGS)|focal segmental glomerulosclerosis (fsgs)
5374959|NCT01835639|Membranoprolfierative Glomerulonephritis|membranoprolfierative glomerulonephritis
5374960|NCT01835639|immunoglobulin A (IgA) Nephropathy|immunoglobulin a (iga) nephropathy
5374961|NCT01835639|FSGS|fsgs
5374962|NCT01835639|IgA Nephropathy|iga nephropathy
5374963|NCT01835626|Locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
5374964|NCT01835626|Skin cancer|skin cancer
5374965|NCT01835626|Radiation therapy|radiation therapy
5374966|NCT01835626|Vismodegib|vismodegib
5374967|NCT01835626|Head and neck cancer|head and neck cancer
5374968|NCT01835626|Cutaneous malignancy|cutaneous malignancy
5374969|NCT01835613|Rheumatoid Arthritis|rheumatoid arthritis
5374970|NCT01835613|Early RA|early ra
5374971|NCT01835613|RA|ra
5374972|NCT01835613|IL-6|il-6
5374973|NCT01835613|IL-6R|il-6r
5374974|NCT01835613|Inhibitor|inhibitor
5374975|NCT01835613|Inhibition|inhibition
5374976|NCT01835613|Tocilizumab|tocilizumab
5374977|NCT01835613|Biomarkers|biomarkers
5374978|NCT01835613|DMARDs|dmards
5374979|NCT01835613|Biological|biological
5374980|NCT01835613|DAS|das
5374981|NCT01835613|SDAI|sdai
5374982|NCT01835613|AR/BIOM|ar/biom
5374983|NCT01835613|OEG|oeg
5374984|NCT01835587|Acute myeloid leukemia,|acute myeloid leukemia,
5374985|NCT01835587|myelodysplastic syndromes,|myelodysplastic syndromes,
5374986|NCT01835587|CC-486, oral Azacitidine,|cc-486, oral azacitidine,
5374987|NCT01835587|transplantation,|transplantation,
5374988|NCT01835587|allogeneic,|allogeneic,
5374989|NCT01835587|HSCT.|hsct.
5374990|NCT01835574|Amphetamine-type substance use|amphetamine-type substance use
5374991|NCT01835561|Hepatic, Liver disease; Pharmacokinetic; Healthy|hepatic, liver disease; pharmacokinetic; healthy
5374992|NCT01835509|Childhood Cancer Survivors|childhood cancer survivors
5374993|NCT01835496|sickle cell disease|sickle cell disease
5374994|NCT01835496|iron overload|iron overload
5370474|NCT01855503|Metastatic|metastatic
5374996|NCT01835496|Ferriprox|ferriprox
5374997|NCT01835496|deferiprone|deferiprone
5374998|NCT01835457|Endotoxemia|endotoxemia
5374999|NCT01835457|Autonomic Nervous System|autonomic nervous system
5375000|NCT01835457|Inflammation|inflammation
5375001|NCT01835457|Meditation|meditation
5375002|NCT01835457|Concentration|concentration
5375008|NCT01835444|Substitution|substitution
5375009|NCT01835444|Hospital ward care|hospital ward care
5375010|NCT01835444|Secondary health care|secondary health care
5375011|NCT01835418|managed with bedtime administration of lisinopril versus amlodipine|managed with bedtime administration of lisinopril versus amlodipine
5375012|NCT01835392|Remote ischemic preconditioning|remote ischemic preconditioning
5375013|NCT01835392|Heart defects, congenital|heart defects, congenital
5375014|NCT01835392|cardiac surgery|cardiac surgery
5375015|NCT01835392|Neurodevelopmental outcomes|neurodevelopmental outcomes
5375016|NCT01835379|Diabetes|diabetes
5375017|NCT01835379|Diabetic Foot Ulcer|diabetic foot ulcer
5375018|NCT01835379|Diabetic Foot Wound|diabetic foot wound
5375019|NCT01835379|Non-healing foot wound|non-healing foot wound
5375020|NCT01835379|Oasis|oasis
5375021|NCT01835379|Diabetic neuropathy|diabetic neuropathy
5375022|NCT01835353|prasugrel|prasugrel
5375023|NCT01835353|ST elevation myocardial infarction|st elevation myocardial infarction
5375024|NCT01835327|intraoperative, post-operative recovery|intraoperative, post-operative recovery
5375025|NCT01835327|thoracic surgery|thoracic surgery
5375026|NCT01835327|cerebral oximetry|cerebral oximetry
5375027|NCT01835262|pain|pain
5375028|NCT01835262|Ketamine|ketamine
5375029|NCT01835262|Emergency Medicine|emergency medicine
5375030|NCT01835262|morphine|morphine
5375031|NCT01835249|Hypertension|hypertension
5348688|NCT01955148|PTB|ptb
5375032|NCT01835249|Nighttime blood pressure|nighttime blood pressure
5375033|NCT01835236|Breast cancer|breast cancer
5375034|NCT01835236|HER2-positive|her2-positive
5375035|NCT01835236|Metastases|metastases
5375036|NCT01835197|Phase 1|phase 1
5375037|NCT01835197|Randomized|randomized
5375038|NCT01835197|Double Blind|double blind
5375039|NCT01835197|Placebo-Controlled|placebo-controlled
5375040|NCT01835197|Single- & Multiple Dose Escalation|single- & multiple dose escalation
5375041|NCT01835197|Safety|safety
5375042|NCT01835197|Tolerability|tolerability
5375043|NCT01835197|PK|pk
5375044|NCT01835197|PD|pd
5375045|NCT01835197|Pf-04965842|pf-04965842
5375046|NCT01835132|Scleritis|scleritis
5375047|NCT01835132|IL-1|il-1
5375048|NCT01835119|gynecological malignancies|gynecological malignancies
5375049|NCT01835119|postoperative|postoperative
5375050|NCT01835119|bowel activity|bowel activity
5375051|NCT01835119|gum chewing|gum chewing
5375052|NCT01835106|Postoperative Care|postoperative care
5375053|NCT01835080|Obstructive Sleep Apnea, OSA, Pulmonary Arterial Hypertension, PAH, sleep study, polysomnogram, Respiratory Disturbance Index, RDI|obstructive sleep apnea, osa, pulmonary arterial hypertension, pah, sleep study, polysomnogram, respiratory disturbance index, rdi
5375057|NCT01835054|Mitral valve prolapse|mitral valve prolapse
5375058|NCT01835054|Echocardiography, Doppler|echocardiography, doppler
5375059|NCT01835054|Stress echocardiography|stress echocardiography
5375060|NCT01835054|Cardiopulmonary exercice testing|cardiopulmonary exercice testing
5375061|NCT01835054|Magnetic Resonance Imaging|magnetic resonance imaging
5375062|NCT01835054|Cardiac neurohormones|cardiac neurohormones
5375063|NCT01835054|Visceral obesity|visceral obesity
5375064|NCT01835054|Cardiometabolic risk|cardiometabolic risk
5375065|NCT01835054|Risk stratification|risk stratification
5375066|NCT01835028|Aortic Stenosis|aortic stenosis
5375067|NCT01835028|Low Flow|low flow
5375068|NCT01835028|Low Gradient|low gradient
5375069|NCT01835028|Left Ventricle|left ventricle
5375070|NCT01835028|Echocardiography, Doppler|echocardiography, doppler
5375071|NCT01835015|First in human|first in human
5375072|NCT01835015|Safety|safety
5375073|NCT01835015|Tolerability|tolerability
5375074|NCT01835015|Serum PK|serum pk
5375075|NCT01835015|Intravitreal (IVT)|intravitreal (ivt)
5375076|NCT01835015|Age-related macular degeneration|age-related macular degeneration
5375077|NCT01835015|AMD|amd
5375078|NCT01835015|Geographic Atrophy|geographic atrophy
5375079|NCT01835015|Choroidal neovascularization|choroidal neovascularization
5375080|NCT01835002|transcorneal electrostimulation|transcorneal electrostimulation
5375081|NCT01834976|cardiac biomarker|cardiac biomarker
5375082|NCT01834976|congenital heart disease|congenital heart disease
5375083|NCT01834976|surgery|surgery
5375084|NCT01834937|ExAblate|exablate
5375085|NCT01834937|MRgFUS|mrgfus
5375086|NCT01834937|Bone Metastases|bone metastases
5375087|NCT01834937|Pain Palliation|pain palliation
5375088|NCT01834924|Health literacy|health literacy
5375089|NCT01834924|Patient education|patient education
5375090|NCT01834911|Huntington disease|huntington disease
5375091|NCT01834911|HD|hd
5375092|NCT01834911|tetrabenazine|tetrabenazine
5375093|NCT01834911|Stroop|stroop
5375094|NCT01834898|postoperative|postoperative
5375095|NCT01834898|analgesia|analgesia
5375096|NCT01834898|adverse effects|adverse effects
5375097|NCT01834898|opioid|opioid
5375098|NCT01834898|oxycodone|oxycodone
5375099|NCT01834885|COPD|copd
5375100|NCT01834859|weight reduction programs|weight reduction programs
5375102|NCT01834859|Caloric restriction|caloric restriction
5375103|NCT01834859|weight loss|weight loss
5375104|NCT01834859|weight gain|weight gain
5375105|NCT01834846|comparative study|comparative study
5375106|NCT01834846|Cardiac Surgical Procedures|cardiac surgical procedures
5375107|NCT01834833|Acute heart failure; rehospitalisation; education; follow-up|acute heart failure; rehospitalisation; education; follow-up
5375108|NCT01834820|Bronchiolitis|bronchiolitis
5375109|NCT01834820|Epinephrine|epinephrine
5375110|NCT01834820|Dexamethasone|dexamethasone
5375111|NCT01834820|Hospitalization|hospitalization
5375112|NCT01834820|Hypertonic Saline|hypertonic saline
5375113|NCT01834794|Tobacco Use|tobacco use
5375114|NCT01834781|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields|multiple chemical sensitivity, re5 therapy, pulsed electromagnetic fields
5375115|NCT01834742|Moviprep|moviprep
5375116|NCT01834742|PEG3350|peg3350
5375117|NCT01834742|Laxative|laxative
5375118|NCT01834742|Stool Output|stool output
5375119|NCT01834690|Liver transplantation/epidemiology|liver transplantation/epidemiology
5375120|NCT01834690|Liver transplantation/pharmacology|liver transplantation/pharmacology
5375121|NCT01834690|Health status/drug effects|health status/drug effects
5375122|NCT01834690|Agents, immunosuppressive agents|agents, immunosuppressive agents
5375123|NCT01834677|Depression|depression
5375124|NCT01834677|Neurocognition|neurocognition
5375125|NCT01834677|Electroconvulsive Therapy (ECT)|electroconvulsive therapy (ect)
5375126|NCT01834677|Parkinson's Disease|parkinson's disease
5375127|NCT01834664|Ataxic Infantile Cerebral Palsy stem cell therapy|ataxic infantile cerebral palsy stem cell therapy
5375128|NCT01834651|liver metastasis|liver metastasis
5375129|NCT01834651|lung metastasis|lung metastasis
5375130|NCT01834651|metastatic castrate-resistant|metastatic castrate-resistant
5375131|NCT01834651|prostate cancer|prostate cancer
5375132|NCT01834638|schizophrenia|schizophrenia
5375133|NCT01834612|blood loss, hemorrhage, hemorrhagic shcok|blood loss, hemorrhage, hemorrhagic shcok
5375134|NCT01834599|placental oxygenation|placental oxygenation
5375135|NCT01834599|obstetric anesthesia|obstetric anesthesia
5375137|NCT01834599|cerebral oximetry|cerebral oximetry
5375138|NCT01834599|cerebral oximeter|cerebral oximeter
5375139|NCT01834573|inflammatory bowel disease|inflammatory bowel disease
5375140|NCT01834573|IBD|ibd
5375141|NCT01834573|quality of life|quality of life
5375142|NCT01834573|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
5375143|NCT01834560|deep brain stimulation|deep brain stimulation
5375144|NCT01834560|subgenual cortex (CG25)|subgenual cortex (cg25)
5375145|NCT01834547|chess, cognition|chess, cognition
5375146|NCT01834521|Breast cancer|breast cancer
5375147|NCT01834521|psychosocial|psychosocial
5375148|NCT01834521|website|website
5375149|NCT01834521|empowerment|empowerment
5375548|NCT01832857|advanced|advanced
5375150|NCT01834508|Experienced Treatment|experienced treatment
5375151|NCT01834495|Peripheral artery disease|peripheral artery disease
5375152|NCT01834495|atherosclerosis|atherosclerosis
5375153|NCT01834495|stent|stent
5375154|NCT01834482|seizures|seizures
5375155|NCT01834482|epilepsy|epilepsy
5375156|NCT01834482|adult|adult
5375157|NCT01834482|intractable|intractable
5375158|NCT01834482|medically refractory|medically refractory
5375159|NCT01834482|Atkins|atkins
5375160|NCT01834482|ketogenic|ketogenic
5375161|NCT01834482|diet|diet
5375162|NCT01834469|Ovarian,metastasis|ovarian,metastasis
5375163|NCT01834456|Medically Complex Children|medically complex children
5375164|NCT01834456|Family Experience in Healthcare|family experience in healthcare
5375165|NCT01834456|Patient Centered Care|patient centered care
5375166|NCT01834456|Family Centered Care|family centered care
5375167|NCT01834456|Case Management|case management
5375168|NCT01834456|Care Management|care management
5375169|NCT01834456|Care Coordination|care coordination
5375170|NCT01834456|Care Plan|care plan
5375171|NCT01834456|Extensivist|extensivist
5375172|NCT01834456|Medical Home|medical home
5375173|NCT01834456|Children with Special Health Care Needs|children with special health care needs
5375174|NCT01834456|Coordinated Care|coordinated care
5375175|NCT01834456|Quality in Healthcare|quality in healthcare
5375176|NCT01834456|Satisfaction in Healthcare|satisfaction in healthcare
5375177|NCT01834456|Cost|cost
5375178|NCT01834456|Utilization|utilization
5375179|NCT01834456|Impact on Family|impact on family
5375180|NCT01834456|Quality of Life|quality of life
5375181|NCT01834456|Palliative Care|palliative care
5375182|NCT01834456|Complex Chronic Conditions|complex chronic conditions
5375183|NCT01834456|Life-limiting illness|life-limiting illness
5375184|NCT01834456|Integrative Care|integrative care
5375185|NCT01834456|Primary Care|primary care
5375186|NCT01834456|Comprehensive Care|comprehensive care
5375187|NCT01834456|Behavioral Care|behavioral care
5375188|NCT01834443|spatial neglect|spatial neglect
5375189|NCT01834443|galvanic vestibular stimulation as therapy|galvanic vestibular stimulation as therapy
5375190|NCT01834417|Pressure ulcer, spinal cord injury, on-board device|pressure ulcer, spinal cord injury, on-board device
5375191|NCT01834404|Obesity|obesity
5375192|NCT01834404|BMI|bmi
5375195|NCT01834404|Phentermine|phentermine
5375196|NCT01834404|Topiramate|topiramate
5375197|NCT01834378|diabetes|diabetes
5375198|NCT01834378|insulin resistance|insulin resistance
5375199|NCT01834378|exercise|exercise
5375200|NCT01834365|Hypertension|hypertension
5375201|NCT01834352|Walnut hypersensitivity|walnut hypersensitivity
5375202|NCT01834352|Tree nut hypersensitivity|tree nut hypersensitivity
5375204|NCT01834326|dental implants|dental implants
5375205|NCT01834326|deficient keratinized oral mucosa|deficient keratinized oral mucosa
5375206|NCT01834313|Willingness-to-pay|willingness-to-pay
5375207|NCT01834313|Patient-centredness|patient-centredness
5375208|NCT01834313|Health insurers|health insurers
5375209|NCT01834313|Fertility care|fertility care
5375210|NCT01834300|Hepatic insulin sensitivity|hepatic insulin sensitivity
5375211|NCT01834300|Muscle insulin sensitivity|muscle insulin sensitivity
5375212|NCT01834300|B cell function|b cell function
5375213|NCT01834300|VLDL1 TG metabolism|vldl1 tg metabolism
5375214|NCT01834300|VLDL2 TG metabolism|vldl2 tg metabolism
5375215|NCT01834287|Physical Activity|physical activity
5375216|NCT01834287|Latinas|latinas
5375217|NCT01834287|Web-based|web-based
5375218|NCT01834287|Spanish-language|spanish-language
5375219|NCT01834274|Drug Therapy|drug therapy
5375220|NCT01834261|oxytocin|oxytocin
5375221|NCT01834261|trust|trust
5375222|NCT01834261|kinship|kinship
5375223|NCT01834261|kin selection|kin selection
5375224|NCT01834235|Pancreatic neoplasms|pancreatic neoplasms
5375225|NCT01834235|Pancreatic cancer|pancreatic cancer
5375226|NCT01834235|Pancreatic cancer, adult|pancreatic cancer, adult
5375227|NCT01834235|Adenoma of the pancreas|adenoma of the pancreas
5375228|NCT01834235|Carcinoma of the pancreas|carcinoma of the pancreas
5375229|NCT01834209|Prostate neoplasms|prostate neoplasms
5375230|NCT01834209|Prostate cancer|prostate cancer
5375231|NCT01834209|Metastatic prostate cancer|metastatic prostate cancer
5375232|NCT01834209|Metatatic castration resistant prostate cancer|metatatic castration resistant prostate cancer
5375233|NCT01834209|Abiraterone acetate|abiraterone acetate
5375234|NCT01834209|Prednisone|prednisone
5375235|NCT01834209|Prednisolone|prednisolone
5375236|NCT01834209|Early access program|early access program
5375237|NCT01834196|retinal vascular disease|retinal vascular disease
5375238|NCT01834196|Swept-Source Ocular Coherence Tomography|swept-source ocular coherence tomography
5375239|NCT01834196|SSOCT|ssoct
5375240|NCT01834183|Metastatic|metastatic
5375241|NCT01834170|Pancreatic cancer|pancreatic cancer
5375242|NCT01834170|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5375243|NCT01834170|Endoscopic ultrasound|endoscopic ultrasound
5375244|NCT01834144|Type 1 Diabetes|type 1 diabetes
5375245|NCT01834144|Hypoglycaemia|hypoglycaemia
5375246|NCT01834144|Glycaemic variability|glycaemic variability
5375247|NCT01834144|Vigorous Intensity Physical Activity|vigorous intensity physical activity
5375248|NCT01834144|Continuous Glucose Monitoring|continuous glucose monitoring
5375249|NCT01834131|hypertension|hypertension
5375250|NCT01834131|community health worker|community health worker
5375251|NCT01834131|home health education|home health education
5375252|NCT01834131|medication adherence|medication adherence
5375253|NCT01834131|mobile health|mobile health
5375254|NCT01834131|physician education|physician education
5375255|NCT01834131|home blood pressure monitoring|home blood pressure monitoring
5375256|NCT01834131|implementation|implementation
5375382|NCT01833533|Interferon-Free|interferon-free
5375257|NCT01834105|Postmenopausal osteoporosis; Kidney Yin deficiency syndrome; Liuwei dihuang pill; CLCF1; JAK - STAT signal pathway|postmenopausal osteoporosis; kidney yin deficiency syndrome; liuwei dihuang pill; clcf1; jak - stat signal pathway
5375258|NCT01834092|Abdominal Aortic Aneurism|abdominal aortic aneurism
5375259|NCT01834092|Endothelia|endothelia
5375260|NCT01834092|Glycocalyx|glycocalyx
5375261|NCT01834092|Reperfusion|reperfusion
5375262|NCT01834092|Plasma|plasma
5375263|NCT01834079|Optic Atrophy,Stem cell therapy|optic atrophy,stem cell therapy
5375264|NCT01834066|muscular Dystrophy stem cell|muscular dystrophy stem cell
5375265|NCT01834053|Huntington Disease,stem cell therapy|huntington disease,stem cell therapy
5375266|NCT01834040|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5375267|NCT01834040|Muscular Dystrophy|muscular dystrophy
5375268|NCT01834040|Myopathy|myopathy
5375269|NCT01834027|music|music
5375270|NCT01834027|stress|stress
5375271|NCT01834027|anxiety|anxiety
5375272|NCT01834027|post-surgical|post-surgical
5375273|NCT01834027|pain|pain
5375274|NCT01834014|Liver only metastasis from KRAS Exon 2 wild type|liver only metastasis from kras exon 2 wild type
5375275|NCT01834014|Liver only metastasis from RAS wild type|liver only metastasis from ras wild type
5375276|NCT01834001|MRI|mri
5375277|NCT01834001|Prostate Cancer|prostate cancer
5375278|NCT01834001|MRI-Guided Biopsy|mri-guided biopsy
5375279|NCT01834001|Radiation|radiation
5375280|NCT01834001|Biochemical Failure|biochemical failure
5375281|NCT01833988|bionic pancreas|bionic pancreas
5375282|NCT01833988|artificial pancreas|artificial pancreas
5375283|NCT01833988|insulin|insulin
5375284|NCT01833988|glucagon|glucagon
5375285|NCT01833988|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5375286|NCT01833988|outpatient|outpatient
5375287|NCT01833988|insulin pump|insulin pump
5375288|NCT01833988|pediatrics|pediatrics
5375289|NCT01833988|children|children
5375291|NCT01833988|summer camp|summer camp
5375292|NCT01833975|Spinal Cord Injury stem cell|spinal cord injury stem cell
5375293|NCT01833962|Lumbar fusion rates|lumbar fusion rates
5375294|NCT01833962|Actifuse synthetic bone graft|actifuse synthetic bone graft
5375295|NCT01833962|Baxter Healthcare|baxter healthcare
5375296|NCT01833962|Other synthetic bone graft|other synthetic bone graft
5375297|NCT01833949|polycystic ovary syndrome,laparoscopic ovarian drilling|polycystic ovary syndrome,laparoscopic ovarian drilling
5375298|NCT01833936|Achilles|achilles
5375299|NCT01833923|Advanced cancer|advanced cancer
5375300|NCT01833910|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5375301|NCT01833910|Education|education
5375302|NCT01833897|Bipolar Disorder|bipolar disorder
5375303|NCT01833884|Hodgkin Lymphoma, Adult|hodgkin lymphoma, adult
5375304|NCT01833884|Cytokines|cytokines
5375305|NCT01833884|TARC|tarc
5375306|NCT01833884|IL-6|il-6
5375307|NCT01833884|IL1-RA|il1-ra
5375308|NCT01833884|sCD30|scd30
5375309|NCT01833884|TNFR1|tnfr1
5375311|NCT01833845|Hepatitis C|hepatitis c
5375312|NCT01833845|Hep-C|hep-c
5680245|NCT00578526|urothelial cancer|urothelial cancer
5375313|NCT01833832|Synergy for Cisplatin and Hyperthermia|synergy for cisplatin and hyperthermia
5375315|NCT01833832|Poor Prognosis|poor prognosis
5375316|NCT01833819|Laparoscopic cholecystectomy,|laparoscopic cholecystectomy,
5375317|NCT01833819|Total intravenous anesthesia,|total intravenous anesthesia,
5470156|NCT01420419|lanolin|lanolin
5362940|NCT01889134|RANKL|rankl
5375318|NCT01833819|Propofol,|propofol,
5375319|NCT01833819|Dexmedetomidine,|dexmedetomidine,
5375320|NCT01833819|Lidocaine,|lidocaine,
5375321|NCT01833819|Remifentanil,|remifentanil,
5375322|NCT01833819|Postoperative analgesic consumption,|postoperative analgesic consumption,
5375323|NCT01833819|Postoperative nausea and vomiting|postoperative nausea and vomiting
5375324|NCT01833793|Mirena|mirena
5375325|NCT01833793|Contraception|contraception
5375326|NCT01833793|Amenorrhea|amenorrhea
5375327|NCT01833780|carriage status|carriage status
5375328|NCT01833780|Culture|culture
5375329|NCT01833780|PCR|pcr
5375330|NCT01833754|Osteoporosis, Bone, Renal, Insufficiency, Kidney, Hemodialysis, Impairment|osteoporosis, bone, renal, insufficiency, kidney, hemodialysis, impairment
5375331|NCT01833715|Pain, Postoperative|pain, postoperative
5375332|NCT01833715|Analgesics, Opioid|analgesics, opioid
5375333|NCT01833715|Methadone|methadone
5375334|NCT01833715|Morphine|morphine
5375335|NCT01833702|Sickle cell|sickle cell
5375336|NCT01833702|Pain|pain
5375337|NCT01833689|glucose response|glucose response
5375338|NCT01833689|glycaemic index|glycaemic index
5375339|NCT01833676|sevoflurane|sevoflurane
5375340|NCT01833676|desflurane|desflurane
5375341|NCT01833676|protective airway reflexes|protective airway reflexes
5375342|NCT01833676|elderly|elderly
5375343|NCT01833663|Overactive Bladder|overactive bladder
5375344|NCT01833663|Solifenacin Succinate Tablets|solifenacin succinate tablets
5375345|NCT01833663|Estrogen|estrogen
5375346|NCT01833650|thyroid cancer|thyroid cancer
5375347|NCT01833650|radioiodine treatment|radioiodine treatment
5375348|NCT01833650|xerostomia|xerostomia
5375349|NCT01833650|sialadenitis|sialadenitis
5375350|NCT01833637|Advanced Care Planning|advanced care planning
5375351|NCT01833637|Palliative Care|palliative care
5375352|NCT01833637|Women|women
5375353|NCT01833598|Chronic tendinopathy|chronic tendinopathy
5375354|NCT01833598|platelet rich plasma|platelet rich plasma
5375355|NCT01833598|tendonitis|tendonitis
5375356|NCT01833598|percutaneous tendon tenotomy|percutaneous tendon tenotomy
5375357|NCT01833598|pain|pain
5375358|NCT01833598|shoulder|shoulder
5375359|NCT01833598|knee|knee
5375360|NCT01833598|ankle|ankle
5375361|NCT01833598|foot|foot
5375362|NCT01833585|critical limb ischemia|critical limb ischemia
5375363|NCT01833585|atherosclerosis|atherosclerosis
5375364|NCT01833585|ischemic ulcer|ischemic ulcer
5375365|NCT01833585|rest pain|rest pain
5375366|NCT01833585|gangrene|gangrene
5375367|NCT01833572|epidermal growth factor receptor|epidermal growth factor receptor
5375368|NCT01833572|EGFR mutation|egfr mutation
5375369|NCT01833572|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5375370|NCT01833572|gefitinib|gefitinib
5375371|NCT01833572|neo-adjuvant therapy|neo-adjuvant therapy
5375372|NCT01833546|Solid tumor|solid tumor
5375373|NCT01833546|Pancreatic cancer|pancreatic cancer
5375374|NCT01833546|TH-302|th-302
5375375|NCT01833546|Gemcitabine|gemcitabine
5375376|NCT01833546|Evofosfamide|evofosfamide
5375377|NCT01833533|Chronic Hepatitis C|chronic hepatitis c
5375378|NCT01833533|Hepatitis C Virus|hepatitis c virus
5375379|NCT01833533|Hepatitis C Genotype 1a|hepatitis c genotype 1a
5375380|NCT01833533|Hepatitis C|hepatitis c
5375381|NCT01833533|Treatment-Naïve|treatment-naïve
5375383|NCT01833533|Paritaprevir|paritaprevir
5375384|NCT01833533|Ombitasvir|ombitasvir
5375385|NCT01833533|Dasabuvir|dasabuvir
5375386|NCT01833533|Ribavirin|ribavirin
5375387|NCT01833533|Viekira PAK|viekira pak
5375388|NCT01833520|Sarcoma|sarcoma
5375389|NCT01833520|Osteosarcoma|osteosarcoma
5375402|NCT01833481|Posterior-lateral|posterior-lateral
5375404|NCT01833481|Total Hip Arthroplasty|total hip arthroplasty
5375405|NCT01833481|Total Hip replacement|total hip replacement
5375406|NCT01833481|Hip replacement|hip replacement
5375407|NCT01833481|Hip prosthesis|hip prosthesis
5375408|NCT01833468|ankylosing spondylitis|ankylosing spondylitis
5375409|NCT01833468|Psoriatic arthritis|psoriatic arthritis
5375410|NCT01833468|Foot|foot
5375411|NCT01833468|FAOS|faos
5375412|NCT01833468|SpA-TRI|spa-tri
5375413|NCT01833442|OCD|ocd
5375414|NCT01833442|YBOCS|ybocs
5375415|NCT01833429|Resistant hypertension|resistant hypertension
5485580|NCT01355614|Fistula|fistula
5375416|NCT01833429|White-coat phenomenon|white-coat phenomenon
5375417|NCT01833429|Heart rate variability|heart rate variability
5375418|NCT01833429|autonomic activity|autonomic activity
5375419|NCT01833416|CMV infection|cmv infection
5375420|NCT01833416|CMV disease|cmv disease
5375421|NCT01833416|Natural history|natural history
5375422|NCT01833416|Kidney transplant|kidney transplant
5375423|NCT01833403|bariatric surgery, l|bariatric surgery, l
5375424|NCT01833403|liver insulin resistance,|liver insulin resistance,
5375425|NCT01833390|Hyperpolarized Xenon|hyperpolarized xenon
5375426|NCT01833390|HXe|hxe
5375427|NCT01833390|MagniXene|magnixene
5375428|NCT01833377|obesity|obesity
5375429|NCT01833377|overweight|overweight
5375430|NCT01833377|BMI|bmi
5375431|NCT01833364|Parkinson's Disease|parkinson's disease
5375432|NCT01833364|Deep Brain Stimulation|deep brain stimulation
5375433|NCT01833364|Peripheral Nerve Graft|peripheral nerve graft
5375434|NCT01833351|Phase I|phase i
5375435|NCT01833351|safety and pharmacokinetics,|safety and pharmacokinetics,
5375436|NCT01833351|intravenous ascorbate,|intravenous ascorbate,
5375437|NCT01833351|IV Vitamin C,|iv vitamin c,
5375438|NCT01833351|Oncology|oncology
5375439|NCT01833338|Non ST elevation myocardial infarction|non st elevation myocardial infarction
5375440|NCT01833338|optical coherence tomography|optical coherence tomography
5375441|NCT01833338|intravascular ultrasound|intravascular ultrasound
5375442|NCT01833338|multi-slice computed tomography|multi-slice computed tomography
5375443|NCT01833325|Age-Related Macular Degeneration|age-related macular degeneration
5375444|NCT01833325|Macular Degeneration|macular degeneration
5375445|NCT01833325|Proton radiation|proton radiation
5375446|NCT01833325|Choroidal Neovascular Membranes|choroidal neovascular membranes
5375447|NCT01833312|acute ischemic stroke|acute ischemic stroke
5375448|NCT01833312|hypothermia|hypothermia
5375449|NCT01833299|TACE|tace
5375450|NCT01833299|Sorafenib|sorafenib
5375451|NCT01833299|overall survival|overall survival
5375452|NCT01833299|time to progression|time to progression
5375453|NCT01833286|hepatocellular carcinoma|hepatocellular carcinoma
5375454|NCT01833286|repeat hepatectomy|repeat hepatectomy
5375455|NCT01833286|radiofrequency ablation|radiofrequency ablation
5375456|NCT01833286|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5375457|NCT01833247|epilepsy|epilepsy
5375458|NCT01833247|lactic acid|lactic acid
5375459|NCT01833247|saliva|saliva
5375460|NCT01833247|postictal|postictal
5375461|NCT01833234|epilepsy|epilepsy
5375462|NCT01833234|quality of life|quality of life
5375463|NCT01833234|seizure severity|seizure severity
5375464|NCT01833234|antiepileptic drug side effects|antiepileptic drug side effects
5375465|NCT01833234|questionnaire|questionnaire
5375466|NCT01833234|patient reported outcomes|patient reported outcomes
5375467|NCT01833221|facial palsy|facial palsy
5375468|NCT01833221|lengthening temporalis myoplasty|lengthening temporalis myoplasty
5375469|NCT01833221|neurotization of facial muscles|neurotization of facial muscles
5375470|NCT01833195|molecular diagnostics|molecular diagnostics
5375471|NCT01833195|heart transplantation|heart transplantation
5375472|NCT01833195|risk factors|risk factors
5375473|NCT01833195|prognosis|prognosis
5375474|NCT01833182|falls in community dwelling older adults|falls in community dwelling older adults
5375475|NCT01833182|falls and ADL performance|falls and adl performance
5375477|NCT01833169|Solid tumor|solid tumor
5375478|NCT01833169|malignancy|malignancy
5375479|NCT01833169|hematologic malignancy|hematologic malignancy
5375480|NCT01833169|PI3K pathway activation|pi3k pathway activation
5375481|NCT01833169|P13K activated tumors|p13k activated tumors
5375482|NCT01833169|BKM120|bkm120
5375483|NCT01833169|signature|signature
5375485|NCT01833169|acute myelogenous leukemia|acute myelogenous leukemia
5375486|NCT01833169|cervical|cervical
5375487|NCT01833169|ovarian|ovarian
5375488|NCT01833169|hepatobiliary|hepatobiliary
5375489|NCT01833169|buparlisib|buparlisib
5375490|NCT01833156|local edema|local edema
5375491|NCT01833156|dielectric constant values|dielectric constant values
5375492|NCT01833156|validation study|validation study
5375498|NCT01833117|Tear film|tear film
5375499|NCT01833117|Tear break-up time|tear break-up time
5375500|NCT01833117|Ocular surface|ocular surface
5375501|NCT01833117|Eye drops|eye drops
5375502|NCT01833104|Healthy subjects|healthy subjects
5375503|NCT01833039|Mantle Cell Lymphoma|mantle cell lymphoma
5375504|NCT01833039|Ibrutinib|ibrutinib
5375505|NCT01833026|pulmonary disease|pulmonary disease
5375506|NCT01833026|chronic obstructive airflow|chronic obstructive airflow
5375507|NCT01833026|spirometry|spirometry
5375508|NCT01833026|primary healthcare|primary healthcare
5375509|NCT01833026|guideline-based therapy|guideline-based therapy
5375510|NCT01833013|Endometriosis|endometriosis
5375511|NCT01833013|Cohort study|cohort study
5375512|NCT01833013|fertility|fertility
5375513|NCT01833013|pregnancy|pregnancy
5375514|NCT01833013|assisted reproductive technics|assisted reproductive technics
5375515|NCT01833013|laparoscopy|laparoscopy
5375516|NCT01833000|rectal bleeding|rectal bleeding
5375517|NCT01833000|necrotizing enterolitis|necrotizing enterolitis
5375518|NCT01833000|splanchnic oxygenation|splanchnic oxygenation
5375519|NCT01833000|mesenteric doppler|mesenteric doppler
5375520|NCT01832987|co-trimoxazole|co-trimoxazole
5375521|NCT01832987|sulfamethoxazole|sulfamethoxazole
5375522|NCT01832987|tuberculosis|tuberculosis
5375523|NCT01832987|pharmacokinetics|pharmacokinetics
5375524|NCT01832974|Adrenal Gland Cancer|adrenal gland cancer
5375525|NCT01832974|Treatment Refractory Malignancies|treatment refractory malignancies
5375526|NCT01832974|Metastatic Cancer|metastatic cancer
5375531|NCT01832935|Glargin|glargin
5375532|NCT01832935|NPH|nph
5375533|NCT01832935|Cost-effectiveness|cost-effectiveness
5375534|NCT01832922|bendamustine|bendamustine
5375535|NCT01832922|rituximab|rituximab
5375536|NCT01832922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5375537|NCT01832922|comorbidities|comorbidities
5375538|NCT01832922|renal insufficiency|renal insufficiency
5375539|NCT01832909|metabolizable energy|metabolizable energy
5375541|NCT01832909|Atwater factors|atwater factors
5375542|NCT01832909|energy value|energy value
5375543|NCT01832896|Hereditary Angioedema|hereditary angioedema
5375544|NCT01832896|Children|children
5375545|NCT01832896|Adolescents|adolescents
5375546|NCT01832896|Ecallantide|ecallantide
5375547|NCT01832857|metastatic|metastatic
5375549|NCT01832857|solid tumor|solid tumor
5375550|NCT01832857|cancer|cancer
5375551|NCT01832857|colon cancer|colon cancer
5375552|NCT01832857|hepatocellular carcinoma|hepatocellular carcinoma
5375553|NCT01832857|breast cancer|breast cancer
5375554|NCT01832857|lung cancer|lung cancer
5375555|NCT01832857|gastric cancer|gastric cancer
5375556|NCT01832857|esophageal cancer|esophageal cancer
5375557|NCT01832844|Scan control|scan control
5375558|NCT01832844|Epidural infiltration|epidural infiltration
5375559|NCT01832844|visual analogue scale (VAS)|visual analogue scale (vas)
5375560|NCT01832818|Total Disc Replacement|total disc replacement
5375561|NCT01832805|depression|depression
5375562|NCT01832779|Achalasia|achalasia
5375563|NCT01832766|schizophrenia|schizophrenia
5375564|NCT01832766|dronabinol|dronabinol
5375565|NCT01832766|P50|p50
5375566|NCT01832766|cannabis|cannabis
5375567|NCT01832766|memory|memory
5375568|NCT01832766|symptoms|symptoms
5375569|NCT01832753|Down syndrome|down syndrome
5375570|NCT01832753|subclinical hypothyroidism|subclinical hypothyroidism
5375571|NCT01832753|thyroid|thyroid
5375572|NCT01832753|levothyroxine|levothyroxine
5375573|NCT01832740|young healthy subjects|young healthy subjects
5375574|NCT01832740|brain stimulation|brain stimulation
5375575|NCT01832740|tSOS|tsos
5375576|NCT01832740|tDCS|tdcs
5375577|NCT01832740|sleep|sleep
5375578|NCT01832740|memory|memory
5375579|NCT01832740|memory consolidation|memory consolidation
5375580|NCT01832727|multiple myeloma|multiple myeloma
5375581|NCT01832727|oprozomib|oprozomib
5375582|NCT01832727|OPZ|opz
5375583|NCT01832727|ONX 0912|onx 0912
5375584|NCT01832727|Onyx|onyx
5375585|NCT01832727|proteasome inhibitor|proteasome inhibitor
5375586|NCT01832727|oprozomib tablets|oprozomib tablets
5375587|NCT01832714|Concussion|concussion
5375588|NCT01832714|mTBI|mtbi
5375589|NCT01832714|military|military
5375590|NCT01832714|MACE|mace
5375591|NCT01832714|NKI|nki
5375594|NCT01832714|VOG|vog
5375595|NCT01832714|Neuro Kinetics|neuro kinetics
5375596|NCT01832714|oculomotor|oculomotor
5375597|NCT01832714|vestibular|vestibular
5375598|NCT01832714|reaction time|reaction time
5375599|NCT01832714|I-Portal|i-portal
5375600|NCT01832714|eye tracking|eye tracking
5375601|NCT01832714|Dizziness Handicap Inventory|dizziness handicap inventory
5375616|NCT01832623|cardiovascular status|cardiovascular status
5375618|NCT01832584|Red Grapes|red grapes
5375619|NCT01832584|polyphenols|polyphenols
5375620|NCT01832584|cyclists|cyclists
5375621|NCT01832584|resveratrol|resveratrol
5375622|NCT01832584|aerobic fitness|aerobic fitness
5375623|NCT01832584|trained|trained
5375624|NCT01832571|HIV|hiv
5375625|NCT01832571|PrEP|prep
5358979|NCT01907321|stroke|stroke
5375626|NCT01832571|Female Sex Workers|female sex workers
5375627|NCT01832571|Kenya|kenya
5375628|NCT01832545|Aquatic exercise|aquatic exercise
5375629|NCT01832545|Knee Osteoarthritis|knee osteoarthritis
5375630|NCT01832545|Exercise|exercise
5375631|NCT01832545|Pain|pain
5375632|NCT01832545|Obesity.|obesity.
5375633|NCT01832532|Sleep Apnea|sleep apnea
5375634|NCT01832532|Sleep Disordered Breathing|sleep disordered breathing
5375635|NCT01832532|liraglutide|liraglutide
5375636|NCT01832532|glucagon-like peptide-1 agonist|glucagon-like peptide-1 agonist
5375637|NCT01832532|Orexin|orexin
5375638|NCT01832532|leptin,|leptin,
5375639|NCT01832519|Cystic Fibrosis|cystic fibrosis
5375640|NCT01832519|CF|cf
5375642|NCT01832519|vascularization|vascularization
5375643|NCT01832519|perfusion|perfusion
5375644|NCT01832506|Solid Tumors|solid tumors
5375645|NCT01832506|MSC2156119J|msc2156119j
5375646|NCT01832506|c-Met inhibitor|c-met inhibitor
5375647|NCT01832506|Japanese|japanese
5375648|NCT01832506|Phase 1|phase 1
5375649|NCT01832480|Trichomonas vaginalis|trichomonas vaginalis
5375650|NCT01832480|metronidazole|metronidazole
5375651|NCT01832467|cetuximab-based chemotherapy|cetuximab-based chemotherapy
5375652|NCT01832467|previously treated|previously treated
5375653|NCT01832454|cerebral palsy stem cells [MNCS]|cerebral palsy stem cells [mncs]
5375654|NCT01832441|Diabetes Mellitus stem cells [MNCS ]|diabetes mellitus stem cells [mncs ]
5375655|NCT01832415|First line treatment|first line treatment
5375656|NCT01832415|Ovarian cancer|ovarian cancer
5375657|NCT01832415|Avastin|avastin
5375865|NCT01831609|Rare Cancer|rare cancer
5375658|NCT01832415|fallopian tube or primary peritoneal|fallopian tube or primary peritoneal
5375659|NCT01832402|Advanced Cancers|advanced cancers
5375660|NCT01832402|Exercise-Induced Breakthrough Dyspnea|exercise-induced breakthrough dyspnea
5375661|NCT01832402|Shortness of breath|shortness of breath
5375662|NCT01832402|Fentanyl pectin nasal spray|fentanyl pectin nasal spray
5375663|NCT01832402|Placebo nasal spray|placebo nasal spray
5375664|NCT01832402|Walk test|walk test
5375665|NCT01832402|Questionnaires|questionnaires
5375666|NCT01832402|Surveys|surveys
5375667|NCT01832402|Mental ability tests|mental ability tests
5375668|NCT01832389|Subarachnoid Haemorrhage (SAH)|subarachnoid haemorrhage (sah)
5375669|NCT01832389|vasospasm|vasospasm
5375670|NCT01832389|delayed cerebral ischaemia (DCI)|delayed cerebral ischaemia (dci)
5375671|NCT01832389|goal directed therapy (GDT)|goal directed therapy (gdt)
5375672|NCT01832389|Pulse Contour Cardiac Output (PiCCO)|pulse contour cardiac output (picco)
5375673|NCT01832376|Calcific tendinitis|calcific tendinitis
5375674|NCT01832376|Shoulder|shoulder
5375675|NCT01832376|Needle lavage|needle lavage
5375676|NCT01832376|Ultrasound-guided|ultrasound-guided
5375677|NCT01832363|Severe asthma|severe asthma
5375678|NCT01832363|Bronchial thermoplasty|bronchial thermoplasty
5375679|NCT01832363|MagniXene|magnixene
5375680|NCT01832363|Hyperpolarized Xenon|hyperpolarized xenon
5375681|NCT01832363|HXe|hxe
5375682|NCT01832363|HyXe|hyxe
5375683|NCT01832324|Food Allergy|food allergy
5375684|NCT01832324|Eosinophilic Esophagitis|eosinophilic esophagitis
5375685|NCT01832324|Food Protein Induced Enterocolitis|food protein induced enterocolitis
5375686|NCT01832324|iNKT Cells|inkt cells
5375687|NCT01832324|T cells|t cells
5375688|NCT01832311|type 2 diabetes mellitus|type 2 diabetes mellitus
5375689|NCT01832311|cataract|cataract
5375690|NCT01832311|cytokines|cytokines
5375691|NCT01832311|chemokines|chemokines
5375692|NCT01832311|aqueous humor|aqueous humor
5375693|NCT01832298|Tolerability|tolerability
5375694|NCT01832298|Pharmacokinetics|pharmacokinetics
5375695|NCT01832285|fluvoxamine|fluvoxamine
5375696|NCT01832285|cognition|cognition
5375697|NCT01832285|schizophrenia|schizophrenia
5375698|NCT01832285|protein expression|protein expression
5375699|NCT01832272|Osteoarthritis|osteoarthritis
5375701|NCT01832272|Total knee arthroplasty|total knee arthroplasty
5375703|NCT01832272|Early release|early release
5375704|NCT01832272|Reinflation|reinflation
5375705|NCT01832246|endoscopy|endoscopy
5375706|NCT01832246|endosonography|endosonography
5375707|NCT01832246|stomach cancer|stomach cancer
5375708|NCT01832246|tumor staging|tumor staging
5375709|NCT01832220|Genomics|genomics
5375710|NCT01832220|Microbiome|microbiome
5371170|NCT01852955|Surgery|surgery
5375712|NCT01832220|Virome|virome
5375713|NCT01832220|Alpha-1|alpha-1
5375714|NCT01832194|Scrotal pain|scrotal pain
5375715|NCT01832194|Botox|botox
5375716|NCT01832181|Diabetes|diabetes
5375717|NCT01832181|MiTy|mity
5375718|NCT01832181|Metformin in Women|metformin in women
5375719|NCT01832181|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
5375720|NCT01832155|Yoga|yoga
5375721|NCT01832155|Knee osteoarthritis|knee osteoarthritis
5375722|NCT01832155|Symptom management|symptom management
5375723|NCT01832155|Older women|older women
5375724|NCT01832155|Pain|pain
5375725|NCT01832155|Stiffness|stiffness
5375726|NCT01832155|Physical function)|physical function)
5375727|NCT01832155|Physical function of the lower extremities|physical function of the lower extremities
5375728|NCT01832155|Quality of sleep|quality of sleep
5375729|NCT01832155|Quality of life|quality of life
5375730|NCT01832116|Pancreatic cancer|pancreatic cancer
5375731|NCT01832116|Ovarian cancer|ovarian cancer
5375732|NCT01832090|aging|aging
5375733|NCT01832090|hands|hands
5375734|NCT01832077|sensibility|sensibility
5375735|NCT01832077|specificity|specificity
5375736|NCT01832077|positive predictive value|positive predictive value
5375737|NCT01832077|negative predictive value|negative predictive value
5375738|NCT01832077|Cost-effectiveness|cost-effectiveness
5375739|NCT01832064|chronic disease|chronic disease
5375740|NCT01832064|patient education|patient education
5375741|NCT01832064|self management|self management
5375742|NCT01832051|HER2-PET|her2-pet
5375743|NCT01832051|89Zr-trastuzumab|89zr-trastuzumab
5375744|NCT01832051|metastatic breast cancer|metastatic breast cancer
5375745|NCT01832051|clinical dilemma|clinical dilemma
5375746|NCT01832038|Lacosamide|lacosamide
5375747|NCT01832038|Epilepsy|epilepsy
5375748|NCT01832038|Partial-onset Seizures|partial-onset seizures
5375749|NCT01832025|intraoperative|intraoperative
5375750|NCT01832025|postoperative|postoperative
5375751|NCT01832025|complications|complications
5375752|NCT01832025|discomfort|discomfort
5375753|NCT01832025|external|external
5375754|NCT01832025|internal|internal
5375755|NCT01832025|maxillary|maxillary
5375756|NCT01832025|elevation|elevation
5375757|NCT01832025|implant|implant
5375758|NCT01832025|reconstruction|reconstruction
5375759|NCT01832025|bone|bone
5375760|NCT01832025|sinus|sinus
5375866|NCT01831583|sleep apnea|sleep apnea
5375761|NCT01832012|Eliciting which type of refresher provides the greatest improvement in BLS CPR skills.|eliciting which type of refresher provides the greatest improvement in bls cpr skills.
5375762|NCT01831999|Web-based|web-based
5375763|NCT01831999|HIV Assessment|hiv assessment
5375764|NCT01831999|Outreach|outreach
5375765|NCT01831999|Retention|retention
5375766|NCT01831999|Substance Abuse Treatment|substance abuse treatment
5375767|NCT01831986|Schizophrenia|schizophrenia
5375768|NCT01831986|Schizoaffective disorder|schizoaffective disorder
5375769|NCT01831986|Pregnenolone|pregnenolone
5375770|NCT01831986|L-Theanine|l-theanine
5375771|NCT01831986|Augmentation|augmentation
5375772|NCT01831960|Intrepid|intrepid
5375773|NCT01831960|cortexolone|cortexolone
5375774|NCT01831960|cortexolone 17α-propionate|cortexolone 17α-propionate
5375775|NCT01831960|anti-androgen|anti-androgen
5375776|NCT01831947|age-related macular degeneration|age-related macular degeneration
5375777|NCT01831947|Ranibizumab|ranibizumab
5375778|NCT01831934|Mitochondrial disorder|mitochondrial disorder
5375779|NCT01831934|Trivalent inactivated influenza vaccine|trivalent inactivated influenza vaccine
5375780|NCT01831934|Adolescents and adults|adolescents and adults
5375781|NCT01831934|Immune response|immune response
5375782|NCT01831934|Metabolic response|metabolic response
5375783|NCT01831921|pre diabetes|pre diabetes
5375785|NCT01831921|weight loss|weight loss
5375786|NCT01831921|lifestyle|lifestyle
5375787|NCT01831921|prevention|prevention
5375788|NCT01831908|cardiovascular health, stroke, ischemic heart disease|cardiovascular health, stroke, ischemic heart disease
5375789|NCT01831895|Hypertension|hypertension
5375790|NCT01831895|Carotid Sinus|carotid sinus
5375791|NCT01831869|Subclinical hypothyroidism|subclinical hypothyroidism
5375792|NCT01831869|L-thyroxine|l-thyroxine
5375793|NCT01831869|Lipid|lipid
5375794|NCT01831869|endothelial function|endothelial function
5375795|NCT01831869|inflammatory factor|inflammatory factor
5375796|NCT01831869|adipocytokine|adipocytokine
5375797|NCT01831856|Cardiovascular diseases|cardiovascular diseases
5375798|NCT01831856|Chronic Heart Failure|chronic heart failure
5375799|NCT01831843|core body temperature|core body temperature
5375800|NCT01831843|humidity|humidity
5375801|NCT01831843|circuit temperature|circuit temperature
5375802|NCT01831830|traumatic brain injury|traumatic brain injury
5375803|NCT01831830|occupational therapy|occupational therapy
5375804|NCT01831830|family|family
5375805|NCT01831804|diabetic foot ulcer|diabetic foot ulcer
5375806|NCT01831804|pharmacodynamics|pharmacodynamics
5375807|NCT01831804|pharmacokinetics|pharmacokinetics
5375808|NCT01831804|ischemic|ischemic
5375809|NCT01831791|male pattern hair loss|male pattern hair loss
5375810|NCT01831791|hair growth|hair growth
5375811|NCT01831791|hair restoration|hair restoration
5375812|NCT01831791|Dutasteride|dutasteride
5375813|NCT01831791|Androgenetic alopecia|androgenetic alopecia
5375814|NCT01831791|safety|safety
5375815|NCT01831791|efficacy|efficacy
5375816|NCT01831778|mammography|mammography
5375817|NCT01831778|screening|screening
5375818|NCT01831752|Diabetes|diabetes
5375819|NCT01831752|Type 1|type 1
5375820|NCT01831752|Continuous glucose monitor|continuous glucose monitor
5375821|NCT01831739|Genomics|genomics
5375822|NCT01831739|Microbiome|microbiome
5375823|NCT01831739|Microflora|microflora
5375824|NCT01831739|Virome|virome
5375825|NCT01831726|Solid tumor malignancy|solid tumor malignancy
5375826|NCT01831726|hematologic malignancy|hematologic malignancy
5375827|NCT01831726|mutation|mutation
5375828|NCT01831726|translocations|translocations
5375829|NCT01831726|FGFR|fgfr
5375830|NCT01831726|PDGFR|pdgfr
5375831|NCT01831726|VEGF|vegf
5375832|NCT01831726|cKIT|ckit
5375833|NCT01831726|FLT3|flt3
5375834|NCT01831726|CSR1|csr1
5375835|NCT01831726|Trk|trk
5375836|NCT01831726|RET|ret
5375837|NCT01831726|TKI258|tki258
5375838|NCT01831726|dovitinib|dovitinib
5375839|NCT01831726|signature|signature
5375840|NCT01831726|AML|aml
5375841|NCT01831726|acute myelogenous leukemia|acute myelogenous leukemia
5375842|NCT01831726|GIST|gist
5375843|NCT01831726|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5375844|NCT01831726|Head and Neck cancer|head and neck cancer
5375845|NCT01831726|Melanoma|melanoma
5375846|NCT01831726|NSCLC|nsclc
5375847|NCT01831726|non-small cell lung carcinoma|non-small cell lung carcinoma
5375848|NCT01831726|lung cancer|lung cancer
5375849|NCT01831726|ovarian cancer|ovarian cancer
5375850|NCT01831726|thyroid cancer|thyroid cancer
5375851|NCT01831726|amplification|amplification
5375852|NCT01831648|IGF1|igf1
5375853|NCT01831648|standards|standards
5375854|NCT01831648|Assays|assays
5375855|NCT01831648|Z-score|z-score
5375856|NCT01831648|Healthy volunteers|healthy volunteers
5375857|NCT01831648|Population|population
5375858|NCT01831622|Decision-Making|decision-making
5375859|NCT01831622|functional MRI|functional mri
5375860|NCT01831622|pharmacological MRI|pharmacological mri
5375861|NCT01831622|Reinforcement Learning|reinforcement learning
5375862|NCT01831622|Methylphenidate|methylphenidate
5375863|NCT01831609|Gastrointestinal|gastrointestinal
5375864|NCT01831609|Genitourinary|genitourinary
5375867|NCT01831570|Hand osteoarthritis|hand osteoarthritis
5375868|NCT01831570|predictive factors|predictive factors
5375869|NCT01831570|erosive hand OA|erosive hand oa
5375870|NCT01831544|Heart Failure|heart failure
5375871|NCT01831518|Heart Failure|heart failure
5375872|NCT01831518|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5375873|NCT01831518|ECG Imaging|ecg imaging
5375874|NCT01831518|Body Surface Mapping|body surface mapping
5375875|NCT01831505|personalized medicine|personalized medicine
5375876|NCT01831505|in vivo drug sensitivity|in vivo drug sensitivity
5375877|NCT01831505|chemotherapy|chemotherapy
5375878|NCT01831505|lymphoma|lymphoma
5375879|NCT01831505|microinjection|microinjection
5375880|NCT01831492|performance|performance
5375881|NCT01831492|acidosis|acidosis
5375882|NCT01831492|oxidative stress|oxidative stress
5375883|NCT01831492|inflammation|inflammation
5375884|NCT01831492|oxygen uptake|oxygen uptake
5375885|NCT01831479|Pharmacokinetics, drug-drug interaction|pharmacokinetics, drug-drug interaction
5375886|NCT01831466|plaque psoriasis|plaque psoriasis
5375887|NCT01831466|vulgaris|vulgaris
5375888|NCT01831466|topical treatment|topical treatment
5375889|NCT01831466|skin diseases|skin diseases
5375890|NCT01831466|papulosquamous|papulosquamous
5375891|NCT01831466|Tofacitinib|tofacitinib
5375892|NCT01831466|CP-690550|cp-690550
5375893|NCT01831466|Xeljanz|xeljanz
5375894|NCT01831466|psoriasis|psoriasis
5375895|NCT01831466|moderate|moderate
5375896|NCT01831466|severe|severe
5375897|NCT01831466|itch|itch
5375898|NCT01831466|nail psoriasis|nail psoriasis
5375899|NCT01831453|omega-3|omega-3
5375900|NCT01831453|recurrent aphthous stomatitis|recurrent aphthous stomatitis
5375901|NCT01831453|quality of life|quality of life
5375902|NCT01831440|depression|depression
5375903|NCT01831440|remission|remission
5375904|NCT01831440|Pharmacotherapy|pharmacotherapy
5375905|NCT01831440|psychotherapy|psychotherapy
5375906|NCT01831440|neuroimaging|neuroimaging
5375907|NCT01831440|psychology|psychology
5375908|NCT01831427|ulcerative colitis|ulcerative colitis
5375909|NCT01831427|moderate|moderate
5375910|NCT01831427|severe|severe
5375911|NCT01831414|Lung function|lung function
5375912|NCT01831414|Water immersion|water immersion
5375913|NCT01831414|Balneotherapy|balneotherapy
5375914|NCT01831401|Acetabular component inclination|acetabular component inclination
5375916|NCT01831388|Breath Training Exercise|breath training exercise
5375917|NCT01831388|12-261|12-261
5375918|NCT01831336|International|international
5375919|NCT01831336|Multicenter|multicenter
5375920|NCT01831336|Observational registry|observational registry
5375921|NCT01831336|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5375922|NCT01831336|Stenting|stenting
5375923|NCT01831336|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5375924|NCT01831336|Coronary revascularization|coronary revascularization
5375925|NCT01831336|Percutaneous Coronary Intervention|percutaneous coronary intervention
5375926|NCT01831336|STEMI|stemi
5375927|NCT01831336|NSTEMI|nstemi
5375928|NCT01831336|Ischemia|ischemia
5375929|NCT01831336|Angina|angina
5375930|NCT01831336|Subgroups|subgroups
5375931|NCT01831336|Acute Myocardial Infarction|acute myocardial infarction
5375932|NCT01831336|Diabetes|diabetes
5375933|NCT01831336|Small Vessels|small vessels
5375934|NCT01831336|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5375935|NCT01831310|Colorectal cancer|colorectal cancer
5375936|NCT01831310|nutrition|nutrition
5375937|NCT01831310|neutrophil phagocytosis|neutrophil phagocytosis
5375938|NCT01831310|neutrophil adhesivity|neutrophil adhesivity
5375939|NCT01831310|glutamine|glutamine
5375940|NCT01831310|omega 3 fatty acids|omega 3 fatty acids
5375941|NCT01831271|Exercise, Physical|exercise, physical
5375942|NCT01831271|Physical Activity|physical activity
5375943|NCT01831271|Outcome Measures|outcome measures
5375944|NCT01831219|osteoarthritis|osteoarthritis
5375945|NCT01831219|arthroplasty|arthroplasty
5375946|NCT01831219|hip arthroplasty|hip arthroplasty
5375947|NCT01831206|corneal ulcer|corneal ulcer
5375948|NCT01831206|keratitis|keratitis
5375949|NCT01831180|hair|hair
5375950|NCT01831180|scalp|scalp
5375951|NCT01831180|blood flow|blood flow
5375952|NCT01831180|Caucasian|caucasian
5375953|NCT01831180|Histamine stimulation|histamine stimulation
5375954|NCT01831180|Wake Forest|wake forest
5375955|NCT01831167|dynamic light application|dynamic light application
5375956|NCT01831167|sustained attention|sustained attention
5375957|NCT01831167|divided attention|divided attention
5375958|NCT01831167|nursing|nursing
5375959|NCT01831154|Glycemic control|glycemic control
5375960|NCT01831141|Congenital Solitary Kidney|congenital solitary kidney
5375961|NCT01831141|Glomerular filtration rate|glomerular filtration rate
5375962|NCT01831141|Chronic kidney damage|chronic kidney damage
5375963|NCT01831141|Hypertension|hypertension
5375964|NCT01831141|Proteinuria|proteinuria
5375965|NCT01831128|Congestive Heart Failure|congestive heart failure
5375966|NCT01831128|Central Sleep Apnea|central sleep apnea
5375967|NCT01831128|Sleep-Disordered Breathing|sleep-disordered breathing
5375968|NCT01831115|heart failure|heart failure
5375970|NCT01831115|acute dyspnoea|acute dyspnoea
5375971|NCT01831102|insulin resistance|insulin resistance
5375972|NCT01831102|ethnic disparities|ethnic disparities
5375973|NCT01831102|adiponectin|adiponectin
5375974|NCT01831076|Breast cancer|breast cancer
5375975|NCT01831076|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5375976|NCT01831076|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5375977|NCT01831076|Postmenopausal|postmenopausal
5375978|NCT01831076|Exemestane|exemestane
5375979|NCT01831076|Tamoxifen|tamoxifen
5375980|NCT01831063|Seizure|seizure
5375981|NCT01831063|Caregivers|caregivers
5375982|NCT01831063|Family Centered Care|family centered care
5375983|NCT01831063|Learning modality|learning modality
5375984|NCT01831050|Poliovirus|poliovirus
5375985|NCT01831050|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
5375986|NCT01831050|Trivalent oral polio vaccine|trivalent oral polio vaccine
5375987|NCT01831050|Bivalent oral polio vaccine|bivalent oral polio vaccine
5375988|NCT01831050|Stool shedding index|stool shedding index
5375989|NCT01831050|Polio eradication|polio eradication
5375990|NCT01831037|Hepatocellular carcinoma|hepatocellular carcinoma
5375991|NCT01831037|Regressed cirrhosis|regressed cirrhosis
5375992|NCT01831037|Hepatitis C|hepatitis c
5375993|NCT01831037|Hepatitis B|hepatitis b
5375994|NCT01831037|Noninvasive markers of fibrosis|noninvasive markers of fibrosis
5375995|NCT01831037|FibroTest|fibrotest
5375996|NCT01831037|FibroSure|fibrosure
5375997|NCT01831037|FibroScan|fibroscan
5375998|NCT01831037|Transient elastography|transient elastography
5375999|NCT01831024|Cold cap|cold cap
5376000|NCT01831024|Scalp cooling|scalp cooling
5376001|NCT01831024|Chemotherapy induced alopecia|chemotherapy induced alopecia
5376002|NCT01831024|Breast cancer|breast cancer
5376003|NCT01831011|randomized trial|randomized trial
5376004|NCT01831011|acute ischemic stroke|acute ischemic stroke
5376005|NCT01831011|mildronate|mildronate
5376006|NCT01830998|Dementia|dementia
5376007|NCT01830998|Olfactory|olfactory
5423324|NCT01616199|BRAF inhibitor|braf inhibitor
5376008|NCT01830959|Sarcoidosis, fibrosis, bronchiectasis|sarcoidosis, fibrosis, bronchiectasis
5376009|NCT01830946|Protein|protein
5376010|NCT01830946|Metabolism|metabolism
5376011|NCT01830946|Nighttime eating|nighttime eating
5376012|NCT01830946|Exercise Training|exercise training
5376013|NCT01830933|Breast cancer concern, breast cancer risk perception, breast cancer risk|breast cancer concern, breast cancer risk perception, breast cancer risk
5376014|NCT01830920|Acute Kidney Injury|acute kidney injury
5376016|NCT01830920|Cardiac surgery|cardiac surgery
5359370|NCT01905202|Safety|safety
5376017|NCT01830907|Malnutrition|malnutrition
5376018|NCT01830907|Gastric cancer|gastric cancer
5376019|NCT01830907|preoperative nutrition|preoperative nutrition
5376021|NCT01830881|anxiety|anxiety
5376022|NCT01830881|surgical abortion|surgical abortion
5376023|NCT01830881|midazolam|midazolam
5376024|NCT01830881|benzodiazepine|benzodiazepine
5376026|NCT01830868|AED|aed
5376027|NCT01830868|Partial Onset Seizures|partial onset seizures
5376028|NCT01830868|Retention Rate|retention rate
5376029|NCT01830868|Seizure Control|seizure control
5376030|NCT01830868|Antiepileptic|antiepileptic
5376031|NCT01830868|Secondary generalization|secondary generalization
5376032|NCT01830868|Seizure freedom rates|seizure freedom rates
5376033|NCT01830842|Nicotine|nicotine
5376034|NCT01830842|Smoking|smoking
5376035|NCT01830842|Cigarettes|cigarettes
5376036|NCT01830842|Reinforcement Learning|reinforcement learning
5376037|NCT01830842|fMRI|fmri
5376038|NCT01830829|BPH|bph
5376039|NCT01830829|CPPS|cpps
5376040|NCT01830816|Drug Therapy|drug therapy
5376041|NCT01830803|howRU|howru
5376042|NCT01830803|howRwe|howrwe
5376043|NCT01830803|reliability|reliability
5376044|NCT01830803|quality of life|quality of life
5376045|NCT01830803|quality of care|quality of care
5376046|NCT01830803|patient satisfaction|patient satisfaction
5376047|NCT01830751|self treatment technique|self treatment technique
5376048|NCT01830751|chronic|chronic
5376049|NCT01830751|non specific|non specific
5376050|NCT01830751|LBP|lbp
5376051|NCT01830751|control trunk flexion|control trunk flexion
5376052|NCT01830751|diurnal|diurnal
5376053|NCT01830738|laparoscopy|laparoscopy
5376054|NCT01830738|hysterectomy|hysterectomy
5376055|NCT01830738|single-port trocar|single-port trocar
5376056|NCT01830738|surgical technique|surgical technique
5376057|NCT01830738|trocar|trocar
5376058|NCT01830725|Xanthine Oxidase|xanthine oxidase
5376059|NCT01830725|Gout|gout
5376060|NCT01830725|Hyperuricemia|hyperuricemia
5376061|NCT01830725|SNP|snp
5376062|NCT01830725|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5376063|NCT01830699|Rilonacept|rilonacept
5376064|NCT01830699|Subacromial Bursitis treatment|subacromial bursitis treatment
5376065|NCT01830699|Corticosteroid Injection|corticosteroid injection
5376066|NCT01830686|Sugarcane bagasse, glucose tolerance, insulin resistance|sugarcane bagasse, glucose tolerance, insulin resistance
5376067|NCT01830673|T-regulatory cells|t-regulatory cells
5376068|NCT01830673|TH1, TH2 cells|th1, th2 cells
5376069|NCT01830673|specific IgE|specific ige
5376070|NCT01830673|specific IgG|specific igg
5376071|NCT01830673|specific IgG4|specific igg4
5376072|NCT01830673|IL2|il2
5376073|NCT01830673|IL5|il5
5376075|NCT01830673|IL12/23|il12/23
5376076|NCT01830673|Y-IFN|y-ifn
5376077|NCT01830673|TNF-a|tnf-a
5376078|NCT01830634|Community-dwelling elderly|community-dwelling elderly
5376079|NCT01830634|Rehabilitation|rehabilitation
5376080|NCT01830634|Theraband|theraband
5376081|NCT01830634|Strengthening and stretching exercise|strengthening and stretching exercise
5376082|NCT01830582|MRI|mri
5376083|NCT01830582|rectum|rectum
5376084|NCT01830582|13-019|13-019
5376085|NCT01830569|Decision Support Systems, Clinical|decision support systems, clinical
5376086|NCT01830569|Evidence-Based practice|evidence-based practice
5376087|NCT01830569|Family Practice|family practice
5376088|NCT01830543|Atrial Fibrillation|atrial fibrillation
5376089|NCT01830543|Irregular heart beat|irregular heart beat
5376090|NCT01830543|rivaroxaban|rivaroxaban
5376091|NCT01830543|aspirin|aspirin
5376092|NCT01830543|clopidogrel|clopidogrel
5376093|NCT01830543|prasugrel|prasugrel
5376094|NCT01830543|ticagrelor|ticagrelor
5376095|NCT01830543|vitamin K antagonist|vitamin k antagonist
5376096|NCT01830530|arterial hypertension|arterial hypertension
5376097|NCT01830530|high altitude|high altitude
5376098|NCT01830530|hypobaric hypoxia|hypobaric hypoxia
5376099|NCT01830530|combination treatment|combination treatment
5376100|NCT01830530|angiotensin receptor blocker|angiotensin receptor blocker
5376101|NCT01830530|calcium antagonist|calcium antagonist
5376102|NCT01830504|thyroid cancers|thyroid cancers
5376103|NCT01830504|refractory|refractory
5376104|NCT01830504|PI3K inhibitor|pi3k inhibitor
5376105|NCT01830465|Non Hodgkin's Follicular Lymphoma|non hodgkin's follicular lymphoma
5376106|NCT01830465|relapsed|relapsed
5376107|NCT01830465|progressed|progressed
5376108|NCT01830452|Chronic pain|chronic pain
5376109|NCT01830452|Progrip Mesh|progrip mesh
5376110|NCT01830452|Self gripping mesh|self gripping mesh
5376111|NCT01830452|Lichtenstein|lichtenstein
5376112|NCT01830439|tuberculosis|tuberculosis
5376113|NCT01830439|PK|pk
5376114|NCT01830439|PA-824|pa-824
5376115|NCT01830439|food effect|food effect
5376116|NCT01830439|pretomanid|pretomanid
5376117|NCT01830439|CL-009|cl-009
5376118|NCT01830413|stent, systematic Intracranial artery stenosis|stent, systematic intracranial artery stenosis
5376119|NCT01830400|ESL|esl
5376120|NCT01830400|Partial onset seizures|partial onset seizures
5376121|NCT01830400|Retention Rate|retention rate
5376122|NCT01830400|Seizure Control|seizure control
5376123|NCT01830400|Antiepileptic|antiepileptic
5376124|NCT01830400|Secondary Generalisation|secondary generalisation
5376125|NCT01830387|Polymetric Clips (Hem-o-Lok)|polymetric clips (hem-o-lok)
5376126|NCT01830387|Laparoscopic Appendectomy|laparoscopic appendectomy
5376127|NCT01830387|Endoscopic Staplers|endoscopic staplers
5376128|NCT01830374|Bulimia nervosa|bulimia nervosa
5376129|NCT01830374|Eating disorder|eating disorder
5376130|NCT01830374|Weight suppression|weight suppression
5376131|NCT01830374|Dieting|dieting
5376133|NCT01830361|Acute Myeloid Leukemia|acute myeloid leukemia
5376134|NCT01830361|c-KIT|c-kit
5376135|NCT01830361|FLT3-ITD|flt3-itd
5376136|NCT01830361|t(8;21)|t(8;21)
5376137|NCT01830361|chemotherapy|chemotherapy
5376138|NCT01830361|midostaurin|midostaurin
5376139|NCT01830348|diabetic foot ulcers|diabetic foot ulcers
5376140|NCT01830348|Wagner Grade 1 or 2 foot ulcers|wagner grade 1 or 2 foot ulcers
5376141|NCT01830322|metastatic|metastatic
5376142|NCT01830322|pancreatic|pancreatic
5376143|NCT01830322|adenocarcinoma|adenocarcinoma
5376144|NCT01830322|cancer|cancer
5376145|NCT01830309|Food-Effect|food-effect
5376146|NCT01830309|Pharmacokinetics|pharmacokinetics
5376147|NCT01830309|Pharmacodynamics|pharmacodynamics
5376148|NCT01830296|Postthoracotomy pain,|postthoracotomy pain,
5376149|NCT01830296|patient controlled analgesia,|patient controlled analgesia,
5376150|NCT01830296|remifentanil and|remifentanil and
5376151|NCT01830296|morphine.|morphine.
5376152|NCT01830270|medical oncology|medical oncology
5376153|NCT01830270|chemotherapy optimization|chemotherapy optimization
5376154|NCT01830270|dose density|dose density
5376155|NCT01830244|chemotherapy|chemotherapy
5376156|NCT01830244|nab paclitaxel|nab paclitaxel
5376157|NCT01830244|neoadjuvant therapy|neoadjuvant therapy
5376158|NCT01830244|breast cancer|breast cancer
5376159|NCT01830244|pathologic complete response|pathologic complete response
5376160|NCT01830231|TCCU|tccu
5376161|NCT01830231|Vinflunine|vinflunine
5376162|NCT01830231|Cabazitaxel|cabazitaxel
5376163|NCT01830231|Metastatic|metastatic
5376164|NCT01830231|Locally advance|locally advance
5376165|NCT01830192|endometrial cancer|endometrial cancer
5376166|NCT01830192|score|score
5376167|NCT01830192|nomogram|nomogram
5376168|NCT01830192|ultrasound|ultrasound
5376170|NCT01830153|Soft tissue sarcomas|soft tissue sarcomas
5376171|NCT01830153|Bone sarcomas|bone sarcomas
5376172|NCT01830153|RAD001|rad001
5376173|NCT01830153|Refractory to conventional chemotherapy|refractory to conventional chemotherapy
5376174|NCT01830114|alcohol abuse|alcohol abuse
5376175|NCT01830114|drug abuse|drug abuse
5376176|NCT01830114|hazardous alcohol use|hazardous alcohol use
5376177|NCT01830114|hazardous drug use|hazardous drug use
5376178|NCT01830101|recurrent glioblastoma|recurrent glioblastoma
5376179|NCT01830101|re-irradiation|re-irradiation
5376180|NCT01830101|continuous low-dose temozolomide|continuous low-dose temozolomide
5376181|NCT01830036|cardiological treatment|cardiological treatment
5376182|NCT01830036|sleep Apnea|sleep apnea
5376183|NCT01830023|cardiac ultrasound|cardiac ultrasound
5376184|NCT01830023|vitality|vitality
5376185|NCT01830023|data|data
5376186|NCT01830023|patients|patients
5376187|NCT01830023|examined|examined
5376188|NCT01829984|Injection Teaching|injection teaching
5376189|NCT01829984|13-057|13-057
5376190|NCT01829971|microRNA|microrna
5376191|NCT01829971|Advanced cancer|advanced cancer
5376192|NCT01829958|Geriatric|geriatric
5376193|NCT01829958|Toxicity|toxicity
5376194|NCT01829958|rituximab|rituximab
5376195|NCT01829958|prednisone|prednisone
5376196|NCT01829958|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
5376197|NCT01829958|13-028|13-028
5376198|NCT01829932|Diet|diet
5376199|NCT01829919|Menopause|menopause
5376200|NCT01829919|Hot flashes|hot flashes
5376201|NCT01829919|Vasomotor symptoms|vasomotor symptoms
5376202|NCT01829919|Climacteric symptoms|climacteric symptoms
5376203|NCT01829919|perimenopause|perimenopause
5376204|NCT01829919|Mesafem|mesafem
5376205|NCT01829919|Brisdelle|brisdelle
5376206|NCT01829919|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5376207|NCT01829906|weight loss|weight loss
5376208|NCT01829906|bariatric surgery|bariatric surgery
5376209|NCT01829906|gastric bypass|gastric bypass
5376210|NCT01829906|health education|health education
5376211|NCT01829906|nutrition therapy|nutrition therapy
5376212|NCT01829906|diet|diet
5376213|NCT01829906|exercise|exercise
5376214|NCT01829906|cognitive therapy|cognitive therapy
5376215|NCT01829893|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5376216|NCT01829893|pharmacokinetics|pharmacokinetics
5376222|NCT01829880|Ramipril|ramipril
5376223|NCT01829880|Pharmacokinetic|pharmacokinetic
5376224|NCT01829880|Cachexia|cachexia
5376225|NCT01829880|Body composition|body composition
5376226|NCT01829880|Renal function|renal function
5376227|NCT01829880|Iohexol|iohexol
5376228|NCT01829841|MRCC|mrcc
5376229|NCT01829841|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5376230|NCT01829841|Famitinib|famitinib
5376231|NCT01829841|Sunitinib|sunitinib
5376232|NCT01829828|Pain|pain
5376233|NCT01829828|Cancer pain|cancer pain
5376234|NCT01829828|Self-reported pain scoring tool|self-reported pain scoring tool
5376235|NCT01829828|Opioid analgesics|opioid analgesics
5376237|NCT01829815|Parents|parents
5376238|NCT01829815|Parenting|parenting
5376239|NCT01829815|Child Development|child development
5376240|NCT01829815|Parent Child Relations|parent child relations
5376241|NCT01829815|Malaria|malaria
5376242|NCT01829815|Primary Prevention|primary prevention
5376243|NCT01829815|Punishment|punishment
5376244|NCT01829815|Education|education
5376246|NCT01829802|Raltegravir|raltegravir
5376247|NCT01829802|Boosted atazanavir|boosted atazanavir
5376248|NCT01829789|Adolescents|adolescents
5376249|NCT01829789|Teens|teens
5376250|NCT01829789|Parents|parents
5376251|NCT01829789|Parenting|parenting
5376252|NCT01829789|Substance Abuse|substance abuse
5376253|NCT01829789|Treatment Efficacy|treatment efficacy
5376254|NCT01829776|Accidental falls|accidental falls
5376255|NCT01829776|Multiple Sclerosis|multiple sclerosis
5376256|NCT01829776|Education|education
5376257|NCT01829776|Exercise|exercise
5376258|NCT01829776|Postural balance|postural balance
5376259|NCT01829750|Univentricular heart|univentricular heart
5376260|NCT01829737|Asymptomatic Parasitemia|asymptomatic parasitemia
5376261|NCT01829737|RBC Polymorphism|rbc polymorphism
5376262|NCT01829737|Acquired Immunity|acquired immunity
5376267|NCT01829711|Moxetumomab Pasudotox|moxetumomab pasudotox
5376268|NCT01829711|CAT-8015|cat-8015
5376269|NCT01829711|Anti-cd22 recombinant immunotoxin|anti-cd22 recombinant immunotoxin
5376270|NCT01829711|Biologic Therapy|biologic therapy
5376271|NCT01829711|Monoclonal Antibody|monoclonal antibody
5376272|NCT01829711|Pseudomonas Exotoxin|pseudomonas exotoxin
5376273|NCT01829711|Targeted Therapy|targeted therapy
5376274|NCT01829698|tudca PBC Cholestasis tauroursodeoxycholic acid taurolite|tudca pbc cholestasis tauroursodeoxycholic acid taurolite
5376275|NCT01829672|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
5376276|NCT01829672|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
5376277|NCT01829646|DWI|dwi
5376278|NCT01829646|DCE MRI|dce mri
5376279|NCT01829646|ADC|adc
5376280|NCT01829646|FDG PET|fdg pet
5376281|NCT01829646|Hypoxia|hypoxia
5376282|NCT01829646|Prognostic and predictive model|prognostic and predictive model
5376283|NCT01829620|suicide|suicide
5376284|NCT01829620|suicide intervention|suicide intervention
5376285|NCT01829620|suicide prevention|suicide prevention
5376286|NCT01829620|military|military
5376287|NCT01829620|military suicide|military suicide
5376288|NCT01829620|caring letters|caring letters
5376289|NCT01829620|caring contacts|caring contacts
5376290|NCT01829620|text messages|text messages
5376291|NCT01829594|Case Management|case management
5376292|NCT01829594|Frail Elderly|frail elderly
5376293|NCT01829594|Health Services Administration|health services administration
5376294|NCT01829594|Delivery of Health Care|delivery of health care
5376295|NCT01829594|Accidental Falls|accidental falls
5376296|NCT01829594|Health Status|health status
5376297|NCT01829594|Health Care Economics|health care economics
5376298|NCT01829542|flow-mediated dilation|flow-mediated dilation
5376299|NCT01829542|blueberry polyphenols|blueberry polyphenols
5376300|NCT01829542|dose-dependency|dose-dependency
5376301|NCT01829529|Antibiotic prophylaxis|antibiotic prophylaxis
5376302|NCT01829503|Phase II|phase ii
5376303|NCT01829503|decitabine|decitabine
5376304|NCT01829503|cytarabine|cytarabine
5376305|NCT01829503|older patients|older patients
5376306|NCT01829503|newly diagnosed|newly diagnosed
5376307|NCT01829503|AML|aml
5376308|NCT01829503|Newly Diagnosed AML|newly diagnosed aml
5376309|NCT01829490|Vaccine|vaccine
5376310|NCT01829490|Immunogenicity|immunogenicity
5376311|NCT01829477|Drug Therapy|drug therapy
5376312|NCT01829464|Drug Therapy|drug therapy
5376313|NCT01829438|exercise tolerance|exercise tolerance
5376314|NCT01829438|6MWT|6mwt
5376315|NCT01829425|Hypnosis|hypnosis
5376316|NCT01829425|Mind-Body Therapy|mind-body therapy
5376317|NCT01829425|Anticholinergics|anticholinergics
5376318|NCT01829425|Female Urogenital Diseases|female urogenital diseases
5376319|NCT01829399|Tourniquet pain|tourniquet pain
5423325|NCT01616199|Vemurafenib|vemurafenib
5376326|NCT01829347|alcoholic hepatitis|alcoholic hepatitis
5376327|NCT01829347|steroid failure|steroid failure
5376328|NCT01829347|Lille criteria|lille criteria
5376329|NCT01829347|ELAD|elad
5376330|NCT01829334|dental caries|dental caries
5376331|NCT01829308|implementation|implementation
5376332|NCT01829308|SBIRT|sbirt
5376333|NCT01829308|alcohol screening|alcohol screening
5376334|NCT01829308|drug screening|drug screening
5376335|NCT01829308|Brief Intervention|brief intervention
5376336|NCT01829308|Referral to Treatment|referral to treatment
5376337|NCT01829308|adolescents|adolescents
5376338|NCT01829308|Federally Qualified Health Centers|federally qualified health centers
5376339|NCT01829295|antimetabolite, noninfectious|antimetabolite, noninfectious
5376340|NCT01829282|Implementation|implementation
5376341|NCT01829282|HIV|hiv
5376342|NCT01829282|serodiscordant couples|serodiscordant couples
5376343|NCT01829282|African American|african american
5376344|NCT01829282|Cultural congruency|cultural congruency
5376345|NCT01829243|Milnacipran|milnacipran
5376346|NCT01829243|Fibromyalgia|fibromyalgia
5376348|NCT01829178|cisplatin|cisplatin
5376349|NCT01829178|nephrotoxicity|nephrotoxicity
5376350|NCT01829178|antioxidant|antioxidant
5376351|NCT01829178|urine neutrophil gelatinase-associated lipocalin (NGAL)|urine neutrophil gelatinase-associated lipocalin (ngal)
5376352|NCT01829152|heart failure|heart failure
5376353|NCT01829139|Common bile duct stone|common bile duct stone
5376354|NCT01829139|Gallbladder in situ|gallbladder in situ
5376355|NCT01829139|Choleretics|choleretics
5376356|NCT01829113|Recurrent Lung Cancer|recurrent lung cancer
5376357|NCT01829113|Stage IV Lung Cancer|stage iv lung cancer
5376358|NCT01829113|OGX-427|ogx-427
5376359|NCT01829113|Sarah Cannon Research Institute|sarah cannon research institute
5376360|NCT01829113|SCRI|scri
5376361|NCT01829113|OncoGenex|oncogenex
5376362|NCT01829113|NSCLC|nsclc
5376363|NCT01829113|Non Small Cell Lung Cancer|non small cell lung cancer
5376364|NCT01829100|Adolescent|adolescent
5376365|NCT01829100|Transdiagnostic therapy|transdiagnostic therapy
5376366|NCT01829100|Behavioral activation|behavioral activation
5376367|NCT01829100|Exposure therapy|exposure therapy
5376368|NCT01829100|Depressive Disorder|depressive disorder
5376369|NCT01829100|Anxiety Disorders|anxiety disorders
5376370|NCT01829074|Laryngopharyngeal Reflux|laryngopharyngeal reflux
5376371|NCT01829074|Hoarseness|hoarseness
5376372|NCT01829074|Throat Clearing|throat clearing
5376373|NCT01829074|Globus Sensation|globus sensation
5376374|NCT01829061|Type I Diabetes|type i diabetes
5376375|NCT01829061|Type II Diabetes|type ii diabetes
5376376|NCT01829061|HbA1C|hba1c
5376377|NCT01829048|PF-02545920|pf-02545920
5376378|NCT01829048|safety|safety
5376379|NCT01829048|schizophrenia|schizophrenia
5376380|NCT01829035|TACE|tace
5376381|NCT01829035|Sorafenib|sorafenib
5376382|NCT01829022|Myoma|myoma
5376383|NCT01829022|Uterine myomectomy|uterine myomectomy
5376384|NCT01829009|Sarcopenia|sarcopenia
5376385|NCT01829009|Elderly|elderly
5376386|NCT01829009|Women|women
5376387|NCT01829009|Resistance|resistance
5376388|NCT01829009|Exercise|exercise
5376389|NCT01828996|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5376390|NCT01828996|Chronic prostatitis|chronic prostatitis
5376391|NCT01828996|Shock wave therapy|shock wave therapy
5376392|NCT01828996|Prostate|prostate
5376393|NCT01828996|Pelvic floor|pelvic floor
5376394|NCT01828996|Pain|pain
5376395|NCT01828983|Telephone|telephone
5376396|NCT01828983|Support groups|support groups
5376397|NCT01828983|Social support|social support
5376398|NCT01828983|Depression|depression
5376399|NCT01828970|Diabetes Mellitus|diabetes mellitus
5376400|NCT01828970|Hemodialysis|hemodialysis
5376401|NCT01828970|Continuous glucose monitoring|continuous glucose monitoring
5376402|NCT01828970|Insulin analogues|insulin analogues
5376403|NCT01828957|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
5376404|NCT01828957|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5376405|NCT01828957|Premature infants|premature infants
5376406|NCT01828944|Vitamin D|vitamin d
5376407|NCT01828944|bone loss|bone loss
5376408|NCT01828918|early diagnosis|early diagnosis
5376409|NCT01828918|prediction|prediction
5376410|NCT01828918|prognosis|prognosis
5376411|NCT01828905|tibia fracture|tibia fracture
5376412|NCT01828905|bone graft|bone graft
5376413|NCT01828905|iliac crest|iliac crest
5423326|NCT01616199|Zelboraf|zelboraf
5376424|NCT01828879|Tacrolimus|tacrolimus
5376425|NCT01828866|EMDR|emdr
5376426|NCT01828866|Alcohol|alcohol
5376427|NCT01828866|Relapse|relapse
5376428|NCT01828866|Craving|craving
5376429|NCT01828853|Membrane sweeping|membrane sweeping
5376430|NCT01828853|Membrane stripping|membrane stripping
5376431|NCT01828853|Maternal outcomes|maternal outcomes
5376432|NCT01828853|Neonatal outcomes|neonatal outcomes
5376433|NCT01828840|morphine|morphine
5376434|NCT01828840|fentanyl|fentanyl
5376435|NCT01828840|methadone|methadone
5376436|NCT01828840|epidural|epidural
5376437|NCT01828840|intravenous|intravenous
5376438|NCT01828840|pain|pain
5376439|NCT01828840|analgesia|analgesia
5376440|NCT01828827|tuberculosis|tuberculosis
5376442|NCT01828827|PA-824|pa-824
5376443|NCT01828827|food effect,|food effect,
5376444|NCT01828827|bioavailability|bioavailability
5376445|NCT01828827|pretomanid|pretomanid
5376446|NCT01828827|CL-003|cl-003
5376447|NCT01828814|pediatrics|pediatrics
5376448|NCT01828814|Ready-to-use Supplementary Food|ready-to-use supplementary food
5376449|NCT01828814|corn soy blend|corn soy blend
5376450|NCT01828814|cash transfer|cash transfer
5376451|NCT01828814|prevention of malnutrition|prevention of malnutrition
5376452|NCT01828814|Niger|niger
5376453|NCT01828801|Adverse Local Tissue Reaction|adverse local tissue reaction
5376454|NCT01828801|Metal Ions|metal ions
5376455|NCT01828801|Serum|serum
5376456|NCT01828801|Whole Blood|whole blood
5376457|NCT01828801|Metal-on-Metal|metal-on-metal
5376458|NCT01828801|Total Hip Arthroplasty|total hip arthroplasty
5376459|NCT01828788|Sternotomy|sternotomy
5376460|NCT01828788|Anesthesia|anesthesia
5376461|NCT01828788|Post-operative pain|post-operative pain
5376463|NCT01828762|Immunotherapy|immunotherapy
5376464|NCT01828762|TC|tc
5376465|NCT01828749|blunt abdominal trauma|blunt abdominal trauma
5376466|NCT01828749|CT|ct
5376467|NCT01828749|radiation exposure, pediatric|radiation exposure, pediatric
5376468|NCT01828736|Urothelial carcinoma|urothelial carcinoma
5376469|NCT01828736|Trastuzumab|trastuzumab
5376470|NCT01828736|Treatment|treatment
5376471|NCT01828723|Autologous Adult Stem Cell|autologous adult stem cell
5376472|NCT01828723|Adipose Derived Stem Cell|adipose derived stem cell
5376473|NCT01828723|Stromal Vascular Fraction|stromal vascular fraction
5376474|NCT01828723|SVF|svf
5376475|NCT01828723|Antria|antria
5376476|NCT01828723|Shah Rahimian|shah rahimian
5376477|NCT01828723|Leonard Maliver|leonard maliver
5376478|NCT01828723|David Bizousky|david bizousky
5376479|NCT01828723|Rahul Gore|rahul gore
5376480|NCT01828723|Lee Quist|lee quist
5376481|NCT01828723|Dudley McNitt|dudley mcnitt
5376482|NCT01828710|Myo-inositol|myo-inositol
5376483|NCT01828710|oligoasthenoteratospermia|oligoasthenoteratospermia
5376484|NCT01828710|semen parameters|semen parameters
5376485|NCT01828710|IVF|ivf
5376486|NCT01828697|Low-molecular-weight heparin|low-molecular-weight heparin
5376487|NCT01828697|Pregnancy|pregnancy
5376488|NCT01828697|Venous thrombosis|venous thrombosis
5376489|NCT01828684|Migraine with Aura|migraine with aura
5376490|NCT01828684|Migraine without Aura|migraine without aura
5376491|NCT01828684|Photophobia|photophobia
5376492|NCT01828684|Chronic Daily Headache|chronic daily headache
5376493|NCT01828671|Soy|soy
5376494|NCT01828671|Corn|corn
5376495|NCT01828671|Flour|flour
5376496|NCT01828671|Tortilla|tortilla
5376497|NCT01828671|Glycemic|glycemic
5376498|NCT01828671|Glucose,|glucose,
5376499|NCT01828671|glycemic index|glycemic index
5376500|NCT01828658|hemodialysis|hemodialysis
5376501|NCT01828658|fluid management|fluid management
5376502|NCT01828658|bioimpedance|bioimpedance
5376503|NCT01828658|mortality|mortality
5376504|NCT01828658|arterial stiffness|arterial stiffness
5376505|NCT01828645|gastric emptying|gastric emptying
5376506|NCT01828645|whey protein|whey protein
5376507|NCT01828645|carbohydrate|carbohydrate
5376508|NCT01828645|fasting|fasting
5423327|NCT01616199|PI-3K inhibitor|pi-3k inhibitor
5380165|NCT01811745|Aged|aged
5685270|NCT00556855|chronic hand dermatitis|chronic hand dermatitis
5685271|NCT00556855|research study|research study
5685272|NCT00556855|E-do|e-do
5376509|NCT01828632|Obesity, Morbid; Hypoxemia; Postoperative complications; Bariatric surgery; Respiratory physical therapy; Preoperative care.|obesity, morbid; hypoxemia; postoperative complications; bariatric surgery; respiratory physical therapy; preoperative care.
5376510|NCT01828619|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5376511|NCT01828619|Busulfan|busulfan
5376512|NCT01828619|Fludarabine|fludarabine
5376513|NCT01828606|leg lymphedema|leg lymphedema
5376514|NCT01828606|volume measurement|volume measurement
5376515|NCT01828606|compression therapy|compression therapy
5376516|NCT01828606|interface pressure|interface pressure
5376517|NCT01828606|static stiffness index (SSI)|static stiffness index (ssi)
5376518|NCT01828606|volume change|volume change
5376519|NCT01828580|laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5376520|NCT01828580|Gallbladder removal|gallbladder removal
5376521|NCT01828580|laparoscope holder|laparoscope holder
5376522|NCT01828567|veterans|veterans
5376523|NCT01828567|health risk assessment|health risk assessment
5376524|NCT01828567|primary prevention|primary prevention
5376525|NCT01828567|shared decision making|shared decision making
5376526|NCT01828567|Healthy Living Assessment|healthy living assessment
5376527|NCT01828554|Capecitabine pharmacokinetics PK|capecitabine pharmacokinetics pk
5376528|NCT01828554|Elevated Body Mass Index (BMI)|elevated body mass index (bmi)
5376529|NCT01828554|Advanced Solid Tumors|advanced solid tumors
5376530|NCT01828541|Burn injuries|burn injuries
5376531|NCT01828528|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5376532|NCT01828528|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5376533|NCT01828528|Obesity|obesity
5376534|NCT01828528|Bariatric surgery|bariatric surgery
5376535|NCT01828528|Weight loss|weight loss
5376536|NCT01828502|Cotinine|cotinine
5376537|NCT01828502|Secondhand Smoke Exposure (SHSE)|secondhand smoke exposure (shse)
5376538|NCT01828502|Secondhand Smoke (SHS)|secondhand smoke (shs)
5376539|NCT01828476|prostate cancer|prostate cancer
5376540|NCT01828476|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5376541|NCT01828476|recurrent prostate cancer|recurrent prostate cancer
5376542|NCT01828476|stage IV prostate cancer|stage iv prostate cancer
5376543|NCT01828424|acute pain|acute pain
5376544|NCT01828411|Cardiac surgery|cardiac surgery
5376545|NCT01828411|Echocardiography|echocardiography
5376546|NCT01828411|Cerebral perfusion|cerebral perfusion
5376547|NCT01828411|Intraoperative period|intraoperative period
5376548|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs
5376549|NCT01828385|Rocuronium|rocuronium
5376550|NCT01828385|Sugammadex sodium|sugammadex sodium
5376551|NCT01828385|Magnesium|magnesium
5376552|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5376553|NCT01828385|Neuromuscular block, antagonism|neuromuscular block, antagonism
5376554|NCT01828385|Pharmacologic Actions|pharmacologic actions
5376556|NCT01828372|multiple drug consumption|multiple drug consumption
5376557|NCT01828372|therapeutic drug monitoring|therapeutic drug monitoring
5376558|NCT01828372|TDM|tdm
5376559|NCT01828372|drug monitoring|drug monitoring
5376560|NCT01828372|drug level|drug level
5376561|NCT01828372|quantification|quantification
5376562|NCT01828372|drug|drug
5376563|NCT01828372|drug concentration|drug concentration
5376564|NCT01828372|concentration|concentration
5376565|NCT01828372|therapeutic range|therapeutic range
5376566|NCT01828372|therapeutic index|therapeutic index
5376567|NCT01828346|TL32711|tl32711
5376568|NCT01828346|Birinapant|birinapant
5376569|NCT01828346|5-Azacitidine|5-azacitidine
5376570|NCT01828346|Myelodysplastic syndrome|myelodysplastic syndrome
5376571|NCT01828346|MDS|mds
5376572|NCT01828346|Relapsed|relapsed
5376573|NCT01828346|Refractory|refractory
5376574|NCT01828346|Failed|failed
5376575|NCT01828346|open-label|open-label
5376576|NCT01828346|non-Randomized|non-randomized
5376577|NCT01828346|dose-escalation|dose-escalation
5376578|NCT01828346|dose-expansion|dose-expansion
5376579|NCT01828333|Malaria|malaria
5376580|NCT01828333|Severe|severe
5376581|NCT01828333|Artesunate|artesunate
5376582|NCT01828333|Quinine|quinine
5376583|NCT01828333|Democratic Republic of Congo|democratic republic of congo
5376584|NCT01828320|Risk: Emotional, Cognitive, Behavioral, Social, Physical|risk: emotional, cognitive, behavioral, social, physical
5376585|NCT01828294|MG|mg
5376586|NCT01828268|HIV|hiv
5376587|NCT01828268|Metabolomics Fingerprinting|metabolomics fingerprinting
5376588|NCT01828242|HbA1C|hba1c
5376589|NCT01828229|Inactivity|inactivity
5376590|NCT01828229|Obesity|obesity
5376591|NCT01828229|Type 2 diabetes|type 2 diabetes
5376592|NCT01828229|glucose metabolism|glucose metabolism
5376593|NCT01828229|Lipid metabolism|lipid metabolism
5376594|NCT01828229|Cognitive function|cognitive function
5376595|NCT01828203|minocycline|minocycline
5376596|NCT01828203|randomized control trial|randomized control trial
5376597|NCT01828203|phase 3|phase 3
5376598|NCT01828203|spinal cord injury|spinal cord injury
5376599|NCT01828190|crohn's disease|crohn's disease
5376600|NCT01828190|perianal fistulas|perianal fistulas
5376601|NCT01828190|TNF alpha blockers|tnf alpha blockers
5471650|NCT01414075|HD|hd
5364191|NCT01883362|CR1|cr1
5376602|NCT01828190|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5376603|NCT01828177|PreCision|precision
5376605|NCT01828177|Foam|foam
5376606|NCT01828164|Orthodontics|orthodontics
5376607|NCT01828164|Braces|braces
5376608|NCT01828164|Tooth|tooth
5376609|NCT01828151|Pressure ulcer|pressure ulcer
5376610|NCT01828151|Noninvasive ventilation|noninvasive ventilation
5376611|NCT01828138|Proteinuria|proteinuria
5376612|NCT01828138|Pregnancy|pregnancy
5376613|NCT01828138|Hypertension|hypertension
5376614|NCT01828138|Plasmin|plasmin
5376615|NCT01828138|Plasminogen|plasminogen
5376616|NCT01828138|Aldosterone|aldosterone
5376617|NCT01828138|Angiotensin|angiotensin
5376618|NCT01828138|Renin|renin
5376619|NCT01828138|sodium chloride|sodium chloride
5376620|NCT01828138|epithelial sodium channel|epithelial sodium channel
5376621|NCT01828138|Placenta|placenta
5376622|NCT01828125|Type 1 diabetes|type 1 diabetes
5376623|NCT01828125|Hypoglycemia|hypoglycemia
5376624|NCT01828125|Glucagon|glucagon
5376625|NCT01828125|Hypoglycaemic hyperinsulinemic clamp|hypoglycaemic hyperinsulinemic clamp
5376626|NCT01828112|Non-Small Cell Lung Cancer|non-small cell lung cancer
5376627|NCT01828112|ALK|alk
5376628|NCT01828112|LDK378|ldk378
5376629|NCT01828112|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5376630|NCT01828112|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5376631|NCT01828112|lung cancer|lung cancer
5376632|NCT01828112|lung adenocarcinoma|lung adenocarcinoma
5376633|NCT01828112|Non small cell lung carcinoma|non small cell lung carcinoma
5376634|NCT01828112|Non small cell lung cancer|non small cell lung cancer
5376635|NCT01828112|NSCLC|nsclc
5376636|NCT01828112|chemotherapy|chemotherapy
5376637|NCT01828112|ALK-positive|alk-positive
5376638|NCT01828112|ALK-rearranged advanced non-small cell lung cancer|alk-rearranged advanced non-small cell lung cancer
5376639|NCT01828112|crizotinib|crizotinib
5376640|NCT01828099|Non-Small Cell Lung Cancer|non-small cell lung cancer
5376641|NCT01828099|NSCLC|nsclc
5376642|NCT01828099|ALK|alk
5376643|NCT01828099|LDK378|ldk378
5376644|NCT01828099|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5376645|NCT01828099|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5376646|NCT01828099|lung cancer|lung cancer
5376647|NCT01828099|lung adenocarcinoma|lung adenocarcinoma
5376648|NCT01828099|Non small cell lung carcinoma|non small cell lung carcinoma
5376649|NCT01828099|Non small cell lung cancer|non small cell lung cancer
5376650|NCT01828099|non-squamous non-small cell lung cancer|non-squamous non-small cell lung cancer
5376651|NCT01828086|Psoriasis, chronic plaque-type psoriasis, IL17, monoclonal antibody|psoriasis, chronic plaque-type psoriasis, il17, monoclonal antibody
5376652|NCT01828034|Gemcitabine|gemcitabine
5376653|NCT01828034|Cisplatin|cisplatin
5376654|NCT01828034|MEK162|mek162
5376655|NCT01828034|13-004|13-004
5376657|NCT01828021|FISH non-amplified|fish non-amplified
5376658|NCT01828021|Relapsed|relapsed
5376659|NCT01828021|Refractory|refractory
5376660|NCT01828021|Advanced|advanced
5376661|NCT01828021|Margetuximab|margetuximab
5376662|NCT01828021|MGAH22|mgah22
5376663|NCT01828008|Mabthera|mabthera
5376664|NCT01828008|cytokine induced killer cell|cytokine induced killer cell
5376665|NCT01827995|Low sensitivity urinary hCG|low sensitivity urinary hcg
5376666|NCT01827995|follow up|follow up
5376667|NCT01827995|medical abortion|medical abortion
5376668|NCT01827995|rural India|rural india
5376669|NCT01827995|RCT|rct
5376670|NCT01827982|Healthy|healthy
5376671|NCT01827982|Safety|safety
5376672|NCT01827982|Tolerability|tolerability
5376673|NCT01827982|Pharmacokinetic|pharmacokinetic
5376674|NCT01827982|Alzheimer's Disease|alzheimer's disease
5376675|NCT01827982|JNJ-54861911|jnj-54861911
5376676|NCT01827969|Women|women
5376677|NCT01827969|breast tumor|breast tumor
5376678|NCT01827969|planned mastectomy|planned mastectomy
5376679|NCT01827956|Upper aero-digestive tract tumours|upper aero-digestive tract tumours
5376680|NCT01827956|FCGR3A and FCGR2A receptor polymorphism|fcgr3a and fcgr2a receptor polymorphism
5376681|NCT01827956|Cetuximab efficacy|cetuximab efficacy
5376682|NCT01827943|Relapsed bladder cancer|relapsed bladder cancer
5376683|NCT01827930|chronic myeloid leukemia in chronic phase|chronic myeloid leukemia in chronic phase
5376684|NCT01827904|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
5376685|NCT01827891|acute kidney injury|acute kidney injury
5376686|NCT01827891|percutaneous coronary intervention|percutaneous coronary intervention
5376687|NCT01827891|remote ischemic preconditioning|remote ischemic preconditioning
5376688|NCT01827839|Adults|adults
5376689|NCT01827839|Safety|safety
5376690|NCT01827839|Immunogenicity|immunogenicity
5376691|NCT01827839|Zoster|zoster
5376692|NCT01827826|Intervention|intervention
5376693|NCT01827826|Telephone|telephone
5376694|NCT01827826|Diabetes|diabetes
5376695|NCT01827826|Prevention|prevention
5376696|NCT01827813|prostate-specific antigen|prostate-specific antigen
5376697|NCT01827813|digital rectal examination|digital rectal examination
5685273|NCT00556855|HK-03|hk-03
5002876|NCT03978052|EGCG Epigallocatechin gallate,|egcg epigallocatechin gallate,
5376698|NCT01827813|transrectal ultrasonography|transrectal ultrasonography
5376700|NCT01827813|prostate cancer|prostate cancer
5376701|NCT01827800|weight loss|weight loss
5376703|NCT01827800|eHealth|ehealth
5376704|NCT01827787|metastatic breast cancer|metastatic breast cancer
5376705|NCT01827774|Pelvic organ prolapse|pelvic organ prolapse
5376706|NCT01827774|Graft repair|graft repair
5376707|NCT01827761|chemotherapy teaching|chemotherapy teaching
5376708|NCT01827761|questionnaire|questionnaire
5376709|NCT01827748|Autorefractor|autorefractor
5376710|NCT01827735|Interleukin 2|interleukin 2
5376711|NCT01827735|Type 1 diabetes|type 1 diabetes
5376712|NCT01827735|T regulatory cells|t regulatory cells
5376713|NCT01827735|Adaptive trial|adaptive trial
5376714|NCT01827722|Macular edema|macular edema
5376715|NCT01827722|Central retinal vein occlusion|central retinal vein occlusion
5376716|NCT01827722|CRVO|crvo
5376717|NCT01827722|Retinal vein occlusion|retinal vein occlusion
5376719|NCT01827722|Ozurdex|ozurdex
5376720|NCT01827722|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
5376721|NCT01827722|Lucentis|lucentis
5376722|NCT01827722|Ranibizumab|ranibizumab
5376723|NCT01827709|DWI|dwi
5376724|NCT01827709|ADC|adc
5376725|NCT01827709|DCE-MRI|dce-mri
5376726|NCT01827709|FDG-PET|fdg-pet
5376727|NCT01827709|SUV|suv
5376728|NCT01827709|Hypoxia|hypoxia
5376729|NCT01827709|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5376730|NCT01827696|Muscle|muscle
5376731|NCT01827696|Soreness|soreness
5376732|NCT01827696|Muscle function|muscle function
5376733|NCT01827696|Damage|damage
5376734|NCT01827696|Ginseng|ginseng
5376735|NCT01827683|hyperbaric oxygen|hyperbaric oxygen
5376736|NCT01827683|fibromyalgia|fibromyalgia
5376737|NCT01827683|chronic pain syndrome|chronic pain syndrome
5376738|NCT01827657|plasma|plasma
5376739|NCT01827657|tolerability|tolerability
5376740|NCT01827657|safety|safety
5376741|NCT01827657|matched control|matched control
5376742|NCT01827657|GSK2336805|gsk2336805
5376743|NCT01827657|hepatic impairment|hepatic impairment
5376744|NCT01827657|pharmacokinetics|pharmacokinetics
5376745|NCT01827644|AKT inhibitor|akt inhibitor
5376746|NCT01827644|formulation|formulation
5376747|NCT01827644|food effect|food effect
5376748|NCT01827644|bioavailability|bioavailability
5376749|NCT01827644|GSK2110183|gsk2110183
5376750|NCT01827631|healthy|healthy
5376751|NCT01827631|GSK1605786|gsk1605786
5376752|NCT01827631|CCR9 receptor antagonist|ccr9 receptor antagonist
5376753|NCT01827631|Chinese subjects|chinese subjects
5376754|NCT01827631|pharmacokinetics|pharmacokinetics
5376755|NCT01827618|bladder|bladder
5376756|NCT01827618|Cancer|cancer
5376757|NCT01827618|Cystectomy|cystectomy
5376758|NCT01827618|Rapamycin|rapamycin
5376759|NCT01827605|Relapsed follicular Lymphoma|relapsed follicular lymphoma
5376760|NCT01827605|RIT|rit
5376761|NCT01827605|Zevalin|zevalin
5376762|NCT01827579|Transplant|transplant
5376763|NCT01827579|CD25/71 allodepleted donor T cells|cd25/71 allodepleted donor t cells
5376765|NCT01827579|Acute Myeloid Leukaemia|acute myeloid leukaemia
5376766|NCT01827579|Acute Lymphoblastic Leukaemia|acute lymphoblastic leukaemia
5376767|NCT01827579|Adult|adult
5376768|NCT01827579|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5376769|NCT01827579|Mantle Cell Lymphoma|mantle cell lymphoma
5376770|NCT01827566|Celiac Disease|celiac disease
5376771|NCT01827566|Gluten Sensitivity|gluten sensitivity
5376772|NCT01827566|Gluten|gluten
5376773|NCT01827566|Double-blind challenge, placebo-controlled challenge|double-blind challenge, placebo-controlled challenge
5376774|NCT01827566|Gluten free flour|gluten free flour
5376775|NCT01827553|pancreatic cancer|pancreatic cancer
5376776|NCT01827553|chemoradiotherapy|chemoradiotherapy
5376777|NCT01827553|chemotherapy|chemotherapy
5376778|NCT01827553|FOLFIRINOX|folfirinox
5376779|NCT01827553|gemcitabine|gemcitabine
5376780|NCT01827540|HIV/AIDS|hiv/aids
5376781|NCT01827540|Cenicriviroc (CVC)|cenicriviroc (cvc)
5376782|NCT01827540|Dolutegravir (DTG)|dolutegravir (dtg)
5376783|NCT01827540|Midazolam|midazolam
5376784|NCT01827540|Healthy Subjects|healthy subjects
5376785|NCT01827527|Adenosine Triphosphate|adenosine triphosphate
5376786|NCT01827527|Validation|validation
5376787|NCT01827527|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5376788|NCT01827527|Optical Spectroscopy|optical spectroscopy
5376789|NCT01827514|cancer, erythropoetin|cancer, erythropoetin
5376790|NCT01827501|postoperative delirium|postoperative delirium
5376791|NCT01827501|hemodynamic management|hemodynamic management
5376792|NCT01827501|goal directed therapy|goal directed therapy
5376793|NCT01827475|musculoskeletal pain|musculoskeletal pain
5376794|NCT01827475|acetaminophen|acetaminophen
5376795|NCT01827475|ibuprofen|ibuprofen
5376796|NCT01827462|Inactivated, trivalent influenza vaccine|inactivated, trivalent influenza vaccine
5376797|NCT01827462|elderly|elderly
5376798|NCT01827462|immunosenescence|immunosenescence
5376799|NCT01827462|longitudinal study|longitudinal study
5376800|NCT01827462|Inactivated, High-Dose trivalent influenza vaccine|inactivated, high-dose trivalent influenza vaccine
5376801|NCT01827462|Inactivated, quadrivalent influenza vaccine|inactivated, quadrivalent influenza vaccine
5376802|NCT01827462|young adults|young adults
5376803|NCT01827449|rewarming|rewarming
5376804|NCT01827449|core cooling|core cooling
5376805|NCT01827449|afterdrop|afterdrop
5376806|NCT01827449|hospital treatment|hospital treatment
5376807|NCT01827449|hypothermia|hypothermia
5376808|NCT01827436|pediatric stroke|pediatric stroke
5376809|NCT01827436|hemiplegia|hemiplegia
5376810|NCT01827436|physical therapy|physical therapy
5376811|NCT01827436|gait training|gait training
5376812|NCT01827436|transcranial magnetic stimulation|transcranial magnetic stimulation
5376813|NCT01827436|gait asymmetry|gait asymmetry
5376814|NCT01827423|squamous cell carcinoma antigen|squamous cell carcinoma antigen
5376815|NCT01827423|sinonasal inverted papilloma|sinonasal inverted papilloma
5376816|NCT01827423|clinical marker|clinical marker
5376817|NCT01827423|hidden reccurence|hidden reccurence
5376818|NCT01827423|surgery|surgery
5376819|NCT01827397|Safety of this HIV vaccine|safety of this hiv vaccine
5376820|NCT01827371|Smallpox, vaccine, IMVAMUNE, Stratis, parent protocol|smallpox, vaccine, imvamune, stratis, parent protocol
5376821|NCT01827358|antibacterial agent|antibacterial agent
5376822|NCT01827358|children|children
5376823|NCT01827358|colonisation|colonisation
5376824|NCT01827358|critically ill|critically ill
5376825|NCT01827358|infants|infants
5376826|NCT01827358|mupirocin|mupirocin
5376827|NCT01827358|prevention|prevention
5376828|NCT01827358|Staphylococcus aureus|staphylococcus aureus
5376829|NCT01827345|Vitamin D|vitamin d
5376830|NCT01827345|Falls|falls
5376831|NCT01827345|Balance|balance
5376832|NCT01827345|Physical Function|physical function
5376833|NCT01827332|marijuana|marijuana
5376834|NCT01827332|substance abuse|substance abuse
5376835|NCT01827332|drug abuse|drug abuse
5376836|NCT01827332|marijuana dependence|marijuana dependence
5376837|NCT01827332|drug addiction|drug addiction
5376838|NCT01827319|Angina|angina
5376839|NCT01827319|Transmyocardial revascularization|transmyocardial revascularization
5376840|NCT01827280|endothelial function|endothelial function
5376841|NCT01827280|microvascular function|microvascular function
5376842|NCT01827280|incretins|incretins
5376843|NCT01827280|diabetes mellitus|diabetes mellitus
5376844|NCT01827280|postprandial lipemia|postprandial lipemia
5376845|NCT01827267|Lung cancer|lung cancer
5376846|NCT01827267|Puma|puma
5376847|NCT01827267|neratinib|neratinib
5376848|NCT01827267|HKI-272|hki-272
5376849|NCT01827267|PB-272|pb-272
5376850|NCT01827267|Nerlynx|nerlynx
5376851|NCT01827254|sutent rechallenge|sutent rechallenge
5376852|NCT01827241|Gastroenterology|gastroenterology
5376853|NCT01827241|Colonoscopy|colonoscopy
5376854|NCT01827241|Screening|screening
5376855|NCT01827241|Surveillance|surveillance
5376856|NCT01827241|Symptom evaluation|symptom evaluation
5376857|NCT01827241|Chart review|chart review
5376858|NCT01827241|Data review|data review
5376859|NCT01827241|Examination findings|examination findings
5376860|NCT01827241|Resection techniques|resection techniques
5376861|NCT01827241|Pathology reports|pathology reports
5376863|NCT01827228|transmission prevention|transmission prevention
5376864|NCT01827228|social network and venue|social network and venue
5376865|NCT01827228|community intervention|community intervention
5376866|NCT01827228|treatment as prevention|treatment as prevention
5376867|NCT01827228|recent infection|recent infection
5376868|NCT01827228|phylogenetics|phylogenetics
5376869|NCT01827228|infection chains|infection chains
5376870|NCT01827215|Preconception Care|preconception care
5376871|NCT01827215|Racial Disparities|racial disparities
5376872|NCT01827215|Health Information Technology|health information technology
5376873|NCT01827202|renin-angiotensin-system|renin-angiotensin-system
5376874|NCT01827202|RAS blockade|ras blockade
5376875|NCT01827189|primary care, Medicare costs, hospitalizations|primary care, medicare costs, hospitalizations
5376876|NCT01827176|Characteristic|characteristic
5376877|NCT01827176|Recurrent Acute Rhinosinusitis|recurrent acute rhinosinusitis
5376878|NCT01827176|Children|children
5362606|NCT01890694|Fluid Restriction|fluid restriction
5376879|NCT01827163|Paclitaxel|paclitaxel
5376880|NCT01827163|Trastuzumab|trastuzumab
5376881|NCT01827163|Lapatinib|lapatinib
5376882|NCT01827163|HER2|her2
5376883|NCT01827163|13-002|13-002
5376884|NCT01827137|WT1 Analog Peptide Vaccine|wt1 analog peptide vaccine
5376885|NCT01827137|12-288|12-288
5376886|NCT01827137|Galinpepimut-S|galinpepimut-s
5376888|NCT01827137|Maintenance therapy|maintenance therapy
5376889|NCT01827137|Autologous Stem Cell Transplant (ASCT)|autologous stem cell transplant (asct)
5376890|NCT01827137|Lenalidomide|lenalidomide
5376891|NCT01827137|Immune Response|immune response
5376892|NCT01827137|Wilms Tumor 1|wilms tumor 1
5376893|NCT01827137|Prevention of progression|prevention of progression
5376894|NCT01827137|Prevention of relapse|prevention of relapse
5376895|NCT01827137|Immuno-Oncology|immuno-oncology
5376896|NCT01827137|Immunotherapeutic Agent|immunotherapeutic agent
5376897|NCT01827137|Direct Immunizer|direct immunizer
5376898|NCT01827137|Heteroclitic|heteroclitic
5376899|NCT01827137|Multivalent|multivalent
5376900|NCT01827137|Post-ASCT maintenance|post-asct maintenance
5376901|NCT01827137|High-risk cytogenetics|high-risk cytogenetics
5376902|NCT01827124|CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION|carbetocin and oxytocin and second trimester interruption
5376903|NCT01827111|Melanoma|melanoma
5376907|NCT01827111|Cutaneous melanoma|cutaneous melanoma
5376908|NCT01827111|Progression-free survival|progression-free survival
5376909|NCT01827111|(PFS)|(pfs)
5376910|NCT01827111|ABI-007|abi-007
5376911|NCT01827111|Nab-paclitaxel|nab-paclitaxel
5376912|NCT01827111|Paclitaxel|paclitaxel
5376913|NCT01827111|Abraxane|abraxane
5376914|NCT01827111|Ipilimumab|ipilimumab
5376915|NCT01827111|Yervoy|yervoy
5376916|NCT01827111|BMS-734016|bms-734016
5376917|NCT01827111|MDX010|mdx010
5376918|NCT01827098|Immature teeth|immature teeth
5376919|NCT01827098|Calcium Hydroxide|calcium hydroxide
5376920|NCT01827098|Blood clot|blood clot
5376921|NCT01827098|Revascularization|revascularization
5376922|NCT01827098|Revitalization|revitalization
5376923|NCT01827072|IVIG in Multifocal Motor Neuropathy|ivig in multifocal motor neuropathy
5376924|NCT01827072|Patients with Multifocal Motor Neuropathy|patients with multifocal motor neuropathy
5376925|NCT01827046|intracerebral hemorrhage|intracerebral hemorrhage
5376927|NCT01827046|brain hemorrhage|brain hemorrhage
5376928|NCT01827046|minimally invasive surgery|minimally invasive surgery
5376929|NCT01827046|rt-PA|rt-pa
5376930|NCT01827007|norepinephrine infusion|norepinephrine infusion
5376931|NCT01827007|under 48 hours in ICU|under 48 hours in icu
5376932|NCT01826968|Lung recruitment, cesarean, lung compliance, atelectasis|lung recruitment, cesarean, lung compliance, atelectasis
5376933|NCT01826955|pneumoperitoneum, cognitive function|pneumoperitoneum, cognitive function
5376934|NCT01826942|Scar prevention|scar prevention
5376935|NCT01826942|CO2 fractional laser|co2 fractional laser
5376936|NCT01826929|Health Services Research|health services research
5376937|NCT01826929|Cardiovascular Diseases|cardiovascular diseases
5376938|NCT01826929|Primary Care|primary care
5376939|NCT01826929|Secondary Prevention.|secondary prevention.
5376940|NCT01826903|Depression|depression
5376941|NCT01826903|Cognitive Behavior Therapy|cognitive behavior therapy
5376942|NCT01826903|Child Development|child development
5376943|NCT01826890|Ventilator Weaning|ventilator weaning
5376944|NCT01826890|Mechanical Ventilation|mechanical ventilation
5376945|NCT01826890|Critical Care|critical care
5376946|NCT01826890|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5376947|NCT01826890|Diaphragm|diaphragm
5376948|NCT01826851|Pain management|pain management
5376949|NCT01826851|Anesthetic, local|anesthetic, local
5376950|NCT01826851|Nerve blockade|nerve blockade
5376951|NCT01826851|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5376952|NCT01826851|Analgesics, opioid|analgesics, opioid
5376953|NCT01826851|Postoperative complications|postoperative complications
5376954|NCT01826851|Bupivacaine|bupivacaine
5376955|NCT01826838|Prostate Cancer|prostate cancer
5376956|NCT01826825|aging|aging
5376957|NCT01826825|cognition|cognition
5376958|NCT01826825|surgery|surgery
5376960|NCT01826799|noise|noise
5376962|NCT01826799|delirium|delirium
5376963|NCT01826799|RCSQ|rcsq
5376964|NCT01826786|Healthy|healthy
5376965|NCT01826786|Anxiety Disorders|anxiety disorders
5376966|NCT01826786|Anxiety Modulation|anxiety modulation
5376967|NCT01826786|Male|male
5376968|NCT01826773|CardioPET|cardiopet
5376969|NCT01826773|Coronary Artery Disease|coronary artery disease
5376970|NCT01826773|Myocardial Perfusion Imaging|myocardial perfusion imaging
5376971|NCT01826773|Coronary Angiography|coronary angiography
5376972|NCT01826773|Myocardial Fatty Acid Utilization|myocardial fatty acid utilization
5376973|NCT01826747|intrauterine insemination|intrauterine insemination
5376974|NCT01826747|luteal phase|luteal phase
5376975|NCT01826747|gonadotrophins|gonadotrophins
5376976|NCT01826734|dacryolith|dacryolith
5376977|NCT01826734|dacryocystorhinostomy|dacryocystorhinostomy
5376978|NCT01826734|composition|composition
5376979|NCT01826734|chemical analysis|chemical analysis
5376980|NCT01826734|infrared spectrometry|infrared spectrometry
5376981|NCT01826734|scanning electron microscopy|scanning electron microscopy
5376982|NCT01826734|elemental analysis|elemental analysis
5376983|NCT01826721|Solid organ transplantation|solid organ transplantation
5376984|NCT01826721|Immunosuppression|immunosuppression
5376985|NCT01826721|Education|education
5376986|NCT01826721|E-learning|e-learning
5376987|NCT01826721|Medication knowledge|medication knowledge
5376988|NCT01826721|Patient satisfaction|patient satisfaction
5376989|NCT01826721|Medication adherence|medication adherence
5376990|NCT01826708|Chromosomal translocations|chromosomal translocations
5376991|NCT01826708|psychomotor delay|psychomotor delay
5376992|NCT01826695|Fibromyalgia, neurodynamic, dexterity|fibromyalgia, neurodynamic, dexterity
5376993|NCT01826682|COPD, physiotherapy, exacerbation|copd, physiotherapy, exacerbation
5376994|NCT01826656|intramembranous bone healing|intramembranous bone healing
5376995|NCT01826656|post-menopausal osteoporosis|post-menopausal osteoporosis
5377010|NCT01826539|dorsal branch of the digital nerve|dorsal branch of the digital nerve
5377011|NCT01826539|dorsal branch of the digital artery|dorsal branch of the digital artery
5377013|NCT01826539|finger pulp defect.|finger pulp defect.
5377014|NCT01826513|Obstructive sleep apnea|obstructive sleep apnea
5377015|NCT01826513|Efficacy|efficacy
5377016|NCT01826513|Subjective feedback|subjective feedback
5377017|NCT01826513|Preference|preference
5377018|NCT01826500|embryo transfer|embryo transfer
5377019|NCT01826500|IVF cycle|ivf cycle
5377020|NCT01826500|endometriosis|endometriosis
5377021|NCT01826487|Duchenne muscular dystrophy|duchenne muscular dystrophy
5377022|NCT01826487|Dystrophinopathy|dystrophinopathy
5377023|NCT01826487|Nonsense mutation|nonsense mutation
5377024|NCT01826487|Premature stop codon|premature stop codon
5377025|NCT01826487|Becker muscular dystrophy|becker muscular dystrophy
5377026|NCT01826487|DMD/BMD|dmd/bmd
5377027|NCT01826487|PTC124|ptc124
5377028|NCT01826487|Ataluren|ataluren
5377029|NCT01826474|Duchenne muscular dystrophy|duchenne muscular dystrophy
5377031|NCT01826474|Prosensa|prosensa
5377032|NCT01826474|Duchenne|duchenne
5377033|NCT01826461|atopic dermatitis|atopic dermatitis
5377034|NCT01826461|eczema|eczema
5377035|NCT01826461|PDI-192|pdi-192
5377036|NCT01826461|Precision|precision
5377037|NCT01826422|Muscular Dystrophy|muscular dystrophy
5377038|NCT01826422|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5377039|NCT01826422|Becker Muscular Dystrophy|becker muscular dystrophy
5377040|NCT01826422|Omega 3|omega 3
5377041|NCT01826422|Eicosapentaenoic fatty acid|eicosapentaenoic fatty acid
5377042|NCT01826422|Docosahexaenoic fatty acid|docosahexaenoic fatty acid
5377043|NCT01826383|Infant|infant
5377044|NCT01826383|Immunization|immunization
5377045|NCT01826357|metabolic syndrome|metabolic syndrome
5377046|NCT01826357|cluster analysis|cluster analysis
5377047|NCT01826357|PCOS|pcos
5377048|NCT01826318|Stress|stress
5377049|NCT01826318|coping|coping
5377050|NCT01826318|simulation|simulation
5377051|NCT01826292|Post anesthesia care unit length of stay|post anesthesia care unit length of stay
5377052|NCT01826279|Obesity|obesity
5377053|NCT01826279|Gastric bypass surgery|gastric bypass surgery
5377054|NCT01826279|Resveratrol|resveratrol
5377055|NCT01826279|Insulin sensitivity|insulin sensitivity
5377056|NCT01826279|Lipid turnover|lipid turnover
5377057|NCT01826279|VLDL-triglyceride uptake|vldl-triglyceride uptake
5377058|NCT01826279|Liver|liver
5377059|NCT01826266|PER977|per977
5377060|NCT01826266|Activated partial thromboplastin time|activated partial thromboplastin time
5377061|NCT01826266|Assessment|assessment
5377062|NCT01826266|D-dimer|d-dimer
5377063|NCT01826266|Enrollment|enrollment
5377064|NCT01826266|Investigational drug|investigational drug
5377065|NCT01826266|Investigational treatment|investigational treatment
5377066|NCT01826266|Period|period
5377067|NCT01826266|Premature subject withdrawal|premature subject withdrawal
5377068|NCT01826266|Prothrombin time|prothrombin time
5377069|NCT01826266|Randomization number|randomization number
5377070|NCT01826266|Study discontinuation|study discontinuation
5377071|NCT01826266|Study drug|study drug
5377072|NCT01826266|Subject number|subject number
5377075|NCT01826253|Hypovolemia|hypovolemia
5377076|NCT01826253|Fluid challenge|fluid challenge
5377077|NCT01826253|Fluid expansion|fluid expansion
5377078|NCT01826253|Oxygene delivery|oxygene delivery
5377079|NCT01826253|Cardiac output|cardiac output
5380769|NCT01808911|Rituximab|rituximab
5377080|NCT01826227|PET (Positron Emission Tomography)|pet (positron emission tomography)
5377082|NCT01826227|Cytoreductive Surgery|cytoreductive surgery
5377083|NCT01826227|13-017|13-017
5377084|NCT01826214|acute myeloid leukemia|acute myeloid leukemia
5377085|NCT01826214|AML|aml
5377086|NCT01826214|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5377087|NCT01826214|ALL|all
5377088|NCT01826214|leukemia|leukemia
5377089|NCT01826214|acute|acute
5377090|NCT01826214|LDE225|lde225
5377091|NCT01826214|adult patients|adult patients
5362884|NCT01889342|MCT|mct
5377092|NCT01826214|relapsed/refractory|relapsed/refractory
5377093|NCT01826201|psoriasis|psoriasis
5377094|NCT01826188|Crohn's disease|crohn's disease
5377095|NCT01826188|IBD Cannabis|ibd cannabis
5377096|NCT01826188|THC|thc
5377097|NCT01826188|CBD|cbd
5377098|NCT01826175|Optical Coherence Tomography|optical coherence tomography
5377099|NCT01826175|ticagrelor|ticagrelor
5377100|NCT01826175|clopidogrel|clopidogrel
5377101|NCT01826123|Coagulopathy|coagulopathy
5377102|NCT01826123|Hemorrhage|hemorrhage
5377103|NCT01826123|Cardiac surgery|cardiac surgery
5377104|NCT01826123|Point-of-Care testing|point-of-care testing
5377105|NCT01826123|POC|poc
5377106|NCT01826123|ROTEM|rotem
5377107|NCT01826123|multiplate|multiplate
5377108|NCT01826123|Multiple electrode aggregometry (MEA)|multiple electrode aggregometry (mea)
5377109|NCT01826097|Cytology|cytology
5377110|NCT01826097|Whole body massage vibration|whole body massage vibration
5377111|NCT01826071|Osgood-Schlatter syndrome (OSS)|osgood-schlatter syndrome (oss)
5377112|NCT01826071|Sinding-Larsen and Johansson syndrome (SLJ)|sinding-larsen and johansson syndrome (slj)
5377114|NCT01826071|apophysitis|apophysitis
5377115|NCT01826058|Stereotactic body radiation therapy|stereotactic body radiation therapy
5377116|NCT01826058|Radiosurgery|radiosurgery
5377117|NCT01826045|Treatment of Cervical Intraepithelial Neoplasia(CIN1)|treatment of cervical intraepithelial neoplasia(cin1)
5377118|NCT01826006|Myocardial Infarction|myocardial infarction
5377119|NCT01826006|No-reflow|no-reflow
5377120|NCT01826006|Primary PCI|primary pci
5377121|NCT01826006|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
5377122|NCT01826006|Primary percoutaneous coronary intervention (primary PCI)|primary percoutaneous coronary intervention (primary pci)
5377123|NCT01825993|Peridural catheter|peridural catheter
5377124|NCT01825993|Morphine PCA|morphine pca
5377125|NCT01825993|Transabdominal Block|transabdominal block
5377126|NCT01825993|laparoscopic sigmoidectomy|laparoscopic sigmoidectomy
5377127|NCT01825954|Fibromyalgia|fibromyalgia
5377128|NCT01825954|Pain|pain
5377129|NCT01825954|Brain|brain
5377130|NCT01825954|Stimulation|stimulation
5377131|NCT01825954|Device|device
5377132|NCT01825941|migraine|migraine
5377133|NCT01825941|headache|headache
5377134|NCT01825941|metoclopramide|metoclopramide
5377135|NCT01825941|diphenhydramine|diphenhydramine
5377136|NCT01825928|Methamphetamine|methamphetamine
5377137|NCT01825928|paliperidone|paliperidone
5377138|NCT01825915|Laparoscopic|laparoscopic
5377139|NCT01825915|Hysterectomy|hysterectomy
5377140|NCT01825915|Total|total
5377141|NCT01825915|Subtotal|subtotal
5377142|NCT01825915|Recovery|recovery
5377143|NCT01825915|Outcomes|outcomes
5377144|NCT01825915|Surgery|surgery
5377145|NCT01825863|Laparoscopy|laparoscopy
5377146|NCT01825863|Adult|adult
5377147|NCT01825863|Nerve block|nerve block
5377148|NCT01825863|Ultrasonography|ultrasonography
5377149|NCT01825837|bipolar I disorder|bipolar i disorder
5377150|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate
5377151|NCT01825837|BIA 2-093|bia 2-093
5377152|NCT01825824|Hepatocellular carcinoma|hepatocellular carcinoma
5377153|NCT01825824|Stereotactic ablative radiotherapy|stereotactic ablative radiotherapy
5377154|NCT01825824|Stereotactic body radiotherapy|stereotactic body radiotherapy
5377155|NCT01825811|Cell mediated gene therapy|cell mediated gene therapy
5377156|NCT01825811|Osteoarthritis|osteoarthritis
5377157|NCT01825811|Fibrin-glue|fibrin-glue
5377158|NCT01825811|Degenerative Arthritis|degenerative arthritis
5377159|NCT01825798|Metformin|metformin
5377160|NCT01825798|Overweight|overweight
5377161|NCT01825798|Atypical Antipsychotic|atypical antipsychotic
5377162|NCT01825798|Medication|medication
5377163|NCT01825798|Randomized Clinical Trial|randomized clinical trial
5377164|NCT01825798|Children|children
5377165|NCT01825772|Cross-Sectional Studies|cross-sectional studies
5377166|NCT01825772|Prevalence|prevalence
5377167|NCT01825772|Peri-Implantitis|peri-implantitis
5377168|NCT01825733|palonosetron, ramosetron, PONV, opioid|palonosetron, ramosetron, ponv, opioid
5377169|NCT01825720|GIK, valvular heart surgery, lactate|gik, valvular heart surgery, lactate
5377171|NCT01825694|Traumatic Stress|traumatic stress
5377172|NCT01825681|positive affect|positive affect
5377173|NCT01825681|caregivers|caregivers
5377174|NCT01825681|caregiving|caregiving
5377175|NCT01825681|stress|stress
5377176|NCT01825681|mood|mood
5377177|NCT01825681|dementia|dementia
5377178|NCT01825681|Alzheimer's|alzheimer's
5377180|NCT01825681|Lewy|lewy
5377184|NCT01825642|sexual function|sexual function
5377584|NCT01823601|Well-Being|well-being
5377185|NCT01825642|seminal vesicle sparing|seminal vesicle sparing
5377186|NCT01825642|nerve-sparing|nerve-sparing
5377187|NCT01825642|radical prostatectomy|radical prostatectomy
5377189|NCT01825629|Temporomandibular joint|temporomandibular joint
5377190|NCT01825629|Manual therapy|manual therapy
5377191|NCT01825629|Physical therapy|physical therapy
5362893|NCT01889303|docetaxel|docetaxel
5377192|NCT01825629|Fibromyalgia Syndrome|fibromyalgia syndrome
5377193|NCT01825616|Strength|strength
5377194|NCT01825616|Anaerobic power|anaerobic power
5377195|NCT01825616|Muscle soreness|muscle soreness
5377196|NCT01825616|Immune function|immune function
5377197|NCT01825590|hemodialysis|hemodialysis
5377198|NCT01825590|dialysate and serum sodium|dialysate and serum sodium
5377199|NCT01825577|Alzheimer Dementia|alzheimer dementia
5377200|NCT01825577|Gait|gait
5377201|NCT01825564|G-tube|g-tube
5377202|NCT01825564|Feeding tube|feeding tube
5377203|NCT01825564|Feeding tube placement verification|feeding tube placement verification
5377204|NCT01825564|Enteral feeding|enteral feeding
5377205|NCT01825551|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5377206|NCT01825551|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5377207|NCT01825538|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5377208|NCT01825538|Pulmonary fibrosis|pulmonary fibrosis
5377209|NCT01825538|Advanced care planning|advanced care planning
5377210|NCT01825512|chronic iron overload|chronic iron overload
5377211|NCT01825512|hereditary haemoglobinopathy|hereditary haemoglobinopathy
5377212|NCT01825512|beta thalassaemia major|beta thalassaemia major
5377213|NCT01825512|chelating agents|chelating agents
5377215|NCT01825512|deferasirox|deferasirox
5377216|NCT01825512|children|children
5377217|NCT01825512|paediatrics|paediatrics
5377218|NCT01825499|Birth weight|birth weight
5377219|NCT01825499|Gestational age|gestational age
5377220|NCT01825499|Very low birth weight|very low birth weight
5377221|NCT01825486|Balance|balance
5377222|NCT01825486|Gait characteristics|gait characteristics
5377223|NCT01825473|neonate|neonate
5377224|NCT01825473|apnea|apnea
5377225|NCT01825473|preterm|preterm
5377226|NCT01825473|reflux|reflux
5377227|NCT01825473|gastroesophageal reflux|gastroesophageal reflux
5377228|NCT01825473|impedance|impedance
5377229|NCT01825473|erythromycin|erythromycin
5377230|NCT01825473|desaturation|desaturation
5377231|NCT01825473|bradycardia|bradycardia
5377232|NCT01825473|hypoxia|hypoxia
5377233|NCT01825460|Cervical spine|cervical spine
5377234|NCT01825460|Neck pain|neck pain
5377235|NCT01825460|Manual therapy|manual therapy
5377236|NCT01825460|Controlled clinical trial|controlled clinical trial
5377237|NCT01825447|abuse potential|abuse potential
5377238|NCT01825447|abuse liability|abuse liability
5377239|NCT01825447|drug liking|drug liking
5377240|NCT01825447|oxycodone|oxycodone
5377241|NCT01825447|naltrexone|naltrexone
5377242|NCT01825447|intravenous|intravenous
5377243|NCT01825447|pharmacodynamic|pharmacodynamic
5377244|NCT01825434|chronic constipation|chronic constipation
5377245|NCT01825434|Lactobacillus acidophilus NCFM|lactobacillus acidophilus ncfm
5377246|NCT01825434|Bifidobacterium lactis HN019|bifidobacterium lactis hn019
5377247|NCT01825421|Infant|infant
5377248|NCT01825421|Infection|infection
5377249|NCT01825421|Newborn|newborn
5377250|NCT01825421|Antibiotics|antibiotics
5377251|NCT01825421|Neutrophil CD64|neutrophil cd64
5377252|NCT01825421|Blood Culture|blood culture
5377253|NCT01825369|congenital heart disease|congenital heart disease
5377254|NCT01825369|ventricular septal defect|ventricular septal defect
5377255|NCT01825369|atrioventricular septal defect|atrioventricular septal defect
5377256|NCT01825369|increased pulmonary blood flow|increased pulmonary blood flow
5377257|NCT01825369|nitric oxide|nitric oxide
5377258|NCT01825343|fall|fall
5377259|NCT01825343|burn|burn
5377260|NCT01825343|road traffic crash|road traffic crash
5377261|NCT01825330|Alzheimer's Disease|alzheimer's disease
5377262|NCT01825330|Alzheimer's|alzheimer's
5377263|NCT01825330|TMS|tms
5377264|NCT01825330|Cognitive Training|cognitive training
5377265|NCT01825330|NeuroAD|neuroad
5377266|NCT01825317|Alzheimer's disease|alzheimer's disease
5377267|NCT01825317|TMS|tms
5377268|NCT01825317|NeuroAd|neuroad
5377269|NCT01825317|cognitive training|cognitive training
5377270|NCT01825317|ADAS-Cog|adas-cog
5377271|NCT01825304|mechanical ventilation|mechanical ventilation
5377272|NCT01825304|Intra-abdominal hypertension|intra-abdominal hypertension
5377273|NCT01825304|positive end-expiratory pressure|positive end-expiratory pressure
5377274|NCT01825291|sleep apnea|sleep apnea
5377275|NCT01825291|co-morbidities of sleep apnea|co-morbidities of sleep apnea
5377276|NCT01825291|CPAP treatment|cpap treatment
5377277|NCT01825278|respiratory rate|respiratory rate
5377278|NCT01825278|tidal volume|tidal volume
5377279|NCT01825278|minute ventilation|minute ventilation
5377280|NCT01825278|obese patients|obese patients
5377281|NCT01825278|obstructive sleep apnea|obstructive sleep apnea
5377282|NCT01825252|HIV|hiv
5377283|NCT01825252|sexually transmitted diseases|sexually transmitted diseases
5377284|NCT01825239|ischemic cardiomyopathy|ischemic cardiomyopathy
5377285|NCT01825239|cardiomyopathy|cardiomyopathy
5377680|NCT01823185|Clopidogrel|clopidogrel
5377286|NCT01825239|left ventricular lead|left ventricular lead
5377287|NCT01825239|cardiac electrophysiologic studies|cardiac electrophysiologic studies
5377288|NCT01825213|Liver disease|liver disease
5377289|NCT01825213|Multi Spectral CT|multi spectral ct
5377290|NCT01825200|Influenza|influenza
5377291|NCT01825148|Diabetes|diabetes
5377292|NCT01825135|muscle strength|muscle strength
5377293|NCT01825135|muscle function|muscle function
5377294|NCT01825135|functional status|functional status
5377295|NCT01825109|Rotavirus|rotavirus
5377296|NCT01825109|Immunogenicity|immunogenicity
5377297|NCT01825109|vaccine, Bangladesh|vaccine, bangladesh
5377298|NCT01825096|cerebral metabolism|cerebral metabolism
5377299|NCT01825096|functional magnetic resonance imaging|functional magnetic resonance imaging
5377300|NCT01825096|near infrared spectroscopy|near infrared spectroscopy
5377301|NCT01825083|Hypercarbia|hypercarbia
5377302|NCT01825083|TOSCA monitor|tosca monitor
5377303|NCT01825083|Ketamine|ketamine
5377304|NCT01825083|Fentanyl|fentanyl
5377305|NCT01825083|Intraoperative monitoring|intraoperative monitoring
5377306|NCT01825070|Montmorency tart cherries|montmorency tart cherries
5377307|NCT01825070|Inflammation|inflammation
5377308|NCT01825070|Uric acid|uric acid
5377309|NCT01825057|implementation study|implementation study
5377310|NCT01825057|motivational interviewing|motivational interviewing
5377311|NCT01825057|substance use|substance use
5377312|NCT01825044|Traumatic Brain Injury|traumatic brain injury
5377314|NCT01825044|ciclosporin|ciclosporin
5377315|NCT01825044|pharmacokinetic|pharmacokinetic
5377316|NCT01825044|safety|safety
5377317|NCT01825044|microdialysis|microdialysis
5377318|NCT01825044|mitochondrial protection|mitochondrial protection
5377320|NCT01825018|HIV|hiv
5377321|NCT01825018|AIDS|aids
5377322|NCT01825018|treatment adherence|treatment adherence
5377323|NCT01825005|cervical cancer|cervical cancer
5377324|NCT01824966|Esophagectomy|esophagectomy
5377325|NCT01824966|Signet Ring Cells|signet ring cells
5377326|NCT01824953|Gastric atrophy|gastric atrophy
5377327|NCT01824953|Helicobacter pylori|helicobacter pylori
5377328|NCT01824953|Pepsinogen|pepsinogen
5377329|NCT01824953|Gastric cancer|gastric cancer
5377330|NCT01824953|Gastric adenoma|gastric adenoma
5377331|NCT01824940|Cluster randomized trial|cluster randomized trial
5377332|NCT01824940|Nutrition|nutrition
5377333|NCT01824940|Water Sanitation Hygiene|water sanitation hygiene
5377334|NCT01824940|Environmental enteropathy|environmental enteropathy
5377335|NCT01824914|videolaryngoscope|videolaryngoscope
5377336|NCT01824914|tracheal intubation|tracheal intubation
5377337|NCT01824914|Cormack-Lehane grade|cormack-lehane grade
5377338|NCT01824914|airway evaluation|airway evaluation
5377339|NCT01824914|sedation|sedation
5377340|NCT01824914|anesthesia|anesthesia
5377341|NCT01824901|AZD4547|azd4547
5377342|NCT01824901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5377343|NCT01824888|JUC|juc
5377344|NCT01824888|hand rub|hand rub
5377345|NCT01824888|European standard|european standard
5377346|NCT01824862|clinically significant macular edema|clinically significant macular edema
5377347|NCT01824862|foveal thickness|foveal thickness
5377348|NCT01824862|foveal sensitivity|foveal sensitivity
5377349|NCT01824862|perimetry|perimetry
5377350|NCT01824862|diabetic retinopathy|diabetic retinopathy
5377351|NCT01824849|Vocal cords|vocal cords
5377352|NCT01824849|Vocal cord paralysis|vocal cord paralysis
5377353|NCT01824849|Arytenoid cartilage|arytenoid cartilage
5377354|NCT01824823|afatinib|afatinib
5377355|NCT01824823|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5377356|NCT01824810|Intramuscular Stimulation|intramuscular stimulation
5377357|NCT01824810|myoActivation|myoactivation
5377358|NCT01824810|Neural Prolotherapy|neural prolotherapy
5377359|NCT01824810|Whiplash-Associated Disorders|whiplash-associated disorders
5377360|NCT01824810|myofascial pain|myofascial pain
5377361|NCT01824797|Bone mineral density|bone mineral density
5377362|NCT01824797|sleeve gastrectomy|sleeve gastrectomy
5377363|NCT01824797|roux-en-y|roux-en-y
5377364|NCT01824797|postmenopausal females|postmenopausal females
5377365|NCT01824797|bone loss|bone loss
5377366|NCT01824784|Normal Eyes|normal eyes
5377367|NCT01824771|Continuous veno-venoous haemofiltration|continuous veno-venoous haemofiltration
5377368|NCT01824771|Plasma lactate|plasma lactate
5377369|NCT01824771|Critical illness|critical illness
5377370|NCT01824771|Acute kidney injurytissue perfusion|acute kidney injurytissue perfusion
5377371|NCT01824771|Multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5377372|NCT01824758|esmolol, injection pain, lidocaine, rocuronium|esmolol, injection pain, lidocaine, rocuronium
5377373|NCT01824706|cranial prosthesis|cranial prosthesis
5377375|NCT01824680|Appetite regulation|appetite regulation
5377376|NCT01824680|Hormones|hormones
5381073|NCT01807559|SSD|ssd
5377377|NCT01824680|Adolescents|adolescents
5377378|NCT01824680|Exercise|exercise
5377379|NCT01824654|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5377380|NCT01824654|Imaging, Three-Dimensional|imaging, three-dimensional
5377381|NCT01824654|Tomography Scanners, X-Ray Computed|tomography scanners, x-ray computed
5377382|NCT01824654|Angiography, Digital Subtraction|angiography, digital subtraction
5377386|NCT01824641|Manual thrombus aspiration|manual thrombus aspiration
5377387|NCT01824641|Coronary physiology|coronary physiology
5377389|NCT01824615|recurrent ovarian cancer|recurrent ovarian cancer
5377390|NCT01824615|clear cell carcinoma|clear cell carcinoma
5377391|NCT01824602|BIPOLAR I DISORDER, Eslicarbazepine acetate|bipolar i disorder, eslicarbazepine acetate
5377392|NCT01824589|traumatic brain injury|traumatic brain injury
5377395|NCT01824589|intrathoracic pressure regulator|intrathoracic pressure regulator
5377396|NCT01824589|hepatic encephalopathy|hepatic encephalopathy
5377397|NCT01824589|pseudotumorcerebri|pseudotumorcerebri
5377398|NCT01824589|obstructive hydrocephalus|obstructive hydrocephalus
5377399|NCT01824589|intracranial hemorrhage|intracranial hemorrhage
5377400|NCT01824576|ITPR|itpr
5377401|NCT01824576|CPP|cpp
5377402|NCT01824576|TBI|tbi
5377403|NCT01824576|traumatic brain injury|traumatic brain injury
5377404|NCT01824576|cerebral perfusion pressure|cerebral perfusion pressure
5377405|NCT01824576|intrathoracic pressure regulator|intrathoracic pressure regulator
5377410|NCT01824524|Pain|pain
5377411|NCT01824524|Hydromorphone|hydromorphone
5377412|NCT01824524|OROS|oros
5377413|NCT01824511|smoking|smoking
5377414|NCT01824511|nicotine|nicotine
5377415|NCT01824511|tobacco|tobacco
5377416|NCT01824511|anhedonia|anhedonia
5377417|NCT01824511|reward|reward
5377418|NCT01824511|withdrawal|withdrawal
5377419|NCT01824498|omega-3 fatty acids|omega-3 fatty acids
5377420|NCT01824498|sex hormones|sex hormones
5377421|NCT01824498|urinary sex hormone metabolites|urinary sex hormone metabolites
5377422|NCT01824485|Osteoarthritis|osteoarthritis
5377423|NCT01824485|Knee|knee
5377424|NCT01824485|Viscosupplementation|viscosupplementation
5377425|NCT01824485|Clinical Trial|clinical trial
5377426|NCT01824459|Non-intestinal type gastric cancer|non-intestinal type gastric cancer
5377427|NCT01824459|Advance Gastric Cancer|advance gastric cancer
5377428|NCT01824459|Recurrent Gastric Cancer|recurrent gastric cancer
5377429|NCT01824459|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5377430|NCT01824459|SOX, S-1+Oxaliplatin|sox, s-1+oxaliplatin
5377431|NCT01824459|OS,|os,
5377432|NCT01824459|ORR,|orr,
5377433|NCT01824459|PFS,|pfs,
5377434|NCT01824459|TTF,|ttf,
5377435|NCT01824459|safety|safety
5377436|NCT01824433|venlafaxine|venlafaxine
5377437|NCT01824433|fluoxetine|fluoxetine
5377438|NCT01824433|postmenopause|postmenopause
5377439|NCT01824433|major depressive disorder|major depressive disorder
5377440|NCT01824420|Refractory overactive bladder syndrome|refractory overactive bladder syndrome
5377441|NCT01824420|Antimuscarinic agent|antimuscarinic agent
5377442|NCT01824407|foot|foot
5377443|NCT01824407|ulcers|ulcers
5377444|NCT01824407|diabetes|diabetes
5377445|NCT01824407|wound|wound
5377446|NCT01824407|healing|healing
5377447|NCT01824394|nMARQ|nmarq
5377448|NCT01824394|Atrial Fibrillation|atrial fibrillation
5377449|NCT01824394|Drug Refractory|drug refractory
5377450|NCT01824394|Radio Frequency|radio frequency
5377451|NCT01824381|extensive wounds|extensive wounds
5377452|NCT01824381|amniotic membrane|amniotic membrane
5377453|NCT01824381|healing|healing
5377454|NCT01824381|patients|patients
5377455|NCT01824381|phase granulation|phase granulation
5377456|NCT01824329|Bladder Cancer|bladder cancer
5377457|NCT01824329|Transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5377458|NCT01824264|Type 2 Diabetes mellitus, SGLT inhibitors, dose-response|type 2 diabetes mellitus, sglt inhibitors, dose-response
5377459|NCT01824251|IVIG in Chronic Inflammatory Demyelinating Polyneuropathy|ivig in chronic inflammatory demyelinating polyneuropathy
5360766|NCT01898806|Kenalog|kenalog
5377460|NCT01824251|Patients with Chronic Inflammatory Demyelinating Polyneuropathy|patients with chronic inflammatory demyelinating polyneuropathy
5377461|NCT01824225|aflibercept|aflibercept
5377462|NCT01824225|intravitreal injection|intravitreal injection
5377463|NCT01824212|Ventricular fibrillation|ventricular fibrillation
5377464|NCT01824212|Cardiac arrest|cardiac arrest
5377465|NCT01824212|Mobile technology|mobile technology
5377466|NCT01824199|Esophagitis|esophagitis
5377467|NCT01824173|muscle|muscle
5377468|NCT01824173|mitochondria|mitochondria
5377469|NCT01824173|amino acids|amino acids
5377470|NCT01824173|exercise|exercise
5377471|NCT01824147|ASS-Nonresponse|ass-nonresponse
5377472|NCT01824147|cardiac|cardiac
5377473|NCT01824147|surgery|surgery
5377474|NCT01824121|Progressive Supranuclear palsy|progressive supranuclear palsy
5377475|NCT01824121|stem cell therapy|stem cell therapy
5377476|NCT01824108|Lumbar disc herniation|lumbar disc herniation
5377477|NCT01824108|Wallis interspinous implants|wallis interspinous implants
5377478|NCT01824108|lumbar discectomy|lumbar discectomy
5372907|NCT01845207|Frailty|frailty
5377479|NCT01824108|interspinous dynamic stability system|interspinous dynamic stability system
5377480|NCT01824082|phantom pain|phantom pain
5377481|NCT01824082|traumatic limb amputation|traumatic limb amputation
5377483|NCT01824069|Critical Ischemia|critical ischemia
5377484|NCT01824069|Amputation|amputation
5377485|NCT01824056|18F-FDG|18f-fdg
5377486|NCT01824043|diabetic retinopathy|diabetic retinopathy
5377487|NCT01824043|vitreous hemorrhage|vitreous hemorrhage
5377488|NCT01824043|intravitreal ranibizumab|intravitreal ranibizumab
5377489|NCT01824030|FFR, OCT, Seattle Angina Questionnaire|ffr, oct, seattle angina questionnaire
5377490|NCT01824017|Type 2 diabetes|type 2 diabetes
5377491|NCT01824017|metabolic syndrome|metabolic syndrome
5377492|NCT01824017|oxidative stress|oxidative stress
5377494|NCT01824004|Gastric cancer|gastric cancer
5377495|NCT01824004|Adjuvant|adjuvant
5377496|NCT01824004|Chemoradiotherapy|chemoradiotherapy
5377497|NCT01824004|S-1|s-1
5377498|NCT01824004|Cisplatin|cisplatin
5377499|NCT01823991|polyphenolics|polyphenolics
5377500|NCT01823991|anthocyanins|anthocyanins
5377501|NCT01823991|n-3 fatty acids|n-3 fatty acids
5377502|NCT01823978|metastatic|metastatic
5377503|NCT01823978|castration resistant prostate cancer|castration resistant prostate cancer
5377504|NCT01823978|Therapeutic Vaccine|therapeutic vaccine
5377505|NCT01823978|Dendritic cell|dendritic cell
5377506|NCT01823978|BPX-201|bpx-201
5377507|NCT01823978|BPX201|bpx201
5377508|NCT01823978|AP1903|ap1903
5377509|NCT01823952|HAMS|hams
5377510|NCT01823952|ORS|ors
5377511|NCT01823952|Cholera|cholera
5377512|NCT01823952|Diarrhea|diarrhea
5377513|NCT01823939|Cholera|cholera
5377514|NCT01823939|V. Cholerae O1|v. cholerae o1
5377515|NCT01823939|iOWH032|iowh032
5377516|NCT01823939|diarrhoea|diarrhoea
5377517|NCT01823939|pharmacokinetic|pharmacokinetic
5377518|NCT01823939|Bangladesh|bangladesh
5377519|NCT01823926|vibrating mesh nebulizers|vibrating mesh nebulizers
5377520|NCT01823926|noninvasive ventilation|noninvasive ventilation
5377521|NCT01823926|residual volume|residual volume
5377522|NCT01823926|pulmonary scintigraphy|pulmonary scintigraphy
5377523|NCT01823926|radioaerosol|radioaerosol
5377524|NCT01823926|nebulization.|nebulization.
5377525|NCT01823913|Pharmacokinetics|pharmacokinetics
5377526|NCT01823900|Pharmacokinetics|pharmacokinetics
5377527|NCT01823887|Heart Failure|heart failure
5377528|NCT01823887|Vagus Nerve|vagus nerve
5377529|NCT01823887|VNS|vns
5377530|NCT01823874|Virtual reality analgesia|virtual reality analgesia
5377531|NCT01823874|pain control|pain control
5377532|NCT01823848|constipation|constipation
5377533|NCT01823848|enema|enema
5377534|NCT01823822|Anorexia nervosa|anorexia nervosa
5377535|NCT01823822|Protein supplements|protein supplements
5377536|NCT01823822|IGF-I|igf-i
5377537|NCT01823809|Coronary Artery Disease|coronary artery disease
5377538|NCT01823809|Computed Tomography|computed tomography
5377539|NCT01823809|Cardiac Magnetic Resonance|cardiac magnetic resonance
5377540|NCT01823809|Fractional Flow Reserve|fractional flow reserve
5377541|NCT01823796|Fibromyalgia|fibromyalgia
5377542|NCT01823796|balance|balance
5377543|NCT01823796|falls|falls
5377544|NCT01823783|Duchenne muscular distrophy|duchenne muscular distrophy
5377545|NCT01823783|Endomysial Fibrosis|endomysial fibrosis
5377546|NCT01823783|Muscular Inflammatory Response|muscular inflammatory response
5377547|NCT01823783|Calcium Homeostasis Dysfunction|calcium homeostasis dysfunction
5377548|NCT01823783|Muscle biopsy|muscle biopsy
5377549|NCT01823770|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
5377550|NCT01823770|Rotigotine|rotigotine
5377552|NCT01823770|Cardiovascular diseases|cardiovascular diseases
5377553|NCT01823770|Periodic Limb Movements in Sleep (PLMS)|periodic limb movements in sleep (plms)
5377554|NCT01823770|dopaminergic agonist|dopaminergic agonist
5377555|NCT01823770|Sympathetic overactivity|sympathetic overactivity
5360853|NCT01898338|MRSA|mrsa
5377556|NCT01823770|blood pressure|blood pressure
5377557|NCT01823757|elderly|elderly
5377558|NCT01823757|potential inappropriate medications|potential inappropriate medications
5377559|NCT01823757|pharmaceutical care|pharmaceutical care
5377560|NCT01823757|quality of life|quality of life
5377561|NCT01823757|medical expenditure|medical expenditure
5377562|NCT01823744|micronutrient|micronutrient
5377563|NCT01823744|genomic|genomic
5377564|NCT01823744|SAM/SAH ratio|sam/sah ratio
5377565|NCT01823731|PCI,SOTOC, Ovarian cancer|pci,sotoc, ovarian cancer
5377566|NCT01823692|Radius Fracture|radius fracture
5377567|NCT01823692|Sensitivity|sensitivity
5377568|NCT01823692|Reduction|reduction
5377569|NCT01823692|Adequacy|adequacy
5377570|NCT01823666|Dementia|dementia
5377571|NCT01823666|Alzheimer's disease|alzheimer's disease
5377572|NCT01823666|mild cognitive impairment|mild cognitive impairment
5377573|NCT01823640|HRV|hrv
5377574|NCT01823640|Pharmacodynamics / kinetics|pharmacodynamics / kinetics
5377575|NCT01823640|Resistance|resistance
5377576|NCT01823627|COPD|copd
5377577|NCT01823627|Psychiatric inpatient|psychiatric inpatient
5377578|NCT01823627|Smoking|smoking
5377579|NCT01823614|HIV infection|hiv infection
5377580|NCT01823614|tropism determination|tropism determination
5377581|NCT01823614|genotypic methodic|genotypic methodic
5377582|NCT01823614|R5-tropic variant|r5-tropic variant
5377587|NCT01823601|Meditation|meditation
5377588|NCT01823601|Cognitive-Behavioral Training|cognitive-behavioral training
5377589|NCT01823575|malignant ureteral obstruction|malignant ureteral obstruction
5377590|NCT01823575|silicone-covered metallic ureteral stent|silicone-covered metallic ureteral stent
5377591|NCT01823575|double-J stent|double-j stent
5377592|NCT01823562|Lyophilized Black Raspberry|lyophilized black raspberry
5377593|NCT01823562|Prostate Cancer|prostate cancer
5377594|NCT01823562|Surgery|surgery
5377595|NCT01823549|CAM|cam
5377596|NCT01823549|Alternative Medicine|alternative medicine
5377597|NCT01823536|Meningitis|meningitis
5377598|NCT01823510|Antiplatelet|antiplatelet
5377599|NCT01823510|Ticagrelor|ticagrelor
5377600|NCT01823510|Clopidogrel|clopidogrel
5377601|NCT01823510|Thrombosis|thrombosis
5377602|NCT01823510|Diabetes|diabetes
5377603|NCT01823510|Coronary Artery Disease|coronary artery disease
5377604|NCT01823497|Neonatal Intensive Care Unit|neonatal intensive care unit
5377605|NCT01823497|neonate|neonate
5377606|NCT01823497|pain|pain
5377607|NCT01823497|morphine|morphine
5377608|NCT01823497|Parent/Nurse Controlled Analgesia|parent/nurse controlled analgesia
5377609|NCT01823484|hemofilter|hemofilter
5377610|NCT01823484|coagulation|coagulation
5377611|NCT01823484|CRRT|crrt
5377612|NCT01823484|critically ill|critically ill
5377613|NCT01823471|HNPCC|hnpcc
5377614|NCT01823471|Hereditary non-polyposis colon carcinoma|hereditary non-polyposis colon carcinoma
5377615|NCT01823471|Lynch syndrome|lynch syndrome
5377616|NCT01823471|i-scan|i-scan
5377617|NCT01823471|virtual chromo-endoscopy|virtual chromo-endoscopy
5377618|NCT01823471|chromo-endoscopy|chromo-endoscopy
5377619|NCT01823471|high definition endoscopy|high definition endoscopy
5377620|NCT01823471|polyp detection|polyp detection
5377621|NCT01823471|adenoma detection|adenoma detection
5377622|NCT01823471|adenoma miss rate|adenoma miss rate
5377623|NCT01823458|behavioral economics|behavioral economics
5377624|NCT01823458|incentives|incentives
5377625|NCT01823458|health behavior|health behavior
5377626|NCT01823458|exercise|exercise
5377627|NCT01823445|Xylitol|xylitol
5377628|NCT01823445|Dental caries|dental caries
5377629|NCT01823393|balloon aortic valvuloplasty indication|balloon aortic valvuloplasty indication
5377630|NCT01823393|heparin|heparin
5377631|NCT01823393|hemorrhagic|hemorrhagic
5377632|NCT01823393|ischemic|ischemic
5377633|NCT01823380|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5377634|NCT01823380|Vitamin D|vitamin d
5377635|NCT01823380|Blood Levels|blood levels
5377636|NCT01823367|type 2 diabetes mellitus prevention|type 2 diabetes mellitus prevention
5377637|NCT01823367|gestational diabetes mellitus|gestational diabetes mellitus
5377638|NCT01823367|pre-diabetes|pre-diabetes
5377639|NCT01823367|lifestyle interventions|lifestyle interventions
5377640|NCT01823367|pediatric primary prevention of type 2 diabetes|pediatric primary prevention of type 2 diabetes
5377641|NCT01823354|Restless Legs Syndrome|restless legs syndrome
5377642|NCT01823354|Polysomnography|polysomnography
5377643|NCT01823354|Executive cognition|executive cognition
5377644|NCT01823341|Type 1 Diabetes|type 1 diabetes
5377645|NCT01823341|Hypoglycemia|hypoglycemia
5377646|NCT01823341|Continuous Glucose Monitoring|continuous glucose monitoring
5377647|NCT01823341|Pump Suspension|pump suspension
5377648|NCT01823328|Intubation|intubation
5377649|NCT01823328|Airway|airway
5377650|NCT01823328|Emergent intubation|emergent intubation
5377651|NCT01823328|Rapid sequence intubation|rapid sequence intubation
5377652|NCT01823328|Rapid sequence induction|rapid sequence induction
5377653|NCT01823328|RSI|rsi
5377654|NCT01823328|Ketamine|ketamine
5377655|NCT01823328|Etomidate|etomidate
5377656|NCT01823328|Sepsis|sepsis
5377657|NCT01823328|Sedative|sedative
5377658|NCT01823328|Sedation|sedation
5377659|NCT01823302|Children with picky-eating behaviors|children with picky-eating behaviors
5377660|NCT01823302|Children aged 2.5 - 5 years|children aged 2.5 - 5 years
5377661|NCT01823302|reported by caregivers|reported by caregivers
5377662|NCT01823302|with weight-for-height z-scores ≤ 25th percentile at enrollment|with weight-for-height z-scores ≤ 25th percentile at enrollment
5377663|NCT01823289|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
5377664|NCT01823289|Itraconazole|itraconazole
5377665|NCT01823250|Hispanic|hispanic
5377666|NCT01823250|adolescent|adolescent
5377667|NCT01823250|drug abuse treatment|drug abuse treatment
5377668|NCT01823250|evidence-based|evidence-based
5377669|NCT01823250|family therapy|family therapy
5377670|NCT01823250|adaptive family treatment|adaptive family treatment
5377671|NCT01823250|Culturally Informed Family-Based Treatment for Adolescents|culturally informed family-based treatment for adolescents
5377672|NCT01823237|Dystonia|dystonia
5377673|NCT01823237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5377674|NCT01823237|Rehabilitation|rehabilitation
5377675|NCT01823237|Plasticity|plasticity
5377676|NCT01823211|ICD (Implantable cardioverter-defibrillator)|icd (implantable cardioverter-defibrillator)
5377677|NCT01823211|Heart rate variability|heart rate variability
5381363|NCT01806064|TRC105|trc105
5377678|NCT01823211|MTWA (Microvolt T-alternans)|mtwa (microvolt t-alternans)
5373097|NCT01844440|GERD|gerd
5377679|NCT01823211|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5377682|NCT01823185|Prasugrel|prasugrel
5377683|NCT01823185|Platelet aggregation inhibitor|platelet aggregation inhibitor
5377684|NCT01823185|Dammam University|dammam university
5377685|NCT01823185|King Fahd Hospital|king fahd hospital
5377686|NCT01823185|Purinergic P2 receptor Antagonists|purinergic p2 receptor antagonists
5377687|NCT01823172|breast cancer|breast cancer
5377688|NCT01823172|melanoma|melanoma
5377689|NCT01823172|sentinel lymph node biopsy|sentinel lymph node biopsy
5377690|NCT01823172|lymphadenectomy|lymphadenectomy
5377691|NCT01823159|retigabine|retigabine
5377692|NCT01823159|cortical excitability|cortical excitability
5377693|NCT01823159|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5377694|NCT01823146|oxytocin|oxytocin
5377695|NCT01823146|socioemotional functioning|socioemotional functioning
5377696|NCT01823146|trust|trust
5377697|NCT01823146|amygdala|amygdala
5377698|NCT01823146|aging|aging
5377699|NCT01823120|Self harm|self harm
5377700|NCT01823120|Emergency Department|emergency department
5377701|NCT01823120|Repetition|repetition
5377702|NCT01823120|Supportive Text messages|supportive text messages
5377703|NCT01823120|Interactive|interactive
5377704|NCT01823107|Meso BioMatrix|meso biomatrix
5377705|NCT01823107|Breast|breast
5377706|NCT01823107|Breast Cancer|breast cancer
5377707|NCT01823107|Mastectomy|mastectomy
5377708|NCT01823107|Biologic Mesh|biologic mesh
5377709|NCT01823107|Breast Reconstruction|breast reconstruction
5377710|NCT01823094|lung cancer|lung cancer
5377712|NCT01823094|blood flow|blood flow
5377713|NCT01823068|Lung cancer|lung cancer
5377714|NCT01823068|RET fusion|ret fusion
5377715|NCT01823068|Vandetanib|vandetanib
5377716|NCT01823042|Crohn's Disease|crohn's disease
5377717|NCT01823042|maintain remission|maintain remission
5377718|NCT01823042|postoperative recurrence|postoperative recurrence
5377719|NCT01823042|surgery|surgery
5377720|NCT01823042|living quality|living quality
5377721|NCT01823029|Crohn's Disease|crohn's disease
5377722|NCT01823029|intravenous iron|intravenous iron
5377723|NCT01823029|iron deficiency anaemia|iron deficiency anaemia
5377724|NCT01823029|Oxidative Stress|oxidative stress
5377725|NCT01823029|inflammation|inflammation
5377726|NCT01823016|Uncontrolled, persistent asthma|uncontrolled, persistent asthma
5377727|NCT01823003|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5377728|NCT01823003|Neoplasm Metastasis|neoplasm metastasis
5377729|NCT01823003|Radiosurgery|radiosurgery
5377730|NCT01822990|Anti-beta2-glycoprotein antibodies|anti-beta2-glycoprotein antibodies
5377731|NCT01822990|Peripheral arterial disease|peripheral arterial disease
5377732|NCT01822990|Inflammation|inflammation
5377733|NCT01822990|Nitric oxide|nitric oxide
5377734|NCT01822990|Endothelial dysfunction|endothelial dysfunction
5377735|NCT01822977|gut microbiota|gut microbiota
5377736|NCT01822977|proton pump inhibitor|proton pump inhibitor
5377737|NCT01822977|Clostridium difficile infection|clostridium difficile infection
5377738|NCT01822977|Fecal microbiome|fecal microbiome
5377739|NCT01822977|single episode of CDI|single episode of cdi
5377740|NCT01822951|DAT Study|dat study
5377741|NCT01822925|Diabetes|diabetes
5377742|NCT01822925|Pain|pain
5377743|NCT01822925|Neuropathy|neuropathy
5377744|NCT01822912|Skilled Nursing Facility|skilled nursing facility
5377745|NCT01822912|Heart Failure|heart failure
5377746|NCT01822912|Transitional Care|transitional care
5377747|NCT01822899|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
5377748|NCT01822899|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
5377749|NCT01822899|GSK573719|gsk573719
5377750|NCT01822899|lung function|lung function
5377751|NCT01822899|GW642444|gw642444
5377752|NCT01822899|salmeterol (SAL)|salmeterol (sal)
5377753|NCT01822899|fluticasone propionate (FP)|fluticasone propionate (fp)
5377754|NCT01822899|vilanterol (VI)|vilanterol (vi)
5377755|NCT01822899|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5377756|NCT01822886|T-cell lymphoma|t-cell lymphoma
5377757|NCT01822886|Romidepsin|romidepsin
5377758|NCT01822860|Hypertension|hypertension
5377759|NCT01822860|Endothelial dysfunction|endothelial dysfunction
5377760|NCT01822847|adrenal|adrenal
5377761|NCT01822847|steroids|steroids
5377762|NCT01822847|cortisol|cortisol
5377763|NCT01822847|stress|stress
5377764|NCT01822821|Males or females|males or females
5377765|NCT01822821|18 years of age or older.|18 years of age or older.
5377766|NCT01822821|Non-emergency|non-emergency
5377767|NCT01822821|cardiac surgery|cardiac surgery
5377768|NCT01822821|midline sternotomy.|midline sternotomy.
5377769|NCT01822808|acute heart failure|acute heart failure
5377770|NCT01822808|left ventricular dysfunction|left ventricular dysfunction
5377771|NCT01822808|hydralazine|hydralazine
5377772|NCT01822808|isosorbide dinitrate|isosorbide dinitrate
5377773|NCT01822795|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5377774|NCT01822795|Endoscopic lung volume reduction|endoscopic lung volume reduction
5377775|NCT01822782|Perineal tear|perineal tear
5377776|NCT01822782|Perineal lesion|perineal lesion
5373202|NCT01843920|eye|eye
5377777|NCT01822782|Vaginal flora|vaginal flora
5377778|NCT01822782|Birth|birth
5377779|NCT01822769|congenital heart disease|congenital heart disease
5377786|NCT01822769|quality of life|quality of life
5377788|NCT01822743|Sleep Apnea Syndromes|sleep apnea syndromes
5377789|NCT01822743|Obstructive Sleep Apnea|obstructive sleep apnea
5377790|NCT01822743|Pcrit|pcrit
5377791|NCT01822743|Polysomnography|polysomnography
5377792|NCT01822730|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
5377793|NCT01822730|Aripiprazole|aripiprazole
5377794|NCT01822730|Risperidone|risperidone
5377795|NCT01822717|Diabetes|diabetes
5377796|NCT01822717|Visual Impairment|visual impairment
5377797|NCT01822717|Blindness|blindness
5377798|NCT01822717|Foot Care|foot care
5377799|NCT01822717|Self-Management|self-management
5377800|NCT01822704|Stroke|stroke
5377801|NCT01822704|Exercise|exercise
5377802|NCT01822704|Rehabilitation|rehabilitation
5377803|NCT01822704|Vibration|vibration
5377804|NCT01822691|myelodysplastic syndromes (MDS)|myelodysplastic syndromes (mds)
5377805|NCT01822691|neoplastic stem cell disorders|neoplastic stem cell disorders
5377806|NCT01822691|refractory cytopenias|refractory cytopenias
5377807|NCT01822691|dysplastic morphological features|dysplastic morphological features
5377808|NCT01822691|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5377809|NCT01822652|Neuroblastoma|neuroblastoma
5377810|NCT01822652|Solid tumor|solid tumor
5671947|NCT00613496|AT-II-antagonist|at-ii-antagonist
5377811|NCT01822652|Neuroblastoma-specific immunotherapy targeting GD2|neuroblastoma-specific immunotherapy targeting gd2
5377812|NCT01822652|CAR T cells|car t cells
5377813|NCT01822652|Gene Therapy|gene therapy
5377814|NCT01822652|Relapsed|relapsed
5377815|NCT01822652|Refractory|refractory
5377816|NCT01822639|Hypertension|hypertension
5377817|NCT01822639|enalapril maleate|enalapril maleate
5377818|NCT01822639|healthy volunteers|healthy volunteers
5377819|NCT01822639|amlodipine|amlodipine
5377820|NCT01822639|pharmacokinetics|pharmacokinetics
5377821|NCT01822626|overweight|overweight
5377822|NCT01822626|obesity|obesity
5377823|NCT01822626|children|children
5377825|NCT01822626|counseling|counseling
5377826|NCT01822626|pediatrician|pediatrician
5377827|NCT01822613|esophageal cancer|esophageal cancer
5377828|NCT01822600|hypoalbuminemia|hypoalbuminemia
5377829|NCT01822600|peptic ulcer|peptic ulcer
5377830|NCT01822600|rebleeding|rebleeding
5377831|NCT01822600|hospitalization|hospitalization
5377832|NCT01822587|Drug Abuse|drug abuse
5377833|NCT01822587|Cocaine|cocaine
5377834|NCT01822587|Addiction|addiction
5377835|NCT01822561|Central Serous Chorioretinopathy|central serous chorioretinopathy
5377836|NCT01822561|Eplerenone|eplerenone
5377837|NCT01822561|Optical Coherence Tomography|optical coherence tomography
5377838|NCT01822561|Enhanced Depth Imaging|enhanced depth imaging
5377839|NCT01822561|Subretinal Fluid|subretinal fluid
5377840|NCT01822548|EPC|epc
5377841|NCT01822548|diabetes|diabetes
5377842|NCT01822548|DPP IV inhibitors|dpp iv inhibitors
5377843|NCT01822535|Quadriplegia|quadriplegia
5377844|NCT01822535|Spinal Cord Injuries|spinal cord injuries
5377845|NCT01822535|Body Temperature Regulation|body temperature regulation
5377846|NCT01822535|Mild Cognitive Impairment|mild cognitive impairment
5377847|NCT01822483|Renal transplantation|renal transplantation
5377848|NCT01822483|mycophenolic acid|mycophenolic acid
5377849|NCT01822483|mycophenolate mofetil|mycophenolate mofetil
5377850|NCT01822483|mycophenolate sodium|mycophenolate sodium
5377851|NCT01822483|area under the curve|area under the curve
5377852|NCT01822470|functional dyspepsia|functional dyspepsia
5377853|NCT01822470|post prandial distress syndrome|post prandial distress syndrome
5377854|NCT01822470|small bowel bacteria overgrowth|small bowel bacteria overgrowth
5377855|NCT01822470|epigastric pain syndrome|epigastric pain syndrome
5377856|NCT01822470|diarrhea|diarrhea
5377857|NCT01822470|bloating|bloating
5377858|NCT01822470|post prandial fullness|post prandial fullness
5377859|NCT01822470|weight loss|weight loss
5377867|NCT01822418|Schizophrenia|schizophrenia
5377868|NCT01822418|Depression|depression
5377869|NCT01822418|Cognition|cognition
5377870|NCT01822418|Agomelatine|agomelatine
5377871|NCT01822418|Antidepressant|antidepressant
5377872|NCT01822392|Online treatment|online treatment
5377873|NCT01822392|Treatment of conduct problems|treatment of conduct problems
5377874|NCT01822392|Parent training|parent training
5377875|NCT01822366|Children|children
5377876|NCT01822366|Adolescents|adolescents
5377877|NCT01822366|Trauma-focused Cognitive Behavioral Therapy (TF-CBT)|trauma-focused cognitive behavioral therapy (tf-cbt)
5377878|NCT01822366|Low- and Middle-Income Countries (LMIC)|low- and middle-income countries (lmic)
5377879|NCT01822366|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5377880|NCT01822366|Evidence-Based Practice (EBP)|evidence-based practice (ebp)
5377881|NCT01822366|Childhood Traumatic Grief (CTG)|childhood traumatic grief (ctg)
5377882|NCT01822366|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5377884|NCT01822366|Tanzania|tanzania
5377885|NCT01822366|East Africa|east africa
5377886|NCT01822366|Mental Health|mental health
5377887|NCT01822353|food allergy|food allergy
5377888|NCT01822353|milk allergy|milk allergy
5377892|NCT01822314|breast|breast
5377893|NCT01822314|cancer|cancer
5377894|NCT01822314|unilateral|unilateral
5377895|NCT01822314|non metastatic|non metastatic
5377896|NCT01822314|HER2 negative|her2 negative
5377897|NCT01822301|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5377898|NCT01822301|Facial Trauma|facial trauma
5377899|NCT01822301|Fat Grafts|fat grafts
5377900|NCT01822301|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5377901|NCT01822301|Wounded warriors|wounded warriors
5377902|NCT01822288|Menopause|menopause
5377903|NCT01822288|Tibolone|tibolone
5377904|NCT01822288|Estradiol|estradiol
5377905|NCT01822288|Hormone therapy|hormone therapy
5377906|NCT01822275|GBM|gbm
5377907|NCT01822262|Cholecystolithotomy with gallbladder reservation|cholecystolithotomy with gallbladder reservation
5377908|NCT01822262|cholecystolithiasis|cholecystolithiasis
5377909|NCT01822249|Rett syndrome|rett syndrome
5377910|NCT01822249|EPI-743|epi-743
5377911|NCT01822249|Edison|edison
5377912|NCT01822236|low back pain|low back pain
5377913|NCT01822236|Manual Therapy|manual therapy
5377914|NCT01822236|Randomized Controlled Trial|randomized controlled trial
5377915|NCT01822236|Quality of life|quality of life
5377916|NCT01822223|Dental Implants|dental implants
5377917|NCT01822223|Implant abutments|implant abutments
5377918|NCT01822210|Botulinum Toxins|botulinum toxins
5377919|NCT01822210|Injections|injections
5377920|NCT01822210|Stomach|stomach
5377921|NCT01822210|Tomography, X-Ray Computed|tomography, x-ray computed
5377922|NCT01822197|Phototherapy|phototherapy
5377923|NCT01822184|Neurodevelopmental Status|neurodevelopmental status
5377924|NCT01822184|Pediatric Hunter syndrome patients|pediatric hunter syndrome patients
5377925|NCT01822184|Central Nervous System (CNS) involvement|central nervous system (cns) involvement
5377926|NCT01822184|Observational study|observational study
5377927|NCT01822184|Cognitive impairment|cognitive impairment
5377928|NCT01822171|Heart Failure|heart failure
5377929|NCT01822171|Medication Therapy Management|medication therapy management
5377930|NCT01822158|Vaginal Delivery|vaginal delivery
5377931|NCT01822158|Debrief|debrief
5377932|NCT01822158|Medical Team Communication|medical team communication
5377933|NCT01822158|Obstetrical Safety|obstetrical safety
5377934|NCT01822145|implantable-cardioverter-defibrillator|implantable-cardioverter-defibrillator
5377935|NCT01822145|ventricular tachycardia|ventricular tachycardia
5377936|NCT01822145|ventricular fibrillation|ventricular fibrillation
5377937|NCT01822145|sudden cardiac arrest|sudden cardiac arrest
5377938|NCT01822080|Endometriosis|endometriosis
5377939|NCT01822080|Efficacy|efficacy
5377940|NCT01822080|Safety|safety
5377941|NCT01822080|Dienogest|dienogest
5377942|NCT01822041|healthy volunteers|healthy volunteers
5377943|NCT01822041|mass balance study|mass balance study
5377944|NCT01822041|Pharmacokinetics|pharmacokinetics
5377945|NCT01822028|diarrhea|diarrhea
5377946|NCT01822002|Vertigo|vertigo
5377947|NCT01822002|Nystagmus|nystagmus
5377948|NCT01822002|BPPV = benign paroxysmal positional vertigo|bppv = benign paroxysmal positional vertigo
5377949|NCT01822002|Treatment outcome|treatment outcome
5377950|NCT01821963|Infection|infection
5377951|NCT01821963|Hepatitis C Genotype 1 Infection|hepatitis c genotype 1 infection
5377952|NCT01821963|Hepatitis C virus|hepatitis c virus
5377953|NCT01821963|HCV|hcv
5377954|NCT01821963|Hepatocellular Carcinoma|hepatocellular carcinoma
5377955|NCT01821963|HCC|hcc
5377956|NCT01821963|Liver Transplantation|liver transplantation
5377957|NCT01821963|Pegylated Interferon Alfa 2a|pegylated interferon alfa 2a
5377958|NCT01821963|PegIFN alfa-2a|pegifn alfa-2a
5377959|NCT01821963|Ribavirin|ribavirin
5377960|NCT01821963|RBV|rbv
5377961|NCT01821963|Telaprevir|telaprevir
5377962|NCT01821963|Incivek|incivek
5377963|NCT01821963|Antiviral drugs|antiviral drugs
5377964|NCT01821950|Mental health|mental health
5377965|NCT01821950|Substance use|substance use
5377966|NCT01821950|Substance use initiation|substance use initiation
5377967|NCT01821950|Education|education
5377968|NCT01821950|Mind Body Therapies|mind body therapies
5377969|NCT01821950|Yoga|yoga
5377970|NCT01821950|Meditation|meditation
5377971|NCT01821950|Adolescent|adolescent
5377972|NCT01821950|Adolescence|adolescence
5377973|NCT01821950|Child|child
5377974|NCT01821950|Children|children
5377975|NCT01821950|Middle School|middle school
5377976|NCT01821898|Eosinophil|eosinophil
5377977|NCT01821898|Reflux|reflux
5377978|NCT01821898|Esophagus|esophagus
5377979|NCT01821898|Food allergy|food allergy
5377980|NCT01821898|Trouble Swallowing|trouble swallowing
5377981|NCT01821898|Pediatrics|pediatrics
5377982|NCT01821885|Spirometry|spirometry
5377983|NCT01821885|screening|screening
5377984|NCT01821885|smoking cessation|smoking cessation
5377986|NCT01821885|COPD|copd
5377987|NCT01821872|paracetamol|paracetamol
5377988|NCT01821872|acetaminophen|acetaminophen
5377989|NCT01821872|AM404|am404
5377990|NCT01821872|CSF|csf
5377991|NCT01821872|pharmacokinetics|pharmacokinetics
5378003|NCT01821807|spinal needle|spinal needle
5378004|NCT01821807|cesarean section|cesarean section
5378005|NCT01821807|headache|headache
5378007|NCT01821781|Immune deficiency|immune deficiency
5378008|NCT01821781|Immune disorders|immune disorders
5378009|NCT01821781|Immune dysregulatory|immune dysregulatory
5378010|NCT01821781|Reduced Intensity|reduced intensity
5378011|NCT01821781|Alemtuzumab|alemtuzumab
5378012|NCT01821781|Campath|campath
5378013|NCT01821742|Shock|shock
5378014|NCT01821742|Fluid bolus|fluid bolus
5378015|NCT01821742|Cardiac output|cardiac output
5378016|NCT01821742|Children in intensive care|children in intensive care
5378017|NCT01821729|Locally Advanced|locally advanced
5378018|NCT01821716|standardization|standardization
5378019|NCT01821716|skin prick test|skin prick test
5378020|NCT01821716|inmunotherapy|inmunotherapy
5378021|NCT01821690|Traumatic Brain Injury|traumatic brain injury
5378022|NCT01821690|Buspirone|buspirone
5378023|NCT01821690|Behavior|behavior
5378024|NCT01821690|Irritability|irritability
5378025|NCT01821690|Aggression|aggression
5378026|NCT01821664|Prosthetic vascular graft infection|prosthetic vascular graft infection
5378027|NCT01821664|negative pressure wound therapy|negative pressure wound therapy
5378028|NCT01821664|microbiology|microbiology
5378029|NCT01821664|antimicrobial therapy|antimicrobial therapy
5378030|NCT01821651|TAVI|tavi
5378031|NCT01821651|MitraClip|mitraclip
5378032|NCT01821651|image modality|image modality
5378033|NCT01821651|echocardiography|echocardiography
5378034|NCT01821651|angiography|angiography
5378035|NCT01821638|Heart failure|heart failure
5378036|NCT01821638|Cognition|cognition
5378037|NCT01821638|Brain|brain
5378038|NCT01821638|Older adults|older adults
5378039|NCT01821625|Thrombocytopenia|thrombocytopenia
5378040|NCT01821625|Hepatitis|hepatitis
5378041|NCT01821625|Platelets|platelets
5378042|NCT01821625|Eltrombopag|eltrombopag
5378043|NCT01821625|Liver Disease|liver disease
5378044|NCT01821625|Antiviral Treatment|antiviral treatment
5378045|NCT01821599|Anterior Cruciate Ligament|anterior cruciate ligament
5378046|NCT01821599|Knee|knee
5378047|NCT01821599|Rehabilitation|rehabilitation
5378048|NCT01821586|Diarrhoea;|diarrhoea;
5378049|NCT01821586|Severe malnutrition;|severe malnutrition;
5378050|NCT01821586|Benefiber;|benefiber;
5378051|NCT01821586|ReSoMal;|resomal;
5378052|NCT01821586|modified ORS|modified ors
5378053|NCT01821573|botulinum toxin injection,3D motion analysis, muscular lengthening,muscle strength|botulinum toxin injection,3d motion analysis, muscular lengthening,muscle strength
5378054|NCT01821560|Nicotine Addiction|nicotine addiction
5378055|NCT01821560|fMRI|fmri
5378056|NCT01821560|Baclofen|baclofen
5378057|NCT01821508|Gastroplasty, Diabetes Mellitus Type II, Obesity|gastroplasty, diabetes mellitus type ii, obesity
5378058|NCT01821495|NPC,DC-CIK|npc,dc-cik
5378059|NCT01821482|Hepatocellular carcinoma, DC-CIK|hepatocellular carcinoma, dc-cik
5378060|NCT01821469|bipolar disorders|bipolar disorders
5378061|NCT01821469|euthymic|euthymic
5378062|NCT01821469|psychotherapy|psychotherapy
5378063|NCT01821469|Functional magnetic resonance imaging|functional magnetic resonance imaging
5378064|NCT01821456|hematological malignancies|hematological malignancies
5378065|NCT01821456|cancer|cancer
5378066|NCT01821456|chemotherapy|chemotherapy
5378067|NCT01821456|anti-infectives|anti-infectives
5378068|NCT01821456|treatment|treatment
5378069|NCT01821456|outcome|outcome
5378070|NCT01821443|1 to 10 measurable brain metastases|1 to 10 measurable brain metastases
5378071|NCT01821430|Chronic Pain|chronic pain
5378072|NCT01821430|Narcotic Abuse|narcotic abuse
5378073|NCT01821430|Opioid related disorders|opioid related disorders
5378074|NCT01821430|Opiate substitution treatment|opiate substitution treatment
5378075|NCT01821430|Buprenorphrine|buprenorphrine
5378076|NCT01821430|Pregabalin|pregabalin
5378077|NCT01821430|Methadone|methadone
5378078|NCT01821417|dental implants|dental implants
5378079|NCT01821417|screw-vent dental implants|screw-vent dental implants
5378080|NCT01821404|Apoptosis|apoptosis
5378081|NCT01821404|Atorvastatin|atorvastatin
5378082|NCT01821404|Inflammation|inflammation
5378083|NCT01821404|Pre-surgical trial|pre-surgical trial
5378084|NCT01821404|Proliferation|proliferation
5378085|NCT01821404|Prostate cancer|prostate cancer
5378086|NCT01821391|actinic keratoses|actinic keratoses
5378087|NCT01821391|photodynamic therapy|photodynamic therapy
5378088|NCT01821391|natural daylight|natural daylight
5378089|NCT01821378|Schizophrenia|schizophrenia
5378090|NCT01821378|Lurasidone|lurasidone
5378091|NCT01821378|Latuda|latuda
5378092|NCT01821365|COPD,PETCO2,PaCO2|copd,petco2,paco2
5378093|NCT01821326|capsule endoscopy|capsule endoscopy
5378094|NCT01821326|obscure gastrointestinal bleeding|obscure gastrointestinal bleeding
5378095|NCT01821326|rebleeding|rebleeding
5378096|NCT01821326|risk factors|risk factors
5378097|NCT01821313|Childhood obesity|childhood obesity
5378098|NCT01821313|Inflammation|inflammation
5378099|NCT01821313|Endothelial function|endothelial function
5378100|NCT01821313|Exercise|exercise
5378101|NCT01821300|Down syndrome|down syndrome
5378102|NCT01821300|Philadelphia|philadelphia
5378103|NCT01821300|The Children's Hospital of Philadelphia|the children's hospital of philadelphia
5378104|NCT01821300|Body composition|body composition
5378111|NCT01821222|Maternal health|maternal health
5378112|NCT01821222|Neonatal health|neonatal health
5378113|NCT01821222|mHealth|mhealth
5378114|NCT01821222|Mobile phones|mobile phones
5378115|NCT01821222|Access to health services|access to health services
5378116|NCT01821222|Health behavior|health behavior
5378117|NCT01821209|prostate cancer, robotic surgery, urethral sling,|prostate cancer, robotic surgery, urethral sling,
5378118|NCT01821196|Tumor Markers, Biological|tumor markers, biological
5378119|NCT01821196|PGP9.5 protein, human|pgp9.5 protein, human
5378120|NCT01821196|adenocarcinoma|adenocarcinoma
5378121|NCT01821170|ADHD|adhd
5378122|NCT01821170|children|children
5378123|NCT01821170|cognitive remediation|cognitive remediation
5378124|NCT01821170|virtual reality|virtual reality
5378125|NCT01821157|crown lengthening|crown lengthening
5378126|NCT01821157|gingivoplasty|gingivoplasty
5378127|NCT01821157|surgical procedures|surgical procedures
5378128|NCT01821157|gingivectomy|gingivectomy
5378129|NCT01821157|esthetic surgery|esthetic surgery
5378130|NCT01821144|dietary salt|dietary salt
5378131|NCT01821144|24 hour urinary sodium|24 hour urinary sodium
5378132|NCT01821144|blood pressure|blood pressure
5378133|NCT01821131|flax|flax
5378134|NCT01821131|muffin|muffin
5378135|NCT01821131|cholesterol|cholesterol
5378136|NCT01821131|lignan|lignan
5378137|NCT01821131|ALA|ala
5378138|NCT01821118|Cerebral amyloid angiopathy (CAA)|cerebral amyloid angiopathy (caa)
5378139|NCT01821118|cerebrovascular reactivity|cerebrovascular reactivity
5378140|NCT01821118|functional MRI|functional mri
5378141|NCT01821118|randomized|randomized
5378142|NCT01821118|double blind|double blind
5378143|NCT01821118|safety|safety
5378144|NCT01821118|efficacy|efficacy
5378145|NCT01821105|computed tomography|computed tomography
5378146|NCT01821105|CT scan|ct scan
5378147|NCT01821105|positron emission tomography|positron emission tomography
5378148|NCT01821105|PET|pet
5378149|NCT01821105|Metastatic Colorectal Cancer|metastatic colorectal cancer
5378150|NCT01821092|osseointegrated Implant, bone level|osseointegrated implant, bone level
5378151|NCT01821079|Single dose|single dose
5378152|NCT01821079|Relative Bioavailability|relative bioavailability
5378153|NCT01821079|Food effect|food effect
5378154|NCT01821079|Healthy subjects|healthy subjects
5378155|NCT01821079|Diabetes Mellitus Type 2|diabetes mellitus type 2
5378156|NCT01821066|PD-0332991|pd-0332991
5378157|NCT01821066|palbociclib|palbociclib
5378158|NCT01821066|tamoxifen|tamoxifen
5378159|NCT01821066|drug-drug interaction (DDI) study|drug-drug interaction (ddi) study
5378160|NCT01821053|Preeclampsia|preeclampsia
5378161|NCT01821053|Pregestational Type 1 diabetes|pregestational type 1 diabetes
5378162|NCT01821053|diabetes mellitus|diabetes mellitus
5378163|NCT01821053|proteinuria|proteinuria
5378164|NCT01821053|plasminogen|plasminogen
5378165|NCT01821053|plasmin|plasmin
5378166|NCT01821053|renin|renin
5378167|NCT01821053|aldosterone|aldosterone
5378168|NCT01821053|angiotensin|angiotensin
5378169|NCT01821053|epithelial sodium channel|epithelial sodium channel
5378170|NCT01821053|ENaC|enac
5378171|NCT01821040|Polymyalgia rheumatica|polymyalgia rheumatica
5378172|NCT01821040|PMR|pmr
5378173|NCT01821040|Modified release prednisone|modified release prednisone
5378174|NCT01821027|Healthy|healthy
5378175|NCT01821027|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5378176|NCT01821027|Pharmacokinetics|pharmacokinetics
5378177|NCT01821027|Pharmacodynamics|pharmacodynamics
5378178|NCT01821027|Simvastatin (ZOCOR)|simvastatin (zocor)
5378179|NCT01821014|Diagnostic concordance|diagnostic concordance
5378180|NCT01821014|Treatment concordance|treatment concordance
5378869|NCT01817595|meter|meter
5378181|NCT01821014|patient satisfaction|patient satisfaction
5378182|NCT01821014|physician satisfaction|physician satisfaction
5378183|NCT01821014|Medical Outreach Clinics|medical outreach clinics
5378184|NCT01821014|Medical Brigades|medical brigades
5378185|NCT01821014|Medical Missions|medical missions
5361495|NCT01895179|Diurnal|diurnal
5378186|NCT01821014|Telemedicine|telemedicine
5378187|NCT01821014|Videoconference|videoconference
5378188|NCT01821014|diagnoses|diagnoses
5378189|NCT01821014|treatments|treatments
5378190|NCT01821014|Satellite Internet|satellite internet
5378191|NCT01821014|VSAT|vsat
5378192|NCT01821014|cross cultural telemedicine|cross cultural telemedicine
5378193|NCT01821001|Adenomyosis|adenomyosis
5378194|NCT01821001|Dysmenorrhea|dysmenorrhea
5378195|NCT01821001|Abnormal Uterine bleeding|abnormal uterine bleeding
5378196|NCT01821001|Heavy Menstrual Bleeding|heavy menstrual bleeding
5378198|NCT01820975|Muscle protein synthesis|muscle protein synthesis
5378199|NCT01820975|Dietary protein|dietary protein
5378200|NCT01820962|hematological patients|hematological patients
5378201|NCT01820962|central venous catheters|central venous catheters
5378202|NCT01820962|catheter related thrombosis|catheter related thrombosis
5378203|NCT01820962|catheter related infections|catheter related infections
5378204|NCT01820962|concentrated citrate|concentrated citrate
5378205|NCT01820949|patient blood management|patient blood management
5378206|NCT01820949|patients safety|patients safety
5378207|NCT01820936|Healthy volunteers|healthy volunteers
5378208|NCT01820936|PCI-32765|pci-32765
5378209|NCT01820936|PCI-45227|pci-45227
5378210|NCT01820936|Pharmacokinetics|pharmacokinetics
5378211|NCT01820871|T2DM|t2dm
5378212|NCT01820871|smartphone application|smartphone application
5378213|NCT01820871|serum fasting glucose|serum fasting glucose
5378214|NCT01820871|HbA1c|hba1c
5378215|NCT01820845|Plethysmographic Variability Index|plethysmographic variability index
5506620|NCT01268046|aging|aging
5378216|NCT01820845|Esophageal Doppler|esophageal doppler
5378217|NCT01820845|Scoliosis|scoliosis
5378218|NCT01820845|Children|children
5378219|NCT01820845|Age < 18 years|age < 18 years
5378220|NCT01820845|Scheduled for Scoliosis Surgery|scheduled for scoliosis surgery
5378221|NCT01820832|mild proteinuria|mild proteinuria
5378222|NCT01820832|calcitriol|calcitriol
5378223|NCT01820832|renal function|renal function
5378224|NCT01820832|blood pressure|blood pressure
5378225|NCT01820819|Inpatient|inpatient
5378226|NCT01820819|Liver cirrhosis|liver cirrhosis
5378227|NCT01820819|Liver Cirrhosis, Alcoholic|liver cirrhosis, alcoholic
5378228|NCT01820819|Physician's Practice Patterns|physician's practice patterns
5378229|NCT01820819|Liver Transplantation|liver transplantation
5378230|NCT01820819|Delivery of Health Care|delivery of health care
5378231|NCT01820819|Resource Allocation|resource allocation
5378232|NCT01820793|antibiotic resistance|antibiotic resistance
5378233|NCT01820793|E.coli|e.coli
5378234|NCT01820793|cefoxitin|cefoxitin
5378235|NCT01820793|pyelonephritis|pyelonephritis
5378236|NCT01820780|Heart failure|heart failure
5378237|NCT01820780|Disease management program|disease management program
5378238|NCT01820767|Chronic Kidney Disease|chronic kidney disease
5378239|NCT01820767|Vd-stadium.|vd-stadium.
5378240|NCT01820767|Inflammatory patterns|inflammatory patterns
5378241|NCT01820767|Paricalcitol|paricalcitol
5378242|NCT01820767|Atorvastatin|atorvastatin
5378243|NCT01820754|Non Small Cell Lung Cancer|non small cell lung cancer
5378244|NCT01820754|Lung Cancer|lung cancer
5378245|NCT01820754|Non Small Cell|non small cell
5378246|NCT01820702|bone metabolism|bone metabolism
5378247|NCT01820702|acid base balance|acid base balance
5378248|NCT01820702|bed rest|bed rest
5378249|NCT01820663|stroke|stroke
5378250|NCT01820663|ketones|ketones
5378251|NCT01820663|ketogenic diet|ketogenic diet
5378252|NCT01820663|impairment|impairment
5378253|NCT01820663|disability|disability
5378254|NCT01820650|osteoarthritis|osteoarthritis
5378255|NCT01820650|knee replacement|knee replacement
5378256|NCT01820650|patient-specific|patient-specific
5378257|NCT01820637|atherosclerosis|atherosclerosis
5378259|NCT01820637|PPA|ppa
5378260|NCT01820637|lower extremities|lower extremities
5378261|NCT01820637|stenting|stenting
5378262|NCT01820637|paclitaxel|paclitaxel
5378263|NCT01820585|fibromyalgia|fibromyalgia
5378264|NCT01820585|Eslicarbazepine acetate (BIA 2-093)|eslicarbazepine acetate (bia 2-093)
5378265|NCT01820585|ESL|esl
5378266|NCT01820559|migraine; ESL; eslicarbazepine acetate|migraine; esl; eslicarbazepine acetate
5378267|NCT01820533|Smoking|smoking
5378268|NCT01820533|Cellular phones|cellular phones
5378269|NCT01820533|Low income population|low income population
5378270|NCT01820507|Post-extubation respiratory failure|post-extubation respiratory failure
5378271|NCT01820507|Endotracheal intubation|endotracheal intubation
5378272|NCT01820507|Mechanical ventilation|mechanical ventilation
5378273|NCT01820494|growth|growth
5378274|NCT01820494|infants|infants
5378275|NCT01820481|Asthma|asthma
5378276|NCT01820481|Bronchial Diseases|bronchial diseases
5378277|NCT01820481|Respiratory Tract Diseases|respiratory tract diseases
5378278|NCT01820481|Lung Diseases, Obstructive|lung diseases, obstructive
5378279|NCT01820481|Lung Diseases|lung diseases
5378280|NCT01820455|MRSA decolonization|mrsa decolonization
5378281|NCT01820455|MRSA subtyping|mrsa subtyping
5378282|NCT01820455|MRSA infection rates|mrsa infection rates
5378283|NCT01820442|lofexidine|lofexidine
5378284|NCT01820442|buprenorphine|buprenorphine
5378285|NCT01820442|interaction|interaction
5378286|NCT01820442|pharmacodynamic|pharmacodynamic
5378287|NCT01820442|ECG|ecg
5378288|NCT01820442|QTc|qtc
5378289|NCT01820429|Platelet aggregation|platelet aggregation
5378290|NCT01820429|Aspirin|aspirin
5378291|NCT01820416|Hearing Loss, Bilateral|hearing loss, bilateral
5378292|NCT01820416|Hearing Loss, Sensorineural|hearing loss, sensorineural
5381955|NCT01803867|MS|ms
5378296|NCT01820377|Peer-mentoring|peer-mentoring
5378297|NCT01820377|Obesity|obesity
5378298|NCT01820377|Type 2 Diabetes|type 2 diabetes
5378299|NCT01820377|Physical Activity|physical activity
5378300|NCT01820377|After-school program|after-school program
5378301|NCT01820364|open-label study|open-label study
5378302|NCT01820364|BRAF inhibitor|braf inhibitor
5378303|NCT01820364|LGX818|lgx818
5378304|NCT01820364|MEK1620|mek1620
5378307|NCT01820364|FGFR|fgfr
5378308|NCT01820364|c-Met|c-met
5378309|NCT01820364|CDK4/6|cdk4/6
5378310|NCT01820364|metastatic melanoma|metastatic melanoma
5378311|NCT01820364|BRAF|braf
5378312|NCT01820364|V600|v600
5378313|NCT01820338|Children, Obesity, Intervention|children, obesity, intervention
5378314|NCT01820325|Squamous non-small cell lung cancer|squamous non-small cell lung cancer
5378315|NCT01820325|NSCLC|nsclc
5378316|NCT01820325|stage IV|stage iv
5378317|NCT01820325|BKM120|bkm120
5378318|NCT01820286|Bipolar disorder|bipolar disorder
5378319|NCT01820286|Depression|depression
5378320|NCT01820286|Positive psychology|positive psychology
5378321|NCT01820273|Type 2 diabetes|type 2 diabetes
5378322|NCT01820273|Bariatric surgery|bariatric surgery
5378323|NCT01820273|incretines|incretines
5378324|NCT01820273|GLP-1|glp-1
5378325|NCT01820273|GIP|gip
5378326|NCT01820273|gastric bypass|gastric bypass
5378327|NCT01820273|foregut|foregut
5378328|NCT01820273|hindgut|hindgut
5378329|NCT01820247|Crohn's Disease|crohn's disease
5378330|NCT01820247|enteral nutrition|enteral nutrition
5378331|NCT01820247|Tripterygium Glycosides|tripterygium glycosides
5378332|NCT01820247|induction remission|induction remission
5378333|NCT01820234|Skin cancer|skin cancer
5378334|NCT01820234|Teledermatology|teledermatology
5378335|NCT01820234|Screening|screening
5378336|NCT01820234|Store-and-forward|store-and-forward
5378337|NCT01820221|cesarean delivery|cesarean delivery
5378338|NCT01820221|wound complications|wound complications
5378339|NCT01820221|skin closure methods|skin closure methods
5378340|NCT01820195|Contrast Nephropathy|contrast nephropathy
5351882|NCT01940276|prednisone|prednisone
5365932|NCT01875874|PNF|pnf
5378341|NCT01820195|N-Acetyl Cystein|n-acetyl cystein
5378342|NCT01820195|Prophylaxy|prophylaxy
5378343|NCT01820117|long-term health outcomes|long-term health outcomes
5378344|NCT01820078|Chronic|chronic
5378345|NCT01820078|Kidney|kidney
5378346|NCT01820078|Disease|disease
5378347|NCT01820078|Proteinuria|proteinuria
5378348|NCT01820078|Albuminuria|albuminuria
5378349|NCT01820078|Paricalcitol|paricalcitol
5378350|NCT01820052|Fibromyalgia|fibromyalgia
5378351|NCT01820039|e-health intervention|e-health intervention
5378352|NCT01820039|infertility|infertility
5378353|NCT01820039|primary care|primary care
5378354|NCT01820039|referral rate|referral rate
5378355|NCT01820026|healthcare infection cirrhosis antibiotic|healthcare infection cirrhosis antibiotic
5378356|NCT01820013|Pelvic Girdle pain|pelvic girdle pain
5378357|NCT01820013|Symphysis Pubis Dysfunction|symphysis pubis dysfunction
5378358|NCT01820013|Sacroiliac Joint|sacroiliac joint
5378359|NCT01820013|Sacroiliitis|sacroiliitis
5378360|NCT01820013|Physiotherapy|physiotherapy
5378361|NCT01820013|Physical Therapy|physical therapy
5378362|NCT01820013|Orthotic Devices|orthotic devices
5378363|NCT01819987|Overweight|overweight
5378364|NCT01819987|mother|mother
5378365|NCT01819987|childhood obesity prevention|childhood obesity prevention
5378366|NCT01819987|Chinese American|chinese american
5378367|NCT01819948|Breast cancer|breast cancer
5378368|NCT01819948|Stage 0-IIIA|stage 0-iiia
5378369|NCT01819948|No evidence of disease|no evidence of disease
5378370|NCT01819935|MRSA. pneumonia|mrsa. pneumonia
5378371|NCT01819935|outcomes|outcomes
5378372|NCT01819922|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5378373|NCT01819922|metabolic parameters|metabolic parameters
5378374|NCT01819922|Diabetes Mellitus Type 2|diabetes mellitus type 2
5378375|NCT01819909|Rotator cuff repair|rotator cuff repair
5378376|NCT01819909|Shoulder|shoulder
5378377|NCT01819909|Surgery|surgery
5378378|NCT01819909|Rehabilitation|rehabilitation
5378379|NCT01819909|Pulleys|pulleys
5378380|NCT01819909|Jackins|jackins
5378381|NCT01819870|Carvedilol|carvedilol
5378382|NCT01819870|Dilatrend SR capsule|dilatrend sr capsule
5378383|NCT01819870|Dilatrend Tablet|dilatrend tablet
5378384|NCT01819870|Pharmacokinetics|pharmacokinetics
5378385|NCT01819870|Healthy male subjects|healthy male subjects
5378386|NCT01819844|Closed-loop blood glucose control|closed-loop blood glucose control
5378387|NCT01819844|Continuous glucose monitoring|continuous glucose monitoring
5378388|NCT01819844|Bionic pancreas|bionic pancreas
5361678|NCT01894308|Phase II|phase ii
5378389|NCT01819844|Artificial pancreas|artificial pancreas
5378390|NCT01819831|extremity soft tissue sarcoma|extremity soft tissue sarcoma
5378398|NCT01819805|Chronic pain|chronic pain
5378399|NCT01819805|Chronic non-malignant pain|chronic non-malignant pain
5378400|NCT01819805|Non-malignant|non-malignant
5378401|NCT01819805|Pain|pain
5378402|NCT01819805|Extended release tablet|extended release tablet
5378403|NCT01819805|Tramadol hydrochloride|tramadol hydrochloride
5378404|NCT01819805|Tramadol HCl|tramadol hcl
5378405|NCT01819805|Acetaminophen|acetaminophen
5378406|NCT01819805|Ultracet ER|ultracet er
5378407|NCT01819792|Acute Myeloid Leukemia|acute myeloid leukemia
5378408|NCT01819766|Cancer|cancer
5378409|NCT01819766|Colorectal Cancer|colorectal cancer
5378410|NCT01819766|Neoplasm|neoplasm
5378411|NCT01819766|Colorectal Neoplasm|colorectal neoplasm
5373805|NCT01840930|Pain|pain
5378412|NCT01819766|Intestinal Neoplasms|intestinal neoplasms
5378413|NCT01819766|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5378414|NCT01819766|Digestive System Neoplasms|digestive system neoplasms
5378415|NCT01819766|Neoplasms by Site|neoplasms by site
5378416|NCT01819766|Neoplasms|neoplasms
5378417|NCT01819766|Digestive System Diseases|digestive system diseases
5378418|NCT01819766|Gastrointestinal Diseases|gastrointestinal diseases
5378419|NCT01819766|Colonic Diseases|colonic diseases
5378420|NCT01819766|Intestinal Diseases|intestinal diseases
5378421|NCT01819766|Inflammatory Bowel Disease|inflammatory bowel disease
5378422|NCT01819766|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5378423|NCT01819753|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5378424|NCT01819753|urinary Stones|urinary stones
5378425|NCT01819753|99m-Technetium-Dimercaptosuccinic Acid|99m-technetium-dimercaptosuccinic acid
5378428|NCT01819727|BioMarin|biomarin
5378429|NCT01819727|rAv-PAL PEG|rav-pal peg
5378430|NCT01819727|BMN 165|bmn 165
5378431|NCT01819727|open label|open label
5378432|NCT01819727|Prism301|prism301
5378433|NCT01819727|Pegvaliase|pegvaliase
5378434|NCT01819714|Snoezelen|snoezelen
5378435|NCT01819714|Multi-sensorial care session|multi-sensorial care session
5378436|NCT01819714|Alzheimer's-type neurodegenerative disease|alzheimer's-type neurodegenerative disease
5378437|NCT01819714|Dementia|dementia
5378438|NCT01819688|laparoscopic liver resection|laparoscopic liver resection
5378439|NCT01819688|cytokine release|cytokine release
5378440|NCT01819675|Neuronal plasticity|neuronal plasticity
5378441|NCT01819675|Neurotransmitter agents|neurotransmitter agents
5366108|NCT01875237|MDS|mds
5378442|NCT01819675|Receptors, neurotransmitter|receptors, neurotransmitter
5378443|NCT01819675|Transcranial magnetic stimulation|transcranial magnetic stimulation
5378444|NCT01819675|Stroke|stroke
5378445|NCT01819675|gamma-Aminobutyric Acid|gamma-aminobutyric acid
5378446|NCT01819662|Pacemaker, heart failure, hospitalisation|pacemaker, heart failure, hospitalisation
5378447|NCT01819649|selenium|selenium
5378448|NCT01819649|selenium supplementation|selenium supplementation
5378449|NCT01819649|randomised controlled trial|randomised controlled trial
5378450|NCT01819649|prevention|prevention
5378451|NCT01819636|Blood triglyceride|blood triglyceride
5378452|NCT01819636|Bicarbonated mineral wate|bicarbonated mineral wate
5378453|NCT01819636|Post-prandial triglyceridemia|post-prandial triglyceridemia
5378454|NCT01819636|lipid metabolism|lipid metabolism
5378455|NCT01819636|Cardiovascular risk|cardiovascular risk
5378456|NCT01819623|Mild Cognitive Impairment|mild cognitive impairment
5378457|NCT01819623|Cognitive training|cognitive training
5378458|NCT01819610|Postoperative pain management|postoperative pain management
5378459|NCT01819597|Intracranial Arterial Stenosis|intracranial arterial stenosis
5378460|NCT01819597|Atherosclerosis|atherosclerosis
5378461|NCT01819597|Stroke|stroke
5378462|NCT01819597|EDAS|edas
5378463|NCT01819597|Angiogenesis|angiogenesis
5378464|NCT01819571|pulse pressure variation|pulse pressure variation
5378465|NCT01819571|fluid responsiveness|fluid responsiveness
5378466|NCT01819571|diastolic dysfunction|diastolic dysfunction
5378467|NCT01819558|acute myeloid leukemia|acute myeloid leukemia
5378468|NCT01819558|chronic myeloid leukemia|chronic myeloid leukemia
5378469|NCT01819558|myelodysplastic syndrome|myelodysplastic syndrome
5378470|NCT01819558|allograft|allograft
5378471|NCT01819558|WT1 expression|wt1 expression
5378472|NCT01819545|Alzheimer's disease|alzheimer's disease
5378473|NCT01819545|diagnosis|diagnosis
5378474|NCT01819545|MicRNA|micrna
5378475|NCT01819545|mRNA|mrna
5378476|NCT01819532|neonate|neonate
5378477|NCT01819532|umbilical cord|umbilical cord
5378478|NCT01819532|cord milking|cord milking
5378479|NCT01819532|prematurity|prematurity
5378480|NCT01819519|Intervention studies|intervention studies
5378481|NCT01819519|Pregnancy|pregnancy
5378482|NCT01819519|Cytomegalovirus Infections|cytomegalovirus infections
5378483|NCT01819506|rehabilitation|rehabilitation
5378484|NCT01819506|occupational therapy|occupational therapy
5378485|NCT01819506|upper extremity|upper extremity
5378486|NCT01819493|Diabetes Prevention|diabetes prevention
5378487|NCT01819493|Lifestyle Intervention|lifestyle intervention
5378488|NCT01819493|African American Families|african american families
5378489|NCT01819480|Surgery|surgery
5378490|NCT01819480|Robotic|robotic
5378491|NCT01819480|Carcinoma|carcinoma
5378492|NCT01819480|squamous cell of head and neck|squamous cell of head and neck
5378493|NCT01819454|chronic rhinosinusitis|chronic rhinosinusitis
5378494|NCT01819454|extraesophageal reflux|extraesophageal reflux
5378495|NCT01819454|Restech system|restech system
5378496|NCT01819454|antireflux therapy|antireflux therapy
5378497|NCT01819441|cerebral small Vessel diseases, blood pressure,CCB, ACEI|cerebral small vessel diseases, blood pressure,ccb, acei
5378498|NCT01819428|EGFR mutation|egfr mutation
5378499|NCT01819428|Lung Adenocarcinoma|lung adenocarcinoma
5378500|NCT01819428|Firstline therapy|firstline therapy
5378501|NCT01819428|Second generation of tyrosine kinase|second generation of tyrosine kinase
5378502|NCT01819415|wet AMD|wet amd
5378503|NCT01819415|Omega-3|omega-3
5378504|NCT01819415|VEGF|vegf
5378505|NCT01819415|Lipidomics|lipidomics
5378506|NCT01819415|DHA|dha
5378507|NCT01819415|EPA|epa
5378515|NCT01819376|Adolescents|adolescents
5378516|NCT01819376|Teenagers|teenagers
5378517|NCT01819376|Facebook|facebook
5378518|NCT01819376|Social Networks|social networks
5378519|NCT01819363|Pleural effusion|pleural effusion
5378520|NCT01819363|Pleural elastance|pleural elastance
5378521|NCT01819363|Pleurodesis|pleurodesis
5378522|NCT01819363|Quality of life|quality of life
5378523|NCT01819363|Computed Tomography|computed tomography
5378524|NCT01819350|Dental caries|dental caries
5378526|NCT01819350|Oral administration|oral administration
5378527|NCT01819350|Ion Concentration of Hydrogen|ion concentration of hydrogen
5378528|NCT01819350|Pediatric medicines|pediatric medicines
5378529|NCT01819324|breast cancer survivors|breast cancer survivors
5378530|NCT01819324|lifestyle intervention|lifestyle intervention
5378531|NCT01819324|health behaviors|health behaviors
5378532|NCT01819285|Malignant Neoplasm of Prostate|malignant neoplasm of prostate
5378533|NCT01819285|Tumor-node-metastasis (TNM) Staging Regional Lymph Nodes (N0-2)|tumor-node-metastasis (tnm) staging regional lymph nodes (n0-2)
5378534|NCT01819285|Not suitable for local treatment with curative intent|not suitable for local treatment with curative intent
5378535|NCT01819259|Nonsmoker|nonsmoker
5378536|NCT01819259|ADHD|adhd
5378537|NCT01819259|Nicotine|nicotine
5378538|NCT01819259|Nicotine Nasal Spray|nicotine nasal spray
5378539|NCT01819259|Nicotine Reinforcement|nicotine reinforcement
5378540|NCT01819181|TAVI|tavi
5378541|NCT01819181|women|women
5378542|NCT01819181|aortic stenosis|aortic stenosis
5378543|NCT01819181|VARC2|varc2
5378544|NCT01819155|influenza|influenza
5378545|NCT01819155|influenza vaccine|influenza vaccine
5378546|NCT01819155|immunogenicity|immunogenicity
5378547|NCT01819155|Africa|africa
5378548|NCT01819155|Senegal|senegal
5378549|NCT01819142|non healing wound|non healing wound
5378550|NCT01819142|pressure ulcer|pressure ulcer
5378551|NCT01819116|Tissue Oxygen Saturation|tissue oxygen saturation
5378552|NCT01819116|Management of the DNC Organ Donor|management of the dnc organ donor
5378553|NCT01819103|Mortality|mortality
5378554|NCT01819103|Acute Myocardial Infarction|acute myocardial infarction
5378555|NCT01819103|Drug Adherence|drug adherence
5378556|NCT01819103|Drug Compliance|drug compliance
5378557|NCT01819103|Health-related quality of life|health-related quality of life
5378558|NCT01819090|Neuromuscular disorder|neuromuscular disorder
5378559|NCT01819090|Mechanical ventilation|mechanical ventilation
5378560|NCT01819090|Speech|speech
5378561|NCT01819090|Respiratory failure|respiratory failure
5378562|NCT01819077|Cervical cancer|cervical cancer
5378563|NCT01819077|TMMR|tmmr
5378564|NCT01819077|therapeutic lymphadenectomy|therapeutic lymphadenectomy
5378565|NCT01819077|register study|register study
5378566|NCT01819064|Atropine|atropine
5378567|NCT01819064|bradycardia|bradycardia
5378568|NCT01819064|tachycardia|tachycardia
5378569|NCT01819025|Depression|depression
5378570|NCT01819025|Behavioral activation|behavioral activation
5378571|NCT01819025|Smartphone application|smartphone application
5378572|NCT01819025|Face-to-face|face-to-face
5378573|NCT01819025|Blended therapy|blended therapy
5378574|NCT01819012|Isoflurane|isoflurane
5378575|NCT01819012|mitral valve annular velocity|mitral valve annular velocity
5378576|NCT01819012|tissue Doppler imaging|tissue doppler imaging
5378577|NCT01819012|Monitoring|monitoring
5378578|NCT01819012|echocardiography|echocardiography
5378579|NCT01818999|METASTATIC BREAST CANCER|metastatic breast cancer
5378588|NCT01818947|gefitinib|gefitinib
5378590|NCT01818934|hip dysplasia|hip dysplasia
5378591|NCT01818934|screening|screening
5378592|NCT01818921|Beloranib|beloranib
5378593|NCT01818921|ZGN-440|zgn-440
5378594|NCT01818921|ZGN-440 for injectable suspension|zgn-440 for injectable suspension
5378595|NCT01818921|ZGN-433|zgn-433
5378596|NCT01818908|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5378597|NCT01818908|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5378598|NCT01818908|DA-EPOCH|da-epoch
5378599|NCT01818908|rituximab|rituximab
5378600|NCT01818895|Mechanical ventilation|mechanical ventilation
5378601|NCT01818895|End of life|end of life
5378602|NCT01818895|Extubation|extubation
5378603|NCT01818895|Terminal weaning|terminal weaning
5378604|NCT01818895|Complicated grief|complicated grief
5378605|NCT01818882|Vscan|vscan
5378606|NCT01818882|portable ultrasound|portable ultrasound
5361891|NCT01893580|NSCLC|nsclc
5378607|NCT01818882|emergency care|emergency care
5378608|NCT01818882|emergency room|emergency room
5378610|NCT01818869|tolerability,|tolerability,
5378611|NCT01818869|Phase I,|phase i,
5378612|NCT01818869|pharmacokinetic,|pharmacokinetic,
5378613|NCT01818869|pharmacodynamic,|pharmacodynamic,
5378614|NCT01818869|inhaled|inhaled
5378615|NCT01818856|Chronic hepatitis C|chronic hepatitis c
5378616|NCT01818856|HIV-infection|hiv-infection
5378617|NCT01818856|Drug interaction|drug interaction
5378618|NCT01818843|Carbon monoxide|carbon monoxide
5378620|NCT01818843|Adverse Reaction|adverse reaction
5378621|NCT01818843|newborn|newborn
5378622|NCT01818817|Ultrasound-guided paravertebral block|ultrasound-guided paravertebral block
5378623|NCT01818817|regional anesthesia|regional anesthesia
5378624|NCT01818817|breast surgery|breast surgery
5378625|NCT01818765|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5378626|NCT01818765|Endocardial|endocardial
5378627|NCT01818765|Pacing|pacing
5378628|NCT01818739|Endometrial Cancer|endometrial cancer
5378629|NCT01818739|Robotic-Assisted Staging|robotic-assisted staging
5378630|NCT01818726|Aplastic anemia|aplastic anemia
5378631|NCT01818726|deferasirox|deferasirox
5378632|NCT01818726|ICL670|icl670
5378633|NCT01818726|renal function|renal function
5378634|NCT01818726|transfusion-dependent iron overload|transfusion-dependent iron overload
5378635|NCT01818726|immunosuppressive treatment|immunosuppressive treatment
5378636|NCT01818726|Cyclosporine A|cyclosporine a
5378637|NCT01818726|unosuppressive treatment without chelation therapy|unosuppressive treatment without chelation therapy
5378638|NCT01818713|2B3-101, liposomal doxorubicin, leptomeningeal metastases|2b3-101, liposomal doxorubicin, leptomeningeal metastases
5378639|NCT01818674|social network|social network
5378640|NCT01818674|microclinic|microclinic
5378641|NCT01818674|middle east|middle east
5378642|NCT01818674|jordan|jordan
5378643|NCT01818674|intervention|intervention
5378644|NCT01818661|apraxia of speech|apraxia of speech
5378645|NCT01818661|non-fluent aphasia|non-fluent aphasia
5378646|NCT01818661|aphasia|aphasia
5378647|NCT01818622|Bipolar disorder|bipolar disorder
5378648|NCT01818622|Mania|mania
5378649|NCT01818622|Blue-blockers|blue-blockers
5378650|NCT01818622|Virtual darkness therapy|virtual darkness therapy
5378651|NCT01818622|Actigraphy|actigraphy
5378652|NCT01818622|Randomized controlled trial|randomized controlled trial
5378663|NCT01818596|HIV|hiv
5378664|NCT01818596|HIV-1 Infected|hiv-1 infected
5378665|NCT01818596|Treatment Experienced|treatment experienced
5378666|NCT01818596|Treatment Naive|treatment naive
5378667|NCT01818583|Atrial fibrillation|atrial fibrillation
5378668|NCT01818583|Atrial flutter|atrial flutter
5378669|NCT01818583|Potassium|potassium
5378670|NCT01818583|Cardioversion|cardioversion
5378671|NCT01818570|Gastroesophageal Reflux|gastroesophageal reflux
5378672|NCT01818557|glucose monitoring|glucose monitoring
5378673|NCT01818557|gestational diabetes|gestational diabetes
5378674|NCT01818544|Elastase Inhibition|elastase inhibition
5378675|NCT01818531|Partial knee replacement|partial knee replacement
5378676|NCT01818518|Preterm delivery|preterm delivery
5378677|NCT01818518|Premature delivery|premature delivery
5378678|NCT01818518|Premature birth|premature birth
5378679|NCT01818505|antiphospholipid syndrome|antiphospholipid syndrome
5378680|NCT01818505|gouty arthritis|gouty arthritis
5378681|NCT01818505|Hyperuricemia|hyperuricemia
5378682|NCT01818505|metabolic syndrome|metabolic syndrome
5378683|NCT01818505|osteoarthritis|osteoarthritis
5378684|NCT01818505|cardiovascular co-morbidities|cardiovascular co-morbidities
5378685|NCT01818492|Emapalumab|emapalumab
5378686|NCT01818453|Mood Disorders|mood disorders
5378687|NCT01818453|Depression|depression
5378688|NCT01818453|Genetics|genetics
5378689|NCT01818453|Treatment response|treatment response
5378690|NCT01818453|Treatment study|treatment study
5378691|NCT01818440|Surgical Navigation|surgical navigation
5378692|NCT01818440|Liver|liver
5378693|NCT01818440|Cancer|cancer
5378694|NCT01818440|Image-guided Therapy|image-guided therapy
5378695|NCT01818427|hemmorhagic shock, plasma, air medical transport, randomized, multicenter|hemmorhagic shock, plasma, air medical transport, randomized, multicenter
5378696|NCT01818414|Misoprostol administration & dosage|misoprostol administration & dosage
5378697|NCT01818414|Abortion techniques|abortion techniques
5378698|NCT01818414|Abortion Induced methods|abortion induced methods
5378699|NCT01818414|Dilatation and Curettage|dilatation and curettage
5378700|NCT01818401|Ancillary tailored|ancillary tailored
5378701|NCT01818401|medico-economic study,|medico-economic study,
5378702|NCT01818401|total knee replacement|total knee replacement
5378703|NCT01818401|primary or secondary osteoarthritis|primary or secondary osteoarthritis
5378704|NCT01818362|Influenza|influenza
5378705|NCT01818362|T cells|t cells
5378706|NCT01818349|stroke|stroke
5378707|NCT01818349|exercise|exercise
5378708|NCT01818349|muscle strength|muscle strength
5378709|NCT01818349|gait|gait
5378710|NCT01818349|rehabilitation|rehabilitation
5378711|NCT01818336|penicillin allergy|penicillin allergy
5378712|NCT01818323|Chimeric antigen receptor|chimeric antigen receptor
5378713|NCT01818323|Immunotherapy|immunotherapy
5378714|NCT01818323|Head and Neck Cancer|head and neck cancer
5378715|NCT01818323|Phase I trial|phase i trial
5378716|NCT01818323|Maximum tolerated dose|maximum tolerated dose
5378719|NCT01818310|bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
5378720|NCT01818284|Blood And Marrow Transplantation|blood and marrow transplantation
5378721|NCT01818284|Normal allogeneic donors|normal allogeneic donors
5378722|NCT01818284|Stem cell mobilization|stem cell mobilization
5378723|NCT01818284|peripheral blood progenitor cells|peripheral blood progenitor cells
5378724|NCT01818284|PBPC|pbpc
5378725|NCT01818284|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5378726|NCT01818284|HSCT|hsct
5378727|NCT01818284|Donating blood stem cells|donating blood stem cells
5378728|NCT01818284|C-CSF|c-csf
5378729|NCT01818284|Neupogen|neupogen
5378730|NCT01818284|Filgrastim|filgrastim
5378731|NCT01818284|Plerixafor|plerixafor
5378732|NCT01818284|Mobozil|mobozil
5378733|NCT01818284|Apheresis|apheresis
5378734|NCT01818271|community-stroke-rehabilitation,|community-stroke-rehabilitation,
5378735|NCT01818271|group-exercise,|group-exercise,
5378736|NCT01818271|balance-mobility-exercise,|balance-mobility-exercise,
5378737|NCT01818271|instrumented treadmill|instrumented treadmill
5378739|NCT01818258|Children|children
5378740|NCT01818258|HAART|haart
5378741|NCT01818258|Malnourished|malnourished
5378742|NCT01818219|Electrical activity of the diaphragm|electrical activity of the diaphragm
5378743|NCT01818219|Neuro regulation of breathing|neuro regulation of breathing
5378744|NCT01818219|Abnormal respiratory mechanics|abnormal respiratory mechanics
5378745|NCT01818219|Assisted mechanical ventilation|assisted mechanical ventilation
5378746|NCT01818219|Pressure support|pressure support
5378747|NCT01818219|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5378748|NCT01818206|Cystic Fibrosis|cystic fibrosis
5378749|NCT01818206|Bacteriophages|bacteriophages
5378750|NCT01818206|Pseudomonas aeruginosa|pseudomonas aeruginosa
5378751|NCT01818206|Sputum|sputum
5378752|NCT01818193|Pulmonary transplant|pulmonary transplant
5378753|NCT01818167|Hidradenitis Suppurativa|hidradenitis suppurativa
5378754|NCT01818167|HS|hs
5378755|NCT01818167|Acne Inversa|acne inversa
5378756|NCT01818167|Velpeau's disease|velpeau's disease
5366333|NCT01874132|Fitness|fitness
5378757|NCT01818167|Verneuil's disease|verneuil's disease
5378758|NCT01818154|phototherapy|phototherapy
5378759|NCT01818154|light emitting diode|light emitting diode
5378760|NCT01818154|minimal erythema dose|minimal erythema dose
5378761|NCT01818154|narrowband UVB|narrowband uvb
5378762|NCT01818115|POAG|poag
5378763|NCT01818115|PXG|pxg
5378764|NCT01818115|IOL Surgery|iol surgery
5378765|NCT01818115|CE Surgery|ce surgery
5378766|NCT01818024|healthy volunteer|healthy volunteer
5378767|NCT01818024|TNFR1|tnfr1
5378768|NCT01818024|domain antibody|domain antibody
5378769|NCT01818024|Lung injury|lung injury
5378770|NCT01818011|Japanese, GSK1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,|japanese, gsk1322322, pharmacokinetics, relative bioavailability, single dose, repeat dose, healthy subjects, dose-escalation, antimicrobial, over granulation,
5378771|NCT01817985|Hepatitis C (HCV) Infection|hepatitis c (hcv) infection
5378772|NCT01817985|Moderate Hepatic Impairment|moderate hepatic impairment
5378780|NCT01817946|Congenital Myopathy|congenital myopathy
5378781|NCT01817946|Centronuclear Myopathy|centronuclear myopathy
5378782|NCT01817946|Myotubular Myopathy|myotubular myopathy
5378783|NCT01817946|Myotubularin|myotubularin
5378784|NCT01817946|MTM1 Gene|mtm1 gene
5378785|NCT01817946|Genetic testing|genetic testing
5378786|NCT01817946|Sequencing|sequencing
5378787|NCT01817946|Deletion/Duplication Mutation|deletion/duplication mutation
5378788|NCT01817946|CGH array|cgh array
5378789|NCT01817907|Apnea- Hypopnea index|apnea- hypopnea index
5378790|NCT01817907|Arousal Threshold|arousal threshold
5378791|NCT01817894|Unwanted facial hair growth|unwanted facial hair growth
5378792|NCT01817868|Hemophilia|hemophilia
5378793|NCT01817868|Turkey|turkey
5378794|NCT01817868|Observational|observational
5378795|NCT01817868|Adult|adult
5378796|NCT01817855|Phase 1,|phase 1,
5378797|NCT01817855|Safety,|safety,
5378798|NCT01817855|Tolerability,|tolerability,
5378799|NCT01817855|Healthy,|healthy,
5378800|NCT01817855|COPD patients|copd patients
5378801|NCT01817842|mHealth|mhealth
5378802|NCT01817842|EMA|ema
5378803|NCT01817842|Ecological Momentary Assessment|ecological momentary assessment
5378804|NCT01817842|Personal Informatics|personal informatics
5378805|NCT01817842|Tobacco Quitline|tobacco quitline
5378806|NCT01817803|Heart failure|heart failure
5378807|NCT01817803|diuretics|diuretics
5378809|NCT01817803|glomerular filtration rate|glomerular filtration rate
5378810|NCT01817777|Socioeconomic category|socioeconomic category
5378811|NCT01817777|Medication compliance|medication compliance
5378812|NCT01817777|Metformin|metformin
5378813|NCT01817777|small pack|small pack
5378814|NCT01817764|umeclidinium bromide (UMEC)|umeclidinium bromide (umec)
5378815|NCT01817764|vilanterol (VI)|vilanterol (vi)
5378816|NCT01817764|salmeterol (SAL)|salmeterol (sal)
5378817|NCT01817764|fluticasone propionate (FP)|fluticasone propionate (fp)
5378818|NCT01817764|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
5378819|NCT01817764|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5378820|NCT01817764|GW642444|gw642444
5378821|NCT01817764|GSK573719|gsk573719
5378822|NCT01817764|lung function|lung function
5378823|NCT01817751|central nervous system|central nervous system
5378824|NCT01817751|Brain and Nervous System|brain and nervous system
5378825|NCT01817738|Metastatic|metastatic
5378826|NCT01817738|Castrate-refractory|castrate-refractory
5378827|NCT01817725|Therapeutic vaccine|therapeutic vaccine
5378828|NCT01817725|HBsAg clearance|hbsag clearance
5378829|NCT01817725|Immune clearance|immune clearance
5378830|NCT01817725|HBsAg clearance induced by vaccination|hbsag clearance induced by vaccination
5378831|NCT01817725|s seroconversion in carriers after vaccination|s seroconversion in carriers after vaccination
5378832|NCT01817712|Posttraumatic neuroses|posttraumatic neuroses
5378833|NCT01817712|posttraumatic stress disorder|posttraumatic stress disorder
5378835|NCT01817712|Supported employment|supported employment
5378836|NCT01817712|IPS|ips
5378837|NCT01817712|CWT|cwt
5378838|NCT01817712|TWP|twp
5378839|NCT01817712|Individual placement and support|individual placement and support
5378840|NCT01817712|Compensated work therapy|compensated work therapy
5378841|NCT01817712|Transitional work program|transitional work program
5378842|NCT01817699|Cholecalciferol|cholecalciferol
5378843|NCT01817699|Methoxy polyethylene glycol-epoetin beta|methoxy polyethylene glycol-epoetin beta
5378844|NCT01817699|Hematinics|hematinics
5378845|NCT01817699|Bone Diseases, Metabolic|bone diseases, metabolic
5378846|NCT01817699|Neoplasms|neoplasms
5378847|NCT01817699|Cardiovascular Diseases|cardiovascular diseases
5378848|NCT01817699|Graft Rejection|graft rejection
5378849|NCT01817660|popliteal artery aneurysm|popliteal artery aneurysm
5378850|NCT01817660|endovascular repair|endovascular repair
5378851|NCT01817660|open surgical repair|open surgical repair
5378852|NCT01817660|comparative study|comparative study
5378853|NCT01817647|AL|al
5378854|NCT01817647|Enhanced recovery after surgery (ERAS)|enhanced recovery after surgery (eras)
5378855|NCT01817647|reduce postoperative complications|reduce postoperative complications
5685274|NCT00556842|Hemi-Arthroplasty|hemi-arthroplasty
5378856|NCT01817647|increased risk of delayed diagnosis and treatment of AL|increased risk of delayed diagnosis and treatment of al
5378857|NCT01817647|diagnose anastomotic leak|diagnose anastomotic leak
5378858|NCT01817634|Malnutrition.|malnutrition.
5378859|NCT01817621|Body Image Disturbance|body image disturbance
5378860|NCT01817621|Medication Adherence|medication adherence
5378861|NCT01817621|Sexual Risk Behavior|sexual risk behavior
5378862|NCT01817621|HIV|hiv
5378863|NCT01817621|MSM|msm
5378864|NCT01817608|sf-36|sf-36
5378865|NCT01817608|Katz|katz
5378866|NCT01817595|Type 2 Diabetes|type 2 diabetes
5378867|NCT01817595|Internet Blood Glucose Monitoring|internet blood glucose monitoring
5378868|NCT01817595|iphone|iphone
5378870|NCT01817582|Dry Eye Disease|dry eye disease
5378871|NCT01817569|Diabetes Mellitus (DM)|diabetes mellitus (dm)
5378872|NCT01817569|Byetta|byetta
5378873|NCT01817569|Exenatide|exenatide
5378874|NCT01817543|venous leg ulcers|venous leg ulcers
5378875|NCT01817543|non healing wounds|non healing wounds
5378876|NCT01817530|Uterine Fibroids|uterine fibroids
5378877|NCT01817530|Leiomyomata|leiomyomata
5378878|NCT01817530|Elagolix|elagolix
5378879|NCT01817530|Menorrhagia|menorrhagia
5378880|NCT01817530|Elagolix sodium|elagolix sodium
5378881|NCT01817530|Heavy Uterine Bleeding|heavy uterine bleeding
5378882|NCT01817530|ABT-620|abt-620
5378883|NCT01817504|Renal failure,|renal failure,
5378884|NCT01817504|Transplantectomy|transplantectomy
5378885|NCT01817504|Immunosuppression|immunosuppression
5378886|NCT01817504|Sensitization|sensitization
5378887|NCT01817491|Vegan Diet|vegan diet
5378888|NCT01817491|Hypercholesterolemia|hypercholesterolemia
5378889|NCT01817491|American Heart Association Diet|american heart association diet
5378890|NCT01817491|Cardiovascular Risk|cardiovascular risk
5378891|NCT01817491|Obesity|obesity
5378892|NCT01817478|conjunctival flora|conjunctival flora
5378893|NCT01817439|oral Amiodarone|oral amiodarone
5378894|NCT01817439|IV Amiodarone|iv amiodarone
5378895|NCT01817439|phlebitis|phlebitis
5378896|NCT01817439|thrombophlebitis|thrombophlebitis
5378897|NCT01817439|adverse events|adverse events
5378898|NCT01817413|Calcium hydroxide|calcium hydroxide
5378899|NCT01817413|Pulp regeneration|pulp regeneration
5378900|NCT01817413|Regenerative endodontics|regenerative endodontics
5378901|NCT01817413|Pulp revitalisation|pulp revitalisation
5378902|NCT01817413|Triple antibiotic paste|triple antibiotic paste
5378903|NCT01817413|Root canal therapy|root canal therapy
5378904|NCT01817413|Root end closure|root end closure
5378905|NCT01817413|Tooth root|tooth root
5378906|NCT01817413|Tooth apex|tooth apex
5378907|NCT01817413|Dental trauma|dental trauma
5378908|NCT01817413|Non-vital|non-vital
5378909|NCT01817413|Immature|immature
5362198|NCT01892111|SET|set
5378911|NCT01817413|Periapical periodontitis|periapical periodontitis
5378912|NCT01817413|Dental pulp|dental pulp
5378913|NCT01817374|Breast Cancer|breast cancer
5378914|NCT01817374|Definity|definity
5378915|NCT01817374|Ultrasound|ultrasound
5378916|NCT01817361|oral health|oral health
5378917|NCT01817348|Adhesive capsulitis|adhesive capsulitis
5374310|NCT01838655|Melanin|melanin
5378919|NCT01817348|Shoulder pain|shoulder pain
5378920|NCT01817348|Intra-articular injection|intra-articular injection
5378921|NCT01817348|Lidocaine injection|lidocaine injection
5378922|NCT01817348|Physiotherapy|physiotherapy
5378923|NCT01817348|Manipulation|manipulation
5378924|NCT01817348|Stretch exercise|stretch exercise
5378925|NCT01817322|kidney transplantation|kidney transplantation
5378926|NCT01817309|renal failure|renal failure
5378927|NCT01817309|survival|survival
5378928|NCT01817309|peritoneal failure|peritoneal failure
5378929|NCT01817296|Klinefelter|klinefelter
5378930|NCT01817296|Fertility|fertility
5378931|NCT01817283|HIV-infected immunological non-responders|hiv-infected immunological non-responders
5378932|NCT01817283|Triptolide|triptolide
5378933|NCT01817283|immune activation|immune activation
5378934|NCT01817283|inflammation|inflammation
5378935|NCT01817283|CD4 T cell|cd4 t cell
5378937|NCT01817257|Thrombosis|thrombosis
5378938|NCT01817257|Venous thromboembolism|venous thromboembolism
5378939|NCT01817257|Deep vein thrombosis|deep vein thrombosis
5378940|NCT01817257|Pulmonary embolus|pulmonary embolus
5378941|NCT01817244|care management|care management
5378942|NCT01817244|depression|depression
5378943|NCT01817244|elderly|elderly
5378944|NCT01817244|Korea|korea
5378945|NCT01817231|breast cancer|breast cancer
5378946|NCT01817231|vitamin D|vitamin d
5378947|NCT01817231|25 OH vitamin D|25 oh vitamin d
5378948|NCT01817218|PRP|prp
5378949|NCT01817218|chronic vascular ulcer|chronic vascular ulcer
5378950|NCT01817218|primary care|primary care
5378951|NCT01817192|Non-Squamous|non-squamous
5378952|NCT01817192|Adjuvant Chemotherapy|adjuvant chemotherapy
5378953|NCT01817179|hemiplegia, cerebral palsy, neuroprosthesis, children|hemiplegia, cerebral palsy, neuroprosthesis, children
5378954|NCT01817166|cholecalciferol|cholecalciferol
5378955|NCT01817166|vitamin D|vitamin d
5378956|NCT01817166|immune disease|immune disease
5378957|NCT01817166|clinically isolated syndrome|clinically isolated syndrome
5378958|NCT01817140|oral cancer|oral cancer
5378959|NCT01817140|mandibular invasion|mandibular invasion
5002879|NCT03978052|Subjective Cognitive Complaints (SCD)|subjective cognitive complaints (scd)
5378960|NCT01817140|SWIFT MRI|swift mri
5378961|NCT01817114|Remote Ischemic Conditioning|remote ischemic conditioning
5378962|NCT01817114|PCI|pci
5378963|NCT01817114|STEMI|stemi
5378964|NCT01817114|LAD|lad
5378965|NCT01817088|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5378966|NCT01817088|Parkinson disease|parkinson disease
5378967|NCT01817088|Stereotaxis Technique|stereotaxis technique
5378968|NCT01817088|Subthalamic nucleus|subthalamic nucleus
5378969|NCT01817062|Capillary leakage|capillary leakage
5378970|NCT01817062|Acute Abdomen|acute abdomen
5378971|NCT01817062|Low birth weight|low birth weight
5378972|NCT01817049|prevention|prevention
5378973|NCT01817049|sport injury|sport injury
5378974|NCT01817049|soccer|soccer
5378975|NCT01817049|youth|youth
5378976|NCT01817049|neuromuscular training|neuromuscular training
5378977|NCT01817049|intervention|intervention
5378978|NCT01817049|behaviour|behaviour
5378979|NCT01817036|vitamin D|vitamin d
5378980|NCT01817036|deficiency|deficiency
5378981|NCT01817036|dose response|dose response
5378982|NCT01817023|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5378983|NCT01817023|current chemotherapy|current chemotherapy
5378984|NCT01817023|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5378985|NCT01817023|low-risk|low-risk
5378986|NCT01817010|Total Hip Arthroplasty|total hip arthroplasty
5378987|NCT01817010|Muscle Strength|muscle strength
5378988|NCT01817010|Hip Osteoarthritis|hip osteoarthritis
5378989|NCT01816997|Statins|statins
5378990|NCT01816997|Glucose homeostasis|glucose homeostasis
5378991|NCT01816997|Diabetes|diabetes
5378992|NCT01816997|Impaired fasting glucose|impaired fasting glucose
5378993|NCT01816958|thalamocortical dysrhythmia|thalamocortical dysrhythmia
5378994|NCT01816958|transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5378995|NCT01816958|transcranial Electrical Stimulation (tES)|transcranial electrical stimulation (tes)
5378996|NCT01816958|(N-methyl-D-aspartate) NMDA-R antagonist|(n-methyl-d-aspartate) nmda-r antagonist
5378997|NCT01816958|ketamine infusion|ketamine infusion
5378998|NCT01816958|neuromodulation|neuromodulation
5378999|NCT01816958|synergistic effect|synergistic effect
5379000|NCT01816958|remission|remission
5379001|NCT01816945|Depression|depression
5379002|NCT01816945|Stress|stress
5379003|NCT01816945|Social support|social support
5362309|NCT01891721|EEG|eeg
5379004|NCT01816945|Social capital|social capital
5379005|NCT01816945|Maternal|maternal
5379006|NCT01816893|Hypoglycemia|hypoglycemia
5379007|NCT01816893|Autonomic Nervous System|autonomic nervous system
5379008|NCT01816893|baroreflex sensitivity|baroreflex sensitivity
5379009|NCT01816893|muscle sympathetic nerve activity|muscle sympathetic nerve activity
5379010|NCT01816893|lower body negative pressure|lower body negative pressure
5379011|NCT01816867|hernia|hernia
5379012|NCT01816867|Treatment|treatment
5379013|NCT01816867|laparoscopic|laparoscopic
5379014|NCT01816867|open technique|open technique
5379015|NCT01816854|Peripheral artery disease|peripheral artery disease
5379016|NCT01816854|SFA|sfa
5379017|NCT01816854|PPA|ppa
5374413|NCT01838200|BCG|bcg
5379018|NCT01816854|Self-expandable nitinol stent|self-expandable nitinol stent
5379019|NCT01816854|Endovascular|endovascular
5379020|NCT01816854|Stenosis|stenosis
5379021|NCT01816854|Primary pantency|primary pantency
5379022|NCT01816841|Direct Visual Fluorescense|direct visual fluorescense
5379023|NCT01816841|Oral Examination|oral examination
5379024|NCT01816841|oral cancer|oral cancer
5379025|NCT01816828|HIV, MSM, unprotected anal intercourse, sexual health|hiv, msm, unprotected anal intercourse, sexual health
5379026|NCT01816815|PK/PD|pk/pd
5379027|NCT01816815|BAY1002670|bay1002670
5379028|NCT01816802|In vitro fertilization|in vitro fertilization
5379029|NCT01816802|Assisted reproductive therapy|assisted reproductive therapy
5379030|NCT01816802|Time-lapse image recording|time-lapse image recording
5379031|NCT01816802|Image analysis software|image analysis software
5379032|NCT01816789|Starting dose|starting dose
5379033|NCT01816789|rFSH|rfsh
5379034|NCT01816789|controlled|controlled
5379035|NCT01816789|ovarian|ovarian
5379036|NCT01816789|stimulation|stimulation
5379037|NCT01816789|IVF/ICSI|ivf/icsi
5379038|NCT01816789|cycles|cycles
5379039|NCT01816763|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5379040|NCT01816763|Primary Health Care|primary health care
5379041|NCT01816763|Medical Informatics|medical informatics
5379042|NCT01816750|CT coronary angiography|ct coronary angiography
5379043|NCT01816750|Coronary disease|coronary disease
5379044|NCT01816750|Gemstone Spectral Imaging|gemstone spectral imaging
5379045|NCT01816750|Diagnostic value|diagnostic value
5379046|NCT01816750|Adaptive statistical iterative reconstruction|adaptive statistical iterative reconstruction
5379047|NCT01816750|iterative reconstruction|iterative reconstruction
5379048|NCT01816750|Feasibility of coronary and myocardial assessment|feasibility of coronary and myocardial assessment
5379049|NCT01816750|novel Cardiac CT GSI protocol|novel cardiac ct gsi protocol
5379050|NCT01816724|NOCTURIA|nocturia
5002880|NCT03978052|Apolipoprotein E4|apolipoprotein e4
5379051|NCT01816724|SYMPTOMATIC QUESTIONNAIRE|symptomatic questionnaire
5379052|NCT01816724|N-QOL|n-qol
5379053|NCT01816711|Frail elderly|frail elderly
5379054|NCT01816711|Hip fracture|hip fracture
5379055|NCT01816711|Vitamin D|vitamin d
5379056|NCT01816711|Geriatrics|geriatrics
5379057|NCT01816698|Hypertension|hypertension
5379058|NCT01816698|Taurine|taurine
5379059|NCT01816698|Metabolism|metabolism
5379060|NCT01816672|Wagner 1|wagner 1
5379061|NCT01816672|Wagner 2|wagner 2
5379062|NCT01816672|Non healing diabetic foot wound|non healing diabetic foot wound
5379063|NCT01816659|Colorectal Carcinoma|colorectal carcinoma
5379064|NCT01816659|Endoscopically Non- Resectable Adenomas|endoscopically non- resectable adenomas
5379065|NCT01816659|Colonic lesion|colonic lesion
5379066|NCT01816659|Biomarker|biomarker
5379067|NCT01816659|Metformin-ER|metformin-er
5379068|NCT01816659|Metformin|metformin
5379069|NCT01816659|Extended release|extended release
5379070|NCT01816659|Colonoscopy|colonoscopy
5379071|NCT01816659|Colon cancer surgery|colon cancer surgery
5379072|NCT01816646|Blood And Marrow Transplantation|blood and marrow transplantation
5379073|NCT01816646|Hemorrhagic Cystitis|hemorrhagic cystitis
5379074|NCT01816646|Bleeding from bladder|bleeding from bladder
5379075|NCT01816646|Foley catheter|foley catheter
5379076|NCT01816646|Probenecid|probenecid
5379077|NCT01816646|Cidofovir|cidofovir
5379078|NCT01816646|Vistide|vistide
5379079|NCT01816633|non healing wound|non healing wound
5379080|NCT01816620|POEMS Syndrome|poems syndrome
5379081|NCT01816620|lenalidomide|lenalidomide
5379082|NCT01816620|newly diagnosed|newly diagnosed
5379083|NCT01816620|plasma cell disorder|plasma cell disorder
5379084|NCT01816620|Dexamethasone|dexamethasone
5379085|NCT01816607|Magnetic Resonance Imaging|magnetic resonance imaging
5379086|NCT01816607|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5379087|NCT01816594|HER2|her2
5379088|NCT01816594|breast cancer|breast cancer
5379089|NCT01816594|neoadjuvant|neoadjuvant
5379090|NCT01816594|PI3K inhibitor|pi3k inhibitor
5379091|NCT01816594|first line chemotherapy|first line chemotherapy
5379092|NCT01816594|trastuzumab|trastuzumab
5379093|NCT01816594|GBG|gbg
5379094|NCT01816594|SOLTI|solti
5379095|NCT01816594|BIG|big
5379096|NCT01816568|appendicitis, laparoscopy, single incision|appendicitis, laparoscopy, single incision
5379097|NCT01816542|patch-testing|patch-testing
5379098|NCT01816542|personal-care|personal-care
5379099|NCT01816542|cosmetic|cosmetic
5379100|NCT01816542|dermatitis|dermatitis
5379101|NCT01816542|allergy|allergy
5379102|NCT01816542|sensitive skin|sensitive skin
5379103|NCT01816516|childhood obesity|childhood obesity
5379104|NCT01816516|low-income|low-income
5379105|NCT01816516|maternal responsiveness|maternal responsiveness
5379106|NCT01816516|infant feeding|infant feeding
5379107|NCT01816516|infant feeding practices|infant feeding practices
5379108|NCT01816516|infant feeding style|infant feeding style
5379109|NCT01816516|primary prevention|primary prevention
5379110|NCT01816503|Pain|pain
5379111|NCT01816503|Cancer pain|cancer pain
5379112|NCT01816503|Fentanyl|fentanyl
5379113|NCT01816503|Fentanyl matrix|fentanyl matrix
5379114|NCT01816503|Opioid analgesic|opioid analgesic
5379115|NCT01816464|Influenza|influenza
5379116|NCT01816464|Vaccination|vaccination
5379118|NCT01816451|cardiorespiratory training|cardiorespiratory training
5379119|NCT01816451|blood lactate concentration|blood lactate concentration
5671948|NCT00613496|Adhesion Molecules|adhesion molecules
5379121|NCT01816438|abnormal histological colorectal lesions|abnormal histological colorectal lesions
5379122|NCT01816425|Dental Prosthesis|dental prosthesis
5379123|NCT01816425|Dental Prosthesis Design|dental prosthesis design
5379125|NCT01816412|Experimental|experimental
5379126|NCT01816412|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5379127|NCT01816412|Active Comparator|active comparator
5379128|NCT01816412|Standard angioplasty balloon|standard angioplasty balloon
5379129|NCT01816386|acupuncture|acupuncture
5379130|NCT01816386|anaesthetic recovery|anaesthetic recovery
5379131|NCT01816386|perioperative care|perioperative care
5379132|NCT01816386|Age 18+|age 18+
5379133|NCT01816386|ASA-score ≤ 2|asa-score ≤ 2
5379134|NCT01816386|Surgery: Uterus|surgery: uterus
5379135|NCT01816386|Surgery: Adnex|surgery: adnex
5379136|NCT01816386|Surgery: Ovaries|surgery: ovaries
5379137|NCT01816373|Chest wall; Chest, funnel; pectus excavatum; congenital abnormality|chest wall; chest, funnel; pectus excavatum; congenital abnormality
5379138|NCT01816360|Womens health|womens health
5379139|NCT01816360|Menopause|menopause
5379140|NCT01816360|Complementary therapies|complementary therapies
5379141|NCT01816360|Aromatherapy|aromatherapy
5379142|NCT01816360|Essential oils|essential oils
5379143|NCT01816360|Yogatherapy|yogatherapy
5379144|NCT01816360|Psychoneuroendocrineimmunology|psychoneuroendocrineimmunology
5379145|NCT01816334|sciatica|sciatica
5379146|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5379147|NCT01816334|Glucocorticoids|glucocorticoids
5379149|NCT01816308|MCI|mci
5379150|NCT01816282|TKR|tkr
5379151|NCT01816282|Blood loss|blood loss
5379152|NCT01816282|Fibrin Sealant|fibrin sealant
5379153|NCT01816269|Helicobacter pylori|helicobacter pylori
5379154|NCT01816269|Dental scaling|dental scaling
5379155|NCT01816269|Eradication|eradication
5379156|NCT01816269|Reinfection|reinfection
5379157|NCT01816269|Helicobacter status|helicobacter status
5379158|NCT01816243|Chronic Pain|chronic pain
5379159|NCT01816243|Chronic Non-Malignant Pain|chronic non-malignant pain
5379160|NCT01816243|TTS-fentanyl|tts-fentanyl
5379161|NCT01816243|Durogesic|durogesic
5379162|NCT01816217|Difficult intubation|difficult intubation
5379163|NCT01816217|Complications|complications
5379164|NCT01816217|Intensive care units|intensive care units
5379165|NCT01816217|Videolaryngoscope|videolaryngoscope
5379166|NCT01816217|Laryngoscopy|laryngoscopy
5379167|NCT01816204|anxiety treatment|anxiety treatment
5379168|NCT01816204|anxiety online treatment|anxiety online treatment
5379169|NCT01816204|anxiety electronic treatment|anxiety electronic treatment
5379170|NCT01816204|anxiety therapist assisted|anxiety therapist assisted
5379171|NCT01816178|Autism spectrum Disorders|autism spectrum disorders
5379172|NCT01816178|Voice Output Communication|voice output communication
5379173|NCT01816165|diabetes|diabetes
5379174|NCT01816165|insulin|insulin
5379175|NCT01816165|blood vessel|blood vessel
5379176|NCT01816165|type 1|type 1
5379177|NCT01816152|light treatment|light treatment
5379178|NCT01816152|circadian rhythms|circadian rhythms
5379179|NCT01816152|sleep|sleep
5379180|NCT01816152|agitation|agitation
5379181|NCT01816152|depression|depression
5379182|NCT01816139|vaginal dryness|vaginal dryness
5379183|NCT01816139|vaginal atrophy|vaginal atrophy
5379184|NCT01816139|estrogen|estrogen
5379185|NCT01816113|PvDBP|pvdbp
5379186|NCT01816113|Malaria|malaria
5379187|NCT01816113|Plasmodium vivax|plasmodium vivax
5379188|NCT01816100|multiple sclerosis|multiple sclerosis
5379189|NCT01816100|exercise|exercise
5379190|NCT01816100|MEG|meg
5379191|NCT01816100|DTI|dti
5379192|NCT01816100|Brain changes|brain changes
5379193|NCT01816074|Mothers|mothers
5379194|NCT01816074|ADHD|adhd
5379195|NCT01816074|Treatment|treatment
5379196|NCT01816074|Child|child
5379197|NCT01816061|Veterans Health|veterans health
5379198|NCT01816061|Social Adjustment|social adjustment
5379199|NCT01816061|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
5379200|NCT01816061|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5379201|NCT01816061|Independent Living|independent living
5379203|NCT01816061|Education|education
5379204|NCT01816048|prostate, prostate cancer|prostate, prostate cancer
5379205|NCT01816022|CMPN|cmpn
5379206|NCT01816022|Fracture|fracture
5379207|NCT01816022|Osteoporosis|osteoporosis
5379208|NCT01816022|Biochemical Bone Markers|biochemical bone markers
5379209|NCT01816009|infection|infection
5379210|NCT01816009|antibiotic|antibiotic
5379211|NCT01816009|prosthesis|prosthesis
5379212|NCT01815996|Pregnancy|pregnancy
5379213|NCT01815996|pulmonary embolism|pulmonary embolism
5379214|NCT01815996|myocardial infarction|myocardial infarction
5379215|NCT01815996|autoimmune disease|autoimmune disease
5379216|NCT01815996|healthy controls|healthy controls
5379217|NCT01815983|Laryngoscopy|laryngoscopy
5379218|NCT01815983|Tracheal Intubation|tracheal intubation
5379219|NCT01815983|Video Laryngoscopy|video laryngoscopy
5379221|NCT01815970|exercise|exercise
5379222|NCT01815970|neuromechanical uncoupling|neuromechanical uncoupling
5379223|NCT01815970|COPD|copd
5379224|NCT01815970|pulmonary rehabilitation|pulmonary rehabilitation
5379225|NCT01815957|coronary microcirculation|coronary microcirculation
5379226|NCT01815957|coronary artery disease|coronary artery disease
5379227|NCT01815957|myocardial disease|myocardial disease
5379228|NCT01815957|ischemia|ischemia
5379229|NCT01815944|onset time|onset time
5379230|NCT01815944|ultrasound-guided supraclavicular block|ultrasound-guided supraclavicular block
5379231|NCT01815944|ropivacaine|ropivacaine
5379232|NCT01815944|normal saline|normal saline
5379233|NCT01815944|dextrose 5%|dextrose 5%
5379234|NCT01815918|Orthopedic Procedures|orthopedic procedures
5379235|NCT01815918|Prostheses and Implants|prostheses and implants
5379236|NCT01815918|Joint Prosthesis|joint prosthesis
5379237|NCT01815918|Knee Prosthesis|knee prosthesis
5379238|NCT01815918|Arthroplasty, Knee|arthroplasty, knee
5379239|NCT01815918|Thromboembolism|thromboembolism
5379240|NCT01815918|Inflammation|inflammation
5379241|NCT01815918|B-Cell Differentiation Factor-2|b-cell differentiation factor-2
5379242|NCT01815918|Differentiation Factor-2, B-Cell|differentiation factor-2, b-cell
5379243|NCT01815918|B-Cell Stimulatory Factor-2|b-cell stimulatory factor-2
5379244|NCT01815918|BSF-2|bsf-2
5379245|NCT01815918|IFN-beta 2|ifn-beta 2
5379246|NCT01815918|MGI-2|mgi-2
5379247|NCT01815918|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5379248|NCT01815918|Steroids|steroids
5379249|NCT01815918|Pregnenediones|pregnenediones
5379250|NCT01815918|Hydrocortisone|hydrocortisone
5379251|NCT01815918|Physiological Effects of Drugs|physiological effects of drugs
5379252|NCT01815918|Therapeutic Uses|therapeutic uses
5379253|NCT01815892|Hemodialysis|hemodialysis
5002881|NCT03978039|patterns of care|patterns of care
5379254|NCT01815892|Response to Furosemide|response to furosemide
5379255|NCT01815879|metastatic colorectal cancer|metastatic colorectal cancer
5379256|NCT01815879|liver metastases|liver metastases
5379257|NCT01815879|90Y resin microsphere radioembolization|90y resin microsphere radioembolization
5379258|NCT01815879|retrospective data analysis|retrospective data analysis
5379259|NCT01815866|Positive Nontuberculous Mycobacteria|positive nontuberculous mycobacteria
5379260|NCT01815853|Neoadjuvant|neoadjuvant
5379261|NCT01815853|Chemoradiotherapy|chemoradiotherapy
5379262|NCT01815853|Chemotherapy|chemotherapy
5379263|NCT01815853|Locally advanced gastric cancer|locally advanced gastric cancer
5379264|NCT01815853|Pathological complete response|pathological complete response
5379265|NCT01815853|D2 gastrectomy|d2 gastrectomy
5379266|NCT01815814|spasticity|spasticity
5379267|NCT01815814|cerebral palsy|cerebral palsy
5379268|NCT01815814|hemiplegia|hemiplegia
5379269|NCT01815814|hemiparesis|hemiparesis
5379270|NCT01815814|diplegia|diplegia
5379271|NCT01815814|paraplegia|paraplegia
5379272|NCT01815814|quadriplegia|quadriplegia
5379273|NCT01815814|quadriparesis|quadriparesis
5379274|NCT01815775|Normal pressure hydrocephalus|normal pressure hydrocephalus
5379275|NCT01815775|flow MRI|flow mri
5379276|NCT01815775|dementia|dementia
5379277|NCT01815775|cerebrospinal fluid|cerebrospinal fluid
5379278|NCT01815775|shunt|shunt
5379279|NCT01815762|bioimpedance|bioimpedance
5379280|NCT01815762|overhydration|overhydration
5379281|NCT01815762|hemodialysis|hemodialysis
5379282|NCT01815762|arterial stiffness|arterial stiffness
5379283|NCT01815762|mortality|mortality
5379284|NCT01815736|HIV|hiv
5379285|NCT01815736|HIV 1 Infected|hiv 1 infected
5379286|NCT01815736|Virologically-Suppressed|virologically-suppressed
5379287|NCT01815723|Psoriasis|psoriasis
5379288|NCT01815723|Dimethyl fumarate|dimethyl fumarate
5379289|NCT01815723|Fumaderm®|fumaderm®
5379290|NCT01815710|Clinical Pathways|clinical pathways
5379291|NCT01815710|Knowledge translation|knowledge translation
5379292|NCT01815710|Evaluation|evaluation
5379293|NCT01815697|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5379294|NCT01815697|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5379295|NCT01815697|Urinary Retention|urinary retention
5379296|NCT01815697|Vascular Endothelium|vascular endothelium
5379297|NCT01815697|Counterpulsation, External|counterpulsation, external
5379298|NCT01815684|Phase I|phase i
5379299|NCT01815684|ASP3652|asp3652
5379300|NCT01815684|Dose escalation|dose escalation
5379301|NCT01815684|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
5379302|NCT01815671|colonoscopy|colonoscopy
5379303|NCT01815671|technique|technique
5379304|NCT01815671|tilt|tilt
5379305|NCT01815671|insertion|insertion
5379306|NCT01815671|safety|safety
5379307|NCT01815671|efficacy|efficacy
5379308|NCT01815645|Cocaine related disorders|cocaine related disorders
5379309|NCT01815645|Contingency Management|contingency management
5379310|NCT01815645|psychosocial treatment|psychosocial treatment
5379311|NCT01815632|multiple sclerosis|multiple sclerosis
5379312|NCT01815632|progressive MS|progressive ms
5379313|NCT01815632|stem cell|stem cell
5379314|NCT01815632|cell therapy|cell therapy
5379315|NCT01815632|neurodegeneration|neurodegeneration
5379316|NCT01815632|CNS repair|cns repair
5379328|NCT01815580|Seek, Test, Treat, Retain Strategies|seek, test, treat, retain strategies
5379329|NCT01815567|Hypertension|hypertension
5379330|NCT01815567|Retinal Disorder|retinal disorder
5379331|NCT01815567|Cognitive impairment|cognitive impairment
5379333|NCT01815554|Spinal Cord Injury|spinal cord injury
5379334|NCT01815554|Ventilator|ventilator
5379335|NCT01815554|Diaphragmatic Pacing System|diaphragmatic pacing system
5379336|NCT01815541|subcutaneous teicoplanin|subcutaneous teicoplanin
5379337|NCT01815541|osteoarticular|osteoarticular
5379338|NCT01815541|infections|infections
5379339|NCT01815541|tolerance|tolerance
5379340|NCT01815541|teicoplanin|teicoplanin
5379341|NCT01815528|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5379342|NCT01815515|Metastatic Prostate Cancer|metastatic prostate cancer
5379343|NCT01815502|Single ventricle|single ventricle
5379344|NCT01815502|Fontan|fontan
5379345|NCT01815502|Sildenafil|sildenafil
5379346|NCT01815502|Pressure-Volume Loops|pressure-volume loops
5379347|NCT01815489|Necrotizing Pancreatitis|necrotizing pancreatitis
5379348|NCT01815489|Pancreatitis|pancreatitis
5379349|NCT01815489|Infection|infection
5379350|NCT01815489|Bacteria|bacteria
5379351|NCT01815489|Microbiology|microbiology
5379352|NCT01815476|DCIS|dcis
5379353|NCT01815476|Early Stage Invasive breast cancer|early stage invasive breast cancer
5379354|NCT01815476|Prone breast radiotherapy|prone breast radiotherapy
5379355|NCT01815463|stool|stool
5379356|NCT01815463|monoclonal antibody|monoclonal antibody
5379357|NCT01815463|Adnab-9|adnab-9
5379358|NCT01815463|FOBT|fobt
5379359|NCT01815463|FIT|fit
5379360|NCT01815463|iFOBT|ifobt
5379361|NCT01815463|colonoscopy|colonoscopy
5379362|NCT01815463|barium enema|barium enema
5379363|NCT01815463|flexible sigmoidoscopy|flexible sigmoidoscopy
5379364|NCT01815424|Tofacitinib|tofacitinib
5379365|NCT01815424|CP-690|cp-690
5379366|NCT01815424|550|550
5379367|NCT01815424|Xeljanz|xeljanz
5379368|NCT01815424|Jak-Inhibitor|jak-inhibitor
5379369|NCT01815424|Oral Treatment|oral treatment
5379370|NCT01815424|Psoriasis vulgaris|psoriasis vulgaris
5379371|NCT01815424|Pruritus|pruritus
5379372|NCT01815424|Itch|itch
5379373|NCT01815424|DLQI|dlqi
5379374|NCT01815424|moderate|moderate
5379375|NCT01815424|severe|severe
5379376|NCT01815424|chronic|chronic
5379377|NCT01815424|plaque psoriasis|plaque psoriasis
5379378|NCT01815411|Rheumatoid arthritis|rheumatoid arthritis
5379386|NCT01815411|Indication for Modification of Patient Physical Status|indication for modification of patient physical status
5379388|NCT01815385|Environmental exposure|environmental exposure
5379390|NCT01815385|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
5379391|NCT01815385|Adiposity|adiposity
5379392|NCT01815385|Cytosine methylation|cytosine methylation
5379393|NCT01815372|nerve blocks|nerve blocks
5379394|NCT01815372|ultrasound-guided|ultrasound-guided
5379395|NCT01815372|leg surgery|leg surgery
5379404|NCT01815346|Breast Cancer|breast cancer
5379405|NCT01815346|Breast cancer survivors|breast cancer survivors
5379406|NCT01815346|Chronic, taxane-based chemotherapy-induced peripheral neuropathy|chronic, taxane-based chemotherapy-induced peripheral neuropathy
5379407|NCT01815346|CIPN|cipn
5379408|NCT01815346|Acupuncture treatments|acupuncture treatments
5379409|NCT01815346|Quality of life|quality of life
5379410|NCT01815346|Hand function|hand function
5379411|NCT01815346|Balance|balance
5379412|NCT01815346|Questionnaires|questionnaires
5379413|NCT01815346|Surveys|surveys
5379414|NCT01815333|Cancer of Lymph Node|cancer of lymph node
5379415|NCT01815333|Magnetic resonance imaging|magnetic resonance imaging
5379416|NCT01815333|MRI|mri
5379417|NCT01815333|Ultrasuperparamagnetic nanoparticle iron oxide|ultrasuperparamagnetic nanoparticle iron oxide
5379418|NCT01815333|USPIO|uspio
5379419|NCT01815333|Feraheme|feraheme
5379420|NCT01815333|Ferumoxytole|ferumoxytole
5379421|NCT01815320|Renal Transplant|renal transplant
5379422|NCT01815320|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5379423|NCT01815320|Acute allograft rejection|acute allograft rejection
5379424|NCT01815294|Ovarian cancer|ovarian cancer
5379426|NCT01815294|Solid malignancy|solid malignancy
5379427|NCT01815294|Advanced or refractory solid malignancy|advanced or refractory solid malignancy
5379428|NCT01815294|Metastatic cancer|metastatic cancer
5379430|NCT01815294|Doxorubicin HCL|doxorubicin hcl
5379431|NCT01815294|Bioequivalence|bioequivalence
5379432|NCT01815268|Randomized Controlled Trial|randomized controlled trial
5379434|NCT01815268|Influenza vaccine|influenza vaccine
5379435|NCT01815268|Flu Vaccine|flu vaccine
5379436|NCT01815268|Fluzone|fluzone
5379437|NCT01815268|HD Fluzone|hd fluzone
5379439|NCT01815268|Hospitalization|hospitalization
5379440|NCT01815268|Mortality|mortality
5379441|NCT01815268|Health Care worker vaccination|health care worker vaccination
5379442|NCT01815268|ADL decline|adl decline
5379443|NCT01815268|Effectiveness|effectiveness
5379444|NCT01815268|Elderly|elderly
5379445|NCT01815268|Morbidity|morbidity
5379446|NCT01815268|Nursing Home resident|nursing home resident
5379447|NCT01815268|Frail|frail
5379448|NCT01815268|Institutionalized|institutionalized
5379449|NCT01815268|Epidemiology|epidemiology
5379450|NCT01815268|CDC|cdc
5379451|NCT01815268|US|us
5379452|NCT01815268|city|city
5379453|NCT01815255|TDF-based regimen|tdf-based regimen
5379454|NCT01815255|HIV-infected children|hiv-infected children
5379455|NCT01815255|Thai|thai
5379456|NCT01815255|generic|generic
5379457|NCT01815255|safety and efficacy|safety and efficacy
5379458|NCT01815255|renal status|renal status
5379459|NCT01815255|To assess effect of TDF on renal problem in HIV-infected children receiving TDF-based once daily regimen|to assess effect of tdf on renal problem in hiv-infected children receiving tdf-based once daily regimen
5379460|NCT01815255|To compare the effectiveness and clinical usefulness of different tools of adherence|to compare the effectiveness and clinical usefulness of different tools of adherence
5379461|NCT01815229|endotracheal|endotracheal
5379462|NCT01815229|intubation|intubation
5379463|NCT01815216|Bariatric surgery|bariatric surgery
5379464|NCT01815216|Cognition|cognition
5379465|NCT01815216|Satiety hormones|satiety hormones
5379466|NCT01815216|Brain networks|brain networks
5379467|NCT01815216|Inhibitory control|inhibitory control
5379468|NCT01815216|Food intake|food intake
5379469|NCT01815203|Caffeine effects|caffeine effects
5379470|NCT01815203|Inhibitory control|inhibitory control
5379471|NCT01815190|immune complex vasculitis|immune complex vasculitis
5379472|NCT01815190|cutaneous vasculitis|cutaneous vasculitis
5379473|NCT01815190|IgA vasculitis|iga vasculitis
5379474|NCT01815190|IgA nephropathy|iga nephropathy
5379764|NCT01813695|Scoliosis|scoliosis
5379475|NCT01815138|OHSS, GnRH agonist trigger, low dose hCG, PCOS, IVF|ohss, gnrh agonist trigger, low dose hcg, pcos, ivf
5379476|NCT01815125|Mild traumatic brain injury|mild traumatic brain injury
5379477|NCT01815125|Brain concussion|brain concussion
5379478|NCT01815125|Post-concussion syndrome|post-concussion syndrome
5379479|NCT01815125|Emergency department|emergency department
5379480|NCT01815125|Ondansetron|ondansetron
5379481|NCT01815112|Neurodegenerative disease|neurodegenerative disease
5379482|NCT01815112|Elderly|elderly
5379483|NCT01815112|Dementia|dementia
5379484|NCT01815112|FDG-PET|fdg-pet
5379485|NCT01815112|MRI|mri
5379486|NCT01815112|Neuroimaging|neuroimaging
5379487|NCT01815086|Radioimmunoimaging|radioimmunoimaging
5379488|NCT01815086|AL Amyloidosis|al amyloidosis
5379489|NCT01815086|PET/CT|pet/ct
5379490|NCT01815047|Vitamin D|vitamin d
5379491|NCT01815047|Pregnancy|pregnancy
5379492|NCT01815047|Inflammation|inflammation
5379493|NCT01815047|Infection|infection
5379494|NCT01815047|Placenta|placenta
5379495|NCT01815047|Cytokine|cytokine
5379496|NCT01815047|Microbiome|microbiome
5379497|NCT01815008|Platelet aggregation|platelet aggregation
5379498|NCT01815008|Clopidogrel|clopidogrel
5379499|NCT01815008|Platelet transcriptome|platelet transcriptome
5379500|NCT01814995|behavioural|behavioural
5379501|NCT01814995|diabetes prevention|diabetes prevention
5379502|NCT01814995|overweight|overweight
5379503|NCT01814995|physical activity|physical activity
5379504|NCT01814995|gestational diabetes|gestational diabetes
5379505|NCT01814982|Traumatic brain injury|traumatic brain injury
5379506|NCT01814982|JNJ-17299425|jnj-17299425
5379507|NCT01814982|Intracranial pressure|intracranial pressure
5379508|NCT01814982|Intravascular bolus injection|intravascular bolus injection
5379509|NCT01814969|Rectal neoplasm|rectal neoplasm
5379510|NCT01814969|Preoperative hyperfractionated radiotherapy|preoperative hyperfractionated radiotherapy
5379511|NCT01814969|Preoperative hyperfractionated radiochemotherapy|preoperative hyperfractionated radiochemotherapy
5379512|NCT01814943|Uncomplicated peptic ulcer|uncomplicated peptic ulcer
5379513|NCT01814943|Acid-suppressing drugs|acid-suppressing drugs
5379514|NCT01814943|Epidemiology|epidemiology
5379515|NCT01814891|vitamin A|vitamin a
5379516|NCT01814891|maize|maize
5379517|NCT01814891|total body reserves|total body reserves
5379518|NCT01814891|Condition is vitamin A status.|condition is vitamin a status.
5379519|NCT01814891|Focus: change in vitamin A status with maize feeding.|focus: change in vitamin a status with maize feeding.
5374904|NCT01835951|Simulation|simulation
5379522|NCT01814878|Pain, Postoperative|pain, postoperative
5379523|NCT01814878|Tramadol Hydrochloride|tramadol hydrochloride
5379524|NCT01814878|Acetaminophen|acetaminophen
5379526|NCT01814865|Post-menopausal|post-menopausal
5379528|NCT01814865|Stage I-IIIA|stage i-iiia
5379529|NCT01814865|Operable|operable
5379530|NCT01814865|Breast Cancer|breast cancer
5379531|NCT01814852|Low Intensity Shockwave|low intensity shockwave
5379532|NCT01814852|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
5379533|NCT01814852|Erectile dysfunction|erectile dysfunction
5379534|NCT01814839|RNAi therapeutic|rnai therapeutic
5379536|NCT01814826|Acute|acute
5379537|NCT01814826|Myelogenous|myelogenous
5379538|NCT01814826|Leukemia|leukemia
5379539|NCT01814800|PIDD, PID, humoral immunity, antibody deficiency|pidd, pid, humoral immunity, antibody deficiency
5379540|NCT01814787|Type 2 Diabetes|type 2 diabetes
5379541|NCT01814787|Pediatrics|pediatrics
5379542|NCT01814787|Computerized Decision Support System|computerized decision support system
5379543|NCT01814748|Diabetes Mellitus|diabetes mellitus
5379544|NCT01814748|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5379545|NCT01814748|Glucose Metabolism Disorders|glucose metabolism disorders
5379546|NCT01814748|Metabolic Diseases|metabolic diseases
5379547|NCT01814748|Endocrine System Diseases|endocrine system diseases
5379548|NCT01814748|Metformin|metformin
5379549|NCT01814748|Hypoglycemic Agents|hypoglycemic agents
5379550|NCT01814748|Pharmacologic Actions|pharmacologic actions
5379551|NCT01814748|Therapeutic Uses|therapeutic uses
5379552|NCT01814722|HIV Infections|hiv infections
5379553|NCT01814722|Anti-HIV Agents|anti-hiv agents
5379554|NCT01814722|Anti-Retroviral Agents|anti-retroviral agents
5379555|NCT01814722|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
5379556|NCT01814722|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5379557|NCT01814722|Protease inhibitors|protease inhibitors
5379558|NCT01814696|Heart Failure|heart failure
5379559|NCT01814696|Congestive Heart Failure|congestive heart failure
5379560|NCT01814696|Medication Adherence|medication adherence
5379561|NCT01814696|Medication Compliance|medication compliance
5379562|NCT01814696|Telemedicine|telemedicine
5379563|NCT01814696|Telehealth|telehealth
5379564|NCT01814683|Vivax malaria|vivax malaria
5379565|NCT01814683|Primaquine|primaquine
5379566|NCT01814683|Placebo|placebo
5379567|NCT01814683|Recurrence|recurrence
5379568|NCT01814657|Infertility|infertility
5379868|NCT01813136|TUTHYREF|tuthyref
5379569|NCT01814605|Sciatic Nerve Block|sciatic nerve block
5379570|NCT01814605|Subgluteal space|subgluteal space
5379571|NCT01814605|Infragluteal space|infragluteal space
5379572|NCT01814592|coronally positioned flap|coronally positioned flap
5379573|NCT01814592|connective tissue|connective tissue
5379574|NCT01814592|gingival margin|gingival margin
5379575|NCT01814592|gingival recession/ treatment|gingival recession/ treatment
5002882|NCT03978039|access to care|access to care
5379576|NCT01814592|gingival recession/ surgery|gingival recession/ surgery
5379577|NCT01814592|subepithelial connective tissue graft|subepithelial connective tissue graft
5379578|NCT01814592|randomized controlled clinical trial|randomized controlled clinical trial
5379579|NCT01814592|surgical flaps|surgical flaps
5379580|NCT01814592|Treatment outcome|treatment outcome
5379581|NCT01814579|vaginal|vaginal
5379582|NCT01814579|cuff|cuff
5379583|NCT01814579|robotic|robotic
5379584|NCT01814579|hysterectomy|hysterectomy
5379585|NCT01814579|vloc|vloc
5379586|NCT01814579|v-loc|v-loc
5379587|NCT01814579|vicryl|vicryl
5379588|NCT01814579|unidirectional|unidirectional
5379589|NCT01814579|barbed|barbed
5379590|NCT01814579|suture|suture
5379591|NCT01814527|Fish oil|fish oil
5379592|NCT01814527|Omega 3 Fatty acids|omega 3 fatty acids
5379593|NCT01814527|Docosahexaenoic acid|docosahexaenoic acid
5379594|NCT01814527|Mild Concussion|mild concussion
5379595|NCT01814527|Brain Concussion|brain concussion
5379596|NCT01814527|Cerebral Concussion|cerebral concussion
5379597|NCT01814514|hypertensive|hypertensive
5379598|NCT01814514|phase|phase
5379599|NCT01814514|success rate|success rate
5379600|NCT01814514|AGV|agv
5379601|NCT01814501|Metastatic colon cancer|metastatic colon cancer
5379602|NCT01814488|Active acute leukemia|active acute leukemia
5379603|NCT01814488|PIF|pif
5379604|NCT01814488|Allogeneic transplant|allogeneic transplant
5379605|NCT01814488|Acute Myeloid Leukemia|acute myeloid leukemia
5379606|NCT01814488|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5379607|NCT01814488|Marrow Unrelated Donor|marrow unrelated donor
5379608|NCT01814488|Cord Blood|cord blood
5379609|NCT01814488|Family Haploidentical donor|family haploidentical donor
5379610|NCT01814475|myelofibrosis|myelofibrosis
5379611|NCT01814475|unfavourable prognostic factors|unfavourable prognostic factors
5379614|NCT01814475|thrombocythemia vera|thrombocythemia vera
5379615|NCT01814475|polycythemia vera|polycythemia vera
5379616|NCT01814475|Reduced-intensity conditioning|reduced-intensity conditioning
5379617|NCT01814462|Obstructive Sleep Apnea|obstructive sleep apnea
5379618|NCT01814462|Pulse wave analysis|pulse wave analysis
5379619|NCT01814449|Breast cancer|breast cancer
5379621|NCT01814449|Hypoxia related gene|hypoxia related gene
5379622|NCT01814449|Endocrine therapy|endocrine therapy
5379623|NCT01814449|Treatment resistance|treatment resistance
5379624|NCT01814423|Plasmodium falciparum|plasmodium falciparum
5379626|NCT01814423|chloroquine|chloroquine
5379627|NCT01814423|pharmacokinetic|pharmacokinetic
5379628|NCT01814423|children|children
5379629|NCT01814410|Intravenous Ethanol|intravenous ethanol
5379630|NCT01814410|Intravenous Nicotine|intravenous nicotine
5379631|NCT01814410|Interactive effects|interactive effects
5379632|NCT01814410|cognition|cognition
5379633|NCT01814410|subjective effects|subjective effects
5379634|NCT01814410|healthy subjects|healthy subjects
5379635|NCT01814397|Aromatase inhibitor|aromatase inhibitor
5379636|NCT01814397|Pain threshold|pain threshold
5379637|NCT01814384|Ancillary tailored|ancillary tailored
5379638|NCT01814384|medico-economic study,|medico-economic study,
5379639|NCT01814384|total knee replacement|total knee replacement
5379640|NCT01814384|primary or secondary osteoarthritis|primary or secondary osteoarthritis
5379641|NCT01814371|Abscesses|abscesses
5379642|NCT01814371|Furunculosis|furunculosis
5379643|NCT01814371|Staphylococcus aureus colonization|staphylococcus aureus colonization
5379644|NCT01814371|Staphylococcal Skin Infection|staphylococcal skin infection
5379645|NCT01814371|MRSA|mrsa
5379646|NCT01814345|Her2 testing (Human Epidermal Growth Factor Receptor 2)|her2 testing (human epidermal growth factor receptor 2)
5379647|NCT01814332|Stress disorders, Post-traumatic|stress disorders, post-traumatic
5379648|NCT01814332|Sleep|sleep
5379649|NCT01814319|heart failure|heart failure
5379650|NCT01814319|ejection fraction equal or less than 40%|ejection fraction equal or less than 40%
5379651|NCT01814306|LMA Supreme,LMA Proseal,airway management,prone position|lma supreme,lma proseal,airway management,prone position
5379652|NCT01814293|Pediatric|pediatric
5379653|NCT01814293|Upper Respiratory infection|upper respiratory infection
5379654|NCT01814293|Over the Counter Drugs|over the counter drugs
5379655|NCT01814293|Drugs, Non-Prescription|drugs, non-prescription
5379656|NCT01814293|Vaporizer|vaporizer
5379657|NCT01814280|Medication errors|medication errors
5379658|NCT01814280|Medication review|medication review
5379659|NCT01814280|Risk stratification|risk stratification
5379660|NCT01814280|Patient safety|patient safety
5379661|NCT01814267|innovative care|innovative care
5379662|NCT01814267|telemedicine|telemedicine
5379663|NCT01814267|cost effectiveness|cost effectiveness
5379664|NCT01814267|diabetes|diabetes
5379665|NCT01814241|Peanut allergy|peanut allergy
5379666|NCT01814215|Obesity|obesity
5379667|NCT01814215|Prevention and Control|prevention and control
5379668|NCT01814215|Diet|diet
5379669|NCT01814215|Motor Activity|motor activity
5379670|NCT01814215|Intervention Studies|intervention studies
5379671|NCT01814215|Child, Preschool|child, preschool
5379672|NCT01814215|Child Care|child care
5379673|NCT01814215|Food Habits|food habits
5002883|NCT03978039|survival|survival
5379674|NCT01814215|Feeding Behavior|feeding behavior
5379675|NCT01814215|Child Behavior|child behavior
5379676|NCT01814163|First line treatment|first line treatment
5379677|NCT01814163|Non small cell lung cancer, non squamous|non small cell lung cancer, non squamous
5379678|NCT01814150|Docetaxel|docetaxel
5379679|NCT01814150|Alpha 1 Acid Glycoprotein|alpha 1 acid glycoprotein
5379680|NCT01814150|Outcome|outcome
5379681|NCT01814111|Hypertension|hypertension
5379682|NCT01814111|Atrial Fibrillation|atrial fibrillation
5379683|NCT01814111|Arrhythmias, Cardiac|arrhythmias, cardiac
5379684|NCT01814111|Heart Diseases|heart diseases
5379685|NCT01814111|Cardiovascular Diseases|cardiovascular diseases
5379686|NCT01814098|Depressive Disorder, Major|depressive disorder, major
5379687|NCT01814098|Escitalopram|escitalopram
5379688|NCT01814098|Lexapro|lexapro
5379689|NCT01814085|Major Depressive Disorder|major depressive disorder
5379690|NCT01814085|Escitalopram|escitalopram
5379691|NCT01814085|Lexapro|lexapro
5379692|NCT01814059|Sirolimus|sirolimus
5379693|NCT01814059|Eosinophilic Esophagitis|eosinophilic esophagitis
5379694|NCT01814059|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5379695|NCT01814059|T -Cells|t -cells
5379696|NCT01814059|Food Allergy|food allergy
5379697|NCT01814046|Metastatic|metastatic
5379698|NCT01814046|Ocular Melanoma|ocular melanoma
5379699|NCT01814046|Autologous Tumor-Infiltrating Lymphocytes|autologous tumor-infiltrating lymphocytes
5379700|NCT01814046|Uveal Melanoma|uveal melanoma
5379701|NCT01814046|Adoptive Cell Therapy|adoptive cell therapy
5379702|NCT01814033|LRU|lru
5379703|NCT01814033|Total Knee Arthroplasty|total knee arthroplasty
5383354|NCT01797562|Eczema|eczema
5379704|NCT01814033|Total Knee Replacement|total knee replacement
5379705|NCT01814033|Acute Rehabilitation Total Knee|acute rehabilitation total knee
5379706|NCT01814033|Total Knee Range of Motion|total knee range of motion
5379707|NCT01814033|Total Knee Acute care Outcomes|total knee acute care outcomes
5379708|NCT01814020|DSO|dso
5379709|NCT01814007|Lipolysis|lipolysis
5379710|NCT01814007|Cryolipolysis|cryolipolysis
5379711|NCT01814007|Fat Reduction|fat reduction
5379712|NCT01813994|Statin; Gastric inflammation; Gastric cancer|statin; gastric inflammation; gastric cancer
5379713|NCT01813968|Ischemic postconditioning|ischemic postconditioning
5379714|NCT01813968|Adult cardiac surgery|adult cardiac surgery
5379715|NCT01813968|Aortic valve surgery|aortic valve surgery
5379716|NCT01813968|Swan-Ganz|swan-ganz
5379717|NCT01813968|Cardiac index|cardiac index
5379718|NCT01813955|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5379719|NCT01813955|Psychophysiology|psychophysiology
5379720|NCT01813955|Cognition|cognition
5379721|NCT01813955|Schizophrenia|schizophrenia
5379722|NCT01813955|Papaverine|papaverine
5379723|NCT01813942|clinical narrative report|clinical narrative report
5379724|NCT01813942|time series data|time series data
5379725|NCT01813942|missing value|missing value
5379726|NCT01813929|Diabetes|diabetes
5379727|NCT01813929|Insulin|insulin
5379728|NCT01813929|Metformin|metformin
5379729|NCT01813929|Vascular|vascular
5379730|NCT01813929|Vessels|vessels
5379731|NCT01813929|Type 1|type 1
5379732|NCT01813916|Osteoarthritis|osteoarthritis
5379733|NCT01813916|synovial fluid|synovial fluid
5379734|NCT01813916|hyaluronic acid|hyaluronic acid
5379735|NCT01813890|Bunionectomy|bunionectomy
5379736|NCT01813890|Acute pain|acute pain
5379737|NCT01813890|Post-operative pain|post-operative pain
5379738|NCT01813890|Tapentadol IR|tapentadol ir
5379739|NCT01813890|Analgesia|analgesia
5379740|NCT01813890|Hallux valgus|hallux valgus
5379741|NCT01813864|treatment planning|treatment planning
5379742|NCT01813864|resource guide|resource guide
5379743|NCT01813864|service matching|service matching
5379744|NCT01813864|Service matching for substance abuse clients|service matching for substance abuse clients
5379745|NCT01813864|CASPAR resource guide|caspar resource guide
5379746|NCT01813864|Improved treatment planning|improved treatment planning
5379747|NCT01813851|Dialysis, Exercise, Protein Energy Wasting, Nutrition and Physical Fitness|dialysis, exercise, protein energy wasting, nutrition and physical fitness
5379748|NCT01813825|Mammosite|mammosite
5379749|NCT01813799|Diabetic Neuropathies|diabetic neuropathies
5379750|NCT01813734|RET gene mutation|ret gene mutation
5379751|NCT01813721|NHL|nhl
5379752|NCT01813721|Breast Cancer|breast cancer
5379753|NCT01813721|Lung Cancer|lung cancer
5379754|NCT01813708|Type 2 Diabetes|type 2 diabetes
5379755|NCT01813708|Intensive Life-Style|intensive life-style
5379756|NCT01813708|Collaborative Education|collaborative education
5379757|NCT01813708|Clinical Trial|clinical trial
5379758|NCT01813708|Metabolic Control|metabolic control
5379759|NCT01813695|Preemptive genetic testing|preemptive genetic testing
5379760|NCT01813695|Pain|pain
5379761|NCT01813695|Pediatrics|pediatrics
5379762|NCT01813695|Orthopedics|orthopedics
5379763|NCT01813695|Pectus excavatum|pectus excavatum
5379765|NCT01813682|preterm infant|preterm infant
5379766|NCT01813682|anemia|anemia
5379767|NCT01813682|iron fortified TPN|iron fortified tpn
5379768|NCT01813669|Childhood anxiety|childhood anxiety
5367328|NCT01869361|tocolysis|tocolysis
5379769|NCT01813669|Pediatric Pain|pediatric pain
5379770|NCT01813669|Yoga|yoga
5379771|NCT01813669|Cognitive behavioral therapy|cognitive behavioral therapy
5379772|NCT01813656|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
5379773|NCT01813656|Aripiprazole|aripiprazole
5379774|NCT01813643|Methamphetamine-Associated Psychosis|methamphetamine-associated psychosis
5379775|NCT01813643|Aripiprazole|aripiprazole
5379776|NCT01813643|Risperidone|risperidone
5379777|NCT01813630|Turner's Syndrome|turner's syndrome
5379778|NCT01813630|Short Stature|short stature
5379779|NCT01813630|Dwarfism|dwarfism
5379780|NCT01813617|Polymyositis|polymyositis
5379781|NCT01813617|Dermatomyositis|dermatomyositis
5379782|NCT01813617|Muscle endurance|muscle endurance
5379783|NCT01813617|Muscle stength|muscle stength
5379784|NCT01813617|Outcome|outcome
5379785|NCT01813604|Polio|polio
5379786|NCT01813604|Inactivated polio vaccine|inactivated polio vaccine
5379787|NCT01813604|oral polio vaccine|oral polio vaccine
5379788|NCT01813604|vaccine trial|vaccine trial
5379789|NCT01813591|Chronic Migraine|chronic migraine
5379790|NCT01813591|Headache|headache
5379791|NCT01813591|Refractory Chronic Migraine|refractory chronic migraine
5379792|NCT01813578|Systemic sclerosis|systemic sclerosis
5379793|NCT01813578|Exercise|exercise
5379794|NCT01813578|Physical capacity|physical capacity
5379795|NCT01813578|Aerobic capacity|aerobic capacity
5379796|NCT01813578|Muscle function|muscle function
5379797|NCT01813578|Fatigue|fatigue
5379798|NCT01813552|HCV|hcv
5379799|NCT01813552|Hepatitis C|hepatitis c
5379800|NCT01813552|antiviral drugs|antiviral drugs
5379801|NCT01813552|liver|liver
5379802|NCT01813539|malignancy|malignancy
5379803|NCT01813513|HCV|hcv
5379804|NCT01813513|Hepatitis C Virus|hepatitis c virus
5379805|NCT01813513|Hepatitis C|hepatitis c
5379807|NCT01813513|liver|liver
5379808|NCT01813474|Cancer|cancer
5379809|NCT01813474|Tumour|tumour
5379810|NCT01813474|Solid Malignancies|solid malignancies
5379811|NCT01813461|BAL8557|bal8557
5379812|NCT01813461|14C-labeled isavuconazole|14c-labeled isavuconazole
5379813|NCT01813461|14C-labeled prodrug isavuconazonium sulfate (BAL8557)/([cyano-14C]ASP9766 sulfate)|14c-labeled prodrug isavuconazonium sulfate (bal8557)/([cyano-14c]asp9766 sulfate)
5379814|NCT01813448|Fidaxomicin|fidaxomicin
5379815|NCT01813448|OPT-80|opt-80
5379816|NCT01813448|Healthy Subjects|healthy subjects
5379817|NCT01813435|CAD|cad
5379818|NCT01813435|ACS|acs
5379819|NCT01813435|All comers|all comers
5379820|NCT01813435|DAPT|dapt
5379821|NCT01813435|PCI|pci
5379822|NCT01813422|Cholesterol|cholesterol
5379823|NCT01813422|High Cholesterol|high cholesterol
5379824|NCT01813422|Elevated Cholesterol|elevated cholesterol
5379825|NCT01813422|Raised Cholesterol|raised cholesterol
5379826|NCT01813396|shoulder|shoulder
5379827|NCT01813396|muscle stiffness|muscle stiffness
5379828|NCT01813396|shoulder physical activity|shoulder physical activity
5379829|NCT01813396|range of motion|range of motion
5379830|NCT01813396|joint mobility|joint mobility
5379831|NCT01813383|Celiac disease|celiac disease
5379832|NCT01813383|HLA-DQ2.2|hla-dq2.2
5379833|NCT01813383|HLA-DQ2.5|hla-dq2.5
5379834|NCT01813383|HLA-DR7-DQ2|hla-dr7-dq2
5379835|NCT01813383|HLA-DR3-DQ2|hla-dr3-dq2
5379836|NCT01813370|TAX 3503|tax 3503
5379837|NCT01813370|MSKCC IRB#07-101|mskcc irb#07-101
5379838|NCT01813370|12-225|12-225
5379839|NCT01813357|HIV|hiv
5379840|NCT01813357|Cardiovascular disease|cardiovascular disease
5379841|NCT01813357|Inflammation|inflammation
5379842|NCT01813357|Statin|statin
5379843|NCT01813344|Adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5379844|NCT01813344|Hyper-CVAD|hyper-cvad
5379845|NCT01813344|first-line treatment|first-line treatment
5379846|NCT01813305|Diabetic Foot Ulcer|diabetic foot ulcer
5379847|NCT01813305|Diabetes Mellitus|diabetes mellitus
5379848|NCT01813305|Debridement|debridement
5379849|NCT01813305|Standard of Care|standard of care
5379850|NCT01813305|wounds|wounds
5379851|NCT01813292|male patients|male patients
5379852|NCT01813292|treated by TRUVADA® or VIREAD® for more than 60 months|treated by truvada® or viread® for more than 60 months
5379853|NCT01813253|epidermal growth factor receptor|epidermal growth factor receptor
5379854|NCT01813253|second line|second line
5379855|NCT01813214|melanoma|melanoma
5379856|NCT01813214|vemurafenib|vemurafenib
5379857|NCT01813214|cobitmetinib|cobitmetinib
5379858|NCT01813201|Testosterone|testosterone
5379859|NCT01813201|Anabolic deterioration|anabolic deterioration
5379860|NCT01813188|Fractures|fractures
5379861|NCT01813188|Bone|bone
5379862|NCT01813188|Stem Cells|stem cells
5379863|NCT01813149|Complex Regional Pain Syndrome (CRPS)|complex regional pain syndrome (crps)
5379864|NCT01813136|radioiodine refractory Differentiated Thyroid Carcinoma|radioiodine refractory differentiated thyroid carcinoma
5379865|NCT01813136|pazopanib|pazopanib
5379866|NCT01813136|intermittent administration|intermittent administration
5379867|NCT01813136|time to treatment failure|time to treatment failure
5379869|NCT01813123|gender-specific|gender-specific
5379870|NCT01813123|web-based|web-based
5379871|NCT01813123|drug abuse|drug abuse
5379872|NCT01813123|prevention|prevention
5379873|NCT01813110|inflammation|inflammation
5379874|NCT01813110|omega-3|omega-3
5379875|NCT01813110|fish oil|fish oil
5379876|NCT01813097|To detective the effect of the treatment of combination iodine 125 seed implants and LHRH agonists for the patients with locally advanced prostate cancer.|to detective the effect of the treatment of combination iodine 125 seed implants and lhrh agonists for the patients with locally advanced prostate cancer.
5379877|NCT01813071|Enterobacteriaceae Infections|enterobacteriaceae infections
5379878|NCT01813071|Gram-Negative Bacterial Infections|gram-negative bacterial infections
5379879|NCT01813071|Bacterial Infections|bacterial infections
5379880|NCT01813071|Gastroenteritis|gastroenteritis
5379881|NCT01813071|Gastrointestinal Diseases|gastrointestinal diseases
5379882|NCT01813071|Digestive System Diseases|digestive system diseases
5379883|NCT01813071|Intestinal Diseases|intestinal diseases
5379884|NCT01813071|Shigellosis|shigellosis
5379885|NCT01813058|Tranexamic acid, Blood loss|tranexamic acid, blood loss
5379886|NCT01813045|Angiogenesis|angiogenesis
5379887|NCT01813045|Fibrosis|fibrosis
5379888|NCT01813045|Myocardial Infarction|myocardial infarction
5379889|NCT01813045|Imaging|imaging
5379890|NCT01813045|CT-PET|ct-pet
5379891|NCT01813045|PET-CT|pet-ct
5379892|NCT01813045|Cardiac MRI|cardiac mri
5379893|NCT01813032|firefighters|firefighters
5379894|NCT01813032|police officers|police officers
5379895|NCT01813032|emergency service professionals|emergency service professionals
5379896|NCT01813032|myocardial infarction|myocardial infarction
5379897|NCT01813032|endothelial function|endothelial function
5379898|NCT01813032|thrombosis|thrombosis
5379899|NCT01813019|Obsessive compulsive disorder (OCD), obsessive fears, obsessions,|obsessive compulsive disorder (ocd), obsessive fears, obsessions,
5379900|NCT01813019|compulsions, OCD SSRI resistant|compulsions, ocd ssri resistant
5423328|NCT01616186|Renal Cell Carcinoma|renal cell carcinoma
5379905|NCT01812954|cost utility analysis|cost utility analysis
5379906|NCT01812954|cost effectiveness analysis|cost effectiveness analysis
5379907|NCT01812954|systemic treatment|systemic treatment
5379908|NCT01812941|burns|burns
5379909|NCT01812941|trauma|trauma
5379910|NCT01812928|Flexible Cystoscopy|flexible cystoscopy
5379911|NCT01812928|Pain control|pain control
5379912|NCT01812928|Diclofenac|diclofenac
5379913|NCT01812928|Non steroidal anti inflammatory drug|non steroidal anti inflammatory drug
5379914|NCT01812915|Cuff pressure|cuff pressure
5379915|NCT01812915|Cylindrical cuff|cylindrical cuff
5379916|NCT01812915|Endotracheal tube|endotracheal tube
5379917|NCT01812915|Nitrous oxide|nitrous oxide
5379918|NCT01812915|Tapered cuff|tapered cuff
5379919|NCT01812902|Prostate cancer|prostate cancer
5379920|NCT01812902|Prostate specific antigen|prostate specific antigen
5379921|NCT01812902|lymphadenectomy|lymphadenectomy
5379922|NCT01812902|Limited lymphadenectomy|limited lymphadenectomy
5379923|NCT01812902|Extended lymphadenectomy|extended lymphadenectomy
5379924|NCT01812902|Immunohistochemistry|immunohistochemistry
5363183|NCT01887873|cataract|cataract
5379925|NCT01812889|bacterial vaginosis, vulvovaginal candidiasis, TOL-463, intravaginal therapy, vaginitis, women, cross-over|bacterial vaginosis, vulvovaginal candidiasis, tol-463, intravaginal therapy, vaginitis, women, cross-over
5379926|NCT01812863|Pain Management|pain management
5379927|NCT01812863|Child|child
5379928|NCT01812863|Surgery|surgery
5379929|NCT01812850|Temporomandibular joint|temporomandibular joint
5379930|NCT01812850|Orofacial muscular complex|orofacial muscular complex
5379931|NCT01812850|Bruxism|bruxism
5379932|NCT01812850|Clenching|clenching
5379933|NCT01812850|Orthodontic treatment|orthodontic treatment
5379934|NCT01812850|Invisalign®|invisalign®
5379935|NCT01812837|actinic keratosis|actinic keratosis
5379936|NCT01812837|microneedles|microneedles
5379937|NCT01812837|photodynamic therapy|photodynamic therapy
5379938|NCT01812837|levulan|levulan
5379939|NCT01812837|Aminolevulinic acid|aminolevulinic acid
5379940|NCT01812824|Preconception Health|preconception health
5379941|NCT01812824|Health Information Technology|health information technology
5379942|NCT01812824|Reproductive Life Plan|reproductive life plan
5379943|NCT01812824|Healthcare Disparities|healthcare disparities
5379944|NCT01812824|Low birth-weight|low birth-weight
5379945|NCT01812824|Preterm Delivery|preterm delivery
5379946|NCT01812811|pulse wave analysis|pulse wave analysis
5379947|NCT01812811|pulse wave velocity|pulse wave velocity
5379948|NCT01812811|Arteriograph24|arteriograph24
5379949|NCT01812811|Ambulatory|ambulatory
5379950|NCT01812811|diabetes|diabetes
5379951|NCT01812811|reproducibility|reproducibility
5379952|NCT01812811|diurnal variation|diurnal variation
5379953|NCT01812798|Peanut allergy|peanut allergy
5379954|NCT01812798|Threshold|threshold
5379955|NCT01812798|Modelling|modelling
5379956|NCT01812798|Risk assessment|risk assessment
5379957|NCT01812785|Fever|fever
5379958|NCT01812785|Children|children
5379959|NCT01812785|Non-malaria fevers|non-malaria fevers
5379960|NCT01812785|Diagnosis|diagnosis
5379961|NCT01812772|urinary stents|urinary stents
5379962|NCT01812772|ureteroscopy|ureteroscopy
5379963|NCT01812759|Pain|pain
5379964|NCT01812759|Breakthrough cancer pain|breakthrough cancer pain
5379965|NCT01812759|Emergency Department|emergency department
5379966|NCT01812759|ED|ed
5379967|NCT01812759|Fentanyl nasal spray|fentanyl nasal spray
5379968|NCT01812759|Lazanda|lazanda
5379969|NCT01812759|Placebo nasal spray|placebo nasal spray
5379970|NCT01812759|Hydromorphone PCA|hydromorphone pca
5379971|NCT01812759|Dilaudid|dilaudid
5379972|NCT01812694|Pregnancy|pregnancy
5379973|NCT01812694|Weight Control|weight control
5379974|NCT01812694|Weight Gain|weight gain
5379975|NCT01812681|vitamin D, Respiratory distress syndrome, sepsis, preterm|vitamin d, respiratory distress syndrome, sepsis, preterm
5379976|NCT01812655|pain|pain
5379977|NCT01812655|anxiety|anxiety
5379978|NCT01812655|children|children
5379979|NCT01812655|adolescents|adolescents
5379980|NCT01812655|burn|burn
5379981|NCT01812655|virtual reality|virtual reality
5379982|NCT01812655|distraction|distraction
5379983|NCT01812642|Schizophrenia|schizophrenia
5379984|NCT01812642|JNJ-37822681|jnj-37822681
5379985|NCT01812642|Placebo|placebo
5379986|NCT01812616|Cancer|cancer
5379987|NCT01812616|Safety|safety
5379988|NCT01812603|Cancer|cancer
5379989|NCT01812603|Safety|safety
5379990|NCT01812564|Platelet rich plasma|platelet rich plasma
5379991|NCT01812564|Interventional|interventional
5379992|NCT01812564|Randomized|randomized
5379993|NCT01812564|Double-blind|double-blind
5423329|NCT01616173|Nerve Block|nerve block
5379995|NCT01812551|children|children
5379996|NCT01812551|adolescents|adolescents
5379997|NCT01812551|low bone mass|low bone mass
5379998|NCT01812551|osteoporosis|osteoporosis
5379999|NCT01812551|alendronate|alendronate
5380000|NCT01812551|fractures|fractures
5380001|NCT01812525|Bronchiolitis|bronchiolitis
5380002|NCT01812525|Moderate to Severe|moderate to severe
5380003|NCT01812525|Hypertonic saline|hypertonic saline
5380004|NCT01812525|NaCl 3% inhalations|nacl 3% inhalations
5380005|NCT01812525|Standard therapy|standard therapy
5380006|NCT01812525|Wang score|wang score
5380007|NCT01812525|in-patients|in-patients
5380008|NCT01812512|Heart Failure|heart failure
5380009|NCT01812512|Communication|communication
5380010|NCT01812512|Telemedicine|telemedicine
5380011|NCT01812512|Veterans|veterans
5380012|NCT01812512|Nurse-patient relations|nurse-patient relations
5380013|NCT01812499|blood transfusion|blood transfusion
5380014|NCT01812499|adverse event|adverse event
5380019|NCT01812473|hematology|hematology
5380020|NCT01812473|intensive care|intensive care
5380021|NCT01812473|albumin|albumin
5380022|NCT01812473|alpha-1-acid-glycoprotein|alpha-1-acid-glycoprotein
5380023|NCT01812460|COPD|copd
5380024|NCT01812460|muscle strength|muscle strength
5380025|NCT01812460|resistance training|resistance training
5380026|NCT01812460|Physiotherapi|physiotherapi
5380027|NCT01812460|m. quadriceps|m. quadriceps
5380028|NCT01812460|Acute exacerbation|acute exacerbation
5380029|NCT01812447|Endobronchial Valves|endobronchial valves
5380030|NCT01812447|Intrabronchial Valves|intrabronchial valves
5380031|NCT01812447|Bronchial Valve|bronchial valve
5380032|NCT01812447|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5380033|NCT01812447|COPD|copd
5380034|NCT01812447|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5380035|NCT01812447|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5380036|NCT01812447|BLVR|blvr
5380037|NCT01812447|TLVR|tlvr
5380038|NCT01812447|Emphysema|emphysema
5380039|NCT01812447|Pulmonary Emphysema|pulmonary emphysema
5380040|NCT01812447|Pathologic Process|pathologic process
5380041|NCT01812447|Lung Diseases|lung diseases
5380042|NCT01812447|Respiratory Tract Disease|respiratory tract disease
5380043|NCT01812395|thyroidectomy|thyroidectomy
5380044|NCT01812395|ultrasonic dissector|ultrasonic dissector
5380045|NCT01812395|harmonic focus device|harmonic focus device
5380046|NCT01812395|superior laryngeal nerve|superior laryngeal nerve
5380047|NCT01812382|Penetration|penetration
5380048|NCT01812382|Antibiotic|antibiotic
5380049|NCT01812382|Microdialysis|microdialysis
5380050|NCT01812382|Formulation Pharmacokinetics|formulation pharmacokinetics
5380051|NCT01812382|Feasibility|feasibility
5380052|NCT01812356|Atrial fibrillation|atrial fibrillation
5380053|NCT01812356|maze operation|maze operation
5380054|NCT01812356|cryoablation|cryoablation
5380055|NCT01812343|Ankle Brachial Index|ankle brachial index
5380056|NCT01812343|Maximal Exercise Test|maximal exercise test
5380059|NCT01812330|PCI|pci
5380060|NCT01812330|Platelet funtion|platelet funtion
5380061|NCT01812330|Ticagrelor|ticagrelor
5380062|NCT01812317|firefighters|firefighters
5380063|NCT01812317|fire-simulation training|fire-simulation training
5380064|NCT01812317|myocardial infarction|myocardial infarction
5380065|NCT01812317|endothelial function|endothelial function
5380072|NCT01812291|Light Affective Disorder|light affective disorder
5380073|NCT01812291|Subclinical Depressive Symptoms|subclinical depressive symptoms
5380074|NCT01812291|Diabetes Mellitus|diabetes mellitus
5380075|NCT01812291|Diabetes-Related Distress|diabetes-related distress
5380076|NCT01812291|Self-Care Behaviour|self-care behaviour
5380077|NCT01812291|Glycaemic Control|glycaemic control
5380078|NCT01812291|Inflammatory Markers|inflammatory markers
5380079|NCT01812252|myelodysplastic syndrome|myelodysplastic syndrome
5380080|NCT01812252|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5380081|NCT01812252|bone marrow transplant|bone marrow transplant
5380082|NCT01812252|hypomethylating agent|hypomethylating agent
5380083|NCT01812252|induction chemotherapy|induction chemotherapy
5380086|NCT01812239|short cervix|short cervix
5380087|NCT01812213|Mild Cognitive Impairment|mild cognitive impairment
5380088|NCT01812187|Alcohol|alcohol
5380089|NCT01812187|Alcohol Abuse|alcohol abuse
5380090|NCT01812187|Alcohol Dependence|alcohol dependence
5380091|NCT01812187|Veterans|veterans
5380092|NCT01812174|heart valve|heart valve
5380093|NCT01812161|Electro-acupuncture|electro-acupuncture
5380094|NCT01812161|HCG stimulation test|hcg stimulation test
5380095|NCT01812161|Menstrual frequency|menstrual frequency
5380096|NCT01812161|polycystic ovary syndrome|polycystic ovary syndrome
5380097|NCT01812161|Randomized|randomized
5380098|NCT01812161|controlled|controlled
5380099|NCT01812161|trial|trial
5380100|NCT01812148|Peritoneal Mesotheliomas|peritoneal mesotheliomas
5380101|NCT01812148|hyperthermic intra-peritoneal chemotherapy (HIPEC)|hyperthermic intra-peritoneal chemotherapy (hipec)
5380102|NCT01812148|Oxaliplatin|oxaliplatin
5380103|NCT01812148|Cytoreductive surgery|cytoreductive surgery
5380104|NCT01812148|Oxaliplatin HIPEC|oxaliplatin hipec
5380105|NCT01812109|Testicular Torsion|testicular torsion
5380106|NCT01812096|multiple myeloma|multiple myeloma
5380107|NCT01812096|bortezomib|bortezomib
5380108|NCT01812096|Subcutaneous|subcutaneous
5380109|NCT01812083|Periodontitis; adverse pregnancy outcomes; IL-1 polymorphism|periodontitis; adverse pregnancy outcomes; il-1 polymorphism
5380110|NCT01812070|smoking cessation|smoking cessation
5380111|NCT01812070|quit smoking|quit smoking
5380112|NCT01812057|Anesthesia|anesthesia
5380113|NCT01812057|Cesarean Section|cesarean section
5380114|NCT01812057|Pain, Postoperative|pain, postoperative
5375493|NCT01833143|KRAS-Mutant|kras-mutant
5380126|NCT01812005|B-cell Non Hodgkin Lymphoma|b-cell non hodgkin lymphoma
5380128|NCT01811979|eye examination, oral sucrose, premature infant pain scale|eye examination, oral sucrose, premature infant pain scale
5380129|NCT01811966|preoperative volume substitution|preoperative volume substitution
5380130|NCT01811966|hypovolemia|hypovolemia
5380131|NCT01811966|preoperative fasting|preoperative fasting
5380132|NCT01811940|cocaine dependence|cocaine dependence
5380133|NCT01811940|adderall|adderall
5380134|NCT01811940|topiramate|topiramate
5380135|NCT01811914|focused TTE|focused tte
5380136|NCT01811914|intraoperative TTE|intraoperative tte
5380137|NCT01811914|transthoracic echocardiography|transthoracic echocardiography
5380138|NCT01811914|high risk non-cardiac surgery|high risk non-cardiac surgery
5380139|NCT01811914|hemodynamic instabilities|hemodynamic instabilities
5380140|NCT01811901|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, SITS, SITS-WATCH, stroke registry|inhospital delays, door-to-needle time, thrombolysis, acute ischemic stroke, sits, sits-watch, stroke registry
5380141|NCT01811875|Haemophilia A|haemophilia a
5380145|NCT01811849|diabetes|diabetes
5363384|NCT01886950|CKD stage 5|ckd stage 5
5380146|NCT01811823|Tuberculosis|tuberculosis
5380147|NCT01811823|HIV infection|hiv infection
5380148|NCT01811823|Immune responses to Influenza vaccination|immune responses to influenza vaccination
5380149|NCT01811810|Men under the age of 75 with histologically confirmed high risk|men under the age of 75 with histologically confirmed high risk
5380150|NCT01811797|Erectile Dysfunction|erectile dysfunction
5380151|NCT01811797|Extracorporeal shockwave|extracorporeal shockwave
5380152|NCT01811797|Low intensity shockwaves|low intensity shockwaves
5380173|NCT01811745|Postural Balance|postural balance
5380174|NCT01811745|Randomized controlled trial|randomized controlled trial
5380175|NCT01811732|Bacterial skin infection|bacterial skin infection
5380176|NCT01811732|skin infection|skin infection
5380178|NCT01811732|skin|skin
5380179|NCT01811732|delafloxacin|delafloxacin
5380180|NCT01811732|vancomycin|vancomycin
5380181|NCT01811732|aztreonam|aztreonam
5380182|NCT01811732|MRSA bacteria|mrsa bacteria
5380183|NCT01811732|bacterial infection|bacterial infection
5380184|NCT01811732|Anti-Infective Agents|anti-infective agents
5380185|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents
5380186|NCT01811719|Intimate Partner Physical Violence|intimate partner physical violence
5380187|NCT01811719|Intimate Partner Emotional Abuse|intimate partner emotional abuse
5380188|NCT01811719|Intimate Partner Controlling Behaivor|intimate partner controlling behaivor
5380189|NCT01811719|Pregnancy Outcomes|pregnancy outcomes
5380190|NCT01811719|Quality of Parental Care Giving|quality of parental care giving
5380191|NCT01811719|Maternal Life Course|maternal life course
5380192|NCT01811693|Stroke|stroke
5380193|NCT01811693|Intracerebral Hemorrhage|intracerebral hemorrhage
5380194|NCT01811693|Prehospital|prehospital
5380195|NCT01811693|Antihypertensive|antihypertensive
5380196|NCT01811680|Stroke|stroke
5380197|NCT01811680|Hemiplegia|hemiplegia
5380198|NCT01811680|Variable automated treadmill treadmill|variable automated treadmill treadmill
5380199|NCT01811667|Vascular Abnormalities|vascular abnormalities
5380204|NCT01811641|season of conception|season of conception
5380205|NCT01811641|maternal nutritional status|maternal nutritional status
5380206|NCT01811641|infant DNA methylation|infant dna methylation
5380207|NCT01811628|Cancer Prevention|cancer prevention
5380208|NCT01811628|Tobacco Use Cessation|tobacco use cessation
5380209|NCT01811628|Smokers|smokers
5380210|NCT01811628|Recent quitters|recent quitters
5380211|NCT01811628|Latino|latino
5380212|NCT01811628|Hispanic|hispanic
5380213|NCT01811628|Information|information
5380214|NCT01811628|Interview|interview
5380215|NCT01811628|Questionnaire|questionnaire
5380216|NCT01811628|Survey|survey
5380217|NCT01811628|Audio-recorded|audio-recorded
5380218|NCT01811602|Training|training
5380219|NCT01811602|Physiotherapy|physiotherapy
5380220|NCT01811602|Pelvic floor muscles|pelvic floor muscles
5380221|NCT01811589|ventricular catheter, hydrocephalus, shunt, brain disease|ventricular catheter, hydrocephalus, shunt, brain disease
5380222|NCT01811576|Growth hormone deficiency|growth hormone deficiency
5380223|NCT01811576|Insulin-like growth factor I (IGF-I)|insulin-like growth factor i (igf-i)
5380225|NCT01811563|Total Knee Replacement|total knee replacement
5380226|NCT01811563|Lower Quarter Y-Balance Test|lower quarter y-balance test
5380227|NCT01811563|Functional Outcomes|functional outcomes
5380228|NCT01811563|Patient Reported Outcomes|patient reported outcomes
5380229|NCT01811537|Artificial Chordae|artificial chordae
5380230|NCT01811537|Mitral Valve Repair|mitral valve repair
5380231|NCT01811524|Brain tumor|brain tumor
5380233|NCT01811524|Meningioma|meningioma
5380234|NCT01811524|Diagnosis|diagnosis
5380235|NCT01811524|Prognosis|prognosis
5380236|NCT01811524|Heredity|heredity
5380237|NCT01811472|Multi-center,|multi-center,
5380238|NCT01811472|randomized,|randomized,
5380239|NCT01811472|double-blind,|double-blind,
5380241|NCT01811472|elevated triglycerides|elevated triglycerides
5380242|NCT01811459|Delirium|delirium
5380243|NCT01811459|ICU|icu
5380244|NCT01811459|Burn patients|burn patients
5491478|NCT01330927|BPH|bph
5380245|NCT01811459|Antipsychotics|antipsychotics
5380246|NCT01811459|Haloperidol|haloperidol
5380247|NCT01811459|Quetiapine|quetiapine
5380248|NCT01811433|Postoperative Period|postoperative period
5380249|NCT01811433|Anesthesia Recovery Period|anesthesia recovery period
5380250|NCT01811433|Postoperative Complications|postoperative complications
5380251|NCT01811433|Pulse Oximetry|pulse oximetry
5380252|NCT01811420|dental caries|dental caries
5380253|NCT01811420|caries removal|caries removal
5380254|NCT01811420|chemomechanical caries removal|chemomechanical caries removal
5380255|NCT01811394|sacral chordoma|sacral chordoma
5380256|NCT01811394|chordoma|chordoma
5380257|NCT01811394|carbon ion therapy|carbon ion therapy
5380258|NCT01811394|proton therapy|proton therapy
5380259|NCT01811394|hypofractionation|hypofractionation
5380260|NCT01811381|Alzheimer|alzheimer
5380261|NCT01811381|Prevention|prevention
5380262|NCT01811381|mild cognitive impairment|mild cognitive impairment
5380263|NCT01811381|physical exercise|physical exercise
5380264|NCT01811381|synergism|synergism
5380265|NCT01811381|curcumin|curcumin
5380266|NCT01811381|dietary supplement|dietary supplement
5380267|NCT01811381|anti-inflammatory|anti-inflammatory
5380268|NCT01811381|anti-tau|anti-tau
5380269|NCT01811381|subjective memory complaints without MCI|subjective memory complaints without mci
5380270|NCT01811381|plasma-exosomes|plasma-exosomes
5380271|NCT01811381|plasm- extracellular-derived-vesicles|plasm- extracellular-derived-vesicles
5380272|NCT01811355|Muscle cramps|muscle cramps
5380273|NCT01811355|Cramp|cramp
5380274|NCT01811355|ALS|als
5380275|NCT01811355|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5380276|NCT01811355|Lou Gehrig's disease|lou gehrig's disease
5380277|NCT01811355|Motor Neuron Disease|motor neuron disease
5380278|NCT01811355|MND|mnd
5380279|NCT01811342|Hemoglobin|hemoglobin
5380280|NCT01811342|Patient Monitoring|patient monitoring
5380281|NCT01811277|palliative chemotherapy|palliative chemotherapy
5380282|NCT01811277|ORR|orr
5380283|NCT01811277|PFS|pfs
5380284|NCT01811277|OS|os
5380285|NCT01811277|safety|safety
5380286|NCT01811277|advanced Biliary Tract Carcinoma|advanced biliary tract carcinoma
5380287|NCT01811264|Metastatic|metastatic
5380288|NCT01811264|Quality of life|quality of life
5380289|NCT01811264|Decision making|decision making
5380290|NCT01811251|Co-analgesia|co-analgesia
5380291|NCT01811251|Dexamethasone|dexamethasone
5380292|NCT01811251|Pregabalin|pregabalin
5380293|NCT01811251|Lumbar slipped disc surgery|lumbar slipped disc surgery
5380294|NCT01811251|Post-operative pain|post-operative pain
5380295|NCT01811238|spinal disorders|spinal disorders
5380296|NCT01811225|Women|women
5380297|NCT01811225|Pregnancy|pregnancy
5380298|NCT01811225|Smoking|smoking
5380299|NCT01811199|Thyroid cancer|thyroid cancer
5380300|NCT01811199|Breast cancer|breast cancer
5380301|NCT01811199|Dexamethasone|dexamethasone
5380302|NCT01811199|Emesis|emesis
5380303|NCT01811186|moderate to severe non-malignant chronic pain|moderate to severe non-malignant chronic pain
5380304|NCT01811173|multimorbidity|multimorbidity
5380305|NCT01811173|primary care|primary care
5380306|NCT01811173|physician - nurse team|physician - nurse team
5380307|NCT01811173|proactive monitoring|proactive monitoring
5380308|NCT01811173|support for self-care|support for self-care
5380309|NCT01811173|primary caregiver|primary caregiver
5380310|NCT01811160|Melatonin|melatonin
5380311|NCT01811160|Second generation antipsychotic|second generation antipsychotic
5380312|NCT01811160|bipolar disorder|bipolar disorder
5380313|NCT01811160|schizophrenia|schizophrenia
5380314|NCT01811160|Metabolic|metabolic
5380315|NCT01811147|Bipolar|bipolar
5380316|NCT01811147|Depression|depression
5380317|NCT01811147|Mania|mania
5380318|NCT01811147|Hypomania|hypomania
5380319|NCT01811147|fMRI|fmri
5380320|NCT01811147|antidepressant|antidepressant
5423330|NCT01616173|Anesthesia Recovery Period|anesthesia recovery period
5380326|NCT01811108|mCRC|mcrc
5380327|NCT01811108|KRAS mutation|kras mutation
5380328|NCT01811108|Chemotherapy|chemotherapy
5375700|NCT01832272|Knee|knee
5380329|NCT01811108|Anti-angiogenic agent|anti-angiogenic agent
5380330|NCT01811108|Bevacizumab|bevacizumab
5380331|NCT01811108|1st Line|1st line
5380332|NCT01811095|Robotics|robotics
5380333|NCT01811095|Computer-assisted surgery|computer-assisted surgery
5380334|NCT01811095|Computer simulation|computer simulation
5380335|NCT01811095|Gynecology|gynecology
5380336|NCT01811095|General surgery|general surgery
5380337|NCT01811069|Obese patients|obese patients
5380338|NCT01811069|Upper airway patency|upper airway patency
5380339|NCT01811056|medical abortion|medical abortion
5380340|NCT01811056|mifepristone|mifepristone
5380341|NCT01811043|breast biopsy|breast biopsy
5380343|NCT01810978|congenital heart disease, probiotic, prebiotic|congenital heart disease, probiotic, prebiotic
5380344|NCT01810965|Hemochromatosis type 1|hemochromatosis type 1
5380345|NCT01810952|glucocorticoids|glucocorticoids
5380346|NCT01810952|hyperglycemia|hyperglycemia
5380347|NCT01810952|diabetes mellitus|diabetes mellitus
5380348|NCT01810939|Chronic Kidney Disease|chronic kidney disease
5380349|NCT01810939|Treatment of Hyperkalemia|treatment of hyperkalemia
5380350|NCT01810939|Hyperkalemia|hyperkalemia
5380351|NCT01810926|indication for HSCT|indication for hsct
5380352|NCT01810926|matched related donor|matched related donor
5380353|NCT01810926|MRD|mrd
5380354|NCT01810926|Matched Unrelated Donor|matched unrelated donor
5380355|NCT01810926|MUD|mud
5380356|NCT01810900|anti-adhesive effect and safety, laparoscopic myomectomy|anti-adhesive effect and safety, laparoscopic myomectomy
5380357|NCT01810887|Healthy|healthy
5380358|NCT01810887|Darunavir|darunavir
5380359|NCT01810887|JNS011|jns011
5380360|NCT01810887|Ritonavir|ritonavir
5380361|NCT01810874|extraperitoneal|extraperitoneal
5380362|NCT01810874|transperitoneal|transperitoneal
5380363|NCT01810874|laparoscopic aortic lymphadenectomy|laparoscopic aortic lymphadenectomy
5380364|NCT01810874|endometrial ovarian cancer|endometrial ovarian cancer
5380365|NCT01810874|ovarian cancer|ovarian cancer
5380366|NCT01810874|surgical staging|surgical staging
5380367|NCT01810861|serotype distribution|serotype distribution
5380368|NCT01810861|streptococcus pneumoniae|streptococcus pneumoniae
5380369|NCT01810861|pneumonia|pneumonia
5380370|NCT01810848|Knee Osteoarthritis|knee osteoarthritis
5380371|NCT01810848|Osteoarthritis|osteoarthritis
5380372|NCT01810848|Synvisc|synvisc
5380373|NCT01810848|Hylan G-F 20|hylan g-f 20
5380374|NCT01810848|Exercise|exercise
5380375|NCT01810848|Cardiovascular risk|cardiovascular risk
5380376|NCT01810848|Knee pain|knee pain
5380377|NCT01810848|Pain|pain
5380378|NCT01810835|HBV mother-to-child transmission|hbv mother-to-child transmission
5380379|NCT01810835|women with HBV DNA > 105 I.U./mL|women with hbv dna > 105 i.u./ml
5380380|NCT01810835|France|france
5380381|NCT01810822|oxidative stress|oxidative stress
5380382|NCT01810822|genetic susceptibility|genetic susceptibility
5380383|NCT01810822|GPX4|gpx4
5380384|NCT01810822|NOX2|nox2
5380385|NCT01810809|Osteoarthritis|osteoarthritis
5380387|NCT01810809|Viscosupplementation|viscosupplementation
5380388|NCT01810809|Clinical Trial|clinical trial
5380389|NCT01810770|Radium-223 Dichloride|radium-223 dichloride
5380390|NCT01810770|Prostatic Neoplasms|prostatic neoplasms
5380391|NCT01810770|Bone Metastasis|bone metastasis
5380392|NCT01810731|influenza vaccine immunogenicity|influenza vaccine immunogenicity
5380393|NCT01810731|HIV|hiv
5380394|NCT01810731|pregnancy|pregnancy
5380395|NCT01810731|influenza vaccine safety|influenza vaccine safety
5380396|NCT01810718|cGVHD|cgvhd
5380397|NCT01810718|steroid therapy|steroid therapy
5380398|NCT01810718|Nilotinib|nilotinib
5380399|NCT01810718|cGVHD steroid refractory|cgvhd steroid refractory
5380400|NCT01810718|intolerant to steroid therapy|intolerant to steroid therapy
5380401|NCT01810718|Tasigna|tasigna
5380402|NCT01810718|MTD|mtd
5380403|NCT01810705|myeloid|myeloid
5380404|NCT01810705|leukemia|leukemia
5380405|NCT01810679|aortic valve replacement|aortic valve replacement
5380406|NCT01810679|aortic stenosis|aortic stenosis
5380407|NCT01810679|aortic steno-insufficiency|aortic steno-insufficiency
5380408|NCT01810679|Perceval|perceval
5380409|NCT01810679|Sutureless aortic heart valve|sutureless aortic heart valve
5380410|NCT01810653|Macrogol|macrogol
5380411|NCT01810640|Liver biopsy|liver biopsy
5380412|NCT01810640|organ donation|organ donation
5380413|NCT01810640|donor management|donor management
5380414|NCT01810627|Prostate|prostate
5380415|NCT01810627|Cancer|cancer
5380416|NCT01810614|ADPKD|adpkd
5380418|NCT01810614|Kidney Disease|kidney disease
5380419|NCT01810614|ADPKD diet|adpkd diet
5380420|NCT01810601|Embryo transfer, transabdominal ultrasound, IVF, ICSI|embryo transfer, transabdominal ultrasound, ivf, icsi
5380421|NCT01810588|Allogeneic transplant|allogeneic transplant
5380422|NCT01810588|Hematologic Malignancies|hematologic malignancies
5380423|NCT01810588|Acute Leukemia|acute leukemia
5380424|NCT01810588|Myeloproliferative disorders|myeloproliferative disorders
5380425|NCT01810588|Lymphoma|lymphoma
5380426|NCT01810588|Myeloma|myeloma
5380427|NCT01810562|Stroke|stroke
5380428|NCT01810562|Tactile|tactile
5380429|NCT01810562|Sensibility|sensibility
5380430|NCT01810562|Stimulation|stimulation
5380431|NCT01810562|Extremities|extremities
5380432|NCT01810562|Arm|arm
5380433|NCT01810562|Leg|leg
5380434|NCT01810549|Fatigue|fatigue
5380435|NCT01810536|Cystic fibrosis|cystic fibrosis
5380436|NCT01810536|oxygen|oxygen
5380437|NCT01810536|respiratory failure|respiratory failure
5380438|NCT01810523|Acute|acute
5380439|NCT01810523|lower|lower
5380440|NCT01810523|extremity|extremity
5380441|NCT01810523|not requiring|not requiring
5380442|NCT01810523|diagnostic|diagnostic
5380443|NCT01810523|imaging|imaging
5380444|NCT01810510|respiration, artificial|respiration, artificial
5380445|NCT01810497|External ear|external ear
5380446|NCT01810497|Ear abnormalities|ear abnormalities
5380447|NCT01810497|External ear cartilages|external ear cartilages
5380448|NCT01810484|Ulthera® System|ulthera® system
5380449|NCT01810484|Ultherapy® Treatment|ultherapy® treatment
5380450|NCT01810484|Ulthera, Inc.|ulthera, inc.
5380451|NCT01810484|Ultrasound treatment for skin|ultrasound treatment for skin
5380452|NCT01810458|Liver|liver
5380454|NCT01810458|Alpha-1|alpha-1
5380455|NCT01810458|AAT|aat
5380456|NCT01810458|AATD|aatd
5380457|NCT01810445|Bladder Cancer|bladder cancer
5380458|NCT01810445|Laser|laser
5380459|NCT01810445|Optical|optical
5380460|NCT01810419|splenomegaly|splenomegaly
5380461|NCT01810419|ultrasound|ultrasound
5380462|NCT01810419|Vscan|vscan
5380463|NCT01810367|PFS|pfs
5380464|NCT01810354|Cefazolin|cefazolin
5380465|NCT01810354|Tissue concentration|tissue concentration
5380466|NCT01810354|infection|infection
5380467|NCT01810354|cesarean section|cesarean section
5380469|NCT01810341|Autism|autism
5380470|NCT01810341|Autism Spectrum Disorders|autism spectrum disorders
5380471|NCT01810341|RNA|rna
5380472|NCT01810341|Gene expression|gene expression
5380473|NCT01810341|Developmental Delay|developmental delay
5380474|NCT01810341|Metabolites|metabolites
5380475|NCT01810341|DNA|dna
5380476|NCT01810302|Vasospasm|vasospasm
5380477|NCT01810302|Subarachnoid hemorrhage|subarachnoid hemorrhage
5380478|NCT01810302|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5380479|NCT01810302|Nicardipine|nicardipine
5380480|NCT01810302|Intrathecal|intrathecal
5380481|NCT01810302|SAH|sah
5380482|NCT01810302|aSAH|asah
5380483|NCT01810289|HIV, ART, CD4|hiv, art, cd4
5363700|NCT01885429|Resistance Exercise|resistance exercise
5380484|NCT01810276|traumatic head injury|traumatic head injury
5380485|NCT01810276|intracranial hemorrhage|intracranial hemorrhage
5380486|NCT01810276|platelets|platelets
5380487|NCT01810276|anti-platelet therapy|anti-platelet therapy
5380488|NCT01810276|plavix|plavix
5380489|NCT01810276|asprin|asprin
5380490|NCT01810263|stroke|stroke
5380491|NCT01810263|malnutrition|malnutrition
5380492|NCT01810263|high protein|high protein
5380493|NCT01810211|Shoulder|shoulder
5380494|NCT01810211|Surgery|surgery
5380495|NCT01810211|Posterior Shoulder Tightness|posterior shoulder tightness
5380496|NCT01810211|Flexibility|flexibility
5380497|NCT01810211|Range of Motion|range of motion
5380498|NCT01810198|Coronary Artery Disease|coronary artery disease
5380499|NCT01810198|Cardiac CT|cardiac ct
5380500|NCT01810198|Catheterization|catheterization
5380501|NCT01810185|Inflammatory Bowel Disease|inflammatory bowel disease
5380502|NCT01810185|Crohn's disease|crohn's disease
5380503|NCT01810185|Ulcerative colitis|ulcerative colitis
5380504|NCT01810185|Naltrexone|naltrexone
5380505|NCT01810185|Low Dose Naltrexone|low dose naltrexone
5380506|NCT01810185|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
5380507|NCT01810172|lobectomy|lobectomy
5380508|NCT01810172|segmentectomy|segmentectomy
5380509|NCT01810172|pneumothorax|pneumothorax
5380510|NCT01810172|pleural|pleural
5380511|NCT01810172|digital|digital
5380512|NCT01810172|air leak|air leak
5380513|NCT01810159|substance use disorders|substance use disorders
5380514|NCT01810159|implementation science|implementation science
5380515|NCT01810159|collaborative care|collaborative care
5380516|NCT01810159|opiate disorders|opiate disorders
5380517|NCT01810159|alcohol disorders|alcohol disorders
5380518|NCT01810146|Patients eligible for bariatric surgery (BMI>40kg/m2)|patients eligible for bariatric surgery (bmi>40kg/m2)
5380519|NCT01810133|Comorbidity|comorbidity
5380520|NCT01810120|Hematologic|hematologic
5380521|NCT01810120|Malignant|malignant
5380522|NCT01810120|Non-Malignant|non-malignant
5380523|NCT01810120|Allogeneic|allogeneic
5380524|NCT01810120|Transplant|transplant
5380525|NCT01810120|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5380526|NCT01810120|Pediatric|pediatric
5380527|NCT01810120|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5380528|NCT01810120|Acute Myeloid leukemia|acute myeloid leukemia
5380529|NCT01810120|Myelodysplastic Syndromes|myelodysplastic syndromes
5380530|NCT01810120|T cells receptor alfa beta|t cells receptor alfa beta
5380531|NCT01810094|thoracolumbar fracture|thoracolumbar fracture
5380532|NCT01810094|fixation|fixation
5380533|NCT01810094|fixateur interne|fixateur interne
5380534|NCT01810094|minimal invasive|minimal invasive
5380535|NCT01810094|percutaneous|percutaneous
5380536|NCT01810081|Cholelithiasis|cholelithiasis
5380537|NCT01810081|Gastric H.Pylori infection|gastric h.pylori infection
5380538|NCT01810081|H.Pylori infection|h.pylori infection
5380539|NCT01810081|Gastric mucosa|gastric mucosa
5863597|NCT00001243|Myeloid Progenitors|myeloid progenitors
5380540|NCT01810068|BPH- Erectile function- Transurethral- Laser|bph- erectile function- transurethral- laser
5380541|NCT01810042|age-related macular degeneration|age-related macular degeneration
5380542|NCT01810042|choroidal neovascularization|choroidal neovascularization
5380543|NCT01810042|ranibizumab|ranibizumab
5380544|NCT01810042|indocyanine angiography|indocyanine angiography
5380545|NCT01810029|transcendental meditation|transcendental meditation
5380546|NCT01810029|cardiac rehabilitation|cardiac rehabilitation
5380547|NCT01810016|NY-ESO-1|ny-eso-1
5380548|NCT01810016|Metastatic Melanoma|metastatic melanoma
5380549|NCT01810016|Ipilimumab|ipilimumab
5380550|NCT01810016|Phase I|phase i
5380551|NCT01810016|Adjuvant|adjuvant
5380552|NCT01810016|Immunologic|immunologic
5380553|NCT01810016|Vaccination|vaccination
5380554|NCT01810016|Immunotherapy|immunotherapy
5380555|NCT01810016|Neoplasm|neoplasm
5380556|NCT01810003|Cardiovascular disease|cardiovascular disease
5380557|NCT01810003|Inflammation|inflammation
5380558|NCT01810003|EPA/DHA supplementation|epa/dha supplementation
5380559|NCT01809990|cognitive behavior therapy|cognitive behavior therapy
5380560|NCT01809990|pediatric obsessive-compulsive disorder|pediatric obsessive-compulsive disorder
5380561|NCT01809990|internet-delivered cognitive behavior therapy|internet-delivered cognitive behavior therapy
5380562|NCT01809977|Keratoconus|keratoconus
5380563|NCT01809977|remove|remove
5380564|NCT01809977|cornea|cornea
5380565|NCT01809977|visual acuity|visual acuity
5380566|NCT01809938|Gastrointestinal tract emptying|gastrointestinal tract emptying
5380567|NCT01809938|Pre-operative fasting|pre-operative fasting
5380568|NCT01809938|Ultrasound|ultrasound
5380569|NCT01809938|Paracetamol Absorption|paracetamol absorption
5380570|NCT01809912|solid tumor|solid tumor
5380571|NCT01809899|Trauma|trauma
5380572|NCT01809899|Abuse|abuse
5380573|NCT01809899|Domestic Violence|domestic violence
5380574|NCT01809899|Rape|rape
5380575|NCT01809899|Assault|assault
5380576|NCT01809899|MRI|mri
5380577|NCT01809886|Neuromuscular relaxants|neuromuscular relaxants
5380578|NCT01809886|short-term pediatric surgery|short-term pediatric surgery
5380579|NCT01809886|reverses neuromuscular blockade|reverses neuromuscular blockade
5380580|NCT01809873|Malaria|malaria
5380581|NCT01809873|Diagnostics|diagnostics
5380582|NCT01809873|Health Services|health services
5380583|NCT01809860|isavuconazole|isavuconazole
5380584|NCT01809860|sirolimus|sirolimus
5380585|NCT01809860|BAL8557|bal8557
5380586|NCT01809860|Healthy Volunteers|healthy volunteers
5380587|NCT01809847|CLL|cll
5380588|NCT01809847|Chronic Lymphatic Leukemia|chronic lymphatic leukemia
5380589|NCT01809847|Leukemia|leukemia
5380590|NCT01809847|HLA|hla
5380591|NCT01809847|Histocompatibility|histocompatibility
5380592|NCT01809847|HCT|hct
5380593|NCT01809847|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5380594|NCT01809847|Ofatumumab|ofatumumab
5380595|NCT01809847|CD20|cd20
5380596|NCT01809821|Hypertension|hypertension
5380597|NCT01809821|Sleep Disorders|sleep disorders
5380598|NCT01809821|Insomnia|insomnia
5380599|NCT01809821|Cardiovascular Diseases|cardiovascular diseases
5380600|NCT01809821|Internet treatment|internet treatment
5380601|NCT01809808|Acromegaly|acromegaly
5380602|NCT01809808|Pituitary tumor|pituitary tumor
5380603|NCT01809795|Obesity|obesity
5380604|NCT01809795|Exercise|exercise
5380605|NCT01809795|Blueberry Plant|blueberry plant
5380606|NCT01809743|Coronary artery disease|coronary artery disease
5380607|NCT01809743|Regadenoson|regadenoson
5380608|NCT01809743|Adenosine|adenosine
5380609|NCT01809743|Maximal hyperemia|maximal hyperemia
5380610|NCT01809743|Fractional flow reserve|fractional flow reserve
5380611|NCT01809743|FFR|ffr
5380612|NCT01809691|Prostate cancer|prostate cancer
5380613|NCT01809691|TAK-700|tak-700
5380614|NCT01809691|Bicalutamide|bicalutamide
5380615|NCT01809691|S1216|s1216
5380616|NCT01809691|androgen therapy|androgen therapy
5380617|NCT01809691|Phase III|phase iii
5380618|NCT01809678|Smoking|smoking
5380619|NCT01809678|Tobacco|tobacco
5380620|NCT01809678|Yoga|yoga
5380621|NCT01809665|ICD therapy|icd therapy
5380622|NCT01809665|CRT-P therapy|crt-p therapy
5380623|NCT01809665|MRI|mri
5380624|NCT01809652|Pacemaker|pacemaker
5380625|NCT01809652|Defibrillator|defibrillator
5380626|NCT01809652|Remote Consultation|remote consultation
5380627|NCT01809639|Concussion|concussion
5380628|NCT01809613|Parkinson disease|parkinson disease
5380629|NCT01809613|Deep Brain Stimulation|deep brain stimulation
5380630|NCT01809613|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5380631|NCT01809574|Interstitial lung disease|interstitial lung disease
5380632|NCT01809574|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5380633|NCT01809574|Connective tissue disease|connective tissue disease
5380634|NCT01809561|endometriosis|endometriosis
5380635|NCT01809561|telomere|telomere
5380636|NCT01809561|telomerase|telomerase
5380637|NCT01809548|complementary feeding|complementary feeding
5380638|NCT01809548|premature infant|premature infant
5380639|NCT01809548|body composition|body composition
5380640|NCT01809548|atopy|atopy
5380641|NCT01809548|neurodevelopmental outcome|neurodevelopmental outcome
5380642|NCT01809548|obesity|obesity
5863598|NCT00001243|Monocytes|monocytes
5380643|NCT01809535|endoscopic variceal ligation|endoscopic variceal ligation
5380644|NCT01809535|post-EVL ulcer|post-evl ulcer
5380645|NCT01809535|variceal bleeding|variceal bleeding
5380646|NCT01809522|Robotic-assisted radical prostatectomy|robotic-assisted radical prostatectomy
5380647|NCT01809522|Urinary continence|urinary continence
5380648|NCT01809522|Posterior reconstruction of the rhabdosphincter|posterior reconstruction of the rhabdosphincter
5380649|NCT01809522|Posterior musculofascial plate reconstruction|posterior musculofascial plate reconstruction
5380650|NCT01809509|CYTOKINES , IL11 IL6 IMLANTATION RATE IVF.|cytokines , il11 il6 imlantation rate ivf.
5380651|NCT01809496|hearing loss|hearing loss
5380652|NCT01809496|hearing aids|hearing aids
5380654|NCT01809496|rehabilitation|rehabilitation
5380655|NCT01809483|mechanical corneal erosion|mechanical corneal erosion
5380656|NCT01809483|bandage contact lens|bandage contact lens
5380657|NCT01809483|pressure patching|pressure patching
5380658|NCT01809483|erosion area|erosion area
5380659|NCT01809483|pain scale|pain scale
5380660|NCT01809470|Blood pressure|blood pressure
5380661|NCT01809470|Appetite|appetite
5380662|NCT01809470|Heart rate|heart rate
5380663|NCT01809470|Salivary cortisol|salivary cortisol
5380664|NCT01809457|educational poster, knowledge, dental trauma,|educational poster, knowledge, dental trauma,
5380665|NCT01809431|gestational diabetes|gestational diabetes
5380666|NCT01809431|women|women
5380672|NCT01809431|self-efficacy|self-efficacy
5380673|NCT01809392|Decitabine|decitabine
5380674|NCT01809392|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5380675|NCT01809392|Wilms' tumor 1|wilms' tumor 1
5380676|NCT01809392|cytolytic T lymphocyte|cytolytic t lymphocyte
5380677|NCT01809392|Regulatory T cell|regulatory t cell
5380678|NCT01809379|ovarian cancer, recurrent, chemotherapy, intraperitoneal|ovarian cancer, recurrent, chemotherapy, intraperitoneal
5380679|NCT01809366|seminal plasma/uterine receptivity|seminal plasma/uterine receptivity
5380680|NCT01809353|Healthy|healthy
5380681|NCT01809353|Japanese|japanese
5380682|NCT01809353|Caucasian|caucasian
5380683|NCT01809353|Male|male
5380684|NCT01809353|Pharmacokinetic|pharmacokinetic
5380685|NCT01809353|JNJ-54452840|jnj-54452840
5380686|NCT01809340|Depressive Disorder|depressive disorder
5380687|NCT01809340|Major Depressive Disorder|major depressive disorder
5380688|NCT01809340|Depression|depression
5380689|NCT01809340|Bipolar Disorder Type II|bipolar disorder type ii
5380690|NCT01809340|Anti-depressant|anti-depressant
5380691|NCT01809340|Ketamine|ketamine
5380692|NCT01809340|Minocycline|minocycline
5380693|NCT01809327|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5380694|NCT01809327|Diabetes Mellitus|diabetes mellitus
5380695|NCT01809327|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5380696|NCT01809327|Metformin|metformin
5380697|NCT01809301|Bioavailability|bioavailability
5380703|NCT01809275|Crohn's Disease|crohn's disease
5380704|NCT01809275|Inflammatory Bowel Disease|inflammatory bowel disease
5380705|NCT01809275|CDAI|cdai
5380706|NCT01809249|Living donor liver transplantation|living donor liver transplantation
5380707|NCT01809249|Donar safety|donar safety
5380708|NCT01809210|MEK1/2 inhibitor,|mek1/2 inhibitor,
5380709|NCT01809210|Non Small Cell Lung Cancer,|non small cell lung cancer,
5380710|NCT01809210|metastatic,|metastatic,
5380711|NCT01809210|first line treatment for Non Small Cell Lung Cancer|first line treatment for non small cell lung cancer
5380712|NCT01809197|Refractive error|refractive error
5380713|NCT01809197|Myopia|myopia
5380714|NCT01809197|Hyperopia|hyperopia
5380715|NCT01809197|Astigmatism|astigmatism
5380716|NCT01809197|Presbyopia|presbyopia
5380717|NCT01809197|Contact lenses|contact lenses
5380718|NCT01809197|Contact lens solution|contact lens solution
5380719|NCT01809197|Comfort|comfort
5380720|NCT01809145|sarcoidosis|sarcoidosis
5380721|NCT01809145|occupational exposure|occupational exposure
5380722|NCT01809145|MELISA|melisa
5380723|NCT01809132|Hepatitis, alcoholic|hepatitis, alcoholic
5380724|NCT01809132|pentoxifylline|pentoxifylline
5380725|NCT01809132|zinc|zinc
5380726|NCT01809132|anakinra|anakinra
5380727|NCT01809132|glucocorticoids|glucocorticoids
5380728|NCT01809132|MELD score|meld score
5380729|NCT01809132|Intestinal mucosa|intestinal mucosa
5380730|NCT01809119|Kidney Neoplasms, Minimally invasive surgery, Renal cell carcinoma|kidney neoplasms, minimally invasive surgery, renal cell carcinoma
5380731|NCT01809106|cancer pain|cancer pain
5380732|NCT01809106|major opioid|major opioid
5380733|NCT01809106|analgesics|analgesics
5380734|NCT01809093|PEDF|pedf
5380735|NCT01809093|TSP1|tsp1
5380736|NCT01809093|Thrombospondin|thrombospondin
5380737|NCT01809093|pigment epithelium derived factor|pigment epithelium derived factor
5380738|NCT01809093|Wills Eye Institute|wills eye institute
5380739|NCT01809093|Pars plana vitrectomy|pars plana vitrectomy
5380740|NCT01809093|Vitreous levels|vitreous levels
5380741|NCT01809093|Mid Atlantic Retina|mid atlantic retina
5380742|NCT01809093|Blood draw|blood draw
5380743|NCT01809093|Blood test|blood test
5380744|NCT01809067|stress|stress
5380745|NCT01809067|anxiety|anxiety
5380746|NCT01809067|MRI|mri
5380747|NCT01809067|aromatherapy|aromatherapy
5862822|NCT00001491|Quantitative Sensory Testing|quantitative sensory testing
5380750|NCT01809015|Oral Anticoagulation|oral anticoagulation
5380751|NCT01809015|Regular Medical Care|regular medical care
5380753|NCT01809015|Vitamin-K Antagonists|vitamin-k antagonists
5380754|NCT01809015|Quality of therapy|quality of therapy
5380755|NCT01809015|Atrial fibrillation|atrial fibrillation
5380756|NCT01809015|Venous thromboembolism|venous thromboembolism
5380757|NCT01809015|Bypass surgery|bypass surgery
5380758|NCT01809015|Prosthetic heart valve|prosthetic heart valve
5380759|NCT01808989|peripheral artery disease|peripheral artery disease
5380761|NCT01808989|treadmill walking test|treadmill walking test
5380762|NCT01808989|intermittent claudication|intermittent claudication
5380763|NCT01808963|Enthalpy|enthalpy
5380764|NCT01808963|Physiologic Monitors|physiologic monitors
5380765|NCT01808963|Critical Care Medicine|critical care medicine
5380781|NCT01808846|functional magnetic resonance imaging|functional magnetic resonance imaging
5380783|NCT01808846|fructose|fructose
5380784|NCT01808846|hypothalamus|hypothalamus
5380785|NCT01808846|neuronal circuits|neuronal circuits
5380786|NCT01808846|feeding behavior|feeding behavior
5380787|NCT01808833|Frailty|frailty
5380788|NCT01808833|Geriatric oncology|geriatric oncology
5380797|NCT01808807|cesarean section rate|cesarean section rate
5380798|NCT01808807|the cesarean section rate audit|the cesarean section rate audit
5380809|NCT01808781|Power|power
5380810|NCT01808781|muscle strength|muscle strength
5380811|NCT01808781|total knee replacement|total knee replacement
5380812|NCT01808781|physical activity behavior|physical activity behavior
5380813|NCT01808755|recurrent urinary tract infections|recurrent urinary tract infections
5380814|NCT01808755|D Mannose|d mannose
5380815|NCT01808755|cystitis|cystitis
5380816|NCT01808755|antibiotic treatment|antibiotic treatment
5380817|NCT01808729|fibromuscular dysplasia|fibromuscular dysplasia
5380818|NCT01808729|coronary artery disease|coronary artery disease
5380819|NCT01808716|low-level laser therapy|low-level laser therapy
5380820|NCT01808716|muscle damage|muscle damage
5380821|NCT01808703|Periodontitis|periodontitis
5380822|NCT01808703|Periodontal pocket|periodontal pocket
5380823|NCT01808703|Periodontal diseases|periodontal diseases
5364023|NCT01883921|CVID|cvid
5380824|NCT01808690|Adolescent|adolescent
5380825|NCT01808690|Youth|youth
5380826|NCT01808690|Diabetes|diabetes
5380827|NCT01808690|Insulin Resistance|insulin resistance
5380828|NCT01808690|Cardiovascular|cardiovascular
5380829|NCT01808690|Metformin|metformin
5380830|NCT01808677|Non-Small Cell Lung Cancer|non-small cell lung cancer
5380831|NCT01808677|NSCLC|nsclc
5380832|NCT01808677|Thoracic reirradiation|thoracic reirradiation
5380833|NCT01808677|Proton beam therapy|proton beam therapy
5380834|NCT01808677|PBT|pbt
5380835|NCT01808677|Intensity modulated radiation therapy|intensity modulated radiation therapy
5380836|NCT01808677|IMRT|imrt
5380837|NCT01808677|Registry|registry
5380838|NCT01808677|Data|data
5380839|NCT01808638|Adenocarcinoma|adenocarcinoma
5380840|NCT01808638|Pancreas|pancreas
5380841|NCT01808638|Gemcitabine|gemcitabine
5380842|NCT01808638|Atu027|atu027
5380843|NCT01808625|BRAIN MALIGNANCIES , RADIATION THERAPY|brain malignancies , radiation therapy
5380844|NCT01808586|Neck|neck
5380845|NCT01808586|chronic pain|chronic pain
5380846|NCT01808586|facet injection|facet injection
5380847|NCT01808573|Neratinib|neratinib
5380848|NCT01808573|Nerlynx|nerlynx
5380849|NCT01808521|Purpura, Thrombotic Thrombocytopenic|purpura, thrombotic thrombocytopenic
5380850|NCT01808521|TTP|ttp
5380851|NCT01808508|Down syndrome|down syndrome
5380852|NCT01808508|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5380853|NCT01808508|Continuous positive airway pressure|continuous positive airway pressure
5380854|NCT01808508|sham or placebo CPAP|sham or placebo cpap
5380855|NCT01808495|Human corneal fibroblasts|human corneal fibroblasts
5380856|NCT01808495|Fibulin-1|fibulin-1
5380857|NCT01808495|Nuclear accumulation|nuclear accumulation
5380858|NCT01808482|monoclonal antibody|monoclonal antibody
5380859|NCT01808482|Multiple Sclerosis|multiple sclerosis
5380860|NCT01808482|Interleukin-7 Receptor|interleukin-7 receptor
5380861|NCT01808456|kidney transplant|kidney transplant
5380862|NCT01808456|heart transplant|heart transplant
5380863|NCT01808456|lung transplant|lung transplant
5380864|NCT01808456|influenza vaccine|influenza vaccine
5380865|NCT01808443|cryotherapy|cryotherapy
5380866|NCT01808443|laser|laser
5380867|NCT01808443|cutaneous warts|cutaneous warts
5380868|NCT01808430|NSCLC|nsclc
5380869|NCT01808404|Acceptance and Commitment Therapy|acceptance and commitment therapy
5380870|NCT01808404|Mindfulness|mindfulness
5380871|NCT01808404|Guided Self-Help|guided self-help
5380872|NCT01808404|College|college
5380873|NCT01808391|Coronary artery disease|coronary artery disease
5380874|NCT01808391|Heart disease|heart disease
5376219|NCT01829893|tamsulosin|tamsulosin
5380880|NCT01808378|Expanded Adipose Derived Stem Cells|expanded adipose derived stem cells
5380881|NCT01808365|Neisseria meningitidis|neisseria meningitidis
5380882|NCT01808365|Philippines|philippines
5380883|NCT01808365|carriage|carriage
5380884|NCT01808365|meningococcus|meningococcus
5380885|NCT01808352|AE adverse event|ae adverse event
5380886|NCT01808352|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5380887|NCT01808352|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5380888|NCT01808352|ART antiretroviral therapy|art antiretroviral therapy
5380889|NCT01808352|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5380890|NCT01808352|DCF data collection forms|dcf data collection forms
5680246|NCT00578526|targeted therapy|targeted therapy
5380891|NCT01808352|DMC Data Monitoring Committee|dmc data monitoring committee
5380892|NCT01808352|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5380893|NCT01808352|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5380894|NCT01808352|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5380895|NCT01808352|ICH International Conference of Harmonisation|ich international conference of harmonisation
5380896|NCT01808352|IND Investigational New Drug Application|ind investigational new drug application
5380897|NCT01808352|IRB Institutional Review Board|irb institutional review board
5380898|NCT01808352|IU International units|iu international units
5380899|NCT01808352|mg milligram(s)|mg milligram(s)
5380900|NCT01808352|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5380901|NCT01808352|PCR polymerase chain reaction|pcr polymerase chain reaction
5380902|NCT01808352|SAE serious adverse event|sae serious adverse event
5380903|NCT01808352|µg microgram|µg microgram
5380904|NCT01808352|ULN upper limit of the normal range|uln upper limit of the normal range
5380905|NCT01808352|WB Western Blot|wb western blot
5380906|NCT01808339|Fluticasone Furoate, FF Inhalation Powder, morning dosing, evening dosing, efficacy, FEV1|fluticasone furoate, ff inhalation powder, morning dosing, evening dosing, efficacy, fev1
5380907|NCT01808287|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5380908|NCT01808287|Aortic Stenosis|aortic stenosis
5380909|NCT01808274|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5380910|NCT01808274|Aortic Stenosis|aortic stenosis
5380911|NCT01808261|Ischemic Stroke|ischemic stroke
5380912|NCT01808248|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5380913|NCT01808248|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5380915|NCT01808248|Sustained Virologic Response|sustained virologic response
5380916|NCT01808248|Direct Acting Antiviral|direct acting antiviral
5380917|NCT01808248|Combination Therapy|combination therapy
5380918|NCT01808248|Treatment-Naïve|treatment-naïve
5380919|NCT01808248|GS-7977|gs-7977
5380920|NCT01808248|Ribavirin|ribavirin
5380921|NCT01808248|RBV|rbv
5380922|NCT01808248|Peginterferon Alfa 2a|peginterferon alfa 2a
5380923|NCT01808248|PEG|peg
5380924|NCT01808248|Additional relevant MeSH terms:|additional relevant mesh terms:
5380925|NCT01808248|Hepatitis|hepatitis
5380926|NCT01808248|Hepatitis A|hepatitis a
5380927|NCT01808248|Hepatitis, Chronic|hepatitis, chronic
5380928|NCT01808248|Hepatitis C|hepatitis c
5380929|NCT01808248|Hepatitis C, Chronic|hepatitis c, chronic
5380930|NCT01808248|Liver Diseases|liver diseases
5380931|NCT01808248|Digestive System Diseases|digestive system diseases
5380932|NCT01808248|Hepatitis, Viral, Human|hepatitis, viral, human
5380933|NCT01808248|Virus Diseases|virus diseases
5380934|NCT01808248|Enterovirus Infections|enterovirus infections
5380935|NCT01808248|Picornaviridae Infections|picornaviridae infections
5380936|NCT01808248|RNA Virus Infections|rna virus infections
5380937|NCT01808248|Flaviviridae Infections|flaviviridae infections
5380938|NCT01808248|Peginterferon alfa-2a|peginterferon alfa-2a
5380939|NCT01808248|Interferon-alpha|interferon-alpha
5380940|NCT01808248|Antiviral Agents|antiviral agents
5380941|NCT01808248|Anti-Infective Agents|anti-infective agents
5380942|NCT01808248|Therapeutic Uses|therapeutic uses
5380943|NCT01808248|Pharmacologic Actions|pharmacologic actions
5380944|NCT01808248|Antimetabolites|antimetabolites
5380945|NCT01808248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5380946|NCT01808248|Immunologic Factors|immunologic factors
5380947|NCT01808248|Physiological Effects of Drugs|physiological effects of drugs
5380948|NCT01808196|Eosinophilic Esophagitis|eosinophilic esophagitis
5380949|NCT01808196|Connective Tissue Disorders|connective tissue disorders
5380950|NCT01808196|Drug trial|drug trial
5354403|NCT01928524|S1|s1
5380951|NCT01808183|supracondylar|supracondylar
5380952|NCT01808183|pediatric|pediatric
5380953|NCT01808183|humerus|humerus
5380969|NCT01808118|Spondylarthropathy|spondylarthropathy
5380970|NCT01808118|Ankylosing Spondyloarthritis|ankylosing spondyloarthritis
5380971|NCT01808118|Spondyloarthritis|spondyloarthritis
5380972|NCT01808118|Spinal Diseases|spinal diseases
5380973|NCT01808118|Musculoskeletal Diseases|musculoskeletal diseases
5380974|NCT01808118|Arthritis|arthritis
5380975|NCT01808118|Joint Diseases|joint diseases
5380976|NCT01808118|Adalimumab|adalimumab
5380977|NCT01808118|Antirheumatic Agents|antirheumatic agents
5380978|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents
5380979|NCT01808092|Ceftazidime,|ceftazidime,
5380980|NCT01808092|Meropenem,|meropenem,
5380981|NCT01808092|Anti-Bacterial Agents,|anti-bacterial agents,
5380982|NCT01808092|Anti-Infective Agents,|anti-infective agents,
5380983|NCT01808092|Therapeutic Uses,|therapeutic uses,
5380984|NCT01808092|Pharmacologic Actions,|pharmacologic actions,
5380985|NCT01808092|Physiological Effects of Drugs|physiological effects of drugs
5380986|NCT01808040|breast cancer|breast cancer
5380987|NCT01808040|ER positive|er positive
5380988|NCT01808040|PR positive|pr positive
5380989|NCT01808040|post menopausal|post menopausal
5380990|NCT01808027|quality of life drug adherence drug compliance mortality|quality of life drug adherence drug compliance mortality
5380991|NCT01808014|nefopam, spinal surgery, postoperative pain control|nefopam, spinal surgery, postoperative pain control
5380992|NCT01807988|Relapse, Recurrence, Depression, Internet, Sick-leave|relapse, recurrence, depression, internet, sick-leave
5380993|NCT01807962|Injections, Subcutaneous|injections, subcutaneous
5380994|NCT01807962|Cortisone|cortisone
5380995|NCT01807962|Anesthetics, Local|anesthetics, local
5380996|NCT01807936|Esophageal Neoplasms|esophageal neoplasms
5380997|NCT01807936|lymphadenectomy|lymphadenectomy
5380998|NCT01807910|Obesity|obesity
5380999|NCT01807910|NAFLD|nafld
5381000|NCT01807910|NASH|nash
5381001|NCT01807910|Steatosis|steatosis
5381002|NCT01807897|Heart Failure|heart failure
5381003|NCT01807897|Sleep Apnea|sleep apnea
5381004|NCT01807897|Ventricular Ejection Fraction|ventricular ejection fraction
5381005|NCT01807897|Exercise Test|exercise test
5381006|NCT01807884|Microaspiration|microaspiration
5381007|NCT01807884|Ventilator acquired Pneumonia|ventilator acquired pneumonia
5381008|NCT01807884|Amylase|amylase
5381009|NCT01807884|Mechanical ventilation|mechanical ventilation
5381010|NCT01807884|Suction|suction
5381011|NCT01807871|nicotine dependence|nicotine dependence
5381012|NCT01807871|smoking cessation|smoking cessation
5381013|NCT01807871|lapse|lapse
5381014|NCT01807871|relapse|relapse
5381015|NCT01807871|tobacco|tobacco
5381016|NCT01807871|nicotine patch|nicotine patch
5381017|NCT01807871|nicotine replacement therapy|nicotine replacement therapy
5381018|NCT01807871|NRT|nrt
5381019|NCT01807858|Necrotizing enterocolitis|necrotizing enterocolitis
5381020|NCT01807858|Sepsis|sepsis
5381021|NCT01807858|Length of hospital stay|length of hospital stay
5381022|NCT01807858|Mortality|mortality
5381023|NCT01807845|Casein micelles|casein micelles
5381024|NCT01807845|vitamin D3 (cholecalciferol)|vitamin d3 (cholecalciferol)
5381025|NCT01807845|Bioavailability|bioavailability
5381026|NCT01807845|Nanoencapsulation|nanoencapsulation
5381027|NCT01807845|Nutrition|nutrition
5381028|NCT01807832|chronic cough|chronic cough
5381029|NCT01807832|cough reflex hypersensitivity|cough reflex hypersensitivity
5381030|NCT01807832|capsaicin|capsaicin
5381034|NCT01807806|veterans, military, families|veterans, military, families
5381035|NCT01807793|Stroke|stroke
5381036|NCT01807793|TIA|tia
5381037|NCT01807793|African American|african american
5381038|NCT01807754|automated ultrasound imaging (AUS)|automated ultrasound imaging (aus)
5381039|NCT01807754|digital breast tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
5381040|NCT01807754|photoacoustic imaging (PAT)|photoacoustic imaging (pat)
5381041|NCT01807741|Bipolar Disorder|bipolar disorder
5381042|NCT01807741|Depression|depression
5381043|NCT01807728|Quality of life|quality of life
5381044|NCT01807728|Participation|participation
5381045|NCT01807728|Training|training
5381046|NCT01807715|first trimester|first trimester
5381047|NCT01807715|surgical abortion|surgical abortion
5381048|NCT01807715|contraception|contraception
5381049|NCT01807702|dichloroacetate|dichloroacetate
5381050|NCT01807702|pyruvate|pyruvate
5381051|NCT01807702|lactate|lactate
5381052|NCT01807702|pyruvate dehydrogenase|pyruvate dehydrogenase
5381053|NCT01807689|Dry mouth|dry mouth
5381054|NCT01807689|Dry eyes|dry eyes
5381055|NCT01807689|Saliva|saliva
5381056|NCT01807689|Salivary gland biopsy|salivary gland biopsy
5381455|NCT01805726|xylocain|xylocain
5381057|NCT01807663|neuromuscular disease|neuromuscular disease
5381058|NCT01807650|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
5381059|NCT01807650|Split-thickness skin graft|split-thickness skin graft
5381060|NCT01807650|STSG|stsg
5381064|NCT01807650|Partial-thickness wound|partial-thickness wound
5381065|NCT01807650|Time to wound closure|time to wound closure
5002884|NCT03978039|experts' network|experts' network
5381067|NCT01807611|Haploidentical donor transplantation|haploidentical donor transplantation
5903858|NCT00261456|Prostate cancer|prostate cancer
5381070|NCT01807559|Single Sided Deafness|single sided deafness
5381071|NCT01807559|Conductive Hearing Loss|conductive hearing loss
5381072|NCT01807559|Unilateral Hearing Loss|unilateral hearing loss
5381074|NCT01807546|Head and neck cancer|head and neck cancer
5381075|NCT01807546|Platinum-resistant|platinum-resistant
5381076|NCT01807546|Squamous cell carcinoma|squamous cell carcinoma
5381077|NCT01807533|Environment|environment
5381078|NCT01807533|Gene|gene
5381079|NCT01807533|Intervention|intervention
5381080|NCT01807533|Neurodevelopment|neurodevelopment
5381081|NCT01807533|Pathways|pathways
5381082|NCT01807533|Preterm infants|preterm infants
5381083|NCT01807520|Moderate nail psoriasis|moderate nail psoriasis
5381084|NCT01807520|Severe nail psoriasis|severe nail psoriasis
5381085|NCT01807520|psoriasis|psoriasis
5381086|NCT01807520|Secukinumab|secukinumab
5381088|NCT01807507|Vascular Access|vascular access
5381089|NCT01807481|Mircera|mircera
5381090|NCT01807481|PD|pd
5381091|NCT01807481|Maitenance|maitenance
5381092|NCT01807468|haploidentical stem cell transplantation|haploidentical stem cell transplantation
5381093|NCT01807468|natural killer cell therapy|natural killer cell therapy
5381094|NCT01807468|pediatric solid tumor|pediatric solid tumor
5381095|NCT01807442|Acute Coronary Syndrome|acute coronary syndrome
5381096|NCT01807442|Positive Psychology|positive psychology
5381097|NCT01807442|Adherence to Health Behaviors|adherence to health behaviors
5381098|NCT01807429|Ketamine,|ketamine,
5381099|NCT01807429|Midazolam,|midazolam,
5381100|NCT01807429|Morphine,|morphine,
5381101|NCT01807429|visual analogue score|visual analogue score
5381102|NCT01807416|Osseointegrated Implant, Bone level|osseointegrated implant, bone level
5381103|NCT01807403|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5381104|NCT01807403|Deep brain stimulation|deep brain stimulation
5381105|NCT01807403|Subthalamic nucleus|subthalamic nucleus
5381106|NCT01807403|Caudate nucleus|caudate nucleus
5381107|NCT01807403|Nucleus accumbens|nucleus accumbens
5381108|NCT01807390|Minimally invasive surgery|minimally invasive surgery
5381109|NCT01807390|Patient perspectives|patient perspectives
5381110|NCT01807390|Lung cancer|lung cancer
5381111|NCT01807390|Esophageal cancer|esophageal cancer
5381112|NCT01807390|Pain|pain
5381113|NCT01807364|Congenital adrenal hyperplasia (CAH)|congenital adrenal hyperplasia (cah)
5381114|NCT01807364|Cardiovascular risk|cardiovascular risk
5381115|NCT01807364|Microvascular dysfunction|microvascular dysfunction
5381116|NCT01807351|Diabetes Mellitus|diabetes mellitus
5381117|NCT01807351|Hypertension|hypertension
5381118|NCT01807351|Impaired Fasting Glucose|impaired fasting glucose
5381119|NCT01807351|Primary Health Care|primary health care
5381120|NCT01807351|Chinese|chinese
5381121|NCT01807312|colonoscopy|colonoscopy
5381125|NCT01807286|Myeloma|myeloma
5381126|NCT01807286|Untreated Systemic AL Amyloidosis|untreated systemic al amyloidosis
5381127|NCT01807286|Amyloid light-chain (AL) amyloidosis|amyloid light-chain (al) amyloidosis
5381128|NCT01807286|Pomalidomide|pomalidomide
5381129|NCT01807286|Melphalan|melphalan
5381130|NCT01807286|Alkeran|alkeran
5381131|NCT01807286|Dexamethasone|dexamethasone
5381132|NCT01807286|Decadron|decadron
5381133|NCT01807286|Questionnaires|questionnaires
5381134|NCT01807286|Surveys|surveys
5381135|NCT01807273|hemiplegic|hemiplegic
5381136|NCT01807273|time up and go test|time up and go test
5381137|NCT01807273|motion analysis|motion analysis
5381138|NCT01807273|center of mass|center of mass
5381139|NCT01807247|Strengthening muscle|strengthening muscle
5381140|NCT01807247|Central nervous system diseases|central nervous system diseases
5381141|NCT01807247|Gait|gait
5381142|NCT01807221|Heart Decompensation|heart decompensation
5381143|NCT01807208|Acute myocardial infarction|acute myocardial infarction
5381144|NCT01807208|patient education|patient education
5381145|NCT01807208|prevention|prevention
5381146|NCT01807195|contrast|contrast
5381147|NCT01807195|Intensive care unit|intensive care unit
5381148|NCT01807195|Acute kidney injury|acute kidney injury
5381149|NCT01807169|colon|colon
5381150|NCT01807169|endoscopy|endoscopy
5381151|NCT01807169|resection|resection
5381152|NCT01807169|clopidogrel|clopidogrel
5381153|NCT01807156|Tivozanib|tivozanib
5381154|NCT01807156|Advanced hepatocellular cancer|advanced hepatocellular cancer
5381155|NCT01807156|Angiogenesis|angiogenesis
5381156|NCT01807130|Heart Failure|heart failure
5381157|NCT01807130|Medical Therapy|medical therapy
5381160|NCT01807104|Anterior Approach|anterior approach
5381161|NCT01807104|Posterior Approach|posterior approach
5381162|NCT01807078|Coronary artery disease|coronary artery disease
5381163|NCT01807039|hip fracture|hip fracture
5381164|NCT01807039|proximal femur|proximal femur
5381165|NCT01807039|pertrochanteric fracture|pertrochanteric fracture
5381166|NCT01807039|subtrochanteric fracture|subtrochanteric fracture
5381167|NCT01807039|subcapital fracture|subcapital fracture
5381168|NCT01807039|safety issue|safety issue
5381169|NCT01807039|anesthesia|anesthesia
5381170|NCT01807013|cirrhosis|cirrhosis
5381171|NCT01807013|liver|liver
5381172|NCT01807013|elastometry|elastometry
5381173|NCT01807013|ultrasound|ultrasound
5381174|NCT01807013|laparoscopy|laparoscopy
5381175|NCT01807013|diagnosis|diagnosis
5381176|NCT01806987|school readiness|school readiness
5381177|NCT01806987|literacy|literacy
5381178|NCT01806987|social emotional skills|social emotional skills
5381179|NCT01806987|self regulation|self regulation
5381180|NCT01806987|caregiver involvement|caregiver involvement
5381181|NCT01806987|socioeconomic disadvantage|socioeconomic disadvantage
5381182|NCT01806974|Periodontitis|periodontitis
5381183|NCT01806974|rheumatoid arthritis|rheumatoid arthritis
5381184|NCT01806974|anti-interleukin 6|anti-interleukin 6
5381185|NCT01806974|immunotherapy|immunotherapy
5381186|NCT01806974|inflammation|inflammation
5381187|NCT01806974|bacteria|bacteria
5381188|NCT01806974|periodontal sulci|periodontal sulci
5381189|NCT01806974|periodontal pockets|periodontal pockets
5381190|NCT01806935|associated|associated
5381191|NCT01806935|aged population|aged population
5381192|NCT01806922|Yoga|yoga
5381193|NCT01806922|Stroke|stroke
5381194|NCT01806922|Standing balance|standing balance
5381195|NCT01806922|Depression|depression
5381196|NCT01806909|Flu Vaccine|flu vaccine
5381197|NCT01806909|Healthy Volunteer|healthy volunteer
5381198|NCT01806883|Hemiparesis,|hemiparesis,
5381199|NCT01806883|Rehabilitation,|rehabilitation,
5381200|NCT01806883|WII,|wii,
5381201|NCT01806883|Upper limb,|upper limb,
5381202|NCT01806883|Movement strategies.|movement strategies.
5381204|NCT01806870|ART|art
5381205|NCT01806857|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5381206|NCT01806857|ALS|als
5381207|NCT01806857|Nuedexta|nuedexta
5381208|NCT01806857|Bulbar function|bulbar function
5381209|NCT01806857|motor neurons|motor neurons
5381210|NCT01806844|Cardiac arrest|cardiac arrest
5381211|NCT01806844|Cerebral oxygenation|cerebral oxygenation
5381212|NCT01806844|Pre-hospital|pre-hospital
5381213|NCT01806805|Movement disorder|movement disorder
5381214|NCT01806805|Myoclonus dystonia|myoclonus dystonia
5381215|NCT01806805|DYT 11|dyt 11
5381216|NCT01806805|Antiepileptic drugs|antiepileptic drugs
5381217|NCT01806805|Zonisamide|zonisamide
5381218|NCT01806805|Clinical Trial|clinical trial
5381219|NCT01806805|Double-mind method|double-mind method
5381220|NCT01806792|Osteoporosis|osteoporosis
5381221|NCT01806779|Nicotine addiction|nicotine addiction
5381222|NCT01806779|Cigarette smoking|cigarette smoking
5381223|NCT01806779|Smoking cessation|smoking cessation
5381224|NCT01806779|Zyban|zyban
5381225|NCT01806779|Chantix|chantix
5381226|NCT01806779|Nicotine patches|nicotine patches
5381227|NCT01806779|varenicline|varenicline
5381228|NCT01806779|bupropion|bupropion
5381229|NCT01806766|cementless total hip arthroplasty|cementless total hip arthroplasty
5381230|NCT01806766|ceramic on ceramic bearing|ceramic on ceramic bearing
5381231|NCT01806766|ceramic on highly cross linked polyethylene|ceramic on highly cross linked polyethylene
5381232|NCT01806766|young patient|young patient
5381233|NCT01806753|Endoscopic submucosal dissection|endoscopic submucosal dissection
5381234|NCT01806753|Sedation|sedation
5381235|NCT01806753|Propofol|propofol
5381236|NCT01806753|Midazolam|midazolam
5381237|NCT01806740|DCE-MRI|dce-mri
5381238|NCT01806740|Sorafenib response|sorafenib response
5381239|NCT01806727|Diabetes|diabetes
5381240|NCT01806727|Diabetes Self Management|diabetes self management
5381241|NCT01806727|LIFT Diabetes|lift diabetes
5381242|NCT01806727|Weight Loss|weight loss
5381243|NCT01806727|Diet|diet
5381244|NCT01806727|Physical Activity|physical activity
5381245|NCT01806727|Overweight|overweight
5381246|NCT01806727|Obese|obese
5381247|NCT01806714|HPV vaccination|hpv vaccination
5381248|NCT01806714|Adolescent well care|adolescent well care
5381249|NCT01806714|Adolescent HPV immunization|adolescent hpv immunization
5381250|NCT01806714|HPV|hpv
5381251|NCT01806701|fMRI|fmri
5381252|NCT01806701|neuroimaging|neuroimaging
5381253|NCT01806701|PTSD|ptsd
5381254|NCT01806701|adolescent|adolescent
5381255|NCT01806701|trauma|trauma
5381256|NCT01806701|brain|brain
5381257|NCT01806688|satiety|satiety
5381258|NCT01806688|appetite|appetite
5381259|NCT01806688|snack|snack
5376604|NCT01828177|PDI-320|pdi-320
5381260|NCT01806662|Atopic Dermatitis|atopic dermatitis
5381262|NCT01806649|esophageal cancer|esophageal cancer
5381263|NCT01806649|second line therapy|second line therapy
5381265|NCT01806636|Coil|coil
5381266|NCT01806636|RePneu|repneu
5381267|NCT01806636|PneumRx|pneumrx
5381268|NCT01806636|LVRC|lvrc
5381269|NCT01806610|Randomized|randomized
5381270|NCT01806610|Placebo-controlled trial|placebo-controlled trial
5381272|NCT01806610|Safety, tolerability, and PK|safety, tolerability, and pk
5381273|NCT01806610|Patients with late-stage chronic kidney disease.|patients with late-stage chronic kidney disease.
5671200|NCT00616785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5671201|NCT00616759|Depression|depression
5002886|NCT03978026|vigilance|vigilance
5381274|NCT01806597|Skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques|skin condition, itching, psoriasis vulgaris, relapsing remitting psoriasis, immune-med systemic disease, skin lesions, scaly patches, papules, plaques
5381275|NCT01806584|Vascular Injury|vascular injury
5381276|NCT01806584|Arteriovenous Graft Surgery|arteriovenous graft surgery
5381277|NCT01806584|Hemodialysis Access|hemodialysis access
5381278|NCT01806558|Breast cancer|breast cancer
5381279|NCT01806558|molecular breast imaging|molecular breast imaging
5381280|NCT01806558|breast|breast
5381281|NCT01806558|breast lesion|breast lesion
5381282|NCT01806545|Arteriovenous Fistula Surgery|arteriovenous fistula surgery
5381283|NCT01806545|Vascular Injury|vascular injury
5381284|NCT01806545|Hemodialysis Access|hemodialysis access
5381285|NCT01806532|computed tomography and positron emission tomography|computed tomography and positron emission tomography
5381286|NCT01806532|respiration, artificial|respiration, artificial
5381287|NCT01806532|respiratory distress syndrome, adult|respiratory distress syndrome, adult
5381288|NCT01806519|neck pain|neck pain
5381289|NCT01806519|motor control|motor control
5381290|NCT01806519|intervention|intervention
5381291|NCT01806519|forward head posture|forward head posture
5381292|NCT01806506|Bariatric surgery|bariatric surgery
5381293|NCT01806506|Gastric bypass|gastric bypass
5381294|NCT01806506|Sleeve gastrectomy|sleeve gastrectomy
5381295|NCT01806506|Weight loss|weight loss
5381296|NCT01806506|Lipoproteins|lipoproteins
5381297|NCT01806506|Insulin resistance|insulin resistance
5381298|NCT01806506|Incretins|incretins
5381299|NCT01806506|Quality of life|quality of life
5381300|NCT01806493|body composition|body composition
5381301|NCT01806493|obesity|obesity
5381302|NCT01806480|Breastfeeding, Preterm Infant, Neonatal Care, Support, Mothers.|breastfeeding, preterm infant, neonatal care, support, mothers.
5381303|NCT01806415|Fenobam,|fenobam,
5381304|NCT01806415|Pharmacokinetics|pharmacokinetics
5381305|NCT01806415|side effects|side effects
5381306|NCT01806389|Breast milk|breast milk
5381307|NCT01806389|Breastfeeding|breastfeeding
5381308|NCT01806389|Lactation|lactation
5381309|NCT01806389|Buprenorphine|buprenorphine
5381310|NCT01806389|Opioid|opioid
5381311|NCT01806363|Pharmacokinetics|pharmacokinetics
5381312|NCT01806363|Safety|safety
5381313|NCT01806363|Male|male
5381314|NCT01806350|Pelvic floor muscle training; incontinence; quality of life|pelvic floor muscle training; incontinence; quality of life
5381315|NCT01806337|peripheral T cell lymphoma|peripheral t cell lymphoma
5381316|NCT01806337|alemtuzumab|alemtuzumab
5381317|NCT01806337|consolidation|consolidation
5381318|NCT01806311|Pharmacokinetics|pharmacokinetics
5381319|NCT01806311|Safety|safety
5381320|NCT01806311|Male|male
5381321|NCT01806298|Adult Growth hormone deficiency|adult growth hormone deficiency
5381322|NCT01806298|Saizen®|saizen®
5381323|NCT01806298|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5381324|NCT01806298|Somatropin|somatropin
5381325|NCT01806285|Respiratory Virus|respiratory virus
5381326|NCT01806272|rhGM-CSF|rhgm-csf
5381327|NCT01806272|Oral Mucositis|oral mucositis
5381328|NCT01806272|Primary Nasopharyngeal Cancers|primary nasopharyngeal cancers
5381329|NCT01806272|Chemoradiotherapy|chemoradiotherapy
5381330|NCT01806246|rehabilitation|rehabilitation
5381331|NCT01806246|adolescent|adolescent
5381332|NCT01806246|heart rate variability biofeedback|heart rate variability biofeedback
5381333|NCT01806246|psychoeducation|psychoeducation
5381334|NCT01806220|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5381335|NCT01806220|Chronic Laryngitis|chronic laryngitis
5381336|NCT01806220|Epidermal Growth factor receptor|epidermal growth factor receptor
5381337|NCT01806168|Post-traumatic stress disorder|post-traumatic stress disorder
5381338|NCT01806168|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5381339|NCT01806168|Civilians|civilians
5381340|NCT01806168|Neurostimulation|neurostimulation
5381341|NCT01806168|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5381342|NCT01806155|craniotomy|craniotomy
5381343|NCT01806155|headache|headache
5381344|NCT01806155|postoperative|postoperative
5381345|NCT01806116|myelodysplastic syndrome|myelodysplastic syndrome
5381346|NCT01806116|higher-risk|higher-risk
5381347|NCT01806116|acute myeloid leukemia|acute myeloid leukemia
5381348|NCT01806116|relapsed /refractory|relapsed /refractory
5381349|NCT01806116|decitabine|decitabine
5376702|NCT01827800|primary care|primary care
5381350|NCT01806116|hematopoietic cell transplantation|hematopoietic cell transplantation
5381351|NCT01806116|bridge therapy|bridge therapy
5381352|NCT01806103|antimicrobial stewardship program|antimicrobial stewardship program
5381353|NCT01806103|inappropriate prescribing of antibiotics|inappropriate prescribing of antibiotics
5381355|NCT01806103|antibiotic prescribing for respiratory tract infections|antibiotic prescribing for respiratory tract infections
5381356|NCT01806103|respiratory tract infections|respiratory tract infections
5381359|NCT01806077|Coronary Artery Disease|coronary artery disease
5381360|NCT01806077|Coronary Disease|coronary disease
5381361|NCT01806077|Arteriosclerosis|arteriosclerosis
5381362|NCT01806077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5510481|NCT01250912|Imaging|imaging
5381364|NCT01806064|CD105|cd105
5381366|NCT01806064|Renal Cell Carcinoma|renal cell carcinoma
5381367|NCT01806064|Axitinib|axitinib
5381368|NCT01806064|INLYTA|inlyta
5381369|NCT01806064|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5381370|NCT01806038|Adverse events|adverse events
5381371|NCT01806038|Drug interactions|drug interactions
5381372|NCT01806038|Healthcare utilization|healthcare utilization
5381373|NCT01806038|Discharge medication counseling|discharge medication counseling
5381374|NCT01806025|Cystic Fibrosis|cystic fibrosis
5381375|NCT01806025|Haptoglobin|haptoglobin
5381376|NCT01806012|Supracervical Hysterectomy|supracervical hysterectomy
5381377|NCT01806012|Leiomyomas|leiomyomas
5381378|NCT01806012|Adenomyosis|adenomyosis
5381379|NCT01805999|Ispaghula|ispaghula
5381380|NCT01805999|Gastrointestinal physiology|gastrointestinal physiology
5381381|NCT01805999|Gastrointestinal response to sugars|gastrointestinal response to sugars
5381382|NCT01805999|MRI|mri
5381383|NCT01805999|gastrointestinal|gastrointestinal
5381384|NCT01805999|stomach|stomach
5381385|NCT01805999|small bowel|small bowel
5381386|NCT01805999|colon|colon
5381387|NCT01805986|Multiple Sclerosis, other neurological conditions|multiple sclerosis, other neurological conditions
5381388|NCT01805934|Helicobacter pylori, rescue, quadruple therapy，dual therapy|helicobacter pylori, rescue, quadruple therapy，dual therapy
5381389|NCT01805921|Respiratory Syncytial Virus|respiratory syncytial virus
5381390|NCT01805921|RSV|rsv
5381391|NCT01805921|Vaccine|vaccine
5381392|NCT01805908|metastatic|metastatic
5381393|NCT01805908|breast cancer|breast cancer
5381394|NCT01805908|herceptin|herceptin
5381395|NCT01805908|imaging|imaging
5381396|NCT01805908|tumour response|tumour response
5381397|NCT01805908|adenocarcinoma|adenocarcinoma
5381398|NCT01805908|SPECT-CT|spect-ct
5381399|NCT01805908|pertuzumab|pertuzumab
5381400|NCT01805908|trastuzumab|trastuzumab
5381401|NCT01805908|locally advanced|locally advanced
5381402|NCT01805895|Stroke|stroke
5381403|NCT01805895|Acute Intracerebral Hemorrhage|acute intracerebral hemorrhage
5381404|NCT01805895|Intracerebral Hemorrhage|intracerebral hemorrhage
5381405|NCT01805895|Hemorrhagic stroke|hemorrhagic stroke
5381406|NCT01805895|Hemorrhage|hemorrhage
5381407|NCT01805895|Minocycline|minocycline
5381408|NCT01805882|Interferon Sparing|interferon sparing
5381409|NCT01805882|Directly Acting Antiviral|directly acting antiviral
5381410|NCT01805882|Ribavarin Sparing|ribavarin sparing
5381413|NCT01805856|antimicrobial prophylaxis|antimicrobial prophylaxis
5381414|NCT01805856|AMP|amp
5381415|NCT01805856|surgical site infection|surgical site infection
5381416|NCT01805856|SSI|ssi
5381417|NCT01805856|thyroid|thyroid
5381418|NCT01805856|thyroidectomy|thyroidectomy
5381419|NCT01805856|parathyroid|parathyroid
5381420|NCT01805856|surgery|surgery
5381421|NCT01805843|Pulmonary hypertension|pulmonary hypertension
5381422|NCT01805843|chronic myeloid leukemia|chronic myeloid leukemia
5381423|NCT01805843|dasatinib|dasatinib
5381424|NCT01805843|nilotinib|nilotinib
5381425|NCT01805830|Type2DM / DPP-IV inhibitors|type2dm / dpp-iv inhibitors
5381426|NCT01805817|lipid profile|lipid profile
5381427|NCT01805817|bleeding scores|bleeding scores
5381428|NCT01805817|menstrual pattern|menstrual pattern
5381429|NCT01805817|beneficial|beneficial
5381430|NCT01805817|side effects|side effects
5381431|NCT01805817|changes in a year period|changes in a year period
5381432|NCT01805804|dual chamber pacing, left ventricle remodeling, valsartan|dual chamber pacing, left ventricle remodeling, valsartan
5381433|NCT01805791|Ulcerative Colitis,|ulcerative colitis,
5381435|NCT01805791|Patients|patients
5381436|NCT01805791|active|active
5381437|NCT01805791|mild|mild
5381438|NCT01805791|moderate|moderate
5381439|NCT01805765|menopausal syndrome|menopausal syndrome
5381440|NCT01805765|climacteric syndrome|climacteric syndrome
5381441|NCT01805765|Hot flashes|hot flashes
5381442|NCT01805765|Sweat|sweat
5381443|NCT01805752|Prevention of mother to child HIV transmission|prevention of mother to child hiv transmission
5381444|NCT01805752|HIV/AIDS|hiv/aids
5381445|NCT01805739|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5381446|NCT01805739|CT|ct
5381447|NCT01805739|MRI|mri
5381448|NCT01805739|angiography|angiography
5381449|NCT01805739|echocardiography|echocardiography
5381450|NCT01805739|rotational C-arm CT|rotational c-arm ct
5381451|NCT01805726|bronchoscopy|bronchoscopy
5381452|NCT01805726|sedation|sedation
5381453|NCT01805726|pulmonary function|pulmonary function
5381460|NCT01805700|diabetes|diabetes
5381461|NCT01805700|caffeine-enhanced energy drink|caffeine-enhanced energy drink
5381462|NCT01805700|cardiac output|cardiac output
5381463|NCT01805700|glucose|glucose
5381464|NCT01805700|cognitive performance|cognitive performance
5381465|NCT01805674|menopause|menopause
5381466|NCT01805674|quality of life|quality of life
5381467|NCT01805674|soy isoflavones|soy isoflavones
5903859|NCT00261456|BRCA1|brca1
5381468|NCT01805674|magnolia extract|magnolia extract
5381469|NCT01805661|early ambulation|early ambulation
5002888|NCT03978026|driving simulation|driving simulation
5381470|NCT01805661|knee arthroplasty|knee arthroplasty
5381471|NCT01805648|ITP|itp
5381472|NCT01805648|rhTPO|rhtpo
5381473|NCT01805635|Children|children
5381474|NCT01805635|Asthma|asthma
5381475|NCT01805635|Allergic rhinitis|allergic rhinitis
5381476|NCT01805635|Atopic dermatitis|atopic dermatitis
5381477|NCT01805635|Urticaria|urticaria
5381478|NCT01805635|Healthy|healthy
5381479|NCT01805622|community-based participatory research|community-based participatory research
5381480|NCT01805622|colorectal cancer screening|colorectal cancer screening
5381481|NCT01805609|practice nurse|practice nurse
5381482|NCT01805609|clinical Nurse|clinical nurse
5381483|NCT01805609|inpatient staff|inpatient staff
5381484|NCT01805609|inpatient social worker|inpatient social worker
5381485|NCT01805609|didactic training sessions|didactic training sessions
5381486|NCT01805609|13-030|13-030
5381487|NCT01805596|coronary artery disease|coronary artery disease
5381488|NCT01805596|endothelial function|endothelial function
5381489|NCT01805596|antiplatelet agent|antiplatelet agent
5381490|NCT01805570|platelet inhibitor|platelet inhibitor
5381491|NCT01805570|ST-segment Elevation|st-segment elevation
5381492|NCT01805570|Myocardial Infarction|myocardial infarction
5381493|NCT01805570|stent|stent
5381494|NCT01805570|prasugrel|prasugrel
5381495|NCT01805570|ticagrelor|ticagrelor
5381496|NCT01805557|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5381497|NCT01805557|Bortezomib|bortezomib
5381498|NCT01805544|SF36 questionnaire|sf36 questionnaire
5381499|NCT01805544|Anti Clot Treatment Scale|anti clot treatment scale
5381500|NCT01805544|Satisfaction|satisfaction
5381501|NCT01805544|Quality of Life|quality of life
5381502|NCT01805544|Rivaroxaban|rivaroxaban
5381503|NCT01805544|Prevention & control|prevention & control
5381504|NCT01805544|Pulmonary embolism|pulmonary embolism
5381505|NCT01805531|SF36 questionnaire|sf36 questionnaire
5381506|NCT01805531|Anti Clot Treatment Scale|anti clot treatment scale
5381507|NCT01805531|Satisfaction|satisfaction
5381508|NCT01805531|Quality of Life|quality of life
5381509|NCT01805531|Rivaroxaban|rivaroxaban
5381510|NCT01805531|Stroke prevention|stroke prevention
5381511|NCT01805518|CNSVS|cnsvs
5381512|NCT01805518|Tower of London|tower of london
5381513|NCT01805518|Letter-Number Test|letter-number test
5381514|NCT01805518|Trail Making Test|trail making test
5381515|NCT01805518|Vital signs|vital signs
5381516|NCT01805518|Mood|mood
5381517|NCT01805518|Suicidal ideation|suicidal ideation
5381518|NCT01805518|ECG|ecg
5381519|NCT01805518|Physical exam|physical exam
5381520|NCT01805518|Blood|blood
5381521|NCT01805518|Urine (Including pregnancy and drug screen)|urine (including pregnancy and drug screen)
5381522|NCT01805518|Cytokines|cytokines
5381523|NCT01805518|Side effects|side effects
5381524|NCT01805518|Brief Psychiatric Rating Scale|brief psychiatric rating scale
5381525|NCT01805518|Positive and Negative Symptom Scale|positive and negative symptom scale
5381526|NCT01805505|Female infertility|female infertility
5381527|NCT01805505|Oocyte donation|oocyte donation
5381528|NCT01805505|Embryo transfer|embryo transfer
5381529|NCT01805505|Transvaginal ultrasonography|transvaginal ultrasonography
5381530|NCT01805505|Transabdominal ultrasonography|transabdominal ultrasonography
5381531|NCT01805492|Heart diseases|heart diseases
5381532|NCT01805492|Cardiovascular diseases|cardiovascular diseases
5381533|NCT01805492|Lifestyle modification|lifestyle modification
5381534|NCT01805492|Diet|diet
5381535|NCT01805492|Exercise|exercise
5381536|NCT01805479|exercise|exercise
5381537|NCT01805479|depression|depression
5381538|NCT01805479|traumatic brain injury|traumatic brain injury
5381539|NCT01805466|Extracorporeal Vacuum Assisted Device Optimised (EVADO)|extracorporeal vacuum assisted device optimised (evado)
5381540|NCT01805453|Glioblastoma|glioblastoma
5381541|NCT01805453|Angiotensin-II inhibitors|angiotensin-ii inhibitors
5381542|NCT01805453|Losartan|losartan
5381543|NCT01805453|steroids|steroids
5381544|NCT01805453|Radiotherapy|radiotherapy
5381545|NCT01805453|Edema|edema
5381546|NCT01805453|Randomized trial|randomized trial
5381547|NCT01805440|Adolescent|adolescent
5381548|NCT01805440|Bipolar Disorder|bipolar disorder
5381549|NCT01805440|Bipolar Depression|bipolar depression
5381550|NCT01805440|Manic Depression|manic depression
5381565|NCT01805401|Neuromodulation|neuromodulation
5381566|NCT01805401|tDCS|tdcs
5381567|NCT01805401|Iowa Gambling Task|iowa gambling task
5381568|NCT01805401|Stroop Word-Color Task|stroop word-color task
5381569|NCT01805388|Dental Pulp Regeneration|dental pulp regeneration
5381570|NCT01805375|Phase I, Cancer, CD19 positive, B-Cell lymphoma, chronic lymphocytic leukaemia|phase i, cancer, cd19 positive, b-cell lymphoma, chronic lymphocytic leukaemia
5381571|NCT01805375|Waldenström Macroglobulinaemia|waldenström macroglobulinaemia
5381572|NCT01805336|Relapsing-Remitting MS|relapsing-remitting ms
5381573|NCT01805336|cognitive impairment|cognitive impairment
5381574|NCT01805336|virtual reality|virtual reality
5381575|NCT01805310|Pelvic organ prolapse|pelvic organ prolapse
5381576|NCT01805310|Prolapse|prolapse
5381577|NCT01805310|Cathartics|cathartics
5002889|NCT03977987|hepatitis B|hepatitis b
5354991|NCT01925859|EryDex|erydex
5381578|NCT01805310|Mechanical bowel preparation|mechanical bowel preparation
5381579|NCT01805297|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5381580|NCT01805284|pneumonia|pneumonia
5381581|NCT01805271|ER-positive HER2-negative|er-positive her2-negative
5367262|NCT01869699|Fever|fever
5381583|NCT01805258|Nevirapine|nevirapine
5381584|NCT01805258|Rifampicin|rifampicin
5381585|NCT01805258|Efavirenz|efavirenz
5381586|NCT01805258|HIV|hiv
5381587|NCT01805258|TB|tb
5381588|NCT01805232|severe|severe
5381589|NCT01805232|Falciaparum|falciaparum
5381590|NCT01805232|Malaria|malaria
5381591|NCT01805206|Prematurity|prematurity
5381592|NCT01805206|Necrotizing Enterocolitis|necrotizing enterocolitis
5381593|NCT01805206|Biomarkers|biomarkers
5381594|NCT01805206|Intestinal Fatty Acid Binding Protein|intestinal fatty acid binding protein
5381595|NCT01805206|Feeding|feeding
5381596|NCT01805193|Coronary heart disease|coronary heart disease
5381597|NCT01805193|computed tomography myocardial perfusion|computed tomography myocardial perfusion
5381598|NCT01805193|positron emission tomography|positron emission tomography
5381599|NCT01805193|oxygen 15 labelled water|oxygen 15 labelled water
5381600|NCT01805193|myocardial perfusion|myocardial perfusion
5381601|NCT01805193|myocardial blood flow|myocardial blood flow
5381602|NCT01805167|Subject with cochlear implant|subject with cochlear implant
5381603|NCT01805141|Cervix Uteri|cervix uteri
5381604|NCT01805128|Schizophrenia|schizophrenia
5381605|NCT01805128|Autistic Disorder|autistic disorder
5381606|NCT01805128|social cognition|social cognition
5381607|NCT01805115|hysteroscopy|hysteroscopy
5381608|NCT01805115|misoprostol|misoprostol
5381609|NCT01805102|In vitro fertilization|in vitro fertilization
5381610|NCT01805102|implantation|implantation
5381611|NCT01805102|miscarriage|miscarriage
5381612|NCT01805102|live birth|live birth
5381613|NCT01805063|firefighters|firefighters
5381614|NCT01805063|myocardial infarction|myocardial infarction
5381615|NCT01805063|endothelial function|endothelial function
5381616|NCT01805063|thrombosis|thrombosis
5381617|NCT01805063|fire suppression|fire suppression
5381618|NCT01805063|non-fire emergency duty|non-fire emergency duty
5381619|NCT01805063|sedentary shift|sedentary shift
5381620|NCT01805050|HAGL|hagl
5381621|NCT01805050|Shoulder instability|shoulder instability
5381622|NCT01804998|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
5381623|NCT01804998|phase 3|phase 3
5381624|NCT01804998|early gastric cancer|early gastric cancer
5381625|NCT01804972|Patient information|patient information
5381626|NCT01804972|Vascular disease|vascular disease
5381627|NCT01804972|Abdominal aortic aneurysm|abdominal aortic aneurysm
5381628|NCT01804972|Varicose veins|varicose veins
5381629|NCT01804972|Web based information|web based information
5376996|NCT01826656|tooth extraction|tooth extraction
5381630|NCT01804933|profound muscle relaxation|profound muscle relaxation
5381631|NCT01804933|muscle trauma|muscle trauma
5381632|NCT01804933|postoperative analgesic demand|postoperative analgesic demand
5381633|NCT01804933|postoperative pulmonary function|postoperative pulmonary function
5381634|NCT01804907|HAART adherence|haart adherence
5381636|NCT01804907|Fatigue|fatigue
5381637|NCT01804907|treatment|treatment
5381638|NCT01804868|case vignette|case vignette
5381639|NCT01804868|nurse|nurse
5381640|NCT01804868|critical assessment|critical assessment
5381641|NCT01804868|randomized controlled trial|randomized controlled trial
5381642|NCT01804855|Obesity; mobile health; telemedicine; family-based treatment|obesity; mobile health; telemedicine; family-based treatment
5381643|NCT01804829|HCV Liver Transplant Immunoglobulin PCR SVR|hcv liver transplant immunoglobulin pcr svr
5381644|NCT01804816|Chronic Heart Failure|chronic heart failure
5381645|NCT01804816|Heart Failure|heart failure
5381646|NCT01804803|glycated hemoglobin|glycated hemoglobin
5381647|NCT01804803|hyperglycemia|hyperglycemia
5381648|NCT01804803|hypoglycemia|hypoglycemia
5381649|NCT01804803|insulin|insulin
5381650|NCT01804803|self-monitoring of blood glucose|self-monitoring of blood glucose
5381651|NCT01804803|telemedicine|telemedicine
5381652|NCT01804790|rectum|rectum
5381653|NCT01804790|cancer|cancer
5381654|NCT01804790|locally advanced|locally advanced
5381655|NCT01804777|ENaC|enac
5381659|NCT01804777|Type II Diabetes|type ii diabetes
5381660|NCT01804777|Natriuresis|natriuresis
5381661|NCT01804777|Proteinuria|proteinuria
5381662|NCT01804764|Severe Sepsis|severe sepsis
5381663|NCT01804764|Septic Shock|septic shock
5381664|NCT01804764|Sepsis Six bundle|sepsis six bundle
5381665|NCT01804738|Ethnic differences|ethnic differences
5381666|NCT01804738|Inter-individual variability|inter-individual variability
5381667|NCT01804738|Glycemic response|glycemic response
5381668|NCT01804738|Insulin response|insulin response
5381669|NCT01804738|Mastication|mastication
5381670|NCT01804738|Salivary alpha-amylase|salivary alpha-amylase
5381671|NCT01804738|Gastric emptying|gastric emptying
5381672|NCT01804738|Metagenome|metagenome
5381673|NCT01804725|bike seats|bike seats
5381674|NCT01804725|Erectile dysfunction|erectile dysfunction
5381675|NCT01804725|Perineum|perineum
5381676|NCT01804725|Impotence|impotence
5381677|NCT01804712|Prostate|prostate
5381678|NCT01804712|Cancer|cancer
5381679|NCT01804712|Castration-resistant|castration-resistant
5381680|NCT01804712|Rituximab|rituximab
5381681|NCT01804712|neoadjuvant|neoadjuvant
5381682|NCT01804712|Rituxan|rituxan
5381683|NCT01804699|ARVC, Cardiomyopathy|arvc, cardiomyopathy
5381684|NCT01804686|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5381685|NCT01804686|Small lymphocytic lymphoma|small lymphocytic lymphoma
5381686|NCT01804686|Mantle cell lymphoma|mantle cell lymphoma
5381687|NCT01804686|Follicular lymphoma|follicular lymphoma
5381688|NCT01804686|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5381690|NCT01804686|Ibrutinib|ibrutinib
5381691|NCT01804686|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5381692|NCT01804686|IMBRUVICA|imbruvica
5381693|NCT01804686|JNJ-54179060|jnj-54179060
5381694|NCT01804673|Postoperative Pain|postoperative pain
5381695|NCT01804673|Fentanyl Hydrochloride|fentanyl hydrochloride
5381696|NCT01804673|IONSYS|ionsys
5381697|NCT01804660|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5381698|NCT01804660|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
5381699|NCT01804660|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
5381700|NCT01804647|Multiple sclerosis (MS)|multiple sclerosis (ms)
5381701|NCT01804647|Relapsing-Remitting MS|relapsing-remitting ms
5381702|NCT01804647|Primary progressive MS|primary progressive ms
5381703|NCT01804647|Secondary progressive MS|secondary progressive ms
5381704|NCT01804647|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5381705|NCT01804647|Multiple Sclerosis associated RetroVirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
5381706|NCT01804647|MSRV envelop protein (MSRV-Env)|msrv envelop protein (msrv-env)
5381707|NCT01804634|Solid Tumors|solid tumors
5381708|NCT01804634|Neuroblastoma|neuroblastoma
5381709|NCT01804634|Osteosarcoma|osteosarcoma
5381710|NCT01804634|Ewing Sarcoma|ewing sarcoma
5381711|NCT01804634|Rhabdomyosarcoma|rhabdomyosarcoma
5381712|NCT01804634|Hepatoblastoma|hepatoblastoma
5381713|NCT01804634|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
5381714|NCT01804621|Exercise|exercise
5381715|NCT01804621|Nutrition|nutrition
5381716|NCT01804621|Mammography|mammography
5381717|NCT01804621|Colorectal screening|colorectal screening
5381718|NCT01804595|Worksite intervention|worksite intervention
5381719|NCT01804595|Sun protection intervention|sun protection intervention
5381720|NCT01804595|Operating Engineers|operating engineers
5381721|NCT01804582|Family navigator|family navigator
5381722|NCT01804582|Patient Centered Outcomes|patient centered outcomes
5381723|NCT01804582|Pediatric Antipsychotic treatment|pediatric antipsychotic treatment
5381724|NCT01804556|muscle cramps, trigger points, sleep disturbance|muscle cramps, trigger points, sleep disturbance
5381725|NCT01804530|solid tumors|solid tumors
5381726|NCT01804530|activating NTRK point or fusion mutations|activating ntrk point or fusion mutations
5381730|NCT01804504|Metabolic syndrome|metabolic syndrome
5381731|NCT01804504|Eating out of home|eating out of home
5381732|NCT01804504|Nutrition education|nutrition education
5381733|NCT01804465|castration resistant|castration resistant
5381735|NCT01804465|cancer|cancer
5381736|NCT01804465|ipilimumab|ipilimumab
5381737|NCT01804465|provenge|provenge
5381738|NCT01804465|SipT|sipt
5381739|NCT01804452|Progressive Supranuclear Palsy|progressive supranuclear palsy
5381740|NCT01804452|Corticobasal Degeneration|corticobasal degeneration
5381741|NCT01804452|Biomarker|biomarker
5381742|NCT01804452|Neuroimaging|neuroimaging
5381743|NCT01804452|MRI|mri
5381744|NCT01804452|Tau|tau
5381745|NCT01804452|Oculomotor|oculomotor
5381746|NCT01804439|Heart diseases|heart diseases
5381747|NCT01804439|Cardiovascular diseases|cardiovascular diseases
5385349|NCT01788423|presbycusis|presbycusis
5381848|NCT01804257|Patient nonadherence|patient nonadherence
5381748|NCT01804439|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
5381749|NCT01804439|Cerebrovascular disorders|cerebrovascular disorders
5381750|NCT01804439|Brain diseases|brain diseases
5381751|NCT01804439|Central nervous system diseases|central nervous system diseases
5381752|NCT01804439|Nervous system diseases|nervous system diseases
5381753|NCT01804439|Atherosclerosis|atherosclerosis
5381754|NCT01804439|Arteriosclerosis|arteriosclerosis
5381755|NCT01804439|Pathologic processes|pathologic processes
5381756|NCT01804439|Acute myocardial infarction|acute myocardial infarction
5381757|NCT01804439|Myocardial infarction|myocardial infarction
5381758|NCT01804439|Myocardial ischemia|myocardial ischemia
5381759|NCT01804439|Infarction|infarction
5381760|NCT01804439|Necrosis|necrosis
5381761|NCT01804439|Unstable angina|unstable angina
5381762|NCT01804439|Chronic stable angina|chronic stable angina
5381763|NCT01804439|Stable angina|stable angina
5381764|NCT01804439|Angina pectoris|angina pectoris
5381765|NCT01804439|Chest pain|chest pain
5381766|NCT01804439|Pain|pain
5381767|NCT01804439|Signs and symptoms|signs and symptoms
5381768|NCT01804439|Ischemia|ischemia
5355183|NCT01925027|DAPT|dapt
5369268|NCT01860586|rd|rd
5381769|NCT01804439|Ischemic stroke|ischemic stroke
5381770|NCT01804439|Hemorrhagic stroke|hemorrhagic stroke
5381771|NCT01804439|Stroke|stroke
5381772|NCT01804439|Subarachnoid hemorrhage|subarachnoid hemorrhage
5367457|NCT01868906|Glioblastoma|glioblastoma
5381773|NCT01804439|Transient ischemic attack|transient ischemic attack
5381774|NCT01804439|Abdominal aortic aneurysm|abdominal aortic aneurysm
5381775|NCT01804439|Aneurysm|aneurysm
5381776|NCT01804439|Aortic aneurysm|aortic aneurysm
5381777|NCT01804439|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
5381778|NCT01804439|Aortic diseases|aortic diseases
5381779|NCT01804439|Peripheral arterial diseases|peripheral arterial diseases
5381780|NCT01804439|Peripheral vascular diseases|peripheral vascular diseases
5381781|NCT01804439|Vascular diseases|vascular diseases
5381782|NCT01804439|Peripheral occlusive diseases|peripheral occlusive diseases
5381783|NCT01804439|Sudden coronary death|sudden coronary death
5381784|NCT01804439|Ventricular arrhythmia|ventricular arrhythmia
5381785|NCT01804439|Sudden cardiac death|sudden cardiac death
5381786|NCT01804439|Cardiac arrest|cardiac arrest
5381787|NCT01804439|Heart failure|heart failure
5381788|NCT01804426|PTSD|ptsd
5381789|NCT01804426|Post Traumatic Stress Disorder|post traumatic stress disorder
5381790|NCT01804426|Cortisol|cortisol
5381791|NCT01804426|Alpha-Amylase|alpha-amylase
5381792|NCT01804426|bio-Markers|bio-markers
5381793|NCT01804413|Pegvisomant|pegvisomant
5381794|NCT01804413|Growth hormone|growth hormone
5381795|NCT01804413|Cortisol|cortisol
5381796|NCT01804413|Glucagon|glucagon
5381797|NCT01804413|Insulin|insulin
5381798|NCT01804387|Chronic Hepatitis B|chronic hepatitis b
5381799|NCT01804387|Telbivudine|telbivudine
5381800|NCT01804387|Adefovir|adefovir
5381801|NCT01804387|Lamivudine resistance|lamivudine resistance
5381802|NCT01804374|osteosarcoma|osteosarcoma
5381803|NCT01804374|sorafenib|sorafenib
5381804|NCT01804374|everolimus|everolimus
5381805|NCT01804374|sarcoma|sarcoma
5381806|NCT01804361|Dry Eye Syndromes|dry eye syndromes
5381807|NCT01804348|PROM|prom
5381808|NCT01804335|Lymphoma|lymphoma
5381809|NCT01804335|Early Stage Cutaneous T-Cell Lymphoma|early stage cutaneous t-cell lymphoma
5381810|NCT01804335|CTCL|ctcl
5381811|NCT01804335|CD5789 0.01% cream|cd5789 0.01% cream
5381812|NCT01804322|epilepsy|epilepsy
5381813|NCT01804322|chronic comorbidities|chronic comorbidities
5381814|NCT01804322|educational strategies|educational strategies
5381815|NCT01804322|drug interactions|drug interactions
5381816|NCT01804322|drug adverse effects|drug adverse effects
5381817|NCT01804309|axyllary lymph node|axyllary lymph node
5381818|NCT01804309|sentinel lymph node|sentinel lymph node
5381819|NCT01804309|lymphatic drainage|lymphatic drainage
5381820|NCT01804309|early breast cancer|early breast cancer
5381821|NCT01804309|axillary lymph node dissection|axillary lymph node dissection
5381822|NCT01804296|Teen|teen
5381823|NCT01804296|Adolescent|adolescent
5381824|NCT01804296|Depression|depression
5381825|NCT01804296|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5381827|NCT01804270|Teen|teen
5381828|NCT01804270|Adolescent|adolescent
5381829|NCT01804270|Depression|depression
5381830|NCT01804270|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5381832|NCT01804257|Adherence|adherence
5381833|NCT01804257|Bipolar disorder|bipolar disorder
5381834|NCT01804257|Cellular phone|cellular phone
5381835|NCT01804257|Cloud computing|cloud computing
5381836|NCT01804257|Computers|computers
5381837|NCT01804257|Computers, handheld|computers, handheld
5381838|NCT01804257|Digital health|digital health
5381839|NCT01804257|Digital health feedback system|digital health feedback system
5381840|NCT01804257|Ingestion Sensor|ingestion sensor
5381841|NCT01804257|Medication adherence|medication adherence
5381842|NCT01804257|Medication non-adherence|medication non-adherence
5381843|NCT01804257|Medication nonadherence|medication nonadherence
5381844|NCT01804257|Mobile phone|mobile phone
5381845|NCT01804257|Mobile health|mobile health
5381846|NCT01804257|Patient adherence|patient adherence
5381852|NCT01804257|Telenursing|telenursing
5381853|NCT01804257|Wearable sensor|wearable sensor
5381855|NCT01804244|Pharmacokinetics|pharmacokinetics
5381856|NCT01804244|Japanese|japanese
5381857|NCT01804231|Prostate Cancer|prostate cancer
5381858|NCT01804231|PET|pet
5381859|NCT01804231|MRI|mri
5381860|NCT01804231|Hybrid|hybrid
5381861|NCT01804231|Recurrence|recurrence
5381862|NCT01804231|Fluorocholine|fluorocholine
5381863|NCT01804205|magnesium sulfate|magnesium sulfate
5381864|NCT01804205|rocuronium|rocuronium
5381865|NCT01804205|neuromuscular block|neuromuscular block
5381866|NCT01804205|onset time|onset time
5381867|NCT01804205|elderly|elderly
5381868|NCT01804192|Acu-TENS|acu-tens
5381869|NCT01804192|MAP|map
5381870|NCT01804192|HR|hr
5381871|NCT01804192|HRV|hrv
5381872|NCT01804179|colon|colon
5381873|NCT01804179|rectum|rectum
5381874|NCT01804179|cancer|cancer
5381875|NCT01804179|screening|screening
5002890|NCT03977987|mother-to-children transmission|mother-to-children transmission
5381876|NCT01804179|questionnaire|questionnaire
5381877|NCT01804179|testing|testing
5381878|NCT01804179|educational materials|educational materials
5680247|NCT00578526|antiangiogenesis therapy|antiangiogenesis therapy
5680248|NCT00578526|SU011248|su011248
5680249|NCT00578526|clinical trial|clinical trial
5381879|NCT01804166|Lymphoma, T-Cell, Peripheral, Infliximab, Golimumab, Remicade, Simponi, Ulcerative Colitis, Crohn's Disease, Inflammatory Bowel Disease|lymphoma, t-cell, peripheral, infliximab, golimumab, remicade, simponi, ulcerative colitis, crohn's disease, inflammatory bowel disease
5381880|NCT01804153|Feminine stress urinary incontinence|feminine stress urinary incontinence
5381881|NCT01804153|Autologous expanded stem cells|autologous expanded stem cells
5381883|NCT01804127|R-CHOP|r-chop
5381884|NCT01804127|PET/CT|pet/ct
5381885|NCT01804088|Peripheral artery disease|peripheral artery disease
5381886|NCT01804088|Iliac arteries|iliac arteries
5381887|NCT01804088|Balloon-expandable stent|balloon-expandable stent
5381888|NCT01804075|NAS|nas
5381889|NCT01804075|NICU|nicu
5381890|NCT01804075|EMMC|emmc
5381891|NCT01804049|metformin|metformin
5381892|NCT01804049|muscle|muscle
5381893|NCT01804049|insulin resistance|insulin resistance
5381894|NCT01804049|sarcopenia|sarcopenia
5381895|NCT01804049|older adults|older adults
5381896|NCT01804049|impaired fasting glucose|impaired fasting glucose
5381897|NCT01803997|Child|child
5381898|NCT01803997|Nutrition|nutrition
5381899|NCT01803997|resonance Raman spectroscopy|resonance raman spectroscopy
5381900|NCT01803997|Fruit & Vegetable|fruit & vegetable
5381901|NCT01803997|Children Cooking|children cooking
5381902|NCT01803984|Migraine|migraine
5381903|NCT01803984|Brain structure|brain structure
5381904|NCT01803984|MRI|mri
5381905|NCT01803971|cardiac arrest|cardiac arrest
5381906|NCT01803971|peripheral venous access|peripheral venous access
5381907|NCT01803971|intraosseous access|intraosseous access
5381908|NCT01803945|Parkinson's disease|parkinson's disease
5381909|NCT01803945|cognitive impairment|cognitive impairment
5381910|NCT01803945|movement disorder|movement disorder
5381911|NCT01803932|intimate partner violence|intimate partner violence
5381912|NCT01803932|gender|gender
5381913|NCT01803932|primary prevention intervention|primary prevention intervention
5381914|NCT01803932|conflict|conflict
5381915|NCT01803932|Cote d'Ivoire|cote d'ivoire
5381916|NCT01803932|Ivory Coast|ivory coast
5381917|NCT01803919|Spinal cord injuries|spinal cord injuries
5381918|NCT01803919|Urinary tract infection|urinary tract infection
5381919|NCT01803919|Urinary catheters|urinary catheters
5381920|NCT01803919|Protocol|protocol
5381921|NCT01803919|Randomized clinical trial|randomized clinical trial
5381922|NCT01803906|mitochondrial disorder|mitochondrial disorder
5381923|NCT01803906|mitochondria|mitochondria
5381924|NCT01803906|oxidative phosphorylation|oxidative phosphorylation
5381925|NCT01803906|oxidative phosphorylation disorders|oxidative phosphorylation disorders
5381926|NCT01803906|respiratory chain disorders|respiratory chain disorders
5381927|NCT01803906|mitochondrial disease|mitochondrial disease
5381929|NCT01803906|kearns sayer|kearns sayer
5381931|NCT01803906|MNGIE|mngie
5381932|NCT01803906|LHON|lhon
5381933|NCT01803906|Mitochondrial depletion syndrome|mitochondrial depletion syndrome
5381934|NCT01803906|Leigh's disease|leigh's disease
5381935|NCT01803893|In vitro fertilization|in vitro fertilization
5381936|NCT01803893|implantation|implantation
5381937|NCT01803893|miscarriage|miscarriage
5381938|NCT01803893|live birth|live birth
5381939|NCT01803880|Articular cartilage|articular cartilage
5381940|NCT01803880|Cartilage lesion|cartilage lesion
5381941|NCT01803880|Cartilage defect|cartilage defect
5381942|NCT01803880|Radiofrequency|radiofrequency
5381943|NCT01803880|Debridement|debridement
5381944|NCT01803880|Cartilage|cartilage
5381945|NCT01803880|Coblation|coblation
5381946|NCT01803880|Knee|knee
5381947|NCT01803880|Meniscus|meniscus
5381948|NCT01803880|Meniscectomy|meniscectomy
5381949|NCT01803880|MR imaging|mr imaging
5381950|NCT01803880|Mechanical debridement|mechanical debridement
5381951|NCT01803880|Mechanical shaver|mechanical shaver
5381952|NCT01803880|Torn meniscus|torn meniscus
5382052|NCT01803529|heat-pack|heat-pack
5381953|NCT01803880|Arthroscopic knee surgery|arthroscopic knee surgery
5381954|NCT01803880|Damaged cartilage|damaged cartilage
5381956|NCT01803867|Multiple Sclerosis|multiple sclerosis
5381957|NCT01803841|Coronary artery disease|coronary artery disease
5381958|NCT01803828|Diabetic Cardiomyopathy|diabetic cardiomyopathy
5381959|NCT01803828|Genders|genders
5381960|NCT01803828|Phosphodiesterase 5A inhibitors|phosphodiesterase 5a inhibitors
5381961|NCT01803828|endothelial dysfunction|endothelial dysfunction
5381962|NCT01803828|inflammation|inflammation
5381963|NCT01803828|diabetic complications|diabetic complications
5381964|NCT01803815|obstructive sleep apnea|obstructive sleep apnea
5381965|NCT01803815|hypertension|hypertension
5381966|NCT01803815|antihypertensive drugs|antihypertensive drugs
5381967|NCT01803802|childhood sexual abuse|childhood sexual abuse
5381968|NCT01803802|depression|depression
5381969|NCT01803802|PTSD|ptsd
5381970|NCT01803802|sexual function|sexual function
5381971|NCT01803802|women|women
5381972|NCT01803789|Metacarpal V Fractures|metacarpal v fractures
5381973|NCT01803789|Single Kirschner Wires|single kirschner wires
5381974|NCT01803789|Double Kirschner Wires|double kirschner wires
5381975|NCT01803776|child|child
5381976|NCT01803776|physical activity|physical activity
5381977|NCT01803776|sedentary activity|sedentary activity
5381978|NCT01803776|nutrition|nutrition
5381979|NCT01803776|diet|diet
5381980|NCT01803776|body composition|body composition
5381981|NCT01803776|overweight|overweight
5381982|NCT01803776|obesity|obesity
5381983|NCT01803776|glucose metabolism disorders|glucose metabolism disorders
5381984|NCT01803776|lipid metabolism disorders|lipid metabolism disorders
5381985|NCT01803776|physical fitness|physical fitness
5381986|NCT01803776|cardiovascular system|cardiovascular system
5381987|NCT01803776|musculoskeletal system|musculoskeletal system
5381988|NCT01803776|bone mineral density|bone mineral density
5381989|NCT01803776|oral health|oral health
5381990|NCT01803776|quality of life|quality of life
5381991|NCT01803776|wellbeing|wellbeing
5381992|NCT01803776|gene-lifestyle interaction|gene-lifestyle interaction
5381993|NCT01803776|health economics|health economics
5381994|NCT01803763|Omalizumab|omalizumab
5381995|NCT01803763|Xolair|xolair
5381996|NCT01803763|Urticaria|urticaria
5381997|NCT01803763|basophils|basophils
5381998|NCT01803763|chronic Urticaria|chronic urticaria
5381999|NCT01803763|Fc Receptor|fc receptor
5382000|NCT01803750|Primary Care Providers|primary care providers
5382001|NCT01803750|Latino Populations|latino populations
5382002|NCT01803750|Disseminate Cancer Prevention|disseminate cancer prevention
5382003|NCT01803750|semi-structured interviews|semi-structured interviews
5382004|NCT01803750|13-031|13-031
5382005|NCT01803737|Weight Loss|weight loss
5382006|NCT01803737|Physical Activity|physical activity
5382007|NCT01803737|Dietary Intake|dietary intake
5382008|NCT01803737|Weight Loss Self-Efficacy|weight loss self-efficacy
5382009|NCT01803737|Motivation|motivation
5382010|NCT01803724|Irritable Bowel Syndrome|irritable bowel syndrome
5382011|NCT01803724|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5382012|NCT01803724|Lactulose breath test|lactulose breath test
5382013|NCT01803724|Glucose breath test|glucose breath test
5382014|NCT01803724|Rifaximin|rifaximin
5382015|NCT01803711|Omega 3 fatty acid|omega 3 fatty acid
5382016|NCT01803711|Fish oil|fish oil
5382017|NCT01803711|Depression|depression
5382018|NCT01803711|cancer|cancer
5382019|NCT01803711|diabetes|diabetes
5382020|NCT01803711|high blood pressure|high blood pressure
5382021|NCT01803711|cardiovascular|cardiovascular
5382022|NCT01803698|Pregnancy|pregnancy
5382023|NCT01803698|Gestational weight gain|gestational weight gain
5382024|NCT01803698|Primary care|primary care
5382025|NCT01803698|Guidelines|guidelines
5382026|NCT01803685|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
5382027|NCT01803685|Surgical removal|surgical removal
5382028|NCT01803685|Endovascular embolism|endovascular embolism
5377393|NCT01824589|TBI|tbi
5382030|NCT01803685|Outcomes|outcomes
5382031|NCT01803672|Adventure-Based training|adventure-based training
5382032|NCT01803672|Health education|health education
5382033|NCT01803672|childhood cancer|childhood cancer
5382034|NCT01803672|physical activity|physical activity
5382035|NCT01803659|b-carotene|b-carotene
5382036|NCT01803659|breastmilk|breastmilk
5382037|NCT01803659|vitamin A|vitamin a
5382038|NCT01803568|Myokine|myokine
5382039|NCT01803568|Insulin sensitivity|insulin sensitivity
5382040|NCT01803568|Exercise|exercise
5382041|NCT01803568|Skeletal muscle|skeletal muscle
5382042|NCT01803555|Budesonide/Formoterol SPIROMAX®|budesonide/formoterol spiromax®
5382043|NCT01803555|SYMBICORT® TURBOHALER®|symbicort® turbohaler®
5382044|NCT01803555|Asthma|asthma
5382045|NCT01803542|Non-small Cell Lung Cancer|non-small cell lung cancer
5382046|NCT01803542|Stereotactic radiation for Lung Cancer|stereotactic radiation for lung cancer
5382047|NCT01803542|Cone beam CT for Lung Cancer|cone beam ct for lung cancer
5382048|NCT01803542|PET/CT for Lung Cancer|pet/ct for lung cancer
5382049|NCT01803529|thorax|thorax
5382050|NCT01803529|Intercostal Muscles|intercostal muscles
5382051|NCT01803529|massage|massage
5382056|NCT01803516|Radiation|radiation
5382057|NCT01803516|Telangiectasias|telangiectasias
5382058|NCT01803516|13-013|13-013
5382059|NCT01803464|Botox|botox
5382060|NCT01803464|Muscle strength|muscle strength
5382061|NCT01803451|gastric bypass|gastric bypass
5382062|NCT01803451|glucose metabolism|glucose metabolism
5382063|NCT01803451|hypoglycemia|hypoglycemia
5382067|NCT01803425|Post-marketing surveillance|post-marketing surveillance
5382068|NCT01803425|Prescribing Information (PI)|prescribing information (pi)
5382069|NCT01803425|Healthy infants and children|healthy infants and children
5382070|NCT01803425|Streptococcus pneumoniae|streptococcus pneumoniae
5382071|NCT01803425|Synflorix™|synflorix™
5382072|NCT01803425|Sri Lanka|sri lanka
5382073|NCT01803412|GSK2402968|gsk2402968
5382074|NCT01803412|open-label extension|open-label extension
5002891|NCT03977987|antiviral treatment|antiviral treatment
5355495|NCT01923740|Angioplasty|angioplasty
5382075|NCT01803412|safety|safety
5382076|NCT01803412|drisapersen|drisapersen
5382077|NCT01803412|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5382078|NCT01803412|tolerability|tolerability
5382079|NCT01803412|Quality of Life|quality of life
5382080|NCT01803399|cardiac repolarization|cardiac repolarization
5382081|NCT01803399|oral|oral
5382083|NCT01803399|GSK1322322|gsk1322322
5382084|NCT01803399|antibiotic|antibiotic
5382085|NCT01803399|12-lead ECG|12-lead ecg
5382086|NCT01803399|placebo|placebo
5382088|NCT01803399|moxifloxacin|moxifloxacin
5382090|NCT01803386|EIM|eim
5382091|NCT01803373|Healthy|healthy
5382092|NCT01803373|Biological Availability|biological availability
5382093|NCT01803373|Bioavailability|bioavailability
5382094|NCT01803373|TMC207|tmc207
5382095|NCT01803373|Bedaquiline|bedaquiline
5382096|NCT01803373|R207910|r207910
5382097|NCT01803347|phase III|phase iii
5382098|NCT01803347|Adipose derived stem cells|adipose derived stem cells
5382099|NCT01803347|Anal fistula|anal fistula
5382100|NCT01803347|Cell therapy|cell therapy
5382101|NCT01803347|Stem cell therapy|stem cell therapy
5382102|NCT01803334|surgical incision|surgical incision
5382103|NCT01803334|laparoscopy|laparoscopy
5382104|NCT01803334|pain|pain
5382105|NCT01803321|SJIA|sjia
5382106|NCT01803308|Hepatitis C Infection|hepatitis c infection
5382107|NCT01803308|Treatment Naïve, Chronic|treatment naïve, chronic
5382108|NCT01803308|First In Human|first in human
5382109|NCT01803308|Single Ascending Dose|single ascending dose
5382110|NCT01803308|Multiple Ascending Dose|multiple ascending dose
5382111|NCT01803295|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5382112|NCT01803295|Intravesical instillation|intravesical instillation
5382113|NCT01803295|Mitomycin C|mitomycin c
5382114|NCT01803295|Hydrogel Reverse thermal gelation|hydrogel reverse thermal gelation
5382115|NCT01803295|Drug retention|drug retention
5382116|NCT01803295|Urinary Bladder Neoplasms|urinary bladder neoplasms
5382117|NCT01803295|Urologic Neoplasms|urologic neoplasms
5382118|NCT01803295|Urinary Bladder Diseases|urinary bladder diseases
5382119|NCT01803295|Urologic Diseases|urologic diseases
5382120|NCT01803295|Mitomycin|mitomycin
5382121|NCT01803282|Solid Tumor|solid tumor
5382122|NCT01803282|NSCLC|nsclc
5382123|NCT01803282|Pancreatic|pancreatic
5382124|NCT01803282|Esophagogastric|esophagogastric
5382125|NCT01803282|Colorectal|colorectal
5382126|NCT01803282|Breast|breast
5382127|NCT01803230|children|children
5382128|NCT01803204|Anxiety|anxiety
5382129|NCT01803204|Orthognathic surgery|orthognathic surgery
5382130|NCT01803204|Patient educational as topic|patient educational as topic
5382131|NCT01803204|Patient educational handout|patient educational handout
5382132|NCT01803204|Pamphlets|pamphlets
5382133|NCT01803191|Transrectal ultrasound-guided prostate biopsy|transrectal ultrasound-guided prostate biopsy
5382134|NCT01803191|Bacteriuria|bacteriuria
5382135|NCT01803191|Antibiotic prophylaxis|antibiotic prophylaxis
5382136|NCT01803191|Prostate-Specific antigen|prostate-specific antigen
5382137|NCT01803178|vascular function|vascular function
5382140|NCT01803165|emesis,post operative.|emesis,post operative.
5382141|NCT01803165|cognitive dysfunction, post operative.|cognitive dysfunction, post operative.
5382142|NCT01803165|wound infection, post operative.|wound infection, post operative.
5382143|NCT01803165|pain, post operative.|pain, post operative.
5382144|NCT01803165|Anesthesia, Conduction/methods|anesthesia, conduction/methods
5382145|NCT01803165|Anesthesiology/methods|anesthesiology/methods
5382146|NCT01803165|Arteriovenous Shunt, Surgical/adverse effects|arteriovenous shunt, surgical/adverse effects
5382147|NCT01803165|Regional Blood Flow/drug effects|regional blood flow/drug effects
5382148|NCT01803165|Risk Factors|risk factors
5382149|NCT01803165|Thrombosis|thrombosis
5382150|NCT01803165|Treatment Outcome|treatment outcome
5382151|NCT01803165|Vascular Surgical Procedures/methods|vascular surgical procedures/methods
5382254|NCT01802645|neoadjuvant|neoadjuvant
5382158|NCT01803152|MDSC Inhibition|mdsc inhibition
5382159|NCT01803139|Breast cancer radiotherapy IMRT|breast cancer radiotherapy imrt
5382160|NCT01803126|atherosclerosis|atherosclerosis
5382161|NCT01803113|Pregnancy|pregnancy
5382163|NCT01803100|Bacterial Colonization|bacterial colonization
5382164|NCT01803087|adolescents|adolescents
5382165|NCT01803087|adults|adults
5382166|NCT01803061|Head and neck cancer|head and neck cancer
5382167|NCT01803061|Quality of life|quality of life
5382168|NCT01803061|Symptom-burden|symptom-burden
5382169|NCT01803061|Late effects|late effects
5382170|NCT01803048|Traumatic Brain Injury|traumatic brain injury
5382171|NCT01803048|Diffusion Weighted Imaging|diffusion weighted imaging
5382172|NCT01803048|Resting State Functional Connectivity|resting state functional connectivity
5382173|NCT01803048|Cognition|cognition
5382174|NCT01803035|Impetigo|impetigo
5382175|NCT01803035|LTX-109|ltx-109
5382176|NCT01803035|Topical|topical
5382177|NCT01803035|Antibiotic|antibiotic
5382178|NCT01803035|Placebo|placebo
5382179|NCT01803035|Lytic|lytic
5382180|NCT01803035|Peptide|peptide
5382181|NCT01803035|Gram Positive|gram positive
5382182|NCT01803022|Venous Thromboembolism|venous thromboembolism
5382183|NCT01803022|Cancer|cancer
5382184|NCT01803022|Low Molecular Weight Heparin|low molecular weight heparin
5382185|NCT01802983|Aged|aged
5382186|NCT01802983|Multiple organ failure|multiple organ failure
5382187|NCT01802983|Extubation|extubation
5382189|NCT01802983|MODS|mods
5382190|NCT01802983|invasive mechanical ventilation|invasive mechanical ventilation
5382191|NCT01802970|Anakinra|anakinra
5382192|NCT01802970|Nab Paclitaxel|nab paclitaxel
5382193|NCT01802970|Capecitabine|capecitabine
5382194|NCT01802970|Eribulin|eribulin
5382195|NCT01802970|Vinorelbin|vinorelbin
5382196|NCT01802931|GSK239512|gsk239512
5382197|NCT01802931|H3 receptor antagonist|h3 receptor antagonist
5382198|NCT01802931|drug-drug interaction|drug-drug interaction
5382199|NCT01802931|pharmacokinetics|pharmacokinetics
5382200|NCT01802931|ketoconazole|ketoconazole
5382201|NCT01802918|single dose|single dose
5382203|NCT01802918|maturation inhibitor|maturation inhibitor
5382204|NCT01802918|GSK2838232|gsk2838232
5382205|NCT01802918|FTIH|ftih
5382206|NCT01802918|healthy subjects|healthy subjects
5382207|NCT01802905|neoplasm|neoplasm
5382208|NCT01802905|metastatic cancer|metastatic cancer
5382209|NCT01802905|cancer genome|cancer genome
5382210|NCT01802905|genomic analysis|genomic analysis
5382211|NCT01802905|adults|adults
5382212|NCT01802892|ronacaleret|ronacaleret
5382213|NCT01802892|parathyroid hormone (PTH)|parathyroid hormone (pth)
5382214|NCT01802892|CD34+cells|cd34+cells
5382215|NCT01802892|calcium sensing receptor antagonist|calcium sensing receptor antagonist
5382216|NCT01802892|hematopoietic stem cells|hematopoietic stem cells
5382217|NCT01802892|stem cell mobilization|stem cell mobilization
5382218|NCT01802892|plerixafor|plerixafor
5382219|NCT01802892|healthy human volunteer, phase Ib|healthy human volunteer, phase ib
5382220|NCT01802879|Hematologic Neoplasms, LBH589,|hematologic neoplasms, lbh589,
5382221|NCT01802879|Panobinostat,|panobinostat,
5382222|NCT01802866|Geographic atrophy|geographic atrophy
5382223|NCT01802866|GA|ga
5382224|NCT01802866|Dry AMD|dry amd
5382225|NCT01802827|airway colonization|airway colonization
5382226|NCT01802827|tracheobronchitis|tracheobronchitis
5382227|NCT01802827|pneumonia|pneumonia
5382228|NCT01802814|ALL|all
5382235|NCT01802749|second line|second line
5382236|NCT01802749|platinum sensitive|platinum sensitive
5382237|NCT01802749|first line bevacizumab|first line bevacizumab
5382238|NCT01802749|biologic factors|biologic factors
5382239|NCT01802749|clinical factors|clinical factors
5382240|NCT01802736|Alcohol HIV intervention counselling|alcohol hiv intervention counselling
5382241|NCT01802736|Alcohol Use in HIV infected Persons|alcohol use in hiv infected persons
5382242|NCT01802697|volunteers|volunteers
5382243|NCT01802684|unresectable|unresectable
5382244|NCT01802684|metastatic|metastatic
5382245|NCT01802684|colorectal|colorectal
5382246|NCT01802684|cancer|cancer
5382247|NCT01802684|OPTIMOX|optimox
5382248|NCT01802684|aflibercept|aflibercept
5382249|NCT01802671|Low back pain|low back pain
5382250|NCT01802671|Cognitive behavioural treatment|cognitive behavioural treatment
5382251|NCT01802671|internet|internet
5382252|NCT01802671|disability|disability
5382253|NCT01802658|Bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid|bone marrow demineralization lesions,: efficacy and tolerability, zoledronic acid
5382255|NCT01802645|cetuximab|cetuximab
5382256|NCT01802645|irinotecan|irinotecan
5382257|NCT01802645|bevacizumab|bevacizumab
5382258|NCT01802645|oxaliplatin|oxaliplatin
5382259|NCT01802645|5-FU|5-fu
5382260|NCT01802645|Resection|resection
5382261|NCT01802645|colorectal liver metastases|colorectal liver metastases
5382262|NCT01802645|liver resection|liver resection
5382263|NCT01802645|Chemotherapy|chemotherapy
5382264|NCT01802645|k-ras|k-ras
5382265|NCT01802645|non-resectable|non-resectable
5382266|NCT01802632|Oncology,|oncology,
5382267|NCT01802632|Non Small Cell Lung Cancer,|non small cell lung cancer,
5382268|NCT01802632|Metastatic,|metastatic,
5382269|NCT01802632|EGFR sensitivity mutation,|egfr sensitivity mutation,
5382270|NCT01802632|T790M resistance mutation|t790m resistance mutation
5382271|NCT01802606|surgery|surgery
5382272|NCT01802606|administration|administration
5382273|NCT01802606|infection|infection
5382274|NCT01802593|Pediatric|pediatric
5382275|NCT01802593|Crohn's disease|crohn's disease
5382276|NCT01802593|Infliximab|infliximab
5382277|NCT01802593|Thiopurine|thiopurine
5382278|NCT01802554|Behavioral Activation|behavioral activation
5382279|NCT01802554|Caregiver|caregiver
5382280|NCT01802554|Dementia|dementia
5382281|NCT01802554|Cardiovascular Disease|cardiovascular disease
5382282|NCT01802554|Alzheimer's Disease|alzheimer's disease
5382283|NCT01802554|Coagulation|coagulation
5382284|NCT01802541|diacylglycerol oil|diacylglycerol oil
5382285|NCT01802541|insulin sensitivity|insulin sensitivity
5382286|NCT01802541|type 2 diabetes|type 2 diabetes
5382287|NCT01802541|cardiovascular disease|cardiovascular disease
5382288|NCT01802541|risk factors|risk factors
5382289|NCT01802528|obturator externus|obturator externus
5382290|NCT01802515|addiction|addiction
5382291|NCT01802515|cocaine|cocaine
5382292|NCT01802515|methadone|methadone
5382293|NCT01802515|opiates|opiates
5382294|NCT01802515|atomoxetine|atomoxetine
5382295|NCT01802502|tuberculous meningitis|tuberculous meningitis
5382296|NCT01802502|rifampicin|rifampicin
5382297|NCT01802502|bioequivalence|bioequivalence
5382298|NCT01802502|oral administration|oral administration
5382299|NCT01802502|intravenous administration|intravenous administration
5382300|NCT01802489|Optic neuritis|optic neuritis
5382301|NCT01802489|Multiple sclerosis|multiple sclerosis
5382302|NCT01802489|Retinal nerve fibre layer|retinal nerve fibre layer
5382303|NCT01802489|Axonal loss|axonal loss
5382304|NCT01802489|Neuroprotection|neuroprotection
5382305|NCT01802489|MRI|mri
5382306|NCT01802489|Optical coherence tomography|optical coherence tomography
5382307|NCT01802489|Amiloride|amiloride
5382308|NCT01802489|Acid Sensing Ion Channels|acid sensing ion channels
5382309|NCT01802476|PD-0332991|pd-0332991
5382310|NCT01802476|Absolute Bioavailability Study|absolute bioavailability study
5382311|NCT01802424|Open trial|open trial
5382312|NCT01802424|Indicative prevention|indicative prevention
5382313|NCT01802424|Youth anxiety|youth anxiety
5382314|NCT01802424|Cognitive behavioral therapy|cognitive behavioral therapy
5382315|NCT01802411|liposome bupivacaine|liposome bupivacaine
5382316|NCT01802411|posterolateral thoracotomy|posterolateral thoracotomy
5382317|NCT01802411|intercostal nerve block|intercostal nerve block
5382318|NCT01802411|postoperative pain|postoperative pain
5382319|NCT01802398|Risk Stratification|risk stratification
5382320|NCT01802398|Syncope|syncope
5382321|NCT01802398|Geriatric|geriatric
5382322|NCT01802385|cryptococcal meningitis|cryptococcal meningitis
5382323|NCT01802385|cryptococcus|cryptococcus
5382324|NCT01802385|meningitis|meningitis
5382325|NCT01802385|yeast|yeast
5382326|NCT01802385|fungus|fungus
5382327|NCT01802372|Hypertension|hypertension
5382328|NCT01802372|High Blood Pressure|high blood pressure
5382329|NCT01802372|Cardiovascular Diseases|cardiovascular diseases
5382330|NCT01802372|Health Insurance Coverage|health insurance coverage
5382331|NCT01802372|Low income countries|low income countries
5382332|NCT01802372|Ghana|ghana
5382333|NCT01802372|Low resource settings|low resource settings
5382334|NCT01802372|Comparative Effectiveness|comparative effectiveness
5382335|NCT01802372|Global Health|global health
5382336|NCT01802359|Erectile dysfunction|erectile dysfunction
5382337|NCT01802359|Mirodenafil|mirodenafil
5382338|NCT01802359|Bravonto|bravonto
5382339|NCT01802307|Focal therapy|focal therapy
5382340|NCT01802307|Brachytherapy|brachytherapy
5382341|NCT01802307|Active surveillance|active surveillance
5382342|NCT01802307|low risk cancer|low risk cancer
5382343|NCT01802294|Randomized Controlled Trials as Topic|randomized controlled trials as topic
5382344|NCT01802294|Child|child
5382345|NCT01802294|Parents|parents
5382346|NCT01802268|sirolimus|sirolimus
5382347|NCT01802268|tacrolimus|tacrolimus
5382348|NCT01802268|early conversion|early conversion
5382349|NCT01802255|Inhalatory sedation|inhalatory sedation
5382350|NCT01802255|Sevoflurane|sevoflurane
5382351|NCT01802255|AnaConDa|anaconda
5382352|NCT01802255|Nephrotoxicity|nephrotoxicity
5382353|NCT01802255|Hepatotoxicity|hepatotoxicity
5382354|NCT01802255|Midazolam|midazolam
5382355|NCT01802255|Propofol|propofol
5382356|NCT01802242|Prostate Cancer|prostate cancer
5382357|NCT01802242|Prostate tumour|prostate tumour
5382358|NCT01802242|Prostate radiotherapy|prostate radiotherapy
5382359|NCT01802242|prostate cancer treatment|prostate cancer treatment
5382360|NCT01802216|chronic kidney disease progression|chronic kidney disease progression
5382361|NCT01802216|periodontal disease|periodontal disease
5382362|NCT01802216|intensive periodontal disease treatment|intensive periodontal disease treatment
5382363|NCT01802203|Barrett esophagus|barrett esophagus
5382364|NCT01802203|Esophageal dysplasia|esophageal dysplasia
5382365|NCT01802203|Upper gastrointestinal squamous dysplasia|upper gastrointestinal squamous dysplasia
5382366|NCT01802203|Esophageal cancer|esophageal cancer
5382367|NCT01802203|Endobronchial cancer|endobronchial cancer
5382368|NCT01802203|Central airway cancer|central airway cancer
5382369|NCT01802203|Central airway precancerous disease|central airway precancerous disease
5382370|NCT01802203|Central airway granulation tissue|central airway granulation tissue
5382371|NCT01802203|Central airway papillomatosis|central airway papillomatosis
5382372|NCT01802203|Central airway sarcoidosis|central airway sarcoidosis
5382373|NCT01802203|Central airway tuberculosis|central airway tuberculosis
5382374|NCT01802203|Tracheal stenosis|tracheal stenosis
5382375|NCT01802203|Bronchial stenosis|bronchial stenosis
5382376|NCT01802190|Genetic deafness|genetic deafness
5382377|NCT01802190|SLC17A8 et POU4F3 genes|slc17a8 et pou4f3 genes
5382378|NCT01802177|Alopecia areata|alopecia areata
5382379|NCT01802177|Excimer|excimer
5382381|NCT01802151|probiotics|probiotics
5382382|NCT01802151|microbiota|microbiota
5382383|NCT01802151|survival|survival
5382384|NCT01802151|gastrointestinal|gastrointestinal
5382385|NCT01802151|wellness|wellness
5382386|NCT01802138|refractory/relapsed neuroblastoma patients|refractory/relapsed neuroblastoma patients
5382387|NCT01802112|Colonic transit|colonic transit
5382388|NCT01802112|Dietary Fiber|dietary fiber
5382389|NCT01802112|Radiopaque marker|radiopaque marker
5382390|NCT01802099|mechanical ventilation|mechanical ventilation
5382391|NCT01802099|early enteral nutrition|early enteral nutrition
5382392|NCT01802099|intensive care unit|intensive care unit
5382393|NCT01802099|early parenteral nutrition|early parenteral nutrition
5382394|NCT01802099|critical care medicine|critical care medicine
5382395|NCT01802099|nosocomial infection|nosocomial infection
5382396|NCT01802099|mortality|mortality
5382397|NCT01802099|shock|shock
5382398|NCT01802099|vasoactive drug|vasoactive drug
5382399|NCT01802086|Children|children
5382400|NCT01802086|Pain|pain
5382401|NCT01802086|Vaccination|vaccination
5382402|NCT01802086|Emla|emla
5382403|NCT01802086|Pneumococcal|pneumococcal
5382404|NCT01802086|Painscale|painscale
5382405|NCT01802073|Inflammation of the bile ducts|inflammation of the bile ducts
5382406|NCT01802073|biliary scarring|biliary scarring
5382407|NCT01802073|obstruction|obstruction
5382408|NCT01802060|Persona|persona
5382409|NCT01802060|E3G|e3g
5382410|NCT01802060|LH|lh
5382411|NCT01802060|ovulation|ovulation
5382412|NCT01802047|Mothers of Preterms|mothers of preterms
5382413|NCT01802047|Breastfeeding Mothers of Preterm infants|breastfeeding mothers of preterm infants
5382414|NCT01802047|mother milk feeding|mother milk feeding
5382415|NCT01802021|chinese medicine|chinese medicine
5382416|NCT01802021|non-small cell lung cancer|non-small cell lung cancer
5382417|NCT01802021|immunosuppression|immunosuppression
5382418|NCT01802008|Polyp/adenoma detection rate|polyp/adenoma detection rate
5382419|NCT01802008|Polyp/adenoma miss rate|polyp/adenoma miss rate
5382420|NCT01802008|Colonoscopy withdrawal time|colonoscopy withdrawal time
5382421|NCT01801982|PPHN; development progress after PPHN; developmental progress after sildenafil.|pphn; development progress after pphn; developmental progress after sildenafil.
5382422|NCT01801969|Brain injuries|brain injuries
5382423|NCT01801969|Rehabilitation services|rehabilitation services
5382424|NCT01801969|Return to Work|return to work
5382425|NCT01801969|Quality of life|quality of life
5382426|NCT01801956|Maximum oxygen uptake|maximum oxygen uptake
5382427|NCT01801956|Physical activity|physical activity
5382428|NCT01801956|Physical inactivity|physical inactivity
5382429|NCT01801956|Motivational interview|motivational interview
5382430|NCT01801956|Cardiorespiratory fitness|cardiorespiratory fitness
5382431|NCT01801956|Primary care|primary care
5382432|NCT01801956|Community care|community care
5382433|NCT01801930|OCV-C02|ocv-c02
5382434|NCT01801930|Colorectal Cancer|colorectal cancer
5382435|NCT01801930|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
5382436|NCT01801917|Polymyositis|polymyositis
5382437|NCT01801917|Myositis|myositis
5382438|NCT01801917|PM|pm
5382439|NCT01801917|chronic muscle inflammation|chronic muscle inflammation
5382440|NCT01801917|inflammatory myopathy|inflammatory myopathy
5382441|NCT01801917|inclusion body myositis|inclusion body myositis
5382442|NCT01801904|cetuximab-refractory|cetuximab-refractory
5382443|NCT01801891|Venous ulceration|venous ulceration
5382444|NCT01801891|Leg ulcers|leg ulcers
5382445|NCT01801891|Venous haemodynamics|venous haemodynamics
5862823|NCT00001491|PGP 9.5 Levels (Skin, Serum and CSF)|pgp 9.5 levels (skin, serum and csf)
5382447|NCT01801891|SNMES|snmes
5382448|NCT01801878|breast cancer|breast cancer
5382449|NCT01801878|loss of elasticity in irradiated breast skin|loss of elasticity in irradiated breast skin
5382450|NCT01801878|Other Reconstructive Surgery|other reconstructive surgery
5382451|NCT01801865|NICU|nicu
5382452|NCT01801865|MRI|mri
5382453|NCT01801865|Neonatal|neonatal
5382454|NCT01801865|Cincinnati|cincinnati
5382455|NCT01801813|Neuro-surgery|neuro-surgery
5382456|NCT01801813|Post-operative complications|post-operative complications
5382457|NCT01801813|Neuro-ICU resources|neuro-icu resources
5382458|NCT01801800|Aneurysmal subarachnoid haemorrhage|aneurysmal subarachnoid haemorrhage
5382459|NCT01801774|post-operative inflammation|post-operative inflammation
5382460|NCT01801774|steroid|steroid
5382461|NCT01801774|intraocular pressure|intraocular pressure
5382462|NCT01801748|wheat allergy|wheat allergy
5382463|NCT01801748|wheat outgrowing|wheat outgrowing
5382464|NCT01801748|wheat hypersensitivity|wheat hypersensitivity
5382465|NCT01801748|omega-5-gliadin|omega-5-gliadin
5671202|NCT00616759|Electroconvulsive therapy|electroconvulsive therapy
5382466|NCT01801748|natural history of wheat hypersensitivity|natural history of wheat hypersensitivity
5382467|NCT01801709|Brain Gene Therapy|brain gene therapy
5382468|NCT01801709|Adeno Associated vector|adeno associated vector
5382469|NCT01801709|Lysosomal sotage diseases|lysosomal sotage diseases
5382470|NCT01801709|Leukodystrophies|leukodystrophies
5382471|NCT01801696|Massage|massage
5382472|NCT01801696|effectiveness|effectiveness
5382473|NCT01801696|autism|autism
5382474|NCT01801696|parent stress|parent stress
5382475|NCT01801683|EBM|ebm
5382476|NCT01801683|general practice|general practice
5382477|NCT01801670|itch|itch
5382478|NCT01801670|pruritus|pruritus
5382479|NCT01801670|skin|skin
5002900|NCT03977909|Early Maladaptative Schemas|early maladaptative schemas
5382480|NCT01801670|vorinostat|vorinostat
5382481|NCT01801670|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5382482|NCT01801670|mycosis fungoides|mycosis fungoides
5382483|NCT01801657|bronchiectasis|bronchiectasis
5382484|NCT01801657|exacerbation|exacerbation
5382485|NCT01801657|virus|virus
5382486|NCT01801644|bladder cancer|bladder cancer
5382487|NCT01801644|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5382488|NCT01801644|gem/cis|gem/cis
5382489|NCT01801631|Type 2 diabetes|type 2 diabetes
5382490|NCT01801631|Acute Coronary Event (ACE)|acute coronary event (ace)
5382491|NCT01801631|Distress|distress
5382492|NCT01801631|Self-efficacy|self-efficacy
5382493|NCT01801631|Quality of Life|quality of life
5382494|NCT01801631|Depression|depression
5382495|NCT01801631|Primary care|primary care
5382496|NCT01801631|Illness representations|illness representations
5382497|NCT01801618|HIV|hiv
5382498|NCT01801618|PI based 2nd line ARV treatment|pi based 2nd line arv treatment
5382499|NCT01801618|Virological failure|virological failure
5382500|NCT01801618|Drug resistance|drug resistance
5382501|NCT01801618|Cambodia|cambodia
5382502|NCT01801618|Adherence|adherence
5382503|NCT01801605|IBS - rectal hypersensitivity - rectal barostat - rTMS.|ibs - rectal hypersensitivity - rectal barostat - rtms.
5382504|NCT01801592|OBSTRUCTIVE SLEEP APNOEA|obstructive sleep apnoea
5382505|NCT01801592|INTERMITTENT CLAUDICATION|intermittent claudication
5382506|NCT01801592|Respiratory disease|respiratory disease
5382507|NCT01801592|Peripheral artery disease|peripheral artery disease
5382508|NCT01801579|Ankle Brachial Index|ankle brachial index
5382509|NCT01801579|Maximal exercise|maximal exercise
5382510|NCT01801566|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
5382511|NCT01801566|Prostheses and Implants|prostheses and implants
5382512|NCT01801566|Denture, Complete, Lower|denture, complete, lower
5382513|NCT01801553|spinal manipulation|spinal manipulation
5382514|NCT01801553|low back pain|low back pain
5382515|NCT01801553|manual therapy|manual therapy
5382516|NCT01801553|clinical predictive rule|clinical predictive rule
5382517|NCT01801527|Telehealth|telehealth
5382518|NCT01801527|Fatigue|fatigue
5382519|NCT01801527|Breast cancer|breast cancer
5382520|NCT01801527|Exercise|exercise
5382521|NCT01801527|Quality of life|quality of life
5382522|NCT01801527|Telerehabilitation|telerehabilitation
5382523|NCT01801475|Pharmacokinetics of ondansetron in women|pharmacokinetics of ondansetron in women
5382524|NCT01801475|Pharmacokinetics of ondansetron in neonates|pharmacokinetics of ondansetron in neonates
5382525|NCT01801475|Term pregnancy|term pregnancy
5382526|NCT01801475|Cesarean section|cesarean section
5382527|NCT01801462|Medical education|medical education
5382528|NCT01801462|Simulation|simulation
5382529|NCT01801462|Ultrasound training|ultrasound training
5382530|NCT01801462|Patient safety|patient safety
5382531|NCT01801449|DIRA|dira
5382532|NCT01801449|Clinical Trial|clinical trial
5382533|NCT01801449|IL-1|il-1
5382534|NCT01801449|Autoinflammatory Syndrome|autoinflammatory syndrome
5382535|NCT01801449|Rilonacept|rilonacept
5382536|NCT01801436|Multiple Myeloma|multiple myeloma
5382537|NCT01801436|Bortezomib|bortezomib
5382538|NCT01801436|Velcade|velcade
5382539|NCT01801423|transcranial Doppler|transcranial doppler
5382540|NCT01801423|stroke|stroke
5382547|NCT01801410|misoprostol|misoprostol
5382548|NCT01801410|Foley catheter|foley catheter
5382549|NCT01801384|pregnancy|pregnancy
5382550|NCT01801384|cigarette smoking|cigarette smoking
5382551|NCT01801384|incentives|incentives
5382552|NCT01801384|smoking cessation|smoking cessation
5382553|NCT01801384|birth outcomes|birth outcomes
5382554|NCT01801371|Glioma|glioma
5382555|NCT01801371|Diagnostic imaging|diagnostic imaging
5382556|NCT01801371|Integrin receptor|integrin receptor
5382557|NCT01801371|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5382558|NCT01801371|PET/CT|pet/ct
5382559|NCT01801358|Melanoma,|melanoma,
5382560|NCT01801358|melanoma of the eye,|melanoma of the eye,
5382561|NCT01801358|uveal,|uveal,
5382562|NCT01801358|MEK162,|mek162,
5382563|NCT01801358|AEB071|aeb071
5382564|NCT01801345|Human Performance|human performance
5382565|NCT01801345|Clinical Performance|clinical performance
5903860|NCT00261456|BRCA2|brca2
5382566|NCT01801319|major depressive disorder (MDD)|major depressive disorder (mdd)
5382567|NCT01801319|deep brain stimulation (DBS)|deep brain stimulation (dbs)
5382568|NCT01801319|subcallosal cingulate gyrus|subcallosal cingulate gyrus
5382569|NCT01801319|Therapy-Resistant Depression|therapy-resistant depression
5382570|NCT01801319|Electrical Stimulation of the Brain|electrical stimulation of the brain
5382571|NCT01801319|Brain Stimulation, Deep|brain stimulation, deep
5382572|NCT01801293|RSV infection|rsv infection
5382573|NCT01801280|immunosuppressive medication|immunosuppressive medication
5382574|NCT01801280|mycophenolic acid|mycophenolic acid
5382575|NCT01801280|interaction|interaction
5382576|NCT01801280|proton pump inhibitor|proton pump inhibitor
5382577|NCT01801280|pantoprazole|pantoprazole
5382578|NCT01801280|renal transplant patients|renal transplant patients
5382579|NCT01801280|pharmacokinetics|pharmacokinetics
5382580|NCT01801280|pharmacodynamics|pharmacodynamics
5382581|NCT01801280|bioavailability|bioavailability
5382582|NCT01801267|Hydrocephalus|hydrocephalus
5382583|NCT01801267|Pediatric|pediatric
5382584|NCT01801267|Ventricular shunt|ventricular shunt
5382585|NCT01801267|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
5382586|NCT01801267|Third ventriculostomy|third ventriculostomy
5382587|NCT01801267|Randomized controlled trial|randomized controlled trial
5382588|NCT01801254|Obesity|obesity
5382589|NCT01801254|Type II diabetes|type ii diabetes
5382590|NCT01801254|Cardiovascular disease|cardiovascular disease
5382591|NCT01801254|Health behavior promotion|health behavior promotion
5382592|NCT01801254|Neuroeconomics|neuroeconomics
5382593|NCT01801254|EEG biofeedback|eeg biofeedback
5382594|NCT01801254|Low-resolution electromagnetic tomography (LORETA)|low-resolution electromagnetic tomography (loreta)
5382596|NCT01801176|proved by biopsy|proved by biopsy
5382597|NCT01801150|Diabetes|diabetes
5382598|NCT01801150|Apnea- hypopnea Syndrome|apnea- hypopnea syndrome
5382599|NCT01801150|Glycemic control|glycemic control
5382600|NCT01801150|Prevalence|prevalence
5382601|NCT01801150|SAHS|sahs
5382602|NCT01801150|life quality|life quality
5382603|NCT01801124|analgesia|analgesia
5382604|NCT01801124|hernia repair|hernia repair
5382605|NCT01801098|TAVI|tavi
5382606|NCT01801098|complete AV-block|complete av-block
5382607|NCT01801098|HV-interval|hv-interval
5382608|NCT01801098|permanent pacemaker|permanent pacemaker
5382609|NCT01801085|Time-and-Motion|time-and-motion
5382610|NCT01801085|Neoplasm|neoplasm
5382611|NCT01801085|Colorectal Cancer|colorectal cancer
5382612|NCT01801059|colon cancer|colon cancer
5382613|NCT01801059|Colorectal Cancer Screening|colorectal cancer screening
5382614|NCT01801033|Trioodothyronine (T3)|trioodothyronine (t3)
5382615|NCT01801033|Thyroid Hormone Action|thyroid hormone action
5382616|NCT01801033|Deiodinases|deiodinases
5382617|NCT01801033|Hypothyroid|hypothyroid
5382618|NCT01801033|Propylthiouracil (PTU)|propylthiouracil (ptu)
5382619|NCT01801020|temperature|temperature
5382620|NCT01800994|convenience|convenience
5382621|NCT01800981|Functionality|functionality
5382622|NCT01800981|extremities|extremities
5382623|NCT01800981|ROM|rom
5382624|NCT01800981|Upper and lower Extremity for burned patients|upper and lower extremity for burned patients
5382625|NCT01800955|physical therapy|physical therapy
5382626|NCT01800955|diathermy|diathermy
5382627|NCT01800955|knee|knee
5382628|NCT01800955|osteoarthritis|osteoarthritis
5382629|NCT01800955|pain|pain
5382630|NCT01800955|physical function|physical function
5382631|NCT01800942|prevention|prevention
5382632|NCT01800942|bacterial infection|bacterial infection
5382633|NCT01800942|neonates|neonates
5382634|NCT01800942|women in labour|women in labour
5382635|NCT01800942|Azithromycin|azithromycin
5382636|NCT01800916|ileostomy|ileostomy
5382637|NCT01800916|Subjects|subjects
5382638|NCT01800890|stoma ileostomy|stoma ileostomy
5382639|NCT01800877|hypotension|hypotension
5382640|NCT01800877|vasopressors|vasopressors
5382641|NCT01800877|titration|titration
5382642|NCT01800877|tissue perfusion|tissue perfusion
5382643|NCT01800877|organ failure|organ failure
5382644|NCT01800851|Kidney transplantation|kidney transplantation
5382645|NCT01800851|Energy expenditure|energy expenditure
5382646|NCT01800851|Weight gain|weight gain
5382647|NCT01800851|Insulin resistance|insulin resistance
5382648|NCT01800825|Pregnancy|pregnancy
5382649|NCT01800825|Prematurity|prematurity
5382650|NCT01800825|Preterm birth|preterm birth
5382651|NCT01800825|bacterial vaginosis|bacterial vaginosis
5382652|NCT01800799|Urinary tract infection|urinary tract infection
5382653|NCT01800799|Urothelium|urothelium
5382654|NCT01800799|Inflammation|inflammation
5382655|NCT01800799|Apoptosis|apoptosis
5382656|NCT01800773|PTSD|ptsd
5382657|NCT01800773|exposure treatment|exposure treatment
5382658|NCT01800773|clinical trial|clinical trial
5382659|NCT01800773|trauma|trauma
5382660|NCT01800760|healthy|healthy
5382661|NCT01800760|obese|obese
5382662|NCT01800760|women|women
5382663|NCT01800747|Delayed antibiotic treatment|delayed antibiotic treatment
5382664|NCT01800747|Acute respiratory infections|acute respiratory infections
5382665|NCT01800747|Pediatrics|pediatrics
5903861|NCT00261456|prostate screening|prostate screening
5382666|NCT01800747|Satisfaction|satisfaction
5382667|NCT01800734|Mixed meal test|mixed meal test
5382668|NCT01800734|Insulin pump|insulin pump
5382669|NCT01800734|Continuous glucose monitoring|continuous glucose monitoring
5382670|NCT01800734|Metabolic control analysis|metabolic control analysis
5382671|NCT01800734|Closed loop control|closed loop control
5382672|NCT01800734|Artificial pancreas|artificial pancreas
5382674|NCT01800721|testing|testing
5382675|NCT01800721|Social Network|social network
5382676|NCT01800721|African American|african american
5382677|NCT01800721|MSM|msm
5382678|NCT01800721|Men who have sex with men|men who have sex with men
5382679|NCT01800695|GBM|gbm
5382680|NCT01800682|Healthy|healthy
5382681|NCT01800682|Tramodol|tramodol
5382682|NCT01800682|Ultram|ultram
5382683|NCT01800669|Computer based clinical decision support|computer based clinical decision support
5382684|NCT01800669|medical legal partnership|medical legal partnership
5382685|NCT01800669|child|child
5382686|NCT01800669|pediatrics|pediatrics
5382687|NCT01800643|Busulfan|busulfan
5382688|NCT01800643|plasmatic dosage|plasmatic dosage
5368423|NCT01864395|albumin|albumin
5382689|NCT01800643|Stem Cell Transplantation|stem cell transplantation
5382690|NCT01800578|Cerebral State Index Monitor|cerebral state index monitor
5382691|NCT01800565|precocious puberty|precocious puberty
5382692|NCT01800565|urinary LH|urinary lh
5382693|NCT01800565|GnRH stimulation test|gnrh stimulation test
5382694|NCT01800565|gonadotropins|gonadotropins
5382695|NCT01800552|Infiltration|infiltration
5382696|NCT01800552|Extravasation|extravasation
5382697|NCT01800552|Leaking|leaking
5382698|NCT01800552|PIV Infiltration|piv infiltration
5382699|NCT01800552|IV Infiltration|iv infiltration
5382700|NCT01800552|Ultrasound Detection of Infiltration|ultrasound detection of infiltration
5382701|NCT01800552|Ultrasound Imaging|ultrasound imaging
5382702|NCT01800539|Autism|autism
5382703|NCT01800539|Early Intervention|early intervention
5382704|NCT01800539|Minority|minority
5382705|NCT01800526|Sickle Cell Disease|sickle cell disease
5382706|NCT01800526|Sickle Cell Anemia|sickle cell anemia
5382707|NCT01800513|Implantation Failure|implantation failure
5382708|NCT01800513|In-vitro Fertilization|in-vitro fertilization
5382709|NCT01800513|Infertility|infertility
5382710|NCT01800513|Endometrial Biopsy|endometrial biopsy
5382711|NCT01800487|Drug-induced liver injury|drug-induced liver injury
5382712|NCT01800487|Tuberculosis|tuberculosis
5382713|NCT01800487|Silymarin|silymarin
5382714|NCT01800461|Participation|participation
5382715|NCT01800461|Occupational Therapy|occupational therapy
5382716|NCT01800461|Valued Activities|valued activities
5382717|NCT01800448|Respiratory monitoring|respiratory monitoring
5382718|NCT01800448|cardiac monitoring|cardiac monitoring
5382719|NCT01800448|skin conductance monitoring|skin conductance monitoring
5382720|NCT01800448|variability|variability
5382721|NCT01800409|Tetraplegia|tetraplegia
5382722|NCT01800396|Bacterial infection|bacterial infection
5382723|NCT01800396|Dairy|dairy
5382724|NCT01800396|Diarrhea|diarrhea
5382725|NCT01800396|Diet|diet
5382726|NCT01800396|E.Coli|e.coli
5382727|NCT01800396|Gastroenteritis|gastroenteritis
5382728|NCT01800396|Milk|milk
5382729|NCT01800396|Stool consistency|stool consistency
5382730|NCT01800383|posttraumatic stress disorder|posttraumatic stress disorder
5382731|NCT01800383|fear conditioning|fear conditioning
5382732|NCT01800383|proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
5382733|NCT01800383|GABA|gaba
5382734|NCT01800370|Healthy|healthy
5382735|NCT01800370|Male|male
5382736|NCT01800357|randomized trial|randomized trial
5382737|NCT01800357|acute ischemic stroke|acute ischemic stroke
5382738|NCT01800357|mildronate|mildronate
5382739|NCT01800344|Airway Cuff|airway cuff
5382741|NCT01800344|Ultra|ultra
5382742|NCT01800344|Cuff Pressure|cuff pressure
5382743|NCT01800344|Ventilation|ventilation
5382744|NCT01800344|Anesthesia|anesthesia
5382745|NCT01800344|Intubation|intubation
5382746|NCT01800318|NESAP|nesap
5382747|NCT01800318|sucrose|sucrose
5382748|NCT01800318|pain|pain
5382749|NCT01800318|infants|infants
5382750|NCT01800305|PK & PD study|pk & pd study
5382751|NCT01800305|rhEPO|rhepo
5382752|NCT01800305|Pegylated rhEPO|pegylated rhepo
5382753|NCT01800305|male healthy subject|male healthy subject
5382754|NCT01800292|Pulmonary Artery Hypertension|pulmonary artery hypertension
5382755|NCT01800292|pulmonary capillary wedge pressure|pulmonary capillary wedge pressure
5382756|NCT01800292|sildenafil|sildenafil
5382757|NCT01800292|echocardiography|echocardiography
5382758|NCT01800292|left ventricular longitudinal wall strain|left ventricular longitudinal wall strain
5382759|NCT01800292|strain rate pre and post medical therapy|strain rate pre and post medical therapy
5382760|NCT01800292|speckle tracking|speckle tracking
5382761|NCT01800279|Fibromyalgia Syndrome, Temporomandibular Joint, Pain.|fibromyalgia syndrome, temporomandibular joint, pain.
5382762|NCT01800266|Supervision|supervision
5382763|NCT01800266|Implementation|implementation
5382764|NCT01800266|Community Based Mental Health Services|community based mental health services
5671203|NCT00616746|Alcohol, nicotine|alcohol, nicotine
5423357|NCT01615965|prostate cancer|prostate cancer
5382765|NCT01800266|Trauma Focused Cognitive Behavioral Therapy|trauma focused cognitive behavioral therapy
5382766|NCT01800266|Skill Building and Behavioral Rehearsal|skill building and behavioral rehearsal
5382767|NCT01800266|Symptom and Fidelity Monitoring|symptom and fidelity monitoring
5382769|NCT01800266|Adolescents|adolescents
5382770|NCT01800214|neurodengeneration|neurodengeneration
5382771|NCT01800214|neuroimaging|neuroimaging
5382772|NCT01800201|Initial occurrence Acute Myocardial Infarction (AMI)|initial occurrence acute myocardial infarction (ami)
5382773|NCT01800188|Dialysis|dialysis
5382774|NCT01800188|Incretin hormones|incretin hormones
5382775|NCT01800149|Tooth extraction|tooth extraction
5382776|NCT01800149|Ridge Preservation|ridge preservation
5382777|NCT01800149|Ridge Augmentation|ridge augmentation
5382778|NCT01800149|Guided Bone Regeneration|guided bone regeneration
5382779|NCT01800136|pain|pain
5382780|NCT01800136|neuropathic|neuropathic
5382781|NCT01800136|cortical stimulation|cortical stimulation
5382782|NCT01800136|motor cortex|motor cortex
5382783|NCT01800136|plasticity|plasticity
5382784|NCT01800136|rTMS|rtms
5382785|NCT01800136|tDCS|tdcs
5382786|NCT01800123|Intoxication, overdose, poisoning, EtCO2, emergency medicine|intoxication, overdose, poisoning, etco2, emergency medicine
5382787|NCT01800097|stroke|stroke
5382788|NCT01800097|fatigue|fatigue
5382789|NCT01800097|modafinil|modafinil
5382790|NCT01800084|ASIR|asir
5382791|NCT01800084|image acquisition|image acquisition
5382793|NCT01800071|Nasopharyngeal cancer|nasopharyngeal cancer
5382794|NCT01800071|Epstein Barr Virus Infections|epstein barr virus infections
5382795|NCT01800071|Vaccination|vaccination
5382796|NCT01800045|Narcolepsy|narcolepsy
5382797|NCT01800045|Cataplexy|cataplexy
5382798|NCT01800045|Sleep disorder|sleep disorder
5382799|NCT01800045|Excessive daytime sleepiness|excessive daytime sleepiness
5382800|NCT01800006|Atrial Fibrillation|atrial fibrillation
5382801|NCT01800006|Observation|observation
5382802|NCT01800006|Stroke|stroke
5382803|NCT01800006|Embolism|embolism
5382804|NCT01799993|Gram-negative pneumonia|gram-negative pneumonia
5382805|NCT01799993|Intubation|intubation
5382806|NCT01799993|Mechanical ventilation|mechanical ventilation
5382807|NCT01799993|Amikacin|amikacin
5382808|NCT01799980|Lung cancer|lung cancer
5382809|NCT01799980|Cervical mediastinoscopy|cervical mediastinoscopy
5382810|NCT01799980|Endobronchial ultrasound|endobronchial ultrasound
5382811|NCT01799980|Staging|staging
5382812|NCT01799967|gastro-esophageal junction|gastro-esophageal junction
5382813|NCT01799967|minimally invasive|minimally invasive
5382814|NCT01799967|Achalasia|achalasia
5382815|NCT01799967|Paraesophageal hernia|paraesophageal hernia
5382816|NCT01799967|GERD|gerd
5382817|NCT01799967|Epiphrenic diverticula|epiphrenic diverticula
5382818|NCT01799967|Zenker's diverticulum|zenker's diverticulum
5382819|NCT01799967|All minimally invasive surgeries of the gastro-esophageal junction|all minimally invasive surgeries of the gastro-esophageal junction
5382820|NCT01799902|Observational|observational
5382821|NCT01799902|Non-Interventional Prospective|non-interventional prospective
5382822|NCT01799902|Phase IV Treatment|phase iv treatment
5382823|NCT01799902|Overactive Bladder Syndrome|overactive bladder syndrome
5382824|NCT01799902|Solifenacin|solifenacin
5382825|NCT01799889|GS-US-339-0102|gs-us-339-0102
5382826|NCT01799889|SYK inhibitor|syk inhibitor
5382827|NCT01799889|GS-9973|gs-9973
5382828|NCT01799889|entospletinib|entospletinib
5382829|NCT01799889|CLL|cll
5382830|NCT01799889|leukemia|leukemia
5382831|NCT01799889|lymphoma|lymphoma
5382832|NCT01799889|MCL|mcl
5382833|NCT01799889|DLBCL|dlbcl
5382834|NCT01799889|iNHL|inhl
5382835|NCT01799889|FL|fl
5382836|NCT01799889|MZL|mzl
5382837|NCT01799889|LPL|lpl
5382838|NCT01799889|SLL|sll
5382843|NCT01799876|microfracture|microfracture
5382844|NCT01799876|cell therapy|cell therapy
5382845|NCT01799863|Conjunctivitis, Viral|conjunctivitis, viral
5382846|NCT01799863|Ketorolac|ketorolac
5382847|NCT01799863|Artificial tears|artificial tears
5382848|NCT01799850|muscle|muscle
5382849|NCT01799850|glucose transporters|glucose transporters
5382850|NCT01799850|GLUT4|glut4
5382851|NCT01799850|GLUT5|glut5
5382852|NCT01799850|Actos|actos
5382853|NCT01799837|PTSD|ptsd
5382854|NCT01799811|allograft|allograft
5382855|NCT01799811|limb salvage|limb salvage
5382856|NCT01799811|patency|patency
5382857|NCT01799811|Cryopreserved|cryopreserved
5382858|NCT01799811|open bypass|open bypass
5382859|NCT01799798|Osteogenesis imperfecta|osteogenesis imperfecta
5382860|NCT01799798|COL1A1/A2|col1a1/a2
5382861|NCT01799798|Denosumab|denosumab
5382862|NCT01799798|Bisphosphonates|bisphosphonates
5382863|NCT01799798|Children|children
5382864|NCT01799798|Areal bone mineral density|areal bone mineral density
5382865|NCT01799759|Body Mass Percentile|body mass percentile
5382866|NCT01799759|Authoritative parenting|authoritative parenting
5382867|NCT01799759|Online interventions|online interventions
5382868|NCT01799759|Prevention|prevention
5382869|NCT01799733|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5382870|NCT01799733|Women|women
5382871|NCT01799733|Depression|depression
5382872|NCT01799733|Light therapy|light therapy
5382873|NCT01799733|Wake therapy|wake therapy
5382874|NCT01799733|Phase|phase
5382875|NCT01799733|Chronobiology|chronobiology
5382876|NCT01799720|blood cholesterol|blood cholesterol
5382877|NCT01799720|blood lipid profile|blood lipid profile
5382878|NCT01799720|triglycerides|triglycerides
5382879|NCT01799720|commercial pills|commercial pills
5382880|NCT01799720|fish oil|fish oil
5382881|NCT01799720|lipid peroxidation|lipid peroxidation
5382882|NCT01799720|Circulating lipidic profile|circulating lipidic profile
5382883|NCT01799707|vision|vision
5382884|NCT01799707|restoration|restoration
5382885|NCT01799707|visual field|visual field
5382886|NCT01799694|Urinary incontinence|urinary incontinence
5002902|NCT03977909|Functioning|functioning
5370416|NCT01855867|HIV|hiv
5382887|NCT01799694|Autologous expanded stem cells|autologous expanded stem cells
5382888|NCT01799694|Radical prostate cancer surgery|radical prostate cancer surgery
5382889|NCT01799681|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls|randomised controlled trial, postural balance, rehabilitation, exercise therapy, accidental falls
5382890|NCT01799668|Psychotherapy|psychotherapy
5382891|NCT01799668|Preferences|preferences
5382892|NCT01799642|dyspnea|dyspnea
5382893|NCT01799642|exercise|exercise
5382894|NCT01799642|cystic fibrosis|cystic fibrosis
5382895|NCT01799642|neuromechanical dissociation|neuromechanical dissociation
5382896|NCT01799629|Glycerin suppositories|glycerin suppositories
5382897|NCT01799629|Feeding intolerance|feeding intolerance
5382898|NCT01799629|preterm infants|preterm infants
5382899|NCT01799629|prophylactic use|prophylactic use
5382900|NCT01799629|elimination of meconium|elimination of meconium
5382901|NCT01799616|MODIC changes|modic changes
5382902|NCT01799616|Chronic low back pain|chronic low back pain
5382903|NCT01799616|Pamidronate|pamidronate
5382904|NCT01799616|Magnetic resonance imaging|magnetic resonance imaging
5382905|NCT01799616|Vertebrae|vertebrae
5382906|NCT01799616|Intervertebral disc|intervertebral disc
5382907|NCT01799603|Healthy|healthy
5382908|NCT01799603|TMC435|tmc435
5382909|NCT01799603|G008|g008
5382910|NCT01799590|Migraine|migraine
5382911|NCT01799590|Topiramate|topiramate
5382912|NCT01799577|laparoscopy, accuracy, duration|laparoscopy, accuracy, duration
5382913|NCT01799564|Geographic atrophy|geographic atrophy
5382914|NCT01799564|Age-related macular degeneration|age-related macular degeneration
5382915|NCT01799564|Fundus autofluorescence|fundus autofluorescence
5382916|NCT01799551|Depression|depression
5382917|NCT01799551|Culture|culture
5382918|NCT01799551|CBT|cbt
5382919|NCT01799551|Adaptation|adaptation
5382920|NCT01799538|Albuterol|albuterol
5382921|NCT01799538|Bronchodilator|bronchodilator
5382922|NCT01799538|Nebulizer|nebulizer
5382923|NCT01799538|Metered Dose Inhaler|metered dose inhaler
5382924|NCT01799525|Aneurysm|aneurysm
5382925|NCT01799525|subarachnoid hemorrhage|subarachnoid hemorrhage
5382926|NCT01799525|vasospasm|vasospasm
5382927|NCT01799525|cerebral ischemia|cerebral ischemia
5382928|NCT01799525|stroke|stroke
5382929|NCT01799512|medical ICU patients|medical icu patients
5382930|NCT01799512|APACHE-II score ≥20|apache-ii score ≥20
5382931|NCT01799499|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5382932|NCT01799499|Intravesical instillation|intravesical instillation
5382933|NCT01799499|Mitomycin C|mitomycin c
5382934|NCT01799499|Hydrogel|hydrogel
5382935|NCT01799499|Reverse thermal gelation|reverse thermal gelation
5382936|NCT01799499|Drug retention|drug retention
5382943|NCT01799499|Urinary Bladder Diseases|urinary bladder diseases
5382944|NCT01799499|Urologic Diseases|urologic diseases
5382945|NCT01799499|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5382946|NCT01799499|Neoplasms by Histologic Type Mitomycins|neoplasms by histologic type mitomycins
5382947|NCT01799499|Mitomycin|mitomycin
5382948|NCT01799499|Antibiotics, Antineoplastic|antibiotics, antineoplastic
5382949|NCT01799499|Antineoplastic Agents|antineoplastic agents
5382950|NCT01799499|Therapeutic Uses|therapeutic uses
5382951|NCT01799499|Pharmacologic Actions|pharmacologic actions
5382952|NCT01799499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors
5382953|NCT01799499|Enzyme Inhibitors|enzyme inhibitors
5382954|NCT01799499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5382955|NCT01799499|Alkylating Agents|alkylating agents
5382956|NCT01799486|Telbivudine|telbivudine
5383456|NCT01797120|Fulvestrant|fulvestrant
5382957|NCT01799486|renoprotective efficacy|renoprotective efficacy
5382958|NCT01799486|liver cirrhosis|liver cirrhosis
5382959|NCT01799473|Tyvaso|tyvaso
5382960|NCT01799473|PAH|pah
5382961|NCT01799460|single-nucleotide-polymorphism|single-nucleotide-polymorphism
5382962|NCT01799460|Traditional Chinese Medicine|traditional chinese medicine
5423358|NCT01615965|lymph node|lymph node
5382966|NCT01799447|Infant mother relations|infant mother relations
5382967|NCT01799447|First time mothers|first time mothers
5382968|NCT01799447|Parental program|parental program
5382969|NCT01799447|Marte Meo method|marte meo method
5382970|NCT01799447|Video guidances|video guidances
5382971|NCT01799369|Surgical Apgar Score|surgical apgar score
5382972|NCT01799356|Treatment, moksifloksasin|treatment, moksifloksasin
5382973|NCT01799343|Prenatal care|prenatal care
5382974|NCT01799343|Blood flow velocity|blood flow velocity
5382975|NCT01799343|Hydrotherapy|hydrotherapy
5382976|NCT01799343|Fetalplacental circulation|fetalplacental circulation
5382977|NCT01799343|Uteroplacental circulation|uteroplacental circulation
5382978|NCT01799330|COPD|copd
5382979|NCT01799330|Rehabilitation|rehabilitation
5382980|NCT01799330|Exercise|exercise
5382981|NCT01799330|TCEMS|tcems
5382982|NCT01799304|Locomotion|locomotion
5382983|NCT01799304|cerebral palsy|cerebral palsy
5382984|NCT01799304|Postural; Defect|postural; defect
5382985|NCT01799291|Decision Making|decision making
5002903|NCT03977896|PET/MRI|pet/mri
5382986|NCT01799291|Pediatric Bipolar Disorder|pediatric bipolar disorder
5382988|NCT01799291|Intervention|intervention
5382989|NCT01799278|Metastatic prostate carcinoma|metastatic prostate carcinoma
5382990|NCT01799265|obstructive sleep apnea|obstructive sleep apnea
5382992|NCT01799265|AutoPAP|autopap
5382994|NCT01799265|sleep disordered breathing|sleep disordered breathing
5382995|NCT01799265|CPAP|cpap
5382996|NCT01799265|Apnea hypopnea index|apnea hypopnea index
5382997|NCT01799265|AHI|ahi
5382998|NCT01799252|medical abortion|medical abortion
5382999|NCT01799252|doxycycline|doxycycline
5383000|NCT01799252|antibiotics|antibiotics
5383001|NCT01799252|adherence|adherence
5383002|NCT01799252|nausea|nausea
5383003|NCT01799239|stoma ileostomy|stoma ileostomy
5383004|NCT01799213|Knee Osteoarthritis|knee osteoarthritis
5383005|NCT01799213|NSAID|nsaid
5383006|NCT01799213|Cognitive Behavioral Therapy|cognitive behavioral therapy
5383007|NCT01799200|Collegiate Athletes|collegiate athletes
5383008|NCT01799200|Hip Pathomorphology|hip pathomorphology
5383009|NCT01799200|Age-Matched Controls|age-matched controls
5383010|NCT01799200|Femoroacetabular Impingement|femoroacetabular impingement
5383011|NCT01799200|Dysplasia|dysplasia
5383012|NCT01799187|Immature Permanent Teeth|immature permanent teeth
5383013|NCT01799161|NSCLC|nsclc
5383014|NCT01799161|Lung Cancer|lung cancer
5383015|NCT01799161|gp96|gp96
5383016|NCT01799161|gp96 Vaccine|gp96 vaccine
5383017|NCT01799161|AD100-gp96Ig-HLA A1|ad100-gp96ig-hla a1
5383018|NCT01799148|Acute coronary syndrome|acute coronary syndrome
5383019|NCT01799148|Air pollution.|air pollution.
5383020|NCT01799148|Inflammation.|inflammation.
5383021|NCT01799148|Oxidative Stress.|oxidative stress.
5383022|NCT01799148|Prognosis|prognosis
5383023|NCT01799109|magnesium sulfate|magnesium sulfate
5383024|NCT01799109|nebulization|nebulization
5383025|NCT01799109|lung function|lung function
5383026|NCT01799083|Advanced solid tumors|advanced solid tumors
5383027|NCT01799083|B cell lymphoma|b cell lymphoma
5383028|NCT01799070|Prediction|prediction
5383029|NCT01799070|Transcranial Doppler|transcranial doppler
5383030|NCT01799057|Peripheral Arterial Disease|peripheral arterial disease
5378391|NCT01819831|proton radiation|proton radiation
5383031|NCT01799057|Intermittent Claudication|intermittent claudication
5383032|NCT01799057|Peripheral Vascular Diseases|peripheral vascular diseases
5383033|NCT01799057|Vascular Diseases|vascular diseases
5383034|NCT01799057|Cardiovascular Diseases|cardiovascular diseases
5383035|NCT01799057|Arterial Occlusive Diseases|arterial occlusive diseases
5383036|NCT01799057|Atherosclerosis|atherosclerosis
5383037|NCT01799057|Insulin Resistance|insulin resistance
5383038|NCT01799057|Glucose Metabolism|glucose metabolism
5383039|NCT01799057|Blood Glucose|blood glucose
5383040|NCT01799057|Metformin|metformin
5383041|NCT01799057|Biguanides|biguanides
5383042|NCT01799057|Hypoglycemic Agents|hypoglycemic agents
5383043|NCT01799057|Endothelium, Vascular|endothelium, vascular
5383044|NCT01799057|Hemorheology|hemorheology
5383045|NCT01799057|Blood Circulation|blood circulation
5383046|NCT01799057|Regional Blood Flow|regional blood flow
5383047|NCT01799057|Microcirculation|microcirculation
5383048|NCT01799057|Exercise|exercise
5383049|NCT01799057|Physical Fitness|physical fitness
5383050|NCT01799057|Exercise Test|exercise test
5383051|NCT01799057|Sedentary Lifestyle|sedentary lifestyle
5383052|NCT01799057|Quality of Life|quality of life
5383053|NCT01799057|Plethysmography|plethysmography
5383054|NCT01799044|Irreversible electroporation|irreversible electroporation
5383055|NCT01799044|IRE|ire
5383056|NCT01799044|Electroporation|electroporation
5383457|NCT01797120|Faslodex|faslodex
5383057|NCT01799044|Colorectal liver metastases|colorectal liver metastases
5383059|NCT01799044|Safety|safety
5383061|NCT01799044|Efficacy|efficacy
5383062|NCT01799044|Single-center|single-center
5383063|NCT01799044|Low Energy Direct Current|low energy direct current
5383064|NCT01799044|Ablate-and-resect|ablate-and-resect
5383065|NCT01799044|Nonthermal ablation|nonthermal ablation
5383066|NCT01799044|Ablation|ablation
5383067|NCT01799018|Xanthine Oxidase|xanthine oxidase
5383068|NCT01799018|Cerebrospinal fluid|cerebrospinal fluid
5383069|NCT01799005|flavanols|flavanols
5383070|NCT01799005|diet|diet
5383071|NCT01799005|endothelial function|endothelial function
5383072|NCT01799005|blood pressure|blood pressure
5383073|NCT01799005|FLAVIOLA|flaviola
5383074|NCT01798992|ejection fraction|ejection fraction
5383075|NCT01798992|beta-blocker|beta-blocker
5383076|NCT01798992|carvedilol|carvedilol
5383077|NCT01798992|metoprolol|metoprolol
5383078|NCT01798992|myocardial gene expression|myocardial gene expression
5383079|NCT01798992|human heart|human heart
5383080|NCT01798992|ventricular remodeling|ventricular remodeling
5383081|NCT01798992|wall stress|wall stress
5383082|NCT01798992|adrenergic signaling|adrenergic signaling
5383083|NCT01798992|myosin heavy chain|myosin heavy chain
5383084|NCT01798953|Ulcerative Colitis|ulcerative colitis
5383085|NCT01798953|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5383086|NCT01798953|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
5383087|NCT01798953|Ileorectal anastomosis|ileorectal anastomosis
5383088|NCT01798953|Surgical outcome|surgical outcome
5383089|NCT01798953|Functional outcome|functional outcome
5383090|NCT01798953|Failure|failure
5383091|NCT01798927|Parkinson's disease|parkinson's disease
5383092|NCT01798927|ankle foot orthosis (AFO)|ankle foot orthosis (afo)
5383093|NCT01798927|gait|gait
5383094|NCT01798901|Acute Myeloid Leukemia|acute myeloid leukemia
5383095|NCT01798901|AML|aml
5383096|NCT01798901|AR-42|ar-42
5383097|NCT01798901|Decitabine|decitabine
5383098|NCT01798888|Deep Brain Stimulation|deep brain stimulation
5383099|NCT01798888|Alcohol Dependence|alcohol dependence
5383100|NCT01798875|pcos|pcos
5383101|NCT01798875|metformin|metformin
5383102|NCT01798875|oral contraception|oral contraception
5383103|NCT01798875|cyproterone acetate|cyproterone acetate
5383104|NCT01798862|Failed IVF cycles|failed ivf cycles
5383105|NCT01798862|IVF outcome parameters|ivf outcome parameters
5383106|NCT01798862|endometrial injury|endometrial injury
5383107|NCT01798862|hysteroscopy|hysteroscopy
5383108|NCT01798862|pipelle sampling|pipelle sampling
5383109|NCT01798862|Repeated implantation failures|repeated implantation failures
5383110|NCT01798836|IVF/ICSI cycles, poor responders, ultrashort flare protocol, antagonist protocol|ivf/icsi cycles, poor responders, ultrashort flare protocol, antagonist protocol
5383111|NCT01798823|children|children
5383112|NCT01798823|asthma|asthma
5383113|NCT01798810|Surgical Site Infection Risk Prediction|surgical site infection risk prediction
5383114|NCT01798810|Bacterial species type and antibacterial sensitivities|bacterial species type and antibacterial sensitivities
5383115|NCT01798810|Resource Utilization and Cost|resource utilization and cost
5383116|NCT01798797|Heart Failure|heart failure
5383117|NCT01798797|HFRS|hfrs
5383118|NCT01798797|OptiVol|optivol
5383119|NCT01798797|ICD|icd
5383120|NCT01798797|CRT-D|crt-d
5383121|NCT01798771|primary brain tumor|primary brain tumor
5383122|NCT01798771|malignant glioma|malignant glioma
5383123|NCT01798771|intraoperative MRI|intraoperative mri
5383124|NCT01798771|5-ALA|5-ala
5383125|NCT01798745|Heart failure|heart failure
5383126|NCT01798745|JNJ-54452840|jnj-54452840
5383127|NCT01798745|Anti-beta-1 adrenergic receptor auto antibodies|anti-beta-1 adrenergic receptor auto antibodies
5383128|NCT01798745|Beta-1 adrenergic receptor|beta-1 adrenergic receptor
5383129|NCT01798745|Antibodies|antibodies
5383131|NCT01798745|Systolic function|systolic function
5383132|NCT01798719|NAFLD|nafld
5383133|NCT01798719|Clinical Trial|clinical trial
5383134|NCT01798719|Mediterranean Diet|mediterranean diet
5383135|NCT01798719|Low Glycemic Index|low glycemic index
5383136|NCT01798693|Shoulder|shoulder
5383137|NCT01798693|Supplement|supplement
5383138|NCT01798693|Amino Acids|amino acids
5383139|NCT01798693|Collagen|collagen
5383140|NCT01798693|Standard of Care|standard of care
5383141|NCT01798641|Hydrocephalus|hydrocephalus
5383142|NCT01798641|Cross-over|cross-over
5383143|NCT01798628|Healthy volunteers|healthy volunteers
5383144|NCT01798628|Abiraterone acetate|abiraterone acetate
5383145|NCT01798628|Pharmacokinetics|pharmacokinetics
5383146|NCT01798602|H1N1|h1n1
5383147|NCT01798602|Rosuvastatin|rosuvastatin
5383148|NCT01798589|ethylenediamine dihydrochloride|ethylenediamine dihydrochloride
5383149|NCT01798563|Parkinson|parkinson
5383150|NCT01798563|Parkinson Disease|parkinson disease
5383151|NCT01798550|Enoxaparin dosing|enoxaparin dosing
5383152|NCT01798550|Obesity|obesity
5383153|NCT01798524|Transplant|transplant
5383154|NCT01798524|Kidney|kidney
5383155|NCT01798524|England|england
5383156|NCT01798511|enteral nutrition|enteral nutrition
5383157|NCT01798511|acute pancreatitis|acute pancreatitis
5383561|NCT01796717|MIC|mic
5383158|NCT01798511|oral food intolerance|oral food intolerance
5671949|NCT00613496|oxidative stress markers|oxidative stress markers
5383159|NCT01798472|displaced femoral neck fractures|displaced femoral neck fractures
5383160|NCT01798472|treatment|treatment
5383161|NCT01798472|uncemented arthroplasty|uncemented arthroplasty
5383162|NCT01798472|cemented arthroplasty|cemented arthroplasty
5383163|NCT01798459|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5383164|NCT01798459|Methylphenidate|methylphenidate
5383165|NCT01798459|Placebo|placebo
5383166|NCT01798459|State anxiety|state anxiety
5383167|NCT01798446|Renal cell carcinoma|renal cell carcinoma
5383168|NCT01798446|Nonclear cell|nonclear cell
5383169|NCT01798446|Temsirolimus resistance|temsirolimus resistance
5383170|NCT01798433|Angioplasty|angioplasty
5383171|NCT01798433|Transluminal|transluminal
5383172|NCT01798433|Percutaneous Coronary|percutaneous coronary
5383173|NCT01798420|COPD|copd
5383174|NCT01798420|Diabetes|diabetes
5383175|NCT01798420|steroids|steroids
5383176|NCT01798420|Hemoglobin A1C DIFFERENCE|hemoglobin a1c difference
5383177|NCT01798407|Deep Brain Stimulation|deep brain stimulation
5383178|NCT01798407|Major Depressive Disorder|major depressive disorder
5383179|NCT01798407|Depression|depression
5383180|NCT01798407|Lateral Habenula|lateral habenula
5383181|NCT01798407|Intractable Depression|intractable depression
5368897|NCT01862328|MLN4924|mln4924
5383182|NCT01798407|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
5383184|NCT01798394|smoker|smoker
5383185|NCT01798394|cigarette|cigarette
5383186|NCT01798394|tobacco|tobacco
5383187|NCT01798355|Dental Fear|dental fear
5383188|NCT01798355|Dental Phobia|dental phobia
5383189|NCT01798355|Cognitive Behavior Therapy|cognitive behavior therapy
5383190|NCT01798355|Specific Phobia|specific phobia
5383191|NCT01798355|Children and Adolescents anxiety|children and adolescents anxiety
5383192|NCT01798355|Self Efficacy|self efficacy
5383193|NCT01798342|preoperative care|preoperative care
5383194|NCT01798342|maltodextrine|maltodextrine
5383195|NCT01798342|glutamine|glutamine
5383196|NCT01798342|gastric residual volume|gastric residual volume
5383197|NCT01798342|MRI|mri
5383198|NCT01798329|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
5383199|NCT01798329|Pre-hepatic Portal Hypertension|pre-hepatic portal hypertension
5383200|NCT01798329|portal vein thrombosis|portal vein thrombosis
5383201|NCT01798316|IV Acetaminophen|iv acetaminophen
5383202|NCT01798316|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5383203|NCT01798316|Postoperative nausea|postoperative nausea
5383204|NCT01798316|Postoperative vomiting|postoperative vomiting
5383205|NCT01798277|Keywords provided by Newmarket Electrophysiology Research Group Inc:|keywords provided by newmarket electrophysiology research group inc:
5383206|NCT01798277|Ventricular tachycardia|ventricular tachycardia
5383207|NCT01798277|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
5383208|NCT01798277|Ablation|ablation
5383209|NCT01798277|Coronary artery disease|coronary artery disease
5383210|NCT01798277|Ischemic heart disease|ischemic heart disease
5383211|NCT01798277|Amiodarone|amiodarone
5383212|NCT01798277|Sotalol|sotalol
5383213|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents
5383214|NCT01798277|Therapeutic Uses|therapeutic uses
5383215|NCT01798277|Pharmacologic Actions|pharmacologic actions
5366493|NCT01873391|VAS|vas
5383216|NCT01798277|Additional relevant MeSH terms:|additional relevant mesh terms:
5383217|NCT01798277|Atrial Fibrillation|atrial fibrillation
5383218|NCT01798277|Arrhythmias, Cardiac|arrhythmias, cardiac
5383219|NCT01798277|Heart Diseases|heart diseases
5383220|NCT01798277|Cardiovascular Diseases|cardiovascular diseases
5383221|NCT01798277|Pathologic Processes|pathologic processes
5383222|NCT01798277|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5383223|NCT01798251|Elderly Gastric Cancer|elderly gastric cancer
5383224|NCT01798251|Capecitabine Maintenance|capecitabine maintenance
5383225|NCT01798238|Type 2 Diabetes Mellitus / Dipeptidyl peptidase-IV inhibitors|type 2 diabetes mellitus / dipeptidyl peptidase-iv inhibitors
5383226|NCT01798225|Periodontal Disease|periodontal disease
5383227|NCT01798225|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5383228|NCT01798225|Gullah African Americans|gullah african americans
5383229|NCT01798212|GERD|gerd
5383230|NCT01798199|Alzheimer|alzheimer
5383231|NCT01798199|virtual reality system|virtual reality system
5383232|NCT01798199|Alzheimer's disease related conditions|alzheimer's disease related conditions
5383233|NCT01798173|Hepatocellular carcinoma|hepatocellular carcinoma
5383234|NCT01798173|Cirrhosis|cirrhosis
5383235|NCT01798173|Environmental risk factors|environmental risk factors
5383236|NCT01798173|Nutrition|nutrition
5383237|NCT01798173|Metabolic syndrome|metabolic syndrome
5383238|NCT01798147|Cholangiocellular Carcinoma|cholangiocellular carcinoma
5383239|NCT01798147|TACE|tace
5383240|NCT01798147|SIRT|sirt
5383241|NCT01798134|To show safety|to show safety
5383242|NCT01798134|and efficacy|and efficacy
5383243|NCT01798134|investigational product|investigational product
5383244|NCT01798121|PPD|ppd
5383245|NCT01798121|Tuberculosis|tuberculosis
5383246|NCT01798108|Advanced skeletal metastases|advanced skeletal metastases
5383247|NCT01798108|Radium-223|radium-223
5383248|NCT01798108|Radium-223 dichloride|radium-223 dichloride
5383249|NCT01798108|Alpharadin|alpharadin
5383250|NCT01798095|TB, Aplisol|tb, aplisol
5383251|NCT01798056|≥18 years of age|≥18 years of age
5383252|NCT01798056|Chemotherapy|chemotherapy
5383253|NCT01798056|Solid tumours|solid tumours
5383254|NCT01798056|Immunogenicity|immunogenicity
5383255|NCT01798056|Herpes Zoster|herpes zoster
5383257|NCT01798056|Shingles|shingles
5383258|NCT01798030|Vitamin D|vitamin d
5383259|NCT01798030|Diabetes|diabetes
5383260|NCT01798030|Osteoporosis|osteoporosis
5383261|NCT01798030|Cardiovascular Risk|cardiovascular risk
5383262|NCT01798017|menstrual regulation|menstrual regulation
5383263|NCT01798017|mifepristone|mifepristone
5383264|NCT01798017|misoprostol|misoprostol
5383265|NCT01797991|Hypersensitivity, drug|hypersensitivity, drug
5383266|NCT01797978|Sepsis|sepsis
5383267|NCT01797978|Septic shock|septic shock
5383268|NCT01797978|Methylene blue|methylene blue
5383269|NCT01797952|lactobacillus CD 2|lactobacillus cd 2
5383270|NCT01797952|oral mucositis|oral mucositis
5383271|NCT01797952|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5383272|NCT01797939|Erosive reflux disease (ERD)|erosive reflux disease (erd)
5383273|NCT01797939|Non-erosive reflux disease (NERD)|non-erosive reflux disease (nerd)
5383274|NCT01797939|Functional heartburn (FH)|functional heartburn (fh)
5383275|NCT01797926|pharmacokinetics|pharmacokinetics
5383276|NCT01797926|Hypertension|hypertension
5383277|NCT01797926|losartan|losartan
5383278|NCT01797926|healthy volunteers|healthy volunteers
5383279|NCT01797926|amlodipine|amlodipine
5383280|NCT01797900|adjuvants|adjuvants
5383281|NCT01797900|inductive|inductive
5383282|NCT01797900|concurrent|concurrent
5383283|NCT01797900|chemoradiotherapy|chemoradiotherapy
5383284|NCT01797900|high-risk|high-risk
5383285|NCT01797900|locally advanced|locally advanced
5383286|NCT01797900|NPC|npc
5383287|NCT01797887|Burnout-Syndrome|burnout-syndrome
5383288|NCT01797887|Ayurveda|ayurveda
5383289|NCT01797887|Ayurvedic|ayurvedic
5383290|NCT01797887|Traditional Indian Medicine|traditional indian medicine
5383291|NCT01797887|CAM|cam
5383292|NCT01797887|Whole Medical System|whole medical system
5383293|NCT01797887|Diet and Lifestyle Counseling|diet and lifestyle counseling
5383294|NCT01797874|pazopanib maintenance|pazopanib maintenance
5383295|NCT01797874|efficacy|efficacy
5383296|NCT01797874|SCLC|sclc
5383297|NCT01797861|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5383298|NCT01797861|photodynamic therapy|photodynamic therapy
5383299|NCT01797861|micropulse laser|micropulse laser
5383300|NCT01797835|adolescents|adolescents
5383301|NCT01797835|intervention|intervention
5383302|NCT01797835|motivational interviewing|motivational interviewing
5383303|NCT01797835|alcohol and drug use|alcohol and drug use
5383304|NCT01797783|Myopia|myopia
5383305|NCT01797783|Presbyopia|presbyopia
5383306|NCT01797783|Refractive error|refractive error
5383307|NCT01797783|Contact lenses|contact lenses
5383308|NCT01797783|Multifocal|multifocal
5383309|NCT01797770|mechanical bowel preparation|mechanical bowel preparation
5383310|NCT01797770|Colon Cancer|colon cancer
5383311|NCT01797757|EPA|epa
5383312|NCT01797757|LC-PUFA|lc-pufa
5383313|NCT01797757|Orlistat|orlistat
5383314|NCT01797757|Obesity|obesity
5383315|NCT01797744|Stroke|stroke
5383316|NCT01797744|Dizziness|dizziness
5383317|NCT01797744|Vestibular rehabiliation|vestibular rehabiliation
5383318|NCT01797744|Balance|balance
5383319|NCT01797731|Orthalign|orthalign
5383320|NCT01797731|KneeAlign|kneealign
5383321|NCT01797731|Total Knee Replacement|total knee replacement
5383322|NCT01797731|Total Knee Arthroplasty|total knee arthroplasty
5383323|NCT01797731|Degenerative joint disease|degenerative joint disease
5383324|NCT01797731|Osteoarthritis|osteoarthritis
5383325|NCT01797731|Unilateral|unilateral
5383327|NCT01797718|Constitutional|constitutional
5383328|NCT01797718|Delay|delay
5383329|NCT01797718|Letrozole|letrozole
5383330|NCT01797718|Testosterone|testosterone
5383331|NCT01797692|prostate cancer cured|prostate cancer cured
5383332|NCT01797692|aged patients|aged patients
5383333|NCT01797679|Osteoarthritis,Articular Cartilage, Relaxometry, Morphometry, MRI, T2 mapping, T1 rho|osteoarthritis,articular cartilage, relaxometry, morphometry, mri, t2 mapping, t1 rho
5383334|NCT01797640|Tibia Fractures|tibia fractures
5383335|NCT01797640|Medial Fractures|medial fractures
5383336|NCT01797640|Posterior Malleolar Fractures|posterior malleolar fractures
5383337|NCT01797627|Pediatric Hydrocephalus|pediatric hydrocephalus
5383338|NCT01797627|Ventricular Size|ventricular size
5383339|NCT01797627|Neuropsychological Outcomes|neuropsychological outcomes
5383340|NCT01797627|Quality of Life|quality of life
5383341|NCT01797614|intra-abdominal pressure|intra-abdominal pressure
5383342|NCT01797614|spontaneous breathing trail|spontaneous breathing trail
5383343|NCT01797614|weaning|weaning
5383344|NCT01797588|Total Knee Arthroplasty|total knee arthroplasty
5383345|NCT01797588|Pain|pain
5383346|NCT01797588|Periarticular infiltration|periarticular infiltration
5383347|NCT01797588|Adductor canal block|adductor canal block
5383348|NCT01797588|Postoperative|postoperative
5383349|NCT01797575|Bipolar Disorder|bipolar disorder
5383350|NCT01797575|Mood Disorder|mood disorder
5383365|NCT01797523|RAD001|rad001
5383366|NCT01797497|Parents|parents
5383367|NCT01797497|Primary Care Providers|primary care providers
5383368|NCT01797497|Specialists|specialists
5383369|NCT01797497|Children with Special Healthcare Needs|children with special healthcare needs
5383370|NCT01797497|Referral|referral
5383371|NCT01797497|Health Outcomes|health outcomes
5383372|NCT01797497|Self-Efficacy|self-efficacy
5383373|NCT01797497|Communication|communication
5383374|NCT01797484|ischemia|ischemia
5383375|NCT01797484|myocardium|myocardium
5383376|NCT01797484|Ranolazine|ranolazine
5383377|NCT01797484|dyskinesia|dyskinesia
5383378|NCT01797484|speckle tracking echocardiography|speckle tracking echocardiography
5383379|NCT01797471|Non-Small Cell Lung Cancer|non-small cell lung cancer
5383380|NCT01797471|NSCLC|nsclc
5383381|NCT01797471|Lung Cancer|lung cancer
5383382|NCT01797458|Class II carious primary molar|class ii carious primary molar
5383383|NCT01797458|Non-Restorative Caries Treatment|non-restorative caries treatment
5383384|NCT01797458|Hall Technique|hall technique
5383385|NCT01797458|Conventional restorations|conventional restorations
5383386|NCT01797458|Children|children
5383388|NCT01797445|Treatment Naive|treatment naive
5383389|NCT01797445|HIV 1 Infected|hiv 1 infected
5383390|NCT01797445|Women|women
5383391|NCT01797445|Female|female
5383392|NCT01797419|Respiratory|respiratory
5383393|NCT01797419|Syncytial|syncytial
5383394|NCT01797419|Virus|virus
5383395|NCT01797419|RSV|rsv
5383396|NCT01797380|Depression|depression
5383397|NCT01797380|HIV|hiv
5383398|NCT01797367|HIV|hiv
5383399|NCT01797367|COPD|copd
5383400|NCT01797367|FEV1|fev1
5383401|NCT01797367|respiratory function|respiratory function
5383402|NCT01797354|patients at the end of treatment|patients at the end of treatment
5383403|NCT01797341|Renal Transplantation|renal transplantation
5383404|NCT01797341|Kidney transplantation|kidney transplantation
5383405|NCT01797341|Pancreas Transplantation|pancreas transplantation
5383406|NCT01797341|Tacrolimus|tacrolimus
5383407|NCT01797341|Advagraf|advagraf
5383408|NCT01797341|Prograf|prograf
5383409|NCT01797341|Drug Adherence|drug adherence
5383410|NCT01797328|brown adipose tissue, human|brown adipose tissue, human
5383411|NCT01797302|Obesity|obesity
5383412|NCT01797302|Vitamin D Deficiency|vitamin d deficiency
5383413|NCT01797302|Vascular Function|vascular function
5383414|NCT01797302|Insulin resistance|insulin resistance
5383415|NCT01797302|metabolic syndrome|metabolic syndrome
5383416|NCT01797289|syncope|syncope
5383417|NCT01797289|pulmonary embolism|pulmonary embolism
5383418|NCT01797276|Dichloroacetate (DCA)|dichloroacetate (dca)
5383419|NCT01797276|Congenital Lactic Acidosis (CLA)|congenital lactic acidosis (cla)
5383420|NCT01797276|acidosis|acidosis
5383421|NCT01797276|orphan disease|orphan disease
5383426|NCT01797237|surgery|surgery
5383427|NCT01797237|fixation|fixation
5383428|NCT01797237|intramedullary nail|intramedullary nail
5383429|NCT01797224|Autoimmune disease|autoimmune disease
5383430|NCT01797224|certolizumab pegol|certolizumab pegol
5383431|NCT01797224|Cimzia|cimzia
5383432|NCT01797224|pregnancy|pregnancy
5383433|NCT01797224|birth defect|birth defect
5383434|NCT01797224|birth outcome|birth outcome
5383435|NCT01797224|TNF|tnf
5383436|NCT01797224|Tumor necrosis factor|tumor necrosis factor
5383437|NCT01797211|Mediterranean diet; FMD; obesity; cardiovascular risk.|mediterranean diet; fmd; obesity; cardiovascular risk.
5383438|NCT01797198|Phase I|phase i
5383439|NCT01797198|ASP3652|asp3652
5383440|NCT01797198|Gemfibrozil|gemfibrozil
5383441|NCT01797198|Repaglinide|repaglinide
5383442|NCT01797198|Pharmacokinetics|pharmacokinetics
5383443|NCT01797185|spasticity|spasticity
5383444|NCT01797172|nucleoplasty|nucleoplasty
5383445|NCT01797172|pulsed radio frequency|pulsed radio frequency
5383447|NCT01797172|cervical|cervical
5383448|NCT01797172|percutaneous disc decompression|percutaneous disc decompression
5383449|NCT01797172|cervical radiculopathy|cervical radiculopathy
5383453|NCT01797120|Post-Menopausal Patients|post-menopausal patients
5383454|NCT01797120|Hormone-Receptor Positive|hormone-receptor positive
5383455|NCT01797120|Resistant to Aromatase Inhibitor Therapy|resistant to aromatase inhibitor therapy
5383458|NCT01797120|mTOR Inhibitor|mtor inhibitor
5383459|NCT01797120|Everolimus|everolimus
5383461|NCT01797120|Afinitor|afinitor
5383462|NCT01797107|Meibomian gland dysfunction|meibomian gland dysfunction
5383463|NCT01797068|HEALTHCARE UTILIZATION|healthcare utilization
5383464|NCT01797068|ED UTILIZATION|ed utilization
5383465|NCT01797068|PRIMARY CARE UTILIZATION|primary care utilization
5383466|NCT01797068|PATIENT NAVIGATION|patient navigation
5383467|NCT01797068|UNDERSERVED POPULATIONS|underserved populations
5383468|NCT01797068|HEALTH DISPARITIES|health disparities
5383469|NCT01797055|transferrin|transferrin
5383470|NCT01797055|anemia|anemia
5383471|NCT01797055|iron overload|iron overload
5383472|NCT01797042|Fructose|fructose
5383473|NCT01797042|High fructose corn syrup|high fructose corn syrup
5383474|NCT01797042|Energy regulation|energy regulation
5383475|NCT01797042|Ectopic fat|ectopic fat
5383476|NCT01797042|Understanding|understanding
5383477|NCT01797042|potential|potential
5383478|NCT01797016|Myocardial Infarction|myocardial infarction
5383479|NCT01797016|flow cytometry|flow cytometry
5383480|NCT01797016|Blood Cell Count|blood cell count
5383481|NCT01797016|Platelet Activation|platelet activation
5383482|NCT01797003|osteoarthritis|osteoarthritis
5383483|NCT01797003|osteotomy|osteotomy
5383484|NCT01797003|closing|closing
5383485|NCT01797003|opening|opening
5383486|NCT01797003|wedge|wedge
5383488|NCT01797003|tibia|tibia
5383489|NCT01796990|physical activity|physical activity
5383490|NCT01796990|psychological well-being|psychological well-being
5383491|NCT01796990|acceptance and commitment therapy|acceptance and commitment therapy
5383492|NCT01796990|adults|adults
5383493|NCT01796977|Nipple-sparing Mastectomy|nipple-sparing mastectomy
5383495|NCT01796977|Nipple Sparing Mastectomy|nipple sparing mastectomy
5383496|NCT01796964|Age-Related Macular Degeneration|age-related macular degeneration
5383497|NCT01796964|Wet|wet
5383498|NCT01796964|Exudative|exudative
5383499|NCT01796964|AMD|amd
5383500|NCT01796964|Intravitreal injection|intravitreal injection
5383501|NCT01796964|Retina|retina
5383502|NCT01796938|Lacosamide|lacosamide
5383503|NCT01796938|Vimpat|vimpat
5383504|NCT01796938|Single Dose|single dose
5383505|NCT01796938|Pharmacokinetics|pharmacokinetics
5383506|NCT01796938|Renal Impairment|renal impairment
5383507|NCT01796925|Apnea|apnea
5383508|NCT01796925|Respiration Disorders|respiration disorders
5383509|NCT01796925|Signs and Symptoms|signs and symptoms
5383510|NCT01796925|Signs and Symptoms, Respiratory|signs and symptoms, respiratory
5383511|NCT01796925|Sleep Apnea Syndromes|sleep apnea syndromes
5383512|NCT01796925|Sleep Apnea, Obstructive|sleep apnea, obstructive
5383513|NCT01796925|Respiratory Tract Diseases|respiratory tract diseases
5383514|NCT01796925|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5383515|NCT01796925|Sleep Disorders|sleep disorders
5383516|NCT01796925|Nervous System Diseases|nervous system diseases
5383517|NCT01796912|Refractory Angina|refractory angina
5383518|NCT01796912|Lipoprotein|lipoprotein
5383519|NCT01796899|Healthy Volunteers|healthy volunteers
5383520|NCT01796899|Brivaracetam|brivaracetam
5383521|NCT01796873|Female|female
5383522|NCT01796873|Hispanic|hispanic
5383523|NCT01796873|Percutaneous Coronary Intervention|percutaneous coronary intervention
5383524|NCT01796860|Gait|gait
5383525|NCT01796860|AFO|afo
5383526|NCT01796860|MS|ms
5383527|NCT01796847|ICU|icu
5383528|NCT01796847|Hyperglycemia|hyperglycemia
5383529|NCT01796847|Length of stay|length of stay
5383530|NCT01796834|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5383531|NCT01796834|Diabetes Management|diabetes management
5383532|NCT01796834|Stress Reduction|stress reduction
5383533|NCT01796834|Diabetes Testing|diabetes testing
5383534|NCT01796821|Condyloma acuminata|condyloma acuminata
5383535|NCT01796821|Genital warts|genital warts
5383536|NCT01796821|Condylomata acuminata|condylomata acuminata
5383537|NCT01796821|Venereal warts|venereal warts
5383538|NCT01796808|pedal|pedal
5383539|NCT01796808|atrophy|atrophy
5383540|NCT01796808|fat grafting|fat grafting
5383541|NCT01796808|adipose tissue|adipose tissue
5383542|NCT01796795|common wart|common wart
5383543|NCT01796795|verruca vulgaris|verruca vulgaris
5366796|NCT01872221|MRI|mri
5383544|NCT01796769|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5383545|NCT01796769|Telemedicine|telemedicine
5383546|NCT01796769|Patient Compliance|patient compliance
5383547|NCT01796756|Handover|handover
5383548|NCT01796756|Handoff|handoff
5383549|NCT01796756|Signout|signout
5383550|NCT01796756|Quality Improvement|quality improvement
5383551|NCT01796756|General Internal Medicine|general internal medicine
5383552|NCT01796743|MRI|mri
5378910|NCT01817413|Incisor|incisor
5383553|NCT01796743|Double Inversion radial fast Spin Echo T2 mapping|double inversion radial fast spin echo t2 mapping
5383554|NCT01796743|Heart failure risk stratification|heart failure risk stratification
5383555|NCT01796743|30 day post hospitalization outcome|30 day post hospitalization outcome
5383556|NCT01796730|efficacy|efficacy
5383557|NCT01796730|safety|safety
5383558|NCT01796730|Bambuterol tablets|bambuterol tablets
5383559|NCT01796730|COPD|copd
5383560|NCT01796717|Piperacillin/tazobactam|piperacillin/tazobactam
5383563|NCT01796704|NYHA class|nyha class
5383564|NCT01796691|Clopidogrel|clopidogrel
5383565|NCT01796691|aspirin|aspirin
5383566|NCT01796691|low response|low response
5383567|NCT01796691|platelet aggregation|platelet aggregation
5383568|NCT01796691|Acute Coronary Syndrome|acute coronary syndrome
5383569|NCT01796691|Coronary Stent Implantation|coronary stent implantation
5383570|NCT01796678|sickle cell disease|sickle cell disease
5383571|NCT01796678|vaso-occlusive pain episodes|vaso-occlusive pain episodes
5383572|NCT01796678|arginine|arginine
5383573|NCT01796678|nitric oxide|nitric oxide
5383574|NCT01796652|Acute interstitial pancreatitis|acute interstitial pancreatitis
5383575|NCT01796652|Home therapy|home therapy
5383576|NCT01796600|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,|distal limbs fracture, acute trauma, imaging, cone beam computed tomography,
5383577|NCT01796574|status epilepticus|status epilepticus
5383578|NCT01796574|seizure|seizure
5383579|NCT01796574|epilepsy|epilepsy
5383580|NCT01796574|ketogenic diet|ketogenic diet
5383581|NCT01796574|modified Atkins diet|modified atkins diet
5383582|NCT01796548|Detrusor function, overactive|detrusor function, overactive
5383583|NCT01796548|Urinary incontinence|urinary incontinence
5383584|NCT01796548|Oxybutynin|oxybutynin
5383585|NCT01796548|Lyrinel|lyrinel
5383586|NCT01796509|Quality of life,|quality of life,
5383587|NCT01796509|Sequela disorders,|sequela disorders,
5383588|NCT01796509|Socio-professional impact,|socio-professional impact,
5383589|NCT01796509|Anxiety, depression,|anxiety, depression,
5383590|NCT01796509|Post traumatic stress disorder,|post traumatic stress disorder,
5383591|NCT01796509|ICU acquired paresis.|icu acquired paresis.
5383592|NCT01796496|Low back pain.|low back pain.
5383593|NCT01796496|Manipulative therapy techniques.|manipulative therapy techniques.
5383594|NCT01796496|Randomized controlled trial.|randomized controlled trial.
5383595|NCT01796496|Chronic pain.|chronic pain.
5383596|NCT01796483|Parkinson disease|parkinson disease
5383597|NCT01796483|STN-DBS|stn-dbs
5383598|NCT01796483|Impulsivity|impulsivity
5383599|NCT01796483|Akinesia|akinesia
5383600|NCT01796483|Noradrenergic|noradrenergic
5383601|NCT01796483|system|system
5383602|NCT01796470|GS-US-339-0103|gs-us-339-0103
5371097|NCT01853267|Surgery|surgery
5383603|NCT01796470|SYK inhibitor|syk inhibitor
5383604|NCT01796470|PI3K inhibitor|pi3k inhibitor
5383605|NCT01796470|GS-9973|gs-9973
5383606|NCT01796470|GS 9973|gs 9973
5383607|NCT01796470|GS-1101|gs-1101
5383608|NCT01796470|GS 1101|gs 1101
5383609|NCT01796470|Cal-101|cal-101
5383610|NCT01796470|Cal 101|cal 101
5383611|NCT01796470|idelalisib|idelalisib
5383612|NCT01796470|leukemia|leukemia
5383613|NCT01796470|lymphoma|lymphoma
5383615|NCT01796470|MCL|mcl
5383616|NCT01796470|DLBCL|dlbcl
5383617|NCT01796470|iNHL|inhl
5383618|NCT01796470|FL|fl
5383619|NCT01796470|MZL|mzl
5383620|NCT01796470|LPL|lpl
5383621|NCT01796470|SLL|sll
5383622|NCT01796470|WM|wm
5383623|NCT01796470|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5383624|NCT01796457|Hepatitis B|hepatitis b
5383625|NCT01796457|Immunology|immunology
5383626|NCT01796457|HBV|hbv
5383627|NCT01796457|Immune tolerant|immune tolerant
5383628|NCT01796457|Immune active|immune active
5383629|NCT01796444|Breast Cancer|breast cancer
5383630|NCT01796444|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5383631|NCT01796444|Axillary Lymph Node Dissection|axillary lymph node dissection
5383632|NCT01796392|emphysema|emphysema
5383633|NCT01796392|endobronchial valve|endobronchial valve
5383634|NCT01796392|treatments|treatments
5383635|NCT01796392|pulmonary rehabilitation|pulmonary rehabilitation
5383636|NCT01796392|lung volume reduction|lung volume reduction
5383637|NCT01796353|heart disease|heart disease
5383638|NCT01796353|sexual dysfunction|sexual dysfunction
5383639|NCT01796353|exercise test|exercise test
5383640|NCT01796353|comprehensive rehabilitation|comprehensive rehabilitation
5383641|NCT01796353|complex intervention|complex intervention
5383642|NCT01796340|cue exposure|cue exposure
5383643|NCT01796340|childhood|childhood
5383644|NCT01796340|overeating|overeating
5383645|NCT01796340|overweight|overweight
5383646|NCT01796340|obese|obese
5383647|NCT01796340|treatment|treatment
5383648|NCT01796327|dacomitinib|dacomitinib
5383649|NCT01796327|PF-00299804|pf-00299804
5383650|NCT01796327|pharmacokinetics|pharmacokinetics
5383651|NCT01796327|bioavailability|bioavailability
5383652|NCT01796314|Therapeutic educational programme for Alzheimer's disease patients and their caregiver|therapeutic educational programme for alzheimer's disease patients and their caregiver
5423332|NCT01616147|Intensive Lifestyle Intervention|intensive lifestyle intervention
5383653|NCT01796314|Alzheimer's disease, mild to moderately severe stages|alzheimer's disease, mild to moderately severe stages
5383654|NCT01796314|Community dwelling patients with family caregiver|community dwelling patients with family caregiver
5383655|NCT01796314|quality of life|quality of life
5383656|NCT01796301|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5383657|NCT01796288|NSCLC|nsclc
5383658|NCT01796288|oligometastatic|oligometastatic
5383659|NCT01796288|second-line|second-line
5383660|NCT01796288|Radiotherapy|radiotherapy
5383661|NCT01796288|Erlotinib|erlotinib
5383675|NCT01796236|Health Utility Index (HUI)|health utility index (hui)
5383676|NCT01796236|Holgers Index|holgers index
5383677|NCT01796236|Implant stability|implant stability
5383678|NCT01796223|Community mental health services|community mental health services
5383679|NCT01796223|Psychotherapy|psychotherapy
5383680|NCT01796223|Physician-Patient Relations|physician-patient relations
5383681|NCT01796223|Norway|norway
5383682|NCT01796210|Analgesia/nociception index|analgesia/nociception index
5383683|NCT01796210|Bispectral index|bispectral index
5383684|NCT01796210|Propofol|propofol
5383685|NCT01796210|Remifentanil|remifentanil
5383686|NCT01796210|Suspension laryngoscopy|suspension laryngoscopy
5383687|NCT01796210|Endoscopy|endoscopy
5383688|NCT01796210|Ear-nose-throat|ear-nose-throat
5383689|NCT01796184|Inflammation|inflammation
5383690|NCT01796184|Glycation|glycation
5383691|NCT01796184|Continuous glucose monitoring|continuous glucose monitoring
5383692|NCT01796184|Adult population|adult population
5383693|NCT01796171|Radioimmunotherapy|radioimmunotherapy
5383694|NCT01796171|Lu-177|lu-177
5383695|NCT01796171|Phase I study|phase i study
5383696|NCT01796171|Phase II study|phase ii study
5383697|NCT01796171|Betalutin|betalutin
5383698|NCT01796158|adolescents|adolescents
5383699|NCT01796158|alcohol abuse|alcohol abuse
5383700|NCT01796158|drug abuse|drug abuse
5383701|NCT01796158|substance use|substance use
5383702|NCT01796132|Depression|depression
5383703|NCT01796132|Lactation|lactation
5383704|NCT01796132|Breastfeeding|breastfeeding
5383705|NCT01796132|Pharmacokinetics|pharmacokinetics
5383706|NCT01796132|Antidepressant|antidepressant
5383707|NCT01796119|Dental implants, Ridge splitting, Ridge expansion|dental implants, ridge splitting, ridge expansion
5383708|NCT01796106|caries infiltration|caries infiltration
5383709|NCT01796106|caries progression|caries progression
5383710|NCT01796106|Icon|icon
5383711|NCT01796093|Digoxin|digoxin
5383712|NCT01796093|Ivabradine|ivabradine
5383713|NCT01796093|Cardiac failure|cardiac failure
5383715|NCT01796067|Motivational intervention|motivational intervention
5371206|NCT01852799|PAD|pad
5383716|NCT01796067|Positive Parenting Intervention|positive parenting intervention
5383717|NCT01796067|Obesity|obesity
5383718|NCT01796067|Physical Activity|physical activity
5383719|NCT01796067|Diet|diet
5383720|NCT01796067|African American|african american
5383721|NCT01796067|Adolescent|adolescent
5383722|NCT01796054|Perceived stress|perceived stress
5383723|NCT01796054|Burnout|burnout
5383724|NCT01796054|Mindfulness|mindfulness
5383725|NCT01796054|Intent to leave nursing|intent to leave nursing
5383726|NCT01796028|Prostate Cancer|prostate cancer
5383727|NCT01796015|paediatrics|paediatrics
5383728|NCT01796015|optic nerve sheath diameter|optic nerve sheath diameter
5383729|NCT01796015|ultrasound|ultrasound
5383730|NCT01796002|PTCL|ptcl
5383731|NCT01795989|Coil|coil
5383733|NCT01795989|safety|safety
5383734|NCT01795989|efficacy|efficacy
5383735|NCT01795989|musculoskeletal imaging|musculoskeletal imaging
5383736|NCT01795989|Cincinnati|cincinnati
5383737|NCT01795989|Safety and efficacy of a new elbow coil on pediatric patients and healthy participants|safety and efficacy of a new elbow coil on pediatric patients and healthy participants
5383738|NCT01795976|Oesophageal cancer|oesophageal cancer
5383739|NCT01795963|intimate partner violence|intimate partner violence
5383740|NCT01795950|cell therapy|cell therapy
5383741|NCT01795950|Pulmonary arterial hypertension|pulmonary arterial hypertension
5383742|NCT01795898|Osteoarthritis|osteoarthritis
5383743|NCT01795898|Low back pain|low back pain
5383744|NCT01795898|Fentanyl transdermal patch|fentanyl transdermal patch
5383745|NCT01795898|Durogesic-D-Trans|durogesic-d-trans
5383746|NCT01795885|Pregnancy in Adolescence|pregnancy in adolescence
5383747|NCT01795885|Contraception|contraception
5383748|NCT01795859|Huntington disease|huntington disease
5383749|NCT01795859|Chorea|chorea
5383750|NCT01795859|Tetrabenazine|tetrabenazine
5445447|NCT01521767|tolterodine microspheres in powder blend|tolterodine microspheres in powder blend
5445448|NCT01521767|Overactive Urinary Bladder|overactive urinary bladder
5383751|NCT01795846|allergen specific immunotherapy, house dust mite (Der p), monosensitization, polysensitization, allergic rhinitis, asthma,|allergen specific immunotherapy, house dust mite (der p), monosensitization, polysensitization, allergic rhinitis, asthma,
5383752|NCT01795833|Prediabetes|prediabetes
5383753|NCT01795833|Prediabetic State|prediabetic state
5383754|NCT01795820|ticagrelor|ticagrelor
5383755|NCT01795820|clopidogrel|clopidogrel
5383756|NCT01795820|platelet aggregation|platelet aggregation
5383757|NCT01795781|Anticoagulant measurement|anticoagulant measurement
5383758|NCT01795781|Anticoagulant reversal|anticoagulant reversal
5383759|NCT01795781|Dabigatran|dabigatran
5383760|NCT01795781|Rivaroxaban|rivaroxaban
5383761|NCT01795768|Non randomised|non randomised
5383762|NCT01795768|Open label|open label
5383773|NCT01795742|Developing Countries|developing countries
5383774|NCT01795729|Heart transplant|heart transplant
5383775|NCT01795729|Coronary artery disease|coronary artery disease
5383777|NCT01795729|Coronary stent|coronary stent
5383778|NCT01795729|Optimal medical therapy|optimal medical therapy
5383779|NCT01795729|Prognosis|prognosis
5383780|NCT01795703|Prostate Cancer|prostate cancer
5383781|NCT01795703|Abiraterone Acetate|abiraterone acetate
5383782|NCT01795703|JNJ-212082|jnj-212082
5383783|NCT01795690|Anemia|anemia
5383784|NCT01795690|Cancer|cancer
5383785|NCT01795690|Hemoglobin|hemoglobin
5383786|NCT01795690|Quality of Life|quality of life
5383787|NCT01795690|FACT-An|fact-an
5383788|NCT01795690|FACT-GP|fact-gp
5383789|NCT01795690|Erythropoiesis-Stimulating Agents (ESA)|erythropoiesis-stimulating agents (esa)
5383790|NCT01795690|Epoetin|epoetin
5383791|NCT01795690|Ferric Carboxymaltose|ferric carboxymaltose
5383792|NCT01795690|Blood Transfusions|blood transfusions
5383793|NCT01795677|JAK2 inhibitor RUXOLITINIB|jak2 inhibitor ruxolitinib
5383794|NCT01795677|Primary or secondary myelofibrosis|primary or secondary myelofibrosis
5383795|NCT01795664|Asthma|asthma
5383796|NCT01795664|Salmeterol xinafoate and Fluticasone propionate|salmeterol xinafoate and fluticasone propionate
5383797|NCT01795664|Seretide Evohaler|seretide evohaler
5383798|NCT01795664|Functional Respiratory Imaging|functional respiratory imaging
5383799|NCT01795664|Computational Fluid Dynamic|computational fluid dynamic
5383800|NCT01795651|teaching|teaching
5383801|NCT01795651|knowledge translation|knowledge translation
5383802|NCT01795651|ICU|icu
5383803|NCT01795651|postgraduate|postgraduate
5383804|NCT01795651|lecture|lecture
5383805|NCT01795638|anthropometrics|anthropometrics
5383806|NCT01795638|weight|weight
5383807|NCT01795638|nutrition|nutrition
5383808|NCT01795586|breast - female|breast - female
5383809|NCT01795586|advanced breast cancer|advanced breast cancer
5383810|NCT01795586|histologically confirmed|histologically confirmed
5383811|NCT01795586|cytologically confirmed|cytologically confirmed
5383812|NCT01795586|metastatic|metastatic
5383813|NCT01795586|locally advanced|locally advanced
5383814|NCT01795586|unresectable|unresectable
5383816|NCT01795573|AML|aml
5383817|NCT01795573|ALL|all
5383818|NCT01795573|MDS|mds
5383819|NCT01795573|CLL|cll
5383820|NCT01795573|NHL|nhl
5383821|NCT01795573|HL|hl
5383822|NCT01795573|MM|mm
5369498|NCT01859715|CYP2D6|cyp2d6
5383823|NCT01795560|Periappendicular abscess|periappendicular abscess
5383824|NCT01795560|Ultrasound|ultrasound
5480426|NCT01377389|ADT|adt
5371306|NCT01852409|Bevacizumab|bevacizumab
5383825|NCT01795521|NSCLC, SBRT, PET, Medically Inoperable|nsclc, sbrt, pet, medically inoperable
5383826|NCT01795508|Parent training|parent training
5383827|NCT01795508|Child behavior|child behavior
5383828|NCT01795508|Randomized Controlled Trials|randomized controlled trials
5383829|NCT01795495|Spinal Fusion|spinal fusion
5383830|NCT01795495|Scoliosis|scoliosis
5383831|NCT01795495|Methadone|methadone
5383832|NCT01795495|Magnesium|magnesium
5383833|NCT01795495|Adolescents|adolescents
5383834|NCT01795495|Back Surgery|back surgery
5383835|NCT01795482|perioperative hypothermia|perioperative hypothermia
5383836|NCT01795482|prewarming|prewarming
5383837|NCT01795482|preoperative warming|preoperative warming
5383838|NCT01795482|general anaesthesia|general anaesthesia
5383839|NCT01795482|epidural anaesthesia|epidural anaesthesia
5383840|NCT01795482|temperature measurement|temperature measurement
5383841|NCT01795469|POTS|pots
5383842|NCT01795469|Orthostatic|orthostatic
5383843|NCT01795469|Adolescent|adolescent
5383844|NCT01795456|Takayasu's arteritis|takayasu's arteritis
5383845|NCT01795456|Giant Cell arteritis|giant cell arteritis
5383846|NCT01795456|Arteritis|arteritis
5383847|NCT01795456|Vasculitis|vasculitis
5383848|NCT01795456|Aortitis|aortitis
5383849|NCT01795456|Disease Activity|disease activity
5383850|NCT01795456|Carotidynia|carotidynia
5383851|NCT01795456|Neovascularization|neovascularization
5383852|NCT01795456|Carotid Intima Media Thickness|carotid intima media thickness
5383853|NCT01795443|vibration|vibration
5383854|NCT01795443|proprioception|proprioception
5383855|NCT01795417|wrinkles|wrinkles
5383856|NCT01795417|rhytids|rhytids
5383857|NCT01795417|periorbital|periorbital
5383858|NCT01795404|IBSR|ibsr
5383859|NCT01795404|Cancer Survivors|cancer survivors
5383860|NCT01795404|Katie Byron|katie byron
5383861|NCT01795404|Quality of Life|quality of life
5383862|NCT01795404|Stress|stress
5383863|NCT01795404|Stress reduction|stress reduction
5383864|NCT01795391|Prevention|prevention
5383865|NCT01795391|Dressings|dressings
5383866|NCT01795391|Catheters|catheters
5383867|NCT01795378|acute myelogenous leukemia|acute myelogenous leukemia
5383868|NCT01795378|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5383869|NCT01795378|donor natural killer cells|donor natural killer cells
5383870|NCT01795378|HLA-haploidentical hematopoietic cell transplantation|hla-haploidentical hematopoietic cell transplantation
5383871|NCT01795352|EGFR,|egfr,
5383872|NCT01795352|lung cancer,|lung cancer,
5383873|NCT01795352|mutated|mutated
5383874|NCT01795339|AZD3293|azd3293
5383875|NCT01795339|Healthy volunteers|healthy volunteers
5383876|NCT01795339|Elderly volunteers|elderly volunteers
5383877|NCT01795339|Alzheimer's Disease patients|alzheimer's disease patients
5383878|NCT01795339|AD patients|ad patients
5383879|NCT01795339|Phase 1|phase 1
5383880|NCT01795339|Multiple Ascending Dose Study|multiple ascending dose study
5383881|NCT01795326|Effectiveness of risk minimization|effectiveness of risk minimization
5383882|NCT01795326|Metabolic monitoring|metabolic monitoring
5383883|NCT01795326|Seroquel®|seroquel®
5383884|NCT01795326|Seroquel® XR/quetiapine fumarate|seroquel® xr/quetiapine fumarate
5383885|NCT01795287|tibial fracture|tibial fracture
5383886|NCT01795287|intramedullary nailing|intramedullary nailing
5383887|NCT01795287|spinal anesthesia|spinal anesthesia
5383888|NCT01795287|patient safety|patient safety
5383890|NCT01795248|gestational diabetes mellitus|gestational diabetes mellitus
5383891|NCT01795248|incretin|incretin
5383892|NCT01795248|glucose homeostasis|glucose homeostasis
5383893|NCT01795248|GLP-1|glp-1
5383894|NCT01795248|type 2 diabetes mellitus|type 2 diabetes mellitus
5383895|NCT01795248|liraglutide|liraglutide
5383896|NCT01795248|Victoza|victoza
5383897|NCT01795235|men|men
5383898|NCT01795222|conscious sedation|conscious sedation
5383899|NCT01795222|stress psychological|stress psychological
5383900|NCT01795222|dental care for children|dental care for children
5383901|NCT01795222|child behavior|child behavior
5383902|NCT01795222|saliva|saliva
5383903|NCT01795209|Branch retinal vein occlusion|branch retinal vein occlusion
5383904|NCT01795209|Macular edema|macular edema
5383905|NCT01795209|Ranibizumab|ranibizumab
5383906|NCT01795196|pediatric extubation failure|pediatric extubation failure
5383907|NCT01795196|weaning|weaning
5383908|NCT01795196|integrated pulmonary index|integrated pulmonary index
5383909|NCT01795196|mechanical ventilation|mechanical ventilation
5383910|NCT01795196|extubation readiness|extubation readiness
5383911|NCT01795196|respiratory monitoring tool|respiratory monitoring tool
5383912|NCT01795196|Endotracheal Extubation|endotracheal extubation
5383913|NCT01795196|Pediatric Intensive Care Unit|pediatric intensive care unit
5383914|NCT01795196|Rapid Shallow Breathing Index|rapid shallow breathing index
5383915|NCT01795196|Physiologic Deadspace|physiologic deadspace
5383916|NCT01795170|Pyridoxine Dependant Epilepsy|pyridoxine dependant epilepsy
5383917|NCT01795170|Antiquitin Deficiency|antiquitin deficiency
5383918|NCT01795170|Lysine Restricted Diet|lysine restricted diet
5369606|NCT01859143|Vaccine|vaccine
5480567|NCT01376895|HIV|hiv
5371401|NCT01852032|Breast Cancer|breast cancer
5383919|NCT01795157|decision support systems, clinical|decision support systems, clinical
5383920|NCT01795157|decision making, computer assisted|decision making, computer assisted
5383921|NCT01795157|evidence based practice|evidence based practice
5383922|NCT01795157|practice guidelines as topic|practice guidelines as topic
5383923|NCT01795131|Nutritional anemia|nutritional anemia
5383924|NCT01795131|Vitamin B12|vitamin b12
5383925|NCT01795131|flu vaccine|flu vaccine
5383926|NCT01795131|immunity|immunity
5383927|NCT01795092|Cellulitis|cellulitis
5383928|NCT01795092|Outpatient Medicine|outpatient medicine
5383929|NCT01795079|transcranial stimulation|transcranial stimulation
5383930|NCT01795079|direct current|direct current
5383931|NCT01795053|ADHD preschoolers|adhd preschoolers
5383932|NCT01795053|playtraining|playtraining
5383933|NCT01795053|child-focused intervention|child-focused intervention
5383934|NCT01795040|omega-3/omega-6 fatty acids|omega-3/omega-6 fatty acids
5383935|NCT01795040|Pre-school children with ADHD symptoms|pre-school children with adhd symptoms
5383936|NCT01795040|randomized controlled trial|randomized controlled trial
5383937|NCT01795027|gastric cancer|gastric cancer
5383938|NCT01795027|chemotherapy|chemotherapy
5383939|NCT01795027|D2 resection|d2 resection
5383940|NCT01795027|S-1|s-1
5383941|NCT01795001|pathophysiology|pathophysiology
5383942|NCT01794988|Acute Pain|acute pain
5383943|NCT01794988|Low Back Pain|low back pain
5383944|NCT01794988|Back Pain|back pain
5383945|NCT01794988|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5383946|NCT01794988|Cognitive Behavioral Therapy|cognitive behavioral therapy
5383947|NCT01794988|Pain Education|pain education
5383948|NCT01794975|PET|pet
5383949|NCT01794975|striatum|striatum
5383950|NCT01794975|receptor occupancy|receptor occupancy
5383951|NCT01794975|noradrenaline|noradrenaline
5383952|NCT01794975|alpha2c|alpha2c
5383953|NCT01794962|Classification|classification
5383954|NCT01794962|LBP|lbp
5445449|NCT01521741|Breast Cancer|breast cancer
5383955|NCT01794962|Cognitive functional therapy|cognitive functional therapy
5383956|NCT01794962|Manual Therapy|manual therapy
5383957|NCT01794949|Angioplasty|angioplasty
5383958|NCT01794949|Atherosclerosis|atherosclerosis
5383959|NCT01794949|Wound Healing|wound healing
5383960|NCT01794936|Prostate cancer|prostate cancer
5383961|NCT01794936|Nerve Sparing Prostatectomy|nerve sparing prostatectomy
5383962|NCT01794936|VTI Probe|vti probe
5383963|NCT01794923|Delayed onset muscle soreness|delayed onset muscle soreness
5383964|NCT01794923|ibuprofen|ibuprofen
5383966|NCT01794910|Pregnancy|pregnancy
5383967|NCT01794910|Pelvic Floor|pelvic floor
5383968|NCT01794910|Muscle strength|muscle strength
5383969|NCT01794910|Exercise therapy|exercise therapy
5383970|NCT01794910|natural childbirth|natural childbirth
5383971|NCT01794910|cesarean section|cesarean section
5383972|NCT01794910|physiotherapy|physiotherapy
5383973|NCT01794884|Glutamine|glutamine
5383974|NCT01794884|Cardiosurgery|cardiosurgery
5383975|NCT01794884|Cardiopulmonary bypass|cardiopulmonary bypass
5383976|NCT01794884|Cardiac function|cardiac function
5383978|NCT01794845|SCCHN|scchn
5383979|NCT01794845|Head and Neck Cancer|head and neck cancer
5383980|NCT01794845|Squamous Cell Carcinoma|squamous cell carcinoma
5383981|NCT01794845|Recurrent|recurrent
5383982|NCT01794832|HRQoL|hrqol
5383983|NCT01794832|Aortic stenosis|aortic stenosis
5383984|NCT01794832|Aortic valve surgery|aortic valve surgery
5383985|NCT01794819|antibiotics|antibiotics
5383986|NCT01794819|primary care|primary care
5383987|NCT01794819|radiology/radiography|radiology/radiography
5383988|NCT01794819|respiratory tract infections|respiratory tract infections
5383989|NCT01794793|SOM230,|som230,
5383990|NCT01794793|roll-over study|roll-over study
5383991|NCT01794793|pasireotide LAR|pasireotide lar
5383992|NCT01794793|Cushing's disease|cushing's disease
5383993|NCT01794793|Acromegaly|acromegaly
5383994|NCT01794793|neuroendocrine tumorsNETs|neuroendocrine tumorsnets
5383995|NCT01794793|pituitary tumors|pituitary tumors
5383996|NCT01794793|Ectopic ACTH secreting|ectopic acth secreting
5383997|NCT01794793|EAS|eas
5383998|NCT01794793|Dumping Syndrome|dumping syndrome
5383999|NCT01794793|metastatic prostate cancer, metastatic melanoma|metastatic prostate cancer, metastatic melanoma
5384000|NCT01794793|bRAF|braf
5384001|NCT01794793|nRAS|nras
5384002|NCT01794780|COPD|copd
5384003|NCT01794780|Chronic obstructive pulmonary disease (COPD),|chronic obstructive pulmonary disease (copd),
5384004|NCT01794780|Chronic obstructive lung disease (COLD),|chronic obstructive lung disease (cold),
5384005|NCT01794780|Chronic obstructive airway disease (COAD),|chronic obstructive airway disease (coad),
5384006|NCT01794780|Cronchitis,|cronchitis,
5384007|NCT01794780|Emphysema|emphysema
5384008|NCT01794767|peripheral venous catheter, children.|peripheral venous catheter, children.
5384009|NCT01794754|Hand osteoarthritis|hand osteoarthritis
5384010|NCT01794754|CMC1-joint|cmc1-joint
5384011|NCT01794754|surgery|surgery
5384012|NCT01794754|occupational therapy|occupational therapy
5384013|NCT01794754|hand exercises|hand exercises
5384014|NCT01794754|assistive devices|assistive devices
5384015|NCT01794754|orthoses|orthoses
5384016|NCT01794728|Pain Management|pain management
5384017|NCT01794715|Heart failure|heart failure
5384018|NCT01794715|Nurse led|nurse led
5384019|NCT01794715|Outpatient clinic|outpatient clinic
5384020|NCT01794715|Echocardiography|echocardiography
5384021|NCT01794715|Pocket-size|pocket-size
5384022|NCT01794715|Ultrasound|ultrasound
5384023|NCT01794702|Leukemia|leukemia
5384024|NCT01794702|Acute Leukemia|acute leukemia
5384025|NCT01794702|Acute myelogenous leukemia|acute myelogenous leukemia
5384026|NCT01794702|AML|aml
5384027|NCT01794702|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5384028|NCT01794702|ALL|all
5384029|NCT01794702|Maximum Tolerated Dose|maximum tolerated dose
5384030|NCT01794702|MTD|mtd
5384031|NCT01794702|Response Rate|response rate
5384032|NCT01794702|Decitabine|decitabine
5384033|NCT01794702|Dacogen|dacogen
5384034|NCT01794702|Idarubicin|idarubicin
5384035|NCT01794702|Idamycin|idamycin
5384036|NCT01794702|Cytarabine|cytarabine
5384037|NCT01794702|Ara-C|ara-c
5384038|NCT01794702|Cytosar|cytosar
5384039|NCT01794702|DepoCyt|depocyt
5384040|NCT01794702|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5384041|NCT01794676|Pancreatic cancer|pancreatic cancer
5384042|NCT01794676|Thymic cancer|thymic cancer
5384043|NCT01794676|Parathyroid disease|parathyroid disease
5384044|NCT01794676|MEN1 syndrome|men1 syndrome
5384045|NCT01794676|Genomic DNA|genomic dna
5384046|NCT01794676|MEN1 gene sequence|men1 gene sequence
5384047|NCT01794663|Early kidney graft dysfunction|early kidney graft dysfunction
5384048|NCT01794663|renal transplantation|renal transplantation
5384049|NCT01794650|T1DM, Exercise, Hypoglycaemia|t1dm, exercise, hypoglycaemia
5445450|NCT01521741|Lymphedema|lymphedema
5384050|NCT01794637|End stage liver disease|end stage liver disease
5384051|NCT01794637|Peripheral microcirculatory dysfunction|peripheral microcirculatory dysfunction
5384052|NCT01794637|Liver transplantation|liver transplantation
5384053|NCT01794637|Near infrared spectroscopy|near infrared spectroscopy
5384054|NCT01794624|TMD|tmd
5384055|NCT01794624|TMJD|tmjd
5384056|NCT01794624|Temporomandibular Joint Disorders|temporomandibular joint disorders
5384057|NCT01794624|Sleep Continuity Disturbance|sleep continuity disturbance
5384058|NCT01794624|Pain Catastrophizing|pain catastrophizing
5384059|NCT01794624|Cognitive Therapy|cognitive therapy
5384060|NCT01794624|Behavioral Therapy|behavioral therapy
5384061|NCT01794598|Heart failure|heart failure
5384066|NCT01794585|virtual reality|virtual reality
5384067|NCT01794585|home-based therapy|home-based therapy
5384068|NCT01794572|Multiple Myeloma|multiple myeloma
5384070|NCT01794572|Complete Remission|complete remission
5384071|NCT01794572|Very Good Partial Remission|very good partial remission
5384072|NCT01794559|Depression, EEG, QEEG, mTBI, PTSD, efficiency, safety, suicidality|depression, eeg, qeeg, mtbi, ptsd, efficiency, safety, suicidality
5384073|NCT01794546|pediatric obesity|pediatric obesity
5384074|NCT01794546|telehealth|telehealth
5384075|NCT01794533|Irreversible Pulpitis|irreversible pulpitis
5384076|NCT01794533|Infiltration injection|infiltration injection
5384077|NCT01794533|Fentanyl|fentanyl
5384078|NCT01794533|Lidocaine|lidocaine
5379433|NCT01815268|Influenza|influenza
5384083|NCT01794507|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5384084|NCT01794507|relapsed multiple myeloma|relapsed multiple myeloma
5384085|NCT01794507|refractory multiple myeloma|refractory multiple myeloma
5384087|NCT01794494|Peripheal arterial disease|peripheal arterial disease
5384088|NCT01794494|Critical limb ischemia|critical limb ischemia
5384089|NCT01794494|Bypass surgery|bypass surgery
5384090|NCT01794494|Subintimal angioplasty|subintimal angioplasty
5384091|NCT01794494|Health related cost|health related cost
5384092|NCT01794468|Dermal blood flow|dermal blood flow
5384093|NCT01794468|critically ill|critically ill
5384094|NCT01794455|Depression|depression
5384095|NCT01794455|Depressive Disorder|depressive disorder
5384096|NCT01794455|Geriatrics|geriatrics
5384097|NCT01794455|Hypertension|hypertension
5384098|NCT01794429|Obesity|obesity
5384099|NCT01794429|The Metabolic Syndrome/disturbances|the metabolic syndrome/disturbances
5384100|NCT01794429|Drug-induced adipositas|drug-induced adipositas
5384101|NCT01794429|Schizophrenia|schizophrenia
5384102|NCT01794429|GLP-1 analogue|glp-1 analogue
5384103|NCT01794429|cerebral effects|cerebral effects
5384104|NCT01794403|Prostate Cancer|prostate cancer
5384105|NCT01794403|Prostate|prostate
5384106|NCT01794403|Radiation Therapy|radiation therapy
5384107|NCT01794403|Hypofractionation Radiotherapy|hypofractionation radiotherapy
5384108|NCT01794403|Extended Hypofractionation Radiotherapy|extended hypofractionation radiotherapy
5384109|NCT01794403|Accelerated Hypofractionation Radiotherapy|accelerated hypofractionation radiotherapy
5384110|NCT01794403|AHRT|ahrt
5384111|NCT01794403|EHRT|ehrt
5384112|NCT01794390|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5384113|NCT01794390|Asthma|asthma
5384114|NCT01794390|Pulmojet|pulmojet
5384115|NCT01794390|Inhalers|inhalers
5384116|NCT01794390|Respiratory|respiratory
5384117|NCT01794390|Inhaler Technique|inhaler technique
5384118|NCT01794390|Critical Errors|critical errors
5371615|NCT01851148|migraine|migraine
5384119|NCT01794377|Obesity|obesity
5384120|NCT01794364|T2DM|t2dm
5384121|NCT01794364|Diabetes Mellitus Type 2|diabetes mellitus type 2
5384122|NCT01794325|Occupational radiation exposure|occupational radiation exposure
5384123|NCT01794325|Transradial approach|transradial approach
5384124|NCT01794325|Transfemoral approach|transfemoral approach
5384125|NCT01794299|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5384126|NCT01794299|Graft-versus-host disease|graft-versus-host disease
5384127|NCT01794299|Immune reconstitution|immune reconstitution
5384128|NCT01794299|Alloreactive T-cells|alloreactive t-cells
5384129|NCT01794299|Photodepletion|photodepletion
5384130|NCT01794299|Photodynamic treatment|photodynamic treatment
5384131|NCT01794299|TH9402|th9402
5384132|NCT01794299|Transplant-related mortality|transplant-related mortality
5384133|NCT01794299|Hematologic malignancy|hematologic malignancy
5384134|NCT01794273|Ephedrine|ephedrine
5384135|NCT01794273|Phenylephrine|phenylephrine
5384136|NCT01794273|Vasopressor|vasopressor
5384137|NCT01794273|Carotid surgery|carotid surgery
5384138|NCT01794273|Hypotension|hypotension
5384139|NCT01794273|Haemodynamics|haemodynamics
5384140|NCT01794273|Brain ischemia|brain ischemia
5384141|NCT01794273|Tissue perfusion|tissue perfusion
5384142|NCT01794273|Stroke|stroke
5384143|NCT01794273|anaesthesia|anaesthesia
5384144|NCT01794260|Osteoarthritis|osteoarthritis
5384145|NCT01794260|Moderate ot severe pain|moderate ot severe pain
5384146|NCT01794260|ZINGIBER CASSUMUNAR ROXB|zingiber cassumunar roxb
5384147|NCT01794221|circumcision|circumcision
5384148|NCT01794221|2 octyl cyanoacrylate|2 octyl cyanoacrylate
5384149|NCT01794221|phimosis|phimosis
5384150|NCT01794208|in-vitro fertilization|in-vitro fertilization
5384151|NCT01794208|reproductive disorder|reproductive disorder
5384152|NCT01794195|Parkinson's disease|parkinson's disease
5384153|NCT01794195|Apathy|apathy
5384154|NCT01794195|diffusion tensor imaging|diffusion tensor imaging
5384155|NCT01794195|tractography|tractography
5384156|NCT01794156|Inference-based therapy|inference-based therapy
5384157|NCT01794156|Cognitive behavior therapy|cognitive behavior therapy
5384158|NCT01794156|Obsessive compulsive disorder|obsessive compulsive disorder
5384159|NCT01794156|Randomized clinical trial|randomized clinical trial
5384160|NCT01794143|Treatment of Type 2 diabetes|treatment of type 2 diabetes
5384161|NCT01794143|Comparative effectiveness research|comparative effectiveness research
5384162|NCT01794143|Clinical trial|clinical trial
5384163|NCT01794143|Patient-centered outcomes|patient-centered outcomes
5384164|NCT01794117|Anakinra|anakinra
5384165|NCT01794117|Pustular Psoriasis|pustular psoriasis
5384166|NCT01794117|Palmoplantar Pustulosis|palmoplantar pustulosis
5384167|NCT01794117|DITRA|ditra
5384168|NCT01794117|Subcorneal Pustular Dermatosis|subcorneal pustular dermatosis
5384169|NCT01794104|Topoisomerase Inhibitor|topoisomerase inhibitor
5384170|NCT01794104|Advanced Malignancies|advanced malignancies
5671951|NCT00613496|ICAM|icam
5384171|NCT01794104|Pharmacodynamics|pharmacodynamics
5384172|NCT01794104|DNA Damage|dna damage
5384173|NCT01794104|Pharmacokinetics|pharmacokinetics
5384174|NCT01794091|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5384175|NCT01794091|Diabetes|diabetes
5384178|NCT01794026|diffusion weighted|diffusion weighted
5384179|NCT01794026|magnetic resonance imaging|magnetic resonance imaging
5384180|NCT01794026|surgery|surgery
5384181|NCT01794026|histopathology|histopathology
5384182|NCT01794013|Parent training|parent training
5384183|NCT01794013|DIR/ Floortime Approach|dir/ floortime approach
5384184|NCT01794013|Children with developmental disabilities|children with developmental disabilities
5384185|NCT01793987|blood loss between two groups|blood loss between two groups
5384186|NCT01793974|LADA|lada
5384187|NCT01793974|Latent Autoimmune Diabetes in Adults|latent autoimmune diabetes in adults
5384188|NCT01793974|Latent Autoimmune Diabetes|latent autoimmune diabetes
5384189|NCT01793974|Latent Diabetes in Adults|latent diabetes in adults
5384190|NCT01793935|Schizophrenia|schizophrenia
5384191|NCT01793935|Sensoril|sensoril
5384192|NCT01793935|Withania Somnifera extract|withania somnifera extract
5384193|NCT01793935|Total/ Positive / Negative Symptoms|total/ positive / negative symptoms
5384194|NCT01793935|Stress|stress
5384195|NCT01793935|Inflammation|inflammation
5384196|NCT01793935|Immunomodulation|immunomodulation
5384197|NCT01793909|Type 2 Diabetes|type 2 diabetes
5384198|NCT01793909|Exercise Impairment|exercise impairment
5384199|NCT01793909|Blood Flow|blood flow
5384200|NCT01793909|Muscle Oxygen Uptake|muscle oxygen uptake
5384201|NCT01793909|Exercise Training|exercise training
5384202|NCT01793896|Metabolic syndrome|metabolic syndrome
5384203|NCT01793896|Ageing|ageing
5384204|NCT01793896|Mitochondrial density|mitochondrial density
5384205|NCT01793896|Oxidative damage|oxidative damage
5384206|NCT01793896|Inflammatory mediators|inflammatory mediators
5384207|NCT01793896|AMPK|ampk
5384208|NCT01793896|Adipogenesis|adipogenesis
5384209|NCT01793883|Influenza Laninamivir Octanoate|influenza laninamivir octanoate
5384210|NCT01793870|pharmacokinetic|pharmacokinetic
5384211|NCT01793870|carvedilol|carvedilol
5384212|NCT01793870|Stable isotope technique|stable isotope technique
5384213|NCT01793857|Primary caregiver|primary caregiver
5384214|NCT01793857|Survey|survey
5384215|NCT01793857|Acute Otitis Media|acute otitis media
5384216|NCT01793857|Ear infection|ear infection
5384217|NCT01793857|Panama|panama
5384218|NCT01793857|Healthcare seeking behaviour|healthcare seeking behaviour
5384219|NCT01793844|diffuse large B cell lymphoma|diffuse large b cell lymphoma
5384220|NCT01793844|DFS|dfs
5384221|NCT01793844|OS|os
5384222|NCT01793831|Crohn's diseases|crohn's diseases
5384223|NCT01793831|Inflammatory bowel disease|inflammatory bowel disease
5384224|NCT01793831|Fecal transplantation|fecal transplantation
5384225|NCT01793831|Fecal bacteriotherapy|fecal bacteriotherapy
5384226|NCT01793831|Fecal microbiota transplantation|fecal microbiota transplantation
5384227|NCT01793818|Vaccine|vaccine
5384228|NCT01793818|HIV-1|hiv-1
5384229|NCT01793818|Tat|tat
5384230|NCT01793792|intracranial, saccular, aneurysms, stenting, coiling|intracranial, saccular, aneurysms, stenting, coiling
5384231|NCT01793740|sickle cell disease|sickle cell disease
5384232|NCT01793740|pediatric|pediatric
5384233|NCT01793740|learning disability|learning disability
5384234|NCT01793740|cognitive impairment|cognitive impairment
5384235|NCT01793740|memory|memory
5384236|NCT01793740|attention|attention
5384237|NCT01793740|Children with sickle cell disease|children with sickle cell disease
5384238|NCT01793727|infants|infants
5384239|NCT01793727|general anesthesia|general anesthesia
5384240|NCT01793727|tracheal intubation|tracheal intubation
5384241|NCT01793714|Magnetic Resonance Imaging|magnetic resonance imaging
5384242|NCT01793688|UNASYN-S|unasyn-s
5384243|NCT01793688|High Dose|high dose
5384244|NCT01793662|Aortobifemoral bypass|aortobifemoral bypass
5384245|NCT01793662|Laparoscopic aortic surgery|laparoscopic aortic surgery
5384246|NCT01793662|Aortoiliac occlusive disease|aortoiliac occlusive disease
5384247|NCT01793662|TASC Type D Lesions|tasc type d lesions
5384248|NCT01793662|Open aortic surgery|open aortic surgery
5384249|NCT01793649|Respiratory health|respiratory health
5384250|NCT01793649|Cystic Fibrosis|cystic fibrosis
5384544|NCT01792531|obesity|obesity
5384251|NCT01793649|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5384253|NCT01793623|genetics|genetics
5384254|NCT01793623|cardiac arrhythmias|cardiac arrhythmias
5384255|NCT01793623|heart disease|heart disease
5384256|NCT01793610|MDMA|mdma
5384257|NCT01793610|Posttraumatic stress disorder|posttraumatic stress disorder
5384258|NCT01793610|sleep|sleep
5384259|NCT01793610|Depression|depression
5384260|NCT01793610|Safety|safety
5384261|NCT01793597|ticagrelor|ticagrelor
5384262|NCT01793597|Coronary artery bypass surgery|coronary artery bypass surgery
5384263|NCT01793597|platelet function|platelet function
5384264|NCT01793597|receptor binding|receptor binding
5671952|NCT00613496|VCAM|vcam
5384265|NCT01793597|platelet reactivity|platelet reactivity
5384266|NCT01793597|reversible binding|reversible binding
5384267|NCT01793584|Comparative effectiveness|comparative effectiveness
5384268|NCT01793584|Surgical success|surgical success
5384269|NCT01793571|Abdominal Muscles/Ultrasonography|abdominal muscles/ultrasonography
5384270|NCT01793571|Adult|adult
5384271|NCT01793571|Ambulatory Surgical Procedures|ambulatory surgical procedures
5384272|NCT01793571|Anesthetics, Local/Administration & Dosage|anesthetics, local/administration & dosage
5384273|NCT01793571|Levobupivacaine/Administration & Dosage|levobupivacaine/administration & dosage
5384274|NCT01793571|Levobupivacaine/Analogs & Derivatives|levobupivacaine/analogs & derivatives
5384275|NCT01793571|Hernia, Inguinal/Surgery|hernia, inguinal/surgery
5384276|NCT01793571|Humans|humans
5384277|NCT01793571|Nerve Block/Methods|nerve block/methods
5384278|NCT01793571|Pain Measurement/Methods|pain measurement/methods
5384279|NCT01793571|Pain, Postoperative/Prevention & Control|pain, postoperative/prevention & control
5384280|NCT01793571|Ultrasonography, Interventional|ultrasonography, interventional
5384281|NCT01793558|Thermoregulation Impairment|thermoregulation impairment
5384282|NCT01793558|hypothermia|hypothermia
5384283|NCT01793558|Postoperative shivering|postoperative shivering
5384284|NCT01793558|cesarean section|cesarean section
5384285|NCT01793558|newborn|newborn
5384286|NCT01793545|Endometrial Cancer|endometrial cancer
5384287|NCT01793545|Gynecological Cancers|gynecological cancers
5384288|NCT01793545|Screening|screening
5384289|NCT01793532|PET Imaging|pet imaging
5384290|NCT01793532|Epilepsy|epilepsy
5384291|NCT01793532|Inflammation|inflammation
5384292|NCT01793532|Brain Imaging|brain imaging
5384293|NCT01793519|Rheumatoid Arthritis|rheumatoid arthritis
5384294|NCT01793519|Autoimmune Diseases|autoimmune diseases
5384295|NCT01793519|Anti-TNF|anti-tnf
5384296|NCT01793506|immunodeficiency|immunodeficiency
5384297|NCT01793493|Mild Cognitive Impairment|mild cognitive impairment
5384298|NCT01793493|Cognitive Stimulation|cognitive stimulation
5384299|NCT01793493|Aging|aging
5384300|NCT01793493|Elderly|elderly
5384301|NCT01793493|Randomized Controlled Trial|randomized controlled trial
5384302|NCT01793480|Methadone in cancer pain|methadone in cancer pain
5384303|NCT01793428|adults admitted in vital emergency unit|adults admitted in vital emergency unit
5384304|NCT01793389|gingival recession|gingival recession
5002905|NCT03977896|posterior brain fossa tumors|posterior brain fossa tumors
5384305|NCT01793389|fibrin|fibrin
5384306|NCT01793389|connective tissue|connective tissue
5384307|NCT01793389|root coverage|root coverage
5384308|NCT01793389|microsurgery|microsurgery
5384309|NCT01793389|case-control studies|case-control studies
5384310|NCT01793363|Tracheotomy|tracheotomy
5384311|NCT01793363|Weaning from mechanical ventilation|weaning from mechanical ventilation
5384312|NCT01793363|Lung ultrasound score|lung ultrasound score
5384313|NCT01793350|Diabetes|diabetes
5384314|NCT01793350|Mellitus|mellitus
5384315|NCT01793350|Painful|painful
5384316|NCT01793350|Neuropathy|neuropathy
5384317|NCT01793350|Peripheral|peripheral
5384318|NCT01793324|Effectiveness of risk minimization|effectiveness of risk minimization
5384319|NCT01793324|Metabolic monitoring|metabolic monitoring
5384320|NCT01793324|Seroquel® or Seroquel® XR/quetiapine fumarate|seroquel® or seroquel® xr/quetiapine fumarate
5384321|NCT01793311|intraocular pressure|intraocular pressure
5384322|NCT01793311|caffeine|caffeine
5384323|NCT01793311|dosage|dosage
5384324|NCT01793246|lung cancer|lung cancer
5384325|NCT01793246|lung neoplasms|lung neoplasms
5384326|NCT01793246|lung transplant|lung transplant
5384327|NCT01793194|venous insufficiency|venous insufficiency
5384328|NCT01793194|varicose veins|varicose veins
5384329|NCT01793194|pregnancy|pregnancy
5384331|NCT01793194|superficial thrombophlebitis|superficial thrombophlebitis
5384332|NCT01793181|Vitamin d deficiency|vitamin d deficiency
5384333|NCT01793181|Central retinal vein occlusion|central retinal vein occlusion
5384334|NCT01793168|Rare Diseases|rare diseases
5384335|NCT01793168|Neglected Diseases|neglected diseases
5384336|NCT01793168|Orphan Diseases|orphan diseases
5384337|NCT01793168|Rare Disease Research|rare disease research
5384338|NCT01793168|Registries|registries
5384339|NCT01793168|WAGR Syndrome|wagr syndrome
5384340|NCT01793168|Ataxia|ataxia
5384341|NCT01793168|Cornelia de Lange Syndrome|cornelia de lange syndrome
5384342|NCT01793168|Stickler Syndrome|stickler syndrome
5384343|NCT01793168|Ataxia Telangiectasia|ataxia telangiectasia
5384344|NCT01793168|Kawasaki Disease|kawasaki disease
5384345|NCT01793168|Batten Disease|batten disease
5384346|NCT01793168|Mucolipidosis IV|mucolipidosis iv
5384347|NCT01793168|Klippel-Feil Syndrome|klippel-feil syndrome
5384348|NCT01793168|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5384349|NCT01793168|Atypical Hemolytic Uremic Syndrome|atypical hemolytic uremic syndrome
5384350|NCT01793168|Undiagnosed|undiagnosed
5384351|NCT01793168|Uncommon Disease|uncommon disease
5384352|NCT01793168|Kabuki Syndrome|kabuki syndrome
5384353|NCT01793168|Hypersomnia|hypersomnia
5384354|NCT01793168|Hyperacusis|hyperacusis
5384355|NCT01793168|Kleine-Levin Syndrome|kleine-levin syndrome
5384356|NCT01793168|Marinesco-Sjogren Syndrome|marinesco-sjogren syndrome
5384357|NCT01793168|Leiomyosarcoma|leiomyosarcoma
5671953|NCT00613496|MCP-1|mcp-1
5384358|NCT01793168|4p-/Wolf-Hirschhorn Syndrome|4p-/wolf-hirschhorn syndrome
5384359|NCT01793168|Hypophosphatasia|hypophosphatasia
5384360|NCT01793168|Narcolepsy|narcolepsy
5384361|NCT01793168|Wiedermann-Steiner Syndrome|wiedermann-steiner syndrome
5384362|NCT01793168|Breast Implant-Associated Anaplastic Large Cell Lymphoma|breast implant-associated anaplastic large cell lymphoma
5384363|NCT01793168|Autoimmune/inflammatory Syndrome Induced by Adjuvants (ASIA)|autoimmune/inflammatory syndrome induced by adjuvants (asia)
5384364|NCT01793168|Hemophagocytic Lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5384366|NCT01793168|Alagille Syndrome|alagille syndrome
5384367|NCT01793168|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia (IBMPFD)|inclusion body myopathy with early-onset paget disease and frontotemporal dementia (ibmpfd)
5384368|NCT01793168|Lowe Syndrome|lowe syndrome
5384369|NCT01793168|Pitt Hopkins Syndrome|pitt hopkins syndrome
5384370|NCT01793168|1p36 deletion syndrome|1p36 deletion syndrome
5384371|NCT01793168|Jansen metaphyseal chondrodysplasia|jansen metaphyseal chondrodysplasia
5384372|NCT01793168|Cockayne Syndrome|cockayne syndrome
5384373|NCT01793168|Chronic recurrent multifocal osteomyelitis (CRMO)|chronic recurrent multifocal osteomyelitis (crmo)
5384374|NCT01793168|Malan syndrome|malan syndrome
5384375|NCT01793168|Hereditary Sensory and Autonomic Neuropathy|hereditary sensory and autonomic neuropathy
5384376|NCT01793155|Lung cancer surgery|lung cancer surgery
5384377|NCT01793155|Inspiratory muscle training|inspiratory muscle training
5384378|NCT01793155|Postoperative pulmonary complications|postoperative pulmonary complications
5384379|NCT01793155|Functional outcomes|functional outcomes
5384380|NCT01793155|Health related quality of life|health related quality of life
5384381|NCT01793142|Osteoporosis|osteoporosis
5384382|NCT01793142|postmenopausal|postmenopausal
5384383|NCT01793142|SERM|serm
5384384|NCT01793129|NICHD Neonatal Research Network|nichd neonatal research network
5384385|NCT01793129|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5384386|NCT01793129|Hypothermia|hypothermia
5384387|NCT01793129|Neonatal depression|neonatal depression
5384388|NCT01793129|Perinatal asphyxia|perinatal asphyxia
5384389|NCT01793116|NICHD Neonatal Research Network|nichd neonatal research network
5384390|NCT01793116|Moderately Preterm|moderately preterm
5384391|NCT01793090|Cobalamin C defect|cobalamin c defect
5384392|NCT01793090|methylmalonic aciduria with homocystinuria|methylmalonic aciduria with homocystinuria
5384393|NCT01793090|Visual function|visual function
5384395|NCT01793090|ERG|erg
5384396|NCT01793090|antioxidant drugs|antioxidant drugs
5384397|NCT01793077|Prostate Cancer|prostate cancer
5384398|NCT01793077|Phase 4|phase 4
5384399|NCT01793077|Data collection|data collection
5384400|NCT01793077|Observational|observational
5384401|NCT01793077|Depo-Eligard|depo-eligard
5384402|NCT01793077|Prospective|prospective
5384403|NCT01793077|Non-interventional|non-interventional
5384404|NCT01793077|Treatment|treatment
5384405|NCT01793064|Pedometer,|pedometer,
5384406|NCT01793064|adaptive,|adaptive,
5384407|NCT01793064|exercise,|exercise,
5384408|NCT01793064|reinforcement,|reinforcement,
5384409|NCT01793064|goal setting,|goal setting,
5384410|NCT01793064|technology,|technology,
5384411|NCT01793064|email,|email,
5384412|NCT01793064|weight loss|weight loss
5384413|NCT01793064|mHealth|mhealth
5384414|NCT01793064|eHealth|ehealth
5384415|NCT01793051|Myeloma|myeloma
5384416|NCT01793051|Multiple Myeloma|multiple myeloma
5384417|NCT01793051|MM|mm
5384418|NCT01793051|Symptom Burden|symptom burden
5384419|NCT01793051|Symptom reduction|symptom reduction
5384420|NCT01793051|Maintenance therapy with lenalidomide|maintenance therapy with lenalidomide
5384421|NCT01793051|Minocycline|minocycline
5384422|NCT01793051|Dynacin|dynacin
5384423|NCT01793051|Minocin|minocin
5384424|NCT01793051|Minocin PAC|minocin pac
5384425|NCT01793051|Myrac|myrac
5384426|NCT01793051|Solodyn|solodyn
5384427|NCT01793051|Placebo|placebo
5384428|NCT01793051|Sugar pill|sugar pill
5384429|NCT01793051|MD Anderson Symptom Inventory|md anderson symptom inventory
5384430|NCT01793051|MDASI|mdasi
5384431|NCT01793051|Questionnaires|questionnaires
5384432|NCT01793051|Surveys|surveys
5384433|NCT01793038|PCOS|pcos
5384434|NCT01793038|clomiphene citrate resistant PCOS|clomiphene citrate resistant pcos
5384435|NCT01793038|Aromatase inhibitors|aromatase inhibitors
5384436|NCT01793025|leukemia|leukemia
5384437|NCT01793025|myeloid|myeloid
5384438|NCT01793025|acute|acute
5423333|NCT01616134|overweight,|overweight,
5384439|NCT01793025|acute myeloid leukemia|acute myeloid leukemia
5384440|NCT01793025|allogeneic|allogeneic
5384441|NCT01793025|transient chimerism|transient chimerism
5384442|NCT01793025|cell therapy|cell therapy
5384443|NCT01793025|immunotherapy|immunotherapy
5384444|NCT01793012|therapeutic drug monitoring|therapeutic drug monitoring
5384445|NCT01793012|antibiotics|antibiotics
5384446|NCT01793012|inflammation parameters|inflammation parameters
5384447|NCT01793012|critically ill patients|critically ill patients
5384448|NCT01793012|septicaemia|septicaemia
5384449|NCT01793012|intensive care unit|intensive care unit
5384450|NCT01792999|Breast CT|breast ct
5384451|NCT01792986|Diabetes|diabetes
5384452|NCT01792986|Fasting|fasting
5384453|NCT01792986|Pre-diabetes|pre-diabetes
5384454|NCT01792986|Hemoglobin A1C|hemoglobin a1c
5384456|NCT01792973|HPV|hpv
5384457|NCT01792973|Women|women
5384458|NCT01792973|Thailand|thailand
5384463|NCT01792921|regular education system|regular education system
5384464|NCT01792921|no moderate or severe neurological and/or psychiatric disorders|no moderate or severe neurological and/or psychiatric disorders
5384465|NCT01792908|ankle lateral ligament|ankle lateral ligament
5384466|NCT01792908|athletic tape|athletic tape
5384467|NCT01792908|position sense|position sense
5384468|NCT01792908|Proprioception|proprioception
5384469|NCT01792895|Posterior Neck Pain|posterior neck pain
5384470|NCT01792895|Cervical spine pain|cervical spine pain
5384471|NCT01792895|Manual therapy|manual therapy
5384473|NCT01792856|early psychosis|early psychosis
5384474|NCT01792856|schizophrenia|schizophrenia
5384475|NCT01792830|Coronary Artery Bypass Graft surgery|coronary artery bypass graft surgery
5384476|NCT01792817|Cluster Headache|cluster headache
5384477|NCT01792817|GammaCore|gammacore
5384478|NCT01792817|vagal nerve stimulation|vagal nerve stimulation
5384479|NCT01792817|nVNS|nvns
5384480|NCT01792817|VNS|vns
5384481|NCT01792817|non invasive|non invasive
5384482|NCT01792817|vagus nerve stimulation|vagus nerve stimulation
5384483|NCT01792804|Staphylococcus aureus|staphylococcus aureus
5384484|NCT01792804|Bloodstream infection|bloodstream infection
5384485|NCT01792804|Oral switch|oral switch
5384486|NCT01792778|IV Catheters|iv catheters
5384487|NCT01792778|Blood control|blood control
5384488|NCT01792765|urolithiasis|urolithiasis
5384489|NCT01792765|radiation free|radiation free
5384490|NCT01792765|ultrasound guidance|ultrasound guidance
5384491|NCT01792765|ureteroscopy|ureteroscopy
5384492|NCT01792752|HIV/AIDS|hiv/aids
5384493|NCT01792752|Drug Users|drug users
5384494|NCT01792752|Puerto Rico|puerto rico
5384495|NCT01792739|Probiotics|probiotics
5370212|NCT01856751|TGA|tga
5384496|NCT01792739|Diarrhea|diarrhea
5384497|NCT01792739|Intentive care units|intentive care units
5384498|NCT01792726|breast cancer|breast cancer
5384499|NCT01792726|radiotherapy|radiotherapy
5384500|NCT01792726|TARGIT|targit
5384502|NCT01792713|Skin alterations|skin alterations
5384503|NCT01792713|Atopic Dermatitis|atopic dermatitis
5384504|NCT01792687|Metastatic castrate resistant prostate cancer (CRPC)|metastatic castrate resistant prostate cancer (crpc)
5384505|NCT01792674|Education|education
5384506|NCT01792674|Patient simulation|patient simulation
5384507|NCT01792674|In situ simulation|in situ simulation
5384508|NCT01792674|Stress|stress
5384509|NCT01792661|Chronic Kidney Disease|chronic kidney disease
5384510|NCT01792661|Electronic Health Record|electronic health record
5384511|NCT01792661|Personal Health Record|personal health record
5384512|NCT01792661|Chronic Kidney Disease registry|chronic kidney disease registry
5384513|NCT01792661|Glomerular Filtration Rate|glomerular filtration rate
5384514|NCT01792661|Patient Navigator|patient navigator
5384515|NCT01792648|Almond|almond
5384516|NCT01792648|Carbohydrate|carbohydrate
5384517|NCT01792648|Diet|diet
5384518|NCT01792648|Cholesterol|cholesterol
5384519|NCT01792635|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5384520|NCT01792635|Pharmacodynamics|pharmacodynamics
5384521|NCT01792635|Safety & Tolerability|safety & tolerability
5384522|NCT01792622|Instrument Development|instrument development
5384523|NCT01792622|Patient Reported Outcomes|patient reported outcomes
5384524|NCT01792622|Pulmonary Arterial Hypertension.|pulmonary arterial hypertension.
5384525|NCT01792609|Scoliosis|scoliosis
5384526|NCT01792609|Cobb Angle|cobb angle
5384527|NCT01792609|Screw Density|screw density
5384528|NCT01792609|Outcomes Measures|outcomes measures
5384529|NCT01792583|pregnancy|pregnancy
5384530|NCT01792570|HIV-1|hiv-1
5384531|NCT01792570|darunavir|darunavir
5384532|NCT01792570|rilpivirine|rilpivirine
5384533|NCT01792570|strategic study|strategic study
5384534|NCT01792557|Pilonidal sinus|pilonidal sinus
5384535|NCT01792557|Crystallized phenol|crystallized phenol
5384536|NCT01792557|Limberg Flap|limberg flap
5384537|NCT01792557|Modified Limberg Flap|modified limberg flap
5384538|NCT01792557|Karydakis|karydakis
5384539|NCT01792557|Recurrence|recurrence
5384547|NCT01792492|Thyroid Neoplasms|thyroid neoplasms
5384548|NCT01792492|Optical Devices|optical devices
5384549|NCT01792492|Spectrum Analysis|spectrum analysis
5384550|NCT01792492|Thyroid diseases|thyroid diseases
5384551|NCT01792479|NSCLC|nsclc
5384552|NCT01792479|lung cancer|lung cancer
5384553|NCT01792466|difficult biliary cannulation|difficult biliary cannulation
5384554|NCT01792453|Gastrointestinal physiology|gastrointestinal physiology
5384556|NCT01792453|Small bowel water volumes|small bowel water volumes
5384557|NCT01792453|Gastric volumes|gastric volumes
5384558|NCT01792401|Critical illness|critical illness
5384560|NCT01792401|Gastrointestinal tract/physio-pathology|gastrointestinal tract/physio-pathology
5384561|NCT01792388|Crohn's Disease|crohn's disease
5384562|NCT01792388|Vitamin D|vitamin d
5384563|NCT01792388|Intestinal Permeability|intestinal permeability
5384564|NCT01792388|Tara Raftery|tara raftery
5384565|NCT01792375|Cervical ripening|cervical ripening
5384566|NCT01792375|Dinoprostone|dinoprostone
5384567|NCT01792375|Labor induction|labor induction
5384568|NCT01792375|Membrane sweeping|membrane sweeping
5384569|NCT01792375|Nulliparous women|nulliparous women
5384570|NCT01792375|Trial|trial
5384571|NCT01792362|Anti-mullerian hormone (AMH) level, poly cystic ovarian syndrome obese infertility weight loss diet|anti-mullerian hormone (amh) level, poly cystic ovarian syndrome obese infertility weight loss diet
5384572|NCT01792336|Repetitive TMS (rTMS)|repetitive tms (rtms)
5384573|NCT01792336|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5384574|NCT01792336|Motor Cortex|motor cortex
5384575|NCT01792336|Focal Hand Dystonia|focal hand dystonia
5384576|NCT01792336|Facilitation|facilitation
5384577|NCT01792323|insulin pump therapy|insulin pump therapy
5384578|NCT01792323|insulin bolus|insulin bolus
5384579|NCT01792323|rapid acting insulin|rapid acting insulin
5384580|NCT01792323|insulin lispro|insulin lispro
5384581|NCT01792323|pharmacodynamics|pharmacodynamics
5384582|NCT01792323|pharmacokinetics|pharmacokinetics
5384583|NCT01792323|glucose clamp|glucose clamp
5384584|NCT01792310|Glioma|glioma
5384585|NCT01792310|Solid Tumours|solid tumours
5384586|NCT01792310|Minerval|minerval
5384587|NCT01792297|Sarcopenia|sarcopenia
5384588|NCT01792297|Osteoporosis|osteoporosis
5384589|NCT01792297|Cognition|cognition
5384590|NCT01792297|Inflammation|inflammation
5384591|NCT01792271|COPD|copd
5384592|NCT01792271|Chronic Bronchitis|chronic bronchitis
5384593|NCT01792271|Hypertonic Saline|hypertonic saline
5384594|NCT01792258|Percutaneous tracheostomy|percutaneous tracheostomy
5384595|NCT01792258|Intensive Care Unit|intensive care unit
5384596|NCT01792258|Ineffective Airway Clearance|ineffective airway clearance
5384597|NCT01792258|Weaning failure|weaning failure
5384598|NCT01792245|narrow band UVB; PUVA; psoriasis; eczema; hand|narrow band uvb; puva; psoriasis; eczema; hand
5384599|NCT01792232|Diesel exhaust|diesel exhaust
5384600|NCT01792232|Air pollution|air pollution
5384601|NCT01792232|Airway responsiveness|airway responsiveness
5384602|NCT01792232|Allergies|allergies
5384603|NCT01792219|interprofessional learning|interprofessional learning
5002906|NCT03977896|children|children
5384604|NCT01792219|interprofessional collaboration|interprofessional collaboration
5384605|NCT01792219|residents|residents
5384606|NCT01792219|nursing homes|nursing homes
5384607|NCT01792206|Stage 3 chronic kidney disease (CKD)|stage 3 chronic kidney disease (ckd)
5384608|NCT01792206|Stage 4 chronic kidney disease (CKD)|stage 4 chronic kidney disease (ckd)
5384609|NCT01792206|CKD|ckd
5384610|NCT01792180|Gait speed|gait speed
5384611|NCT01792180|Mobility|mobility
5384612|NCT01792180|Falls|falls
5384613|NCT01792180|Fall risk|fall risk
5384614|NCT01792180|Self-management|self-management
5384615|NCT01792180|Mental wellbeing|mental wellbeing
5384616|NCT01792180|Elderly|elderly
5384617|NCT01792115|Fatty Liver|fatty liver
5384618|NCT01792115|Alpha-Tocopherol|alpha-tocopherol
5384619|NCT01792115|Vitamin E|vitamin e
5384620|NCT01792115|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5384621|NCT01792102|Multiple Myeloma|multiple myeloma
5384622|NCT01792102|Carfilzomib|carfilzomib
5384623|NCT01792102|Krypolis|krypolis
5384624|NCT01792102|60 minute infusion|60 minute infusion
5384625|NCT01792089|de novo lipogenesis|de novo lipogenesis
5384626|NCT01792089|fructose|fructose
5384627|NCT01792089|roux-en-Y gastric bypass|roux-en-y gastric bypass
5384628|NCT01792089|post-prandial triglycerides|post-prandial triglycerides
5384629|NCT01792050|IDO|ido
5384630|NCT01792050|IDO Inhibitor|ido inhibitor
5384631|NCT01792050|Metastatic Breast Cancer|metastatic breast cancer
5384632|NCT01792011|Elective living donor liver transplantation|elective living donor liver transplantation
5384633|NCT01791985|Breast Cancer|breast cancer
5384635|NCT01791985|Safety Run-In|safety run-in
5384636|NCT01791985|FGFR1|fgfr1
5384637|NCT01791985|ER positive breast cancer|er positive breast cancer
5384638|NCT01791985|Single arm phase IIa study|single arm phase iia study
5384639|NCT01791972|Exercise-Induced Bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
5384640|NCT01791972|Spiromax®|spiromax®
5384641|NCT01791972|Albuterol sulfate|albuterol sulfate
5384642|NCT01791946|lazy eye|lazy eye
5384643|NCT01791946|cross eye|cross eye
5384644|NCT01791946|cross eyed|cross eyed
5384645|NCT01791933|LBP|lbp
5384646|NCT01791933|Neck pain|neck pain
5384647|NCT01791933|Integrative package|integrative package
5384648|NCT01791933|CAM|cam
5671954|NCT00613496|vWF|vwf
5384649|NCT01791868|Generalized convulsive status epilepticus|generalized convulsive status epilepticus
5384650|NCT01791868|Sodium valproate|sodium valproate
5384651|NCT01791868|Refractory status epilepticus|refractory status epilepticus
5384652|NCT01791868|Mortality|mortality
5384653|NCT01791868|Epilepsy|epilepsy
5384654|NCT01791868|Intensive Care Unit|intensive care unit
5384655|NCT01791868|Neurological sequela|neurological sequela
5384656|NCT01791868|Quality of life|quality of life
5384657|NCT01791868|Adult|adult
5384658|NCT01791855|Subjects with Renal Impairment|subjects with renal impairment
5384659|NCT01791855|healthy|healthy
5384660|NCT01791842|fibrous dysplasia of bone|fibrous dysplasia of bone
5384661|NCT01791842|tocilizumab|tocilizumab
5384662|NCT01791842|McCune-Albright syndrome|mccune-albright syndrome
5384663|NCT01791829|Luminal A|luminal a
5384664|NCT01791829|Ipsilateral Breast Tumour Recurrence|ipsilateral breast tumour recurrence
5384665|NCT01791816|Vasovagal Syncope|vasovagal syncope
5384666|NCT01791816|Postural Tachycardia Syndrome|postural tachycardia syndrome
5384667|NCT01791816|Orthostatic Intolerance|orthostatic intolerance
5384668|NCT01791816|Nitric Oxide (NO)|nitric oxide (no)
5384669|NCT01791816|Orthostatic Stress|orthostatic stress
5384670|NCT01791816|L-Ng-monomethyl Arginine (L-NMMA)|l-ng-monomethyl arginine (l-nmma)
5384671|NCT01791816|Phenylephrine|phenylephrine
5384672|NCT01791816|Sodium Nitroprusside|sodium nitroprusside
5384673|NCT01791803|Smoking cessation|smoking cessation
5384674|NCT01791803|Tobacco abstinence|tobacco abstinence
5384675|NCT01791803|hypnotherapy|hypnotherapy
5384676|NCT01791803|Nicotine replacement therapy|nicotine replacement therapy
5384677|NCT01791790|old Subjects|old subjects
5384678|NCT01791790|Controls|controls
5384679|NCT01791790|brain stimulation|brain stimulation
5384680|NCT01791790|tSOS|tsos
5384681|NCT01791790|tDCS|tdcs
5384682|NCT01791790|sleep|sleep
5384683|NCT01791790|memory|memory
5384684|NCT01791790|memory consolidation|memory consolidation
5384685|NCT01791777|fidelity|fidelity
5384686|NCT01791777|implementation science|implementation science
5384687|NCT01791777|competence|competence
5384688|NCT01791777|training|training
5384689|NCT01791777|coaching|coaching
5384690|NCT01791738|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
5384691|NCT01791738|Patient-Specific Instruments|patient-specific instruments
5384692|NCT01791738|Acetabular Cup Placement|acetabular cup placement
5384693|NCT01791738|Accuracy|accuracy
5384694|NCT01791699|atrial fibrillation|atrial fibrillation
5384695|NCT01791699|paroxysmal|paroxysmal
5384696|NCT01791699|persistent|persistent
5384697|NCT01791699|ablation|ablation
5384698|NCT01791699|pulmonary vein isolation|pulmonary vein isolation
5384699|NCT01791699|recurrence|recurrence
5372235|NCT01848418|ICF|icf
5384700|NCT01791686|Dense Deposit Disease|dense deposit disease
5384702|NCT01791673|Glaucoma|glaucoma
5384703|NCT01791673|Cyclocoagulation|cyclocoagulation
5384704|NCT01791673|HIFU - High Intensity Focused Ultrasound|hifu - high intensity focused ultrasound
5384705|NCT01791673|Ciliary Body|ciliary body
5384706|NCT01791647|Polycystic ovary syndrome|polycystic ovary syndrome
5384707|NCT01791647|myoinositol|myoinositol
5384708|NCT01791647|metformin|metformin
5384709|NCT01791647|glucose-insulinemic metabolism|glucose-insulinemic metabolism
5384710|NCT01791647|menstrual pattern|menstrual pattern
5384711|NCT01791647|insulin-lowering therapies|insulin-lowering therapies
5384712|NCT01791621|Irritable Bowel Syndrome|irritable bowel syndrome
5384713|NCT01791621|Elimination diet|elimination diet
5384714|NCT01791621|Food allergies|food allergies
5384715|NCT01791608|Child, Preschool|child, preschool
5384716|NCT01791608|Dietary Zinc|dietary zinc
5384717|NCT01791608|Zinc sulfate|zinc sulfate
5384718|NCT01791608|zinc-glycine chelate|zinc-glycine chelate
5384719|NCT01791595|Phase I|phase i
5384720|NCT01791595|Cancer|cancer
5384721|NCT01791595|Solid Tumours|solid tumours
5384722|NCT01791595|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5384723|NCT01791595|Monocarboxylate Transporter 1 Inhibitor|monocarboxylate transporter 1 inhibitor
5384724|NCT01791595|lactate|lactate
5384725|NCT01791595|Burkitt Lymphoma|burkitt lymphoma
5384726|NCT01791556|HIV|hiv
5384727|NCT01791556|AIDS|aids
5384728|NCT01791556|Kenya|kenya
5384729|NCT01791556|viral load|viral load
5384730|NCT01791556|Antiretroviral therapy|antiretroviral therapy
5384731|NCT01791556|randomized clinical trial|randomized clinical trial
5384733|NCT01791556|treatment failure|treatment failure
5384734|NCT01791556|HIV resistance|hiv resistance
5384735|NCT01791543|ventricular tachycardia|ventricular tachycardia
5384737|NCT01791543|ventricular arrhythmia|ventricular arrhythmia
5384738|NCT01791530|VAT|vat
5384739|NCT01791530|VAP|vap
5384740|NCT01791530|Transition from VAT to VAP|transition from vat to vap
5384741|NCT01791504|Abdominoplasty|abdominoplasty
5384742|NCT01791478|-Metastatic breast cancer, PI3K inhibitor, Endocrine therapy|-metastatic breast cancer, pi3k inhibitor, endocrine therapy
5384743|NCT01791465|HIV|hiv
5384744|NCT01791465|Diabetes|diabetes
5384745|NCT01791400|Metoclopramide|metoclopramide
5384746|NCT01791400|Sumatriptan|sumatriptan
5384747|NCT01791400|migraine|migraine
5384748|NCT01791400|headache|headache
5384749|NCT01791387|Renal cell|renal cell
5384750|NCT01791387|Kidney|kidney
5384751|NCT01791387|Cancer|cancer
5384752|NCT01791387|Metastatic carcinoma|metastatic carcinoma
5384753|NCT01791374|Advanced Solid Tumors|advanced solid tumors
5384754|NCT01791374|Advanced or Metastatic Gastric Cancer|advanced or metastatic gastric cancer
5384755|NCT01791374|Advanced or Metastatic GEJ|advanced or metastatic gej
5384756|NCT01791374|Gastric Cancer|gastric cancer
5384757|NCT01791361|Metastatic colorectal cancer|metastatic colorectal cancer
5384759|NCT01791335|Respiratory Muscles|respiratory muscles
5384760|NCT01791335|Upper airway|upper airway
5384761|NCT01791335|Noninvasive ventilation|noninvasive ventilation
5384762|NCT01791309|Vemurafenib|vemurafenib
5384763|NCT01791309|Panitumumab|panitumumab
5384764|NCT01791309|V600E BRAF mutation|v600e braf mutation
5384765|NCT01791309|colon|colon
5384766|NCT01791309|12-221|12-221
5384767|NCT01791296|sedation|sedation
5384768|NCT01791296|sleep|sleep
5384769|NCT01791296|delirium|delirium
5384770|NCT01791296|critical illness|critical illness
5384771|NCT01791296|sub-syndromal delirium|sub-syndromal delirium
5384772|NCT01791296|intensive care|intensive care
5384773|NCT01791283|Left ventricular stroke volume|left ventricular stroke volume
5384774|NCT01791283|Arterial waveform analysis|arterial waveform analysis
5384775|NCT01791283|Esofageal doppler|esofageal doppler
5384776|NCT01791283|Ultrasound|ultrasound
5384777|NCT01791283|Cardiac magnetic Imaging|cardiac magnetic imaging
5384778|NCT01791283|Limits of agreement|limits of agreement
5384779|NCT01791270|Obstructive Sleep Apnea|obstructive sleep apnea
5384780|NCT01791270|Hypertension|hypertension
5384781|NCT01791270|β1 Subunit of Maxi-k+Channel|β1 subunit of maxi-k+channel
5384782|NCT01791270|Cardiovascular Risk|cardiovascular risk
5384783|NCT01791257|delayed|delayed
5384784|NCT01791257|cerebral|cerebral
5384785|NCT01791257|ischemia|ischemia
5384786|NCT01791257|microrna|microrna
5384787|NCT01791257|cerebrospinal fluid|cerebrospinal fluid
5384788|NCT01791257|subarachnoid|subarachnoid
5384789|NCT01791257|hemorrhage|hemorrhage
5384790|NCT01791244|Multiple Sclerosis|multiple sclerosis
5384791|NCT01791244|Relapsing-Remitting|relapsing-remitting
5384792|NCT01791244|Rebif|rebif
5384793|NCT01791244|RebiSmart|rebismart
5384794|NCT01791244|Patient support program|patient support program
5384795|NCT01791231|Healthy|healthy
5384796|NCT01791231|Male|male
5384797|NCT01791231|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5384798|NCT01791231|Radiolabeled 14C-canagliflozin|radiolabeled 14c-canagliflozin
5384799|NCT01791231|Absorption|absorption
5384800|NCT01791231|Metabolism|metabolism
5384801|NCT01791231|Excretion|excretion
5002907|NCT03977896|surgery|surgery
5002908|NCT03977896|feasibility|feasibility
5384802|NCT01791231|Radioactivity|radioactivity
5384803|NCT01791218|Pulmonary vein isolation|pulmonary vein isolation
5384804|NCT01791218|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5384805|NCT01791218|Quality of life|quality of life
5384806|NCT01791192|Uveitis, Fingolimod, Phase II, Visual Acuity, Vitreous Haze, OCT|uveitis, fingolimod, phase ii, visual acuity, vitreous haze, oct
5384807|NCT01791114|Insulin sensitivity|insulin sensitivity
5384808|NCT01791114|Diabetes Prevention|diabetes prevention
5384809|NCT01791114|Obesity|obesity
5384810|NCT01791114|Brown adipose tissue|brown adipose tissue
5384811|NCT01791101|Thrombocytopenia|thrombocytopenia
5384812|NCT01791101|Eltrombopag|eltrombopag
5384813|NCT01791075|DSAEK|dsaek
5384814|NCT01791075|Tan Endoglide|tan endoglide
5384815|NCT01791075|Endosaver/Endoserter|endosaver/endoserter
5384816|NCT01791062|cartilage tissue engineering|cartilage tissue engineering
5384817|NCT01791062|hyaluronan|hyaluronan
5384818|NCT01791062|hyaluronic acid|hyaluronic acid
5384819|NCT01791049|Gram-positive|gram-positive
5384820|NCT01791049|Infections|infections
5384821|NCT01791049|Bacterial infections|bacterial infections
5384822|NCT01791036|Adductor canal block|adductor canal block
5384823|NCT01791036|Femoral Nerve Block|femoral nerve block
5384824|NCT01791023|Depression|depression
5384825|NCT01791023|Physical exercise|physical exercise
5384826|NCT01791023|Stress|stress
5384827|NCT01791010|Breathing exercises|breathing exercises
5384828|NCT01791010|Aged|aged
5384829|NCT01790997|DLBS1033|dlbs1033
5384830|NCT01790997|Lumbrokinase|lumbrokinase
5423334|NCT01616134|ginseng|ginseng
5384831|NCT01790997|Acute ischemic stroke|acute ischemic stroke
5384833|NCT01790997|Clinical outcome|clinical outcome
5384834|NCT01790997|Aspirin|aspirin
5384835|NCT01790997|Clopidogrel|clopidogrel
5445451|NCT01521741|symptoms|symptoms
5445452|NCT01521728|ALS|als
5384836|NCT01790984|Dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver|dietary extrinsic sugars, atherogenic lipoprotein phenotype, lipoprotein kinetics, fatty liver
5384837|NCT01790971|Obstructive sleep apnea|obstructive sleep apnea
5384838|NCT01790971|Spinal morphine|spinal morphine
5384839|NCT01790932|Metastatic|metastatic
5384840|NCT01790932|Triple Negative|triple negative
5384841|NCT01790919|Depression, Adults|depression, adults
5384842|NCT01790906|Chronic Heart Failure|chronic heart failure
5384843|NCT01790906|Renal Sympathetic Denervation|renal sympathetic denervation
5384844|NCT01790893|Histoplasmosis|histoplasmosis
5384846|NCT01790880|Stroke|stroke
5384847|NCT01790880|Speech Rehabilitation|speech rehabilitation
5384848|NCT01790854|prasugrel|prasugrel
5384849|NCT01790854|antiplatelet|antiplatelet
5384850|NCT01790854|Acute Coronary Syndrome|acute coronary syndrome
5384851|NCT01790815|Acute Malnutrition|acute malnutrition
5384852|NCT01790815|Mid Upper Arm Circumference|mid upper arm circumference
5384853|NCT01790815|Screening|screening
5384854|NCT01790802|laser treatment, high risk, early AMD|laser treatment, high risk, early amd
5384855|NCT01790776|urethrography|urethrography
5384862|NCT01790737|myeloma, stem cell mobilization, autologous stem cell transplantation|myeloma, stem cell mobilization, autologous stem cell transplantation
5384863|NCT01790737|induction treatment, maintenance treatment|induction treatment, maintenance treatment
5384864|NCT01790711|Gut bacteria|gut bacteria
5384865|NCT01790711|Bacteria|bacteria
5384866|NCT01790711|Fecal transplant|fecal transplant
5384867|NCT01790711|Bacteriotherapy|bacteriotherapy
5384868|NCT01790698|Necrotizing fasciitis|necrotizing fasciitis
5384869|NCT01790698|Streptococcus pyogenes|streptococcus pyogenes
5384870|NCT01790698|Staphylococcus aureus|staphylococcus aureus
5384871|NCT01790698|Immunopathogenesis|immunopathogenesis
5384872|NCT01790672|Antioxidants|antioxidants
5384873|NCT01790672|Central Nervous System Agents|central nervous system agents
5384874|NCT01790672|Wine|wine
5384875|NCT01790659|leishmaniasis|leishmaniasis
5384876|NCT01790659|cutaneous leishmaniasis|cutaneous leishmaniasis
5384877|NCT01790659|Leishmania panamensis|leishmania panamensis
5384878|NCT01790659|L panamensis|l panamensis
5384879|NCT01790659|Paromomycin|paromomycin
5384880|NCT01790659|Paromomycin/Gentamicin|paromomycin/gentamicin
5384881|NCT01790633|rapid test|rapid test
5384882|NCT01790633|screening|screening
5384883|NCT01790633|ELISA|elisa
5384884|NCT01790633|hepatitis B virus|hepatitis b virus
5384885|NCT01790633|hepatitis C virus|hepatitis c virus
5384886|NCT01790633|human immunodeficiency virus|human immunodeficiency virus
5384887|NCT01790633|access to care|access to care
5384888|NCT01790620|Sepsis|sepsis
5384889|NCT01790620|Septic shock|septic shock
5384890|NCT01790620|Acute renal failure|acute renal failure
5384891|NCT01790620|Acute kidney injury|acute kidney injury
5384892|NCT01790620|Continuous renal replacement therapies CRRT|continuous renal replacement therapies crrt
5384893|NCT01790607|Adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and BMI (± 15%)|adult healthy subjects will be matched with individual subjects by age (± 5 years, gender, and bmi (± 15%)
5384894|NCT01790594|transplantation|transplantation
5384895|NCT01790594|kidney|kidney
5384896|NCT01790594|pancreas|pancreas
5384897|NCT01790594|immunosuppression|immunosuppression
5358249|NCT01910883|Safety|safety
5384898|NCT01790594|calcineurin inhibitor (CNI)|calcineurin inhibitor (cni)
5384899|NCT01790581|Chronic Ankle Instability|chronic ankle instability
5384900|NCT01790555|Postsurgical|postsurgical
5384901|NCT01790555|Pain|pain
5384903|NCT01790555|Sensitization|sensitization
5384904|NCT01790542|Iron|iron
5384905|NCT01790542|Intestinal inflammation|intestinal inflammation
5384906|NCT01790542|ROS|ros
5384907|NCT01790516|Head and neck cancer|head and neck cancer
5384908|NCT01790516|genetic testing|genetic testing
5384909|NCT01790516|cisplatin|cisplatin
5384910|NCT01790516|erbitux|erbitux
5384911|NCT01790516|radiation therapy|radiation therapy
5384912|NCT01790503|glioblastoma|glioblastoma
5384913|NCT01790503|GBM|gbm
5384914|NCT01790477|Tonsillectomy|tonsillectomy
5384915|NCT01790477|Acupuncture|acupuncture
5384916|NCT01790464|Glossopharyngeal nerve block|glossopharyngeal nerve block
5384917|NCT01790464|Airway anesthesia|airway anesthesia
5384918|NCT01790464|Awake intubation|awake intubation
5384919|NCT01790451|focal therapy|focal therapy
5384920|NCT01790451|irreversible electroporation|irreversible electroporation
5384921|NCT01790451|prostate cancer|prostate cancer
5384922|NCT01790412|pregnancy, exercise, gestational diabetes|pregnancy, exercise, gestational diabetes
5384923|NCT01790399|SENTINEL NODE|sentinel node
5384924|NCT01790386|hemostasis|hemostasis
5384925|NCT01790386|thromboelastography|thromboelastography
5384926|NCT01790386|coagulation|coagulation
5384927|NCT01790386|TEG|teg
5384928|NCT01790373|Suubi|suubi
5384929|NCT01790373|Adolescents|adolescents
5384930|NCT01790373|Poverty|poverty
5384931|NCT01790373|Economic empowerment interventions|economic empowerment interventions
5384932|NCT01790373|Adherence to HIV antiretroviral therapy|adherence to hiv antiretroviral therapy
5384933|NCT01790373|Wisepill|wisepill
5384934|NCT01790373|HIV/AIDS infected Children|hiv/aids infected children
5384935|NCT01790373|Medical event monitoring system|medical event monitoring system
5384936|NCT01790373|Uganda|uganda
5384937|NCT01790360|MSM|msm
5384938|NCT01790360|HIV|hiv
5384939|NCT01790360|Substance Abuse|substance abuse
5384940|NCT01790360|Sexual Behavior|sexual behavior
5384941|NCT01790347|Exercise|exercise
5384942|NCT01790347|Aerobic|aerobic
5384943|NCT01790347|Resistance training|resistance training
5384944|NCT01790347|Pregnancy|pregnancy
5384945|NCT01790347|Maternal weight gain|maternal weight gain
5384946|NCT01790347|IOM recommendations|iom recommendations
5384947|NCT01790295|Myelofibrosis|myelofibrosis
5384948|NCT01790295|Stem cell transplant|stem cell transplant
5384949|NCT01790295|Ruxolitinib|ruxolitinib
5384950|NCT01790282|luteal support|luteal support
5384951|NCT01790282|high responder|high responder
5384952|NCT01790282|ICSI|icsi
5384953|NCT01790282|ivf|ivf
5384954|NCT01790282|cycle outcome|cycle outcome
5384955|NCT01790269|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5384956|NCT01790269|NK cells|nk cells
5384957|NCT01790269|Fingolimod|fingolimod
5384958|NCT01790204|mutant p53|mutant p53
5384959|NCT01790204|watercress|watercress
5384960|NCT01790204|Phenethyl isothyocyanate|phenethyl isothyocyanate
5384961|NCT01790204|oral cells of smokers|oral cells of smokers
5384962|NCT01790191|Children|children
5384963|NCT01790191|Eating behaviour|eating behaviour
5384964|NCT01790191|Intake|intake
5384965|NCT01790191|Liking|liking
5384966|NCT01790191|Conditioned liking|conditioned liking
5384967|NCT01790191|Flavour|flavour
5384968|NCT01790191|Nutrient|nutrient
5384969|NCT01790191|Vegetable|vegetable
5384970|NCT01790165|Onychomycosis|onychomycosis
5384971|NCT01790165|Open Label|open label
5384972|NCT01790165|PK|pk
5384973|NCT01790126|Men with Biochemically Relapsed Hormone Sensitive Prostate Cancer|men with biochemically relapsed hormone sensitive prostate cancer
5384974|NCT01790074|cervicogenic headache|cervicogenic headache
5384975|NCT01790074|trigger point|trigger point
5384976|NCT01790074|sternocleidomastoid|sternocleidomastoid
5384977|NCT01790074|manual therapy|manual therapy
5384978|NCT01790061|Gut bacteria|gut bacteria
5384979|NCT01790061|Gut flora|gut flora
5384980|NCT01790061|Bacteriotherapy|bacteriotherapy
5384981|NCT01790061|Fecal Microbiota Transplantation|fecal microbiota transplantation
5384982|NCT01790061|Inflammatory bowel disease|inflammatory bowel disease
5384983|NCT01790061|Ulcerative colitis|ulcerative colitis
5384984|NCT01790048|MAM|mam
5384985|NCT01790009|ADME|adme
5384986|NCT01790009|Flavanols|flavanols
5384987|NCT01790009|Age|age
5384988|NCT01790009|Pharmacokinetics|pharmacokinetics
5384989|NCT01789996|6 minute walk test|6 minute walk test
5384990|NCT01789996|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5384991|NCT01789996|pulmonary arterial hypertension|pulmonary arterial hypertension
5384992|NCT01789983|Physical Activity|physical activity
5384993|NCT01789983|Chemotherapy|chemotherapy
5384994|NCT01789983|Elderly|elderly
5384995|NCT01789983|Geriatric|geriatric
5384996|NCT01789983|Walking|walking
5384997|NCT01789983|Geriatric Assessment|geriatric assessment
5384998|NCT01789983|Geriatric Oncology|geriatric oncology
5384999|NCT01789970|chronic low back pain|chronic low back pain
5385000|NCT01789970|hydrocodone bitartrate|hydrocodone bitartrate
5385001|NCT01789970|opioids|opioids
5385002|NCT01789944|Childhood Obesity|childhood obesity
5385003|NCT01789918|Hypertension|hypertension
5385004|NCT01789918|Blood pressure|blood pressure
5385005|NCT01789918|Renal denervation|renal denervation
5385006|NCT01789905|Tygacil|tygacil
5385007|NCT01789905|Tigecycline|tigecycline
5385008|NCT01789905|Post marketing surveillance|post marketing surveillance
5385009|NCT01789905|Japanese|japanese
5385010|NCT01789905|Infection|infection
5385011|NCT01789879|Levonorgestrel|levonorgestrel
5385012|NCT01789879|Efavirenz|efavirenz
5385013|NCT01789879|Nevirapine|nevirapine
5385014|NCT01789879|Pharmacokinetics|pharmacokinetics
5385015|NCT01789866|DHA|dha
5385016|NCT01789866|lutein|lutein
5385017|NCT01789866|cognitive development|cognitive development
5385018|NCT01789866|fMRI|fmri
5385019|NCT01789853|stroke, rehabilitation, gait training|stroke, rehabilitation, gait training
5385020|NCT01789840|BPH|bph
5385021|NCT01789840|Prostate|prostate
5385022|NCT01789840|Prostatic Hyperplasia|prostatic hyperplasia
5385023|NCT01789840|enlarged prostate|enlarged prostate
5385024|NCT01789840|LUTS|luts
5385025|NCT01789840|urinary retention|urinary retention
5385026|NCT01789814|Percutaneous Coronary Intervention|percutaneous coronary intervention
5385027|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5385028|NCT01789814|bivalirudin|bivalirudin
5385029|NCT01789762|Platelet transfusions|platelet transfusions
5385030|NCT01789762|Pathogen reduction|pathogen reduction
5385031|NCT01789762|Haemorrhagic episodes|haemorrhagic episodes
5385032|NCT01789749|snare tip soft coagulation|snare tip soft coagulation
5385033|NCT01789749|endoscopic mucosal resection|endoscopic mucosal resection
5385034|NCT01789749|adenoma recurrence|adenoma recurrence
5385035|NCT01789749|adenoma|adenoma
5385036|NCT01789749|colonoscopy|colonoscopy
5385037|NCT01789736|Glaucoma|glaucoma
5385038|NCT01789736|Ocular hypertension|ocular hypertension
5385039|NCT01789736|AR-12286|ar-12286
5385040|NCT01789736|Travoprost|travoprost
5385041|NCT01789710|smoking|smoking
5385042|NCT01789710|homelessness|homelessness
5385043|NCT01789710|contingency management|contingency management
5385044|NCT01789684|cluster|cluster
5385045|NCT01789684|genetic counseling|genetic counseling
5385048|NCT01789684|provider intervention|provider intervention
5385049|NCT01789671|Childhood Obesity|childhood obesity
5385050|NCT01789658|Oral Mucositis|oral mucositis
5385051|NCT01789658|Children|children
5385052|NCT01789658|Cryotherapy|cryotherapy
5385053|NCT01789658|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5385054|NCT01789645|Carpal tunnel|carpal tunnel
5385055|NCT01789645|Physical therapy|physical therapy
5385056|NCT01789645|Surgery|surgery
5385057|NCT01789645|Efficacy|efficacy
5385058|NCT01789606|Self-selection and actual use/compliance trial.|self-selection and actual use/compliance trial.
5385059|NCT01789580|Experimental study, moderators, online gambling,|experimental study, moderators, online gambling,
5385060|NCT01789580|problem gambling prevention|problem gambling prevention
5385061|NCT01789554|Out of hospital cardiac arrest|out of hospital cardiac arrest
5385062|NCT01789554|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5385063|NCT01789554|Bystander CPR|bystander cpr
5385064|NCT01789554|Mobile phone positioning system|mobile phone positioning system
5385065|NCT01789528|Phase I,|phase i,
5385066|NCT01789528|open label,|open label,
5385067|NCT01789528|CAZ-AVI,|caz-avi,
5385068|NCT01789528|CXL,|cxl,
5385069|NCT01789528|healthy volunteers,|healthy volunteers,
5385070|NCT01789528|intestinal flora.|intestinal flora.
5385071|NCT01789502|self-expandable metal stent; plastic stent|self-expandable metal stent; plastic stent
5385072|NCT01789476|pain|pain
5385073|NCT01789476|acute pain|acute pain
5385074|NCT01789476|kappa agonis|kappa agonis
5385075|NCT01789476|opioid analgesia|opioid analgesia
5385076|NCT01789476|bunionectomy|bunionectomy
5385077|NCT01789476|peripheral nervous system agents|peripheral nervous system agents
5385078|NCT01789476|physiological effects of drugs|physiological effects of drugs
5385079|NCT01789476|surgery|surgery
5385080|NCT01789476|post-operative|post-operative
5385081|NCT01789476|post-operative complications|post-operative complications
5385082|NCT01789450|sensitivity|sensitivity
5385083|NCT01789450|section of periareolar dermis|section of periareolar dermis
5385084|NCT01789450|breast reduction|breast reduction
5385085|NCT01789437|retinal vein occlusion|retinal vein occlusion
5385086|NCT01789437|systemic hypertension|systemic hypertension
5385087|NCT01789437|arteriolar diameter|arteriolar diameter
5385088|NCT01789385|Deep brain stimulation|deep brain stimulation
5385089|NCT01789385|Parkinson|parkinson
5385090|NCT01789372|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5385091|NCT01789372|yoga|yoga
5385092|NCT01789372|quality of life|quality of life
5385093|NCT01789372|blood pressure|blood pressure
5385094|NCT01789372|heart rate|heart rate
5385095|NCT01789372|heart rate variability|heart rate variability
5385096|NCT01789359|anthocyanin|anthocyanin
5385097|NCT01789359|bioavailability|bioavailability
5385098|NCT01789359|urine|urine
5385099|NCT01789359|long-term|long-term
5385100|NCT01789346|Scar|scar
5385101|NCT01789346|Scars|scars
5385102|NCT01789346|Surgical Scar|surgical scar
5385103|NCT01789346|Surgical Scars|surgical scars
5385104|NCT01789346|Cicatrix|cicatrix
5385105|NCT01789346|Hypertrophic Cicatrix|hypertrophic cicatrix
5385106|NCT01789346|Keloid|keloid
5385107|NCT01789346|Hypertrophic Scar|hypertrophic scar
5385108|NCT01789346|Surgical Incision|surgical incision
5385109|NCT01789346|Scarring|scarring
5385110|NCT01789346|Abdominoplasty|abdominoplasty
5385111|NCT01789346|Tummy Tuck|tummy tuck
5385112|NCT01789346|Augmentation Mammoplasty|augmentation mammoplasty
5385113|NCT01789346|Breast Augmentation|breast augmentation
5385114|NCT01789346|Thyroidectomy|thyroidectomy
5385115|NCT01789333|Keratoconus|keratoconus
5385116|NCT01789333|Ectasia|ectasia
5385117|NCT01789333|UVA light|uva light
5385118|NCT01789333|riboflavin|riboflavin
5385119|NCT01789333|post-LASIK|post-lasik
5385120|NCT01789333|irregular astigmatism|irregular astigmatism
5385121|NCT01789320|uveitis|uveitis
5385122|NCT01789320|intermediate uveitis|intermediate uveitis
5385123|NCT01789320|posterior uveitis|posterior uveitis
5385124|NCT01789320|panuveitis|panuveitis
5385125|NCT01789320|noninfectious uveitis|noninfectious uveitis
5385126|NCT01789320|microneedle|microneedle
5385127|NCT01789320|suprachoroidal space|suprachoroidal space
5385129|NCT01789320|inflammation|inflammation
5445453|NCT01521728|Exercise|exercise
5385130|NCT01789320|ocular inflammatory conditions|ocular inflammatory conditions
5385131|NCT01789320|triamcinolone acetonide|triamcinolone acetonide
5385133|NCT01789320|Triesence|triesence
5385134|NCT01789320|injection|injection
5385135|NCT01789320|IVT|ivt
5385136|NCT01789320|intravitreal|intravitreal
5385137|NCT01789320|corticosteroid|corticosteroid
5385138|NCT01789320|sympathetic ophthalmia|sympathetic ophthalmia
5385139|NCT01789320|temporal arteritis|temporal arteritis
5385140|NCT01789320|vitreous haze|vitreous haze
5385141|NCT01789294|lymphoid nodular hyperplasia|lymphoid nodular hyperplasia
5385142|NCT01789294|food allergy|food allergy
5385144|NCT01789268|acute|acute
5385145|NCT01789268|adaptive cellular immune phenotypes|adaptive cellular immune phenotypes
5385146|NCT01789268|infants|infants
5385147|NCT01789268|Lymphocyte|lymphocyte
5385148|NCT01789268|premature|premature
5385149|NCT01789268|respiratory viral infections|respiratory viral infections
5385150|NCT01789229|biobank|biobank
5385151|NCT01789229|fresh-frozen tissue|fresh-frozen tissue
5385152|NCT01789216|Pilon fractures|pilon fractures
5385153|NCT01789216|Calcaneus fractures|calcaneus fractures
5385154|NCT01789216|Acute pain|acute pain
5385155|NCT01789216|Chronic pain|chronic pain
5385156|NCT01789216|Isolated|isolated
5385157|NCT01789216|unilateral|unilateral
5385158|NCT01789216|Grade I|grade i
5385159|NCT01789216|Grade II|grade ii
5385160|NCT01789216|open|open
5385161|NCT01789216|closed|closed
5385162|NCT01789203|BK infection|bk infection
5385163|NCT01789203|BK viremia|bk viremia
5385164|NCT01789203|BK nephropathy|bk nephropathy
5385165|NCT01789203|polyomavirus|polyomavirus
5385166|NCT01789203|fluoroquinolone|fluoroquinolone
5385167|NCT01789203|ciprofloxacin|ciprofloxacin
5385168|NCT01789190|Honeymoon|honeymoon
5385169|NCT01789190|Type 1 diabetes|type 1 diabetes
5385170|NCT01789177|Spirometry|spirometry
5385171|NCT01789177|Postoperative Care|postoperative care
5385172|NCT01789164|TBI|tbi
5385173|NCT01789164|fNIRS|fnirs
5385174|NCT01789164|hypercapnea|hypercapnea
5385175|NCT01789164|Cerebrovascular reactivity|cerebrovascular reactivity
5385176|NCT01789151|arthritis|arthritis
5385177|NCT01789151|nuclear imaging|nuclear imaging
5385178|NCT01789151|rheumatoid|rheumatoid
5385179|NCT01789151|ankylosing spondylitis|ankylosing spondylitis
5385180|NCT01789151|glucosamine|glucosamine
5385181|NCT01789138|Antiretroviral Therapy|antiretroviral therapy
5385182|NCT01789138|Adherence|adherence
5385183|NCT01789138|Intervention|intervention
5385184|NCT01789125|anxiety|anxiety
5385185|NCT01789125|stress|stress
5385186|NCT01789125|smoking|smoking
5385187|NCT01789125|cessation|cessation
5385188|NCT01789099|Lung cancer|lung cancer
5385189|NCT01789099|Peptide vaccine|peptide vaccine
5385190|NCT01789073|Postoperative|postoperative
5385191|NCT01789073|Complications|complications
5385192|NCT01789073|Elective|elective
5385193|NCT01789073|Surgery|surgery
5385194|NCT01789073|GI surgery|gi surgery
5385195|NCT01789073|Immunonutrition|immunonutrition
5385196|NCT01789073|Immune-enhancing|immune-enhancing
5385197|NCT01789073|Immune-modulating|immune-modulating
5385198|NCT01789073|Nutrition|nutrition
5385199|NCT01789073|Pancreatic cancer|pancreatic cancer
5385200|NCT01789073|Postoperative complications and length of hospital stay after major gastrointestinal (GI) elective surgery.|postoperative complications and length of hospital stay after major gastrointestinal (gi) elective surgery.
5385201|NCT01789047|Parkinson's disease|parkinson's disease
5385203|NCT01789047|Indonesia|indonesia
5385204|NCT01789047|amantadine|amantadine
5385205|NCT01789021|blood glucose monitoring systems|blood glucose monitoring systems
5385206|NCT01789021|ISO 15197|iso 15197
5385207|NCT01789021|system accuracy|system accuracy
5385208|NCT01789008|Transient elastography|transient elastography
5385209|NCT01789008|Alcoholic liver disease|alcoholic liver disease
5385210|NCT01789008|liver fibrosis|liver fibrosis
5385211|NCT01788982|Thyroid Cancer|thyroid cancer
5385212|NCT01788982|Medullary thyroid cancer (MTC)|medullary thyroid cancer (mtc)
5385213|NCT01788982|Differentiated thyroid cancer (DTC)|differentiated thyroid cancer (dtc)
5385214|NCT01788969|Gait training|gait training
5385215|NCT01788969|Lexapro|lexapro
5385216|NCT01788969|Tizanidine|tizanidine
5385217|NCT01788956|venous oximeter|venous oximeter
5385218|NCT01788956|CO-Oximeter|co-oximeter
5385219|NCT01788956|ICU Patients|icu patients
5385220|NCT01788956|Sepsis|sepsis
5385221|NCT01788956|non-invasive device|non-invasive device
5385222|NCT01788943|positron emission tomography|positron emission tomography
5385223|NCT01788943|nicotine receptor|nicotine receptor
5385224|NCT01788917|n-3 LC-PUFA, vegetarians, fatty acids, blood lipids|n-3 lc-pufa, vegetarians, fatty acids, blood lipids
5385225|NCT01788904|Acute mesenteric ischemia|acute mesenteric ischemia
5385226|NCT01788904|Percutaneous endovascular revascularization|percutaneous endovascular revascularization
5385227|NCT01788904|Intestinal plasma fatty acid binding protein (i-FABP)|intestinal plasma fatty acid binding protein (i-fabp)
5385228|NCT01788904|Bowel necrosis|bowel necrosis
5385229|NCT01788891|longitudinal observational cohort study|longitudinal observational cohort study
5385230|NCT01788891|multicenter|multicenter
5385231|NCT01788891|pediatrics|pediatrics
5385232|NCT01788891|Asian|asian
5385233|NCT01788891|treatment failure|treatment failure
5385234|NCT01788891|renal status|renal status
5385235|NCT01788891|toxicities|toxicities
5423335|NCT01616108|strabismus|strabismus
5385236|NCT01788891|therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
5385237|NCT01788891|drug levels in blood and hair|drug levels in blood and hair
5385238|NCT01788878|socio-professional future|socio-professional future
5385239|NCT01788865|covered Metal stent|covered metal stent
5385240|NCT01788865|ureteral obstruction|ureteral obstruction
5385241|NCT01788852|HPV|hpv
5385242|NCT01788852|HIV|hiv
5385243|NCT01788852|cervical/anal dysplasia|cervical/anal dysplasia
5385244|NCT01788852|intraepithelial neoplasia|intraepithelial neoplasia
5385245|NCT01788852|E6/E7 biomarker|e6/e7 biomarker
5385348|NCT01788436|Learning performance|learning performance
5385246|NCT01788852|perinatally HIV-infected adolescents|perinatally hiv-infected adolescents
5385247|NCT01788852|behaviorally HIV-infected adolescents|behaviorally hiv-infected adolescents
5385248|NCT01788852|anal and pap smear|anal and pap smear
5385249|NCT01788839|Sexual and Reproductive Health|sexual and reproductive health
5385250|NCT01788839|premenopausal|premenopausal
5385251|NCT01788839|postmenopausal|postmenopausal
5385252|NCT01788839|12-249|12-249
5385253|NCT01788839|Fertility|fertility
5385254|NCT01788826|Ventral hernia|ventral hernia
5385255|NCT01788826|surgical meshes|surgical meshes
5385256|NCT01788826|polypropylenes|polypropylenes
5385257|NCT01788813|Repeat Dose Safety|repeat dose safety
5385258|NCT01788813|Allergic Asthma|allergic asthma
5385259|NCT01788813|Effect on Allergen Reactivity|effect on allergen reactivity
5385260|NCT01788813|Allergic Rhinitis|allergic rhinitis
5385261|NCT01788813|TLR7 Agonist|tlr7 agonist
5385262|NCT01788813|Pharmacodynamics|pharmacodynamics
5385263|NCT01788800|Panic disorder|panic disorder
5385264|NCT01788800|Physical activity|physical activity
5385265|NCT01788787|Cancer Prevention|cancer prevention
5385266|NCT01788787|Tobacco Use Cessation|tobacco use cessation
5385267|NCT01788787|Ask Advise Connect|ask advise connect
5385268|NCT01788787|AAC|aac
5385269|NCT01788787|Smoking Cessation Treatment|smoking cessation treatment
5385270|NCT01788787|Texas Quitline|texas quitline
5385271|NCT01788787|Saliva sample|saliva sample
5385272|NCT01788787|Telephone Counseling|telephone counseling
5385273|NCT01788787|Nicotine replacement|nicotine replacement
5385274|NCT01788787|Interviews|interviews
5385275|NCT01788774|Pharmacokinetics|pharmacokinetics
5385276|NCT01788774|Safety|safety
5385277|NCT01788774|Risperidone ISM®|risperidone ism®
5385278|NCT01788774|Intramuscular|intramuscular
5385279|NCT01788774|Schizophrenia|schizophrenia
5385280|NCT01788761|Probiotics|probiotics
5385281|NCT01788761|Feeding Tolerance|feeding tolerance
5385282|NCT01788761|Extremely Low Birthweight Infants|extremely low birthweight infants
5385283|NCT01788748|fractional|fractional
5385284|NCT01788748|bipolar|bipolar
5385285|NCT01788748|radiofrequency|radiofrequency
5385286|NCT01788748|striae|striae
5385287|NCT01788748|infrared|infrared
5385288|NCT01788748|combined|combined
5385289|NCT01788735|unexplained infertility|unexplained infertility
5385290|NCT01788735|asthma|asthma
5385291|NCT01788735|allergy|allergy
5385292|NCT01788709|colonoscopy|colonoscopy
5385293|NCT01788709|preparation|preparation
5385294|NCT01788696|Parkinsonism|parkinsonism
5385295|NCT01788696|Idiopathic Parkinson Disease|idiopathic parkinson disease
5385296|NCT01788683|Rotator Cuff|rotator cuff
5385297|NCT01788683|Rotator Cuff Tear|rotator cuff tear
5385298|NCT01788683|Supraspinatus Tear|supraspinatus tear
5385299|NCT01788670|Antioxidants, Central Nervous System Agents|antioxidants, central nervous system agents
5385300|NCT01788657|Depression|depression
5385301|NCT01788657|Internet|internet
5385302|NCT01788657|Cognitive Behavior Therapy|cognitive behavior therapy
5385303|NCT01788644|Child adiposity|child adiposity
5385304|NCT01788644|Infancy|infancy
5385305|NCT01788644|Motor activity|motor activity
5385306|NCT01788644|Feeding behavior|feeding behavior
5385307|NCT01788644|Sleep|sleep
5385308|NCT01788644|Stress, Physiological|stress, physiological
5385309|NCT01788618|Cognitive functions|cognitive functions
5385310|NCT01788618|Quality of life|quality of life
5385311|NCT01788618|Cancer|cancer
5385312|NCT01788605|hematologic malignancies|hematologic malignancies
5385313|NCT01788605|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5385314|NCT01788605|ramosetron|ramosetron
5385315|NCT01788605|emesis|emesis
5385316|NCT01788592|coronary artery disease|coronary artery disease
5385317|NCT01788592|drug eluting stent|drug eluting stent
5385318|NCT01788579|Intimate Partner Violence (IPV)|intimate partner violence (ipv)
5385319|NCT01788579|Drug Abuse|drug abuse
5385320|NCT01788579|Criminal Justice|criminal justice
5385321|NCT01788553|remission|remission
5385322|NCT01788553|generalized anxiety disorder|generalized anxiety disorder
5385323|NCT01788540|Recurrent miscarriage|recurrent miscarriage
5385324|NCT01788540|Implantation failure|implantation failure
5385325|NCT01788540|Intralipid|intralipid
5385326|NCT01788540|ICSI / IVF failure|icsi / ivf failure
5385327|NCT01788527|Diabetes|diabetes
5385328|NCT01788527|Type 1|type 1
5385330|NCT01788527|Continuous Glucose Monitor|continuous glucose monitor
5385331|NCT01788527|HGM|hgm
5385332|NCT01788527|HbA1c|hba1c
5385333|NCT01788488|procalcitonin|procalcitonin
5385334|NCT01788488|antimicrobial stewardship|antimicrobial stewardship
5385335|NCT01788488|pneumonia|pneumonia
5385336|NCT01788475|Diabetic Macular Edema|diabetic macular edema
5385337|NCT01788475|DME|dme
5385338|NCT01788475|Pars Plana Vitrectomy|pars plana vitrectomy
5385339|NCT01788462|Tesamorelin|tesamorelin
5385340|NCT01788462|Egrifta|egrifta
5385341|NCT01788462|HIV|hiv
5385342|NCT01788462|Lipodystrophy|lipodystrophy
5385343|NCT01788462|Sleep Apnea|sleep apnea
5385344|NCT01788449|Antibiotic Bacterial Resistance|antibiotic bacterial resistance
5385345|NCT01788436|Schizophrenia|schizophrenia
5385346|NCT01788436|Young healthy volunteers|young healthy volunteers
5385347|NCT01788436|Elderly healthy volunteers|elderly healthy volunteers
5385353|NCT01788410|Facet joint|facet joint
5385354|NCT01788410|Pain|pain
5385355|NCT01788410|Neuralgia|neuralgia
5385356|NCT01788410|Neuropathy|neuropathy
5385357|NCT01788410|Image-guided|image-guided
5385358|NCT01788397|physical disabilities|physical disabilities
5385359|NCT01788397|rehabilitation|rehabilitation
5385360|NCT01788384|acne|acne
5385361|NCT01788384|Clindamycin Phosphate/Benzoyl Peroxide|clindamycin phosphate/benzoyl peroxide
5385362|NCT01788384|Acanya|acanya
5385363|NCT01788384|Mild to severe acne vulgaris|mild to severe acne vulgaris
5385364|NCT01788358|Drug combination|drug combination
5385366|NCT01788358|Candesartan Cilexetil|candesartan cilexetil
5385367|NCT01788358|Hypertension|hypertension
5385368|NCT01788358|Combination therapy|combination therapy
5385369|NCT01788345|non-invasion ventilation|non-invasion ventilation
5385370|NCT01788345|Boussignac|boussignac
5385371|NCT01788332|NSCLC|nsclc
5385372|NCT01788332|non-small cell|non-small cell
5385373|NCT01788332|lung cancer|lung cancer
5385374|NCT01788319|laser trabeculoplasty|laser trabeculoplasty
5385375|NCT01788319|glaucoma|glaucoma
5385376|NCT01788306|Elevated risk|elevated risk
5385377|NCT01788306|opioid overdose|opioid overdose
5385378|NCT01788293|Fluid management|fluid management
5385379|NCT01788293|Pleth Variability Index (PVI)|pleth variability index (pvi)
5385380|NCT01788293|monitoring|monitoring
5385381|NCT01788293|high-risk surgery|high-risk surgery
5385382|NCT01788267|Cystic Fibrosis|cystic fibrosis
5385383|NCT01788267|High-Resolution peripheral Quantitative Computed Tomography|high-resolution peripheral quantitative computed tomography
5385384|NCT01788267|Bone Mass Density|bone mass density
5385385|NCT01788254|pharmacokinetic/genetic|pharmacokinetic/genetic
5385386|NCT01788254|Cyp450 polymorphisms|cyp450 polymorphisms
5385387|NCT01788254|Noninvasive functional characterization of liver heart and kidneys using MRI|noninvasive functional characterization of liver heart and kidneys using mri
5385388|NCT01788241|coronary artery disease|coronary artery disease
5385389|NCT01788241|Atherosclerosis|atherosclerosis
5385390|NCT01788241|Coronary Stenosis|coronary stenosis
5385391|NCT01788241|Cardiovascular Diseases|cardiovascular diseases
5385392|NCT01788241|Non-significant coronary artery disease|non-significant coronary artery disease
5385393|NCT01788241|Mild Stenosis|mild stenosis
5385394|NCT01788241|Vascular Irregularities|vascular irregularities
5385395|NCT01788241|Psychosocial factors|psychosocial factors
5385396|NCT01788241|Personality|personality
5385397|NCT01788241|Type D personality|type d personality
5385398|NCT01788241|Hostility|hostility
5385399|NCT01788241|Depression|depression
5385400|NCT01788241|Anxiety|anxiety
5385401|NCT01788241|Fatigue|fatigue
5385402|NCT01788241|Social Support|social support
5385403|NCT01788241|Socioeconomic Status|socioeconomic status
5385404|NCT01788241|Patient Reported Outcomes|patient reported outcomes
5385405|NCT01788241|Patient Perceived Symptoms|patient perceived symptoms
5385406|NCT01788241|Health Status|health status
5385407|NCT01788241|Quality of Life|quality of life
5385408|NCT01788241|Chest pain|chest pain
5385409|NCT01788241|Cardiac risk factors|cardiac risk factors
5385410|NCT01788241|Metabolic Syndrome|metabolic syndrome
5385411|NCT01788241|BMI|bmi
5385412|NCT01788241|Obesity|obesity
5385413|NCT01788241|Waist Circumference|waist circumference
5385414|NCT01788241|Lifestyle|lifestyle
5385415|NCT01788241|Smoking|smoking
5385416|NCT01788241|Alcohol use|alcohol use
5385417|NCT01788241|Activity|activity
5385418|NCT01788241|Hypertension|hypertension
5385419|NCT01788241|Diabetes|diabetes
5385420|NCT01788241|Familial Cardiovascular Disease|familial cardiovascular disease
5385421|NCT01788241|Coronary angiography|coronary angiography
5385422|NCT01788241|Computed Tomography|computed tomography
5385423|NCT01788228|Vaccine|vaccine
5385424|NCT01788228|Occupational exposure|occupational exposure
5385425|NCT01788228|Influenza|influenza
5385426|NCT01788228|H5N1|h5n1
5385427|NCT01788215|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5385428|NCT01788215|Irregular Menstrual Cycles|irregular menstrual cycles
5385429|NCT01788215|Androgen Excess in Women|androgen excess in women
5385430|NCT01788202|cocaine and general anesthesia|cocaine and general anesthesia
5385435|NCT01788176|Complex Regional Pain Syndromes|complex regional pain syndromes
5385436|NCT01788176|drug therapy|drug therapy
5385437|NCT01788176|zoledronic acid|zoledronic acid
5385438|NCT01788163|EGFR|egfr
5385439|NCT01788163|aNSCLC|ansclc
5385440|NCT01788163|mutation status|mutation status
5385441|NCT01788163|diagnostic study|diagnostic study
5385442|NCT01788163|Russia|russia
5385443|NCT01788163|China|china
5385444|NCT01788163|Asia|asia
5385445|NCT01788137|T-cell lymphoma,DFS,OS|t-cell lymphoma,dfs,os
5385446|NCT01788124|Speculum|speculum
5385447|NCT01788124|Metal|metal
5385448|NCT01788124|Plastic|plastic
5385449|NCT01788124|Visual Analoge Scale|visual analoge scale
5385450|NCT01788124|Discomfort|discomfort
5385451|NCT01788085|GERD|gerd
5385452|NCT01788072|Autism Spectrum Disorders|autism spectrum disorders
5385453|NCT01788072|Oxytocin|oxytocin
5385454|NCT01788072|Adults|adults
5385455|NCT01788059|nonunion|nonunion
5385456|NCT01788059|mesenchymal stem cell|mesenchymal stem cell
5385457|NCT01788059|long bone|long bone
5385458|NCT01788046|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
5385459|NCT01788020|DRC|drc
5385460|NCT01788020|Bortezomib|bortezomib
5385461|NCT01788020|Oncology|oncology
5385462|NCT01788007|Actinic Keratosis|actinic keratosis
5385463|NCT01788007|Imiquimod Topical Cream 3.75%|imiquimod topical cream 3.75%
5385464|NCT01788007|Zyclara® (imiquimod) Topical Cream 3.75%|zyclara® (imiquimod) topical cream 3.75%
5385465|NCT01787968|Congenital transmission|congenital transmission
5385466|NCT01787968|Trypanosoma cruzi|trypanosoma cruzi
5385467|NCT01787968|Chagas disease|chagas disease
5385468|NCT01787955|Pylorus preserving pancreaticoduodenectomy(PPPD), Delayed gastric emptying syndrome(DGE), Braun anastomosis|pylorus preserving pancreaticoduodenectomy(pppd), delayed gastric emptying syndrome(dge), braun anastomosis
5385469|NCT01787942|Lipid thickness|lipid thickness
5385470|NCT01787942|Blepharoplasty|blepharoplasty
5385471|NCT01787942|Tear break up time|tear break up time
5385472|NCT01787942|Corneal staining|corneal staining
5385473|NCT01787916|type 1 diabetes|type 1 diabetes
5385474|NCT01787916|overweight|overweight
5385475|NCT01787916|insulin|insulin
5385476|NCT01787916|liraglutide|liraglutide
5385477|NCT01787903|Type 1 diabetes mellitus|type 1 diabetes mellitus
5385478|NCT01787903|Hypoglycemia unawareness|hypoglycemia unawareness
5385479|NCT01787903|Real-time continuous glucose monitoring|real-time continuous glucose monitoring
5385480|NCT01787903|Glucose control|glucose control
5385481|NCT01787877|Cerebrovascular Accident, Inflammatory biomarkers|cerebrovascular accident, inflammatory biomarkers
5385482|NCT01787864|Barrett's Esophagus|barrett's esophagus
5385483|NCT01787864|Intestinal metaplasia|intestinal metaplasia
5385484|NCT01787864|Intramucosal Adenocarcinoma|intramucosal adenocarcinoma
5385485|NCT01787864|Gastric Cardia|gastric cardia
5385486|NCT01787864|High Cardia Dysplasia|high cardia dysplasia
5385487|NCT01787864|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5385488|NCT01787851|Heart failure|heart failure
5385489|NCT01787851|Anaplerosis|anaplerosis
5385490|NCT01787851|Medium-chain fatty acid|medium-chain fatty acid
5385491|NCT01787838|Pneumococcal vaccination rates, ambulatory settings|pneumococcal vaccination rates, ambulatory settings
5385492|NCT01787825|intestinal disease|intestinal disease
5385493|NCT01787825|inflammatory bowel disease|inflammatory bowel disease
5385494|NCT01787825|crohn disease|crohn disease
5385495|NCT01787825|ulcer|ulcer
5385496|NCT01787825|celiac disease|celiac disease
5385497|NCT01787825|angioectasia|angioectasia
5385498|NCT01787825|polyp|polyp
5385499|NCT01787799|Drug-eluting stents|drug-eluting stents
5373016|NCT01844765|Tasigna|tasigna
5385500|NCT01787786|Crohn's Disease|crohn's disease
5385501|NCT01787786|Ulcerative Colitis|ulcerative colitis
5385502|NCT01787786|Optimal Use of infliximab|optimal use of infliximab
5385503|NCT01787773|Inferior Vena Cava Filter|inferior vena cava filter
5385504|NCT01787773|Vena Cava Filters|vena cava filters
5385505|NCT01787747|Pharmacokinetics|pharmacokinetics
5385506|NCT01787747|Healthy Volunteers|healthy volunteers
5385507|NCT01787747|dextromethorphan with quinidine|dextromethorphan with quinidine
5385508|NCT01787747|deuterated dextromethorphan|deuterated dextromethorphan
5385509|NCT01787721|Gait|gait
5385510|NCT01787721|Ankle joint|ankle joint
5385511|NCT01787721|Manipulation, Chiropractic|manipulation, chiropractic
5385512|NCT01787708|Vitiligo|vitiligo
5385513|NCT01787708|red|red
5385514|NCT01787708|laser|laser
5385515|NCT01787708|light|light
5385516|NCT01787695|Vitiligo|vitiligo
5385517|NCT01787695|UVA1|uva1
5385518|NCT01787695|Phototherapy|phototherapy
5385519|NCT01787682|CHF|chf
5385520|NCT01787682|Protein digestion|protein digestion
5385521|NCT01787682|Fat digestion|fat digestion
5385522|NCT01787682|Gut function|gut function
5385523|NCT01787682|Glucose absorption|glucose absorption
5385524|NCT01787682|Muscle function|muscle function
5385525|NCT01787669|diabetic macular oedema|diabetic macular oedema
5385526|NCT01787669|diabetic macular edema|diabetic macular edema
5385527|NCT01787669|diabetic retinopathy|diabetic retinopathy
5385528|NCT01787669|dexamethasone|dexamethasone
5385529|NCT01787669|Ozurdex|ozurdex
5385530|NCT01787669|Avastin|avastin
5385531|NCT01787669|bevacizumab|bevacizumab
5385532|NCT01787669|DME|dme
5385533|NCT01787669|DMO|dmo
5385534|NCT01787643|height-adjustable desk|height-adjustable desk
5385535|NCT01787643|office workers|office workers
5385536|NCT01787643|sitting occupations|sitting occupations
5385537|NCT01787643|energy expenditure|energy expenditure
5385538|NCT01787643|BMI|bmi
5385539|NCT01787643|Weight|weight
5423336|NCT01616108|diplopia|diplopia
5385540|NCT01787643|Lower fat diet|lower fat diet
5385541|NCT01787630|Prostatic cancer|prostatic cancer
5385542|NCT01787630|Radiotherapy|radiotherapy
5385543|NCT01787630|Hyaluronic acid|hyaluronic acid
5385544|NCT01787617|Exercise Training|exercise training
5385545|NCT01787617|Strength Training|strength training
5385550|NCT01787591|Vitamin E|vitamin e
5385551|NCT01787591|Metabolic syndrome|metabolic syndrome
5515712|NCT01227655|PD|pd
5385552|NCT01787591|Liver disease|liver disease
5385553|NCT01787591|Non-alcoholic liver steatohepatitis|non-alcoholic liver steatohepatitis
5385554|NCT01787591|Fatty liver|fatty liver
5385555|NCT01787591|Dairy consumption|dairy consumption
5385556|NCT01787578|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
5385557|NCT01787578|adrenomyeloneuropathy|adrenomyeloneuropathy
5385558|NCT01787578|sobetirome|sobetirome
5385559|NCT01787578|thyroid|thyroid
5385560|NCT01787578|thyromimetic|thyromimetic
5385561|NCT01787565|non-interventional|non-interventional
5385562|NCT01787565|clinical|clinical
5385563|NCT01787565|investigation|investigation
5385565|NCT01787565|back|back
5385566|NCT01787565|pain|pain
5385567|NCT01787565|painPREMIER|painpremier
5385573|NCT01787552|Efficacy|efficacy
5385574|NCT01787552|Myelofibrosis|myelofibrosis
5385575|NCT01787552|Post-polycythemia vera myelofbrosis (Post PV-PMF)|post-polycythemia vera myelofbrosis (post pv-pmf)
5385576|NCT01787552|Post essential thrombocythemia myelofibrosis (Post ET-MF)|post essential thrombocythemia myelofibrosis (post et-mf)
5385577|NCT01787552|Primary myelofibrosis (PMF)|primary myelofibrosis (pmf)
5385578|NCT01787552|Intermediate risk myelofibrosis|intermediate risk myelofibrosis
5385579|NCT01787552|High risk myelofibrosis|high risk myelofibrosis
5385580|NCT01787552|Combination Treatment|combination treatment
5385581|NCT01787552|Hedgehog Signaling Pathway|hedgehog signaling pathway
5385582|NCT01787552|Smoothened inhibitor|smoothened inhibitor
5385583|NCT01787552|JAK inhibitor|jak inhibitor
5385584|NCT01787539|gastric cancer|gastric cancer
5385585|NCT01787539|perioperative chemotherapy|perioperative chemotherapy
5385586|NCT01787539|combined modality therapy|combined modality therapy
5385587|NCT01787539|gastrectomy|gastrectomy
5385588|NCT01787526|iron depletion|iron depletion
5385589|NCT01787526|donor safety|donor safety
5385590|NCT01787526|blood donation|blood donation
5385591|NCT01787526|transfusion medicine|transfusion medicine
5385592|NCT01787526|iron deficiency|iron deficiency
5385593|NCT01787526|intravenous iron|intravenous iron
5385594|NCT01787526|fatigue|fatigue
5385595|NCT01787526|restless legs syndrome|restless legs syndrome
5385596|NCT01787526|anemia|anemia
5680430|NCT00577798|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5385597|NCT01787461|Trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.|trial assessing effects of an oral dietary supplement on overall facial appearance among healthy women with photodamaged skin.
5385598|NCT01787448|repeat insult patch test|repeat insult patch test
5385600|NCT01787435|acid-suppressing drugs,|acid-suppressing drugs,
5385601|NCT01787435|pregnancy,|pregnancy,
5385602|NCT01787435|epidemiology|epidemiology
5385603|NCT01787422|Telemedicine|telemedicine
5385604|NCT01787383|Actinic Keratosis|actinic keratosis
5385605|NCT01787383|Ingenol mebutate gel|ingenol mebutate gel
5385606|NCT01787370|coronary artery disease, endothelial dysfunction|coronary artery disease, endothelial dysfunction
5385608|NCT01787357|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5385609|NCT01787357|Pharmacokinetics|pharmacokinetics
5385610|NCT01787357|Moxifloxacin|moxifloxacin
5385611|NCT01787357|Electrocardiogram Parameters|electrocardiogram parameters
5385612|NCT01787357|QT/QTc Interval|qt/qtc interval
5385613|NCT01787357|Therapeutic dose|therapeutic dose
5385614|NCT01787357|Supra-Therapeutic dose|supra-therapeutic dose
5385615|NCT01787344|Other Infantile Cerebral Palsy|other infantile cerebral palsy
5385616|NCT01787305|microbiome|microbiome
5385617|NCT01787305|commensals|commensals
5385618|NCT01787305|autoantibodies|autoantibodies
5385619|NCT01787305|autoreactive T cells|autoreactive t cells
5385624|NCT01787214|glucose variability|glucose variability
5385625|NCT01787214|glycemia|glycemia
5385626|NCT01787214|type-2 diabetes|type-2 diabetes
5385627|NCT01787175|Medication Therapy Management|medication therapy management
5385628|NCT01787175|Clinical Decision Support Systems|clinical decision support systems
5385629|NCT01787175|Medical Informatics|medical informatics
5385630|NCT01787175|Patient Care Management|patient care management
5385631|NCT01787175|United States Department of Veterans Affairs|united states department of veterans affairs
5385632|NCT01787162|Myeloproliferative disorders|myeloproliferative disorders
5385633|NCT01787162|pulmonary hypertension|pulmonary hypertension
5385634|NCT01787162|pulmonary vascular diseases|pulmonary vascular diseases
5385635|NCT01787149|ENIA11|enia11
5385636|NCT01787149|DMARDs|dmards
5385637|NCT01787149|RA|ra
5385638|NCT01787149|TNF|tnf
5385639|NCT01787110|Acute coronary syndrome|acute coronary syndrome
5385740|NCT01786668|Spondylitis|spondylitis
5385640|NCT01787110|Acute myocardial infarction|acute myocardial infarction
5385641|NCT01787110|Non ST-segment Myocardial Infarction|non st-segment myocardial infarction
5385642|NCT01787110|ST-segment Myocardial Infarction|st-segment myocardial infarction
5385643|NCT01787110|STEMI|stemi
5385644|NCT01787110|NSTEMI|nstemi
5385645|NCT01787110|Oxygen|oxygen
5385646|NCT01787110|Unstable angina|unstable angina
5903862|NCT00261456|PSA|psa
5385647|NCT01787110|Randomised trial|randomised trial
5385648|NCT01787110|CMR|cmr
5385649|NCT01787110|Mortality|mortality
5385650|NCT01787110|RCRT|rcrt
5385651|NCT01787110|RRCT|rrct
5385652|NCT01787084|Aortic Stenosis|aortic stenosis
5385653|NCT01787084|TAVR|tavr
5385654|NCT01787071|fluids|fluids
5385655|NCT01787071|crtically ill patients|crtically ill patients
5385656|NCT01787071|functional hemodynamics|functional hemodynamics
5385657|NCT01787071|cvp|cvp
5385658|NCT01787058|WASH|wash
5385659|NCT01787058|schoolchildren|schoolchildren
5385660|NCT01787058|absenteeism|absenteeism
5385661|NCT01787045|SEPSIS|sepsis
5385662|NCT01787006|non resectable|non resectable
5385663|NCT01787006|locally advanced|locally advanced
5385664|NCT01787006|Cetuximab|cetuximab
5385665|NCT01787006|radiation|radiation
5385666|NCT01786967|overactive bladder|overactive bladder
5385667|NCT01786967|urge urinary incontinence|urge urinary incontinence
5385668|NCT01786967|pharmacogenetics|pharmacogenetics
5385669|NCT01786954|vitreoretinal surgery|vitreoretinal surgery
5385670|NCT01786954|intraocular pressure|intraocular pressure
5385671|NCT01786954|applanation|applanation
5385672|NCT01786954|rebound|rebound
5385673|NCT01786954|tonometry|tonometry
5385674|NCT01786941|Branched-chain Amino Acids|branched-chain amino acids
5385675|NCT01786941|Insulin Sensitivity|insulin sensitivity
5385676|NCT01786941|Exercise|exercise
5385677|NCT01786941|Leucine|leucine
5385678|NCT01786928|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5385679|NCT01786928|exacerbation|exacerbation
5385680|NCT01786928|resistance training|resistance training
5385681|NCT01786928|muscle force|muscle force
5385682|NCT01786902|growth hormone|growth hormone
5385683|NCT01786876|Radiolabelled|radiolabelled
5385684|NCT01786876|AME|ame
5385685|NCT01786850|Locally advanced Pancreatic Cancer|locally advanced pancreatic cancer
5385686|NCT01786850|Noninvasive treatment|noninvasive treatment
5385687|NCT01786850|High Intensity focused ultrasound|high intensity focused ultrasound
5385688|NCT01786850|Magnetic Resonance|magnetic resonance
5385689|NCT01786837|constipation|constipation
5385690|NCT01786837|gastric emptying|gastric emptying
5385691|NCT01786824|contrast induced nephropathy|contrast induced nephropathy
5385692|NCT01786824|hydration strategy|hydration strategy
5385693|NCT01786824|L-carnitine|l-carnitine
5385694|NCT01786798|Transvaginal sonography|transvaginal sonography
5385695|NCT01786798|Endometrial thickness|endometrial thickness
5385696|NCT01786798|Endometrial pattern|endometrial pattern
5385697|NCT01786798|Abnormal uterine bleeding|abnormal uterine bleeding
5385698|NCT01786798|Endometrial hyperplasia|endometrial hyperplasia
5385699|NCT01786798|Endometrial cancer|endometrial cancer
5385700|NCT01786772|arthroscopic partial meniscectomy|arthroscopic partial meniscectomy
5385701|NCT01786772|meniscus|meniscus
5385702|NCT01786772|quadriceps strength|quadriceps strength
5385703|NCT01786772|quadriceps voluntary activation|quadriceps voluntary activation
5385704|NCT01786772|cryotherapy|cryotherapy
5385705|NCT01786772|compression|compression
5385706|NCT01786772|vasopneumatic compression|vasopneumatic compression
5385707|NCT01786772|intermittent pneumatic compression|intermittent pneumatic compression
5385708|NCT01786759|lipids|lipids
5385709|NCT01786759|preterm infants|preterm infants
5385710|NCT01786759|parenteral nutrition|parenteral nutrition
5385711|NCT01786759|liver function|liver function
5385712|NCT01786746|depression|depression
5385713|NCT01786746|cognitive behavioral therapy|cognitive behavioral therapy
5385714|NCT01786746|culture|culture
5385715|NCT01786746|Chinese Americans|chinese americans
5385716|NCT01786746|psychotherapy|psychotherapy
5385717|NCT01786733|Acute Inpatient Psychiatry|acute inpatient psychiatry
5385718|NCT01786733|Continuity of Care|continuity of care
5385719|NCT01786733|Behavioral Activation|behavioral activation
5385720|NCT01786733|Depression|depression
5385721|NCT01786720|COPD|copd
5385722|NCT01786720|Triple Therapy|triple therapy
5385723|NCT01786720|ICS|ics
5385724|NCT01786720|LABA|laba
5385725|NCT01786720|LAMA|lama
5385726|NCT01786707|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5385727|NCT01786707|Hyperbaric oxygen therapy (HOT)|hyperbaric oxygen therapy (hot)
5385728|NCT01786707|Autologous Bone Marrow-Derived Buffy Coat|autologous bone marrow-derived buffy coat
5385729|NCT01786707|Stem cells (SC)|stem cells (sc)
5385730|NCT01786694|rectum|rectum
5385731|NCT01786694|microdialysis|microdialysis
5385732|NCT01786694|quality of life|quality of life
5385733|NCT01786681|Morbid obesity|morbid obesity
5385734|NCT01786681|Bariatric Surgery|bariatric surgery
5385735|NCT01786681|Pulmonary Atelectasis|pulmonary atelectasis
5385736|NCT01786681|Spirometry|spirometry
5385737|NCT01786681|Continuous Positive Airway Pressure|continuous positive airway pressure
5385738|NCT01786681|Physical Therapy Specialty|physical therapy specialty
5385739|NCT01786668|Ankylosing Spondylitis|ankylosing spondylitis
5385741|NCT01786668|Ankylosing|ankylosing
5385742|NCT01786668|Spondyloarthritis|spondyloarthritis
5385743|NCT01786668|Spondyloarthropathy|spondyloarthropathy
5385744|NCT01786668|Oral preparation|oral preparation
5385745|NCT01786655|local anesthetic|local anesthetic
5385746|NCT01786655|neosaxitoxin|neosaxitoxin
5385747|NCT01786655|neoSTX|neostx
5385748|NCT01786655|bupivacaine|bupivacaine
5385749|NCT01786655|safety|safety
5385750|NCT01786655|phase 1|phase 1
5385751|NCT01786655|pharmacokinetic|pharmacokinetic
5385752|NCT01786577|Neuroimaging Biomarkers|neuroimaging biomarkers
5385753|NCT01786577|Cognitive Decline in Elderly|cognitive decline in elderly
5385754|NCT01786577|Memory, Thinking problems for Older Adults|memory, thinking problems for older adults
5385755|NCT01786577|Executive Decline|executive decline
5385756|NCT01786577|Post-operative cognitive change|post-operative cognitive change
5385757|NCT01786564|diabetes|diabetes
5385758|NCT01786564|sleep|sleep
5385759|NCT01786525|Live Donor Kidney Transplantation|live donor kidney transplantation
5385761|NCT01786525|African American|african american
5385762|NCT01786525|Disparity|disparity
5385763|NCT01786525|Education|education
5385764|NCT01786525|Patient Support|patient support
5385765|NCT01786512|Pharmacokinetics|pharmacokinetics
5385766|NCT01786512|Omecamtiv mecarbil|omecamtiv mecarbil
5385767|NCT01786512|AMG 423|amg 423
5385768|NCT01786512|Double-blind|double-blind
5385769|NCT01786512|Randomized|randomized
5385770|NCT01786512|Placebo-controlled|placebo-controlled
5385771|NCT01786512|Oral forumlation|oral forumlation
5385772|NCT01786512|CK-1827452|ck-1827452
5385773|NCT01786512|Cardiac myosin activator|cardiac myosin activator
5385774|NCT01786499|Burnout|burnout
5385775|NCT01786499|Stress|stress
5385776|NCT01786499|Provider|provider
5385777|NCT01786499|Relaxation Response|relaxation response
5385778|NCT01786434|colonoscopy|colonoscopy
5385779|NCT01786434|pain|pain
5385780|NCT01786421|Ethanol|ethanol
5385781|NCT01786421|Lipemia|lipemia
5385782|NCT01786421|Postprandial|postprandial
5385783|NCT01786421|Triglyceride|triglyceride
5385784|NCT01786395|UF-021|uf-021
5385785|NCT01786395|unoprostone|unoprostone
5385787|NCT01786369|Schizophrenia|schizophrenia
5385788|NCT01786369|Psychotic Disorders|psychotic disorders
5385789|NCT01786369|Bipolar Disorder|bipolar disorder
5385790|NCT01786369|Antipsychotic Agents|antipsychotic agents
5385791|NCT01786369|Drug Monitoring|drug monitoring
5385792|NCT01786356|posterior capsule opacification|posterior capsule opacification
5385793|NCT01786356|PCO|pco
5385794|NCT01786356|after cataract|after cataract
5385795|NCT01786356|intraocular lens|intraocular lens
5385796|NCT01786343|Leukemia|leukemia
5385797|NCT01786343|Acute myeloid leukemia|acute myeloid leukemia
5385799|NCT01786343|Response rates|response rates
5385800|NCT01786343|Decitabine|decitabine
5385801|NCT01786343|Dacogen|dacogen
5385802|NCT01786317|Fecal incontinence, ano-rectal manometry|fecal incontinence, ano-rectal manometry
5385803|NCT01786304|Fecal incontinence, sacral nerve stimulation|fecal incontinence, sacral nerve stimulation
5359141|NCT01906489|hemoglobin|hemoglobin
5385804|NCT01786291|obstructive sleep apnea|obstructive sleep apnea
5385805|NCT01786291|continuous positive airway pressure|continuous positive airway pressure
5385806|NCT01786291|cardiopulmonary exercise test|cardiopulmonary exercise test
5385807|NCT01786291|VE/VCO2|ve/vco2
5385808|NCT01786278|adenocarcinoma|adenocarcinoma
5385809|NCT01786278|esophago-gastric junction|esophago-gastric junction
5385810|NCT01786278|dysphagia|dysphagia
5385811|NCT01786278|brachytherapy|brachytherapy
5385812|NCT01786278|endoscopic stenting|endoscopic stenting
5385813|NCT01786252|embryo|embryo
5385814|NCT01786252|implantation|implantation
5385815|NCT01786252|blastocyst|blastocyst
5385816|NCT01786252|in vitro fertilization|in vitro fertilization
5385817|NCT01786252|human chorionic gonadotropin|human chorionic gonadotropin
5385818|NCT01786239|Adolescence|adolescence
5385819|NCT01786239|Adult|adult
5385820|NCT01786239|Antipsychotic Agents|antipsychotic agents
5385821|NCT01786239|Female|female
5385822|NCT01786239|Human|human
5385823|NCT01786239|Male|male
5385824|NCT01786239|Risperidone|risperidone
5385825|NCT01786239|Omega-3|omega-3
5385826|NCT01786239|Schizophrenia|schizophrenia
5385827|NCT01786239|Schizophreniform|schizophreniform
5385828|NCT01786239|Schizoaffective|schizoaffective
5385829|NCT01786239|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
5385830|NCT01786226|leiomyoma, fibroid, mifepristone, antiprogestins|leiomyoma, fibroid, mifepristone, antiprogestins
5385831|NCT01786213|adenoma detection rate, colonoscopy, trainee, learning curve|adenoma detection rate, colonoscopy, trainee, learning curve
5385832|NCT01786200|colon|colon
5385833|NCT01786200|cancer|cancer
5385834|NCT01786200|NSAID|nsaid
5385835|NCT01786200|inflammation|inflammation
5385836|NCT01786187|Lung Cancer|lung cancer
5385837|NCT01786187|Symptoms|symptoms
5385838|NCT01786174|ALS|als
5385839|NCT01786174|Gilenya|gilenya
5385840|NCT01786174|Fingolimod|fingolimod
5385841|NCT01786148|HIV/AIDS|hiv/aids
5385842|NCT01786148|Adherence|adherence
5385843|NCT01786148|Self-management|self-management
5385844|NCT01786148|Antiretroviral therapy|antiretroviral therapy
5385845|NCT01786135|Antibodies, Monoclonal|antibodies, monoclonal
5385846|NCT01786135|Antibody-Drug Conjugate|antibody-drug conjugate
5385847|NCT01786135|Antigens, CD19|antigens, cd19
5385848|NCT01786135|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
5516063|NCT01226004|cancer|cancer
5385849|NCT01786135|Burkitt Lymphoma|burkitt lymphoma
5385850|NCT01786135|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5385851|NCT01786135|Mantle Cell Lymphoma|mantle cell lymphoma
5385852|NCT01786135|B-Cell Lymphoma|b-cell lymphoma
5385853|NCT01786135|Drug Therapy|drug therapy
5385854|NCT01786135|Monomethylauristatin F|monomethylauristatin f
5385855|NCT01786135|Follicular Lymphoma Grade 3|follicular lymphoma grade 3
5385856|NCT01786122|physical exercise|physical exercise
5385857|NCT01786122|Health Related Quality of Life|health related quality of life
5385858|NCT01786122|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5385859|NCT01786122|digestive system neoplasms|digestive system neoplasms
5385863|NCT01786109|fatty acid amide hydrolase|fatty acid amide hydrolase
5385864|NCT01786109|gastric|gastric
5385865|NCT01786109|motility|motility
5385866|NCT01786109|small bowel|small bowel
5385867|NCT01786109|sensory|sensory
5385868|NCT01786109|motor|motor
5385869|NCT01786096|Burkitt Lymphoma|burkitt lymphoma
5385870|NCT01786096|Antibodies, Monoclonal|antibodies, monoclonal
5385871|NCT01786096|Antibody-Drug Conjugate|antibody-drug conjugate
5385872|NCT01786096|B-Lineage Acute Lymphoblastic Leukemia|b-lineage acute lymphoblastic leukemia
5385873|NCT01786096|B-Lineage Lymphoblastic Lymphoma|b-lineage lymphoblastic lymphoma
5385874|NCT01786096|Burkitt Leukemia|burkitt leukemia
5385875|NCT01786096|Monomethylauristatin F|monomethylauristatin f
5385876|NCT01786096|Antigens, CD19|antigens, cd19
5385877|NCT01786096|Drug Therapy|drug therapy
5385878|NCT01786083|family caregivers|family caregivers
5385879|NCT01786083|dependency|dependency
5385880|NCT01786083|Problem Solving Technique|problem solving technique
5385881|NCT01786083|home based nursing|home based nursing
5385882|NCT01786044|patient education|patient education
5385883|NCT01786044|primary health care|primary health care
5385884|NCT01786018|Non Hodgkin lymphomas|non hodgkin lymphomas
5385885|NCT01786018|Allogeneic Transplantation|allogeneic transplantation
5385886|NCT01786018|Thiotepa|thiotepa
5385887|NCT01786018|Busulfan|busulfan
5385888|NCT01786018|Fludarabin|fludarabin
5385889|NCT01785992|Oestrogen receptor|oestrogen receptor
5385890|NCT01785992|Locally advanced|locally advanced
5385891|NCT01785992|Metastatic|metastatic
5385892|NCT01785992|Breast cancer|breast cancer
5385893|NCT01785992|Sulfatase inhibitor|sulfatase inhibitor
5385894|NCT01785966|Critical care|critical care
5385895|NCT01785966|quality improvement|quality improvement
5385896|NCT01785966|checklist|checklist
5385897|NCT01785940|Interscalene Block|interscalene block
5385898|NCT01785940|Perineural catheter|perineural catheter
5385899|NCT01785940|Ropivacaine|ropivacaine
5385900|NCT01785940|Postoperative pain|postoperative pain
5385901|NCT01785940|Home regional|home regional
5385902|NCT01785927|Antituberculosis|antituberculosis
5385903|NCT01785927|Dry powder aerosols|dry powder aerosols
5385904|NCT01785927|Inhalation|inhalation
5385905|NCT01785901|asthma|asthma
5385906|NCT01785901|control rate|control rate
5385907|NCT01785901|budesonide/formoterol|budesonide/formoterol
5385908|NCT01785901|Non-Interventional study|non-interventional study
5385909|NCT01785888|EGFR,|egfr,
5385910|NCT01785888|aNSCLC,|ansclc,
5385911|NCT01785888|mutation status,|mutation status,
5385912|NCT01785888|diagnostic study,|diagnostic study,
5385913|NCT01785888|Europe,|europe,
5385914|NCT01785888|Japan|japan
5385915|NCT01785875|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
5385916|NCT01785862|sore throat pain|sore throat pain
5385917|NCT01785862|tonsillopharyngitis|tonsillopharyngitis
5385918|NCT01785862|upper respiratory tract infection|upper respiratory tract infection
5385919|NCT01785849|Secondary Hyperparathyroidism (SHPT), chronic kidney disease (CKD), hemodialysis, parathyroid hormone (PTH), hypocalcemia, bone and mineral metabolism|secondary hyperparathyroidism (shpt), chronic kidney disease (ckd), hemodialysis, parathyroid hormone (pth), hypocalcemia, bone and mineral metabolism
5385920|NCT01785823|analgesia|analgesia
5385921|NCT01785823|fentanyl|fentanyl
5385922|NCT01785823|total intravenous anesthesia|total intravenous anesthesia
5385923|NCT01785758|complications, renal;|complications, renal;
5385924|NCT01785758|kidney, failure;|kidney, failure;
5385925|NCT01785758|neuromuscular block, antagonism;|neuromuscular block, antagonism;
5385926|NCT01785758|neuromuscular block, rocuronium;|neuromuscular block, rocuronium;
5385927|NCT01785758|safety, drug|safety, drug
5385928|NCT01785758|sugammadex|sugammadex
5385929|NCT01785745|conservative treatment|conservative treatment
5385930|NCT01785745|shoulder|shoulder
5385931|NCT01785745|neurocognitive therapeutic exercise|neurocognitive therapeutic exercise
5385932|NCT01785745|traditional therapeutic exercise|traditional therapeutic exercise
5385933|NCT01785745|pain|pain
5385934|NCT01785719|Weight Loss|weight loss
5386236|NCT01784432|microarrays|microarrays
5385935|NCT01785719|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5903863|NCT00261456|prostate biopsy|prostate biopsy
5385936|NCT01785719|Ovarian Follicle Development|ovarian follicle development
5385937|NCT01785719|Metabolism|metabolism
5385938|NCT01785693|Nerve block|nerve block
5385939|NCT01785693|Femoropopliteal bypass|femoropopliteal bypass
5385940|NCT01785693|Postoperative analgesia|postoperative analgesia
5385941|NCT01785693|Peripheral circulation|peripheral circulation
5385942|NCT01785693|Levobupivacaine|levobupivacaine
5385943|NCT01785693|Clonidine|clonidine
5385944|NCT01785693|Pain|pain
5385947|NCT01785654|Reventilation collapse|reventilation collapse
5385948|NCT01785654|Rate of reventilation collapse|rate of reventilation collapse
5385949|NCT01785654|Risk factor of reventilation collapse|risk factor of reventilation collapse
5385950|NCT01785654|Hemodynamic profile of reventilation collapse|hemodynamic profile of reventilation collapse
5385951|NCT01785654|Biologic approach of reventilation collapse|biologic approach of reventilation collapse
5385952|NCT01785641|peritoneal dialysis|peritoneal dialysis
5385953|NCT01785641|peritonitis|peritonitis
5385954|NCT01785628|Parkinson's disease|parkinson's disease
5385955|NCT01785628|dementia|dementia
5385956|NCT01785628|NMDA|nmda
5385957|NCT01785628|event related potential|event related potential
5385958|NCT01785628|Bereitschaftspotential|bereitschaftspotential
5385959|NCT01785615|metabolic syndrome|metabolic syndrome
5385960|NCT01785615|atorvastatin|atorvastatin
5385961|NCT01785615|women|women
5385962|NCT01785602|Atopic eczema|atopic eczema
5385963|NCT01785602|Skin Diseases|skin diseases
5385964|NCT01785589|coronary artery disease|coronary artery disease
5385965|NCT01785589|cardiac nuclear medicine|cardiac nuclear medicine
5385966|NCT01785589|myocardial perfusion imaging|myocardial perfusion imaging
5385967|NCT01785589|invasive coronary angiography|invasive coronary angiography
5385968|NCT01785576|couples|couples
5385969|NCT01785576|head and neck cancer|head and neck cancer
5385970|NCT01785576|oncology|oncology
5385971|NCT01785576|spousal support|spousal support
5385972|NCT01785563|NAVA|nava
5385973|NCT01785563|NIV-NAVA|niv-nava
5385974|NCT01785563|VLBW|vlbw
5385975|NCT01785563|electrical activity of the diaphragm|electrical activity of the diaphragm
5385976|NCT01785563|neural trigger, mechanical ventilation|neural trigger, mechanical ventilation
5385977|NCT01785563|respiratory distress syndrome|respiratory distress syndrome
5385978|NCT01785537|e-cigarette smoking|e-cigarette smoking
5385979|NCT01785537|cigarette smoking|cigarette smoking
5385980|NCT01785537|cardiovascular disease|cardiovascular disease
5385981|NCT01785537|hospitalization|hospitalization
5385982|NCT01785537|chronic obstructive pulmonary diseases|chronic obstructive pulmonary diseases
5385983|NCT01785537|observational study|observational study
5385984|NCT01785537|efficacy|efficacy
5385985|NCT01785537|safety|safety
5385986|NCT01785524|Cardiovascular Diseases|cardiovascular diseases
5385987|NCT01785524|Vascular Diseases|vascular diseases
5373522|NCT01842243|MRI|mri
5385988|NCT01785524|Arterial Occlusive Diseases|arterial occlusive diseases
5385989|NCT01785524|Diabetes|diabetes
5385990|NCT01785524|Exercise|exercise
5385991|NCT01785524|Functional Capacity|functional capacity
5385992|NCT01785511|hypertension|hypertension
5385993|NCT01785511|UV radiation|uv radiation
5385994|NCT01785511|coronary flow reserve|coronary flow reserve
5385995|NCT01785511|nitric oxide|nitric oxide
5385996|NCT01785498|children|children
5385997|NCT01785498|quality of life|quality of life
5385998|NCT01785498|physical activity|physical activity
5385999|NCT01785498|healthy lifestyle|healthy lifestyle
5386000|NCT01785485|Integrative medicine|integrative medicine
5386001|NCT01785485|primary care|primary care
5386002|NCT01785485|cost-effectiveness|cost-effectiveness
5386003|NCT01785472|Essential hypertension|essential hypertension
5386004|NCT01785472|LCZ696|lcz696
5386005|NCT01785459|headache|headache
5386006|NCT01785459|migraine|migraine
5386007|NCT01785459|bupivacaine|bupivacaine
5386008|NCT01785446|Dexmedetomidine|dexmedetomidine
5386009|NCT01785446|Cisatracurion infusion|cisatracurion infusion
5386010|NCT01785446|Sufentanil|sufentanil
5386011|NCT01785446|Recovery Index|recovery index
5386012|NCT01785446|Closed loop computer control system|closed loop computer control system
5386013|NCT01785433|COPD, pharmacokinetics, tiotropium|copd, pharmacokinetics, tiotropium
5386014|NCT01785420|Pre-operative Trastuzumab Protocol|pre-operative trastuzumab protocol
5386015|NCT01785407|Iron bio availability|iron bio availability
5386016|NCT01785407|Hepcidin|hepcidin
5386017|NCT01785407|Iron absorption|iron absorption
5386018|NCT01785394|pollinosis|pollinosis
5386019|NCT01785394|sublingual immunotherapy|sublingual immunotherapy
5386020|NCT01785394|exhaled breath temperature|exhaled breath temperature
5386021|NCT01785381|Osteoporosis, hip fracture, fractures, Bone density|osteoporosis, hip fracture, fractures, bone density
5386022|NCT01785368|guidelines|guidelines
5386023|NCT01785368|referral guidelines|referral guidelines
5386024|NCT01785368|exam delays|exam delays
5386025|NCT01785368|exam relevance|exam relevance
5386026|NCT01785355|periodontal disease|periodontal disease
5386028|NCT01785355|nutrition|nutrition
5386029|NCT01785355|inflammation|inflammation
5389617|NCT01769248|FNA|fna
5386030|NCT01785355|anemia response to ESA|anemia response to esa
5386031|NCT01785355|quality of life|quality of life
5386032|NCT01785355|hemodialysis|hemodialysis
5386033|NCT01785316|Perfusion Cancer Chemotherapy, Regional|perfusion cancer chemotherapy, regional
5386034|NCT01785303|CBT|cbt
5386035|NCT01785303|CPAP|cpap
5386036|NCT01785303|Multidisciplinary Treatment|multidisciplinary treatment
5386037|NCT01785303|Combination treatment|combination treatment
5386038|NCT01785290|Delirium|delirium
5386039|NCT01785290|Survival|survival
5386040|NCT01785290|Side-effects|side-effects
5386041|NCT01785290|QoL|qol
5386042|NCT01785277|Spinal Cord Independence Measure|spinal cord independence measure
5386043|NCT01785277|SCIM|scim
5386044|NCT01785277|Spinal cord injury|spinal cord injury
5386045|NCT01785277|Traumatic spine injury|traumatic spine injury
5386046|NCT01785264|Achilles|achilles
5386047|NCT01785264|Tendon|tendon
5386048|NCT01785264|Rupture|rupture
5386049|NCT01785264|Acute|acute
5386050|NCT01785264|Treatment|treatment
5386051|NCT01785264|Outcome measure|outcome measure
5386052|NCT01785251|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5386053|NCT01785251|NMES|nmes
5386054|NCT01785251|Deep vein thrombosis|deep vein thrombosis
5386055|NCT01785251|DVT|dvt
5386056|NCT01785251|total hip arthroplasty|total hip arthroplasty
5386057|NCT01785251|lower limb hemodynamics|lower limb hemodynamics
5386058|NCT01785238|preterm infants|preterm infants
5386059|NCT01785238|acute renal failure|acute renal failure
5386060|NCT01785238|nephronic reduction|nephronic reduction
5386061|NCT01785199|apnea-hypopnea index|apnea-hypopnea index
5386062|NCT01785199|obstructive sleep apnea|obstructive sleep apnea
5386063|NCT01785199|body posture|body posture
5386064|NCT01785199|ultra-wideband|ultra-wideband
5386065|NCT01785186|TB|tb
5386066|NCT01785186|Tuberculosis|tuberculosis
5386067|NCT01785186|MAMS - Multiple-arm, multiple-stage|mams - multiple-arm, multiple-stage
5386068|NCT01785186|Pulmonary|pulmonary
5386069|NCT01785186|SQ109|sq109
5386070|NCT01785186|High dose rifampicin|high dose rifampicin
5386071|NCT01785186|moxifloxacin|moxifloxacin
5386072|NCT01785173|Endoscopes|endoscopes
5386073|NCT01785173|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
5386074|NCT01785173|Transnasal endoscopy|transnasal endoscopy
5386075|NCT01785173|Nasal anesthesia|nasal anesthesia
5386076|NCT01785147|Tobacco addition|tobacco addition
5386077|NCT01785134|Obesity|obesity
5386078|NCT01785134|Bariatric Surgery|bariatric surgery
5386079|NCT01785134|Insulin Sensitivity|insulin sensitivity
5386080|NCT01785108|Diamyd|diamyd
5386081|NCT01785108|Diabetes|diabetes
5386082|NCT01785108|Juvenile Diabetes|juvenile diabetes
5386083|NCT01785108|Diabetes type 1|diabetes type 1
5386084|NCT01785108|Autoimmune Diabetes|autoimmune diabetes
5386085|NCT01785108|Insulin dependent Diabetes|insulin dependent diabetes
5386086|NCT01785108|Type 1 diabetes|type 1 diabetes
5386087|NCT01785108|Type 1 diabetes mellitus|type 1 diabetes mellitus
5386088|NCT01785108|rhGAD65|rhgad65
5386089|NCT01785108|GAD|gad
5386090|NCT01785108|GAD65|gad65
5386091|NCT01785108|GAD-alum|gad-alum
5386092|NCT01785108|Diabetes Mellitus|diabetes mellitus
5386093|NCT01785108|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5386094|NCT01785108|Glucose Metabolism Disorders|glucose metabolism disorders
5386095|NCT01785108|Metabolic Diseases|metabolic diseases
5386096|NCT01785108|Vitamin D|vitamin d
5386097|NCT01785108|Ibuprofen|ibuprofen
5386098|NCT01785082|13-C-Methacetin|13-c-methacetin
5386099|NCT01785082|partial liver resection|partial liver resection
5386100|NCT01785082|liver function tests|liver function tests
5386101|NCT01785056|Systemic Sclerosis|systemic sclerosis
5386102|NCT01785056|Diffuse Scleroderma|diffuse scleroderma
5386103|NCT01785056|SSc|ssc
5386104|NCT01785043|DIABETES Mellitus Type 2|diabetes mellitus type 2
5386105|NCT01785043|Difficult control|difficult control
5386106|NCT01785017|critical|critical
5386107|NCT01785017|asthma|asthma
5386108|NCT01785017|children|children
5386109|NCT01785004|Adiposity|adiposity
5386110|NCT01785004|Body composition|body composition
5386111|NCT01785004|Vitamin D|vitamin d
5386112|NCT01785004|Adipokines|adipokines
5386113|NCT01785004|Omega-3 fatty acid|omega-3 fatty acid
5386114|NCT01784991|Pain|pain
5386115|NCT01784991|Opioids|opioids
5386116|NCT01784991|Hydromorphone|hydromorphone
5386117|NCT01784991|regimen|regimen
5386118|NCT01784978|cancer|cancer
5386119|NCT01784978|renal|renal
5386120|NCT01784978|metastatic|metastatic
5386121|NCT01784978|clear|clear
5386122|NCT01784978|cell|cell
5386123|NCT01784978|Sunitinib|sunitinib
5386124|NCT01784978|Everolimus|everolimus
5386125|NCT01784978|Alternating|alternating
5386126|NCT01784939|hereditary hemochromatosis C282Y homozygous|hereditary hemochromatosis c282y homozygous
5386127|NCT01784939|Iron Reabsorption Index (IRI)|iron reabsorption index (iri)
5386128|NCT01784939|Hepcidin / ferritin (H / F) ratio|hepcidin / ferritin (h / f) ratio
5386129|NCT01784926|cataract surgery|cataract surgery
5386130|NCT01784926|scleral suturing|scleral suturing
5386131|NCT01784926|Verisyse|verisyse
5386132|NCT01784926|Late in-the-bag IOL dislocation|late in-the-bag iol dislocation
5386133|NCT01784913|Prostate|prostate
5386136|NCT01784874|Rabies|rabies
5386137|NCT01784874|Human Diploid Cell Vaccine|human diploid cell vaccine
5386138|NCT01784874|Imovax® Rabies|imovax® rabies
5386139|NCT01784848|high blood pressure|high blood pressure
5386140|NCT01784848|hypertension|hypertension
5386141|NCT01784848|bariatric surgery|bariatric surgery
5386142|NCT01784848|Laparoscopic Roux-en-Y gastric bypass (LRYGB)|laparoscopic roux-en-y gastric bypass (lrygb)
5386143|NCT01784848|obesity|obesity
5386144|NCT01784835|Osteopathic manipulative treatment|osteopathic manipulative treatment
5386145|NCT01784835|neonatology|neonatology
5386146|NCT01784835|neonatal care|neonatal care
5386147|NCT01784835|prematurity|prematurity
5386148|NCT01784835|complementary and alternative medicine|complementary and alternative medicine
5386149|NCT01784835|length of stay|length of stay
5386150|NCT01784822|Ventral hernia|ventral hernia
5386154|NCT01784809|Condom Use|condom use
5386155|NCT01784809|Criminal Justice|criminal justice
5386156|NCT01784809|Drug Use|drug use
5386157|NCT01784796|cardiovascular disease|cardiovascular disease
5386158|NCT01784796|women's health|women's health
5386159|NCT01784796|psychological stress|psychological stress
5386160|NCT01784796|Veterans|veterans
5386162|NCT01784783|HIV transmission|hiv transmission
5386163|NCT01784783|PMTCT|pmtct
5386164|NCT01784783|Discordancy|discordancy
5386165|NCT01784783|Home-based testing|home-based testing
5386166|NCT01784783|Couple counseling|couple counseling
5386167|NCT01784783|Couple testing|couple testing
5386168|NCT01784783|Facility delivery|facility delivery
5386169|NCT01784783|Exclusive breastfeeding|exclusive breastfeeding
5386170|NCT01784783|Family planning|family planning
5386171|NCT01784783|Postpartum contraceptives|postpartum contraceptives
5386172|NCT01784783|Linkage to care|linkage to care
5386173|NCT01784783|ART initiation|art initiation
5386174|NCT01784770|Legionnaires' disease|legionnaires' disease
5386175|NCT01784770|Legionella pneumophila|legionella pneumophila
5386176|NCT01784770|Zithromax|zithromax
5386177|NCT01784770|Zithromac|zithromac
5386178|NCT01784770|Japanese|japanese
5386179|NCT01784770|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5386180|NCT01784744|Autism|autism
5386181|NCT01784744|ASD|asd
5386182|NCT01784744|Aspergers|aspergers
5386183|NCT01784744|Autism Spectrum Disorder|autism spectrum disorder
5386184|NCT01784692|Immulina|immulina
5386185|NCT01784692|Elderly|elderly
5386186|NCT01784692|Immune|immune
5386187|NCT01784679|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5386188|NCT01784679|GNE Myopathy|gne myopathy
5386189|NCT01784679|Nonaka Disease|nonaka disease
5386190|NCT01784679|Quadriceps Sparing Myopathy|quadriceps sparing myopathy
5386191|NCT01784679|distal myopathy with rimmed vacuoles|distal myopathy with rimmed vacuoles
5386192|NCT01784679|ultragenyx|ultragenyx
5386193|NCT01784679|rare disease|rare disease
5386194|NCT01784666|Bipolar Disorder|bipolar disorder
5386195|NCT01784666|Depression|depression
5386196|NCT01784666|Lithium|lithium
5386197|NCT01784666|Valproate|valproate
5386198|NCT01784666|Isradipine|isradipine
5386199|NCT01784653|Substance abuse|substance abuse
5386200|NCT01784653|Drug abuse|drug abuse
5386201|NCT01784653|Alcohol abuse|alcohol abuse
5386202|NCT01784653|Tobacco|tobacco
5386203|NCT01784653|Adolescent|adolescent
5386204|NCT01784627|substance use|substance use
5386205|NCT01784627|alcohol abuse|alcohol abuse
5386206|NCT01784627|cannabis abuse|cannabis abuse
5386207|NCT01784627|nicotine dependence|nicotine dependence
5386208|NCT01784627|adolescents|adolescents
5386209|NCT01784601|Interscalene block|interscalene block
5386210|NCT01784601|Hemidiaphragm palsy|hemidiaphragm palsy
5386211|NCT01784575|Quality of care|quality of care
5386212|NCT01784575|Pediatric|pediatric
5386213|NCT01784575|Pregnancy|pregnancy
5386214|NCT01784575|Low-income|low-income
5386215|NCT01784575|Low literacy|low literacy
5386216|NCT01784562|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5386217|NCT01784549|NSCL|nscl
5386218|NCT01784549|biomarkers|biomarkers
5386219|NCT01784549|Customized Neoadjuvant Therapy|customized neoadjuvant therapy
5386220|NCT01784523|antiphospholipid autoantibodies|antiphospholipid autoantibodies
5386221|NCT01784523|antiphospholipid positive|antiphospholipid positive
5386222|NCT01784497|Health Related Quality of Life (HRQL)|health related quality of life (hrql)
5445454|NCT01521728|Resistance|resistance
5369500|NCT01859715|pain|pain
5386223|NCT01784497|Living Donor Liver Transplantation(LDLT)|living donor liver transplantation(ldlt)
5386224|NCT01784471|Foot Symptoms|foot symptoms
5386225|NCT01784471|Diabetes|diabetes
5386226|NCT01784471|Peripheral Vascular Disease|peripheral vascular disease
5386227|NCT01784471|Magic Foot shoe|magic foot shoe
5386228|NCT01784458|severe sepsis|severe sepsis
5386229|NCT01784458|intra-abdominal hypertension|intra-abdominal hypertension
5386230|NCT01784458|intra-abdominal pressure|intra-abdominal pressure
5386231|NCT01784445|Endoscopic Retrograde Cholangiopancreatography,|endoscopic retrograde cholangiopancreatography,
5386232|NCT01784432|low-level laser therapy|low-level laser therapy
5386233|NCT01784432|muscle performance|muscle performance
5386234|NCT01784432|strength training|strength training
5386235|NCT01784432|gene expression|gene expression
5386237|NCT01784419|Cystic fibrosis|cystic fibrosis
5386238|NCT01784419|Ivacaftor|ivacaftor
5386239|NCT01784419|Genotype|genotype
5386240|NCT01784419|Phenotype|phenotype
5386241|NCT01784419|Sweat chloride|sweat chloride
5386242|NCT01784419|Pancreatic sufficient|pancreatic sufficient
5386243|NCT01784406|Self-management intervention|self-management intervention
5386244|NCT01784406|Psychosocial care|psychosocial care
5386245|NCT01784406|Autonomy-supportive|autonomy-supportive
5386246|NCT01784406|Gynaecological cancer survivors|gynaecological cancer survivors
5386247|NCT01784406|Guided self-Determination|guided self-determination
5386248|NCT01784367|Hypercapnia|hypercapnia
5386249|NCT01784367|noninvasive ventilation|noninvasive ventilation
5386250|NCT01784367|acute respiratory failure|acute respiratory failure
5386251|NCT01784367|endotracheal intubation|endotracheal intubation
5386252|NCT01784367|invasive mechanical ventilation|invasive mechanical ventilation
5386253|NCT01784341|Bipolar, Circadian, Melatonin|bipolar, circadian, melatonin
5386254|NCT01784328|Peristeen Bowel Irrigation System|peristeen bowel irrigation system
5386255|NCT01784328|Cauda Equina Syndrome|cauda equina syndrome
5386256|NCT01784328|Lower Motor Neuron Neurogenic Bowel|lower motor neuron neurogenic bowel
5386257|NCT01784315|The presence of parasites in the blood|the presence of parasites in the blood
5386258|NCT01784289|Interleukin 7|interleukin 7
5386259|NCT01784289|adipose tissue|adipose tissue
5386260|NCT01784276|Children|children
5386261|NCT01784276|Autism Spectrum Disorders|autism spectrum disorders
5386262|NCT01784276|Electronic Screen Media|electronic screen media
5386263|NCT01784276|Dental fear|dental fear
5386264|NCT01784263|Intervention|intervention
5386266|NCT01784263|Treatment sensitivity|treatment sensitivity
5386267|NCT01784263|School aged|school aged
5386268|NCT01784263|Cognitive behavioral therapy|cognitive behavioral therapy
5386269|NCT01784250|Clonidine|clonidine
5386270|NCT01784250|Propranolol|propranolol
5386271|NCT01784250|Third molar|third molar
5386272|NCT01784250|Anxiety|anxiety
5386273|NCT01784237|Endoscopes|endoscopes
5386274|NCT01784237|Esophago-gastro-duodenoscopy|esophago-gastro-duodenoscopy
5386275|NCT01784237|Transnasal endoscopy|transnasal endoscopy
5386276|NCT01784237|Anterior meatoscopy|anterior meatoscopy
5386277|NCT01784198|pregnancy|pregnancy
5386278|NCT01784198|protein requirements|protein requirements
5386279|NCT01784198|Indicator Amino acid oxidation|indicator amino acid oxidation
5386280|NCT01784198|Stable isotopes|stable isotopes
5386281|NCT01784185|EBUS guided transbronchial needle aspiration (EBUS-TBNA)|ebus guided transbronchial needle aspiration (ebus-tbna)
5386282|NCT01784185|virtual bronchoscopy (VB)|virtual bronchoscopy (vb)
5386283|NCT01784185|VB guided transbronchial needle aspiration VB-TBNA)|vb guided transbronchial needle aspiration vb-tbna)
5386284|NCT01784185|mediastinal sampling|mediastinal sampling
5002909|NCT03977883|New onset atrial fibrillation|new onset atrial fibrillation
5386285|NCT01784185|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
5386287|NCT01784172|safety|safety
5386288|NCT01784172|electroacupuncture|electroacupuncture
5386289|NCT01784172|simple female stress urinary incontinence|simple female stress urinary incontinence
5386290|NCT01784159|ICU|icu
5386291|NCT01784159|Sepsis|sepsis
5386292|NCT01784159|Aspirin|aspirin
5386293|NCT01784159|Septic shock|septic shock
5386294|NCT01784133|rosacea|rosacea
5386295|NCT01784120|breast cancer|breast cancer
5386296|NCT01784120|doxorubicin|doxorubicin
5386297|NCT01784120|genexol-PM|genexol-pm
5386298|NCT01784120|paclitaxel|paclitaxel
5386299|NCT01784107|SCLC|sclc
5386300|NCT01784107|belotecan|belotecan
5386301|NCT01784107|Ifosfamide|ifosfamide
5386302|NCT01784081|palliative care|palliative care
5386303|NCT01784081|decision aid|decision aid
5386304|NCT01784068|Ph+ CML-CP|ph+ cml-cp
5386305|NCT01784068|chronic phase|chronic phase
5386306|NCT01784068|nilotinib treatment|nilotinib treatment
5386307|NCT01784068|2 years treatment|2 years treatment
5386308|NCT01784068|MR 4.5|mr 4.5
5386309|NCT01784068|Loss of MR 4|loss of mr 4
5386310|NCT01784068|Loss of MMR|loss of mmr
5386311|NCT01784055|NeoChord|neochord
5386312|NCT01784055|DS1000|ds1000
5386313|NCT01784055|Mitral Valve|mitral valve
5386314|NCT01784055|Mitral Valve Regurgitation|mitral valve regurgitation
5386316|NCT01784055|Mitral Valve Repair|mitral valve repair
5386317|NCT01784055|Mitral Valve Prolapse|mitral valve prolapse
5386318|NCT01784055|Artificial Chordae|artificial chordae
5386319|NCT01784042|breast cancer|breast cancer
5445455|NCT01521728|Endurance|endurance
5386320|NCT01784042|omega-3 fatty acids|omega-3 fatty acids
5386321|NCT01784029|adolescents|adolescents
5386322|NCT01784029|minority|minority
5386323|NCT01783964|Elacytarabine|elacytarabine
5386324|NCT01783964|pharmacokinetic|pharmacokinetic
5386325|NCT01783964|Microdose|microdose
5386326|NCT01783964|Mass Balance Recovery|mass balance recovery
5386327|NCT01783951|Gastric cancer|gastric cancer
5386328|NCT01783951|S-1|s-1
5386329|NCT01783951|DC-CIK|dc-cik
5386330|NCT01783951|T cell|t cell
5386331|NCT01783912|Smoking|smoking
5386332|NCT01783912|Nicotine Dependence|nicotine dependence
5386333|NCT01783912|Mental Disorders|mental disorders
5386334|NCT01783886|Diabetic Macular Edema|diabetic macular edema
5386335|NCT01783886|DME|dme
5386343|NCT01783847|Visual function|visual function
5386344|NCT01783834|Pemetrexed|pemetrexed
5386345|NCT01783834|Gefitinib|gefitinib
5386346|NCT01783834|iressa|iressa
5386347|NCT01783834|alimta|alimta
5386348|NCT01783821|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5386349|NCT01783808|COPD|copd
5386350|NCT01783808|Physical capacity|physical capacity
5386351|NCT01783808|Physical activity|physical activity
5386352|NCT01783808|Inflammatory markers|inflammatory markers
5386353|NCT01783808|Health related quality of life|health related quality of life
5386354|NCT01783795|Dent|dent
5386355|NCT01783795|Dents|dents
5386356|NCT01783795|Dent Disease|dent disease
5386361|NCT01783795|Hereditary study for Dent Disease|hereditary study for dent disease
5386363|NCT01783782|colon cleansing|colon cleansing
5386364|NCT01783782|children|children
5386365|NCT01783782|age 2 -18 years|age 2 -18 years
5386366|NCT01783769|neurosurgery|neurosurgery
5386367|NCT01783769|operating room personnel|operating room personnel
5386368|NCT01783769|sterile procedures|sterile procedures
5386369|NCT01783769|infection|infection
5386370|NCT01783769|Conditions requiring surgery|conditions requiring surgery
5386371|NCT01783743|Trichiasis|trichiasis
5386372|NCT01783743|Trachoma|trachoma
5386373|NCT01783743|Mass treatment|mass treatment
5386374|NCT01783730|Rheumatoid arthritis|rheumatoid arthritis
5386375|NCT01783704|hip fracture|hip fracture
5386376|NCT01783704|randomized controlled trial|randomized controlled trial
5386377|NCT01783704|exercise|exercise
5386378|NCT01783691|Sickle cell disease|sickle cell disease
5386379|NCT01783652|Adolescent depression|adolescent depression
5386380|NCT01783652|internet intervention|internet intervention
5386381|NCT01783639|Carotid|carotid
5386382|NCT01783639|Carotid artery stenting|carotid artery stenting
5386383|NCT01783639|Stent|stent
5386384|NCT01783639|Embolic protection|embolic protection
5386385|NCT01783639|Atherosclerotic Disease|atherosclerotic disease
5386386|NCT01783600|Peripheral Arterial Disease|peripheral arterial disease
5386387|NCT01783600|Infrapopliteal lesions|infrapopliteal lesions
5386388|NCT01783600|balloon catheter|balloon catheter
5386389|NCT01783574|Depression|depression
5386390|NCT01783574|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5386391|NCT01783561|caffeine|caffeine
5386392|NCT01783561|intubation|intubation
5386393|NCT01783561|hemodynamic|hemodynamic
5386394|NCT01783548|allergic rhinitis|allergic rhinitis
5386395|NCT01783548|pediatric subjects|pediatric subjects
5386396|NCT01783548|BDP nasal aerosol|bdp nasal aerosol
5386397|NCT01783535|intraocular retinoblastoma|intraocular retinoblastoma
5386398|NCT01783509|GENETICALLY CONFIRMED limb girdle muscular dystrophy|genetically confirmed limb girdle muscular dystrophy
5386399|NCT01783483|CABG|cabg
5386400|NCT01783483|Valve replacement|valve replacement
5386401|NCT01783483|sternal closure|sternal closure
5386402|NCT01783483|midline sternotomy|midline sternotomy
5386403|NCT01783483|sternal plates|sternal plates
5386404|NCT01783470|adipose tissue, brown|adipose tissue, brown
5386405|NCT01783470|obesity|obesity
5386406|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists
5386407|NCT01783470|thermogenesis|thermogenesis
5386408|NCT01783470|metabolism|metabolism
5386409|NCT01783457|First psychotic episode|first psychotic episode
5386410|NCT01783457|Individual psychoeducation|individual psychoeducation
5386411|NCT01783457|Telemedicine|telemedicine
5386412|NCT01783457|BDNF|bdnf
5386413|NCT01783457|Oxidative stress|oxidative stress
5386414|NCT01783444|Estrogen receptor positive, locally advanced, metastatic breast cancer, Everolimus, Exemestane, Capecitabine|estrogen receptor positive, locally advanced, metastatic breast cancer, everolimus, exemestane, capecitabine
5386415|NCT01783418|mindfulness-based meditation|mindfulness-based meditation
5386416|NCT01783418|pediatric cancer|pediatric cancer
5386417|NCT01783418|adolescence|adolescence
5386418|NCT01783418|quality of life|quality of life
5386419|NCT01783418|sleep|sleep
5386420|NCT01783418|affect|affect
5386421|NCT01783418|health psychology|health psychology
5386422|NCT01783405|LDLR mutation|ldlr mutation
5386423|NCT01783405|Statin|statin
5386424|NCT01783405|Cardiovascular disease|cardiovascular disease
5386425|NCT01783392|overactive bladder|overactive bladder
5671955|NCT00613496|TGFβ1|tgfβ1
5386426|NCT01783392|transcutaneous posterior tibial nerve stimulation|transcutaneous posterior tibial nerve stimulation
5386427|NCT01783392|placebo PTNS|placebo ptns
5369718|NCT01858662|Liver|liver
5386428|NCT01783379|invasive fungal infection|invasive fungal infection
5386429|NCT01783379|micafungin|micafungin
5386430|NCT01783379|intensive care|intensive care
5386431|NCT01783379|pharmacokinetics|pharmacokinetics
5386532|NCT01782963|Newly diagnosed|newly diagnosed
5386432|NCT01783366|nasogastric tube, tube exchange catheter|nasogastric tube, tube exchange catheter
5386433|NCT01783353|Recalcitrant cutaneous warts|recalcitrant cutaneous warts
5386435|NCT01783340|Malaria|malaria
5386436|NCT01783340|P falciparum|p falciparum
5386437|NCT01783340|Chloroquine|chloroquine
5386438|NCT01783340|Azithromycin|azithromycin
5386439|NCT01783340|Immunization|immunization
5386440|NCT01783327|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5386441|NCT01783327|Self care|self care
5386442|NCT01783327|Coping skills|coping skills
5386443|NCT01783327|Adolescent|adolescent
5386444|NCT01783327|Internet|internet
5386445|NCT01783327|Intervention Studies|intervention studies
5386446|NCT01783327|Chronic Disease|chronic disease
5386447|NCT01783314|hepatic fibrosis|hepatic fibrosis
5386448|NCT01783314|Eovist|eovist
5386449|NCT01783314|gadoxetate disodium|gadoxetate disodium
5386450|NCT01783314|biomarker|biomarker
5386451|NCT01783314|liver biopsy|liver biopsy
5386452|NCT01783314|liver function|liver function
5386454|NCT01783314|Hepatitis C|hepatitis c
5386455|NCT01783301|follicle stimulating hormone|follicle stimulating hormone
5386456|NCT01783301|ovarian stimulation|ovarian stimulation
5386457|NCT01783301|antimullerian hormone|antimullerian hormone
5386458|NCT01783301|antral follicle count|antral follicle count
5386459|NCT01783301|assisted reproductive technologies|assisted reproductive technologies
5386460|NCT01783288|Postural tachycardia syndrome|postural tachycardia syndrome
5386461|NCT01783288|orthostatic intolerance|orthostatic intolerance
5386462|NCT01783288|orthostatic tachycardia|orthostatic tachycardia
5386463|NCT01783288|POTS|pots
5386464|NCT01783275|Obesity|obesity
5386465|NCT01783275|Type 2 diabetes|type 2 diabetes
5386466|NCT01783275|Liver|liver
5386467|NCT01783236|VATS|vats
5386468|NCT01783236|thoracic surgery|thoracic surgery
5386469|NCT01783236|acetaminophen|acetaminophen
5386470|NCT01783236|ofirmev|ofirmev
5386471|NCT01783236|lung surgery|lung surgery
5386472|NCT01783236|thoracoscopic|thoracoscopic
5386473|NCT01783236|intravenous acetaminophen|intravenous acetaminophen
5386474|NCT01783158|head and neck carcinoma|head and neck carcinoma
5386475|NCT01783158|chromoendoscopy|chromoendoscopy
5386476|NCT01783158|Lugol's solution|lugol's solution
5386477|NCT01783158|esophageal carcinoma|esophageal carcinoma
5386478|NCT01783158|synchronous tumors|synchronous tumors
5386479|NCT01783158|deglutition|deglutition
5386480|NCT01783158|deglutition disorders|deglutition disorders
5386481|NCT01783158|Newly diagnosed HNSCC|newly diagnosed hnscc
5386482|NCT01783145|survivorship care|survivorship care
5386483|NCT01783145|testicular cancer|testicular cancer
5386484|NCT01783145|shared care model|shared care model
5386485|NCT01783119|Ulcerative Colitis|ulcerative colitis
5386486|NCT01783119|Aloe Vera|aloe vera
5386487|NCT01783106|Crohn's|crohn's
5386488|NCT01783106|antibiotics|antibiotics
5386489|NCT01783106|hydroxychloroquine|hydroxychloroquine
5386490|NCT01783106|ciprofloxacin|ciprofloxacin
5386491|NCT01783106|doxycycline|doxycycline
5386492|NCT01783080|Chronic depression|chronic depression
5386493|NCT01783080|Dysthymic disorder|dysthymic disorder
5386494|NCT01783080|Double Depression|double depression
5386495|NCT01783080|Behavioral Activation therapy|behavioral activation therapy
5386496|NCT01783080|Work impairment|work impairment
5386497|NCT01783080|Unemployment|unemployment
5386498|NCT01783067|Biofortification|biofortification
5386499|NCT01783067|Pearl millet|pearl millet
5386500|NCT01783067|Iron absorption|iron absorption
5386501|NCT01783067|Zinc absorption|zinc absorption
5386502|NCT01783054|NEOADJUVANT GEMCITABINE AND ABRAXANE CHEMOTHERAPY|neoadjuvant gemcitabine and abraxane chemotherapy
5386504|NCT01783054|RESECTABLE ADENOCARCINOMA OF THE PANCREAS|resectable adenocarcinoma of the pancreas
5386505|NCT01783041|Prematurity|prematurity
5386506|NCT01783041|Carnitine supplementation|carnitine supplementation
5386507|NCT01783041|Neonatal Intensive Care|neonatal intensive care
5386508|NCT01783041|MRI|mri
5386509|NCT01783041|Amplitude-integrated EEG|amplitude-integrated eeg
5386510|NCT01783041|NICU Network Neurobehavioral Scale|nicu network neurobehavioral scale
5386511|NCT01783041|Bayley Scale of Infant Development III|bayley scale of infant development iii
5386512|NCT01783028|asthma|asthma
5386513|NCT01783015|Rheumatoid arthritis|rheumatoid arthritis
5386514|NCT01783015|etanercept|etanercept
5386515|NCT01783015|methotrexate|methotrexate
5386516|NCT01783015|infliximab|infliximab
5386517|NCT01783015|adalimumab|adalimumab
5386518|NCT01783015|anti-drug antibody|anti-drug antibody
5369827|NCT01858129|TTN|ttn
5386519|NCT01782989|geographic atrophy|geographic atrophy
5423337|NCT01616095|Growth hormone deficiency|growth hormone deficiency
5386520|NCT01782989|non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
5386521|NCT01782989|macular degeneration|macular degeneration
5386522|NCT01782989|dry macular degeneration|dry macular degeneration
5386523|NCT01782989|dry AMD|dry amd
5386524|NCT01782976|Glioblastoma|glioblastoma
5386525|NCT01782976|GBM|gbm
5386526|NCT01782976|Intracranial glioblastoma|intracranial glioblastoma
5386527|NCT01782976|Recurrent|recurrent
5386528|NCT01782976|MD Anderson Symptom Inventory for Brain Tumors|md anderson symptom inventory for brain tumors
5386529|NCT01782976|MDASI-BT|mdasi-bt
5386530|NCT01782976|Questionnaire|questionnaire
5386533|NCT01782950|HIV|hiv
5386534|NCT01782950|Tuberculosis|tuberculosis
5386535|NCT01782950|Antituberculosis drugs|antituberculosis drugs
5386536|NCT01782911|Androgen|androgen
5386537|NCT01782911|IVF|ivf
5386538|NCT01782911|Resveratrol|resveratrol
5386539|NCT01782911|PCOS.|pcos.
5386540|NCT01782898|Anesthesia|anesthesia
5386541|NCT01782898|MEDOC neuro sensory analyzer|medoc neuro sensory analyzer
5386542|NCT01782898|Pain|pain
5386543|NCT01782898|Quality of recovery|quality of recovery
5386544|NCT01782885|Osteoarthritis|osteoarthritis
5386545|NCT01782885|Platelet-Rich Plasma|platelet-rich plasma
5386546|NCT01782885|Intra-articular|intra-articular
5386547|NCT01782885|Injection|injection
5386548|NCT01782807|Ovarian function|ovarian function
5386550|NCT01782807|Salpingectomy|salpingectomy
5386551|NCT01782807|Anti mullerian hormone|anti mullerian hormone
5386552|NCT01782794|Vaccination|vaccination
5386553|NCT01782794|Acceptability|acceptability
5386554|NCT01782794|General population|general population
5386555|NCT01782794|Hepatitis B|hepatitis b
5386556|NCT01782794|Vaccine coverage|vaccine coverage
5386557|NCT01782781|Analgesia|analgesia
5386558|NCT01782781|Local infiltration analgesia|local infiltration analgesia
5386559|NCT01782781|Pain, relief|pain, relief
5386560|NCT01782781|Pain, Postoperative|pain, postoperative
5386561|NCT01782781|Ropivacaine|ropivacaine
5386562|NCT01782781|Ketorolac|ketorolac
5386563|NCT01782781|Epinephrine|epinephrine
5386564|NCT01782781|Adrenergic Agonists|adrenergic agonists
5386565|NCT01782781|Sympathomimetics|sympathomimetics
5386566|NCT01782781|Therapeutic Uses|therapeutic uses
5386567|NCT01782781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5386568|NCT01782781|Analgesics, Non-Narcotic|analgesics, non-narcotic
5386569|NCT01782781|Analgesics|analgesics
5386570|NCT01782781|Opioids|opioids
5386571|NCT01782781|Morphine|morphine
5386572|NCT01782781|Pain|pain
5386573|NCT01782781|Postoperative Complications|postoperative complications
5386574|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs
5386575|NCT01782781|Anesthetics, Local|anesthetics, local
5386576|NCT01782781|Anesthetics|anesthetics
5386577|NCT01782768|Neural respiratory drive in different level of NPPV|neural respiratory drive in different level of nppv
5386578|NCT01782755|Probiotics|probiotics
5386579|NCT01782755|Ventilator Associated Pneumonia (VAP)|ventilator associated pneumonia (vap)
5386580|NCT01782755|Infection|infection
5386581|NCT01782755|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
5386582|NCT01782755|C-Difficile|c-difficile
5386583|NCT01782742|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5386584|NCT01782729|Dermatitis, Atopic|dermatitis, atopic
5386585|NCT01782729|Tacrolimus|tacrolimus
5386586|NCT01782716|Mortality|mortality
5386587|NCT01782716|Length|length
5386588|NCT01782716|hospitalization|hospitalization
5386589|NCT01782716|cardiac surgery|cardiac surgery
5386590|NCT01782716|patients|patients
5483950|NCT01362452|NHL|nhl
5386591|NCT01782703|Atopic Dermatitis|atopic dermatitis
5386592|NCT01782703|Filaggrin|filaggrin
5386593|NCT01782703|Biomarkers|biomarkers
5386594|NCT01782703|Eczema|eczema
5386595|NCT01782664|PASI|pasi
5386596|NCT01782664|DLQI|dlqi
5386597|NCT01782664|GSK2586184|gsk2586184
5386598|NCT01782664|plaque-type psoriasis|plaque-type psoriasis
5386599|NCT01782664|PGA|pga
5386600|NCT01782664|inflammatory gene transcription|inflammatory gene transcription
5386601|NCT01782664|JAK-1 inhibitor|jak-1 inhibitor
5386602|NCT01782664|serum neopterin|serum neopterin
5386603|NCT01782664|skin biopsy|skin biopsy
5386604|NCT01782664|ACR response criteria|acr response criteria
5386605|NCT01782664|VAS itch score|vas itch score
5386606|NCT01782651|HER2 positive|her2 positive
5386607|NCT01782651|Breast Cancer|breast cancer
5386608|NCT01782651|treatment patterns|treatment patterns
5386609|NCT01782638|Parkinson's disease|parkinson's disease
5386610|NCT01782638|Deep brain stimulation|deep brain stimulation
5386611|NCT01782638|Gait|gait
5386612|NCT01782638|Freezing|freezing
5386613|NCT01782638|Electrode placements|electrode placements
5386614|NCT01782625|diving|diving
5386615|NCT01782625|cognitive impairment|cognitive impairment
5386616|NCT01782625|nitrogen narcosis|nitrogen narcosis
5386617|NCT01782625|narcosis|narcosis
5386618|NCT01782625|end tidal carbon dioxide|end tidal carbon dioxide
5386619|NCT01782625|arterial carbon dioxide|arterial carbon dioxide
5386620|NCT01782625|immersion|immersion
5386621|NCT01782612|Balanced Anesthesia|balanced anesthesia
5386622|NCT01782612|Nerve Block|nerve block
5386623|NCT01782612|Postoperative Recovery|postoperative recovery
5386624|NCT01782612|Delirium|delirium
5386625|NCT01782612|Postoperative Complications|postoperative complications
5517057|NCT01221610|SFA|sfa
5386627|NCT01782612|Inflammation|inflammation
5386628|NCT01782586|kidney transplant|kidney transplant
5386629|NCT01782586|gene expression markers|gene expression markers
5386630|NCT01782586|renal allograft function|renal allograft function
5386631|NCT01782573|pre - disinfection scrubbing solution|pre - disinfection scrubbing solution
5386632|NCT01782573|surgical site culture|surgical site culture
5386633|NCT01782573|surgical site infection|surgical site infection
5386634|NCT01782573|liver tumors|liver tumors
5386638|NCT01782560|Acid-reflux|acid-reflux
5386639|NCT01782547|diabetes mellitus|diabetes mellitus
5386640|NCT01782547|adolescents|adolescents
5386641|NCT01782521|Bracket failure rate|bracket failure rate
5386642|NCT01782521|Orthodontic bonding|orthodontic bonding
5386644|NCT01782508|melanoma,adjuvant therapy,kit mutated melanoma|melanoma,adjuvant therapy,kit mutated melanoma
5386645|NCT01782495|Hepatitis C Genotype 4|hepatitis c genotype 4
5386646|NCT01782495|Chronic Hepatitis|chronic hepatitis
5386647|NCT01782495|Interferon-Free|interferon-free
5386648|NCT01782495|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5386649|NCT01782495|Renal Transplant|renal transplant
5382087|NCT01803399|IV|iv
5386651|NCT01782495|Hepatitis C Genotype 1|hepatitis c genotype 1
5386652|NCT01782482|Color contact lenses|color contact lenses
5386653|NCT01782482|Refractive error|refractive error
5386655|NCT01782469|Synovitis|synovitis
5386656|NCT01782469|Rheumatoid Arthritis|rheumatoid arthritis
5386657|NCT01782443|Progressive|progressive
5386658|NCT01782443|Metastatic|metastatic
5386659|NCT01782430|Preoxygenation|preoxygenation
5386660|NCT01782430|Intubation|intubation
5386661|NCT01782417|osteoarthritis|osteoarthritis
5386662|NCT01782417|Hispanic|hispanic
5386663|NCT01782417|behavior|behavior
5386664|NCT01782417|intervention|intervention
5386665|NCT01782417|Spanish|spanish
5386666|NCT01782391|mild cognitive impairment|mild cognitive impairment
5386667|NCT01782391|dementia|dementia
5386668|NCT01782391|MCI|mci
5386669|NCT01782391|brain stimulation|brain stimulation
5386670|NCT01782391|tSOS|tsos
5386671|NCT01782391|tDCS|tdcs
5386672|NCT01782391|sleep|sleep
5386673|NCT01782391|memory|memory
5386674|NCT01782391|memory consolidation|memory consolidation
5386675|NCT01782378|Gulf War Veterans Illness|gulf war veterans illness
5386676|NCT01782378|Veterans Health|veterans health
5386677|NCT01782378|Executive Function|executive function
5386678|NCT01782378|Memory|memory
5386679|NCT01782378|Attention|attention
5386680|NCT01782378|Cognition|cognition
5386681|NCT01782378|Laser Therapy, Low-Level|laser therapy, low-level
5386682|NCT01782378|Phototherapy|phototherapy
5386683|NCT01782378|Light Therapy|light therapy
5372414|NCT01847651|Cogstate|cogstate
5386684|NCT01782378|Depression|depression
5386685|NCT01782378|Light-Emitting Diodes|light-emitting diodes
5386686|NCT01782365|mild cognitive impairment|mild cognitive impairment
5386687|NCT01782365|dementia|dementia
5386689|NCT01782365|brain stimulation|brain stimulation
5386690|NCT01782365|tSOS|tsos
5386691|NCT01782365|tDCS|tdcs
5386692|NCT01782365|sleep|sleep
5386693|NCT01782365|nap|nap
5386694|NCT01782365|daytime sleep|daytime sleep
5386695|NCT01782365|memory|memory
5386696|NCT01782365|memory consolidation|memory consolidation
5386697|NCT01782352|age-related macular degeneration|age-related macular degeneration
5386698|NCT01782352|incidence|incidence
5386699|NCT01782352|progression|progression
5386700|NCT01782326|COPD, QVA149, FLAME( EFfect of Indacaterol Glycopyronium Vs Fluticasone salmeterol on COPD Exacerbations)|copd, qva149, flame( effect of indacaterol glycopyronium vs fluticasone salmeterol on copd exacerbations)
5386701|NCT01782287|Neoplasm Metastasis|neoplasm metastasis
5386702|NCT01782287|Brain metastasis|brain metastasis
5386703|NCT01782287|Lung cancer|lung cancer
5386704|NCT01782274|Neoplasm Metastasis|neoplasm metastasis
5386705|NCT01782274|Brain metastasis|brain metastasis
5386706|NCT01782274|Breast cancer|breast cancer
5386707|NCT01782261|autoimmune disease|autoimmune disease
5386708|NCT01782261|diabetes type 1|diabetes type 1
5386709|NCT01782261|incretin effect|incretin effect
5386710|NCT01782222|Parkinson's Disease|parkinson's disease
5386711|NCT01782222|Rotigotine|rotigotine
5386712|NCT01782222|Apathy|apathy
5386713|NCT01782222|Nonmotor|nonmotor
5386714|NCT01782222|Motor|motor
5386715|NCT01782222|Neupro|neupro
5386719|NCT01782183|sore throat|sore throat
5386720|NCT01782183|thermal camera photo|thermal camera photo
5386721|NCT01782183|normal tonsils and pharynx|normal tonsils and pharynx
5386722|NCT01782183|redness of tonsils and/or pharynx|redness of tonsils and/or pharynx
5386723|NCT01782183|exudates on tonsils|exudates on tonsils
5386724|NCT01782183|petechiae of the palate|petechiae of the palate
5386725|NCT01782170|Gingivitis|gingivitis
5386726|NCT01782170|Biomarkers|biomarkers
5386727|NCT01782170|Biological Markers of Inflammation|biological markers of inflammation
5386728|NCT01782157|dementia|dementia
5386729|NCT01782144|Obesity|obesity
5386730|NCT01782144|Foot pain|foot pain
5386731|NCT01782105|weight gain|weight gain
5386732|NCT01782105|healthy lifestyle|healthy lifestyle
5386733|NCT01782105|gestational diabetes|gestational diabetes
5386734|NCT01782105|adipokins|adipokins
5386735|NCT01782105|glycemic regulation|glycemic regulation
5386736|NCT01782092|diabetes|diabetes
5386737|NCT01782079|Lactobacillus brevis|lactobacillus brevis
5386738|NCT01782079|Oral health|oral health
5386739|NCT01782079|Bacterial adhesion|bacterial adhesion
5386740|NCT01782040|Premenstrual syndrome|premenstrual syndrome
5386741|NCT01782040|Physical distress|physical distress
5386742|NCT01782040|Behavioral changes|behavioral changes
5386743|NCT01782027|healthy controls|healthy controls
5386744|NCT01782027|Tangier Disease|tangier disease
5386745|NCT01782027|Adenosine triphosphate-binding cassette transporter 1 (ABCA1)|adenosine triphosphate-binding cassette transporter 1 (abca1)
5386746|NCT01782027|apoA-I|apoa-i
5386747|NCT01782027|LCAT deficiency|lcat deficiency
5386748|NCT01782027|Scavenger receptor BI (SRBI) deficiency|scavenger receptor bi (srbi) deficiency
5386749|NCT01782027|CETP deficiency|cetp deficiency
5386750|NCT01782014|Screening colonoscopy|screening colonoscopy
5386751|NCT01782014|Water method|water method
5386752|NCT01782014|Carbon dioxide method|carbon dioxide method
5386753|NCT01782014|Air method|air method
5386754|NCT01782014|Water versus carbon dioxide versus air insufflation colonoscopy|water versus carbon dioxide versus air insufflation colonoscopy
5386755|NCT01782014|Adenoma Detection Rate|adenoma detection rate
5386756|NCT01782014|Pain Scores in colonoscopy|pain scores in colonoscopy
5386757|NCT01782001|Vitamin A|vitamin a
5386758|NCT01782001|Zinc|zinc
5386759|NCT01782001|Malaria|malaria
5386760|NCT01782001|Morbidity|morbidity
5386761|NCT01782001|MRDR|mrdr
5386762|NCT01781988|lung cancer|lung cancer
5386763|NCT01781988|gemcitabine|gemcitabine
5386764|NCT01781988|carboplatin|carboplatin
5386765|NCT01781988|pemetrexed|pemetrexed
5386766|NCT01781949|HIV infection|hiv infection
5386767|NCT01781949|Targeted screening|targeted screening
5386768|NCT01781949|Nontargeted screening|nontargeted screening
5386769|NCT01781949|Emergency department|emergency department
5386770|NCT01781949|Urgent care|urgent care
5386771|NCT01781949|Effectiveness|effectiveness
5386772|NCT01781923|Cognitive remediation|cognitive remediation
5386773|NCT01781923|Social Cognition|social cognition
5386774|NCT01781910|branched chain amino acids, exercise, delayed onset muscle soreness|branched chain amino acids, exercise, delayed onset muscle soreness
5386775|NCT01781897|acupuncture|acupuncture
5386776|NCT01781897|electro-acupuncture|electro-acupuncture
5386777|NCT01781871|Pneumococcal vaccination|pneumococcal vaccination
5386778|NCT01781871|immunogenicity|immunogenicity
5386779|NCT01781871|solid organ transplant|solid organ transplant
5386780|NCT01781858|Pulmonary embolism|pulmonary embolism
5386781|NCT01781858|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5386782|NCT01781858|Venous thromboembolism|venous thromboembolism
5386783|NCT01781793|dyspnea, exercise endurance, lung disease|dyspnea, exercise endurance, lung disease
5386784|NCT01781780|Obesity|obesity
5386785|NCT01781780|Weight Loss|weight loss
5386786|NCT01781780|Breakfast|breakfast
5386787|NCT01781767|UCP2|ucp2
5386788|NCT01781767|Thyroid function|thyroid function
5386789|NCT01781767|Thyroid carcinoma|thyroid carcinoma
5386790|NCT01781754|Glycemic control|glycemic control
5386791|NCT01781754|Metabolic control|metabolic control
5386792|NCT01781754|Oxidative stress|oxidative stress
5386793|NCT01781754|Diabetes|diabetes
5386794|NCT01781728|recurrent|recurrent
5386795|NCT01781728|unresectable|unresectable
5386796|NCT01781728|residual|residual
5386797|NCT01781728|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5386798|NCT01781728|palliative management|palliative management
5386799|NCT01781715|STEMI, Multivessel Coronary Artery Disease, Primary PCI, multivessel stenting, zotarolimus-eluting stent|stemi, multivessel coronary artery disease, primary pci, multivessel stenting, zotarolimus-eluting stent
5386800|NCT01781689|cortical activation|cortical activation
5386801|NCT01781689|motor function|motor function
5386802|NCT01781689|activity of daily living|activity of daily living
5386803|NCT01781650|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
5386804|NCT01781650|Water Immersion colonoscopy|water immersion colonoscopy
5386805|NCT01781650|Water Exchange colonoscopy|water exchange colonoscopy
5386806|NCT01781650|Painless unsedated colonoscopy|painless unsedated colonoscopy
5386807|NCT01781650|Adenoma detection rate|adenoma detection rate
5386808|NCT01781650|Adenoma resection rate|adenoma resection rate
5386809|NCT01781637|Xolair|xolair
5386810|NCT01781637|omalizumab|omalizumab
5386811|NCT01781637|peanut|peanut
5386812|NCT01781637|oral desensitization|oral desensitization
5386813|NCT01781611|lupus|lupus
5386814|NCT01781611|dipyridamole|dipyridamole
5386815|NCT01781598|Total knee arthroplasty|total knee arthroplasty
5386816|NCT01781598|Patient specific instruments|patient specific instruments
5386817|NCT01781598|Patient matched cutting blocks|patient matched cutting blocks
5386818|NCT01781598|Alignment|alignment
5386819|NCT01781598|Learning curve|learning curve
5386820|NCT01781598|VISIONAIRE|visionaire
5386821|NCT01781585|Sustained low-efficiency dialysis;|sustained low-efficiency dialysis;
5671956|NCT00613496|TNF-α|tnf-α
5386822|NCT01781585|Continuous venovenous hemofiltration;|continuous venovenous hemofiltration;
5386823|NCT01781585|hemodynamic stability,|hemodynamic stability,
5386824|NCT01781585|Intracranial pressure|intracranial pressure
5386825|NCT01781546|drug eluting balloon|drug eluting balloon
5386826|NCT01781546|bare metal stent|bare metal stent
5386827|NCT01781546|coronary artery disease|coronary artery disease
5386828|NCT01781546|acute coronary syndrome|acute coronary syndrome
5386829|NCT01781546|percutaneous coronary intervention|percutaneous coronary intervention
5386830|NCT01781546|DEB|deb
5386831|NCT01781546|BMS|bms
5386832|NCT01781520|Pancreatic Cancer|pancreatic cancer
5386833|NCT01781520|S1|s1
5386834|NCT01781520|DC-CIK|dc-cik
5386835|NCT01781507|Asthma|asthma
5386836|NCT01781507|Allergic rhinitis|allergic rhinitis
5386837|NCT01781507|Cetirizine|cetirizine
5386838|NCT01781507|Impulse oscillometry|impulse oscillometry
5386839|NCT01781481|Psychosocial Stress and Adjustment|psychosocial stress and adjustment
5386840|NCT01781481|Pediatric Chronic Illness|pediatric chronic illness
5386841|NCT01781481|Decision-support tool|decision-support tool
5386842|NCT01781481|Integrated Health Care|integrated health care
5386843|NCT01781481|Case Complexity|case complexity
5386844|NCT01781442|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5386845|NCT01781416|cardiovascular risk|cardiovascular risk
5386847|NCT01781416|cardiovascular primary prevention|cardiovascular primary prevention
5386848|NCT01781416|risk factors|risk factors
5386849|NCT01781403|Temozolomide|temozolomide
5386850|NCT01781403|capecitabine|capecitabine
5386851|NCT01781403|rectal cancer|rectal cancer
5386852|NCT01781390|Acute Myocardial Infarction|acute myocardial infarction
5386853|NCT01781390|STEMI|stemi
5386854|NCT01781390|Heart Attack|heart attack
5386855|NCT01781390|AMI|ami
5386856|NCT01781390|Stem Cells|stem cells
5386857|NCT01781377|NAUSEA|nausea
5386858|NCT01781377|VOMITING|vomiting
5386859|NCT01781377|CESAREAN SECTION|cesarean section
5386860|NCT01781377|PREVENTION|prevention
5386861|NCT01781377|PROPOFOL|propofol
5386862|NCT01781364|Brain Oscillations|brain oscillations
5386863|NCT01781364|Cognitive Performance|cognitive performance
5386864|NCT01781325|musculoskeletal, physical therapy|musculoskeletal, physical therapy
5386865|NCT01781299|Breast Cancer|breast cancer
5386866|NCT01781299|Mastectomy|mastectomy
5386867|NCT01781299|Immediate reconstruction|immediate reconstruction
5386868|NCT01781286|Obesity|obesity
5386869|NCT01781286|Snacking|snacking
5386870|NCT01781286|Appetite|appetite
5386871|NCT01781286|Protein|protein
5386872|NCT01781286|Soy|soy
5386873|NCT01781286|Reward driven eating|reward driven eating
5386874|NCT01781286|Satiety|satiety
5386875|NCT01781273|impaired driving|impaired driving
5386876|NCT01781260|Prone position|prone position
5386877|NCT01781260|Cardiac output|cardiac output
5386878|NCT01781260|Liver Circulation|liver circulation
5386879|NCT01781247|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5386880|NCT01781247|Myocardial Infarction|myocardial infarction
5386881|NCT01781247|Psychotherapy|psychotherapy
5386882|NCT01781247|Preventive Therapy|preventive therapy
5386883|NCT01781247|Randomized Controlled Trial|randomized controlled trial
5386884|NCT01781247|Cardiovascular Diseases|cardiovascular diseases
5386885|NCT01781247|Psychological Stress|psychological stress
5386886|NCT01781247|Biomarkers|biomarkers
5386887|NCT01781195|Advagraf|advagraf
5386888|NCT01781195|MELD-score|meld-score
5386889|NCT01781195|Na-MELD-score|na-meld-score
5386890|NCT01781195|liver function|liver function
5386891|NCT01781195|LiMAx-test|limax-test
5386892|NCT01781195|infection rate|infection rate
5386893|NCT01781195|HLA-DR status|hla-dr status
5386894|NCT01781195|immunostatus|immunostatus
5386895|NCT01781169|Vitamin D,|vitamin d,
5386896|NCT01781169|Oral supplementation,|oral supplementation,
5386897|NCT01781169|Obese males|obese males
5386898|NCT01781156|phosphorus|phosphorus
5386899|NCT01781156|hemodialysis|hemodialysis
5386900|NCT01781156|cardiac biomarkers|cardiac biomarkers
5386901|NCT01781117|Benign prostatic obstruction (BPO)|benign prostatic obstruction (bpo)
5386902|NCT01781117|Detrusor overactivity (DO)|detrusor overactivity (do)
5386903|NCT01781117|Urinary nerve growth factor (NGF)|urinary nerve growth factor (ngf)
5386904|NCT01781104|constipation gastric emptying gastrointestinal motility ghrelin|constipation gastric emptying gastrointestinal motility ghrelin
5386905|NCT01781078|Single chamber pacing|single chamber pacing
5386906|NCT01781078|Dual chamber pacing|dual chamber pacing
5386907|NCT01781078|MRI|mri
5386908|NCT01781078|MR scans|mr scans
5386909|NCT01781052|Iloprost Compliance|iloprost compliance
5386910|NCT01781039|"hair cell"|"hair cell"
5386911|NCT01781039|"hearing aid"|"hearing aid"
5386912|NCT01781039|"hearing loss"|"hearing loss"
5386913|NCT01781039|"auditory nerve"|"auditory nerve"
5386914|NCT01781039|synaptopathy|synaptopathy
5386915|NCT01781026|B-raf V600E|b-raf v600e
5386916|NCT01781026|V600K mutation|v600k mutation
5386917|NCT01781026|metastatic melanoma|metastatic melanoma
5386918|NCT01781013|Depression screening|depression screening
5386919|NCT01781013|Depression monitoring|depression monitoring
5390529|NCT01765283|CN,|cn,
5386920|NCT01781013|Chronic illness|chronic illness
5386921|NCT01781013|Behavioral health|behavioral health
5386922|NCT01781013|Care management|care management
5386923|NCT01781013|Automatic telephone assessment|automatic telephone assessment
5386924|NCT01781013|Clinical decision support|clinical decision support
5386925|NCT01781013|Suicide alert|suicide alert
5386926|NCT01781000|Cognitive Training|cognitive training
5386927|NCT01781000|Neuroplasticity|neuroplasticity
5386929|NCT01781000|MATRICS|matrics
5386930|NCT01780987|DVT|dvt
5386932|NCT01780987|VTE|vte
5386933|NCT01780974|Hypertension|hypertension
5386934|NCT01780974|Vascular Risk|vascular risk
5386935|NCT01780974|Alzheimer's Risk|alzheimer's risk
5386936|NCT01780974|fish oil|fish oil
5386937|NCT01780974|Lipoic acid|lipoic acid
5386938|NCT01780961|Esophageal Cancer|esophageal cancer
5386939|NCT01780961|ESBX|esbx
5386940|NCT01780948|Drug Interaction|drug interaction
5386941|NCT01780948|Pharmacokinetics|pharmacokinetics
5386942|NCT01780948|Everolimus|everolimus
5386943|NCT01780948|Atorvastatin|atorvastatin
5386944|NCT01780922|Inflammation|inflammation
5386945|NCT01780922|Oxidative Stress|oxidative stress
5386946|NCT01780922|Vaccinium macrocarpon|vaccinium macrocarpon
5386947|NCT01780896|Topographical Memory|topographical memory
5386948|NCT01780896|Non-Topographical Memory|non-topographical memory
5386949|NCT01780896|Vestibular Function|vestibular function
5386950|NCT01780896|Alzheimer's Disease|alzheimer's disease
5386951|NCT01780883|melatonin|melatonin
5386952|NCT01780883|childhood autism|childhood autism
5386953|NCT01780883|6-Sulphatoxymelatonin|6-sulphatoxymelatonin
5386954|NCT01780883|autistic disorder|autistic disorder
5386955|NCT01780883|dose-effect relation|dose-effect relation
5386956|NCT01780870|Overweight|overweight
5386958|NCT01780870|Obese|obese
5386959|NCT01780870|Weight loss|weight loss
5386960|NCT01780857|palmoplantar pustulosis|palmoplantar pustulosis
5386961|NCT01780857|psoriasis|psoriasis
5386962|NCT01780844|Kidney Transplantation|kidney transplantation
5386963|NCT01780844|de novo Kidney Transplantation|de novo kidney transplantation
5386964|NCT01780844|ASKP1240|askp1240
5386965|NCT01780818|Warm Water Infusion colonoscopy|warm water infusion colonoscopy
5386966|NCT01780818|Water Immersion colonoscopy|water immersion colonoscopy
5386967|NCT01780818|Water Exchange colonoscopy|water exchange colonoscopy
5386968|NCT01780818|Painless unsedated colonoscopy|painless unsedated colonoscopy
5386969|NCT01780818|Adenoma detection rate|adenoma detection rate
5386970|NCT01780818|Adenoma resection rate|adenoma resection rate
5386971|NCT01780792|multiple sclerosis|multiple sclerosis
5386972|NCT01780792|mobility|mobility
5386973|NCT01780792|cognition|cognition
5386974|NCT01780792|neuroplasticity|neuroplasticity
5386975|NCT01780792|videogame play|videogame play
5386976|NCT01780779|Diffusion weighted MRI|diffusion weighted mri
5386977|NCT01780779|Patient outcome assessment|patient outcome assessment
5386978|NCT01780779|Treatment response|treatment response
5386979|NCT01780779|Histopathology|histopathology
5386980|NCT01780766|Whole body MRI|whole body mri
5386981|NCT01780766|Multiple myeloma|multiple myeloma
5386982|NCT01780766|Diffusion Weighted MRI|diffusion weighted mri
5386983|NCT01780766|Whole body scan|whole body scan
5386984|NCT01780753|Primaquine|primaquine
5386985|NCT01780753|Vivax malaria|vivax malaria
5386986|NCT01780753|G6PD|g6pd
5386987|NCT01780740|Bypass Surgery, Coronary Artery|bypass surgery, coronary artery
5386988|NCT01780740|Atrial fibrillation|atrial fibrillation
5386989|NCT01780740|Ischaemia-reperfusion injury|ischaemia-reperfusion injury
5386990|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5386991|NCT01780740|Statins, HMG-CoA|statins, hmg-coa
5386992|NCT01780727|echocardiography|echocardiography
5386993|NCT01780727|hemodynamic management|hemodynamic management
5386994|NCT01780714|smoking|smoking
5386995|NCT01780714|cigarette|cigarette
5386996|NCT01780714|exposure|exposure
5386997|NCT01780714|biomarker|biomarker
5386998|NCT01780714|human smoking topography (HST)|human smoking topography (hst)
5386999|NCT01780714|modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
5387000|NCT01780714|THS 2.1|ths 2.1
5387001|NCT01780701|prostate cancer aggressiveness|prostate cancer aggressiveness
5387002|NCT01780701|magnetic resonance imaging|magnetic resonance imaging
5387003|NCT01780701|fatty acid synthase|fatty acid synthase
5387004|NCT01780688|Modified risk tobacco product (MRTP)|modified risk tobacco product (mrtp)
5387005|NCT01780688|Smoking|smoking
5387006|NCT01780688|Nicotine profile|nicotine profile
5387007|NCT01780675|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5387008|NCT01780675|Hippocampal Avoidance Prophylactic Cranial Irradiation|hippocampal avoidance prophylactic cranial irradiation
5387009|NCT01780649|IMSI|imsi
5387010|NCT01780649|ICSI|icsi
5387011|NCT01780649|ART Assisted reproductive technology|art assisted reproductive technology
5387012|NCT01780649|Spermatozoa|spermatozoa
5387013|NCT01780649|male infertility|male infertility
5387014|NCT01780649|vacuoles|vacuoles
5387015|NCT01780636|Non relaxing puborectalis syndrome|non relaxing puborectalis syndrome
5387016|NCT01780636|Botulinum toxin A|botulinum toxin a
5517556|NCT01219517|IVF|ivf
5370315|NCT01856309|Sirukumab|sirukumab
5387024|NCT01780610|endometrium preparation protocols|endometrium preparation protocols
5387025|NCT01780610|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5387026|NCT01780610|irregular cycle|irregular cycle
5387027|NCT01780610|randomized controlled trial|randomized controlled trial
5387028|NCT01780597|Heart transplantation|heart transplantation
5387039|NCT01780558|hormone replacement therapy cycles|hormone replacement therapy cycles
5387040|NCT01780558|randomized controlled trial|randomized controlled trial
5387041|NCT01780545|OGX-427|ogx-427
5387042|NCT01780545|Docetaxel|docetaxel
5387043|NCT01780519|Alzheimer's disease (AD)|alzheimer's disease (ad)
5387044|NCT01780506|HIV|hiv
5387045|NCT01780506|Treatment Naive|treatment naive
5387046|NCT01780506|HIV 1 Infected|hiv 1 infected
5387047|NCT01780506|Female|female
5387048|NCT01780506|Women|women
5387049|NCT01780493|Nipple|nipple
5387050|NCT01780493|Technique|technique
5387051|NCT01780493|Ureter|ureter
5387052|NCT01780493|Vesicoureteral Reflux|vesicoureteral reflux
5387053|NCT01780480|Ischemic Stroke|ischemic stroke
5387054|NCT01780480|Convalescence|convalescence
5387055|NCT01780480|Randomized Controlled Trial|randomized controlled trial
5387056|NCT01780480|Pilot Study|pilot study
5387057|NCT01780480|Traditional Chinese Medicine|traditional chinese medicine
5387058|NCT01780467|Loss aversion|loss aversion
5387061|NCT01780454|End Stage Renal Disease|end stage renal disease
5387062|NCT01780454|Renal Transplant|renal transplant
5387063|NCT01780454|Bone Marrow Transplant|bone marrow transplant
5387064|NCT01780454|Tolerance|tolerance
5387065|NCT01780454|Chimerism|chimerism
5387067|NCT01780441|Tuberous Sclerosis Complex|tuberous sclerosis complex
5387069|NCT01780441|Autism|autism
5387070|NCT01780441|ASD|asd
5387071|NCT01780441|Biomarkers|biomarkers
5387072|NCT01780441|Infants|infants
5387073|NCT01780428|Pain|pain
5387074|NCT01780428|Nausea|nausea
5387075|NCT01780428|Vomiting|vomiting
5387076|NCT01780415|Blastocoele fluid|blastocoele fluid
5387077|NCT01780415|Human DNA|human dna
5387078|NCT01780415|molecular diagnosis|molecular diagnosis
5387079|NCT01780402|feeding difficulty|feeding difficulty
5387080|NCT01780402|eating difficulty|eating difficulty
5387081|NCT01780402|dementia|dementia
5387082|NCT01780402|nursing home|nursing home
5387083|NCT01780402|careful hand feeding|careful hand feeding
5387084|NCT01780389|Knee|knee
5387085|NCT01780389|Pain|pain
5387086|NCT01780389|Osteoarthritis|osteoarthritis
5387087|NCT01780376|whole-body vibration|whole-body vibration
5387088|NCT01780376|latency|latency
5387089|NCT01780376|reflex response|reflex response
5387090|NCT01780376|muscle|muscle
5387091|NCT01780337|Oxytocin|oxytocin
5387092|NCT01780337|Arrhythmia|arrhythmia
5387093|NCT01780298|COPD|copd
5387094|NCT01780298|Biomarkers|biomarkers
5387095|NCT01780298|Cigarette Smoke|cigarette smoke
5387096|NCT01780298|Lung Inflammation|lung inflammation
5387097|NCT01780298|FEV|fev
5387098|NCT01780298|Sputum|sputum
5387099|NCT01780285|Hiatal hernia|hiatal hernia
5387100|NCT01780285|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5387101|NCT01780285|Laparoscopic hiatal repair|laparoscopic hiatal repair
5387102|NCT01780285|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
5387103|NCT01780285|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
5387104|NCT01780285|Polytetrafluoroethylene|polytetrafluoroethylene
5387105|NCT01780285|PTFE|ptfe
5387106|NCT01780285|Nitinol|nitinol
5387107|NCT01780285|Nitinol-framed lightweight PTFE mesh|nitinol-framed lightweight ptfe mesh
5387108|NCT01780259|Healthy|healthy
5387109|NCT01780259|Esketamine|esketamine
5387110|NCT01780259|Pharmacokinetics|pharmacokinetics
5387111|NCT01780259|Intranasal|intranasal
5387112|NCT01780246|Spinal Muscular Atrophy|spinal muscular atrophy
5387113|NCT01780246|SMA|sma
5387114|NCT01780246|SMN|smn
5387115|NCT01780246|SMNRx|smnrx
5387116|NCT01780246|ISIS-SMNRx|isis-smnrx
5387117|NCT01780246|ISIS 396443|isis 396443
5387118|NCT01780220|abiraterone|abiraterone
5387119|NCT01780220|biochemically-relapsing|biochemically-relapsing
5387120|NCT01780220|prostate adenocarcinoma|prostate adenocarcinoma
5387121|NCT01780181|lung cancer|lung cancer
5387122|NCT01780181|traditional Chinese medicine|traditional chinese medicine
5387141|NCT01780116|cost-effectiveness|cost-effectiveness
5387142|NCT01780090|autism|autism
5387143|NCT01780090|prosody|prosody
5387144|NCT01780090|speech|speech
5387145|NCT01780090|autism spectrum disorder|autism spectrum disorder
5387146|NCT01780077|Scar|scar
5387147|NCT01780077|Scar prevention|scar prevention
5387148|NCT01780077|Fibrosis|fibrosis
5387149|NCT01780051|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5387150|NCT01780051|Pharmacokinetics|pharmacokinetics
5387151|NCT01780038|Cigarette Smoking|cigarette smoking
5387152|NCT01780038|Nicotine Dependence|nicotine dependence
5387153|NCT01780038|Smoking Abstinence|smoking abstinence
5387154|NCT01780038|Health Literacy|health literacy
5387155|NCT01780038|Genetic Predisposition Testing|genetic predisposition testing
5387156|NCT01780038|Heredity|heredity
5387158|NCT01780025|Thresholds|thresholds
5387159|NCT01780025|Coupling to the inner ear|coupling to the inner ear
5387160|NCT01780012|osteoporosis|osteoporosis
5387161|NCT01780012|fragility fracture|fragility fracture
5387162|NCT01780012|secondary prevention|secondary prevention
5387163|NCT01779999|central venous catheters|central venous catheters
5387164|NCT01779999|thrombosis|thrombosis
5387165|NCT01779999|secondary prevention|secondary prevention
5387166|NCT01779973|Skype|skype
5387167|NCT01779973|compliance|compliance
5387168|NCT01779973|remote dosing|remote dosing
5387169|NCT01779973|suboxone|suboxone
5387170|NCT01779973|opiate|opiate
5387171|NCT01779973|opiates|opiates
5387172|NCT01779973|heroin|heroin
5387173|NCT01779973|oxycontin|oxycontin
5387174|NCT01779973|Philadelphia|philadelphia
5387175|NCT01779960|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5387176|NCT01779960|Motor activity|motor activity
5387177|NCT01779960|Climatologic station|climatologic station
5387178|NCT01779908|Vitamin D supplementation|vitamin d supplementation
5387179|NCT01779908|Insulin resistance|insulin resistance
5387180|NCT01779895|Dust mite|dust mite
5387181|NCT01779895|Perennial allergic rhinitis|perennial allergic rhinitis
5387182|NCT01779869|PET MR myocardial perfusion imaging|pet mr myocardial perfusion imaging
5387183|NCT01779856|End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM|end stage renal disease, hemodialysis, arrhythmia, reveal icm
5387184|NCT01779843|Newly diagnosed|newly diagnosed
5387185|NCT01779804|foot , ankle, injury|foot , ankle, injury
5387186|NCT01779791|Lymphoma|lymphoma
5387187|NCT01779791|Refractory follicular lymphoma|refractory follicular lymphoma
5387188|NCT01779791|Chemoimmunotherapy-resistant follicular lymphoma|chemoimmunotherapy-resistant follicular lymphoma
5387189|NCT01779791|PCI-32765|pci-32765
5387190|NCT01779791|Ibrutinib|ibrutinib
5387191|NCT01779791|IMBRUVICA|imbruvica
5387193|NCT01779765|Diarrhea|diarrhea
5387194|NCT01779765|Constipation|constipation
5387195|NCT01779765|Fibers|fibers
5387196|NCT01779739|vaginal prolapse|vaginal prolapse
5387197|NCT01779739|sexual function|sexual function
5387198|NCT01779739|sexual dysfunction|sexual dysfunction
5387199|NCT01779739|prolapse surgery|prolapse surgery
5387200|NCT01779726|Organization|organization
5387201|NCT01779726|of fast track|of fast track
5387202|NCT01779713|Aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5387203|NCT01779713|Vasospasm|vasospasm
5387204|NCT01779713|Transcriptomic|transcriptomic
5387205|NCT01779713|Case-Control Study|case-control study
5387207|NCT01779700|schizophrenia|schizophrenia
5387208|NCT01779700|cognition|cognition
5387209|NCT01779700|fingolimod|fingolimod
5387210|NCT01779687|pharmacokinetic|pharmacokinetic
5387211|NCT01779687|interaction|interaction
5387212|NCT01779687|cholesterol|cholesterol
5387213|NCT01779687|raltegravir|raltegravir
5387214|NCT01779687|atorvastatin|atorvastatin
5387215|NCT01779661|Neurodevelopment, Infant-Aquatics, Prematurity|neurodevelopment, infant-aquatics, prematurity
5387216|NCT01779648|deep vein thrombosis|deep vein thrombosis
5387217|NCT01779648|intermittent pneumatic compression|intermittent pneumatic compression
5387218|NCT01779648|venous hemodynamics|venous hemodynamics
5387219|NCT01779635|Heparin-grafted membrane|heparin-grafted membrane
5387220|NCT01779635|Circuit lifespan|circuit lifespan
5387221|NCT01779635|Continuous renal replacement therapy|continuous renal replacement therapy
5387222|NCT01779635|Anticoagulation free|anticoagulation free
5387223|NCT01779635|Bleeding risk|bleeding risk
5387224|NCT01779635|Acute kidney injury|acute kidney injury
5387225|NCT01779635|Critical illness|critical illness
5387226|NCT01779622|mixed meal¨|mixed meal¨
5387227|NCT01779622|insulin|insulin
5387228|NCT01779622|glucagon|glucagon
5387229|NCT01779622|GIP|gip
5387230|NCT01779622|GLP-1|glp-1
5387231|NCT01779596|diabetes|diabetes
5387232|NCT01779596|endothelial function|endothelial function
5387233|NCT01779596|exercise|exercise
5387234|NCT01779596|blood flow|blood flow
5387235|NCT01779596|bosentan|bosentan
5387236|NCT01779583|Advanced gastric cancer|advanced gastric cancer
5387237|NCT01779570|Influenza|influenza
5387238|NCT01779570|Macrolide|macrolide
5387239|NCT01779570|Anti-inflammatory|anti-inflammatory
5387240|NCT01779557|CAPD|capd
5387241|NCT01779557|efficacy|efficacy
5387242|NCT01779557|safety|safety
5387243|NCT01779557|survival rate|survival rate
5423338|NCT01616095|hrGH therapy|hrgh therapy
5390821|NCT01763892|TBI|tbi
5387244|NCT01779544|rehabilitation,surgery,brief intervention, exercises|rehabilitation,surgery,brief intervention, exercises
5387245|NCT01779531|HER2-negative Luminal B breast cancer|her2-negative luminal b breast cancer
5387247|NCT01779518|Sustained Virologic Response|sustained virologic response
5517794|NCT01218256|T2DM|t2dm
5387248|NCT01779518|Direct Acting Antiviral|direct acting antiviral
5387249|NCT01779518|GS-7977|gs-7977
5387250|NCT01779518|Pegylated interferon|pegylated interferon
5387251|NCT01779518|Ribavirin|ribavirin
5387252|NCT01779518|Open Label|open label
5387253|NCT01779518|Sofosbuvir|sofosbuvir
5387254|NCT01779518|Liver transplant|liver transplant
5387255|NCT01779518|Hepatitis|hepatitis
5387256|NCT01779518|Hepatitis, Chronic|hepatitis, chronic
5387257|NCT01779518|Hepatitis C|hepatitis c
5387258|NCT01779518|Hepatitis C, Chronic|hepatitis c, chronic
5387259|NCT01779518|Liver Diseases|liver diseases
5387260|NCT01779518|Digestive System Diseases|digestive system diseases
5387261|NCT01779518|Hepatitis, Viral, Human|hepatitis, viral, human
5387262|NCT01779518|Virus Diseases|virus diseases
5387263|NCT01779518|Enterovirus Infections|enterovirus infections
5387264|NCT01779518|Picornaviridae Infections|picornaviridae infections
5387265|NCT01779518|RNA Virus Infections|rna virus infections
5387266|NCT01779518|Flaviviridae Infections|flaviviridae infections
5387267|NCT01779518|Antiviral Agents|antiviral agents
5387268|NCT01779518|Anti-Infective Agents|anti-infective agents
5387269|NCT01779518|Therapeutic Uses|therapeutic uses
5387270|NCT01779518|Pharmacologic Actions|pharmacologic actions
5387271|NCT01779518|Antimetabolites|antimetabolites
5387272|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5387273|NCT01779492|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
5387274|NCT01779479|German Breast Group|german breast group
5387275|NCT01779479|GBG Forschungs GmbH|gbg forschungs gmbh
5387276|NCT01779479|GBG|gbg
5387277|NCT01779479|GBG 74|gbg 74
5387280|NCT01779479|Primary Breast Cancer|primary breast cancer
5387282|NCT01779479|Paclitaxel|paclitaxel
5387283|NCT01779479|neo-adjuvant|neo-adjuvant
5387284|NCT01779479|triple negative|triple negative
5387285|NCT01779479|luminal B|luminal b
5387286|NCT01779453|Atorvastatin|atorvastatin
5387287|NCT01779453|Drug-drug interaction|drug-drug interaction
5387288|NCT01779453|Combination therapy|combination therapy
5387289|NCT01779440|Mental Illness|mental illness
5387290|NCT01779440|Tobacco Smoking|tobacco smoking
5387291|NCT01779440|Young Adults|young adults
5387292|NCT01779440|Treatment Engagement|treatment engagement
5387293|NCT01779440|Motivational Intervention|motivational intervention
5387294|NCT01779427|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5387295|NCT01779427|intracranial edema|intracranial edema
5387296|NCT01779427|brain edema|brain edema
5387297|NCT01779427|craniocerebral trauma|craniocerebral trauma
5387298|NCT01779427|head injury|head injury
5387299|NCT01779427|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5387300|NCT01779427|subdural hematoma|subdural hematoma
5387301|NCT01779427|brain concussion|brain concussion
5387302|NCT01779427|head injuries, closed|head injuries, closed
5387303|NCT01779427|epidural hematoma|epidural hematoma
5387304|NCT01779427|extra-axial hemorrhage|extra-axial hemorrhage
5387305|NCT01779427|cortical contusion|cortical contusion
5387306|NCT01779427|wounds and injuries|wounds and injuries
5387307|NCT01779427|disorders of environmental origin|disorders of environmental origin
5387308|NCT01779427|trauma, nervous system|trauma, nervous system
5387309|NCT01779427|brain injuries|brain injuries
5387310|NCT01779427|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5387311|NCT01779427|attention|attention
5387312|NCT01779414|Suicide Ideation|suicide ideation
5387313|NCT01779401|PCI|pci
5387314|NCT01779401|platelet function monitoring|platelet function monitoring
5387315|NCT01779401|Thrombelastography|thrombelastography
5387316|NCT01779401|clopidogrel|clopidogrel
5387317|NCT01779401|cilostazol|cilostazol
5387318|NCT01779401|in-stent thrombosis|in-stent thrombosis
5387319|NCT01779388|Lung nodule|lung nodule
5387320|NCT01779388|PET scanner|pet scanner
5002915|NCT03977857|Acute-on-Chronic liver failure|acute-on-chronic liver failure
5387321|NCT01779388|Bronchoscopy|bronchoscopy
5387322|NCT01779388|Electromagnetic navigation|electromagnetic navigation
5387323|NCT01779375|Children|children
5387324|NCT01779375|Pediatric|pediatric
5387325|NCT01779349|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5387326|NCT01779349|acoustic vibration|acoustic vibration
5387327|NCT01779336|Advanced Refractory Solid Tumors|advanced refractory solid tumors
5387328|NCT01779323|SUI|sui
5387329|NCT01779323|stress urinary incontinence|stress urinary incontinence
5387330|NCT01779323|male|male
5387331|NCT01779323|transobturator sling|transobturator sling
5387332|NCT01779297|new integrative weaning indexes|new integrative weaning indexes
5387333|NCT01779297|mechanical ventilation|mechanical ventilation
5387334|NCT01779297|ICU|icu
5387335|NCT01779284|glaucoma|glaucoma
5387336|NCT01779284|fixed combinations|fixed combinations
5387337|NCT01779284|24-hour monitoring|24-hour monitoring
5387338|NCT01779271|Pelubi|pelubi
5387340|NCT01779271|Loxoprofen|loxoprofen
5387341|NCT01779271|Anti-pyretic|anti-pyretic
5387342|NCT01779271|Fever|fever
5387343|NCT01779258|xerosis|xerosis
5387344|NCT01779258|dry skin|dry skin
5387345|NCT01779258|dermatitis|dermatitis
5387346|NCT01779258|eczema|eczema
5387347|NCT01779258|emollient|emollient
5387348|NCT01779258|corticosteroid|corticosteroid
5387349|NCT01779258|flare|flare
5387350|NCT01779232|endometriosis|endometriosis
5387351|NCT01779232|ivf|ivf
5387352|NCT01779232|ovarian reserve|ovarian reserve
5387353|NCT01779232|danazol|danazol
5387354|NCT01779219|intraoperative magnetic resonance|intraoperative magnetic resonance
5387355|NCT01779219|stereotactic biopsy|stereotactic biopsy
5387356|NCT01779219|brain tumor|brain tumor
5387357|NCT01779219|frameless stereotaxy|frameless stereotaxy
5387358|NCT01779219|image-guided neurosurgery|image-guided neurosurgery
5387359|NCT01779193|group B streptococcus|group b streptococcus
5387360|NCT01779193|pregnancy|pregnancy
5387361|NCT01779193|probiotics|probiotics
5387362|NCT01779180|Vitamin A supplementation|vitamin a supplementation
5387363|NCT01779180|BCG vaccination|bcg vaccination
5387364|NCT01779180|diphtheria-tetanus-pertussis vaccination|diphtheria-tetanus-pertussis vaccination
5387365|NCT01779180|measles vaccination|measles vaccination
5387366|NCT01779180|atopy|atopy
5387367|NCT01779167|WM|wm
5387368|NCT01779154|eosinophilic esophagitis|eosinophilic esophagitis
5387369|NCT01779154|eosinophilic gastritis|eosinophilic gastritis
5387370|NCT01779154|eosinophilic enteritis|eosinophilic enteritis
5387371|NCT01779154|eosinophilic colitis|eosinophilic colitis
5387372|NCT01779141|Type 1 Diabetes Mellitus - T1DM|type 1 diabetes mellitus - t1dm
5387373|NCT01779141|Pregnancy|pregnancy
5387374|NCT01779141|Insulin Pump|insulin pump
5387375|NCT01779141|Glucose Sensor|glucose sensor
5382768|NCT01800266|Children|children
5387376|NCT01779141|Continuous Subcutaneous Insulin Infusion - CSII|continuous subcutaneous insulin infusion - csii
5387377|NCT01779141|Sensor Augmented Pump - SAP|sensor augmented pump - sap
5387378|NCT01779141|Continuous Glucose Monitoring - CGM|continuous glucose monitoring - cgm
5387379|NCT01779115|Registry,Diabetes,Health Maintenance Organization|registry,diabetes,health maintenance organization
5387380|NCT01779089|diabetic nephropathy|diabetic nephropathy
5387381|NCT01779089|diabetic kidney disease|diabetic kidney disease
5387382|NCT01779089|minocycline|minocycline
5387383|NCT01779089|proteinuria|proteinuria
5387384|NCT01779089|albuminuria|albuminuria
5387385|NCT01779063|lymphedema|lymphedema
5387386|NCT01779063|self-care|self-care
5387387|NCT01779063|breast cancer|breast cancer
5387388|NCT01779024|Addiction|addiction
5387389|NCT01779024|Alcohol|alcohol
5387390|NCT01779024|Alcohol Clamp|alcohol clamp
5387391|NCT01778998|incision|incision
5387392|NCT01778998|pre-cut|pre-cut
5387393|NCT01778998|wound architecture|wound architecture
5387394|NCT01778998|OCT|oct
5387395|NCT01778985|Pelvic organ prolapse|pelvic organ prolapse
5387396|NCT01778985|Menopause|menopause
5387397|NCT01778985|Estrogen|estrogen
5387398|NCT01778985|Premarin|premarin
5387399|NCT01778972|Fall prevention|fall prevention
5387400|NCT01778972|Home exercise|home exercise
5387401|NCT01778972|Strength training|strength training
5387402|NCT01778972|Balance training|balance training
5387403|NCT01778946|Nicotine|nicotine
5387404|NCT01778946|Down Syndrome|down syndrome
5387405|NCT01778946|Mild Cognitive Impairment|mild cognitive impairment
5387406|NCT01778946|Event Related Potential|event related potential
5387407|NCT01778946|Memory|memory
5387408|NCT01778946|Attention|attention
5387409|NCT01778946|Trisomy 21|trisomy 21
5387410|NCT01778946|Neuroprotection|neuroprotection
5387411|NCT01778946|Cognitive Enhancement|cognitive enhancement
5387412|NCT01778946|Alzheimer's Disease|alzheimer's disease
5387413|NCT01778946|Dementia|dementia
5387414|NCT01778946|APOE|apoe
5387415|NCT01778933|Renal cell carcinoma|renal cell carcinoma
5387416|NCT01778933|Renal nodules|renal nodules
5387417|NCT01778907|Pharmacogenetics|pharmacogenetics
5387418|NCT01778907|Depression|depression
5387419|NCT01778907|Depressive Disorder|depressive disorder
5387420|NCT01778907|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
5387421|NCT01778907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
5387422|NCT01778907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
5387423|NCT01778907|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant|poor metabolizer due to cytochrome p450 cyp2d6 variant
5387424|NCT01778907|Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 Variant|intermediate metabolizer due to cytochrome p450 cyp2d6 variant
5387425|NCT01778907|Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant|ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
5387426|NCT01778907|Multicenter studies|multicenter studies
5387427|NCT01778894|Diastolic Dysfunction, Diastolic Heart Failure, Diastolic|diastolic dysfunction, diastolic heart failure, diastolic
5387439|NCT01778855|collateral circulation|collateral circulation
5387441|NCT01778855|reperfusion|reperfusion
5387442|NCT01778842|antiplatelet effect|antiplatelet effect
5387443|NCT01778842|prasugrel|prasugrel
5387444|NCT01778842|clopidogrel|clopidogrel
5387445|NCT01778842|acute coronary syndrome|acute coronary syndrome
5387447|NCT01778777|rotator cuff tear arthropathy|rotator cuff tear arthropathy
5387448|NCT01778777|inverse prosthesis|inverse prosthesis
5387449|NCT01778777|safety|safety
5387450|NCT01778777|universe reverse|universe reverse
5387451|NCT01778751|Self-Management Support|self-management support
5387452|NCT01778751|Depression|depression
5387453|NCT01778751|Home Telehealth|home telehealth
5387454|NCT01778725|Chorioamnionitis, S100B, Brain, Neuro-development|chorioamnionitis, s100b, brain, neuro-development
5387455|NCT01778712|Multi-level intervention|multi-level intervention
5387456|NCT01778712|Menopause|menopause
5387457|NCT01778712|Body composition|body composition
5387458|NCT01778712|Abdominal adipose tissue|abdominal adipose tissue
5387459|NCT01778712|Visceral adipose tissue|visceral adipose tissue
5387460|NCT01778712|Perceived stress|perceived stress
5387461|NCT01778712|Computed tomography|computed tomography
5387462|NCT01778712|Dual energy X-ray absorptiometry|dual energy x-ray absorptiometry
5387463|NCT01778699|Lactobacillus brevis CD2|lactobacillus brevis cd2
5387464|NCT01778699|caries incidence|caries incidence
5387465|NCT01778699|plaque-pH|plaque-ph
5387466|NCT01778686|Positron Emission Tomography|positron emission tomography
5387467|NCT01778686|Serotonin|serotonin
5387468|NCT01778686|5-HT2A|5-ht2a
5387469|NCT01778686|Radioligand|radioligand
5387470|NCT01778660|Fecal Incontinence|fecal incontinence
5387471|NCT01778660|Treatment options|treatment options
5387472|NCT01778660|Patient Satisfaction|patient satisfaction
5387473|NCT01778647|ADHD|adhd
5387474|NCT01778647|Omega- 3 Fatty acids|omega- 3 fatty acids
5387475|NCT01778647|CGI|cgi
5387476|NCT01778647|Conners rating scale|conners rating scale
5387477|NCT01778647|Stimulants|stimulants
5387478|NCT01778634|Ureaplasma parvum|ureaplasma parvum
5387479|NCT01778634|Ureaplasma urealyticum|ureaplasma urealyticum
5387480|NCT01778634|prematurity|prematurity
5387481|NCT01778634|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5387482|NCT01778634|azithromycin|azithromycin
5387488|NCT01778595|Feces|feces
5387489|NCT01778595|Cancer Screening|cancer screening
5387490|NCT01778582|Emotion|emotion
5387491|NCT01778582|Informed Consent|informed consent
5387497|NCT01778556|Lipodystrophy|lipodystrophy
5387498|NCT01778556|Leptin|leptin
5387499|NCT01778556|Energy Expenditure|energy expenditure
5387500|NCT01778556|Diabetes|diabetes
5387501|NCT01778556|Hypertriglyceridemia|hypertriglyceridemia
5387505|NCT01778530|Glioblastoma|glioblastoma
5387506|NCT01778530|Anti-Angiogenesis|anti-angiogenesis
5387507|NCT01778530|Radiotherapy|radiotherapy
5387508|NCT01778530|Malignant Glioma|malignant glioma
5387509|NCT01778530|Progression|progression
5387510|NCT01778517|Psychogenic Movement Disorders|psychogenic movement disorders
5387516|NCT01778491|Phenotype-Genotype correlation|phenotype-genotype correlation
5387517|NCT01778491|Phenotype|phenotype
5387518|NCT01778491|Phenotypes|phenotypes
5387519|NCT01778491|Age Related Macular Degeneration|age related macular degeneration
5387520|NCT01778478|Anxiety|anxiety
5387521|NCT01778478|Depression|depression
5387522|NCT01778478|Adolescents and Adults|adolescents and adults
5387523|NCT01778478|Cancer Diagnosis|cancer diagnosis
5387524|NCT01778465|Chronic Rhinosinusitis|chronic rhinosinusitis
5387525|NCT01778465|Aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease
5387526|NCT01778465|Asthma|asthma
5387527|NCT01778465|Aspirin sensitivity|aspirin sensitivity
5387528|NCT01778465|Salicylate|salicylate
5387529|NCT01778452|Endometrial priming, genomic expression. Natural cycle. Antagonist GnRH.|endometrial priming, genomic expression. natural cycle. antagonist gnrh.
5387530|NCT01778439|Phase 1|phase 1
5387531|NCT01778439|Dose escalation|dose escalation
5387532|NCT01778439|relapsed or refractory|relapsed or refractory
5387533|NCT01778439|solid tumor|solid tumor
5387534|NCT01778426|Chronic neuropathic pain syndrome|chronic neuropathic pain syndrome
5387535|NCT01778426|Spinal Cord Stimulation|spinal cord stimulation
5387536|NCT01778426|Painstim devices|painstim devices
5387537|NCT01778426|Efficacy|efficacy
5387538|NCT01778426|Safety|safety
5387539|NCT01778400|Ultrasound|ultrasound
5387540|NCT01778400|Radiofrequency|radiofrequency
5387541|NCT01778400|Ethanol|ethanol
5387542|NCT01778400|Predominantly cystic thyroid nodule|predominantly cystic thyroid nodule
5387543|NCT01778400|Thyroid nodule|thyroid nodule
5387544|NCT01778400|Thyroid|thyroid
5387545|NCT01778374|Emergency Medicine|emergency medicine
5387546|NCT01778374|Screening|screening
5387547|NCT01778374|Point of care testing|point of care testing
5387548|NCT01778374|Video assisted counseling|video assisted counseling
5387549|NCT01778361|Human immunodeficiency virus|human immunodeficiency virus
5387550|NCT01778361|low bone mineral density|low bone mineral density
5387551|NCT01778361|osteopenia|osteopenia
5387552|NCT01778361|osteoporosis|osteoporosis
5387554|NCT01778348|Type 1 diabetes|type 1 diabetes
5387555|NCT01778348|Closed-loop glucose control|closed-loop glucose control
5387556|NCT01778348|Artificial Pancreas|artificial pancreas
5387557|NCT01778348|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5387558|NCT01778348|Continuous glucose monitoring|continuous glucose monitoring
5387559|NCT01778335|recanalization|recanalization
5387560|NCT01778335|endovascular|endovascular
5387561|NCT01778335|thrombectomy|thrombectomy
5387562|NCT01778309|aseptic inflammation|aseptic inflammation
5387563|NCT01778309|skeletal muscle function|skeletal muscle function
5387564|NCT01778309|exercise|exercise
5387565|NCT01778296|Dorsal branch of the digital nerve;|dorsal branch of the digital nerve;
5387566|NCT01778296|dorsal digital artery;|dorsal digital artery;
5387567|NCT01778296|dorsal digital island flap;|dorsal digital island flap;
5387568|NCT01778296|neurocutaneous island flap.|neurocutaneous island flap.
5387569|NCT01778270|pleural effusion|pleural effusion
5387570|NCT01778270|pleural drainage|pleural drainage
5387571|NCT01778270|thorax impedance|thorax impedance
5387572|NCT01778270|respiration parameters|respiration parameters
5387573|NCT01778270|heart sounds analysis|heart sounds analysis
5387574|NCT01778257|Mate extracts|mate extracts
5387575|NCT01778257|Obesity|obesity
5387576|NCT01778257|abdominal fat|abdominal fat
5387577|NCT01778244|schizophrenia; dyslipidemia|schizophrenia; dyslipidemia
5387578|NCT01778231|Focus|focus
5387579|NCT01778231|uptake|uptake
5387580|NCT01778231|Lutein|lutein
5387581|NCT01778231|Zeaxanthin|zeaxanthin
5387582|NCT01778231|individuals|individuals
5387583|NCT01778218|Coronary Artery Disease|coronary artery disease
5387584|NCT01778218|CAD|cad
5387585|NCT01778192|Bowel preparation|bowel preparation
5387586|NCT01778192|Polyethylene glycol|polyethylene glycol
5387587|NCT01778192|Sodium picosulphate|sodium picosulphate
5387588|NCT01778179|Lentigines|lentigines
5387589|NCT01778179|Cryotherapy|cryotherapy
5387590|NCT01778179|hyperpigmentation|hyperpigmentation
5382964|NCT01799447|Early intervention|early intervention
5387591|NCT01778166|Early enteral nutrition|early enteral nutrition
5387592|NCT01778166|Laparoscopic gastrointestinal surgery|laparoscopic gastrointestinal surgery
5387593|NCT01778166|Immuno-enhanced nutrition|immuno-enhanced nutrition
5387594|NCT01778153|Fitness training|fitness training
5387595|NCT01778153|Personal training|personal training
5387596|NCT01778140|Clinical Decision Support Systems|clinical decision support systems
5387597|NCT01778140|Contrast-induced nephropathy|contrast-induced nephropathy
5387598|NCT01778127|Cancer Survivor|cancer survivor
5387599|NCT01778127|Physical Activity|physical activity
5387600|NCT01778127|Health Outcomes|health outcomes
5387601|NCT01778127|Rewards-Based Intervention|rewards-based intervention
5387602|NCT01778127|Cardiovascular Health|cardiovascular health
5387603|NCT01778127|Musculoskeletal Health|musculoskeletal health
5387604|NCT01778127|Exercise|exercise
5387605|NCT01778114|Vitamin D2|vitamin d2
5387606|NCT01778114|Vitamin D3|vitamin d3
5387607|NCT01778114|Vitamin D|vitamin d
5387608|NCT01778114|Orange Juice|orange juice
5387609|NCT01778101|preterm infants|preterm infants
5387611|NCT01778101|impedance|impedance
5387612|NCT01778101|pH|ph
5387613|NCT01778101|monitoring|monitoring
5387614|NCT01778101|lansoprazole|lansoprazole
5387615|NCT01778075|Healthy|healthy
5387616|NCT01778075|Ultracet extended release (ER)|ultracet extended release (er)
5387617|NCT01778075|Tramadol hydrochloride|tramadol hydrochloride
5387618|NCT01778075|Acetaminophen|acetaminophen
5387619|NCT01778075|Bioequivalence|bioequivalence
5387620|NCT01778036|Neck movement|neck movement
5387621|NCT01778036|motor control|motor control
5387622|NCT01778036|disability|disability
5387623|NCT01778036|psychological variables|psychological variables
5387624|NCT01778036|Head Movements|head movements
5387625|NCT01778036|Physical therapy|physical therapy
5387626|NCT01778036|Fear avoidance|fear avoidance
5387627|NCT01778036|Self Efficacy|self efficacy
5387628|NCT01778036|Catastrophizing|catastrophizing
5387629|NCT01778036|Fly test|fly test
5387630|NCT01778036|Postural sway|postural sway
5387632|NCT01778010|modafinil|modafinil
5387633|NCT01778010|self-administration|self-administration
5387634|NCT01778010|DRD4|drd4
5387635|NCT01777906|nasal polyps|nasal polyps
5387636|NCT01777906|nasal steriod sprays|nasal steriod sprays
5387637|NCT01777893|Type-2 diabetes mellitus|type-2 diabetes mellitus
5387638|NCT01777893|Obesity|obesity
5387639|NCT01777893|High protein diet|high protein diet
5387640|NCT01777893|Low GI|low gi
5387641|NCT01777893|Physical activity|physical activity
5387642|NCT01777815|NeoChord|neochord
5387643|NCT01777815|DS1000|ds1000
5387644|NCT01777815|Mitral Valve|mitral valve
5387645|NCT01777815|Mitral Valve Regurgitation|mitral valve regurgitation
5387646|NCT01777815|MR|mr
5387647|NCT01777815|Mitral Valve Repair|mitral valve repair
5387648|NCT01777815|Mitral Valve Prolapse|mitral valve prolapse
5387649|NCT01777815|Artificial Chordae|artificial chordae
5387650|NCT01777789|fMRI|fmri
5387651|NCT01777789|Dementia|dementia
5387652|NCT01777789|Alzheimer's disease|alzheimer's disease
5391216|NCT01762059|insulin|insulin
5387656|NCT01777776|BRAF inhibitor|braf inhibitor
5387658|NCT01777776|CDK4/6|cdk4/6
5387659|NCT01777776|LGX818|lgx818
5387660|NCT01777776|RAF kinase inhibitor|raf kinase inhibitor
5387661|NCT01777776|Metastatic melanoma|metastatic melanoma
5387662|NCT01777776|BRAF|braf
5387663|NCT01777776|V600|v600
5387664|NCT01777750|Myocardial Infarction|myocardial infarction
5387665|NCT01777750|Myocardial Reperfusion Injury|myocardial reperfusion injury
5387666|NCT01777750|Reperfusion Injury|reperfusion injury
5387667|NCT01777750|Anterior Wall Myocardial Infarction|anterior wall myocardial infarction
5387668|NCT01777750|Inferior Wall Myocardial Infarction|inferior wall myocardial infarction
5387669|NCT01777750|Pathologic Processes|pathologic processes
5387670|NCT01777750|Myocardial Ischemia|myocardial ischemia
5387671|NCT01777737|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5387672|NCT01777737|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5387673|NCT01777737|Pneumocystis jiroveci|pneumocystis jiroveci
5387674|NCT01777711|mental contrasting|mental contrasting
5387675|NCT01777711|weight loss|weight loss
5387676|NCT01777711|obese couples|obese couples
5387677|NCT01777711|obesity|obesity
5387678|NCT01777711|overweight|overweight
5387679|NCT01777711|planning|planning
5387680|NCT01777711|health|health
5387681|NCT01777711|diet|diet
5387682|NCT01777711|exercise|exercise
5387683|NCT01777711|physical activity|physical activity
5387684|NCT01777711|goal|goal
5387685|NCT01777711|goal-setting|goal-setting
5387686|NCT01777698|body composition|body composition
5387687|NCT01777698|hepatocellular carcinoma|hepatocellular carcinoma
5387688|NCT01777698|chemoembolization|chemoembolization
5387689|NCT01777685|Sulpiride|sulpiride
5387690|NCT01777685|Therapeutic drug monitoring|therapeutic drug monitoring
5387691|NCT01777685|Pharmacokinetics|pharmacokinetics
5387692|NCT01777659|exercise|exercise
5387693|NCT01777659|neuromodulation|neuromodulation
5387694|NCT01777659|blood flow|blood flow
5387695|NCT01777659|exercise capacity|exercise capacity
5383060|NCT01799044|Feasibility|feasibility
5387697|NCT01777646|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5387698|NCT01777646|Neuroprotection|neuroprotection
5387699|NCT01777646|Neurodegeneration|neurodegeneration
5387700|NCT01777646|Stem cells|stem cells
5387701|NCT01777594|hepatocellular carcinoma|hepatocellular carcinoma
5387702|NCT01777594|HCC|hcc
5387703|NCT01777594|liver|liver
5387704|NCT01777594|liver cancer|liver cancer
5387705|NCT01777594|sorafenib|sorafenib
5387706|NCT01777581|sciatica radiculopathy lumbar disc lumbosacral disc|sciatica radiculopathy lumbar disc lumbosacral disc
5387707|NCT01777555|Parkinson's Disease|parkinson's disease
5387708|NCT01777555|Motor fluctuations|motor fluctuations
5387709|NCT01777555|levodopa|levodopa
5387710|NCT01777555|inhaled drugs|inhaled drugs
5387711|NCT01777555|Off episodes|off episodes
5387712|NCT01777542|Rett syndrome|rett syndrome
5387713|NCT01777542|RTT|rtt
5387714|NCT01777542|IGF-1|igf-1
5387715|NCT01777542|autism spectrum disorder|autism spectrum disorder
5387716|NCT01777529|Measles|measles
5387717|NCT01777529|Mumps|mumps
5387718|NCT01777529|Rubella|rubella
5387719|NCT01777516|Platelet Aggregation|platelet aggregation
5387720|NCT01777516|Cardiovascular Diseases|cardiovascular diseases
5387721|NCT01777516|Salicylic Acid|salicylic acid
5387722|NCT01777503|acute coronary syndrome|acute coronary syndrome
5387724|NCT01777503|percutaneous revascularization|percutaneous revascularization
5387725|NCT01777503|antiaggregant drugs|antiaggregant drugs
5387726|NCT01777490|Caregivers - Not professionals|caregivers - not professionals
5387727|NCT01777490|Frail Elderly|frail elderly
5387728|NCT01777490|Long-term Care|long-term care
5387729|NCT01777490|Quality of Life|quality of life
5387730|NCT01777451|Whole Body Imaging|whole body imaging
5387731|NCT01777451|Magnetic Resonance Imaging|magnetic resonance imaging
5387732|NCT01777451|Neurofibromatosis 1|neurofibromatosis 1
5387733|NCT01777451|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5387734|NCT01777451|Peripheral Nerve Sheath Tumors, Malignant|peripheral nerve sheath tumors, malignant
5387735|NCT01777412|NMO|nmo
5387736|NCT01777412|NMOSD|nmosd
5387737|NCT01777412|NMO-IgG|nmo-igg
5387738|NCT01777412|Aquaporin-4|aquaporin-4
5387739|NCT01777412|AQP4|aqp4
5387740|NCT01777412|anti-AQP4|anti-aqp4
5387741|NCT01777386|scar|scar
5387742|NCT01777386|contracture|contracture
5387743|NCT01777386|perforator flap|perforator flap
5387744|NCT01777386|preexpanded perforator flap|preexpanded perforator flap
5387745|NCT01777386|perforator vessel|perforator vessel
5387746|NCT01777386|artery diameter|artery diameter
5387747|NCT01777373|conducting airway, bronchiolization|conducting airway, bronchiolization
5387748|NCT01777360|severe|severe
5387749|NCT01777360|uncontrolled|uncontrolled
5387750|NCT01777347|Keywords provided by ASSISTANCE PUBLIQUE HOPITAUX DE PARIS:|keywords provided by assistance publique hopitaux de paris:
5387751|NCT01777347|Acute Viral bronchiolitis|acute viral bronchiolitis
5387752|NCT01777347|Hypertonic saline|hypertonic saline
5387753|NCT01777347|Hospitalization|hospitalization
5387754|NCT01777347|Infants|infants
5387755|NCT01777347|Hospital admissions|hospital admissions
5387756|NCT01777347|Additional relevant MeSH terms:|additional relevant mesh terms:
5387757|NCT01777347|Bronchiolitis|bronchiolitis
5387758|NCT01777347|Bronchiolitis, Viral|bronchiolitis, viral
5387759|NCT01777347|Bronchial Diseases|bronchial diseases
5387760|NCT01777347|Respiratory Tract Diseases|respiratory tract diseases
5387761|NCT01777347|Lung Diseases, Obstructive|lung diseases, obstructive
5387762|NCT01777347|Respiratory Tract Infections|respiratory tract infections
5387763|NCT01777347|Virus Diseases|virus diseases
5387764|NCT01777321|Herpes Zoster|herpes zoster
5387765|NCT01777321|Intramuscular|intramuscular
5387766|NCT01777321|Subcutaneous|subcutaneous
5387767|NCT01777321|Safety|safety
5387768|NCT01777321|≥50 years of age|≥50 years of age
5387769|NCT01777321|Adults|adults
5387770|NCT01777321|Immunogenicity|immunogenicity
5387771|NCT01777321|Elderly|elderly
5387772|NCT01777308|Immunogenicity|immunogenicity
5387773|NCT01777308|Booster|booster
5387774|NCT01777308|Healthy|healthy
5387775|NCT01777308|Vaccine response|vaccine response
5387776|NCT01777308|Safety|safety
5387777|NCT01777308|Neisseria meningiditis|neisseria meningiditis
5387778|NCT01777308|Antibody persistence|antibody persistence
5387779|NCT01777308|Meningococcal conjugate vaccine|meningococcal conjugate vaccine
5387780|NCT01777295|Adults|adults
5387781|NCT01777295|Reactogenicity|reactogenicity
5387782|NCT01777295|Naive|naive
5387783|NCT01777295|Immune responses|immune responses
5387784|NCT01777295|Read-outs|read-outs
5387785|NCT01777295|Hepatitis B|hepatitis b
5387786|NCT01777295|Healthy|healthy
5387787|NCT01777282|albiglutide|albiglutide
5387788|NCT01777282|Japanese|japanese
5387789|NCT01777282|glucagon-like peptide-1|glucagon-like peptide-1
5387790|NCT01777282|GSK716155|gsk716155
5387791|NCT01777256|systemic lupus erythematosus|systemic lupus erythematosus
5387792|NCT01777256|adaptive design|adaptive design
5387793|NCT01777256|clinical safety and efficacy|clinical safety and efficacy
5387794|NCT01777256|pharmacodynamics|pharmacodynamics
5387795|NCT01777243|pharmacokinetic|pharmacokinetic
5387796|NCT01777243|systemic amyloidosis|systemic amyloidosis
5387798|NCT01777243|dose escalation|dose escalation
5387799|NCT01777243|Carboxy Pyrrolidine Hexanoyl Pyrrolidine Carboxylate (CPHPC)|carboxy pyrrolidine hexanoyl pyrrolidine carboxylate (cphpc)
5387800|NCT01777243|biomarker|biomarker
5387801|NCT01777243|GSK2315698|gsk2315698
5387802|NCT01777243|GSK2398852|gsk2398852
5387803|NCT01777243|SAP|sap
5387804|NCT01777243|pharmacodynamic|pharmacodynamic
5387805|NCT01777243|co-administration|co-administration
5387806|NCT01777243|intravenous|intravenous
5387807|NCT01777217|Urination Disorder|urination disorder
5387808|NCT01777217|Overactive Bladder|overactive bladder
5387809|NCT01777217|Prostate Cancer Radiation|prostate cancer radiation
5387810|NCT01777217|Vesicare|vesicare
5387811|NCT01777204|Renal transplant, Gastrointestinal motility, Biomagnetism|renal transplant, gastrointestinal motility, biomagnetism
5387812|NCT01777178|bicarbonate|bicarbonate
5387813|NCT01777178|dialysis|dialysis
5387814|NCT01777165|GFR|gfr
5387815|NCT01777165|Acute Kidney Injury|acute kidney injury
5387816|NCT01777165|High Risk cardiac surgery|high risk cardiac surgery
5387817|NCT01777152|Antibodies, Monoclonal|antibodies, monoclonal
5387818|NCT01777152|Antibody-Drug Conjugate|antibody-drug conjugate
5387819|NCT01777152|Antigens, CD30|antigens, cd30
5387820|NCT01777152|Drug Therapy|drug therapy
5387821|NCT01777152|Hematologic Diseases|hematologic diseases
5387822|NCT01777152|Lymphoma|lymphoma
5387823|NCT01777152|Monomethyl auristatin E|monomethyl auristatin e
5387824|NCT01777152|Lymphoma, T-Cell|lymphoma, t-cell
5387825|NCT01777152|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5388027|NCT01776307|BBI608|bbi608
5387826|NCT01777152|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5387827|NCT01777139|Retigabine|retigabine
5387828|NCT01777139|Drug-Resistant|drug-resistant
5387829|NCT01777139|Epilepsy|epilepsy
5387830|NCT01777139|Partial-Onset Seizures|partial-onset seizures
5387831|NCT01777139|Safety and Tolerability|safety and tolerability
5387832|NCT01777139|Immediate Release|immediate release
5387833|NCT01777139|Long-Term|long-term
5387834|NCT01777139|Adjunctive Therapy|adjunctive therapy
5387835|NCT01777139|Asian Subjects|asian subjects
5387836|NCT01777139|Efficacy|efficacy
5387837|NCT01777139|GW582892|gw582892
5387838|NCT01777126|cystectomy|cystectomy
5387839|NCT01777126|parenteral nutrition|parenteral nutrition
5387840|NCT01777126|discharge|discharge
5387841|NCT01777126|outcome|outcome
5387842|NCT01777113|Chronic Stroke|chronic stroke
5387843|NCT01777113|Gait|gait
5387844|NCT01777113|Exercise|exercise
5375314|NCT01833832|Rare Tumor|rare tumor
5387845|NCT01777113|High intensity aerobic training|high intensity aerobic training
5387846|NCT01777113|Strength training|strength training
5387847|NCT01777113|Randomized controlled trial|randomized controlled trial
5387848|NCT01777100|Postoperative pain|postoperative pain
5387849|NCT01777100|Patient controlled analgesia|patient controlled analgesia
5387850|NCT01777100|Hyperalgesia|hyperalgesia
5387851|NCT01777100|Remifentanil|remifentanil
5387853|NCT01777100|Morphine|morphine
5387854|NCT01777100|Abdominal surgery|abdominal surgery
5387855|NCT01777100|Safety|safety
5387856|NCT01777087|Pain|pain
5387857|NCT01777087|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5387858|NCT01777074|Vaccination|vaccination
5387859|NCT01777074|Acceptability|acceptability
5387860|NCT01777074|Hepatitis B|hepatitis b
5387861|NCT01777061|Prostate Cancer|prostate cancer
5387862|NCT01777061|Recurrent Prostate Cancer|recurrent prostate cancer
5387863|NCT01777061|PET Scan|pet scan
5387864|NCT01777061|FDG-PET|fdg-pet
5387865|NCT01777061|[11C]Acetate|[11c]acetate
5387866|NCT01777061|C11-Acetate|c11-acetate
5387867|NCT01777035|mechanical ventilation|mechanical ventilation
5387868|NCT01777035|physical therapy|physical therapy
5387869|NCT01777035|occupational therapy|occupational therapy
5387870|NCT01777035|ICU acquired weakness|icu acquired weakness
5387871|NCT01777035|critical illness myopathy|critical illness myopathy
5387872|NCT01777022|Education, Stillbirth, Prevention, Management|education, stillbirth, prevention, management
5387873|NCT01777009|Total Knee Replacement|total knee replacement
5387874|NCT01777009|Patellar Eversion|patellar eversion
5387875|NCT01777009|Surgical Exposure|surgical exposure
5387876|NCT01777009|Outcomes|outcomes
5387877|NCT01777009|Quadriceps Strength|quadriceps strength
5387878|NCT01777009|Straight Leg Raise|straight leg raise
5387879|NCT01777009|SF-36|sf-36
5387880|NCT01776996|Expanded access, HIV, maraviroc|expanded access, hiv, maraviroc
5387881|NCT01776970|Motor Neuron Disease|motor neuron disease
5387882|NCT01776970|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5387883|NCT01776970|Cannabinoids|cannabinoids
5387884|NCT01776970|Sativex|sativex
5387885|NCT01776970|Spasticity|spasticity
5387886|NCT01776957|Abortion rate|abortion rate
5387887|NCT01776957|Intrauterine device|intrauterine device
5387888|NCT01776944|Resting energy expenditure|resting energy expenditure
5387889|NCT01776944|Handheld calorimeter|handheld calorimeter
5387890|NCT01776944|Obese and overweight|obese and overweight
5387891|NCT01776944|Pediatrics|pediatrics
5387892|NCT01776931|Indicator Amino acid technique|indicator amino acid technique
5387893|NCT01776931|Lysine requirements|lysine requirements
5387906|NCT01776866|Quantitative Coronary Angiography|quantitative coronary angiography
5387907|NCT01776853|Irritable Bowel Syndrome|irritable bowel syndrome
5387908|NCT01776853|Fructose|fructose
5387909|NCT01776853|Fructans|fructans
5387911|NCT01776853|Fermentation|fermentation
5387912|NCT01776853|Breath Tests|breath tests
5387913|NCT01776853|Flatulence|flatulence
5387914|NCT01776853|Abdominal Pain|abdominal pain
5387915|NCT01776853|Diarrhoea|diarrhoea
5387916|NCT01776840|Mantle cell lymphoma|mantle cell lymphoma
5387917|NCT01776840|Ibrutinib|ibrutinib
5387918|NCT01776840|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5387919|NCT01776840|Bendamustine hydrochloride|bendamustine hydrochloride
5387920|NCT01776840|Rituximab|rituximab
5387921|NCT01776827|GERD|gerd
5387922|NCT01776827|Hiatal Hernia|hiatal hernia
5387923|NCT01776827|Paraesophageal Hernia|paraesophageal hernia
5387924|NCT01776827|Biologic Mesh|biologic mesh
5387925|NCT01776814|Entecair|entecair
5387926|NCT01776814|Tenofovir|tenofovir
5387927|NCT01776801|intracranial baroreflex|intracranial baroreflex
5387928|NCT01776762|Nutrition|nutrition
5387929|NCT01776762|Rehabilitation|rehabilitation
5387930|NCT01776762|Weightloss|weightloss
5387931|NCT01776749|low back pain|low back pain
5388062|NCT01776164|FRDA|frda
5387932|NCT01776749|failed back surgery syndrome|failed back surgery syndrome
5387933|NCT01776749|spinal cord stimulation|spinal cord stimulation
5387934|NCT01776749|subcutaneous stimulation|subcutaneous stimulation
5387935|NCT01776749|peripheral nerve field stimulation|peripheral nerve field stimulation
5387936|NCT01776736|Scoliosis|scoliosis
5387937|NCT01776736|Posture correction|posture correction
5387938|NCT01776723|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5387939|NCT01776723|CMML|cmml
5387940|NCT01776723|Leukemia|leukemia
5387941|NCT01776710|Intermittent claudication|intermittent claudication
5387942|NCT01776710|Behavior therapy|behavior therapy
5387943|NCT01776710|Walking|walking
5387944|NCT01776710|Exercise|exercise
5387945|NCT01776710|Patient education|patient education
5387946|NCT01776710|Randomized controlled trial|randomized controlled trial
5387948|NCT01776658|Dry Eye Syndrome|dry eye syndrome
5387949|NCT01776658|siRNA|sirna
5387950|NCT01776658|RNAi|rnai
5387951|NCT01776658|TRPV1|trpv1
5387952|NCT01776619|Safety|safety
5387953|NCT01776619|tolerability|tolerability
5387955|NCT01776593|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms|bladder capacity; bladder diary; bladder oversensitivity; lower urinary tract symptoms
5387956|NCT01776580|Pelvic organ prolapse|pelvic organ prolapse
5387957|NCT01776580|lower urinary tract symptoms|lower urinary tract symptoms
5387958|NCT01776580|sexual dysfunction|sexual dysfunction
5387959|NCT01776567|coronary artery disease|coronary artery disease
5387960|NCT01776567|stents|stents
5387961|NCT01776567|optical imaging|optical imaging
5387962|NCT01776554|Influenza, Pandemic, H5N1, Children|influenza, pandemic, h5n1, children
5387963|NCT01776541|Influenza, Pandemic, H5N1, Adults|influenza, pandemic, h5n1, adults
5387964|NCT01776515|Low back pain|low back pain
5387965|NCT01776515|Wontran|wontran
5387966|NCT01776515|Wontran SR Tab.|wontran sr tab.
5387967|NCT01776515|Tramadol Hydrochloride/Acetaminophen|tramadol hydrochloride/acetaminophen
5387968|NCT01776489|Food allergy|food allergy
5387969|NCT01776489|Sphingosine-1-phosphate|sphingosine-1-phosphate
5387970|NCT01776489|Biomarker|biomarker
5387971|NCT01776489|Double-blind placebo-controlled food challenge|double-blind placebo-controlled food challenge
5387972|NCT01776489|Anaphylaxis|anaphylaxis
5387973|NCT01776463|Z-360|z-360
5387974|NCT01776463|Japanese|japanese
5387975|NCT01776463|pK|pk
5387976|NCT01776450|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5387977|NCT01776424|Cardiovascular events|cardiovascular events
5387978|NCT01776424|Rivaroxaban|rivaroxaban
5387979|NCT01776424|Xarelto|xarelto
5387980|NCT01776424|Anticoagulant|anticoagulant
5387981|NCT01776424|Blood thinner|blood thinner
5387982|NCT01776424|Aspirin|aspirin
5387983|NCT01776424|ASA|asa
5387989|NCT01776424|Coronary artery bypass graft|coronary artery bypass graft
5387990|NCT01776424|Stroke|stroke
5387991|NCT01776424|Heart attack|heart attack
5387992|NCT01776424|Angina|angina
5387993|NCT01776424|Arterial vascular disease|arterial vascular disease
5387994|NCT01776424|Myocardial infarction|myocardial infarction
5387995|NCT01776424|MI|mi
5387996|NCT01776424|Cardiovascular Death|cardiovascular death
5387997|NCT01776424|CV Death|cv death
5387998|NCT01776424|Heart disease|heart disease
5387999|NCT01776398|COPD|copd
5388000|NCT01776398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5388001|NCT01776398|Lung disease|lung disease
5388002|NCT01776398|Emphysema|emphysema
5388003|NCT01776398|Smoking|smoking
5388004|NCT01776398|Healthy Smoker|healthy smoker
5388005|NCT01776398|Smoker|smoker
5388006|NCT01776398|Non-smoker|non-smoker
5388007|NCT01776398|IPF|ipf
5388008|NCT01776398|RA-ILD|ra-ild
5388009|NCT01776398|SSC-ILD|ssc-ild
5388010|NCT01776398|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5388011|NCT01776398|Rheumatoid Arthritis-Associated Interstitial Lung Disease|rheumatoid arthritis-associated interstitial lung disease
5388012|NCT01776398|Scleroderma-Associated Interstitial Lung Disease|scleroderma-associated interstitial lung disease
5388013|NCT01776385|[C08.785.640]|[c08.785.640]
5388014|NCT01776385|(C08.528.778)|(c08.528.778)
5388015|NCT01776385|[C19.642.713]|[c19.642.713]
5388016|NCT01776385|mesothelium|mesothelium
5373711|NCT01841281|Asthma|asthma
5388017|NCT01776372|Drainage|drainage
5388018|NCT01776372|Chest tubes|chest tubes
5388019|NCT01776372|Randomized Controlled Trial|randomized controlled trial
5388020|NCT01776359|Muscle|muscle
5388021|NCT01776359|Protein|protein
5388022|NCT01776359|Diet|diet
5388023|NCT01776359|Exercise|exercise
5388024|NCT01776333|ICU|icu
5388025|NCT01776320|Erectile Dysfunction|erectile dysfunction
5388026|NCT01776320|Topical Alprostadil|topical alprostadil
5388028|NCT01776294|Prehypertension|prehypertension
5388029|NCT01776294|Prevalence|prevalence
5388030|NCT01776294|Cardiovascular Risk Factors|cardiovascular risk factors
5388031|NCT01776281|effects|effects
5388032|NCT01776281|KMC|kmc
5388033|NCT01776281|LBW|lbw
5388034|NCT01776281|preterm|preterm
5388035|NCT01776281|temperature|temperature
5388036|NCT01776281|breastfeeding|breastfeeding
5388037|NCT01776281|secondary hospitals|secondary hospitals
5388038|NCT01776268|antimicrobial proteins|antimicrobial proteins
5388039|NCT01776255|Obesity|obesity
5388040|NCT01776255|Overweight|overweight
5388041|NCT01776255|Lifestyle|lifestyle
5388042|NCT01776255|American Indian|american indian
5388043|NCT01776242|low back pain|low back pain
5388044|NCT01776242|elderly|elderly
5388045|NCT01776242|back pain|back pain
5388046|NCT01776242|lumbar pain|lumbar pain
5388047|NCT01776242|over 65|over 65
5388048|NCT01776229|nightmare|nightmare
5388049|NCT01776229|PTSD|ptsd
5388050|NCT01776229|trauma|trauma
5388051|NCT01776229|children|children
5388052|NCT01776229|cognitive behavior therapy|cognitive behavior therapy
5388054|NCT01776229|sleep|sleep
5388055|NCT01776216|Endothelial function|endothelial function
5388056|NCT01776216|Dairy|dairy
5388057|NCT01776177|Allergic asthma|allergic asthma
5388058|NCT01776177|Omalizumab therapy|omalizumab therapy
5388059|NCT01776177|IgE profile|ige profile
5388060|NCT01776164|Friedreich|friedreich
5388061|NCT01776164|ataxia|ataxia
5388063|NCT01776164|FA|fa
5388064|NCT01776164|recessive|recessive
5388065|NCT01776164|neurodegenerative|neurodegenerative
5388066|NCT01776164|cerebellum|cerebellum
5388067|NCT01776151|HIV|hiv
5388068|NCT01776151|cardiovascular diseases|cardiovascular diseases
5388069|NCT01776151|vascular stiffness|vascular stiffness
5388070|NCT01776138|Elderly|elderly
5388071|NCT01776138|Chemotherapy|chemotherapy
5388072|NCT01776138|Cystectomy|cystectomy
5388073|NCT01776138|Radical Cystectomy|radical cystectomy
5388074|NCT01776138|University of North Carolina|university of north carolina
5388075|NCT01776138|Cancer|cancer
5388076|NCT01776138|Bladder Cancer|bladder cancer
5388077|NCT01776138|Bladder|bladder
5388078|NCT01776125|Neurofibromatosis Type One|neurofibromatosis type one
5388079|NCT01776125|Scoliosis|scoliosis
5388080|NCT01776112|schizophrenia|schizophrenia
5388081|NCT01776112|negative symptoms|negative symptoms
5388082|NCT01776112|cognitive deficits|cognitive deficits
5388083|NCT01776112|synaptic plasticity|synaptic plasticity
5388084|NCT01776099|type 2 diabetes|type 2 diabetes
5388085|NCT01776099|nutrition|nutrition
5388086|NCT01776099|fibers|fibers
5388087|NCT01776073|Transplantation|transplantation
5388088|NCT01776073|Healthcare Disparities|healthcare disparities
5388089|NCT01776073|Quality Assurance|quality assurance
5388090|NCT01776060|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5388091|NCT01776060|Multiple Sclerosis|multiple sclerosis
5388092|NCT01776060|biomarker|biomarker
5388094|NCT01776060|progression|progression
5388095|NCT01776034|Self Care|self care
5388096|NCT01776034|Exercise|exercise
5388097|NCT01776034|Weight management|weight management
5388098|NCT01776021|Urinary tract infection|urinary tract infection
5388099|NCT01776021|Recurrent urinary tract infection|recurrent urinary tract infection
5388100|NCT01776021|Cranberry|cranberry
5388101|NCT01776021|Prevention|prevention
5388102|NCT01776021|E-coli|e-coli
5388103|NCT01775995|Chronic Pain|chronic pain
5388104|NCT01775995|Low Back Pain|low back pain
5388105|NCT01775982|French language validation|french language validation
5445456|NCT01521702|adenocarcinoma|adenocarcinoma
5388106|NCT01775982|The Confusion Assessment Method (CAM)|the confusion assessment method (cam)
5388107|NCT01775943|Epidermal growth factor receptor|epidermal growth factor receptor
5388108|NCT01775943|Mutation|mutation
5388109|NCT01775943|Lung cancer|lung cancer
5388110|NCT01775943|Drug sensitivity|drug sensitivity
5388111|NCT01775930|Kidney Cancer|kidney cancer
5388112|NCT01775930|Refractory Renal Cell Carcinoma|refractory renal cell carcinoma
5388113|NCT01775930|RCC|rcc
5388114|NCT01775930|Clear cell kidney cancer with metastatic disease|clear cell kidney cancer with metastatic disease
5388115|NCT01775930|Carfilzomib|carfilzomib
5388116|NCT01775891|pilsicainide|pilsicainide
5388117|NCT01775891|class IC antiarrhythmic drug|class ic antiarrhythmic drug
5388118|NCT01775891|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5388119|NCT01775891|catheter ablation|catheter ablation
5388120|NCT01775878|Diabetes|diabetes
5388121|NCT01775878|HbA1c|hba1c
5388122|NCT01775878|Fructosamine|fructosamine
5388123|NCT01775878|Blood Pressure|blood pressure
5388124|NCT01775878|Telemonitoring|telemonitoring
5388125|NCT01775865|aortic stiffness|aortic stiffness
5388126|NCT01775865|endothelium-dependent dilation|endothelium-dependent dilation
5388127|NCT01775865|vascular aging|vascular aging
5388128|NCT01775865|oxidative stress|oxidative stress
5388129|NCT01775865|inflammation|inflammation
5388130|NCT01775865|nitric oxide|nitric oxide
5388131|NCT01775865|nuclear factor kappa B|nuclear factor kappa b
5388132|NCT01775852|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5388133|NCT01775852|Depression|depression
5388134|NCT01775852|Illness Management|illness management
5388135|NCT01775852|Behavioral treatment|behavioral treatment
5388136|NCT01775852|Impairment|impairment
5388137|NCT01775826|physical activity|physical activity
5388138|NCT01775826|sedentary behavior|sedentary behavior
5388139|NCT01775826|accelerometer|accelerometer
5388140|NCT01775826|GPS|gps
5388141|NCT01775826|GIS|gis
5388142|NCT01775826|machine learning|machine learning
5388143|NCT01775813|Insulin resistance|insulin resistance
5388144|NCT01775813|Puberty|puberty
5388145|NCT01775813|Obesity|obesity
5388146|NCT01775813|Hypogonadism|hypogonadism
5388147|NCT01775813|Gonadal dysfunction|gonadal dysfunction
5388148|NCT01775813|Metformin|metformin
5388149|NCT01775787|smoking|smoking
5388150|NCT01775774|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5388151|NCT01775774|Acute Lung Injury|acute lung injury
5388152|NCT01775774|Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|allogeneic bone marrow-derived human mesenchymal stem cells
5423339|NCT01616095|metabolic health|metabolic health
5388153|NCT01775761|Thorough QTc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.|thorough qtc evaluation of tafamidis compared to the effects of moxifloxacin and placebo in healthy volunteers.
5388155|NCT01775735|headache|headache
5388156|NCT01775735|pain|pain
5388157|NCT01775735|chronic|chronic
5388158|NCT01775709|middler ear infection|middler ear infection
5388159|NCT01775696|Alzheimer's disease|alzheimer's disease
5388160|NCT01775696|Pittsburgh binding Compound (PiB)|pittsburgh binding compound (pib)
5388161|NCT01775696|Positron Emission Tomography (PET)|positron emission tomography (pet)
5388162|NCT01775696|Inflammation|inflammation
5388163|NCT01775696|Anti Abeta immune responses|anti abeta immune responses
5388164|NCT01775696|Blood markers|blood markers
5388165|NCT01775696|MRI|mri
5388166|NCT01775683|homelessness|homelessness
5388167|NCT01775670|Arthrosis|arthrosis
5388168|NCT01775657|pulmonary air leak|pulmonary air leak
5388169|NCT01775657|Thopaz|thopaz
5388170|NCT01775657|digital|digital
5388171|NCT01775657|analog|analog
5388172|NCT01775657|randomized|randomized
5388173|NCT01775618|Hemophilia A|hemophilia a
5388174|NCT01775618|Factor VIII|factor viii
5388175|NCT01775618|Prophylaxis|prophylaxis
5388176|NCT01775618|Pediatric|pediatric
5388177|NCT01775605|Subject|subject
5388178|NCT01775592|P.f resistance|p.f resistance
5388179|NCT01775553|Relapsed Multiple Myeloma|relapsed multiple myeloma
5388180|NCT01775553|Refractory Multiple Myeloma|refractory multiple myeloma
5388181|NCT01775553|High-Dose Carfilzomib|high-dose carfilzomib
5388182|NCT01775553|Standard Dose Carfilzomib|standard dose carfilzomib
5388183|NCT01775553|Carfilzomib|carfilzomib
5388184|NCT01775540|Dry eye|dry eye
5388185|NCT01775540|Artificial tears|artificial tears
5388186|NCT01775540|Ocular surface inflammation|ocular surface inflammation
5388188|NCT01775501|FOLFOX|folfox
5388189|NCT01775488|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5388190|NCT01775488|BPH|bph
5388191|NCT01775488|LUTS|luts
5388192|NCT01775488|Vortx Rx|vortx rx
5388193|NCT01775488|Histotripsy|histotripsy
5388194|NCT01775462|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5388195|NCT01775462|XLHED|xlhed
5388196|NCT01775449|Anticancer drug;|anticancer drug;
5388197|NCT01775449|Oxaliplatin;|oxaliplatin;
5388198|NCT01775449|Digestive cancer system|digestive cancer system
5388199|NCT01775449|Acute oxaliplatin-induced hypersensitivity|acute oxaliplatin-induced hypersensitivity
5388200|NCT01775449|Hyperalgesia;|hyperalgesia;
5388201|NCT01775449|Allodynia;|allodynia;
5388202|NCT01775449|Dysesthesia|dysesthesia
5388203|NCT01775449|Polyamines depleted diet|polyamines depleted diet
5388204|NCT01775436|palliative care|palliative care
5388205|NCT01775436|HIV/AIDS|hiv/aids
5388206|NCT01775436|quality of life|quality of life
5388207|NCT01775436|adherence|adherence
5388208|NCT01775436|spiritual|spiritual
5388209|NCT01775436|threat appraisal|threat appraisal
5388210|NCT01775436|treatment congruence|treatment congruence
5388211|NCT01775436|treatment preferences|treatment preferences
5388212|NCT01775436|dialysis|dialysis
5388213|NCT01775436|hospitalization|hospitalization
5388214|NCT01775436|communication|communication
5388215|NCT01775436|family intervention|family intervention
5388216|NCT01775436|Family Centered Advance Care Planning|family centered advance care planning
5388217|NCT01775436|decision making|decision making
5388218|NCT01775436|advance care planning|advance care planning
5388219|NCT01775436|end of life|end of life
5388220|NCT01775397|Dificid|dificid
5388221|NCT01775397|Infections|infections
5373905|NCT01840501|Male|male
5388222|NCT01775397|Clostridium|clostridium
5388223|NCT01775397|Transplantation|transplantation
5388224|NCT01775397|Efficacy|efficacy
5388225|NCT01775397|Adult|adult
5388226|NCT01775397|Stem Cells|stem cells
5388227|NCT01775397|Fidaxomicin|fidaxomicin
5388228|NCT01775397|Difficile|difficile
5388229|NCT01775397|Immunosuppression|immunosuppression
5388230|NCT01775397|Vancomycin|vancomycin
5388231|NCT01775384|Inflammation|inflammation
5388232|NCT01775384|Oxidative stress|oxidative stress
5388233|NCT01775384|Immune dysfunction|immune dysfunction
5388234|NCT01775384|Metabolomics.|metabolomics.
5388235|NCT01775371|Pain|pain
5388242|NCT01775345|Physiotherapy|physiotherapy
5388243|NCT01775345|Isokinetics|isokinetics
5388244|NCT01775345|Cost-effectiveness|cost-effectiveness
5388245|NCT01775319|Zinc|zinc
5388246|NCT01775293|Non-absorbable polypropylene mesh|non-absorbable polypropylene mesh
5388247|NCT01775293|WSRS|wsrs
5388248|NCT01775293|Rhytidectomy|rhytidectomy
5388249|NCT01775254|Colon Cancer|colon cancer
5388250|NCT01775254|FOLFOX|folfox
5388251|NCT01775254|Laparoscopic Colectomy|laparoscopic colectomy
5388252|NCT01775254|Open Colectomy|open colectomy
5388253|NCT01775254|Robotic Colectomy|robotic colectomy
5388254|NCT01775254|Quality of Life|quality of life
5388255|NCT01775254|Sexual Function|sexual function
5388256|NCT01775254|Peripheral Neuropathy|peripheral neuropathy
5388257|NCT01775254|Demands of Illness|demands of illness
5388258|NCT01775254|Cancer Survivor|cancer survivor
5388259|NCT01775228|Depression, peer support, recovery, health services|depression, peer support, recovery, health services
5388260|NCT01775215|Left Ventricular Function|left ventricular function
5388261|NCT01775215|Aortic Valve Replacement|aortic valve replacement
5388262|NCT01775215|Late Gadolinium Enhancement|late gadolinium enhancement
5388263|NCT01775215|Cardiac I123 MIBG|cardiac i123 mibg
5388264|NCT01775215|Longitudinal Strain|longitudinal strain
5388265|NCT01775215|Brain Natriuretic Peptide|brain natriuretic peptide
5388266|NCT01775215|High Sensitivity Troponin I|high sensitivity troponin i
5388267|NCT01775189|Relative abuse potential study|relative abuse potential study
5388268|NCT01775189|Chronic pain|chronic pain
5388269|NCT01775189|oxycodone|oxycodone
5388270|NCT01775189|naltrexone|naltrexone
5388271|NCT01775189|opioid-related disorders|opioid-related disorders
5388272|NCT01775189|drug abusers|drug abusers
5388273|NCT01775176|PCOS, Weight, Insulin Sensitivity, Reproductive Function|pcos, weight, insulin sensitivity, reproductive function
5388274|NCT01775163|Energy|energy
5388275|NCT01775163|Metabolism|metabolism
5388276|NCT01775163|Weight Loss|weight loss
5388277|NCT01775163|Exercise|exercise
5388278|NCT01775150|mobile phone text messaging|mobile phone text messaging
5388279|NCT01775150|maternality|maternality
5388280|NCT01775150|infant|infant
5388281|NCT01775150|death rate|death rate
5388282|NCT01775137|CF, Open-label, TIP, phase IV, extension study|cf, open-label, tip, phase iv, extension study
5388283|NCT01775124|Macular degeneration,|macular degeneration,
5388284|NCT01775124|age-related macular degeneration (ARMD),|age-related macular degeneration (armd),
5388285|NCT01775124|vision loss,|vision loss,
5388286|NCT01775124|macula damage,|macula damage,
5388287|NCT01775124|retina damage,|retina damage,
5388288|NCT01775124|dry macular degeneration,|dry macular degeneration,
5388289|NCT01775124|wet macular degeneration,|wet macular degeneration,
5388291|NCT01775111|strength training|strength training
5388310|NCT01775072|Clinical Assay|clinical assay
5388311|NCT01775072|Research Assay|research assay
5388312|NCT01775072|12-245|12-245
5388313|NCT01775046|Valiant|valiant
5388314|NCT01775046|Captivia|captivia
5388315|NCT01775046|Stent Graft|stent graft
5388316|NCT01775046|Thoracic|thoracic
5388317|NCT01775046|Aortic|aortic
5388318|NCT01775033|Pediatrics|pediatrics
5388319|NCT01775033|Emergency medical services|emergency medical services
5388320|NCT01775033|Emergency Treatment|emergency treatment
5388321|NCT01775033|Telemedicine|telemedicine
5388322|NCT01775007|Lens|lens
5388323|NCT01775007|Cornea|cornea
5388324|NCT01775007|Presbyopia|presbyopia
5388325|NCT01774994|volunteers|volunteers
5388326|NCT01774942|Diabetes Mellitus|diabetes mellitus
5388327|NCT01774942|C-Reactive Protein|c-reactive protein
5388328|NCT01774942|Dental Implants, Single-Tooth|dental implants, single-tooth
5388329|NCT01774942|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5388330|NCT01774929|Osteoarthritis|osteoarthritis
5388331|NCT01774929|Transdermal Therapeutic System (TTS)-fentanyl|transdermal therapeutic system (tts)-fentanyl
5388332|NCT01774929|Durogesic|durogesic
5501418|NCT01290263|GBM|gbm
5388333|NCT01774903|Low Back Pain|low back pain
5388334|NCT01774903|TTS-fentanyl|tts-fentanyl
5388335|NCT01774903|Durogesic|durogesic
5388336|NCT01774877|xinfeng capsule;|xinfeng capsule;
5388337|NCT01774877|rheumatoid arthritis (RA);|rheumatoid arthritis (ra);
5388338|NCT01774877|randomized;|randomized;
5388339|NCT01774877|double-blind;|double-blind;
5388340|NCT01774851|HER-2 Gene Amplification|her-2 gene amplification
5388341|NCT01774851|Esophagus Cancer|esophagus cancer
5388342|NCT01774851|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5388343|NCT01774851|Stomach Cancer|stomach cancer
5388344|NCT01774851|Her2 Positive|her2 positive
5388345|NCT01774851|Her2+|her2+
5388346|NCT01774851|Esophageal Cancer|esophageal cancer
5388347|NCT01774851|Metastatic|metastatic
5388348|NCT01774825|Irritable bowel syndrome|irritable bowel syndrome
5388349|NCT01774825|IBS|ibs
5388350|NCT01774812|vitamin D|vitamin d
5388351|NCT01774812|hemodialysis|hemodialysis
5388352|NCT01774812|sudden cardiac death|sudden cardiac death
5388353|NCT01774812|heart rate variability|heart rate variability
5388354|NCT01774812|cardiac autonomic tone|cardiac autonomic tone
5388355|NCT01774799|advanced dementia|advanced dementia
5388356|NCT01774799|advance care planning|advance care planning
5388357|NCT01774799|nursing home|nursing home
5388358|NCT01774760|18F-EF5|18f-ef5
5388359|NCT01774760|PET/CT|pet/ct
5388360|NCT01774760|Reproducibility|reproducibility
5388361|NCT01774747|Pharmacokinetics|pharmacokinetics
5388362|NCT01774734|Chronic neck pain|chronic neck pain
5388363|NCT01774734|Neck strength exerciser|neck strength exerciser
5388364|NCT01774734|Biofeedback|biofeedback
5388365|NCT01774734|Physiotherapy|physiotherapy
5388366|NCT01774734|Strengthening exercise|strengthening exercise
5388377|NCT01774721|PF-00299804|pf-00299804
5388378|NCT01774695|IBS|ibs
5388379|NCT01774695|physical activity|physical activity
5388380|NCT01774695|exercise|exercise
5388381|NCT01774682|obesity|obesity
5388382|NCT01774682|surgery|surgery
5388383|NCT01774669|ischemic stroke|ischemic stroke
5388384|NCT01774669|hemorrhagic stroke|hemorrhagic stroke
5388385|NCT01774669|upper limb|upper limb
5388386|NCT01774669|virtual reality|virtual reality
5388387|NCT01774669|physiotherapy|physiotherapy
5388388|NCT01774669|occupational therapy|occupational therapy
5388389|NCT01774656|heart-assist device|heart-assist device
5388390|NCT01774643|Pancreatic cancer|pancreatic cancer
5388391|NCT01774643|Liver metastases|liver metastases
5388392|NCT01774643|Tumor tissue biopsy|tumor tissue biopsy
5388393|NCT01774643|Blood samples|blood samples
5388394|NCT01774643|Xenografts|xenografts
5361613|NCT01894607|DEFINITY|definity
5388395|NCT01774643|Murine|murine
5388396|NCT01774643|Genomic profiling|genomic profiling
5388397|NCT01774643|Circulating biomarkers|circulating biomarkers
5388398|NCT01774630|Treatment, relapse, complete molecular response|treatment, relapse, complete molecular response
5388399|NCT01774617|portal hypertension|portal hypertension
5388400|NCT01774617|elastography|elastography
5388401|NCT01774617|Hepatic venous pressure gradient measurement|hepatic venous pressure gradient measurement
5388402|NCT01774604|Post ERCP acute pancreatitis|post ercp acute pancreatitis
5388403|NCT01774604|Post Fine Needle Aspiration (FNA) acute pancreatitis|post fine needle aspiration (fna) acute pancreatitis
5388404|NCT01774604|Indomethacin|indomethacin
5388405|NCT01774604|Rectal Non Steroidal Anti-Inflammatory Drugs (NSAIDs)|rectal non steroidal anti-inflammatory drugs (nsaids)
5388406|NCT01774591|Post Menopause|post menopause
5388408|NCT01774591|Obese|obese
5388409|NCT01774578|Non-small Cell Lung Cancer|non-small cell lung cancer
5388410|NCT01774578|Vaccine Therapy|vaccine therapy
5388411|NCT01774578|Immunotherapy|immunotherapy
5388412|NCT01774578|Second line therapy|second line therapy
5388413|NCT01774578|Progressive|progressive
5388414|NCT01774578|Relapsed|relapsed
5388415|NCT01774565|Diabetes|diabetes
5388416|NCT01774565|Insulin|insulin
5388417|NCT01774565|Closed-Loop|closed-loop
5388418|NCT01774565|Real-time CGM|real-time cgm
5388419|NCT01774565|Subcutaneous insulin pump|subcutaneous insulin pump
5388420|NCT01774565|Hospital|hospital
5388421|NCT01774539|Fracture|fracture
5388422|NCT01774539|Physeal injury|physeal injury
5388423|NCT01774539|Diffusion MRI|diffusion mri
5388424|NCT01774500|biomarkers|biomarkers
5388425|NCT01774500|Emergency Department|emergency department
5388426|NCT01774500|Seizures|seizures
5388427|NCT01774500|epilepsy|epilepsy
5388428|NCT01774500|S100b|s100b
5388429|NCT01774500|copeptin|copeptin
5388430|NCT01774487|Biliary Atresia|biliary atresia
5388431|NCT01774487|Pentoxifylline|pentoxifylline
5388432|NCT01774487|Trental|trental
5388433|NCT01774487|Serum bilirubin|serum bilirubin
5388434|NCT01774487|Conjugated bilirubin|conjugated bilirubin
5388435|NCT01774487|Liver transplantation|liver transplantation
5388436|NCT01774487|Fibrosis|fibrosis
5388437|NCT01774474|Prevention|prevention
5388438|NCT01774448|Dementia|dementia
5388440|NCT01774448|Depression|depression
5388441|NCT01774448|Mind Body Therapy|mind body therapy
5388442|NCT01774448|Cognitive Therapy|cognitive therapy
5388443|NCT01774448|Quality of Life|quality of life
5388444|NCT01774448|Attention|attention
5388445|NCT01774448|Memory|memory
5388446|NCT01774435|Schizophrenia|schizophrenia
5388447|NCT01774435|Schizophrenic|schizophrenic
5388448|NCT01774435|Stable Schizophrenic|stable schizophrenic
5388449|NCT01774422|Hypercapnia|hypercapnia
5388450|NCT01774422|Respiratory Distress Syndrome|respiratory distress syndrome
5388451|NCT01774422|Extracorporeal CO2 remover|extracorporeal co2 remover
5388452|NCT01774422|Noninvasive ventilation|noninvasive ventilation
5388454|NCT01774396|Hands Rejuvenation, fillers|hands rejuvenation, fillers
5388455|NCT01774383|Parkinson's disease|parkinson's disease
5388456|NCT01774383|sub-thalamic nucleus|sub-thalamic nucleus
5388457|NCT01774383|oscillation|oscillation
5388458|NCT01774383|local field potential|local field potential
5388459|NCT01774344|Regorafenib|regorafenib
5388460|NCT01774344|BAY73-4506|bay73-4506
5388462|NCT01774318|preterm infants|preterm infants
5388463|NCT01774318|aEEG|aeeg
5388464|NCT01774318|conventional EEG|conventional eeg
5388465|NCT01774318|polysomnography|polysomnography
5388466|NCT01774292|Impact of alkalized lidocaine on coughing at extubation|impact of alkalized lidocaine on coughing at extubation
5388467|NCT01774266|Gastric Cancer|gastric cancer
5388468|NCT01774266|DNA methylation|dna methylation
5388469|NCT01774266|Reprimo|reprimo
5388470|NCT01774266|cell-free DNA|cell-free dna
5388471|NCT01774266|non-invasive|non-invasive
5388472|NCT01774253|DIPG|dipg
5388473|NCT01774240|Delirium|delirium
5388474|NCT01774240|Cardiac surgery|cardiac surgery
5388475|NCT01774240|DOS scale|dos scale
5388476|NCT01774227|Refractory glaucoma|refractory glaucoma
5388477|NCT01774227|Transcleral cyclophotocoagulation (TSCPC)|transcleral cyclophotocoagulation (tscpc)
5388478|NCT01774227|Dark iris|dark iris
5388479|NCT01774227|Pops-titration|pops-titration
5388480|NCT01774227|Slow-coagulation|slow-coagulation
5388481|NCT01774227|Neovascular glaucoma|neovascular glaucoma
5388482|NCT01774214|Resuscitation|resuscitation
5388483|NCT01774214|Shock|shock
5388484|NCT01774214|Fluid Therapy|fluid therapy
5388485|NCT01774214|Pediatrics|pediatrics
5388486|NCT01774201|Multiple sclerosis|multiple sclerosis
5388487|NCT01774201|Self-assessment|self-assessment
5388488|NCT01774201|Physical endurance|physical endurance
5388489|NCT01774201|Respiratory function|respiratory function
5388490|NCT01774201|Fatigue|fatigue
5388491|NCT01774188|Enhanced Extracorporeal Counterpulsation|enhanced extracorporeal counterpulsation
5388492|NCT01774188|intraocular pressure|intraocular pressure
5388493|NCT01774188|Pen type tonometer|pen type tonometer
5388494|NCT01774175|Bowel preparation|bowel preparation
5002917|NCT03977857|prognostic model|prognostic model
5361717|NCT01894217|statins|statins
5388495|NCT01774175|PEG with ascorbic acid|peg with ascorbic acid
5388496|NCT01774175|Picosulfate|picosulfate
5388497|NCT01774162|Endoscopic Ultrasound|endoscopic ultrasound
5388498|NCT01774162|Fine needle aspiration|fine needle aspiration
5388499|NCT01774162|Fine needle biopsy|fine needle biopsy
5388500|NCT01774162|ProCore|procore
5388501|NCT01774136|community health workers|community health workers
5388503|NCT01774136|PMTCT|pmtct
5388504|NCT01774136|antenatal|antenatal
5388505|NCT01774136|postnatal|postnatal
5388506|NCT01774136|breastfeeding|breastfeeding
5388507|NCT01774136|South Africa|south africa
5388508|NCT01774110|stroke|stroke
5388509|NCT01774110|gait|gait
5388510|NCT01774110|acute|acute
5388511|NCT01774097|Peripheral Artery Disease|peripheral artery disease
5388512|NCT01774097|Intermittent Claudication|intermittent claudication
5388513|NCT01774097|Autologous Stem Cells|autologous stem cells
5388514|NCT01774097|ALDH cells|aldh cells
5388515|NCT01774097|Claudicants|claudicants
5388516|NCT01774097|PAD|pad
5388517|NCT01774097|Peak Walking Time|peak walking time
5388518|NCT01774097|MRI|mri
5388519|NCT01774097|Vascular Flow|vascular flow
5388520|NCT01774097|Anatomy|anatomy
5388521|NCT01774097|Perfusion|perfusion
5388522|NCT01774084|Insulin sensitivity|insulin sensitivity
5388523|NCT01774084|Beta cell function|beta cell function
5388524|NCT01774084|Carbohydrate preload|carbohydrate preload
5388525|NCT01774084|Elective hip replacement|elective hip replacement
5388526|NCT01774084|Double-blind randomized control study|double-blind randomized control study
5388527|NCT01774071|89Zr-DFO-MSTP2109A|89zr-dfo-mstp2109a
5388528|NCT01774071|tracer|tracer
5388529|NCT01774071|pet scan|pet scan
5388530|NCT01774071|12-178|12-178
5388531|NCT01774058|blood flow volume|blood flow volume
5388532|NCT01774058|ilomedin|ilomedin
5388533|NCT01774058|measurement|measurement
5388534|NCT01774058|intraarterial|intraarterial
5388535|NCT01774058|neuropathy|neuropathy
5388536|NCT01774045|Major depressive disorder|major depressive disorder
5388537|NCT01774045|Depression|depression
5388538|NCT01774019|Pancreatic|pancreatic
5388539|NCT01774019|Periampullary Cancer|periampullary cancer
5388540|NCT01774019|Preoperative Biliary Drainage|preoperative biliary drainage
5388541|NCT01774019|Resectable|resectable
5388542|NCT01774006|In vitro fertilization|in vitro fertilization
5388543|NCT01774006|Embryo transfer|embryo transfer
5388544|NCT01774006|Embryo culture|embryo culture
5388545|NCT01774006|individual culture|individual culture
5388546|NCT01774006|Group culture|group culture
5388547|NCT01774006|embryo quality|embryo quality
5388548|NCT01774006|Pregnancy rate|pregnancy rate
5388549|NCT01774006|Implantation|implantation
5388551|NCT01773993|pregabalin|pregabalin
5388552|NCT01773993|Good post marketing practice|good post marketing practice
5388553|NCT01773993|Post Marketing Surveillance|post marketing surveillance
5388554|NCT01773993|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5388555|NCT01773993|Fibromyalgia|fibromyalgia
5388556|NCT01773967|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
5388557|NCT01773967|LGG|lgg
5388558|NCT01773967|Probiotic|probiotic
5388559|NCT01773967|Gastroenteritis|gastroenteritis
5388560|NCT01773967|acute gastroenteritis|acute gastroenteritis
5388561|NCT01773967|child|child
5388562|NCT01773967|pediatric|pediatric
5388563|NCT01773967|RCT|rct
5388564|NCT01773954|amd|amd
5388566|NCT01773954|macular degeneration|macular degeneration
5388567|NCT01773954|neovascular|neovascular
5388568|NCT01773928|Active immunization against influenza disease|active immunization against influenza disease
5388569|NCT01773889|Epithelial Ovarian Cancer|epithelial ovarian cancer
5388570|NCT01773889|FIGO (Int Federation of Gyn and Ob )Stage III or Stage IV|figo (int federation of gyn and ob )stage iii or stage iv
5388571|NCT01773889|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
5388572|NCT01773889|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
5388573|NCT01773876|survival without proven invasive candidiasis|survival without proven invasive candidiasis
5388574|NCT01773876|effectiveness|effectiveness
5388575|NCT01773876|micafungin versus placebo|micafungin versus placebo
5388576|NCT01773876|pharmacokinetic|pharmacokinetic
5388577|NCT01773876|pharmacodynamic|pharmacodynamic
5388578|NCT01773876|tolerance|tolerance
5388579|NCT01773863|Community-acquired pneumonia|community-acquired pneumonia
5388580|NCT01773863|Acute myocardial infarction|acute myocardial infarction
5388581|NCT01773863|Platelet activation|platelet activation
5388582|NCT01773863|Coagulation abnormalities,|coagulation abnormalities,
5388583|NCT01773863|Thrombosis|thrombosis
5388584|NCT01773863|Isoprosantes|isoprosantes
5388585|NCT01773863|NADPH oxidase|nadph oxidase
5388586|NCT01773863|Major adverse cardiac and cerebrovascular events|major adverse cardiac and cerebrovascular events
5388587|NCT01773850|breast cancer|breast cancer
5388588|NCT01773837|asthenia|asthenia
5388589|NCT01773837|advanced cancer|advanced cancer
5388590|NCT01773837|randomized controlled trial|randomized controlled trial
5486358|NCT01352312|NHL|nhl
5388591|NCT01773824|antibiotic|antibiotic
5388592|NCT01773824|prescription rate|prescription rate
5388593|NCT01773811|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5388594|NCT01773811|Narrative Writing|narrative writing
5388595|NCT01773759|Immunizations|immunizations
5388596|NCT01773759|Child care|child care
5388597|NCT01773759|School health promotion|school health promotion
5388598|NCT01773746|neonatal|neonatal
5388599|NCT01773746|resuscitation|resuscitation
5388600|NCT01773746|room air|room air
5388601|NCT01773720|cardiac index|cardiac index
5388602|NCT01773720|coronary artery bypass|coronary artery bypass
5388603|NCT01773720|uncalibrated pulse contour analysis|uncalibrated pulse contour analysis
5388604|NCT01773720|hemodynamic monitoring|hemodynamic monitoring
5388605|NCT01773707|prevention of type 1 diabetes|prevention of type 1 diabetes
5388606|NCT01773707|prevention of abnormal glucose tolerance|prevention of abnormal glucose tolerance
5388607|NCT01773694|Post-operative management|post-operative management
5388608|NCT01773694|Post-operative complications|post-operative complications
5388609|NCT01773694|Post-operative treatment|post-operative treatment
5388611|NCT01773694|skin|skin
5388612|NCT01773694|Dermatologic Surgical Procedures|dermatologic surgical procedures
5388613|NCT01773655|somatic|somatic
5388614|NCT01773655|germline|germline
5388615|NCT01773655|mutations|mutations
5388616|NCT01773655|BAP1 (BRCA associated protein-1)|bap1 (brca associated protein-1)
5388617|NCT01773655|12-235|12-235
5388618|NCT01773642|pediatric HIV diagnosis disclosure|pediatric hiv diagnosis disclosure
5388619|NCT01773642|cognitive behavioral intervention|cognitive behavioral intervention
5388620|NCT01773642|Uganda|uganda
5388621|NCT01773629|Depression|depression
5388622|NCT01773629|Pregnancy|pregnancy
5388623|NCT01773629|Postpartum|postpartum
5388624|NCT01773629|Perinatal|perinatal
5388625|NCT01773616|Systemic lupus erythematosus|systemic lupus erythematosus
5388626|NCT01773616|Lupus|lupus
5388627|NCT01773616|Nephritis|nephritis
5388628|NCT01773603|Time-lapse|time-lapse
5388629|NCT01773603|morphokinetics|morphokinetics
5388630|NCT01773603|blastocyst transfer|blastocyst transfer
5388631|NCT01773603|eSET|eset
5388632|NCT01773577|EHR|ehr
5388633|NCT01773577|VHR|vhr
5388634|NCT01773577|Electronic Health Record|electronic health record
5388635|NCT01773564|Dressings, Prevention,|dressings, prevention,
5388636|NCT01773538|quality of life|quality of life
5388637|NCT01773512|Intravascular ultrasound|intravascular ultrasound
5371872|NCT01849991|Gas|gas
5388638|NCT01773512|Virtual histology|virtual histology
5388639|NCT01773512|Optical coherence tomography|optical coherence tomography
5388640|NCT01773512|Coronary atherosclerosis|coronary atherosclerosis
5388641|NCT01773512|Statins|statins
5388642|NCT01773512|Retinal imaging|retinal imaging
5388643|NCT01773499|cellulitis|cellulitis
5388644|NCT01773499|ultrasound|ultrasound
5388645|NCT01773486|Obesity|obesity
5388646|NCT01773486|Insulin Resistance|insulin resistance
5388647|NCT01773486|Endothelial dysfunction|endothelial dysfunction
5388648|NCT01773486|Blood pressure|blood pressure
5388649|NCT01773460|everolimus progress exemestane|everolimus progress exemestane
5388650|NCT01773460|treated with exemestane and everolimus|treated with exemestane and everolimus
5388651|NCT01773460|progress under this treatment|progress under this treatment
5388652|NCT01773395|Advanced|advanced
5388653|NCT01773369|cerebral palsy|cerebral palsy
5388654|NCT01773369|physical therapy|physical therapy
5388655|NCT01773369|rehabilitation|rehabilitation
5388656|NCT01773369|hemiplegia|hemiplegia
5388657|NCT01773356|Obesity|obesity
5388658|NCT01773356|Body Weight|body weight
5388659|NCT01773356|Body Composition|body composition
5388660|NCT01773356|Metabolism|metabolism
5388661|NCT01773356|Resting Energy Expenditure|resting energy expenditure
5388662|NCT01773343|skin texture, efficacy, adverse effects|skin texture, efficacy, adverse effects
5388663|NCT01773330|high resolution manometry|high resolution manometry
5388664|NCT01773330|provocative swallow|provocative swallow
5388665|NCT01773330|impedence|impedence
5388667|NCT01773304|Adults|adults
5388668|NCT01773304|Bone metabolism|bone metabolism
5388669|NCT01773304|Metabolic profile|metabolic profile
5388670|NCT01773304|Dairy protein|dairy protein
5388671|NCT01773304|Meat protein|meat protein
5388672|NCT01773291|Acupuncture; laser acupuncture; traumatic brain injury|acupuncture; laser acupuncture; traumatic brain injury
5388673|NCT01773278|Antioxidant treatment|antioxidant treatment
5388674|NCT01773278|Oxysterols|oxysterols
5388675|NCT01773278|Cholesterol deficiency|cholesterol deficiency
5388676|NCT01773278|Accumulation of 7-dehydrocholesterol|accumulation of 7-dehydrocholesterol
5388677|NCT01773278|electroretinogram (ERG)|electroretinogram (erg)
5388678|NCT01773278|Auditory Brainstem Response (ABR)|auditory brainstem response (abr)
5388680|NCT01773252|RTLS|rtls
5388681|NCT01773252|PFO|pfo
5388682|NCT01773252|ASD|asd
5388683|NCT01773252|shunt|shunt
5388684|NCT01773252|cardiac|cardiac
5388685|NCT01773252|paradoxical thromboembolism|paradoxical thromboembolism
5388686|NCT01773252|interventional cardiology|interventional cardiology
5388687|NCT01773252|stroke|stroke
5388688|NCT01773252|migraine|migraine
5388689|NCT01773252|aura|aura
5388690|NCT01773252|obstructive sleep apnea|obstructive sleep apnea
5388691|NCT01773252|decompression illness|decompression illness
5388692|NCT01773252|neurology|neurology
5388693|NCT01773252|transesophageal echocardiography|transesophageal echocardiography
5388694|NCT01773252|TEE|tee
5388695|NCT01773252|transthoracic echocardiography|transthoracic echocardiography
5388696|NCT01773252|TTE|tte
5388697|NCT01773252|transcranial Doppler|transcranial doppler
5388698|NCT01773252|ultrasound|ultrasound
5388699|NCT01773252|TCD|tcd
5388700|NCT01773252|power m Mode|power m mode
5388701|NCT01773252|indocyanine green dye|indocyanine green dye
5388702|NCT01773252|ICG|icg
5388703|NCT01773252|Valsalva|valsalva
5388704|NCT01773239|social cognition|social cognition
5388705|NCT01773239|cognitive deficits|cognitive deficits
5388706|NCT01773239|prodromal schizophrenia|prodromal schizophrenia
5388707|NCT01773239|recent-onset schizophrenia|recent-onset schizophrenia
5388708|NCT01773239|remediation|remediation
5388709|NCT01773239|computer training|computer training
5388710|NCT01773239|cognitive training exercises|cognitive training exercises
5388711|NCT01773226|Autologous Protein Solution|autologous protein solution
5388713|NCT01773226|Osteoarthritis|osteoarthritis
5388714|NCT01773226|Injection|injection
5388715|NCT01773213|Lower urinary tract|lower urinary tract
5388716|NCT01773213|Bladder|bladder
5388717|NCT01773213|Neuropathic bladder|neuropathic bladder
5388718|NCT01773213|Overactive bladder|overactive bladder
5388719|NCT01773200|endothelial progenitor cells|endothelial progenitor cells
5388720|NCT01773200|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5388721|NCT01773200|vasospasm|vasospasm
5388722|NCT01773200|BNP|bnp
5388723|NCT01773187|Myelofibrosis|myelofibrosis
5388724|NCT01773187|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5388725|NCT01773187|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5388726|NCT01773187|Primary Myelofibrosis|primary myelofibrosis
5388727|NCT01773187|Polycythemia|polycythemia
5388728|NCT01773187|Polycythemia Vera|polycythemia vera
5388729|NCT01773187|Thrombocythemia, Essential|thrombocythemia, essential
5388730|NCT01773187|Thrombocythemia|thrombocythemia
5388731|NCT01773187|Myeloproliferative Disorders|myeloproliferative disorders
5388732|NCT01773187|Bone Marrow Disease|bone marrow disease
5388733|NCT01773187|Hematologic Diseases|hematologic diseases
5388734|NCT01773187|Blood Platelet Disorders|blood platelet disorders
5388735|NCT01773187|Hemorrhagic Disorders|hemorrhagic disorders
5388736|NCT01773187|Splenomegaly|splenomegaly
5388737|NCT01773187|Pacritinib|pacritinib
5388739|NCT01773187|MPN-SAF TSS|mpn-saf tss
5388740|NCT01773187|Anemia|anemia
5388741|NCT01773187|Myeloproliferative|myeloproliferative
5388742|NCT01773187|Myeloproliferative Neoplasm|myeloproliferative neoplasm
5388743|NCT01773187|Spleen|spleen
5388744|NCT01773187|Spleen volume|spleen volume
5388745|NCT01773187|Thrombocytopenia|thrombocytopenia
5388746|NCT01773187|SB1518|sb1518
5388747|NCT01773161|Cerebral Palsy|cerebral palsy
5388748|NCT01773161|Hip surgery|hip surgery
5388749|NCT01773161|Quality of Life|quality of life
5388750|NCT01773135|threatened preterm labor|threatened preterm labor
5388751|NCT01773135|ACTH|acth
5388752|NCT01773135|PTL|ptl
5388753|NCT01773109|Male/female subjects 18 years of age and older|male/female subjects 18 years of age and older
5388754|NCT01773109|metastatic or recurrent NSCLC|metastatic or recurrent nsclc
5388755|NCT01773109|who failed 2nd line therapy|who failed 2nd line therapy
5388756|NCT01773096|opioid-induced|opioid-induced
5388757|NCT01773083|Inhalation trauma|inhalation trauma
5388758|NCT01773083|pulmonary coagulopathy|pulmonary coagulopathy
5388759|NCT01773083|heparin nebulization|heparin nebulization
5388760|NCT01773083|mechanical ventilation|mechanical ventilation
5388761|NCT01773070|Chronic Hepatitis C|chronic hepatitis c
5388762|NCT01773070|Hepatitis C virus|hepatitis c virus
5388763|NCT01773070|Direct Acting Antiviral|direct acting antiviral
5388764|NCT01773070|Sustained Virologic Response|sustained virologic response
5388765|NCT01773070|Hepatitis C|hepatitis c
5388766|NCT01773070|Persistence of treatment-emergent substitutions|persistence of treatment-emergent substitutions
5388767|NCT01773057|Computerized Decision Support System|computerized decision support system
5388768|NCT01773057|Heart failure|heart failure
5388769|NCT01773057|Effects on quality of care|effects on quality of care
5388770|NCT01773057|Process of care|process of care
5388771|NCT01773057|Patient outcomes|patient outcomes
5388772|NCT01773031|Autoimmune pancreatitis|autoimmune pancreatitis
5388773|NCT01773031|MR pancreatography|mr pancreatography
5388774|NCT01773005|Anesthetics, Intravenous|anesthetics, intravenous
5388775|NCT01772992|HIV couples adherence linkage to care viral suppression|hiv couples adherence linkage to care viral suppression
5388776|NCT01772979|Trabectedin|trabectedin
5388777|NCT01772979|BRCA1 and BRCA2|brca1 and brca2
5388778|NCT01772979|BRCAness|brcaness
5388779|NCT01772979|Ovarian cancer|ovarian cancer
5388780|NCT01772966|neck|neck
5388781|NCT01772966|pain|pain
5388782|NCT01772966|chronic|chronic
5388783|NCT01772966|manipulation|manipulation
5388784|NCT01772966|control|control
5388785|NCT01772966|randomized trial|randomized trial
5388786|NCT01772953|AML|aml
5388787|NCT01772953|MDS|mds
5388788|NCT01772953|Treosulfan|treosulfan
5388789|NCT01772940|First-line therapy|first-line therapy
5388790|NCT01772940|Protease inhibitor|protease inhibitor
5388791|NCT01772940|Non-Nucleoside Reverse transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5388792|NCT01772940|Resource-limited setting|resource-limited setting
5388793|NCT01772927|parenteral nutrition|parenteral nutrition
5388794|NCT01772927|Very low birth weight infants|very low birth weight infants
5388795|NCT01772927|preterm infants|preterm infants
5388796|NCT01772927|biochemical tolerance|biochemical tolerance
5388797|NCT01772927|nutritional intake|nutritional intake
5388798|NCT01772914|Copeptin|copeptin
5388799|NCT01772914|eating|eating
5388800|NCT01772914|glucose tolerance test|glucose tolerance test
5388802|NCT01772914|physiological|physiological
5388803|NCT01772901|influenza|influenza
5388804|NCT01772901|influenza vaccines|influenza vaccines
5388805|NCT01772901|infectious disease|infectious disease
5388806|NCT01772901|pregnancy|pregnancy
5388807|NCT01772875|urinary catheter|urinary catheter
5388809|NCT01772875|bladder lavage|bladder lavage
5388810|NCT01772862|childhood|childhood
5388811|NCT01772862|cancer|cancer
5388812|NCT01772862|physical activity|physical activity
5388813|NCT01772862|quality of life|quality of life
5388814|NCT01772849|childhood|childhood
5388815|NCT01772849|cancer|cancer
5388816|NCT01772849|education|education
5388817|NCT01772849|physical activity|physical activity
5388818|NCT01772849|quality of life|quality of life
5388819|NCT01772823|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
5388820|NCT01772810|Paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury|paralysis, spinal cord injury, chronic spinal cord injury, cspine injury, neck injury
5388821|NCT01772797|anaplastic lymphoma kinase, ALK-rearranged lung cancer, non-small cell lung cancer|anaplastic lymphoma kinase, alk-rearranged lung cancer, non-small cell lung cancer
5388822|NCT01772784|subjects|subjects
5388823|NCT01772771|Cancer|cancer
5388824|NCT01772771|Molecular testing|molecular testing
5388825|NCT01772771|Personalized Cancer Therapy Program|personalized cancer therapy program
5388826|NCT01772771|Bladder|bladder
5388827|NCT01772771|Bone|bone
5388828|NCT01772771|Breast|breast
5388829|NCT01772771|Cytology|cytology
5388830|NCT01772771|Endocrine|endocrine
5388831|NCT01772771|Gynecology|gynecology
5388832|NCT01772771|Endocrine - Neoplasia|endocrine - neoplasia
5388833|NCT01772771|genitourinary|genitourinary
5388834|NCT01772771|Research Biorepository|research biorepository
5388835|NCT01772771|Head and Neck|head and neck
5388836|NCT01772771|Aerodigestive Tract|aerodigestive tract
5388837|NCT01772771|Hematopathology|hematopathology
5388838|NCT01772771|Human Cancer Genetics|human cancer genetics
5388839|NCT01772771|Kidney|kidney
5388840|NCT01772771|Leukemia|leukemia
5388841|NCT01772771|Lower Gastrointestinal|lower gastrointestinal
5388842|NCT01772771|Lymphoma|lymphoma
5388843|NCT01772771|Melanoma|melanoma
5388844|NCT01772771|Neurology|neurology
5388845|NCT01772771|Brain|brain
5388846|NCT01772771|Non-Melanoma Skin|non-melanoma skin
5388847|NCT01772771|Pancreas|pancreas
5388848|NCT01772771|Pediatrics|pediatrics
5388849|NCT01772771|Prostate|prostate
5388850|NCT01772771|Breast Cancer Patients, Serum|breast cancer patients, serum
5388851|NCT01772771|Plasma|plasma
5388852|NCT01772771|Soft Tissue Sarcoma|soft tissue sarcoma
5388853|NCT01772771|Thoracic|thoracic
5388854|NCT01772771|Lung|lung
5388855|NCT01772771|S.P.O.R.E.|s.p.o.r.e.
5388856|NCT01772771|Upper Gastrointestinal|upper gastrointestinal
5388857|NCT01772758|CF, cystic fibrosis, exercise|cf, cystic fibrosis, exercise
5388858|NCT01772745|single incision|single incision
5388859|NCT01772745|cholecystectomy|cholecystectomy
5388860|NCT01772745|laparoscopy|laparoscopy
5388861|NCT01772732|Simotinib|simotinib
5388862|NCT01772732|Non-small Cell Lung Cancer|non-small cell lung cancer
5388863|NCT01772719|refractory multiple myeloma|refractory multiple myeloma
5388864|NCT01772706|Head and neck cancer|head and neck cancer
5388865|NCT01772706|Low level laser therapy|low level laser therapy
5388866|NCT01772706|Mucositis induced by radiochemotherpy|mucositis induced by radiochemotherpy
5388867|NCT01772693|ExAblate Transcranial MRgFUS|exablate transcranial mrgfus
5388869|NCT01772680|Diabetes|diabetes
5388870|NCT01772680|Zinc|zinc
5388871|NCT01772680|Iron-Overload|iron-overload
5388872|NCT01772667|pulmonary fibrosis|pulmonary fibrosis
5388873|NCT01772667|interstitial lung disease|interstitial lung disease
5388874|NCT01772667|pulmonary rehabilitation|pulmonary rehabilitation
5388875|NCT01772667|exercise capacity|exercise capacity
5388876|NCT01772667|physical activity|physical activity
5388877|NCT01772667|quality of life|quality of life
5388878|NCT01772654|Epilepsy|epilepsy
5388879|NCT01772654|Arterial Spin Labeled MRI|arterial spin labeled mri
5388880|NCT01772654|Brain lesions|brain lesions
5388881|NCT01772654|Cerebral blood flow|cerebral blood flow
5388882|NCT01772641|cigarette|cigarette
5388883|NCT01772641|smoking|smoking
5388884|NCT01772641|cessation|cessation
5388885|NCT01772641|varenicline|varenicline
5388886|NCT01772641|scheduled reduction|scheduled reduction
5388888|NCT01772628|Communication|communication
5388889|NCT01772628|Healthy sexual behaviour|healthy sexual behaviour
5388890|NCT01772628|Sexual and reproductive health|sexual and reproductive health
5388891|NCT01772628|Adolescents|adolescents
5388892|NCT01772615|EcN, Nissle, Mutaflor, Ulcerative Colitis, antibiotics, Inflammatory Bowel Diseases|ecn, nissle, mutaflor, ulcerative colitis, antibiotics, inflammatory bowel diseases
5388893|NCT01772602|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5388894|NCT01772602|Lou Gehrig's Disease|lou gehrig's disease
5388895|NCT01772602|Motor Neuron Disease|motor neuron disease
5388896|NCT01772576|Reliance|reliance
5388897|NCT01772576|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5388898|NCT01772576|Cardiac Resynchronization Therapy - Defibrillator (CRT-D)|cardiac resynchronization therapy - defibrillator (crt-d)
5388899|NCT01772550|CECT, catheter, contrast|cect, catheter, contrast
5388900|NCT01772537|thoracoabdominal|thoracoabdominal
5388902|NCT01772537|open|open
5388903|NCT01772537|stent|stent
5388904|NCT01772537|cardiopulmonary|cardiopulmonary
5388905|NCT01772537|abdominal|abdominal
5388906|NCT01772537|bypass|bypass
5388907|NCT01772524|Migraine Disorders|migraine disorders
5388908|NCT01772524|Phase 1|phase 1
5388909|NCT01772524|ALD403|ald403
5388910|NCT01772511|questionnaire|questionnaire
5388911|NCT01772511|prior therapy|prior therapy
5388912|NCT01772511|prior study volunteer|prior study volunteer
5388913|NCT01772511|prior study patient|prior study patient
5388914|NCT01772511|cancer|cancer
5388915|NCT01772511|oncology|oncology
5388916|NCT01772498|depression|depression
5388917|NCT01772498|anxiety|anxiety
5388918|NCT01772498|sleep|sleep
5388919|NCT01772498|pain|pain
5388920|NCT01772498|biofeedback|biofeedback
5388921|NCT01772498|breathing|breathing
5388922|NCT01772498|resonant|resonant
5388923|NCT01772459|Scoliosis|scoliosis
5388924|NCT01772459|Adolescents|adolescents
5388925|NCT01772459|Questionnaire|questionnaire
5388926|NCT01772459|Reliability|reliability
5388927|NCT01772446|diabetes|diabetes
5388928|NCT01772446|management|management
5388929|NCT01772446|glycated hemoglobin|glycated hemoglobin
5388930|NCT01772446|preventive activities|preventive activities
5388931|NCT01772433|Low Back Pain|low back pain
5389719|NCT01768858|Monoclonals|monoclonals
5388932|NCT01772433|Topical Olive Oil|topical olive oil
5388933|NCT01772433|Phonophoresis|phonophoresis
5388934|NCT01772407|Colon Cancer Surgery|colon cancer surgery
5388935|NCT01772407|Laparoscopy|laparoscopy
5388936|NCT01772407|Open surgery|open surgery
5388937|NCT01772407|Costs|costs
5388938|NCT01772407|Mortality|mortality
5388939|NCT01772407|Morbidity|morbidity
5388940|NCT01772407|Quality of life|quality of life
5388941|NCT01772394|Anorexia Nervosa|anorexia nervosa
5388942|NCT01772394|Cognitive remediation therapy|cognitive remediation therapy
5388943|NCT01772394|Randomized clinical trial|randomized clinical trial
5388944|NCT01772381|Dexamethasone, term, elective cesarean section|dexamethasone, term, elective cesarean section
5388945|NCT01772368|Asthma|asthma
5388946|NCT01772368|dry powder inhaler|dry powder inhaler
5388947|NCT01772368|long-acting beta2-agonist|long-acting beta2-agonist
5388948|NCT01772368|bronchodilation|bronchodilation
5388949|NCT01772368|bronchodilator|bronchodilator
5388950|NCT01772368|metered dose inhaler|metered dose inhaler
5388951|NCT01772368|inhaled corticosteroid|inhaled corticosteroid
5388952|NCT01772355|orbit; tumor; core biopsy|orbit; tumor; core biopsy
5388953|NCT01772342|Sleep Fragmentation|sleep fragmentation
5388958|NCT01772277|Mitomycin C|mitomycin c
5388959|NCT01772251|Diabetes Mellitus|diabetes mellitus
5388960|NCT01772251|Oral Insulin|oral insulin
5388961|NCT01772238|Mexico|mexico
5388962|NCT01772238|Respiratory infections|respiratory infections
5388963|NCT01772238|Amoxicillin-Clavulanic Acid|amoxicillin-clavulanic acid
5388964|NCT01772238|Bioequivalence|bioequivalence
5388965|NCT01772225|Observational Retrospective|observational retrospective
5388966|NCT01772225|Health-related quality of life (HRQoL)|health-related quality of life (hrqol)
5388967|NCT01772225|Patients|patients
5388968|NCT01772225|Stage IB-IIIA|stage ib-iiia
5388969|NCT01772225|Burden of Illness|burden of illness
5388970|NCT01772225|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5388971|NCT01772212|Mexico|mexico
5388972|NCT01772212|terbinafine|terbinafine
5388973|NCT01772212|mycoses|mycoses
5388974|NCT01772212|pharmacokinetics|pharmacokinetics
5388975|NCT01772199|GSK239512|gsk239512
5388976|NCT01772199|remyelination|remyelination
5388977|NCT01772199|magnetic resonance imaging|magnetic resonance imaging
5388978|NCT01772199|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5388979|NCT01772199|Histamine 3 Receptor Antagonist|histamine 3 receptor antagonist
5388980|NCT01772199|magnetization transfer ratio|magnetization transfer ratio
5388981|NCT01772186|Freezing of gait|freezing of gait
5388982|NCT01772186|Parkinson's disease|parkinson's disease
5388983|NCT01772186|Somatosensory stimulation|somatosensory stimulation
5388984|NCT01772186|Fall prevention|fall prevention
5388985|NCT01772173|diabetes|diabetes
5388986|NCT01772173|computer|computer
5388987|NCT01772173|retina|retina
5388988|NCT01772173|vessel|vessel
5388989|NCT01772173|analysis|analysis
5388990|NCT01772160|Adults|adults
5388991|NCT01772160|Italy|italy
5388992|NCT01772160|Herpes Zoster|herpes zoster
5388993|NCT01772160|Complications|complications
5388994|NCT01772160|Quality of life|quality of life
5388995|NCT01772160|Surveillance|surveillance
5388996|NCT01772160|Burden|burden
5388997|NCT01772160|Cost|cost
5388998|NCT01772160|Incidence|incidence
5388999|NCT01772121|HBV, HCV, chronic, India, observational study, prevalence,|hbv, hcv, chronic, india, observational study, prevalence,
5389000|NCT01772121|genotypes, SNPs, viral hepatitis|genotypes, snps, viral hepatitis
5389001|NCT01772108|Heart Valve Diseases|heart valve diseases
5389002|NCT01772095|Donepezil (Dementis)|donepezil (dementis)
5389003|NCT01772095|Elderly|elderly
5389004|NCT01772069|systemic lupus erythematosus, disease activity, sleep, quality of life|systemic lupus erythematosus, disease activity, sleep, quality of life
5389005|NCT01772056|Dermatitis, Atopic|dermatitis, atopic
5389006|NCT01772056|Randomized Controlled Trial|randomized controlled trial
5389007|NCT01772056|Child|child
5389008|NCT01772056|Fluticasone|fluticasone
5389009|NCT01772056|Preventive therapy|preventive therapy
5389010|NCT01772043|muscular dystrophy|muscular dystrophy
5389011|NCT01772043|tissue bank|tissue bank
5389012|NCT01772030|Atrial Fibrillation|atrial fibrillation
5389013|NCT01772030|Cryoballoon Ablation|cryoballoon ablation
5389014|NCT01772017|Obstructive Sleep Apnea|obstructive sleep apnea
5389016|NCT01772017|Snoring|snoring
5389017|NCT01772017|Tongue Advancement Retainer Device|tongue advancement retainer device
5389018|NCT01772004|Solid Tumors|solid tumors
5389019|NCT01772004|MSB0010718C|msb0010718c
5389020|NCT01772004|Phase 1|phase 1
5389021|NCT01772004|Pharmacokinetic|pharmacokinetic
5389022|NCT01772004|anti PD-L1|anti pd-l1
5389023|NCT01772004|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5389024|NCT01772004|Metastatic breast cancer (MBC)|metastatic breast cancer (mbc)
5389025|NCT01772004|Gastric and gastroesophageal junction (GEJ) cancer|gastric and gastroesophageal junction (gej) cancer
5389026|NCT01772004|Ovarian cancer|ovarian cancer
5389720|NCT01768858|Rheumatoid|rheumatoid
5389027|NCT01772004|Colorectal cancer (CRC)|colorectal cancer (crc)
5389028|NCT01772004|Castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
5389029|NCT01772004|Melanoma|melanoma
5389030|NCT01772004|Urothelial carcinoma|urothelial carcinoma
5389031|NCT01772004|Bladder cancer|bladder cancer
5389032|NCT01772004|Head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5389033|NCT01772004|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5389034|NCT01772004|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
5389035|NCT01771991|fibrosis|fibrosis
5389036|NCT01771991|radiation|radiation
5389037|NCT01771991|neck|neck
5389038|NCT01771991|cancer|cancer
5389039|NCT01771991|Sodermix|sodermix
5389040|NCT01771978|ischaemia-reperfusion injury|ischaemia-reperfusion injury
5389041|NCT01771978|cardiac surgery|cardiac surgery
5389042|NCT01771978|oxidative stress markers|oxidative stress markers
5389044|NCT01771978|diltiazem|diltiazem
5389045|NCT01771978|acetylcystein|acetylcystein
5389046|NCT01771952|Patellofemoral Chondromalacia|patellofemoral chondromalacia
5389047|NCT01771952|Anterior Knee Pain|anterior knee pain
5389048|NCT01771952|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
5389049|NCT01771952|Synvisc-One|synvisc-one
5389050|NCT01771952|Hyaluronic Acid|hyaluronic acid
5389051|NCT01771939|Idiopathic epiretinal membranes|idiopathic epiretinal membranes
5389052|NCT01771939|25-G surgery in idiopathic epiretinal membranes|25-g surgery in idiopathic epiretinal membranes
5389053|NCT01771926|resistant starch|resistant starch
5389054|NCT01771926|lifestyle intervention|lifestyle intervention
5389055|NCT01771913|adipocytes|adipocytes
5389056|NCT01771913|cell transplantations|cell transplantations
5389057|NCT01771913|mesenchymal stem cell|mesenchymal stem cell
5389058|NCT01771913|immunophenotyping|immunophenotyping
5389059|NCT01771913|adipose tissue|adipose tissue
5389060|NCT01771913|breast reconstruction|breast reconstruction
5389061|NCT01771913|mammaplasty|mammaplasty
5389062|NCT01771913|magnetic resonance imaging|magnetic resonance imaging
5389063|NCT01771913|fat necrosis|fat necrosis
5389064|NCT01771900|heart failure|heart failure
5389065|NCT01771900|exercise|exercise
5389066|NCT01771900|adherence to exercise|adherence to exercise
5389067|NCT01771887|Diabetic Type2|diabetic type2
5389068|NCT01771887|education|education
5389069|NCT01771887|self-management behaviors|self-management behaviors
5389070|NCT01771887|self-efficacy|self-efficacy
5389071|NCT01771887|HbA1c|hba1c
5389072|NCT01771874|MDMA|mdma
5389073|NCT01771874|pharmacokinetics|pharmacokinetics
5389074|NCT01771874|pharmacodynamics|pharmacodynamics
5389075|NCT01771874|emotions|emotions
5389076|NCT01771874|Mechanism of action of MDMA|mechanism of action of mdma
5389077|NCT01771874|Interaction study|interaction study
5389078|NCT01771874|Effect of MDMA and bupropion on emotions|effect of mdma and bupropion on emotions
5389079|NCT01771848|Malaria|malaria
5389080|NCT01771848|Plasmodium falciparum|plasmodium falciparum
5389081|NCT01771835|diabetes mellitus|diabetes mellitus
5389082|NCT01771835|retinal venous pressure|retinal venous pressure
5389083|NCT01771835|endothelin-1|endothelin-1
5389084|NCT01771822|cumulative irritancy patch test (CIPT)|cumulative irritancy patch test (cipt)
5389085|NCT01771809|Anti-TNF Refractory|anti-tnf refractory
5389086|NCT01771809|Active Ulcerative Colitis|active ulcerative colitis
5389087|NCT01771809|Immunosuppressant Refractory|immunosuppressant refractory
5389088|NCT01771796|Exercise; lung cancer; aerobic training, resistance training; respiratory muscle training|exercise; lung cancer; aerobic training, resistance training; respiratory muscle training
5389089|NCT01771783|RAS-Peptide Profile|ras-peptide profile
5389090|NCT01771783|Renin-Angiotensin-System|renin-angiotensin-system
5389091|NCT01771783|Angiotensin-Converting-Enzyme-Inhibitor|angiotensin-converting-enzyme-inhibitor
5389092|NCT01771783|Angiotensin-Receptor-Antagonist|angiotensin-receptor-antagonist
5389097|NCT01771770|mountain sickness|mountain sickness
5389098|NCT01771757|retinal venous pressure|retinal venous pressure
5389099|NCT01771757|reduced ambient pressure|reduced ambient pressure
5389100|NCT01771757|oxygen partial pressure|oxygen partial pressure
5389101|NCT01771757|short-term hypoxic changes|short-term hypoxic changes
5389102|NCT01771705|Transplantation|transplantation
5389103|NCT01771705|Kidney|kidney
5389104|NCT01771705|calcineurin inhibitor|calcineurin inhibitor
5389105|NCT01771705|NFAT|nfat
5389106|NCT01771705|tacrolimus|tacrolimus
5389107|NCT01771692|Orthodontics|orthodontics
5389108|NCT01771679|Mesenchymal Stem Cells|mesenchymal stem cells
5389109|NCT01771679|Bone Marrow Cells|bone marrow cells
5389110|NCT01771679|Allogeneic Transplantation|allogeneic transplantation
5389111|NCT01771679|Skin Wrinkling|skin wrinkling
5389112|NCT01771679|Solar Aging of Skin|solar aging of skin
5389113|NCT01771679|Intravenous Administration|intravenous administration
5389114|NCT01771653|Hepatitis C infection|hepatitis c infection
5389115|NCT01771653|Hepatitis C Virus|hepatitis c virus
5389117|NCT01771640|ALS intrathecal injection bone marrow mesenchymal stem cell|als intrathecal injection bone marrow mesenchymal stem cell
5389118|NCT01771614|Glucotoxicity|glucotoxicity
5389119|NCT01771614|Exercise|exercise
5389120|NCT01771614|Beta-cell function|beta-cell function
5445457|NCT01521702|pancreatic head|pancreatic head
5445458|NCT01521689|MRD negative CR|mrd negative cr
5389121|NCT01771601|Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,|near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,
5389122|NCT01771562|HIV-1|hiv-1
5389123|NCT01771562|Child|child
5389124|NCT01771562|Adolescent|adolescent
5389125|NCT01771562|Growth|growth
5389126|NCT01771562|Lipodystrophy|lipodystrophy
5389127|NCT01771562|ARV treatment|arv treatment
5389128|NCT01771562|Senegal|senegal
5389129|NCT01771549|Adriamycin|adriamycin
5389130|NCT01771549|Trastuzumab|trastuzumab
5389131|NCT01771549|Brain Natriuretic Peptide (BNP)|brain natriuretic peptide (bnp)
5389132|NCT01771549|Troponin|troponin
5389133|NCT01771523|thyroidectomy|thyroidectomy
5389134|NCT01771523|drain use|drain use
5389139|NCT01771471|back pain|back pain
5389140|NCT01771471|intervertebral disc|intervertebral disc
5389141|NCT01771471|lumbar spine|lumbar spine
5389142|NCT01771458|Metastatic/Reccurent|metastatic/reccurent
5389143|NCT01771458|Solid Tumor|solid tumor
5389144|NCT01771458|Refractory|refractory
5389145|NCT01771458|Molecular profile|molecular profile
5389146|NCT01771458|Targeted treatment|targeted treatment
5389148|NCT01771445|IL-6|il-6
5389149|NCT01771445|Inflammation|inflammation
5389150|NCT01771419|loop-tip|loop-tip
5389151|NCT01771419|ERCP|ercp
5389152|NCT01771419|cannulation of CBD|cannulation of cbd
5389153|NCT01771393|arthroscanner|arthroscanner
5389154|NCT01771393|cone-beam computed tomodensitometry|cone-beam computed tomodensitometry
5389155|NCT01771354|Volunteers|volunteers
5389156|NCT01771354|Identify|identify
5389157|NCT01771354|Biomarkers|biomarkers
5389158|NCT01771354|Vaccine Safety|vaccine safety
5389159|NCT01771341|NAVA|nava
5389160|NCT01771341|post operative|post operative
5389161|NCT01771328|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
5389162|NCT01771315|total knee arthroplasty|total knee arthroplasty
5389163|NCT01771315|telephone follow-up|telephone follow-up
5389164|NCT01771315|physical function|physical function
5389165|NCT01771315|health related quality of life|health related quality of life
5389166|NCT01771315|self-efficacy|self-efficacy
5389167|NCT01771302|PRGF-Endoret|prgf-endoret
5389168|NCT01771302|Bone graft|bone graft
5389169|NCT01771302|Maxillary sinus|maxillary sinus
5389170|NCT01771302|Vertical bone augmentation|vertical bone augmentation
5389171|NCT01771289|Lung Cancer|lung cancer
5389172|NCT01771276|POSE|pose
5389173|NCT01771263|Anesthesia|anesthesia
5389174|NCT01771263|Propofol|propofol
5389175|NCT01771263|Remifentanil|remifentanil
5389176|NCT01771263|NeuroSENSE|neurosense
5389177|NCT01771237|HIV infection|hiv infection
5389178|NCT01771224|Palmitoleic acid ulcerative colitis|palmitoleic acid ulcerative colitis
5389180|NCT01771211|Word-retrieval|word-retrieval
5389181|NCT01771211|tDCS|tdcs
5389182|NCT01771211|fMRI|fmri
5389183|NCT01771198|Chronic rhinosinusitis|chronic rhinosinusitis
5389184|NCT01771198|Refractory to treatment|refractory to treatment
5389185|NCT01771198|SIMVASTATIN|simvastatin
5389186|NCT01771185|Diabetes|diabetes
5362425|NCT01891344|Clovis|clovis
5389187|NCT01771185|metabolic surgery|metabolic surgery
5389188|NCT01771185|insulin resistance|insulin resistance
5389189|NCT01771159|Spinal cord injury|spinal cord injury
5389190|NCT01771159|Urinary dysfunction|urinary dysfunction
5389191|NCT01771159|Bladder drainage|bladder drainage
5389192|NCT01771146|Non-metastatic Pancreas Cancer|non-metastatic pancreas cancer
5389193|NCT01771146|Pancreatic Cancer|pancreatic cancer
5389194|NCT01771146|Cancer of Pancreas|cancer of pancreas
5389195|NCT01771146|Adenocarcinoma of Pancreas|adenocarcinoma of pancreas
5389197|NCT01771133|Obesity|obesity
5389198|NCT01771133|Maternal Welfare|maternal welfare
5389199|NCT01771133|Child Welfare|child welfare
5389200|NCT01771133|Nutritional Sciences|nutritional sciences
5389201|NCT01771133|Clinical Trial|clinical trial
5389202|NCT01771133|Pregnancy|pregnancy
5389203|NCT01771133|Physical activity|physical activity
5389204|NCT01771133|Fetal Development|fetal development
5389205|NCT01771133|Metabolic Diseases|metabolic diseases
5389206|NCT01771133|Life style|life style
5389207|NCT01771133|Behavior and Behavior Mechanisms|behavior and behavior mechanisms
5389208|NCT01771133|LIFE-Moms|life-moms
5389209|NCT01771120|Asthma|asthma
5389210|NCT01771120|Rhinitis|rhinitis
5389211|NCT01771120|Control|control
5389212|NCT01771120|Burden|burden
5389213|NCT01771081|Longitudinal Studies,|longitudinal studies,
5389214|NCT01771081|Observation|observation
5389215|NCT01771081|Epidemiology|epidemiology
5389216|NCT01771055|Trauma|trauma
5389217|NCT01771055|Hypovolemia|hypovolemia
5389218|NCT01771042|weight loss|weight loss
5389219|NCT01771042|metabolic syndrome|metabolic syndrome
5389220|NCT01771042|sympathetic nervous system|sympathetic nervous system
5389221|NCT01771042|insulin resistance|insulin resistance
5389721|NCT01768858|Antibodies|antibodies
5389222|NCT01771042|glucose tolerance|glucose tolerance
5389223|NCT01771029|Procalcitonin|procalcitonin
5389224|NCT01771029|Infection|infection
5389225|NCT01771029|Point-of-Care|point-of-care
5389226|NCT01771016|Emergency contraception|emergency contraception
5389227|NCT01771016|Emergency hormonal contraception|emergency hormonal contraception
5389228|NCT01771016|Community pharmacies|community pharmacies
5389229|NCT01771016|Pharmaceutical care|pharmaceutical care
5389230|NCT01771016|Time to access|time to access
5389231|NCT01771016|Written assessments|written assessments
5389232|NCT01771016|Switzerland|switzerland
5389233|NCT01771003|Partial nephrectomy|partial nephrectomy
5389234|NCT01771003|renal cell carcinoma|renal cell carcinoma
5389235|NCT01771003|Renal Function|renal function
5389236|NCT01771003|Remote ischemia preconditioning|remote ischemia preconditioning
5389237|NCT01770990|depression|depression
5389238|NCT01770990|telephone-based psychotherapy|telephone-based psychotherapy
5389239|NCT01770990|cognitive-behavioral psychotherapy|cognitive-behavioral psychotherapy
5389240|NCT01770990|manualized psychotherapy|manualized psychotherapy
5389241|NCT01770990|telephone counseling|telephone counseling
5389242|NCT01770990|telephone psychological treatment|telephone psychological treatment
5389243|NCT01770990|telephone-administered therapy|telephone-administered therapy
5389244|NCT01770990|low-intensity treatment|low-intensity treatment
5389245|NCT01770990|motivational mail|motivational mail
5389246|NCT01770990|reminder|reminder
5389248|NCT01770977|Light-emitting diode therapy|light-emitting diode therapy
5389249|NCT01770977|Muscle performance|muscle performance
5389250|NCT01770977|Aerobic performance|aerobic performance
5389251|NCT01770977|Lactate|lactate
5389252|NCT01770977|Creatine kinase|creatine kinase
5389253|NCT01770938|Light-emitting diode therapy|light-emitting diode therapy
5389254|NCT01770938|Muscle performance|muscle performance
5389255|NCT01770938|Gene expression|gene expression
5389256|NCT01770938|Functional performance|functional performance
5389257|NCT01770912|facial pain|facial pain
5389258|NCT01770912|temporomandibular joint|temporomandibular joint
5389259|NCT01770912|arthrocentesis|arthrocentesis
5389260|NCT01770912|steroid|steroid
5389261|NCT01770899|Montelukast|montelukast
5389262|NCT01770899|Singulair|singulair
5389263|NCT01770899|status asthmaticus|status asthmaticus
5389264|NCT01770886|Drug Safety|drug safety
5389265|NCT01770873|Youth|youth
5389266|NCT01770873|Violence|violence
5389267|NCT01770873|Assault-injured|assault-injured
5389268|NCT01770873|Mentoring|mentoring
5389269|NCT01770873|Emergency Room|emergency room
5389270|NCT01770873|Urban|urban
5389271|NCT01770860|Adhesive Bandages|adhesive bandages
5389272|NCT01770860|Dermabrasion Wounds|dermabrasion wounds
5389273|NCT01770821|sip drink|sip drink
5389274|NCT01770821|protein|protein
5389275|NCT01770821|muscle strength|muscle strength
5389276|NCT01770821|6 minutes walking test|6 minutes walking test
5389277|NCT01770808|Bloating|bloating
5389278|NCT01770808|Flatulence|flatulence
5389279|NCT01770808|Stomach discomfort|stomach discomfort
5389280|NCT01770795|non-small cell lung cancer|non-small cell lung cancer
5389281|NCT01770795|gemcitabine|gemcitabine
5389282|NCT01770795|genexol-PM|genexol-pm
5389283|NCT01770795|paclitaxel|paclitaxel
5389284|NCT01770782|Palatal Expansion Technique|palatal expansion technique
5389285|NCT01770782|Orthognathic Surgery|orthognathic surgery
5389286|NCT01770782|Three Dimensional images|three dimensional images
5389287|NCT01770769|Femoral Neck Fracture|femoral neck fracture
5389288|NCT01770769|undisplaced|undisplaced
5389289|NCT01770769|minimally displaced|minimally displaced
5389290|NCT01770769|internal fixation|internal fixation
5389291|NCT01770769|hemiarthroplasty|hemiarthroplasty
5389292|NCT01770769|harris hip score|harris hip score
5389294|NCT01770769|society cost|society cost
5389295|NCT01770769|quality of life|quality of life
5389296|NCT01770769|Timed Up and go test|timed up and go test
5389297|NCT01770756|Hypertension|hypertension
5389298|NCT01770756|High blood pressure|high blood pressure
5389300|NCT01770756|Self care|self care
5389301|NCT01770743|post-exposure prophylaxis|post-exposure prophylaxis
5389302|NCT01770743|toxin neutralization assay|toxin neutralization assay
5389303|NCT01770730|urine LAM strip test|urine lam strip test
5389304|NCT01770730|diagnostics|diagnostics
5389305|NCT01770730|tuberculosis|tuberculosis
5389306|NCT01770704|Bipolar disorder|bipolar disorder
5389307|NCT01770704|Clinical management|clinical management
5389308|NCT01770704|Clinical outcomes|clinical outcomes
5389309|NCT01770678|Children|children
5389310|NCT01770678|Cerebral Palsy|cerebral palsy
5389311|NCT01770678|Randomised|randomised
5389312|NCT01770678|Constraint Induced Movement Therapy|constraint induced movement therapy
5389313|NCT01770652|Renal Impairment|renal impairment
5389314|NCT01770652|Kidney Impairment|kidney impairment
5389315|NCT01770652|Kidney Disease|kidney disease
5389316|NCT01770652|Ferriprox|ferriprox
5389317|NCT01770652|Deferiprone|deferiprone
5389318|NCT01770652|DFP (deferiprone)|dfp (deferiprone)
5389320|NCT01770639|charcot foot|charcot foot
5389321|NCT01770639|charcot neuroarthropathy|charcot neuroarthropathy
5389722|NCT01768858|Ankylosing|ankylosing
5389322|NCT01770639|midfoot arthrodesis|midfoot arthrodesis
5389323|NCT01770639|midfoot fusion|midfoot fusion
5389324|NCT01770613|Adult|adult
5389325|NCT01770613|Allogeneic|allogeneic
5389326|NCT01770613|Stem|stem
5389327|NCT01770613|Cells|cells
5389328|NCT01770613|Myocardial|myocardial
5389329|NCT01770613|Infarction|infarction
5389330|NCT01770600|Age 19 to 64|age 19 to 64
5389331|NCT01770600|Medically stable|medically stable
5389332|NCT01770600|No current or history of psychosis|no current or history of psychosis
5389333|NCT01770600|No alcohol or benzodiazepine withdrawal|no alcohol or benzodiazepine withdrawal
5389334|NCT01770587|Insomnia|insomnia
5389339|NCT01770574|calcaneal lengthening|calcaneal lengthening
5389340|NCT01770574|calcium ceramics|calcium ceramics
5389341|NCT01770574|noninferiority|noninferiority
5389342|NCT01770574|radiostereometric analysis|radiostereometric analysis
5389343|NCT01770535|Ovarian cancer, paclitaxel|ovarian cancer, paclitaxel
5389344|NCT01770522|Bodyweight|bodyweight
5389345|NCT01770522|Physical Acivitiy|physical acivitiy
5389346|NCT01770522|Diet|diet
5389347|NCT01770522|Bodymass index|bodymass index
5389348|NCT01770522|Pregnancy|pregnancy
5389349|NCT01770522|Postnatal|postnatal
5389350|NCT01770509|Chronic venous leg ulcers|chronic venous leg ulcers
5389351|NCT01770509|Venous ulcer|venous ulcer
5389352|NCT01770509|Stasis ulcer|stasis ulcer
5389353|NCT01770509|Varicose ulcer|varicose ulcer
5389354|NCT01770496|immunization|immunization
5389355|NCT01770496|vaccination|vaccination
5389356|NCT01770496|immunization information system|immunization information system
5389357|NCT01770496|immunization registry|immunization registry
5389358|NCT01770496|reminder / recall|reminder / recall
5389359|NCT01770483|Nitazoxanide,|nitazoxanide,
5389360|NCT01770483|Sustained viral response|sustained viral response
5389361|NCT01770483|Type 2 DIABETICS|type 2 diabetics
5389362|NCT01770470|serum phosphate|serum phosphate
5389363|NCT01770470|chitosan|chitosan
5389364|NCT01770470|kidney disease|kidney disease
5389365|NCT01770470|salivary phosphate|salivary phosphate
5389366|NCT01770457|ICU population|icu population
5389367|NCT01770444|Acute coronary syndrome|acute coronary syndrome
5389368|NCT01770444|Cardiac computed tomographic angiography|cardiac computed tomographic angiography
5389369|NCT01770444|Radiation dose reduction|radiation dose reduction
5389370|NCT01770444|Medical radiation exposure|medical radiation exposure
5389371|NCT01770431|Huaier Granule;|huaier granule;
5389372|NCT01770431|After radical hepatectomy;|after radical hepatectomy;
5389373|NCT01770431|Prevention of Recurrence and Metastasis;|prevention of recurrence and metastasis;
5389374|NCT01770431|Safety.|safety.
5389375|NCT01770418|Non Small Cell Lung Cancer|non small cell lung cancer
5389376|NCT01770418|Cancer|cancer
5389377|NCT01770418|Lung|lung
5389378|NCT01770418|Proton|proton
5389379|NCT01770418|Radiation|radiation
5389380|NCT01770405|endomicroscopy|endomicroscopy
5389381|NCT01770405|needle-based|needle-based
5389382|NCT01770405|pancreatic|pancreatic
5389383|NCT01770405|cyst|cyst
5389384|NCT01770405|mass|mass
5389385|NCT01770405|EUSFNA|eusfna
5389386|NCT01770379|Rheumatoid Arthritis, RA, IL-17 blocker, subcutaneous, self-injection, AIN457, AIN457F, secukinumab, anti-TNFα, pre-filled syringe|rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe
5002918|NCT03977831|Bladder Cancer|bladder cancer
5389387|NCT01770366|obesity|obesity
5389388|NCT01770366|weight loss surgery|weight loss surgery
5389389|NCT01770366|virtual support|virtual support
5389390|NCT01770366|wireless devices|wireless devices
5389391|NCT01770366|Internet|internet
5389392|NCT01770353|solid tumors|solid tumors
5384736|NCT01791543|ablation|ablation
5389394|NCT01770353|Colorectal Cancer|colorectal cancer
5389395|NCT01770353|MM-398|mm-398
5389396|NCT01770353|nanoliposomal irinotecan|nanoliposomal irinotecan
5389397|NCT01770353|Ferumoxytol|ferumoxytol
5389398|NCT01770353|ER/PR positive Breast Cancer|er/pr positive breast cancer
5389399|NCT01770353|Pancreatic Cancer|pancreatic cancer
5389400|NCT01770353|Ovarian Cancer|ovarian cancer
5389401|NCT01770353|Gastric Cancer|gastric cancer
5389402|NCT01770353|Gastro-Esophageal Junction Adenocarcinoma|gastro-esophageal junction adenocarcinoma
5389403|NCT01770353|Head and Neck Cancer|head and neck cancer
5389404|NCT01770353|TNBC|tnbc
5389405|NCT01770340|radical prostatectomy|radical prostatectomy
5389406|NCT01770340|erectile function|erectile function
5389407|NCT01770340|nerve grafting|nerve grafting
5389408|NCT01770340|allogenic|allogenic
5389409|NCT01770340|prostate cancer|prostate cancer
5389410|NCT01770340|Allogenic nerve graft|allogenic nerve graft
5389411|NCT01770340|Time required for nerve grafting|time required for nerve grafting
5389412|NCT01770314|Opioid Pain Medication|opioid pain medication
5389413|NCT01770314|Medication Safety|medication safety
5389414|NCT01770314|Correct storage|correct storage
5389415|NCT01770314|Correct disposal|correct disposal
5389416|NCT01770314|Correct Use|correct use
5389417|NCT01770288|Anerobic exercise|anerobic exercise
5389418|NCT01770288|Pain|pain
5389419|NCT01770288|Analgesia|analgesia
5389420|NCT01770288|Diffuse Noxious Inhibitory Control (DNIC)|diffuse noxious inhibitory control (dnic)
5389421|NCT01770288|psychological stress|psychological stress
5389422|NCT01770275|esophagus|esophagus
5389423|NCT01770249|dysphagia|dysphagia
5389424|NCT01770210|hypercholesterolemia|hypercholesterolemia
5389425|NCT01770210|atorvastatin|atorvastatin
5389426|NCT01770210|cardiovascular events|cardiovascular events
5389427|NCT01770197|China|china
5389428|NCT01770197|Stroke|stroke
5389429|NCT01770197|Thrombolytic therapy|thrombolytic therapy
5389430|NCT01770184|Self-management|self-management
5389431|NCT01770184|Rehabilitation|rehabilitation
5389432|NCT01770184|Occupational Therapy|occupational therapy
5389433|NCT01770171|endometrial cancer|endometrial cancer
5389434|NCT01770171|recurrent endometrial cancer|recurrent endometrial cancer
5389435|NCT01770171|bevacizumab|bevacizumab
5671957|NCT00613496|Interleukin-6|interleukin-6
5389436|NCT01770158|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5389437|NCT01770158|Histamine Dihydrochloride|histamine dihydrochloride
5389439|NCT01770145|Motor symptoms|motor symptoms
5389440|NCT01770145|Parkinson's Disease|parkinson's disease
5389441|NCT01770145|Delayed Onset|delayed onset
5389442|NCT01770145|Akinesia|akinesia
5389443|NCT01770145|Hypomobility|hypomobility
5389444|NCT01770145|Unified Parkinson Disease Rating Scale (UPDRS) motor scores|unified parkinson disease rating scale (updrs) motor scores
5389445|NCT01770145|Dopamine agonist|dopamine agonist
5389446|NCT01770145|Apomorphine|apomorphine
5389447|NCT01770145|Apokyn|apokyn
5389448|NCT01770145|Levodopa|levodopa
5389449|NCT01770119|Measles|measles
5389450|NCT01770119|Mumps|mumps
5389451|NCT01770119|Rubella|rubella
5389452|NCT01770119|Pediatric|pediatric
5389453|NCT01770119|Solid-organ transplant|solid-organ transplant
5389454|NCT01770119|serology|serology
5389455|NCT01770119|vaccine|vaccine
5389456|NCT01770106|Rheumatoid arthritis|rheumatoid arthritis
5389457|NCT01770106|Bone density|bone density
5389458|NCT01770106|Bone microarchitecture|bone microarchitecture
5389459|NCT01770106|HR-pQCT|hr-pqct
5389460|NCT01770067|Cardiac Resynchronization Therapy Devices|cardiac resynchronization therapy devices
5389461|NCT01770054|metabolic syndrome|metabolic syndrome
5389462|NCT01770054|diabetes mellitus|diabetes mellitus
5389463|NCT01770028|Obesity|obesity
5389464|NCT01770028|Pregnancy|pregnancy
5389465|NCT01770028|Spouse|spouse
5389466|NCT01770028|Weight loss|weight loss
5389467|NCT01770028|Behavioral|behavioral
5389468|NCT01770015|patient ventilated for at least five days|patient ventilated for at least five days
5389469|NCT01769963|Advanced glycation end-products|advanced glycation end-products
5389470|NCT01769963|chronic kidney disease|chronic kidney disease
5389471|NCT01769963|nutrition|nutrition
5389472|NCT01769963|inflammation|inflammation
5389473|NCT01769963|insulin resistance|insulin resistance
5389474|NCT01769963|endothelial function|endothelial function
5389475|NCT01769950|Choline PET|choline pet
5389476|NCT01769950|Choline PET-CT|choline pet-ct
5389477|NCT01769950|Positron emission tomography|positron emission tomography
5389478|NCT01769950|Prostate cancer|prostate cancer
5389479|NCT01769937|Lupus|lupus
5389481|NCT01769937|ACTH|acth
5389482|NCT01769937|Acthar|acthar
5389483|NCT01769924|Kidney donors|kidney donors
5389484|NCT01769924|Arterial stiffness|arterial stiffness
5389486|NCT01769924|Nephrectomy|nephrectomy
5389487|NCT01769898|Bronchiectasis|bronchiectasis
5389488|NCT01769898|Theophylline|theophylline
5389489|NCT01769898|Therapeutic Uses|therapeutic uses
5389490|NCT01769898|HDAC|hdac
5389491|NCT01769898|HAT|hat
5389492|NCT01769898|Random placebo study|random placebo study
5389493|NCT01769898|ICS(inhaled corticosteroid)|ics(inhaled corticosteroid)
5389494|NCT01769898|corticosteroid|corticosteroid
5389495|NCT01769898|Inhaled corticosteroid|inhaled corticosteroid
5389496|NCT01769859|Bipolar Disorder|bipolar disorder
5389497|NCT01769859|Major Depressive Disorder|major depressive disorder
5389498|NCT01769859|Genetics|genetics
5389500|NCT01769833|Chronic hepatitis B|chronic hepatitis b
5389501|NCT01769833|PEGinterferon Alfa-2A|peginterferon alfa-2a
5389502|NCT01769820|Heavy menstrual bleeding (HMB)|heavy menstrual bleeding (hmb)
5389503|NCT01769820|Dexamethasone|dexamethasone
5389504|NCT01769820|glucocorticoid|glucocorticoid
5389505|NCT01769807|Sleep apnea|sleep apnea
5389506|NCT01769807|CPAP treatment|cpap treatment
5389507|NCT01769807|Plasma nitrate|plasma nitrate
5389508|NCT01769807|Urinary norepinephrine|urinary norepinephrine
5389509|NCT01769807|Blood pressure|blood pressure
5389510|NCT01769794|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5389511|NCT01769794|Medicine, Chinese Traditional|medicine, chinese traditional
5389512|NCT01769794|Enterovirus|enterovirus
5389513|NCT01769794|Fever|fever
5389514|NCT01769781|endometriosis recurrence|endometriosis recurrence
5389515|NCT01769781|pelvic pain|pelvic pain
5389516|NCT01769781|aromatase inhibitor|aromatase inhibitor
5389517|NCT01769768|Adults, Hh (Hedgehog) pathway inhibitor, LDE225, Warfarin, Bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic|adults, hh (hedgehog) pathway inhibitor, lde225, warfarin, bupropion, advanced solid tumor, drug-drug interaction, pharmacokinetic
5389518|NCT01769755|Crohn's disease|crohn's disease
5389519|NCT01769755|Fistula|fistula
5389520|NCT01769755|Diarrhea|diarrhea
5389521|NCT01769755|Colon|colon
5389522|NCT01769755|Stem cells|stem cells
5389523|NCT01769742|Pneumonia|pneumonia
5389524|NCT01769742|promotion of activity|promotion of activity
5389525|NCT01769729|integrated primary care|integrated primary care
5393100|NCT01753011|TOT|tot
5389534|NCT01769690|deep brain stimulation|deep brain stimulation
5389535|NCT01769677|Bioequivalence|bioequivalence
5375203|NCT01834339|vestibuloplasty|vestibuloplasty
5389536|NCT01769677|Hydrocodone bitartrate extended-release tablets|hydrocodone bitartrate extended-release tablets
5389537|NCT01769664|Acne vulgaris|acne vulgaris
5389538|NCT01769664|Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel|clindamycin 1%/benzoyl peroxide 5% topical gel
5389539|NCT01769664|Duac® Topical Gel|duac® topical gel
5389540|NCT01769651|drug user patients|drug user patients
5389541|NCT01769651|addiction nurses|addiction nurses
5389542|NCT01769651|overdose risk|overdose risk
5389543|NCT01769638|Orally disintegrating Film|orally disintegrating film
5389544|NCT01769638|Film Coated Tablet|film coated tablet
5389545|NCT01769638|Sildenafil|sildenafil
5389546|NCT01769638|Pharmacokinetics|pharmacokinetics
5389547|NCT01769625|breast|breast
5389548|NCT01769625|high risk women|high risk women
5389549|NCT01769625|biomarkers|biomarkers
5389550|NCT01769625|vitamin D|vitamin d
5389551|NCT01769612|Leishmaniasis, Leishmania|leishmaniasis, leishmania
5389552|NCT01769586|Sedation|sedation
5389553|NCT01769586|Endoscopy|endoscopy
5389554|NCT01769586|Diphenhydramine|diphenhydramine
5389555|NCT01769586|Midazolam|midazolam
5389556|NCT01769573|normal|normal
5389557|NCT01769560|tailored intervention|tailored intervention
5389558|NCT01769560|college aged students|college aged students
5389559|NCT01769560|HPV|hpv
5389560|NCT01769521|Glaucoma|glaucoma
5389561|NCT01769521|IOP|iop
5389562|NCT01769521|Blood pressure|blood pressure
5389563|NCT01769521|ECG|ecg
5389564|NCT01769508|Esophagogastric Adenocarcinoma|esophagogastric adenocarcinoma
5389565|NCT01769508|5-Fluorouracil|5-fluorouracil
5389566|NCT01769508|Oxaliplatin|oxaliplatin
5389567|NCT01769508|Lapatinib|lapatinib
5389568|NCT01769508|Radiation Therapy|radiation therapy
5389569|NCT01769508|Surgery|surgery
5389570|NCT01769495|Emergency department, Geriatrics, mortality, readmission rates.|emergency department, geriatrics, mortality, readmission rates.
5389571|NCT01769495|Patients 75 years of age and older.|patients 75 years of age and older.
5389572|NCT01769482|microvascular angina|microvascular angina
5389573|NCT01769482|PDE-5 inhibitors|pde-5 inhibitors
5389574|NCT01769482|Heart disease|heart disease
5389575|NCT01769482|Ischemia|ischemia
5389576|NCT01769482|Cardiac MRI|cardiac mri
5389577|NCT01769469|Tenofovir|tenofovir
5389578|NCT01769469|Emtricitabine|emtricitabine
5389579|NCT01769469|Truvada|truvada
5389580|NCT01769469|Renal, endocrine, bone changes|renal, endocrine, bone changes
5389581|NCT01769469|HIV prevention|hiv prevention
5389582|NCT01769469|PrEP|prep
5389583|NCT01769456|HIV, PrEP, FTC/TDF, Truvada®|hiv, prep, ftc/tdf, truvada®
5389584|NCT01769443|desensitization therapy|desensitization therapy
5389585|NCT01769443|bortezomib (VELCADE®)|bortezomib (velcade®)
5389586|NCT01769443|plasmapheresis|plasmapheresis
5389587|NCT01769430|influenza virus|influenza virus
5002919|NCT03977831|Radical cystectomy|radical cystectomy
5389588|NCT01769430|aerosol transmission|aerosol transmission
5389589|NCT01769430|contact transmission|contact transmission
5389590|NCT01769430|large droplet transmission|large droplet transmission
5389591|NCT01769430|airborne infection|airborne infection
5389593|NCT01769365|Helicobacter pylori infection|helicobacter pylori infection
5389594|NCT01769352|cystoid macular edema|cystoid macular edema
5389595|NCT01769339|Vulvar Candidiasis|vulvar candidiasis
5389596|NCT01769339|Miconazole|miconazole
5389597|NCT01769339|Hydrocortisone|hydrocortisone
5389598|NCT01769339|Daktacort Feminine Care Cream|daktacort feminine care cream
5389599|NCT01769326|Stroke|stroke
5389600|NCT01769313|Cataract|cataract
5389601|NCT01769313|Laser-assisted|laser-assisted
5389602|NCT01769313|Femtosecond|femtosecond
5389603|NCT01769300|Clinical decision support|clinical decision support
5389604|NCT01769300|Electronic health records|electronic health records
5389605|NCT01769300|Electronic medical records|electronic medical records
5389606|NCT01769300|Attention deficit-hyperactivity disorder|attention deficit-hyperactivity disorder
5389607|NCT01769300|Primary care Pediatric research network|primary care pediatric research network
5389608|NCT01769287|Atrial fibrillation|atrial fibrillation
5389609|NCT01769287|Electrophysiological Assessment|electrophysiological assessment
5389610|NCT01769287|12 months post-operatively|12 months post-operatively
5389611|NCT01769287|High Intensity Ultrasound|high intensity ultrasound
5389612|NCT01769261|quality of health care|quality of health care
5389613|NCT01769261|continuity of patient care|continuity of patient care
5393195|NCT01752712|CBSST|cbsst
5389723|NCT01768858|Plaque psoriasis|plaque psoriasis
5389615|NCT01769261|outcome and process assessment (health care)|outcome and process assessment (health care)
5389619|NCT01769235|Acne Vulgaris|acne vulgaris
5389620|NCT01769235|Clindamycin Phosphate and Benzoyl Peroxide Gel|clindamycin phosphate and benzoyl peroxide gel
5389621|NCT01769235|Acanya® Gel|acanya® gel
5389622|NCT01769196|Idiopathic|idiopathic
5389623|NCT01769196|Pulmonary|pulmonary
5389624|NCT01769196|Fibrosis|fibrosis
5389625|NCT01769196|IPF|ipf
5389626|NCT01769183|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5389627|NCT01769170|CMV|cmv
5389628|NCT01769170|Hematopoietic Stem Cell Transplant Recipients|hematopoietic stem cell transplant recipients
5389629|NCT01769170|CMV seropositive|cmv seropositive
5389630|NCT01769144|wound healing|wound healing
5389631|NCT01769144|wound infection|wound infection
5389632|NCT01769144|pain|pain
5389633|NCT01769144|pruritus|pruritus
5389634|NCT01769144|cicatrix|cicatrix
5389635|NCT01769144|dressings|dressings
5389636|NCT01769144|acticoat absorbent|acticoat absorbent
5389637|NCT01769144|BCT|bct
5389638|NCT01769144|KoCarbonAg|kocarbonag
5389639|NCT01769131|cervix|cervix
5389640|NCT01769131|Allis|allis
5389641|NCT01769131|Tenaculum|tenaculum
5389642|NCT01769131|gynecology|gynecology
5389643|NCT01769118|Autonomic nervous system|autonomic nervous system
5389644|NCT01769105|Meibomian Gland Dysfunction|meibomian gland dysfunction
5389645|NCT01769105|Lipiflow|lipiflow
5389646|NCT01769092|Epilepsy|epilepsy
5389647|NCT01769092|Seizure|seizure
5389648|NCT01769092|Fish Oil|fish oil
5389649|NCT01769053|Acute Lung Injury|acute lung injury
5389650|NCT01769053|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
5389651|NCT01769053|Interactive Ventilatory Support|interactive ventilatory support
5389652|NCT01769053|Positive-Pressure Respiration|positive-pressure respiration
5389653|NCT01769053|Ventilator-Induced Lung Injury|ventilator-induced lung injury
5389654|NCT01769040|Decompensated liver cirrhosis|decompensated liver cirrhosis
5389655|NCT01769040|Ascites|ascites
5389656|NCT01769040|Haemodynamics|haemodynamics
5389657|NCT01769040|Small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
5389658|NCT01769040|Pathophysiology|pathophysiology
5389659|NCT01769014|adherence|adherence
5389660|NCT01768975|Knee|knee
5389661|NCT01768975|Osteoarthritis|osteoarthritis
5389662|NCT01768975|OA|oa
5389663|NCT01768975|Knee pain|knee pain
5389664|NCT01768975|Moderate pain|moderate pain
5389665|NCT01768975|Severe pain|severe pain
5389666|NCT01768975|Inflammation|inflammation
5389667|NCT01768975|Safety|safety
5389668|NCT01768975|Efficacy|efficacy
5389669|NCT01768975|Randomized|randomized
5389670|NCT01768975|Topical|topical
5389671|NCT01768975|Gel|gel
5389672|NCT01768975|Olatec|olatec
5389673|NCT01768975|OLT1177|olt1177
5389674|NCT01768975|Joint Diseases|joint diseases
5389675|NCT01768975|Musculoskeletal Diseases|musculoskeletal diseases
5389676|NCT01768975|Rheumatic Diseases|rheumatic diseases
5389677|NCT01768975|Arthritis|arthritis
5389678|NCT01768975|Therapeutic|therapeutic
5389679|NCT01768975|Analgesic|analgesic
5389680|NCT01768962|Microbicides|microbicides
5389681|NCT01768962|Tenofovir|tenofovir
5389682|NCT01768962|Reduced-glycerin|reduced-glycerin
5389683|NCT01768962|Vaginal use|vaginal use
5389684|NCT01768962|Rectal use|rectal use
5389685|NCT01768962|Pharmacokinetics|pharmacokinetics
5002920|NCT03977818|outcome|outcome
5389686|NCT01768949|Acute respiratory distress syndrome|acute respiratory distress syndrome
5389687|NCT01768949|Echocardiography|echocardiography
5389688|NCT01768949|Recruitment maneuver|recruitment maneuver
5389689|NCT01768936|on-demand relaparotomy|on-demand relaparotomy
5389690|NCT01768936|PCT|pct
5389691|NCT01768936|procalcitonin|procalcitonin
5389692|NCT01768936|peritonitis|peritonitis
5389693|NCT01768936|sepsis|sepsis
5389694|NCT01768936|focus index|focus index
5389695|NCT01768923|Early Rheumatoid Arthritis|early rheumatoid arthritis
5389696|NCT01768923|Arterial stiffness|arterial stiffness
5389697|NCT01768923|SDAI remission group|sdai remission group
5389698|NCT01768923|Minimal disease activity remission group|minimal disease activity remission group
5389699|NCT01768910|lower urinary tract|lower urinary tract
5389700|NCT01768910|bladder|bladder
5389701|NCT01768910|supraspinal control|supraspinal control
5389702|NCT01768910|neuroimaging|neuroimaging
5389703|NCT01768910|functional magnetic resonance imaging|functional magnetic resonance imaging
5389704|NCT01768910|diffusion tensor imaging|diffusion tensor imaging
5389705|NCT01768910|functional connectivity|functional connectivity
5389706|NCT01768910|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5389707|NCT01768910|overactive bladder|overactive bladder
5389708|NCT01768910|multiple sclerosis|multiple sclerosis
5389709|NCT01768910|spinal cord injury|spinal cord injury
5389710|NCT01768884|Infants|infants
5389711|NCT01768884|Bronchiolitis|bronchiolitis
5389712|NCT01768884|NO|no
5389713|NCT01768884|inhalation|inhalation
5389714|NCT01768858|Arthritis|arthritis
5389715|NCT01768858|Morbus Crohn|morbus crohn
5389716|NCT01768858|Adherence|adherence
5389717|NCT01768858|Spondylitis|spondylitis
5389718|NCT01768858|Ulcerative colitis|ulcerative colitis
5389724|NCT01768858|Psoriatic|psoriatic
5389725|NCT01768858|Crohn´s disease|crohn´s disease
5389726|NCT01768858|Antirheumatic Agents|antirheumatic agents
5389727|NCT01768845|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
5389728|NCT01768845|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5389729|NCT01768845|Myelodysplastic syndrome|myelodysplastic syndrome
5389730|NCT01768845|Multiple myeloma|multiple myeloma
5389731|NCT01768845|Hodgkin lymphoma|hodgkin lymphoma
5389732|NCT01768845|Non Hodgkin lymphoma|non hodgkin lymphoma
5389733|NCT01768845|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5375396|NCT01833507|obesity|obesity
5671958|NCT00613496|8isoProstaglandinF2α|8isoprostaglandinf2α
5389734|NCT01768845|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5389735|NCT01768845|Severe Aplastic Anemia|severe aplastic anemia
5389736|NCT01768845|Cord Blood|cord blood
5389737|NCT01768845|Umbilical cord blood transplantation|umbilical cord blood transplantation
5389738|NCT01768845|UBC transplantation|ubc transplantation
5389739|NCT01768832|Parkinson disease|parkinson disease
5389742|NCT01768832|exercise|exercise
5389743|NCT01768832|dance|dance
5389744|NCT01768832|treadmill|treadmill
5389745|NCT01768819|aging|aging
5389746|NCT01768819|exercise|exercise
5389747|NCT01768819|muscle strength|muscle strength
5389748|NCT01768819|physical activity|physical activity
5389749|NCT01768806|Autism|autism
5389750|NCT01768806|Autism Spectrum Disorder|autism spectrum disorder
5389751|NCT01768806|PLAY and Language for Autistic Youngsters|play and language for autistic youngsters
5389752|NCT01768806|Intensive Early Intervention|intensive early intervention
5389753|NCT01768806|Parent Training|parent training
5389754|NCT01768793|Obesity|obesity
5389755|NCT01768793|Pregnancy|pregnancy
5389756|NCT01768793|Body Weight Changes|body weight changes
5389757|NCT01768793|Diet Therapy|diet therapy
5389758|NCT01768780|spinal anesthesia|spinal anesthesia
5389759|NCT01768780|peripheral nerve stimulator|peripheral nerve stimulator
5389760|NCT01768780|sensory block level|sensory block level
5389761|NCT01768754|Exercise testing|exercise testing
5389762|NCT01768754|Functional status|functional status
5389763|NCT01768754|Pulmonary rehabilitation|pulmonary rehabilitation
5389764|NCT01768741|hepatocellular carcinoma|hepatocellular carcinoma
5389765|NCT01768715|Alcoholic hepatitis|alcoholic hepatitis
5389766|NCT01768715|Liver transplantation|liver transplantation
5389767|NCT01768715|Survival|survival
5389768|NCT01768715|Alcoholism|alcoholism
5389769|NCT01768702|Chronic Heart Failure of Ischemic Origin|chronic heart failure of ischemic origin
5389770|NCT01768689|adherence|adherence
5389771|NCT01768689|chronic myeloid leukemia|chronic myeloid leukemia
5389772|NCT01768689|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5389773|NCT01768676|healthy male|healthy male
5389774|NCT01768650|traumatic brain injury|traumatic brain injury
5389775|NCT01768650|chronic pain|chronic pain
5389776|NCT01768650|headache|headache
5389777|NCT01768650|Veteran|veteran
5389778|NCT01768637|Chronic kidney disease|chronic kidney disease
5389779|NCT01768637|Platelet function|platelet function
5389780|NCT01768637|aspirin|aspirin
5389781|NCT01768637|antiplatelet agent|antiplatelet agent
5389782|NCT01768624|chronic kidney disease|chronic kidney disease
5389783|NCT01768624|dialysis|dialysis
5377319|NCT01825031|HIV|hiv
5389784|NCT01768624|pre dialysis education|pre dialysis education
5389785|NCT01768624|transplantation|transplantation
5389786|NCT01768624|conservative care|conservative care
5389787|NCT01768598|Wrist Fracture|wrist fracture
5389788|NCT01768598|Adolescents|adolescents
5389789|NCT01768598|Risk Taking Behaviour|risk taking behaviour
5389790|NCT01768598|Bone Microstructure|bone microstructure
5389791|NCT01768546|Diabetes Prevention Program|diabetes prevention program
5389792|NCT01768546|obesity|obesity
5389793|NCT01768546|activity|activity
5389794|NCT01768546|diabetes|diabetes
5389795|NCT01768533|pediatric|pediatric
5389796|NCT01768533|obesity|obesity
5389797|NCT01768533|prevention|prevention
5389798|NCT01768533|health behaviors|health behaviors
5389800|NCT01768481|Obesity|obesity
5389801|NCT01768481|Dyslipidemia|dyslipidemia
5389802|NCT01768481|Cholesterol|cholesterol
5389803|NCT01768481|Intima media thickness|intima media thickness
5389804|NCT01768468|LAYLA|layla
5389805|NCT01768468|Non-inferiority|non-inferiority
5389806|NCT01768468|100mm pain VAS|100mm pain vas
5389807|NCT01768442|Head and neck cancer|head and neck cancer
5389808|NCT01768403|Hypercholesterolemia|hypercholesterolemia
5389809|NCT01768403|Cardiovascular disease|cardiovascular disease
5389810|NCT01768403|Hypertension|hypertension
5389811|NCT01768403|Coronary Heart disease|coronary heart disease
5389812|NCT01768403|Peripheral Arterial disease|peripheral arterial disease
5389813|NCT01768390|caries|caries
5389814|NCT01768390|prevention|prevention
5389815|NCT01768390|orthodontics|orthodontics
5389816|NCT01768390|fixed appliances|fixed appliances
5389817|NCT01768390|adolescents|adolescents
5389818|NCT01768377|Awake intubation|awake intubation
5389819|NCT01768377|Nerve block|nerve block
5389820|NCT01768377|Sedation|sedation
5389821|NCT01768377|Physician satisfaction|physician satisfaction
5389822|NCT01768351|anemia|anemia
5390022|NCT01767584|Mexico|mexico
5389823|NCT01768351|chronic kidney disease|chronic kidney disease
5389824|NCT01768351|vitamin D|vitamin d
5389825|NCT01768351|paricalcitol|paricalcitol
5389826|NCT01768351|hyperparathyroidism|hyperparathyroidism
5389827|NCT01768325|ProCore Needle|procore needle
5389828|NCT01768299|abortion|abortion
5389829|NCT01768299|medical abortion|medical abortion
5389830|NCT01768299|mifepristone|mifepristone
5389831|NCT01768299|misoprostol|misoprostol
5389832|NCT01768286|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5389833|NCT01768286|HCV|hcv
5389834|NCT01768286|Sustained Virologic Response|sustained virologic response
5389835|NCT01768286|Direct Acting Antiviral|direct acting antiviral
5389836|NCT01768286|Combination Therapy|combination therapy
5389837|NCT01768286|GS-7977|gs-7977
5389838|NCT01768286|GS-5885|gs-5885
5389839|NCT01768286|Ribavirin|ribavirin
5389840|NCT01768286|Open Label|open label
5389841|NCT01768286|Sofosbuvir|sofosbuvir
5389842|NCT01768286|Additional relevant MeSH terms:|additional relevant mesh terms:
5389843|NCT01768286|Hepatitis|hepatitis
5389844|NCT01768286|Hepatitis, Chronic|hepatitis, chronic
5389845|NCT01768286|Hepatitis C|hepatitis c
5389846|NCT01768286|Hepatitis C, Chronic|hepatitis c, chronic
5389847|NCT01768286|Liver Diseases|liver diseases
5389848|NCT01768286|Digestive System Diseases|digestive system diseases
5389849|NCT01768286|Hepatitis, Viral, Human|hepatitis, viral, human
5389850|NCT01768286|Virus Diseases|virus diseases
5389851|NCT01768286|Enterovirus Infections|enterovirus infections
5389852|NCT01768286|Picornaviridae Infections|picornaviridae infections
5389853|NCT01768286|RNA Virus Infections|rna virus infections
5389854|NCT01768286|Flaviviridae Infections|flaviviridae infections
5389855|NCT01768286|Antiviral Agents|antiviral agents
5389856|NCT01768286|Anti-Infective Agents|anti-infective agents
5389857|NCT01768286|Therapeutic Uses|therapeutic uses
5389858|NCT01768286|Pharmacologic Actions|pharmacologic actions
5389859|NCT01768286|Antimetabolites|antimetabolites
5389860|NCT01768286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5389861|NCT01768273|PA-824,|pa-824,
5389862|NCT01768273|midazolam|midazolam
5389863|NCT01768273|drug-drug interaction|drug-drug interaction
5389864|NCT01768273|pharmacokinetics|pharmacokinetics
5389865|NCT01768273|pretomanid|pretomanid
5389866|NCT01768273|CL-006|cl-006
5389867|NCT01768260|visual acuity|visual acuity
5389868|NCT01768260|artery flow velocity|artery flow velocity
5389869|NCT01768260|Enhanced External Counterpulsation|enhanced external counterpulsation
5389870|NCT01768260|Ischemic|ischemic
5389871|NCT01768260|Optic Neuropathy|optic neuropathy
5389872|NCT01768247|endometrium|endometrium
5389873|NCT01768247|thickness|thickness
5389874|NCT01768247|pregnancy|pregnancy
5389875|NCT01768247|HCG|hcg
5389876|NCT01768247|frozen cycles|frozen cycles
5389877|NCT01768234|cognition|cognition
5389878|NCT01768234|hydration|hydration
5389879|NCT01768234|schoolchildren|schoolchildren
5389880|NCT01768221|Palliative Care|palliative care
5389881|NCT01768221|Caregiver Outlook|caregiver outlook
5389882|NCT01768195|Lymphoma|lymphoma
5389883|NCT01768195|Hepatitis B Virus|hepatitis b virus
5389884|NCT01768195|Therapeutic Uses|therapeutic uses
5389885|NCT01768195|Antiviral Agents|antiviral agents
5389886|NCT01768195|rituximab|rituximab
5389887|NCT01768182|folic acid; folates; Vascular Reactivity; HIV|folic acid; folates; vascular reactivity; hiv
5389888|NCT01768169|metabolic syndrome,|metabolic syndrome,
5389889|NCT01768169|waist, blood pressure,|waist, blood pressure,
5389890|NCT01768169|fasting plasma glucose,|fasting plasma glucose,
5389891|NCT01768169|HDL cholesterol,|hdl cholesterol,
5389892|NCT01768169|triglycerides|triglycerides
5389893|NCT01768156|ovarian cancer|ovarian cancer
5389894|NCT01768156|biomarker|biomarker
5389895|NCT01768156|metastatic|metastatic
5389896|NCT01768143|Propofol|propofol
5389897|NCT01768143|Sedation|sedation
5389898|NCT01768143|Endoscopy|endoscopy
5389899|NCT01768143|nonanesthesiologist|nonanesthesiologist
5389900|NCT01768104|upper gastrointestinal submucosal tumors|upper gastrointestinal submucosal tumors
5389902|NCT01768104|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5389903|NCT01768104|GISTs|gists
5389904|NCT01768104|Leiomyoma|leiomyoma
5389905|NCT01768104|Endoscopic submucosal tunnel dissection|endoscopic submucosal tunnel dissection
5389906|NCT01768104|ESTD|estd
5389907|NCT01768104|Submucosal tunneling endoscopic resection|submucosal tunneling endoscopic resection
5389908|NCT01768104|STER|ster
5389909|NCT01768104|Submucosal endoscopic tumor resection|submucosal endoscopic tumor resection
5389910|NCT01768104|SET|set
5389911|NCT01768091|Esophageal achalasia|esophageal achalasia
5389912|NCT01768091|Peroral endoscopic myotomy|peroral endoscopic myotomy
5389913|NCT01768091|POEM|poem
5389914|NCT01768091|Pneumatic dilation|pneumatic dilation
5389915|NCT01768065|NEPAP|nepap
5389916|NCT01768065|CPAP|cpap
5389917|NCT01768065|alternative|alternative
5389918|NCT01768065|OSAS|osas
5389919|NCT01768052|MDD, major depression, treatment-resistant|mdd, major depression, treatment-resistant
5389920|NCT01768039|Multiple sclerosis|multiple sclerosis
5389921|NCT01768039|Vitamin D|vitamin d
5389922|NCT01768039|EDSS|edss
5389923|NCT01768039|ARR|arr
5389924|NCT01768026|Dystrophic Epidermolysis Bullosa|dystrophic epidermolysis bullosa
5389925|NCT01768026|Type VII Collagen|type vii collagen
5389926|NCT01768026|QOL Evaluation in Epidermolysis Bullosa|qol evaluation in epidermolysis bullosa
5680431|NCT00577798|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5389927|NCT01768026|Instrument for Scoring Clinical Outcomes for Research of Epidermolysis Bullosa|instrument for scoring clinical outcomes for research of epidermolysis bullosa
5389928|NCT01768026|Birmingham Epidermolysis Bullosa Severity Score|birmingham epidermolysis bullosa severity score
5389929|NCT01768000|Psychosis|psychosis
5389930|NCT01768000|Psychosis NOS|psychosis nos
5389931|NCT01768000|Schizophrenia|schizophrenia
5389932|NCT01768000|Schizoaffective Disorder|schizoaffective disorder
5373171|NCT01844180|IBS|ibs
5389933|NCT01768000|Bipolar Disorder|bipolar disorder
5389934|NCT01767987|Acute Coronary Syndrome|acute coronary syndrome
5389936|NCT01767987|Percutaneous Coronary Intervention|percutaneous coronary intervention
5389937|NCT01767987|PCI|pci
5389938|NCT01767987|Ranolazine|ranolazine
5389939|NCT01767987|Coronary Angiogram|coronary angiogram
5389940|NCT01767987|Cardioprotectant|cardioprotectant
5389941|NCT01767974|Non-Small Cell lung cancer|non-small cell lung cancer
5389942|NCT01767948|Hepatic Impairment|hepatic impairment
5389943|NCT01767948|PCI 32765|pci 32765
5389944|NCT01767948|Metabolite PCI-45227|metabolite pci-45227
5389945|NCT01767948|Pharmacokinetics|pharmacokinetics
5389946|NCT01767922|Super-Oxyd-Dismutase|super-oxyd-dismutase
5389947|NCT01767922|SOD|sod
5389948|NCT01767922|melon juce|melon juce
5389949|NCT01767922|perceived stress|perceived stress
5389950|NCT01767909|Intranasal insulin|intranasal insulin
5389951|NCT01767909|Alzheimer's disease|alzheimer's disease
5389952|NCT01767909|Amnestic mild cognitive impairment|amnestic mild cognitive impairment
5389953|NCT01767909|Dementia|dementia
5389954|NCT01767909|Brain diseases|brain diseases
5389955|NCT01767909|Memory problems|memory problems
5389956|NCT01767909|Mental disorders|mental disorders
5389957|NCT01767909|Cognitive disorders|cognitive disorders
5389958|NCT01767896|Influenza vaccine|influenza vaccine
5389959|NCT01767883|Chronic Kidney Disease|chronic kidney disease
5389960|NCT01767883|CKD|ckd
5389961|NCT01767883|TRANSLATE|translate
5389962|NCT01767883|Practice Facilitation|practice facilitation
5389963|NCT01767883|Practice-based research|practice-based research
5389964|NCT01767883|CKD Guidelines|ckd guidelines
5389965|NCT01767870|advanced colorectal adenoma|advanced colorectal adenoma
5389966|NCT01767870|colonoscopy|colonoscopy
5389967|NCT01767870|sigmoidoscopy|sigmoidoscopy
5389968|NCT01767870|fecal immunochemical test|fecal immunochemical test
5389969|NCT01767857|Pivotal|pivotal
5389970|NCT01767857|Colorectal|colorectal
5389971|NCT01767857|Survival|survival
5389972|NCT01767857|Phase 3|phase 3
5389973|NCT01767844|Rheumatoid Arthritis|rheumatoid arthritis
5389974|NCT01767844|Arthritis|arthritis
5389975|NCT01767844|Rheumatology|rheumatology
5389976|NCT01767844|Creatine|creatine
5389977|NCT01767831|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5389978|NCT01767831|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5389979|NCT01767831|Simulation-based Education|simulation-based education
5389980|NCT01767818|Parkinson's Disease|parkinson's disease
5389981|NCT01767792|Neurofibromatosis Type 2|neurofibromatosis type 2
5389982|NCT01767792|Progressive Vestibular Schwannomas|progressive vestibular schwannomas
5389983|NCT01767779|Epilepsy|epilepsy
5389984|NCT01767779|TSC|tsc
5389985|NCT01767779|Tuberous Sclerosis Complex|tuberous sclerosis complex
5389986|NCT01767779|Infants|infants
5389987|NCT01767779|Seizures|seizures
5389988|NCT01767779|Biomarkers|biomarkers
5389989|NCT01767779|EEG|eeg
5389990|NCT01767753|Glaucoma|glaucoma
5389991|NCT01767753|SLT|slt
5389992|NCT01767740|Rotator Cuff Tear|rotator cuff tear
5389993|NCT01767740|Supraspinatus Tear|supraspinatus tear
5389994|NCT01767727|surgical flap;|surgical flap;
5389995|NCT01767727|dorsal branch of the digital artery|dorsal branch of the digital artery
5389996|NCT01767714|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5389998|NCT01767701|MS|ms
5389999|NCT01767701|RRMS|rrms
5390000|NCT01767701|Charcot Project|charcot project
5390001|NCT01767688|Diabetes Mellitus|diabetes mellitus
5390002|NCT01767688|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5390003|NCT01767688|Glucose Metabolism Disorders|glucose metabolism disorders
5390004|NCT01767688|Metabolic Diseases|metabolic diseases
5390005|NCT01767688|Endocrine System Diseases|endocrine system diseases
5390006|NCT01767675|Secondary Cytoreductive Surgery|secondary cytoreductive surgery
5390007|NCT01767675|Carboplatin|carboplatin
5390008|NCT01767675|Hyperthermic Intraperitoneal Chemotherapy (HIPEC)|hyperthermic intraperitoneal chemotherapy (hipec)
5390009|NCT01767675|12-275|12-275
5390010|NCT01767662|TCV|tcv
5390011|NCT01767649|Pregnancy|pregnancy
5390012|NCT01767649|Remodelling|remodelling
5390013|NCT01767649|Extracellular matrix|extracellular matrix
5390014|NCT01767649|Biomarkers|biomarkers
5390015|NCT01767597|rapid test|rapid test
5390016|NCT01767597|screening|screening
5390017|NCT01767597|ELISA|elisa
5390018|NCT01767597|hepatitis B virus|hepatitis b virus
5390021|NCT01767584|Bioequivalence|bioequivalence
5390032|NCT01767506|Trachoma|trachoma
5390033|NCT01767506|Azithromycin|azithromycin
5390034|NCT01767506|Mass treatment|mass treatment
5390035|NCT01767493|Multiple sclerosis|multiple sclerosis
5390036|NCT01767480|Intensive Robot Assisted Therapy|intensive robot assisted therapy
5375702|NCT01832272|Tourniquet|tourniquet
5390037|NCT01767480|Subacute Stroke|subacute stroke
5390038|NCT01767480|Brain Reorganization|brain reorganization
5390039|NCT01767480|Sensory Motor|sensory motor
5390040|NCT01767480|Physiological Marker|physiological marker
5390041|NCT01767467|Immunogenicity|immunogenicity
5390042|NCT01767467|Safety|safety
5390043|NCT01767467|Herpes zoster|herpes zoster
5390044|NCT01767467|Vaccination|vaccination
5390045|NCT01767467|Haematologic malignancies|haematologic malignancies
5390046|NCT01767454|BRAF V600E|braf v600e
5390047|NCT01767454|Melanoma|melanoma
5390048|NCT01767454|V600K|v600k
5390049|NCT01767454|Trametinib|trametinib
5390050|NCT01767454|Dabrafenib|dabrafenib
5390051|NCT01767454|Ipilimumab|ipilimumab
5390061|NCT01767415|brain tumor|brain tumor
5390062|NCT01767415|resection|resection
5390063|NCT01767415|indigo carmine dye|indigo carmine dye
5390064|NCT01767402|Safety|safety
5390065|NCT01767402|Pneumococcal Infections|pneumococcal infections
5390066|NCT01767402|Immunogenicity|immunogenicity
5390067|NCT01767402|PhtD vaccine|phtd vaccine
5390068|NCT01767402|Healthy adults|healthy adults
5390069|NCT01767402|Reactogenicity|reactogenicity
5390070|NCT01767389|utilization|utilization
5390071|NCT01767389|acute pancreatitis|acute pancreatitis
5390072|NCT01767389|Exenatide|exenatide
5390073|NCT01767389|DPP-4 inhibitors|dpp-4 inhibitors
5390074|NCT01767389|liraglutide|liraglutide
5390075|NCT01767389|GLP-1 receptor agonist|glp-1 receptor agonist
5390076|NCT01767389|adherence|adherence
5390077|NCT01767376|Young adults|young adults
5390078|NCT01767376|Adolescents|adolescents
5390079|NCT01767376|Reactogenicity|reactogenicity
5390080|NCT01767376|Diphtheria|diphtheria
5390081|NCT01767376|pertussis|pertussis
5390082|NCT01767376|Immunogenicity|immunogenicity
5390084|NCT01767376|Meningococcal vaccines|meningococcal vaccines
5390085|NCT01767376|Safety|safety
5390086|NCT01767376|Neisseria meningitidis|neisseria meningitidis
5390087|NCT01767376|Healthy|healthy
5390088|NCT01767363|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5390089|NCT01767363|benign prostatic hyperplasia treatment|benign prostatic hyperplasia treatment
5390090|NCT01767363|Prostate cancer mortality|prostate cancer mortality
5390091|NCT01767350|Pediatric transplantation|pediatric transplantation
5390092|NCT01767350|Pharmacogenetics|pharmacogenetics
5390093|NCT01767350|Pharmacokinetics|pharmacokinetics
5390094|NCT01767350|Calcineurin inhibitors|calcineurin inhibitors
5390095|NCT01767350|CYP3A|cyp3a
5390096|NCT01767350|Pgp|pgp
5390097|NCT01767337|microneedle-based delivery|microneedle-based delivery
5390098|NCT01767337|hollow microneedle|hollow microneedle
5390099|NCT01767337|intracutaneous|intracutaneous
5390100|NCT01767337|drug delivery|drug delivery
5488224|NCT01344785|Pain|pain
5390101|NCT01767324|microneedle-based array|microneedle-based array
5390102|NCT01767324|hollow microneedle|hollow microneedle
5390103|NCT01767324|intracutaneous|intracutaneous
5390104|NCT01767324|drug delivery|drug delivery
5390105|NCT01767324|vaccine delivery|vaccine delivery
5390108|NCT01767298|Fixed dose combination|fixed dose combination
5390109|NCT01767298|Pharmacokinetics|pharmacokinetics
5390110|NCT01767298|Valsartan|valsartan
5390111|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide
5390112|NCT01767285|Etonogestrel Implant|etonogestrel implant
5390113|NCT01767285|Implanon|implanon
5390114|NCT01767285|Nexplanon|nexplanon
5390115|NCT01767285|Long Acting Reversible Contraception|long acting reversible contraception
5390116|NCT01767272|Fexofenadine|fexofenadine
5390117|NCT01767272|Pharmacokinetics|pharmacokinetics
5390118|NCT01767272|Bioavailability|bioavailability
5390119|NCT01767272|Linearity|linearity
5390120|NCT01767272|HPLC|hplc
5390121|NCT01767272|Dose proportionality of fexofenadine in Egyptian volunteers|dose proportionality of fexofenadine in egyptian volunteers
5390122|NCT01767259|Fixed dose combination|fixed dose combination
5390123|NCT01767259|Pharmacokinetics|pharmacokinetics
5390124|NCT01767259|Valsartan|valsartan
5390125|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide
5390126|NCT01767233|Acute necrotizing pancreatitis|acute necrotizing pancreatitis
5390127|NCT01767233|ERCP|ercp
5390128|NCT01767233|Pancreatic stenting|pancreatic stenting
5390129|NCT01767220|ventricular tachycardia|ventricular tachycardia
5390130|NCT01767220|endocardial ablation|endocardial ablation
5390131|NCT01767220|epicardial ablation|epicardial ablation
5390132|NCT01767181|Light therapy|light therapy
5390133|NCT01767181|physical exercise|physical exercise
5390134|NCT01767181|night shift workers|night shift workers
5390135|NCT01767181|genetic markers|genetic markers
5390136|NCT01767181|PBMCs|pbmcs
5390137|NCT01767142|Lipolysis|lipolysis
5390138|NCT01767142|Cryolipolysis|cryolipolysis
5390139|NCT01767142|Fat Reduction|fat reduction
5390140|NCT01767129|levodopa|levodopa
5390141|NCT01767129|dyskinesia|dyskinesia
5390142|NCT01767129|parkinson's disease|parkinson's disease
5390143|NCT01767129|AVP-923|avp-923
5390144|NCT01767129|dextromethorphan|dextromethorphan
5390145|NCT01767129|quinidine|quinidine
5390146|NCT01767116|Interferon-Free|interferon-free
5390147|NCT01767116|Hepatitis C Genotype 1b|hepatitis c genotype 1b
5390148|NCT01767116|Chronic Hepatitis C|chronic hepatitis c
5390149|NCT01767116|Hepatitis C Virus|hepatitis c virus
5390150|NCT01767116|Hepatitis C|hepatitis c
5390151|NCT01767116|Treatment-Naive|treatment-naive
5390152|NCT01767116|Paritaprevir|paritaprevir
5390153|NCT01767116|Ombitasvir|ombitasvir
5390154|NCT01767116|Dasabuvir|dasabuvir
5390155|NCT01767116|Viekira PAK|viekira pak
5390156|NCT01767116|Ribavirin|ribavirin
5390157|NCT01767103|Hepatic Impairment|hepatic impairment
5390158|NCT01767103|Liver Impairment|liver impairment
5390159|NCT01767103|Liver Disease|liver disease
5390160|NCT01767103|Ferriprox®|ferriprox®
5390161|NCT01767103|LI|li
5390162|NCT01767103|DFP|dfp
5390163|NCT01767103|Deferiprone|deferiprone
5390164|NCT01767090|Phase 2|phase 2
5390165|NCT01767090|Double-blind|double-blind
5390166|NCT01767090|Pelvic pain|pelvic pain
5390167|NCT01767090|ASP1707|asp1707
5390168|NCT01767090|Placebo-controlled|placebo-controlled
5390169|NCT01767090|Endometriosis|endometriosis
5390170|NCT01767077|Saturated fat|saturated fat
5390171|NCT01767077|Dairy products|dairy products
5390172|NCT01767077|Milk fat globule membrane|milk fat globule membrane
5390173|NCT01767077|Cholesterol|cholesterol
5390174|NCT01767077|Butter|butter
5390175|NCT01767077|Cream|cream
5390176|NCT01767064|ARIs, antibiotics, public commitment, quality improvement|aris, antibiotics, public commitment, quality improvement
5390177|NCT01767051|PCOS|pcos
5390178|NCT01767051|Children|children
5390179|NCT01767051|Cardiovascular|cardiovascular
5390180|NCT01767051|Follow-up|follow-up
5390181|NCT01767025|Influence|influence
5390182|NCT01767025|oxytocin|oxytocin
5390183|NCT01767025|automatic imitation|automatic imitation
5390184|NCT01767025|behaviour|behaviour
5390185|NCT01767025|volunteers|volunteers
5390186|NCT01766999|pulse oximetry|pulse oximetry
5390187|NCT01766999|tumescent anesthesia|tumescent anesthesia
5390188|NCT01766960|Bile acids|bile acids
5390189|NCT01766960|Pharmacokinetics|pharmacokinetics
5390190|NCT01766947|Glaucoma|glaucoma
5390191|NCT01766947|Deep sclerectomy|deep sclerectomy
5390192|NCT01766934|Peripheral blood progenitor cell mobilization|peripheral blood progenitor cell mobilization
5390193|NCT01766934|allogenic hematopoetic stem cell transplantation|allogenic hematopoetic stem cell transplantation
5390194|NCT01766934|recombinant human granulocyte colony stimulating factor|recombinant human granulocyte colony stimulating factor
5390195|NCT01766934|filgrastim|filgrastim
5390196|NCT01766921|Influenza, Pandemic, H5N1, Elderly adults|influenza, pandemic, h5n1, elderly adults
5390197|NCT01766908|Timing of Umbilical Cord clamping|timing of umbilical cord clamping
5390198|NCT01766908|Cord Clamp 20 seconds|cord clamp 20 seconds
5390199|NCT01766908|Cord Clamp 40 seconds|cord clamp 40 seconds
5390200|NCT01766908|Cord Clamp 60 seconds|cord clamp 60 seconds
5390201|NCT01766895|uremia|uremia
5390202|NCT01766895|HBV|hbv
5390203|NCT01766895|HCV|hcv
5390204|NCT01766895|seroclearance|seroclearance
5390205|NCT01766882|Hemodialysis|hemodialysis
5390206|NCT01766882|Blood Pressure|blood pressure
5390207|NCT01766882|Hydration Status|hydration status
5390208|NCT01766882|Low-sodium diet|low-sodium diet
5390209|NCT01766869|Prostate Cancer|prostate cancer
5390210|NCT01766869|MRI/MRS|mri/mrs
5390211|NCT01766856|perforation|perforation
5390212|NCT01766856|tympanoplasty|tympanoplasty
5390213|NCT01766856|myringoplasty|myringoplasty
5390214|NCT01766856|Eustachian tube function|eustachian tube function
5390215|NCT01766856|tympanostomy tube|tympanostomy tube
5390216|NCT01766817|IPF|ipf
5390217|NCT01766804|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5390218|NCT01766804|Bovine Colostrum|bovine colostrum
5390219|NCT01766804|Inflammation|inflammation
5390220|NCT01766804|Infection|infection
5390221|NCT01766804|Toxicity|toxicity
5390222|NCT01766791|resistance exercise|resistance exercise
5390223|NCT01766791|muscle mass|muscle mass
5390224|NCT01766791|abdominal fat|abdominal fat
5390225|NCT01766791|strength|strength
5390226|NCT01766791|Coronary Heart Disease (CHD)-risk|coronary heart disease (chd)-risk
5390227|NCT01766791|myocardial mass|myocardial mass
5390228|NCT01766778|type-2 diabetes mellitus, inadequately controlled Metformin|type-2 diabetes mellitus, inadequately controlled metformin
5390229|NCT01766739|GL-ONC1|gl-onc1
5390230|NCT01766739|pleural effusion|pleural effusion
5390231|NCT01766739|12-169|12-169
5390232|NCT01766726|HIV|hiv
5390233|NCT01766726|Atherosclerosis|atherosclerosis
5390234|NCT01766700|Obesity, weight loss, weight maintenance|obesity, weight loss, weight maintenance
5390235|NCT01766687|Chronic Kidney Disease|chronic kidney disease
5390236|NCT01766687|estimated glomerular filtration rate|estimated glomerular filtration rate
5390237|NCT01766687|water intake|water intake
5390238|NCT01766687|fluid intake|fluid intake
5390239|NCT01766687|renal decline|renal decline
5390240|NCT01766674|Kyphosis|kyphosis
5390241|NCT01766648|Distal|distal
5390242|NCT01766648|Femur|femur
5390244|NCT01766648|Screw|screw
5390245|NCT01766648|Fracture|fracture
5390246|NCT01766648|Healing|healing
5390247|NCT01766622|Apoptosis|apoptosis
5390248|NCT01766622|Pro-Apoptotic Effects|pro-apoptotic effects
5390249|NCT01766622|PET Imaging|pet imaging
5390250|NCT01766622|TL32711|tl32711
5671340|NCT00616499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5390251|NCT01766622|Relapsed Platinum Resistant or Refractory Epithelial Ovarian Cancer|relapsed platinum resistant or refractory epithelial ovarian cancer
5390252|NCT01766609|Vitiligo; Intralesional; Triamcinolone acetonide|vitiligo; intralesional; triamcinolone acetonide
5390253|NCT01766596|Ophthalmology|ophthalmology
5390254|NCT01766596|Age-related ocular pathologies|age-related ocular pathologies
5390255|NCT01766583|Open label, 3 + 3 dose escalation study followed by an expansion phase.|open label, 3 + 3 dose escalation study followed by an expansion phase.
5390256|NCT01766570|insulin sensitivity,|insulin sensitivity,
5390257|NCT01766570|glucose tolerance,|glucose tolerance,
5390258|NCT01766570|inflammatory markers,|inflammatory markers,
5390259|NCT01766570|lipid profile,|lipid profile,
5390260|NCT01766570|oxidative stress,|oxidative stress,
5390261|NCT01766570|pancreatic β-cell function|pancreatic β-cell function
5390262|NCT01766557|Polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation|polycystic ovarian syndrome, sex hormones, ovarian function, women, fish protein, insulin sensitivity, glucose tolerance, β-cell function, inflammation
5390263|NCT01766544|asthma|asthma
5390264|NCT01766544|COPD|copd
5390265|NCT01766544|guidelines|guidelines
5390266|NCT01766544|knowledge transfer|knowledge transfer
5390267|NCT01766544|medical education|medical education
5390268|NCT01766544|care gaps|care gaps
5390269|NCT01766531|Bioelectrical impedance|bioelectrical impedance
5390270|NCT01766531|Nutrition|nutrition
5390271|NCT01766531|Phase angle|phase angle
5390272|NCT01766531|ICU patients|icu patients
5390273|NCT01766518|liver transplantation|liver transplantation
5390274|NCT01766518|LT|lt
5390275|NCT01766518|Mycophenolate mofetil|mycophenolate mofetil
5390276|NCT01766518|MMF|mmf
5390277|NCT01766505|hypertension, heart failure, candesartan, losartan|hypertension, heart failure, candesartan, losartan
5390278|NCT01766492|prostate cancer|prostate cancer
5390279|NCT01766492|CyberKnife|cyberknife
5390280|NCT01766479|Colorectal cancer|colorectal cancer
5390281|NCT01766479|colorectal neoplasia|colorectal neoplasia
5390282|NCT01766479|CT colonography|ct colonography
5390283|NCT01766479|advanced neoplasia|advanced neoplasia
5390284|NCT01766479|colonoscopy|colonoscopy
5390285|NCT01766479|family history|family history
5390286|NCT01766453|South Asian|south asian
5390287|NCT01766453|Cardiovascular|cardiovascular
5390288|NCT01766453|Exercise|exercise
5390289|NCT01766453|Obesity|obesity
5390290|NCT01766453|Visceral Adipose Tissue|visceral adipose tissue
5390291|NCT01766401|Generalized Anxiety Disorder|generalized anxiety disorder
5390292|NCT01766401|GAD|gad
5390293|NCT01766375|idarubicin|idarubicin
5390294|NCT01766375|busulfan|busulfan
5390295|NCT01766375|cyclophosphamide|cyclophosphamide
5390296|NCT01766375|pretreatment|pretreatment
5390297|NCT01766375|high-risk acute myeloid leukemia patient|high-risk acute myeloid leukemia patient
5390298|NCT01766349|Esophageal cancer|esophageal cancer
5390299|NCT01766349|Respiratory muscle strength|respiratory muscle strength
5390300|NCT01766349|Pulmonary function testing|pulmonary function testing
5390301|NCT01766349|Functional exercise capacity|functional exercise capacity
5390302|NCT01766336|Agitation|agitation
5390303|NCT01766336|Aggression|aggression
5390304|NCT01766336|AD patients|ad patients
5390305|NCT01766323|Morphine|morphine
5390306|NCT01766323|Palliation|palliation
5390307|NCT01766323|Cancer|cancer
5390308|NCT01766323|Hospice|hospice
5390309|NCT01766323|Sleepiness|sleepiness
5390310|NCT01766323|Modafinil|modafinil
5390311|NCT01766310|Folic acid|folic acid
5390312|NCT01766310|Folate|folate
5390313|NCT01766310|Homocysteine|homocysteine
5390314|NCT01766310|Obese|obese
5390315|NCT01766310|Children|children
5390316|NCT01766297|Breast Cancer|breast cancer
5390317|NCT01766297|Proton|proton
5390318|NCT01766297|Radiation|radiation
5390319|NCT01766284|Human Papillomavirus|human papillomavirus
5390320|NCT01766284|Optical Coherence Tomography|optical coherence tomography
5390321|NCT01766284|Imaging Systems|imaging systems
5390322|NCT01766284|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5390323|NCT01766284|Cervical Cancer|cervical cancer
5390324|NCT01766284|Cervical Dysplasia|cervical dysplasia
5390325|NCT01766271|Coronary heart disease|coronary heart disease
5390326|NCT01766271|cardiovascular disease|cardiovascular disease
5390327|NCT01766271|risk|risk
5390328|NCT01766258|Parkinson's Disease|parkinson's disease
5390329|NCT01766258|Motor-fluctuation|motor-fluctuation
5390330|NCT01766258|Wearing-off|wearing-off
5390331|NCT01766245|mm|mm
5390332|NCT01766206|conjugate vaccine|conjugate vaccine
5390333|NCT01766206|phase IV clinical trial|phase iv clinical trial
5390334|NCT01766206|Neisseria meningitidis|neisseria meningitidis
5390335|NCT01766193|Delivery, obstetric|delivery, obstetric
5390336|NCT01766193|Obstetric Surgical Procedures|obstetric surgical procedures
5390337|NCT01766193|Vacuum Extraction, Obstetrical|vacuum extraction, obstetrical
5390338|NCT01766193|Cesarean Section|cesarean section
5390339|NCT01766193|Obstetrical Forceps|obstetrical forceps
5390341|NCT01766193|Norway|norway
5390342|NCT01766180|Memory|memory
5390343|NCT01766180|Fruitflow|fruitflow
5390344|NCT01766180|Resveratrol (resVida)|resveratrol (resvida)
5390345|NCT01766180|Cerebral blood flow|cerebral blood flow
5390346|NCT01766180|Cardiopulmonary exercise test|cardiopulmonary exercise test
5390347|NCT01766180|Maximal VO2|maximal vo2
5390348|NCT01766167|Genotype 2|genotype 2
5390349|NCT01766154|tirofiban|tirofiban
5390350|NCT01766154|pharmacokinetic|pharmacokinetic
5390351|NCT01766154|renal insufficiency|renal insufficiency
5390352|NCT01766154|Phase 1|phase 1
5390353|NCT01766154|pharmacodynamic|pharmacodynamic
5390354|NCT01766141|Spinal manipulation|spinal manipulation
5390355|NCT01766141|Tumor necrosis factor|tumor necrosis factor
5373597|NCT01841853|ADL|adl
5390356|NCT01766141|Interleukin 1|interleukin 1
5390357|NCT01766141|Interleukin 10|interleukin 10
5390358|NCT01766141|Inflammatory cytokines|inflammatory cytokines
5390359|NCT01766128|Parkinson disease|parkinson disease
5390360|NCT01766128|Early stage|early stage
5390361|NCT01766128|Zonisamide|zonisamide
5390362|NCT01766128|UPDRS|updrs
5390363|NCT01766115|HCV|hcv
5390364|NCT01766115|needlestick|needlestick
5390365|NCT01766115|occupational|occupational
5390366|NCT01766115|transmission|transmission
5390367|NCT01766115|health care worker|health care worker
5390368|NCT01766115|telaprevir|telaprevir
5390369|NCT01766102|Mammography|mammography
5390370|NCT01766089|Caesarean delivery|caesarean delivery
5390371|NCT01766089|severe pre-eclampsia|severe pre-eclampsia
5390372|NCT01766089|remifentanil|remifentanil
5390373|NCT01766089|dexmedetomidine|dexmedetomidine
5390374|NCT01766089|cardiovascular response|cardiovascular response
5390375|NCT01766076|immune activation|immune activation
5390376|NCT01766076|antiretroviral therapy|antiretroviral therapy
5390377|NCT01766076|atorvastatin|atorvastatin
5390378|NCT01766076|immune exhaustion|immune exhaustion
5390379|NCT01766076|adults|adults
5390380|NCT01766076|Africa|africa
5390381|NCT01766063|Multiple Sclerosis|multiple sclerosis
5390382|NCT01766063|Sleep|sleep
5390383|NCT01766063|Quality of life|quality of life
5390384|NCT01766063|Observational study|observational study
5390385|NCT01766037|obesity|obesity
5390386|NCT01766037|obese|obese
5390387|NCT01766037|weight loss|weight loss
5390388|NCT01766024|interferon beta-1a|interferon beta-1a
5390389|NCT01766024|pharmacokinetics|pharmacokinetics
5390390|NCT01766024|pharmacodynamics|pharmacodynamics
5390391|NCT01766024|volunteers|volunteers
5390392|NCT01765998|Crohn's disease, endothelial progenitor cells, probiotic|crohn's disease, endothelial progenitor cells, probiotic
5390393|NCT01765985|palmoplantar|palmoplantar
5390394|NCT01765959|Insomnia|insomnia
5390395|NCT01765959|Auricular acupuncture|auricular acupuncture
5390396|NCT01765959|CBT|cbt
5390397|NCT01765946|Insulin resistance|insulin resistance
5390398|NCT01765946|Prediabetes|prediabetes
5390399|NCT01765946|Longevity genes|longevity genes
5390400|NCT01765946|Inflammation|inflammation
5390401|NCT01765946|Metformin|metformin
5390402|NCT01765933|1,3-dimethylamylamine|1,3-dimethylamylamine
5390403|NCT01765894|glucose homeostasis|glucose homeostasis
5390404|NCT01765894|endogenous glucose production|endogenous glucose production
5390405|NCT01765894|moderate exercise|moderate exercise
5390406|NCT01765894|type 2 diabetes|type 2 diabetes
5390407|NCT01765894|metformin|metformin
5390408|NCT01765881|Induction of labor|induction of labor
5390409|NCT01765881|cervical ripening|cervical ripening
5390410|NCT01765881|misoprostol,|misoprostol,
5390411|NCT01765881|prostaglandin|prostaglandin
5390412|NCT01765881|cost-effectiveness|cost-effectiveness
5390413|NCT01765868|Betrixaban|betrixaban
5390414|NCT01765868|Healthy|healthy
5390415|NCT01765868|Bioavailability|bioavailability
5390416|NCT01765855|Betrixaban|betrixaban
5390417|NCT01765855|Healthy|healthy
5390418|NCT01765855|Mass Balance|mass balance
5390419|NCT01765842|Lupus Nephritis|lupus nephritis
5390420|NCT01765842|remission|remission
5390421|NCT01765842|immunosuppressive treatment|immunosuppressive treatment
5390422|NCT01765829|Non Affective Psychosis|non affective psychosis
5390423|NCT01765829|First episode|first episode
5390424|NCT01765829|Discontinuation scheme|discontinuation scheme
5390425|NCT01765816|Exercise|exercise
5390427|NCT01765816|Blood volume|blood volume
5390428|NCT01765816|Hemoglobin|hemoglobin
5390429|NCT01765803|Mellaril|mellaril
5390528|NCT01765309|Botox|botox
5390430|NCT01765803|Thioridazine|thioridazine
5390431|NCT01765803|CD34+|cd34+
5390432|NCT01765803|Stem cells|stem cells
5390433|NCT01765803|Progenitor cells|progenitor cells
5390434|NCT01765803|Peripheral blood|peripheral blood
5390435|NCT01765803|mobilization|mobilization
5390436|NCT01765803|circulation|circulation
5390437|NCT01765777|Low back pain|low back pain
5390438|NCT01765777|Lower back pain|lower back pain
5390439|NCT01765777|Chronic back pain|chronic back pain
5390440|NCT01765751|Cervical pain|cervical pain
5390441|NCT01765751|Neck pain|neck pain
5390442|NCT01765751|Arm pain|arm pain
5390443|NCT01765738|PICC|picc
5390444|NCT01765725|Chronic Fatigue Syndrome|chronic fatigue syndrome
5390445|NCT01765725|Coping|coping
5390446|NCT01765725|Patient education|patient education
5390447|NCT01765712|PRP|prp
5390448|NCT01765712|BPTB|bptb
5390449|NCT01765712|VAS|vas
5390450|NCT01765712|Anterior Knee Pain|anterior knee pain
5390451|NCT01765673|Swallowing|swallowing
5390453|NCT01765673|Sensory stimulation|sensory stimulation
5390454|NCT01765673|Home based therapy|home based therapy
5390455|NCT01765673|Head and Neck Cancer|head and neck cancer
5390456|NCT01765660|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5390457|NCT01765660|Mesenchymal Stem Cells|mesenchymal stem cells
5390458|NCT01765660|Chronic Graft-versus-host disease|chronic graft-versus-host disease
5390459|NCT01765647|Celiac disease|celiac disease
5390460|NCT01765647|AGY|agy
5373676|NCT01841476|Mobilization|mobilization
5390461|NCT01765634|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5390462|NCT01765634|Mesenchymal Stem Cells|mesenchymal stem cells
5390463|NCT01765634|Acute Graft-versus-host disease|acute graft-versus-host disease
5390464|NCT01765621|health care expenditure|health care expenditure
5390465|NCT01765621|drug drug interactions|drug drug interactions
5390466|NCT01765621|electronic decision support systems|electronic decision support systems
5390467|NCT01765621|pharmacogenetics|pharmacogenetics
5390468|NCT01765621|Potential Reduction|potential reduction
5390469|NCT01765608|Zonisamide|zonisamide
5390470|NCT01765608|Zonegran|zonegran
5390471|NCT01765608|Obstructive Sleep apnea|obstructive sleep apnea
5390472|NCT01765608|Apnea|apnea
5390473|NCT01765608|Respiration Disorders|respiration disorders
5390474|NCT01765608|Sleep Disorders|sleep disorders
5390475|NCT01765608|Obesity|obesity
5390476|NCT01765608|Anti-Obesity Agents|anti-obesity agents
5390477|NCT01765608|Carbonic Anhydrase|carbonic anhydrase
5390478|NCT01765608|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors
5390479|NCT01765608|Enzyme Inhibitors|enzyme inhibitors
5390480|NCT01765608|Sulfonamides|sulfonamides
5390481|NCT01765608|Therapeutic Uses|therapeutic uses
5390482|NCT01765608|Pharmacologic Actions|pharmacologic actions
5390483|NCT01765595|health care expenditure|health care expenditure
5390484|NCT01765595|drug drug interactions|drug drug interactions
5390485|NCT01765595|electronic decision support systems|electronic decision support systems
5390486|NCT01765595|Potential reduction|potential reduction
5390487|NCT01765530|Medical Devices|medical devices
5390488|NCT01765530|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
5390489|NCT01765530|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
5390490|NCT01765530|Endotracheal Tube|endotracheal tube
5390491|NCT01765530|Microbial Diversity|microbial diversity
5390492|NCT01765530|Anti-Resistance|anti-resistance
5390493|NCT01765530|Computed Tomography (CT)|computed tomography (ct)
5390494|NCT01765517|Diabetes Mellitus|diabetes mellitus
5390495|NCT01765504|Cardiac surgery; near infrared spectroscopy|cardiac surgery; near infrared spectroscopy
5390497|NCT01765491|bowel preparation|bowel preparation
5390498|NCT01765491|polyethylene glycol|polyethylene glycol
5390499|NCT01765478|Rheumatoid Arthritis|rheumatoid arthritis
5390500|NCT01765465|postcholecystectomy syndrome|postcholecystectomy syndrome
5390501|NCT01765465|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5390502|NCT01765465|Rowachol|rowachol
5390503|NCT01765439|bile acids|bile acids
5390504|NCT01765439|metabolism|metabolism
5390505|NCT01765439|probiotics|probiotics
5390506|NCT01765426|Prophylactic vaccination|prophylactic vaccination
5390507|NCT01765413|To identify|to identify
5390508|NCT01765413|biomarkers|biomarkers
5390509|NCT01765413|of vaccine safety|of vaccine safety
5390510|NCT01765413|Volunteers|volunteers
5390511|NCT01765400|Heart failure|heart failure
5390512|NCT01765400|Antiplatelet therapy|antiplatelet therapy
5390513|NCT01765400|Platelet aggregation|platelet aggregation
5390514|NCT01765400|Clopidogrel|clopidogrel
5390515|NCT01765400|Prasugrel|prasugrel
5390516|NCT01765387|Spatherpy|spatherpy
5390517|NCT01765387|Aerobic exercise|aerobic exercise
5390518|NCT01765374|rituximab|rituximab
5390519|NCT01765374|sonography|sonography
5390520|NCT01765374|clinical response|clinical response
5390521|NCT01765348|language impairment|language impairment
5390522|NCT01765348|language disorders|language disorders
5390523|NCT01765348|syntax treatment|syntax treatment
5390524|NCT01765348|narrative-based treatment|narrative-based treatment
5390525|NCT01765335|heart failure, BNP, NICaS system, readmition|heart failure, bnp, nicas system, readmition
5390526|NCT01765309|Tissue expanders|tissue expanders
5390527|NCT01765309|Botulinum toxin|botulinum toxin
5390531|NCT01765270|Diabetes|diabetes
5390532|NCT01765270|Diabetes Mellitus|diabetes mellitus
5390533|NCT01765270|Type 2 Diabetes|type 2 diabetes
5390534|NCT01765270|Cardiovascular Disease|cardiovascular disease
5390535|NCT01765270|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5390536|NCT01765257|Drug-naïve patients with Parkinson's disease|drug-naïve patients with parkinson's disease
5390537|NCT01765257|Apathy|apathy
5390538|NCT01765257|Rasagiline|rasagiline
5423340|NCT01616095|adipose tissue metabolism|adipose tissue metabolism
5390539|NCT01765244|Corneal trophic ulcers, limbal deficiency, cornea blindness|corneal trophic ulcers, limbal deficiency, cornea blindness
5390541|NCT01765231|Hepatitis B virus|hepatitis b virus
5376218|NCT01829893|finasteirde|finasteirde
5390542|NCT01765231|Therapeutic Uses|therapeutic uses
5390543|NCT01765231|Antiviral Agents|antiviral agents
5521900|NCT01201122|5-ASA|5-asa
5390544|NCT01765218|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5390545|NCT01765218|HIE|hie
5390546|NCT01765218|Perinatal depression|perinatal depression
5390547|NCT01765218|Whole body cooling|whole body cooling
5390548|NCT01765218|Therapeutic hypothermia|therapeutic hypothermia
5390549|NCT01765205|congenital cardiovascular malformation|congenital cardiovascular malformation
5390550|NCT01765205|newborn|newborn
5390551|NCT01765192|Drug therapy|drug therapy
5390552|NCT01765179|testosterone|testosterone
5390553|NCT01765179|male hypogonadism|male hypogonadism
5390554|NCT01765179|low testosterone|low testosterone
5373779|NCT01840969|peak strain|peak strain
5390555|NCT01765166|Social Skill Training|social skill training
5390556|NCT01765166|Social Interaction|social interaction
5390557|NCT01765166|Peer relations|peer relations
5390558|NCT01765153|physical therapy|physical therapy
5390559|NCT01765153|rehabilitation|rehabilitation
5390560|NCT01765153|neuroplasticity|neuroplasticity
5390561|NCT01765140|3,4 diaminopyridine (DAP)|3,4 diaminopyridine (dap)
5390562|NCT01765101|knee osteoarthritis|knee osteoarthritis
5390563|NCT01765101|therapeutic effect|therapeutic effect
5390564|NCT01765101|insole|insole
5390565|NCT01765088|High-grade glioma|high-grade glioma
5390566|NCT01765088|chemotherapy|chemotherapy
5390567|NCT01765088|Temozolomide|temozolomide
5390568|NCT01765088|Interferon-alpha|interferon-alpha
5390569|NCT01765075|Electrophysiological mapping|electrophysiological mapping
5390570|NCT01765075|Multi-electrode catheter|multi-electrode catheter
5390571|NCT01765062|Rapid maxillary expansion|rapid maxillary expansion
5390572|NCT01765062|Cross bite|cross bite
5390573|NCT01765062|Haas appliance|haas appliance
5390574|NCT01765062|Lateral cephalograms|lateral cephalograms
5390575|NCT01765049|breast density change|breast density change
5390576|NCT01765049|endocrine therapy response|endocrine therapy response
5390577|NCT01765049|aromatase inhibitor|aromatase inhibitor
5390578|NCT01765036|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
5390579|NCT01765036|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5390580|NCT01765010|Vitamin D|vitamin d
5390581|NCT01765010|Serum sclerostin|serum sclerostin
5390582|NCT01765010|Serum dickkopf1|serum dickkopf1
5390583|NCT01764984|total knee arthroplasty|total knee arthroplasty
5390584|NCT01764984|trabecular metal|trabecular metal
5390585|NCT01764984|bone mineral density|bone mineral density
5390586|NCT01764971|Chronic ITP, Cerebral dysfunction|chronic itp, cerebral dysfunction
5390587|NCT01764958|mother-infant interaction|mother-infant interaction
5390588|NCT01764958|general movements|general movements
5390589|NCT01764958|preterm infants|preterm infants
5390590|NCT01764893|Overactive Bladder|overactive bladder
5390591|NCT01764880|Heparanase inhibitor|heparanase inhibitor
5390592|NCT01764880|Multiple myeloma|multiple myeloma
5390593|NCT01764867|major depressive disorder|major depressive disorder
5390594|NCT01764867|algorithm guided treatment|algorithm guided treatment
5390595|NCT01764867|treatment as usual|treatment as usual
5390596|NCT01764867|escitalopram|escitalopram
5390597|NCT01764867|mirtazapine|mirtazapine
5390598|NCT01764867|transcranial magnetic stimulation (rTMS)|transcranial magnetic stimulation (rtms)
5390599|NCT01764867|modified electroconvulsive therapy (mECT)|modified electroconvulsive therapy (mect)
5390600|NCT01764867|remission|remission
5390601|NCT01764867|relapse|relapse
5390602|NCT01764867|quality of life|quality of life
5390603|NCT01764854|Hemodialysis|hemodialysis
5390604|NCT01764841|Ciprofloxacin|ciprofloxacin
5390605|NCT01764841|Dry Powder for Inhalation|dry powder for inhalation
5390606|NCT01764841|Exacerbation|exacerbation
5390607|NCT01764841|Bronchiectasis|bronchiectasis
5390608|NCT01764828|Phase I|phase i
5390609|NCT01764828|Pharmacokinetics|pharmacokinetics
5390610|NCT01764828|Safety measurements|safety measurements
5390611|NCT01764802|Psychosexual Intervention|psychosexual intervention
5390612|NCT01764802|Cancer|cancer
5390613|NCT01764802|Gynecologic Cancer|gynecologic cancer
5390614|NCT01764802|Breast Cancer|breast cancer
5390616|NCT01764789|breast cancer|breast cancer
5390617|NCT01764789|gynecologic cancer|gynecologic cancer
5390619|NCT01764776|Pharmacokinetics|pharmacokinetics
5390620|NCT01764776|PK|pk
5390621|NCT01764776|Postmenopausal women|postmenopausal women
5390622|NCT01764776|normal hepatic function|normal hepatic function
5390623|NCT01764776|mild hepatic impairment|mild hepatic impairment
5390624|NCT01764776|moderate hepatic impairment|moderate hepatic impairment
5390625|NCT01764776|severe hepatic impairment|severe hepatic impairment
5390626|NCT01764750|Intrasite|intrasite
5390627|NCT01764750|Antibiotic|antibiotic
5390628|NCT01764750|Vancomycin|vancomycin
5390629|NCT01764750|Infection|infection
5390630|NCT01764750|Pharmacokinetics|pharmacokinetics
5390631|NCT01764737|VX15/2503|vx15/2503
5390632|NCT01764737|Semaphorin 4D|semaphorin 4d
5390634|NCT01764737|CD100|cd100
5390635|NCT01764737|safety|safety
5376322|NCT01829373|lung cancer|lung cancer
5390636|NCT01764737|tolerability|tolerability
5390637|NCT01764737|pharmacokinetics|pharmacokinetics
5390638|NCT01764737|immunogenicity|immunogenicity
5390639|NCT01764737|multiple sclerosis|multiple sclerosis
5390640|NCT01764737|monoclonal antibody|monoclonal antibody
5390641|NCT01764724|Attitudes and understanding of sodium claims|attitudes and understanding of sodium claims
5390642|NCT01764724|General canadian population|general canadian population
5390643|NCT01764711|POTS|pots
5390644|NCT01764698|anxiety disorders|anxiety disorders
5390645|NCT01764698|substance use disorders|substance use disorders
5390646|NCT01764698|treatment effectiveness|treatment effectiveness
5390647|NCT01764698|cognitive behavioral therapy|cognitive behavioral therapy
5390648|NCT01764672|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5390649|NCT01764672|Healthy Adults|healthy adults
5390650|NCT01764672|Methylphenidate|methylphenidate
5390651|NCT01764672|Functional connectivity|functional connectivity
5390652|NCT01764672|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5390653|NCT01764659|4D-CT|4d-ct
5390654|NCT01764659|Contrast Enhanced CT|contrast enhanced ct
5390655|NCT01764659|Radiotherapy Simulation|radiotherapy simulation
5390656|NCT01764646|Prostate cancer|prostate cancer
5390657|NCT01764646|Radiation therapy|radiation therapy
5390658|NCT01764633|High cholesterol|high cholesterol
5390659|NCT01764633|Treatment for high cholesterol|treatment for high cholesterol
5390660|NCT01764633|Lowering cholesterol|lowering cholesterol
5390661|NCT01764633|Lowering high cholesterol|lowering high cholesterol
5390662|NCT01764633|Hypercholesterolemia|hypercholesterolemia
5390663|NCT01764620|shoulder|shoulder
5390664|NCT01764620|muscle fatigue|muscle fatigue
5390665|NCT01764620|kinematics|kinematics
5390666|NCT01764620|athletes|athletes
5390667|NCT01764607|Squamous|squamous
5390668|NCT01764607|Renal|renal
5390669|NCT01764607|Transplant|transplant
5390670|NCT01764594|Lupus|lupus
5390672|NCT01764581|immune monitoring|immune monitoring
5390673|NCT01764581|immune cell function ImmuKnow|immune cell function immuknow
5390674|NCT01764581|randomized controlled trial|randomized controlled trial
5390675|NCT01764581|immunosuppression management|immunosuppression management
5390676|NCT01764581|infection|infection
5390677|NCT01764581|rejection|rejection
5390678|NCT01764581|liver transplantation|liver transplantation
5390679|NCT01764581|Cylex|cylex
5390680|NCT01764568|Metacognitive training|metacognitive training
5390681|NCT01764568|Cognitive behavioral therapy|cognitive behavioral therapy
5390682|NCT01764568|Clinical trial|clinical trial
5390683|NCT01764568|Group intervention|group intervention
5390684|NCT01764568|Group therapy|group therapy
5390685|NCT01764568|Schizophrenia|schizophrenia
5390686|NCT01764568|Psychosis|psychosis
5390687|NCT01764568|Cognitive remediation|cognitive remediation
5489017|NCT01341132|HCC|hcc
5390688|NCT01764542|Ulcerative colitis|ulcerative colitis
5390689|NCT01764542|dysplasia|dysplasia
5390690|NCT01764542|risk factor|risk factor
5390691|NCT01764542|surgery|surgery
5390692|NCT01764516|zinc|zinc
5390693|NCT01764516|selenium|selenium
5390694|NCT01764516|serum|serum
5390695|NCT01764516|epilepsy|epilepsy
5390696|NCT01764516|antioxidants|antioxidants
5390697|NCT01764503|ampullary tumors|ampullary tumors
5390698|NCT01764503|endoscopic treatment|endoscopic treatment
5390699|NCT01764490|Bloodstream infections caused by multidrug-resistant Enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms|bloodstream infections caused by multidrug-resistant enterobacteriaceae, extended-spectrum β-lactamase-producers, carbapenemase-producing organisms
5390700|NCT01764464|post laminectomy pain syndrome, failed back surgery syndrome|post laminectomy pain syndrome, failed back surgery syndrome
5390701|NCT01764451|Hispanic|hispanic
5390702|NCT01764425|P7435|p7435
5390703|NCT01764425|Healthy,overweight and or obese subjects|healthy,overweight and or obese subjects
5390704|NCT01764425|Single ascending dose|single ascending dose
5390705|NCT01764425|Multiple ascending dose|multiple ascending dose
5390706|NCT01764425|Pharmacokinetics|pharmacokinetics
5390707|NCT01764412|Healthy women|healthy women
5390708|NCT01764412|Menstrual cycle|menstrual cycle
5390710|NCT01764412|Seric iron|seric iron
5390711|NCT01764399|cardiovascular risk factors|cardiovascular risk factors
5390712|NCT01764386|obesity, overweight|obesity, overweight
5390713|NCT01764373|Pain|pain
5390714|NCT01764373|Fitness|fitness
5390715|NCT01764373|Diabetes|diabetes
5390716|NCT01764373|Aerobic Exercise|aerobic exercise
5390717|NCT01764334|NonST elevation myocardial infarction (NSTEMI)|nonst elevation myocardial infarction (nstemi)
5390718|NCT01764334|Fractional flow reserve (FFR)|fractional flow reserve (ffr)
5390729|NCT01764308|acne; omega-3; isotretinoin; placebo|acne; omega-3; isotretinoin; placebo
5390730|NCT01764282|HIV|hiv
5390731|NCT01764282|serodiscordant couples HIV sero-conversion|serodiscordant couples hiv sero-conversion
5390732|NCT01764282|anti-retroviral therapy|anti-retroviral therapy
5390733|NCT01764282|intervention|intervention
5390734|NCT01764256|rotavirus|rotavirus
5390735|NCT01764256|vaccine|vaccine
5390741|NCT01764230|Hodgkin lymphoma|hodgkin lymphoma
5390742|NCT01764230|Hodgkin disease|hodgkin disease
5390743|NCT01764217|Cervix Cancer|cervix cancer
5390744|NCT01764217|SUV|suv
5390745|NCT01764217|Radiotherapy|radiotherapy
5390746|NCT01764217|Outcome Prediction|outcome prediction
5390747|NCT01764217|Imaging|imaging
5390748|NCT01764217|PET|pet
5390749|NCT01764178|Pitavastatin|pitavastatin
5390750|NCT01764178|Valsartan|valsartan
5390751|NCT01764165|COPD|copd
5390752|NCT01764165|Sleep|sleep
5390753|NCT01764165|Supplemental oxygen|supplemental oxygen
5390754|NCT01764165|Breathing mechanics|breathing mechanics
5390755|NCT01764165|nasal insufflation|nasal insufflation
5390756|NCT01764152|Prevention,|prevention,
5390757|NCT01764152|influenza,|influenza,
5390758|NCT01764152|adults hospitalized,|adults hospitalized,
5390759|NCT01764152|vaccines,|vaccines,
5390760|NCT01764152|Effectiveness|effectiveness
5390761|NCT01764139|Minimal knee changes|minimal knee changes
5390762|NCT01764126|Safety|safety
5390763|NCT01764126|immunogenicity|immunogenicity
5390764|NCT01764126|pneumococcal|pneumococcal
5390765|NCT01764126|protein|protein
5390766|NCT01764126|vaccine|vaccine
5390767|NCT01764113|Obesity|obesity
5390768|NCT01764113|Adolescence|adolescence
5390769|NCT01764113|Mindful Eating|mindful eating
5390770|NCT01764087|Stomach Neoplasms|stomach neoplasms
5390771|NCT01764087|Breast Neoplasms|breast neoplasms
5390772|NCT01764087|Carcinoma|carcinoma
5390773|NCT01764087|Neoplasms|neoplasms
5390774|NCT01764087|Paclitaxel|paclitaxel
5390775|NCT01764087|Tubulin Modulators|tubulin modulators
5390776|NCT01764087|Antimitotic Agents|antimitotic agents
5390777|NCT01764087|Protein Kinase Inhibitors|protein kinase inhibitors
5390778|NCT01764087|Enzyme Inhibitors|enzyme inhibitors
5390779|NCT01764087|Pharmacologic Actions|pharmacologic actions
5390780|NCT01764074|Bipolar Disorder|bipolar disorder
5390781|NCT01764074|Sleep Intervention|sleep intervention
5390782|NCT01764074|Suicide|suicide
5390783|NCT01764074|Cognitive Behavioral Therapy|cognitive behavioral therapy
5390784|NCT01764074|Sleep Quality|sleep quality
5390785|NCT01764061|Red Cells|red cells
5390786|NCT01764061|Blood donors|blood donors
5390787|NCT01764048|pain management|pain management
5390788|NCT01764048|cesarean section|cesarean section
5390789|NCT01764035|Psychotherapy|psychotherapy
5390790|NCT01764035|Bipolar Disorder|bipolar disorder
5390791|NCT01764035|Sleep Problems|sleep problems
5390792|NCT01764035|Insomnia|insomnia
5390793|NCT01764035|Hypersomnia|hypersomnia
5390794|NCT01764035|Mindfulness|mindfulness
5390795|NCT01764035|Meditation|meditation
5390796|NCT01764035|Sleep Disturbance|sleep disturbance
5390797|NCT01764022|breast cancer|breast cancer
5390798|NCT01764022|trastuzumab|trastuzumab
5390799|NCT01764009|Advanced Melanoma|advanced melanoma
5390800|NCT01764009|Metastatic Melanoma|metastatic melanoma
5390801|NCT01764009|Melanoma Stage III and IV|melanoma stage iii and iv
5390802|NCT01763996|Drug therapy|drug therapy
5390803|NCT01763983|Multiple Sclerosis|multiple sclerosis
5390804|NCT01763983|Stress, Psychological|stress, psychological
5390805|NCT01763983|Psychological Stress|psychological stress
5390806|NCT01763983|Emotional Stress|emotional stress
5390807|NCT01763983|Cognitive Deficits|cognitive deficits
5390808|NCT01763983|Cognitive Dysfunction|cognitive dysfunction
5390809|NCT01763970|Stereotactic|stereotactic
5390810|NCT01763970|Radiotherapy|radiotherapy
5390811|NCT01763970|Hypofractionated|hypofractionated
5390812|NCT01763944|diet|diet
5390813|NCT01763944|prostate cancer|prostate cancer
5390814|NCT01763944|carbohydrate|carbohydrate
5390815|NCT01763944|lifestyle|lifestyle
5390816|NCT01763931|Digoxin|digoxin
5390935|NCT01763463|long-acting bronchodilators (LABD)|long-acting bronchodilators (labd)
5390817|NCT01763918|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
5390909|NCT01763554|DOTA-TATE|dota-tate
5390818|NCT01763905|High Cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
5390819|NCT01763892|Pediatric|pediatric
5390820|NCT01763892|Traumatic Brain Injury|traumatic brain injury
5390822|NCT01763892|Apolipoprotein E|apolipoprotein e
5390824|NCT01763892|Vasospasm|vasospasm
5390825|NCT01763892|Genetics|genetics
5390826|NCT01763892|Physiologic Mechanisms|physiologic mechanisms
5394402|NCT01746901|Chronic pain|chronic pain
5390832|NCT01763879|volume-controlled ventilation|volume-controlled ventilation
5390833|NCT01763879|right ventricular function|right ventricular function
5671204|NCT00616733|Multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, MRI|multiple sclerosis, relapsing, secondary progressive, clinically isolated syndrome, mri
5390834|NCT01763866|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
5390835|NCT01763853|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5390836|NCT01763853|Pulmonary edema|pulmonary edema
5390837|NCT01763853|Alveolar fluid clearance|alveolar fluid clearance
5390838|NCT01763853|Alveolar epithelial dysfunction|alveolar epithelial dysfunction
5390839|NCT01763853|Receptor for advanced glycation end-products (RAGE)|receptor for advanced glycation end-products (rage)
5390840|NCT01763853|Fluid resuscitation therapy|fluid resuscitation therapy
5390842|NCT01763853|Crystalloid|crystalloid
5390843|NCT01763853|Hydroxyethyl Starch|hydroxyethyl starch
5390844|NCT01763853|Intensive care unit|intensive care unit
5390845|NCT01763840|Pediatric Abdominal Trauma Ultrasound Contrast|pediatric abdominal trauma ultrasound contrast
5445459|NCT01521676|breast cancer|breast cancer
5390846|NCT01763827|High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia|high cholesterol, treatment for high cholesterol, lowering cholesterol, lowering high cholesterol, hypercholesterolemia
5390847|NCT01763801|chemo port|chemo port
5390848|NCT01763801|intravenous electrocardiographic guidance|intravenous electrocardiographic guidance
5390849|NCT01763801|P maximal wave|p maximal wave
5390850|NCT01763801|P submaximal wave|p submaximal wave
5390851|NCT01763801|catheter tip|catheter tip
5390852|NCT01763775|weight|weight
5390853|NCT01763775|total body water|total body water
5390854|NCT01763775|body fat|body fat
5390855|NCT01763775|muscle mass|muscle mass
5390856|NCT01763775|bone mass|bone mass
5390857|NCT01763762|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
5390858|NCT01763762|Pelvic floor muscle training|pelvic floor muscle training
5390859|NCT01763762|Transvaginal electrical stimulation|transvaginal electrical stimulation
5390860|NCT01763762|Stress urinary incontinence|stress urinary incontinence
5390861|NCT01763762|Comparative study|comparative study
5390862|NCT01763723|Intense pulsed light,|intense pulsed light,
5390863|NCT01763723|UV-exposure,|uv-exposure,
5390864|NCT01763723|skin type,|skin type,
5390865|NCT01763723|safety,|safety,
5390866|NCT01763723|pigment,|pigment,
5390867|NCT01763723|home-use|home-use
5390868|NCT01763723|subjects|subjects
5390869|NCT01763710|Breast cancer|breast cancer
5390870|NCT01763710|Neurotoxicity|neurotoxicity
5390871|NCT01763697|Taste acuity|taste acuity
5390872|NCT01763697|Feeding behavior|feeding behavior
5390873|NCT01763697|opioid|opioid
5390874|NCT01763697|Quantitative assessment|quantitative assessment
5390875|NCT01763684|Osteoarthritis|osteoarthritis
5390876|NCT01763684|Osteoarthritis, Knee|osteoarthritis, knee
5390877|NCT01763684|Osteonecrosis|osteonecrosis
5390878|NCT01763684|Arthritis|arthritis
5390879|NCT01763684|Knee Arthritis|knee arthritis
5390880|NCT01763684|Knee Replacement|knee replacement
5390881|NCT01763671|Lung cancer|lung cancer
5390882|NCT01763671|Paclitaxel bevacizumab|paclitaxel bevacizumab
5390883|NCT01763658|ITP, antioxidant therapy, oxidant status|itp, antioxidant therapy, oxidant status
5390884|NCT01763645|NSCLC|nsclc
5390885|NCT01763645|bevacizumab|bevacizumab
5390886|NCT01763645|pharmacokinetics|pharmacokinetics
5390887|NCT01763632|Hyperbilirubinemia|hyperbilirubinemia
5390888|NCT01763632|Neonatal|neonatal
5390889|NCT01763632|Transcutaneous Bilirubin|transcutaneous bilirubin
5390890|NCT01763619|Cervical DDD|cervical ddd
5390891|NCT01763619|DDD|ddd
5390892|NCT01763619|degenerative disc disease|degenerative disc disease
5390893|NCT01763619|C3-C7|c3-c7
5390894|NCT01763606|Enoxaparin|enoxaparin
5390895|NCT01763606|Aspirin|aspirin
5390896|NCT01763606|stroke|stroke
5390897|NCT01763606|12-264|12-264
5390898|NCT01763593|Patients having cataract|patients having cataract
5390899|NCT01763580|Glomerulonephritis|glomerulonephritis
5390900|NCT01763580|Tacrolimus|tacrolimus
5390901|NCT01763580|Nephrotic syndrome|nephrotic syndrome
5390902|NCT01763567|Medtronic|medtronic
5390903|NCT01763567|Diabetes|diabetes
5390904|NCT01763567|Hospital|hospital
5390905|NCT01763567|Continuous Glucose Monitor|continuous glucose monitor
5390906|NCT01763567|Intensive Care Unit|intensive care unit
5390907|NCT01763554|Lu-177|lu-177
5390908|NCT01763554|Lutetium-177|lutetium-177
5390910|NCT01763554|Neuroendocrine tumors|neuroendocrine tumors
5390911|NCT01763554|radiopharmaceutical|radiopharmaceutical
5390912|NCT01763541|Natriuretic Peptides|natriuretic peptides
5390913|NCT01763528|body weight|body weight
5390914|NCT01763528|Low-density-lipoprotein-type|low-density-lipoprotein-type
5390915|NCT01763515|Joint Diseases|joint diseases
5390916|NCT01763515|Arthritis|arthritis
5390926|NCT01763489|applicability|applicability
5390927|NCT01763489|ASSIST tool|assist tool
5390928|NCT01763489|surgery|surgery
5390929|NCT01763489|digestive cancer|digestive cancer
5390930|NCT01763476|long infrapopliteal artery lesions|long infrapopliteal artery lesions
5390931|NCT01763476|drug-coated balloon angioplasty|drug-coated balloon angioplasty
5390932|NCT01763476|atherectomy|atherectomy
5390933|NCT01763463|pneumonia requiring hospitalization|pneumonia requiring hospitalization
5390934|NCT01763463|COPD|copd
5391059|NCT01762852|efficacy|efficacy
5390936|NCT01763463|Inhaled Corticosteroids (ICS)|inhaled corticosteroids (ics)
5390937|NCT01763450|Bevacizumab|bevacizumab
5390938|NCT01763450|conversion therapy|conversion therapy
5390939|NCT01763450|liver metastases|liver metastases
5390940|NCT01763450|colorectal cancer|colorectal cancer
5390941|NCT01763450|objective response rate|objective response rate
5390942|NCT01763437|Chalazia|chalazia
5390943|NCT01763437|Chalazion|chalazion
5390944|NCT01763437|Meibomian gland dysfunction|meibomian gland dysfunction
5390945|NCT01763437|Rosacea|rosacea
5390946|NCT01763437|Ocular rosacea|ocular rosacea
5390947|NCT01763411|Cataract|cataract
5390948|NCT01763411|Vision|vision
5390949|NCT01763411|Intraocular lens|intraocular lens
5390950|NCT01763411|Multifocal|multifocal
5390951|NCT01763411|Monofocal|monofocal
5390952|NCT01763385|Erlotinib|erlotinib
5390953|NCT01763385|brain radiotherapy|brain radiotherapy
5390954|NCT01763385|NSCLC|nsclc
5390955|NCT01763385|brain metastases|brain metastases
5390956|NCT01763372|Arthroscopic|arthroscopic
5390957|NCT01763372|Iliopsoas|iliopsoas
5390959|NCT01763359|acetabular fracture|acetabular fracture
5390960|NCT01763359|pelvic fracture|pelvic fracture
5390961|NCT01763359|hip adductor strength|hip adductor strength
5390962|NCT01763359|obturator nerve palsy|obturator nerve palsy
5390963|NCT01763359|modified Stoppa approach|modified stoppa approach
5390964|NCT01763346|type 2 diabetes|type 2 diabetes
5390965|NCT01763346|prediabetes|prediabetes
5390966|NCT01763346|obesity|obesity
5390967|NCT01763346|gastric banding|gastric banding
5390968|NCT01763346|metformin|metformin
5390969|NCT01763320|ischemic stroke|ischemic stroke
5390970|NCT01763320|intracranial stenting|intracranial stenting
5390971|NCT01763320|vascular risk factor management|vascular risk factor management
5390972|NCT01763307|EGFRI|egfri
5390973|NCT01763307|COLON CANCER|colon cancer
5390974|NCT01763307|SKIN TOXICITY|skin toxicity
5390975|NCT01763307|RECONVAL K1 cream|reconval k1 cream
5390976|NCT01763294|multifocal refractory epilepsy|multifocal refractory epilepsy
5390977|NCT01763294|tDCS|tdcs
5390978|NCT01763294|neurostimulation|neurostimulation
5390979|NCT01763294|seizures|seizures
5390980|NCT01763268|Immunogenicity|immunogenicity
5390981|NCT01763268|Reactogenicity|reactogenicity
5390982|NCT01763268|Trivivac|trivivac
5390983|NCT01763268|Measles|measles
5390984|NCT01763268|Mump|mump
5390985|NCT01763268|Rubella|rubella
5390986|NCT01763255|cerebral palsy CD133 cells intrathecal injection|cerebral palsy cd133 cells intrathecal injection
5390987|NCT01763242|CKD, Anaemia, Synchronization, Monthly dosing, Home Delivery|ckd, anaemia, synchronization, monthly dosing, home delivery
5390988|NCT01763216|depressive symptoms|depressive symptoms
5390989|NCT01763216|clinical depression|clinical depression
5390990|NCT01763216|visual processing speed|visual processing speed
5390991|NCT01763216|anxiety|anxiety
5390992|NCT01763216|pain|pain
5390993|NCT01763216|health-related quality of life|health-related quality of life
5390994|NCT01763203|Self-management|self-management
5390995|NCT01763203|Chronic Care Model|chronic care model
5390996|NCT01763203|Community health worker|community health worker
5390997|NCT01763177|nebulizer|nebulizer
5390998|NCT01763177|oxygen|oxygen
5390999|NCT01763177|post-operative sore throat|post-operative sore throat
5391000|NCT01763164|Melanoma|melanoma
5391001|NCT01763164|Cutaneous melanoma|cutaneous melanoma
5391002|NCT01763164|Skin disease|skin disease
5391003|NCT01763164|Skin cancer|skin cancer
5391004|NCT01763164|Skin Neoplasms|skin neoplasms
5391005|NCT01763164|Neoplasm Metastasis|neoplasm metastasis
5391006|NCT01763151|cataract surgery, astigmatism, opposite clear corneal incision, toric IOL, IOL rotational stability|cataract surgery, astigmatism, opposite clear corneal incision, toric iol, iol rotational stability
5391007|NCT01763125|circulating tumor cells|circulating tumor cells
5391008|NCT01763125|CTC|ctc
5391009|NCT01763125|tumor marker|tumor marker
5391502|NCT01760811|cetuximab|cetuximab
5391010|NCT01763112|Influence of training with whole body vibration device|influence of training with whole body vibration device
5391011|NCT01763099|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5391013|NCT01763099|Cord Blood|cord blood
5391014|NCT01763099|Graft failure|graft failure
5391015|NCT01763086|Poor Graft Function|poor graft function
5391016|NCT01763086|Mesenchymal Stem Cells|mesenchymal stem cells
5391017|NCT01763086|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5391018|NCT01763086|Third-party Donors|third-party donors
5391019|NCT01763060|ards|ards
5391020|NCT01763060|ecmo|ecmo
5391021|NCT01763060|h1n1|h1n1
5391022|NCT01763060|pandemics|pandemics
5391023|NCT01763021|Healthy participants|healthy participants
5522532|NCT01198665|RAD001|rad001
5391024|NCT01763021|PCI-32765|pci-32765
5391025|NCT01763021|Rifampin|rifampin
5391026|NCT01763021|PCI-45227|pci-45227
5391027|NCT01763021|CYP3A4|cyp3a4
5391028|NCT01763008|Pneumonia, Bacterial|pneumonia, bacterial
5391029|NCT01763008|Nosocomial Infection|nosocomial infection
5391030|NCT01763008|Intraabdominal Infections|intraabdominal infections
5391031|NCT01763008|Urinary Tract Infection|urinary tract infection
5391032|NCT01763008|Ventilator-associated pneumonia|ventilator-associated pneumonia
5391033|NCT01763008|Doripenem|doripenem
5391034|NCT01763008|Doribax|doribax
5391035|NCT01763008|Filipino|filipino
5391036|NCT01762995|Dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers|dolutegravir, pharmacokinetics, calcium, iron, drug interaction, healthy volunteers
5391037|NCT01762956|Pelvic floor|pelvic floor
5391038|NCT01762956|Physical Therapy|physical therapy
5391039|NCT01762956|Prostate cancer|prostate cancer
5391040|NCT01762956|Radiotherapy|radiotherapy
5391041|NCT01762956|Nuclear magnetic resonance|nuclear magnetic resonance
5391042|NCT01762904|Antiseptics|antiseptics
5391043|NCT01762904|Administration cutaneously|administration cutaneously
5391044|NCT01762904|Anti-infecting agents, local|anti-infecting agents, local
5391045|NCT01762891|Coumadin|coumadin
5391046|NCT01762891|celecoxib|celecoxib
5391047|NCT01762891|rofecoxib|rofecoxib
5391048|NCT01762891|acetaminophen|acetaminophen
5391049|NCT01762891|antiphospholipid syndrome and INR|antiphospholipid syndrome and inr
5391050|NCT01762878|pharmacodynamics|pharmacodynamics
5391051|NCT01762878|pharmacokinetics|pharmacokinetics
5391052|NCT01762878|healthy volunteers|healthy volunteers
5391053|NCT01762878|Pi3K-delta|pi3k-delta
5391054|NCT01762878|GSK2269557|gsk2269557
5391055|NCT01762878|safety|safety
5391056|NCT01762878|dry powder inhaler|dry powder inhaler
5391057|NCT01762865|acute bronchitis, bacteria, virus, clinical symoptoms|acute bronchitis, bacteria, virus, clinical symoptoms
5391058|NCT01762852|Benlysta|benlysta
5391060|NCT01762852|proteinuria|proteinuria
5391061|NCT01762852|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
5391062|NCT01762852|GSK1550188|gsk1550188
5391063|NCT01762852|anti-phospholipase A2 receptor antibodies|anti-phospholipase a2 receptor antibodies
5391064|NCT01762852|safety|safety
5391065|NCT01762852|placebo|placebo
5391066|NCT01762852|BLyS|blys
5391067|NCT01762852|belimumab|belimumab
5391068|NCT01762852|Lymphostat-B|lymphostat-b
5391069|NCT01762852|membrane attack complex|membrane attack complex
5391070|NCT01762826|Inositol|inositol
5391071|NCT01762826|GDM|gdm
5391072|NCT01762813|Colon cancer|colon cancer
5391073|NCT01762813|rectal cancer|rectal cancer
5391074|NCT01762813|liver metastasis|liver metastasis
5391075|NCT01762813|survival|survival
5391076|NCT01762813|biomarker|biomarker
5391077|NCT01762813|molecular profile|molecular profile
5391078|NCT01762774|COPD|copd
5391079|NCT01762774|forearm blood flow|forearm blood flow
5391080|NCT01762774|soluble Epoxide Hydrolase inhibitor|soluble epoxide hydrolase inhibitor
5391081|NCT01762761|eltrombopag|eltrombopag
5391082|NCT01762761|TPO-R agonist|tpo-r agonist
5391083|NCT01762761|Chronic ITP|chronic itp
5391084|NCT01762761|ETB115|etb115
5391085|NCT01762761|Chinese chronic ITP patients|chinese chronic itp patients
5391086|NCT01762748|Probiotic|probiotic
5391087|NCT01762748|liver|liver
5391088|NCT01762748|transplant|transplant
5391089|NCT01762748|permeability|permeability
5391090|NCT01762722|Spectroscopy, near infrared|spectroscopy, near infrared
5391091|NCT01762722|Oximetry|oximetry
5391092|NCT01762722|Hypoxemia|hypoxemia
5391093|NCT01762722|Tissue oxygenation|tissue oxygenation
5391094|NCT01762709|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5391095|NCT01762709|one lung ventilation|one lung ventilation
5391096|NCT01762709|low tidal volume|low tidal volume
5391097|NCT01762709|acute lung injury|acute lung injury
5391098|NCT01762709|lung water content|lung water content
5391099|NCT01762696|marijuana|marijuana
5391100|NCT01762696|intervention|intervention
5391101|NCT01762696|adolescent, young adult|adolescent, young adult
5391102|NCT01762696|primary care|primary care
5391103|NCT01762696|mobile|mobile
5391104|NCT01762683|pregnancy|pregnancy
5391105|NCT01762683|obesity|obesity
5391106|NCT01762683|differentiation|differentiation
5391107|NCT01762670|Bacterial Vaginosis|bacterial vaginosis
5391109|NCT01762657|Type 1 Diabetes|type 1 diabetes
5391110|NCT01762657|Insulin Independence|insulin independence
5391111|NCT01762657|Beta Regeneration|beta regeneration
5391112|NCT01762657|Immune Tolerance Agent|immune tolerance agent
5391114|NCT01762657|Cyclosporine|cyclosporine
5391115|NCT01762644|Type 1 Diabetes|type 1 diabetes
5391116|NCT01762644|Insulin Independence|insulin independence
5391117|NCT01762644|Beta Regeneration|beta regeneration
5391118|NCT01762644|Immune Tolerance Agent|immune tolerance agent
5391120|NCT01762644|Cyclosporine|cyclosporine
5671205|NCT00616720|stage I multiple myeloma|stage i multiple myeloma
5671959|NCT00613470|Depression|depression
5391121|NCT01762618|Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡|group cognitive behavior therapy, alzheimer's disease, caregivers¡
5391122|NCT01762579|Not-celiac wheat sensitivity|not-celiac wheat sensitivity
5391124|NCT01762579|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5391126|NCT01762566|Not-celiac gluten (wheat) sensitivity|not-celiac gluten (wheat) sensitivity
5391127|NCT01762566|Bioelectrical impedance analysis|bioelectrical impedance analysis
5391128|NCT01762566|Bloating|bloating
5391129|NCT01762566|Swelling|swelling
5391130|NCT01762540|Protein breakdown|protein breakdown
5391131|NCT01762540|Insulin resistance|insulin resistance
5391132|NCT01762540|Glucose intolerance|glucose intolerance
5391133|NCT01762540|Lipolysis|lipolysis
5391134|NCT01762527|Adaptive radiotherapy|adaptive radiotherapy
5391135|NCT01762527|Bladder cancer|bladder cancer
5391136|NCT01762514|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5391137|NCT01762514|Amifostine|amifostine
5391138|NCT01762514|Myelosuppression|myelosuppression
5391139|NCT01762514|Xerostomia|xerostomia
5391140|NCT01762514|Mucositis|mucositis
5391141|NCT01762501|Hypertension|hypertension
5391142|NCT01762488|Treatment Resistant Hypertension|treatment resistant hypertension
5391143|NCT01762488|Renal Denervation|renal denervation
5391144|NCT01762475|Magnetic resonance imaging|magnetic resonance imaging
5391145|NCT01762475|Blood oxygen level dependent signal|blood oxygen level dependent signal
5391146|NCT01762475|Hypercapnia|hypercapnia
5391147|NCT01762475|Endothelial progenitor cells|endothelial progenitor cells
5391148|NCT01762449|Scleroderma|scleroderma
5391149|NCT01762449|interstitial lung disease|interstitial lung disease
5391150|NCT01762410|Advanced refractory solid tumors|advanced refractory solid tumors
5391152|NCT01762371|Knee|knee
5391153|NCT01762371|Ligament|ligament
5391154|NCT01762371|Cruciate|cruciate
5391155|NCT01762371|Anterior|anterior
5391156|NCT01762358|ACL|acl
5391157|NCT01762358|Ligament|ligament
5391158|NCT01762358|Knee|knee
5391159|NCT01762345|Stress urinary incontinence|stress urinary incontinence
5391160|NCT01762345|SUI|sui
5391161|NCT01762332|nociception|nociception
5391162|NCT01762332|analgesia|analgesia
5391163|NCT01762332|intraoperative monitoring|intraoperative monitoring
5391164|NCT01762293|CRC|crc
5391165|NCT01762293|Famitinib|famitinib
5391166|NCT01762293|Phase II|phase ii
5391167|NCT01762293|Colorectal Cancer|colorectal cancer
5391168|NCT01762280|Famitinib|famitinib
5391169|NCT01762280|Advanced Solid tumor|advanced solid tumor
5391170|NCT01762280|Phase I|phase i
5391171|NCT01762254|pain score|pain score
5391172|NCT01762254|complication|complication
5391173|NCT01762241|Prostate cancer|prostate cancer
5391174|NCT01762241|Androgen deprivation therapy|androgen deprivation therapy
5391175|NCT01762241|Exercise|exercise
5391176|NCT01762241|Xbox|xbox
5391177|NCT01762228|Oropharyngeal dysphagia|oropharyngeal dysphagia
5391178|NCT01762228|Elderly|elderly
5391179|NCT01762228|Transcutaneous electrical stimulation|transcutaneous electrical stimulation
5391180|NCT01762228|TRPV1 agonist|trpv1 agonist
5391181|NCT01762215|Epilepsy|epilepsy
5391182|NCT01762215|Seizure|seizure
5391183|NCT01762215|Veteran|veteran
5391184|NCT01762202|CLL|cll
5391185|NCT01762202|Fludarabine|fludarabine
5391186|NCT01762202|Cyclophosphamide|cyclophosphamide
5391187|NCT01762202|Ofatumumab|ofatumumab
5391188|NCT01762189|Hyperbilirubinemia|hyperbilirubinemia
5391189|NCT01762189|Neonatal|neonatal
5391190|NCT01762189|Incidence|incidence
5391191|NCT01762189|Risk factors|risk factors
5391192|NCT01762176|Early Rheumatoid Arthritis|early rheumatoid arthritis
5391193|NCT01762176|Usual care|usual care
5391194|NCT01762176|Intensive Care|intensive care
5391195|NCT01762176|Boolean criteria|boolean criteria
5489583|NCT01338896|Neupro|neupro
5391196|NCT01762163|Ischemic Stroke,adaptive design, randomized, double-blind|ischemic stroke,adaptive design, randomized, double-blind
5391197|NCT01762150|collected duct carcinoma|collected duct carcinoma
5391198|NCT01762150|sorafenib|sorafenib
5391199|NCT01762137|Aneurysm|aneurysm
5391200|NCT01762137|Coiling|coiling
5391201|NCT01762137|Flow Diversion|flow diversion
5391202|NCT01762124|Pulmonary valve|pulmonary valve
5391203|NCT01762124|Congenital heart disease|congenital heart disease
5391204|NCT01762124|Transcatheter pulmonary valve|transcatheter pulmonary valve
5391205|NCT01762124|Percutaneous pulmonary valve|percutaneous pulmonary valve
5391206|NCT01762111|Anti-Mullerian Hormone|anti-mullerian hormone
5391221|NCT01762059|insulin pump|insulin pump
5391222|NCT01762046|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5391223|NCT01762046|Pharmacogenetics|pharmacogenetics
5391225|NCT01762046|Obesity|obesity
5391226|NCT01762033|Renal cell carcinoma|renal cell carcinoma
5391227|NCT01762033|Renal cell cancer|renal cell cancer
5391228|NCT01762033|ASONEP|asonep
5391229|NCT01762033|Sonepcizumab|sonepcizumab
5391230|NCT01762020|Women with Breast Cancer|women with breast cancer
5391231|NCT01762020|Receiving Adjuvant Radiation Therapy|receiving adjuvant radiation therapy
5391232|NCT01762007|hypospadias, bladder outlet obstruction, ultrasonography|hypospadias, bladder outlet obstruction, ultrasonography
5391233|NCT01761994|nafamostat mesilate|nafamostat mesilate
5391234|NCT01761994|heparin|heparin
5391235|NCT01761994|continuous renal replacement therapy|continuous renal replacement therapy
5391236|NCT01761981|Haemorrhagic Hereditary Telangiectasia|haemorrhagic hereditary telangiectasia
5391237|NCT01761981|Rendu Osler Weber Syndrome|rendu osler weber syndrome
5391238|NCT01761981|Osler Weber Rendu Syndrome|osler weber rendu syndrome
5391239|NCT01761981|HHT|hht
5391240|NCT01761968|chronic myeloproliferative neoplasms|chronic myeloproliferative neoplasms
5391241|NCT01761968|Polycythemia Vera|polycythemia vera
5391242|NCT01761968|Essential Thrombocythemia|essential thrombocythemia
5391243|NCT01761968|Primary Myelofibrosis|primary myelofibrosis
5391244|NCT01761968|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5391245|NCT01761968|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5391246|NCT01761968|Givinostat|givinostat
5391247|NCT01761955|body weight|body weight
5391248|NCT01761955|lipids|lipids
5391249|NCT01761955|glucose|glucose
5391250|NCT01761955|insulin|insulin
5391251|NCT01761942|omega-3 fatty acids|omega-3 fatty acids
5391252|NCT01761942|anorexia nervosa|anorexia nervosa
5391253|NCT01761942|efficacy|efficacy
5391254|NCT01761942|safety|safety
5391255|NCT01761929|oligometastatic|oligometastatic
5391256|NCT01761929|oligometastases|oligometastases
5391257|NCT01761929|stereotactic body radiotherapy|stereotactic body radiotherapy
5391258|NCT01761929|radiation therapy|radiation therapy
5391259|NCT01761929|Oligometastasis|oligometastasis
5391260|NCT01761929|Stereotactic ablative body|stereotactic ablative body
5391261|NCT01761929|radiotherapy|radiotherapy
5391262|NCT01761916|captopril, clonidine, pregnancy-induced hypertension,|captopril, clonidine, pregnancy-induced hypertension,
5391263|NCT01761890|Chronic Myeloid Leukemia|chronic myeloid leukemia
5391264|NCT01761890|Early phase|early phase
5391265|NCT01761890|CML|cml
5391266|NCT01761890|Dasatinib|dasatinib
5391267|NCT01761877|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors|breast cancer, nonsteroidal antiinflammatory drug , breast density, chemoprevention, aromatase inhibitors
5391268|NCT01761851|Resting metabolic rate|resting metabolic rate
5391269|NCT01761851|nutrition status|nutrition status
5391270|NCT01761851|dietary intake|dietary intake
5391271|NCT01761838|spinal manipulative therapy|spinal manipulative therapy
5391272|NCT01761838|low back pain|low back pain
5391273|NCT01761838|experimental pain|experimental pain
5391274|NCT01761838|spinal stiffness|spinal stiffness
5391275|NCT01761838|lumbar multifidus|lumbar multifidus
5391276|NCT01761838|degeneration|degeneration
5391277|NCT01761812|Prostate cancer|prostate cancer
5391278|NCT01761812|MRI|mri
5391279|NCT01761812|Elastography|elastography
5391280|NCT01761812|Gadofosveset|gadofosveset
5391281|NCT01761799|Influenza|influenza
5391282|NCT01761799|Pertussis|pertussis
5391283|NCT01761799|Vaccination|vaccination
5391284|NCT01761786|Myocardial Infarction|myocardial infarction
5391288|NCT01761786|Heart Diseases|heart diseases
5391289|NCT01761786|Cardiovascular Diseases|cardiovascular diseases
5391290|NCT01761786|Vascular Diseases|vascular diseases
5391291|NCT01761786|Embolism and Thrombosis|embolism and thrombosis
5391292|NCT01761786|Genetic Testing|genetic testing
5391293|NCT01761786|Clopidogrel|clopidogrel
5391294|NCT01761786|Prasugrel|prasugrel
5391295|NCT01761786|Ticagrelor|ticagrelor
5391296|NCT01761786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5391297|NCT01761786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
5391298|NCT01761747|Squamous Cell Carcinoma|squamous cell carcinoma
5391299|NCT01761734|Influenza vaccination|influenza vaccination
5391300|NCT01761721|Endometrial cancer (MeSH)|endometrial cancer (mesh)
5391301|NCT01761721|Robotics (MeSH)|robotics (mesh)
5391305|NCT01761708|C-Qur V-patch|c-qur v-patch
5364490|NCT01882075|Closed-loop|closed-loop
5391306|NCT01761708|Size tailored repair|size tailored repair
5391307|NCT01761708|preperitoneal repair|preperitoneal repair
5391308|NCT01761708|abdominal hernia|abdominal hernia
5391309|NCT01761708|dual sided mesh|dual sided mesh
5391310|NCT01761708|trocar-site hernia|trocar-site hernia
5391311|NCT01761656|stable angina|stable angina
5391312|NCT01761656|unstable angina|unstable angina
5391313|NCT01761656|acute non-ST-segment elevation myocardial infarction|acute non-st-segment elevation myocardial infarction
5391315|NCT01761656|perioperative myocardial infarction|perioperative myocardial infarction
5391316|NCT01761656|major adverse cardiac events|major adverse cardiac events
5391318|NCT01761643|Pre exposure Prophylaxis|pre exposure prophylaxis
5391319|NCT01761643|Text Messaging|text messaging
5391320|NCT01761643|Truvada|truvada
5391321|NCT01761643|iTab|itab
5391322|NCT01761643|CCTG|cctg
5391323|NCT01761643|595|595
5391324|NCT01761630|Asthma|asthma
5391325|NCT01761630|Severe Asthma|severe asthma
5391326|NCT01761630|SARP|sarp
5391327|NCT01761617|Yoga|yoga
5391328|NCT01761617|Chronic Low Back Pain|chronic low back pain
5391329|NCT01761617|CAM|cam
5391330|NCT01761617|Complementary and Alternative Medicine|complementary and alternative medicine
5391331|NCT01761617|Minorities|minorities
5391332|NCT01761591|CAD|cad
5391333|NCT01761591|PCI|pci
5391334|NCT01761591|BMS|bms
5391335|NCT01761591|Svelte|svelte
5391336|NCT01761591|Acrobat|acrobat
5391337|NCT01761591|direct stenting|direct stenting
5391338|NCT01761591|RCT|rct
5391340|NCT01761578|Coronary|coronary
5391341|NCT01761578|Stent|stent
5391342|NCT01761578|Vascular Remodeling|vascular remodeling
5391343|NCT01761578|Angioplasty|angioplasty
5391344|NCT01761578|Coronary Artery Disease|coronary artery disease
5391345|NCT01761552|in ASA 4 AND ASA 4E patients|in asa 4 and asa 4e patients
5391346|NCT01761539|pancreatitis|pancreatitis
5391347|NCT01761539|pancreatitis, alcoholic|pancreatitis, alcoholic
5391348|NCT01761526|Rotigotine|rotigotine
5391349|NCT01761526|Neupro|neupro
5391350|NCT01761526|Japanese|japanese
5391351|NCT01761526|Caucasian|caucasian
5391352|NCT01761526|Male|male
5391353|NCT01761526|Female|female
5391354|NCT01761526|Single dose|single dose
5391355|NCT01761526|Pharmacokinetics|pharmacokinetics
5391356|NCT01761500|Non-Hodgkin's lymphoma;|non-hodgkin's lymphoma;
5391357|NCT01761500|Childhood and adolescence;|childhood and adolescence;
5391358|NCT01761500|Survival Rate|survival rate
5391359|NCT01761474|Carbon dioxide insufflation|carbon dioxide insufflation
5391360|NCT01761474|Air insufflatioin|air insufflatioin
5391361|NCT01761474|ERCP|ercp
5391362|NCT01761474|Sedation|sedation
5391363|NCT01761448|Coronary Artery Disease|coronary artery disease
5391364|NCT01761448|Cardiac rehabilitation program|cardiac rehabilitation program
5391365|NCT01761448|telemedical homely rehabilitation|telemedical homely rehabilitation
5391366|NCT01761448|guided exercise|guided exercise
5391367|NCT01761448|ECG- vest|ecg- vest
5391368|NCT01761435|Influenza|influenza
5391369|NCT01761435|Solid Organ Transplant Recipients|solid organ transplant recipients
5391370|NCT01761396|Anxiety|anxiety
5391371|NCT01761396|Fear|fear
5391372|NCT01761396|Worry|worry
5391373|NCT01761396|Therapy|therapy
5391374|NCT01761396|Cognitive behavioral therapy|cognitive behavioral therapy
5391375|NCT01761383|Chronic Schizophrenia|chronic schizophrenia
5391376|NCT01761383|Nintendo Wii|nintendo wii
5391377|NCT01761383|Quality of Life|quality of life
5391378|NCT01761370|Non alcoholic Steatohepatitis|non alcoholic steatohepatitis
5391379|NCT01761370|Intra-gastric balloon|intra-gastric balloon
5391380|NCT01761357|Aortic valve stenosis|aortic valve stenosis
5391381|NCT01761357|Quality of life|quality of life
5391382|NCT01761357|Burden co morbidities|burden co morbidities
5391383|NCT01761357|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5391384|NCT01761357|Geriatric assessment|geriatric assessment
5391385|NCT01761331|infant, colic, crying, acupuncture, stooling, sleep|infant, colic, crying, acupuncture, stooling, sleep
5391386|NCT01761318|Diabetes mellitus type 2|diabetes mellitus type 2
5391387|NCT01761318|Glucagon-Like Peptide 1|glucagon-like peptide 1
5391388|NCT01761318|Magnetic Resonance Imaging|magnetic resonance imaging
5391389|NCT01761318|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5391390|NCT01761318|Steatosis|steatosis
5391395|NCT01761279|Colonic polyps|colonic polyps
5391396|NCT01761266|Hepatocellular Carcinoma|hepatocellular carcinoma
5391397|NCT01761266|Neoplasms|neoplasms
5391399|NCT01761253|comorbidity, multiple chronic conditions, Medicaid, prediction of cost|comorbidity, multiple chronic conditions, medicaid, prediction of cost
5391400|NCT01761253|Predictive models, cost containment, managed care|predictive models, cost containment, managed care
5391401|NCT01761227|Vascular dementia|vascular dementia
5391402|NCT01761227|Fufangdanshen Tablets|fufangdanshen tablets
5391403|NCT01761227|Randomized Controlled trial|randomized controlled trial
5391404|NCT01761227|Chinese Medicine|chinese medicine
5391405|NCT01761214|bacteriology, inflammation, bronchiectasis, exacerbation|bacteriology, inflammation, bronchiectasis, exacerbation
5391406|NCT01761201|Prophylaxis|prophylaxis
5391407|NCT01761201|Tuberculosis|tuberculosis
5391408|NCT01761201|Transplant recipients|transplant recipients
5391409|NCT01761201|Transplant waiting list|transplant waiting list
5391410|NCT01761188|Persistent Atrial fibrillation;LA substrate;ablation;voltage mapping|persistent atrial fibrillation;la substrate;ablation;voltage mapping
5391411|NCT01761149|remifentanil,|remifentanil,
5391412|NCT01761149|opioid,|opioid,
5391413|NCT01761149|hyperalgesia,|hyperalgesia,
5391414|NCT01761149|visual analogue score|visual analogue score
5391415|NCT01761149|thyroidectomy,|thyroidectomy,
5391416|NCT01761123|Prevention of Influenza|prevention of influenza
5391417|NCT01761110|Opioid dependence|opioid dependence
5391418|NCT01761110|Injection drug use|injection drug use
5391419|NCT01761110|Buprenorphine|buprenorphine
5391420|NCT01761110|Opioid agonist treatment|opioid agonist treatment
5391421|NCT01761110|Access to care|access to care
5391422|NCT01761110|HIV risk behaviors|hiv risk behaviors
5391423|NCT01761110|Opioids|opioids
5391424|NCT01761097|Adenoma, polyp, colonoscopy.|adenoma, polyp, colonoscopy.
5391426|NCT01761084|Spine fracture|spine fracture
5391427|NCT01761084|Vertebral fracture|vertebral fracture
5391428|NCT01761084|Exercise Interventions|exercise interventions
5391429|NCT01761084|Exercise|exercise
5391430|NCT01761058|Asthma|asthma
5391431|NCT01761058|Bronchial Diseases|bronchial diseases
5391432|NCT01761058|Respiratory Tract Diseases|respiratory tract diseases
5391433|NCT01761058|Lung Diseases, Obstructive|lung diseases, obstructive
5391434|NCT01761058|Lung Diseases|lung diseases
5391435|NCT01761058|Respiratory Hypersensitivity|respiratory hypersensitivity
5391436|NCT01761058|Hypersensitivity, Immediate|hypersensitivity, immediate
5391437|NCT01761058|Hypersensitivity|hypersensitivity
5391438|NCT01761058|Immune System Disease|immune system disease
5391439|NCT01761045|Monosodium L-Glutamate (MSG)|monosodium l-glutamate (msg)
5391440|NCT01761045|Nucleic Acid (IMP)|nucleic acid (imp)
5391442|NCT01761045|Gastrointestinal Sensation|gastrointestinal sensation
5391443|NCT01761045|Consommé Soups|consommé soups
5391444|NCT01761045|Snack Intake|snack intake
5391446|NCT01761032|neuroimaging|neuroimaging
5391447|NCT01761032|dopamine|dopamine
5391448|NCT01761032|MRI|mri
5391449|NCT01761032|SPECT|spect
5391450|NCT01761019|psoriasis|psoriasis
5391451|NCT01761019|Taclonex|taclonex
5391452|NCT01761019|Acitretin|acitretin
5391453|NCT01761019|Methotrexate|methotrexate
5391454|NCT01761006|COPD|copd
5391455|NCT01761006|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5391456|NCT01761006|Exhaled Nitric Oxide|exhaled nitric oxide
5391457|NCT01761006|NIOX MINO|niox mino
5391458|NCT01761006|Acute COPD exacerbation|acute copd exacerbation
5391459|NCT01760993|Not Required|not required
5391460|NCT01760980|Rate and extend of absorption of Exemestane|rate and extend of absorption of exemestane
5391461|NCT01760967|Dexmedetomidine|dexmedetomidine
5391462|NCT01760967|sepsis|sepsis
5391463|NCT01760967|mortality|mortality
5391464|NCT01760967|duration of mechanical ventilation|duration of mechanical ventilation
5391465|NCT01760967|organ failure|organ failure
5391466|NCT01760954|Endometriosis associated pain|endometriosis associated pain
5391467|NCT01760954|Elagolix|elagolix
5391468|NCT01760954|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
5391469|NCT01760954|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5391470|NCT01760954|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
5391471|NCT01760941|Urology|urology
5391472|NCT01760941|Prostate|prostate
5391473|NCT01760941|Breast|breast
5391474|NCT01760941|Lung|lung
5391475|NCT01760941|Chest|chest
5391476|NCT01760915|asthma|asthma
5391477|NCT01760915|severe|severe
5391478|NCT01760902|Inflammation|inflammation
5391479|NCT01760876|Optical Coherence Tomography|optical coherence tomography
5391480|NCT01760876|Biofreedom Stent|biofreedom stent
5391481|NCT01760863|Revision|revision
5391482|NCT01760863|Knee|knee
5391483|NCT01760863|Hip|hip
5391484|NCT01760863|Arthroplasty|arthroplasty
5391485|NCT01760863|Oral|oral
5391486|NCT01760863|Antibiotics|antibiotics
5391487|NCT01760863|Infection|infection
5391488|NCT01760837|cow's milk allergy|cow's milk allergy
5391489|NCT01760837|baked milk|baked milk
5391490|NCT01760837|tolerance|tolerance
5391491|NCT01760837|infants and children|infants and children
5391492|NCT01760824|Sequential|sequential
5391493|NCT01760824|Quadruple|quadruple
5391494|NCT01760824|First|first
5391495|NCT01760824|Line|line
5391496|NCT01760824|Helicobacter|helicobacter
5391497|NCT01760824|pylori|pylori
5391498|NCT01760824|infection|infection
5391499|NCT01760811|tongue|tongue
5391500|NCT01760811|Squamous cell carcinoma|squamous cell carcinoma
5391501|NCT01760811|locally advanced|locally advanced
5391503|NCT01760798|osteoporosis|osteoporosis
5391504|NCT01760798|Teriparatide|teriparatide
5391505|NCT01760785|Veterans|veterans
5391506|NCT01760785|Traumatic Brain Injury(TBI)|traumatic brain injury(tbi)
5391507|NCT01760785|Alcoholism|alcoholism
5391508|NCT01760772|heart disease|heart disease
5391509|NCT01760772|GLP-1|glp-1
5391510|NCT01760772|Exendin-9|exendin-9
5391511|NCT01760772|postprandial lipids|postprandial lipids
5391512|NCT01760759|HIV|hiv
5391513|NCT01760759|Antiretroviral therapy adherence|antiretroviral therapy adherence
5391514|NCT01760746|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5391515|NCT01760746|Vitrectomy|vitrectomy
5391516|NCT01760746|Inflammatory Cytokines|inflammatory cytokines
5391518|NCT01760707|Peripheral neuropathy|peripheral neuropathy
5391519|NCT01760707|Exercise|exercise
5391520|NCT01760707|Balance performance|balance performance
5391521|NCT01760694|Pancreatic|pancreatic
5391522|NCT01760694|Pancreas|pancreas
5391523|NCT01760694|Intraoperative Radiation Therapy|intraoperative radiation therapy
5391524|NCT01760694|Chemotherapy|chemotherapy
5391525|NCT01760668|Sex chromosome|sex chromosome
5391526|NCT01760668|Turner Syndrome|turner syndrome
5391527|NCT01760668|Marfan syndrome|marfan syndrome
5391528|NCT01760668|Bicuspid aortic valve|bicuspid aortic valve
5391529|NCT01760668|Aortic Aneurysm|aortic aneurysm
5391530|NCT01760668|Epigenetics|epigenetics
5391531|NCT01760668|Transcriptome|transcriptome
5391532|NCT01760668|non-coding RNA|non-coding rna
5391533|NCT01760668|Electron microscopy|electron microscopy
5391534|NCT01760668|Proteomics|proteomics
5391535|NCT01760642|metabolite profiles|metabolite profiles
5391536|NCT01760642|pharmacokinetics|pharmacokinetics
5391537|NCT01760642|CYP3A|cyp3a
5391538|NCT01760642|metabolomics|metabolomics
5680432|NCT00577798|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5391539|NCT01760629|Encephalopathy, Newborn, Low and Middle-income countries, Hypothermia|encephalopathy, newborn, low and middle-income countries, hypothermia
5391540|NCT01760616|Huaier Granule;|huaier granule;
5391541|NCT01760616|After non-radical hepatectomy;|after non-radical hepatectomy;
5391542|NCT01760616|Prevention of Disease Progression of Hepatocarcinoma;|prevention of disease progression of hepatocarcinoma;
5391543|NCT01760616|Safety.|safety.
5391544|NCT01760603|pelvic organ prolapse|pelvic organ prolapse
5391545|NCT01760590|neck pain|neck pain
5391546|NCT01760590|cervical pain|cervical pain
5391547|NCT01760590|pain pressure thresholds|pain pressure thresholds
5391548|NCT01760590|pain catastrophizing|pain catastrophizing
5391549|NCT01760577|osteoarthritis, botulinum toxin, hyaluronate|osteoarthritis, botulinum toxin, hyaluronate
5391550|NCT01760564|Niemann-Pick disease type C|niemann-pick disease type c
5391551|NCT01760564|miglustat|miglustat
5391552|NCT01760551|Fracture|fracture
5391553|NCT01760551|Trauma|trauma
5391554|NCT01760551|impairment|impairment
5391555|NCT01760538|Cardiac transplant recipients|cardiac transplant recipients
5391556|NCT01760538|Heart rate variability|heart rate variability
5391557|NCT01760538|Exercise training|exercise training
5391558|NCT01760525|p53, solid tumor|p53, solid tumor
5391559|NCT01760512|Gastric bypass|gastric bypass
5391560|NCT01760512|Robot-assisted surgery|robot-assisted surgery
5391561|NCT01760512|Conventional laparoscopy|conventional laparoscopy
5391562|NCT01760512|Pain assessment|pain assessment
5391563|NCT01760512|Health economics outcomes|health economics outcomes
5391564|NCT01760499|skin|skin
5391565|NCT01760499|metastatic|metastatic
5391566|NCT01760473|opioid dependence|opioid dependence
5391567|NCT01760434|scoliosis|scoliosis
5391568|NCT01760434|long-term outcomes|long-term outcomes
5391569|NCT01760434|sagittal plane|sagittal plane
5391570|NCT01760434|quality of life|quality of life
5391571|NCT01760434|curve progression|curve progression
5391572|NCT01760434|pulmonary function|pulmonary function
5391573|NCT01760382|Acute myocardial infarction|acute myocardial infarction
5391574|NCT01760382|ST elevation myocardial infarction|st elevation myocardial infarction
5391575|NCT01760382|primary PCI|primary pci
5391576|NCT01760382|reperfusion therapy|reperfusion therapy
5391577|NCT01760382|angioplasty|angioplasty
5391578|NCT01760382|stent|stent
5391579|NCT01760356|Liver transplantation|liver transplantation
5391580|NCT01760356|Calcineurin inhibitors|calcineurin inhibitors
5391581|NCT01760356|Pharmacodynamic biomarkers|pharmacodynamic biomarkers
5391582|NCT01760356|Calcineurin pathway|calcineurin pathway
5391583|NCT01760356|Tacrolimus|tacrolimus
5391584|NCT01760356|interindividual variability|interindividual variability
5391585|NCT01760304|COPD|copd
5391586|NCT01760278|Time-lapse monitoring of embryos.|time-lapse monitoring of embryos.
5391587|NCT01760278|Embryoscope|embryoscope
5391588|NCT01760278|IVF-ET/ICSI|ivf-et/icsi
5391589|NCT01760278|Cetrorelix|cetrorelix
5391590|NCT01760278|Gonal-F|gonal-f
5391591|NCT01760265|dysbetalipoproteinemia|dysbetalipoproteinemia
5391592|NCT01760265|artery calcium score|artery calcium score
5391593|NCT01760265|carotid intima media|carotid intima media
5391594|NCT01760265|ankle brachial index|ankle brachial index
5391595|NCT01760265|dysbetalipoproteinemic patients|dysbetalipoproteinemic patients
5391596|NCT01760252|Pancreatic Cancer|pancreatic cancer
5391597|NCT01760239|Adolescent Hypertension|adolescent hypertension
5391598|NCT01760239|Adolescent Pre Hypertension|adolescent pre hypertension
5391791|NCT01759329|coffee|coffee
5391599|NCT01760239|Adolescent Pre Hypertension and Obesity|adolescent pre hypertension and obesity
5391600|NCT01760226|DLBCL|dlbcl
5391601|NCT01760226|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5391602|NCT01760226|dose adjusted|dose adjusted
5391603|NCT01760226|EPOCH|epoch
5391604|NCT01760226|Etoposide|etoposide
5391605|NCT01760226|Doxorubicin|doxorubicin
5391606|NCT01760226|Vincristine|vincristine
5391607|NCT01760226|Cyclophosphamide|cyclophosphamide
5391608|NCT01760226|Prednisone|prednisone
5391609|NCT01760226|Rituximab|rituximab
5391610|NCT01760200|Coronary angioplasty|coronary angioplasty
5391611|NCT01760200|Coronary stent|coronary stent
5391612|NCT01760200|paclitaxel drug-eluting stent|paclitaxel drug-eluting stent
5391613|NCT01760200|drug eluting balloon|drug eluting balloon
5391614|NCT01760174|Transversus abdominis plane catheter|transversus abdominis plane catheter
5391615|NCT01760161|postoperative pain|postoperative pain
5391616|NCT01760161|opioid consumption|opioid consumption
5391617|NCT01760161|termanalgesia|termanalgesia
5391618|NCT01760161|plasmaropivacain level|plasmaropivacain level
5391619|NCT01760148|Hepatitis C Virus|hepatitis c virus
5391621|NCT01760148|Interferon|interferon
5391622|NCT01760148|Prediction|prediction
5391623|NCT01760148|SVR|svr
5391630|NCT01760122|Chronic hepatitis B|chronic hepatitis b
5391631|NCT01760109|Respiratory and urinary tract infections|respiratory and urinary tract infections
5391632|NCT01760109|Piperacillin Sodium and Sulbactam Sodium for Injection (2:1)|piperacillin sodium and sulbactam sodium for injection (2:1)
5391633|NCT01760109|Phase IV|phase iv
5391634|NCT01760096|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5391635|NCT01760096|Anemia|anemia
5391636|NCT01760096|Hematologic Diseases|hematologic diseases
5391637|NCT01760096|bone marrow failure|bone marrow failure
5391638|NCT01760096|Immunologic Factors|immunologic factors
5391639|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs
5391640|NCT01760096|Levamisole|levamisole
5391641|NCT01760096|cyclosporine A|cyclosporine a
5391642|NCT01760070|cancer|cancer
5391643|NCT01760070|endoscopy|endoscopy
5391644|NCT01760070|endoscopic submucosal dissection|endoscopic submucosal dissection
5391645|NCT01760044|tissue oxygenation|tissue oxygenation
5391646|NCT01760044|perfusion status|perfusion status
5391647|NCT01760031|preconditioning|preconditioning
5391648|NCT01760031|contrast-induced acute kidney injury|contrast-induced acute kidney injury
5391649|NCT01760031|renal faliure|renal faliure
5391650|NCT01760018|desflurane, total intravenous anesthesia, QoR-40|desflurane, total intravenous anesthesia, qor-40
5391651|NCT01760005|Alzheimer's|alzheimer's
5391652|NCT01760005|Alzheimer's Disease|alzheimer's disease
5391653|NCT01760005|Dementia|dementia
5391654|NCT01760005|Mutation|mutation
5391655|NCT01760005|Genetic Mutation|genetic mutation
5391656|NCT01760005|Dominantly Inherited Alzheimer's Disease|dominantly inherited alzheimer's disease
5391657|NCT01760005|Dominantly Inherited Alzheimer's Network|dominantly inherited alzheimer's network
5391658|NCT01760005|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
5391659|NCT01760005|Early Onset Alzheimer's Disease|early onset alzheimer's disease
5391660|NCT01760005|DIAN|dian
5391661|NCT01760005|DIAN-TU|dian-tu
5391662|NCT01760005|DIAN TU|dian tu
5391663|NCT01759992|Frail elderly|frail elderly
5391664|NCT01759992|Muscle weakness|muscle weakness
5391665|NCT01759992|Institutionalization|institutionalization
5391666|NCT01759992|Respiratory muscle training|respiratory muscle training
5391667|NCT01759979|Cholelithiasis, Common Bile Duct|cholelithiasis, common bile duct
5391668|NCT01759979|Choledocholithiasis|choledocholithiasis
5391669|NCT01759966|Heart transplantation|heart transplantation
5391670|NCT01759966|Autonomic cardiovascular control|autonomic cardiovascular control
5391671|NCT01759966|Acute rejection|acute rejection
5391672|NCT01759966|Cardiac allograft vasculopathy|cardiac allograft vasculopathy
5391673|NCT01759953|Diabetes Mellitus|diabetes mellitus
5391674|NCT01759953|Insulin|insulin
5391675|NCT01759953|Video Games|video games
5391676|NCT01759953|Medical Education|medical education
5391677|NCT01759953|Educational Technology|educational technology
5391678|NCT01759953|Continuing Medical Education|continuing medical education
5391679|NCT01759940|carotid|carotid
5391680|NCT01759940|endarterectomy|endarterectomy
5391684|NCT01759927|Active and healthy lifestyle|active and healthy lifestyle
5391685|NCT01759901|hepatectomy|hepatectomy
5391686|NCT01759901|vascular inflow occlusion|vascular inflow occlusion
5391687|NCT01759862|kidney transplant|kidney transplant
5391688|NCT01759862|Aminophylline|aminophylline
5391689|NCT01759862|pediatric|pediatric
5391690|NCT01759849|Asthma|asthma
5391691|NCT01759849|β-chain signaling|β-chain signaling
5391692|NCT01759849|allergen inhalation challenges|allergen inhalation challenges
5391693|NCT01759849|sputum|sputum
5391694|NCT01759849|bone marrow aspirate|bone marrow aspirate
5391695|NCT01759849|blood collection|blood collection
5391696|NCT01759849|-methacholine challenge|-methacholine challenge
5391697|NCT01759836|Prostatectomy|prostatectomy
5391698|NCT01759836|Statins|statins
5391699|NCT01759810|Glioblastoma, recurrent glioblastoma|glioblastoma, recurrent glioblastoma
5391700|NCT01759797|ALS bone marrow mesenchymal stem cell intravenous injection|als bone marrow mesenchymal stem cell intravenous injection
5391701|NCT01759784|mesenchymal stem cell intraventricular injection ALS|mesenchymal stem cell intraventricular injection als
5391702|NCT01759771|Prostate Cancer|prostate cancer
5391703|NCT01759771|Vitamin D3|vitamin d3
5391704|NCT01759771|Active surveillance|active surveillance
5490239|NCT01336218|RA|ra
5391705|NCT01759758|boxer's fracture|boxer's fracture
5391706|NCT01759758|metacarpal neck fracture|metacarpal neck fracture
5391707|NCT01759758|metacarpal fracture|metacarpal fracture
5391708|NCT01759732|Aplastic anemia|aplastic anemia
5391709|NCT01759732|T cell dose|t cell dose
5391710|NCT01759732|CD3 depletion|cd3 depletion
5391711|NCT01759732|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5391713|NCT01759719|concertina effect|concertina effect
5391714|NCT01759719|stent deformation|stent deformation
5391715|NCT01759719|everolimus eluting stents|everolimus eluting stents
5391716|NCT01759719|stent lenght|stent lenght
5391717|NCT01759693|Platelet activation|platelet activation
5391718|NCT01759680|Risk of falls|risk of falls
5391719|NCT01759680|Whole Body Vibration|whole body vibration
5391720|NCT01759680|Nursing Home|nursing home
5391721|NCT01759667|Diet-induced Thermogenesis;|diet-induced thermogenesis;
5391722|NCT01759667|Respiratory Quotient;|respiratory quotient;
5391723|NCT01759667|Roux-en-Y Gastric Bypass;|roux-en-y gastric bypass;
5391724|NCT01759667|Energy Expenditure.|energy expenditure.
5391725|NCT01759641|Dialysis|dialysis
5391726|NCT01759641|Monitoring|monitoring
5391727|NCT01759641|Cardiovascular stability|cardiovascular stability
5391728|NCT01759641|biosignals|biosignals
5391729|NCT01759628|Steatohepatitis,|steatohepatitis,
5391730|NCT01759628|Helicobacter pylori,|helicobacter pylori,
5391731|NCT01759628|Insulin resistance,|insulin resistance,
5391732|NCT01759628|Alanine aminotransferase,|alanine aminotransferase,
5391733|NCT01759628|Aspartate aminotransferase,|aspartate aminotransferase,
5391734|NCT01759615|Preterm|preterm
5391735|NCT01759615|SGA|sga
5391736|NCT01759615|AREDF|aredf
5391737|NCT01759615|Early feeding|early feeding
5391738|NCT01759615|Late feeding|late feeding
5391739|NCT01759615|Feed intolerence|feed intolerence
5391740|NCT01759615|Necrotizing enterocolitis|necrotizing enterocolitis
5391741|NCT01759602|Neuromyelitis optica|neuromyelitis optica
5391742|NCT01759602|Devic's disease|devic's disease
5391743|NCT01759602|NMO|nmo
5391744|NCT01759602|Devic|devic
5391745|NCT01759589|electroconvulsive therapy,sevoflurane,propofol,remifentanil|electroconvulsive therapy,sevoflurane,propofol,remifentanil
5391746|NCT01759576|Renal Insufficiency|renal insufficiency
5391747|NCT01759576|Healthy|healthy
5391748|NCT01759576|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5391749|NCT01759576|Pharmacokinetics|pharmacokinetics
5391750|NCT01759576|Pharmacodynamics|pharmacodynamics
5391751|NCT01759576|Dialysis|dialysis
5391752|NCT01759550|Gastric Procedures|gastric procedures
5391753|NCT01759550|Force Triad|force triad
5391754|NCT01759550|LigaSure Advance Pistol Grip|ligasure advance pistol grip
5391755|NCT01759550|LigaSure Blunt Tip|ligasure blunt tip
5391756|NCT01759524|local anaesthesia|local anaesthesia
5391757|NCT01759524|analgesia|analgesia
5391758|NCT01759524|bupivacaine|bupivacaine
5391759|NCT01759524|lidocaine|lidocaine
5391760|NCT01759524|clonidine|clonidine
5391761|NCT01759524|sciatic nerve|sciatic nerve
5391762|NCT01759524|saphenous nerve|saphenous nerve
5391763|NCT01759511|Idiopathic|idiopathic
5391764|NCT01759511|Pulmonary|pulmonary
5391765|NCT01759511|Fibrosis|fibrosis
5391766|NCT01759511|IPF|ipf
5391767|NCT01759498|Inflammation|inflammation
5391768|NCT01759498|Pain intensity|pain intensity
5391769|NCT01759498|Flexibility|flexibility
5391770|NCT01759498|RICE protocol|rice protocol
5391771|NCT01759498|Swelling|swelling
5391772|NCT01759485|Clozapine|clozapine
5391773|NCT01759485|Schizophrenia|schizophrenia
5395397|NCT01742442|Cancer|cancer
5391775|NCT01759485|Treatment-resistant|treatment-resistant
5391776|NCT01759472|leukotriene|leukotriene
5391777|NCT01759472|leukotriene receptor antagonist|leukotriene receptor antagonist
5391778|NCT01759420|Ondansetron|ondansetron
5391779|NCT01759420|QT interval|qt interval
5391780|NCT01759420|QTc|qtc
5391781|NCT01759420|QT prolongation|qt prolongation
5391782|NCT01759420|Drug induced QT prolongation|drug induced qt prolongation
5391783|NCT01759381|Spinal Deformity|spinal deformity
5391784|NCT01759381|Complex Spinal Surgery|complex spinal surgery
5391785|NCT01759381|Negative Pressure Wound Therapy|negative pressure wound therapy
5391786|NCT01759381|Post-Operative Infection|post-operative infection
5391787|NCT01759368|self-care, heart failure, telemonitoring, health care utilization|self-care, heart failure, telemonitoring, health care utilization
5391788|NCT01759342|Cystic fibrosis; pulmonary exacerbation, exercise|cystic fibrosis; pulmonary exacerbation, exercise
5391789|NCT01759329|overweight|overweight
5391792|NCT01759290|Angioplasty|angioplasty
5391793|NCT01759290|Bioabsorbable|bioabsorbable
5391794|NCT01759290|Bioresorbable|bioresorbable
5391795|NCT01759290|BVS|bvs
5391796|NCT01759290|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5391797|NCT01759290|Coronary Scaffold|coronary scaffold
5391798|NCT01759290|Coronary Stent|coronary stent
5391799|NCT01759264|Fecal Calprotectin|fecal calprotectin
5391800|NCT01759264|Crohn's Disease|crohn's disease
5391801|NCT01759264|Adalimumab|adalimumab
5391802|NCT01759251|Meniere Disease|meniere disease
5391803|NCT01759251|Betahistine Dihydrochloride|betahistine dihydrochloride
5391804|NCT01759251|Vertigo|vertigo
5391805|NCT01759238|colorectal cancer|colorectal cancer
5391806|NCT01759238|metastases|metastases
5391807|NCT01759238|non resectable|non resectable
5391808|NCT01759238|chemoradiation|chemoradiation
5391809|NCT01759225|Registry, Cardiovascular, CVD, Health Maintenance Organization|registry, cardiovascular, cvd, health maintenance organization
5391810|NCT01759212|stem cell implantation|stem cell implantation
5391811|NCT01759212|coronary artery disease|coronary artery disease
5391812|NCT01759212|left ventricular assist device|left ventricular assist device
5391814|NCT01759199|ST6: The six minute Stepper Test|st6: the six minute stepper test
5391815|NCT01759199|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
5391816|NCT01759199|Pulmonary rehabilitation|pulmonary rehabilitation
5391817|NCT01759186|Asthma|asthma
5391818|NCT01759186|Biomakers|biomakers
5391819|NCT01759186|Phenotype|phenotype
5391820|NCT01759173|Minor traumatic brain injury (TBI)|minor traumatic brain injury (tbi)
5391821|NCT01759173|Concussion|concussion
5391822|NCT01759160|Target control infusion|target control infusion
5391824|NCT01759160|cardiac depression|cardiac depression
5391825|NCT01759160|induction of anesthesia|induction of anesthesia
5391826|NCT01759160|hemodynamics|hemodynamics
5391827|NCT01759134|Premature neonate|premature neonate
5391828|NCT01759134|Post-discharge|post-discharge
5391829|NCT01759134|Formula|formula
5391830|NCT01759121|severe non-proliferative diabetic retinopathy|severe non-proliferative diabetic retinopathy
5391831|NCT01759121|subthreshold|subthreshold
5391832|NCT01759121|panretinal photocoagulation|panretinal photocoagulation
5391833|NCT01759121|PASCAL|pascal
5391834|NCT01759121|endpoint management|endpoint management
5391835|NCT01759108|xerostomia|xerostomia
5391836|NCT01759108|rebamipide|rebamipide
5391837|NCT01759108|efficacy|efficacy
5391838|NCT01759108|safety|safety
5391839|NCT01759095|adherence|adherence
5391840|NCT01759095|electronic monitoring|electronic monitoring
5391841|NCT01759095|primary care|primary care
5391842|NCT01759095|community pharmacy|community pharmacy
5391843|NCT01759095|multidrug blister pack|multidrug blister pack
5391844|NCT01759095|pill box|pill box
5391845|NCT01759056|Ulcerative colitis|ulcerative colitis
5391846|NCT01759043|coronary artery disease|coronary artery disease
5391847|NCT01759043|Myocardial Infarction|myocardial infarction
5391848|NCT01759043|Radial Artery|radial artery
5391849|NCT01759043|Catheters|catheters
5391850|NCT01759030|rheumatoid arthritis, DMARDs|rheumatoid arthritis, dmards
5391851|NCT01759030|rituximab|rituximab
5391852|NCT01759030|biosimilar|biosimilar
5391853|NCT01759030|interchangeability|interchangeability
5391854|NCT01759017|Crohn's disease|crohn's disease
5391855|NCT01759017|Inflammatory bowel disease|inflammatory bowel disease
5391857|NCT01759017|Infliximab|infliximab
5391858|NCT01759017|PET|pet
5391859|NCT01759017|PET/CT|pet/ct
5391860|NCT01759004|lipoedema|lipoedema
5391861|NCT01759004|obesity|obesity
5391862|NCT01758978|bioequivalence, hydrocodone bitartrate extended-release tablets|bioequivalence, hydrocodone bitartrate extended-release tablets
5391863|NCT01758952|Peri-operative stroke|peri-operative stroke
5391864|NCT01758952|incidence|incidence
5391865|NCT01758952|risk factors|risk factors
5391866|NCT01758952|prospective|prospective
5391867|NCT01758939|Peg Interferon,|peg interferon,
5391868|NCT01758939|Ribavirin,|ribavirin,
5391869|NCT01758939|HCV,|hcv,
5391870|NCT01758939|Genotype IV.|genotype iv.
5391871|NCT01758926|Inflammatory Bowel Disease|inflammatory bowel disease
5391872|NCT01758926|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5391873|NCT01758913|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5391874|NCT01758913|patent ductus arteriosus|patent ductus arteriosus
5391875|NCT01758913|prostaglandin|prostaglandin
5391876|NCT01758913|Respiratory distress syndrome|respiratory distress syndrome
5391877|NCT01758900|Single-Balloon Enteroscopy|single-balloon enteroscopy
5391878|NCT01758874|Critical limb ischemia|critical limb ischemia
5391879|NCT01758874|Phlebotomy|phlebotomy
5391880|NCT01758874|Amputation|amputation
5391881|NCT01758874|Rutherford classification Grade 3, Category 5 or 6|rutherford classification grade 3, category 5 or 6
5391882|NCT01758874|Fontaine stage IV|fontaine stage iv
5391883|NCT01758861|Erythropoietin|erythropoietin
5391884|NCT01758861|acute kidney injury|acute kidney injury
5391885|NCT01758861|valvular heart surgery|valvular heart surgery
5391886|NCT01758848|overactive bladder|overactive bladder
5391887|NCT01758848|pelvic floor muscles|pelvic floor muscles
5391888|NCT01758848|deep abdominal muscles|deep abdominal muscles
5391889|NCT01758835|ER-stress-test negative|er-stress-test negative
5391890|NCT01758835|unimalleolar|unimalleolar
5391891|NCT01758835|fibula|fibula
5391892|NCT01758835|Weber-B fractures|weber-b fractures
5391893|NCT01758822|meconium stained amniotic fluid|meconium stained amniotic fluid
5391894|NCT01758822|endotracheal suction|endotracheal suction
5391895|NCT01758822|non vigorous neonates|non vigorous neonates
5391896|NCT01758809|Video Assisted Thoracic Surgery|video assisted thoracic surgery
5391897|NCT01758809|Postoperative Pain|postoperative pain
5391898|NCT01758809|Intravenous Patient Controlled Analgesia|intravenous patient controlled analgesia
5391899|NCT01758809|Bupivacaine|bupivacaine
5391900|NCT01758809|Major Pulmonary Resection|major pulmonary resection
5391901|NCT01758809|Post Pulmonary Resection|post pulmonary resection
5391902|NCT01758796|ER-stress positive|er-stress positive
5391903|NCT01758796|Unimalleolar fibula fracture|unimalleolar fibula fracture
5391904|NCT01758796|Operative vs non-operative treatment|operative vs non-operative treatment
5391905|NCT01758770|osteoporosis|osteoporosis
5391906|NCT01758770|osteoarthritis|osteoarthritis
5391908|NCT01758770|computed xray tomography|computed xray tomography
5391909|NCT01758770|liver steatosis|liver steatosis
5391910|NCT01758770|obesity|obesity
5391911|NCT01758757|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5391912|NCT01758757|Vitrectomy|vitrectomy
5391913|NCT01758744|COPD PH|copd ph
5391914|NCT01758744|COPD associated Pulmonary Hypertension|copd associated pulmonary hypertension
5391915|NCT01758744|COPD and Pulmonary Hypertension|copd and pulmonary hypertension
5391916|NCT01758744|Disease|disease
5391917|NCT01758731|Stage IVA-B Squamous Cell Carcinomas|stage iva-b squamous cell carcinomas
5391918|NCT01758731|Head and Neck Cancer|head and neck cancer
5391919|NCT01758731|Heavy drinking|heavy drinking
5391920|NCT01758731|Smoking|smoking
5391921|NCT01758718|Down's syndrome|down's syndrome
5391922|NCT01758718|entropion|entropion
5391923|NCT01758718|lid plasty|lid plasty
5391924|NCT01758705|Psoriasis|psoriasis
5391925|NCT01758705|Related to Health Quality of Life|related to health quality of life
5391926|NCT01758705|Patient Reported Outcomes|patient reported outcomes
5391927|NCT01758705|Venezuelan Patients|venezuelan patients
5391928|NCT01758692|spinal cord injury|spinal cord injury
5391929|NCT01758692|autonomic integrity|autonomic integrity
5391930|NCT01758692|autonomic dysreflexia|autonomic dysreflexia
5391931|NCT01758692|baroreceptor integrity|baroreceptor integrity
5391932|NCT01758692|sympathetic integrity|sympathetic integrity
5391933|NCT01758692|vagal integrity|vagal integrity
5391934|NCT01758679|Iodine[131I] Metuximab Injection|iodine[131i] metuximab injection
5391935|NCT01758653|CO poisoning|co poisoning
5391936|NCT01758640|mechanical heart valve|mechanical heart valve
5391937|NCT01758640|pregnancy|pregnancy
5391938|NCT01758640|warfarin|warfarin
5391939|NCT01758640|phenindione|phenindione
5391940|NCT01758627|Peritoneal dialysis,|peritoneal dialysis,
5391941|NCT01758627|chronic kidney disease,|chronic kidney disease,
5391942|NCT01758627|refractory heart failure|refractory heart failure
5391943|NCT01758614|carotid artery occlusion|carotid artery occlusion
5391944|NCT01758614|middle cerebral artery occlusion|middle cerebral artery occlusion
5391945|NCT01758614|EC-IC bypass surgery|ec-ic bypass surgery
5391946|NCT01758614|stroke|stroke
5391947|NCT01758601|white fish|white fish
5391948|NCT01758601|Metabolic syndrome|metabolic syndrome
5391949|NCT01758601|Cardiovascular risk|cardiovascular risk
5391950|NCT01758588|Primary myelofibrosis|primary myelofibrosis
5391952|NCT01758575|Patients|patients
5391953|NCT01758549|pancreatitis|pancreatitis
5391954|NCT01758549|cholangiopancreatography, endoscopic retrograde|cholangiopancreatography, endoscopic retrograde
5391955|NCT01758549|hyperamylasemia|hyperamylasemia
5391956|NCT01758536|ischemic stroke|ischemic stroke
5391957|NCT01758536|neural function|neural function
5391958|NCT01758536|life quality|life quality
5391959|NCT01758523|neuroactive steroids|neuroactive steroids
5391960|NCT01758510|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5391962|NCT01758510|Neurodegenerative disease|neurodegenerative disease
5391963|NCT01758510|Motor Neuron Disease|motor neuron disease
5391964|NCT01758510|Central Nervous System Disease|central nervous system disease
5391965|NCT01758510|Neuromuscular Disease|neuromuscular disease
5391966|NCT01758510|Bone marrow derived stem cell|bone marrow derived stem cell
5391967|NCT01758510|stem cell therapy|stem cell therapy
5391968|NCT01758510|intrathecal injection|intrathecal injection
5391969|NCT01758497|Fascia Iliaca compartment block, Pain, Sensorial blockade|fascia iliaca compartment block, pain, sensorial blockade
5391970|NCT01758484|Hematopoietic cell transplantation|hematopoietic cell transplantation
5391971|NCT01758484|Supportive/palliative care|supportive/palliative care
5391972|NCT01758471|Type 2 Diabetes|type 2 diabetes
5391973|NCT01758471|gut microbiome|gut microbiome
5391974|NCT01758471|incretin|incretin
5391975|NCT01758471|Sulfonylurea|sulfonylurea
5391976|NCT01758471|α-glucosidase inhibitor|α-glucosidase inhibitor
5391978|NCT01758445|Cancer|cancer
5391979|NCT01758445|Radiation|radiation
5391980|NCT01758445|Proton|proton
5391981|NCT01758432|Healthy volunteers|healthy volunteers
5391982|NCT01758419|post-RT|post-rt
5391983|NCT01758419|myocardial perfusion images|myocardial perfusion images
5391992|NCT01758367|immunogenicity|immunogenicity
5391993|NCT01758367|decitabine(DAC)|decitabine(dac)
5391994|NCT01758367|donor lymphocyte infusion(DLI)|donor lymphocyte infusion(dli)
5391995|NCT01758367|AML|aml
5391996|NCT01758354|Pompe disease|pompe disease
5391997|NCT01758354|alpha glucosidase deficiency|alpha glucosidase deficiency
5391998|NCT01758341|Malignant biliary obstruction|malignant biliary obstruction
5391999|NCT01758341|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
5392000|NCT01758341|Therapeutic endoscopy|therapeutic endoscopy
5392001|NCT01758328|BUSULFAN|busulfan
5392002|NCT01758328|FLUDARABINE|fludarabine
5392003|NCT01758328|G-CSF|g-csf
5392004|NCT01758328|MELPHALAN|melphalan
5392005|NCT01758328|RABBIT ATG WT1|rabbit atg wt1
5392006|NCT01758328|PEPTIDE SPECIFIC T CELLS|peptide specific t cells
5392007|NCT01758328|12-175|12-175
5392008|NCT01758315|Ambulatory|ambulatory
5392009|NCT01758315|Outpatient|outpatient
5392010|NCT01758315|Malpractice|malpractice
5392011|NCT01758315|Quality Improvement|quality improvement
5392016|NCT01758289|Venezuelan Patients|venezuelan patients
5392017|NCT01758289|Depressive Symptoms|depressive symptoms
5392018|NCT01758289|Health Related Quality of Life|health related quality of life
5392019|NCT01758276|smoking, pregnancy|smoking, pregnancy
5392020|NCT01758263|Hypertension|hypertension
5392021|NCT01758263|Health Care Cost|health care cost
5392022|NCT01758263|Monthly health care cost|monthly health care cost
5392032|NCT01758237|Laser Peripheral Iridotomy|laser peripheral iridotomy
5392033|NCT01758237|Visual Dysphotopsia|visual dysphotopsia
5392034|NCT01758237|Visual Disturbances|visual disturbances
5392035|NCT01758237|Angle Closure Glaucoma|angle closure glaucoma
5392036|NCT01758224|Multiple Sclerosis|multiple sclerosis
5392037|NCT01758224|Functional Magnetic Stimulation|functional magnetic stimulation
5392038|NCT01758224|Pulmonary Function|pulmonary function
5392039|NCT01758211|Intracranial Arteriovenous Malformations|intracranial arteriovenous malformations
5392040|NCT01758211|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5392041|NCT01758211|Neuronavigation|neuronavigation
5392042|NCT01758185|Inactivated split influenza vaccine|inactivated split influenza vaccine
5392043|NCT01758185|Immunogenicity|immunogenicity
5392044|NCT01758185|Safety|safety
5392045|NCT01758185|Consistence|consistence
5392046|NCT01758172|pancreaticoduodenectomy|pancreaticoduodenectomy
5392047|NCT01758172|postoperative patient|postoperative patient
5392048|NCT01758172|colloid|colloid
5392049|NCT01758172|albumin|albumin
5392050|NCT01758172|hetastarch|hetastarch
5392051|NCT01758146|Breast cancer|breast cancer
5392052|NCT01758146|obesity|obesity
5392053|NCT01758146|aromatase inhibitors|aromatase inhibitors
5392054|NCT01758146|postmenopausal|postmenopausal
5392055|NCT01758120|IgA nephropathy|iga nephropathy
5392056|NCT01758120|Cyclophosphamide|cyclophosphamide
5392057|NCT01758120|prednisone|prednisone
5392058|NCT01758094|hypogonadism|hypogonadism
5392059|NCT01758094|Retinol binding globulin 4|retinol binding globulin 4
5392060|NCT01758094|Testosterone treatment|testosterone treatment
5392061|NCT01758068|Preterms|preterms
5392062|NCT01758068|Coconut Oil application|coconut oil application
5392063|NCT01758068|Trans epidermal water loss|trans epidermal water loss
5392064|NCT01758068|Weight gain|weight gain
5392065|NCT01758055|Mesenchymal stem cell, emphysema, lung function|mesenchymal stem cell, emphysema, lung function
5392066|NCT01758042|Kidney|kidney
5392067|NCT01758042|Chronic Kidney Disease|chronic kidney disease
5392068|NCT01758042|CKD|ckd
5392069|NCT01758042|Bone Marrow|bone marrow
5392070|NCT01758042|Bone Marrow Transplant|bone marrow transplant
5392071|NCT01758042|BMT|bmt
5392072|NCT01758042|Leukemia|leukemia
5392073|NCT01758042|AML|aml
5392074|NCT01758042|ALL|all
5392075|NCT01758042|CML|cml
5392076|NCT01758042|CLL|cll
5392077|NCT01758042|MM|mm
5392078|NCT01758042|NHL|nhl
5392079|NCT01758042|MDS|mds
5392080|NCT01758029|quality of life|quality of life
5392081|NCT01758029|Testosterone Undecanoate|testosterone undecanoate
5392082|NCT01758029|partner|partner
5392091|NCT01757990|Stevioside|stevioside
5392092|NCT01757990|Rebaudioside|rebaudioside
5392093|NCT01757990|plaque pH|plaque ph
5392094|NCT01757990|Streptococcus mutans|streptococcus mutans
5392095|NCT01757977|Vivasight DL|vivasight dl
5392096|NCT01757977|double lumen endotracheal tube|double lumen endotracheal tube
5392097|NCT01757977|fiberoptic confirmation of tube position|fiberoptic confirmation of tube position
5392098|NCT01757964|Crohns Disease|crohns disease
5392099|NCT01757964|Ulcerative Colitis|ulcerative colitis
5392100|NCT01757964|Inflammatory Bowel Disease|inflammatory bowel disease
5392102|NCT01757951|Ankle|ankle
5392103|NCT01757951|Fracture|fracture
5392104|NCT01757951|medial malleolus|medial malleolus
5392105|NCT01757951|Osteosynthesis|osteosynthesis
5392106|NCT01757938|HIV|hiv
5392107|NCT01757938|Prevention|prevention
5392108|NCT01757938|Adult Male Circumcision|adult male circumcision
5392109|NCT01757938|Uganda|uganda
5392110|NCT01757938|Shang Ring|shang ring
5392111|NCT01757925|activity|activity
5392112|NCT01757925|gaming|gaming
5392113|NCT01757925|obesity|obesity
5392114|NCT01757925|Active Gaming|active gaming
5392115|NCT01757925|Control|control
5392116|NCT01757912|mechanical ventilation|mechanical ventilation
5392117|NCT01757899|ALI|ali
5392118|NCT01757899|Acute Lung Injury|acute lung injury
5392119|NCT01757899|ARDS|ards
5392120|NCT01757899|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5392121|NCT01757899|Pediatric Critical Care Medicine|pediatric critical care medicine
5392122|NCT01757899|Inflammatory Response|inflammatory response
5392123|NCT01757886|Myocardial infarction, Inflammation, Thrombus, Coronary angioplasty.|myocardial infarction, inflammation, thrombus, coronary angioplasty.
5392124|NCT01757847|Binge-Eating Disorder|binge-eating disorder
5392126|NCT01757847|emotional eating|emotional eating
5392127|NCT01757834|Thyroid Nodule|thyroid nodule
5392128|NCT01757834|Thyroid Neoplasm|thyroid neoplasm
5392129|NCT01757834|Differential Diagnosis|differential diagnosis
5392131|NCT01757834|Elasticity Imaging Technique|elasticity imaging technique
5392132|NCT01757834|Sonoelastography|sonoelastography
5392133|NCT01757821|Stroke|stroke
5392134|NCT01757821|rTMS|rtms
5392135|NCT01757821|TMS|tms
5392136|NCT01757808|PAH|pah
5392137|NCT01757808|Ranolazine|ranolazine
5392138|NCT01757808|right ventricle|right ventricle
5392139|NCT01757808|Safety|safety
5392140|NCT01757808|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5392141|NCT01757795|acute ischemic stroke|acute ischemic stroke
5392142|NCT01757795|ischemic stroke|ischemic stroke
5392143|NCT01757795|stroke|stroke
5392144|NCT01757769|Lower urinary tract symptoms|lower urinary tract symptoms
5392145|NCT01757769|benign prostatic hyperplasia|benign prostatic hyperplasia
5392146|NCT01757743|Heart Septal Defects, Atrial|heart septal defects, atrial
5392147|NCT01757743|Oedema formation|oedema formation
5392148|NCT01757717|radiation therapy|radiation therapy
5392149|NCT01757717|HDR brachytherapy|hdr brachytherapy
5392150|NCT01757717|Ir-192 high dose rate|ir-192 high dose rate
5392151|NCT01757717|12-260|12-260
5392152|NCT01757704|Cardiac de-airing|cardiac de-airing
5392153|NCT01757704|Air emboli|air emboli
5392154|NCT01757704|Trans-cranial Echo-Doppler|trans-cranial echo-doppler
5392155|NCT01757704|Intraoperative Trans-esophageal Echocardiography|intraoperative trans-esophageal echocardiography
5392156|NCT01757691|Acute demyelinating optic neuritis|acute demyelinating optic neuritis
5392157|NCT01757691|Optic neuritis|optic neuritis
5392158|NCT01757678|Coronary Artery Disease Computed Fractional Flow Reserve|coronary artery disease computed fractional flow reserve
5392159|NCT01757665|Aortic valve replacement|aortic valve replacement
5392160|NCT01757665|Mitral valve replacement|mitral valve replacement
5392161|NCT01757626|Bone Marrow|bone marrow
5392162|NCT01757626|Hu3F8|hu3f8
5392163|NCT01757626|GM-CSF|gm-csf
5392164|NCT01757626|12-230|12-230
5392165|NCT01757587|Type 2 Diabetes|type 2 diabetes
5392166|NCT01757587|Galvus|galvus
5392167|NCT01757587|basal insulin|basal insulin
5392168|NCT01757587|HbA1c|hba1c
5392169|NCT01757574|CIDP- chronic inflammatory demyelinating neuropathy|cidp- chronic inflammatory demyelinating neuropathy
5392170|NCT01757574|demyelinating neuropathy|demyelinating neuropathy
5392171|NCT01757574|alemtuzumab|alemtuzumab
5395807|NCT01740648|MEK Inhibitor|mek inhibitor
5392172|NCT01757561|jugular bulb oxygen saturation|jugular bulb oxygen saturation
5392173|NCT01757561|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5392175|NCT01757561|sevoflurane|sevoflurane
5392176|NCT01757548|varicocele; male infertile;varicocelectomy|varicocele; male infertile;varicocelectomy
5392177|NCT01757535|Maintenance therapy|maintenance therapy
5392178|NCT01757535|AML|aml
5392179|NCT01757535|Acute Myeloid Leukemia|acute myeloid leukemia
5392180|NCT01757535|oral Azacitidine|oral azacitidine
5392182|NCT01757535|complete remission|complete remission
5392183|NCT01757509|Parkinson's disease|parkinson's disease
5392184|NCT01757509|Set dancing|set dancing
5392185|NCT01757496|Bronchiolitis|bronchiolitis
5392186|NCT01757496|Respiratory Syncytial Virus|respiratory syncytial virus
5392187|NCT01757496|Cough Assist|cough assist
5392188|NCT01757496|Physiotherapy|physiotherapy
5392189|NCT01757470|effectiveness of risk mitigation,|effectiveness of risk mitigation,
5392190|NCT01757470|knowledge and understanding survey,|knowledge and understanding survey,
5392191|NCT01757470|drug utilisation study,|drug utilisation study,
5392192|NCT01757470|post marketing commitments|post marketing commitments
5392193|NCT01757457|inflammation|inflammation
5392194|NCT01757457|thrombosis|thrombosis
5392195|NCT01757457|platelets|platelets
5392196|NCT01757457|adhesion molecules|adhesion molecules
5392197|NCT01757457|endothelium|endothelium
5392198|NCT01757418|Sickle Cell Disease|sickle cell disease
5392199|NCT01757418|Pain|pain
5392200|NCT01757418|Immune Globulin|immune globulin
5392201|NCT01757405|with Factor VIII (FVIII) or Factor IX (FIX) inhibitors|with factor viii (fviii) or factor ix (fix) inhibitors
5392202|NCT01757392|Treatment|treatment
5392203|NCT01757392|common wart lesions|common wart lesions
5392204|NCT01757392|(verruca vulgaris)|(verruca vulgaris)
5392205|NCT01757379|Short chain fatty acids|short chain fatty acids
5392206|NCT01757379|Acetate|acetate
5392207|NCT01757379|Propionate|propionate
5392208|NCT01757379|Butyrate|butyrate
5392209|NCT01757379|Bioavailability|bioavailability
5392210|NCT01757314|arterial lines|arterial lines
5392211|NCT01757301|Pain|pain
5392212|NCT01757301|Depression|depression
5392213|NCT01757301|Anxiety|anxiety
5392214|NCT01757301|Musculoskeletal|musculoskeletal
5392215|NCT01757301|Fibromyalgia|fibromyalgia
5392216|NCT01757288|STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER|stage iiia/b nsclc / inoperable lung cancer
5392217|NCT01757275|peptic ulcer bleeding|peptic ulcer bleeding
5392218|NCT01757275|prevention of rebleeding|prevention of rebleeding
5392219|NCT01757275|successful endoscopic haemostatic therapy|successful endoscopic haemostatic therapy
5002921|NCT03977818|time to next treatment|time to next treatment
5392220|NCT01757262|Coronary Heart Disease|coronary heart disease
5392221|NCT01757236|Antibiotic|antibiotic
5392222|NCT01757236|linezolid|linezolid
5392223|NCT01757236|linezolid/rifampin|linezolid/rifampin
5392229|NCT01757184|Enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
5392230|NCT01757184|Lysosomal storage disease|lysosomal storage disease
5392231|NCT01757184|Late-onset lysosomal acid lipase deficiency (LAL-D)|late-onset lysosomal acid lipase deficiency (lal-d)
5392232|NCT01757184|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5392233|NCT01757184|Acid lipase disease|acid lipase disease
5392234|NCT01757184|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5392235|NCT01757184|LAL-D|lal-d
5392236|NCT01757184|LIPA deficiency|lipa deficiency
5392237|NCT01757184|Wolman disease|wolman disease
5392238|NCT01757184|Cholesterol ester storage disease (CESD)|cholesterol ester storage disease (cesd)
5392239|NCT01757171|Gastric Cancer|gastric cancer
5392240|NCT01757158|lung cancer|lung cancer
5392241|NCT01757158|lobectomy|lobectomy
5392242|NCT01757158|local recurrence|local recurrence
5392243|NCT01757145|Cord blood transplantation|cord blood transplantation
5392244|NCT01757145|Eltrombopag|eltrombopag
5392245|NCT01757145|Platelet engraftment|platelet engraftment
5392246|NCT01757106|xenon anesthesia|xenon anesthesia
5392247|NCT01757106|sevoflurane anesthesia|sevoflurane anesthesia
5392248|NCT01757106|off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
5392249|NCT01757093|INDIRECT CALORIMETRY|indirect calorimetry
5392250|NCT01757093|MECHANICAL VENTILATION|mechanical ventilation
5392251|NCT01757093|WEANING VENTILATOR|weaning ventilator
5392252|NCT01757093|AUTOMATIC TUBE COMPENSATION|automatic tube compensation
5392253|NCT01757067|ablations|ablations
5392254|NCT01757067|CHF|chf
5392255|NCT01757067|PVC|pvc
5392256|NCT01757054|probiotic|probiotic
5392257|NCT01757054|LGG|lgg
5392258|NCT01757054|BB-12|bb-12
5392259|NCT01757054|fecal recovery|fecal recovery
5392260|NCT01757054|healthy subjects|healthy subjects
5392261|NCT01757041|Streptococcus agalactiae|streptococcus agalactiae
5392262|NCT01757041|Maternal|maternal
5392263|NCT01757041|Newborn|newborn
5392264|NCT01757041|Africa|africa
5392265|NCT01757028|Maternal and newborn health|maternal and newborn health
5392266|NCT01757028|Africa|africa
5392267|NCT01757015|COPD|copd
5392268|NCT01757015|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5392269|NCT01757015|Moderate to severe airflow limitation|moderate to severe airflow limitation
5375476|NCT01833182|tailored home intervention|tailored home intervention
5392270|NCT01757015|GOLD spirometric classification 2 and 3|gold spirometric classification 2 and 3
5392271|NCT01757015|GOLD group B and D|gold group b and d
5392272|NCT01757015|NVA237|nva237
5392273|NCT01757015|Salmeterol fluticasone propionate|salmeterol fluticasone propionate
5392274|NCT01757002|Urban adolescents|urban adolescents
5392275|NCT01757002|Acute asthma|acute asthma
5392276|NCT01757002|Asthma|asthma
5392277|NCT01757002|Computer tailoring|computer tailoring
5392278|NCT01757002|Web-based intervention|web-based intervention
5392279|NCT01757002|Puff City|puff city
5392280|NCT01756950|Influenza|influenza
5392281|NCT01756950|Virus|virus
5392282|NCT01756950|Monoclonal|monoclonal
5392283|NCT01756950|Antibody|antibody
5392284|NCT01756950|Immunization|immunization
5392285|NCT01756950|Treatment|treatment
5392286|NCT01756937|osteoarthritis of the knee|osteoarthritis of the knee
5392287|NCT01756924|prosthetic joint infection|prosthetic joint infection
5392288|NCT01756924|hip arthroplasty|hip arthroplasty
5392289|NCT01756924|MRSA|mrsa
5392290|NCT01756924|knee arthroplasty|knee arthroplasty
5392291|NCT01756911|MFM|mfm
5392292|NCT01756911|Multilayer Flow Modulator|multilayer flow modulator
5392293|NCT01756911|Multilayer stent|multilayer stent
5392294|NCT01756911|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
5392295|NCT01756898|Atopic Dermatitis|atopic dermatitis
5392296|NCT01756898|eczema|eczema
5392297|NCT01756885|Smoking cessation|smoking cessation
5392298|NCT01756885|Nicotine dependence|nicotine dependence
5392299|NCT01756885|Varenicline|varenicline
5392300|NCT01756885|Chantix|chantix
5392301|NCT01756885|Cancer|cancer
5392302|NCT01756872|infertility|infertility
5392303|NCT01756872|Assisted reproductive technology|assisted reproductive technology
5392304|NCT01756872|ovarian reserve|ovarian reserve
5392305|NCT01756859|Portal hypertension|portal hypertension
5392306|NCT01756859|HVPG|hvpg
5392308|NCT01756846|HEART score|heart score
5392309|NCT01756846|risk score|risk score
5392310|NCT01756846|impact|impact
5392311|NCT01756846|chest pain|chest pain
5392312|NCT01756833|abdominal|abdominal
5392313|NCT01756833|aortic|aortic
5392314|NCT01756833|aneurysm|aneurysm
5392315|NCT01756820|Carpal Tunnel Syndrome|carpal tunnel syndrome
5392316|NCT01756820|transverse ligament|transverse ligament
5392317|NCT01756820|carpal tunnel release|carpal tunnel release
5392318|NCT01756820|endoscopic|endoscopic
5392319|NCT01756820|minimal invasive|minimal invasive
5392320|NCT01756820|mini-open|mini-open
5392321|NCT01756820|median nerve|median nerve
5392322|NCT01756807|Optical Coherence Tomography|optical coherence tomography
5392323|NCT01756807|Geneous Stent|geneous stent
5392325|NCT01756794|Alcoholic hepatitis|alcoholic hepatitis
5392326|NCT01756794|Liver transplantation|liver transplantation
5392327|NCT01756794|Alcohol relapse|alcohol relapse
5392328|NCT01756794|Alcoholic cirrhosis|alcoholic cirrhosis
5392329|NCT01756781|PD-0332991|pd-0332991
5392330|NCT01756781|Midazolam|midazolam
5392331|NCT01756781|Drug-Drug Interaction Study|drug-drug interaction study
5392332|NCT01756781|Healthy Adult Volunteer|healthy adult volunteer
5392333|NCT01756768|Phase 1|phase 1
5392334|NCT01756768|Mass Balance study|mass balance study
5392335|NCT01756768|Radio-labeled dose|radio-labeled dose
5392337|NCT01756755|Sepsis|sepsis
5392338|NCT01756742|Pleural Effusion|pleural effusion
5392339|NCT01756742|Respiratory physiotherapy|respiratory physiotherapy
5392340|NCT01756742|Length of stay|length of stay
5392341|NCT01756729|Brain tumor|brain tumor
5392342|NCT01756729|Treatment|treatment
5392343|NCT01756729|Minimal toxicity|minimal toxicity
5392344|NCT01756729|GBM|gbm
5392345|NCT01756729|Glioblastoma|glioblastoma
5392346|NCT01756729|Recurrent|recurrent
5392347|NCT01756729|TTFields|ttfields
5392348|NCT01756716|Diabetic Nephropathy|diabetic nephropathy
5392349|NCT01756703|Diabetic Nephropathy|diabetic nephropathy
5392350|NCT01756690|respiratory distress syndrome, adult|respiratory distress syndrome, adult
5392351|NCT01756690|blood component transfusion|blood component transfusion
5392352|NCT01756690|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5392353|NCT01756690|blood coagulation|blood coagulation
5392354|NCT01756651|Intranasal fentanyl|intranasal fentanyl
5392355|NCT01756651|Cystoscopy|cystoscopy
5392356|NCT01756638|Prostate cancer|prostate cancer
5392357|NCT01756638|Abiraterone acetate|abiraterone acetate
5392358|NCT01756638|JNJ-212082|jnj-212082
5392359|NCT01756625|cetuximab|cetuximab
5392360|NCT01756625|nicotine|nicotine
5392361|NCT01756625|magnesium|magnesium
5392362|NCT01756586|popliteal block|popliteal block
5392363|NCT01756586|analgesia duration|analgesia duration
5392364|NCT01756573|block duration|block duration
5392365|NCT01756573|analgesia|analgesia
5392366|NCT01756560|anterior cruciate ligament|anterior cruciate ligament
5392367|NCT01756560|block duration|block duration
5392368|NCT01756547|Nephrocalcinosis|nephrocalcinosis
5392369|NCT01756547|Extreme premature|extreme premature
5392370|NCT01756521|QT,|qt,
5392371|NCT01756521|QTc,|qtc,
5392372|NCT01756521|electrocardiogram,|electrocardiogram,
5392374|NCT01756508|eculizumab|eculizumab
5392375|NCT01756508|kidney transplantation|kidney transplantation
5392376|NCT01756508|reperfusion|reperfusion
5392377|NCT01756508|rejection|rejection
5392378|NCT01756508|infection|infection
5392379|NCT01756495|QTc,|qtc,
5392380|NCT01756495|GW856553 .|gw856553 .
5392381|NCT01756495|P38,|p38,
5392382|NCT01756482|Respiratory|respiratory
5392383|NCT01756482|Syncytial|syncytial
5392384|NCT01756482|Virus|virus
5392385|NCT01756482|Infections|infections
5392386|NCT01756482|RSV|rsv
5392387|NCT01756456|Keratitis|keratitis
5392388|NCT01756456|Corneal Ulcer|corneal ulcer
5392389|NCT01756443|sciatic nerve block|sciatic nerve block
5392390|NCT01756443|ORIF lateral malleolus|orif lateral malleolus
5392391|NCT01756443|sequential injection|sequential injection
5392392|NCT01756443|premixed injection|premixed injection
5392393|NCT01756443|local anaesthetics|local anaesthetics
5392394|NCT01756430|Carvedilol SR|carvedilol sr
5392395|NCT01756430|Carvedilol IR|carvedilol ir
5392396|NCT01756430|Hypertension|hypertension
5392397|NCT01756430|Essential Hypertension|essential hypertension
5392398|NCT01756417|Healthy|healthy
5392399|NCT01756417|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5392400|NCT01756417|Metformin|metformin
5392401|NCT01756417|Pharmacokinetics|pharmacokinetics
5392403|NCT01756404|Healthy|healthy
5392404|NCT01756404|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5392405|NCT01756404|Pharmacokinetics|pharmacokinetics
5392406|NCT01756404|Pharmacodynamics|pharmacodynamics
5392407|NCT01756404|Obesity|obesity
5392408|NCT01756391|pediatric|pediatric
5392409|NCT01756391|childhood|childhood
5392410|NCT01756391|allergy|allergy
5392411|NCT01756378|Mobilization with movement,knee osteoarthritis,|mobilization with movement,knee osteoarthritis,
5392412|NCT01756352|FET|fet
5392413|NCT01756352|Fluoroethyl tyrosine|fluoroethyl tyrosine
5392414|NCT01756352|GBM|gbm
5392415|NCT01756352|Response to treatment|response to treatment
5392416|NCT01756352|Avastin|avastin
5392417|NCT01756352|Brain Tumor|brain tumor
5392418|NCT01756339|Pneumonia|pneumonia
5392419|NCT01756339|CABP|cabp
5392420|NCT01756339|CAP|cap
5392421|NCT01756339|Macrolide|macrolide
5392422|NCT01756326|Non-Union Fractures|non-union fractures
5392423|NCT01756326|Impaired Healing|impaired healing
5392424|NCT01756326|Fractures|fractures
5392425|NCT01756326|Orthopedics|orthopedics
5392426|NCT01756326|Bone|bone
5392427|NCT01756326|Musculoskeletal Disorders|musculoskeletal disorders
5392428|NCT01756300|Essential Hypertension|essential hypertension
5392429|NCT01756300|Renal Denervation|renal denervation
5392431|NCT01756300|Renal Catheter Ablation|renal catheter ablation
5392432|NCT01756300|Primary Hypertension|primary hypertension
5392433|NCT01756261|EYLEA|eylea
5392434|NCT01756261|Age-Related Macular Degeneration|age-related macular degeneration
5392435|NCT01756261|QOL|qol
5392436|NCT01756248|EYLEA|eylea
5392437|NCT01756248|Age-Related Macular Degeneration|age-related macular degeneration
5392438|NCT01756235|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
5392439|NCT01756235|Rheumatoid Arthritis|rheumatoid arthritis
5392440|NCT01756235|Physical Activity|physical activity
5392441|NCT01756235|Adalimumab|adalimumab
5392442|NCT01756235|Humira®|humira®
5392443|NCT01756222|Bicuspid Aortic Valve Disease|bicuspid aortic valve disease
5392444|NCT01756222|Bicuspid Aortic Valve|bicuspid aortic valve
5392445|NCT01756222|BAV|bav
5392446|NCT01756196|Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor|spinal injection; steroid; systemic reaction; complication; side effect; diabetes mellitus; hypertension; risk factor
5392447|NCT01756170|cervical cancer|cervical cancer
5392448|NCT01756170|radiotherapy|radiotherapy
5392449|NCT01756170|postoperative therapy|postoperative therapy
5392450|NCT01756170|chemotherapy|chemotherapy
5392451|NCT01756157|Crossover|crossover
5392452|NCT01756157|C1 esterase inhibitor|c1 esterase inhibitor
5392453|NCT01756157|Prevention|prevention
5392454|NCT01756157|C1 inhibitor|c1 inhibitor
5392455|NCT01756157|Hereditary Angioedema|hereditary angioedema
5392456|NCT01756157|Subcutaneous|subcutaneous
5392457|NCT01756157|Recombinant human hyaluronidase|recombinant human hyaluronidase
5392458|NCT01756092|Breast Cancer|breast cancer
5392459|NCT01756092|Lumpectomy|lumpectomy
5392460|NCT01756092|Mastectomy, Segmental|mastectomy, segmental
5392461|NCT01756066|Obesity|obesity
5392462|NCT01756066|Weight loss program|weight loss program
5392463|NCT01756066|incentives|incentives
5392464|NCT01756053|Smoking|smoking
5392465|NCT01756053|Tobacco|tobacco
5392466|NCT01756040|intestinal permeability|intestinal permeability
5392467|NCT01756040|preterm infants|preterm infants
5392468|NCT01756040|dual sugar test|dual sugar test
5392469|NCT01756027|Rosacea|rosacea
5392470|NCT01756027|Ulthera System|ulthera system
5392471|NCT01756027|Ultherapy™ Treatment|ultherapy™ treatment
5392472|NCT01756027|Ulthera, Inc.|ulthera, inc.
5392473|NCT01756027|Ultrasound treatment for the skin|ultrasound treatment for the skin
5392474|NCT01755988|Telemedicine|telemedicine
5392475|NCT01755988|Heart Failure|heart failure
5392476|NCT01755988|Self care|self care
5392477|NCT01755988|Quality of life|quality of life
5392478|NCT01755988|Mortality|mortality
5392479|NCT01755988|Hospitalization|hospitalization
5392480|NCT01755975|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
5392481|NCT01755975|Romidepsin (Istodax)|romidepsin (istodax)
5392482|NCT01755975|12-170|12-170
5392483|NCT01755962|diet|diet
5392484|NCT01755962|obese|obese
5392485|NCT01755962|overweight|overweight
5392486|NCT01755962|exercise|exercise
5392487|NCT01755962|resistance training|resistance training
5392488|NCT01755962|nutrition|nutrition
5392489|NCT01755962|glycemic load|glycemic load
5392490|NCT01755962|body composition|body composition
5392491|NCT01755962|weight training|weight training
5392492|NCT01755962|lifestyle|lifestyle
5392493|NCT01755949|atrial fibrillation|atrial fibrillation
5392494|NCT01755949|catheter ablation|catheter ablation
5392495|NCT01755949|colchicine|colchicine
5392496|NCT01755949|c reactive protein|c reactive protein
5392497|NCT01755949|CRP|crp
5392498|NCT01755936|Aortic Stenosis|aortic stenosis
5392499|NCT01755936|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5392500|NCT01755936|Late Gadolinium enhancement|late gadolinium enhancement
5392501|NCT01755936|T1 mapping techniques|t1 mapping techniques
5392502|NCT01755936|Replacement fibrosis|replacement fibrosis
5392503|NCT01755936|Diffuse interstitial fibrosis|diffuse interstitial fibrosis
5392504|NCT01755923|non-small cell lung cancer|non-small cell lung cancer
5392505|NCT01755923|wild-type EGFR|wild-type egfr
5392506|NCT01755923|gefitinib|gefitinib
5392507|NCT01755923|docetaxel|docetaxel
5392508|NCT01755923|second-line therapy|second-line therapy
5392509|NCT01755910|Breast Surgery|breast surgery
5392510|NCT01755910|Thoracic Paravertebral Block|thoracic paravertebral block
5392511|NCT01755910|HRV|hrv
5392512|NCT01755910|Autonomic Nervous System|autonomic nervous system
5392513|NCT01755884|Wheat allergy|wheat allergy
5392514|NCT01755884|Immunotherapy|immunotherapy
5392515|NCT01755884|Desensitization|desensitization
5392516|NCT01755884|Food allergy|food allergy
5392517|NCT01755884|T cells|t cells
5392518|NCT01755858|elamipretide|elamipretide
5392519|NCT01755845|cervical cancer|cervical cancer
5392520|NCT01755845|radiotherapy|radiotherapy
5392521|NCT01755845|postoperative therapy|postoperative therapy
5392522|NCT01755845|chemotherapy|chemotherapy
5392523|NCT01755832|inflammatory rheumatic joint disease|inflammatory rheumatic joint disease
5392524|NCT01755832|text message|text message
5392525|NCT01755832|> 18 years|> 18 years
5392526|NCT01755832|Norwegian speaking|norwegian speaking
5392527|NCT01755806|Aortic annulus|aortic annulus
5392528|NCT01755806|Aortic calcification|aortic calcification
5392529|NCT01755806|Multislice computed tomography|multislice computed tomography
5392531|NCT01755767|MET diagnostic-high|met diagnostic-high
5392532|NCT01755767|Unresectable|unresectable
5392533|NCT01755767|Hepatocellular|hepatocellular
5392534|NCT01755767|Carcinoma|carcinoma
5392535|NCT01755767|c-Met inhibitor|c-met inhibitor
5392536|NCT01755728|Paracetamol|paracetamol
5392537|NCT01755728|Acetaminophen|acetaminophen
5392538|NCT01755728|PDA|pda
5392539|NCT01755728|Preterm infants|preterm infants
5392540|NCT01755715|Abortion|abortion
5392541|NCT01755715|Contraception|contraception
5392542|NCT01755715|Intrauterine Devices|intrauterine devices
5392543|NCT01755715|Intrauterine Device Expulsion|intrauterine device expulsion
5392544|NCT01755702|caffeine|caffeine
5392545|NCT01755702|paracetamol|paracetamol
5392546|NCT01755702|tension headache|tension headache
5392547|NCT01755689|pertussis|pertussis
5392548|NCT01755689|Meningococcal meningitis|meningococcal meningitis
5392549|NCT01755689|Meningococcal infections|meningococcal infections
5392550|NCT01755689|HPV|hpv
5392551|NCT01755689|Neisseria meningitidis|neisseria meningitidis
5392552|NCT01755689|Vaccines, conjugate|vaccines, conjugate
5392553|NCT01755689|tetanus|tetanus
5392554|NCT01755689|diphtheria|diphtheria
5392555|NCT01755689|Meningococcal vaccines|meningococcal vaccines
5392556|NCT01755689|Immunogenicity|immunogenicity
5392557|NCT01755663|CT coronary|ct coronary
5392558|NCT01755663|Coronary arterial disease|coronary arterial disease
5392559|NCT01755663|ivabradine|ivabradine
5392560|NCT01755663|metoprolol|metoprolol
5392561|NCT01755650|18F FPM|18f fpm
5392562|NCT01755650|PET/CT|pet/ct
5392563|NCT01755650|microdosing|microdosing
5392564|NCT01755624|Non-Small Cell Lung Cancer|non-small cell lung cancer
5392565|NCT01755624|NSCLC|nsclc
5392566|NCT01755624|Brain metastases|brain metastases
5392567|NCT01755624|Treatment|treatment
5392568|NCT01755624|Minimal toxicity|minimal toxicity
5392569|NCT01755624|TTFields|ttfields
5392570|NCT01755624|TTF|ttf
5392571|NCT01755624|Tumor Treating Fields|tumor treating fields
5392572|NCT01755624|NovoCure|novocure
5392573|NCT01755611|Minocycline|minocycline
5392574|NCT01755611|Mexico|mexico
5392575|NCT01755611|Acne|acne
5392576|NCT01755611|bioequivalence|bioequivalence
5392577|NCT01755598|Positive Interferon-γ release assay|positive interferon-γ release assay
5392578|NCT01755598|Efficacy|efficacy
5392579|NCT01755598|Adults|adults
5392580|NCT01755598|Tuberculosis vaccine|tuberculosis vaccine
5392582|NCT01755585|Radiation therapy|radiation therapy
5392583|NCT01755585|5-fluorouracil|5-fluorouracil
5392584|NCT01755585|Cisplatin|cisplatin
5392585|NCT01755585|Pharmacokinetics|pharmacokinetics
5392586|NCT01755585|Matrix Metalloproteinase|matrix metalloproteinase
5392593|NCT01755559|artemisinin-based combination therapies|artemisinin-based combination therapies
5392594|NCT01755559|Plasmodium falciparum|plasmodium falciparum
5392595|NCT01755559|efficacy|efficacy
5392596|NCT01755546|Chronic Pain|chronic pain
5392597|NCT01755546|CLBP|clbp
5392598|NCT01755546|Chronic Low Back Pain|chronic low back pain
5392599|NCT01755546|Back Pain|back pain
5392600|NCT01755546|Osteoarthritis|osteoarthritis
5392602|NCT01755546|Neuropathic Pain|neuropathic pain
5392603|NCT01755546|Nerve pain|nerve pain
5392604|NCT01755546|Painful neuropathy|painful neuropathy
5392605|NCT01755533|adolescent substance use|adolescent substance use
5392606|NCT01755533|rural substance use|rural substance use
5392607|NCT01755533|middle school prevention|middle school prevention
5392608|NCT01755533|implementation processes|implementation processes
5392609|NCT01755533|implementation quality|implementation quality
5392610|NCT01755533|adaptation of prevention curricula|adaptation of prevention curricula
5392611|NCT01755533|dissemination|dissemination
5392613|NCT01755520|CAD|cad
5392614|NCT01755520|antiplatelet drug|antiplatelet drug
5392615|NCT01755520|Ticagrelor|ticagrelor
5392616|NCT01755520|Aspirin|aspirin
5392617|NCT01755507|PSC|psc
5392618|NCT01755494|Type 2 diabetes, Saxagliptin, Metformin,Fixed dose combination tablet, Bioequivalence, pharmacokinetic, safety, tolerability|type 2 diabetes, saxagliptin, metformin,fixed dose combination tablet, bioequivalence, pharmacokinetic, safety, tolerability
5392619|NCT01755468|beta-cell function, type 2 diabetes, intermittent insulin|beta-cell function, type 2 diabetes, intermittent insulin
5392620|NCT01755455|Cystic fibrosis|cystic fibrosis
5392621|NCT01755455|Iron|iron
5392622|NCT01755455|Hepcidin|hepcidin
5392623|NCT01755455|Anemia|anemia
5392624|NCT01755455|Erythropoiesis|erythropoiesis
5392625|NCT01755442|Ambulatory blood pressure|ambulatory blood pressure
5392626|NCT01755442|Type 2 diabetes|type 2 diabetes
5392627|NCT01755416|Type 1 diabetes|type 1 diabetes
5392628|NCT01755416|closed loop|closed loop
5392629|NCT01755416|artificial pancreas|artificial pancreas
5392630|NCT01755416|insulin|insulin
5392631|NCT01755416|victoza|victoza
5392632|NCT01755416|liraglutide|liraglutide
5392633|NCT01755338|cerebrospinal fluid|cerebrospinal fluid
5392634|NCT01755338|inflammatory markers|inflammatory markers
5392635|NCT01755338|heart surgery|heart surgery
5392636|NCT01755338|neuronal damage|neuronal damage
5392638|NCT01755299|Energy drinks|energy drinks
5392639|NCT01755299|Wakefulness|wakefulness
5392640|NCT01755299|Caffeine|caffeine
5392641|NCT01755273|Pancreaticoduodenectomy|pancreaticoduodenectomy
5392642|NCT01755273|Diabetes|diabetes
5392643|NCT01755260|POPF|popf
5392644|NCT01755260|pancreaticoduodenectomy|pancreaticoduodenectomy
5392645|NCT01755260|enteral nutrition|enteral nutrition
5392646|NCT01755260|parenteral nutrition|parenteral nutrition
5392647|NCT01755247|acne|acne
5392648|NCT01755234|Outpatient|outpatient
5392649|NCT01755234|Surgery|surgery
5392650|NCT01755234|Anesthesia|anesthesia
5392651|NCT01755221|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
5392652|NCT01755221|Extraesophageal reflux|extraesophageal reflux
5392653|NCT01755221|Reflux laryngitis|reflux laryngitis
5392654|NCT01755221|Posterior laryngitis|posterior laryngitis
5392655|NCT01755221|Proton pump inhibitor (PPI) medication|proton pump inhibitor (ppi) medication
5392656|NCT01755221|Restech pH probe|restech ph probe
5392662|NCT01755182|locoregional treatment|locoregional treatment
5392663|NCT01755182|liver metastases|liver metastases
5392664|NCT01755182|transarterial embolization|transarterial embolization
5392665|NCT01755182|upfront treatment|upfront treatment
5392666|NCT01755182|inoperable|inoperable
5392667|NCT01755182|octreotide|octreotide
5392668|NCT01755182|gastroenteropancreatic (GEP)primary|gastroenteropancreatic (gep)primary
5392669|NCT01755182|pulmonary primary|pulmonary primary
5392670|NCT01755182|primary unknown origin|primary unknown origin
5392671|NCT01755182|systemic therapy|systemic therapy
5392672|NCT01755169|Chronic pain|chronic pain
5392673|NCT01755169|Child|child
5392674|NCT01755169|Pediatric|pediatric
5392675|NCT01755169|Ketamine|ketamine
5392676|NCT01755130|Breast Cancer|breast cancer
5392677|NCT01755130|LOUIS-3D|louis-3d
5392678|NCT01755130|Breast Study|breast study
5392679|NCT01755130|x-ray|x-ray
5392680|NCT01755130|Multimode Laser Optoacoustic Ultrasonic Tomography System|multimode laser optoacoustic ultrasonic tomography system
5392681|NCT01755130|Mass palpable or nonpalpable|mass palpable or nonpalpable
5392682|NCT01755130|Breast lesions|breast lesions
5392683|NCT01755130|Ductal carcinomas|ductal carcinomas
5392684|NCT01755130|Lobular carcinomas|lobular carcinomas
5392685|NCT01755130|Fibroadenomas|fibroadenomas
5392686|NCT01755078|Phosphate binder|phosphate binder
5392687|NCT01755065|laparoscopic surgery|laparoscopic surgery
5392688|NCT01755065|teenager|teenager
5392689|NCT01755052|Acute Myocardial Infarction|acute myocardial infarction
5392690|NCT01755052|Geriatrics|geriatrics
5392691|NCT01755052|Cardiology|cardiology
5392693|NCT01755052|Heart Attack|heart attack
5392694|NCT01755052|Risk Factors|risk factors
5392695|NCT01755052|Quality of Care|quality of care
5392696|NCT01755052|Risk Models|risk models
5392697|NCT01755026|Cesarean Delivery|cesarean delivery
5392698|NCT01755026|Wound infection|wound infection
5392699|NCT01755026|Obesity|obesity
5392700|NCT01755026|Prophylactic antibiotics|prophylactic antibiotics
5392701|NCT01755013|Cholangiocarcinoma|cholangiocarcinoma
5392702|NCT01755013|Biliary Stricture|biliary stricture
5392703|NCT01755013|Biliary obstruction|biliary obstruction
5392704|NCT01755013|Bile Duct Cancer|bile duct cancer
5392705|NCT01755013|PDT|pdt
5392706|NCT01755013|Photodynamic Therapy|photodynamic therapy
5392707|NCT01755013|Plastic optic Diffuser|plastic optic diffuser
5392708|NCT01755013|Laser|laser
5392709|NCT01754987|Vitamins|vitamins
5392710|NCT01754987|Malignant Tumor, Tumour|malignant tumor, tumour
5392711|NCT01754987|Integrative Medicine|integrative medicine
5392712|NCT01754987|Complementary Medicine|complementary medicine
5392713|NCT01754987|Alternative Medicine Antioxidants|alternative medicine antioxidants
5392714|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5392715|NCT01754987|Pharmacologic Actions|pharmacologic actions
5392716|NCT01754987|Protective Agents|protective agents
5392717|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs
5392719|NCT01754987|Growth Substances|growth substances
5392720|NCT01754987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5392721|NCT01754987|Antineoplastic Agents|antineoplastic agents
5392722|NCT01754987|Therapeutic Uses|therapeutic uses
5392723|NCT01754987|Radiation-Sensitizing Agents|radiation-sensitizing agents
5392724|NCT01754987|Liver Cancer|liver cancer
5392725|NCT01754948|asthma|asthma
5392726|NCT01754948|reactive airway disease|reactive airway disease
5392727|NCT01754948|cough|cough
5392728|NCT01754948|air pollution|air pollution
5392729|NCT01754948|nano particles|nano particles
5392730|NCT01754922|exercise tolerance|exercise tolerance
5392731|NCT01754922|Veterans|veterans
5392732|NCT01754922|operation enduring freedom|operation enduring freedom
5392733|NCT01754922|operation Iraqi freedom|operation iraqi freedom
5392734|NCT01754909|lung cancer|lung cancer
5392735|NCT01754909|radiation pneumonitis|radiation pneumonitis
5392736|NCT01754909|mitigation|mitigation
5002922|NCT03977818|overall survival|overall survival
5392737|NCT01754909|enalapril|enalapril
5392738|NCT01754909|placebo|placebo
5392739|NCT01754896|colorectal cancer|colorectal cancer
5392740|NCT01754896|fecal immunochemical test|fecal immunochemical test
5392742|NCT01754896|screening|screening
5392743|NCT01754883|Posttraumatic Stess Disorder|posttraumatic stess disorder
5392744|NCT01754883|Lithium|lithium
5392745|NCT01754870|CLL|cll
5392746|NCT01754870|SLL|sll
5392747|NCT01754857|Lymphoid Leukemia|lymphoid leukemia
5392748|NCT01754857|Bendamustine|bendamustine
5392749|NCT01754857|Rituximab|rituximab
5392750|NCT01754857|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5392751|NCT01754844|Phase 1|phase 1
5392752|NCT01754844|Healthy Volunteers|healthy volunteers
5392753|NCT01754844|Single Ascending Dose (SAD)|single ascending dose (sad)
5392754|NCT01754844|First Time in Man|first time in man
5392755|NCT01754844|Pharmacokinetics|pharmacokinetics
5392756|NCT01754844|Pharmacodynamics|pharmacodynamics
5392757|NCT01754831|children|children
5392758|NCT01754831|fluoride varnish|fluoride varnish
5392759|NCT01754818|Pharmacokinetics|pharmacokinetics
5392760|NCT01754818|volunteers|volunteers
5392761|NCT01754805|ASP015K|asp015k
5392762|NCT01754805|Rheumatoid Arthritis|rheumatoid arthritis
5392763|NCT01754779|calcium phosphate|calcium phosphate
5392764|NCT01754779|urolithiasis|urolithiasis
5392765|NCT01754779|kidney stones|kidney stones
5392766|NCT01754779|hypercalciuria|hypercalciuria
5392767|NCT01754753|Mental well-being|mental well-being
5392768|NCT01754753|Befriending|befriending
5392769|NCT01754740|Xerostomia, Salivary flow, Burning Mouth Syndrome.|xerostomia, salivary flow, burning mouth syndrome.
5392770|NCT01754727|Ankylosing Spondylitis|ankylosing spondylitis
5392771|NCT01754727|Effectiveness|effectiveness
5392772|NCT01754727|Post-marketing observational study (PMOS)|post-marketing observational study (pmos)
5392773|NCT01754727|Adalimumab|adalimumab
5392774|NCT01754727|Humira®|humira®
5392775|NCT01754714|Steatohepatitis|steatohepatitis
5392776|NCT01754688|Acute Bilirubin Encephalopathy|acute bilirubin encephalopathy
5392777|NCT01754688|Bilirubin Induced Neurologic Dysfunction score|bilirubin induced neurologic dysfunction score
5392778|NCT01754688|Hearing Test|hearing test
5392779|NCT01754688|Neonate|neonate
5392780|NCT01754662|Type 2 diabetes|type 2 diabetes
5392781|NCT01754662|Cardiovascular risk|cardiovascular risk
5392782|NCT01754662|Endothelial function|endothelial function
5392787|NCT01754662|Diet|diet
5392788|NCT01754649|intrauterine device|intrauterine device
5392789|NCT01754649|insertion failure|insertion failure
5392790|NCT01754636|Colorectal neoplasms|colorectal neoplasms
5392791|NCT01754636|Elderly|elderly
5392792|NCT01754636|Randomized clinical trials|randomized clinical trials
5392793|NCT01754636|Inclusion.|inclusion.
5392794|NCT01754623|Pancreas|pancreas
5392795|NCT01754623|Pancreatic|pancreatic
5392796|NCT01754623|Neoplasms|neoplasms
5392797|NCT01754623|Stereotactic|stereotactic
5392798|NCT01754623|Radiosurgery|radiosurgery
5376020|NCT01830881|pain|pain
5392799|NCT01754623|Borderline|borderline
5392800|NCT01754623|Resectable|resectable
5392801|NCT01754623|Gastrointestinal|gastrointestinal
5392802|NCT01754623|Gemcitabine|gemcitabine
5392803|NCT01754623|Capecitabine|capecitabine
5392804|NCT01754623|Fluorouracil|fluorouracil
5392805|NCT01754623|Docetaxel|docetaxel
5392807|NCT01754623|GTX Chemotherapy|gtx chemotherapy
5392808|NCT01754610|family trauma|family trauma
5392809|NCT01754610|multi-family therapy|multi-family therapy
5392810|NCT01754610|Posttraumatic Stress Disorder|posttraumatic stress disorder
5392811|NCT01754610|poverty|poverty
5671206|NCT00616720|stage II multiple myeloma|stage ii multiple myeloma
5392812|NCT01754597|Patients with breast cancer requiring surgical management with general anesthesia|patients with breast cancer requiring surgical management with general anesthesia
5392813|NCT01754584|hyaluronan including concentrations|hyaluronan including concentrations
5392814|NCT01754584|molecular weight|molecular weight
5392815|NCT01754584|mucociliary differentiation|mucociliary differentiation
5392816|NCT01754584|human respiratory epithelial cells|human respiratory epithelial cells
5392817|NCT01754571|medication overuse headache|medication overuse headache
5392818|NCT01754545|Infusions, Intravenous|infusions, intravenous
5392819|NCT01754545|Plasma|plasma
5392820|NCT01754545|ADAMTS-13 protein, human|adamts-13 protein, human
5392821|NCT01754532|Schizophrenia|schizophrenia
5392822|NCT01754532|Schizo-Affective Disorder|schizo-affective disorder
5392823|NCT01754532|Stress|stress
5392824|NCT01754532|Cortisol|cortisol
5392825|NCT01754532|PANSS|panss
5392826|NCT01754506|leg ulcers|leg ulcers
5392827|NCT01754506|wounds|wounds
5392828|NCT01754506|fish oil|fish oil
5392829|NCT01754506|lipid mediators|lipid mediators
5392830|NCT01754506|chronic venous stasis ulcers|chronic venous stasis ulcers
5392831|NCT01754493|Major Depression|major depression
5392832|NCT01754493|Irritable Bowel Syndrome|irritable bowel syndrome
5392833|NCT01754493|Somatization|somatization
5392834|NCT01754493|Cymbalta|cymbalta
5392835|NCT01754493|Duloxetine|duloxetine
5392836|NCT01754480|Fibrin Sealant|fibrin sealant
5392837|NCT01754480|Parenchymous tissue open surgery|parenchymous tissue open surgery
5392838|NCT01754480|Hepatic Resection|hepatic resection
5392839|NCT01754480|Oxidized cellulose pads|oxidized cellulose pads
5392843|NCT01754428|Respiratory|respiratory
5392844|NCT01754428|Syncytial|syncytial
5392845|NCT01754428|Virus|virus
5392846|NCT01754428|RSV|rsv
5392847|NCT01754415|Aging|aging
5392848|NCT01754415|Chronic illness|chronic illness
5392849|NCT01754415|Resistance circuit training|resistance circuit training
5392850|NCT01754402|Multiple Myeloma|multiple myeloma
5392851|NCT01754376|Metastatic|metastatic
5392852|NCT01754376|Unresectable|unresectable
5392853|NCT01754376|V600E mutation|v600e mutation
5392854|NCT01754363|Osteoarthritis|osteoarthritis
5392855|NCT01754350|ketogenic diet|ketogenic diet
5392856|NCT01754350|glioma|glioma
5392857|NCT01754350|fasting|fasting
5392858|NCT01754350|reirradiation|reirradiation
5392859|NCT01754350|nutrition|nutrition
5392860|NCT01754337|Type 1 diabetes|type 1 diabetes
5392861|NCT01754337|Hypoglycemia|hypoglycemia
5392862|NCT01754337|Insulin|insulin
5392863|NCT01754337|Glucagon|glucagon
5392864|NCT01754337|Closed-loop system|closed-loop system
5392865|NCT01754337|Artificial pancreas|artificial pancreas
5392866|NCT01754324|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5392867|NCT01754324|Pharmacokinetics|pharmacokinetics
5392868|NCT01754324|Methadone|methadone
5392869|NCT01754324|Neonate|neonate
5392870|NCT01754324|Newborn|newborn
5392871|NCT01754311|HTLV-I|htlv-i
5392872|NCT01754298|osteochondritis dissecans (OCD)|osteochondritis dissecans (ocd)
5392873|NCT01754298|juvenile osteochondritis dissecans (JOCD)|juvenile osteochondritis dissecans (jocd)
5392874|NCT01754298|knee osteochondritis dissecans|knee osteochondritis dissecans
5392875|NCT01754298|retro-articular drilling|retro-articular drilling
5392876|NCT01754298|trans-articular drilling|trans-articular drilling
5392877|NCT01754298|stable osteochondritis dissecans lesion|stable osteochondritis dissecans lesion
5392878|NCT01754272|metastatic colorectal cancer|metastatic colorectal cancer
5392879|NCT01754272|mCRC|mcrc
5392880|NCT01754272|Aflibercept|aflibercept
5392881|NCT01754272|FOLFIRI|folfiri
5392882|NCT01754272|translational research|translational research
5392883|NCT01754272|retrospective|retrospective
5392884|NCT01754272|noninterventional|noninterventional
5392885|NCT01754272|biomarkers|biomarkers
5392886|NCT01754272|angiogenesis|angiogenesis
5392887|NCT01754259|type 1 diabetes|type 1 diabetes
5392888|NCT01754259|type 2 diabetes|type 2 diabetes
5392889|NCT01754259|exertion angina|exertion angina
5392890|NCT01754259|suspected CAD|suspected cad
5392891|NCT01754259|known CAD|known cad
5392892|NCT01754194|Gastric Sleeve|gastric sleeve
5392893|NCT01754194|Gastric Bypass|gastric bypass
5392894|NCT01754194|Roux en Y|roux en y
5396514|NCT01737775|Age|age
5392907|NCT01754129|Quality of Life|quality of life
5392908|NCT01754129|Parkinson's Disease|parkinson's disease
5392909|NCT01754116|healthy subjects|healthy subjects
5392910|NCT01754116|GSK1265744 LAP|gsk1265744 lap
5392911|NCT01754116|integrase inhibitor|integrase inhibitor
5376132|NCT01830361|AML|aml
5392912|NCT01754116|HIV-1 infection|hiv-1 infection
5392913|NCT01754116|long acting retroviral|long acting retroviral
5392914|NCT01754116|relative bioavailability|relative bioavailability
5392915|NCT01754103|blind|blind
5392916|NCT01754103|tactile stimulation|tactile stimulation
5392917|NCT01754103|cross-modality|cross-modality
5392918|NCT01754103|visual qualia|visual qualia
5392919|NCT01754103|resting state MRI|resting state mri
5392920|NCT01754103|functional connectivity|functional connectivity
5392921|NCT01754103|neuroplasticity|neuroplasticity
5392922|NCT01754090|alcohol|alcohol
5392923|NCT01754090|online intervention|online intervention
5392924|NCT01754090|hazardous drinking|hazardous drinking
5392925|NCT01754090|harmful drinking|harmful drinking
5392926|NCT01754090|early intervention|early intervention
5392927|NCT01754090|behavior change intervention|behavior change intervention
5392928|NCT01754077|Language|language
5392929|NCT01754077|Behavior change|behavior change
5392930|NCT01754077|Intervention|intervention
5392931|NCT01754077|Home visiting|home visiting
5392932|NCT01754077|Child language development|child language development
5392939|NCT01754038|Patient Reported Outcomes|patient reported outcomes
5392941|NCT01754038|Registry|registry
5392942|NCT01754025|Gene Mutation|gene mutation
5392943|NCT01754012|Nutrition|nutrition
5392944|NCT01754012|Dietary intervention|dietary intervention
5392945|NCT01754012|Aging|aging
5392946|NCT01754012|Inflammation|inflammation
5392947|NCT01754012|Elderly|elderly
5392948|NCT01754012|Europe|europe
5392949|NCT01753999|World Trade Center (WTC)|world trade center (wtc)
5392950|NCT01753999|nasal symptoms|nasal symptoms
5392951|NCT01753999|nasal inflammation|nasal inflammation
5392952|NCT01753999|CPAP|cpap
5392953|NCT01753973|Metabolic syndrome|metabolic syndrome
5392954|NCT01753973|Renal transplantation|renal transplantation
5392955|NCT01753895|Healthy Volunteers|healthy volunteers
5392956|NCT01753882|Gait training|gait training
5392957|NCT01753882|Lexapro|lexapro
5392958|NCT01753882|Tizanidine|tizanidine
5392959|NCT01753843|Preterm Birth|preterm birth
5380453|NCT01810458|Fibrosis|fibrosis
5392960|NCT01753830|Double-blind|double-blind
5392961|NCT01753830|Randomized|randomized
5392962|NCT01753830|Intraarticular injection|intraarticular injection
5392963|NCT01753830|Hyaluronic acid|hyaluronic acid
5392964|NCT01753830|Placebo|placebo
5392965|NCT01753830|Knee osteoarthritis|knee osteoarthritis
5392966|NCT01753817|Coronary catheterization|coronary catheterization
5392976|NCT01753726|stretching, diaphragm, spinal movement, thoracic movement|stretching, diaphragm, spinal movement, thoracic movement
5392978|NCT01753700|UHT milk|uht milk
5392979|NCT01753700|Pasteurised milk|pasteurised milk
5392980|NCT01753700|supplement|supplement
5392981|NCT01753687|break up time|break up time
5392982|NCT01753687|tear film thickness|tear film thickness
5392983|NCT01753687|tear film osmolarity|tear film osmolarity
5392984|NCT01753687|objective scattering index|objective scattering index
5392985|NCT01753687|impression cytology|impression cytology
5392986|NCT01753687|tear cytokines/chemokines|tear cytokines/chemokines
5392989|NCT01753674|metabolic syndrome, insulin resistance, HDL cholesterol,|metabolic syndrome, insulin resistance, hdl cholesterol,
5392992|NCT01753661|Behavior change|behavior change
5392993|NCT01753661|Early Intervention|early intervention
5392994|NCT01753661|Home visiting|home visiting
5392996|NCT01753648|retinal blood velocity|retinal blood velocity
5392997|NCT01753648|retinal oxygen saturation|retinal oxygen saturation
5392998|NCT01753648|retinal vessel diameter|retinal vessel diameter
5392999|NCT01753648|ocular perfusion pressure|ocular perfusion pressure
5393000|NCT01753635|Baska mask|baska mask
5393002|NCT01753635|single use LMA device|single use lma device
5393003|NCT01753635|laryngeal mask airway|laryngeal mask airway
5393004|NCT01753635|supraglottic airway device|supraglottic airway device
5393005|NCT01753622|Overweight, obese, pregnant, depression, outcomes|overweight, obese, pregnant, depression, outcomes
5393006|NCT01753609|Over weight|over weight
5393007|NCT01753609|Obesity|obesity
5393008|NCT01753596|topical lubricants|topical lubricants
5393009|NCT01753596|tear film thickness|tear film thickness
5393010|NCT01753596|break up time|break up time
5393011|NCT01753596|ocular surface disease index|ocular surface disease index
5393012|NCT01753596|Schirmer I test|schirmer i test
5393016|NCT01753570|Feron|feron
5393017|NCT01753557|Pegasys|pegasys
5393018|NCT01753531|Ultra Influenza A and B|ultra influenza a and b
5393019|NCT01753531|Influenza Type A|influenza type a
5393020|NCT01753531|Influenza Type B|influenza type b
5393021|NCT01753531|Flu|flu
5393022|NCT01753531|Sekisui Diagnostics|sekisui diagnostics
5393023|NCT01753518|Subcuticular suture|subcuticular suture
5393024|NCT01753518|Subcuticular staple|subcuticular staple
5393025|NCT01753518|Skin closure|skin closure
5393026|NCT01753518|Incision closure|incision closure
5393027|NCT01753518|Wound|wound
5393028|NCT01753505|multidetector coronary CT angiography, renal transplantation|multidetector coronary ct angiography, renal transplantation
5393029|NCT01753492|Intraocular pressure|intraocular pressure
5393030|NCT01753492|glaucoma|glaucoma
5393031|NCT01753492|trabeculectomy|trabeculectomy
5393032|NCT01753492|Ologen|ologen
5376236|NCT01829815|Child|child
5393033|NCT01753479|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5393034|NCT01753453|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5393035|NCT01753453|Tumour cell mobilization|tumour cell mobilization
5393036|NCT01753440|coronary artery disease|coronary artery disease
5393037|NCT01753440|heart failure|heart failure
5393038|NCT01753440|stem cells implantation|stem cells implantation
5393039|NCT01753427|COPD,|copd,
5393040|NCT01753427|symptoms,|symptoms,
5393041|NCT01753427|Non-Interventional study,|non-interventional study,
5393042|NCT01753414|Lung Cancer|lung cancer
5393045|NCT01753375|Multiple Sclerosis|multiple sclerosis
5393046|NCT01753375|Relapsing rate|relapsing rate
5393047|NCT01753375|Expanded disability status scale|expanded disability status scale
5393048|NCT01753375|Vitamin D3|vitamin d3
5393049|NCT01753323|acute malaria, KAF156|acute malaria, kaf156
5393050|NCT01753245|Anti-TNF drugs efficacy|anti-tnf drugs efficacy
5393051|NCT01753245|Moderate-to-severe psoriasis vulgaris|moderate-to-severe psoriasis vulgaris
5393052|NCT01753245|Gene polymorphism|gene polymorphism
5393053|NCT01753232|DALI adsorber|dali adsorber
5393054|NCT01753232|MONET lipoprotein filter|monet lipoprotein filter
5393055|NCT01753193|Systemic Lupus Erythematosus|systemic lupus erythematosus
5393056|NCT01753180|CTO|cto
5393057|NCT01753180|PCI|pci
5393058|NCT01753180|Angioplasty|angioplasty
5393059|NCT01753154|Peritoneal Dialysis|peritoneal dialysis
5393060|NCT01753154|Biocompatible dialysis solution|biocompatible dialysis solution
5393061|NCT01753154|Hydration status|hydration status
5393062|NCT01753154|Residual renal function|residual renal function
5393064|NCT01753154|Bioimpedance spectroscopy|bioimpedance spectroscopy
5393065|NCT01753154|Cancer antigen 125|cancer antigen 125
5393066|NCT01753141|Cognitive Behavioral Therapy|cognitive behavioral therapy
5393067|NCT01753141|Smoking Cessation|smoking cessation
5393068|NCT01753115|post-exposure prophylaxis|post-exposure prophylaxis
5393069|NCT01753115|toxin neutralization assay|toxin neutralization assay
5393070|NCT01753102|Estradiol|estradiol
5393071|NCT01753102|Vulvar atrophy|vulvar atrophy
5393072|NCT01753102|vaginal atrophy|vaginal atrophy
5393073|NCT01753089|Metastatic|metastatic
5393074|NCT01753076|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5393075|NCT01753076|efficacy|efficacy
5393076|NCT01753076|ozanezumab|ozanezumab
5393077|NCT01753076|safety|safety
5393078|NCT01753063|Obesity|obesity
5393079|NCT01753063|Children|children
5393080|NCT01753063|Adolescents|adolescents
5393081|NCT01753063|Attrition|attrition
5393082|NCT01753037|Hyperandrogenism|hyperandrogenism
5393083|NCT01753037|Inflammation|inflammation
5393084|NCT01753037|Insulin sensitivity|insulin sensitivity
5393085|NCT01753037|Body composition|body composition
5393086|NCT01753024|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5393087|NCT01753024|fecal elastase-1|fecal elastase-1
5393088|NCT01753024|amylase|amylase
5393089|NCT01753024|lipase|lipase
5393090|NCT01753024|critical illness|critical illness
5393091|NCT01753024|enteral nutrition|enteral nutrition
5393092|NCT01753024|malnutrition|malnutrition
5393093|NCT01753024|sepsis|sepsis
5393094|NCT01753024|diabetes|diabetes
5393095|NCT01753024|hyperlactacidemia|hyperlactacidemia
5393099|NCT01753011|Transobturator sling|transobturator sling
5393101|NCT01752998|pain|pain
5393102|NCT01752998|depression|depression
5393103|NCT01752998|substance use|substance use
5393104|NCT01752972|Arsenic|arsenic
5393105|NCT01752972|Keratosis|keratosis
5393106|NCT01752972|Linoleic acid|linoleic acid
5393107|NCT01752972|Palm|palm
5393108|NCT01752972|Spirulina|spirulina
5393109|NCT01752972|Vitamin E|vitamin e
5393110|NCT01752972|Zinc|zinc
5393111|NCT01752920|FGFR|fgfr
5393112|NCT01752920|ARQ 087|arq 087
5393113|NCT01752920|Targeted therapy|targeted therapy
5393114|NCT01752920|Molecular therapy|molecular therapy
5393115|NCT01752920|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5393117|NCT01752920|Receptor tyrosine kinase|receptor tyrosine kinase
5393118|NCT01752920|RTK|rtk
5393119|NCT01752920|Biomarker|biomarker
5393120|NCT01752920|Phase 1|phase 1
5393121|NCT01752920|Phase I|phase i
5393122|NCT01752920|Solid tumor|solid tumor
5393123|NCT01752920|Liver Cancer|liver cancer
5393124|NCT01752920|Hepatobiliary carcinoma|hepatobiliary carcinoma
5393125|NCT01752920|Biliary tract cancer|biliary tract cancer
5393126|NCT01752920|Cholangiocarcinoma|cholangiocarcinoma
5393127|NCT01752920|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5393128|NCT01752920|FGFR inhibitor|fgfr inhibitor
5393129|NCT01752920|Targeted FGFR kinase inhibitor|targeted fgfr kinase inhibitor
5393130|NCT01752920|Pan-FGFR inhibitor|pan-fgfr inhibitor
5393131|NCT01752920|Selective FGFR inhibitor|selective fgfr inhibitor
5393132|NCT01752920|FGFR pathway|fgfr pathway
5393133|NCT01752920|FGFR signaling|fgfr signaling
5393134|NCT01752920|Fibroblast growth factor|fibroblast growth factor
5393135|NCT01752920|FGFR1|fgfr1
5393136|NCT01752920|FGFR2|fgfr2
5393137|NCT01752920|FGFR3|fgfr3
5393138|NCT01752920|FGFR4|fgfr4
5393139|NCT01752920|FGF|fgf
5393140|NCT01752920|FGF19|fgf19
5393141|NCT01752920|FGF21|fgf21
5393142|NCT01752920|FGF23|fgf23
5393143|NCT01752920|FGFR mutation|fgfr mutation
5393144|NCT01752920|FGFR gene fusion|fgfr gene fusion
5393145|NCT01752920|FGFR gene translocation|fgfr gene translocation
5393146|NCT01752920|FGFR genetic aberration|fgfr genetic aberration
5393147|NCT01752920|FGFR2 fusion|fgfr2 fusion
5393148|NCT01752920|FGFR2 translocation|fgfr2 translocation
5393149|NCT01752920|Phase 1 Clinical Trial|phase 1 clinical trial
5393150|NCT01752920|Phase I Clinical Trial|phase i clinical trial
5393151|NCT01752920|Clinical oncology|clinical oncology
5393152|NCT01752920|Tumor|tumor
5393153|NCT01752920|Tumour|tumour
5393154|NCT01752920|derazantinib|derazantinib
5393155|NCT01752907|Breast cancer|breast cancer
5393156|NCT01752907|Chemotherapy|chemotherapy
5393157|NCT01752907|Pegfilgrastim|pegfilgrastim
5393158|NCT01752907|Neulasta|neulasta
5393159|NCT01752907|Bone Pain|bone pain
5393160|NCT01752907|Education|education
5393161|NCT01752881|Influenza|influenza
5393162|NCT01752881|Vaccine|vaccine
5393163|NCT01752881|Immunogenicity|immunogenicity
5393164|NCT01752855|Rheumatoid Arthritis|rheumatoid arthritis
5393165|NCT01752842|Diabetes|diabetes
5393166|NCT01752842|Diabetic Cardiomyopathy|diabetic cardiomyopathy
5393167|NCT01752842|Triglycerides|triglycerides
5393168|NCT01752829|Obesity|obesity
5393169|NCT01752829|gastric|gastric
5393170|NCT01752829|banding|banding
5393171|NCT01752829|Weight|weight
5393172|NCT01752829|co-morbidities|co-morbidities
5393173|NCT01752829|dilatation|dilatation
5393175|NCT01752829|adjustable gastric banding|adjustable gastric banding
5393176|NCT01752816|endurance training,|endurance training,
5393177|NCT01752816|strength training,|strength training,
5393178|NCT01752816|aerobic capacity,|aerobic capacity,
5393179|NCT01752816|muscle strenght|muscle strenght
5393180|NCT01752816|physical capacity|physical capacity
5393181|NCT01752790|Pediatric Crohn's disease|pediatric crohn's disease
5393182|NCT01752790|Biologics|biologics
5393183|NCT01752790|Immunomodulators|immunomodulators
5393184|NCT01752790|Top-down|top-down
5393185|NCT01752790|step-up|step-up
5393186|NCT01752777|HIV/AIDS, HIV infectiousness, Medication adherence, Sexual risks reduction|hiv/aids, hiv infectiousness, medication adherence, sexual risks reduction
5393187|NCT01752751|Neck cancer|neck cancer
5393188|NCT01752751|Head cancer|head cancer
5393197|NCT01752699|post-herpetic neuralgia,|post-herpetic neuralgia,
5393198|NCT01752699|methadone,|methadone,
5393199|NCT01752686|Triple negative breast cancer|triple negative breast cancer
5393200|NCT01752686|adjuvant chemotherapy|adjuvant chemotherapy
5393201|NCT01752673|randomized controlled study|randomized controlled study
5393202|NCT01752660|Exercise therapy|exercise therapy
5393203|NCT01752660|Aerobic training|aerobic training
5393204|NCT01752660|Endurance training|endurance training
5393205|NCT01752647|lung cancer|lung cancer
5393216|NCT01752608|Real-time|real-time
5393219|NCT01752608|Cognitive behavioral therapy|cognitive behavioral therapy
5393220|NCT01752582|BuMA|buma
5393221|NCT01752582|EXCEL|excel
5393222|NCT01752582|OCT|oct
5393223|NCT01752582|stent|stent
5393224|NCT01752582|neointima formation|neointima formation
5393225|NCT01752569|HIV|hiv
5393226|NCT01752569|Kaposi's sarcoma|kaposi's sarcoma
5393227|NCT01752569|Anti-retroviral therapy|anti-retroviral therapy
5393228|NCT01752569|HAART|haart
5393229|NCT01752569|AIDS|aids
5393230|NCT01752556|Sleep apnea, Portable monitor,autoCPAP|sleep apnea, portable monitor,autocpap
5393231|NCT01752543|Vasopressin|vasopressin
5393232|NCT01752543|Exercise capacity|exercise capacity
5393233|NCT01752543|Conivaptan|conivaptan
5393234|NCT01752530|ADHD|adhd
5393235|NCT01752517|small cell lung cancer|small cell lung cancer
5393236|NCT01752517|chemotherapy|chemotherapy
5393237|NCT01752517|vinorelbine|vinorelbine
5393238|NCT01752517|ifosfamide|ifosfamide
5393239|NCT01752517|third-line treatment|third-line treatment
5393240|NCT01752504|HIV prevention|hiv prevention
5393241|NCT01752504|HIV positive communities|hiv positive communities
5393242|NCT01752491|Ascorbate|ascorbate
5393243|NCT01752491|Ascorbic acid|ascorbic acid
5393244|NCT01752491|Vitamin C|vitamin c
5393245|NCT01752491|Radiation|radiation
5393246|NCT01752491|Temozolomide|temozolomide
5393247|NCT01752478|ptosis|ptosis
5393248|NCT01752478|retina surgery|retina surgery
5393249|NCT01752478|droopy eye lid|droopy eye lid
5393250|NCT01752465|Health behaviour|health behaviour
5393251|NCT01752465|Antipsychotic agents|antipsychotic agents
5393252|NCT01752465|Adverse effects|adverse effects
5393253|NCT01752465|Goals|goals
5393254|NCT01752465|Life style|life style
5393255|NCT01752439|Chronic Migraine|chronic migraine
5393256|NCT01752439|Medication Overuse Headache|medication overuse headache
5393257|NCT01752439|Refractory|refractory
5393258|NCT01752439|transcranial direct current stimulation|transcranial direct current stimulation
5393269|NCT01752413|Iron depletion|iron depletion
5393270|NCT01752413|blood donors|blood donors
5393271|NCT01752413|iron replacement|iron replacement
5393272|NCT01752400|Advanced|advanced
5393273|NCT01752361|Gastrointestinal Motility|gastrointestinal motility
5393274|NCT01752361|Inflammatory Bowel Disease|inflammatory bowel disease
5393275|NCT01752361|Transit time|transit time
5393276|NCT01752348|sepsis|sepsis
5393277|NCT01752348|cytokine release|cytokine release
5393278|NCT01752348|fever|fever
5393279|NCT01752335|Rheumatoid Arthritis, tocilizumab, cardiovascular risk factors|rheumatoid arthritis, tocilizumab, cardiovascular risk factors
5393280|NCT01752309|Early Rheumatoid arthritis|early rheumatoid arthritis
5393281|NCT01752309|Rheumatoid arthritis|rheumatoid arthritis
5393282|NCT01752309|Ultrasound|ultrasound
5393283|NCT01752309|Predictive|predictive
5393284|NCT01752309|Prognosis|prognosis
5393285|NCT01752296|Morquio|morquio
5393286|NCT01752296|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
5393287|NCT01752296|Psychological health|psychological health
5393288|NCT01752283|Videoassited|videoassited
5393289|NCT01752283|Thyroidectomy|thyroidectomy
5393290|NCT01752283|Minimal invasive surgery|minimal invasive surgery
5393291|NCT01752283|General anesthesia|general anesthesia
5393292|NCT01752283|Hypnosis|hypnosis
5393293|NCT01752257|Melanoma|melanoma
5393294|NCT01752244|Obesity, vitamin D analogue, VDR, PPARg, PGC1a|obesity, vitamin d analogue, vdr, pparg, pgc1a
5393295|NCT01752218|Femto-second Laser|femto-second laser
5393296|NCT01752218|arcuate incision|arcuate incision
5393297|NCT01752218|corneal astigmatism|corneal astigmatism
5393298|NCT01752218|astigmatic keratotomy|astigmatic keratotomy
5393299|NCT01752218|Cataract|cataract
5393300|NCT01752205|Esophageal Squamous Carcinoma|esophageal squamous carcinoma
5393301|NCT01752205|Erlotinib|erlotinib
5393302|NCT01752205|Chemoradiotherapy|chemoradiotherapy
5393303|NCT01752192|Rehabilitation|rehabilitation
5393304|NCT01752192|Telemedicine|telemedicine
5393305|NCT01752192|Heart patients|heart patients
5393306|NCT01752192|Social media|social media
5393307|NCT01752192|Organisational aspects|organisational aspects
5393308|NCT01752179|Kinesio taping|kinesio taping
5393309|NCT01752179|Piriformis syndrome|piriformis syndrome
5393310|NCT01752179|Trigger point|trigger point
5393313|NCT01752166|Blood culture|blood culture
5393314|NCT01752166|Diagnostics|diagnostics
5393315|NCT01752153|Focus|focus
5393316|NCT01752153|immunomodulatory effect|immunomodulatory effect
5393317|NCT01752153|of silymarin|of silymarin
5393318|NCT01752153|on cell mediated immunity|on cell mediated immunity
5393319|NCT01752153|Beta-Thalassemia|beta-thalassemia
5393320|NCT01752153|major patients.|major patients.
5393321|NCT01752140|Prostate cancer|prostate cancer
5393322|NCT01752140|Prostate biopsy|prostate biopsy
5393323|NCT01752140|Vienna nomogram|vienna nomogram
5393324|NCT01752127|Drug-eluting stent|drug-eluting stent
5393325|NCT01752127|diabetes|diabetes
5393326|NCT01752127|small vessel disease|small vessel disease
5393327|NCT01752114|Precancerous conditions|precancerous conditions
5393328|NCT01752114|Carcinoma|carcinoma
5393329|NCT01752101|Precancerous Conditions|precancerous conditions
5393330|NCT01752101|Carcinoma|carcinoma
5393331|NCT01752088|apularis, MRI clinical, results|apularis, mri clinical, results
5393332|NCT01752075|Multiple myeloma|multiple myeloma
5393333|NCT01752062|Chronic Myeloid Leukemia|chronic myeloid leukemia
5393335|NCT01752062|Pregnancy|pregnancy
5393336|NCT01752049|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5393337|NCT01752049|Anti-angiogenic Therapy|anti-angiogenic therapy
5393338|NCT01752049|vascular malformations|vascular malformations
5393340|NCT01752036|stereotactic radiotherapy|stereotactic radiotherapy
5393342|NCT01751984|lipid-lowering drugs|lipid-lowering drugs
5393343|NCT01751984|statin intolerance|statin intolerance
5393345|NCT01751945|Neonatal mortality|neonatal mortality
5393346|NCT01751945|Perinatal mortality|perinatal mortality
5393347|NCT01751919|CML|cml
5393348|NCT01751919|GIST|gist
5393349|NCT01751906|Absorb™ BVS|absorb™ bvs
5393350|NCT01751906|Angioplasty|angioplasty
5393351|NCT01751906|Bioabsorbable|bioabsorbable
5393352|NCT01751906|BVS|bvs
5393353|NCT01751906|Bioresorbable|bioresorbable
5393354|NCT01751906|Coronary Artery Disease|coronary artery disease
5393355|NCT01751906|Coronary Artery Endothelial Responsiveness|coronary artery endothelial responsiveness
5393356|NCT01751906|Coronary artery restenosis|coronary artery restenosis
5393357|NCT01751906|Coronary artery stenosis|coronary artery stenosis
5393358|NCT01751906|Coronary scaffold|coronary scaffold
5393359|NCT01751906|Coronary Stent|coronary stent
5393360|NCT01751906|Drug eluting stents|drug eluting stents
5393361|NCT01751906|Everolimus|everolimus
5393362|NCT01751906|Myocardial ischemia|myocardial ischemia
5393363|NCT01751906|Stent thrombosis|stent thrombosis
5393364|NCT01751906|Stents|stents
5393365|NCT01751893|Hand-foot syndrome|hand-foot syndrome
5393366|NCT01751893|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5393367|NCT01751893|capecitabine|capecitabine
5393368|NCT01751893|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5393369|NCT01751893|henna|henna
5393370|NCT01751880|Gastric cancer, minimally invasive gastrectomy, Physical activity intervention|gastric cancer, minimally invasive gastrectomy, physical activity intervention
5393371|NCT01751867|Myelodysplastic Syndrome|myelodysplastic syndrome
5393372|NCT01751867|Dacogen|dacogen
5393373|NCT01751867|Oncology|oncology
5393374|NCT01751867|Decitabine|decitabine
5393375|NCT01751867|Bone marrow disorders|bone marrow disorders
5393376|NCT01751854|pharmacology|pharmacology
5393377|NCT01751854|rehabilitation|rehabilitation
5393378|NCT01751854|locomotion|locomotion
5393379|NCT01751828|Depression|depression
5393380|NCT01751828|Major Depressive Disorder|major depressive disorder
5393381|NCT01751802|Lesch Nyhan Disease|lesch nyhan disease
5393382|NCT01751802|Self-Injury|self-injury
5393383|NCT01751789|illicit opioid drug use|illicit opioid drug use
5393384|NCT01751789|health service utilization|health service utilization
5393385|NCT01751737|prostate|prostate
5393386|NCT01751737|cancer|cancer
5393387|NCT01751737|biopsy|biopsy
5393388|NCT01751737|18F-choline|18f-choline
5393389|NCT01751737|PET|pet
5393390|NCT01751737|MRI|mri
5393391|NCT01751724|Premature infants|premature infants
5393392|NCT01751724|Caffeine|caffeine
5393393|NCT01751724|Methylxanthines|methylxanthines
5393394|NCT01751724|Mechanical ventilation|mechanical ventilation
5393395|NCT01751724|Oxygen|oxygen
5393396|NCT01751724|Weaning|weaning
5393397|NCT01751724|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5393398|NCT01751698|Autism|autism
5393399|NCT01751698|Minimally Verbal|minimally verbal
5393400|NCT01751698|School Age|school age
5393401|NCT01751685|kyphosis|kyphosis
5393402|NCT01751672|SBIRT|sbirt
5393403|NCT01751672|Substance Use|substance use
5393404|NCT01751672|Screening|screening
5393405|NCT01751672|Brief Intervention|brief intervention
5393406|NCT01751672|Primary Care|primary care
5393407|NCT01751633|Burst fractures|burst fractures
5393408|NCT01751633|Thoracic or Lumbar Vertebrae/injuries [MeSH]|thoracic or lumbar vertebrae/injuries [mesh]
5393409|NCT01751633|Thoracic or Lumbar Vertebrae/surgery [MeSH]|thoracic or lumbar vertebrae/surgery [mesh]
5393417|NCT01751581|Sleep|sleep
5393418|NCT01751581|Eating|eating
5393419|NCT01751555|HBV co-infection ART TDF|hbv co-infection art tdf
5393420|NCT01751529|renal malignancy|renal malignancy
5393421|NCT01751529|Pilot Study|pilot study
5393422|NCT01751529|LCCC 1219|lccc 1219
5393423|NCT01751529|UNC Lineberger|unc lineberger
5393424|NCT01751529|kidney cancer|kidney cancer
5393425|NCT01751529|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5393426|NCT01751529|ultrasound|ultrasound
5393427|NCT01751503|Foot drop deformity|foot drop deformity
5393428|NCT01751503|gold standard treatment|gold standard treatment
5393429|NCT01751503|Tibialis posterior tendon transfer|tibialis posterior tendon transfer
5393430|NCT01751503|Interosseous route|interosseous route
5393431|NCT01751503|Extramembranous or circumtibial route|extramembranous or circumtibial route
5393432|NCT01751490|shoulder|shoulder
5393433|NCT01751490|instability|instability
5393434|NCT01751490|atraumatic|atraumatic
5393435|NCT01751477|Very Low Birth Weight Infants|very low birth weight infants
5393436|NCT01751477|Probiotics|probiotics
5393437|NCT01751477|Necrotizing Enterocolitis|necrotizing enterocolitis
5393439|NCT01751464|violence|violence
5393440|NCT01751464|injury|injury
5393441|NCT01751464|emergency department|emergency department
5393442|NCT01751464|intervention|intervention
5393443|NCT01751451|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
5393444|NCT01751451|DEGARELIX|degarelix
5393445|NCT01751451|PREDNISONE|prednisone
5393446|NCT01751451|12-187|12-187
5393447|NCT01751438|Prostate cancer|prostate cancer
5393448|NCT01751438|Prostate carcinoma|prostate carcinoma
5393449|NCT01751438|Metastatic|metastatic
5393451|NCT01751438|Best Systemic Therapy|best systemic therapy
5393452|NCT01751438|BST|bst
5393453|NCT01751438|Androgen deprivation therapy|androgen deprivation therapy
5393454|NCT01751438|Bilateral orchiectomy|bilateral orchiectomy
5393455|NCT01751438|Radiation|radiation
5393456|NCT01751438|Radiation Therapy|radiation therapy
5393457|NCT01751438|External beam radiation therapy|external beam radiation therapy
5393458|NCT01751438|External-beam radiotherapy|external-beam radiotherapy
5393459|NCT01751438|Xray therapy|xray therapy
5393460|NCT01751438|XRT|xrt
5393461|NCT01751438|Surgery|surgery
5393462|NCT01751412|Hodgkin|hodgkin
5393463|NCT01751412|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5393464|NCT01751412|Mediastinal|mediastinal
5393465|NCT01751412|Adult Lymphoma|adult lymphoma
5393466|NCT01751412|Pediatric Lymphoma|pediatric lymphoma
5393467|NCT01751386|Addiction|addiction
5393468|NCT01751386|Cue-Induced Craving|cue-induced craving
5393469|NCT01751386|Craving|craving
5393470|NCT01751386|Anxiety|anxiety
5393471|NCT01751386|Alcohol Consumption|alcohol consumption
5393472|NCT01751373|Botulinum Toxin|botulinum toxin
5393473|NCT01751373|Rehabilitation|rehabilitation
5393474|NCT01751373|Electromyography|electromyography
5393475|NCT01751373|Electroencephalography|electroencephalography
5393476|NCT01751373|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5393477|NCT01751347|Local anesthetics|local anesthetics
5393478|NCT01751347|Elective hand surgeries|elective hand surgeries
5393479|NCT01751334|Arthroplasty|arthroplasty
5393480|NCT01751334|Replacement|replacement
5393481|NCT01751334|Knee|knee
5393482|NCT01751334|Rotational Alignment|rotational alignment
5393483|NCT01751282|Stem Cells|stem cells
5393484|NCT01751282|chronic wounds|chronic wounds
5393485|NCT01751282|fibrin|fibrin
5393486|NCT01751282|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
5376656|NCT01828021|HER2 2+|her2 2+
5393487|NCT01751256|Postcesarean Section|postcesarean section
5393488|NCT01751256|Postoperative Pain|postoperative pain
5393489|NCT01751256|Care, Postoperative|care, postoperative
5393490|NCT01751256|Anesthesia, Local|anesthesia, local
5393491|NCT01751256|Breast Feeding|breast feeding
5393492|NCT01751256|Morphine|morphine
5393493|NCT01751256|Pain Measurement|pain measurement
5393494|NCT01751256|levobupivacaine|levobupivacaine
5393495|NCT01751230|pregnancy|pregnancy
5393496|NCT01751230|weight loss|weight loss
5393497|NCT01751217|Substance Abuse|substance abuse
5393498|NCT01751217|Adolescents|adolescents
5393499|NCT01751217|Families|families
5393500|NCT01751217|Functional Family Therapy|functional family therapy
5393501|NCT01751217|Video|video
5393502|NCT01751217|Teleconferencing|teleconferencing
5393507|NCT01751165|Immunogenicity|immunogenicity
5393508|NCT01751165|Adults|adults
5393509|NCT01751139|Endemic regions|endemic regions
5393510|NCT01751139|Brazil|brazil
5393511|NCT01751139|Incidence|incidence
5393512|NCT01751139|Surveillance|surveillance
5393513|NCT01751139|Dengue|dengue
5393514|NCT01751126|vernal keratoconjunctivitis|vernal keratoconjunctivitis
5393515|NCT01751126|ciclosporin|ciclosporin
5393516|NCT01751126|cyclosporine|cyclosporine
5393517|NCT01751087|abortion, induced|abortion, induced
5862824|NCT00001491|Fabry Disease|fabry disease
5862826|NCT00001491|Fabry's|fabry's
5393518|NCT01751074|Drug interaction, rosuvastatin, healthy volunteer, Lp-PLA2, atherosclerosis, darapladib, pharmacokinetics.|drug interaction, rosuvastatin, healthy volunteer, lp-pla2, atherosclerosis, darapladib, pharmacokinetics.
5393519|NCT01751061|prolonged mechanical ventilation|prolonged mechanical ventilation
5393520|NCT01751061|chronic critical illness|chronic critical illness
5393521|NCT01751061|decision making|decision making
5393522|NCT01751061|decision aid|decision aid
5393523|NCT01751061|decisional support|decisional support
5393524|NCT01751061|critical illness|critical illness
5393525|NCT01751061|intensive care unit|intensive care unit
5393526|NCT01751048|GLA-SE,LEISH-F3,leishmaniasis,MPL-SE,parent protocol,vaccine|gla-se,leish-f3,leishmaniasis,mpl-se,parent protocol,vaccine
5393527|NCT01751022|heart failure|heart failure
5393528|NCT01751022|cardiac pacing|cardiac pacing
5393529|NCT01751022|cardiac resynchronization therapy|cardiac resynchronization therapy
5393530|NCT01751022|left ventricular lead|left ventricular lead
5393531|NCT01751009|vitamin A, complementary foods, malnutrition, children|vitamin a, complementary foods, malnutrition, children
5393532|NCT01750983|Advanced Cancers|advanced cancers
5393533|NCT01750983|Advanced Malignancies|advanced malignancies
5393534|NCT01750983|Metastatic cancers|metastatic cancers
5393535|NCT01750983|Ipilimumab|ipilimumab
5393536|NCT01750983|Yervoy|yervoy
5393537|NCT01750983|BMS-734016|bms-734016
5393538|NCT01750983|MDX010|mdx010
5393539|NCT01750983|Lenalidomide|lenalidomide
5393540|NCT01750983|CC-5013|cc-5013
5393541|NCT01750983|Revlimid|revlimid
5393542|NCT01750944|Blood pressure site|blood pressure site
5393543|NCT01750944|Good health|good health
5393544|NCT01750944|Brachial blood pressure|brachial blood pressure
5393545|NCT01750944|Ankle|ankle
5393546|NCT01750944|Toe|toe
5393547|NCT01750944|Walking test|walking test
5393548|NCT01750944|Exercise|exercise
5393549|NCT01750931|BE study of Meloxicam GSK 15mg|be study of meloxicam gsk 15mg
5393550|NCT01750918|MEK inhibitor|mek inhibitor
5393551|NCT01750918|anti-EGFR antibody|anti-egfr antibody
5393552|NCT01750918|colorectal cancer|colorectal cancer
5393553|NCT01750918|BRAF inhibitor|braf inhibitor
5393554|NCT01750879|peanut|peanut
5393555|NCT01750879|allergy|allergy
5393556|NCT01750879|food|food
5393557|NCT01750879|immunotherapy|immunotherapy
5393558|NCT01750879|tolerance|tolerance
5393559|NCT01750879|desensitization|desensitization
5393560|NCT01750866|Prostrate Cancer|prostrate cancer
5393687|NCT01750164|Breast Cancer|breast cancer
5393561|NCT01750866|Castrate-resistant metastatic prostate cancer|castrate-resistant metastatic prostate cancer
5393562|NCT01750866|Cabazitaxel|cabazitaxel
5393563|NCT01750827|platelet function|platelet function
5393564|NCT01750827|atherosclerosis,|atherosclerosis,
5393565|NCT01750827|SB-659032|sb-659032
5393566|NCT01750801|clinical trial|clinical trial
5393567|NCT01750801|mouthwash|mouthwash
5393568|NCT01750801|propolis|propolis
5393569|NCT01750801|plaque|plaque
5393570|NCT01750801|gingivitis|gingivitis
5393571|NCT01750801|compliance|compliance
5393572|NCT01750788|Stroke|stroke
5393573|NCT01750788|Embolism|embolism
5393574|NCT01750788|Atrial Fibrillation|atrial fibrillation
5393575|NCT01750775|sinus bradycardia|sinus bradycardia
5393576|NCT01750775|ventricular premature contraction|ventricular premature contraction
5393577|NCT01750749|Venous ulcer|venous ulcer
5393578|NCT01750749|Cell therapy|cell therapy
5393579|NCT01750736|Augmented Exercise|augmented exercise
5393580|NCT01750736|Cervicalgia|cervicalgia
5393581|NCT01750736|Manual Therapy|manual therapy
5393582|NCT01750736|Manipulation|manipulation
5393583|NCT01750736|Quantitative Sensory|quantitative sensory
5393584|NCT01750723|Acetazolamide|acetazolamide
5393585|NCT01750723|Headache|headache
5393586|NCT01750723|Migraine|migraine
5376764|NCT01827579|Infection|infection
5393587|NCT01750710|Charcot-Marie-Tooth disease type 1A neuropathy|charcot-marie-tooth disease type 1a neuropathy
5393588|NCT01750710|Isokinetic|isokinetic
5393589|NCT01750710|Electromyography|electromyography
5393590|NCT01750710|Walking|walking
5393591|NCT01750684|Acute|acute
5393592|NCT01750684|Traumatic|traumatic
5393593|NCT01750684|SCI|sci
5393695|NCT01750099|spinal|spinal
5393594|NCT01750684|Spinal Cord Injury|spinal cord injury
5393595|NCT01750671|ICU|icu
5393596|NCT01750671|Body composition|body composition
5393597|NCT01750671|Nutrition|nutrition
5393598|NCT01750671|Survival|survival
5393605|NCT01750593|nodule|nodule
5393606|NCT01750567|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5393607|NCT01750567|untreated CLL patients|untreated cll patients
5393608|NCT01750567|genomic deletion 11q|genomic deletion 11q
5393609|NCT01750554|SpHb; hemoglobin monitoring;bupivacaine digital nerve block|sphb; hemoglobin monitoring;bupivacaine digital nerve block
5393610|NCT01750515|Acupuncture|acupuncture
5393611|NCT01750515|Hepatitis C (HCV)|hepatitis c (hcv)
5393612|NCT01750489|COPD|copd
5393613|NCT01750476|oral contraception|oral contraception
5393614|NCT01750476|Depo-Provera|depo-provera
5393615|NCT01750476|Mirena|mirena
5393616|NCT01750463|Pediatric critically ill|pediatric critically ill
5393617|NCT01750463|Masimo|masimo
5393618|NCT01750463|hemoglobin|hemoglobin
5393619|NCT01750463|monitoring|monitoring
5393620|NCT01750463|UNC|unc
5393621|NCT01750463|PICU|picu
5393628|NCT01750424|Adipose Grafting|adipose grafting
5393629|NCT01750424|3-D imaging|3-d imaging
5393630|NCT01750424|Manchester Scar Scale|manchester scar scale
5393631|NCT01750411|Severe Asthma|severe asthma
5393633|NCT01750398|Testosterone, Leuprolide, Goserelin|testosterone, leuprolide, goserelin
5393634|NCT01750385|Esophageal Achalasia|esophageal achalasia
5381087|NCT01807507|Veins|veins
5393635|NCT01750385|antibiotic prophylaxis|antibiotic prophylaxis
5393636|NCT01750385|blood culture|blood culture
5393637|NCT01750385|procalcitonin levels|procalcitonin levels
5393638|NCT01750372|Artificial limbs|artificial limbs
5393639|NCT01750372|Questionnaires|questionnaires
5393640|NCT01750372|Mobility limitation|mobility limitation
5393641|NCT01750359|antioxidants|antioxidants
5393642|NCT01750359|curcumin|curcumin
5393643|NCT01750359|depression|depression
5393644|NCT01750346|Blepharospasm|blepharospasm
5393645|NCT01750346|Treatment|treatment
5393646|NCT01750346|Dystonia|dystonia
5393647|NCT01750346|Acetyl-Hexapeptide|acetyl-hexapeptide
5393648|NCT01750320|Breast CT|breast ct
5393649|NCT01750320|Biopsy|biopsy
5393650|NCT01750307|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5393651|NCT01750307|Essential fatty acids (EFAs)|essential fatty acids (efas)
5393652|NCT01750307|Electroencephalography (EEG)|electroencephalography (eeg)
5393653|NCT01750307|Event-related potential (ERP)|event-related potential (erp)
5393654|NCT01750307|Omega 3|omega 3
5393655|NCT01750307|Randomised Control Trial|randomised control trial
5393656|NCT01750307|Fish oil|fish oil
5393657|NCT01750307|Supplementation|supplementation
5393658|NCT01750307|Reading|reading
5393659|NCT01750307|Spelling|spelling
5393660|NCT01750307|Behaviour|behaviour
5393661|NCT01750307|Emotional lability|emotional lability
5393662|NCT01750294|hypertension|hypertension
5393663|NCT01750294|kidney disease|kidney disease
5393664|NCT01750281|Mitogen-Activated Protein Kinase Kinase inhibitor|mitogen-activated protein kinase kinase inhibitor
5393665|NCT01750281|Non Small Cell Lung Cancer|non small cell lung cancer
5393666|NCT01750281|Metastatic|metastatic
5393667|NCT01750281|Second line treatment for Non Small Cell Lung Cancer|second line treatment for non small cell lung cancer
5393668|NCT01750268|TBI|tbi
5393669|NCT01750268|hazardous and harmful alcohol use|hazardous and harmful alcohol use
5393670|NCT01750268|veterans|veterans
5393671|NCT01750268|co-occurring disorders|co-occurring disorders
5393672|NCT01750268|pharmacotherapy|pharmacotherapy
5393673|NCT01750255|Pharmaceutical care|pharmaceutical care
5393674|NCT01750255|Pharmacotherapy follow-up|pharmacotherapy follow-up
5393675|NCT01750255|Bipolar disorder|bipolar disorder
5393676|NCT01750255|Pharmacy services|pharmacy services
5393677|NCT01750203|Diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds|diabetic foot ulcers, venous leg ulcers, pressure sores, acute wounds
5393678|NCT01750190|anemia|anemia
5393679|NCT01750190|chronic kidney disease (CKD)|chronic kidney disease (ckd)
5393680|NCT01750190|non-dialysis|non-dialysis
5393681|NCT01750190|Hemoglobin (Hb)|hemoglobin (hb)
5393682|NCT01750190|End-Stage Renal Disease|end-stage renal disease
5393683|NCT01750190|erythropoeitin|erythropoeitin
5393684|NCT01750190|ASP1517|asp1517
5393685|NCT01750190|erythropoeisis stimulating-agent|erythropoeisis stimulating-agent
5393686|NCT01750190|AZD9941|azd9941
5393688|NCT01750125|Doppler|doppler
5393689|NCT01750112|Pectus excavatum|pectus excavatum
5393690|NCT01750112|funnel chest|funnel chest
5393691|NCT01750112|sunken chest|sunken chest
5393692|NCT01750099|Labor|labor
5393693|NCT01750099|analgesia|analgesia
5393694|NCT01750099|epidural|epidural
5393696|NCT01750086|osteoporosis|osteoporosis
5393697|NCT01750086|postmenopausal|postmenopausal
5393698|NCT01750086|denosumab|denosumab
5393699|NCT01750086|teriparatide|teriparatide
5393700|NCT01750086|alendronate|alendronate
5393701|NCT01750086|Forteo®|forteo®
5393702|NCT01750086|Prolia®|prolia®
5393703|NCT01750047|pain perception|pain perception
5393704|NCT01750047|postoperative pain|postoperative pain
5393705|NCT01750047|demography|demography
5393706|NCT01750047|smoking|smoking
5393707|NCT01750047|alcohol|alcohol
5393708|NCT01750034|Burns|burns
5393709|NCT01750034|Wounds and injuries|wounds and injuries
5393710|NCT01750034|Bandages|bandages
5393711|NCT01750008|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5393712|NCT01750008|Menorrhagia|menorrhagia
5393713|NCT01750008|Heavy Bleeding|heavy bleeding
5393714|NCT01750008|Myomas|myomas
5393715|NCT01750008|Radiofrequency Ablation|radiofrequency ablation
5393716|NCT01750008|RFA|rfa
5393717|NCT01750008|Leiomyoma|leiomyoma
5393718|NCT01750008|Fibroids|fibroids
5393719|NCT01749995|Elderly cancer patients|elderly cancer patients
5393721|NCT01749995|Cognitive impairment|cognitive impairment
5393722|NCT01749995|Freund Clock Drawing Test|freund clock drawing test
5393723|NCT01749982|arsenic|arsenic
5393724|NCT01749982|Bangladesh|bangladesh
5393725|NCT01749982|choline|choline
5393726|NCT01749982|betaine|betaine
5393727|NCT01749982|methylation|methylation
5393728|NCT01749956|Rectal Cancer|rectal cancer
5393729|NCT01749956|Chemoradiation|chemoradiation
5393730|NCT01749956|Aflibercept|aflibercept
5393731|NCT01749956|Surgery|surgery
5393732|NCT01749930|Intraocular pressure|intraocular pressure
5393733|NCT01749917|Parkinson.|parkinson.
5393734|NCT01749917|Dexterity.|dexterity.
5393735|NCT01749917|Balance.|balance.
5393736|NCT01749917|Exercises.|exercises.
5393737|NCT01749904|Intraocular pressure|intraocular pressure
5393738|NCT01749891|Age Related Wet Macular Degeneration|age related wet macular degeneration
5393739|NCT01749826|Inflammation, opioids, immune system|inflammation, opioids, immune system
5393740|NCT01749813|Carbohydrate Specific Diet|carbohydrate specific diet
5393741|NCT01749813|Crohn's Disease|crohn's disease
5393742|NCT01749813|Immunomodulators|immunomodulators
5393744|NCT01749800|Attention deficits|attention deficits
5393745|NCT01749800|Upper extremity weakness|upper extremity weakness
5393746|NCT01749787|arthritis|arthritis
5393747|NCT01749787|rheumatoid|rheumatoid
5393748|NCT01749787|methotrexate|methotrexate
5393749|NCT01749787|leflunomide|leflunomide
5393750|NCT01749774|Physical activity|physical activity
5393751|NCT01749774|Testicular cancer|testicular cancer
5393752|NCT01749774|Chemotherapy|chemotherapy
5393753|NCT01749774|Feasibility|feasibility
5393754|NCT01749761|IDH, intradialytic hypotension,|idh, intradialytic hypotension,
5393755|NCT01749761|hypotension on hemodialysis,|hypotension on hemodialysis,
5393756|NCT01749761|hemodialysis,|hemodialysis,
5393757|NCT01749761|Blood pressure guided biofeedback|blood pressure guided biofeedback
5393758|NCT01749748|Breast diseases|breast diseases
5393759|NCT01749748|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5393760|NCT01749722|Colorectal Cancer|colorectal cancer
5393761|NCT01749722|Polyp|polyp
5393762|NCT01749722|Adenoma|adenoma
5393763|NCT01749722|Detection Rate|detection rate
5393764|NCT01749722|Colonoscopy|colonoscopy
5393765|NCT01749722|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
5393766|NCT01749722|NaviAid™ G-Eye system|naviaid™ g-eye system
5393767|NCT01749722|G-Eye procedure|g-eye procedure
5393768|NCT01749722|G-Eye system|g-eye system
5393769|NCT01749709|Stroke|stroke
5393770|NCT01749709|Recovery|recovery
5393771|NCT01749709|Music|music
5393772|NCT01749696|Pelvic organ prolapse|pelvic organ prolapse
5393773|NCT01749696|Connective tissue|connective tissue
5393774|NCT01749696|Elastin|elastin
5393775|NCT01749696|Collagen|collagen
5393776|NCT01749670|Autism Spectrum Disorder|autism spectrum disorder
5393777|NCT01749670|Exosomal miRNA expression|exosomal mirna expression
5393778|NCT01749657|biomechanics|biomechanics
5393779|NCT01749657|outcomes|outcomes
5393780|NCT01749657|foot|foot
5393781|NCT01749657|orthotic device|orthotic device
5393782|NCT01749644|Cystic Fibrosis, Chronic Pseudomonas Infection, Inhaled Tobramycin|cystic fibrosis, chronic pseudomonas infection, inhaled tobramycin
5393783|NCT01749631|Patients suspected to have difficult intubation|patients suspected to have difficult intubation
5393784|NCT01749631|Intratracheal intubation|intratracheal intubation
5393785|NCT01749631|Difficult to intubate|difficult to intubate
5393786|NCT01749618|Seronegative Inflammatory Arthritis|seronegative inflammatory arthritis
5393787|NCT01749618|SpA|spa
5393788|NCT01749618|PsA|psa
5393789|NCT01749618|Randomized|randomized
5393790|NCT01749618|Behavioural Change|behavioural change
5393791|NCT01749592|hearing loss|hearing loss
5393792|NCT01749592|cochlear implant|cochlear implant
5393793|NCT01749592|PET|pet
5393794|NCT01749592|EEG|eeg
5393795|NCT01749592|MEG|meg
5393796|NCT01749579|propofol|propofol
5393797|NCT01749579|midazolam|midazolam
5393798|NCT01749579|duration of recovery|duration of recovery
5393799|NCT01749579|emergency procedure|emergency procedure
5393800|NCT01749566|HIV/AIDS, preexposure prophylaxis, women's health|hiv/aids, preexposure prophylaxis, women's health
5393801|NCT01749527|24-hour pad test|24-hour pad test
5393802|NCT01749527|Activity|activity
5393803|NCT01749527|Stress urinary incontinence|stress urinary incontinence
5393804|NCT01749514|Myelodysplastic Syndrome|myelodysplastic syndrome
5393805|NCT01749488|Dietitian|dietitian
5393806|NCT01749488|Nutritional recommendations|nutritional recommendations
5393807|NCT01749488|ICU nutrition|icu nutrition
5393808|NCT01749462|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5393809|NCT01749462|COPD,|copd,
5393810|NCT01749462|Oxis,|oxis,
5393811|NCT01749449|high protein|high protein
5393812|NCT01749449|high carbohydrate|high carbohydrate
5393813|NCT01749449|meal frequency|meal frequency
5393814|NCT01749449|abdominal body fat|abdominal body fat
5393815|NCT01749449|postprandial thermogenesis|postprandial thermogenesis
5393816|NCT01749436|Atelectasis|atelectasis
5393817|NCT01749436|Pneumoperitoneum|pneumoperitoneum
5393818|NCT01749436|Hypoxemia|hypoxemia
5393823|NCT01749371|Isoprostanes|isoprostanes
5393824|NCT01749371|Lung Dysfunction|lung dysfunction
5393825|NCT01749371|Wound Healing|wound healing
5393826|NCT01749358|stroke|stroke
5393827|NCT01749358|hemiparesis|hemiparesis
5393828|NCT01749358|physical therapy|physical therapy
5393829|NCT01749358|occupational therapy|occupational therapy
5393830|NCT01749358|neurorehabilitation|neurorehabilitation
5393831|NCT01749358|patient focused|patient focused
5393832|NCT01749358|motor learning|motor learning
5393833|NCT01749358|motor control|motor control
5393834|NCT01749358|skill acquisition|skill acquisition
5393835|NCT01749358|skill training|skill training
5393836|NCT01749358|motor recovery|motor recovery
5393837|NCT01749358|task oriented training|task oriented training
5393838|NCT01749358|task specific training|task specific training
5393839|NCT01749358|arm function|arm function
5393840|NCT01749358|hand function|hand function
5393841|NCT01749358|upper extremity|upper extremity
5393843|NCT01749358|physical rehabilitation|physical rehabilitation
5393844|NCT01749358|arm rehabilitation|arm rehabilitation
5393845|NCT01749358|motor function|motor function
5393846|NCT01749332|blood draw|blood draw
5393847|NCT01749332|Perihepatic Phlebotomy|perihepatic phlebotomy
5393848|NCT01749332|12-236|12-236
5393849|NCT01749319|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral|baclofen, withdrawal, interuption, spasticity, pharmacokinetics, tolerability, intravenous, oral
5393850|NCT01749306|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, Dermagraft|epidermolysis bullosa, chronic wound, wound healing, dermal repair, fibroblasts, dermagraft
5393851|NCT01749280|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5393852|NCT01749280|MRI|mri
5393853|NCT01749280|USPIO|uspio
5393854|NCT01749267|dentin remineralization|dentin remineralization
5393855|NCT01749267|caries regression|caries regression
5393856|NCT01749254|Culprit plaques|culprit plaques
5393857|NCT01749254|Vulnerable Plaques|vulnerable plaques
5393858|NCT01749254|PET|pet
5393859|NCT01749254|calcification|calcification
5393860|NCT01749254|inflammation|inflammation
5393861|NCT01749228|Fed|fed
5393862|NCT01749215|pharmacotherapy|pharmacotherapy
5393863|NCT01749215|alcohol dependence|alcohol dependence
5393864|NCT01749215|Veterans|veterans
5393865|NCT01749202|Omega 3 fatty acids|omega 3 fatty acids
5393866|NCT01749202|Omega 3 Index|omega 3 index
5393867|NCT01749202|Stearidonic acid (SDA)|stearidonic acid (sda)
5393868|NCT01749202|Red Blood Cells|red blood cells
5393869|NCT01749202|Lipids|lipids
5393870|NCT01749189|soy|soy
5393871|NCT01749189|whey|whey
5393872|NCT01749189|casein|casein
5393873|NCT01749189|muscle|muscle
5393874|NCT01749189|strength|strength
5393875|NCT01749189|protein|protein
5393876|NCT01749176|High risk Latino patients with diabetes|high risk latino patients with diabetes
5393877|NCT01749137|Overweight|overweight
5393878|NCT01749124|mental illness|mental illness
5393879|NCT01749124|depression|depression
5393880|NCT01749124|schizophrenia|schizophrenia
5393881|NCT01749124|bipolar disorder|bipolar disorder
5393882|NCT01749124|IVR|ivr
5393883|NCT01749124|automated|automated
5393884|NCT01749124|telephone|telephone
5393885|NCT01749111|bone marrow transplantation|bone marrow transplantation
5393886|NCT01749111|graft versus host disease|graft versus host disease
5393887|NCT01749111|Acute myelogenous leukemia|acute myelogenous leukemia
5393888|NCT01749111|Acute lymphoid leukemia|acute lymphoid leukemia
5393889|NCT01749111|Myeloproliferative disease|myeloproliferative disease
5393890|NCT01749111|Myelodysplastic syndrome|myelodysplastic syndrome
5393891|NCT01749111|Chronic myeloid leukemia|chronic myeloid leukemia
5393892|NCT01749111|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5393893|NCT01749098|PF-04958242|pf-04958242
5393894|NCT01749098|ketamine|ketamine
5393895|NCT01749098|cognition|cognition
5393896|NCT01749098|healthy volunteers|healthy volunteers
5393897|NCT01749085|PF-04449913|pf-04449913
5393898|NCT01749085|Food Effect|food effect
5393899|NCT01749085|Drug-drug interaction|drug-drug interaction
5393900|NCT01749085|CYP3A4 inhibitor|cyp3a4 inhibitor
5393901|NCT01749085|Pharmacokinetics|pharmacokinetics
5393902|NCT01749072|non small cell lung cancer|non small cell lung cancer
5393903|NCT01749072|chemotherapy|chemotherapy
5393904|NCT01749072|gefitinib|gefitinib
5393905|NCT01749072|vinorelbine|vinorelbine
5393906|NCT01749072|ifosfamide|ifosfamide
5393907|NCT01749046|Epileptic seizures, Partial seizures|epileptic seizures, partial seizures
5393908|NCT01749033|Intubation|intubation
5393909|NCT01749033|Airway|airway
5393910|NCT01749033|Laryngeal Mask Airway|laryngeal mask airway
5393911|NCT01749020|Diabetes type II, Insulin sensitivity|diabetes type ii, insulin sensitivity
5393912|NCT01749007|Veterans|veterans
5393913|NCT01749007|HIV|hiv
5393914|NCT01749007|AIDS|aids
5393915|NCT01749007|Cognitive Functioning|cognitive functioning
5393917|NCT01748994|Obesity|obesity
5393918|NCT01748994|Fat distribution|fat distribution
5393919|NCT01748994|Adipogenesis|adipogenesis
5393920|NCT01748994|Adipocyte|adipocyte
5393921|NCT01748994|Preadipocyte|preadipocyte
5393922|NCT01748994|Ectopic fat|ectopic fat
5393923|NCT01748981|Pulmonary function|pulmonary function
5393924|NCT01748981|Maximal oxygen uptake|maximal oxygen uptake
5393925|NCT01748981|Cardiorespiratory fitness|cardiorespiratory fitness
5393926|NCT01748981|High-intensity training|high-intensity training
5393927|NCT01748981|Surgery|surgery
5393928|NCT01748968|Veterans|veterans
5393929|NCT01748968|Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)|human immunodeficiency virus infection(hiv)/acquired immunodeficiency syndrome (aids)
5393930|NCT01748968|Self-Directed Violence|self-directed violence
5393931|NCT01748955|Major Depressive Disorder|major depressive disorder
5393932|NCT01748955|MDD|mdd
5393933|NCT01748955|Reward|reward
5393934|NCT01748955|BOLD signal|bold signal
5393935|NCT01748955|Suicide|suicide
5393937|NCT01748929|Deworming|deworming
5393938|NCT01748929|Postpartum|postpartum
5393939|NCT01748929|Soil-Transmitted Helminths|soil-transmitted helminths
5393940|NCT01748929|Pregnant Women|pregnant women
5393941|NCT01748916|Papaya|papaya
5393942|NCT01748916|Carrot|carrot
5393943|NCT01748916|Tomato|tomato
5393944|NCT01748916|Carotenoids|carotenoids
5393945|NCT01748916|Lycopene|lycopene
5393946|NCT01748916|Beta-carotene|beta-carotene
5393947|NCT01748916|Beta-cryptoxanthin|beta-cryptoxanthin
5393948|NCT01748903|intracranial aneurysm|intracranial aneurysm
5393949|NCT01748903|cerebral aneurysm|cerebral aneurysm
5393950|NCT01748903|packing density|packing density
5393951|NCT01748903|Target Coils|target coils
5393952|NCT01748903|aneurysm embolization|aneurysm embolization
5393953|NCT01748877|shingles,|shingles,
5393954|NCT01748877|neuropathic pain|neuropathic pain
5393955|NCT01748877|post herpetic neuralgia|post herpetic neuralgia
5393956|NCT01748877|sleep|sleep
5393957|NCT01748864|Volunteers|volunteers
5393958|NCT01748825|MK-1775|mk-1775
5393959|NCT01748825|Refractory|refractory
5393960|NCT01748825|Solid Tumors|solid tumors
5393961|NCT01748825|Wee1 Inhibitor|wee1 inhibitor
5393962|NCT01748825|Tyrosine Kinase|tyrosine kinase
5393963|NCT01748812|Tumor Induced Osteomalacia|tumor induced osteomalacia
5393964|NCT01748812|Hypophosphatemic Rickets|hypophosphatemic rickets
5393965|NCT01748799|Cannabis dependence|cannabis dependence
5393966|NCT01748799|Sativex|sativex
5393967|NCT01748786|Fibromyalgia|fibromyalgia
5393968|NCT01748786|Mindfulness|mindfulness
5393969|NCT01748786|On-line intervention|on-line intervention
5393970|NCT01748786|Chronic pain|chronic pain
5393971|NCT01748760|Suicide Attempts|suicide attempts
5393972|NCT01748760|Suicidal Ideation|suicidal ideation
5393973|NCT01748734|Depression|depression
5393974|NCT01748708|Magnetic seizure therapy|magnetic seizure therapy
5393975|NCT01748708|Electroconvulsive therapy|electroconvulsive therapy
5393976|NCT01748708|Treatment resistant depression|treatment resistant depression
5393977|NCT01748708|Treatment resistance|treatment resistance
5393978|NCT01748708|Randomized controlled trial|randomized controlled trial
5393979|NCT01748695|Neuropathic pain|neuropathic pain
5393980|NCT01748695|Spinal cord injury|spinal cord injury
5393981|NCT01748682|Very low calorie diet|very low calorie diet
5393982|NCT01748682|liquid diet|liquid diet
5393983|NCT01748682|visceral fat|visceral fat
5393984|NCT01748682|liver fat.|liver fat.
5393985|NCT01748669|Arsenic|arsenic
5393986|NCT01748669|Arsenicosis|arsenicosis
5393987|NCT01748669|Garlic oil|garlic oil
5393988|NCT01748669|Keratosis|keratosis
5393989|NCT01748656|Noninvasive ventilation|noninvasive ventilation
5393990|NCT01748656|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5393991|NCT01748630|scoliosis, sedation, children, fentanyl consumption, pain|scoliosis, sedation, children, fentanyl consumption, pain
5393992|NCT01748604|Lymphedema|lymphedema
5393993|NCT01748604|Physical Therapies|physical therapies
5393994|NCT01748604|Randomized controlled study|randomized controlled study
5393995|NCT01748604|Decongestive lymphatic therapy|decongestive lymphatic therapy
5393996|NCT01748604|Manual lymph drainage|manual lymph drainage
5393997|NCT01748604|Intermittent pneumatic compression|intermittent pneumatic compression
5394498|NCT01746407|Sepsis|sepsis
5393998|NCT01748604|Multilayer bandages|multilayer bandages
5394000|NCT01748578|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
5394001|NCT01748578|Dry Eye|dry eye
5394002|NCT01748565|biomarkers|biomarkers
5377170|NCT01825694|Substance Abuse|substance abuse
5394003|NCT01748565|oxidative stress|oxidative stress
5394004|NCT01748565|BPD|bpd
5394005|NCT01748565|prematurity|prematurity
5394006|NCT01748526|Healthy|healthy
5394007|NCT01748526|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5394008|NCT01748526|Pharmacokinetics|pharmacokinetics
5394009|NCT01748526|Pharmacodynamics|pharmacodynamics
5394010|NCT01748526|Indian|indian
5394011|NCT01748513|morbidly obese patients,|morbidly obese patients,
5394012|NCT01748513|preoperative volume-challenge,|preoperative volume-challenge,
5389247|NCT01770990|letter|letter
5394017|NCT01748513|bariatric surgery,|bariatric surgery,
5394018|NCT01748513|left ventricular outflow tract,|left ventricular outflow tract,
5394019|NCT01748513|stroke volume,|stroke volume,
5394020|NCT01748513|diastolic function,|diastolic function,
5394021|NCT01748513|hypervolemia,|hypervolemia,
5394022|NCT01748513|hypovolemia|hypovolemia
5394023|NCT01748500|metastatic|metastatic
5394024|NCT01748461|intervention study in elderly (65+)|intervention study in elderly (65+)
5394025|NCT01748461|cycle ergometer|cycle ergometer
5394026|NCT01748461|physical activity|physical activity
5394027|NCT01748461|physical fitness|physical fitness
5394028|NCT01748461|assisted living facility|assisted living facility
5394029|NCT01748448|Cutaneous malignant melanoma|cutaneous malignant melanoma
5394031|NCT01748448|Cholecalciferol|cholecalciferol
5394032|NCT01748435|Neuropathic pain|neuropathic pain
5394033|NCT01748435|Lower limb amputation|lower limb amputation
5394034|NCT01748435|Pre-emptive analgesia|pre-emptive analgesia
5394035|NCT01748422|Neuropathic pain|neuropathic pain
5394036|NCT01748422|Arteriovenous fistulae|arteriovenous fistulae
5394037|NCT01748422|End stage renal disease|end stage renal disease
5394038|NCT01748409|Autonomic failure, Parkinson's disease, electrophysiological assessment, neuropathological assessment|autonomic failure, parkinson's disease, electrophysiological assessment, neuropathological assessment
5394039|NCT01748396|FGF-23|fgf-23
5394040|NCT01748396|Calcitriol|calcitriol
5394041|NCT01748396|Calcium carbonate|calcium carbonate
5394042|NCT01748396|CKD Stage 3|ckd stage 3
5394043|NCT01748383|Bone marrow cells|bone marrow cells
5394044|NCT01748383|Acute myocardial infarction|acute myocardial infarction
5394045|NCT01748383|Transplantation of autologous mononuclear|transplantation of autologous mononuclear
5394046|NCT01748383|Transplantation of autologous CD133 + cells|transplantation of autologous cd133 + cells
5394047|NCT01748370|vitamin D|vitamin d
5394048|NCT01748370|hypogonadism|hypogonadism
5394049|NCT01748370|testosterone|testosterone
5394050|NCT01748370|intervention|intervention
5394051|NCT01748357|Tuberculosis|tuberculosis
5394052|NCT01748357|Volatile organic compounds|volatile organic compounds
5394053|NCT01748357|exhaled breath|exhaled breath
5394054|NCT01748357|Siemens|siemens
5394055|NCT01748331|Heart Failure|heart failure
5394056|NCT01748331|Hyponatremia|hyponatremia
5394057|NCT01748331|Fluid restriction|fluid restriction
5394058|NCT01748318|Community acquired MRSA|community acquired mrsa
5394059|NCT01748318|New Mexico Honey|new mexico honey
5394060|NCT01748305|GDM|gdm
5394061|NCT01748305|A1GDM|a1gdm
5394062|NCT01748305|A2GDM|a2gdm
5394063|NCT01748292|Age related|age related
5394064|NCT01748292|Macular|macular
5394065|NCT01748292|sub retinal fluid|sub retinal fluid
5394066|NCT01748292|Age related Macular degeneration|age related macular degeneration
5394067|NCT01748279|COPD|copd
5394068|NCT01748279|Atorvastatin|atorvastatin
5394069|NCT01748279|statins|statins
5394070|NCT01748279|COPD treatment|copd treatment
5394071|NCT01748279|microarrays|microarrays
5394072|NCT01748266|StO2|sto2
5394073|NCT01748266|microcirculation|microcirculation
5394074|NCT01748266|NIRS|nirs
5394075|NCT01748227|self-management|self-management
5394076|NCT01748227|peer support|peer support
5394077|NCT01748227|social support|social support
5394078|NCT01748214|continuous positive airway pressure|continuous positive airway pressure
5394079|NCT01748214|high flow nasal cannula|high flow nasal cannula
5394080|NCT01748214|hearing outcomes|hearing outcomes
5394081|NCT01748214|noise exposure|noise exposure
5394082|NCT01748214|preterm infants|preterm infants
5394083|NCT01748201|Osteoarthritis|osteoarthritis
5394084|NCT01748201|Hemarthrosis|hemarthrosis
5394085|NCT01748201|Hemophilia A|hemophilia a
5394086|NCT01748201|Hemophilia B|hemophilia b
5394087|NCT01748201|Viscosupplementation|viscosupplementation
5394088|NCT01748188|Subacromial syndrome|subacromial syndrome
5394089|NCT01748188|Dexketoprofen|dexketoprofen
5394090|NCT01748188|Phonophoresis|phonophoresis
5394091|NCT01748188|Iontophoresis|iontophoresis
5394092|NCT01748188|Ultrasounds|ultrasounds
5394093|NCT01748188|VAS|vas
5394094|NCT01748188|DASH score|dash score
5394095|NCT01748188|Constant score|constant score
5394096|NCT01748175|Severe asthma|severe asthma
5394097|NCT01748175|longitudinal study|longitudinal study
5394098|NCT01748175|phenotypes|phenotypes
5394099|NCT01748162|croup|croup
5394100|NCT01748162|recurrent croup|recurrent croup
5394101|NCT01748162|barky cough|barky cough
5394102|NCT01748149|recurrent/refractory BRAFV600E-mutant gliomas|recurrent/refractory brafv600e-mutant gliomas
5394103|NCT01748149|pediatrics|pediatrics
5394104|NCT01748149|children|children
5394105|NCT01748149|neo-adjuvant vemurafenib|neo-adjuvant vemurafenib
5394106|NCT01748123|Pragmatic|pragmatic
5394107|NCT01748123|Comparative Effectiveness|comparative effectiveness
5394108|NCT01748110|quality of life|quality of life
5394110|NCT01748097|infiltration|infiltration
5394111|NCT01748097|extravasation|extravasation
5394112|NCT01748097|sodium bicarbonate|sodium bicarbonate
5394113|NCT01748097|capnography|capnography
5394114|NCT01748097|end tidal carbon dioxide|end tidal carbon dioxide
5394115|NCT01748097|chemotherapy|chemotherapy
5394116|NCT01748084|Systemic sclerosis|systemic sclerosis
5394117|NCT01748084|Arthritis|arthritis
5394118|NCT01748084|B-cell therapy, Anti-CD20 therapy|b-cell therapy, anti-cd20 therapy
5394119|NCT01748084|Quality of life|quality of life
5394120|NCT01748084|Scleroderma|scleroderma
5394121|NCT01748084|Lung fibrosis|lung fibrosis
5394122|NCT01748084|Randomised controled trial|randomised controled trial
5394123|NCT01748071|fentanyl|fentanyl
5394124|NCT01748071|sufentanil|sufentanil
5394125|NCT01748071|individual variation|individual variation
5394126|NCT01748071|pain threshold|pain threshold
5394127|NCT01748071|nacro-trend index|nacro-trend index
5394128|NCT01748045|Inhaled Nitric Oxide|inhaled nitric oxide
5394129|NCT01748045|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5394130|NCT01748045|Late Prematurity|late prematurity
5394131|NCT01748045|Chronic Respiratory Morbidity|chronic respiratory morbidity
5394132|NCT01748032|depression|depression
5394133|NCT01748032|intervention studies|intervention studies
5394134|NCT01748019|ST1968|st1968
5394135|NCT01748019|Camptothecin|camptothecin
5394136|NCT01748019|Solid tumors|solid tumors
5002923|NCT03977818|patterns of care|patterns of care
5394137|NCT01748019|Topoisomerase I|topoisomerase i
5394138|NCT01747993|Urinary retention; urinary catheterization; alpha blocking agents; women; elder|urinary retention; urinary catheterization; alpha blocking agents; women; elder
5394139|NCT01747980|Gaucher disease|gaucher disease
5394140|NCT01747980|human glucocerebrosidase|human glucocerebrosidase
5394141|NCT01747980|plant recombinant human glucocerebrosidase|plant recombinant human glucocerebrosidase
5394142|NCT01747967|Antibodies|antibodies
5394143|NCT01747967|Beta cells|beta cells
5394144|NCT01747967|C-peptide|c-peptide
5394146|NCT01747967|Glucose|glucose
5394147|NCT01747967|Glycemia|glycemia
5394148|NCT01747967|Insulin|insulin
5394149|NCT01747967|Meal test|meal test
5394150|NCT01747967|Pancreas|pancreas
5394151|NCT01747967|Proinsulin,|proinsulin,
5394152|NCT01747967|T lymphocytes|t lymphocytes
5394153|NCT01747954|Respiratory Insufficiency|respiratory insufficiency
5394154|NCT01747954|Physiotherapy Techniques|physiotherapy techniques
5394155|NCT01747954|Respiratory Mechanics|respiratory mechanics
5394156|NCT01747928|usability study|usability study
5394157|NCT01747915|Primary Generalized Tonic Clonic Seizures|primary generalized tonic clonic seizures
5394158|NCT01747915|Epilepsy|epilepsy
5394159|NCT01747915|Safety|safety
5394160|NCT01747915|Efficacy|efficacy
5394161|NCT01747915|Tolerability|tolerability
5394162|NCT01747915|Pregabalin|pregabalin
5394163|NCT01747915|Lyrica|lyrica
5394164|NCT01747915|Adjunctive treatment|adjunctive treatment
5394165|NCT01747915|Placebo Controlled|placebo controlled
5394166|NCT01747915|Blinded|blinded
5394167|NCT01747889|chest tube|chest tube
5394168|NCT01747889|lung resection|lung resection
5394169|NCT01747889|patient satisfaction|patient satisfaction
5394170|NCT01747889|mobility|mobility
5394171|NCT01747876|LEE011|lee011
5394172|NCT01747876|Phase 1|phase 1
5394173|NCT01747876|pediatric|pediatric
5394174|NCT01747876|CDK4/6 inhibitor|cdk4/6 inhibitor
5394175|NCT01747876|dose escalation|dose escalation
5394176|NCT01747876|malignant rhabdoid tumors|malignant rhabdoid tumors
5394177|NCT01747876|MRT|mrt
5394178|NCT01747876|neuroblastoma|neuroblastoma
5394179|NCT01747863|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
5394180|NCT01747837|Renal sympathetic denervation|renal sympathetic denervation
5394181|NCT01747837|Renal catheter ablation|renal catheter ablation
5394182|NCT01747837|Ventricular tachycardia|ventricular tachycardia
5394183|NCT01747824|agitation|agitation
5394184|NCT01747824|excited delirium|excited delirium
5394185|NCT01747824|pain|pain
5394186|NCT01747824|unexplained-in-custody-death|unexplained-in-custody-death
5394187|NCT01747824|UICD|uicd
5394188|NCT01747824|visual analog scale|visual analog scale
5394189|NCT01747824|VAS|vas
5394190|NCT01747824|altered mental status|altered mental status
5394191|NCT01747824|AMS|ams
5394192|NCT01747811|Mild traumatic brain injury|mild traumatic brain injury
5394193|NCT01747811|Concussion|concussion
5394194|NCT01747811|Sleep problems|sleep problems
5394195|NCT01747811|brain imaging|brain imaging
5394196|NCT01747811|functional magnetic resonance imaging (FMRI)|functional magnetic resonance imaging (fmri)
5394197|NCT01747785|Heart failure|heart failure
5394198|NCT01747785|HFpEF|hfpef
5394199|NCT01747785|Dyspnea|dyspnea
5394200|NCT01747785|Fatigue|fatigue
5394201|NCT01747785|Shortness of Breath|shortness of breath
5394202|NCT01747785|exercise|exercise
5394203|NCT01747785|strain|strain
5394204|NCT01747785|myocardial deformation|myocardial deformation
5394205|NCT01747785|cardiac rehabilitation|cardiac rehabilitation
5394206|NCT01747785|cardiac hemodynamics|cardiac hemodynamics
5394207|NCT01747772|Non-focal Liver Disease|non-focal liver disease
5394208|NCT01747772|Fibrosis|fibrosis
5389480|NCT01769937|SLE|sle
5394216|NCT01747746|Rivaroxaban|rivaroxaban
5394217|NCT01747746|Warfarin|warfarin
5394218|NCT01747746|Anticoagulation|anticoagulation
5394219|NCT01747746|Stroke|stroke
5394220|NCT01747746|Thrombo-embolism|thrombo-embolism
5394221|NCT01747746|Bleeding|bleeding
5394222|NCT01747746|Atrial Fibrillation|atrial fibrillation
5394223|NCT01747746|Cardioversion|cardioversion
5394224|NCT01747733|Endoscopy|endoscopy
5394225|NCT01747733|ERCP|ercp
5394227|NCT01747733|Sedation|sedation
5394228|NCT01747733|Bispectral index|bispectral index
5394229|NCT01747720|breast cancer|breast cancer
5394230|NCT01747720|mammographic breast density|mammographic breast density
5394231|NCT01747720|vitamin D|vitamin d
5394232|NCT01747720|prevention|prevention
5394233|NCT01747720|randomized controlled trial|randomized controlled trial
5394234|NCT01747707|gastric cancer|gastric cancer
5394235|NCT01747707|gastroesophageal junction cancer|gastroesophageal junction cancer
5394236|NCT01747707|chemotherapy|chemotherapy
5394237|NCT01747707|docetaxel|docetaxel
5394238|NCT01747707|cisplatin|cisplatin
5394239|NCT01747707|S-1|s-1
5394240|NCT01747694|COPD,Respiratory muscle training,Exercise tolerance|copd,respiratory muscle training,exercise tolerance
5394241|NCT01747681|chondral defect|chondral defect
5394242|NCT01747681|microfracture|microfracture
5394243|NCT01747681|arthroscopy|arthroscopy
5381689|NCT01804686|PCI-32765|pci-32765
5394244|NCT01747681|cartilage repair|cartilage repair
5394245|NCT01747681|outcome study|outcome study
5394246|NCT01747681|Lysholm score|lysholm score
5394247|NCT01747668|Mother and Infant Pairs|mother and infant pairs
5394248|NCT01747655|Early Observational Advanced|early observational advanced
5394249|NCT01747655|Parkinson's Disease|parkinson's disease
5394250|NCT01747642|Hepatocellular carcinoma|hepatocellular carcinoma
5394251|NCT01747642|Oncoxin|oncoxin
5394252|NCT01747642|Surafenib|surafenib
5394253|NCT01747629|Asthma|asthma
5394254|NCT01747629|dry powder inhaler|dry powder inhaler
5394255|NCT01747629|short-acting beta2-agonist|short-acting beta2-agonist
5394256|NCT01747629|SABA|saba
5394257|NCT01747629|bronchoconstriction|bronchoconstriction
5394258|NCT01747629|bronchodilation|bronchodilation
5394259|NCT01747629|bronchodilator|bronchodilator
5394260|NCT01747629|metered dose inhaler|metered dose inhaler
5394261|NCT01747629|Albuterol Spiromax®|albuterol spiromax®
5394262|NCT01747616|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
5394263|NCT01747616|contact lenses|contact lenses
5394264|NCT01747616|safety and tolerability|safety and tolerability
5394265|NCT01747603|Late preterm infant|late preterm infant
5394266|NCT01747603|Complications|complications
5394267|NCT01747603|Hospital readmissions|hospital readmissions
5394268|NCT01747603|Follow-up|follow-up
5394269|NCT01747603|Pilot study|pilot study
5394270|NCT01747577|Muscarine antagonist|muscarine antagonist
5394271|NCT01747577|Prostatectomy|prostatectomy
5394272|NCT01747577|Uroflowmetry|uroflowmetry
5394273|NCT01747564|Pharmacokinetics|pharmacokinetics
5394274|NCT01747564|Mirabegron|mirabegron
5394275|NCT01747564|Phase 1|phase 1
5394276|NCT01747564|YM178|ym178
5394277|NCT01747551|Advanced|advanced
5394278|NCT01747538|Uveitis|uveitis
5394279|NCT01747538|Non-infectious Uveitis|non-infectious uveitis
5394280|NCT01747538|Intermediate Uveitis|intermediate uveitis
5394281|NCT01747538|Posterior Uveitis|posterior uveitis
5394282|NCT01747538|Panuveitis|panuveitis
5394283|NCT01747512|99mTc Pertechnetate|99mtc pertechnetate
5394284|NCT01747512|thyroidectomy|thyroidectomy
5394285|NCT01747512|thyroid neoplasms|thyroid neoplasms
5394286|NCT01747473|Subjects|subjects
5394287|NCT01747460|Subjects|subjects
5394288|NCT01747408|subarachnoid hemorrhage|subarachnoid hemorrhage
5394289|NCT01747395|Heart Failure|heart failure
5394290|NCT01747395|Exercise and Physical Fitness|exercise and physical fitness
5394291|NCT01747382|Treatment-resistant Hypertension|treatment-resistant hypertension
5394292|NCT01747382|Chronic Kidney Disease|chronic kidney disease
5394293|NCT01747382|Symplicity catheters|symplicity catheters
5394294|NCT01747382|Renal denervation|renal denervation
5394295|NCT01747369|surveillance study|surveillance study
5394296|NCT01747369|prospective|prospective
5394297|NCT01747369|observational|observational
5394298|NCT01747369|health center-based|health center-based
5394299|NCT01747369|pneumonia, bacterial|pneumonia, bacterial
5394300|NCT01747369|pneumonia, viral|pneumonia, viral
5394301|NCT01747369|meningitis, bacterial|meningitis, bacterial
5389526|NCT01769729|depression|depression
5394302|NCT01747369|Africa south of the Sahara|africa south of the sahara
5394304|NCT01747343|Enuresis|enuresis
5394305|NCT01747330|cystic fibrosis|cystic fibrosis
5394306|NCT01747317|FFR|ffr
5394307|NCT01747317|fractional flow reserve|fractional flow reserve
5394308|NCT01747317|CT|ct
5394309|NCT01747317|Computed Tomography|computed tomography
5394310|NCT01747304|Atypical Femur Fracture|atypical femur fracture
5394311|NCT01747304|DXA|dxa
5394312|NCT01747278|Pneumocystis carinii pneumonia|pneumocystis carinii pneumonia
5394313|NCT01747278|prophylaxis|prophylaxis
5377493|NCT01824017|GSH|gsh
5394314|NCT01747278|trimethoprim/sulfamethoxazole|trimethoprim/sulfamethoxazole
5394315|NCT01747239|Ovarian cancer|ovarian cancer
5394316|NCT01747239|Platinum refractory|platinum refractory
5394317|NCT01747226|Oral malodor|oral malodor
5394318|NCT01747226|Halitosis|halitosis
5394319|NCT01747226|Bad Breath|bad breath
5394320|NCT01747226|Mouth rinses|mouth rinses
5394321|NCT01747226|Mouthwashes|mouthwashes
5394322|NCT01747226|Amine fluoride/Stannous fluoride|amine fluoride/stannous fluoride
5394323|NCT01747226|Zinc ions|zinc ions
5394324|NCT01747226|Chlorhexidine|chlorhexidine
5394325|NCT01747213|Neurodegenerative|neurodegenerative
5394326|NCT01747213|Cholinergic|cholinergic
5394327|NCT01747213|Single Dose|single dose
5394328|NCT01747213|Inhibitor|inhibitor
5394329|NCT01747213|Tolerability|tolerability
5394330|NCT01747213|Clinical Trial|clinical trial
5394331|NCT01747213|Alzheimer Disease|alzheimer disease
5394332|NCT01747213|Healthy Volunteers|healthy volunteers
5394333|NCT01747213|Neurotransmitters|neurotransmitters
5394334|NCT01747200|Repetitive TMS (rTMS)|repetitive tms (rtms)
5394335|NCT01747187|Septic shock|septic shock
5394336|NCT01747187|Critical care|critical care
5394337|NCT01747187|cardiac failure|cardiac failure
5394339|NCT01747174|Microvascular Obstruction|microvascular obstruction
5394340|NCT01747174|No-reflow|no-reflow
5394341|NCT01747174|Adenosine|adenosine
5394342|NCT01747174|Sodium Nitroprusside|sodium nitroprusside
5002924|NCT03977792|Herpes Simplex|herpes simplex
5394344|NCT01747148|Influenza|influenza
5394345|NCT01747148|IV Injection|iv injection
5394346|NCT01747148|RNA Based Therapeutic|rna based therapeutic
5394347|NCT01747148|RNA Interference|rna interference
5394348|NCT01747135|2-Hydroxypropyl-B-Cyclodextrin|2-hydroxypropyl-b-cyclodextrin
5394349|NCT01747135|Niemann-Pick Disease, Type C1|niemann-pick disease, type c1
5394350|NCT01747135|Neurodegeneration|neurodegeneration
5394351|NCT01747122|epidurals|epidurals
5394352|NCT01747122|wound catheters|wound catheters
5394353|NCT01747122|liver resection|liver resection
5394354|NCT01747122|liver surgery|liver surgery
5394355|NCT01747109|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5394356|NCT01747109|Preoxygenation|preoxygenation
5394357|NCT01747109|Crash induction|crash induction
5394358|NCT01747096|Gastroenteropancreatic Neuroendocrine Tumors|gastroenteropancreatic neuroendocrine tumors
5394359|NCT01747096|immuno PET (iPET)|immuno pet (ipet)
5394360|NCT01747096|Gallium (68-Ga)|gallium (68-ga)
5394361|NCT01747096|DOTANOC|dotanoc
5394362|NCT01747070|Electro Acupuncture|electro acupuncture
5394363|NCT01747070|Knee Osteoarthritis|knee osteoarthritis
5394364|NCT01747070|Chronic pain|chronic pain
5394365|NCT01747070|Cortical Excitability|cortical excitability
5394366|NCT01747044|Fibromyalgia|fibromyalgia
5394367|NCT01747044|Diffuse Noxious Inhibitory Controls|diffuse noxious inhibitory controls
5394368|NCT01747044|Milnacipran|milnacipran
5394369|NCT01747031|iFR|ifr
5394370|NCT01747031|FFR|ffr
5394371|NCT01747031|instantaneous wave-free ratio|instantaneous wave-free ratio
5394372|NCT01747031|fractional flow reserve|fractional flow reserve
5394373|NCT01747018|Platelet-Rich Plasma|platelet-rich plasma
5394374|NCT01747018|Knee pain|knee pain
5394375|NCT01747018|osteoarthritis|osteoarthritis
5394376|NCT01747018|degenerative chondropathy|degenerative chondropathy
5394377|NCT01747018|Intraarticular injection|intraarticular injection
5394378|NCT01747005|abdominal hysterectomy|abdominal hysterectomy
5394379|NCT01747005|enhanced recovery after surgery|enhanced recovery after surgery
5394380|NCT01747005|inflammatory response|inflammatory response
5394381|NCT01747005|ERAS|eras
5394382|NCT01747005|combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
5394383|NCT01746979|TH-302|th-302
5394384|NCT01746979|Evofosfamide|evofosfamide
5394385|NCT01746979|Pancreatic Cancer|pancreatic cancer
5394386|NCT01746979|EMR200592-001|emr200592-001
5394387|NCT01746966|gleno-humeral joint synovitis|gleno-humeral joint synovitis
5394388|NCT01746966|anterior shoulder US|anterior shoulder us
5394389|NCT01746966|rotator interval|rotator interval
5394390|NCT01746940|Surgery|surgery
5394391|NCT01746940|Surgeries|surgeries
5394392|NCT01746940|Nasal|nasal
5394393|NCT01746940|Cavities|cavities
5394394|NCT01746940|Diagnosis|diagnosis
5394395|NCT01746940|Diagnostic|diagnostic
5394396|NCT01746940|Nose|nose
5394397|NCT01746940|Rhinoplasty|rhinoplasty
5394398|NCT01746940|Endoscopy|endoscopy
5394399|NCT01746940|Bronchoscopy|bronchoscopy
5394499|NCT01746394|obesity|obesity
5394404|NCT01746875|Photochemotherapy|photochemotherapy
5394405|NCT01746875|Vascular Endothelium Growth Factors|vascular endothelium growth factors
5394407|NCT01746862|Saizen®|saizen®
5394408|NCT01746862|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5394409|NCT01746862|Idiopathic short stature|idiopathic short stature
5394410|NCT01746862|Height velocity|height velocity
5394411|NCT01746862|Bone age|bone age
5394412|NCT01746849|LUPRON DEPOT|lupron depot
5394413|NCT01746849|PALIFERMIN|palifermin
5394414|NCT01746849|12-077|12-077
5394415|NCT01746823|Keratoconus|keratoconus
5394416|NCT01746823|Proteomics|proteomics
5394417|NCT01746810|Metastatic|metastatic
5394418|NCT01746810|Lung Cancer|lung cancer
5394419|NCT01746810|NSCLC|nsclc
5394420|NCT01746797|infertility|infertility
5394421|NCT01746797|depression|depression
5394422|NCT01746797|IVF|ivf
5394423|NCT01746797|IUI|iui
5394424|NCT01746797|fertility treatment|fertility treatment
5394425|NCT01746784|Cystic Fibrosis|cystic fibrosis
5394426|NCT01746784|F508del-CFTR|f508del-cftr
5394427|NCT01746784|N6022|n6022
5380057|NCT01812330|ACS|acs
5394428|NCT01746784|S-Nitrosoglutathione|s-nitrosoglutathione
5394429|NCT01746771|HM781-36B, Paclitaxel, Trastuzumab|hm781-36b, paclitaxel, trastuzumab
5394430|NCT01746758|Reproductive health, mHealth, Cluster randomised trial|reproductive health, mhealth, cluster randomised trial
5394436|NCT01746680|rheumatoid arthritis|rheumatoid arthritis
5394437|NCT01746680|RA|ra
5394438|NCT01746680|tacrolimus|tacrolimus
5394439|NCT01746680|Disease Activity Score 28|disease activity score 28
5394440|NCT01746680|EULAR|eular
5394441|NCT01746667|Social Anxiety Disorder|social anxiety disorder
5394442|NCT01746667|Social Phobia|social phobia
5394443|NCT01746667|Virtual Reality|virtual reality
5394444|NCT01746667|Exposure|exposure
5394445|NCT01746654|S.aureus|s.aureus
5394446|NCT01746654|Methicillin Resistant S.aureus (MRSA)|methicillin resistant s.aureus (mrsa)
5394447|NCT01746654|Nasal carrier status|nasal carrier status
5394448|NCT01746654|Prophylaxis|prophylaxis
5394449|NCT01746641|Remifentanil|remifentanil
5394450|NCT01746641|Propofol|propofol
5394451|NCT01746641|Sedation|sedation
5394452|NCT01746641|Endoscopy|endoscopy
5394453|NCT01746641|Gastroenterology|gastroenterology
5394454|NCT01746641|Target controlled infusion effect site|target controlled infusion effect site
5394455|NCT01746628|type 0 myomata|type 0 myomata
5394456|NCT01746628|type 1 myomata|type 1 myomata
5394457|NCT01746628|type 2 myomata|type 2 myomata
5394458|NCT01746628|bleeding|bleeding
5394459|NCT01746628|hemorrhage|hemorrhage
5394460|NCT01746628|hysteroscopy|hysteroscopy
5394462|NCT01746615|branch retinal vein occlusion|branch retinal vein occlusion
5394463|NCT01746615|dynamic vessel analyzer|dynamic vessel analyzer
5394464|NCT01746615|fourier-domain OCT|fourier-domain oct
5394465|NCT01746615|retinal oxygen saturation|retinal oxygen saturation
5394466|NCT01746602|topical lubricants|topical lubricants
5394467|NCT01746602|tear film thickness|tear film thickness
5394468|NCT01746602|anti-glaucoma drugs|anti-glaucoma drugs
5394469|NCT01746602|break up time|break up time
5394470|NCT01746602|anti-glaucoma treatment|anti-glaucoma treatment
5394471|NCT01746589|LASIK|lasik
5394472|NCT01746576|volunteers|volunteers
5394473|NCT01746563|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5394474|NCT01746563|Ranibizumab|ranibizumab
5394475|NCT01746563|Panretinal Photocoagulation|panretinal photocoagulation
5394476|NCT01746524|Arthroplasty|arthroplasty
5394477|NCT01746524|Replacement|replacement
5394478|NCT01746524|Knee|knee
5394479|NCT01746511|glycerin suppositories|glycerin suppositories
5394480|NCT01746511|glycerin shaves|glycerin shaves
5394481|NCT01746511|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5394482|NCT01746511|idiopathic hyperbilirubinemia|idiopathic hyperbilirubinemia
5394483|NCT01746511|jaundice|jaundice
5394484|NCT01746511|neonatal jaundice|neonatal jaundice
5394485|NCT01746511|prematurity|prematurity
5394486|NCT01746498|Alzheimer disease|alzheimer disease
5394487|NCT01746498|Direct current stimulation|direct current stimulation
5394488|NCT01746498|cognitive function|cognitive function
5394489|NCT01746498|memory|memory
5394490|NCT01746485|Volunteers|volunteers
5394491|NCT01746459|Sustainability of Innovations|sustainability of innovations
5394492|NCT01746459|Knowledge Translation|knowledge translation
5394493|NCT01746459|Gerontology|gerontology
5394494|NCT01746459|Mobility|mobility
5394495|NCT01746420|elbow|elbow
5394496|NCT01746407|Emergency Department|emergency department
5394497|NCT01746407|Infection|infection
5394510|NCT01746355|atypical odontalgia|atypical odontalgia
5394511|NCT01746355|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5394512|NCT01746355|neuropathic pain|neuropathic pain
5394513|NCT01746355|chronic pain|chronic pain
5394514|NCT01746355|assessment|assessment
5394515|NCT01746329|Obesity, insulin resistance, muscle perfusion|obesity, insulin resistance, muscle perfusion
5394516|NCT01746303|Working memory|working memory
5394517|NCT01746303|Long-term memory|long-term memory
5394518|NCT01746303|Neurocognition|neurocognition
5394519|NCT01746303|Dietary supplementation|dietary supplementation
5394520|NCT01746303|dementia|dementia
5423341|NCT01616095|adipose tissue inflammation|adipose tissue inflammation
5423342|NCT01616095|adipokines|adipokines
5394521|NCT01746290|Cardiac Arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones|cardiac arrest, cardiopulmonary resuscitation, automated external defibrillators, smartphones
5394522|NCT01746277|non small cell lung cancer|non small cell lung cancer
5394523|NCT01746277|chemotherapy|chemotherapy
5394524|NCT01746277|epidermal growth factor receptor tyrosine kinase inhibitor|epidermal growth factor receptor tyrosine kinase inhibitor
5394525|NCT01746277|retreatment|retreatment
5394527|NCT01746264|Endothelial dysfunction|endothelial dysfunction
5394528|NCT01746264|Vitamin D deficiency|vitamin d deficiency
5394529|NCT01746251|EGFR mutation|egfr mutation
5394530|NCT01746251|Resected|resected
5394531|NCT01746238|soft tissue|soft tissue
5394532|NCT01746238|high grade|high grade
5394533|NCT01746225|Metastatic|metastatic
5394534|NCT01746225|Breast|breast
5394535|NCT01746225|Cancer|cancer
5394536|NCT01746225|HER2-negative Stage IV|her2-negative stage iv
5394537|NCT01746225|No previous chemotherapy|no previous chemotherapy
5394538|NCT01746212|Degenerative Disc Disease|degenerative disc disease
5394539|NCT01746212|InQu Bone Graft Extender and Substitute|inqu bone graft extender and substitute
5394540|NCT01746212|Anterior Lumbar Interbody Fusion|anterior lumbar interbody fusion
5394541|NCT01746212|Oswestry Disability Index|oswestry disability index
5394542|NCT01746212|Visual Analog Scale|visual analog scale
5394543|NCT01746212|Stand-alone ALIF|stand-alone alif
5394544|NCT01746212|Bone Marrow Aspirate Concentrate|bone marrow aspirate concentrate
5394545|NCT01746212|Fusion rate|fusion rate
5394546|NCT01746212|Disc Height|disc height
5394547|NCT01746212|Mean Optical Density|mean optical density
5394548|NCT01746212|Integrated Optical Density|integrated optical density
5394549|NCT01746173|T Cell lymphoma|t cell lymphoma
5394550|NCT01746160|dental implant|dental implant
5394552|NCT01746160|implant stability|implant stability
5394553|NCT01746147|MDS|mds
5394554|NCT01746147|AML|aml
5394555|NCT01746147|allogeneic SCT|allogeneic sct
5394556|NCT01746108|Pneumococcal infection|pneumococcal infection
5394557|NCT01746108|Synflorix|synflorix
5394558|NCT01746108|Children|children
5394559|NCT01746108|Immunogenicity|immunogenicity
5394560|NCT01746108|Safety|safety
5394561|NCT01746095|Cystic Fibrosis|cystic fibrosis
5394562|NCT01746095|MRSA|mrsa
5394563|NCT01746095|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5394564|NCT01746095|Lung infection|lung infection
5394565|NCT01746095|AeroVanc|aerovanc
5394566|NCT01746095|Vancomycin|vancomycin
5394567|NCT01746082|influenza, H3N2, H3N2v, vaccine, unadjuvanted, Parent Protocol|influenza, h3n2, h3n2v, vaccine, unadjuvanted, parent protocol
5394568|NCT01746069|smoking|smoking
5394569|NCT01746069|smoke cessation|smoke cessation
5394570|NCT01746069|sms|sms
5394571|NCT01746069|quit smoke|quit smoke
5394572|NCT01746056|Warts|warts
5394573|NCT01746056|Verruca|verruca
5394574|NCT01746056|Heat patch|heat patch
5394575|NCT01746043|Esophageal cancer|esophageal cancer
5394576|NCT01746043|Chemotherapy|chemotherapy
5394577|NCT01746043|Radiation therapy|radiation therapy
5394578|NCT01746043|XRT|xrt
5394579|NCT01746043|Chemoradiation|chemoradiation
5394580|NCT01746043|CXRT|cxrt
5394581|NCT01746043|Symptom Burden|symptom burden
5394582|NCT01746043|Armodafinil|armodafinil
5394583|NCT01746043|Nuvigil|nuvigil
5394584|NCT01746043|Minocycline|minocycline
5394585|NCT01746043|Dynacin|dynacin
5394586|NCT01746043|Minocin|minocin
5394587|NCT01746043|Minocin PAC|minocin pac
5394588|NCT01746043|Myrac|myrac
5394589|NCT01746043|Solodyn|solodyn
5394590|NCT01746043|Placebo|placebo
5394591|NCT01746043|Sugar pill|sugar pill
5394592|NCT01746043|Questionnaires|questionnaires
5394593|NCT01746043|Surveys|surveys
5394594|NCT01745952|Epilepsies, Partial|epilepsies, partial
5394595|NCT01745952|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5394596|NCT01745939|Back pain|back pain
5394597|NCT01745913|Leukemia|leukemia
5394598|NCT01745913|Lymphoma|lymphoma
5394599|NCT01745900|Diabetes|diabetes
5394600|NCT01745900|Gestational Diabetes|gestational diabetes
5394601|NCT01745900|Female|female
5394602|NCT01745887|Dry Eye Syndrome|dry eye syndrome
5394603|NCT01745887|Interleukin 1 Receptor Inhibitor|interleukin 1 receptor inhibitor
5394604|NCT01745874|Rectal cancer|rectal cancer
5394605|NCT01745874|Whole-body MRI|whole-body mri
5394606|NCT01745874|FDG-PET-CT|fdg-pet-ct
5394607|NCT01745874|preoperative staging|preoperative staging
5394608|NCT01745848|Roflumilast|roflumilast
5394609|NCT01745848|COPD|copd
5394610|NCT01745822|Hepatitis B|hepatitis b
5394611|NCT01745822|Hepatitis B sAg|hepatitis b sag
5394612|NCT01745822|Hepatitis B eAg|hepatitis b eag
5394613|NCT01745822|pregnancy|pregnancy
5394614|NCT01745796|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5394615|NCT01745796|Ventilated Acquired Pneumonia|ventilated acquired pneumonia
5394616|NCT01745796|Transmission modes|transmission modes
5394617|NCT01745718|prostate cancer|prostate cancer
5394618|NCT01745718|targeted biopsies|targeted biopsies
5394619|NCT01745718|cytological imprints|cytological imprints
5394620|NCT01745718|histology|histology
5394621|NCT01745705|Manipulation|manipulation
5394622|NCT01745705|Balance|balance
5394636|NCT01745614|Bioequivalence|bioequivalence
5394637|NCT01745614|Nimesulide|nimesulide
5394638|NCT01745614|Pharmacokinetics|pharmacokinetics
5394639|NCT01745614|Mexico|mexico
5394640|NCT01745588|CC-4047(Pomalidomide)Pomalyst|cc-4047(pomalidomide)pomalyst
5394641|NCT01745588|Clarithromycin|clarithromycin
5394642|NCT01745588|Biaxin|biaxin
5394643|NCT01745588|DEXAMETHASONE|dexamethasone
5394644|NCT01745588|(ClaPD)|(clapd)
5394645|NCT01745588|Stem cell|stem cell
5394646|NCT01745588|12-138|12-138
5394647|NCT01745575|Bioequivalence|bioequivalence
5394648|NCT01745575|Alprazolam|alprazolam
5394649|NCT01745575|Anxiety disorders|anxiety disorders
5394650|NCT01745575|Mexico|mexico
5394651|NCT01745562|Alprazolam|alprazolam
5394652|NCT01745562|Anxiety disorders|anxiety disorders
5394653|NCT01745562|Bioequivalence|bioequivalence
5394654|NCT01745562|Mexico|mexico
5380240|NCT01811472|NAFLD,|nafld,
5394655|NCT01745549|diabetes|diabetes
5394656|NCT01745549|insulin therapy|insulin therapy
5394657|NCT01745549|needle|needle
5394658|NCT01745536|Oocyte vitrification|oocyte vitrification
5394659|NCT01745536|survival rate|survival rate
5394660|NCT01745536|egg banking|egg banking
5394661|NCT01745536|ovum donation|ovum donation
5394662|NCT01745523|Oocyte vitrification|oocyte vitrification
5394663|NCT01745523|survival rate|survival rate
5394664|NCT01745523|egg banking|egg banking
5394665|NCT01745523|ovum donation|ovum donation
5394666|NCT01745510|docosahexaenoic acid|docosahexaenoic acid
5394667|NCT01745510|n-3 fatty acids|n-3 fatty acids
5394668|NCT01745510|necrotizing enterocolitis|necrotizing enterocolitis
5394669|NCT01745510|preterm infants|preterm infants
5394670|NCT01745497|Autism Spectrum Disorder|autism spectrum disorder
5394671|NCT01745497|Insomnia|insomnia
5394672|NCT01745484|SPECT|spect
5394673|NCT01745484|Toxicity|toxicity
5394674|NCT01745484|Non-small-cell lung cancer|non-small-cell lung cancer
5394675|NCT01745484|Definitive Radiotherapy|definitive radiotherapy
5394676|NCT01745484|Radiation pneumonitis|radiation pneumonitis
5394677|NCT01745484|Randomized study|randomized study
5394678|NCT01745471|Abdominal Adipose|abdominal adipose
5394679|NCT01745471|Gluteal Adipose|gluteal adipose
5394680|NCT01745471|Polycystic Ovary Syndrome|polycystic ovary syndrome
5394681|NCT01745471|Obesity|obesity
5394682|NCT01745471|Women|women
5394683|NCT01745445|limited-stage small cell lung cancer|limited-stage small cell lung cancer
5394684|NCT01745445|concurrent chemo-radiotherapy|concurrent chemo-radiotherapy
5394685|NCT01745432|ADBLOCK|adblock
5394686|NCT01745432|Adhesion Barrier System|adhesion barrier system
5394687|NCT01745432|laparoscopic surgery|laparoscopic surgery
5394688|NCT01745432|myomectomy|myomectomy
5394689|NCT01745419|COPD|copd
5394690|NCT01745419|Exacerbation|exacerbation
5394691|NCT01745419|Haptoglobin|haptoglobin
5394692|NCT01745393|Smoking Cessation|smoking cessation
5394693|NCT01745393|Secondhand Smoke|secondhand smoke
5394694|NCT01745393|Passive Smoking|passive smoking
5394695|NCT01745393|Cotinine|cotinine
5394696|NCT01745393|Nicotine Replacement Products|nicotine replacement products
5394697|NCT01745380|operative|operative
5394698|NCT01745380|dental procedure|dental procedure
5394699|NCT01745367|Tivozanib hydrochloride|tivozanib hydrochloride
5394700|NCT01745367|triple negative breast cancer|triple negative breast cancer
5394701|NCT01745367|paclitaxel|paclitaxel
5394702|NCT01745367|pharmacokinetics|pharmacokinetics
5394703|NCT01745367|biomarkers|biomarkers
5394704|NCT01745367|metastatic breast cancer|metastatic breast cancer
5394706|NCT01745367|TNBC|tnbc
5394707|NCT01745328|recurrent urinary tract infection|recurrent urinary tract infection
5394708|NCT01745328|antibiotics|antibiotics
5394709|NCT01745328|traditional chinese medicine|traditional chinese medicine
5394710|NCT01745315|total laparoscopic hysterectomy|total laparoscopic hysterectomy
5394711|NCT01745315|LigaSure|ligasure
5394712|NCT01745315|EnSeal|enseal
5394713|NCT01745315|Halo PKS Cutting forceps|halo pks cutting forceps
5394714|NCT01745315|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
5394715|NCT01745315|advanced bipolar device|advanced bipolar device
5394716|NCT01745302|lung cancer|lung cancer
5394717|NCT01745302|traditional Chinese medicine|traditional chinese medicine
5394718|NCT01745302|EGFR-TKI|egfr-tki
5394719|NCT01745289|Breast Cancer|breast cancer
5394720|NCT01745289|Survival|survival
5394721|NCT01745289|Recurrence|recurrence
5394722|NCT01745276|Pin fixation|pin fixation
5394723|NCT01745276|Osteotomy|osteotomy
5394724|NCT01745276|hemicallotasis|hemicallotasis
5394725|NCT01745250|lip|lip
5394726|NCT01745250|fillers|fillers
5394727|NCT01745250|Hyaluronic acid|hyaluronic acid
5394728|NCT01745237|Sarcoidosis|sarcoidosis
5394729|NCT01745237|Cardiac Magnetic Resonance|cardiac magnetic resonance
5394730|NCT01745198|homocysteinemia|homocysteinemia
5394731|NCT01745198|dementia|dementia
5394732|NCT01745198|depression|depression
5394733|NCT01745198|vitamin B12|vitamin b12
5394734|NCT01745198|folate|folate
5394735|NCT01745198|mild cognitive impairment|mild cognitive impairment
5394736|NCT01745198|alzheimer's|alzheimer's
5394737|NCT01745198|homocysteine|homocysteine
5394738|NCT01745185|Fabry Disease|fabry disease
5394739|NCT01745185|immunity|immunity
5394740|NCT01745185|antibody|antibody
5394741|NCT01745159|tacrolimus|tacrolimus
5394744|NCT01745159|atopic dermatitis|atopic dermatitis
5394745|NCT01745159|China|china
5394746|NCT01745146|traumatic brain injury|traumatic brain injury
5394748|NCT01745146|head injury|head injury
5394749|NCT01745146|brain injury|brain injury
5394750|NCT01745146|Psych-educational treatment|psych-educational treatment
5394751|NCT01745146|Anger|anger
5394752|NCT01745146|irritability|irritability
5394753|NCT01745146|anger management|anger management
5394754|NCT01745133|Olux E foam|olux e foam
5394755|NCT01745133|Sorilux foam|sorilux foam
5394756|NCT01745120|gene therapy|gene therapy
5394757|NCT01745120|β thalassemia|β thalassemia
5394758|NCT01745120|hemoglobin|hemoglobin
5394759|NCT01745120|anemia|anemia
5394760|NCT01745120|CD34|cd34
5394761|NCT01745107|T2-3N0M0 disease of esophageal neoplasm|t2-3n0m0 disease of esophageal neoplasm
5394762|NCT01745107|postoperative radiotherapy|postoperative radiotherapy
5394763|NCT01745107|intensity modulated radiation therapy|intensity modulated radiation therapy
5394764|NCT01745107|survival|survival
5394765|NCT01745094|mirabegron|mirabegron
5394766|NCT01745094|solifenacin|solifenacin
5394767|NCT01745068|fragility fracture|fragility fracture
5394768|NCT01745068|osteoporosis|osteoporosis
5394769|NCT01745068|fall prevention|fall prevention
5394770|NCT01745068|integrated program|integrated program
5394771|NCT01745068|interorganizational collaboration|interorganizational collaboration
5394772|NCT01745068|Canada|canada
5394773|NCT01745068|controlled clinical trial|controlled clinical trial
5394774|NCT01745068|evaluation|evaluation
5394775|NCT01745055|Pharmacokinetics|pharmacokinetics
5394776|NCT01745055|oral JAK inhibitor|oral jak inhibitor
5394777|NCT01745055|methotrexate (MTX)|methotrexate (mtx)
5394778|NCT01745055|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5394779|NCT01745042|Postmenopausal Women|postmenopausal women
5394780|NCT01745042|Body Composition|body composition
5394781|NCT01745042|Metabolic Syndrome|metabolic syndrome
5394782|NCT01745042|Menopause Symptoms|menopause symptoms
5394783|NCT01745029|Gastrointestinal Motility|gastrointestinal motility
5394784|NCT01745029|Inflammatory Bowel Disease|inflammatory bowel disease
5394785|NCT01745029|Transit time|transit time
5394786|NCT01745016|dietary supplement|dietary supplement
5394787|NCT01745016|carnosine|carnosine
5394788|NCT01745003|Fibromyalgia|fibromyalgia
5394789|NCT01744990|Nuts|nuts
5394790|NCT01744990|allergy|allergy
5394791|NCT01744990|Oral food challenge|oral food challenge
5394792|NCT01744990|skin testing|skin testing
5394793|NCT01744990|basophil activation tests|basophil activation tests
5394794|NCT01744990|specific IgE's|specific ige's
5394795|NCT01744964|apomorphine|apomorphine
5394796|NCT01744964|dopamine transporter gene|dopamine transporter gene
5394797|NCT01744964|SLC6A3|slc6a3
5394798|NCT01744964|cold pressor test|cold pressor test
5394799|NCT01744964|tolerance|tolerance
5394800|NCT01744964|experimental pain|experimental pain
5394801|NCT01744964|dopamine agonist|dopamine agonist
5394802|NCT01744951|Adoption|adoption
5394803|NCT01744951|Foster care|foster care
5394804|NCT01744951|Substance abuse|substance abuse
5394805|NCT01744951|Older children|older children
5394806|NCT01744951|Mental health|mental health
5394807|NCT01744938|Postoperative Complications,|postoperative complications,
5394808|NCT01744938|mortality,|mortality,
5394809|NCT01744938|length of Stay,|length of stay,
5394810|NCT01744938|economics|economics
5394811|NCT01744912|Lymphoma|lymphoma
5394812|NCT01744912|monoclonal antibody|monoclonal antibody
5394813|NCT01744912|immunomodulatory agent|immunomodulatory agent
5394814|NCT01744912|ublituximab|ublituximab
5394815|NCT01744912|lenalidomide|lenalidomide
5394816|NCT01744899|Lumbosacral spine|lumbosacral spine
5394817|NCT01744899|Nerve roots|nerve roots
5394819|NCT01744899|H-reflex|h-reflex
5394820|NCT01744886|One-Lung Ventilation|one-lung ventilation
5394821|NCT01744886|Thoracic Surgical Procedures|thoracic surgical procedures
5394822|NCT01744886|Cardiac Surgical Procedures|cardiac surgical procedures
5394823|NCT01744834|Reward-based learning|reward-based learning
5394824|NCT01744834|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
5394825|NCT01744834|Functional imaging|functional imaging
5394826|NCT01744834|alcohol use disorder risk|alcohol use disorder risk
5394827|NCT01744821|High Risk|high risk
5394829|NCT01744808|Normal|normal
5394830|NCT01744795|cardiac output|cardiac output
5394831|NCT01744795|thermodilution|thermodilution
5394832|NCT01744795|esophageal doppler|esophageal doppler
5394833|NCT01744795|trending ability|trending ability
5394834|NCT01744782|Nephropathic Cystinosis|nephropathic cystinosis
5394835|NCT01744782|Cysteamine|cysteamine
5394836|NCT01744782|Delayed-release Cysteamine|delayed-release cysteamine
5394837|NCT01744782|CTNS Protein, Human|ctns protein, human
5394838|NCT01744782|Orphan Disease|orphan disease
5394839|NCT01744769|thyroid cancer|thyroid cancer
5394840|NCT01744769|hypothyroidism|hypothyroidism
5394841|NCT01744769|metabolic parameters|metabolic parameters
5390019|NCT01767597|access to care|access to care
5394842|NCT01744769|Hypothyroidism after levothyroxine withdrawal|hypothyroidism after levothyroxine withdrawal
5394843|NCT01744756|Subconjunctival Bevacizumab|subconjunctival bevacizumab
5394844|NCT01744756|Recurrent pterygium|recurrent pterygium
5394845|NCT01744743|preconception|preconception
5394846|NCT01744743|hypothyroidism|hypothyroidism
5394847|NCT01744743|neurocognitive development|neurocognitive development
5394848|NCT01744730|Bacterial infections|bacterial infections
5394849|NCT01744730|Obesity|obesity
5394850|NCT01744730|pharmacokinetics|pharmacokinetics
5394851|NCT01744730|clindamycin|clindamycin
5394852|NCT01744717|Pain|pain
5394853|NCT01744717|mechanical ventilation|mechanical ventilation
5394854|NCT01744717|uncommunicative|uncommunicative
5394855|NCT01744717|Adult ICU patients pain|adult icu patients pain
5394856|NCT01744704|Nerve Growth Factor|nerve growth factor
5394857|NCT01744704|Ophthalmic Solutions|ophthalmic solutions
5394858|NCT01744704|Eye Drops|eye drops
5394859|NCT01744704|rh-NGF|rh-ngf
5394860|NCT01744691|CLL|cll
5394861|NCT01744691|SLL|sll
5394862|NCT01744665|CML, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, MR4.5, undetectable, bcr-abl|cml, chronic myeloid leukemia, stop, niotinib, discontinue, imatinib, switch, mr4.5, undetectable, bcr-abl
5394863|NCT01744652|Advanced Cancers|advanced cancers
5394864|NCT01744652|Advanced Malignancies|advanced malignancies
5394865|NCT01744652|Unresectable|unresectable
5394867|NCT01744652|Crizotinib|crizotinib
5394868|NCT01744652|PF-02341066|pf-02341066
5394869|NCT01744652|Xalkori|xalkori
5394870|NCT01744652|Dasatinib|dasatinib
5394871|NCT01744652|BMS-354825|bms-354825
5394872|NCT01744652|Sprycel|sprycel
5394873|NCT01744639|Hepatocellular carcinoma|hepatocellular carcinoma
5394874|NCT01744639|Radioablation|radioablation
5394875|NCT01744626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5394876|NCT01744626|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5394877|NCT01744613|Clopidogrel|clopidogrel
5394878|NCT01744613|platelet inhibition|platelet inhibition
5394879|NCT01744613|antiplatelet therapy|antiplatelet therapy
5394880|NCT01744613|peripheral arterial disease|peripheral arterial disease
5394881|NCT01744613|endovascular treatment|endovascular treatment
5394882|NCT01744613|angioplasty|angioplasty
5394883|NCT01744613|stenting|stenting
5394884|NCT01744600|Dementia|dementia
5394885|NCT01744600|Music Therapy|music therapy
5394887|NCT01744587|EGCG|egcg
5394888|NCT01744561|Exercise|exercise
5394889|NCT01744561|Motivation|motivation
5394890|NCT01744561|Feedback|feedback
5394891|NCT01744561|web-based diary|web-based diary
5394892|NCT01744561|pedometer|pedometer
5394893|NCT01744535|smartphone|smartphone
5394894|NCT01744535|smartphone app|smartphone app
5394895|NCT01744535|smartphone application|smartphone application
5394896|NCT01744535|obesity|obesity
5394897|NCT01744535|overweight|overweight
5394898|NCT01744535|self monitoring|self monitoring
5394899|NCT01744496|Parkinson's Disease|parkinson's disease
5394900|NCT01744496|Rotigotine|rotigotine
5394901|NCT01744496|Chronic Pain|chronic pain
5394902|NCT01744496|Nonmotor symptoms|nonmotor symptoms
5394903|NCT01744483|pneumonia|pneumonia
5394904|NCT01744483|endotracheal intubation|endotracheal intubation
5394905|NCT01744470|Renal|renal
5394906|NCT01744470|Transplantation|transplantation
5394907|NCT01744470|Tacrolimus|tacrolimus
5394937|NCT01744314|Elbow trauma,Heterotopic Ossification,Indomethacin, Prophylaxis|elbow trauma,heterotopic ossification,indomethacin, prophylaxis
5394939|NCT01744301|Acid-suppressing drugs|acid-suppressing drugs
5394940|NCT01744301|Epidemiology|epidemiology
5394941|NCT01744288|Phase 1 Safety ,|phase 1 safety ,
5394942|NCT01744288|pharmacodynamic,|pharmacodynamic,
5394943|NCT01744288|Ticagrelor,|ticagrelor,
5394944|NCT01744288|Clopidogrel,|clopidogrel,
5394945|NCT01744288|Platelets|platelets
5394946|NCT01744275|Epilepsy|epilepsy
5394947|NCT01744275|Omega 3 fatty acids|omega 3 fatty acids
5423343|NCT01616082|fatty acid oxidation|fatty acid oxidation
5394948|NCT01744262|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy|intraocular pressure, total intravenous anesthesia, laparoscopic prostatectomy
5394949|NCT01744249|Advanced neuroendocrine tumours of non-pancreatic origin|advanced neuroendocrine tumours of non-pancreatic origin
5394950|NCT01744249|axitinib|axitinib
5394951|NCT01744236|GLP-1 Receptor Agonists, DPP-4 inhibitors|glp-1 receptor agonists, dpp-4 inhibitors
5394952|NCT01744223|iCaspase9|icaspase9
5394954|NCT01744223|Inducible Caspase|inducible caspase
5394955|NCT01744223|AP1903|ap1903
5394956|NCT01744223|Dimerizer drug|dimerizer drug
5394957|NCT01744223|T depleted|t depleted
5394958|NCT01744223|Suicide gene|suicide gene
5394959|NCT01744223|CD-34 selection|cd-34 selection
5394960|NCT01744223|haplotransplantation|haplotransplantation
5394961|NCT01744223|Graft versus host disease|graft versus host disease
5394962|NCT01744223|Allogenic transplantation|allogenic transplantation
5394963|NCT01744197|Pain control|pain control
5394964|NCT01744197|Needle stick pain|needle stick pain
5394965|NCT01744197|Venipuncture pain|venipuncture pain
5394966|NCT01744184|gastroscopy|gastroscopy
5394967|NCT01744184|diagnostic|diagnostic
5394968|NCT01744184|entonox|entonox
5394969|NCT01744158|cerebral palsy|cerebral palsy
5394970|NCT01744158|spasticity|spasticity
5394972|NCT01744158|hypertonia|hypertonia
5394973|NCT01744158|register|register
5394974|NCT01744158|motor function|motor function
5394975|NCT01744132|eye care utilization|eye care utilization
5394976|NCT01744132|ophthalmology|ophthalmology
5394977|NCT01744132|educational intervention|educational intervention
5394978|NCT01744132|public health screening|public health screening
5394979|NCT01744093|HIV|hiv
5394980|NCT01744093|COPD|copd
5378105|NCT01821300|Obesity|obesity
5394981|NCT01744093|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5394982|NCT01744093|Emphysema|emphysema
5394983|NCT01744080|Rotator cuff|rotator cuff
5394984|NCT01744067|Renal transplantation|renal transplantation
5394985|NCT01744067|Interventional study|interventional study
5394986|NCT01744067|Glomerular filtration rate|glomerular filtration rate
5394987|NCT01744067|Renal function|renal function
5394988|NCT01744067|Proteinuria|proteinuria
5394989|NCT01744067|Cardiovascular risk markers|cardiovascular risk markers
5394990|NCT01744067|Blood pressure|blood pressure
5394991|NCT01744067|Flow mediated vasodilation|flow mediated vasodilation
5394992|NCT01744067|Heart rate variability|heart rate variability
5394993|NCT01744067|Pulse wave velocity|pulse wave velocity
5394994|NCT01744067|Lipids|lipids
5394995|NCT01744067|Blood glucose|blood glucose
5394996|NCT01744067|Bone mineral density|bone mineral density
5394997|NCT01744067|Body composition|body composition
5394998|NCT01744067|Fat distribution|fat distribution
5394999|NCT01744067|Body mass index|body mass index
5395000|NCT01744067|Fatty acid composition|fatty acid composition
5395001|NCT01744067|Tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
5395002|NCT01744067|Omega-3 fatty acids|omega-3 fatty acids
5395003|NCT01744067|Marine n-3 fatty acids|marine n-3 fatty acids
5395008|NCT01744041|depression|depression
5395009|NCT01744041|pregnancy|pregnancy
5395010|NCT01744041|postpartum|postpartum
5395011|NCT01744041|psychotherapy|psychotherapy
5395012|NCT01744028|COPD, remote patient monitoring, Hub, exacerbations, EXACT|copd, remote patient monitoring, hub, exacerbations, exact
5395013|NCT01744015|Low back pain|low back pain
5395014|NCT01744002|Shoulder, Impingement syndrome, Neck|shoulder, impingement syndrome, neck
5395015|NCT01743976|neuropathic pain|neuropathic pain
5395016|NCT01743976|diabetic neuropathy|diabetic neuropathy
5395017|NCT01743976|neuropathic pain after back surgery|neuropathic pain after back surgery
5395018|NCT01743963|efficacy|efficacy
5395019|NCT01743963|glucocorticoid|glucocorticoid
5395020|NCT01743950|Glioblastoma|glioblastoma
5395021|NCT01743950|anaplastic glioma|anaplastic glioma
5395022|NCT01743937|Ischemic preconditioning|ischemic preconditioning
5395023|NCT01743937|Ticagrelor|ticagrelor
5395024|NCT01743937|Antiplatelet therapy|antiplatelet therapy
5395025|NCT01743937|Acute coronary syndrome|acute coronary syndrome
5395026|NCT01743924|Broccoli; Isothiocyanates; Pharmacokinetics; Sulforaphane; Myrosinase|broccoli; isothiocyanates; pharmacokinetics; sulforaphane; myrosinase
5395027|NCT01743911|Tadalafil|tadalafil
5395028|NCT01743911|Resistant Hypertension|resistant hypertension
5395029|NCT01743911|Left Ventricle Diastolic Dysfunction|left ventricle diastolic dysfunction
5395030|NCT01743911|Brain natriuretic peptide|brain natriuretic peptide
5395031|NCT01743885|Hemangioma|hemangioma
5395032|NCT01743885|Beta-blocker|beta-blocker
5395033|NCT01743885|Acebutolol|acebutolol
5395034|NCT01743885|Propranolol|propranolol
5395035|NCT01743885|Randomized controlled trial|randomized controlled trial
5395036|NCT01743885|Infants|infants
5395037|NCT01743872|Optical Coherence Tomography|optical coherence tomography
5395038|NCT01743872|Contrast|contrast
5395039|NCT01743872|Dextran|dextran
5395040|NCT01743872|Carbon Dioxide|carbon dioxide
5395041|NCT01743872|Imaging|imaging
5395042|NCT01743872|Catheter|catheter
5395043|NCT01743872|Lower Extremity Artery|lower extremity artery
5395044|NCT01743859|Myeloid|myeloid
5395045|NCT01743859|Leukemia|leukemia
5395046|NCT01743807|Relapsed|relapsed
5395047|NCT01743807|Minimal Residual Disease|minimal residual disease
5395048|NCT01743807|MRD|mrd
5395049|NCT01743807|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5395050|NCT01743807|Acute Myelogenous Leukemia|acute myelogenous leukemia
5395051|NCT01743807|ALL|all
5395052|NCT01743807|AML|aml
5395053|NCT01743807|GNKG168|gnkg168
5395054|NCT01743807|Pediatric|pediatric
5395055|NCT01743807|Childhood|childhood
5395056|NCT01743781|comprehensive eye examination|comprehensive eye examination
5395057|NCT01743781|acceptance|acceptance
5395058|NCT01743781|glaucoma|glaucoma
5395059|NCT01743781|diabetic retinopathy|diabetic retinopathy
5395060|NCT01743768|Antisense oligonucleotide|antisense oligonucleotide
5395061|NCT01743768|Asthma|asthma
5395062|NCT01743768|Healthy subjects|healthy subjects
5395063|NCT01743768|Phase 1|phase 1
5395064|NCT01743768|Transcription factor GATA-3|transcription factor gata-3
5395065|NCT01743768|Oral inhalation|oral inhalation
5395066|NCT01743755|Community-acquired pneumonia|community-acquired pneumonia
5395067|NCT01743755|Dexamethasone|dexamethasone
5395068|NCT01743755|Corticosteroid|corticosteroid
5395069|NCT01743742|Oral vitamin E and vitamin C|oral vitamin e and vitamin c
5395070|NCT01743729|SAR 1118|sar 1118
5395075|NCT01743703|traumatic injuries|traumatic injuries
5395077|NCT01743703|Skeletal survey|skeletal survey
5395078|NCT01743703|Children|children
5395079|NCT01743703|Diagnostic|diagnostic
5395080|NCT01743690|Probiotic|probiotic
5395081|NCT01743690|Candida|candida
5395082|NCT01743690|Oral Lichen Planus|oral lichen planus
5395083|NCT01743677|TQT study|tqt study
5395084|NCT01743677|CP-690,550|cp-690,550
5395085|NCT01743664|Posttraumatic Stress Disorders|posttraumatic stress disorders
5395086|NCT01743664|Multiple Sclerosis|multiple sclerosis
5395087|NCT01743664|Eye Movement Desensitization Reprocessing|eye movement desensitization reprocessing
5395088|NCT01743664|Psychotherapy|psychotherapy
5395090|NCT01743664|Depression|depression
5395091|NCT01743664|Quality of Life|quality of life
5395092|NCT01743651|spasticity|spasticity
5395094|NCT01743651|arbaclofen|arbaclofen
5395095|NCT01743612|healthy subject|healthy subject
5395096|NCT01743612|hand blood flow|hand blood flow
5395097|NCT01743612|laser speckle contrast imaging|laser speckle contrast imaging
5395098|NCT01743586|Lung cancer|lung cancer
5395099|NCT01743586|Chest physiotherapy|chest physiotherapy
5395100|NCT01743586|Respiratory muscle strength|respiratory muscle strength
5395101|NCT01743586|Dyspnea, Functional capacity|dyspnea, functional capacity
5395102|NCT01743586|Quality of life|quality of life
5395103|NCT01743560|Breast Neoplasms|breast neoplasms
5395104|NCT01743560|Neoplasms|neoplasms
5395105|NCT01743560|Breast diseases|breast diseases
5395106|NCT01743560|Skin diseases|skin diseases
5395107|NCT01743560|Exemestane|exemestane
5395108|NCT01743560|Antibiotics, Antineoplastic|antibiotics, antineoplastic
5395109|NCT01743560|Everolimus|everolimus
5395110|NCT01743560|Antineoplastic Agents|antineoplastic agents
5395111|NCT01743560|Therapeutic Uses|therapeutic uses
5395112|NCT01743560|Pharmacologic Actions|pharmacologic actions
5395113|NCT01743560|Immunosuppressive Agents|immunosuppressive agents
5395114|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs
5395115|NCT01743560|Aromatase Inhibitors|aromatase inhibitors
5395116|NCT01743560|Enzyme Inhibitors|enzyme inhibitors
5395117|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5395118|NCT01743547|Women|women
5395119|NCT01743547|Yoga|yoga
5395120|NCT01743547|Ovarian Cancer|ovarian cancer
5395121|NCT01743547|Lifestyle|lifestyle
5395122|NCT01743521|Hepatitis C|hepatitis c
5395123|NCT01743521|Individualised therapy|individualised therapy
5395124|NCT01743521|Response-guided therapy|response-guided therapy
5395125|NCT01743521|Telaprevir|telaprevir
5395126|NCT01743521|PEG-IFN|peg-ifn
5395127|NCT01743521|Ribavirin|ribavirin
5395128|NCT01743521|Hepatitis|hepatitis
5395129|NCT01743508|incomplete abortion|incomplete abortion
5395130|NCT01743508|misoprostol treatment|misoprostol treatment
5395131|NCT01743508|midwife|midwife
5395132|NCT01743508|uganda|uganda
5395133|NCT01743495|Medical Costs|medical costs
5395134|NCT01743495|improved IADLs|improved iadls
5395135|NCT01743495|and/or ADL's|and/or adl's
5395136|NCT01743495|decreased nursing home admissions|decreased nursing home admissions
5395137|NCT01743482|Testicular Cancer|testicular cancer
5395138|NCT01743482|Germ Cell Tumors|germ cell tumors
5395139|NCT01743482|Salvage Therapy|salvage therapy
5395140|NCT01743482|Pazopanib|pazopanib
5395141|NCT01743469|Advanced|advanced
5395142|NCT01743469|Metastatic|metastatic
5395143|NCT01743469|Hepatocellular cancer|hepatocellular cancer
5395144|NCT01743469|Ovarian cancer|ovarian cancer
5395145|NCT01743469|Renal cell cancer|renal cell cancer
5395146|NCT01743469|Gastric carcinoma|gastric carcinoma
5395147|NCT01743456|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5395148|NCT01743456|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5395149|NCT01743456|Postoperative cognitive improvement|postoperative cognitive improvement
5395150|NCT01743456|Postoperative delirium|postoperative delirium
5395151|NCT01743443|Corneal sensitivity|corneal sensitivity
5395152|NCT01743443|Cross-linking|cross-linking
5395153|NCT01743443|Keratoconus|keratoconus
5395154|NCT01743430|telerehabilitation|telerehabilitation
5395155|NCT01743430|stroke|stroke
5395156|NCT01743430|Berg balance scale|berg balance scale
5395157|NCT01743430|stroke impact scale|stroke impact scale
5395158|NCT01743430|mobility|mobility
5395159|NCT01743417|Cognitive rehabilitation|cognitive rehabilitation
5395160|NCT01743417|malaria|malaria
5395161|NCT01743417|neuropsychology|neuropsychology
5395162|NCT01743417|attention|attention
5395163|NCT01743417|working memory|working memory
5395164|NCT01743404|atherosclerosis|atherosclerosis
5395165|NCT01743404|inflammation|inflammation
5395166|NCT01743404|intima-media thickness|intima-media thickness
5395167|NCT01743391|IVF treatment|ivf treatment
5395168|NCT01743391|Office-hysteroscopy|office-hysteroscopy
5395169|NCT01743391|Endometrial biopsy|endometrial biopsy
5395170|NCT01743352|Large arteries|large arteries
5395171|NCT01743352|stiffness|stiffness
5395172|NCT01743352|intima media thickness|intima media thickness
5395173|NCT01743352|ultrasound imaging|ultrasound imaging
5395174|NCT01743339|Randomized Controlled Trial|randomized controlled trial
5395175|NCT01743339|Cognitive Therapy|cognitive therapy
5395176|NCT01743339|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5395177|NCT01743339|Depression|depression
5395178|NCT01743339|Sleep|sleep
5395179|NCT01743326|Zygapophyseal Joint|zygapophyseal joint
5395180|NCT01743313|glucose metabolism disorders|glucose metabolism disorders
5395181|NCT01743313|metabolic syndrome|metabolic syndrome
5395182|NCT01743313|joint replacement|joint replacement
5395183|NCT01743313|osteoarthritis|osteoarthritis
5395184|NCT01743300|sunitinib|sunitinib
5380752|NCT01809015|Coagulation Service|coagulation service
5395185|NCT01743300|pharmacokinetics|pharmacokinetics
5395186|NCT01743300|phenotyping|phenotyping
5395187|NCT01743300|interaction|interaction
5395188|NCT01743287|osteoarthritis of the knee|osteoarthritis of the knee
5395189|NCT01743274|acute coronary syndromes|acute coronary syndromes
5395190|NCT01743274|non-ST elevation myocardial infarction|non-st elevation myocardial infarction
5395191|NCT01743274|angioplasty|angioplasty
5395192|NCT01743274|fractional flow reserve|fractional flow reserve
5395193|NCT01743274|optical coherence tomography|optical coherence tomography
5395194|NCT01743261|severe brain injury|severe brain injury
5395195|NCT01743261|graded intensive rehabilitation|graded intensive rehabilitation
5395196|NCT01743248|vestibular schwannoma|vestibular schwannoma
5395198|NCT01743248|psychological factors|psychological factors
5395199|NCT01743235|HSDD|hsdd
5395200|NCT01743209|androgen antagonists|androgen antagonists
5395201|NCT01743196|Folic acid|folic acid
5395202|NCT01743196|Folate|folate
5395203|NCT01743196|Pharmacokinetics|pharmacokinetics
5395204|NCT01743196|Women of Child Bearing Age|women of child bearing age
5395205|NCT01743183|hypertension|hypertension
5395206|NCT01743170|Blood pressure control|blood pressure control
5395207|NCT01743170|Hypertension|hypertension
5395208|NCT01743170|Office blood pressure|office blood pressure
5395209|NCT01743170|Self-measured blood pressure|self-measured blood pressure
5395210|NCT01743170|Telemonitoring|telemonitoring
5395211|NCT01743144|emergence agitation in children|emergence agitation in children
5395212|NCT01743144|sevoflurane|sevoflurane
5395213|NCT01743144|general anesthesia|general anesthesia
5395214|NCT01743144|magnesium sulphate|magnesium sulphate
5395215|NCT01743105|diaphragm movement|diaphragm movement
5395216|NCT01743105|ultrasound|ultrasound
5395217|NCT01743105|emergency room|emergency room
5395218|NCT01743092|Pathological gambling|pathological gambling
5395219|NCT01743092|treatment|treatment
5395220|NCT01743092|online counselling|online counselling
5395221|NCT01743092|webinar|webinar
5395222|NCT01743092|workbook|workbook
5395223|NCT01743079|Telbivudine|telbivudine
5395224|NCT01743079|Lamivudine|lamivudine
5395225|NCT01743079|safety|safety
5395226|NCT01743079|efficacy|efficacy
5395227|NCT01743079|pregnancy|pregnancy
5395228|NCT01743066|Arsenic|arsenic
5395229|NCT01743066|Arsenicosis|arsenicosis
5395230|NCT01743066|Buccal cells|buccal cells
5395231|NCT01743066|Serum|serum
5395232|NCT01743066|Vitamin E|vitamin e
5395233|NCT01743066|Cholesterol|cholesterol
5395234|NCT01743040|Coronary Artery Disease|coronary artery disease
5395235|NCT01743040|Nuclear Stress Test|nuclear stress test
5395236|NCT01743040|CT Angiography|ct angiography
5395237|NCT01743040|Angiography|angiography
5395238|NCT01743027|Allergic conjunctivitis|allergic conjunctivitis
5395239|NCT01743027|Olopatadine HCl solution|olopatadine hcl solution
5395240|NCT01743027|Conjunctival Allergen Challenge|conjunctival allergen challenge
5395241|NCT01743027|Itching eyes|itching eyes
5395242|NCT01743027|Ocular allergies|ocular allergies
5395243|NCT01743027|PATADAY|pataday
5395244|NCT01743027|PATANOL|patanol
5395245|NCT01743014|diabetes|diabetes
5395246|NCT01743014|diabetic nephropathy|diabetic nephropathy
5395247|NCT01743014|vascular inflammation|vascular inflammation
5395248|NCT01743014|oxidative stress|oxidative stress
5395249|NCT01743014|endothelial dysfunction|endothelial dysfunction
5395250|NCT01743014|Asymmetric dimethylarginine|asymmetric dimethylarginine
5395251|NCT01743014|High sensitivity CRP|high sensitivity crp
5395252|NCT01743014|albumine to creatinine ratio|albumine to creatinine ratio
5395253|NCT01743014|isoprostane|isoprostane
5395254|NCT01743014|clopidogrel|clopidogrel
5395255|NCT01743014|ramipril|ramipril
5395256|NCT01743014|carotid intima media thickness|carotid intima media thickness
5395257|NCT01743001|exercise capacity|exercise capacity
5395258|NCT01743001|Eisenmenger Syndrome|eisenmenger syndrome
5395259|NCT01742988|Lymphoma|lymphoma
5395261|NCT01742988|MYC|myc
5395262|NCT01742988|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5395263|NCT01742988|HGBL|hgbl
5395264|NCT01742988|High-grade B-Cell Lymphoma|high-grade b-cell lymphoma
5395265|NCT01742988|Double-hit Lymphoma (DHL)|double-hit lymphoma (dhl)
5395266|NCT01742988|Triple-hit Lymphoma (THL)|triple-hit lymphoma (thl)
5395267|NCT01742988|Double-expressor Lymphoma (DEL)|double-expressor lymphoma (del)
5395268|NCT01742988|P13K|p13k
5395269|NCT01742988|HDAC|hdac
5395270|NCT01742988|Open-Label|open-label
5395271|NCT01742962|Prostatectomy|prostatectomy
5395272|NCT01742962|Prostate cancer|prostate cancer
5395273|NCT01742962|Orgasm|orgasm
5395274|NCT01742962|Urinary incontinence|urinary incontinence
5395275|NCT01742962|Climacturia(orgasm related urinary incontinence)|climacturia(orgasm related urinary incontinence)
5395277|NCT01742962|Dysorgasmia (pain in relation to orgasm)|dysorgasmia (pain in relation to orgasm)
5395278|NCT01742962|Pain|pain
5395279|NCT01742962|Anorgasmia|anorgasmia
5395280|NCT01742962|Penile shortening|penile shortening
5395281|NCT01742962|Erectile dysfunction|erectile dysfunction
5395282|NCT01742923|hypertension|hypertension
5395283|NCT01742923|medication adherence|medication adherence
5395284|NCT01742923|motivational interviewing|motivational interviewing
5378427|NCT01819727|PEG-PAL|peg-pal
5395285|NCT01742897|Osteoarthritis, Knee|osteoarthritis, knee
5395286|NCT01742897|Transdermal therapeutic system (TTS) fentanyl|transdermal therapeutic system (tts) fentanyl
5395288|NCT01742884|Dry Eye Syndrome|dry eye syndrome
5395289|NCT01742871|Antivitamin K|antivitamin k
5395290|NCT01742871|Bleeding|bleeding
5395291|NCT01742871|Haemorrhage|haemorrhage
5395292|NCT01742871|Nutritional status|nutritional status
5395293|NCT01742871|impedancemetry|impedancemetry
5395294|NCT01742845|Ultrasound-guided|ultrasound-guided
5395295|NCT01742845|regional anaesthesia|regional anaesthesia
5395296|NCT01742845|Cervical block|cervical block
5395297|NCT01742832|Vilazodone|vilazodone
5395298|NCT01742832|Citalopram|citalopram
5395299|NCT01742832|Major Depressive Disorder|major depressive disorder
5395300|NCT01742819|Glaucoma, Optical Coherence Tomography, Progression|glaucoma, optical coherence tomography, progression
5395301|NCT01742806|Gastric cancer|gastric cancer
5395302|NCT01742806|Minimally invasive surgery|minimally invasive surgery
5395303|NCT01742806|Distal gastrectomy|distal gastrectomy
5395304|NCT01742806|Bio-absorbable Felt|bio-absorbable felt
5395305|NCT01742793|relapsed /refractory Hodgkin lymphoma|relapsed /refractory hodgkin lymphoma
5002925|NCT03977792|Skin Diseases, Infectious|skin diseases, infectious
5395306|NCT01742793|mature T-cell lymphoma|mature t-cell lymphoma
5395307|NCT01742793|multiple myeloma|multiple myeloma
5395308|NCT01742780|Intraosseous Vascular Access|intraosseous vascular access
5395309|NCT01742780|IO Access|io access
5395310|NCT01742780|IO Vascular Access|io vascular access
5395311|NCT01742780|EZ-IO|ez-io
5395312|NCT01742767|NSCLC; split dose Cisplatinum; Pemetrexed|nsclc; split dose cisplatinum; pemetrexed
5395313|NCT01742741|Diabetes Mellitus, Type 1 (T1DM)|diabetes mellitus, type 1 (t1dm)
5395314|NCT01742741|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5395315|NCT01742741|Artificial Pancreas (AP)|artificial pancreas (ap)
5395316|NCT01742741|Insulin Pump|insulin pump
5395317|NCT01742741|Closed Loop Control (CLC)|closed loop control (clc)
5395318|NCT01742741|Open Loop treatment|open loop treatment
5395319|NCT01742741|Diabetes Assistant|diabetes assistant
5395320|NCT01742741|DiAs|dias
5395321|NCT01742728|oxidative stress, antioxidant, periodontitis, serum immunoglobulin G|oxidative stress, antioxidant, periodontitis, serum immunoglobulin g
5395322|NCT01742728|antibody titer|antibody titer
5395323|NCT01742715|ARDS|ards
5395324|NCT01742715|Lung compliance|lung compliance
5395325|NCT01742702|Blood pressure|blood pressure
5395326|NCT01742702|Hypertension|hypertension
5395327|NCT01742702|Arterial stiffness|arterial stiffness
5395328|NCT01742702|Cardiac output|cardiac output
5395329|NCT01742702|Vascular resistance|vascular resistance
5395330|NCT01742702|Pulse wave reflection|pulse wave reflection
5395331|NCT01742702|Head-up tilt|head-up tilt
5395332|NCT01742689|Renal colic|renal colic
5395333|NCT01742689|Pain|pain
5395334|NCT01742689|Desmopressin|desmopressin
5395335|NCT01742689|Urinary obstruction|urinary obstruction
5395336|NCT01742689|Indomethacin|indomethacin
5395337|NCT01742676|tacrolimus|tacrolimus
5395338|NCT01742676|kidney|kidney
5395339|NCT01742663|Diclofenac Sodium Gel 3%|diclofenac sodium gel 3%
5395340|NCT01742663|Solaraze® (diclofenac sodium) Gel 3%|solaraze® (diclofenac sodium) gel 3%
5395341|NCT01742663|Actinic Keratosis|actinic keratosis
5395342|NCT01742650|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
5395343|NCT01742637|Acne Vulgaris|acne vulgaris
5395344|NCT01742637|Adapalene and Benzoyl Peroxide Gel 0.1%/2.5%|adapalene and benzoyl peroxide gel 0.1%/2.5%
5395345|NCT01742637|Epiduo®|epiduo®
5395346|NCT01742624|immunosuppressant|immunosuppressant
5395347|NCT01742624|new-onset diabetes after kidney transplantation|new-onset diabetes after kidney transplantation
5395348|NCT01742624|NODAT|nodat
5395349|NCT01742611|CKD|ckd
5395350|NCT01742611|Not on dialysis|not on dialysis
5395351|NCT01742611|ASP1585|asp1585
5395352|NCT01742611|Bixalomer|bixalomer
5395353|NCT01742598|TAVI|tavi
5395354|NCT01742598|TAVR|tavr
5395355|NCT01742598|aortic stenosis|aortic stenosis
5395356|NCT01742598|Transcatheter|transcatheter
5395357|NCT01742598|valvular heart disease|valvular heart disease
5395358|NCT01742598|aortic valve stenosis|aortic valve stenosis
5395359|NCT01742598|aortic valve replacement|aortic valve replacement
5395360|NCT01742598|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5395361|NCT01742585|CKD|ckd
5395362|NCT01742585|Not on dialysis|not on dialysis
5395363|NCT01742585|ASP1585|asp1585
5395364|NCT01742585|Bixalomer|bixalomer
5395365|NCT01742572|weight loss|weight loss
5395366|NCT01742572|obesity|obesity
5395367|NCT01742572|overweight|overweight
5395368|NCT01742572|diet|diet
5395369|NCT01742559|Treatment|treatment
5395370|NCT01742546|myofascial pain syndrome|myofascial pain syndrome
5395371|NCT01742546|therapeutic ultrasound|therapeutic ultrasound
5378513|NCT01819376|Obesity|obesity
5395372|NCT01742546|combine therapy|combine therapy
5395373|NCT01742533|Hormone Replacement Therapy，|hormone replacement therapy，
5395374|NCT01742533|Premature Ovarian Failure，|premature ovarian failure，
5395375|NCT01742533|Stem Cell Therapy|stem cell therapy
5395376|NCT01742520|Preterm infant|preterm infant
5395378|NCT01742520|neurodevelopment|neurodevelopment
5395379|NCT01742507|Stent, OCT|stent, oct
5395380|NCT01742494|Esophageal Achalasia,|esophageal achalasia,
5395381|NCT01742494|Peroral endoscopic myotomy,|peroral endoscopic myotomy,
5395382|NCT01742494|Water-jet assisted|water-jet assisted
5395383|NCT01742481|childhood cancer survivors|childhood cancer survivors
5395384|NCT01742481|long-term follow-up care|long-term follow-up care
5395385|NCT01742481|health communication|health communication
5395386|NCT01742481|ethnic/racial minorities|ethnic/racial minorities
5395387|NCT01742481|longterm survivors|longterm survivors
5395388|NCT01742468|n-3 LC-PUFA, DHA, rheumatoid arthritis|n-3 lc-pufa, dha, rheumatoid arthritis
5395389|NCT01742455|Peripheral artery disease|peripheral artery disease
5395390|NCT01742455|Arterial Occlusive Diseases|arterial occlusive diseases
5395391|NCT01742455|Vascular Diseases|vascular diseases
5395392|NCT01742455|Cardiovascular Diseases|cardiovascular diseases
5395393|NCT01742455|Coronary Artery Disease|coronary artery disease
5395394|NCT01742455|Myocardial Ischemia|myocardial ischemia
5395395|NCT01742455|Arteriosclerosis|arteriosclerosis
5395695|NCT01741077|pregnancy|pregnancy
5395400|NCT01742442|geriatric assessment|geriatric assessment
5395401|NCT01742429|Helicobacter pylori|helicobacter pylori
5395402|NCT01742429|second line treatment|second line treatment
5395403|NCT01742416|Arterial Cannulation|arterial cannulation
5395404|NCT01742416|Ultrasound|ultrasound
5395405|NCT01742416|Palpation Method|palpation method
5395406|NCT01742416|Pediatrics|pediatrics
5395407|NCT01742416|Cardiac Surgery|cardiac surgery
5395408|NCT01742416|Craniotomies|craniotomies
5395409|NCT01742416|Cranial Vault Surgery|cranial vault surgery
5395410|NCT01742416|Abdominal Procedures|abdominal procedures
5395411|NCT01742403|Prostate|prostate
5395412|NCT01742403|IGRT|igrt
5395413|NCT01742403|VMAT|vmat
5395414|NCT01742390|schizophrenia|schizophrenia
5395415|NCT01742390|risperidone|risperidone
5395416|NCT01742390|paliperidone|paliperidone
5395417|NCT01742390|aripiprazole|aripiprazole
5395418|NCT01742377|GERD|gerd
5395419|NCT01742377|Dyspepsia|dyspepsia
5395420|NCT01742377|Ambulatory 24-hour Esophageal pH Monitoring|ambulatory 24-hour esophageal ph monitoring
5395421|NCT01742377|Minimal change erosions|minimal change erosions
5395422|NCT01742364|disposable syringe jet injector (DSJI)|disposable syringe jet injector (dsji)
5395423|NCT01742364|DSJI|dsji
5395425|NCT01742364|tuberculosis|tuberculosis
5395426|NCT01742364|intradermal delivery|intradermal delivery
5395427|NCT01742364|South Africa|south africa
5395428|NCT01742338|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5395429|NCT01742338|COPD|copd
5395430|NCT01742338|Chronic bronchitis|chronic bronchitis
5395431|NCT01742338|emphysema|emphysema
5395432|NCT01742338|Corticosteroids|corticosteroids
5395433|NCT01742325|fatigue|fatigue
5395434|NCT01742325|walking|walking
5395435|NCT01742325|childhood cancer|childhood cancer
5395436|NCT01742325|sleep disturbance|sleep disturbance
5395437|NCT01742312|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5395438|NCT01742312|oesophageal cancer|oesophageal cancer
5395439|NCT01742312|cardiorespiratory performance|cardiorespiratory performance
5395440|NCT01742299|Glivec/Gleevec|glivec/gleevec
5395441|NCT01742299|CML|cml
5395442|NCT01742299|GIST|gist
5395443|NCT01742299|Imatinib mesylate|imatinib mesylate
5395444|NCT01742286|pediatric|pediatric
5395445|NCT01742286|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5395446|NCT01742286|ALK|alk
5395447|NCT01742286|ALK-activated tumors|alk-activated tumors
5395448|NCT01742286|neuroblastoma|neuroblastoma
5395449|NCT01742286|rhabdomyosarcoma|rhabdomyosarcoma
5395450|NCT01742286|anaplastic large-cell lymphoma|anaplastic large-cell lymphoma
5395451|NCT01742286|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
5395452|NCT01742260|Cranioplasty|cranioplasty
5395453|NCT01742260|Mesenchymal stromal cells|mesenchymal stromal cells
5395454|NCT01742260|Bioceramic polymer|bioceramic polymer
5395455|NCT01742247|Moisturizer, laser|moisturizer, laser
5395456|NCT01742221|HemaMax, NM-IL-12, HSARS, Safety|hemamax, nm-il-12, hsars, safety
5395457|NCT01742195|Endobronchial ultrasound|endobronchial ultrasound
5395458|NCT01742195|Bronchoscopy|bronchoscopy
5395459|NCT01742195|Patient satisfaction|patient satisfaction
5395464|NCT01742169|Colorectal Cancer Screening|colorectal cancer screening
5395465|NCT01742169|Fecal Occult Blood Testing|fecal occult blood testing
5395467|NCT01742156|microangiopathy|microangiopathy
5395468|NCT01742156|patients|patients
5395469|NCT01742156|more likely|more likely
5395470|NCT01742156|to have tortuosity|to have tortuosity
5395471|NCT01742156|of conjunctival vessels|of conjunctival vessels
5395472|NCT01742143|Quality of life|quality of life
5395473|NCT01742143|cancer|cancer
5395474|NCT01742143|12-223|12-223
5395475|NCT01742130|Contrast-induced nephropathy|contrast-induced nephropathy
5395476|NCT01742130|Contrast media|contrast media
5378609|NCT01818869|Safety,|safety,
5395482|NCT01742104|primary open-angle glaucoma|primary open-angle glaucoma
5395483|NCT01742104|observational study|observational study
5395484|NCT01742104|quality of life|quality of life
5395485|NCT01742091|Postmenopausal females|postmenopausal females
5395487|NCT01742078|Postmenopausal females|postmenopausal females
5395488|NCT01742078|Volunteers|volunteers
5395489|NCT01742065|Colorectal Cancer Screening|colorectal cancer screening
5395490|NCT01742065|Cancer Screening|cancer screening
5395491|NCT01742065|Pragmatic Trial|pragmatic trial
5395492|NCT01742052|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5395493|NCT01742052|RRMS|rrms
5395696|NCT01741077|folic acid supplementation|folic acid supplementation
5395494|NCT01742026|High risk aspergillosis infection patients|high risk aspergillosis infection patients
5395495|NCT01742013|Chronic Fatigue|chronic fatigue
5395496|NCT01742013|CFS|cfs
5395497|NCT01742013|ICF|icf
5395498|NCT01742013|human placenta|human placenta
5395499|NCT01742000|postmenopause|postmenopause
5395500|NCT01742000|phytoestrogen|phytoestrogen
5395501|NCT01742000|atherosclerosis|atherosclerosis
5395502|NCT01742000|intima-media thickness|intima-media thickness
5395503|NCT01741974|perimenopause|perimenopause
5395504|NCT01741974|phytoestrogen|phytoestrogen
5395505|NCT01741974|atherosclerosis|atherosclerosis
5395506|NCT01741974|intima-media thickness|intima-media thickness
5395507|NCT01741961|uncontrolled glaucoma|uncontrolled glaucoma
5395508|NCT01741961|glaucoma drainage device|glaucoma drainage device
5494799|NCT01316874|CIS|cis
5395509|NCT01741948|Provoked vestibulodynia|provoked vestibulodynia
5395510|NCT01741948|Hormonal contraceptives|hormonal contraceptives
5395511|NCT01741922|Low dose|low dose
5395512|NCT01741922|aspirin|aspirin
5395513|NCT01741922|ASA|asa
5395514|NCT01741922|Hypertension|hypertension
5395515|NCT01741922|blood pressure|blood pressure
5395516|NCT01741909|azythromycin|azythromycin
5395517|NCT01741909|community acquired pneumonia|community acquired pneumonia
5395518|NCT01741909|intravenous|intravenous
5395519|NCT01741909|oral|oral
5395520|NCT01741883|Randomized Controlled Trial|randomized controlled trial
5395521|NCT01741883|Patients´ Expectations|patients´ expectations
5395522|NCT01741883|Breast Cancer|breast cancer
5395523|NCT01741883|Adjuvant Endocrine Treatment|adjuvant endocrine treatment
5395524|NCT01741883|Nocebo|nocebo
5395525|NCT01741870|Nutritional supplement|nutritional supplement
5395526|NCT01741870|Nutritional status|nutritional status
5395527|NCT01741870|Physical functional activity|physical functional activity
5395528|NCT01741870|Nursing home elderly|nursing home elderly
5395529|NCT01741844|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5395530|NCT01741844|TMC125|tmc125
5395531|NCT01741844|Etravirine|etravirine
5395532|NCT01741844|Intelence|intelence
5395533|NCT01741844|AIDS|aids
5395534|NCT01741831|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5395535|NCT01741831|AIDS|aids
5395536|NCT01741831|TMC114|tmc114
5395537|NCT01741831|Darunavir|darunavir
5395538|NCT01741831|Prezista|prezista
5395539|NCT01741818|IVC|ivc
5395540|NCT01741818|ultrasonography|ultrasonography
5395541|NCT01741818|IVC collapsibility index|ivc collapsibility index
5395542|NCT01741818|IVC diameter|ivc diameter
5395543|NCT01741792|Relapsed DLBCL|relapsed dlbcl
5395544|NCT01741792|Refractory DLBCL|refractory dlbcl
5395545|NCT01741792|adult DLBCL|adult dlbcl
5395546|NCT01741792|Lymphoma|lymphoma
5395547|NCT01741792|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5395548|NCT01741792|Lymphatic diseases|lymphatic diseases
5395549|NCT01741792|Lymphoproliferative disorders|lymphoproliferative disorders
5395557|NCT01741779|hypertension|hypertension
5395558|NCT01741779|obesity|obesity
5395559|NCT01741779|arterial function|arterial function
5395560|NCT01741779|arterial stiffness|arterial stiffness
5395561|NCT01741779|pulse wave velocity|pulse wave velocity
5395562|NCT01741779|autonomic function|autonomic function
5395563|NCT01741779|endothelial function|endothelial function
5395564|NCT01741779|adipocytokines|adipocytokines
5395565|NCT01741766|prehypertension|prehypertension
5395566|NCT01741766|hypertension|hypertension
5395567|NCT01741766|obesity|obesity
5395568|NCT01741766|stretching|stretching
5395569|NCT01741766|arterial function|arterial function
5395570|NCT01741766|arterial stiffness|arterial stiffness
5395571|NCT01741766|pulse wave velocity|pulse wave velocity
5395572|NCT01741766|autonomic function|autonomic function
5395573|NCT01741766|endothelial function|endothelial function
5395574|NCT01741753|Docetaxel Pretreated|docetaxel pretreated
5395575|NCT01741753|Castrate Resistant|castrate resistant
5395576|NCT01741753|Metastatic|metastatic
5395582|NCT01741649|Clorhexidine|clorhexidine
5395583|NCT01741649|Povidone|povidone
5395584|NCT01741610|Anaesthesia Spinal|anaesthesia spinal
5395585|NCT01741610|Ephedrine|ephedrine
5381203|NCT01806870|HIV|hiv
5395586|NCT01741610|Fluid Therapy|fluid therapy
5395587|NCT01741610|Hypotension|hypotension
5395588|NCT01741558|Myocardial Ischemia|myocardial ischemia
5395589|NCT01741558|Myocardial Infarction|myocardial infarction
5395590|NCT01741558|Methotrexate|methotrexate
5395591|NCT01741558|Inflammation|inflammation
5395592|NCT01741558|Anti-Inflammatory Agents|anti-inflammatory agents
5395593|NCT01741558|Inflammation Mediators|inflammation mediators
5395594|NCT01741532|Pantothenate Kinase-associated Neurodegeneration|pantothenate kinase-associated neurodegeneration
5395595|NCT01741532|PKAN|pkan
5395596|NCT01741532|NBIA|nbia
5395597|NCT01741532|Deferiprone|deferiprone
5395598|NCT01741532|Ferriprox|ferriprox
5395599|NCT01741532|Neurodegeneration with brain iron accumulation|neurodegeneration with brain iron accumulation
5395601|NCT01741519|PD|pd
5395602|NCT01741519|landiolol|landiolol
5395603|NCT01741519|esmolol|esmolol
5395604|NCT01741519|healthy volunteers phase I study|healthy volunteers phase i study
5395605|NCT01741506|Lung cancer|lung cancer
5395606|NCT01741506|Surgery|surgery
5395607|NCT01741506|Thromboembolism|thromboembolism
5395608|NCT01741506|Bleeding|bleeding
5395609|NCT01741493|Rheumatoid Arthritis|rheumatoid arthritis
5395610|NCT01741493|Methotrexate|methotrexate
5395611|NCT01741493|Tolerability|tolerability
5395612|NCT01741493|Pharmacokinetics|pharmacokinetics
5395613|NCT01741493|Safety|safety
5395614|NCT01741493|Tofacitinib|tofacitinib
5395615|NCT01741480|Outcomes|outcomes
5395616|NCT01741480|Early warning systems|early warning systems
5395617|NCT01741480|ICU transfer|icu transfer
5395618|NCT01741454|Tolterodine|tolterodine
5395619|NCT01741454|Tamsulosin|tamsulosin
5395620|NCT01741454|Ureteral Obstruction|ureteral obstruction
5382987|NCT01799291|Assessment|assessment
5395621|NCT01741441|Duodenogastroesophageal reflux|duodenogastroesophageal reflux
5395622|NCT01741441|Weakly acidic reflux|weakly acidic reflux
5395623|NCT01741441|Gastric emptying|gastric emptying
5395624|NCT01741441|Laparoscopic fundoplication|laparoscopic fundoplication
5395634|NCT01741402|Control posture|control posture
5395635|NCT01741402|Gait|gait
5395636|NCT01741402|Virtual Reality|virtual reality
5395637|NCT01741402|Elderly|elderly
5395638|NCT01741389|Circadian variation, hemostasis, melatonin, tetraplegia|circadian variation, hemostasis, melatonin, tetraplegia
5395639|NCT01741363|iFOBT|ifobt
5395640|NCT01741363|one-day sample|one-day sample
5395641|NCT01741363|two-day sample|two-day sample
5395642|NCT01741363|Helicobacter pylori stool antigen|helicobacter pylori stool antigen
5395643|NCT01741350|Methadone-maintenance|methadone-maintenance
5395644|NCT01741350|HIV|hiv
5395645|NCT01741350|Risk behavior|risk behavior
5395646|NCT01741350|Injection drug use|injection drug use
5395647|NCT01741350|Condom use|condom use
5395648|NCT01741350|Health care participation|health care participation
5395649|NCT01741350|Opioid replacement therapy|opioid replacement therapy
5395650|NCT01741337|central sleep apneas syndrome|central sleep apneas syndrome
5395651|NCT01741337|heart failure|heart failure
5395652|NCT01741337|all coronary reperfusions|all coronary reperfusions
5395653|NCT01741337|adaptive servo-ventilation treatment|adaptive servo-ventilation treatment
5395654|NCT01741311|viral load|viral load
5395656|NCT01741311|CD4|cd4
5395657|NCT01741311|methadone maintenance|methadone maintenance
5395658|NCT01741311|substance use|substance use
5395659|NCT01741311|Antiretroviral therapy (ART)|antiretroviral therapy (art)
5395660|NCT01741298|Metabolic syndrome|metabolic syndrome
5395661|NCT01741285|Asthma|asthma
5395662|NCT01741285|Adenosine|adenosine
5395663|NCT01741285|Small airways|small airways
5395664|NCT01741285|Smokers|smokers
5395665|NCT01741285|Ex-smokers|ex-smokers
5395666|NCT01741272|rotator cuff tear|rotator cuff tear
5395667|NCT01741272|arthroscopically assisted|arthroscopically assisted
5395668|NCT01741272|health related quality of life(HRQL)|health related quality of life(hrql)
5395669|NCT01741272|functional outcome|functional outcome
5395670|NCT01741259|analgesia|analgesia
5395671|NCT01741259|meperidine|meperidine
5395672|NCT01741259|epidural|epidural
5395673|NCT01741246|Episodic migraine|episodic migraine
5395674|NCT01741246|Chronic migraine|chronic migraine
5395675|NCT01741246|Magnetic resonance imaging|magnetic resonance imaging
5395676|NCT01741246|Positron emission tomography|positron emission tomography
5395677|NCT01741233|SNPs|snps
5395678|NCT01741233|vitamin D|vitamin d
5395679|NCT01741233|Vitamin D status|vitamin d status
5395680|NCT01741233|UVB irradiation|uvb irradiation
5395681|NCT01741233|genetics|genetics
5395683|NCT01741181|Diabetes mellitus|diabetes mellitus
5395684|NCT01741181|Endothelial Function|endothelial function
5395685|NCT01741142|Major Depressive Disorder|major depressive disorder
5395686|NCT01741129|Nasal CPAP|nasal cpap
5395687|NCT01741129|Nasal IMV|nasal imv
5395688|NCT01741129|Surfactant|surfactant
5395689|NCT01741129|Preterm infants|preterm infants
5395690|NCT01741116|castration-resistant prostate cancer|castration-resistant prostate cancer
5395692|NCT01741116|FGF23|fgf23
5395693|NCT01741090|Autologous Mesenchymal stem cell|autologous mesenchymal stem cell
5395694|NCT01741090|alcoholic liver cirrhosis|alcoholic liver cirrhosis
5395697|NCT01741077|reproduction|reproduction
5395698|NCT01741077|folate|folate
5395699|NCT01741064|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5395700|NCT01741064|Renal Transplantation|renal transplantation
5395701|NCT01741064|Myocardial Infarction|myocardial infarction
5395702|NCT01741064|Fracture|fracture
5395703|NCT01741064|Graft Failure|graft failure
5395704|NCT01741051|Air pollution|air pollution
5395705|NCT01741051|Particulate matter|particulate matter
5395706|NCT01741051|Mongolia|mongolia
5395707|NCT01741051|Pregnancy|pregnancy
5395708|NCT01741051|Intrauterine growth restriction (IUGR)|intrauterine growth restriction (iugr)
5395709|NCT01741051|Fetal growth|fetal growth
5395710|NCT01741051|Birth weight|birth weight
5395711|NCT01741051|Gestational age|gestational age
5395712|NCT01741051|Obesity|obesity
5395714|NCT01741051|Autism|autism
5395715|NCT01741051|Wheeze|wheeze
5395716|NCT01741038|Cancer Vaccine|cancer vaccine
5395717|NCT01741038|AlloStim®|allostim®
5395718|NCT01741038|Immunovative|immunovative
5395719|NCT01741038|Immunotherapy|immunotherapy
5395720|NCT01741038|Allogeneic Cell Therapy|allogeneic cell therapy
5395721|NCT01741038|Cryoablation|cryoablation
5395722|NCT01741012|Lupus|lupus
5395723|NCT01740986|Asthma|asthma
5395724|NCT01740973|SILC|silc
5395725|NCT01740973|lap. cholecystectomy|lap. cholecystectomy
5395726|NCT01740973|trocar-site hernia|trocar-site hernia
5395727|NCT01740960|delta-9-tetrahydrocannabinol|delta-9-tetrahydrocannabinol
5395729|NCT01740960|Cannabis|cannabis
5395730|NCT01740947|Selective decontamination of the digestive tract|selective decontamination of the digestive tract
5395731|NCT01740947|anastomotic leakage|anastomotic leakage
5395732|NCT01740947|colorectal cancer|colorectal cancer
5395733|NCT01740934|rosacea|rosacea
5002926|NCT03977792|Herpesviridae Infections|herpesviridae infections
5395735|NCT01740934|Anatabloc|anatabloc
5395736|NCT01740934|dermatology|dermatology
5395737|NCT01740921|GLP-1 analogues|glp-1 analogues
5395738|NCT01740921|microvascular|microvascular
5395739|NCT01740921|inflammation|inflammation
5395740|NCT01740921|fat tissue|fat tissue
5395741|NCT01740921|clot structure|clot structure
5395742|NCT01740908|hyperbaric oxygen|hyperbaric oxygen
5395743|NCT01740908|stem cell|stem cell
5395744|NCT01740882|incisional hernia|incisional hernia
5395745|NCT01740882|mesh fixation|mesh fixation
5395746|NCT01740882|absorbable tacks|absorbable tacks
5395747|NCT01740869|autism|autism
5395748|NCT01740869|autism spectrum|autism spectrum
5395749|NCT01740869|stem cells|stem cells
5395750|NCT01740869|children|children
5395751|NCT01740856|cardiac catheterization|cardiac catheterization
5395752|NCT01740856|safety|safety
5395753|NCT01740856|nursing care|nursing care
5395754|NCT01740856|rest|rest
5395755|NCT01740856|Patients|patients
5395756|NCT01740817|diabetes|diabetes
5395757|NCT01740817|obesity|obesity
5395758|NCT01740817|inflammation|inflammation
5395759|NCT01740804|Circulating tumor cell|circulating tumor cell
5395760|NCT01740804|Non-small cell lung cancer|non-small cell lung cancer
5395761|NCT01740804|chemotherapy|chemotherapy
5395762|NCT01740791|Hepatitis C|hepatitis c
5395763|NCT01740791|HCV|hcv
5395764|NCT01740791|Genotype 1|genotype 1
5395765|NCT01740791|Genotype 2|genotype 2
5395766|NCT01740791|Genotype 3|genotype 3
5395767|NCT01740791|Genotype 4|genotype 4
5395768|NCT01740791|Genotype 5|genotype 5
5395769|NCT01740791|Genotype 6|genotype 6
5395770|NCT01740791|Liver Disease|liver disease
5395771|NCT01740778|Diabetes|diabetes
5395772|NCT01740778|Medical Device|medical device
5395773|NCT01740778|Lancing|lancing
5395774|NCT01740752|anorexia nervosa|anorexia nervosa
5395775|NCT01740752|eating disorder|eating disorder
5395776|NCT01740752|couples|couples
5395777|NCT01740752|relationships|relationships
5395778|NCT01740752|couple therapy|couple therapy
5395779|NCT01740739|Health Risk Appraisal|health risk appraisal
5395780|NCT01740739|HCardiac Risk Factors|hcardiac risk factors
5395781|NCT01740726|Depression|depression
5395782|NCT01740726|Behavioral Activation|behavioral activation
5395783|NCT01740726|Fluoxetine|fluoxetine
5395784|NCT01740726|Prozac|prozac
5395785|NCT01740726|Treatment|treatment
5395786|NCT01740726|Therapy|therapy
5395787|NCT01740726|Psychotherapy|psychotherapy
5395788|NCT01740726|Antidepressant|antidepressant
5395789|NCT01740726|Intervention|intervention
5395790|NCT01740713|chronic iron overload|chronic iron overload
5395792|NCT01740713|beta thalassaemia major|beta thalassaemia major
5395793|NCT01740700|Abdominal aortic aneurysm|abdominal aortic aneurysm
5395794|NCT01740700|Endovascular|endovascular
5395795|NCT01740700|Fenestration|fenestration
5395796|NCT01740700|Juxtarenal|juxtarenal
5395797|NCT01740700|Off-the-shelf|off-the-shelf
5395798|NCT01740700|Pararenal|pararenal
5395799|NCT01740687|Endometrial Ablation|endometrial ablation
5395800|NCT01740687|Permanent Sterilization|permanent sterilization
5395801|NCT01740687|Essure|essure
5395802|NCT01740687|NovaSure|novasure
5395803|NCT01740687|Prevention of Pregnancy|prevention of pregnancy
5395813|NCT01740648|Fluorouracil|fluorouracil
5395814|NCT01740635|rehabilitation|rehabilitation
5395815|NCT01740635|wheelchair|wheelchair
5395816|NCT01740635|manual wheelchair|manual wheelchair
5395817|NCT01740635|wheelchair users|wheelchair users
5395818|NCT01740635|older adults|older adults
5395819|NCT01740635|cognitive computer games|cognitive computer games
5395820|NCT01740635|home-based training|home-based training
5378918|NCT01817348|Frozen shoulder|frozen shoulder
5395821|NCT01740635|community mobility|community mobility
5395822|NCT01740622|Injury|injury
5395823|NCT01740622|Injury Prevention|injury prevention
5395824|NCT01740622|Cincinnati Home Injury Prevention|cincinnati home injury prevention
5395825|NCT01740622|Injury Hazards|injury hazards
5395826|NCT01740622|Modifiable Injury Hazards|modifiable injury hazards
5395827|NCT01740609|Phase 1|phase 1
5395828|NCT01740609|RN168|rn168
5395829|NCT01740609|Healthy Volunteers|healthy volunteers
5395830|NCT01740596|NYHA III|nyha iii
5395831|NCT01740596|NYHA IV|nyha iv
5395832|NCT01740596|ACC Stage C|acc stage c
5395833|NCT01740596|Heart Failure|heart failure
5395834|NCT01740596|Congestive Heart Failure|congestive heart failure
5395835|NCT01740596|C-Pulse|c-pulse
5395836|NCT01740596|Counterpulsation|counterpulsation
5395837|NCT01740596|Heart Assist|heart assist
5395838|NCT01740596|Sunshine Heart|sunshine heart
5395839|NCT01740596|Left Heart Failure|left heart failure
5395840|NCT01740583|mitral valve, regurgitation, annuloplasty|mitral valve, regurgitation, annuloplasty
5395841|NCT01740570|Brain cancer|brain cancer
5395842|NCT01740570|Malignant glioma|malignant glioma
5395843|NCT01740570|Glioblastoma multiforme|glioblastoma multiforme
5395844|NCT01740570|Gliosarcoma|gliosarcoma
5395845|NCT01740570|Anaplastic astrocytoma|anaplastic astrocytoma
5395846|NCT01740570|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5002929|NCT03977766|digital application|digital application
5395847|NCT01740570|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5395848|NCT01740570|Cabazitaxel|cabazitaxel
5395849|NCT01740570|Jevtana|jevtana
5395850|NCT01740531|S303 treated RBCs|s303 treated rbcs
5395851|NCT01740505|energy cost of walking|energy cost of walking
5395852|NCT01740505|energy metabolism|energy metabolism
5395853|NCT01740505|aged|aged
5395854|NCT01740505|older adult|older adult
5395855|NCT01740505|exercise|exercise
5395856|NCT01740505|gait|gait
5395857|NCT01740505|walking|walking
5395858|NCT01740505|aerobic|aerobic
5395859|NCT01740505|motor skill|motor skill
5395860|NCT01740492|Ketamine|ketamine
5395861|NCT01740492|Acute pain|acute pain
5395862|NCT01740492|Pain control|pain control
5395863|NCT01740492|Pain|pain
5395864|NCT01740479|STEMI|stemi
5395865|NCT01740479|ticagrelor|ticagrelor
5395866|NCT01740479|multi-vessel disease|multi-vessel disease
5395867|NCT01740479|culprit lesion|culprit lesion
5395868|NCT01740466|Prevalence|prevalence
5395869|NCT01740466|Vision disorders|vision disorders
5395870|NCT01740466|Eye diseases|eye diseases
5395871|NCT01740466|Visual acuity|visual acuity
5395872|NCT01740466|Primary health care|primary health care
5395873|NCT01740440|Healthy females|healthy females
5395882|NCT01740414|prescription opioid abuse|prescription opioid abuse
5395884|NCT01740414|opioid withdrawal|opioid withdrawal
5395885|NCT01740414|oxycodone|oxycodone
5395886|NCT01740414|ibudilast|ibudilast
5395887|NCT01740401|Melanoma|melanoma
5395888|NCT01740401|Advanced Malignant Melanoma|advanced malignant melanoma
5395889|NCT01740401|Anti CTLA4 Blockade|anti ctla4 blockade
5395890|NCT01740401|Progression Free Survival|progression free survival
5395891|NCT01740401|Interventional Therapy|interventional therapy
5395892|NCT01740401|Phase II Clinical Trial|phase ii clinical trial
5395893|NCT01740401|Immunotherapy|immunotherapy
5395894|NCT01740401|T Cell Activation|t cell activation
5395895|NCT01740362|CP-690|cp-690
5395896|NCT01740362|550|550
5395897|NCT01740362|pharmacokinetics|pharmacokinetics
5395898|NCT01740362|renal impairment|renal impairment
5395899|NCT01740323|Breast Cancer|breast cancer
5395900|NCT01740323|Chemotherapy|chemotherapy
5395901|NCT01740323|Radiotherapy|radiotherapy
5395902|NCT01740323|NF-kB|nf-kb
5395903|NCT01740323|DNA Binding|dna binding
5395904|NCT01740323|Curcumin|curcumin
5395905|NCT01740323|IL-6|il-6
5395906|NCT01740323|TNF|tnf
5395907|NCT01740323|sTNFR2|stnfr2
5395908|NCT01740323|IL-1-ra|il-1-ra
5395909|NCT01740323|Fatigue|fatigue
5395911|NCT01740310|pregnancy,|pregnancy,
5395912|NCT01740310|vaccine acceptance,|vaccine acceptance,
5395913|NCT01740310|vaccination,|vaccination,
5395915|NCT01740310|pertussis,|pertussis,
5395916|NCT01740310|Tdap,|tdap,
5395917|NCT01740310|minority,|minority,
5395918|NCT01740310|African-American|african-american
5395919|NCT01740297|melanoma|melanoma
5395920|NCT01740297|talimogene laherparepvec|talimogene laherparepvec
5395921|NCT01740297|ipilimumab|ipilimumab
5395922|NCT01740297|immunotherapy|immunotherapy
5395923|NCT01740271|breast cancer|breast cancer
5395924|NCT01740271|non-metastatic carcinoma of the breast chemotherapy|non-metastatic carcinoma of the breast chemotherapy
5395925|NCT01740271|adjuvant therapy|adjuvant therapy
5395927|NCT01740258|malignant glioma|malignant glioma
5395928|NCT01740258|Grade 4 malignant glioma|grade 4 malignant glioma
5395929|NCT01740258|glioblastoma|glioblastoma
5395930|NCT01740258|gliosarcoma|gliosarcoma
5395931|NCT01740258|adult brain tumor|adult brain tumor
5395932|NCT01740245|Laser therapy|laser therapy
5395933|NCT01740245|Cervical lesions|cervical lesions
5395934|NCT01740245|Polyhexamethylene biguanide|polyhexamethylene biguanide
5395935|NCT01740245|Chlorhexidine|chlorhexidine
5395936|NCT01740219|Health promotion|health promotion
5395937|NCT01740219|Religion and medicine|religion and medicine
5395938|NCT01740219|Hispanic Americans|hispanic americans
5395939|NCT01740219|Randomized controlled trial|randomized controlled trial
5395940|NCT01740219|Program evaluation|program evaluation
5395941|NCT01740219|Neoplasms/prevention & control|neoplasms/prevention & control
5395942|NCT01740219|Mass screening|mass screening
5395943|NCT01740219|Female|female
5395944|NCT01740219|Male|male
5395945|NCT01740219|Preventive Health Services/methods|preventive health services/methods
5395946|NCT01740219|Adult|adult
5395947|NCT01740219|Organizations|organizations
5395948|NCT01740193|Pain|pain
5395949|NCT01740193|Regional Anesthesia|regional anesthesia
5395950|NCT01740193|ultrasound|ultrasound
5395951|NCT01740193|transversus abdominis plane|transversus abdominis plane
5395952|NCT01740193|herniorrhaphy|herniorrhaphy
5395953|NCT01740193|pediatrics|pediatrics
5395954|NCT01740167|prodrome|prodrome
5395955|NCT01740167|mental illness|mental illness
5395956|NCT01740167|health promotion|health promotion
5395957|NCT01740167|lifestyle behavior|lifestyle behavior
5395958|NCT01740141|Pain|pain
5395959|NCT01740128|spinal cord injuries|spinal cord injuries
5395960|NCT01740128|paraplegia|paraplegia
5395961|NCT01740128|postural balance|postural balance
5395962|NCT01740128|locomotor activity|locomotor activity
5395963|NCT01740128|exercise therapy|exercise therapy
5395964|NCT01740128|electromyography|electromyography
5395965|NCT01740128|transcranial magnetic stimulation, single pulse|transcranial magnetic stimulation, single pulse
5395966|NCT01740115|HIV|hiv
5395967|NCT01740115|Alcohol Use|alcohol use
5395968|NCT01740115|Bone Disease|bone disease
5395969|NCT01740115|Bone Mineral Density|bone mineral density
5395970|NCT01740115|Bone Microarchitecture|bone microarchitecture
5395971|NCT01740115|Substance Dependence|substance dependence
5395972|NCT01740102|Ischemic preconditioning|ischemic preconditioning
5395973|NCT01740102|Coronary artery bypass|coronary artery bypass
5395974|NCT01740102|Preoperative care|preoperative care
5395975|NCT01740102|Postoperative period|postoperative period
5395976|NCT01740089|Hepatitis C|hepatitis c
5395977|NCT01740089|Cepeginterferon alfa|cepeginterferon alfa
5395978|NCT01740089|Peginterferon|peginterferon
5395979|NCT01740089|Treatment|treatment
5395980|NCT01740076|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes|isoflavones, hypertension, soy, diet, nutrition, women, inflammation, hot flashes
5395981|NCT01740037|Integrated chronic care program|integrated chronic care program
5395982|NCT01740037|specialized outpatient AF clinic|specialized outpatient af clinic
5395983|NCT01740037|Atrial Fibrillation guideline|atrial fibrillation guideline
5395985|NCT01740024|Subcutaneous immunotherapy|subcutaneous immunotherapy
5395986|NCT01740024|Skin Prick Test|skin prick test
5395987|NCT01740024|Dose Response Prick Test|dose response prick test
5395988|NCT01739985|Postoperative|postoperative
5395989|NCT01739985|Vomiting|vomiting
5395990|NCT01739985|Children|children
5395991|NCT01739985|Prophylaxis|prophylaxis
5395992|NCT01739985|Droperidol|droperidol
5395993|NCT01739985|Ondansetron|ondansetron
5395994|NCT01739985|Dexamethasone|dexamethasone
5395995|NCT01739972|Desiccated thyroid extract and levothyroxine|desiccated thyroid extract and levothyroxine
5395996|NCT01739959|Necrotizing fasciitis|necrotizing fasciitis
5395997|NCT01739959|Fournier's gangrene|fournier's gangrene
5395998|NCT01739959|Cellulitis|cellulitis
5395999|NCT01739959|Serum Lactate|serum lactate
5396000|NCT01739933|Delirium|delirium
5396001|NCT01739933|Delirium/coma-free days|delirium/coma-free days
5396002|NCT01739933|Long term cognitive impairment|long term cognitive impairment
5396003|NCT01739933|Sedation|sedation
5396004|NCT01739933|Intensive care|intensive care
5396005|NCT01739933|Mechanical Ventilation|mechanical ventilation
5396006|NCT01739933|Dexmedetomidine|dexmedetomidine
5396007|NCT01739933|Propofol|propofol
5396008|NCT01739933|Coma-free days|coma-free days
5396009|NCT01739933|Sepsis|sepsis
5396010|NCT01739933|Organ dysfunction|organ dysfunction
5396011|NCT01739933|Acute Respiratory Distress|acute respiratory distress
5396025|NCT01739894|cancer cells on peritoneal cytology|cancer cells on peritoneal cytology
5396026|NCT01739881|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
5396027|NCT01739881|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
5396029|NCT01739881|Confocal Endoscopy|confocal endoscopy
5396030|NCT01739881|Exhaled alveolar gas|exhaled alveolar gas
5396031|NCT01739868|Pre-diabetes|pre-diabetes
5396032|NCT01739868|Type 2 diabetes|type 2 diabetes
5396033|NCT01739868|Biomarkers|biomarkers
5396034|NCT01739868|Diabetes risk score|diabetes risk score
5396035|NCT01739842|Alcohol consumption|alcohol consumption
5396036|NCT01739842|Kudzu extract|kudzu extract
5396037|NCT01739842|Cerebral blood flow|cerebral blood flow
5396038|NCT01739829|xenotransplantation|xenotransplantation
5396039|NCT01739829|type 1 diabetes|type 1 diabetes
5396040|NCT01739829|porcine islets|porcine islets
5396041|NCT01739816|Compliance|compliance
5396042|NCT01739816|Adherence|adherence
5396043|NCT01739816|Polypharmacy|polypharmacy
5396044|NCT01739816|Medicines use|medicines use
5396045|NCT01739816|Medication review|medication review
5396046|NCT01739816|Pharmaceutical care|pharmaceutical care
5396047|NCT01739816|Primary care|primary care
5396048|NCT01739816|Drug related problem|drug related problem
5396049|NCT01739816|Patient safety|patient safety
5396050|NCT01739803|Immunosuppressant therapy adherence|immunosuppressant therapy adherence
5396051|NCT01739803|Quality of life|quality of life
5396052|NCT01739803|Economic outcomes|economic outcomes
5396053|NCT01739790|COPD|copd
5396054|NCT01739790|Chronic Bronchitis|chronic bronchitis
5396055|NCT01739790|N-acetylcysteine|n-acetylcysteine
5396056|NCT01739777|Heart Failure|heart failure
5396057|NCT01739777|Coronary Heart Disease|coronary heart disease
5396058|NCT01739777|Adult Stem Cells|adult stem cells
5396059|NCT01739777|Umbilical Progenitor Cells|umbilical progenitor cells
5396060|NCT01739777|Umbilical Cord Stem Cells Allogenic|umbilical cord stem cells allogenic
5396061|NCT01739777|Left Ventricular Function|left ventricular function
5396062|NCT01739777|Intravenous Injection|intravenous injection
5396063|NCT01739751|COPD|copd
5396064|NCT01739751|Physical activity|physical activity
5396065|NCT01739751|Pedometers|pedometers
5396066|NCT01739751|steps|steps
5396067|NCT01739751|non pharmacological treatment|non pharmacological treatment
5396068|NCT01739751|rehabilitation|rehabilitation
5396069|NCT01739751|exercise|exercise
5396070|NCT01739738|peristalsis, kidney stones, hydronephrosis, ureteral stent|peristalsis, kidney stones, hydronephrosis, ureteral stent
5396071|NCT01739725|kidney stones, ureteral stent, pain,|kidney stones, ureteral stent, pain,
5396072|NCT01739712|Diabetes|diabetes
5396073|NCT01739712|Sleep problems|sleep problems
5396074|NCT01739712|School|school
5396081|NCT01739686|Symptoms|symptoms
5396082|NCT01739686|Palliative care|palliative care
5396083|NCT01739686|Symptom management|symptom management
5396084|NCT01739686|Disease management|disease management
5396085|NCT01739686|Health delivery|health delivery
5396086|NCT01739673|Infectious Keratitis|infectious keratitis
5396087|NCT01739660|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
5396088|NCT01739660|Hemodialysis|hemodialysis
5396089|NCT01739660|pegloticase|pegloticase
5396090|NCT01739647|AZD3293|azd3293
5396091|NCT01739647|Healthy volunteers|healthy volunteers
5396092|NCT01739647|Elderly volunteers|elderly volunteers
5396093|NCT01739647|Phase 1|phase 1
5396094|NCT01739647|Single Ascending Dose Study|single ascending dose study
5396095|NCT01739634|Diarrhea|diarrhea
5396096|NCT01739634|Medullary thyroid cancer|medullary thyroid cancer
5396098|NCT01739569|Diet treatment|diet treatment
5396099|NCT01739569|Mental Health|mental health
5396103|NCT01739569|Medical Hospital Staff|medical hospital staff
5396104|NCT01739556|antiplatelet therapy|antiplatelet therapy
5396106|NCT01739556|modification|modification
5396107|NCT01739517|Short bowel syndrome|short bowel syndrome
5396108|NCT01739517|Cholestasis|cholestasis
5396109|NCT01739517|Omegaven|omegaven
5396110|NCT01739517|Parenteral nutrition-associated Liver Disease|parenteral nutrition-associated liver disease
5396111|NCT01739504|Arthritis|arthritis
5396112|NCT01739504|Joint pain|joint pain
5396113|NCT01739504|Articular cartilage|articular cartilage
5396114|NCT01739504|Mesenchymal stem cells|mesenchymal stem cells
5396115|NCT01739504|Autologous|autologous
5396116|NCT01739504|Adipose tissue|adipose tissue
5396117|NCT01739491|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5396118|NCT01739491|Bendamustine hydrochloride|bendamustine hydrochloride
5396119|NCT01739491|Leukemia|leukemia
5396120|NCT01739491|Filipino|filipino
5396121|NCT01739465|Cholangiocarcinoma|cholangiocarcinoma
5396122|NCT01739465|Pathologic|pathologic
5396123|NCT01739465|Digestive System|digestive system
5396124|NCT01739465|Neoplasms|neoplasms
5396125|NCT01739465|Neoplasms by Site|neoplasms by site
5396126|NCT01739465|Digestive System Diseases|digestive system diseases
5396127|NCT01739465|Bile Duct Diseases|bile duct diseases
5396128|NCT01739465|Biliary Tract Diseases|biliary tract diseases
5396129|NCT01739465|Pathological Conditions|pathological conditions
5396130|NCT01739465|Constriction|constriction
5396131|NCT01739465|Adenocarcinoma|adenocarcinoma
5396132|NCT01739465|Carcinoma|carcinoma
5396133|NCT01739452|Low-risk MDS|low-risk mds
5396134|NCT01739452|myelodysplastic syndrome|myelodysplastic syndrome
5396135|NCT01739452|retrospective|retrospective
5396136|NCT01739426|LigaSure V (TM)|ligasure v (tm)
5396137|NCT01739400|Eisenmenger Syndrome|eisenmenger syndrome
5396138|NCT01739400|exercise capacity|exercise capacity
5396139|NCT01739387|Flutiform®|flutiform®
5396141|NCT01739387|COPD|copd
5396142|NCT01739374|pelvic floor reconstruction|pelvic floor reconstruction
5396143|NCT01739374|mesh implants|mesh implants
5396144|NCT01739335|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5396145|NCT01739335|Mifepristone|mifepristone
5396146|NCT01739335|Veterans|veterans
5396147|NCT01739335|Clinical Trial|clinical trial
5396148|NCT01739322|skin prick test|skin prick test
5396149|NCT01739322|inmunotherapy|inmunotherapy
5396150|NCT01739322|standarization|standarization
5396151|NCT01739309|Non- Hodgkins Lymphoma|non- hodgkins lymphoma
5396152|NCT01739296|osteoarthritis|osteoarthritis
5396153|NCT01739296|osteoarthritis, knee|osteoarthritis, knee
5396154|NCT01739296|foot orthoses|foot orthoses
5396155|NCT01739296|orthotic insoles|orthotic insoles
5396156|NCT01739270|analgesia|analgesia
5396157|NCT01739270|regional anesthesia|regional anesthesia
5396158|NCT01739270|surgery|surgery
5396159|NCT01739270|duration of analgesia|duration of analgesia
5396160|NCT01739270|dexamethasone added to levobupivacaine compared to levobupivacaine alone|dexamethasone added to levobupivacaine compared to levobupivacaine alone
5396161|NCT01739244|Glaucoma|glaucoma
5396162|NCT01739244|Open Angle Glaucoma|open angle glaucoma
5396163|NCT01739244|Ocular Hypertension|ocular hypertension
5396165|NCT01739244|RNAi|rnai
5396166|NCT01739244|siRNA|sirna
5396167|NCT01739244|beta inhibitor|beta inhibitor
5396168|NCT01739205|Type 2 diabetes and depression|type 2 diabetes and depression
5396169|NCT01739179|Ventricular peritoneal Shunt|ventricular peritoneal shunt
5396170|NCT01739179|Shunt Complications|shunt complications
5396171|NCT01739179|Shunt Failure|shunt failure
5396172|NCT01739179|Hydrocephalus|hydrocephalus
5396173|NCT01739166|Health Services Research|health services research
5396174|NCT01739166|Quality Assurance|quality assurance
5396175|NCT01739153|Dairy|dairy
5396176|NCT01739153|Cheese|cheese
5396177|NCT01739153|Blood lipid concentrations|blood lipid concentrations
5369175|NCT01860989|parasitemia|parasitemia
5396178|NCT01739153|Blood lipid sizes|blood lipid sizes
5396179|NCT01739153|Fecal fat|fecal fat
5396180|NCT01739153|Fat digestibility|fat digestibility
5396181|NCT01739153|bile acids|bile acids
5396182|NCT01739127|Antipsychotic agents|antipsychotic agents
5396183|NCT01739127|Adverse effects|adverse effects
5396184|NCT01739127|Magnetic Resonance Imaging|magnetic resonance imaging
5396185|NCT01739114|Lung aeration|lung aeration
5396186|NCT01739114|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5396187|NCT01739114|Positive Pressure Respiration|positive pressure respiration
5396188|NCT01739114|Sustained Inflation|sustained inflation
5396189|NCT01739114|Continuous Positive Airway Pressure|continuous positive airway pressure
5396190|NCT01739088|Congenital heart disease|congenital heart disease
5396191|NCT01739088|pediatrics|pediatrics
5396192|NCT01739088|ischemia-reperfusion injury|ischemia-reperfusion injury
5396193|NCT01739088|long term outcomes|long term outcomes
5396194|NCT01739062|PSA test|psa test
5396195|NCT01739062|Prostate cancer|prostate cancer
5396197|NCT01739036|Malaria|malaria
5396198|NCT01739036|Vaccine|vaccine
5396199|NCT01739036|Plasmodium|plasmodium
5396200|NCT01739036|Falciparum|falciparum
5396201|NCT01739023|paraplegia|paraplegia
5396202|NCT01739023|cell therapy|cell therapy
5396203|NCT01739023|Schwann cells|schwann cells
5396204|NCT01739023|spinal cord injury|spinal cord injury
5396205|NCT01738997|Benign|benign
5396206|NCT01738997|Esophageal strictures|esophageal strictures
5396207|NCT01738997|Esophagus|esophagus
5396208|NCT01738997|Balloon Dilation|balloon dilation
5396209|NCT01738984|exercise|exercise
5396210|NCT01738984|video|video
5396211|NCT01738984|DVD|dvd
5396212|NCT01738984|mother|mother
5396213|NCT01738984|infant|infant
5396214|NCT01738971|emergency contraception|emergency contraception
5396215|NCT01738971|community pharmacy|community pharmacy
5396216|NCT01738958|Probiotic bacteria|probiotic bacteria
5396217|NCT01738958|Caries dentalis|caries dentalis
5396218|NCT01738958|QLF|qlf
5396219|NCT01738932|endometriosis|endometriosis
5396220|NCT01738932|mannan-binding lectin|mannan-binding lectin
5396221|NCT01738932|immunology|immunology
5396222|NCT01738893|Gabapentin|gabapentin
5396223|NCT01738893|Bioequivalence|bioequivalence
5396224|NCT01738893|Pharmacokinetics|pharmacokinetics
5396225|NCT01738893|Mexico|mexico
5396226|NCT01738867|Pharmacogenetics|pharmacogenetics
5396227|NCT01738867|OPRM1|oprm1
5396228|NCT01738867|Pharmacodynamics|pharmacodynamics
5396229|NCT01738867|Addiction|addiction
5396230|NCT01738867|mu opioid receptors|mu opioid receptors
5396231|NCT01738854|laryngeal mask airway supreme|laryngeal mask airway supreme
5396232|NCT01738854|airway sealing|airway sealing
5396233|NCT01738854|intracuff pressure|intracuff pressure
5396234|NCT01738841|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
5396235|NCT01738841|Priorix-Tetra™|priorix-tetra™
5396236|NCT01738841|MMRV|mmrv
5396237|NCT01738841|children|children
5396238|NCT01738841|Post-marketing surveillance|post-marketing surveillance
5396239|NCT01738841|Philippines|philippines
5396240|NCT01738815|bladder cancer|bladder cancer
5396241|NCT01738815|hematuria|hematuria
5396242|NCT01738815|sodium valproate|sodium valproate
5396243|NCT01738815|valproic acid|valproic acid
5396244|NCT01738802|Type 2 Diabetes|type 2 diabetes
5396245|NCT01738802|carotid intima medial thickness|carotid intima medial thickness
5396246|NCT01738802|micronutrient|micronutrient
5396247|NCT01738802|anti-oxidant|anti-oxidant
5396248|NCT01738789|Adnexal masses|adnexal masses
5396249|NCT01738789|Magnetic resonance imaging|magnetic resonance imaging
5396250|NCT01738789|Ovarian tumor|ovarian tumor
5396251|NCT01738776|hip fracture|hip fracture
5396252|NCT01738776|risk factors|risk factors
5396253|NCT01738776|vitamin K1|vitamin k1
5396254|NCT01738776|vitamin D|vitamin d
5396255|NCT01738776|bone turnover markers|bone turnover markers
5396256|NCT01738776|osteocalcin|osteocalcin
5396257|NCT01738776|undercarboxylated osteocalcin|undercarboxylated osteocalcin
5396258|NCT01738776|bone specific alkaline phosphatase (BALP)|bone specific alkaline phosphatase (balp)
5396259|NCT01738776|insulin like growth factor 1 (IGF1)|insulin like growth factor 1 (igf1)
5396260|NCT01738776|parathyroid hormone (PTH)|parathyroid hormone (pth)
5396261|NCT01738763|Glucose|glucose
5396262|NCT01738763|Insulin|insulin
5396263|NCT01738763|3-O-methyl-D-chiro-inositol|3-o-methyl-d-chiro-inositol
5396264|NCT01738750|surgical choice|surgical choice
5396265|NCT01738750|cost of care|cost of care
5396266|NCT01738750|decision making|decision making
5396267|NCT01738750|health care|health care
5396268|NCT01738750|health care cost|health care cost
5396269|NCT01738750|pediatric|pediatric
5396270|NCT01738750|children|children
5396271|NCT01738750|appendicitis|appendicitis
5396272|NCT01738750|patient satisfaction|patient satisfaction
5396273|NCT01738711|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5396274|NCT01738711|Cognitive behavioural therapy|cognitive behavioural therapy
5396276|NCT01738711|Quality of life|quality of life
5396277|NCT01738685|Breast Cancer.|breast cancer.
5396278|NCT01738685|Adjuvant Endocrine therapy.|adjuvant endocrine therapy.
5396279|NCT01738672|Nitrous oxide|nitrous oxide
5396280|NCT01738672|labor and delivery|labor and delivery
5396281|NCT01738672|analgesia|analgesia
5396282|NCT01738659|sodium ,diuretics, PCWP|sodium ,diuretics, pcwp
5396283|NCT01738646|vorinostat|vorinostat
5396284|NCT01738646|SAHA|saha
5396285|NCT01738646|bevacizumab|bevacizumab
5396286|NCT01738646|AVASTIN|avastin
5396287|NCT01738646|malignant glioma|malignant glioma
5396288|NCT01738646|GBM|gbm
5396289|NCT01738646|glioblastoma multiforme|glioblastoma multiforme
5396290|NCT01738646|brain tumor|brain tumor
5396291|NCT01738633|Esophageal Cancer|esophageal cancer
5396292|NCT01738633|Quality of Life|quality of life
5396293|NCT01738620|esophageal cancer|esophageal cancer
5396294|NCT01738620|sleep disturbance|sleep disturbance
5396295|NCT01738620|quality of life|quality of life
5396296|NCT01738607|fecal incontinence, dietary fiber|fecal incontinence, dietary fiber
5396297|NCT01738581|focal hand dystonia (FHD)|focal hand dystonia (fhd)
5391398|NCT01761266|Cancer|cancer
5396298|NCT01738581|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5396299|NCT01738581|sensorimotor retraining|sensorimotor retraining
5396300|NCT01738568|High intensity aerobic training|high intensity aerobic training
5396302|NCT01738555|zidovudine|zidovudine
5396303|NCT01738555|HIV|hiv
5396304|NCT01738555|HAART|haart
5396305|NCT01738555|antiretroviral|antiretroviral
5396306|NCT01738542|Bosentan|bosentan
5396307|NCT01738542|Peripheral Arterial Disease|peripheral arterial disease
5396308|NCT01738529|confocal laser endomicroscopy|confocal laser endomicroscopy
5396309|NCT01738529|Crohn´disease|crohn´disease
5396310|NCT01738503|Opioid Dependence, Buprenorphine, Depot, SUBUTEX, RBP-6000|opioid dependence, buprenorphine, depot, subutex, rbp-6000
5396311|NCT01738490|Bone anchored hearing aid|bone anchored hearing aid
5396312|NCT01738490|Bone anchored implant|bone anchored implant
5396313|NCT01738490|Implant stability|implant stability
5396314|NCT01738490|Wide diameter implant|wide diameter implant
5396315|NCT01738490|Linear incision|linear incision
5396316|NCT01738490|Ponto|ponto
5396317|NCT01738477|Booster|booster
5396318|NCT01738477|Tdap|tdap
5396319|NCT01738477|Immunogenicity|immunogenicity
5396320|NCT01738477|Repeat dose|repeat dose
5396321|NCT01738477|Safety|safety
5396322|NCT01738477|BoostrixTM|boostrixtm
5396323|NCT01738477|Persistence|persistence
5396324|NCT01738464|Pelvic Pain|pelvic pain
5396325|NCT01738464|Interstitial Cystitis|interstitial cystitis
5396326|NCT01738464|Microbiome|microbiome
5396327|NCT01738464|Prostatitis|prostatitis
5396328|NCT01738464|Chronic|chronic
5396329|NCT01738464|Depression|depression
5396330|NCT01738451|ECG intervals and morphology|ecg intervals and morphology
5396331|NCT01738451|BRAF-mutation positive tumor|braf-mutation positive tumor
5396332|NCT01738451|Holter monitor|holter monitor
5396333|NCT01738451|BRAF inhibitor|braf inhibitor
5396334|NCT01738451|GSK2118436|gsk2118436
5396335|NCT01738451|safety|safety
5396336|NCT01738451|cancer|cancer
5396337|NCT01738451|QTc|qtc
5396338|NCT01738451|pharmacokinetics|pharmacokinetics
5396339|NCT01738438|Metastatic|metastatic
5396340|NCT01738438|Triple Negative|triple negative
5396341|NCT01738438|Stage IV|stage iv
5396342|NCT01738425|GIC-1001|gic-1001
5396343|NCT01738425|opioid agonist|opioid agonist
5396344|NCT01738425|sulfide|sulfide
5396345|NCT01738425|colonoscopy|colonoscopy
5396346|NCT01738425|gicare|gicare
5396347|NCT01738425|Phase I|phase i
5396348|NCT01738425|safety|safety
5396349|NCT01738425|tolerability|tolerability
5396350|NCT01738425|pharmacokinetics|pharmacokinetics
5396351|NCT01738425|healthy subjects|healthy subjects
5396352|NCT01738425|single ascending dose|single ascending dose
5396353|NCT01738425|multiple ascending dose|multiple ascending dose
5396354|NCT01738425|SAD|sad
5396355|NCT01738425|MAD|mad
5396356|NCT01738425|food effect|food effect
5396357|NCT01738412|Stroke|stroke
5396358|NCT01738399|Insulin resistance|insulin resistance
5396359|NCT01738399|Coffee|coffee
5396360|NCT01738399|Glucose metabolism|glucose metabolism
5396361|NCT01738386|Adaptation|adaptation
5396362|NCT01738386|Coping|coping
5396363|NCT01738386|Presenile Dementia|presenile dementia
5396364|NCT01738386|Caregiver Burden|caregiver burden
5396365|NCT01738373|autologous stem cell transplantation|autologous stem cell transplantation
5396366|NCT01738373|lymphoma|lymphoma
5396367|NCT01738373|multiple myeloma|multiple myeloma
5396368|NCT01738360|Arsenic trioxide|arsenic trioxide
5396369|NCT01738360|Systemic Lupus|systemic lupus
5396370|NCT01738360|clinically|clinically
5396371|NCT01738360|biologically active|biologically active
5396372|NCT01738334|Meditation|meditation
5396373|NCT01738334|Cognition|cognition
5396374|NCT01738334|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5396375|NCT01738308|Healing Touch|healing touch
5396376|NCT01738308|Pediatrics|pediatrics
5396377|NCT01738308|surgery|surgery
5396378|NCT01738308|stress|stress
5396379|NCT01738308|pain|pain
5396380|NCT01738308|Pediatric Stress|pediatric stress
5396381|NCT01738308|maladaptive behaviors|maladaptive behaviors
5396382|NCT01738308|energy medicine|energy medicine
5396383|NCT01738308|emergence delirium|emergence delirium
5396384|NCT01738308|emergence agitation|emergence agitation
5396385|NCT01738308|length of stay|length of stay
5396386|NCT01738308|ease of wake up|ease of wake up
5396387|NCT01738308|distress parents|distress parents
5396388|NCT01738308|distress pediatric patients|distress pediatric patients
5396389|NCT01738308|Pediatric Post-Traumatic Stress Disorder|pediatric post-traumatic stress disorder
5396390|NCT01738295|acetylcholine|acetylcholine
5396391|NCT01738295|cholinergic system|cholinergic system
5396392|NCT01738295|visual perception|visual perception
5396393|NCT01738295|visual attention|visual attention
5396394|NCT01738295|multiple objects tracking|multiple objects tracking
5396395|NCT01738295|perceptual learning|perceptual learning
5396396|NCT01738295|vision training|vision training
5396397|NCT01738282|baclofene|baclofene
5396398|NCT01738282|Alcohol dependence|alcohol dependence
5396399|NCT01738282|Maintenance of abstinence|maintenance of abstinence
5396400|NCT01738269|Ovarian cancer, HE4, normal range|ovarian cancer, he4, normal range
5862827|NCT00001487|Menopause|menopause
5396401|NCT01738256|Cognitive Behavior Therapy|cognitive behavior therapy
5396402|NCT01738256|Acceptance Commitment Therapy|acceptance commitment therapy
5396403|NCT01738256|Psychological Stress|psychological stress
5396404|NCT01738256|Metabolic Syndrome|metabolic syndrome
5396405|NCT01738256|Overweight|overweight
5396406|NCT01738256|Life Style|life style
5396408|NCT01738243|Thyroid Eye Disease|thyroid eye disease
5396409|NCT01738243|Thyroid Orbitopathy|thyroid orbitopathy
5396410|NCT01738243|Eyelid Retraction|eyelid retraction
5396411|NCT01738243|Upper Eyelid Retraction|upper eyelid retraction
5396412|NCT01738217|Intra-operative imaging|intra-operative imaging
5396413|NCT01738217|NIR Fluorescence|nir fluorescence
5396414|NCT01738217|Liver surgery|liver surgery
5396415|NCT01738217|Tumoral margins|tumoral margins
5396416|NCT01738204|endometriosis|endometriosis
5396417|NCT01738204|dysmenorrhea|dysmenorrhea
5396418|NCT01738204|pelvic pain|pelvic pain
5396419|NCT01738204|women's health|women's health
5396420|NCT01738204|adolescence|adolescence
5396421|NCT01738204|biorepository|biorepository
5396422|NCT01738204|observational|observational
5396423|NCT01738204|women|women
5396424|NCT01738204|female|female
5396425|NCT01738204|gynecology|gynecology
5396426|NCT01738204|fertility|fertility
5511224|NCT01247454|CVD|cvd
5396427|NCT01738204|infertility|infertility
5396428|NCT01738191|Parkinson's disease|parkinson's disease
5396429|NCT01738152|HYALOGYN VAGINAL GEL|hyalogyn vaginal gel
5396430|NCT01738152|vaginal dryness|vaginal dryness
5396431|NCT01738152|12-232|12-232
5396432|NCT01738126|cerebellum|cerebellum
5396433|NCT01738126|fMRI|fmri
5396434|NCT01738126|DTI|dti
5396435|NCT01738126|pain|pain
5396436|NCT01738126|heat|heat
5396437|NCT01738126|noxious|noxious
5396438|NCT01738126|aversion|aversion
5396439|NCT01738126|unpleasantness|unpleasantness
5396440|NCT01738126|anger|anger
5396441|NCT01738126|aversive stimulus|aversive stimulus
5396442|NCT01738126|motor|motor
5396443|NCT01738126|human|human
5396444|NCT01738126|image analysis|image analysis
5396445|NCT01738126|perception|perception
5396446|NCT01738126|central nervous system|central nervous system
5396447|NCT01738126|sensory|sensory
5396448|NCT01738126|somatosensory cortex|somatosensory cortex
5396449|NCT01738126|trigeminal system|trigeminal system
5396450|NCT01738126|white matter|white matter
5396451|NCT01738113|Ilizarov|ilizarov
5396452|NCT01738113|distraction osteogenesis|distraction osteogenesis
5396453|NCT01738113|Muscle architecture|muscle architecture
5396454|NCT01738113|muscle mechanics|muscle mechanics
5396455|NCT01738113|Rehabilitation|rehabilitation
5396456|NCT01738087|patients|patients
5396457|NCT01738087|Adult|adult
5396458|NCT01738074|rotavirus|rotavirus
5396459|NCT01738074|trivalent genetic reassortment vaccine|trivalent genetic reassortment vaccine
5396460|NCT01738074|Phase three clinical trials|phase three clinical trials
5396461|NCT01738061|Older workers|older workers
5396462|NCT01738061|Multidimensional intervention|multidimensional intervention
5396463|NCT01738061|Worksite health promotion|worksite health promotion
5396464|NCT01738061|Taiwan|taiwan
5396465|NCT01738048|Pain|pain
5396466|NCT01738048|Neuropathic pain|neuropathic pain
5396467|NCT01738048|Chronic pain|chronic pain
5396468|NCT01738035|IgA nephropathy|iga nephropathy
5396469|NCT01738022|Sleep apnea|sleep apnea
5396470|NCT01738022|Pathophysiology|pathophysiology
5396471|NCT01738009|Sleep Apnea|sleep apnea
5396472|NCT01738009|Pathophysiology|pathophysiology
5396473|NCT01737983|cystic fibrosis|cystic fibrosis
5396474|NCT01737983|probiotics|probiotics
5396475|NCT01737983|Lactobacillus reuteri|lactobacillus reuteri
5396476|NCT01737957|Proliferative Diabetic retinopathy|proliferative diabetic retinopathy
5396477|NCT01737957|Pan-retinal photocoagulation|pan-retinal photocoagulation
5396478|NCT01737944|methotrexate injection, subcutaneous, autoinjector|methotrexate injection, subcutaneous, autoinjector
5685275|NCT00556842|Total Hip Arthroplasty|total hip arthroplasty
5002930|NCT03977766|outpatients chemotherapy|outpatients chemotherapy
5383889|NCT01795261|HIV|hiv
5396482|NCT01737918|urge urinary incontinence, cesa, vasa, TOT, solifenacin|urge urinary incontinence, cesa, vasa, tot, solifenacin
5396483|NCT01737905|Asthma|asthma
5396484|NCT01737905|Safety|safety
5396485|NCT01737905|Efficacy|efficacy
5396486|NCT01737905|Epinephrine|epinephrine
5396487|NCT01737905|Bronchodilator|bronchodilator
5396488|NCT01737905|Metered dose inhaler|metered dose inhaler
5396489|NCT01737892|Asthma|asthma
5396490|NCT01737892|Pharmacokinetics|pharmacokinetics
5396491|NCT01737892|Epinephrine|epinephrine
5396492|NCT01737892|Bronchodilator|bronchodilator
5396493|NCT01737892|Metered dose inhaler|metered dose inhaler
5396494|NCT01737879|Anemia, Chronic Kidney Disease, End Stage Renal Disease, erythropoiesis-stimulating agents, Hemodialysis, Hemoglobin|anemia, chronic kidney disease, end stage renal disease, erythropoiesis-stimulating agents, hemodialysis, hemoglobin
5396495|NCT01737866|Heart, Failure, Renal, Insufficiency, Cardiac, Kidney, Hemodialysis, Impairment, omecamtiv mecarbil, cardiac myosin activator, CK-1827452|heart, failure, renal, insufficiency, cardiac, kidney, hemodialysis, impairment, omecamtiv mecarbil, cardiac myosin activator, ck-1827452
5396496|NCT01737853|Primary Open-Angle Glaucoma|primary open-angle glaucoma
5396497|NCT01737853|Ocular Hypertension|ocular hypertension
5396498|NCT01737853|Ganfort|ganfort
5396499|NCT01737840|dyspepsia|dyspepsia
5396500|NCT01737840|pantoprazole|pantoprazole
5396505|NCT01737814|vaso-occlusive crisis|vaso-occlusive crisis
5396507|NCT01737801|Physiotherapy|physiotherapy
5396508|NCT01737788|Cervical cerclage|cervical cerclage
5396509|NCT01737788|Uterine Cervical Incompetence|uterine cervical incompetence
5396510|NCT01737775|diaphragmatic dysfunction|diaphragmatic dysfunction
5396511|NCT01737775|ultrasonography|ultrasonography
5396512|NCT01737775|respiratory distress|respiratory distress
5396513|NCT01737775|abdominal surgery|abdominal surgery
5396515|NCT01737775|gender|gender
5396516|NCT01737775|biometric|biometric
5396517|NCT01737775|body mass index|body mass index
5396518|NCT01737775|ASA score|asa score
5396519|NCT01737775|smoking status|smoking status
5396520|NCT01737775|history of respiratory disease|history of respiratory disease
5396521|NCT01737762|Venous leg ulcer|venous leg ulcer
5396522|NCT01737762|ulcer|ulcer
5396523|NCT01737762|Venous stasis|venous stasis
5396524|NCT01737762|compression|compression
5396525|NCT01737762|venous|venous
5396526|NCT01737762|venous stasis ulcer|venous stasis ulcer
5396527|NCT01737762|vlu|vlu
5396528|NCT01737762|wound|wound
5396529|NCT01737762|varicose veins|varicose veins
5396530|NCT01737762|venous insufficiency|venous insufficiency
5396531|NCT01737762|dvt|dvt
5396532|NCT01737762|deep vein thrombosis|deep vein thrombosis
5396533|NCT01737749|Stroke|stroke
5396534|NCT01737736|Stroke|stroke
5396535|NCT01737723|Stroke|stroke
5396536|NCT01737710|Influenza Vaccines|influenza vaccines
5396537|NCT01737710|Dermatitis|dermatitis
5396538|NCT01737710|Injections, Intradermal|injections, intradermal
5396539|NCT01737710|Injections, Intramuscular|injections, intramuscular
5396540|NCT01737710|Skin Diseases|skin diseases
5396541|NCT01737710|Skin Diseases, Eczematous|skin diseases, eczematous
5396542|NCT01737710|Hypersensitivity, Immediate|hypersensitivity, immediate
5396543|NCT01737710|Hypersensitivity|hypersensitivity
5396544|NCT01737710|Immune System Diseases|immune system diseases
5396545|NCT01737710|Genetic Diseases, Inborn|genetic diseases, inborn
5379620|NCT01814449|Hypoxia|hypoxia
5396546|NCT01737710|Skin Diseases, Genetic|skin diseases, genetic
5396547|NCT01737671|Brain tumor|brain tumor
5396548|NCT01737671|Malignant Fourth Ventricular Brain Tumors|malignant fourth ventricular brain tumors
5396549|NCT01737671|Ependymoma involving brain|ependymoma involving brain
5396550|NCT01737671|Ependymoma involving spine|ependymoma involving spine
5396551|NCT01737671|Recurrent ependymoma involving brain and/or spine|recurrent ependymoma involving brain and/or spine
5396552|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving brain|recurrent atypical teratoid/rhabdoid tumor involving brain
5396553|NCT01737671|Recurrent atypical teratoid/rhabdoid tumor involving spine|recurrent atypical teratoid/rhabdoid tumor involving spine
5396554|NCT01737671|AT/RT|at/rt
5396555|NCT01737671|Ommaya reservoir catheter|ommaya reservoir catheter
5396556|NCT01737671|Methotrexate|methotrexate
5396557|NCT01737671|Medulloblastoma|medulloblastoma
5396558|NCT01737671|ATRT|atrt
5396559|NCT01737671|Atypical teratoid rhabdoid tumor|atypical teratoid rhabdoid tumor
5396560|NCT01737671|Ependymoma|ependymoma
5396561|NCT01737671|Pediatric brain tumor|pediatric brain tumor
5396562|NCT01737671|Intraventricular chemotherapy|intraventricular chemotherapy
5396563|NCT01737632|Adolescents|adolescents
5396564|NCT01737632|Residential Treatment|residential treatment
5396565|NCT01737632|Outpatient Treatment|outpatient treatment
5396566|NCT01737632|Substance Abuse|substance abuse
5396567|NCT01737632|Delinquency|delinquency
5396568|NCT01737632|Family Therapy|family therapy
5400121|NCT01721213|survey|survey
5396569|NCT01737632|Multidimensional Family therapy|multidimensional family therapy
5396571|NCT01737606|Fast Cerebral Pulsatility Imaging or FCPI|fast cerebral pulsatility imaging or fcpi
5396572|NCT01737606|MRI|mri
5396573|NCT01737606|Arteriel Spin Labelling|arteriel spin labelling
5396574|NCT01737606|Cognitive tasks|cognitive tasks
5002931|NCT03977766|chemotherapy validation|chemotherapy validation
5396575|NCT01737606|Aging|aging
5396576|NCT01737593|acetaminophen|acetaminophen
5396577|NCT01737593|emergence agitation|emergence agitation
5396578|NCT01737593|children|children
5396579|NCT01737593|sevoflurane|sevoflurane
5396580|NCT01737580|influenza, human|influenza, human
5396581|NCT01737580|influenza vaccines|influenza vaccines
5396582|NCT01737580|older adults|older adults
5396583|NCT01737580|immune response|immune response
5396584|NCT01737554|Central venous access device|central venous access device
5396585|NCT01737554|Catheter resistance monitoring|catheter resistance monitoring
5396586|NCT01737541|Cerebrovascular Disorders|cerebrovascular disorders
5396587|NCT01737541|Cardiovascular Diseases|cardiovascular diseases
5396588|NCT01737541|Intracerebral Hemorrhage|intracerebral hemorrhage
5396589|NCT01737541|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5396590|NCT01737541|Therapeutic Uses|therapeutic uses
5396591|NCT01737528|severe symptomatic native aortic valve stenosis|severe symptomatic native aortic valve stenosis
5396592|NCT01737528|inoperable or high risk for open aortic valve replacement|inoperable or high risk for open aortic valve replacement
5396594|NCT01737463|Ampulla of Vater adenoma|ampulla of vater adenoma
5396595|NCT01737450|Metastatic head and neck cancer|metastatic head and neck cancer
5396596|NCT01737450|PI3K inhibitor|pi3k inhibitor
5396597|NCT01737450|Recurrent head and meck cancer|recurrent head and meck cancer
5396604|NCT01737398|Transthyretin|transthyretin
5396605|NCT01737398|Amyloidosis|amyloidosis
5396606|NCT01737385|microcirculation|microcirculation
5396607|NCT01737385|proximal humeral fractures|proximal humeral fractures
5396608|NCT01737385|O2C|o2c
5396609|NCT01737372|Multiple Sclerosis|multiple sclerosis
5396610|NCT01737372|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5396611|NCT01737372|Clinically Isolated Syndrome|clinically isolated syndrome
5396612|NCT01737359|amdoxovir|amdoxovir
5396613|NCT01737359|zidovudine|zidovudine
5396614|NCT01737359|tenofovir DF|tenofovir df
5396615|NCT01737359|HIV|hiv
5396616|NCT01737359|HAART|haart
5396617|NCT01737359|antiretroviral|antiretroviral
5396618|NCT01737346|glioblastoma, recurrent, refractory, CCNU, procarbazine|glioblastoma, recurrent, refractory, ccnu, procarbazine
5396619|NCT01737320|gram negative bacteremia|gram negative bacteremia
5396620|NCT01737320|Duration of antibiotic treatment|duration of antibiotic treatment
5396621|NCT01737320|safety|safety
5396622|NCT01737320|efficacy|efficacy
5396623|NCT01737320|short-course|short-course
5396624|NCT01737307|Fluoride Varnish|fluoride varnish
5396625|NCT01737307|CPP-ACP paste|cpp-acp paste
5396626|NCT01737307|Dry mouth|dry mouth
5396627|NCT01737307|Burning sensation|burning sensation
5396628|NCT01737307|Chemotherapy|chemotherapy
5396629|NCT01737294|Phase IV|phase iv
5396630|NCT01737294|Peripheral Neuropathic Pain|peripheral neuropathic pain
5396631|NCT01737294|QUTENZA|qutenza
5396632|NCT01737281|Smoking|smoking
5396633|NCT01737281|Tobacco control|tobacco control
5396634|NCT01737281|Counseling|counseling
5396635|NCT01737281|mental health|mental health
5396636|NCT01737268|patients|patients
5396637|NCT01737268|Major depressive episode|major depressive episode
5396638|NCT01737268|FK949E|fk949e
5396645|NCT01737216|Aged|aged
5396646|NCT01737216|patients|patients
5396647|NCT01737203|Viagra|viagra
5396648|NCT01737203|ODT|odt
5396649|NCT01737203|bioquivalence|bioquivalence
5365472|NCT01878019|Pain|pain
5396650|NCT01737190|esophageal pressure|esophageal pressure
5396651|NCT01737190|ARDSnet protocol|ardsnet protocol
5396652|NCT01737177|MCL|mcl
5396653|NCT01737177|Mantle Cell Lymphoma|mantle cell lymphoma
5396654|NCT01737177|RELAPSED-REFRACTORY|relapsed-refractory
5396655|NCT01737164|Glucose|glucose
5396656|NCT01737164|Lipid|lipid
5396657|NCT01737164|Metabolism|metabolism
5396658|NCT01737164|Non Diabetic|non diabetic
5396659|NCT01737164|Healthy|healthy
5396660|NCT01737138|Resistant hypertension|resistant hypertension
5396661|NCT01737138|All-cause mortality|all-cause mortality
5396662|NCT01737138|Renal function|renal function
5396663|NCT01737112|Lung Cancer|lung cancer
5396664|NCT01737112|integrin αvβ3 receptor|integrin αvβ3 receptor
5396665|NCT01737112|99mTc-3PRGD2|99mtc-3prgd2
5396666|NCT01737112|SPECT/CT|spect/ct
5396667|NCT01737112|efficacy and safety|efficacy and safety
5396668|NCT01737099|omega-3|omega-3
5396669|NCT01737099|DHA|dha
5396670|NCT01737099|triglycerides|triglycerides
5396671|NCT01737099|lipids|lipids
5396672|NCT01737099|cardiovascular|cardiovascular
5396673|NCT01737099|hypertriglyceridemia|hypertriglyceridemia
5396674|NCT01737073|chronic pain|chronic pain
5396675|NCT01737073|opioid|opioid
5396676|NCT01737073|cognitive behavior therapy|cognitive behavior therapy
5396677|NCT01737060|Reversed prosthesis, Philos, Severe displaced|reversed prosthesis, philos, severe displaced
5396678|NCT01737047|HIV|hiv
5396680|NCT01737034|partitioning of weight gain|partitioning of weight gain
5396681|NCT01737034|refeeding|refeeding
5396682|NCT01737034|catch-up fat phenomenon|catch-up fat phenomenon
5396683|NCT01737034|glycemic index|glycemic index
5396684|NCT01737021|PICU|picu
5685276|NCT00556816|COPD|copd
5396685|NCT01737021|Critical illness|critical illness
5396686|NCT01737021|Outcomes|outcomes
5396687|NCT01737021|Mental health|mental health
5396688|NCT01737021|Education|education
5396689|NCT01737021|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5396690|NCT01737021|Pilot|pilot
5396691|NCT01737021|Feasibility|feasibility
5396692|NCT01737008|Head and neck|head and neck
5396693|NCT01737008|Squamous cell carcinoma|squamous cell carcinoma
5396694|NCT01737008|Phase 1|phase 1
5396695|NCT01737008|Dacomitinib|dacomitinib
5396696|NCT01737008|Radiation|radiation
5396697|NCT01737008|Radiotherapy|radiotherapy
5396698|NCT01737008|Chemotherapy|chemotherapy
5396699|NCT01737008|Chemoradiation|chemoradiation
5396700|NCT01737008|Chemoradiotherapy|chemoradiotherapy
5396701|NCT01737008|Cisplatin|cisplatin
5397597|NCT01732913|CAL-101|cal-101
5396702|NCT01737008|Pharmacokinetics|pharmacokinetics
5396703|NCT01737008|Maximum tolerated dose|maximum tolerated dose
5396704|NCT01737008|Safety|safety
5396705|NCT01737008|Human epidermal growth factor receptor|human epidermal growth factor receptor
5396706|NCT01737008|Previously Untreated|previously untreated
5396707|NCT01737008|Local or Locally Advanced|local or locally advanced
5396708|NCT01736995|Substance Abuse|substance abuse
5396709|NCT01736995|Adolescents|adolescents
5396710|NCT01736995|Families|families
5396711|NCT01736995|Functional Family Therapy|functional family therapy
5396712|NCT01736995|Cognitive Behavioral Therapy|cognitive behavioral therapy
5396713|NCT01736995|Motivational Therapy|motivational therapy
5396714|NCT01736995|Contingency Management|contingency management
5396715|NCT01736982|Cigarette Smoking|cigarette smoking
5396716|NCT01736982|Homeless|homeless
5396717|NCT01736982|Contingency Management|contingency management
5396718|NCT01736982|Smoking Cessation|smoking cessation
5396719|NCT01736956|aortic stenosis|aortic stenosis
5396720|NCT01736956|hypoplastic left heart syndrome|hypoplastic left heart syndrome
5396721|NCT01736956|fetal aortic valvuloplasty|fetal aortic valvuloplasty
5396722|NCT01736943|Bortezomib|bortezomib
5396723|NCT01736943|Doxil|doxil
5396724|NCT01736930|Type 1 Diabetes|type 1 diabetes
5396725|NCT01736930|Hypoglycemia|hypoglycemia
5396726|NCT01736930|Continuous Glucose Monitoring|continuous glucose monitoring
5396727|NCT01736930|Pump Suspension|pump suspension
5396728|NCT01736917|Fosaprepitant|fosaprepitant
5396729|NCT01736917|5HT3 Receptor Antagonists|5ht3 receptor antagonists
5396730|NCT01736917|Dexamethasone|dexamethasone
5396732|NCT01736917|Testis Cancer|testis cancer
5396733|NCT01736917|Rescue Medications|rescue medications
5396734|NCT01736904|advanced colorectal cancer|advanced colorectal cancer
5396735|NCT01736904|FOLFIRI|folfiri
5396736|NCT01736904|XELIRI|xeliri
5396737|NCT01736891|Motor fluctuations|motor fluctuations
5396738|NCT01736891|Parkinson´s Disease|parkinson´s disease
5396739|NCT01736891|Rasagiline|rasagiline
5396740|NCT01736878|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
5396741|NCT01736878|Sorafenib|sorafenib
5396742|NCT01736878|Efficacy|efficacy
5396743|NCT01736852|Premature Rupture of Membrane (Pregnancy)|premature rupture of membrane (pregnancy)
5396744|NCT01736852|PROM|prom
5396745|NCT01736852|Cervical Ripening|cervical ripening
5396746|NCT01736852|Induced Labor|induced labor
5396747|NCT01736826|plasma nucleosome concentration|plasma nucleosome concentration
5396748|NCT01736826|plasma free DNA concentration|plasma free dna concentration
5396749|NCT01736813|colorectal cancer|colorectal cancer
5396750|NCT01736813|liver metastases|liver metastases
5396751|NCT01736813|chemotherapy|chemotherapy
5396752|NCT01736813|chemokine|chemokine
5396753|NCT01736813|CCR5 inhibition|ccr5 inhibition
5396754|NCT01736800|Temozolomide|temozolomide
5396755|NCT01736800|Topotecan|topotecan
5396756|NCT01736800|Central Nervous System Metastases|central nervous system metastases
5396757|NCT01736800|Chemotherapy|chemotherapy
5396758|NCT01736800|Brain Metastases|brain metastases
5396759|NCT01736800|Solid Tumors|solid tumors
5396760|NCT01736787|Cauliflower Mushroom extract|cauliflower mushroom extract
5396761|NCT01736787|immunity|immunity
5396762|NCT01736774|Manual therapy|manual therapy
5396763|NCT01736774|Exercise|exercise
5396764|NCT01736748|obesity|obesity
5396765|NCT01736748|physical activity|physical activity
5396766|NCT01736748|metabolism|metabolism
5396767|NCT01736748|environment|environment
5396768|NCT01736748|obese children, as defined by a body mass index > 95th percentile|obese children, as defined by a body mass index > 95th percentile
5396769|NCT01736748|for age and sex|for age and sex
5396770|NCT01736722|Laser Induced Thermal Therapy|laser induced thermal therapy
5396771|NCT01736722|Metastatic cancer|metastatic cancer
5396772|NCT01736722|Brain Tumor|brain tumor
5396773|NCT01736722|Visualase|visualase
5396774|NCT01736722|Treatment resistant|treatment resistant
5396775|NCT01736722|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5396777|NCT01736709|2012-2013 trivalent seasonal influenza vaccine|2012-2013 trivalent seasonal influenza vaccine
5396779|NCT01736709|safety|safety
5396780|NCT01736696|Psoriasis|psoriasis
5396781|NCT01736696|PASI|pasi
5396782|NCT01736696|plaques|plaques
5396783|NCT01736696|skin biopsy|skin biopsy
5396784|NCT01736696|immunomodulation|immunomodulation
5396786|NCT01736683|anemia|anemia
5396787|NCT01736683|dose-ranging|dose-ranging
5396788|NCT01736683|intermediate-1 risk myelodysplastic syndromes|intermediate-1 risk myelodysplastic syndromes
5396789|NCT01736683|low risk myelodysplastic syndromes (MDS)|low risk myelodysplastic syndromes (mds)
5396790|NCT01736683|multicenter|multicenter
5396791|NCT01736683|open-label|open-label
5396792|NCT01736683|parallel|parallel
5396793|NCT01736683|phase 2|phase 2
5396794|NCT01736683|randomized|randomized
5396795|NCT01736683|Sotatercept|sotatercept
5396796|NCT01736683|Non-proliferative chronic myelomonocytic leukemia (CMML)|non-proliferative chronic myelomonocytic leukemia (cmml)
5396797|NCT01736683|hemoglobin|hemoglobin
5396798|NCT01736683|transfusions|transfusions
5396806|NCT01736631|cognitive behavioural therapy|cognitive behavioural therapy
5396807|NCT01736618|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, Cameron Health defibrillator|subcutaneous implantable defibrillator, post approval study, sudden cardiac arrest, cameron health defibrillator
5396808|NCT01736605|Massage|massage
5396809|NCT01736605|Meditation|meditation
5396810|NCT01736605|Breast Cancer|breast cancer
5396811|NCT01736605|Breast Surgery|breast surgery
5396812|NCT01736605|Breast Reconstruction|breast reconstruction
5396814|NCT01736566|Cardiology|cardiology
5396815|NCT01736566|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5396816|NCT01736566|Dilated Cardiomyopathy|dilated cardiomyopathy
5396817|NCT01736566|Whole Genome Sequencing|whole genome sequencing
5396818|NCT01736553|Spinal Muscular Atrophy (SMA) Biomarkers|spinal muscular atrophy (sma) biomarkers
5396819|NCT01736553|Healthy controls|healthy controls
5396820|NCT01736553|Infants|infants
5396821|NCT01736540|iron overload, liver iron concentration (LIC), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (MRI)|iron overload, liver iron concentration (lic), cardiac siderosis, transfusional siderosis, magnetic resonance imaging (mri)
5396822|NCT01736514|xanthine oxidase inhibitor|xanthine oxidase inhibitor
5396823|NCT01736514|Uric acid lowering drug|uric acid lowering drug
5396824|NCT01736488|Hypertension|hypertension
5396825|NCT01736488|Antihypertensive efficacy|antihypertensive efficacy
5396826|NCT01736488|Neurohormonal markers|neurohormonal markers
5396827|NCT01736488|Blood Pressure Response|blood pressure response
5396828|NCT01736488|Exercise|exercise
5396829|NCT01736462|Cornea|cornea
5396830|NCT01736462|Endothelial cell density|endothelial cell density
5396831|NCT01736449|pterygium|pterygium
5396832|NCT01736449|bevacizumab|bevacizumab
5396833|NCT01736449|recurrence of pterygium|recurrence of pterygium
5396835|NCT01736436|Myelodysplastic syndrome|myelodysplastic syndrome
5396836|NCT01736436|Low and intermediate risk|low and intermediate risk
5396837|NCT01736436|Transfusion-dependent patients|transfusion-dependent patients
5396838|NCT01736436|Transfusion|transfusion
5396839|NCT01736436|Anemia|anemia
5396840|NCT01736423|YM060|ym060
5396841|NCT01736423|Ramosetron|ramosetron
5396842|NCT01736423|long term study|long term study
5396843|NCT01736423|Diarrhea-predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5396844|NCT01736423|Female|female
5396846|NCT01736397|Chronic Kidney Disease|chronic kidney disease
5396847|NCT01736397|Phosphorus|phosphorus
5396848|NCT01736397|Iron Deficiency|iron deficiency
5396849|NCT01736397|Iron Deficiency Anemia|iron deficiency anemia
5396850|NCT01736397|Elevated Phosphorus|elevated phosphorus
5396851|NCT01736371|Sevoflurane|sevoflurane
5396852|NCT01736371|Cisatracurium infusion consumption|cisatracurium infusion consumption
5396853|NCT01736371|Closed loop computer control system|closed loop computer control system
5396854|NCT01736371|Recovery Index|recovery index
5396855|NCT01736358|Sprix|sprix
5396856|NCT01736358|Intranasal ketoralac|intranasal ketoralac
5396857|NCT01736358|Ketoralac|ketoralac
5396858|NCT01736358|Urolithiasis|urolithiasis
5396859|NCT01736358|Kidney stone|kidney stone
5396860|NCT01736358|Uretal stone|uretal stone
5396861|NCT01736358|Ureteroscopic removal of stones|ureteroscopic removal of stones
5396862|NCT01736358|URS|urs
5396863|NCT01736358|Pain management|pain management
5396864|NCT01736358|Pain|pain
5396865|NCT01736332|Methamphetamine|methamphetamine
5396866|NCT01736332|Amphetamines|amphetamines
5396867|NCT01736332|Opiates|opiates
5396868|NCT01736332|Oral Opiates (poppy seeds)|oral opiates (poppy seeds)
5396869|NCT01736332|Intranasal amphetamines|intranasal amphetamines
5396870|NCT01736319|Artemisinin-based Combination Therapies|artemisinin-based combination therapies
5396871|NCT01736319|Recrudescence|recrudescence
5396872|NCT01736319|DHA-PPQ|dha-ppq
5396873|NCT01736319|Parasite Clearance Rate|parasite clearance rate
5396877|NCT01736293|Retinal Degeneration|retinal degeneration
5396878|NCT01736280|Symptoms|symptoms
5396879|NCT01736280|Immunogenetics|immunogenetics
5396880|NCT01736280|Digestive Disorders|digestive disorders
5396881|NCT01736280|Gastrointestinal|gastrointestinal
5396882|NCT01736267|Auditory Brainstem Implant|auditory brainstem implant
5396884|NCT01736267|Nucleus 24|nucleus 24
5396885|NCT01736267|Deafness|deafness
5396886|NCT01736267|Hearing loss|hearing loss
5396887|NCT01736267|Non-tumor|non-tumor
5396888|NCT01736267|Non-NF2|non-nf2
5396889|NCT01736267|ABI541|abi541
5396890|NCT01736228|xenotransplantation|xenotransplantation
5369898|NCT01857869|Safety|safety
5396891|NCT01736228|type 1 diabetes|type 1 diabetes
5396892|NCT01736228|porcine islets|porcine islets
5396893|NCT01736215|Anemia - cancer related|anemia - cancer related
5396894|NCT01736215|Eprex (Erythropoietin alfa)|eprex (erythropoietin alfa)
5396906|NCT01736137|Heart failure|heart failure
5396907|NCT01736137|Autonomic Nervous System|autonomic nervous system
5396908|NCT01736137|Heart rate|heart rate
5396909|NCT01736137|Quality of life|quality of life
5396910|NCT01736124|computerize cognitive training|computerize cognitive training
5396911|NCT01736124|dementia|dementia
5396912|NCT01736124|cognitive decline|cognitive decline
5396913|NCT01736124|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5396914|NCT01736111|obesity|obesity
5396915|NCT01736111|weight loss|weight loss
5396916|NCT01736111|text message|text message
5396926|NCT01736072|Rectal Cancer|rectal cancer
5396927|NCT01736072|Colorectal Cancer|colorectal cancer
5396928|NCT01736072|Laparoscopic Surgery|laparoscopic surgery
5396929|NCT01736072|Robotic Surgery|robotic surgery
5396930|NCT01736072|Robotic Assisted Laparoscopic Surgery|robotic assisted laparoscopic surgery
5396931|NCT01736059|Stem cells|stem cells
5396932|NCT01736059|intravitreal|intravitreal
5396940|NCT01736033|Lower Urinary Tracts Symptoms|lower urinary tracts symptoms
5396941|NCT01736033|5 alpha reductase inhibitor|5 alpha reductase inhibitor
5396943|NCT01736033|Finasteride|finasteride
5396944|NCT01736033|alpha blocker|alpha blocker
5396945|NCT01736033|Tamsulosin|tamsulosin
5396946|NCT01736033|Harnal D|harnal d
5396947|NCT01736007|alopecia areata child|alopecia areata child
5396948|NCT01736007|scalp|scalp
5396949|NCT01735994|Eating disorders|eating disorders
5396950|NCT01735994|body image|body image
5396951|NCT01735994|female athletes|female athletes
5396952|NCT01735994|female athlete triad|female athlete triad
5396953|NCT01735994|eating disorder prevention|eating disorder prevention
5396954|NCT01735994|cluster randomization|cluster randomization
5396955|NCT01735994|risk factors|risk factors
5396957|NCT01735981|Huntington's Disease|huntington's disease
5396958|NCT01735981|gait|gait
5396959|NCT01735981|exercise|exercise
5396960|NCT01735981|balance|balance
5396961|NCT01735981|video game|video game
5396962|NCT01735968|Imatinib mesylate|imatinib mesylate
5396963|NCT01735968|STI571|sti571
5396964|NCT01735968|BYL719|byl719
5396965|NCT01735968|GIST|gist
5396966|NCT01735968|3rd line GIST|3rd line gist
5396967|NCT01735955|Tasigna|tasigna
5396968|NCT01735955|CML|cml
5396969|NCT01735955|GIST|gist
5396970|NCT01735955|nilotinib|nilotinib
5396971|NCT01735890|Safety|safety
5396972|NCT01735890|Pharmacokinetics|pharmacokinetics
5396973|NCT01735877|Hemispatial neglect, Stroke|hemispatial neglect, stroke
5396974|NCT01735864|Indigo naturalis extract in oil|indigo naturalis extract in oil
5396975|NCT01735851|Thoracic epidural analgesia|thoracic epidural analgesia
5396976|NCT01735851|Paravertebral block|paravertebral block
5396977|NCT01735851|pain|pain
5396978|NCT01735851|postoperative|postoperative
5396979|NCT01735825|coronary artery disease|coronary artery disease
5396980|NCT01735825|stent|stent
5396981|NCT01735825|restenosis|restenosis
5396982|NCT01735812|cryoablation|cryoablation
5396983|NCT01735812|uterine fibroid|uterine fibroid
5396984|NCT01735812|uterine myoma|uterine myoma
5396985|NCT01735812|who completed her family planning|who completed her family planning
5396986|NCT01735812|but wishes to preserve her uterus|but wishes to preserve her uterus
5396987|NCT01735786|Endoscopic Hemostasis|endoscopic hemostasis
5396988|NCT01735786|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
5396989|NCT01735786|Colonic Polyps|colonic polyps
5396990|NCT01735773|hemodialysis|hemodialysis
5396991|NCT01735773|inflammation|inflammation
5396992|NCT01735773|iron|iron
5396993|NCT01735773|peritoneal dialysis|peritoneal dialysis
5396994|NCT01735773|prohepcidin|prohepcidin
5396995|NCT01735773|uremia|uremia
5396996|NCT01735760|airway management|airway management
5397598|NCT01732913|Rituximab|rituximab
5396997|NCT01735760|cricothyroid membrane|cricothyroid membrane
5396998|NCT01735747|Lymphoma|lymphoma
5396999|NCT01735734|Skin disease|skin disease
5397000|NCT01735734|Capillary Malformation|capillary malformation
5397001|NCT01735734|Laser therapy|laser therapy
5397002|NCT01735721|Sinus Floor Augmentation|sinus floor augmentation
5397003|NCT01735721|Bone Transplantation|bone transplantation
5397004|NCT01735721|Bone Substitute|bone substitute
5397005|NCT01735708|pain|pain
5397006|NCT01735708|depression|depression
5397008|NCT01735708|adherence|adherence
5397009|NCT01735695|Meconium|meconium
5397010|NCT01735695|concentration|concentration
5397011|NCT01735695|level|level
5397012|NCT01735682|older adults|older adults
5397013|NCT01735682|exercise|exercise
5397014|NCT01735682|balance|balance
5397015|NCT01735682|gait|gait
5397016|NCT01735682|fall|fall
5397017|NCT01735682|rehabilitation|rehabilitation
5397018|NCT01735682|vibration|vibration
5397019|NCT01735682|muscle|muscle
5397020|NCT01735669|Remifentanil|remifentanil
5002932|NCT03977714|peri-implantitis|peri-implantitis
5397021|NCT01735669|Breech presentation|breech presentation
5397022|NCT01735669|Nitrous oxide|nitrous oxide
5397023|NCT01735669|Pregnancy complications|pregnancy complications
5397024|NCT01735669|Caesarean section|caesarean section
5397025|NCT01735669|Fetal version|fetal version
5397026|NCT01735656|Coronary heart disease;|coronary heart disease;
5397027|NCT01735656|Percutaneous coronary intervention;|percutaneous coronary intervention;
5397028|NCT01735656|Bifurcation lesion;|bifurcation lesion;
5392083|NCT01758029|questionnaire|questionnaire
5397029|NCT01735656|Double kissing culotte technique;|double kissing culotte technique;
5397030|NCT01735656|clinical trial|clinical trial
5397031|NCT01735643|type 2 diabetes mellitus|type 2 diabetes mellitus
5397032|NCT01735643|physical activity|physical activity
5397033|NCT01735643|lifestyle change|lifestyle change
5397035|NCT01735643|patient empowerment|patient empowerment
5397036|NCT01735630|Agitation|agitation
5397037|NCT01735630|Aggression|aggression
5397038|NCT01735630|patients|patients
5397039|NCT01735617|congenital adrenal hyperplasia|congenital adrenal hyperplasia
5397040|NCT01735617|glucocorticoids|glucocorticoids
5397041|NCT01735617|cortisol|cortisol
5397042|NCT01735617|adrenal|adrenal
5397043|NCT01735591|Liver cirrhosis|liver cirrhosis
5397044|NCT01735591|Liver transplantation|liver transplantation
5397045|NCT01735591|Probiotics|probiotics
5397046|NCT01735591|Mortality|mortality
5397047|NCT01735591|Liver function|liver function
5397048|NCT01735591|Infections|infections
5397049|NCT01735578|splanchnic oxygen saturations|splanchnic oxygen saturations
5397050|NCT01735565|NET formation|net formation
5397051|NCT01735565|neutraphil extracellular traps|neutraphil extracellular traps
5397052|NCT01735565|post-engraftment immune system|post-engraftment immune system
5397053|NCT01735552|gut reperfusion injury|gut reperfusion injury
5397054|NCT01735552|blood transfusions|blood transfusions
5397055|NCT01735552|premature infants|premature infants
5397056|NCT01735552|anemia|anemia
5397057|NCT01735552|regional oxygen saturations|regional oxygen saturations
5397058|NCT01735552|necrotizing enterocolitis|necrotizing enterocolitis
5397059|NCT01735552|mesenteric oxygenation|mesenteric oxygenation
5397060|NCT01735539|old age|old age
5397061|NCT01735539|sarcopenia|sarcopenia
5397062|NCT01735539|essential amino acid|essential amino acid
5397063|NCT01735539|arginine|arginine
5397064|NCT01735539|contrast enhanced ultrasound|contrast enhanced ultrasound
5397065|NCT01735539|muscle microcirculation|muscle microcirculation
5397066|NCT01735539|muscle protein synthesis|muscle protein synthesis
5397067|NCT01735526|Allogeneic and autologous|allogeneic and autologous
5397068|NCT01735526|hematopoietic stem-cell transplantation|hematopoietic stem-cell transplantation
5397069|NCT01735526|Lung diffusing capacity|lung diffusing capacity
5397070|NCT01735526|for nitric oxide|for nitric oxide
5397071|NCT01735526|carbon monoxide|carbon monoxide
5397072|NCT01735526|Lung tissue density|lung tissue density
5397073|NCT01735526|microvascular damage|microvascular damage
5397074|NCT01735513|transaortic TAVI or TAVR|transaortic tavi or tavr
5397075|NCT01735513|embolic protection device|embolic protection device
5397076|NCT01735513|EmbolX|embolx
5397077|NCT01735513|efficacy|efficacy
5397078|NCT01735513|during transaortic TAVI|during transaortic tavi
5397079|NCT01735513|reduce the incidence of new foci of restricted diffusion on diffusion-weighted MRI|reduce the incidence of new foci of restricted diffusion on diffusion-weighted mri
5397080|NCT01735500|Prei-procedural|prei-procedural
5397081|NCT01735500|Elevation|elevation
5397082|NCT01735500|cardia Troponin T|cardia troponin t
5397083|NCT01735500|in stable|in stable
5397084|NCT01735500|unknown|unknown
5397085|NCT01735474|manual therapy|manual therapy
5397086|NCT01735474|respiratory disease|respiratory disease
5397087|NCT01735474|thoracic movement|thoracic movement
5397088|NCT01735448|smoking cessation|smoking cessation
5397089|NCT01735448|tobacco|tobacco
5397090|NCT01735448|addiction|addiction
5397091|NCT01735448|Aboriginal|aboriginal
5397092|NCT01735448|youth|youth
5397093|NCT01735448|Indigenous|indigenous
5397094|NCT01735448|pharmacological|pharmacological
5397095|NCT01735448|focus group|focus group
5397096|NCT01735448|interview|interview
5397103|NCT01735422|Recombinant human Follicle Stimulating Hormone (Gonal-f®)|recombinant human follicle stimulating hormone (gonal-f®)
5397104|NCT01735409|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
5397105|NCT01735409|Abraxane|abraxane
5397106|NCT01735409|Cisplatin|cisplatin
5397108|NCT01735396|African American men|african american men
5397109|NCT01735396|metastatic prostate cancer|metastatic prostate cancer
5397110|NCT01735396|castration resistant|castration resistant
5397111|NCT01735357|Eicosapentaenoic acid|eicosapentaenoic acid
5397112|NCT01735357|Docosahexaenoic acid|docosahexaenoic acid
5397113|NCT01735357|Cardiovascular risk|cardiovascular risk
5397114|NCT01735357|Platelet function|platelet function
5397115|NCT01735357|Endothelial function|endothelial function
5397116|NCT01735357|Vascular function|vascular function
5397117|NCT01735357|young males|young males
5685277|NCT00556816|outpatient on demand clinic|outpatient on demand clinic
5397118|NCT01735331|Vascular endothelial growth factor, Recurrent Pregnancy Loss|vascular endothelial growth factor, recurrent pregnancy loss
5397119|NCT01735305|Coronary Artery Disease|coronary artery disease
5397120|NCT01735305|antiplatelet therapy|antiplatelet therapy
5397121|NCT01735292|Ventilation, timer|ventilation, timer
5397122|NCT01735279|tobacco dependence|tobacco dependence
5397123|NCT01735279|tobacco treatment|tobacco treatment
5397124|NCT01735279|omega 3 series|omega 3 series
5397125|NCT01735279|polyunsaturated fatty acids|polyunsaturated fatty acids
5397127|NCT01735253|metabolic surgery|metabolic surgery
5397128|NCT01735253|gastric bypass|gastric bypass
5397129|NCT01735253|duodenojejunal bypass|duodenojejunal bypass
5397130|NCT01735253|type 2 DM|type 2 dm
5397131|NCT01735240|Phase I,|phase i,
5397132|NCT01735240|healthy volunteers,|healthy volunteers,
5397133|NCT01735240|fixed-sequence,|fixed-sequence,
5397134|NCT01735240|open-label,|open-label,
5397135|NCT01735240|ketoconazole,|ketoconazole,
5397136|NCT01735240|combination,|combination,
5397138|NCT01735227|pantoprazole|pantoprazole
5397139|NCT01735227|omeprazole|omeprazole
5397140|NCT01735227|anti - platelet effect|anti - platelet effect
5397141|NCT01735188|Natural history study|natural history study
5397142|NCT01735175|biosimilars|biosimilars
5397143|NCT01735175|Pegfilgrastim,|pegfilgrastim,
5397144|NCT01735175|G-CSF,|g-csf,
5397145|NCT01735175|neutropenia,|neutropenia,
5397146|NCT01735175|breast cancer,|breast cancer,
5397147|NCT01735175|myelosuppressive chemotherapy,|myelosuppressive chemotherapy,
5397148|NCT01735175|supportive care|supportive care
5397149|NCT01735175|granulocyte-colony-stimulating factor|granulocyte-colony-stimulating factor
5397150|NCT01735162|Renal angina|renal angina
5397151|NCT01735162|AKI|aki
5397152|NCT01735162|Pediatric Intensive Care|pediatric intensive care
5397153|NCT01735123|infant formula|infant formula
5397154|NCT01735123|diet|diet
5397155|NCT01735123|diabetes mellitus, type 1|diabetes mellitus, type 1
5397156|NCT01735123|autoimmunity|autoimmunity
5397157|NCT01735097|Arsenic|arsenic
5397158|NCT01735097|Keratosis|keratosis
5397159|NCT01735097|Nigella sativa|nigella sativa
5397160|NCT01735097|Palm|palm
5397161|NCT01735097|Vitamin E|vitamin e
5397162|NCT01735084|randomized controlled trial|randomized controlled trial
5397163|NCT01735084|pneumococcal conjugate vaccines|pneumococcal conjugate vaccines
5397164|NCT01735084|booster dose|booster dose
5397165|NCT01735084|immunogenicity|immunogenicity
5397166|NCT01735084|nasopharyngeal carriage|nasopharyngeal carriage
5397167|NCT01735084|Australian Indigenous|australian indigenous
5397168|NCT01735084|pediatric|pediatric
5397169|NCT01735071|ovarian cancer|ovarian cancer
5397170|NCT01735071|bevacizumab|bevacizumab
5397171|NCT01735071|trabectedin|trabectedin
5397172|NCT01735071|carboplatin|carboplatin
5397173|NCT01735071|randomized trial|randomized trial
5397174|NCT01735071|phase II|phase ii
5397175|NCT01735032|focal epilepsy|focal epilepsy
5397176|NCT01735032|pre-surgical evaluation|pre-surgical evaluation
5397177|NCT01735032|multimodal imaging|multimodal imaging
5397178|NCT01735032|SEEG|seeg
5397179|NCT01735019|EC95, effective concentration in 95% of subjects|ec95, effective concentration in 95% of subjects
5397187|NCT01734980|Endobronchial Ultrasound|endobronchial ultrasound
5397188|NCT01734980|transbronchial needle aspiration|transbronchial needle aspiration
5397189|NCT01734967|confocal laser endomicroscopy|confocal laser endomicroscopy
5397190|NCT01734967|Pancreatic Neoplasms|pancreatic neoplasms
5398382|NCT01729117|Insulin|insulin
5397194|NCT01734954|Sciatic nerve|sciatic nerve
5397195|NCT01734954|Ultrasonography|ultrasonography
5397196|NCT01734954|Orthopedics|orthopedics
5397197|NCT01734954|Hallux Valgus|hallux valgus
5397198|NCT01734954|Amputation|amputation
5397199|NCT01734954|Arthrodesis|arthrodesis
5397200|NCT01734954|Arthroscopy|arthroscopy
5397201|NCT01734954|Fracture fixation|fracture fixation
5397202|NCT01734954|Osteotomy|osteotomy
5397203|NCT01734954|Tendon transfer|tendon transfer
5397204|NCT01734954|Tenodesis|tenodesis
5397205|NCT01734954|Tenotomy|tenotomy
5397206|NCT01734954|Orthopedic procedure|orthopedic procedure
5397207|NCT01734941|Autism|autism
5397208|NCT01734941|Trichuris Suis Ova|trichuris suis ova
5397209|NCT01734941|Behavior|behavior
5397210|NCT01734941|Irritability|irritability
5397211|NCT01734928|Multiple Myeloma|multiple myeloma
5397212|NCT01734928|Pomalidomide|pomalidomide
5397213|NCT01734915|Advanced|advanced
5397214|NCT01734915|EGFR mutation|egfr mutation
5397215|NCT01734889|nitisinone|nitisinone
5397216|NCT01734889|Orfadin|orfadin
5397217|NCT01734889|suspension|suspension
5397218|NCT01734889|taste|taste
5397219|NCT01734889|acceptability|acceptability
5397220|NCT01734876|Parkinson´s disease|parkinson´s disease
5397221|NCT01734876|Pain|pain
5397222|NCT01734876|Sleep|sleep
5397223|NCT01734876|HPA axis function|hpa axis function
5397224|NCT01734876|Health Related Quality of Life|health related quality of life
5397225|NCT01734850|HIV-1|hiv-1
5397226|NCT01734837|Laparoscopic appendectomy|laparoscopic appendectomy
5397227|NCT01734837|appendical stump closure|appendical stump closure
5002933|NCT03977714|ceramic dental implant|ceramic dental implant
5397228|NCT01734824|bone marrow edema, denosumab, PTH 1-84|bone marrow edema, denosumab, pth 1-84
5397229|NCT01734811|Vaccine|vaccine
5397230|NCT01734811|Bronchospasm|bronchospasm
5397231|NCT01734798|locally advanced bladder cancer|locally advanced bladder cancer
5397232|NCT01734798|Postoperative radiotherapy|postoperative radiotherapy
5397233|NCT01734798|Adjuvant chemotherapy|adjuvant chemotherapy
5397234|NCT01734798|Radical Cystectomy|radical cystectomy
5397235|NCT01734759|medication palatability|medication palatability
5397236|NCT01734759|medication taste|medication taste
5397237|NCT01734746|ovarian cancer|ovarian cancer
5397238|NCT01734746|sentinel node|sentinel node
5397242|NCT01734707|atherosclerosis|atherosclerosis
5397243|NCT01734707|regression|regression
5397244|NCT01734707|Allicor|allicor
5397245|NCT01734707|garlic|garlic
5397247|NCT01734642|Medication errors, patients hospitalized, ADRs, adverse events|medication errors, patients hospitalized, adrs, adverse events
5397248|NCT01734629|Coronary Disease|coronary disease
5397249|NCT01734629|COPD|copd
5397250|NCT01734629|Spirometry|spirometry
5397251|NCT01734629|Coronary tomography|coronary tomography
5397252|NCT01734616|Microvascular|microvascular
5397253|NCT01734616|Muscle|muscle
5397254|NCT01734616|Nutrition|nutrition
5397255|NCT01734616|Exercise|exercise
5397256|NCT01734616|Ageing|ageing
5397257|NCT01734603|Assessment|assessment
5397258|NCT01734603|Rehabilitation|rehabilitation
5397259|NCT01734603|Walking Constant Test|walking constant test
5397260|NCT01734603|Walking Graded test|walking graded test
5397261|NCT01734603|Six minute Walking test|six minute walking test
5397262|NCT01734603|Walking Distance|walking distance
5397263|NCT01734590|Flour,|flour,
5397264|NCT01734590|carbohydrate,|carbohydrate,
5397265|NCT01734590|digestibility|digestibility
5397266|NCT01734590|subjects|subjects
5397267|NCT01734577|Back pain|back pain
5397268|NCT01734551|Prenatal opiate exposure|prenatal opiate exposure
5397269|NCT01734551|neonatal withdrawal|neonatal withdrawal
5397270|NCT01734551|Pharmacologic treatment|pharmacologic treatment
5397272|NCT01734525|intensive care unit|intensive care unit
5397273|NCT01734525|1,3 beta-D-glucan|1,3 beta-d-glucan
5397274|NCT01734512|pediatric recurrent progressive low-grade gliomas|pediatric recurrent progressive low-grade gliomas
5397275|NCT01734512|pediatric progressive low-grade gliomas|pediatric progressive low-grade gliomas
5397276|NCT01734512|everolimus|everolimus
5397277|NCT01734512|mTOR inhibition|mtor inhibition
5397278|NCT01734499|Breast cancer|breast cancer
5397279|NCT01734499|Survivorship|survivorship
5397280|NCT01734499|Coping|coping
5397281|NCT01734499|Quality of Life|quality of life
5397282|NCT01734473|COPD|copd
5397283|NCT01734473|Protein synthesis|protein synthesis
5397284|NCT01734473|Protein breakdown|protein breakdown
5397285|NCT01734473|Muscle wasting|muscle wasting
5397286|NCT01734473|Leucine|leucine
5397287|NCT01734473|Hydrolyzed|hydrolyzed
5397288|NCT01734473|Casein protein|casein protein
5397289|NCT01734473|Carbohydrates|carbohydrates
5397290|NCT01734460|pregnancy, snoring, fetal growth|pregnancy, snoring, fetal growth
5397291|NCT01734434|Health care access, Pregnant women|health care access, pregnant women
5397292|NCT01734421|Smoking cessation|smoking cessation
5397298|NCT01734408|inactivated EV71 vaccine|inactivated ev71 vaccine
5397299|NCT01734395|Alzheimer's disease|alzheimer's disease
5397300|NCT01734395|Caregiver's Burden in Alzheimer's disease|caregiver's burden in alzheimer's disease
5397301|NCT01734395|Galantamine|galantamine
5397302|NCT01734395|Razadyne|razadyne
5397303|NCT01734395|Reminyl|reminyl
5397309|NCT01734356|iPS|ips
5397310|NCT01734356|fibroblast|fibroblast
5397311|NCT01734356|arrhythmias|arrhythmias
5397312|NCT01734356|valvulopathies|valvulopathies
5397313|NCT01734356|electrophysiology|electrophysiology
5397314|NCT01734356|genetics|genetics
5397315|NCT01734343|posterior capsule opacification|posterior capsule opacification
5397316|NCT01734343|PCO|pco
5397317|NCT01734343|after cataract|after cataract
5397318|NCT01734343|intraocular lens|intraocular lens
5397319|NCT01734330|behavior cognitive therapy|behavior cognitive therapy
5397320|NCT01734330|Smokers|smokers
5397321|NCT01734330|randomized clinical trial|randomized clinical trial
5397322|NCT01734304|vaccination|vaccination
5397323|NCT01734304|postremission therapy|postremission therapy
5397324|NCT01734304|acute myeloid leukemia|acute myeloid leukemia
5397325|NCT01734304|dendritic cells|dendritic cells
5397326|NCT01734291|Family psychoeducation|family psychoeducation
5397327|NCT01734291|Major depressive disorder|major depressive disorder
5397328|NCT01734291|Family burden|family burden
5397329|NCT01734174|transesophageal and transthoracic echocardiogram|transesophageal and transthoracic echocardiogram
5397333|NCT01734161|cesarean section|cesarean section
5397334|NCT01734161|nausea|nausea
5397335|NCT01734161|vomiting|vomiting
5397336|NCT01734161|dexamethasone|dexamethasone
5397337|NCT01734161|postoperative nausea and vomiting|postoperative nausea and vomiting
5397338|NCT01734161|antiemetics|antiemetics
5397339|NCT01734148|pediatric|pediatric
5397340|NCT01734148|sleep difficulties in children|sleep difficulties in children
5397341|NCT01734148|Sleep Education|sleep education
5397342|NCT01734135|B type natriuretic peptide|b type natriuretic peptide
5397343|NCT01734135|heart failure|heart failure
5397344|NCT01734135|cardiac imaging|cardiac imaging
5397345|NCT01734135|quality of care|quality of care
5530246|NCT01167153|ABPM|abpm
5397346|NCT01734122|Stereotactic Radiosurgery|stereotactic radiosurgery
5397347|NCT01734122|Essential Tremor|essential tremor
5397348|NCT01734122|Parkinsonian Tremor|parkinsonian tremor
5397349|NCT01734122|Quality of Life|quality of life
5397350|NCT01734122|Severity of Tremor|severity of tremor
5397351|NCT01734109|Negative Pressure Wound Therapy|negative pressure wound therapy
5397352|NCT01734109|Irrigation Therapy|irrigation therapy
5397353|NCT01734109|Pressure Ulcers|pressure ulcers
5397354|NCT01734109|Sacral Ulcers|sacral ulcers
5397355|NCT01734096|hypertension|hypertension
5397356|NCT01734096|obesity|obesity
5397358|NCT01734096|resistant hypertension|resistant hypertension
5397359|NCT01734083|rehabilitation|rehabilitation
5397360|NCT01734083|exercise|exercise
5397361|NCT01734083|fall|fall
5397362|NCT01734083|muscle|muscle
5397363|NCT01734083|vibration|vibration
5397364|NCT01734083|mobility|mobility
5397365|NCT01734083|cognition|cognition
5397366|NCT01734070|anthocyanins|anthocyanins
5397367|NCT01734070|catechins|catechins
5397368|NCT01734070|chlorogenic acid|chlorogenic acid
5397369|NCT01734070|flavanol glycosides|flavanol glycosides
5397370|NCT01734057|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
5397371|NCT01734057|rhTPO|rhtpo
5397372|NCT01734057|Rituximab|rituximab
5397373|NCT01734057|Dexamethasone|dexamethasone
5397374|NCT01734044|Recombinant Human Thrombopoietin|recombinant human thrombopoietin
5397375|NCT01734044|rhTPO|rhtpo
5397376|NCT01734044|Dexamethasone|dexamethasone
5397377|NCT01733953|Cardiovascular Disease|cardiovascular disease
5397378|NCT01733953|Childhood ALL|childhood all
5397379|NCT01733953|Childhood NHL|childhood nhl
5397381|NCT01733927|Rapid test for HIV|rapid test for hiv
5397382|NCT01733914|shoulder pain|shoulder pain
5397383|NCT01733914|acupuncture|acupuncture
5397384|NCT01733901|Coronary heart disease|coronary heart disease
5397386|NCT01733901|Renal sympathetic denervation|renal sympathetic denervation
5397387|NCT01733901|Hypertension|hypertension
5397388|NCT01733901|Diabetes|diabetes
5397389|NCT01733888|caries|caries
5397390|NCT01733888|caries infiltration|caries infiltration
5397391|NCT01733888|fluorosis treatment|fluorosis treatment
5397392|NCT01733875|Safety|safety
5397393|NCT01733875|Pharmacokinetics|pharmacokinetics
5397394|NCT01733875|Food effect|food effect
5397395|NCT01733875|Healthy subjects|healthy subjects
5397396|NCT01733862|Impact|impact
5397397|NCT01733862|Vaccination|vaccination
5397398|NCT01733862|Hospitalizations|hospitalizations
5397399|NCT01733862|Rotavirus gastroenteritis|rotavirus gastroenteritis
5397400|NCT01733862|Japan|japan
5397401|NCT01733849|Bulgaria|bulgaria
5397402|NCT01733849|Primary care settings|primary care settings
5397403|NCT01733849|Children|children
5397404|NCT01733849|Latvia|latvia
5397405|NCT01733849|Acute gastroenteritis|acute gastroenteritis
5397406|NCT01733810|Esophagitis|esophagitis
5397407|NCT01733810|Reflux esophagitis|reflux esophagitis
5397408|NCT01733810|Gastroesophageal reflux disease|gastroesophageal reflux disease
5397409|NCT01733810|Acid|acid
5397410|NCT01733810|Inflammation|inflammation
5397411|NCT01733810|Esophagus|esophagus
5397412|NCT01733810|Cytokines|cytokines
5397413|NCT01733810|Esophageal squamous cell|esophageal squamous cell
5397414|NCT01733810|Reflux|reflux
5397415|NCT01733810|Squamous epithelium|squamous epithelium
5397416|NCT01733797|Trismus|trismus
5397417|NCT01733797|Therabite|therabite
5397418|NCT01733797|Wooden spatula|wooden spatula
5397419|NCT01733797|Head and Neck cancer|head and neck cancer
5397420|NCT01733784|Sleep Apnea|sleep apnea
5397421|NCT01733784|Pathophysiology|pathophysiology
5397422|NCT01733771|complementary medicine|complementary medicine
5397423|NCT01733771|hospitalized|hospitalized
5397424|NCT01733758|albiglutide|albiglutide
5397425|NCT01733758|Japanese|japanese
5397426|NCT01733758|GSK716155|gsk716155
5397427|NCT01733758|Type 2 diabetes mellitus|type 2 diabetes mellitus
5397428|NCT01733758|glucagon-like peptide 1|glucagon-like peptide 1
5397429|NCT01733745|dry eye|dry eye
5397430|NCT01733745|lipid deficiency|lipid deficiency
5397431|NCT01733745|meibomian gland|meibomian gland
5397432|NCT01733732|Dry eye|dry eye
5397433|NCT01733732|Lipid deficiency|lipid deficiency
5397434|NCT01733732|Inflammatory markers|inflammatory markers
5397435|NCT01733706|No Nicotine Electronic Cigarette|no nicotine electronic cigarette
5397436|NCT01733706|Antismoke intervention|antismoke intervention
5397437|NCT01733693|Buprenorphine|buprenorphine
5397438|NCT01733693|Methadone|methadone
5397439|NCT01733693|Cognition|cognition
5397440|NCT01733680|ADHD|adhd
5397441|NCT01733680|executive function|executive function
5397442|NCT01733680|emotional self-regulation|emotional self-regulation
5397443|NCT01733667|synechia|synechia
5397444|NCT01733667|Fess|fess
5397445|NCT01733667|sinus surgery|sinus surgery
5397446|NCT01733654|depression|depression
5397447|NCT01733654|major depressive disorder|major depressive disorder
5397448|NCT01733628|Hypertension|hypertension
5397449|NCT01733628|Bevacizumab Response Predictors|bevacizumab response predictors
5397450|NCT01733628|Metastatic Breast Cancer|metastatic breast cancer
5397451|NCT01733628|Metastatic Colon Cancer|metastatic colon cancer
5397452|NCT01733615|Mucopolysaccharidosis Type IVA|mucopolysaccharidosis type iva
5397453|NCT01733615|Mucopolysaccharidosis Type IV|mucopolysaccharidosis type iv
5397454|NCT01733615|MPS Type IVA|mps type iva
5397455|NCT01733615|MPS Type IV|mps type iv
5397456|NCT01733615|Morquio Syndrome|morquio syndrome
5397457|NCT01733615|Morquio Syndrome Type A|morquio syndrome type a
5397458|NCT01733615|Urine biomarkers|urine biomarkers
5862828|NCT00001487|Andropause|andropause
5397460|NCT01733589|Non-small-Cell Lung Cancer|non-small-cell lung cancer
5397461|NCT01733589|chemoradiotherapy|chemoradiotherapy
5397462|NCT01733563|sugar sweetened beverages|sugar sweetened beverages
5397464|NCT01733563|lipogenesis|lipogenesis
5397465|NCT01733563|beta-oxidation|beta-oxidation
5397466|NCT01733550|Intraocular Pressure|intraocular pressure
5397467|NCT01733550|Tonometry, Ocular|tonometry, ocular
5397468|NCT01733550|iCare|icare
5397469|NCT01733537|traffic accidents, motorcycle, injury, conspicuity|traffic accidents, motorcycle, injury, conspicuity
5397470|NCT01733524|adolescence|adolescence
5397471|NCT01733524|self care|self care
5397472|NCT01733485|Asthma|asthma
5397473|NCT01733485|Electrophilic Fatty Acids|electrophilic fatty acids
5397474|NCT01733485|Inflammation|inflammation
5397475|NCT01733472|anaesthetic techniques|anaesthetic techniques
5397476|NCT01733472|subarachnoid|subarachnoid
5397477|NCT01733472|analgesia|analgesia
5397478|NCT01733459|PCOS, DLBS3233, metformin,oral anti-hyperglycemic agent|pcos, dlbs3233, metformin,oral anti-hyperglycemic agent
5397479|NCT01733446|High frequency jet ventilation|high frequency jet ventilation
5397480|NCT01733407|inherited neuropathies|inherited neuropathies
5397481|NCT01733394|Epilepsy|epilepsy
5397482|NCT01733394|Generic|generic
5397483|NCT01733381|Barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ANS) functioning and mood state.|barefoot running, minimally shod running, non-invasive measures of autonomic nervous system (ans) functioning and mood state.
5397484|NCT01733368|CRT|crt
5397485|NCT01733368|Optimization|optimization
5397486|NCT01733368|Responders|responders
5397487|NCT01733329|Buccal Misoprostol|buccal misoprostol
5397488|NCT01733329|Uterine Atony|uterine atony
5397489|NCT01733329|Postpartum Hemorrhage|postpartum hemorrhage
5397490|NCT01733316|Nephropathic Cystinosis|nephropathic cystinosis
5397491|NCT01733316|Cysteamine|cysteamine
5398383|NCT01729117|Hispanic|hispanic
5397492|NCT01733316|Delayed-Release Cysteamine|delayed-release cysteamine
5397493|NCT01733316|Orphan Disease|orphan disease
5397494|NCT01733316|CTNS Protein, Human|ctns protein, human
5397495|NCT01733290|Botulinum Toxin A (BoNT-A)|botulinum toxin a (bont-a)
5397496|NCT01733290|Dysfunctional voiding|dysfunctional voiding
5397497|NCT01733277|Neuropathic pain|neuropathic pain
5397498|NCT01733277|Knee osteoarthritis|knee osteoarthritis
5397499|NCT01733277|MRI|mri
5397500|NCT01733238|PNT2258|pnt2258
5397501|NCT01733238|Lymphoma|lymphoma
5397502|NCT01733238|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5397503|NCT01733238|NHL|nhl
5397504|NCT01733212|Nausea|nausea
5397505|NCT01733212|Vomiting|vomiting
5397506|NCT01733212|Cesaraen|cesaraen
5397507|NCT01733212|Ginger|ginger
5397508|NCT01733212|cesarean section|cesarean section
5397509|NCT01733199|Parkinson's disease|parkinson's disease
5397510|NCT01733199|Behavioural addictions|behavioural addictions
5397511|NCT01733199|Pathological gambling|pathological gambling
5397512|NCT01733199|Dopamine agonist|dopamine agonist
5397513|NCT01733199|Dopamine dysregulation syndrome|dopamine dysregulation syndrome
5397514|NCT01733199|Pharmacokinetic|pharmacokinetic
5397515|NCT01733199|Pramipexole|pramipexole
5397516|NCT01733186|human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
5397517|NCT01733186|MSC|msc
5397518|NCT01733186|cartilage lesion|cartilage lesion
5397519|NCT01733186|cartilage defect|cartilage defect
5397520|NCT01733186|degenerative arthritis|degenerative arthritis
5397521|NCT01733186|stem cell implantation|stem cell implantation
5397533|NCT01733147|Barrett's esophagus|barrett's esophagus
5397534|NCT01733147|Obesity|obesity
5397535|NCT01733147|Omega-3 fatty acid|omega-3 fatty acid
5397536|NCT01733134|acute heart failure|acute heart failure
5397537|NCT01733134|emergency department|emergency department
5397538|NCT01733134|copeptin|copeptin
5397539|NCT01733134|adh antagonists|adh antagonists
5397540|NCT01733108|Healthy|healthy
5903872|NCT00249678|Behavior Therapy|behavior therapy
5397541|NCT01733108|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5397542|NCT01733108|Pharmacokinetics|pharmacokinetics
5397543|NCT01733108|Pharmacodynamics|pharmacodynamics
5397544|NCT01733108|Glyburide (MICRONASE)|glyburide (micronase)
5397545|NCT01733056|Dermatology|dermatology
5397546|NCT01733056|Influenza Vaccine|influenza vaccine
5397547|NCT01733030|PTSD|ptsd
5397548|NCT01733017|heart failure|heart failure
5397549|NCT01733017|nutrition therapy|nutrition therapy
5397550|NCT01733017|symptoms|symptoms
5397551|NCT01733017|quality of life|quality of life
5397552|NCT01733017|lycopene|lycopene
5397553|NCT01733017|omega-3 fatty acids|omega-3 fatty acids
5397554|NCT01733004|Cancer|cancer
5397555|NCT01733004|Hepatocellular Carcinoma|hepatocellular carcinoma
5397556|NCT01733004|Oncology|oncology
5397557|NCT01733004|Phase I|phase i
5397558|NCT01733004|ErbB3|erbb3
5397559|NCT01733004|IGF-1R|igf-1r
5397560|NCT01733004|Everolimus|everolimus
5397561|NCT01733004|Gemcitabine|gemcitabine
5397562|NCT01733004|Abraxane|abraxane
5397563|NCT01732991|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
5397564|NCT01732991|Greenlight laser|greenlight laser
5397565|NCT01732991|Prostatic photovaporization|prostatic photovaporization
5397566|NCT01732991|Prostatic MRI|prostatic mri
5397567|NCT01732991|Prostatic contrast-enhanced ultrasound|prostatic contrast-enhanced ultrasound
5397568|NCT01732991|Urinary irritative signs|urinary irritative signs
5397569|NCT01732991|Postoperative necrotic area|postoperative necrotic area
5397570|NCT01732978|Crying record|crying record
5397572|NCT01732965|Vitiligo|vitiligo
5397573|NCT01732965|Phototherapy|phototherapy
5397574|NCT01732965|Photochemotherapy|photochemotherapy
5397575|NCT01732952|the prevalence,lipid abnormalities,CV risks|the prevalence,lipid abnormalities,cv risks
5397576|NCT01732926|iNHL|inhl
5397577|NCT01732926|indolent NHL|indolent nhl
5397578|NCT01732926|follicular lymphoma|follicular lymphoma
5397579|NCT01732926|CAL-101|cal-101
5397580|NCT01732926|rituximab|rituximab
5397581|NCT01732926|bendamustine|bendamustine
5397582|NCT01732926|small lymphocytic lymphoma|small lymphocytic lymphoma
5397583|NCT01732926|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
5397584|NCT01732926|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5397586|NCT01732926|WM|wm
5397587|NCT01732926|Marginal zone lymphoma|marginal zone lymphoma
5397588|NCT01732926|MZL|mzl
5397589|NCT01732926|SLL|sll
5397590|NCT01732926|FL|fl
5397591|NCT01732926|GS-1101|gs-1101
5397592|NCT01732926|PI3K inhibitor|pi3k inhibitor
5397593|NCT01732926|idelalisib|idelalisib
5397594|NCT01732913|iNHL|inhl
5397595|NCT01732913|indolent NHL|indolent nhl
5397596|NCT01732913|follicular lymphoma|follicular lymphoma
5397599|NCT01732913|Small lymphocytic lymphoma|small lymphocytic lymphoma
5397600|NCT01732913|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
5397601|NCT01732913|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5397602|NCT01732913|LPL|lpl
5397603|NCT01732913|WM|wm
5397604|NCT01732913|Marginal zone lymphoma|marginal zone lymphoma
5397605|NCT01732913|MZL|mzl
5397606|NCT01732913|SLL|sll
5397607|NCT01732913|FL|fl
5397608|NCT01732913|GS-1101|gs-1101
5397609|NCT01732913|idelalisib|idelalisib
5397610|NCT01732900|In vitro fertilization|in vitro fertilization
5397611|NCT01732900|Assisted reproduction|assisted reproduction
5397612|NCT01732900|pregnancy outcome|pregnancy outcome
5397613|NCT01732900|cumulus cells|cumulus cells
5397614|NCT01732887|cochlear implants|cochlear implants
5397615|NCT01732887|speech comprehension|speech comprehension
5397616|NCT01732887|cognitive training|cognitive training
5397617|NCT01732887|cognitive fitness|cognitive fitness
5397618|NCT01732887|intervention|intervention
5397622|NCT01732874|DHA|dha
5380653|NCT01809496|spouses|spouses
5397623|NCT01732874|Preterm infant|preterm infant
5397624|NCT01732874|Inflammation|inflammation
5397625|NCT01732874|Growth|growth
5397626|NCT01732874|Developement|developement
5397627|NCT01732861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5397628|NCT01732861|Small Lymphocytic Leukemia|small lymphocytic leukemia
5397629|NCT01732848|Volunteers|volunteers
5397630|NCT01732835|Aortic Insufficiency (AI) Aortic Regurgitation (AR)|aortic insufficiency (ai) aortic regurgitation (ar)
5397631|NCT01732822|Peripheral artery disease Atherothrombotic events Atherosclerosis|peripheral artery disease atherothrombotic events atherosclerosis
5397632|NCT01732809|wrinkles|wrinkles
5397633|NCT01732809|botulinum toxin|botulinum toxin
5397634|NCT01732783|Wild-type RAS|wild-type ras
5397635|NCT01732783|Metastatic Colorectal Cancer|metastatic colorectal cancer
5397636|NCT01732783|Vectibix|vectibix
5397637|NCT01732744|biofilm, castor bean, sodium hypochlorite, alkaline peroxide|biofilm, castor bean, sodium hypochlorite, alkaline peroxide
5397638|NCT01732731|Cerebral palsy|cerebral palsy
5397639|NCT01732731|treadmill training|treadmill training
5397640|NCT01732718|sickle cell disease|sickle cell disease
5397641|NCT01732718|endothelial function|endothelial function
5397642|NCT01732718|albuminuria|albuminuria
5397643|NCT01732718|atorvastatin|atorvastatin
5397644|NCT01732718|soluble fms-like tyrosine kinase-1|soluble fms-like tyrosine kinase-1
5397645|NCT01732705|Type 2 diabetes|type 2 diabetes
5397646|NCT01732705|Insulin sensitivity|insulin sensitivity
5397647|NCT01732705|High intensity interval training|high intensity interval training
5397648|NCT01732692|Bowel preparation, MOVIPREP®|bowel preparation, moviprep®
5397649|NCT01732679|stroke, rehabilitation, multidisciplinary, description|stroke, rehabilitation, multidisciplinary, description
5397650|NCT01732666|Opioid-induced hyperalgesia (OIH)|opioid-induced hyperalgesia (oih)
5397651|NCT01732653|virtual reality,|virtual reality,
5397652|NCT01732653|falls,|falls,
5397654|NCT01732653|Parkinson's disease,|parkinson's disease,
5397655|NCT01732653|MCI|mci
5397656|NCT01732640|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5397657|NCT01732627|Meningitis|meningitis
5397658|NCT01732627|Meningococcal Meningitis|meningococcal meningitis
5397659|NCT01732627|Menactra®|menactra®
5397660|NCT01732627|Menomune® A/C/Y/W-135|menomune® a/c/y/w-135
5397661|NCT01732614|Diabetic Macular Edema|diabetic macular edema
5397662|NCT01732614|DME|dme
5397663|NCT01732614|Laser|laser
5397664|NCT01732614|Topcon|topcon
5397665|NCT01732614|EndPoint Management|endpoint management
5397666|NCT01732601|Suicide Attempt|suicide attempt
5397668|NCT01732601|NSSI|nssi
5397669|NCT01732601|Substance Use|substance use
5397670|NCT01732588|Bioavailability|bioavailability
5397671|NCT01732575|everyday activities|everyday activities
5397672|NCT01732575|rehabilitation|rehabilitation
5397673|NCT01732575|mental illness|mental illness
5397674|NCT01732575|occupational therapy|occupational therapy
5397675|NCT01732562|Primary Total Knee Arthroplasty|primary total knee arthroplasty
5397676|NCT01732562|Patient Expectations|patient expectations
5397677|NCT01732562|Patient Satisfaction|patient satisfaction
5397678|NCT01732562|Patient Education|patient education
5397679|NCT01732562|e-Learning|e-learning
5397680|NCT01732536|corticosteroid-eluting sinus implant|corticosteroid-eluting sinus implant
5397681|NCT01732536|chronic rhinosinusitis|chronic rhinosinusitis
5397682|NCT01732536|mometasone furoate|mometasone furoate
5397683|NCT01732536|polyposis|polyposis
5397684|NCT01732523|Carotid stenosis|carotid stenosis
5397685|NCT01732523|Vasa Vasorum|vasa vasorum
5397686|NCT01732523|Ultrasonography|ultrasonography
5397687|NCT01732497|Underarm Hair|underarm hair
5397688|NCT01732497|Underarm Hair Reduction|underarm hair reduction
5397689|NCT01732497|Axillary Hair|axillary hair
5397690|NCT01732497|Axillary Hair Reduction|axillary hair reduction
5397691|NCT01732497|Underarm Odor|underarm odor
5397692|NCT01732497|Axillary Odor|axillary odor
5397788|NCT01732003|Skeletal Muscle|skeletal muscle
5397789|NCT01732003|Eicosapentaenoic acid|eicosapentaenoic acid
5397693|NCT01732471|EMR 700733_510, Genetic disorder, Phenylketonuria, phenylalanine, Kuvan, sapropterin dihydrochloride|emr 700733_510, genetic disorder, phenylketonuria, phenylalanine, kuvan, sapropterin dihydrochloride
5397694|NCT01732419|Rehabilitation, exercise therapy, coronary artery disease|rehabilitation, exercise therapy, coronary artery disease
5397695|NCT01732393|Quercetin|quercetin
5397696|NCT01732393|Chemotherapy|chemotherapy
5397697|NCT01732393|Mucositis|mucositis
5397698|NCT01732393|Hematologic Malignancies|hematologic malignancies
5397699|NCT01732367|Tenofovir|tenofovir
5397700|NCT01732367|Lamivudine|lamivudine
5397701|NCT01732367|Adefovir|adefovir
5397702|NCT01732367|Chronic Hepatitis B|chronic hepatitis b
5397703|NCT01732354|Hepatitis B virus, Tenofovir|hepatitis b virus, tenofovir
5397704|NCT01732341|STEMI|stemi
5397705|NCT01732341|BMS|bms
5401216|NCT01716494|asthma|asthma
5397709|NCT01732315|Barriers to vaccination|barriers to vaccination
5397711|NCT01732315|Intentions|intentions
5397712|NCT01732302|Drug Utilization Review|drug utilization review
5397713|NCT01732302|Aged|aged
5397714|NCT01732302|Aged, 80 and over|aged, 80 and over
5397715|NCT01732302|Primary Health Care|primary health care
5397716|NCT01732289|Age-related hearing loss|age-related hearing loss
5397717|NCT01732289|Gene|gene
5397718|NCT01732289|Single nucleotide polymorphism|single nucleotide polymorphism
5397719|NCT01732289|environmental factors|environmental factors
5397720|NCT01732276|Triple-negative breast cancer|triple-negative breast cancer
5397721|NCT01732276|Epidermal growth factor receptor|epidermal growth factor receptor
5397722|NCT01732276|Gefitinib|gefitinib
5397723|NCT01732250|Gram-Negative Bacterial Infections|gram-negative bacterial infections
5397724|NCT01732250|Resistant Bacteria|resistant bacteria
5397725|NCT01732250|Drug Resistance, Bacterial|drug resistance, bacterial
5397726|NCT01732250|Colistin|colistin
5397727|NCT01732237|Healthy|healthy
5397728|NCT01732237|JNJ-42396302|jnj-42396302
5397729|NCT01732237|JNJ-42692507|jnj-42692507
5397730|NCT01732237|JNJ-53773187|jnj-53773187
5397731|NCT01732237|Pharmacokinetics|pharmacokinetics
5397732|NCT01732211|Phase 2|phase 2
5397733|NCT01732211|Randomized|randomized
5397734|NCT01732211|Double Blind|double blind
5397735|NCT01732211|Placebo Controlled|placebo controlled
5397736|NCT01732211|Parallel|parallel
5397737|NCT01732211|20 Week Safety|20 week safety
5397738|NCT01732211|Tolerability|tolerability
5397739|NCT01732211|and Efficacy Study|and efficacy study
5397740|NCT01732185|Congenital lung malformation|congenital lung malformation
5397741|NCT01732185|Congenital Cystic Adenomatoid Malformation|congenital cystic adenomatoid malformation
5397742|NCT01732185|Cystic lung disease|cystic lung disease
5397743|NCT01732172|Urethritis|urethritis
5397744|NCT01732172|Prevalence of a chronic inflammatory male genital tract|prevalence of a chronic inflammatory male genital tract
5397745|NCT01732159|Ambulatory surgery|ambulatory surgery
5397746|NCT01732159|Checklist|checklist
5397747|NCT01732159|Cancellation|cancellation
5397748|NCT01732146|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5397749|NCT01732146|Term neonate|term neonate
5397750|NCT01732146|Neuroprotection|neuroprotection
5397751|NCT01732146|erythropoietin|erythropoietin
5397752|NCT01732133|Hypotension|hypotension
5397753|NCT01732133|Cesarean delivery|cesarean delivery
5397754|NCT01732120|off-clamp|off-clamp
5397755|NCT01732120|partial nephrectomy|partial nephrectomy
5397756|NCT01732120|renal cancer treatment|renal cancer treatment
5397757|NCT01732120|renal ischemia|renal ischemia
5397758|NCT01732107|Dovitinib|dovitinib
5397759|NCT01732107|FGFR3 Mutations|fgfr3 mutations
5397760|NCT01732107|BCG-Refractory Urothelial Carcinoma|bcg-refractory urothelial carcinoma
5397761|NCT01732094|Poor ovarian response|poor ovarian response
5397771|NCT01732055|Psychotherapy|psychotherapy
5397772|NCT01732055|Antidepressant Medication|antidepressant medication
5397773|NCT01732055|Partners|partners
5397775|NCT01732055|Interpersonal Psychotherapy|interpersonal psychotherapy
5397776|NCT01732042|retinal venous pressure|retinal venous pressure
5397777|NCT01732029|pulse oximeter|pulse oximeter
5383256|NCT01798056|Safety|safety
5397778|NCT01732029|oxygen saturation|oxygen saturation
5397779|NCT01732029|heart rate|heart rate
5397780|NCT01732029|calibration|calibration
5397781|NCT01732029|accuracy|accuracy
5397782|NCT01732016|pulse oximeter|pulse oximeter
5397783|NCT01732016|oxygen saturation|oxygen saturation
5397784|NCT01732016|heart rate|heart rate
5397785|NCT01732016|calibration|calibration
5397786|NCT01732016|accuracy|accuracy
5397787|NCT01732003|Omega-3|omega-3
5398078|NCT01730495|TNF-alpha|tnf-alpha
5397790|NCT01732003|Docosahexaenoic acid|docosahexaenoic acid
5397791|NCT01732003|Exercise|exercise
5397792|NCT01732003|Membrane Composition|membrane composition
5397793|NCT01732003|Lipid Metabolism|lipid metabolism
5397794|NCT01731990|Peripheral artery disease|peripheral artery disease
5397795|NCT01731990|Intermittent claudication|intermittent claudication
5397796|NCT01731990|magnetic resonance imaging|magnetic resonance imaging
5397797|NCT01731977|Psychotherapy, Psychotic disorders, Caregiver|psychotherapy, psychotic disorders, caregiver
5401317|NCT01715857|Chinese|chinese
5397798|NCT01731964|Macular Degeneration|macular degeneration
5397799|NCT01731964|Visual Impairment|visual impairment
5397800|NCT01731964|Implantable Telescope|implantable telescope
5397801|NCT01731951|Myelofibrosis|myelofibrosis
5397802|NCT01731951|Myelodysplastic Syndromes|myelodysplastic syndromes
5397803|NCT01731951|Myeloproliferative Neoplasm|myeloproliferative neoplasm
5397804|NCT01731951|Imetelstat|imetelstat
5397805|NCT01731951|GRN163L|grn163l
5397806|NCT01731938|Fibrin Sealant|fibrin sealant
5397807|NCT01731938|Soft tissue open surgery|soft tissue open surgery
5397808|NCT01731938|Oxidized cellulose pads|oxidized cellulose pads
5397809|NCT01731925|midgut carcinoid tumors|midgut carcinoid tumors
5397810|NCT01731925|progressive|progressive
5397811|NCT01731925|advanced|advanced
5397812|NCT01731925|metastatic|metastatic
5397813|NCT01731899|major depression|major depression
5397814|NCT01731899|fibromyalgia|fibromyalgia
5397815|NCT01731899|agomelatine|agomelatine
5397816|NCT01731899|Becks' Depression Inventory (BDI)|becks' depression inventory (bdi)
5397817|NCT01731899|Pittsburgh's Sleep Quality Index (PSQI)|pittsburgh's sleep quality index (psqi)
5397818|NCT01731886|Stem cell transplant|stem cell transplant
5397819|NCT01731886|plasma cell myeloma|plasma cell myeloma
5397820|NCT01731886|multiple myeloma|multiple myeloma
5397821|NCT01731873|postoperative pain|postoperative pain
5397822|NCT01731873|children|children
5397823|NCT01731873|pharmacogenetic|pharmacogenetic
5397824|NCT01731873|opioid adverse effects|opioid adverse effects
5397825|NCT01731873|respiratory depression|respiratory depression
5397826|NCT01731873|analgesia|analgesia
5397827|NCT01731873|genetic polymorphisms|genetic polymorphisms
5397828|NCT01731873|chronic postsurgical pain|chronic postsurgical pain
5397829|NCT01731860|PET/CT|pet/ct
5397830|NCT01731860|Philips|philips
5397831|NCT01731847|dysphagia,endoscopy, electrical stimulation,stroke|dysphagia,endoscopy, electrical stimulation,stroke
5397832|NCT01731834|Pain|pain
5397833|NCT01731834|Stress|stress
5397834|NCT01731834|Physiotherapy|physiotherapy
5397835|NCT01731834|Children|children
5397836|NCT01731821|Pancreaticoduodenectomy|pancreaticoduodenectomy
5397837|NCT01731821|Pancreaticojejunostomy|pancreaticojejunostomy
5397838|NCT01731808|Nursing counseling|nursing counseling
5397839|NCT01731808|diabetic foot|diabetic foot
5397840|NCT01731795|acute respiratory distress syndrome, mechanical ventilation|acute respiratory distress syndrome, mechanical ventilation
5397841|NCT01731782|colorectal surgery|colorectal surgery
5397842|NCT01731769|Seroma Formation|seroma formation
5397843|NCT01731769|Axillary Lymph Node Dissection|axillary lymph node dissection
5397844|NCT01731769|Breast cancer|breast cancer
5392895|NCT01754194|Morbid Obesity|morbid obesity
5397846|NCT01731756|Palm|palm
5397847|NCT01731756|Arsenic|arsenic
5397848|NCT01731756|Keratosis|keratosis
5397849|NCT01731756|Salicylic acid|salicylic acid
5397850|NCT01731756|Azadirachta indica|azadirachta indica
5397851|NCT01731756|Neem|neem
5397852|NCT01731730|Postsurgical pain|postsurgical pain
5397853|NCT01731730|Total knee arthroplasty|total knee arthroplasty
5397854|NCT01731730|Total knee replacement|total knee replacement
5397855|NCT01731717|depression|depression
5397856|NCT01731717|stepped care|stepped care
5397857|NCT01731717|evidence-based medicine|evidence-based medicine
5397858|NCT01731717|health services research|health services research
5397859|NCT01731717|psychotherapy|psychotherapy
5397860|NCT01731717|complex intervention|complex intervention
5397861|NCT01731717|guideline|guideline
5397862|NCT01731704|5 or more brain metastases|5 or more brain metastases
5397863|NCT01731704|proven diagnosis of a non-hematopoietic malignancy|proven diagnosis of a non-hematopoietic malignancy
5397864|NCT01731704|non-small cell lung cancer or germ cell malignancy|non-small cell lung cancer or germ cell malignancy
5397865|NCT01731665|Crohn's disease|crohn's disease
5397866|NCT01731665|ulcerative colitis|ulcerative colitis
5397867|NCT01731665|epidemiology|epidemiology
5397868|NCT01731665|Korea|korea
5397869|NCT01731652|bladder cancer|bladder cancer
5397870|NCT01731652|carcinoma in situ|carcinoma in situ
5397871|NCT01731652|non muscle invasive bladder cancer|non muscle invasive bladder cancer
5397872|NCT01731587|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5397873|NCT01731587|exploratory study|exploratory study
5397875|NCT01731561|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
5397876|NCT01731561|Microscopic polyangiitis|microscopic polyangiitis
5397877|NCT01731561|Renal limited forms|renal limited forms
5397878|NCT01731561|ANCA-associated vasculitis|anca-associated vasculitis
5397879|NCT01731561|Rituximab|rituximab
5397880|NCT01731535|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate|osteoporosis, low trauma fracture, non-union fracture, delayed healing fracture, bisphosphonate
5398079|NCT01730495|Etanercept|etanercept
5397881|NCT01731509|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5397882|NCT01731509|fetoscopy|fetoscopy
5397883|NCT01731509|fetal endoscopic tracheal occlusion|fetal endoscopic tracheal occlusion
5397884|NCT01731509|pulmonary hypoplasia|pulmonary hypoplasia
5397885|NCT01731509|fetal surgery|fetal surgery
5397886|NCT01731509|fetal lung|fetal lung
5397887|NCT01731496|Human Papillomavirus|human papillomavirus
5397888|NCT01731483|virulence factors|virulence factors
5397889|NCT01731457|ischemia, reperfusion, kidney, transplantation|ischemia, reperfusion, kidney, transplantation
5397890|NCT01731444|blood loss|blood loss
5397891|NCT01731444|burn|burn
5397892|NCT01731444|hemostasis|hemostasis
5397893|NCT01731431|Gestational Diabetes,|gestational diabetes,
5397894|NCT01731431|Insulin,|insulin,
5397895|NCT01731431|Glyburide,|glyburide,
5397896|NCT01731431|Glycemia|glycemia
5397897|NCT01731418|Post Traumatic Stress Disorder|post traumatic stress disorder
5397898|NCT01731418|Depression|depression
5397899|NCT01731418|Intimate Partner violence|intimate partner violence
5397900|NCT01731418|Narrative Exposure Therapy|narrative exposure therapy
5397901|NCT01731405|Medication Guides|medication guides
5397903|NCT01731405|Prototype|prototype
5397904|NCT01731405|Format|format
5397905|NCT01731392|Diarrhea|diarrhea
5397906|NCT01731392|Children|children
5397907|NCT01731392|Lactobacilli|lactobacilli
5397908|NCT01731379|spectroscopy|spectroscopy
5397909|NCT01731379|nerve|nerve
5397910|NCT01731379|muscle|muscle
5397912|NCT01731353|invasive fungal infection|invasive fungal infection
5397913|NCT01731353|Web-based registry|web-based registry
5397914|NCT01731340|Calcium Supplements|calcium supplements
5397915|NCT01731340|Dairy Foods|dairy foods
5397916|NCT01731340|Cardiovascular Diseases|cardiovascular diseases
5397917|NCT01731340|Osteoporosis|osteoporosis
5397918|NCT01731340|Postmenopause|postmenopause
5397919|NCT01731340|Vitamin D|vitamin d
5397920|NCT01731340|Micronutrients|micronutrients
5397921|NCT01731340|Primary Prevention|primary prevention
5397922|NCT01731340|Bone Health|bone health
5397923|NCT01731327|Phase 1|phase 1
5397924|NCT01731327|relative bioavailability|relative bioavailability
5397925|NCT01731327|modified release|modified release
5397926|NCT01731327|tofacitinib|tofacitinib
5397928|NCT01731327|550|550
5397929|NCT01731327|pharmacokinetic|pharmacokinetic
5397930|NCT01731301|Chronic hepatitis C|chronic hepatitis c
5397931|NCT01731301|HCV|hcv
5397932|NCT01731301|End stage renal disease|end stage renal disease
5397933|NCT01731301|ESRD|esrd
5397934|NCT01731301|Boceprevir|boceprevir
5397935|NCT01731301|Ribavirin|ribavirin
5397936|NCT01731301|Peg-interferon|peg-interferon
5397937|NCT01731301|Triple therapy|triple therapy
5397938|NCT01731288|pregnancy|pregnancy
5397939|NCT01731288|childbirth|childbirth
5397940|NCT01731288|pain|pain
5397941|NCT01731288|vulvodynia|vulvodynia
5397942|NCT01731288|provoked vestibulodynia|provoked vestibulodynia
5397943|NCT01731275|Healthy volunteers|healthy volunteers
5393001|NCT01753635|LMA|lma
5397947|NCT01731262|Sonic hedgehog protein, human|sonic hedgehog protein, human
5397948|NCT01731262|Neovascularization, Pathologic|neovascularization, pathologic
5397950|NCT01731249|Sublingual immunotherapy|sublingual immunotherapy
5397951|NCT01731249|Birch pollen extract solution|birch pollen extract solution
5397952|NCT01731249|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5397953|NCT01731236|Carnitine metabolism|carnitine metabolism
5397954|NCT01731236|gut flora|gut flora
5385202|NCT01789047|dyskinesia|dyskinesia
5397955|NCT01731223|Insomnia|insomnia
5397956|NCT01731223|Primary health care|primary health care
5397957|NCT01731197|obesity, isolated soy protein, satiety, food intake|obesity, isolated soy protein, satiety, food intake
5397958|NCT01731184|acute traumatic pain, pre-hospital setting, Midazolam|acute traumatic pain, pre-hospital setting, midazolam
5397959|NCT01731171|mania|mania
5397960|NCT01731171|manic episode|manic episode
5397961|NCT01731171|mixed episode|mixed episode
5397962|NCT01731171|bipolar disorder|bipolar disorder
5397963|NCT01731171|schizoaffective disorder|schizoaffective disorder
5397964|NCT01731171|probiotics|probiotics
5397965|NCT01731171|probiotic supplement|probiotic supplement
5397966|NCT01731171|relapse prevention|relapse prevention
5397967|NCT01731171|new mood episode|new mood episode
5383487|NCT01797003|kne|kne
5397968|NCT01731171|re-hospitalization|re-hospitalization
5397969|NCT01731145|Tremor|tremor
5397970|NCT01731145|SNUMAP|snumap
5397971|NCT01731145|accelerometry|accelerometry
5397972|NCT01731145|gyroscope|gyroscope
5397973|NCT01731145|clinical rating scale|clinical rating scale
5397974|NCT01731132|HRQoL|hrqol
5397975|NCT01731132|IUD|iud
5397976|NCT01731132|Contraception|contraception
5397977|NCT01731132|SEC-QoL|sec-qol
5397978|NCT01731119|Latuda,lurasidone,antipsychotics,autism, mood, psychosis|latuda,lurasidone,antipsychotics,autism, mood, psychosis
5397979|NCT01731093|aged|aged
5397980|NCT01731093|health|health
5397981|NCT01731093|brain|brain
5397982|NCT01731054|lupus nephritis|lupus nephritis
5398080|NCT01730482|excretion|excretion
5397983|NCT01731054|normal healthy volunteer|normal healthy volunteer
5397984|NCT01731054|MRI|mri
5397985|NCT01731041|coronary disease, platelet function, platelet inhibitors|coronary disease, platelet function, platelet inhibitors
5397986|NCT01731002|Glaucoma|glaucoma
5397987|NCT01730989|menopause|menopause
5397988|NCT01730989|Kupperman|kupperman
5397989|NCT01730989|hot flushes|hot flushes
5397990|NCT01730989|isoflavones|isoflavones
5397991|NCT01730989|magnolia|magnolia
5397992|NCT01730989|chaste tree|chaste tree
5397993|NCT01730976|asthma, elderly, vitamin D|asthma, elderly, vitamin d
5397994|NCT01730924|Atrial fibrillation|atrial fibrillation
5397995|NCT01730924|Contact force|contact force
5397996|NCT01730924|Ablation|ablation
5397997|NCT01730911|Bleeding|bleeding
5397998|NCT01730911|Cramping|cramping
5397999|NCT01730911|Pregnancy with intrauterine device in place|pregnancy with intrauterine device in place
5398000|NCT01730911|Intrauterine device expulsion|intrauterine device expulsion
5398001|NCT01730911|Intrauterine device removal|intrauterine device removal
5398002|NCT01730859|Balance exercise|balance exercise
5398004|NCT01730859|Postural stability|postural stability
5398005|NCT01730859|Taping|taping
5398006|NCT01730859|Biodex|biodex
5398007|NCT01730846|smoking lapse behavior|smoking lapse behavior
5398008|NCT01730846|smoking cessation|smoking cessation
5398009|NCT01730846|doxazosin|doxazosin
5398010|NCT01730846|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5398011|NCT01730846|medication effect on smoking cessation|medication effect on smoking cessation
5398012|NCT01730846|stress|stress
5398013|NCT01730807|Atrial Flutter|atrial flutter
5398014|NCT01730807|Ablation|ablation
5398015|NCT01730807|Type I Atrial Flutter|type i atrial flutter
5398016|NCT01730807|Atrial Arrhythmia|atrial arrhythmia
5398017|NCT01730794|Acute Respiratory Failure|acute respiratory failure
5398018|NCT01730794|Mechanical Ventilation|mechanical ventilation
5398019|NCT01730794|NAVA|nava
5398020|NCT01730794|Lung protective ventilation|lung protective ventilation
5398021|NCT01730794|invasive ventilation|invasive ventilation
5398022|NCT01730794|noninvasive ventilation|noninvasive ventilation
5398023|NCT01730781|Cannabis dependence|cannabis dependence
5398024|NCT01730781|Brain Imaging|brain imaging
5398025|NCT01730781|Schizophrenia|schizophrenia
5398026|NCT01730781|Control|control
5398027|NCT01730768|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, CogState|schizophrenia, chronic stable schizophrenia, cognition, memory, visual learning, cogstate
5398028|NCT01730755|Polycythemia|polycythemia
5398029|NCT01730716|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
5398030|NCT01730716|ALS|als
5398031|NCT01730703|walking|walking
5398032|NCT01730703|incentives|incentives
5398033|NCT01730703|elderly|elderly
5393116|NCT01752920|TKI|tki
5398043|NCT01730638|endocrine tumour|endocrine tumour
5398044|NCT01730638|Nuclear medicine,|nuclear medicine,
5398045|NCT01730638|molecular imaging|molecular imaging
5398046|NCT01730638|ImmunoTEP|immunotep
5398047|NCT01730625|Attention bias modification treatment (ABMT)|attention bias modification treatment (abmt)
5398048|NCT01730625|Attention biases|attention biases
5398049|NCT01730625|Anxious children|anxious children
5398050|NCT01730625|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5398051|NCT01730612|ImmunoTEP|immunotep
5398052|NCT01730612|HER2 negative|her2 negative
5398053|NCT01730612|Breast Cancer|breast cancer
5398054|NCT01730586|Colorectal Cancer|colorectal cancer
5398055|NCT01730586|Cancer of Gastrointestinal Tract|cancer of gastrointestinal tract
5398056|NCT01730586|CIMP-high Colorectal Adenocarcinoma|cimp-high colorectal adenocarcinoma
5398057|NCT01730586|Small Bowel Adenocarcinomas|small bowel adenocarcinomas
5398058|NCT01730586|Colorectal|colorectal
5398059|NCT01730586|Small bowel cancer|small bowel cancer
5398060|NCT01730586|Abraxane|abraxane
5398061|NCT01730586|Nab-Paclitaxel|nab-paclitaxel
5398062|NCT01730586|Paclitaxel (Protein-Bound)|paclitaxel (protein-bound)
5398063|NCT01730586|ABI-007|abi-007
5398064|NCT01730573|interscalene|interscalene
5398065|NCT01730573|suprascapular|suprascapular
5398066|NCT01730573|axillary|axillary
5398067|NCT01730547|Mesenchymal stem cells|mesenchymal stem cells
5398068|NCT01730547|Multiple Sclerosis|multiple sclerosis
5398069|NCT01730547|Autoimmune diseases|autoimmune diseases
5398070|NCT01730534|Phase IIIb|phase iiib
5398071|NCT01730534|T2DM|t2dm
5398072|NCT01730534|cardiovascular events|cardiovascular events
5398073|NCT01730495|Chronic fatigue syndrome|chronic fatigue syndrome
5398075|NCT01730495|Myalgic Encephalomyelitis (ME)|myalgic encephalomyelitis (me)
5398076|NCT01730495|CFS/ME|cfs/me
5398077|NCT01730495|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5398081|NCT01730482|healthy volunteer|healthy volunteer
5398082|NCT01730482|migalastat hydrochloride|migalastat hydrochloride
5398083|NCT01730482|AT1001|at1001
5398084|NCT01730482|pharmacokinetics|pharmacokinetics
5398085|NCT01730482|Fabry disease|fabry disease
5398086|NCT01730469|Pharmacokinetics|pharmacokinetics
5398087|NCT01730469|GR181413|gr181413
5398088|NCT01730469|Safety|safety
5398089|NCT01730469|AT1001|at1001
5398090|NCT01730469|Migalastat hydrochloride|migalastat hydrochloride
5398091|NCT01730443|traumatic brain injury|traumatic brain injury
5398092|NCT01730430|non-AD dementias|non-ad dementias
5398093|NCT01730430|healthy elderly controls|healthy elderly controls
5398094|NCT01730417|Phase 1|phase 1
5398095|NCT01730417|no carrier added metaiodobenzylguanidine|no carrier added metaiodobenzylguanidine
5398096|NCT01730417|radiation dosimetry|radiation dosimetry
5398097|NCT01730378|Influenza vaccine|influenza vaccine
5398098|NCT01730365|spectroscopy|spectroscopy
5398099|NCT01730365|tumour|tumour
5398100|NCT01730365|biopsy|biopsy
5398101|NCT01730365|malignancy|malignancy
5398102|NCT01730352|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5398103|NCT01730352|chronic immune thrombocytopenic purpura|chronic immune thrombocytopenic purpura
5398104|NCT01730352|secondary immune thrombocytopenic purpura|secondary immune thrombocytopenic purpura
5398105|NCT01730352|Helicobacter pylori infection|helicobacter pylori infection
5398106|NCT01730352|Helicobacter pylori gastritis|helicobacter pylori gastritis
5398107|NCT01730352|children|children
5398108|NCT01730352|adolescents|adolescents
5398109|NCT01730339|Skin scarring|skin scarring
5398110|NCT01730339|cicatrix|cicatrix
5398111|NCT01730339|breast scar|breast scar
5398112|NCT01730339|hypertrophic scar|hypertrophic scar
5398113|NCT01730326|Headache|headache
5398114|NCT01730326|paracetamol|paracetamol
5398115|NCT01730326|dexketoprofen|dexketoprofen
5398116|NCT01730326|emergency department|emergency department
5398117|NCT01730313|Nodding syndrome|nodding syndrome
5398118|NCT01730287|Stepwise Excavation|stepwise excavation
5398119|NCT01730287|Pulpal vitality|pulpal vitality
5398120|NCT01730287|Deep caries lesions|deep caries lesions
5398121|NCT01730287|Clinical symptoms|clinical symptoms
5398122|NCT01730287|Radiographic evaluation|radiographic evaluation
5398123|NCT01730261|Traumatic Brain Injury|traumatic brain injury
5398125|NCT01730261|Executive Dysfunction|executive dysfunction
5398126|NCT01730261|Emotional Regulation|emotional regulation
5398127|NCT01730261|Problem Solving|problem solving
5398128|NCT01730261|Self-regulation|self-regulation
5398129|NCT01730261|Cognitive Rehabilitation|cognitive rehabilitation
5398130|NCT01730261|Metacognitive Strategies|metacognitive strategies
5398131|NCT01730261|Cognitive-behavioral therapy|cognitive-behavioral therapy
5398132|NCT01730261|Online Therapy|online therapy
5398133|NCT01730261|Group therapy|group therapy
5398134|NCT01730261|Group videoconference|group videoconference
5398135|NCT01730261|Telehealth|telehealth
5398136|NCT01730261|Telerehabilitation|telerehabilitation
5398137|NCT01730248|Myelofibrosis,|myelofibrosis,
5398138|NCT01730248|PMF,|pmf,
5398139|NCT01730248|PPV-MF,|ppv-mf,
5398140|NCT01730248|PET-MF,|pet-mf,
5398141|NCT01730248|Primary Myelofibrosis,|primary myelofibrosis,
5398142|NCT01730248|Post-polycythemia vera myelofibrosis,|post-polycythemia vera myelofibrosis,
5398143|NCT01730248|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5398144|NCT01730222|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5398145|NCT01730222|stage III disease|stage iii disease
5398146|NCT01730222|stage IV disease|stage iv disease
5398147|NCT01730222|chemotherapy|chemotherapy
5398148|NCT01730209|Tuberous Sclerosis Complex|tuberous sclerosis complex
5398149|NCT01730209|TSC|tsc
5398150|NCT01730209|Autism|autism
5398151|NCT01730209|Learning problems|learning problems
5398152|NCT01730209|Everolimus|everolimus
5398153|NCT01730209|RAD001|rad001
5398154|NCT01730209|Treatment|treatment
5398155|NCT01730209|Cognition|cognition
5398156|NCT01730209|Intellectual disability|intellectual disability
5398157|NCT01730170|Epilepsy|epilepsy
5398158|NCT01730170|Pregnancy|pregnancy
5398159|NCT01730144|Nasal Spray Vaccine|nasal spray vaccine
5398160|NCT01730144|Nasal Cells|nasal cells
5398161|NCT01730131|Encephalitis|encephalitis
5398162|NCT01730131|Immune Reconstitution Syndrome|immune reconstitution syndrome
5398163|NCT01730131|Human Immunodeficiency Virus|human immunodeficiency virus
5398164|NCT01730131|Multiple Sclerosis|multiple sclerosis
5398165|NCT01730118|Metastatic Solid Tumors|metastatic solid tumors
5398166|NCT01730118|Human Epidermal Growth Factor Receptor 2 Expression (HER2/neu)|human epidermal growth factor receptor 2 expression (her2/neu)
5398167|NCT01730118|Trastuzumab Exposure|trastuzumab exposure
5398168|NCT01730118|Dendritic Cell Vaccine|dendritic cell vaccine
5398169|NCT01730118|Breast Cancer|breast cancer
5398170|NCT01730105|Adaptive Thermogenesis|adaptive thermogenesis
5398171|NCT01730105|Adipose Tissue|adipose tissue
5398172|NCT01730105|Body Composition|body composition
5398173|NCT01730105|Body Weight Regulation|body weight regulation
5398174|NCT01730105|Brown Adipose Tissue|brown adipose tissue
5398175|NCT01730092|Vascular Inflammation|vascular inflammation
5398176|NCT01730092|Microarray|microarray
5398281|NCT01729520|Fatigue|fatigue
5398177|NCT01730092|Right Ventricular Function|right ventricular function
5398178|NCT01730092|Endothelial Dysfunction|endothelial dysfunction
5398179|NCT01730092|Magnetic Resonance Imaging|magnetic resonance imaging
5398180|NCT01730079|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5398181|NCT01730079|Autism|autism
5398182|NCT01730079|Near Infrared Spectroscopy|near infrared spectroscopy
5398183|NCT01730079|Brain Activity|brain activity
5398184|NCT01730066|Probiotics|probiotics
5398185|NCT01730066|Pathogenic enteric bacteria|pathogenic enteric bacteria
5398186|NCT01730066|Oropharyngeal flora|oropharyngeal flora
5398187|NCT01730066|CRP|crp
5398188|NCT01730066|WBC|wbc
5398189|NCT01729949|Nutrition|nutrition
5398190|NCT01729949|Polyphenols|polyphenols
5398191|NCT01729949|Berries|berries
5398192|NCT01729949|Overweight|overweight
5398193|NCT01729949|Lipid Panels|lipid panels
5398194|NCT01729936|Sitting time|sitting time
5398195|NCT01729936|Overweight|overweight
5398196|NCT01729936|Obese|obese
5398197|NCT01729936|Primary Health Care|primary health care
5398198|NCT01729910|overweight|overweight
5398199|NCT01729910|obesity|obesity
5398200|NCT01729910|rural|rural
5398201|NCT01729910|primary care|primary care
5398202|NCT01729897|gastroscopy|gastroscopy
5398203|NCT01729897|sedation|sedation
5398204|NCT01729897|etomidate|etomidate
5398205|NCT01729871|Atrial Fibrillation|atrial fibrillation
5398206|NCT01729871|Irregular heart beat|irregular heart beat
5398207|NCT01729871|Catheter Ablation|catheter ablation
5398208|NCT01729871|Rivaroxaban|rivaroxaban
5398209|NCT01729793|TNFalpha|tnfalpha
5398211|NCT01729793|postprandial|postprandial
5398212|NCT01729793|digestive|digestive
5398213|NCT01729793|inflammation|inflammation
5398214|NCT01729793|IL1beta|il1beta
5398215|NCT01729793|CRP|crp
5398216|NCT01729793|CBC|cbc
5398217|NCT01729793|ESR|esr
5398218|NCT01729780|EEG-NF|eeg-nf
5398219|NCT01729780|Neurofeedback|neurofeedback
5398220|NCT01729780|Prevention|prevention
5398221|NCT01729780|ACS|acs
5398222|NCT01729741|Drain or no drain|drain or no drain
5398223|NCT01729741|Thyroid surgery|thyroid surgery
5398224|NCT01729741|Randomized Trial|randomized trial
5398234|NCT01729702|3- NT-proBNP|3- nt-probnp
5398235|NCT01729702|4- Neurohormons|4- neurohormons
5398236|NCT01729663|melanoma|melanoma
5398237|NCT01729663|irradiated-allogeneic cells|irradiated-allogeneic cells
5398238|NCT01729663|therapeutic vaccine|therapeutic vaccine
5398239|NCT01729663|Interferon alpha 2-b|interferon alpha 2-b
5398240|NCT01729650|Psychotic Disorders,|psychotic disorders,
5398241|NCT01729650|Heart Diseases|heart diseases
5398242|NCT01729637|Lung Transplantation|lung transplantation
5398243|NCT01729637|Respiratory Mechanics|respiratory mechanics
5398244|NCT01729637|Isolated lung perfusion|isolated lung perfusion
5398245|NCT01729637|Ex-vivo lung perfusion|ex-vivo lung perfusion
5398246|NCT01729637|Lung mechanics|lung mechanics
5398247|NCT01729624|Wegener Granulomatosis|wegener granulomatosis
5398248|NCT01729624|Microscopic Polyangiitis|microscopic polyangiitis
5398249|NCT01729624|Churg-Strauss Syndrome|churg-strauss syndrome
5398250|NCT01729624|Antibodies, Antineutrophil Cytoplasmic|antibodies, antineutrophil cytoplasmic
5398251|NCT01729611|Scleroderma|scleroderma
5398252|NCT01729611|Cirrhosis|cirrhosis
5398253|NCT01729598|cognitively normal elderly population|cognitively normal elderly population
5398254|NCT01729598|safety and tolerability|safety and tolerability
5398255|NCT01729585|cystic fibrosis|cystic fibrosis
5398256|NCT01729585|quality of life|quality of life
5398257|NCT01729572|schizophrenia|schizophrenia
5398258|NCT01729572|Schizoaffective Disorder|schizoaffective disorder
5398259|NCT01729572|disease management|disease management
5398260|NCT01729572|treatment|treatment
5398261|NCT01729572|rehabilitation|rehabilitation
5398262|NCT01729572|pharmacotherapy|pharmacotherapy
5685278|NCT00556803|hepatocellular carcinoma|hepatocellular carcinoma
5398263|NCT01729559|venous thromboembolic disease|venous thromboembolic disease
5398264|NCT01729559|deep vein thrombosis|deep vein thrombosis
5398265|NCT01729559|pulmonary embolism|pulmonary embolism
5398266|NCT01729559|trauma|trauma
5398267|NCT01729559|antithrombotic prophylaxis|antithrombotic prophylaxis
5398268|NCT01729546|SMBG (self-monitoring of blood glucose)|smbg (self-monitoring of blood glucose)
5398269|NCT01729546|POCT|poct
5398270|NCT01729546|System Accuracy|system accuracy
5398271|NCT01729533|ICSI|icsi
5398272|NCT01729533|IMSI|imsi
5398273|NCT01729533|Pregnancy|pregnancy
5398274|NCT01729533|Sperm morphology|sperm morphology
5398275|NCT01729533|Unexplained infertility|unexplained infertility
5398276|NCT01729520|Total knee arthroplasty|total knee arthroplasty
5398277|NCT01729520|Total knee replacement|total knee replacement
5398278|NCT01729520|Strength training|strength training
5398279|NCT01729520|Resistance training|resistance training
5398280|NCT01729520|Physical therapy modalities|physical therapy modalities
5398293|NCT01729468|Intra-uterine Growth Restriction|intra-uterine growth restriction
5398294|NCT01729468|Primiparous Women|primiparous women
5398295|NCT01729468|Bilateral Uterine Artery Notches|bilateral uterine artery notches
5398296|NCT01729468|First Quarter|first quarter
5398308|NCT01729429|Papillomavirus Vaccines|papillomavirus vaccines
5398309|NCT01729429|Intervention Studies|intervention studies
5398310|NCT01729429|Health Services Research|health services research
5398311|NCT01729429|Cancer of Cervix|cancer of cervix
5398312|NCT01729416|colon|colon
5398313|NCT01729416|cancer|cancer
5398314|NCT01729416|screening|screening
5398315|NCT01729416|water exchange|water exchange
5398317|NCT01729416|method|method
5398318|NCT01729416|polyp|polyp
5398319|NCT01729416|adenoma|adenoma
5398320|NCT01729416|detection|detection
5398321|NCT01729416|rate|rate
5398322|NCT01729416|sedation|sedation
5398323|NCT01729416|time|time
5398324|NCT01729416|procedure|procedure
5398325|NCT01729390|Feeding behavior|feeding behavior
5398326|NCT01729364|elective CABG|elective cabg
5398327|NCT01729364|renal impairment|renal impairment
5398328|NCT01729364|GFR|gfr
5398329|NCT01729364|renal blood flow|renal blood flow
5398330|NCT01729364|colloid|colloid
5398331|NCT01729364|crystalloid|crystalloid
5398332|NCT01729364|thermodilution technique|thermodilution technique
5398333|NCT01729364|oxygen supply demand|oxygen supply demand
5398334|NCT01729351|Primary Care|primary care
5398335|NCT01729351|Particle size|particle size
5398336|NCT01729351|beclomethasone dipropionate|beclomethasone dipropionate
5398337|NCT01729351|Asthma Management|asthma management
5398338|NCT01729351|Maintenance Therapy|maintenance therapy
5398339|NCT01729351|Metered-Dose Inhaler|metered-dose inhaler
5398342|NCT01729325|Aggressive Behavior|aggressive behavior
5398343|NCT01729325|Appetitive Aggression|appetitive aggression
5398345|NCT01729325|Preventive Narrative Exposure Therapy|preventive narrative exposure therapy
5398346|NCT01729299|ghrelin|ghrelin
5398347|NCT01729299|glucose control|glucose control
5398348|NCT01729299|GLP-1|glp-1
5398349|NCT01729299|Exendin (9-39)|exendin (9-39)
5398350|NCT01729299|insulin|insulin
5398351|NCT01729260|Glioblastoma|glioblastoma
5398352|NCT01729260|mebendazole|mebendazole
5398353|NCT01729260|temozolomide|temozolomide
5398354|NCT01729247|Asthma|asthma
5398355|NCT01729234|age related Endothelial Dysfunction|age related endothelial dysfunction
5398356|NCT01729221|Hepatocellular carcinoma|hepatocellular carcinoma
5398357|NCT01729221|Hepatitis C virus|hepatitis c virus
5398360|NCT01729195|bioabsorbable implant|bioabsorbable implant
5398361|NCT01729195|bone screw|bone screw
5398362|NCT01729195|local antibiotic prophylaxis|local antibiotic prophylaxis
5398363|NCT01729195|syndesmosis injury|syndesmosis injury
5398364|NCT01729195|ankle fracture|ankle fracture
5398365|NCT01729195|ciprofloxacin|ciprofloxacin
5398366|NCT01729182|Low dose Aspirin(LDA)|low dose aspirin(lda)
5398367|NCT01729182|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
5398368|NCT01729182|Nexium|nexium
5398369|NCT01729169|Sarcoidosis|sarcoidosis
5398370|NCT01729169|Cardiac sarcoidosis|cardiac sarcoidosis
5398371|NCT01729169|18-FDG PET|18-fdg pet
5398372|NCT01729169|68Ga-DOTANOC PET|68ga-dotanoc pet
5398373|NCT01729156|Type 2 diabetes|type 2 diabetes
5398374|NCT01729156|Hepatic fatty acid oxidation|hepatic fatty acid oxidation
5398375|NCT01729156|Dyslipidemia|dyslipidemia
5398376|NCT01729156|Metformin|metformin
5398377|NCT01729143|black pepper|black pepper
5398378|NCT01729143|metabolic chamber|metabolic chamber
5398379|NCT01729143|respiratory chamber|respiratory chamber
5398380|NCT01729117|Type 2 diabetes|type 2 diabetes
5398381|NCT01729117|Obesity|obesity
5398385|NCT01729117|Meal replacement|meal replacement
5398386|NCT01729104|Lymphoma|lymphoma
5398387|NCT01729104|Mantle cell lymphoma|mantle cell lymphoma
5398389|NCT01729104|Relapsed|relapsed
5398390|NCT01729104|Refractory|refractory
5398391|NCT01729104|Carfilzomib|carfilzomib
5398392|NCT01729104|Rituximab|rituximab
5398394|NCT01729104|Lenalidomide|lenalidomide
5398395|NCT01729104|CC-5013|cc-5013
5398396|NCT01729104|Revlimid|revlimid
5385599|NCT01787435|Asthma,|asthma,
5398397|NCT01729065|Spinal Accessory Nerve Palsy, Cranial Nerve XI, shoulder weakness, neck stiffness, head and neck cancer, neck dissection|spinal accessory nerve palsy, cranial nerve xi, shoulder weakness, neck stiffness, head and neck cancer, neck dissection
5398398|NCT01729052|Acupuncture|acupuncture
5398399|NCT01729052|Children|children
5398400|NCT01729052|Postoperative nausea and vomiting|postoperative nausea and vomiting
5398401|NCT01729052|Postoperative pain|postoperative pain
5398402|NCT01729052|Parental attitudes|parental attitudes
5398403|NCT01729052|Parental expectations|parental expectations
5398404|NCT01729039|rehabilitation|rehabilitation
5398405|NCT01729039|aged|aged
5398406|NCT01729039|aged, 80 and over|aged, 80 and over
5398407|NCT01729039|vestibular diseases|vestibular diseases
5398408|NCT01729026|Veterans|veterans
5398409|NCT01729026|Posttraumatic Stress Disorder|posttraumatic stress disorder
5398410|NCT01729026|dog adoption|dog adoption
5398411|NCT01729026|companion animal|companion animal
5398412|NCT01729013|vitamin D|vitamin d
5398414|NCT01729013|biopsy|biopsy
5398415|NCT01729000|prematurity|prematurity
5398416|NCT01729000|infection control|infection control
5398417|NCT01729000|necrotizing entercolitis|necrotizing entercolitis
5398418|NCT01728974|Obstructive Sleep Apnea|obstructive sleep apnea
5398425|NCT01728961|nevirapine|nevirapine
5398426|NCT01728961|Coartem Dispersible|coartem dispersible
5398427|NCT01728961|Artemether|artemether
5398428|NCT01728961|Lumefantrine|lumefantrine
5398429|NCT01728961|Pharmacokinetics|pharmacokinetics
5398430|NCT01728948|Sorafenib|sorafenib
5398431|NCT01728948|renal cell carcinoma(RCC)|renal cell carcinoma(rcc)
5398432|NCT01728948|elderly|elderly
5398433|NCT01728948|effectiveness|effectiveness
5398434|NCT01728948|safety|safety
5398435|NCT01728935|HBV|hbv
5398436|NCT01728935|Tenofovir|tenofovir
5398437|NCT01728935|HBV DNA|hbv dna
5398438|NCT01728935|HBsAg|hbsag
5398439|NCT01728935|Resistance|resistance
5398440|NCT01728922|Clinically isolated syndrome|clinically isolated syndrome
5398441|NCT01728922|Multiple sclerosis|multiple sclerosis
5398442|NCT01728922|Vitamin D|vitamin d
5398443|NCT01728922|Immune response|immune response
5398444|NCT01728922|CD4 T cell subsets|cd4 t cell subsets
5398445|NCT01728922|Cytokine|cytokine
5398446|NCT01728909|Oxytocin|oxytocin
5398447|NCT01728909|Syntocinon|syntocinon
5398448|NCT01728909|Social Cognition|social cognition
5398449|NCT01728909|Social Approach Behaviors|social approach behaviors
5393506|NCT01751165|Safety|safety
5398454|NCT01728883|Maculopathy|maculopathy
5398455|NCT01728883|home monitoring|home monitoring
5398456|NCT01728883|shape discrimination hyperacuity|shape discrimination hyperacuity
5398457|NCT01728883|Psychophysical Testing|psychophysical testing
5398458|NCT01728870|Pediatric|pediatric
5398459|NCT01728870|Crohn's disease|crohn's disease
5398460|NCT01728870|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5398461|NCT01728870|Diet|diet
5398462|NCT01728870|Enteral Nutrition|enteral nutrition
5398463|NCT01728857|Lipolysis|lipolysis
5398464|NCT01728857|Cryolipolysis|cryolipolysis
5398465|NCT01728857|Fat Reduction|fat reduction
5398466|NCT01728831|Red Cell Transfusion|red cell transfusion
5398467|NCT01728831|Cerebral tissue oxygenation|cerebral tissue oxygenation
5398468|NCT01728831|Traumatic brain injury|traumatic brain injury
5398469|NCT01728805|Cutaneous T-Cell Lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
5398470|NCT01728805|myocis fungoides (MF)|myocis fungoides (mf)
5398471|NCT01728805|Sezary Syndrome (SS)|sezary syndrome (ss)
5398472|NCT01728792|Prophylactic vaccination|prophylactic vaccination
5398473|NCT01728766|Breast milk zinc transfer|breast milk zinc transfer
5398474|NCT01728766|Bangladeshi infants|bangladeshi infants
5398475|NCT01728766|appropriate-for-gestational-age|appropriate-for-gestational-age
5398476|NCT01728766|small-for-gestational-age|small-for-gestational-age
5398477|NCT01728766|plasma zinc|plasma zinc
5398478|NCT01728740|Bioequivalence|bioequivalence
5398479|NCT01728740|Acarbose|acarbose
5398480|NCT01728740|Metformin|metformin
5398482|NCT01728727|liver cirrhosis|liver cirrhosis
5398483|NCT01728727|end stage liver disease|end stage liver disease
5398484|NCT01728727|umbilical cord|umbilical cord
5398485|NCT01728727|mesenchymal stem cells|mesenchymal stem cells
5398486|NCT01728727|HBV|hbv
5398487|NCT01728714|Diabetes; compliance|diabetes; compliance
5398488|NCT01728701|Malaria|malaria
5398489|NCT01728701|Plasmodium falciparum|plasmodium falciparum
5398490|NCT01728701|PfSPZ Challenge|pfspz challenge
5398491|NCT01728701|Chemoprophylaxis|chemoprophylaxis
5398492|NCT01728701|PfSPZ-CVac|pfspz-cvac
5398493|NCT01728688|liver cirrhosis|liver cirrhosis
5398494|NCT01728688|stem cell|stem cell
5398495|NCT01728688|peripheral blood|peripheral blood
5398496|NCT01728688|autologous|autologous
5398498|NCT01728688|end stage liver disease|end stage liver disease
5398500|NCT01728675|Skeletal muscle|skeletal muscle
5398501|NCT01728675|Biomarkers|biomarkers
5398502|NCT01728675|Adaptation|adaptation
5398503|NCT01728662|emphysema|emphysema
5398504|NCT01728662|lung volume reduction therapy|lung volume reduction therapy
5398505|NCT01728649|Acute Ischemic Stroke|acute ischemic stroke
5398506|NCT01728649|Mild Hypothermia|mild hypothermia
5398507|NCT01728649|Stroke|stroke
5398508|NCT01728649|Hypothermia|hypothermia
5398509|NCT01728623|Thyroid cancer|thyroid cancer
5398510|NCT01728610|irritable bowel syndrome|irritable bowel syndrome
5398511|NCT01728610|probiotic|probiotic
5398512|NCT01728610|pain|pain
5398513|NCT01728610|bloating|bloating
5398514|NCT01728610|diarrhoea|diarrhoea
5398515|NCT01728610|constipation|constipation
5398516|NCT01728597|no history of cardiovascular diseases|no history of cardiovascular diseases
5398517|NCT01728571|COPD|copd
5398518|NCT01728571|asthma|asthma
5398519|NCT01728571|pulmonary function|pulmonary function
5398520|NCT01728571|pneumonia|pneumonia
5398521|NCT01728558|Sedation|sedation
5398522|NCT01728558|Delirium|delirium
5398523|NCT01728558|Goal Directed|goal directed
5398524|NCT01728558|Dexmedetomidine|dexmedetomidine
5398525|NCT01728558|Mortality|mortality
5398526|NCT01728558|Mechanical ventilation|mechanical ventilation
5398527|NCT01728558|Intensive care|intensive care
5398528|NCT01728558|Critically Ill|critically ill
5398529|NCT01728545|Cord blood registry|cord blood registry
5398530|NCT01728545|Umbilical Cord Blood|umbilical cord blood
5398531|NCT01728545|fetal blood|fetal blood
5398532|NCT01728545|placenta|placenta
5398533|NCT01728545|Placental Blood Stem Cell Transplantation|placental blood stem cell transplantation
5398534|NCT01728545|hematopoietic progenitor cells|hematopoietic progenitor cells
5398535|NCT01728545|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5398536|NCT01728545|cord blood unit total nucleated cell|cord blood unit total nucleated cell
5398538|NCT01728545|CD34-positive(+) cell|cd34-positive(+) cell
5398539|NCT01728545|human leukocyte antigen|human leukocyte antigen
5398541|NCT01728545|allogeneic transplantation|allogeneic transplantation
5381557|NCT01805427|HIV|hiv
5398542|NCT01728519|Allergy|allergy
5398543|NCT01728519|Birch Pollen|birch pollen
5398544|NCT01728519|Immunotherapy|immunotherapy
5398545|NCT01728506|breast cancer survivor|breast cancer survivor
5398546|NCT01728506|Weight loss|weight loss
5398547|NCT01728506|Exercise|exercise
5398548|NCT01728493|Prevalence|prevalence
5398549|NCT01728493|Primary aldosteronism|primary aldosteronism
5398550|NCT01728493|Organ damage|organ damage
5398551|NCT01728493|Mineralocorticoid receptor antagonists|mineralocorticoid receptor antagonists
5398552|NCT01728441|PAD|pad
5398553|NCT01728441|stenting|stenting
5398554|NCT01728441|angioplasty|angioplasty
5398555|NCT01728428|hemifacial spasm|hemifacial spasm
5398556|NCT01728428|observational study|observational study
5398557|NCT01728428|clinical manifestation|clinical manifestation
5398558|NCT01728428|treatment|treatment
5398559|NCT01728428|Chinese|chinese
5398560|NCT01728415|Exercise|exercise
5398561|NCT01728415|Hemodialysis|hemodialysis
5398562|NCT01728415|Physical therapy|physical therapy
5398563|NCT01728415|high-intensity|high-intensity
5398564|NCT01728389|allogenic stem cell transplantation|allogenic stem cell transplantation
5398565|NCT01728389|peripheral blood stem cells|peripheral blood stem cells
5398566|NCT01728389|intrabone|intrabone
5398567|NCT01728389|intra-bone|intra-bone
5398568|NCT01728389|leukemia|leukemia
5398569|NCT01728389|lymphoma|lymphoma
5398570|NCT01728363|Staphylococcal|staphylococcal
5398571|NCT01728350|traumatic brain injury|traumatic brain injury
5398572|NCT01728350|volunteering|volunteering
5398573|NCT01728350|well being|well being
5398574|NCT01728350|cortisol|cortisol
5398575|NCT01728337|botulinum toxin,|botulinum toxin,
5398576|NCT01728337|wrinkles|wrinkles
5398577|NCT01728298|House Dust Mite|house dust mite
5398578|NCT01728298|allergy|allergy
5398579|NCT01728298|rhinitis|rhinitis
5398580|NCT01728298|asthma|asthma
5398581|NCT01728285|specific allergen immunotherapy|specific allergen immunotherapy
5398582|NCT01728285|sublingual immunotherapy|sublingual immunotherapy
5398583|NCT01728285|allergen tablets|allergen tablets
5398584|NCT01728285|compliance|compliance
5398585|NCT01728285|electronic compliance device|electronic compliance device
5398586|NCT01728272|metoprolol, atrial fibrillation|metoprolol, atrial fibrillation
5398587|NCT01728246|Osteoarthritis|osteoarthritis
5398588|NCT01728246|Celecoxib|celecoxib
5398589|NCT01728246|Tramadol|tramadol
5398590|NCT01728246|Paracetamol|paracetamol
5398591|NCT01728233|Molecular Targeted Therapy|molecular targeted therapy
5398592|NCT01728233|Neoadjuvant therapy|neoadjuvant therapy
5398593|NCT01728233|Dacomitinib|dacomitinib
5398594|NCT01728220|Inhaled nitric oxide (iNO)|inhaled nitric oxide (ino)
5398595|NCT01728220|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
5398596|NCT01728220|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5398597|NCT01728220|Long term oxygen therapy (LTOT)|long term oxygen therapy (ltot)
5398599|NCT01728207|CLL|cll
5398600|NCT01728207|follicular lymphoma|follicular lymphoma
5398601|NCT01728207|mantle cell lymphoma|mantle cell lymphoma
5398602|NCT01728207|marginal zone lymphoma|marginal zone lymphoma
5398603|NCT01728207|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5398604|NCT01728207|small lymphocytic lymphoma|small lymphocytic lymphoma
5385798|NCT01786343|AML|aml
5398605|NCT01728194|Depression|depression
5398606|NCT01728194|Depressive Disorder|depressive disorder
5398607|NCT01728194|Behavioral Symptoms|behavioral symptoms
5398608|NCT01728194|Mood Disorders|mood disorders
5398609|NCT01728194|Mental Disorders|mental disorders
5398610|NCT01728194|Escitalopram|escitalopram
5398611|NCT01728194|Central Nervous System Agents|central nervous system agents
5398612|NCT01728194|Therapeutic Uses|therapeutic uses
5398613|NCT01728194|Pharmacologic Actions|pharmacologic actions
5398614|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs
5398615|NCT01728194|Muscarinic Antagonists|muscarinic antagonists
5398616|NCT01728194|Antidepressive Agents|antidepressive agents
5398617|NCT01728194|Psychotropic Drugs|psychotropic drugs
5398618|NCT01728194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5398619|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
5398620|NCT01728194|Serotonin Agents|serotonin agents
5398621|NCT01728194|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5398622|NCT01728194|fMRI|fmri
5398623|NCT01728194|Magnetic Resonance Imaging|magnetic resonance imaging
5398624|NCT01728168|lupin|lupin
5398625|NCT01728168|peanut|peanut
5398626|NCT01728168|soy|soy
5398627|NCT01728168|pea|pea
5398628|NCT01728168|legumes|legumes
5398629|NCT01728168|cross-reactivity|cross-reactivity
5398630|NCT01728168|sensitization|sensitization
5398631|NCT01728168|atopy|atopy
5398632|NCT01728155|NEUROBLASTOMA, LOW RISK, INTERMEDIATE RISK|neuroblastoma, low risk, intermediate risk
5398633|NCT01728142|DANA|dana
5398634|NCT01728142|ANAM|anam
5398635|NCT01728142|Concussion|concussion
5398636|NCT01728142|mild traumatic brain injury|mild traumatic brain injury
5398637|NCT01728129|Concussion|concussion
5398638|NCT01728129|Mild traumatic brain injury|mild traumatic brain injury
5398639|NCT01728129|DANA|dana
5398640|NCT01728129|MACE|mace
5381635|NCT01804907|HIV|hiv
5398641|NCT01728116|glycemic control, type 2 diabetes, device, obese|glycemic control, type 2 diabetes, device, obese
5398642|NCT01728090|handwashing|handwashing
5398643|NCT01728090|hand sanitizer|hand sanitizer
5398644|NCT01728090|absenteeism|absenteeism
5398645|NCT01728090|school age children|school age children
5398646|NCT01728090|preschool children|preschool children
5398647|NCT01728077|Brivaracetam|brivaracetam
5398648|NCT01728077|Long-term Follow-up|long-term follow-up
5398649|NCT01728077|Epilepsy|epilepsy
5398650|NCT01728077|Partial Onset Seizures|partial onset seizures
5398651|NCT01728077|Adjunctive treatment|adjunctive treatment
5398652|NCT01728064|Friedreich's|friedreich's
5398653|NCT01728064|Ataxia|ataxia
5398654|NCT01728064|FRDA|frda
5398655|NCT01728064|FA|fa
5398656|NCT01728064|EPI-743|epi-743
5398657|NCT01728064|Edison|edison
5398658|NCT01728038|Bronchiolitis|bronchiolitis
5398659|NCT01728038|Cough|cough
5398660|NCT01728038|Ear Infection|ear infection
5398661|NCT01728038|Respiratory Infection|respiratory infection
5398662|NCT01728038|Wheezing|wheezing
5398663|NCT01728025|Long QT syndrome|long qt syndrome
5398664|NCT01728025|Ranolazine|ranolazine
5398665|NCT01728012|Successful transplantation|successful transplantation
5398666|NCT01728012|Long-term observation|long-term observation
5398667|NCT01727999|TPO response|tpo response
5398668|NCT01727999|ITP|itp
5398669|NCT01727999|immune thrombocytopenia|immune thrombocytopenia
5398670|NCT01727973|Graves' orbitopathy|graves' orbitopathy
5398671|NCT01727973|Graves´ ophthalmopathy|graves´ ophthalmopathy
5398672|NCT01727973|Thyroid eye disease|thyroid eye disease
5398673|NCT01727973|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5398674|NCT01727973|Doxycycline|doxycycline
5398675|NCT01727973|EUGOGO|eugogo
5398676|NCT01727973|CAS|cas
5398677|NCT01727960|Education|education
5398678|NCT01727960|Neck pain|neck pain
5398679|NCT01727960|Shoulder pain|shoulder pain
5398680|NCT01727960|Prevalence|prevalence
5398681|NCT01727960|Associated factors|associated factors
5398682|NCT01727960|Students|students
5398683|NCT01727934|Antisense|antisense
5398684|NCT01727934|miR-122 antagonist|mir-122 antagonist
5398685|NCT01727934|host factor|host factor
5398686|NCT01727934|Chronic hepatitis C|chronic hepatitis c
5398687|NCT01727934|Hepatitis C|hepatitis c
5398688|NCT01727921|ProCore FNA biopsy|procore fna biopsy
5398689|NCT01727908|Familial Gastric Cancer Screening|familial gastric cancer screening
5398788|NCT01727492|prevention|prevention
5398690|NCT01727895|Betaglucan, immune modulation, immunoparalysis, immune suppression|betaglucan, immune modulation, immunoparalysis, immune suppression
5398691|NCT01727882|Paroled offenders|paroled offenders
5398692|NCT01727882|Interactive Voice Response|interactive voice response
5398694|NCT01727882|Mental symptoms|mental symptoms
5398695|NCT01727882|Alcohol consumption|alcohol consumption
5398696|NCT01727882|Substance use|substance use
5398697|NCT01727856|rehabilitation|rehabilitation
5398698|NCT01727856|physical therapy|physical therapy
5398699|NCT01727856|telemedicine|telemedicine
5398700|NCT01727843|fracture|fracture
5398701|NCT01727843|hip|hip
5398702|NCT01727843|tranexamic acid|tranexamic acid
5398703|NCT01727843|topical|topical
5371634|NCT01851083|TBI|tbi
5398704|NCT01727817|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5398705|NCT01727817|Continuous Glucose Monitor|continuous glucose monitor
5398706|NCT01727817|Artificial Pancreas|artificial pancreas
5398707|NCT01727817|Insulin Pump|insulin pump
5398708|NCT01727817|Closed Loop|closed loop
5398709|NCT01727817|Open Loop|open loop
5398710|NCT01727817|Diabetes Assistant|diabetes assistant
5398711|NCT01727817|DiAs|dias
5398712|NCT01727817|Cell Phone|cell phone
5398713|NCT01727791|pharmacokinetic|pharmacokinetic
5398714|NCT01727791|pregabalin|pregabalin
5398715|NCT01727791|lactation|lactation
5398716|NCT01727765|Asthma, inspiratory muscle training|asthma, inspiratory muscle training
5398717|NCT01727739|Tibial tunnel widening|tibial tunnel widening
5398718|NCT01727739|Interference screws|interference screws
5398719|NCT01727726|OPC-34712|opc-34712
5398720|NCT01727726|brexpiprazole|brexpiprazole
5398721|NCT01727726|Major Depressive Disorder|major depressive disorder
5398722|NCT01727726|Adjunctive Treatment|adjunctive treatment
5398723|NCT01727713|Tourette Syndrome|tourette syndrome
5398724|NCT01727713|Basal Ganglia Diseases|basal ganglia diseases
5398725|NCT01727713|Brain Diseases|brain diseases
5398726|NCT01727713|Central Nervous System Diseases|central nervous system diseases
5398727|NCT01727713|Tic Disorders|tic disorders
5398728|NCT01727713|Tics|tics
5398729|NCT01727713|Movement Disorders|movement disorders
5398730|NCT01727713|Mental Disorders|mental disorders
5398731|NCT01727713|Aripiprazole|aripiprazole
5398732|NCT01727700|Tourette Syndrome|tourette syndrome
5398733|NCT01727700|Basal Ganglia Diseases|basal ganglia diseases
5398734|NCT01727700|Brain Diseases|brain diseases
5398735|NCT01727700|Central Nervous System Diseases|central nervous system diseases
5398736|NCT01727700|Tic Disorders|tic disorders
5398737|NCT01727700|Tics|tics
5398738|NCT01727700|Movement Disorders|movement disorders
5398739|NCT01727700|Mental Disorders|mental disorders
5398740|NCT01727700|Aripiprazole|aripiprazole
5398741|NCT01727687|To asses the training effects on traffic safety between normal and patients with Parkinson's disease|to asses the training effects on traffic safety between normal and patients with parkinson's disease
5398742|NCT01727674|Depression|depression
5398743|NCT01727674|experiences of communication|experiences of communication
5398744|NCT01727661|diabetes mellitus|diabetes mellitus
5398745|NCT01727661|cardiopulmonary fitness|cardiopulmonary fitness
5398746|NCT01727661|lung function|lung function
5398747|NCT01727661|muscular oxygenation|muscular oxygenation
5398748|NCT01727648|Stroke rehabilitation|stroke rehabilitation
5398749|NCT01727648|Comparative efficacy research|comparative efficacy research
5398750|NCT01727648|Combined therapy|combined therapy
5398751|NCT01727648|Robot-Assisted Therapy|robot-assisted therapy
5398752|NCT01727648|Constraint-Induced Therapy|constraint-induced therapy
5398753|NCT01727648|Kinematic analysis|kinematic analysis
5398754|NCT01727635|Breast cancer, survivors, partners, group therapy|breast cancer, survivors, partners, group therapy
5398755|NCT01727609|Preterm|preterm
5398756|NCT01727609|Very low birth weight|very low birth weight
5398757|NCT01727609|Feeding|feeding
5398758|NCT01727609|Enteral|enteral
5398759|NCT01727609|Milk|milk
5398760|NCT01727609|Sepsis|sepsis
5398761|NCT01727609|Necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
5398762|NCT01727583|Healthy|healthy
5398763|NCT01727570|Cancer|cancer
5398764|NCT01727570|Colon|colon
5398765|NCT01727570|Rectum|rectum
5398766|NCT01727570|Surgery|surgery
5398767|NCT01727557|Hemodialysis and AV fistula|hemodialysis and av fistula
5398768|NCT01727544|superior semicircular canal|superior semicircular canal
5398769|NCT01727544|non-vestibular dizziness|non-vestibular dizziness
5398770|NCT01727544|vestibular dizziness|vestibular dizziness
5398771|NCT01727531|chloroquine|chloroquine
5398772|NCT01727531|WBRT|wbrt
5398773|NCT01727531|survival|survival
5398774|NCT01727531|brain metastasis|brain metastasis
5398775|NCT01727531|radiotherapy|radiotherapy
5398776|NCT01727531|SNPs|snps
5398777|NCT01727531|gene coding|gene coding
5398778|NCT01727531|immunoregulatory enzyme IDO2|immunoregulatory enzyme ido2
5398779|NCT01727518|natural history|natural history
5398780|NCT01727518|lung function|lung function
5398781|NCT01727518|general population|general population
5398782|NCT01727518|COPD|copd
5398783|NCT01727505|hypoxemia|hypoxemia
5398784|NCT01727505|desaturation|desaturation
5398785|NCT01727505|mechanical ventilation|mechanical ventilation
5398786|NCT01727505|preterm infants|preterm infants
5398787|NCT01727505|volume guarantee ventilation|volume guarantee ventilation
5398789|NCT01727492|noise-induced tinnitus|noise-induced tinnitus
5398790|NCT01727492|noise-induced hearing loss|noise-induced hearing loss
5398791|NCT01727492|young population|young population
5398792|NCT01727479|Peak VO2 consumption|peak vo2 consumption
5398793|NCT01727479|3km time trial|3km time trial
5398794|NCT01727479|fatigue perception|fatigue perception
5398795|NCT01727479|lactate|lactate
5398796|NCT01727479|time to complete|time to complete
5398797|NCT01727440|severe acne|severe acne
5398798|NCT01727440|severe acne vulgaris|severe acne vulgaris
5398799|NCT01727440|acne|acne
5398800|NCT01727440|acne vulgaris|acne vulgaris
5398801|NCT01727440|isotretinoin|isotretinoin
5398802|NCT01727440|Accutane|accutane
5398803|NCT01727440|Sortret|sortret
5398804|NCT01727440|Amnesteem|amnesteem
5398805|NCT01727440|Claravis|claravis
5398806|NCT01727440|Clarus|clarus
5398807|NCT01727440|Decutan|decutan
5398808|NCT01727440|Isotane|isotane
5398809|NCT01727440|Izotek|izotek
5398810|NCT01727440|Oratane|oratane
5398811|NCT01727440|Isotret|isotret
5398812|NCT01727440|Roaccutane|roaccutane
5398813|NCT01727427|Unsuspected|unsuspected
5398814|NCT01727427|pulmonary embolism|pulmonary embolism
5398815|NCT01727427|cancer|cancer
5398816|NCT01727414|ADHD|adhd
5398817|NCT01727414|Inattention|inattention
5398818|NCT01727414|Methylphenidate|methylphenidate
5398819|NCT01727414|Pharmacogenetics|pharmacogenetics
5398820|NCT01727401|Fondaparinux|fondaparinux
5398821|NCT01727401|medical patient|medical patient
5398822|NCT01727401|vein thromboembolism|vein thromboembolism
5398823|NCT01727401|prophylaxis|prophylaxis
5398824|NCT01727401|thrombocytopenia|thrombocytopenia
5398825|NCT01727388|rectal examination|rectal examination
5398826|NCT01727388|colorectal cancer|colorectal cancer
5398827|NCT01727375|delirium, light, ICU, sleep|delirium, light, icu, sleep
5398828|NCT01727362|Breast Cancer|breast cancer
5398829|NCT01727362|Acupuncture|acupuncture
5398830|NCT01727362|Quality of Life|quality of life
5398831|NCT01727258|Tooth Sensitivity|tooth sensitivity
5398833|NCT01727232|Rituximab|rituximab
5398834|NCT01727232|Efficacy|efficacy
5398835|NCT01727232|Anti-CD20|anti-cd20
5398836|NCT01727232|Regimen|regimen
5398837|NCT01727206|Erdheim-Chester disease|erdheim-chester disease
5398838|NCT01727206|Tocilizumab|tocilizumab
5398839|NCT01727206|Treatment|treatment
5398840|NCT01727206|Phase II|phase ii
5398841|NCT01727193|myasthenia gravis|myasthenia gravis
5398842|NCT01727193|leflunomide|leflunomide
5398843|NCT01727167|cardiac disease|cardiac disease
5398844|NCT01727167|mitochondrial biogenesis|mitochondrial biogenesis
5398845|NCT01727167|carbon monoxide|carbon monoxide
5398846|NCT01727141|COPD, QVA149|copd, qva149
5398847|NCT01727128|Hepatic impairment|hepatic impairment
5398848|NCT01727128|Clinical pharmacology study|clinical pharmacology study
5398849|NCT01727128|Volunteer study|volunteer study
5398850|NCT01727063|Chronic ischemic heart disease|chronic ischemic heart disease
5398851|NCT01727063|Coronary artery disease|coronary artery disease
5398852|NCT01727063|Angina pectoris|angina pectoris
5398853|NCT01727063|Myocardial ischemia|myocardial ischemia
5398854|NCT01727063|Cardiac surgery|cardiac surgery
5398855|NCT01727037|Emphysema|emphysema
5398856|NCT01727037|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5398857|NCT01727037|COPD|copd
5398858|NCT01727037|Bulla|bulla
5398859|NCT01727037|Interventional bronchoscopy|interventional bronchoscopy
5398860|NCT01727037|Lung volume reduction|lung volume reduction
5398861|NCT01727024|Breezhaler|breezhaler
5398862|NCT01727024|Respimat|respimat
5398863|NCT01727024|Indacaterol|indacaterol
5398864|NCT01727024|Tiotropium|tiotropium
5398865|NCT01727011|Single fraction|single fraction
5398866|NCT01727011|Elderly|elderly
5398867|NCT01727011|Breast Irradiation|breast irradiation
5398868|NCT01726959|methotrexate|methotrexate
5398869|NCT01726946|Chronic Hepatitis C|chronic hepatitis c
5398872|NCT01726933|psoriasis, systemic treatment|psoriasis, systemic treatment
5398873|NCT01726920|Migraine|migraine
5398874|NCT01726920|Naratriptan|naratriptan
5398875|NCT01726920|Naproxen|naproxen
5398876|NCT01726907|submandibular gland|submandibular gland
5398877|NCT01726907|robotic|robotic
5398878|NCT01726907|endoscopic|endoscopic
5398879|NCT01726907|face lift|face lift
5398880|NCT01726907|hairline|hairline
5398881|NCT01726894|Focal Therapy|focal therapy
5398882|NCT01726881|chronic|chronic
5398883|NCT01726881|Spinal Cord Injury patients|spinal cord injury patients
5398884|NCT01726855|tendon repair|tendon repair
5398885|NCT01726829|Type 1 Diabetes|type 1 diabetes
5398886|NCT01726829|Artificial Pancreas|artificial pancreas
5398887|NCT01726829|Closed Loop|closed loop
5398888|NCT01726816|Diabetic nephropathy|diabetic nephropathy
5398889|NCT01726816|Albumin creatinine ratio|albumin creatinine ratio
5398890|NCT01726816|Probucol|probucol
5398891|NCT01726803|Low Back Pain|low back pain
5398892|NCT01726803|Primary Care|primary care
5398893|NCT01726803|Physical Therapy|physical therapy
5398894|NCT01726790|corneal endothelium|corneal endothelium
5398895|NCT01726790|Bevacizumab|bevacizumab
5398896|NCT01726790|Intravitreal injection|intravitreal injection
5398897|NCT01726790|Confoscan|confoscan
5398898|NCT01726777|Randomized controlled clinical trial|randomized controlled clinical trial
5398899|NCT01726777|Diabetes|diabetes
5398900|NCT01726777|Vitamin D|vitamin d
5398901|NCT01726777|Oral glucose tolerance|oral glucose tolerance
5398902|NCT01726777|Blood glucose|blood glucose
5398903|NCT01726777|Insulin resistance|insulin resistance
5398904|NCT01726751|Spinal cord stimulation|spinal cord stimulation
5398905|NCT01726751|Irritable bowel syndrome|irritable bowel syndrome
5398907|NCT01726751|Diarrhea|diarrhea
5398908|NCT01726738|Melanoma|melanoma
5398909|NCT01726738|Stage III|stage iii
5398910|NCT01726738|Stage IV|stage iv
5398911|NCT01726738|Unresectable|unresectable
5398912|NCT01726738|BRAF Mutant|braf mutant
5398913|NCT01726738|Dabrafenib|dabrafenib
5398914|NCT01726738|Trametinib|trametinib
5398915|NCT01726738|Kinome|kinome
5398916|NCT01726738|Resistance|resistance
5398917|NCT01726738|Sequencing|sequencing
5398918|NCT01726738|Mutations|mutations
5398919|NCT01726738|Kinases|kinases
5398920|NCT01726738|Mechanism|mechanism
5398921|NCT01726725|hemifacial spasm|hemifacial spasm
5398922|NCT01726725|microvascular decompression surgery|microvascular decompression surgery
5398923|NCT01726725|desflurane|desflurane
5398924|NCT01726712|Patient Care Management|patient care management
5398925|NCT01726712|Primary Health Care|primary health care
5398927|NCT01726712|Patient Acceptance of Health Care|patient acceptance of health care
5398928|NCT01726686|Total Knee Arthroplasty|total knee arthroplasty
5398929|NCT01726673|Stroke|stroke
5398930|NCT01726673|Cerebrovascular Accident|cerebrovascular accident
5398931|NCT01726673|Cerebral Stroke|cerebral stroke
5398933|NCT01726673|Robotic therapy|robotic therapy
5398934|NCT01726673|Upper extremity recovery|upper extremity recovery
5398935|NCT01726673|tDCS|tdcs
5398936|NCT01726673|Non-invasive brain stimulation|non-invasive brain stimulation
5398937|NCT01726660|Stroke|stroke
5398938|NCT01726660|Cerebrovascular Accident|cerebrovascular accident
5398939|NCT01726660|Cerebral stroke|cerebral stroke
5398940|NCT01726660|CVA|cva
5398941|NCT01726660|robotic therapy|robotic therapy
5398942|NCT01726660|upper extremity recovery|upper extremity recovery
5398943|NCT01726660|kinematic training|kinematic training
5398944|NCT01726647|obese women|obese women
5398945|NCT01726647|fat mass distribution|fat mass distribution
5398946|NCT01726647|Metabolomic profiles|metabolomic profiles
5398947|NCT01726634|upper limb|upper limb
5398948|NCT01726634|functional test|functional test
5381930|NCT01803906|NARP|narp
5398949|NCT01726634|elastic tape|elastic tape
5398950|NCT01726595|critical care|critical care
5398951|NCT01726595|severe sepsis|severe sepsis
5398952|NCT01726595|microvascular function|microvascular function
5398953|NCT01726595|ultrasound|ultrasound
5398954|NCT01726582|pancreas|pancreas
5398955|NCT01726582|adenocarcinoma|adenocarcinoma
5398956|NCT01726582|molecular profile|molecular profile
5398957|NCT01726582|molecular profiling|molecular profiling
5398958|NCT01726582|pancreatic cancer|pancreatic cancer
5398959|NCT01726582|pancreas cancer|pancreas cancer
5398960|NCT01726582|cancer|cancer
5398961|NCT01726582|molecular target|molecular target
5398962|NCT01726582|pancreas head|pancreas head
5398963|NCT01726582|pancreas neck|pancreas neck
5398964|NCT01726582|pancreas uncinate|pancreas uncinate
5398965|NCT01726582|pancreas body|pancreas body
5398966|NCT01726582|pancreas tail|pancreas tail
5398967|NCT01726569|glaucoma|glaucoma
5398968|NCT01726569|educational intervention|educational intervention
5398969|NCT01726569|post-operative satisfaction|post-operative satisfaction
5398970|NCT01726569|knowledges|knowledges
5398971|NCT01726556|Pleural effusion|pleural effusion
5398972|NCT01726556|Semirigid thoracoscopy|semirigid thoracoscopy
5398973|NCT01726556|Rigid thoracoscopy|rigid thoracoscopy
5398974|NCT01726543|canaloplasty|canaloplasty
5398975|NCT01726543|non-penetrating deep sclerectomy|non-penetrating deep sclerectomy
5398976|NCT01726543|glaucoma|glaucoma
5398977|NCT01726543|cataract|cataract
5398978|NCT01726543|ophthalmology|ophthalmology
5398979|NCT01726543|glaucoma surgery|glaucoma surgery
5398980|NCT01726530|transdermal fentanyl patch, postoperative pain,|transdermal fentanyl patch, postoperative pain,
5398981|NCT01726517|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5398983|NCT01726517|Sustained Virologic Response|sustained virologic response
5398984|NCT01726517|Direct Acting Antiviral|direct acting antiviral
5398985|NCT01726517|Combination Therapy|combination therapy
5398986|NCT01726517|GS-7977|gs-7977
5398987|NCT01726517|GS-5885|gs-5885
5398988|NCT01726517|Ribavirin|ribavirin
5398989|NCT01726517|Open Label|open label
5398990|NCT01726517|Sofosbuvir|sofosbuvir
5398991|NCT01726517|Treatment-Naïve|treatment-naïve
5398992|NCT01726517|Protease Inhibitors|protease inhibitors
5398993|NCT01726517|PI|pi
5398994|NCT01726504|chronic functional constipation|chronic functional constipation
5398995|NCT01726504|electro-acupuncture|electro-acupuncture
5398996|NCT01726504|multi-center randomized controlled trial|multi-center randomized controlled trial
5398997|NCT01726504|efficacy|efficacy
5398998|NCT01726504|safety|safety
5398999|NCT01726491|Insulin resistance|insulin resistance
5399000|NCT01726491|Exercise|exercise
5399001|NCT01726491|Type 2 diabetes mellitus|type 2 diabetes mellitus
5399002|NCT01726491|Obesity|obesity
5399003|NCT01726491|Epigenetic studies|epigenetic studies
5399004|NCT01726478|Oxytocin|oxytocin
5399005|NCT01726478|Uterine tone|uterine tone
5399006|NCT01726478|Mulago Hospital|mulago hospital
5399007|NCT01726478|Dose|dose
5399008|NCT01726478|Side effects|side effects
5399009|NCT01726465|N-Acetylcysteine|n-acetylcysteine
5399010|NCT01726465|Methylprednisolone|methylprednisolone
5399011|NCT01726465|Liver ischemia reperfusion injury|liver ischemia reperfusion injury
5399012|NCT01726465|Pringle manoeuvre|pringle manoeuvre
5399013|NCT01726465|Hepatic resection|hepatic resection
5399014|NCT01726426|Chronic arsenic poisoning|chronic arsenic poisoning
5399015|NCT01726426|Palmer arsenical keratosis|palmer arsenical keratosis
5399016|NCT01726413|Diabetic neuropathy|diabetic neuropathy
5399017|NCT01726400|Hepatitis C|hepatitis c
5399018|NCT01726400|Interferon|interferon
5399019|NCT01726400|Ribavirin|ribavirin
5399020|NCT01726400|Hepcidin|hepcidin
5399021|NCT01726400|Iron metabolism|iron metabolism
5399022|NCT01726361|Multidimension Treatment Foster Care|multidimension treatment foster care
5399023|NCT01726361|Adolescents|adolescents
5399024|NCT01726361|Disadvantaged families|disadvantaged families
5399025|NCT01726361|Out-of-home placement|out-of-home placement
5399026|NCT01726361|Conduct Disorder|conduct disorder
5399027|NCT01726361|Family program|family program
5399028|NCT01726361|Denmark|denmark
5399029|NCT01726361|Youth|youth
5399030|NCT01726348|Human Immunodeficiency Virus-Type 1|human immunodeficiency virus-type 1
5399032|NCT01726348|TMC114|tmc114
5399033|NCT01726348|Darunavir|darunavir
5399034|NCT01726348|Ritonavir|ritonavir
5399035|NCT01726348|Filipino|filipino
5399036|NCT01726335|Schizophrenia|schizophrenia
5399037|NCT01726335|Risperidone|risperidone
5399038|NCT01726335|Risperdal consta|risperdal consta
5399039|NCT01726283|fruste keratoconus|fruste keratoconus
5399040|NCT01726283|ectasia|ectasia
5399041|NCT01726257|Infrarenal|infrarenal
5399042|NCT01726257|Abdominal|abdominal
5399043|NCT01726257|Aortic|aortic
5399044|NCT01726257|Aneurysm|aneurysm
5399045|NCT01726257|AAA|aaa
5399046|NCT01726257|Endologix|endologix
5399047|NCT01726257|EVAS|evas
5399048|NCT01726257|EndoVascular|endovascular
5399049|NCT01726257|Sealing|sealing
5399050|NCT01726257|System|system
5399051|NCT01726231|Laparoscopic access|laparoscopic access
5399052|NCT01726231|Abdominal wall lifting|abdominal wall lifting
5399053|NCT01726231|Direct trocar insertion|direct trocar insertion
5399054|NCT01726231|Safety endoscopy|safety endoscopy
5399055|NCT01726218|Stroke|stroke
5399056|NCT01726218|Physical Medicine & Rehabilitation|physical medicine & rehabilitation
5399057|NCT01726218|Neurology|neurology
5399058|NCT01726218|Neurophysiology|neurophysiology
5399059|NCT01726218|Neuroscience|neuroscience
5399060|NCT01726218|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5399061|NCT01726179|caries infiltration|caries infiltration
5399062|NCT01726179|caries arrest|caries arrest
5399063|NCT01726179|dental anxiety|dental anxiety
5399064|NCT01726179|dental stress|dental stress
5399065|NCT01726166|Infant|infant
5399066|NCT01726166|contamination rates|contamination rates
5399067|NCT01726166|urinary catheterization|urinary catheterization
5399068|NCT01726166|suprapubic aspiration|suprapubic aspiration
5399069|NCT01726153|Condom Use|condom use
5399070|NCT01726153|HIV+ gay males|hiv+ gay males
5399071|NCT01726153|Intervention|intervention
5399072|NCT01726153|Tailored|tailored
5399073|NCT01726153|On-line|on-line
5399074|NCT01726153|Internet|internet
5399075|NCT01726153|Web-based|web-based
5399076|NCT01726140|intubation|intubation
5399077|NCT01726140|respiratory failure|respiratory failure
5399078|NCT01726140|cardiac surgery|cardiac surgery
5399079|NCT01726114|Diabetes|diabetes
5399080|NCT01726114|Diabetes Mellitus|diabetes mellitus
5399081|NCT01726114|continuous Glucose Monitor|continuous glucose monitor
5399082|NCT01726088|Modafinil|modafinil
5399084|NCT01726088|Attentional Bias|attentional bias
5399085|NCT01726075|diabetic retinopathy|diabetic retinopathy
5399086|NCT01726062|Motivational Incentives|motivational incentives
5399087|NCT01726062|Motivational Interviewing|motivational interviewing
5399088|NCT01726062|Secondhand Smoke|secondhand smoke
5399089|NCT01726062|Neonatal Intensive Care Unit|neonatal intensive care unit
5399090|NCT01726062|NICU|nicu
5399091|NCT01726062|High respiratory risk infants|high respiratory risk infants
5399092|NCT01726062|Low birth weight infants|low birth weight infants
5399093|NCT01726062|Environmental Tobacco Smoke|environmental tobacco smoke
5399094|NCT01726062|Smoking|smoking
5399095|NCT01726062|Contingency management|contingency management
5399096|NCT01726062|Infants|infants
5399097|NCT01726062|Children|children
5399098|NCT01726049|HFpEF|hfpef
5399099|NCT01726049|PH|ph
5399100|NCT01726036|neonatal circumcision|neonatal circumcision
5399101|NCT01726036|neonatal surgical pain|neonatal surgical pain
5399102|NCT01726036|Mogen|mogen
5399103|NCT01726036|Gomco|gomco
5399104|NCT01726023|Ceftazidime-avibactam,|ceftazidime-avibactam,
5399105|NCT01726023|Metronidazole,|metronidazole,
5399106|NCT01726023|Meropenem,|meropenem,
5399107|NCT01726023|Anti-Bacterial Agents,|anti-bacterial agents,
5399108|NCT01726023|Anti-Infective Agents,|anti-infective agents,
5399109|NCT01726023|Therapeutic Uses,|therapeutic uses,
5399110|NCT01726023|Pharmacologic Actions,|pharmacologic actions,
5399111|NCT01726023|Physiological Effects of Drugs|physiological effects of drugs
5399112|NCT01725997|acromioclavicular joint dislocation|acromioclavicular joint dislocation
5399113|NCT01725997|ac joint dislocation|ac joint dislocation
5399114|NCT01725997|acromioclavicular joint separation|acromioclavicular joint separation
5399115|NCT01725997|hook plate|hook plate
5399116|NCT01725997|Rockwood|rockwood
5399117|NCT01725984|Male Incontinence|male incontinence
5399118|NCT01725984|AdVance Male Sling|advance male sling
5399119|NCT01725984|AdVance XP Male Sling|advance xp male sling
5399120|NCT01725984|Male Sling|male sling
5399121|NCT01725971|Silicosis|silicosis
5399122|NCT01725971|forced oscillations|forced oscillations
5399123|NCT01725971|respiratory mechanics|respiratory mechanics
5399124|NCT01725945|DASH|dash
5399125|NCT01725945|diet|diet
5399126|NCT01725945|asthma|asthma
5399127|NCT01725945|adults|adults
5399128|NCT01725945|asthma control|asthma control
5399129|NCT01725932|culture, depression, cognitive therapy, behaviour therapy,|culture, depression, cognitive therapy, behaviour therapy,
5399130|NCT01725919|motor|motor
5399131|NCT01725919|stroke|stroke
5399132|NCT01725919|hemiparesis|hemiparesis
5399133|NCT01725919|rehabilitation|rehabilitation
5399134|NCT01725919|constraint induced movement therapy|constraint induced movement therapy
5399135|NCT01725919|CI therapy|ci therapy
5399136|NCT01725906|genotypic resistance guided therapy|genotypic resistance guided therapy
5399137|NCT01725893|Claw Toe|claw toe
5399138|NCT01725880|Spinal Cord Injury|spinal cord injury
5399139|NCT01725880|HuCNS-SC cells|hucns-sc cells
5399140|NCT01725880|Human Neural Stem Cells|human neural stem cells
5399141|NCT01725880|Neural Stem Cells|neural stem cells
5399142|NCT01725880|Stem Cells|stem cells
5399143|NCT01725867|temporomandibular joint disorder|temporomandibular joint disorder
5399144|NCT01725867|myofascial pain|myofascial pain
5399145|NCT01725867|manual myofascial release|manual myofascial release
5399146|NCT01725867|physical therapy|physical therapy
5399147|NCT01725867|oral appliance|oral appliance
5399148|NCT01725841|To determine the prevalence of ESBL-producing among Enterobacteriaceae isolates in Taiwan|to determine the prevalence of esbl-producing among enterobacteriaceae isolates in taiwan
5671207|NCT00616720|stage III multiple myeloma|stage iii multiple myeloma
5671208|NCT00616720|refractory multiple myeloma|refractory multiple myeloma
5671209|NCT00616707|Inflammation|inflammation
5399149|NCT01725841|To determine the susceptibility of ertapenem and other antimicrobial agents against Enterobacteriaceae isolates with and without expression of ESBLs|to determine the susceptibility of ertapenem and other antimicrobial agents against enterobacteriaceae isolates with and without expression of esbls
5399150|NCT01725841|To determine the molecular typing of the Enterobacteriaceae isolates with expression of ESBLs|to determine the molecular typing of the enterobacteriaceae isolates with expression of esbls
5399151|NCT01725841|To analyze the association between geographic area, hospital types against the antimicrobial susceptibility|to analyze the association between geographic area, hospital types against the antimicrobial susceptibility
5862829|NCT00001487|Depression|depression
5399152|NCT01725828|Cricothyroid membrane|cricothyroid membrane
5399153|NCT01725828|Ultrasound|ultrasound
5399154|NCT01725828|Neck landmarks|neck landmarks
5399155|NCT01725828|External palpation|external palpation
5399156|NCT01725789|Acute isovolemic anemia after gastrectomy for gastric cancer|acute isovolemic anemia after gastrectomy for gastric cancer
5399157|NCT01725776|Pulmonary hypertension|pulmonary hypertension
5399158|NCT01725776|Cardiac surgery|cardiac surgery
5399159|NCT01725776|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5399160|NCT01725750|Traumatic Brain Injury|traumatic brain injury
5399161|NCT01725750|TBI|tbi
5399162|NCT01725750|Fatigue|fatigue
5399163|NCT01725750|Post-TBI Fatigue|post-tbi fatigue
5399164|NCT01725750|PTBIF|ptbif
5399165|NCT01725750|Depressed Mood|depressed mood
5399166|NCT01725750|Excessive Daytime Sleepiness|excessive daytime sleepiness
5399167|NCT01725750|Circadian Rhythm|circadian rhythm
5399168|NCT01725750|Anxiety|anxiety
5399169|NCT01725750|Cognitive Dysfunction|cognitive dysfunction
5399170|NCT01725750|Intervention|intervention
5399171|NCT01725750|Treatment|treatment
5399172|NCT01725737|ADHD|adhd
5399173|NCT01725737|GlyTI-M|glyti-m
5399174|NCT01725724|Autologous blood transfusion|autologous blood transfusion
5399175|NCT01725724|Allogeneic blood transfusion|allogeneic blood transfusion
5399176|NCT01725724|Infection rate|infection rate
5399177|NCT01725685|healthy volunteers|healthy volunteers
5399178|NCT01725685|Umeclidinium|umeclidinium
5399179|NCT01725685|tolerability|tolerability
5399180|NCT01725685|Safety|safety
5399181|NCT01725685|Fluticasone Furoate|fluticasone furoate
5399182|NCT01725685|Pharmacokinetics|pharmacokinetics
5399183|NCT01725672|healthy volunteers|healthy volunteers
5399184|NCT01725672|Diabetes mellitus|diabetes mellitus
5399185|NCT01725672|glimepiride|glimepiride
5399186|NCT01725672|pharmacokinetics|pharmacokinetics
5399187|NCT01725672|metformin|metformin
5399188|NCT01725659|Stroke|stroke
5399189|NCT01725659|electric stimulation|electric stimulation
5399190|NCT01725659|robotics|robotics
5399191|NCT01725659|motor learning|motor learning
5399192|NCT01725646|Hypertriglyceridemia, omega-3-acid ethyl ester|hypertriglyceridemia, omega-3-acid ethyl ester
5399193|NCT01725633|Stretching|stretching
5399194|NCT01725633|Nonlinear Aerobic Training|nonlinear aerobic training
5399195|NCT01725633|14-170|14-170
5685279|NCT00556803|liver cancer|liver cancer
5399196|NCT01725607|dexmedetomidine, thoracic epidural anesthesia|dexmedetomidine, thoracic epidural anesthesia
5399197|NCT01725581|OSAT|osat
5399198|NCT01725581|Pelvic Examination|pelvic examination
5399199|NCT01725581|Validation|validation
5399200|NCT01725581|Reliability|reliability
5399201|NCT01725542|HCV-HIV Co-Infection|hcv-hiv co-infection
5399202|NCT01725542|Quadruple therapy|quadruple therapy
5399203|NCT01725542|null responder to a standard Pegylated interferon/Ribavirin regimen|null responder to a standard pegylated interferon/ribavirin regimen
5399204|NCT01725529|Hepatitis C, Chronic|hepatitis c, chronic
5399205|NCT01725529|TMC435|tmc435
5399206|NCT01725529|Ribavirin|ribavirin
5399207|NCT01725529|peginterferon-alpha (PegIFNα-2a)|peginterferon-alpha (pegifnα-2a)
5399208|NCT01725503|creatine synthesis|creatine synthesis
5399209|NCT01725490|chemoprevention, metformin, familial adenomatous polyposis|chemoprevention, metformin, familial adenomatous polyposis
5399210|NCT01725464|thoracotomy|thoracotomy
5399211|NCT01725464|oxygen saturation|oxygen saturation
5399212|NCT01725464|postoperative|postoperative
5399213|NCT01725438|Circulating Trophoblastic Cells|circulating trophoblastic cells
5399214|NCT01725438|Non-Invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
5399215|NCT01725438|Genetic analysis|genetic analysis
5399216|NCT01725438|Trisomy 21|trisomy 21
5399217|NCT01725438|Down's Syndrome|down's syndrome
5399218|NCT01725425|snack food (chips)|snack food (chips)
5399219|NCT01725425|fruit (red grapes) consumed in each condition|fruit (red grapes) consumed in each condition
5399220|NCT01725425|mood|mood
5399221|NCT01725399|post-operative vomiting|post-operative vomiting
5399222|NCT01725373|left main, stent,angioplasty|left main, stent,angioplasty
5399223|NCT01725360|asthma|asthma
5399224|NCT01725360|airway hyperresponsiveness|airway hyperresponsiveness
5399225|NCT01725347|nutrition assessment|nutrition assessment
5399226|NCT01725347|children|children
5399227|NCT01725347|preschool|preschool
5399228|NCT01725347|eating behavior|eating behavior
5399229|NCT01725347|Head Start|head start
5399230|NCT01725347|digital technology|digital technology
5399231|NCT01725334|Schizophrenia|schizophrenia
5399232|NCT01725334|Negative Symptoms|negative symptoms
5399233|NCT01725334|Treatment Resistance|treatment resistance
5399234|NCT01725334|Deep Brain Stimulation|deep brain stimulation
5399235|NCT01725334|Electrical Stimulation|electrical stimulation
5399236|NCT01725334|Mental Disorders|mental disorders
5399237|NCT01725334|Brain Diseases|brain diseases
5399238|NCT01725334|Neurologic Manifestations|neurologic manifestations
5399239|NCT01725334|Signs and Symptoms|signs and symptoms
5399240|NCT01725321|Colonoscopy|colonoscopy
5399241|NCT01725321|colonic adenoma|colonic adenoma
5399242|NCT01725321|serrated polyps|serrated polyps
5399243|NCT01725308|FK949E|fk949e
5399244|NCT01725308|Major depressive episode|major depressive episode
5399245|NCT01725308|patients|patients
5399246|NCT01725295|fibromyalgia treatment|fibromyalgia treatment
5399247|NCT01725295|physical therapy|physical therapy
5399248|NCT01725295|hydrotherapy|hydrotherapy
5399249|NCT01725282|patients|patients
5399250|NCT01725282|FK949E|fk949e
5399251|NCT01725269|AIR001|air001
5399252|NCT01725269|sodium nitrite|sodium nitrite
5399254|NCT01725269|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5399255|NCT01725269|inhaled sodium nitrite|inhaled sodium nitrite
5399256|NCT01725256|AIR001|air001
5399257|NCT01725256|sodium nitrite|sodium nitrite
5399258|NCT01725256|PAH|pah
5399259|NCT01725256|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5399260|NCT01725256|inhaled sodium nitrite|inhaled sodium nitrite
5399261|NCT01725243|pregnancy|pregnancy
5399262|NCT01725243|postpartum hemorrhage|postpartum hemorrhage
5399263|NCT01725243|Cesarean delivery|cesarean delivery
5399264|NCT01725243|carbetocin|carbetocin
5399265|NCT01725243|failure to progress in labor|failure to progress in labor
5399266|NCT01725230|Fostamatinib,|fostamatinib,
5399267|NCT01725230|simvastatin,|simvastatin,
5399268|NCT01725230|rosuvastatin,|rosuvastatin,
5399269|NCT01725230|Phase I,|phase i,
5399270|NCT01725230|Healthy Subjects,|healthy subjects,
5399271|NCT01725230|Pharmacokinetics|pharmacokinetics
5399272|NCT01725217|Meningitis|meningitis
5399273|NCT01725217|children|children
5399274|NCT01725217|adolescents|adolescents
5399275|NCT01725217|adults|adults
5399276|NCT01725217|MenACWY|menacwy
5399277|NCT01725204|dasatinib|dasatinib
5399278|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors
5399279|NCT01725204|pegylated IFN-alpha 2B|pegylated ifn-alpha 2b
5399280|NCT01725204|Interferon-alpha|interferon-alpha
5399281|NCT01725178|Mild Cognitive Impairment|mild cognitive impairment
5399282|NCT01725178|Dementia|dementia
5399283|NCT01725178|Memory disorders|memory disorders
5399284|NCT01725178|Physical fitness|physical fitness
5399285|NCT01725152|fragile x syndrome|fragile x syndrome
5399286|NCT01725152|ganaxolone|ganaxolone
5399287|NCT01725152|anxiety|anxiety
5399288|NCT01725152|attention|attention
5399289|NCT01725152|pediatric|pediatric
5399290|NCT01725126|metformin|metformin
5399291|NCT01725126|diabetes|diabetes
5399292|NCT01725126|obesity|obesity
5399293|NCT01725126|liraglutide|liraglutide
5399294|NCT01725100|GSK1120212|gsk1120212
5399295|NCT01725100|DMSO content|dmso content
5399296|NCT01725100|pharmacokinetics|pharmacokinetics
5399297|NCT01725100|solid tumors|solid tumors
5399298|NCT01725100|MEK inhibitor|mek inhibitor
5399299|NCT01725100|dissolution|dissolution
5399300|NCT01725100|trametinib|trametinib
5399301|NCT01725100|relative bioavailability|relative bioavailability
5399302|NCT01725074|Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support|coronary heart disease, multimorbidity, primary care, case management, loneliness, depression, social support
5399303|NCT01725048|Major depressive disorder|major depressive disorder
5399304|NCT01725048|Neoplasms|neoplasms
5399305|NCT01725035|De Novo Lipogenesis|de novo lipogenesis
5399306|NCT01725035|Fatty Liver|fatty liver
5399307|NCT01725035|Hepatic Steatosis|hepatic steatosis
5399308|NCT01725035|Gene variants|gene variants
5399309|NCT01725022|stem cell transplant|stem cell transplant
5399310|NCT01725022|bowel microbiota|bowel microbiota
5399311|NCT01725022|home care|home care
5399312|NCT01725009|Healthy volunteers|healthy volunteers
5399313|NCT01725009|Japanese|japanese
5399314|NCT01725009|Caucasian|caucasian
5399315|NCT01724983|pain|pain
5399316|NCT01724983|mood|mood
5399317|NCT01724983|depression|depression
5399318|NCT01724983|respiration|respiration
5399319|NCT01724970|anesthesia|anesthesia
5399320|NCT01724970|postanesthetic recovery|postanesthetic recovery
5399321|NCT01724970|ventilation|ventilation
5399322|NCT01724970|bariatric surgery|bariatric surgery
5399323|NCT01724957|Fractional flow reserve,|fractional flow reserve,
5399324|NCT01724957|coronary bifurcation stenosis,|coronary bifurcation stenosis,
5399325|NCT01724957|intracoronary ECG,|intracoronary ecg,
5399326|NCT01724957|coronary stent|coronary stent
5399327|NCT01724957|Coronary bifurcation lesions|coronary bifurcation lesions
5399328|NCT01724957|icECG|icecg
5399329|NCT01724944|Interval debulking surgery|interval debulking surgery
5399330|NCT01724944|IDS|ids
5399331|NCT01724944|NACT|nact
5399332|NCT01724944|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5399333|NCT01724944|Lymphadenectomy|lymphadenectomy
5399334|NCT01724944|Ovarian cancer|ovarian cancer
5399335|NCT01724931|antifolate|antifolate
5399336|NCT01724931|antiinflammatory|antiinflammatory
5399337|NCT01724931|autoimmune disease|autoimmune disease
5399338|NCT01724931|hematological treatment|hematological treatment
5399339|NCT01724931|rheumatic disease|rheumatic disease
5399340|NCT01724931|folic acid antagonist|folic acid antagonist
5399341|NCT01724931|enzyme inhibitor|enzyme inhibitor
5399342|NCT01724918|IV lacosamide|iv lacosamide
5399343|NCT01724918|focal epilepsy|focal epilepsy
5399345|NCT01724918|EKG|ekg
5399346|NCT01724905|Diet|diet
5399347|NCT01724905|Obesity|obesity
5399348|NCT01724905|Chronic disease|chronic disease
5399349|NCT01724879|philadelphia chromosome|philadelphia chromosome
5399350|NCT01724879|BCR-ABL|bcr-abl
5399351|NCT01724879|ALL|all
5399352|NCT01724879|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5399354|NCT01724879|Sprycel|sprycel
5399355|NCT01724853|Carpometacarpal|carpometacarpal
5399356|NCT01724853|osteoarthritis|osteoarthritis
5399357|NCT01724853|outcome measures|outcome measures
5399358|NCT01724827|Dental caries|dental caries
5399359|NCT01724827|inlays|inlays
5399360|NCT01724827|composite resins|composite resins
5399361|NCT01724827|IPS-Empress ceramic|ips-empress ceramic
5399362|NCT01724827|bicuspid|bicuspid
5399363|NCT01724827|FDI dental restorations evaluation criteria|fdi dental restorations evaluation criteria
5399364|NCT01724801|EGFR mutant|egfr mutant
5399365|NCT01724775|complete mesocolic excision|complete mesocolic excision
5399366|NCT01724775|colon cancer|colon cancer
5399367|NCT01724775|efficacy|efficacy
5399368|NCT01724775|safety|safety
5399369|NCT01724762|Baths|baths
5399370|NCT01724762|Anxiety|anxiety
5399371|NCT01724762|Acute Coronary Syndrome|acute coronary syndrome
5399372|NCT01724762|Education, Nursing|education, nursing
5399373|NCT01724749|Atherosclerosis|atherosclerosis
5399374|NCT01724749|Sodium-Fluoride|sodium-fluoride
5399375|NCT01724749|18F-Sodium Fluoride|18f-sodium fluoride
5399376|NCT01724749|18F-NaF|18f-naf
5399377|NCT01724749|fluorodeoxyglucose|fluorodeoxyglucose
5399378|NCT01724749|18F-FDG|18f-fdg
5399379|NCT01724749|FDG|fdg
5399380|NCT01724749|Positron emission tomography|positron emission tomography
5399381|NCT01724749|PET|pet
5399382|NCT01724736|microbiome|microbiome
5399383|NCT01724736|prebiotic|prebiotic
5399384|NCT01724736|cobiotic|cobiotic
5399385|NCT01724736|NM504|nm504
5399386|NCT01724736|GI microbiome|gi microbiome
5399387|NCT01724723|hepatitis during anti-tuberculous treatment|hepatitis during anti-tuberculous treatment
5399388|NCT01724723|tuberculosis|tuberculosis
5399389|NCT01724723|hepatitis B virus|hepatitis b virus
5399390|NCT01724723|viral load|viral load
5399391|NCT01724723|entecavir|entecavir
5399392|NCT01724697|liver cirrhosis|liver cirrhosis
5399393|NCT01724697|end stage liver disease|end stage liver disease
5399394|NCT01724697|HBV|hbv
5399395|NCT01724697|autologous|autologous
5399396|NCT01724697|stem cell|stem cell
5399397|NCT01724697|bone morrow|bone morrow
5399398|NCT01724671|MRSA|mrsa
5399399|NCT01724671|Bacteremia|bacteremia
5399400|NCT01724671|ABSSSI|absssi
5399401|NCT01724671|Pneumonia|pneumonia
5399402|NCT01724671|Vancomycin|vancomycin
5399403|NCT01724671|Ceftaroline|ceftaroline
5399404|NCT01724658|female sexual function|female sexual function
5399405|NCT01724658|postmenopause|postmenopause
5399406|NCT01724658|testosterone|testosterone
5399407|NCT01724645|Korean Traditional diets|korean traditional diets
5399408|NCT01724645|hypertension|hypertension
5399409|NCT01724645|diabetes|diabetes
5399410|NCT01724632|Overweight|overweight
5399411|NCT01724632|Obesity|obesity
5399412|NCT01724632|Weight Loss|weight loss
5399413|NCT01724606|Whole Brain Radiotherapy (WBRT)|whole brain radiotherapy (wbrt)
5399414|NCT01724606|Sorafenib (BAY 43-9006)|sorafenib (bay 43-9006)
5399415|NCT01724606|12-046|12-046
5399416|NCT01724593|functional recovery, critical illness, pediatrics|functional recovery, critical illness, pediatrics
5399417|NCT01724567|Interval Training|interval training
5399418|NCT01724567|Weight Loss|weight loss
5399419|NCT01724567|Secondary Prevention|secondary prevention
5399420|NCT01724567|Rehabilitation|rehabilitation
5399421|NCT01724567|Cardiovascular Risk Factors|cardiovascular risk factors
5399422|NCT01724528|Febuxostat, Tumor lysis syndrome, leukemia, lymphoma|febuxostat, tumor lysis syndrome, leukemia, lymphoma
5399423|NCT01724515|insulin resistance|insulin resistance
5399424|NCT01724502|insulin resistance|insulin resistance
5399425|NCT01724463|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5399426|NCT01724463|Sepsis|sepsis
5399427|NCT01724463|Severe Sepsis|severe sepsis
5399428|NCT01724463|Septic Shock|septic shock
5399429|NCT01724463|Electronic Health Record|electronic health record
5399430|NCT01724463|Health Screening|health screening
5399431|NCT01724463|Goal Directed Therapy|goal directed therapy
5399432|NCT01724463|Infant|infant
5399433|NCT01724463|Child|child
5399434|NCT01724463|Pediatric|pediatric
5399435|NCT01724463|Adolescent|adolescent
5399436|NCT01724463|Critical Illness|critical illness
5399437|NCT01724463|Outcomes Research|outcomes research
5399438|NCT01724463|Resource Utilization|resource utilization
5399439|NCT01724450|Breast Cancer|breast cancer
5399440|NCT01724450|Heart Failure|heart failure
5399441|NCT01724450|Cardiotoxicity|cardiotoxicity
5399442|NCT01724450|Biomarkers|biomarkers
5399443|NCT01724411|Overweight and Obesity|overweight and obesity
5399444|NCT01724411|Appetite|appetite
5399445|NCT01724411|Gut hormones and obesity|gut hormones and obesity
5399446|NCT01724411|Resistant Starch|resistant starch
5399447|NCT01724411|Gut microbiota and obesity|gut microbiota and obesity
5399448|NCT01724411|SmartPill|smartpill
5399449|NCT01724398|mesenchymal stem cells|mesenchymal stem cells
5399450|NCT01724398|plasma exchange|plasma exchange
5399451|NCT01724398|liver failure|liver failure
5399452|NCT01724398|hepatitis B virus|hepatitis b virus
5399453|NCT01724385|bevacizumab,|bevacizumab,
5399454|NCT01724385|proliferative diabetic retinopathy,|proliferative diabetic retinopathy,
5399467|NCT01724320|first-in-man|first-in-man
5399468|NCT01724320|phase I|phase i
5399469|NCT01724320|cancer|cancer
5399470|NCT01724320|galectin|galectin
5399471|NCT01724281|lateral ventricles|lateral ventricles
5399472|NCT01724281|Asymetry|asymetry
5399473|NCT01724255|Caesarian section|caesarian section
5399474|NCT01724255|Surgical Wound|surgical wound
5399475|NCT01724242|Vaginal dryness|vaginal dryness
5399476|NCT01724242|Breast Cancer|breast cancer
5399477|NCT01724242|Urinary Incontinence|urinary incontinence
5399478|NCT01724242|Quality of Life|quality of life
5399479|NCT01724242|Sexual Satisfaction|sexual satisfaction
5399480|NCT01724229|Incontinence-associated dermatitis|incontinence-associated dermatitis
5399481|NCT01724229|Skin care regimen for moisture-associated conditions|skin care regimen for moisture-associated conditions
5399482|NCT01724229|Perineal skin care|perineal skin care
5399483|NCT01724229|Fungal infection in perineal area|fungal infection in perineal area
5399484|NCT01724203|Probiotics for infants|probiotics for infants
5399485|NCT01724203|Bacterial and viral infections in infants|bacterial and viral infections in infants
5399486|NCT01724190|Type 1 Diabetes|type 1 diabetes
5399487|NCT01724190|Vitamin D|vitamin d
5399488|NCT01724190|Clinical Remission|clinical remission
5399489|NCT01724177|Lenalidomide|lenalidomide
5399491|NCT01724177|ATLL|atll
5399492|NCT01724138|deferasirox|deferasirox
5399493|NCT01724125|serious mental illness|serious mental illness
5399494|NCT01724099|Obesity|obesity
5399495|NCT01724099|Herbal product|herbal product
5399496|NCT01724099|Korean Medicine|korean medicine
5399497|NCT01724086|Chronic hepatitis C|chronic hepatitis c
5399498|NCT01724086|Chronic hepatitis C-infected patients|chronic hepatitis c-infected patients
5399499|NCT01724086|TMC647055|tmc647055
5399500|NCT01724086|TMC435|tmc435
5399501|NCT01724086|Ritonavir|ritonavir
5399502|NCT01724086|Ribavirin|ribavirin
5399503|NCT01724086|Genotype 1a|genotype 1a
5399504|NCT01724086|Genotype 1b|genotype 1b
5399505|NCT01724086|GSK2336805|gsk2336805
5399506|NCT01724073|food to food fortification strategy|food to food fortification strategy
5002934|NCT03977714|non-invasive|non-invasive
5399507|NCT01724073|leafy vegetable|leafy vegetable
5399508|NCT01724073|iron|iron
5399509|NCT01724073|zinc|zinc
5399510|NCT01724073|vitamin A|vitamin a
5399511|NCT01724073|growth|growth
5399512|NCT01724047|Autism|autism
5399513|NCT01724047|School Based Intervention|school based intervention
5399514|NCT01724034|Weaning|weaning
5399515|NCT01724034|Mechanical Ventilation|mechanical ventilation
5399516|NCT01724034|Lung Ultrasound|lung ultrasound
5399517|NCT01723995|nipple/injure|nipple/injure
5399518|NCT01723995|breastfeeding|breastfeeding
5399519|NCT01723995|pain|pain
5399520|NCT01723995|laser|laser
5399521|NCT01723956|Cervical Dysplasia|cervical dysplasia
5399522|NCT01723956|Cin 2|cin 2
5399523|NCT01723956|Cin 3|cin 3
5399524|NCT01723956|HIV positive women|hiv positive women
5399525|NCT01723956|South Africa|south africa
5399527|NCT01723904|Neupro|neupro
5399528|NCT01723865|Heart failure|heart failure
5399529|NCT01723865|Remote Monitoring|remote monitoring
5399531|NCT01723865|Follow-up|follow-up
5399532|NCT01723852|Vitamin D|vitamin d
5399533|NCT01723852|Infectious diseases|infectious diseases
5399534|NCT01723852|cognitive development|cognitive development
5399535|NCT01723852|Bone mineral density|bone mineral density
5399536|NCT01723852|Immunoregulation|immunoregulation
5399537|NCT01723852|Allergy|allergy
5399538|NCT01723852|Growth|growth
5399539|NCT01723839|CLL|cll
5399540|NCT01723839|FCR|fcr
5399541|NCT01723839|Rituximab|rituximab
5399542|NCT01723839|Lenalidomide|lenalidomide
5399543|NCT01723839|Cyclophosphamide|cyclophosphamide
5399545|NCT01723813|Tumor-specific peptides|tumor-specific peptides
5399546|NCT01723813|GM-CT-01|gm-ct-01
5399547|NCT01723761|air pollution|air pollution
5399548|NCT01723761|pacemaker|pacemaker
5399549|NCT01723761|ICD|icd
5399550|NCT01723761|remote monitoring|remote monitoring
5399551|NCT01723761|supraventricular arrhythmias|supraventricular arrhythmias
5399552|NCT01723761|ventricular arrhythmias|ventricular arrhythmias
5399553|NCT01723748|Acromegaly|acromegaly
5399554|NCT01723748|Somatostatin treatment|somatostatin treatment
5399555|NCT01723748|metabolic effect|metabolic effect
5399556|NCT01723722|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5399557|NCT01723722|Methadone|methadone
5399558|NCT01723722|Diluted Deodorized Tincture of Opium|diluted deodorized tincture of opium
5399559|NCT01723722|dDTO|ddto
5399560|NCT01723722|Phenobarbital|phenobarbital
5399561|NCT01723709|multiple sclerosis|multiple sclerosis
5399562|NCT01723709|immune response|immune response
5399563|NCT01723709|genetic|genetic
5399564|NCT01723709|progression|progression
5399565|NCT01723709|relapse|relapse
5399566|NCT01723709|biomarkers|biomarkers
5399567|NCT01723709|disease|disease
5399568|NCT01723709|proteomics|proteomics
5399569|NCT01723709|genome|genome
5399570|NCT01723709|gene|gene
5399571|NCT01723696|In-utero smoke;|in-utero smoke;
5399572|NCT01723696|Pulmonary function testing;|pulmonary function testing;
5399573|NCT01723696|Wheeze;|wheeze;
5399574|NCT01723696|Vitamin C;|vitamin c;
5399575|NCT01723696|Forced expiratory flows|forced expiratory flows
5399576|NCT01723683|Preterm infants|preterm infants
5399577|NCT01723683|RDS|rds
5399578|NCT01723683|Surfactant|surfactant
5399579|NCT01723683|MISTCPAP|mistcpap
5399580|NCT01723683|CPAP|cpap
5399581|NCT01723657|Leukemia|leukemia
5399582|NCT01723657|Myeloid|myeloid
5399583|NCT01723657|Acute|acute
5399584|NCT01723657|Young|young
5399585|NCT01723657|CETLAM|cetlam
5399586|NCT01723644|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment|antibiotherapy, community acquired pneumonia, procalcitonin guided guidelines, clinical reassessment
5399587|NCT01723631|Multiple sclerosis|multiple sclerosis
5399588|NCT01723631|TRAP|trap
5399589|NCT01723631|TRAP-Myéline|trap-myéline
5399590|NCT01723605|insitu repair|insitu repair
5399591|NCT01723605|intestinal motility|intestinal motility
5399592|NCT01723592|chemotherapy|chemotherapy
5399593|NCT01723592|vaginal flora|vaginal flora
5399594|NCT01723553|aphasia|aphasia
5399595|NCT01723553|logopenic|logopenic
5399596|NCT01723553|PCA|pca
5399597|NCT01723553|LPA|lpa
5399598|NCT01723540|Cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection|cholecystectomy,minilaparotomy,laparascopy,ultrasonic dissection
5399599|NCT01723527|Cocaine|cocaine
5399600|NCT01723527|Heroin|heroin
5399601|NCT01723527|HIV|hiv
5399602|NCT01723527|Contingency Management|contingency management
5399603|NCT01723527|Incentives|incentives
5399604|NCT01723527|Criminal Justice|criminal justice
5399605|NCT01723527|Methadone|methadone
5399606|NCT01723527|Buprenorphine|buprenorphine
5399607|NCT01723527|Employment|employment
5399608|NCT01723527|Job Training|job training
5399609|NCT01723527|Wage Subsidies|wage subsidies
5399610|NCT01723514|Migraine|migraine
5399611|NCT01723501|chlorhexidine|chlorhexidine
5399612|NCT01723501|sepsis|sepsis
5399613|NCT01723501|neonatal|neonatal
5399614|NCT01723501|whole-body skin cleansing|whole-body skin cleansing
5399615|NCT01723488|AD|ad
5399616|NCT01723475|Phase I|phase i
5399617|NCT01723475|Dose Escalation|dose escalation
5399618|NCT01723475|Prostate cancer|prostate cancer
5399619|NCT01723475|Antibodies|antibodies
5399620|NCT01723475|Bispecific T-cell Engager (BiTE)|bispecific t-cell engager (bite)
5399621|NCT01723436|Decision fatigue|decision fatigue
5399622|NCT01723423|breast cancer|breast cancer
5399623|NCT01723423|evidence based medicine|evidence based medicine
5399624|NCT01723423|reconstruction|reconstruction
5399625|NCT01723423|mastectomy|mastectomy
5399626|NCT01723423|outcomes|outcomes
5399627|NCT01723423|quality of life|quality of life
5399628|NCT01723384|methamphetamine|methamphetamine
5399629|NCT01723384|alcohol|alcohol
5399630|NCT01723384|HIV|hiv
5399631|NCT01723384|sexual behavior|sexual behavior
5399632|NCT01723371|Pulmonary Arterial Hypertension (PAH|pulmonary arterial hypertension (pah
5399633|NCT01723371|Pediatrics|pediatrics
5403182|NCT01707628|NHL|nhl
5399634|NCT01723371|Right Heart Failure (RHF)|right heart failure (rhf)
5399635|NCT01723371|Carvedilol|carvedilol
5399636|NCT01723371|Beta-blockers|beta-blockers
5399637|NCT01723358|pediatrics|pediatrics
5399638|NCT01723358|dysphagia|dysphagia
5399639|NCT01723345|elective percutaneous coronary intervention|elective percutaneous coronary intervention
5399640|NCT01723345|omega 3 polyunsaturated fatty acids (PUFAs)|omega 3 polyunsaturated fatty acids (pufas)
5399641|NCT01723345|short-term MACE|short-term mace
5399642|NCT01723345|long-term MACE|long-term mace
5399643|NCT01723332|Transition from pediatric to adult clinical care|transition from pediatric to adult clinical care
5399645|NCT01723319|TMS|tms
5399646|NCT01723319|brain stimulation|brain stimulation
5399647|NCT01723319|clinical improvement|clinical improvement
5399649|NCT01723306|gene transfer|gene transfer
5399650|NCT01723306|immunotherapy|immunotherapy
5399651|NCT01723306|metastatic cancers|metastatic cancers
5399652|NCT01723306|lung cancer|lung cancer
5399653|NCT01723306|gastric cancer|gastric cancer
5399654|NCT01723306|colorectal cancer|colorectal cancer
5399655|NCT01723306|solid tumors|solid tumors
5445460|NCT01521663|Moderate to severe idiopathic RLS|moderate to severe idiopathic rls
5399656|NCT01723293|Fetal heart rate, pregnancy, fetus, cardiovascular system|fetal heart rate, pregnancy, fetus, cardiovascular system
5399658|NCT01723267|3D ultrasound|3d ultrasound
5399659|NCT01723267|SonoAVC|sonoavc
5399660|NCT01723267|patients in IVF treatment|patients in ivf treatment
5399661|NCT01723254|Vaccines|vaccines
5399662|NCT01723254|Phase 1|phase 1
5399663|NCT01723254|Allergic Rhinitis|allergic rhinitis
5399664|NCT01723241|volunteers|volunteers
5399665|NCT01723228|Parkinson's Disease|parkinson's disease
5399666|NCT01723228|Cognition|cognition
5399667|NCT01723228|Rasagiline|rasagiline
5399668|NCT01723215|Attention bias modification|attention bias modification
5399669|NCT01723215|resilience|resilience
5399670|NCT01723215|combat|combat
5399671|NCT01723215|PTSD|ptsd
5399672|NCT01723215|Depression|depression
5399673|NCT01723215|Anxiety|anxiety
5399674|NCT01723202|BRAF|braf
5399675|NCT01723202|BRAFi|brafi
5399676|NCT01723202|thyroid cancer|thyroid cancer
5399677|NCT01723202|thyroid carcinoma|thyroid carcinoma
5399678|NCT01723189|central apnoeas|central apnoeas
5399679|NCT01723189|stroke|stroke
5399680|NCT01723176|goal-directed echocardiography|goal-directed echocardiography
5399681|NCT01723176|cardiopulmonary failure|cardiopulmonary failure
5399682|NCT01723176|critical care ultrasound|critical care ultrasound
5399683|NCT01723163|veteran|veteran
5399684|NCT01723163|smoking cessation|smoking cessation
5399685|NCT01723150|Klebsiella pneumoniae|klebsiella pneumoniae
5399686|NCT01723137|Pain|pain
5399687|NCT01723137|Pain measurement|pain measurement
5399688|NCT01723137|Visual analog scale|visual analog scale
5399689|NCT01723137|Anxiety|anxiety
5399690|NCT01723137|Stress|stress
5399691|NCT01723137|Opioid|opioid
5399692|NCT01723137|Emergency department|emergency department
5399693|NCT01723137|Demographics|demographics
5399694|NCT01723124|Dense breast tissue|dense breast tissue
5399695|NCT01723124|breast cancer screening|breast cancer screening
5399696|NCT01723124|molecular breast imaging|molecular breast imaging
5399697|NCT01723124|breast cancer|breast cancer
5399698|NCT01723124|breast|breast
5399699|NCT01723111|hepcidin|hepcidin
5399700|NCT01723111|ESA|esa
5399701|NCT01723111|hemodialysis|hemodialysis
5399702|NCT01723111|peritoneal dialysis|peritoneal dialysis
5399703|NCT01723111|iron metabolism|iron metabolism
5399704|NCT01723111|dialysis modality|dialysis modality
5399705|NCT01723098|Pregnancy, cardiovascular system, physical exercise|pregnancy, cardiovascular system, physical exercise
5399706|NCT01723085|Anti-Mullerian hormone|anti-mullerian hormone
5399707|NCT01723085|Myomectomy|myomectomy
5399712|NCT01723046|Robot assisted therapy|robot assisted therapy
5399714|NCT01723046|Devices|devices
5399715|NCT01723046|Orthosis|orthosis
5399716|NCT01723046|clinical outcome|clinical outcome
5399717|NCT01723033|PTSD|ptsd
5399718|NCT01723033|OCD|ocd
5399719|NCT01723020|Solid Tumors|solid tumors
5399720|NCT01723020|Multiple Myeloma|multiple myeloma
5399721|NCT01723007|Weight loss|weight loss
5399722|NCT01723007|cholesterol|cholesterol
5399723|NCT01722968|Metastatic breast cancer|metastatic breast cancer
5399724|NCT01722955|Prewarmed fluid|prewarmed fluid
5399725|NCT01722955|monitored anesthesia care|monitored anesthesia care
5399726|NCT01722955|core body temperature|core body temperature
5399727|NCT01722955|anesthetic satisfaction|anesthetic satisfaction
5399728|NCT01722942|Chagas cardiomyopathy|chagas cardiomyopathy
5399729|NCT01722942|sudden cardiac death|sudden cardiac death
5399730|NCT01722942|primary prevention of death|primary prevention of death
5399731|NCT01722942|amiodarone|amiodarone
5399732|NCT01722942|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5399733|NCT01722903|colorectal cancer|colorectal cancer
5399734|NCT01722903|liver metastases|liver metastases
5399735|NCT01722903|lung metastases|lung metastases
5399741|NCT01722877|Restenosis|restenosis
5399742|NCT01722877|aspiration|aspiration
5399743|NCT01722877|in-stent restenosis|in-stent restenosis
5399744|NCT01722877|atherectomy|atherectomy
5399745|NCT01722877|superficial femoral artery|superficial femoral artery
5399746|NCT01722877|popliteal artery|popliteal artery
5399748|NCT01722851|miRNAs|mirnas
5399749|NCT01722851|Newly diagnosed|newly diagnosed
5399750|NCT01722851|Recurrent|recurrent
5399751|NCT01722838|Black MSM|black msm
5399752|NCT01722838|HIV Prevention|hiv prevention
5399753|NCT01722799|angioplasty|angioplasty
5399754|NCT01722799|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5399755|NCT01722799|Drug elluting Balloon|drug elluting balloon
5399756|NCT01722799|Coronary Balloon|coronary balloon
5399757|NCT01722799|Dilatation|dilatation
5533239|NCT01154296|HIV|hiv
5399758|NCT01722786|severe bleeding|severe bleeding
5399759|NCT01722786|dabigatran|dabigatran
5399760|NCT01722786|rivaroxaban|rivaroxaban
5399761|NCT01722786|apixaban|apixaban
5399762|NCT01722786|edoxaban|edoxaban
5399764|NCT01722786|aPCC|apcc
5399765|NCT01722786|rVIIa|rviia
5399766|NCT01722786|hemodialysis|hemodialysis
5399767|NCT01722786|antidots|antidots
5399768|NCT01722786|idarucizumab|idarucizumab
5399769|NCT01722773|COPD|copd
5445461|NCT01521650|Probiotics|probiotics
5445462|NCT01521650|Anaesthesia|anaesthesia
5399773|NCT01722760|Nasal Continuous Positive airway Pressure (CPAP)|nasal continuous positive airway pressure (cpap)
5399774|NCT01722760|Oxygen|oxygen
5399775|NCT01722760|Vitamin A|vitamin a
5399776|NCT01722760|Vitamin D|vitamin d
5399777|NCT01722760|Nitrogen oxide (NO)|nitrogen oxide (no)
5399778|NCT01722760|Reference material|reference material
5399779|NCT01722734|Malaria|malaria
5399780|NCT01722734|ACTs|acts
5399781|NCT01722708|Abnormal vaginal flora|abnormal vaginal flora
5399782|NCT01722708|clindamycin Vs metronidazole|clindamycin vs metronidazole
5399783|NCT01722708|High risk pregnancies for preterm labor|high risk pregnancies for preterm labor
5399784|NCT01722708|Preterm labor|preterm labor
5399785|NCT01722708|Late abortion|late abortion
5399786|NCT01722708|bacterial vaginosis|bacterial vaginosis
5399787|NCT01722682|Diabetes|diabetes
5399788|NCT01722669|quercetin|quercetin
5399789|NCT01722669|isoquercetin|isoquercetin
5399790|NCT01722669|pharmacokinetic|pharmacokinetic
5399791|NCT01722669|pharmacodynamic|pharmacodynamic
5399792|NCT01722656|PED|ped
5399793|NCT01722656|AMD|amd
5399794|NCT01722656|CNV|cnv
5399795|NCT01722630|dopamine|dopamine
5399796|NCT01722630|laparoscopy|laparoscopy
5399797|NCT01722630|fluid management|fluid management
5399798|NCT01722578|Cirrhosis|cirrhosis
5399799|NCT01722578|Encephalopathy|encephalopathy
5399800|NCT01722578|L-ornithine L-aspartate|l-ornithine l-aspartate
5399801|NCT01722565|Parastomal hernias|parastomal hernias
5399802|NCT01722565|Tolerance of lightweight meshes|tolerance of lightweight meshes
5399803|NCT01722565|laparoscopic abdominoperineal resection|laparoscopic abdominoperineal resection
5399804|NCT01722552|HIV|hiv
5399805|NCT01722552|AIDS|aids
5399806|NCT01722552|antiretroviral therapy|antiretroviral therapy
5399807|NCT01722552|adherence|adherence
5399808|NCT01722552|China|china
5399809|NCT01722539|intermittent|intermittent
5399810|NCT01722539|preventive|preventive
5399811|NCT01722539|treatment|treatment
5399812|NCT01722539|malaria|malaria
5399813|NCT01722539|soil transmitted helminths|soil transmitted helminths
5399814|NCT01722539|schistosomiasis|schistosomiasis
5399815|NCT01722539|schoolchildren|schoolchildren
5399816|NCT01722526|Human acid sphingomyelinase deficiency|human acid sphingomyelinase deficiency
5399817|NCT01722513|Contrast Induced Nephropathy|contrast induced nephropathy
5399818|NCT01722500|International|international
5399819|NCT01722500|Childhood|childhood
5399820|NCT01722500|Obesity|obesity
5399821|NCT01722500|ISCOLE|iscole
5399822|NCT01722500|Pennington Biomedical Research Center|pennington biomedical research center
5399823|NCT01722500|PBRC|pbrc
5399824|NCT01722500|longitudinal|longitudinal
5399825|NCT01722500|multinational|multinational
5399826|NCT01722487|CLL, SLL|cll, sll
5399827|NCT01722474|Pulse Wave Analysis|pulse wave analysis
5399828|NCT01722474|Arterial Stiffness|arterial stiffness
5399829|NCT01722461|Excessive underarm sweating|excessive underarm sweating
5399830|NCT01722448|muscle|muscle
5399831|NCT01722448|muscle dysfunction|muscle dysfunction
5399832|NCT01722448|choline|choline
5399833|NCT01722448|exercise|exercise
5399834|NCT01722448|exertional rhabdomyolysis|exertional rhabdomyolysis
5399836|NCT01722435|opioid dependence|opioid dependence
5399837|NCT01722435|opiate substitution treatment|opiate substitution treatment
5399838|NCT01722435|methadone|methadone
5399839|NCT01722435|completion|completion
5399840|NCT01722435|termination|termination
5399841|NCT01722422|sepsis|sepsis
5399842|NCT01722422|shock|shock
5399843|NCT01722422|hyperoxia|hyperoxia
5399844|NCT01722422|hypertonic saline|hypertonic saline
5399845|NCT01722409|dexmedetomidine, endovascular coil embolization|dexmedetomidine, endovascular coil embolization
5399846|NCT01722357|bariatric surgery|bariatric surgery
5399847|NCT01722357|physical activity|physical activity
5399848|NCT01722357|morbid obesity|morbid obesity
5399849|NCT01722344|Severe mental illness|severe mental illness
5399852|NCT01722344|Individual placement and support|individual placement and support
5399853|NCT01722344|Cognitive remediation|cognitive remediation
5399854|NCT01722344|Social skill training|social skill training
5399855|NCT01722279|bariatric surgery|bariatric surgery
5399856|NCT01722279|long-term outcomes|long-term outcomes
5399857|NCT01722279|obesity|obesity
5399858|NCT01722266|Liraglutide|liraglutide
5399859|NCT01722266|Glucagon|glucagon
5399860|NCT01722266|Systolic blood pressure|systolic blood pressure
5399861|NCT01722266|Weight|weight
5399862|NCT01722266|Carbohydrate intake|carbohydrate intake
5399863|NCT01722266|Insulin dose|insulin dose
5399864|NCT01722266|HbA1c|hba1c
5399865|NCT01722266|Post-prandial glucagon|post-prandial glucagon
5399866|NCT01722253|electroacupuncture|electroacupuncture
5399867|NCT01722253|acupuncture|acupuncture
5399868|NCT01722253|pain management|pain management
5399869|NCT01722214|Psoriasis|psoriasis
5399870|NCT01722214|Vascular Inflammation|vascular inflammation
5394953|NCT01744223|iCasp9|icasp9
5399871|NCT01722214|Coronary Atherosclerosis|coronary atherosclerosis
5399873|NCT01722214|Pet scan|pet scan
5399874|NCT01722214|MRI|mri
5399877|NCT01722149|malignant pleural mesothelioma|malignant pleural mesothelioma
5399878|NCT01722149|re-directed T cells|re-directed t cells
5399879|NCT01722149|FAP|fap
5399880|NCT01722149|fibroblast activation protein|fibroblast activation protein
5399881|NCT01722149|CD8 positive T cells|cd8 positive t cells
5399882|NCT01722149|pleural effusion|pleural effusion
5399883|NCT01722123|Decision fatigue|decision fatigue
5399884|NCT01722071|Oxytocin|oxytocin
5399885|NCT01722071|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5399886|NCT01722071|Social|social
5399887|NCT01722071|Motivation|motivation
5399888|NCT01722058|peptide|peptide
5399889|NCT01722058|colon|colon
5399890|NCT01722058|flat lesions|flat lesions
5399891|NCT01722045|AMD|amd
5399892|NCT01722032|childhood obesity, early childhood, nutrition|childhood obesity, early childhood, nutrition
5399893|NCT01722019|venous insufficiency|venous insufficiency
5399894|NCT01722006|methamphetamine|methamphetamine
5399895|NCT01722006|subjective|subjective
5399896|NCT01722006|conditioning|conditioning
5399897|NCT01722006|preference|preference
5399898|NCT01721993|oral zoledronic acid|oral zoledronic acid
5399899|NCT01721967|chest pain|chest pain
5399900|NCT01721967|dyspnea|dyspnea
5399901|NCT01721954|colon|colon
5399902|NCT01721954|rectum|rectum
5399903|NCT01721954|metastatic colorectal cancer|metastatic colorectal cancer
5399904|NCT01721954|liver metastases|liver metastases
5399905|NCT01721941|hepatocellular carcinoma|hepatocellular carcinoma
5399906|NCT01721941|HCC|hcc
5399907|NCT01721941|liver cancer|liver cancer
5399908|NCT01721941|hepatoma|hepatoma
5399909|NCT01721941|TACE|tace
5399910|NCT01721941|transarterial chemoembolization|transarterial chemoembolization
5399911|NCT01721941|TH302|th302
5399912|NCT01721928|Acute kidney injury|acute kidney injury
5399913|NCT01721928|Deep venous thrombosis|deep venous thrombosis
5399914|NCT01721928|Dialysis|dialysis
5399915|NCT01721928|Prophylaxis|prophylaxis
5399916|NCT01721915|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5399917|NCT01721915|glucose metabolism|glucose metabolism
5399918|NCT01721915|Vitamin D deficiency|vitamin d deficiency
5399919|NCT01721915|vitamin D supplementation|vitamin d supplementation
5399920|NCT01721915|pharmakogenetics|pharmakogenetics
5399922|NCT01721863|Atrial Fibrillation|atrial fibrillation
5399923|NCT01721863|Exercise Training|exercise training
5399924|NCT01721863|Endothelial Function|endothelial function
5399925|NCT01721863|Autonomic Nerve Modulation|autonomic nerve modulation
5399926|NCT01721863|Exercise Capacity|exercise capacity
5399927|NCT01721863|Quality of Life|quality of life
5399928|NCT01721850|infant nutrition, infantile colic|infant nutrition, infantile colic
5399929|NCT01721824|Supported employment|supported employment
5399930|NCT01721824|Individual Placement and Support|individual placement and support
5399931|NCT01721824|Workability|workability
5399932|NCT01721824|Return to work|return to work
5399933|NCT01721798|AE adverse event|ae adverse event
5399934|NCT01721798|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5399935|NCT01721798|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5399936|NCT01721798|ART antiretroviral therapy|art antiretroviral therapy
5399937|NCT01721798|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5399938|NCT01721798|DCF data collection forms|dcf data collection forms
5399939|NCT01721798|DMC Data Monitoring Committee|dmc data monitoring committee
5399940|NCT01721798|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5399941|NCT01721798|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5399942|NCT01721798|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5399943|NCT01721798|ICH International Council for Harmonization|ich international council for harmonization
5399944|NCT01721798|IND Investigational New Drug Application|ind investigational new drug application
5399945|NCT01721798|IRB Institutional Review Board|irb institutional review board
5399948|NCT01721798|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5399949|NCT01721798|PCR polymerase chain reaction|pcr polymerase chain reaction
5399950|NCT01721798|SAE serious adverse event|sae serious adverse event
5399951|NCT01721798|µg microgram|µg microgram
5399952|NCT01721798|ULN upper limit of the normal range|uln upper limit of the normal range
5399953|NCT01721798|WB Western Blot|wb western blot
5399954|NCT01721785|Nodal imaging|nodal imaging
5399955|NCT01721785|Restaging|restaging
5399957|NCT01721733|Leigh syndrome|leigh syndrome
5399958|NCT01721733|respiratory chain disease|respiratory chain disease
5399959|NCT01721733|mitochondrial disorders|mitochondrial disorders
5399960|NCT01721720|Peer and Family Networks|peer and family networks
5399961|NCT01721720|Longitudinal Outcome|longitudinal outcome
5399962|NCT01721720|MRI Imaging|mri imaging
5399963|NCT01721720|Genetics|genetics
5399964|NCT01721720|Childhood Psychiatric Disorders|childhood psychiatric disorders
5399965|NCT01721707|glaucoma|glaucoma
5399966|NCT01721707|ocular hypertension|ocular hypertension
5399967|NCT01721707|latanoprost|latanoprost
5399968|NCT01721707|brinzolamide|brinzolamide
5399969|NCT01721694|bacterial ocular inflammation|bacterial ocular inflammation
5399970|NCT01721694|blepharitis|blepharitis
5399971|NCT01721694|keratitis|keratitis
5399972|NCT01721694|conjunctivitis|conjunctivitis
5399973|NCT01721655|Spironolactone|spironolactone
5399974|NCT01721655|Preterm Infants|preterm infants
5399975|NCT01721655|Chronic Lung Disease|chronic lung disease
5399976|NCT01721655|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5399977|NCT01721655|Electrolyte Supplementation|electrolyte supplementation
5399978|NCT01721642|access|access
5399979|NCT01721642|closure|closure
5399980|NCT01721642|trans-apical|trans-apical
5399981|NCT01721642|trans-catheter aortic valve implantation|trans-catheter aortic valve implantation
5399982|NCT01721642|TAVI|tavi
5399983|NCT01721642|trans-catheter aortic valve repair|trans-catheter aortic valve repair
5399984|NCT01721642|TAVR|tavr
5399985|NCT01721629|Nasal cpap weaning|nasal cpap weaning
5399986|NCT01721629|Premature infants|premature infants
5399987|NCT01721629|Respiratory distress syndrome|respiratory distress syndrome
5399988|NCT01721629|Randomized controlled trial|randomized controlled trial
5399989|NCT01721603|BRAFV600E melanoma patients|brafv600e melanoma patients
5399990|NCT01721603|melanoma|melanoma
5399991|NCT01721603|stereotactic radiosurgery|stereotactic radiosurgery
5399992|NCT01721603|BRAFV600E melanoma brain metastases|brafv600e melanoma brain metastases
5399993|NCT01721603|dabrafenib|dabrafenib
5399994|NCT01721603|SRS|srs
5399995|NCT01721538|stroke|stroke
5399996|NCT01721538|prevention|prevention
5399997|NCT01721538|obesity|obesity
5399998|NCT01721538|weight reduction|weight reduction
5399999|NCT01721512|Prospective observational study|prospective observational study
5400000|NCT01721512|Breast feeding|breast feeding
5400001|NCT01721512|Infant formula|infant formula
5400002|NCT01721512|Infant|infant
5400003|NCT01721512|Indonesia|indonesia
5400004|NCT01721421|haemodialysis|haemodialysis
5400005|NCT01721421|Crossover|crossover
5400006|NCT01721421|Treatment time|treatment time
5400007|NCT01721421|nutritional status|nutritional status
5400008|NCT01721590|high on-treatment platelet reactivity|high on-treatment platelet reactivity
5400009|NCT01721590|Coronary Heart Disease|coronary heart disease
5400010|NCT01721590|Tongxinluo|tongxinluo
5400011|NCT01721577|glioblastoma|glioblastoma
5400012|NCT01721577|gliosarcoma|gliosarcoma
5400013|NCT01721577|anaplastic astrocytoma|anaplastic astrocytoma
5400014|NCT01721577|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5400015|NCT01721577|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5400016|NCT01721577|AXL1717|axl1717
5400017|NCT01721577|IGF-1 receptor inhibitor|igf-1 receptor inhibitor
5400018|NCT01721577|picropodophyllin|picropodophyllin
5400019|NCT01721551|Dialysis fatigue,|dialysis fatigue,
5400020|NCT01721551|exercise intolerance,|exercise intolerance,
5400021|NCT01721551|muscle atrophy,|muscle atrophy,
5400022|NCT01721551|cachexia,|cachexia,
5400023|NCT01721551|disability,|disability,
5400024|NCT01721551|Sleep disorders|sleep disorders
5400025|NCT01721551|Depression|depression
5400026|NCT01721551|Mental Fatigue,|mental fatigue,
5400027|NCT01721551|Cognitive function|cognitive function
5400028|NCT01721551|Physical Fatigue|physical fatigue
5400029|NCT01721525|BIBW2992 (AFATINIB)|bibw2992 (afatinib)
5400030|NCT01721525|CARBOPLATIN|carboplatin
5400031|NCT01721525|RIBAVIRIN-ICN (VIRAZOLE)|ribavirin-icn (virazole)
5400032|NCT01721525|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5400033|NCT01721525|OROPHARYNX|oropharynx
5400034|NCT01721525|HPV associated|hpv associated
5400035|NCT01721525|12-150|12-150
5400036|NCT01721499|Stress|stress
5400037|NCT01721499|obesity|obesity
5400038|NCT01721499|overeating|overeating
5400039|NCT01721486|tonsillitis|tonsillitis
5400040|NCT01721486|recurrent tonsillitis|recurrent tonsillitis
5400044|NCT01721473|Positron Emission Tomography|positron emission tomography
5400045|NCT01721473|Marijuana|marijuana
5400046|NCT01721473|Caffeine|caffeine
5400047|NCT01721473|Menthol|menthol
5400048|NCT01721460|SubThalamic Nucleus|subthalamic nucleus
5400049|NCT01721460|Microelectrode recording|microelectrode recording
5400050|NCT01721460|Deep Brain Stimulation Electrode implantation|deep brain stimulation electrode implantation
5400051|NCT01721447|Atrial fibrillation|atrial fibrillation
5400052|NCT01721447|stroke|stroke
5400053|NCT01721447|TEE|tee
5400054|NCT01721447|Left atrial thrombus|left atrial thrombus
5400055|NCT01721434|levosimendan|levosimendan
5400056|NCT01721434|diaphragm function|diaphragm function
5400057|NCT01721434|mechanically ventilated patients|mechanically ventilated patients
5400058|NCT01721434|neuro-mechanical efficiency|neuro-mechanical efficiency
5400059|NCT01721395|Cough|cough
5400060|NCT01721395|Nocturnal Cough|nocturnal cough
5400061|NCT01721395|Agave|agave
5400062|NCT01721395|Sleep Quality|sleep quality
5400063|NCT01721395|Childhood cough|childhood cough
5400064|NCT01721382|cystic fibrosis|cystic fibrosis
5400065|NCT01721382|CF|cf
5400066|NCT01721382|CFRD|cfrd
5400067|NCT01721382|sitagliptin|sitagliptin
5400068|NCT01721382|incretins|incretins
5400069|NCT01721382|GLP1|glp1
5400070|NCT01721382|GIP|gip
5400071|NCT01721382|beta cell function|beta cell function
5400072|NCT01721382|adolescents|adolescents
5400074|NCT01721330|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5400075|NCT01721330|Psychopharmacology|psychopharmacology
5400076|NCT01721330|Psychiatry|psychiatry
5400077|NCT01721330|Non-stimulant treatment|non-stimulant treatment
5400078|NCT01721317|Ezogabine/Retigabine|ezogabine/retigabine
5400079|NCT01721317|Adjunctive Treatment|adjunctive treatment
5400080|NCT01721317|Safety|safety
5400081|NCT01721317|Efficacy|efficacy
5400082|NCT01721317|Epilepsy|epilepsy
5400083|NCT01721317|Tolerability|tolerability
5400084|NCT01721317|Immediate Release|immediate release
5400085|NCT01721317|GW582892|gw582892
5400086|NCT01721317|Dose-Optimization|dose-optimization
5400087|NCT01721317|Partial-Onset Seizures|partial-onset seizures
5400088|NCT01721304|decision making|decision making
5400089|NCT01721304|abnormal uterine bleeding|abnormal uterine bleeding
5400090|NCT01721304|adaptive conjoint analysis|adaptive conjoint analysis
5400091|NCT01721304|satisfaction|satisfaction
5400092|NCT01721304|regret|regret
5400093|NCT01721291|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|chronic obstructive pulmonary disease
5400094|NCT01721291|ASTHMA|asthma
5400095|NCT01721291|SALBUTAMOL|salbutamol
5400096|NCT01721291|ALBUTEROL|albuterol
5400097|NCT01721291|VENTOLIN|ventolin
5400098|NCT01721291|LUNG PHYSIOLOGY|lung physiology
5400099|NCT01721291|LUNG DEPOSITION|lung deposition
5400100|NCT01721291|INHALERS|inhalers
5400101|NCT01721291|DRUG THERAPY|drug therapy
5400102|NCT01721265|HCV|hcv
5400103|NCT01721265|Hepatitis C|hepatitis c
5400104|NCT01721265|IDX184|idx184
5400105|NCT01721265|IDX719|idx719
5400106|NCT01721252|non-small cell lung cancer|non-small cell lung cancer
5400107|NCT01721252|Erlotinib|erlotinib
5400108|NCT01721252|TarcevaTM|tarcevatm
5400109|NCT01721252|proteomic signature|proteomic signature
5400111|NCT01721239|Follow-up consultations|follow-up consultations
5400112|NCT01721239|Quality of life|quality of life
5400113|NCT01721239|Sense Of Coherence|sense of coherence
5400114|NCT01721239|RCT multicenter study|rct multicenter study
5400115|NCT01721226|Linkage to HIV care following release from prison|linkage to hiv care following release from prison
5400116|NCT01721226|Anti-retroviral therapy adherence after release from prison|anti-retroviral therapy adherence after release from prison
5400117|NCT01721226|HIV loads after release from prison|hiv loads after release from prison
5400118|NCT01721226|information technology and ART adherence|information technology and art adherence
5400119|NCT01721226|information technology and linkage to HIV care|information technology and linkage to hiv care
5400120|NCT01721213|Epilepsy|epilepsy
5400122|NCT01721213|retigabine|retigabine
5400123|NCT01721213|patient information leaflet|patient information leaflet
5400124|NCT01721213|physician's guide|physician's guide
5400125|NCT01721213|Trobalt™|trobalt™
5400126|NCT01721200|Rheumatoid Arthritis|rheumatoid arthritis
5400127|NCT01721200|web based interactive learning tool|web based interactive learning tool
5400128|NCT01721187|fMRI|fmri
5400129|NCT01721187|Satiety|satiety
5400130|NCT01721187|Willingness to Pay|willingness to pay
5400131|NCT01721187|Incentive Delay|incentive delay
5400132|NCT01721187|Dietary Disinhibition|dietary disinhibition
5400133|NCT01721174|Pancreatic cancer|pancreatic cancer
5400134|NCT01721174|Cholangiocarcinoma|cholangiocarcinoma
5400135|NCT01721174|Endoscopic radiofrequency ablation|endoscopic radiofrequency ablation
5400136|NCT01721161|Optic Neuritis|optic neuritis
5400137|NCT01721135|moxifloxacin|moxifloxacin
5400138|NCT01721135|GSK2190915|gsk2190915
5400143|NCT01721109|HIV|hiv
5400144|NCT01721109|Treatment Naive|treatment naive
5400145|NCT01721096|Angioplasty|angioplasty
5400146|NCT01721096|Drug eluting stents|drug eluting stents
5400147|NCT01721096|Stents|stents
5400148|NCT01721096|Real world|real world
5400149|NCT01721083|intramuscular injection|intramuscular injection
5400150|NCT01721083|bunch|bunch
5400151|NCT01721083|z-track|z-track
5400152|NCT01721070|Area under curve, time to maximum concentration|area under curve, time to maximum concentration
5400153|NCT01721031|Catheter Related Bladder Discomfort|catheter related bladder discomfort
5400154|NCT01721031|Dorsal Penile Nerve Block|dorsal penile nerve block
5400155|NCT01721018|Oncolytic virus|oncolytic virus
5400156|NCT01721018|HSV1716|hsv1716
5400157|NCT01721018|Mesothelioma|mesothelioma
5400159|NCT01721018|Woll|woll
5400160|NCT01721018|Sheffield|sheffield
5400161|NCT01721018|Weston Park|weston park
5400162|NCT01721018|Virttu|virttu
5400163|NCT01721018|Crusade|crusade
5400164|NCT01721005|atrial fibrillation|atrial fibrillation
5400165|NCT01721005|thromboembolism|thromboembolism
5400166|NCT01721005|patient education|patient education
5400167|NCT01720979|TBI|tbi
5400168|NCT01720979|Traumatic Brain Injury|traumatic brain injury
5400169|NCT01720979|Children|children
5400170|NCT01720979|Prognosis|prognosis
5400171|NCT01720979|Neurocognition|neurocognition
5400172|NCT01720966|Adhesions|adhesions
5400173|NCT01720966|laparoscopy|laparoscopy
5400174|NCT01720966|laparotomy|laparotomy
5400175|NCT01720966|liver resection|liver resection
5400176|NCT01720966|colorectal malignancy|colorectal malignancy
5400177|NCT01720953|Borderline Personality Disorder|borderline personality disorder
5395260|NCT01742988|DLBCL|dlbcl
5400178|NCT01720953|Mentalization Based Therapy|mentalization based therapy
5400179|NCT01720953|DNA methylation|dna methylation
5400180|NCT01720953|BDNF|bdnf
5400181|NCT01720953|Cortisol|cortisol
5400182|NCT01720953|Neuropsychology|neuropsychology
5400183|NCT01720927|Acute Pharyngitis, GABHS|acute pharyngitis, gabhs
5400184|NCT01720888|Autologous|autologous
5400185|NCT01720888|Bone Marrow|bone marrow
5400186|NCT01720888|Mesenchymal Stem Cells|mesenchymal stem cells
5400187|NCT01720888|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
5400188|NCT01720862|migraine|migraine
5400189|NCT01720862|episodic migraine|episodic migraine
5400190|NCT01720862|chronic migraine|chronic migraine
5400191|NCT01720862|obesity|obesity
5400192|NCT01720862|non-obese|non-obese
5400193|NCT01720823|Obstructive Sleep Apnea syndrome|obstructive sleep apnea syndrome
5400194|NCT01720823|polysomnography|polysomnography
5400195|NCT01720823|Home monitoring|home monitoring
5400196|NCT01720797|Malocclusion|malocclusion
5400197|NCT01720797|Accelerated tooth movement|accelerated tooth movement
5400198|NCT01720797|Braces|braces
5400199|NCT01720797|Orthodontic treatment|orthodontic treatment
5400200|NCT01720797|Propel|propel
5400201|NCT01720771|bacteriotherapy|bacteriotherapy
5400202|NCT01720771|caries|caries
5400203|NCT01720771|preschool children|preschool children
5400204|NCT01720771|probiotics|probiotics
5400205|NCT01720745|EUS|eus
5400206|NCT01720745|FNA|fna
5400207|NCT01720745|Wet suction|wet suction
5400208|NCT01720745|Dry suction|dry suction
5400209|NCT01720745|Solid lesions|solid lesions
5400210|NCT01720719|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5400211|NCT01720719|Dyslipidemias|dyslipidemias
5400212|NCT01720719|Diabetes Mellitus|diabetes mellitus
5400213|NCT01720719|atorvastatin|atorvastatin
5400214|NCT01720719|Vitamin E|vitamin e
5400215|NCT01720706|Liver tumour|liver tumour
5400216|NCT01720706|Kidney tumour|kidney tumour
5400217|NCT01720706|Hepatectomy|hepatectomy
5400218|NCT01720706|Nephrectomy|nephrectomy
5400219|NCT01720706|Metastatic Colon Cancer|metastatic colon cancer
5400220|NCT01720706|Renal Cell Carcinoma|renal cell carcinoma
5400221|NCT01720693|partial nephrectomy|partial nephrectomy
5400222|NCT01720693|hypoperfusion|hypoperfusion
5400223|NCT01720693|renal function|renal function
5400225|NCT01720680|Functional Imaging|functional imaging
5400226|NCT01720680|Patient Reported Outcome (PRO)|patient reported outcome (pro)
5400227|NCT01720680|Lung Function|lung function
5400228|NCT01720680|AlphaCore|alphacore
5400229|NCT01720680|Computational Fluid Dynamics|computational fluid dynamics
5400230|NCT01720667|Seizures|seizures
5400231|NCT01720667|Neonates|neonates
5400232|NCT01720667|Anticonvulsants|anticonvulsants
5400233|NCT01720667|Treatment|treatment
5400234|NCT01720667|Levetiracetam|levetiracetam
5400235|NCT01720667|Phenobarbital|phenobarbital
5400236|NCT01720654|Expedited Partner Therapy|expedited partner therapy
5400238|NCT01720654|Peru|peru
5400239|NCT01720654|Gonorrhea|gonorrhea
5400240|NCT01720654|Chlamydia|chlamydia
5400241|NCT01720641|MSM|msm
5400242|NCT01720641|Transgender Women|transgender women
5400243|NCT01720641|Partner Notification|partner notification
5400244|NCT01720641|Syphilis|syphilis
5400245|NCT01720641|Peru|peru
5400246|NCT01720628|Angiogenin, Behçet's disease, bFGF, VEGF|angiogenin, behçet's disease, bfgf, vegf
5400247|NCT01720615|EEG|eeg
5400248|NCT01720615|AEP|aep
5400249|NCT01720615|Propofol|propofol
5400250|NCT01720615|Sevoflurane|sevoflurane
5400251|NCT01720615|Remifentanil|remifentanil
5400252|NCT01720615|General anesthesia|general anesthesia
5400253|NCT01720589|Obesity|obesity
5400254|NCT01720589|Dietary fat|dietary fat
5400255|NCT01720589|Energy expenditure|energy expenditure
5400256|NCT01720589|Food intake|food intake
5400257|NCT01720563|Cancer-related fatigue|cancer-related fatigue
5400258|NCT01720563|astragalus polysaccharides|astragalus polysaccharides
5400259|NCT01720563|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5400260|NCT01720563|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5400261|NCT01720550|Cancer-related fatigue|cancer-related fatigue
5400262|NCT01720550|Palliative Treatment|palliative treatment
5400263|NCT01720550|Astragalus polysaccharides|astragalus polysaccharides
5400264|NCT01720537|High Cholesterol|high cholesterol
5400265|NCT01720537|Dyslipidemia|dyslipidemia
5400266|NCT01720524|persistent pulmonary hypertension|persistent pulmonary hypertension
5400267|NCT01720524|newborn|newborn
5400268|NCT01720524|neonates|neonates
5400269|NCT01720524|iv sildenafil|iv sildenafil
5400270|NCT01720524|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn|hypoxic respiratory failure and at risk of persistent pulmonary hypertension of the newborn
5400271|NCT01720472|Aging|aging
5400272|NCT01720472|Healthy Aging|healthy aging
5400273|NCT01720472|Physical Performance|physical performance
5400274|NCT01720472|Physical Functioning|physical functioning
5400275|NCT01720472|Cognitive Functioning|cognitive functioning
5400276|NCT01720472|Fitness|fitness
5400277|NCT01720472|Physical Activity|physical activity
5400278|NCT01720433|laparoscopic pain prospective blinded trial|laparoscopic pain prospective blinded trial
5400279|NCT01720420|edentulous|edentulous
5400280|NCT01720420|maxilla|maxilla
5400282|NCT01720420|dental implant|dental implant
5400283|NCT01720420|bar|bar
5400284|NCT01720420|overdenture|overdenture
5400285|NCT01720420|Oral Health Impact Profile (OHIP)|oral health impact profile (ohip)
5400286|NCT01720420|survival rate|survival rate
5400287|NCT01720420|technical complications|technical complications
5400288|NCT01720420|marginal bone level|marginal bone level
5400289|NCT01720420|soft tissue|soft tissue
5400290|NCT01720407|Dermatology/ Skin cancers/Lentigo maligna melanoma|dermatology/ skin cancers/lentigo maligna melanoma
5400291|NCT01720381|monitoring|monitoring
5400292|NCT01720381|blood glucose|blood glucose
5400293|NCT01720381|intensive care unit|intensive care unit
5400294|NCT01720368|IBD|ibd
5400295|NCT01720368|Crohn's|crohn's
5400296|NCT01720342|Medtronic Enable® aortic bioprosthesis|medtronic enable® aortic bioprosthesis
5400297|NCT01720342|Aortic valve stenosis|aortic valve stenosis
5400298|NCT01720342|Aortic valve insufficiency|aortic valve insufficiency
5400299|NCT01720342|"Real world patients"|"real world patients"
5400300|NCT01720316|Glycine|glycine
5400301|NCT01720316|Glycine decarboxylase|glycine decarboxylase
5400302|NCT01720316|Psychosis|psychosis
5400303|NCT01720316|Mutation|mutation
5400304|NCT01720277|Randomized Controlled Trial|randomized controlled trial
5400305|NCT01720277|Influenza|influenza
5400306|NCT01720277|Influenza vaccine|influenza vaccine
5400307|NCT01720277|Flu Vaccine|flu vaccine
5400308|NCT01720277|Fluzone|fluzone
5400309|NCT01720277|HD Fluzone|hd fluzone
5400310|NCT01720277|Nursing Homes|nursing homes
5400311|NCT01720277|Hospitalization|hospitalization
5400312|NCT01720277|Mortality|mortality
5400313|NCT01720277|Health Care worker vaccination|health care worker vaccination
5400314|NCT01720277|ADL decline|adl decline
5400315|NCT01720277|Pilot|pilot
5400316|NCT01720277|Effectiveness|effectiveness
5400317|NCT01720251|allergic rhinitis|allergic rhinitis
5385786|NCT01786395|rp|rp
5400318|NCT01720251|birch pollen|birch pollen
5400319|NCT01720251|immunotherapy|immunotherapy
5400320|NCT01720238|Compensated Liver Cirrhosis|compensated liver cirrhosis
5400321|NCT01720238|Early Antiviral Therapy|early antiviral therapy
5400322|NCT01720238|Cost Effectiveness|cost effectiveness
5400323|NCT01720225|Leukemia|leukemia
5400324|NCT01720225|Myelodysplastic syndromes|myelodysplastic syndromes
5400325|NCT01720225|MDS|mds
5400326|NCT01720225|Low and Intermediate-1 Risk Disease|low and intermediate-1 risk disease
5400327|NCT01720225|Decitabine|decitabine
5400328|NCT01720225|DAC|dac
5400329|NCT01720225|Dacogen|dacogen
5400330|NCT01720225|Azacitidine|azacitidine
5400331|NCT01720225|AZA|aza
5400332|NCT01720225|5-azacytidine|5-azacytidine
5400333|NCT01720225|5-aza|5-aza
5400334|NCT01720225|Vidaza|vidaza
5400335|NCT01720225|5-AZC|5-azc
5400336|NCT01720225|AZA-CR|aza-cr
5400337|NCT01720225|Ladakamycin|ladakamycin
5400338|NCT01720225|NSC-102816|nsc-102816
5400339|NCT01720212|YM178|ym178
5400340|NCT01720212|Mirabegron|mirabegron
5400341|NCT01720212|OCAS|ocas
5400342|NCT01720212|Chinese Healthy Volunteers|chinese healthy volunteers
5400343|NCT01720212|PK|pk
5400344|NCT01720212|Safety|safety
5400345|NCT01720199|universal prevention|universal prevention
5400346|NCT01720199|primary prevention|primary prevention
5400347|NCT01720199|health promotion|health promotion
5400349|NCT01720199|smoking|smoking
5400350|NCT01720199|alcohol|alcohol
5400351|NCT01720199|diet|diet
5400352|NCT01720199|physical activity|physical activity
5400353|NCT01720199|emotional and social skills|emotional and social skills
5400354|NCT01720186|Lung Cancer|lung cancer
5400355|NCT01720186|PET/CT|pet/ct
5400356|NCT01720186|FDG|fdg
5400357|NCT01720186|Respiratory synchronization|respiratory synchronization
5400358|NCT01720160|Systolic Heart Failure|systolic heart failure
5400359|NCT01720160|Congestive Heart Failure|congestive heart failure
5671210|NCT00616707|Oxidative Stress|oxidative stress
5400360|NCT01720160|Reduced left ventricular ejection fraction|reduced left ventricular ejection fraction
5400362|NCT01720147|Fanconi Anemia|fanconi anemia
5400363|NCT01720147|FA|fa
5400364|NCT01720147|Quercetin|quercetin
5400365|NCT01720043|multiple myeloma|multiple myeloma
5400366|NCT01720030|Renal|renal
5400367|NCT01720030|Acute Kidney Injury|acute kidney injury
5400368|NCT01720030|AKI|aki
5400369|NCT01720030|Levosimendan|levosimendan
5400370|NCT01720030|Simdax|simdax
5400371|NCT01720030|Renal perfusion|renal perfusion
5400372|NCT01720030|Mortality|mortality
5400373|NCT01720030|Renal flow|renal flow
5400374|NCT01720017|Airtraq|airtraq
5400375|NCT01720017|laryngoscope|laryngoscope
5400376|NCT01720017|airway|airway
5400377|NCT01720017|difficult|difficult
5400378|NCT01720017|training|training
5400379|NCT01720017|manikin|manikin
5400380|NCT01720004|human labour|human labour
5400381|NCT01720004|hands-and-knees positioning|hands-and-knees positioning
5400382|NCT01720004|pilot trial|pilot trial
5400383|NCT01719991|Primary care|primary care
5400384|NCT01719991|Self-management|self-management
5400385|NCT01719991|Self-support|self-support
5400386|NCT01719991|Nurse case management|nurse case management
5400387|NCT01719978|Local Anaesthetics|local anaesthetics
5445463|NCT01521650|Intubation|intubation
5400395|NCT01719965|Community Engagement|community engagement
5400397|NCT01719952|pregnancy|pregnancy
5400398|NCT01719952|anaesthesia|anaesthesia
5400399|NCT01719952|caesarean section|caesarean section
5400400|NCT01719926|Colorectal|colorectal
5400401|NCT01719926|Esophageal|esophageal
5400402|NCT01719926|Indomethacin|indomethacin
5400403|NCT01719926|PIFA|pifa
5400404|NCT01719900|Dietary intervention|dietary intervention
5400405|NCT01719900|Dietary fibre|dietary fibre
5400406|NCT01719900|Obesity|obesity
5400407|NCT01719900|Metabolic syndrome|metabolic syndrome
5400408|NCT01719900|Weight loss|weight loss
5400409|NCT01719900|Glucose regulation|glucose regulation
5400410|NCT01719900|Pulse fibre|pulse fibre
5400411|NCT01719887|humerus|humerus
5400412|NCT01719887|humeral|humeral
5400413|NCT01719887|shaft|shaft
5400414|NCT01719887|diaphysis|diaphysis
5400415|NCT01719887|fracture|fracture
5400416|NCT01719887|RCT|rct
5400417|NCT01719874|Influenza|influenza
5400418|NCT01719874|monoclonal antibody|monoclonal antibody
5400419|NCT01719848|Physical examinations, Percentage of glottic opening(POGO)|physical examinations, percentage of glottic opening(pogo)
5400420|NCT01719835|T-Cell Lymphoma|t-cell lymphoma
5400421|NCT01719835|Untreated|untreated
5400422|NCT01719822|Treatment Outcome [E01.789.800]|treatment outcome [e01.789.800]
5400423|NCT01719822|Rehabilitation [N02.421.784]|rehabilitation [n02.421.784]
5400424|NCT01719822|Physical Fitness [I03.621]|physical fitness [i03.621]
5400425|NCT01719822|Lung Diseases, Obstructive [C08.381.495]|lung diseases, obstructive [c08.381.495]
5400426|NCT01719822|Pulmonary Disease, Chronic Obstructive [C08.381.495.389]|pulmonary disease, chronic obstructive [c08.381.495.389]
5400427|NCT01719822|Bronchitis, Chronic [C08.381.495.389.500]|bronchitis, chronic [c08.381.495.389.500]
5400428|NCT01719809|Glaucoma|glaucoma
5400429|NCT01719809|Eye Drop|eye drop
5400430|NCT01719809|Eye Drop Technique|eye drop technique
5400431|NCT01719809|Training|training
5400432|NCT01719809|Instilling Eye Drops|instilling eye drops
5400433|NCT01719783|influenza|influenza
5400434|NCT01719783|vaccine|vaccine
5400435|NCT01719783|pandemic|pandemic
5400436|NCT01719770|cardiac arrest|cardiac arrest
5400437|NCT01719770|therapeutic hypothermia|therapeutic hypothermia
5400438|NCT01719770|skeletal muscle paralysis|skeletal muscle paralysis
5400439|NCT01719770|shivering|shivering
5400440|NCT01719770|serum drug levels|serum drug levels
5400441|NCT01719770|basal metabolism|basal metabolism
5400442|NCT01719757|Targin, Cancer Pain|targin, cancer pain
5400443|NCT01719744|ENMD-2076|enmd-2076
5400444|NCT01719744|advanced|advanced
5400445|NCT01719744|metastatic|metastatic
5400446|NCT01719744|soft tissue sarcoma|soft tissue sarcoma
5400447|NCT01719731|BPD|bpd
5400448|NCT01719718|ventral hernia|ventral hernia
5400449|NCT01719705|caesarean delivery|caesarean delivery
5400450|NCT01719705|spinal anesthesia|spinal anesthesia
5400452|NCT01719705|postoperative pain|postoperative pain
5400453|NCT01719705|morphine|morphine
5400454|NCT01719679|school located vaccine program|school located vaccine program
5400455|NCT01719666|MPFL|mpfl
5400456|NCT01719666|patella|patella
5387631|NCT01778010|cocaine|cocaine
5400457|NCT01719666|dislocation|dislocation
5400458|NCT01719666|release|release
5400459|NCT01719653|Colonoscopy|colonoscopy
5400460|NCT01719653|Bowel Preparation|bowel preparation
5400461|NCT01719653|MiraLAX|miralax
5400462|NCT01719653|Gatorade|gatorade
5400463|NCT01719653|PEG-3350|peg-3350
5400464|NCT01719653|MoviPrep|moviprep
5400465|NCT01719653|SUPREP|suprep
5400466|NCT01719653|Chicago Bowel Preparation Scale|chicago bowel preparation scale
5400467|NCT01719653|Boston Bowel Preparation Scale|boston bowel preparation scale
5400468|NCT01719640|mesenchymal stem cells|mesenchymal stem cells
5400469|NCT01719640|bone marrow mononeclear cells|bone marrow mononeclear cells
5400470|NCT01719640|type 2 diabetes mellitus|type 2 diabetes mellitus
5400471|NCT01719627|HIV, Maraviroc, PrEP, Ex vivo infection, rectal mucosa.|hiv, maraviroc, prep, ex vivo infection, rectal mucosa.
5400472|NCT01719614|Healthy participants|healthy participants
5400473|NCT01719614|Rilpivirine|rilpivirine
5400474|NCT01719614|Metformin|metformin
5400475|NCT01719614|Pharmacokinetics|pharmacokinetics
5400476|NCT01719601|Moderate to severe acute non-cancer pain|moderate to severe acute non-cancer pain
5400477|NCT01719601|Immediate release tapentadol hydrochloride|immediate release tapentadol hydrochloride
5400478|NCT01719601|Tapentadol IR|tapentadol ir
5400480|NCT01719588|Moderate to severe chronic non-cancer pain|moderate to severe chronic non-cancer pain
5400481|NCT01719588|Prolonged release tapentadol hydrochloride|prolonged release tapentadol hydrochloride
5400483|NCT01719588|Extended release tapentadol hydrochloride|extended release tapentadol hydrochloride
5400484|NCT01719588|Nucynta PR|nucynta pr
5400485|NCT01719549|Gastric Cancer|gastric cancer
5400486|NCT01719549|Dovitinib|dovitinib
5400487|NCT01719523|Tourette syndrome|tourette syndrome
5400488|NCT01719523|Tics|tics
5400489|NCT01719523|Tic Disorders|tic disorders
5400490|NCT01719510|Group B Streptococcus,|group b streptococcus,
5400491|NCT01719510|Vaginal screening|vaginal screening
5400492|NCT01719510|Per partum antibiotic prophylaxis|per partum antibiotic prophylaxis
5400493|NCT01719510|Meningitis|meningitis
5400494|NCT01719510|Neonatal infection|neonatal infection
5400495|NCT01719510|PCR|pcr
5400496|NCT01719510|Streptococcus agalactiae.|streptococcus agalactiae.
5400497|NCT01719445|Energy Intake|energy intake
5400498|NCT01719432|Filgrastim|filgrastim
5400499|NCT01719432|Obese|obese
5400500|NCT01719432|Non-obese|non-obese
5400501|NCT01719432|Pharmacokinetics|pharmacokinetics
5400502|NCT01719406|Gestational diabetes|gestational diabetes
5400503|NCT01719406|Exercise|exercise
5400504|NCT01719406|Diet|diet
5400505|NCT01719406|Fruits|fruits
5400506|NCT01719406|Vegetables|vegetables
5400507|NCT01719406|Whole grains|whole grains
5400508|NCT01719406|pregnancy weight|pregnancy weight
5400509|NCT01719393|Asthma|asthma
5400510|NCT01719393|Pulse spectrum analysis|pulse spectrum analysis
5400511|NCT01719393|lung function|lung function
5400512|NCT01719393|exhaled nitric oxide|exhaled nitric oxide
5400513|NCT01719393|metabolites|metabolites
5400514|NCT01719393|exhaled breath condensate|exhaled breath condensate
5400612|NCT01718847|Pan-Her inhibitor|pan-her inhibitor
5400613|NCT01718834|prophylactic vaccine|prophylactic vaccine
5400614|NCT01718834|chronic HCV patients|chronic hcv patients
5680250|NCT00578500|chemotherapy, female, fertility preservation, gonadotoxicity|chemotherapy, female, fertility preservation, gonadotoxicity
5400515|NCT01719380|Open-label dose escalation; BRAF inhibitor; LGX818; PI3K inhibitor; BYL719; EGFR; cetuximab; metastatic colorectal cancer; KRAS; BRAF; V600|open-label dose escalation; braf inhibitor; lgx818; pi3k inhibitor; byl719; egfr; cetuximab; metastatic colorectal cancer; kras; braf; v600
5400516|NCT01719367|Baseline (pre-atenolol)|baseline (pre-atenolol)
5400517|NCT01719367|Post-atenolol|post-atenolol
5400518|NCT01719354|Community Mental Health Centers|community mental health centers
5400519|NCT01719354|Norway|norway
5400520|NCT01719354|Aftercare|aftercare
5400521|NCT01719328|yoga,|yoga,
5400522|NCT01719328|exercise|exercise
5400523|NCT01719328|affect|affect
5400524|NCT01719328|mind/body therapies|mind/body therapies
5400525|NCT01719328|stress, psychological|stress, psychological
5400526|NCT01719302|Soft tissue sarcoma|soft tissue sarcoma
5400527|NCT01719302|gemcitabine|gemcitabine
5400528|NCT01719302|docetaxel|docetaxel
5400529|NCT01719302|pazopanib|pazopanib
5400530|NCT01719289|depression|depression
5400531|NCT01719289|problem solving|problem solving
5400532|NCT01719263|emphysema|emphysema
5400533|NCT01719263|InterVapor|intervapor
5400534|NCT01719263|treatments|treatments
5400535|NCT01719263|pulmonary rehabilitation|pulmonary rehabilitation
5400536|NCT01719263|lung volume reduction|lung volume reduction
5400537|NCT01719263|endoscopic lung volume reduction|endoscopic lung volume reduction
5400538|NCT01719237|Onset|onset
5400539|NCT01719237|Duration|duration
5400540|NCT01719237|Upper Limb Block|upper limb block
5400541|NCT01719237|Ultrasound guided supraclavicular block|ultrasound guided supraclavicular block
5400542|NCT01719237|Ropivacaine|ropivacaine
5400543|NCT01719237|Chloroprocaine|chloroprocaine
5400544|NCT01719211|MVP, mitral valve|mvp, mitral valve
5400546|NCT01719198|calprotectin|calprotectin
5400547|NCT01719159|Progressive multiple sclerosis|progressive multiple sclerosis
5400548|NCT01719159|Monoclonal antibodies|monoclonal antibodies
5400549|NCT01719159|Mabthera|mabthera
5400550|NCT01719159|Intrathecal treatment|intrathecal treatment
5400551|NCT01719146|Anemia|anemia
5400552|NCT01719146|Chronic Kidney Disease|chronic kidney disease
5400553|NCT01719146|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
5400554|NCT01719146|Erythropoietin|erythropoietin
5400555|NCT01719146|Iron|iron
5400556|NCT01719146|Iron Deficiency|iron deficiency
5400557|NCT01719133|allergy|allergy
5400558|NCT01719133|birch|birch
5400559|NCT01719120|Insomnia|insomnia
5400560|NCT01719120|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5400561|NCT01719120|Internet-Based|internet-based
5400562|NCT01719120|Self-Help|self-help
5400563|NCT01719120|Randomized Controlled Trial|randomized controlled trial
5400564|NCT01719107|Functional abdominal pain|functional abdominal pain
5400565|NCT01719107|Probiotics|probiotics
5400566|NCT01719107|Lactobacilus reuteri|lactobacilus reuteri
5400567|NCT01719081|Sacroiliac Joint|sacroiliac joint
5400568|NCT01719081|Ultrasound|ultrasound
5400569|NCT01719081|Fluoroscopy|fluoroscopy
5400570|NCT01719081|Chronic Pain|chronic pain
5400571|NCT01719068|Mesothelioma|mesothelioma
5400572|NCT01719068|Lung Cancer|lung cancer
5400573|NCT01719068|Early Detection|early detection
5400574|NCT01719055|stimulation|stimulation
5400575|NCT01719055|implantable|implantable
5400576|NCT01719055|pulse generator|pulse generator
5400577|NCT01719055|back pain|back pain
5400578|NCT01719055|chronic pain|chronic pain
5400579|NCT01719055|leg pain|leg pain
5400580|NCT01719029|continuous glucose monitoring|continuous glucose monitoring
5400581|NCT01719029|gestational diabetes|gestational diabetes
5400582|NCT01719029|diet therapy|diet therapy
5400583|NCT01719016|Reversible ischemia|reversible ischemia
5400584|NCT01719016|microvascular dysfunction|microvascular dysfunction
5400585|NCT01718977|Intervention|intervention
5400586|NCT01718977|Body Weight Supported Treadmill Training|body weight supported treadmill training
5400587|NCT01718977|Arm Cycle Ergometry Training|arm cycle ergometry training
5400588|NCT01718977|carotid-to-femoral pulse wave velocity|carotid-to-femoral pulse wave velocity
5400589|NCT01718951|spondyloarthropathy|spondyloarthropathy
5400590|NCT01718951|ankylosing spondylitis|ankylosing spondylitis
5400591|NCT01718938|Gastroparesis|gastroparesis
5400592|NCT01718938|Diabetic|diabetic
5400593|NCT01718938|Idiopathic|idiopathic
5400594|NCT01718938|Delayed gastric emptying|delayed gastric emptying
5400595|NCT01718912|periodontal disease|periodontal disease
5400596|NCT01718912|bleeding on probing|bleeding on probing
5400597|NCT01718912|periodontal pockets|periodontal pockets
5400598|NCT01718912|disabled|disabled
5400599|NCT01718886|Obesity|obesity
5400600|NCT01718886|Weight loss|weight loss
5400601|NCT01718886|Weight control|weight control
5400602|NCT01718886|Intragastric balloon|intragastric balloon
5400603|NCT01718886|gastric balloon|gastric balloon
5400604|NCT01718873|metastatic|metastatic
5400605|NCT01718873|stage IV|stage iv
5400606|NCT01718860|Cost Analysis|cost analysis
5400607|NCT01718860|Postoperative Complications|postoperative complications
5400608|NCT01718860|Length of Stay|length of stay
5400609|NCT01718860|Intensive Care Units|intensive care units
5400610|NCT01718847|EGFR Tyrosine Kinase Inhibitor|egfr tyrosine kinase inhibitor
5400611|NCT01718847|Aquired resistance to EGFR TKI|aquired resistance to egfr tki
5401014|NCT01717417|miniscrew|miniscrew
5400615|NCT01718834|healthy risk volunteers|healthy risk volunteers
5400616|NCT01718808|Metastatic Colorectal Cancer|metastatic colorectal cancer
5400617|NCT01718808|KRAS|kras
5400618|NCT01718808|BRAF|braf
5400619|NCT01718808|Wild-type Metastatic|wild-type metastatic
5400620|NCT01718808|Cetuximab|cetuximab
5400621|NCT01718808|Capecitabine|capecitabine
5400622|NCT01718808|Phase II Trial|phase ii trial
5400623|NCT01718808|Elderly Patients|elderly patients
5400624|NCT01718795|Airway|airway
5400625|NCT01718795|Cardiac Arrest|cardiac arrest
5400626|NCT01718795|CPR|cpr
5400627|NCT01718795|Ventilation|ventilation
5400628|NCT01718782|laryngeal mask, leakage pressure, ventilation|laryngeal mask, leakage pressure, ventilation
5400629|NCT01718769|Nutritional assessment|nutritional assessment
5400630|NCT01718769|children|children
5400631|NCT01718769|malnutrition|malnutrition
5400632|NCT01718756|Orthopaedic|orthopaedic
5400633|NCT01718756|General anaesthesia|general anaesthesia
5400634|NCT01718756|lornoxicam|lornoxicam
5400635|NCT01718756|patient controlled analgesia|patient controlled analgesia
5400636|NCT01718756|morphine consumption|morphine consumption
5400637|NCT01718730|TMS|tms
5400638|NCT01718730|Adolescent|adolescent
5400639|NCT01718730|Child|child
5400640|NCT01718730|MDD|mdd
5400641|NCT01718730|Major depressive disorder|major depressive disorder
5400642|NCT01718730|Mild MDD|mild mdd
5400643|NCT01718730|Mild depression|mild depression
5400644|NCT01718730|SSRI|ssri
5400645|NCT01718730|Motor cortex|motor cortex
5400646|NCT01718730|Cortical excitability|cortical excitability
5400647|NCT01718730|Cortical inhibition|cortical inhibition
5400648|NCT01718730|Cortical silent period|cortical silent period
5400649|NCT01718730|Motor threshold|motor threshold
5400650|NCT01718730|Intracortical facilitation|intracortical facilitation
5400651|NCT01718730|Intracortical inhibition|intracortical inhibition
5400652|NCT01718730|gamma-aminobutyric acid (GABA)|gamma-aminobutyric acid (gaba)
5400654|NCT01718730|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
5400655|NCT01718730|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5400657|NCT01718717|Thoracotomy|thoracotomy
5400658|NCT01718717|Thoracic epidural analgesia|thoracic epidural analgesia
5400659|NCT01718717|Arrythmiogenesis|arrythmiogenesis
5400660|NCT01718717|Atrial fibrillation|atrial fibrillation
5400661|NCT01718717|Sympathetic outflow|sympathetic outflow
5400662|NCT01718704|rehabilitation|rehabilitation
5400663|NCT01718704|erectile dysfunction|erectile dysfunction
5400664|NCT01718704|incontinence|incontinence
5400665|NCT01718678|Multiple sclerosis|multiple sclerosis
5400666|NCT01718678|Melatonin|melatonin
5400667|NCT01718678|Fatigue|fatigue
5400668|NCT01718678|Quality of life|quality of life
5400669|NCT01718652|Healthy|healthy
5400670|NCT01718652|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5400671|NCT01718652|Pharmacokinetics|pharmacokinetics
5400672|NCT01718652|Cyclosporine|cyclosporine
5862830|NCT00001487|DHEA|dhea
5400673|NCT01718600|carotid artery stenting|carotid artery stenting
5400674|NCT01718600|neuropsychological testing|neuropsychological testing
5400675|NCT01718600|microembolization|microembolization
5400677|NCT01718587|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
5400678|NCT01718587|liver cirrhosis|liver cirrhosis
5400679|NCT01718587|antiviral therapy|antiviral therapy
5400680|NCT01718574|self-help book|self-help book
5400681|NCT01718574|support service|support service
5400682|NCT01718561|Airway assessment|airway assessment
5400683|NCT01718561|Intubation|intubation
5400684|NCT01718561|Mask ventilation|mask ventilation
5400685|NCT01718535|Cyp2C19|cyp2c19
5400686|NCT01718535|Genotyping|genotyping
5400687|NCT01718535|Spartan|spartan
5400688|NCT01718535|Comparison|comparison
5400689|NCT01718535|Sequencing|sequencing
5400690|NCT01718496|dyspnea|dyspnea
5400691|NCT01718496|COPD|copd
5400692|NCT01718496|exercise tolerance|exercise tolerance
5400693|NCT01718496|opioids|opioids
5400694|NCT01718496|morphine|morphine
5400695|NCT01718496|single dose oral Morphine|single dose oral morphine
5400696|NCT01718470|Systolic blood pressure|systolic blood pressure
5400697|NCT01718470|Heart rate|heart rate
5400698|NCT01718470|Laryngeal mask|laryngeal mask
5400699|NCT01718470|Endotracheal tube|endotracheal tube
5400700|NCT01718470|craniotomy|craniotomy
5400701|NCT01718457|Endobarrier|endobarrier
5400702|NCT01718457|Diabetes|diabetes
5400703|NCT01718457|Obesity|obesity
5400704|NCT01718457|Weight|weight
5400705|NCT01718457|BMI|bmi
5400706|NCT01718457|Lipid profile|lipid profile
5400707|NCT01718457|fatty liver|fatty liver
5400708|NCT01718457|gut peptides|gut peptides
5400709|NCT01718457|HbA1c|hba1c
5400710|NCT01718444|PCOS|pcos
5400711|NCT01718444|Polycystic ovary syndrome|polycystic ovary syndrome
5400712|NCT01718444|Infertility|infertility
5400713|NCT01718444|Anovulation|anovulation
5400714|NCT01718444|Clomiphene citrate|clomiphene citrate
5400715|NCT01718444|Clomid|clomid
5400716|NCT01718444|Progestin|progestin
5400717|NCT01718444|Provera|provera
5386135|NCT01784913|vaccine|vaccine
5400718|NCT01718444|Progesterone|progesterone
5400719|NCT01718444|Endometrial shedding|endometrial shedding
5401015|NCT01717417|cone beam|cone beam
5400720|NCT01718392|combined training|combined training
5400721|NCT01718392|insulin resistance|insulin resistance
5400722|NCT01718379|Myelodysplasia|myelodysplasia
5400723|NCT01718340|PCOS|pcos
5400724|NCT01718340|Hyper insulinaemia|hyper insulinaemia
5400725|NCT01718340|metformin|metformin
5400726|NCT01718340|recurrent abortion|recurrent abortion
5400727|NCT01718327|Cholangiocarcinoma|cholangiocarcinoma
5400728|NCT01718314|Hysteroscopy|hysteroscopy
5400729|NCT01718314|Misoprostol|misoprostol
5400730|NCT01718314|Lidocaine|lidocaine
5400731|NCT01718314|Visual analogue score|visual analogue score
5400732|NCT01718301|HCV|hcv
5400733|NCT01718301|HIV|hiv
5400734|NCT01718301|Coinfection|coinfection
5400735|NCT01718288|PAD; iloprost; walking distance; cardiovascular events|pad; iloprost; walking distance; cardiovascular events
5400736|NCT01718275|Appendicitis|appendicitis
5400737|NCT01718275|Pediatrics|pediatrics
5400738|NCT01718275|Children|children
5400739|NCT01718275|Non-operative|non-operative
5400740|NCT01718262|Ropivacaine Level|ropivacaine level
5400741|NCT01718262|continuous peripheral nerve blocks.|continuous peripheral nerve blocks.
5400742|NCT01718249|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5400743|NCT01718249|Post-coma|post-coma
5400744|NCT01718249|Consciousness|consciousness
5400745|NCT01718249|Vegetative state|vegetative state
5400746|NCT01718249|Minimally conscious state|minimally conscious state
5400747|NCT01718236|caesarean section|caesarean section
5400748|NCT01718236|rocuronium|rocuronium
5400769|NCT01718106|percutaneous coronary intervention|percutaneous coronary intervention
5400770|NCT01718106|restenosis|restenosis
5400771|NCT01718106|late thrombosis|late thrombosis
5400772|NCT01718093|Adolescents|adolescents
5400773|NCT01718080|Obese, Lean, Pubertal, Prepubertal, Glucose, Adolescents, Type 2 Diabetes|obese, lean, pubertal, prepubertal, glucose, adolescents, type 2 diabetes
5400774|NCT01718067|Chest physiotherapy|chest physiotherapy
5400775|NCT01718067|Rehabilitation|rehabilitation
5400776|NCT01718067|Chronic respiratory diseases|chronic respiratory diseases
5400777|NCT01718054|Vascular function|vascular function
5400778|NCT01718054|Ready to use supplementary foods|ready to use supplementary foods
5400779|NCT01718054|Chloroquine|chloroquine
5400780|NCT01718054|Children|children
5400782|NCT01718054|Nitric Oxide|nitric oxide
5400783|NCT01718041|Growth hormone|growth hormone
5400784|NCT01718041|Growth hormone deficiency|growth hormone deficiency
5400785|NCT01718041|Growth|growth
5400786|NCT01718041|Pediatric growth hormone deficiency|pediatric growth hormone deficiency
5400787|NCT01718041|Long acting growth hormone|long acting growth hormone
5400788|NCT01718041|GHD|ghd
5400789|NCT01718041|PGHD|pghd
5400790|NCT01718041|VRS 317|vrs 317
5400791|NCT01718041|Exten|exten
5400792|NCT01718041|Versartis|versartis
5400793|NCT01718028|Systane BALANCE|systane balance
5400794|NCT01718028|Dry eye|dry eye
5400796|NCT01718028|NITFBUT|nitfbut
5400797|NCT01718015|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5400798|NCT01718015|Brain-Derived Neurothropic Factor|brain-derived neurothropic factor
5400799|NCT01718015|Diabetes Mellitus|diabetes mellitus
5400800|NCT01718015|CD-163|cd-163
5400801|NCT01718015|Cerebrospinal fluid|cerebrospinal fluid
5400802|NCT01718015|Peripheral Nervous System Diseases|peripheral nervous system diseases
5400803|NCT01718015|Mass spectrometry|mass spectrometry
5400804|NCT01718002|Nursing|nursing
5400805|NCT01718002|Simulation|simulation
5400806|NCT01718002|Education|education
5400807|NCT01717989|Dialysis|dialysis
5400808|NCT01717989|Prospective Payment System|prospective payment system
5400809|NCT01717989|Center for Medicare and Medicaide Services|center for medicare and medicaide services
5400810|NCT01717989|End Stage Renal Disease|end stage renal disease
5400811|NCT01717989|Concomitant Medications Dosage /Treatment patterns|concomitant medications dosage /treatment patterns
5400812|NCT01717976|emergency department use|emergency department use
5400813|NCT01717976|Veterans|veterans
5400814|NCT01717950|Human Hookworm|human hookworm
5400815|NCT01717950|Necator americanus|necator americanus
5400816|NCT01717950|Hookworm|hookworm
5401016|NCT01717404|IBS|ibs
5400817|NCT01717950|Hookworm Disease|hookworm disease
5400818|NCT01717950|Iron-deficiency anemia|iron-deficiency anemia
5400819|NCT01717950|Soil-transmitted helminth infection|soil-transmitted helminth infection
5400820|NCT01717950|Neglected Tropical Disease|neglected tropical disease
5400821|NCT01717950|Na-APR-1|na-apr-1
5400822|NCT01717937|retinovascular disease|retinovascular disease
5400823|NCT01717937|imaging|imaging
5400824|NCT01717937|fluorescein angiography|fluorescein angiography
5400825|NCT01717937|FA|fa
5400826|NCT01717937|angiography|angiography
5400827|NCT01717937|optical coherence tomography|optical coherence tomography
5400828|NCT01717937|OCT|oct
5400829|NCT01717937|phase variance|phase variance
5400830|NCT01717937|comparison|comparison
5516562|NCT01223430|ICU|icu
5400831|NCT01717937|age-related macular degeneration|age-related macular degeneration
5400832|NCT01717937|diabetic retinopathy|diabetic retinopathy
5400833|NCT01717937|hypertensive retinopathy|hypertensive retinopathy
5400834|NCT01717937|retinal vein occlusion|retinal vein occlusion
5400835|NCT01717937|retinal artery occlusion|retinal artery occlusion
5400836|NCT01717924|Signet ring cell|signet ring cell
5400837|NCT01717924|gastric adenocarcinoma|gastric adenocarcinoma
5400838|NCT01717924|peri-operative chemotherapy|peri-operative chemotherapy
5400839|NCT01717924|surgery|surgery
5400840|NCT01717911|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
5400841|NCT01717911|Insulin, metformin, sitagliptin|insulin, metformin, sitagliptin
5400842|NCT01717911|beta-cell function, glycemic control|beta-cell function, glycemic control
5400843|NCT01717898|Castrate-resistant prostate cancer|castrate-resistant prostate cancer
5400844|NCT01717885|Pharmacokinetics|pharmacokinetics
5400845|NCT01717885|Antimalarial|antimalarial
5400846|NCT01717885|HIV|hiv
5400847|NCT01717885|Antiretrovirals|antiretrovirals
5400848|NCT01717885|Childhood development|childhood development
5400849|NCT01717885|Pregnancy|pregnancy
5400850|NCT01717872|glottis, laryngoscopy, laryngoscope blade|glottis, laryngoscopy, laryngoscope blade
5400851|NCT01717859|Rheumatoid Arthritis|rheumatoid arthritis
5400852|NCT01717846|Apoptosos|apoptosos
5400853|NCT01717846|Rheumatoid Arthritis|rheumatoid arthritis
5400854|NCT01717846|T cells, B cells|t cells, b cells
5400855|NCT01717846|DAS28|das28
5400856|NCT01717846|Clinical Disease activity Index|clinical disease activity index
5400857|NCT01717846|CDAI|cdai
5400858|NCT01717833|ICU acquired weakness|icu acquired weakness
5400859|NCT01717833|Critical illness polyneuromyopathy|critical illness polyneuromyopathy
5400860|NCT01717833|post ICU rehabilitation|post icu rehabilitation
5002935|NCT03977714|periodontal disease|periodontal disease
5400861|NCT01717833|neuromuscular electrical rehabilitation|neuromuscular electrical rehabilitation
5400862|NCT01717833|handgrip|handgrip
5400863|NCT01717820|Obesity|obesity
5400864|NCT01717820|Postmenopausal women|postmenopausal women
5400865|NCT01717820|Body composition|body composition
5400866|NCT01717820|Resveratrol|resveratrol
5400867|NCT01717820|Inflammatory biomarkers|inflammatory biomarkers
5400868|NCT01717820|Bone formation|bone formation
5400869|NCT01717820|Adipose metabolism|adipose metabolism
5400870|NCT01717807|epithelial growth factor receptors|epithelial growth factor receptors
5400871|NCT01717807|lung cancer|lung cancer
5400872|NCT01717807|advanced tumor of pancrease|advanced tumor of pancrease
5400873|NCT01717807|erlotinib|erlotinib
5400874|NCT01717807|C11-Erlotinib PET/CT|c11-erlotinib pet/ct
5400875|NCT01717794|operative time|operative time
5400876|NCT01717794|laparoscopy|laparoscopy
5400877|NCT01717794|total hysterectomy|total hysterectomy
5400878|NCT01717794|pelvic lymphadenectomy|pelvic lymphadenectomy
5400879|NCT01717794|endometrial cancer|endometrial cancer
5400880|NCT01717794|Thunderbeat|thunderbeat
5400881|NCT01717781|operative time|operative time
5400882|NCT01717781|laparoscopy|laparoscopy
5400883|NCT01717781|radical hysterectomy|radical hysterectomy
5400884|NCT01717781|pelvic lymphadenectomy|pelvic lymphadenectomy
5400885|NCT01717781|cervical cancer|cervical cancer
5400886|NCT01717781|thunderbeat|thunderbeat
5400892|NCT01717768|Testosterone undecanoate|testosterone undecanoate
5400893|NCT01717768|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
5400895|NCT01717768|Androgens|androgens
5400896|NCT01717768|Hormones|hormones
5400897|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5400898|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs
5400899|NCT01717768|Pharmacologic Actions|pharmacologic actions
5400900|NCT01717768|Therapeutic Uses|therapeutic uses
5400901|NCT01717768|Anabolic Agents|anabolic agents
5400902|NCT01717755|basilar|basilar
5400903|NCT01717755|stroke|stroke
5400904|NCT01717755|mechanical|mechanical
5400905|NCT01717755|thrombolysis|thrombolysis
5400906|NCT01717755|intra-arterial|intra-arterial
5400907|NCT01717755|trombectomy|trombectomy
5400908|NCT01717742|Randomized controlled trial|randomized controlled trial
5400909|NCT01717742|Pleural Empyema|pleural empyema
5400911|NCT01717742|DNase|dnase
5401013|NCT01717417|impacted canine|impacted canine
5400915|NCT01717716|glucose|glucose
5400916|NCT01717716|sucrose|sucrose
5400917|NCT01717716|high-fructose corn syrup-55|high-fructose corn syrup-55
5400918|NCT01717703|prevention|prevention
5400919|NCT01717690|MRSA|mrsa
5400920|NCT01717690|chlorhexidine|chlorhexidine
5400921|NCT01717664|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5400923|NCT01717664|antibiotic|antibiotic
5400924|NCT01717664|Interferon beta 1-a|interferon beta 1-a
5400926|NCT01717664|MRI|mri
5400927|NCT01717664|EDSS|edss
5400928|NCT01717664|relapse rate|relapse rate
5400929|NCT01717651|Atrophy|atrophy
5400930|NCT01717651|Muscle wasting|muscle wasting
5400931|NCT01717651|Sepsis|sepsis
5400932|NCT01717638|Meningococcal disease, vaccines, children, persistence|meningococcal disease, vaccines, children, persistence
5400933|NCT01717625|montelukast|montelukast
5400934|NCT01717625|BPD|bpd
5400935|NCT01717625|singulair|singulair
5400936|NCT01717625|prematurity|prematurity
5400937|NCT01717612|gastric varices, thrombin, histoacryl|gastric varices, thrombin, histoacryl
5400938|NCT01717599|Post ERCP pancreatitis|post ercp pancreatitis
5400939|NCT01717599|Diclofenac|diclofenac
5400940|NCT01717599|NSAID|nsaid
5400941|NCT01717586|preeclampsia|preeclampsia
5400942|NCT01717586|pravastatin|pravastatin
5400943|NCT01717586|Pravachol®|pravachol®
5400944|NCT01717586|statin|statin
5400945|NCT01717586|high-risk pregnancy|high-risk pregnancy
5400946|NCT01717586|safety|safety
5400947|NCT01717586|fetal morbidity and mortality|fetal morbidity and mortality
5400948|NCT01717586|maternal morbidity and mortality|maternal morbidity and mortality
5400949|NCT01717586|neonatal mortality|neonatal mortality
5400950|NCT01717586|premature delivery|premature delivery
5400951|NCT01717586|preemie|preemie
5400952|NCT01717573|STEMI|stemi
5400953|NCT01717573|No-reflow|no-reflow
5400954|NCT01717573|Primary percutaneous intervention|primary percutaneous intervention
5400955|NCT01717573|Deferred stenting|deferred stenting
5400956|NCT01717560|chronic hepatitis C|chronic hepatitis c
5400957|NCT01717560|illicit drug use|illicit drug use
5400958|NCT01717560|Substance-Related Disorders|substance-related disorders
5400959|NCT01717560|multidisciplinary care|multidisciplinary care
5400960|NCT01717560|integrated care|integrated care
5400961|NCT01717560|mental health care|mental health care
5400962|NCT01717560|intensive case management|intensive case management
5400963|NCT01717547|Veterans|veterans
5400964|NCT01717547|Yoga|yoga
5400965|NCT01717547|Stress|stress
5400966|NCT01717534|Diarrhea|diarrhea
5400967|NCT01717534|Children|children
5400968|NCT01717534|Heat-treated lactobacilli|heat-treated lactobacilli
5400969|NCT01717521|intraoperative monitoring|intraoperative monitoring
5400970|NCT01717521|hysterectomy|hysterectomy
5400971|NCT01717521|robotic-assisted|robotic-assisted
5400972|NCT01717521|abdominal gynecological surgery|abdominal gynecological surgery
5400977|NCT01717495|Pacemaker|pacemaker
5400978|NCT01717495|Implantable-cardioverter defibrillator|implantable-cardioverter defibrillator
5400979|NCT01717495|Cardiac Pacing, Artificial/adverse effects|cardiac pacing, artificial/adverse effects
5400980|NCT01717495|Venous thrombosis|venous thrombosis
5400981|NCT01717495|Pulmonary embolism|pulmonary embolism
5400982|NCT01717495|Phlebography|phlebography
5400983|NCT01717495|Biological markers|biological markers
5400984|NCT01717495|Computed tomography angiography|computed tomography angiography
5400985|NCT01717482|Bronchoscopy|bronchoscopy
5400986|NCT01717482|Metformin|metformin
5400987|NCT01717469|Pacemaker|pacemaker
5400988|NCT01717469|Pacemaker implantation|pacemaker implantation
5400989|NCT01717469|Coronary sinus|coronary sinus
5400990|NCT01717469|Ventricular dysfunction|ventricular dysfunction
5400991|NCT01717469|Right ventricular pacing|right ventricular pacing
5400992|NCT01717469|Left ventricular pacing|left ventricular pacing
5400993|NCT01717456|Fecal incontinence|fecal incontinence
5400994|NCT01717456|Frail elders|frail elders
5400995|NCT01717456|Home health care|home health care
5400996|NCT01717456|Nurse|nurse
5400997|NCT01717456|Patient education|patient education
5400998|NCT01717443|Human Papillomavirus|human papillomavirus
5400999|NCT01717443|Renal transplantation|renal transplantation
5401000|NCT01717430|Injections, epidural|injections, epidural
5401001|NCT01717430|Injections, intra-articular|injections, intra-articular
5401002|NCT01717430|Chronic pain|chronic pain
5401003|NCT01717430|Neck pain|neck pain
5401004|NCT01717430|Back pain|back pain
5401005|NCT01717430|Low back pain|low back pain
5401006|NCT01717430|Sciatica|sciatica
5401007|NCT01717430|Sacroiliac joint|sacroiliac joint
5401008|NCT01717430|Corticosteroids|corticosteroids
5401009|NCT01717430|Dexamethasone|dexamethasone
5401010|NCT01717430|Adrenocorticotropic hormone|adrenocorticotropic hormone
5401011|NCT01717430|Adrenal insufficiency|adrenal insufficiency
5401012|NCT01717430|Hemoglobin A, glycosylated|hemoglobin a, glycosylated
5401017|NCT01717391|radiotherapy|radiotherapy
5401018|NCT01717391|Positron-Emission Tomography and Computed Tomography|positron-emission tomography and computed tomography
5401019|NCT01717391|chemotherapy|chemotherapy
5401020|NCT01717391|bone marrow|bone marrow
5401021|NCT01717378|Patient Recruitment|patient recruitment
5401022|NCT01717378|Research Subject Recruitment|research subject recruitment
5401023|NCT01717378|Research Subject Selection|research subject selection
5401024|NCT01717378|Selection of Subjects|selection of subjects
5401025|NCT01717378|Health Surveys|health surveys
5401026|NCT01717378|Health Questionnaires|health questionnaires
5401027|NCT01717378|Health Interviews|health interviews
5401028|NCT01717365|SCOPE|scope
5401029|NCT01717352|Weight loss|weight loss
5401030|NCT01717274|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5401031|NCT01717274|Hot water irrigation|hot water irrigation
5401032|NCT01717261|breast cancer|breast cancer
5401033|NCT01717261|early breast cancer|early breast cancer
5401034|NCT01717261|partial breast irradiation|partial breast irradiation
5401035|NCT01717261|preoperative radiation|preoperative radiation
5401036|NCT01717222|Lignocaine|lignocaine
5401037|NCT01717222|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5401038|NCT01717222|Pain relief|pain relief
5401039|NCT01717209|heart failure|heart failure
5401040|NCT01717209|hypertension, pulmonary|hypertension, pulmonary
5401041|NCT01717209|heart failure, right-sided|heart failure, right-sided
5401042|NCT01717209|heart-assist devices|heart-assist devices
5401043|NCT01717209|Heart Transplantation|heart transplantation
5401044|NCT01717196|sample adequacy|sample adequacy
5401045|NCT01717196|diagnostic accuracy|diagnostic accuracy
5401046|NCT01717196|complications|complications
5401048|NCT01717170|Non-infectious Uveitis, Tocilizumab|non-infectious uveitis, tocilizumab
5401049|NCT01717157|Healthy|healthy
5401051|NCT01717157|Transdermal patch|transdermal patch
5401052|NCT01717157|DUROGESIC|durogesic
5401053|NCT01717144|therapeutic education|therapeutic education
5401054|NCT01717144|Parkinson's disease|parkinson's disease
5401055|NCT01717144|quality of life|quality of life
5401056|NCT01717131|Invasive breast cancer|invasive breast cancer
5401057|NCT01717118|Evaluation|evaluation
5401058|NCT01717118|Immunogenicity|immunogenicity
5401059|NCT01717118|Levels|levels
5401060|NCT01717118|Women|women
5401061|NCT01717118|HPV|hpv
5401062|NCT01717118|Vaccine|vaccine
5401063|NCT01717118|Mexico|mexico
5401064|NCT01717105|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5401065|NCT01717105|Epidermal growth factor receptor (EGFR) positive mutation|epidermal growth factor receptor (egfr) positive mutation
5401066|NCT01717066|Hepatocellular Carcinoma|hepatocellular carcinoma
5401067|NCT01717066|ginsenoside Rg3|ginsenoside rg3
5401068|NCT01717040|Bipolar Disorder|bipolar disorder
5401069|NCT01717040|Insulin Resistance|insulin resistance
5401070|NCT01717027|pharmacokinetics|pharmacokinetics
5401071|NCT01717027|bioavailability|bioavailability
5401072|NCT01717027|oxycodone|oxycodone
5401073|NCT01717027|management of moderate to severe pain|management of moderate to severe pain
5401074|NCT01717014|rectal cancer|rectal cancer
5401075|NCT01717014|stapler|stapler
5401076|NCT01717001|kinematics|kinematics
5401077|NCT01717001|knee joint|knee joint
5401078|NCT01716988|Micafungin|micafungin
5401079|NCT01716988|pharmacokinetics|pharmacokinetics
5401080|NCT01716988|invasive candidiasis|invasive candidiasis
5401081|NCT01716988|intensive care|intensive care
5401082|NCT01716975|Schizophrenia|schizophrenia
5401083|NCT01716975|Cognition|cognition
5401084|NCT01716975|Cognition Impairment|cognition impairment
5401085|NCT01716975|Alpha-7 nAChR|alpha-7 nachr
5401086|NCT01716962|Acute respiratory distress syndrome, Fluid responsiveness, Pulse pressure variation|acute respiratory distress syndrome, fluid responsiveness, pulse pressure variation
5401087|NCT01716962|Pleth variability index, Passive leg raising test|pleth variability index, passive leg raising test
5401088|NCT01716949|rectal cancer|rectal cancer
5862831|NCT00001487|Steroids|steroids
5401090|NCT01716949|hyperthermia|hyperthermia
5401091|NCT01716949|radiation|radiation
5401092|NCT01716949|chemoradiation|chemoradiation
5401093|NCT01716949|5-FU|5-fu
5401094|NCT01716949|capecitabine|capecitabine
5401095|NCT01716949|oxaliplatin|oxaliplatin
5401096|NCT01716936|Thoracic Insufficiency Syndrome|thoracic insufficiency syndrome
5401097|NCT01716936|Early Onset Spinal Deformity|early onset spinal deformity
5401098|NCT01716884|STEMI|stemi
5401099|NCT01716884|reperfution|reperfution
5401100|NCT01716884|primary PCI|primary pci
5401101|NCT01716858|Schizophrenia|schizophrenia
5401102|NCT01716858|Sulforaphane|sulforaphane
5401103|NCT01716858|Psychosis|psychosis
5401104|NCT01716858|Cognition|cognition
5401105|NCT01716858|Oxidative stress|oxidative stress
5401106|NCT01716858|Antioxidant|antioxidant
5401107|NCT01716858|Anti-inflammatory|anti-inflammatory
5401108|NCT01716845|autism|autism
5401109|NCT01716845|autism spectrum disorders|autism spectrum disorders
5401110|NCT01716845|RNA|rna
5401111|NCT01716845|gene expression|gene expression
5401112|NCT01716845|developmental delay|developmental delay
5401113|NCT01716819|Heart failure, abdominal obesity, RAAS|heart failure, abdominal obesity, raas
5401133|NCT01716754|asthma|asthma
5401134|NCT01716754|asthma control|asthma control
5401135|NCT01716754|allergy|allergy
5401136|NCT01716754|atopic|atopic
5401137|NCT01716754|IgE|ige
5401138|NCT01716754|double-blind|double-blind
5401139|NCT01716754|placebo|placebo
5401140|NCT01716754|omalizumab|omalizumab
5401141|NCT01716741|Gaucher disease|gaucher disease
5401142|NCT01716741|lysosomal storage disorder|lysosomal storage disorder
5401143|NCT01716741|metabolic disease|metabolic disease
5401144|NCT01716741|medical records review|medical records review
5401145|NCT01716728|Lysosomal Acid Lipase Deficiency|lysosomal acid lipase deficiency
5401146|NCT01716728|Cholesterol Ester Storage Disease|cholesterol ester storage disease
5401147|NCT01716728|Wolman Disease|wolman disease
5401148|NCT01716728|Lysosomal Storage Disorder|lysosomal storage disorder
5401149|NCT01716728|Metabolic Disease|metabolic disease
5401150|NCT01716728|Recessive Inheritance|recessive inheritance
5401151|NCT01716702|Prostate Cancer|prostate cancer
5401152|NCT01716702|Psychosocial Intervention|psychosocial intervention
5401153|NCT01716702|Sexual Rehabilitation|sexual rehabilitation
5401154|NCT01716702|Online Intervention|online intervention
5401155|NCT01716663|Symptomatic paroxysmal|symptomatic paroxysmal
5401156|NCT01716663|Atrial fibrillation|atrial fibrillation
5401157|NCT01716663|Observational|observational
5401158|NCT01716663|Acute procedural outcomes|acute procedural outcomes
5401159|NCT01716663|Ablation|ablation
5401160|NCT01716650|ankle|ankle
5401161|NCT01716650|saphenous nerve block|saphenous nerve block
5401162|NCT01716637|Alzheimer's Disease|alzheimer's disease
5401163|NCT01716637|Dementia|dementia
5401164|NCT01716637|Cognitive decline|cognitive decline
5401165|NCT01716637|Cognitive disorder|cognitive disorder
5401166|NCT01716637|Degenerative brain disease|degenerative brain disease
5401167|NCT01716637|Cognitive impairment|cognitive impairment
5401168|NCT01716637|Memory loss|memory loss
5401169|NCT01716637|TNF-alpha|tnf-alpha
5401170|NCT01716624|Pediatric|pediatric
5401171|NCT01716611|liver cirrhosis|liver cirrhosis
5401172|NCT01716611|hyponatemia|hyponatemia
5401173|NCT01716611|ascites|ascites
5401174|NCT01716611|vaptans|vaptans
5401175|NCT01716611|antidiuretic hormon|antidiuretic hormon
5401176|NCT01716611|arginine vasopressin|arginine vasopressin
5401177|NCT01716598|COPD|copd
5401178|NCT01716598|TLD Therapy|tld therapy
5401179|NCT01716598|Targeted Lung Denervation Therapy|targeted lung denervation therapy
5401180|NCT01716598|IPS|ips
5401181|NCT01716598|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
5401182|NCT01716598|Holaira, Inc.|holaira, inc.
5401183|NCT01716585|Hepatitis C Virus|hepatitis c virus
5401184|NCT01716585|Hepatitis C Genotype 1|hepatitis c genotype 1
5401185|NCT01716585|Hepatitis C|hepatitis c
5401186|NCT01716585|Treatment-Naïve|treatment-naïve
5401187|NCT01716585|Interferon-Free|interferon-free
5401188|NCT01716585|Chronic Hepatitis C|chronic hepatitis c
5002937|NCT03977701|PHONOLOGY|phonology
5401189|NCT01716585|Viekira Pak|viekira pak
5401190|NCT01716585|ombitasvir|ombitasvir
5401191|NCT01716585|paritaprevir|paritaprevir
5401192|NCT01716585|dasabuvir|dasabuvir
5401193|NCT01716572|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5401194|NCT01716572|Endoscopy|endoscopy
5401195|NCT01716572|Erythromycin|erythromycin
5401196|NCT01716572|Gastric lavage|gastric lavage
5401197|NCT01716546|Advanced cancer of the stomach|advanced cancer of the stomach
5401198|NCT01716546|Chemotherapy - naive patients|chemotherapy - naive patients
5401200|NCT01716533|Serological|serological
5401201|NCT01716533|Adults|adults
5401202|NCT01716533|Clostridium difficile|clostridium difficile
5401203|NCT01716533|Adult CDI patients|adult cdi patients
5401204|NCT01716520|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5401205|NCT01716520|long-acting beta-agonist|long-acting beta-agonist
5401206|NCT01716520|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5401207|NCT01716520|vilanterol|vilanterol
5401208|NCT01716520|umeclidinium|umeclidinium
5401209|NCT01716507|RRD|rrd
5401210|NCT01716507|Rhegmatogenous|rhegmatogenous
5401211|NCT01716507|Retinal|retinal
5401212|NCT01716507|Detachment|detachment
5401213|NCT01716507|PPV|ppv
5401214|NCT01716507|Pars Plana Vitrectomy|pars plana vitrectomy
5401215|NCT01716507|Gauge|gauge
5401219|NCT01716481|Stem cells|stem cells
5401220|NCT01716481|Neurogenesis|neurogenesis
5401221|NCT01716468|Ketogenic Diet, Advanced Cancer, Neoplasm|ketogenic diet, advanced cancer, neoplasm
5401222|NCT01716468|Low carbohydrate|low carbohydrate
5401223|NCT01716442|rituximab|rituximab
5401224|NCT01716442|nephrotic|nephrotic
5401225|NCT01716442|refractory|refractory
5401226|NCT01716429|vegetarian|vegetarian
5401227|NCT01716429|vegan|vegan
5401228|NCT01716429|low calorie|low calorie
5401229|NCT01716429|weight Loss|weight loss
5401230|NCT01716429|infertility|infertility
5401231|NCT01716429|PCOS|pcos
5401232|NCT01716403|C hepatitis, telaprevir concentration, ribavirin oncentration, anemia|c hepatitis, telaprevir concentration, ribavirin oncentration, anemia
5401233|NCT01716377|Neck Pain|neck pain
5401234|NCT01716377|Musculoskeletal pain|musculoskeletal pain
5401235|NCT01716377|Venlafaxine|venlafaxine
5401236|NCT01716351|Randomized Clinical Control Trial|randomized clinical control trial
5401237|NCT01716351|Complementary and Alternative Medicine|complementary and alternative medicine
5401238|NCT01716351|Yoga|yoga
5401239|NCT01716351|Electrophysiology|electrophysiology
5445464|NCT01521650|Pathogenic bacteria|pathogenic bacteria
5401240|NCT01716351|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5401241|NCT01716351|Psychosocial|psychosocial
5401242|NCT01716351|Anxiety|anxiety
5401243|NCT01716351|Self-Compassion|self-compassion
5401244|NCT01716351|Anti-Tachycardia Pacing Events|anti-tachycardia pacing events
5401245|NCT01716338|glyburide|glyburide
5401246|NCT01716338|glybenclamide|glybenclamide
5401247|NCT01716338|hypoglycemia|hypoglycemia
5401251|NCT01716299|Diagnostics|diagnostics
5401252|NCT01716247|Mammography (CESM)|mammography (cesm)
5401254|NCT01716247|Breast screening|breast screening
5401255|NCT01716247|12-214|12-214
5401256|NCT01716208|Fresh Frozen Plasma|fresh frozen plasma
5401257|NCT01716208|Complement|complement
5401258|NCT01716208|Monoclonal Antibody|monoclonal antibody
5401259|NCT01716195|Human Papillomavirus|human papillomavirus
5401261|NCT01716143|atrial fibrillation|atrial fibrillation
5401262|NCT01716143|catheter ablation|catheter ablation
5401263|NCT01716143|Mapping|mapping
5401264|NCT01716130|Fluzone Intradermal vaccine|fluzone intradermal vaccine
5401265|NCT01716117|Large aneurysm|large aneurysm
5401266|NCT01716117|Giant aneurysm|giant aneurysm
5401267|NCT01716117|Wide neck aneurysm|wide neck aneurysm
5401268|NCT01716091|focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery|focus of study is postoperative enfectious morbidity and postoperative gis functionally recovery
5401269|NCT01716078|Brachial Plexus|brachial plexus
5401270|NCT01716078|Nerve Block|nerve block
5401271|NCT01716078|Nerve Conduction|nerve conduction
5401272|NCT01716065|Anesthesia, Circulating tumor cells|anesthesia, circulating tumor cells
5401273|NCT01716052|Mammogram|mammogram
5401274|NCT01716052|Ibuprofen|ibuprofen
5401275|NCT01716052|Pain management|pain management
5401276|NCT01716039|Moderately to severely active Ulcerative Colitis|moderately to severely active ulcerative colitis
5401277|NCT01716026|high myopia|high myopia
5401278|NCT01716026|choroidal neovascularization|choroidal neovascularization
5401279|NCT01716000|vaginal gel|vaginal gel
5401280|NCT01716000|vaginal coating|vaginal coating
5401281|NCT01716000|sensory perceptions|sensory perceptions
5401282|NCT01715987|Hepatitis B|hepatitis b
5401283|NCT01715987|Antiviral|antiviral
5401284|NCT01715987|Tubular dysfunction|tubular dysfunction
5401285|NCT01715987|Entecavir|entecavir
5401286|NCT01715987|Tenofovir|tenofovir
5401287|NCT01715974|G-CSF, IVF failure,pregnancy|g-csf, ivf failure,pregnancy
5401288|NCT01715961|70 years old|70 years old
5401289|NCT01715961|DLBCL|dlbcl
5401290|NCT01715961|Rituximab-CHOP|rituximab-chop
5401291|NCT01715961|Sarcopenia|sarcopenia
5401292|NCT01715948|CROS hearing aid|cros hearing aid
5401293|NCT01715948|Bone-anchored hearing device|bone-anchored hearing device
5401294|NCT01715935|Clear cells renal carcinoma|clear cells renal carcinoma
5401295|NCT01715935|everolimus|everolimus
5401296|NCT01715935|neo-adjuvant treatment|neo-adjuvant treatment
5401297|NCT01715922|Cryptococcal meningitis|cryptococcal meningitis
5401298|NCT01715922|HIV Infections|hiv infections
5401299|NCT01715922|Oral treatment|oral treatment
5401300|NCT01715922|High dose of fluconazole|high dose of fluconazole
5401301|NCT01715922|Flucytosine|flucytosine
5401303|NCT01715922|Ivory Coast|ivory coast
5401304|NCT01715896|Rheumatoid Arthritis|rheumatoid arthritis
5401305|NCT01715896|Golimumab|golimumab
5401306|NCT01715896|Mavrilimumab|mavrilimumab
5401307|NCT01715883|Lung transplant|lung transplant
5401308|NCT01715883|Pulmonary Graft Dysfunction|pulmonary graft dysfunction
5401309|NCT01715883|Sodium Nitrite|sodium nitrite
5401310|NCT01715870|Age related macular degeneration|age related macular degeneration
5401311|NCT01715870|Food habits|food habits
5401312|NCT01715870|Life style|life style
5401313|NCT01715870|Risk factors|risk factors
5401314|NCT01715870|questionnaire|questionnaire
5401323|NCT01715805|MDD|mdd
5401324|NCT01715805|Major Depressive Disorder|major depressive disorder
5401325|NCT01715792|Solid organ transplant rejection|solid organ transplant rejection
5401326|NCT01715792|United Kingdom|united kingdom
5401327|NCT01715792|Influenza|influenza
5401328|NCT01715792|H1N1|h1n1
5401329|NCT01715792|Pandemrix™|pandemrix™
5401330|NCT01715779|Liver transplantation|liver transplantation
5401331|NCT01715779|ENABLE|enable
5401332|NCT01715779|observational|observational
5401333|NCT01715779|mortality|mortality
5401334|NCT01715779|Thromboembolic Events|thromboembolic events
5401335|NCT01715779|Hepatic decompensation|hepatic decompensation
5401336|NCT01715779|Long-Term follow-up|long-term follow-up
5401337|NCT01715779|TEE|tee
5401338|NCT01715766|Proteomics study|proteomics study
5401339|NCT01715766|biomarker study of pain|biomarker study of pain
5401340|NCT01715753|Function|function
5401341|NCT01715753|Muscle mass|muscle mass
5401342|NCT01715740|Chinese herbal medicine|chinese herbal medicine
5401343|NCT01715740|Urticaria|urticaria
5401344|NCT01715740|Antipruritics|antipruritics
5401345|NCT01715740|Phase III clinical trial|phase iii clinical trial
5401346|NCT01715727|diffusion kurtosis imaging|diffusion kurtosis imaging
5401347|NCT01715727|parkinson disease|parkinson disease
5401348|NCT01715727|parkinsonism|parkinsonism
5401349|NCT01715727|diagnosis|diagnosis
5401350|NCT01715727|differential diagnosis|differential diagnosis
5401355|NCT01715675|asthma|asthma
5401356|NCT01715675|allergy|allergy
5401357|NCT01715675|sitostanol|sitostanol
5401358|NCT01715675|cytokines|cytokines
5401359|NCT01715675|Th1|th1
5401360|NCT01715675|Treg|treg
5401361|NCT01715675|antibodies|antibodies
5401362|NCT01715675|IgE|ige
5401363|NCT01715675|vaccination|vaccination
5401364|NCT01715662|rehabilitation|rehabilitation
5401365|NCT01715662|lower limb amputation|lower limb amputation
5517193|NCT01220960|women|women
5401366|NCT01715662|unilateral transtibial amputation|unilateral transtibial amputation
5401367|NCT01715662|unilateral transfemoral amputation|unilateral transfemoral amputation
5401368|NCT01715662|older adults|older adults
5401369|NCT01715662|cognitive computer games|cognitive computer games
5401370|NCT01715662|home-based training|home-based training
5401371|NCT01715662|Nintendo Wii|nintendo wii
5401372|NCT01715662|virtual reality|virtual reality
5401373|NCT01715649|Type 2 diabetes|type 2 diabetes
5401374|NCT01715649|self-management|self-management
5401375|NCT01715649|remote patient monitoring|remote patient monitoring
5401376|NCT01715623|polymorphism|polymorphism
5401377|NCT01715623|serum Ig|serum ig
5401378|NCT01715597|uterine leiomyoma|uterine leiomyoma
5401379|NCT01715597|laparoscopic myomectomy|laparoscopic myomectomy
5401380|NCT01715597|intraoperative blood loss|intraoperative blood loss
5401381|NCT01715597|ascorbic acid|ascorbic acid
5401382|NCT01715584|Hypertension|hypertension
5401383|NCT01715584|Sevoflurane|sevoflurane
5401384|NCT01715584|Inhaled Anesthetic|inhaled anesthetic
5401385|NCT01715584|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5401386|NCT01715584|Angiotensin II Receptor Blocking Agent|angiotensin ii receptor blocking agent
5401387|NCT01715571|erectile dysfunction|erectile dysfunction
5401388|NCT01715571|vibratory stimulation|vibratory stimulation
5401389|NCT01715571|viberect|viberect
5401390|NCT01715545|day-3 poor quality embryo|day-3 poor quality embryo
5401391|NCT01715545|vitrification|vitrification
5401392|NCT01715545|clinical outcome|clinical outcome
5401393|NCT01715532|Huachansu|huachansu
5401394|NCT01715532|Na+/K+-ATPase α3|na+/k+-atpase α3
5401395|NCT01715532|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5401396|NCT01715532|randomized controlled trial|randomized controlled trial
5401397|NCT01715519|Vilazodone|vilazodone
5401398|NCT01715519|PTSD|ptsd
5401399|NCT01715519|Depression|depression
5401400|NCT01715506|Dementia|dementia
5401401|NCT01715506|Resident|resident
5002938|NCT03977701|MORPHOLOGY|morphology
5501673|NCT01289340|pain|pain
5401402|NCT01715506|Nursinghome|nursinghome
5401403|NCT01715506|Use of restraint|use of restraint
5401404|NCT01715506|Agitation|agitation
5401405|NCT01715493|COPD|copd
5401406|NCT01715493|Asthma|asthma
5401407|NCT01715493|Lysozyme Hydrochloride|lysozyme hydrochloride
5401408|NCT01715480|broccoli sprout|broccoli sprout
5401409|NCT01715480|sickle cell|sickle cell
5401410|NCT01715480|NRF2|nrf2
5401411|NCT01715467|Dupuytren|dupuytren
5401412|NCT01715467|Contracture|contracture
5401413|NCT01715467|Auxilium|auxilium
5401414|NCT01715467|XIAFLEX|xiaflex
5401415|NCT01715441|Metastatic colorectal cancer patients|metastatic colorectal cancer patients
5401416|NCT01715441|KRAS mutation|kras mutation
5401417|NCT01715441|Sorafenib|sorafenib
5401418|NCT01715428|diabetes, cardiovascular risk|diabetes, cardiovascular risk
5401419|NCT01715415|Hepatitis C|hepatitis c
5401420|NCT01715415|Treatment-Experienced|treatment-experienced
5401421|NCT01715415|Null responder|null responder
5401423|NCT01715415|Chronic Hepatitis|chronic hepatitis
5401424|NCT01715415|Hepatitis C Genotype 1|hepatitis c genotype 1
5401425|NCT01715415|Interferon-Free|interferon-free
5401426|NCT01715415|Hepatitis C Virus|hepatitis c virus
5401428|NCT01715415|Non responder|non responder
5401429|NCT01715415|Viekira Pak|viekira pak
5401430|NCT01715415|ombitasvir|ombitasvir
5401431|NCT01715415|ribavirin|ribavirin
5401432|NCT01715415|ritonavir|ritonavir
5401433|NCT01715415|paritaprevir|paritaprevir
5401434|NCT01715415|dasabuvir|dasabuvir
5401435|NCT01715402|liver tumor|liver tumor
5401436|NCT01715402|carcinoma|carcinoma
5401437|NCT01715402|cholangiocarcinoma|cholangiocarcinoma
5401438|NCT01715402|metastasis|metastasis
5401439|NCT01715389|Asthma|asthma
5401440|NCT01715389|Goals|goals
5401441|NCT01715389|Shared Decision Making|shared decision making
5401442|NCT01715389|Patient Portal|patient portal
5401443|NCT01715389|Electronic Medical Record|electronic medical record
5401444|NCT01715376|traditional chinese medicine|traditional chinese medicine
5401445|NCT01715376|complementary therapies|complementary therapies
5401446|NCT01715376|traditional chinese medicine syndrome scale|traditional chinese medicine syndrome scale
5401447|NCT01715350|Alzheimer's Disease|alzheimer's disease
5401448|NCT01715337|muscle fibre|muscle fibre
5401449|NCT01715337|capillary|capillary
5401450|NCT01715337|rehabilitation|rehabilitation
5401451|NCT01715337|exercise training|exercise training
5401452|NCT01715324|In vitro fertilization|in vitro fertilization
5401453|NCT01715324|Antagonist protocol|antagonist protocol
5401454|NCT01715324|Growth Hormone|growth hormone
5401455|NCT01715311|COPD|copd
5384365|NCT01793168|Behcet's Disease|behcet's disease
5401456|NCT01715311|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5401457|NCT01715311|indacaterol|indacaterol
5401458|NCT01715311|tiotropium|tiotropium
5401459|NCT01715298|Anticholinergic|anticholinergic
5401460|NCT01715298|Antimuscarinic|antimuscarinic
5401461|NCT01715298|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5423359|NCT01615965|micrometastasis|micrometastasis
5401462|NCT01715298|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5401463|NCT01715298|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5401464|NCT01715298|COPD|copd
5401465|NCT01715298|LAMA|lama
5401466|NCT01715298|Lung Disease|lung disease
5401467|NCT01715298|Lung Diseases, Obstructive|lung diseases, obstructive
5401468|NCT01715298|Lung Function|lung function
5401469|NCT01715298|Muscarinic receptor antagonist|muscarinic receptor antagonist
5401470|NCT01715298|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5401471|NCT01715298|Respiratory Tract Diseases|respiratory tract diseases
5401472|NCT01715285|Prostate neoplasms|prostate neoplasms
5401473|NCT01715285|Prostate cancer|prostate cancer
5401474|NCT01715285|Metastatic prostate cancer|metastatic prostate cancer
5401475|NCT01715285|Abiraterone acetate|abiraterone acetate
5401476|NCT01715285|ZYTIGA|zytiga
5401477|NCT01715285|Prednisone|prednisone
5401478|NCT01715285|Androgen deprivation therapy|androgen deprivation therapy
5401479|NCT01715259|Renal insufficiency|renal insufficiency
5401480|NCT01715259|Renal impairment|renal impairment
5401481|NCT01715259|End-stage renal disease|end-stage renal disease
5401482|NCT01715259|Abiraterone acetate|abiraterone acetate
5401483|NCT01715259|Pharmacokinetics|pharmacokinetics
5401484|NCT01715246|healthy babbies|healthy babbies
5401485|NCT01715246|infant formula|infant formula
5401486|NCT01715246|growth|growth
5401488|NCT01715220|Nitroglycerin|nitroglycerin
5401489|NCT01715220|Biliary Colic|biliary colic
5401490|NCT01715220|Cholelithiasis|cholelithiasis
5401491|NCT01715220|Abdominal Pain.|abdominal pain.
5401492|NCT01715194|OSAS|osas
5401493|NCT01715194|CPAP|cpap
5401494|NCT01715194|Adherence|adherence
5401495|NCT01715194|Telemedicine|telemedicine
5401496|NCT01715168|Doxil generic|doxil generic
5401497|NCT01715168|Caelyx generic|caelyx generic
5401498|NCT01715168|generic treatment|generic treatment
5401499|NCT01715168|ovarian cancer|ovarian cancer
5401500|NCT01715168|ovary|ovary
5401501|NCT01715168|progressed|progressed
5401502|NCT01715168|recurred cancer|recurred cancer
5401503|NCT01715168|platinum based therapy|platinum based therapy
5401504|NCT01715155|Metastatic Breast Cancer,|metastatic breast cancer,
5401505|NCT01715155|retrospective study,|retrospective study,
5401506|NCT01715155|disease progression,|disease progression,
5401507|NCT01715155|clinical management|clinical management
5401508|NCT01715142|Pancreatic cancer|pancreatic cancer
5401509|NCT01715142|Nab-paclitaxel|nab-paclitaxel
5401510|NCT01715142|Gemcitabine|gemcitabine
5401511|NCT01715142|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5401512|NCT01715116|Cardiac arrhythmias|cardiac arrhythmias
5401513|NCT01715116|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5401514|NCT01715116|Patient Safety|patient safety
5401515|NCT01715116|Quality of life|quality of life
5401516|NCT01715103|HIV infection|hiv infection
5401517|NCT01715103|mucosa|mucosa
5401518|NCT01715103|immunological parameters|immunological parameters
5401519|NCT01715103|genital sampling|genital sampling
5401521|NCT01715077|melanoma|melanoma
5401522|NCT01715077|stage IV|stage iv
5401523|NCT01715077|stage III|stage iii
5401524|NCT01715077|unresectable|unresectable
5401525|NCT01715064|Prostate Cancer|prostate cancer
5401526|NCT01715064|Exercise|exercise
5401527|NCT01715064|Cortical Inhibition|cortical inhibition
5401528|NCT01715064|Cortical Silent Period|cortical silent period
5401529|NCT01715064|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5401531|NCT01715051|D-serine|d-serine
5401532|NCT01715051|Drug dependence|drug dependence
5401533|NCT01715038|malnutrition|malnutrition
5401534|NCT01715038|stunting|stunting
5401535|NCT01715038|LNS|lns
5401536|NCT01715038|micronutrient powder|micronutrient powder
5401537|NCT01715038|hemoglobin|hemoglobin
5401538|NCT01715025|measured|measured
5401539|NCT01715025|heavy menstrual bleeding|heavy menstrual bleeding
5401540|NCT01715025|combined oral contraceptive|combined oral contraceptive
5401541|NCT01715025|alkaline haematin method|alkaline haematin method
5401542|NCT01715012|Burn|burn
5401543|NCT01715012|Diabetes|diabetes
5401544|NCT01715012|Skin graft|skin graft
5401545|NCT01715012|Donor site|donor site
5401546|NCT01714999|olecranon|olecranon
5401547|NCT01714999|prepatellar|prepatellar
5401548|NCT01714999|bursa|bursa
5401549|NCT01714999|trauma|trauma
5401550|NCT01714999|laceration|laceration
5401551|NCT01714999|bursectomy|bursectomy
5401552|NCT01714999|bursa reconstruction|bursa reconstruction
5401553|NCT01714986|Diabetes mellitus|diabetes mellitus
5401554|NCT01714986|Depression|depression
5401555|NCT01714986|Anxiety|anxiety
5401556|NCT01714986|Alexithymia|alexithymia
5401557|NCT01714986|Self Image|self image
5401558|NCT01714986|HbA1c|hba1c
5401559|NCT01714986|Psychoeducation|psychoeducation
5401560|NCT01714947|Drug Therapy|drug therapy
5401561|NCT01714934|IDIOPATHIC PULMONARY FIBROSIS|idiopathic pulmonary fibrosis
5401562|NCT01714934|MICROASPIRATION|microaspiration
5401563|NCT01714908|NSCLC|nsclc
5401564|NCT01714908|EGFR mutation|egfr mutation
5401565|NCT01714908|unresectable|unresectable
5401566|NCT01714908|erlotinib|erlotinib
5401567|NCT01714908|concurrent radiotherapy|concurrent radiotherapy
5401568|NCT01714895|Interstitial glucose dynamics|interstitial glucose dynamics
5401569|NCT01714895|Accuracy of continuous glucose monitoring under hypoglycemia|accuracy of continuous glucose monitoring under hypoglycemia
5401570|NCT01714895|Glucose clamp|glucose clamp
5401571|NCT01714882|Infertility|infertility
5401572|NCT01714882|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5401573|NCT01714882|Stress Management|stress management
5401574|NCT01714882|Stress Reduction|stress reduction
5401575|NCT01714869|Swedish massage|swedish massage
5401576|NCT01714869|massage|massage
5401577|NCT01714869|osteoarthritis|osteoarthritis
5401578|NCT01714869|knee|knee
5401579|NCT01714843|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5401580|NCT01714843|linaclotide|linaclotide
5401581|NCT01714843|constipation|constipation
5401582|NCT01714843|ASP0456|asp0456
5401583|NCT01714804|Bone Morphogenetic Protein (BMP)|bone morphogenetic protein (bmp)
5401584|NCT01714804|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
5401585|NCT01714804|Fusion rates|fusion rates
5401586|NCT01714804|Interbody fusion|interbody fusion
5401587|NCT01714804|Lumbar spine|lumbar spine
5401588|NCT01714804|Transverse lumbar interbody fusion (TLIF)|transverse lumbar interbody fusion (tlif)
5401589|NCT01714804|Patient reported outcomes|patient reported outcomes
5401590|NCT01714804|Posterolateral lumbar fusion (PLF)|posterolateral lumbar fusion (plf)
5401591|NCT01714791|Coronary Artery Bypass Graft|coronary artery bypass graft
5401592|NCT01714791|Osteopathic Medicine|osteopathic medicine
5401593|NCT01714791|Vital Capacity|vital capacity
5401594|NCT01714791|Quality of Life|quality of life
5401595|NCT01714791|Cardiac rehabilitation|cardiac rehabilitation
5401596|NCT01714765|Metastatic Clear Cell Renal Cancer Dovitinib Everolimus Cohort Maximum administered dose maximum tolerated dose|metastatic clear cell renal cancer dovitinib everolimus cohort maximum administered dose maximum tolerated dose
5401597|NCT01714752|Diagnosis|diagnosis
5685280|NCT00556803|radiofrequency ablation|radiofrequency ablation
5401598|NCT01714752|Left ventricular end diastolic pressure (LVEDP)|left ventricular end diastolic pressure (lvedp)
5401599|NCT01714752|Exercise echocardiography|exercise echocardiography
5401600|NCT01714752|Left atrial remodeling|left atrial remodeling
5401601|NCT01714726|MEDI2070|medi2070
5401602|NCT01714726|inflammatory bowel disease|inflammatory bowel disease
5401603|NCT01714726|moderate to severe Crohn's disease|moderate to severe crohn's disease
5401604|NCT01714713|Schizophrenia|schizophrenia
5401605|NCT01714713|Cognition|cognition
5401606|NCT01714713|Cognition Impairment|cognition impairment
5401607|NCT01714713|Alpha-7 nAChR|alpha-7 nachr
5401608|NCT01714700|protein|protein
5401609|NCT01714700|resistance exercise ghrelin|resistance exercise ghrelin
5401610|NCT01714700|overweight|overweight
5401611|NCT01714674|cardiac troponin T|cardiac troponin t
5401612|NCT01714674|cTnT|ctnt
5401613|NCT01714674|exercise|exercise
5401614|NCT01714674|dietary nitrate|dietary nitrate
5401615|NCT01714661|Schizophrenia|schizophrenia
5401616|NCT01714661|Cognition|cognition
5401619|NCT01714648|OVULATION INDUCTION|ovulation induction
5401620|NCT01714635|cataract|cataract
5401622|NCT01714635|intraocular lens|intraocular lens
5401623|NCT01714622|metabolic syndrome|metabolic syndrome
5401624|NCT01714622|insulin resistance|insulin resistance
5401625|NCT01714622|gastric cancer|gastric cancer
5401626|NCT01714609|portal hypertension|portal hypertension
5401627|NCT01714609|sorafenib|sorafenib
5401628|NCT01714596|Oral Antibiotic|oral antibiotic
5401629|NCT01714596|Intravenous Antibiotic|intravenous antibiotic
5401630|NCT01714596|Wound infection|wound infection
5401631|NCT01714596|Randomized Controlled Trial|randomized controlled trial
5401632|NCT01714583|Mechanical ventilation|mechanical ventilation
5401633|NCT01714583|ARDS|ards
5401634|NCT01714583|acute lung injury|acute lung injury
5401635|NCT01714583|cardiac function|cardiac function
5401636|NCT01714583|cardiac index|cardiac index
5401637|NCT01714583|heart-lung interaction|heart-lung interaction
5401638|NCT01714531|Mild TBI|mild tbi
5401639|NCT01714518|Interstitial Lung Disease|interstitial lung disease
5401640|NCT01714518|Diagnosis|diagnosis
5401641|NCT01714518|Cryobiopsy|cryobiopsy
5401642|NCT01714518|Video-assisted thoracic surgery|video-assisted thoracic surgery
5401643|NCT01714518|Lung biopsy|lung biopsy
5401644|NCT01714505|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5401645|NCT01714505|Continuous Glucose Monitor|continuous glucose monitor
5401646|NCT01714505|Artificial Pancreas|artificial pancreas
5401647|NCT01714505|Insulin Pump|insulin pump
5401648|NCT01714505|Closed Loop control|closed loop control
5401649|NCT01714505|Open Loop treatment|open loop treatment
5401650|NCT01714492|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5401651|NCT01714492|in vivo mechanics|in vivo mechanics
5401652|NCT01714492|kinematics|kinematics
5401653|NCT01714492|fluoroscopy|fluoroscopy
5401654|NCT01714440|genomics of kidney transplantation|genomics of kidney transplantation
5401655|NCT01714440|genetic variation|genetic variation
5401656|NCT01714440|recipient genotypes|recipient genotypes
5401657|NCT01714440|donor genotypes|donor genotypes
5401659|NCT01714414|Fozivudine|fozivudine
5401660|NCT01714414|Zidovudine|zidovudine
5401662|NCT01714388|remifentanil|remifentanil
5401663|NCT01714388|heart rate|heart rate
5401664|NCT01714388|autonomic nervous system|autonomic nervous system
5401665|NCT01714388|heart rate variability|heart rate variability
5401666|NCT01714388|autonomic nervous activity|autonomic nervous activity
5401667|NCT01714388|vagotonic effect|vagotonic effect
5401668|NCT01714388|single dose|single dose
5401669|NCT01714362|oculocardiac effect|oculocardiac effect
5401670|NCT01714362|bradycardia|bradycardia
5401671|NCT01714362|HRV|hrv
5401672|NCT01714349|Spinal cord injury|spinal cord injury
5401673|NCT01714349|nerve transfer|nerve transfer
5401674|NCT01714349|tetraplegia|tetraplegia
5535478|NCT01144910|atopy|atopy
5401675|NCT01714349|quadriplegia|quadriplegia
5401676|NCT01714336|Arbeitsgemeinschaft für Osteosynthesefragen (AO) fracture|arbeitsgemeinschaft für osteosynthesefragen (ao) fracture
5401677|NCT01714336|Orthopaedic Trauma Association (OTA) fracture|orthopaedic trauma association (ota) fracture
5401678|NCT01714323|Cigarette smoking|cigarette smoking
5401679|NCT01714323|Tobacco smoking|tobacco smoking
5401680|NCT01714323|Tobacco use disorder|tobacco use disorder
5401681|NCT01714310|severe mood dysregulation|severe mood dysregulation
5401682|NCT01714310|irritability|irritability
5401683|NCT01714310|lisdexamfetamine|lisdexamfetamine
5401684|NCT01714310|fluoxetine|fluoxetine
5401685|NCT01714310|newly recognized syndrome|newly recognized syndrome
5401686|NCT01714297|cemented total hip arthroplasty|cemented total hip arthroplasty
5401687|NCT01714297|blood loss|blood loss
5401688|NCT01714297|wound discharge|wound discharge
5401689|NCT01714297|thromboprophylaxis|thromboprophylaxis
5401690|NCT01714297|biomarkers|biomarkers
5401691|NCT01714284|psoriasis|psoriasis
5401692|NCT01714258|cardiac output|cardiac output
5401693|NCT01714258|fick method|fick method
5401694|NCT01714258|thermodilution|thermodilution
5401695|NCT01714245|Eczema|eczema
5401696|NCT01714245|Atopic Dermatitis|atopic dermatitis
5401697|NCT01714245|Compromised Skin|compromised skin
5401698|NCT01714245|Inflamed Skin|inflamed skin
5401699|NCT01714219|prostatic neoplasms|prostatic neoplasms
5401700|NCT01714219|prostatectomy|prostatectomy
5401701|NCT01714219|robotics|robotics
5401702|NCT01714219|urinary incontinence|urinary incontinence
5401703|NCT01714206|Healthy|healthy
5401704|NCT01714206|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5401705|NCT01714206|Pharmacokinetics|pharmacokinetics
5401706|NCT01714206|Digoxin (LANOXIN)|digoxin (lanoxin)
5401707|NCT01714193|Healthy|healthy
5401708|NCT01714193|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5401709|NCT01714193|Pharmacokinetics|pharmacokinetics
5401710|NCT01714193|Contraceptives, Oral|contraceptives, oral
5401711|NCT01714193|Ethinyl Estradiol|ethinyl estradiol
5401712|NCT01714193|Levonorgestrel|levonorgestrel
5401713|NCT01714193|LEVORA|levora
5401714|NCT01714180|Acyclovir|acyclovir
5401715|NCT01714180|Pharmacokinetics|pharmacokinetics
5401719|NCT01714180|Distribution|distribution
5401720|NCT01714180|Clearance|clearance
5401721|NCT01714167|Chronic|chronic
5401722|NCT01714167|Ischemic Stroke|ischemic stroke
5401723|NCT01714167|Intracerebral Hemorrhage|intracerebral hemorrhage
5401724|NCT01714167|Bone Marrow Mesenchymal Stem Cell|bone marrow mesenchymal stem cell
5401725|NCT01714141|Technology based intervention|technology based intervention
5401726|NCT01714141|Emerging adults|emerging adults
5401727|NCT01714141|African Americans|african americans
5401728|NCT01714141|Asthma|asthma
5401729|NCT01714141|Controller medications|controller medications
5401730|NCT01714141|Motivational intervention|motivational intervention
5401731|NCT01714128|NCI protocol #8762|nci protocol #8762
5401732|NCT01714128|Estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
5401733|NCT01714128|recurrent breast cancer|recurrent breast cancer
5401734|NCT01714128|stage IV breast cancer|stage iv breast cancer
5401735|NCT01714102|Obesity|obesity
5401736|NCT01714102|Insulin resistance|insulin resistance
5401737|NCT01714102|Metabolic syndrome|metabolic syndrome
5401738|NCT01714102|Pre-diabetes|pre-diabetes
5401739|NCT01714089|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5401740|NCT01714089|RR-MS|rr-ms
5401741|NCT01714063|pediatric|pediatric
5401742|NCT01714063|asthma|asthma
5401743|NCT01714063|metered dose inhaler|metered dose inhaler
5401744|NCT01714063|valved holding chamber|valved holding chamber
5401745|NCT01714063|pMDI|pmdi
5401746|NCT01714063|VHC|vhc
5401747|NCT01714050|seasonal affective disorder|seasonal affective disorder
5401748|NCT01714050|winter depression|winter depression
5401749|NCT01714050|cognitive-behavioral therapy|cognitive-behavioral therapy
5401750|NCT01714050|light therapy|light therapy
5401751|NCT01714037|Safety|safety
5401752|NCT01714037|Efficacy|efficacy
5401753|NCT01714037|HSP90|hsp90
5401754|NCT01714037|Debio 0932|debio 0932
5401755|NCT01714037|Standard of care treatment, NSCLC|standard of care treatment, nsclc
5401756|NCT01714024|Dental|dental
5401757|NCT01714024|Implant|implant
5401758|NCT01714024|UNC Dental School|unc dental school
5401759|NCT01714024|Trabecular Metal|trabecular metal
5401760|NCT01714024|Titanium|titanium
5401761|NCT01714024|Healthy Volunteers|healthy volunteers
5401762|NCT01714024|Diabetic|diabetic
5401763|NCT01714024|Osteopenic|osteopenic
5401764|NCT01714024|Bone Inductive Properties|bone inductive properties
5401765|NCT01714024|Osseous Healing|osseous healing
5401766|NCT01714024|GO Health|go health
5401767|NCT01714024|Offenbacher|offenbacher
5401768|NCT01714024|Zimmer Dental, Inc.|zimmer dental, inc.
5401769|NCT01714011|Randomized|randomized
5401770|NCT01714011|Controlled|controlled
5401771|NCT01714011|Trial|trial
5401772|NCT01714011|Safety|safety
5401773|NCT01714011|Efficacy|efficacy
5401774|NCT01714011|Aripiprazole|aripiprazole
5401775|NCT01714011|Ziprasidone|ziprasidone
5401776|NCT01714011|Metabolic Syndrome|metabolic syndrome
5401777|NCT01713998|Ulthera® System|ulthera® system
5401778|NCT01713998|Ultherapy™ Treatment|ultherapy™ treatment
5401779|NCT01713998|Ulthera, Inc.|ulthera, inc.
5401780|NCT01713998|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5401781|NCT01713985|Ulthera® System|ulthera® system
5401782|NCT01713985|Ultherapy™ Treatment|ultherapy™ treatment
5401783|NCT01713985|Ulthera, Inc.|ulthera, inc.
5401784|NCT01713985|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5401785|NCT01713972|BRAFi|brafi
5401786|NCT01713972|BRAF-mutated|braf-mutated
5401787|NCT01713959|Underarm sweating|underarm sweating
5401788|NCT01713946|TSC seizures|tsc seizures
5401789|NCT01713946|TSC epilepsy|tsc epilepsy
5401790|NCT01713946|mTOR inhibitor|mtor inhibitor
5401791|NCT01713946|RAD001|rad001
5401792|NCT01713946|Everolimus|everolimus
5401793|NCT01713933|Ulthera® System|ulthera® system
5401794|NCT01713933|Ultherapy™ treatment|ultherapy™ treatment
5401795|NCT01713933|Ulthera, Inc.|ulthera, inc.
5401796|NCT01713907|Ultherapy™ treatment|ultherapy™ treatment
5401797|NCT01713907|Ulthera® System|ulthera® system
5401798|NCT01713907|Ulthera, Inc.|ulthera, inc.
5401799|NCT01713907|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5401800|NCT01713894|Counseling|counseling
5401801|NCT01713894|Limits of viability|limits of viability
5401802|NCT01713881|Polyp|polyp
5401803|NCT01713881|colonoscopy|colonoscopy
5401804|NCT01713881|surveillance|surveillance
5401805|NCT01713868|Breastfeeding|breastfeeding
5401806|NCT01713868|Safe Sleep|safe sleep
5401807|NCT01713868|Messaging|messaging
5401808|NCT01713868|Social Media|social media
5401810|NCT01713855|Rituximab|rituximab
5401811|NCT01713855|Vaccine|vaccine
5401812|NCT01713855|Immune Reconstitution|immune reconstitution
5401813|NCT01713842|Tocilizumab|tocilizumab
5401814|NCT01713842|Polymyalgia Rheumatica|polymyalgia rheumatica
5401815|NCT01713842|Glucocorticotherapy|glucocorticotherapy
5401816|NCT01713842|PMR-AS|pmr-as
5401817|NCT01713829|cranberry|cranberry
5401818|NCT01713829|gamma delta T cell|gamma delta t cell
5401819|NCT01713829|improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
5401820|NCT01713829|proliferation|proliferation
5401821|NCT01713816|Glutathione|glutathione
5401822|NCT01713816|Ascorbate|ascorbate
5401823|NCT01713816|Alzheimer's disease|alzheimer's disease
5401824|NCT01713816|Aging|aging
5401825|NCT01713816|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5401826|NCT01713790|physical functional performance|physical functional performance
5401827|NCT01713790|postural balance|postural balance
5401828|NCT01713790|reaction time|reaction time
5401829|NCT01713790|mobility|mobility
5401830|NCT01713790|muscle strength|muscle strength
5401831|NCT01713790|cognition|cognition
5401832|NCT01713777|Seizures|seizures
5401833|NCT01713764|diabetes|diabetes
5401834|NCT01713764|obesity|obesity
5401835|NCT01713764|mindful eating|mindful eating
5401836|NCT01713764|positive affect|positive affect
5401837|NCT01713764|low carbohydrate|low carbohydrate
5401838|NCT01713764|diet|diet
5401839|NCT01713751|Surgical site infection|surgical site infection
5401840|NCT01713751|Cesarean section|cesarean section
5401842|NCT01713738|rituximab|rituximab
5401843|NCT01713738|bleeding score|bleeding score
5401844|NCT01713738|platelet count|platelet count
5401845|NCT01713738|health-related quality of life|health-related quality of life
5401846|NCT01713738|HRQL|hrql
5401847|NCT01713725|Chronic urticaria|chronic urticaria
5401848|NCT01713725|Chronic spontaneous urticaria|chronic spontaneous urticaria
5401849|NCT01713725|Autoimmune and non autoimmune urticaria|autoimmune and non autoimmune urticaria
5401850|NCT01713725|UAS7|uas7
5401851|NCT01713712|Pregnancy|pregnancy
5401852|NCT01713712|Obesity|obesity
5401853|NCT01713712|Nutrition therapy|nutrition therapy
5384758|NCT01791335|Glottis|glottis
5680433|NCT00577798|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5401854|NCT01713699|CTC, cytology, meningeal carcinomatosis, leptomeningeal metastases|ctc, cytology, meningeal carcinomatosis, leptomeningeal metastases
5401855|NCT01713686|Ulthera® System|ulthera® system
5401856|NCT01713686|Ultherapy™ Treatment|ultherapy™ treatment
5401857|NCT01713686|Ulthera, Inc.|ulthera, inc.
5423360|NCT01615952|Supraclavicular Block|supraclavicular block
5401858|NCT01713686|Micro-focused Ultrasound with Visualization (MFU-V)|micro-focused ultrasound with visualization (mfu-v)
5401860|NCT01713673|Axillary sweating|axillary sweating
5401861|NCT01713673|Ulthera® System|ulthera® system
5401862|NCT01713673|Ultherapy™ Treatment|ultherapy™ treatment
5401863|NCT01713673|Ulthera, Inc.|ulthera, inc.
5401864|NCT01713660|Cataract surgery|cataract surgery
5401865|NCT01713660|Femtosecond laser|femtosecond laser
5401866|NCT01713660|Corneal incisions|corneal incisions
5401867|NCT01713647|Bio-equivalence, crossover|bio-equivalence, crossover
5401868|NCT01713634|Bone resorption|bone resorption
5401869|NCT01713634|Diet|diet
5401870|NCT01713621|P. falciparum|p. falciparum
5401871|NCT01713621|malaria|malaria
5401872|NCT01713608|malaria|malaria
5401873|NCT01713608|dose escalation|dose escalation
5401874|NCT01713608|safety|safety
5401875|NCT01713608|tolerability|tolerability
5401876|NCT01713608|maximum tolerated dose|maximum tolerated dose
5401877|NCT01713595|Acute Lung Injury|acute lung injury
5401878|NCT01713595|Mechanical Ventilation|mechanical ventilation
5401879|NCT01713569|Ulthera® System|ulthera® system
5401880|NCT01713569|Ultherapy™ Treatment|ultherapy™ treatment
5401881|NCT01713569|Ulthera, Inc.|ulthera, inc.
5401882|NCT01713569|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5401883|NCT01713556|PTSD, Propranolol|ptsd, propranolol
5401884|NCT01713543|falls|falls
5401885|NCT01713517|Mosquito Control|mosquito control
5401886|NCT01713517|Insecticide Resistance|insecticide resistance
5401887|NCT01713491|brain ischemia|brain ischemia
5401888|NCT01713491|thrombolytic therapy|thrombolytic therapy
5401889|NCT01713491|Impaired cognition|impaired cognition
5401890|NCT01713491|dementia|dementia
5401891|NCT01713478|hepatic cirrhosis|hepatic cirrhosis
5401892|NCT01713478|subclinical myocardial dysfunction|subclinical myocardial dysfunction
5401893|NCT01713478|echocardiography|echocardiography
5401894|NCT01713478|specific biomarkers|specific biomarkers
5401895|NCT01713478|vascular assessment|vascular assessment
5401896|NCT01713465|Diabetes|diabetes
5401897|NCT01713465|Hypertension|hypertension
5401898|NCT01713465|Hypercholesterolemia|hypercholesterolemia
5401899|NCT01713465|Obesity|obesity
5401900|NCT01713452|Surgical Stomas|surgical stomas
5401901|NCT01713452|ileostomy|ileostomy
5401902|NCT01713452|surgical site infection|surgical site infection
5401903|NCT01713439|Relapsed/Refractory Neuroblastoma|relapsed/refractory neuroblastoma
5401904|NCT01713439|Retroviral vector injections|retroviral vector injections
5401905|NCT01713439|Allogeneic neuroblastoma cells|allogeneic neuroblastoma cells
5401906|NCT01713439|Lymphotactin|lymphotactin
5401907|NCT01713439|Interleukin-2 (IL-2)|interleukin-2 (il-2)
5401908|NCT01713426|Post herpetic neuralgia|post herpetic neuralgia
5401909|NCT01713426|Qutenza|qutenza
5401910|NCT01713426|NGX-4010|ngx-4010
5401911|NCT01713426|Peripheral Neuropathic Pain|peripheral neuropathic pain
5401912|NCT01713426|Pregabalin|pregabalin
5401913|NCT01713413|Oxymizer|oxymizer
5401914|NCT01713413|endurance time|endurance time
5401915|NCT01713413|exercise test|exercise test
5401916|NCT01713413|nasal cannula|nasal cannula
5401917|NCT01713413|COPD|copd
5401918|NCT01713413|ILD|ild
5401919|NCT01713413|oxygenation|oxygenation
5401920|NCT01713400|Acute Graft vs. Host Disease (aGVHD)|acute graft vs. host disease (agvhd)
5401921|NCT01713400|Graft vs. Host Disease (GVHD)|graft vs. host disease (gvhd)
5401922|NCT01713387|adjuvant chemotherapy|adjuvant chemotherapy
5401923|NCT01713374|endothelial function|endothelial function
5401924|NCT01713374|sympathetic nervous system|sympathetic nervous system
5401925|NCT01713361|total knee arthroplasty|total knee arthroplasty
5401926|NCT01713361|Prophylaxis|prophylaxis
5401927|NCT01713348|CGM|cgm
5401928|NCT01713348|MDI|mdi
5401929|NCT01713322|parent education|parent education
5401930|NCT01713322|pain management|pain management
5401931|NCT01713322|immunization|immunization
5401932|NCT01713322|infant|infant
5401933|NCT01713309|Filgrastim|filgrastim
5401934|NCT01713309|G-CSF|g-csf
5401935|NCT01713309|Heparin-binding protein|heparin-binding protein
5401936|NCT01713309|critically ill|critically ill
5401937|NCT01713309|acute respiratory failure|acute respiratory failure
5401938|NCT01713296|SCLC|sclc
5401939|NCT01713296|2nd Line|2nd line
5401940|NCT01713296|Relapsed or Refractory|relapsed or refractory
5401941|NCT01713270|Hypertension|hypertension
5401942|NCT01713270|Atrial Fibrillation|atrial fibrillation
5401943|NCT01713270|Arrhythmias, Cardiac|arrhythmias, cardiac
5401944|NCT01713270|Heart Diseases|heart diseases
5384856|NCT01790763|Burn|burn
5401945|NCT01713257|Critically ill patients|critically ill patients
5401946|NCT01713244|Hepatocellular Carcinoma|hepatocellular carcinoma
5401947|NCT01713244|Radiofrequency Ablation|radiofrequency ablation
5401948|NCT01713244|Hepatectomy|hepatectomy
5401949|NCT01713244|Recurrence|recurrence
5401950|NCT01713231|osteogenesis imperfecta|osteogenesis imperfecta
5401951|NCT01713231|high-dose vitamin D|high-dose vitamin d
5401952|NCT01713231|bone density|bone density
5401953|NCT01713231|muscle function|muscle function
5401954|NCT01713218|Pancreas|pancreas
5401956|NCT01713218|Hedgehog inhibitor|hedgehog inhibitor
5401957|NCT01713218|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5401958|NCT01713218|Dynamic imaging|dynamic imaging
5401959|NCT01713205|trauma ; sepsis; Multiple Organ Dysfunction Syndrome; Prediction; risk|trauma ; sepsis; multiple organ dysfunction syndrome; prediction; risk
5401960|NCT01713153|postpartum hemorrhage|postpartum hemorrhage
5401961|NCT01713153|prevention|prevention
5401962|NCT01713153|misoprostol|misoprostol
5401963|NCT01713153|Uniject|uniject
5401964|NCT01713153|oxytocin|oxytocin
5401965|NCT01713140|strength training|strength training
5401966|NCT01713140|resistance training|resistance training
5401967|NCT01713140|fatigue|fatigue
5401968|NCT01713140|knee extension|knee extension
5401969|NCT01713140|total knee arthroplasty|total knee arthroplasty
5401970|NCT01713140|total knee replacement|total knee replacement
5401971|NCT01713140|electromyography|electromyography
5401972|NCT01713140|physical therapy modalities|physical therapy modalities
5401973|NCT01713101|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5401974|NCT01713101|Peptic Ulcer Hemorrhage|peptic ulcer hemorrhage
5401975|NCT01713101|Hematemesis|hematemesis
5401976|NCT01713101|Melena|melena
5401977|NCT01713101|Tranexamic acid|tranexamic acid
5401978|NCT01713088|multisystemic therapy, RCT, young offenders, U.K.|multisystemic therapy, rct, young offenders, u.k.
5401979|NCT01713075|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5401980|NCT01713075|Symbicort|symbicort
5401981|NCT01713075|long-term use|long-term use
5401982|NCT01713049|FLT PET|flt pet
5401983|NCT01713049|breast neoplasms|breast neoplasms
5401984|NCT01713049|mammography|mammography
5401985|NCT01713049|breast ultrasound|breast ultrasound
5401986|NCT01713036|Mass balance, bioavailability, cancer, 14C|mass balance, bioavailability, cancer, 14c
5401987|NCT01713023|type 1 diabetes|type 1 diabetes
5401988|NCT01713023|fructose|fructose
5401989|NCT01713023|glucose|glucose
5401990|NCT01713023|TAS1R2|tas1r2
5401991|NCT01713023|oxidative stress|oxidative stress
5401992|NCT01713010|Keywords provided by Atlantic Health System:|keywords provided by atlantic health system:
5401993|NCT01713010|Rapid Shallow Breathing Index|rapid shallow breathing index
5401994|NCT01713010|Mechanical Ventilation|mechanical ventilation
5401995|NCT01713010|Additional relevant MeSH terms:|additional relevant mesh terms:
5401996|NCT01713010|Respiration Disorders|respiration disorders
5401997|NCT01713010|Traumatic Brain Injury|traumatic brain injury
5401998|NCT01713010|Weaning Failure|weaning failure
5401999|NCT01713010|Mechanical ventilation complication|mechanical ventilation complication
5402000|NCT01712997|Treatment of|treatment of
5402001|NCT01712984|Influenza|influenza
5402002|NCT01712984|Fluzone® Intradermal vaccine|fluzone® intradermal vaccine
5402003|NCT01712984|Influenza Virus Vaccine USP Quadrivalent|influenza virus vaccine usp quadrivalent
5402004|NCT01712984|Influenza Virus Vaccine USP Trivalent Types A and B|influenza virus vaccine usp trivalent types a and b
5402005|NCT01712971|surgery|surgery
5402006|NCT01712971|pancreas|pancreas
5402007|NCT01712971|tumour|tumour
5402008|NCT01712971|blood loss|blood loss
5402009|NCT01712958|CRC miRNA|crc mirna
5402010|NCT01712945|Alemtuzumab|alemtuzumab
5402011|NCT01712945|Palifermin|palifermin
5402012|NCT01712945|Reconstitution|reconstitution
5402013|NCT01712945|Thymus|thymus
5402018|NCT01712893|adjuvant therapy|adjuvant therapy
5402019|NCT01712893|Ovarian suppression|ovarian suppression
5402020|NCT01712854|COPD|copd
5402021|NCT01712854|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5402022|NCT01712854|Long acting beta agonist|long acting beta agonist
5402023|NCT01712841|Dry AMD|dry amd
5402024|NCT01712841|Age-related macular degeneration|age-related macular degeneration
5402025|NCT01712841|Optical coherenece tomography|optical coherenece tomography
5402026|NCT01712841|Imaging|imaging
5402027|NCT01712841|Blood flow|blood flow
5402028|NCT01712828|Lenalidomide,|lenalidomide,
5402029|NCT01712828|Revlimid,|revlimid,
5402030|NCT01712828|pharmacokinetics,|pharmacokinetics,
5402031|NCT01712828|healthy male subjects|healthy male subjects
5402032|NCT01712789|Multiple Myeloma|multiple myeloma
5402033|NCT01712789|Relapsed Multiple Myeloma|relapsed multiple myeloma
5402034|NCT01712789|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5402035|NCT01712789|Pomalidomide|pomalidomide
5402036|NCT01712789|Dexamethasone|dexamethasone
5402037|NCT01712776|Vapocoolant|vapocoolant
5402038|NCT01712763|Endometriosis|endometriosis
5402039|NCT01712763|long acting GnRH antagonist|long acting gnrh antagonist
5402040|NCT01712763|Degarelix|degarelix
5402041|NCT01712763|Recurrence|recurrence
5402042|NCT01712763|Pelvic Pain|pelvic pain
5402043|NCT01712750|Regional tissue oximetry|regional tissue oximetry
5402044|NCT01712750|Cardiopulmonary bypass|cardiopulmonary bypass
5402045|NCT01712750|Cardiac surgical procedures|cardiac surgical procedures
5402046|NCT01712737|raisins, grapes, snacks, appetite, food intake|raisins, grapes, snacks, appetite, food intake
5402047|NCT01712724|exercise therapy|exercise therapy
5402048|NCT01712724|rehabilitation|rehabilitation
5402049|NCT01712711|Steatohepatitis,|steatohepatitis,
5402050|NCT01712711|Helicobacter pylori,|helicobacter pylori,
5402051|NCT01712711|Insulin resistance,|insulin resistance,
5402052|NCT01712711|Alanine aminotransferase,|alanine aminotransferase,
5402053|NCT01712711|Aspartate aminotransferase,|aspartate aminotransferase,
5402059|NCT01712685|Biodistribution of 18F-VM4-037|biodistribution of 18f-vm4-037
5402060|NCT01712685|CAIX Staining|caix staining
5402061|NCT01712685|Tumor Angiogenesis|tumor angiogenesis
5402071|NCT01712646|Oxytocin|oxytocin
5402072|NCT01712646|Childhood Onset Schizophrenia|childhood onset schizophrenia
5402073|NCT01712646|Double Blind|double blind
5402074|NCT01712633|fMRI|fmri
5402075|NCT01712633|Brain Perfusion|brain perfusion
5402076|NCT01712620|Magnetic Resonance Imaging|magnetic resonance imaging
5402077|NCT01712607|laparoscopy|laparoscopy
5402078|NCT01712607|surgery|surgery
5402079|NCT01712607|warm-up|warm-up
5402080|NCT01712607|preoperative|preoperative
5402081|NCT01712607|surgical skills|surgical skills
5402082|NCT01712594|United Kingdom Overnight closed loop|united kingdom overnight closed loop
5402083|NCT01712581|normal myocardial T1, T2 and T2* values|normal myocardial t1, t2 and t2* values
5402084|NCT01712555|Anophthalmic orbits|anophthalmic orbits
5402085|NCT01712555|autologous fat|autologous fat
5402086|NCT01712555|platelet rich plasma|platelet rich plasma
5402087|NCT01712555|orbital atrophy|orbital atrophy
5402088|NCT01712555|anophthalmos|anophthalmos
5402089|NCT01712555|cannula|cannula
5402090|NCT01712529|Systemic lupus erythematosus|systemic lupus erythematosus
5402091|NCT01712529|endothelium|endothelium
5402092|NCT01712529|exercise|exercise
5402093|NCT01712516|COPD, QVA149|copd, qva149
5402094|NCT01712503|Cataract|cataract
5402095|NCT01712503|Astigmatism|astigmatism
5402096|NCT01712503|Toric|toric
5402097|NCT01712503|Phacoemulsification|phacoemulsification
5402098|NCT01712503|Intraocular lens|intraocular lens
5402099|NCT01712490|Hodgkin Lymphoma|hodgkin lymphoma
5402100|NCT01712490|Hodgkins Lymphoma|hodgkins lymphoma
5402101|NCT01712490|Antibody, Monoclonal|antibody, monoclonal
5402102|NCT01712490|Antibody-Drug Conjugate|antibody-drug conjugate
5402103|NCT01712490|Antigens, CD-30|antigens, cd-30
5402104|NCT01712490|Immunotherapy|immunotherapy
5402105|NCT01712490|Lymphoma|lymphoma
5402106|NCT01712490|Lymphoma, Classical|lymphoma, classical
5402107|NCT01712490|ECHELON-1|echelon-1
5402108|NCT01712451|adiposity|adiposity
5402109|NCT01712438|Previously untreated patients|previously untreated patients
5402110|NCT01712425|vaccine|vaccine
5402111|NCT01712425|recently HIV-1 infected individuals|recently hiv-1 infected individuals
5402112|NCT01712373|Multiple sclerosis|multiple sclerosis
5402113|NCT01712373|Ginseng|ginseng
5402114|NCT01712373|Fatigue|fatigue
5402115|NCT01712373|Quality of life|quality of life
5402116|NCT01712360|Tinea Pedis|tinea pedis
5402117|NCT01712360|Tinea Cruris|tinea cruris
5402118|NCT01712360|Athlete foot|athlete foot
5402119|NCT01712360|Jock itch|jock itch
5402120|NCT01712321|Social Anxiety Disorder|social anxiety disorder
5402121|NCT01712321|Social Anxiety|social anxiety
5402122|NCT01712321|Social Phobia|social phobia
5402123|NCT01712321|SAD|sad
5402124|NCT01712295|Warts|warts
5402125|NCT01712295|salicylic acid|salicylic acid
5402126|NCT01712295|ethyl pyruvate|ethyl pyruvate
5402127|NCT01712282|Physical Activity|physical activity
5402128|NCT01712282|Accelerometer|accelerometer
5402132|NCT01712256|HIV|hiv
5402133|NCT01712256|Immunomodulary|immunomodulary
5402134|NCT01712256|Infection|infection
5402135|NCT01712256|Phase II|phase ii
5402136|NCT01712256|Re-boost|re-boost
5402137|NCT01712256|Vaccine|vaccine
5402138|NCT01712256|Vacc-4x|vacc-4x
5402139|NCT01712230|hormone therapy|hormone therapy
5402140|NCT01712230|obesity|obesity
5402141|NCT01712230|menopause|menopause
5402142|NCT01712230|disease /disorder proneness /risk|disease /disorder proneness /risk
5402143|NCT01712230|insulin sensitivity /resistance|insulin sensitivity /resistance
5402144|NCT01712230|metabolic syndrome|metabolic syndrome
5402145|NCT01712230|women's health|women's health
5402146|NCT01712217|Non-small cell lung cancer|non-small cell lung cancer
5402147|NCT01712204|Prophylaxis of Acute Gout Flares|prophylaxis of acute gout flares
5402148|NCT01712204|Urate-Lowering Therapy|urate-lowering therapy
5402149|NCT01712204|Hyperuricemia|hyperuricemia
5402150|NCT01712204|Gouty arthritis|gouty arthritis
5402151|NCT01712191|NUsurface|nusurface
5402152|NCT01712191|Meniscus|meniscus
5402153|NCT01712191|Knee|knee
5402154|NCT01712191|KOOS|koos
5402155|NCT01712178|Pharmacodynamic,Pharmacokinetic|pharmacodynamic,pharmacokinetic
5402156|NCT01712165|Folic acid supplement|folic acid supplement
5402157|NCT01712165|Neural tube defect-affected pregnancy|neural tube defect-affected pregnancy
5402158|NCT01712165|Homocysteine concentration|homocysteine concentration
5402159|NCT01712165|Plasma Folate concentration|plasma folate concentration
5402160|NCT01712165|Plasma vitamin B12 concentration|plasma vitamin b12 concentration
5402161|NCT01712152|Duchenne muscular dystrophy|duchenne muscular dystrophy
5402162|NCT01712152|carrier|carrier
5402163|NCT01712152|cardiac MRI|cardiac mri
5402164|NCT01712152|myocardial fibrosis|myocardial fibrosis
5402165|NCT01712152|female|female
5402166|NCT01712087|spasticity|spasticity
5402167|NCT01712087|muscle spasticity|muscle spasticity
5402168|NCT01712087|muscle rigidity|muscle rigidity
5402169|NCT01712087|motor neuron disease|motor neuron disease
5402170|NCT01712087|hyperreflexia|hyperreflexia
5402171|NCT01712074|Randomized|randomized
5402172|NCT01712074|Double Blind|double blind
5402173|NCT01712074|Safety and Efficacy|safety and efficacy
5402174|NCT01712061|Diabetic nephropathy|diabetic nephropathy
5402175|NCT01712061|type 2 diabetes|type 2 diabetes
5402176|NCT01712061|albuminuria|albuminuria
5402177|NCT01712061|chemokine antagonist|chemokine antagonist
5402178|NCT01712035|Wet AMD|wet amd
5402179|NCT01712035|Age-related macular degeneration|age-related macular degeneration
5402180|NCT01712035|Optical coherenece tomography|optical coherenece tomography
5402181|NCT01712035|Imaging|imaging
5402182|NCT01712035|Blood flow|blood flow
5402183|NCT01712009|Breast cancer|breast cancer
5402184|NCT01712009|Chemotherapy|chemotherapy
5402185|NCT01712009|Neulasta|neulasta
5402186|NCT01712009|Pegfilgrastim|pegfilgrastim
5402187|NCT01712009|Naproxen|naproxen
5402188|NCT01712009|Loratadine|loratadine
5402189|NCT01712009|Non-steroidal antiinflammatory drug (NSAID)|non-steroidal antiinflammatory drug (nsaid)
5402190|NCT01712009|Anti-histamine|anti-histamine
5402191|NCT01712009|Bone Pain|bone pain
5402192|NCT01711996|hydronephrosis|hydronephrosis
5402193|NCT01711996|biopsy|biopsy
5402194|NCT01711996|biomarker|biomarker
5402195|NCT01711957|Complications|complications
5402196|NCT01711957|Mortality|mortality
5402197|NCT01711957|Liver transplantation|liver transplantation
5402198|NCT01711957|Platelet count|platelet count
5402199|NCT01711957|Survival|survival
5402200|NCT01711944|childhood cancer|childhood cancer
5402201|NCT01711944|Internet communication|internet communication
5402202|NCT01711944|parents|parents
5402203|NCT01711944|caregivers|caregivers
5402204|NCT01711944|problem solving|problem solving
5402205|NCT01711931|percutaneous coronary intervention|percutaneous coronary intervention
5402206|NCT01711931|bioresorbable vascular scaffold stents|bioresorbable vascular scaffold stents
5402207|NCT01711931|everolimus|everolimus
5402208|NCT01711931|biolimus|biolimus
5402209|NCT01711918|gastroparesis|gastroparesis
5402210|NCT01711918|domperidone|domperidone
5402211|NCT01711918|nausea|nausea
5402212|NCT01711918|vomiting|vomiting
5402213|NCT01711892|Prostatic Neoplasms|prostatic neoplasms
5402215|NCT01711892|Exercise|exercise
5402216|NCT01711892|Soccer|soccer
5402217|NCT01711892|Androgen Deprivation Therapy|androgen deprivation therapy
5402218|NCT01711892|Body Composition|body composition
5402219|NCT01711892|Cardiovascular fitness|cardiovascular fitness
5402220|NCT01711892|Bone Health|bone health
5402221|NCT01711892|Health Related Quality of Life|health related quality of life
5402222|NCT01711866|Rotigotine|rotigotine
5402223|NCT01711866|Neupro|neupro
5402224|NCT01711866|Switch|switch
5402225|NCT01711866|Dopamine agonists|dopamine agonists
5402226|NCT01711840|Bronchial asthma|bronchial asthma
5397330|NCT01734174|thermodilution|thermodilution
5402227|NCT01711840|Symbicort Turbuhaler|symbicort turbuhaler
5402229|NCT01711827|prednisone|prednisone
5402230|NCT01711827|prednisolone|prednisolone
5402231|NCT01711827|BAL8557|bal8557
5402232|NCT01711827|healthy volunteers|healthy volunteers
5402233|NCT01711814|Rheumatoid Arthritis|rheumatoid arthritis
5402234|NCT01711814|ASP015K|asp015k
5402235|NCT01711788|Hematopoietic stem cells|hematopoietic stem cells
5402236|NCT01711788|Umbilical cord blood transplantation|umbilical cord blood transplantation
5402237|NCT01711788|Intrabone infusion|intrabone infusion
5402238|NCT01711788|Platelet recovery|platelet recovery
5402239|NCT01711788|Neutrophil recovery|neutrophil recovery
5402240|NCT01711788|Pediatric patients|pediatric patients
5402241|NCT01711736|Immunogenicity|immunogenicity
5402242|NCT01711736|Children|children
5402243|NCT01711736|Safety|safety
5402244|NCT01711736|Seasonal influenza|seasonal influenza
5402245|NCT01711736|Fluarix|fluarix
5402246|NCT01711723|darapladib|darapladib
5402247|NCT01711723|Lp-PLA2- inhibitor|lp-pla2- inhibitor
5402248|NCT01711723|healthy volunteer|healthy volunteer
5402249|NCT01711723|renal impairment|renal impairment
5402250|NCT01711723|pharmacokinetics|pharmacokinetics
5402251|NCT01711710|Breast cancer|breast cancer
5402252|NCT01711710|reconstruction|reconstruction
5402253|NCT01711710|augmentation|augmentation
5402254|NCT01711710|cohesive silicone gel|cohesive silicone gel
5402255|NCT01711710|breast implant|breast implant
5402256|NCT01711710|rupture|rupture
5402257|NCT01711710|capsular contracture|capsular contracture
5402258|NCT01711684|Neoplasm Metastasis|neoplasm metastasis
5402259|NCT01711684|Melanoma|melanoma
5402260|NCT01711645|Acellular|acellular
5402261|NCT01711645|Adacel®|adacel®
5402262|NCT01711645|Diptheria toxoids|diptheria toxoids
5402263|NCT01711645|Pertussis|pertussis
5402264|NCT01711645|postpartum|postpartum
5402265|NCT01711645|Tdap|tdap
5402266|NCT01711645|Tetanus|tetanus
5402268|NCT01711632|VEMURAFENIB|vemurafenib
5402269|NCT01711632|BRAF Inhibitor|braf inhibitor
5402270|NCT01711632|12-200|12-200
5402271|NCT01711632|Zelboraf™|zelboraf™
5402272|NCT01711606|Fragile-X Syndrome|fragile-x syndrome
5402273|NCT01711606|registry|registry
5402274|NCT01711606|non-interventional trial|non-interventional trial
5402275|NCT01711606|patient-related outcome study|patient-related outcome study
5402276|NCT01711606|drug utilization|drug utilization
5402277|NCT01711606|effectiveness|effectiveness
5402278|NCT01711606|treatment patterns|treatment patterns
5402279|NCT01711606|patient characteristics under real life conditions|patient characteristics under real life conditions
5402280|NCT01711606|quality of life|quality of life
5402281|NCT01711606|economics|economics
5402282|NCT01711593|Asthma|asthma
5402283|NCT01711593|Allergic|allergic
5402284|NCT01711593|Inflammation|inflammation
5402285|NCT01711593|Airway|airway
5402286|NCT01711593|Challenge|challenge
5402287|NCT01711593|Chemokines|chemokines
5402288|NCT01711593|Tolerization|tolerization
5402289|NCT01711580|Recurrent glioma|recurrent glioma
5402290|NCT01711580|Quality of life|quality of life
5402291|NCT01711580|Glioblastoma multiforme|glioblastoma multiforme
5402292|NCT01711580|Anaplastic glioma|anaplastic glioma
5402293|NCT01711580|Cognition|cognition
5402294|NCT01711580|Re-irradiation|re-irradiation
5402295|NCT01711567|Chronic Hepatitis B|chronic hepatitis b
5402296|NCT01711567|TENOFOVIR|tenofovir
5402297|NCT01711567|ENTECAVIR|entecavir
5402298|NCT01711567|PARTIAL RESPONDER|partial responder
5402299|NCT01711502|metastatic breast cancer,|metastatic breast cancer,
5402300|NCT01711502|epidemiology,|epidemiology,
5402301|NCT01711502|retrospective cohort|retrospective cohort
5402302|NCT01711489|isavuconazole|isavuconazole
5402303|NCT01711489|mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5402304|NCT01711489|BAL8557|bal8557
5402305|NCT01711489|BAL4815|bal4815
5402306|NCT01711489|healthy volunteers|healthy volunteers
5402307|NCT01711489|Mycophenolic acid (MPA)|mycophenolic acid (mpa)
5402308|NCT01711489|Phenolic glucuronide of MPA (MPAG)|phenolic glucuronide of mpa (mpag)
5402309|NCT01711489|CellCept|cellcept
5402310|NCT01711476|PCOS|pcos
5402311|NCT01711476|Bdiet|bdiet
5402312|NCT01711476|Ddiet|ddiet
5402313|NCT01711476|OGTT|ogtt
5402314|NCT01711463|Pharmacodynamics|pharmacodynamics
5402315|NCT01711463|Fluticasone furoate (FF)|fluticasone furoate (ff)
5402316|NCT01711463|novel dry powder device|novel dry powder device
5402317|NCT01711463|Safety and tolerability|safety and tolerability
5402318|NCT01711463|vilanterol(VI)|vilanterol(vi)
5402319|NCT01711463|Healthy Chinese subjects|healthy chinese subjects
5402320|NCT01711463|Pharmacokinetics|pharmacokinetics
5402321|NCT01711437|colonoscopy|colonoscopy
5402322|NCT01711437|colon cleansing|colon cleansing
5402323|NCT01711437|children|children
5402324|NCT01711437|age 2 -18 years|age 2 -18 years
5402325|NCT01711411|HIV prevention|hiv prevention
5402326|NCT01711411|PrePex|prepex
5402327|NCT01711411|voluntary medical male circumcision|voluntary medical male circumcision
5402328|NCT01711411|non-surgical|non-surgical
5402329|NCT01711411|medical device|medical device
5402330|NCT01711411|wound healing|wound healing
5402342|NCT01711320|Metformin|metformin
5402343|NCT01711307|Achilles|achilles
5402344|NCT01711307|Rupture|rupture
5402345|NCT01711294|Pancreatic Cystic Lesions|pancreatic cystic lesions
5402347|NCT01711294|EUS-FNA|eus-fna
5402348|NCT01711281|Heart Failure|heart failure
5402349|NCT01711281|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5402350|NCT01711281|Intracardiac Impedance Measurement|intracardiac impedance measurement
5402351|NCT01711281|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5402352|NCT01711281|Home Monitoring|home monitoring
5402353|NCT01711281|Reverse Remodeling|reverse remodeling
5402354|NCT01711268|Sunitinib|sunitinib
5402355|NCT01711268|Renal Cell Carcinoma|renal cell carcinoma
5402356|NCT01711268|Therapeutic Drug Monitoring|therapeutic drug monitoring
5402357|NCT01711268|Pharmacokinetic|pharmacokinetic
5402358|NCT01711268|Treatment toxicity|treatment toxicity
5402359|NCT01711255|Multiple sclerosis|multiple sclerosis
5402360|NCT01711255|Coagulation|coagulation
5402361|NCT01711255|Alternative Medicine|alternative medicine
5402362|NCT01711255|Clotting|clotting
5402363|NCT01711255|Complementary Medicine|complementary medicine
5402364|NCT01711255|Inflammation|inflammation
5402365|NCT01711242|gastric cancer|gastric cancer
5402366|NCT01711242|radiotherapy|radiotherapy
5402367|NCT01711242|postoperative therapy|postoperative therapy
5402368|NCT01711242|chemotherapy|chemotherapy
5402369|NCT01711229|oral acetaminophen|oral acetaminophen
5402370|NCT01711229|IV acetaminophen|iv acetaminophen
5402372|NCT01711229|equianalgesic|equianalgesic
5402373|NCT01711229|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5402374|NCT01711216|Dydrogesterone|dydrogesterone
5402375|NCT01711216|Irregular Menstrual Cycle|irregular menstrual cycle
5402376|NCT01711216|Progestins|progestins
5402377|NCT01711203|Spondylolysis|spondylolysis
5402378|NCT01711203|Spondylolisthesis|spondylolisthesis
5402380|NCT01711203|Physical Therapy|physical therapy
5402381|NCT01711203|Children|children
5402382|NCT01711190|glaucoma|glaucoma
5402383|NCT01711190|trabeculectomy|trabeculectomy
5402384|NCT01711190|astigmatism|astigmatism
5402385|NCT01711190|intraocular pressure|intraocular pressure
5402386|NCT01711177|primary open angle glaucoma|primary open angle glaucoma
5402387|NCT01711177|retinal oximetry|retinal oximetry
5402388|NCT01711164|HCV|hcv
5402389|NCT01711164|T regulatory cells (Tregs)|t regulatory cells (tregs)
5402390|NCT01711164|FGL2|fgl2
5402391|NCT01711151|ILD|ild
5402392|NCT01711138|Physical Activity|physical activity
5402393|NCT01711138|Physical Fitness|physical fitness
5402394|NCT01711138|Transportation|transportation
5402395|NCT01711138|Environment Design|environment design
5402396|NCT01711138|Child|child
5402397|NCT01711138|Adolescent|adolescent
5402398|NCT01711086|asthma|asthma
5402399|NCT01711086|dry powder inhaler|dry powder inhaler
5402400|NCT01711047|catheter ablation|catheter ablation
5402401|NCT01711047|atrial fibrillation|atrial fibrillation
5402402|NCT01711047|pulmonary vein isolation|pulmonary vein isolation
5402403|NCT01711047|linear ablation|linear ablation
5402404|NCT01711047|CFAE ablation|cfae ablation
5402405|NCT01711034|Solid tumors|solid tumors
5402406|NCT01711021|ADHD|adhd
5402407|NCT01711008|Breakfast size|breakfast size
5402408|NCT01711008|Exercise|exercise
5402409|NCT01711008|Cognitive performance|cognitive performance
5402410|NCT01711008|Mood|mood
5402411|NCT01711008|Appetite|appetite
5402412|NCT01711008|Active women|active women
5402413|NCT01710956|concurrent chemoradiation in patients with limited disease small cell lung cancer|concurrent chemoradiation in patients with limited disease small cell lung cancer
5402414|NCT01710943|Web-based CBT|web-based cbt
5402415|NCT01710943|PTSD|ptsd
5402416|NCT01710943|Alcohol Misuse|alcohol misuse
5402417|NCT01710943|Substance Misuse|substance misuse
5402418|NCT01710943|Integrated Primary Care|integrated primary care
5402419|NCT01710943|OEF/OIF Veterans|oef/oif veterans
5402420|NCT01710930|Allergic Broncho-Pulmonary Aspergillosis|allergic broncho-pulmonary aspergillosis
5402421|NCT01710917|Chronic pain|chronic pain
5402422|NCT01710917|Severe pain|severe pain
5402423|NCT01710917|Oxycodon|oxycodon
5402424|NCT01710917|Naloxon|naloxon
5402427|NCT01710917|Quality of life|quality of life
5402429|NCT01710917|Analgesic rescue medication|analgesic rescue medication
5402430|NCT01710904|Chronic pain|chronic pain
5402431|NCT01710904|Severe pain|severe pain
5002942|NCT03977675|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5402433|NCT01710904|Naloxone|naloxone
5402434|NCT01710904|Opioid-induced constipation|opioid-induced constipation
5402435|NCT01710904|Opioid|opioid
5402436|NCT01710904|Quality of life|quality of life
5402437|NCT01710904|Laxative|laxative
5402438|NCT01710904|Analgesic rescue medication|analgesic rescue medication
5402439|NCT01710891|endotracheal intubation|endotracheal intubation
5402440|NCT01710891|direct laryngoscopy|direct laryngoscopy
5402441|NCT01710891|video laryngoscopy|video laryngoscopy
5402442|NCT01710865|Caries prevention|caries prevention
5402443|NCT01710865|pit and fissure sealants|pit and fissure sealants
5402444|NCT01710852|Atrial Fibrillation|atrial fibrillation
5402445|NCT01710852|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5402446|NCT01710852|AF|af
5402447|NCT01710839|CRVO|crvo
5402448|NCT01710839|BRVO|brvo
5402449|NCT01710839|HRVO|hrvo
5402450|NCT01710839|Macular edema|macular edema
5402451|NCT01710839|vein occlusion|vein occlusion
5402452|NCT01710813|pompe disease|pompe disease
5402453|NCT01710813|alglucosidase alfa|alglucosidase alfa
5402454|NCT01710813|anaphylaxis|anaphylaxis
5402455|NCT01710813|severe cutaneous|severe cutaneous
5402456|NCT01710813|systemic immune complex-mediated reactions|systemic immune complex-mediated reactions
5402457|NCT01710800|impedance|impedance
5402458|NCT01710800|reflux|reflux
5402459|NCT01710800|GERD|gerd
5402460|NCT01710787|operative|operative
5402461|NCT01710787|dental procedure|dental procedure
5402462|NCT01710774|Diabetic Foot|diabetic foot
5402463|NCT01710774|Diabetes Mellitus|diabetes mellitus
5402464|NCT01710774|Foot Ulcer|foot ulcer
5402465|NCT01710774|Wound Healing|wound healing
5402466|NCT01710774|Delivery of Health Care|delivery of health care
5402467|NCT01710774|Depression|depression
5402468|NCT01710774|sequela|sequela
5402469|NCT01710774|Sick Leave|sick leave
5402470|NCT01710774|Quality of Life|quality of life
5402471|NCT01710774|Amputation|amputation
5402472|NCT01710774|Legg ulcer|legg ulcer
5402473|NCT01710761|nitric oxide|nitric oxide
5402474|NCT01710761|cycling performance|cycling performance
5402475|NCT01710761|lactate|lactate
5402476|NCT01710761|VO2|vo2
5402477|NCT01710748|Percutaneous coronary intervention|percutaneous coronary intervention
5402478|NCT01710748|Drug eluting stent|drug eluting stent
5402479|NCT01710748|Neointimal hyperplasia|neointimal hyperplasia
5402480|NCT01710748|Diabetes Mellitus|diabetes mellitus
5402481|NCT01710735|TP|tp
5402482|NCT01710735|Myofascial pain|myofascial pain
5402483|NCT01710709|Aripiprazole, Intramuscular (IM) Depot, Bipolar|aripiprazole, intramuscular (im) depot, bipolar
5402484|NCT01710683|Discectomy|discectomy
5402485|NCT01710683|1st postoperative day|1st postoperative day
5402486|NCT01710683|Intensive exercise training|intensive exercise training
5402487|NCT01710683|Randomized controlled trial|randomized controlled trial
5402488|NCT01710670|Brivaracetam|brivaracetam
5402489|NCT01710670|Ethanol|ethanol
5402490|NCT01710670|Pharmacodynamics|pharmacodynamics
5402491|NCT01710670|Pharmacokinetic|pharmacokinetic
5402492|NCT01710670|Interaction|interaction
5402493|NCT01710657|Lacosamide|lacosamide
5402494|NCT01710657|Epilepsy|epilepsy
5402495|NCT01710657|Partial Onset Seizures|partial onset seizures
5402496|NCT01710631|Sleep|sleep
5402497|NCT01710618|Protein Expression of Sciatic Nerve|protein expression of sciatic nerve
5402498|NCT01710618|traumatized sciatic nerve|traumatized sciatic nerve
5402499|NCT01710605|Circulating tumor cells|circulating tumor cells
5402500|NCT01710605|Breast Cancer|breast cancer
5402501|NCT01710605|Hormone-receptors positive|hormone-receptors positive
5402502|NCT01710579|Primary esophageal achalasia|primary esophageal achalasia
5402503|NCT01710579|endoscopic myotomy|endoscopic myotomy
5402504|NCT01710579|high resolution manometry|high resolution manometry
5402505|NCT01710566|Postpartum hemorrhage|postpartum hemorrhage
5402506|NCT01710566|prevention|prevention
5402507|NCT01710566|oxytocin|oxytocin
5402508|NCT01710566|misoprostol|misoprostol
5402509|NCT01710566|Uniject|uniject
5402510|NCT01710566|community|community
5402511|NCT01710527|Healthy Volunteers|healthy volunteers
5402512|NCT01710488|COPD exacerbation|copd exacerbation
5402513|NCT01710488|fluoroquinolones,|fluoroquinolones,
5402514|NCT01710449|Lung Transplant|lung transplant
5402515|NCT01710423|Obesity|obesity
5402516|NCT01710423|Nutrition|nutrition
5402517|NCT01710423|Home Food Preparation|home food preparation
5402518|NCT01710423|Peer Mentoring|peer mentoring
5402519|NCT01710423|Early Head Start|early head start
5402520|NCT01710423|Cooking|cooking
5402521|NCT01710423|Diet|diet
5402522|NCT01710410|transcranial direct current stimulation|transcranial direct current stimulation
5402523|NCT01710410|nicotine dependence|nicotine dependence
5397619|NCT01732887|memory|memory
5402528|NCT01710410|smoking cessation|smoking cessation
5402530|NCT01710397|Antiretroviral therapy|antiretroviral therapy
5402531|NCT01710397|South Africa|south africa
5402532|NCT01710384|late preterm, betamethasone,|late preterm, betamethasone,
5402533|NCT01710332|Persistent|persistent
5375310|NCT01833845|HCV|hcv
5402534|NCT01710332|Central|central
5402535|NCT01710332|Serous|serous
5402536|NCT01710332|Chorioretinopathy|chorioretinopathy
5402537|NCT01710332|Regeneron|regeneron
5402538|NCT01710332|CSR|csr
5402539|NCT01710332|CSCR|cscr
5402540|NCT01710319|Immunoregulation|immunoregulation
5402541|NCT01710319|Natural Killer Cells|natural killer cells
5402542|NCT01710306|Women|women
5402543|NCT01710306|Veterans|veterans
5402544|NCT01710306|PTSD|ptsd
5402545|NCT01710306|Access to Care|access to care
5402546|NCT01710306|Shared Decision Making|shared decision making
5402547|NCT01710293|Electronic Health Records|electronic health records
5402548|NCT01710293|Diagnostic Delay|diagnostic delay
5402549|NCT01710293|Triggers|triggers
5402550|NCT01710280|Lipemia|lipemia
5402551|NCT01710280|Vascular function|vascular function
5402552|NCT01710280|Blood pressure|blood pressure
5402553|NCT01710254|MRI|mri
5402554|NCT01710254|Atrial Fibrillation|atrial fibrillation
5402555|NCT01710228|MS|ms
5402556|NCT01710228|Natalizumab|natalizumab
5402557|NCT01710228|copaxone|copaxone
5402558|NCT01710215|Colorectal Neoplasms|colorectal neoplasms
5402559|NCT01710215|Colorectal Cancer|colorectal cancer
5402560|NCT01710215|Colon Cancer|colon cancer
5402561|NCT01710215|Mass Screening|mass screening
5402562|NCT01710215|Health Services Research|health services research
5402563|NCT01710215|Comparative Effectiveness Research|comparative effectiveness research
5402564|NCT01710202|Hydrocortisone|hydrocortisone
5402565|NCT01710202|Cortisol|cortisol
5402566|NCT01710202|Testosterone|testosterone
5402567|NCT01710202|Stress|stress
5402568|NCT01710202|Serotonin|serotonin
5402569|NCT01710202|5-HTTLPR|5-httlpr
5402570|NCT01710202|Amygdala|amygdala
5402571|NCT01710202|Depression|depression
5402572|NCT01710189|Tick-Borne Encephalitis Virus|tick-borne encephalitis virus
5402573|NCT01710163|Lithium Carbonate|lithium carbonate
5402574|NCT01710163|Lithium|lithium
5402575|NCT01710163|Central Nervous System Agents|central nervous system agents
5402576|NCT01710163|Therapeutic Uses|therapeutic uses
5402577|NCT01710163|Pharmacologic Actions|pharmacologic actions
5402578|NCT01710163|Enzyme Inhibitors|enzyme inhibitors
5402579|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5402580|NCT01710163|Neurotransmitter Agents|neurotransmitter agents
5402581|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs
5402582|NCT01710163|Antimanic Agents|antimanic agents
5402583|NCT01710163|Tranquilizing Agents|tranquilizing agents
5402584|NCT01710163|Central Nervous System Depressants|central nervous system depressants
5402585|NCT01710163|Psychotropic Drugs|psychotropic drugs
5402586|NCT01710163|Sensory System Agents|sensory system agents
5402587|NCT01710163|Antipsychotic Agents|antipsychotic agents
5402588|NCT01710163|Antidepressive Agents|antidepressive agents
5402589|NCT01710150|typical aflutter (AFLT)|typical aflutter (aflt)
5402590|NCT01710150|CTI ablation|cti ablation
5402591|NCT01710150|Atrial Fibrillation (AF)|atrial fibrillation (af)
5402592|NCT01710150|PVI|pvi
5402593|NCT01710137|Smoking cessation|smoking cessation
5402594|NCT01710137|Nicotine dependence|nicotine dependence
5402595|NCT01710137|Varenicline|varenicline
5402596|NCT01710137|Chantix|chantix
5402597|NCT01710137|HIV|hiv
5402598|NCT01710137|AIDS|aids
5402599|NCT01710124|grocery purchases|grocery purchases
5402600|NCT01710124|financial incentives|financial incentives
5402601|NCT01710124|obesogenic home food environment|obesogenic home food environment
5402602|NCT01710111|Human challenge model|human challenge model
5402603|NCT01710111|Quarantine study|quarantine study
5402604|NCT01710111|Influenza virus|influenza virus
5402605|NCT01710111|Modes of transmission|modes of transmission
5402606|NCT01710111|Droplet spray|droplet spray
5402607|NCT01710111|Droplet nuclei|droplet nuclei
5402608|NCT01710111|Secondary attack rate|secondary attack rate
5402609|NCT01710111|Face shield|face shield
5402610|NCT01710111|Hand hygiene|hand hygiene
5402611|NCT01710111|Fomites|fomites
5402612|NCT01710111|Environmental deposition|environmental deposition
5402613|NCT01710111|Environmental dispersion|environmental dispersion
5402614|NCT01710098|testosterone|testosterone
5402615|NCT01710098|S3-Adherence|s3-adherence
5402616|NCT01710098|Quality of Life|quality of life
5402617|NCT01710085|Diffusion weighted MRI|diffusion weighted mri
5402618|NCT01710085|Curative surgery|curative surgery
5402620|NCT01710072|aneurysm, inflammation, MRI|aneurysm, inflammation, mri
5402621|NCT01710059|Health Status Disparities|health status disparities
5402622|NCT01710059|Minority Health|minority health
5402623|NCT01710059|Pediatrics|pediatrics
5402624|NCT01710059|Behavioral Intervention|behavioral intervention
5403026|NCT01708317|Youth|youth
5402625|NCT01710059|Cellular Phone|cellular phone
5402626|NCT01710059|Peer Group|peer group
5402627|NCT01710046|plaque psoriasis|plaque psoriasis
5402628|NCT01710046|tofacitinib|tofacitinib
5402629|NCT01710046|biopsy|biopsy
5402630|NCT01710046|Janus Kinase|janus kinase
5402631|NCT01710046|randomized placebo controlled clinical trial|randomized placebo controlled clinical trial
5002943|NCT03977675|Ketamine|ketamine
5393450|NCT01751438|M1|m1
5402632|NCT01710046|psoriasis vulgaris|psoriasis vulgaris
5402633|NCT01710033|CP-690,550|cp-690,550
5402634|NCT01710033|kidney transplant|kidney transplant
5402635|NCT01710020|CP-690|cp-690
5402636|NCT01710020|550|550
5402637|NCT01710020|pharmacokinetics|pharmacokinetics
5402638|NCT01710020|end-stage renal disease|end-stage renal disease
5402639|NCT01710007|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5402640|NCT01709994|cardiovascular events|cardiovascular events
5402641|NCT01709994|chronic kidney disease|chronic kidney disease
5402642|NCT01709994|bleedings|bleedings
5402643|NCT01709994|progression|progression
5402644|NCT01709994|antiinflammatory effects|antiinflammatory effects
5402645|NCT01709968|Nocturnal Leg Cramps|nocturnal leg cramps
5402646|NCT01709968|Quality of life|quality of life
5402647|NCT01709968|Quality of sleep|quality of sleep
5402648|NCT01709955|Obesity|obesity
5402649|NCT01709955|Overweight|overweight
5402650|NCT01709955|Glucomannan|glucomannan
5402651|NCT01709942|GnRH antagonist|gnrh antagonist
5402652|NCT01709942|PCOS|pcos
5402653|NCT01709942|OHSS|ohss
5402654|NCT01709942|COH|coh
5402655|NCT01709942|IVF|ivf
5402656|NCT01709916|Glaucoma|glaucoma
5402657|NCT01709916|intra ocular pressure|intra ocular pressure
5402658|NCT01709916|diurnal fluctuations|diurnal fluctuations
5402659|NCT01709903|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5402660|NCT01709877|Multiport laparoscopy|multiport laparoscopy
5402661|NCT01709877|Single Port Laparoscopy|single port laparoscopy
5402662|NCT01709877|Symptomatic Gallstones|symptomatic gallstones
5402663|NCT01709864|Anticholinergic|anticholinergic
5402664|NCT01709864|Antimuscarinic|antimuscarinic
5402665|NCT01709864|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5402666|NCT01709864|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5402667|NCT01709864|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5402668|NCT01709864|COPD|copd
5402669|NCT01709864|LAMA|lama
5402670|NCT01709864|Lung Disease|lung disease
5406162|NCT01694381|M5|m5
5402671|NCT01709864|Lung Diseases, Obstructive|lung diseases, obstructive
5402672|NCT01709864|Lung Function|lung function
5402673|NCT01709864|Muscarinic receptor antagonist|muscarinic receptor antagonist
5402674|NCT01709864|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5402675|NCT01709864|Respiratory Tract Diseases|respiratory tract diseases
5402676|NCT01709851|Type 1 diabetes|type 1 diabetes
5402677|NCT01709851|Intravascular continuous glucose monitoring|intravascular continuous glucose monitoring
5402678|NCT01709851|Subcutaneous continuous glucose monitoring|subcutaneous continuous glucose monitoring
5402679|NCT01709838|Non-transfusion dependent thalassemia|non-transfusion dependent thalassemia
5402680|NCT01709838|NTDT|ntdt
5402681|NCT01709838|deferasirox|deferasirox
5402682|NCT01709838|ICL670|icl670
5402683|NCT01709838|LIC|lic
5402684|NCT01709838|Liver Iron Concentration|liver iron concentration
5402685|NCT01709825|probiotics|probiotics
5402686|NCT01709825|cold|cold
5402687|NCT01709825|flu|flu
5402688|NCT01709825|immune function|immune function
5402689|NCT01709825|microbiota|microbiota
5402690|NCT01709799|Cognitive Training|cognitive training
5402691|NCT01709799|Aging|aging
5402692|NCT01709799|Seniors|seniors
5402693|NCT01709786|Hemorrhage|hemorrhage
5402694|NCT01709786|Hemoglobin|hemoglobin
5402695|NCT01709786|Non-invasive monitoring|non-invasive monitoring
5402696|NCT01709786|Medical device accuracy|medical device accuracy
5402697|NCT01709760|ENIA11|enia11
5402698|NCT01709760|MTX|mtx
5402699|NCT01709760|RA|ra
5402700|NCT01709760|TNF|tnf
5402701|NCT01709747|Hydromorphone Hydrochloride|hydromorphone hydrochloride
5402702|NCT01709747|Hydromorphone|hydromorphone
5402703|NCT01709747|Pain|pain
5402704|NCT01709747|Chronic Pain|chronic pain
5402705|NCT01709747|Implantable Pump|implantable pump
5402706|NCT01709747|Pump|pump
5402707|NCT01709747|Intrathecal|intrathecal
5402708|NCT01709734|prostate cancer CRPC|prostate cancer crpc
5402709|NCT01709721|Hydromorphone|hydromorphone
5402710|NCT01709721|Hydromorphone Hydrochloride|hydromorphone hydrochloride
5402711|NCT01709721|Pain Management|pain management
5402712|NCT01709721|Non-narcotic analgesics|non-narcotic analgesics
5402713|NCT01709708|Migraine|migraine
5402714|NCT01709708|Headache|headache
5402715|NCT01709708|Chronic Migraine|chronic migraine
5402716|NCT01709708|Marcaine|marcaine
5402717|NCT01709708|Tx360|tx360
5402718|NCT01709695|Intuniv|intuniv
5402719|NCT01709695|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5402721|NCT01709682|atrial fibrillation|atrial fibrillation
5402722|NCT01709682|arrhythmias|arrhythmias
5402723|NCT01709682|anti-arrhythmic agents|anti-arrhythmic agents
5402724|NCT01709669|acute coronary syndrome|acute coronary syndrome
5402725|NCT01709669|gratitude|gratitude
5402726|NCT01709669|health behavior|health behavior
5402727|NCT01709669|myocardial infarction|myocardial infarction
5402728|NCT01709669|unstable angina|unstable angina
5402729|NCT01709617|carbohydrate, glycogen, glucose|carbohydrate, glycogen, glucose
5503281|NCT01281995|HV|hv
5402730|NCT01709604|acute paraquat poisoning|acute paraquat poisoning
5402731|NCT01709604|hemoperfusion|hemoperfusion
5402732|NCT01709604|continuous blood purification|continuous blood purification
5402733|NCT01709591|intrapartum pain management, epidural|intrapartum pain management, epidural
5402734|NCT01709565|Sepsis|sepsis
5402735|NCT01709565|Lactic acid|lactic acid
5402736|NCT01709565|Shock|shock
5402737|NCT01709565|Resuscitation|resuscitation
5402738|NCT01709539|Cancer diagnosis center|cancer diagnosis center
5402739|NCT01709539|Time to diagnosis|time to diagnosis
5402740|NCT01709539|Survival|survival
5402741|NCT01709539|Health economics|health economics
5402742|NCT01709539|Biomarkers|biomarkers
5402743|NCT01709526|Psychosocial functioning|psychosocial functioning
5402744|NCT01709526|Cognitive performance of inpatients|cognitive performance of inpatients
5402745|NCT01709526|Psychiatric diseases|psychiatric diseases
5402746|NCT01709487|HIPEC|hipec
5402747|NCT01709487|ovarian carcinoma|ovarian carcinoma
5402748|NCT01709487|Bordet|bordet
5402749|NCT01709474|SLE|sle
5402750|NCT01709474|Vitamin D3|vitamin d3
5402751|NCT01709474|Vitamin D deficiency|vitamin d deficiency
5402752|NCT01709474|IFN alpha expression|ifn alpha expression
5402753|NCT01709448|Neoplasms, Squamous Cell|neoplasms, squamous cell
5402754|NCT01709448|Papillomavirus Infections|papillomavirus infections
5402755|NCT01709448|HIV|hiv
5402756|NCT01709422|Propofol|propofol
5402757|NCT01709422|Midazolam|midazolam
5402758|NCT01709422|Meperidine|meperidine
5402759|NCT01709409|Prematurity|prematurity
5402760|NCT01709383|Aphasia|aphasia
5402761|NCT01709383|Stroke|stroke
5402762|NCT01709383|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5402763|NCT01709383|Neuroplasticity|neuroplasticity
5402764|NCT01709357|manual therapy|manual therapy
5402766|NCT01709357|range of motion|range of motion
5402767|NCT01709357|pain threshold|pain threshold
5402768|NCT01709357|pain perception|pain perception
5402769|NCT01709292|Thyroid Cancer|thyroid cancer
5402770|NCT01709292|ERK|erk
5402771|NCT01709292|Extracellular-signal-regulated kinase|extracellular-signal-regulated kinase
5402785|NCT01709240|Plasma|plasma
5402786|NCT01709240|Incision Closure|incision closure
5402787|NCT01709227|Acute kidney injury|acute kidney injury
5402788|NCT01709227|AKI|aki
5402789|NCT01709227|cardiopulmonary bypass|cardiopulmonary bypass
5402790|NCT01709214|Osteoarthritis|osteoarthritis
5402791|NCT01709214|Knee|knee
5402792|NCT01709214|Pain|pain
5402793|NCT01709214|Chronic|chronic
5402794|NCT01709214|OA|oa
5402795|NCT01709214|Arthritis|arthritis
5402796|NCT01709201|Alcohol abuse|alcohol abuse
5402797|NCT01709201|Drug abuse|drug abuse
5402798|NCT01709201|Diabetes Mellitus|diabetes mellitus
5402799|NCT01709201|Persistent Asthma|persistent asthma
5402800|NCT01709201|Juvenile Arthritis|juvenile arthritis
5402801|NCT01709201|Ulcerative Colitis|ulcerative colitis
5402802|NCT01709188|Musical Dual Task Training|musical dual task training
5402803|NCT01709188|dementia|dementia
5402804|NCT01709188|attention control|attention control
5402805|NCT01709188|dual task cost|dual task cost
5402806|NCT01709188|gait stability|gait stability
5402807|NCT01709175|Cancer|cancer
5402808|NCT01709175|Breast Cancer|breast cancer
5402809|NCT01709175|Gynecologic Cancer|gynecologic cancer
5402810|NCT01709175|Strength Training|strength training
5402811|NCT01709175|Exercise|exercise
5402812|NCT01709175|Physical Activity|physical activity
5402813|NCT01709175|Fatigue|fatigue
5402814|NCT01709175|Quality of Life|quality of life
5402815|NCT01709175|Strength|strength
5402816|NCT01709175|Fitness|fitness
5402817|NCT01709175|Cancer Survivor|cancer survivor
5402818|NCT01709175|Survivor|survivor
5402819|NCT01709123|Diabetes Mellitus, Juvenile Onset|diabetes mellitus, juvenile onset
5402820|NCT01709123|Cardiovascular Diseases|cardiovascular diseases
5402821|NCT01709123|Hyperglycemia|hyperglycemia
5402822|NCT01709123|Hyperketonemia|hyperketonemia
5402823|NCT01709110|Bone Loss|bone loss
5402824|NCT01709110|Vertebral fractures|vertebral fractures
5402825|NCT01709097|Adherence|adherence
5402826|NCT01709097|Compliance|compliance
5402827|NCT01709097|Kidney Transplant Recipient|kidney transplant recipient
5402828|NCT01709097|An electronic drug dispenser|an electronic drug dispenser
5402829|NCT01709097|The Portal|the portal
5403027|NCT01708317|Adolescents|adolescents
5402830|NCT01709084|Human immunodeficiency virus-type 1 infection|human immunodeficiency virus-type 1 infection
5402831|NCT01709084|HIV-1|hiv-1
5402832|NCT01709084|Infectious diseases|infectious diseases
5402833|NCT01709084|Ribonucleic acid|ribonucleic acid
5402835|NCT01709084|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5402836|NCT01709084|Emtricitabine|emtricitabine
5402837|NCT01709084|Rilpivirine|rilpivirine
5402838|NCT01709084|Efavirenz|efavirenz
5402839|NCT01709084|Edurant|edurant
5402840|NCT01709084|TMC278|tmc278
5402841|NCT01709084|R278474|r278474
5402842|NCT01709084|Fixed dose combination|fixed dose combination
5402843|NCT01709071|Vaccination|vaccination
5402844|NCT01709071|Inactivated poliomyelitis vaccine|inactivated poliomyelitis vaccine
5402845|NCT01709071|poliomyelitis|poliomyelitis
5402846|NCT01709071|Sabin strains|sabin strains
5402847|NCT01709058|Back Pain|back pain
5402848|NCT01709058|Therapeutics|therapeutics
5402849|NCT01709058|Aged|aged
5402850|NCT01709058|Injections, Intramuscular|injections, intramuscular
5402851|NCT01709058|Oxygen|oxygen
5402852|NCT01709058|Ozone|ozone
5402853|NCT01709058|Geriatric Assessment|geriatric assessment
5402854|NCT01709058|Trace Elements|trace elements
5402855|NCT01709058|Oxidative stress|oxidative stress
5402856|NCT01709045|Endarterectomy, Carotid|endarterectomy, carotid
5402857|NCT01709045|Carotid Arteries|carotid arteries
5402858|NCT01709032|Thalassemia|thalassemia
5402859|NCT01709032|Chelation|chelation
5402860|NCT01709032|Transfusion|transfusion
5402861|NCT01709032|Safety|safety
5406329|NCT01693718|advanced|advanced
5402866|NCT01708980|Physical Therapy Modalities|physical therapy modalities
5402867|NCT01708967|transnasal endoscopy|transnasal endoscopy
5402868|NCT01708967|pretreatment method|pretreatment method
5402869|NCT01708928|Ulthera® System|ulthera® system
5402870|NCT01708928|Ultherapy™ Treatment|ultherapy™ treatment
5402871|NCT01708928|Ulthera, Inc.|ulthera, inc.
5402872|NCT01708928|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5402873|NCT01708876|uncomplicated|uncomplicated
5402875|NCT01708876|knowlesi|knowlesi
5402876|NCT01708876|malaria|malaria
5402877|NCT01708876|infection|infection
5402878|NCT01708863|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5402879|NCT01708863|Stage II palliative surgery|stage ii palliative surgery
5402880|NCT01708863|Glenn procedure|glenn procedure
5402881|NCT01708863|Congenital heart defect|congenital heart defect
5402882|NCT01708863|Congenital heart disease|congenital heart disease
5388290|NCT01775124|AMD|amd
5402883|NCT01708863|Underdeveloped left ventricle|underdeveloped left ventricle
5402884|NCT01708837|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5402885|NCT01708837|Bispectral index|bispectral index
5402886|NCT01708824|colorectal cancer|colorectal cancer
5402887|NCT01708824|cancer survivor|cancer survivor
5402888|NCT01708824|western pattern diet|western pattern diet
5402889|NCT01708824|physical activity|physical activity
5402890|NCT01708824|behavioral intervention|behavioral intervention
5402891|NCT01708824|acceptability|acceptability
5402892|NCT01708824|feasibility|feasibility
5402893|NCT01708824|randomized controlled trial|randomized controlled trial
5402894|NCT01708824|compliance|compliance
5402895|NCT01708811|Contractility|contractility
5402897|NCT01708811|myometrium|myometrium
5402898|NCT01708811|hyponatraemia|hyponatraemia
5402899|NCT01708798|Diastolic heart failure|diastolic heart failure
5402900|NCT01708785|obesity|obesity
5402901|NCT01708785|overweight|overweight
5402902|NCT01708785|overweight children|overweight children
5402903|NCT01708785|overweight parents|overweight parents
5402904|NCT01708785|overeating|overeating
5402905|NCT01708785|eating in the absence of hunger|eating in the absence of hunger
5385760|NCT01786525|LDKT|ldkt
5402906|NCT01708785|families with overweight child|families with overweight child
5402907|NCT01708785|body mass index|body mass index
5402908|NCT01708785|BMI|bmi
5402909|NCT01708785|weight|weight
5402910|NCT01708785|childhood obesity|childhood obesity
5402911|NCT01708785|treatment|treatment
5402912|NCT01708785|cue exposure treatment|cue exposure treatment
5402913|NCT01708785|cravings|cravings
5402914|NCT01708785|habituation to food cues|habituation to food cues
5402915|NCT01708785|psychophysiological response to food cues|psychophysiological response to food cues
5402916|NCT01708785|intervention|intervention
5402917|NCT01708785|experiments|experiments
5402918|NCT01708785|family based treatment|family based treatment
5402919|NCT01708785|behavioral treatment|behavioral treatment
5402920|NCT01708772|TNF alpha|tnf alpha
5402921|NCT01708772|SOFA score|sofa score
5402922|NCT01708759|Serum Il-8|serum il-8
5402923|NCT01708759|IL8 polymorphism|il8 polymorphism
5402924|NCT01708759|critically ill patients|critically ill patients
5402925|NCT01708733|HCV carrier|hcv carrier
5402926|NCT01708733|Chinese herbal medicine|chinese herbal medicine
5402927|NCT01708733|Liver function|liver function
5402928|NCT01708733|HCV RNA titer|hcv rna titer
5402929|NCT01708720|Vaccination|vaccination
5402930|NCT01708720|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5402931|NCT01708720|Polio|polio
5402932|NCT01708720|Sabin|sabin
5402933|NCT01708681|Seafood|seafood
5402934|NCT01708681|Meat|meat
5402935|NCT01708681|Egg|egg
5402936|NCT01708681|Milk|milk
5402937|NCT01708681|Postprandial lipid metabolism|postprandial lipid metabolism
5402938|NCT01708681|Postprandial glucose metabolism|postprandial glucose metabolism
5402939|NCT01708681|Triglycerides|triglycerides
5402940|NCT01708681|Cholesterol|cholesterol
5402941|NCT01708681|Postprandial incretins|postprandial incretins
5402942|NCT01708681|Postprandial hormones|postprandial hormones
5402943|NCT01708668|Fever|fever
5402944|NCT01708668|Patient controlled epidural analgesia|patient controlled epidural analgesia
5402945|NCT01708668|Labor analgesia|labor analgesia
5402946|NCT01708668|Epidural analgesia|epidural analgesia
5402947|NCT01708668|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
5002948|NCT03977636|Diagnosis-related groups|diagnosis-related groups
5402948|NCT01708655|Cystic Fibrosis|cystic fibrosis
5402949|NCT01708655|Sweat Evaporimeter|sweat evaporimeter
5402950|NCT01708629|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
5402951|NCT01708603|psoriasis, brodalumab, AMG 827|psoriasis, brodalumab, amg 827
5402952|NCT01708590|psoriasis, brodalumab (AMG 827)|psoriasis, brodalumab (amg 827)
5402953|NCT01708577|heart rate|heart rate
5402954|NCT01708577|sweating|sweating
5402956|NCT01708577|acceleration of body movement|acceleration of body movement
5402957|NCT01708577|heart activity.|heart activity.
5402958|NCT01708551|Hyperhidrosis|hyperhidrosis
5402959|NCT01708551|Axillary sweating|axillary sweating
5402960|NCT01708551|Ulthera® System|ulthera® system
5402961|NCT01708551|Ultherapy™ Treatment|ultherapy™ treatment
5402962|NCT01708551|Ulthera, Inc.|ulthera, inc.
5402963|NCT01708538|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia|keratoconus, corneal collagen crosslinking, riboflavin, corneal ectasia
5402964|NCT01708525|Ulthera® System|ulthera® system
5402965|NCT01708525|Ultherapy® Treatment|ultherapy® treatment
5402966|NCT01708525|Ulthera, Inc.|ulthera, inc.
5402967|NCT01708525|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5402968|NCT01708512|Ulthera® System|ulthera® system
5402969|NCT01708512|Ultherapy™ Treatment|ultherapy™ treatment
5402970|NCT01708512|Ulthera, Inc.|ulthera, inc.
5402971|NCT01708512|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5402972|NCT01708499|Ulthera® System|ulthera® system
5402973|NCT01708499|Ultherapy™ Treatment|ultherapy™ treatment
5402974|NCT01708499|Ulthera, Inc.|ulthera, inc.
5402975|NCT01708499|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5402976|NCT01708486|asthma|asthma
5402977|NCT01708486|Dry Powder Inhalers|dry powder inhalers
5402978|NCT01708486|FSI-10 questionnaire|fsi-10 questionnaire
5402979|NCT01708460|Ulthera® System|ulthera® system
5402980|NCT01708460|Ultherapy™ Treatment|ultherapy™ treatment
5402981|NCT01708460|Ulthera, Inc.|ulthera, inc.
5402982|NCT01708460|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5402983|NCT01708434|Skin laxity|skin laxity
5402984|NCT01708434|Knees|knees
5402985|NCT01708408|biorepository|biorepository
5402986|NCT01708408|biobank|biobank
5402987|NCT01708408|registry|registry
5402988|NCT01708408|community|community
5402989|NCT01708408|biospecimens|biospecimens
5402990|NCT01708408|volunteers|volunteers
5402991|NCT01708408|chronic disease|chronic disease
5402992|NCT01708408|longitudinal|longitudinal
5402993|NCT01708408|blood|blood
5402994|NCT01708408|electronic health records|electronic health records
5402995|NCT01708408|follow-up|follow-up
5402996|NCT01708395|Ulcerative colitis|ulcerative colitis
5402997|NCT01708382|Ulthera® System|ulthera® system
5402998|NCT01708382|Ultherapy™ Treatment|ultherapy™ treatment
5402999|NCT01708382|Ulthera, Inc.|ulthera, inc.
5403000|NCT01708382|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5403001|NCT01708369|human carboxylesterase-1|human carboxylesterase-1
5403002|NCT01708369|human carboxylesterase-2|human carboxylesterase-2
5403003|NCT01708369|alcohol|alcohol
5403004|NCT01708369|pharmacokinetics|pharmacokinetics
5403005|NCT01708356|Air Pollution|air pollution
5403006|NCT01708356|Particulate Matter|particulate matter
5403007|NCT01708356|Exercise|exercise
5403008|NCT01708356|Respiratory Rate|respiratory rate
5403009|NCT01708356|Inflammation|inflammation
5403010|NCT01708356|Oxidative Stress|oxidative stress
5403011|NCT01708356|Plethysmography|plethysmography
5403012|NCT01708343|Myofascial Pain Syndrome,|myofascial pain syndrome,
5403013|NCT01708343|intramuscular stimulation,|intramuscular stimulation,
5403014|NCT01708343|acupuncture,|acupuncture,
5403015|NCT01708343|sleep quality,|sleep quality,
5403016|NCT01708343|pain threshold.|pain threshold.
5403017|NCT01708330|manual vacuum aspiration|manual vacuum aspiration
5403018|NCT01708330|missed abortion|missed abortion
5403019|NCT01708330|incomplete abortion|incomplete abortion
5403020|NCT01708330|nonviable pregnancy|nonviable pregnancy
5403021|NCT01708330|topical lidocaine|topical lidocaine
5403022|NCT01708317|ACASI|acasi
5403023|NCT01708317|Gonorrhea|gonorrhea
5403024|NCT01708317|Chlamydia|chlamydia
5403025|NCT01708317|Emergency Department|emergency department
5403028|NCT01708317|Computer|computer
5403029|NCT01708317|Questionnaire|questionnaire
5403030|NCT01708304|Dementia|dementia
5403031|NCT01708304|Alzheimer's Disease|alzheimer's disease
5403032|NCT01708304|Exercise|exercise
5403033|NCT01708304|Caregiver|caregiver
5403034|NCT01708304|Behavior modification|behavior modification
5403035|NCT01708291|youth|youth
5403036|NCT01708291|Stress|stress
5403038|NCT01708291|foster care|foster care
5403039|NCT01708291|stress reduction|stress reduction
5403040|NCT01708291|high risk teens|high risk teens
5403041|NCT01708278|COPD|copd
5403042|NCT01708278|Emphysema|emphysema
5403043|NCT01708278|chronic bronchitis|chronic bronchitis
5403044|NCT01708278|Quercetin|quercetin
5403045|NCT01708278|flavonoids|flavonoids
5403046|NCT01708265|Mitral Valve Insufficiency|mitral valve insufficiency
5403047|NCT01708265|Mitral Valve Regurgitation|mitral valve regurgitation
5403048|NCT01708265|Asymptomatic Mitral Valve Regurgitation|asymptomatic mitral valve regurgitation
5403049|NCT01708265|Asymptomatic Mitral Valve Insufficiency|asymptomatic mitral valve insufficiency
5403050|NCT01708265|Mitral Valve Repair|mitral valve repair
5403051|NCT01708265|Watchful Waiting|watchful waiting
5403052|NCT01708252|Ulthera® System|ulthera® system
5403053|NCT01708252|Ultherapy™ Treatment|ultherapy™ treatment
5403054|NCT01708252|Ulthera, Inc.|ulthera, inc.
5403055|NCT01708252|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5403057|NCT01708239|Deep vein thrombosis|deep vein thrombosis
5403058|NCT01708239|Clinical probability|clinical probability
5403059|NCT01708239|D-Dimer|d-dimer
5403060|NCT01708239|Compression ultrasonography|compression ultrasonography
5403062|NCT01708226|obsessive compulsive disorder|obsessive compulsive disorder
5403063|NCT01708226|children|children
5403064|NCT01708213|soft tissue|soft tissue
5403065|NCT01708213|augmentation|augmentation
5403066|NCT01708213|correction|correction
5403067|NCT01708213|wrinkles|wrinkles
5403068|NCT01708200|Memory|memory
5403069|NCT01708200|Intervention|intervention
5403070|NCT01708200|Computerized|computerized
5403071|NCT01708200|Psychoeducational|psychoeducational
5403072|NCT01708200|Mental Illness|mental illness
5403073|NCT01708187|Peroneal tendon|peroneal tendon
5403074|NCT01708174|medulloblastoma,|medulloblastoma,
5403075|NCT01708174|relapsed,|relapsed,
5403076|NCT01708174|pediatric,|pediatric,
5403077|NCT01708174|children,|children,
5403078|NCT01708174|adults,|adults,
5403079|NCT01708174|Hh pathway inhibitor,|hh pathway inhibitor,
5403080|NCT01708174|LDE225|lde225
5403081|NCT01708161|PIK3CA mutation|pik3ca mutation
5403082|NCT01708161|advanced solid tumor|advanced solid tumor
5403083|NCT01708161|breast cancer|breast cancer
5403084|NCT01708161|ovarian cancer|ovarian cancer
5403085|NCT01708161|cancers with a mass|cancers with a mass
5403086|NCT01708161|bulky tumor|bulky tumor
5403087|NCT01708161|nodule|nodule
5403088|NCT01708161|lump|lump
5403089|NCT01708161|advanced cancer|advanced cancer
5403090|NCT01708161|advanced solid malignancies|advanced solid malignancies
5403091|NCT01708122|Intranasal fentanyl|intranasal fentanyl
5403092|NCT01708122|Cystoscopy|cystoscopy
5403093|NCT01708070|asthma|asthma
5403094|NCT01708070|depression|depression
5403095|NCT01708070|anxiety|anxiety
5403096|NCT01708057|COPD|copd
5403097|NCT01708057|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5403098|NCT01708044|Pramlintide,|pramlintide,
5403099|NCT01708044|insulin,|insulin,
5403100|NCT01708044|type 1 diabetes,|type 1 diabetes,
5403101|NCT01708044|reduction in postprandial glucose,|reduction in postprandial glucose,
5403102|NCT01708044|pramlintide:insulin dose-ratio|pramlintide:insulin dose-ratio
5403103|NCT01708018|Pregnancy|pregnancy
5403104|NCT01708018|Stress, Psychological|stress, psychological
5403105|NCT01708018|Low Back Pain|low back pain
5403106|NCT01708018|Breech Presentation|breech presentation
5403107|NCT01708018|Relaxation|relaxation
5403108|NCT01708018|Hydrotherapy|hydrotherapy
5403109|NCT01708018|Acupressure|acupressure
5403110|NCT01708018|WATSU|watsu
5403111|NCT01708005|Mild Cognitive Impairment|mild cognitive impairment
5403112|NCT01708005|Vitamin D|vitamin d
5403113|NCT01708005|Cholecalciferol|cholecalciferol
5403114|NCT01708005|Lecitone®Se-Vitamin D3|lecitone®se-vitamin d3
5403115|NCT01707979|Near infrared light|near infrared light
5403116|NCT01707979|Diabetic neuropathy|diabetic neuropathy
5403117|NCT01707979|Sensory neuropathy|sensory neuropathy
5403118|NCT01707979|Autonomic neuropathy|autonomic neuropathy
5403119|NCT01707979|Vagus|vagus
5403120|NCT01707979|Sudomotor function|sudomotor function
5403121|NCT01707979|Monofilament|monofilament
5403122|NCT01707979|Impedance|impedance
5403123|NCT01707966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5403124|NCT01707966|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5403125|NCT01707966|maintenance therapy|maintenance therapy
5403126|NCT01707966|orteronel|orteronel
5403127|NCT01707966|TAK-700|tak-700
5403129|NCT01707914|oxidative stress|oxidative stress
5403130|NCT01707914|dyslipidemia|dyslipidemia
5403131|NCT01707914|inflammation|inflammation
5403132|NCT01707901|GERD|gerd
5403133|NCT01707862|Intravenous leiomyomatosis|intravenous leiomyomatosis
5403134|NCT01707862|Surgery|surgery
5403135|NCT01707862|Smooth muscle tumor|smooth muscle tumor
5403136|NCT01707849|Hepatitis C|hepatitis c
5403137|NCT01707849|Liver Fibrosis|liver fibrosis
5403138|NCT01707849|m-TOR inhibitors|m-tor inhibitors
5403139|NCT01707810|Liver transplatation|liver transplatation
5403140|NCT01707797|dental caries|dental caries
5403141|NCT01707797|high risk|high risk
5403142|NCT01707797|dental cavities|dental cavities
5403143|NCT01707797|children dental care|children dental care
5403144|NCT01707784|Pregnancy|pregnancy
5403146|NCT01707784|Anxiety|anxiety
5403147|NCT01707784|Cortisol|cortisol
5403148|NCT01707784|Copeptin|copeptin
5403149|NCT01707784|Gestational diabetes|gestational diabetes
5403150|NCT01707758|pancreatic cancer|pancreatic cancer
5403151|NCT01707758|nanoparticle|nanoparticle
5403152|NCT01707758|proteases|proteases
5403153|NCT01707758|cell survival|cell survival
5403154|NCT01707758|tumor progression|tumor progression
5406633|NCT01692483|Taxane|taxane
5403159|NCT01707732|Enoxaparin|enoxaparin
5403160|NCT01707719|Alzheimer's disease|alzheimer's disease
5403161|NCT01707719|Oxidative stress|oxidative stress
5403162|NCT01707719|HPA axis|hpa axis
5403163|NCT01707706|Insomnia|insomnia
5403164|NCT01707706|Depression|depression
5403165|NCT01707706|Electroacupuncture|electroacupuncture
5403166|NCT01707706|Acupuncture|acupuncture
5403167|NCT01707706|Randomized Clinical Trial|randomized clinical trial
5403168|NCT01707706|Traditional Chinese Medicine|traditional chinese medicine
5403169|NCT01707693|physical activity|physical activity
5403170|NCT01707693|prevention|prevention
5403171|NCT01707693|coronary heart disease|coronary heart disease
5403172|NCT01707693|women|women
5403173|NCT01707680|weaning|weaning
5403174|NCT01707680|mechanical ventilation|mechanical ventilation
5403175|NCT01707680|dexmedetomidine|dexmedetomidine
5403176|NCT01707680|propofol|propofol
5403177|NCT01707680|midazolam|midazolam
5403178|NCT01707654|defect;|defect;
5403179|NCT01707654|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
5403180|NCT01707654|proper digital nerve;|proper digital nerve;
5403181|NCT01707654|finger sensory reconstruction.|finger sensory reconstruction.
5403183|NCT01707628|influenza vaccination|influenza vaccination
5403184|NCT01707628|rituximab|rituximab
5403185|NCT01707615|proanthocyanidin,atherosclerosis, carotid plaque|proanthocyanidin,atherosclerosis, carotid plaque
5403186|NCT01707602|Intradermal|intradermal
5403187|NCT01707602|transcutaneous|transcutaneous
5403188|NCT01707602|influenza|influenza
5403189|NCT01707602|routes of vaccination|routes of vaccination
5403190|NCT01707602|T cell responses|t cell responses
5403191|NCT01707602|humoral responses|humoral responses
5403192|NCT01707602|skin|skin
5403193|NCT01707602|clinical trial|clinical trial
5403194|NCT01707602|Novel application of influenza vaccine|novel application of influenza vaccine
5403195|NCT01707602|Transcutaneous vaccination(hair follicular targeting)|transcutaneous vaccination(hair follicular targeting)
5403196|NCT01707602|Intradermal vaccination(micro-needle)|intradermal vaccination(micro-needle)
5403197|NCT01707589|monitoring|monitoring
5403198|NCT01707589|heart rate|heart rate
5403199|NCT01707589|respiration rate|respiration rate
5403200|NCT01707589|temperature|temperature
5403201|NCT01707589|motion|motion
5403202|NCT01707589|noninvasive|noninvasive
5403203|NCT01707589|physiologic parameters|physiologic parameters
5403204|NCT01707589|NICU|nicu
5403205|NCT01707576|Follow-Up Studies|follow-up studies
5403206|NCT01707576|Adolescent|adolescent
5403207|NCT01707576|Depressive Disorder, Major/diagnosis|depressive disorder, major/diagnosis
5403208|NCT01707576|Attempted/prevention & control|attempted/prevention & control
5403209|NCT01707576|Self-report questionnaire|self-report questionnaire
5403210|NCT01707576|emmergency department|emmergency department
5403211|NCT01707576|parental perception|parental perception
5403212|NCT01707576|Emergency|emergency
5403213|NCT01707563|Marfan syndrome|marfan syndrome
5403214|NCT01707563|Variability|variability
5403215|NCT01707563|Fibrillin 1|fibrillin 1
5403216|NCT01707563|clinical expression|clinical expression
5403217|NCT01707537|OCV|ocv
5403218|NCT01707537|cholera|cholera
5403219|NCT01707511|Arterial carbondioxide pressure|arterial carbondioxide pressure
5403220|NCT01707511|Colon surgery|colon surgery
5403221|NCT01707511|End-tidal carbondioxide|end-tidal carbondioxide
5403222|NCT01707511|Laparoscopic Trendelenburg|laparoscopic trendelenburg
5403223|NCT01707498|BCI|bci
5403224|NCT01707498|TETRAPLEGIA|tetraplegia
5403225|NCT01707498|COMMUNICATION|communication
5403226|NCT01707498|P300|p300
5403227|NCT01707498|ASSISTIVE TECHNOLOGIE|assistive technologie
5403228|NCT01707485|Antibiotics|antibiotics
5403229|NCT01707472|Liver Fibrosis|liver fibrosis
5403230|NCT01707472|Fibrosis|fibrosis
5403231|NCT01707472|HIV|hiv
5403232|NCT01707472|HCV|hcv
5403233|NCT01707472|GS-6624|gs-6624
5403234|NCT01707472|Hepatitis|hepatitis
5403235|NCT01707472|Hepatitis C|hepatitis c
5403236|NCT01707459|platelet function|platelet function
5403237|NCT01707459|perioperative complications|perioperative complications
5403238|NCT01707459|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5403239|NCT01707459|thromboelastography|thromboelastography
5403240|NCT01707459|polymorphism analysis|polymorphism analysis
5403241|NCT01707459|coronary stents|coronary stents
5403242|NCT01707459|non-cardiac surgery|non-cardiac surgery
5403243|NCT01707446|Cardiac surgery|cardiac surgery
5403248|NCT01707433|bilateral Legg Calve Perthes|bilateral legg calve perthes
5403249|NCT01707433|bilateral proximal femoral epiphyseal dysplasia|bilateral proximal femoral epiphyseal dysplasia
5403251|NCT01707420|pediatric pain|pediatric pain
5403252|NCT01707420|post operative pain|post operative pain
5403253|NCT01707420|opioids|opioids
5403254|NCT01707420|emergence agitation|emergence agitation
5503893|NCT01279044|HIV|hiv
5403255|NCT01707420|preoperative anxiety|preoperative anxiety
5403256|NCT01707420|pharmacogenomics|pharmacogenomics
5403257|NCT01707407|CC-4047|cc-4047
5403258|NCT01707407|Pomalidomide|pomalidomide
5403259|NCT01707407|Ketoconazole|ketoconazole
5403260|NCT01707407|Fluvoxamine|fluvoxamine
5403261|NCT01707407|Carbamazepine|carbamazepine
5403262|NCT01707407|DDI|ddi
5403263|NCT01707407|safety|safety
5403264|NCT01707407|tolerability|tolerability
5403265|NCT01707407|pharmacokinetic|pharmacokinetic
5403266|NCT01707368|Psoriasis|psoriasis
5403267|NCT01707368|Psoriasis vulgaris|psoriasis vulgaris
5403268|NCT01707368|Plaque Psoriasis|plaque psoriasis
5403269|NCT01707368|Daivobet® Gel|daivobet® gel
5403270|NCT01707368|Germany|germany
5403271|NCT01707355|education, knowledge, poster, dental trauma|education, knowledge, poster, dental trauma
5403272|NCT01707342|Healthy male participants|healthy male participants
5403273|NCT01707342|Absolute bioavailability|absolute bioavailability
5403274|NCT01707342|Bioavailability|bioavailability
5403275|NCT01707342|Pharmacokinetics|pharmacokinetics
5403276|NCT01707342|Simeprevir|simeprevir
5403277|NCT01707342|TMC435|tmc435
5403278|NCT01707342|[3H]-TMC435|[3h]-tmc435
5403279|NCT01707342|Hepatitis C virus|hepatitis c virus
5403280|NCT01707342|HCV|hcv
5403281|NCT01707316|Healthy|healthy
5403282|NCT01707316|JNJ-28431754|jnj-28431754
5403283|NCT01707316|Canagliflozin|canagliflozin
5403284|NCT01707316|Pharmacokinetics|pharmacokinetics
5403285|NCT01707316|Pharmacodynamics|pharmacodynamics
5403286|NCT01707303|ICU|icu
5403287|NCT01707303|Critical Care|critical care
5403288|NCT01707303|Intensive Care|intensive care
5403289|NCT01707303|Critical Illness|critical illness
5403290|NCT01707303|Acute Respiratory Failure|acute respiratory failure
5403291|NCT01707303|Mechanical Ventilation|mechanical ventilation
5403292|NCT01707303|Physical Therapy|physical therapy
5403293|NCT01707303|Strength|strength
5403294|NCT01707303|Functional Status|functional status
5403295|NCT01707303|Short Physical Performance Battery|short physical performance battery
5403296|NCT01707277|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5403297|NCT01707277|Inspiratory muscle training|inspiratory muscle training
5403298|NCT01707277|Exercise capacity|exercise capacity
5403299|NCT01707264|AL amyloidosis|al amyloidosis
5403300|NCT01707264|Primary amyloidosis|primary amyloidosis
5403301|NCT01707251|Obesity, Morbid|obesity, morbid
5403302|NCT01707251|Bariatric Surgery|bariatric surgery
5403303|NCT01707251|Laparoscopy|laparoscopy
5403304|NCT01707251|Intravenous Ibuprofen|intravenous ibuprofen
5403305|NCT01707251|Analgesia|analgesia
5403306|NCT01707251|Morphine|morphine
5403307|NCT01707225|GI Bleeding|gi bleeding
5403308|NCT01707225|Gastrointestinal bleeding|gastrointestinal bleeding
5403309|NCT01707225|LVAD|lvad
5403310|NCT01707212|parent education|parent education
5403311|NCT01707212|pain management|pain management
5403312|NCT01707212|immunization|immunization
5403313|NCT01707212|infant|infant
5403314|NCT01707199|P. falciparum|p. falciparum
5403315|NCT01707199|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5403316|NCT01707199|Artesunate|artesunate
5403317|NCT01707199|Artemisinin Combination Therapy (ACT)|artemisinin combination therapy (act)
5403318|NCT01707173|SIDS|sids
5403319|NCT01707121|morbidity|morbidity
5403320|NCT01707121|sick-leave|sick-leave
5403321|NCT01707121|hospital stay|hospital stay
5403322|NCT01707108|dental implants|dental implants
5403323|NCT01707108|bone loss|bone loss
5403324|NCT01707095|Electrosurgery|electrosurgery
5403325|NCT01707095|Radiofrequency energy|radiofrequency energy
5403326|NCT01707095|Monopolar instruments|monopolar instruments
5403327|NCT01707095|Capacitive coupling|capacitive coupling
5403328|NCT01707095|Thermal injury|thermal injury
5403329|NCT01707095|Surgical complications|surgical complications
5403330|NCT01707056|levothyroxine|levothyroxine
5403331|NCT01707056|synthroid|synthroid
5403332|NCT01707056|coffee|coffee
5403333|NCT01707056|absorption|absorption
5403334|NCT01707056|tea|tea
5403335|NCT01707056|thyroid carcinoma|thyroid carcinoma
5403336|NCT01707043|plaque psoriasis|plaque psoriasis
5403337|NCT01707043|taclonex|taclonex
5403338|NCT01707043|crossover|crossover
5403339|NCT01707030|clinical trial|clinical trial
5403340|NCT01707030|veteran|veteran
5403341|NCT01707030|substance use disorder|substance use disorder
5403342|NCT01706978|rotator cuff tear|rotator cuff tear
5403343|NCT01706952|Endoscopic sinus surgery|endoscopic sinus surgery
5403344|NCT01706952|Bleeding|bleeding
5403345|NCT01706952|Topical Vasocontriction|topical vasocontriction
5403346|NCT01706952|Cocaine|cocaine
5403347|NCT01706952|Adrenaline|adrenaline
5403348|NCT01706939|Reduced radiotherapy|reduced radiotherapy
5403349|NCT01706939|Randomization, Phase III|randomization, phase iii
5403350|NCT01706939|Reduced radiation therapy|reduced radiation therapy
5403351|NCT01706939|head and neck|head and neck
5403352|NCT01706939|oropharynx|oropharynx
5403353|NCT01706939|unknown primary (cervical lymph nodes)|unknown primary (cervical lymph nodes)
5403356|NCT01706939|p16|p16
5403357|NCT01706926|Rheumatoid Arthritis|rheumatoid arthritis
5403358|NCT01706926|Mavrilimumab|mavrilimumab
5403359|NCT01706926|CAM-3001|cam-3001
5403360|NCT01706887|Nedd4-2|nedd4-2
5403361|NCT01706887|blood pressure|blood pressure
5403362|NCT01706887|polymorphism|polymorphism
5403363|NCT01706887|salt intake|salt intake
5403364|NCT01706887|between 18 and 35 years old|between 18 and 35 years old
5403365|NCT01706887|BMI between 18 and 28 Kg per m2|bmi between 18 and 28 kg per m2
5403366|NCT01706887|no active disease|no active disease
5403367|NCT01706887|no alcool or drug abuse or smoke|no alcool or drug abuse or smoke
5403368|NCT01706874|Rheumatoid arthritis|rheumatoid arthritis
5403369|NCT01706874|P.gingivalis|p.gingivalis
5403370|NCT01706874|Periodontal disease|periodontal disease
5403371|NCT01706874|Plaque control|plaque control
5403372|NCT01706874|Prophylaxis|prophylaxis
5403373|NCT01706874|Oral hygiene instruction|oral hygiene instruction
5403374|NCT01706835|solid tumor|solid tumor
5403375|NCT01706835|aldoxorubicin|aldoxorubicin
5403376|NCT01706835|phase 1|phase 1
5403377|NCT01706835|pharmacokinetic|pharmacokinetic
5403378|NCT01706835|INNO-206|inno-206
5403379|NCT01706796|Pain|pain
5403380|NCT01706744|Hospital Readmissions|hospital readmissions
5403381|NCT01706744|Community Health Services|community health services
5403382|NCT01706744|Preventive Health Services|preventive health services
5403383|NCT01706744|Norway|norway
5403384|NCT01706731|Buddhist monks|buddhist monks
5403386|NCT01706731|elderly|elderly
5403387|NCT01706731|depression|depression
5403388|NCT01706718|Beetroot|beetroot
5403389|NCT01706718|Blood pressure|blood pressure
5403390|NCT01706718|Vascular function|vascular function
5403391|NCT01706705|Cervical Cancer|cervical cancer
5403392|NCT01706705|Radiation therapy|radiation therapy
5403393|NCT01706705|XRT|xrt
5403394|NCT01706705|External beam therapy|external beam therapy
5403395|NCT01706705|Brachytherapy|brachytherapy
5403396|NCT01706705|Intracavitary brachytherapy|intracavitary brachytherapy
5403397|NCT01706705|ICBT|icbt
5403398|NCT01706705|MRI compatible intracavitary applicators|mri compatible intracavitary applicators
5403399|NCT01706705|Computed tomography|computed tomography
5403401|NCT01706705|Magnetic resonance imaging|magnetic resonance imaging
5403402|NCT01706705|MRI|mri
5403403|NCT01706705|MRI compatible applicators|mri compatible applicators
5403404|NCT01706705|3D image guided treatment planning|3d image guided treatment planning
5403405|NCT01706705|2D treatment planning|2d treatment planning
5403406|NCT01706692|Methotrexate|methotrexate
5403407|NCT01706692|Acitretin|acitretin
5403408|NCT01706692|Cyclosporine A|cyclosporine a
5403409|NCT01706692|Systemic PUVA|systemic puva
5403410|NCT01706692|Infliximab|infliximab
5403411|NCT01706692|Adalimumab|adalimumab
5403412|NCT01706692|Etanercept|etanercept
5403413|NCT01706692|Ustekinumab|ustekinumab
5403414|NCT01706692|Fumaric acids|fumaric acids
5403415|NCT01706692|Psoriasis|psoriasis
5403416|NCT01706692|Psoriatic arthritis|psoriatic arthritis
5403417|NCT01706692|Skin disease|skin disease
5403418|NCT01706679|Healthy volunteers|healthy volunteers
5403419|NCT01706666|Maintenance|maintenance
5403420|NCT01706666|Consolidation|consolidation
5403421|NCT01706653|Polyphenol|polyphenol
5403422|NCT01706653|Fruit|fruit
5403423|NCT01706653|Metabolic|metabolic
5403424|NCT01706653|Healthy|healthy
5403425|NCT01706627|cancer|cancer
5403426|NCT01706627|melatonin|melatonin
5403427|NCT01706627|adjuvant therapy|adjuvant therapy
5403428|NCT01706627|quality of life|quality of life
5403429|NCT01706627|survival|survival
5403430|NCT01706627|adverse events|adverse events
5403431|NCT01706627|oxidative stress|oxidative stress
5403432|NCT01706588|diclofenac, postsurgical pain, oral surgery|diclofenac, postsurgical pain, oral surgery
5403433|NCT01706562|Neutropenia|neutropenia
5403434|NCT01706562|Hematologic malignancy|hematologic malignancy
5403435|NCT01706562|Itraconazole|itraconazole
5403436|NCT01706562|Fungal infection|fungal infection
5403437|NCT01706562|Antifungal agent|antifungal agent
5404136|NCT01703689|elderly|elderly
5403438|NCT01706562|Neutropenic fever|neutropenic fever
5403439|NCT01706549|Chronic pain|chronic pain
5403440|NCT01706549|Hysterectomy|hysterectomy
5403441|NCT01706549|Quality of life|quality of life
5403442|NCT01706523|Autism Spectrum Disorders|autism spectrum disorders
5403443|NCT01706523|Autism|autism
5403444|NCT01706523|Asperger|asperger
5398537|NCT01728545|TNC|tnc
5862832|NCT00001487|Mid-Life Depression|mid-life depression
5403445|NCT01706523|Pervasive Developmental Disorder - Not otherwise specified|pervasive developmental disorder - not otherwise specified
5403446|NCT01706510|Clopidogrel|clopidogrel
5403447|NCT01706510|Ticagrelor|ticagrelor
5403448|NCT01706510|Coronary Artery Disease|coronary artery disease
5403449|NCT01706510|Myocardial Ischemia|myocardial ischemia
5403450|NCT01706510|Coronary Disease|coronary disease
5403451|NCT01706510|Heart Diseases|heart diseases
5403452|NCT01706510|Cardiovascular Diseases|cardiovascular diseases
5403453|NCT01706510|Arteriosclerosis|arteriosclerosis
5403454|NCT01706510|Arterial Occlusive Diseases|arterial occlusive diseases
5403455|NCT01706510|Vascular Diseases|vascular diseases
5002949|NCT03977636|Activity-based funding|activity-based funding
5403456|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5403457|NCT01706510|Hematologic Agents|hematologic agents
5403458|NCT01706510|Therapeutic Uses|therapeutic uses
5403459|NCT01706510|Pharmacologic Actions|pharmacologic actions
5403460|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists
5403461|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists
5403462|NCT01706510|Purinergic Antagonists|purinergic antagonists
5403463|NCT01706510|Purinergic Agents|purinergic agents
5403464|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs
5403465|NCT01706497|cerebral tissue oxygen saturation|cerebral tissue oxygen saturation
5403466|NCT01706497|congenital cardiac surgery|congenital cardiac surgery
5403467|NCT01706497|pediatric intensive care unit|pediatric intensive care unit
5403468|NCT01706497|Near Infra-Red Spectroscopy|near infra-red spectroscopy
5403469|NCT01706497|early warning monitor|early warning monitor
5403470|NCT01706497|outcome prediction|outcome prediction
5403471|NCT01706484|randomized clinical trial|randomized clinical trial
5403472|NCT01706484|chronic rhinosinusitis|chronic rhinosinusitis
5403473|NCT01706484|herbal extract BNO 1016|herbal extract bno 1016
5403474|NCT01706484|exacerbation|exacerbation
5403475|NCT01706484|pharmacoeconomic|pharmacoeconomic
5403476|NCT01706484|quality of life|quality of life
5403477|NCT01706471|verLowCNI|verlowcni
5403478|NCT01706458|Vaccine|vaccine
5403479|NCT01706458|pTVG-HP|ptvg-hp
5403480|NCT01706458|Prostate Cancer|prostate cancer
5403481|NCT01706458|Castrate Resistant|castrate resistant
5403482|NCT01706445|cystic fibrosis|cystic fibrosis
5403483|NCT01706445|exercise|exercise
5403484|NCT01706445|children|children
5403485|NCT01706445|cardiorespiratory fitness|cardiorespiratory fitness
5403486|NCT01706445|muscle strength|muscle strength
5403487|NCT01706445|pulmonary function|pulmonary function
5403488|NCT01706445|quality of life|quality of life
5403489|NCT01706419|vitamin A|vitamin a
5403490|NCT01706419|iron|iron
5403491|NCT01706419|zinc|zinc
5403492|NCT01706419|school children|school children
5403493|NCT01706419|fortified rice|fortified rice
5403494|NCT01706419|morbidity|morbidity
5403495|NCT01706419|growth|growth
5403496|NCT01706406|female sexual arousal|female sexual arousal
5403497|NCT01706406|female sexual desire|female sexual desire
5403498|NCT01706406|psychoeducational intervention|psychoeducational intervention
5403499|NCT01706393|probiotics|probiotics
5403500|NCT01706393|intestinal microbiome|intestinal microbiome
5403501|NCT01706393|radiotherapy|radiotherapy
5403502|NCT01706380|Substance use disorders|substance use disorders
5403503|NCT01706380|Adolescents|adolescents
5403504|NCT01706380|Retention|retention
5403505|NCT01706380|Mobile telephone|mobile telephone
5403506|NCT01706380|Follow-up|follow-up
5403507|NCT01706380|Interactive voice response|interactive voice response
5403508|NCT01706367|Clostridium difficile|clostridium difficile
5403509|NCT01706367|vaccine|vaccine
5403510|NCT01706354|end stage renal disease|end stage renal disease
5403511|NCT01706354|vascular access|vascular access
5403512|NCT01706354|regional anaesthesia|regional anaesthesia
5403513|NCT01706341|cesarean section|cesarean section
5403514|NCT01706341|intravenous fluid|intravenous fluid
5403515|NCT01706341|a glucose-containing solution|a glucose-containing solution
5403516|NCT01706341|fetal hypoglycemia|fetal hypoglycemia
5403517|NCT01706341|neonatal hypoglycemia|neonatal hypoglycemia
5403518|NCT01706328|Vilanterol (VI)|vilanterol (vi)
5403519|NCT01706328|Novel Dry Powder Inhaler (NDPI)|novel dry powder inhaler (ndpi)
5403520|NCT01706328|FEV1|fev1
5403521|NCT01706328|Fluticasone Furoate (FF)|fluticasone furoate (ff)
5403522|NCT01706328|COPD|copd
5403523|NCT01706302|General Practice Research Database|general practice research database
5403524|NCT01706302|Burden of Disease|burden of disease
5403525|NCT01706302|Clinical Practice Research Datalink|clinical practice research datalink
5403526|NCT01706302|Hospital Episode Statistics|hospital episode statistics
5403527|NCT01706302|Office of National Statistics|office of national statistics
5403529|NCT01706289|diabetes|diabetes
5403530|NCT01706289|cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5403531|NCT01706289|VAP 1|vap 1
5403532|NCT01706237|Myopia|myopia
5403533|NCT01706237|LASIK|lasik
5403534|NCT01706224|Pertussis antibodies|pertussis antibodies
5403535|NCT01706224|Bordetella pertussis|bordetella pertussis
5403536|NCT01706224|sero-prevalence|sero-prevalence
5403537|NCT01706224|Healthcare professionals (HCP)|healthcare professionals (hcp)
5403538|NCT01706224|Spain|spain
5862833|NCT00001487|Mid Life|mid life
5403539|NCT01706211|non insulin dependent diabetes mellitus, rosiglitazone|non insulin dependent diabetes mellitus, rosiglitazone
5403540|NCT01706198|respiratory|respiratory
5403541|NCT01706198|adult|adult
5403542|NCT01706198|asthma|asthma
5403543|NCT01706185|Patients|patients
5403544|NCT01706185|Tumor antigens|tumor antigens
5403545|NCT01706185|Bladder cancer|bladder cancer
5403546|NCT01706172|TMD|tmd
5403547|NCT01706172|temporomandibular|temporomandibular
5403548|NCT01706172|dextrose|dextrose
5403549|NCT01706172|prolotherapy|prolotherapy
5002950|NCT03977610|Prostate cancer|prostate cancer
5403550|NCT01706146|atrial fibrillation|atrial fibrillation
5403551|NCT01706146|reveal xt|reveal xt
5403552|NCT01706146|oral anticoagulation|oral anticoagulation
5403554|NCT01706146|rivaroxaban|rivaroxaban
5403555|NCT01706146|apixaban|apixaban
5403556|NCT01706133|Frailty, emergency services, elderly|frailty, emergency services, elderly
5403557|NCT01706120|prognostic factors|prognostic factors
5403558|NCT01706120|biologic factors|biologic factors
5403559|NCT01706120|clinical factors|clinical factors
5403560|NCT01706120|routine clinical practice|routine clinical practice
5403561|NCT01706107|Quality of life|quality of life
5403562|NCT01706094|stroke|stroke
5403563|NCT01706094|head position|head position
5403564|NCT01706081|acupuncture|acupuncture
5403565|NCT01706068|acute ECG changes|acute ecg changes
5403566|NCT01706068|acute illness of gallbladder|acute illness of gallbladder
5403567|NCT01706068|acute illness of biliary tract|acute illness of biliary tract
5403568|NCT01706055|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5403569|NCT01706055|Interferon|interferon
5403570|NCT01706003|Migraine|migraine
5403571|NCT01706003|Headaches|headaches
5403572|NCT01706003|Telemedicine|telemedicine
5403573|NCT01705990|HIV|hiv
5403574|NCT01705990|AIDS|aids
5403575|NCT01705990|HIV vaccine|hiv vaccine
5403576|NCT01705990|HIV prevention|hiv prevention
5403577|NCT01705977|Antibodies|antibodies
5403578|NCT01705977|Lupus|lupus
5403580|NCT01705977|Systemic Lupus Erythematosus|systemic lupus erythematosus
5403581|NCT01705977|Autoimmune Disease|autoimmune disease
5403582|NCT01705977|Belimumab|belimumab
5403583|NCT01705964|Status asthmaticus|status asthmaticus
5403584|NCT01705964|Asthma exacerbation|asthma exacerbation
5403585|NCT01705964|Epinephrine|epinephrine
5403586|NCT01705964|Adjunctive therapy|adjunctive therapy
5403587|NCT01705951|Smoking|smoking
5403588|NCT01705951|Insulin resistance|insulin resistance
5403589|NCT01705951|Metabolic Syndrome|metabolic syndrome
5403590|NCT01705951|Endothelial Function|endothelial function
5403591|NCT01705951|Smoking Cessation|smoking cessation
5403592|NCT01705951|Resistance Training|resistance training
5403593|NCT01705951|Nicotine Replacement|nicotine replacement
5403594|NCT01705951|Exercise|exercise
5403595|NCT01705951|Cardiovascular Disease|cardiovascular disease
5403596|NCT01705951|Arterial Stiffness|arterial stiffness
5403597|NCT01705951|Body Composition|body composition
5403598|NCT01705912|fall|fall
5403599|NCT01705912|prevention|prevention
5403600|NCT01705899|Type 1 Diabetes|type 1 diabetes
5403601|NCT01705899|Islet transplant|islet transplant
5403602|NCT01705899|Kidney transplant|kidney transplant
5403603|NCT01705886|Osteoarthritis|osteoarthritis
5403604|NCT01705886|Joint Disease|joint disease
5403605|NCT01705886|Arthritis|arthritis
5403606|NCT01705886|Musculoskeletal Disease|musculoskeletal disease
5403607|NCT01705886|Knee osteoarthritis|knee osteoarthritis
5403608|NCT01705873|HIV|hiv
5403609|NCT01705873|cardiovascular|cardiovascular
5403610|NCT01705873|risk|risk
5403611|NCT01705873|mortality|mortality
5403612|NCT01705860|Collagen, collagenase, scar|collagen, collagenase, scar
5403613|NCT01705847|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5403614|NCT01705847|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5403615|NCT01705847|Hodgkin lymphoma (HL)|hodgkin lymphoma (hl)
5403616|NCT01705847|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
5403617|NCT01705847|diffuse large B-cell lymphoma-activated B-cell (DLBCL-ABC)|diffuse large b-cell lymphoma-activated b-cell (dlbcl-abc)
5403618|NCT01705847|DLBCL-germinal center B-cell (GCB)|dlbcl-germinal center b-cell (gcb)
5403619|NCT01705847|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5403620|NCT01705847|GS-9820|gs-9820
5403621|NCT01705847|phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5403622|NCT01705834|Arthritis|arthritis
5403623|NCT01705834|Stiffness|stiffness
5403624|NCT01705834|Range of movement|range of movement
5403625|NCT01705834|Goniometry|goniometry
5403626|NCT01705834|Digital|digital
5403627|NCT01705834|Dataglove|dataglove
5403628|NCT01705834|Outcome|outcome
5403629|NCT01705821|Skull base|skull base
5403630|NCT01705821|Pituitary|pituitary
5403631|NCT01705821|Robotics|robotics
5403632|NCT01705821|Endonasal surgery|endonasal surgery
5403633|NCT01705821|Sinus surgery|sinus surgery
5403634|NCT01705769|treatment|treatment
5404237|NCT01703390|mCRC|mcrc
5403638|NCT01705756|Colchicine resistance|colchicine resistance
5403639|NCT01705756|Familial Mediterranean fever|familial mediterranean fever
5403640|NCT01705743|anaesthesia|anaesthesia
5403641|NCT01705743|middle aged|middle aged
5403642|NCT01705743|minimal alveolar concentration|minimal alveolar concentration
5403643|NCT01705743|sevoflurane|sevoflurane
5403645|NCT01705743|isoelectric EEG|isoelectric eeg
5403646|NCT01705678|Males|males
5403647|NCT01705678|Metabolic syndrome|metabolic syndrome
5403648|NCT01705678|Otherwise healthy|otherwise healthy
5403649|NCT01705652|nexrutine|nexrutine
5403650|NCT01705652|prostate cancer|prostate cancer
5403651|NCT01705639|diabetes|diabetes
5403652|NCT01705639|melatonin|melatonin
5403653|NCT01705639|glucose tolerance|glucose tolerance
5403654|NCT01705639|sleep|sleep
5423361|NCT01615939|Sciatic Nerve Block|sciatic nerve block
5403655|NCT01705626|Peripheral Nervous System Diseases|peripheral nervous system diseases
5403656|NCT01705626|Neuromuscular Diseases|neuromuscular diseases
5403657|NCT01705613|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5403658|NCT01705613|ADHD|adhd
5403659|NCT01705613|Methylphenidate Immediate-release|methylphenidate immediate-release
5403660|NCT01705613|Cost-effectiveness|cost-effectiveness
5403661|NCT01705613|Cost-utility|cost-utility
5403662|NCT01705613|QALYs|qalys
5403663|NCT01705600|Central Sensitization|central sensitization
5403664|NCT01705600|Low Back Pain|low back pain
5403665|NCT01705600|Pain|pain
5403666|NCT01705600|Pain Catastrophizing|pain catastrophizing
5403667|NCT01705600|Brence|brence
5403668|NCT01705587|osteoporosis|osteoporosis
5403669|NCT01705587|atypical femoral fractures|atypical femoral fractures
5403670|NCT01705587|prior bisphosphonate treatment|prior bisphosphonate treatment
5403671|NCT01705587|postmenopausal women|postmenopausal women
5403672|NCT01705587|bone loss|bone loss
5403673|NCT01705574|HIV-1|hiv-1
5403674|NCT01705574|HIV|hiv
5403675|NCT01705574|Treatment-Naive|treatment-naive
5403676|NCT01705574|Women|women
5403677|NCT01705574|WAVES|waves
5403678|NCT01705561|fertility|fertility
5403679|NCT01705561|chemotherapy|chemotherapy
5403680|NCT01705561|breast cancer|breast cancer
5403681|NCT01705561|latin american women|latin american women
5403682|NCT01705561|pre menopausal|pre menopausal
5403683|NCT01705548|Brain metastasis|brain metastasis
5403684|NCT01705535|Fecal incontinence|fecal incontinence
5403685|NCT01705535|Pelvic floor muscle exercises|pelvic floor muscle exercises
5403686|NCT01705535|Physiotherapy|physiotherapy
5403688|NCT01705522|ulcerative colitis|ulcerative colitis
5403689|NCT01705522|Crohn's disease|crohn's disease
5403690|NCT01705522|NAFLD|nafld
5403691|NCT01705522|biomarkers|biomarkers
5403692|NCT01705522|vitamin D|vitamin d
5403695|NCT01705496|Phase II|phase ii
5403696|NCT01705496|FIAU|fiau
5403697|NCT01705496|Fialuridine|fialuridine
5403698|NCT01705496|Prosthetic|prosthetic
5403699|NCT01705496|Joint|joint
5403700|NCT01705496|Infection|infection
5403701|NCT01705496|PET-CT|pet-ct
5403702|NCT01705483|ASP9853|asp9853
5403703|NCT01705483|Docetaxel|docetaxel
5403704|NCT01705483|Paclitaxel|paclitaxel
5403705|NCT01705470|Furosemide|furosemide
5403706|NCT01705470|Anemia|anemia
5403707|NCT01705470|LV dysfunction|lv dysfunction
5403708|NCT01705470|blood transfusion|blood transfusion
5403709|NCT01705457|multiple sclerosis|multiple sclerosis
5403710|NCT01705457|Vitamin A|vitamin a
5403711|NCT01705457|retinoic acid receptor|retinoic acid receptor
5403712|NCT01705457|retinoic x receptor|retinoic x receptor
5403713|NCT01705444|Urinary retention|urinary retention
5403714|NCT01705444|Foley catheter|foley catheter
5403715|NCT01705444|The Spanner|the spanner
5403716|NCT01705444|Quality of life|quality of life
5403717|NCT01705431|Emotional Disturbance|emotional disturbance
5403718|NCT01705431|Behavioral Disturbance|behavioral disturbance
5403719|NCT01705431|EBD|ebd
5403720|NCT01705431|Middle School|middle school
5403721|NCT01705431|Special Education|special education
5403722|NCT01705431|School Psychology|school psychology
5403723|NCT01705418|Parkinson disease|parkinson disease
5403724|NCT01705418|Deep brain stimulation|deep brain stimulation
5403725|NCT01705418|behavior and psychiatric symptoms improvement|behavior and psychiatric symptoms improvement
5403726|NCT01705405|cancer|cancer
5403727|NCT01705405|prostate|prostate
5403728|NCT01705379|Neisseria meningitidis, conjugate vaccine, phase IV clinical trial|neisseria meningitidis, conjugate vaccine, phase iv clinical trial
5403729|NCT01705366|Osteoarthritis|osteoarthritis
5403730|NCT01705366|Joint Disease|joint disease
5403731|NCT01705366|Arthritis|arthritis
5403732|NCT01705366|Musculoskeletal Disease|musculoskeletal disease
5403733|NCT01705353|Stroke|stroke
5403734|NCT01705353|Cerebrovascular Accident|cerebrovascular accident
5403735|NCT01705353|HMGB-1|hmgb-1
5403736|NCT01705353|cytokines|cytokines
5404238|NCT01703390|ERCC-1|ercc-1
5403739|NCT01705353|immune response|immune response
5403740|NCT01705327|Parkinson's|parkinson's
5403741|NCT01705327|Biomarkers|biomarkers
5403742|NCT01705327|Neurodegenerative disorder|neurodegenerative disorder
5403743|NCT01705314|human influenza children|human influenza children
5403746|NCT01705262|compliance|compliance
5403747|NCT01705262|Bowel preparations|bowel preparations
5403748|NCT01705262|Moviprep|moviprep
5403749|NCT01705262|Phosphoral|phosphoral
5403750|NCT01705223|prophylactic|prophylactic
5403751|NCT01705223|vaccine|vaccine
5403752|NCT01705184|Stop and go|stop and go
5403753|NCT01705184|Non-small cell lung cancer|non-small cell lung cancer
5403754|NCT01705184|Non-squamous|non-squamous
5403755|NCT01705184|Bevacizumab|bevacizumab
5403756|NCT01705171|IBS|ibs
5403757|NCT01705171|fructose intolerance|fructose intolerance
5403758|NCT01705171|GLUT 5|glut 5
5403759|NCT01705171|GLUT 2|glut 2
5403760|NCT01705158|ovarian cancer in relapse|ovarian cancer in relapse
5403761|NCT01705158|sensitive in platin|sensitive in platin
5403762|NCT01705145|Cystic Fibrosis|cystic fibrosis
5403763|NCT01705119|Mechanically Ventilated|mechanically ventilated
5403764|NCT01705119|Critical Care|critical care
5403765|NCT01705093|strawberry, cardiovascular, obesity, adolescent|strawberry, cardiovascular, obesity, adolescent
5403766|NCT01705080|Renal Denervation|renal denervation
5403767|NCT01705080|Renal artery|renal artery
5403768|NCT01705067|Osteoarthritis, Degenerative Knee Disease, TKA|osteoarthritis, degenerative knee disease, tka
5403769|NCT01705054|Angina|angina
5403770|NCT01705054|Stable ischemic heart disease|stable ischemic heart disease
5403771|NCT01705054|Quality of Life|quality of life
5403772|NCT01705054|Seattle Angina Questionnaire (SAQ)|seattle angina questionnaire (saq)
5403773|NCT01705015|exercise|exercise
5403774|NCT01705002|phase 1|phase 1
5403775|NCT01705002|dose escalating|dose escalating
5403776|NCT01705002|prodrug|prodrug
5403777|NCT01705002|mitomycin C|mitomycin c
5403778|NCT01705002|Capecitabine|capecitabine
5403779|NCT01704989|Glaucoma, SLT|glaucoma, slt
5403780|NCT01704963|Recurrent mature B-cell neoplasms|recurrent mature b-cell neoplasms
5403781|NCT01704963|B-cell malignancies|b-cell malignancies
5403782|NCT01704963|Bruton's Tyrosine Kinase (Btk) Inhibitor|bruton's tyrosine kinase (btk) inhibitor
5403783|NCT01704963|PCI-32765|pci-32765
5403784|NCT01704963|Tumor|tumor
5403785|NCT01704963|Pharmacokinetics|pharmacokinetics
5403786|NCT01704963|Japanese|japanese
5403787|NCT01704937|Fecal Microbiota Transplant|fecal microbiota transplant
5389147|NCT01771445|IL-1|il-1
5403788|NCT01704937|Clostridium difficile|clostridium difficile
5403789|NCT01704937|Diarrhea|diarrhea
5403790|NCT01704924|Prevena|prevena
5403791|NCT01704924|negative pressure wound therapy|negative pressure wound therapy
5403792|NCT01704924|Incisional wound vac|incisional wound vac
5403793|NCT01704911|Transradial|transradial
5403794|NCT01704911|Transfemoral|transfemoral
5403795|NCT01704911|Coronary Intervention|coronary intervention
5403796|NCT01704898|efavirenz|efavirenz
5403797|NCT01704898|bioequivalence|bioequivalence
5403798|NCT01704898|fasting|fasting
5403799|NCT01704898|healthy volunteers|healthy volunteers
5403800|NCT01704885|Childhood Cancer|childhood cancer
5403801|NCT01704885|Sibling Play intervention|sibling play intervention
5403802|NCT01704885|Sibling Behavioral Intervention|sibling behavioral intervention
5403803|NCT01704885|Siblings of Cancer Patients|siblings of cancer patients
5403804|NCT01704872|Neuroblastoma|neuroblastoma
5403805|NCT01704872|Refractory neuroblastoma|refractory neuroblastoma
5403806|NCT01704872|ch14.18/CHO|ch14.18/cho
5403807|NCT01704859|fracture|fracture
5403808|NCT01704833|Psychosis|psychosis
5403809|NCT01704833|Paranoia|paranoia
5403810|NCT01704833|Cognitive Behavioral Therapy|cognitive behavioral therapy
5403811|NCT01704833|Delusions|delusions
5403812|NCT01704833|Group Therapy|group therapy
5403813|NCT01704820|Colon Polyps|colon polyps
5403814|NCT01704820|Colon Cancer screening|colon cancer screening
5403815|NCT01704820|Colonoscopy|colonoscopy
5403816|NCT01704807|Low Back Pain|low back pain
5403817|NCT01704807|Chronic|chronic
5403818|NCT01704807|Orthotic Device|orthotic device
5403819|NCT01704807|Applied Kinesiology|applied kinesiology
5403820|NCT01704807|Manual Muscle Testing|manual muscle testing
5403821|NCT01704807|Chiropractic|chiropractic
5403822|NCT01704794|Sickle Cell Anemia|sickle cell anemia
5403823|NCT01704794|Quality of Life|quality of life
5403824|NCT01704794|Antioxidant|antioxidant
5403825|NCT01704794|Anti inflammatory|anti inflammatory
5403826|NCT01704794|Sorghum bicolor|sorghum bicolor
5403827|NCT01704781|CD4|cd4
5403828|NCT01704781|Clinical trial|clinical trial
5403829|NCT01704781|Dose escalation assessment lenalidomide|dose escalation assessment lenalidomide
5403830|NCT01704781|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
5403831|NCT01704781|HIV|hiv
5403832|NCT01704781|Immunomodulatory|immunomodulatory
5403833|NCT01704781|Infection|infection
5403834|NCT01704781|Lenalidomide|lenalidomide
5403835|NCT01704781|Phase I/II|phase i/ii
5403836|NCT01704781|Vaccine|vaccine
5403837|NCT01704781|Vacc-4x|vacc-4x
5403838|NCT01704768|Randomized Controlled Trial|randomized controlled trial
5403839|NCT01704768|School-Based Intervention|school-based intervention
5403840|NCT01704755|Cirrhosis|cirrhosis
5403841|NCT01704755|Hepatitis C|hepatitis c
5403842|NCT01704755|Child Pugh A|child pugh a
5403843|NCT01704755|Compensated Cirrhosis|compensated cirrhosis
5403844|NCT01704755|Hepatitis C Genotype 1|hepatitis c genotype 1
5403845|NCT01704755|Cirrhotic|cirrhotic
5403846|NCT01704755|Chronic Hepatitis C|chronic hepatitis c
5403847|NCT01704755|Hepatitis C Virus|hepatitis c virus
5403848|NCT01704755|ombitasvir|ombitasvir
5403849|NCT01704755|paritaprevir|paritaprevir
5403850|NCT01704755|dasabuvir|dasabuvir
5403851|NCT01704755|Interferon-Free|interferon-free
5403852|NCT01704755|Viekira Pak|viekira pak
5403853|NCT01704742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5403854|NCT01704742|Hodgkin's Lymphoma|hodgkin's lymphoma
5403856|NCT01704742|Epstein Barr Virus (EBV)|epstein barr virus (ebv)
5403857|NCT01704742|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5403858|NCT01704742|Kaposi's Sarcoma Herpes Virus (KSHV)|kaposi's sarcoma herpes virus (kshv)
5403860|NCT01704729|Focus groups|focus groups
5403861|NCT01704729|refraction|refraction
5403862|NCT01704729|Glasses|glasses
5403863|NCT01704729|spectacles|spectacles
5403864|NCT01704716|neuroblastoma|neuroblastoma
5403865|NCT01704716|immunotherapy|immunotherapy
5403867|NCT01704716|antibody treatment|antibody treatment
5403868|NCT01704703|colorectal cancer|colorectal cancer
5403869|NCT01704703|FOLFIRI|folfiri
5403870|NCT01704703|Panitumumab|panitumumab
5403871|NCT01704703|KRAS, PIK3Ca,BRAF and NRAS genes|kras, pik3ca,braf and nras genes
5403872|NCT01704703|highly sensitive techniques|highly sensitive techniques
5403873|NCT01704690|Esophageal cancer|esophageal cancer
5403874|NCT01704690|Chemotherapy|chemotherapy
5403875|NCT01704690|Efficacy|efficacy
5403876|NCT01704690|Toxicity|toxicity
5403877|NCT01704677|Chronic low back pain|chronic low back pain
5403878|NCT01704677|Degenerated disc|degenerated disc
5403879|NCT01704677|Total disc replacement|total disc replacement
5403880|NCT01704677|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
5403881|NCT01704677|Long term results|long term results
5403882|NCT01704664|malnutrition,|malnutrition,
5671211|NCT00616707|Microalbuminuria|microalbuminuria
5403883|NCT01704664|perioperative artificial nutrition,|perioperative artificial nutrition,
5403884|NCT01704664|immunonutrition,|immunonutrition,
5403885|NCT01704664|gastrectomy,|gastrectomy,
5403886|NCT01704664|lymphocytes,|lymphocytes,
5403887|NCT01704664|interleukin,|interleukin,
5403888|NCT01704664|blood platelets,|blood platelets,
5403889|NCT01704664|phagocytic and bactericidal activity of blood platelets|phagocytic and bactericidal activity of blood platelets
5403891|NCT01704651|Ovarian|ovarian
5403892|NCT01704651|Fallopian|fallopian
5403893|NCT01704651|Peritoneal|peritoneal
5403894|NCT01704651|Cancer|cancer
5403895|NCT01704651|Gynecological|gynecological
5403896|NCT01704651|Female|female
5403897|NCT01704625|pain|pain
5403898|NCT01704625|headache|headache
5403899|NCT01704612|local anesthetic|local anesthetic
5403900|NCT01704612|sciatic|sciatic
5403901|NCT01704612|diabetes|diabetes
5403902|NCT01704612|block|block
5403903|NCT01704612|duration|duration
5403904|NCT01704599|Psoriasis|psoriasis
5403905|NCT01704599|Adalimumab|adalimumab
5403906|NCT01704599|B vitamins|b vitamins
5403907|NCT01704599|Homocysteine|homocysteine
5403908|NCT01704599|Folic acid|folic acid
5403909|NCT01704599|Cyanocobalamin|cyanocobalamin
5403910|NCT01704599|Pyridoxine|pyridoxine
5403911|NCT01704599|Vitamin B6|vitamin b6
5403912|NCT01704599|Vitamin B9|vitamin b9
5403913|NCT01704599|Vitamin B12|vitamin b12
5403914|NCT01704586|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5403915|NCT01704586|PET/CT|pet/ct
5403916|NCT01704586|Radioiodine Remnant Ablation|radioiodine remnant ablation
5403917|NCT01704586|I-124|i-124
5403918|NCT01704586|Quality of life|quality of life
5403919|NCT01704573|PET Scan|pet scan
5403920|NCT01704547|Breast cancer|breast cancer
5403921|NCT01704547|Lumpectomy|lumpectomy
5403922|NCT01704547|Breast Irradiation|breast irradiation
5403923|NCT01704534|Hidradenitis suppurativa|hidradenitis suppurativa
5403924|NCT01704534|Acne ectopica|acne ectopica
5403925|NCT01704534|Inverse acne|inverse acne
5403926|NCT01704534|Ustekinumab|ustekinumab
5403927|NCT01704534|Stelara|stelara
5403928|NCT01704521|Hepatitis C|hepatitis c
5403930|NCT01704521|Hemophilia|hemophilia
5403931|NCT01704508|Falciparum malaria|falciparum malaria
5403932|NCT01704508|children|children
5403933|NCT01704508|treatment|treatment
5403934|NCT01704495|Uncontrolled Asthma,|uncontrolled asthma,
5403935|NCT01704495|Exacerbation,|exacerbation,
5403936|NCT01704495|Safety|safety
5403937|NCT01704469|Opioid induced hyperalgesia|opioid induced hyperalgesia
5403938|NCT01704456|provoked vestibulodynia|provoked vestibulodynia
5403939|NCT01704456|dyspareunia|dyspareunia
5403940|NCT01704456|vulvodynia|vulvodynia
5403941|NCT01704456|mindfulness|mindfulness
5404040|NCT01704105|Environmental enteropathy|environmental enteropathy
5403942|NCT01704456|cognitive behavioural therapy|cognitive behavioural therapy
5403943|NCT01704443|provoked vestibulodynia|provoked vestibulodynia
5403944|NCT01704443|dyspareunia|dyspareunia
5403945|NCT01704443|vulvodynia|vulvodynia
5403946|NCT01704443|mindfulness|mindfulness
5403947|NCT01704443|cognitive behavioural therapy|cognitive behavioural therapy
5403948|NCT01704430|Cardiac surgery|cardiac surgery
5403949|NCT01704430|Cardiac bypass|cardiac bypass
5403950|NCT01704430|Intensive Care|intensive care
5403951|NCT01704430|Nosocomial infection|nosocomial infection
5403952|NCT01704430|Glutamine|glutamine
5403953|NCT01704430|Randomized trial|randomized trial
5403954|NCT01704404|Long acting muscarinic antagonist|long acting muscarinic antagonist
5403955|NCT01704404|Chronic Bronchitis|chronic bronchitis
5403957|NCT01704404|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5403958|NCT01704404|COPD|copd
5403959|NCT01704352|Cognitive Behavioral Therapy|cognitive behavioral therapy
5403961|NCT01704339|End stage renal failure|end stage renal failure
5403962|NCT01704339|Neuropathic pain|neuropathic pain
5403963|NCT01704339|Critical digital ischaemia|critical digital ischaemia
5403964|NCT01704326|Deuce|deuce
5403965|NCT01704326|Journey Deuce|journey deuce
5403966|NCT01704326|Knee pain|knee pain
5403967|NCT01704326|Osteoarthritis|osteoarthritis
5403968|NCT01704326|Bicompartmental|bicompartmental
5403969|NCT01704326|Femoral|femoral
5403970|NCT01704326|Medial|medial
5403971|NCT01704313|Vascular access|vascular access
5403972|NCT01704313|Haemodialysis|haemodialysis
5403973|NCT01704313|Suturing technique|suturing technique
5403974|NCT01704300|Abdominal aortic aneurysm|abdominal aortic aneurysm
5403975|NCT01704300|Acute Myocardial Infarction|acute myocardial infarction
5403976|NCT01704300|Coronary heart disease not otherwise specified|coronary heart disease not otherwise specified
5403977|NCT01704300|Haemorrhagic stroke|haemorrhagic stroke
5403978|NCT01704300|Heart failure|heart failure
5403979|NCT01704300|Ischaemic stroke|ischaemic stroke
5403980|NCT01704300|Peripheral arterial disease|peripheral arterial disease
5403981|NCT01704300|Stable angina|stable angina
5403982|NCT01704300|Unheralded coronary death|unheralded coronary death
5403983|NCT01704300|Unstable angina|unstable angina
5403984|NCT01704300|Ventricular arrhythmias, cardiac arrest and sudden cardiac death|ventricular arrhythmias, cardiac arrest and sudden cardiac death
5403985|NCT01704300|Transient Ischemic Attack|transient ischemic attack
5403986|NCT01704287|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5403987|NCT01704287|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5403988|NCT01704274|biochemical|biochemical
5403989|NCT01704274|recurrence|recurrence
5403990|NCT01704274|prostate|prostate
5403991|NCT01704274|cancer|cancer
5403992|NCT01704274|active|active
5403993|NCT01704274|surveillence|surveillence
5403994|NCT01704248|eye drops self-instillation|eye drops self-instillation
5403995|NCT01704235|screening|screening
5403996|NCT01704222|Children|children
5403997|NCT01704222|nursery|nursery
5403998|NCT01704222|CMV|cmv
5403999|NCT01704222|Infection|infection
5404000|NCT01704183|relapse-remitting multiple sclerosis|relapse-remitting multiple sclerosis
5404001|NCT01704183|heart rate variability|heart rate variability
5404002|NCT01704183|fingolimod|fingolimod
5404003|NCT01704183|cardiac autonomic regulation|cardiac autonomic regulation
5404004|NCT01704157|Osteoarthritis|osteoarthritis
5404005|NCT01704157|knee|knee
5404006|NCT01704157|chronic pain|chronic pain
5404007|NCT01704144|Efavirenz|efavirenz
5404008|NCT01704144|rifampin|rifampin
5404009|NCT01704144|Pharmacokinetics|pharmacokinetics
5404010|NCT01704144|Drug-drug interactions|drug-drug interactions
5404011|NCT01704144|Drug-gene interactions|drug-gene interactions
5404012|NCT01704144|Children|children
5404013|NCT01704131|Levosimendan|levosimendan
5404014|NCT01704131|Children|children
5404015|NCT01704131|Pharmacokinetics|pharmacokinetics
5404016|NCT01704118|I-gel|i-gel
5404017|NCT01704118|ProSeal laryngeal mask|proseal laryngeal mask
5404018|NCT01704118|small infants|small infants
5404019|NCT01704118|neonates|neonates
5404020|NCT01704105|Chlorine water treatment|chlorine water treatment
5404021|NCT01704105|Point-of-use water treatment|point-of-use water treatment
5404022|NCT01704105|Household water treatment with safe storage|household water treatment with safe storage
5404023|NCT01704105|Handwashing with soap|handwashing with soap
5404024|NCT01704105|Hand hygiene|hand hygiene
5404025|NCT01704105|Latrines|latrines
5404026|NCT01704105|Water|water
5404027|NCT01704105|Sanitation|sanitation
5404028|NCT01704105|Handwashing|handwashing
5404029|NCT01704105|Breast Feeding|breast feeding
5404030|NCT01704105|Complementary Feeding|complementary feeding
5404031|NCT01704105|Micronutrients|micronutrients
5404032|NCT01704105|Malnutrition|malnutrition
5404033|NCT01704105|Nutrition Disorders|nutrition disorders
5404034|NCT01704105|Diarrhea|diarrhea
5404035|NCT01704105|Child Development|child development
5404036|NCT01704105|Child potties|child potties
5404037|NCT01704105|Point-of-use fortification|point-of-use fortification
5404038|NCT01704105|Lipid-based nutrient supplement|lipid-based nutrient supplement
5404039|NCT01704105|Exclusive breastfeeding|exclusive breastfeeding
5404041|NCT01704105|Tropical enteropathy|tropical enteropathy
5404042|NCT01704105|Gut function|gut function
5404043|NCT01704105|Intestinal parasitic infection|intestinal parasitic infection
5404044|NCT01704105|Soil transmitted helminths|soil transmitted helminths
5404045|NCT01704105|Intestinal protozoans|intestinal protozoans
5404046|NCT01704105|Antibody response|antibody response
5404047|NCT01704079|Parathyroid Diseases|parathyroid diseases
5404048|NCT01704079|Renal Insufficiency|renal insufficiency
5404049|NCT01704079|Kidney Failure, Chronic|kidney failure, chronic
5404050|NCT01704079|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5404051|NCT01704079|Vitamin D|vitamin d
5404052|NCT01704079|Hyperparathyroidism|hyperparathyroidism
5404053|NCT01704079|Kidney Diseases|kidney diseases
5404054|NCT01704079|Kidney Failure|kidney failure
5391125|NCT01762579|Rectoscopy|rectoscopy
5391151|NCT01762371|ACL|acl
5404055|NCT01704079|Renal Insufficiency, Chronic|renal insufficiency, chronic
5404056|NCT01704066|ARDS|ards
5404057|NCT01704066|Chest radiograph|chest radiograph
5404058|NCT01704066|Berlin Definition|berlin definition
5404059|NCT01704066|Inter-observer agreement|inter-observer agreement
5404060|NCT01704053|New Oral Anticoagulants|new oral anticoagulants
5404061|NCT01704053|Dabigatran|dabigatran
5404062|NCT01704053|Rivaroxaban|rivaroxaban
5404063|NCT01704053|Thrombelastometry/-graphy (ROTEM, TEG)|thrombelastometry/-graphy (rotem, teg)
5404064|NCT01704053|Multiple Platelet Function Analyzer (Multiplate)|multiple platelet function analyzer (multiplate)
5404065|NCT01704040|Healthy volunteers and asthma|healthy volunteers and asthma
5404066|NCT01704040|CNTO 3157|cnto 3157
5404067|NCT01704040|Rhinovirus|rhinovirus
5404068|NCT01704027|Localized|localized
5404069|NCT01704027|High risk|high risk
5404070|NCT01704014|occurrence of|occurrence of
5404071|NCT01704001|ART-123|art-123
5404072|NCT01704001|Disseminated Intravascular Coagulation|disseminated intravascular coagulation
5404073|NCT01704001|Pharmacokinetics|pharmacokinetics
5404074|NCT01703988|Spinal Muscular Atrophy|spinal muscular atrophy
5404075|NCT01703988|SMA|sma
5404076|NCT01703988|SMN|smn
5404077|NCT01703988|SMNRx|smnrx
5404078|NCT01703988|ISIS-SMNRx|isis-smnrx
5404079|NCT01703988|ISIS 396443|isis 396443
5404080|NCT01703975|Simulation efficiency|simulation efficiency
5404081|NCT01703975|Collaborative learning|collaborative learning
5404082|NCT01703962|Glioma|glioma
5404083|NCT01703962|IDH1|idh1
5404084|NCT01703962|Spectroscopy|spectroscopy
5404085|NCT01703962|Plasma|plasma
5404086|NCT01703936|economic intervention|economic intervention
5404087|NCT01703936|ex-combatant|ex-combatant
5404088|NCT01703936|agriculture|agriculture
5404089|NCT01703936|life skills|life skills
5404090|NCT01703910|Genomic expression profile in tumor samples|genomic expression profile in tumor samples
5404091|NCT01703910|Adult patients|adult patients
5404092|NCT01703910|metastatic disease status and progression after two lines of systemic therapy|metastatic disease status and progression after two lines of systemic therapy
5404093|NCT01703897|gastric by-pass surgery|gastric by-pass surgery
5404094|NCT01703884|Malria diagnosis|malria diagnosis
5404095|NCT01703884|Malaria prevention in pregnancy|malaria prevention in pregnancy
5404096|NCT01703884|ANC services improvement|anc services improvement
5404097|NCT01703832|acute stress reaction|acute stress reaction
5404098|NCT01703832|stress|stress
5404099|NCT01703832|stress perception|stress perception
5404100|NCT01703832|physiological stress response|physiological stress response
5404101|NCT01703832|Neurexan|neurexan
5404102|NCT01703819|acute stress reaction|acute stress reaction
5404103|NCT01703819|stress|stress
5404104|NCT01703819|stress perception|stress perception
5404105|NCT01703819|physiological stress response|physiological stress response
5404106|NCT01703819|Neurexan|neurexan
5404107|NCT01703806|Mitral regurgitation|mitral regurgitation
5404108|NCT01703806|Mitral valve repair|mitral valve repair
5404109|NCT01703806|Watchful waiting|watchful waiting
5404110|NCT01703767|patient satisfaction|patient satisfaction
5404111|NCT01703767|Gulf War 1 Veteran|gulf war 1 veteran
5404112|NCT01703767|Desert Storm Veteran|desert storm veteran
5404113|NCT01703754|Genetically Modified Organism|genetically modified organism
5404114|NCT01703754|Metastatic Breast Cancer|metastatic breast cancer
5404115|NCT01703754|Recurrent Breast Cancer|recurrent breast cancer
5404116|NCT01703754|Breast Cancer|breast cancer
5404117|NCT01703754|Palifosfamide|palifosfamide
5404118|NCT01703754|INXN1001|inxn1001
5404119|NCT01703754|INXN2001|inxn2001
5404120|NCT01703754|Adenoviral vector|adenoviral vector
5404121|NCT01703715|Hydration|hydration
5404122|NCT01703715|Elderly patients|elderly patients
5404123|NCT01703715|Age 65 years and over|age 65 years and over
5404124|NCT01703715|Admitted acutely to medical admissions ward|admitted acutely to medical admissions ward
5404125|NCT01703689|Quality indicators|quality indicators
5404126|NCT01703689|quality of care|quality of care
5404127|NCT01703689|nursing home|nursing home
5404128|NCT01703689|long-term care unit|long-term care unit
5404129|NCT01703689|nursing home organisation|nursing home organisation
5404130|NCT01703689|nursing home structure|nursing home structure
5404131|NCT01703689|disability|disability
5404132|NCT01703689|dependence|dependence
5404133|NCT01703689|functional decline|functional decline
5404134|NCT01703689|functional impairment|functional impairment
5404135|NCT01703689|older adults|older adults
5404137|NCT01703689|audit and feedback|audit and feedback
5404138|NCT01703689|cooperative work|cooperative work
5404139|NCT01703689|geriatrician|geriatrician
5404140|NCT01703689|medication|medication
5404141|NCT01703689|hospitalisation|hospitalisation
5404142|NCT01703689|comorbidity|comorbidity
5404143|NCT01703676|Hypogonadism, Klinefelter Syndrome, Cardiovascular Risk, Epigenetics, Methylation of Genes|hypogonadism, klinefelter syndrome, cardiovascular risk, epigenetics, methylation of genes
5404144|NCT01703676|Cardiovascular risk factors|cardiovascular risk factors
5404145|NCT01703676|Gonadal status|gonadal status
5404146|NCT01703676|Gene expression|gene expression
5404147|NCT01703676|Methylation|methylation
5404149|NCT01703663|Sleep Apnea|sleep apnea
5404151|NCT01703650|pancreas adenocarcinoma|pancreas adenocarcinoma
5404153|NCT01703650|perfusion|perfusion
5404154|NCT01703637|Sitagliptin|sitagliptin
5404155|NCT01703637|Vildagliptin|vildagliptin
5404156|NCT01703637|Saxagliptin|saxagliptin
5404157|NCT01703637|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5404158|NCT01703624|glycopyrronium bromide|glycopyrronium bromide
5404159|NCT01703624|glycopyrrolate|glycopyrrolate
5404160|NCT01703624|oral inhalation|oral inhalation
5404161|NCT01703624|COPD|copd
5404162|NCT01703624|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5404165|NCT01703624|tolerability|tolerability
5404166|NCT01703624|safety|safety
5404167|NCT01703624|cross-over|cross-over
5404168|NCT01703624|single-dose|single-dose
5404169|NCT01703624|dose-ranging|dose-ranging
5404170|NCT01703611|Nutrition|nutrition
5404171|NCT01703611|Medical Nutrition Therapy|medical nutrition therapy
5404172|NCT01703611|Diabetes Mellitus|diabetes mellitus
5404173|NCT01703611|Nutrition outcomes|nutrition outcomes
5404174|NCT01703611|Evidence Based Guidelines|evidence based guidelines
5404175|NCT01703598|Parkinson's disease|parkinson's disease
5404176|NCT01703598|Deep Brain Stimulation|deep brain stimulation
5404177|NCT01703585|genomic analysis|genomic analysis
5404178|NCT01703585|genome|genome
5538520|NCT01133015|FFR|ffr
5404179|NCT01703585|tumor|tumor
5404180|NCT01703585|tissue|tissue
5404181|NCT01703585|archival|archival
5404182|NCT01703585|biopsy|biopsy
5404183|NCT01703585|core needle|core needle
5404184|NCT01703585|fine needle|fine needle
5404185|NCT01703585|DNA|dna
5404186|NCT01703585|gene|gene
5404187|NCT01703585|expression|expression
5404188|NCT01703585|sequencing|sequencing
5404189|NCT01703572|Phase 1|phase 1
5404190|NCT01703572|Dose escalation|dose escalation
5404191|NCT01703572|relapsed or refractory|relapsed or refractory
5404192|NCT01703572|lymphoid malignancies|lymphoid malignancies
5404193|NCT01703559|Glare|glare
5404194|NCT01703559|Starbursts|starbursts
5404195|NCT01703559|Halos|halos
5404196|NCT01703559|Reduced Contrast Sensitivity|reduced contrast sensitivity
5404197|NCT01703559|Night Vision Disturbances|night vision disturbances
5404198|NCT01703559|NVD|nvd
5404199|NCT01703559|NVDs|nvds
5404200|NCT01703546|Morbid Obesity|morbid obesity
5404201|NCT01703546|Weight Loss Surgery|weight loss surgery
5404202|NCT01703546|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
5404203|NCT01703546|Laparoscopic Gastric Plication|laparoscopic gastric plication
5404204|NCT01703546|Imbrication|imbrication
5404205|NCT01703533|Autism|autism
5404206|NCT01703533|Rett's Syndrome|rett's syndrome
5404207|NCT01703533|Rett Disorder|rett disorder
5404208|NCT01703533|Rett's Disorder|rett's disorder
5404209|NCT01703533|Ataxia|ataxia
5404210|NCT01703520|Males breast cancer|males breast cancer
5404211|NCT01703520|Finasteride|finasteride
5404212|NCT01703520|PROSCAR®|proscar®
5404213|NCT01703520|PROPECIA®|propecia®
5404214|NCT01703494|C. difficile|c. difficile
5404215|NCT01703494|fecal transplant|fecal transplant
5404216|NCT01703494|stool transplant|stool transplant
5404217|NCT01703494|fecal flora reconstitution|fecal flora reconstitution
5404218|NCT01703494|fecal microbiota transplant|fecal microbiota transplant
5404219|NCT01703494|FMT|fmt
5404220|NCT01703481|Tumor|tumor
5445465|NCT01521611|Radioimmunotherapy|radioimmunotherapy
5404221|NCT01703481|Fibroblast Growth Factor Receptor (FGFR)|fibroblast growth factor receptor (fgfr)
5404222|NCT01703481|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5404223|NCT01703481|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5404224|NCT01703481|JNJ-42756493|jnj-42756493
5404225|NCT01703455|Salivary gland cancer metastatic disease recurrent disease clinical trial|salivary gland cancer metastatic disease recurrent disease clinical trial
5404226|NCT01703429|Multiple Sclerosis|multiple sclerosis
5404227|NCT01703429|MS|ms
5404228|NCT01703429|Complementary and Alternative|complementary and alternative
5404229|NCT01703429|CAM|cam
5404230|NCT01703416|COPD|copd
5404231|NCT01703416|GOLD group C and D|gold group c and d
5404232|NCT01703416|CDLM questionnaire|cdlm questionnaire
5404233|NCT01703416|visual scale - physician evaluation|visual scale - physician evaluation
5404234|NCT01703403|physical therapy|physical therapy
5404235|NCT01703403|treated at NTUH and received rehabilitation at the PTC in recent ten years.|treated at ntuh and received rehabilitation at the ptc in recent ten years.
5404236|NCT01703390|metastatic colorectal cancer|metastatic colorectal cancer
5404239|NCT01703390|ERCC1|ercc1
5404240|NCT01703390|AGMT|agmt
5404241|NCT01703364|CLL|cll
5404242|NCT01703364|Lenalidomide|lenalidomide
5404243|NCT01703364|Revlimid|revlimid
5404244|NCT01703364|AGMT|agmt
5404245|NCT01703364|T cell|t cell
5404246|NCT01703351|pain control, VATS|pain control, vats
5404247|NCT01703338|assessment model|assessment model
5404248|NCT01703338|biomechanical changes|biomechanical changes
5404249|NCT01703338|functional activities|functional activities
5404250|NCT01703338|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5404251|NCT01703338|causal relationship|causal relationship
5404252|NCT01703338|core muscles activation pattern|core muscles activation pattern
5404253|NCT01703338|pathological changes|pathological changes
5404255|NCT01703338|core stability exercise|core stability exercise
5404256|NCT01703338|minimally invasive lumbar spinal fusion surgery|minimally invasive lumbar spinal fusion surgery
5404257|NCT01703325|Psoriatic nails|psoriatic nails
5404258|NCT01703325|Triamcinolone injection|triamcinolone injection
5404259|NCT01703325|clobetasol propionate|clobetasol propionate
5404260|NCT01703312|Allergies, asthma, IgE|allergies, asthma, ige
5404261|NCT01703299|imipenem|imipenem
5404262|NCT01703299|ertapenem|ertapenem
5404263|NCT01703299|resistance|resistance
5404264|NCT01703299|commensal flora|commensal flora
5404265|NCT01703273|Extreme Obesity Keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|extreme obesity keywords: obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
5404266|NCT01703260|Drug therapy|drug therapy
5404267|NCT01703247|Arrhythmias|arrhythmias
5404268|NCT01703247|Ablation|ablation
5404269|NCT01703234|FGF-23 , ramipril, endothelial dysfunction|fgf-23 , ramipril, endothelial dysfunction
5404270|NCT01703195|Vaginal Cancer|vaginal cancer
5404271|NCT01703195|Malignancies involving the vagina|malignancies involving the vagina
5404272|NCT01703195|Middle third and the distal third of the vagina|middle third and the distal third of the vagina
5404273|NCT01703195|Pre and post radiation therapy|pre and post radiation therapy
5404274|NCT01703195|Diffusion weighted magnetic resonance imaging|diffusion weighted magnetic resonance imaging
5404276|NCT01703195|Magnetic resonance imaging|magnetic resonance imaging
5404277|NCT01703195|MRI|mri
5404278|NCT01703195|Tumor involvement|tumor involvement
5404279|NCT01703195|Response to radiation therapy|response to radiation therapy
5404280|NCT01703195|XRT|xrt
5404281|NCT01703182|transcutaneous oximetry|transcutaneous oximetry
5404282|NCT01703182|transcutaneous carbon dioxide|transcutaneous carbon dioxide
5404283|NCT01703182|leg amputation|leg amputation
5404284|NCT01703182|wound healing failure|wound healing failure
5404285|NCT01703182|amputation revision|amputation revision
5404286|NCT01703169|severe aplastic anemia|severe aplastic anemia
5404287|NCT01703169|very severe aplastic anemia|very severe aplastic anemia
5404288|NCT01703169|moderate aplastic anemia|moderate aplastic anemia
5404289|NCT01703169|bleeding|bleeding
5404290|NCT01703156|Low Risk ACS, Acute Coronary Syndrome, Stress Testing, Non-Stress Testing|low risk acs, acute coronary syndrome, stress testing, non-stress testing
5404291|NCT01703130|ISPB|ispb
5404292|NCT01703130|Brachial Plexus Block|brachial plexus block
5404293|NCT01703130|Anesthesia|anesthesia
5404294|NCT01703130|Pain Management|pain management
5404295|NCT01703130|Surgery|surgery
5404296|NCT01703117|Alzheimer's Disease|alzheimer's disease
5404297|NCT01703117|Dementia|dementia
5404298|NCT01703104|Sorghum bicolor|sorghum bicolor
5404299|NCT01703104|sickle cell anaemia|sickle cell anaemia
5404300|NCT01703104|haematological parameters|haematological parameters
5404301|NCT01703065|Prostate cancer|prostate cancer
5404302|NCT01703065|Bone metastases|bone metastases
5404303|NCT01703039|Major Depression|major depression
5404304|NCT01703039|Major Depressive Disorder|major depressive disorder
5404305|NCT01703039|Depression|depression
5404306|NCT01703039|Riluzole|riluzole
5404307|NCT01703039|Glutamate|glutamate
5404308|NCT01703039|Sertraline|sertraline
5404309|NCT01703013|Demonstrate that DEFA4 is a reliable biomarker for the prediction of adrenal insufficiency|demonstrate that defa4 is a reliable biomarker for the prediction of adrenal insufficiency
5404310|NCT01703000|drug eluting coronary stent|drug eluting coronary stent
5404311|NCT01702987|ubiquinol (coenzyme Q10)|ubiquinol (coenzyme q10)
5404312|NCT01702974|HIV|hiv
5404313|NCT01702974|cholecalciferol|cholecalciferol
5404314|NCT01702974|sodium phenylbutyrate|sodium phenylbutyrate
5404315|NCT01702974|antimicrobial peptides|antimicrobial peptides
5404316|NCT01702974|immune response|immune response
5404317|NCT01702974|inflammation|inflammation
5404318|NCT01702961|Lymphoma|lymphoma
5404319|NCT01702961|Hodgkin's Disease|hodgkin's disease
5404320|NCT01702948|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5404321|NCT01702948|Nicotine|nicotine
5404322|NCT01702948|Repetitive TMS (rTMS)|repetitive tms (rtms)
5404323|NCT01702948|fMRI|fmri
5404324|NCT01702935|Ovarian Failure|ovarian failure
5404325|NCT01702935|Premature Ovarian Failure|premature ovarian failure
5404326|NCT01702935|Infertility|infertility
5404327|NCT01702935|Primary Ovarian Insufficiency|primary ovarian insufficiency
5404328|NCT01702935|Stem Cells|stem cells
5404329|NCT01702922|Stress|stress
5404330|NCT01702922|Marriage|marriage
5404353|NCT01702844|Phase II|phase ii
5404354|NCT01702844|Non-Randomized|non-randomized
5404355|NCT01702844|Elderly|elderly
5404356|NCT01702844|Lineberger|lineberger
5404357|NCT01702844|UNC|unc
5404358|NCT01702844|LCCC 1210|lccc 1210
5404359|NCT01702831|Newly Diagnosed multiple myeloma|newly diagnosed multiple myeloma
5404360|NCT01702818|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5404361|NCT01702818|HSDD|hsdd
5404362|NCT01702818|Cortisol|cortisol
5391445|NCT01761032|Tanning|tanning
5404363|NCT01702818|DHEA|dhea
5404364|NCT01702818|Stress Hormones|stress hormones
5404365|NCT01702818|Sexual Desire|sexual desire
5404366|NCT01702818|Mood|mood
5404367|NCT01702818|Sexual Function|sexual function
5404370|NCT01702805|NICHD Neonatal Research Network|nichd neonatal research network
5404371|NCT01702805|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5404372|NCT01702805|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5404373|NCT01702805|Transfusions|transfusions
5404374|NCT01702792|Immunotherapy, cancer vaccine, glioblastoma, hybridoma|immunotherapy, cancer vaccine, glioblastoma, hybridoma
5404375|NCT01702779|Weaning from mechanical ventilation|weaning from mechanical ventilation
5404376|NCT01702779|Lung ultrasound|lung ultrasound
5404377|NCT01702779|Oxygen inhalation therapy|oxygen inhalation therapy
5404378|NCT01702740|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
5404379|NCT01702740|Systemic lupus erythematosus|systemic lupus erythematosus
5404380|NCT01702740|Lupus erythematosus|lupus erythematosus
5404381|NCT01702740|Human anti-IL 6 monoclonal antibody|human anti-il 6 monoclonal antibody
5404382|NCT01702740|Sirukumab|sirukumab
5404383|NCT01702727|Amblyopia|amblyopia
5404384|NCT01702727|I-BiT TM|i-bit tm
5404385|NCT01702727|Interactive games|interactive games
5404386|NCT01702727|Binocular|binocular
5404387|NCT01702675|Safety|safety
5404388|NCT01702675|Pharmacokinetics|pharmacokinetics
5404389|NCT01702675|Tolerability|tolerability
5404390|NCT01702675|Healthy men|healthy men
5404412|NCT01702584|stent|stent
5404413|NCT01702584|intracranial aneurysm|intracranial aneurysm
5404414|NCT01702584|embolization|embolization
5404415|NCT01702584|adverse event|adverse event
5404416|NCT01702532|provoked craving|provoked craving
5404417|NCT01702506|Dacomitinib|dacomitinib
5404418|NCT01702506|PF-00299804|pf-00299804
5404420|NCT01702506|fasted|fasted
5404421|NCT01702506|antacid|antacid
5404422|NCT01702506|relative Bioavailability|relative bioavailability
5404423|NCT01702493|SRT2104|srt2104
5404424|NCT01702493|Modified Release|modified release
5404425|NCT01702493|Bioavailability|bioavailability
5404426|NCT01702493|Crossover|crossover
5404427|NCT01702480|Consumer Healthcare|consumer healthcare
5404428|NCT01702480|Ketones|ketones
5404429|NCT01702480|Medium Chain Triglycerides|medium chain triglycerides
5404430|NCT01702480|Age related cognitive decline|age related cognitive decline
5404743|NCT01701245|gammacore|gammacore
5404431|NCT01702480|GSK Nutrition|gsk nutrition
5404432|NCT01702467|Lp-PLA2|lp-pla2
5404433|NCT01702467|Alzheimer's disease|alzheimer's disease
5404434|NCT01702454|GSK Biologicals quadrivalent influenza vaccine|gsk biologicals quadrivalent influenza vaccine
5404435|NCT01702454|Influenza|influenza
5404436|NCT01702454|Children|children
5404437|NCT01702454|Safety|safety
5404438|NCT01702454|Immunogenicity|immunogenicity
5404439|NCT01702428|Safety|safety
5404440|NCT01702428|Consistency study|consistency study
5404441|NCT01702428|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
5404442|NCT01702428|Healthy children|healthy children
5404443|NCT01702428|Immunogenicity|immunogenicity
5404444|NCT01702415|Cystic fibrosis|cystic fibrosis
5404445|NCT01702415|Bone density|bone density
5404446|NCT01702402|intervention|intervention
5404447|NCT01702389|opioid induced hyperalgesia|opioid induced hyperalgesia
5404448|NCT01702389|Pain|pain
5404449|NCT01702389|Postoperative pain|postoperative pain
5404450|NCT01702389|Hyperalgesia|hyperalgesia
5445466|NCT01521611|Transplant|transplant
5445467|NCT01521611|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
5404451|NCT01702363|Chronic Obstructive Pulmonary Disease (COPD), GSK573719, Pharmacogenetics|chronic obstructive pulmonary disease (copd), gsk573719, pharmacogenetics
5404452|NCT01702350|Healthy Subjects|healthy subjects
5404453|NCT01702350|Relative Bioavailability|relative bioavailability
5404454|NCT01702350|Pharmacokinetics|pharmacokinetics
5404455|NCT01702350|Elderly Subjects|elderly subjects
5404456|NCT01702337|Gardasil|gardasil
5404457|NCT01702337|Prevalence-model|prevalence-model
5404458|NCT01702337|Cervarix|cervarix
5404459|NCT01702337|economic|economic
5404460|NCT01702337|health|health
5404461|NCT01702324|Psoriasis Vulgaris|psoriasis vulgaris
5404462|NCT01702324|Plaque|plaque
5404463|NCT01702324|Topical|topical
5404464|NCT01702324|Treatment|treatment
5404465|NCT01702311|Diabetes|diabetes
5404466|NCT01702311|Point of care testing|point of care testing
5404467|NCT01702311|Hypoglycemia|hypoglycemia
5404468|NCT01702311|Basal bolus insulin|basal bolus insulin
5404469|NCT01702285|Advanced Solid Tumors|advanced solid tumors
5404470|NCT01702285|EGFR|egfr
5404471|NCT01702285|HDAC|hdac
5404472|NCT01702285|Her2|her2
5404473|NCT01702285|Open-Label|open-label
5404474|NCT01702285|Dose-Escalation|dose-escalation
5404475|NCT01702246|sickle cell disease|sickle cell disease
5404476|NCT01702246|statins|statins
5404477|NCT01702246|vaso-occlusive pain|vaso-occlusive pain
5404478|NCT01702246|inflammation|inflammation
5404479|NCT01702246|biomarkers|biomarkers
5404480|NCT01702220|Generalized Anxiety Disorder|generalized anxiety disorder
5404481|NCT01702220|Geriatric|geriatric
5404482|NCT01702207|Prograf®|prograf®
5404483|NCT01702207|Advagraf®|advagraf®
5377214|NCT01825512|deferiprone|deferiprone
5404484|NCT01702207|tacrolimus|tacrolimus
5404485|NCT01702207|kidney transplant|kidney transplant
5404486|NCT01702207|renal transplant|renal transplant
5404488|NCT01702207|Framingham Risk|framingham risk
5404489|NCT01702207|Reynolds Risk|reynolds risk
5404490|NCT01702207|immunosuppression|immunosuppression
5404491|NCT01702194|OIC|oic
5404492|NCT01702194|Opioid Induced Constipation|opioid induced constipation
5404493|NCT01702194|Constipation|constipation
5404494|NCT01702181|Atopic Dermatitis, Eczema|atopic dermatitis, eczema
5404495|NCT01702168|PTSD|ptsd
5404500|NCT01702142|Addiction Treatment|addiction treatment
5404501|NCT01702129|EGFR|egfr
5404502|NCT01702129|liposomes|liposomes
5404503|NCT01702129|immunoliposomes|immunoliposomes
5404504|NCT01702116|rectal adenocarcinoma|rectal adenocarcinoma
5404505|NCT01702116|Standard APR|standard apr
5404506|NCT01702116|Extralevator APR|extralevator apr
5404507|NCT01702090|HIV-1|hiv-1
5404508|NCT01702090|TMC114|tmc114
5404509|NCT01702090|Darunavir|darunavir
5404510|NCT01702090|PREZISTA|prezista
5404511|NCT01702090|Ritonavir|ritonavir
5404512|NCT01702090|Antiretrovirals|antiretrovirals
5404513|NCT01702090|Early access|early access
5404514|NCT01702090|Early treatment|early treatment
5404515|NCT01702090|Treatment naive|treatment naive
5404516|NCT01702077|neurofeedback|neurofeedback
5404517|NCT01702077|biofeedback|biofeedback
5404518|NCT01702077|real-time fMRI|real-time fmri
5404519|NCT01702077|rt-fMRI|rt-fmri
5404520|NCT01702077|functional connectivity|functional connectivity
5404521|NCT01702077|fMRI|fmri
5404523|NCT01702064|CP-CML|cp-cml
5404524|NCT01702064|Chronic Phase-CML (CP-CML)|chronic phase-cml (cp-cml)
5404525|NCT01702064|chronic myeloid leukemia|chronic myeloid leukemia
5404526|NCT01702051|Pancreatogenic diabetes|pancreatogenic diabetes
5404527|NCT01702051|Autologou Islet Transplantation|autologou islet transplantation
5404528|NCT01702051|Pancreas|pancreas
5404529|NCT01702051|Pancreatectomy|pancreatectomy
5404530|NCT01702025|Hypoxia|hypoxia
5404531|NCT01702025|Altitude|altitude
5404532|NCT01702025|Exercise|exercise
5404533|NCT01702012|Diabetes-Obesity|diabetes-obesity
5404534|NCT01701999|Botulism Vaccine|botulism vaccine
5404535|NCT01701973|obesity|obesity
5404536|NCT01701973|growth hormone|growth hormone
5404537|NCT01701947|Factor XI deficiency|factor xi deficiency
5404538|NCT01701947|EAP|eap
5404539|NCT01701947|postpartum hemorrhage|postpartum hemorrhage
5404540|NCT01701947|surgery|surgery
5404541|NCT01701947|delivery|delivery
5404542|NCT01701947|Child birth|child birth
5404543|NCT01701934|COPD|copd
5404544|NCT01701934|Intrabdominal adiposity|intrabdominal adiposity
5404545|NCT01701934|Body composition|body composition
5404546|NCT01701934|Triglycerides|triglycerides
5404547|NCT01701934|Cholesterol|cholesterol
5404548|NCT01701921|cardiac surgery|cardiac surgery
5404549|NCT01701921|pregabalin|pregabalin
5404550|NCT01701921|postoperative pain|postoperative pain
5404551|NCT01701908|PPCs|ppcs
5404552|NCT01701908|abdominal surgery|abdominal surgery
5404553|NCT01701908|postoperative infections|postoperative infections
5404554|NCT01701908|postoperative residual curarization|postoperative residual curarization
5404555|NCT01701908|tracheal re-intubation|tracheal re-intubation
5404556|NCT01701908|mortality|mortality
5404557|NCT01701908|ICU stay|icu stay
5404558|NCT01701895|Complera|complera
5404559|NCT01701895|short-term|short-term
5404560|NCT01701895|long-term|long-term
5404561|NCT01701895|compliance|compliance
5404562|NCT01701895|caloric|caloric
5404563|NCT01701895|intake|intake
5404564|NCT01701895|HIV|hiv
5404565|NCT01701895|positive|positive
5404566|NCT01701895|women|women
5404567|NCT01701856|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5404568|NCT01701856|natalizumab|natalizumab
5404569|NCT01701856|de-escalation|de-escalation
5404570|NCT01701856|interferon beta-1b|interferon beta-1b
5404571|NCT01701830|omentin-1|omentin-1
5404572|NCT01701830|carotid atherosclerosis|carotid atherosclerosis
5404573|NCT01701830|kidney disease|kidney disease
5404574|NCT01701817|Atrial Fibrillation|atrial fibrillation
5404575|NCT01701817|Irregular heart beat|irregular heart beat
5404576|NCT01701804|Failed Back Surgery Syndrome|failed back surgery syndrome
5404577|NCT01701791|Depression|depression
5404578|NCT01701791|Primary care|primary care
5404579|NCT01701791|Computerized decision support system|computerized decision support system
5404580|NCT01701791|General practitioner|general practitioner
5404581|NCT01701778|Dexmedetomidine|dexmedetomidine
5404582|NCT01701778|Postoperative pain reaction|postoperative pain reaction
5404583|NCT01701778|anesthesia|anesthesia
5404584|NCT01701778|children|children
5404585|NCT01701765|Severe mental disorders|severe mental disorders
5404586|NCT01701765|Discharge|discharge
5404587|NCT01701765|Outcome evaluation|outcome evaluation
5404588|NCT01701752|Influenza A|influenza a
5404589|NCT01701726|Essential Hypertension|essential hypertension
5404590|NCT01701726|Acupuncture|acupuncture
5404591|NCT01701726|Specificity|specificity
5404592|NCT01701726|Acupoints effect|acupoints effect
5404593|NCT01701726|randomized controlled trials|randomized controlled trials
5404594|NCT01701713|TDCS|tdcs
5404595|NCT01701713|STROKE|stroke
5404596|NCT01701713|APHASIA|aphasia
5404598|NCT01701700|portable electronic magnifiers|portable electronic magnifiers
5404600|NCT01701687|Alcoholic liver disease|alcoholic liver disease
5404601|NCT01701687|Decompensated liver cirrhosis|decompensated liver cirrhosis
5404603|NCT01701674|skin cancer|skin cancer
5404604|NCT01701661|venous surgery|venous surgery
5404605|NCT01701661|compression therapy|compression therapy
5404606|NCT01701648|Vitiligo, amniotic membrane, malanocytes, C02 laser.|vitiligo, amniotic membrane, malanocytes, c02 laser.
5404607|NCT01701635|Disclosure|disclosure
5404608|NCT01701635|HIV-infected children|hiv-infected children
5404609|NCT01701635|Resource-limited settings|resource-limited settings
5404610|NCT01701622|Blood Pressure|blood pressure
5404611|NCT01701622|Gout|gout
5404612|NCT01701622|allopurinol|allopurinol
5404613|NCT01701622|febuxostat|febuxostat
5404614|NCT01701622|uric acid|uric acid
5404615|NCT01701609|early-onset schizophrenia|early-onset schizophrenia
5404616|NCT01701609|adolescents|adolescents
5404617|NCT01701609|cognition|cognition
5404618|NCT01701609|cognitive remediation therapy|cognitive remediation therapy
5404619|NCT01701596|Rotational atherectomy|rotational atherectomy
5404620|NCT01701596|Coronary dissection|coronary dissection
5404621|NCT01701596|Percutaneous coronary intervention|percutaneous coronary intervention
5404622|NCT01701596|Calcification|calcification
5404623|NCT01701583|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5404624|NCT01701583|CIU|ciu
5404625|NCT01701583|Urticaria|urticaria
5404626|NCT01701583|Chronic Hives|chronic hives
5404627|NCT01701583|Xolair|xolair
5404628|NCT01701570|Type 2 Diabetes|type 2 diabetes
5404629|NCT01701570|Exercise|exercise
5404630|NCT01701570|Rate of Perceived Exertion|rate of perceived exertion
5404631|NCT01701557|Ketoacidosis Fluids|ketoacidosis fluids
5404632|NCT01701518|Ozurdex|ozurdex
5404633|NCT01701518|Dexamethasone|dexamethasone
5404634|NCT01701518|Epiretinal membrane|epiretinal membrane
5404635|NCT01701518|Macular edema|macular edema
5404636|NCT01701505|operative|operative
5404637|NCT01701505|dental procedure|dental procedure
5404638|NCT01701492|pediatric|pediatric
5405240|NCT01699087|myopia|myopia
5404639|NCT01701492|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5404640|NCT01701492|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5404641|NCT01701479|Neuroblastoma|neuroblastoma
5404642|NCT01701479|Refractory neuroblastoma|refractory neuroblastoma
5404643|NCT01701479|Relapsed neuroblastoma|relapsed neuroblastoma
5404644|NCT01701479|ch14.18/CHO|ch14.18/cho
5404645|NCT01701479|Aldesleukin (IL-2)|aldesleukin (il-2)
5404646|NCT01701466|Patients|patients
5404647|NCT01701466|with|with
5404648|NCT01701453|duration of DAPT|duration of dapt
5404649|NCT01701427|Hyperalgesia|hyperalgesia
5404650|NCT01701427|Persistent pain|persistent pain
5404651|NCT01701427|deep pain|deep pain
5404652|NCT01701427|electrical stimulation|electrical stimulation
5404653|NCT01701427|groin hernia|groin hernia
5404654|NCT01701414|Femur|femur
5404656|NCT01701414|Fracture|fracture
5404657|NCT01701414|Femoral neck|femoral neck
5404658|NCT01701414|Femoral head|femoral head
5404659|NCT01701401|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5404660|NCT01701401|HCV|hcv
5404661|NCT01701401|Sustained Virologic Response|sustained virologic response
5404662|NCT01701401|Direct Acting Antiviral|direct acting antiviral
5404663|NCT01701401|Combination Therapy|combination therapy
5404664|NCT01701401|GS-7977|gs-7977
5404665|NCT01701401|GS-5885|gs-5885
5404666|NCT01701401|Ribavirin|ribavirin
5404667|NCT01701401|Open Label|open label
5404668|NCT01701401|Sofosbuvir|sofosbuvir
5404669|NCT01701401|Additional relevant MeSH terms:|additional relevant mesh terms:
5404670|NCT01701401|Hepatitis|hepatitis
5404671|NCT01701401|Hepatitis, Chronic|hepatitis, chronic
5404672|NCT01701401|Hepatitis C|hepatitis c
5404673|NCT01701401|Hepatitis C, Chronic|hepatitis c, chronic
5404674|NCT01701401|Liver Diseases|liver diseases
5404675|NCT01701401|Digestive System Diseases|digestive system diseases
5404676|NCT01701401|Hepatitis, Viral, Human|hepatitis, viral, human
5404677|NCT01701401|Virus Diseases|virus diseases
5404678|NCT01701401|Enterovirus Infections|enterovirus infections
5404679|NCT01701401|Picornaviridae Infections|picornaviridae infections
5404680|NCT01701401|RNA Virus Infections|rna virus infections
5404681|NCT01701401|Flaviviridae Infections|flaviviridae infections
5404682|NCT01701401|Antiviral Agents|antiviral agents
5404683|NCT01701401|Anti-Infective Agents|anti-infective agents
5404684|NCT01701401|Therapeutic Uses|therapeutic uses
5404685|NCT01701401|Pharmacologic Actions|pharmacologic actions
5404686|NCT01701401|Antimetabolites|antimetabolites
5404687|NCT01701401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5404688|NCT01701388|Ekso|ekso
5404689|NCT01701388|Exoskeleton|exoskeleton
5404690|NCT01701388|Spinal Cord Injury|spinal cord injury
5404691|NCT01701388|Motor Complete Incomplete|motor complete incomplete
5404692|NCT01701362|post-traumatic peripheral neuropathic pain|post-traumatic peripheral neuropathic pain
5404693|NCT01701349|ATC|atc
5404694|NCT01701349|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5404697|NCT01701349|Head and Neck Tumors|head and neck tumors
5404699|NCT01701336|Hepatitis C|hepatitis c
5404700|NCT01701336|HCV|hcv
5404701|NCT01701336|vaccine|vaccine
5404702|NCT01701336|adenovirus|adenovirus
5404703|NCT01701336|MVA|mva
5404704|NCT01701336|T cells|t cells
5404705|NCT01701336|ELISpot|elispot
5404706|NCT01701310|Adenocarcinoma|adenocarcinoma
5404707|NCT01701310|Anemia|anemia
5404708|NCT01701310|Blood Transfusion|blood transfusion
5404709|NCT01701310|Colorectal surgery|colorectal surgery
5404710|NCT01701310|Preoperative care|preoperative care
5404711|NCT01701310|Perioperative care|perioperative care
5404712|NCT01701310|Postoperative care|postoperative care
5404713|NCT01701310|Iron|iron
5404714|NCT01701310|Hematinics|hematinics
5404715|NCT01701310|Hepcidin|hepcidin
5404716|NCT01701310|Quality of life|quality of life
5539016|NCT01131325|Ph+|ph+
5404717|NCT01701310|Postoperative complications|postoperative complications
5404718|NCT01701297|Cirrhosis, ascites, infection|cirrhosis, ascites, infection
5404719|NCT01701284|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5404720|NCT01701284|Cancer Survivors|cancer survivors
5404721|NCT01701284|Depression|depression
5404722|NCT01701284|Anxiety|anxiety
5404723|NCT01701271|Baldness|baldness
5404724|NCT01701271|Androgenetic Alopecia|androgenetic alopecia
5404725|NCT01701271|Alopecia|alopecia
5404726|NCT01701258|Depression|depression
5404727|NCT01701258|Childhood Sexual Abuse|childhood sexual abuse
5404728|NCT01701258|Dopamine|dopamine
5404729|NCT01701258|MRI|mri
5404730|NCT01701258|PET|pet
5404731|NCT01701258|ERP|erp
5404732|NCT01701258|Stress|stress
5404733|NCT01701258|Reward|reward
5404734|NCT01701258|Childhood trauma|childhood trauma
5404735|NCT01701258|Amisulpride|amisulpride
5404736|NCT01701245|vagus nerve stimulation|vagus nerve stimulation
5404737|NCT01701245|vagal nerve stimulation|vagal nerve stimulation
5404738|NCT01701245|nVNS|nvns
5404739|NCT01701245|VNS|vns
5404740|NCT01701245|cluster headache|cluster headache
5404741|NCT01701245|chronic|chronic
5404742|NCT01701245|non invasive|non invasive
5404744|NCT01701232|lymphoma, non-Hodgkin's|lymphoma, non-hodgkin's
5404745|NCT01701219|Staphylococcus aureus bacteremia|staphylococcus aureus bacteremia
5404746|NCT01701219|Methicillin-resistant Staphylococcus aureus bacteremia|methicillin-resistant staphylococcus aureus bacteremia
5404747|NCT01701219|MRSA bacteremia|mrsa bacteremia
5404748|NCT01701219|Blood|blood
5404749|NCT01701219|Adult|adult
5404750|NCT01701219|Infections|infections
5404751|NCT01701219|Blood Culture|blood culture
5404753|NCT01701206|social networking|social networking
5404754|NCT01701206|at-risk populations|at-risk populations
5404755|NCT01701206|sexual risk behaviors|sexual risk behaviors
5404756|NCT01701180|Male Volunteers|male volunteers
5404757|NCT01701154|Pompe respiratory|pompe respiratory
5404758|NCT01701141|Positron Emission Tomography (PET)|positron emission tomography (pet)
5404759|NCT01701141|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5404760|NCT01701141|reward|reward
5404761|NCT01701141|stress|stress
5404762|NCT01701141|learning|learning
5404763|NCT01701141|Major Depressive Disorder|major depressive disorder
5404764|NCT01701141|Anhedonia|anhedonia
5404765|NCT01701128|Physical activity, treadmill training, rehabilitation|physical activity, treadmill training, rehabilitation
5445468|NCT01521611|yttrium|yttrium
5404766|NCT01701115|Interscalene Block|interscalene block
5404767|NCT01701076|Relapsed / refractory multiple myeloma|relapsed / refractory multiple myeloma
5404768|NCT01701076|2nd line treatment|2nd line treatment
5404769|NCT01701050|circulating tumor cells|circulating tumor cells
5404770|NCT01701050|CTC|ctc
5404771|NCT01701050|metastatic breast cancer|metastatic breast cancer
5404772|NCT01701050|endocrine therapy|endocrine therapy
5404773|NCT01701050|hormone therapy|hormone therapy
5404774|NCT01701037|Melanoma, B-RAF, biomarkers, targeted therapy, resistance|melanoma, b-raf, biomarkers, targeted therapy, resistance
5404775|NCT01701024|Acne|acne
5404776|NCT01701011|coping|coping
5404777|NCT01701011|intervention|intervention
5404778|NCT01701011|waiting-period|waiting-period
5404779|NCT01700985|psoriasis|psoriasis
5404780|NCT01700985|plaque psoriasis|plaque psoriasis
5404781|NCT01700985|122-0551|122-0551
5404782|NCT01700985|steroid|steroid
5404783|NCT01700959|Melatonin|melatonin
5404784|NCT01700959|Neurocognitive impairment|neurocognitive impairment
5404785|NCT01700959|Sleep disturbance|sleep disturbance
5404786|NCT01700959|Childhood cancer survivors|childhood cancer survivors
5404787|NCT01700946|leukemia|leukemia
5404788|NCT01700946|lymphoma|lymphoma
5404789|NCT01700946|Non-Hodgkins|non-hodgkins
5404790|NCT01700933|Exercise therapy|exercise therapy
5404791|NCT01700920|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
5404792|NCT01700920|Stem Cell|stem cell
5404793|NCT01700920|Mesenchymal Stem Cells|mesenchymal stem cells
5404794|NCT01700920|Femoral Head|femoral head
5404797|NCT01700907|long surgery|long surgery
5404798|NCT01700894|Physical Activity|physical activity
5404799|NCT01700894|African American|african american
5404800|NCT01700894|Adherence|adherence
5404801|NCT01700881|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
5404802|NCT01700868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5404803|NCT01700868|Diet, Vegetarian|diet, vegetarian
5404804|NCT01700868|Diet, Fat-Restricted|diet, fat-restricted
5404805|NCT01700868|Glycemic Index|glycemic index
5404806|NCT01700855|Electroacupuncture|electroacupuncture
5404807|NCT01700855|Analgesia|analgesia
5404808|NCT01700855|Anesthesia|anesthesia
5404809|NCT01700855|Nasal septoplasty|nasal septoplasty
5404810|NCT01700855|Mammaplasty|mammaplasty
5404811|NCT01700842|ceftaroline, infection, CAPB, CAP, ABSSSI, cSSTI|ceftaroline, infection, capb, cap, absssi, cssti
5404812|NCT01700829|Ketamine|ketamine
5404813|NCT01700829|Midazolam|midazolam
5404814|NCT01700829|Major Depressive Disorder|major depressive disorder
5404815|NCT01700829|Suicidal ideation|suicidal ideation
5404816|NCT01700829|Suicide|suicide
5404817|NCT01700829|Depression|depression
5404818|NCT01700829|Treatment|treatment
5404819|NCT01700829|Ketamine Treatment|ketamine treatment
5404820|NCT01700816|Delirium|delirium
5404821|NCT01700816|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5404822|NCT01700816|Bone marrow transplantation|bone marrow transplantation
5404823|NCT01700816|Bright Light Therapy|bright light therapy
5404824|NCT01700803|Betadine|betadine
5404825|NCT01700803|Povidine Iodine|povidine iodine
5404826|NCT01700803|Hand scrubbing|hand scrubbing
5404827|NCT01700803|Cesarean section wound infections|cesarean section wound infections
5404828|NCT01700803|post cesarean section|post cesarean section
5404829|NCT01700790|HIV|hiv
5404830|NCT01700790|AIDS|aids
5404831|NCT01700790|Tuberculosis|tuberculosis
5404832|NCT01700790|Rifampin|rifampin
5404833|NCT01700790|Lopinavir|lopinavir
5404834|NCT01700790|Pharmacokinetic|pharmacokinetic
5404835|NCT01700777|bimanual training|bimanual training
5404836|NCT01700777|lower limb|lower limb
5404837|NCT01700777|intensive rehabilitation|intensive rehabilitation
5404838|NCT01700777|regular rehabilitation|regular rehabilitation
5404839|NCT01700777|hemiplegia|hemiplegia
5404840|NCT01700725|Gulf War Illness|gulf war illness
5404841|NCT01700725|xylitol|xylitol
5404842|NCT01700725|nasal irrigation|nasal irrigation
5404843|NCT01700725|Desert Storm|desert storm
5404844|NCT01700725|Persian Gulf Conflicts|persian gulf conflicts
5404845|NCT01700725|neti pot|neti pot
5404846|NCT01700725|cytokines|cytokines
5404847|NCT01700725|nasal mucus|nasal mucus
5404848|NCT01700725|inflammatory mediator|inflammatory mediator
5404849|NCT01700725|lactoferrin|lactoferrin
5404850|NCT01700725|lysozyme|lysozyme
5404851|NCT01700712|Caries, probiotic bacteria|caries, probiotic bacteria
5404852|NCT01700699|thyroid cancer|thyroid cancer
5404853|NCT01700699|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5404854|NCT01700699|BRAF|braf
5404855|NCT01700699|Sorafenib|sorafenib
5404856|NCT01700699|Pazopanib|pazopanib
5404857|NCT01700699|Sunitinib|sunitinib
5404858|NCT01700699|Cabozantinib|cabozantinib
5404859|NCT01700673|maintenance treatment|maintenance treatment
5404860|NCT01700673|stem cell transplant|stem cell transplant
5404861|NCT01700673|cytarabine-based chemotherapy|cytarabine-based chemotherapy
5404862|NCT01700647|Larynx cancer|larynx cancer
5404863|NCT01700647|Volatile organic compounds|volatile organic compounds
5404864|NCT01700647|Diagnosis|diagnosis
5445469|NCT01521611|indium|indium
5404865|NCT01700647|Bronchoscopy|bronchoscopy
5404866|NCT01700647|Cancer staging|cancer staging
5404867|NCT01700634|fMRI, BOLD, pressure stimuli|fmri, bold, pressure stimuli
5404868|NCT01700621|rotavirus|rotavirus
5404869|NCT01700582|lung cancer|lung cancer
5404870|NCT01700582|biomarkers|biomarkers
5404871|NCT01700582|EGFR|egfr
5404872|NCT01700582|KRAS|kras
5404873|NCT01700582|ALK|alk
5404874|NCT01700582|HER2|her2
5404875|NCT01700582|PI3K|pi3k
5404876|NCT01700582|BRAF|braf
5404877|NCT01700569|high-grade|high-grade
5404878|NCT01700569|glioma|glioma
5404879|NCT01700569|epigenetic|epigenetic
5404880|NCT01700556|Alzheimer Disease|alzheimer disease
5404881|NCT01700556|Family Caregiver|family caregiver
5404882|NCT01700556|Caregiver Burden|caregiver burden
5404883|NCT01700556|Home Care Services|home care services
5404884|NCT01700556|Assistive Technologies|assistive technologies
5404885|NCT01700543|Stemless shoulder implant|stemless shoulder implant
5404886|NCT01700543|Osteoarthritis|osteoarthritis
5404887|NCT01700543|Rheumatoid Arthritis|rheumatoid arthritis
5404888|NCT01700543|Hemi Shoulder Arthroplasty|hemi shoulder arthroplasty
5404889|NCT01700543|Total Shoulder Arthroplasty|total shoulder arthroplasty
5404890|NCT01700543|Prospective|prospective
5404891|NCT01700543|Multi-center|multi-center
5404892|NCT01700543|Europe|europe
5404893|NCT01700543|Non-Controlled|non-controlled
5404897|NCT01700530|statins|statins
5404898|NCT01700530|cholesterol|cholesterol
5404899|NCT01700530|metabolic syndrome|metabolic syndrome
5404900|NCT01700517|total knee arthroplasty, analgesia, ultrasonography|total knee arthroplasty, analgesia, ultrasonography
5404901|NCT01700504|Axillary drainage volume|axillary drainage volume
5404902|NCT01700504|Lavage with gentamicin solution|lavage with gentamicin solution
5404903|NCT01700491|Paravertebral Catheter|paravertebral catheter
5404904|NCT01700491|Epidural Catheter|epidural catheter
5404905|NCT01700491|Analgesia|analgesia
5404906|NCT01700491|Hypotension|hypotension
5404907|NCT01700491|Analgesia,Epidural|analgesia,epidural
5404908|NCT01700491|Analgesia,Paravertebral|analgesia,paravertebral
5404909|NCT01700478|Myomectomy|myomectomy
5404910|NCT01700465|Hemodialysis|hemodialysis
5404911|NCT01700465|Hemodynamics|hemodynamics
5404912|NCT01700452|Lung cancer|lung cancer
5404913|NCT01700452|Pulmonary nodules|pulmonary nodules
5404914|NCT01700452|FISH Test|fish test
5404915|NCT01700439|Aortic valve|aortic valve
5404916|NCT01700439|Heart valve|heart valve
5404917|NCT01700439|Tissue valve|tissue valve
5404918|NCT01700439|Bioprosthesis|bioprosthesis
5404919|NCT01700439|Valve disorder|valve disorder
5404920|NCT01700439|Valve disease|valve disease
5404921|NCT01700439|Cardiac surgery|cardiac surgery
5404922|NCT01700439|Less invasive cardiac surgery|less invasive cardiac surgery
5404923|NCT01700439|Aortic valve stenosis|aortic valve stenosis
5404924|NCT01700439|Aortic valve regurgitation|aortic valve regurgitation
5404925|NCT01700439|Bovine pericardium|bovine pericardium
5404926|NCT01700426|Iron Deficiency|iron deficiency
5404927|NCT01700426|Iron Deficiency Anemia|iron deficiency anemia
5404928|NCT01700413|acute|acute
5404929|NCT01700413|myeloid|myeloid
5404930|NCT01700413|leukemia|leukemia
5404931|NCT01700413|CETLAM|cetlam
5404932|NCT01700413|Idarubicin|idarubicin
5404933|NCT01700400|Lung Cancer|lung cancer
5404934|NCT01700400|Non Small Cell Lung Cancer|non small cell lung cancer
5404935|NCT01700400|Advanced Lung Cancer|advanced lung cancer
5404936|NCT01700387|Migraine|migraine
5404937|NCT01700387|Chronic Migraine|chronic migraine
5404938|NCT01700387|Cognitive Efficiency|cognitive efficiency
5404939|NCT01700387|Pilot Study|pilot study
5404940|NCT01700387|Long Term Effect|long term effect
5404941|NCT01700374|pregnancy|pregnancy
5404942|NCT01700374|stress, psychological|stress, psychological
5405241|NCT01699087|astigmatism|astigmatism
5404943|NCT01700374|stress, physiological|stress, physiological
5404944|NCT01700374|maternal-fetal relations|maternal-fetal relations
5404945|NCT01700361|sexual arousal|sexual arousal
5404946|NCT01700361|pelvic floor sEMG|pelvic floor semg
5404947|NCT01700348|moderate gingivitis|moderate gingivitis
5404948|NCT01700322|Coronary artery disease|coronary artery disease
5404949|NCT01700322|coronary stenting|coronary stenting
5404950|NCT01700322|platelet aggregation|platelet aggregation
5404951|NCT01700309|Obesity prevention; Adolescent; Physical activity; Health counselling|obesity prevention; adolescent; physical activity; health counselling
5404952|NCT01700283|Colorectal Cancer、Fatigue、Muscle strength、Metabolomics|colorectal cancer、fatigue、muscle strength、metabolomics
5404953|NCT01700257|Lung cancer screening|lung cancer screening
5404954|NCT01700257|Smokers or former smokers|smokers or former smokers
5404955|NCT01700257|Family history of lung cancer|family history of lung cancer
5404956|NCT01700231|hepatorenal syndrome, liver regeneration, liver dysfunction|hepatorenal syndrome, liver regeneration, liver dysfunction
5404957|NCT01700218|telemonitoring|telemonitoring
5404958|NCT01700205|Formula Feeding|formula feeding
5404959|NCT01700205|Mother|mother
5404960|NCT01700205|Moms|moms
5404961|NCT01700205|Infants|infants
5404962|NCT01700205|Babies|babies
5404963|NCT01700205|Baby|baby
5404964|NCT01700205|growth|growth
5404965|NCT01700205|energy balance|energy balance
5404966|NCT01700166|Autologous|autologous
5404967|NCT01700166|Cord Blood|cord blood
5404968|NCT01700166|Stem Cells|stem cells
5404969|NCT01700166|Pediatric stroke|pediatric stroke
5404970|NCT01700166|Children with ischemic stroke|children with ischemic stroke
5404971|NCT01700166|Cerebral Palsy|cerebral palsy
5404972|NCT01700166|Perinatal AIS|perinatal ais
5404973|NCT01700153|Robotic-assisted therapy|robotic-assisted therapy
5404974|NCT01700153|cerebral palsy|cerebral palsy
5404976|NCT01700127|immune response|immune response
5404977|NCT01700127|infants|infants
5404978|NCT01700127|rotavirus vaccine|rotavirus vaccine
5404979|NCT01700114|Pigmented Skin Lesions|pigmented skin lesions
5404980|NCT01700114|Dermatology|dermatology
5404981|NCT01700114|Skin Cancer|skin cancer
5404982|NCT01700114|Melanoma|melanoma
5404983|NCT01700114|MelaFind|melafind
5404984|NCT01700088|hypoxemia|hypoxemia
5404985|NCT01700088|Post Pulmonary Resection|post pulmonary resection
5404986|NCT01700075|atherosclerosis, development of concept, weight loss therapy|atherosclerosis, development of concept, weight loss therapy
5404987|NCT01700062|medium-calorie|medium-calorie
5400043|NCT01721473|Tobacco|tobacco
5404990|NCT01700049|advanced BCC|advanced bcc
5404991|NCT01700049|high risk|high risk
5404992|NCT01700049|locally advanced|locally advanced
5404993|NCT01700023|acute heart failure|acute heart failure
5404994|NCT01700010|Urothelial|urothelial
5404995|NCT01700010|Bladder|bladder
5404996|NCT01700010|Cancer|cancer
5404997|NCT01699997|Schizophrenia|schizophrenia
5404998|NCT01699997|Oxytocin|oxytocin
5405000|NCT01699984|Cognitive impairment.|cognitive impairment.
5405001|NCT01699984|Geriatrics.|geriatrics.
5405002|NCT01699984|Hospital admission.|hospital admission.
5405003|NCT01699984|Hospital discharge.|hospital discharge.
5405004|NCT01699958|Problem solving therapy|problem solving therapy
5405005|NCT01699958|Behavior change|behavior change
5405006|NCT01699945|Verbal autopsies|verbal autopsies
5405007|NCT01699945|Maternal deaths|maternal deaths
5405008|NCT01699945|Still births|still births
5405009|NCT01699919|perioperative lignocaine infusion|perioperative lignocaine infusion
5405010|NCT01699919|elective open abdominal surgeries|elective open abdominal surgeries
5405011|NCT01699919|postoperative pain|postoperative pain
5405012|NCT01699906|Obesity|obesity
5405013|NCT01699880|tracheal intubation|tracheal intubation
5405014|NCT01699880|preoxygenation|preoxygenation
5405015|NCT01699880|desaturation|desaturation
5405016|NCT01699880|hypoxemia|hypoxemia
5405017|NCT01699880|oxygen therapy|oxygen therapy
5405018|NCT01699880|high flow nasal cannula oxygen therapy|high flow nasal cannula oxygen therapy
5405019|NCT01699867|lumpectomy|lumpectomy
5405020|NCT01699867|breast cancer|breast cancer
5405021|NCT01699867|optical coherence tomography|optical coherence tomography
5405022|NCT01699867|tumor margin|tumor margin
5405023|NCT01699867|imaging|imaging
5405024|NCT01699828|buspirone|buspirone
5405025|NCT01699828|smoking cessation|smoking cessation
5405026|NCT01699828|dopamine|dopamine
5405027|NCT01699828|PET imaging|pet imaging
5405028|NCT01699828|[11C]-(+)-PHNO|[11c]-(+)-phno
5405029|NCT01699815|acetaminophen|acetaminophen
5405031|NCT01699815|arthroplasty|arthroplasty
5405032|NCT01699789|Community Partnered Participatory Research|community partnered participatory research
5405033|NCT01699789|Community Engagement|community engagement
5405034|NCT01699789|Implementation|implementation
5405035|NCT01699789|Community Based Participatory Research|community based participatory research
5405036|NCT01699789|Quality Improvement|quality improvement
5405037|NCT01699789|Evidence Based Practice|evidence based practice
5405038|NCT01699789|Patient Centered Outcomes Research|patient centered outcomes research
5405039|NCT01699776|Digoxin|digoxin
5405040|NCT01699776|Ivabradine|ivabradine
5405041|NCT01699776|with atrial fibrillation.|with atrial fibrillation.
5405042|NCT01699750|contact lenses|contact lenses
5405043|NCT01699750|contact lens solution|contact lens solution
5405044|NCT01699750|myopia|myopia
5405045|NCT01699750|astigmatism|astigmatism
5405046|NCT01699737|Diabetes|diabetes
5405047|NCT01699724|JZoloft|jzoloft
5405048|NCT01699724|Sertraline hydrochloride|sertraline hydrochloride
5405049|NCT01699724|ODT|odt
5405050|NCT01699724|bioequivalence|bioequivalence
5405051|NCT01699711|APP function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program|app function (amyloid precursor protein, cognitive stimulation, alzheimer disease. program
5405052|NCT01699698|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5405053|NCT01699685|Moderate to severe COPD patients are included|moderate to severe copd patients are included
5405054|NCT01699685|NVA|nva
5405055|NCT01699685|QAB|qab
5387894|NCT01776931|Pregnancy|pregnancy
5405056|NCT01699672|Patient education|patient education
5405057|NCT01699672|information|information
5405058|NCT01699672|communication|communication
5405059|NCT01699659|Allergic Rhinitis|allergic rhinitis
5405060|NCT01699659|Allergen Immunotherapy|allergen immunotherapy
5405061|NCT01699646|Intrapartum fetal surveillance|intrapartum fetal surveillance
5405062|NCT01699646|CTG|ctg
5405063|NCT01699646|cardiotocography|cardiotocography
5405064|NCT01699646|STAN|stan
5405065|NCT01699646|ST-Analysis|st-analysis
5405066|NCT01699646|metabolic acidosis in umbilical artery|metabolic acidosis in umbilical artery
5405067|NCT01699646|operative delivery|operative delivery
5405068|NCT01699633|Drug-drug interactions|drug-drug interactions
5405069|NCT01699633|Drug-gene interactions|drug-gene interactions
5405070|NCT01699633|Nevirapine|nevirapine
5405071|NCT01699633|Rifampicin|rifampicin
5405072|NCT01699633|children|children
5405073|NCT01699620|Bone anchored hearing aid|bone anchored hearing aid
5405074|NCT01699620|Soft tissue healing|soft tissue healing
5405075|NCT01699620|Implant stability|implant stability
5405076|NCT01699620|Linear incision|linear incision
5405077|NCT01699620|Dermatome technique|dermatome technique
5405078|NCT01699620|Hearing Aids|hearing aids
5405079|NCT01699620|Implants, Artificial|implants, artificial
5405080|NCT01699620|Surgical Procedures, Operative|surgical procedures, operative
5405081|NCT01699607|Cigarette Smokers|cigarette smokers
5405082|NCT01699607|Healthy Non Smokers|healthy non smokers
5405083|NCT01699607|Amphetamine|amphetamine
5405084|NCT01699607|PET|pet
5405085|NCT01699607|Controls|controls
5405086|NCT01699594|asthma|asthma
5405087|NCT01699594|allergies|allergies
5405088|NCT01699594|mannitol|mannitol
5405089|NCT01699594|methacholine|methacholine
5405090|NCT01699581|Hodgkin's Lymphoma|hodgkin's lymphoma
5405091|NCT01699581|Multiple Myeloma|multiple myeloma
5405092|NCT01699581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5405093|NCT01699568|dental implant stability|dental implant stability
5405094|NCT01699568|dental implant surface treatment|dental implant surface treatment
5405095|NCT01699568|resonance frequence analysis|resonance frequence analysis
5405096|NCT01699555|Multiple sclerosis|multiple sclerosis
5405097|NCT01699555|GNbAC1|gnbac1
5405099|NCT01699555|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
5405100|NCT01699542|Refractory Anastomotic esophageal strictures|refractory anastomotic esophageal strictures
5405101|NCT01699516|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography|allogeneic transplantation; intestinal graft-vs.-host disease; contrast enhanced ultrasound sonography
5405102|NCT01699503|Dementia|dementia
5405103|NCT01699503|Alzheimer's Disease|alzheimer's disease
5405104|NCT01699503|Mild Cognitive Impairment|mild cognitive impairment
5405105|NCT01699503|Screening|screening
5405106|NCT01699490|Major Depressive Disorder|major depressive disorder
5405107|NCT01699490|Antidepressants|antidepressants
5405108|NCT01699490|Insulin|insulin
5405109|NCT01699490|Fluoxetine|fluoxetine
5405110|NCT01699477|FUS|fus
5405111|NCT01699477|focused ultrasound|focused ultrasound
5405112|NCT01699477|functional brain disorders|functional brain disorders
5405113|NCT01699477|neuropathic pain|neuropathic pain
5405114|NCT01699477|movement disorders|movement disorders
5405115|NCT01699464|Glaucoma|glaucoma
5405116|NCT01699438|Irritable Bowel Syndrome|irritable bowel syndrome
5405117|NCT01699438|Inflammation|inflammation
5405118|NCT01699438|Mesalazine|mesalazine
5405119|NCT01699425|Stress urinary incontinence.|stress urinary incontinence.
5405120|NCT01699425|Suburethral sling.|suburethral sling.
5405121|NCT01699425|Single-incision suburethral sling.|single-incision suburethral sling.
5405122|NCT01699425|Ajust.|ajust.
5405123|NCT01699425|Transobturator tape.|transobturator tape.
5405124|NCT01699412|Bone Marrow Transplantation|bone marrow transplantation
5405125|NCT01699412|Graft vs Host Disease|graft vs host disease
5405126|NCT01699412|Oral Manifestations|oral manifestations
5405127|NCT01699399|colonoscopy|colonoscopy
5405128|NCT01699399|pain|pain
5405129|NCT01699399|sedation|sedation
5405130|NCT01699399|water|water
5405131|NCT01699360|Kidney Transplantation|kidney transplantation
5405132|NCT01699360|Immunosuppressive Agents|immunosuppressive agents
5405133|NCT01699360|Hydrocortisone|hydrocortisone
5405134|NCT01699360|Cortisone|cortisone
5405135|NCT01699347|OK432, CYSTIC MALFORMATION|ok432, cystic malformation
5405136|NCT01699334|Whiplash injuries|whiplash injuries
5405137|NCT01699334|patient education|patient education
5405138|NCT01699334|illness perceptions|illness perceptions
5405139|NCT01699334|RCT|rct
5405140|NCT01699334|motor vehicle accidents|motor vehicle accidents
5405141|NCT01699321|physical activity|physical activity
5405142|NCT01699321|barbershop|barbershop
5405143|NCT01699321|cancer prevention|cancer prevention
5405144|NCT01699321|exercise|exercise
5405145|NCT01699321|men's health|men's health
5405146|NCT01699321|African American men|african american men
5405147|NCT01699308|Traumatic Brain Injury|traumatic brain injury
5405148|NCT01699308|Growth Hormone|growth hormone
5405149|NCT01699308|Neuroimaging|neuroimaging
5405150|NCT01699295|academic achievement|academic achievement
5405151|NCT01699295|elementary school|elementary school
5405152|NCT01699295|physical activity|physical activity
5405153|NCT01699295|exercise|exercise
5405154|NCT01699282|oral anticoagulant|oral anticoagulant
5405155|NCT01699282|in the long term (> 12 months)|in the long term (> 12 months)
5405156|NCT01699269|High grade brain tumor|high grade brain tumor
5405157|NCT01699269|Glioma|glioma
5405158|NCT01699269|Glioblastoma Multiform|glioblastoma multiform
5405159|NCT01699269|Brain Cancer|brain cancer
5405160|NCT01699269|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5405161|NCT01699269|High order diffusion tensor|high order diffusion tensor
5405162|NCT01699269|Imaging guided biopsy|imaging guided biopsy
5405163|NCT01699269|Histopathologic evaluation|histopathologic evaluation
5405164|NCT01699269|Infiltration percentage|infiltration percentage
5405165|NCT01699256|General Practice|general practice
5405166|NCT01699256|Low Back Pain|low back pain
5405167|NCT01699256|Guideline|guideline
5405168|NCT01699256|Health Plan Implementation|health plan implementation
5405169|NCT01699256|Referral and Consultation|referral and consultation
5405170|NCT01699243|pregnancy|pregnancy
5405171|NCT01699243|labor|labor
5405172|NCT01699243|epidural|epidural
5405173|NCT01699243|fetal intervention|fetal intervention
5405174|NCT01699230|Elective cardiac surgery|elective cardiac surgery
5405175|NCT01699230|with sternotomy and|with sternotomy and
5405176|NCT01699230|cardiopulmonary bypass|cardiopulmonary bypass
5405177|NCT01699230|for coronary artery|for coronary artery
5405178|NCT01699230|bypass graft.|bypass graft.
5405179|NCT01699217|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
5405181|NCT01699217|BCR-ABL positive|bcr-abl positive
5405182|NCT01699204|Air pollution|air pollution
5405183|NCT01699204|Diesel exhaust|diesel exhaust
5405184|NCT01699204|Airway responsiveness|airway responsiveness
5405185|NCT01699204|Asthma|asthma
5405186|NCT01699204|Anti-oxidant|anti-oxidant
5405187|NCT01699191|Irritable Bowel Syndrome|irritable bowel syndrome
5405188|NCT01699191|Celiac Desease|celiac desease
5405189|NCT01699191|Probiotic|probiotic
5405190|NCT01699191|Lactobacillus plantarum|lactobacillus plantarum
5408653|NCT01683656|HDL|hdl
5405193|NCT01699191|Bifidobacterium animalis|bifidobacterium animalis
5405195|NCT01699165|allergic|allergic
5405196|NCT01699165|seasonal|seasonal
5405197|NCT01699165|double blind|double blind
5405198|NCT01699165|doubleblind|doubleblind
5405199|NCT01699165|randomized|randomized
5405200|NCT01699165|randomised|randomised
5405201|NCT01699165|placebo|placebo
5405202|NCT01699165|crossover|crossover
5405203|NCT01699165|clinical|clinical
5405204|NCT01699165|nasal|nasal
5405205|NCT01699165|filter|filter
5405206|NCT01699165|controlled|controlled
5405207|NCT01699165|trial|trial
5405208|NCT01699165|hayfever|hayfever
5405209|NCT01699165|hay|hay
5405210|NCT01699165|fever|fever
5405211|NCT01699165|efficacy|efficacy
5405212|NCT01699165|safety|safety
5405213|NCT01699165|prevention|prevention
5405214|NCT01699165|adult|adult
5405215|NCT01699165|grass|grass
5405216|NCT01699165|pollen|pollen
5405217|NCT01699165|symptom|symptom
5405218|NCT01699165|Total nasal symptom score|total nasal symptom score
5405219|NCT01699165|acoustic rhinometry|acoustic rhinometry
5405220|NCT01699152|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5405221|NCT01699152|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5405222|NCT01699139|supine position|supine position
5405223|NCT01699126|Obstructive Sleep Apnea|obstructive sleep apnea
5405224|NCT01699126|CPAP|cpap
5405225|NCT01699126|Endothelium dysfunction|endothelium dysfunction
5405226|NCT01699126|Hypertension|hypertension
5405227|NCT01699113|YF476|yf476
5405228|NCT01699113|gastrin receptor antagonist|gastrin receptor antagonist
5405229|NCT01699113|gastric pH|gastric ph
5405230|NCT01699113|gastrin|gastrin
5405231|NCT01699113|rabeprazole|rabeprazole
5405232|NCT01699113|proton-pump inhibitor|proton-pump inhibitor
5405233|NCT01699113|gastric function|gastric function
5405234|NCT01699113|healthy subjects|healthy subjects
5405235|NCT01699100|offloading|offloading
5405236|NCT01699100|plantar pressure|plantar pressure
5405237|NCT01699100|insole|insole
5405238|NCT01699100|foot ulcer|foot ulcer
5405239|NCT01699087|PRK|prk
5405242|NCT01699074|Korean White Ginseng|korean white ginseng
5405243|NCT01699074|Type 2 diabetes|type 2 diabetes
5405244|NCT01699074|Metabolic syndrome|metabolic syndrome
5405245|NCT01699048|multivessel PCI,MIDCAB,CABG|multivessel pci,midcab,cabg
5405246|NCT01699048|Hybrid coronary revascularization|hybrid coronary revascularization
5405247|NCT01699035|stroke|stroke
5405248|NCT01699035|work|work
5405249|NCT01699035|vocational rehabilitation|vocational rehabilitation
5405250|NCT01699022|Contraceptive|contraceptive
5405251|NCT01699022|Injectable|injectable
5405252|NCT01699009|Migraines, diet, vegan, vegetarian, plant-based|migraines, diet, vegan, vegetarian, plant-based
5405253|NCT01698996|abscess|abscess
5405254|NCT01698996|packing|packing
5405255|NCT01698996|emergency medicine|emergency medicine
5405256|NCT01698996|wound care|wound care
5405257|NCT01698996|incision and drainage|incision and drainage
5405258|NCT01698970|Probiotic|probiotic
5405259|NCT01698970|capsules|capsules
5405260|NCT01698970|Crohn's disease|crohn's disease
5405261|NCT01698970|recurrent endoscopic ileo-colonic lesions|recurrent endoscopic ileo-colonic lesions
5405262|NCT01698957|Pregnant women|pregnant women
5405263|NCT01698957|Uterine Artery Doppler Velocimetry|uterine artery doppler velocimetry
5405265|NCT01698905|Phase II, single arm, open label, nilotinib, treatment-free remission, MR4.5, confirmed loss of MR4, loss of MMR, Ph+ CML-CP|phase ii, single arm, open label, nilotinib, treatment-free remission, mr4.5, confirmed loss of mr4, loss of mmr, ph+ cml-cp
5405266|NCT01698892|I.V. sedation, midazolam, bronchoscopy|i.v. sedation, midazolam, bronchoscopy
5405267|NCT01698866|Low grade lymphoma|low grade lymphoma
5405268|NCT01698866|follicular lymphoma|follicular lymphoma
5405269|NCT01698866|indolent lymphoproliferative disorders|indolent lymphoproliferative disorders
5405270|NCT01698866|Vaccin GenHevac B Pasteur|vaccin genhevac b pasteur
5405271|NCT01698840|Vitamin D|vitamin d
5405272|NCT01698840|Transitional Formula|transitional formula
5405273|NCT01698827|gastrostomy|gastrostomy
5405274|NCT01698827|tube|tube
5405275|NCT01698827|endoscopic|endoscopic
5405276|NCT01698827|replacement|replacement
5405277|NCT01698827|tube rupture|tube rupture
5405278|NCT01698827|durability|durability
5405279|NCT01698827|tube loss|tube loss
5405280|NCT01698827|balloon rupture|balloon rupture
5405281|NCT01698814|ocular safety|ocular safety
5405282|NCT01698814|allergic conjunctivitis|allergic conjunctivitis
5405283|NCT01698801|Lenalidomide|lenalidomide
5405284|NCT01698801|dexamethasone|dexamethasone
5400348|NCT01720199|wellbeing|wellbeing
5405285|NCT01698801|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5405287|NCT01698788|taut posterior hyaloid membrane|taut posterior hyaloid membrane
5405288|NCT01698788|ozurdex|ozurdex
5405289|NCT01698762|Musculoskeletal Diseases|musculoskeletal diseases
5405290|NCT01698762|Osteoarthritis|osteoarthritis
5405292|NCT01698762|Rheumatoid Arthritis|rheumatoid arthritis
5405293|NCT01698762|RA|ra
5405294|NCT01698762|Osteoporosis|osteoporosis
5405295|NCT01698762|OP|op
5405296|NCT01698762|Multimedia Patient Decision Aids|multimedia patient decision aids
5405297|NCT01698762|MM-PtDAs|mm-ptdas
5405298|NCT01698762|DVD|dvd
5685281|NCT00556803|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5405299|NCT01698762|Comparative Effectiveness Research Summary Guide|comparative effectiveness research summary guide
5405300|NCT01698762|CERSG|cersg
5405301|NCT01698762|Booklet|booklet
5405302|NCT01698762|Questionnaires|questionnaires
5405303|NCT01698762|Surveys|surveys
5405304|NCT01698749|Ozurdex|ozurdex
5405305|NCT01698749|Diabetic macular edema|diabetic macular edema
5405306|NCT01698749|Central macular thickness|central macular thickness
5405307|NCT01698736|ABO isoagglutinins|abo isoagglutinins
5405308|NCT01698736|ABO incompatible transplantation|abo incompatible transplantation
5405309|NCT01698736|immunoadsorption|immunoadsorption
5405310|NCT01698736|membrane filtration|membrane filtration
5405311|NCT01698736|plasmapheresis|plasmapheresis
5405312|NCT01698723|ACLF|aclf
5405313|NCT01698723|HEV|hev
5405314|NCT01698723|Ribavirin|ribavirin
5405315|NCT01698710|Premalignant|premalignant
5405316|NCT01698710|Malignant|malignant
5405317|NCT01698684|ED|ed
5405318|NCT01698645|quality of life|quality of life
5405319|NCT01698645|PecFent|pecfent
5405320|NCT01698645|Lazanda|lazanda
5405321|NCT01698645|fentanyl|fentanyl
5405322|NCT01698645|intranasal|intranasal
5405323|NCT01698645|breakthrough cancer pain|breakthrough cancer pain
5405324|NCT01698632|Adnexal masses|adnexal masses
5405325|NCT01698632|Ovarian cysts|ovarian cysts
5405326|NCT01698632|Ovarian tumors|ovarian tumors
5405327|NCT01698606|childhood obesity|childhood obesity
5405328|NCT01698606|multidisciplinary|multidisciplinary
5405329|NCT01698606|preschool children|preschool children
5405330|NCT01698606|community-based|community-based
5405331|NCT01698606|lifestyle intervention|lifestyle intervention
5405332|NCT01698606|family-centered|family-centered
5405333|NCT01698593|Bupivacaine|bupivacaine
5405334|NCT01698593|digital nerve block|digital nerve block
5405335|NCT01698593|epinephrine|epinephrine
5405336|NCT01698593|duration of action|duration of action
5405337|NCT01698593|pain|pain
5405338|NCT01698593|touch|touch
5405339|NCT01698593|pressure|pressure
5405340|NCT01698593|temperature|temperature
5405341|NCT01698580|accidental falls|accidental falls
5405342|NCT01698580|aged|aged
5405343|NCT01698580|aged, 80 and over|aged, 80 and over
5405344|NCT01698580|prevention and control|prevention and control
5405345|NCT01698567|Infants|infants
5405346|NCT01698567|Cardiopulmonary bypass|cardiopulmonary bypass
5405347|NCT01698567|anticoaglution|anticoaglution
5405348|NCT01698541|Renal|renal
5405349|NCT01698541|Transplantation|transplantation
5405350|NCT01698541|Elderly|elderly
5405351|NCT01698528|Diabetes|diabetes
5405352|NCT01698528|diabetes technologies|diabetes technologies
5405353|NCT01698528|telemedicine|telemedicine
5405354|NCT01698502|Incretin|incretin
5405355|NCT01698502|Training|training
5388187|NCT01775501|sorafenib|sorafenib
5405356|NCT01698502|Glucagon like peptide|glucagon like peptide
5405357|NCT01698502|glucose dependent insulinotropic peptide|glucose dependent insulinotropic peptide
5405358|NCT01698502|Gut|gut
5405359|NCT01698502|Exercise|exercise
5405360|NCT01698502|Insulin|insulin
5405361|NCT01698502|Focus:|focus:
5405362|NCT01698502|Gut hormone|gut hormone
5405363|NCT01698502|adaptations|adaptations
5405364|NCT01698476|pulmonary TB|pulmonary tb
5405365|NCT01698476|cholecalciferol|cholecalciferol
5405366|NCT01698476|sodium phenylbutyrate|sodium phenylbutyrate
5405367|NCT01698476|antimicrobial peptides|antimicrobial peptides
5405368|NCT01698476|immune response|immune response
5405369|NCT01698463|Falls, Fractures, Osteoporosis, Frailty, Older Adults.|falls, fractures, osteoporosis, frailty, older adults.
5405370|NCT01698450|FUS|fus
5405371|NCT01698450|focused ultrasound|focused ultrasound
5405372|NCT01698450|functional brain disorder|functional brain disorder
5405373|NCT01698450|neuropathic pain|neuropathic pain
5405374|NCT01698450|movement disorders|movement disorders
5405375|NCT01698450|malignant brain tumors|malignant brain tumors
5405376|NCT01698437|FUS|fus
5405377|NCT01698437|focused ultrasound|focused ultrasound
5405378|NCT01698437|functional brain disorders|functional brain disorders
5405379|NCT01698437|neuropathic pain|neuropathic pain
5405380|NCT01698437|movement disorders|movement disorders
5405381|NCT01698437|malignant of brain tumors|malignant of brain tumors
5405382|NCT01698411|hypertension|hypertension
5405383|NCT01698411|sleep|sleep
5405384|NCT01698411|insomnia|insomnia
5405385|NCT01698372|Cardiac surgery.|cardiac surgery.
5405386|NCT01698372|Wound healing.|wound healing.
5405387|NCT01698372|Leg wound infection.|leg wound infection.
5405388|NCT01698372|Wound care.|wound care.
5405390|NCT01698346|Infants|infants
5405391|NCT01698346|Vaccination|vaccination
5405392|NCT01698346|Pregnancy|pregnancy
5405393|NCT01698333|122-0551|122-0551
5405394|NCT01698333|steroid|steroid
5405395|NCT01698333|HPA|hpa
5405396|NCT01698307|Crohn's Disease|crohn's disease
5405397|NCT01698307|Deep Remission|deep remission
5405398|NCT01698307|Complications|complications
5405399|NCT01698294|gut microbiome|gut microbiome
5405400|NCT01698294|hormones|hormones
5405401|NCT01698294|women|women
5405402|NCT01698294|race|race
5405403|NCT01698294|phytoestrogens|phytoestrogens
5405405|NCT01698255|Geriatrics|geriatrics
5405406|NCT01698242|Heart failure|heart failure
5405407|NCT01698242|Self-Management|self-management
5405408|NCT01698242|Behavioral Clinical Trial|behavioral clinical trial
5405409|NCT01698229|Cerebrospinal fluid|cerebrospinal fluid
5539876|NCT01127685|acl|acl
5405410|NCT01698229|Lumbar puncture|lumbar puncture
5405411|NCT01698229|Spinal tap|spinal tap
5405412|NCT01698229|Late infantile neuronal ceroid lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
5405413|NCT01698229|Batten disease|batten disease
5405414|NCT01698216|Paliperidone|paliperidone
5405415|NCT01698216|Palmitate|palmitate
5405416|NCT01698216|switching|switching
5405417|NCT01698216|schizophrenia|schizophrenia
5405418|NCT01698216|subjective well-being|subjective well-being
5405419|NCT01698177|Influenza|influenza
5405421|NCT01698177|Vaccination|vaccination
5405422|NCT01698177|Immune response to influenza vaccination|immune response to influenza vaccination
5405423|NCT01698164|lipid profiles|lipid profiles
5405424|NCT01698164|coronary heart disease|coronary heart disease
5405425|NCT01698164|menopausal syndrome|menopausal syndrome
5405426|NCT01698164|MMSE|mmse
5405427|NCT01698164|MENQOL|menqol
5405428|NCT01698164|HAD|had
5405429|NCT01698151|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5405430|NCT01698151|COPD|copd
5405431|NCT01698138|Spinal cord injury|spinal cord injury
5405432|NCT01698138|Neurogenic overactive bladder|neurogenic overactive bladder
5405433|NCT01698138|Onabotulinum toxin A|onabotulinum toxin a
5405434|NCT01698138|Prevention|prevention
5405435|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a
5405436|NCT01698125|Delirium|delirium
5405437|NCT01698125|Autonomic cardiovascular control|autonomic cardiovascular control
5405438|NCT01698125|Abdominal surgery|abdominal surgery
5405439|NCT01698125|Tilt-test|tilt-test
5405440|NCT01698086|Multiple Sclerosis|multiple sclerosis
5405441|NCT01698086|Balance|balance
5405442|NCT01698086|Fatigue|fatigue
5405539|NCT01697358|RCT|rct
5405443|NCT01698086|Eye movement|eye movement
5405444|NCT01698073|Teen pregnancy prevention|teen pregnancy prevention
5405445|NCT01698073|American Indian|american indian
5405446|NCT01698073|Group-randomized trial|group-randomized trial
5405447|NCT01698060|Prevention of Avian Influenza|prevention of avian influenza
5388293|NCT01775111|sarcopenia|sarcopenia
5405448|NCT01698047|Depressive symptoms|depressive symptoms
5405449|NCT01698047|sub-threshold depression|sub-threshold depression
5405450|NCT01698047|resiliency|resiliency
5405451|NCT01698047|Health Promotion|health promotion
5405452|NCT01698047|minority health|minority health
5405453|NCT01698034|volunteering|volunteering
5405454|NCT01698034|cardiovascular health|cardiovascular health
5405455|NCT01698021|Creatine Kinase, MB form|creatine kinase, mb form
5405456|NCT01698021|Troponin|troponin
5405457|NCT01698021|Acute coronary syndrome|acute coronary syndrome
5405458|NCT01698021|myocardial infarction|myocardial infarction
5405459|NCT01698021|Unstable angina|unstable angina
5405460|NCT01697995|right ventricle|right ventricle
5405461|NCT01697995|radiotracer uptake|radiotracer uptake
5405462|NCT01697995|Myocardial Perfusion Imaging|myocardial perfusion imaging
5405463|NCT01697995|balanced ischemia|balanced ischemia
5405464|NCT01697982|pilot study|pilot study
5405465|NCT01697982|psychosocial intervention|psychosocial intervention
5405466|NCT01697982|advanced cancer|advanced cancer
5405467|NCT01697969|allergic conjunctivitis|allergic conjunctivitis
5405468|NCT01697969|Pataday|pataday
5405469|NCT01697969|Olopatadine|olopatadine
5405470|NCT01697956|Pediatric Subjects|pediatric subjects
5405471|NCT01697943|Gastric Malignant Tumor|gastric malignant tumor
5405472|NCT01697943|Total Gastrectomy|total gastrectomy
5405473|NCT01697943|Reconstruction|reconstruction
5405474|NCT01697930|PET Imaging|pet imaging
5405475|NCT01697930|18F] 4-L-Fluoroglutam (2S,4R)|18f] 4-l-fluoroglutam (2s,4r)
5405476|NCT01697930|12-168|12-168
5405477|NCT01697917|Adenocarcinoma of Esophagogastric Junction|adenocarcinoma of esophagogastric junction
5405478|NCT01697917|Total Gastrectomy|total gastrectomy
5405479|NCT01697917|Proximal Gastrectomy|proximal gastrectomy
5405480|NCT01697891|Radiation Treatment|radiation treatment
5405481|NCT01697891|Head and Neck Cancer|head and neck cancer
5405482|NCT01697891|Dysphagia|dysphagia
5405483|NCT01697878|obstructive sleep apnea|obstructive sleep apnea
5405484|NCT01697878|obesity|obesity
5405485|NCT01697878|respiratory function|respiratory function
5405486|NCT01697878|weight loss surgery|weight loss surgery
5405487|NCT01697865|Reverse total shoulder|reverse total shoulder
5405488|NCT01697852|vector control|vector control
5405490|NCT01697852|IRS|irs
5405491|NCT01697826|Clindamycin|clindamycin
5405492|NCT01697826|Clotrimazole|clotrimazole
5405493|NCT01697826|Vaginal formulation|vaginal formulation
5405494|NCT01697826|Bacterial vaginosis|bacterial vaginosis
5405495|NCT01697826|Candidiasis|candidiasis
5405496|NCT01697826|Trichomoniasis|trichomoniasis
5405497|NCT01697826|Mixed vaginitis|mixed vaginitis
5405498|NCT01697826|Infective vaginitis|infective vaginitis
5405504|NCT01697748|wound infection|wound infection
5405505|NCT01697748|scar appearance|scar appearance
5405506|NCT01697748|post operative pain|post operative pain
5405507|NCT01697722|Primary care|primary care
5405508|NCT01697722|Asthma management|asthma management
5405509|NCT01697722|Inhaled corticosteroids|inhaled corticosteroids
5405510|NCT01697722|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
5405511|NCT01697722|Long-acting beta-agonist|long-acting beta-agonist
5405512|NCT01697722|Fixed-dose combination therapy|fixed-dose combination therapy
5405513|NCT01697709|cannabis|cannabis
5405514|NCT01697709|marijuana|marijuana
5405515|NCT01697709|pharmacotherapy|pharmacotherapy
5405516|NCT01697696|COPD, NVA237, QAB149, glycopyrronium bromide|copd, nva237, qab149, glycopyrronium bromide
5405517|NCT01697605|Phase I, open-label, dose escalation, BGJ398, Japanese, Asian, FGF-R|phase i, open-label, dose escalation, bgj398, japanese, asian, fgf-r
5405518|NCT01697566|Gynecology|gynecology
5405519|NCT01697566|Endometrial Cancer Chemoprevention|endometrial cancer chemoprevention
5405520|NCT01697566|Obese|obese
5405521|NCT01697566|Body Mass Index (BMI) >/= 35 kg.m2|body mass index (bmi) >/= 35 kg.m2
5405522|NCT01697566|Post-menopausal|post-menopausal
5405523|NCT01697566|Hyperinsulinemia|hyperinsulinemia
5405524|NCT01697566|Metformin|metformin
5405525|NCT01697566|Placebo|placebo
5405526|NCT01697566|Sugar pill|sugar pill
5405527|NCT01697566|Lifestyle intervention|lifestyle intervention
5405528|NCT01697566|Diet|diet
5405529|NCT01697566|Exercise|exercise
5405530|NCT01697514|recurrent medulloblastoma|recurrent medulloblastoma
5405531|NCT01697397|Irritable bowel syndrome|irritable bowel syndrome
5405532|NCT01697397|IBS|ibs
5405533|NCT01697397|Gastrointestinal pain|gastrointestinal pain
5405534|NCT01697397|Gastrointestinal functional disorder|gastrointestinal functional disorder
5405535|NCT01697384|prostate cancer, PSA|prostate cancer, psa
5405536|NCT01697358|FBSS|fbss
5405537|NCT01697358|post laminectomy syndrome|post laminectomy syndrome
5405538|NCT01697358|SCS|scs
5405540|NCT01697358|back pain|back pain
5405541|NCT01697345|Vaginal Testosterone|vaginal testosterone
5405542|NCT01697345|Vaginal atrophy|vaginal atrophy
5405543|NCT01697345|Female Sexual Dysfunction|female sexual dysfunction
5405544|NCT01697345|Aromatase Inhibitors|aromatase inhibitors
5405545|NCT01697332|COPD|copd
5405546|NCT01697319|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
5405547|NCT01697319|MPS IVA Type A|mps iva type a
5405548|NCT01697319|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5405549|NCT01697319|MPS IVA|mps iva
5405550|NCT01697319|Morquio A Syndrome|morquio a syndrome
5405551|NCT01697319|Lysosomal Storage Disorder|lysosomal storage disorder
5405552|NCT01697319|LSD|lsd
5405553|NCT01697319|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5405554|NCT01697319|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5405555|NCT01697319|sulfatase|sulfatase
5405556|NCT01697319|galactose-6-sulfatase|galactose-6-sulfatase
5405557|NCT01697319|GALNS|galns
5405558|NCT01697319|enzyme replacement therapy|enzyme replacement therapy
5405559|NCT01697319|ERT|ert
5405560|NCT01697319|MOR-006|mor-006
5405561|NCT01697319|CPET|cpet
5405562|NCT01697319|Limited ambulation|limited ambulation
5405563|NCT01697319|Grip/ Pinch|grip/ pinch
5405564|NCT01697306|non muscle invasive bladder cancer|non muscle invasive bladder cancer
5405565|NCT01697280|Polio supplementary immunization activities|polio supplementary immunization activities
5405566|NCT01697280|Routine EPI vaccine|routine epi vaccine
5405567|NCT01697280|Integration of polio NID and routine EPI|integration of polio nid and routine epi
5405575|NCT01697241|Exercise Therapy|exercise therapy
5405576|NCT01697241|Education|education
5405577|NCT01697241|Osteoarthritis|osteoarthritis
5405578|NCT01697241|Hip|hip
5405579|NCT01697241|Hip replacement|hip replacement
5405580|NCT01697228|Diabetes|diabetes
5405581|NCT01697228|Vitamin D|vitamin d
5405582|NCT01697228|Proinflammatory markers|proinflammatory markers
5405583|NCT01697189|professional drivers|professional drivers
5405584|NCT01697189|sleepiness|sleepiness
5405585|NCT01697189|stress|stress
5405586|NCT01697189|safe driving|safe driving
5405587|NCT01697189|training|training
5405588|NCT01697163|De Novo Resistance|de novo resistance
5405589|NCT01697163|Iressa|iressa
5405590|NCT01697163|EGFR mutation|egfr mutation
5405591|NCT01697163|lung cancer|lung cancer
5405592|NCT01697150|Type 1 diabetes mellitus|type 1 diabetes mellitus
5405593|NCT01697150|closed loop artificial pancreas|closed loop artificial pancreas
5405594|NCT01697124|Physical activity|physical activity
5405595|NCT01697124|children|children
5405596|NCT01697124|Head Start|head start
5405597|NCT01697124|SPARK-EC|spark-ec
5405598|NCT01697111|YAZ|yaz
5405599|NCT01697111|Flexible regimen|flexible regimen
5405620|NCT01696942|Crohn's disease|crohn's disease
5405621|NCT01696942|certolizumab|certolizumab
5405622|NCT01696942|mesalamine|mesalamine
5405623|NCT01696942|recurrence|recurrence
5405624|NCT01696929|tocilizumab|tocilizumab
5405625|NCT01696929|safety|safety
5405626|NCT01696929|tolerability|tolerability
5405627|NCT01696929|efficacy|efficacy
5405628|NCT01696929|schizophrenia|schizophrenia
5405629|NCT01696929|improvement|improvement
5405630|NCT01696929|cognition|cognition
5405631|NCT01696929|psychotic symptoms|psychotic symptoms
5405632|NCT01696929|baseline IL-6 levels|baseline il-6 levels
5405634|NCT01696916|carbon dioxide|carbon dioxide
5405635|NCT01696916|6-minute walking test|6-minute walking test
5405636|NCT01696903|Postoperative pancreatic fistula|postoperative pancreatic fistula
5405637|NCT01696903|Pancreatic texture|pancreatic texture
5405638|NCT01696903|Pancreatic duct diameter|pancreatic duct diameter
5405639|NCT01696903|Pancreatic consistency|pancreatic consistency
5405640|NCT01696903|Pancreaticoduodenectomy|pancreaticoduodenectomy
5405641|NCT01696890|chronic heart failure|chronic heart failure
5405642|NCT01696890|telemonitoring|telemonitoring
5405643|NCT01696890|first line practitioners|first line practitioners
5405644|NCT01696890|integrated approach|integrated approach
5405645|NCT01696890|efficacy|efficacy
5405646|NCT01696838|Crohn's disease|crohn's disease
5405647|NCT01696838|acupuncture|acupuncture
5405648|NCT01696838|moxibustion|moxibustion
5405649|NCT01696838|fMRI|fmri
5405650|NCT01696838|Gut|gut
5405651|NCT01696812|electrodeposition|electrodeposition
5405652|NCT01696812|Subthalamic Nucleus|subthalamic nucleus
5405653|NCT01696812|Deep Brain Stimulation|deep brain stimulation
5405654|NCT01696812|Parkinson Disease|parkinson disease
5405655|NCT01696773|tomato|tomato
5405656|NCT01696773|tangerine tomato|tangerine tomato
5405657|NCT01696773|carotenoids|carotenoids
5405658|NCT01696773|lycopene|lycopene
5405659|NCT01696773|flavonoids|flavonoids
5405660|NCT01696747|gastroparesis|gastroparesis
5405661|NCT01696747|idiopathic gastroparesis|idiopathic gastroparesis
5405662|NCT01696747|diabetic gastroparesis|diabetic gastroparesis
5405663|NCT01696747|post-Nissen gastroparesis|post-nissen gastroparesis
5405664|NCT01696721|Proton Therapy|proton therapy
5405665|NCT01696721|Pediatrics|pediatrics
5405666|NCT01696721|Radiation Oncology|radiation oncology
5405667|NCT01696721|Photon Therapy|photon therapy
5405668|NCT01696682|minimally invasive esophagectomy|minimally invasive esophagectomy
5405669|NCT01696682|anastomotic leakage|anastomotic leakage
5405670|NCT01696682|gastric conduit|gastric conduit
5405671|NCT01696669|Ewing's Sarcoma|ewing's sarcoma
5405672|NCT01696669|P6 protocol MSKCC|p6 protocol mskcc
5405673|NCT01696669|Gemcitabine|gemcitabine
5405674|NCT01696669|Docetaxel|docetaxel
5405675|NCT01696656|Gastrointestinal drugs|gastrointestinal drugs
5405676|NCT01696656|Antibiotics|antibiotics
5405677|NCT01696656|Vitamins|vitamins
5405678|NCT01696656|Minerals|minerals
5400749|NCT01718236|sugammadex|sugammadex
5405679|NCT01696656|Intestinal insufficiency|intestinal insufficiency
5405680|NCT01696656|Short Bowel syndrome|short bowel syndrome
5405681|NCT01696656|Adjuvant therapy|adjuvant therapy
5405682|NCT01696656|Antacids|antacids
5405683|NCT01696656|Gastrointestinal motility modifiers|gastrointestinal motility modifiers
5405684|NCT01696656|Micronutrients|micronutrients
5405685|NCT01696643|Opioid|opioid
5405686|NCT01696643|Constipation|constipation
5405687|NCT01696643|Chronic|chronic
5405688|NCT01696643|Pain|pain
5405689|NCT01696630|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change|anesthesia, epidural anagesia, colorectal surgery, xenon, hemodynamic change
5405690|NCT01696604|safety|safety
5405691|NCT01696604|pharmacokinetics|pharmacokinetics
5405692|NCT01696604|FTIH|ftih
5405693|NCT01696604|SARM|sarm
5405694|NCT01696591|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
5405695|NCT01696578|PTSD|ptsd
5405696|NCT01696578|Depression|depression
5405697|NCT01696578|Anxiety|anxiety
5405698|NCT01696578|Chronic pain|chronic pain
5405699|NCT01696578|Anger|anger
5405700|NCT01696578|Heart rate variability|heart rate variability
5405701|NCT01696578|Disability|disability
5405702|NCT01696565|myelosuppression|myelosuppression
5405703|NCT01696565|chemotherapy|chemotherapy
5405704|NCT01696565|Astragalus membranaceus|astragalus membranaceus
5405705|NCT01696565|hematopoietic response|hematopoietic response
5405706|NCT01696552|Gonarthritis|gonarthritis
5405708|NCT01696552|Conventional|conventional
5405709|NCT01696552|Positioning Guides|positioning guides
5405710|NCT01696552|PSPG|pspg
5405711|NCT01696552|CT Perth|ct perth
5405712|NCT01696539|Prostate Cancer|prostate cancer
5405713|NCT01696526|vitamin D|vitamin d
5405714|NCT01696526|bioeffiency|bioeffiency
5405715|NCT01696526|vitamin d fortified fish|vitamin d fortified fish
5405716|NCT01696500|IVIG in Stevens-Johnson syndrome|ivig in stevens-johnson syndrome
5405717|NCT01696500|Toxic Epidermal Necrolysis|toxic epidermal necrolysis
5405718|NCT01696500|Patients with Stevens-Johnson syndrome|patients with stevens-johnson syndrome
5405719|NCT01696500|Toxic Epidermal Necrolysis unresponsive to corticosteroids|toxic epidermal necrolysis unresponsive to corticosteroids
5405720|NCT01696487|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5405721|NCT01696487|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5405722|NCT01696487|NAFLD|nafld
5405723|NCT01696487|NASH|nash
5405724|NCT01696474|Refractory cold agglutinin disease|refractory cold agglutinin disease
5405725|NCT01696474|Bortezomib|bortezomib
5405726|NCT01696474|blood-transfusion|blood-transfusion
5405727|NCT01696448|Appetite Suppression|appetite suppression
5405728|NCT01696448|CAR-191|car-191
5405729|NCT01696435|Depression|depression
5506868|NCT01266954|PK|pk
5405730|NCT01696435|Depressive Symptoms|depressive symptoms
5405731|NCT01696435|Mood|mood
5405732|NCT01696435|Geriatric|geriatric
5405733|NCT01696435|Prevention|prevention
5405734|NCT01696422|Dengue|dengue
5405735|NCT01696422|tetravalent attenuated Vaccine|tetravalent attenuated vaccine
5405736|NCT01696422|Healthy adults|healthy adults
5405737|NCT01696396|IBD, Crohn's Disease|ibd, crohn's disease
5405738|NCT01696383|Intraocular Pressure (IOP)|intraocular pressure (iop)
5405739|NCT01696383|Glaucoma|glaucoma
5405740|NCT01696383|Ocular hypertension|ocular hypertension
5405741|NCT01696383|DuoTrav|duotrav
5405742|NCT01696383|Prostaglandin analogue|prostaglandin analogue
5405743|NCT01696383|Beta-blocker|beta-blocker
5405744|NCT01696370|Trimetazidine|trimetazidine
5405745|NCT01696357|Asthma|asthma
5405746|NCT01696357|Adolescents|adolescents
5405747|NCT01696357|Self-monitoring|self-monitoring
5405748|NCT01696357|Quality of life|quality of life
5405749|NCT01696357|Biomedical device|biomedical device
5405750|NCT01696357|Symptom monitoring|symptom monitoring
5405751|NCT01696357|Self-management|self-management
5405752|NCT01696344|LSPAF|lspaf
5405753|NCT01696344|AF termination|af termination
5405754|NCT01696344|PVAI|pvai
5405755|NCT01696344|nonPV triggers|nonpv triggers
5405756|NCT01696344|Long-standing persistent|long-standing persistent
5405757|NCT01696305|Thyroid disease|thyroid disease
5405758|NCT01696305|Hyalobarrier|hyalobarrier
5405759|NCT01696305|Thyroidectomy|thyroidectomy
5405760|NCT01696305|anti-adhesive effect|anti-adhesive effect
5405761|NCT01696240|Pulmonary Hypertension|pulmonary hypertension
5405762|NCT01696240|Exercise Capacity|exercise capacity
5405763|NCT01696240|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5405764|NCT01696240|Udenafil (Zydena)|udenafil (zydena)
5405765|NCT01696240|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5405766|NCT01696227|Nissle 1917|nissle 1917
5405767|NCT01696227|Probiotic|probiotic
5405768|NCT01696227|Uropathogen|uropathogen
5405769|NCT01696214|asthma,smokers|asthma,smokers
5405770|NCT01696201|Pregnancy, outcomes, depression, mood, physical exercise|pregnancy, outcomes, depression, mood, physical exercise
5405771|NCT01696188|Interscalene|interscalene
5405772|NCT01696188|nerve block|nerve block
5405773|NCT01696188|nerve catheter|nerve catheter
5405774|NCT01696188|in-plane|in-plane
5405775|NCT01696188|out-of-plane|out-of-plane
5405776|NCT01696188|anterolateral approach|anterolateral approach
5405777|NCT01696188|posterior approach|posterior approach
5405778|NCT01696188|shoulder surgery|shoulder surgery
5405780|NCT01696175|venous|venous
5405781|NCT01696175|oxymetry|oxymetry
5405782|NCT01696175|lactate|lactate
5405783|NCT01696175|children|children
5405784|NCT01696175|PICU|picu
5405785|NCT01696175|Admission parameters of shock|admission parameters of shock
5405786|NCT01696162|Knee pain|knee pain
5405787|NCT01696162|Anterior knee pain|anterior knee pain
5405788|NCT01696162|Patellofemoral|patellofemoral
5405789|NCT01696162|Patellofemoral syndrome|patellofemoral syndrome
5405790|NCT01696162|Runners knee|runners knee
5405791|NCT01696149|TENS, sympathetic skin response, skin temperature|tens, sympathetic skin response, skin temperature
5405792|NCT01696136|Ablation|ablation
5405793|NCT01696136|Multi-electrode catheter|multi-electrode catheter
5405794|NCT01696136|Single-tip catheter|single-tip catheter
5405795|NCT01696136|Holter|holter
5405796|NCT01696123|Alzheimer disease|alzheimer disease
5405797|NCT01696123|Cholinesterase inhibitors|cholinesterase inhibitors
5405799|NCT01696123|NeuroAiD|neuroaid
5405800|NCT01696123|neuroprotection|neuroprotection
5405801|NCT01696123|neuroregeneration|neuroregeneration
5405802|NCT01696110|Bivalirudin|bivalirudin
5405803|NCT01696110|Acute myocardial infarction|acute myocardial infarction
5405804|NCT01696110|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5405805|NCT01696084|AML|aml
5405806|NCT01696084|Acute Myeloid Leukemia|acute myeloid leukemia
5405807|NCT01696084|high risk AML|high risk aml
5405808|NCT01696084|secondary AML|secondary aml
5405809|NCT01696084|AML in elderly|aml in elderly
5405810|NCT01696032|Ovarian Cancer|ovarian cancer
5405811|NCT01696019|magnetic resonance imaging|magnetic resonance imaging
5405812|NCT01696019|cognition|cognition
5405813|NCT01696019|Tai Chi|tai chi
5405814|NCT01696019|physical exercise|physical exercise
5405815|NCT01696019|mental exercise|mental exercise
5405816|NCT01696019|intervention trial|intervention trial
5405817|NCT01696019|prevention|prevention
5405818|NCT01696019|dementia|dementia
5405819|NCT01696019|Alzheimer disease|alzheimer disease
5405820|NCT01696019|mild cognitive impairment|mild cognitive impairment
5405821|NCT01696006|perfusion computed tomography|perfusion computed tomography
5405822|NCT01696006|coronary artery disease|coronary artery disease
5405823|NCT01695993|Nausea|nausea
5405824|NCT01695993|Quality of life|quality of life
5405825|NCT01695993|Chemotherapy|chemotherapy
5405826|NCT01695993|Expectancy|expectancy
5405827|NCT01695980|adenotonsillectomy|adenotonsillectomy
5405828|NCT01695967|nasal obstruction|nasal obstruction
5405829|NCT01695954|HIV|hiv
5378511|NCT01819389|imatinib|imatinib
5405830|NCT01695954|Hyperlipidemia|hyperlipidemia
5405831|NCT01695954|Pharmacokinetics|pharmacokinetics
5405832|NCT01695954|Statins|statins
5405833|NCT01695954|Darunavir|darunavir
5405834|NCT01695954|Efavirenz|efavirenz
5405835|NCT01695954|Pitavastatin|pitavastatin
5405836|NCT01695928|Velocity|velocity
5405837|NCT01695928|Location|location
5405838|NCT01695928|Periodontal status|periodontal status
5405839|NCT01695915|constipation|constipation
5405840|NCT01695915|children|children
5405841|NCT01695915|healthy|healthy
5405842|NCT01695915|rectal diameter|rectal diameter
5405943|NCT01695382|Cancer|cancer
5405843|NCT01695863|Miralax with gatorade and dulcolax|miralax with gatorade and dulcolax
5405844|NCT01695863|Movi pre|movi pre
5405845|NCT01695863|Patient satisfaction and efficacy|patient satisfaction and efficacy
5405846|NCT01695850|Randomized controlled trial|randomized controlled trial
5405847|NCT01695850|Drugs,Chinese Herbal|drugs,chinese herbal
5405848|NCT01695850|Constipation/drug therapy|constipation/drug therapy
5405849|NCT01695837|Diet counseling|diet counseling
5405850|NCT01695837|primary care|primary care
5405851|NCT01695824|catheter ablation|catheter ablation
5405852|NCT01695811|Keratoconus, PKP, femtosecond laser assisted keratoplasty|keratoconus, pkp, femtosecond laser assisted keratoplasty
5405853|NCT01695798|poliomyelitis|poliomyelitis
5405854|NCT01695798|oral polio vaccine|oral polio vaccine
5405855|NCT01695798|OPV|opv
5405856|NCT01695798|seroconversion|seroconversion
5405857|NCT01695798|mucosal immunity|mucosal immunity
5405858|NCT01695798|malnutrition|malnutrition
5405859|NCT01695798|IPV|ipv
5405860|NCT01695798|Inactivated polio vaccine|inactivated polio vaccine
5405861|NCT01695798|Pakistan|pakistan
5405862|NCT01695759|Anemia Secondary|anemia secondary
5405863|NCT01695759|Chronic Kidney Disease|chronic kidney disease
5405864|NCT01695720|Knee Injuries|knee injuries
5405865|NCT01695720|Meniscus Injuries|meniscus injuries
5405866|NCT01695720|Articular Cartilage Injuries|articular cartilage injuries
5405867|NCT01695720|Orthopaedic Diagnostic|orthopaedic diagnostic
5405868|NCT01695720|Magnetic Resonance Imaging|magnetic resonance imaging
5405869|NCT01695707|atopic dermatitis|atopic dermatitis
5405870|NCT01695707|eczema|eczema
5405871|NCT01695681|Quality of life|quality of life
5405872|NCT01695681|Celiac Disease/diet therapy|celiac disease/diet therapy
5405873|NCT01695681|Celiac Disease/diagnosis|celiac disease/diagnosis
5405874|NCT01695681|Prospective Studies|prospective studies
5405875|NCT01695668|Graft versus Host Disease (GVHD)|graft versus host disease (gvhd)
5405877|NCT01695668|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
5405878|NCT01695668|Restasis|restasis
5405879|NCT01695668|Lotemax|lotemax
5405880|NCT01695642|lasik, intralase, microkeratome|lasik, intralase, microkeratome
5405881|NCT01695603|Brain injury|brain injury
5405882|NCT01695603|Controlled ventilation|controlled ventilation
5405883|NCT01695603|Intellivent|intellivent
5405884|NCT01695603|Capnia control|capnia control
5405885|NCT01695590|Myeloma|myeloma
5405886|NCT01695590|PRLX93936|prlx93936
5405887|NCT01695577|Traumatic brain injury|traumatic brain injury
5405888|NCT01695577|Dizziness|dizziness
5405889|NCT01695577|Vestibular rehabilitation|vestibular rehabilitation
5405890|NCT01695577|Balance rehabilitation|balance rehabilitation
5405891|NCT01695564|atrial enlargement|atrial enlargement
5405892|NCT01695564|left atrial appendage|left atrial appendage
5405893|NCT01695551|Radiofrequency ablation|radiofrequency ablation
5405894|NCT01695551|fast heart rhythm|fast heart rhythm
5405895|NCT01695551|ventricle|ventricle
5405896|NCT01695551|catheter ablation|catheter ablation
5405897|NCT01695551|ablation|ablation
5405898|NCT01695538|Yoga|yoga
5405899|NCT01695538|atrial tachycardia|atrial tachycardia
5405900|NCT01695525|Neurocardiogenic Syncope|neurocardiogenic syncope
5405901|NCT01695525|Yoga|yoga
5405903|NCT01695486|Comfort|comfort
5405904|NCT01695486|open muscle biopsy|open muscle biopsy
5405905|NCT01695473|Prostate cancer|prostate cancer
5405906|NCT01695473|High-risk prostate cancer|high-risk prostate cancer
5405907|NCT01695473|Radical prostatectomy|radical prostatectomy
5405908|NCT01695473|BKM120|bkm120
5405909|NCT01695460|Migraine|migraine
5405910|NCT01695460|Vitamin D|vitamin d
5405911|NCT01695434|multiple sclerosis|multiple sclerosis
5405912|NCT01695434|MRI|mri
5405913|NCT01695434|Copaxone|copaxone
5405914|NCT01695434|healthy controls|healthy controls
5405915|NCT01695434|glatiramer acetate|glatiramer acetate
5405916|NCT01695421|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5405917|NCT01695421|Oxygen Consumption|oxygen consumption
5405918|NCT01695421|Heart Failure|heart failure
5405919|NCT01695408|Drug Treatment|drug treatment
5405920|NCT01695408|Treatment pathways|treatment pathways
5405921|NCT01695408|Clinical routine|clinical routine
5405922|NCT01695408|Registry|registry
5522871|NCT01197144|TNF|tnf
5405923|NCT01695408|Outcomes|outcomes
5405924|NCT01695408|Survival|survival
5405925|NCT01695408|Patient-related outcomes|patient-related outcomes
5405926|NCT01695408|Quality of life|quality of life
5392973|NCT01753804|Muscle testing|muscle testing
5405928|NCT01695408|Azathioprine|azathioprine
5405929|NCT01695408|N-Acetylcysteine|n-acetylcysteine
5405930|NCT01695408|Pirfenidone|pirfenidone
5405931|NCT01695408|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5405932|NCT01695408|Nintedanib|nintedanib
5405933|NCT01695408|multicenter|multicenter
5405934|NCT01695408|Germany|germany
5405935|NCT01695408|Safety|safety
5405936|NCT01695408|Adverse event|adverse event
5405937|NCT01695395|intellectual disability|intellectual disability
5405938|NCT01695395|mental disorder|mental disorder
5405939|NCT01695395|dual diagnosis|dual diagnosis
5405940|NCT01695395|provision|provision
5405941|NCT01695395|needs assessment|needs assessment
5405942|NCT01695395|quality of life|quality of life
5405944|NCT01695382|Palliative Care|palliative care
5405945|NCT01695382|Patient Navigation|patient navigation
5405946|NCT01695356|Melasma|melasma
5405947|NCT01695356|sunscreens|sunscreens
5405948|NCT01695356|visible light|visible light
5405949|NCT01695356|ultraviolet light|ultraviolet light
5405950|NCT01695343|Cystic Fibrosis|cystic fibrosis
5405951|NCT01695343|Pseudomonas aeruginosa (Pa)|pseudomonas aeruginosa (pa)
5405952|NCT01695343|CF|cf
5405953|NCT01695330|Multiple Myeloma|multiple myeloma
5405954|NCT01695330|Relapsed|relapsed
5405955|NCT01695330|Refractory|refractory
5405956|NCT01695330|Bortezomib|bortezomib
5405957|NCT01695330|Subcutaneous|subcutaneous
5405958|NCT01695330|Oncotherapeutics|oncotherapeutics
5405959|NCT01695317|Migraine|migraine
5405960|NCT01695317|Preventive medication|preventive medication
5405961|NCT01695304|Cryptosporidiosis|cryptosporidiosis
5405962|NCT01695304|Waterborne disease|waterborne disease
5405963|NCT01695304|Diarrheal disease|diarrheal disease
5405964|NCT01695304|Ceramic water filters|ceramic water filters
5405965|NCT01695304|infants|infants
5405966|NCT01695304|young children|young children
5405967|NCT01695304|drinking water|drinking water
5405968|NCT01695304|Kenya|kenya
5405969|NCT01695291|Obsessive compulsive disorder|obsessive compulsive disorder
5405970|NCT01695278|motivational interviewing|motivational interviewing
5405971|NCT01695278|telephone counseling|telephone counseling
5405972|NCT01695278|medical education|medical education
5405973|NCT01695278|diabetes self management|diabetes self management
5405974|NCT01695265|Airflow Obstruction|airflow obstruction
5405975|NCT01695226|Celecoxib|celecoxib
5405976|NCT01695226|Clinical trial, Phase II|clinical trial, phase ii
5405977|NCT01695226|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
5405978|NCT01695213|uncemented hip|uncemented hip
5405979|NCT01695213|bone remodeling|bone remodeling
5388808|NCT01772875|UTI|uti
5405981|NCT01695213|clinical evaluation|clinical evaluation
5405982|NCT01695187|Herpes, Herpes Labialis, nanoemulsion, NanoBio, NB-001|herpes, herpes labialis, nanoemulsion, nanobio, nb-001
5405983|NCT01695174|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5405984|NCT01695174|Xifaxan|xifaxan
5405985|NCT01695161|Mucopolysaccharidosis|mucopolysaccharidosis
5405986|NCT01695161|Fabry disease|fabry disease
5405987|NCT01695148|beta-carotene biofortified maize|beta-carotene biofortified maize
5405988|NCT01695148|micronutrients|micronutrients
5405989|NCT01695148|vitamin A|vitamin a
5405990|NCT01695148|serum retinol|serum retinol
5405991|NCT01695148|dark adaptation|dark adaptation
5405992|NCT01695135|Prostate neoplasms|prostate neoplasms
5405993|NCT01695135|Prostate cancer|prostate cancer
5405994|NCT01695135|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5405995|NCT01695135|Abiraterone acetate|abiraterone acetate
5405996|NCT01695135|JNJ-212082|jnj-212082
5405997|NCT01695122|Head and Neck Cancer|head and neck cancer
5405998|NCT01695122|Oropharyngeal cancer|oropharyngeal cancer
5405999|NCT01695122|Oral cavity cancer|oral cavity cancer
5406000|NCT01695122|Chemoradiation|chemoradiation
5406001|NCT01695122|valproic acid|valproic acid
5406002|NCT01695122|histone deacetylase|histone deacetylase
5406004|NCT01695109|obesity|obesity
5406005|NCT01695109|fMRI|fmri
5406006|NCT01695109|ghrelin|ghrelin
5406007|NCT01695083|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
5406008|NCT01695083|Liver fibrosis,Steatosis|liver fibrosis,steatosis
5406009|NCT01695083|Liver inflammation|liver inflammation
5406010|NCT01695083|Morbid obesity|morbid obesity
5406011|NCT01695083|Non invasive tests|non invasive tests
5406012|NCT01695031|Urban adolescents|urban adolescents
5406013|NCT01695031|Acute asthma|acute asthma
5406014|NCT01695031|Emergency department|emergency department
5406015|NCT01695031|Computer tailoring|computer tailoring
5406016|NCT01695031|Web-based intervention|web-based intervention
5406017|NCT01695018|oral epithelial dysplasia|oral epithelial dysplasia
5406018|NCT01695018|p16 methylation|p16 methylation
5406019|NCT01695018|diagnostic reagents|diagnostic reagents
5406020|NCT01695018|early diagnosis|early diagnosis
5406021|NCT01694992|Stroke|stroke
5406023|NCT01694992|Rehabilitation|rehabilitation
5406024|NCT01694992|Physical Therapy|physical therapy
5406025|NCT01694992|Randomized controlled trial|randomized controlled trial
5406026|NCT01694979|Pelvic floor|pelvic floor
5406027|NCT01694979|Rehabilitation|rehabilitation
5406028|NCT01694979|Respiration|respiration
5406029|NCT01694979|Urinary incontinence|urinary incontinence
5406030|NCT01694953|MNGIE|mngie
5406031|NCT01694953|Mitochondrial|mitochondrial
5406032|NCT01694953|Mitochondrial Neurogastrointestinal encephalopathy|mitochondrial neurogastrointestinal encephalopathy
5406033|NCT01694940|mitochondrial disorders|mitochondrial disorders
5406034|NCT01694940|Mito Disease|mito disease
5406035|NCT01694940|Mitochondria|mitochondria
5406036|NCT01694940|Mitochondrial disease|mitochondrial disease
5406037|NCT01694940|Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) Syndrome|mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (melas) syndrome
5406038|NCT01694940|Myoclonic Epilepsy with Ragged Red Fibers (MERRF)|myoclonic epilepsy with ragged red fibers (merrf)
5406328|NCT01693718|cancer|cancer
5406039|NCT01694940|Leber Hereditary Optic Neuropathy (LHON)|leber hereditary optic neuropathy (lhon)
5406040|NCT01694940|Leigh Syndrome|leigh syndrome
5406041|NCT01694940|Neuropathy, ataxia, and retinitis pigmentosa (NARP)|neuropathy, ataxia, and retinitis pigmentosa (narp)
5406042|NCT01694940|Kearns Sayre syndrome|kearns sayre syndrome
5406043|NCT01694940|Alpers Huttenlocher|alpers huttenlocher
5406044|NCT01694940|Pearson|pearson
5406045|NCT01694940|Mitochondrial Neurogastrointestinal Encephalopathy (MNGIE)|mitochondrial neurogastrointestinal encephalopathy (mngie)
5406046|NCT01694940|Barth Syndrome|barth syndrome
5406047|NCT01694940|Coenzyme Q (CoQ) Deficiency|coenzyme q (coq) deficiency
5406048|NCT01694940|Chronic progressive external ophthalmoplegia (CPEO)|chronic progressive external ophthalmoplegia (cpeo)
5406049|NCT01694940|DAD|dad
5406050|NCT01694940|Diabetes and Deafness|diabetes and deafness
5406051|NCT01694940|Encephalopathy|encephalopathy
5406052|NCT01694940|Encephalomyopathy|encephalomyopathy
5406053|NCT01694940|Familial Bilateral Striatal Necrosis (FBSN)|familial bilateral striatal necrosis (fbsn)
5406054|NCT01694940|Hepatocerebral Disease|hepatocerebral disease
5406055|NCT01694940|Leukoencephalopathy|leukoencephalopathy
5406056|NCT01694940|Maternally Inherited Leigh Syndrome (MILS)|maternally inherited leigh syndrome (mils)
5406057|NCT01694940|Complex I Deficiency|complex i deficiency
5406058|NCT01694940|Complex II Deficiency|complex ii deficiency
5406059|NCT01694940|Complex III Deficiency|complex iii deficiency
5406060|NCT01694940|Complex IV Deficiency|complex iv deficiency
5406061|NCT01694940|Complex V Deficiency|complex v deficiency
5406062|NCT01694940|mitochondrial DNA depletion syndrome|mitochondrial dna depletion syndrome
5406063|NCT01694940|mtDNA depletion syndrome|mtdna depletion syndrome
5406064|NCT01694927|Mesenchymal stem cell|mesenchymal stem cell
5406065|NCT01694927|Spinal cord injury|spinal cord injury
5406066|NCT01694914|Corneal Transplantation|corneal transplantation
5406067|NCT01694914|corneal organ culture medium|corneal organ culture medium
5406068|NCT01694914|free animal compound medium|free animal compound medium
5406069|NCT01694888|Students practice, Lecture; Nursing records; Nursing education; Midwifery|students practice, lecture; nursing records; nursing education; midwifery
5406070|NCT01694875|cervix cancer|cervix cancer
5406072|NCT01694875|APTIMA|aptima
5406073|NCT01694862|quasi experimental|quasi experimental
5406074|NCT01694862|evaluation|evaluation
5406075|NCT01694862|intervention|intervention
5406076|NCT01694862|service integration|service integration
5406077|NCT01694862|cost analysis|cost analysis
5406078|NCT01694862|HIV|hiv
5406079|NCT01694862|FP|fp
5406080|NCT01694862|PNC|pnc
5406081|NCT01694862|Sub-Saharan Africa|sub-saharan africa
5406082|NCT01694849|PPARs|ppars
5406083|NCT01694849|NASH|nash
5406084|NCT01694849|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5406085|NCT01694849|Liver Diseases|liver diseases
5406086|NCT01694849|Fibrosis|fibrosis
5406087|NCT01694836|Allergic rhinitis|allergic rhinitis
5406088|NCT01694836|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5406089|NCT01694836|Allergy induced asthma|allergy induced asthma
5406090|NCT01694836|Birch (Betula alba)|birch (betula alba)
5406091|NCT01694836|Hayfever|hayfever
5406092|NCT01694836|Immunotherapy|immunotherapy
5406093|NCT01694823|Cartilage repair|cartilage repair
5406094|NCT01694823|Cartilage defects|cartilage defects
5406095|NCT01694823|cell sheet|cell sheet
5406096|NCT01694823|Autologous chondrocyte implantation|autologous chondrocyte implantation
5406097|NCT01694810|acne vulgaris|acne vulgaris
5406098|NCT01694758|Benchmarking could improve quality of patient care|benchmarking could improve quality of patient care
5406099|NCT01694758|ESC and ATP III Guidelines|esc and atp iii guidelines
5406100|NCT01694745|Newborns|newborns
5406101|NCT01694745|Premature|premature
5406102|NCT01694745|Pain|pain
5406103|NCT01694745|Pain assessment|pain assessment
5406104|NCT01694745|Endotracheal Intubation|endotracheal intubation
5406105|NCT01694745|Analgesia|analgesia
5406106|NCT01694745|Sedation|sedation
5406107|NCT01694745|Longterm effects of pain|longterm effects of pain
5406108|NCT01694745|Epidemiology|epidemiology
5406109|NCT01694732|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5406110|NCT01694732|Varenicline|varenicline
5406111|NCT01694732|Smoking cessation|smoking cessation
5406112|NCT01694719|Depression|depression
5406113|NCT01694719|Major Depressive Disorder|major depressive disorder
5406114|NCT01694719|Behavioral Activation|behavioral activation
5507369|NCT01264757|adult|adult
5406115|NCT01694719|Cognitive Training|cognitive training
5406117|NCT01694680|Lutein|lutein
5406118|NCT01694680|Visual function|visual function
5406119|NCT01694680|Early signs of AMD|early signs of amd
5406120|NCT01694680|AREDS-category 2|areds-category 2
5406121|NCT01694641|time lapse monitoring|time lapse monitoring
5406122|NCT01694641|blastocyst|blastocyst
5406123|NCT01694641|single embryo transfer|single embryo transfer
5406124|NCT01694641|clinical pregnancy|clinical pregnancy
5406125|NCT01694641|implantation rate|implantation rate
5406126|NCT01694615|Lung Transplantation|lung transplantation
5406127|NCT01694615|Acute Rejection|acute rejection
5406128|NCT01694602|Cachexia|cachexia
5406129|NCT01694602|Sarcopenia|sarcopenia
5406130|NCT01694602|De Novo|de novo
5406131|NCT01694602|Deuterated|deuterated
5406132|NCT01694589|pancreatic cancer|pancreatic cancer
5406133|NCT01694589|resectable pancreatic cancer|resectable pancreatic cancer
5406134|NCT01694576|Nasopharyngeal carcinoma staged N2-3M0|nasopharyngeal carcinoma staged n2-3m0
5406135|NCT01694576|Adjuvant chemotherapy|adjuvant chemotherapy
5406136|NCT01694563|Atrial Fibrillation|atrial fibrillation
5406137|NCT01694550|pacemaker|pacemaker
5406138|NCT01694550|ICD / CRTD|icd / crtd
5406139|NCT01694550|corrected QT-interval|corrected qt-interval
5406140|NCT01694537|lumbrokinase|lumbrokinase
5406141|NCT01694537|fibrinolytic|fibrinolytic
5406142|NCT01694537|plasmin-antiplasmin complex|plasmin-antiplasmin complex
5406143|NCT01694537|euglobulin clot lysis time|euglobulin clot lysis time
5406144|NCT01694537|platelet aggregation|platelet aggregation
5406145|NCT01694511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5406146|NCT01694485|Ulcerative Colitis, IBD|ulcerative colitis, ibd
5406147|NCT01694459|angioplasty|angioplasty
5406148|NCT01694459|heparin|heparin
5406149|NCT01694459|trial|trial
5406150|NCT01694446|Intestinal lipoprotein|intestinal lipoprotein
5406151|NCT01694446|Apo B48 and apoB100|apo b48 and apob100
5406152|NCT01694446|Pancreatic clamp|pancreatic clamp
5406153|NCT01694407|Prevention|prevention
5406154|NCT01694394|atrial fibrillation|atrial fibrillation
5406155|NCT01694394|implantable cardiac monitor|implantable cardiac monitor
5406156|NCT01694394|left atrial enlargement|left atrial enlargement
5406157|NCT01694394|CHA2DS2 VASc Score|cha2ds2 vasc score
5406158|NCT01694394|cardiovascular risk|cardiovascular risk
5406159|NCT01694381|Acute Ischemic Stroke|acute ischemic stroke
5406160|NCT01694381|TS01|ts01
5406161|NCT01694381|Mutant pro-urokinase|mutant pro-urokinase
5406163|NCT01694381|C1 inhibitor|c1 inhibitor
5406164|NCT01694381|Safety|safety
5406165|NCT01694381|Stroke|stroke
5406166|NCT01694381|Tolerability|tolerability
5406167|NCT01694381|Ischemia|ischemia
5401253|NCT01716247|MRI|mri
5406168|NCT01694381|Cerebral Infarction|cerebral infarction
5406169|NCT01694381|Cerebrovascular Disorders|cerebrovascular disorders
5406170|NCT01694381|Vascular Diseases|vascular diseases
5406171|NCT01694381|Cardiovascular Diseases|cardiovascular diseases
5406172|NCT01694381|Brain Infarction|brain infarction
5406173|NCT01694381|Brain Ischemia|brain ischemia
5406174|NCT01694381|Fibrinolytic Agents|fibrinolytic agents
5406175|NCT01694381|Thrombolytic Agents|thrombolytic agents
5406176|NCT01694381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5406177|NCT01694381|Pharmacologic Actions|pharmacologic actions
5406178|NCT01694381|Cardiovascular Agents|cardiovascular agents
5406179|NCT01694381|Therapeutic Uses|therapeutic uses
5406180|NCT01694381|Hematologic Agents|hematologic agents
5406181|NCT01694368|Near infrared spectroscopy; lipid core; vulnerable plaque|near infrared spectroscopy; lipid core; vulnerable plaque
5406182|NCT01694329|Streptococcus pneumoniae|streptococcus pneumoniae
5406183|NCT01694329|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
5406184|NCT01694329|Immunization|immunization
5406186|NCT01694316|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
5406187|NCT01694277|Gastrointestinal Stromal Tumour|gastrointestinal stromal tumour
5406189|NCT01694277|non-resectable|non-resectable
5406190|NCT01694277|metastatic|metastatic
5406191|NCT01694277|second line treatment|second line treatment
5406192|NCT01694277|resistance to imatinib|resistance to imatinib
5406193|NCT01694277|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5406194|NCT01694264|HBV surface antigen|hbv surface antigen
5406195|NCT01694264|Anti-HBc positive|anti-hbc positive
5406196|NCT01694264|Anti-TNFα Treatment|anti-tnfα treatment
5406197|NCT01694264|Reactivation|reactivation
5406198|NCT01694251|mitral valve area|mitral valve area
5406199|NCT01694251|pressure half time|pressure half time
5406200|NCT01694251|3 dimensional transesophageal echocardiography|3 dimensional transesophageal echocardiography
5406201|NCT01694251|computed tomography|computed tomography
5406202|NCT01694238|Colostomy|colostomy
5406203|NCT01694238|Surgical technique|surgical technique
5406204|NCT01694225|Breast cancer|breast cancer
5391517|NCT01760707|Diabetes mellitus|diabetes mellitus
5406205|NCT01694225|Anti-estrogen therapy|anti-estrogen therapy
5406206|NCT01694212|Macular edema|macular edema
5406207|NCT01694212|Cataract|cataract
5406208|NCT01694212|Diabetic retinopathy|diabetic retinopathy
5393339|NCT01752049|HHT|hht
5406209|NCT01694212|Anti-inflammatory agents,Non-steroidal|anti-inflammatory agents,non-steroidal
5406210|NCT01694199|Pulsed Radiofrequency Energy (PRFE)|pulsed radiofrequency energy (prfe)
5406211|NCT01694199|Pain|pain
5406212|NCT01694199|Postsurgical|postsurgical
5406213|NCT01694199|Opioids|opioids
5406214|NCT01694199|Pain relief|pain relief
5406215|NCT01694199|Medical device|medical device
5406216|NCT01694199|Endorphins|endorphins
5406217|NCT01694173|Type 2 diabetes mellitus, F18-FDG labelled stem cells|type 2 diabetes mellitus, f18-fdg labelled stem cells
5406218|NCT01694160|kidney transplant patients|kidney transplant patients
5406219|NCT01694160|Albuminuria|albuminuria
5406220|NCT01694147|relationship|relationship
5406221|NCT01694147|endothelial injury|endothelial injury
5406222|NCT01694147|vascular permeability|vascular permeability
5406223|NCT01694147|severe sepsis related ALI/ARDS|severe sepsis related ali/ards
5406224|NCT01694134|Discopathy|discopathy
5406225|NCT01694134|Modic I|modic i
5406226|NCT01694134|Corticoids|corticoids
5406227|NCT01694134|Local Anaesthetic|local anaesthetic
5406228|NCT01694134|Intradiscal injection|intradiscal injection
5406229|NCT01694121|HIV prevention|hiv prevention
5406230|NCT01694121|African American men|african american men
5406231|NCT01694121|evaluation study|evaluation study
5406232|NCT01694095|Geographic atrophy, prognosis, risk factors, natural history|geographic atrophy, prognosis, risk factors, natural history
5406233|NCT01694082|brief intervention|brief intervention
5406234|NCT01694082|web-based interventions|web-based interventions
5406235|NCT01694082|computer-based interventions|computer-based interventions
5406236|NCT01694082|harm reduction|harm reduction
5406237|NCT01694082|young adult|young adult
5406238|NCT01694082|college student|college student
5406239|NCT01694069|piperacillin|piperacillin
5406240|NCT01694069|tazobactam|tazobactam
5406241|NCT01694069|pseudomonas aeruginosa|pseudomonas aeruginosa
5406242|NCT01694069|cystic fibrosis|cystic fibrosis
5406243|NCT01694069|pulmonary exacerbation|pulmonary exacerbation
5406244|NCT01694069|continuous infusion|continuous infusion
5406245|NCT01694069|beta lactam|beta lactam
5406246|NCT01694030|Attachment security priming|attachment security priming
5406247|NCT01694030|depressed mood|depressed mood
5406248|NCT01694017|HIV,treatment,cost effectiveness,drug toxicity,QOL,costs|hiv,treatment,cost effectiveness,drug toxicity,qol,costs
5406249|NCT01694004|Nutrient absorption|nutrient absorption
5406250|NCT01694004|Duodenal feeding tube|duodenal feeding tube
5406251|NCT01694004|Gut-brain-gut axis|gut-brain-gut axis
5406252|NCT01693978|PTSD|ptsd
5406253|NCT01693978|Prolonged Exposure|prolonged exposure
5406254|NCT01693978|Comorbidity|comorbidity
5406255|NCT01693978|Treatment|treatment
5406256|NCT01693978|Methadone Maintenance|methadone maintenance
5406257|NCT01693978|Substance Use Disorder|substance use disorder
5406258|NCT01693939|Lasik|lasik
5406259|NCT01693939|Myopia|myopia
5406260|NCT01693939|Femtosecond Laser|femtosecond laser
5406261|NCT01693926|Obesity|obesity
5406262|NCT01693926|Children|children
5406263|NCT01693926|Physical activity|physical activity
5406264|NCT01693926|Stress|stress
5406265|NCT01693926|Snacking|snacking
5406266|NCT01693900|joint replacement|joint replacement
5406267|NCT01693900|total hip replacement|total hip replacement
5406268|NCT01693900|regional pain block|regional pain block
5406269|NCT01693900|ultrasound guidance|ultrasound guidance
5406270|NCT01693900|fascia iliaca compartment block|fascia iliaca compartment block
5406271|NCT01693887|IFI|ifi
5406272|NCT01693887|empirical therapy|empirical therapy
5406273|NCT01693887|preemptive therapy|preemptive therapy
5406274|NCT01693887|Itraconazole|itraconazole
5406275|NCT01693874|anxiety|anxiety
5406276|NCT01693874|depression|depression
5406277|NCT01693874|cognition|cognition
5406278|NCT01693874|MBSR|mbsr
5406279|NCT01693874|mindfulness|mindfulness
5406285|NCT01693861|Chronotherapy|chronotherapy
5406286|NCT01693861|Urine|urine
5406287|NCT01693861|Nucleosides|nucleosides
5406288|NCT01693861|Chemotherapy|chemotherapy
5406289|NCT01693861|Treated with chemotherapy|treated with chemotherapy
5406290|NCT01693848|Colorectal|colorectal
5406291|NCT01693848|Cancer|cancer
5406292|NCT01693848|Metastatic|metastatic
5406293|NCT01693848|Control|control
5406294|NCT01693848|Urine|urine
5406295|NCT01693848|Nucleosides|nucleosides
5406296|NCT01693848|Surgery|surgery
5406297|NCT01693848|General anesthesia|general anesthesia
5406298|NCT01693848|Scheduled for surgery|scheduled for surgery
5406299|NCT01693835|Colorectal|colorectal
5406300|NCT01693835|Cancer|cancer
5406301|NCT01693835|Metastatic|metastatic
5406302|NCT01693835|Healthy|healthy
5406303|NCT01693835|Control|control
5406304|NCT01693835|Circadian|circadian
5406305|NCT01693835|Urine|urine
5406306|NCT01693835|Nucleosides|nucleosides
5406307|NCT01693822|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5406308|NCT01693822|predominant clear cell histology|predominant clear cell histology
5406309|NCT01693822|Unsuitable for nephrectomy|unsuitable for nephrectomy
5406310|NCT01693822|unsuitable for 'watch and wait' policy|unsuitable for 'watch and wait' policy
5406311|NCT01693809|Caffeine|caffeine
5406312|NCT01693809|Vestibular Evoked Myogenic Potentials|vestibular evoked myogenic potentials
5406313|NCT01693809|dizziness|dizziness
5406314|NCT01693809|vertigo|vertigo
5406315|NCT01693809|tinnitus|tinnitus
5406316|NCT01693770|Bone Metastasis|bone metastasis
5406317|NCT01693770|Pain Palliation|pain palliation
5406318|NCT01693770|High Intensity Focused Ultrasound|high intensity focused ultrasound
5406319|NCT01693757|Anterior Cruciate Ligament|anterior cruciate ligament
5406320|NCT01693757|Hamstrings versus patellar tendon|hamstrings versus patellar tendon
5406321|NCT01693757|Hop test|hop test
5406322|NCT01693757|Return to sports|return to sports
5406323|NCT01693744|Pseudoexfoliation, chronic kidney disease|pseudoexfoliation, chronic kidney disease
5406324|NCT01693731|Breast cancer|breast cancer
5406325|NCT01693731|Periodontal Diseases|periodontal diseases
5406326|NCT01693731|Aromatase Inhibitors|aromatase inhibitors
5406327|NCT01693731|Oral Health Related Quality of Life|oral health related quality of life
5406343|NCT01693614|Diffuse large B-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma, PI3K inhibitor, Non-Hodgkin lymphoma, NHL|diffuse large b-cell lymphoma, mantle cell lymphoma, follicular lymphoma, pi3k inhibitor, non-hodgkin lymphoma, nhl
5406344|NCT01693601|Myelofibrosis|myelofibrosis
5406345|NCT01693601|Panobinostat|panobinostat
5406346|NCT01693601|Ruxolitinib|ruxolitinib
5406347|NCT01693588|Pain|pain
5406348|NCT01693588|Postoperative Pain|postoperative pain
5406349|NCT01693588|Surgical Pain|surgical pain
5406350|NCT01693588|Neurosurgical Pain|neurosurgical pain
5406351|NCT01693575|Small pupil cataract surgery|small pupil cataract surgery
5406352|NCT01693575|Intraoperative floppy iris syndrome (IFIS)|intraoperative floppy iris syndrome (ifis)
5406353|NCT01693562|Advanced solid tumors|advanced solid tumors
5406354|NCT01693549|HER-2 negative|her-2 negative
5406355|NCT01693549|Metastatic breast adenocarcinoma|metastatic breast adenocarcinoma
5406356|NCT01693536|Elderly|elderly
5406357|NCT01693536|Sodium reduction|sodium reduction
5406358|NCT01693536|Fitness increase|fitness increase
5406359|NCT01693536|Primary Care|primary care
5406375|NCT01693510|Excess gestational weight gain (GWG)|excess gestational weight gain (gwg)
5406376|NCT01693510|Obesity|obesity
5406377|NCT01693510|Type 2 diabetes|type 2 diabetes
5406378|NCT01693510|Elevated fats in the blood|elevated fats in the blood
5406379|NCT01693510|High blood pressure|high blood pressure
5406380|NCT01693497|Posttraumatic Stress Disorder|posttraumatic stress disorder
5406381|NCT01693497|PTSD|ptsd
5406382|NCT01693497|psychotherapy|psychotherapy
5406383|NCT01693497|randomized trial|randomized trial
5406384|NCT01693497|gestalt|gestalt
5406385|NCT01693484|Calcaneus|calcaneus
5406386|NCT01693484|Fracture|fracture
5406387|NCT01693484|Indocyanine Green|indocyanine green
5406388|NCT01693484|Angiography|angiography
5406389|NCT01693484|Open Reduction and Internal Fixation|open reduction and internal fixation
5406390|NCT01693471|asthma|asthma
5406391|NCT01693471|SF-36|sf-36
5406392|NCT01693471|HRQOL|hrqol
5406393|NCT01693458|HIV|hiv
5406394|NCT01693458|prevention|prevention
5406395|NCT01693458|HIV-positive|hiv-positive
5406397|NCT01693445|Gastrointestinal neoplasms|gastrointestinal neoplasms
5406398|NCT01693445|Oxaliplatin|oxaliplatin
5406399|NCT01693445|Irinotecan|irinotecan
5406400|NCT01693445|S-1|s-1
5406401|NCT01693432|Esophageal neoplasms|esophageal neoplasms
5406402|NCT01693432|Docetaxel|docetaxel
5406403|NCT01693432|S-1|s-1
5406404|NCT01693419|pancreas neoplasm|pancreas neoplasm
5406405|NCT01693419|gemcitabine|gemcitabine
5409846|NCT01678378|Female|female
5406406|NCT01693419|erlotinib|erlotinib
5406407|NCT01693419|S-1|s-1
5406408|NCT01693406|human milk|human milk
5406409|NCT01693406|infant growth|infant growth
5406410|NCT01693406|obesity|obesity
5406411|NCT01693406|diabetes|diabetes
5406412|NCT01693406|breastfeeding|breastfeeding
5406413|NCT01693393|primary Sjogren´s Syndrome|primary sjogren´s syndrome
5406414|NCT01693393|Cyclosporine|cyclosporine
5406415|NCT01693380|Influenza|influenza
5406416|NCT01693380|Vaccination|vaccination
5406417|NCT01693380|Vaccines|vaccines
5406418|NCT01693380|Schoolchildren|schoolchildren
5406419|NCT01693380|Effectiveness|effectiveness
5406420|NCT01693380|Intervention studies|intervention studies
5406421|NCT01693380|Adolescents|adolescents
5406422|NCT01693380|Laboratory Confirmed Influenza|laboratory confirmed influenza
5406423|NCT01693367|Femoral fracture|femoral fracture
5406424|NCT01693367|Periprosthetic fracture|periprosthetic fracture
5406425|NCT01693367|Fracture fixation, internal|fracture fixation, internal
5406426|NCT01693367|Distal femur fractures|distal femur fractures
5406427|NCT01693367|Dynamic Locking Screw|dynamic locking screw
5406428|NCT01693367|WOMAC|womac
5406429|NCT01693354|dialysis|dialysis
5406430|NCT01693354|mortality|mortality
5406431|NCT01693354|cardiovascular stability|cardiovascular stability
5406437|NCT01693341|Caregiver-mediated intervention|caregiver-mediated intervention
5406438|NCT01693328|quality of life|quality of life
5406439|NCT01693328|PecFent|pecfent
5406440|NCT01693328|Lazanda|lazanda
5406441|NCT01693328|fentanyl|fentanyl
5406442|NCT01693328|intranasal|intranasal
5406443|NCT01693328|breakthrough cancer pain|breakthrough cancer pain
5406444|NCT01693302|Blood Glucose|blood glucose
5406445|NCT01693302|Meal insulin|meal insulin
5406446|NCT01693289|Metformin|metformin
5406447|NCT01693289|letrozole|letrozole
5406448|NCT01693289|ovarian drilling|ovarian drilling
5406449|NCT01693289|clomiphene resistance|clomiphene resistance
5406450|NCT01693289|polycystic ovary.|polycystic ovary.
5406451|NCT01693276|pancreatic cancer|pancreatic cancer
5406452|NCT01693263|end stage renal disease (ESRD)|end stage renal disease (esrd)
5406453|NCT01693263|brachiocephalic fistula (BCF)|brachiocephalic fistula (bcf)
5406454|NCT01693263|cephalic arch stenosis (CAS)|cephalic arch stenosis (cas)
5406455|NCT01693263|dialysis|dialysis
5406456|NCT01693250|technology|technology
5406457|NCT01693250|healthy weight management|healthy weight management
5406458|NCT01693250|primary care setting|primary care setting
5406459|NCT01693224|Tests, Diagnostic|tests, diagnostic
5406460|NCT01693224|Mycobacterium tuberculosis|mycobacterium tuberculosis
5406461|NCT01693224|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
5406462|NCT01693224|TB|tb
5406463|NCT01693224|Tuberculosis|tuberculosis
5406464|NCT01693224|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5406465|NCT01693224|Tuberculosis, Miliary|tuberculosis, miliary
5406466|NCT01693224|Lipoarabinomannan|lipoarabinomannan
5406467|NCT01693211|femtosecond laser|femtosecond laser
5406468|NCT01693211|cataract|cataract
5406469|NCT01693211|control study|control study
5406470|NCT01693211|prospective|prospective
5406471|NCT01693198|allergy|allergy
5406472|NCT01693198|cyanobacteria|cyanobacteria
5406473|NCT01693198|sweet water swimming|sweet water swimming
5406474|NCT01693185|colonoscopy|colonoscopy
5406475|NCT01693185|remifentanil|remifentanil
5406476|NCT01693185|midazolam|midazolam
5406477|NCT01693185|meperidine|meperidine
5406478|NCT01693172|exercise|exercise
5406479|NCT01693172|neoplasm|neoplasm
5406480|NCT01693159|Painful cetuximab-induced rhagades|painful cetuximab-induced rhagades
5406481|NCT01693159|Radioimmunotherapy|radioimmunotherapy
5406482|NCT01693159|Head and neck cancer|head and neck cancer
5406483|NCT01693146|Oxygen|oxygen
5406484|NCT01693146|High Flow|high flow
5406485|NCT01693146|COPD|copd
5406486|NCT01693146|Hypercapnia|hypercapnia
5406487|NCT01693120|ablation|ablation
5406488|NCT01693120|atrial fibrillation|atrial fibrillation
5406489|NCT01693120|Radio frequency|radio frequency
5406490|NCT01693107|Atrial Fibrillation|atrial fibrillation
5406491|NCT01693107|Catheter Ablation|catheter ablation
5406492|NCT01693107|Electrophysiology|electrophysiology
5406493|NCT01693107|Cardiac Arrhythmias|cardiac arrhythmias
5406494|NCT01693081|Parkinson's disease|parkinson's disease
5406495|NCT01693081|inhaled apomorphine|inhaled apomorphine
5406496|NCT01693081|"convert off to on"|"convert off to on"
5406497|NCT01693068|Cutaneous Melanoma|cutaneous melanoma
5406498|NCT01693068|Dacarbazine|dacarbazine
5406499|NCT01693068|Pimasertib|pimasertib
5406500|NCT01693068|N-Ras|n-ras
5406501|NCT01693055|orbital Computed Tomography|orbital computed tomography
5406502|NCT01693055|baggy eyelids|baggy eyelids
5406503|NCT01693055|orbital fat prolapse|orbital fat prolapse
5406504|NCT01693055|UltheraTM|ultheratm
5406505|NCT01693055|high intensity focused ultrasound|high intensity focused ultrasound
5406511|NCT01693029|erythropoietin alfa|erythropoietin alfa
5406513|NCT01693016|non-invasive Hb measurement in children|non-invasive hb measurement in children
5406514|NCT01693003|COPD|copd
5406515|NCT01692990|Appetite|appetite
5406516|NCT01692990|Fish oil|fish oil
5406517|NCT01692990|Long-chain n-3 fatty acids|long-chain n-3 fatty acids
5406518|NCT01692912|Psoriatic Arthritis|psoriatic arthritis
5406519|NCT01692912|Randomized|randomized
5406520|NCT01692912|Single blind|single blind
5406521|NCT01692912|Treat to target|treat to target
5406522|NCT01692899|Retention Rates|retention rates
5406523|NCT01692899|of Adalimumab|of adalimumab
5406524|NCT01692899|Etanercept and Infliximab|etanercept and infliximab
5406525|NCT01692899|as First and Second-Line Biotherapy|as first and second-line biotherapy
5406526|NCT01692899|in Patients with Rheumatoid Arthritis|in patients with rheumatoid arthritis
5406527|NCT01692899|in Daily Practice.|in daily practice.
5406528|NCT01692899|TNF inhibitors|tnf inhibitors
5406529|NCT01692899|biotherapy|biotherapy
5406530|NCT01692899|retrospective study|retrospective study
5406531|NCT01692886|13vPnC|13vpnc
5406532|NCT01692886|7vPnC|7vpnc
5406533|NCT01692886|Healthy subjects|healthy subjects
5406534|NCT01692886|China|china
5406535|NCT01692873|pancreatic tumor|pancreatic tumor
5406536|NCT01692860|the impact of a higher dairy-based protein diet in|the impact of a higher dairy-based protein diet in
5406537|NCT01692860|combination with energy restriction on muscle health,|combination with energy restriction on muscle health,
5406538|NCT01692860|metabolic health (including blood pressure) in overweight|metabolic health (including blood pressure) in overweight
5406539|NCT01692860|and obese, middle aged adults|and obese, middle aged adults
5406540|NCT01692847|patient deterioration|patient deterioration
5406541|NCT01692847|rapid response teams|rapid response teams
5406542|NCT01692847|acute care teams|acute care teams
5406543|NCT01692847|early warning scoring|early warning scoring
5406544|NCT01692834|bioequivalence|bioequivalence
5393632|NCT01750411|SARP|sarp
5406545|NCT01692834|pharmacokinetics|pharmacokinetics
5406546|NCT01692834|tolerability|tolerability
5406547|NCT01692834|safety|safety
5406548|NCT01692834|ciclosporin|ciclosporin
5406549|NCT01692834|cyclosporine|cyclosporine
5406550|NCT01692834|cyclosporine A|cyclosporine a
5406551|NCT01692834|Sandimmune|sandimmune
5406552|NCT01692834|Sandimmun|sandimmun
5406553|NCT01692834|CicloMulsion|ciclomulsion
5406554|NCT01692834|NeuroSTAT|neurostat
5406555|NCT01692821|retinal oxygen saturation|retinal oxygen saturation
5406556|NCT01692821|retinal blood flow|retinal blood flow
5406557|NCT01692821|hyperoxia|hyperoxia
5406558|NCT01692821|hypoxia|hypoxia
5406559|NCT01692808|Crohn|crohn
5406560|NCT01692808|vitamin D|vitamin d
5406561|NCT01692808|remission|remission
5406562|NCT01692808|inflammation|inflammation
5406563|NCT01692808|tolerance|tolerance
5406564|NCT01692795|Myocardial infarction|myocardial infarction
5406565|NCT01692795|Antiplatelets|antiplatelets
5406566|NCT01692795|Lipid lowering agents|lipid lowering agents
5406567|NCT01692795|ACE inhibitors|ace inhibitors
5406568|NCT01692795|Angiotensin Receptor Blockers|angiotensin receptor blockers
5406569|NCT01692795|Beta blockers|beta blockers
5406570|NCT01692795|Blood pressure lowering drugs|blood pressure lowering drugs
5406571|NCT01692782|ADHD|adhd
5406572|NCT01692782|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5406573|NCT01692769|Trauma|trauma
5406574|NCT01692769|Pediatric|pediatric
5406575|NCT01692769|Intravenous Fluid|intravenous fluid
5406576|NCT01692769|Normal Saline|normal saline
5406577|NCT01692769|Ringer's Lactate|ringer's lactate
5406578|NCT01692743|Telemedicine|telemedicine
5406579|NCT01692743|Inflammatory bowel disease|inflammatory bowel disease
5406580|NCT01692743|Crohn's disease|crohn's disease
5406581|NCT01692743|Ulcerative colitis|ulcerative colitis
5406582|NCT01692743|Quality of life|quality of life
5406583|NCT01692743|Health care utilization|health care utilization
5406584|NCT01692730|Smoking Cessation|smoking cessation
5406585|NCT01692730|Web Assisted Tobacco Intervention|web assisted tobacco intervention
5406586|NCT01692691|Melanoma Metastatic|melanoma metastatic
5406587|NCT01692678|Advanced or Metastatic liposarcoma or leiomyosarcoma|advanced or metastatic liposarcoma or leiomyosarcoma
5406588|NCT01692678|Sarcoma|sarcoma
5406589|NCT01692678|L-sarcoma|l-sarcoma
5406590|NCT01692678|Liposarcoma|liposarcoma
5406591|NCT01692678|Leiomyosarcoma|leiomyosarcoma
5406592|NCT01692678|Trabectedin|trabectedin
5406593|NCT01692678|Dacarbazine|dacarbazine
5406594|NCT01692678|Yondelis|yondelis
5406595|NCT01692678|Chinese patients|chinese patients
5406596|NCT01692678|Overall survival|overall survival
5406597|NCT01692678|Pharmacokinetics|pharmacokinetics
5406598|NCT01692665|meibomian gland dysfunction|meibomian gland dysfunction
5406599|NCT01692665|keratometric value|keratometric value
5406600|NCT01692665|ocular aberration|ocular aberration
5406601|NCT01692626|Cetuximab rash|cetuximab rash
5406602|NCT01692626|Erbitux rash|erbitux rash
5406603|NCT01692626|Rash|rash
5401661|NCT01714414|FATI|fati
5406605|NCT01692626|1% Topical pimecrolimus cream|1% topical pimecrolimus cream
5406606|NCT01692600|Late oral radiation toxicity|late oral radiation toxicity
5406607|NCT01692600|head and neck cancer patients|head and neck cancer patients
5406608|NCT01692600|optical coherence tomography|optical coherence tomography
5406609|NCT01692600|subsurface imaging|subsurface imaging
5406610|NCT01692600|mirometer-resolution imaging|mirometer-resolution imaging
5406611|NCT01692600|vascular imaging|vascular imaging
5541372|NCT01121250|Spouses|spouses
5406612|NCT01692600|Doppler optical coherence tomography|doppler optical coherence tomography
5406613|NCT01692600|speckle variance optical coherence tomography|speckle variance optical coherence tomography
5406615|NCT01692587|protein|protein
5406616|NCT01692587|prostate|prostate
5406617|NCT01692574|depression and obesity treatment|depression and obesity treatment
5406618|NCT01692561|Dysautonomia|dysautonomia
5406619|NCT01692561|Postural orthostatic tachycardic hypotension|postural orthostatic tachycardic hypotension
5406620|NCT01692561|Neurocardiogenic vasovagal syncope|neurocardiogenic vasovagal syncope
5406621|NCT01692509|Non invasive ventilation|non invasive ventilation
5406622|NCT01692509|Respiratory failure|respiratory failure
5406623|NCT01692509|Respiratory comfort|respiratory comfort
5406624|NCT01692496|Advanced|advanced
5406625|NCT01692496|Metastatic|metastatic
5406626|NCT01692496|Liposarcoma|liposarcoma
5406627|NCT01692496|Pazopanib|pazopanib
5406628|NCT01692483|Prostate neoplasms|prostate neoplasms
5406629|NCT01692483|Prostate cancer|prostate cancer
5406630|NCT01692483|Castration resistant prostate cancer|castration resistant prostate cancer
5406631|NCT01692483|Hormone refractory prostate cancer|hormone refractory prostate cancer
5391961|NCT01758510|ALS|als
5406632|NCT01692483|Abiraterone acetate|abiraterone acetate
5406634|NCT01692470|Human immunodeficiency virus type 1 (HIV-1) infection|human immunodeficiency virus type 1 (hiv-1) infection
5406635|NCT01692470|HIV-1|hiv-1
5406636|NCT01692470|Anti-retroviral naive|anti-retroviral naive
5406637|NCT01692470|ARV|arv
5406638|NCT01692470|Filipino patients|filipino patients
5406639|NCT01692470|Rilpivirine hydrochloride|rilpivirine hydrochloride
5406640|NCT01692470|Edurant|edurant
5406641|NCT01692457|Rheumatoid Arthritis|rheumatoid arthritis
5406642|NCT01692457|Psoriatic Arthritis|psoriatic arthritis
5406643|NCT01692457|Ankylosing Spondylitis|ankylosing spondylitis
5406644|NCT01692457|Arthritis|arthritis
5406645|NCT01692457|Spondylitis|spondylitis
5406646|NCT01692457|Joint pain|joint pain
5406647|NCT01692457|CNTO148|cnto148
5406648|NCT01692457|Golimumab|golimumab
5406649|NCT01692457|Simponi|simponi
5406650|NCT01692457|Filipino|filipino
5406651|NCT01692457|Post-Marketing|post-marketing
5406652|NCT01692457|Surveillance|surveillance
5406653|NCT01692444|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5406654|NCT01692444|Fibrosis|fibrosis
5406655|NCT01692444|Fibroblast|fibroblast
5406656|NCT01692444|Lung attenuation|lung attenuation
5406657|NCT01692444|Pletysmography|pletysmography
5406658|NCT01692418|Anaemia|anaemia
5406659|NCT01692418|Blood transfusion|blood transfusion
5406660|NCT01692418|Surgery|surgery
5406661|NCT01692418|Iron|iron
5406662|NCT01692418|Ferric carboxymaltose|ferric carboxymaltose
5406663|NCT01692392|Pectus carinatum|pectus carinatum
5406664|NCT01692392|Quality of life|quality of life
5406665|NCT01692392|Pain, postoperative|pain, postoperative
5406666|NCT01692392|Somatosensory disorders|somatosensory disorders
5406667|NCT01692379|Acute ischemic stroke|acute ischemic stroke
5406668|NCT01692379|endovascular treatment|endovascular treatment
5406669|NCT01692379|clinical trial|clinical trial
5406670|NCT01692353|Flow mediated dilation|flow mediated dilation
5406671|NCT01692353|Carotid intima-media thickness|carotid intima-media thickness
5406672|NCT01692353|Ankle-brachial index|ankle-brachial index
5406673|NCT01692353|Smokeless tobacco|smokeless tobacco
5406674|NCT01692353|Biological markers|biological markers
5406675|NCT01692353|Nicotine|nicotine
5406676|NCT01692353|Tobacco-specific nitrosamines|tobacco-specific nitrosamines
5406677|NCT01692353|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
5406678|NCT01692353|Aromatic amines|aromatic amines
5406679|NCT01692353|Mercapturic acid metabolites|mercapturic acid metabolites
5406680|NCT01692353|Cholesterol|cholesterol
5406681|NCT01692353|Blood lipids|blood lipids
5406682|NCT01692353|Oxidative stress|oxidative stress
5406683|NCT01692353|Inflammation|inflammation
5406684|NCT01692353|Cytokines|cytokines
5406685|NCT01692340|tomato|tomato
5406686|NCT01692340|prostate cancer|prostate cancer
5406687|NCT01692340|metabolism|metabolism
5406688|NCT01692327|glucose intolerance (20)|glucose intolerance (20)
5406689|NCT01692327|Control (20)|control (20)
5406690|NCT01692314|Endothelial function|endothelial function
5406691|NCT01692314|Microvascular reactivity|microvascular reactivity
5406692|NCT01692314|Obesity|obesity
5406693|NCT01692314|Adolescents|adolescents
5406694|NCT01692301|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity|hypertension, elderly, central aortic pulse pressure, central pulse pressure, pulse wave velocity
5862834|NCT00001487|Perimenopause|perimenopause
5406696|NCT01692262|adenocarcinoma of the prostate,|adenocarcinoma of the prostate,
5406697|NCT01692262|prostate cancer,|prostate cancer,
5406698|NCT01692262|progressive disease,|progressive disease,
5406699|NCT01692262|advanced disease.|advanced disease.
5406700|NCT01692249|chronic shoulder pain|chronic shoulder pain
5406701|NCT01692249|rotator cuff tendinopathy|rotator cuff tendinopathy
5406702|NCT01692249|sap therapy|sap therapy
5406703|NCT01692249|balneotherapy|balneotherapy
5406704|NCT01692236|MRI|mri
5406705|NCT01692236|HIV|hiv
5406706|NCT01692236|Neurocognitive Disorders|neurocognitive disorders
5406707|NCT01692236|Major Depression|major depression
5406708|NCT01692236|Vasculopathy|vasculopathy
5406709|NCT01692223|Personal genomics|personal genomics
5406710|NCT01692223|Genome Sequencing Results|genome sequencing results
5406712|NCT01692210|Breast Cancer|breast cancer
5406713|NCT01692210|Dexmedetomidine|dexmedetomidine
5406714|NCT01692210|Unilateral mastectomy|unilateral mastectomy
5406715|NCT01692210|Blood sample collections|blood sample collections
5406716|NCT01692210|Immune system|immune system
5406717|NCT01692210|White blood cell levels|white blood cell levels
5406718|NCT01692197|Leukemia|leukemia
5406719|NCT01692197|Acute Myeloid Leukemia|acute myeloid leukemia
5406720|NCT01692197|Acute Myelogenous Leukemia|acute myelogenous leukemia
5406721|NCT01692197|AML|aml
5406722|NCT01692197|Relapsed or Refractory|relapsed or refractory
5406727|NCT01692197|Idamycin|idamycin
5406728|NCT01692197|Cytarabine|cytarabine
5406729|NCT01692197|Cytarabine (ARA-C)|cytarabine (ara-c)
5406731|NCT01692197|DepoCyt|depocyt
5406732|NCT01692197|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5406733|NCT01692197|Dexamethasone|dexamethasone
5406734|NCT01692197|Decadron|decadron
5406735|NCT01692184|AVL-292|avl-292
5406736|NCT01692184|Safety|safety
5406737|NCT01692184|Pharmacokinetics|pharmacokinetics
5406738|NCT01692184|Pharmacodynamics|pharmacodynamics
5406739|NCT01692184|Pharmacology, Clinical|pharmacology, clinical
5406740|NCT01692171|Subjects|subjects
5406741|NCT01692158|subjects|subjects
5406742|NCT01692145|Dry eye syndromes|dry eye syndromes
5379438|NCT01815268|Nursing Home|nursing home
5406743|NCT01692145|Corneal diseases|corneal diseases
5406744|NCT01692145|Conjunctival diseases|conjunctival diseases
5406745|NCT01692132|Chronic Constipation|chronic constipation
5406746|NCT01692132|Prucalopride|prucalopride
5406747|NCT01692132|Post Marketing Surveillance|post marketing surveillance
5406748|NCT01692119|chronic heart failure|chronic heart failure
5406749|NCT01692119|medication adherence|medication adherence
5406750|NCT01692119|pharmacy|pharmacy
5406751|NCT01692119|interdisciplinary care|interdisciplinary care
5406752|NCT01692119|randomized controlled trial|randomized controlled trial
5406753|NCT01692119|mortality|mortality
5406754|NCT01692119|hospitalization|hospitalization
5406755|NCT01692106|Heller myotomy|heller myotomy
5406756|NCT01692093|SCORAD|scorad
5406757|NCT01692093|Atopic dermatits|atopic dermatits
5406758|NCT01692093|Skin health|skin health
5406759|NCT01692067|Rape|rape
5406760|NCT01692067|Women|women
5406761|NCT01692067|Military|military
5406762|NCT01692067|Veterans|veterans
5406763|NCT01692067|Post-traumatic Stress Disorder|post-traumatic stress disorder
5406764|NCT01692067|Traumatic Brain Injury|traumatic brain injury
5406765|NCT01692041|asthma|asthma
5406766|NCT01692041|children|children
5406767|NCT01692028|vitamin D|vitamin d
5406768|NCT01692028|Associational study|associational study
5406769|NCT01692002|Diabetes Mellitus|diabetes mellitus
5406770|NCT01692002|Propionate|propionate
5406771|NCT01691976|Mild cognitive impairment|mild cognitive impairment
5406772|NCT01691976|Androgen deprivation therapy|androgen deprivation therapy
5406773|NCT01691963|Epiglottis|epiglottis
5406774|NCT01691963|Intubation|intubation
5406775|NCT01691963|Laryngoscopy|laryngoscopy
5406781|NCT01691937|Thoracic paravertebral block|thoracic paravertebral block
5406782|NCT01691937|Postoperative pain|postoperative pain
5406783|NCT01691937|Right lobe hepatectomy|right lobe hepatectomy
5406784|NCT01691937|Patient controlled analgesia|patient controlled analgesia
5406785|NCT01691924|Adenosine A2a receptor antagonist|adenosine a2a receptor antagonist
5406786|NCT01691924|adenosine receptor modulator|adenosine receptor modulator
5406787|NCT01691924|Cancer|cancer
5406788|NCT01691911|Vascular disease|vascular disease
5406789|NCT01691911|Open aortic aneurysm repair|open aortic aneurysm repair
5406790|NCT01691911|Endovascular aneurysm repair|endovascular aneurysm repair
5406791|NCT01691911|Carotid endartrectomy|carotid endartrectomy
5406792|NCT01691911|Lower limb surgical revascularisation|lower limb surgical revascularisation
5406793|NCT01691911|Major lower limb amputation|major lower limb amputation
5406794|NCT01691859|extension study|extension study
5406795|NCT01691859|Severe refractory asthma|severe refractory asthma
5406796|NCT01691859|safety|safety
5406797|NCT01691859|SB-240563|sb-240563
5406798|NCT01691859|mepolizumab|mepolizumab
5406799|NCT01691859|eosinophils|eosinophils
5406800|NCT01691833|Vitamin D|vitamin d
5406801|NCT01691833|nonunion|nonunion
5406802|NCT01691833|long bone fracture|long bone fracture
5406803|NCT01691833|hypovitaminosis D|hypovitaminosis d
5406804|NCT01691820|Adolescent females|adolescent females
5406805|NCT01691820|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5406806|NCT01691807|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5406807|NCT01691807|drug-drug interaction|drug-drug interaction
5406809|NCT01691807|bendamustine|bendamustine
5406810|NCT01691781|Hyperparathyroidism|hyperparathyroidism
5406811|NCT01691781|Renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5406812|NCT01691781|ACE inhibitors|ace inhibitors
5406813|NCT01691768|microbicides|microbicides
5406814|NCT01691768|women|women
5410280|NCT01676480|ADT|adt
5406815|NCT01691768|HIV prevention|hiv prevention
5406816|NCT01691768|PrEP|prep
5406817|NCT01691768|Tenofovir gel|tenofovir gel
5406818|NCT01691742|Postoperative constipation|postoperative constipation
5406819|NCT01691742|Urogynecologic Surgery|urogynecologic surgery
5406820|NCT01691742|MiraLax|miralax
5406821|NCT01691742|Docusate Sodium|docusate sodium
5406822|NCT01691716|Achilles tendinopathy|achilles tendinopathy
5406823|NCT01691716|Tendoactive|tendoactive
5406824|NCT01691716|Eccentric training|eccentric training
5406825|NCT01691703|Fiber Optic Technology/methods|fiber optic technology/methods
5406826|NCT01691703|Intubation, Intratracheal/methods|intubation, intratracheal/methods
5406827|NCT01691703|Laryngoscopy/methods|laryngoscopy/methods
5406828|NCT01691664|Esophageal Cancer|esophageal cancer
5406829|NCT01691664|DC-CIK|dc-cik
5406830|NCT01691664|immunotherapy|immunotherapy
5406831|NCT01691664|cellular therapy|cellular therapy
5406832|NCT01691664|radiation therapy|radiation therapy
5406833|NCT01691651|Keratoconus|keratoconus
5406834|NCT01691651|Tetanus toxin|tetanus toxin
5406835|NCT01691625|Locally advanced esophageal carcinoma|locally advanced esophageal carcinoma
5406837|NCT01691625|Immunotherapy|immunotherapy
5406838|NCT01691612|Role of Pin-1 enzyme in Asthma|role of pin-1 enzyme in asthma
5406839|NCT01691599|Infection|infection
5406840|NCT01691599|Open tibia fractures|open tibia fractures
5406841|NCT01691599|Closed tibia fractures|closed tibia fractures
5406842|NCT01691599|Wound infection|wound infection
5406843|NCT01691586|implantable defibrillators|implantable defibrillators
5406844|NCT01691586|remote patient monitoring|remote patient monitoring
5406845|NCT01691586|patient-reported outcomes|patient-reported outcomes
5406846|NCT01691586|cost-effectiveness|cost-effectiveness
5406847|NCT01691573|ablation|ablation
5406848|NCT01691573|procedure|procedure
5406849|NCT01691573|pediatric|pediatric
5406850|NCT01691573|european|european
5406851|NCT01691573|cardiac|cardiac
5406852|NCT01691573|arrhythmias|arrhythmias
5406853|NCT01691573|registry|registry
5406854|NCT01691573|observational|observational
5406855|NCT01691573|prospective|prospective
5406856|NCT01691573|catheter|catheter
5406857|NCT01691573|cryoablation|cryoablation
5406858|NCT01691573|atrioventricular|atrioventricular
5406859|NCT01691547|GW642444 (Vilanterol)|gw642444 (vilanterol)
5406860|NCT01691547|pharmacokinetics|pharmacokinetics
5406861|NCT01691547|pharmacodynamics|pharmacodynamics
5406862|NCT01691547|GSK573719 (Umeclidinium)|gsk573719 (umeclidinium)
5406863|NCT01691547|healthy subjects|healthy subjects
5406864|NCT01691547|GW685698 (Fluticasone Furoate)|gw685698 (fluticasone furoate)
5406865|NCT01691534|Tuberculosis|tuberculosis
5406866|NCT01691534|EBA|eba
5406867|NCT01691534|PA824|pa824
5406868|NCT01691534|pretomanid|pretomanid
5406869|NCT01691534|TMC207|tmc207
5406870|NCT01691521|safety|safety
5406871|NCT01691521|SB-240563|sb-240563
5406872|NCT01691521|efficacy|efficacy
5406873|NCT01691521|placebo|placebo
5406874|NCT01691521|eosinophils|eosinophils
5406875|NCT01691521|mepolizumab|mepolizumab
5406876|NCT01691521|Severe refractory asthma|severe refractory asthma
5406877|NCT01691508|Safety|safety
5406878|NCT01691508|Steroid Reduction|steroid reduction
5406879|NCT01691508|Efficacy|efficacy
5406880|NCT01691508|SB-240563|sb-240563
5406881|NCT01691508|Eosinophils|eosinophils
5406882|NCT01691508|Quality of Life|quality of life
5406883|NCT01691508|Mepolizumab|mepolizumab
5406884|NCT01691508|Severe Refractory Asthma|severe refractory asthma
5406885|NCT01691495|Physician Adherence|physician adherence
5406886|NCT01691495|superficial vein thrombosis|superficial vein thrombosis
5406887|NCT01691495|Fondaparinux|fondaparinux
5406888|NCT01691469|Bioequivalence|bioequivalence
5406889|NCT01691469|Montelukast Sodium|montelukast sodium
5406890|NCT01691469|crossover|crossover
5406891|NCT01691456|Bioequivalence|bioequivalence
5406892|NCT01691456|Montelukast Sodium|montelukast sodium
5406893|NCT01691456|crossover|crossover
5406894|NCT01691404|Flavonoids|flavonoids
5406895|NCT01691404|Quercetin|quercetin
5406896|NCT01691404|Epicatechin|epicatechin
5406897|NCT01691404|Vascular function|vascular function
5406898|NCT01691404|Blood pressure|blood pressure
5406899|NCT01691404|Endothelial function|endothelial function
5406900|NCT01691391|Advanced CRC|advanced crc
5406901|NCT01691378|Veterans|veterans
5406902|NCT01691378|Window to Hope|window to hope
5406903|NCT01691378|Cognitive Behavioral Therapy|cognitive behavioral therapy
5406908|NCT01691365|vitamins|vitamins
5406909|NCT01691365|Diet|diet
5406910|NCT01691352|Wound infection|wound infection
5406911|NCT01691352|Ostomy reversal|ostomy reversal
5406912|NCT01691339|Influenza|influenza
5406913|NCT01691339|Influenza virus vaccine|influenza virus vaccine
5671341|NCT00616499|adenocarcinoma of the lung|adenocarcinoma of the lung
5406914|NCT01691339|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
5423344|NCT01616082|Proton magnetic resonance spectroscopy|proton magnetic resonance spectroscopy
5406915|NCT01691339|Fluzone® High-Dose (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® high-dose (influenza virus vaccine) 2012-2013 formulation
5406916|NCT01691339|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5406917|NCT01691339|Fluzone® Intradermal (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® intradermal (influenza virus vaccine) 2012-2013 formulation
5406918|NCT01691326|Influenza|influenza
5406919|NCT01691326|Fluzone® (Influenza Virus Vaccine) 2012-2013 Formulation|fluzone® (influenza virus vaccine) 2012-2013 formulation
5406920|NCT01691326|Influenza virus vaccine|influenza virus vaccine
5406921|NCT01691326|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5406922|NCT01691313|vanoxerine|vanoxerine
5406923|NCT01691313|atrial fibrillation|atrial fibrillation
5406924|NCT01691313|atrial flutter|atrial flutter
5406926|NCT01691300|C11-acetate PET/CT|c11-acetate pet/ct
5406927|NCT01691300|Multiple myeloma|multiple myeloma
5406928|NCT01691300|Pretreatment staging|pretreatment staging
5406929|NCT01691300|Response assessment|response assessment
5406930|NCT01691287|Type 1 Diabetes|type 1 diabetes
5406931|NCT01691287|Metabolic Control|metabolic control
5406932|NCT01691287|Quality of Life|quality of life
5406933|NCT01691274|Epilepsy|epilepsy
5406935|NCT01691274|Multiple Dose|multiple dose
5406936|NCT01691274|Safety|safety
5406937|NCT01691274|Pharmacokinetics|pharmacokinetics
5406938|NCT01691274|Toleration|toleration
5406939|NCT01691248|Clostridium difficile|clostridium difficile
5406940|NCT01691248|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5406941|NCT01691248|Prophylaxis|prophylaxis
5406942|NCT01691248|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5379625|NCT01814423|malaria|malaria
5394030|NCT01748448|Vitamin D|vitamin d
5406943|NCT01691235|SIMpill|simpill
5406945|NCT01691235|Chronic Hepatitis C Virus|chronic hepatitis c virus
5406946|NCT01691222|Bedside percutaneous tracheostomy|bedside percutaneous tracheostomy
5406947|NCT01691222|Intensive Care Unit|intensive care unit
5406948|NCT01691222|Dedicated Double-lumen tube|dedicated double-lumen tube
5406949|NCT01691222|Ineffective Airway Clearance|ineffective airway clearance
5406950|NCT01691222|weaning failure|weaning failure
5406951|NCT01691209|Phoenix|phoenix
5406952|NCT01691209|Hydrocortison|hydrocortison
5406953|NCT01691209|mild atopic dermatitis|mild atopic dermatitis
5406954|NCT01691209|efficacy|efficacy
5406955|NCT01691209|safety|safety
5406956|NCT01691196|Obesity|obesity
5406957|NCT01691196|Peritoneal dialysis|peritoneal dialysis
5406958|NCT01691196|Inflammation|inflammation
5406959|NCT01691196|Macrophages|macrophages
5406960|NCT01691196|Innate immunity|innate immunity
5406961|NCT01691183|Hertel|hertel
5406962|NCT01691183|exophthalmometer|exophthalmometer
5406963|NCT01691183|proptosis|proptosis
5406964|NCT01691183|eye disease|eye disease
5406965|NCT01691170|Pattelofemoral pain syndrome|pattelofemoral pain syndrome
5406966|NCT01691170|Stretching|stretching
5406967|NCT01691170|Strengthening|strengthening
5406968|NCT01691157|Subacromial impingement syndrome|subacromial impingement syndrome
5406969|NCT01691157|Rotator cuff|rotator cuff
5406970|NCT01691157|Exercise|exercise
5406971|NCT01691157|Physiotherapy|physiotherapy
5406972|NCT01691144|cancer|cancer
5406973|NCT01691144|gynecological|gynecological
5406974|NCT01691144|expectations|expectations
5406975|NCT01691144|satisfaction|satisfaction
5406976|NCT01691144|cooperation|cooperation
5406977|NCT01691131|Physical activity in daily life|physical activity in daily life
5406978|NCT01691131|Balance|balance
5406979|NCT01691131|COPD|copd
5406980|NCT01691131|Exercise training|exercise training
5406981|NCT01691118|Hypertension|hypertension
5406982|NCT01691118|Angiotensin Receptor Blocker|angiotensin receptor blocker
5406983|NCT01691118|Diastolic Dysfunction|diastolic dysfunction
5406984|NCT01691105|Tobacco Use Cessation|tobacco use cessation
5406985|NCT01691105|Smoking Cessation|smoking cessation
5406986|NCT01691105|Nicotine Replacement Therapy|nicotine replacement therapy
5406987|NCT01691105|Hospitalized Smokers|hospitalized smokers
5406988|NCT01691092|Depression|depression
5406989|NCT01691092|Ketamine|ketamine
5406991|NCT01691092|PTSD|ptsd
5406992|NCT01691053|End stage renal disease|end stage renal disease
5406993|NCT01691053|Hemodialysis|hemodialysis
5406994|NCT01691053|Spironolactone|spironolactone
5406995|NCT01691053|Left ventricular hypertrophy|left ventricular hypertrophy
5406996|NCT01691040|Hepcidin|hepcidin
5406997|NCT01691040|Iron|iron
5406998|NCT01691040|Anemia of Chronic Disease|anemia of chronic disease
5406999|NCT01691040|Anemia|anemia
5407000|NCT01691040|Cancer|cancer
5407001|NCT01691040|Interleukin-6|interleukin-6
5407002|NCT01691040|Iron restriction|iron restriction
5407003|NCT01691040|Lymphoma|lymphoma
5407004|NCT01691040|CLL|cll
5407005|NCT01691040|Multiple Myeloma|multiple myeloma
5407006|NCT01691040|Hodgkin|hodgkin
5407007|NCT01691040|anti-hepcidin|anti-hepcidin
5407008|NCT01691027|scotoma, central|scotoma, central
5407009|NCT01691027|visual motor coordination|visual motor coordination
5407010|NCT01690988|Delirium|delirium
5407011|NCT01690988|ketamine|ketamine
5407012|NCT01690988|surgery|surgery
5407013|NCT01690988|neurological complications|neurological complications
5423345|NCT01616069|CABG|cabg
5407014|NCT01690962|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
5407015|NCT01690949|inflammation|inflammation
5407017|NCT01690949|respiratory disease|respiratory disease
5407018|NCT01690949|healthy volunteers|healthy volunteers
5407019|NCT01690936|Almonds|almonds
5407020|NCT01690936|Body weight|body weight
5407021|NCT01690936|Snacking|snacking
5407022|NCT01690910|Ventilator|ventilator
5407023|NCT01690910|Mobility Limitations|mobility limitations
5407024|NCT01690910|Critical Care|critical care
5407025|NCT01690910|Rifton Gait Trainer|rifton gait trainer
5407026|NCT01690897|Female sexual desire|female sexual desire
5407027|NCT01690897|Psychoeducational intervention|psychoeducational intervention
5407028|NCT01690897|Mindfulness|mindfulness
5407029|NCT01690884|Adenosine|adenosine
5407030|NCT01690884|Ticagrelor|ticagrelor
5407031|NCT01690884|Microdialysis|microdialysis
5392307|NCT01756859|MRI|mri
5407032|NCT01690871|Malignant PEComa|malignant pecoma
5407033|NCT01690871|Angiomyolipoma|angiomyolipoma
5407034|NCT01690871|Tuberous Sclerosis Complex|tuberous sclerosis complex
5407035|NCT01690871|Pi3kinase /m-tor inhibitors|pi3kinase /m-tor inhibitors
5407036|NCT01690858|Foetal loss|foetal loss
5407037|NCT01690858|complement|complement
5407038|NCT01690858|antiangiogenic factors|antiangiogenic factors
5407039|NCT01690858|Repeated fetal losses|repeated fetal losses
5407040|NCT01690832|Contrast induced acute kidney injury|contrast induced acute kidney injury
5407041|NCT01690819|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5407042|NCT01690819|Acute Brain Injury|acute brain injury
5407043|NCT01690793|ASTHMA|asthma
5407044|NCT01690793|ACUTE EXACERBATION OF ASTHMA|acute exacerbation of asthma
5407045|NCT01690780|fracture|fracture
5407046|NCT01690780|pediatric|pediatric
5407047|NCT01690780|oral morphine|oral morphine
5407048|NCT01690780|ibuprofen|ibuprofen
5407049|NCT01690767|Urethral catheterization|urethral catheterization
5407050|NCT01690767|Lidocaine|lidocaine
5407052|NCT01690754|tuberculosis|tuberculosis
5407053|NCT01690754|impact evaluation|impact evaluation
5407054|NCT01690741|Cancer|cancer
5407055|NCT01690741|Malignancy|malignancy
5407056|NCT01690741|Solid tumors|solid tumors
5407057|NCT01690728|Obesity|obesity
5407058|NCT01690728|Gastric bypass|gastric bypass
5407059|NCT01690715|Hepatocellular Carcinoma|hepatocellular carcinoma
5407060|NCT01690715|Thrombosis|thrombosis
5407061|NCT01690715|Portal Vein Invasion|portal vein invasion
5407062|NCT01690702|breast cancer|breast cancer
5407063|NCT01690702|tailored|tailored
5407064|NCT01690702|high-risk|high-risk
5407065|NCT01690676|FMD|fmd
5407066|NCT01690676|epicatechin|epicatechin
5407067|NCT01690676|apple polyphenol|apple polyphenol
5407068|NCT01690676|borderline hypertension|borderline hypertension
5407069|NCT01690650|Preterm|preterm
5407070|NCT01690650|Newborn|newborn
5407071|NCT01690650|Neonate|neonate
5407072|NCT01690650|Cerebral oxygenation|cerebral oxygenation
5407073|NCT01690650|Oxygen|oxygen
5407074|NCT01690637|Oseltamivir|oseltamivir
5407075|NCT01690637|Tamiflu|tamiflu
5407076|NCT01690611|Balance Training|balance training
5407077|NCT01690611|Walking|walking
5407078|NCT01690611|Falls|falls
5407079|NCT01690598|Epithelial ovarian cancer|epithelial ovarian cancer
5407080|NCT01690598|BRCA mutation|brca mutation
5407081|NCT01690598|Platinum resistant|platinum resistant
5407082|NCT01690598|Platinum sensitive|platinum sensitive
5407083|NCT01690598|Relapsed ovarian cancer|relapsed ovarian cancer
5407084|NCT01690572|drug eluting balloon|drug eluting balloon
5407085|NCT01690572|constrictive remodeling|constrictive remodeling
5407086|NCT01690559|Ciprofloxacin|ciprofloxacin
5407087|NCT01690559|sepsis|sepsis
5407088|NCT01690559|infection|infection
5407089|NCT01690559|pneumonia|pneumonia
5407090|NCT01690559|peritonitis|peritonitis
5407091|NCT01690559|cholecystitis|cholecystitis
5407092|NCT01690559|cholangitis|cholangitis
5407093|NCT01690559|anthrax|anthrax
5407094|NCT01690546|Opioid Addiction|opioid addiction
5407095|NCT01690546|Addiction|addiction
5407096|NCT01690546|Drug Dependence|drug dependence
5407097|NCT01690533|Avelox|avelox
5407098|NCT01690533|Laryngopharyngitis|laryngopharyngitis
5407099|NCT01690533|Tonsillitis|tonsillitis
5407100|NCT01690533|Bronchitis acute|bronchitis acute
5407101|NCT01690533|Pneumonia|pneumonia
5863599|NCT00001243|Plasmid Libraries|plasmid libraries
5389901|NCT01768104|SMTs|smts
5407102|NCT01690533|Secondary infection in chronic respiratory diseases Sinusitis|secondary infection in chronic respiratory diseases sinusitis
5407104|NCT01690507|immunogenicity|immunogenicity
5407105|NCT01690494|STI|sti
5407106|NCT01690494|sexually transmitted infection|sexually transmitted infection
5407107|NCT01690494|HIV|hiv
5407108|NCT01690494|criminal justice|criminal justice
5407109|NCT01690494|probation|probation
5407110|NCT01690494|couples|couples
5407111|NCT01690494|drug use|drug use
5407112|NCT01690442|HIV|hiv
5407113|NCT01690442|AIDS|aids
5407114|NCT01690442|Prevention|prevention
5407115|NCT01690429|Arousal detection|arousal detection
5407116|NCT01690429|Pulse Wave Amplitude|pulse wave amplitude
5407117|NCT01690429|Obstructive Sleep Apnea|obstructive sleep apnea
5407118|NCT01690429|Daytime sleepiness|daytime sleepiness
5407127|NCT01690338|airway extubation|airway extubation
5407128|NCT01690338|PACU (postanesthesia care unit)|pacu (postanesthesia care unit)
5407129|NCT01690338|PORC (postoperative residual curarization)|porc (postoperative residual curarization)
5407130|NCT01690325|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5407131|NCT01690325|Neoadjuvant cytotoxic-antiangiogenic therapy|neoadjuvant cytotoxic-antiangiogenic therapy
5407132|NCT01690325|Bevacizumab|bevacizumab
5407134|NCT01690312|Humans|humans
5407135|NCT01690312|Cardiovascular Disease|cardiovascular disease
5407136|NCT01690312|Statins|statins
5407137|NCT01690312|Fish Oil|fish oil
5407140|NCT01690312|High-DHA|high-dha
5407141|NCT01690312|Triglycerides|triglycerides
5407142|NCT01690312|Total cholesterol [TC]|total cholesterol [tc]
5407143|NCT01690312|Lipoproteins|lipoproteins
5407144|NCT01690312|High-density lipoprotein [HDL2, HDL3]|high-density lipoprotein [hdl2, hdl3]
5407145|NCT01690312|Low-density lipoprotein [LDL1+2+3+4]|low-density lipoprotein [ldl1+2+3+4]
5407146|NCT01690312|Lipoprotein A [Lp(a)]|lipoprotein a [lp(a)]
5407147|NCT01690312|Intermediate-density lipoprotein (IDL)|intermediate-density lipoprotein (idl)
5407148|NCT01690312|Very low-density lipoprotein (VLDL1+2, VLDL3)|very low-density lipoprotein (vldl1+2, vldl3)
5407149|NCT01690312|Remnant Lipoproteins|remnant lipoproteins
5407150|NCT01690312|High-sensitivity C-Reactive Protein [hs-CRP]|high-sensitivity c-reactive protein [hs-crp]
5407151|NCT01690312|Homocysteine|homocysteine
5407152|NCT01690312|Essential Fatty Acid Profile|essential fatty acid profile
5407154|NCT01690312|Apolipoprotein A-1|apolipoprotein a-1
5407155|NCT01690312|Glucose|glucose
5407156|NCT01690312|Insulin|insulin
5407157|NCT01690312|Fasted|fasted
5407158|NCT01690312|Post-Prandial|post-prandial
5407159|NCT01690299|Psoriasis|psoriasis
5407160|NCT01690299|arthritis|arthritis
5407161|NCT01690299|psoriatic|psoriatic
5407162|NCT01690299|palmoplantar|palmoplantar
5407163|NCT01690299|scalp|scalp
5407164|NCT01690299|psoriasis pill|psoriasis pill
5407165|NCT01690299|psoriasis tablet|psoriasis tablet
5407166|NCT01690299|plaque psoriasis|plaque psoriasis
5407167|NCT01690299|plaque type psoriasis|plaque type psoriasis
5407168|NCT01690299|moderate to severe plaque type psoriasis|moderate to severe plaque type psoriasis
5407169|NCT01690299|psoriatic arthritis|psoriatic arthritis
5407170|NCT01690286|Healthy|healthy
5407171|NCT01690286|Ketoconazole|ketoconazole
5407172|NCT01690286|JNJ-38518168|jnj-38518168
5407173|NCT01690286|Pharmacokinetics|pharmacokinetics
5407174|NCT01690273|exercise|exercise
5407175|NCT01690273|mobility|mobility
5407176|NCT01690273|strengthening|strengthening
5407177|NCT01690273|physiotherapy|physiotherapy
5407178|NCT01690260|Bone|bone
5407179|NCT01690260|Morphogenetic|morphogenetic
5407180|NCT01690260|Protein|protein
5407181|NCT01690260|Ilizarow|ilizarow
5407182|NCT01690260|Autologous|autologous
5407183|NCT01690260|Osteoarthritis|osteoarthritis
5407184|NCT01690247|mesenchymal stem cells|mesenchymal stem cells
5407185|NCT01690247|liver transplantation|liver transplantation
5407186|NCT01690247|clinical trial|clinical trial
5407187|NCT01690247|rejection|rejection
5407188|NCT01690234|Low back pain|low back pain
5407189|NCT01690234|Return to work|return to work
5407190|NCT01690234|Sickness absence|sickness absence
5407191|NCT01690234|Rehabilitation|rehabilitation
5407192|NCT01690234|Multidisciplinary intervention|multidisciplinary intervention
5407193|NCT01690221|Anal|anal
5407194|NCT01690221|Fissure|fissure
5407195|NCT01690221|Pain|pain
5407196|NCT01690208|Diabetes|diabetes
5407197|NCT01690208|Structure Care|structure care
5407198|NCT01690182|Gastrointestinal physiology|gastrointestinal physiology
5407199|NCT01690182|MRI|mri
5407200|NCT01690182|gastric volumes|gastric volumes
5407201|NCT01690182|satiety|satiety
5407202|NCT01690156|In-plane|in-plane
5407203|NCT01690156|Ultrasound-guided regional anesthesia performance|ultrasound-guided regional anesthesia performance
5407204|NCT01690156|Probe position|probe position
5407205|NCT01690156|Needle visualization|needle visualization
5407206|NCT01690130|nicotine|nicotine
5407207|NCT01690130|craving|craving
5407208|NCT01690130|smoking|smoking
5407209|NCT01690130|TMS|tms
5407210|NCT01690130|prefrontal cortex|prefrontal cortex
5407212|NCT01690117|dementia|dementia
5407214|NCT01690117|implementation|implementation
5407215|NCT01690104|rifampicin|rifampicin
5407216|NCT01690104|pregnane X receptor|pregnane x receptor
5407217|NCT01690104|blood pressure|blood pressure
5407218|NCT01690091|chronic heart failure|chronic heart failure
5407219|NCT01690091|type 2 diabetes|type 2 diabetes
5407220|NCT01690091|metformin|metformin
5407221|NCT01690091|insulin resistance|insulin resistance
5407222|NCT01690078|Airway modeling|airway modeling
5407223|NCT01690078|Pierre Robin Sequence or PRS|pierre robin sequence or prs
5407224|NCT01690078|Micrognathia|micrognathia
5407225|NCT01690078|Subglottic Stenosis or SGS|subglottic stenosis or sgs
5407226|NCT01690065|chronic myeloid leukemia|chronic myeloid leukemia
5407227|NCT01690065|myeloid blastic phase|myeloid blastic phase
5407228|NCT01690065|bcr-abl(+) acute myeloid leukemia|bcr-abl(+) acute myeloid leukemia
5407229|NCT01690065|nilotinib|nilotinib
5407230|NCT01690052|dry mouth|dry mouth
5407231|NCT01690039|renal tubular acidosis|renal tubular acidosis
5407232|NCT01690039|V-ATPase|v-atpase
5407233|NCT01690039|kidney stones|kidney stones
5407234|NCT01689974|Metastatic Melanoma|metastatic melanoma
5407235|NCT01689974|Radiation Therapy|radiation therapy
5407236|NCT01689974|Immunology|immunology
5407237|NCT01689974|Abscopal|abscopal
5407238|NCT01689961|Nutrition|nutrition
5407239|NCT01689961|Physical activity|physical activity
5407240|NCT01689961|Gestational weight gain|gestational weight gain
5407241|NCT01689961|Pregnancy outcomes|pregnancy outcomes
5407242|NCT01689961|Birth|birth
5407243|NCT01689948|Home care, rehabilitation therapy, Alzheimer's disease|home care, rehabilitation therapy, alzheimer's disease
5407244|NCT01689935|Acne vulgaris|acne vulgaris
5407245|NCT01689935|Photodynamic Therapy|photodynamic therapy
5407246|NCT01689935|Side-effects|side-effects
5407247|NCT01689935|Pain|pain
5407248|NCT01689909|Insomnia|insomnia
5407249|NCT01689909|Depression|depression
5407250|NCT01689909|Suicidal ideation|suicidal ideation
5407251|NCT01689909|Zolpidem CR|zolpidem cr
5407252|NCT01689909|Placebo|placebo
5407253|NCT01689896|Hypogonadism|hypogonadism
5407254|NCT01689896|Low testosterone|low testosterone
5407255|NCT01689896|Pain|pain
5407256|NCT01689883|stroke|stroke
5407257|NCT01689883|electrical stimulation|electrical stimulation
5407258|NCT01689870|OX40|ox40
5407259|NCT01689870|Anti-OX40|anti-ox40
5407260|NCT01689870|Ipilimumab|ipilimumab
5407261|NCT01689870|Melanoma|melanoma
5407262|NCT01689857|hypertropic scar, Vancouver scar scale, silicon gel sheet|hypertropic scar, vancouver scar scale, silicon gel sheet
5407263|NCT01689844|controlled high blood pressure|controlled high blood pressure
5407264|NCT01689818|insomnia, elderly, exercise training|insomnia, elderly, exercise training
5407265|NCT01689805|Atopic dermatitis|atopic dermatitis
5407266|NCT01689805|Filaggrin|filaggrin
5407267|NCT01689779|vitamin D|vitamin d
5407268|NCT01689779|surgery|surgery
5407269|NCT01689779|acute stress|acute stress
5407270|NCT01689766|Renal Cell|renal cell
5407271|NCT01689753|Renal dialyse|renal dialyse
5407272|NCT01689753|Catheter, indwelling|catheter, indwelling
5407273|NCT01689753|Catheter-related infection|catheter-related infection
5407274|NCT01689740|MDMA|mdma
5407275|NCT01689740|Posttraumatic stress disorder|posttraumatic stress disorder
5407276|NCT01689740|PTSD|ptsd
5407277|NCT01689740|Israel|israel
5407278|NCT01689740|psychotherapy|psychotherapy
5407279|NCT01689727|Pituitary Tumors|pituitary tumors
5407280|NCT01689714|Ovarian Carcinoma|ovarian carcinoma
5407281|NCT01689714|Recurrent Endometrial Carcinoma|recurrent endometrial carcinoma
5407282|NCT01689701|Erosive Gastritis|erosive gastritis
5407283|NCT01689701|Hizikia Fusiformis|hizikia fusiformis
5407284|NCT01689675|musculoskeletal|musculoskeletal
5407285|NCT01689675|pain|pain
5407286|NCT01689675|pain management|pain management
5407287|NCT01689675|computer based intervention|computer based intervention
5407288|NCT01689662|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5407289|NCT01689649|Epilepsy|epilepsy
5407290|NCT01689649|Seizures|seizures
5407291|NCT01689649|Topiramate|topiramate
5407292|NCT01689649|Anti-epileptic drug|anti-epileptic drug
5407293|NCT01689649|Nervous disorder|nervous disorder
5407294|NCT01689636|Ovarian Cancer|ovarian cancer
5407295|NCT01689623|Healthy participants|healthy participants
5407296|NCT01689623|TMC435|tmc435
5407297|NCT01689623|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5407298|NCT01689623|Atorvastatin|atorvastatin
5407299|NCT01689623|Simvastatin|simvastatin
5407300|NCT01689623|Pharmacokinetic interaction|pharmacokinetic interaction
5407301|NCT01689610|Nab-Paclitaxel|nab-paclitaxel
5407302|NCT01689610|Abraxane|abraxane
5407303|NCT01689610|Nabucco|nabucco
5407304|NCT01689610|safety|safety
5407305|NCT01689610|breast cancer|breast cancer
5407306|NCT01689610|daily routine|daily routine
5407307|NCT01689610|peripheral neuropathy|peripheral neuropathy
5407308|NCT01689610|iOMEDICO|iomedico
5407309|NCT01689584|BRCA1|brca1
5407310|NCT01689584|BRCA2|brca2
5407312|NCT01689584|co-segregation|co-segregation
5407313|NCT01689584|genetic counseling|genetic counseling
5407315|NCT01689571|PDE4 inhibitor|pde4 inhibitor
5407316|NCT01689571|Allergen Challenge|allergen challenge
5407318|NCT01689558|nasopharynx cancer,Image department of nose pharynx ministry|nasopharynx cancer,image department of nose pharynx ministry
5407320|NCT01689545|drug abuse|drug abuse
5407321|NCT01689545|social stigma|social stigma
5407322|NCT01689545|Vietnam|vietnam
5407323|NCT01689532|Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine|active rheumatoid arthritis unresponsive to methotrexate or sulfasalazine
5407324|NCT01689532|Sirukumab|sirukumab
5407325|NCT01689532|Human Anti-IL-6 Monoclonal Antibody|human anti-il-6 monoclonal antibody
5407326|NCT01689519|Zelboraf|zelboraf
5407327|NCT01689519|vemurafenib|vemurafenib
5407328|NCT01689519|RG7204|rg7204
5407329|NCT01689519|PLX4032|plx4032
5407330|NCT01689519|Genentech MEK inhibitor|genentech mek inhibitor
5407331|NCT01689519|Genentech BRAF inhibitor|genentech braf inhibitor
5407332|NCT01689519|Roche MEK inhibitor|roche mek inhibitor
5407333|NCT01689519|Roche BRAF inhibitor|roche braf inhibitor
5407334|NCT01689519|RO5185426|ro5185426
5407335|NCT01689519|metastatic melanoma|metastatic melanoma
5407336|NCT01689519|BRAF positive melanoma|braf positive melanoma
5407337|NCT01689519|BRAF mutant melanoma|braf mutant melanoma
5407338|NCT01689519|advanced melanoma|advanced melanoma
5407339|NCT01689519|Genentech RAF inhibitor|genentech raf inhibitor
5407340|NCT01689519|Roche RAF inhibitor|roche raf inhibitor
5407341|NCT01689519|BRAF V600E kinase inhibitor|braf v600e kinase inhibitor
5407342|NCT01689519|Oncogenic BRAF inhibitor|oncogenic braf inhibitor
5407343|NCT01689519|BRAF kinase inhibitor|braf kinase inhibitor
5407344|NCT01689519|GDC-0973|gdc-0973
5407345|NCT01689519|XL518|xl518
5407346|NCT01689519|melanoma|melanoma
5407347|NCT01689480|Muscular Dystrophy|muscular dystrophy
5407348|NCT01689480|Facioscapulohumeral|facioscapulohumeral
5407349|NCT01689480|Physical training|physical training
5407350|NCT01689480|Exercise|exercise
5407351|NCT01689454|IVF|ivf
5407352|NCT01689454|embryo culture|embryo culture
5407353|NCT01689454|Ongoing pregnancy rate|ongoing pregnancy rate
5407354|NCT01689454|Ongoing implantation rate|ongoing implantation rate
5407355|NCT01689454|Miscarriage|miscarriage
5407356|NCT01689428|IVF|ivf
5407357|NCT01689428|Embryo culture|embryo culture
5002951|NCT03977610|Androgen deprivation therapy|androgen deprivation therapy
5407358|NCT01689428|Ongoing Pregnancy rate|ongoing pregnancy rate
5407359|NCT01689428|Ongoing Implantation rate|ongoing implantation rate
5407360|NCT01689428|Miscarriage|miscarriage
5407361|NCT01689415|Renal nerve denervation|renal nerve denervation
5407362|NCT01689389|Schizophrenia|schizophrenia
5407363|NCT01689389|Bipolar episodes|bipolar episodes
5407364|NCT01689389|France|france
5407365|NCT01689389|Xeroquel|xeroquel
5407366|NCT01689389|Real-life|real-life
5407367|NCT01689363|hyaluronidase|hyaluronidase
5407368|NCT01689363|enzymes with tissue spreading activity|enzymes with tissue spreading activity
5407369|NCT01689363|allergic reaction|allergic reaction
5407370|NCT01689363|intradermal skin testing|intradermal skin testing
5407371|NCT01689350|Cyclophosphamide|cyclophosphamide
5407372|NCT01689350|genotype-based therapy|genotype-based therapy
5407373|NCT01689350|prospective study|prospective study
5407374|NCT01689337|Microfracture surgery|microfracture surgery
5407375|NCT01689337|Cartilage repair|cartilage repair
5407376|NCT01689337|Knee surgery|knee surgery
5407377|NCT01689324|Pertussis|pertussis
5407378|NCT01689324|Tetanus|tetanus
5407379|NCT01689324|Diphtheria|diphtheria
5407380|NCT01689324|Acellular pertussis|acellular pertussis
5407381|NCT01689324|ADACEL®|adacel®
5407382|NCT01689324|Tdap vaccine|tdap vaccine
5407383|NCT01689311|Uterine contraction|uterine contraction
5407384|NCT01689311|Dose response|dose response
5407385|NCT01689311|Non-laboring|non-laboring
5407386|NCT01689311|Laboring|laboring
5407387|NCT01689311|Laboring with oxytocin augmentation|laboring with oxytocin augmentation
5407388|NCT01689311|Oxytocin|oxytocin
5407389|NCT01689311|Ergonovine|ergonovine
5407390|NCT01689311|Prostaglandin F2alpha|prostaglandin f2alpha
5407391|NCT01689311|Misoprostol|misoprostol
5407392|NCT01689298|Uterine contraction|uterine contraction
5407393|NCT01689298|Dose response|dose response
5407394|NCT01689298|Oxytocin pretreatment|oxytocin pretreatment
5407395|NCT01689298|Oxytocin|oxytocin
5407396|NCT01689298|Carbetocin|carbetocin
5407397|NCT01689285|bioequivalence|bioequivalence
5407398|NCT01689285|pharmacokinetics|pharmacokinetics
5407399|NCT01689285|valacyclovir|valacyclovir
5407400|NCT01689285|paediatric formulation|paediatric formulation
5407401|NCT01689272|Kidney transplantation,functional status,survival.|kidney transplantation,functional status,survival.
5407402|NCT01689246|Alzheimer's Disease|alzheimer's disease
5407403|NCT01689246|Alzheimer Disease|alzheimer disease
5407404|NCT01689246|TRx0237|trx0237
5407405|NCT01689246|AD|ad
5407406|NCT01689246|Neurodegenerative Diseases|neurodegenerative diseases
5407407|NCT01689246|Dementia|dementia
5407408|NCT01689246|Brain Diseases|brain diseases
5407409|NCT01689233|Alzheimer's Disease|alzheimer's disease
5407410|NCT01689233|Alzheimer Disease|alzheimer disease
5407411|NCT01689233|TRx0237|trx0237
5407412|NCT01689233|AD|ad
5407413|NCT01689233|Neurodegenerative Diseases|neurodegenerative diseases
5407414|NCT01689233|Dementia|dementia
5407415|NCT01689233|Brain Diseases|brain diseases
5407416|NCT01689207|Phase I, Safety, tolerability, healthy.|phase i, safety, tolerability, healthy.
5407417|NCT01689155|Meningitis|meningitis
5407418|NCT01689155|Meningococcal Infection|meningococcal infection
5407419|NCT01689155|Menactra®|menactra®
5407420|NCT01689103|Alcohol use disorders|alcohol use disorders
5407421|NCT01689103|Treatment|treatment
5407422|NCT01689103|Outpatient|outpatient
5407423|NCT01689103|Therapeutic alliance|therapeutic alliance
5407424|NCT01689051|Type 2 diabetes|type 2 diabetes
5407425|NCT01689051|Blod pressure|blod pressure
5407426|NCT01689051|Glucagon-like peptide-1|glucagon-like peptide-1
5407427|NCT01689051|Human physiology|human physiology
5407428|NCT01689051|Blood flow|blood flow
5407429|NCT01688999|Kidney Cancer|kidney cancer
5407430|NCT01688999|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5407431|NCT01688999|Bladder Cancer|bladder cancer
5407432|NCT01688986|Complex Disease|complex disease
5407433|NCT01688986|DNA Biorepository|dna biorepository
5407434|NCT01688986|Genotype-Phenotype Correlation|genotype-phenotype correlation
5407435|NCT01688986|Genetics|genetics
5407436|NCT01688986|Environmental Factors|environmental factors
5407437|NCT01688947|Pain|pain
5407438|NCT01688947|Neuralgia, Postherpetic|neuralgia, postherpetic
5407439|NCT01688934|Pain|pain
5407440|NCT01688934|Osteoarthritis|osteoarthritis
5407441|NCT01688934|Knee|knee
5407442|NCT01688921|Injections, Jet|injections, jet
5407443|NCT01688921|Influenza Vaccines|influenza vaccines
5407444|NCT01688908|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5407445|NCT01688908|Endoscopic Screening|endoscopic screening
5407446|NCT01688908|Efficacy|efficacy
5407447|NCT01688908|Cost-utility|cost-utility
5407448|NCT01688908|High risk region|high risk region
5407449|NCT01688908|China|china
5407450|NCT01688895|erythropoietic|erythropoietic
5407451|NCT01688895|protoporphyria|protoporphyria
5407452|NCT01688895|cutaneous|cutaneous
5407453|NCT01688895|porphyria|porphyria
5407454|NCT01688882|bullous pemphigoid|bullous pemphigoid
5407455|NCT01688882|QGE031|qge031
5407456|NCT01688869|brain concussion|brain concussion
5407457|NCT01688856|hand|hand
5407458|NCT01688856|arm|arm
5407459|NCT01688856|stroke|stroke
5407460|NCT01688856|hemiplegia|hemiplegia
5407461|NCT01688856|electrical stimulation|electrical stimulation
5407462|NCT01688856|recovery|recovery
5407463|NCT01688856|rehabilitation|rehabilitation
5407464|NCT01688843|bradycardia|bradycardia
5407465|NCT01688843|sinus node dysfunction|sinus node dysfunction
5407466|NCT01688817|Colorectal Neoplasms|colorectal neoplasms
5407467|NCT01688817|Colonoscopy|colonoscopy
5407468|NCT01688817|Early Detection of Cancer|early detection of cancer
5407469|NCT01688817|Patient Selection|patient selection
5407470|NCT01688817|Patient Participation|patient participation
5407471|NCT01688817|Physicians, Primary Care|physicians, primary care
5407472|NCT01688817|Conscious Sedation|conscious sedation
5407473|NCT01688804|Sedentary behavior|sedentary behavior
5407474|NCT01688804|Physical activity|physical activity
5407475|NCT01688804|Obesity|obesity
5407476|NCT01688804|Mobile health|mobile health
5407477|NCT01688804|Smartphone|smartphone
5407478|NCT01688778|Type 2 diabetes|type 2 diabetes
5407479|NCT01688778|Quality of life|quality of life
5407480|NCT01688778|Lifestyle intervention|lifestyle intervention
5407481|NCT01688778|Telemedicine|telemedicine
5407482|NCT01688778|Videoconference|videoconference
5407483|NCT01688765|Schizophrenia|schizophrenia
5407484|NCT01688765|Schizoaffective disorder|schizoaffective disorder
5407485|NCT01688765|Bipolar disorder|bipolar disorder
5407486|NCT01688739|Migraine|migraine
5407487|NCT01688726|Dry eye|dry eye
5407488|NCT01688726|Ocular surface|ocular surface
5407489|NCT01688726|Vision complaint|vision complaint
5407490|NCT01688726|Tear film stability|tear film stability
5407491|NCT01688726|Time controlled functional visual acuity|time controlled functional visual acuity
5407492|NCT01688726|Tear film kinetics|tear film kinetics
5407493|NCT01688700|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5407494|NCT01688700|neoadjuvant therapy|neoadjuvant therapy
5407495|NCT01688700|Nimotuzumab|nimotuzumab
5407496|NCT01688648|Coronary artery bypass graft|coronary artery bypass graft
5407497|NCT01688648|dexmedetomidine|dexmedetomidine
5407498|NCT01688648|lidocaine|lidocaine
5407499|NCT01688648|myocardial injury|myocardial injury
5407500|NCT01688648|arrhythmia|arrhythmia
5407501|NCT01688648|blood electrolyte balance|blood electrolyte balance
5407502|NCT01688635|Volunteers|volunteers
5407503|NCT01688596|Local|local
5407504|NCT01688596|Anesthesia|anesthesia
5407505|NCT01688596|Pain|pain
5407506|NCT01688596|Laparoscopic hysterectomy|laparoscopic hysterectomy
5407507|NCT01688596|Trocar site|trocar site
5407508|NCT01688596|Port site|port site
5407509|NCT01688583|Chronic pain|chronic pain
5407510|NCT01688583|Chronic non-cancer pain|chronic non-cancer pain
5407511|NCT01688583|Fentanyl matrix|fentanyl matrix
5407512|NCT01688583|Transdermal system|transdermal system
5407513|NCT01688570|neuromuscular fatigue|neuromuscular fatigue
5407514|NCT01688570|motor impairment|motor impairment
5407516|NCT01688557|dual focus|dual focus
5407517|NCT01688557|responsive insertion technique|responsive insertion technique
5407518|NCT01688557|scope guide|scope guide
5407519|NCT01688557|colonoscopy|colonoscopy
5407520|NCT01688557|colorectal cancer screening|colorectal cancer screening
5407521|NCT01688544|Ilaprazole|ilaprazole
5407522|NCT01688544|Intragastric pH|intragastric ph
5407523|NCT01688544|Serum Gastrin|serum gastrin
5407524|NCT01688544|Pharmacokinetics|pharmacokinetics
5407525|NCT01688518|Evaluation|evaluation
5407526|NCT01688518|Depth and Duration|depth and duration
5407527|NCT01688518|Anesthesia|anesthesia
5407528|NCT01688505|cerebral small vessel diseases|cerebral small vessel diseases
5407529|NCT01688505|cognitive impairment|cognitive impairment
5407530|NCT01688505|Blood pressure variability|blood pressure variability
5407531|NCT01688492|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
5407532|NCT01688492|ABIRATERONE ACETATE (CB 7630)|abiraterone acetate (cb 7630)
5407533|NCT01688492|PREDNISONE|prednisone
5407738|NCT01687712|AFOLIA|afolia
5407534|NCT01688492|Immunotherapy-naïve|immunotherapy-naïve
5407535|NCT01688492|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
5407536|NCT01688492|12-120|12-120
5407537|NCT01688479|Postoperative radiotherapy|postoperative radiotherapy
5407538|NCT01688479|breast cancer|breast cancer
5407539|NCT01688466|Immune Modulatory|immune modulatory
5407540|NCT01688466|Systemic Absorption|systemic absorption
5407541|NCT01688466|Oral Agent|oral agent
5407542|NCT01688453|overweight/obesity|overweight/obesity
5407543|NCT01688453|adolescence|adolescence
5407544|NCT01688453|care management|care management
5407545|NCT01688440|Endotracheal Cares|endotracheal cares
5407546|NCT01688440|Neonate|neonate
5407547|NCT01688440|TAC's|tac's
5407548|NCT01688440|Endotracheal Suctioning|endotracheal suctioning
5407549|NCT01688440|Tracheal Aspirate Culture|tracheal aspirate culture
5407550|NCT01688440|Oral Cares|oral cares
5407551|NCT01688440|Neonate oxygen Therapy|neonate oxygen therapy
5685282|NCT00556803|adjuvant therapy|adjuvant therapy
5002952|NCT03977610|Ga-68 PSMA Ligand|ga-68 psma ligand
5407552|NCT01688401|diffuse intrinsic pontine glioma (DIPG)|diffuse intrinsic pontine glioma (dipg)
5407553|NCT01688401|intra-arterial chemotherapy|intra-arterial chemotherapy
5407554|NCT01688401|angiography|angiography
5407555|NCT01688388|Breast Cancer|breast cancer
5407556|NCT01688388|Carcinoma|carcinoma
5407557|NCT01688388|Radiotherapy|radiotherapy
5407558|NCT01688388|Intraoperative Radiotherapy|intraoperative radiotherapy
5407559|NCT01688388|IORT|iort
5407560|NCT01688375|obstructive jaundice|obstructive jaundice
5407561|NCT01688375|ursodeoxycholic acid|ursodeoxycholic acid
5407562|NCT01688362|Prospective Randomized Controlled Double Blinded Trial|prospective randomized controlled double blinded trial
5407563|NCT01688362|Rotator Cuff Tear|rotator cuff tear
5407564|NCT01688362|Platelet Rich Plasma|platelet rich plasma
5407565|NCT01688362|Corticosteroid|corticosteroid
5407566|NCT01688362|Ultrasound|ultrasound
5407567|NCT01688349|Glucocorticoids|glucocorticoids
5407568|NCT01688349|adipose tissue|adipose tissue
5407569|NCT01688349|Cushing|cushing
5407570|NCT01688349|lipodystrophy|lipodystrophy
5407571|NCT01688349|11 beta-HSD1|11 beta-hsd1
5407572|NCT01688336|Pancreatic|pancreatic
5407573|NCT01688336|Phase II|phase ii
5407574|NCT01688336|FOLFIRINOX|folfirinox
5407575|NCT01688336|Unresectable|unresectable
5407576|NCT01688336|Regimen|regimen
5407577|NCT01688336|First-line|first-line
5407578|NCT01688336|Resectable|resectable
5407579|NCT01688336|Borderline|borderline
5407580|NCT01688336|Oxaliplatin|oxaliplatin
5407581|NCT01688336|Leucovorin|leucovorin
5407582|NCT01688336|Irinotecan|irinotecan
5407584|NCT01688336|Lineberger|lineberger
5407585|NCT01688336|University of North Carolina|university of north carolina
5407586|NCT01688323|Geriatrics|geriatrics
5407587|NCT01688323|Oncology|oncology
5407588|NCT01688323|Biological Markers|biological markers
5407589|NCT01688323|Survey Instruments|survey instruments
5407590|NCT01688323|p16|p16
5407591|NCT01688323|Geriatric Oncology|geriatric oncology
5407592|NCT01688323|Biological Markers of Aging|biological markers of aging
5407593|NCT01688323|Symptom Assessment|symptom assessment
5407594|NCT01688323|Cancer|cancer
5407595|NCT01688323|Older Persons|older persons
5407596|NCT01688323|Head and Neck Cancer|head and neck cancer
5407597|NCT01688310|Gomco clamp instrument|gomco clamp instrument
5407598|NCT01688310|Tissue adhesive|tissue adhesive
5407599|NCT01688310|Open surgical circumcision|open surgical circumcision
5407600|NCT01688310|Minimally-invasive circumcision|minimally-invasive circumcision
5407601|NCT01688297|Influenza|influenza
5407602|NCT01688297|H1N1|h1n1
5407603|NCT01688297|flu|flu
5407604|NCT01688297|seasonal|seasonal
5407605|NCT01688284|uterine natural killer cells|uterine natural killer cells
5407606|NCT01688284|recurrent miscarriages|recurrent miscarriages
5407607|NCT01688284|alloimmunity|alloimmunity
5407608|NCT01688271|simulation|simulation
5407609|NCT01688271|ultrasound|ultrasound
5407610|NCT01688271|perineural infusion|perineural infusion
5407611|NCT01688271|continuous peripheral nerve block|continuous peripheral nerve block
5407612|NCT01688245|young adults|young adults
5407613|NCT01688245|alcohol consumption|alcohol consumption
5407614|NCT01688245|mobile health|mobile health
5407615|NCT01688245|text message|text message
5407616|NCT01688232|colorectal cancer|colorectal cancer
5407617|NCT01688232|tumor resection|tumor resection
5407618|NCT01688232|immunoscore|immunoscore
5407619|NCT01688232|lymphocytic density|lymphocytic density
5407634|NCT01688180|bronchiectasis|bronchiectasis
5407635|NCT01688180|depression|depression
5407636|NCT01688180|anxiety|anxiety
5407637|NCT01688167|HIV|hiv
5407638|NCT01688167|Male circumcision|male circumcision
5407639|NCT01688167|Sexual risk reduction|sexual risk reduction
5407640|NCT01688167|Stages of change|stages of change
5407641|NCT01688141|CKD|ckd
5407642|NCT01688128|Mild cognitive impairment|mild cognitive impairment
5407643|NCT01688128|Cognitive rehabilitation|cognitive rehabilitation
5407644|NCT01688128|Cognitive therapy|cognitive therapy
5407645|NCT01688128|Spaced retrieval Training|spaced retrieval training
5407646|NCT01688128|Alzheimer's disease|alzheimer's disease
5407647|NCT01688128|Memory enhancement|memory enhancement
5407648|NCT01688128|U-healthcare|u-healthcare
5407649|NCT01688089|volunteer|volunteer
5407650|NCT01688089|study|study
5407651|NCT01688063|Skin Elasticity|skin elasticity
5407652|NCT01688063|Scar Elasticity|scar elasticity
5407653|NCT01688063|Cutometer|cutometer
5407654|NCT01688063|Dermal Torque Meter|dermal torque meter
5407655|NCT01688050|Blunt thoracic aortic injury|blunt thoracic aortic injury
5407656|NCT01688050|Transection|transection
5407657|NCT01688050|Endovascular graft|endovascular graft
5407658|NCT01688024|mitomycin C|mitomycin c
5407659|NCT01688011|Myelodysplastic Syndromes|myelodysplastic syndromes
5407660|NCT01688011|MDS|mds
5407661|NCT01688011|Acute Myeloid Leukemia|acute myeloid leukemia
5407662|NCT01688011|AML|aml
5407663|NCT01688011|Registry|registry
5407664|NCT01688011|Connect®|connect®
5407665|NCT01687972|cesarean section|cesarean section
5407666|NCT01687972|insorb staples|insorb staples
5380342|NCT01811043|anxiety|anxiety
5407667|NCT01687972|absorbable staples|absorbable staples
5407668|NCT01687972|transverse skin incision|transverse skin incision
5407669|NCT01687959|cholelithiasis|cholelithiasis
5407670|NCT01687959|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5407671|NCT01687959|endoscopic sphincterotomy|endoscopic sphincterotomy
5407672|NCT01687959|choledocholithiasis|choledocholithiasis
5407673|NCT01687946|Biology of Fibrosis|biology of fibrosis
5407674|NCT01687933|Labor pain|labor pain
5407675|NCT01687933|Virtual reality|virtual reality
5407676|NCT01687933|the first stage of labor|the first stage of labor
5407677|NCT01687933|Pain relief|pain relief
5407678|NCT01687933|Simulator|simulator
5407679|NCT01687920|Cardiac disorders|cardiac disorders
5407680|NCT01687907|fear of childbirth|fear of childbirth
5407681|NCT01687907|outcome of delivery|outcome of delivery
5407682|NCT01687907|music|music
5407683|NCT01687907|mother-baby relationship|mother-baby relationship
5407684|NCT01687894|cerebral oxygen saturation|cerebral oxygen saturation
5407685|NCT01687894|beach chair position|beach chair position
5407686|NCT01687894|hemodynamic|hemodynamic
5407687|NCT01687894|jugular venous oximetry|jugular venous oximetry
5407688|NCT01687881|Chiropractic|chiropractic
5407689|NCT01687881|Manipulative therapy|manipulative therapy
5407690|NCT01687881|Cervicogenic headache|cervicogenic headache
5407691|NCT01687855|Obstructive Sleep|obstructive sleep
5407692|NCT01687855|Apnoea|apnoea
5407693|NCT01687855|tongue|tongue
5407694|NCT01687855|alteration|alteration
5407695|NCT01687829|Macular Holes|macular holes
5407696|NCT01687829|Internal limiting membrane|internal limiting membrane
5407697|NCT01687829|peeling|peeling
5407698|NCT01687829|Surgery|surgery
5407699|NCT01687816|Influenza-Like-Illness|influenza-like-illness
5407700|NCT01687816|nasal swabs|nasal swabs
5407701|NCT01687816|Detection of influenza|detection of influenza
5407702|NCT01687816|sensitivity of detection assays|sensitivity of detection assays
5407703|NCT01687803|Obesity|obesity
5407704|NCT01687803|Sedentary lifestyle|sedentary lifestyle
5407705|NCT01687803|Body weight|body weight
5407706|NCT01687803|Physical fitness|physical fitness
5407707|NCT01687790|molecular breast imaging|molecular breast imaging
5407708|NCT01687790|breast disease|breast disease
5402774|NCT01709292|PTC|ptc
5407714|NCT01687764|Generalized Anxiety Disorder (GAD)|generalized anxiety disorder (gad)
5407715|NCT01687764|Separation Anxiety Disorder (SeAD)|separation anxiety disorder (sead)
5407716|NCT01687764|Social Anxiety Disorder (SoAD)|social anxiety disorder (soad)
5407718|NCT01687751|conscious sedation/|conscious sedation/
5407719|NCT01687751|dexmedetomidine/|dexmedetomidine/
5407720|NCT01687751|midazolam/|midazolam/
5407721|NCT01687751|infusions, subcutaneous/|infusions, subcutaneous/
5407722|NCT01687751|palliative care/|palliative care/
5407723|NCT01687751|terminal care/|terminal care/
5407724|NCT01687751|terminally ill/|terminally ill/
5407725|NCT01687751|neoplasms/|neoplasms/
5407726|NCT01687751|treatment outcome|treatment outcome
5407727|NCT01687751|Precedex|precedex
5407728|NCT01687751|"end of life"|"end of life"
5407729|NCT01687751|Dying|dying
5407730|NCT01687751|Advanced cancer|advanced cancer
5407731|NCT01687751|mood/delirium/delirious|mood/delirium/delirious
5407732|NCT01687738|non small cell lung cancer|non small cell lung cancer
5407733|NCT01687738|health disparities|health disparities
5407734|NCT01687712|IVF|ivf
5407735|NCT01687712|In vitro fertilization|in vitro fertilization
5407736|NCT01687712|Controlled ovarian stimulation|controlled ovarian stimulation
5407737|NCT01687712|Follitropin|follitropin
5407741|NCT01687699|hemodialysis|hemodialysis
5407742|NCT01687699|spironolactone|spironolactone
5407743|NCT01687673|Advanced HCC|advanced hcc
5407744|NCT01687673|Temsirolimus|temsirolimus
5407745|NCT01687673|TORISEL|torisel
5407746|NCT01687673|Sorafenib|sorafenib
5407749|NCT01687647|Lung cancer screening|lung cancer screening
5407750|NCT01687647|Asbestos exposed workers|asbestos exposed workers
5407751|NCT01687647|Sputum analysis|sputum analysis
5407752|NCT01687647|Automated cytometry|automated cytometry
5407753|NCT01687647|Predictive biomarkers|predictive biomarkers
5407754|NCT01687634|pregnancy|pregnancy
5407755|NCT01687634|home healthcare visits|home healthcare visits
5407756|NCT01687634|breast feeding|breast feeding
5407757|NCT01687634|nutrition|nutrition
5407758|NCT01687634|community health workers|community health workers
5407759|NCT01687621|Omphalitis|omphalitis
5407760|NCT01687621|Neonate|neonate
5407761|NCT01687621|Zambia|zambia
5407762|NCT01687621|Neonatal mortality|neonatal mortality
5407763|NCT01687621|Umbilical cord infection|umbilical cord infection
5407764|NCT01687608|Hemophilia B|hemophilia b
5407765|NCT01687608|factor IX deficiency|factor ix deficiency
5407766|NCT01687608|gene therapy|gene therapy
5407767|NCT01687595|herpes simplex virus type 2,|herpes simplex virus type 2,
5407768|NCT01687595|genital herpes|genital herpes
5407769|NCT01687582|type 2 diabetes|type 2 diabetes
5407770|NCT01687582|psoriasis|psoriasis
5407771|NCT01687582|exenatide|exenatide
5407772|NCT01687582|liraglutide|liraglutide
5407773|NCT01687569|Glycaemic Response|glycaemic response
5407775|NCT01687556|green tea|green tea
5407776|NCT01687543|Clostridium difficile|clostridium difficile
5407777|NCT01687543|WBC|wbc
5407778|NCT01687543|CRP|crp
5407779|NCT01687543|Lactate|lactate
5407780|NCT01687543|Urea|urea
5407781|NCT01687543|Creatinine|creatinine
5407782|NCT01687517|sarcoidosis|sarcoidosis
5407783|NCT01687517|healthy volunteers|healthy volunteers
5407784|NCT01687504|pharmacokinetics|pharmacokinetics
5407785|NCT01687504|children|children
5407786|NCT01687504|HIV|hiv
5407787|NCT01687504|Tuberculosis|tuberculosis
5407788|NCT01687504|Pharmacogenetics|pharmacogenetics
5407789|NCT01687491|Enoxaparin|enoxaparin
5407790|NCT01687491|Acute Coronary Syndrome|acute coronary syndrome
5407791|NCT01687491|Factor X|factor x
5407792|NCT01687465|glaucoma|glaucoma
5407793|NCT01687465|laser|laser
5407794|NCT01687465|SLT|slt
5407795|NCT01687465|ALT|alt
5407796|NCT01687374|proximal humeral fracture|proximal humeral fracture
5407797|NCT01687335|chemotherapy|chemotherapy
5407798|NCT01687322|quality of life|quality of life
5407799|NCT01687322|functioning|functioning
5407800|NCT01687296|PEF|pef
5407801|NCT01687296|inhaled|inhaled
5407802|NCT01687296|Fluticasone Propionate|fluticasone propionate
5407803|NCT01687296|safety|safety
5407804|NCT01687296|prednisone|prednisone
5407805|NCT01687296|acute exacerbation|acute exacerbation
5407806|NCT01687296|asthma|asthma
5407807|NCT01687296|efficacy|efficacy
5407808|NCT01687283|fluticasone propionate inhalation solution|fluticasone propionate inhalation solution
5407809|NCT01687283|budesonide suspension for inhalation|budesonide suspension for inhalation
5407810|NCT01687283|efficacy|efficacy
5407811|NCT01687283|severe persistent asthma|severe persistent asthma
5407813|NCT01687283|safety|safety
5407814|NCT01687244|BCG Refractory or Relapsed Superficial Bladder Cancer|bcg refractory or relapsed superficial bladder cancer
5407815|NCT01687244|rAd-IFN|rad-ifn
5407816|NCT01687244|Syn3|syn3
5407817|NCT01687244|Intravesical|intravesical
5407818|NCT01687244|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5407819|NCT01687244|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
5407820|NCT01687244|Interferon alpha2b|interferon alpha2b
5407821|NCT01687244|INSTILADRIN|instiladrin
5407822|NCT01687231|Neutropenic Diet, Non-Neutropenic Diet, Allogeneic SCT|neutropenic diet, non-neutropenic diet, allogeneic sct
5407823|NCT01687192|Seroconversion|seroconversion
5407824|NCT01687192|Immunosuppressed treatment|immunosuppressed treatment
5407825|NCT01687192|HPV vaccination|hpv vaccination
5407826|NCT01687192|Immunogenicity|immunogenicity
5407827|NCT01687179|LAM|lam
5407828|NCT01687179|TSC|tsc
5407829|NCT01687179|lymphangioleiomyomatosis|lymphangioleiomyomatosis
5407830|NCT01687166|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5407831|NCT01687166|Cardiac Arrhythmias|cardiac arrhythmias
5407832|NCT01687166|Heart Disease|heart disease
5407833|NCT01687166|Cardiovascular Disease|cardiovascular disease
5407834|NCT01687166|Radiofrequency Ablation|radiofrequency ablation
5407835|NCT01687153|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5407836|NCT01687153|post traumatic stress disorder (PTSD)|post traumatic stress disorder (ptsd)
5407837|NCT01687153|Alzheimer's disease (AD)|alzheimer's disease (ad)
5407838|NCT01687153|mild cognitive impairment (MCI)|mild cognitive impairment (mci)
5407839|NCT01687153|dementia|dementia
5407840|NCT01687153|biomarkers|biomarkers
5407841|NCT01687153|amyloid|amyloid
5407842|NCT01687153|neuroimaging|neuroimaging
5407843|NCT01687153|cognition disorder|cognition disorder
5407844|NCT01687153|tau|tau
5407845|NCT01687127|folic acid|folic acid
5407846|NCT01687127|folate|folate
5407847|NCT01687127|5-methyltetrahydrofolate|5-methyltetrahydrofolate
5407848|NCT01687127|supplements|supplements
5407849|NCT01687127|women|women
5407850|NCT01687127|one-carbon metabolism|one-carbon metabolism
5407851|NCT01687127|methionine|methionine
5407852|NCT01687127|DNA methylation|dna methylation
5407853|NCT01687127|in vivo kinetics|in vivo kinetics
5407854|NCT01687114|compliance, proanthocyanidin, phenoic acids, cranberry|compliance, proanthocyanidin, phenoic acids, cranberry
5407855|NCT01687101|acute migraine|acute migraine
5407856|NCT01687101|acute migraine treatment|acute migraine treatment
5407857|NCT01687101|topical treatment|topical treatment
5407858|NCT01687075|coronary angioplasty|coronary angioplasty
5407859|NCT01687075|de novo lesion|de novo lesion
5407860|NCT01687062|NaFeEDTA|nafeedta
5407861|NCT01687062|phytate|phytate
5407862|NCT01687062|injera|injera
5407863|NCT01687062|iron absorption|iron absorption
5407864|NCT01687049|nonmetastatic|nonmetastatic
5407865|NCT01687049|localized|localized
5407866|NCT01687049|prostate|prostate
5407867|NCT01687049|active surveillance|active surveillance
5407868|NCT01687036|Atrial fibrillation|atrial fibrillation
5407869|NCT01687036|Cryoablation|cryoablation
5407870|NCT01687023|Tai Chi|tai chi
5407871|NCT01687023|Wearable sensors|wearable sensors
5407872|NCT01687023|Movement|movement
5407873|NCT01687010|CRP, PCT, IL-6, Diagnosis, Prediction|crp, pct, il-6, diagnosis, prediction
5407874|NCT01686997|Bariatric surgery|bariatric surgery
5407875|NCT01686997|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5407876|NCT01686958|Prostate Cancer|prostate cancer
5407877|NCT01686958|High intensity transurethral ultrasound ablation|high intensity transurethral ultrasound ablation
5407878|NCT01686958|MRI-guided|mri-guided
5407879|NCT01686958|Minimally invasive|minimally invasive
5407880|NCT01686958|Real-time temperature feedback control|real-time temperature feedback control
5407881|NCT01686932|vildagliptin|vildagliptin
5407882|NCT01686932|sitagliptin|sitagliptin
5407883|NCT01686932|continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5407884|NCT01686932|glycemic fluctuations|glycemic fluctuations
5407885|NCT01686932|MAGE|mage
5407886|NCT01686932|impact of hypoglycemia on heart function (cardiac dysfuction measured via ECG)|impact of hypoglycemia on heart function (cardiac dysfuction measured via ecg)
5407887|NCT01686932|difference in glycemic profile of vildagliptin compared to sitagliptin|difference in glycemic profile of vildagliptin compared to sitagliptin
5407888|NCT01686919|Gastric bypass|gastric bypass
5407889|NCT01686919|Questionnaires|questionnaires
5407890|NCT01686919|Diet|diet
5407891|NCT01686919|Milk|milk
5407892|NCT01686906|Keratoconus|keratoconus
5407893|NCT01686906|Bowman layer|bowman layer
5407894|NCT01686893|Oxygen, Insufflation, COPD, High Flow Treatment|oxygen, insufflation, copd, high flow treatment
5407895|NCT01686880|Hepatocellular Carcinoma|hepatocellular carcinoma
5407896|NCT01686880|Liver Cirrhosis|liver cirrhosis
5407897|NCT01686880|radioembolization|radioembolization
5407898|NCT01686880|SIRT|sirt
5407899|NCT01686880|TARE|tare
5407900|NCT01686880|Sirspheres|sirspheres
5407901|NCT01686880|neoadjuvant|neoadjuvant
5407902|NCT01686880|liver cancer|liver cancer
5407903|NCT01686867|improved cookstove|improved cookstove
5407904|NCT01686867|ventilated cookstove|ventilated cookstove
5407905|NCT01686867|behavior change|behavior change
5407906|NCT01686867|adoption|adoption
5407907|NCT01686867|indoor air pollution|indoor air pollution
5407908|NCT01686867|DLCO|dlco
5407909|NCT01686867|spirometry|spirometry
5407910|NCT01686867|biomass fuel|biomass fuel
5407911|NCT01686854|cognitive-behavioral approach|cognitive-behavioral approach
5407912|NCT01686854|obesity treatment|obesity treatment
5407913|NCT01686841|Lipolysis|lipolysis
5407914|NCT01686841|Cryolipolysis|cryolipolysis
5407915|NCT01686841|Fat Reduction|fat reduction
5407916|NCT01686828|insulin|insulin
5407917|NCT01686828|androgens|androgens
5407918|NCT01686828|insulin resistance|insulin resistance
5407919|NCT01686828|testosterone|testosterone
5407920|NCT01686828|estradiol|estradiol
5407927|NCT01686802|post-operative pain|post-operative pain
5407928|NCT01686776|Plasma albumine|plasma albumine
5407929|NCT01686776|Plasma volume|plasma volume
5407930|NCT01686776|Transcapillary escape rate|transcapillary escape rate
5407931|NCT01686776|Inflammation|inflammation
5407932|NCT01686776|Circulation|circulation
5407934|NCT01686750|injection drug use|injection drug use
5407935|NCT01686750|men who have sex with men|men who have sex with men
5407936|NCT01686750|voluntary counselling and testing|voluntary counselling and testing
5407937|NCT01686750|risk reduction|risk reduction
5407938|NCT01686750|sexually transmitted infections|sexually transmitted infections
5407939|NCT01686750|community viral load|community viral load
5407940|NCT01686750|antiretroviral therapy|antiretroviral therapy
5407941|NCT01686724|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5407942|NCT01686724|Psychosocial Intervention|psychosocial intervention
5407943|NCT01686724|Behavioral Intervention|behavioral intervention
5407944|NCT01686724|School-home collaborative intervention|school-home collaborative intervention
5390709|NCT01764412|Hepcidin|hepcidin
5407945|NCT01686698|cirrhosis, VSL#3, cognitive function, falls, quality of life|cirrhosis, vsl#3, cognitive function, falls, quality of life
5407946|NCT01686685|ASD|asd
5407947|NCT01686685|autism|autism
5407948|NCT01686685|prematurity|prematurity
5407949|NCT01686685|oxygen-dependant gene activation|oxygen-dependant gene activation
5407951|NCT01686685|Language delay|language delay
5407952|NCT01686685|Cognitive delay|cognitive delay
5407953|NCT01686672|Cystic Fibrosis|cystic fibrosis
5407954|NCT01686672|Behavioral Intervention|behavioral intervention
5407955|NCT01686672|Children|children
5407956|NCT01686659|Transfusion|transfusion
5407957|NCT01686659|Continuous Hemoglobin Monitoring|continuous hemoglobin monitoring
5407958|NCT01686659|SpHb|sphb
5407959|NCT01686646|alertness|alertness
5407960|NCT01686633|asthma|asthma
5407961|NCT01686633|pharmacogenetics|pharmacogenetics
5407962|NCT01686633|adult|adult
5407963|NCT01686633|vilanterol|vilanterol
5407964|NCT01686633|adolescents|adolescents
5407965|NCT01686633|fluticasone furoate|fluticasone furoate
5407966|NCT01686620|Mealtime insulin|mealtime insulin
5407967|NCT01686620|Ultra-rapid acting insulin|ultra-rapid acting insulin
5407968|NCT01686620|Prandial insulin|prandial insulin
5407969|NCT01686607|Hepatic toxicity|hepatic toxicity
5407970|NCT01686607|Renal toxicity|renal toxicity
5407971|NCT01686607|Micafungin|micafungin
5407972|NCT01686607|Hepatocellular carcinoma|hepatocellular carcinoma
5407973|NCT01686607|Antifungals (parenteral)|antifungals (parenteral)
5407974|NCT01686594|Mycosis fungoides|mycosis fungoides
5407975|NCT01686594|Psoralen and UVA (PUVA)|psoralen and uva (puva)
5407976|NCT01686594|Photochemotherapy|photochemotherapy
5407977|NCT01686594|Maintenance treatment|maintenance treatment
5407978|NCT01686594|Immune function|immune function
5407979|NCT01686542|atrial fibrillation|atrial fibrillation
5407980|NCT01686529|Pterygium|pterygium
5407981|NCT01686529|bevacizumab|bevacizumab
5407982|NCT01686529|autoconjunctival graft|autoconjunctival graft
5407983|NCT01686516|age|age
5407984|NCT01686516|microstructure|microstructure
5407985|NCT01686516|diffusion MRI|diffusion mri
5407986|NCT01686490|AICD|aicd
5407987|NCT01686490|focus groups|focus groups
5407988|NCT01686490|cognitive-behavioral video/workbook training|cognitive-behavioral video/workbook training
5407989|NCT01686490|pre-implant concern/distress about upcoming AICD|pre-implant concern/distress about upcoming aicd
5407990|NCT01686464|magnetic|magnetic
5407991|NCT01686464|oxygen|oxygen
5407992|NCT01686464|Bell's Palsy|bell's palsy
5407993|NCT01686464|acupuncture|acupuncture
5407994|NCT01686438|cost effectiveness|cost effectiveness
5407995|NCT01686438|patient satisfaction|patient satisfaction
5407996|NCT01686425|Cholestasis|cholestasis
5407997|NCT01686425|Malignancy|malignancy
5407998|NCT01686425|ERCP|ercp
5407999|NCT01686425|PTC|ptc
5408000|NCT01686425|EUS-BD|eus-bd
5408001|NCT01686412|Breast Cancer|breast cancer
5408002|NCT01686412|Hepatocellular carcinoma|hepatocellular carcinoma
5408003|NCT01686399|Sustainable diet|sustainable diet
5408004|NCT01686399|Health promotion|health promotion
5408005|NCT01686399|Obesity|obesity
5408006|NCT01686386|Relapsed|relapsed
5408007|NCT01686386|Multiple Myeloma|multiple myeloma
5408008|NCT01686386|Lenalidomide|lenalidomide
5408009|NCT01686386|Bendamustine|bendamustine
5408010|NCT01686373|Aphasia|aphasia
5403061|NCT01708226|OCD|ocd
5408016|NCT01686373|Phase II Clinical Trial|phase ii clinical trial
5408018|NCT01686373|tDCS|tdcs
5408019|NCT01686373|Fridriksson|fridriksson
5408020|NCT01686347|epidural analgesia|epidural analgesia
5408021|NCT01686347|fetal cardiac rythm|fetal cardiac rythm
5408022|NCT01686347|ropivacaine|ropivacaine
5408023|NCT01686347|sufentanil|sufentanil
5408024|NCT01686334|in complete remission|in complete remission
5408025|NCT01686334|Adult (>18 years) at very high risk of relapse|adult (>18 years) at very high risk of relapse
5408026|NCT01686321|elderly patients|elderly patients
5408027|NCT01686321|bendamustine|bendamustine
5408028|NCT01686308|cataract|cataract
5408029|NCT01686308|circadian rhythm|circadian rhythm
5408030|NCT01686308|pupillometry|pupillometry
5408031|NCT01686308|blue light transmission|blue light transmission
5408032|NCT01686308|questionnaire|questionnaire
5408033|NCT01686308|sleep|sleep
5408034|NCT01686295|androgenetic alopecia|androgenetic alopecia
5408035|NCT01686295|Baldness|baldness
5408036|NCT01686282|Blood pressure|blood pressure
5408037|NCT01686282|Arterial Stiffness|arterial stiffness
5408038|NCT01686282|Blueberry Supplementation|blueberry supplementation
5408039|NCT01686282|Aortic Blood Pressure|aortic blood pressure
5408040|NCT01686282|Hypertension|hypertension
5408043|NCT01686269|Endothelial progenitor cell|endothelial progenitor cell
5408044|NCT01686269|coronary artery bypass|coronary artery bypass
5408046|NCT01686256|Endometrial Cancer|endometrial cancer
5408047|NCT01686243|epidural|epidural
5408051|NCT01686217|ASP015K Extended Release|asp015k extended release
5408052|NCT01686217|ASP015K Immediate Release|asp015k immediate release
5408053|NCT01686217|Food Effect|food effect
5408054|NCT01686217|Healthy Volunteers|healthy volunteers
5408055|NCT01686204|Yogurt|yogurt
5408056|NCT01686204|Intestine|intestine
5408057|NCT01686204|Inflammation|inflammation
5408058|NCT01686204|Obese|obese
5408059|NCT01686191|heart transplantation|heart transplantation
5408060|NCT01686191|chronic renal insufficiency|chronic renal insufficiency
5408061|NCT01686191|pharmacogenomics|pharmacogenomics
5408062|NCT01686191|cyclosporine|cyclosporine
5408063|NCT01686191|tacrolimus|tacrolimus
5408064|NCT01686178|Smoking|smoking
5408065|NCT01686178|Smoking Cessation|smoking cessation
5408066|NCT01686178|Tobacco Use Cessation|tobacco use cessation
5408067|NCT01686178|Social Networks|social networks
5408068|NCT01686178|Social Control, Informal|social control, informal
5408069|NCT01686139|Diabetic mellitus|diabetic mellitus
5408070|NCT01686139|Diabetic foot ulcers|diabetic foot ulcers
5408071|NCT01686139|Ischemic Limb|ischemic limb
5408072|NCT01686126|endometrial hyperplasia|endometrial hyperplasia
5408073|NCT01686126|endometrial adenocarcinoma|endometrial adenocarcinoma
5408074|NCT01686126|Gynecological Cancer|gynecological cancer
5408075|NCT01686113|Taste|taste
5408076|NCT01686113|Fat Taste|fat taste
5408077|NCT01686113|Threshold Testing|threshold testing
5408078|NCT01686100|Coronary artery bypass grafting|coronary artery bypass grafting
5408079|NCT01686100|Saphenous vein grafts|saphenous vein grafts
5408080|NCT01686074|Motor control|motor control
5408081|NCT01686074|walking|walking
5408082|NCT01686074|physical activity|physical activity
5408083|NCT01686074|Muscle activity|muscle activity
5408084|NCT01686022|Grass|grass
5408085|NCT01686022|Major allergen|major allergen
5408086|NCT01686022|cross-reactivity|cross-reactivity
5408087|NCT01686009|pain|pain
5408088|NCT01686009|analgesia|analgesia
5408089|NCT01686009|ketamine|ketamine
5408090|NCT01686009|intranasal|intranasal
5408091|NCT01686009|emergency|emergency
5408092|NCT01685996|tobacco|tobacco
5408093|NCT01685996|smoking cessation|smoking cessation
5408094|NCT01685996|nicotine|nicotine
5408095|NCT01685996|cigarettes|cigarettes
5408096|NCT01685996|nicotine withdrawal|nicotine withdrawal
5408097|NCT01685983|Prostate Cancer|prostate cancer
5408098|NCT01685983|Metastatic-castration resistant prostate cancer|metastatic-castration resistant prostate cancer
5408099|NCT01685983|Prostate specific antigen|prostate specific antigen
5408100|NCT01685983|Abiraterone acetate|abiraterone acetate
5408101|NCT01685983|JNJ-212082|jnj-212082
5408102|NCT01685983|Abiraterone|abiraterone
5408103|NCT01685983|Prednisolone|prednisolone
5408104|NCT01685983|Androgen Deprivation|androgen deprivation
5408105|NCT01685983|Docetaxel-based chemotherapy|docetaxel-based chemotherapy
5408106|NCT01685970|Bowel preparation|bowel preparation
5408107|NCT01685970|colonoscopy|colonoscopy
5408108|NCT01685970|polyethylene glycol|polyethylene glycol
5408109|NCT01685970|picosulfate|picosulfate
5408110|NCT01685957|Weight loss|weight loss
5408111|NCT01685957|Dietary intervention|dietary intervention
5408112|NCT01685957|Self-help book|self-help book
5408113|NCT01685957|Cooking|cooking
5408114|NCT01685957|Dietitian|dietitian
5408115|NCT01685957|Dietary therapy|dietary therapy
5408116|NCT01685931|Schizophrenia|schizophrenia
5408117|NCT01685931|Paliperidone Palmitate|paliperidone palmitate
5408118|NCT01685931|Oral Antipsychotics|oral antipsychotics
5408119|NCT01685931|Invega Sustenna|invega sustenna
5408120|NCT01685918|Rheumatoid arthritis|rheumatoid arthritis
5411556|NCT01670994|cancer|cancer
5408122|NCT01685905|rheumatic disease, latent tuberculosis|rheumatic disease, latent tuberculosis
5408123|NCT01685879|postprandial glycemic response|postprandial glycemic response
5408124|NCT01685879|postprandial insulin response|postprandial insulin response
5408125|NCT01685879|rice|rice
5408126|NCT01685879|appetite|appetite
5408127|NCT01685879|hunger|hunger
5408128|NCT01685866|anesthesia|anesthesia
5408129|NCT01685866|venous access|venous access
5408130|NCT01685840|Heart Failure|heart failure
5408131|NCT01685814|multiple myeloma|multiple myeloma
5408132|NCT01685814|autologous stem cell transplant|autologous stem cell transplant
5408133|NCT01685814|allogeneic stem cell transplant|allogeneic stem cell transplant
5408134|NCT01685814|lenalidomide|lenalidomide
5408135|NCT01685814|bortezomib|bortezomib
5408136|NCT01685775|Gallbladder|gallbladder
5408137|NCT01685775|cholecystectomy|cholecystectomy
5408138|NCT01685775|NOTES|notes
5408139|NCT01685775|natural orifice transluminal endoscopic surgery|natural orifice transluminal endoscopic surgery
5408140|NCT01685775|gallstone|gallstone
5408141|NCT01685762|Endometrial hyperplasia|endometrial hyperplasia
5408143|NCT01685762|Pilot|pilot
5408144|NCT01685762|Metformin|metformin
5408145|NCT01685723|Cancer patients|cancer patients
5408146|NCT01685723|Smoking cessation|smoking cessation
5408147|NCT01685723|Risk communication|risk communication
5408148|NCT01685710|Arteriovenous fistula|arteriovenous fistula
5408149|NCT01685710|Patency|patency
5408150|NCT01685710|GTN patch|gtn patch
5408151|NCT01685684|Low back pain|low back pain
5408152|NCT01685684|Chronic back pain|chronic back pain
5408153|NCT01685684|Back pain|back pain
5408154|NCT01685684|Opioid|opioid
5408155|NCT01685684|Oxycodone|oxycodone
5408156|NCT01685684|DETERx|deterx
5408157|NCT01685684|Chronic pain|chronic pain
5408158|NCT01685684|Chronic low back pain|chronic low back pain
5408159|NCT01685684|CLBP|clbp
5408160|NCT01685684|Xtampza|xtampza
5408161|NCT01685671|CKD-11101|ckd-11101
5408162|NCT01685671|NESP|nesp
5408163|NCT01685671|Darbepoetin alfa|darbepoetin alfa
5408164|NCT01685671|Anemia|anemia
5408165|NCT01685671|subcutaneous|subcutaneous
5408166|NCT01685671|Pharmacokinetics|pharmacokinetics
5408167|NCT01685671|Phase 1|phase 1
5408168|NCT01685632|intra peritonal chemo hyperthermia|intra peritonal chemo hyperthermia
5408169|NCT01685632|peritoneal carcinomatosis|peritoneal carcinomatosis
5408170|NCT01685632|colorectal cancer|colorectal cancer
5408171|NCT01685632|ovarian cancer|ovarian cancer
5408172|NCT01685619|AML|aml
5408173|NCT01685619|Acute Myeloid Leukemia|acute myeloid leukemia
5408174|NCT01685619|MDS|mds
5408175|NCT01685619|Myelodysplastic Syndrome|myelodysplastic syndrome
5408176|NCT01685619|Prognostic|prognostic
5408177|NCT01685619|Economic|economic
5408178|NCT01685606|Leukemia|leukemia
5408179|NCT01685606|Lymphoma|lymphoma
5408180|NCT01685606|Mantle cell|mantle cell
5408181|NCT01685606|DLBCL|dlbcl
5408182|NCT01685606|DLBC|dlbc
5408183|NCT01685606|Diffuse large B cell|diffuse large b cell
5408184|NCT01685606|T cell|t cell
5408185|NCT01685606|AML|aml
5408186|NCT01685606|ALL|all
5408187|NCT01685593|abdominal binder|abdominal binder
5408188|NCT01685580|primary lung cancer|primary lung cancer
5408189|NCT01685580|lobectomy|lobectomy
5408190|NCT01685580|pneumonectomy|pneumonectomy
5408191|NCT01685580|non-invasive ventilation|non-invasive ventilation
5408192|NCT01685567|carotid artery disease|carotid artery disease
5408193|NCT01685567|reverse flow|reverse flow
5408194|NCT01685554|perfusion|perfusion
5408195|NCT01685554|cardiopulmonary bypass|cardiopulmonary bypass
5408196|NCT01685554|hypothermia|hypothermia
5408197|NCT01685554|cerebral oxygenation|cerebral oxygenation
5408198|NCT01685528|Anxiety|anxiety
5408199|NCT01685528|Depression|depression
5408200|NCT01685528|Geriatric|geriatric
5408201|NCT01685528|Veteran|veteran
5408202|NCT01685502|Glucobay OD|glucobay od
5408203|NCT01685502|Diabetes Mellitus|diabetes mellitus
5408204|NCT01685489|Prostate|prostate
5408205|NCT01685489|Neoplasm|neoplasm
5408206|NCT01685489|Adenocarcinoma|adenocarcinoma
5408207|NCT01685489|Cancer|cancer
5408208|NCT01685489|Metastatic|metastatic
5408209|NCT01685489|Castrate resistant|castrate resistant
5408210|NCT01685489|Docetaxel|docetaxel
5408211|NCT01685489|PSK|psk
5408212|NCT01685489|Krestin|krestin
5408213|NCT01685489|Trametes versicolor|trametes versicolor
5408214|NCT01685489|Safety|safety
5408215|NCT01685489|Maximum tolerated dose|maximum tolerated dose
5408216|NCT01685489|Mushroom|mushroom
5408217|NCT01685489|Natural|natural
5408218|NCT01685489|Immunotherapy|immunotherapy
5408219|NCT01685476|Cochlear microphonic potential|cochlear microphonic potential
5408220|NCT01685476|non invasive method|non invasive method
5408221|NCT01685476|indirect monitoring|indirect monitoring
5403250|NCT01707433|GALNS|galns
5408223|NCT01685463|methamphetamine, craving, TMS, cortical excitability, prefrontal cortex|methamphetamine, craving, tms, cortical excitability, prefrontal cortex
5408224|NCT01685450|Cochlear microphonic potential|cochlear microphonic potential
5408225|NCT01685450|non invasive method|non invasive method
5408226|NCT01685450|indirect measurement|indirect measurement
5408227|NCT01685450|intracranial pressure|intracranial pressure
5408232|NCT01685424|Osteoarthritis|osteoarthritis
5408233|NCT01685424|Rheumatoid Arthritis|rheumatoid arthritis
5408234|NCT01685424|Ankylosing Spondylitis|ankylosing spondylitis
5408235|NCT01685424|Gout|gout
5408236|NCT01685424|Arthritis|arthritis
5408237|NCT01685385|Dyspnoea|dyspnoea
5408238|NCT01685385|BNP|bnp
5408239|NCT01685385|Chronic heart failure|chronic heart failure
5408240|NCT01685385|congestive heart failure|congestive heart failure
5408241|NCT01685346|advanced (stage IV) non-small cell lung cancer (NSCLC)|advanced (stage iv) non-small cell lung cancer (nsclc)
5408242|NCT01685346|biofeedback-mediated stress management (BFSM)|biofeedback-mediated stress management (bfsm)
5408243|NCT01685333|subject|subject
5408244|NCT01685320|Force|force
5408245|NCT01685320|Pressure|pressure
5408246|NCT01685320|Intubation|intubation
5408247|NCT01685320|laryngoscopy|laryngoscopy
5408248|NCT01685307|ileal digestibility|ileal digestibility
5408249|NCT01685307|metabolism|metabolism
5408250|NCT01685307|stable isotopes|stable isotopes
5408251|NCT01685294|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5408252|NCT01685294|Suicidality|suicidality
5408253|NCT01685294|Incarcerated Populations|incarcerated populations
5408254|NCT01685294|Prisons|prisons
5408255|NCT01685294|Interpersonal Psychotherapy (IPT)|interpersonal psychotherapy (ipt)
5408256|NCT01685281|ADHD , Inattention|adhd , inattention
5408257|NCT01685268|Prostate Cancer|prostate cancer
5408258|NCT01685255|FIGO Stage III or IV EOC|figo stage iii or iv eoc
5408259|NCT01685255|PPC FTC|ppc ftc
5408260|NCT01685255|increasing CA 125|increasing ca 125
5408261|NCT01685216|VPRIV|vpriv
5408262|NCT01685216|velaglucerase alfa|velaglucerase alfa
5408263|NCT01685203|Hepatitis C Virus|hepatitis c virus
5408264|NCT01685203|Ribavirin-Free|ribavirin-free
5408265|NCT01685203|Hepatitis C Genotype 1|hepatitis c genotype 1
5408266|NCT01685203|Hepatitis C|hepatitis c
5408267|NCT01685203|Interferon-Free|interferon-free
5408268|NCT01685203|Chronic Hepatitis C|chronic hepatitis c
5408269|NCT01685203|Compensated cirrhosis|compensated cirrhosis
5408270|NCT01685203|Hepatitis C Genotype 4|hepatitis c genotype 4
5408271|NCT01685203|Paritaprevir|paritaprevir
5408272|NCT01685203|Ombitasvir|ombitasvir
5408273|NCT01685203|Ritonavir|ritonavir
5408274|NCT01685203|Ribavirin|ribavirin
5408275|NCT01685177|Morbid obesity|morbid obesity
5408276|NCT01685177|Sleeve gastrectomy|sleeve gastrectomy
5408277|NCT01685177|Duodenal Switch|duodenal switch
5408278|NCT01685177|SADI-S|sadi-s
5408279|NCT01685164|nulliparous|nulliparous
5408280|NCT01685164|IUD|iud
5408281|NCT01685164|IUS|ius
5408282|NCT01685164|insertion|insertion
5408283|NCT01685164|expulsion|expulsion
5408284|NCT01685151|Drug therapy|drug therapy
5408285|NCT01685138|Non-Small Cell Lung Cancer|non-small cell lung cancer
5408286|NCT01685138|Non small cell lung carcinoma|non small cell lung carcinoma
5408287|NCT01685138|NSCLC|nsclc
5408288|NCT01685138|ALK|alk
5408289|NCT01685138|LDK378|ldk378
5408290|NCT01685138|Ceritinib|ceritinib
5408291|NCT01685138|crizotinib naïve adult patients|crizotinib naïve adult patients
5408292|NCT01685138|ALK-activated non-small cell lung cancer|alk-activated non-small cell lung cancer
5408293|NCT01685138|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5408294|NCT01685138|lung cancer|lung cancer
5408295|NCT01685138|lung adenocarcinoma|lung adenocarcinoma
5408296|NCT01685112|adults|adults
5408297|NCT01685112|ECMO|ecmo
5408423|NCT01684592|pregnancy|pregnancy
5408298|NCT01685099|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy|diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy
5408299|NCT01685086|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis|latent tuberculosis infection, tuberculosis, chronic kidney disease, peritoneal dialysis, hemodialysis
5408300|NCT01685073|marijuana|marijuana
5408301|NCT01685073|cannabis|cannabis
5408302|NCT01685073|treatment|treatment
5408303|NCT01685073|insomnia|insomnia
5408304|NCT01685073|relapse|relapse
5408305|NCT01685060|Non-Small Cell Lung Cancer|non-small cell lung cancer
5408306|NCT01685060|NSCLC|nsclc
5408308|NCT01685060|LDK378|ldk378
5408309|NCT01685060|Ceritinib|ceritinib
5408310|NCT01685047|Coronary Artery Disease|coronary artery disease
5408311|NCT01685047|Ventricular Arrhythmias|ventricular arrhythmias
5408312|NCT01685047|ST Segment Changes|st segment changes
5408313|NCT01685034|Eosinophilic esophagitis|eosinophilic esophagitis
5408314|NCT01685034|Environmental allergens|environmental allergens
5408315|NCT01685034|Allergy immunotherapy|allergy immunotherapy
5408316|NCT01685034|Tolerance|tolerance
5408317|NCT01685034|Allergic rhinitis|allergic rhinitis
5408318|NCT01685034|Asthma|asthma
5408319|NCT01685034|Seasonal variation|seasonal variation
5408320|NCT01685021|B-ALL|b-all
5408321|NCT01685021|CD19|cd19
5408322|NCT01685021|MOR208|mor208
5408323|NCT01685021|MOR00208|mor00208
5408324|NCT01685021|Xmab5574|xmab5574
5408325|NCT01685021|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
5408326|NCT01685021|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
5408327|NCT01685008|NHL|nhl
5408328|NCT01685008|CD19|cd19
5408329|NCT01685008|MOR208|mor208
5408330|NCT01685008|MOR00208|mor00208
5408331|NCT01685008|Xmab5574|xmab5574
5408332|NCT01685008|B-Cell Non-Hodgkin´s Lymphoma|b-cell non-hodgkin´s lymphoma
5408333|NCT01685008|Fc-optimized Anti-CD19 Antibody|fc-optimized anti-cd19 antibody
5408334|NCT01685008|Tafasitamab|tafasitamab
5408335|NCT01684982|Primary PCI|primary pci
5408336|NCT01684982|Drug Eluting Stent|drug eluting stent
5408337|NCT01684969|Nausea|nausea
5408338|NCT01684969|vomiting|vomiting
5408339|NCT01684969|gastrointestinal symptoms|gastrointestinal symptoms
5408340|NCT01684969|palliative care|palliative care
5408341|NCT01684956|intradermal|intradermal
5408342|NCT01684956|pharmacokinetics|pharmacokinetics
5408343|NCT01684956|microneedle|microneedle
5408344|NCT01684956|insulin|insulin
5408345|NCT01684956|glucagon|glucagon
5408346|NCT01684943|Pharmacokinetics|pharmacokinetics
5408447|NCT01684488|War|war
5408347|NCT01684930|Cardiovascular Diseases|cardiovascular diseases
5408348|NCT01684930|Vascular Diseases|vascular diseases
5408349|NCT01684930|Arterial Occlusive Diseases|arterial occlusive diseases
5408350|NCT01684930|Exercise|exercise
5408351|NCT01684930|Functional Capacity|functional capacity
5408352|NCT01684917|Obesity|obesity
5408353|NCT01684917|Metabolites|metabolites
5408354|NCT01684852|dry eye, sicca, HA, Hyaluronic Acid, ectoin, ectoine, bitop|dry eye, sicca, ha, hyaluronic acid, ectoin, ectoine, bitop
5408355|NCT01684839|Painful digital neuroma|painful digital neuroma
5408356|NCT01684839|nerve defect|nerve defect
5391108|NCT01762670|BV|bv
5408357|NCT01684839|dorsal branch of the digital nerve|dorsal branch of the digital nerve
5408358|NCT01684839|digital nerve|digital nerve
5408359|NCT01684839|pedicled nerve flap|pedicled nerve flap
5408360|NCT01684839|Pain Disorder Associated with Psychological and Physical Factors|pain disorder associated with psychological and physical factors
5408362|NCT01684826|Image processing|image processing
5408363|NCT01684826|Cardiovascular procedure|cardiovascular procedure
5408364|NCT01684813|Diabetes mellitus.|diabetes mellitus.
5408365|NCT01684813|Acute coronary syndrome.|acute coronary syndrome.
5408366|NCT01684813|Percutaneous coronary intervention.|percutaneous coronary intervention.
5408367|NCT01684787|chronic hepatitis C|chronic hepatitis c
5408368|NCT01684787|normal ALT|normal alt
5408369|NCT01684787|HIV/HCV patients|hiv/hcv patients
5408370|NCT01684761|Multicenter Study|multicenter study
5408371|NCT01684761|Randomized Controlled Trial|randomized controlled trial
5408372|NCT01684761|Individualized Medicine|individualized medicine
5408373|NCT01684761|Immunotherapy|immunotherapy
5408374|NCT01684761|Myelin Proteins|myelin proteins
5408375|NCT01684761|Biological Agents|biological agents
5408376|NCT01684748|angiotensin II|angiotensin ii
5408377|NCT01684748|obesity|obesity
5408378|NCT01684748|diabetes|diabetes
5408379|NCT01684735|diffusion-weighted magnetic resonance imaging|diffusion-weighted magnetic resonance imaging
5408380|NCT01684722|vitamin D3|vitamin d3
5408381|NCT01684722|omega-3 fatty acids|omega-3 fatty acids
5408382|NCT01684722|fish oil|fish oil
5408383|NCT01684722|diabetes|diabetes
5408384|NCT01684722|kidney disease|kidney disease
5408385|NCT01684722|albuminuria|albuminuria
5408386|NCT01684722|urine albumin excretion|urine albumin excretion
5408387|NCT01684722|glomerular filtration rate|glomerular filtration rate
5408388|NCT01684722|diabetic kidney disease|diabetic kidney disease
5408389|NCT01684709|Type 2 Diabetes|type 2 diabetes
5408390|NCT01684709|Informal Caregivers|informal caregivers
5408391|NCT01684709|Self Care|self care
5408392|NCT01684709|Quality of Life|quality of life
5408393|NCT01684709|Health Information Technology|health information technology
5408394|NCT01684696|Lung cancer|lung cancer
5408395|NCT01684696|stigma|stigma
5408396|NCT01684696|virtual intervention|virtual intervention
5408397|NCT01684696|mHealth|mhealth
5408398|NCT01684683|Bronchiectasis|bronchiectasis
5408399|NCT01684683|Theophylline|theophylline
5408400|NCT01684683|Therapeutic Uses|therapeutic uses
5408401|NCT01684683|HDAC|hdac
5408402|NCT01684683|HAT|hat
5408403|NCT01684683|Random placebo study|random placebo study
5408404|NCT01684657|Stuttering|stuttering
5408405|NCT01684644|ADHD|adhd
5408406|NCT01684644|Parent Training|parent training
5408407|NCT01684644|RCT|rct
5408408|NCT01684644|Preschool|preschool
5408409|NCT01684618|Preterm|preterm
5408410|NCT01684618|Neonate|neonate
5408411|NCT01684618|Newborn|newborn
5408412|NCT01684618|Cerebral oxygenation|cerebral oxygenation
5408413|NCT01684618|CPAP|cpap
5408414|NCT01684605|CKD-11101|ckd-11101
5408415|NCT01684605|NESP|nesp
5408416|NCT01684605|Darbepoetin alfa|darbepoetin alfa
5408417|NCT01684605|Anemia|anemia
5408418|NCT01684605|intravenous|intravenous
5408419|NCT01684605|Pharmacokinetics|pharmacokinetics
5408420|NCT01684605|Phase 1|phase 1
5408421|NCT01684592|smoking cessation|smoking cessation
5408422|NCT01684592|relapse prevention|relapse prevention
5408424|NCT01684592|postpartum|postpartum
5408426|NCT01684579|African-American Women|african-american women
5408427|NCT01684579|Aerobic Exercise|aerobic exercise
5408428|NCT01684553|Eating speed|eating speed
5408429|NCT01684553|energy intake|energy intake
5408430|NCT01684540|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, SNS, SNS01|sinusitis, rhinosinusitis, ectoin, ectoine, bitop, sns, sns01
5408431|NCT01684514|confocal laser endomicroscopy|confocal laser endomicroscopy
5408432|NCT01684514|inflammatory bowel disease|inflammatory bowel disease
5408433|NCT01684514|colitis, ulcerative|colitis, ulcerative
5408434|NCT01684501|prosthesis|prosthesis
5408435|NCT01684501|amputees|amputees
5408436|NCT01684501|gait|gait
5408437|NCT01684488|Depression/therapy;|depression/therapy;
5408438|NCT01684488|Developing Countries;|developing countries;
5408439|NCT01684488|Interpersonal Relations;|interpersonal relations;
5408440|NCT01684488|Life Change Events;|life change events;
5408441|NCT01684488|Psychotherapy, Group;|psychotherapy, group;
5408442|NCT01684488|Resilience, Psychological;|resilience, psychological;
5408443|NCT01684488|Sierra Leone;|sierra leone;
5408444|NCT01684488|Survivors/psychology;|survivors/psychology;
5408445|NCT01684488|Social Adjustment;|social adjustment;
5408446|NCT01684488|Social Behavior;|social behavior;
5408448|NCT01684475|Novel Treatment Parkinson's disease|novel treatment parkinson's disease
5408449|NCT01684462|Acute Ischemic Stroke|acute ischemic stroke
5408450|NCT01684462|Albumin|albumin
5408451|NCT01684449|Soft tissue sarcoma|soft tissue sarcoma
5408452|NCT01684449|Gemcitabine|gemcitabine
5408453|NCT01684449|Rapamycin|rapamycin
5408454|NCT01684449|Sirolimus|sirolimus
5408455|NCT01684449|mTOR inhibitor|mtor inhibitor
5408456|NCT01684449|Molecular biomarkers|molecular biomarkers
5408457|NCT01684410|Cystic Fibrosis|cystic fibrosis
5408458|NCT01684410|Alpha1-proteinase inhibitor|alpha1-proteinase inhibitor
5408459|NCT01684410|Alpha1-antitrypsin|alpha1-antitrypsin
5408460|NCT01684384|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5408461|NCT01684384|COPD|copd
5408462|NCT01684384|Exacerbation|exacerbation
5408463|NCT01684384|Functional Respiratory Imaging|functional respiratory imaging
5408464|NCT01684384|High Resolution Computed Tomography|high resolution computed tomography
5408465|NCT01684384|HRCT scan|hrct scan
5408466|NCT01684384|Patient Reported Outcome|patient reported outcome
5408467|NCT01684384|PRO|pro
5408468|NCT01684384|Computational Fluid Dynamic|computational fluid dynamic
5408469|NCT01684384|CFD|cfd
5408470|NCT01684384|Lung function parameters|lung function parameters
5408471|NCT01684371|Osteoarthritis|osteoarthritis
5408472|NCT01684371|Osteoarthritic pain|osteoarthritic pain
5408473|NCT01684371|Arthritic pain|arthritic pain
5408474|NCT01684371|Arthritis|arthritis
5408475|NCT01684371|joint inflammation|joint inflammation
5408476|NCT01684371|Arthralgia|arthralgia
5408477|NCT01684358|Prostate-specific antigen|prostate-specific antigen
5408478|NCT01684358|Contraceptive implant|contraceptive implant
5408479|NCT01684358|Biological marker|biological marker
5408480|NCT01684358|Condoms|condoms
5408481|NCT01684358|Women|women
5408482|NCT01684345|Uveitis|uveitis
5408483|NCT01684345|Non-infectious Uveitis|non-infectious uveitis
5408484|NCT01684345|Intermediate Uveitis|intermediate uveitis
5408485|NCT01684345|Posterior Uveitis|posterior uveitis
5408486|NCT01684345|Panuveitis|panuveitis
5408487|NCT01684332|Antioxidant|antioxidant
5408488|NCT01684332|glucose metabolism|glucose metabolism
5408489|NCT01684332|jam|jam
5408490|NCT01684332|polyphenols|polyphenols
5408491|NCT01684332|postprandial|postprandial
5002954|NCT03977597|lung transplant|lung transplant
5408492|NCT01684332|strawberry|strawberry
5408493|NCT01684319|Constipation|constipation
5408494|NCT01684319|Gastroeosphageal reflux|gastroeosphageal reflux
5408495|NCT01684319|Colics|colics
5408496|NCT01684306|RsfMRI, brain plasticity, cognitive enhancer|rsfmri, brain plasticity, cognitive enhancer
5408497|NCT01684293|Cocaine|cocaine
5408498|NCT01684293|Cognitive Impairment|cognitive impairment
5408499|NCT01684293|Cognitive Rehabilitation|cognitive rehabilitation
5408500|NCT01684280|abdominal adipose tissue; microRNA|abdominal adipose tissue; microrna
5408501|NCT01684267|Stroke|stroke
5408502|NCT01684267|Gait|gait
5408503|NCT01684267|Rehabilitation|rehabilitation
5408504|NCT01684254|Cerebral Palsy|cerebral palsy
5408505|NCT01684254|Home monitoring|home monitoring
5408506|NCT01684254|Gait|gait
5408507|NCT01684254|Sensorized Shoe|sensorized shoe
5408508|NCT01684241|Biontech|biontech
5408509|NCT01684241|Biontech RNA Pharmaceuticals GmbH|biontech rna pharmaceuticals gmbh
5408510|NCT01684241|Biontech RNA|biontech rna
5408511|NCT01684241|MERIT|merit
5408512|NCT01684241|RNA|rna
5408513|NCT01684241|Immuno Therapy|immuno therapy
5408514|NCT01684241|RB_0001-01|rb_0001-01
5408515|NCT01684241|Ribological|ribological
5408516|NCT01684241|Melanoma|melanoma
5408517|NCT01684241|RBL001|rbl001
5408518|NCT01684241|RBL002|rbl002
5408519|NCT01684241|cancer vaccine|cancer vaccine
5408520|NCT01684228|End stage renal disease|end stage renal disease
5408521|NCT01684228|hemodialysis|hemodialysis
5408522|NCT01684228|breath test|breath test
5408523|NCT01684228|volatile organic compound|volatile organic compound
5408524|NCT01684228|dialysis adequacy|dialysis adequacy
5408526|NCT01684215|PD-0332991|pd-0332991
5408527|NCT01684215|palbociclib|palbociclib
5671960|NCT00613470|Antidepressants|antidepressants
5408528|NCT01684215|Cyclin Dependent Kinase 4/6 inhibitor|cyclin dependent kinase 4/6 inhibitor
5408529|NCT01684215|Japanese|japanese
5408530|NCT01684215|solid tumors|solid tumors
5408531|NCT01684215|breast cancer|breast cancer
5408532|NCT01684215|A5481010|a5481010
5408533|NCT01684176|Stroke|stroke
5408534|NCT01684176|Ischemic Attack, Transient|ischemic attack, transient
5408535|NCT01684176|Medication adherence|medication adherence
5408536|NCT01684176|Motivational interviewing|motivational interviewing
5408537|NCT01684176|Stroke prevention|stroke prevention
5408538|NCT01684163|depression|depression
5408539|NCT01684163|MDD|mdd
5408540|NCT01684163|GLYX-13|glyx-13
5408541|NCT01684163|HDRS-17|hdrs-17
5408542|NCT01684163|HAMD-17|hamd-17
5408543|NCT01684150|Leukemia|leukemia
5408544|NCT01684150|Advanced hematologic malignancies|advanced hematologic malignancies
5408545|NCT01684150|Epizyme|epizyme
5408546|NCT01684150|Phase 1|phase 1
5408547|NCT01684150|Mixed Lineage Leukemia (MLL)|mixed lineage leukemia (mll)
5408548|NCT01684137|Food supplements|food supplements
5408549|NCT01684137|Asthma bronchiale|asthma bronchiale
5408550|NCT01684124|oxygen|oxygen
5408551|NCT01684124|critical illness|critical illness
5408552|NCT01684124|mechanical ventilation|mechanical ventilation
5408553|NCT01684111|Non Small Cell Lung Cancer - Stage IV|non small cell lung cancer - stage iv
5408554|NCT01684111|NSCLC Stage IV|nsclc stage iv
5408555|NCT01684098|recurrent or metastatic cancer|recurrent or metastatic cancer
5408556|NCT01684098|head and neck cancer|head and neck cancer
5408557|NCT01684098|pancreas cancer|pancreas cancer
5408558|NCT01684098|bladder cancer|bladder cancer
5408559|NCT01684098|testicular cancer|testicular cancer
5408560|NCT01684085|sleep deprivation, PTSD,prevention|sleep deprivation, ptsd,prevention
5408561|NCT01684072|varicella vaccine|varicella vaccine
5408562|NCT01684072|gelatin|gelatin
5408563|NCT01684046|multi-purpose solution|multi-purpose solution
5408564|NCT01684046|silicone hydrogel|silicone hydrogel
5408565|NCT01684046|contact lenses|contact lenses
5408566|NCT01684046|comfort|comfort
5408567|NCT01684046|Opti-Free|opti-free
5408568|NCT01684046|RevitaLens|revitalens
5408569|NCT01684033|multi-purpose solution|multi-purpose solution
5408570|NCT01684033|silicone hydrogel|silicone hydrogel
5408571|NCT01684033|contact lenses|contact lenses
5408572|NCT01684033|comfort|comfort
5408573|NCT01684033|Opti-Free|opti-free
5408574|NCT01684033|Biotrue|biotrue
5408575|NCT01684020|rhinoplasty|rhinoplasty
5408576|NCT01684020|external rhinoplasty|external rhinoplasty
5408577|NCT01684020|open rhinoplasty|open rhinoplasty
5408578|NCT01684020|nose job|nose job
5408579|NCT01684007|Intraocular lens|intraocular lens
5408580|NCT01684007|Multifocal intraocular lens (MIOL)|multifocal intraocular lens (miol)
5408581|NCT01683994|Angiogenesis Inhibitors|angiogenesis inhibitors
5408582|NCT01683994|Small Molecules|small molecules
5408583|NCT01683994|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5408584|NCT01683981|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5408585|NCT01683981|Eisenmenger Syndrome|eisenmenger syndrome
5408586|NCT01683981|Exercise Capacity|exercise capacity
5408587|NCT01683981|Quality of Life|quality of life
5408588|NCT01683955|Tranexamic Acid|tranexamic acid
5408589|NCT01683955|Blood transfusion|blood transfusion
5408590|NCT01683955|Total hip arthroplasty|total hip arthroplasty
5408591|NCT01683942|cup disc ratio measurement|cup disc ratio measurement
5408592|NCT01683942|digital stereo optic disc images|digital stereo optic disc images
5408593|NCT01683929|Obesity|obesity
5408594|NCT01683929|Overweight|overweight
5408595|NCT01683929|Sugar consumption|sugar consumption
5408596|NCT01683929|Metabolic syndrome|metabolic syndrome
5408597|NCT01683929|Artificially sweetened foods and beverages|artificially sweetened foods and beverages
5408598|NCT01683916|spinal cord injury|spinal cord injury
5408599|NCT01683916|stress hormone|stress hormone
5408600|NCT01683916|surgery|surgery
5408601|NCT01683916|bispectral index value|bispectral index value
5408602|NCT01683916|volatile anesthetic|volatile anesthetic
5408603|NCT01683903|heart failure|heart failure
5408604|NCT01683903|cardiac rehabilitation|cardiac rehabilitation
5408605|NCT01683903|myocardial infarction|myocardial infarction
5408606|NCT01683890|Bladder symptoms|bladder symptoms
5408607|NCT01683890|Sexual function|sexual function
5408608|NCT01683890|Quality of life|quality of life
5408609|NCT01683890|Simple hysterectomy|simple hysterectomy
5408610|NCT01683851|pediatric|pediatric
5408611|NCT01683851|conscious sedation|conscious sedation
5408612|NCT01683851|mouthpiece|mouthpiece
5408613|NCT01683851|airway|airway
5408614|NCT01683851|isolite system|isolite system
5408615|NCT01683838|spinal cord injury|spinal cord injury
5408616|NCT01683838|muscle spasticity|muscle spasticity
5408617|NCT01683825|Amyloidosis|amyloidosis
5408618|NCT01683825|Cardiac|cardiac
5408619|NCT01683825|Heart|heart
5408620|NCT01683825|Imaging|imaging
5408621|NCT01683825|Diagnosis|diagnosis
5408622|NCT01683799|Osteoarthritis|osteoarthritis
5408623|NCT01683799|Insomnia|insomnia
5408624|NCT01683799|Chronic pain|chronic pain
5408625|NCT01683799|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
5408626|NCT01683799|Inflammation|inflammation
5408627|NCT01683799|Inflammatory cytokines|inflammatory cytokines
5408628|NCT01683773|Tuberculosis|tuberculosis
5408629|NCT01683773|Phase I|phase i
5408630|NCT01683773|MVA85A|mva85a
5408631|NCT01683773|AERAS-402|aeras-402
5408632|NCT01683760|Fluconazole|fluconazole
5408633|NCT01683747|sepsis|sepsis
5408634|NCT01683747|shock|shock
5408635|NCT01683747|placebo controlled|placebo controlled
5408636|NCT01683747|double blinded|double blinded
5408637|NCT01683747|interventional|interventional
5408638|NCT01683708|sepsis|sepsis
5408639|NCT01683708|jaundice|jaundice
5408640|NCT01683708|symbiotic|symbiotic
5408641|NCT01683708|translocation|translocation
5408642|NCT01683708|abdominal collection|abdominal collection
5408643|NCT01683708|morbidity|morbidity
5408644|NCT01683695|Lupus Arthritis, Systemic Lupus Erythematosus, AMG 557, Lupus|lupus arthritis, systemic lupus erythematosus, amg 557, lupus
5408645|NCT01683682|Non-Small Lung Cancer|non-small lung cancer
5408646|NCT01683682|NSCLC Stage IV|nsclc stage iv
5408647|NCT01683669|ALI|ali
5408648|NCT01683669|ARDS|ards
5408649|NCT01683669|Noisy pressure support ventilation|noisy pressure support ventilation
5408650|NCT01683656|HIV|hiv
5408651|NCT01683656|Atherosclerosis|atherosclerosis
5408851|NCT01682707|intubation|intubation
5408652|NCT01683656|Niacin/laropiprant|niacin/laropiprant
5408654|NCT01683630|Influenza|influenza
5408655|NCT01683630|Influenza type A|influenza type a
5408656|NCT01683630|Influenza type B|influenza type b
5408657|NCT01683630|hospitalization|hospitalization
5408658|NCT01683630|Manitoba|manitoba
5408659|NCT01683630|Canada|canada
5408660|NCT01683617|Psychological stress|psychological stress
5408661|NCT01683591|Acute stroke|acute stroke
5408663|NCT01683591|High-resolution manometry|high-resolution manometry
5408664|NCT01683578|mechanical ventilation|mechanical ventilation
5408665|NCT01683578|lung function|lung function
5408666|NCT01683578|abdominal surgery, open|abdominal surgery, open
5408667|NCT01683578|systemic inflammation|systemic inflammation
5408668|NCT01683552|ITCH|itch
5408669|NCT01683539|Schizophrenia|schizophrenia
5408670|NCT01683539|Chronic Mental Disorder|chronic mental disorder
5408671|NCT01683539|Employment|employment
5408672|NCT01683539|Cognitive remediation|cognitive remediation
5408673|NCT01683539|Vocational rehabilitation|vocational rehabilitation
5408674|NCT01683539|Brain-derived Neurotrophic Factor (BDNF)|brain-derived neurotrophic factor (bdnf)
5408675|NCT01683526|Urgent endotrachel intubation|urgent endotrachel intubation
5408676|NCT01683526|Direct laryngoscopy|direct laryngoscopy
5408677|NCT01683526|Video laryngoscopy|video laryngoscopy
5408678|NCT01683526|Glidescope|glidescope
5408679|NCT01683526|Critical Care|critical care
5408680|NCT01683513|OHSS|ohss
5408681|NCT01683513|mataphase II oocytes (MII)|mataphase ii oocytes (mii)
5408682|NCT01683513|good quality embryo's|good quality embryo's
5408683|NCT01683513|pregnancy|pregnancy
5408684|NCT01683474|aortic valve stenosis|aortic valve stenosis
5408685|NCT01683474|Calcification|calcification
5408686|NCT01683474|TAVI|tavi
5408687|NCT01683474|aortic valve Prosthesis|aortic valve prosthesis
5408688|NCT01683461|HIV|hiv
5408689|NCT01683461|AIDS|aids
5408690|NCT01683448|Perioperative medications|perioperative medications
5408692|NCT01683448|outcomes|outcomes
5408693|NCT01683396|Erosive Osteoarthritis|erosive osteoarthritis
5408694|NCT01683396|Osteoarthritis|osteoarthritis
5408695|NCT01683396|Osteoarthritis of the Hand|osteoarthritis of the hand
5408696|NCT01683383|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5408697|NCT01683383|Therapeutic hypothermia|therapeutic hypothermia
5408698|NCT01683383|Whole body cooling|whole body cooling
5408699|NCT01683383|Transport cooling|transport cooling
5408700|NCT01683357|Liver Metastases|liver metastases
5408701|NCT01683357|Surgery|surgery
5408702|NCT01683357|Intraoperative Ultrasound|intraoperative ultrasound
5408703|NCT01683331|Kidney transplant|kidney transplant
5408704|NCT01683331|New onset diabetes|new onset diabetes
5408705|NCT01683331|Prevention|prevention
5408706|NCT01683331|Insulin|insulin
5408707|NCT01683305|biomarker,|biomarker,
5408708|NCT01683305|NAF|naf
5408709|NCT01683305|Subjects|subjects
5408710|NCT01683292|apomorphine|apomorphine
5408711|NCT01683292|inhaled|inhaled
5408712|NCT01683292|motor fluctuations|motor fluctuations
5408713|NCT01683279|pediatric|pediatric
5408714|NCT01683279|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5408715|NCT01683279|CD19|cd19
5408716|NCT01683279|Chimeric Antigen Receptor|chimeric antigen receptor
5408717|NCT01683240|cholangiography|cholangiography
5408718|NCT01683240|cholangioscopy|cholangioscopy
5408719|NCT01683240|mother-baby|mother-baby
5408720|NCT01683240|cholangioscope|cholangioscope
5408721|NCT01683240|Frimberger cholangioscope|frimberger cholangioscope
5408722|NCT01683240|short access cholangioscopy|short access cholangioscopy
5408723|NCT01683240|ERCP|ercp
5408724|NCT01683240|gallstone therapy|gallstone therapy
5423346|NCT01616069|Echocardiography|echocardiography
5863600|NCT00001243|Cytokines|cytokines
5408725|NCT01683227|drug use; emergency department; brief intervention|drug use; emergency department; brief intervention
5408726|NCT01683201|Total hip replacement|total hip replacement
5408727|NCT01683201|Functional exercise class|functional exercise class
5408728|NCT01683201|Randomised controlled trial|randomised controlled trial
5408731|NCT01683188|Stage IV|stage iv
5408732|NCT01683175|Erlotinib|erlotinib
5408733|NCT01683175|adjuvant therapy|adjuvant therapy
5408734|NCT01683175|radical operation|radical operation
5408735|NCT01683175|IIIA NSCLC|iiia nsclc
5408736|NCT01683175|EGFR mutation|egfr mutation
5408737|NCT01683162|parenteral nutrition|parenteral nutrition
5408738|NCT01683162|lipid emulsion|lipid emulsion
5408739|NCT01683162|olive oil|olive oil
5408740|NCT01683162|liver function|liver function
5408741|NCT01683162|fatty acid|fatty acid
5408742|NCT01683162|clinical outcomes|clinical outcomes
5408743|NCT01683149|Refractory|refractory
5408744|NCT01683149|Relapsed|relapsed
5408745|NCT01683149|Recurrent|recurrent
5408746|NCT01683149|Pediatric|pediatric
5408747|NCT01683149|Malignancy|malignancy
5408748|NCT01683123|Allogeneic HSCT|allogeneic hsct
5408749|NCT01683123|Busulfan|busulfan
5408750|NCT01683123|Fludarabina|fludarabina
5408751|NCT01683084|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5408752|NCT01683084|AAA|aaa
5408753|NCT01683084|telmisartan|telmisartan
5408754|NCT01683071|Total knee arthroplasty|total knee arthroplasty
5408755|NCT01683071|Analgesia|analgesia
5408756|NCT01683071|Pain management|pain management
5408757|NCT01683058|Schizophrenia|schizophrenia
5408758|NCT01683045|non-paroxysmal atrial fibrillation|non-paroxysmal atrial fibrillation
5408759|NCT01683045|persistent atrial fibrillation|persistent atrial fibrillation
5408760|NCT01683045|atrial fibrillation|atrial fibrillation
5408761|NCT01683045|heart palpitations|heart palpitations
5408762|NCT01683045|irregular heart beat|irregular heart beat
5408763|NCT01683045|temperature-controlled radiofrequency ablation|temperature-controlled radiofrequency ablation
5408764|NCT01683045|radiofrequency energy|radiofrequency energy
5408765|NCT01683045|TCRF energy|tcrf energy
5408766|NCT01683045|RF energy|rf energy
5408767|NCT01683045|epicardial and endocardial lesions|epicardial and endocardial lesions
5408768|NCT01683045|concomitant heart surgery|concomitant heart surgery
5408769|NCT01683045|surgical ablation|surgical ablation
5408770|NCT01683019|Depression|depression
5408771|NCT01683019|magnetic field|magnetic field
5408772|NCT01683019|alpha frequency|alpha frequency
5408774|NCT01683019|NeoSync EEG Synchronization Therapy|neosync eeg synchronization therapy
5408775|NCT01682993|corneal cross linking|corneal cross linking
5408776|NCT01682993|topography guided excimer laser|topography guided excimer laser
5408777|NCT01682993|Keratoconus|keratoconus
5408778|NCT01682993|Pellucid marginal degeneration|pellucid marginal degeneration
5408779|NCT01682993|Post Excimer ectasia|post excimer ectasia
5408780|NCT01682980|Osteoarthritis|osteoarthritis
5408781|NCT01682980|Pain|pain
5408782|NCT01682980|Exercise|exercise
5408783|NCT01682980|Function|function
5408784|NCT01682980|Cartilage quality|cartilage quality
5408785|NCT01682967|Parturients|parturients
5408786|NCT01682967|Analgesia, epidural|analgesia, epidural
5408787|NCT01682967|Headache, post-dural puncture|headache, post-dural puncture
5408788|NCT01682954|lifestyle risk reduction|lifestyle risk reduction
5395926|NCT01740271|neoadjuvant|neoadjuvant
5408789|NCT01682941|soy, isoflavones, functional food, prostate cancer|soy, isoflavones, functional food, prostate cancer
5408790|NCT01682928|Oligohydramnios|oligohydramnios
5408791|NCT01682928|Hydrotherapy|hydrotherapy
5408792|NCT01682928|Pregnancy|pregnancy
5408793|NCT01682915|ADHD|adhd
5408794|NCT01682915|endophenotype|endophenotype
5408795|NCT01682915|executive function|executive function
5408796|NCT01682915|diffusion spectrum imaging|diffusion spectrum imaging
5408797|NCT01682915|resting-state fMRI|resting-state fmri
5408798|NCT01682915|frontostriatal and frontoparietal circuitries|frontostriatal and frontoparietal circuitries
5408799|NCT01682915|DAT1|dat1
5408800|NCT01682876|Prevention of meningococcal disease, children, vaccine|prevention of meningococcal disease, children, vaccine
5408801|NCT01682863|COPD, QAB149, QVA149, indacaterol maleate, gylcopyrronium bromide|copd, qab149, qva149, indacaterol maleate, gylcopyrronium bromide
5408802|NCT01682850|COPD|copd
5408803|NCT01682850|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5408804|NCT01682850|lung cancer|lung cancer
5408805|NCT01682850|emphysema|emphysema
5408806|NCT01682850|Pulmonary Rehabilitation|pulmonary rehabilitation
5408807|NCT01682785|Major depressive disorder|major depressive disorder
5408808|NCT01682785|Metabolic syndrome|metabolic syndrome
5408809|NCT01682785|Thyroid dysfunction|thyroid dysfunction
5408810|NCT01682785|incidence|incidence
5408811|NCT01682772|Olaparib|olaparib
5408812|NCT01682772|Adenocarcinoma|adenocarcinoma
5408813|NCT01682772|Prostate|prostate
5408814|NCT01682759|diabetes|diabetes
5408815|NCT01682746|Brain Tumor|brain tumor
5408816|NCT01682746|Photodynamic Therapy|photodynamic therapy
5408817|NCT01682746|Photochemotherapy|photochemotherapy
5408818|NCT01682746|Astrocytoma|astrocytoma
5408819|NCT01682746|Pilocytic Astrocytoma|pilocytic astrocytoma
5408821|NCT01682746|Anaplastic Astrocytoma|anaplastic astrocytoma
5403866|NCT01704716|MAT|mat
5408822|NCT01682746|Glioblastoma|glioblastoma
5408824|NCT01682746|Chordoma|chordoma
5408825|NCT01682746|Germinoma|germinoma
5408826|NCT01682746|Germ Cell Tumor|germ cell tumor
5408827|NCT01682746|Non-germinaoma|non-germinaoma
5408828|NCT01682746|CNS Lymphoma|cns lymphoma
5408829|NCT01682746|Craniopharyngioma|craniopharyngioma
5408830|NCT01682746|Brain Stem Glioma|brain stem glioma
5408831|NCT01682746|Ependymoma|ependymoma
5408832|NCT01682746|Mixed Glioma|mixed glioma
5408833|NCT01682746|Optic Nerve Glioma|optic nerve glioma
5408834|NCT01682746|Subependymoma|subependymoma
5408835|NCT01682746|Medulloblastoma|medulloblastoma
5408836|NCT01682746|Meningioma|meningioma
5408837|NCT01682746|Metastatic Brain Tumors|metastatic brain tumors
5408838|NCT01682746|Oligodendroglioma|oligodendroglioma
5408839|NCT01682746|Pituitary Tumors|pituitary tumors
5408840|NCT01682746|Primitive Neuroectodermal|primitive neuroectodermal
5408841|NCT01682746|PNET|pnet
5408842|NCT01682746|Desmoplastic Neuroepithelial Tumor|desmoplastic neuroepithelial tumor
5408843|NCT01682746|DNET|dnet
5408844|NCT01682733|Obesity|obesity
5408845|NCT01682733|Weight loss|weight loss
5408846|NCT01682733|Gastric reduction (volume)|gastric reduction (volume)
5408847|NCT01682733|BMI 30-40|bmi 30-40
5408848|NCT01682720|HCV|hcv
5408849|NCT01682720|Genotype 2|genotype 2
5408850|NCT01682720|Genotype 3|genotype 3
5408852|NCT01682707|coronary disease|coronary disease
5408853|NCT01682707|hemodynamic response|hemodynamic response
5408854|NCT01682707|anesthesia with tracheal intubation|anesthesia with tracheal intubation
5391625|NCT01760135|trauma|trauma
5408855|NCT01682707|assessment of hemodynamic response|assessment of hemodynamic response
5408856|NCT01682681|Epilepsy|epilepsy
5394145|NCT01747967|GAD|gad
5408857|NCT01682681|Topiramate|topiramate
5408858|NCT01682681|Topmax|topmax
5408859|NCT01682668|parkinson's disease|parkinson's disease
5408860|NCT01682668|subthalamic nucleus|subthalamic nucleus
5408861|NCT01682668|akinesia|akinesia
5408862|NCT01682668|gait initiation|gait initiation
5408863|NCT01682668|neuronal activity|neuronal activity
5408864|NCT01682668|before STN stimulation|before stn stimulation
5408865|NCT01682668|with STN stimulation|with stn stimulation
5408866|NCT01682668|functional MRI|functional mri
5408867|NCT01682642|endometriosis|endometriosis
5408868|NCT01682642|pregnancy|pregnancy
5408869|NCT01682642|In Vitro Fertilization (IVF)/Intra Cytoplastic Sperm Injection (ICSI)|in vitro fertilization (ivf)/intra cytoplastic sperm injection (icsi)
5408870|NCT01682642|peritoneal implants|peritoneal implants
5408871|NCT01682642|embryo quality|embryo quality
5408872|NCT01682629|Pediatric|pediatric
5408873|NCT01682629|Cardiac|cardiac
5408874|NCT01682629|Arrest|arrest
5408875|NCT01682629|Simulation|simulation
5408876|NCT01682629|Debriefing|debriefing
5408877|NCT01682629|Realism|realism
5408878|NCT01682616|Safety|safety
5408879|NCT01682616|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5408880|NCT01682616|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5408881|NCT01682616|Rituximab|rituximab
5408882|NCT01682616|Tolerability|tolerability
5408883|NCT01682616|Pharmacokinetics|pharmacokinetics
5408884|NCT01682616|ABT-199|abt-199
5408885|NCT01682616|Cancer|cancer
5408886|NCT01682616|Preliminary|preliminary
5408887|NCT01682616|Efficacy|efficacy
5408888|NCT01682616|Maximum Tolerated Dose|maximum tolerated dose
5408889|NCT01682616|Venetoclax|venetoclax
5408890|NCT01682603|Nerve growth factor|nerve growth factor
5408891|NCT01682603|P2X3 receptor|p2x3 receptor
5408892|NCT01682603|Transient Receptor Potential Vanilloid 1 (TRPV-1) receptor|transient receptor potential vanilloid 1 (trpv-1) receptor
5408893|NCT01682603|Bladder function|bladder function
5408894|NCT01682603|Glomerular filtration rate|glomerular filtration rate
5408895|NCT01682603|Detrusor overactivity|detrusor overactivity
5408896|NCT01682603|Spinal cord injury|spinal cord injury
5408897|NCT01682590|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury|septic shock; acute renal failure; renal remplacement therapy; mortality; intensive care; critical care; acute kidney injury
5408898|NCT01682577|Perindopril|perindopril
5408899|NCT01682577|Perindoprilat|perindoprilat
5408900|NCT01682577|Bioequivalence|bioequivalence
5408901|NCT01682577|Pharmacokinetic|pharmacokinetic
5408902|NCT01682577|Angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5408903|NCT01682564|Candemore|candemore
5408904|NCT01682564|Atacand|atacand
5408905|NCT01682564|Candesartan cilexetil|candesartan cilexetil
5408906|NCT01682564|Primary Hypertension|primary hypertension
5408907|NCT01682564|Congestive Hypertension|congestive hypertension
5408908|NCT01682551|High altitude illness|high altitude illness
5408909|NCT01682551|Chinese medicine body constitution|chinese medicine body constitution
5408910|NCT01682551|Chinese Medicine|chinese medicine
5408911|NCT01682551|High altitude medicine|high altitude medicine
5408912|NCT01682551|Mountain trekking|mountain trekking
5408913|NCT01682538|Orfadin|orfadin
5408914|NCT01682538|Nitisinone|nitisinone
5408915|NCT01682538|Bioequivalence|bioequivalence
5408916|NCT01682538|Bioavailability|bioavailability
5408917|NCT01682525|Fertility preservation|fertility preservation
5408919|NCT01682525|Cryopreservation|cryopreservation
5671961|NCT00613444|Acne|acne
5408920|NCT01682525|Assisted Reproductive Technology|assisted reproductive technology
5408921|NCT01682499|neuropathy|neuropathy
5408922|NCT01682499|taxane|taxane
5408923|NCT01682499|paclitaxel|paclitaxel
5408924|NCT01682499|calcium|calcium
5408925|NCT01682499|magnesium|magnesium
5408926|NCT01682499|prevention|prevention
5408927|NCT01682486|Medical device|medical device
5408928|NCT01682486|Endotracheal Tube(s), ETT|endotracheal tube(s), ett
5408929|NCT01682486|Bactiguard Coated ETT|bactiguard coated ett
5408930|NCT01682486|Tolerability|tolerability
5408931|NCT01682486|Safety|safety
5408932|NCT01682486|Performance|performance
5408933|NCT01682486|Bacterial colonization on ETT surface|bacterial colonization on ett surface
5408934|NCT01682486|Hospital Acquired Infections, HAI|hospital acquired infections, hai
5408935|NCT01682486|Ventilator Associated Pneumonia, VAP|ventilator associated pneumonia, vap
5408936|NCT01682473|PI3K inhibitor|pi3k inhibitor
5408937|NCT01682473|clinical trial|clinical trial
5408938|NCT01682447|COPD|copd
5408939|NCT01682447|Cognitive Dysfunction|cognitive dysfunction
5408940|NCT01682447|Pulmonary Rehabilitation|pulmonary rehabilitation
5408941|NCT01682447|Quality of life|quality of life
5408942|NCT01682447|Cognitive rehabilitation|cognitive rehabilitation
5408943|NCT01682408|R406,|r406,
5408944|NCT01682408|Fostamatinib,|fostamatinib,
5408945|NCT01682408|Phase I,|phase i,
5408946|NCT01682408|Healthy Subjects,|healthy subjects,
5408947|NCT01682408|Pharmacokinetics,|pharmacokinetics,
5408948|NCT01682408|Fed/Fasted|fed/fasted
5408949|NCT01682395|Intestinal volvulus|intestinal volvulus
5408950|NCT01682395|Colon, sigmoid|colon, sigmoid
5408951|NCT01682395|Anastomosis, surgical|anastomosis, surgical
5408952|NCT01682395|Anastomotic leak|anastomotic leak
5408954|NCT01682395|Developing Country|developing country
5408955|NCT01682382|age-related macular degeneration|age-related macular degeneration
5408956|NCT01682382|choroidal neovascular age-related macular degeneration|choroidal neovascular age-related macular degeneration
5408957|NCT01682382|genetics|genetics
5408958|NCT01682382|macular pigment optical density (MPOD)|macular pigment optical density (mpod)
5408959|NCT01682356|heart failure|heart failure
5408960|NCT01682356|hypertension, pulmonary|hypertension, pulmonary
5408961|NCT01682356|oxygen consumption|oxygen consumption
5408962|NCT01682356|exercise tolerance|exercise tolerance
5408963|NCT01682317|eating frequency|eating frequency
5408964|NCT01682304|preeclampsia|preeclampsia
5408965|NCT01682304|hypertension|hypertension
5408966|NCT01682304|blood pressure|blood pressure
5408967|NCT01682304|pregnancy induced hypertension|pregnancy induced hypertension
5408968|NCT01682304|chronic hypertension|chronic hypertension
5408969|NCT01682291|Prehypertension|prehypertension
5408970|NCT01682291|Life-style modifications|life-style modifications
5408971|NCT01682291|Dietary supplementation|dietary supplementation
5408972|NCT01682278|Health complaints|health complaints
5408973|NCT01682278|Amalgam|amalgam
5408974|NCT01682278|Mercury|mercury
5408975|NCT01682278|Plasma|plasma
5408976|NCT01682278|Cytokine|cytokine
5408977|NCT01682226|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5408978|NCT01682226|CYCLOSPORINE|cyclosporine
5408980|NCT01682226|G-CSF|g-csf
5408981|NCT01682226|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
5408982|NCT01682226|Cord Blood Transplantation|cord blood transplantation
5408983|NCT01682226|CliniMACS|clinimacs
5408984|NCT01682226|12-153|12-153
5408985|NCT01682213|Dabrafenib|dabrafenib
5408986|NCT01682213|(GSK2118436)|(gsk2118436)
5408987|NCT01682213|BRAFV600E/K|brafv600e/k
5408988|NCT01682213|Resected AJCC Stage IIIC|resected ajcc stage iiic
5408989|NCT01682213|12-124|12-124
5408990|NCT01682200|moderate|moderate
5408991|NCT01682200|facial acne|facial acne
5408992|NCT01682200|acne vulgaris|acne vulgaris
5408993|NCT01682161|Schizophrenia|schizophrenia
5408994|NCT01682161|Paliperidone Palmitate|paliperidone palmitate
5408995|NCT01682161|Invega Sustenna|invega sustenna
5408996|NCT01682161|Antipsychotics|antipsychotics
5408997|NCT01682161|Atypical antipsychotics|atypical antipsychotics
5408998|NCT01682161|Medication Satisfaction and Adherence|medication satisfaction and adherence
5408999|NCT01682148|Dysport|dysport
5409000|NCT01682148|arm spasticity|arm spasticity
5409001|NCT01682148|Modified Ashworth Scale|modified ashworth scale
5409002|NCT01682148|neuromuscular junction|neuromuscular junction
5409003|NCT01682148|Botulinum toxin|botulinum toxin
5409004|NCT01682148|upper limb spasticity|upper limb spasticity
5409005|NCT01682122|Blood Pressure|blood pressure
5409006|NCT01682122|Pediatrics|pediatrics
5409007|NCT01682122|Infant, Newborn|infant, newborn
5409008|NCT01682122|Cardiology|cardiology
5409009|NCT01682109|prophylaxis|prophylaxis
5409010|NCT01682109|herpes zoster|herpes zoster
5409011|NCT01682109|herpes simplex|herpes simplex
5409012|NCT01682109|valacyclovir|valacyclovir
5409013|NCT01682109|palatability|palatability
5409014|NCT01682109|paediatric|paediatric
5409015|NCT01682096|Chest pain|chest pain
5409016|NCT01682096|Emergency room|emergency room
5409017|NCT01682096|Acute coronary syndrome|acute coronary syndrome
5409018|NCT01682096|Computed tomography coronary angiography|computed tomography coronary angiography
5409019|NCT01682096|Stress echocardiography|stress echocardiography
5409022|NCT01682083|Oncology|oncology
5409023|NCT01682083|adjuvant melanoma|adjuvant melanoma
5409024|NCT01682083|dabrafenib|dabrafenib
5409025|NCT01682083|dabrafenib and trametinib combination therapy|dabrafenib and trametinib combination therapy
5409026|NCT01682083|BRAF mutation-positive melanoma|braf mutation-positive melanoma
5409027|NCT01682083|BRAF inhibitor|braf inhibitor
5409028|NCT01682070|Sublingual immunotherapy|sublingual immunotherapy
5409029|NCT01682070|Dose range finding|dose range finding
5409030|NCT01682070|Dose tolerability|dose tolerability
5409031|NCT01682070|grass pollen|grass pollen
5409032|NCT01682070|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
5409034|NCT01682070|Immunogenicity|immunogenicity
5409035|NCT01682057|High Blood Pressure|high blood pressure
5409036|NCT01682057|Hypertension|hypertension
5409037|NCT01682057|Resistant Hypertension|resistant hypertension
5409038|NCT01682018|emphysema|emphysema
5409039|NCT01682018|lung transplantation|lung transplantation
5409040|NCT01682005|Cost|cost
5409041|NCT01682005|Children|children
5409042|NCT01682005|Rotavirus|rotavirus
5409043|NCT01682005|Rotavirus vaccination|rotavirus vaccination
5409044|NCT01682005|Clinical|clinical
5409045|NCT01681992|Safety|safety
5409046|NCT01681992|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
5409047|NCT01681992|Immunogenicity|immunogenicity
5409048|NCT01681979|fluticasone propionate|fluticasone propionate
5409050|NCT01681979|pregnancy|pregnancy
5409051|NCT01681979|major congenital malformations|major congenital malformations
5409052|NCT01681927|idiopathic edema nocturia|idiopathic edema nocturia
5409053|NCT01681914|adult HIV positive patients|adult hiv positive patients
5409054|NCT01681875|Biomarkers of exposure|biomarkers of exposure
5409055|NCT01681875|Compensatory smoking|compensatory smoking
5409056|NCT01681875|Nicotine dependence|nicotine dependence
5409057|NCT01681875|Reduced nicotine cigarettes|reduced nicotine cigarettes
5409058|NCT01681875|Tobacco withdrawal|tobacco withdrawal
5409059|NCT01681862|Hypertension|hypertension
5409060|NCT01681862|African American|african american
5409061|NCT01681862|Personal Health Record|personal health record
5409062|NCT01681862|Faith-based Organizations|faith-based organizations
5409063|NCT01681849|PTSD|ptsd
5409064|NCT01681849|childhood abuse|childhood abuse
5409065|NCT01681823|Prostate Cancer|prostate cancer
5409066|NCT01681823|Prostatic Neoplasms|prostatic neoplasms
5409067|NCT01681823|Prostate Specific Antigen|prostate specific antigen
5409068|NCT01681823|Modified Citrus Pectin|modified citrus pectin
5409069|NCT01681823|PectaSol-C|pectasol-c
5409070|NCT01681823|Biochemical Relapse|biochemical relapse
5409071|NCT01681797|fluorescent angiography|fluorescent angiography
5409072|NCT01681797|reconstructive surgery|reconstructive surgery
5409073|NCT01681797|perforator flap|perforator flap
5409074|NCT01681784|lower urinary tract symptoms|lower urinary tract symptoms
5409075|NCT01681784|biomarkers|biomarkers
5409076|NCT01681784|urodynamic studies|urodynamic studies
5409077|NCT01681758|cardiac surgery|cardiac surgery
5409078|NCT01681758|Pulse pressure variation|pulse pressure variation
5409079|NCT01681758|intravenous fluids|intravenous fluids
5409080|NCT01681732|Asthma|asthma
5409081|NCT01681732|child|child
5409082|NCT01681732|pediatric|pediatric
5409083|NCT01681719|VO2|vo2
5409084|NCT01681719|VCO2|vco2
5409085|NCT01681719|VE/VO2|ve/vo2
5409086|NCT01681719|heart rate|heart rate
5409087|NCT01681706|HIV|hiv
5409088|NCT01681706|Indicator disease|indicator disease
5409089|NCT01681654|Head/Neck Cancer|head/neck cancer
5409090|NCT01681654|Exercise|exercise
5409091|NCT01681654|Progressive Strength Training|progressive strength training
5409092|NCT01681654|Quality of Life|quality of life
5409093|NCT01681654|Cancer|cancer
5409094|NCT01681654|Randomized Controlled Trial|randomized controlled trial
5409095|NCT01681654|Nutrition|nutrition
5409096|NCT01681654|Lifestyle Intervention|lifestyle intervention
5409097|NCT01681641|Patients|patients
5409098|NCT01681641|Nursing|nursing
5409099|NCT01681641|Parkinsons disease|parkinsons disease
5409100|NCT01681641|Deep Brain Stimulation|deep brain stimulation
5409101|NCT01681641|Spouses|spouses
5409102|NCT01681628|Thought Field Therapy.|thought field therapy.
5409103|NCT01681628|Post-traumatic stress disorder.|post-traumatic stress disorder.
5409104|NCT01681628|Post-traumatic stress disorder check list for Civilians.|post-traumatic stress disorder check list for civilians.
5409105|NCT01681628|Uganda|uganda
5409106|NCT01681628|Ugandan therapists.|ugandan therapists.
5409107|NCT01681628|Community treatment.|community treatment.
5409108|NCT01681615|Challenge test for Aspirin Hypersensitivity|challenge test for aspirin hypersensitivity
5409109|NCT01681615|Challenge test for Acetylsalicylic Hypersensitivity|challenge test for acetylsalicylic hypersensitivity
5409110|NCT01681602|Alzheimer Disease|alzheimer disease
5409111|NCT01681602|Exercise|exercise
5409112|NCT01681602|Cognition|cognition
5409113|NCT01681602|Quality of life|quality of life
5409114|NCT01681602|Cardiovascular fitness|cardiovascular fitness
5404163|NCT01703624|lung function|lung function
5409115|NCT01681602|Behavioural or psychological symptoms|behavioural or psychological symptoms
5409116|NCT01681602|Physical fitness|physical fitness
5409118|NCT01681589|Traumatic Brain Injury|traumatic brain injury
5409119|NCT01681589|Rehabilitation|rehabilitation
5409120|NCT01681589|Therapy|therapy
5409121|NCT01681576|hypertension, salt sensitivity, valsartan, LCZ696|hypertension, salt sensitivity, valsartan, lcz696
5409122|NCT01681537|Relapsed|relapsed
5409123|NCT01681537|Refractory|refractory
5409124|NCT01681524|Flurpiridaz F18 Injection|flurpiridaz f18 injection
5409125|NCT01681524|Positron Emission Tomography Myocardial Perfusion Imaging|positron emission tomography myocardial perfusion imaging
5409126|NCT01681524|Single Positron Emission Computed Tomography|single positron emission computed tomography
5409127|NCT01681524|Coronary Artery Disease|coronary artery disease
5409128|NCT01681524|Myocardia Ischemia|myocardia ischemia
5409129|NCT01681524|Coronary Disease|coronary disease
5409130|NCT01681524|Heart Diseases|heart diseases
5409131|NCT01681524|Cardiovascular Diseases|cardiovascular diseases
5409132|NCT01681524|Arteriosclerosis|arteriosclerosis
5409133|NCT01681524|Arterial Occlusive Diseases|arterial occlusive diseases
5409134|NCT01681524|Vascular Diseases|vascular diseases
5409135|NCT01681511|Catheter Associated Urinary Tract Infections|catheter associated urinary tract infections
5409136|NCT01681511|CAUTI|cauti
5409137|NCT01681498|pregnant|pregnant
5409138|NCT01681498|fetal ecg|fetal ecg
5409139|NCT01681498|ecg|ecg
5409140|NCT01681485|Traditional Chinese medicine|traditional chinese medicine
5409141|NCT01681485|Non small cell lung cancer|non small cell lung cancer
5409142|NCT01681485|Surgery|surgery
5409143|NCT01681485|Chemotherapy|chemotherapy
5409144|NCT01681485|Radiation therapy|radiation therapy
5409145|NCT01681472|Colon cancer|colon cancer
5409146|NCT01681472|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
5409147|NCT01681472|Rectal Neoplasms|rectal neoplasms
5409148|NCT01681472|Colorectal Neoplasms|colorectal neoplasms
5409149|NCT01681472|Intestinal Neoplasms|intestinal neoplasms
5409150|NCT01681472|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5409151|NCT01681472|Digestive System Neoplasms|digestive system neoplasms
5409152|NCT01681472|Gastrointestinal Diseases|gastrointestinal diseases
5409153|NCT01681472|Therapeutic Uses|therapeutic uses
5409154|NCT01681472|Pharmacokinetics|pharmacokinetics
5409155|NCT01681472|Pharmacodynamics|pharmacodynamics
5409156|NCT01681459|Free fatty acid|free fatty acid
5409157|NCT01681459|Triglyceride|triglyceride
5409158|NCT01681459|Gastric emptying|gastric emptying
5409159|NCT01681459|Satiety hormones|satiety hormones
5409160|NCT01681459|Appetite|appetite
5409161|NCT01681459|Severe obesity|severe obesity
5409162|NCT01681446|hepatocellular carcinoma|hepatocellular carcinoma
5409163|NCT01681446|interferon-alpha|interferon-alpha
5409164|NCT01681446|miR-26|mir-26
5409165|NCT01681433|OGX-427|ogx-427
5409166|NCT01681433|Abiraterone Acetate|abiraterone acetate
5409167|NCT01681420|HIV counseling|hiv counseling
5409168|NCT01681420|Blood donor HIV testing|blood donor hiv testing
5409169|NCT01681420|Brazil|brazil
5409170|NCT01681420|Blood banks|blood banks
5409171|NCT01681420|Blood donors|blood donors
5409172|NCT01681407|Depression|depression
5409173|NCT01681407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5409174|NCT01681407|MicroRNAs|micrornas
5409175|NCT01681407|Proteome|proteome
5409176|NCT01681368|NF-Kappa B Pathway|nf-kappa b pathway
5409177|NCT01681368|Response Biomarkers|response biomarkers
5409178|NCT01681368|Progression-Free Survival|progression-free survival
5409179|NCT01681368|Pharmacokinetics|pharmacokinetics
5409180|NCT01681368|Pharmacodynamics|pharmacodynamics
5409181|NCT01681355|Healthy, term, Asian infants|healthy, term, asian infants
5409182|NCT01681355|Infant formula|infant formula
5409183|NCT01681342|stade Ib to IV cervix cancer|stade ib to iv cervix cancer
5409184|NCT01681342|ambulatory high dose rate brachytherapy|ambulatory high dose rate brachytherapy
5409185|NCT01681329|Cognitive-behavioral therapy|cognitive-behavioral therapy
5409186|NCT01681329|Interpretation modification training|interpretation modification training
5409187|NCT01681329|Randomized clinical trial|randomized clinical trial
5409188|NCT01681329|Adults|adults
5409189|NCT01681316|Chronic Stable Angina|chronic stable angina
5409190|NCT01681316|Randomized Controlled Trial|randomized controlled trial
5409191|NCT01681316|Traditional Chinese Medicine|traditional chinese medicine
5409192|NCT01681264|Pain|pain
5409193|NCT01681264|Pain Management|pain management
5409194|NCT01681264|Back pain|back pain
5409195|NCT01681264|Neck pain|neck pain
5409196|NCT01681238|perioperative fluid optimization|perioperative fluid optimization
5409197|NCT01681238|goal-directed therapy|goal-directed therapy
5409198|NCT01681238|elderly|elderly
5409199|NCT01681238|high-risk surgery|high-risk surgery
5409200|NCT01681225|ARDS|ards
5409201|NCT01681225|mechanical ventilation|mechanical ventilation
5409202|NCT01681225|ALI|ali
5409203|NCT01681225|esophageal pressure|esophageal pressure
5409204|NCT01681199|statin|statin
5409205|NCT01681199|atherosclerosis|atherosclerosis
5409206|NCT01681199|Coronary heart disease|coronary heart disease
5544540|NCT01109095|CMV|cmv
5409207|NCT01681199|OPN|opn
5404275|NCT01703195|DWMR|dwmr
5409211|NCT01681173|Diabetes prevention|diabetes prevention
5409212|NCT01681173|Insoluble fiber|insoluble fiber
5409213|NCT01681173|Healthy life style|healthy life style
5409214|NCT01681173|Weight loss|weight loss
5409215|NCT01681160|MAGGOT THERAPY|maggot therapy
5409216|NCT01681160|DIABETIC FOOT|diabetic foot
5409217|NCT01681160|NURSING CARE|nursing care
5409218|NCT01681160|DRESSING|dressing
5409219|NCT01681147|Gestational Diabetes|gestational diabetes
5409220|NCT01681147|postpartum|postpartum
5409221|NCT01681147|nutrition|nutrition
5409222|NCT01681147|exercise|exercise
5409223|NCT01681134|tacrolimus|tacrolimus
5409224|NCT01681134|Advagraf®|advagraf®
5409225|NCT01681134|Prograf®|prograf®
5409226|NCT01681134|Glomerular Filtration Rate|glomerular filtration rate
5409227|NCT01681134|Effective Renal Plasma Flow|effective renal plasma flow
5409228|NCT01681134|Pharmacokinetics|pharmacokinetics
5409229|NCT01681134|Pharmacodynamics|pharmacodynamics
5409230|NCT01681095|Physiological Effects of Drugs|physiological effects of drugs
5409231|NCT01681095|Cardiovascular Agents|cardiovascular agents
5409232|NCT01681095|Therapeutic Uses|therapeutic uses
5409233|NCT01681095|Pharmacologic Actions|pharmacologic actions
5409234|NCT01681095|Mannitol|mannitol
5409235|NCT01681095|Cardiac Surgery|cardiac surgery
5409236|NCT01681095|Cardioplegic Solutions|cardioplegic solutions
5409237|NCT01681095|HTK solution|htk solution
5409239|NCT01681095|Coronary Artery Disease|coronary artery disease
5409240|NCT01681095|Myocardial Ischemia|myocardial ischemia
5409241|NCT01681095|Coronary Disease|coronary disease
5409242|NCT01681095|Heart Diseases|heart diseases
5409243|NCT01681056|autosuggestion|autosuggestion
5409244|NCT01681056|quality of life|quality of life
5409245|NCT01681056|geriatric|geriatric
5409246|NCT01681056|serum cortisol|serum cortisol
5409247|NCT01681056|Interferon gamma|interferon gamma
5409248|NCT01681056|interleukin-2|interleukin-2
5409249|NCT01681056|interleukin-6|interleukin-6
5409250|NCT01681056|neuroplasticity|neuroplasticity
5409251|NCT01681043|Sleep|sleep
5409252|NCT01681017|Perinatal Mortality|perinatal mortality
5409253|NCT01681017|Asphyxia|asphyxia
5409254|NCT01681017|Stillbirth|stillbirth
5409255|NCT01681017|Neonatal Death|neonatal death
5409256|NCT01681017|Resuscitation|resuscitation
5409257|NCT01681017|Helping Babies Breathe|helping babies breathe
5409258|NCT01681017|among births greater than one thousand five hundred grams|among births greater than one thousand five hundred grams
5409259|NCT01681004|si joint|si joint
5409260|NCT01681004|si joint pain|si joint pain
5409261|NCT01681004|si joint injury|si joint injury
5409262|NCT01681004|si joint treatment|si joint treatment
5409263|NCT01681004|si joint injections|si joint injections
5409264|NCT01681004|si joint inflammation|si joint inflammation
5409265|NCT01681004|si joint problems|si joint problems
5409266|NCT01681004|si joint symptoms|si joint symptoms
5409267|NCT01681004|hypermobile si joint|hypermobile si joint
5409268|NCT01681004|si joint arthritis|si joint arthritis
5409269|NCT01681004|si joint pain treatment|si joint pain treatment
5409270|NCT01681004|inflamed si joint|inflamed si joint
5409271|NCT01681004|si joint sclerosis|si joint sclerosis
5409272|NCT01681004|locked si joint|locked si joint
5002955|NCT03977597|diaphragm evaluation|diaphragm evaluation
5409273|NCT01681004|si joint injuries|si joint injuries
5409274|NCT01681004|si joint disease|si joint disease
5409275|NCT01681004|si joint infection|si joint infection
5409276|NCT01681004|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
5409277|NCT01681004|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
5409278|NCT01680965|Graft vs. Host Disease|graft vs. host disease
5409279|NCT01680965|GVHD|gvhd
5409280|NCT01680965|chronic graft versus host disease (cGVHD)|chronic graft versus host disease (cgvhd)
5409281|NCT01680965|Allogeneic Transplant|allogeneic transplant
5409282|NCT01680965|Ofatumumab|ofatumumab
5409283|NCT01680952|RECORD study|record study
5409284|NCT01680939|Pediatrics|pediatrics
5409285|NCT01680939|Obstructive Sleep Apnea|obstructive sleep apnea
5409286|NCT01680939|Adenotonsillectomy|adenotonsillectomy
5409287|NCT01680939|Analgesia|analgesia
5409288|NCT01680926|type 2 diabetes mellitus|type 2 diabetes mellitus
5409289|NCT01680926|insulin|insulin
5409290|NCT01680926|hbA1c|hba1c
5409291|NCT01680926|body weight|body weight
5409292|NCT01680900|menopause|menopause
5409293|NCT01680900|hot flashes|hot flashes
5409294|NCT01680900|vilazodone|vilazodone
5409295|NCT01680887|Cocaine dependence|cocaine dependence
5409296|NCT01680874|Clostridium difficile|clostridium difficile
5409297|NCT01680874|Diarrhea|diarrhea
5409298|NCT01680874|Infection|infection
5409299|NCT01680874|Lactobacilli|lactobacilli
5409300|NCT01680874|Bifidobacteria|bifidobacteria
5409301|NCT01680874|Lactobacillus acidophilus|lactobacillus acidophilus
5409302|NCT01680874|Lactobacillus paracasei|lactobacillus paracasei
5409303|NCT01680874|Bifidobacterium lactis|bifidobacterium lactis
5409304|NCT01680874|Yogurt|yogurt
5409305|NCT01680874|Probiotics|probiotics
5409306|NCT01680861|Kidney transplant patients|kidney transplant patients
5409307|NCT01680848|Dental caries,|dental caries,
5409308|NCT01680848|Caries diagnosis,|caries diagnosis,
5409309|NCT01680848|Caries treatment,|caries treatment,
5409312|NCT01680848|Clinical epidemiology,|clinical epidemiology,
5409313|NCT01680848|Dental Practice-Based Research Network|dental practice-based research network
5409314|NCT01680822|Nontuberculous, Atypical, Mycobacterial|nontuberculous, atypical, mycobacterial
5409315|NCT01680809|Venous insufficiency|venous insufficiency
5409316|NCT01680809|Venous stasis ulcerations|venous stasis ulcerations
5409317|NCT01680809|Compression stockings|compression stockings
5409318|NCT01680809|Compression stocking compliance|compression stocking compliance
5409319|NCT01680796|Multiple Myeloma|multiple myeloma
5409320|NCT01680796|Relapsed Multiple Myeloma|relapsed multiple myeloma
5409321|NCT01680796|Refractory Multiple Myeloma|refractory multiple myeloma
5409322|NCT01680783|noninvasive ventilation|noninvasive ventilation
5409323|NCT01680783|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5409324|NCT01680783|Acute respiratory distress syndrome|acute respiratory distress syndrome
5409327|NCT01680770|transthoracic echocardiography|transthoracic echocardiography
5409328|NCT01680770|critical care|critical care
5409329|NCT01680757|Left Atrial Appendage|left atrial appendage
5409330|NCT01680757|LARIAT|lariat
5409331|NCT01680757|atrial fibrillation|atrial fibrillation
5409332|NCT01680757|contraindication to oral anticoagulation therapy|contraindication to oral anticoagulation therapy
5409333|NCT01680744|Transplantation|transplantation
5409334|NCT01680744|Terminal creatinine|terminal creatinine
5409335|NCT01680744|Renal function|renal function
5409337|NCT01680731|Pelvic floor injury|pelvic floor injury
5409338|NCT01680731|Levator ani muscle|levator ani muscle
5409339|NCT01680718|oxytocin|oxytocin
5409340|NCT01680718|vasopressin|vasopressin
5409341|NCT01680718|intranasal administration|intranasal administration
5409342|NCT01680718|healthy sample|healthy sample
5409343|NCT01680705|Chronic Rhinosinusitis|chronic rhinosinusitis
5409344|NCT01680705|Endoscopic Sinus Surgery|endoscopic sinus surgery
5409345|NCT01680705|Sinonasal saline irrigation|sinonasal saline irrigation
5409346|NCT01680705|Frequency|frequency
5409347|NCT01680705|Postoperative|postoperative
5409348|NCT01680705|High Volume|high volume
5409349|NCT01680705|Randomized Control Trial|randomized control trial
5409350|NCT01680705|Single Blinded|single blinded
5409351|NCT01680705|Prospective Study|prospective study
5409352|NCT01680705|Quality of Life|quality of life
5409353|NCT01680705|Endoscopic Sinus Score|endoscopic sinus score
5409354|NCT01680692|Analgesia TKA|analgesia tka
5409355|NCT01680692|Total knee arthroplasty|total knee arthroplasty
5409356|NCT01680692|Continuous femoral catheter|continuous femoral catheter
5409357|NCT01680692|Continuous tibial catheter|continuous tibial catheter
5409358|NCT01680692|Single shot sciatic|single shot sciatic
5409359|NCT01680679|Influenza|influenza
5409360|NCT01680679|India|india
5409361|NCT01680679|Children|children
5409362|NCT01680679|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
5409363|NCT01680679|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
5409364|NCT01680679|Direct influenza vaccine effectiveness|direct influenza vaccine effectiveness
5409365|NCT01680679|Total influenza vaccine effectiveness|total influenza vaccine effectiveness
5685283|NCT00556777|stage I breast cancer|stage i breast cancer
5409366|NCT01680679|Indirect influenza vaccine effectiveness|indirect influenza vaccine effectiveness
5409367|NCT01680640|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5409368|NCT01680640|NAFLD|nafld
5409369|NCT01680640|synbiotic|synbiotic
5409370|NCT01680640|gut microbiota|gut microbiota
5409371|NCT01680640|intervention|intervention
5409372|NCT01680640|RCT|rct
5409373|NCT01680640|biomarkers|biomarkers
5409374|NCT01680588|Alzheimer|alzheimer
5409375|NCT01680575|Neutropenia|neutropenia
5409376|NCT01680575|Paclitaxel|paclitaxel
5409377|NCT01680575|Carboplatin|carboplatin
5409378|NCT01680575|Epithelial ovarian cancer|epithelial ovarian cancer
5409379|NCT01680562|in-vivo skin imaging|in-vivo skin imaging
5409380|NCT01680562|non-invasive non-melanoma skin cancer diagnostics|non-invasive non-melanoma skin cancer diagnostics
5409381|NCT01680523|cervical cancer|cervical cancer
5409382|NCT01680523|bulky early-stage|bulky early-stage
5409383|NCT01680523|locally advanced|locally advanced
5409384|NCT01680523|radical hysterectomy|radical hysterectomy
5409385|NCT01680523|concurrent chemoradiation therapy|concurrent chemoradiation therapy
5409386|NCT01680484|non-stress test|non-stress test
5409387|NCT01680471|emergence agitation|emergence agitation
5409388|NCT01680471|midazolam|midazolam
5409389|NCT01680471|sevoflurane|sevoflurane
5409390|NCT01680471|strabismus|strabismus
5409391|NCT01680458|antifungal treatment|antifungal treatment
5409392|NCT01680458|prophylaxis|prophylaxis
5409393|NCT01680458|administration|administration
5409394|NCT01680458|Japanese|japanese
5409395|NCT01680458|infants|infants
5409396|NCT01680458|fluconazole|fluconazole
5409397|NCT01680458|Diflucan|diflucan
5409398|NCT01680458|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
5409399|NCT01680445|osteoarthritis, arthritis|osteoarthritis, arthritis
5409400|NCT01680432|constipation|constipation
5409401|NCT01680432|probiotics|probiotics
5409404|NCT01680419|Veterans|veterans
5409405|NCT01680419|Reintegration|reintegration
5409406|NCT01680419|Resilience|resilience
5409407|NCT01680419|Marital|marital
5409408|NCT01680419|Spouse|spouse
5409409|NCT01680419|Behavioral intervention|behavioral intervention
5409410|NCT01680419|PTSD|ptsd
5409411|NCT01680419|Integrative therapies|integrative therapies
5409412|NCT01680419|Complementary therapies|complementary therapies
5409413|NCT01680419|Massage|massage
5409414|NCT01680419|Meditation|meditation
5409415|NCT01680419|Mindfulness|mindfulness
5409416|NCT01680419|Compassion|compassion
5409417|NCT01680419|Mental health|mental health
5409418|NCT01680406|Plasmodium vivax|plasmodium vivax
5409419|NCT01680406|malaria|malaria
5409420|NCT01680406|Ethiopia|ethiopia
5409421|NCT01680406|Sub-Saharan Africa|sub-saharan africa
5409422|NCT01680406|primaquine|primaquine
5409423|NCT01680406|artemether lumefantrine|artemether lumefantrine
5409424|NCT01680406|chloroquine|chloroquine
5409425|NCT01680380|sleep apnea|sleep apnea
5409426|NCT01680380|snoring|snoring
5409427|NCT01680315|Satiety,|satiety,
5409428|NCT01680315|satiation,|satiation,
5409429|NCT01680315|anticipation,|anticipation,
5409430|NCT01680315|food intake|food intake
5409431|NCT01680302|Atrial fibrillation|atrial fibrillation
5409432|NCT01680302|Prevention|prevention
5409433|NCT01680302|Exercise|exercise
5409434|NCT01680289|Dentin bonding agents|dentin bonding agents
5409435|NCT01680289|Composite restorations|composite restorations
5409436|NCT01680289|Dental restoration failure|dental restoration failure
5409534|NCT01679886|Women;|women;
5409437|NCT01680276|intellectual disability|intellectual disability
5409438|NCT01680276|developmental disability|developmental disability
5409439|NCT01680276|challenging behaviour|challenging behaviour
5409440|NCT01680276|behavioural intervention|behavioural intervention
5409441|NCT01680276|training|training
5409442|NCT01680263|Kinesiotaping|kinesiotaping
5409443|NCT01680263|pes anserinus tendino-bursitis|pes anserinus tendino-bursitis
5409444|NCT01680263|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5409445|NCT01680263|physical therapy|physical therapy
5409446|NCT01680250|Total liver volume|total liver volume
5409447|NCT01680250|Liver cyst|liver cyst
5409448|NCT01680237|cognitive behavior therapy|cognitive behavior therapy
5409449|NCT01680237|exposure in-vivo|exposure in-vivo
5409450|NCT01680237|panic disorder with agoraphobia|panic disorder with agoraphobia
5409451|NCT01680224|Obesity|obesity
5409452|NCT01680224|Weight Gain|weight gain
5409453|NCT01680224|Dissonance|dissonance
5409454|NCT01680224|College,University Students|college,university students
5409455|NCT01680224|Eating Disorders|eating disorders
5409456|NCT01680224|Obesity Prevention|obesity prevention
5409457|NCT01680224|Selective Prevention|selective prevention
5409458|NCT01680224|Effectiveness|effectiveness
5409459|NCT01680211|Blood Sugar,|blood sugar,
5409460|NCT01680211|Lipoproteins,|lipoproteins,
5409461|NCT01680211|Salacia,|salacia,
5409462|NCT01680211|Sesame,|sesame,
5409463|NCT01680211|Prediabetes,|prediabetes,
5409464|NCT01680211|Hyperlipidemia,|hyperlipidemia,
5409465|NCT01680211|Herbal supplement|herbal supplement
5409466|NCT01680198|Vitamin D|vitamin d
5409467|NCT01680198|Paracalcitol|paracalcitol
5685284|NCT00556764|ANAM|anam
5002956|NCT03977597|ultrasound|ultrasound
5409468|NCT01680198|Chronic kidney disease|chronic kidney disease
5409469|NCT01680198|Endothelial dysfunction|endothelial dysfunction
5409470|NCT01680198|Flow mediated vasodilation|flow mediated vasodilation
5409471|NCT01680185|Hyperglycemia|hyperglycemia
5409472|NCT01680185|NODAT|nodat
5409473|NCT01680185|Insulin pump|insulin pump
5409474|NCT01680185|Semiclosed loop|semiclosed loop
5409475|NCT01680172|cancer|cancer
5409476|NCT01680172|depression|depression
5409477|NCT01680172|anxiety|anxiety
5409478|NCT01680172|palliative care|palliative care
5409479|NCT01680159|Infliximab|infliximab
5409480|NCT01680159|REMICADE|remicade
5409481|NCT01680159|TA-650|ta-650
5409482|NCT01680159|psoriasis|psoriasis
5409483|NCT01680107|d-cycloserine, cognitive-behaviour therapy, panic disorder|d-cycloserine, cognitive-behaviour therapy, panic disorder
5409484|NCT01680094|HIV Infection|hiv infection
5409485|NCT01680094|Panobinostat|panobinostat
5409486|NCT01680094|Lentivirus Infections|lentivirus infections
5409487|NCT01680094|Retroviridae Infections|retroviridae infections
5409488|NCT01680094|RNA Virus Infections|rna virus infections
5409489|NCT01680094|Virus Diseases|virus diseases
5409490|NCT01680094|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5409491|NCT01680094|Sexually Transmitted Diseases|sexually transmitted diseases
5409492|NCT01680094|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5409493|NCT01680094|Immune System Diseases|immune system diseases
5409494|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5671962|NCT00613444|laser|laser
5409495|NCT01680094|Therapeutic Uses|therapeutic uses
5409496|NCT01680068|Macular hole|macular hole
5409497|NCT01680068|Vitreoretinal surgery|vitreoretinal surgery
5409498|NCT01680068|Macular surgery|macular surgery
5409499|NCT01680068|Air tamponade|air tamponade
5409500|NCT01680042|inflammatory halo|inflammatory halo
5409502|NCT01680016|Rabies virus, postexposure, vaccine schedule, children, older adults|rabies virus, postexposure, vaccine schedule, children, older adults
5409503|NCT01679964|HIV infection|hiv infection
5409504|NCT01679964|Raltegravir|raltegravir
5409505|NCT01679964|Adverse event|adverse event
5409506|NCT01679964|Life quality|life quality
5409507|NCT01679951|Rheumatoid arthritis|rheumatoid arthritis
5409508|NCT01679951|Swollen and tender joints|swollen and tender joints
5409509|NCT01679951|Methotrexate|methotrexate
5409510|NCT01679951|Immunology|immunology
5409511|NCT01679951|Dose range finding study|dose range finding study
5409512|NCT01679938|obesity prevention|obesity prevention
5409513|NCT01679938|cluster-randomized controlled trial|cluster-randomized controlled trial
5409514|NCT01679938|preschool-aged children|preschool-aged children
5409515|NCT01679925|Early puberty|early puberty
5409516|NCT01679925|Psychosocial impact|psychosocial impact
5409517|NCT01679925|Qualitative assessment|qualitative assessment
5409518|NCT01679912|Hereditary angioedema|hereditary angioedema
5409519|NCT01679912|Emergency Medical Service|emergency medical service
5409520|NCT01679912|Health care coast|health care coast
5409521|NCT01679912|Telephone|telephone
5409522|NCT01679899|diabetes|diabetes
5409523|NCT01679899|type 2 diabetes mellitus|type 2 diabetes mellitus
5409524|NCT01679899|osteopenia|osteopenia
5409525|NCT01679899|osteoporosis|osteoporosis
5409526|NCT01679899|glycemic variability|glycemic variability
5409527|NCT01679899|bone markers|bone markers
5409528|NCT01679899|osteocalcin|osteocalcin
5409529|NCT01679899|NTX|ntx
5409530|NCT01679899|CTX|ctx
5409531|NCT01679899|BALP|balp
5409532|NCT01679886|Position emission tomography;|position emission tomography;
5409533|NCT01679886|Rubidium;|rubidium;
5409535|NCT01679886|Overweighted patients|overweighted patients
5409536|NCT01679873|confidence|confidence
5409537|NCT01679873|funding sources|funding sources
5409538|NCT01679873|conflicts of interests|conflicts of interests
5409539|NCT01679873|general practitioner|general practitioner
5409540|NCT01679847|Elemene|elemene
5409541|NCT01679847|pharmacokinetics|pharmacokinetics
5409542|NCT01679847|Blood-brain barrier|blood-brain barrier
5409543|NCT01679821|Temporomandibular disorders.|temporomandibular disorders.
5409544|NCT01679821|Dental prosthesis.|dental prosthesis.
5409545|NCT01679821|Dental students|dental students
5409546|NCT01679808|copd|copd
5409547|NCT01679808|airway obstruction|airway obstruction
5409548|NCT01679808|Tracheobronchomalacia|tracheobronchomalacia
5409549|NCT01679795|hormone replacement therapy; Dopplervelocimetry; Flow-mediated dilation; menopause; tibolone|hormone replacement therapy; dopplervelocimetry; flow-mediated dilation; menopause; tibolone
5409550|NCT01679782|COPD, nervous system, peripheral muscle dysfunction|copd, nervous system, peripheral muscle dysfunction
5409551|NCT01679756|Colorectal cancer|colorectal cancer
5409552|NCT01679756|Laparoscopic right hemicolectomy|laparoscopic right hemicolectomy
5409553|NCT01679756|Intracorporeal anastomosis|intracorporeal anastomosis
5409554|NCT01679743|Metastatic Breast Cancer|metastatic breast cancer
5409555|NCT01679743|Metastatic Lung Cancer|metastatic lung cancer
5409556|NCT01679743|Monoclonal Antibody|monoclonal antibody
5409557|NCT01679743|18FLT|18flt
5409558|NCT01679743|Surgery|surgery
5409559|NCT01679717|Osteoarthritis|osteoarthritis
5396731|NCT01736917|Germ Cell Tumors|germ cell tumors
5409560|NCT01679717|CMC1-joint|cmc1-joint
5409561|NCT01679717|Postoperative therapy|postoperative therapy
5409562|NCT01679717|Interposition arthroplasty of the thumb|interposition arthroplasty of the thumb
5409563|NCT01679717|Occupational therapy|occupational therapy
5409564|NCT01679652|Essential hypertension|essential hypertension
5409565|NCT01679652|Nitric oxide|nitric oxide
5409566|NCT01679652|Nebivolol|nebivolol
5409567|NCT01679652|Fractional excretion of sodium|fractional excretion of sodium
5409568|NCT01679626|cricoid pressure (CP)|cricoid pressure (cp)
5409569|NCT01679626|backward upward rightward pressure (BURP)|backward upward rightward pressure (burp)
5409570|NCT01679626|AP-rima distances|ap-rima distances
5409571|NCT01679626|Glottic area|glottic area
5409572|NCT01679626|Extralaryngeal manoeuvres|extralaryngeal manoeuvres
5409573|NCT01679600|Rehabilitation|rehabilitation
5409574|NCT01679600|Robotics-assisted Treadmill Exercise|robotics-assisted treadmill exercise
5409575|NCT01679600|Aerobic Capacity|aerobic capacity
5409576|NCT01679600|Exercise Testing|exercise testing
5409577|NCT01679574|PCO|pco
5409578|NCT01679561|implantation failure|implantation failure
5409579|NCT01679561|recurrent abortion|recurrent abortion
5409580|NCT01679561|intralipid|intralipid
5409581|NCT01679535|Infant nutrition disorder|infant nutrition disorder
5409582|NCT01679535|Child nutrition disorders|child nutrition disorders
5409583|NCT01679535|Malnutrition|malnutrition
5409584|NCT01679535|Protein-energy malnutrition|protein-energy malnutrition
5409585|NCT01679522|endometrial cancer|endometrial cancer
5409586|NCT01679522|laparoscopic surgical staging|laparoscopic surgical staging
5409587|NCT01679522|single-port|single-port
5409588|NCT01679522|four-port|four-port
5409589|NCT01679496|LDL-cholesterol|ldl-cholesterol
5409590|NCT01679470|cancer|cancer
5409591|NCT01679470|lung|lung
5409592|NCT01679470|laser|laser
5409593|NCT01679470|ablation|ablation
5409594|NCT01679470|airway obstruction|airway obstruction
5409595|NCT01679444|MRS|mrs
5409596|NCT01679444|Heavy dose drinkers|heavy dose drinkers
5409597|NCT01679444|Alcohol|alcohol
5409598|NCT01679444|NIAAA|niaaa
5409599|NCT01679431|Aortic Stenosis|aortic stenosis
5409600|NCT01679431|Obesity, Abdominal|obesity, abdominal
5409601|NCT01679431|Metabolic Syndrome X|metabolic syndrome x
5409602|NCT01679431|Insulin Resistance|insulin resistance
5409603|NCT01679431|Echocardiography, Doppler|echocardiography, doppler
5409604|NCT01679431|Multidetector Computed Tomography|multidetector computed tomography
5409605|NCT01679431|Magnetic Resonance Imaging|magnetic resonance imaging
5409606|NCT01679418|PONV|ponv
5409607|NCT01679418|thyroid|thyroid
5409608|NCT01679418|surgery|surgery
5409609|NCT01679418|nausea and vomiting|nausea and vomiting
5409610|NCT01679418|postoperative|postoperative
5409611|NCT01679405|metastatic biliary tract cancer|metastatic biliary tract cancer
5409612|NCT01679392|Transversus abdominis plane block|transversus abdominis plane block
5409613|NCT01679392|Ultrasound guided nerve block|ultrasound guided nerve block
5409614|NCT01679379|Cesarean Section|cesarean section
5409615|NCT01679379|Obese Women|obese women
5409616|NCT01679379|Surgical Site Infection|surgical site infection
5680434|NCT00577798|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5409617|NCT01679353|inguinal hernia, caudal analgesia, magnesium|inguinal hernia, caudal analgesia, magnesium
5409618|NCT01679340|Gastric cancer|gastric cancer
5409619|NCT01679340|D2 surgery|d2 surgery
5409621|NCT01679340|Oxaliplatin|oxaliplatin
5409622|NCT01679340|cisplatin|cisplatin
5409623|NCT01679314|COPD|copd
5409624|NCT01679314|vagus nerve stimulation|vagus nerve stimulation
5409625|NCT01679314|vagal nerve stimulation|vagal nerve stimulation
5409626|NCT01679314|nVNS|nvns
5409627|NCT01679314|VNS|vns
5409628|NCT01679314|non invasive|non invasive
5409629|NCT01679314|gammacore|gammacore
5409630|NCT01679301|oxygen|oxygen
5409631|NCT01679288|Hand-Held ultrasonography|hand-held ultrasonography
5409632|NCT01679288|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5409633|NCT01679288|Abdominal Aortic Atherosclerosis|abdominal aortic atherosclerosis
5409634|NCT01679288|Cardiovascular risk|cardiovascular risk
5409635|NCT01679288|Primary Health Care|primary health care
5409636|NCT01679275|Heart Defects, congenital|heart defects, congenital
5409637|NCT01679275|Patient Monitoring|patient monitoring
5409638|NCT01679275|Infant, Newborn|infant, newborn
5409639|NCT01679275|Physiology|physiology
5409640|NCT01679249|extracellular fluid volume|extracellular fluid volume
5409641|NCT01679249|hypotension|hypotension
5409642|NCT01679249|hemodialysis|hemodialysis
5409643|NCT01679236|Smoking|smoking
5409644|NCT01679236|Smoking cessation|smoking cessation
5409645|NCT01679236|Nicotine|nicotine
5409646|NCT01679236|Tobacco|tobacco
5409647|NCT01679236|Mindfulness|mindfulness
5409648|NCT01679236|Meditation|meditation
5409649|NCT01679236|MBSR|mbsr
5409650|NCT01679236|Mindfulness Training|mindfulness training
5409651|NCT01679236|Behavioral Intervention|behavioral intervention
5409652|NCT01679236|Alcohol|alcohol
5409653|NCT01679236|Young Adults|young adults
5409654|NCT01679223|Breast reconstruction|breast reconstruction
5511725|NCT01245049|MMR|mmr
5396834|NCT01736436|MDS|mds
5409655|NCT01679223|Hydroxyproline concentration|hydroxyproline concentration
5409656|NCT01679223|neoangiogenesis|neoangiogenesis
5409657|NCT01679223|collagen deposition|collagen deposition
5409658|NCT01679197|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5409659|NCT01679197|NAFLD|nafld
5409660|NCT01679197|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5409661|NCT01679197|NASH|nash
5409662|NCT01679197|Lipodystrophy|lipodystrophy
5409663|NCT01679197|Leptin|leptin
5409664|NCT01679197|Metreleptin|metreleptin
5409665|NCT01679197|Hypertriglyceridemia|hypertriglyceridemia
5409666|NCT01679197|Diabetes mellitus|diabetes mellitus
5409667|NCT01679171|Elderly|elderly
5409668|NCT01679171|Intensive care unit|intensive care unit
5409669|NCT01679171|Outcome|outcome
5409670|NCT01679171|Comprehensive geriatric assessment|comprehensive geriatric assessment
5409671|NCT01679158|Using POSE as a treatment for Obesity|using pose as a treatment for obesity
5409672|NCT01679145|Reward- based learning|reward- based learning
5409673|NCT01679145|Pavlovian-to-instrumental transfer|pavlovian-to-instrumental transfer
5409674|NCT01679145|Functional imaging|functional imaging
5409675|NCT01679145|Relapse risk|relapse risk
5409676|NCT01679119|Diffuse large b cell lymphoma|diffuse large b cell lymphoma
5409677|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin
5409678|NCT01679119|Gemcitabine|gemcitabine
5409679|NCT01679119|Rituximab|rituximab
5409680|NCT01679119|Cyclophosphamide|cyclophosphamide
5409681|NCT01679119|Vincristine|vincristine
5409682|NCT01679119|Prednisolone|prednisolone
5409683|NCT01679106|renal transplant|renal transplant
5409684|NCT01679106|flank incision|flank incision
5409685|NCT01679093|postoperative analgesia|postoperative analgesia
5409686|NCT01679093|paracetamol|paracetamol
5409687|NCT01679093|5-HT3 antagonist|5-ht3 antagonist
5409688|NCT01679093|ondansetron|ondansetron
5409689|NCT01679093|PainMatcher|painmatcher
5409690|NCT01679080|Drug therapy|drug therapy
5409691|NCT01679080|Adult|adult
5409693|NCT01679067|GALT|galt
5409694|NCT01679054|Neoplasm|neoplasm
5409695|NCT01679054|Gastric Cancer|gastric cancer
5409696|NCT01679054|Cost|cost
5409697|NCT01679028|T89 Safety in Healthy Japanese population|t89 safety in healthy japanese population
5409698|NCT01679015|Burning|burning
5409699|NCT01679015|Dryness|dryness
5409700|NCT01679015|Itching|itching
5409701|NCT01679015|Blurry Vision|blurry vision
5409702|NCT01679002|Epilepsy|epilepsy
5409703|NCT01679002|Oxcarbazepine|oxcarbazepine
5409704|NCT01679002|Eslicarbazepine Acetate|eslicarbazepine acetate
5409705|NCT01679002|BIA 2-093|bia 2-093
5409706|NCT01678989|Bipolar disorder|bipolar disorder
5409707|NCT01678989|Children|children
5409708|NCT01678989|Cranial MRI|cranial mri
5409709|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate
5409710|NCT01678976|Epilepsy|epilepsy
5409711|NCT01678976|Oxcarbazepine|oxcarbazepine
5409712|NCT01678963|Neovascular AMD|neovascular amd
5409713|NCT01678963|Wet AMD|wet amd
5409715|NCT01678963|Age related macular degeneration|age related macular degeneration
5409716|NCT01678950|Cardiac output monitoring|cardiac output monitoring
5409717|NCT01678950|Echocardiography|echocardiography
5409718|NCT01678950|Pulse contour system|pulse contour system
5409719|NCT01678937|Immunosuppression|immunosuppression
5395093|NCT01743651|multiple sclerosis|multiple sclerosis
5409720|NCT01678911|Pelvic Pain|pelvic pain
5409721|NCT01678911|Chronic Pelvic Pain|chronic pelvic pain
5409722|NCT01678911|Irritable Bowel Syndrome|irritable bowel syndrome
5409723|NCT01678911|IBS|ibs
5409724|NCT01678911|Ulcerative Colitis|ulcerative colitis
5409725|NCT01678911|UC|uc
5409726|NCT01678911|Interstitial Cystitis|interstitial cystitis
5409727|NCT01678911|IC|ic
5409728|NCT01678911|Prostatitis|prostatitis
5409729|NCT01678911|Pain|pain
5409730|NCT01678898|Fabry disease|fabry disease
5409731|NCT01678898|Alpha galactosidase deficiency|alpha galactosidase deficiency
5409732|NCT01678898|Metabolic storage disease|metabolic storage disease
5409733|NCT01678859|infertility|infertility
5409736|NCT01678859|sperm|sperm
5409737|NCT01678859|interaction|interaction
5409738|NCT01678846|corporal punishment|corporal punishment
5409739|NCT01678846|violence|violence
5409740|NCT01678846|education|education
5409741|NCT01678846|depression|depression
5409742|NCT01678846|anxiety|anxiety
5409743|NCT01678846|conduct disorder|conduct disorder
5409744|NCT01678833|Drug Abuse/Dependence|drug abuse/dependence
5409745|NCT01678794|Chronic heart failure (CHF)|chronic heart failure (chf)
5409746|NCT01678794|cardiac and renal dysfunction|cardiac and renal dysfunction
5409747|NCT01678781|Abdominal pain|abdominal pain
5409748|NCT01678781|Diarrhea|diarrhea
5409749|NCT01678781|Mebeverine hydrochloride|mebeverine hydrochloride
5409750|NCT01678781|Constipation|constipation
5409751|NCT01678781|Pinaverium bromide|pinaverium bromide
5409752|NCT01678781|Irritable bowel syndrome|irritable bowel syndrome
5409753|NCT01678781|Bloating|bloating
5409754|NCT01678781|Quality of life|quality of life
5409755|NCT01678755|schizophrenia|schizophrenia
5409756|NCT01678742|Diet|diet
5409757|NCT01678742|Incretins|incretins
5409758|NCT01678742|Gastrointestinal Hormones|gastrointestinal hormones
5409759|NCT01678742|Fish Proteins|fish proteins
5409760|NCT01678729|refractive surgery|refractive surgery
5409761|NCT01678729|pupil|pupil
5409762|NCT01678729|Pupil size|pupil size
5409763|NCT01678716|Anemia|anemia
5409764|NCT01678716|Breastfeeding|breastfeeding
5409765|NCT01678716|Complementary feeding|complementary feeding
5409766|NCT01678716|Stunting|stunting
5409767|NCT01678716|Wasting|wasting
5409768|NCT01678716|Underweight|underweight
5409769|NCT01678716|Micronutrient powder|micronutrient powder
5409770|NCT01678716|Behavior change counseling|behavior change counseling
5409771|NCT01678716|Frontline health worker|frontline health worker
5409772|NCT01678703|late abortion|late abortion
5409773|NCT01678703|laminaria|laminaria
5409774|NCT01678703|Misoprostol|misoprostol
5409775|NCT01678703|Cervical preparation|cervical preparation
5409776|NCT01678677|non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
5409777|NCT01678677|immunogenicity|immunogenicity
5409778|NCT01678677|reactogenicity|reactogenicity
5409779|NCT01678677|safety|safety
5409780|NCT01678664|cancer|cancer
5409781|NCT01678664|neuroendocrine tumors|neuroendocrine tumors
5409782|NCT01678664|gastrointestinal tract|gastrointestinal tract
5409783|NCT01678664|metastases|metastases
5409784|NCT01678664|liver|liver
5409785|NCT01678664|hepatic|hepatic
5409786|NCT01678651|time-lapse, FSH, kinetics|time-lapse, fsh, kinetics
5409787|NCT01678638|inguinal hernia|inguinal hernia
5409788|NCT01678638|premature infants|premature infants
5409789|NCT01678638|anesthesia safety|anesthesia safety
5409790|NCT01678638|neurodevelopmental outcome|neurodevelopmental outcome
5409791|NCT01678638|preterm infants|preterm infants
5409792|NCT01678638|neonatal prematurity|neonatal prematurity
5409793|NCT01678625|Residual neuromuscular blockade|residual neuromuscular blockade
5409794|NCT01678625|Train-of-four|train-of-four
5409795|NCT01678625|Acceleromyography|acceleromyography
5409796|NCT01678625|Electromyography|electromyography
5409797|NCT01678612|Copper|copper
5409798|NCT01678612|Health-Acquired Infections|health-acquired infections
5409799|NCT01678612|Bacterial Load|bacterial load
5409800|NCT01678612|Intensive Care Units, Pediatric|intensive care units, pediatric
5409810|NCT01678573|JNJ-212082|jnj-212082
5409812|NCT01678573|Chinese|chinese
5409813|NCT01678573|Fasted|fasted
5409814|NCT01678560|Obstructive sleep apnea PAP adherence efficacy economics|obstructive sleep apnea pap adherence efficacy economics
5409815|NCT01678547|Stroke|stroke
5409816|NCT01678547|Robot|robot
5409817|NCT01678547|Treatment|treatment
5409818|NCT01678547|Rehabilitation|rehabilitation
5409819|NCT01678534|Cerebral infarction|cerebral infarction
5409820|NCT01678534|Cellular therapy|cellular therapy
5409821|NCT01678521|Hypercholesterolemia|hypercholesterolemia
5409822|NCT01678521|LDL-apheresis|ldl-apheresis
5409823|NCT01678521|Coronary artery disease|coronary artery disease
5409824|NCT01678521|PTX3|ptx3
5409825|NCT01678521|CRP|crp
5409826|NCT01678521|IL6|il6
5409827|NCT01678521|IL10|il10
5409828|NCT01678482|Acne, LED, blue light|acne, led, blue light
5409829|NCT01678456|Atrial Fibrillation|atrial fibrillation
5409830|NCT01678456|Critical Event Committee|critical event committee
5409831|NCT01678456|Serious adverse events|serious adverse events
5395197|NCT01743248|balance|balance
5409832|NCT01678456|Thromboembolic complications|thromboembolic complications
5409833|NCT01678456|Cardiac and noncardiac complications|cardiac and noncardiac complications
5409834|NCT01678456|Bleeding complications|bleeding complications
5409835|NCT01678456|Acute heart failure|acute heart failure
5409836|NCT01678456|Syncope|syncope
5410732|NCT01674478|enteral fat|enteral fat
5409840|NCT01678430|CD20 antibody|cd20 antibody
5409841|NCT01678430|Ofatumumab|ofatumumab
5409842|NCT01678430|Chlorambucil|chlorambucil
5409843|NCT01678430|Bendamustine|bendamustine
5409844|NCT01678378|Adolescent|adolescent
5409845|NCT01678378|Intervention|intervention
5409847|NCT01678378|Male|male
5409848|NCT01678378|Interpersonal Relations|interpersonal relations
5409849|NCT01678378|School Health Services|school health services
5409850|NCT01678378|Community-Based Participatory Research|community-based participatory research
5409851|NCT01678378|Randomized Controlled Trial|randomized controlled trial
5409852|NCT01678378|Health Care Provider|health care provider
5409853|NCT01678378|Training Program|training program
5409854|NCT01678378|Harm Reduction|harm reduction
5409855|NCT01678378|Prevention|prevention
5409856|NCT01678378|Reproductive Coercion|reproductive coercion
5409857|NCT01678378|Tech-Based Abuse|tech-based abuse
5409858|NCT01678378|Social Environment|social environment
5409859|NCT01678378|Sexual Partners|sexual partners
5409860|NCT01678365|complicated appendicitis|complicated appendicitis
5409861|NCT01678365|Children|children
5409862|NCT01678365|conservative therapy|conservative therapy
5409863|NCT01678365|Study population: Children 1 month - 14 years with Complicated appendicitis|study population: children 1 month - 14 years with complicated appendicitis
5409864|NCT01678365|Type of the study: prospective, open randomized|type of the study: prospective, open randomized
5409869|NCT01678339|ACS|acs
5409870|NCT01678339|AMI|ami
5409871|NCT01678326|Diseases Classified Elsewhere|diseases classified elsewhere
5409872|NCT01678313|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5409873|NCT01678313|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5409874|NCT01678313|Prostatic specific antigen (PSA)|prostatic specific antigen (psa)
5409875|NCT01678313|Cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
5409876|NCT01678300|Ulcerative Colitis|ulcerative colitis
5409877|NCT01678287|ASP1941|asp1941
5409878|NCT01678274|Turner Syndrome|turner syndrome
5409879|NCT01678274|Aortic Aneurysm|aortic aneurysm
5409880|NCT01678274|Ischemic heart disease|ischemic heart disease
5409881|NCT01678274|Hypertension|hypertension
5409882|NCT01678274|Congenital Heart Defect|congenital heart defect
5409883|NCT01678274|Pulse Wave Velocity|pulse wave velocity
5409884|NCT01678274|Augmentation Index|augmentation index
5409885|NCT01678274|Central Blood Pressure|central blood pressure
5409886|NCT01678274|Agatston Score|agatston score
5409887|NCT01678274|Segment involvement score|segment involvement score
5409888|NCT01678261|Sex chromosome|sex chromosome
5409889|NCT01678261|Turner Syndrome|turner syndrome
5409890|NCT01678261|Klinefelter Syndrome|klinefelter syndrome
5409891|NCT01678261|Triple X Syndrome|triple x syndrome
5409892|NCT01678261|47 XYY syndrome|47 xyy syndrome
5409893|NCT01678261|Aortic Aneurysm|aortic aneurysm
5409894|NCT01678261|Epigenetics|epigenetics
5409895|NCT01678261|Transcriptome|transcriptome
5409896|NCT01678261|non-coding RNA|non-coding rna
5409897|NCT01678235|diabetes|diabetes
5409898|NCT01678235|insulin pump|insulin pump
5409899|NCT01678235|glulisine|glulisine
5409900|NCT01678235|aspart|aspart
5409901|NCT01678235|glycemic index|glycemic index
5409905|NCT01678209|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5409907|NCT01678209|Non-stimulant|non-stimulant
5409908|NCT01678209|Drug|drug
5409909|NCT01678209|Methylphenidate|methylphenidate
5409910|NCT01678209|Atomoxetine|atomoxetine
5409911|NCT01678209|Strattera|strattera
5409912|NCT01678209|Concerta|concerta
5409913|NCT01678209|MACRO|macro
5409914|NCT01678209|Medication|medication
5409915|NCT01678209|Treatment|treatment
5409916|NCT01678209|Youth|youth
5409917|NCT01678209|Adolescent|adolescent
5409918|NCT01678209|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5409919|NCT01678209|Brain scan|brain scan
5409921|NCT01678209|Response inhibition|response inhibition
5409922|NCT01678209|Inattentive|inattentive
5409923|NCT01678209|Hyperactive|hyperactive
5409924|NCT01678209|Combined|combined
5409925|NCT01678209|Medication Treatment|medication treatment
5409926|NCT01678209|Brain Imaging|brain imaging
5409927|NCT01678196|Family Members|family members
5409928|NCT01678196|Community Outreach|community outreach
5409929|NCT01678196|Internet|internet
5409930|NCT01678170|blood-oxygen functional imaging technology|blood-oxygen functional imaging technology
5409931|NCT01678170|diagnosis|diagnosis
5409932|NCT01678157|Esophageal Hernia|esophageal hernia
5409933|NCT01678157|Hernia, Esophageal|hernia, esophageal
5409934|NCT01678157|Hernia, Paraesophageal|hernia, paraesophageal
5409935|NCT01678157|Hiatal Hernia|hiatal hernia
5409936|NCT01678157|Paraesophageal Hiatal Hernia|paraesophageal hiatal hernia
5409937|NCT01678157|Sliding Esophageal Hernia|sliding esophageal hernia
5409938|NCT01678157|Sliding Hiatal Hernia|sliding hiatal hernia
5409939|NCT01678144|mitral valve|mitral valve
5409940|NCT01678144|mitral surgery|mitral surgery
5409941|NCT01678144|mitral repair|mitral repair
5409942|NCT01678144|mitral annuloplasty|mitral annuloplasty
5409943|NCT01678144|mitral valve surgery|mitral valve surgery
5409944|NCT01678144|mitral valve repair|mitral valve repair
5409945|NCT01678144|mitral valve annuloplasty|mitral valve annuloplasty
5409946|NCT01678118|Patient Navigation|patient navigation
5409947|NCT01678118|Tobacco dependent|tobacco dependent
5409949|NCT01678118|Cessation|cessation
5409950|NCT01678118|11-028|11-028
5409951|NCT01678105|Recurrent Adenoid Cystic Carcinoma of the Salivary Glands|recurrent adenoid cystic carcinoma of the salivary glands
5409952|NCT01678105|Metastatic Adenoid Cystic Carcinoma of the Salivary Glands|metastatic adenoid cystic carcinoma of the salivary glands
5409953|NCT01678105|Salivary Gland Cancers|salivary gland cancers
5409954|NCT01678105|ACC|acc
5409955|NCT01678105|Dovitinib|dovitinib
5409956|NCT01678105|TKI258|tki258
5409957|NCT01678105|RTK Inhibitor|rtk inhibitor
5409958|NCT01678079|Pregnancy|pregnancy
5409959|NCT01678079|Micronutrient Powder|micronutrient powder
5409960|NCT01678079|Calcium|calcium
5409961|NCT01678079|Iron|iron
5409962|NCT01678079|Bangladesh|bangladesh
5409963|NCT01678066|Noninvasive cardiac output.|noninvasive cardiac output.
5409964|NCT01678066|Pediatrics.|pediatrics.
5409965|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a
5409966|NCT01678040|Ventricular Volume|ventricular volume
5409967|NCT01678040|Cardiac Magnetic Resonance|cardiac magnetic resonance
5409968|NCT01678040|Echocardiogram|echocardiogram
5409969|NCT01678027|Stomach neoplasm|stomach neoplasm
5409970|NCT01678027|Helicobacter pylori|helicobacter pylori
5409971|NCT01678014|Anorexia|anorexia
5409972|NCT01678014|DBS|dbs
5409973|NCT01678014|Capsulotomy|capsulotomy
5409974|NCT01678014|Signs and Symptoms|signs and symptoms
5409975|NCT01678001|plantar fascia|plantar fascia
5409976|NCT01678001|plantar fascitis|plantar fascitis
5409977|NCT01678001|botulinum toxin|botulinum toxin
5409978|NCT01678001|Xeomin|xeomin
5409979|NCT01677988|NEOADJUVANT FOLFIRINOX CHEMOTHERAPY|neoadjuvant folfirinox chemotherapy
5409980|NCT01677988|LOCALIZED PANCREATIC HEAD ADENOCARCINOMA|localized pancreatic head adenocarcinoma
5409981|NCT01677988|RADIATION THERAPY|radiation therapy
5409982|NCT01677962|locally advanced, unresectable pancreatic adenocarcinoma|locally advanced, unresectable pancreatic adenocarcinoma
5409983|NCT01677962|Poly ICLC|poly iclc
5409984|NCT01677962|dendritic cells|dendritic cells
5409985|NCT01677936|diabetes|diabetes
5409986|NCT01677936|blood pressure|blood pressure
5409987|NCT01677936|lipid|lipid
5409988|NCT01677936|waist circumference|waist circumference
5409989|NCT01677936|BMI|bmi
5409990|NCT01677923|weight|weight
5409991|NCT01677923|body mass index|body mass index
5409992|NCT01677923|lipid profile|lipid profile
5409993|NCT01677923|glucose profile|glucose profile
5409994|NCT01677845|Localized Prostate Cancer|localized prostate cancer
5409995|NCT01677845|Radiation|radiation
5409996|NCT01677806|Percutaneous vertebroplasty|percutaneous vertebroplasty
5409997|NCT01677741|Children and Adolescents|children and adolescents
5409998|NCT01677741|BRAF|braf
5409999|NCT01677741|dabrafenib|dabrafenib
5410000|NCT01677741|dose escalation|dose escalation
5410001|NCT01677741|BRF116013|brf116013
5410002|NCT01677741|V600-mutation positive|v600-mutation positive
5410003|NCT01677741|BRF|brf
5410004|NCT01677728|colorectal liver metastases|colorectal liver metastases
5410010|NCT01677689|cough|cough
5410011|NCT01677689|nasal obstruction|nasal obstruction
5410012|NCT01677689|sore throat|sore throat
5410013|NCT01677689|fever|fever
5410014|NCT01677676|Influenza A|influenza a
5410015|NCT01677663|autism|autism
5410016|NCT01677663|clinical phenotypes|clinical phenotypes
5410017|NCT01677663|neuropsychology|neuropsychology
5410018|NCT01677663|imaging endophenotypes|imaging endophenotypes
5410019|NCT01677663|family-based cohort|family-based cohort
5410020|NCT01677663|knoutout mice|knoutout mice
5410021|NCT01677650|Spinal Fusion|spinal fusion
5410022|NCT01677650|Opioid Analgesia|opioid analgesia
5410023|NCT01677637|osteopenia, postmenopausal|osteopenia, postmenopausal
5410026|NCT01677624|arterial embolization|arterial embolization
5410028|NCT01677611|SIRT1|sirt1
5410029|NCT01677611|AMPK|ampk
5410030|NCT01677598|Plaque Psoriasis|plaque psoriasis
5410031|NCT01677598|Ustekinumab|ustekinumab
5410032|NCT01677598|CNTO 1275|cnto 1275
5410033|NCT01677598|Asia-Pacific|asia-pacific
5410034|NCT01677572|Aducanumab|aducanumab
5410035|NCT01677572|BIIB037|biib037
5410036|NCT01677546|diabetes|diabetes
5410037|NCT01677546|insulin pump|insulin pump
5410038|NCT01677546|bolus calculator|bolus calculator
5410039|NCT01677546|Contour Link|contour link
5410040|NCT01677533|Panel management|panel management
5410041|NCT01677533|Clinical microsystems|clinical microsystems
5410042|NCT01677533|Hypertension management|hypertension management
5410043|NCT01677533|Smoking cessation|smoking cessation
5410044|NCT01677533|Continuing medical education|continuing medical education
5410045|NCT01677533|Quality improvement,|quality improvement,
5410046|NCT01677533|Population health|population health
5410047|NCT01677520|adipose-derived stem cells|adipose-derived stem cells
5410048|NCT01677520|viable ADSCs|viable adscs
5410049|NCT01677520|apoptosis|apoptosis
5410050|NCT01677520|necrosis|necrosis
5410051|NCT01677520|cryopreservation|cryopreservation
5410052|NCT01677507|glaucoma|glaucoma
5410053|NCT01677507|aqueous humor dynamics|aqueous humor dynamics
5410054|NCT01677507|intraocular pressure|intraocular pressure
5410055|NCT01677468|Hepatocellular carcinoma|hepatocellular carcinoma
5410056|NCT01677468|Transarterial chemoembolization|transarterial chemoembolization
5410057|NCT01677455|Hsp90 inhibitor|hsp90 inhibitor
5410058|NCT01677455|ganetespib|ganetespib
5410059|NCT01677455|STA 9090|sta 9090
5410060|NCT01677442|nonintubated|nonintubated
5410061|NCT01677442|anaesthesia|anaesthesia
5410063|NCT01677429|panic disorder|panic disorder
5410064|NCT01677429|balance impairment|balance impairment
5410065|NCT01677429|virtual reality|virtual reality
5410066|NCT01677416|Rheumatoid arthritis|rheumatoid arthritis
5410067|NCT01677416|Ultrasonography|ultrasonography
5410068|NCT01677416|Synovitis|synovitis
5410069|NCT01677416|Foot joints|foot joints
5410070|NCT01677403|Bronchiectasis|bronchiectasis
5410071|NCT01677403|Tobramycin|tobramycin
5410072|NCT01677403|nebulised|nebulised
5410073|NCT01677390|Antibody-Drug Conjugate|antibody-drug conjugate
5410074|NCT01677390|monomethylauristatin F|monomethylauristatin f
5410075|NCT01677390|Carcinoma, Renal Cell|carcinoma, renal cell
5410076|NCT01677390|Antigens, CD70|antigens, cd70
5410077|NCT01677390|Drug Therapy|drug therapy
5410078|NCT01677377|Schizophrenia|schizophrenia
5410079|NCT01677377|Schizophrenic|schizophrenic
5410080|NCT01677377|Schizophrenias|schizophrenias
5410081|NCT01677364|induction of labour|induction of labour
5410082|NCT01677364|heart disease patients|heart disease patients
5410083|NCT01677351|clonidine|clonidine
5382792|NCT01800084|FBP|fbp
5397271|NCT01734525|candidemia|candidemia
5410084|NCT01677351|cataract surgery|cataract surgery
5410085|NCT01677351|arrythmia|arrythmia
5410086|NCT01677351|anesthesic medication|anesthesic medication
5410087|NCT01677286|AL Amyloidosis|al amyloidosis
5410088|NCT01677286|Primary Amyloidosis|primary amyloidosis
5410089|NCT01677286|Hereditary Amyloidosis|hereditary amyloidosis
5410090|NCT01677286|Familial Amyloidosis|familial amyloidosis
5410091|NCT01677286|SSA Amyloidosis|ssa amyloidosis
5410092|NCT01677286|Senile Systemic Amyloidosis|senile systemic amyloidosis
5410093|NCT01677286|AA Amyloidosis|aa amyloidosis
5410094|NCT01677286|Secondary Amyloidosis|secondary amyloidosis
5410095|NCT01677286|Localized Amyloidosis|localized amyloidosis
5410096|NCT01677286|Systemic Amyloidosis|systemic amyloidosis
5410097|NCT01677273|Respiratory chambers|respiratory chambers
5410098|NCT01677273|Energy expenditure|energy expenditure
5410099|NCT01677273|Appetite|appetite
5410100|NCT01677273|Dairy proteins|dairy proteins
5410101|NCT01677273|Diet induced thermogenesis|diet induced thermogenesis
5410102|NCT01677273|Obesity|obesity
5410103|NCT01677260|Biguanide|biguanide
5410104|NCT01677260|anti-hyperglycaemic|anti-hyperglycaemic
5410105|NCT01677260|bioavailability|bioavailability
5410106|NCT01677260|bioequivalence|bioequivalence
5410107|NCT01677260|metformin|metformin
5410108|NCT01677260|pharmacokinetics|pharmacokinetics
5410109|NCT01677247|sulphonylurea|sulphonylurea
5410110|NCT01677247|anti-hyperglycaemic|anti-hyperglycaemic
5410111|NCT01677247|bioavailability|bioavailability
5410112|NCT01677247|bioequivalence|bioequivalence
5410113|NCT01677247|glimepiride|glimepiride
5410114|NCT01677247|pharmacokinetics|pharmacokinetics
5410115|NCT01677234|Blood pressure|blood pressure
5410116|NCT01677221|acne|acne
5410117|NCT01677221|inflammatory acne|inflammatory acne
5410118|NCT01677221|intense pulsed light|intense pulsed light
5410119|NCT01677208|Acute Ischemic Stroke|acute ischemic stroke
5410120|NCT01677208|Randomized Controlled Trial|randomized controlled trial
5410121|NCT01677208|Traditional Chinese Medicine|traditional chinese medicine
5410122|NCT01677195|Mycotoxins|mycotoxins
5410123|NCT01677195|Aflatoxin|aflatoxin
5410124|NCT01677195|Fumonisin|fumonisin
5410125|NCT01677195|Aflatoxicosis|aflatoxicosis
5410127|NCT01677195|Cancer|cancer
5410128|NCT01677182|Drug therapy|drug therapy
5410129|NCT01677156|ASGES|asges
5410130|NCT01677156|Corus CAD|corus cad
5410131|NCT01677156|Age/Sex/Gene Expression Score|age/sex/gene expression score
5410132|NCT01677156|Gene Expression|gene expression
5410133|NCT01677156|GES|ges
5410134|NCT01677156|CAD|cad
5410135|NCT01677156|CVD|cvd
5410136|NCT01677156|CHD|chd
5410137|NCT01677156|Precision Medicine|precision medicine
5410138|NCT01677156|Clinical Utility|clinical utility
5410139|NCT01677156|Registry|registry
5411553|NCT01671033|Internet|internet
5410140|NCT01677156|Coronary Artery Disease|coronary artery disease
5410141|NCT01677156|Angina Pectoris|angina pectoris
5410142|NCT01677156|Chest Pain|chest pain
5410143|NCT01677156|Cardiovascular Disease|cardiovascular disease
5410144|NCT01677156|Coronary Heart Disease|coronary heart disease
5410145|NCT01677156|PRESET|preset
5410146|NCT01677143|Local anesthetic|local anesthetic
5410147|NCT01677143|Preemptive analgesia|preemptive analgesia
5410148|NCT01677143|Postoperative pain|postoperative pain
5410149|NCT01677143|Laparoscopy|laparoscopy
5410150|NCT01677143|Gynecological surgery|gynecological surgery
5410151|NCT01677143|Day-case surgery|day-case surgery
5410152|NCT01677130|Clinical efficacy|clinical efficacy
5410153|NCT01677130|safety|safety
5410154|NCT01677130|of HFOV treatment|of hfov treatment
5410155|NCT01677130|of patients|of patients
5410156|NCT01677104|GLP-1|glp-1
5410157|NCT01677104|DPP-IV inhibitor|dpp-iv inhibitor
5410158|NCT01677104|microcirculation|microcirculation
5410159|NCT01677104|Exenatide|exenatide
5410160|NCT01677104|Liraglutide|liraglutide
5410161|NCT01677104|Linagliptin|linagliptin
5410162|NCT01677091|Balance,Hemiplegia,Cervical vibration,Prism adaptation,Rehabilitation|balance,hemiplegia,cervical vibration,prism adaptation,rehabilitation
5410163|NCT01677078|Major depressive disorder|major depressive disorder
5410164|NCT01677078|rTMS|rtms
5410165|NCT01677078|Neuronavigation|neuronavigation
5410166|NCT01677065|Bioavailability|bioavailability
5410167|NCT01677065|Oxycodone|oxycodone
5410168|NCT01677065|Healthy Volunteers|healthy volunteers
5410169|NCT01677039|Bioavailability|bioavailability
5410170|NCT01677039|oxycodone|oxycodone
5410171|NCT01677039|ethanol interaction|ethanol interaction
5410172|NCT01677039|healthy volunteers|healthy volunteers
5410173|NCT01677013|Type 2; diabetes mellitus; stem cell; safety; efficacy|type 2; diabetes mellitus; stem cell; safety; efficacy
5410174|NCT01677000|bone infection|bone infection
5410175|NCT01677000|staphylococcus aureus|staphylococcus aureus
5410176|NCT01677000|registry|registry
5410177|NCT01676987|Asthma|asthma
5410178|NCT01676987|Budesonide|budesonide
5410179|NCT01676987|Adrenergic beta-2 receptor agonists.|adrenergic beta-2 receptor agonists.
5410180|NCT01676974|Drug Resistance, Microbial|drug resistance, microbial
5397380|NCT01733927|HIV screening|hiv screening
5410181|NCT01676974|Enterobacteriaceae|enterobacteriaceae
5410182|NCT01676974|ESBL|esbl
5410183|NCT01676974|Carbapenemase|carbapenemase
5410184|NCT01676974|Travel|travel
5410185|NCT01676948|SJIA|sjia
5410186|NCT01676948|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5410187|NCT01676948|children|children
5410188|NCT01676948|systemic autoinflammatory disease, ACZ885, canakinumab|systemic autoinflammatory disease, acz885, canakinumab
5410189|NCT01676948|human monoclonal anti-interleukin-1β (IL-1 β) antibody|human monoclonal anti-interleukin-1β (il-1 β) antibody
5410190|NCT01676948|hildhood immunizations vaccinations|hildhood immunizations vaccinations
5410191|NCT01676909|self-management|self-management
5410192|NCT01676896|children|children
5410193|NCT01676896|asthma|asthma
5410194|NCT01676896|quality of life|quality of life
5410195|NCT01676896|self-management|self-management
5410196|NCT01676883|Body constitution|body constitution
5410197|NCT01676883|Anthropometry|anthropometry
5410198|NCT01676883|Electric impedance|electric impedance
5410199|NCT01676870|exercise training|exercise training
5410200|NCT01676870|exercise therapy|exercise therapy
5410201|NCT01676870|physical fitness|physical fitness
5410202|NCT01676870|risk factors|risk factors
5410203|NCT01676857|chronic pain, prostatitis, pelvic pain|chronic pain, prostatitis, pelvic pain
5410204|NCT01676844|Phosphorus|phosphorus
5410205|NCT01676844|Phosphate|phosphate
5410206|NCT01676844|Hypophosphataemia|hypophosphataemia
5410207|NCT01676844|Osteopenia|osteopenia
5410208|NCT01676844|Prematurity|prematurity
5410209|NCT01676805|Developing Novel Treatment Approaches|developing novel treatment approaches
5410210|NCT01676805|Developing Therapeutic Agents|developing therapeutic agents
5410211|NCT01676805|Analysis of Genetic and Genomic Biology|analysis of genetic and genomic biology
5410212|NCT01676805|New Prognostic and Diagnostic Models|new prognostic and diagnostic models
5410213|NCT01676805|Analysis of Cellular and Molecular Biology|analysis of cellular and molecular biology
5410214|NCT01676792|condyloma acuminate|condyloma acuminate
5410215|NCT01676792|ano-genital warts|ano-genital warts
5410216|NCT01676792|genital warts|genital warts
5410217|NCT01676792|cutaneous condyloma|cutaneous condyloma
5410218|NCT01676792|Vulva pre-cancerous lesions|vulva pre-cancerous lesions
5410219|NCT01676792|Vulvar Intraepitheral Neoplasia|vulvar intraepitheral neoplasia
5410220|NCT01676792|VIN|vin
5410221|NCT01676792|EGW|egw
5410222|NCT01676779|melanoma|melanoma
5410223|NCT01676779|no evidence of disease|no evidence of disease
5410224|NCT01676779|resection|resection
5410225|NCT01676779|macro-metastases|macro-metastases
5410226|NCT01676766|Stargardt Disease|stargardt disease
5410227|NCT01676766|Macular degeneration|macular degeneration
5410228|NCT01676766|Retinal dystrophy|retinal dystrophy
5410229|NCT01676740|hematinic therapy|hematinic therapy
5410230|NCT01676740|blood transfusion|blood transfusion
5410231|NCT01676740|joint replacement|joint replacement
5410232|NCT01676727|Transcatheter Aortic valve Implantation|transcatheter aortic valve implantation
5410233|NCT01676727|Heart Valve Diseases|heart valve diseases
5411554|NCT01671020|fimasartan|fimasartan
5410234|NCT01676727|Cardiovascular Diseases|cardiovascular diseases
5410235|NCT01676714|Dovitinib|dovitinib
5410236|NCT01676714|Fibroblast Growth Factor Receptor Biomarkers|fibroblast growth factor receptor biomarkers
5393063|NCT01753154|Body composition monitor|body composition monitor
5410237|NCT01676714|Anti-Vascular Endothelial Growth Factor Therapy|anti-vascular endothelial growth factor therapy
5410238|NCT01676688|alpha-1 antitrypsin|alpha-1 antitrypsin
5410239|NCT01676688|deficiency|deficiency
5410240|NCT01676688|Alfalastin|alfalastin
5410241|NCT01676688|safety|safety
5410242|NCT01676675|whole virus|whole virus
5410243|NCT01676675|inactivated|inactivated
5410244|NCT01676675|influenza|influenza
5410245|NCT01676675|H5N1 vaccine|h5n1 vaccine
5410246|NCT01676675|safety|safety
5410247|NCT01676675|immunogenicity|immunogenicity
5410248|NCT01676662|Urinary Incontinence|urinary incontinence
5410249|NCT01676662|Urinary Incontinence, Stress|urinary incontinence, stress
5410250|NCT01676662|Urination Disorders|urination disorders
5410251|NCT01676662|Urologic Diseases|urologic diseases
5410252|NCT01676662|Urological Manifestations|urological manifestations
5410253|NCT01676662|Signs and Symptoms|signs and symptoms
5410254|NCT01676636|Pregnancy|pregnancy
5410255|NCT01676636|Calcium|calcium
5410256|NCT01676636|Supplements|supplements
5410257|NCT01676623|Child nutrition|child nutrition
5410258|NCT01676623|Stunting|stunting
5410259|NCT01676623|Exclusive breastfeeding|exclusive breastfeeding
5410260|NCT01676623|Complementary feeding|complementary feeding
5410261|NCT01676623|Social franchise|social franchise
5410262|NCT01676623|Mass media|mass media
5410263|NCT01676623|Counseling|counseling
5410264|NCT01676623|Facility-based|facility-based
5410265|NCT01676610|Pulse Oximetry|pulse oximetry
5410266|NCT01676610|Pediatrics|pediatrics
5410267|NCT01676610|Pakistan|pakistan
5410268|NCT01676610|Hypoxemia|hypoxemia
5410269|NCT01676610|Neonatal Sepsis|neonatal sepsis
5410270|NCT01676610|Pneumonia|pneumonia
5410271|NCT01676558|diffuse large B cell lymphoma|diffuse large b cell lymphoma
5410272|NCT01676558|radioimmunotherapy|radioimmunotherapy
5410273|NCT01676558|131I-rituximab|131i-rituximab
5410274|NCT01676532|School Board Health Center|school board health center
5410275|NCT01676532|Pediatrics|pediatrics
5410276|NCT01676506|Wet AMD|wet amd
5410277|NCT01676506|genetic polymorphisms|genetic polymorphisms
5410278|NCT01676506|Ranibizumab|ranibizumab
5410279|NCT01676480|Prostate cancer|prostate cancer
5410281|NCT01676480|Endurance training|endurance training
5410282|NCT01676454|Vasopressin|vasopressin
5410283|NCT01676454|Trauma|trauma
5410284|NCT01676454|Injury|injury
5410285|NCT01676441|spinal cord injury|spinal cord injury
5410286|NCT01676441|mesenchymal stem cell|mesenchymal stem cell
5410287|NCT01676428|Kidney|kidney
5410288|NCT01676428|Renal|renal
5410289|NCT01676428|Radiotherapy|radiotherapy
5410290|NCT01676428|Stereotactic|stereotactic
5410291|NCT01676428|Cancer|cancer
5410292|NCT01676415|Sinus disease|sinus disease
5410293|NCT01676415|Sinonasal complaints|sinonasal complaints
5410294|NCT01676415|Chronic sinusitis|chronic sinusitis
5410295|NCT01676415|Nasal polyps|nasal polyps
5410296|NCT01676415|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
5410297|NCT01676415|Glucocorticoids|glucocorticoids
5410298|NCT01676415|Prednisone|prednisone
5410299|NCT01676415|Topical mometasone|topical mometasone
5410300|NCT01676415|Anti-inflammatory agents|anti-inflammatory agents
5410301|NCT01676402|Influenza A (H1)|influenza a (h1)
5410302|NCT01676402|Influenza A (H3)|influenza a (h3)
5410303|NCT01676402|Influenza B|influenza b
5410304|NCT01676402|DNA Vaccine|dna vaccine
5410305|NCT01676402|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
5410306|NCT01676402|Healthy Adults|healthy adults
5410307|NCT01676402|Intradermal (ID)|intradermal (id)
5410308|NCT01676389|Autism Spectrum Disorders|autism spectrum disorders
5410309|NCT01676376|CABG|cabg
5410310|NCT01676376|SVG|svg
5410311|NCT01676376|nitinol mesh|nitinol mesh
5410312|NCT01676376|external saphenous vein graft support|external saphenous vein graft support
5410313|NCT01676363|diflunisal|diflunisal
5410314|NCT01676363|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
5410315|NCT01676363|antiviral agents|antiviral agents
5410316|NCT01676350|Intraosseous (IO) vascular access|intraosseous (io) vascular access
5410317|NCT01676337|Text messaging|text messaging
5410318|NCT01676337|Clinic appointment attendance|clinic appointment attendance
5410325|NCT01676311|transcranial magnetic stimulation|transcranial magnetic stimulation
5410326|NCT01676311|huperzine|huperzine
5410327|NCT01676311|chinese club moss|chinese club moss
5410328|NCT01676298|Cyp2C19|cyp2c19
5410329|NCT01676298|Genotyping|genotyping
5410330|NCT01676298|Spartan|spartan
5410331|NCT01676298|Reproducibility|reproducibility
5410332|NCT01676285|Cirrhosis|cirrhosis
5410333|NCT01676285|cirrhotic cardiomyopathy|cirrhotic cardiomyopathy
5410334|NCT01676285|cardiac remodeling|cardiac remodeling
5410335|NCT01676285|cardiomyopathy|cardiomyopathy
5410336|NCT01676285|metoprolol succinate|metoprolol succinate
5410337|NCT01676285|betablockers|betablockers
5410338|NCT01676259|siRNA|sirna
5410339|NCT01676259|RNA interference (RNAi)|rna interference (rnai)
5410340|NCT01676259|Cancer|cancer
5410341|NCT01676259|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5410342|NCT01676259|Locally Advanced Pancreatic cancer|locally advanced pancreatic cancer
5393218|NCT01752608|CBT|cbt
5410343|NCT01676259|Solid tumor|solid tumor
5410344|NCT01676259|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
5410345|NCT01676207|coronary collateral circulation|coronary collateral circulation
5410346|NCT01676207|extracardiac coronary collaterals|extracardiac coronary collaterals
5410347|NCT01676207|coronary artery disease|coronary artery disease
5410348|NCT01676207|coronary circulation|coronary circulation
5410349|NCT01676207|internal mammary artery|internal mammary artery
5410350|NCT01676194|Transarterial Chemoembolization|transarterial chemoembolization
5410351|NCT01676194|Liver transplantation|liver transplantation
5410352|NCT01676194|Hepatocellular carcinoma|hepatocellular carcinoma
5410353|NCT01676181|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5410354|NCT01676181|Children|children
5410355|NCT01676181|Polysomnography|polysomnography
5410356|NCT01676181|Surgery|surgery
5410357|NCT01676181|Coblation|coblation
5410358|NCT01676181|Tonsils|tonsils
5410359|NCT01676181|Tonsillectomy|tonsillectomy
5410360|NCT01676155|Tuberculosis, latent tuberculosis infection, apoptosis, predictor|tuberculosis, latent tuberculosis infection, apoptosis, predictor
5410361|NCT01676129|temporomandibular joint disorders|temporomandibular joint disorders
5410362|NCT01676129|nocipoint|nocipoint
5410363|NCT01676129|physical therapy|physical therapy
5410364|NCT01676103|Parkinson's Disease (PD)|parkinson's disease (pd)
5410365|NCT01676103|Orthostatic hypotension (OH)|orthostatic hypotension (oh)
5410366|NCT01676077|LGMD2B|lgmd2b
5410367|NCT01676077|Miyoshi Myopathy|miyoshi myopathy
5410368|NCT01676077|Dysferlin|dysferlin
5410369|NCT01676077|Dysferlinopathy|dysferlinopathy
5410370|NCT01676077|Limb Girdle muscular dystrophy type 2b|limb girdle muscular dystrophy type 2b
5410371|NCT01676077|Muscular Dystrophy|muscular dystrophy
5410372|NCT01676064|intraocular pressure|intraocular pressure
5410373|NCT01676064|perioperative fluid|perioperative fluid
5410374|NCT01676064|trendelenburg position|trendelenburg position
5410375|NCT01676064|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5410376|NCT01676038|Total Knee Replacement, Computer-Assisted Surgery|total knee replacement, computer-assisted surgery
5410377|NCT01676025|pheochromocytoma|pheochromocytoma
5410378|NCT01676025|aldosteronism|aldosteronism
5410379|NCT01676025|cushing's syndrome|cushing's syndrome
5410380|NCT01676025|adrenal incidentaloma|adrenal incidentaloma
5410381|NCT01676025|Conn's syndrome|conn's syndrome
5410382|NCT01675999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5410383|NCT01675999|Locally advanced malignant neoplasm|locally advanced malignant neoplasm
5410384|NCT01675999|colon cancer|colon cancer
5410385|NCT01675973|Ranolazine|ranolazine
5410386|NCT01675973|renal impairment|renal impairment
5410387|NCT01675960|chronic irritability|chronic irritability
5410388|NCT01675960|chronic pain|chronic pain
5410389|NCT01675960|Neurologically impaired|neurologically impaired
5410390|NCT01675960|gabapentin|gabapentin
5410391|NCT01675921|Asthma|asthma
5410392|NCT01675921|Facebook|facebook
5410393|NCT01675921|teenagers|teenagers
5410403|NCT01675882|Specific Immunotherapy|specific immunotherapy
5410404|NCT01675882|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5410405|NCT01675869|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5410406|NCT01675869|Executive function|executive function
5410407|NCT01675869|Preschooler|preschooler
5410408|NCT01675869|Metacognition|metacognition
5410409|NCT01675856|Glasgow-Blatchford score|glasgow-blatchford score
5410410|NCT01675856|Gastrointestinal bleeding|gastrointestinal bleeding
5410411|NCT01675843|Infertility|infertility
5410412|NCT01675843|PCOS|pcos
5410413|NCT01675843|IUI|iui
5410414|NCT01675817|heparin rebound|heparin rebound
5405502|NCT01697748|silver|silver
5410416|NCT01675817|cardiopulmonary bypass|cardiopulmonary bypass
5410417|NCT01675817|cardiac surgery|cardiac surgery
5410418|NCT01675817|anti-Xa|anti-xa
5410419|NCT01675817|anti-IIa|anti-iia
5410420|NCT01675804|ADHD|adhd
5410421|NCT01675778|hydromorphone|hydromorphone
5410422|NCT01675778|acute pain|acute pain
5410423|NCT01675778|emergency department|emergency department
5410424|NCT01675765|Cancer|cancer
5410425|NCT01675765|Cancer vaccine|cancer vaccine
5410426|NCT01675765|Listeria monocytogenes|listeria monocytogenes
5410427|NCT01675765|Listeria-based vaccines|listeria-based vaccines
5410428|NCT01675765|Pemetrexed|pemetrexed
5410429|NCT01675765|Cisplatin|cisplatin
5410430|NCT01675765|T regulatory cells|t regulatory cells
5410431|NCT01675765|Mesothelin|mesothelin
5410432|NCT01675765|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5410433|NCT01675765|Chemotherapy|chemotherapy
5410434|NCT01675765|Standard of care|standard of care
5410436|NCT01675765|Front-line|front-line
5410437|NCT01675765|Immunotherapy|immunotherapy
5410438|NCT01675765|MPM|mpm
5410439|NCT01675752|colonoscopy, narrow-band imaging|colonoscopy, narrow-band imaging
5410440|NCT01675739|colonoscopy|colonoscopy
5410441|NCT01675739|bowel preparation|bowel preparation
5410442|NCT01675739|short message service|short message service
5410443|NCT01675713|Lifestyle|lifestyle
5410444|NCT01675713|Physical activity|physical activity
5410445|NCT01675700|Myofascial pain|myofascial pain
5410446|NCT01675700|Trigger point|trigger point
5393341|NCT01752036|SRS|srs
5410447|NCT01675700|Nitroglycerin|nitroglycerin
5410448|NCT01675687|dietary habits and obesity|dietary habits and obesity
5410449|NCT01675687|exercise habits and obesity|exercise habits and obesity
5410450|NCT01675687|cognition and obesity|cognition and obesity
5410451|NCT01675674|Mucopolysaccharidoses|mucopolysaccharidoses
5410452|NCT01675674|Prevalence|prevalence
5410453|NCT01675674|Pediatric|pediatric
5410454|NCT01675674|Rheumatology|rheumatology
5410455|NCT01675674|Mucopolysaccharidosis I|mucopolysaccharidosis i
5410456|NCT01675674|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5410457|NCT01675674|Mucopolysaccharidosis IV|mucopolysaccharidosis iv
5410458|NCT01675674|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
5410459|NCT01675648|Opiate dependent|opiate dependent
5410460|NCT01675648|inpatient detoxification|inpatient detoxification
5410461|NCT01675622|Cancer Pain|cancer pain
5410462|NCT01675596|Aortic Stenosis|aortic stenosis
5410463|NCT01675596|Transfemoral|transfemoral
5410464|NCT01675596|Transcatheter Heart Valve|transcatheter heart valve
5410465|NCT01675583|Diabetic Wounds|diabetic wounds
5410466|NCT01675583|Hyperbaric Oxygen|hyperbaric oxygen
5410467|NCT01675583|Laser Speckle Imaging|laser speckle imaging
5410468|NCT01675583|Hyperbaric Oxygenation|hyperbaric oxygenation
5410469|NCT01675570|RX-10045|rx-10045
5410470|NCT01675570|Dry Eye Disease|dry eye disease
5410471|NCT01675557|chronic kidney disease|chronic kidney disease
5410472|NCT01675544|Heart failure|heart failure
5410473|NCT01675531|Targin|targin
5410474|NCT01675531|Chemotherapy Induced Peripheral Neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
5410475|NCT01675518|Plasma concentration|plasma concentration
5410476|NCT01675518|ASP7991|asp7991
5410477|NCT01675518|food effect|food effect
5410478|NCT01675518|PTH (parathyroid hormone)|pth (parathyroid hormone)
5410479|NCT01675492|Astigmatism|astigmatism
5410480|NCT01675492|refractive|refractive
5410482|NCT01675492|LASIK|lasik
5410483|NCT01675479|refractive|refractive
5410484|NCT01675479|errors|errors
5410485|NCT01675466|non-specific abdominal pain|non-specific abdominal pain
5413946|NCT01659762|Crohn's disease|crohn's disease
5410486|NCT01675466|undifferentiated abdominal pain|undifferentiated abdominal pain
5410487|NCT01675466|appendicitis|appendicitis
5410488|NCT01675466|appendicectomy|appendicectomy
5410489|NCT01675466|appendectomy|appendectomy
5410490|NCT01675466|surgery|surgery
5410491|NCT01675466|laparoscopy|laparoscopy
5410492|NCT01675466|antibiotics|antibiotics
5410493|NCT01675466|randomised controlled trial|randomised controlled trial
5410494|NCT01675466|randomized controlled trial|randomized controlled trial
5410495|NCT01675466|controlled clinical trial|controlled clinical trial
5410496|NCT01675466|randomised|randomised
5410497|NCT01675466|placebo|placebo
5410498|NCT01675453|Organ dysfunction|organ dysfunction
5410499|NCT01675453|Hypertonic solution|hypertonic solution
5410500|NCT01675453|Extravascular water|extravascular water
5410501|NCT01675453|Cardiopulmonary Bypass|cardiopulmonary bypass
5410502|NCT01675414|ASD|asd
5410503|NCT01675414|autism|autism
5410504|NCT01675414|gastrointestinal|gastrointestinal
5410505|NCT01675414|gastrointestinal conditions in children with ASD|gastrointestinal conditions in children with asd
5410506|NCT01675401|Body Weight|body weight
5410507|NCT01675401|Obesity|obesity
5410508|NCT01675401|Weight Loss|weight loss
5410509|NCT01675401|Vascular Function Markers|vascular function markers
5410510|NCT01675388|Neonatal hypoxemic respiratory failure|neonatal hypoxemic respiratory failure
5410511|NCT01675388|Extra Corporeal Membrane Oxygenation|extra corporeal membrane oxygenation
5410512|NCT01675388|Neurodevelopmental outcomes|neurodevelopmental outcomes
5410513|NCT01675388|Neuroimaging|neuroimaging
5410514|NCT01675362|Extracorporeal shockwave lithotripsy (ESWL)|extracorporeal shockwave lithotripsy (eswl)
5410515|NCT01675362|Kidney calculi|kidney calculi
5410516|NCT01675362|Renal protection|renal protection
5410517|NCT01675362|Antioxidants|antioxidants
5410518|NCT01675362|Calcium channel blockers|calcium channel blockers
5410519|NCT01675362|Angiotensin receptor blockers|angiotensin receptor blockers
5410520|NCT01675349|Standardization|standardization
5410521|NCT01675349|Immunotherapy|immunotherapy
5410522|NCT01675349|Skin prick test|skin prick test
5410523|NCT01675323|Restless Legs Syndrome|restless legs syndrome
5410524|NCT01675323|RLS|rls
5410525|NCT01675310|obesity, polycystic ovary syndrome, gestational diabetes|obesity, polycystic ovary syndrome, gestational diabetes
5410733|NCT01674465|Kidney fibrosis|kidney fibrosis
5410526|NCT01675297|Risedronate, cholecalciferol, BMD|risedronate, cholecalciferol, bmd
5410527|NCT01675284|Avian Influenza|avian influenza
5410528|NCT01675284|Influenza A Virus Subtype H5N1|influenza a virus subtype h5n1
5410529|NCT01675284|Inactivated H5N1 Influenza Virion Vaccine|inactivated h5n1 influenza virion vaccine
5410530|NCT01675284|Phase I|phase i
5410531|NCT01675284|Preventive H5N1 vaccination|preventive h5n1 vaccination
5410532|NCT01675271|gestational diabetes|gestational diabetes
5410533|NCT01675271|inflammation|inflammation
5410534|NCT01675271|autonomic nervous system|autonomic nervous system
5410535|NCT01675245|Multiple Myeloma|multiple myeloma
5410536|NCT01675245|Cancer|cancer
5410537|NCT01675245|Velcade|velcade
5410538|NCT01675245|Bortezomib|bortezomib
5410539|NCT01675245|Chinese patients|chinese patients
5410540|NCT01675232|Atopic dermatitis|atopic dermatitis
5410541|NCT01675232|Topical corticosteroid|topical corticosteroid
5410542|NCT01675232|Pediatric|pediatric
5410543|NCT01675232|Eczema|eczema
5410544|NCT01675219|bladder cancer|bladder cancer
5410545|NCT01675219|recurrence|recurrence
5410546|NCT01675219|photodynamic diagnosis|photodynamic diagnosis
5410547|NCT01675219|PDD|pdd
5410548|NCT01675219|cost analysis|cost analysis
5410549|NCT01675206|Vascular calcification|vascular calcification
5410550|NCT01675206|Hemodialysis|hemodialysis
5410551|NCT01675206|Matrix Gla Protein|matrix gla protein
5410552|NCT01675206|Vitamin K2|vitamin k2
5410553|NCT01675193|Amblyopia|amblyopia
5410554|NCT01675193|Vision-Screening|vision-screening
5410555|NCT01675180|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress|pregnancy, oral health, attitude, awareness, streptococcus mutans, lactobacilli, oxidative stress
5410556|NCT01675167|CLBP|clbp
5410557|NCT01675167|Chronic Low Back Pain|chronic low back pain
5410558|NCT01675167|Chronic Pain|chronic pain
5410559|NCT01675167|Back Pain|back pain
5410560|NCT01675154|hypertriglyceridemia|hypertriglyceridemia
5410561|NCT01675141|NK Cell Function|nk cell function
5410562|NCT01675141|Immunomodulatory Drugs|immunomodulatory drugs
5410563|NCT01675141|T Cell Activity|t cell activity
5410564|NCT01675141|Immune Stimulatory Effects|immune stimulatory effects
5410565|NCT01675141|Extended Dosing|extended dosing
5410566|NCT01675128|Human Eukaryotic Translation Initiation Factor 4E (eIF4E) protein|human eukaryotic translation initiation factor 4e (eif4e) protein
5410567|NCT01675128|Refractory|refractory
5410568|NCT01675128|Oncogene|oncogene
5410569|NCT01675128|Maximum Tolerated Dose|maximum tolerated dose
5410570|NCT01675128|Safety|safety
5002957|NCT03977571|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
5410571|NCT01675115|Ischemic stroke|ischemic stroke
5410572|NCT01675115|Traditional Chinese Medication|traditional chinese medication
5410573|NCT01675115|Aspirin|aspirin
5410574|NCT01675102|del 17p|del 17p
5410575|NCT01675102|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5410577|NCT01675102|mutation|mutation
5410578|NCT01675102|p53|p53
5410579|NCT01675089|bone disease|bone disease
5410580|NCT01675089|kidney transplantation|kidney transplantation
5410581|NCT01675089|bisphosphonates|bisphosphonates
5410582|NCT01675076|Hematoma|hematoma
5410583|NCT01675076|novel oral anti-coagulant (NOAC)|novel oral anti-coagulant (noac)
5410584|NCT01675076|Device surgery|device surgery
5410585|NCT01675037|hypothalamic|hypothalamic
5410586|NCT01675037|pituitary,|pituitary,
5410587|NCT01675037|endoscopic third ventriculostomy|endoscopic third ventriculostomy
5410588|NCT01675037|hydrocephalus|hydrocephalus
5410589|NCT01675024|Neupro, Pharmacokinetics, healthy Chinese subjects|neupro, pharmacokinetics, healthy chinese subjects
5410590|NCT01674998|REM Sleep Behavior Disorder|rem sleep behavior disorder
5410591|NCT01674998|RBD|rbd
5410592|NCT01674998|Dream|dream
5410593|NCT01674998|Dreams|dreams
5410594|NCT01674985|Decitabine|decitabine
5410595|NCT01674985|microtransplantation|microtransplantation
5410596|NCT01674985|myelodysplastic syndromes|myelodysplastic syndromes
5410597|NCT01674985|chemotherapy|chemotherapy
5410598|NCT01674972|NAFLD|nafld
5410599|NCT01674972|NASH|nash
5410600|NCT01674972|GLP-1|glp-1
5410601|NCT01674959|gastric cancer|gastric cancer
5410602|NCT01674959|radiation|radiation
5410603|NCT01674959|chemotherapy|chemotherapy
5410604|NCT01674946|GI-physiology|gi-physiology
5410605|NCT01674946|CDCA|cdca
5410606|NCT01674946|bile acids|bile acids
5410607|NCT01674946|TGR5|tgr5
5410608|NCT01674946|satiation peptides|satiation peptides
5410609|NCT01674933|dental|dental
5410610|NCT01674933|prevention|prevention
5410611|NCT01674933|caries|caries
5410613|NCT01674933|children|children
5410614|NCT01674920|Pediatric obesity|pediatric obesity
5410615|NCT01674920|resiliency|resiliency
5410616|NCT01674920|physical activity|physical activity
5410617|NCT01674920|dietary patterns|dietary patterns
5410618|NCT01674920|children|children
5410619|NCT01674881|Mindfulness|mindfulness
5410620|NCT01674881|breast cancer|breast cancer
5410621|NCT01674881|chronic pain|chronic pain
5410622|NCT01674881|mediators|mediators
5410623|NCT01674881|distress|distress
5410624|NCT01674881|Breast cancer survivors|breast cancer survivors
5410625|NCT01674881|Effectiveness of MBCT on chronic pain|effectiveness of mbct on chronic pain
5411337|NCT01671956|Colitis|colitis
5410635|NCT01674842|Triple negative|triple negative
5410636|NCT01674842|Stage II|stage ii
5410637|NCT01674842|Stage III|stage iii
5410647|NCT01674777|ASP1941|asp1941
5410648|NCT01674777|Food effect|food effect
5410649|NCT01674777|Pharmacokinetics|pharmacokinetics
5410650|NCT01674751|pre-ordering|pre-ordering
5410651|NCT01674751|healthy eating|healthy eating
5410652|NCT01674751|mindfulness|mindfulness
5410653|NCT01674751|incentives|incentives
5410654|NCT01674751|employees|employees
5410655|NCT01674738|Non Small Cell Lung Cancer|non small cell lung cancer
5410656|NCT01674738|NSCLC Stage IV|nsclc stage iv
5410657|NCT01674738|Non-Squamous Advanced Non-Small-Cell Lung-Cancer (Stage IV)|non-squamous advanced non-small-cell lung-cancer (stage iv)
5410658|NCT01674725|Hepatitis C virus|hepatitis c virus
5410659|NCT01674725|Hepatitis C Genotype 1|hepatitis c genotype 1
5410660|NCT01674725|Hepatitis C|hepatitis c
5410661|NCT01674725|Interferon-Free|interferon-free
5410662|NCT01674725|Chronic Hepatitis C|chronic hepatitis c
5410663|NCT01674725|Ombitasvir|ombitasvir
5410664|NCT01674725|Ribavirin|ribavirin
5410665|NCT01674725|Viekira PAK|viekira pak
5410666|NCT01674725|Dasabuvir|dasabuvir
5410667|NCT01674725|Paritaprevir|paritaprevir
5410668|NCT01674712|Fibrates|fibrates
5410669|NCT01674712|Dyslipidemia|dyslipidemia
5410670|NCT01674686|Vasospasm|vasospasm
5410671|NCT01674686|Sarpogrelate|sarpogrelate
5410672|NCT01674686|Statin|statin
5410673|NCT01674673|panic disorder|panic disorder
5410674|NCT01674673|SSRIs pharmacotherapy|ssris pharmacotherapy
5410675|NCT01674673|Cognitive Behavioral therapy|cognitive behavioral therapy
5410676|NCT01674660|hemodialysis|hemodialysis
5410677|NCT01674660|blood pressure variability|blood pressure variability
5410678|NCT01674660|volume status|volume status
5410679|NCT01674647|rivaroxaban|rivaroxaban
5410680|NCT01674647|oral anticoagulant|oral anticoagulant
5410681|NCT01674647|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5410682|NCT01674647|cardioversion|cardioversion
5410683|NCT01674647|stroke|stroke
5410684|NCT01674647|transient ischemic attack|transient ischemic attack
5410685|NCT01674647|thromboembolism|thromboembolism
5410686|NCT01674647|cardiovascular event|cardiovascular event
5410687|NCT01674634|XIAFLEX|xiaflex
5410688|NCT01674634|XIAPEX|xiapex
5410689|NCT01674634|Dupuytren's disease|dupuytren's disease
5410690|NCT01674634|contracture|contracture
5410691|NCT01674621|BA058|ba058
5410692|NCT01674621|Abaloparatide-SC|abaloparatide-sc
5410693|NCT01674621|abaloparatide|abaloparatide
5410694|NCT01674621|Abaloparatide-TD|abaloparatide-td
5410695|NCT01674621|Osteo|osteo
5410696|NCT01674621|Osteoporosis|osteoporosis
5410697|NCT01674621|Transdermal|transdermal
5410698|NCT01674621|Patch|patch
5410699|NCT01674608|intensive care|intensive care
5410700|NCT01674608|mobilization|mobilization
5410701|NCT01674608|rehabilitation|rehabilitation
5410702|NCT01674608|critical care|critical care
5410703|NCT01674595|Olea sensitization|olea sensitization
5410705|NCT01674582|Brain tumors|brain tumors
5410706|NCT01674582|Brain metastases|brain metastases
5410708|NCT01674582|Cognitive measurement|cognitive measurement
5410709|NCT01674582|Neuropsychological evaluation|neuropsychological evaluation
5410710|NCT01674582|DW-MRI|dw-mri
5410711|NCT01674582|P-MRI|p-mri
5410712|NCT01674582|MRS|mrs
5410713|NCT01674569|VEGF|vegf
5410714|NCT01674569|PDGF|pdgf
5410715|NCT01674569|AMD|amd
5410716|NCT01674556|pancreatic|pancreatic
5410717|NCT01674556|cancer|cancer
5410718|NCT01674556|adenocarcinoma|adenocarcinoma
5410719|NCT01674556|Ultrasound|ultrasound
5410720|NCT01674556|CEUS|ceus
5410721|NCT01674543|Physical exercise|physical exercise
5410722|NCT01674543|Schizophrenia|schizophrenia
5410723|NCT01674543|symptoms|symptoms
5410724|NCT01674543|IGF-1|igf-1
5410725|NCT01674517|Bioequivalence|bioequivalence
5410726|NCT01674517|Montelukast Sodium|montelukast sodium
5410727|NCT01674517|crossover|crossover
5410728|NCT01674504|Bioequivalence|bioequivalence
5410729|NCT01674504|Montelukast Sodium|montelukast sodium
5410730|NCT01674504|crossover|crossover
5410731|NCT01674478|NEC, SBS, enterostomy, fish oil, Microlipid, Intralipid,|nec, sbs, enterostomy, fish oil, microlipid, intralipid,
5410734|NCT01674465|Kidney hypoxia|kidney hypoxia
5410735|NCT01674465|Calcineurin inhibitors|calcineurin inhibitors
5410737|NCT01674452|Exercise and Physical Fitness|exercise and physical fitness
5405798|NCT01696123|MLC601|mlc601
5410738|NCT01674439|Adipose-derived regenerative cells|adipose-derived regenerative cells
5410739|NCT01674439|Cell therapy|cell therapy
5410740|NCT01674439|Autologous fat transfer|autologous fat transfer
5410741|NCT01674439|Tissue engineering|tissue engineering
5410742|NCT01674439|Craniofacial microsomia|craniofacial microsomia
5410743|NCT01674426|functional hypothalamic amenorrhea|functional hypothalamic amenorrhea
5410744|NCT01674426|stress induced anovulation|stress induced anovulation
5410745|NCT01674413|Crohn's Disease|crohn's disease
5410747|NCT01674413|Crohns|crohns
5410748|NCT01674413|Inflammatory Bowel Disease|inflammatory bowel disease
5410749|NCT01674413|IBD|ibd
5396164|NCT01739244|IOP|iop
5410750|NCT01674413|Humira|humira
5410751|NCT01674413|Adalimumab|adalimumab
5410752|NCT01674413|Adalimumab injection|adalimumab injection
5410753|NCT01674413|Higgins|higgins
5410754|NCT01674413|Calprotectin|calprotectin
5410755|NCT01674413|biomarkers|biomarkers
5410756|NCT01674413|Gastroenterology|gastroenterology
5410757|NCT01674413|University of Michigan|university of michigan
5410758|NCT01674413|U of M|u of m
5410759|NCT01674387|electroacupuncture therapy|electroacupuncture therapy
5410760|NCT01674387|neck pain|neck pain
5410761|NCT01674387|McGill Pain Questionnaire|mcgill pain questionnaire
5410762|NCT01674387|Acupuncture Therapy|acupuncture therapy
5410763|NCT01674387|Electroacupuncture|electroacupuncture
5410764|NCT01674387|Meridians|meridians
5410765|NCT01674348|Diabetes Mellitus|diabetes mellitus
5410766|NCT01674335|Fibromyalgia|fibromyalgia
5410767|NCT01674335|Chronic pain|chronic pain
5410768|NCT01674335|Chronic fatigue|chronic fatigue
5410769|NCT01674335|Activity pacing|activity pacing
5410770|NCT01674335|Operant learning|operant learning
5410771|NCT01674335|Energy conservation|energy conservation
5410772|NCT01674335|Treatment|treatment
5410773|NCT01674335|Intervention|intervention
5410774|NCT01674335|Biopsychosocial factors|biopsychosocial factors
5410775|NCT01674335|Coping|coping
5410776|NCT01674335|Mood|mood
5410777|NCT01674335|Quality of life|quality of life
5410778|NCT01674322|Healthy participants|healthy participants
5410779|NCT01674322|Ibrutinib|ibrutinib
5410780|NCT01674322|PCI-32765|pci-32765
5410781|NCT01674322|B-cell malignancies|b-cell malignancies
5410782|NCT01674322|CYP3A4|cyp3a4
5410783|NCT01674296|Body Weight/physiology*|body weight/physiology*
5410784|NCT01674296|Diet*/statistics & numerical data|diet*/statistics & numerical data
5410785|NCT01674296|Diet*/trends|diet*/trends
5410786|NCT01674296|Exercise/physiology*|exercise/physiology*
5410787|NCT01674296|Female|female
5410788|NCT01674296|Humans|humans
5410789|NCT01674296|Longitudinal Studies|longitudinal studies
5410790|NCT01674296|Middle Aged|middle aged
5410791|NCT01674296|Obesity/epidemiology*|obesity/epidemiology*
5410792|NCT01674296|Seasons*|seasons*
5410793|NCT01674296|Time Factors|time factors
5410794|NCT01674257|Atherosclerosis|atherosclerosis
5410795|NCT01674257|Stroke|stroke
5410796|NCT01674257|Positron-emission tomography|positron-emission tomography
5410797|NCT01674257|Ferumoxytol|ferumoxytol
5002958|NCT03977571|Nephrectomy|nephrectomy
5410798|NCT01674257|Magnetic resonance imaging|magnetic resonance imaging
5410799|NCT01674257|Genetics|genetics
5410800|NCT01674257|Calcification|calcification
5410801|NCT01674257|Inflammation|inflammation
5410802|NCT01674257|Flurodeoxyglucose F18|flurodeoxyglucose f18
5410803|NCT01674257|Radiopharmaceuticals|radiopharmaceuticals
5671212|NCT00616668|Transtibial amputees due to vascular diseases.|transtibial amputees due to vascular diseases.
5410804|NCT01674218|tuberculosis, safety, PA-824, QTc interval, moxifloxacin, healthy volunteers, crossover|tuberculosis, safety, pa-824, qtc interval, moxifloxacin, healthy volunteers, crossover
5410805|NCT01674179|Fibromyalgia|fibromyalgia
5410807|NCT01674179|Sleep|sleep
5410808|NCT01674179|Pain|pain
5410809|NCT01674153|Intra-dialytic exercise|intra-dialytic exercise
5410810|NCT01674153|Toxin removal|toxin removal
5410811|NCT01674153|Hemodiafiltration|hemodiafiltration
5410812|NCT01674153|Inter-compartmental resistance|inter-compartmental resistance
5410813|NCT01674153|Cardiac output|cardiac output
5410814|NCT01674140|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5410815|NCT01674140|HER2-negative breast cancer|her2-negative breast cancer
5410816|NCT01674140|stage IA breast cancer|stage ia breast cancer
5410817|NCT01674140|stage IB breast cancer|stage ib breast cancer
5410818|NCT01674140|stage II breast cancer|stage ii breast cancer
5410819|NCT01674140|stage IIIA breast cancer|stage iiia breast cancer
5410820|NCT01674140|stage IIIB breast cancer|stage iiib breast cancer
5410821|NCT01674140|stage IIIC breast cancer|stage iiic breast cancer
5410822|NCT01674140|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5410823|NCT01674140|male breast cancer|male breast cancer
5410824|NCT01674114|Cesarean Section|cesarean section
5410825|NCT01674114|Anesthetics, Local|anesthetics, local
5410826|NCT01674101|Lower extremity malignancy|lower extremity malignancy
5410827|NCT01674088|Irritable Bowel Syndrome|irritable bowel syndrome
5410828|NCT01674088|breath testing|breath testing
5410829|NCT01674088|carbon-13|carbon-13
5410830|NCT01674075|safety|safety
5410831|NCT01674075|J-Tip Delivery System|j-tip delivery system
5410832|NCT01674075|pharmacokinetic profile|pharmacokinetic profile
5410834|NCT01674049|nutrient|nutrient
5410835|NCT01674049|timing|timing
5410836|NCT01674049|diabetes|diabetes
5410837|NCT01674049|family history|family history
5410838|NCT01674049|dairy|dairy
5410839|NCT01673971|hemangioma|hemangioma
5410840|NCT01673958|Eccentric exercise|eccentric exercise
5410841|NCT01673958|Aging|aging
5410842|NCT01673958|Heart failure|heart failure
5410843|NCT01673958|Muscle strength loss|muscle strength loss
5410844|NCT01673958|Sarcopenia|sarcopenia
5410845|NCT01673945|EUS-FNA, Forward viewing EUS scope, Curvilinear EUS scope|eus-fna, forward viewing eus scope, curvilinear eus scope
5410846|NCT01673932|stroke|stroke
5410847|NCT01673932|chronic stroke|chronic stroke
5410848|NCT01673932|ischemic stroke|ischemic stroke
5410849|NCT01673932|umbilical cord blood|umbilical cord blood
5410850|NCT01673932|mononuclear cell|mononuclear cell
5410851|NCT01673932|transplant|transplant
5410852|NCT01673906|positron-emission tomography|positron-emission tomography
5410853|NCT01673906|neuroendocrine tumors|neuroendocrine tumors
5410854|NCT01673906|endosonography|endosonography
5410855|NCT01673906|tomography, X-ray computed|tomography, x-ray computed
5410856|NCT01673906|biopsy, fine needle|biopsy, fine needle
5410857|NCT01673906|sensitivity and sensibility|sensitivity and sensibility
5410858|NCT01673893|ClearWay|clearway
5410859|NCT01673893|Glycoprotein|glycoprotein
5410860|NCT01673893|Primary Coronary Intervention|primary coronary intervention
5410861|NCT01673893|Abciximab|abciximab
5410862|NCT01673893|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5410863|NCT01673893|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
5410864|NCT01673893|Medicare|medicare
5410865|NCT01673893|Medicaid|medicaid
5410866|NCT01673893|Registry|registry
5410867|NCT01673893|catheterization|catheterization
5410868|NCT01673893|readmission|readmission
5410869|NCT01673893|Acute Coronary Syndrome|acute coronary syndrome
5410870|NCT01673893|ClearwayRx Catheter|clearwayrx catheter
5410871|NCT01673841|bypass grafting|bypass grafting
5410872|NCT01673828|Brain Injuries|brain injuries
5410873|NCT01673828|Pregnanolone|pregnanolone
5410874|NCT01673828|Epilepsy|epilepsy
5410875|NCT01673815|optic disk|optic disk
5410876|NCT01673815|fundoscopy|fundoscopy
5410877|NCT01673815|pediatric|pediatric
5410878|NCT01673815|clinical examination|clinical examination
5410879|NCT01673802|Cholangiocarcinoma|cholangiocarcinoma
5410880|NCT01673789|Stem Cell Educator|stem cell educator
5410881|NCT01673789|Cord blood stem cells|cord blood stem cells
5410882|NCT01673789|Immune modulation|immune modulation
5410883|NCT01673789|Alopecia Areata|alopecia areata
5410884|NCT01673776|Proximal femoral fracture|proximal femoral fracture
5410885|NCT01673776|multimodal intervention|multimodal intervention
5410886|NCT01673776|goal directed therapy (GDT)|goal directed therapy (gdt)
5410887|NCT01673776|hemodynamic intervention|hemodynamic intervention
5410888|NCT01673776|outcome|outcome
5410889|NCT01673763|ERCP|ercp
5410890|NCT01673763|endoscopy|endoscopy
5410891|NCT01673763|pancreatitis|pancreatitis
5410892|NCT01673750|Adolescents|adolescents
5410893|NCT01673750|Body Image|body image
5410895|NCT01673698|weight loss|weight loss
5410896|NCT01673685|COPD|copd
5410897|NCT01673685|Oxygen cylinder|oxygen cylinder
5410898|NCT01673685|Portable oxygen cylinder|portable oxygen cylinder
5410899|NCT01673685|Battery powered delivery device|battery powered delivery device
5410900|NCT01673685|mobility|mobility
5410901|NCT01673685|dyspnoea|dyspnoea
5410902|NCT01673685|Quality of Life|quality of life
5410903|NCT01673685|Cost effectiveness|cost effectiveness
5410905|NCT01673646|Pasireotide|pasireotide
5410906|NCT01673646|acromegaly|acromegaly
5410907|NCT01673646|Phase II|phase ii
5410908|NCT01673646|growth disorder|growth disorder
5410909|NCT01673646|gigantism|gigantism
5410910|NCT01673646|Pituitary adenoma|pituitary adenoma
5410911|NCT01673646|pituitary gigantism|pituitary gigantism
5410912|NCT01673594|ADHD|adhd
5410913|NCT01673594|Naltrexone|naltrexone
5410914|NCT01673594|SODAS MPH|sodas mph
5410915|NCT01673594|Stimulant-Induced Euphoria|stimulant-induced euphoria
5410916|NCT01673594|Substance Abuse|substance abuse
5410917|NCT01673594|Adults|adults
5410918|NCT01673581|Low Risk|low risk
5410919|NCT01673555|GSK1278863|gsk1278863
5410920|NCT01673555|Pulmonary artery pressure|pulmonary artery pressure
5410921|NCT01673529|Pruritus|pruritus
5410922|NCT01673529|TRPV1|trpv1
5410923|NCT01673529|Cowhage|cowhage
5410924|NCT01673529|Atopic Dermatitis|atopic dermatitis
5410925|NCT01673529|Capsaicin|capsaicin
5410926|NCT01673529|Itch|itch
5410927|NCT01673529|Histamine|histamine
5410928|NCT01673529|healthy volunteers|healthy volunteers
5410929|NCT01673529|SB705498|sb705498
5410930|NCT01673529|Clinical|clinical
5410931|NCT01673516|Renal sympathetic denervation|renal sympathetic denervation
5410932|NCT01673516|Impedance cardiography|impedance cardiography
5410933|NCT01673503|Myopia|myopia
5410934|NCT01673503|refractive surgery|refractive surgery
5410935|NCT01673503|all femtosecond laser|all femtosecond laser
5410936|NCT01673503|ReLEx flex|relex flex
5410937|NCT01673503|ReLEx smile|relex smile
5410938|NCT01673490|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5410939|NCT01673490|dutasteride and tamsulosin|dutasteride and tamsulosin
5410940|NCT01673464|mild Traumatic Brain Injury|mild traumatic brain injury
5410941|NCT01673464|mTBI|mtbi
5410942|NCT01673464|Concussion|concussion
5410943|NCT01673451|insomnia|insomnia
5410944|NCT01673438|solid tumor|solid tumor
5410945|NCT01673438|aldoxorubicin|aldoxorubicin
5410946|NCT01673438|phase 1|phase 1
5410947|NCT01673438|INNO-206|inno-206
5410948|NCT01673438|doxorubicin|doxorubicin
5410949|NCT01673425|Influenza|influenza
5410950|NCT01673425|Influenza Vaccines|influenza vaccines
5410951|NCT01673425|Vaccines, Attenuated|vaccines, attenuated
5410952|NCT01673425|Immunity, Mucosal|immunity, mucosal
5410953|NCT01673412|venous leg ulcer healing prognostic factors|venous leg ulcer healing prognostic factors
5410954|NCT01673399|repeated implantation failure (RIF)|repeated implantation failure (rif)
5410955|NCT01673399|atosiban|atosiban
5410956|NCT01673399|pregnancy|pregnancy
5410957|NCT01673386|Tivozanib hydrochloride|tivozanib hydrochloride
5410958|NCT01673386|renal cell carcinoma|renal cell carcinoma
5410959|NCT01673386|subject preference|subject preference
5410960|NCT01673386|quality of life|quality of life
5410961|NCT01673373|Renal Artery Stenosis|renal artery stenosis
5410962|NCT01673373|Renal Artery Obstruction|renal artery obstruction
5410963|NCT01673373|Renovascular Hypertension|renovascular hypertension
5410964|NCT01673373|Resistant Hypertension|resistant hypertension
5410965|NCT01673373|Renal Revascularization|renal revascularization
5410966|NCT01673373|Atherosclerotic Renal Artery Stenosis|atherosclerotic renal artery stenosis
5410967|NCT01673373|Atherosclerotic Renal Artery Stenosis (ARAS)|atherosclerotic renal artery stenosis (aras)
5410968|NCT01673373|Renal Artery Stenosis (RAS)|renal artery stenosis (ras)
5410969|NCT01673373|Uncontrolled hypertension|uncontrolled hypertension
5410970|NCT01673373|Hypertension|hypertension
5410971|NCT01673373|Systolic blood pressure|systolic blood pressure
5410972|NCT01673373|Blood pressure|blood pressure
5410973|NCT01673360|vaginal repair|vaginal repair
5410974|NCT01673360|urinary slings|urinary slings
5410976|NCT01673360|SUI|sui
5410977|NCT01673360|prolapse|prolapse
5410978|NCT01673360|incontinence|incontinence
5410979|NCT01673347|allograft|allograft
5410980|NCT01673347|great toe|great toe
5410981|NCT01673334|Pancreas Tumor EUS FNA Core Biopsy Procore FNB|pancreas tumor eus fna core biopsy procore fnb
5410982|NCT01673321|Yogurt|yogurt
5410983|NCT01673321|Milk|milk
5410984|NCT01673321|Protein|protein
5410985|NCT01673321|Food intake|food intake
5410986|NCT01673321|Appetite|appetite
5410987|NCT01673321|Glucose|glucose
5410988|NCT01673321|Insulin|insulin
5410989|NCT01673295|Lupus Nephritis|lupus nephritis
5410990|NCT01673295|Rituximab|rituximab
5410991|NCT01673282|Lacosamide|lacosamide
5410992|NCT01673282|Vimpat|vimpat
5410993|NCT01673282|Focal Epilepsy|focal epilepsy
5002959|NCT03977571|Ipilimumab|ipilimumab
5410994|NCT01673282|Drug Load|drug load
5410995|NCT01673282|AED|aed
5410996|NCT01673282|SP1065|sp1065
5410997|NCT01673269|ERCP|ercp
5410998|NCT01673269|Direct cholangioscopic examination of the common bile duct|direct cholangioscopic examination of the common bile duct
5410999|NCT01673269|Choledocholithiasis|choledocholithiasis
5411000|NCT01673269|Cholangiocarcinoma|cholangiocarcinoma
5411001|NCT01673269|Benign stricture of common bile duct|benign stricture of common bile duct
5411002|NCT01673243|Smoking cessation|smoking cessation
5411003|NCT01673243|Household smoking bans|household smoking bans
5411005|NCT01673243|Sickle cell disease|sickle cell disease
5411006|NCT01673204|surrogate marker,|surrogate marker,
5411007|NCT01673204|circulating soluble TNF receptor,|circulating soluble tnf receptor,
5411008|NCT01673204|diabetic nephropathy|diabetic nephropathy
5411009|NCT01673178|Type 2 diabetes|type 2 diabetes
5411017|NCT01673152|Prebiotic|prebiotic
5411018|NCT01673139|Atrial fibrillation|atrial fibrillation
5411019|NCT01673139|Exercise|exercise
5411020|NCT01673126|vegetative state|vegetative state
5411021|NCT01673126|minimally conscious state|minimally conscious state
5411022|NCT01673126|disorders of consciousness|disorders of consciousness
5411023|NCT01673126|transcranial direct current stimulation|transcranial direct current stimulation
5411024|NCT01673113|cryolipolysis, sensory nerve function, Zeltiq|cryolipolysis, sensory nerve function, zeltiq
5411025|NCT01673100|physical activity|physical activity
5411026|NCT01673100|percutaneous coronary intervention|percutaneous coronary intervention
5411027|NCT01673100|heart disease|heart disease
5411028|NCT01673087|stress biology|stress biology
5411029|NCT01673087|cortisol|cortisol
5411030|NCT01673087|adrenocorticotropin|adrenocorticotropin
5411031|NCT01673087|salivary biomarkers|salivary biomarkers
5411032|NCT01673061|Abscess|abscess
5411033|NCT01673061|Boils|boils
5412163|NCT01668316|Obesity|obesity
5411034|NCT01673061|Anesthetics, Local|anesthetics, local
5411035|NCT01673061|Lidocaine|lidocaine
5411036|NCT01673061|Vapocoolant|vapocoolant
5411037|NCT01673061|1,1,1,3,3-Pentafluoropropane|1,1,1,3,3-pentafluoropropane
5411038|NCT01673061|1,1,1,2-Tetrafluoroethane|1,1,1,2-tetrafluoroethane
5411039|NCT01673048|Elastic stable intramedullary nailing|elastic stable intramedullary nailing
5411040|NCT01673048|biomechanical testing|biomechanical testing
5411041|NCT01673048|fracture|fracture
5411045|NCT01673048|adolescents|adolescents
5411046|NCT01673009|Gleevec|gleevec
5411047|NCT01672996|Use in Abdominal|use in abdominal
5411048|NCT01672996|Contrast Enhanced|contrast enhanced
5411049|NCT01672996|Computed Tomography|computed tomography
5411050|NCT01672996|Optimize concentration|optimize concentration
5411051|NCT01672996|dosage of Ioforminol Injection|dosage of ioforminol injection
5411052|NCT01672983|Japanese|japanese
5411053|NCT01672983|Hepatitis C|hepatitis c
5411054|NCT01672983|Genotype 2|genotype 2
5411055|NCT01672983|Genotype 1b|genotype 1b
5411056|NCT01672983|paritaprevir|paritaprevir
5411057|NCT01672983|ombitasvir|ombitasvir
5411058|NCT01672983|ritonavir|ritonavir
5411059|NCT01672983|VIEKIRAX Combination Tablets|viekirax combination tablets
5411060|NCT01672944|Biological specimen banks|biological specimen banks
5411061|NCT01672944|Health education|health education
5411062|NCT01672944|Tissue banks|tissue banks
5411063|NCT01672944|Health care survey|health care survey
5411064|NCT01672944|Tissue|tissue
5411065|NCT01672918|PET/CT|pet/ct
5411066|NCT01672918|Lymphoma|lymphoma
5411067|NCT01672918|Lymphadenopathy|lymphadenopathy
5411068|NCT01672918|ALPS|alps
5411069|NCT01672905|recurrent prostate cancer|recurrent prostate cancer
5411070|NCT01672905|stage I prostate cancer|stage i prostate cancer
5411071|NCT01672905|stage IIA prostate cancer|stage iia prostate cancer
5411072|NCT01672905|stage IIB prostate cancer|stage iib prostate cancer
5411073|NCT01672905|stage III prostate cancer|stage iii prostate cancer
5411074|NCT01672892|gastrointestinal complications|gastrointestinal complications
5411075|NCT01672892|perioperative/postoperative complications|perioperative/postoperative complications
5411076|NCT01672892|radiation toxicity|radiation toxicity
5411077|NCT01672892|urinary complications|urinary complications
5411078|NCT01672892|urinary tract toxicity|urinary tract toxicity
5411079|NCT01672892|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5411080|NCT01672892|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5411081|NCT01672892|stage IA endometrial carcinoma|stage ia endometrial carcinoma
5411082|NCT01672892|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5411083|NCT01672892|stage II endometrial carcinoma|stage ii endometrial carcinoma
5411084|NCT01672892|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5411085|NCT01672892|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5411086|NCT01672892|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5411087|NCT01672892|endometrial adenocarcinoma|endometrial adenocarcinoma
5411088|NCT01672892|cervical adenocarcinoma|cervical adenocarcinoma
5411089|NCT01672892|stage IB cervical cancer|stage ib cervical cancer
5411090|NCT01672892|stage IIA cervical cancer|stage iia cervical cancer
5411091|NCT01672892|stage IIB cervical cancer|stage iib cervical cancer
5411092|NCT01672879|NASH|nash
5411093|NCT01672879|cirrhosis|cirrhosis
5411094|NCT01672879|Compensated Liver disease|compensated liver disease
5411095|NCT01672879|Monoclonal antibody|monoclonal antibody
5411096|NCT01672879|LOXL2|loxl2
5411097|NCT01672879|Simtuzumab|simtuzumab
5414554|NCT01656876|Combined therapy|combined therapy
5411098|NCT01672879|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5411099|NCT01672879|Hepatic venous pressure gradient|hepatic venous pressure gradient
5411101|NCT01672879|NAFLD|nafld
5411102|NCT01672879|MRE|mre
5411103|NCT01672879|Liver biopsy|liver biopsy
5411104|NCT01672879|Liver fibrosis|liver fibrosis
5411105|NCT01672879|Ishak|ishak
5411106|NCT01672866|NASH|nash
5411107|NCT01672866|noncirrhotic|noncirrhotic
5411108|NCT01672866|Monoclonal antibody|monoclonal antibody
5411109|NCT01672866|LOXL2|loxl2
5411110|NCT01672866|Simtuzumab|simtuzumab
5411111|NCT01672866|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5411112|NCT01672866|NAFLD|nafld
5411113|NCT01672866|Liver biopsy|liver biopsy
5411114|NCT01672866|MRE|mre
5411115|NCT01672866|Liver fibrosis|liver fibrosis
5411116|NCT01672866|Ishak|ishak
5411117|NCT01672853|PSC|psc
5411118|NCT01672853|Sclerosis|sclerosis
5411119|NCT01672853|Monoclonal antibody|monoclonal antibody
5411120|NCT01672853|LOXL2|loxl2
5411121|NCT01672853|Simtuzumab|simtuzumab
5411122|NCT01672853|Primary sclerosing cholangitis|primary sclerosing cholangitis
5411123|NCT01672853|Liver fibrosis|liver fibrosis
5411124|NCT01672853|Liver disease|liver disease
5411125|NCT01672853|MRCP|mrcp
5411126|NCT01672853|MRE|mre
5411127|NCT01672853|Liver biopsy|liver biopsy
5411128|NCT01672840|Stage 1 Hypertension|stage 1 hypertension
5411129|NCT01672840|cocoa consumption|cocoa consumption
5411130|NCT01672840|Blood pressure|blood pressure
5411131|NCT01672840|Endothelial function|endothelial function
5411132|NCT01672840|arterial stiffness|arterial stiffness
5411133|NCT01672827|Alzheimer's Disease|alzheimer's disease
5411134|NCT01672827|Mild Cognitive Impairment|mild cognitive impairment
5411135|NCT01672827|Positron Emission Tomography (PET)|positron emission tomography (pet)
5411136|NCT01672827|PET Images|pet images
5411137|NCT01672814|Keratoconus|keratoconus
5411138|NCT01672814|Collagen Crosslinking|collagen crosslinking
5411143|NCT01672775|AGS-16C3F|ags-16c3f
5411144|NCT01672775|Pharmacokinetics of AGS-16C3F|pharmacokinetics of ags-16c3f
5411145|NCT01672762|glucose excretion|glucose excretion
5411146|NCT01672762|ipragliflozin|ipragliflozin
5411148|NCT01672762|serum Insulin|serum insulin
5411149|NCT01672762|diabetes mellitus|diabetes mellitus
5411150|NCT01672762|blood glucose|blood glucose
5411151|NCT01672749|Scoliosis [MESH]|scoliosis [mesh]
5411152|NCT01672749|Pediatrics [MESH]|pediatrics [mesh]
5411153|NCT01672749|Early onset|early onset
5411154|NCT01672749|Growth guidance|growth guidance
5411155|NCT01672749|Growing rod|growing rod
5411156|NCT01672749|Trolley|trolley
5411157|NCT01672749|Dual growing rod technique|dual growing rod technique
5411158|NCT01672736|Relapsed or relapse/refractory Multiple Myeloma|relapsed or relapse/refractory multiple myeloma
5411159|NCT01672723|opioids|opioids
5411160|NCT01672723|social connection|social connection
5411161|NCT01672710|Hubbard detoxification|hubbard detoxification
5411162|NCT01672710|Exercise|exercise
5394014|NCT01748513|TTE,|tte,
5411163|NCT01672710|Sauna therapy|sauna therapy
5411164|NCT01672710|Niacin|niacin
5411165|NCT01672710|Gulf War illness|gulf war illness
5411166|NCT01672697|anal incontinence|anal incontinence
5411167|NCT01672697|genital trauma|genital trauma
5411168|NCT01672697|physical therapy|physical therapy
5411169|NCT01672697|anal manometry|anal manometry
5411170|NCT01672684|quality of life|quality of life
5411171|NCT01672658|TBI,|tbi,
5411172|NCT01672658|vestibular|vestibular
5411173|NCT01672645|Smoking cessation|smoking cessation
5411174|NCT01672645|vaccine|vaccine
5411175|NCT01672645|Phase 1|phase 1
5411176|NCT01672619|craniosynostoses|craniosynostoses
5411177|NCT01672619|Osteogenesis Distraction|osteogenesis distraction
5411178|NCT01672619|craniotomy|craniotomy
5411179|NCT01672593|Autologous platelet rich fibrin glue;|autologous platelet rich fibrin glue;
5411180|NCT01672593|Enterocutaneous fistulas;|enterocutaneous fistulas;
5411181|NCT01672593|Single low output GI fistulas;|single low output gi fistulas;
5411182|NCT01672580|social networks|social networks
5411183|NCT01672580|nutrition|nutrition
5411184|NCT01672580|vitamins|vitamins
5411185|NCT01672580|chlorine|chlorine
5411186|NCT01672567|Coronary Artery Disease|coronary artery disease
5411187|NCT01672567|Egg Consumption|egg consumption
5411188|NCT01672567|Endothelial Function|endothelial function
5411189|NCT01672554|Schizophrenia|schizophrenia
5411190|NCT01672554|Anxiety disorder|anxiety disorder
5411191|NCT01672541|dating violence|dating violence
5411192|NCT01672541|healthy relationship behaviors|healthy relationship behaviors
5411193|NCT01672528|Patient Reported Outcome Measures|patient reported outcome measures
5411194|NCT01672528|PROMs|proms
5411195|NCT01672528|Cardiac arrhythmia|cardiac arrhythmia
5411196|NCT01672528|Cardiac ablation|cardiac ablation
5411197|NCT01672502|sleep|sleep
5411198|NCT01672502|firefighter|firefighter
5398393|NCT01729104|Rituxan|rituxan
5411199|NCT01672502|fire|fire
5411200|NCT01672502|apnea|apnea
5411201|NCT01672502|insomnia|insomnia
5411202|NCT01672502|shift|shift
5411203|NCT01672502|narcolepsy|narcolepsy
5411204|NCT01672502|restless leg|restless leg
5411206|NCT01672502|fatigue|fatigue
5411207|NCT01672502|Optalert|optalert
5411208|NCT01672502|actigraph|actigraph
5411209|NCT01672502|actigraphy|actigraphy
5411210|NCT01672502|actiwatch|actiwatch
5411211|NCT01672502|safety|safety
5411212|NCT01672502|sleepiness|sleepiness
5411213|NCT01672502|sleepy|sleepy
5411214|NCT01672502|work|work
5411215|NCT01672502|hours|hours
5411216|NCT01672502|FEMA|fema
5411217|NCT01672502|drowsy|drowsy
5411218|NCT01672489|Drowsy|drowsy
5411219|NCT01672489|Drive|drive
5411220|NCT01672489|Driving|driving
5411221|NCT01672489|Shift Work Disorder|shift work disorder
5411222|NCT01672489|SWD|swd
5411223|NCT01672489|EEG|eeg
5411224|NCT01672489|ECG|ecg
5411225|NCT01672489|Actiwatch|actiwatch
5411226|NCT01672489|Diary|diary
5411227|NCT01672489|Bioharness|bioharness
5411228|NCT01672489|Q-Sensor|q-sensor
5411229|NCT01672489|Q Sensor|q sensor
5411230|NCT01672489|Liberty Mutual|liberty mutual
5411231|NCT01672489|sleep|sleep
5411232|NCT01672489|impaired|impaired
5411233|NCT01672489|Optalert|optalert
5411234|NCT01672489|tracker|tracker
5411235|NCT01672489|vehicle|vehicle
5411236|NCT01672489|questionnaire|questionnaire
5411237|NCT01672489|survey|survey
5411238|NCT01672476|Fimasartan|fimasartan
5411338|NCT01671956|Ulcerative Colitis|ulcerative colitis
5412761|NCT01665612|MPDS|mpds
5411239|NCT01672450|Histologically or cytologically proven melanoma; Stages III-IV; accessible cutaneous, subcutaneous, and/or nodal lesions; ECOG performance status 0 to 2|histologically or cytologically proven melanoma; stages iii-iv; accessible cutaneous, subcutaneous, and/or nodal lesions; ecog performance status 0 to 2
5406280|NCT01693874|stress|stress
5411240|NCT01672437|Birth and parent preparation|birth and parent preparation
5411241|NCT01672437|Parenting stress|parenting stress
5411242|NCT01672437|Depression|depression
5411243|NCT01672437|self-efficacy|self-efficacy
5411244|NCT01672437|social network and support|social network and support
5411245|NCT01672424|NPO|npo
5411246|NCT01672424|Gastric Emptying|gastric emptying
5411247|NCT01672424|Ice Chips|ice chips
5411248|NCT01672424|Protein Drink|protein drink
5411249|NCT01672424|Ultrasound|ultrasound
5411250|NCT01672411|prostate cancer, PSA, markers, diagnosis, prognosis, pro-PSA|prostate cancer, psa, markers, diagnosis, prognosis, pro-psa
5411251|NCT01672398|CarePartner|carepartner
5411252|NCT01672398|informal caregiver|informal caregiver
5411253|NCT01672398|interactive voice response|interactive voice response
5411254|NCT01672398|transition|transition
5411255|NCT01672398|post-discharge|post-discharge
5411256|NCT01672398|chronic illness|chronic illness
5411257|NCT01672398|readmission|readmission
5411258|NCT01672398|self-care|self-care
5411259|NCT01672385|CarePartner|carepartner
5411260|NCT01672385|informal caregiver|informal caregiver
5411261|NCT01672385|interactive voice response|interactive voice response
5411262|NCT01672385|transition|transition
5411263|NCT01672385|post-discharge|post-discharge
5411264|NCT01672385|chronic illness|chronic illness
5411265|NCT01672385|readmission|readmission
5411266|NCT01672385|self-care|self-care
5411267|NCT01672359|cognitive functioning|cognitive functioning
5411268|NCT01672359|immune function|immune function
5411269|NCT01672359|cytokines|cytokines
5411270|NCT01672359|growth factors|growth factors
5411271|NCT01672359|quality of life|quality of life
5411272|NCT01672359|dietary supplementation|dietary supplementation
5411273|NCT01672359|Ginkgo biloba|ginkgo biloba
5411274|NCT01672359|Improvement of cognitive function|improvement of cognitive function
5411276|NCT01672320|Robotic|robotic
5411277|NCT01672320|Arthroplasty|arthroplasty
5411278|NCT01672320|Total Hip Arthroplasty|total hip arthroplasty
5411279|NCT01672320|Cup Positioning|cup positioning
5411280|NCT01672320|Outcomes|outcomes
5411281|NCT01672307|hypotrichosis of eyebrows|hypotrichosis of eyebrows
5411282|NCT01672307|thinning eyebrows|thinning eyebrows
5411283|NCT01672307|minoxidil|minoxidil
5411284|NCT01672307|placebo|placebo
5411285|NCT01672307|randomized|randomized
5411286|NCT01672294|caregiver|caregiver
5411287|NCT01672294|end of life|end of life
5411288|NCT01672294|self-disclosure|self-disclosure
5411289|NCT01672268|cardiac computed tomography|cardiac computed tomography
5411290|NCT01672268|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5411291|NCT01672268|safety and efficacy|safety and efficacy
5411292|NCT01672255|exercise|exercise
5411293|NCT01672255|diabetes|diabetes
5411294|NCT01672255|SSRIs|ssris
5411295|NCT01672216|Exercise Therapy|exercise therapy
5411296|NCT01672216|Biofeedback (Psychology)|biofeedback (psychology)
5411297|NCT01672216|Adult|adult
5411298|NCT01672216|Chronic Obstipation/*therapy|chronic obstipation/*therapy
5411299|NCT01672216|EMG - Biofeedback|emg - biofeedback
5411300|NCT01672216|EMG - Triggered Stimulation|emg - triggered stimulation
5002960|NCT03977571|Nivolumab|nivolumab
5398499|NCT01728675|Aging|aging
5411301|NCT01672216|Augmented biofeedback|augmented biofeedback
5411302|NCT01672177|Geriatrics|geriatrics
5411303|NCT01672177|Aged|aged
5411304|NCT01672177|Aging|aging
5411305|NCT01672177|Chronic disease|chronic disease
5411306|NCT01672177|Self management|self management
5411307|NCT01672164|proteogenomic biomarker panels|proteogenomic biomarker panels
5411308|NCT01672151|Refractory Immune Thrombocytopenic Purpura|refractory immune thrombocytopenic purpura
5411309|NCT01672151|rapamycin|rapamycin
5411310|NCT01672151|regulatory T cells|regulatory t cells
5411311|NCT01672138|PVAI|pvai
5411312|NCT01672138|NPAF|npaf
5411313|NCT01672138|Non-PV triggers|non-pv triggers
5411314|NCT01672112|analgesic efficacy|analgesic efficacy
5411315|NCT01672112|oral codeine|oral codeine
5411316|NCT01672112|oral oxycodone|oral oxycodone
5411317|NCT01672112|postcraniotomy|postcraniotomy
5411318|NCT01672099|vitamin K2|vitamin k2
5411319|NCT01672099|menaquinone-7|menaquinone-7
5411320|NCT01672099|vascular health|vascular health
5411321|NCT01672073|pressure|pressure
5411322|NCT01672073|waveform|waveform
5411323|NCT01672073|arterial|arterial
5411324|NCT01672047|The 25(OH) vitamin D level|the 25(oh) vitamin d level
5411325|NCT01672047|The 1.25(OH) vitamin D level|the 1.25(oh) vitamin d level
5411326|NCT01672047|The intact PTH level|the intact pth level
5411327|NCT01672047|The calcification score of coronary artery|the calcification score of coronary artery
5411328|NCT01672047|The microalbuminuria level|the microalbuminuria level
5411329|NCT01672021|Breast Cancer|breast cancer
5411330|NCT01672021|MRI PET-CT|mri pet-ct
5411331|NCT01672008|NOX-100|nox-100
5411332|NCT01671995|Heart failure|heart failure
5411333|NCT01671995|Quality of life|quality of life
5411334|NCT01671969|determine effects of diet on renal and other parameters|determine effects of diet on renal and other parameters
5411335|NCT01671956|IBD|ibd
5411336|NCT01671956|UC|uc
5411339|NCT01671943|small malignant invasive breast tumors|small malignant invasive breast tumors
5411340|NCT01671917|Total knee arthroplasty|total knee arthroplasty
5411341|NCT01671917|Total knee replacement|total knee replacement
5411342|NCT01671917|Knee osteoarthritis|knee osteoarthritis
5411343|NCT01671917|Education|education
5411344|NCT01671917|Exercise|exercise
5411345|NCT01671917|Handicap|handicap
5411346|NCT01671917|Function|function
5411347|NCT01671917|Cost-effectiveness|cost-effectiveness
5411348|NCT01671917|Cost-utility|cost-utility
5411349|NCT01671917|Quality of life|quality of life
5411350|NCT01671891|rectal cancer|rectal cancer
5411351|NCT01671891|circulating tumor cells|circulating tumor cells
5411352|NCT01671891|predict responses|predict responses
5411353|NCT01671865|FSHD|fshd
5411354|NCT01671865|magnetic resonance imaging|magnetic resonance imaging
5411355|NCT01671865|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5411356|NCT01671826|Multiple Myeloma|multiple myeloma
5411357|NCT01671826|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5411358|NCT01671826|Elderly Patients|elderly patients
5411359|NCT01671813|positive|positive
5411360|NCT01671813|diffuse|diffuse
5411361|NCT01671813|B-Cell|b-cell
5411362|NCT01671813|elderly|elderly
5411363|NCT01671813|EBV|ebv
5411364|NCT01671813|DLBCL|dlbcl
5411365|NCT01671813|malignant|malignant
5411366|NCT01671813|pilot|pilot
5411367|NCT01671800|Hyperhidrosis|hyperhidrosis
5411368|NCT01671800|Botulinum Toxin|botulinum toxin
5411369|NCT01671800|Amputation|amputation
5411370|NCT01671800|Phantom limb pain|phantom limb pain
5411371|NCT01671787|Hepatitis B|hepatitis b
5411372|NCT01671787|HBV|hbv
5411373|NCT01671787|GS-7340|gs-7340
5411374|NCT01671787|TDF|tdf
5411375|NCT01671787|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5411376|NCT01671787|Gilead|gilead
5411377|NCT01671787|Viread|viread
5411378|NCT01671761|Healthy|healthy
5411379|NCT01671761|Control|control
5411380|NCT01671748|Venous Leg Ulcer|venous leg ulcer
5411381|NCT01671748|Varicose Ulcer|varicose ulcer
5411382|NCT01671748|Chronic ulcer|chronic ulcer
5411383|NCT01671748|Chronic wound|chronic wound
5411384|NCT01671748|Ultrasound therapy|ultrasound therapy
5411385|NCT01671748|MIST device|mist device
5411386|NCT01671748|Wound healing|wound healing
5411387|NCT01671748|Low frequency non contact ultrasound|low frequency non contact ultrasound
5411388|NCT01671735|prevention|prevention
5411389|NCT01671735|diabetes|diabetes
5411390|NCT01671722|Bioequivalence|bioequivalence
5411391|NCT01671722|Montelukast Sodium|montelukast sodium
5411392|NCT01671722|crossover|crossover
5411393|NCT01671709|Bioequivalence|bioequivalence
5411394|NCT01671709|Montelukast Sodium|montelukast sodium
5411395|NCT01671709|crossover|crossover
5411396|NCT01671683|rectal cancer|rectal cancer
5411397|NCT01671683|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5411398|NCT01671683|Capecitabine|capecitabine
5411399|NCT01671670|Functional dyspepsia|functional dyspepsia
5411400|NCT01671670|postprandial distress syndrome|postprandial distress syndrome
5411401|NCT01671657|In vitro fertilization|in vitro fertilization
5398598|NCT01728207|NHL|nhl
5411402|NCT01671657|Assisted reproductive therapy|assisted reproductive therapy
5411403|NCT01671657|Time-lapse image recording|time-lapse image recording
5411404|NCT01671657|Image analysis software|image analysis software
5411405|NCT01671644|In vitro fertilization|in vitro fertilization
5411406|NCT01671644|Assisted reproductive therapy|assisted reproductive therapy
5411407|NCT01671644|Time-lapse image recording|time-lapse image recording
5411408|NCT01671644|Image analysis software|image analysis software
5411409|NCT01671618|Aortic dissection|aortic dissection
5411410|NCT01671618|Aortic dilation|aortic dilation
5411411|NCT01671618|Aortic Aneurysm|aortic aneurysm
5411412|NCT01671618|ultrasound|ultrasound
5411413|NCT01671618|point-of-care|point-of-care
5411414|NCT01671618|echocardiography|echocardiography
5411415|NCT01671592|Cancer|cancer
5411416|NCT01671592|colorectal|colorectal
5411417|NCT01671592|tumor|tumor
5411418|NCT01671592|neoplasms|neoplasms
5411419|NCT01671592|carcinoma|carcinoma
5411420|NCT01671592|vaccine|vaccine
5411421|NCT01671566|Congenital Heart defect|congenital heart defect
5411422|NCT01671566|Exercise and Physical fitness|exercise and physical fitness
5411423|NCT01671566|Rehabilitation|rehabilitation
5411424|NCT01671566|Quality of life|quality of life
5411425|NCT01671566|Behaviour|behaviour
5411426|NCT01671540|COPD|copd
5411427|NCT01671540|IPV|ipv
5411428|NCT01671527|Deep Brain Stimulation|deep brain stimulation
5411429|NCT01671527|DBS|dbs
5411430|NCT01671527|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5411431|NCT01671527|TMS|tms
5411432|NCT01671527|Cervical Dystonia|cervical dystonia
5411433|NCT01671527|Dystonia|dystonia
5411434|NCT01671527|Control|control
5411435|NCT01671527|Healthy|healthy
5411436|NCT01671514|mitochondrial biogenesis|mitochondrial biogenesis
5411437|NCT01671514|skeletal muscle|skeletal muscle
5411438|NCT01671514|epicatechin|epicatechin
5411439|NCT01671501|HIV|hiv
5411440|NCT01671501|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5411441|NCT01671501|Alcoholism|alcoholism
5411442|NCT01671501|Alcoholic Intoxication|alcoholic intoxication
5411454|NCT01671475|Altered Mental Status|altered mental status
5411455|NCT01671475|Non-convulsive seizure|non-convulsive seizure
5411456|NCT01671475|Electroencephalography|electroencephalography
5411457|NCT01671462|HPV|hpv
5411458|NCT01671462|Cervical Cancer|cervical cancer
5411459|NCT01671462|Cervical Neoplasms|cervical neoplasms
5411460|NCT01671449|Gastric cancer|gastric cancer
5411462|NCT01671449|Cisplatin|cisplatin
5411463|NCT01671449|Oxaliplatin|oxaliplatin
5411464|NCT01671436|Depression|depression
5411465|NCT01671436|Guided Imagery|guided imagery
5411466|NCT01671436|Psychotherapy|psychotherapy
5411467|NCT01671436|Meditation|meditation
5411468|NCT01671423|Cellulitis|cellulitis
5411469|NCT01671423|Skin infection|skin infection
5411470|NCT01671423|Prednisone|prednisone
5411471|NCT01671423|Steroid|steroid
5411472|NCT01671423|Anti-inflammatory|anti-inflammatory
5411473|NCT01671410|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5411474|NCT01671410|buprenorphine|buprenorphine
5411475|NCT01671410|morphine|morphine
5411476|NCT01671410|benzodiazepine|benzodiazepine
5411477|NCT01671397|Obesity|obesity
5411478|NCT01671397|weight loss|weight loss
5411479|NCT01671397|sleep hygiene|sleep hygiene
5411480|NCT01671397|diet|diet
5411481|NCT01671397|exercise|exercise
5411482|NCT01671384|Valproate|valproate
5411483|NCT01671384|levocarnitine|levocarnitine
5411484|NCT01671384|SMA|sma
5411485|NCT01671384|physiotherapy|physiotherapy
5411486|NCT01671384|placebo|placebo
5411487|NCT01671371|syncope|syncope
5411488|NCT01671371|point of care|point of care
5411489|NCT01671371|ultrasound|ultrasound
5411490|NCT01671371|echocardiography|echocardiography
5411491|NCT01671358|MRSA|mrsa
5411492|NCT01671358|Contamination|contamination
5411493|NCT01671358|Isolation|isolation
5411494|NCT01671332|Carcinoma, non small cell lung|carcinoma, non small cell lung
5411495|NCT01671332|Second line|second line
5411496|NCT01671332|Third line|third line
5411497|NCT01671319|breast cancer|breast cancer
5411498|NCT01671319|female|female
5411499|NCT01671319|women|women
5411500|NCT01671319|adjuvant|adjuvant
5411501|NCT01671306|Coronary collaterals|coronary collaterals
5411502|NCT01671306|diabetes mellitus|diabetes mellitus
5411503|NCT01671306|monocyte subsets|monocyte subsets
5411504|NCT01671280|pneumonia|pneumonia
5411505|NCT01671280|pelvic inflammatory disease|pelvic inflammatory disease
5411506|NCT01671280|Zithromax|zithromax
5411507|NCT01671280|Zithromac|zithromac
5411508|NCT01671280|Japanese|japanese
5411509|NCT01671280|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5411510|NCT01671228|dialysis|dialysis
5411511|NCT01671228|chronic kidney failure|chronic kidney failure
5411512|NCT01671228|informed choice|informed choice
5411513|NCT01671228|patient decision making|patient decision making
5411514|NCT01671228|decision aid|decision aid
5411515|NCT01671215|endometrium|endometrium
5411516|NCT01671215|myometrium|myometrium
5411517|NCT01671215|fibroids|fibroids
5411518|NCT01671215|uterine malformations|uterine malformations
5411519|NCT01671176|Wide diameter implant|wide diameter implant
5411520|NCT01671176|ISQ|isq
5411521|NCT01671176|Ponto|ponto
5411522|NCT01671176|Bone anchored implant|bone anchored implant
5411523|NCT01671163|Cancer|cancer
5411524|NCT01671163|Radiation therapy|radiation therapy
5411525|NCT01671163|Fiducial markers|fiducial markers
5411526|NCT01671150|inflammation|inflammation
5411527|NCT01671150|depression|depression
5411530|NCT01671137|Lactobacillus GG|lactobacillus gg
5411531|NCT01671137|Functional Abdominal Pain|functional abdominal pain
5411532|NCT01671137|Children|children
5411533|NCT01671137|Acute|acute
5411534|NCT01671137|Gastroenteritis|gastroenteritis
5411536|NCT01671124|TC|tc
5411537|NCT01671124|HDL|hdl
5411538|NCT01671124|LDL|ldl
5411539|NCT01671124|Albumin|albumin
5411540|NCT01671124|Hemoglobin|hemoglobin
5411541|NCT01671124|Hematocrit|hematocrit
5411542|NCT01671124|Uric acid|uric acid
5411543|NCT01671124|Sodium|sodium
5411544|NCT01671124|Potassium|potassium
5411545|NCT01671124|Calcium|calcium
5411546|NCT01671098|nitric oxide|nitric oxide
5411547|NCT01671098|sinuplasty|sinuplasty
5411548|NCT01671072|Chondrocyte cells|chondrocyte cells
5411549|NCT01671072|Osteoarthritis|osteoarthritis
5411550|NCT01671072|Gene therapy|gene therapy
5411551|NCT01671033|Panic disorder|panic disorder
5411552|NCT01671033|cognitive behavior therapy|cognitive behavior therapy
5411555|NCT01671020|absolute bioavailability|absolute bioavailability
5411557|NCT01670994|immunotherapy|immunotherapy
5411558|NCT01670994|immunochemotherapy|immunochemotherapy
5411559|NCT01670994|targeted|targeted
5411560|NCT01670994|metastatic|metastatic
5411561|NCT01670994|interleukin-2|interleukin-2
5411562|NCT01670994|antitumor|antitumor
5411563|NCT01670994|TCR|tcr
5411564|NCT01670994|T-cell receptor|t-cell receptor
5411565|NCT01670994|p53|p53
5411566|NCT01670994|p53 gene|p53 gene
5411567|NCT01670994|p53 tumor supressor protein|p53 tumor supressor protein
5411568|NCT01670994|HLA-A2 positive|hla-a2 positive
5411569|NCT01670994|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
5411570|NCT01670994|HLA complex|hla complex
5411571|NCT01670994|multiple myeloma|multiple myeloma
5411572|NCT01670994|IFN-γ and TNF-α|ifn-γ and tnf-α
5411573|NCT01670994|refractory|refractory
5411574|NCT01670994|relapsed|relapsed
5411575|NCT01670981|Ischemic dilated cardiomyopathy|ischemic dilated cardiomyopathy
5411577|NCT01670981|ixCELL|ixcell
5411578|NCT01670981|ixCELL DCM|ixcell dcm
5411579|NCT01670981|IDCM|idcm
5411580|NCT01670981|DCM|dcm
5411581|NCT01670981|stem cells|stem cells
5411582|NCT01670981|MSC|msc
5411583|NCT01670981|cell therapy|cell therapy
5411584|NCT01670955|Anemia|anemia
5411585|NCT01670955|preoperative|preoperative
5411586|NCT01670955|gynecological patients|gynecological patients
5411587|NCT01670955|Sorghum bicolor|sorghum bicolor
5411588|NCT01670955|Packed Cells Volume|packed cells volume
5411589|NCT01670942|pneumothorax|pneumothorax
5411590|NCT01670942|trauma|trauma
5411591|NCT01670942|commercial air travel|commercial air travel
5411592|NCT01670929|recurrent miscarriages|recurrent miscarriages
5411593|NCT01670929|progesterone|progesterone
5411594|NCT01670916|Necrotizing enterocolitis|necrotizing enterocolitis
5411595|NCT01670916|Probiotics|probiotics
5411596|NCT01670916|Preterm|preterm
5411597|NCT01670916|Infant|infant
5411598|NCT01670890|temozolomide(TMZ)|temozolomide(tmz)
5411599|NCT01670890|cisplatin(CDDP)|cisplatin(cddp)
5411600|NCT01670890|recurrent malignant gliomas|recurrent malignant gliomas
5411601|NCT01670851|eLAPE,|elape,
5411602|NCT01670851|perineum,|perineum,
5411603|NCT01670851|pelvic floor reconstruction|pelvic floor reconstruction
5411604|NCT01670838|subarachnoid haemorrhage|subarachnoid haemorrhage
5411605|NCT01670838|cardiopulmonary complications|cardiopulmonary complications
5411606|NCT01670825|Occipital neuralgia|occipital neuralgia
5411607|NCT01670825|corticosteroid injection|corticosteroid injection
5411608|NCT01670825|pulsed radiofrequency|pulsed radiofrequency
5411609|NCT01670812|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5411610|NCT01670812|ultra-high risk|ultra-high risk
5411611|NCT01670812|fresh frozen plasma|fresh frozen plasma
5411612|NCT01670812|methylprednisolone|methylprednisolone
5411613|NCT01670812|rituximab|rituximab
5411617|NCT01670760|Deep Tissue Temperature|deep tissue temperature
5411618|NCT01670760|Zero Heat Flux Thermometry|zero heat flux thermometry
5411619|NCT01670760|Thermometry|thermometry
5411620|NCT01670760|Core Temperature|core temperature
5411621|NCT01670708|Substance Use|substance use
5411622|NCT01670708|Illicit Drug Use|illicit drug use
5411623|NCT01670708|Criminal Behavior|criminal behavior
5411624|NCT01670695|IgG4-related disease|igg4-related disease
5411625|NCT01670695|IgG4-RD|igg4-rd
5411626|NCT01670682|Stage III|stage iii
5411627|NCT01670643|AMD|amd
5411628|NCT01670643|vision rehabilitation|vision rehabilitation
5411629|NCT01670643|video camera magnifier|video camera magnifier
5411630|NCT01670643|IVI|ivi
5411631|NCT01670643|DASS|dass
5411632|NCT01670630|speculum|speculum
5411633|NCT01670630|vagina|vagina
5411634|NCT01670630|cervix|cervix
5411635|NCT01670630|examination|examination
5411636|NCT01670578|P.R.P.|p.r.p.
5411637|NCT01670578|viscosupplementation|viscosupplementation
5411638|NCT01670578|double-blind randomized|double-blind randomized
5411639|NCT01670578|intra-articular injections|intra-articular injections
5411640|NCT01670578|knee degenerative pathology|knee degenerative pathology
5411641|NCT01670578|early osteoarthritis|early osteoarthritis
5411642|NCT01670565|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
5411643|NCT01670565|Early Diffuse cutaneous systemic sclerosis|early diffuse cutaneous systemic sclerosis
5411644|NCT01670539|Lung Cancer|lung cancer
5411645|NCT01670539|Telemonitoring|telemonitoring
5411646|NCT01670539|Rural|rural
5411647|NCT01670539|Nursing|nursing
5411648|NCT01670526|Traumatic Brain Injury|traumatic brain injury
5411649|NCT01670526|Cognitive Impairment|cognitive impairment
5411650|NCT01670526|Rivastigmine|rivastigmine
5411651|NCT01670526|Pharmacologic Actions|pharmacologic actions
5411653|NCT01670526|Memory|memory
5411654|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors
5411655|NCT01670526|Cognition|cognition
5411656|NCT01670526|Head Trauma|head trauma
5411657|NCT01670513|Psoriasis|psoriasis
5411658|NCT01670500|germline mutation|germline mutation
5411659|NCT01670500|BRCA1 mutation|brca1 mutation
5411660|NCT01670500|BRCA2 mutation|brca2 mutation
5411661|NCT01670487|Vapocoolant|vapocoolant
5411662|NCT01670474|Temporary hemodialysis catheters|temporary hemodialysis catheters
5411663|NCT01670474|Non-cuffed hemodialysis catheters|non-cuffed hemodialysis catheters
5411664|NCT01670474|Thrombolysis|thrombolysis
5411665|NCT01670474|rt-PA|rt-pa
5411666|NCT01670474|Thrombosis|thrombosis
5411667|NCT01670474|Lifespan|lifespan
5411668|NCT01670474|Blood flow rate|blood flow rate
5411669|NCT01670474|Catheter related bacteriemia|catheter related bacteriemia
5411670|NCT01670461|advance care planning, palliative care, pediatric|advance care planning, palliative care, pediatric
5411671|NCT01670448|Postoperative pain|postoperative pain
5411672|NCT01670448|Chronic pain prevention|chronic pain prevention
5411673|NCT01670448|Regional anesthesia|regional anesthesia
5411674|NCT01670448|Mastectomy|mastectomy
5411675|NCT01670435|Ciprofloxacin|ciprofloxacin
5411676|NCT01670435|sepsis|sepsis
5411677|NCT01670435|infection|infection
5411678|NCT01670435|pneumonia|pneumonia
5411679|NCT01670435|peritonitis|peritonitis
5411680|NCT01670435|cholecystitis|cholecystitis
5411681|NCT01670435|cholangitis|cholangitis
5411683|NCT01670422|CSOJ|csoj
5411684|NCT01670422|recurrence|recurrence
5411685|NCT01670422|life-threatening complications|life-threatening complications
5411686|NCT01670422|risk factors|risk factors
5411687|NCT01670409|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5411688|NCT01670409|SMART|smart
5411689|NCT01670409|IMRT|imrt
5411690|NCT01670409|Chemotherapy|chemotherapy
5411691|NCT01670396|coronary stent implant|coronary stent implant
5411692|NCT01670396|polymorphism|polymorphism
5411693|NCT01670396|G protein|g protein
5411694|NCT01670396|drug-eluting stent|drug-eluting stent
5411695|NCT01670396|restenosis|restenosis
5411696|NCT01670383|Cardiac Arrest|cardiac arrest
5411697|NCT01670383|Sepsis|sepsis
5411698|NCT01670383|Biological Markers|biological markers
5411699|NCT01670383|Anti-Inflammation Agents|anti-inflammation agents
5411700|NCT01670383|Antioxidants|antioxidants
5411701|NCT01670370|Rituximab|rituximab
5411702|NCT01670370|Gemcitabine|gemcitabine
5411703|NCT01670370|Oxaliplatin|oxaliplatin
5411704|NCT01670370|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5411705|NCT01670357|Dry Eye Syndrome|dry eye syndrome
5411706|NCT01670318|Chronic total occlusion|chronic total occlusion
5411707|NCT01670318|Bifurcation lesion|bifurcation lesion
5411708|NCT01670318|Left main trunk lesion|left main trunk lesion
5411709|NCT01670318|Small vessel disease|small vessel disease
5411710|NCT01670318|Multi vessel disease|multi vessel disease
5411711|NCT01670292|Low Back Pain|low back pain
5411712|NCT01670279|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5411713|NCT01670266|ONO-9054|ono-9054
5411714|NCT01670266|ocular hypertension|ocular hypertension
5411716|NCT01670266|Open angle-glaucoma|open angle-glaucoma
5411717|NCT01670266|OAG|oag
5411718|NCT01670266|Glaucoma|glaucoma
5411719|NCT01670266|Eye diseases|eye diseases
5411720|NCT01670240|IPAA|ipaa
5411721|NCT01670240|Pouchitis|pouchitis
5411722|NCT01670240|Ulcerative colitis|ulcerative colitis
5411723|NCT01670240|Pouch|pouch
5411724|NCT01670240|Adalimumab|adalimumab
5411725|NCT01670240|Humira|humira
5411726|NCT01670227|EARLY CHILDHOOD|early childhood
5411727|NCT01670227|UNIVERSAL PREVENTION|universal prevention
5411728|NCT01670214|RM|rm
5411729|NCT01670214|R-CM|r-cm
5411730|NCT01670214|based on ICHD-2 criteria|based on ichd-2 criteria
5671213|NCT00616655|Anxiety|anxiety
5411731|NCT01670188|Pneumatic sequential compression device (SCD)|pneumatic sequential compression device (scd)
5411732|NCT01670188|Peripherally Inserted Central Catheters (PICC)|peripherally inserted central catheters (picc)
5514250|NCT01234519|urethra|urethra
5398932|NCT01726673|CVA|cva
5411733|NCT01670175|Histologic verification of solid tumor, including lymphomas|histologic verification of solid tumor, including lymphomas
5411734|NCT01670175|Original diagnosis or relapse|original diagnosis or relapse
5411735|NCT01670162|Pigment Epithelium of Eye|pigment epithelium of eye
5411736|NCT01670162|Wet macular degeneration|wet macular degeneration
5411737|NCT01670162|Macular degeneration|macular degeneration
5411738|NCT01670149|Clostridium difficile|clostridium difficile
5411739|NCT01670149|Diarrhoea|diarrhoea
5411740|NCT01670149|Rifaximin|rifaximin
5411741|NCT01670136|sildenafil|sildenafil
5411742|NCT01670136|preterm infants|preterm infants
5411743|NCT01670136|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
5411744|NCT01670123|Mobile phone|mobile phone
5411745|NCT01670123|electronic intervention|electronic intervention
5411746|NCT01670123|behavioral intervention|behavioral intervention
5411747|NCT01670123|telehealth|telehealth
5411748|NCT01670123|bipolar disorder|bipolar disorder
5411749|NCT01670110|Polycystic Liver Disease|polycystic liver disease
5411750|NCT01670110|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5411751|NCT01670110|Autosomal dominant polycystic liver disease|autosomal dominant polycystic liver disease
5411752|NCT01670110|Somatostatin analogs|somatostatin analogs
5411753|NCT01670110|Pasireotide LAR|pasireotide lar
5411754|NCT01670110|SOM230|som230
5411755|NCT01670097|Advanced Cancers|advanced cancers
5412762|NCT01665612|comfort|comfort
5411760|NCT01670097|Shortness of breath|shortness of breath
5411761|NCT01670097|Dexamethasone|dexamethasone
5411762|NCT01670097|Decadron|decadron
5411763|NCT01670097|Placebo|placebo
5411764|NCT01670097|Sugar pill|sugar pill
5411765|NCT01670097|Questionnaires|questionnaires
5411766|NCT01670097|Surveys|surveys
5411767|NCT01670097|Spirometer|spirometer
5411768|NCT01670097|Phone calls|phone calls
5411769|NCT01670071|Schizophrenia|schizophrenia
5411770|NCT01670071|Paliperidone|paliperidone
5411771|NCT01670071|Risperidone|risperidone
5411772|NCT01670071|Paliperidone extended-release (ER)|paliperidone extended-release (er)
5411773|NCT01670071|Risperidone immediate-release (IR)|risperidone immediate-release (ir)
5411774|NCT01670019|Depression|depression
5411775|NCT01670019|Antidepressant|antidepressant
5411776|NCT01670019|Antipsychotic|antipsychotic
5411777|NCT01669993|Outcomes|outcomes
5411778|NCT01669993|Quality improvement|quality improvement
5411779|NCT01669993|Patient Safety|patient safety
5411780|NCT01669993|PACU|pacu
5411781|NCT01669993|Complications|complications
5411782|NCT01669993|Adverse events|adverse events
5411783|NCT01669993|Respiratory arrest|respiratory arrest
5411784|NCT01669993|Pain|pain
5411785|NCT01669993|PONV|ponv
5411787|NCT01669993|Neonate|neonate
5411788|NCT01669993|Infant|infant
5411789|NCT01669993|Child|child
5411790|NCT01669993|Ambulatory|ambulatory
5411791|NCT01669993|Inpatient|inpatient
5411792|NCT01669993|General Anesthesia|general anesthesia
5411793|NCT01669993|Otolaryngology|otolaryngology
5411794|NCT01669993|Tonsillectomy|tonsillectomy
5411795|NCT01669993|Obstructive sleep apnea|obstructive sleep apnea
5411796|NCT01669980|Infections|infections
5411797|NCT01669980|Pediatrics|pediatrics
5411798|NCT01669980|Teflaro|teflaro
5411799|NCT01669980|Ceftriaxone|ceftriaxone
5411800|NCT01669980|cephalosporin|cephalosporin
5411801|NCT01669980|Vancomycin|vancomycin
5411802|NCT01669980|Clindamycin|clindamycin
5411803|NCT01669980|Amoxicillin Clavulanate|amoxicillin clavulanate
5411804|NCT01669980|Linezolid|linezolid
5411805|NCT01669980|MRSA|mrsa
5411806|NCT01669980|pneumonia|pneumonia
5411808|NCT01669954|Bone mineral density|bone mineral density
5411809|NCT01669954|Osteoporosis|osteoporosis
5411810|NCT01669954|Vitamin D|vitamin d
5411811|NCT01669954|Fractures|fractures
5411812|NCT01669941|Pregnancy|pregnancy
5411813|NCT01669941|Plasmodium|plasmodium
5411814|NCT01669941|Malaria|malaria
5411815|NCT01669941|Prevention|prevention
5411816|NCT01669941|Kenya|kenya
5411817|NCT01669941|Piperaquine|piperaquine
5411818|NCT01669941|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
5411819|NCT01669941|Sulfadoxine Pyrimethamine|sulfadoxine pyrimethamine
5411820|NCT01669876|Randomized|randomized
5411821|NCT01669876|Double-Blind|double-blind
5411822|NCT01669876|Dietary Supplements|dietary supplements
5411823|NCT01669863|ARDS|ards
5411824|NCT01669850|Chronic kidney disease|chronic kidney disease
5411825|NCT01669850|Arteriovenous fistula|arteriovenous fistula
5411826|NCT01669850|Surgical anastomosis|surgical anastomosis
5411827|NCT01669850|Complications|complications
5411828|NCT01669850|Patency|patency
5411829|NCT01669850|Dialysis access|dialysis access
5411830|NCT01669837|Inguinal hernia|inguinal hernia
5411831|NCT01669837|Laparoscopy|laparoscopy
5411832|NCT01669837|Surgical tissue glue|surgical tissue glue
5411833|NCT01669811|Refractory Reflux Esophagitis,|refractory reflux esophagitis,
5411834|NCT01669811|Japanese,|japanese,
5411835|NCT01669811|Nexium,|nexium,
5411836|NCT01669811|twice daily,|twice daily,
5411837|NCT01669811|oral administration|oral administration
5411838|NCT01669798|Recurrent epithelial ovarian carcinoma|recurrent epithelial ovarian carcinoma
5411839|NCT01669798|Persistent epithelial ovarian carcinoma|persistent epithelial ovarian carcinoma
5411840|NCT01669798|Bevacizumab resistant epithelial ovarian carcinoma|bevacizumab resistant epithelial ovarian carcinoma
5411841|NCT01669746|Androgenetic Alopecia|androgenetic alopecia
5411842|NCT01669746|Male Pattern Baldness|male pattern baldness
5411843|NCT01669746|Female Pattern Baldness|female pattern baldness
5411845|NCT01669746|Baldness|baldness
5411846|NCT01669733|Breast Surgery|breast surgery
5411847|NCT01669733|Breast Biopsy|breast biopsy
5411848|NCT01669733|Music Therapy|music therapy
5411853|NCT01669707|Endostar|endostar
5411854|NCT01669707|advanced Non-small cell lung cancer|advanced non-small cell lung cancer
5411855|NCT01669707|Continued Pumping into vein|continued pumping into vein
5411856|NCT01669707|Gemcitabine|gemcitabine
5411857|NCT01669707|Carboplatin|carboplatin
5411858|NCT01669694|Pelvic Pain|pelvic pain
5411859|NCT01669694|Pelvic Floor Physical Therapy|pelvic floor physical therapy
5411860|NCT01669694|Biomarkers|biomarkers
5411861|NCT01669681|Severe asthma|severe asthma
5411862|NCT01669681|Medical economic|medical economic
5411863|NCT01669681|care|care
5411864|NCT01669681|Cost efficiency|cost efficiency
5411865|NCT01669681|CPAM|cpam
5411866|NCT01669681|EQ5D|eq5d
5411867|NCT01669642|ketamine sedation|ketamine sedation
5411868|NCT01669642|pediatric|pediatric
5411869|NCT01669642|abscess drainage|abscess drainage
5411870|NCT01669642|fracture reduction|fracture reduction
5411871|NCT01669616|Type 2 Diabetes|type 2 diabetes
5411872|NCT01669616|Adults 18 years and older|adults 18 years and older
5411873|NCT01669603|Common cold|common cold
5411874|NCT01669577|predictors|predictors
5411875|NCT01669577|trauma|trauma
5411876|NCT01669577|mortality|mortality
5411877|NCT01669564|Quality of Life|quality of life
5411878|NCT01669564|Tobacco Use Cessation|tobacco use cessation
5411879|NCT01669564|Physical Activity|physical activity
5411880|NCT01669538|Galantamine|galantamine
5411881|NCT01669538|Nicotine Bitartrate|nicotine bitartrate
5411882|NCT01669538|Nicotine Tartrate|nicotine tartrate
5411883|NCT01669538|Nicotine dependence|nicotine dependence
5411884|NCT01669538|Tobacco Dependence|tobacco dependence
5411885|NCT01669512|Malaria vaccine|malaria vaccine
5411886|NCT01669512|Matrix M|matrix m
5411887|NCT01669499|Bone metastases, radiotherapy, dexamethasone, pain flare|bone metastases, radiotherapy, dexamethasone, pain flare
5411888|NCT01669486|Pain|pain
5411889|NCT01669486|ICU|icu
5411890|NCT01669486|Mechanical ventilation|mechanical ventilation
5411892|NCT01669486|BPS|bps
5411893|NCT01669473|Diabetes|diabetes
5411894|NCT01669447|dmri, mnvc, lucentis|dmri, mnvc, lucentis
5411895|NCT01669434|Perioperative Period|perioperative period
5411896|NCT01669421|Alpha 1|alpha 1
5411897|NCT01669408|ischemic stroke|ischemic stroke
5411898|NCT01669408|hemorrhagic stroke|hemorrhagic stroke
5411899|NCT01669408|prehospital cooling|prehospital cooling
5411900|NCT01669408|induction of cooling|induction of cooling
5411901|NCT01669408|ambulance|ambulance
5411902|NCT01669408|emergency room|emergency room
5411903|NCT01669408|cold infusions|cold infusions
5411904|NCT01669408|hypothermia|hypothermia
5411905|NCT01669408|normothermia|normothermia
5411906|NCT01669395|Severe heart failure|severe heart failure
5411907|NCT01669395|Homebased rehabilitation|homebased rehabilitation
5411908|NCT01669395|Physical exercise|physical exercise
5411909|NCT01669395|Activities of daily living|activities of daily living
5411910|NCT01669395|Intersectoral Cooperation|intersectoral cooperation
5411911|NCT01669382|AngioSeal, ExoSeal, PCI, puncture site|angioseal, exoseal, pci, puncture site
5411912|NCT01669369|Lithium Carbonate|lithium carbonate
5411913|NCT01669369|Chemotherapy|chemotherapy
5411914|NCT01669369|prognosis|prognosis
5411915|NCT01669356|malnutrition|malnutrition
5411916|NCT01669356|parenteral supplement|parenteral supplement
5411917|NCT01669356|rest metabolic rate|rest metabolic rate
5411918|NCT01669356|postoperative complications|postoperative complications
5411919|NCT01669343|Aromatase Inhibitors|aromatase inhibitors
5411920|NCT01669330|Gastroesophageal Reflux|gastroesophageal reflux
5411921|NCT01669330|Fundoplication|fundoplication
5411922|NCT01669330|Surgical Procedures|surgical procedures
5411923|NCT01669317|Cherry Juice Pilot|cherry juice pilot
5411924|NCT01669304|migraine variant|migraine variant
5411925|NCT01669304|chronic dizziness|chronic dizziness
5411926|NCT01669304|pharmacologic dissection|pharmacologic dissection
5411927|NCT01669278|sheath|sheath
5411928|NCT01669278|flexible|flexible
5411929|NCT01669278|endoscopy|endoscopy
5411930|NCT01669278|otolaryngology|otolaryngology
5411931|NCT01669278|office|office
5411932|NCT01669265|Breast cancer|breast cancer
5411933|NCT01669265|OSNA|osna
5411934|NCT01669265|sentinel lymph node|sentinel lymph node
5411935|NCT01669252|Breast cancer|breast cancer
5411936|NCT01669252|Eribulin|eribulin
5411937|NCT01669252|Neoadjuvant|neoadjuvant
5411938|NCT01669252|PAM50|pam50
5411939|NCT01669252|Triple-negative|triple-negative
5411940|NCT01669252|Luminal A|luminal a
5411941|NCT01669252|Luminal B|luminal b
5411942|NCT01669239|Breast Cancer|breast cancer
5411943|NCT01669239|HER2 positive|her2 positive
5411944|NCT01669239|Neoadjuvant|neoadjuvant
5411945|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin
5411946|NCT01669239|Paclitaxel|paclitaxel
5411947|NCT01669239|Trastuzumab|trastuzumab
5411948|NCT01669239|Pertuzumab|pertuzumab
5411949|NCT01669239|Safety|safety
5411950|NCT01669226|Ovarian Cancer|ovarian cancer
5411951|NCT01669226|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5411952|NCT01669213|5-HT3 receptor antagonist|5-ht3 receptor antagonist
5411953|NCT01669213|hypotension|hypotension
5411954|NCT01669213|spinal anesthesia|spinal anesthesia
5411955|NCT01669174|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5411956|NCT01669174|COPD; cachexia; muscle wasting|copd; cachexia; muscle wasting
5411957|NCT01669161|Upper|upper
5411958|NCT01669161|Limb|limb
5411959|NCT01669161|Deficits|deficits
5411960|NCT01669161|Rehabilitation|rehabilitation
5411961|NCT01669161|VNS|vns
5411962|NCT01669148|breast cancer|breast cancer
5411963|NCT01669148|imaging|imaging
5411964|NCT01669135|cerebral oximetry|cerebral oximetry
5411965|NCT01669135|cesarean delivery|cesarean delivery
5411966|NCT01669109|Yoga|yoga
5411967|NCT01669109|Colorectal Neoplasms|colorectal neoplasms
5411968|NCT01669109|Quality of Life|quality of life
5411969|NCT01669109|Randomized Controlled Trial|randomized controlled trial
5411970|NCT01669096|adults|adults
5411971|NCT01669096|Tuberculosis vaccine|tuberculosis vaccine
5411972|NCT01669096|HIV negative|hiv negative
5411973|NCT01669096|healthy|healthy
5411974|NCT01669096|mRNA expression|mrna expression
5411975|NCT01669083|Oxytocin Antagonist|oxytocin antagonist
5411976|NCT01669083|Embryo/Blastocyst Implantation|embryo/blastocyst implantation
5411977|NCT01669070|bioavailability|bioavailability
5411978|NCT01669070|Fluticasone Furoate|fluticasone furoate
5411979|NCT01669070|pharmacokinetics|pharmacokinetics
5411980|NCT01669070|dose proportionality|dose proportionality
5411981|NCT01669057|Congenital heart disease|congenital heart disease
5411982|NCT01669057|DNA variation|dna variation
5411983|NCT01669057|methylation|methylation
5411984|NCT01669057|risk factors|risk factors
5411985|NCT01669057|supplements|supplements
5411986|NCT01669031|automated perimetry|automated perimetry
5411987|NCT01669031|visual fields|visual fields
5411988|NCT01669031|reliability|reliability
5411989|NCT01669031|vision tests/standards|vision tests/standards
5411990|NCT01669031|randomized controlled trial|randomized controlled trial
5411991|NCT01669031|false positive reactions|false positive reactions
5407016|NCT01690949|COPD|copd
5412002|NCT01669031|female|female
5412003|NCT01669031|male|male
5412004|NCT01669031|prospective studies|prospective studies
5412005|NCT01669031|reproducibility of results|reproducibility of results
5412006|NCT01669005|neutropenia|neutropenia
5412007|NCT01669005|multiplex PCR|multiplex pcr
5412008|NCT01669005|infection|infection
5412009|NCT01668992|Parenting|parenting
5412010|NCT01668992|Discipline|discipline
5412011|NCT01668992|Family interventions|family interventions
5412012|NCT01668992|Thailand|thailand
5412013|NCT01668992|Migration|migration
5412014|NCT01668953|Lateral Epicondylitis|lateral epicondylitis
5412015|NCT01668953|Tennis Elbow|tennis elbow
5412016|NCT01668953|Platelet Rich Plasma|platelet rich plasma
5412017|NCT01668953|Whole Blood|whole blood
5412018|NCT01668953|Tendon Fenestration|tendon fenestration
5412019|NCT01668940|Morning Sickness|morning sickness
5412020|NCT01668940|Lillipops Iced Soothies|lillipops iced soothies
5412021|NCT01668940|Pregnancy|pregnancy
5412022|NCT01668940|Obstetrics|obstetrics
5412023|NCT01668914|Breast Cancer|breast cancer
5412024|NCT01668914|Clinically Axillary Node -Positive|clinically axillary node -positive
5412025|NCT01668914|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5412026|NCT01668914|Internal Mammary|internal mammary
5412027|NCT01668901|warfarin|warfarin
5412028|NCT01668901|aspirin|aspirin
5412029|NCT01668875|head down postural drainage|head down postural drainage
5412030|NCT01668849|Plant exosomes|plant exosomes
5412031|NCT01668849|Grape exosomes|grape exosomes
5412032|NCT01668849|Grape extract|grape extract
5412033|NCT01668849|Oral mucositis|oral mucositis
5412034|NCT01668849|Head and Neck Cancer|head and neck cancer
5412035|NCT01668849|Immune response|immune response
5412036|NCT01668836|sirtuin|sirtuin
5412037|NCT01668836|atherosclerosis|atherosclerosis
5412038|NCT01668836|longevity|longevity
5412039|NCT01668836|calorie restriction|calorie restriction
5412040|NCT01668836|resveratrol|resveratrol
5412041|NCT01668836|vascular reactivity|vascular reactivity
5412042|NCT01668810|prescription|prescription
5412043|NCT01668810|schizophrenia|schizophrenia
5412044|NCT01668810|depression|depression
5412045|NCT01668810|bipolar disorder|bipolar disorder
5412046|NCT01668771|Self-Affirmation|self-affirmation
5412047|NCT01668771|Affect|affect
5412048|NCT01668771|Alcohol|alcohol
5412049|NCT01668758|Near Infrared Spectroscopy|near infrared spectroscopy
5412050|NCT01668758|Traumatic Brain Injury|traumatic brain injury
5412051|NCT01668745|Child mortality|child mortality
5685285|NCT00556764|Parkinson's|parkinson's
5412052|NCT01668745|Measles vaccine|measles vaccine
5412059|NCT01668693|personalized embryo transfer|personalized embryo transfer
5412061|NCT01668680|Anti-Angiogenic|anti-angiogenic
5412062|NCT01668680|Maintenance Treatment|maintenance treatment
5412063|NCT01668680|Colorectal Cancer Metastatic|colorectal cancer metastatic
5412064|NCT01668667|gabapentin enacarbil|gabapentin enacarbil
5412065|NCT01668667|Horizant|horizant
5412066|NCT01668654|Epilepsy|epilepsy
5412067|NCT01668654|Partial Onset epilepsy|partial onset epilepsy
5412068|NCT01668654|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5412069|NCT01668654|Open-label extension study|open-label extension study
5412070|NCT01668641|Methotrexate insufficient responders|methotrexate insufficient responders
5412071|NCT01668628|quality of life|quality of life
5412072|NCT01668628|depression|depression
5412073|NCT01668628|BCM (body composition minitor)|bcm (body composition minitor)
5412074|NCT01668628|hydrational status|hydrational status
5412075|NCT01668615|idiopathicthrombocytopenic purpura|idiopathicthrombocytopenic purpura
5412076|NCT01668615|all-trans retinoic acid|all-trans retinoic acid
5412077|NCT01668615|regulory T cells|regulory t cells
5412078|NCT01668602|Rehabilitation|rehabilitation
5412079|NCT01668602|Gait disorders|gait disorders
5412080|NCT01668576|mesenchymal stem cells|mesenchymal stem cells
5412081|NCT01668576|Lung transplantation|lung transplantation
5412082|NCT01668563|Aneurysm|aneurysm
5412083|NCT01668563|Intracranial Aneurysm|intracranial aneurysm
5412084|NCT01668563|Vascular Diseases|vascular diseases
5412085|NCT01668563|Cardiovascular Diseases|cardiovascular diseases
5412086|NCT01668563|Intracranial Arterial Diseases|intracranial arterial diseases
5412087|NCT01668563|Cerebrovascular Disorders|cerebrovascular disorders
5412088|NCT01668563|Brain Diseases|brain diseases
5412089|NCT01668563|Central Nervous System Diseases|central nervous system diseases
5412090|NCT01668563|Nervous System Diseases|nervous system diseases
5412092|NCT01668550|Src/Abl inhibitor|src/abl inhibitor
5412093|NCT01668550|Solid Tumours|solid tumours
5412094|NCT01668550|Cancer|cancer
5412095|NCT01668511|Immunogenicity|immunogenicity
5412096|NCT01668511|Safety|safety
5412097|NCT01668511|Tolerability|tolerability
5412098|NCT01668511|Osteoarthritis|osteoarthritis
5412099|NCT01668511|Pharmacokinetics|pharmacokinetics
5412100|NCT01668498|Can preemptive treatment of panitumumab mediated skin|can preemptive treatment of panitumumab mediated skin
5412101|NCT01668498|toxicity with oral doxycycline be replaced by local treatment with erythromycin?|toxicity with oral doxycycline be replaced by local treatment with erythromycin?
5412102|NCT01668498|Panitumumab|panitumumab
5412103|NCT01668485|Type 1 diabetes mellitus|type 1 diabetes mellitus
5412104|NCT01668485|hypoglycemia counterregulation,|hypoglycemia counterregulation,
5412105|NCT01668485|pancreatic islet transplantation|pancreatic islet transplantation
5412106|NCT01668472|Pregnant|pregnant
5412107|NCT01668472|leaking fluid|leaking fluid
5412108|NCT01668459|Transitional cell carcinoma|transitional cell carcinoma
5412109|NCT01668459|Bladder cancer|bladder cancer
5412110|NCT01668459|Cancer|cancer
5412111|NCT01668459|Oncology|oncology
5412112|NCT01668459|Cabazitaxel|cabazitaxel
5412113|NCT01668446|Sildenafil|sildenafil
5412114|NCT01668446|Endometrial thickness|endometrial thickness
5412115|NCT01668446|Frozen embryo transfer|frozen embryo transfer
5412116|NCT01668446|ultrasonographic endometrial thickness|ultrasonographic endometrial thickness
5412117|NCT01668446|endometrial pattern|endometrial pattern
5412118|NCT01668446|Implantation rate|implantation rate
5412119|NCT01668446|chemical pregnancy rate|chemical pregnancy rate
5412120|NCT01668433|G6PD|g6pd
5412121|NCT01668433|Primaquine|primaquine
5412122|NCT01668433|Methylene blue|methylene blue
5412123|NCT01668420|thermal stimulation|thermal stimulation
5412124|NCT01668420|lower extremity|lower extremity
5412125|NCT01668420|temperature|temperature
5412126|NCT01668420|efficacy|efficacy
5412127|NCT01668407|Parkinson's disease|parkinson's disease
5412128|NCT01668407|PSP|psp
5412129|NCT01668407|Robot|robot
5412130|NCT01668407|Gait rehabilitation|gait rehabilitation
5412131|NCT01668381|hepatocellular carcinoma|hepatocellular carcinoma
5412132|NCT01668381|Catheter Ablation|catheter ablation
5412133|NCT01668381|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5412134|NCT01668381|IL-10|il-10
5412135|NCT01668381|TGF-β|tgf-β
5412136|NCT01668381|IFN-γ|ifn-γ
5412137|NCT01668368|ARDS|ards
5412138|NCT01668368|Esophageal pressure|esophageal pressure
5412139|NCT01668368|pleural pressure|pleural pressure
5412140|NCT01668368|pulmonary compliance|pulmonary compliance
5412166|NCT01668303|adolescents|adolescents
5412167|NCT01668303|substance abuse|substance abuse
5412168|NCT01668303|delinquency|delinquency
5412169|NCT01668303|family therapy|family therapy
5412170|NCT01668303|multidimensional family therapy|multidimensional family therapy
5412171|NCT01668290|Coronary Artery Disease|coronary artery disease
5412172|NCT01668290|Stress Echocardiography|stress echocardiography
5412173|NCT01668290|Single Photon Emission Computed Tomography|single photon emission computed tomography
5412174|NCT01668290|Cardiac Computed Tomographic Angiography|cardiac computed tomographic angiography
5412175|NCT01668290|outcomes|outcomes
5412176|NCT01668277|Pulmonary Hypertensive Crisis|pulmonary hypertensive crisis
5412177|NCT01668277|Pediatrics|pediatrics
5412178|NCT01668277|Hypertonic Saline|hypertonic saline
5412179|NCT01668264|Pediatrics|pediatrics
5412180|NCT01668264|Congenital Heart Disease|congenital heart disease
5412181|NCT01668264|Diastolic Function|diastolic function
5412182|NCT01668264|Echocardiograph|echocardiograph
5412183|NCT01668264|MRI|mri
5412184|NCT01668251|Turner syndrome|turner syndrome
5412185|NCT01668251|Diagnosis, prenatal|diagnosis, prenatal
5412186|NCT01668238|Thyroid tumor|thyroid tumor
5412187|NCT01668238|Breast tumor|breast tumor
5412188|NCT01668238|Fourier Transform Infrared Spectrometry|fourier transform infrared spectrometry
5412189|NCT01668238|Tumor Diagnosis|tumor diagnosis
5412195|NCT01668173|HSP90 Inhibitor|hsp90 inhibitor
5412196|NCT01668173|AUY922|auy922
5412197|NCT01668173|12-076|12-076
5412198|NCT01668160|clinical outcomes|clinical outcomes
5412199|NCT01668160|radiographic outcomes|radiographic outcomes
5412200|NCT01668160|total hip arthroplasty|total hip arthroplasty
5412201|NCT01668160|survivorship|survivorship
5412202|NCT01668147|PET Imaging|pet imaging
5412203|NCT01668147|Efavirenz|efavirenz
5412204|NCT01668147|Ritonavir|ritonavir
5412205|NCT01668147|[11C] desmethyl-loperamide|[11c] desmethyl-loperamide
5412206|NCT01668147|Healthy volunteers|healthy volunteers
5412207|NCT01668108|carcinoma|carcinoma
5412208|NCT01668108|breast cancer|breast cancer
5412209|NCT01668108|non-small cell lung cancer|non-small cell lung cancer
5412210|NCT01668108|ovarial cancer|ovarial cancer
5412211|NCT01668108|ambulant chemotherapy|ambulant chemotherapy
5412212|NCT01668108|treatment cycles|treatment cycles
5412213|NCT01668108|Paclitaxel|paclitaxel
5412214|NCT01668108|Paclitaxel onkovis|paclitaxel onkovis
5412215|NCT01668108|Quantity of Paclitaxel|quantity of paclitaxel
5412217|NCT01668082|Patients with newly identified brain mass|patients with newly identified brain mass
5412218|NCT01668069|nausea|nausea
5412219|NCT01668069|vomiting|vomiting
5412220|NCT01668069|pregnancy|pregnancy
5412221|NCT01668069|ondansetron|ondansetron
5412222|NCT01668069|doxylamine|doxylamine
5412223|NCT01668069|vitamin B6|vitamin b6
5412224|NCT01668069|pyridoxine|pyridoxine
5412225|NCT01668056|in vitro fertilization|in vitro fertilization
5412226|NCT01668056|ovarian stimulation|ovarian stimulation
5412227|NCT01668056|follicular waves|follicular waves
5412228|NCT01668056|luteal phase|luteal phase
5412229|NCT01668043|HIV-1|hiv-1
5412230|NCT01668043|CD4|cd4
5412231|NCT01668043|antibody|antibody
5412232|NCT01668043|immunotherapy|immunotherapy
5412233|NCT01668030|Facial|facial
5412234|NCT01668030|Partial thickness|partial thickness
5412235|NCT01668017|Advanced solid tumors|advanced solid tumors
5412236|NCT01668017|Hepatocellular carcinoma|hepatocellular carcinoma
5412237|NCT01668017|cancer, liver|cancer, liver
5412238|NCT01667991|Colonization|colonization
5412239|NCT01667991|infection|infection
5412240|NCT01667991|multidrug-resistant bacteria|multidrug-resistant bacteria
5412241|NCT01667991|guideline|guideline
5412242|NCT01667978|contraception|contraception
5412243|NCT01667978|mini pill|mini pill
5412244|NCT01667978|norethindrone|norethindrone
5412245|NCT01667978|atazanavir|atazanavir
5412246|NCT01667978|ritonavir|ritonavir
5412247|NCT01667978|norvir|norvir
5412248|NCT01667978|reyataz|reyataz
5412249|NCT01667978|pregnancy prevent|pregnancy prevent
5412250|NCT01667978|birth control|birth control
5412252|NCT01667978|AIDS|aids
5412253|NCT01667978|antiviral|antiviral
5412254|NCT01667978|antiretroviral|antiretroviral
5395076|NCT01743703|Whole-body MRI|whole-body mri
5412255|NCT01667965|palliative radiation|palliative radiation
5412256|NCT01667965|12-172|12-172
5412257|NCT01667952|Family History Questionnaire (FHQ)|family history questionnaire (fhq)
5412258|NCT01667952|Blood sample|blood sample
5412259|NCT01667952|Salvia sample|salvia sample
5412260|NCT01667952|12-145|12-145
5412261|NCT01667939|adequacy|adequacy
5412262|NCT01667939|diet|diet
5412263|NCT01667939|pregnancy|pregnancy
5412264|NCT01667913|Hip Fracture|hip fracture
5412265|NCT01667913|6-minutes walking test|6-minutes walking test
5412266|NCT01667913|Reliability|reliability
5412267|NCT01667887|Far Cortical Locking|far cortical locking
5412268|NCT01667887|Distal Femur Fracture|distal femur fracture
5412269|NCT01667887|Locking Plate|locking plate
5412270|NCT01667887|MotionLoc|motionloc
5412271|NCT01667887|Fracture Fixation|fracture fixation
5412272|NCT01667874|Randomized controlled trial|randomized controlled trial
5412273|NCT01667874|early joint infection|early joint infection
5412274|NCT01667874|gentamicin impregnated sponges|gentamicin impregnated sponges
5412275|NCT01667861|Glaucoma|glaucoma
5412276|NCT01667861|Wind instruments|wind instruments
5412277|NCT01667848|pain|pain
5412278|NCT01667835|yoga|yoga
5412279|NCT01667835|postmenopausal, sedentary South Asian women|postmenopausal, sedentary south asian women
5412280|NCT01667796|Multiple sclerosis|multiple sclerosis
5412281|NCT01667796|Healthy controls|healthy controls
5412282|NCT01667796|Pharmacokinetics|pharmacokinetics
5412283|NCT01667796|Vitamin D|vitamin d
5412284|NCT01667783|Obesity|obesity
5412285|NCT01667783|Diabetes|diabetes
5412286|NCT01667757|coronary atherosclerosis|coronary atherosclerosis
5412287|NCT01667757|drug eluting stent|drug eluting stent
5412288|NCT01667757|intravascular ultrasound|intravascular ultrasound
5412289|NCT01667757|fractional flow reserve|fractional flow reserve
5412290|NCT01667744|Angina|angina
5412291|NCT01667744|Acute Coronary Syndrome|acute coronary syndrome
5412292|NCT01667744|Emotional Distress|emotional distress
5412293|NCT01667744|Citalopram|citalopram
5412294|NCT01667744|Health Care Utilization|health care utilization
5412295|NCT01667731|Hepatitis C|hepatitis c
5412296|NCT01667731|Chronic|chronic
5412298|NCT01667731|HIV|hiv
5412299|NCT01667731|Human Immunodeficiency Virus|human immunodeficiency virus
5412300|NCT01667731|Co-Infected|co-infected
5412301|NCT01667718|eradication|eradication
5412302|NCT01667718|helicobacter pylori|helicobacter pylori
5412303|NCT01667718|bismuth|bismuth
5412304|NCT01667705|Stress|stress
5412305|NCT01667705|Anxiety|anxiety
5412306|NCT01667705|Skyceiling|skyceiling
5412307|NCT01667705|Nature|nature
5412308|NCT01667692|H-pylori|h-pylori
5412309|NCT01667692|eradication|eradication
5412310|NCT01667692|azithromycin|azithromycin
5412311|NCT01667692|clarithromycin|clarithromycin
5412312|NCT01667679|Migraine|migraine
5412313|NCT01667679|Headaches|headaches
5412314|NCT01667679|Sumatriptan|sumatriptan
5412315|NCT01667666|trauma|trauma
5412316|NCT01667666|acute lung injury|acute lung injury
5412317|NCT01667666|adult respiratory distress syndrome|adult respiratory distress syndrome
5412318|NCT01667640|Brain metastases|brain metastases
5412319|NCT01667640|radiation|radiation
5412320|NCT01667640|sector|sector
5412321|NCT01667640|singular|singular
5412322|NCT01667640|solitary|solitary
5412323|NCT01667640|neurocognition|neurocognition
5412324|NCT01667627|IBS|ibs
5412325|NCT01667627|Probiotic|probiotic
5412326|NCT01667627|hs-CRP|hs-crp
5412327|NCT01667627|Cholinergic status|cholinergic status
5412328|NCT01667627|Micro-inflammation|micro-inflammation
5412329|NCT01667601|mindfulness-based program|mindfulness-based program
5412330|NCT01667601|Psychoeducation|psychoeducation
5412331|NCT01667601|schizophrenia|schizophrenia
5412332|NCT01667601|Chinese|chinese
5412333|NCT01667601|outpatients|outpatients
5412334|NCT01667588|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5412335|NCT01667588|Pediatrics|pediatrics
5412336|NCT01667588|Sleep Disorders|sleep disorders
5412337|NCT01667549|Breastfeeding|breastfeeding
5412338|NCT01667549|Flavor learning|flavor learning
5412339|NCT01667549|Mother|mother
5412340|NCT01667549|Moms|moms
5412341|NCT01667549|Infants|infants
5412342|NCT01667549|Babies|babies
5412343|NCT01667549|Baby|baby
5412344|NCT01667549|Food Habits|food habits
5412345|NCT01667549|Fruits|fruits
5412346|NCT01667549|Vegetables|vegetables
5412347|NCT01667536|PROSTATE CANCER|prostate cancer
5412348|NCT01667536|HIGH-RISK|high-risk
5412349|NCT01667536|PROSTATECTOMY SURGERY|prostatectomy surgery
5412350|NCT01667536|NEWLY DIAGNOSED|newly diagnosed
5412351|NCT01667523|capsaicin|capsaicin
5412352|NCT01667523|cinnamaldehyde|cinnamaldehyde
5412353|NCT01667510|Prehypertension|prehypertension
5412354|NCT01667510|anti oxidation|anti oxidation
5412355|NCT01667510|lycopene|lycopene
5412356|NCT01667497|Cognitive fatigue|cognitive fatigue
5412357|NCT01667497|multiple sclerosis|multiple sclerosis
5412358|NCT01667484|Cognitive Impairment|cognitive impairment
5412359|NCT01667484|Multiple Sclerosis|multiple sclerosis
5412360|NCT01667484|Processing Speed|processing speed
5412361|NCT01667484|Treatment|treatment
5412362|NCT01667445|total knee arthroplasty|total knee arthroplasty
5412363|NCT01667445|epimorph|epimorph
5412364|NCT01667445|analgesia|analgesia
5412365|NCT01667406|kisspeptin|kisspeptin
5412366|NCT01667406|infertility|infertility
5412367|NCT01667406|in vitro fertilisation|in vitro fertilisation
5412368|NCT01667354|Parental Childhood Vaccine Hesitancy|parental childhood vaccine hesitancy
5412369|NCT01667341|HSV|hsv
5412370|NCT01667341|Herpes|herpes
5412371|NCT01667341|genital infection|genital infection
5412372|NCT01667341|vaccine|vaccine
5412373|NCT01667328|Anxiety|anxiety
5412374|NCT01667328|Presurgical anxiety|presurgical anxiety
5412375|NCT01667328|Breast Cancer|breast cancer
5412376|NCT01667302|NK/T-cell lymphoma|nk/t-cell lymphoma
5412377|NCT01667302|Radiotherapy|radiotherapy
5412378|NCT01667302|Adjuvant chemotherapy|adjuvant chemotherapy
5412379|NCT01667289|NK/T-cell lymphoma|nk/t-cell lymphoma
5412380|NCT01667289|Methotrexate|methotrexate
5412381|NCT01667289|Radiotherapy|radiotherapy
5412382|NCT01667289|Concurrent chemoradiation|concurrent chemoradiation
5412383|NCT01667276|AE adverse event|ae adverse event
5412384|NCT01667276|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5412385|NCT01667276|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5412386|NCT01667276|ART antiretroviral therapy|art antiretroviral therapy
5412387|NCT01667276|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5412388|NCT01667276|DCF data collection forms|dcf data collection forms
5412389|NCT01667276|DMC Data Monitoring Committee|dmc data monitoring committee
5412390|NCT01667276|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5412391|NCT01667276|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5412392|NCT01667276|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5412393|NCT01667276|ICH International Conference of Harmonisation|ich international conference of harmonisation
5412394|NCT01667276|IND Investigational New Drug Application|ind investigational new drug application
5412395|NCT01667276|IRB Institutional Review Board|irb institutional review board
5412396|NCT01667276|IU international units|iu international units
5412397|NCT01667276|mg milligram(s)|mg milligram(s)
5412398|NCT01667276|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5412399|NCT01667276|PCR polymerase chain reaction|pcr polymerase chain reaction
5412400|NCT01667276|SAE serious adverse event|sae serious adverse event
5412401|NCT01667276|µg microgram|µg microgram
5412402|NCT01667276|ULN upper limit of the normal range|uln upper limit of the normal range
5412403|NCT01667276|WB Western Blot|wb western blot
5412404|NCT01667263|All-trans retinoic acid|all-trans retinoic acid
5412405|NCT01667263|primary immune thrombocytopenia|primary immune thrombocytopenia
5412406|NCT01667263|corticosteroid-resistant|corticosteroid-resistant
5412407|NCT01667263|refractory|refractory
5412409|NCT01667250|vagus nerve stimulation|vagus nerve stimulation
5412410|NCT01667250|vagal nerve stimulation|vagal nerve stimulation
5412411|NCT01667250|nVNS|nvns
5412412|NCT01667250|VNS|vns
5412413|NCT01667250|chronic migraine|chronic migraine
5412414|NCT01667250|migraine|migraine
5412415|NCT01667250|non invasive|non invasive
5412416|NCT01667250|gammacore|gammacore
5412417|NCT01667237|Pulmonary rehabilitation program|pulmonary rehabilitation program
5412418|NCT01667237|Lung cancer|lung cancer
5412419|NCT01667237|Lung resection surgery|lung resection surgery
5412420|NCT01667237|Home-based|home-based
5412421|NCT01667224|Actiponin|actiponin
5412424|NCT01667211|Advanced uterine cervical cancer|advanced uterine cervical cancer
5412425|NCT01667185|pediatric|pediatric
5412426|NCT01667185|diabetes mellitus|diabetes mellitus
5412427|NCT01667159|Depression|depression
5412428|NCT01667159|Alcohol Use|alcohol use
5412429|NCT01667159|Outpatient Therapy|outpatient therapy
5412430|NCT01667133|Leukemia|leukemia
5412431|NCT01667133|Leukemia, Myeloid|leukemia, myeloid
5412432|NCT01667133|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5412433|NCT01667133|Neoplasms by Histologic Type|neoplasms by histologic type
5412434|NCT01667133|Neoplasms|neoplasms
5412435|NCT01667133|Lymphoproliferative Disorders|lymphoproliferative disorders
5412436|NCT01667133|Lymphatic Diseases|lymphatic diseases
5412437|NCT01667133|Immunoproliferative Disorders|immunoproliferative disorders
5412438|NCT01667133|Immune System Diseases|immune system diseases
5412439|NCT01667133|Myeloproliferative Disorders|myeloproliferative disorders
5412440|NCT01667133|Bone Marrow Diseases|bone marrow diseases
5412441|NCT01667133|Hematologic Diseases|hematologic diseases
5412442|NCT01667120|Ketorolac|ketorolac
5412443|NCT01667120|postoperative pain|postoperative pain
5412444|NCT01667120|bleeding events|bleeding events
5412445|NCT01667094|Pulmonary exacerbation|pulmonary exacerbation
5412446|NCT01667094|Continuous infusion|continuous infusion
5412447|NCT01667094|Antipseudomonal beta-lactams|antipseudomonal beta-lactams
5412448|NCT01667068|Cardiac Diseases|cardiac diseases
5412449|NCT01667068|HIV-Infection|hiv-infection
5412450|NCT01667068|AIDS|aids
5412451|NCT01667068|Antiretroviral Therapy|antiretroviral therapy
5412452|NCT01667068|Cardiovascular Medication|cardiovascular medication
5412454|NCT01667068|coronary heart disease|coronary heart disease
5412455|NCT01667068|heart failure|heart failure
5412456|NCT01667068|metabolic syndrome|metabolic syndrome
5412457|NCT01667055|drug allergy|drug allergy
5412458|NCT01667055|drug hypersensitivity|drug hypersensitivity
5412459|NCT01667055|beta-lactam allergy|beta-lactam allergy
5412460|NCT01667055|penicillin allergy|penicillin allergy
5412461|NCT01667055|adverse drug reaction|adverse drug reaction
5412462|NCT01667042|Scleroderma Lung|scleroderma lung
5412463|NCT01667042|Gastroesophageal Reflux|gastroesophageal reflux
5412464|NCT01667042|Microaspiration|microaspiration
5412465|NCT01667042|Cough|cough
5412466|NCT01667016|International|international
5412467|NCT01667016|Multicenter|multicenter
5412468|NCT01667016|Observational registry|observational registry
5412469|NCT01667016|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5412470|NCT01667016|Stenting|stenting
5412471|NCT01667016|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5412472|NCT01667016|Coronary revascularization|coronary revascularization
5412473|NCT01667016|Percutaneous Coronary Intervention|percutaneous coronary intervention
5412474|NCT01667016|STEMI|stemi
5412475|NCT01667016|NSTEMI|nstemi
5412476|NCT01667016|Ischemia|ischemia
5412477|NCT01667016|Angina|angina
5412478|NCT01667016|Subgroups|subgroups
5412479|NCT01667016|Acute Myocardial Infarction|acute myocardial infarction
5412480|NCT01667016|Diabetes|diabetes
5412481|NCT01667016|Small Vessels|small vessels
5412482|NCT01667016|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5412483|NCT01667003|International|international
5412485|NCT01667003|Observational registry|observational registry
5412486|NCT01667003|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5412487|NCT01667003|Stenting|stenting
5412488|NCT01667003|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5412489|NCT01667003|Coronary revascularization|coronary revascularization
5412490|NCT01667003|Percutaneous Coronary Intervention|percutaneous coronary intervention
5412491|NCT01667003|STEMI|stemi
5412492|NCT01667003|NSTEMI|nstemi
5412493|NCT01667003|Ischemia|ischemia
5412494|NCT01667003|Angina|angina
5412495|NCT01667003|Subgroups|subgroups
5412496|NCT01667003|Acute Myocardial Infarction|acute myocardial infarction
5412497|NCT01667003|Diabetes|diabetes
5412498|NCT01667003|Small Vessels|small vessels
5412499|NCT01666990|Tripterygium wilfordii Hook F (TwHF)|tripterygium wilfordii hook f (twhf)
5412501|NCT01666990|CD4|cd4
5412502|NCT01666990|immune over-activation|immune over-activation
5412503|NCT01666964|Traumatic brain injury|traumatic brain injury
5412504|NCT01666964|hypopituitarism|hypopituitarism
5412505|NCT01666938|Diabetes Mellitus|diabetes mellitus
5412506|NCT01666938|Telephone|telephone
5412507|NCT01666938|Physical activity|physical activity
5412508|NCT01666912|adolescence|adolescence
5412509|NCT01666912|contraception|contraception
5412510|NCT01666912|postpartum|postpartum
5412511|NCT01666912|rapid repeat pregnancy|rapid repeat pregnancy
5412512|NCT01666873|osteoarthritis|osteoarthritis
5412513|NCT01666860|anterior lumbar interbody fusion|anterior lumbar interbody fusion
5412514|NCT01666847|Umbilical Cord Milking|umbilical cord milking
5412515|NCT01666847|Extremely Low Birth Weight Infant (ELBW)|extremely low birth weight infant (elbw)
5412516|NCT01666834|mechanical ventilation, ARDS, Ventilator strategy, outcome|mechanical ventilation, ards, ventilator strategy, outcome
5412517|NCT01666821|macular degeneration; choroidal neovascularization|macular degeneration; choroidal neovascularization
5412518|NCT01666782|Influenza vaccine|influenza vaccine
5412520|NCT01666782|Chemotherapy|chemotherapy
5412521|NCT01666769|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5412522|NCT01666769|ECMO|ecmo
5412523|NCT01666769|Extracorporeal life support|extracorporeal life support
5412524|NCT01666769|Micafungin|micafungin
5412525|NCT01666769|Mycamine|mycamine
5412526|NCT01666769|Pharmacokinetics|pharmacokinetics
5412527|NCT01666743|Community-Acquired Pneumonia|community-acquired pneumonia
5412528|NCT01666743|Lung|lung
5412529|NCT01666743|Adult|adult
5412530|NCT01666743|Infections|infections
5412531|NCT01666691|Obese|obese
5412532|NCT01666691|Obesity|obesity
5412533|NCT01666691|Overweight|overweight
5412534|NCT01666691|Weight loss|weight loss
5412535|NCT01666691|Weight reduction|weight reduction
5412536|NCT01666691|Beloranib|beloranib
5412537|NCT01666678|Bioequivalence|bioequivalence
5412538|NCT01666665|Burn|burn
5412539|NCT01666652|Dengue|dengue
5412540|NCT01666652|Dengue fever|dengue fever
5412541|NCT01666652|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5412542|NCT01666652|Flavivirus|flavivirus
5412543|NCT01666626|crohn's disease|crohn's disease
5412544|NCT01666626|ultrasound|ultrasound
5412545|NCT01666626|intestinal fibrosis|intestinal fibrosis
5412546|NCT01666626|shear wave imaging|shear wave imaging
5412547|NCT01666626|acoustic radiation force impulse|acoustic radiation force impulse
5415946|NCT01650441|NEXThaler®|nexthaler®
5412558|NCT01666535|Influenza vaccine|influenza vaccine
5412559|NCT01666535|Immune response|immune response
5412560|NCT01666535|Remicade (infliximab)|remicade (infliximab)
5412561|NCT01666535|Inflammatory bowel disease|inflammatory bowel disease
5412864|NCT01665118|thigh|thigh
5412563|NCT01666522|osteopenia/osteoporosis|osteopenia/osteoporosis
5412564|NCT01666522|older adults|older adults
5412565|NCT01666522|vitamin D supplementation|vitamin d supplementation
5412566|NCT01666522|physical activity|physical activity
5412567|NCT01666496|Adolescent|adolescent
5412568|NCT01666496|risk|risk
5412569|NCT01666496|HIV|hiv
5412570|NCT01666496|video games|video games
5412571|NCT01666483|hysterectomy|hysterectomy
5412572|NCT01666483|single-port|single-port
5412573|NCT01666483|micro-laparoscopy|micro-laparoscopy
5412574|NCT01666470|Quality of life|quality of life
5412575|NCT01666457|Supporting Oral Feeding in Fragile Infants (SOFFI)|supporting oral feeding in fragile infants (soffi)
5412576|NCT01666457|Infant Oral Feeding|infant oral feeding
5412577|NCT01666457|Infant Growth|infant growth
5412578|NCT01666457|Preterm infant oral feeding|preterm infant oral feeding
5412579|NCT01666457|Preterm infant growth|preterm infant growth
5412580|NCT01666457|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
5412581|NCT01666444|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5412582|NCT01666444|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5412583|NCT01666444|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5412584|NCT01666444|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5412585|NCT01666444|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5412586|NCT01666444|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5412587|NCT01666444|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5412588|NCT01666444|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5412589|NCT01666444|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5412590|NCT01666444|Brenner tumor|brenner tumor
5412591|NCT01666405|Fecal Incontinence|fecal incontinence
5412592|NCT01666405|Bowel Incontinence|bowel incontinence
5412593|NCT01666392|Omega-3 fatty acid|omega-3 fatty acid
5412595|NCT01666392|Muscle mass|muscle mass
5412596|NCT01666392|Muscle strength|muscle strength
5412597|NCT01666392|Older adults|older adults
5412598|NCT01666392|Circulating inflammatory cytokines|circulating inflammatory cytokines
5412599|NCT01666392|Skeletal muscle mass|skeletal muscle mass
5412600|NCT01666392|Upper body strength|upper body strength
5412601|NCT01666392|Lower body strength|lower body strength
5412602|NCT01666379|Hallux valgus|hallux valgus
5412603|NCT01666379|Forefoot|forefoot
5412604|NCT01666379|transdermal fentanyl|transdermal fentanyl
5412605|NCT01666340|Exercise|exercise
5412606|NCT01666340|Elderly|elderly
5412607|NCT01666340|Mortality|mortality
5412608|NCT01666340|Morbidity|morbidity
5412609|NCT01666340|Prognosis|prognosis
5412610|NCT01666340|Longevity|longevity
5412611|NCT01666327|Crohn's Disease|crohn's disease
5412612|NCT01666327|Ulcerative Colitis|ulcerative colitis
5412613|NCT01666314|castrate resistant prostate cancer,|castrate resistant prostate cancer,
5412614|NCT01666314|CRPC,|crpc,
5412615|NCT01666314|orteronel,|orteronel,
5412616|NCT01666314|TAK-700|tak-700
5412617|NCT01666301|Erythropoietin stimulating agents|erythropoietin stimulating agents
5412618|NCT01666301|Hemoglobin|hemoglobin
5412619|NCT01666301|Reticulocytes|reticulocytes
5412620|NCT01666301|Variability|variability
5412621|NCT01666262|FLU|flu
5412622|NCT01666262|H1N1|h1n1
5412624|NCT01666262|PLAIV|plaiv
5412625|NCT01666249|FMH; anti-Rh; efficacy|fmh; anti-rh; efficacy
5412626|NCT01666236|Age-Related Macular Degeneration|age-related macular degeneration
5412627|NCT01666236|Pigment Epithelial Detachment|pigment epithelial detachment
5412628|NCT01666236|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5412629|NCT01666223|Type 2 diabetes|type 2 diabetes
5412631|NCT01666223|Bile acid|bile acid
5412632|NCT01666223|TGR-5|tgr-5
5412633|NCT01666197|Acute Joint Pain|acute joint pain
5412634|NCT01666184|Biomarkers study|biomarkers study
5412635|NCT01666171|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5412636|NCT01666171|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5412637|NCT01666171|stage IB breast cancer|stage ib breast cancer
5412638|NCT01666171|stage II breast cancer|stage ii breast cancer
5412639|NCT01666171|stage IIIA breast cancer|stage iiia breast cancer
5412640|NCT01666171|stage IIIC breast cancer|stage iiic breast cancer
5412641|NCT01666145|Hepatocellular Cancer|hepatocellular cancer
5412642|NCT01666145|Hepatocellular Carcinoma|hepatocellular carcinoma
5412643|NCT01666145|Hepatoma|hepatoma
5412644|NCT01666145|Liver Cancer, Adult|liver cancer, adult
5412645|NCT01666145|Liver Cell Carcinoma, Adult|liver cell carcinoma, adult
5412646|NCT01666132|LVEF < 40%|lvef < 40%
5412647|NCT01666119|Opioid dependence|opioid dependence
5412648|NCT01666119|Suboxone|suboxone
5412649|NCT01666119|addiction|addiction
5412650|NCT01666119|BEMA Buprenorphine NX|bema buprenorphine nx
5412651|NCT01666119|oral transmucosal|oral transmucosal
5412652|NCT01666093|peripheral artery disease|peripheral artery disease
5412653|NCT01666093|endovascular procedure|endovascular procedure
5412654|NCT01666093|non-healing ulcer|non-healing ulcer
5412655|NCT01666080|second stem cell transplant|second stem cell transplant
5412656|NCT01666080|donor hematopoietic engraftment|donor hematopoietic engraftment
5412657|NCT01666080|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5412658|NCT01666080|inherited metabolic disorder|inherited metabolic disorder
5412659|NCT01666067|insulin resistance|insulin resistance
5412660|NCT01666054|Weaning|weaning
5412661|NCT01666054|mechanical ventilation|mechanical ventilation
5412662|NCT01666054|Proportional Assist Ventilation|proportional assist ventilation
5412663|NCT01666041|insulin resistance|insulin resistance
5412664|NCT01666028|Type 1 Diabetes|type 1 diabetes
5412665|NCT01666028|Closed Loop glucose control|closed loop glucose control
5412666|NCT01666028|Artificial Pancreas|artificial pancreas
5412667|NCT01666028|CSII|csii
5412668|NCT01666028|CGM|cgm
5412669|NCT01666015|pediatric|pediatric
5412670|NCT01666015|exercise|exercise
5412671|NCT01666015|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5412672|NCT01666015|cancer|cancer
5412673|NCT01666015|quality of life|quality of life
5412674|NCT01666015|immune system|immune system
5412675|NCT01666015|physical activity levels|physical activity levels
5412676|NCT01665937|liver cancer|liver cancer
5412677|NCT01665937|advanced liver cancer|advanced liver cancer
5412678|NCT01665937|advanced hepatocellular cancer|advanced hepatocellular cancer
5412679|NCT01665911|Caries|caries
5412680|NCT01665898|cold biopsy forceps|cold biopsy forceps
5412681|NCT01665898|cold snare biopsy|cold snare biopsy
5412682|NCT01665885|hypothermia|hypothermia
5412683|NCT01665885|induction of hypothermia|induction of hypothermia
5412684|NCT01665885|non invasive cooling|non invasive cooling
5412685|NCT01665885|external cooling|external cooling
5412686|NCT01665885|surface cooling|surface cooling
5412687|NCT01665885|endovascular cooling|endovascular cooling
5412688|NCT01665885|cooling catheter|cooling catheter
5412689|NCT01665885|stroke|stroke
5412690|NCT01665885|shivering|shivering
5412691|NCT01665885|neuro monitoring|neuro monitoring
5412692|NCT01665885|coagulation|coagulation
5412693|NCT01665872|Mothers|mothers
5412694|NCT01665872|Depression|depression
5412695|NCT01665872|Stress|stress
5412696|NCT01665872|Trauma|trauma
5412697|NCT01665872|Public Housing|public housing
5412698|NCT01665859|readmission|readmission
5412699|NCT01665859|recurrence|recurrence
5412700|NCT01665859|umbilical|umbilical
5412701|NCT01665859|epigastric|epigastric
5412702|NCT01665859|hernia|hernia
5412703|NCT01665859|outcome|outcome
5412704|NCT01665859|morbidity|morbidity
5412705|NCT01665846|HIV associated neurocognitive disorders|hiv associated neurocognitive disorders
5412706|NCT01665846|MRI|mri
5412707|NCT01665846|Ferumoxytol|ferumoxytol
5412708|NCT01665833|Angina|angina
5412709|NCT01665833|SYNTAX|syntax
5412710|NCT01665833|Coronary|coronary
5412712|NCT01665833|CABG|cabg
5412713|NCT01665820|chest|chest
5412714|NCT01665820|pathology|pathology
5412715|NCT01665807|influenza|influenza
5412716|NCT01665807|vaccine|vaccine
5412717|NCT01665807|administration|administration
5412718|NCT01665781|Hemoglobin|hemoglobin
5412719|NCT01665781|Erythropoietin|erythropoietin
5412720|NCT01665781|Acute Mountain sickness|acute mountain sickness
5412721|NCT01665742|Obesity|obesity
5412722|NCT01665742|Chronic inflammation|chronic inflammation
5412723|NCT01665742|Anti-inflammatory dietary intervention|anti-inflammatory dietary intervention
5412725|NCT01665729|etiology|etiology
5412726|NCT01665729|pathogenesis|pathogenesis
5412727|NCT01665729|minor ischaemic stroke|minor ischaemic stroke
5412728|NCT01665729|types|types
5412729|NCT01665729|intervention|intervention
5412730|NCT01665703|[18F]|[18f]
5412732|NCT01665703|FDG-PET-MRI|fdg-pet-mri
5412733|NCT01665703|Renal Cell Carcinoma|renal cell carcinoma
5412734|NCT01665703|Pilot Study|pilot study
5412735|NCT01665703|LCCC 1213|lccc 1213
5412736|NCT01665703|UNC Lineberger|unc lineberger
5412737|NCT01665690|patient delivered partner therapy|patient delivered partner therapy
5412738|NCT01665690|expedited partner therapy|expedited partner therapy
5412739|NCT01665690|partner notification|partner notification
5412740|NCT01665690|gonorrhea|gonorrhea
5412741|NCT01665690|chlamydia|chlamydia
5412742|NCT01665677|Graft vs Host Disease|graft vs host disease
5412743|NCT01665677|GVHD|gvhd
5412744|NCT01665677|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5412745|NCT01665677|HSCT|hsct
5412746|NCT01665677|Atorvastatin|atorvastatin
5412747|NCT01665664|Indirect calorimetry|indirect calorimetry
5412748|NCT01665664|hypocaloric feeding|hypocaloric feeding
5412749|NCT01665638|Healthy|healthy
5412750|NCT01665638|Clearance|clearance
5412751|NCT01665638|Canagliflozin|canagliflozin
5412752|NCT01665638|JNJ-28431754|jnj-28431754
5412753|NCT01665638|Placebo|placebo
5412754|NCT01665638|Somatostatin|somatostatin
5412755|NCT01665638|C-peptide|c-peptide
5412756|NCT01665625|Pancreatic cancer|pancreatic cancer
5412757|NCT01665625|Intra-arterial infusion|intra-arterial infusion
5412758|NCT01665625|Gemcitabine|gemcitabine
5412759|NCT01665612|Contact lens|contact lens
5412760|NCT01665612|Care solution|care solution
5412764|NCT01665586|sedation in elderly patient|sedation in elderly patient
5412765|NCT01665586|spinal anesthesia|spinal anesthesia
5412766|NCT01665573|Fear Conditioning|fear conditioning
5412767|NCT01665573|Cannabinoids|cannabinoids
5412768|NCT01665573|Fear Response|fear response
5412769|NCT01665560|smoking|smoking
5412770|NCT01665560|fMRI|fmri
5412771|NCT01665560|odors|odors
5412772|NCT01665560|taste|taste
5412773|NCT01665547|clomiphene resistant|clomiphene resistant
5412774|NCT01665547|pcos|pcos
5412775|NCT01665547|induction of ovulation|induction of ovulation
5412776|NCT01665547|l-carnitine|l-carnitine
5412777|NCT01665534|hypertension|hypertension
5412778|NCT01665534|inflammation|inflammation
5412779|NCT01665534|salt intake|salt intake
5412780|NCT01665521|Acute Coronary Syndrome|acute coronary syndrome
5412781|NCT01665521|Chest pain|chest pain
5412782|NCT01665521|Risk Stratification|risk stratification
5412783|NCT01665521|HEART Pathway|heart pathway
5412784|NCT01665521|Emergency Department|emergency department
5412785|NCT01665508|angina|angina
5412786|NCT01665508|cardiopulmonary testing|cardiopulmonary testing
5412787|NCT01665508|metabolomics|metabolomics
5412788|NCT01665508|nebivolol|nebivolol
5412789|NCT01665495|pericardial effusion|pericardial effusion
5412790|NCT01665495|cardiac tamponade|cardiac tamponade
5412791|NCT01665495|pericardiocentesis|pericardiocentesis
5412792|NCT01665495|pericardial drainage|pericardial drainage
5412793|NCT01665495|prevention|prevention
5412794|NCT01665482|Inflammation|inflammation
5412795|NCT01665482|Insulin sensitivity|insulin sensitivity
5412796|NCT01665482|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5412797|NCT01665482|C-peptide|c-peptide
5412798|NCT01665482|Saturated fatty acid (SFA)|saturated fatty acid (sfa)
5412799|NCT01665482|Monounsaturated fatty acid (MUFA)|monounsaturated fatty acid (mufa)
5412800|NCT01665482|Carbohydrate (CARB)|carbohydrate (carb)
5412801|NCT01665469|anti oxidation|anti oxidation
5412802|NCT01665469|lycopene|lycopene
5412804|NCT01665456|complications|complications
5412805|NCT01665417|Icotinib|icotinib
5412806|NCT01665417|EGFR positive mutation|egfr positive mutation
5412807|NCT01665417|First-line treatment|first-line treatment
5412808|NCT01665417|Maintenance treatment|maintenance treatment
5412809|NCT01665378|prepregnancy|prepregnancy
5412810|NCT01665378|micronutrient|micronutrient
5412811|NCT01665378|supplementation|supplementation
5412812|NCT01665378|maternal|maternal
5412813|NCT01665378|child|child
5412814|NCT01665378|health|health
5412815|NCT01665365|Myocardial infarction|myocardial infarction
5412816|NCT01665365|Remote ischemic conditioning|remote ischemic conditioning
5412817|NCT01665365|Clinical outcome|clinical outcome
5412818|NCT01665339|preload|preload
5412819|NCT01665339|anthropometric measures|anthropometric measures
5412820|NCT01665339|cardiovascular risk factors|cardiovascular risk factors
5412821|NCT01665326|Pompe disease|pompe disease
5412822|NCT01665326|Glycogen Storage Disease Type II|glycogen storage disease type ii
5412823|NCT01665326|Acid Maltase Deficiency|acid maltase deficiency
5412824|NCT01665326|CRIM Status|crim status
5412825|NCT01665326|Acid Alpha-Glucosidase Deficiency|acid alpha-glucosidase deficiency
5412826|NCT01665326|Alglucosidase alfa|alglucosidase alfa
5412827|NCT01665326|Myozyme|myozyme
5412828|NCT01665326|Enzyme replacement therapy|enzyme replacement therapy
5412838|NCT01665287|Fullterm|fullterm
5412839|NCT01665287|Infant|infant
5412840|NCT01665274|xelox|xelox
5412841|NCT01665274|advanced gastric cancer|advanced gastric cancer
5412842|NCT01665261|Congenital heart disease|congenital heart disease
5412843|NCT01665261|Newborn|newborn
5412844|NCT01665261|Pulse oximetry|pulse oximetry
5412845|NCT01665261|Screening|screening
5412846|NCT01665248|18-F Sodium Fluoride|18-f sodium fluoride
5412847|NCT01665248|Acute coronary syndrome|acute coronary syndrome
5412848|NCT01665248|Stable Angina|stable angina
5412849|NCT01665196|IgG4-related disease|igg4-related disease
5412850|NCT01665196|IgG4-RD|igg4-rd
5412851|NCT01665196|18F-FDG|18f-fdg
5412852|NCT01665196|PET/CT|pet/ct
5412853|NCT01665183|argininosuccinate synthetase|argininosuccinate synthetase
5412854|NCT01665183|arginine|arginine
5412855|NCT01665183|arginine deiminase|arginine deiminase
5412856|NCT01665170|Pascoflair|pascoflair
5412857|NCT01665170|tsst|tsst
5412858|NCT01665170|passiflora incarnata|passiflora incarnata
5412859|NCT01665170|non smoking male|non smoking male
5412860|NCT01665170|and female volunteers|and female volunteers
5412861|NCT01665157|Diet Control before Colonoscopy|diet control before colonoscopy
5412863|NCT01665118|Radio frequency|radio frequency
5412865|NCT01665118|circumference|circumference
5412866|NCT01665118|reduction|reduction
5412867|NCT01665105|Pulse Rate Variability|pulse rate variability
5412868|NCT01665105|Skin Blood Flow|skin blood flow
5412869|NCT01665105|Skin Temperature|skin temperature
5412870|NCT01665105|Electroacupuncture|electroacupuncture
5412871|NCT01665105|Zusanli|zusanli
5412872|NCT01665105|Yanglingquan|yanglingquan
5412873|NCT01665079|anaesthetics iv|anaesthetics iv
5412874|NCT01665079|propofol|propofol
5412875|NCT01665079|pharmacokinetics|pharmacokinetics
5412876|NCT01665079|pharmacodynamic|pharmacodynamic
5412877|NCT01665053|Drug-Eluting Stents|drug-eluting stents
5412878|NCT01665040|neurostimulation|neurostimulation
5412879|NCT01665040|spinal cord stimulation|spinal cord stimulation
5412880|NCT01665040|peripheral nerve stimulation|peripheral nerve stimulation
5412881|NCT01665027|caesarean section,|caesarean section,
5412882|NCT01665027|vacuum,|vacuum,
5412883|NCT01665027|fetal head extraction,|fetal head extraction,
5412884|NCT01665027|maternal complication,|maternal complication,
5412885|NCT01665027|fetal complication|fetal complication
5412886|NCT01665014|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5412887|NCT01665014|total marrow irradiation|total marrow irradiation
5412888|NCT01665014|melphalan|melphalan
5412889|NCT01665014|multiple myeloma|multiple myeloma
5412890|NCT01665001|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5412891|NCT01665001|Induction|induction
5412892|NCT01665001|Consolidation|consolidation
5412893|NCT01665001|Minimal residual disease|minimal residual disease
5412894|NCT01665001|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5412895|NCT01664975|Peripheral T-cell lymphoma;chemotherapy;|peripheral t-cell lymphoma;chemotherapy;
5412896|NCT01664975|RR;PFS;OS|rr;pfs;os
5412897|NCT01664936|18F-FDG PET/CT scan|18f-fdg pet/ct scan
5412898|NCT01664936|131I therapy|131i therapy
5412899|NCT01664936|Cerenkov Luminescence Imaging|cerenkov luminescence imaging
5412900|NCT01664936|12-050|12-050
5412901|NCT01664936|Lymphoma|lymphoma
5412902|NCT01664936|Leukemia|leukemia
5412903|NCT01664936|Metastatic Lymph Nodes|metastatic lymph nodes
5412904|NCT01664923|prostate cancer|prostate cancer
5412905|NCT01664923|enzalutamide|enzalutamide
5412906|NCT01664923|MDV3100|mdv3100
5412907|NCT01664884|INTERNALIZED STIGMA|internalized stigma
5412908|NCT01664884|INSIGHT|insight
5412909|NCT01664884|SOCIAL ADEQUACY|social adequacy
5412910|NCT01664884|BIPOLAR DISORDER|bipolar disorder
5412911|NCT01664884|SCHIZOPHRENIA|schizophrenia
5412912|NCT01664858|Coronary Heart Disease|coronary heart disease
5412913|NCT01664858|Ischaemic Heart Disease|ischaemic heart disease
5412914|NCT01664858|Angina|angina
5412915|NCT01664858|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5412916|NCT01664845|hepatitis c|hepatitis c
5412917|NCT01664845|metformin|metformin
5412918|NCT01664845|pegylated interferon|pegylated interferon
5412919|NCT01664832|Premature Infants|premature infants
5412920|NCT01664832|snychronized ventilation|snychronized ventilation
5412921|NCT01664832|non-invasive ventilation|non-invasive ventilation
5412922|NCT01664832|RDS|rds
5412923|NCT01664806|Electrosurgery|electrosurgery
5412924|NCT01664806|Radiofrequency energy|radiofrequency energy
5412925|NCT01664806|Monopolar instruments|monopolar instruments
5412926|NCT01664806|Capacitive coupling|capacitive coupling
5412931|NCT01664793|strategies|strategies
5412932|NCT01664793|children/adolescents|children/adolescents
5412933|NCT01664780|standard|standard
5412934|NCT01664780|values|values
5412935|NCT01664780|share|share
5412936|NCT01664780|wave velocity|wave velocity
5412937|NCT01664780|in ARFI imaging|in arfi imaging
5412939|NCT01664767|Thermal water|thermal water
5412940|NCT01664767|Oxidative stress|oxidative stress
5412941|NCT01664767|Inflammation|inflammation
5412942|NCT01664741|Nicotine dependence|nicotine dependence
5412943|NCT01664741|cigarette|cigarette
5412944|NCT01664741|smoking|smoking
5412945|NCT01664741|nicotine replacement therapy|nicotine replacement therapy
5412946|NCT01664741|positron emission tomography|positron emission tomography
5412947|NCT01664728|Prostate neoplasms|prostate neoplasms
5412948|NCT01664728|Hormone refractory prostate cancer|hormone refractory prostate cancer
5412949|NCT01664728|Castration resistant prostate cancer|castration resistant prostate cancer
5412950|NCT01664728|Castration refractory prostate cancer|castration refractory prostate cancer
5412951|NCT01664728|Abiraterone acetate|abiraterone acetate
5412952|NCT01664728|CB7630|cb7630
5412953|NCT01664715|Overweight|overweight
5412954|NCT01664715|Obesity|obesity
5412955|NCT01664715|Exercise|exercise
5412956|NCT01664715|Weight Loss|weight loss
5412957|NCT01664702|Dairy|dairy
5412958|NCT01664702|obesity|obesity
5412959|NCT01664676|liraglutide|liraglutide
5412960|NCT01664676|victoza|victoza
5412961|NCT01664676|GLP-1|glp-1
5412962|NCT01664676|kidney|kidney
5412963|NCT01664676|diabetes|diabetes
5412964|NCT01664676|renal|renal
5412965|NCT01664676|diabetic nephropathy|diabetic nephropathy
5412966|NCT01664663|Radiotherapy|radiotherapy
5412967|NCT01664663|Dose escalation|dose escalation
5412968|NCT01664663|Normal tissue constraints|normal tissue constraints
5412969|NCT01664663|Locally advanced disease|locally advanced disease
5412970|NCT01664663|Good performance status|good performance status
5412971|NCT01664650|menopause|menopause
5412972|NCT01664650|pre-diabetes|pre-diabetes
5412973|NCT01664637|diabetic gastroparesis|diabetic gastroparesis
5412974|NCT01664637|delayed gastric emptying|delayed gastric emptying
5412975|NCT01664637|gastroparesis|gastroparesis
5412976|NCT01664637|diabetes mellitus, Type 1|diabetes mellitus, type 1
5412977|NCT01664637|diabetes mellitus, Type 2|diabetes mellitus, type 2
5412978|NCT01664624|Drug Therapy|drug therapy
5412979|NCT01664611|Remote Ischaemic Conditioning|remote ischaemic conditioning
5412980|NCT01664611|Remodeling|remodeling
5412981|NCT01664611|Heart Failure|heart failure
5412982|NCT01664611|Myocardial Infarction|myocardial infarction
5412983|NCT01664611|Ischaemia/Reperfusion Injury|ischaemia/reperfusion injury
5412984|NCT01664611|successful primary percutaneous coronary intervention following a first STEMI|successful primary percutaneous coronary intervention following a first stemi
5412985|NCT01664585|headache|headache
5412986|NCT01664585|women|women
5412987|NCT01664585|exercise|exercise
5412988|NCT01664585|fear avoidance|fear avoidance
5412989|NCT01664585|physical activity|physical activity
5412990|NCT01664572|laser Doppler flowmetry, skin blood flow|laser doppler flowmetry, skin blood flow
5412991|NCT01664559|intrauterine device|intrauterine device
5412992|NCT01664559|ketorolac|ketorolac
5412993|NCT01664559|toradol|toradol
5412994|NCT01664559|mirena|mirena
5412995|NCT01664559|paragard|paragard
5412996|NCT01664559|pain control|pain control
5412997|NCT01664520|Subarachnoid hemorrhage|subarachnoid hemorrhage
5412998|NCT01664520|Dexmedetomidine|dexmedetomidine
5412999|NCT01664520|Autoregulation|autoregulation
5413000|NCT01664520|Intracranial pressure|intracranial pressure
5413001|NCT01664520|Cerebral oxygenation|cerebral oxygenation
5413002|NCT01664507|croup, dose, epinephrine|croup, dose, epinephrine
5413003|NCT01664273|electroporation|electroporation
5413004|NCT01664273|gen electrotransfer|gen electrotransfer
5413006|NCT01664273|plasmid AMEP|plasmid amep
5413007|NCT01664260|Posttraumatic Stress Disorder|posttraumatic stress disorder
5413008|NCT01664260|N-acetylcysteine|n-acetylcysteine
5413009|NCT01664260|Magnetic Resonance Imaging|magnetic resonance imaging
5413010|NCT01664234|infants with cleft palate|infants with cleft palate
5413011|NCT01664234|Pierre Robin|pierre robin
5413012|NCT01664234|Treacher Collins|treacher collins
5413013|NCT01664234|trisomy 21|trisomy 21
5413014|NCT01664221|subject|subject
5413015|NCT01664195|subjects|subjects
5413016|NCT01664169|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5413017|NCT01664169|recurrent pancreatic cancer|recurrent pancreatic cancer
5413018|NCT01664169|stage III pancreatic cancer|stage iii pancreatic cancer
5413019|NCT01664169|stage IV pancreatic cancer|stage iv pancreatic cancer
5413020|NCT01664169|stage IIB pancreatic cancer|stage iib pancreatic cancer
5413021|NCT01664156|Cold hypersensitivity|cold hypersensitivity
5413022|NCT01664156|Korean red ginseng|korean red ginseng
5413023|NCT01664156|Infrared thermography|infrared thermography
5413025|NCT01664156|Distal-dorsal difference|distal-dorsal difference
5413026|NCT01664091|tissue expander|tissue expander
5413027|NCT01664091|acellular dermal matrix|acellular dermal matrix
5413028|NCT01664078|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5413029|NCT01664065|Patient Safety|patient safety
5413030|NCT01664065|Tolerability|tolerability
5413031|NCT01664065|Pharmacokinetics|pharmacokinetics
5413033|NCT01664039|Ocular hypertension|ocular hypertension
5413034|NCT01664000|Tumors|tumors
5413035|NCT01664000|carcinoma|carcinoma
5413036|NCT01664000|apoptosis|apoptosis
5413037|NCT01664000|p53|p53
5413038|NCT01664000|p21|p21
5413039|NCT01664000|Caspase3|caspase3
5413040|NCT01664000|PARP|parp
5413041|NCT01664000|MDM2|mdm2
5413042|NCT01664000|PUMA|puma
5413043|NCT01663974|Bipolar Disorders|bipolar disorders
5413044|NCT01663974|Sub-syndromal symptoms|sub-syndromal symptoms
5413045|NCT01663974|Acute depressive episode|acute depressive episode
5413046|NCT01663974|Symptomatic remission|symptomatic remission
5413047|NCT01663974|Functioning remission|functioning remission
5413048|NCT01663961|Phase I|phase i
5413049|NCT01663961|Pharmacokinetics|pharmacokinetics
5413050|NCT01663961|YM178 Oral Controlled Absorption System (OCAS)|ym178 oral controlled absorption system (ocas)
5413051|NCT01663961|Digoxin (Lanoxin)|digoxin (lanoxin)
5413052|NCT01663961|DDI (Drug-drug interaction)|ddi (drug-drug interaction)
5413053|NCT01663961|Open-label|open-label
5413054|NCT01663961|Steady-state|steady-state
5413055|NCT01663961|subjects|subjects
5413056|NCT01663948|Plastic bronchitis|plastic bronchitis
5413057|NCT01663948|PB|pb
5413058|NCT01663935|levodopa|levodopa
5413059|NCT01663935|Albinism|albinism
5413060|NCT01663935|dopamine|dopamine
5413061|NCT01663935|oculocutaneous albinism|oculocutaneous albinism
5413062|NCT01663935|vision|vision
5413063|NCT01663935|retina function|retina function
5413064|NCT01663909|Pain|pain
5413065|NCT01663909|Scoliosis|scoliosis
5413066|NCT01663909|Rehabilitation|rehabilitation
5413067|NCT01663909|Cognitive-behavioral interventions|cognitive-behavioral interventions
5413068|NCT01663909|Adolescents|adolescents
5413069|NCT01663883|Blood flow autoregulation|blood flow autoregulation
5413070|NCT01663883|optic nerve head blood flow|optic nerve head blood flow
5413071|NCT01663883|isometric exercise|isometric exercise
5413072|NCT01663883|Autoregulation|autoregulation
5413073|NCT01663883|ocular physiology|ocular physiology
5413074|NCT01663870|Cancer Prevention|cancer prevention
5413075|NCT01663870|Breast cancer survivors|breast cancer survivors
5413076|NCT01663870|Cancer survivorship clinic|cancer survivorship clinic
5413077|NCT01663870|eHealth technology|ehealth technology
5413078|NCT01663870|Internet|internet
5413079|NCT01663870|HealthATM website|healthatm website
5413080|NCT01663870|Questionnaire|questionnaire
5413081|NCT01663870|Clinic stakeholders|clinic stakeholders
5413082|NCT01663870|Clinic nurses|clinic nurses
5413083|NCT01663870|Physicians|physicians
5413084|NCT01663870|Case managers|case managers
5413085|NCT01663870|Oncology patient navigators|oncology patient navigators
5413086|NCT01663870|Audio recorded interviews|audio recorded interviews
5413087|NCT01663844|Cognitive behavior therapy|cognitive behavior therapy
5413088|NCT01663844|Internet treatment|internet treatment
5413089|NCT01663844|Self-help treatment|self-help treatment
5413090|NCT01663844|Insomnia|insomnia
5413091|NCT01663844|Depression|depression
5413092|NCT01663844|ICBT|icbt
5413093|NCT01663844|CBT-i|cbt-i
5413094|NCT01663844|CBT-d|cbt-d
5413095|NCT01663831|Outdoor Malaria Transmission|outdoor malaria transmission
5413096|NCT01663831|Anopheles|anopheles
5413097|NCT01663831|Topical repellent|topical repellent
5413098|NCT01663831|Early biting vector|early biting vector
5413099|NCT01663831|Long Lasting Insecticidal Net (LLIN)|long lasting insecticidal net (llin)
5413100|NCT01663831|Cambodia|cambodia
5413101|NCT01663805|Extended Criteria Donor|extended criteria donor
5413102|NCT01663805|Delayed Graft Function|delayed graft function
5413103|NCT01663805|DGF|dgf
5413104|NCT01663805|Deceased donors aged ≥ 60 years|deceased donors aged ≥ 60 years
5413105|NCT01663805|aged between 50 and 59 years|aged between 50 and 59 years
5413106|NCT01663805|history of systemic hypertension|history of systemic hypertension
5413107|NCT01663805|terminal creatinine levels > 1.5 mg/dL|terminal creatinine levels > 1.5 mg/dl
5413108|NCT01663805|death by a cerebrovascular accident|death by a cerebrovascular accident
5413109|NCT01663792|urokinase receptor|urokinase receptor
5413110|NCT01663792|protein expression|protein expression
5413111|NCT01663792|seaweed (Undaria pinnatifida)|seaweed (undaria pinnatifida)
5413112|NCT01663766|GVHD (acute or chronic)|gvhd (acute or chronic)
5413113|NCT01663766|acute myeloid or lymphoblastic leukemia (AML or ALL)|acute myeloid or lymphoblastic leukemia (aml or all)
5413114|NCT01663766|myelodysplastic syndrome|myelodysplastic syndrome
5413115|NCT01663766|Chronic myelogenous leukemia (CML)|chronic myelogenous leukemia (cml)
5413116|NCT01663766|Multiple Myeloma (MM)|multiple myeloma (mm)
5413117|NCT01663766|Non-Hodgekin lymphoma (NHL-both follicular & diffuse large cell)|non-hodgekin lymphoma (nhl-both follicular & diffuse large cell)
5413126|NCT01663714|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
5413131|NCT01663701|Tuberculosis|tuberculosis
5413133|NCT01663701|Zambia|zambia
5413134|NCT01663675|Down syndrome|down syndrome
5413136|NCT01663649|Online-Therapy|online-therapy
5413137|NCT01663649|Deprexis|deprexis
5413138|NCT01663649|Self-help|self-help
5413139|NCT01663636|vaccines|vaccines
5413140|NCT01663636|SMS|sms
5413141|NCT01663636|mobile phones|mobile phones
5413142|NCT01663623|Wegener's Granulomatosis|wegener's granulomatosis
5413143|NCT01663623|anti-MPO|anti-mpo
5413144|NCT01663623|WG|wg
5413145|NCT01663623|Belimumab|belimumab
5413146|NCT01663623|GPA|gpa
5413147|NCT01663623|anti-proteinase 3|anti-proteinase 3
5413148|NCT01663623|anti-neutrophil cytoplasmic antibody|anti-neutrophil cytoplasmic antibody
5413149|NCT01663623|anti-myeloperoxidase|anti-myeloperoxidase
5413150|NCT01663623|Granulomatosis with polyangiitis|granulomatosis with polyangiitis
5413151|NCT01663623|Vasculitis|vasculitis
5413152|NCT01663623|Autoimmune Diseases|autoimmune diseases
5413153|NCT01663623|Microscopic Polyangiitis|microscopic polyangiitis
5413154|NCT01663623|anti-PR3|anti-pr3
5413155|NCT01663623|ANCA|anca
5413156|NCT01663623|MPA|mpa
5413157|NCT01663623|Systemic Vasculitis|systemic vasculitis
5413158|NCT01663584|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5413159|NCT01663584|Carrier Screening|carrier screening
5413160|NCT01663584|Genetic Testing|genetic testing
5413161|NCT01663558|anal dysplasia|anal dysplasia
5413162|NCT01663558|HPV|hpv
5413163|NCT01663558|HIV|hiv
5413164|NCT01663558|MSM|msm
5413165|NCT01663545|Epilepsy|epilepsy
5413166|NCT01663545|Epileptic Focus|epileptic focus
5413167|NCT01663545|Inflammation|inflammation
5413168|NCT01663545|P-Glycoprotein|p-glycoprotein
5413169|NCT01663545|PET Imaging|pet imaging
5413170|NCT01663532|Schizophrenia|schizophrenia
5413171|NCT01663519|Diabetic foot|diabetic foot
5413172|NCT01663519|Offloading|offloading
5413173|NCT01663519|Prevention|prevention
5413174|NCT01663519|Orthotics|orthotics
5413175|NCT01663467|tinnitus|tinnitus
5413176|NCT01663467|smartphone|smartphone
5413177|NCT01663467|Web|web
5413178|NCT01663441|Chemotherapy|chemotherapy
5413179|NCT01663441|Thrombocytopenia|thrombocytopenia
5413180|NCT01663441|Interleukin-11|interleukin-11
5413181|NCT01663441|Platelet|platelet
5413182|NCT01663428|birth related brachial plexus injury|birth related brachial plexus injury
5413183|NCT01663428|brachial plexus|brachial plexus
5413184|NCT01663428|splint|splint
5413185|NCT01663415|MDV3100|mdv3100
5413186|NCT01663415|prostate|prostate
5413187|NCT01663415|cancer|cancer
5413188|NCT01663415|enzalutamide|enzalutamide
5413189|NCT01663389|mass balance|mass balance
5413190|NCT01663389|radiolabel|radiolabel
5413191|NCT01663389|oral|oral
5413192|NCT01663389|IV|iv
5413193|NCT01663389|GSK1322322|gsk1322322
5413194|NCT01663389|healthy volunteer|healthy volunteer
5413195|NCT01663389|antibiotic|antibiotic
5413196|NCT01663363|refractive|refractive
5413197|NCT01663363|LASIK|lasik
5413198|NCT01663337|Posttraumatic Stress Disorder|posttraumatic stress disorder
5413199|NCT01663337|PTSD|ptsd
5413200|NCT01663337|Alcohol Abuse|alcohol abuse
5413201|NCT01663337|Alcohol Dependance|alcohol dependance
5413202|NCT01663337|Alcoholism|alcoholism
5413203|NCT01663337|Comorbid|comorbid
5413204|NCT01663337|Relapse Prevention (RP)|relapse prevention (rp)
5413205|NCT01663337|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
5413206|NCT01663324|Tinnitus|tinnitus
5413208|NCT01663324|transcranial magnetic stimulation|transcranial magnetic stimulation
5413209|NCT01663324|rTMS|rtms
5413210|NCT01663324|hearing disorders|hearing disorders
5413211|NCT01663311|rTMS|rtms
5413212|NCT01663311|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5413213|NCT01663311|chronic tinnitus|chronic tinnitus
5413214|NCT01663311|subjective tinnitus|subjective tinnitus
5413215|NCT01663311|double cone coil|double cone coil
5413216|NCT01663298|DNA methylation|dna methylation
5413217|NCT01663298|FGF2|fgf2
5002961|NCT03977571|Laboratory biomarker analysis|laboratory biomarker analysis
5413218|NCT01663298|Wound healing|wound healing
5413219|NCT01663298|Smoking|smoking
5413220|NCT01663298|Diabetes|diabetes
5903892|NCT00226915|ovarian neoplasms|ovarian neoplasms
5549374|NCT01089504|neonate|neonate
5413221|NCT01663298|Implant|implant
5413222|NCT01663285|Urothelial|urothelial
5413223|NCT01663285|Bladder|bladder
5413224|NCT01663285|Cancer|cancer
5413225|NCT01663272|oncology|oncology
5413226|NCT01663272|pancrease|pancrease
5413227|NCT01663233|Essential hypertension|essential hypertension
5413228|NCT01663233|High blood pressure|high blood pressure
5413229|NCT01663220|type 2 diabetes|type 2 diabetes
5413230|NCT01663220|beta cell function|beta cell function
5413231|NCT01663220|meal tolerance test|meal tolerance test
5413232|NCT01663220|maximum stimulation test|maximum stimulation test
5413233|NCT01663220|method standardization|method standardization
5413234|NCT01663220|insulin secretion|insulin secretion
5413235|NCT01663220|prediabetes|prediabetes
5413236|NCT01663220|insulin sensitivity|insulin sensitivity
5413237|NCT01663207|type 2 diabetes|type 2 diabetes
5413238|NCT01663207|beta cell function|beta cell function
5413239|NCT01663207|meal tolerance test|meal tolerance test
5413240|NCT01663207|maximum stimulation test|maximum stimulation test
5413241|NCT01663207|method standardization|method standardization
5413242|NCT01663207|insulin secretion|insulin secretion
5413243|NCT01663207|prediabetes|prediabetes
5413244|NCT01663207|insulin sensitivity|insulin sensitivity
5413245|NCT01663194|N/L ratio, STEMI, primary PCI, Long-term mortality|n/l ratio, stemi, primary pci, long-term mortality
5413247|NCT01663168|Tuberculosis|tuberculosis
5413248|NCT01663168|Rifabutin|rifabutin
5413249|NCT01663168|HIV Protease Inhibitors|hiv protease inhibitors
5413250|NCT01663168|EARNEST trial|earnest trial
5413251|NCT01663168|Randomized Controlled Trial|randomized controlled trial
5413252|NCT01663168|Pilot Projects|pilot projects
5413253|NCT01663168|Second-line ART|second-line art
5413254|NCT01663168|Drug Toxicity|drug toxicity
5413255|NCT01663168|Pharmacokinetics|pharmacokinetics
5413256|NCT01663168|Drug Interactions|drug interactions
5413257|NCT01663155|lung cancer|lung cancer
5413258|NCT01663155|chest x-ray|chest x-ray
5413259|NCT01663155|CT scan|ct scan
5413260|NCT01663155|computer aided detection (CAD)|computer aided detection (cad)
5413261|NCT01663155|screening|screening
5413262|NCT01663155|smokers|smokers
5413263|NCT01663142|Crohn's disease|crohn's disease
5413264|NCT01663142|gastrointestinal tract|gastrointestinal tract
5413265|NCT01663129|Children|children
5413266|NCT01663129|Osteoporosis|osteoporosis
5413267|NCT01663129|Vertebral Compression Fractures|vertebral compression fractures
5413268|NCT01663129|Chronic Illness|chronic illness
5413269|NCT01663129|Glucocorticoids|glucocorticoids
5413270|NCT01663129|Bone Fragility|bone fragility
5413271|NCT01663116|Rheumatoid arthritis|rheumatoid arthritis
5413272|NCT01663116|Expanded adipose derived allogeneic adult stem cells (eASCs)|expanded adipose derived allogeneic adult stem cells (eascs)
5413273|NCT01663103|Interleukin-1|interleukin-1
5413274|NCT01663103|Endothelium, Vascular|endothelium, vascular
5413275|NCT01663103|Vascular Stiffness|vascular stiffness
5413276|NCT01663103|Oxidative Stress|oxidative stress
5413277|NCT01663103|Inflammation|inflammation
5413278|NCT01663103|Endothelial cells|endothelial cells
5413279|NCT01663090|Newly diagnosed|newly diagnosed
5413280|NCT01663077|Clozapine|clozapine
5413281|NCT01663077|Schizophrenia|schizophrenia
5413282|NCT01663077|Remissia|remissia
5413283|NCT01663077|polymorphism|polymorphism
5413284|NCT01663064|Abdominal aortic aneurysm|abdominal aortic aneurysm
5413285|NCT01663064|Endovascular|endovascular
5413286|NCT01663064|Fenestration|fenestration
5413287|NCT01663064|Juxtarenal|juxtarenal
5413288|NCT01663064|Off-the-shelf|off-the-shelf
5413289|NCT01663064|Pararenal|pararenal
5413290|NCT01663038|Clopidogrel|clopidogrel
5413291|NCT01663038|Aspirin|aspirin
5413292|NCT01663038|Combination|combination
5413293|NCT01663038|Pharmacokinetics|pharmacokinetics
5413294|NCT01663038|Phase 1|phase 1
5413295|NCT01663025|Randomised controlled trial|randomised controlled trial
5413296|NCT01663025|Pain|pain
5413297|NCT01663025|Anxiety|anxiety
5413298|NCT01663025|Ambulatory surgery|ambulatory surgery
5413299|NCT01663025|Hand massage|hand massage
5413300|NCT01663025|Local anaesthetic|local anaesthetic
5413301|NCT01662973|Primary Biliary Cirrhosis|primary biliary cirrhosis
5413302|NCT01662973|Mesenchymal Stem Cells|mesenchymal stem cells
5413303|NCT01662973|Serum alkaline phosphatase|serum alkaline phosphatase
5413304|NCT01662973|Serum Bilirubin|serum bilirubin
5413305|NCT01662960|stroke|stroke
5413306|NCT01662960|hemiparesis|hemiparesis
5413307|NCT01662960|arm movement|arm movement
5413308|NCT01662960|sensory functioning|sensory functioning
5413309|NCT01662947|blood pressure|blood pressure
5413310|NCT01662934|dysmenorrhea|dysmenorrhea
5413311|NCT01662934|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5413312|NCT01662934|heat therapy|heat therapy
5413313|NCT01662921|bolus treatment|bolus treatment
5413314|NCT01662895|Brain hemorrhage|brain hemorrhage
5002962|NCT03977571|Gene Expression|gene expression
5413315|NCT01662895|Cerebral Hemorrhage|cerebral hemorrhage
5413316|NCT01662895|Deferoxamine|deferoxamine
5413317|NCT01662895|Hi-DEF Trial|hi-def trial
5413318|NCT01662856|Vascular Surgery|vascular surgery
5413319|NCT01662856|Fibrin Sealant|fibrin sealant
5903893|NCT00226915|randomized controlled trial|randomized controlled trial
5413320|NCT01662856|Polytetrafluoroethylene (PTFE) grafts|polytetrafluoroethylene (ptfe) grafts
5413321|NCT01662843|Dyspnea|dyspnea
5413322|NCT01662843|Ultrasonography|ultrasonography
5413323|NCT01662843|Emergencies|emergencies
5413324|NCT01662843|Critical Care|critical care
5413325|NCT01662830|Obesity|obesity
5413326|NCT01662830|Meal replacements|meal replacements
5413327|NCT01662804|INTERLEUKIN 2|interleukin 2
5413328|NCT01662804|MAB 3F8|mab 3f8
5413329|NCT01662804|GD2-positive tumor|gd2-positive tumor
5413330|NCT01662804|12-116|12-116
5413331|NCT01662791|Parkinson's Disease|parkinson's disease
5413332|NCT01662791|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
5413334|NCT01662791|Gastrointestinal|gastrointestinal
5413335|NCT01662791|Rifaximin|rifaximin
5413336|NCT01662778|Monodisperse aerosols|monodisperse aerosols
5413337|NCT01662778|Asthmatics|asthmatics
5413338|NCT01662778|Pharmacokinetics|pharmacokinetics
5413339|NCT01662778|AMP Challenge|amp challenge
5413340|NCT01662778|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
5413341|NCT01662765|Umbilical pilonidal sinus|umbilical pilonidal sinus
5413342|NCT01662765|Treatment|treatment
5413343|NCT01662765|Surgery|surgery
5413344|NCT01662765|Conservative|conservative
5413345|NCT01662765|Investigational treatment|investigational treatment
5413346|NCT01662765|After care|after care
5413347|NCT01662752|Early colonic cancer|early colonic cancer
5413348|NCT01662752|Sentinel lymph node mapping|sentinel lymph node mapping
5413349|NCT01662752|Sentinel lymph node biopsy|sentinel lymph node biopsy
5413350|NCT01662752|Near infrared imaging|near infrared imaging
5413351|NCT01662752|Indocyanine green|indocyanine green
5413352|NCT01662752|Laparoscopic|laparoscopic
5413353|NCT01662739|Population-Based Cancer Registry|population-based cancer registry
5413354|NCT01662739|Stomach|stomach
5413355|NCT01662739|Epidemiology|epidemiology
5413356|NCT01662739|Risk Factor|risk factor
5413357|NCT01662739|Biomolecular Features|biomolecular features
5413358|NCT01662713|skin cancer|skin cancer
5413359|NCT01662713|optical imaging|optical imaging
5413360|NCT01662713|optical coherence tomography|optical coherence tomography
5413361|NCT01662713|optical frequency domain imaging|optical frequency domain imaging
5413464|NCT01662193|vitamin D3|vitamin d3
5413366|NCT01662661|Healthy participants|healthy participants
5413367|NCT01662661|Hepatitis C|hepatitis c
5413368|NCT01662661|Relative bioavailability|relative bioavailability
5413369|NCT01662661|Bioavailability|bioavailability
5413370|NCT01662661|Pharmacokinetics|pharmacokinetics
5413371|NCT01662661|JNJ-47910382|jnj-47910382
5413372|NCT01662648|Schizophrenia|schizophrenia
5413373|NCT01662648|Paliperidone|paliperidone
5413374|NCT01662648|Paliperidone extended-release (ER)|paliperidone extended-release (er)
5413375|NCT01662635|Non-small cell lung cancer.|non-small cell lung cancer.
5413376|NCT01662635|Diagnosis,|diagnosis,
5413377|NCT01662635|Adenocarcinoma,|adenocarcinoma,
5413378|NCT01662635|ALK,|alk,
5413379|NCT01662635|FISH,|fish,
5413380|NCT01662635|IHC|ihc
5413381|NCT01662635|RT-qPCR|rt-qpcr
5413382|NCT01662622|anaesthesia|anaesthesia
5413383|NCT01662622|middle aged|middle aged
5413384|NCT01662622|minimal alveolar concentration|minimal alveolar concentration
5413385|NCT01662622|sevoflurane|sevoflurane
5413386|NCT01662622|isoelectric EEG|isoelectric eeg
5413387|NCT01662609|pancreas|pancreas
5413388|NCT01662609|high-risk|high-risk
5413389|NCT01662596|Risk factors,|risk factors,
5413390|NCT01662596|prenatal diagnosis,|prenatal diagnosis,
5413391|NCT01662596|fetal malformations|fetal malformations
5413392|NCT01662583|Influenza|influenza
5413393|NCT01662583|text message|text message
5413394|NCT01662583|vaccination|vaccination
5413395|NCT01662570|Pediatric Obesity|pediatric obesity
5413396|NCT01662570|Child Overweight|child overweight
5413397|NCT01662557|Pediatric Obesity|pediatric obesity
5413398|NCT01662544|Infants|infants
5413399|NCT01662544|Bronchiolitis|bronchiolitis
5413400|NCT01662544|Hypoxia|hypoxia
5413401|NCT01662544|Emergency Department|emergency department
5413402|NCT01662544|Length of Stay|length of stay
5413403|NCT01662544|Pediatrics|pediatrics
5413409|NCT01662453|epilepsy|epilepsy
5413410|NCT01662453|seizures|seizures
5413411|NCT01662453|mortality|mortality
5413412|NCT01662453|sudep|sudep
5413413|NCT01662453|risk factors|risk factors
5413414|NCT01662440|Rabies|rabies
5413415|NCT01662440|JE|je
5413416|NCT01662440|accelerated schedule|accelerated schedule
5413417|NCT01662427|Quality of life|quality of life
5413418|NCT01662427|Noctural Parkinson's Disease Symptoms|noctural parkinson's disease symptoms
5413419|NCT01662401|children|children
5413420|NCT01662401|laparoscopic appendectomy|laparoscopic appendectomy
5413421|NCT01662401|iliohypogastric nerve block|iliohypogastric nerve block
5413422|NCT01662401|rectus sheath nerve block|rectus sheath nerve block
5413423|NCT01662401|ilioinguinal nerve block|ilioinguinal nerve block
5413424|NCT01662388|proximal caries, composite restoration, proximal contact|proximal caries, composite restoration, proximal contact
5413426|NCT01662362|Trypanosoma cruzi|trypanosoma cruzi
5903894|NCT00226915|paclitaxel|paclitaxel
5413427|NCT01662362|American trypanosomiasis|american trypanosomiasis
5413428|NCT01662362|South American trypanosomiasis|south american trypanosomiasis
5413429|NCT01662362|kissing bugs|kissing bugs
5413430|NCT01662362|reduviid bugs|reduviid bugs
5413431|NCT01662336|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
5413432|NCT01662323|Heart failure, general practitioner, medical therapy, quality of live|heart failure, general practitioner, medical therapy, quality of live
5413433|NCT01662310|Schizophrenia|schizophrenia
5413434|NCT01662310|Paliperidone|paliperidone
5413435|NCT01662310|Paliperidone Extended-Release|paliperidone extended-release
5413437|NCT01662297|Trazodone|trazodone
5413438|NCT01662297|Insomnia|insomnia
5413439|NCT01662297|Dual Diagnosis|dual diagnosis
5413440|NCT01662271|obesity|obesity
5413441|NCT01662271|adiposity|adiposity
5413442|NCT01662271|psychosocial|psychosocial
5413443|NCT01662271|healthcare|healthcare
5413444|NCT01662271|co-morbidities|co-morbidities
5413445|NCT01662271|youth with extreme obesity|youth with extreme obesity
5413446|NCT01662271|weight loss|weight loss
5413447|NCT01662258|Community-acquired pneumonia|community-acquired pneumonia
5413448|NCT01662258|Targeted strategy|targeted strategy
5413449|NCT01662258|Empiric therapy|empiric therapy
5413450|NCT01662232|Green tea|green tea
5413451|NCT01662232|EGCG|egcg
5413452|NCT01662232|Cardiovascular diseases|cardiovascular diseases
5413453|NCT01662232|Endothelial function|endothelial function
5413454|NCT01662232|Flow-mediated dilation|flow-mediated dilation
5413455|NCT01662219|superficial cervical plexus block|superficial cervical plexus block
5413456|NCT01662219|quality of recovery|quality of recovery
5413457|NCT01662206|adults|adults
5413458|NCT01662206|probiotics|probiotics
5413459|NCT01662206|immune function|immune function
5413460|NCT01662206|microbiota|microbiota
5413461|NCT01662206|digestive health|digestive health
5413462|NCT01662193|Cholecalciferol|cholecalciferol
5413463|NCT01662193|Calciol|calciol
5413465|NCT01662193|Diabetes Mellitus|diabetes mellitus
5413466|NCT01662193|Diabetes Mellitus Type 2|diabetes mellitus type 2
5413467|NCT01662193|glucose metabolism disorders|glucose metabolism disorders
5413468|NCT01662193|ergocalciferol|ergocalciferol
5413469|NCT01662193|calcium|calcium
5413470|NCT01662193|adipicytokines|adipicytokines
5413471|NCT01662193|inflammatory biomarkers|inflammatory biomarkers
5413472|NCT01662180|subfertility, IUI, rec FSH, FSH, E2, AMH|subfertility, iui, rec fsh, fsh, e2, amh
5413473|NCT01662141|Cardiac output|cardiac output
5413474|NCT01662141|Perivascular Probe|perivascular probe
5413475|NCT01662128|Breast Cancer|breast cancer
5413476|NCT01662115|ILEUS|ileus
5413477|NCT01662089|Female pattern hair loss|female pattern hair loss
5413478|NCT01662076|Cancer|cancer
5413479|NCT01662076|Fatigue|fatigue
5413480|NCT01662076|Chemotherapy|chemotherapy
5413481|NCT01662076|Pediatrics|pediatrics
5413482|NCT01662076|Homeopathy|homeopathy
5413484|NCT01662050|Mantle Cell Lymphoma|mantle cell lymphoma
5413485|NCT01662050|Older|older
5413486|NCT01662037|Pulmonary vascular resistance|pulmonary vascular resistance
5413487|NCT01662037|Heart defects, Congenital|heart defects, congenital
5413488|NCT01662037|Receptors, endothelin|receptors, endothelin
5413489|NCT01662037|Bosentan|bosentan
5413490|NCT01662024|Obesity|obesity
5413491|NCT01662024|BMI|bmi
5413492|NCT01662024|Weight loss|weight loss
5413493|NCT01662024|Gastric restriction|gastric restriction
5413494|NCT01662024|Bariatrics|bariatrics
5413495|NCT01662011|patient-ventilator interaction|patient-ventilator interaction
5413496|NCT01662011|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5413497|NCT01662011|diaphragm electrical activity|diaphragm electrical activity
5413498|NCT01662011|pressure support ventilation|pressure support ventilation
5413499|NCT01661998|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5413500|NCT01661998|Spinal Deformity|spinal deformity
5413501|NCT01661998|Treatment Outcomes|treatment outcomes
5413502|NCT01661985|Mycoplasma genitalium|mycoplasma genitalium
5413503|NCT01661985|Chlamydia trachomatis|chlamydia trachomatis
5413504|NCT01661985|Treatment|treatment
5413505|NCT01661985|Antibiotic resistance|antibiotic resistance
5413506|NCT01661972|colorectal cancer|colorectal cancer
5413507|NCT01661972|all solid tumors|all solid tumors
5413508|NCT01661972|metastatic|metastatic
5413509|NCT01661972|refractory|refractory
5413510|NCT01661972|advanced solid tumors|advanced solid tumors
5413511|NCT01661959|Scoliosis|scoliosis
5413512|NCT01661959|Multi-center Database Registry|multi-center database registry
5413513|NCT01661959|Spinal Deformity|spinal deformity
5413514|NCT01661959|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5413515|NCT01661946|vascular endothelial growth factor|vascular endothelial growth factor
5413516|NCT01661946|macular edema|macular edema
5413517|NCT01661946|diabetic retinopathy|diabetic retinopathy
5413518|NCT01661933|celiac disease|celiac disease
5413519|NCT01661933|hookworm|hookworm
5413520|NCT01661933|probiotic|probiotic
5413521|NCT01661920|Community Acquired Pneumonia.|community acquired pneumonia.
5413522|NCT01661920|Treatment duration|treatment duration
5413523|NCT01661907|Elderly|elderly
5413524|NCT01661907|Anesthesia and postoperative analgesia|anesthesia and postoperative analgesia
5413525|NCT01661907|Postoperative period|postoperative period
5413526|NCT01661907|Delirium|delirium
5413527|NCT01661907|Postoperative complications|postoperative complications
5413528|NCT01661881|Newly diagnosed|newly diagnosed
5413529|NCT01661868|BRCA1 mutation|brca1 mutation
5413530|NCT01661868|BRCA2 mutation|brca2 mutation
5413531|NCT01661855|Autism Spectrum Disorders|autism spectrum disorders
5413532|NCT01661842|Autoimmune Hepatitis|autoimmune hepatitis
5413533|NCT01661842|Mesenchymal stem cells|mesenchymal stem cells
5413534|NCT01661842|serum albumin|serum albumin
5413535|NCT01661842|serum Tbil|serum tbil
5413536|NCT01661842|serum immunoglobulin G(IgG)|serum immunoglobulin g(igg)
5413537|NCT01661816|breast cancer|breast cancer
5413538|NCT01661816|everyday issues|everyday issues
5413539|NCT01661816|couple|couple
5413540|NCT01661803|bupivacaine|bupivacaine
5413542|NCT01661803|pediatric spinal|pediatric spinal
5413543|NCT01661803|efficacy|efficacy
5413544|NCT01661803|duration|duration
5413545|NCT01661803|quality|quality
5413546|NCT01661803|side effects|side effects
5413547|NCT01661803|intrathecal bupivacaine alone|intrathecal bupivacaine alone
5413548|NCT01661803|bupivacaine plus clonidine|bupivacaine plus clonidine
5413549|NCT01661790|Bevacizumab;|bevacizumab;
5413550|NCT01661790|non-small cell lung cancer;|non-small cell lung cancer;
5413551|NCT01661790|malignant pleural effusion;|malignant pleural effusion;
5413552|NCT01661790|intrapleural administration|intrapleural administration
5413553|NCT01661777|Eustachian tube dysfunction|eustachian tube dysfunction
5413554|NCT01661777|Endolymphatic hydrops|endolymphatic hydrops
5413555|NCT01661777|Diuretic|diuretic
5413556|NCT01661777|Low salt diet|low salt diet
5413557|NCT01661777|Myringotomy|myringotomy
5413558|NCT01661777|Pressure equalization tube|pressure equalization tube
5413559|NCT01661777|Ear tube|ear tube
5413560|NCT01661777|Ear fullness|ear fullness
5413561|NCT01661777|Ear pressure|ear pressure
5413562|NCT01661777|Allergy|allergy
5413567|NCT01661738|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
5413568|NCT01661725|Group ACYW135 Meningococcal Polysaccharide Vaccine|group acyw135 meningococcal polysaccharide vaccine
5413569|NCT01661712|obstructive sleep apnoea,|obstructive sleep apnoea,
5413570|NCT01661712|continuous transcutaneous electrical stimulation|continuous transcutaneous electrical stimulation
5413571|NCT01661699|Obstructive Sleep Apnea|obstructive sleep apnea
5413572|NCT01661686|esophageal cancer|esophageal cancer
5413573|NCT01661686|esophageal stenosis|esophageal stenosis
5413574|NCT01661686|stent|stent
5413575|NCT01661686|endoscopy|endoscopy
5413576|NCT01661634|Acute decompensated heart failure|acute decompensated heart failure
5413577|NCT01661621|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5413578|NCT01661621|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5413579|NCT01661621|Antimuscarinics|antimuscarinics
5413580|NCT01661621|α-blockers|α-blockers
5413581|NCT01661608|Gastric Restriction|gastric restriction
5413582|NCT01661595|Fatigue|fatigue
5413583|NCT01661595|Fatigability|fatigability
5413584|NCT01661595|Surface Electromyography (sEMG)|surface electromyography (semg)
5413711|NCT01661036|Survey|survey
5413585|NCT01661595|cyclic guanosine monophosphate (cGMP)|cyclic guanosine monophosphate (cgmp)
5413586|NCT01661595|Nitric Oxide (NO)|nitric oxide (no)
5413587|NCT01661595|NO-cGMP|no-cgmp
5413588|NCT01661595|Phosphodiesterase (PDE)|phosphodiesterase (pde)
5413589|NCT01661595|Sildenafil|sildenafil
5413590|NCT01661595|Tadalafil|tadalafil
5413591|NCT01661595|Isotope|isotope
5413592|NCT01661595|Infusion|infusion
5413593|NCT01661595|Anabolism|anabolism
5413594|NCT01661595|Upregulation|upregulation
5413595|NCT01661595|Accelerometer|accelerometer
5413596|NCT01661595|Placebo|placebo
5413597|NCT01661595|Nitrosylation|nitrosylation
5413598|NCT01661582|Air Pollution|air pollution
5413599|NCT01661582|Myocardial Ischaemia|myocardial ischaemia
5413600|NCT01661582|Coronary Blood Flow|coronary blood flow
5413601|NCT01661582|Diesel Exhaust|diesel exhaust
5413602|NCT01661582|Troponin|troponin
5413603|NCT01661582|Electrocardiography|electrocardiography
5413604|NCT01661569|Mindfulness|mindfulness
5413605|NCT01661569|meditation|meditation
5413606|NCT01661569|stress|stress
5413607|NCT01661569|well-being|well-being
5413608|NCT01661569|work stress|work stress
5413609|NCT01661569|blood pressure|blood pressure
5413610|NCT01661569|cortisol|cortisol
5413611|NCT01661556|Melasma, miconazole, hydroquinone|melasma, miconazole, hydroquinone
5413612|NCT01661530|asthma|asthma
5413613|NCT01661530|pregnancy|pregnancy
5413614|NCT01661530|diet|diet
5413615|NCT01661530|vitamin E|vitamin e
5413616|NCT01661517|substance use treatment|substance use treatment
5413617|NCT01661439|Recurrent miscarriages|recurrent miscarriages
5002963|NCT03977571|Liquid Biopsy|liquid biopsy
5002964|NCT03977558|Shift Work|shift work
5413618|NCT01661439|recurrent pregnancy loss|recurrent pregnancy loss
5413620|NCT01661439|anti coagulants in pregnancy|anti coagulants in pregnancy
5413621|NCT01661426|Adults|adults
5413622|NCT01661426|Weight loss|weight loss
5413623|NCT01661426|Diet|diet
5903895|NCT00226915|carboplatin|carboplatin
5413624|NCT01661426|Insulin Resistance|insulin resistance
5413625|NCT01661426|Fatty acid composition|fatty acid composition
5413626|NCT01661413|Acute Leukemia|acute leukemia
5413627|NCT01661413|Pediatrics|pediatrics
5413628|NCT01661413|Intrathecal methotrexate|intrathecal methotrexate
5413629|NCT01661413|Chemotherapy|chemotherapy
5413630|NCT01661413|Nausea|nausea
5413631|NCT01661413|Vomiting|vomiting
5413632|NCT01661400|Glioma includes ependymoma and medulloblastoma|glioma includes ependymoma and medulloblastoma
5413638|NCT01661361|vancomycin|vancomycin
5413639|NCT01661361|levels|levels
5413640|NCT01661361|central venous port device|central venous port device
5413641|NCT01661361|peripherally obtained levels|peripherally obtained levels
5413642|NCT01661361|dose adjustments|dose adjustments
5413644|NCT01661348|Cesarian section|cesarian section
5413645|NCT01661348|Pregnancy|pregnancy
5413646|NCT01661348|Incision management|incision management
5413647|NCT01661335|Nausea|nausea
5413648|NCT01661335|Vomiting|vomiting
5413649|NCT01661335|Children|children
5413650|NCT01661335|Aprepitant|aprepitant
5413651|NCT01661335|Emend®|emend®
5413652|NCT01661322|Acute ischaemic stroke|acute ischaemic stroke
5413653|NCT01661322|TIA|tia
5413654|NCT01661309|Hyperhomocysteinemia|hyperhomocysteinemia
5413655|NCT01661309|Methylcobalamin|methylcobalamin
5413656|NCT01661309|Cardiovascular disease|cardiovascular disease
5413657|NCT01661309|Plasma total homocysteine|plasma total homocysteine
5413658|NCT01661309|Vegetarians|vegetarians
5413659|NCT01661296|cutaneous leishmaniasis, heat therapy, antimony|cutaneous leishmaniasis, heat therapy, antimony
5413660|NCT01661283|MPNST|mpnst
5413661|NCT01661283|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
5413662|NCT01661283|RAD001|rad001
5413663|NCT01661283|Everolimus|everolimus
5413664|NCT01661283|Bevacizumab|bevacizumab
5413665|NCT01661283|Sarcoma|sarcoma
5413666|NCT01661283|Avastin|avastin
5413667|NCT01661283|mTOR inhibitor|mtor inhibitor
5413668|NCT01661257|Crohn's disease|crohn's disease
5413669|NCT01661257|Infliximab|infliximab
5413670|NCT01661257|T-cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3)|t-cell immunoglobulin- and mucin-domain-containing molecule 3 (tim-3)
5413671|NCT01661231|Vascular intervention|vascular intervention
5413672|NCT01661231|Endovascular|endovascular
5413673|NCT01661231|Peripheral stent|peripheral stent
5413674|NCT01661218|catheters|catheters
5413675|NCT01661218|Central Venous|central venous
5413676|NCT01661218|complications|complications
5413677|NCT01661218|cancer|cancer
5413678|NCT01661205|Persistent AF|persistent af
5413679|NCT01661205|Longstanding Persistent AF|longstanding persistent af
5413680|NCT01661205|Ablation|ablation
5413681|NCT01661205|catheter ablation|catheter ablation
5413682|NCT01661192|Type 1 Diabetes|type 1 diabetes
5413683|NCT01661192|newly diagnosed|newly diagnosed
5413684|NCT01661192|Beta cell preservation|beta cell preservation
5413685|NCT01661179|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
5413686|NCT01661179|Medullary Thyroid Cancer|medullary thyroid cancer
5413687|NCT01661179|Vandetanib|vandetanib
5413688|NCT01661166|Male adult subjects|male adult subjects
5413689|NCT01661166|aged 30-90 years|aged 30-90 years
5413690|NCT01661166|RARP|rarp
5413691|NCT01661166|AUA symptom score greater than 7 will be included|aua symptom score greater than 7 will be included
5413692|NCT01661114|Gemcitabine, Infusional 5-Fluorouracil,Cisplatin|gemcitabine, infusional 5-fluorouracil,cisplatin
5413693|NCT01661114|Advanced Pancreatic and Biliary Cancers|advanced pancreatic and biliary cancers
5413694|NCT01661114|untreated & previously treated pancreatic & biliary cancer.|untreated & previously treated pancreatic & biliary cancer.
5413695|NCT01661101|Perioperative myocardial infarction|perioperative myocardial infarction
5413696|NCT01661101|Myocardial injury|myocardial injury
5413697|NCT01661101|noncardiac surgery|noncardiac surgery
5413698|NCT01661088|Neoadjuvant FOLFIRINOX|neoadjuvant folfirinox
5413699|NCT01661088|FDR-Gemcitabine|fdr-gemcitabine
5413700|NCT01661088|Concurrent|concurrent
5413701|NCT01661088|IMRT|imrt
5413702|NCT01661088|Borderline Resectable Pancreatic Cancer|borderline resectable pancreatic cancer
5413703|NCT01661075|mTBI|mtbi
5413704|NCT01661075|concussion|concussion
5413705|NCT01661075|mild traumatic brain injury|mild traumatic brain injury
5413706|NCT01661075|athlete|athlete
5413707|NCT01661075|college|college
5413708|NCT01661075|football|football
5413709|NCT01661075|soccer|soccer
5413710|NCT01661036|Cognitive Testing|cognitive testing
5413712|NCT01661036|Interview|interview
5413713|NCT01661023|Breast Cancer|breast cancer
5413714|NCT01661023|Epidemiology|epidemiology
5413715|NCT01661010|Infertility|infertility
5413716|NCT01661010|Turner's Syndrome|turner's syndrome
5002965|NCT03977558|Night Work|night work
5413717|NCT01661010|X-Chromosome|x-chromosome
5413718|NCT01661010|Y-Chromosome|y-chromosome
5413719|NCT01661010|Aneuploidy|aneuploidy
5413720|NCT01660997|Proteasome Inhibitor|proteasome inhibitor
5413721|NCT01660997|Induction Combination Therapy|induction combination therapy
5413722|NCT01660997|Maintenance Strategy|maintenance strategy
5413723|NCT01660997|Potent Anti-Myeloma Effect|potent anti-myeloma effect
5413724|NCT01660997|Precursor Disease|precursor disease
5413725|NCT01660984|Thyroid Tumor|thyroid tumor
5413726|NCT01660984|Multiple Endocrine Neoplasia 2|multiple endocrine neoplasia 2
5413727|NCT01660984|Pheochromocytoma|pheochromocytoma
5413728|NCT01660984|RET Mutations|ret mutations
5413729|NCT01660958|Micronutrient Deficiencies|micronutrient deficiencies
5413730|NCT01660958|Early Child Development|early child development
5413731|NCT01660958|Infant Growth|infant growth
5413732|NCT01660958|Iron Deficiency|iron deficiency
5413733|NCT01660945|statins, insulin resistance|statins, insulin resistance
5413734|NCT01660932|insulin resistance|insulin resistance
5413735|NCT01660919|insulin resistance|insulin resistance
5413736|NCT01660893|operative|operative
5413737|NCT01660893|dental procedure|dental procedure
5408729|NCT01683188|melanoma|melanoma
5862835|NCT00001487|Climecteric-Related Mood Disorder|climecteric-related mood disorder
5413738|NCT01660867|hospital admission within 7 days of 3% NaCl nebulizer vs dexamethasone|hospital admission within 7 days of 3% nacl nebulizer vs dexamethasone
5399083|NCT01726088|p50|p50
5413741|NCT01660854|malaria|malaria
5413742|NCT01660854|heterologous|heterologous
5413743|NCT01660854|immunity|immunity
5413744|NCT01660841|Magnetic resonance imaging|magnetic resonance imaging
5413745|NCT01660841|central nervous system|central nervous system
5413746|NCT01660841|contrast media|contrast media
5413747|NCT01660841|gadobutrol|gadobutrol
5413748|NCT01660828|Exercise induced (high sensitive) troponin release|exercise induced (high sensitive) troponin release
5413749|NCT01660828|Ischemia reperfusion injury|ischemia reperfusion injury
5413750|NCT01660828|Remote ischemic preconditioning|remote ischemic preconditioning
5413751|NCT01660789|Obesity|obesity
5413752|NCT01660789|Diabetes|diabetes
5413753|NCT01660789|Physical activity|physical activity
5413754|NCT01660776|diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5413755|NCT01660776|Hodgkin lymphoma|hodgkin lymphoma
5413756|NCT01660776|metastatic breast cancer.|metastatic breast cancer.
5413757|NCT01660776|non-small cell lung cancer|non-small cell lung cancer
5413758|NCT01660750|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5413759|NCT01660750|transplant eligible multiple myeloma|transplant eligible multiple myeloma
5413760|NCT01660737|Hay fever|hay fever
5413761|NCT01660737|Pascallerg|pascallerg
5413762|NCT01660711|neoadjuvant|neoadjuvant
5413763|NCT01660711|chemotherapy|chemotherapy
5413764|NCT01660711|resectable|resectable
5413765|NCT01660711|adjuvant|adjuvant
5413766|NCT01660711|pancreas|pancreas
5413767|NCT01660711|cancer|cancer
5413768|NCT01660711|adenocarcinoma|adenocarcinoma
5413769|NCT01660711|surgery|surgery
5413770|NCT01660685|Weight loss|weight loss
5413771|NCT01660685|Web-based|web-based
5413772|NCT01660685|Journaling|journaling
5413773|NCT01660685|Body Mass Index between 27 and 45|body mass index between 27 and 45
5413774|NCT01660659|Indoor air pollution|indoor air pollution
5413775|NCT01660659|pneumococcal carriage|pneumococcal carriage
5413776|NCT01660646|Tuberculosis case finding|tuberculosis case finding
5413777|NCT01660633|Multiple Myeloma|multiple myeloma
5413778|NCT01660633|High-Dose Melphalan|high-dose melphalan
5413779|NCT01660633|Propylene Glycol-Free|propylene glycol-free
5413780|NCT01660633|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5413781|NCT01660633|Captisol|captisol
5413782|NCT01660620|betaxolol/ retinopathy of prematurity|betaxolol/ retinopathy of prematurity
5413783|NCT01660594|coronary disease|coronary disease
5413784|NCT01660594|tomography, x-ray computed|tomography, x-ray computed
5413785|NCT01660594|calcium|calcium
5413786|NCT01660594|exercise test|exercise test
5413787|NCT01660581|CD133+|cd133+
5413788|NCT01660581|stem cells|stem cells
5413789|NCT01660581|Coronary Artery Disease|coronary artery disease
5413790|NCT01660581|Stable Angina Pectoris|stable angina pectoris
5413791|NCT01660555|Microbiota|microbiota
5413792|NCT01660555|HITChip|hitchip
5413793|NCT01660555|biopsies|biopsies
5413794|NCT01660555|colon|colon
5413795|NCT01660555|protected biopsies|protected biopsies
5413796|NCT01660529|Subjects with metastatic breast cancer who have failed at least one standard|subjects with metastatic breast cancer who have failed at least one standard
5413797|NCT01660529|of care regimen|of care regimen
5413798|NCT01660516|Camellia sinensis|camellia sinensis
5413799|NCT01660516|flavonoids|flavonoids
5413800|NCT01660516|cardiovascular risk|cardiovascular risk
5413801|NCT01660516|flow mediated dilation|flow mediated dilation
5413802|NCT01660503|Calcium absorption|calcium absorption
5413803|NCT01660503|Osteoporosis|osteoporosis
5413804|NCT01660503|Bone Health|bone health
5413805|NCT01660503|Adolescent|adolescent
5413806|NCT01660490|Radiographic Image Enhancement,|radiographic image enhancement,
5413807|NCT01660490|Intraoperative Care|intraoperative care
5413809|NCT01660490|Femoral Neck Fractures|femoral neck fractures
5413810|NCT01660490|Hip Fractures, Internal Fixators|hip fractures, internal fixators
5413811|NCT01660490|Fracture Fixation Internal|fracture fixation internal
5413812|NCT01660490|Fracture Fixation Intramedullary|fracture fixation intramedullary
5413813|NCT01660490|Fractures Bone|fractures bone
5413814|NCT01660477|Isavuconazole|isavuconazole
5413815|NCT01660477|Lopinavir/ritonavir|lopinavir/ritonavir
5413816|NCT01660477|Healthy Volunteers|healthy volunteers
5413818|NCT01660477|Kaletra ®|kaletra ®
5413819|NCT01660464|Program evaluation|program evaluation
5413820|NCT01660464|ADHD|adhd
5413821|NCT01660451|Clinical trial, phase II|clinical trial, phase ii
5413822|NCT01660451|Phosphatidylinositol 3-Kinase|phosphatidylinositol 3-kinase
5413823|NCT01660451|Class I, Non-Hodgkin's lymphoma|class i, non-hodgkin's lymphoma
5413824|NCT01660438|Stress urinary incontinence|stress urinary incontinence
5413825|NCT01660438|Suburethral sling|suburethral sling
5413826|NCT01660425|Attention deficit-/hyperactivity disorder|attention deficit-/hyperactivity disorder
5413827|NCT01660425|parenting enhancement training|parenting enhancement training
5413828|NCT01660425|guided self-help|guided self-help
5413829|NCT01660425|methylphenidate|methylphenidate
5413831|NCT01660412|Alkalinization|alkalinization
5413832|NCT01660412|Technetium 99m Sulfur Colloid|technetium 99m sulfur colloid
5532432|NCT01157338|embolus|embolus
5413833|NCT01660412|sentinel lymphoscintigraphy?|sentinel lymphoscintigraphy?
5413834|NCT01660399|salvage chemotherapy|salvage chemotherapy
5413835|NCT01660399|advanced squamous cell lung cancer|advanced squamous cell lung cancer
5413836|NCT01660399|Boanmycin|boanmycin
5413837|NCT01660386|Type 2 Diabetes|type 2 diabetes
5413838|NCT01660386|Dpp-4 inhibitor|dpp-4 inhibitor
5413839|NCT01660386|Sulfonylurea|sulfonylurea
5413840|NCT01660386|beta cell function|beta cell function
5413841|NCT01660373|ticagrelor|ticagrelor
5413842|NCT01660373|tirofiban|tirofiban
5413843|NCT01660373|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
5413844|NCT01660373|P2Y12 blockers|p2y12 blockers
5413845|NCT01660373|acute coronary syndrome|acute coronary syndrome
5413846|NCT01660360|Tanibirumab Phase I trial|tanibirumab phase i trial
5413847|NCT01660334|Systemic Mycosis|systemic mycosis
5413848|NCT01660334|Scedosporium infection|scedosporium infection
5413849|NCT01660334|Scedosporisis|scedosporisis
5413850|NCT01660334|Japanese|japanese
5413851|NCT01660334|voriconazole|voriconazole
5413852|NCT01660334|VFEND|vfend
5413853|NCT01660334|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
5413854|NCT01660321|Pediculosis capitis|pediculosis capitis
5413855|NCT01660321|Head Lice|head lice
5413856|NCT01660295|Severe renal insufficiency certoparin|severe renal insufficiency certoparin
5413857|NCT01660295|Severe renal insufficiency|severe renal insufficiency
5413858|NCT01660243|Pruritus|pruritus
5413859|NCT01660243|Renal dialysis|renal dialysis
5413860|NCT01660243|Receptors, Opioid, kappa|receptors, opioid, kappa
5413861|NCT01660243|Sleep Disorders|sleep disorders
5413862|NCT01660243|Quality of Life|quality of life
5413863|NCT01660230|APC, 3K3A, 3K3A-APC, volunteer, healthy|apc, 3k3a, 3k3a-apc, volunteer, healthy
5413864|NCT01660217|atopic dermatitis|atopic dermatitis
5413865|NCT01660217|eczema action plan|eczema action plan
5413866|NCT01660217|patient education|patient education
5413867|NCT01660217|written handout|written handout
5413868|NCT01660217|investigator's global assessment|investigator's global assessment
5413869|NCT01660217|randomized controlled trial|randomized controlled trial
5413870|NCT01660204|pneumonia, anti-bacterial agents, (cost)efficacy|pneumonia, anti-bacterial agents, (cost)efficacy
5413871|NCT01660191|LDL, HDL|ldl, hdl
5413872|NCT01660178|newborns|newborns
5413873|NCT01660178|intensive care unit|intensive care unit
5413874|NCT01660178|early stimulation|early stimulation
5413875|NCT01660165|Nutritional status|nutritional status
5413876|NCT01660165|Mental Health|mental health
5413877|NCT01660165|Omega-3|omega-3
5413878|NCT01660165|Pregnancy|pregnancy
5413879|NCT01660165|Postpartum depression|postpartum depression
5413880|NCT01660152|male erectile disorder|male erectile disorder
5413881|NCT01660152|prostate cancer|prostate cancer
5413882|NCT01660152|Laparoscopic prostatectomy|laparoscopic prostatectomy
5413883|NCT01660126|Aged|aged
5413884|NCT01660126|Cardiovascular disease|cardiovascular disease
5413885|NCT01660126|Levothyroxine|levothyroxine
5413886|NCT01660126|Randomised controlled trial|randomised controlled trial
5413887|NCT01660126|Quality of life|quality of life
5413888|NCT01660126|Subclinical hypothyroidism|subclinical hypothyroidism
5413889|NCT01660100|Atrial fibrillation ablation|atrial fibrillation ablation
5413890|NCT01660087|Exhaled breath condensate (EBC) method|exhaled breath condensate (ebc) method
5413891|NCT01660087|Volatile Organic Compounds (VOCs)|volatile organic compounds (vocs)
5413892|NCT01660087|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
5413893|NCT01660087|Confocal Endoscopy|confocal endoscopy
5413894|NCT01660087|Exhaled alveolar gas|exhaled alveolar gas
5413895|NCT01660074|glycemic index, resistant starch, glycemic response|glycemic index, resistant starch, glycemic response
5413896|NCT01660061|Antiphospholipid syndrome|antiphospholipid syndrome
5413897|NCT01660061|Antiphospholipid antibodies|antiphospholipid antibodies
5413898|NCT01660061|Vitamin-K antagonists|vitamin-k antagonists
5413899|NCT01660061|International normalized ratio|international normalized ratio
5413901|NCT01660048|Laparoscopic total extraperitoneal Inguinal hernia repair|laparoscopic total extraperitoneal inguinal hernia repair
5413903|NCT01660022|Volunteers|volunteers
5413904|NCT01660009|Endothelial Function|endothelial function
5413905|NCT01660009|Hypoglycemia|hypoglycemia
5413906|NCT01660009|Mitochondria|mitochondria
5413907|NCT01659996|Meningitis|meningitis
5413908|NCT01659996|Meningococcal Infection|meningococcal infection
5413909|NCT01659996|Diphtheria|diphtheria
5413910|NCT01659996|Pertussis|pertussis
5413911|NCT01659996|Menactra®|menactra®
5413912|NCT01659996|Pentacel®|pentacel®
5413913|NCT01659983|complicated appendicitis|complicated appendicitis
5413914|NCT01659983|wound closure|wound closure
5413915|NCT01659983|infection|infection
5413916|NCT01659957|Alcoholism|alcoholism
5413917|NCT01659957|Couples|couples
5413918|NCT01659944|Drug-drug interaction|drug-drug interaction
5413919|NCT01659879|Parents|parents
5413920|NCT01659879|Caregivers|caregivers
5413921|NCT01659879|Anxiety|anxiety
5413922|NCT01659879|Consumer satisfaction|consumer satisfaction
5413923|NCT01659866|Infection|infection
5413925|NCT01659866|Prostate biopsy|prostate biopsy
5413926|NCT01659840|laser,|laser,
5413927|NCT01659840|quality of life,|quality of life,
5413928|NCT01659840|orofacial pain|orofacial pain
5413929|NCT01659814|Major Depressive Disorder|major depressive disorder
5413930|NCT01659814|Anhedonia|anhedonia
5413931|NCT01659814|Dopamine|dopamine
5413932|NCT01659814|Electroencephalography (EEG)|electroencephalography (eeg)
5413933|NCT01659814|Positron Emission Tomography (PET)|positron emission tomography (pet)
5413934|NCT01659814|Reward|reward
5413935|NCT01659801|cataract|cataract
5413936|NCT01659801|cataract surgery|cataract surgery
5413937|NCT01659801|intaocular lens|intaocular lens
5413938|NCT01659801|toric lens|toric lens
5413939|NCT01659788|Advanced Reproductive Age|advanced reproductive age
5413940|NCT01659788|poor ovarian response|poor ovarian response
5413941|NCT01659788|Mitochondrial dysfunction|mitochondrial dysfunction
5413942|NCT01659788|Mitochondrial nutrients|mitochondrial nutrients
5413943|NCT01659788|Coenzyme Q10|coenzyme q10
5413944|NCT01659788|Electron transfer chain|electron transfer chain
5413954|NCT01659723|Urinary bladder|urinary bladder
5413955|NCT01659723|Hyperbaric Oxygen|hyperbaric oxygen
5413956|NCT01659697|lifestyle|lifestyle
5413957|NCT01659697|diabetes prevention|diabetes prevention
5413958|NCT01659697|BMI|bmi
5413959|NCT01659697|physical activity|physical activity
5413960|NCT01659684|congenital CMV infection|congenital cmv infection
5413961|NCT01659684|standard immunoglobulins|standard immunoglobulins
5413962|NCT01659684|immunoglobulin therapy|immunoglobulin therapy
5413963|NCT01659684|IgG CMV avidity index|igg cmv avidity index
5413964|NCT01659684|Cytomegalovirus|cytomegalovirus
5413965|NCT01659658|MLN9708|mln9708
5413966|NCT01659658|Amyloidosis|amyloidosis
5413967|NCT01659658|Light Chain|light chain
5413968|NCT01659658|IXAZOMIB|ixazomib
5413969|NCT01659658|Tourmaline AL1|tourmaline al1
5413970|NCT01659658|Drug Therapy|drug therapy
5413979|NCT01659593|cognitive disorders|cognitive disorders
5413980|NCT01659593|multiple sclerosis|multiple sclerosis
5413981|NCT01659593|neuropsychology|neuropsychology
5413982|NCT01659580|Angina Pectoris Treatment Prevention|angina pectoris treatment prevention
5413983|NCT01659554|Primary peritoneal|primary peritoneal
5413984|NCT01659541|spinal cord injury|spinal cord injury
5413985|NCT01659541|paralysis|paralysis
5413986|NCT01659541|cough|cough
5413987|NCT01659541|cervical spinal cord injury|cervical spinal cord injury
5413988|NCT01659541|thoracic spinal cord injury|thoracic spinal cord injury
5413989|NCT01659528|Penis|penis
5413990|NCT01659528|Micropenis|micropenis
5413991|NCT01659528|Nomograms|nomograms
5413992|NCT01659528|Ultrasound|ultrasound
5413993|NCT01659528|Fetus|fetus
5413994|NCT01659502|Patients|patients
5413995|NCT01659489|adnexal torsion|adnexal torsion
5413996|NCT01659489|laparoscopy|laparoscopy
5413997|NCT01659476|methacholine|methacholine
5413998|NCT01659476|deep inspiration|deep inspiration
5413999|NCT01659476|bronchoprotective effect|bronchoprotective effect
5414000|NCT01659476|bronchodilating effect|bronchodilating effect
5414001|NCT01659463|CARIES INFILTRATION|caries infiltration
5414002|NCT01659463|CARIES LESION|caries lesion
5414003|NCT01659463|INFILTRANT|infiltrant
5414004|NCT01659450|overweight|overweight
5414005|NCT01659450|obesity|obesity
5414006|NCT01659450|low energy dense|low energy dense
5414007|NCT01659437|M. ulcerans|m. ulcerans
5414008|NCT01659437|Buruli ulcer|buruli ulcer
5414009|NCT01659437|drug trial|drug trial
5414010|NCT01659437|clarithromycin|clarithromycin
5414011|NCT01659424|Rectal cancer|rectal cancer
5414012|NCT01659411|Congenital Heart Disease|congenital heart disease
5414013|NCT01659411|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5414014|NCT01659398|Alzheimer's Disease|alzheimer's disease
5414015|NCT01659398|cerebral blood flow|cerebral blood flow
5414017|NCT01659398|blood viscosity|blood viscosity
5414018|NCT01659372|temporomandibular disorder|temporomandibular disorder
5414019|NCT01659372|myofascial pain syndrome|myofascial pain syndrome
5414020|NCT01659333|Peritoneal, Dialysis|peritoneal, dialysis
5414021|NCT01659307|Acute Lung Injury|acute lung injury
5414022|NCT01659307|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5414024|NCT01659294|Type 2 diabetes|type 2 diabetes
5414025|NCT01659294|outcomes|outcomes
5414026|NCT01659294|case management|case management
5414027|NCT01659281|Artesunate|artesunate
5414028|NCT01659281|Mefloquine|mefloquine
5414029|NCT01659281|Plasmodium Falciparum|plasmodium falciparum
5414030|NCT01659281|Thailand|thailand
5414031|NCT01659281|Uncomplicated Plasmodium Falciparum malaria|uncomplicated plasmodium falciparum malaria
5414032|NCT01659268|teaching|teaching
5414033|NCT01659268|patient simulation|patient simulation
5414034|NCT01659268|laryngeal masks|laryngeal masks
5414035|NCT01659268|baccalaureate nursing education|baccalaureate nursing education
5414036|NCT01659268|teaching strategies|teaching strategies
5414037|NCT01659268|simulation|simulation
5414038|NCT01659242|Rheumatoid arthritis|rheumatoid arthritis
5414039|NCT01659242|Ultrasound|ultrasound
5414040|NCT01659242|Magnetic Resonance Imaging|magnetic resonance imaging
5414041|NCT01659229|knee osteoarthritis|knee osteoarthritis
5414042|NCT01659216|Electrical Pudendal Nerve Stimulation|electrical pudendal nerve stimulation
5414044|NCT01659216|long-term efficacy|long-term efficacy
5414045|NCT01659203|extraskeletal chondrosarcoma|extraskeletal chondrosarcoma
5414046|NCT01659164|Cognitive Behavioral Therapy|cognitive behavioral therapy
5414047|NCT01659164|Dialectical Behavioral Therapy|dialectical behavioral therapy
5414048|NCT01659164|Group Treatment|group treatment
5414049|NCT01659164|ADHD|adhd
5414050|NCT01659151|metastatic|metastatic
5414051|NCT01659151|melanoma|melanoma
5414052|NCT01659151|cell transfer|cell transfer
5414053|NCT01659151|ACT|act
5414054|NCT01659151|T-cell|t-cell
5414055|NCT01659151|immunotherapy|immunotherapy
5414056|NCT01659151|antibodies|antibodies
5414057|NCT01659151|lymphocytes|lymphocytes
5414058|NCT01659112|core stabilization, upper extremity, kinetic chain, movement|core stabilization, upper extremity, kinetic chain, movement
5414059|NCT01659099|DLBCL|dlbcl
5414060|NCT01659099|aa-IPI > or equal to 1|aa-ipi > or equal to 1
5414061|NCT01659099|Diagnosis|diagnosis
5414062|NCT01659099|18 to 60 years|18 to 60 years
5414063|NCT01659099|Lymphoma|lymphoma
5414064|NCT01659086|Influenza|influenza
5414065|NCT01659086|Immunogenicity|immunogenicity
5414066|NCT01659086|H9N2|h9n2
5414067|NCT01659086|Safety|safety
5414068|NCT01659073|Caloric Vestibular Stimulation|caloric vestibular stimulation
5414069|NCT01659073|Functional Imaging|functional imaging
5414070|NCT01659060|Cacao|cacao
5414071|NCT01659060|Chocolate|chocolate
5414072|NCT01659060|Theobromine|theobromine
5414073|NCT01659060|Flavonoids|flavonoids
5414074|NCT01659060|Pregnant women|pregnant women
5414075|NCT01659060|Hypertension pregnancy-induced|hypertension pregnancy-induced
5414076|NCT01659060|Pre-eclampsia|pre-eclampsia
5414077|NCT01659060|Epicatechin|epicatechin
5414078|NCT01659047|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5414079|NCT01659047|CLL|cll
5414080|NCT01659047|CAL-101|cal-101
5414081|NCT01659047|Ofatumumab|ofatumumab
5414082|NCT01659034|Anti-platelet therapy|anti-platelet therapy
5414083|NCT01659021|CLL|cll
5414084|NCT01659021|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5414085|NCT01659021|GS-1101|gs-1101
5414086|NCT01659021|CAL-101|cal-101
5414087|NCT01659021|Ofatumumab|ofatumumab
5414088|NCT01659008|acute cyclical heavy menstrual bleeding|acute cyclical heavy menstrual bleeding
5414089|NCT01658995|Implanon|implanon
5414090|NCT01658995|Etonogestrel subdermal implant|etonogestrel subdermal implant
5414091|NCT01658995|Nexplanon|nexplanon
5414092|NCT01658995|Contraception|contraception
5414093|NCT01658995|Irregular Bleeding|irregular bleeding
5414094|NCT01658995|Menometrorrhagia|menometrorrhagia
5414095|NCT01658956|GCSF|gcsf
5414096|NCT01658956|Chemotherapy|chemotherapy
5414097|NCT01658956|Breast cancer|breast cancer
5414098|NCT01658956|Prophylaxis|prophylaxis
5414099|NCT01658917|Tissue Acquisition|tissue acquisition
5414100|NCT01658904|Autologous Transplant|autologous transplant
5414101|NCT01658904|Proteasome Inhibitor|proteasome inhibitor
5414102|NCT01658904|Melphalan|melphalan
5414103|NCT01658904|Filgrastim|filgrastim
5414104|NCT01658839|pediatric glaucoma|pediatric glaucoma
5414105|NCT01658839|pediatric ocular hypertension|pediatric ocular hypertension
5414106|NCT01658839|travoprost|travoprost
5414107|NCT01658826|AIC316|aic316
5414108|NCT01658826|Viral shedding|viral shedding
5414109|NCT01658813|Metastatic Gastrointestinal|metastatic gastrointestinal
5414110|NCT01658813|Metastatic Kidney|metastatic kidney
5414111|NCT01658813|Metastatic Lung|metastatic lung
5414112|NCT01658800|H5N1 Influenza|h5n1 influenza
5414113|NCT01658800|H5N1 Influenza vaccine|h5n1 influenza vaccine
5414114|NCT01658787|Aorta|aorta
5414115|NCT01658761|Myopic traction maculopathy|myopic traction maculopathy
5414116|NCT01658761|vitrectomy|vitrectomy
5414117|NCT01658761|internal limiting membrane|internal limiting membrane
5414118|NCT01658761|Retrospective, case control study|retrospective, case control study
5414119|NCT01658748|Pilot Study|pilot study
5414120|NCT01658748|Longitudinal Study|longitudinal study
5414121|NCT01658748|Amygdaloid Body|amygdaloid body
5414122|NCT01658748|Insula of Reil|insula of reil
5414123|NCT01658748|Cortex, prefrontal|cortex, prefrontal
5414124|NCT01658748|Stimulation, Deep Brain|stimulation, deep brain
5414125|NCT01658748|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
5414126|NCT01658748|Combat Stress Disorder|combat stress disorder
5414127|NCT01658748|Social Adjustments|social adjustments
5414128|NCT01658748|Positron-Emission Tomography, Computed Tomography|positron-emission tomography, computed tomography
5414129|NCT01658735|Chronic low back pain|chronic low back pain
5414130|NCT01658735|Electrotherapy|electrotherapy
5414131|NCT01658735|H-Wave|h-wave
5414132|NCT01658735|H wave|h wave
5414133|NCT01658735|TENS|tens
5414134|NCT01658735|Trial|trial
5414135|NCT01658683|Coronary Artery Disease|coronary artery disease
5414136|NCT01658683|Cardiac Rehabilitation|cardiac rehabilitation
5414137|NCT01658683|Exercise Maintenance|exercise maintenance
5414138|NCT01658683|Facilitator|facilitator
5414139|NCT01658683|Managed Home Exercise|managed home exercise
5414140|NCT01658683|Community Based Exercise|community based exercise
5414143|NCT01658670|adherence|adherence
5414144|NCT01658670|quality of life|quality of life
5414145|NCT01658644|Patient satisfaction|patient satisfaction
5414146|NCT01658644|Memory recall|memory recall
5414147|NCT01658644|Patient-clinician communication|patient-clinician communication
5414148|NCT01658644|health communication|health communication
5414149|NCT01658644|clinical care team recall|clinical care team recall
5414150|NCT01658644|hospital quality of care|hospital quality of care
5414151|NCT01658618|Venous leg ulcer|venous leg ulcer
5414153|NCT01658618|venous stasis|venous stasis
5414154|NCT01658618|compression|compression
5414155|NCT01658618|venous|venous
5414156|NCT01658618|venous stasis ulcer|venous stasis ulcer
5414157|NCT01658618|vlu|vlu
5414158|NCT01658618|hp802-247-09-029|hp802-247-09-029
5414159|NCT01658605|GSK1605786|gsk1605786
5414160|NCT01658605|ulcerative colitis|ulcerative colitis
5414161|NCT01658605|CCR9 antagonist|ccr9 antagonist
5414162|NCT01658605|proof of concept|proof of concept
5414163|NCT01658592|Alcohol Addiction;|alcohol addiction;
5414164|NCT01658592|Deep Brain Stimulation;|deep brain stimulation;
5414165|NCT01658592|Nucleus Accumbens;|nucleus accumbens;
5414166|NCT01658592|Ventral Anterior Internal capsule;|ventral anterior internal capsule;
5414167|NCT01658553|solid tumors|solid tumors
5414168|NCT01658540|Drug Eluting Balloon (DEB) technology|drug eluting balloon (deb) technology
5414169|NCT01658540|long SFA lesions disease|long sfa lesions disease
5414170|NCT01658527|metastatic|metastatic
5414171|NCT01658527|prostate cancer|prostate cancer
5414172|NCT01658488|Iron deficiency anemia|iron deficiency anemia
5414173|NCT01658488|rice|rice
5414174|NCT01658475|IgG titer|igg titer
5414175|NCT01658475|periodontopathic bacteria|periodontopathic bacteria
5414176|NCT01658462|locally recurrent or metastatic breast cancer|locally recurrent or metastatic breast cancer
5414177|NCT01658462|Docetaxel|docetaxel
5414178|NCT01658462|Nintedanib|nintedanib
5414179|NCT01658436|advanced pancreatic neuroendocrine tumor|advanced pancreatic neuroendocrine tumor
5414180|NCT01658436|BEZ235|bez235
5414181|NCT01658436|pNET|pnet
5414182|NCT01658423|pubic hair|pubic hair
5414183|NCT01658423|sprint velocity|sprint velocity
5414184|NCT01658423|vertical jump height|vertical jump height
5414185|NCT01658423|body composition|body composition
5414186|NCT01658423|maximal voluntary torque|maximal voluntary torque
5414187|NCT01658410|Coronary artery disease|coronary artery disease
5414188|NCT01658410|bypass grafting|bypass grafting
5414189|NCT01658397|Healthy subjects|healthy subjects
5414190|NCT01658397|Fasting|fasting
5414191|NCT01658397|Weight loss|weight loss
5414192|NCT01658371|HIV|hiv
5414193|NCT01658358|ErbB receptor|erbb receptor
5414194|NCT01658358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5414195|NCT01658358|Anthracycline|anthracycline
5414196|NCT01658345|aortic stenosis|aortic stenosis
5414197|NCT01658345|asymptomatic|asymptomatic
5414198|NCT01658345|microvascular dysfunction|microvascular dysfunction
5414199|NCT01658345|Cardiac MRI|cardiac mri
5414200|NCT01658332|lung cancer|lung cancer
5414201|NCT01658332|circulating tumor cells|circulating tumor cells
5414202|NCT01658332|prospective|prospective
5414203|NCT01658332|monocentrique trial|monocentrique trial
5414204|NCT01658306|remote ischemic preconditioning|remote ischemic preconditioning
5414205|NCT01658306|random-controlled|random-controlled
5414206|NCT01658306|double blind|double blind
5414207|NCT01658306|RIPC|ripc
5414208|NCT01658293|stroke|stroke
5414209|NCT01658293|follow up|follow up
5414210|NCT01658293|upper limb|upper limb
5414211|NCT01658293|rehabilitation|rehabilitation
5414212|NCT01658280|transbronchial needle aspiration|transbronchial needle aspiration
5414213|NCT01658280|ultrasound guided transbronchial needle aspiration|ultrasound guided transbronchial needle aspiration
5002966|NCT03977558|Rotating Shift Work|rotating shift work
5414214|NCT01658280|sensitivity|sensitivity
5414215|NCT01658280|hilar/mediastinal adenopathy|hilar/mediastinal adenopathy
5414216|NCT01658254|Clinical trials|clinical trials
5414217|NCT01658254|Basic results|basic results
5414218|NCT01658254|Registry|registry
5414219|NCT01658228|Depression|depression
5414220|NCT01658228|Dysthymia|dysthymia
5414221|NCT01658228|Cognitive Impairment|cognitive impairment
5414222|NCT01658228|Cognitive Decline|cognitive decline
5414223|NCT01658228|Memory|memory
5414224|NCT01658215|Smoking cessation|smoking cessation
5414225|NCT01658215|Nicotine|nicotine
5414226|NCT01658215|Tobacco Use Disorder|tobacco use disorder
5414227|NCT01658215|Central Nervous System Agents|central nervous system agents
5414228|NCT01658202|Smoking cessation|smoking cessation
5414229|NCT01658202|Nicotine|nicotine
5414230|NCT01658202|Tobacco Use Disorder|tobacco use disorder
5414231|NCT01658202|Central Nervous System Agents|central nervous system agents
5414232|NCT01658176|Estrogen receptor positive|estrogen receptor positive
5414233|NCT01658176|Her-2 negative|her-2 negative
5414234|NCT01658176|advanced breast cancer|advanced breast cancer
5399544|NCT01723813|Immunotherapy|immunotherapy
5414235|NCT01658176|Breast Cancer|breast cancer
5414236|NCT01658163|abdominoplasty,|abdominoplasty,
5414237|NCT01658163|skin closure, dressings|skin closure, dressings
5414238|NCT01658150|Cognition|cognition
5414239|NCT01658150|Schizophrenia|schizophrenia
5414240|NCT01658150|Schizoaffective disorder|schizoaffective disorder
5414241|NCT01658137|diet|diet
5414242|NCT01658137|dietary pattern|dietary pattern
5414243|NCT01658137|gene|gene
5414244|NCT01658137|gene expression|gene expression
5414245|NCT01658137|epigenomics|epigenomics
5414246|NCT01658137|diet-gene interaction|diet-gene interaction
5414247|NCT01658137|inflammation|inflammation
5414248|NCT01658137|9p21|9p21
5414249|NCT01658137|fruits|fruits
5414250|NCT01658137|vegetables|vegetables
5414251|NCT01658124|haemorrhage,antifibrinolytic, clinical trial,|haemorrhage,antifibrinolytic, clinical trial,
5414252|NCT01658111|Stroke|stroke
5414253|NCT01658111|Robots|robots
5414256|NCT01658098|postpartum|postpartum
5414257|NCT01658098|depression|depression
5414258|NCT01658098|edinburgh postpartum depression scale|edinburgh postpartum depression scale
5414259|NCT01658098|mexican population|mexican population
5414260|NCT01658085|Thyroidectomy|thyroidectomy
5414261|NCT01658085|Multinodular goiter|multinodular goiter
5414262|NCT01658085|Harmonic Focus|harmonic focus
5414263|NCT01658085|budget impact|budget impact
5414264|NCT01658085|Harmonic scalpel|harmonic scalpel
5414265|NCT01658072|Total Hip Arthroplasty|total hip arthroplasty
5414266|NCT01658072|Total Hip Replacement|total hip replacement
5414267|NCT01658046|COPD|copd
5414268|NCT01658046|exercise|exercise
5414269|NCT01658046|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5414270|NCT01658033|Metastatic Breast Cancer, Her-2 negative Breast Cancer|metastatic breast cancer, her-2 negative breast cancer
5414271|NCT01658033|Avastin, FOLFOX regimen|avastin, folfox regimen
5445470|NCT01521598|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5414272|NCT01658020|Acute exacerbation of Chronic obstructive pulmonary disease|acute exacerbation of chronic obstructive pulmonary disease
5414273|NCT01658020|Acute Exacerbation|acute exacerbation
5414274|NCT01658020|Chronic obstructive pulmonary disease(COPD)|chronic obstructive pulmonary disease(copd)
5414275|NCT01658020|Zabofloxacin|zabofloxacin
5414276|NCT01658020|Moxifloxacin|moxifloxacin
5414277|NCT01657994|cerebral palsy|cerebral palsy
5414278|NCT01657994|gait training|gait training
5414279|NCT01657994|robotic|robotic
5414280|NCT01657994|functional electrical stimulation|functional electrical stimulation
5414281|NCT01657981|Pharmacokinetics|pharmacokinetics
5414282|NCT01657981|Phase 1|phase 1
5414283|NCT01657981|14C-labeled|14c-labeled
5414284|NCT01657968|Acute tonsillitis|acute tonsillitis
5414285|NCT01657968|Procalcitonin|procalcitonin
5414286|NCT01657968|Streptococcal antigen test|streptococcal antigen test
5414287|NCT01657968|Centor Criteria|centor criteria
5414288|NCT01657968|Infection marker|infection marker
5414289|NCT01657942|MRgFUS|mrgfus
5414290|NCT01657942|Prostate|prostate
5414291|NCT01657942|Intermediate Risk Prostate Lesions|intermediate risk prostate lesions
5414292|NCT01657942|Focal Prostate treatment|focal prostate treatment
5414293|NCT01657942|InSightec|insightec
5414294|NCT01657942|ExAblate|exablate
5414295|NCT01657942|Non-invasive|non-invasive
5414296|NCT01657942|Prostate cancer|prostate cancer
5414297|NCT01657942|Gleason 7|gleason 7
5414298|NCT01657929|Influenza|influenza
5414299|NCT01657929|Avian|avian
5414300|NCT01657929|H5N1|h5n1
5414301|NCT01657929|H5-VLP|h5-vlp
5414303|NCT01657929|GLA-AF|gla-af
5414304|NCT01657916|mid-urethral sling|mid-urethral sling
5414305|NCT01657916|Align urethral support system|align urethral support system
5414306|NCT01657916|tension free vaginal tape|tension free vaginal tape
5414307|NCT01657916|cough stress test|cough stress test
5414308|NCT01657916|pelvic exam|pelvic exam
5414309|NCT01657916|PFDI-20|pfdi-20
5414310|NCT01657916|PFIQ|pfiq
5414311|NCT01657916|SSQ|ssq
5414312|NCT01657916|Urinary retention|urinary retention
5414313|NCT01657916|mesh erosion|mesh erosion
5414314|NCT01657916|urodynamics|urodynamics
5414315|NCT01657890|isavuconazole|isavuconazole
5414316|NCT01657890|BAL8557|bal8557
5414317|NCT01657864|Aseptic Meningitis|aseptic meningitis
5414318|NCT01657864|Epidemiology|epidemiology
5414319|NCT01657864|Bipolar Disorder|bipolar disorder
5414320|NCT01657864|Lamotrigine|lamotrigine
5414321|NCT01657864|Epilepsy|epilepsy
5414322|NCT01657838|Isavuconazole|isavuconazole
5414323|NCT01657838|Ketoconazole|ketoconazole
5414324|NCT01657838|Healthy Volunteers|healthy volunteers
5414326|NCT01657838|BAL4815|bal4815
5414327|NCT01657825|isavuconazole|isavuconazole
5414328|NCT01657825|warfarin|warfarin
5414329|NCT01657825|Healthy Volunteers|healthy volunteers
5414330|NCT01657825|BAL8557|bal8557
5414331|NCT01657825|Coumadin|coumadin
5414332|NCT01657812|dexmedetomidine|dexmedetomidine
5414333|NCT01657812|Epidural Anesthesia|epidural anesthesia
5414334|NCT01657812|stress response|stress response
5414335|NCT01657812|anesthesia recovery|anesthesia recovery
5414336|NCT01657786|ondanstron|ondanstron
5399648|NCT01723306|T cells|t cells
5414337|NCT01657786|gene polymorphism|gene polymorphism
5414338|NCT01657786|postoperative nausea and vomiting|postoperative nausea and vomiting
5414339|NCT01657786|laparoscopic surgery under general anesthesia|laparoscopic surgery under general anesthesia
5414340|NCT01657760|craving|craving
5414341|NCT01657760|dopamine|dopamine
5414342|NCT01657760|citalopram|citalopram
5414343|NCT01657760|ssri|ssri
5414344|NCT01657747|Ovarian carcinoma|ovarian carcinoma
5414345|NCT01657747|Staging|staging
5414346|NCT01657747|Early treatment follow-up|early treatment follow-up
5414448|NCT01657227|self-management|self-management
5414347|NCT01657747|Identifying tumor recurrence|identifying tumor recurrence
5414348|NCT01657747|Whole body diffusion-weighted MRI|whole body diffusion-weighted mri
5414349|NCT01657734|therapy-induced inflammatory response with|therapy-induced inflammatory response with
5414350|NCT01657734|magnetic resonance imaging|magnetic resonance imaging
5414352|NCT01657695|Computed tomography|computed tomography
5414353|NCT01657695|Gene expression|gene expression
5414354|NCT01657695|Fractional growth|fractional growth
5414355|NCT01657682|FLT3|flt3
5414356|NCT01657682|Crenolanib|crenolanib
5414357|NCT01657682|Acute|acute
5414358|NCT01657682|Myeloid|myeloid
5414359|NCT01657682|AML|aml
5414360|NCT01657669|Choroidal neovascularization due to AMD|choroidal neovascularization due to amd
5414361|NCT01657643|Health related quality of life|health related quality of life
5414362|NCT01657643|Functional Status|functional status
5414363|NCT01657630|Insulin Pump Therapy|insulin pump therapy
5414364|NCT01657630|Type 1 Diabetes|type 1 diabetes
5414365|NCT01657630|Treatment Satisfaction|treatment satisfaction
5414366|NCT01657604|CML|cml
5414367|NCT01657604|Tasigna|tasigna
5414368|NCT01657604|Nilotinib|nilotinib
5414369|NCT01657604|Interferon|interferon
5414370|NCT01657591|skin cancer|skin cancer
5414371|NCT01657591|unresectable|unresectable
5414372|NCT01657591|BRAF|braf
5414373|NCT01657578|neonates|neonates
5414374|NCT01657578|reflux disease|reflux disease
5414375|NCT01657578|population pharmacokinetics, omeprazole|population pharmacokinetics, omeprazole
5414376|NCT01657565|LOS|los
5414377|NCT01657565|Ileus|ileus
5414378|NCT01657565|Fever|fever
5414379|NCT01657565|reoperation|reoperation
5414380|NCT01657552|Drug interaction|drug interaction
5414381|NCT01657552|INCIVEK (telaprevir),|incivek (telaprevir),
5414382|NCT01657552|SB-497115 (eltrombopag)|sb-497115 (eltrombopag)
5414383|NCT01657552|Pharmacokinetics|pharmacokinetics
5414384|NCT01657552|Thrombocytopenia|thrombocytopenia
5414385|NCT01657552|VICTRELIS (boceprevir)|victrelis (boceprevir)
5414386|NCT01657526|Healthy adults|healthy adults
5414387|NCT01657526|Safety|safety
5414388|NCT01657526|Reactogenicity|reactogenicity
5414389|NCT01657526|Immunogenicity|immunogenicity
5414390|NCT01657526|Non-typeable H. Influenzae (NTHi)|non-typeable h. influenzae (nthi)
5414391|NCT01657513|psoriasis|psoriasis
5414392|NCT01657513|treatment failure|treatment failure
5414393|NCT01657513|tnf-alfa|tnf-alfa
5414394|NCT01657500|endothelial keratoplasty|endothelial keratoplasty
5414395|NCT01657487|COPD|copd
5414396|NCT01657487|Fluticasone/Salmeterol|fluticasone/salmeterol
5414397|NCT01657487|high dose|high dose
5414398|NCT01657448|Symptom of Dysuria|symptom of dysuria
5414399|NCT01657435|Total hip replacement|total hip replacement
5414400|NCT01657435|Total hip arthroplasty|total hip arthroplasty
5414401|NCT01657435|Hip joint replacement|hip joint replacement
5414402|NCT01657435|Hip prosthesis replacement|hip prosthesis replacement
5414403|NCT01657422|Nutrition|nutrition
5414404|NCT01657422|Physical Activity|physical activity
5414405|NCT01657422|Adolescents|adolescents
5414406|NCT01657409|botulinum toxin|botulinum toxin
5414407|NCT01657409|detrusor overactivity|detrusor overactivity
5414408|NCT01657396|Oral Care|oral care
5414409|NCT01657396|Oral Hygiene|oral hygiene
5414410|NCT01657396|Intensive Care|intensive care
5414411|NCT01657396|Mechanical Ventilation|mechanical ventilation
5414412|NCT01657396|Chlorhexidine|chlorhexidine
5414413|NCT01657331|Hodgkin Lymphoma|hodgkin lymphoma
5414414|NCT01657331|Hodgkin Disease|hodgkin disease
5414415|NCT01657331|Hodgkin's Disease|hodgkin's disease
5414416|NCT01657331|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5414417|NCT01657331|ALCL|alcl
5414418|NCT01657331|SGN+Benda|sgn+benda
5414419|NCT01657331|Bendamustine|bendamustine
5414420|NCT01657331|Brentuximab Vedotin|brentuximab vedotin
5414421|NCT01657318|diabetic foot|diabetic foot
5414422|NCT01657318|leg ulcer|leg ulcer
5414423|NCT01657305|Split-Thickness Skin Graft (STSG) donor site|split-thickness skin graft (stsg) donor site
5414424|NCT01657305|Split-thickness skin graft|split-thickness skin graft
5414426|NCT01657305|Wound healing|wound healing
5414427|NCT01657305|Skin grafting|skin grafting
5414428|NCT01657305|Superficial wound|superficial wound
5414429|NCT01657305|Partial-thickness wound|partial-thickness wound
5414430|NCT01657305|Time to wound closure|time to wound closure
5414431|NCT01657292|Wound healing|wound healing
5414432|NCT01657292|Burn wound|burn wound
5414433|NCT01657292|Superficial partial-thickness burn wound|superficial partial-thickness burn wound
5414434|NCT01657292|Grade 2a burn wounds|grade 2a burn wounds
5414435|NCT01657292|Time to wound closure|time to wound closure
5414436|NCT01657279|stroke|stroke
5414437|NCT01657279|risk score|risk score
5414438|NCT01657279|iScore|iscore
5414439|NCT01657279|outcomes|outcomes
5414440|NCT01657279|mortality|mortality
5414441|NCT01657279|disability|disability
5414442|NCT01657279|institutionalization|institutionalization
5414443|NCT01657266|bromfenac|bromfenac
5414444|NCT01657266|nepafenac|nepafenac
5414445|NCT01657266|cataract|cataract
5414446|NCT01657266|phacoemulsification cataract surgery|phacoemulsification cataract surgery
5414447|NCT01657227|diabetes|diabetes
5414449|NCT01657227|lifestyle|lifestyle
5414450|NCT01657227|diet|diet
5414451|NCT01657227|physical exercise|physical exercise
5414452|NCT01657227|computer-assisted decision support systems|computer-assisted decision support systems
5414453|NCT01657188|Heart failure, congestive|heart failure, congestive
5414454|NCT01657188|Sleep apnea syndromes|sleep apnea syndromes
5414455|NCT01657188|Adaptive servoventilation|adaptive servoventilation
5414456|NCT01657188|Prognosis|prognosis
5414457|NCT01657188|Cheyne-Stokes respiration|cheyne-stokes respiration
5414458|NCT01657175|Cancer|cancer
5414459|NCT01657175|long-term follow-up|long-term follow-up
5414460|NCT01657175|quality of life|quality of life
5414461|NCT01657175|Surgery|surgery
5414462|NCT01657175|Nursing|nursing
5414463|NCT01657162|BA058|ba058
5414464|NCT01657162|Abaloparatide-SC|abaloparatide-sc
5414465|NCT01657162|abaloparatide|abaloparatide
5414466|NCT01657162|ACTIVExtend|activextend
5414467|NCT01657162|osteoporosis|osteoporosis
5414468|NCT01657162|fracture|fracture
5414469|NCT01657162|bone loss|bone loss
5414470|NCT01657136|Inappropriate sinus tachycardia|inappropriate sinus tachycardia
5414471|NCT01657136|ivabradine|ivabradine
5414472|NCT01657136|beta blockers|beta blockers
5414473|NCT01657123|exercise capacity|exercise capacity
5414474|NCT01657123|Addison's disease|addison's disease
5414475|NCT01657110|acne|acne
5414476|NCT01657110|inflamed lesions|inflamed lesions
5414477|NCT01657110|non-inflamed lesions|non-inflamed lesions
5414478|NCT01657110|complementary medicine|complementary medicine
5414479|NCT01657110|essential oil|essential oil
5414480|NCT01657058|soluble fiber|soluble fiber
5414481|NCT01657058|second meal effect|second meal effect
5414482|NCT01657058|glycemia|glycemia
5414483|NCT01657058|satiety|satiety
5414484|NCT01657058|Individuals|individuals
5414485|NCT01657045|Cicatrix|cicatrix
5414486|NCT01657045|Wound healing|wound healing
5414487|NCT01657032|diarrhea|diarrhea
5414488|NCT01657032|probiotics|probiotics
5414489|NCT01657032|diosmectite|diosmectite
5414490|NCT01657006|Heart rate variability|heart rate variability
5414491|NCT01657006|ischemic heart disease|ischemic heart disease
5414492|NCT01657006|myocardial ischemia|myocardial ischemia
5414493|NCT01656993|Aspirin|aspirin
5414495|NCT01656993|aortopulmonary shunt|aortopulmonary shunt
5414496|NCT01656993|cavopulmonary shunt|cavopulmonary shunt
5414497|NCT01656993|shunt|shunt
5414498|NCT01656993|TEG|teg
5414499|NCT01656993|Antiplatelet|antiplatelet
5414500|NCT01656967|Laryngeal Mask Airway|laryngeal mask airway
5414501|NCT01656967|LMA|lma
5414502|NCT01656967|Intubation|intubation
5414503|NCT01656967|AMBU|ambu
5414504|NCT01656967|AScope|ascope
5414505|NCT01656967|Aura-I|aura-i
5414506|NCT01656967|Fastrach|fastrach
5414507|NCT01656967|Fiberoptic|fiberoptic
5414508|NCT01656967|Disposable Fiberoptic|disposable fiberoptic
5414509|NCT01656967|Blind Intubation|blind intubation
5414510|NCT01656967|Fiberoptic Intubation|fiberoptic intubation
5414511|NCT01656954|stroke volume|stroke volume
5414512|NCT01656954|cardiac output|cardiac output
5414513|NCT01656954|pulse pressure variance|pulse pressure variance
5414514|NCT01656954|stroke volume variance|stroke volume variance
5414515|NCT01656954|passive leg raise|passive leg raise
5414516|NCT01656954|fluid challenge|fluid challenge
5401658|NCT01714414|HIV|hiv
5414517|NCT01656954|central venous pressure|central venous pressure
5414518|NCT01656941|neonate|neonate
5414519|NCT01656941|congenital heart disease|congenital heart disease
5414520|NCT01656941|single ventricle cardiac disease|single ventricle cardiac disease
5414521|NCT01656941|hypoplastic left heart syndrome|hypoplastic left heart syndrome
5414522|NCT01656941|hypoplastic right heart syndrome|hypoplastic right heart syndrome
5414523|NCT01656941|d-Transposition of the Great Arteries|d-transposition of the great arteries
5414524|NCT01656915|inflammation|inflammation
5414526|NCT01656915|resilience|resilience
5414527|NCT01656915|cytokines|cytokines
5414528|NCT01656915|pre-diabetes|pre-diabetes
5414529|NCT01656902|Autologous Chondrocyte Transplantation|autologous chondrocyte transplantation
5414530|NCT01656902|NOVOCART 3D plus|novocart 3d plus
5414531|NCT01656902|knee joint pain|knee joint pain
5414532|NCT01656902|safety|safety
5414533|NCT01656902|efficacy|efficacy
5414534|NCT01656902|treatment|treatment
5414535|NCT01656902|TETEC|tetec
5414536|NCT01656902|cartilage|cartilage
5414537|NCT01656902|ACT|act
5414538|NCT01656902|cartilage repair|cartilage repair
5414539|NCT01656902|tissue|tissue
5414540|NCT01656902|MOCART|mocart
5414541|NCT01656889|Venous leg ulcer|venous leg ulcer
5414543|NCT01656889|venous stasis|venous stasis
5414544|NCT01656889|compression|compression
5414545|NCT01656889|venous|venous
5414546|NCT01656889|venous stasis ulcer|venous stasis ulcer
5414547|NCT01656889|vlu|vlu
5414548|NCT01656876|Comparative effectiveness research|comparative effectiveness research
5414549|NCT01656876|Mirror therapy|mirror therapy
5414550|NCT01656876|Stroke rehabilitation|stroke rehabilitation
5409501|NCT01680042|VAS|vas
5414551|NCT01656876|Clinical evaluation|clinical evaluation
5414552|NCT01656876|Kinematic analysis|kinematic analysis
5414553|NCT01656876|Mesh glove|mesh glove
5414560|NCT01656837|Multisystemic Therapy|multisystemic therapy
5414561|NCT01656837|Child Trauma|child trauma
5414562|NCT01656824|Bv8/PK-2|bv8/pk-2
5414563|NCT01656824|MDSC Myeloid Derived Suppressor Cells|mdsc myeloid derived suppressor cells
5414564|NCT01656824|BMDC Bone Marrow Derived Cells|bmdc bone marrow derived cells
5414565|NCT01656824|Angiogenesis|angiogenesis
5414566|NCT01656824|Pancreatic Cancer|pancreatic cancer
5414567|NCT01656785|stroke|stroke
5414568|NCT01656785|cerebrovascular disease|cerebrovascular disease
5414569|NCT01656785|angiogenesis imaging|angiogenesis imaging
5414570|NCT01656785|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5414571|NCT01656785|PET/CT|pet/ct
5414572|NCT01656772|magnetic navigation|magnetic navigation
5414573|NCT01656772|robotic control|robotic control
5414574|NCT01656772|RMT ThermoCool catheter|rmt thermocool catheter
5414575|NCT01656759|Blood Loss|blood loss
5414576|NCT01656759|Hemoglobin|hemoglobin
5414577|NCT01656759|Hematocrit|hematocrit
5414578|NCT01656759|Blood Transfusions|blood transfusions
5414579|NCT01656746|Colorectal Disease|colorectal disease
5414580|NCT01656746|SILS|sils
5414581|NCT01656746|colorectal surgery|colorectal surgery
5414582|NCT01656733|Smoking Cessation|smoking cessation
5414583|NCT01656733|Pregnancy|pregnancy
5414584|NCT01656733|Nicotrol Inhaler|nicotrol inhaler
5414585|NCT01656733|Placebo Inhaler|placebo inhaler
5414586|NCT01656733|Nicotine Inhaler|nicotine inhaler
5414587|NCT01656720|Faecal Incontinence|faecal incontinence
5414588|NCT01656720|Suppository|suppository
5414589|NCT01656720|Wexner score|wexner score
5414590|NCT01656707|Adolescents|adolescents
5414591|NCT01656707|Substance Use Disorders|substance use disorders
5414592|NCT01656694|Osteoarthritis|osteoarthritis
5414593|NCT01656694|Knee|knee
5414594|NCT01656694|Replacement|replacement
5414595|NCT01656694|Unicompartmental|unicompartmental
5414596|NCT01656694|DePuy|depuy
5414597|NCT01656694|Sigma HP|sigma hp
5414598|NCT01656668|Chronic|chronic
5414599|NCT01656668|Acute|acute
5414600|NCT01656668|Persistent|persistent
5414601|NCT01656668|Longterm|longterm
5414602|NCT01656668|Cough|cough
5414603|NCT01656655|ptsd, parenting|ptsd, parenting
5414612|NCT01656616|Pharmacoeconomics|pharmacoeconomics
5414613|NCT01656616|Cost effectiveness|cost effectiveness
5414614|NCT01656616|Cyanide|cyanide
5414615|NCT01656616|Fire|fire
5414616|NCT01656616|Emergency Medical Services|emergency medical services
5414617|NCT01656616|Smoke Inhalation|smoke inhalation
5414618|NCT01656603|cord blood|cord blood
5414619|NCT01656603|transplantation|transplantation
5414620|NCT01656603|stem cells|stem cells
5414621|NCT01656603|adverse event|adverse event
5414622|NCT01656590|Pompe disease|pompe disease
5414623|NCT01656590|Acid Maltase Deficiency|acid maltase deficiency
5414624|NCT01656577|CRF1 antagonist|crf1 antagonist
5414625|NCT01656577|Stress|stress
5414626|NCT01656577|Eating Behavior|eating behavior
5414627|NCT01656577|Food Craving|food craving
5414629|NCT01656564|Childhood|childhood
5414630|NCT01656564|Antiviral Therapy|antiviral therapy
5414631|NCT01656564|Cardiac|cardiac
5414632|NCT01656564|Natural History|natural history
5414633|NCT01656551|elderly|elderly
5414634|NCT01656551|chemotherapy|chemotherapy
5414635|NCT01656512|ALL|all
5414636|NCT01656512|zoledronic acid|zoledronic acid
5414637|NCT01656512|Osteoporosis|osteoporosis
5414638|NCT01656486|Pancreas|pancreas
5414639|NCT01656486|Pancreatic fistula|pancreatic fistula
5414640|NCT01656486|Stereotactic radiation|stereotactic radiation
5414641|NCT01656473|Concurrent Disorders|concurrent disorders
5414642|NCT01656473|Adolescents|adolescents
5414643|NCT01656473|Motivational Interviewing|motivational interviewing
5414644|NCT01656473|Dialectical Behaviour Therapy|dialectical behaviour therapy
5414646|NCT01656460|Lung Cancer|lung cancer
5414647|NCT01656447|Scleroderma|scleroderma
5414648|NCT01656447|Scleroderma Registry|scleroderma registry
5414649|NCT01656447|Hospital for Special Surgery Scleroderma|hospital for special surgery scleroderma
5414650|NCT01656434|Combined Oral Contraceptives|combined oral contraceptives
5414651|NCT01656382|ABLC|ablc
5414652|NCT01656382|cryptococcosis|cryptococcosis
5414653|NCT01656369|Delorme operation,incontinence|delorme operation,incontinence
5414654|NCT01656356|Avian Flu|avian flu
5414655|NCT01656356|H5N2|h5n2
5414656|NCT01656330|Healthy|healthy
5414657|NCT01656330|Rivaroxaban|rivaroxaban
5414658|NCT01656330|JNJ-39039039|jnj-39039039
5414659|NCT01656330|BAY59-7939|bay59-7939
5414949|NCT01655160|Functional performance|functional performance
5414660|NCT01656330|Prothrombin Complex Concentrate (PCC)|prothrombin complex concentrate (pcc)
5414662|NCT01656317|Early rehabilitation|early rehabilitation
5414663|NCT01656317|Mobilisation|mobilisation
5414664|NCT01656278|Arthritis, Rheumatoid/drug therapy|arthritis, rheumatoid/drug therapy
5414665|NCT01656278|Arthritis, Rheumatoid/pathology|arthritis, rheumatoid/pathology
5414666|NCT01656278|Disease Progression|disease progression
5414667|NCT01656278|Longitudinal Studies|longitudinal studies
5414668|NCT01656278|Prospective Studies|prospective studies
5414669|NCT01656278|Imaging, Magnetic Resonance|imaging, magnetic resonance
5414670|NCT01656278|Remission Induction|remission induction
5414671|NCT01656278|Synovitis/immunology|synovitis/immunology
5414672|NCT01656278|Synovitis/pathology|synovitis/pathology
5414673|NCT01656278|Wrist Joint/pathology|wrist joint/pathology
5414674|NCT01656278|Wrist Joint/physiopathology|wrist joint/physiopathology
5414675|NCT01656252|Acute Leukemia|acute leukemia
5414676|NCT01656252|Complete Remission|complete remission
5414677|NCT01656252|Consolidation|consolidation
5414678|NCT01656252|Consolidation Chemotherapy|consolidation chemotherapy
5414680|NCT01656252|Eltrombopag|eltrombopag
5414681|NCT01656252|Leukemia|leukemia
5414682|NCT01656252|Thrombocytopenia|thrombocytopenia
5414683|NCT01656252|Thrombopoietin|thrombopoietin
5414684|NCT01656239|VA106483, fedovapagon, Nocturia, males, nocturnal voids, anti-diuretic|va106483, fedovapagon, nocturia, males, nocturnal voids, anti-diuretic
5414685|NCT01656226|Actinic Keratosis|actinic keratosis
5414686|NCT01656226|AK|ak
5414687|NCT01656213|Stroke|stroke
5414688|NCT01656213|End Stage Renal Disease|end stage renal disease
5414689|NCT01656213|Recovery|recovery
5414690|NCT01656213|Haemodialysis|haemodialysis
5414691|NCT01656200|Japanese encephalitis|japanese encephalitis
5414692|NCT01656200|Japanese encephalitis vaccine|japanese encephalitis vaccine
5414693|NCT01656200|T lymphocyte|t lymphocyte
5414694|NCT01656200|Immune response|immune response
5414695|NCT01656187|memantine|memantine
5414696|NCT01656187|cognition|cognition
5414697|NCT01656187|corticosteroid|corticosteroid
5414698|NCT01656187|prednisone|prednisone
5414699|NCT01656187|memory|memory
5414700|NCT01656187|hippocampus|hippocampus
5414701|NCT01656148|Multiple sclerosis|multiple sclerosis
5414702|NCT01656148|Walking disablility|walking disablility
5414703|NCT01656148|Mobility|mobility
5414704|NCT01656148|Six Spot Step Test|six spot step test
5414705|NCT01656148|Outcome measures|outcome measures
5414706|NCT01656148|Fampridine-SR|fampridine-sr
5414707|NCT01656148|Fampyra|fampyra
5414708|NCT01656135|gold standard treatment|gold standard treatment
5414709|NCT01656135|immune monitoring|immune monitoring
5414710|NCT01656135|acute rejection|acute rejection
5414711|NCT01656135|graft rejection|graft rejection
5414712|NCT01656135|living-donor|living-donor
5414713|NCT01656135|renal transplantation|renal transplantation
5414714|NCT01656135|kidney transplantation|kidney transplantation
5414715|NCT01656122|pharmacokinetic paramters|pharmacokinetic paramters
5414716|NCT01656122|abacavir|abacavir
5414717|NCT01656122|lamuvidine|lamuvidine
5414718|NCT01656122|HIV-infected children|hiv-infected children
5414719|NCT01656109|pharmacokinetics|pharmacokinetics
5414720|NCT01656109|atazanavir/ritonavir|atazanavir/ritonavir
5414721|NCT01656109|HIV-infected children|hiv-infected children
5414722|NCT01656083|Mobile phone text messaging (SM)|mobile phone text messaging (sm)
5414723|NCT01656083|Varenicline|varenicline
5414724|NCT01656083|The compliance|the compliance
5414725|NCT01656083|The abstinence rate|the abstinence rate
5414727|NCT01656070|children|children
5414728|NCT01656070|adolescents|adolescents
5414729|NCT01656070|Vitamin D|vitamin d
5414730|NCT01656070|immunity|immunity
5414731|NCT01656070|T cell phenotype|t cell phenotype
5414732|NCT01656057|Bile acids|bile acids
5414733|NCT01656057|Gall bladder emptying|gall bladder emptying
5414734|NCT01656057|Human|human
5414735|NCT01656057|Glucagon like peptide 1|glucagon like peptide 1
5414736|NCT01656057|GLP-1|glp-1
5414737|NCT01656031|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5414738|NCT01656031|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5414739|NCT01656031|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5414740|NCT01656031|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5414741|NCT01656031|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5414742|NCT01656031|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5414743|NCT01656031|adult acute basophilic leukemia|adult acute basophilic leukemia
5414744|NCT01656031|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5414745|NCT01656031|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5414746|NCT01656031|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5414747|NCT01656031|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5414748|NCT01656031|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5414749|NCT01656031|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5414750|NCT01656031|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5414751|NCT01656031|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5414752|NCT01656031|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5414753|NCT01656031|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5414754|NCT01656018|Healthy|healthy
5414755|NCT01656018|TMC278|tmc278
5414756|NCT01656018|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5414757|NCT01656018|HIV-1|hiv-1
5414764|NCT01656005|Impulse oscillometry|impulse oscillometry
5414766|NCT01655992|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
5414767|NCT01655966|chronic hepatitis c|chronic hepatitis c
5414769|NCT01655966|vitamin d|vitamin d
5414770|NCT01655927|Neoplasms|neoplasms
5414771|NCT01655927|Tranexamic Acid|tranexamic acid
5414772|NCT01655927|Brain Tumors|brain tumors
5414773|NCT01655901|Active video games|active video games
5414774|NCT01655901|Food intake|food intake
5414775|NCT01655901|Energy balance|energy balance
5414776|NCT01655901|Adolescents|adolescents
5414777|NCT01655888|Tremelimumab|tremelimumab
5414778|NCT01655888|anti-CTLA-4 monoclonal antibody|anti-ctla-4 monoclonal antibody
5414779|NCT01655888|malignant mesothelioma|malignant mesothelioma
5414780|NCT01655875|Allogeneic Blood and Marrow Transplantation|allogeneic blood and marrow transplantation
5414781|NCT01655823|Pain|pain
5414782|NCT01655823|Puffer fish|puffer fish
5414783|NCT01655823|Tetrodotoxin|tetrodotoxin
5414784|NCT01655823|TTX|ttx
5414785|NCT01655823|Neuropathy|neuropathy
5414786|NCT01655823|Chemotherapy|chemotherapy
5414787|NCT01655823|WEX Pharmaceuticals|wex pharmaceuticals
5414788|NCT01655797|insomnia|insomnia
5414789|NCT01655797|cognitive behavior therapy|cognitive behavior therapy
5414790|NCT01655797|primary care|primary care
5414791|NCT01655784|aneurysm|aneurysm
5414792|NCT01655784|intracranial aneurysm|intracranial aneurysm
5414793|NCT01655784|cerebral aneurysm|cerebral aneurysm
5414794|NCT01655784|intracranial embolization|intracranial embolization
5414795|NCT01655784|aneurysm embolization|aneurysm embolization
5414796|NCT01655784|intracranial coil|intracranial coil
5414797|NCT01655784|eighteen coils|eighteen coils
5414798|NCT01655784|bare platinum coils|bare platinum coils
5414799|NCT01655784|GDC Coil|gdc coil
5414800|NCT01655784|Target Coil|target coil
5414801|NCT01655771|Opioid induced constipation|opioid induced constipation
5414802|NCT01655771|Constipation|constipation
5414803|NCT01655758|glaucoma|glaucoma
5414804|NCT01655758|24-hour IOP|24-hour iop
5414805|NCT01655758|outflow drugs|outflow drugs
5414806|NCT01655758|inflow drugs|inflow drugs
5414807|NCT01655745|[18F]|[18f]
5414808|NCT01655745|FDG Positron Emission Tomography-Magnetic Resonance Imaging|fdg positron emission tomography-magnetic resonance imaging
5414809|NCT01655745|FDG-PET-MRI|fdg-pet-mri
5414810|NCT01655745|Muscle-Invasive Bladder Cancer|muscle-invasive bladder cancer
5414811|NCT01655745|Pilot Study|pilot study
5414812|NCT01655745|LCCC 1209|lccc 1209
5414813|NCT01655745|UNC Lineberger|unc lineberger
5414814|NCT01655745|MDCT|mdct
5414815|NCT01655732|Pregnancy|pregnancy
5414816|NCT01655706|major depression|major depression
5414817|NCT01655706|major depressive disorder|major depressive disorder
5414818|NCT01655706|biomarkers|biomarkers
5414819|NCT01655706|escitalopram|escitalopram
5414820|NCT01655706|aripiprazole|aripiprazole
5414821|NCT01655706|MDD|mdd
5414822|NCT01655706|neuroimaging|neuroimaging
5414823|NCT01655706|proteomic|proteomic
5414824|NCT01655706|genomics|genomics
5414825|NCT01655693|Intermediate/advanced hepatocellular carcinoma|intermediate/advanced hepatocellular carcinoma
5414826|NCT01655693|After failure or intolerance to Sorafenib.|after failure or intolerance to sorafenib.
5414827|NCT01655680|Schizophrenia|schizophrenia
5414828|NCT01655667|Diagnosis|diagnosis
5414829|NCT01655667|Primary Care|primary care
5401955|NCT01713218|Cancer|cancer
5414830|NCT01655667|Comorbidities|comorbidities
5414831|NCT01655667|Healthcare utilisation|healthcare utilisation
5414832|NCT01655654|Hypertension|hypertension
5414833|NCT01655654|Acute hospital staff|acute hospital staff
5414834|NCT01655654|Exercise|exercise
5414835|NCT01655654|Diet|diet
5414836|NCT01655641|Blood transfusion|blood transfusion
5414837|NCT01655641|Bleeding|bleeding
5414838|NCT01655641|Major Gastro-intestinal surgery|major gastro-intestinal surgery
5414839|NCT01655641|Tranexamic Acid|tranexamic acid
5414840|NCT01655628|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5414841|NCT01655628|metastasis|metastasis
5414842|NCT01655628|gemcitabine|gemcitabine
5414843|NCT01655628|CIK cells|cik cells
5414844|NCT01655615|Adolescent cognitive development|adolescent cognitive development
5414845|NCT01655615|mental disorders|mental disorders
5414846|NCT01655615|Mood disorders|mood disorders
5414847|NCT01655615|Alcohol-Related disorders|alcohol-related disorders
5414950|NCT01655160|Kinematic analysis|kinematic analysis
5414848|NCT01655615|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
5414849|NCT01655615|Substance related disorders|substance related disorders
5414851|NCT01655602|hair transplantation|hair transplantation
5414852|NCT01655602|donor site|donor site
5414853|NCT01655602|Androgenetic alopecia|androgenetic alopecia
5414854|NCT01655576|drainage|drainage
5414855|NCT01655576|pregnancy|pregnancy
5414856|NCT01655576|active management|active management
5414857|NCT01655576|postpartum hemorrhage|postpartum hemorrhage
5414858|NCT01655563|Transplant|transplant
5414859|NCT01655563|Pediatrics|pediatrics
5414860|NCT01655563|Tacrolimus|tacrolimus
5414861|NCT01655563|Prograf|prograf
5414862|NCT01655537|fibromyalgia|fibromyalgia
5414863|NCT01655537|cognitive dysfunction|cognitive dysfunction
5414864|NCT01655524|Regadenoson|regadenoson
5414865|NCT01655524|Aminophylline|aminophylline
5414866|NCT01655524|ASSUAGE|assuage
5414867|NCT01655524|Myocardial Perfusion Imaging (MPI)|myocardial perfusion imaging (mpi)
5414868|NCT01655511|Pharmacokinetic|pharmacokinetic
5414869|NCT01655511|pharmacodynamic|pharmacodynamic
5414870|NCT01655498|fecal incontinence|fecal incontinence
5414871|NCT01655498|bowel control|bowel control
5414872|NCT01655485|child anxiety|child anxiety
5414873|NCT01655485|challenging behaviors|challenging behaviors
5414874|NCT01655485|time|time
5414875|NCT01655485|Parent anxiety|parent anxiety
5414876|NCT01655472|schizophrenia|schizophrenia
5414877|NCT01655472|imaging|imaging
5414878|NCT01655459|ultrasound, LMA, fiberoptic bronchoscopy|ultrasound, lma, fiberoptic bronchoscopy
5414879|NCT01655446|Comparative effectiveness research|comparative effectiveness research
5414880|NCT01655446|Robotic rehabilitation|robotic rehabilitation
5414881|NCT01655446|Mirror therapy|mirror therapy
5414882|NCT01655446|Functional electrical therapy|functional electrical therapy
5414883|NCT01655446|Combined therapy|combined therapy
5414884|NCT01655446|Stroke rehabilitation|stroke rehabilitation
5414885|NCT01655446|Translational science|translational science
5414886|NCT01655433|ST-elevation MI|st-elevation mi
5414887|NCT01655433|Hypothermia|hypothermia
5414888|NCT01655420|Myopia|myopia
5414889|NCT01655420|Hyperopia|hyperopia
5414890|NCT01655420|Astigmatism|astigmatism
5414891|NCT01655420|Patient-reported outcomes|patient-reported outcomes
5414892|NCT01655420|Patient satisfaction|patient satisfaction
5414893|NCT01655420|Refractive Error|refractive error
5414894|NCT01655420|Emmetropia|emmetropia
5414895|NCT01655420|Dry eyes|dry eyes
5414896|NCT01655420|Glare|glare
5414897|NCT01655420|Halos|halos
5414898|NCT01655420|Patient expectations|patient expectations
5414899|NCT01655407|Split-thickness Autograft|split-thickness autograft
5414900|NCT01655407|Engraftment|engraftment
5414901|NCT01655407|Wound Closure|wound closure
5414902|NCT01655407|Engineered Skin Substitute|engineered skin substitute
5414903|NCT01655407|ESS-W|ess-w
5414904|NCT01655407|Cultured Skin Substitutes|cultured skin substitutes
5414905|NCT01655407|Burn|burn
5414906|NCT01655342|pulpotomy|pulpotomy
5414907|NCT01655342|primary teeth|primary teeth
5414908|NCT01655342|Biodentine®|biodentine®
5414909|NCT01655342|formocresol|formocresol
5414910|NCT01655329|Image Processing|image processing
5414911|NCT01655329|tubes|tubes
5414912|NCT01655329|lines|lines
5414913|NCT01655329|catheters|catheters
5414914|NCT01655329|wires|wires
5414915|NCT01655329|Bedside|bedside
5414916|NCT01655329|chest|chest
5414917|NCT01655329|radiographs|radiographs
5414918|NCT01655264|Stroke|stroke
5414919|NCT01655264|Tele-health|tele-health
5414920|NCT01655264|Rehabilitation|rehabilitation
5414921|NCT01655264|Intervention|intervention
5414922|NCT01655264|Gesture recognition system|gesture recognition system
5414923|NCT01655251|children|children
5414924|NCT01655251|fever|fever
5414925|NCT01655251|emergency department|emergency department
5414926|NCT01655225|Advanced Breast Cancer|advanced breast cancer
5414927|NCT01655225|Advanced Lung Cancer|advanced lung cancer
5414928|NCT01655225|Mesothelioma|mesothelioma
5414929|NCT01655225|Lymphoma|lymphoma
5402054|NCT01712698|trauma|trauma
5414930|NCT01655212|Cytomegalovirus|cytomegalovirus
5414931|NCT01655212|Congenital infection|congenital infection
5414932|NCT01655212|Sensorineural hearing loss|sensorineural hearing loss
5414933|NCT01655212|Randomized controlled trial|randomized controlled trial
5414934|NCT01655212|Valganciclovir|valganciclovir
5414935|NCT01655199|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5414936|NCT01655199|Lung function|lung function
5414937|NCT01655199|Exertional dyspnea|exertional dyspnea
5414938|NCT01655199|Exercise capacity|exercise capacity
5414939|NCT01655199|Pulmonary function|pulmonary function
5414940|NCT01655199|Pleural pressures|pleural pressures
5414941|NCT01655186|Chronic Kidney Disease|chronic kidney disease
5414942|NCT01655186|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5414943|NCT01655173|Asperger syndrome|asperger syndrome
5414944|NCT01655173|Autistic disorder|autistic disorder
5414945|NCT01655173|Adult|adult
5414946|NCT01655173|Psychotherapy|psychotherapy
5414947|NCT01655160|Stroke rehabilitation|stroke rehabilitation
5414948|NCT01655160|Mirror therapy|mirror therapy
5415146|NCT01654120|liraglutide|liraglutide
5414951|NCT01655160|Functional magnetic resonance image|functional magnetic resonance image
5414958|NCT01655147|JNJ-212082|jnj-212082
5414959|NCT01655147|Zytiga|zytiga
5414960|NCT01655147|Rifampicin|rifampicin
5414961|NCT01655147|Rifadin|rifadin
5414962|NCT01655147|CYP3A4 inducer|cyp3a4 inducer
5414963|NCT01655134|Heart Failure|heart failure
5414964|NCT01655134|Telemonitoring systems for congestive HF|telemonitoring systems for congestive hf
5414965|NCT01655134|Biomarkers|biomarkers
5414966|NCT01655108|Androgenetic Alopecia|androgenetic alopecia
5414967|NCT01655108|Mesotherapy|mesotherapy
5414968|NCT01655108|Minoxidil|minoxidil
5414969|NCT01655108|Trichogram|trichogram
5414970|NCT01655095|Colon capsule|colon capsule
5414971|NCT01655095|Picosalax|picosalax
5414973|NCT01655095|Prucalopride|prucalopride
5414974|NCT01655082|Smoking cessation|smoking cessation
5414975|NCT01655082|Nicotine|nicotine
5414976|NCT01655082|Tobacco Use Disorder|tobacco use disorder
5414977|NCT01655082|Central Nervous System Agents|central nervous system agents
5414978|NCT01655069|Overactive bladder (OAB)|overactive bladder (oab)
5414979|NCT01655069|Solifenacin succinate suspension|solifenacin succinate suspension
5414980|NCT01655069|Phase 3|phase 3
5414981|NCT01655069|Pediatric|pediatric
5414982|NCT01655056|Pharmacokinetics|pharmacokinetics
5414983|NCT01655056|Pharmacodynamics|pharmacodynamics
5414984|NCT01655056|Phase 1|phase 1
5414985|NCT01655056|YM150|ym150
5414986|NCT01655056|Dose-escalating|dose-escalating
5414987|NCT01655056|Ethnicity|ethnicity
5414988|NCT01655056|Caucasian|caucasian
5414989|NCT01655056|Japanese|japanese
5414990|NCT01655043|Magnetic Resonance Imaging|magnetic resonance imaging
5414991|NCT01655043|regadenoson|regadenoson
5414992|NCT01655017|Obesity|obesity
5414993|NCT01655017|adipose tissue fibrosis|adipose tissue fibrosis
5414994|NCT01655017|Adipose tissue inflammation|adipose tissue inflammation
5414995|NCT01655017|Low grade systemic inflammation|low grade systemic inflammation
5414996|NCT01655017|non invasive device|non invasive device
5414997|NCT01655017|Bariatric surgery|bariatric surgery
5414998|NCT01655004|hormone receptor positive|hormone receptor positive
5414999|NCT01655004|breast cancer|breast cancer
5415000|NCT01654939|HIV|hiv
5415001|NCT01654939|hepatitis C|hepatitis c
5415002|NCT01654926|Feasibility of using the FlexFlowTM ultrafiltration pump in a non hospital environment|feasibility of using the flexflowtm ultrafiltration pump in a non hospital environment
5415003|NCT01654913|hemoglobin determination|hemoglobin determination
5415004|NCT01654913|oxygen|oxygen
5415005|NCT01654887|Comparative Effectiveness|comparative effectiveness
5415006|NCT01654887|Lung Ultrasound versus Chest X-ray|lung ultrasound versus chest x-ray
5415007|NCT01654887|Pneumonia|pneumonia
5415008|NCT01654887|Emergency Department|emergency department
5415009|NCT01654848|liver transplantation|liver transplantation
5415010|NCT01654848|thrombocytes|thrombocytes
5415011|NCT01654848|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5415012|NCT01654848|multivariate analysis of associated factors of HIT 2 after OLT|multivariate analysis of associated factors of hit 2 after olt
5415013|NCT01654848|laboratory investigations of HIT-antibodies|laboratory investigations of hit-antibodies
5415014|NCT01654822|HPV|hpv
5415015|NCT01654822|cervix|cervix
5415016|NCT01654796|Depression|depression
5415017|NCT01654796|Treatment Resistant Depression|treatment resistant depression
5415018|NCT01654783|5-ASA, ulcerative colitis, active, remission, adherence|5-asa, ulcerative colitis, active, remission, adherence
5415019|NCT01654770|VCE, DBE,OGIB|vce, dbe,ogib
5415020|NCT01654770|consecutive|consecutive
5415021|NCT01654770|patients|patients
5415022|NCT01654731|PBC|pbc
5415023|NCT01654731|Bezafibrate|bezafibrate
5415024|NCT01654692|metastatic melanoma|metastatic melanoma
5415025|NCT01654692|Ipilimumab|ipilimumab
5415026|NCT01654679|wound infection|wound infection
5415028|NCT01654679|surgical wound infection rate|surgical wound infection rate
5415029|NCT01654679|wound healing|wound healing
5415030|NCT01654666|Remote ischemic preconditioning|remote ischemic preconditioning
5415031|NCT01654666|Stroke secondary prevention|stroke secondary prevention
5415032|NCT01654666|Carotid artery stenting|carotid artery stenting
5415033|NCT01654666|Carotid stenosis|carotid stenosis
5418396|NCT01639001|ALK|alk
5415034|NCT01654666|Inflammation|inflammation
5415035|NCT01654653|Heart disease|heart disease
5415036|NCT01654653|cardiac surgery|cardiac surgery
5415037|NCT01654653|CABG|cabg
5415038|NCT01654653|Totilac|totilac
5415039|NCT01654653|Voluven|voluven
5415040|NCT01654653|6% HES|6% hes
5415041|NCT01654640|schizophrenia|schizophrenia
5415042|NCT01654640|obesity|obesity
5415043|NCT01654640|clozapine|clozapine
5415044|NCT01654640|metformin|metformin
5415045|NCT01654627|Guided Tissue Regeneration|guided tissue regeneration
5415046|NCT01654627|Dental Implants|dental implants
5415047|NCT01654627|Membrane, Synthetic|membrane, synthetic
5415048|NCT01654614|Keratoconus match index|keratoconus match index
5415049|NCT01654614|keratoconus probability index|keratoconus probability index
5415050|NCT01654614|ocular response analyzer|ocular response analyzer
5415051|NCT01654614|Pentacam|pentacam
5415052|NCT01654614|forme fruste keratoconus|forme fruste keratoconus
5415053|NCT01654601|Schizophrenia|schizophrenia
5415054|NCT01654588|BRONCHIAL CHALLANGE TEST, ASTHMA, METACHLINE, ADENOSINE|bronchial challange test, asthma, metachline, adenosine
5415055|NCT01654575|Methotrexate|methotrexate
5415056|NCT01654575|Knee Osteoarthritis|knee osteoarthritis
5415057|NCT01654575|Synovitis|synovitis
5415058|NCT01654575|Pain reduction|pain reduction
5415059|NCT01654575|Function scores|function scores
5415060|NCT01654549|Steatohepatitis,|steatohepatitis,
5415061|NCT01654549|Helicobacter pylori,|helicobacter pylori,
5415062|NCT01654549|Insulin resistance,|insulin resistance,
5415063|NCT01654549|Alanine aminotransferase,|alanine aminotransferase,
5415064|NCT01654549|Aspartate aminotransferase,|aspartate aminotransferase,
5415065|NCT01654536|PAR|par
5415066|NCT01654523|Trichotillomania|trichotillomania
5415067|NCT01654497|Brain|brain
5415068|NCT01654497|Glioma|glioma
5415069|NCT01654497|glioblastoma|glioblastoma
5415070|NCT01654497|metastases|metastases
5415071|NCT01654497|cancer|cancer
5415072|NCT01654497|ETS2101|ets2101
5415073|NCT01654497|leptomeningeal|leptomeningeal
5415074|NCT01654497|astrocytoma|astrocytoma
5415075|NCT01654497|oligodendroglioma|oligodendroglioma
5415076|NCT01654497|meningioma|meningioma
5415077|NCT01654471|Walking Impairment Questionnaire|walking impairment questionnaire
5415078|NCT01654471|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
5415079|NCT01654471|Korean version|korean version
5415080|NCT01654458|Sexual Dysfunctions, Psychological|sexual dysfunctions, psychological
5415081|NCT01654458|Psychotherapy, Group|psychotherapy, group
5415082|NCT01654458|Genital Neoplasms, Female|genital neoplasms, female
5415083|NCT01654458|Endometrial Neoplasms|endometrial neoplasms
5415084|NCT01654458|Fallopian Tube Neoplasms|fallopian tube neoplasms
5415085|NCT01654458|Ovarian Neoplasms|ovarian neoplasms
5415086|NCT01654458|Urogenital Neoplasms|urogenital neoplasms
5415087|NCT01654458|Uterine Cervical Neoplasms|uterine cervical neoplasms
5415088|NCT01654458|Uterine Neoplasms|uterine neoplasms
5415089|NCT01654458|Vaginal Neoplasms|vaginal neoplasms
5415090|NCT01654458|Vulvar Neoplasms|vulvar neoplasms
5415091|NCT01654445|Minor stroke|minor stroke
5415092|NCT01654419|sliding jig|sliding jig
5415093|NCT01654419|Class II malocclusion|class ii malocclusion
5415094|NCT01654419|Distalization mechanics|distalization mechanics
5415095|NCT01654419|Intermaxillary elastics|intermaxillary elastics
5415096|NCT01654406|Cesarian scar|cesarian scar
5415097|NCT01654406|Fractional CO2 laser|fractional co2 laser
5415098|NCT01654393|Triage nurse|triage nurse
5415099|NCT01654393|Ottawa ankle rules|ottawa ankle rules
5415100|NCT01654354|Qualitative Evaluation of abdominal CT image using 4 point scale: Excellent(4)/ Good(3) / Fair(2) / Unacceptable(1)|qualitative evaluation of abdominal ct image using 4 point scale: excellent(4)/ good(3) / fair(2) / unacceptable(1)
5415101|NCT01654328|contrast media|contrast media
5415102|NCT01654328|kidney injury|kidney injury
5415103|NCT01654328|hydration|hydration
5415104|NCT01654315|RTP Only Group|rtp only group
5415105|NCT01654315|Myomo Only Group|myomo only group
5415106|NCT01654315|Myomo + RTP Group|myomo + rtp group
5415107|NCT01654289|respiratory tract infections|respiratory tract infections
5415108|NCT01654289|common cold|common cold
5415109|NCT01654289|exercise|exercise
5415110|NCT01654289|influenza|influenza
5415111|NCT01654289|meditation|meditation
5415112|NCT01654263|13-valent|13-valent
5415113|NCT01654263|23-valent|23-valent
5415115|NCT01654263|parent protocol|parent protocol
5415116|NCT01654263|Pneumococcal infections|pneumococcal infections
5415117|NCT01654263|vaccine|vaccine
5415118|NCT01654250|ADHD|adhd
5415119|NCT01654250|methylphenidate extended-release|methylphenidate extended-release
5415120|NCT01654237|work|work
5415121|NCT01654237|WMSD|wmsd
5415122|NCT01654237|prevalence|prevalence
5415123|NCT01654237|occupational risks|occupational risks
5415124|NCT01654237|industry|industry
5415125|NCT01654237|questionnaires|questionnaires
5415126|NCT01654237|musculoskeletal pain|musculoskeletal pain
5415127|NCT01654237|lifestyle|lifestyle
5415128|NCT01654224|Influenza in Long Term Care Setting|influenza in long term care setting
5415129|NCT01654224|High dose Inactivated influenza vaccine|high dose inactivated influenza vaccine
5415130|NCT01654224|Standard dose inactivated influenza vaccine|standard dose inactivated influenza vaccine
5415132|NCT01654172|peripheral neuropathy|peripheral neuropathy
5415133|NCT01654172|Cocoa flavanols|cocoa flavanols
5415134|NCT01654159|intraocular lenses|intraocular lenses
5415135|NCT01654159|evaluation|evaluation
5415136|NCT01654159|cataract|cataract
5415137|NCT01654146|Ovarian cancer|ovarian cancer
5415138|NCT01654146|Epithelial ovarian carcinoma|epithelial ovarian carcinoma
5415139|NCT01654146|Fallopian tube carcinoma|fallopian tube carcinoma
5415140|NCT01654146|Primary serous peritoneal carcinoma|primary serous peritoneal carcinoma
5415141|NCT01654146|Gynaecological carcinoma|gynaecological carcinoma
5415142|NCT01654146|Randomised controlled trial|randomised controlled trial
5415143|NCT01654133|Aortic Aneurysm, abdominal|aortic aneurysm, abdominal
5415144|NCT01654120|insulin|insulin
5415145|NCT01654120|Type II Diabetes|type ii diabetes
5415147|NCT01654120|Glucagon-Like Peptide 1|glucagon-like peptide 1
5415148|NCT01654107|tobacco|tobacco
5415149|NCT01654107|smoking cessation|smoking cessation
5415150|NCT01654107|nicotine dependence|nicotine dependence
5415151|NCT01654081|Lung Cancer|lung cancer
5415152|NCT01654081|POSITIVE NON SMALL CELL CARCINOMA|positive non small cell carcinoma
5415153|NCT01654081|ISG15|isg15
5415154|NCT01654081|IRINOTECAN|irinotecan
5415155|NCT01654068|Female Breast Cancer|female breast cancer
5415156|NCT01654068|Kidney Cancer|kidney cancer
5415157|NCT01654068|Lung Cancer|lung cancer
5415158|NCT01654068|Prostate Cancer|prostate cancer
5415159|NCT01654068|Vertebral metastasis|vertebral metastasis
5415160|NCT01654055|Morphine|morphine
5415161|NCT01654055|Adverse events|adverse events
5415162|NCT01654055|Predictive factors|predictive factors
5415163|NCT01654042|anticoagulation|anticoagulation
5415164|NCT01654042|warfarin|warfarin
5415165|NCT01654042|monitoring|monitoring
5415166|NCT01654042|bleeding|bleeding
5415167|NCT01654042|thromboembolism|thromboembolism
5415168|NCT01654029|Stroke|stroke
5415169|NCT01654029|Communication impairments|communication impairments
5415170|NCT01654029|Nurse-patient communication|nurse-patient communication
5415171|NCT01654029|Patient-centred care|patient-centred care
5415172|NCT01654016|varicose veins|varicose veins
5415173|NCT01654016|inflammation|inflammation
5415174|NCT01654003|Goal-directed therapy|goal-directed therapy
5415175|NCT01654003|severe sepsis|severe sepsis
5415176|NCT01654003|emergency surgery|emergency surgery
5415177|NCT01654003|vasopressor|vasopressor
5415178|NCT01654003|dynamic flow-related parameters|dynamic flow-related parameters
5415179|NCT01653977|Hypovolemic shock|hypovolemic shock
5415180|NCT01653977|trauma|trauma
5415181|NCT01653977|emergency|emergency
5415182|NCT01653977|surgery|surgery
5415184|NCT01653977|Picco|picco
5415185|NCT01653964|suspicious|suspicious
5415186|NCT01653964|lesion|lesion
5415187|NCT01653964|breast|breast
5415188|NCT01653964|cancer|cancer
5415189|NCT01653964|screening|screening
5415190|NCT01653964|mammogram|mammogram
5415191|NCT01653964|negative|negative
5415192|NCT01653938|CHF|chf
5415193|NCT01653925|Prostatic Neoplasms|prostatic neoplasms
5415194|NCT01653925|Low grade prostate cancer|low grade prostate cancer
5415195|NCT01653912|cancer|cancer
5415196|NCT01653912|ovarian|ovarian
5415197|NCT01653912|platinum-resistant|platinum-resistant
5415198|NCT01653899|Type I Diabetes|type i diabetes
5415199|NCT01653886|Palatability|palatability
5415200|NCT01653886|Taste|taste
5415201|NCT01653873|fracture|fracture
5415202|NCT01653873|vertebral column|vertebral column
5415203|NCT01653873|osteoporosis|osteoporosis
5415204|NCT01653873|predictor|predictor
5415205|NCT01653873|vertebroplasty|vertebroplasty
5415206|NCT01653860|Behavior therapy|behavior therapy
5415207|NCT01653860|Group therapy|group therapy
5415208|NCT01653847|transplant|transplant
5415209|NCT01653847|kidney|kidney
5415210|NCT01653847|renal disease|renal disease
5415211|NCT01653834|lymphopenia|lymphopenia
5415212|NCT01653821|carotid body|carotid body
5415213|NCT01653821|heart failure|heart failure
5415214|NCT01653821|chemoreceptor|chemoreceptor
5415215|NCT01653821|hypersensitivity|hypersensitivity
5415216|NCT01653808|CKD dialysis|ckd dialysis
5415217|NCT01653808|hemodialysis|hemodialysis
5415218|NCT01653808|hemodiafiltration|hemodiafiltration
5415219|NCT01653808|Elisio dialyzer|elisio dialyzer
5415220|NCT01653808|efficacy|efficacy
5415221|NCT01653808|biocompatibility|biocompatibility
5415223|NCT01653782|RCT|rct
5415224|NCT01653782|Intervention study|intervention study
5415225|NCT01653782|Cost effectiveness|cost effectiveness
5415226|NCT01653782|Yoga|yoga
5415227|NCT01653782|evidence based|evidence based
5415228|NCT01653782|advice to stay active|advice to stay active
5415229|NCT01653782|exercise training|exercise training
5415230|NCT01653769|CoSeal|coseal
5415231|NCT01653769|Surgical bleeding|surgical bleeding
5415232|NCT01653769|hemostasis|hemostasis
5415233|NCT01653769|Aortic anastamoses|aortic anastamoses
5415234|NCT01653769|bleeding|bleeding
5415235|NCT01653769|Cardiac surgery|cardiac surgery
5415236|NCT01653769|Aneurysms|aneurysms
5415237|NCT01653769|Aortic Dissection|aortic dissection
5415238|NCT01653756|Asthma|asthma
5415239|NCT01653756|Allergen Challenge|allergen challenge
5415240|NCT01653743|Japanese|japanese
5415241|NCT01653730|portable oxygen concentrator|portable oxygen concentrator
5415242|NCT01653730|6-minute walk test|6-minute walk test
5415243|NCT01653730|chronic obstructive lung disease|chronic obstructive lung disease
5415244|NCT01653730|pulmonary fibrosis|pulmonary fibrosis
5415245|NCT01653730|long term oxygen therapy|long term oxygen therapy
5415246|NCT01653717|Advanced Cancers|advanced cancers
5415247|NCT01653717|Leukemia|leukemia
5415248|NCT01653717|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5415249|NCT01653717|B-CLL|b-cll
5415250|NCT01653717|CD19 positivity|cd19 positivity
5415251|NCT01653717|CD19-specific T cells|cd19-specific t cells
5415252|NCT01653717|T-Cell Infusion|t-cell infusion
5415253|NCT01653717|Gene Transfer|gene transfer
5415352|NCT01653327|oral|oral
5415254|NCT01653717|Leukapheresis|leukapheresis
5415255|NCT01653717|Fludarabine|fludarabine
5415256|NCT01653717|Fludarabine Phosphate|fludarabine phosphate
5415257|NCT01653717|Fludara|fludara
5415258|NCT01653717|Cyclophosphamide|cyclophosphamide
5415259|NCT01653717|Cytoxan|cytoxan
5415260|NCT01653717|Neosar|neosar
5415261|NCT01653691|Pediatric|pediatric
5415262|NCT01653691|Burns|burns
5415263|NCT01653691|Scars|scars
5415264|NCT01653691|Pulse Dye laser|pulse dye laser
5415265|NCT01653678|vitamin D-3|vitamin d-3
5415266|NCT01653678|omega-3 fatty acids|omega-3 fatty acids
5415267|NCT01653678|fish oil|fish oil
5415268|NCT01653678|hypertension|hypertension
5415269|NCT01653678|blood pressure|blood pressure
5415270|NCT01653652|grass pollen|grass pollen
5415271|NCT01653652|allergic rhinitis|allergic rhinitis
5415272|NCT01653652|TNSS|tnss
5415273|NCT01653652|miniRQLQ|minirqlq
5415274|NCT01653639|BAY14-2222|bay14-2222
5415275|NCT01653639|Pharmacokinetics|pharmacokinetics
5415276|NCT01653613|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5398124|NCT01730261|TBI|tbi
5415277|NCT01653613|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5415278|NCT01653613|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5415279|NCT01653613|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5415280|NCT01653600|peripheral arterial disease|peripheral arterial disease
5415281|NCT01653600|atherosclerosis|atherosclerosis
5415282|NCT01653600|nitinol|nitinol
5415283|NCT01653600|stents|stents
5415284|NCT01653587|Transradial Approach|transradial approach
5415285|NCT01653587|Transfemoral Approach|transfemoral approach
5415286|NCT01653587|Vascular Closure Device|vascular closure device
5415287|NCT01653574|Famitinib Malate|famitinib malate
5415288|NCT01653574|Metastatic Breast Cancer|metastatic breast cancer
5415289|NCT01653574|HER-2 negative|her-2 negative
5415290|NCT01653561|Metastatic breast cancer|metastatic breast cancer
5415291|NCT01653561|Apatinib|apatinib
5415292|NCT01653561|non-triple-negative|non-triple-negative
5415293|NCT01653548|emotion dysregulation|emotion dysregulation
5415294|NCT01653548|borderline personality disorder|borderline personality disorder
5415295|NCT01653548|anxiety|anxiety
5415296|NCT01653548|depression|depression
5415297|NCT01653548|negative emotions|negative emotions
5415298|NCT01653548|outpatient interventions for negative emotions|outpatient interventions for negative emotions
5415299|NCT01653548|psychological distress|psychological distress
5415300|NCT01653548|emotion regulation problems|emotion regulation problems
5415301|NCT01653535|Prevention|prevention
5415302|NCT01653535|Health Service Use|health service use
5415303|NCT01653535|Behavioral Intervention|behavioral intervention
5415304|NCT01653535|Conduct Problems|conduct problems
5415305|NCT01653535|Anti-Social Behavior|anti-social behavior
5415306|NCT01653509|cold sore|cold sore
5415307|NCT01653496|Gastric cancer|gastric cancer
5415308|NCT01653496|Perioperative care|perioperative care
5415309|NCT01653496|Enhanced recovery after surgery|enhanced recovery after surgery
5415310|NCT01653496|Multimodal rehabilitation|multimodal rehabilitation
5415311|NCT01653496|Fast track surgery|fast track surgery
5415312|NCT01653496|Gastrectomy|gastrectomy
5415313|NCT01653483|Asthma|asthma
5415314|NCT01653483|Umeclidinium|umeclidinium
5415315|NCT01653483|Adolescent|adolescent
5415316|NCT01653483|Pharmacokinetics|pharmacokinetics
5415317|NCT01653457|Fibromyalgia|fibromyalgia
5415318|NCT01653457|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5415319|NCT01653457|Memantine|memantine
5415320|NCT01653457|electroencephalic cordance|electroencephalic cordance
5415321|NCT01653405|anticoagulants|anticoagulants
5415322|NCT01653405|pharmacists|pharmacists
5415323|NCT01653405|quality improvement|quality improvement
5415324|NCT01653405|quality of health care|quality of health care
5415325|NCT01653392|Maternal Mortality|maternal mortality
5415326|NCT01653392|Obstetric Labor, Premature|obstetric labor, premature
5415327|NCT01653392|Eclampsia|eclampsia
5415328|NCT01653392|Pre-Eclampsia|pre-eclampsia
5415329|NCT01653392|Abortion, Spontaneous|abortion, spontaneous
5415330|NCT01653392|Diabetes, Gestational|diabetes, gestational
5415331|NCT01653392|Pregnancy, Ectopic|pregnancy, ectopic
5415332|NCT01653392|Hydatidiform Mole|hydatidiform mole
5415333|NCT01653392|Fetal death|fetal death
5415334|NCT01653392|Live birth|live birth
5415335|NCT01653392|Still birth|still birth
5415336|NCT01653392|Premature Birth|premature birth
5415337|NCT01653392|Sex ratio|sex ratio
5415338|NCT01653392|Birth weight|birth weight
5415339|NCT01653366|Breast Cancer|breast cancer
5415340|NCT01653353|nursing home|nursing home
5415341|NCT01653353|vitamin D supplements|vitamin d supplements
5415342|NCT01653353|calcium supplements|calcium supplements
5415343|NCT01653353|guideline adherence|guideline adherence
5415344|NCT01653340|Refractory Chronic Migraine|refractory chronic migraine
5415345|NCT01653340|Medically Intractable Chronic Migraine|medically intractable chronic migraine
5415346|NCT01653340|High Frequency Spinal Cord Stimulator|high frequency spinal cord stimulator
5415347|NCT01653327|mucositis|mucositis
5415358|NCT01653262|Levetiracetam|levetiracetam
5415359|NCT01653262|Epilepsy|epilepsy
5415360|NCT01653262|Nonpsychotic behavior|nonpsychotic behavior
5415361|NCT01653249|human papillomavirus (HPV)|human papillomavirus (hpv)
5415362|NCT01653249|vaccine|vaccine
5415363|NCT01653249|treatment|treatment
5415364|NCT01653210|Insulin Pump|insulin pump
5415365|NCT01653210|Continuous Glucose Monitor|continuous glucose monitor
5415366|NCT01653210|Premenopausal women|premenopausal women
5415367|NCT01653184|AMD|amd
5415368|NCT01653184|Vision loss|vision loss
5415369|NCT01653184|omega-3|omega-3
5415370|NCT01653184|supplement|supplement
5415371|NCT01653184|age related macular degeneration|age related macular degeneration
5415372|NCT01653171|Acetylcysteine, Simethicone, Stomach Neoplasms|acetylcysteine, simethicone, stomach neoplasms
5398233|NCT01729702|2- BNP|2- bnp
5415373|NCT01653158|non-hematologic cancer|non-hematologic cancer
5415374|NCT01653158|advanced solid tumors|advanced solid tumors
5415375|NCT01653158|prostrate cancer|prostrate cancer
5415376|NCT01653145|Appetite|appetite
5415377|NCT01653145|Satiety|satiety
5415378|NCT01653132|PD|pd
5415379|NCT01653119|Acute coronary syndrome|acute coronary syndrome
5415380|NCT01653119|Diabetes mellitus|diabetes mellitus
5415381|NCT01653119|Statins|statins
5415382|NCT01653119|High loading dose|high loading dose
5415383|NCT01653119|Recurrent events|recurrent events
5415384|NCT01653106|cryotherapy|cryotherapy
5415385|NCT01653106|Melphalan|melphalan
5415386|NCT01653106|Mucositis|mucositis
5415387|NCT01653080|Solid Tumor|solid tumor
5415388|NCT01653080|Eye|eye
5415389|NCT01653080|Orbit|orbit
5415390|NCT01653067|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
5415391|NCT01653067|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5415392|NCT01653067|Aggressive Lymphoma|aggressive lymphoma
5415393|NCT01653067|Aggressive Non Hodgkin´s Lymphoma|aggressive non hodgkin´s lymphoma
5415394|NCT01653067|NHL|nhl
5415395|NCT01653067|aNHL|anhl
5415396|NCT01653067|Temsirolimus|temsirolimus
5415397|NCT01653067|Torisel|torisel
5415398|NCT01653067|Relapsed Non Hodgkin´s Lymphoma|relapsed non hodgkin´s lymphoma
5415399|NCT01653067|Relapsed Diffuse Large B-Cell Lymphoma|relapsed diffuse large b-cell lymphoma
5415400|NCT01653067|aggressive NHL|aggressive nhl
5415401|NCT01653067|B-NHL|b-nhl
5415402|NCT01653067|aggressive B-NHL|aggressive b-nhl
5415403|NCT01653041|immunosuppression, identical HLA, kidney transplantation, everolimus|immunosuppression, identical hla, kidney transplantation, everolimus
5415404|NCT01653002|Lung cancer|lung cancer
5415405|NCT01653002|EBUS-TBNA|ebus-tbna
5415406|NCT01653002|Epigenetics|epigenetics
5415407|NCT01653002|shox2 protein, human|shox2 protein, human
5415408|NCT01652989|weight loss|weight loss
5415409|NCT01652989|weight loss maintenance|weight loss maintenance
5415410|NCT01652989|community based participatory research|community based participatory research
5415411|NCT01652989|overweight|overweight
5415412|NCT01652976|Metastatic|metastatic
5415413|NCT01652976|Pancreatic Cancer|pancreatic cancer
5415414|NCT01652976|Adenocarcinoma|adenocarcinoma
5415415|NCT01652950|Physical activity|physical activity
5415416|NCT01652950|health-insured|health-insured
5415417|NCT01652950|Financial Incentives|financial incentives
5415418|NCT01652950|Benefits design|benefits design
5415419|NCT01652937|Rheumatoid Arthritis|rheumatoid arthritis
5415420|NCT01652937|DMARD-IR|dmard-ir
5415421|NCT01652924|mechanical ventilation|mechanical ventilation
5415422|NCT01652924|manual ventilation|manual ventilation
5415423|NCT01652911|Islet Transplantation|islet transplantation
5415424|NCT01652911|Cell Pouch|cell pouch
5415425|NCT01652898|PK|pk
5415426|NCT01652885|atopic dermatitis|atopic dermatitis
5415427|NCT01652872|anemia|anemia
5415428|NCT01652872|chronic kidney disease|chronic kidney disease
5415429|NCT01652872|kidney disease|kidney disease
5415430|NCT01652872|renal failure|renal failure
5415431|NCT01652833|Metastatic Colorectal Cancer|metastatic colorectal cancer
5415432|NCT01652820|LUNG|lung
5415433|NCT01652820|DOCETAXEL|docetaxel
5415434|NCT01652820|GEMCITABINE|gemcitabine
5415435|NCT01652820|CARBOPLATIN|carboplatin
5415436|NCT01652820|RADIOTHERAPY|radiotherapy
5415437|NCT01652781|myelodysplastic syndrome|myelodysplastic syndrome
5415438|NCT01652781|azacitidine|azacitidine
5415439|NCT01652781|dosing schedule|dosing schedule
5415440|NCT01652768|Malignant Brain Tumors|malignant brain tumors
5415441|NCT01652768|Malignant Glioma|malignant glioma
5410396|NCT01675895|İntrathecal|intrathecal
5415442|NCT01652768|High-grade Gliomas|high-grade gliomas
5415443|NCT01652768|Oncology|oncology
5415444|NCT01652768|Cancer|cancer
5415445|NCT01652768|Patient Caregiver|patient caregiver
5415446|NCT01652768|Caregiver Stress, Anxiety, Depression|caregiver stress, anxiety, depression
5415447|NCT01652768|Palliative Care Intervention|palliative care intervention
5415448|NCT01652755|cystatin C,acute kidney injury,|cystatin c,acute kidney injury,
5415449|NCT01652729|Diabetes, Type 2, exenatide, Sitagliptin|diabetes, type 2, exenatide, sitagliptin
5415450|NCT01652703|Japanese, hypercholesterolemia, high risk for cardiovascular events|japanese, hypercholesterolemia, high risk for cardiovascular events
5415451|NCT01652677|navigation transcranial magnetic stimulation|navigation transcranial magnetic stimulation
5415452|NCT01652677|stroke rehabilitation|stroke rehabilitation
5415453|NCT01652651|Learning Disorders|learning disorders
5415454|NCT01652638|subjects|subjects
5415455|NCT01652625|Yunnan Baiyao|yunnan baiyao
5415456|NCT01652625|recurrent aphthous stomatitis|recurrent aphthous stomatitis
5415457|NCT01652625|clinical trial|clinical trial
5415458|NCT01652612|positive end expiratory pressure|positive end expiratory pressure
5415459|NCT01652599|Eltrombopag|eltrombopag
5415460|NCT01652599|Dexamethasone|dexamethasone
5415461|NCT01652599|High-dose|high-dose
5415463|NCT01652586|cardiac ablation|cardiac ablation
5415464|NCT01652573|X linked hypophosphatemia|x linked hypophosphatemia
5415465|NCT01652573|calcitonin|calcitonin
5398340|NCT01729351|Smoking|smoking
5415466|NCT01652573|FGF twenty three|fgf twenty three
5415467|NCT01652560|bevacizumab|bevacizumab
5415468|NCT01652560|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5415469|NCT01652560|HER2-negative breast cancer|her2-negative breast cancer
5415470|NCT01652547|Melanoma|melanoma
5415471|NCT01652547|Merkel cell carcinoma|merkel cell carcinoma
5415472|NCT01652547|Metastatic skin cancer|metastatic skin cancer
5415473|NCT01652534|Freezing of gait|freezing of gait
5415474|NCT01652534|gait dysfunction|gait dysfunction
5415475|NCT01652521|lung compliance|lung compliance
5415476|NCT01652521|pleural effusion|pleural effusion
5415477|NCT01652521|esophageal pressure|esophageal pressure
5415478|NCT01652508|smoking cessation|smoking cessation
5415479|NCT01652508|Acceptance and Commitment Therapy|acceptance and commitment therapy
5415480|NCT01652508|primary care setting|primary care setting
5415481|NCT01652508|randomised controlled trial|randomised controlled trial
5415482|NCT01652495|rotatory cuff calcific tendonitis|rotatory cuff calcific tendonitis
5415483|NCT01652495|corticosteroids|corticosteroids
5415484|NCT01652495|US guided percutaneous treatment|us guided percutaneous treatment
5415485|NCT01652495|methylprednisolone|methylprednisolone
5415486|NCT01652495|triamcinolone|triamcinolone
5415487|NCT01652495|hypothalamus pituitary adrenal axis|hypothalamus pituitary adrenal axis
5415488|NCT01652469|squamous cell|squamous cell
5415489|NCT01652469|NSCLC|nsclc
5415490|NCT01652469|TKI|tki
5415491|NCT01652469|Erlotinib|erlotinib
5415492|NCT01652469|Docetaxel|docetaxel
5415493|NCT01652469|VeriStrat|veristrat
5415494|NCT01652469|protein signature|protein signature
5415495|NCT01652456|addiction support|addiction support
5415496|NCT01652456|addiction specialist|addiction specialist
5415497|NCT01652456|lung cancer|lung cancer
5415498|NCT01652456|head and neck cancer|head and neck cancer
5415499|NCT01652443|OEF/OIF Veterans|oef/oif veterans
5415500|NCT01652443|Relationships|relationships
5415501|NCT01652430|PTSD|ptsd
5415502|NCT01652430|Suicidal ideation|suicidal ideation
5415503|NCT01652430|Cognitive processes|cognitive processes
5415504|NCT01652417|Methylprednisolone|methylprednisolone
5415505|NCT01652417|prednisone|prednisone
5415506|NCT01652417|renal sarcoidosis treatment|renal sarcoidosis treatment
5415507|NCT01652404|ICU|icu
5415508|NCT01652404|sepsis|sepsis
5415509|NCT01652404|antibiotic therapy|antibiotic therapy
5415510|NCT01652404|procalcitonin|procalcitonin
5415511|NCT01652378|cocaine addiction|cocaine addiction
5415512|NCT01652378|neuroimaging|neuroimaging
5415513|NCT01652378|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5415514|NCT01652365|Malaria Diagnosis|malaria diagnosis
5415515|NCT01652365|Rapid Diagnostic Tests|rapid diagnostic tests
5415516|NCT01652365|RDTs|rdts
5415517|NCT01652365|Private Sector|private sector
5415518|NCT01652365|Retail Sector|retail sector
5415519|NCT01652365|Drug Shops|drug shops
5415520|NCT01652352|Disabled|disabled
5415521|NCT01652352|Disability|disability
5415522|NCT01652352|Power wheelchair|power wheelchair
5415523|NCT01652352|Wheelchair|wheelchair
5415524|NCT01652352|Wheelchair mounted robotic arm|wheelchair mounted robotic arm
5415525|NCT01652352|WMRA|wmra
5415526|NCT01652352|Assistive|assistive
5415527|NCT01652352|Assistive robot|assistive robot
5415528|NCT01652352|Assistive robotics|assistive robotics
5415529|NCT01652352|Rehabilitation robot|rehabilitation robot
5415530|NCT01652352|Rehabilitation engineering|rehabilitation engineering
5415531|NCT01652352|Rehabilitation robotics|rehabilitation robotics
5415532|NCT01652300|Oral health|oral health
5415533|NCT01652300|education|education
5415534|NCT01652300|knowledge|knowledge
5415535|NCT01652300|attitude|attitude
5415536|NCT01652300|performance|performance
5415537|NCT01652274|Child Passenger Safety|child passenger safety
5415538|NCT01652274|Parental perception of vulnerability|parental perception of vulnerability
5415539|NCT01652274|Neonatology|neonatology
5415540|NCT01652274|Newborn|newborn
5415541|NCT01652261|advanced stage|advanced stage
5415542|NCT01652248|Heart failure|heart failure
5415543|NCT01652248|Pacemaker|pacemaker
5415544|NCT01652248|cardiac resynchronization therapy|cardiac resynchronization therapy
5415545|NCT01652235|Abdominal aortic aneurysm|abdominal aortic aneurysm
5415546|NCT01652235|Endovascular|endovascular
5415547|NCT01652235|Fenestration|fenestration
5415548|NCT01652235|Juxtarenal|juxtarenal
5415549|NCT01652235|Off-the-shelf|off-the-shelf
5415550|NCT01652235|Pararenal|pararenal
5415551|NCT01652222|Alzheimer|alzheimer
5415552|NCT01652222|caregiver|caregiver
5415553|NCT01652222|dementia|dementia
5415554|NCT01652222|social support|social support
5415555|NCT01652222|Montessori|montessori
5415556|NCT01652222|Therapeutic game|therapeutic game
5415557|NCT01652196|colorectal cancer|colorectal cancer
5415558|NCT01652196|rectal cancer|rectal cancer
5415559|NCT01652196|FOLFOX|folfox
5415560|NCT01652196|Aflibercept|aflibercept
5398453|NCT01728883|Macular Edema|macular edema
5415561|NCT01652183|Intravenous paracetamol|intravenous paracetamol
5415562|NCT01652183|catheter related bladder discomfort|catheter related bladder discomfort
5415563|NCT01652183|urologic surgery|urologic surgery
5415564|NCT01652157|prospective|prospective
5415565|NCT01652157|observational|observational
5415566|NCT01652157|pancreatic insufficiency|pancreatic insufficiency
5415567|NCT01652157|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5415568|NCT01652157|fibrosing colonopathy|fibrosing colonopathy
5415569|NCT01652157|patients with cystic fibrosis|patients with cystic fibrosis
5415570|NCT01652131|general anesthesia|general anesthesia
5415571|NCT01652131|volume kinetics|volume kinetics
5415572|NCT01652118|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5415573|NCT01652118|clarithromycin|clarithromycin
5415574|NCT01652118|preterm babies|preterm babies
5415575|NCT01652105|Gastric bypass|gastric bypass
5415576|NCT01652105|Preoperative diet|preoperative diet
5415577|NCT01652105|Prodimed|prodimed
5415578|NCT01652092|immunodeficiency disorder|immunodeficiency disorder
5415579|NCT01652092|histiocytic disorder|histiocytic disorder
5415580|NCT01652079|Epithelial|epithelial
5415581|NCT01652079|Primary|primary
5415582|NCT01652053|InterCushion|intercushion
5415583|NCT01652040|Spinal Cord Injury|spinal cord injury
5415584|NCT01652040|Rehabilitation|rehabilitation
5415585|NCT01652040|Electrical Stimulation|electrical stimulation
5415586|NCT01652040|Testosterone|testosterone
5415587|NCT01652040|Body Composition|body composition
5415588|NCT01652040|Lipid and Glucose profile|lipid and glucose profile
5415589|NCT01652040|Ectopic Adiposity|ectopic adiposity
5415590|NCT01652027|FVIII inhibitors|fviii inhibitors
5415591|NCT01652014|Transplantation|transplantation
5415592|NCT01652014|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5415593|NCT01652001|Xerostomia|xerostomia
5415594|NCT01652001|Antidepressant agents|antidepressant agents
5415595|NCT01652001|Antihypertensive agents|antihypertensive agents
5415596|NCT01651988|ketamine|ketamine
5415597|NCT01651988|propofol anesthesia|propofol anesthesia
5415598|NCT01651975|Dysphagia|dysphagia
5415599|NCT01651975|Thickening liquid|thickening liquid
5415600|NCT01651975|Thickening agent|thickening agent
5415601|NCT01651975|Fluoroscopic swallow study|fluoroscopic swallow study
5415602|NCT01651975|Aspiration|aspiration
5415603|NCT01651975|History of dysphagia|history of dysphagia
5415605|NCT01651975|Age > 18|age > 18
5415606|NCT01651975|comprehensive DSS|comprehensive dss
5415607|NCT01651975|informed consent|informed consent
5415608|NCT01651962|Labor Pain|labor pain
5415609|NCT01651962|Analgesia, Epidural|analgesia, epidural
5415610|NCT01651923|subjects|subjects
5415611|NCT01651910|Cancer Pain|cancer pain
5415612|NCT01651910|Breakthrough Pain|breakthrough pain
5415613|NCT01651910|Unmet Needs|unmet needs
5415614|NCT01651910|Supportive care needs|supportive care needs
5415615|NCT01651897|delirium|delirium
5415616|NCT01651897|emergency department|emergency department
5415617|NCT01651897|natural course|natural course
5415618|NCT01651897|outcomes|outcomes
5552308|NCT01077674|BIS|bis
5415619|NCT01651897|elderly|elderly
5415620|NCT01651884|Stroke|stroke
5415621|NCT01651884|Anomia|anomia
5415622|NCT01651871|Agents, anti allergic|agents, anti allergic
5415623|NCT01651871|Nasal congestion|nasal congestion
5415624|NCT01651871|Sneezing|sneezing
5415625|NCT01651871|Nasal discharge|nasal discharge
5415626|NCT01651871|D prostanoid (DP) receptor antagonist|d prostanoid (dp) receptor antagonist
5415627|NCT01651832|Colorectal Neoplasms/*drug therapy/*secondary|colorectal neoplasms/*drug therapy/*secondary
5415628|NCT01651832|Health Services Accessibility|health services accessibility
5415629|NCT01651832|Humans|humans
5402765|NCT01709357|trigger point|trigger point
5415630|NCT01651832|Supportive Care Needs|supportive care needs
5415631|NCT01651832|Psychooncology|psychooncology
5415632|NCT01651832|Rural Population|rural population
5415633|NCT01651832|Primary Health Care/*methods|primary health care/*methods
5415634|NCT01651832|Treatment Outcome|treatment outcome
5415636|NCT01651832|Quality Assurance, Health Care|quality assurance, health care
5415637|NCT01651832|Quality of Life|quality of life
5415641|NCT01651819|HTLV-1|htlv-1
5415642|NCT01651819|neurogenic bladder|neurogenic bladder
5415643|NCT01651819|physical therapy|physical therapy
5415644|NCT01651819|Tropical Spastic Paraparesis|tropical spastic paraparesis
5415645|NCT01651806|Blood loss|blood loss
5415646|NCT01651806|transfusion rates|transfusion rates
5415647|NCT01651806|complications|complications
5415648|NCT01651793|cacao|cacao
5415649|NCT01651793|theobromine|theobromine
5415650|NCT01651793|flavanols|flavanols
5415651|NCT01651793|caffeine|caffeine
5415652|NCT01651793|sustained attention|sustained attention
5415653|NCT01651793|vigilance|vigilance
5415654|NCT01651793|vigor|vigor
5415655|NCT01651793|vitality|vitality
5415656|NCT01651793|energy|energy
5415657|NCT01651793|fatigue|fatigue
5415658|NCT01651780|Transcatheter aortic valve replacement|transcatheter aortic valve replacement
5415659|NCT01651780|Aortic valve replacement|aortic valve replacement
5415660|NCT01651780|Severe aortic stenosis|severe aortic stenosis
5415661|NCT01651767|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
5415662|NCT01651767|JNJ-47910382|jnj-47910382
5415663|NCT01651767|Pharmacokinetics|pharmacokinetics
5415664|NCT01651767|Caucasian genotype-1|caucasian genotype-1
5415665|NCT01651767|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
5415666|NCT01651741|Intestinal Microbiota|intestinal microbiota
5415667|NCT01651741|Probiotics|probiotics
5415668|NCT01651741|Seaweed|seaweed
5415669|NCT01651741|Healthy Subject|healthy subject
5415670|NCT01651728|Simvastatin|simvastatin
5415671|NCT01651728|Pneumonia|pneumonia
5415672|NCT01651728|Elderly|elderly
5415673|NCT01651728|TNF-α|tnf-α
5415674|NCT01651728|IFN-ϒ|ifn-ϒ
5415675|NCT01651728|PAI-1|pai-1
5415676|NCT01651728|CRP|crp
5415677|NCT01651702|Arrhythmia|arrhythmia
5415678|NCT01651702|Electroanatomical mapping|electroanatomical mapping
5415679|NCT01651689|Scalp biopsy|scalp biopsy
5415680|NCT01651689|Hair count|hair count
5415681|NCT01651689|Vertical section|vertical section
5415682|NCT01651689|Horizontal section|horizontal section
5415683|NCT01651689|Thais|thais
5415684|NCT01651676|VQ11 questionnaire|vq11 questionnaire
5415685|NCT01651676|COPD|copd
5415686|NCT01651676|LBD|lbd
5415687|NCT01651663|Influenza|influenza
5415688|NCT01651650|Asthma|asthma
5415689|NCT01651650|PIF|pif
5415690|NCT01651637|Respiratory Distress syndrome|respiratory distress syndrome
5415691|NCT01651637|Complications of prematurity|complications of prematurity
5415692|NCT01651624|Colorectal Cancer|colorectal cancer
5415693|NCT01651624|Screening|screening
5415694|NCT01651624|Fecal Occult Blood Test|fecal occult blood test
5415695|NCT01651624|CT Colonography|ct colonography
5415696|NCT01651624|Virtual Colonoscopy|virtual colonoscopy
5415697|NCT01651624|Colonoscopy|colonoscopy
5415698|NCT01651611|Tobacco Cessation|tobacco cessation
5415699|NCT01651611|Public Housing|public housing
5415700|NCT01651611|Community Health Workers|community health workers
5415701|NCT01651611|Motivational Interviewing|motivational interviewing
5415702|NCT01651611|Patient centered|patient centered
5415703|NCT01651611|Low-income|low-income
5415704|NCT01651611|Tobacco Treatment Advocates|tobacco treatment advocates
5415705|NCT01651611|Social Epidemiology|social epidemiology
5415706|NCT01651611|Smoking cessation predictors|smoking cessation predictors
5415707|NCT01651611|Behavioral Intervention|behavioral intervention
5415708|NCT01651611|Non-pharmacologic|non-pharmacologic
5415709|NCT01651585|viral disease|viral disease
5415710|NCT01651585|cytomegalovirus infection|cytomegalovirus infection
5415711|NCT01651585|is the first cause|is the first cause
5415712|NCT01651585|of congenital|of congenital
5415713|NCT01651585|neurological handicap|neurological handicap
5415714|NCT01651585|of infectious origin.|of infectious origin.
5415715|NCT01651572|Postoperative residual curarization|postoperative residual curarization
5415716|NCT01651572|Residual neuromuscular block|residual neuromuscular block
5552480|NCT01077414|Cancer|cancer
5415717|NCT01651572|Complications|complications
5415718|NCT01651572|Postoperative|postoperative
5415719|NCT01651572|Neuromuscular function|neuromuscular function
5415720|NCT01651572|Neuromuscular block|neuromuscular block
5415721|NCT01651559|modified PASI|modified pasi
5415722|NCT01651559|narrow band UVB phototherapy|narrow band uvb phototherapy
5415723|NCT01651559|Dead Sea Minerals|dead sea minerals
5415724|NCT01651559|Skin auto-Fluorescence|skin auto-fluorescence
5415725|NCT01651559|Skin wash samples|skin wash samples
5415726|NCT01651546|Clean Intermittent Self Catheterization|clean intermittent self catheterization
5401050|NCT01717157|Fentanyl|fentanyl
5415727|NCT01651546|acceptance|acceptance
5415728|NCT01651546|test|test
5002967|NCT03977558|Metabolic Syndrome|metabolic syndrome
5415729|NCT01651533|Mental practice group|mental practice group
5415730|NCT01651533|Active control group|active control group
5415731|NCT01651520|Neurodegeneration|neurodegeneration
5415733|NCT01651520|Cognition|cognition
5415734|NCT01651520|Prognosis|prognosis
5410704|NCT01674582|Glioma|glioma
5415735|NCT01651507|Pulmonary Langerhans cell histiocytosis|pulmonary langerhans cell histiocytosis
5415737|NCT01651494|Influenza|influenza
5415738|NCT01651494|inhalation|inhalation
5415739|NCT01651494|inpatient clinic|inpatient clinic
5415740|NCT01651494|Multi-Dose|multi-dose
5415741|NCT01651494|recombinant neuraminidase|recombinant neuraminidase
5415742|NCT01651481|Rhinitis|rhinitis
5415743|NCT01651468|mild bleeding disorder|mild bleeding disorder
5415744|NCT01651455|Cystic Fibrosis|cystic fibrosis
5415745|NCT01651455|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5415746|NCT01651429|Sleep Deprivation|sleep deprivation
5415747|NCT01651416|Home management of malaria|home management of malaria
5415748|NCT01651416|Seasonal malaria chemoprevention|seasonal malaria chemoprevention
5415749|NCT01651403|Hepatitis|hepatitis
5415750|NCT01651403|Hepatitis B|hepatitis b
5415752|NCT01651390|Restenosis|restenosis
5415753|NCT01651390|Drug coated balloon|drug coated balloon
5415754|NCT01651390|Drug eluting stent|drug eluting stent
5415755|NCT01651390|Paclitaxel|paclitaxel
5415756|NCT01651390|Sirolimus|sirolimus
5415757|NCT01651377|Pramipexole|pramipexole
5415759|NCT01651377|Cocaine|cocaine
5415760|NCT01651364|Cocaine|cocaine
5415761|NCT01651364|Cabergoline|cabergoline
5415762|NCT01651351|for this study|for this study
5415763|NCT01651351|volunteers|volunteers
5415764|NCT01651351|Focus|focus
5415765|NCT01651351|Condition:|condition:
5415766|NCT01651338|Acupuncture|acupuncture
5415767|NCT01651338|quality of life|quality of life
5415768|NCT01651325|Isavuconazole|isavuconazole
5415769|NCT01651325|dextromethorphan|dextromethorphan
5415770|NCT01651325|dextrorphan|dextrorphan
5415772|NCT01651325|Healthy Volunteers|healthy volunteers
5415773|NCT01651325|BAL4815|bal4815
5415774|NCT01651312|Radioactivity|radioactivity
5415775|NCT01651312|Excretion rate|excretion rate
5415776|NCT01651312|Human subjects|human subjects
5415777|NCT01651312|Pharmacokinetics|pharmacokinetics
5415778|NCT01651312|YM178|ym178
5415779|NCT01651312|Radio-labeled|radio-labeled
5415780|NCT01651312|Phase 1|phase 1
5415781|NCT01651299|copperhead snake envenomation|copperhead snake envenomation
5415782|NCT01651286|General anesthesia|general anesthesia
5415783|NCT01651286|Positive-pressure ventilation|positive-pressure ventilation
5415784|NCT01651286|Masks|masks
5415785|NCT01651247|Toddlers|toddlers
5415786|NCT01651247|Retrospective|retrospective
5415787|NCT01651247|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
5415788|NCT01651247|Infants|infants
5415789|NCT01651247|Laboratory evaluations|laboratory evaluations
5415790|NCT01651247|IPV|ipv
5415791|NCT01651221|gustatory response|gustatory response
5415792|NCT01651221|olfactory response|olfactory response
5415793|NCT01651208|Coronary stents|coronary stents
5415794|NCT01651208|Medication adherence|medication adherence
5415795|NCT01651208|Antiplatelet medications|antiplatelet medications
5415796|NCT01651208|Motivational Interviewing|motivational interviewing
5415797|NCT01651182|Blood transfusion|blood transfusion
5415798|NCT01651182|Blood loss|blood loss
5415799|NCT01651182|Postoperative complications|postoperative complications
5415800|NCT01651182|Outcome|outcome
5415801|NCT01651169|Paired Transcranial Magnetic Stimulation|paired transcranial magnetic stimulation
5415802|NCT01651169|Methamphetamine abuse, ADHD, Methylphenidate|methamphetamine abuse, adhd, methylphenidate
5415803|NCT01651169|We study the effect of Methamphetamine abuse on Intracortical Inhibition, in ADHD patients, treated with Methylphenidate.|we study the effect of methamphetamine abuse on intracortical inhibition, in adhd patients, treated with methylphenidate.
5415804|NCT01651130|pregnancy|pregnancy
5415805|NCT01651130|postpartum hemorrhage|postpartum hemorrhage
5415806|NCT01651130|Cesarean delivery|cesarean delivery
5415807|NCT01651130|carbetocin|carbetocin
5415808|NCT01651117|Diabetes Mellitus|diabetes mellitus
5415809|NCT01651117|Mentors|mentors
5415810|NCT01651117|Glucose control|glucose control
5415811|NCT01651117|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5415812|NCT01651117|Randomized Controlled Trial|randomized controlled trial
5415813|NCT01651117|Veterans|veterans
5671214|NCT00616642|recurrent pituitary tumor|recurrent pituitary tumor
5415814|NCT01651104|Influenza, Trivalent, Adjuvanted, Adjuvant, MF59, MF-59, Fluad, Seasonal|influenza, trivalent, adjuvanted, adjuvant, mf59, mf-59, fluad, seasonal
5415815|NCT01651078|Metastatic Brain Tumors|metastatic brain tumors
5415816|NCT01651078|Progression|progression
5415817|NCT01651078|Radiation Necrosis|radiation necrosis
5415818|NCT01651078|Quality of Life|quality of life
5415819|NCT01651052|Aortic valve replacement/regurgitation|aortic valve replacement/regurgitation
5415820|NCT01651039|Panobinostat|panobinostat
5534854|NCT01147679|MRI|mri
5415821|NCT01651039|Lenalidomide|lenalidomide
5415822|NCT01651039|Dexamethasone|dexamethasone
5415823|NCT01651000|Parathyroid Diseases|parathyroid diseases
5415824|NCT01651000|Renal Insufficiency|renal insufficiency
5415825|NCT01651000|Kidney Failure, Chronic|kidney failure, chronic
5415826|NCT01651000|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5415827|NCT01651000|Vitamin D|vitamin d
5415828|NCT01651000|Hyperparathyroidism|hyperparathyroidism
5415830|NCT01651000|Kidney Failure|kidney failure
5415831|NCT01651000|Renal Insufficiency, Chronic|renal insufficiency, chronic
5415832|NCT01650987|carcinoma|carcinoma
5415833|NCT01650987|uterus|uterus
5415834|NCT01650987|Not metastatic|not metastatic
5415835|NCT01650974|high flow nasal oxygen therapy|high flow nasal oxygen therapy
5415836|NCT01650974|diagnostic bronchoscopy|diagnostic bronchoscopy
5415837|NCT01650948|age-related macular degeneration|age-related macular degeneration
5415838|NCT01650948|AMD|amd
5415839|NCT01650935|Nephrolithiasis|nephrolithiasis
5415840|NCT01650935|Recurrent stone former|recurrent stone former
5415841|NCT01650935|DASH|dash
5415842|NCT01650935|Urine oxalate|urine oxalate
5415843|NCT01650935|Urine calcium oxalate supersaturation|urine calcium oxalate supersaturation
5415844|NCT01650896|Delirium|delirium
5415845|NCT01650896|Dementia|dementia
5415846|NCT01650896|Instrumental activities of daily living|instrumental activities of daily living
5415847|NCT01650883|Vitamin D3|vitamin d3
5415848|NCT01650883|Vitamin D 25 OH|vitamin d 25 oh
5415849|NCT01650870|Cathartics|cathartics
5415850|NCT01650870|Laxatives|laxatives
5415851|NCT01650870|Lactulose|lactulose
5415852|NCT01650870|Gastrointestinal Agents|gastrointestinal agents
5415853|NCT01650870|Therapeutic Uses|therapeutic uses
5415854|NCT01650870|Pharmacologic Actions|pharmacologic actions
5415855|NCT01650857|Pulmonary hypertension|pulmonary hypertension
5415856|NCT01650857|Rehabilitation|rehabilitation
5415857|NCT01650857|Exercise capacity|exercise capacity
5415858|NCT01650857|Body composition|body composition
5415859|NCT01650857|Health related Quality of Life|health related quality of life
5415860|NCT01650831|Helicobacter Pylori|helicobacter pylori
5415861|NCT01650831|13C Urea Breath Test|13c urea breath test
5415862|NCT01650831|BreathID|breathid
5415863|NCT01650818|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5415864|NCT01650818|Aerobic training|aerobic training
5415865|NCT01650818|Peak oxygen consumption|peak oxygen consumption
5415866|NCT01650818|Quality of life|quality of life
5415867|NCT01650805|Leukemia|leukemia
5415868|NCT01650805|Leukemia, Myeloid|leukemia, myeloid
5415869|NCT01650805|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5415870|NCT01650805|Neoplasms by Histologic Type|neoplasms by histologic type
5415871|NCT01650805|Neoplasms|neoplasms
5415872|NCT01650805|Lymphoproliferative Disorders|lymphoproliferative disorders
5415873|NCT01650805|Lymphatic Diseases|lymphatic diseases
5415874|NCT01650805|Immunoproliferative Disorders|immunoproliferative disorders
5415875|NCT01650805|Immune System Diseases|immune system diseases
5415876|NCT01650805|Myeloproliferative Disorders|myeloproliferative disorders
5415877|NCT01650805|Bone Marrow Diseases|bone marrow diseases
5415878|NCT01650805|Hematologic Diseases|hematologic diseases
5415879|NCT01650792|Chagas disease|chagas disease
5415880|NCT01650792|Heart failure|heart failure
5415881|NCT01650792|Stroke|stroke
5415882|NCT01650792|Dementia|dementia
5415883|NCT01650779|alpha-galactosidase A|alpha-galactosidase a
5415884|NCT01650779|a-GAL|a-gal
5415885|NCT01650779|Fabry|fabry
5415886|NCT01650779|GL-3|gl-3
5415887|NCT01650779|Fabrazyme|fabrazyme
5415888|NCT01650701|follicular lymphoma|follicular lymphoma
5415889|NCT01650701|non-hodgkins follicular lymphoma|non-hodgkins follicular lymphoma
5415890|NCT01650701|treatment for follicular lymphoma|treatment for follicular lymphoma
5415891|NCT01650701|rituximab treatment|rituximab treatment
5415892|NCT01650701|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
5415893|NCT01650688|Epiblepharon, general anesthesia, positional change|epiblepharon, general anesthesia, positional change
5415894|NCT01650675|pregnancy|pregnancy
5415895|NCT01650675|screening|screening
5415896|NCT01650675|motivation|motivation
5415897|NCT01650662|Acute Myocardial Infarction|acute myocardial infarction
5415898|NCT01650662|Cyclosporine A|cyclosporine a
5415899|NCT01650662|Reperfusion|reperfusion
5415900|NCT01650662|Clinical Trial|clinical trial
5415901|NCT01650649|lofexidine|lofexidine
5415902|NCT01650649|methadone|methadone
5415903|NCT01650649|interaction|interaction
5415904|NCT01650649|pharmacodynamic|pharmacodynamic
5415905|NCT01650649|ECG|ecg
5415906|NCT01650649|QTc|qtc
5671963|NCT00613431|pharmacodynamics|pharmacodynamics
5552753|NCT01076101|SLE|sle
5415907|NCT01650636|Videophone-delivered stress management intervention|videophone-delivered stress management intervention
5415908|NCT01650636|Chronic fatigue syndrome|chronic fatigue syndrome
5415909|NCT01650636|Symptoms|symptoms
5415910|NCT01650636|Neuroimmune processes|neuroimmune processes
5415911|NCT01650636|Psychosocial|psychosocial
5415912|NCT01650623|Parkinson´s Disease|parkinson´s disease
5415913|NCT01650623|Rehabilitation|rehabilitation
5415914|NCT01650623|Cognition|cognition
5415915|NCT01650610|Parkinson´s Disease|parkinson´s disease
5415916|NCT01650610|Rehabilitation|rehabilitation
5415917|NCT01650610|Cognition|cognition
5415918|NCT01650597|Healthy volunteers|healthy volunteers
5415919|NCT01650597|Pharmacokinetics|pharmacokinetics
5415920|NCT01650597|Free fatty amides|free fatty amides
5415921|NCT01650558|Malaria|malaria
5415922|NCT01650558|HIV|hiv
5415923|NCT01650558|Prophylaxis|prophylaxis
5415924|NCT01650558|Antiretroviral therapy|antiretroviral therapy
5415925|NCT01650545|case-control study|case-control study
5415931|NCT01650506|Triple Negative|triple negative
5415932|NCT01650506|Basal-like|basal-like
5415933|NCT01650493|remineralization|remineralization
5415934|NCT01650493|demineralzation|demineralzation
5415936|NCT01650493|dentrifice|dentrifice
5415937|NCT01650480|COPD|copd
5415938|NCT01650480|holistic|holistic
5415939|NCT01650480|pilot|pilot
5415940|NCT01650480|intervention|intervention
5415941|NCT01650467|abl polymorphisms|abl polymorphisms
5415942|NCT01650454|Alzheimer|alzheimer
5415943|NCT01650454|Sleep|sleep
5415944|NCT01650454|Somnolence|somnolence
5415945|NCT01650441|Asthma|asthma
5415947|NCT01650441|Formoterol|formoterol
5415948|NCT01650441|Beclomethasone Dipropionate|beclomethasone dipropionate
5415949|NCT01650441|Computational Fluid Dynamics|computational fluid dynamics
5415950|NCT01650441|Functional Imaging|functional imaging
5415951|NCT01650441|Central and Peripheral Airways|central and peripheral airways
5415952|NCT01650441|Asthma Control Test (ACT™)|asthma control test (act™)
5415953|NCT01650441|Asthma Control Questionnaire (ACQ)|asthma control questionnaire (acq)
5415954|NCT01650428|Rectal Cancer|rectal cancer
5415955|NCT01650428|Bevacizumab|bevacizumab
5415956|NCT01650428|Neoadjuvant|neoadjuvant
5415957|NCT01650428|Chemotherapy|chemotherapy
5415958|NCT01650428|Randomised|randomised
5415959|NCT01650415|Cerebral Palsy|cerebral palsy
5415960|NCT01650415|Erythropoietin|erythropoietin
5398871|NCT01726946|CHC|chc
5415961|NCT01650415|Rehabilitation|rehabilitation
5415962|NCT01650402|Hypertension, systolic|hypertension, systolic
5415963|NCT01650402|Elderly (> or equal to 75 years)|elderly (> or equal to 75 years)
5415964|NCT01650402|Cerebrovascular disease|cerebrovascular disease
5415965|NCT01650389|Tuberculosis|tuberculosis
5415966|NCT01650389|HIV|hiv
5415967|NCT01650389|BCG|bcg
5415968|NCT01650389|Infant|infant
5415969|NCT01650376|Ovarian Neoplasms|ovarian neoplasms
5415970|NCT01650376|Cancer of the Ovary|cancer of the ovary
5415971|NCT01650376|Ovarian Cancer|ovarian cancer
5415972|NCT01650376|Uterine Neoplasms|uterine neoplasms
5415973|NCT01650376|Cancer of the Uterus|cancer of the uterus
5415974|NCT01650376|Uterine Cancer|uterine cancer
5415975|NCT01650376|Olaparib|olaparib
5415976|NCT01650376|AZD2281|azd2281
5415977|NCT01650376|Carboplatin|carboplatin
5415978|NCT01650376|Paclitaxel|paclitaxel
5415979|NCT01650376|Relapsed|relapsed
5415980|NCT01650363|Complementary and alternative medicine|complementary and alternative medicine
5415981|NCT01650363|Post operative recovery|post operative recovery
5415982|NCT01650363|Cardio- thoracic surgery|cardio- thoracic surgery
5415983|NCT01650350|Melanoma|melanoma
5415984|NCT01650350|Prostate Cancer|prostate cancer
5415985|NCT01650350|Renal Cancer|renal cancer
5415986|NCT01650324|DBPR108|dbpr108
5415987|NCT01650324|DPP4|dpp4
5415988|NCT01650324|Diabetes|diabetes
5415989|NCT01650324|GLP-1|glp-1
5415990|NCT01650324|Incretins|incretins
5415992|NCT01650285|Prostate Cancer|prostate cancer
5415993|NCT01650285|Radical prostatectomy|radical prostatectomy
5415994|NCT01650207|electroacupuncture|electroacupuncture
5415995|NCT01650207|TENS|tens
5415996|NCT01650207|shoulder disorder|shoulder disorder
5415997|NCT01650207|hemiplegia|hemiplegia
5415998|NCT01650194|abiraterone acetate|abiraterone acetate
5415999|NCT01650194|prednisone|prednisone
5416000|NCT01650194|enzalutamide|enzalutamide
5416001|NCT01650194|cancer|cancer
5416002|NCT01650194|prostate|prostate
5416003|NCT01650194|MDV3100|mdv3100
5416004|NCT01650181|nafld, nash, fatty liver|nafld, nash, fatty liver
5416005|NCT01650168|NOMAC-E2|nomac-e2
5416006|NCT01650168|Nomegestrol acetate|nomegestrol acetate
5416007|NCT01650168|Estradiol|estradiol
5416008|NCT01650168|Levonorgestrel|levonorgestrel
5416009|NCT01650168|Safety|safety
5416010|NCT01650142|Neurofibromatosis 1|neurofibromatosis 1
5416011|NCT01650142|Phenotype|phenotype
5416012|NCT01650142|Modifiers|modifiers
5416013|NCT01650116|hypovolemia|hypovolemia
5416014|NCT01650116|renal hypoperfusion|renal hypoperfusion
5416015|NCT01650116|liver transplantation|liver transplantation
5416016|NCT01650116|sodium|sodium
5416017|NCT01650116|chloride|chloride
5416019|NCT01650116|ScvO2|scvo2
5416020|NCT01650116|PiCCO|picco
5416021|NCT01650116|O2-delivery|o2-delivery
5416022|NCT01650116|hemodynamic indexes|hemodynamic indexes
5416023|NCT01650103|hypovolemia|hypovolemia
5416024|NCT01650103|renal hypoperfusion|renal hypoperfusion
5416025|NCT01650103|major surgery|major surgery
5416026|NCT01650103|sodium|sodium
5419372|NCT01634126|FIT|fit
5416035|NCT01650090|Inhaled chemotherapy|inhaled chemotherapy
5416036|NCT01650090|Inhaled Lipid Cisplatin|inhaled lipid cisplatin
5416038|NCT01650077|Yondelis|yondelis
5416039|NCT01650077|Intolerance to doxorubicin/ifosfamide|intolerance to doxorubicin/ifosfamide
5416040|NCT01650077|CHOI criteria|choi criteria
5416041|NCT01650064|Hip fracture|hip fracture
5416042|NCT01650064|Mortality|mortality
5416043|NCT01650038|faecal transplantation|faecal transplantation
5416044|NCT01650038|ulcerative colitis|ulcerative colitis
5416045|NCT01650038|inflammatory bowel disease|inflammatory bowel disease
5416046|NCT01650025|probiotic, obesity, BMI, metabolic profile, metabolomics|probiotic, obesity, bmi, metabolic profile, metabolomics
5416047|NCT01649999|Rheumatoid Arthritis|rheumatoid arthritis
5416048|NCT01649999|ASP015K|asp015k
5416456|NCT01647971|Relapsed|relapsed
5416060|NCT01649921|SIRS|sirs
5416061|NCT01649921|Septic shock|septic shock
5416062|NCT01649921|Immunoparalysis|immunoparalysis
5416063|NCT01649921|Interferon-gamma|interferon-gamma
5416064|NCT01649895|Obsessive-compulsive disorder|obsessive-compulsive disorder
5416065|NCT01649895|internet|internet
5416066|NCT01649895|cognitive-behaviour therapy|cognitive-behaviour therapy
5416067|NCT01649895|D-Cycloserine|d-cycloserine
5416068|NCT01649882|endotracheal tube position|endotracheal tube position
5416069|NCT01649882|intubation|intubation
5416071|NCT01649869|Cytomegalovirus|cytomegalovirus
5416072|NCT01649869|Hearing Loss|hearing loss
5416073|NCT01649869|Infants|infants
5416074|NCT01649869|Valganciclovir|valganciclovir
5416075|NCT01649843|Peroral endoscopic myotomy|peroral endoscopic myotomy
5416076|NCT01649843|Esophageal Achalasia|esophageal achalasia
5416077|NCT01649830|low-grade glioma|low-grade glioma
5416078|NCT01649830|radiotherapy|radiotherapy
5416079|NCT01649830|chemotherapy|chemotherapy
5416095|NCT01649752|Stem cells|stem cells
5416096|NCT01649752|Uterine cavity|uterine cavity
5416097|NCT01649752|Implantation|implantation
5416098|NCT01649752|ICSI|icsi
5416099|NCT01649739|PAH|pah
5416100|NCT01649713|Fluval AB|fluval ab
5416101|NCT01649713|influenza|influenza
5416102|NCT01649713|vaccine|vaccine
5416103|NCT01649713|immunization|immunization
5416104|NCT01649713|infections|infections
5416105|NCT01649661|MRI|mri
5416106|NCT01649661|12-125|12-125
5416107|NCT01649661|premenopausal women|premenopausal women
5416108|NCT01649661|postmenopausal women|postmenopausal women
5416109|NCT01649661|questionnaire|questionnaire
5416110|NCT01649648|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5416111|NCT01649648|Autologous cord blood|autologous cord blood
5416112|NCT01649622|Leukemia|leukemia
5416113|NCT01649622|Lymphoma|lymphoma
5416114|NCT01649622|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5416115|NCT01649622|ALL|all
5416116|NCT01649622|Relapsed or primary refractory B-cell/T-cell|relapsed or primary refractory b-cell/t-cell
5416117|NCT01649622|Bendamustine|bendamustine
5416118|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride
5416119|NCT01649622|Bendamustine HCL|bendamustine hcl
5416120|NCT01649622|CEP-18083|cep-18083
5416121|NCT01649622|SDX-105|sdx-105
5416122|NCT01649622|Treanda|treanda
5416123|NCT01649609|BK Viremia|bk viremia
5416124|NCT01649609|BK Nephropathy|bk nephropathy
5416125|NCT01649609|mTOR inhibitor|mtor inhibitor
5416126|NCT01649609|renal transplant|renal transplant
5416127|NCT01649557|Schizophrenia|schizophrenia
5416128|NCT01649544|Mitral valvulopathy|mitral valvulopathy
5416129|NCT01649544|Atrial Fibrillation|atrial fibrillation
5416130|NCT01649544|Amiodarone|amiodarone
5416131|NCT01649544|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5416132|NCT01649544|Chronic Atrial Fibrillation|chronic atrial fibrillation
5416133|NCT01649544|Ultrasound Technique|ultrasound technique
5416134|NCT01649492|diclofenac|diclofenac
5416135|NCT01649492|CYP2C9|cyp2c9
5416136|NCT01649492|bromelain|bromelain
5416137|NCT01649492|pineapple juice|pineapple juice
5416138|NCT01649479|Obstetrical antiphospholipid syndrome|obstetrical antiphospholipid syndrome
5416139|NCT01649479|Thrombophilia|thrombophilia
5416140|NCT01649466|Type 2 diabetes mellitus, diabetes|type 2 diabetes mellitus, diabetes
5416141|NCT01649453|Neoplasms|neoplasms
5416142|NCT01649453|Neoplasm Metastasis|neoplasm metastasis
5416143|NCT01649453|Neoplastic Processes|neoplastic processes
5416144|NCT01649453|Pathologic Processes|pathologic processes
5416145|NCT01649440|Metabolomics|metabolomics
5416146|NCT01649440|serum|serum
5416149|NCT01649427|Pharmacokinetics Study|pharmacokinetics study
5416150|NCT01649427|Tacroliums|tacroliums
5416151|NCT01649427|GFR|gfr
5416152|NCT01649427|kidney|kidney
5416153|NCT01649427|transplant rejection|transplant rejection
5416154|NCT01649427|allograft rejection|allograft rejection
5416155|NCT01649427|xenograft rejection|xenograft rejection
5416156|NCT01649427|host vs graft disease|host vs graft disease
5416157|NCT01649427|renal transplant|renal transplant
5416158|NCT01649401|nebulizer|nebulizer
5416159|NCT01649401|PARI LC Spring SP|pari lc spring sp
5416160|NCT01649388|Kidney transplant|kidney transplant
5416161|NCT01649388|Delayed tolerance|delayed tolerance
5416162|NCT01649388|Marrow/enriched hematopoetic stem cell transplant|marrow/enriched hematopoetic stem cell transplant
5416163|NCT01649375|Ankylosing spondylitis|ankylosing spondylitis
5416165|NCT01649375|Chronic inflammatory disease|chronic inflammatory disease
5416166|NCT01649375|Inflammatory back pain|inflammatory back pain
5416167|NCT01649375|Secukinumab|secukinumab
5388666|NCT01773304|Obesity|obesity
5416168|NCT01649375|Prefilled syringe|prefilled syringe
5416169|NCT01649375|PFS|pfs
5416170|NCT01649375|Subcutaneous injection|subcutaneous injection
5416171|NCT01649375|AIN457|ain457
5416172|NCT01649375|AIN457F|ain457f
5416173|NCT01649375|AIN457F2310|ain457f2310
5416174|NCT01649375|adult|adult
5416175|NCT01649362|preterm infant|preterm infant
5416176|NCT01649362|feeding difficulties|feeding difficulties
5416177|NCT01649362|prefeeding oral stimulation|prefeeding oral stimulation
5416178|NCT01649310|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5416179|NCT01649310|Muscle strenght|muscle strenght
5416180|NCT01649310|Aged|aged
5416181|NCT01649245|Chronic hepatitis C|chronic hepatitis c
5416182|NCT01649245|Egyptian patients|egyptian patients
5416183|NCT01649245|pegylated interferon|pegylated interferon
5416184|NCT01649245|Ribavirin|ribavirin
5416185|NCT01649245|Reiferon retard|reiferon retard
5416186|NCT01649232|tdcs|tdcs
5416187|NCT01649232|tms|tms
5416188|NCT01649232|qeeg|qeeg
5416189|NCT01649232|neuroplasticity|neuroplasticity
5416190|NCT01649232|brain networks|brain networks
5416191|NCT01649232|add|add
5416192|NCT01649232|adhs|adhs
5416193|NCT01649219|Prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.|prediabetes, objectively measured exercise, glucose and lipid metabolism, dose response, muscle metabolism.
5416194|NCT01649206|Thyroid Nodule|thyroid nodule
5416195|NCT01649206|Radiofrequency Thermal Ablation|radiofrequency thermal ablation
5416196|NCT01649206|Pressure symptoms|pressure symptoms
5416197|NCT01649206|Hyperthyroidism|hyperthyroidism
5416198|NCT01649193|Rehabilitation [E02.831]|rehabilitation [e02.831]
5416199|NCT01649193|Exercise [G11.427.394.380]|exercise [g11.427.394.380]
5416200|NCT01649193|Health Education [I02.233.332]|health education [i02.233.332]
5416201|NCT01649193|[C08]|[c08]
5416202|NCT01649193|[C08.381]|[c08.381]
5416203|NCT01649180|RCC|rcc
5416204|NCT01649180|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
5416205|NCT01649180|ccRCC|ccrcc
5416206|NCT01649180|Metastatic RCC|metastatic rcc
5416207|NCT01649180|Recurrent RCC|recurrent rcc
5416208|NCT01649180|Kidney Cancer|kidney cancer
5416209|NCT01649180|Kidney Neoplasms|kidney neoplasms
5416210|NCT01649180|Axitinib|axitinib
5416211|NCT01649180|AG-013736|ag-013736
5416212|NCT01649180|Tyrosine Kinase Inhibition|tyrosine kinase inhibition
5416213|NCT01649180|TKI|tki
5416214|NCT01649167|body mass index|body mass index
5416215|NCT01649167|gestational diabetes|gestational diabetes
5416216|NCT01649167|leptin|leptin
5416217|NCT01649167|obesity|obesity
5416218|NCT01649167|pregnancy.|pregnancy.
5416219|NCT01649141|posttraumatic stress disorder|posttraumatic stress disorder
5416220|NCT01649141|trauma-focused cognitive behavioral therapy|trauma-focused cognitive behavioral therapy
5416221|NCT01649141|trauma|trauma
5416222|NCT01649141|child abuse|child abuse
5416223|NCT01649128|preeclampsia|preeclampsia
5416224|NCT01649115|obesity|obesity
5416225|NCT01649115|overweight|overweight
5416226|NCT01649115|childhood obesity|childhood obesity
5416227|NCT01649115|prevention|prevention
5416228|NCT01649115|Z score|z score
5416229|NCT01649115|weight for length|weight for length
5416230|NCT01649115|WFL|wfl
5416231|NCT01649115|body mass index|body mass index
5416232|NCT01649115|BMI|bmi
5416233|NCT01649115|prenatal|prenatal
5416234|NCT01649115|maternal|maternal
5416235|NCT01649115|nutrition education|nutrition education
5416236|NCT01649115|health education|health education
5416237|NCT01649115|health literacy|health literacy
5416238|NCT01649115|health numeracy|health numeracy
5416239|NCT01649115|passport|passport
5416240|NCT01649115|healthy lifestyles|healthy lifestyles
5416241|NCT01649115|growth|growth
5416242|NCT01649115|growth chart|growth chart
5416243|NCT01649102|Chronic hemodialysis|chronic hemodialysis
5416244|NCT01649102|Tunneled cuffed catheter|tunneled cuffed catheter
5416245|NCT01649102|Catheter-related bloodstream infection|catheter-related bloodstream infection
5416246|NCT01649102|Mechanical catheter dysfunction|mechanical catheter dysfunction
5416247|NCT01649102|impact of catheter design on outcome|impact of catheter design on outcome
5416248|NCT01649063|Uterine contraction;|uterine contraction;
5416249|NCT01649063|Shape; Frequency;|shape; frequency;
5416250|NCT01649063|First stage labor;|first stage labor;
5416251|NCT01649063|Fall|fall
5416252|NCT01649063|Rise ratio.|rise ratio.
5416253|NCT01649050|Spasticity|spasticity
5416457|NCT01647971|Refractory|refractory
5416256|NCT01649024|Malignant Mesothelioma|malignant mesothelioma
5416257|NCT01649024|anti-CTLA-4 mAb|anti-ctla-4 mab
5416258|NCT01649011|Oswestry Disability Index|oswestry disability index
5416260|NCT01649011|Roland Morris Disability Questionnaire|roland morris disability questionnaire
5416261|NCT01649011|RMDQ|rmdq
5416262|NCT01648998|Mineralocorticoid receptor|mineralocorticoid receptor
5416263|NCT01648998|Fludrocortisone|fludrocortisone
5416264|NCT01648998|Information Processing|information processing
5416265|NCT01648998|Cognition|cognition
5416266|NCT01648998|Depression|depression
5416267|NCT01648946|Strategies of transfusion|strategies of transfusion
5416268|NCT01648946|Red blood cells|red blood cells
5416269|NCT01648946|Liberal|liberal
5416270|NCT01648946|Restrictive|restrictive
5416271|NCT01648946|Oncologic critically ill patients|oncologic critically ill patients
5416272|NCT01648933|sarcoidosis|sarcoidosis
5416273|NCT01648933|heart|heart
5416274|NCT01648933|Rubidium|rubidium
5416276|NCT01648920|Asthma|asthma
5416277|NCT01648920|Suspected but undiagnosed asthma|suspected but undiagnosed asthma
5416278|NCT01648907|DESIR|desir
5416279|NCT01648907|SPONDYLARTHRITIS|spondylarthritis
5416280|NCT01648907|EARLY INFLAMMATORY RACHIIALGIA|early inflammatory rachiialgia
5416281|NCT01648907|BACK PAIN|back pain
5416282|NCT01648894|Rectal cancer|rectal cancer
5416283|NCT01648894|radiochemotherapy|radiochemotherapy
5416284|NCT01648894|complete pathological response|complete pathological response
5416285|NCT01648868|TMSAutism|tmsautism
5416286|NCT01648868|Eye-tracking|eye-tracking
5416287|NCT01648868|Social perception|social perception
5416288|NCT01648868|Social cognition|social cognition
5416289|NCT01648855|Circulating antiangiogenic factors|circulating antiangiogenic factors
5416290|NCT01648855|Preeclampsia|preeclampsia
5416291|NCT01648855|Developing lung|developing lung
5416292|NCT01648855|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5416293|NCT01648842|Preeclampsia|preeclampsia
5416294|NCT01648842|Vitamin D deficiency|vitamin d deficiency
5416295|NCT01648842|Pregnancy|pregnancy
5416296|NCT01648842|First trimester|first trimester
5416297|NCT01648777|Pneumonia|pneumonia
5416298|NCT01648777|Postoperative infection|postoperative infection
5416299|NCT01648777|Cardiac surgery|cardiac surgery
5416300|NCT01648777|Multiperforated catheter|multiperforated catheter
5416301|NCT01648777|Analgesia|analgesia
5416302|NCT01648751|Pelvic organ prolapse|pelvic organ prolapse
5416303|NCT01648751|Pelvic floor physical therapy|pelvic floor physical therapy
5416304|NCT01648751|Vaginal estrogen|vaginal estrogen
5416305|NCT01648751|Placebo|placebo
5416306|NCT01648738|Subacute low back pain|subacute low back pain
5416307|NCT01648738|Chronic low back pain|chronic low back pain
5416308|NCT01648738|Low back pain|low back pain
5416309|NCT01648738|Disability|disability
5416310|NCT01648738|Education|education
5416311|NCT01648738|Exercise|exercise
5416312|NCT01648738|Spa therapy|spa therapy
5416313|NCT01648738|Physiotherapy|physiotherapy
5416314|NCT01648738|Multidisciplinary|multidisciplinary
5416315|NCT01648738|Cost-effectiveness|cost-effectiveness
5416316|NCT01648738|Sick leave|sick leave
5416317|NCT01648725|Hypnosis|hypnosis
5416318|NCT01648725|Anesthesia|anesthesia
5416319|NCT01648725|Propofol|propofol
5416320|NCT01648725|Closed-loop|closed-loop
5416321|NCT01648712|extracorporeal circuit, platelet function|extracorporeal circuit, platelet function
5416322|NCT01648699|Pain|pain
5416323|NCT01648699|Cancer|cancer
5416324|NCT01648699|Osmotic Release Oral System|osmotic release oral system
5416325|NCT01648699|OROS Hydromorphone|oros hydromorphone
5416326|NCT01648699|Jurnista|jurnista
5416327|NCT01648686|Alendronate|alendronate
5416328|NCT01648686|Dental extraction|dental extraction
5416329|NCT01648686|Bone healing|bone healing
5416330|NCT01648686|postmenopausal women|postmenopausal women
5416331|NCT01648686|dental radiography|dental radiography
5416334|NCT01648634|Nebivolol|nebivolol
5416335|NCT01648634|beta-blockade treatment|beta-blockade treatment
5416336|NCT01648621|COPD|copd
5416337|NCT01648621|case management|case management
5416338|NCT01648595|Fentanyl|fentanyl
5416339|NCT01648595|analgesia|analgesia
5416340|NCT01648595|duration of the active phase|duration of the active phase
5416341|NCT01648595|pain severity|pain severity
5416342|NCT01648556|Purpura thrombopenic|purpura thrombopenic
5416343|NCT01648556|Medullary cytogenetics|medullary cytogenetics
5416344|NCT01648556|Myelodysplasic syndrome|myelodysplasic syndrome
5416345|NCT01648556|bone marrow biopsy|bone marrow biopsy
5416474|NCT01647919|Attention|attention
5416346|NCT01648517|on-small cell lung carcinoma|on-small cell lung carcinoma
5416347|NCT01648517|chemotherapy naive patient|chemotherapy naive patient
5416348|NCT01648504|Colonoscopy|colonoscopy
5416349|NCT01648504|Screening colonoscopy|screening colonoscopy
5416350|NCT01648504|Electronic education|electronic education
5416352|NCT01648504|Patient education|patient education
5416353|NCT01648478|IRAP|irap
5416358|NCT01648465|advanced|advanced
5416359|NCT01648452|Achromatopsia|achromatopsia
5416360|NCT01648452|Ciliary Neurotrophic Factor|ciliary neurotrophic factor
5416361|NCT01648452|CNTF|cntf
5416362|NCT01648322|Breast Cancer|breast cancer
5416363|NCT01648322|Taxotere Chemotherapy|taxotere chemotherapy
5416364|NCT01648322|Neulasta|neulasta
5416365|NCT01648322|efficacy and safety|efficacy and safety
5416366|NCT01648322|single cycle doses of F-627|single cycle doses of f-627
5416367|NCT01648322|pegfilgrastim|pegfilgrastim
5416368|NCT01648309|aortic stenosis|aortic stenosis
5416369|NCT01648309|TAVI|tavi
5416370|NCT01648309|neuropsychological|neuropsychological
5416371|NCT01648309|cognitive|cognitive
5416372|NCT01648309|candidates for TAVI|candidates for tavi
5416377|NCT01648283|methadone polymorphisms|methadone polymorphisms
5416378|NCT01648270|buprenorphine|buprenorphine
5416379|NCT01648270|CYP3A|cyp3a
5388868|NCT01772680|Thalassemia|thalassemia
5416380|NCT01648257|healthy subjects|healthy subjects
5416381|NCT01648257|relative bioavailability|relative bioavailability
5416382|NCT01648257|HIV|hiv
5416383|NCT01648257|GSK1265744|gsk1265744
5416384|NCT01648244|DM, T2DM, Diabetes|dm, t2dm, diabetes
5416385|NCT01648231|Healthy Volunteer|healthy volunteer
5416386|NCT01648218|glucocorticoid|glucocorticoid
5416387|NCT01648218|diabetes mellitus|diabetes mellitus
5416388|NCT01648218|post-transplant|post-transplant
5416389|NCT01648218|insulin|insulin
5416390|NCT01648205|ranolazine|ranolazine
5416391|NCT01648205|clinical trial|clinical trial
5416392|NCT01648179|GSK1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect|gsk1322322, relative bioavailability, healthy subjects, open label, food effect, weight effect
5416393|NCT01648166|trace|trace
5416394|NCT01648166|element|element
5416395|NCT01648166|lung|lung
5416396|NCT01648166|cancer|cancer
5416397|NCT01648166|Appalachia|appalachia
5416398|NCT01648153|Efficacy|efficacy
5416399|NCT01648153|Obese|obese
5416400|NCT01648153|T2DM|t2dm
5416401|NCT01648153|IL-18|il-18
5416402|NCT01648153|Monoclonal antibody (mAb)|monoclonal antibody (mab)
5416403|NCT01648140|Genotype 4|genotype 4
5416404|NCT01648140|GSK2336805|gsk2336805
5416405|NCT01648140|pegylated interferon|pegylated interferon
5416406|NCT01648140|telaprevir|telaprevir
5416407|NCT01648140|Genotype 1|genotype 1
5416408|NCT01648140|chronic hepatitis C|chronic hepatitis c
5416409|NCT01648140|ribavirin|ribavirin
5416410|NCT01648140|NS5A inhibitor|ns5a inhibitor
5416411|NCT01648140|hepatitis C virus (HCV) infection|hepatitis c virus (hcv) infection
5416412|NCT01648127|Ceftaroline|ceftaroline
5416413|NCT01648127|Pharmacokinetics|pharmacokinetics
5416414|NCT01648127|Obesity|obesity
5416415|NCT01648114|breastfeeding|breastfeeding
5416416|NCT01648114|pregnancy|pregnancy
5416417|NCT01648114|antenatal|antenatal
5416418|NCT01648114|exclusive breastfeeding|exclusive breastfeeding
5416419|NCT01648114|education|education
5416420|NCT01648101|Retigabine IR|retigabine ir
5416421|NCT01648101|Asian Subjects|asian subjects
5416422|NCT01648101|Adjunctive Therapy|adjunctive therapy
5416423|NCT01648101|Efficacy|efficacy
5416424|NCT01648101|Drug-Resistant|drug-resistant
5416425|NCT01648101|Safety & tolerability|safety & tolerability
5416426|NCT01648101|Partial-Onset Seizures|partial-onset seizures
5416427|NCT01648101|Epilepsy|epilepsy
5416428|NCT01648088|staphylococcus aureus|staphylococcus aureus
5416429|NCT01648088|prosthetic joint implantation|prosthetic joint implantation
5416430|NCT01648075|caries|caries
5416431|NCT01648075|probiotics|probiotics
5416432|NCT01648075|lactobacilli|lactobacilli
5416433|NCT01648062|Sleep|sleep
5416434|NCT01648062|self-regulation|self-regulation
5416435|NCT01648062|Implementation intentions|implementation intentions
5416436|NCT01648062|intervention|intervention
5416437|NCT01648062|mental simulation|mental simulation
5416438|NCT01648023|LC Bead|lc bead
5416439|NCT01648023|Irinotecan|irinotecan
5416440|NCT01648023|ONCOZENE BEAD|oncozene bead
5416441|NCT01648010|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5416442|NCT01648010|Carcinoma of urinary bladder, invasive|carcinoma of urinary bladder, invasive
5416443|NCT01648010|Intravesical instillation|intravesical instillation
5416444|NCT01648010|Mitomycin C|mitomycin c
5416445|NCT01648010|Hydrogel|hydrogel
5416446|NCT01648010|Reverse thermal gelation|reverse thermal gelation
5416447|NCT01648010|Drug retention|drug retention
5416448|NCT01648010|radical cystectomy|radical cystectomy
5416449|NCT01647997|bacterial lipopolysaccharides|bacterial lipopolysaccharides
5416450|NCT01647997|hyperlactatemia|hyperlactatemia
5416451|NCT01647997|muscle lactate|muscle lactate
5416452|NCT01647984|Arrhythmias|arrhythmias
5416453|NCT01647984|Life quality|life quality
5416454|NCT01647971|Lymphoma|lymphoma
5416455|NCT01647971|Rituxan|rituxan
5416458|NCT01647958|TEMPO|tempo
5416459|NCT01647958|TIF|tif
5416460|NCT01647958|Transoral Incisionless Fundoplication|transoral incisionless fundoplication
5416461|NCT01647958|EsophyX System|esophyx system
5416462|NCT01647958|refractory symptoms|refractory symptoms
5416463|NCT01647958|proton pump inhibitors|proton pump inhibitors
5416464|NCT01647958|EndoGastric Solutions|endogastric solutions
5416465|NCT01647958|EGS|egs
5416466|NCT01647958|Acid Reflux|acid reflux
5416467|NCT01647958|Heartburn|heartburn
5416468|NCT01647958|Regurgitation|regurgitation
5416469|NCT01647945|PAH WHO group 1|pah who group 1
5416470|NCT01647932|Heart Failure|heart failure
5416471|NCT01647932|Diuretics|diuretics
5416472|NCT01647932|Diuretic resistance|diuretic resistance
5416473|NCT01647919|Cognition|cognition
5416475|NCT01647919|Memory|memory
5416476|NCT01647919|Mood|mood
5416477|NCT01647867|Met fragments expression|met fragments expression
5416478|NCT01647854|emergency medical service|emergency medical service
5416479|NCT01647854|telemedicine|telemedicine
5416480|NCT01647854|teleconsultation|teleconsultation
5416481|NCT01647854|safety|safety
5416483|NCT01647815|Axillary vein ultrasound|axillary vein ultrasound
5002968|NCT03977558|Diet Therapy|diet therapy
5389015|NCT01772017|OSA|osa
5416484|NCT01647815|Subclavian vein ultrasound|subclavian vein ultrasound
5416486|NCT01647802|transfer devices|transfer devices
5416487|NCT01647789|prostate cancer, castration resistant,|prostate cancer, castration resistant,
5416488|NCT01647776|Colon Neoplasia|colon neoplasia
5416489|NCT01647776|Colorectal carcinoma|colorectal carcinoma
5416490|NCT01647776|colon cancer|colon cancer
5416491|NCT01647776|colon polyp|colon polyp
5416492|NCT01647776|colonoscopy|colonoscopy
5416493|NCT01647776|sDNA test|sdna test
5416494|NCT01647776|FIT tests (fecal immunochemical test)|fit tests (fecal immunochemical test)
5416495|NCT01647776|relating colon neoplasia to obesity, type 2 diabetes|relating colon neoplasia to obesity, type 2 diabetes
5416496|NCT01647776|colonoscopy and pathology confirmed advanced adenomas|colonoscopy and pathology confirmed advanced adenomas
5416497|NCT01647763|Hemorrhoids|hemorrhoids
5416498|NCT01647737|Xerostomia|xerostomia
5416499|NCT01647737|Sjogren syndrome|sjogren syndrome
5416500|NCT01647737|dry mouth|dry mouth
5416501|NCT01647724|cervical cancer|cervical cancer
5416502|NCT01647724|prevention|prevention
5416503|NCT01647724|screening|screening
5416504|NCT01647698|Parkinson Disease|parkinson disease
5416505|NCT01647698|near transfer|near transfer
5416506|NCT01647698|far transfer|far transfer
5416507|NCT01647698|working memory|working memory
5416508|NCT01647698|fluid intelligence|fluid intelligence
5416509|NCT01647698|cognitive training|cognitive training
5416510|NCT01647698|dual n-back|dual n-back
5416511|NCT01647685|Vesselwall inflammation|vesselwall inflammation
5416512|NCT01647685|liposomal prednisolone|liposomal prednisolone
5416513|NCT01647659|MEK inhibitor GSK1120212|mek inhibitor gsk1120212
5416514|NCT01647659|pharmacokinetics|pharmacokinetics
5416515|NCT01647659|powder for oral solution|powder for oral solution
5416516|NCT01647659|Solid Tumors|solid tumors
5416517|NCT01647659|pediatric formulation|pediatric formulation
5416518|NCT01647646|asthma|asthma
5416519|NCT01647646|SMART|smart
5416520|NCT01647646|fixed dose|fixed dose
5416521|NCT01647633|rhinitis|rhinitis
5416522|NCT01647633|stuffy nose|stuffy nose
5416523|NCT01647633|congestion|congestion
5416524|NCT01647633|Sneezing|sneezing
5416525|NCT01647607|Breast Cancer|breast cancer
5416526|NCT01647607|Young Women|young women
5416527|NCT01647607|Fertility|fertility
5416528|NCT01647607|Physical Activity|physical activity
5416529|NCT01647607|Survivorship|survivorship
5416530|NCT01647594|Breast cancer|breast cancer
5416531|NCT01647594|Young women|young women
5416532|NCT01647594|Fertility|fertility
5416533|NCT01647594|Physical activity|physical activity
5416534|NCT01647594|Survivorship|survivorship
5416535|NCT01647581|hemoclip|hemoclip
5416536|NCT01647581|colonoscopy|colonoscopy
5416537|NCT01647581|post-polypectomy bleed|post-polypectomy bleed
5416538|NCT01647555|Cetuximab|cetuximab
5416539|NCT01647555|radiotherapy|radiotherapy
5416540|NCT01647555|epidermoid head and neck cancer|epidermoid head and neck cancer
5416541|NCT01647542|Drug therapy|drug therapy
5416542|NCT01647529|Cytomegalovirus|cytomegalovirus
5416543|NCT01647529|uveitis|uveitis
5416544|NCT01647529|endotheliitis|endotheliitis
5416545|NCT01647529|ganciclovir|ganciclovir
5416546|NCT01647503|parathyroid gland|parathyroid gland
5416547|NCT01647503|primary hyperparathyroidism|primary hyperparathyroidism
5416548|NCT01647503|proteins|proteins
5416549|NCT01647477|non treated cancer|non treated cancer
5416550|NCT01647477|oral cavity|oral cavity
5416551|NCT01647477|oropharynx|oropharynx
5416552|NCT01647477|hypopharynx|hypopharynx
5416553|NCT01647477|larynx|larynx
5416554|NCT01647477|first consultation|first consultation
5416555|NCT01647438|South Asians|south asians
5416556|NCT01647438|Diabetes|diabetes
5416557|NCT01647438|Physical Activity|physical activity
5416558|NCT01647438|Coronary Heart Disease|coronary heart disease
5416559|NCT01647438|Lifestyle|lifestyle
5416560|NCT01647425|head and neck cancer|head and neck cancer
5416561|NCT01647425|lung cancer|lung cancer
5416562|NCT01647425|tobacco use disorder|tobacco use disorder
5416563|NCT01647425|alcoholism|alcoholism
5416564|NCT01647412|Crohn's disease|crohn's disease
5416565|NCT01647412|Inflammatory Bowel Disease|inflammatory bowel disease
5416566|NCT01647412|Growth Hormone|growth hormone
5416567|NCT01647412|Nutraceuticals|nutraceuticals
5416568|NCT01647399|Obesity|obesity
5416569|NCT01647399|Asthma|asthma
5416570|NCT01647399|Vitamin D|vitamin d
5416571|NCT01647399|Allergy|allergy
5416572|NCT01647399|Genetic|genetic
5416573|NCT01647399|Childhood|childhood
5416574|NCT01647399|Pediatric|pediatric
5416575|NCT01647399|cohort|cohort
5416576|NCT01647399|observational|observational
5416577|NCT01647399|prospective|prospective
5416578|NCT01647399|molecular|molecular
5416579|NCT01647373|retinal detachment|retinal detachment
5416580|NCT01647373|scleral buckle|scleral buckle
5416581|NCT01647373|silicone sponge|silicone sponge
5416583|NCT01647373|surgery included silicone sponge scleral buckling|surgery included silicone sponge scleral buckling
5002969|NCT03977558|Canola oil|canola oil
5389116|NCT01771653|HCV|hcv
5416584|NCT01647373|retina currently attached|retina currently attached
5416585|NCT01647373|at least 6 months after surgery|at least 6 months after surgery
5416586|NCT01647360|Metrorrhagia|metrorrhagia
5416587|NCT01647360|Menorrhagia|menorrhagia
5416588|NCT01647347|bacteria|bacteria
5416589|NCT01647347|bacteremia|bacteremia
5416590|NCT01647347|PVP-iodine|pvp-iodine
5416591|NCT01647347|periodontitis|periodontitis
5416593|NCT01647295|visual exploration|visual exploration
5416594|NCT01647295|pupil size|pupil size
5416595|NCT01647295|social interactions|social interactions
5416596|NCT01647295|faces|faces
5416597|NCT01647295|human motion|human motion
5416598|NCT01647256|Bioavailability|bioavailability
5416600|NCT01647256|Fasting|fasting
5416601|NCT01647243|Knee osteoarthritis|knee osteoarthritis
5416602|NCT01647243|Total knee arthroplasty|total knee arthroplasty
5416603|NCT01647243|Preoperative training|preoperative training
5416604|NCT01647243|Strength training|strength training
5416605|NCT01647230|Anaesthesia, spinal|anaesthesia, spinal
5416606|NCT01647230|Cerebral oximetry|cerebral oximetry
5416607|NCT01647230|Blood pressure|blood pressure
5416608|NCT01647230|Heart rate|heart rate
5416609|NCT01647230|Cognitive Symptom|cognitive symptom
5416610|NCT01647217|Blepharitis|blepharitis
5416611|NCT01647217|Demodex|demodex
5416612|NCT01647217|Mites|mites
5416613|NCT01647217|Tea Tree oil|tea tree oil
5416614|NCT01647217|Terpinen|terpinen
5416615|NCT01647204|Nutrition|nutrition
5416616|NCT01647204|older|older
5416617|NCT01647204|hospital|hospital
5416618|NCT01647204|volunteer|volunteer
5416619|NCT01647191|HCV，|hcv，
5416620|NCT01647191|drug users，|drug users，
5416621|NCT01647191|intervention|intervention
5416622|NCT01647165|Maintenance Strategy|maintenance strategy
5416623|NCT01647165|Plasma Cell Neoplasm|plasma cell neoplasm
5416624|NCT01647165|Proteasome Inhibitor|proteasome inhibitor
5416625|NCT01647165|Immunomodulatory Drugs|immunomodulatory drugs
5416626|NCT01647165|Novel Therapy|novel therapy
5416627|NCT01647152|Uveitis|uveitis
5416628|NCT01647152|Ustekinumab|ustekinumab
5416629|NCT01647152|IL 12/23|il 12/23
5416630|NCT01647152|Stelara|stelara
5416631|NCT01646866|autism|autism
5416632|NCT01646866|siblings|siblings
5416633|NCT01646866|genetic test|genetic test
5416634|NCT01646866|screening|screening
5416635|NCT01646840|PF-04958242|pf-04958242
5416636|NCT01646840|bioequivalence|bioequivalence
5416637|NCT01646840|pharmacokinetics|pharmacokinetics
5416638|NCT01646840|Schizophrenia|schizophrenia
5416639|NCT01646827|Schizophrenia, extended release antipsychotic|schizophrenia, extended release antipsychotic
5416640|NCT01646814|Healthy volunteer|healthy volunteer
5416641|NCT01646814|comparison of incidence of|comparison of incidence of
5416642|NCT01646814|treatment groups.|treatment groups.
5416643|NCT01646775|opioid|opioid
5416644|NCT01646775|malignancy|malignancy
5416645|NCT01646775|epidural|epidural
5416646|NCT01646749|Energy intake|energy intake
5416647|NCT01646749|Beef protein|beef protein
5416648|NCT01646749|Satiety|satiety
5416649|NCT01646749|Protein leverage hypothesis|protein leverage hypothesis
5416650|NCT01646736|Lupus Nephritis|lupus nephritis
5416651|NCT01646736|Cyclophosphamide|cyclophosphamide
5416652|NCT01646736|Tripterygium|tripterygium
5416653|NCT01646710|Tool|tool
5416655|NCT01646710|Advocacy|advocacy
5416656|NCT01646710|Development of a tool|development of a tool
5416657|NCT01646710|advocacy materials|advocacy materials
5416658|NCT01646697|pancreatic cancer|pancreatic cancer
5416659|NCT01646697|adenocarcinoma|adenocarcinoma
5416660|NCT01646697|pancreatic resection|pancreatic resection
5416661|NCT01646684|Prostate cancer, pasireotide LAR, castration resistant prostatate cancer, CRPC, SOM230 LAR|prostate cancer, pasireotide lar, castration resistant prostatate cancer, crpc, som230 lar
5416662|NCT01646671|Hypertension, Severe, LCZ696|hypertension, severe, lcz696
5416663|NCT01646645|CMVpp65 specific T-cells|cmvpp65 specific t-cells
5416664|NCT01646645|Stem Cell Transplantation|stem cell transplantation
5416675|NCT01646580|dermatomycoses, tinea, candidiasis, children|dermatomycoses, tinea, candidiasis, children
5416677|NCT01646554|Liver metastases|liver metastases
5416678|NCT01646554|Colorectal Cancer|colorectal cancer
5416679|NCT01646554|KRAS mutated|kras mutated
5416681|NCT01646554|Aflibercept|aflibercept
5416682|NCT01646554|Randomized|randomized
5416683|NCT01646554|Phase II-III|phase ii-iii
5416684|NCT01646554|Perioperative treatment|perioperative treatment
5416685|NCT01646554|Adjuvant|adjuvant
5535924|NCT01143142|HPV|hpv
5416686|NCT01646554|Neo-adjuvant|neo-adjuvant
5416687|NCT01646554|Surgery|surgery
5416688|NCT01646554|Progression Free Survival|progression free survival
5416689|NCT01646528|Gastric Intestinal Metaplasia|gastric intestinal metaplasia
5416690|NCT01646528|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5416691|NCT01646515|systolic heart failure|systolic heart failure
5416692|NCT01646515|udenafil|udenafil
5416693|NCT01646515|exercise capacity|exercise capacity
5416694|NCT01646502|chronic wound|chronic wound
5416695|NCT01646502|treatment|treatment
5416696|NCT01646502|biofilms|biofilms
5416697|NCT01646502|venous insufficiency|venous insufficiency
5416699|NCT01646489|Antisense|antisense
5416700|NCT01646489|miR-122 antagonist|mir-122 antagonist
5416701|NCT01646489|Safety in healthy volunteers|safety in healthy volunteers
5416702|NCT01646489|Hepatitis C|hepatitis c
5416718|NCT01646450|EGFR Mutation|egfr mutation
5416719|NCT01646450|Elder patients|elder patients
5416720|NCT01646424|COPD,|copd,
5416721|NCT01646424|Patient satisfaction,|patient satisfaction,
5416722|NCT01646424|fix combination,|fix combination,
5416723|NCT01646424|NIS Turkey,|nis turkey,
5416724|NCT01646424|turbuhaler,|turbuhaler,
5416725|NCT01646424|FSI-10|fsi-10
5416726|NCT01646411|cytomegalovirus (CMV) IgM &IgG|cytomegalovirus (cmv) igm &igg
5416727|NCT01646411|Lyme|lyme
5416728|NCT01646411|Toxoplasma|toxoplasma
5416729|NCT01646411|Rubella|rubella
5416730|NCT01646411|Rubeola IgM|rubeola igm
5416731|NCT01646411|Rocky mountain Spotted Fever IgM|rocky mountain spotted fever igm
5416732|NCT01646411|Ebv IgM|ebv igm
5416733|NCT01646411|Herpes|herpes
5416734|NCT01646411|Babesia|babesia
5416735|NCT01646411|Measles|measles
5416736|NCT01646411|Tetanus|tetanus
5416737|NCT01646411|Mumps|mumps
5416738|NCT01646411|Mycoplasma|mycoplasma
5416739|NCT01646411|Legionella|legionella
5416740|NCT01646411|Giardia|giardia
5416741|NCT01646411|Syphilis|syphilis
5416742|NCT01646411|Bordetella Pertussis|bordetella pertussis
5416743|NCT01646411|H Pylori|h pylori
5416744|NCT01646411|Antibody Titre|antibody titre
5416745|NCT01646411|Elevated IgG|elevated igg
5416746|NCT01646411|Abnormal IgM|abnormal igm
5416748|NCT01646398|13VPNC|13vpnc
5416749|NCT01646398|23VPS|23vps
5416750|NCT01646385|observational|observational
5416751|NCT01646385|non-interventional|non-interventional
5416752|NCT01646385|cohort|cohort
5416753|NCT01646385|retrospective|retrospective
5416754|NCT01646385|register|register
5416755|NCT01646385|rheumatoid arthritis|rheumatoid arthritis
5416756|NCT01646372|Medical Education|medical education
5416757|NCT01646372|Cognitive Aid|cognitive aid
5416758|NCT01646372|Crisis Resource Management|crisis resource management
5416759|NCT01646372|Advanced Cardiac Life Support|advanced cardiac life support
5416760|NCT01646372|Skills Retention|skills retention
5416761|NCT01646346|Breast Cancer|breast cancer
5416762|NCT01646346|Radiation for Breast Cancer|radiation for breast cancer
5416763|NCT01646333|Parkinson Disease|parkinson disease
5416764|NCT01646333|Mild Cognitive Impairment|mild cognitive impairment
5416765|NCT01646333|Cognition|cognition
5416766|NCT01646333|Executive Function|executive function
5416767|NCT01646333|Learning|learning
5416768|NCT01646333|Memory|memory
5416769|NCT01646333|Problem Solving|problem solving
5416770|NCT01646294|Pharmacokinetics|pharmacokinetics
5416772|NCT01646294|YM178|ym178
5416773|NCT01646294|Modified release (Oral Controlled Absorption System (OCAS))|modified release (oral controlled absorption system (ocas))
5416774|NCT01646294|Immediate release (IR)|immediate release (ir)
5416775|NCT01646294|Fasted conditions|fasted conditions
5416776|NCT01646294|Fed conditions|fed conditions
5416777|NCT01646281|Atrial fibrillation|atrial fibrillation
5416778|NCT01646281|Vernakalant|vernakalant
5416779|NCT01646281|Flecainide|flecainide
5416780|NCT01646281|Echocardiography|echocardiography
5416781|NCT01646268|Rotigotine|rotigotine
5416782|NCT01646268|Neupro phase 3|neupro phase 3
5416783|NCT01646268|Early phase|early phase
5416784|NCT01646268|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5416785|NCT01646255|Rotigotine|rotigotine
5416786|NCT01646255|Neupro phase 3|neupro phase 3
5416787|NCT01646255|Advanced-stage|advanced-stage
5416788|NCT01646255|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5416789|NCT01646229|Hemoperfusion|hemoperfusion
5416790|NCT01646229|Polymyxin-B|polymyxin-b
5416791|NCT01646229|Emergency abdominal surgery|emergency abdominal surgery
5416792|NCT01646229|Sepsis|sepsis
5416793|NCT01646229|Endotoxin|endotoxin
5416794|NCT01646216|stroke|stroke
5416795|NCT01646216|treadmill|treadmill
5416796|NCT01646216|walking|walking
5416797|NCT01646216|hemiparesis|hemiparesis
5416798|NCT01646216|training|training
5416799|NCT01646203|Advanced Solid Tumors|advanced solid tumors
5416800|NCT01646190|Fast-track|fast-track
5420069|NCT01630954|H Mole|h mole
5416801|NCT01646190|multimodal perioperative care|multimodal perioperative care
5416802|NCT01646190|enhanced recovery|enhanced recovery
5416803|NCT01646190|colorectal surgery|colorectal surgery
5416804|NCT01646190|elderly patients|elderly patients
5416805|NCT01646190|seniors|seniors
5416806|NCT01646164|Dill seed|dill seed
5416807|NCT01646164|Pattern of uterus contractions|pattern of uterus contractions
5416808|NCT01646164|Active phase of labor|active phase of labor
5416809|NCT01646138|H1N1|h1n1
5416810|NCT01646138|Influenza|influenza
5416811|NCT01646138|Human|human
5416812|NCT01646138|Challenge Study|challenge study
5416813|NCT01646138|Healthy Volunteer|healthy volunteer
5416814|NCT01646125|Non-small cell lung carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5416815|NCT01646125|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5416817|NCT01646125|lung adenocarcinoma|lung adenocarcinoma
5416818|NCT01646125|Squamous cell lung carcinoma|squamous cell lung carcinoma
5416819|NCT01646125|Large-cell lung carcinoma|large-cell lung carcinoma
5416820|NCT01646125|Non small cell lung carcinoma|non small cell lung carcinoma
5416821|NCT01646125|Non small cell lung cancer|non small cell lung cancer
5416822|NCT01646125|Non-small cell lung cancer|non-small cell lung cancer
5416824|NCT01646125|Large cell lung carcinoma|large cell lung carcinoma
5416825|NCT01646125|Large cell lung cancer|large cell lung cancer
5416826|NCT01646125|HSP90|hsp90
5416827|NCT01646125|AUY922|auy922
5416828|NCT01646125|Pemetrexed|pemetrexed
5416829|NCT01646125|Docetaxel|docetaxel
5416830|NCT01646125|EGFR TKI|egfr tki
5416831|NCT01646125|EGFR mutations|egfr mutations
5416832|NCT01646112|Uncertainty|uncertainty
5416833|NCT01646112|HNPCC|hnpcc
5416834|NCT01646112|Lynch Syndrome|lynch syndrome
5416835|NCT01646112|Genetic Tests|genetic tests
5416836|NCT01646099|Kidney transplant|kidney transplant
5416837|NCT01646099|Renal transplant|renal transplant
5416838|NCT01646099|Sun protection|sun protection
5416839|NCT01646099|Skin cancer|skin cancer
5416840|NCT01646086|Weight Loss|weight loss
5416841|NCT01646086|Self-Weighing|self-weighing
5416842|NCT01646086|Weight Tracking|weight tracking
5416843|NCT01646073|Plaque Psoriasis|plaque psoriasis
5416844|NCT01646073|Psoriasis|psoriasis
5416845|NCT01646073|Placebo Controlled|placebo controlled
5416846|NCT01646073|Skin Disease|skin disease
5416847|NCT01646073|Double Blind|double blind
5416848|NCT01646060|blood|blood
5416849|NCT01646060|loss|loss
5416850|NCT01646060|healthy|healthy
5416851|NCT01646060|volume|volume
5445471|NCT01521572|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5399657|NCT01723267|IVF|ivf
5416852|NCT01646060|To evaluate the ability of the Zynex BVM to non-invasively detect blood loss in healthy subjects during a blood draw.|to evaluate the ability of the zynex bvm to non-invasively detect blood loss in healthy subjects during a blood draw.
5416853|NCT01646047|diabetes|diabetes
5416854|NCT01646047|diabetic retinopathy|diabetic retinopathy
5416855|NCT01646047|nutritional supplements|nutritional supplements
5416856|NCT01646047|visual function|visual function
5416857|NCT01646047|macular pigment|macular pigment
5416858|NCT01646047|macular threshold sensitivity|macular threshold sensitivity
5416859|NCT01646047|contrast sensitivity|contrast sensitivity
5416860|NCT01646047|color vision|color vision
5416861|NCT01646047|optical coherence tomography|optical coherence tomography
5416862|NCT01646034|oligo metastatic|oligo metastatic
5416863|NCT01646034|HRD deficiency|hrd deficiency
5416864|NCT01646021|Mantle cell lymphoma|mantle cell lymphoma
5416865|NCT01646021|Relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
5416866|NCT01646021|Refractory mantle cell lymphoma|refractory mantle cell lymphoma
5416867|NCT01646021|Ibrutinib|ibrutinib
5416868|NCT01646021|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5416869|NCT01646021|Temsirolimus|temsirolimus
5416870|NCT01645956|obesity|obesity
5416871|NCT01645956|exercise|exercise
5416872|NCT01645956|energy intake|energy intake
5416873|NCT01645956|physical activity|physical activity
5416874|NCT01645943|Non-ST-elevation acute myocardial infarction|non-st-elevation acute myocardial infarction
5416875|NCT01645943|Comorbidities|comorbidities
5416876|NCT01645930|Drug Therapy|drug therapy
5416877|NCT01645917|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5416878|NCT01645904|Hereditary Diseases|hereditary diseases
5416879|NCT01645904|Genetic|genetic
5416880|NCT01645904|Lynch syndrome|lynch syndrome
5416881|NCT01645904|Positive or indeterminate test results for Lynch syndrome|positive or indeterminate test results for lynch syndrome
5416882|NCT01645904|Social media|social media
5416883|NCT01645904|Internet-based program|internet-based program
5416884|NCT01645904|Questionnaire|questionnaire
5416886|NCT01645904|My Family Garden website|my family garden website
5416887|NCT01645904|Interview|interview
5416888|NCT01645904|Focus group|focus group
5416889|NCT01645904|Website Analysis and MeasureMent Inventory|website analysis and measurement inventory
5416890|NCT01645904|WAMMI|wammi
5416891|NCT01645891|Diabetic Foot Ulcer|diabetic foot ulcer
5416892|NCT01645878|Primiparous Mothers|primiparous mothers
5416893|NCT01645878|self-efficacy,|self-efficacy,
5416894|NCT01645878|hands off,|hands off,
5416895|NCT01645878|hands on ,|hands on ,
5416896|NCT01645878|social cognitive theory|social cognitive theory
5416898|NCT01645865|AIDS|aids
5416899|NCT01645865|PMTCT|pmtct
5416900|NCT01645865|Mobile Phone|mobile phone
5416902|NCT01645839|Leptomeningeal metastasis|leptomeningeal metastasis
5416903|NCT01645839|Intrathecal chemotherapy|intrathecal chemotherapy
5416904|NCT01645839|Depocyte|depocyte
5416905|NCT01645800|Lysozyme hydrochloride|lysozyme hydrochloride
5416906|NCT01645800|COPD|copd
5416907|NCT01645787|Spinal Muscular Atrophy|spinal muscular atrophy
5416908|NCT01645787|4-aminopyridine|4-aminopyridine
5416909|NCT01645787|dalfampridine|dalfampridine
5416910|NCT01645787|Ampyra|ampyra
5416911|NCT01645774|subcutaneous injection heparin|subcutaneous injection heparin
5416912|NCT01645774|injection duration|injection duration
5416913|NCT01645774|bruising pain|bruising pain
5416914|NCT01645774|decrease pain|decrease pain
5416915|NCT01645774|decrease bruising|decrease bruising
5416916|NCT01645761|Helicobacter pylori eradication|helicobacter pylori eradication
5416917|NCT01645761|Peptic ulcer|peptic ulcer
5416918|NCT01645748|head and neck cancer|head and neck cancer
5416920|NCT01645748|cisplatin|cisplatin
5416921|NCT01645748|S-1|s-1
5416922|NCT01645735|Infections|infections
5416923|NCT01645735|Teflaro|teflaro
5416924|NCT01645735|cephalosporin|cephalosporin
5416925|NCT01645735|Ceftaroline|ceftaroline
5416926|NCT01645735|antibiotics|antibiotics
5416927|NCT01645735|pneumonia|pneumonia
5416928|NCT01645722|Fat Grafts|fat grafts
5416929|NCT01645722|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5416930|NCT01645722|Wounded warriors|wounded warriors
5416931|NCT01645722|Amputation pain|amputation pain
5416932|NCT01645696|Diabetes|diabetes
5416933|NCT01645696|Type 1 Diabetes|type 1 diabetes
5416934|NCT01645696|Continuous glucose monitoring|continuous glucose monitoring
5416935|NCT01645696|Blood glucose|blood glucose
5416936|NCT01645696|Blood glucose sensor|blood glucose sensor
5416937|NCT01645696|Glucose Binding Protein (GBP)|glucose binding protein (gbp)
5416938|NCT01645566|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5416939|NCT01645566|stress|stress
5416940|NCT01645566|intervention|intervention
5416941|NCT01645475|enuresis|enuresis
5416942|NCT01645449|Bioequivalence|bioequivalence
5416943|NCT01645449|Atorvastatin calcium|atorvastatin calcium
5416944|NCT01645449|crossover|crossover
5416945|NCT01645436|randomized controlled trial|randomized controlled trial
5416946|NCT01645436|in-hospital exercise|in-hospital exercise
5416947|NCT01645436|children|children
5416948|NCT01645436|cancer|cancer
5416949|NCT01645423|Bioequivalence|bioequivalence
5416950|NCT01645423|Atorvastatin calcium|atorvastatin calcium
5416951|NCT01645423|crossover|crossover
5416952|NCT01645410|Bioequivalence|bioequivalence
5416953|NCT01645410|Atorvastatin calcium|atorvastatin calcium
5416954|NCT01645410|crossover|crossover
5416955|NCT01645397|Asthma|asthma
5416956|NCT01645397|Deep inhalation|deep inhalation
5416957|NCT01645397|Exhaled nitric oxide|exhaled nitric oxide
5416958|NCT01645384|Bioequivalence|bioequivalence
5416959|NCT01645384|Atorvastatin calcium|atorvastatin calcium
5416960|NCT01645384|crossover|crossover
5416961|NCT01645371|opioid-induced constipation|opioid-induced constipation
5416962|NCT01645358|COPD|copd
5416963|NCT01645358|NIV|niv
5416964|NCT01645358|Acute Hypercapnic Respiratory Failure|acute hypercapnic respiratory failure
5416965|NCT01645358|COPD patients with hypercapnic respiratory failure|copd patients with hypercapnic respiratory failure
5416966|NCT01645345|wrinkles|wrinkles
5416967|NCT01645345|acne scars|acne scars
5416968|NCT01645332|DLBS3233|dlbs3233
5416969|NCT01645332|new onset|new onset
5416970|NCT01645332|type-2-diabetes mellitus|type-2-diabetes mellitus
5416971|NCT01645332|oral anti-hyperglycemic agent|oral anti-hyperglycemic agent
5416972|NCT01645280|Active rheumatoid arthritis|active rheumatoid arthritis
5416973|NCT01645280|Ustekinumab|ustekinumab
5416974|NCT01645280|STELARA|stelara
5416975|NCT01645280|CNTO 1959|cnto 1959
5416976|NCT01645254|healthy volunteers|healthy volunteers
5416977|NCT01645254|pharmacokinetics|pharmacokinetics
5416978|NCT01645254|malaria|malaria
5416979|NCT01645254|Argemone mexicana|argemone mexicana
5416980|NCT01645241|Ovarian stimulation|ovarian stimulation
5416981|NCT01645241|Luteal phase|luteal phase
5416982|NCT01645241|Egg donors|egg donors
5416983|NCT01645241|Fertility preservation|fertility preservation
5416984|NCT01645202|Aortic stenosis|aortic stenosis
5416985|NCT01645202|TAVI|tavi
5416986|NCT01645202|Device success|device success
5416987|NCT01645202|Aortic regurgitation|aortic regurgitation
5416988|NCT01645189|Hunter syndrome|hunter syndrome
5416989|NCT01645189|idursulfase-beta|idursulfase-beta
5416990|NCT01645189|Hunterase|hunterase
5416991|NCT01645189|GC1111|gc1111
5416993|NCT01645176|Knee|knee
5416994|NCT01645163|mHealth|mhealth
5416995|NCT01645163|Complementary feeding|complementary feeding
5416996|NCT01645163|ICDS|icds
5416997|NCT01645150|physical activity|physical activity
5416998|NCT01645150|exercise|exercise
5416999|NCT01645150|training|training
5417000|NCT01645150|fatigue|fatigue
5417001|NCT01645150|cancer|cancer
5417004|NCT01645137|prematurity|prematurity
5417005|NCT01645137|OMT|omt
5417006|NCT01645137|complementary and alternative medicine|complementary and alternative medicine
5417007|NCT01645137|neonates|neonates
5417008|NCT01645137|length of stay|length of stay
5417009|NCT01645124|Polycythemia|polycythemia
5417010|NCT01645124|Hematocrit|hematocrit
5417011|NCT01645124|Thrombosis|thrombosis
5417012|NCT01645085|R406|r406
5417013|NCT01645085|Fostamatinib|fostamatinib
5417014|NCT01645085|Phase I|phase i
5417015|NCT01645085|Healthy Subjects|healthy subjects
5417016|NCT01645085|Pharmacokinetics|pharmacokinetics
5417017|NCT01645085|Bioequivalence|bioequivalence
5417018|NCT01645072|Drug refractory epilepsy|drug refractory epilepsy
5389438|NCT01770158|Interleukin-2|interleukin-2
5417026|NCT01645020|Prolift|prolift
5417027|NCT01645020|Prolift + M|prolift + m
5417028|NCT01645020|mesh related complications|mesh related complications
5417029|NCT01645007|Hepatitis B|hepatitis b
5417030|NCT01645007|Prevalence|prevalence
5417031|NCT01645007|HBsAg|hbsag
5417032|NCT01645007|Vaccination|vaccination
5417033|NCT01645007|Galilee|galilee
5417034|NCT01644968|metastatic carcinoma|metastatic carcinoma
5417035|NCT01644968|lymphoma|lymphoma
5417036|NCT01644968|sarcoma|sarcoma
5417037|NCT01644968|anti-OX40|anti-ox40
5417038|NCT01644955|Gliomas|gliomas
5417039|NCT01644955|Carboplatin|carboplatin
5417040|NCT01644942|Obese|obese
5417041|NCT01644942|insulin sensitive|insulin sensitive
5417042|NCT01644942|insulin resistant|insulin resistant
5417043|NCT01644942|myotubes|myotubes
5417044|NCT01644942|lipid accumulation|lipid accumulation
5417045|NCT01644929|hemiparesis|hemiparesis
5417046|NCT01644929|bihemispheric transcranial direct current stimulation|bihemispheric transcranial direct current stimulation
5417047|NCT01644929|ischemic stroke|ischemic stroke
5417048|NCT01644929|subacute|subacute
5417049|NCT01644929|rehabilitation|rehabilitation
5417050|NCT01644929|physiotherapy|physiotherapy
5417051|NCT01644929|ergotherapy|ergotherapy
5417052|NCT01644916|COPD|copd
5417053|NCT01644916|Integrated care|integrated care
5417054|NCT01644916|IPCL|ipcl
5417055|NCT01644890|NK105, Paclitaxel, Breast cancer, Micelle|nk105, paclitaxel, breast cancer, micelle
5417056|NCT01644851|veterans|veterans
5417057|NCT01644851|neuropsychology|neuropsychology
5417058|NCT01644851|neuroimaging|neuroimaging
5417059|NCT01644851|attention|attention
5417060|NCT01644851|working memory|working memory
5417061|NCT01644851|inhibition|inhibition
5399872|NCT01722214|Ascending aorta|ascending aorta
5417062|NCT01644851|magnetic resonance imaging, functional|magnetic resonance imaging, functional
5417063|NCT01644851|trauma|trauma
5417064|NCT01644851|stress|stress
5417065|NCT01644851|anxiety|anxiety
5417066|NCT01644851|emotion|emotion
5417067|NCT01644851|prefrontal cortex|prefrontal cortex
5417068|NCT01644838|Hyoscine,|hyoscine,
5417069|NCT01644838|Promethazine,|promethazine,
5417070|NCT01644838|The first stage of labor,|the first stage of labor,
5417071|NCT01644838|Labor pain|labor pain
5417072|NCT01644825|platinum resistant|platinum resistant
5417073|NCT01644825|platinum refractory|platinum refractory
5417074|NCT01644799|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417495|NCT01643057|Neonatal|neonatal
5417075|NCT01644799|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417076|NCT01644799|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417077|NCT01644786|head and neck|head and neck
5417078|NCT01644786|HNSCC|hnscc
5417079|NCT01644786|orophaynx|orophaynx
5417080|NCT01644786|hypopharynx|hypopharynx
5417081|NCT01644786|larynx|larynx
5417082|NCT01644786|nasopharynx|nasopharynx
5417083|NCT01644786|oral cavity|oral cavity
5417084|NCT01644786|prospective study|prospective study
5417085|NCT01644786|predictive models for HNSCC|predictive models for hnscc
5417086|NCT01644786|genomic analyses|genomic analyses
5417087|NCT01644786|outcome prediction|outcome prediction
5417088|NCT01644760|Diaphragmatic excursion|diaphragmatic excursion
5417089|NCT01644760|normality|normality
5417090|NCT01644747|Resistant Depression|resistant depression
5417091|NCT01644747|Moods disorders|moods disorders
5417092|NCT01644747|Unipolar depression|unipolar depression
5417093|NCT01644747|Bipolar disorder|bipolar disorder
5417095|NCT01644721|Child mortality|child mortality
5417096|NCT01644721|Measles vaccine|measles vaccine
5417097|NCT01644721|Non-specific effects|non-specific effects
5417098|NCT01644708|Obesity|obesity
5417099|NCT01644708|Overweight|overweight
5417100|NCT01644708|Individual empowerment|individual empowerment
5417101|NCT01644708|Physical parameters|physical parameters
5417102|NCT01644708|Self esteem|self esteem
5417103|NCT01644695|BARS|bars
5420337|NCT01629459|exercise|exercise
5417104|NCT01644695|Bony Anchoring Reinforcement System|bony anchoring reinforcement system
5417106|NCT01644695|Incisional|incisional
5417107|NCT01644695|Recurrent|recurrent
5417108|NCT01644695|abdominal wall reconstruction|abdominal wall reconstruction
5417109|NCT01644695|abdominal wall defect|abdominal wall defect
5417110|NCT01644695|mesh|mesh
5417111|NCT01644695|component separation|component separation
5417112|NCT01644682|Visceral leishmaniasis|visceral leishmaniasis
5417113|NCT01644682|insecticide|insecticide
5417114|NCT01644682|wall lining|wall lining
5417127|NCT01644604|Vascular Diseases|vascular diseases
5417128|NCT01644604|Cardiovascular Diseases|cardiovascular diseases
5417129|NCT01644604|Renal denervation|renal denervation
5417130|NCT01644578|MRI|mri
5417131|NCT01644578|real-time imaging|real-time imaging
5417132|NCT01644578|workflow|workflow
5417133|NCT01644552|aniridia|aniridia
5417134|NCT01644552|positive angle kappa|positive angle kappa
5417135|NCT01644539|Satiation|satiation
5417136|NCT01644539|Brain activation|brain activation
5417137|NCT01644539|Gut peptides|gut peptides
5417138|NCT01644526|dialysis|dialysis
5417139|NCT01644526|vascular access|vascular access
5417140|NCT01644526|arteriovenous grafts|arteriovenous grafts
5417141|NCT01644526|valve system|valve system
5417142|NCT01644513|Age Related Macular Degeneration|age related macular degeneration
5417143|NCT01644513|Choroidal Neovascular|choroidal neovascular
5417144|NCT01644513|anti-VEGF Therapy|anti-vegf therapy
5417145|NCT01644409|OAB|oab
5417146|NCT01644409|Overactive bladder|overactive bladder
5417147|NCT01644409|Urgency|urgency
5417148|NCT01644409|Incontinence|incontinence
5417149|NCT01644396|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5417150|NCT01644383|meaning of life|meaning of life
5417151|NCT01644383|logotherapy|logotherapy
5417152|NCT01644383|HIV-infected teenagers|hiv-infected teenagers
5417153|NCT01644383|adherence|adherence
5417154|NCT01644370|HIV-infected children|hiv-infected children
5417155|NCT01644370|T cell response|t cell response
5417156|NCT01644370|asthma|asthma
5417157|NCT01644292|Mobility Impairment|mobility impairment
5417158|NCT01644292|Manual Wheelchair|manual wheelchair
5417159|NCT01644292|Older Adults|older adults
5417160|NCT01644279|aging|aging
5417161|NCT01644279|sarcopenia|sarcopenia
5417162|NCT01644279|mitochondria|mitochondria
5417163|NCT01644279|skeletal muscle|skeletal muscle
5417164|NCT01644279|apoptosis|apoptosis
5417165|NCT01644253|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5417166|NCT01644253|CLL|cll
5417167|NCT01644253|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
5417168|NCT01644253|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5417169|NCT01644253|PTCL|ptcl
5417170|NCT01644227|Hip surgery|hip surgery
5417171|NCT01644227|dual mobility cup|dual mobility cup
5417172|NCT01644227|dislocation|dislocation
5417173|NCT01644227|total hip arthroplasty|total hip arthroplasty
5417174|NCT01644214|Pelvic organ prolapse|pelvic organ prolapse
5417175|NCT01644214|Pessary|pessary
5417176|NCT01644162|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
5417177|NCT01644162|Disease Exacerbation|disease exacerbation
5417178|NCT01644162|Respiratory Failure|respiratory failure
5417179|NCT01644149|Jet Injector|jet injector
5417180|NCT01644149|Stratis®|stratis®
5417181|NCT01644149|PharmaJet|pharmajet
5417182|NCT01644149|Jet Injection|jet injection
5417183|NCT01644123|Spasticity|spasticity
5417184|NCT01644123|Diagnostic Algorithm|diagnostic algorithm
5417185|NCT01644097|Quality of Life|quality of life
5417186|NCT01644084|albumin|albumin
5417187|NCT01644084|hydroxyethyl starch 130/0.4|hydroxyethyl starch 130/0.4
5417188|NCT01644084|cardiopulmonary bypass|cardiopulmonary bypass
5417189|NCT01644071|violent video games|violent video games
5417190|NCT01644071|serotonergic system|serotonergic system
5417191|NCT01644058|immediate-loading|immediate-loading
5417192|NCT01644058|patient-based outcomes|patient-based outcomes
5417193|NCT01644045|Asthma|asthma
5417194|NCT01644045|COPD|copd
5417195|NCT01644045|emergency medical service|emergency medical service
5417196|NCT01644045|teleconsultation|teleconsultation
5417197|NCT01644045|telemedicine|telemedicine
5417198|NCT01644032|telemedicine|telemedicine
5417199|NCT01644032|teleconsultation|teleconsultation
5417200|NCT01644032|analgesia|analgesia
5417201|NCT01644032|emergency|emergency
5417202|NCT01644032|prehospital|prehospital
5417203|NCT01644019|stroke|stroke
5417204|NCT01644019|teleconsultation|teleconsultation
5417205|NCT01644019|telemedicine|telemedicine
5417215|NCT01643967|diabetes Mellitus|diabetes mellitus
5417217|NCT01643954|surgery|surgery
5417218|NCT01643954|prostate cancer|prostate cancer
5417219|NCT01643941|Staphylococcus aureus|staphylococcus aureus
5417220|NCT01643941|vaccine|vaccine
5417221|NCT01643941|Staphylococcal infection|staphylococcal infection
5417222|NCT01643928|extension trial|extension trial
5417223|NCT01643928|rheumatoid arthritis|rheumatoid arthritis
5417224|NCT01643928|rituximab|rituximab
5417225|NCT01643915|Audiovisual distraction|audiovisual distraction
5417226|NCT01643915|Pediatric dentistry|pediatric dentistry
5417227|NCT01643902|Stroke|stroke
5417228|NCT01643902|Wake up|wake up
5417229|NCT01643902|IV tPA|iv tpa
5417230|NCT01643902|Thrombolytic|thrombolytic
5417231|NCT01643889|Healthy|healthy
5417232|NCT01643889|Domperidone|domperidone
5417233|NCT01643889|Cardiac Repolarization|cardiac repolarization
5417234|NCT01643876|Denture stomatitis|denture stomatitis
5417235|NCT01643876|Denture Plaque|denture plaque
5417236|NCT01643876|Oral Candidiasis|oral candidiasis
5417237|NCT01643876|Oral Hygiene|oral hygiene
5417245|NCT01643837|Mastalgia|mastalgia
5417246|NCT01643837|Breast Pain|breast pain
5417247|NCT01643837|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5417248|NCT01643837|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5417249|NCT01643811|early gastric cancer, diabetes, hypertension|early gastric cancer, diabetes, hypertension
5417250|NCT01643785|therapeutic efficacy endonase addictive effect|therapeutic efficacy endonase addictive effect
5417251|NCT01643759|osteoarthritis disorders|osteoarthritis disorders
5417252|NCT01643733|Angioplasty|angioplasty
5417253|NCT01643707|Sick Sinus Syndrome|sick sinus syndrome
5417254|NCT01643707|Bradycardia|bradycardia
5417255|NCT01643616|Sciatic Nerve|sciatic nerve
5417256|NCT01643616|Ultrasound|ultrasound
5417257|NCT01643616|Anesthesia, Regional|anesthesia, regional
5417258|NCT01643616|Orthopedic Surgery|orthopedic surgery
5417259|NCT01643603|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5417260|NCT01643603|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5417261|NCT01643603|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5417262|NCT01643603|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5417263|NCT01643603|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5417264|NCT01643603|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5417265|NCT01643603|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5417266|NCT01643603|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5417267|NCT01643603|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5417268|NCT01643603|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5417496|NCT01643044|pregnancy|pregnancy
5417269|NCT01643603|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5417270|NCT01643603|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5417271|NCT01643603|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5417272|NCT01643603|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5417273|NCT01643603|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5417274|NCT01643603|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5417275|NCT01643603|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5417276|NCT01643603|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5417277|NCT01643603|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5417278|NCT01643603|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5417279|NCT01643603|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5417280|NCT01643603|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5417281|NCT01643603|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5417282|NCT01643603|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5417283|NCT01643603|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5417284|NCT01643603|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5417287|NCT01643603|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5417288|NCT01643603|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5417289|NCT01643603|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5417290|NCT01643603|intraocular lymphoma|intraocular lymphoma
5417291|NCT01643603|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5417292|NCT01643603|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5417293|NCT01643603|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5417294|NCT01643603|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5412251|NCT01667978|HIV|hiv
5417295|NCT01643603|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5417296|NCT01643603|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5417297|NCT01643603|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5417298|NCT01643603|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5417299|NCT01643603|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5417300|NCT01643603|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5417301|NCT01643603|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5417302|NCT01643603|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5417303|NCT01643603|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5417304|NCT01643603|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5417305|NCT01643603|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5417306|NCT01643603|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5417307|NCT01643603|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5417308|NCT01643603|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5417309|NCT01643603|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5417310|NCT01643603|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5417311|NCT01643603|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5417312|NCT01643603|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5417313|NCT01643603|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5389740|NCT01768832|walking|walking
5417314|NCT01643603|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5417315|NCT01643603|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5417316|NCT01643603|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5417317|NCT01643603|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5417318|NCT01643603|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5417319|NCT01643603|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5417320|NCT01643603|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5417321|NCT01643603|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5417322|NCT01643603|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5417323|NCT01643603|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5417324|NCT01643603|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5417325|NCT01643603|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5417326|NCT01643603|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5417327|NCT01643603|refractory hairy cell leukemia|refractory hairy cell leukemia
5417328|NCT01643603|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5417329|NCT01643603|small intestine lymphoma|small intestine lymphoma
5417330|NCT01643603|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5417331|NCT01643603|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5417332|NCT01643603|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5417333|NCT01643603|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5417334|NCT01643603|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5417335|NCT01643603|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5417336|NCT01643603|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5417337|NCT01643603|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5417338|NCT01643603|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5417339|NCT01643603|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5417340|NCT01643603|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5417341|NCT01643603|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5417342|NCT01643603|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5417343|NCT01643603|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5417344|NCT01643603|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5417345|NCT01643603|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5417346|NCT01643603|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5417347|NCT01643603|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
5417348|NCT01643603|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
5417349|NCT01643603|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5417350|NCT01643603|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5417351|NCT01643603|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5417352|NCT01643603|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
5417353|NCT01643603|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
5417354|NCT01643603|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5417355|NCT01643603|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5417356|NCT01643603|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5417357|NCT01643603|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5417358|NCT01643603|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5417359|NCT01643603|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5417360|NCT01643603|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5417361|NCT01643603|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5417362|NCT01643603|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5417363|NCT01643603|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5417364|NCT01643603|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5417365|NCT01643603|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5417366|NCT01643603|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5417368|NCT01643603|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5417369|NCT01643603|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5417370|NCT01643603|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
5417371|NCT01643603|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
5417372|NCT01643603|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5417373|NCT01643603|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5417374|NCT01643603|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5417375|NCT01643603|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5417376|NCT01643603|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5417377|NCT01643603|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5417378|NCT01643603|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5417379|NCT01643603|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5417380|NCT01643603|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5417381|NCT01643603|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5417382|NCT01643603|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5417383|NCT01643603|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5417384|NCT01643603|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5417385|NCT01643603|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5417386|NCT01643603|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5417387|NCT01643603|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5417388|NCT01643603|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
5417389|NCT01643603|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
5417390|NCT01643603|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5417391|NCT01643603|testicular lymphoma|testicular lymphoma
5417392|NCT01643603|Waldenström macroglobulinemia|waldenström macroglobulinemia
5417394|NCT01643577|gastroparesis|gastroparesis
5417395|NCT01643577|delayed gastric emptying|delayed gastric emptying
5417397|NCT01643577|vomiting|vomiting
5417398|NCT01643577|abdominal pain|abdominal pain
5417399|NCT01643577|bloating|bloating
5417400|NCT01643564|Transplant|transplant
5417401|NCT01643564|Cytokines|cytokines
5417402|NCT01643564|Graft Dysfunction|graft dysfunction
5417403|NCT01643551|Heart Failure|heart failure
5417404|NCT01643551|Left Ventricular Assist Device|left ventricular assist device
5417405|NCT01643551|Reperfusion Injury|reperfusion injury
5417406|NCT01643551|Neuron Specific Enolase|neuron specific enolase
5417407|NCT01643538|physical activity|physical activity
5417408|NCT01643538|adults age 65 and older|adults age 65 and older
5417409|NCT01643538|financial incentives|financial incentives
5417410|NCT01643525|Ischemic Stroke|ischemic stroke
5417411|NCT01643486|peritoneal dialysis|peritoneal dialysis
5417412|NCT01643486|phosphate|phosphate
5417413|NCT01643486|iTouch|itouch
5417414|NCT01643473|Hypertension|hypertension
5417415|NCT01643473|Latinos|latinos
5417416|NCT01643473|Medication Adherence|medication adherence
5417420|NCT01643460|Intraductal papillary mucinous neoplasms (IPMNs)|intraductal papillary mucinous neoplasms (ipmns)
5417422|NCT01643460|Invasive IPMNs or mucinous cystadenocarcinomas) tumors|invasive ipmns or mucinous cystadenocarcinomas) tumors
5417423|NCT01643447|Hepatocellular Carcinoma|hepatocellular carcinoma
5417424|NCT01643447|Ulinastatin|ulinastatin
5417425|NCT01643447|Hepatic Failure|hepatic failure
5417426|NCT01643434|Resistant Hypertension|resistant hypertension
5417427|NCT01643408|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5417428|NCT01643408|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5417429|NCT01643408|Erwinaze|erwinaze
5417430|NCT01643408|asparaginase|asparaginase
5417431|NCT01643408|Eusa Pharma|eusa pharma
5417432|NCT01643408|Pharmacokinetic study|pharmacokinetic study
5417433|NCT01643408|NSAA|nsaa
5417434|NCT01643395|Trauma|trauma
5417435|NCT01643395|vertebral|vertebral
5417436|NCT01643395|compression fracture|compression fracture
5417437|NCT01643395|spinal|spinal
5417438|NCT01643395|acute|acute
5417439|NCT01643395|vertebroplasty|vertebroplasty
5417453|NCT01643343|autism spectrum disorders|autism spectrum disorders
5417454|NCT01643343|autism|autism
5417455|NCT01643343|joint attention|joint attention
5417456|NCT01643343|imitation|imitation
5417457|NCT01643343|fluency|fluency
5417458|NCT01643330|Cardiomegaly|cardiomegaly
5417459|NCT01643330|Heart Diseases|heart diseases
5417460|NCT01643330|Cardiovascular Diseases|cardiovascular diseases
5417461|NCT01643304|Menorrhagia|menorrhagia
5417462|NCT01643304|Heavy menstrual bleeding|heavy menstrual bleeding
5417463|NCT01643304|Uterine Hemorrhage|uterine hemorrhage
5417464|NCT01643304|Menstruation Disturbancies|menstruation disturbancies
5417465|NCT01643252|Corneal Ectasia|corneal ectasia
5417466|NCT01643252|Refractive surgery|refractive surgery
5417467|NCT01643252|Cross-Linking|cross-linking
5417468|NCT01643239|Modified constraint-induced therapy|modified constraint-induced therapy
5417469|NCT01643239|Children with cerebral palsy|children with cerebral palsy
5417470|NCT01643239|Kinematic analysis|kinematic analysis
5417471|NCT01643239|Group therapy|group therapy
5417472|NCT01643148|biomarker|biomarker
5417473|NCT01643148|BMI|bmi
5417474|NCT01643148|breast cancer|breast cancer
5417475|NCT01643148|CA-15-3|ca-15-3
5417476|NCT01643148|leptin|leptin
5417477|NCT01643135|tranexamic acid|tranexamic acid
5417478|NCT01643135|bleeding|bleeding
5417479|NCT01643135|blood transfusion|blood transfusion
5417480|NCT01643135|spine surgery|spine surgery
5417481|NCT01643122|Endometriosis, Validation study|endometriosis, validation study
5417482|NCT01643109|Cerebral Palsy|cerebral palsy
5417483|NCT01643109|Hemiplegia|hemiplegia
5417484|NCT01643109|Constraint Induced Movement Therapy|constraint induced movement therapy
5417485|NCT01643096|Zataria multiflora Boiss Sumac TEF temperament|zataria multiflora boiss sumac tef temperament
5417486|NCT01643083|Post-prandial distress syndrome|post-prandial distress syndrome
5417487|NCT01643070|Rectal cancer|rectal cancer
5417488|NCT01643070|Liver metastases|liver metastases
5417489|NCT01643070|Capecitabine|capecitabine
5417490|NCT01643070|Oxaliplatin|oxaliplatin
5417491|NCT01643057|Apnea|apnea
5417492|NCT01643057|Prematurity|prematurity
5417493|NCT01643057|Biomarkers|biomarkers
5417494|NCT01643057|Stochastic Resonance|stochastic resonance
5417497|NCT01643044|screening|screening
5417498|NCT01643044|motivation|motivation
5417499|NCT01643031|Diabetes|diabetes
5417500|NCT01643031|Platelets aggregation inhibitors|platelets aggregation inhibitors
5417501|NCT01643031|Platelet function tests|platelet function tests
5417502|NCT01643018|cystic echinococcosis|cystic echinococcosis
5417503|NCT01643018|liver cyst hydatique|liver cyst hydatique
5417504|NCT01643018|treatment|treatment
5417505|NCT01643018|surgery|surgery
5417506|NCT01643018|laparoscopy|laparoscopy
5417508|NCT01642992|Coronary bifurcation lesion|coronary bifurcation lesion
5417509|NCT01642992|Drug-eluting stent|drug-eluting stent
5417510|NCT01642979|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5417511|NCT01642979|Anemia|anemia
5417512|NCT01642979|Hematologic Diseases|hematologic diseases
5417513|NCT01642979|bone marrow failure|bone marrow failure
5420841|NCT01627067|Aromasin|aromasin
5417514|NCT01642979|Immunologic Factors|immunologic factors
5417515|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs
5417516|NCT01642979|Levamisole|levamisole
5417517|NCT01642979|cyclosporine A|cyclosporine a
5417518|NCT01642966|ticagrelor|ticagrelor
5417519|NCT01642966|doppler echocardiography|doppler echocardiography
5417520|NCT01642953|Gastric cancer surgery|gastric cancer surgery
5417521|NCT01642953|Early oral feeding|early oral feeding
5417522|NCT01642953|Fast track surgery|fast track surgery
5417523|NCT01642927|LVAD|lvad
5417524|NCT01642927|IABP|iabp
5417525|NCT01642927|Heart Failure|heart failure
5417526|NCT01642927|Thrombosis|thrombosis
5417527|NCT01642927|Hemorrhage|hemorrhage
5417528|NCT01642914|Chronic Constipation|chronic constipation
5417529|NCT01642914|Abdominal Bloating|abdominal bloating
5417531|NCT01642901|spinal cord injury|spinal cord injury
5417532|NCT01642901|bone mineral density|bone mineral density
5417533|NCT01642875|Periampullary tumor|periampullary tumor
5417534|NCT01642875|Chronic pancreatitis|chronic pancreatitis
5417535|NCT01642875|Pancreatoduodenectomy|pancreatoduodenectomy
5417536|NCT01642875|Oral Nutrition|oral nutrition
5417537|NCT01642875|Enteral Nutrition|enteral nutrition
5417538|NCT01642849|high protein diet|high protein diet
5417539|NCT01642849|high carbohydrate diet|high carbohydrate diet
5402896|NCT01708811|human|human
5417540|NCT01642849|weight loss|weight loss
5417541|NCT01642849|oxidative stress|oxidative stress
5417542|NCT01642849|inflammation|inflammation
5417543|NCT01642849|cardiovascular risk factors|cardiovascular risk factors
5417544|NCT01642823|retinoblastoma|retinoblastoma
5417545|NCT01642810|Online treatment for Fibromyalgia Syndrome|online treatment for fibromyalgia syndrome
5417546|NCT01642810|Acceptance-based behavioural treatment|acceptance-based behavioural treatment
5417547|NCT01642797|confocal laser endomicroscopy|confocal laser endomicroscopy
5417548|NCT01642797|gastric intestinal metaplasia|gastric intestinal metaplasia
5417549|NCT01642797|gastric intraepithelial neoplasia|gastric intraepithelial neoplasia
5417550|NCT01642797|gastric carcinoma|gastric carcinoma
5417551|NCT01642784|STEMI|stemi
5417552|NCT01642784|NSTEMI|nstemi
5417553|NCT01642784|revascularization|revascularization
5417554|NCT01642784|stents|stents
5417555|NCT01642771|Triple-negative Breast Cancer|triple-negative breast cancer
5417556|NCT01642771|Post-operative adjuvant Chemotherapy|post-operative adjuvant chemotherapy
5417557|NCT01642771|Docetaxel|docetaxel
5417558|NCT01642771|Capecitabine|capecitabine
5417559|NCT01642771|Epirubicin|epirubicin
5417560|NCT01642771|Cyclophosphamide|cyclophosphamide
5417561|NCT01642771|Fluorouracil|fluorouracil
5417562|NCT01642758|Thalassemia intermedia|thalassemia intermedia
5417563|NCT01642758|Fetal hemoglobin|fetal hemoglobin
5417564|NCT01642758|Hemoglobin|hemoglobin
5417565|NCT01642732|Prostate|prostate
5417566|NCT01642732|Cancer|cancer
5417567|NCT01642732|Everolimus|everolimus
5417568|NCT01642732|Radiation|radiation
5417569|NCT01642719|Sleep disturbance|sleep disturbance
5417570|NCT01642719|Aging|aging
5417571|NCT01642719|Sleep restriction|sleep restriction
5417572|NCT01642719|Health status|health status
5417573|NCT01642719|Glucose tolerance|glucose tolerance
5417574|NCT01642719|Inflammation|inflammation
5417575|NCT01642706|Regulatory B cells|regulatory b cells
5417576|NCT01642706|Rheumatoid arthritis|rheumatoid arthritis
5417577|NCT01642706|Biomarker|biomarker
5417578|NCT01642693|root resorption|root resorption
5417579|NCT01642693|low-power laser|low-power laser
5417580|NCT01642693|orthodontic tooth movement|orthodontic tooth movement
5417581|NCT01642693|pulp changes|pulp changes
5417582|NCT01642680|Physical activity program|physical activity program
5417583|NCT01642680|Chemotherapy|chemotherapy
5417584|NCT01642680|Metabolic syndrome|metabolic syndrome
5417585|NCT01642680|Reducing cardiovascular risk factors|reducing cardiovascular risk factors
5417586|NCT01642680|low physical activity level|low physical activity level
5417587|NCT01642628|Mirror|mirror
5417588|NCT01642628|Body Image|body image
5417589|NCT01642628|Mastectomy|mastectomy
5417590|NCT01642615|Drug therapy|drug therapy
5417591|NCT01642602|Drug Therapy|drug therapy
5417592|NCT01642589|Meningitis|meningitis
5417593|NCT01642589|Meningococcal disease|meningococcal disease
5417594|NCT01642589|Menactra®|menactra®
5417595|NCT01642589|Adacel®|adacel®
5417596|NCT01642576|obesity|obesity
5417597|NCT01642576|men|men
5417598|NCT01642576|sexual function|sexual function
5417599|NCT01642576|urinary tract symptoms|urinary tract symptoms
5417600|NCT01642576|endothelial function|endothelial function
5417601|NCT01642576|inflammation|inflammation
5417602|NCT01642576|quality of life|quality of life
5417603|NCT01642563|Platelet transfusion|platelet transfusion
5417604|NCT01642563|Leukemia|leukemia
5417605|NCT01642563|Transfusion transmissible infections|transfusion transmissible infections
5417606|NCT01642563|Chemotherapy|chemotherapy
5417607|NCT01642563|Allogeneic hemopoietic stem cell transplant|allogeneic hemopoietic stem cell transplant
5417608|NCT01642550|Anorexia nervosa|anorexia nervosa
5417609|NCT01642550|Anorexia|anorexia
5417610|NCT01642550|Eating disorders|eating disorders
5417611|NCT01642524|resuscitation|resuscitation
5417612|NCT01642511|Breast Cancer|breast cancer
5417613|NCT01642511|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5417614|NCT01642511|Internal Mammary|internal mammary
5417615|NCT01642511|Lymphoscintigraphy|lymphoscintigraphy
5417616|NCT01642498|High Blood Pressure|high blood pressure
5417617|NCT01642498|Hypertension|hypertension
5417618|NCT01642498|Resistant Hypertension|resistant hypertension
5417619|NCT01642485|Insulin clamp|insulin clamp
5417620|NCT01642485|Glucose clamp|glucose clamp
5417621|NCT01642485|Moxifloxacin|moxifloxacin
5417623|NCT01642485|Fasted|fasted
5417624|NCT01642485|QT/QTC interval|qt/qtc interval
5417625|NCT01642485|TQT|tqt
5417626|NCT01642485|ECG|ecg
5417627|NCT01642485|Meal effects|meal effects
5417628|NCT01642485|C Peptide|c peptide
5417631|NCT01642485|FDA standard breakfast|fda standard breakfast
5417632|NCT01642485|Adaptive study design|adaptive study design
5417633|NCT01642459|arteriovenous fistula|arteriovenous fistula
5417635|NCT01642459|aneurysm|aneurysm
5417636|NCT01642459|vascular stenosis|vascular stenosis
5417637|NCT01642459|cannulation|cannulation
5417638|NCT01642446|precise hepatectomy|precise hepatectomy
5417639|NCT01642446|hepatocellular carcinoma|hepatocellular carcinoma
5417640|NCT01642446|cirrhotic|cirrhotic
5417641|NCT01642446|portal hypertension|portal hypertension
5417642|NCT01642446|safety|safety
5417643|NCT01642446|combined interventional treatment|combined interventional treatment
5417644|NCT01642394|Diabetes Mellitus|diabetes mellitus
5417645|NCT01642394|Chronic Disease|chronic disease
5417646|NCT01642394|Education|education
5417647|NCT01642394|Primary Care|primary care
5417648|NCT01642394|Self care|self care
5417649|NCT01642394|Self Management|self management
5417650|NCT01642381|Drinking|drinking
5417651|NCT01642381|Alcohol Problems|alcohol problems
5417652|NCT01642381|Alcoholism|alcoholism
5417653|NCT01642381|Moderation-Oriented Treatment|moderation-oriented treatment
5417654|NCT01642381|Controlled Drinking|controlled drinking
5417655|NCT01642381|Reduced Drinking|reduced drinking
5417656|NCT01642381|Heavy Drinking|heavy drinking
5417657|NCT01642381|Problematic Drinking|problematic drinking
5417658|NCT01642381|Non-Abstinence-based Drinking|non-abstinence-based drinking
5417659|NCT01642368|Omega-3 fatty acids|omega-3 fatty acids
5417660|NCT01642368|Omega-3 to omega-6 ratio|omega-3 to omega-6 ratio
5417661|NCT01642368|Cognitive response|cognitive response
5417662|NCT01642368|Physical performance|physical performance
5417663|NCT01642329|Myocardial Infarction|myocardial infarction
5417664|NCT01642329|Angina, Unstable|angina, unstable
5417665|NCT01642316|washback, reading comprehension|washback, reading comprehension
5417666|NCT01642303|vodcasting,listening,language education|vodcasting,listening,language education
5417667|NCT01642277|Overactive Bladder|overactive bladder
5417668|NCT01642277|OAB|oab
5417669|NCT01642277|Urinary Tract Infection|urinary tract infection
5417670|NCT01642277|UTI|uti
5417671|NCT01642277|Microbiome|microbiome
5417672|NCT01642277|Bacteria|bacteria
5417673|NCT01642277|Solifenacin|solifenacin
5417674|NCT01642277|16S rRNA sequence|16s rrna sequence
5417675|NCT01642264|Tobacco Cessation|tobacco cessation
5417676|NCT01642264|Continuing Education|continuing education
5417677|NCT01642264|Pediatric|pediatric
5417678|NCT01642264|Respiratory Therapist|respiratory therapist
5417679|NCT01642264|Nurse|nurse
5417680|NCT01642251|Veliparib|veliparib
5417681|NCT01642251|Small cell lung cancer|small cell lung cancer
5417682|NCT01642238|Antiplatelet|antiplatelet
5417683|NCT01642238|ticagrelor|ticagrelor
5417684|NCT01642238|clopidogrel|clopidogrel
5417685|NCT01642238|bivalirudin|bivalirudin
5417686|NCT01642238|thrombosis|thrombosis
5417688|NCT01642199|obesity|obesity
5417689|NCT01642199|weight loss|weight loss
5417690|NCT01642199|lay health coach|lay health coach
5417691|NCT01642199|peer coach|peer coach
5417692|NCT01642199|mentor coach|mentor coach
5417693|NCT01642199|reduced intensity weight loss program|reduced intensity weight loss program
5417694|NCT01642186|LETROZOLE|letrozole
5417695|NCT01642186|LUPRON DEPOT|lupron depot
5417696|NCT01642186|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5417697|NCT01642186|11-211|11-211
5417698|NCT01642147|Cerebral blood flow|cerebral blood flow
5417699|NCT01642147|Transcranial Doppler|transcranial doppler
5417700|NCT01642147|Emergence from general anesthesia|emergence from general anesthesia
5417701|NCT01642134|Antiplatelet|antiplatelet
5417702|NCT01642134|Anticoagulation|anticoagulation
5417703|NCT01642056|Oxidative Stress|oxidative stress
5417704|NCT01642056|Oxidative Phosphorylation|oxidative phosphorylation
5417705|NCT01642056|Mitochondrial Disease|mitochondrial disease
5417706|NCT01642043|greater trochanteric pain syndrome|greater trochanteric pain syndrome
5417707|NCT01642043|trochanteric bursitis|trochanteric bursitis
5417708|NCT01642043|lateral hip pain|lateral hip pain
5417709|NCT01642030|Quantitative sensory testing|quantitative sensory testing
5417710|NCT01642030|Cold pressor test|cold pressor test
5417711|NCT01642030|Opioid dependence|opioid dependence
5417712|NCT01642030|Methadone maintenance|methadone maintenance
5417713|NCT01642030|Buprenorphine maintenance|buprenorphine maintenance
5417714|NCT01642030|Abuse liability|abuse liability
5417715|NCT01642030|Diffuse Noxious Inhibitory Controls (DNIC)|diffuse noxious inhibitory controls (dnic)
5417716|NCT01642030|Temporal Summation|temporal summation
5417717|NCT01642017|Phase I, Pazopanib, Frail elderly patients, Pharmacokinetics|phase i, pazopanib, frail elderly patients, pharmacokinetics
5417718|NCT01641991|Bacillus anthracis, anthrax, vaccine, BioThrax®, dose-sparing|bacillus anthracis, anthrax, vaccine, biothrax®, dose-sparing
5417719|NCT01641913|Eosinophilic Esophagitis|eosinophilic esophagitis
5417720|NCT01641900|sleep|sleep
5417721|NCT01641900|memory|memory
5417727|NCT01641874|Knee|knee
5417728|NCT01641874|Osteoarthritis|osteoarthritis
5417729|NCT01641874|McKenzie system|mckenzie system
5417730|NCT01641874|Exercise|exercise
5417731|NCT01641874|Mechanical Diagnosis and Therapy|mechanical diagnosis and therapy
5417732|NCT01641874|Directional preference|directional preference
5417733|NCT01641861|Chemo-mechanical caries removal|chemo-mechanical caries removal
5417734|NCT01641861|Papacarie®|papacarie®
5417735|NCT01641848|Total Ankle Arthroplasty|total ankle arthroplasty
5417736|NCT01641809|HIV -1|hiv -1
5417737|NCT01641809|GSK1265744|gsk1265744
5417738|NCT01641809|maintenance phase|maintenance phase
5417739|NCT01641809|dose selection|dose selection
5417740|NCT01641796|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5417742|NCT01641796|Lesion|lesion
5417743|NCT01641796|Topical|topical
5417744|NCT01641796|Treatment|treatment
5417745|NCT01641796|Cream|cream
5417746|NCT01641796|Expanded Access|expanded access
5417747|NCT01641783|advanced|advanced
5417748|NCT01641783|paclitaxel|paclitaxel
5417749|NCT01641783|capecitabine|capecitabine
5417750|NCT01641783|first line therapy|first line therapy
5417751|NCT01641757|hemodialysis|hemodialysis
5417752|NCT01641757|periodontitis|periodontitis
5417753|NCT01641744|Parent Child Relationship|parent child relationship
5417754|NCT01641744|Maltreatment|maltreatment
5417755|NCT01641744|Risk Behaviors|risk behaviors
5417756|NCT01641744|Social and Emotional Development|social and emotional development
5417757|NCT01641744|Violence and Abuse|violence and abuse
5417758|NCT01641744|Policy|policy
5417759|NCT01641731|cow's milk protein allergy|cow's milk protein allergy
5417760|NCT01641731|oral tolerance induction|oral tolerance induction
5417761|NCT01641718|Hernia, Inguinal|hernia, inguinal
5417762|NCT01641705|rheumatoid arthritis|rheumatoid arthritis
5417763|NCT01641705|respiratory mechanics|respiratory mechanics
5417764|NCT01641705|time of disease|time of disease
5417765|NCT01641692|Asthma|asthma
5417766|NCT01641692|Pharmacokinetics|pharmacokinetics
5417767|NCT01641692|GSK573719|gsk573719
5417768|NCT01641692|Adults|adults
5417769|NCT01641692|Pharmacogenetics|pharmacogenetics
5417770|NCT01641679|Recurrent differentiated thyroid cancer|recurrent differentiated thyroid cancer
5417771|NCT01641679|I124-PET/CT|i124-pet/ct
5417772|NCT01641679|FDG-PET/CT|fdg-pet/ct
5417773|NCT01641653|Nondiabetics undergoing hernia repair.|nondiabetics undergoing hernia repair.
5417774|NCT01641640|HCV genotype 1 (GT-1)|hcv genotype 1 (gt-1)
5417775|NCT01641640|HCV genotype 4 (GT-4)|hcv genotype 4 (gt-4)
5417776|NCT01641640|HCV genotype 5 (GT-5)|hcv genotype 5 (gt-5)
5417777|NCT01641640|HCV genotype 6 (GT-6)|hcv genotype 6 (gt-6)
5417778|NCT01641640|HCV|hcv
5417779|NCT01641640|Sustained Virologic Response|sustained virologic response
5417780|NCT01641640|Direct Acting Antiviral|direct acting antiviral
5417781|NCT01641640|Combination Therapy|combination therapy
5417782|NCT01641640|Treatment-Naïve|treatment-naïve
5417783|NCT01641640|GS-7977|gs-7977
5417784|NCT01641640|Ribavirin|ribavirin
5417785|NCT01641640|RBV|rbv
5417786|NCT01641640|Peginterferon Alfa 2a|peginterferon alfa 2a
5417787|NCT01641640|PEG|peg
5417788|NCT01641627|knee arthritis|knee arthritis
5417789|NCT01641627|muscle atrophy|muscle atrophy
5417790|NCT01641627|proprioceptive stimulation|proprioceptive stimulation
5417791|NCT01641627|vibrations|vibrations
5417792|NCT01641614|Mitral valve|mitral valve
5417793|NCT01641614|valve replacement|valve replacement
5417794|NCT01641614|arrested heart|arrested heart
5417795|NCT01641614|beating heart|beating heart
5417796|NCT01641601|Induction of labor|induction of labor
5417797|NCT01641601|Outpatient cervical ripening|outpatient cervical ripening
5417798|NCT01641588|cognitive executive function|cognitive executive function
5417800|NCT01641588|cognitive performance|cognitive performance
5417801|NCT01641588|heart rate|heart rate
5417803|NCT01641575|CO-1.01|co-1.01
5417804|NCT01641575|CO-101|co-101
5417805|NCT01641575|gemcitabine elaidate|gemcitabine elaidate
5417806|NCT01641575|hENT1|hent1
5417807|NCT01641575|nucleoside equilibrative transporter|nucleoside equilibrative transporter
5417808|NCT01641575|solid tumor|solid tumor
5417809|NCT01641575|non-small-cell lung cancer|non-small-cell lung cancer
5417810|NCT01641575|NSCLC|nsclc
5417811|NCT01641575|lung cancer|lung cancer
5417812|NCT01641562|BREAST CANCER,|breast cancer,
5417813|NCT01641562|TAXANES,|taxanes,
5417814|NCT01641562|SUBCLINICAL CARDIAC DYSFUNCTION ,|subclinical cardiac dysfunction ,
5417816|NCT01641562|PREDICTIVE MODELS|predictive models
5417817|NCT01641549|Prosthetic valve thrombosis|prosthetic valve thrombosis
5417818|NCT01641549|Fibrinolytic therapy|fibrinolytic therapy
5417819|NCT01641549|Emergency surgery|emergency surgery
5417820|NCT01641536|Hepatitis, Chronic|hepatitis, chronic
5412833|NCT01665313|attention|attention
5417822|NCT01641536|DNA Virus Infections|dna virus infections
5417823|NCT01641536|Hepatitis B|hepatitis b
5417824|NCT01641536|Liver|liver
5417825|NCT01641536|Chronic Disease|chronic disease
5417826|NCT01641536|HBV|hbv
5417827|NCT01641523|Cranioplasty prosthesis|cranioplasty prosthesis
5417828|NCT01641523|Hydroxyapatite|hydroxyapatite
5417829|NCT01641523|PolyMethylMethacrylate|polymethylmethacrylate
5417830|NCT01641523|Autologous Bone|autologous bone
5417831|NCT01641510|reduced-function CYP2C19 allele|reduced-function cyp2c19 allele
5417832|NCT01641510|high platelet reactivity|high platelet reactivity
5417833|NCT01641510|clopidogrel|clopidogrel
5417834|NCT01641510|prasugrel|prasugrel
5417835|NCT01641497|endometrial cancer|endometrial cancer
5417836|NCT01641497|IMRT|imrt
5417837|NCT01641497|age over 70|age over 70
5417838|NCT01641471|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5417839|NCT01641471|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5417840|NCT01641471|Pain|pain
5417841|NCT01641471|Function|function
5417842|NCT01641471|Knee Osteoarthritis|knee osteoarthritis
5417843|NCT01641458|Genotyping|genotyping
5417844|NCT01641458|Area-under-the concentration-time curve|area-under-the concentration-time curve
5417845|NCT01641458|Toxicity|toxicity
5417846|NCT01641458|5-fluorouracil|5-fluorouracil
5417847|NCT01641458|Capecitabine|capecitabine
5417848|NCT01641419|Pain|pain
5417849|NCT01641419|Ropivacaine|ropivacaine
5417850|NCT01641419|sciatic block|sciatic block
5417851|NCT01641419|dexamethasone|dexamethasone
5417852|NCT01641406|NAC Protocol|nac protocol
5417853|NCT01641406|NAC and Oncotype Guided Hormonal therapy for breast cancer|nac and oncotype guided hormonal therapy for breast cancer
5417854|NCT01641406|Neoadjuvant and Oncotype|neoadjuvant and oncotype
5417855|NCT01641406|NAC CCAM 1101|nac ccam 1101
5417856|NCT01641393|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5417857|NCT01641393|Cystic Fibrosis|cystic fibrosis
5417858|NCT01641393|Pancreatic Insufficiency|pancreatic insufficiency
5417859|NCT01641380|Depoprovera|depoprovera
5417860|NCT01641380|Contraception|contraception
5417861|NCT01641380|Appointment adherence/attendance|appointment adherence/attendance
5417862|NCT01641380|Pregnancy Prevention|pregnancy prevention
5417863|NCT01641354|Hemiepiphysiodesis|hemiepiphysiodesis
5417864|NCT01641341|Irritable Bowel Syndrome|irritable bowel syndrome
5417865|NCT01641341|Genova Diagnostics kit|genova diagnostics kit
5417866|NCT01641341|Stool test|stool test
5417867|NCT01641341|Rome III|rome iii
5417868|NCT01641341|Practice-based research|practice-based research
5417869|NCT01641341|treatable parasite|treatable parasite
5417870|NCT01641341|Pancreatic insufficiency|pancreatic insufficiency
5417871|NCT01641341|Bowel dysbiosis|bowel dysbiosis
5417872|NCT01641341|High levels of inflammation, C. difficile, or H. pylori|high levels of inflammation, c. difficile, or h. pylori
5417873|NCT01641328|Mild Cognitive Impairment|mild cognitive impairment
5417874|NCT01641328|MCI|mci
5417875|NCT01641328|Meditation|meditation
5417876|NCT01641328|Mindfulness|mindfulness
5417877|NCT01641328|Cognitive Activation|cognitive activation
5417878|NCT01641328|Cognitive Training|cognitive training
5417879|NCT01641328|Tai Chi|tai chi
5417880|NCT01641315|rabies|rabies
5417881|NCT01641315|rabies immunoglobulin|rabies immunoglobulin
5417882|NCT01641289|Falciparum malaria|falciparum malaria
5417883|NCT01641289|Paracetamol|paracetamol
5417884|NCT01641289|Renal function|renal function
5417885|NCT01641289|Oxidative stress|oxidative stress
5417886|NCT01641276|biofeedback response|biofeedback response
5417887|NCT01641263|Depression Prevention|depression prevention
5417888|NCT01641263|Sleep Disturbances|sleep disturbances
5417889|NCT01641263|Inflammatory Markers|inflammatory markers
5417890|NCT01641263|Treatments for Sleep Problems|treatments for sleep problems
5417891|NCT01641224|Irritable bowel syndrome,|irritable bowel syndrome,
5417893|NCT01641224|Herbal medication for IBS,|herbal medication for ibs,
5417894|NCT01641224|Tong Xie Yao Fang (Formula for pain and diarrhea)|tong xie yao fang (formula for pain and diarrhea)
5417895|NCT01641198|Implant, acid-etched fixture, machined collar, bone healing|implant, acid-etched fixture, machined collar, bone healing
5417896|NCT01641185|prostate|prostate
5417898|NCT01641185|hypofractionation|hypofractionation
5417899|NCT01641185|carbon ions|carbon ions
5417900|NCT01641185|proton|proton
5417901|NCT01641172|taste|taste
5417902|NCT01641172|smell|smell
5417903|NCT01641172|cancer|cancer
5417904|NCT01641172|nutrition|nutrition
5417905|NCT01641159|Cocaine|cocaine
5417906|NCT01641159|Crack|crack
5417907|NCT01641159|Buspirone|buspirone
5417908|NCT01641159|Relapse Prevention|relapse prevention
5417909|NCT01641146|HIV risk reduction|hiv risk reduction
5417910|NCT01641146|Stress reduction|stress reduction
5417911|NCT01641146|Trauma reduction|trauma reduction
5417912|NCT01641146|PTSD|ptsd
5417913|NCT01641133|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5417914|NCT01641133|Synflorix|synflorix
5417915|NCT01641133|Prevnar 13|prevnar 13
5417916|NCT01641133|Pneumococcal diseases|pneumococcal diseases
5417917|NCT01641120|Multiple Sclerosis|multiple sclerosis
5417918|NCT01641120|Intramuscular Injections|intramuscular injections
5417920|NCT01641107|Ph+|ph+
5417921|NCT01641107|BCR-ABL+|bcr-abl+
5417922|NCT01641107|ALL|all
5417923|NCT01641107|Ponatinib|ponatinib
5417924|NCT01641107|stem cell transplantation|stem cell transplantation
5417925|NCT01641094|Hepatitis C|hepatitis c
5417926|NCT01641094|Liver|liver
5417927|NCT01641094|Immunology|immunology
5417928|NCT01641094|Genotype 1|genotype 1
5417929|NCT01641094|Treatment|treatment
5417930|NCT01641094|Chronic|chronic
5417931|NCT01641094|RNA Virus Infections|rna virus infections
5417932|NCT01641094|Ribavirin|ribavirin
5417933|NCT01641094|Peginterferon alfa-2a|peginterferon alfa-2a
5417934|NCT01641094|Protease Inhibitors|protease inhibitors
5417935|NCT01641094|Telaprevir|telaprevir
5417936|NCT01641068|Memory|memory
5417937|NCT01641068|Attention|attention
5537401|NCT01137773|SAH|sah
5417938|NCT01641068|Chemo-brain|chemo-brain
5417939|NCT01641068|Survivor|survivor
5417940|NCT01641068|Treatment|treatment
5417941|NCT01641042|Meningococcal vaccines|meningococcal vaccines
5417942|NCT01641042|Vaccines, conjugate|vaccines, conjugate
5417943|NCT01641042|Neisseria meningitidis|neisseria meningitidis
5417944|NCT01641042|Immunocompromised patient|immunocompromised patient
5417945|NCT01641016|short cycle therapy|short cycle therapy
5417946|NCT01641016|young people|young people
5417947|NCT01641016|HIV|hiv
5417948|NCT01641003|cancer stem cells|cancer stem cells
5417949|NCT01640990|Healthy male volunteers, intravenous infusion, GW328267X, dose escalation,|healthy male volunteers, intravenous infusion, gw328267x, dose escalation,
5417950|NCT01640977|Open PLIF|open plif
5417951|NCT01640977|MAS PLIF|mas plif
5417952|NCT01640977|Lumbar spine|lumbar spine
5417953|NCT01640964|Portal hypertension, cirrhosis, TIPSS, MRI, MRA, portal pressure, portal pressure gradient|portal hypertension, cirrhosis, tipss, mri, mra, portal pressure, portal pressure gradient
5417954|NCT01640951|Psoriasis|psoriasis
5417955|NCT01640951|Plaque|plaque
5417956|NCT01640951|Inflammatory skin disease|inflammatory skin disease
5417957|NCT01640951|Scaly patches|scaly patches
5417958|NCT01640951|AIN457|ain457
5417959|NCT01640951|Secukinumab|secukinumab
5417960|NCT01640951|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
5417961|NCT01640925|nosocomial infection|nosocomial infection
5417962|NCT01640925|hospital acquired infection|hospital acquired infection
5417963|NCT01640925|chlorhexidine|chlorhexidine
5417964|NCT01640925|pneumonia, ventilator-associated|pneumonia, ventilator-associated
5417965|NCT01640925|catheter-related infections|catheter-related infections
5417966|NCT01640925|urinary tract infections, catheter-related|urinary tract infections, catheter-related
5417967|NCT01640925|surgical site infection|surgical site infection
5417968|NCT01640912|Scar|scar
5417969|NCT01640912|Scar prevention|scar prevention
5417970|NCT01640912|Fibrosis|fibrosis
5417971|NCT01640899|Orthotic Devices|orthotic devices
5417972|NCT01640899|Activities of Daily Living|activities of daily living
5417973|NCT01640899|Pain Measurement|pain measurement
5417974|NCT01640899|Lower Extremity|lower extremity
5417975|NCT01640899|Foot|foot
5417976|NCT01640899|Personal Satisfaction|personal satisfaction
5417977|NCT01640886|Staphylococcus aureus|staphylococcus aureus
5417978|NCT01640886|methicillin resistant|methicillin resistant
5417979|NCT01640886|MRSA|mrsa
5417980|NCT01640886|MSSA|mssa
5417981|NCT01640886|Blood Culture|blood culture
5417982|NCT01640886|Diagnostic|diagnostic
5417983|NCT01640873|Type 2 Diabetes|type 2 diabetes
5417984|NCT01640860|docetaxel|docetaxel
5417985|NCT01640860|cisplatin|cisplatin
5390452|NCT01765673|Stroke|stroke
5417986|NCT01640860|combined modality therapy|combined modality therapy
5417987|NCT01640847|Painful bone metastases|painful bone metastases
5417989|NCT01640847|Bone Cancer Pain|bone cancer pain
5417990|NCT01640847|Patients with|patients with
5417991|NCT01640821|Health-At-Every-Size intervention|health-at-every-size intervention
5417992|NCT01640782|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5417993|NCT01640782|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5417994|NCT01640769|Cardiomyopathy|cardiomyopathy
5417995|NCT01640769|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5417996|NCT01640756|Glaucoma Implant|glaucoma implant
5417997|NCT01640756|Trabeculectomy|trabeculectomy
5417998|NCT01640756|POAG|poag
5417999|NCT01640743|Kidney transplantation|kidney transplantation
5418000|NCT01640743|Regulatory T cells|regulatory t cells
5418001|NCT01640743|Tolerance|tolerance
5418002|NCT01640743|Tacrolimus|tacrolimus
5418003|NCT01640743|Rejection|rejection
5418004|NCT01640691|pandemic influenza|pandemic influenza
5418005|NCT01640691|pandemic influenza vaccine|pandemic influenza vaccine
5418006|NCT01640691|Influenza|influenza
5418007|NCT01640691|Orthomyxoviruses|orthomyxoviruses
5418008|NCT01640691|A/H5N1|a/h5n1
5418009|NCT01640665|histologically|histologically
5418010|NCT01640665|unresectable|unresectable
5418011|NCT01640665|metastatic|metastatic
5400887|NCT01717768|hypogonadism|hypogonadism
5418017|NCT01640639|left ventricular function|left ventricular function
5418018|NCT01640626|Health Education|health education
5418019|NCT01640626|Soil-transmitted helminthiasis|soil-transmitted helminthiasis
5418020|NCT01640626|Ascaris|ascaris
5418028|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more cognitive problems.
5418029|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have poorer motor development.
5418030|NCT01640587|Uncomplicated falciparum infection|uncomplicated falciparum infection
5418032|NCT01640587|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5418033|NCT01640574|Vivax|vivax
5418034|NCT01640574|Chloroquine|chloroquine
5418035|NCT01640574|Primaquine|primaquine
5418036|NCT01640574|Dihydroartemisinin-Piperaquine|dihydroartemisinin-piperaquine
5418037|NCT01640561|HIV affected|hiv affected
5418038|NCT01640561|Child Neurodevelopment|child neurodevelopment
5418039|NCT01640561|Low and Middle Income Country|low and middle income country
5418040|NCT01640535|PAR|par
5418041|NCT01640522|Hepatocellular carcinoma|hepatocellular carcinoma
5418042|NCT01640522|Cholangio carcinoma|cholangio carcinoma
5418043|NCT01640522|Primary Liver Cancer|primary liver cancer
5418044|NCT01640522|Bile Duct CancerPancreatic Cancer|bile duct cancerpancreatic cancer
5418045|NCT01640522|Gallbladder Cancer|gallbladder cancer
5418046|NCT01640522|Colorectal Carcinoma|colorectal carcinoma
5418047|NCT01640522|Other Primary Cancers with Liver Metastases|other primary cancers with liver metastases
5418048|NCT01640509|Radiotherapy, Targeted|radiotherapy, targeted
5418049|NCT01640496|Ulcerative Colitis|ulcerative colitis
5418050|NCT01640496|Inflammatory Bowel disease|inflammatory bowel disease
5418051|NCT01640496|IBD|ibd
5418052|NCT01640496|Vitamin D|vitamin d
5418053|NCT01640470|assistive technology|assistive technology
5418054|NCT01640470|environmental modification|environmental modification
5418055|NCT01640470|caregiver|caregiver
5418056|NCT01640470|client-centred|client-centred
5418057|NCT01640457|degenerative disc|degenerative disc
5418058|NCT01640457|herniated disc|herniated disc
5418059|NCT01640457|sequestrectomy|sequestrectomy
5418060|NCT01640457|Autologous Disc Chondrocyte Transplantation|autologous disc chondrocyte transplantation
5418061|NCT01640457|nucleotomy|nucleotomy
5418062|NCT01640457|safety|safety
5418063|NCT01640457|efficacy|efficacy
5418064|NCT01640457|treatment|treatment
5418065|NCT01640457|lumbar spine|lumbar spine
5418066|NCT01640457|low back pain|low back pain
5418067|NCT01640457|adjacent degenerative disc|adjacent degenerative disc
5418068|NCT01640457|black disc|black disc
5418069|NCT01640457|NOVOCART|novocart
5418070|NCT01640444|colorectal carcinoma|colorectal carcinoma
5418071|NCT01640444|BRAF and PIK3K|braf and pik3k
5418072|NCT01640444|FOLFIRI -Bevacizumab -Cetuximab|folfiri -bevacizumab -cetuximab
5418073|NCT01640444|circulating tumor cells|circulating tumor cells
5418074|NCT01640431|lumbar disc herniation|lumbar disc herniation
5418075|NCT01640431|clinical trial|clinical trial
5418076|NCT01640431|exercise therapy|exercise therapy
5418078|NCT01640418|pressure ulcer|pressure ulcer
5418079|NCT01640418|dressing|dressing
5418080|NCT01640418|prevention|prevention
5418081|NCT01640418|higher risk patients|higher risk patients
5418082|NCT01640405|colorectal cancer|colorectal cancer
5418083|NCT01640405|FOLFOX|folfox
5418084|NCT01640405|Bevacizumab|bevacizumab
5418085|NCT01640405|FOLFOXIRI|folfoxiri
5418086|NCT01640405|circulating tumor cell|circulating tumor cell
5418087|NCT01640392|Gay men|gay men
5418088|NCT01640392|African American males|african american males
5418089|NCT01640392|Unprotected anal sex|unprotected anal sex
5418090|NCT01640392|HIV risk|hiv risk
5418091|NCT01640392|behavioral intervention|behavioral intervention
5418092|NCT01640392|group-level intervention|group-level intervention
5418093|NCT01640379|Pelvic Inflammatory Disease (PID)|pelvic inflammatory disease (pid)
5418094|NCT01640379|Community Health Nursing|community health nursing
5418097|NCT01640379|Adolescents|adolescents
5421438|NCT01624428|Tobacco|tobacco
5418107|NCT01640353|si joint inflammation|si joint inflammation
5418108|NCT01640353|si joint problems|si joint problems
5418109|NCT01640353|si joint symptoms|si joint symptoms
5418110|NCT01640353|hypermobile si joint|hypermobile si joint
5418111|NCT01640353|si joint arthritis|si joint arthritis
5418112|NCT01640353|si joint pain treatment|si joint pain treatment
5418113|NCT01640353|inflamed si joint|inflamed si joint
5418114|NCT01640353|si joint sclerosis|si joint sclerosis
5418115|NCT01640353|locked si joint|locked si joint
5418116|NCT01640353|si joint injuries|si joint injuries
5418117|NCT01640353|si joint disease|si joint disease
5418118|NCT01640353|si joint infection|si joint infection
5418119|NCT01640353|sacroiliac joint pelvic pain|sacroiliac joint pelvic pain
5418120|NCT01640353|sacroiliac joint arthritis treatment|sacroiliac joint arthritis treatment
5418121|NCT01640340|ondansetron|ondansetron
5418122|NCT01640340|palonosetron|palonosetron
5418123|NCT01640340|emetogenic chemotherapy|emetogenic chemotherapy
5418124|NCT01640340|HEC|hec
5418125|NCT01640327|Interpandemic influenza|interpandemic influenza
5418126|NCT01640327|Adult|adult
5418127|NCT01640327|Elderly|elderly
5418128|NCT01640327|Safety|safety
5418129|NCT01640327|Tolerability|tolerability
5418130|NCT01640327|Immunology|immunology
5418131|NCT01640314|Influenza|influenza
5418133|NCT01640314|Elderly|elderly
5418134|NCT01640314|Immunology|immunology
5418135|NCT01640314|Safety|safety
5418136|NCT01640288|COPD|copd
5418137|NCT01640288|Pulmonary Function Testing|pulmonary function testing
5418138|NCT01640288|MRI|mri
5418139|NCT01640288|Normal Lung Function|normal lung function
5418140|NCT01640288|Current Smoker|current smoker
5418141|NCT01640288|Non Smoker|non smoker
5418142|NCT01640288|Ex Smoker|ex smoker
5418143|NCT01640275|General Anesthesia|general anesthesia
5418144|NCT01640275|Alzheimers Disease|alzheimers disease
5418145|NCT01640275|Cognitive decline|cognitive decline
5418146|NCT01640262|prostate biopsy|prostate biopsy
5418147|NCT01640262|prostate cancer|prostate cancer
5418148|NCT01640262|Magnetic Resonance Imaging|magnetic resonance imaging
5418149|NCT01640262|Neoplasm Staging|neoplasm staging
5418150|NCT01640236|Ocular flare|ocular flare
5418151|NCT01640197|Cognitive performance|cognitive performance
5418152|NCT01640197|Cerebral blood flow|cerebral blood flow
5418153|NCT01640197|Subjective sleep|subjective sleep
5418154|NCT01640197|Subjective mood|subjective mood
5418155|NCT01640197|Subjective health|subjective health
5418156|NCT01640184|hyperparathyroidism|hyperparathyroidism
5418157|NCT01640184|vitamin D|vitamin d
5418158|NCT01640184|ultrasonic ablation|ultrasonic ablation
5418159|NCT01640184|surgery|surgery
5418160|NCT01640171|anesthesia|anesthesia
5418161|NCT01640171|pain|pain
5418162|NCT01640171|intravitreal|intravitreal
5418163|NCT01640171|anti-vegf|anti-vegf
5418164|NCT01640158|mild Traumatic Brain Injury|mild traumatic brain injury
5418165|NCT01640158|Cognitive remediation|cognitive remediation
5418166|NCT01640158|computer|computer
5418167|NCT01640119|metabolic acidosis|metabolic acidosis
5418168|NCT01640119|renal death|renal death
5418169|NCT01640106|Language|language
5418170|NCT01640106|Fatty acids|fatty acids
5418171|NCT01640106|Nutrition|nutrition
5418172|NCT01640106|Developmental delay|developmental delay
5418173|NCT01640093|Healthy participants|healthy participants
5418174|NCT01640093|Bioavailability|bioavailability
5418175|NCT01640093|Pharmacokinetics|pharmacokinetics
5418176|NCT01640093|Abiraterone acetate|abiraterone acetate
5418177|NCT01640093|Abiraterone|abiraterone
5418178|NCT01640080|Major depressive disorder|major depressive disorder
5418179|NCT01640080|Treatment resistant depression|treatment resistant depression
5418180|NCT01640080|Depression|depression
5418181|NCT01640080|Esketamine|esketamine
5418182|NCT01640067|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5418373|NCT01639131|Gemcitabine|gemcitabine
5418183|NCT01640067|motor neuron disease|motor neuron disease
5418184|NCT01640067|stem cells|stem cells
5418185|NCT01640067|safety|safety
5418186|NCT01640067|ALS-FRS-Functional scale R and FVC (%) variation|als-frs-functional scale r and fvc (%) variation
5418187|NCT01640067|Survival analysis|survival analysis
5418308|NCT01639469|Exercise Therapy|exercise therapy
5418188|NCT01640067|Changes in quality of life scales|changes in quality of life scales
5418189|NCT01640054|Rheumatoid Arthritis|rheumatoid arthritis
5418190|NCT01640015|Blood pressure|blood pressure
5418191|NCT01640015|eating episode|eating episode
5418192|NCT01640015|eating frequency|eating frequency
5418193|NCT01640015|insulin sensitivity|insulin sensitivity
5418194|NCT01640002|overactive bladder|overactive bladder
5418195|NCT01640002|HTLV-1|htlv-1
5421623|NCT01623661|BCM|bcm
5418196|NCT01640002|Propantheline|propantheline
5418197|NCT01640002|anticholinergic|anticholinergic
5418198|NCT01639989|Doppler, Pregnancy|doppler, pregnancy
5418199|NCT01639976|Missed abortion, early pregnancy loss.|missed abortion, early pregnancy loss.
5418200|NCT01639950|Self-Report|self-report
5418202|NCT01639950|Validate|validate
5418203|NCT01639950|Pain Severity|pain severity
5418204|NCT01639950|Reliability|reliability
5418205|NCT01639937|Cardiac MRI|cardiac mri
5418206|NCT01639937|Congestive Heart Failure|congestive heart failure
5418207|NCT01639937|Cardiac Fibrosis|cardiac fibrosis
5418208|NCT01639937|Late Gadolinium Enhancement|late gadolinium enhancement
5418209|NCT01639924|Upper GI Disease|upper gi disease
5418210|NCT01639924|Small Bowel Disease|small bowel disease
5418211|NCT01639924|Digestive Disease|digestive disease
5418212|NCT01639924|Gastrointestinal Disease|gastrointestinal disease
5418213|NCT01639924|Lower GI Disease|lower gi disease
5418214|NCT01639911|malignant solid tumor|malignant solid tumor
5418215|NCT01639911|advanced non-hematologic|advanced non-hematologic
5418216|NCT01639898|POEMS|poems
5418217|NCT01639898|VEGF|vegf
5418218|NCT01639898|Free light|free light
5418219|NCT01639898|lenalidomide|lenalidomide
5418220|NCT01639898|dexamethasone|dexamethasone
5418221|NCT01639885|p53 overexpression|p53 overexpression
5418222|NCT01639885|platinum-resistant|platinum-resistant
5418223|NCT01639872|Schizophrenia|schizophrenia
5418224|NCT01639872|Cannabis Abuse|cannabis abuse
5418225|NCT01639872|Cannabis Dependence|cannabis dependence
5418226|NCT01639872|Dual Diagnosis|dual diagnosis
5418227|NCT01639872|Clozapine|clozapine
5418228|NCT01639872|Risperidone|risperidone
5418229|NCT01639859|prostate cancer|prostate cancer
5403579|NCT01705977|SLE|sle
5418230|NCT01639859|elastography|elastography
5418231|NCT01639859|elasticity|elasticity
5418232|NCT01639820|Cervical cancer|cervical cancer
5418233|NCT01639820|early stage carcinoma|early stage carcinoma
5418234|NCT01639820|FIGO IA1 IA2 IB1 IIA|figo ia1 ia2 ib1 iia
5418235|NCT01639820|sentinel lymph node biopsy|sentinel lymph node biopsy
5418236|NCT01639820|pelvic lymphadenectomy|pelvic lymphadenectomy
5418237|NCT01639820|Surgery of uterine cervical carcinoma|surgery of uterine cervical carcinoma
5418238|NCT01639820|medico economic impact|medico economic impact
5418239|NCT01639820|quality of life|quality of life
5418240|NCT01639807|Open Angle Glaucoma or Ocular hypertension|open angle glaucoma or ocular hypertension
5418241|NCT01639794|LUTS (Lower Urinary Tract Symptoms)|luts (lower urinary tract symptoms)
5418242|NCT01639794|Overactive Bladder (OAB)Vesitirim|overactive bladder (oab)vesitirim
5418243|NCT01639794|Solifenacin|solifenacin
5418244|NCT01639794|Anti-muscarinic treatment|anti-muscarinic treatment
5418245|NCT01639794|Cholinergic receptor antagonist|cholinergic receptor antagonist
5418246|NCT01639794|Storage Symptom improvement|storage symptom improvement
5418247|NCT01639781|flavanols|flavanols
5418248|NCT01639781|age related cardiovascular effects|age related cardiovascular effects
5418249|NCT01639768|Sublingual immunotherapy|sublingual immunotherapy
5418250|NCT01639768|Dose range finding|dose range finding
5418251|NCT01639768|Dose tolerability|dose tolerability
5418252|NCT01639768|Birch pollen|birch pollen
5418253|NCT01639768|Allergic rhinitis/rhinoconjunctivitis|allergic rhinitis/rhinoconjunctivitis
5418254|NCT01639768|Safety|safety
5418255|NCT01639768|Immunogenicity|immunogenicity
5418256|NCT01639729|pharmacokinetics|pharmacokinetics
5418257|NCT01639729|area under curve|area under curve
5418258|NCT01639729|time to maximum concentration|time to maximum concentration
5418259|NCT01639716|Survey, interleukin status|survey, interleukin status
5418260|NCT01639703|CT perfusion|ct perfusion
5418261|NCT01639703|Hepatocellular Carcinoma|hepatocellular carcinoma
5418262|NCT01639703|Xenetix|xenetix
5418263|NCT01639703|Contrast agent|contrast agent
5418264|NCT01639690|BUSULFAN|busulfan
5418265|NCT01639690|G-CSF|g-csf
5418266|NCT01639690|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
5418267|NCT01639690|Blood transfusion|blood transfusion
5418268|NCT01639690|10-164|10-164
5418269|NCT01639690|Autologous CD34+ cells transduced with TNS9.3.55, a lentiviral vector encoding the human β-globin gene|autologous cd34+ cells transduced with tns9.3.55, a lentiviral vector encoding the human β-globin gene
5418270|NCT01639677|Obesity|obesity
5418271|NCT01639677|weight loss|weight loss
5418272|NCT01639677|surgery|surgery
5418273|NCT01639677|gastric bypass|gastric bypass
5418275|NCT01639651|Physical Therapy|physical therapy
5418276|NCT01639651|Glenohumeral Internal Rotation Deficits|glenohumeral internal rotation deficits
5418277|NCT01639651|Joint Mobilization|joint mobilization
5418278|NCT01639651|Posterior capsule|posterior capsule
5418279|NCT01639651|Capsular contracture|capsular contracture
5418280|NCT01639638|Recurrent and non-recurrent genital condyloma|recurrent and non-recurrent genital condyloma
5418281|NCT01639612|Stem Cell|stem cell
5418282|NCT01639612|Grade IV Malignant Glioma|grade iv malignant glioma
5418283|NCT01639599|non-smoker|non-smoker
5418284|NCT01639599|female|female
5418285|NCT01639599|IV PCA|iv pca
5418286|NCT01639599|patient-controlled analgesia|patient-controlled analgesia
5418287|NCT01639573|Patients with Scleroderma|patients with scleroderma
5418288|NCT01639560|smoking|smoking
5418289|NCT01639560|tobacco dependence|tobacco dependence
5418290|NCT01639560|nicotine dependence|nicotine dependence
5418291|NCT01639547|PEGASYS® PLUS RIBAVIRIN|pegasys® plus ribavirin
5418292|NCT01639534|Biomarkers of ischemia|biomarkers of ischemia
5418293|NCT01639534|Carotid Stenting procedure|carotid stenting procedure
5418294|NCT01639534|Levels Xanthine Hypoxanthine and Inosine|levels xanthine hypoxanthine and inosine
5418297|NCT01639508|XL184 (CABOZANTINIB)|xl184 (cabozantinib)
5418298|NCT01639508|KIF5B/RET Positive|kif5b/ret positive
5418299|NCT01639508|RET Fusion Positive|ret fusion positive
5418300|NCT01639508|12-097|12-097
5418301|NCT01639508|Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity|genotypes: ros1 or ntrk fusions or increased met or axl activity
5418302|NCT01639495|Drug refractory|drug refractory
5418303|NCT01639495|Atrial fibrillation|atrial fibrillation
5418304|NCT01639495|Antiarrhythmic drug failure|antiarrhythmic drug failure
5418305|NCT01639495|Atrial tachyarrhythmias|atrial tachyarrhythmias
5418306|NCT01639469|Parkinson Disease|parkinson disease
5418307|NCT01639469|Quality of Life|quality of life
5418309|NCT01639456|acute myelogenous leukemia|acute myelogenous leukemia
5418310|NCT01639443|quality improvement|quality improvement
5418311|NCT01639443|Organization and Administration|organization and administration
5418312|NCT01639443|Costs and cost analysis|costs and cost analysis
5418313|NCT01639443|Patient satisfaction|patient satisfaction
5418314|NCT01639443|Health plan implementation|health plan implementation
5418315|NCT01639404|Cerebral Palsy|cerebral palsy
5418316|NCT01639404|Umbilical Cord Blood|umbilical cord blood
5418317|NCT01639404|Rehabilitation|rehabilitation
5418318|NCT01639365|Ventricular tachycardia|ventricular tachycardia
5403687|NCT01705522|IBD|ibd
5418319|NCT01639365|Catheter ablation|catheter ablation
5418320|NCT01639365|Tissue contact|tissue contact
5418321|NCT01639352|Hepatocellular Carcinoma|hepatocellular carcinoma
5418323|NCT01639352|SOM230|som230
5418324|NCT01639352|Pasireotide LAR|pasireotide lar
5418325|NCT01639339|Antibodies|antibodies
5418326|NCT01639339|Systemic Lupus Erythematosus|systemic lupus erythematosus
5418327|NCT01639339|Autoimmune Disease|autoimmune disease
5418328|NCT01639339|Glomerulonephritis|glomerulonephritis
5418329|NCT01639339|Belimumab|belimumab
5418330|NCT01639339|Lupus|lupus
5418331|NCT01639339|Nephritis|nephritis
5418332|NCT01639339|Kidney Diseases|kidney diseases
5418333|NCT01639339|SLE|sle
5418334|NCT01639300|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5418335|NCT01639300|Progressive Forms of Multiple Sclerosis|progressive forms of multiple sclerosis
5418336|NCT01639300|GNbAC1|gnbac1
5418337|NCT01639300|Monoclonal antibody|monoclonal antibody
5418338|NCT01639300|Multiple Sclerosis Associated Retrovirus (MSRV)|multiple sclerosis associated retrovirus (msrv)
5418339|NCT01639261|steroid-refractory|steroid-refractory
5418340|NCT01639261|bronchiolitis obliterans|bronchiolitis obliterans
5418341|NCT01639261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5418342|NCT01639261|interferon gamma|interferon gamma
5418343|NCT01639248|Breast Cancer|breast cancer
5418344|NCT01639235|Secondhand Smoke|secondhand smoke
5418345|NCT01639235|Flight Attendants|flight attendants
5418346|NCT01639235|Lung function|lung function
5418347|NCT01639235|Cardiac function|cardiac function
5418348|NCT01639235|Reproductive health|reproductive health
5418349|NCT01639222|Drug therapy|drug therapy
5418350|NCT01639222|Increase in calcium urinary excretion and PTH decrease in serum|increase in calcium urinary excretion and pth decrease in serum
5418351|NCT01639209|Retinal detachment|retinal detachment
5418352|NCT01639209|Pneumatic retinopexy|pneumatic retinopexy
5418353|NCT01639209|Vitrectomy|vitrectomy
5418354|NCT01639196|Chronic pain|chronic pain
5418355|NCT01639196|Psychological adjustment|psychological adjustment
5418356|NCT01639196|Writing|writing
5418357|NCT01639196|Brief intervention|brief intervention
5418358|NCT01639196|Online|online
5418359|NCT01639196|Internet interventions|internet interventions
5418360|NCT01639183|oral inflammation|oral inflammation
5418361|NCT01639183|systemic inflammation|systemic inflammation
5418362|NCT01639183|compliance|compliance
5418363|NCT01639183|power toothbrushing|power toothbrushing
5418364|NCT01639183|nursing home residents|nursing home residents
5418365|NCT01639170|Pneumoperitoneum|pneumoperitoneum
5418366|NCT01639170|Free air|free air
5418367|NCT01639170|Surgery|surgery
5418368|NCT01639170|Perforation|perforation
5418369|NCT01639170|Radiograph|radiograph
5418370|NCT01639144|Infection|infection
5418371|NCT01639144|delayed wound healing|delayed wound healing
5418372|NCT01639144|platelet-rich plasma|platelet-rich plasma
5418374|NCT01639131|Docetaxel|docetaxel
5418375|NCT01639131|Filgrastim|filgrastim
5418376|NCT01639131|Pegfilgrastim|pegfilgrastim
5418377|NCT01639118|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
5418378|NCT01639118|umbilical hernia repair|umbilical hernia repair
5418379|NCT01639118|epigastric hernia repair|epigastric hernia repair
5418380|NCT01639118|C-Qur V-patch|c-qur v-patch
5418381|NCT01639118|Size tailored repair|size tailored repair
5418382|NCT01639118|preperitoneal repair|preperitoneal repair
5418383|NCT01639118|abdominal hernia|abdominal hernia
5418384|NCT01639118|dual sided mesh|dual sided mesh
5418385|NCT01639092|Resistance of Entecavir|resistance of entecavir
5418386|NCT01639079|cigarette smoking behavior|cigarette smoking behavior
5418387|NCT01639079|smoking cessation|smoking cessation
5418388|NCT01639079|Latino smoking cessation|latino smoking cessation
5413483|NCT01662050|MCL|mcl
5418389|NCT01639066|Resistance of Adefovir|resistance of adefovir
5418390|NCT01639053|Breast Augmentation|breast augmentation
5418391|NCT01639053|Breast Reconstruction|breast reconstruction
5418393|NCT01639053|Silicone breast implants|silicone breast implants
5418394|NCT01639001|Crizotinib|crizotinib
5418395|NCT01639001|ALK positive|alk positive
5418397|NCT01639001|Anaplastic Lymphoma Kinase|anaplastic lymphoma kinase
5418398|NCT01639001|NSCLC|nsclc
5418399|NCT01639001|Non-Small Cell Lung Cancer|non-small cell lung cancer
5418400|NCT01639001|Frontline|frontline
5418402|NCT01639001|Previously Untreated|previously untreated
5418403|NCT01639001|East Asian|east asian
5418404|NCT01639001|Non-Squamous|non-squamous
5418405|NCT01638962|Exercise Therapy|exercise therapy
5418406|NCT01638962|Gait|gait
5418407|NCT01638962|Joint load|joint load
5418408|NCT01638962|Knee Joint|knee joint
5418409|NCT01638962|Middle Aged|middle aged
5418410|NCT01638962|Osteoarthritis, Knee/therapy|osteoarthritis, knee/therapy
5418411|NCT01638962|Pain Management|pain management
5418412|NCT01638949|Alzheimer's disease|alzheimer's disease
5418413|NCT01638949|MCI|mci
5418414|NCT01638949|genetic|genetic
5418415|NCT01638949|AV45-PET|av45-pet
5418416|NCT01638936|Combination|combination
5418417|NCT01638936|Multiple Myeloma|multiple myeloma
5418418|NCT01638923|Heavy Menstrual Bleeding|heavy menstrual bleeding
5418419|NCT01638923|Efficacy|efficacy
5418420|NCT01638923|Safety|safety
5418421|NCT01638923|Oral contraceptive|oral contraceptive
5418422|NCT01638923|Estradiol valerate|estradiol valerate
5418423|NCT01638923|Dienogest|dienogest
5418424|NCT01638910|Efficacy|efficacy
5418425|NCT01638910|Safety|safety
5418426|NCT01638910|oral contraception|oral contraception
5418427|NCT01638910|estradiol valerate|estradiol valerate
5418428|NCT01638910|dienogest|dienogest
5418429|NCT01638897|ICD|icd
5418430|NCT01638897|CRTD|crtd
5418431|NCT01638897|DF4|df4
5418432|NCT01638884|Prospective Memory|prospective memory
5418433|NCT01638884|Healthy Aging|healthy aging
5418434|NCT01638884|Alzheimer Disease|alzheimer disease
5418435|NCT01638884|Brain Imaging|brain imaging
5418436|NCT01638832|NASH; coronary artery disease|nash; coronary artery disease
5418437|NCT01638806|Acute Coronary Syndrome|acute coronary syndrome
5418438|NCT01638806|Myocardial infarction|myocardial infarction
5418439|NCT01638806|Angioplasty|angioplasty
5418440|NCT01638806|Prehospital emergency care|prehospital emergency care
5418441|NCT01638806|Biological markers|biological markers
5418442|NCT01638806|Troponin|troponin
5418443|NCT01638806|Point-of-Care systems|point-of-care systems
5418444|NCT01638767|In Vitro Fertilization long protocol|in vitro fertilization long protocol
5418445|NCT01638767|NuvaRing|nuvaring
5418446|NCT01638767|Marvelon|marvelon
5418447|NCT01638767|In vitro fertilization|in vitro fertilization
5418448|NCT01638715|Rheumatoid Arthritis|rheumatoid arthritis
5418449|NCT01638715|Biologic therapies|biologic therapies
5418450|NCT01638715|Biomarker|biomarker
5418451|NCT01638715|Mode of Action|mode of action
5418452|NCT01638702|Catheterisation, Central Venous|catheterisation, central venous
5418453|NCT01638702|Catheters, Indwelling|catheters, indwelling
5418454|NCT01638689|Mechanism of Action of escitalopram|mechanism of action of escitalopram
5418455|NCT01638676|Unresectable melanoma|unresectable melanoma
5418456|NCT01638676|Stage IIIC and Stage IV BRAFV600E+ Melanoma|stage iiic and stage iv brafv600e+ melanoma
5418457|NCT01638663|Tolvaptan|tolvaptan
5418458|NCT01638663|L-NMMA|l-nmma
5418459|NCT01638663|Healthy subjects|healthy subjects
5418460|NCT01638663|Nephrology|nephrology
5418461|NCT01638663|Cardiology|cardiology
5418462|NCT01638624|Propofol|propofol
5418463|NCT01638624|antioxidant capacity|antioxidant capacity
5418464|NCT01638624|total knee arthroplasty|total knee arthroplasty
5418465|NCT01638624|Propofol,antioxidant|propofol,antioxidant
5418466|NCT01638611|Healthy male volunteers|healthy male volunteers
5418467|NCT01638572|Neuroblastoma|neuroblastoma
5418468|NCT01638572|B4GALNT3|b4galnt3
5418469|NCT01638572|Prognosis|prognosis
5418470|NCT01638559|liver transplant|liver transplant
5418471|NCT01638559|allograft function|allograft function
5418472|NCT01638559|anti-rejection|anti-rejection
5418473|NCT01638559|immunosuppression withdrawal|immunosuppression withdrawal
5418474|NCT01638559|tolerance|tolerance
5418475|NCT01638520|Immune Therapy|immune therapy
5418476|NCT01638520|Interleukin 4|interleukin 4
5418477|NCT01638520|monoclonal antibody|monoclonal antibody
5418478|NCT01638507|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5418479|NCT01638507|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5418480|NCT01638507|Coronary Artery Disease|coronary artery disease
5418481|NCT01638507|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5418482|NCT01638507|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5418483|NCT01638507|STENT THROMBOSIS|stent thrombosis
5418484|NCT01638507|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5418485|NCT01638494|25-Hydroxyvitamin D|25-hydroxyvitamin d
5418486|NCT01638494|dietary counseling|dietary counseling
5418488|NCT01638494|allergy|allergy
5418489|NCT01638494|bone metabolism|bone metabolism
5418490|NCT01638468|Pulmonary Embolism|pulmonary embolism
5418491|NCT01638468|Acute Pulmonary Embolism|acute pulmonary embolism
5418492|NCT01638468|Sub-massive Pulmonary Embolism|sub-massive pulmonary embolism
5418493|NCT01638468|Massive Pulmonary Embolism|massive pulmonary embolism
5418494|NCT01638468|Pulmonary Thromboembolism|pulmonary thromboembolism
5418495|NCT01638442|Male subjects, healthy|male subjects, healthy
5418496|NCT01638403|narcolepsy|narcolepsy
5418497|NCT01638403|excessive daytime sleepiness|excessive daytime sleepiness
5418498|NCT01638403|cataplexy|cataplexy
5418499|NCT01638377|Back on Track|back on track
5418500|NCT01638377|convicted drinking drivers|convicted drinking drivers
5418501|NCT01638377|naltrexone|naltrexone
5418502|NCT01638377|alcohol dependence|alcohol dependence
5418503|NCT01638351|Diabetes mellitus|diabetes mellitus
5418504|NCT01638351|Resistance exercise|resistance exercise
5418505|NCT01638351|Elderly|elderly
5418506|NCT01638351|Skeletal muscle dysfunction|skeletal muscle dysfunction
5418507|NCT01638351|Metabolomics|metabolomics
5418508|NCT01638338|Alcohol|alcohol
5418509|NCT01638338|Risky drinking|risky drinking
5418510|NCT01638338|Web site|web site
5418511|NCT01638338|Primary Care|primary care
5418512|NCT01638338|General Practice|general practice
5418513|NCT01638338|Local Community|local community
5418514|NCT01638338|Mayors|mayors
5418515|NCT01638312|HIV, fructose|hiv, fructose
5418516|NCT01638299|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5418517|NCT01638299|Artificial Pancreas|artificial pancreas
5418518|NCT01638273|Pregabalin, GLARS|pregabalin, glars
5418519|NCT01638260|NEAT|neat
5418520|NCT01638260|liraglutide|liraglutide
5418521|NCT01638260|glycemic control|glycemic control
5418522|NCT01638247|Male breast cancer|male breast cancer
5418523|NCT01638247|neoadjuvant, adjuvant or metastatic situation|neoadjuvant, adjuvant or metastatic situation
5418524|NCT01638247|anti-hormonal therapy|anti-hormonal therapy
5418525|NCT01638234|atopic dermatitis|atopic dermatitis
5418526|NCT01638234|eczema|eczema
5418527|NCT01638182|phylloquinone,|phylloquinone,
5418528|NCT01638182|menaquinone-7|menaquinone-7
5418529|NCT01638182|vitamin K-status|vitamin k-status
5418530|NCT01638182|efficacy|efficacy
5418531|NCT01638156|Aortic stenosis|aortic stenosis
5418532|NCT01638143|vitamin K2|vitamin k2
5418533|NCT01638143|menaquinone-7|menaquinone-7
5418534|NCT01638143|bioavailability|bioavailability
5418535|NCT01638091|Narrow band imaging|narrow band imaging
5418536|NCT01638091|Screening colonoscopy|screening colonoscopy
5418537|NCT01638091|Histology|histology
5418538|NCT01638078|coronary restenosis|coronary restenosis
5418539|NCT01638065|vein identification|vein identification
5418540|NCT01638065|vascular access|vascular access
5418541|NCT01638052|Tympanomastoid Surgery|tympanomastoid surgery
5418542|NCT01638052|Cochlear Implant|cochlear implant
5418543|NCT01638052|Mastoidectomy|mastoidectomy
5418544|NCT01638052|Cholesteatoma|cholesteatoma
5418545|NCT01638052|Pediatrics|pediatrics
5418546|NCT01638052|Clonidine|clonidine
5418547|NCT01638052|Bupivacaine|bupivacaine
5418548|NCT01638052|Greater Auricular Nerve Block|greater auricular nerve block
5418549|NCT01638052|Regional Anesthesia|regional anesthesia
5418550|NCT01638026|Gnrh agonist|gnrh agonist
5418551|NCT01638013|Smyraf|smyraf
5418552|NCT01638013|Rheumatoid Arthritis|rheumatoid arthritis
5418553|NCT01638013|Peficitinib|peficitinib
5418554|NCT01638013|ASP015K|asp015k
5418555|NCT01638000|Vesitrim|vesitrim
5418556|NCT01638000|Frequency|frequency
5418557|NCT01638000|Urgency|urgency
5418558|NCT01638000|Urgency incontinence|urgency incontinence
5418559|NCT01638000|Urinary incontinence|urinary incontinence
5418560|NCT01638000|Overactive Bladder (OAB)|overactive bladder (oab)
5418561|NCT01638000|Micturition|micturition
5418562|NCT01638000|Mirabegron|mirabegron
5418563|NCT01638000|YM178|ym178
5418564|NCT01638000|Vesicare|vesicare
5418565|NCT01638000|Solifenacin|solifenacin
5418566|NCT01637987|Peripheral intravenous catheter|peripheral intravenous catheter
5418567|NCT01637987|Vein visualization|vein visualization
5418568|NCT01637987|Transillumination|transillumination
5418569|NCT01637987|Near infrared light|near infrared light
5418570|NCT01637948|Chinese medicine|chinese medicine
5418571|NCT01637948|gingivitis|gingivitis
5418572|NCT01637948|cytokine|cytokine
5418573|NCT01637948|microbial|microbial
5418574|NCT01637935|Drug therapy|drug therapy
5418575|NCT01637909|Prehypertension, Hypertension|prehypertension, hypertension
5418576|NCT01637883|benzydamine HCl|benzydamine hcl
5418577|NCT01637883|endotracheal tube|endotracheal tube
5418578|NCT01637883|postoperative sore throat|postoperative sore throat
5418579|NCT01637870|Cesarean delivery|cesarean delivery
5418580|NCT01637870|Postpartum infection|postpartum infection
5418581|NCT01637870|Wound complications|wound complications
5418582|NCT01637870|Wound seroma|wound seroma
5418583|NCT01637870|Wound separation|wound separation
5418584|NCT01637870|Wound infection|wound infection
5421962|NCT01621906|Breast|breast
5418593|NCT01637831|Obstructive Sleep Apnea|obstructive sleep apnea
5418594|NCT01637831|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5418595|NCT01637818|Inguinal hernia repair|inguinal hernia repair
5418596|NCT01637818|long-term follow-up|long-term follow-up
5418597|NCT01637818|Surgical technique|surgical technique
5418598|NCT01637792|peritoneal dialysis|peritoneal dialysis
5418599|NCT01637792|dose|dose
5418600|NCT01637792|residual kidney function|residual kidney function
5418601|NCT01637792|technique survival|technique survival
5418602|NCT01637792|patient survival|patient survival
5418603|NCT01637792|peritonitis|peritonitis
5418604|NCT01637779|randomized controlled trial|randomized controlled trial
5418605|NCT01637779|parent education|parent education
5418606|NCT01637779|pain management|pain management
5418607|NCT01637779|infant|infant
5418608|NCT01637779|immunization|immunization
5418609|NCT01637766|Spinal Metastases|spinal metastases
5418610|NCT01637766|Spinal Metastatic Disease|spinal metastatic disease
5418611|NCT01637766|Cord Compression|cord compression
5418612|NCT01637766|Intra-arterial Chemotherapy|intra-arterial chemotherapy
5418613|NCT01637766|Spinal Tumors|spinal tumors
5418614|NCT01637740|myopia|myopia
5418615|NCT01637740|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5418616|NCT01637740|optical low coherence reflectometry|optical low coherence reflectometry
5418617|NCT01637740|ocular optical components|ocular optical components
5418618|NCT01637740|cataract|cataract
5445472|NCT01521572|bronchial reversibility,|bronchial reversibility,
5418619|NCT01637727|Long term effects of gestational diabetes mellitus in a population of parous women|long term effects of gestational diabetes mellitus in a population of parous women
5418620|NCT01637727|Gestational diabetes mellitus- GDM is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth|gestational diabetes mellitus- gdm is defined as glucose intolerance diagnosed during pregnancy and not present shortly after birth
5418621|NCT01637701|benign prostatic hypertrophy|benign prostatic hypertrophy
5418622|NCT01637701|bipolar transurethral resection of the prostate|bipolar transurethral resection of the prostate
5418623|NCT01637701|plasmakinetic enucleation of the prostate|plasmakinetic enucleation of the prostate
5418624|NCT01637688|cow milk allergy|cow milk allergy
5418625|NCT01637688|amino acid formula|amino acid formula
5418626|NCT01637675|sodium tanshinone IIA sulfonate|sodium tanshinone iia sulfonate
5418627|NCT01637675|pulmonary hypertension|pulmonary hypertension
5418628|NCT01637649|dysphagia,diaphragm, ultrasonography, inspiration, expiration,|dysphagia,diaphragm, ultrasonography, inspiration, expiration,
5418629|NCT01637636|rifampin,|rifampin,
5418630|NCT01637636|ketoconazole,|ketoconazole,
5418631|NCT01637636|CYP3A4,|cyp3a4,
5418632|NCT01637636|tasimelteon,|tasimelteon,
5418633|NCT01637636|VEC-162|vec-162
5418634|NCT01637636|Pharmacokinetics|pharmacokinetics
5418635|NCT01637623|Hypertension|hypertension
5418636|NCT01637623|High Blood Pressure|high blood pressure
5418637|NCT01637623|Sleep Apnea|sleep apnea
5418638|NCT01637623|Obstructive Sleep Apnea|obstructive sleep apnea
5418640|NCT01637610|placental alpha microglobulin-1|placental alpha microglobulin-1
5418641|NCT01637610|AmniSure|amnisure
5418642|NCT01637610|preterm|preterm
5418643|NCT01637610|rupture of fetal membranes|rupture of fetal membranes
5418644|NCT01637597|Non-small cell lung cancer(NSCLC)|non-small cell lung cancer(nsclc)
5418645|NCT01637571|GERD|gerd
5418646|NCT01637571|NCCP|nccp
5418647|NCT01637571|chest pain|chest pain
5418648|NCT01637571|reflux|reflux
5556140|NCT01061931|MRI|mri
5418649|NCT01637571|GERD related non-cardiac chest pain|gerd related non-cardiac chest pain
5418650|NCT01637545|facial bones|facial bones
5418651|NCT01637545|Post operative nasea vomiting|post operative nasea vomiting
5418652|NCT01637545|fractures|fractures
5418653|NCT01637545|reduction|reduction
5418654|NCT01637519|kidney stones|kidney stones
5418655|NCT01637519|ureteral stones|ureteral stones
5418656|NCT01637519|stent|stent
5418657|NCT01637506|urine|urine
5418658|NCT01637506|stool|stool
5418659|NCT01637506|kidney stones|kidney stones
5418660|NCT01637493|Pegylation|pegylation
5418661|NCT01637493|G-CSF|g-csf
5418662|NCT01637493|Pharmacokinetics|pharmacokinetics
5418663|NCT01637493|Pharmacodynamics|pharmacodynamics
5418664|NCT01637467|critical illness|critical illness
5418665|NCT01637467|myopathy|myopathy
5418666|NCT01637467|electrical muscle stimulation|electrical muscle stimulation
5418667|NCT01637454|noradrenaline terlipressin type 2 HRS|noradrenaline terlipressin type 2 hrs
5423347|NCT01616069|Heart Failure|heart failure
5418668|NCT01637441|bladder prolapse (cystocele)|bladder prolapse (cystocele)
5418669|NCT01637441|Pelvic organ prolapse repair|pelvic organ prolapse repair
5418670|NCT01637441|coelioscopic|coelioscopic
5418671|NCT01637441|prosthetic surgery|prosthetic surgery
5418672|NCT01637441|vaginal approach|vaginal approach
5418673|NCT01637441|Randomized study|randomized study
5418674|NCT01637441|laparoscopic sacropexy|laparoscopic sacropexy
5418675|NCT01637441|vaginal mesh surgery|vaginal mesh surgery
5418676|NCT01637441|Stage II|stage ii
5418677|NCT01637441|Clavien Dindo|clavien dindo
5418678|NCT01637415|alcohol withdrawal syndrome|alcohol withdrawal syndrome
5418679|NCT01637415|prediction|prediction
5418680|NCT01637415|severity|severity
5418681|NCT01637415|alcohol use disorder|alcohol use disorder
5418682|NCT01637415|complicated alcohol withdrawal|complicated alcohol withdrawal
5418683|NCT01637415|alcohol withdrawal seizures|alcohol withdrawal seizures
5418684|NCT01637415|delirium tremens|delirium tremens
5418686|NCT01637402|CRPC|crpc
5418687|NCT01637402|prostate|prostate
5418688|NCT01637402|cancer|cancer
5418689|NCT01637376|Lung neoplasms|lung neoplasms
5418691|NCT01637376|Non small cell lung cancer|non small cell lung cancer
5418692|NCT01637376|Large cell carcinoma|large cell carcinoma
5418693|NCT01637376|squamous cell carcinoma|squamous cell carcinoma
5418695|NCT01637363|Psychoeducation|psychoeducation
5418696|NCT01637363|Stress|stress
5418697|NCT01637363|Sickness absence|sickness absence
5418698|NCT01637363|Psychiatric symptoms|psychiatric symptoms
5418699|NCT01637363|Locus of control|locus of control
5418700|NCT01637363|Self reported health|self reported health
5418701|NCT01637324|To assess VCT and linkage into care|to assess vct and linkage into care
5418702|NCT01637324|nPEP|npep
5418703|NCT01637324|STIs|stis
5418704|NCT01637324|anal dysplasia/cancer|anal dysplasia/cancer
5418705|NCT01637324|hyperlipidemia|hyperlipidemia
5418706|NCT01637324|diabetes|diabetes
5680252|NCT00578500|oocyte cryopreservation, ovarian transplantation|oocyte cryopreservation, ovarian transplantation
5680253|NCT00578474|Acute otitis media|acute otitis media
5445473|NCT01521572|bronchodilator,|bronchodilator,
5445474|NCT01521572|respiratory impedance,|respiratory impedance,
5418707|NCT01637324|Proportion of first-time MSM clients attending multidisciplinary services who undergo HIV testing|proportion of first-time msm clients attending multidisciplinary services who undergo hiv testing
5418708|NCT01637324|Proportion of MSM clients who have repeated HIV testing during the first six months after the first negative HIV test|proportion of msm clients who have repeated hiv testing during the first six months after the first negative hiv test
5418709|NCT01637324|Proportion of HIV-positive MSM who receive HIV care within three months after HIV diagnosis or enrolment|proportion of hiv-positive msm who receive hiv care within three months after hiv diagnosis or enrolment
5418710|NCT01637324|Proportion of HIV-positive MSM who still remain in HIV care at six months after enrollment|proportion of hiv-positive msm who still remain in hiv care at six months after enrollment
5418711|NCT01637311|Peroral endoscopic myotomy|peroral endoscopic myotomy
5418712|NCT01637311|Heller myotomy|heller myotomy
5418713|NCT01637311|persistent/recurrent achalasia.|persistent/recurrent achalasia.
5418714|NCT01637298|Histological HGAIN|histological hgain
5418715|NCT01637298|detected biomarkers|detected biomarkers
5418716|NCT01637298|MSM population|msm population
5418717|NCT01637298|HPV subtypes|hpv subtypes
5418718|NCT01637298|AIN study|ain study
5418719|NCT01637298|HIV-positive and HIV-negative MSM|hiv-positive and hiv-negative msm
5418720|NCT01637298|anal cytology and biomarkers|anal cytology and biomarkers
5418721|NCT01637298|likelihood of AIN development at month 12 and yearly thereafter|likelihood of ain development at month 12 and yearly thereafter
5418722|NCT01637272|Dumping syndrome|dumping syndrome
5418723|NCT01637272|SOM230|som230
5418724|NCT01637272|pasireotide LAR|pasireotide lar
5418725|NCT01637259|proteinuria|proteinuria
5418726|NCT01637259|HIV|hiv
5418727|NCT01637233|HIV-1 infection|hiv-1 infection
5418728|NCT01637233|neurocognitive function|neurocognitive function
5418729|NCT01637233|switch study|switch study
5418730|NCT01637220|Anaphylaxis|anaphylaxis
5418731|NCT01637220|Neutrophils|neutrophils
5418732|NCT01637220|Platelet activating factor|platelet activating factor
5418733|NCT01637220|Neutrophil Extracellular Traps (NETs)|neutrophil extracellular traps (nets)
5418734|NCT01637168|Disorders of cognitive function|disorders of cognitive function
5418735|NCT01637155|Cholecalciferol|cholecalciferol
5418736|NCT01637129|Childhood stroke|childhood stroke
5418737|NCT01637129|Perinatal stroke|perinatal stroke
5418738|NCT01637129|Pediatric stroke|pediatric stroke
5418739|NCT01637129|Presumed perinatal stroke|presumed perinatal stroke
5418740|NCT01637129|Children who have hemiparesis|children who have hemiparesis
5418741|NCT01637103|Cancer|cancer
5418742|NCT01637103|Depression|depression
5418743|NCT01637103|Anxiety|anxiety
5418744|NCT01637103|Fatigue|fatigue
5418745|NCT01637103|Sleep|sleep
5418746|NCT01637103|Quality of life|quality of life
5418747|NCT01637103|Cognitive therapy|cognitive therapy
5418748|NCT01637103|Bright light therapy|bright light therapy
5418749|NCT01637064|Myositis|myositis
5418750|NCT01637064|Acthar treatment|acthar treatment
5418751|NCT01637038|ischemia/reperfusion injury|ischemia/reperfusion injury
5418752|NCT01637038|remote ischemic postconditioning|remote ischemic postconditioning
5418753|NCT01637012|ALEX|alex
5418754|NCT01637012|coronary stent|coronary stent
5418755|NCT01637012|cobalt-chromium|cobalt-chromium
5418756|NCT01637012|sirolimus|sirolimus
5418757|NCT01637012|OCT|oct
5418758|NCT01636999|Sedara|sedara
5418759|NCT01636999|Nitrous Oxide|nitrous oxide
5418760|NCT01636999|Butorphanol|butorphanol
5418761|NCT01636999|Visual Analog Scale|visual analog scale
5418762|NCT01636986|myopia|myopia
5418763|NCT01636986|contact lenses|contact lenses
5418764|NCT01636986|dry eyes|dry eyes
5418765|NCT01636986|comfort|comfort
5418766|NCT01636986|replacement|replacement
5418767|NCT01636973|Lung cancer|lung cancer
5418768|NCT01636947|chemotherapy|chemotherapy
5418769|NCT01636947|nausea|nausea
5002971|NCT03977558|Cardiometabolic parameters|cardiometabolic parameters
5418770|NCT01636947|vomiting|vomiting
5418771|NCT01636947|emetogenic|emetogenic
5418772|NCT01636947|cancer|cancer
5418773|NCT01636947|antiemetics|antiemetics
5418774|NCT01636947|tumor|tumor
5418775|NCT01636934|Lung Cancer|lung cancer
5418776|NCT01636934|Non Small Cell Lung Cancer|non small cell lung cancer
5418777|NCT01636934|NSCLC|nsclc
5418780|NCT01636934|CXRT|cxrt
5418781|NCT01636934|Minocycline|minocycline
5418782|NCT01636934|Dynacin|dynacin
5418783|NCT01636934|Minocin|minocin
5418784|NCT01636934|Minocin PAC|minocin pac
5418785|NCT01636934|Myrac|myrac
5418786|NCT01636934|Solodyn|solodyn
5418787|NCT01636934|Placebo|placebo
5418788|NCT01636934|Sugar Pill|sugar pill
5418789|NCT01636934|Questionnaires|questionnaires
5418790|NCT01636934|Surveys|surveys
5418791|NCT01636895|malaria|malaria
5418792|NCT01636895|pregnancy|pregnancy
5418793|NCT01636895|prevention|prevention
5418794|NCT01636895|treatment|treatment
5418795|NCT01636895|molecular markers|molecular markers
5418796|NCT01636882|Melanoma|melanoma
5418797|NCT01636882|CALM|calm
5418798|NCT01636869|bupivacaine level|bupivacaine level
5418799|NCT01636869|periarticular block|periarticular block
5418800|NCT01636869|total knee arthroplasty|total knee arthroplasty
5418927|NCT01636245|71 vaccine|71 vaccine
5418801|NCT01636856|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, PCRIT, negative expiratory pressure, snore|oropharyngeal exercises, obstructive sleep apnea, speech therapy, magnetic resonance, pcrit, negative expiratory pressure, snore
5418802|NCT01636830|Toothbrushing|toothbrushing
5418803|NCT01636830|gingival recession|gingival recession
5418804|NCT01636804|Quicksite|quicksite
5418805|NCT01636804|Quickflex|quickflex
5418806|NCT01636804|St. Jude Medical|st. jude medical
5418807|NCT01636778|Thrombocytopenia|thrombocytopenia
5418808|NCT01636778|Hepatitis C, chronic|hepatitis c, chronic
5418809|NCT01636739|Intussusceptions|intussusceptions
5418810|NCT01636739|Special Drug Use Investigation|special drug use investigation
5418811|NCT01636739|Rotavirus|rotavirus
5418812|NCT01636726|COPD|copd
5418813|NCT01636726|AMI|ami
5418814|NCT01636726|Asthma|asthma
5418815|NCT01636726|LABAs|labas
5418816|NCT01636700|Tramadol infiltration|tramadol infiltration
5418817|NCT01636700|Analgesic effect|analgesic effect
5418818|NCT01636700|Serum IL-6|serum il-6
5418819|NCT01636687|Psoriasis|psoriasis
5418820|NCT01636687|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
5418821|NCT01636687|Skin condition|skin condition
5418822|NCT01636687|skin disease|skin disease
5418823|NCT01636687|itching condition|itching condition
5418824|NCT01636687|psoriasis vulgaris|psoriasis vulgaris
5418825|NCT01636687|relapsing/remitting psoriasis|relapsing/remitting psoriasis
5418826|NCT01636687|immune-mediated systemic disease|immune-mediated systemic disease
5418827|NCT01636687|skin lesions|skin lesions
5418828|NCT01636687|red skin lesions|red skin lesions
5418829|NCT01636687|scaly patches|scaly patches
5418830|NCT01636687|papules|papules
5418831|NCT01636687|plaques|plaques
5418832|NCT01636687|itching|itching
5418833|NCT01636674|positron emission tomography|positron emission tomography
5418834|NCT01636674|computed tomography|computed tomography
5418835|NCT01636674|fluordeoxyglucose|fluordeoxyglucose
5418836|NCT01636674|colon cancer|colon cancer
5418837|NCT01636674|cancer|cancer
5556364|NCT01060982|Calcium|calcium
5418838|NCT01636674|staging|staging
5418839|NCT01636674|imaging|imaging
5418840|NCT01636648|Aortic Valve Replacement|aortic valve replacement
5418841|NCT01636648|Aortic Valve Bioprosthesis|aortic valve bioprosthesis
5418842|NCT01636622|Advanced Cancers|advanced cancers
5418843|NCT01636622|Advanced Malignancy|advanced malignancy
5418844|NCT01636622|BRAF Mutation|braf mutation
5418845|NCT01636622|Advanced solid tumor|advanced solid tumor
5418846|NCT01636622|Lymphoma|lymphoma
5418847|NCT01636622|Vemurafenib|vemurafenib
5418848|NCT01636622|PLX4032|plx4032
5418849|NCT01636622|RO5185426|ro5185426
5418850|NCT01636622|Carboplatin|carboplatin
5418851|NCT01636622|Paraplatin|paraplatin
5418852|NCT01636622|Paclitaxel|paclitaxel
5418853|NCT01636622|Taxol|taxol
5418854|NCT01636596|Alzheimer's Disease|alzheimer's disease
5418855|NCT01636596|Mild Cognitive Impairment|mild cognitive impairment
5418856|NCT01636596|Insulin|insulin
5418857|NCT01636596|Pulsatile|pulsatile
5418858|NCT01636583|zinc|zinc
5418859|NCT01636583|absorption|absorption
5418860|NCT01636583|bio-availability|bio-availability
5418861|NCT01636583|aqueous zinc|aqueous zinc
5418862|NCT01636583|zinc deficiency|zinc deficiency
5418863|NCT01636583|zinc fortification|zinc fortification
5418864|NCT01636570|Vitamin D|vitamin d
5418865|NCT01636570|Cholecalciferol|cholecalciferol
5418866|NCT01636570|Heart Failure|heart failure
5418867|NCT01636570|Congestive heart failure|congestive heart failure
5418868|NCT01636570|Cardiomyopathy|cardiomyopathy
5418869|NCT01636570|Strength|strength
5418870|NCT01636570|Parathyroid Hormone|parathyroid hormone
5418871|NCT01636570|Calcium|calcium
5406022|NCT01694992|Early Ambulation|early ambulation
5418872|NCT01636570|Quality of Life|quality of life
5418873|NCT01636570|C reactive protein|c reactive protein
5418874|NCT01636570|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5418875|NCT01636570|Prognosis|prognosis
5418876|NCT01636557|Rheumatoid arthritis|rheumatoid arthritis
5418877|NCT01636557|sirukumab|sirukumab
5418878|NCT01636557|CNTO 136|cnto 136
5418880|NCT01636557|anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
5418881|NCT01636466|Chronic allograft failure|chronic allograft failure
5418882|NCT01636466|Kidney Transplantation|kidney transplantation
5418884|NCT01636453|saccular|saccular
5418885|NCT01636453|intracranial aneurysms|intracranial aneurysms
5418887|NCT01636453|Stent assisted coiling|stent assisted coiling
5418888|NCT01636453|Liberty Stent|liberty stent
5418889|NCT01636440|Conditioned Pain Modulation|conditioned pain modulation
5418890|NCT01636427|myocardial infarction|myocardial infarction
5418891|NCT01636427|coronary angiography|coronary angiography
5418892|NCT01636427|STEMI|stemi
5418893|NCT01636427|NSTEMI|nstemi
5418894|NCT01636414|Total joint arthroplasty, blood loss|total joint arthroplasty, blood loss
5418895|NCT01636388|Relapsed Hodgkins Lymphoma|relapsed hodgkins lymphoma
5418896|NCT01636388|Refractory Hodgkins Lymphoma|refractory hodgkins lymphoma
5418897|NCT01636388|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5418898|NCT01636388|Adoptive Immunotherapy|adoptive immunotherapy
5418899|NCT01636388|Cellular Therapy|cellular therapy
5418900|NCT01636388|Cytotoxic T cell lymphocytes|cytotoxic t cell lymphocytes
5418901|NCT01636362|Partial-thickness second degree burns|partial-thickness second degree burns
5418902|NCT01636362|Mepitel Ag|mepitel ag
5418903|NCT01636362|Silver dressing|silver dressing
5418904|NCT01636349|Type 2 diabetes|type 2 diabetes
5418905|NCT01636349|hypertension|hypertension
5418906|NCT01636349|obesity|obesity
5418907|NCT01636349|metabolic syndrome|metabolic syndrome
5418908|NCT01636297|Parkinson's disease|parkinson's disease
5418909|NCT01636297|Exercise|exercise
5418910|NCT01636284|Liver Cancer|liver cancer
5418911|NCT01636284|HCC|hcc
5418912|NCT01636284|first line HCC|first line hcc
5418913|NCT01636284|Pexa-Vec|pexa-vec
5418914|NCT01636284|JX-594|jx-594
5418915|NCT01636271|CV Risk|cv risk
5418916|NCT01636271|Cardiovascular Disease|cardiovascular disease
5418917|NCT01636271|Atherosclerosis|atherosclerosis
5418918|NCT01636271|Acute coronary syndrome|acute coronary syndrome
5418919|NCT01636258|Prediabetes|prediabetes
5418920|NCT01636258|Overweight|overweight
5418921|NCT01636258|African American|african american
5418922|NCT01636258|Women|women
5418923|NCT01636258|Cooking|cooking
5418924|NCT01636258|Nutrition|nutrition
5418925|NCT01636258|Exercise|exercise
5418926|NCT01636258|Stress Management|stress management
5418929|NCT01636245|consistency of three consecutive lots|consistency of three consecutive lots
5418930|NCT01636245|immunogenicity|immunogenicity
5418931|NCT01636232|Vitamin D|vitamin d
5418932|NCT01636232|infection|infection
5418933|NCT01636232|disease severity|disease severity
5418934|NCT01636232|mortality|mortality
5418935|NCT01636232|critically ill|critically ill
5418936|NCT01636232|sepsis|sepsis
5418937|NCT01636219|Spirometry,|spirometry,
5418938|NCT01636219|Cough|cough
5418939|NCT01636193|Rotavirus|rotavirus
5418940|NCT01636193|Rotarix|rotarix
5418941|NCT01636193|Drug Use Investigation|drug use investigation
5418943|NCT01636180|STEMI|stemi
5418944|NCT01636180|NSTEMI|nstemi
5418945|NCT01636180|clopidogrel|clopidogrel
5418946|NCT01636180|Areplex|areplex
5418947|NCT01636180|REL-0609|rel-0609
5418948|NCT01636154|fire-heat syndrome|fire-heat syndrome
5418949|NCT01636154|blood stasis syndrome|blood stasis syndrome
5418950|NCT01636154|method of clearing heat|method of clearing heat
5418951|NCT01636154|method of promoting blood circulation|method of promoting blood circulation
5418952|NCT01636154|medicinal fractions-based herbal combinations|medicinal fractions-based herbal combinations
5418953|NCT01636141|Safety|safety
5418954|NCT01636141|Tolerability|tolerability
5418955|NCT01636141|Pharmacokinetics|pharmacokinetics
5418956|NCT01636141|Dose escalation|dose escalation
5418957|NCT01636141|Randomized|randomized
5418958|NCT01636141|Healthy volunteers|healthy volunteers
5418959|NCT01636141|Topical|topical
5418960|NCT01636141|OLT1177|olt1177
5418961|NCT01636141|Olatec|olatec
5418962|NCT01636141|Pain|pain
5418963|NCT01636141|Inflammation|inflammation
5418964|NCT01636128|Urinary|urinary
5418965|NCT01636128|biomarkers|biomarkers
5418966|NCT01636128|DFMO|dfmo
5418967|NCT01636128|sulindac|sulindac
5418968|NCT01636102|Influenza|influenza
5418969|NCT01636102|Adults|adults
5418970|NCT01636102|Elderly|elderly
5418971|NCT01636102|Immunology|immunology
5418972|NCT01636102|Safety|safety
5418973|NCT01636089|intensive care unit|intensive care unit
5418974|NCT01636076|COPD|copd
5418975|NCT01636063|Induced Abortion|induced abortion
5418976|NCT01636063|Abortion Techniques|abortion techniques
5418977|NCT01636063|Mifepristone|mifepristone
5406116|NCT01694680|AMD|amd
5418978|NCT01636063|Misoprostol|misoprostol
5418979|NCT01636063|Initial Cervical Dilation|initial cervical dilation
5418980|NCT01636050|squat exercise|squat exercise
5418981|NCT01636037|schizophrenia|schizophrenia
5418982|NCT01636037|negative symptoms|negative symptoms
5418983|NCT01636037|deficit syndrome|deficit syndrome
5418984|NCT01636037|SANS|sans
5418985|NCT01636037|Sinemet|sinemet
5418986|NCT01636037|L-dopa|l-dopa
5418987|NCT01636037|levodopa|levodopa
5418988|NCT01636037|carbidopa|carbidopa
5418989|NCT01636037|augmentation|augmentation
5418990|NCT01636037|antipsychotics|antipsychotics
5418991|NCT01636024|Phase 1,|phase 1,
5418992|NCT01636024|healthy volunteers,|healthy volunteers,
5418993|NCT01636024|safety,|safety,
5418994|NCT01636024|tolerability,|tolerability,
5418995|NCT01636024|pharmacokinetics,|pharmacokinetics,
5418996|NCT01636024|pharmacodynamics,|pharmacodynamics,
5418997|NCT01636024|single ascending dose study,|single ascending dose study,
5418998|NCT01636024|multiple|multiple
5418999|NCT01636011|Parkinson's Disease|parkinson's disease
5419000|NCT01636011|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5419001|NCT01636011|Speech|speech
5419002|NCT01636011|Pulmonary Function|pulmonary function
5419003|NCT01635998|renal sympathetic denervation|renal sympathetic denervation
5419004|NCT01635998|renal catheter ablation|renal catheter ablation
5419005|NCT01635998|hypertension|hypertension
5419006|NCT01635985|Phase I, Healthy male volunteers, pharmacokinetics|phase i, healthy male volunteers, pharmacokinetics
5419007|NCT01635972|Isavuconazole|isavuconazole
5419008|NCT01635972|Bupropion|bupropion
5419009|NCT01635972|Bupropion hydrochloride|bupropion hydrochloride
5419010|NCT01635972|Healthy Volunteers|healthy volunteers
5419012|NCT01635972|BAL4815|bal4815
5419013|NCT01635972|BAL8728|bal8728
5419014|NCT01635959|upper gastro-intestinal symptoms, GERD|upper gastro-intestinal symptoms, gerd
5419015|NCT01635946|Isavuconazole|isavuconazole
5419016|NCT01635946|Atorvastatin|atorvastatin
5419017|NCT01635946|Healthy Volunteers|healthy volunteers
5419018|NCT01635946|BAL8557|bal8557
5419019|NCT01635946|BAL4815|bal4815
5419020|NCT01635946|BAL8728|bal8728
5419021|NCT01635933|contact lenses|contact lenses
5419022|NCT01635933|color contact lenses|color contact lenses
5419023|NCT01635933|myopia|myopia
5419024|NCT01635920|contact lenses|contact lenses
5419025|NCT01635920|color contact lenses|color contact lenses
5419026|NCT01635920|myopia|myopia
5419027|NCT01635894|female pelvic floor condition|female pelvic floor condition
5419028|NCT01635894|pelvic floor training|pelvic floor training
5419029|NCT01635894|supervised pelvic floor training|supervised pelvic floor training
5419030|NCT01635894|practice nurse|practice nurse
5419031|NCT01635894|nurse specialist|nurse specialist
5419032|NCT01635842|Patient|patient
5419033|NCT01635842|information leaflet|information leaflet
5419034|NCT01635842|informed consent|informed consent
5419035|NCT01635842|awareness|awareness
5419036|NCT01635829|Healthy participants|healthy participants
5419037|NCT01635829|Hepatitis C virus|hepatitis c virus
5419038|NCT01635829|Telaprevir|telaprevir
5419039|NCT01635829|Phenytoin|phenytoin
5419040|NCT01635829|Carbamazepine|carbamazepine
5419041|NCT01635829|HCV|hcv
5419042|NCT01635829|Interaction|interaction
5419043|NCT01635816|Immunogenicity|immunogenicity
5419044|NCT01635816|SA 14-14-2 JE vaccine|sa 14-14-2 je vaccine
5419045|NCT01635816|Bangladesh|bangladesh
5419046|NCT01635803|bevacizumab|bevacizumab
5419047|NCT01635803|ranibizumab|ranibizumab
5419048|NCT01635803|retinal vein occlusions|retinal vein occlusions
5419049|NCT01635803|randomized clinical trial|randomized clinical trial
5419050|NCT01635803|Macular edema|macular edema
5419051|NCT01635790|bevacizumab|bevacizumab
5419052|NCT01635790|ranibizumab|ranibizumab
5419053|NCT01635790|diabetic macular edema|diabetic macular edema
5419054|NCT01635790|randomized clinical trial|randomized clinical trial
5419055|NCT01635777|PKDL|pkdl
5419056|NCT01635777|miltefosine|miltefosine
5419057|NCT01635764|hidradenitis suppurativa|hidradenitis suppurativa
5419058|NCT01635764|open-label|open-label
5419059|NCT01635764|acne inversa|acne inversa
5419060|NCT01635764|PIONEER (OPEN-LABEL EXTENSION)|pioneer (open-label extension)
5419061|NCT01635764|adalimumab|adalimumab
5419062|NCT01635764|HS|hs
5419063|NCT01635764|acne|acne
5419064|NCT01635764|tumor necrosis factor|tumor necrosis factor
5419065|NCT01635764|abscess|abscess
5419066|NCT01635764|inflammatory nodule|inflammatory nodule
5419067|NCT01635751|Pregabalin|pregabalin
5419068|NCT01635751|GLARS|glars
5419069|NCT01635738|Probiotics|probiotics
5419070|NCT01635738|Lactobacillus paracasei GMNL-133|lactobacillus paracasei gmnl-133
5419071|NCT01635738|Lactobacillus fermentum GM-090|lactobacillus fermentum gm-090
5419072|NCT01635738|Atopic dermatitis|atopic dermatitis
5419074|NCT01635738|Lactobacillus paracasei|lactobacillus paracasei
5419075|NCT01635738|Lactobacillus fermentum|lactobacillus fermentum
5419076|NCT01635738|efficacy and safety|efficacy and safety
5419077|NCT01635725|colonoscopy|colonoscopy
5419078|NCT01635725|bowel cleanliness|bowel cleanliness
5419079|NCT01635725|bowel rating scale|bowel rating scale
5419080|NCT01635712|Hematological Malignancy|hematological malignancy
5419081|NCT01635712|Hsp90|hsp90
5419082|NCT01635699|DNA oxidation|dna oxidation
5419083|NCT01635699|obstructive sleep apnea|obstructive sleep apnea
5419084|NCT01635699|lipid peroxidation|lipid peroxidation
5419085|NCT01635699|oxidative stresses|oxidative stresses
5419086|NCT01635673|Exercise|exercise
5419087|NCT01635673|Latino|latino
5419088|NCT01635673|Hispanic|hispanic
5419089|NCT01635673|Boys|boys
5419090|NCT01635660|Out-of-hospital|out-of-hospital
5419091|NCT01635660|airway management|airway management
5419092|NCT01635660|intubation|intubation
5419093|NCT01635660|video laryngoscope|video laryngoscope
5419094|NCT01635634|Fibromyalgia|fibromyalgia
5419095|NCT01635634|Cupping|cupping
5419096|NCT01635621|Olokizumab|olokizumab
5419097|NCT01635621|OKZ|okz
5419098|NCT01635621|CDP6038|cdp6038
5419099|NCT01635621|Crohn's Disease|crohn's disease
5419100|NCT01635621|CDAI|cdai
5419101|NCT01635621|IBDQ|ibdq
5419102|NCT01635608|Pharmacokinetics|pharmacokinetics
5419103|NCT01635608|Talinolol|talinolol
5419104|NCT01635608|Amoxicillin|amoxicillin
5419105|NCT01635608|Acetaminophen|acetaminophen
5419106|NCT01635608|Magnetic Resonance Imaging|magnetic resonance imaging
5419107|NCT01635582|Hand exercises|hand exercises
5419108|NCT01635582|Hand function|hand function
5419109|NCT01635582|Computer based exercises|computer based exercises
5419110|NCT01635582|Therapeutic gaming|therapeutic gaming
5419111|NCT01635569|Obsessive-compulsive disorder|obsessive-compulsive disorder
5419112|NCT01635569|Pediatric|pediatric
5419113|NCT01635569|Group-based|group-based
5419114|NCT01635569|Cognitive-behavioural therapy|cognitive-behavioural therapy
5419115|NCT01635556|borderline personality disorder|borderline personality disorder
5419116|NCT01635556|dialectical behavior therapy|dialectical behavior therapy
5419117|NCT01635556|psychological treatment|psychological treatment
5419118|NCT01635530|doxycycline|doxycycline
5419119|NCT01635530|ceftriaxone|ceftriaxone
5419120|NCT01635517|Diuretics|diuretics
5419121|NCT01635517|Vasopressins|vasopressins
5419122|NCT01635517|Sodium|sodium
5419123|NCT01635504|HIV lipoatrophy|hiv lipoatrophy
5419124|NCT01635504|masseter hypertrophy|masseter hypertrophy
5419125|NCT01635504|parotid enlargement|parotid enlargement
5419126|NCT01635504|botulinum toxin|botulinum toxin
5419127|NCT01635491|Gastrointestinal Motility|gastrointestinal motility
5419128|NCT01635491|Transit time|transit time
5419129|NCT01635426|Aspirin|aspirin
5419130|NCT01635426|Clopidogrel|clopidogrel
5419131|NCT01635426|Unexplained recurrent pregnancy loss|unexplained recurrent pregnancy loss
5419132|NCT01635426|Uterine artery pulsatility index|uterine artery pulsatility index
5419133|NCT01635400|Irinotecan|irinotecan
5419134|NCT01635400|UGT1A1 Gene Polymorphisms|ugt1a1 gene polymorphisms
5419135|NCT01635400|Small Cell Carcinoma of Lung|small cell carcinoma of lung
5419136|NCT01635348|gait speed|gait speed
5419137|NCT01635348|cognitive processing speed|cognitive processing speed
5419138|NCT01635335|HIV prevention|hiv prevention
5419139|NCT01635335|adolescents|adolescents
5419140|NCT01635335|Latinos|latinos
5419141|NCT01635335|Hispanics|hispanics
5419142|NCT01635335|family|family
5419143|NCT01635335|health promotion|health promotion
5419144|NCT01635335|disease prevention|disease prevention
5419145|NCT01635335|family communication|family communication
5419146|NCT01635335|parental supervision|parental supervision
5419147|NCT01635322|deformity|deformity
5419148|NCT01635322|adult|adult
5419149|NCT01635322|lumbar|lumbar
5419150|NCT01635322|thoraco-lumbar|thoraco-lumbar
5419151|NCT01635322|Sagittal vertebral Alignement (SVA)|sagittal vertebral alignement (sva)
5419152|NCT01635322|Oswestry Disability Index (ODI)|oswestry disability index (odi)
5419153|NCT01635257|pulmonary embolism diagnosis|pulmonary embolism diagnosis
5419154|NCT01635257|ultrasound|ultrasound
5419155|NCT01635244|Aortic valve prosthesis|aortic valve prosthesis
5419156|NCT01635244|Aortic valve hemodynamics|aortic valve hemodynamics
5419157|NCT01635244|Prosthesis-patient mismatch|prosthesis-patient mismatch
5419158|NCT01635244|Left ventricular diastolic function|left ventricular diastolic function
5419159|NCT01635244|Left ventricular remodeling|left ventricular remodeling
5419160|NCT01635231|Nephrology|nephrology
5419161|NCT01635231|sodium-channels|sodium-channels
5419162|NCT01635231|water-channels|water-channels
5419163|NCT01635231|BCM|bcm
5419164|NCT01635231|central blood pressure|central blood pressure
5419165|NCT01635218|Depression|depression
5419166|NCT01635218|Perimenopause|perimenopause
5419167|NCT01635218|Postmenopause|postmenopause
5419168|NCT01635218|Homeopathy|homeopathy
5419169|NCT01635205|Paraspinous block|paraspinous block
5419170|NCT01635205|Non-responsive chronic pelvic pain|non-responsive chronic pelvic pain
5419171|NCT01635192|renin|renin
5419172|NCT01635192|angiotensin|angiotensin
5419173|NCT01635192|probiotic|probiotic
5419174|NCT01635192|glucose absorption|glucose absorption
5419175|NCT01635192|intestinal|intestinal
5419176|NCT01635179|Videolaryngoscopy|videolaryngoscopy
5419177|NCT01635179|Bronchial Aspiration|bronchial aspiration
5419178|NCT01635179|Hypoxia|hypoxia
5419179|NCT01635166|Arthroplasty|arthroplasty
5419180|NCT01635166|Replacement|replacement
5419182|NCT01635166|Cementless|cementless
5419183|NCT01635166|Ceramic on Ceramic|ceramic on ceramic
5419184|NCT01635153|HIV|hiv
5419185|NCT01635153|Tuberculosis|tuberculosis
5419186|NCT01635153|Nutrition|nutrition
5419187|NCT01635140|DIPG|dipg
5419188|NCT01635140|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5419189|NCT01635140|Radiotherapy|radiotherapy
5419190|NCT01635140|Median survival|median survival
5419191|NCT01635101|Moderate to severe acute pain following surgery or trauma|moderate to severe acute pain following surgery or trauma
5419193|NCT01635088|FEV1 and IOS change after mometasone for asthma|fev1 and ios change after mometasone for asthma
5419194|NCT01635075|psychiatric|psychiatric
5419195|NCT01635075|comorbidity|comorbidity
5419196|NCT01635075|craving|craving
5419197|NCT01635075|tobacco|tobacco
5419198|NCT01635049|in vitro fertilization|in vitro fertilization
5419199|NCT01635049|assisted reproduction techniques|assisted reproduction techniques
5419200|NCT01635049|noninvasive imaging of embryos|noninvasive imaging of embryos
5419201|NCT01635049|time lapse imaging of embryos|time lapse imaging of embryos
5419202|NCT01635049|traditional morphological grading of embryos|traditional morphological grading of embryos
5419203|NCT01635049|prediction of blastocysts|prediction of blastocysts
5419204|NCT01635049|infertility|infertility
5419205|NCT01635049|preimplantation genetic diagnosis|preimplantation genetic diagnosis
5419206|NCT01635049|comprehensive chromosome screening|comprehensive chromosome screening
5419207|NCT01635036|in vitro fertilization|in vitro fertilization
5419208|NCT01635036|assisted reproduction techniques|assisted reproduction techniques
5402129|NCT01712256|CD4|cd4
5419209|NCT01635036|noninvasive imaging of embryos|noninvasive imaging of embryos
5419210|NCT01635036|time lapse imaging of embryos|time lapse imaging of embryos
5419211|NCT01635036|traditional morphological grading of embryos|traditional morphological grading of embryos
5419212|NCT01635036|prediction of blastocyst formation|prediction of blastocyst formation
5419213|NCT01635036|infertility|infertility
5419214|NCT01635036|male factor female factor|male factor female factor
5419215|NCT01635036|embryo viability|embryo viability
5419216|NCT01635023|Phase I|phase i
5419217|NCT01635023|healthy volunteers|healthy volunteers
5419218|NCT01635023|AZD6244|azd6244
5419219|NCT01635023|pharmacokinetics|pharmacokinetics
5419221|NCT01635023|Cmax|cmax
5419222|NCT01635023|tmax|tmax
5419223|NCT01635023|AUC(0-t)|auc(0-t)
5419224|NCT01635010|obstructive sleep apnea|obstructive sleep apnea
5419225|NCT01635010|inflammation|inflammation
5419226|NCT01635010|oxidative stress|oxidative stress
5419227|NCT01635010|arterial stiffness|arterial stiffness
5419228|NCT01634997|Screening for Type 2 Diabetes|screening for type 2 diabetes
5419229|NCT01634984|expression of CDK5RAP2|expression of cdk5rap2
5419230|NCT01634971|Postoperative pancreatic fistula(POPF);|postoperative pancreatic fistula(popf);
5419231|NCT01634971|Postpancreatectomy hemorrhage(PPH);|postpancreatectomy hemorrhage(pph);
5419232|NCT01634971|Delayed gastric emptying (DGE);|delayed gastric emptying (dge);
5419233|NCT01634971|Bile leakage after pancreatic surgery;|bile leakage after pancreatic surgery;
5419234|NCT01634971|Anastomotic leakage|anastomotic leakage
5419235|NCT01634958|Allergic Rhinitis|allergic rhinitis
5419236|NCT01634958|Hayfever|hayfever
5419237|NCT01634958|Immunotherapy|immunotherapy
5419238|NCT01634958|Dose-Finding-Study|dose-finding-study
5419239|NCT01634945|anemia|anemia
5419240|NCT01634945|malaria|malaria
5419241|NCT01634945|malnutrition|malnutrition
5419242|NCT01634945|iron fortification|iron fortification
5419243|NCT01634945|intermittent preventive treatment|intermittent preventive treatment
5419244|NCT01634945|subsaharan africa|subsaharan africa
5419245|NCT01634945|ivory coast|ivory coast
5419246|NCT01634945|young children|young children
5419247|NCT01634932|Iron deficiency|iron deficiency
5419248|NCT01634932|Biofortification|biofortification
5419249|NCT01634932|Pearl Millet|pearl millet
5419250|NCT01634932|Benin|benin
5419251|NCT01634919|Chronic hepatitis C|chronic hepatitis c
5419252|NCT01634919|Liver fibrosis|liver fibrosis
5419253|NCT01634919|ARFI(Acoustic radiation force impulse)|arfi(acoustic radiation force impulse)
5419254|NCT01634906|Apolipoprotein B, erythrocytes, statins|apolipoprotein b, erythrocytes, statins
5419255|NCT01634893|Refractory or Relapsed Solid Tumors|refractory or relapsed solid tumors
5419256|NCT01634880|Salivary Gland Malignancies|salivary gland malignancies
5419257|NCT01634880|Panitumumab|panitumumab
5419258|NCT01634880|Postoperative|postoperative
5419259|NCT01634880|Radiotherapy|radiotherapy
5419260|NCT01634841|walnuts|walnuts
5419261|NCT01634841|age related cognitive decline|age related cognitive decline
5419262|NCT01634841|age related macular degeneration|age related macular degeneration
5419263|NCT01634841|healthy elderly subjects|healthy elderly subjects
5419264|NCT01634802|Clinical Decision Support Systems|clinical decision support systems
5419265|NCT01634802|Electronic Medical Record|electronic medical record
5419266|NCT01634802|Resource constrained countries|resource constrained countries
5419268|NCT01634789|bioavailability|bioavailability
5419269|NCT01634763|Phase I, open-label, dose escalation, oral LDK378, Japanese patients with tumors characterized by ALK genetic alterations|phase i, open-label, dose escalation, oral ldk378, japanese patients with tumors characterized by alk genetic alterations
5523403|NCT01194804|PNH|pnh
5419270|NCT01634750|N-Acetyl-D-mannosamine (ManNAc)|n-acetyl-d-mannosamine (mannac)
5419271|NCT01634750|HIBM|hibm
5419272|NCT01634750|GNE Myopathy|gne myopathy
5419273|NCT01634737|shellfish|shellfish
5419274|NCT01634737|tropomyosin|tropomyosin
5419275|NCT01634737|mites|mites
5419276|NCT01634737|food allergy|food allergy
5419277|NCT01634724|GnRH agonist withdrawal|gnrh agonist withdrawal
5419278|NCT01634724|OHSS|ohss
5419279|NCT01634724|E2|e2
5419280|NCT01634724|VEGF|vegf
5419281|NCT01634711|ACL|acl
5414351|NCT01657695|HCC|hcc
5419282|NCT01634711|Anterior Cruciate Ligament|anterior cruciate ligament
5419283|NCT01634711|Ligament|ligament
5419284|NCT01634711|Resorbable polymer|resorbable polymer
5419285|NCT01634711|Knee ligament|knee ligament
5419286|NCT01634698|chronic liver disease|chronic liver disease
5419287|NCT01634698|cirrhosis|cirrhosis
5419288|NCT01634698|vitamin A|vitamin a
5419289|NCT01634698|RDR test|rdr test
5419290|NCT01634698|retinol-binding protein|retinol-binding protein
5419291|NCT01634685|Rectal cancer|rectal cancer
5419292|NCT01634685|Bavituximab|bavituximab
5419293|NCT01634685|Capecitabine|capecitabine
5419294|NCT01634685|Radiation Therapy|radiation therapy
5419295|NCT01634672|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5419296|NCT01634672|peritoneal dialysis|peritoneal dialysis
5419297|NCT01634672|hemodialysis|hemodialysis
5419298|NCT01634659|contact lenses|contact lenses
5419300|NCT01634646|Observational study|observational study
5419301|NCT01634633|Endometrial nerve fibres|endometrial nerve fibres
5402228|NCT01711827|isavuconazole|isavuconazole
5419302|NCT01634620|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5419303|NCT01634620|Chronic Obstructive Airways Disease|chronic obstructive airways disease
5419304|NCT01634620|Chronic Bronchitis|chronic bronchitis
5419305|NCT01634620|Chronic Emphysema|chronic emphysema
5419306|NCT01634620|Asthma|asthma
5419307|NCT01634607|osteopenia|osteopenia
5419308|NCT01634607|vitamin D deficiency|vitamin d deficiency
5419309|NCT01634607|HIV-infected patients|hiv-infected patients
5419310|NCT01634607|bone health|bone health
5419311|NCT01634607|Bone mineral density (BMD)|bone mineral density (bmd)
5419312|NCT01634607|HIV-uninfected patients|hiv-uninfected patients
5419313|NCT01634607|effects of TDF on the patients' bone|effects of tdf on the patients' bone
5419314|NCT01634594|Deliberate hypotension, QTc, Tp-e, heart rate variability|deliberate hypotension, qtc, tp-e, heart rate variability
5419315|NCT01634555|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5419316|NCT01634516|Diet|diet
5419317|NCT01634516|Pregnant|pregnant
5419318|NCT01634503|3+3 design|3+3 design
5419319|NCT01634503|Phase 1|phase 1
5419320|NCT01634503|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5419321|NCT01634503|Adult|adult
5419322|NCT01634503|Safety|safety
5419323|NCT01634503|Dose Finding|dose finding
5419324|NCT01634490|cow's milk allergy|cow's milk allergy
5419325|NCT01634490|formulas|formulas
5419326|NCT01634490|probiotics|probiotics
5419327|NCT01634477|morbidity|morbidity
5419328|NCT01634477|mortality|mortality
5419329|NCT01634477|HIV-infected patients|hiv-infected patients
5419330|NCT01634477|prospective cohort study|prospective cohort study
5419331|NCT01634477|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5419332|NCT01634477|opportunistic infections|opportunistic infections
5419333|NCT01634477|Non HIV-related illness|non hiv-related illness
5419334|NCT01634477|cardiovascular disease (CVD)|cardiovascular disease (cvd)
5419335|NCT01634477|HIV negative patients|hiv negative patients
5419336|NCT01634477|Thai HIV-infected patients|thai hiv-infected patients
5419337|NCT01634451|Sedation|sedation
5419338|NCT01634451|Quality|quality
5419339|NCT01634438|coronary angiography|coronary angiography
5419340|NCT01634425|NSTEMI|nstemi
5419341|NCT01634425|Point of Care Biomarkers|point of care biomarkers
5419342|NCT01634334|Secondhand smoke|secondhand smoke
5419343|NCT01634295|CKD-828|ckd-828
5419344|NCT01634295|Hypertension|hypertension
5419345|NCT01634295|Stage 2 Hypertension|stage 2 hypertension
5419346|NCT01634295|S-Amlodipine|s-amlodipine
5419347|NCT01634295|Telmisartan|telmisartan
5419348|NCT01634269|Valvular Heart Disease|valvular heart disease
5419349|NCT01634269|Severe Aortic Stenosis|severe aortic stenosis
5419350|NCT01634269|Aortic Valve Replacement|aortic valve replacement
5419351|NCT01634243|SPM 962|spm 962
5419352|NCT01634243|rotigotine|rotigotine
5419353|NCT01634243|Parkinson's disease|parkinson's disease
5419354|NCT01634204|weight reduction|weight reduction
5419355|NCT01634204|web-based intervention|web-based intervention
5419356|NCT01634204|cost-effective|cost-effective
5419357|NCT01634204|overweight|overweight
5419358|NCT01634204|obesity|obesity
5419359|NCT01634204|cardiovascular risk|cardiovascular risk
5419360|NCT01634191|Apremilast|apremilast
5419361|NCT01634191|pharmacokinetic|pharmacokinetic
5419362|NCT01634191|safety|safety
5419363|NCT01634191|Pharmacokinetics and safety in healthy volunteer subjects|pharmacokinetics and safety in healthy volunteer subjects
5419364|NCT01634178|Apremilast,|apremilast,
5419365|NCT01634178|pharmacokinetic|pharmacokinetic
5419367|NCT01634178|Safety and pharmacokinetics in healthy volunteer subjects|safety and pharmacokinetics in healthy volunteer subjects
5419368|NCT01634126|Colon|colon
5419369|NCT01634126|Rectal|rectal
5419370|NCT01634126|Cancer|cancer
5419371|NCT01634126|Screening|screening
5419373|NCT01634126|Fecal|fecal
5419374|NCT01634061|Castration-resistant prostate cancer, abiraterone acetate, BEZ235, BKM120, dose escalation, abiraterone acetate failure|castration-resistant prostate cancer, abiraterone acetate, bez235, bkm120, dose escalation, abiraterone acetate failure
5419375|NCT01634048|high protein diet|high protein diet
5419376|NCT01634048|meal replacements|meal replacements
5419377|NCT01634048|low calorie diet|low calorie diet
5419378|NCT01634048|intra hepatocellular lipid|intra hepatocellular lipid
5419379|NCT01634035|glycated hemoglobin|glycated hemoglobin
5419380|NCT01634035|mean plasma glucose|mean plasma glucose
5419381|NCT01634022|Acupuncture|acupuncture
5419382|NCT01634022|Antidepressant|antidepressant
5419383|NCT01634022|Monotherapy|monotherapy
5419384|NCT01634022|Depression|depression
5419385|NCT01634022|Alternative treatments|alternative treatments
5419386|NCT01634009|Severe acute malnutrition|severe acute malnutrition
5419387|NCT01634009|Ready to use therapeutic food|ready to use therapeutic food
5419388|NCT01634009|Soy protein|soy protein
5419389|NCT01634009|Community based management|community based management
5419390|NCT01634009|Efficacy|efficacy
5680254|NCT00578474|Tympanostomy tubes|tympanostomy tubes
5419391|NCT01634009|Management of Children with SAM in Bangladesh|management of children with sam in bangladesh
5419393|NCT01633996|Antidepressant|antidepressant
5419394|NCT01633996|Augmentation|augmentation
5419395|NCT01633996|Depression|depression
5419396|NCT01633983|Central Serous Chorioretinopathy|central serous chorioretinopathy
5419397|NCT01633983|Methotrexate|methotrexate
5419398|NCT01633957|anticoagulation|anticoagulation
5419399|NCT01633957|bleeding|bleeding
5419400|NCT01633957|CYP2C9|cyp2c9
5419401|NCT01633957|CYP4F2|cyp4f2
5419402|NCT01633957|VKORC1|vkorc1
5419403|NCT01633957|warfarin dosing|warfarin dosing
5419404|NCT01633957|Heart Valve Diseases|heart valve diseases
5419405|NCT01633957|pharmacogenomics|pharmacogenomics
5419406|NCT01633944|CLBP|clbp
5419407|NCT01633944|Chronic Low Back Pain|chronic low back pain
5419408|NCT01633944|Chronic Pain|chronic pain
5419409|NCT01633944|Back Pain|back pain
5419410|NCT01633918|intervention|intervention
5419411|NCT01633918|health education|health education
5419412|NCT01633918|physical activity|physical activity
5419413|NCT01633918|sedentary behavior|sedentary behavior
5419414|NCT01633918|health promotion|health promotion
5419415|NCT01633918|evaluation|evaluation
5419416|NCT01633918|RE-AIM|re-aim
5419417|NCT01633905|alcohol-dependence|alcohol-dependence
5419418|NCT01633905|event-related potentials|event-related potentials
5419419|NCT01633905|emotion|emotion
5419420|NCT01633905|crossmodal|crossmodal
5419421|NCT01633905|peripheral processing|peripheral processing
5419422|NCT01633892|Craniomaxillofacial (CMF)|craniomaxillofacial (cmf)
5419423|NCT01633892|Battle-injured (BI)|battle-injured (bi)
5419424|NCT01633892|Facial Trauma|facial trauma
5419425|NCT01633892|Fat Grafts|fat grafts
5419426|NCT01633892|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5419427|NCT01633892|Wounded warriors|wounded warriors
5419428|NCT01633892|Adipose Tissue|adipose tissue
5419429|NCT01633879|parenting, prevention, HIV/AIDS, adolescents, Latino|parenting, prevention, hiv/aids, adolescents, latino
5419430|NCT01633866|Magnetic Resonance Imaging|magnetic resonance imaging
5419431|NCT01633853|chronic kidney disease mineral and bone disorder|chronic kidney disease mineral and bone disorder
5419432|NCT01633853|vitamin D2|vitamin d2
5419433|NCT01633853|parathyroid hormone|parathyroid hormone
5419434|NCT01633840|double-blind placebo-controlled food challenges|double-blind placebo-controlled food challenges
5419435|NCT01633840|food allergy|food allergy
5419436|NCT01633840|food hypersensitivity|food hypersensitivity
5419437|NCT01633840|triangle test|triangle test
5419438|NCT01633840|validated recipes|validated recipes
5419439|NCT01633814|Physiological Processes|physiological processes
5419440|NCT01633814|Exercise|exercise
5419441|NCT01633814|Hormone replacement therapy|hormone replacement therapy
5419442|NCT01633775|Refractory primary open angle glaucoma|refractory primary open angle glaucoma
5419443|NCT01633775|trabeculectomy|trabeculectomy
5419444|NCT01633775|ahmed valve implant|ahmed valve implant
5419445|NCT01633749|Influenza|influenza
5419446|NCT01633749|Vaccine|vaccine
5419447|NCT01633749|CHMP criteria|chmp criteria
5419448|NCT01633736|single blinded|single blinded
5419449|NCT01633736|randomised|randomised
5419450|NCT01633736|controlled|controlled
5419451|NCT01633736|physiotherapy|physiotherapy
5419452|NCT01633736|children|children
5419453|NCT01633736|cerebral palsy|cerebral palsy
5419454|NCT01633710|Ankle brachial pressure index|ankle brachial pressure index
5419455|NCT01633710|Colour duplex ultrasound|colour duplex ultrasound
5419456|NCT01633710|Diabetes|diabetes
5419457|NCT01633710|Photoplethysmography|photoplethysmography
5419464|NCT01633671|Pulmonary Embolism Without Mention of Acute Cor Pulmonale|pulmonary embolism without mention of acute cor pulmonale
5419465|NCT01633658|vitamin D|vitamin d
5419466|NCT01633632|Smoking cessation|smoking cessation
5002972|NCT03977519|primary dysmenorrhea|primary dysmenorrhea
5419468|NCT01633632|Cognitive behavioral therapy|cognitive behavioral therapy
5419469|NCT01633619|Prosthetic Joint Infection|prosthetic joint infection
5419470|NCT01633606|severity of illness|severity of illness
5419471|NCT01633606|scoring|scoring
5419472|NCT01633606|medium care|medium care
5419473|NCT01633606|intensive care|intensive care
5419474|NCT01633606|staffing|staffing
5419475|NCT01633580|ICSI|icsi
5419476|NCT01633580|GnRH antagonist|gnrh antagonist
5419477|NCT01633580|corifollitropin alfa|corifollitropin alfa
5419478|NCT01633567|Smoking Cessation|smoking cessation
5419479|NCT01633567|Cigarette Smoking|cigarette smoking
5419480|NCT01633567|Tobacco|tobacco
5419482|NCT01633567|LGBTQ|lgbtq
5419483|NCT01633554|ST-2, IL-33, prediction, fibrosis, hepatitis B|st-2, il-33, prediction, fibrosis, hepatitis b
5419484|NCT01633528|low dose aspirin endometrial thickness pregnancy rate ICSI IVF embryo transfer|low dose aspirin endometrial thickness pregnancy rate icsi ivf embryo transfer
5419485|NCT01633515|Basal cell carcinoma (BCC)|basal cell carcinoma (bcc)
5419486|NCT01633515|Cryotherapy|cryotherapy
5419487|NCT01633515|Cryosurgery|cryosurgery
5419489|NCT01633476|ANCA associated vasculitis|anca associated vasculitis
5419490|NCT01633476|CD4+CD28- T-cells|cd4+cd28- t-cells
5419491|NCT01633476|Valaciclovir|valaciclovir
5419492|NCT01633463|EMERGENCY CANCER PAIN, ASSESSMENT, TREATMENT ADEQUACY.|emergency cancer pain, assessment, treatment adequacy.
5419493|NCT01633437|tyramine|tyramine
5419495|NCT01633437|cheese effect|cheese effect
5419496|NCT01633437|depression|depression
5419497|NCT01633398|Heart Failure|heart failure
5419498|NCT01633398|HF|hf
5419499|NCT01633385|bronchial inflammation|bronchial inflammation
5419500|NCT01633385|Bronchiolitis obliterans|bronchiolitis obliterans
5419501|NCT01633385|Sputum|sputum
5419502|NCT01633385|Blood|blood
5419503|NCT01633385|Inflammation|inflammation
5419504|NCT01633385|adaptive immune system|adaptive immune system
5419505|NCT01633385|innate immune system|innate immune system
5419512|NCT01633333|Colonoscopy|colonoscopy
5419513|NCT01633333|Colorectal cancer|colorectal cancer
5419514|NCT01633333|Colorectal adenomas|colorectal adenomas
5419515|NCT01633333|Pain|pain
5419516|NCT01633320|Analgesia/Nociception index|analgesia/nociception index
5419517|NCT01633307|education|education
5419518|NCT01633307|intravenous infusion|intravenous infusion
5419519|NCT01633294|premature rupture of membranes|premature rupture of membranes
5419520|NCT01633294|term pregnancy|term pregnancy
5419521|NCT01633294|chorioamnionitis|chorioamnionitis
5419522|NCT01633294|endometritis|endometritis
5419523|NCT01633294|neonatal sepsis|neonatal sepsis
5419524|NCT01633294|antibiotic prophylaxis|antibiotic prophylaxis
5419525|NCT01633281|peripheral neuropathy|peripheral neuropathy
5419526|NCT01633281|acupuncture|acupuncture
5419527|NCT01633281|Bortezomib|bortezomib
5419528|NCT01633281|Thalidomide|thalidomide
5419529|NCT01633268|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5419530|NCT01633268|Traumatic Brain Injury|traumatic brain injury
5419531|NCT01633255|Anti-Angiogenic|anti-angiogenic
5419532|NCT01633255|Dynamic Contrast Enhanced Magnetic Resonance Imaging|dynamic contrast enhanced magnetic resonance imaging
5419533|NCT01633255|PET/CT Imaging Studies|pet/ct imaging studies
5419534|NCT01633242|MRI|mri
5419535|NCT01633242|Muscular Dystrophy|muscular dystrophy
5419536|NCT01633242|Cardiac|cardiac
5419537|NCT01633242|Myocardium|myocardium
5419538|NCT01633242|Intramyocardial fat|intramyocardial fat
5419539|NCT01633229|Immune Suppression|immune suppression
5419540|NCT01633229|BMSC|bmsc
5419541|NCT01633229|GVHD|gvhd
5419542|NCT01633229|Marrow Failure|marrow failure
5419543|NCT01633229|Regimen Related Toxicity|regimen related toxicity
5419544|NCT01633229|Graft-Versus-Host Disease|graft-versus-host disease
5419545|NCT01633216|poliovirus,|poliovirus,
5419546|NCT01633216|trivalent oral polio vaccine,|trivalent oral polio vaccine,
5419547|NCT01633216|bivalent oral polio vaccine,|bivalent oral polio vaccine,
5419548|NCT01633216|monovalent oral polio vaccine|monovalent oral polio vaccine
5419549|NCT01633203|gastric cancer|gastric cancer
5419550|NCT01633203|combination chemotherapy|combination chemotherapy
5419551|NCT01633203|HER-2 gene|her-2 gene
5419552|NCT01633203|quality of life|quality of life
5419558|NCT01633177|Type 2 diabetes|type 2 diabetes
5419559|NCT01633177|Oral glucose tolerance test (OGTT)|oral glucose tolerance test (ogtt)
5419560|NCT01633177|Insulin sensitivity|insulin sensitivity
5419561|NCT01633177|Beta-cell function|beta-cell function
5419562|NCT01633164|Spinal Cord Injury|spinal cord injury
5419563|NCT01633164|Self-Efficacy|self-efficacy
5419564|NCT01633164|Life Satisfaction|life satisfaction
5419565|NCT01633164|Community Participation|community participation
5419566|NCT01633138|cognitive remediation therapy|cognitive remediation therapy
5419567|NCT01633138|substance abuse treatment|substance abuse treatment
5419568|NCT01633125|Group music therapy|group music therapy
5419569|NCT01633125|prisoners|prisoners
5419570|NCT01633125|Anxiety|anxiety
5419577|NCT01633060|fulvestrant|fulvestrant
5419578|NCT01633060|breast cancer|breast cancer
5419579|NCT01633060|metastatic|metastatic
5419580|NCT01633060|locally advanced|locally advanced
5419581|NCT01633060|AI treated|ai treated
5419582|NCT01633060|mTOR inhibitor|mtor inhibitor
5419583|NCT01633060|PI3K|pi3k
5419584|NCT01633060|PIK3CA|pik3ca
5419585|NCT01633060|PTEN|pten
5419586|NCT01633060|HER2-|her2-
5419587|NCT01633060|HR+|hr+
5419588|NCT01633047|Anterior Cruciate Ligament|anterior cruciate ligament
5419589|NCT01633047|Electric Stimulation Therapy|electric stimulation therapy
5419590|NCT01633034|intervertebral disc degeneration|intervertebral disc degeneration
5419591|NCT01633034|back pain|back pain
5419592|NCT01633034|spine surgery|spine surgery
5419593|NCT01633021|Support|support
5419594|NCT01633021|Cancer|cancer
5419595|NCT01633021|Network|network
5419596|NCT01633021|Sickle Cell Disease|sickle cell disease
5419597|NCT01633021|Sickle Trait|sickle trait
5419599|NCT01633021|Sickle Cell Trait / Sickle Cell Disease|sickle cell trait / sickle cell disease
5402526|NCT01710410|nicotine patch|nicotine patch
5419600|NCT01633008|Modified Brief Pain Inventory|modified brief pain inventory
5419601|NCT01633008|Quality of Life|quality of life
5419602|NCT01633008|Pain-Related Coping|pain-related coping
5419603|NCT01633008|Pain-Related Anxiety|pain-related anxiety
5419604|NCT01633008|Depression|depression
5419605|NCT01632982|opioid abuse|opioid abuse
5419606|NCT01632982|substance abuse|substance abuse
5419607|NCT01632982|methadone maintenance treatment|methadone maintenance treatment
5419608|NCT01632982|mobile technology|mobile technology
5419609|NCT01632982|technology-based intervention|technology-based intervention
5419610|NCT01632982|behavioral intervention|behavioral intervention
5419611|NCT01632982|psychosocial treatment|psychosocial treatment
5419613|NCT01632956|Support Groups|support groups
5419614|NCT01632956|Breast cancer|breast cancer
5419615|NCT01632956|Mandarin speaking|mandarin speaking
5419616|NCT01632956|12-105|12-105
5419617|NCT01632943|Uncontrolled Hypertension|uncontrolled hypertension
5419618|NCT01632930|diagnosis|diagnosis
5419619|NCT01632930|prostate cancer|prostate cancer
5419620|NCT01632930|urine|urine
5419621|NCT01632930|medical economics|medical economics
5419622|NCT01632917|Healthy volunteers|healthy volunteers
5419623|NCT01632904|Polycythemia Vera|polycythemia vera
5419624|NCT01632904|PV|pv
5419625|NCT01632878|Secondary prevention post MI|secondary prevention post mi
5419626|NCT01632865|occlusion|occlusion
5419627|NCT01632865|recanalization|recanalization
5419628|NCT01632865|stenting|stenting
5419629|NCT01632839|PISQ-R|pisq-r
5419630|NCT01632839|new sexuality questionnaire|new sexuality questionnaire
5419631|NCT01632826|Relapsed|relapsed
5419632|NCT01632826|refractory multiple myeloma|refractory multiple myeloma
5419633|NCT01632826|pomalidomide|pomalidomide
5419634|NCT01632813|neurocognitive testing|neurocognitive testing
5419635|NCT01632813|critical illness|critical illness
5419636|NCT01632813|executive function|executive function
5419637|NCT01632813|intelligence|intelligence
5419638|NCT01632800|Magnetic fields discomfort|magnetic fields discomfort
5419639|NCT01632787|Anxiety|anxiety
5419640|NCT01632787|Binocular|binocular
5419641|NCT01632787|Chronic Headache|chronic headache
5419642|NCT01632787|Dizziness|dizziness
5419643|NCT01632787|Vertical Heterophoria|vertical heterophoria
5419644|NCT01632787|Vision Dysfunction|vision dysfunction
5419645|NCT01632761|anemia|anemia
5419646|NCT01632761|vitamin D3|vitamin d3
5419647|NCT01632761|omega-3 fatty acids|omega-3 fatty acids
5419648|NCT01632761|fish oil|fish oil
5419649|NCT01632761|primary prevention|primary prevention
5419650|NCT01632735|Continuing Care|continuing care
5419651|NCT01632735|Youth Substance Abuse|youth substance abuse
5419652|NCT01632735|Recovery Support|recovery support
5419653|NCT01632735|Mobile Texting|mobile texting
5419654|NCT01632722|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy|colorectal cancer, liver metastasis, bevacizumab, perioperative/postoperative chemotherapy
5419655|NCT01632696|Antibodies, Monoclonal|antibodies, monoclonal
5419656|NCT01632696|Biologics|biologics
5419657|NCT01632696|F(ab')2|f(ab')2
5419658|NCT01632696|Positron-emission tomography (PET)|positron-emission tomography (pet)
5419659|NCT01632696|Phosphatidylserine (PS)|phosphatidylserine (ps)
5419660|NCT01632696|Solid Tumors|solid tumors
5419661|NCT01632696|Tumor Imaging|tumor imaging
5419662|NCT01632683|difficult airway|difficult airway
5419663|NCT01632683|video laryngoscopy|video laryngoscopy
5419664|NCT01632670|music|music
5419665|NCT01632670|cardiac catheterization|cardiac catheterization
5419666|NCT01632670|endothelial function|endothelial function
5419667|NCT01632631|suitable for endovascular exclusion|suitable for endovascular exclusion
5419668|NCT01632605|ADPKD|adpkd
5419669|NCT01632605|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5419670|NCT01632605|Sirolimus|sirolimus
5419671|NCT01632605|Rapamune|rapamune
5419672|NCT01632605|Polycystic liver disease|polycystic liver disease
5419673|NCT01632605|Rapamycin|rapamycin
5419674|NCT01632605|Mammalian target of rapamycin|mammalian target of rapamycin
5419675|NCT01632605|m-TOR|m-tor
5419676|NCT01632605|m-TOR inhibition|m-tor inhibition
5419677|NCT01632553|Observation|observation
5419678|NCT01632553|Domestic Violence|domestic violence
5419679|NCT01632553|Partner Abuse|partner abuse
5419680|NCT01632553|Spousal Abuse|spousal abuse
5419681|NCT01632553|Battered Women|battered women
5419682|NCT01632553|Abused Women|abused women
5419683|NCT01632553|Cortisol|cortisol
5419684|NCT01632553|Mental Health|mental health
5419685|NCT01632553|Depression|depression
5419686|NCT01632553|Anxiety|anxiety
5419687|NCT01632553|Posttraumatic Stress Disorders|posttraumatic stress disorders
5419688|NCT01632527|Age-Related Macular Degeneration|age-related macular degeneration
5419689|NCT01632527|Dry AMD with GA|dry amd with ga
5419690|NCT01632527|Geographic Atrophy of Age-Related Macular Degeneration|geographic atrophy of age-related macular degeneration
5419691|NCT01632527|Stem Cell Transplantation|stem cell transplantation
5419692|NCT01632527|Stem Cell transplant|stem cell transplant
5419693|NCT01632527|Stem cells for AMD|stem cells for amd
5419694|NCT01632527|Human neural stem cells|human neural stem cells
5419695|NCT01632527|multipotent stem cells|multipotent stem cells
5419696|NCT01632527|Macular Degeneration|macular degeneration
5419697|NCT01632527|Dry AMD|dry amd
5419698|NCT01632527|Human central nervous system stemcells|human central nervous system stemcells
5419699|NCT01632527|dry age-related macular degeneration|dry age-related macular degeneration
5419700|NCT01632514|hypocalcemia|hypocalcemia
5419701|NCT01632514|vitamin D deficiency|vitamin d deficiency
5419702|NCT01632514|cholecalciferol|cholecalciferol
5419703|NCT01632514|thyroidectomy|thyroidectomy
5419704|NCT01632488|Irritable Bowel Syndrome|irritable bowel syndrome
5419705|NCT01632488|Inflammatory Bowel Disease|inflammatory bowel disease
5419706|NCT01632488|Confocal Laser Endomicroscopy|confocal laser endomicroscopy
5419707|NCT01632475|Human umbilical cord blood-derived mesenchymal stem cells|human umbilical cord blood-derived mesenchymal stem cells
5419708|NCT01632475|Premature infants|premature infants
5419709|NCT01632475|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5419710|NCT01632475|Lung injury|lung injury
5419711|NCT01632475|Lung diseases|lung diseases
5419712|NCT01632475|Hyperplasia|hyperplasia
5419713|NCT01632475|Ventilator-induced lung injury|ventilator-induced lung injury
5419714|NCT01632475|Respiratory lung diseases|respiratory lung diseases
5419715|NCT01632475|Pathologic Processes|pathologic processes
5419716|NCT01632475|Infant, Premature, Diseases|infant, premature, diseases
5419717|NCT01632475|Infant, Newborn, Diseases|infant, newborn, diseases
5419718|NCT01632462|Crohn's disease|crohn's disease
5419719|NCT01632462|VSL#3|vsl#3
5419720|NCT01632462|probiotics|probiotics
5419721|NCT01632462|metabolic profile|metabolic profile
5419722|NCT01632449|bioequivalence|bioequivalence
5419723|NCT01632436|Hepatic impairment|hepatic impairment
5419724|NCT01632436|Metastatic Cancer|metastatic cancer
5419725|NCT01632410|autonomic nerve system|autonomic nerve system
5419726|NCT01632410|post stroke|post stroke
5419727|NCT01632410|focus of study: to describe the autonomic nerve system function post stroke|focus of study: to describe the autonomic nerve system function post stroke
5419728|NCT01632410|autonomic nervous system|autonomic nervous system
5419729|NCT01632397|PrEP|prep
5419730|NCT01632397|HIV|hiv
5419731|NCT01632397|Adherence|adherence
5419732|NCT01632397|MSM|msm
5419733|NCT01632397|Men having sex with men|men having sex with men
5419734|NCT01632384|Smoker|smoker
5419735|NCT01632384|Non-Smoker|non-smoker
5419736|NCT01632384|Healthy|healthy
5419737|NCT01632384|Drug free|drug free
5419738|NCT01632384|MRI|mri
5419739|NCT01632371|In-stent Restenosis|in-stent restenosis
5419740|NCT01632371|Drug Eluting Stent|drug eluting stent
5419741|NCT01632371|Paclitaxel Coated Balloon|paclitaxel coated balloon
5419742|NCT01632371|Scoring Balloon|scoring balloon
5419743|NCT01632371|Cutting Balloon|cutting balloon
5419744|NCT01632371|Angiographic follow-up|angiographic follow-up
5419745|NCT01632371|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5419746|NCT01632358|safety|safety
5419747|NCT01632358|tolerability|tolerability
5419748|NCT01632358|pharmacokinetics|pharmacokinetics
5419749|NCT01632280|Obesity|obesity
5419750|NCT01632280|Gastric Banding|gastric banding
5419751|NCT01632280|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5419752|NCT01632241|Systemic Lupus Erythematosus|systemic lupus erythematosus
5419753|NCT01632241|African Continental Ancestry Group|african continental ancestry group
5419754|NCT01632241|Autoimmune Disease|autoimmune disease
5419755|NCT01632241|Antibodies|antibodies
5419756|NCT01632241|Minority Groups|minority groups
5419757|NCT01632241|Black Race|black race
5419758|NCT01632241|African Americans|african americans
5419759|NCT01632241|SLE|sle
5419760|NCT01632241|Belimumab|belimumab
5419765|NCT01632202|intrauterine adhesions|intrauterine adhesions
5419766|NCT01632202|hysteroscopic myomectomy|hysteroscopic myomectomy
5419767|NCT01632202|seprafilm|seprafilm
5419768|NCT01632189|Varenicline|varenicline
5419769|NCT01632189|PET imaging|pet imaging
5419770|NCT01632189|[11C]-(+)-PHNO PET|[11c]-(+)-phno pet
5419771|NCT01632189|neuroimaging in smokers|neuroimaging in smokers
5419772|NCT01632176|dating abuse|dating abuse
5419773|NCT01632176|dating violence|dating violence
5419774|NCT01632176|domestic violence|domestic violence
5419775|NCT01632176|sexual violence|sexual violence
5419776|NCT01632176|sexual assault|sexual assault
5419777|NCT01632176|youth violence|youth violence
5419778|NCT01632176|underage alcohol use|underage alcohol use
5419779|NCT01632176|alcohol use|alcohol use
5419780|NCT01632098|psychosocial|psychosocial
5419781|NCT01632098|healthcare|healthcare
5419782|NCT01632098|co-morbidities|co-morbidities
5419783|NCT01632098|extremely obese adolescents|extremely obese adolescents
5419784|NCT01632059|ADMA|adma
5419785|NCT01632059|DDAH II|ddah ii
5419786|NCT01632059|SAPS|saps
5419787|NCT01632059|SOFA|sofa
5419788|NCT01632059|Sepsis|sepsis
5419789|NCT01632059|Procalcitonin|procalcitonin
5419790|NCT01632059|ICU|icu
5419791|NCT01632059|mortality|mortality
5419792|NCT01632059|length of stay|length of stay
5419793|NCT01632046|peritoneal dialysis|peritoneal dialysis
5419794|NCT01632046|bicarbonate/lactate buffer|bicarbonate/lactate buffer
5419795|NCT01632046|peritoneal transport capacity|peritoneal transport capacity
5419796|NCT01632046|ultrafiltration|ultrafiltration
5419797|NCT01632046|children|children
5419798|NCT01632033|Peripheral artery disease|peripheral artery disease
5419799|NCT01632033|claudication|claudication
5419800|NCT01632033|walking|walking
5419801|NCT01632033|questionnaire|questionnaire
5419802|NCT01632020|colorectal tumor|colorectal tumor
5419803|NCT01632020|colorectal cancer|colorectal cancer
5419804|NCT01632020|colorectal carcinoma|colorectal carcinoma
5419805|NCT01632020|neoplasms, colorectal|neoplasms, colorectal
5419806|NCT01632020|Metformin|metformin
5419807|NCT01631994|metoclopramide video capsule endoscopy gastric transit time|metoclopramide video capsule endoscopy gastric transit time
5419808|NCT01631955|Acute cystitis|acute cystitis
5419809|NCT01631955|Antibiotics|antibiotics
5419810|NCT01631955|Quality of life|quality of life
5419811|NCT01631929|Diabetes|diabetes
5419812|NCT01631929|Ketoacidosis|ketoacidosis
5419813|NCT01631929|Children|children
5419814|NCT01631916|community-acquired pneumonia|community-acquired pneumonia
5419815|NCT01631916|children|children
5419816|NCT01631916|respiratory infections|respiratory infections
5419817|NCT01631864|Hypertension, obesity, insulin sensitivity, lipolysis, LCZ696|hypertension, obesity, insulin sensitivity, lipolysis, lcz696
5419818|NCT01631851|Autism|autism
5419819|NCT01631851|Irritability|irritability
5419820|NCT01631851|Disruptive Behavior|disruptive behavior
5419821|NCT01631851|Aggression|aggression
5419822|NCT01631851|Behavior Therapy|behavior therapy
5419823|NCT01631851|Cognitive Behavioral Therapy|cognitive behavioral therapy
5419824|NCT01631838|Tocotrienols|tocotrienols
5419825|NCT01631838|Platelet aggregation|platelet aggregation
5419826|NCT01631838|Metabolic syndrome|metabolic syndrome
5419827|NCT01631838|Platelet activation|platelet activation
5419828|NCT01631838|Thrombosis|thrombosis
5419829|NCT01631825|SPM 962|spm 962
5419830|NCT01631825|rotigotine|rotigotine
5419831|NCT01631825|Parkinson's disease|parkinson's disease
5419832|NCT01631825|concomitant use of L-dopa|concomitant use of l-dopa
5419833|NCT01631812|SPM 962|spm 962
5419834|NCT01631812|rotigotine|rotigotine
5419835|NCT01631812|Parkinson's disease|parkinson's disease
5419836|NCT01631812|concomitant use of L-dopa|concomitant use of l-dopa
5419837|NCT01631799|epidural anesthesia|epidural anesthesia
5419838|NCT01631799|femoral block|femoral block
5419839|NCT01631799|patient control analgesia|patient control analgesia
5419840|NCT01631786|Ovaries|ovaries
5419841|NCT01631786|Imaging|imaging
5419842|NCT01631786|Ultrasonography|ultrasonography
5419843|NCT01631786|Synchrotron|synchrotron
5419844|NCT01631786|Histology|histology
5419845|NCT01631773|Aspirin-exacerbated respiratory disease|aspirin-exacerbated respiratory disease
5419846|NCT01631773|Nasal polyp|nasal polyp
5419847|NCT01631760|Asthma|asthma
5419848|NCT01631760|Asthma Exacerbations|asthma exacerbations
5419849|NCT01631747|Pregnancy|pregnancy
5419850|NCT01631747|Weight gain|weight gain
5419851|NCT01631747|Obesity|obesity
5419852|NCT01631747|Pregnancy and weight gain|pregnancy and weight gain
5419853|NCT01631721|adolescent couple decision-making|adolescent couple decision-making
5419854|NCT01631721|parenting practices|parenting practices
5419855|NCT01631721|sexual risk behavior|sexual risk behavior
5419856|NCT01631708|Hereditary haemochromatosis|hereditary haemochromatosis
5419857|NCT01631708|Moderate iron overload|moderate iron overload
5419858|NCT01631708|Serum ferritin|serum ferritin
5419859|NCT01631708|Treatment|treatment
5419860|NCT01631682|Posttraumatic Stress Disorder|posttraumatic stress disorder
5419861|NCT01631682|PTSD|ptsd
5419862|NCT01631682|Anxiety|anxiety
5419863|NCT01631682|Fear of spiders|fear of spiders
5419864|NCT01631682|Reconsolidation|reconsolidation
5419865|NCT01631682|Reconsolidation blockade|reconsolidation blockade
5419866|NCT01631669|Ossification|ossification
5419867|NCT01631669|Heterotopic Ossification|heterotopic ossification
5419868|NCT01631656|Rosacea, Laser, Finacea Gel, Azelaic Acid,|rosacea, laser, finacea gel, azelaic acid,
5419869|NCT01631643|Blood glucose monitor|blood glucose monitor
5419870|NCT01631643|Pattern management|pattern management
5419871|NCT01631643|Pattern guide|pattern guide
5419872|NCT01631643|Education|education
5419873|NCT01631630|Alcohol|alcohol
5419874|NCT01631630|Alcohol Dependence|alcohol dependence
5419875|NCT01631630|Alcohol Use|alcohol use
5419876|NCT01631630|Nicotine Dependence|nicotine dependence
5419877|NCT01631630|Nicotine|nicotine
5419878|NCT01631617|Investigator-Blinded|investigator-blinded
5419879|NCT01631617|Skin Biopsy|skin biopsy
5419880|NCT01631617|Randomized|randomized
5419881|NCT01631617|Antibiotics|antibiotics
5419882|NCT01631617|Topical|topical
5419883|NCT01631604|risk of falling|risk of falling
5419884|NCT01631604|gait patterns|gait patterns
5419885|NCT01631604|muscle activity|muscle activity
5419886|NCT01631604|fall prevention|fall prevention
5419887|NCT01631604|motor impairment|motor impairment
5419888|NCT01631578|mitochondrial injection|mitochondrial injection
5419889|NCT01631565|Palliative Care|palliative care
5419890|NCT01631565|Survival|survival
5419891|NCT01631565|Quality of life|quality of life
5419892|NCT01631552|Gastric adenocarcinoma (GC)|gastric adenocarcinoma (gc)
5419893|NCT01631552|Esophageal cancer (EC)|esophageal cancer (ec)
5419894|NCT01631552|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5419895|NCT01631552|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5419896|NCT01631552|Small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5680255|NCT00578461|Stem Cell Transplant|stem cell transplant
5419897|NCT01631552|Ovarian epithelial cancer (OEC)|ovarian epithelial cancer (oec)
5419898|NCT01631552|Triple-negative breast cancer (TNBC)|triple-negative breast cancer (tnbc)
5419899|NCT01631552|Hormone-refractory prostate cancer (HRPC)|hormone-refractory prostate cancer (hrpc)
5419900|NCT01631552|Head and neck cancers- squamous cell (SCCHN)|head and neck cancers- squamous cell (scchn)
5419901|NCT01631552|Renal cell cancer -clear cell (RCC)|renal cell cancer -clear cell (rcc)
5419902|NCT01631552|Bladder cancer|bladder cancer
5419903|NCT01631552|Endometrial Cancer|endometrial cancer
5419904|NCT01631552|Cervical Cancer|cervical cancer
5419905|NCT01631552|Metastatic non-triple negative breast cancer|metastatic non-triple negative breast cancer
5419906|NCT01631552|Glioblastoma multiforme|glioblastoma multiforme
5419907|NCT01631552|Follicular thyroid cancer|follicular thyroid cancer
5419908|NCT01631552|pancreatic cancer|pancreatic cancer
5419909|NCT01631539|chemoembolization|chemoembolization
5419911|NCT01631539|Irinotecan|irinotecan
5419912|NCT01631539|Cetuximab|cetuximab
5419913|NCT01631539|5FU/LV|5fu/lv
5419914|NCT01631539|KRAS|kras
5419915|NCT01631539|metastatic colorectal cancer|metastatic colorectal cancer
5419916|NCT01631526|Lung cancer|lung cancer
5419917|NCT01631526|vitamin D|vitamin d
5419918|NCT01631526|pharmacokinetics|pharmacokinetics
5419919|NCT01631513|Chronic Low Back Pain|chronic low back pain
5419920|NCT01631513|Osteoarthritis Pain In The Hip or Knee|osteoarthritis pain in the hip or knee
5419921|NCT01631513|Oxycodone|oxycodone
5419922|NCT01631513|Morphine, Hydrocodone|morphine, hydrocodone
5419923|NCT01631513|Tapentadol|tapentadol
5419924|NCT01631513|NUCYNTA ER|nucynta er
5419925|NCT01631500|Integrative medicine|integrative medicine
5419926|NCT01631500|Acupuncture|acupuncture
5419927|NCT01631500|Minor mental health problems|minor mental health problems
5419928|NCT01631500|Medically unexplained symptoms|medically unexplained symptoms
5419929|NCT01631500|Minor mental health problems (e.g. minor depression and anxiety) and Medically unexplained symptoms (e.g. IBS, fibromyalgia, etc)|minor mental health problems (e.g. minor depression and anxiety) and medically unexplained symptoms (e.g. ibs, fibromyalgia, etc)
5419930|NCT01631487|Healthy|healthy
5419931|NCT01631487|JNJ-39439335|jnj-39439335
5419932|NCT01631487|Japanese|japanese
5419933|NCT01631487|Caucasian|caucasian
5419934|NCT01631487|Male|male
5419935|NCT01631474|Intrepid|intrepid
5419936|NCT01631474|acne|acne
5419937|NCT01631474|antiandrogen|antiandrogen
5419938|NCT01631461|pain|pain
5419939|NCT01631461|breast feeding|breast feeding
5419940|NCT01631461|yeast|yeast
5419941|NCT01631461|candida albicance|candida albicance
5419942|NCT01631461|staphylococcus aureus|staphylococcus aureus
5419943|NCT01631461|Signs and symptoms|signs and symptoms
5419944|NCT01631448|Fibrin sealant|fibrin sealant
5419945|NCT01631448|renal transplantation|renal transplantation
5419946|NCT01631448|surgical complication|surgical complication
5419947|NCT01631435|All subjects will have evidence of active symptoms associated with Crohn's disease|all subjects will have evidence of active symptoms associated with crohn's disease
5419948|NCT01631409|clinical research|clinical research
5419949|NCT01631409|coronary heart disease|coronary heart disease
5419950|NCT01631409|cardiac shock wave therapy|cardiac shock wave therapy
5419951|NCT01631409|ischemic heart disease|ischemic heart disease
5419952|NCT01631409|myocardial revascularization|myocardial revascularization
5419953|NCT01631409|observational research|observational research
5419954|NCT01631409|prospective research|prospective research
5419955|NCT01631396|Morbid obesity|morbid obesity
5419956|NCT01631396|Bariatric Surgery|bariatric surgery
5419957|NCT01631396|Neuromuscular block reversal|neuromuscular block reversal
5419958|NCT01631383|Cocaine Use|cocaine use
5419959|NCT01631305|Euthyroid Sick Syndromes|euthyroid sick syndromes
5419960|NCT01631305|Thyroxine|thyroxine
5419961|NCT01631305|Intensive care|intensive care
5419963|NCT01631279|non-small cell lung cancer|non-small cell lung cancer
5392402|NCT01756417|Pharmacodynamics|pharmacodynamics
5419964|NCT01631279|non-squamous, non-small cell lung cancer|non-squamous, non-small cell lung cancer
5419966|NCT01631279|lung cancer|lung cancer
5419967|NCT01631240|Sodium|sodium
5419968|NCT01631240|Potassium|potassium
5419969|NCT01631240|Iodine|iodine
5419970|NCT01631240|Creatinine|creatinine
5419971|NCT01631214|Osteoporosis, Osteoporosis-postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
5419972|NCT01631201|Chlamydia|chlamydia
5419973|NCT01631188|Minimally Invasive Surgery|minimally invasive surgery
5419974|NCT01631188|Port Access Surgery|port access surgery
5419975|NCT01631188|Heart|heart
5419976|NCT01631188|Pacing|pacing
5419977|NCT01631188|Wire|wire
5419978|NCT01631188|MICS|mics
5419979|NCT01631188|Cardiac Bypass|cardiac bypass
5419980|NCT01631188|Epicardial pacing|epicardial pacing
5419981|NCT01631188|pacing catheter|pacing catheter
5419982|NCT01631188|pacing wire|pacing wire
5419983|NCT01631188|pacing swan|pacing swan
5419984|NCT01631188|pacing pulmonary catheter|pacing pulmonary catheter
5419985|NCT01631188|Pulmonary Endovent|pulmonary endovent
5537071|NCT01138267|ATV|atv
5419987|NCT01631188|Aortic Valve Surgery|aortic valve surgery
5419988|NCT01631188|Edwards Lifesciences|edwards lifesciences
5419989|NCT01631175|sarcoma|sarcoma
5419990|NCT01631175|distress|distress
5419991|NCT01631175|tumor|tumor
5419992|NCT01631175|quality of life|quality of life
5419993|NCT01631175|cancer|cancer
5419994|NCT01631162|Asthma|asthma
5419995|NCT01631162|COPD|copd
5419996|NCT01631149|urology|urology
5419997|NCT01631149|muscle relaxation|muscle relaxation
5419998|NCT01631149|laparoscopy|laparoscopy
5419999|NCT01631149|anesthesia|anesthesia
5420000|NCT01631149|rocuronium|rocuronium
5420001|NCT01631136|Non Small Cell Lung Cancer|non small cell lung cancer
5420002|NCT01631136|IFCT|ifct
5420003|NCT01631136|Maintenance|maintenance
5420004|NCT01631136|Switch|switch
5420005|NCT01631123|Twins|twins
5420006|NCT01631123|High carbohydrat diet|high carbohydrat diet
5420007|NCT01631123|High fat diet|high fat diet
5420008|NCT01631123|Isocaloric|isocaloric
5420009|NCT01631123|Nutrigenomics|nutrigenomics
5420010|NCT01631110|Influenza|influenza
5420011|NCT01631110|Virus|virus
5420012|NCT01631110|Vaccination|vaccination
5420013|NCT01631110|Inflexal V|inflexal v
5420014|NCT01631084|Diabetes|diabetes
5420015|NCT01631084|Structured care|structured care
5420016|NCT01631071|Influenza|influenza
5420017|NCT01631071|Virus|virus
5420018|NCT01631071|Vaccination|vaccination
5420019|NCT01631071|Virosomal influenza vaccine|virosomal influenza vaccine
5420020|NCT01631058|kidney transplantation|kidney transplantation
5420021|NCT01631058|chronic renal failure|chronic renal failure
5420022|NCT01631058|immunosuppressive therapy|immunosuppressive therapy
5420023|NCT01631058|elderly|elderly
5420024|NCT01631058|pharmacokinetic|pharmacokinetic
5420025|NCT01631058|tacrolimus|tacrolimus
5420026|NCT01631058|everolimus|everolimus
5420027|NCT01631058|mycophenolate sodium|mycophenolate sodium
5420028|NCT01631058|serious adverse events|serious adverse events
5420029|NCT01631058|biopsy|biopsy
5420030|NCT01631058|Cystatin C|cystatin c
5420031|NCT01631058|metabolic effects|metabolic effects
5420032|NCT01631058|Left Ventricular Mass (LVM)|left ventricular mass (lvm)
5420033|NCT01631058|Left Ventricle Ejection Fraction|left ventricle ejection fraction
5420034|NCT01631045|Obesity|obesity
5420035|NCT01631032|Allergic rhinitis|allergic rhinitis
5420036|NCT01631032|Chinese herbal products|chinese herbal products
5420037|NCT01631032|Qi deficiency|qi deficiency
5420038|NCT01631019|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5420039|NCT01631019|Pulmonary Rehabilitation|pulmonary rehabilitation
5420040|NCT01631019|Mobile phone|mobile phone
5420041|NCT01631019|Biomarker|biomarker
5420042|NCT01631006|CPAP|cpap
5420043|NCT01631006|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5420044|NCT01631006|Blood Pressure|blood pressure
5420143|NCT01630590|Androgen-Dependent Prostate Cancer|androgen-dependent prostate cancer
5420045|NCT01631006|The focus of the present study is to evaluate the acute hemodynamic effects of CPAP in patients with non-obstructive and obstructive hypertrophic cardiomyopathy|the focus of the present study is to evaluate the acute hemodynamic effects of cpap in patients with non-obstructive and obstructive hypertrophic cardiomyopathy
5420046|NCT01630993|umbilical cord milking|umbilical cord milking
5420047|NCT01630993|umbilical cord stripping|umbilical cord stripping
5420048|NCT01630993|umbilical cord clamping|umbilical cord clamping
5420049|NCT01630993|placental transfusion|placental transfusion
5420050|NCT01630993|placental residual blood volume|placental residual blood volume
5420051|NCT01630980|Systematic review and meta-analysis|systematic review and meta-analysis
5420052|NCT01630980|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5420053|NCT01630980|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5420054|NCT01630980|Clinical practice guidelines|clinical practice guidelines
5420055|NCT01630980|Clinical trials|clinical trials
5420056|NCT01630980|Tree nuts|tree nuts
5420057|NCT01630980|Cardiometabolic risk factors|cardiometabolic risk factors
5420058|NCT01630980|Triglycerides|triglycerides
5420059|NCT01630980|Cholesterol|cholesterol
5420060|NCT01630980|Glycemic control|glycemic control
5420061|NCT01630980|Insulin resistance|insulin resistance
5420062|NCT01630980|Body weight|body weight
5420063|NCT01630980|Blood pressure|blood pressure
5420064|NCT01630967|castrate resistance|castrate resistance
5420065|NCT01630967|PSA progression|psa progression
5420066|NCT01630967|LHRH antagonism|lhrh antagonism
5420067|NCT01630954|Hydatidiform mole|hydatidiform mole
5420068|NCT01630954|Molar pregnancy|molar pregnancy
5420070|NCT01630954|GTN|gtn
5420071|NCT01630954|GTD|gtd
5420072|NCT01630941|Osteoarthritis of the hip|osteoarthritis of the hip
5420073|NCT01630941|Uncemented Total Hip Arthroplasty|uncemented total hip arthroplasty
5420074|NCT01630941|DXA|dxa
5420075|NCT01630941|BMD|bmd
5420076|NCT01630941|PET|pet
5420077|NCT01630941|CT|ct
5420078|NCT01630941|Biochemical bone markers|biochemical bone markers
5420079|NCT01630928|Renal denervation|renal denervation
5420080|NCT01630928|Resistant Hypertension|resistant hypertension
5420081|NCT01630928|Cardiovascular disease|cardiovascular disease
5420082|NCT01630928|Diabetes|diabetes
5420083|NCT01630928|Quality of LIfe|quality of life
5420085|NCT01630889|ESRD|esrd
5420086|NCT01630889|End Stage Renal Disease|end stage renal disease
5420087|NCT01630889|Anemia|anemia
5420088|NCT01630889|Oral anemia treatment|oral anemia treatment
5420089|NCT01630889|Hemoglobin levels|hemoglobin levels
5420090|NCT01630889|Hemodialysis|hemodialysis
5420092|NCT01630889|Chronic Kidney Disease|chronic kidney disease
5420093|NCT01630889|Peritoneal|peritoneal
5420094|NCT01630889|HD|hd
5420095|NCT01630889|PD|pd
5420096|NCT01630889|Hb|hb
5420097|NCT01630889|Erythropoietin|erythropoietin
5420098|NCT01630889|Blood count|blood count
5420099|NCT01630876|Epiretinal membrane|epiretinal membrane
5420100|NCT01630876|triamcinolone acetonide|triamcinolone acetonide
5420101|NCT01630863|Central serous chorioretinopathy|central serous chorioretinopathy
5420102|NCT01630863|photodynamic therapy|photodynamic therapy
5420103|NCT01630863|safe and effective dose|safe and effective dose
5420104|NCT01630824|education program|education program
5420105|NCT01630824|kidney transplantation|kidney transplantation
5420106|NCT01630824|renal transplantation|renal transplantation
5420107|NCT01630824|evaluation|evaluation
5420108|NCT01630811|Adults|adults
5420109|NCT01630798|barrett's esophgus|barrett's esophgus
5420110|NCT01630798|High grade dysplasia|high grade dysplasia
5420111|NCT01630798|Esophageal adenocarcinoma|esophageal adenocarcinoma
5420112|NCT01630772|women with preeclampsia|women with preeclampsia
5420113|NCT01630772|physical therapy|physical therapy
5420114|NCT01630772|maternal-fetal hemodynamics|maternal-fetal hemodynamics
5420115|NCT01630772|perinatal outcomes|perinatal outcomes
5420116|NCT01630759|Gestational diabetes|gestational diabetes
5420117|NCT01630759|telemonitoring|telemonitoring
5420118|NCT01630759|telehealth|telehealth
5420119|NCT01630759|feasibility study|feasibility study
5420120|NCT01630733|Metastatic|metastatic
5420121|NCT01630733|Stage IV|stage iv
5420122|NCT01630733|Advanced|advanced
5420123|NCT01630733|lung cancer|lung cancer
5420124|NCT01630720|ascorbic acid|ascorbic acid
5420125|NCT01630720|cholecalciferol|cholecalciferol
5420126|NCT01630720|vitamin C|vitamin c
5420127|NCT01630720|vitamin D|vitamin d
5420128|NCT01630720|hypovitaminosis|hypovitaminosis
5420129|NCT01630720|mood|mood
5420130|NCT01630720|distress|distress
5420131|NCT01630694|Difficult airway management|difficult airway management
5420132|NCT01630694|anesthesia|anesthesia
5420133|NCT01630694|difficult intubation|difficult intubation
5420134|NCT01630629|Lactation|lactation
5420135|NCT01630629|Weaning|weaning
5420136|NCT01630629|Bone Density|bone density
5420137|NCT01630629|Endocrine|endocrine
5420138|NCT01630629|Physiological Properties|physiological properties
5420139|NCT01630629|Bone Metabolism|bone metabolism
5420140|NCT01630590|Prostate Cancer|prostate cancer
5420141|NCT01630590|Metastatic Prostate Cancer|metastatic prostate cancer
5420142|NCT01630590|Prostate adenocarcinoma|prostate adenocarcinoma
5420144|NCT01630590|Cabozantinib|cabozantinib
5420145|NCT01630590|XL 184|xl 184
5420146|NCT01630590|Androgen Ablation|androgen ablation
5420147|NCT01630577|acute circulatory failure|acute circulatory failure
5420148|NCT01630577|hemodynamic stability|hemodynamic stability
5420149|NCT01630577|hypovolemia|hypovolemia
5420150|NCT01630551|tears|tears
5420151|NCT01630551|dry eyes|dry eyes
5420152|NCT01630551|ocular surface disease|ocular surface disease
5420153|NCT01630538|Transplantation|transplantation
5420154|NCT01630525|Alzheimer's disease|alzheimer's disease
5420155|NCT01630525|neurodegenerative signs|neurodegenerative signs
5420156|NCT01630499|Cancer|cancer
5420157|NCT01630499|Breast cancer|breast cancer
5420158|NCT01630499|Breast cancer prevention|breast cancer prevention
5420159|NCT01630499|Breast cancer recurrence|breast cancer recurrence
5420160|NCT01630499|Weight loss|weight loss
5420161|NCT01630499|Weight management|weight management
5420162|NCT01630499|Overweight|overweight
5420163|NCT01630499|Obesity|obesity
5420164|NCT01630486|renal progression|renal progression
5420165|NCT01630486|mortality|mortality
5420166|NCT01630486|complications|complications
5420167|NCT01630486|risk factors|risk factors
5420168|NCT01630486|role of biochemical parameters|role of biochemical parameters
5420169|NCT01630486|genetic influence|genetic influence
5420170|NCT01630473|Tooth crowding|tooth crowding
5420171|NCT01630473|Teeth malpositions|teeth malpositions
5420172|NCT01630473|corticotomy|corticotomy
5420173|NCT01630473|orthodontics|orthodontics
5420174|NCT01630473|tooth movement|tooth movement
5420175|NCT01630473|periodontal parameters|periodontal parameters
5420176|NCT01630460|Craniometaphyseal dysplasia|craniometaphyseal dysplasia
5420177|NCT01630460|bone|bone
5420178|NCT01630460|hyperostosis|hyperostosis
5420179|NCT01630460|osteoblast|osteoblast
5420180|NCT01630460|osteoclast|osteoclast
5420181|NCT01630447|cherubism|cherubism
5420182|NCT01630447|bone|bone
5420183|NCT01630447|autoinflammatory disorder|autoinflammatory disorder
5420184|NCT01630447|osteoblast|osteoblast
5420185|NCT01630447|osteoclast|osteoclast
5420186|NCT01630447|mandible|mandible
5420187|NCT01630447|maxilla|maxilla
5420188|NCT01630421|Aplasia cutis congenita|aplasia cutis congenita
5420189|NCT01630421|bone|bone
5403145|NCT01707784|Stress|stress
5420190|NCT01630421|osteoblast|osteoblast
5420191|NCT01630421|osteoclast|osteoclast
5420192|NCT01630421|skin|skin
5420193|NCT01630408|Preserved ejection fraction|preserved ejection fraction
5420194|NCT01630408|Left ventricular hypertrophy|left ventricular hypertrophy
5420195|NCT01630408|Activated vitamin D|activated vitamin d
5420196|NCT01630408|Cardiac lusitropic effect|cardiac lusitropic effect
5420197|NCT01630408|Hospitalizations|hospitalizations
5420198|NCT01630356|Secondhand Smoke|secondhand smoke
5420199|NCT01630356|Nicotine|nicotine
5420200|NCT01630356|Indoor Air Pollution|indoor air pollution
5420201|NCT01630343|Geriatric hip fracture|geriatric hip fracture
5420202|NCT01630343|pain management|pain management
5420203|NCT01630304|telecommunications|telecommunications
5420204|NCT01630304|Africa|africa
5420205|NCT01630304|randomized controlled trial|randomized controlled trial
5420206|NCT01630278|Prematurity|prematurity
5420207|NCT01630278|patent ductus arteriosus|patent ductus arteriosus
5420208|NCT01630278|ibuprofen|ibuprofen
5420209|NCT01630265|Discharge Instructions|discharge instructions
5420210|NCT01630265|Video Discharge Instructions|video discharge instructions
5420211|NCT01630265|Video|video
5420212|NCT01630265|Emergency Department Discharge Instructions|emergency department discharge instructions
5420213|NCT01630265|ED Discharge|ed discharge
5420214|NCT01630226|BRCA1|brca1
5420215|NCT01630226|pathological complete response|pathological complete response
5420216|NCT01630226|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5420217|NCT01630213|Vitamin D3|vitamin d3
5420218|NCT01630213|Left ventricular mass|left ventricular mass
5420219|NCT01630213|Echocardiography|echocardiography
5420220|NCT01630213|Left ventricular systolic and diastolic function|left ventricular systolic and diastolic function
5420221|NCT01630200|COPD|copd
5420222|NCT01630200|comorbidity|comorbidity
5420223|NCT01630200|arterial stiffness|arterial stiffness
5420224|NCT01630200|roflumilast|roflumilast
5420225|NCT01630187|Carbetocin|carbetocin
5420226|NCT01630187|Uterotonic drug|uterotonic drug
5420227|NCT01630187|elective cesarean section|elective cesarean section
5420228|NCT01630174|IMRT,Pemetrexed,Cisplatin , Esophageal Cancer|imrt,pemetrexed,cisplatin , esophageal cancer
5420229|NCT01630161|relapse|relapse
5420230|NCT01630161|prevention|prevention
5420231|NCT01630161|smoking|smoking
5420232|NCT01630161|habit|habit
5420233|NCT01630161|Forever Free|forever free
5420234|NCT01630148|Thromboprophylaxis|thromboprophylaxis
5420235|NCT01630148|Bemiparin|bemiparin
5420236|NCT01630148|Low Molecular Weight Heparin|low molecular weight heparin
5420237|NCT01630148|Major Gynaecological Surgeries|major gynaecological surgeries
5420238|NCT01630148|Benign Gynaecological Surgeries|benign gynaecological surgeries
5420239|NCT01630122|Trans-thoracic Needle Biopsy (TNB)|trans-thoracic needle biopsy (tnb)
5420240|NCT01630122|Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS-TBNA)|endobronchial ultrasound guided transbronchial needle aspiration (ebus-tbna)
5420336|NCT01629472|Economic Well-being|economic well-being
5420241|NCT01630122|Trans-esophageal Ultrasound Scanning with FNA (EUS-FNA)|trans-esophageal ultrasound scanning with fna (eus-fna)
5420242|NCT01630083|IMAB362|imab362
5420243|NCT01630083|ASP8951|asp8951
5420244|NCT01630083|zolbetuximab|zolbetuximab
5420245|NCT01630070|Critical limb ischemia|critical limb ischemia
5420246|NCT01630070|Rest pain|rest pain
5420247|NCT01630070|Minor tissue loss|minor tissue loss
5420248|NCT01630070|Below the knee|below the knee
5420249|NCT01630031|atrial fibrillation|atrial fibrillation
5420250|NCT01630031|paroxysmal|paroxysmal
5420251|NCT01630031|contact force|contact force
5420252|NCT01630031|radiofrequency|radiofrequency
5420253|NCT01630031|catheter ablation|catheter ablation
5420254|NCT01630031|pulmonary vein isolation|pulmonary vein isolation
5420255|NCT01630031|recurrence|recurrence
5420256|NCT01630031|follow-up|follow-up
5420257|NCT01630018|Epithelial Ovarian Cancer|epithelial ovarian cancer
5392718|NCT01754987|Micronutrients|micronutrients
5420258|NCT01630018|Belotecan|belotecan
5420259|NCT01630018|Topotecan|topotecan
5420260|NCT01629992|Vomiting|vomiting
5420261|NCT01629992|Nausea|nausea
5420262|NCT01629992|Postoperative pain|postoperative pain
5420263|NCT01629992|Feeling|feeling
5420264|NCT01629966|Generalized Anxiety Disorder|generalized anxiety disorder
5420266|NCT01629940|X-linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5420267|NCT01629940|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5420268|NCT01629940|XLHED|xlhed
5420270|NCT01629927|X-linked hypohidrotic ectodermal dysplasia|x-linked hypohidrotic ectodermal dysplasia
5420271|NCT01629927|Hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5420272|NCT01629927|HED|hed
5420273|NCT01629927|XLHED|xlhed
5420274|NCT01629914|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5420275|NCT01629914|executive functioning|executive functioning
5420276|NCT01629914|mindfulness meditation|mindfulness meditation
5420277|NCT01629914|magnetic resonance imaging|magnetic resonance imaging
5420278|NCT01629914|healthy|healthy
5420279|NCT01629901|Healthy volunteer|healthy volunteer
5420280|NCT01629888|Plant sterol|plant sterol
5420281|NCT01629888|Hypercholesterolemia|hypercholesterolemia
5420282|NCT01629888|dairy|dairy
5862841|NCT00001483|Manic-Depressive Disorder|manic-depressive disorder
5420283|NCT01629810|Motion platform at appropriate settings.|motion platform at appropriate settings.
5420284|NCT01629810|Relief of pain.|relief of pain.
5420285|NCT01629810|Improvement in quality of life, cognition, and mood.|improvement in quality of life, cognition, and mood.
5420286|NCT01629810|Effects of WBPA on cognition, mood, behavior, and functioning.|effects of wbpa on cognition, mood, behavior, and functioning.
5420287|NCT01629810|Dose response effect .|dose response effect .
5420288|NCT01629810|Gather data for long-term (2 year) study|gather data for long-term (2 year) study
5420289|NCT01629745|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5420290|NCT01629745|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5420291|NCT01629693|contact lenses|contact lenses
5420292|NCT01629693|myopia|myopia
5420293|NCT01629693|astigmatism|astigmatism
5420294|NCT01629680|moxaverine|moxaverine
5420295|NCT01629680|ocular blood flow|ocular blood flow
5420296|NCT01629654|Poststroke fatigue|poststroke fatigue
5420297|NCT01629654|Health promotion|health promotion
5420298|NCT01629654|Patient education|patient education
5420299|NCT01629641|goniometry|goniometry
5420300|NCT01629641|outcome measures|outcome measures
5420301|NCT01629641|shoulder assessment|shoulder assessment
5420302|NCT01629628|Crohn Disease|crohn disease
5420303|NCT01629628|Colitis Granulomatous|colitis granulomatous
5420304|NCT01629628|Crohn's Disease|crohn's disease
5420305|NCT01629628|Enteritis Regional|enteritis regional
5420306|NCT01629628|Ileitis Regional|ileitis regional
5420307|NCT01629628|Ileitis Terminal|ileitis terminal
5420308|NCT01629628|Ileocolitis|ileocolitis
5420309|NCT01629615|breast cancer|breast cancer
5420310|NCT01629615|metastatic|metastatic
5420311|NCT01629615|triple negative breast cancer|triple negative breast cancer
5420312|NCT01629615|BKM120|bkm120
5420313|NCT01629615|SOLTI|solti
5420314|NCT01629615|PI3K inhibitor|pi3k inhibitor
5420315|NCT01629602|defect;|defect;
5420316|NCT01629602|dorsal branch of the proper digital nerve;|dorsal branch of the proper digital nerve;
5420317|NCT01629602|proper digital nerve;|proper digital nerve;
5420318|NCT01629602|vascularized nerve graft|vascularized nerve graft
5420319|NCT01629589|Adacel® vaccine|adacel® vaccine
5420320|NCT01629589|Tetanus|tetanus
5420321|NCT01629589|Diphtheria|diphtheria
5420322|NCT01629589|whooping cough|whooping cough
5420323|NCT01629589|Pertussis|pertussis
5420324|NCT01629589|BOOSTRIX® vaccine|boostrix® vaccine
5420325|NCT01629537|Post Traumatic Stress Disorder|post traumatic stress disorder
5420326|NCT01629485|Mastery Learning|mastery learning
5420327|NCT01629485|Surgical Education|surgical education
5420328|NCT01629485|Laparoscopic Hernia Repair|laparoscopic hernia repair
5420329|NCT01629485|Part vs Whole Task|part vs whole task
5420330|NCT01629485|Contextual Interference|contextual interference
5420331|NCT01629485|laparoscopy|laparoscopy
5420332|NCT01629485|training|training
5420333|NCT01629485|curriculum|curriculum
5420334|NCT01629472|Gender norms|gender norms
5420335|NCT01629472|Financial Autonomy|financial autonomy
5420339|NCT01629459|training|training
5420340|NCT01629459|barth syndrome|barth syndrome
5420341|NCT01629459|mitochondria|mitochondria
5420342|NCT01629459|amino acid|amino acid
5420343|NCT01629459|protein|protein
5420344|NCT01629446|Phase 1|phase 1
5420345|NCT01629446|Normal healthy volunteers|normal healthy volunteers
5420346|NCT01629446|Mass Balance|mass balance
5420347|NCT01629433|idiopathic detrusor overactivity|idiopathic detrusor overactivity
5420348|NCT01629433|neurogenic dysfunction|neurogenic dysfunction
5420349|NCT01629433|onabotulinumtoxinA|onabotulinumtoxina
5420350|NCT01629420|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5420351|NCT01629381|knee arthroscopy|knee arthroscopy
5420352|NCT01629381|venous thromboembolism|venous thromboembolism
5420353|NCT01629381|prevention|prevention
5420354|NCT01629355|Auditory Brainstem Response|auditory brainstem response
5420355|NCT01629355|ABR|abr
5420356|NCT01629355|SD-BERA|sd-bera
5420357|NCT01629329|Headache|headache
5420358|NCT01629329|prochlorperazine|prochlorperazine
5420359|NCT01629329|excedrin migraine|excedrin migraine
5420360|NCT01629329|treatment efficacy|treatment efficacy
5420361|NCT01629329|pain scores|pain scores
5420362|NCT01629316|HIV|hiv
5420363|NCT01629316|prisoners|prisoners
5420364|NCT01629316|test|test
5420365|NCT01629316|treat|treat
5420366|NCT01629316|link coordination|link coordination
5420367|NCT01629316|retain|retain
5420368|NCT01629316|behavioral|behavioral
5420369|NCT01629316|intervention|intervention
5420370|NCT01629316|text reminders|text reminders
5420371|NCT01629316|motivational interviewing|motivational interviewing
5420372|NCT01629316|medication adherence|medication adherence
5420373|NCT01629303|constipation|constipation
5420374|NCT01629303|sacral nerve modulation|sacral nerve modulation
5420375|NCT01629277|Closed-loop insulin delivery|closed-loop insulin delivery
5403355|NCT01706939|HPV|hpv
5420376|NCT01629277|Non-compliant behaviours during adolescence|non-compliant behaviours during adolescence
5420377|NCT01629264|Cornea|cornea
5420378|NCT01629264|biomechanics|biomechanics
5420379|NCT01629264|pregnancy|pregnancy
5540374|NCT01125423|Female|female
5420380|NCT01629264|keratoconus|keratoconus
5420381|NCT01629264|refractive surgery|refractive surgery
5420382|NCT01629251|Closed-loop insulin delivery|closed-loop insulin delivery
5420383|NCT01629251|Post-prandial hypoglycaemia|post-prandial hypoglycaemia
5420384|NCT01629251|Meal insulin dosing|meal insulin dosing
5420385|NCT01629238|cardiovascular risk|cardiovascular risk
5420386|NCT01629238|dairy enriched product with plant sterols|dairy enriched product with plant sterols
5420387|NCT01629238|general practitioners|general practitioners
5420388|NCT01629238|adults followed by general practitioners|adults followed by general practitioners
5420389|NCT01629225|men and women|men and women
5420390|NCT01629225|in southwestern Han Chinese|in southwestern han chinese
5420391|NCT01629186|CPR|cpr
5420392|NCT01629186|flexible bronchoscope|flexible bronchoscope
5420393|NCT01629186|resuscitation|resuscitation
5420394|NCT01629186|ventilation|ventilation
5420395|NCT01629173|plantar pressure|plantar pressure
5420396|NCT01629173|metatarsalgia|metatarsalgia
5420397|NCT01629173|insole|insole
5420398|NCT01629147|Constipation|constipation
5420399|NCT01629108|Normative Data|normative data
5420400|NCT01629108|Vestibular|vestibular
5420401|NCT01629108|Auditory|auditory
5420402|NCT01629108|Healthy Volunteers|healthy volunteers
5420403|NCT01629108|Hearing|hearing
5420406|NCT01629082|Myelodysplastic Syndromes|myelodysplastic syndromes
5420407|NCT01629082|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5420408|NCT01629082|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5420409|NCT01629069|stress|stress
5420410|NCT01629069|mindfulness|mindfulness
5420411|NCT01629069|coping|coping
5420412|NCT01629056|atrial fibrillation|atrial fibrillation
5420413|NCT01629056|ablation|ablation
5420414|NCT01629056|contact|contact
5420415|NCT01629043|Parkinson's|parkinson's
5420416|NCT01629043|Quality of Care|quality of care
5420417|NCT01629043|Improvement|improvement
5420418|NCT01629043|Mobility|mobility
5420419|NCT01629043|Cognition|cognition
5420420|NCT01629043|Caregiver burden|caregiver burden
5420421|NCT01629043|Center difference|center difference
5420422|NCT01629030|sternal wound infection|sternal wound infection
5420423|NCT01629030|coronary artery bypass graft|coronary artery bypass graft
5420424|NCT01629030|risk factor|risk factor
5420425|NCT01629004|colorectal cancer|colorectal cancer
5420426|NCT01629004|screening|screening
5420427|NCT01629004|fecal occult blood testing|fecal occult blood testing
5420428|NCT01629004|mailed invitation|mailed invitation
5420429|NCT01628991|Behavioral Intervention Program|behavioral intervention program
5420430|NCT01628991|Vaginal Cones|vaginal cones
5420431|NCT01628991|Stress Urinary Incontinence|stress urinary incontinence
5420432|NCT01628991|treatment|treatment
5420433|NCT01628991|Women|women
5420434|NCT01628978|depth of endotracheal tube placement|depth of endotracheal tube placement
5420435|NCT01628978|endotracheal intubation|endotracheal intubation
5420436|NCT01628978|endobronchial intubation|endobronchial intubation
5420437|NCT01628965|SPM 962|spm 962
5420438|NCT01628965|rotigotine|rotigotine
5420439|NCT01628965|Parkinson's disease|parkinson's disease
5420440|NCT01628965|monotherapy|monotherapy
5420441|NCT01628939|low back pain|low back pain
5420442|NCT01628939|facet joint pain|facet joint pain
5420443|NCT01628913|Pancreatic|pancreatic
5420444|NCT01628913|Neuroendocrine tumors|neuroendocrine tumors
5420445|NCT01628913|PNET|pnet
5420446|NCT01628913|BEZ235|bez235
5420447|NCT01628913|Everolimus|everolimus
5420448|NCT01628900|pyelonephritis|pyelonephritis
5420449|NCT01628900|Infection|infection
5420450|NCT01628900|Antibiotic treatment|antibiotic treatment
5420451|NCT01628887|Breast Cancer|breast cancer
5420452|NCT01628874|Lumbar Puncture|lumbar puncture
5524902|NCT01188681|CLL|cll
5420453|NCT01628874|J-Tip|j-tip
5420454|NCT01628874|Jet injection|jet injection
5420455|NCT01628874|Local Analgesia|local analgesia
5420456|NCT01628861|occupation|occupation
5420457|NCT01628861|work|work
5420458|NCT01628861|sitting|sitting
5420459|NCT01628861|sedentary behaviour|sedentary behaviour
5420460|NCT01628861|office worker|office worker
5420461|NCT01628861|adult|adult
5420462|NCT01628861|education|education
5420463|NCT01628861|point-of-choice prompt|point-of-choice prompt
5420464|NCT01628848|SPM 962|spm 962
5420465|NCT01628848|rotigotine|rotigotine
5420466|NCT01628848|Parkinson's disease|parkinson's disease
5420467|NCT01628848|concomitant use of L-dopa|concomitant use of l-dopa
5420468|NCT01628835|overweight|overweight
5420469|NCT01628835|pregnancy|pregnancy
5420470|NCT01628835|diet counselling|diet counselling
5420471|NCT01628835|glycemic|glycemic
5420472|NCT01628822|Fibromyalgia|fibromyalgia
5420473|NCT01628822|Relaxation|relaxation
5420474|NCT01628822|Improving the quality of life|improving the quality of life
5420475|NCT01628809|MBSR|mbsr
5420476|NCT01628809|mindfulness|mindfulness
5420477|NCT01628809|stress|stress
5420478|NCT01628783|Depression|depression
5420479|NCT01628783|emotional processing|emotional processing
5420480|NCT01628783|fMRI|fmri
5420481|NCT01628783|autobiographic memory|autobiographic memory
5405902|NCT01695486|BIS|bis
5420482|NCT01628783|moderator of treatment response|moderator of treatment response
5420483|NCT01628783|mediator of treatment response|mediator of treatment response
5420484|NCT01628770|iron|iron
5420485|NCT01628770|monofer|monofer
5420489|NCT01628731|urine output|urine output
5420490|NCT01628731|acute renal dysfunction|acute renal dysfunction
5420491|NCT01628718|OEF/OIF|oef/oif
5420492|NCT01628718|Veterans|veterans
5420493|NCT01628718|Psychotherapy|psychotherapy
5420494|NCT01628718|PTSD|ptsd
5420495|NCT01628705|Green tea|green tea
5420496|NCT01628705|oxLDL|oxldl
5420497|NCT01628705|fat mass|fat mass
5420498|NCT01628679|provoked|provoked
5420499|NCT01628679|vulvar|vulvar
5420500|NCT01628679|vestibulodynia|vestibulodynia
5420501|NCT01628679|vestibulitis|vestibulitis
5420502|NCT01628666|Arrhythmia|arrhythmia
5420503|NCT01628666|Device Procedure|device procedure
5420504|NCT01628666|Antibiotics|antibiotics
5420505|NCT01628666|Infection|infection
5420506|NCT01628666|Cluster|cluster
5420507|NCT01628653|Mild cognitive impairment|mild cognitive impairment
5420508|NCT01628653|Cognitive rehabilitation|cognitive rehabilitation
5420509|NCT01628653|Cognitive therapy|cognitive therapy
5420510|NCT01628653|Spaced retrieval Training|spaced retrieval training
5420511|NCT01628653|Alzheimer's disease|alzheimer's disease
5420512|NCT01628653|Memory enhancement|memory enhancement
5420513|NCT01628653|U-healthcare|u-healthcare
5420514|NCT01628627|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5420515|NCT01628575|periodontally accelerated orthodontics PAO|periodontally accelerated orthodontics pao
5420516|NCT01628562|Remifentanil|remifentanil
5420517|NCT01628562|Esmolol|esmolol
5420518|NCT01628562|Intracranial surgery|intracranial surgery
5420519|NCT01628562|Heart rate|heart rate
5420520|NCT01628562|Blood pressure|blood pressure
5420521|NCT01628549|acne|acne
5420522|NCT01628536|Black Cohosh|black cohosh
5420523|NCT01628536|Ductal Carcinoma in situ|ductal carcinoma in situ
5420524|NCT01628536|Breast Cancer|breast cancer
5420525|NCT01628523|Respiratory failure|respiratory failure
5420526|NCT01628523|Mechanical ventilation|mechanical ventilation
5420527|NCT01628523|Acute lung injury|acute lung injury
5420528|NCT01628510|preterm|preterm
5420529|NCT01628471|Phase I b : advanced solid malignancy|phase i b : advanced solid malignancy
5420530|NCT01628471|Phase II a: stage III b or IV, Non Small Cell Lung Cancer|phase ii a: stage iii b or iv, non small cell lung cancer
5420531|NCT01628458|Pancreatic cancer|pancreatic cancer
5420532|NCT01628458|locally advanced|locally advanced
5420533|NCT01628458|irresectable|irresectable
5420534|NCT01628458|Radiofrequency|radiofrequency
5420535|NCT01628458|RFA|rfa
5420536|NCT01628445|Diabetes|diabetes
5420537|NCT01628445|Insulin|insulin
5420538|NCT01628419|Health promotion|health promotion
5420539|NCT01628419|Intervention|intervention
5420540|NCT01628419|Workplace|workplace
5420541|NCT01628419|Exercise program|exercise program
5420542|NCT01628380|HIPEC|hipec
5420543|NCT01628380|Ovarian Cancer|ovarian cancer
5420544|NCT01628380|Cytoreductive Surgery|cytoreductive surgery
5420545|NCT01628354|Choroidal neovascularization|choroidal neovascularization
5420546|NCT01628354|Lucentis|lucentis
5420547|NCT01628328|colonic stenting|colonic stenting
5420548|NCT01628328|colorectal cancer obstruction|colorectal cancer obstruction
5420549|NCT01628328|circulating tumor cell|circulating tumor cell
5420550|NCT01628315|Multiple Sclerosis|multiple sclerosis
5420551|NCT01628315|ASA|asa
5420552|NCT01628315|MRI|mri
5420553|NCT01628315|Lesion activity|lesion activity
5420554|NCT01628302|Hypertension,plasma renin activity,salt consumption|hypertension,plasma renin activity,salt consumption
5420555|NCT01628289|diabetic retinopathy|diabetic retinopathy
5420556|NCT01628289|screening|screening
5420557|NCT01628289|co-payment|co-payment
5420558|NCT01628289|health service|health service
5420559|NCT01628276|Multiple Sclerosis|multiple sclerosis
5420560|NCT01628276|MRI Scans|mri scans
5420561|NCT01628263|PICU|picu
5420562|NCT01628263|Follow up|follow up
5420563|NCT01628263|PTSD|ptsd
5420564|NCT01628224|Task saturation|task saturation
5420565|NCT01628211|hyperthermic chemotherapy|hyperthermic chemotherapy
5420566|NCT01628211|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5420567|NCT01628211|second-look laparoscopy|second-look laparoscopy
5420568|NCT01628211|peritoneal carcinosis|peritoneal carcinosis
5420569|NCT01628211|mucinous colorectal cancer|mucinous colorectal cancer
5420570|NCT01628198|Hypertension|hypertension
5420571|NCT01628198|renal denervation|renal denervation
5420572|NCT01628198|renal ablation|renal ablation
5420573|NCT01628198|uncontrolled high blood pressure|uncontrolled high blood pressure
5420574|NCT01628172|renal sympathetic denervation|renal sympathetic denervation
5420575|NCT01628172|renal catheter ablation|renal catheter ablation
5420576|NCT01628172|hypertension|hypertension
5420577|NCT01628146|Presbyopia|presbyopia
5420578|NCT01628146|hyperopia|hyperopia
5420579|NCT01628146|Supracor|supracor
5420580|NCT01628146|contrast sensitivity|contrast sensitivity
5420581|NCT01628133|Transfusion|transfusion
5420582|NCT01628133|Neonate|neonate
5420583|NCT01628133|Infant, Very Low Birth Weight|infant, very low birth weight
5420585|NCT01628133|Packed Red Blood Cell|packed red blood cell
5420586|NCT01628120|Chronic renal failure|chronic renal failure
5420587|NCT01628120|Hemodialysis|hemodialysis
5420588|NCT01628107|Chronic renal failure|chronic renal failure
5420589|NCT01628107|hemodialysis|hemodialysis
5420590|NCT01628081|psoriasis|psoriasis
5420591|NCT01628081|Alga Dunaliella Bardawil|alga dunaliella bardawil
5420592|NCT01628068|Left atrial appendage occlusion|left atrial appendage occlusion
5420593|NCT01628068|gastrointestinal bleeding|gastrointestinal bleeding
5420594|NCT01628055|IVIg|ivig
5420595|NCT01628055|Acute Ischemic Stroke|acute ischemic stroke
5420596|NCT01628055|Stroke|stroke
5420598|NCT01628055|Cerebrovascular Accident|cerebrovascular accident
5420599|NCT01628029|Advanced Cancers|advanced cancers
5420600|NCT01628029|Metastatic|metastatic
5420601|NCT01628029|Locally advanced|locally advanced
5420602|NCT01628029|Sleep disturbance|sleep disturbance
5420603|NCT01628029|Sleep problems|sleep problems
5420604|NCT01628029|Litebook|litebook
5420605|NCT01628029|Melatonin|melatonin
5420606|NCT01628029|Methylphenidate|methylphenidate
5420607|NCT01628029|Methylphenidate hydrochloride|methylphenidate hydrochloride
5420608|NCT01628029|Ritalin|ritalin
5420609|NCT01628029|Concerta|concerta
5420610|NCT01628029|Placebo|placebo
5420611|NCT01628029|Supportive counseling|supportive counseling
5420612|NCT01628029|Questionnaires|questionnaires
5420613|NCT01628029|Study Diaries|study diaries
5420614|NCT01628016|depression|depression
5420615|NCT01628016|attention|attention
5420616|NCT01628016|training|training
5420617|NCT01628016|modification|modification
5420618|NCT01628003|Traumatic Brain Injury|traumatic brain injury
5420619|NCT01628003|long-term outcome|long-term outcome
5420620|NCT01628003|Brain Reserves|brain reserves
5420621|NCT01628003|Cognitive Reserves|cognitive reserves
5420622|NCT01628003|Emotional Reserves|emotional reserves
5420623|NCT01628003|Patients 1 year or more after Moderate or Severe Traumatic Brain Injury|patients 1 year or more after moderate or severe traumatic brain injury
5420624|NCT01627990|cytotoxic chemotherapy|cytotoxic chemotherapy
5420625|NCT01627990|G-CSF|g-csf
5420626|NCT01627990|Solid tumour|solid tumour
5420627|NCT01627990|Malignant haematological tumour|malignant haematological tumour
5420628|NCT01627977|chromovitrectomy|chromovitrectomy
5420629|NCT01627977|epiretinal membrane|epiretinal membrane
5420630|NCT01627964|Heart Wall Motion Function|heart wall motion function
5420631|NCT01627951|Plasmodium falciparum|plasmodium falciparum
5420632|NCT01627951|malaria|malaria
5420633|NCT01627938|Multiple Sclerosis|multiple sclerosis
5420635|NCT01627938|Mitoxantrone|mitoxantrone
5420636|NCT01627938|Dexrazoxane|dexrazoxane
5420637|NCT01627938|Cardioxane|cardioxane
5420638|NCT01627938|cardiotoxicity|cardiotoxicity
5420639|NCT01627938|cardiac toxicity|cardiac toxicity
5420640|NCT01627938|cardiotoxic side effects|cardiotoxic side effects
5420641|NCT01627938|cardiac MRI|cardiac mri
5420646|NCT01627925|upper airway obstruction|upper airway obstruction
5420647|NCT01627925|mask ventilation|mask ventilation
5420648|NCT01627912|wine|wine
5420649|NCT01627912|inflammation|inflammation
5420650|NCT01627912|oxidative stress|oxidative stress
5420651|NCT01627912|randomized control trial|randomized control trial
5420652|NCT01627912|postprandial intervention|postprandial intervention
5420653|NCT01627912|platelet aggregation|platelet aggregation
5420654|NCT01627912|haemostasis|haemostasis
5420655|NCT01627912|robola|robola
5420656|NCT01627912|cabernet sauvignon|cabernet sauvignon
5420657|NCT01627912|alcohol|alcohol
5420658|NCT01627912|PAF metabolism|paf metabolism
5420659|NCT01627899|Blood glucose monitor|blood glucose monitor
5420660|NCT01627899|Pattern management|pattern management
5420661|NCT01627899|Pattern guide|pattern guide
5420662|NCT01627899|Education|education
5420663|NCT01627886|Bioequivalence|bioequivalence
5420664|NCT01627886|Ibandronate Sodium|ibandronate sodium
5420665|NCT01627886|crossover|crossover
5420666|NCT01627873|Major abdominal surgery|major abdominal surgery
5420667|NCT01627873|analgesic method|analgesic method
5420668|NCT01627873|Fentanyl|fentanyl
5420669|NCT01627873|Remifentanyl|remifentanyl
5420670|NCT01627873|Postoperative cognitive disorder|postoperative cognitive disorder
5420671|NCT01627873|Pro and anti inflammatory cytokines|pro and anti inflammatory cytokines
5420672|NCT01627860|Epilepsy|epilepsy
5420673|NCT01627860|Topiramate|topiramate
5420674|NCT01627860|Neuro-surgical patients|neuro-surgical patients
5420675|NCT01627860|Nervous disorder|nervous disorder
5420676|NCT01627860|Seizures|seizures
5420677|NCT01627847|Bioequivalence|bioequivalence
5420678|NCT01627847|Ropinirole Hydrochloride|ropinirole hydrochloride
5420679|NCT01627847|crossover|crossover
5420680|NCT01627834|Bioequivalence|bioequivalence
5420681|NCT01627834|Ropinirole Hydrochloride|ropinirole hydrochloride
5420682|NCT01627834|crossover|crossover
5420683|NCT01627821|Heart Failure|heart failure
5420684|NCT01627808|intraoperative monitoring|intraoperative monitoring
5420685|NCT01627808|fluid management|fluid management
5420686|NCT01627795|Malignant Mesothelioma|malignant mesothelioma
5420688|NCT01627795|Anti cancer agents|anti cancer agents
5420689|NCT01627782|Major depressive disorder|major depressive disorder
5420690|NCT01627782|Treatment-resistant depression|treatment-resistant depression
5420691|NCT01627782|Ketamine|ketamine
5420692|NCT01627769|scars|scars
5420693|NCT01627769|blisters|blisters
5420694|NCT01627769|second degree burns|second degree burns
5420695|NCT01627769|cryosurgery|cryosurgery
5420696|NCT01627769|keloid scars|keloid scars
5420697|NCT01627769|hypertrophic scars|hypertrophic scars
5420702|NCT01627743|CDLM|cdlm
5420703|NCT01627743|visual scale - physician evaluation|visual scale - physician evaluation
5420704|NCT01627743|COPD|copd
5420705|NCT01627743|GOLD group C and D|gold group c and d
5420706|NCT01627717|maraviroc|maraviroc
5420707|NCT01627717|boceprevir|boceprevir
5420710|NCT01627717|drug interaction|drug interaction
5420711|NCT01627717|pharmacokinetics|pharmacokinetics
5420712|NCT01627704|PET/CT,fluoroestradiol (18F)|pet/ct,fluoroestradiol (18f)
5420713|NCT01627704|breast cancer|breast cancer
5420714|NCT01627704|metastatic|metastatic
5420715|NCT01627704|prediction of response|prediction of response
5420716|NCT01627704|hormone therapy|hormone therapy
5420717|NCT01627678|HIV-1, Vacc-C5|hiv-1, vacc-c5
5420718|NCT01627665|dabigatran|dabigatran
5420719|NCT01627665|rivaroxaban|rivaroxaban
5420720|NCT01627665|PKC|pkc
5420721|NCT01627665|PKD|pkd
5420722|NCT01627665|p-glycoprotein|p-glycoprotein
5420723|NCT01627665|polymorphism|polymorphism
5420724|NCT01627652|hypoxia|hypoxia
5420725|NCT01627626|xerostomia|xerostomia
5420726|NCT01627626|pilocarpine mouthwash|pilocarpine mouthwash
5420727|NCT01627626|minor salivary gland secretion|minor salivary gland secretion
5420728|NCT01627613|Peptide|peptide
5420729|NCT01627600|stroke|stroke
5420730|NCT01627600|myocardial infarction|myocardial infarction
5420731|NCT01627600|cardiovascular health|cardiovascular health
5420732|NCT01627600|population study|population study
5420733|NCT01627587|preterm labor|preterm labor
5420734|NCT01627574|Pregnancy|pregnancy
5420735|NCT01627574|STI prevention|sti prevention
5420736|NCT01627574|adolescents|adolescents
5420737|NCT01627574|probation|probation
5420738|NCT01627561|Immune response|immune response
5420739|NCT01627561|Human papillomavirus|human papillomavirus
5420740|NCT01627561|HPV vaccine|hpv vaccine
5420741|NCT01627561|Safety|safety
5420742|NCT01627548|PTSD|ptsd
5420743|NCT01627548|Couples|couples
5420744|NCT01627548|Combat Veteran|combat veteran
5420745|NCT01627548|Warfighter|warfighter
5420746|NCT01627548|OEF|oef
5420747|NCT01627548|OIF|oif
5420748|NCT01627548|OND|ond
5420749|NCT01627548|Structured Approach Therapy|structured approach therapy
5420750|NCT01627548|Trauma|trauma
5420751|NCT01627535|Brain Tumor|brain tumor
5420752|NCT01627509|continuous glucose monitoring system|continuous glucose monitoring system
5420753|NCT01627509|hypoglycemia|hypoglycemia
5420754|NCT01627509|insulin regimen|insulin regimen
5420755|NCT01627509|basal bolus therapy|basal bolus therapy
5420756|NCT01627509|modern premixed insulin|modern premixed insulin
5420757|NCT01627509|diabetes control|diabetes control
5420758|NCT01627496|malnutrition|malnutrition
5420759|NCT01627496|elderly care|elderly care
5420760|NCT01627496|quality of life|quality of life
5420761|NCT01627496|hospital|hospital
5420762|NCT01627483|elderly|elderly
5420763|NCT01627483|hip fracture|hip fracture
5420764|NCT01627483|osteoporosis|osteoporosis
5420765|NCT01627483|fall risk|fall risk
5420766|NCT01627483|medication review|medication review
5420767|NCT01627470|non-invasive arterial pressure|non-invasive arterial pressure
5420768|NCT01627470|emergency|emergency
5420769|NCT01627470|intensive care|intensive care
5420770|NCT01627457|Coronary Artery Disease|coronary artery disease
5420771|NCT01627457|Guided Exercise System including ECG Vest with vital signs sensors and PDA|guided exercise system including ecg vest with vital signs sensors and pda
5420772|NCT01627457|Validation Telemedical Device in regard to accuracy and safety of data|validation telemedical device in regard to accuracy and safety of data
5420773|NCT01627457|Homely Rehabilitation|homely rehabilitation
5420774|NCT01627457|Practicability and technical problems at home|practicability and technical problems at home
5420775|NCT01627444|Acupuncture|acupuncture
5420776|NCT01627444|Anxiety|anxiety
5420777|NCT01627444|Human Milk|human milk
5420778|NCT01627444|Very low birth weight infants|very low birth weight infants
5420779|NCT01627444|Mother of very low birth weight infants|mother of very low birth weight infants
5420780|NCT01627431|PAD|pad
5420781|NCT01627431|Peripheral revascularization|peripheral revascularization
5420782|NCT01627431|Antiplatelet therapy|antiplatelet therapy
5420783|NCT01627431|Residual platelet activity|residual platelet activity
5420784|NCT01627418|COPD|copd
5420785|NCT01627418|CORD|cord
5420786|NCT01627418|COAD|coad
5420787|NCT01627379|nonresectable|nonresectable
5420788|NCT01627379|advanced|advanced
5420789|NCT01627379|metastatic esophageal squamous cell cancer|metastatic esophageal squamous cell cancer
5420790|NCT01627379|Panitumumab|panitumumab
5420791|NCT01627353|Hysterectomy|hysterectomy
5420792|NCT01627353|Pain Prevention|pain prevention
5420793|NCT01627353|Wound Infiltration|wound infiltration
5420794|NCT01627340|Engerix™-B|engerix™-b
5420795|NCT01627340|hepatitis B|hepatitis b
5420797|NCT01627340|Type 2 diabetes mellitus|type 2 diabetes mellitus
5420798|NCT01627327|Cardiovascular event|cardiovascular event
5420799|NCT01627327|Cardiovascular disease|cardiovascular disease
5420800|NCT01627275|Naive T Cell Depletion|naive t cell depletion
5420801|NCT01627275|Donor Lymphocyte Infusion|donor lymphocyte infusion
5420802|NCT01627275|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5420803|NCT01627262|diverticular disease|diverticular disease
5420804|NCT01627262|colonic diverticulosis|colonic diverticulosis
5420805|NCT01627262|mesalamine|mesalamine
5420807|NCT01627262|randomized|randomized
5420808|NCT01627249|Diabetic Macular Edema|diabetic macular edema
5420809|NCT01627249|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5420810|NCT01627223|Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B|spontaneous severe acute exacerbation of chronic hepatitis b
5420811|NCT01627223|Lamivudine (Zeffix®)|lamivudine (zeffix®)
5420812|NCT01627223|Entecavir (Baraclude®)|entecavir (baraclude®)
5420813|NCT01627210|Diabetes Mellitus|diabetes mellitus
5420814|NCT01627197|Effects of Chemotherapy|effects of chemotherapy
5420815|NCT01627197|intraarterial chemotherapy|intraarterial chemotherapy
5420816|NCT01627145|overactive bladder syndrome|overactive bladder syndrome
5420817|NCT01627145|derusor overactivity|derusor overactivity
5420818|NCT01627145|urodynamic studies|urodynamic studies
5420819|NCT01627145|bladder oversensitivity|bladder oversensitivity
5420820|NCT01627119|CTGF|ctgf
5420821|NCT01627119|Peritoneal metastasis|peritoneal metastasis
5420822|NCT01627080|Esophagus|esophagus
5420823|NCT01627080|Esophageal Cancer|esophageal cancer
5420824|NCT01627080|Radiation therapy|radiation therapy
5420825|NCT01627080|RT|rt
5420826|NCT01627080|Chemotherapy|chemotherapy
5420827|NCT01627080|Mid thoracic tumor|mid thoracic tumor
5420828|NCT01627080|Distal esophageal tumor|distal esophageal tumor
5420829|NCT01627080|Gastroesophageal junction tumor|gastroesophageal junction tumor
5420830|NCT01627080|Cardiac biomarkers|cardiac biomarkers
5420831|NCT01627067|Breast Cancer|breast cancer
5420832|NCT01627067|Hormone Receptor Positive Metastatic Breast Cancer|hormone receptor positive metastatic breast cancer
5420833|NCT01627067|Hormone-sensitive|hormone-sensitive
5420834|NCT01627067|Postmenopausal|postmenopausal
5420835|NCT01627067|Body Mass Index|body mass index
5420836|NCT01627067|BMI|bmi
5420837|NCT01627067|Everolimus|everolimus
5420838|NCT01627067|Afinitor|afinitor
5420839|NCT01627067|RAD001|rad001
5420840|NCT01627067|Exemestane|exemestane
5420845|NCT01627028|Bone resorption|bone resorption
5420846|NCT01627015|Fully formula fed|fully formula fed
5420848|NCT01627002|First in Human|first in human
5420849|NCT01627002|Healthy Volunteers|healthy volunteers
5420850|NCT01627002|Lipopolysaccharide Challenge|lipopolysaccharide challenge
5420851|NCT01626976|safety|safety
5420852|NCT01626976|tolerability|tolerability
5420853|NCT01626976|pharmacokinetics|pharmacokinetics
5420854|NCT01626976|oral|oral
5420855|NCT01626976|single ascending dose|single ascending dose
5420856|NCT01626976|placebo-controlled|placebo-controlled
5420857|NCT01626976|healthy subjects|healthy subjects
5420858|NCT01626963|single-port access|single-port access
5420859|NCT01626963|laparoscopic surgery|laparoscopic surgery
5420860|NCT01626963|surgical trauma|surgical trauma
5420861|NCT01626950|Breast cancer|breast cancer
5420862|NCT01626950|living conditions|living conditions
5420863|NCT01626950|social fragility|social fragility
5420864|NCT01626937|Acute respiratory failure|acute respiratory failure
5420865|NCT01626937|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5420866|NCT01626937|Non invasive ventilation|non invasive ventilation
5420868|NCT01626924|Perinatal Asphyxia|perinatal asphyxia
5420869|NCT01626924|Neonatal encephalopathy|neonatal encephalopathy
5420870|NCT01626924|Oxygen shortage at birth|oxygen shortage at birth
5420871|NCT01626924|Antenatal asphyxia|antenatal asphyxia
5420872|NCT01626924|hypoxia-ischaemia|hypoxia-ischaemia
5420873|NCT01626924|birth asphyxia|birth asphyxia
5420874|NCT01626924|asphyxia neonatorum|asphyxia neonatorum
5420875|NCT01626911|severe acute pancreatitis;|severe acute pancreatitis;
5420876|NCT01626911|continuous regional arterial infusion;|continuous regional arterial infusion;
5420877|NCT01626911|low molecular weight heparin|low molecular weight heparin
5420878|NCT01626885|Schizophrenia|schizophrenia
5420879|NCT01626885|Antipsychotic Agents|antipsychotic agents
5420880|NCT01626885|Mental Disorder|mental disorder
5420881|NCT01626885|Psychotropic Drugs|psychotropic drugs
5420882|NCT01626885|Dopamine Agents|dopamine agents
5420883|NCT01626885|Central Nervous System Agents|central nervous system agents
5420884|NCT01626872|Schizophrenia|schizophrenia
5420885|NCT01626872|Antipsychotic Agents|antipsychotic agents
5420886|NCT01626872|Mental Disorder|mental disorder
5420887|NCT01626872|Psychotropic Drugs|psychotropic drugs
5420888|NCT01626872|Dopamine Agents|dopamine agents
5420889|NCT01626872|Risperidone|risperidone
5420890|NCT01626872|Central Nervous System Agents|central nervous system agents
5420891|NCT01626859|Schizophrenia|schizophrenia
5415935|NCT01650493|in situ|in situ
5420900|NCT01626833|Growth velocity|growth velocity
5420901|NCT01626820|Immunogenicity|immunogenicity
5420902|NCT01626820|Influenza|influenza
5420903|NCT01626820|Safety|safety
5420904|NCT01626820|Adults|adults
5420905|NCT01626820|Fluviral|fluviral
5420906|NCT01626807|Safe Routes to School|safe routes to school
5420907|NCT01626807|Walking School Bus|walking school bus
5420908|NCT01626807|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5420909|NCT01626807|Physical Activity|physical activity
5420910|NCT01626807|Obesity|obesity
5420911|NCT01626807|Overweight|overweight
5420912|NCT01626755|Phantom limb pain|phantom limb pain
5420913|NCT01626755|Chronic pain|chronic pain
5420914|NCT01626755|Amputation|amputation
5420915|NCT01626755|Peripheral vascular disease|peripheral vascular disease
5420916|NCT01626729|Food Labeling|food labeling
5420917|NCT01626677|Umbilical Cord Blood|umbilical cord blood
5420918|NCT01626677|Mesenchymal Stem Cells|mesenchymal stem cells
5420919|NCT01626677|Cartilage injury|cartilage injury
5420920|NCT01626677|Osteoarthritis|osteoarthritis
5420921|NCT01626664|Adult T cell Leukemia-Lymphoma (ATL)|adult t cell leukemia-lymphoma (atl)
5420922|NCT01626651|Healthy|healthy
5420923|NCT01626651|Ketoconazole|ketoconazole
5420924|NCT01626651|Ibrutinib|ibrutinib
5420925|NCT01626638|Patients with malignant and pre-malignant pharyngo laryngeal tumors|patients with malignant and pre-malignant pharyngo laryngeal tumors
5420926|NCT01626625|nonunion|nonunion
5420927|NCT01626625|stem cells|stem cells
5420928|NCT01626625|autograft|autograft
5420929|NCT01626625|hydroxyapatite|hydroxyapatite
5420930|NCT01626599|ECG|ecg
5420931|NCT01626599|Accelerometer|accelerometer
5420932|NCT01626599|Device|device
5420938|NCT01626573|Rheumatoid Arthritis|rheumatoid arthritis
5420939|NCT01626573|RA|ra
5420940|NCT01626573|Active|active
5420941|NCT01626547|symptomatic anameia|symptomatic anameia
5420942|NCT01626508|breast milk|breast milk
5420943|NCT01626508|breast-milk bank|breast-milk bank
5420944|NCT01626508|plasma profile|plasma profile
5420945|NCT01626508|essential fatty acids|essential fatty acids
5420946|NCT01626495|Biological: CART19|biological: cart19
5420947|NCT01626443|PCOS|pcos
5420948|NCT01626443|Metabolic disorders|metabolic disorders
5420949|NCT01626443|Ovarian functionality|ovarian functionality
5420950|NCT01626443|Myo-inositol|myo-inositol
5420951|NCT01626443|D-chiro-inositol|d-chiro-inositol
5420952|NCT01626430|Gamma delta TRF|gamma delta trf
5420953|NCT01626430|Insulin sensitivity|insulin sensitivity
5420954|NCT01626430|Postprandial lipaemia|postprandial lipaemia
5420955|NCT01626430|Inflammatory markers|inflammatory markers
5420956|NCT01626430|NF-κB|nf-κb
5420957|NCT01626417|Stroke|stroke
5420958|NCT01626417|Tibion|tibion
5420959|NCT01626417|Bionics|bionics
5420960|NCT01626417|Rehab|rehab
5420961|NCT01626417|Therapy|therapy
5420962|NCT01626417|Robotics|robotics
5420963|NCT01626417|Intention|intention
5420964|NCT01626404|Thoratec Corporation|thoratec corporation
5420965|NCT01626391|Alzheimer's Disease|alzheimer's disease
5420966|NCT01626391|TRx0237|trx0237
5420967|NCT01626391|Safety Study|safety study
5420968|NCT01626391|AD|ad
5420974|NCT01626365|thermosoftening|thermosoftening
5420975|NCT01626352|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5420976|NCT01626352|Ofatumumab|ofatumumab
5420977|NCT01626352|Bendamustine|bendamustine
5420978|NCT01626339|Anti vascular endothelial growth factor|anti vascular endothelial growth factor
5420979|NCT01626339|retinal vessels|retinal vessels
5420980|NCT01626326|smoking|smoking
5420981|NCT01626326|smoking cessation|smoking cessation
5420982|NCT01626326|mobile app|mobile app
5420983|NCT01626313|Veteran families|veteran families
5420985|NCT01626313|OIF|oif
5420986|NCT01626313|OND|ond
5420987|NCT01626313|Resiliency|resiliency
5420988|NCT01626313|Psycho educational training|psycho educational training
5420989|NCT01626313|Stress|stress
5420990|NCT01626313|Military|military
5420991|NCT01626287|perineal|perineal
5420992|NCT01626287|postpartum|postpartum
5420993|NCT01626287|pain|pain
5420994|NCT01626287|treatment|treatment
5420995|NCT01626287|ice and black tea|ice and black tea
5420996|NCT01626287|maternal satisfaction|maternal satisfaction
5420997|NCT01626274|Polysomnography|polysomnography
5680256|NCT00578461|myeloproliferative disease|myeloproliferative disease
5420999|NCT01626274|In-ear sensor system|in-ear sensor system
5421000|NCT01626274|Photoplethysmographic micro-optic device|photoplethysmographic micro-optic device
5421001|NCT01626274|High wearing comfort|high wearing comfort
5421002|NCT01626248|Immunological|immunological
5421003|NCT01626248|biomarkers|biomarkers
5421004|NCT01626248|observational|observational
5421005|NCT01626248|RRMS|rrms
5421006|NCT01626248|Relapsing|relapsing
5421007|NCT01626248|Remitting Multiple Sclerosis|remitting multiple sclerosis
5421008|NCT01626235|pain control|pain control
5421009|NCT01626235|fractures|fractures
5421010|NCT01626235|sprains|sprains
5421011|NCT01626235|strains|strains
5421012|NCT01626235|dysmenorrhea|dysmenorrhea
5421013|NCT01626235|kidney stones|kidney stones
5421014|NCT01626235|gouty arthritis|gouty arthritis
5421015|NCT01626235|opioids|opioids
5421016|NCT01626235|NSDAIDs|nsdaids
5421017|NCT01626235|Emergency Department|emergency department
5421018|NCT01626235|patient reported outcomes|patient reported outcomes
5421019|NCT01626222|Postmenopausal|postmenopausal
5421020|NCT01626222|Estrogen Receptor Positive|estrogen receptor positive
5421021|NCT01626222|HER2 negative|her2 negative
5421022|NCT01626222|Locally Advanced|locally advanced
5421023|NCT01626222|Metastatic Breast Cancer|metastatic breast cancer
5421024|NCT01626222|Everolimus (RAD001)|everolimus (rad001)
5421025|NCT01626222|Exemestane|exemestane
5421026|NCT01626209|Breast cancer, NSCLC, SCCHN, esophageal cancer|breast cancer, nsclc, scchn, esophageal cancer
5421027|NCT01626183|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5421028|NCT01626183|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5421029|NCT01626144|Exemestane|exemestane
5421030|NCT01626144|Metabolism|metabolism
5421031|NCT01626144|Metabolizing enzyme genotype|metabolizing enzyme genotype
5421032|NCT01626144|Breast cancer|breast cancer
5421033|NCT01626131|combat disorders|combat disorders
5421034|NCT01626131|exercise therapy|exercise therapy
5421035|NCT01626105|Hemophilia A|hemophilia a
5421036|NCT01626105|Factor VIII|factor viii
5421037|NCT01626105|Inhibitors|inhibitors
5421038|NCT01626105|Immunogenicity|immunogenicity
5421039|NCT01626105|Pharmacogenetics|pharmacogenetics
5421040|NCT01626105|Mutation|mutation
5421041|NCT01626105|Nonsynonymous Single Nucleotide Polymorphisms|nonsynonymous single nucleotide polymorphisms
5421042|NCT01626105|Class II Human Leukocyte Antigens|class ii human leukocyte antigens
5421043|NCT01626092|bone marrow transplantation|bone marrow transplantation
5421044|NCT01626092|reduced intensity conditioning|reduced intensity conditioning
5421045|NCT01626092|Adrenoleukodystrophy|adrenoleukodystrophy
5421046|NCT01626092|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5421047|NCT01626092|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
5421048|NCT01626092|Wolman's disease|wolman's disease
5421049|NCT01626092|GM1 gangliosidosis|gm1 gangliosidosis
5421050|NCT01626092|Tay Sachs disease|tay sachs disease
5421051|NCT01626092|Sanfilippo syndrome|sanfilippo syndrome
5421052|NCT01626092|Sandhoff disease|sandhoff disease
5421053|NCT01626092|inherited metabolic|inherited metabolic
5421054|NCT01626092|I-cell disease|i-cell disease
5421055|NCT01626092|mucolipidosis II|mucolipidosis ii
5421056|NCT01626079|Functional Mitral Regurgitation|functional mitral regurgitation
5421057|NCT01626079|Mitral Valve Regurgitation|mitral valve regurgitation
5421058|NCT01626079|Symptomatic Heart Failure|symptomatic heart failure
5424446|NCT01610960|NEXT Helmet|next helmet
5421060|NCT01626079|MitraClip|mitraclip
5421061|NCT01626079|Mitral Valve Insufficiency|mitral valve insufficiency
5421062|NCT01626079|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5421063|NCT01626079|COAPT CAS|coapt cas
5421064|NCT01626079|COAPT Continued Access Study|coapt continued access study
5421065|NCT01626079|MitraClip NT|mitraclip nt
5421066|NCT01626053|psychological|psychological
5421067|NCT01626053|intervention|intervention
5421068|NCT01626053|stages of change|stages of change
5421069|NCT01626053|motivational interviewing|motivational interviewing
5421070|NCT01626053|coping skills|coping skills
5421071|NCT01626053|HbA1C|hba1c
5421072|NCT01626053|psychological testing|psychological testing
5421073|NCT01626053|integrated care|integrated care
5421074|NCT01626053|behavioral health|behavioral health
5421075|NCT01626027|Coronary Heart Disease|coronary heart disease
5421076|NCT01626027|Depression|depression
5421077|NCT01626027|Health Care Services|health care services
5421078|NCT01626014|Stage III ovarian cancer|stage iii ovarian cancer
5421079|NCT01626014|Stage IV ovarian cancer|stage iv ovarian cancer
5421080|NCT01626014|recurrent ovarian cancer|recurrent ovarian cancer
5421081|NCT01626014|primary peritoneal cancer|primary peritoneal cancer
5421082|NCT01626014|fallopian tube cancer|fallopian tube cancer
5421083|NCT01626001|Esophagus Cancer|esophagus cancer
5421084|NCT01626001|Lung Cancer|lung cancer
5421085|NCT01626001|4-dimensional computed tomography|4-dimensional computed tomography
5421086|NCT01626001|4D CT|4d ct
5421087|NCT01625975|Growth modulation|growth modulation
5421088|NCT01625975|Eight plate|eight plate
5416147|NCT01649440|sepsis|sepsis
5421089|NCT01625975|Leg length discrepancy|leg length discrepancy
5421090|NCT01625975|Varus/valgus deformities|varus/valgus deformities
5421091|NCT01625975|Pediatric|pediatric
5421093|NCT01625962|mTBI|mtbi
5421094|NCT01625962|mild TBI|mild tbi
5421095|NCT01625962|extracranial injury|extracranial injury
5421097|NCT01625962|Brain Indices|brain indices
5421098|NCT01625949|myocardial infarction|myocardial infarction
5421099|NCT01625936|metastatic|metastatic
5421100|NCT01625936|locally advanced|locally advanced
5421101|NCT01625936|unresectable|unresectable
5421102|NCT01625923|Gastroparesis|gastroparesis
5421103|NCT01625923|Idiopathic|idiopathic
5421104|NCT01625923|Olanzapine|olanzapine
5421105|NCT01625910|Childhood obesity treatment|childhood obesity treatment
5421106|NCT01625910|Motivational interviewing|motivational interviewing
5421107|NCT01625897|Schizophrenia|schizophrenia
5421108|NCT01625897|Antipsychotic Agents|antipsychotic agents
5421109|NCT01625897|Mental Disorder|mental disorder
5421110|NCT01625897|Psychotropic Drugs|psychotropic drugs
5421111|NCT01625897|Dopamine Agents|dopamine agents
5421112|NCT01625897|Risperidone|risperidone
5421113|NCT01625897|Central Nervous System Agents|central nervous system agents
5421114|NCT01625884|Statin|statin
5421115|NCT01625884|Hypercholesterolemia|hypercholesterolemia
5421116|NCT01625871|malaria|malaria
5421117|NCT01625871|vivax|vivax
5421118|NCT01625871|artemether/lumefantrine|artemether/lumefantrine
5421119|NCT01625871|Sudan|sudan
5421120|NCT01625858|LMA Supreme|lma supreme
5421121|NCT01625845|Major Depressive Disorder|major depressive disorder
5421122|NCT01625845|Depression|depression
5421123|NCT01625845|Depressive Symptoms|depressive symptoms
5421124|NCT01625845|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5421125|NCT01625845|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5421126|NCT01625845|Heart Disease|heart disease
5421127|NCT01625845|Endothelial Function|endothelial function
5421128|NCT01625845|Inflammation|inflammation
5421129|NCT01625832|intermittent coronary sinus occlusion|intermittent coronary sinus occlusion
5421130|NCT01625832|collateral flow index|collateral flow index
5421131|NCT01625832|collateral circulation|collateral circulation
5421132|NCT01625832|coronary artery occlusion|coronary artery occlusion
5421133|NCT01625819|Tai Chi|tai chi
5421134|NCT01625793|Hepatitis C|hepatitis c
5421135|NCT01625793|interferon|interferon
5421136|NCT01625793|stress|stress
5421137|NCT01625793|social behavior|social behavior
5421138|NCT01625767|Nicotine|nicotine
5421139|NCT01625767|Smoking|smoking
5421140|NCT01625767|Adolescent|adolescent
5421141|NCT01625767|Tobacco|tobacco
5421142|NCT01625754|Ceramides|ceramides
5421143|NCT01625754|Lipids|lipids
5421144|NCT01625728|Voice|voice
5421145|NCT01625728|aerodynamics|aerodynamics
5421146|NCT01625728|acoustics|acoustics
5421147|NCT01625715|peanut allergy|peanut allergy
5421148|NCT01625702|no-prior chemotherapy|no-prior chemotherapy
5421149|NCT01625689|Influenza vaccines|influenza vaccines
5421150|NCT01625689|Influenza, Human|influenza, human
5421151|NCT01625689|Live Attenuated Influenza Vaccine|live attenuated influenza vaccine
5421152|NCT01625676|Aphasia|aphasia
5421153|NCT01625676|Rehabilitation of Speech and Language Disorders|rehabilitation of speech and language disorders
5421154|NCT01625663|barth syndrome|barth syndrome
5421155|NCT01625663|heart failure|heart failure
5421156|NCT01625663|mitochondria|mitochondria
5421157|NCT01625663|metabolism|metabolism
5421158|NCT01625663|amino acid|amino acid
5421159|NCT01625650|Rheumatoid Arthritis|rheumatoid arthritis
5421160|NCT01625650|Registry|registry
5421162|NCT01625650|Biologic|biologic
5421163|NCT01625650|Medications|medications
5421164|NCT01625650|Rheumatology|rheumatology
5421165|NCT01625637|Nicotine|nicotine
5421166|NCT01625637|Smoking|smoking
5421167|NCT01625637|Adolescent|adolescent
5421168|NCT01625637|Tobacco|tobacco
5421169|NCT01625611|Alcohol|alcohol
5421170|NCT01625611|Drinking|drinking
5421171|NCT01625611|Drinkers|drinkers
5421172|NCT01625611|Alcohol Drinking|alcohol drinking
5421173|NCT01625611|Naltrexone|naltrexone
5421174|NCT01625611|Alcohol Dependence|alcohol dependence
5421175|NCT01625611|Alcohol Abuse|alcohol abuse
5421176|NCT01625611|Alcohol-Related Disorders|alcohol-related disorders
5421177|NCT01625611|Ethanol|ethanol
5421178|NCT01625611|Alcoholism|alcoholism
5685286|NCT00556751|Electrocardiogram|electrocardiogram
5421179|NCT01625598|Nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
5421180|NCT01625598|diabetic macular edema|diabetic macular edema
5421181|NCT01625598|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5421182|NCT01625598|ophthalmologists|ophthalmologists
5421183|NCT01625598|dilated eye exam|dilated eye exam
5421184|NCT01625585|Push-and-Pull Enteroscopy|push-and-pull enteroscopy
5421185|NCT01625585|Single-Balloon-Enteroscopy|single-balloon-enteroscopy
5421186|NCT01625572|general anaesthesia|general anaesthesia
5421187|NCT01625572|epidural catheter|epidural catheter
5421188|NCT01625572|intravenous pain therapy|intravenous pain therapy
5421189|NCT01625546|Major Depressive Disorder|major depressive disorder
5421190|NCT01625546|Whole Body Hyperthermia|whole body hyperthermia
5421192|NCT01625533|Rotational Coronary Angiography|rotational coronary angiography
5421193|NCT01625533|Contrast media|contrast media
5421194|NCT01625533|Radiation|radiation
5421195|NCT01625520|Progressive metastatic|progressive metastatic
5421196|NCT01625520|postoperative persistent|postoperative persistent
5421197|NCT01625468|Secondhand smoke exposure|secondhand smoke exposure
5421198|NCT01625468|Smoke-free homes|smoke-free homes
5421199|NCT01625468|Smoke-free home bans|smoke-free home bans
5421200|NCT01625455|Sezary Syndrome|sezary syndrome
5421201|NCT01625455|Pruritus|pruritus
5421202|NCT01625455|Aprepitant|aprepitant
5421203|NCT01625455|Neurokinin-1|neurokinin-1
5421204|NCT01625442|Metabolic syndrome|metabolic syndrome
5421205|NCT01625442|hypercholesterolemia|hypercholesterolemia
5421206|NCT01625442|hypertriglyceridemia|hypertriglyceridemia
5421207|NCT01625442|hyperglycemia|hyperglycemia
5421208|NCT01625416|Posttraumatic Stress Disorder|posttraumatic stress disorder
5421209|NCT01625416|Depression|depression
5421210|NCT01625416|Suicide|suicide
5421211|NCT01625416|Traumatic Brain Injury|traumatic brain injury
5421212|NCT01625416|Alcohol Use|alcohol use
5421213|NCT01625416|Drug Use|drug use
5421214|NCT01625416|Information Technology|information technology
5421215|NCT01625403|Recombinant BNP|recombinant bnp
5421216|NCT01625403|Diuretics|diuretics
5421217|NCT01625403|Acute decompensated heart failure|acute decompensated heart failure
5421218|NCT01625403|Acute renal injury|acute renal injury
5421219|NCT01625403|Heart function|heart function
5421220|NCT01625403|Renal function|renal function
5421221|NCT01625390|hemophilia, haemophilia, inhibitor, FVIIa, Factor VII activated, bypassing|hemophilia, haemophilia, inhibitor, fviia, factor vii activated, bypassing
5421222|NCT01625377|Everolimus,|everolimus,
5421223|NCT01625377|liver transplantation,|liver transplantation,
5421224|NCT01625377|early introduction,|early introduction,
5421225|NCT01625377|renal function|renal function
5421226|NCT01625364|Health Education|health education
5421227|NCT01625364|Health Counseling|health counseling
5421228|NCT01625364|Patient Education|patient education
5421229|NCT01625338|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5421230|NCT01625338|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5421232|NCT01625338|Sustained Virologic Response|sustained virologic response
5421233|NCT01625338|Direct Acting Antiviral|direct acting antiviral
5421234|NCT01625338|Combination Therapy|combination therapy
5421235|NCT01625338|GS-7977|gs-7977
5421236|NCT01625338|Ribavirin|ribavirin
5421237|NCT01625338|Open Label|open label
5421337|NCT01625000|Risperidone|risperidone
5421238|NCT01625325|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life|obesity, adiposity, psychosocial, healthcare, co-morbidities, low key intervention, quality of life
5421239|NCT01625299|intestinal permeability|intestinal permeability
5421241|NCT01625299|gluten|gluten
5421242|NCT01625299|dairy|dairy
5421243|NCT01625286|advanced breast cancer,|advanced breast cancer,
5421244|NCT01625286|metastatic breast cancer,|metastatic breast cancer,
5421245|NCT01625286|ER+ve breast cancer,|er+ve breast cancer,
5421246|NCT01625286|Estrogen receptor positive breast cancer,|estrogen receptor positive breast cancer,
5421247|NCT01625286|PIK3CA mutated advanced or metastatic breast cancer|pik3ca mutated advanced or metastatic breast cancer
5421248|NCT01625286|AKT inhibitor|akt inhibitor
5421249|NCT01625273|F19|f19
5421250|NCT01625273|Lactobacillus paracasei paracasei|lactobacillus paracasei paracasei
5421251|NCT01625260|cancer|cancer
5421252|NCT01625260|immunotherapy|immunotherapy
5421253|NCT01625260|targeted|targeted
5421254|NCT01625260|non-muscle invasive|non-muscle invasive
5421255|NCT01625260|interleukin-2|interleukin-2
5421256|NCT01625260|antitumor|antitumor
5421258|NCT01625260|T-cell receptor|t-cell receptor
5421259|NCT01625260|p53|p53
5421260|NCT01625260|p53 gene|p53 gene
5421261|NCT01625260|p53 tumor supressor protein|p53 tumor supressor protein
5421262|NCT01625260|urothelial cancer|urothelial cancer
5421263|NCT01625260|bladder cancer|bladder cancer
5421264|NCT01625260|HLA-A2 positive|hla-a2 positive
5421265|NCT01625260|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
5421266|NCT01625260|HLA complex|hla complex
5421267|NCT01625260|refractory|refractory
5421268|NCT01625260|relapsed|relapsed
5421269|NCT01625260|BCG|bcg
5421270|NCT01625260|multi-focal|multi-focal
5421271|NCT01625260|carcinoma in situ|carcinoma in situ
5421272|NCT01625260|transitional cell carcinoma|transitional cell carcinoma
5421273|NCT01625260|gemcitabine|gemcitabine
5421274|NCT01625234|Cancer|cancer
5421275|NCT01625234|Tumors|tumors
5421276|NCT01625234|ALK|alk
5421277|NCT01625234|NSCLC|nsclc
5421278|NCT01625234|Advanced Malignancies|advanced malignancies
5421279|NCT01625234|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5421280|NCT01625234|Inflammatory Myofibroblastic Tumors|inflammatory myofibroblastic tumors
5421281|NCT01625221|FENIX|fenix
5421282|NCT01625182|chronic inflammatory demyelinating polyradiculoneuropathy, CIDP, FTY720, fingolimod.|chronic inflammatory demyelinating polyradiculoneuropathy, cidp, fty720, fingolimod.
5421283|NCT01625169|Pharmacokinetics|pharmacokinetics
5421284|NCT01625169|HIV|hiv
5421285|NCT01625169|Breast milk|breast milk
5416351|NCT01648504|Ipad|ipad
5421286|NCT01625130|sulforaphane|sulforaphane
5421287|NCT01625130|ozone|ozone
5421288|NCT01625130|airway inflammation|airway inflammation
5421289|NCT01625130|broccoli sprouts|broccoli sprouts
5421290|NCT01625130|NRF2|nrf2
5421291|NCT01625130|controls|controls
5421292|NCT01625117|Treatment of ex-combatants|treatment of ex-combatants
5421293|NCT01625117|Narrative Exposure Therapy for ex-combatants|narrative exposure therapy for ex-combatants
5421294|NCT01625117|Appetitive Aggression|appetitive aggression
5421295|NCT01625117|Posttraumatic Stress Disorder|posttraumatic stress disorder
5421296|NCT01625104|Myocardial Infarction|myocardial infarction
5421297|NCT01625104|Time to Treatment|time to treatment
5421298|NCT01625104|Door to Balloon Time|door to balloon time
5421299|NCT01625091|HIV|hiv
5421300|NCT01625091|women|women
5421301|NCT01625091|drinking|drinking
5421302|NCT01625091|Naltrexone|naltrexone
5421303|NCT01625078|Baska Mask|baska mask
5421304|NCT01625078|Supraglottic airway device|supraglottic airway device
5421305|NCT01625078|Children|children
5421306|NCT01625078|Pediatric|pediatric
5421307|NCT01625065|medication compliance|medication compliance
5421308|NCT01625065|adherence|adherence
5421309|NCT01625065|toxicological analyzes|toxicological analyzes
5421310|NCT01625065|GC-MS|gc-ms
5421311|NCT01625065|HPLC|hplc
5421312|NCT01625065|pain patients|pain patients
5421313|NCT01625065|opioid misuse|opioid misuse
5421314|NCT01625065|patients with current pain|patients with current pain
5421315|NCT01625052|mask size|mask size
5421316|NCT01625052|Baska mask|baska mask
5421317|NCT01625052|supraglottic airway|supraglottic airway
5421318|NCT01625052|airway management|airway management
5421319|NCT01625039|Occupational health|occupational health
5421320|NCT01625039|cognitive behavioural therapy|cognitive behavioural therapy
5421321|NCT01625039|physiotherapy|physiotherapy
5421322|NCT01625039|physical activity|physical activity
5421323|NCT01625026|Morbidly obesity|morbidly obesity
5421324|NCT01625026|Gastric bypass|gastric bypass
5421325|NCT01625026|Cholecystolithiasis|cholecystolithiasis
5421326|NCT01625013|osteoarthritis|osteoarthritis
5421327|NCT01625013|viscosupplementation|viscosupplementation
5421329|NCT01625013|Knee|knee
5421330|NCT01625013|Synvisc-One|synvisc-one
5421331|NCT01625000|Schizophrenia|schizophrenia
5421332|NCT01625000|Antipsychotic Agents|antipsychotic agents
5421333|NCT01625000|Acute Schizophrenia|acute schizophrenia
5421334|NCT01625000|Mental Disorder|mental disorder
5421335|NCT01625000|Psychotropic Drugs|psychotropic drugs
5421336|NCT01625000|Dopamine Agents|dopamine agents
5421338|NCT01625000|Central Nervous System Agents|central nervous system agents
5421339|NCT01624987|Treatment of ex-combatants|treatment of ex-combatants
5421340|NCT01624987|FORNET for ex-combatants|fornet for ex-combatants
5421341|NCT01624987|Appetitive Aggression|appetitive aggression
5421342|NCT01624987|Post-traumatic Stress Disorder|post-traumatic stress disorder
5421343|NCT01624961|Controlled human malaria infection (CHMI)|controlled human malaria infection (chmi)
5421344|NCT01624961|Malaria challenge|malaria challenge
5421345|NCT01624961|Plasmodium falciparum|plasmodium falciparum
5421346|NCT01624961|PfSPZ Challenge|pfspz challenge
5421347|NCT01624948|BK virus|bk virus
5421348|NCT01624948|Kidney Transplantation|kidney transplantation
5421349|NCT01624948|Immunologic Monitoring|immunologic monitoring
5421350|NCT01624935|PTSD|ptsd
5421351|NCT01624935|earthquake|earthquake
5421352|NCT01624935|disaster|disaster
5421353|NCT01624935|global mental health|global mental health
5421354|NCT01624935|disaster mental health|disaster mental health
5421355|NCT01624935|depression|depression
5421356|NCT01624870|Aortic Valve Stenosis|aortic valve stenosis
5421357|NCT01624870|Valvular Heart Disease|valvular heart disease
5421358|NCT01624870|Transcatheter Aortic Valve Implantation|transcatheter aortic valve implantation
5421359|NCT01624844|ultrasound|ultrasound
5421360|NCT01624831|Psychosis|psychosis
5421361|NCT01624831|schizophrenia|schizophrenia
5421362|NCT01624831|schizoaffective disorder|schizoaffective disorder
5421363|NCT01624831|Bipolar disorder with psychotic features|bipolar disorder with psychotic features
5421364|NCT01624831|Major depression with psychotic features|major depression with psychotic features
5421365|NCT01624831|Psychosis NOS|psychosis nos
5421366|NCT01624831|Social Cognition|social cognition
5421367|NCT01624818|coping|coping
5421368|NCT01624818|physical activity|physical activity
5421369|NCT01624818|psychosocial|psychosocial
5421370|NCT01624818|children|children
5421371|NCT01624818|heart disease|heart disease
5421372|NCT01624818|habilitation|habilitation
5421373|NCT01624792|Protein metabolism|protein metabolism
5421374|NCT01624792|casein protein|casein protein
5421376|NCT01624792|Fish oil|fish oil
5421377|NCT01624779|autologous adipose tissue|autologous adipose tissue
5421378|NCT01624753|interstitial lung disease|interstitial lung disease
5421379|NCT01624753|interstitial pneumonia|interstitial pneumonia
5421380|NCT01624753|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5421381|NCT01624727|Coronary heart disease|coronary heart disease
5421382|NCT01624727|metabolic syndrome|metabolic syndrome
5421383|NCT01624727|CT angiography|ct angiography
5421384|NCT01624714|Treatment Refractory|treatment refractory
5421385|NCT01624701|Cord blood|cord blood
5421386|NCT01624701|unrelated donor|unrelated donor
5421387|NCT01624701|allogeneic|allogeneic
5421388|NCT01624701|cell dose|cell dose
5421389|NCT01624688|Tattoo|tattoo
5421390|NCT01624688|Tattoo Removal|tattoo removal
5421391|NCT01624675|Autistic disorder in children and adolescents|autistic disorder in children and adolescents
5421392|NCT01624675|Risperidone (R064766)|risperidone (r064766)
5421393|NCT01624675|Children|children
5421394|NCT01624675|Adolescents|adolescents
5421395|NCT01624675|Irritability|irritability
5421396|NCT01624675|Autistic disorder|autistic disorder
5421397|NCT01624649|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5421398|NCT01624649|Developmental disorder|developmental disorder
5421399|NCT01624649|Atomoxetine|atomoxetine
5421400|NCT01624649|Methylphenidate|methylphenidate
5421401|NCT01624649|Psychiatric disorder|psychiatric disorder
5421403|NCT01624636|Age-related Macular Degeneration|age-related macular degeneration
5421404|NCT01624636|Wet AMD|wet amd
5421405|NCT01624636|Neovascular AMD|neovascular amd
5421406|NCT01624623|radiation|radiation
5421407|NCT01624623|Calypso|calypso
5421408|NCT01624623|prostatectomy|prostatectomy
5421409|NCT01624610|Irritable bowel syndrome|irritable bowel syndrome
5421410|NCT01624610|Diarrhea|diarrhea
5421411|NCT01624610|abdominal pain|abdominal pain
5421412|NCT01624610|diet|diet
5421413|NCT01624610|nutrition|nutrition
5421414|NCT01624597|Road traffic safety|road traffic safety
5421415|NCT01624584|child|child
5421416|NCT01624584|anxiety|anxiety
5421418|NCT01624558|malignant hyperthermia|malignant hyperthermia
5421419|NCT01624545|chronic subdural hematoma|chronic subdural hematoma
5421420|NCT01624545|burr hole trepanation|burr hole trepanation
5421421|NCT01624545|radiologic follow-up|radiologic follow-up
5421422|NCT01624545|outcome|outcome
5421423|NCT01624545|recurrence|recurrence
5421424|NCT01624532|Anthrax vaccine|anthrax vaccine
5421425|NCT01624519|Arterial Lactate|arterial lactate
5421426|NCT01624519|Central Venous Lactate|central venous lactate
5421427|NCT01624519|Peripheral Venous Lactate|peripheral venous lactate
5421428|NCT01624506|GERD|gerd
5421429|NCT01624506|Fundoplication|fundoplication
5421430|NCT01624506|Magnetic Sphincter Augmentation|magnetic sphincter augmentation
5421431|NCT01624493|Vascular Disrupting Agents|vascular disrupting agents
5421432|NCT01624493|BNC105P|bnc105p
5421433|NCT01624493|Partially platinum sensitive|partially platinum sensitive
5421434|NCT01624480|Pediatric Narcolepsy|pediatric narcolepsy
5421531|NCT01624090|Lung Tumors|lung tumors
5421435|NCT01624467|Advanced Solid Tumors|advanced solid tumors
5421436|NCT01624454|colonoscopy|colonoscopy
5421437|NCT01624454|bowel cleansing|bowel cleansing
5421439|NCT01624428|Adolescent|adolescent
5421440|NCT01624428|Nicotine|nicotine
5421441|NCT01624428|Magnetic Resonance Imaging|magnetic resonance imaging
5421442|NCT01624428|Varenicline|varenicline
5421443|NCT01624389|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
5421444|NCT01624389|Alzheimer's disease|alzheimer's disease
5421445|NCT01624376|non-invasive management|non-invasive management
5421446|NCT01624376|Fistula|fistula
5421447|NCT01624376|Crohn's Disease|crohn's disease
5421448|NCT01624376|local administration|local administration
5421449|NCT01624376|non-invasive|non-invasive
5421450|NCT01624363|Pancreatic cysts incidentally found during EUS|pancreatic cysts incidentally found during eus
5421451|NCT01624350|Anorectal Fistulas|anorectal fistulas
5421452|NCT01624337|Plasmodium falciparum|plasmodium falciparum
5421453|NCT01624337|Plasmodium vivax|plasmodium vivax
5421455|NCT01624324|KIM-1|kim-1
5421456|NCT01624324|DPOAE|dpoae
5421457|NCT01624324|nephrotoxicity|nephrotoxicity
5421458|NCT01624324|ototoxicity|ototoxicity
5421459|NCT01624311|High ammonia level|high ammonia level
5421460|NCT01624311|Hyperammonemia|hyperammonemia
5421461|NCT01624311|Poor suck|poor suck
5421462|NCT01624311|Lethargy|lethargy
5421463|NCT01624311|Coma|coma
5421464|NCT01624311|Encephalopathy|encephalopathy
5421465|NCT01624311|Seizures|seizures
5421466|NCT01624311|Brain edema|brain edema
5421467|NCT01624311|Urea Cycle Disorder|urea cycle disorder
5421468|NCT01624311|Ornithine Transcarbamylase Deficiency|ornithine transcarbamylase deficiency
5421469|NCT01624311|Carbamoyl Phosphate Synthetase Deficiency|carbamoyl phosphate synthetase deficiency
5421470|NCT01624311|Citrullinemia|citrullinemia
5421471|NCT01624311|Argininosuccinic Aciduria|argininosuccinic aciduria
5421472|NCT01624311|Organic Acidemia|organic acidemia
5421473|NCT01624311|Propionic Aciduria|propionic aciduria
5421474|NCT01624311|Methylmalonic Aciduria|methylmalonic aciduria
5421475|NCT01624311|Isovaleric Aciduria|isovaleric aciduria
5421476|NCT01624298|Randomized controlled trial|randomized controlled trial
5421477|NCT01624298|Traumatized youth|traumatized youth
5421478|NCT01624298|HIV risk|hiv risk
5421479|NCT01624272|Physical Therapy|physical therapy
5421480|NCT01624272|Respiratory Muscle Training|respiratory muscle training
5421481|NCT01624272|Elderly|elderly
5421482|NCT01624220|Spinal tumor|spinal tumor
5421483|NCT01624220|Tumor of the mid or lower spine|tumor of the mid or lower spine
5421484|NCT01624220|Non-small cell lung cancer|non-small cell lung cancer
5406934|NCT01691274|Phase 1|phase 1
5421486|NCT01624220|Prostate cancer|prostate cancer
5421487|NCT01624220|Renal cell cancer|renal cell cancer
5421488|NCT01624220|Melanoma|melanoma
5421489|NCT01624220|Gastrointestinal cancer|gastrointestinal cancer
5421490|NCT01624220|Sarcoma|sarcoma
5421491|NCT01624220|Thyroid cancer|thyroid cancer
5421492|NCT01624220|Head and neck primary cancer|head and neck primary cancer
5421493|NCT01624220|Carcinoma of unknown primary|carcinoma of unknown primary
5421494|NCT01624220|Fiducial markers|fiducial markers
5421495|NCT01624220|Gold seed markers|gold seed markers
5421496|NCT01624220|Spinal stereotactic body radiation therapy|spinal stereotactic body radiation therapy
5421497|NCT01624220|Spinal SBRT|spinal sbrt
5421498|NCT01624220|Stereotactic Radiotherapy|stereotactic radiotherapy
5421499|NCT01624207|Atorva|atorva
5421500|NCT01624207|generic|generic
5421501|NCT01624207|atorvastatin|atorvastatin
5421502|NCT01624207|hypercholesterolemia|hypercholesterolemia
5421503|NCT01624181|ion mobility spectrometry|ion mobility spectrometry
5421504|NCT01624181|hospital-acquired pneumonia|hospital-acquired pneumonia
5404487|NCT01702207|cardiovascular risk|cardiovascular risk
5421505|NCT01624181|microbiological investigation|microbiological investigation
5421506|NCT01624181|intensive care|intensive care
5421507|NCT01624168|anxiety|anxiety
5421508|NCT01624168|sleep quality|sleep quality
5421509|NCT01624168|tai chi chuan|tai chi chuan
5421510|NCT01624168|young adults|young adults
5421511|NCT01624155|teratogens|teratogens
5421512|NCT01624155|contraception|contraception
5421513|NCT01624155|electronic medical record|electronic medical record
5421514|NCT01624142|Hypercholesterolemia|hypercholesterolemia
5421515|NCT01624142|Elevated Cholesterol|elevated cholesterol
5421516|NCT01624142|High Cholesterol|high cholesterol
5421517|NCT01624142|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5421518|NCT01624142|PCSK9 mutations|pcsk9 mutations
5421519|NCT01624142|Severe Familial Hypercholesterolemia|severe familial hypercholesterolemia
5421520|NCT01624103|Arm Injuries|arm injuries
5421521|NCT01624103|Wounds and Injuries|wounds and injuries
5421522|NCT01624103|Lidocaine|lidocaine
5421523|NCT01624103|Levobupivacaine|levobupivacaine
5421524|NCT01624103|Bupivacaine|bupivacaine
5421525|NCT01624103|Anesthetics|anesthetics
5421526|NCT01624103|Central Nervous System Depressants|central nervous system depressants
5421527|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs
5421528|NCT01624090|Cancer Stem Cell|cancer stem cell
5421529|NCT01624090|Thoracic Malignancies|thoracic malignancies
5421530|NCT01624090|Mithramycin Treatment|mithramycin treatment
5421535|NCT01624077|Rejection|rejection
5421536|NCT01624077|Tolerance|tolerance
5421537|NCT01624077|Cell tolerance|cell tolerance
5421538|NCT01624077|Survival|survival
5421539|NCT01624064|Renal Insufficiency, Chronic|renal insufficiency, chronic
5421540|NCT01624064|Uncertain aetiology|uncertain aetiology
5421542|NCT01624051|cisplatin based chemotherapy|cisplatin based chemotherapy
5421543|NCT01624051|non-small cell lung cancer|non-small cell lung cancer
5421544|NCT01624051|lean body mass|lean body mass
5421545|NCT01624051|sarcopenia|sarcopenia
5421546|NCT01624038|Hydroxyurea|hydroxyurea
5421547|NCT01624038|Erythropoitin therapy|erythropoitin therapy
5421548|NCT01624038|Thalassemia intermedia|thalassemia intermedia
5421549|NCT01624025|AGC, second-line, docetaxel, epirubicin|agc, second-line, docetaxel, epirubicin
5421550|NCT01624012|NIV NAVA|niv nava
5421551|NCT01624012|non-invasive ventilation|non-invasive ventilation
5421552|NCT01623973|hemiparetic|hemiparetic
5421553|NCT01623973|cognitive|cognitive
5421554|NCT01623973|balance|balance
5421555|NCT01623960|severe haemophilia|severe haemophilia
5421556|NCT01623960|quality of life|quality of life
5421557|NCT01623947|glutamine|glutamine
5421558|NCT01623947|cycling performance|cycling performance
5421559|NCT01623947|mental function|mental function
5421560|NCT01623934|Gestational diabetes|gestational diabetes
5421561|NCT01623934|Adiponectin|adiponectin
5421563|NCT01623934|Single Nucleotides Polymorphisms|single nucleotides polymorphisms
5421564|NCT01623934|Insulin resistance|insulin resistance
5421565|NCT01623921|Lung|lung
5421566|NCT01623921|Contusion|contusion
5421567|NCT01623921|Injury|injury
5421568|NCT01623921|Cyclooxygenase|cyclooxygenase
5421569|NCT01623921|Statin|statin
5421570|NCT01623908|Breast neoplasms|breast neoplasms
5421571|NCT01623908|Zoledronate|zoledronate
5421572|NCT01623908|Bone loss|bone loss
5421573|NCT01623882|Diabetes Mellitus|diabetes mellitus
5421574|NCT01623882|Wounds|wounds
5421575|NCT01623882|Ulcers|ulcers
5421581|NCT01623830|reconsolidation|reconsolidation
5421582|NCT01623830|fear of flying|fear of flying
5421583|NCT01623830|virtual reality|virtual reality
5421584|NCT01623830|virtual reality exposure therapy|virtual reality exposure therapy
5421585|NCT01623804|Ultrasound therapy|ultrasound therapy
5421586|NCT01623804|Tibiofemoral joint, medial|tibiofemoral joint, medial
5421587|NCT01623804|Nonsurgical|nonsurgical
5421588|NCT01623791|Pre-eclampsia|pre-eclampsia
5421589|NCT01623791|Proteinuria|proteinuria
5421590|NCT01623791|Protein - creatinine ratio|protein - creatinine ratio
5407051|NCT01690754|SMS|sms
5421591|NCT01623791|Dipstick proteinuria|dipstick proteinuria
5416680|NCT01646554|FOLFOX|folfox
5421592|NCT01623791|Severity of disease|severity of disease
5421593|NCT01623778|HBeAg seroconversion|hbeag seroconversion
5421594|NCT01623778|Peginterferon alfa-2a|peginterferon alfa-2a
5421595|NCT01623778|chronic hepatitis B(CHB|chronic hepatitis b(chb
5421596|NCT01623778|Optimal therapy|optimal therapy
5421597|NCT01623778|Response guild treatment(RGT);|response guild treatment(rgt);
5421598|NCT01623765|Endobronchial ultrasound, lung cancer|endobronchial ultrasound, lung cancer
5421599|NCT01623739|Dental implants|dental implants
5421600|NCT01623739|Esthetic score|esthetic score
5421601|NCT01623739|Immediate implants|immediate implants
5421602|NCT01623739|Early placement|early placement
5421603|NCT01623726|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5421604|NCT01623726|Schizophrenia|schizophrenia
5421605|NCT01623713|schizophrenia|schizophrenia
5421607|NCT01623713|Risperidone|risperidone
5421608|NCT01623713|Efficacy|efficacy
5421609|NCT01623713|Safety|safety
5421610|NCT01623700|clopidogrel|clopidogrel
5421611|NCT01623700|aspirin|aspirin
5404597|NCT01701713|NAMING|naming
5421612|NCT01623700|percutaneous coronary intervention|percutaneous coronary intervention
5421613|NCT01623700|coronary stenting|coronary stenting
5421614|NCT01623700|antiplatelet|antiplatelet
5421615|NCT01623687|total hip arthroplasty|total hip arthroplasty
5421616|NCT01623687|bone metabolism|bone metabolism
5421617|NCT01623687|mineralisation|mineralisation
5421618|NCT01623674|Sleep deprivation in surgeons during night shifts and the effect on performance.|sleep deprivation in surgeons during night shifts and the effect on performance.
5421619|NCT01623661|Nephrology|nephrology
5421620|NCT01623661|chronic kidney disease|chronic kidney disease
5421621|NCT01623661|sodium-channels|sodium-channels
5421622|NCT01623661|water-channels|water-channels
5421624|NCT01623648|whey protein|whey protein
5421625|NCT01623648|hunger|hunger
5421626|NCT01623609|Phase 1|phase 1
5421627|NCT01623609|Healthy volunteers|healthy volunteers
5421628|NCT01623609|Naloxegol|naloxegol
5421629|NCT01623609|Bioequivalence|bioequivalence
5421630|NCT01623583|lidocaine|lidocaine
5421631|NCT01623583|tetracaine|tetracaine
5421632|NCT01623583|Renal dialysis|renal dialysis
5421743|NCT01623011|Shoulder|shoulder
5421633|NCT01623570|Luteinizing Hormone|luteinizing hormone
5421634|NCT01623570|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5421635|NCT01623570|Ovulation Induction|ovulation induction
5421636|NCT01623570|Chorionic Gonadotropin|chorionic gonadotropin
5421637|NCT01623557|Malaria|malaria
5421638|NCT01623557|Vaccine|vaccine
5421639|NCT01623557|Plasmodium|plasmodium
5421640|NCT01623557|falciparum|falciparum
5421641|NCT01623544|Asthma|asthma
5421642|NCT01623544|Comparative Effectiveness|comparative effectiveness
5421643|NCT01623544|Symbicort|symbicort
5421644|NCT01623531|Fibrinogen|fibrinogen
5421645|NCT01623531|cardiac surgery|cardiac surgery
5421646|NCT01623531|high risk|high risk
5421647|NCT01623531|cardiopulmonary bypass|cardiopulmonary bypass
5421648|NCT01623531|bleeding|bleeding
5421649|NCT01623531|blood transfusion|blood transfusion
5421650|NCT01623505|Smoking Cessation|smoking cessation
5421651|NCT01623505|Psychiatric Illness|psychiatric illness
5421652|NCT01623505|Pharmacotherapy|pharmacotherapy
5421653|NCT01623492|Eisenmenger|eisenmenger
5421654|NCT01623466|PK and Safety|pk and safety
5421655|NCT01623453|crohn's disease|crohn's disease
5421656|NCT01623453|fistula|fistula
5421657|NCT01623453|complex|complex
5421658|NCT01623427|pediatric|pediatric
5421659|NCT01623427|laparoscopy|laparoscopy
5421660|NCT01623427|vacuum|vacuum
5421661|NCT01623427|dressing|dressing
5424997|NCT01609101|Trauma|trauma
5421662|NCT01623362|Dentifrices|dentifrices
5421663|NCT01623362|Dental Caries|dental caries
5421664|NCT01623362|Fluorides|fluorides
5421665|NCT01623362|Nails|nails
5421666|NCT01623362|pH|ph
5421667|NCT01623349|Recurrent|recurrent
5421668|NCT01623349|High Grade|high grade
5421669|NCT01623349|Serous|serous
5421670|NCT01623349|Triple Negative|triple negative
5421671|NCT01623336|HEPATITIS|hepatitis
5421672|NCT01623336|HEPATITIS C|hepatitis c
5421673|NCT01623336|PEGINTERFERON|peginterferon
5421674|NCT01623336|BIOEQUIVALENCE|bioequivalence
5421675|NCT01623336|TREATMENT|treatment
5421677|NCT01623297|Surgery|surgery
5421678|NCT01623297|Acute Phase Reaction|acute phase reaction
5421679|NCT01623297|Aged|aged
5421680|NCT01623297|Aged 80 and over|aged 80 and over
5421681|NCT01623297|Confusion|confusion
5421682|NCT01623297|Inflammation|inflammation
5421683|NCT01623297|Delirium|delirium
5421684|NCT01623284|aphasia|aphasia
5421685|NCT01623284|apraxia of speech|apraxia of speech
5421686|NCT01623284|language|language
5421687|NCT01623271|CRPS I|crps i
5421688|NCT01623232|vaccine|vaccine
5421689|NCT01623232|influenzavirus A|influenzavirus a
5421690|NCT01623232|influenzavirus B|influenzavirus b
5421691|NCT01623232|adjuvant|adjuvant
5421692|NCT01623219|PTSD|ptsd
5421693|NCT01623219|trauma|trauma
5407138|NCT01690312|DHA|dha
5421694|NCT01623219|combat trauma|combat trauma
5421695|NCT01623219|veterans|veterans
5421696|NCT01623219|telemedicine|telemedicine
5421697|NCT01623219|prolonged exposure|prolonged exposure
5421698|NCT01623193|Cardioplegia|cardioplegia
5421699|NCT01623193|Blood transfusion|blood transfusion
5421700|NCT01623193|Cardiac function|cardiac function
5421701|NCT01623193|Myocardial edema|myocardial edema
5421702|NCT01623193|Coronary artery disease|coronary artery disease
5421703|NCT01623193|Valve disease|valve disease
5421705|NCT01623180|coronary stent|coronary stent
5421706|NCT01623180|bare metal stent|bare metal stent
5421707|NCT01623180|high bleeding|high bleeding
5421708|NCT01623180|MI|mi
5421709|NCT01623180|angina|angina
5421710|NCT01623167|Pancytopenia|pancytopenia
5421711|NCT01623167|Immunosuppression|immunosuppression
5421712|NCT01623167|Hematopoesis|hematopoesis
5421713|NCT01623167|Autoimmunity|autoimmunity
5421714|NCT01623167|Thrombocytopenia|thrombocytopenia
5421715|NCT01623154|Helicobacter pylori|helicobacter pylori
5421716|NCT01623141|CRPS|crps
5421717|NCT01623141|TPBS|tpbs
5421718|NCT01623141|Pressure pain thresholds|pressure pain thresholds
5421719|NCT01623141|limb pain of other origin|limb pain of other origin
5421720|NCT01623128|Breastfeeding initiation|breastfeeding initiation
5421721|NCT01623128|Breastfeeding duration|breastfeeding duration
5421722|NCT01623128|WIC|wic
5421723|NCT01623128|Video education|video education
5421724|NCT01623128|Breastfeeding rates|breastfeeding rates
5559961|NCT01047683|niacin|niacin
5421725|NCT01623115|PCSK9|pcsk9
5421726|NCT01623102|Bevacizumab|bevacizumab
5421727|NCT01623102|gemcitabine|gemcitabine
5421728|NCT01623102|cisplatin|cisplatin
5421729|NCT01623102|EGFR wild-type|egfr wild-type
5421730|NCT01623089|severe asthma, phenotype, data|severe asthma, phenotype, data
5421731|NCT01623076|Neuromyelitis Optica|neuromyelitis optica
5421732|NCT01623076|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5421733|NCT01623076|Transverse Myelitis|transverse myelitis
5421734|NCT01623076|Optic Neuritis|optic neuritis
5421735|NCT01623076|Biorepository|biorepository
5421736|NCT01623063|endometrium|endometrium
5421737|NCT01623063|infertility|infertility
5421738|NCT01623063|uterus|uterus
5421739|NCT01623063|histeroscopy|histeroscopy
5421740|NCT01623037|Lipolysis|lipolysis
5421741|NCT01623037|Cryolipolysis|cryolipolysis
5421742|NCT01623037|Fat Reduction|fat reduction
5421744|NCT01623011|Sub-acromial|sub-acromial
5421745|NCT01623011|Rotator Cuff|rotator cuff
5421746|NCT01623011|Impingement|impingement
5421747|NCT01622998|Pharmacotherapy|pharmacotherapy
5421748|NCT01622998|Titration|titration
5421749|NCT01622998|Smoking Cessation|smoking cessation
5421750|NCT01622959|emergency departement|emergency departement
5421751|NCT01622959|acute pain|acute pain
5421752|NCT01622959|acupuncture|acupuncture
5421753|NCT01622959|morphine|morphine
5421754|NCT01622946|total hip arthroplasty|total hip arthroplasty
5421755|NCT01622946|tranexamic acid|tranexamic acid
5421756|NCT01622946|postoperative blood loss|postoperative blood loss
5421757|NCT01622933|melanoma|melanoma
5421758|NCT01622933|recurrent|recurrent
5421759|NCT01622933|metastatic|metastatic
5421760|NCT01622920|enamel erosion|enamel erosion
5421761|NCT01622920|ultrasound|ultrasound
5421762|NCT01622920|reproducibility|reproducibility
5421763|NCT01622920|human central incisor|human central incisor
5421764|NCT01622920|reliability|reliability
5421765|NCT01622907|Catheter ablation, radiofrequency|catheter ablation, radiofrequency
5421766|NCT01622907|Epicardially applied radiofrequency ablation|epicardially applied radiofrequency ablation
5421767|NCT01622907|Minimally invasive surgical approach|minimally invasive surgical approach
5421768|NCT01622894|Alzheimer genetics|alzheimer genetics
5421770|NCT01622855|Secondary prevention|secondary prevention
5421771|NCT01622855|Intervention|intervention
5421772|NCT01622842|Impedance|impedance
5421773|NCT01622842|Electrical|electrical
5421774|NCT01622842|Tissue|tissue
5421775|NCT01622842|Excitation frequency|excitation frequency
5421776|NCT01622842|arterial distension|arterial distension
5421777|NCT01622842|distension wave form|distension wave form
5421778|NCT01622777|Rosuvastatin|rosuvastatin
5421779|NCT01622777|Diabetic polyneuropathy|diabetic polyneuropathy
5421780|NCT01622777|Nerve conduction|nerve conduction
5421781|NCT01622777|Oxidative stress|oxidative stress
5421782|NCT01622777|Nerve growth factor|nerve growth factor
5421783|NCT01622764|RO5323441|ro5323441
5421784|NCT01622764|bevacizumab|bevacizumab
5421785|NCT01622764|PET imaging|pet imaging
5421786|NCT01622764|recurrent glioblastoma|recurrent glioblastoma
5421787|NCT01622751|REM sleep|rem sleep
5421788|NCT01622751|Adiponectin|adiponectin
5421789|NCT01622751|Prader-Willi syndrome|prader-willi syndrome
5421790|NCT01622725|ventral hernia|ventral hernia
5421791|NCT01622712|inguinal hernia|inguinal hernia
5421792|NCT01622699|Jaundice|jaundice
5421793|NCT01622699|Neonatal Jaundice|neonatal jaundice
5421794|NCT01622699|Hyperbilirubinemia|hyperbilirubinemia
5421795|NCT01622699|Transcutaneous bilirubin measurement|transcutaneous bilirubin measurement
5421796|NCT01622699|Transcutaneous bilirubinometry|transcutaneous bilirubinometry
5421797|NCT01622699|jaundice meter|jaundice meter
5421798|NCT01622699|Visual assessment of bilirubin|visual assessment of bilirubin
5421803|NCT01622686|Spanish|spanish
5421804|NCT01622660|URETER|ureter
5421805|NCT01622660|URINARY BLADDER|urinary bladder
5421806|NCT01622660|renal pelvis|renal pelvis
5421807|NCT01622660|GEMCITABINE|gemcitabine
5421808|NCT01622660|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
5421809|NCT01622660|11-191|11-191
5421810|NCT01622647|NCPAP|ncpap
5421811|NCT01622634|cardiovascular disease|cardiovascular disease
5421812|NCT01622634|diabetes mellitus|diabetes mellitus
5421813|NCT01622621|Lung|lung
5421814|NCT01622621|Cancer|cancer
5421815|NCT01622608|Adolescent vaccination|adolescent vaccination
5421816|NCT01622608|Immunization rates|immunization rates
5421817|NCT01622608|Informational kiosk|informational kiosk
5421818|NCT01622608|Tailored health messaging|tailored health messaging
5421819|NCT01622608|Barriers to vaccination|barriers to vaccination
5421820|NCT01622608|Attitudes|attitudes
5421821|NCT01622608|Intentions|intentions
5421822|NCT01622595|Aspergillosis|aspergillosis
5421823|NCT01622595|Candidemia|candidemia
5421824|NCT01622595|Candidiasis|candidiasis
5421825|NCT01622595|C. Difficile|c. difficile
5421826|NCT01622595|cytomegalovirus|cytomegalovirus
5421827|NCT01622595|respiratory syncytial virus (RSV)|respiratory syncytial virus (rsv)
5421828|NCT01622595|Influenza|influenza
5421830|NCT01622582|Multiple Myeloma, Engraftment syndrome|multiple myeloma, engraftment syndrome
5421831|NCT01622556|Chronic Myeloid Leukemia|chronic myeloid leukemia
5421832|NCT01622556|Acute Myeloid Leukemia|acute myeloid leukemia
5421833|NCT01622556|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5421834|NCT01622556|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5421835|NCT01622556|Hodgkin's Disease|hodgkin's disease
5421836|NCT01622556|Myelodysplastic Syndromes|myelodysplastic syndromes
5421837|NCT01622556|Myeloproliferative Disorder|myeloproliferative disorder
5421838|NCT01622504|Intranasal|intranasal
5421839|NCT01622504|nasal spray|nasal spray
5421840|NCT01622504|opioid|opioid
5421841|NCT01622504|overdose|overdose
5421842|NCT01622491|H1N1|h1n1
5421843|NCT01622491|pandemic|pandemic
5421844|NCT01622491|influenza|influenza
5421845|NCT01622491|pneumonia|pneumonia
5421846|NCT01622491|vaccine|vaccine
5421847|NCT01622491|effectiveness|effectiveness
5421848|NCT01622491|Manitoba|manitoba
5421849|NCT01622491|Canada|canada
5421850|NCT01622478|sentinel lymph node biopsy|sentinel lymph node biopsy
5421851|NCT01622478|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5421852|NCT01622478|breast cancer|breast cancer
5421853|NCT01622478|locally advanced breast cancer|locally advanced breast cancer
5421854|NCT01622478|positive axillary lymph node|positive axillary lymph node
5421855|NCT01622478|negative conversion|negative conversion
5421856|NCT01622465|Hip arthroplasty|hip arthroplasty
5421857|NCT01622465|Aged|aged
5421858|NCT01622465|Rehabilitation|rehabilitation
5421859|NCT01622465|Exercise therapy|exercise therapy
5421860|NCT01622452|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5421861|NCT01622452|Cognitive decline|cognitive decline
5421862|NCT01622452|Valve surgery|valve surgery
5421863|NCT01622452|Cardiac surgery|cardiac surgery
5421864|NCT01622452|Diffusion Tensor Imaging|diffusion tensor imaging
5421865|NCT01622452|Brain Morphometry|brain morphometry
5421866|NCT01622452|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
5421867|NCT01622439|Lymphoma|lymphoma
5421868|NCT01622439|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5421870|NCT01622439|R-CHOP|r-chop
5421871|NCT01622439|CD 20|cd 20
5421872|NCT01622413|lumbar spine|lumbar spine
5421873|NCT01622413|herniated disc|herniated disc
5421874|NCT01622413|slipped disc|slipped disc
5421875|NCT01622413|disc herniation|disc herniation
5421876|NCT01622413|discectomy|discectomy
5421877|NCT01622413|nucleotomy|nucleotomy
5421878|NCT01622413|disc surgery|disc surgery
5421879|NCT01622413|endoscopy|endoscopy
5421880|NCT01622413|spine|spine
5421881|NCT01622400|Cardiovascular risk, Therapeutic education, General practice|cardiovascular risk, therapeutic education, general practice
5421882|NCT01622387|Coronary artery bypass surgery|coronary artery bypass surgery
5421883|NCT01622387|Arteries|arteries
5421884|NCT01622387|Veins|veins
5421885|NCT01622387|Conduits|conduits
5421886|NCT01622374|Music|music
5421887|NCT01622374|dental anxiety|dental anxiety
5421888|NCT01622374|"music for the mind"|"music for the mind"
5421889|NCT01622374|mozart|mozart
5421890|NCT01622374|iranian traditional music|iranian traditional music
5421891|NCT01622361|Neoadjuvant|neoadjuvant
5421892|NCT01622361|endocrine therapy|endocrine therapy
5421893|NCT01622361|premenopausal|premenopausal
5421894|NCT01622361|hormone responsive|hormone responsive
5421895|NCT01622361|HER2 negative|her2 negative
5421896|NCT01622361|lymph node positive|lymph node positive
5421897|NCT01622348|Psoriasis|psoriasis
5421898|NCT01622348|Plaque Psoriasis|plaque psoriasis
5417002|NCT01645150|TKI|tki
5421900|NCT01622309|Obesity|obesity
5421901|NCT01622309|Solanum melongena|solanum melongena
5421902|NCT01622218|Medical clown|medical clown
5421903|NCT01622192|Probing|probing
5421904|NCT01622192|manual probe|manual probe
5421905|NCT01622192|automated probe|automated probe
5421906|NCT01622192|Periodontal disease|periodontal disease
5421907|NCT01622179|surgery|surgery
5421908|NCT01622179|suture method|suture method
5421909|NCT01622179|blood supply|blood supply
5421910|NCT01622140|T-SPOT.TB|t-spot.tb
5421911|NCT01622140|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
5421912|NCT01622140|Latent tuberculosis infection|latent tuberculosis infection
5421913|NCT01622140|Tuberculin skin test|tuberculin skin test
5421914|NCT01622140|Discordance|discordance
5421915|NCT01622140|Predictive value|predictive value
5421916|NCT01622140|Tuberculosis disease development|tuberculosis disease development
5421917|NCT01622114|Obesity|obesity
5421918|NCT01622114|Weight reduction|weight reduction
5421919|NCT01622114|premenopausal Women|premenopausal women
5421920|NCT01622114|Menstrual cycle|menstrual cycle
5421921|NCT01622114|quality of life|quality of life
5421922|NCT01622114|food cravings|food cravings
5421923|NCT01622101|Energy expenditure|energy expenditure
5421924|NCT01622101|Appetite|appetite
5421925|NCT01622101|Bioactive herbal compounds|bioactive herbal compounds
5421926|NCT01622101|blood pressure|blood pressure
5421927|NCT01622088|ALS, Motor Neuron Disease, Amyotrophic Lateral Sclerosis|als, motor neuron disease, amyotrophic lateral sclerosis
5421928|NCT01622062|Rabies|rabies
5421929|NCT01622062|Verorab®|verorab®
5421930|NCT01622062|Favirab®|favirab®
5421931|NCT01622036|Malnutrition|malnutrition
5421932|NCT01622036|pre-cachexia|pre-cachexia
5421933|NCT01622036|cancer|cancer
5421934|NCT01622036|cachexia|cachexia
5421935|NCT01622036|MNA|mna
5421936|NCT01622036|weight loss|weight loss
5421937|NCT01622023|insemination|insemination
5421938|NCT01622023|donor sperm|donor sperm
5421939|NCT01622023|natural cycle|natural cycle
5421940|NCT01622010|Heart Failure|heart failure
5421941|NCT01622010|Patient Education as Topic|patient education as topic
5421942|NCT01622010|Physical Therapy Specialty|physical therapy specialty
5421943|NCT01621997|peritoneal dialysis|peritoneal dialysis
5421944|NCT01621997|retraining|retraining
5421945|NCT01621997|peritonitis|peritonitis
5421946|NCT01621984|Cerebral palsy|cerebral palsy
5421947|NCT01621984|brain injury|brain injury
5421948|NCT01621984|spinal cord injuries|spinal cord injuries
5421949|NCT01621984|muscular disease|muscular disease
5421950|NCT01621971|inhaled milrinone|inhaled milrinone
5421951|NCT01621971|pulmonary hypertension|pulmonary hypertension
5421952|NCT01621971|mitral regurgitation|mitral regurgitation
5421953|NCT01621971|mitral valve surgery|mitral valve surgery
5421954|NCT01621958|balance loss|balance loss
5421955|NCT01621958|dynamic stability|dynamic stability
5421956|NCT01621958|motor learning|motor learning
5421957|NCT01621958|plasticity|plasticity
5421958|NCT01621945|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5421959|NCT01621945|Serum bactericidal activity|serum bactericidal activity
5421960|NCT01621945|OMV vaccine|omv vaccine
5421961|NCT01621932|Anterior approach|anterior approach
5421963|NCT01621906|brain metastases|brain metastases
5421964|NCT01621906|18F-FLT-PET Imaging|18f-flt-pet imaging
5421965|NCT01621906|FLT(3'DEOXY-3'FLUOROTHYMIDINE)|flt(3'deoxy-3'fluorothymidine)
5421966|NCT01621906|MR Imaging|mr imaging
5421967|NCT01621906|12-039|12-039
5421968|NCT01621893|bone marrow edema|bone marrow edema
5421969|NCT01621893|bone marrow defects|bone marrow defects
5421970|NCT01621880|radiation-induced brain necrosis|radiation-induced brain necrosis
5421971|NCT01621880|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5421972|NCT01621880|Bevacizumab|bevacizumab
5421973|NCT01621880|Methylprednisolone|methylprednisolone
5421974|NCT01621867|Cystic fibrosis|cystic fibrosis
5421975|NCT01621867|Gene therapy|gene therapy
5421976|NCT01621867|CFTR gene|cftr gene
5421977|NCT01621867|Gene expression|gene expression
5421978|NCT01621867|Non-viral|non-viral
5421979|NCT01621867|Multi dose|multi dose
5421980|NCT01621854|cancer|cancer
5421981|NCT01621854|nucleoside analogue|nucleoside analogue
5421982|NCT01621854|advanced solid tumours|advanced solid tumours
5421983|NCT01621828|pre-operative anxiety|pre-operative anxiety
5421984|NCT01621828|multimedia information|multimedia information
5421985|NCT01621828|operating theatre|operating theatre
5421986|NCT01621815|ADHD|adhd
5421987|NCT01621815|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5421988|NCT01621815|Conduct|conduct
5421989|NCT01621815|Depression|depression
5421990|NCT01621815|Anxiety|anxiety
5421991|NCT01621815|PDD|pdd
5421992|NCT01621815|Pervasive Developmental Disorders|pervasive developmental disorders
5421993|NCT01621802|Safety|safety
5421994|NCT01621802|Measles, mumps and rubella diseases|measles, mumps and rubella diseases
5421995|NCT01621802|Immunogenicity|immunogenicity
5421996|NCT01621789|lutein|lutein
5421997|NCT01621789|zeaxanthin|zeaxanthin
5421998|NCT01621789|trypan blue|trypan blue
5421999|NCT01621789|dye|dye
5417105|NCT01644695|Hernia|hernia
5422008|NCT01621711|Substance, addiction|substance, addiction
5422010|NCT01621711|prevention and control|prevention and control
5422011|NCT01621711|preventative health services|preventative health services
5422012|NCT01621711|patient centered care|patient centered care
5422013|NCT01621698|VATS|vats
5422014|NCT01621698|Paravertebral blocks.|paravertebral blocks.
5422015|NCT01621698|Thoracoscopic surgery.|thoracoscopic surgery.
5422016|NCT01621698|Analgesia.|analgesia.
5422017|NCT01621685|Capsaicin|capsaicin
5422018|NCT01621685|Cough|cough
5422019|NCT01621685|Cough reflex|cough reflex
5422020|NCT01621685|Inhalation agents|inhalation agents
5422021|NCT01621685|Inhalation challenge|inhalation challenge
5422022|NCT01621685|TRPV1 receptor|trpv1 receptor
5422023|NCT01621672|Revlimid|revlimid
5422024|NCT01621672|progression free|progression free
5422025|NCT01621672|Lenalidomide|lenalidomide
5422026|NCT01621659|multidisciplinary team|multidisciplinary team
5422027|NCT01621659|exercise|exercise
5422028|NCT01621659|nutrition|nutrition
5422029|NCT01621659|cardiology|cardiology
5422030|NCT01621659|physiotherapy|physiotherapy
5422031|NCT01621659|imaging|imaging
5422032|NCT01621646|lutein|lutein
5422033|NCT01621646|eggs|eggs
5422034|NCT01621646|mild cognitive impairment|mild cognitive impairment
5422035|NCT01621646|elderly|elderly
5422036|NCT01621633|hepatic impairment|hepatic impairment
5422037|NCT01621607|fMRI|fmri
5422038|NCT01621607|Monoamines|monoamines
5422039|NCT01621607|Environment|environment
5422040|NCT01621607|Genes|genes
5422041|NCT01621607|Reward Learning|reward learning
5422042|NCT01621594|Cardiac|cardiac
5422043|NCT01621594|Computed Tomography|computed tomography
5422044|NCT01621594|Radiation Reduction|radiation reduction
5422045|NCT01621594|Iterative Reconstruction|iterative reconstruction
5422046|NCT01621581|Gene Therapy|gene therapy
5422047|NCT01621581|Parkinson's Disease|parkinson's disease
5422048|NCT01621581|Convection-Ehanced Delivery|convection-ehanced delivery
5422049|NCT01621581|Viral Vector|viral vector
5422061|NCT01621542|Oncology|oncology
5422062|NCT01621542|Malignancies|malignancies
5422063|NCT01621542|Wilms' Tumor|wilms' tumor
5422064|NCT01621542|WT1|wt1
5422065|NCT01621542|Ovarian|ovarian
5422066|NCT01621542|Glioblastoma [GBM]|glioblastoma [gbm]
5422067|NCT01621542|Acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
5422068|NCT01621529|Positron-Emission Tomography|positron-emission tomography
5422069|NCT01621529|PET Scan|pet scan
5422070|NCT01621529|FDG|fdg
5422071|NCT01621529|SUV|suv
5422072|NCT01621529|Invasive Breast cancer|invasive breast cancer
5422073|NCT01621529|Surgery compare|surgery compare
5422074|NCT01621529|Tumor measurement|tumor measurement
5422075|NCT01621516|Beta-cell function|beta-cell function
5422076|NCT01621516|Liver/small bowel transplant|liver/small bowel transplant
5422077|NCT01621516|Donor pancreas|donor pancreas
5422078|NCT01621516|Diabetes|diabetes
5422079|NCT01621516|Long-term immunesuppression|long-term immunesuppression
5422080|NCT01621477|Hematologic malignancy|hematologic malignancy
5422081|NCT01621477|Hematopoietic cell transplant|hematopoietic cell transplant
5422082|NCT01621464|Neuromediated syncope|neuromediated syncope
5422083|NCT01621464|Tilt test|tilt test
5422084|NCT01621464|Pacemaker|pacemaker
5422085|NCT01621464|CLS sensor|cls sensor
5422092|NCT01621425|lean body mass|lean body mass
5422093|NCT01621425|Body Surface Area|body surface area
5422094|NCT01621425|body weight|body weight
5422095|NCT01621425|dexascan|dexascan
5422096|NCT01621412|Medication Adherence|medication adherence
5422097|NCT01621412|HIV infection|hiv infection
5422098|NCT01621412|Disclosure|disclosure
5422099|NCT01621373|neonatology|neonatology
5422100|NCT01621373|intratracheal intubation|intratracheal intubation
5422101|NCT01621373|propofol|propofol
5422102|NCT01621360|Randomized controlled trial|randomized controlled trial
5422103|NCT01621360|Intention to treat|intention to treat
5422105|NCT01621347|Pregnancy|pregnancy
5422106|NCT01621347|Postpartum|postpartum
5422107|NCT01621347|Women|women
5422108|NCT01621347|Medication Adherence|medication adherence
5422109|NCT01621308|Diabetes Mellitus type 1|diabetes mellitus type 1
5422110|NCT01621308|Intraperitoneal insulin administration|intraperitoneal insulin administration
5409238|NCT01681095|Myocardial protection|myocardial protection
5422111|NCT01621308|Subcutaneous insulin administration|subcutaneous insulin administration
5417207|NCT01644006|acute coronary syndrome|acute coronary syndrome
5422114|NCT01621269|Multiple Sclerosis|multiple sclerosis
5422116|NCT01621269|Fingolimod|fingolimod
5422117|NCT01621269|Gilenya|gilenya
5422118|NCT01621269|Neutralizing Antibodies|neutralizing antibodies
5422119|NCT01621269|NAb|nab
5422120|NCT01621243|necuparanib|necuparanib
5422121|NCT01621243|gemcitabine|gemcitabine
5422122|NCT01621243|heparin|heparin
5422123|NCT01621243|low molecular weight heparin|low molecular weight heparin
5422124|NCT01621243|nab-Paclitaxel|nab-paclitaxel
5422125|NCT01621230|Bupivacaine|bupivacaine
5422126|NCT01621230|Fentanyl|fentanyl
5422127|NCT01621230|Epidural|epidural
5422128|NCT01621230|Second Stage of Labor|second stage of labor
5422129|NCT01621230|Randomized Controlled Trial|randomized controlled trial
5422143|NCT01621165|treatment of bipolar, mania|treatment of bipolar, mania
5422144|NCT01621165|double-blind, placebo-controlled study|double-blind, placebo-controlled study
5422145|NCT01621165|drug intervention|drug intervention
5422146|NCT01621165|add-on study|add-on study
5422147|NCT01621165|prazosin|prazosin
5422148|NCT01621165|alpha-1 adrenergic antagonist|alpha-1 adrenergic antagonist
5422149|NCT01621152|Acute renal failure|acute renal failure
5422150|NCT01621152|acute kidney injury|acute kidney injury
5422151|NCT01621152|electronic surveillance|electronic surveillance
5422152|NCT01621152|AKI|aki
5422153|NCT01621152|sniffer|sniffer
5422154|NCT01621152|AKIN|akin
5422155|NCT01621152|improvement in the process of care and outcomes|improvement in the process of care and outcomes
5422156|NCT01621126|Shoulder instability|shoulder instability
5422157|NCT01621126|Latarjet procedure|latarjet procedure
5422158|NCT01621126|Nerve injury|nerve injury
5422159|NCT01621113|Spinal Cord Injuries|spinal cord injuries
5422160|NCT01621113|4-Aminopyridine|4-aminopyridine
5422161|NCT01621113|Physical Therapy Modalities|physical therapy modalities
5422162|NCT01621113|Randomized Controlled Trial|randomized controlled trial
5422163|NCT01621113|Rehabilitation|rehabilitation
5422164|NCT01621113|Walking|walking
5422165|NCT01621100|Cancer pain|cancer pain
5422166|NCT01621100|OROS|oros
5422167|NCT01621100|Osmotic release oral system|osmotic release oral system
5422168|NCT01621100|Hydromorphone|hydromorphone
5422169|NCT01621100|Painkiller|painkiller
5422170|NCT01621100|Opioid analgesic|opioid analgesic
5422171|NCT01621100|Korean patients|korean patients
5422172|NCT01621061|high altitude illness|high altitude illness
5422173|NCT01621061|pulmonary hypertension|pulmonary hypertension
5422174|NCT01621061|sleep apnea|sleep apnea
5422175|NCT01621061|hypoxia|hypoxia
5422176|NCT01621048|Head and Neck Neoplasmsr|head and neck neoplasmsr
5422177|NCT01621048|Radiotherapy|radiotherapy
5422178|NCT01621048|Xerostomia|xerostomia
5422179|NCT01621048|Deglutition Disorders|deglutition disorders
5422180|NCT01621022|smoking cessation|smoking cessation
5422181|NCT01621022|tobacco dependence|tobacco dependence
5422182|NCT01621009|smoking cessation medications|smoking cessation medications
5422183|NCT01621009|smoking cessation counseling|smoking cessation counseling
5422184|NCT01620996|preintervention and postintervention cohort longitudinal prospective study|preintervention and postintervention cohort longitudinal prospective study
5422185|NCT01620983|arthroplasty|arthroplasty
5422186|NCT01620983|pain|pain
5422187|NCT01620970|Transitional Cell Carcinoma|transitional cell carcinoma
5422188|NCT01620970|Metastatic disease|metastatic disease
5422189|NCT01620970|Bladder tumors, Recurrent|bladder tumors, recurrent
5422190|NCT01620970|Angiogenesis|angiogenesis
5422192|NCT01620970|Transforming growth factor beta|transforming growth factor beta
5422193|NCT01620970|Activin receptor like kinase 1|activin receptor like kinase 1
5422194|NCT01620970|Monoclonal Antibody|monoclonal antibody
5422195|NCT01620970|Locally advanced or metastatic disease|locally advanced or metastatic disease
5422196|NCT01620970|Failure of one platinum-based chemotherapy|failure of one platinum-based chemotherapy
5422197|NCT01620970|Measurable disease|measurable disease
5422198|NCT01620957|Default-mode network|default-mode network
5422199|NCT01620957|Difussion tensor imaging|difussion tensor imaging
5422200|NCT01620957|Cortical thickness|cortical thickness
5422201|NCT01620957|Coma|coma
5422202|NCT01620957|Vegetative state|vegetative state
5422203|NCT01620957|Minimally conscious state|minimally conscious state
5422204|NCT01620957|Neural correlate of consciousness|neural correlate of consciousness
5422205|NCT01620892|unicondylar knee arthroplasty|unicondylar knee arthroplasty
5422206|NCT01620892|partial knee replacement|partial knee replacement
5422207|NCT01620866|EMDR|emdr
5422208|NCT01620866|bipolar disorder|bipolar disorder
5422209|NCT01620866|trauma|trauma
5422210|NCT01620866|subsyndromal symptoms|subsyndromal symptoms
5422211|NCT01620866|PTSD|ptsd
5422212|NCT01620853|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5422213|NCT01620853|ALK probe|alk probe
5422214|NCT01620853|FISH|fish
5422215|NCT01620853|Chromosomal aberrations|chromosomal aberrations
5417286|NCT01643603|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5409336|NCT01680744|GFR|gfr
5422216|NCT01620840|oral administration of Lacosamide is not possible or adequate|oral administration of lacosamide is not possible or adequate
5422217|NCT01620827|follow up|follow up
5422218|NCT01620827|cell phone|cell phone
5422219|NCT01620827|hospital landline|hospital landline
5422220|NCT01620814|misoprostol|misoprostol
5422221|NCT01620814|dinoprostone|dinoprostone
5422222|NCT01620814|cervical ripening|cervical ripening
5422223|NCT01620814|diagnostic hysteroscopy|diagnostic hysteroscopy
5422225|NCT01620801|AAV8|aav8
5422226|NCT01620801|Adeno-associated virus|adeno-associated virus
5422227|NCT01620801|Adeno-associated viral vectors|adeno-associated viral vectors
5422228|NCT01620801|Hemophilia|hemophilia
5422229|NCT01620801|Hemophilia B|hemophilia b
5422230|NCT01620801|Severe hemophilia B|severe hemophilia b
5422231|NCT01620801|Factor IX deficiency|factor ix deficiency
5422232|NCT01620801|Factor IX|factor ix
5422233|NCT01620801|FIX|fix
5422234|NCT01620762|Cat allergy|cat allergy
5422235|NCT01620762|Rhinoconjunctivitis|rhinoconjunctivitis
5422236|NCT01620749|melanoma metastatic diagnosis|melanoma metastatic diagnosis
5422237|NCT01620736|Raltegravir|raltegravir
5422238|NCT01620736|HTLV|htlv
5422239|NCT01620736|Integrase|integrase
5422240|NCT01620723|Breastfeeding|breastfeeding
5422241|NCT01620723|Breastfeeding self efficacy|breastfeeding self efficacy
5422242|NCT01620710|prostatectomy|prostatectomy
5422243|NCT01620658|Occupational Exposure to Radiation|occupational exposure to radiation
5422244|NCT01620632|laparoscopy assisted ERCP|laparoscopy assisted ercp
5422245|NCT01620632|altered gastric anatomy|altered gastric anatomy
5422246|NCT01620619|Shoulder|shoulder
5422247|NCT01620619|Bankart|bankart
5422248|NCT01620619|Anterior Instability|anterior instability
5422731|NCT01618786|Gerontology|gerontology
5422249|NCT01620619|Rotator Cuff|rotator cuff
5422250|NCT01620606|FAP|fap
5422251|NCT01620606|RAP|rap
5422252|NCT01620606|Abdominal Pain|abdominal pain
5422253|NCT01620606|IBS|ibs
5422254|NCT01620593|Prostate Cancer|prostate cancer
5422255|NCT01620593|Metformin|metformin
5422256|NCT01620593|Castration therapy|castration therapy
5422257|NCT01620580|sleep disturbance|sleep disturbance
5422258|NCT01620580|tiredness|tiredness
5422259|NCT01620580|itching & numbness|itching & numbness
5422260|NCT01620567|lutein|lutein
5422261|NCT01620567|avocados|avocados
5422262|NCT01620567|chickpeas|chickpeas
5422263|NCT01620567|potatoes|potatoes
5422264|NCT01620567|elderly|elderly
5422265|NCT01620554|Sleep disorder|sleep disorder
5422266|NCT01620554|Obstructive Sleep Apnoea|obstructive sleep apnoea
5422267|NCT01620554|Excessive Daytime Sleepiness|excessive daytime sleepiness
5422268|NCT01620528|Gonadotropin-Releasing Hormone Antagonist|gonadotropin-releasing hormone antagonist
5422269|NCT01620528|Endometriosis associated pain|endometriosis associated pain
5422270|NCT01620528|Dysmenorrhea (DYS)|dysmenorrhea (dys)
5422271|NCT01620528|Non-Menstrual Pelvic Pain (NMPP)|non-menstrual pelvic pain (nmpp)
5422272|NCT01620528|Elagolix|elagolix
5422273|NCT01620515|Prostate|prostate
5422274|NCT01620515|Prostate Cancer|prostate cancer
5422275|NCT01620515|Localized Prostate Cancer|localized prostate cancer
5422276|NCT01620515|T1c Prostate Cancer|t1c prostate cancer
5422277|NCT01620515|Focal Therapy|focal therapy
5422278|NCT01620515|NX-1207|nx-1207
5422279|NCT01620411|Active Duty|active duty
5422280|NCT01620411|Comprehensive Medical Management|comprehensive medical management
5422281|NCT01620411|Spinal Cord Stimulator|spinal cord stimulator
5422282|NCT01620411|Veteran|veteran
5422283|NCT01620411|sustained|sustained
5422284|NCT01620411|military|military
5422285|NCT01620398|cardiovascular diseases|cardiovascular diseases
5422286|NCT01620398|secondary prevention|secondary prevention
5422287|NCT01620398|diet|diet
5422288|NCT01620385|Cochlear implants|cochlear implants
5422289|NCT01620359|Breast cancer|breast cancer
5422290|NCT01620359|Breast tumor|breast tumor
5422291|NCT01620359|stage 1 disease|stage 1 disease
5422292|NCT01620359|T1 M0 N0|t1 m0 n0
5422293|NCT01620346|advanced maternal age|advanced maternal age
5422294|NCT01620346|infertility|infertility
5422295|NCT01620346|IMSI|imsi
5422296|NCT01620346|ICSI|icsi
5422297|NCT01620346|implantation|implantation
5422298|NCT01620320|Left main coronary artery|left main coronary artery
5422299|NCT01620320|Coronary artery disease|coronary artery disease
5422300|NCT01620320|Stress echography|stress echography
5422301|NCT01620320|Intrastent stenosis|intrastent stenosis
5422302|NCT01620307|H1N1 patients with severe hypoxemia requiring ventilator support|h1n1 patients with severe hypoxemia requiring ventilator support
5422303|NCT01620294|surgical site infection|surgical site infection
5422304|NCT01620294|elective colorectal surgery|elective colorectal surgery
5422305|NCT01620294|level of surgical site infection|level of surgical site infection
5422306|NCT01620294|complication of surgical site infection|complication of surgical site infection
5422307|NCT01620294|type of changed bandage|type of changed bandage
5422308|NCT01620294|frequency of bandage changing|frequency of bandage changing
5422309|NCT01620281|Back Pain|back pain
5422310|NCT01620268|leflunomide|leflunomide
5422311|NCT01620268|orotic acid|orotic acid
5422312|NCT01620268|Polyoma BK Viruria|polyoma bk viruria
5422313|NCT01620268|Polyoma BK Viremia|polyoma bk viremia
5422317|NCT01620242|cabazitaxel|cabazitaxel
5422318|NCT01620203|Premature infants|premature infants
5422319|NCT01620203|Intracranial hemorrhage|intracranial hemorrhage
5422320|NCT01620203|Intraventricular hemorrhage|intraventricular hemorrhage
5422321|NCT01620203|Cerebral oxygenation|cerebral oxygenation
5422322|NCT01620203|Brain function|brain function
5422323|NCT01620203|Cerebral perfusion|cerebral perfusion
5422324|NCT01620177|Cannabis|cannabis
5422325|NCT01620177|Marijuana|marijuana
5422326|NCT01620177|Marihuana|marihuana
5422327|NCT01620177|Alcohol|alcohol
5422328|NCT01620177|Driving|driving
5422329|NCT01620164|three-dimensional vision|three-dimensional vision
5422330|NCT01620164|Parkinson|parkinson
5422331|NCT01620151|Post-operative pain|post-operative pain
5422332|NCT01620151|Wound bleeding requiring exploration|wound bleeding requiring exploration
5422333|NCT01620151|PTH|pth
5422334|NCT01620151|RLN complication|rln complication
5422335|NCT01620151|Hypocalcaemia complication|hypocalcaemia complication
5422336|NCT01620138|Non-functioning pituitary adenomas|non-functioning pituitary adenomas
5422337|NCT01620138|Prolactinomas|prolactinomas
5422338|NCT01620138|Cabergoline|cabergoline
5422339|NCT01620138|Pasireotide|pasireotide
5422340|NCT01620138|somatostatin receptors|somatostatin receptors
5422341|NCT01620138|Dopamine receptors|dopamine receptors
5422342|NCT01620125|Lactobacillus|lactobacillus
5422343|NCT01620125|Gut microbiota|gut microbiota
5422344|NCT01620125|Diabetes mellitus|diabetes mellitus
5422345|NCT01620112|brachial plexus|brachial plexus
5422346|NCT01620112|lidocaine|lidocaine
5422732|NCT01618773|acne|acne
5422347|NCT01620112|alfa 2 adrenergic receptor clonidine|alfa 2 adrenergic receptor clonidine
5422348|NCT01620112|orthopedic procedure|orthopedic procedure
5422349|NCT01620099|Asthma|asthma
5422350|NCT01620099|Cigarette smoke|cigarette smoke
5422351|NCT01620099|Small airways|small airways
5422352|NCT01620099|Lung function|lung function
5422353|NCT01620099|Asthma control|asthma control
5422354|NCT01620086|Schizophrenia|schizophrenia
5422355|NCT01620086|Auditory hallucinations (AH)|auditory hallucinations (ah)
5422356|NCT01620086|Phantom sound perception|phantom sound perception
5422357|NCT01620086|repetitive transcranial magnetic stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5422358|NCT01620086|Percent habituation in the P50 amplitude with 250 ms ISI|percent habituation in the p50 amplitude with 250 ms isi
5422359|NCT01620073|Male partner|male partner
5422360|NCT01620073|HIV counseling and testing|hiv counseling and testing
5422361|NCT01620073|Home based|home based
5422362|NCT01620073|Pregnancy|pregnancy
5422363|NCT01620060|Schizophrenia|schizophrenia
5422364|NCT01620060|autism|autism
5422365|NCT01620060|bipolar|bipolar
5422366|NCT01620060|Lurasidone|lurasidone
5422367|NCT01620060|Latuda|latuda
5422368|NCT01620047|Regional Anesthesia|regional anesthesia
5422369|NCT01620047|Post-operative pain management|post-operative pain management
5422370|NCT01620047|Femoral Nerve Block|femoral nerve block
5422371|NCT01620047|Total Knee Replacement|total knee replacement
5422372|NCT01620021|wearable sensors|wearable sensors
5422373|NCT01620021|kinematics|kinematics
5422374|NCT01620021|gait|gait
5422375|NCT01620008|cord clamping (delayed or immediate)|cord clamping (delayed or immediate)
5422376|NCT01620008|Myelin content|myelin content
5422377|NCT01620008|Ferritin|ferritin
5422378|NCT01619995|urge incontinence|urge incontinence
5422379|NCT01619956|dental implants|dental implants
5422380|NCT01619956|osteotome sinus floor elevation|osteotome sinus floor elevation
5422381|NCT01619956|survival rate|survival rate
5422382|NCT01619956|sinus grafting|sinus grafting
5422383|NCT01619956|bone remodeling|bone remodeling
5422384|NCT01619956|RCT|rct
5422385|NCT01619956|radiographic analysis|radiographic analysis
5422386|NCT01619943|Minor head injury|minor head injury
5422387|NCT01619943|CT scan|ct scan
5422388|NCT01619943|Canadian CT Head Rules|canadian ct head rules
5422389|NCT01619943|The New Orleans Criteria|the new orleans criteria
5422390|NCT01619930|Depression|depression
5422391|NCT01619930|Behavioral activation|behavioral activation
5422392|NCT01619917|burn|burn
5422393|NCT01619917|scar|scar
5422394|NCT01619917|laser|laser
5422395|NCT01619917|fractional|fractional
5422396|NCT01619917|vascular|vascular
5422397|NCT01619904|Pancreas Transplantation|pancreas transplantation
5422398|NCT01619904|Goal-directed therapy|goal-directed therapy
5422399|NCT01619904|Outcomes|outcomes
5422400|NCT01619904|Immunometric|immunometric
5422401|NCT01619878|plasmodium|plasmodium
5422402|NCT01619878|P. falciparum|p. falciparum
5422403|NCT01619878|malaria|malaria
5422404|NCT01619878|infant|infant
5422405|NCT01619878|neonate|neonate
5422406|NCT01619865|GA-68|ga-68
5422407|NCT01619865|Gallium 68|gallium 68
5422408|NCT01619865|GA-68 PET|ga-68 pet
5422409|NCT01619852|Surgery|surgery
5422410|NCT01619852|Breast|breast
5422411|NCT01619852|Pain|pain
5422412|NCT01619852|Chronic Pain|chronic pain
5422413|NCT01619852|Lidocaine|lidocaine
5422414|NCT01619852|Anesthesia|anesthesia
5422415|NCT01619852|Gynecologic|gynecologic
5422416|NCT01619852|Urologic|urologic
5422417|NCT01619839|Nektar|nektar
5422418|NCT01619839|NKTR-181|nktr-181
5422419|NCT01619826|physical activity|physical activity
5422420|NCT01619826|fitness|fitness
5422421|NCT01619826|brain health|brain health
5422422|NCT01619826|cognition|cognition
5422423|NCT01619826|scholastic achievement|scholastic achievement
5422424|NCT01619826|preadolescent children|preadolescent children
5422425|NCT01619800|Chronotropic Incompetence|chronotropic incompetence
5422426|NCT01619800|Pacemaker|pacemaker
5422427|NCT01619800|Mount Sinai School of Medicine|mount sinai school of medicine
5422428|NCT01619774|Melanoma|melanoma
5422429|NCT01619774|Metastatic melanoma|metastatic melanoma
5422430|NCT01619774|Refractory or Resistant to BRAF Inhibitor|refractory or resistant to braf inhibitor
5422431|NCT01619774|Advanced melanoma|advanced melanoma
5422432|NCT01619774|GSK2118436|gsk2118436
5422433|NCT01619774|GSK1120212|gsk1120212
5422434|NCT01619735|Kidney Calculi|kidney calculi
5422435|NCT01619735|Kidney Stones|kidney stones
5422436|NCT01619735|Nephrolithiasis|nephrolithiasis
5422437|NCT01619735|Renal Stones|renal stones
5422439|NCT01619722|Osteoporosis|osteoporosis
5422440|NCT01619722|HMP|hmp
5422441|NCT01619722|Life quality|life quality
5422442|NCT01619722|Neuropsychological|neuropsychological
5422443|NCT01619722|Nutritial evaluation|nutritial evaluation
5422444|NCT01619722|Phenylketonuria|phenylketonuria
5422445|NCT01619722|Hyperphenylalaninemia|hyperphenylalaninemia
5422446|NCT01619709|Intracerebral Hemorrhage|intracerebral hemorrhage
5422447|NCT01619709|Cerebral Amyloid angiopathy|cerebral amyloid angiopathy
5422448|NCT01619709|Amyloid imaging|amyloid imaging
5422449|NCT01619709|18F-AV-45|18f-av-45
5422450|NCT01619696|chemotherapy|chemotherapy
5422451|NCT01619696|rectal adenocarcinoma|rectal adenocarcinoma
5422452|NCT01619696|proctectomy|proctectomy
5422453|NCT01619696|Fmiso TEP|fmiso tep
5422454|NCT01619696|MRI|mri
5422455|NCT01619657|Cystic Fibrosis|cystic fibrosis
5422456|NCT01619657|Hypertonic Saline|hypertonic saline
5422457|NCT01619657|Infant|infant
5422458|NCT01619657|Newborn|newborn
5422459|NCT01619657|Prevention|prevention
5422460|NCT01619644|RTS|rts
5422461|NCT01619644|Rubinstein Taybi|rubinstein taybi
5422462|NCT01619644|explorative phase 2|explorative phase 2
5422463|NCT01619644|clinical approach|clinical approach
5422464|NCT01619644|biological approach|biological approach
5422465|NCT01619644|motor skills|motor skills
5422466|NCT01619631|Depression|depression
5422467|NCT01619631|Tai Chi|tai chi
5422468|NCT01619631|Alternative medicine|alternative medicine
5422469|NCT01619631|Mind body medicine|mind body medicine
5422470|NCT01619618|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5422471|NCT01619618|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5422472|NCT01619618|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5422473|NCT01619618|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5422474|NCT01619618|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5422475|NCT01619618|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5422476|NCT01619618|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5422477|NCT01619618|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5422478|NCT01619618|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5422479|NCT01619618|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5422480|NCT01619618|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5422481|NCT01619618|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5422482|NCT01619618|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5422483|NCT01619618|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5422484|NCT01619618|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5422485|NCT01619618|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5422486|NCT01619618|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5422487|NCT01619618|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5422488|NCT01619618|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5422489|NCT01619618|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5422490|NCT01619618|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5422491|NCT01619618|recurrent salivary gland cancer|recurrent salivary gland cancer
5422492|NCT01619618|stage IVA salivary gland cancer|stage iva salivary gland cancer
5685287|NCT00556751|Electrocardiography|electrocardiography
5422493|NCT01619618|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5422494|NCT01619618|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5422496|NCT01619605|anaphylaxis|anaphylaxis
5422497|NCT01619605|shrimp allergy|shrimp allergy
5422498|NCT01619592|patients|patients
5422499|NCT01619592|adaptable|adaptable
5422500|NCT01619592|insulin|insulin
5422502|NCT01619579|Fibromyalgia|fibromyalgia
5422503|NCT01619579|Pain|pain
5422504|NCT01619579|Non-Invasive|non-invasive
5422505|NCT01619579|Arthritis|arthritis
5422506|NCT01619579|Rheumatoid Disease|rheumatoid disease
5422507|NCT01619566|Fibromyalgia|fibromyalgia
5422508|NCT01619566|Duloxetine|duloxetine
5422509|NCT01619566|Cymbalta|cymbalta
5422510|NCT01619566|Pain|pain
5422511|NCT01619566|Peripheral Nerve|peripheral nerve
5422512|NCT01619566|Biopsy|biopsy
5422513|NCT01619566|Predictive|predictive
5422514|NCT01619553|keloid|keloid
5422515|NCT01619553|fibrosis|fibrosis
5422516|NCT01619553|wound healing|wound healing
5422517|NCT01619553|scar|scar
5422518|NCT01619540|COPD|copd
5422519|NCT01619540|Left Ventricular Failure|left ventricular failure
5422520|NCT01619540|Valsalva Manoeuver|valsalva manoeuver
5422521|NCT01619527|Healthy participants|healthy participants
5422522|NCT01619527|Darunavir|darunavir
5422523|NCT01619527|Cobicistat|cobicistat
5422524|NCT01619527|Bioequivalence|bioequivalence
5422525|NCT01619527|Fixed dose combination|fixed dose combination
5422526|NCT01619527|Pharmacokinetics|pharmacokinetics
5422527|NCT01619527|Human immunodeficiency virus|human immunodeficiency virus
5422528|NCT01619527|Protease inhibitor|protease inhibitor
5422529|NCT01619488|Lap-Band|lap-band
5422530|NCT01619488|morbid obesity|morbid obesity
5422531|NCT01619488|adolescents|adolescents
5422532|NCT01619475|Living Donor|living donor
5422733|NCT01618773|Epiduo|epiduo
5422533|NCT01619475|Liver Transplantation|liver transplantation
5422534|NCT01619475|Quality of Life|quality of life
5422535|NCT01619475|Biosamples|biosamples
5422536|NCT01619475|Liver Recipient|liver recipient
5422537|NCT01619462|pneumococcal|pneumococcal
5422538|NCT01619462|vaccine|vaccine
5422539|NCT01619462|papua new guinea|papua new guinea
5422540|NCT01619449|Acute Kidney Injury|acute kidney injury
5422541|NCT01619449|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5422542|NCT01619449|Liver Transplant|liver transplant
5422543|NCT01619423|Metastatic colorectal cancer|metastatic colorectal cancer
5422544|NCT01619423|stage IV|stage iv
5422545|NCT01619423|FOLFOX6|folfox6
5422546|NCT01619423|Chemotherapy|chemotherapy
5422547|NCT01619423|PledOx|pledox
5422548|NCT01619423|Mangafodipir|mangafodipir
5422549|NCT01619423|Febrile neutropenia|febrile neutropenia
5422550|NCT01619423|Oxidative stress|oxidative stress
5422551|NCT01619423|Antioxidant|antioxidant
5422552|NCT01619423|neutropenia|neutropenia
5422553|NCT01619423|neuropathy|neuropathy
5422554|NCT01619397|Condom|condom
5422555|NCT01619397|Medical Device|medical device
5422556|NCT01619384|posttraumatic stress|posttraumatic stress
5422557|NCT01619384|irritable bowel|irritable bowel
5422558|NCT01619371|breast pump|breast pump
5422559|NCT01619371|engorgement|engorgement
5422560|NCT01619371|lactation|lactation
5422561|NCT01619332|Healthy volunteers,|healthy volunteers,
5422562|NCT01619332|Diabetes|diabetes
5422563|NCT01619332|Glucose|glucose
5422564|NCT01619332|Pharmacokinetics|pharmacokinetics
5422565|NCT01619319|schizophrenia prodrome|schizophrenia prodrome
5422566|NCT01619319|clinical high risk of psychosis|clinical high risk of psychosis
5422567|NCT01619293|CCT|cct
5422568|NCT01619293|brain|brain
5422569|NCT01619293|trauma|trauma
5422570|NCT01619293|injury|injury
5422571|NCT01619280|Acute Lung Injury|acute lung injury
5422572|NCT01619280|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5422573|NCT01619280|Sodium Nitroprusside|sodium nitroprusside
5422575|NCT01619280|Safety|safety
5422576|NCT01619280|Dose Finding|dose finding
5422577|NCT01619280|Phase 1|phase 1
5422578|NCT01619280|3 + 3 design|3 + 3 design
5422579|NCT01619280|Nebulizers and Vaporizers|nebulizers and vaporizers
5422580|NCT01619280|High-Frequency Ventilation|high-frequency ventilation
5422581|NCT01619280|nitric oxide|nitric oxide
5422582|NCT01619280|lung injury|lung injury
5422583|NCT01619280|Pulmonary Gas Exchange|pulmonary gas exchange
5422584|NCT01619280|Pulmonary Alveoli|pulmonary alveoli
5422585|NCT01619267|pacemaker defibrillator infection|pacemaker defibrillator infection
5422586|NCT01619254|Intestinal parasitic infections|intestinal parasitic infections
5422587|NCT01619254|Anaemia|anaemia
5422588|NCT01619254|School-aged children|school-aged children
5422589|NCT01619254|Hand washing and nail clipping|hand washing and nail clipping
5422590|NCT01619241|lung cancer|lung cancer
5422591|NCT01619241|F-18 FLT PET/CT|f-18 flt pet/ct
5422592|NCT01619228|premature infant|premature infant
5422593|NCT01619228|neonate|neonate
5422594|NCT01619228|skin maturation|skin maturation
5422595|NCT01619228|stratum corneum maturation|stratum corneum maturation
5422597|NCT01619228|sunflower oil|sunflower oil
5422598|NCT01619228|effect of Vitamin B3 on premature skin maturation|effect of vitamin b3 on premature skin maturation
5422599|NCT01619228|skin acidity|skin acidity
5422600|NCT01619228|stratum corneum barrier integrity|stratum corneum barrier integrity
5422601|NCT01619228|stratum corneum lipid composition|stratum corneum lipid composition
5422602|NCT01619228|stratum corneum biomarkers|stratum corneum biomarkers
5422603|NCT01619228|stratum corneum cytokines|stratum corneum cytokines
5422604|NCT01619228|stratum corneum structural proteins|stratum corneum structural proteins
5422605|NCT01619202|accident prevention|accident prevention
5422606|NCT01619202|Adolescent|adolescent
5422607|NCT01619202|examination, automobile driver|examination, automobile driver
5422608|NCT01619202|Driving simulator|driving simulator
5422609|NCT01619202|Young drivers|young drivers
5422610|NCT01619202|Driving education|driving education
5422611|NCT01619189|Cell therapy|cell therapy
5422612|NCT01619189|Limbal deficiency|limbal deficiency
5422613|NCT01619189|Limbal stem cell|limbal stem cell
5422614|NCT01619189|Transplantation|transplantation
5422615|NCT01619176|Rheumatoid Arthritis|rheumatoid arthritis
5422616|NCT01619176|blood|blood
5422617|NCT01619176|gut intestinal microbiome|gut intestinal microbiome
5422618|NCT01619163|Prednisolone,|prednisolone,
5422619|NCT01619163|pain,|pain,
5422620|NCT01619163|inflammation,|inflammation,
5422621|NCT01619163|mobility|mobility
5422622|NCT01619163|Function|function
5422623|NCT01619150|knee|knee
5422624|NCT01619150|osteoarthritis|osteoarthritis
5422625|NCT01619150|central sensitization|central sensitization
5422626|NCT01619150|mechanical detection|mechanical detection
5422627|NCT01619150|pain threshold|pain threshold
5422628|NCT01619150|quantitative sensory testing|quantitative sensory testing
5422629|NCT01619150|pain biomarkers|pain biomarkers
5422630|NCT01619150|COX-2 inhibitors|cox-2 inhibitors
5422631|NCT01619150|etoricoxib.|etoricoxib.
5422632|NCT01619137|ununion wound|ununion wound
5422633|NCT01619137|soap|soap
5422634|NCT01619137|irrigation|irrigation
5422635|NCT01619137|Povidone-iodine|povidone-iodine
5422636|NCT01619137|normal salin|normal salin
5422637|NCT01619124|osteonecrosis|osteonecrosis
5422638|NCT01619124|children|children
5422639|NCT01619124|pediatric|pediatric
5422640|NCT01619124|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5422641|NCT01619124|lymphoblastic lymphoma|lymphoblastic lymphoma
5422642|NCT01619111|metastatic breast cancer|metastatic breast cancer
5422643|NCT01619111|circulating tumor cells|circulating tumor cells
5422644|NCT01619111|lapatinib|lapatinib
5422645|NCT01619098|Hospital readmission|hospital readmission
5422646|NCT01619098|Care transition|care transition
5422647|NCT01619098|Discharge-transfer intervention|discharge-transfer intervention
5422648|NCT01619098|Community health worker|community health worker
5422649|NCT01619098|Patient Navigatgor|patient navigatgor
5422650|NCT01619072|postpartum hemorrhage|postpartum hemorrhage
5422651|NCT01619072|treatment|treatment
5422652|NCT01619072|misoprostol|misoprostol
5422653|NCT01619072|home births|home births
5422654|NCT01619046|GreenGene™F, Previously Treated Patients|greengene™f, previously treated patients
5422655|NCT01619033|Renal impairment|renal impairment
5422656|NCT01619020|Healthy|healthy
5422657|NCT01619020|Colon|colon
5422658|NCT01619007|Treatment of Venous Thromboembolism|treatment of venous thromboembolism
5422659|NCT01619007|Thromboembolism|thromboembolism
5422660|NCT01619007|Venous Thromboembolism|venous thromboembolism
5422661|NCT01619007|Embolism and Thrombosis|embolism and thrombosis
5422662|NCT01619007|Vascular Diseases|vascular diseases
5422663|NCT01619007|Cardiovascular Diseases|cardiovascular diseases
5422664|NCT01619007|Thrombosis|thrombosis
5422665|NCT01618994|Robotic Simulator|robotic simulator
5422666|NCT01618994|EBL|ebl
5422667|NCT01618994|Robotic Surgeons|robotic surgeons
5422668|NCT01618994|Intuitive Surgical|intuitive surgical
5422669|NCT01618994|simulation modules|simulation modules
5422670|NCT01618994|benchmarks|benchmarks
5422671|NCT01618994|Morristown Protocol|morristown protocol
5422672|NCT01618994|Study Surgeons|study surgeons
5422673|NCT01618994|Control Surgeons|control surgeons
5422674|NCT01618994|Expert Surgeons|expert surgeons
5422675|NCT01618994|dual-console daVinci system|dual-console davinci system
5422676|NCT01618994|blinded skill assessment|blinded skill assessment
5422677|NCT01618981|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5422678|NCT01618981|atrial dyssynchrony syndrome|atrial dyssynchrony syndrome
5422679|NCT01618981|left atrio-ventricular asynchrony|left atrio-ventricular asynchrony
5422680|NCT01618981|pacemaker|pacemaker
5422681|NCT01618981|left atrial pacing therapy|left atrial pacing therapy
5422682|NCT01618929|Food allergy|food allergy
5422683|NCT01618929|Asthma|asthma
5422684|NCT01618929|Children|children
5422685|NCT01618929|Montelukast|montelukast
5422686|NCT01618929|Inflammation|inflammation
5422687|NCT01618903|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
5422688|NCT01618903|Oral tablets|oral tablets
5422689|NCT01618903|Bioequivalence|bioequivalence
5422691|NCT01618903|Safety|safety
5422693|NCT01618890|Prevention|prevention
5422694|NCT01618890|Esophageal variceal bleeding|esophageal variceal bleeding
5422695|NCT01618890|Hepatic Venous Pressure Gradient|hepatic venous pressure gradient
5422696|NCT01618890|Betablocker therapy|betablocker therapy
5422697|NCT01618877|Keppra Levetiracetam intravenous|keppra levetiracetam intravenous
5422698|NCT01618877|Multiple dose|multiple dose
5422699|NCT01618877|Safety|safety
5422700|NCT01618877|Pharmacokinetics|pharmacokinetics
5422701|NCT01618877|Chinese healthy volunteers|chinese healthy volunteers
5422702|NCT01618851|prostate cancer|prostate cancer
5422703|NCT01618838|prostate cancer|prostate cancer
5422704|NCT01618812|Artificial bone graft|artificial bone graft
5422705|NCT01618812|Hydroxyapatite|hydroxyapatite
5422706|NCT01618812|Children|children
5422707|NCT01618812|Osteotomy|osteotomy
5422708|NCT01618812|Pes plano valgus|pes plano valgus
5422709|NCT01618812|Flatfeet|flatfeet
5422710|NCT01618786|Falls|falls
5422711|NCT01618786|Fall injuries|fall injuries
5422712|NCT01618786|Bone fracture|bone fracture
5422713|NCT01618786|Hip fracture|hip fracture
5422714|NCT01618786|Skull fracture|skull fracture
5422716|NCT01618786|Closed head injury|closed head injury
5422717|NCT01618786|Traumatic brain injury|traumatic brain injury
5422718|NCT01618786|Concussion|concussion
5422719|NCT01618786|Spinal cord injury|spinal cord injury
5405707|NCT01696552|TKR|tkr
5422720|NCT01618786|Trauma|trauma
5422721|NCT01618786|Older adults|older adults
5422722|NCT01618786|Long-term care|long-term care
5422723|NCT01618786|Compliant flooring|compliant flooring
5422724|NCT01618786|Safety floors|safety floors
5422725|NCT01618786|Balance|balance
5422726|NCT01618786|Injury biomechanics|injury biomechanics
5422727|NCT01618786|Biomedical engineering|biomedical engineering
5422728|NCT01618786|Environmental hazards|environmental hazards
5422729|NCT01618786|Environmental interventions|environmental interventions
5422730|NCT01618786|Fall prevention|fall prevention
5422734|NCT01618773|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
5422735|NCT01618734|Immune Thrombocytopenia|immune thrombocytopenia
5422736|NCT01618734|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
5422737|NCT01618721|Chronic obstructive lung disease;|chronic obstructive lung disease;
5422738|NCT01618721|Interstitial lung disease;|interstitial lung disease;
5422739|NCT01618721|Ultrasound Doppler;|ultrasound doppler;
5422740|NCT01618721|Lung disease diagnosis;|lung disease diagnosis;
5422741|NCT01618695|Partial-onset Seizures|partial-onset seizures
5422742|NCT01618695|partial seizures|partial seizures
5422743|NCT01618695|seizure|seizure
5422744|NCT01618695|epilepsy|epilepsy
5422745|NCT01618682|hand transplant|hand transplant
5422746|NCT01618682|hand replant|hand replant
5422747|NCT01618669|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5422748|NCT01618669|regadenoson|regadenoson
5422749|NCT01618669|pharmacologic stress|pharmacologic stress
5422750|NCT01618643|Barrett's|barrett's
5422751|NCT01618643|High grade dysplasia|high grade dysplasia
5422752|NCT01618643|HGD|hgd
5422753|NCT01618643|IMC|imc
5422754|NCT01618643|Intramucosal cancer|intramucosal cancer
5422755|NCT01618643|Acetic acid|acetic acid
5422756|NCT01618643|Chromoendoscopy|chromoendoscopy
5422757|NCT01618630|burn injury|burn injury
5422758|NCT01618630|children|children
5422759|NCT01618630|nutrition|nutrition
5422760|NCT01618630|lipid metabolism|lipid metabolism
5422761|NCT01618630|insulin sensitivity|insulin sensitivity
5422762|NCT01618630|amino acids|amino acids
5422763|NCT01618617|Constipation|constipation
5422764|NCT01618617|Probiotic|probiotic
5422765|NCT01618617|Randomized Controlled Trial|randomized controlled trial
5422766|NCT01618604|Conditioned Pain Modulation|conditioned pain modulation
5422767|NCT01618604|Quantitative Sensory Testing|quantitative sensory testing
5422768|NCT01618604|duration|duration
5422770|NCT01618591|diarrhea|diarrhea
5422771|NCT01618591|travelers' diarrhea|travelers' diarrhea
5422772|NCT01618591|watery diarrhea|watery diarrhea
5422773|NCT01618591|enteric illness|enteric illness
5422774|NCT01618591|dysentery|dysentery
5422775|NCT01618591|gastrointestinal|gastrointestinal
5422776|NCT01618578|rubber hand illusion|rubber hand illusion
5422778|NCT01618578|body image|body image
5422779|NCT01618578|body ownership|body ownership
5422780|NCT01618565|shoulder dystocia|shoulder dystocia
5422781|NCT01618565|training|training
5422782|NCT01618565|To assess the effectiveness of hands-on training versus expert demonstration|to assess the effectiveness of hands-on training versus expert demonstration
5422783|NCT01618552|Chronic disease|chronic disease
5422784|NCT01618552|Cluster randomization|cluster randomization
5422785|NCT01618552|Comorbidity|comorbidity
5422786|NCT01618552|Depression|depression
5422787|NCT01618552|Diabetes|diabetes
5422788|NCT01618552|Medical history taking|medical history taking
5422789|NCT01618552|Office visits|office visits
5422790|NCT01618552|Patient acceptance of health care|patient acceptance of health care
5422791|NCT01618552|Patient compliance|patient compliance
5422792|NCT01618552|Patient simulation|patient simulation
5422793|NCT01618552|Physician patient relations|physician patient relations
5422794|NCT01618552|Primary health care|primary health care
5422795|NCT01618552|Randomized controlled trials|randomized controlled trials
5422796|NCT01618552|Self care|self care
5422797|NCT01618552|Self efficacy|self efficacy
5422798|NCT01618539|Total intravenous anesthesia, Bispectral Index Score|total intravenous anesthesia, bispectral index score
5422799|NCT01618526|Dietary fibers|dietary fibers
5422800|NCT01618526|Butyrate|butyrate
5422801|NCT01618526|Short Chain Fatty Acids|short chain fatty acids
5422803|NCT01618526|Metabolic Syndrome|metabolic syndrome
5422804|NCT01618513|Acromegaly|acromegaly
5422805|NCT01618513|Somatostatin analogs|somatostatin analogs
5422806|NCT01618513|Treatment|treatment
5422807|NCT01618500|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5422808|NCT01618500|Neuropsychological Test|neuropsychological test
5422809|NCT01618500|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
5422939|NCT01617993|in vitro fertilization|in vitro fertilization
5422810|NCT01618500|Neuropsychological assessment|neuropsychological assessment
5422811|NCT01618487|tennis elbow|tennis elbow
5422812|NCT01618487|lateral epicondylitis|lateral epicondylitis
5422813|NCT01618474|gastric cancer|gastric cancer
5422814|NCT01618474|adjuvant chemotherapy|adjuvant chemotherapy
5422815|NCT01618461|Prescription drug information|prescription drug information
5422816|NCT01618461|Medication management|medication management
5422817|NCT01618435|Fusion surgery|fusion surgery
5422818|NCT01618435|Degenerative olisthesis|degenerative olisthesis
5422819|NCT01618435|i-FACTOR|i-factor
5422820|NCT01618435|ODI|odi
5422821|NCT01618435|Spinal stenosis|spinal stenosis
5422822|NCT01618422|DOTS plus|dots plus
5422823|NCT01618422|DOTS|dots
5422824|NCT01618422|multidrug resistant tuberculosis (MDR TB)|multidrug resistant tuberculosis (mdr tb)
5422825|NCT01618409|PictureRx|picturerx
5422826|NCT01618409|Health Literacy|health literacy
5422827|NCT01618409|Limited English Proficiency|limited english proficiency
5422828|NCT01618409|Latinos|latinos
5422829|NCT01618409|Spanish|spanish
5422830|NCT01618396|Microcirculation|microcirculation
5422831|NCT01618396|Hypnotics and Sedatives,|hypnotics and sedatives,
5422832|NCT01618396|Propofol,|propofol,
5422833|NCT01618396|Midazolam|midazolam
5422834|NCT01618383|Parkinson's disease|parkinson's disease
5422835|NCT01618383|gut|gut
5422836|NCT01618383|colon|colon
5422837|NCT01618383|biopsies|biopsies
5422838|NCT01618383|LRRK2|lrrk2
5422839|NCT01618370|Radium 223|radium 223
5422840|NCT01618370|Alpharadin|alpharadin
5422841|NCT01618370|Prostate Cancer|prostate cancer
5422842|NCT01618370|Bone metastases|bone metastases
5422843|NCT01618370|Castrate resistant prostate cancer|castrate resistant prostate cancer
5422844|NCT01618370|Hormone refractory prostate cancer|hormone refractory prostate cancer
5422845|NCT01618357|Veliparib|veliparib
5422846|NCT01618357|ABT-888|abt-888
5422847|NCT01618357|Radiation|radiation
5422848|NCT01618357|POPI|popi
5422849|NCT01618344|neoplasms|neoplasms
5422850|NCT01618344|adolescent|adolescent
5422851|NCT01618344|young adult|young adult
5422852|NCT01618344|medication adherence|medication adherence
5422853|NCT01618331|FSHD|fshd
5422854|NCT01618331|Endurance exercise|endurance exercise
5422855|NCT01618331|Protein supplementation|protein supplementation
5422856|NCT01618331|Placebo RCT|placebo rct
5422857|NCT01618318|Asthma|asthma
5422858|NCT01618318|Allergy|allergy
5422859|NCT01618318|Diagnosis|diagnosis
5422860|NCT01618318|Correlation study|correlation study
5422861|NCT01618292|pelvic organ prolapse|pelvic organ prolapse
5422862|NCT01618292|constipation|constipation
5422863|NCT01618292|bowel dysfunction|bowel dysfunction
5422864|NCT01618292|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5422865|NCT01618292|CRADI-8|cradi-8
5422866|NCT01618292|CRAIQ-7|craiq-7
5422868|NCT01618292|excessive straining|excessive straining
5422869|NCT01618292|bowel movements|bowel movements
5422870|NCT01618292|fecal incontinence|fecal incontinence
5422871|NCT01618292|bowel symptoms|bowel symptoms
5422872|NCT01618279|tryptase|tryptase
5422873|NCT01618279|coronary|coronary
5422874|NCT01618279|stemi|stemi
5422875|NCT01618279|nstemi|nstemi
5422876|NCT01618253|Transarterial Chemoembolization|transarterial chemoembolization
5422877|NCT01618253|TACE|tace
5422878|NCT01618253|Sorafenib Tosylate|sorafenib tosylate
5422879|NCT01618253|Sorafenib|sorafenib
5422880|NCT01618253|Nexavar|nexavar
5422881|NCT01618253|External Beam Radiation Therapy|external beam radiation therapy
5422882|NCT01618253|Radiation Therapy|radiation therapy
5422883|NCT01618253|Radiotherapy|radiotherapy
5422884|NCT01618253|Radiation|radiation
5422885|NCT01618240|FEES|fees
5422886|NCT01618240|PAS|pas
5422887|NCT01618240|VPSR|vpsr
5422888|NCT01618240|MRC|mrc
5422889|NCT01618201|Inflammation|inflammation
5422890|NCT01618201|Migraine|migraine
5422891|NCT01618201|Headache|headache
5422892|NCT01618175|Bronchiolitis, Viral|bronchiolitis, viral
5422893|NCT01618175|Home oxygen therapy|home oxygen therapy
5422894|NCT01618175|Home Nursing|home nursing
5422895|NCT01618175|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5422896|NCT01618175|bronchiolitis severity score|bronchiolitis severity score
5422900|NCT01618136|PARP inhibitors|parp inhibitors
5422901|NCT01618136|Malignant Solid Tumour|malignant solid tumour
5422902|NCT01618136|ovarian cancer|ovarian cancer
5422903|NCT01618136|triple negative breast cancer|triple negative breast cancer
5422904|NCT01618136|advanced melanoma|advanced melanoma
5422905|NCT01618123|Endothelial function|endothelial function
5422906|NCT01618123|Coronary disease|coronary disease
5422907|NCT01618123|Atherosclerosis|atherosclerosis
5422908|NCT01618123|Chest pain|chest pain
5671964|NCT00613405|substance-related disorders|substance-related disorders
5422910|NCT01618110|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5422911|NCT01618110|TMS|tms
5422912|NCT01618110|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5422913|NCT01618097|Osteoarthritis|osteoarthritis
5422914|NCT01618097|Decision Aids|decision aids
5422915|NCT01618097|Health Literacy|health literacy
5422916|NCT01618084|hipreplacement|hipreplacement
5422917|NCT01618084|uncemented|uncemented
5422918|NCT01618084|migration|migration
5422919|NCT01618084|boneremodeling|boneremodeling
5422920|NCT01618071|n-3 PUFA|n-3 pufa
5422921|NCT01618071|Endothelial cells|endothelial cells
5422922|NCT01618071|Nitric oxide|nitric oxide
5422923|NCT01618071|Oxidative stress|oxidative stress
5422924|NCT01618071|Blood pressure|blood pressure
5422925|NCT01618071|Vasodilation|vasodilation
5422926|NCT01618071|Lipemia|lipemia
5422927|NCT01618071|Unsaturated dietary fats|unsaturated dietary fats
5422928|NCT01618058|HIV Infections|hiv infections
5422929|NCT01618058|Anti-HIV Agents|anti-hiv agents
5422930|NCT01618058|HIV-1|hiv-1
5422931|NCT01618045|Diabetes|diabetes
5422932|NCT01618045|FPP|fpp
5422933|NCT01618045|fermented papaya preparation|fermented papaya preparation
5422934|NCT01618019|n-3 PUFA|n-3 pufa
5422935|NCT01618019|rheumatoid arthritis|rheumatoid arthritis
5422936|NCT01618019|inflammation|inflammation
5422937|NCT01618019|eicosanoids|eicosanoids
5422938|NCT01618019|bone turnover markers|bone turnover markers
5422940|NCT01617993|assisted reproduction|assisted reproduction
5422941|NCT01617993|noninvasive imaging of embryos|noninvasive imaging of embryos
5422942|NCT01617993|time lapse imaging of embryos|time lapse imaging of embryos
5422943|NCT01617993|traditional morphological grading of embryos|traditional morphological grading of embryos
5422944|NCT01617993|prediction of blastocysts|prediction of blastocysts
5422945|NCT01617993|infertility|infertility
5422946|NCT01617993|Genital Diseases, Male|genital diseases, male
5422947|NCT01617993|Genital Diseases, Female|genital diseases, female
5422948|NCT01617980|Hypoxia imaging|hypoxia imaging
5422949|NCT01617980|FMISO-PET|fmiso-pet
5422950|NCT01617980|functional MRI|functional mri
5422951|NCT01617980|Intensity modulated radiation therapy|intensity modulated radiation therapy
5422952|NCT01617967|RNAi therapeutic|rnai therapeutic
5422953|NCT01617941|non-chronic migraine, migraine prevention|non-chronic migraine, migraine prevention
5422954|NCT01617902|Hyperbilirubinemia|hyperbilirubinemia
5422955|NCT01617902|cardiac|cardiac
5422956|NCT01617902|surgery|surgery
5422957|NCT01617902|aorta|aorta
5422958|NCT01617902|prognosis|prognosis
5422959|NCT01617876|Stomach Neoplasms|stomach neoplasms
5422960|NCT01617876|early gastric cancer|early gastric cancer
5422961|NCT01617876|magnifying endoscopy|magnifying endoscopy
5422962|NCT01617876|narrow band imaging|narrow band imaging
5422963|NCT01617876|acetic acid|acetic acid
5422964|NCT01617876|indigocarmine|indigocarmine
5422965|NCT01617837|Postoperative nausea and vomiting|postoperative nausea and vomiting
5422967|NCT01617837|Craniotomy.|craniotomy.
5422968|NCT01617824|Diabetes|diabetes
5422969|NCT01617824|Kidney|kidney
5422970|NCT01617824|Inflammation|inflammation
5422971|NCT01617824|Metabolism|metabolism
5422972|NCT01617772|Non-alcoholic steatohepatitis, Atorvastatin, L-Carnitine|non-alcoholic steatohepatitis, atorvastatin, l-carnitine
5422973|NCT01617746|Asthma|asthma
5422974|NCT01617746|Endothelin|endothelin
5422975|NCT01617746|Airway hyperreactivity|airway hyperreactivity
5422976|NCT01617720|mitral|mitral
5422977|NCT01617720|valve|valve
5422978|NCT01617720|annuloplasty|annuloplasty
5422979|NCT01617720|mitral regurgitation|mitral regurgitation
5422980|NCT01617707|sedation|sedation
5422981|NCT01617707|endoscopy|endoscopy
5422982|NCT01617707|midazolam|midazolam
5422983|NCT01617707|propofol|propofol
5422984|NCT01617707|chronic alcoholics|chronic alcoholics
5422985|NCT01617694|dexmedetomidine|dexmedetomidine
5422986|NCT01617694|remifentanil|remifentanil
5422987|NCT01617694|target-controlled infusion|target-controlled infusion
5422988|NCT01617681|Hypertension; CKD; Pediatric|hypertension; ckd; pediatric
5422989|NCT01617668|Breast cancer,|breast cancer,
5422990|NCT01617668|LCL161,|lcl161,
5422991|NCT01617668|paclitaxel,|paclitaxel,
5418012|NCT01640665|Phase 1|phase 1
5422997|NCT01617642|Iron status|iron status
5422998|NCT01617629|Cvac|cvac
5422999|NCT01617603|diabetes type 2|diabetes type 2
5423000|NCT01617603|insulin resistance|insulin resistance
5423001|NCT01617603|glycaemic control|glycaemic control
5423002|NCT01617603|Endothelial function|endothelial function
5423003|NCT01617603|Cocoa Polyphenols|cocoa polyphenols
5423005|NCT01617590|Leflunomide|leflunomide
5423006|NCT01617590|Methotrexate|methotrexate
5423007|NCT01617577|G-CSF|g-csf
5423008|NCT01617577|granulocyte colony stimulating factor|granulocyte colony stimulating factor
5423009|NCT01617577|Filgrastim|filgrastim
5423010|NCT01617564|medical abortion|medical abortion
5423011|NCT01617564|second trimester|second trimester
5423012|NCT01617564|para cervical blockage|para cervical blockage
5423013|NCT01617564|pain management|pain management
5423014|NCT01617551|Essential hypertension|essential hypertension
5423015|NCT01617551|Nitric oxide|nitric oxide
5423016|NCT01617551|Renal denervation|renal denervation
5423017|NCT01617551|Sodium|sodium
5423018|NCT01617551|GFR|gfr
5423019|NCT01617538|atherosclerosis|atherosclerosis
5423020|NCT01617538|stenosis|stenosis
5423021|NCT01617538|statin therapy|statin therapy
5423022|NCT01617538|Signs and Symptoms|signs and symptoms
5423023|NCT01617538|Circulatory; Change|circulatory; change
5423024|NCT01617499|physical activity|physical activity
5423025|NCT01617499|pedometer|pedometer
5423026|NCT01617499|worksite|worksite
5423027|NCT01617499|wellness|wellness
5423028|NCT01617499|cardiovascular|cardiovascular
5423029|NCT01617499|lifestyle program|lifestyle program
5423030|NCT01617460|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
5423031|NCT01617460|aripiprazole|aripiprazole
5423032|NCT01617460|Long-term safety study|long-term safety study
5423033|NCT01617460|children and adolescents|children and adolescents
5405980|NCT01695213|DEXA|dexa
5423034|NCT01617447|Autistic Disorder, children and adolescents|autistic disorder, children and adolescents
5423142|NCT01617031|aspirin|aspirin
5423040|NCT01617421|Arthritis|arthritis
5423045|NCT01617395|Multiple Sclerosis|multiple sclerosis
5423046|NCT01617395|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5423047|NCT01617382|HIPEC|hipec
5423048|NCT01617382|Hyperthermic (heated) chemotherapy after debulking|hyperthermic (heated) chemotherapy after debulking
5423049|NCT01617356|TMD|tmd
5423050|NCT01617356|temporomandibular|temporomandibular
5423051|NCT01617356|dextrose|dextrose
5423052|NCT01617356|prolotherapy|prolotherapy
5423053|NCT01617330|Particulate matter|particulate matter
5423054|NCT01617330|Air pollution|air pollution
5423055|NCT01617330|Diesel exhaust|diesel exhaust
5423056|NCT01617330|Allergic rhinitis|allergic rhinitis
5423057|NCT01617317|H1N1 2009|h1n1 2009
5423058|NCT01617317|hyperimmune IVIG|hyperimmune ivig
5423059|NCT01617317|mortality|mortality
5423060|NCT01617317|length of stay|length of stay
5423061|NCT01617317|viral load|viral load
5423062|NCT01617317|cytokine|cytokine
5423063|NCT01617304|advanced glycation end products|advanced glycation end products
5423064|NCT01617304|insulin sensitivity|insulin sensitivity
5423065|NCT01617304|obesity|obesity
5423066|NCT01617304|inflammation|inflammation
5423067|NCT01617304|metabolomics|metabolomics
5423068|NCT01617304|appetite|appetite
5423069|NCT01617304|CVD|cvd
5423070|NCT01617291|Pre-hospital hypothermia|pre-hospital hypothermia
5423071|NCT01617291|Induced therapeutic hypothermia|induced therapeutic hypothermia
5423072|NCT01617291|Cardiac arrest|cardiac arrest
5423073|NCT01617278|Colonoscopy|colonoscopy
5423074|NCT01617278|I Scan|i scan
5423075|NCT01617278|High definition white light|high definition white light
5423076|NCT01617278|Adenomas|adenomas
5423077|NCT01617265|intensive care|intensive care
5423078|NCT01617265|mechanical ventilation|mechanical ventilation
5423079|NCT01617265|sedatives|sedatives
5423080|NCT01617265|morphinics|morphinics
5423081|NCT01617265|oversedation|oversedation
5423082|NCT01617265|mortality|mortality
5423083|NCT01617265|midazolam|midazolam
5423084|NCT01617265|propofol|propofol
5423085|NCT01617265|pain|pain
5423086|NCT01617265|agitation|agitation
5423087|NCT01617252|Cardiac surgery|cardiac surgery
5423088|NCT01617252|Acute respiratory failure|acute respiratory failure
5423089|NCT01617252|High flow oxygen therapy|high flow oxygen therapy
5423090|NCT01617239|Influenza|influenza
5423091|NCT01617239|Vaccination|vaccination
5423092|NCT01617239|Virosomal influenza vaccine|virosomal influenza vaccine
5423093|NCT01617213|Multiple Myeloma|multiple myeloma
5423094|NCT01617174|prostate|prostate
5423095|NCT01617174|pain assessment|pain assessment
5423096|NCT01617174|12-110|12-110
5423097|NCT01617161|Low Risk|low risk
5423098|NCT01617161|Intermediate Risk|intermediate risk
5423099|NCT01617148|Exudative Macular Degeneration|exudative macular degeneration
5423100|NCT01617148|Aflibercept|aflibercept
5423101|NCT01617135|Parkinson's disease|parkinson's disease
5423102|NCT01617135|Motor fluctuations|motor fluctuations
5423103|NCT01617135|levodopa|levodopa
5423104|NCT01617135|inhaled drugs|inhaled drugs
5423105|NCT01617135|"Motor fluctuation (off episodes)"|"motor fluctuation (off episodes)"
5423107|NCT01617122|PIDD|pidd
5423108|NCT01617122|antibody deficiency|antibody deficiency
5423109|NCT01617122|CVID|cvid
5423110|NCT01617122|recurrent infections|recurrent infections
5423111|NCT01617109|Vitamin D|vitamin d
5423112|NCT01617109|Calcium|calcium
5423113|NCT01617109|Parathyroid hormone|parathyroid hormone
5423114|NCT01617109|Bone|bone
5423115|NCT01617109|Bone formation|bone formation
5423116|NCT01617109|Bone resorption|bone resorption
5423117|NCT01617109|Micronutrients|micronutrients
5423118|NCT01617109|Trace Elements|trace elements
5423119|NCT01617096|HIV Infections|hiv infections
5423120|NCT01617096|Anti-HIV agents|anti-hiv agents
5423121|NCT01617096|HIV-1|hiv-1
5423122|NCT01617083|PANS|pans
5423123|NCT01617083|PANDAS|pandas
5423124|NCT01617083|OCD|ocd
5423125|NCT01617083|Tics|tics
5423126|NCT01617083|Azithromycin|azithromycin
5423127|NCT01617083|Antibiotic Treatment|antibiotic treatment
5423128|NCT01617070|Tetrahydrobiopterin|tetrahydrobiopterin
5423129|NCT01617070|Kuvan|kuvan
5423130|NCT01617070|Phenylketonuria (PKU)|phenylketonuria (pku)
5423131|NCT01617070|Large Neutral Amino Acids|large neutral amino acids
5423132|NCT01617070|Serotonin|serotonin
5423133|NCT01617070|Dopamine|dopamine
5423134|NCT01617070|Melatonin|melatonin
5423135|NCT01617057|otosclerosis|otosclerosis
5423136|NCT01617057|inner ear|inner ear
5423137|NCT01617057|tiludronic acid|tiludronic acid
5423138|NCT01617044|Iron|iron
5423139|NCT01617044|Deficiency|deficiency
5423140|NCT01617044|Restless|restless
5423143|NCT01617031|diabetes mellitus|diabetes mellitus
5423144|NCT01617031|coronary artery disease|coronary artery disease
5423145|NCT01617018|Psoriasis; Biological therapy; Methotrexate; Cyclosporine|psoriasis; biological therapy; methotrexate; cyclosporine
5423146|NCT01616979|Off-pump coronary artery bypass surgery|off-pump coronary artery bypass surgery
5423147|NCT01616979|Transesophageal echocardiography|transesophageal echocardiography
5423148|NCT01616966|hoarseness|hoarseness
5423149|NCT01616966|sore throat|sore throat
5423150|NCT01616966|vocal cord injuries|vocal cord injuries
5423151|NCT01616953|dental implants|dental implants
5423152|NCT01616940|HIV/AIDS|hiv/aids
5423153|NCT01616940|Peer support|peer support
5423154|NCT01616927|ADPKD|adpkd
5423155|NCT01616927|lanreotide|lanreotide
5423156|NCT01616927|polycystic kidney|polycystic kidney
5423157|NCT01616927|polycystic liver|polycystic liver
5423158|NCT01616914|delirium|delirium
5423159|NCT01616914|outcome|outcome
5423160|NCT01616901|Obese|obese
5423161|NCT01616901|Intensive Care|intensive care
5423162|NCT01616901|Respiratory weaning|respiratory weaning
5423163|NCT01616901|Spontaneous Breathing trial|spontaneous breathing trial
5423164|NCT01616901|Work of breathing|work of breathing
5423165|NCT01616888|drug eluting balloon with paclitaxel|drug eluting balloon with paclitaxel
5423166|NCT01616888|in stent restenosis|in stent restenosis
5423167|NCT01616888|femoropopliteal arteries|femoropopliteal arteries
5423168|NCT01616888|angioplasty|angioplasty
5423169|NCT01616875|Bladder cancer|bladder cancer
5423170|NCT01616875|Transitional cell carcinoma|transitional cell carcinoma
5423171|NCT01616875|Urothelial cancer|urothelial cancer
5423172|NCT01616875|Cisplatin|cisplatin
5423173|NCT01616875|Cabazitaxel|cabazitaxel
5423174|NCT01616875|Chemotherapy|chemotherapy
5423175|NCT01616875|Neo adjuvant chemotherapy|neo adjuvant chemotherapy
5423176|NCT01616862|Pseudomonas aeruginosa|pseudomonas aeruginosa
5423177|NCT01616862|cystic fibrosis|cystic fibrosis
5423178|NCT01616823|Human immunodeficiency virus (HIV) positive women|human immunodeficiency virus (hiv) positive women
5423179|NCT01616810|urinary tract|urinary tract
5423373|NCT01615900|Kidney transplant failure score|kidney transplant failure score
5423374|NCT01615848|polycystic Ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5423375|NCT01615848|diet|diet
5423376|NCT01615848|mediterranean diet|mediterranean diet
5423377|NCT01615848|high protein diet|high protein diet
5423378|NCT01615822|Malaria|malaria
5423379|NCT01615822|PK|pk
5423380|NCT01615822|OZ439|oz439
5423381|NCT01615822|Mefloquine|mefloquine
5423382|NCT01615822|Healthy Volunteers|healthy volunteers
5423383|NCT01615809|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5423384|NCT01615809|IFI|ifi
5423385|NCT01615809|Leukaemia|leukaemia
5423386|NCT01615809|Leukemia|leukemia
5423387|NCT01615809|Pediatric|pediatric
5423388|NCT01615809|Paediatrics|paediatrics
5423389|NCT01615809|Amphotericin B|amphotericin b
5423390|NCT01615809|Aspergillosis|aspergillosis
5423391|NCT01615809|Pulmonary Aspergillosis|pulmonary aspergillosis
5423392|NCT01615809|Invasive Aspergillosis|invasive aspergillosis
5423393|NCT01615809|Antifungal agents|antifungal agents
5423394|NCT01615809|Fungal infections|fungal infections
5423395|NCT01615809|Invasive Fungal Infection|invasive fungal infection
5423396|NCT01615796|GSK2140944|gsk2140944
5423398|NCT01615796|first time in human|first time in human
5423399|NCT01615796|pharmacokinetics|pharmacokinetics
5423400|NCT01615796|intravenous|intravenous
5423401|NCT01615796|safety|safety
5423402|NCT01615796|absolute bioavailability|absolute bioavailability
5423403|NCT01615796|Bacterial Type II|bacterial type ii
5423404|NCT01615796|tolerability|tolerability
5423405|NCT01615796|infection|infection
5423406|NCT01615783|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5423407|NCT01615783|Costs|costs
5423408|NCT01615783|Resource utilization|resource utilization
5423409|NCT01615783|Medicaid|medicaid
5423411|NCT01615757|Acute Myeloid Leukemia|acute myeloid leukemia
5423412|NCT01615757|Cytarabine dose|cytarabine dose
5423413|NCT01615757|Ara-c dose|ara-c dose
5423414|NCT01615757|Consolidation|consolidation
5423415|NCT01615744|calcaneal fractures|calcaneal fractures
5423416|NCT01615744|surgical treatment|surgical treatment
5423417|NCT01615744|conservative treatment|conservative treatment
5423418|NCT01615744|VAS scoring|vas scoring
5423419|NCT01615744|SF-36|sf-36
5423420|NCT01615744|AOFAS|aofas
5423421|NCT01615744|Olerud-Molander score|olerud-molander score
5423422|NCT01615744|outcome|outcome
5423423|NCT01615731|Mifepristone|mifepristone
5423424|NCT01615731|Induced Abortion|induced abortion
5423425|NCT01615731|Dilation and Evacuation|dilation and evacuation
5423426|NCT01615731|Cervical preparation|cervical preparation
5423427|NCT01615731|Osmotic dilators|osmotic dilators
5423428|NCT01615718|noninvasive stimulation|noninvasive stimulation
5423429|NCT01615718|motor function|motor function
5423430|NCT01615718|transcranial stimulation|transcranial stimulation
5423431|NCT01615718|transcranial ultrasound|transcranial ultrasound
5423432|NCT01615718|brain stimulation|brain stimulation
5423433|NCT01615705|Postphlebitic Syndrome|postphlebitic syndrome
5423434|NCT01615705|Post-Thrombotic Syndrome|post-thrombotic syndrome
5423435|NCT01615705|Biomarkers|biomarkers
5423436|NCT01615705|Markers of Inflammation|markers of inflammation
5423437|NCT01615705|Genetic Thrombophilia|genetic thrombophilia
5423438|NCT01615705|Coagulation Activation|coagulation activation
5423439|NCT01615692|Elastic Stockings|elastic stockings
5423440|NCT01615692|Stockings, Compression|stockings, compression
5423441|NCT01615692|Randomized Controlled Trials|randomized controlled trials
5423442|NCT01615692|Quality of Life|quality of life
5423443|NCT01615679|Non-interventional study|non-interventional study
5423444|NCT01615679|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5423445|NCT01615679|ADHD|adhd
5423446|NCT01615666|Alzheimer's disease|alzheimer's disease
5423447|NCT01615666|Mild Cognitive Impairment|mild cognitive impairment
5423448|NCT01615666|Frontotemporal dementia|frontotemporal dementia
5423449|NCT01615666|fMRI|fmri
5423450|NCT01615666|functional neuroimaging|functional neuroimaging
5423451|NCT01615666|Memory|memory
5423452|NCT01615653|Pancreatic cancer|pancreatic cancer
5423453|NCT01615653|Pancreas cancer|pancreas cancer
5423454|NCT01615653|Pain|pain
5423455|NCT01615653|Celiac Plexus|celiac plexus
5423456|NCT01615653|Neurolysis|neurolysis
5423457|NCT01615640|Osteosarcoma|osteosarcoma
5423458|NCT01615640|Response of chemotherapy|response of chemotherapy
5423459|NCT01615640|Dynamic contrast medium examination|dynamic contrast medium examination
5423460|NCT01615640|Diffusion-weighted MR imaging|diffusion-weighted mr imaging
5423461|NCT01615627|Subcutaneous Treprostinil|subcutaneous treprostinil
5423462|NCT01615614|Rilpivirine|rilpivirine
5423463|NCT01615614|Rifabutin|rifabutin
5423464|NCT01615614|Pharmacokinetics|pharmacokinetics
5423465|NCT01615614|Healthy participants|healthy participants
5423466|NCT01615601|Human Immunodeficiency Virus|human immunodeficiency virus
5423467|NCT01615601|HIV|hiv
5423468|NCT01615601|HIV-1|hiv-1
5423469|NCT01615601|HIV type 1|hiv type 1
5423470|NCT01615601|Darunavir|darunavir
5423471|NCT01615601|PREZISTA|prezista
5423472|NCT01615601|Etravirine|etravirine
5423474|NCT01615601|HIV symptom Distress Module|hiv symptom distress module
5423475|NCT01615601|HIV-SDM|hiv-sdm
5423476|NCT01615601|Antiretroviral therapy|antiretroviral therapy
5423477|NCT01615601|HIV Symptom Index (HSI),|hiv symptom index (hsi),
5423478|NCT01615588|manuka honey|manuka honey
5423479|NCT01615588|glycaemic index|glycaemic index
5423480|NCT01615588|blood glucose control|blood glucose control
5423481|NCT01615588|individuals|individuals
5423482|NCT01615588|current disease|current disease
5423483|NCT01615588|medication use|medication use
5423484|NCT01615562|Polycystic Ovary Syndrome|polycystic ovary syndrome
5423485|NCT01615562|PCOS|pcos
5423486|NCT01615562|Infertility|infertility
5423487|NCT01615549|Cholecystectomy|cholecystectomy
5423488|NCT01615549|Virtual reality device|virtual reality device
5423489|NCT01615549|Training|training
5423490|NCT01615536|chronic rhinosinusitis|chronic rhinosinusitis
5423491|NCT01615536|canine fossa trephine|canine fossa trephine
5423492|NCT01615536|canine fossa puncture|canine fossa puncture
5423493|NCT01615523|Executive functions|executive functions
5423494|NCT01615497|cognitive behavior therapy|cognitive behavior therapy
5423495|NCT01615497|computer assisted instruction|computer assisted instruction
5418296|NCT01639508|Lung|lung
5423497|NCT01615497|educational resource design and development|educational resource design and development
5423498|NCT01615484|Lung Transplant|lung transplant
5423499|NCT01615484|Emphysema|emphysema
5423500|NCT01615484|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5423501|NCT01615484|Cystic Fibrosis|cystic fibrosis
5423502|NCT01615484|Pulmonary Fibrosis|pulmonary fibrosis
5423503|NCT01615484|Bronchiectasis|bronchiectasis
5528412|NCT01174394|CVA|cva
5410435|NCT01675765|Naive|naive
5423504|NCT01615484|Sarcoidosis|sarcoidosis
5423505|NCT01615484|Pulmonary Hypertension|pulmonary hypertension
5423506|NCT01615484|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5423507|NCT01615471|Obesity|obesity
5423508|NCT01615471|Lifestyle Intervention|lifestyle intervention
5423509|NCT01615471|Group treatment|group treatment
5423510|NCT01615471|Internet Intervention|internet intervention
5423511|NCT01615458|Care Management|care management
5423512|NCT01615458|Implementation|implementation
5423513|NCT01615458|Intervention|intervention
5423514|NCT01615458|Mood Disorders|mood disorders
5423515|NCT01615380|smoking cessation|smoking cessation
5423516|NCT01615380|Aerobic Exercise|aerobic exercise
5423517|NCT01615380|Women|women
5423518|NCT01615380|YMCA|ymca
5423519|NCT01615367|Bipolar disorder|bipolar disorder
5423520|NCT01615367|Nutrition|nutrition
5423521|NCT01615367|Exercise|exercise
5423522|NCT01615367|Symptoms|symptoms
5423523|NCT01615367|Functioning|functioning
5423524|NCT01615341|Kidney transplantation|kidney transplantation
5423525|NCT01615341|Subclinical Viral Infection|subclinical viral infection
5423526|NCT01615341|Renal Allograft Injury|renal allograft injury
5423527|NCT01615328|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5423528|NCT01615328|bone graft substitute|bone graft substitute
5562200|NCT01039025|Myeloma|myeloma
5423529|NCT01615328|PEEK cage|peek cage
5423530|NCT01615328|hydroxyapatite|hydroxyapatite
5423531|NCT01615328|demineralized bone matrix|demineralized bone matrix
5423532|NCT01615328|b-tricalcium phosphate|b-tricalcium phosphate
5423533|NCT01615328|Bonion|bonion
5423534|NCT01615328|Cervios ChronOs|cervios chronos
5423535|NCT01615315|aspirin|aspirin
5423536|NCT01615315|screening|screening
5423537|NCT01615315|microscopic hematuria|microscopic hematuria
5423538|NCT01615302|Rectal Fistula|rectal fistula
5423539|NCT01615302|Peri-anal Fistula|peri-anal fistula
5423540|NCT01615302|Platelet-Rich Plasma|platelet-rich plasma
5423541|NCT01615302|Mucosa advancement flap|mucosa advancement flap
5423542|NCT01615276|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
5423543|NCT01615276|Ageing|ageing
5423544|NCT01615276|Protein ingestion|protein ingestion
5423545|NCT01615263|Video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5423546|NCT01615263|One lung ventilation|one lung ventilation
5423547|NCT01615263|Bronchial blocker|bronchial blocker
5423548|NCT01615263|Lung collapse|lung collapse
5423549|NCT01615263|Double lumen tube|double lumen tube
5423550|NCT01615224|missed abortion|missed abortion
5423551|NCT01615224|miscarriage|miscarriage
5423552|NCT01615211|Abortion|abortion
5423553|NCT01615211|medical abortion|medical abortion
5423554|NCT01615211|termination of pregnancy|termination of pregnancy
5423555|NCT01615211|Mifepristone|mifepristone
5423556|NCT01615211|misoprostol|misoprostol
5423557|NCT01615211|letrozole|letrozole
5423558|NCT01615211|trilostane|trilostane
5423559|NCT01615211|femara|femara
5423560|NCT01615211|Modrenal|modrenal
5423561|NCT01615198|Hypertension, blood pressure, LCZ696, dual inhibitor, neprilysin, NEP inhibition, vasopeptidase, ARNi, angiotensin receptor|hypertension, blood pressure, lcz696, dual inhibitor, neprilysin, nep inhibition, vasopeptidase, arni, angiotensin receptor
5423562|NCT01615185|schizophrenia|schizophrenia
5423563|NCT01615185|amisulpride|amisulpride
5423564|NCT01615185|sulpiride|sulpiride
5423565|NCT01615185|antipsychotic combination|antipsychotic combination
5423566|NCT01615159|Sodium|sodium
5423567|NCT01615159|Diet|diet
5423575|NCT01615146|transfusions|transfusions
5423576|NCT01615146|Outpatient|outpatient
5423577|NCT01615081|Malt extract|malt extract
5423578|NCT01615081|carbohydrate|carbohydrate
5423579|NCT01615081|glucose response|glucose response
5423580|NCT01615081|insulin response|insulin response
5423581|NCT01615081|Appetite|appetite
5423582|NCT01615081|Appetite regulating hormones|appetite regulating hormones
5423583|NCT01615055|Chemotherapy|chemotherapy
5423584|NCT01615055|Cognitive|cognitive
5423586|NCT01615055|Fluoxetine|fluoxetine
5423587|NCT01615055|FDG|fdg
5423588|NCT01615055|PET|pet
5423589|NCT01615042|Acute Leukemia|acute leukemia
5423590|NCT01615042|Bone Marrow Transplant|bone marrow transplant
5423591|NCT01615042|High Dose Lenalidomide|high dose lenalidomide
5423599|NCT01615016|Preterm infant|preterm infant
5423600|NCT01615016|Surfactant application|surfactant application
5423601|NCT01615016|Respiratory Distress Syndrome|respiratory distress syndrome
5423602|NCT01615016|Minimally invasive Surfactant Application|minimally invasive surfactant application
5423603|NCT01615016|INSURE (Intubate-Surfactant-Extubate)|insure (intubate-surfactant-extubate)
5423604|NCT01615003|MicroRNA|microrna
5423605|NCT01615003|coronary heart disease|coronary heart disease
5423608|NCT01615003|Xuesaitong soft capsule|xuesaitong soft capsule
5423609|NCT01614977|nontuberculous mycobacteria|nontuberculous mycobacteria
5423610|NCT01614977|corticosteroids|corticosteroids
5423611|NCT01614977|children|children
5423612|NCT01614977|lymphadeniti|lymphadeniti
5680257|NCT00578461|myelodsyplastic disease|myelodsyplastic disease
5395910|NCT01740323|Cytokine|cytokine
5680258|NCT00578461|Leukemia|leukemia
5423613|NCT01614977|Therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.|therapeutic intervention in immunocompetent children with nontuberculous mycobacterial lymphadenitis.
5423614|NCT01614964|Plasmodium falciparum|plasmodium falciparum
5423615|NCT01614964|pharmacokinetics|pharmacokinetics
5423616|NCT01614964|antimalarials (antimalarial drugs)|antimalarials (antimalarial drugs)
5423617|NCT01614964|chloroquine (chloroquine-resistant)|chloroquine (chloroquine-resistant)
5423618|NCT01614964|QT (QTc) interval|qt (qtc) interval
5423619|NCT01614938|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5423620|NCT01614938|Locally advanced|locally advanced
5423621|NCT01614938|Cetuximab|cetuximab
5423622|NCT01614938|Weekly cisplatin chemotherapy|weekly cisplatin chemotherapy
5423623|NCT01614938|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5423624|NCT01614886|Rivastigmine, Alzheimer's disease, Transdermal patch|rivastigmine, alzheimer's disease, transdermal patch
5423625|NCT01614873|Breathing Pattern|breathing pattern
5423626|NCT01614873|Mechanical Ventilation|mechanical ventilation
5423627|NCT01614873|Pressure support ventilation|pressure support ventilation
5423628|NCT01614873|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5423629|NCT01614860|Aldosterone|aldosterone
5423630|NCT01614860|Echocardiography|echocardiography
5423631|NCT01614860|Neurohormones|neurohormones
5423633|NCT01614847|artificial tears|artificial tears
5423634|NCT01614847|tear osmolarity|tear osmolarity
5423635|NCT01614847|residence time|residence time
5423636|NCT01614834|urticaria|urticaria
5423637|NCT01614834|disease control|disease control
5423638|NCT01614834|severity|severity
5423639|NCT01614834|test|test
5423640|NCT01614821|Relapsed|relapsed
5423641|NCT01614821|Refractory|refractory
5423642|NCT01614743|Rosacea|rosacea
5423643|NCT01614730|EMS|ems
5423644|NCT01614730|Modified Device|modified device
5423645|NCT01614717|Hypertrophic Obstructive Cardiomyopathy|hypertrophic obstructive cardiomyopathy
5406396|NCT01693458|education|education
5423646|NCT01614717|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5423647|NCT01614704|Breast cancer|breast cancer
5423648|NCT01614704|Fertility|fertility
5423649|NCT01614678|myopia|myopia
5423650|NCT01614665|Transplant|transplant
5423651|NCT01614665|Prograf|prograf
5423652|NCT01614665|Heart|heart
5423653|NCT01614665|Advagraf|advagraf
5423654|NCT01614665|Tacrolimus|tacrolimus
5423655|NCT01614665|Immunosuppression|immunosuppression
5423656|NCT01614665|Kidney|kidney
5423657|NCT01614665|Liver|liver
5423658|NCT01614665|Pharmacokinetic|pharmacokinetic
5423659|NCT01614665|Pediatric|pediatric
5423660|NCT01614652|Congestive Heart Failure Due to LV Systolic Dysfunction|congestive heart failure due to lv systolic dysfunction
5423661|NCT01614639|Acupuncture|acupuncture
5423662|NCT01614639|fMRI|fmri
5423664|NCT01614639|Pain|pain
5423665|NCT01614639|Low Back Pain|low back pain
5423666|NCT01614639|Back Pain|back pain
5423667|NCT01614626|HIV|hiv
5423668|NCT01614626|Alcohol Use|alcohol use
5423669|NCT01614626|Microbial Translocation|microbial translocation
5423670|NCT01614626|Inflammation|inflammation
5423671|NCT01614626|Altered Coagulation|altered coagulation
5423672|NCT01614626|Russia|russia
5423673|NCT01614600|contact lens|contact lens
5423674|NCT01614600|dry eye syndrome|dry eye syndrome
5423675|NCT01614600|symptomatic|symptomatic
5423676|NCT01614600|daily disposable|daily disposable
5423677|NCT01614600|myopia|myopia
5423678|NCT01614587|pelvic organ prolapse|pelvic organ prolapse
5423679|NCT01614587|recurrence of pelvic organ prolapse|recurrence of pelvic organ prolapse
5423680|NCT01614587|genetic predisposition|genetic predisposition
5423681|NCT01614587|SNP microarray analysis|snp microarray analysis
5423682|NCT01614587|pelvic floor|pelvic floor
5423683|NCT01614587|genetic factors|genetic factors
5423684|NCT01614587|adequate prolapse repair|adequate prolapse repair
5423685|NCT01614587|polymorphisms|polymorphisms
5423686|NCT01614587|surgical failure|surgical failure
5423687|NCT01614587|reoperation|reoperation
5423688|NCT01614587|DNA|dna
5423689|NCT01614587|buccal swabs|buccal swabs
5423690|NCT01614587|TaqMan SNP allelic discriminiation assays|taqman snp allelic discriminiation assays
5423691|NCT01614587|duplex real-time PCR|duplex real-time pcr
5423692|NCT01614587|genome-wide SNP microarrays|genome-wide snp microarrays
5423693|NCT01614587|next-generation sequencing|next-generation sequencing
5423694|NCT01614561|Hypercholesterolemia|hypercholesterolemia
5423695|NCT01614561|Lipid lowering drugs|lipid lowering drugs
5423696|NCT01614561|Cholesterol level in blood|cholesterol level in blood
5418487|NCT01638494|pediatrics|pediatrics
5862842|NCT00001483|Antidepressants|antidepressants
5423703|NCT01614522|Metastatic gastro-oesophageal carcinoma|metastatic gastro-oesophageal carcinoma
5423704|NCT01614522|Recurrent gastro-oesophageal carcinoma|recurrent gastro-oesophageal carcinoma
5423705|NCT01614522|Gastric cancer|gastric cancer
5544178|NCT01110603|Cancer|cancer
5423706|NCT01614522|HER-1|her-1
5423707|NCT01614522|HER-2|her-2
5423708|NCT01614509|branch retinal vein occlusion|branch retinal vein occlusion
5423709|NCT01614509|bevacizumab|bevacizumab
5423710|NCT01614509|triamcinolone acetonide|triamcinolone acetonide
5423711|NCT01614483|Vitamin A deficiency|vitamin a deficiency
5423712|NCT01614483|Biofortification|biofortification
5423713|NCT01614483|Cassava|cassava
5423714|NCT01614483|B-carotene|b-carotene
5423715|NCT01614483|School children|school children
5423716|NCT01614483|Kenya|kenya
5671965|NCT00613392|antioxidant|antioxidant
5423717|NCT01614431|renal function|renal function
5423718|NCT01614431|before and after N acetyl cysteine|before and after n acetyl cysteine
5423719|NCT01614431|Cystinosis patients|cystinosis patients
5423720|NCT01614405|PBC|pbc
5423721|NCT01614392|Resistance Exercise|resistance exercise
5423722|NCT01614392|Physical Activity|physical activity
5423723|NCT01614392|Mobility disability|mobility disability
5423724|NCT01614392|Physical function|physical function
5423725|NCT01614392|Muscle Strength|muscle strength
5423726|NCT01614392|Older Adults|older adults
5423727|NCT01614392|Mobility-Limited|mobility-limited
5423728|NCT01614392|Peak power and strength|peak power and strength
5423729|NCT01614366|amlodipine|amlodipine
5423730|NCT01614366|DMTA07|dmta07
5423731|NCT01614366|hypertension|hypertension
5423732|NCT01614353|Multiple Chronic Conditions|multiple chronic conditions
5423733|NCT01614353|Older Adults|older adults
5423734|NCT01614353|New Prescription|new prescription
5423735|NCT01614340|Home care|home care
5423736|NCT01614340|Cognitive-Behavioral techniques|cognitive-behavioral techniques
5423737|NCT01614340|Physical Therapy|physical therapy
5423738|NCT01614340|Pain|pain
5423739|NCT01614340|Older Adults|older adults
5423740|NCT01614327|Diabetes Type One|diabetes type one
5423741|NCT01614327|Diabetes Type Two|diabetes type two
5423742|NCT01614327|PreDiabetes|prediabetes
5423743|NCT01614327|Retinal Screening|retinal screening
5423744|NCT01614327|RiskAnalyzer|riskanalyzer
5423745|NCT01614327|Retinal Imaging|retinal imaging
5423746|NCT01614327|Algorithm|algorithm
5423747|NCT01614327|Diabetic Retinopathy|diabetic retinopathy
5423748|NCT01614327|Microaneurysms|microaneurysms
5423749|NCT01614327|Neovascularization|neovascularization
5423750|NCT01614327|Intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
5423751|NCT01614314|Preceptorship, simulation, nursing, catheters|preceptorship, simulation, nursing, catheters
5423752|NCT01614301|advanced Melanoma|advanced melanoma
5423753|NCT01614288|HTO|hto
5423754|NCT01614288|Arthroscopy|arthroscopy
5423755|NCT01614288|Quality-of-Life|quality-of-life
5423756|NCT01614288|Gait Analysis|gait analysis
5423757|NCT01614275|Autism|autism
5423758|NCT01614275|Early Intervention|early intervention
5423759|NCT01614275|Parent Training|parent training
5423760|NCT01614275|EIBI|eibi
5423761|NCT01614275|Applied Behavior Analysis|applied behavior analysis
5423762|NCT01614249|Omega-3|omega-3
5423764|NCT01614249|Depression|depression
5423765|NCT01614249|HIV infected|hiv infected
5423766|NCT01614249|Pregnant women|pregnant women
5423767|NCT01614236|pregabalin|pregabalin
5423768|NCT01614236|analgesia|analgesia
5423769|NCT01614236|postoperative pain|postoperative pain
5423770|NCT01614236|orthopedic oncology patients|orthopedic oncology patients
5423771|NCT01614223|Plantar fasciitis|plantar fasciitis
5423772|NCT01614223|Autologous Conditioned Plasma|autologous conditioned plasma
5423773|NCT01614197|Relapse|relapse
5423774|NCT01614197|Lymphoblastic|lymphoblastic
5423775|NCT01614197|Leukemia|leukemia
5423776|NCT01614197|Refractory|refractory
5423777|NCT01614197|Temsirolimus|temsirolimus
5423778|NCT01614197|Acute|acute
5423779|NCT01614197|Childhood|childhood
5423780|NCT01614197|Pediatric|pediatric
5423781|NCT01614197|ALL|all
5423782|NCT01614197|NHL|nhl
5423783|NCT01614197|LL|ll
5423784|NCT01614197|PTL|ptl
5423785|NCT01614171|osteoporosis pseudoglioma|osteoporosis pseudoglioma
5423786|NCT01614171|OPPG|oppg
5423787|NCT01614171|growth hormone|growth hormone
5423788|NCT01614171|osteoporosis|osteoporosis
5423789|NCT01614158|N-AION|n-aion
5423790|NCT01614158|perimetry|perimetry
5423791|NCT01614158|visual field loss|visual field loss
5423792|NCT01614158|Mean Defect|mean defect
5423793|NCT01614158|Total Loss Volume|total loss volume
5423794|NCT01614158|D-BCVA|d-bcva
5423795|NCT01614158|RAPD|rapd
5423796|NCT01614158|retinal nerve fibre thickness/volume|retinal nerve fibre thickness/volume
5423797|NCT01614158|optic nerve head|optic nerve head
5423798|NCT01614132|medulloblastoma|medulloblastoma
5423799|NCT01614132|CNS|cns
5423800|NCT01614132|malignant neoplasm|malignant neoplasm
5423801|NCT01614132|NOA|noa
5423802|NCT01614132|neuroectodermal tumor|neuroectodermal tumor
5423803|NCT01614132|Vincristin|vincristin
5423804|NCT01614132|CCNU|ccnu
5423805|NCT01614132|Cisplatin|cisplatin
5423806|NCT01614119|Cerebral|cerebral
5423807|NCT01614119|Oxygenation|oxygenation
5423808|NCT01614119|Performance|performance
5423809|NCT01614119|Exercise|exercise
5423810|NCT01614106|HIV/AIDS|hiv/aids
5423811|NCT01614106|Drug Users|drug users
5423812|NCT01614106|Crack-Cocaine Use|crack-cocaine use
5423813|NCT01614106|HIV Primary Care|hiv primary care
5423814|NCT01614093|Schizophrenia|schizophrenia
5423815|NCT01614093|Appetite|appetite
5423816|NCT01614093|Oxytocin|oxytocin
5423817|NCT01614080|Stroke|stroke
5423818|NCT01614080|Ischemic stroke|ischemic stroke
5423819|NCT01614080|thrombolysis|thrombolysis
5423820|NCT01614080|toxicity of t-PA|toxicity of t-pa
5423821|NCT01614067|DOR|dor
5423822|NCT01614067|Infertility|infertility
5423823|NCT01614067|IVF|ivf
5423824|NCT01614067|ART|art
5423825|NCT01614067|GnRHa|gnrha
5423826|NCT01614067|GnRH Antagonist Protocol|gnrh antagonist protocol
5423827|NCT01614067|Ganirelix|ganirelix
5423828|NCT01614054|Smoking cessation|smoking cessation
5423829|NCT01614054|Nicotine replacement therapy|nicotine replacement therapy
5423830|NCT01614054|NRT|nrt
5423831|NCT01614054|Inpatient|inpatient
5423832|NCT01614054|General Medicine|general medicine
5423833|NCT01614041|Generalized Anxiety Disorder|generalized anxiety disorder
5423834|NCT01614015|Recording|recording
5423835|NCT01614015|Supervision|supervision
5423836|NCT01614015|Observation|observation
5423837|NCT01614002|carcinoma|carcinoma
5423838|NCT01614002|breast cancer|breast cancer
5423839|NCT01614002|non-small cell lung cancer|non-small cell lung cancer
5423840|NCT01614002|prostata cancer|prostata cancer
5423841|NCT01614002|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5423842|NCT01614002|squamous cell carcinoma of the head and neck region|squamous cell carcinoma of the head and neck region
5423843|NCT01614002|ambulant chemotherapy|ambulant chemotherapy
5423844|NCT01614002|treatment cycles|treatment cycles
5423845|NCT01614002|Docetaxel|docetaxel
5424344|NCT01611402|IRIS|iris
5423846|NCT01614002|Doce onkovis|doce onkovis
5423847|NCT01614002|Quantity of Docetaxel|quantity of docetaxel
5423848|NCT01614002|Packaging Sizes|packaging sizes
5423849|NCT01613989|Hip arthroplasty|hip arthroplasty
5423850|NCT01613989|navigation|navigation
5423851|NCT01613976|Myelodysplastic Syndromes|myelodysplastic syndromes
5423852|NCT01613976|MDS|mds
5423853|NCT01613976|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5423854|NCT01613976|CMML|cmml
5406604|NCT01692626|Pimecrolimus|pimecrolimus
5423855|NCT01613976|Acute Myeloid Leukemia|acute myeloid leukemia
5423856|NCT01613976|AML|aml
5423857|NCT01613976|Panobinostat|panobinostat
5423858|NCT01613976|LBH589|lbh589
5423859|NCT01613976|5-Aza|5-aza
5423860|NCT01613976|Azacitidine|azacitidine
5423861|NCT01613963|Uveitis|uveitis
5423862|NCT01613963|Scleritis|scleritis
5423863|NCT01613950|gastric cancer advanced gastric or metastatic gastric cancer PI3K PIK3CA mutation Her2 amplification HSP90 inhibitor PI3K inhibitor PIK3CA amplification|gastric cancer advanced gastric or metastatic gastric cancer pi3k pik3ca mutation her2 amplification hsp90 inhibitor pi3k inhibitor pik3ca amplification
5423864|NCT01613937|Latinas|latinas
5423866|NCT01613937|Prevention|prevention
5423867|NCT01613911|Epilepsy|epilepsy
5423868|NCT01613911|Invasive monitoring|invasive monitoring
5423869|NCT01613911|Human sensory perception|human sensory perception
5423870|NCT01613898|Cerebrotendinous xanthomatosis (CTX),|cerebrotendinous xanthomatosis (ctx),
5423871|NCT01613898|lipoprotein,atherosclerosis,|lipoprotein,atherosclerosis,
5423872|NCT01613898|carotid artery intima-media thickness (cIMT).|carotid artery intima-media thickness (cimt).
5423873|NCT01613833|Alpha2 macroglobulin|alpha2 macroglobulin
5423874|NCT01613833|Osteoarthritis|osteoarthritis
5423875|NCT01613833|plasma and synovium|plasma and synovium
5423876|NCT01613807|gestational diabetes mellitus|gestational diabetes mellitus
5423877|NCT01613807|insulin analogues in pregnancy|insulin analogues in pregnancy
5423878|NCT01613794|Deep vein thrombosis|deep vein thrombosis
5423879|NCT01613794|Pulmonary embolism|pulmonary embolism
5423880|NCT01613794|Rosuvastatin treatment|rosuvastatin treatment
5423881|NCT01613794|Pharmacologic actions|pharmacologic actions
5423882|NCT01613781|hemifacial spasm|hemifacial spasm
5423883|NCT01613781|microvascular decompression|microvascular decompression
5423884|NCT01613781|neuromuscular blockade|neuromuscular blockade
5423885|NCT01613781|electromyography|electromyography
5423886|NCT01613755|Effect Dipyridamole on pharmacokinetics of metformin|effect dipyridamole on pharmacokinetics of metformin
5423887|NCT01613729|Dyslipidemia|dyslipidemia
5423888|NCT01613729|Rosuvastatin|rosuvastatin
5423889|NCT01613729|Efficacy|efficacy
5423890|NCT01613729|Safety|safety
5423891|NCT01613716|Diabetes|diabetes
5423892|NCT01613716|Macular Edema|macular edema
5423893|NCT01613716|Epiretinal Membrane|epiretinal membrane
5423894|NCT01613716|Vitrectomy|vitrectomy
5423895|NCT01613703|ONO-2952|ono-2952
5423896|NCT01613703|Healthy adult subjects|healthy adult subjects
5423897|NCT01613703|single doe|single doe
5423898|NCT01613703|PET study|pet study
5423899|NCT01613703|Safety|safety
5423900|NCT01613703|Tolerability|tolerability
5423901|NCT01613690|Renal impairment|renal impairment
5423902|NCT01613690|NVA237|nva237
5423903|NCT01613690|Pharmacokinetics|pharmacokinetics
5423904|NCT01613677|advanced cervical cancer, BKM 120, progression free survival|advanced cervical cancer, bkm 120, progression free survival
5423905|NCT01613664|obesity|obesity
5423906|NCT01613664|surgical management|surgical management
5423907|NCT01613664|sleeve gastrectomy|sleeve gastrectomy
5423908|NCT01613638|congenital malformation|congenital malformation
5423909|NCT01613638|pollutants|pollutants
5423911|NCT01613586|Painful Bladder Syndrome|painful bladder syndrome
5423912|NCT01613586|Interstitial Cystitis|interstitial cystitis
5423913|NCT01613586|Bladder Pain Syndrome|bladder pain syndrome
5423914|NCT01613573|pegylated Somatropin|pegylated somatropin
5423915|NCT01613573|PEG-GH|peg-gh
5423916|NCT01613573|Phase 1 study|phase 1 study
5423917|NCT01613573|Pharmacokinetics|pharmacokinetics
5423918|NCT01613534|chronic radiation proctopathy|chronic radiation proctopathy
5423919|NCT01613534|argon plasma coagulation|argon plasma coagulation
5423920|NCT01613534|sucralfate|sucralfate
5423921|NCT01613521|DCE-MRI|dce-mri
5423922|NCT01613521|18F-FMISO PET|18f-fmiso pet
5423923|NCT01613521|11-174|11-174
5423924|NCT01613495|obesity|obesity
5423925|NCT01613469|fluorouracil|fluorouracil
5423926|NCT01613469|leucovorin|leucovorin
5423927|NCT01613469|radiotherapy|radiotherapy
5423928|NCT01613469|neoadjuvant therapy|neoadjuvant therapy
5423929|NCT01613443|Dabigatran, Rivaroxaban, Point of Care-testing|dabigatran, rivaroxaban, point of care-testing
5423930|NCT01613417|Have confirmed or are highly suspected of brain disease|have confirmed or are highly suspected of brain disease
5423931|NCT01613404|Chronic kidney disease|chronic kidney disease
5423932|NCT01613404|Hemodialysis|hemodialysis
5423933|NCT01613404|Eprex|eprex
5423934|NCT01613404|Aranesp|aranesp
5423935|NCT01613404|ESA|esa
5423936|NCT01613404|Anemia|anemia
5423937|NCT01613391|Visfatin|visfatin
5423938|NCT01613391|Resistin|resistin
5423939|NCT01613391|Apelin|apelin
5423940|NCT01613391|roux-en-y gastric bypass|roux-en-y gastric bypass
5424445|NCT01610960|Helmet|helmet
5423941|NCT01613391|laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
5423942|NCT01613391|morbid obesity|morbid obesity
5423943|NCT01613352|Early breast cancer surgery|early breast cancer surgery
5423944|NCT01613352|Psychosocial wellbeing|psychosocial wellbeing
5423945|NCT01613352|Ambulatory surgery|ambulatory surgery
5423946|NCT01613339|stroke|stroke
5423947|NCT01613339|postural control|postural control
5423948|NCT01613339|body awareness therapy|body awareness therapy
5423949|NCT01613326|COPD|copd
5423950|NCT01613313|Lipoma|lipoma
5423951|NCT01613313|Fatty Tumor|fatty tumor
5423952|NCT01613300|hodgkin|hodgkin
5423953|NCT01613300|disease|disease
5423954|NCT01613300|ofatumumab|ofatumumab
5423955|NCT01613287|Pulmonary Hypertension|pulmonary hypertension
5423956|NCT01613287|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5423957|NCT01613287|TheraSorb|therasorb
5423958|NCT01613287|immunoadsorption|immunoadsorption
5423959|NCT01613274|colon resection|colon resection
5423960|NCT01613261|TAK-733,|tak-733,
5423961|NCT01613261|alisertib,|alisertib,
5423962|NCT01613261|MLN8237,|mln8237,
5423963|NCT01613261|Oral MEK Inhibitor,|oral mek inhibitor,
5423964|NCT01613261|Oral Aurora A Kinase Inhibitor|oral aurora a kinase inhibitor
5423965|NCT01613235|subarachnoid hemorrhage|subarachnoid hemorrhage
5423966|NCT01613235|ischemia|ischemia
5423967|NCT01613235|vasospasm|vasospasm
5423968|NCT01613235|CT|ct
5423969|NCT01613235|perfusion|perfusion
5423970|NCT01613235|induced hypertension|induced hypertension
5423971|NCT01613235|delayed cerebral ischemia|delayed cerebral ischemia
5423972|NCT01613209|Hypertension|hypertension
5423973|NCT01613209|ABPM|abpm
5423974|NCT01613209|office blood pressure|office blood pressure
5423975|NCT01613209|olmesartan|olmesartan
5423976|NCT01613209|amlodipine|amlodipine
5423977|NCT01613209|fixed combination|fixed combination
5423978|NCT01613209|time of intake|time of intake
5423979|NCT01613196|Extrapulmonary tuberculosis|extrapulmonary tuberculosis
5423980|NCT01613196|FDG-TEP|fdg-tep
5423981|NCT01613196|cohorts|cohorts
5423982|NCT01613170|Overactive Bladder|overactive bladder
5423983|NCT01613170|Vaginal Estrogen|vaginal estrogen
5423984|NCT01613170|Anticholinergics|anticholinergics
5423985|NCT01613170|Antimuscarinics|antimuscarinics
5423986|NCT01613157|pharmacokinetics|pharmacokinetics
5423987|NCT01613157|HIV infected women|hiv infected women
5423988|NCT01613118|Primary FSGS|primary fsgs
5423989|NCT01613118|Nephrotic syndrome|nephrotic syndrome
5423990|NCT01613118|Steroid Resistant|steroid resistant
5423991|NCT01613105|Diabetes Mellitus|diabetes mellitus
5423992|NCT01613105|Type-2|type-2
5423993|NCT01613105|Acarbose|acarbose
5423994|NCT01613105|Drug Therapy|drug therapy
5423995|NCT01613105|Combination|combination
5423996|NCT01613092|Arrhythmia|arrhythmia
5423997|NCT01613092|Device Procedure|device procedure
5423998|NCT01613092|High risk patients|high risk patients
5423999|NCT01613092|Antibiotics|antibiotics
5424000|NCT01613092|Infection|infection
5424001|NCT01613092|Cluster|cluster
5424002|NCT01613079|Rheumatoid Arthritis|rheumatoid arthritis
5424003|NCT01613079|Methotrexate|methotrexate
5424004|NCT01613079|Tripterygium|tripterygium
5424005|NCT01613066|Haematological malignancies|haematological malignancies
5424006|NCT01613066|Allogeneic Cord Blood transplantation|allogeneic cord blood transplantation
5424007|NCT01613066|Intrabone|intrabone
5424008|NCT01613053|Gastrointestinal Stromal Tumor, GIST|gastrointestinal stromal tumor, gist
5424009|NCT01613014|Alcohol|alcohol
5424010|NCT01613014|Alcohol Dependence|alcohol dependence
5396301|NCT01738555|amdoxovir|amdoxovir
5410975|NCT01673360|POP|pop
5424011|NCT01613014|Alcohol Abuse|alcohol abuse
5424012|NCT01613014|Alcohol Use Disorders|alcohol use disorders
5424013|NCT01613014|Alcoholism|alcoholism
5424014|NCT01612988|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5424015|NCT01612988|relapse|relapse
5424016|NCT01612988|Bendamustine|bendamustine
5424017|NCT01612988|Ofatumumab|ofatumumab
5424018|NCT01612988|Méthylprednisolone|méthylprednisolone
5424019|NCT01612975|Chest tubes|chest tubes
5424020|NCT01612975|Length of stay|length of stay
5424021|NCT01612975|Pleural effusion|pleural effusion
5424022|NCT01612975|Lung resection|lung resection
5424023|NCT01612975|Post-operative|post-operative
5424024|NCT01612975|Lung cancer|lung cancer
5424025|NCT01612949|endotracheal intubation|endotracheal intubation
5424026|NCT01612949|facial structure|facial structure
5424027|NCT01612949|Mallampati score|mallampati score
5424028|NCT01612949|computerized facial analysis|computerized facial analysis
5424030|NCT01612936|Allergic|allergic
5424031|NCT01612936|Inflammation|inflammation
5424032|NCT01612936|Constriction|constriction
5424033|NCT01612936|Airway|airway
5424034|NCT01612936|Challenge|challenge
5424035|NCT01612936|Chemokines|chemokines
5424036|NCT01612923|abortion|abortion
5424037|NCT01612923|medical abortion|medical abortion
5424038|NCT01612910|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5424039|NCT01612910|HER2-negative breast cancer|her2-negative breast cancer
5424040|NCT01612910|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5424041|NCT01612910|recurrent breast cancer|recurrent breast cancer
5424042|NCT01612910|stage II breast cancer|stage ii breast cancer
5424043|NCT01612910|stage IIIA breast cancer|stage iiia breast cancer
5424044|NCT01612910|stage IIIB breast cancer|stage iiib breast cancer
5424045|NCT01612910|stage IIIC breast cancer|stage iiic breast cancer
5424046|NCT01612910|triple-negative breast cancer|triple-negative breast cancer
5424047|NCT01612897|autism|autism
5424048|NCT01612897|well child care|well child care
5424049|NCT01612897|screening|screening
5424050|NCT01612897|computer|computer
5424051|NCT01612897|reminders|reminders
5424052|NCT01612871|Breast cancer,|breast cancer,
5424053|NCT01612871|hormonotherapy,|hormonotherapy,
5424054|NCT01612871|miRNAs,|mirnas,
5424055|NCT01612871|biomarkers|biomarkers
5424056|NCT01612871|hormone therapy|hormone therapy
5424057|NCT01612858|Lipodystrophy|lipodystrophy
5424058|NCT01612858|Insulin resistance|insulin resistance
5424059|NCT01612858|HIV infection|hiv infection
5424060|NCT01612845|rotator cuff|rotator cuff
5424061|NCT01612845|shoulder|shoulder
5424062|NCT01612845|platelet rich plasma|platelet rich plasma
5424063|NCT01612845|fibrin|fibrin
5424064|NCT01612793|COPD|copd
5424065|NCT01612780|Sinusitis|sinusitis
5424066|NCT01612780|Sinus balloon dilation patients|sinus balloon dilation patients
5424067|NCT01612767|de novo coronary lesions|de novo coronary lesions
5424068|NCT01612767|restenotic coronary lesions|restenotic coronary lesions
5424069|NCT01612767|coronary arteries|coronary arteries
5424070|NCT01612754|Reduction of noise pollution|reduction of noise pollution
5424071|NCT01612754|Specifically enforced workplace rules|specifically enforced workplace rules
5424072|NCT01612754|Stress|stress
5424073|NCT01612754|Sound Ears (TM)|sound ears (tm)
5424074|NCT01612754|Error|error
5424075|NCT01612741|Diabetes Mellitus, Type-2|diabetes mellitus, type-2
5424076|NCT01612741|Acarbose|acarbose
5424077|NCT01612741|Drug Therapy|drug therapy
5424078|NCT01612741|Combination|combination
5424079|NCT01612728|Aromatase Inhibitors|aromatase inhibitors
5424080|NCT01612715|Asthma, allergen challenge, T cells, Fel d 1.|asthma, allergen challenge, t cells, fel d 1.
5424081|NCT01612702|postoperative nausea and vomiting|postoperative nausea and vomiting
5424082|NCT01612702|postoperative pain|postoperative pain
5424083|NCT01612689|Accelerometer|accelerometer
5424085|NCT01612689|Ambulatory|ambulatory
5424086|NCT01612689|ECG|ecg
5424087|NCT01612689|Heart rate|heart rate
5424088|NCT01612663|Knee pain|knee pain
5424089|NCT01612663|Acupuncture|acupuncture
5424090|NCT01612663|Sham acupuncture|sham acupuncture
5424091|NCT01612650|breast cancer|breast cancer
5424092|NCT01612650|surveillance|surveillance
5424093|NCT01612650|diagnosis|diagnosis
5424094|NCT01612650|2D mammography|2d mammography
5424095|NCT01612650|3D mammography|3d mammography
5424096|NCT01612637|Pelvic organ prolapse|pelvic organ prolapse
5424097|NCT01612637|Pelvic floor muscle training|pelvic floor muscle training
5424098|NCT01612637|Prolapse symptoms|prolapse symptoms
5424099|NCT01612637|Pelvic organ prolapse quantification system|pelvic organ prolapse quantification system
5424100|NCT01612637|Ultrasonography|ultrasonography
5424101|NCT01612637|Predictors|predictors
5424102|NCT01612520|type 2 Diabetes Mellitus|type 2 diabetes mellitus
5424103|NCT01612520|telenursing|telenursing
5424104|NCT01612520|RCT|rct
5424105|NCT01612520|economic analysis|economic analysis
5424106|NCT01612507|Phase 1|phase 1
5424107|NCT01612507|healthy volunteers|healthy volunteers
5424108|NCT01612507|Parallel Group Study|parallel group study
5424109|NCT01612507|ceftaroline fosamil different doses|ceftaroline fosamil different doses
5424110|NCT01612507|safety|safety
5424111|NCT01612507|Cmax|cmax
5424112|NCT01612507|tmax|tmax
5424113|NCT01612507|AUC|auc
5424114|NCT01612481|soft tissue sarcoma|soft tissue sarcoma
5424115|NCT01612481|lung metastasis|lung metastasis
5424116|NCT01612481|surveillance|surveillance
5424117|NCT01612468|Diabetes|diabetes
5424118|NCT01612468|Liraglutide|liraglutide
5424119|NCT01612468|Hypoglycaemia|hypoglycaemia
5424120|NCT01612468|Hyperglycaemia|hyperglycaemia
5424121|NCT01612468|CIMT|cimt
5424122|NCT01612468|PWV|pwv
5424123|NCT01612468|Food preference|food preference
5424124|NCT01612468|Blood pressure|blood pressure
5424125|NCT01612455|HIV|hiv
5424126|NCT01612455|drug addiction|drug addiction
5424127|NCT01612455|Russia|russia
5424128|NCT01612455|case management|case management
5424129|NCT01612442|complementary feeding|complementary feeding
5424130|NCT01612442|mothers|mothers
5424131|NCT01612442|6-24 months children|6-24 months children
5424132|NCT01612442|community health volunteers|community health volunteers
5424133|NCT01612442|nutrition education|nutrition education
5424134|NCT01612442|agricultural education|agricultural education
5424135|NCT01612429|Carbamylation|carbamylation
5424136|NCT01612429|Albumin|albumin
5424137|NCT01612429|Protein structure|protein structure
5424138|NCT01612429|Kidney disease|kidney disease
5424139|NCT01612416|Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma|ganglion cell complex, retinal nerve fiber layer,glaucoma
5424140|NCT01612403|zinc binding protein|zinc binding protein
5424141|NCT01612390|postpartum hemorrhage|postpartum hemorrhage
5424142|NCT01612377|Moderate to Severe|moderate to severe
5424143|NCT01612364|CRPS I|crps i
5424144|NCT01612351|Head and neck cancer|head and neck cancer
5424145|NCT01612351|Squamous Cell Carcinoma|squamous cell carcinoma
5424146|NCT01612351|Phase II|phase ii
5424147|NCT01612351|Transoral Surgery|transoral surgery
5406906|NCT01691378|Suicide|suicide
5424148|NCT01612351|Induction Chemotherapy|induction chemotherapy
5424149|NCT01612351|Carboplatin|carboplatin
5424150|NCT01612351|Paclitaxel|paclitaxel
5424151|NCT01612351|Lapatinib|lapatinib
5424152|NCT01612338|breast cancer|breast cancer
5424153|NCT01612338|young age of onset|young age of onset
5424154|NCT01612338|family history|family history
5424155|NCT01612338|screening interventions|screening interventions
5424156|NCT01612338|family support|family support
5424157|NCT01612325|liver tumors|liver tumors
5424158|NCT01612312|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5424159|NCT01612312|thrombectomy|thrombectomy
5424160|NCT01612312|magnetic resonance imaging|magnetic resonance imaging
5424161|NCT01612312|microvascular obstruction|microvascular obstruction
5424162|NCT01612286|Recombinant human endostatin|recombinant human endostatin
5424163|NCT01612286|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5424164|NCT01612286|chemotherapy|chemotherapy
5424165|NCT01612273|Vasospastic syndrome|vasospastic syndrome
5424166|NCT01612273|Vascular dysregulation|vascular dysregulation
5424167|NCT01612260|heart failure|heart failure
5424168|NCT01612260|ventricular premature complex|ventricular premature complex
5424169|NCT01612260|Shensong Yangxin capsule|shensong yangxin capsule
5424170|NCT01612247|Breast Cancer|breast cancer
5424171|NCT01612247|Neoadjuvant therapy|neoadjuvant therapy
5424172|NCT01612234|humans|humans
5424173|NCT01612234|lean|lean
5424174|NCT01612234|obese|obese
5424175|NCT01612234|saturated fat|saturated fat
5424176|NCT01612234|monounsaturated fat|monounsaturated fat
5424177|NCT01612234|insulin sensitivity|insulin sensitivity
5424178|NCT01612234|inflammation|inflammation
5424179|NCT01612234|oxidant stress|oxidant stress
5424180|NCT01612195|anal fistula|anal fistula
5424181|NCT01612195|anal continence|anal continence
5424182|NCT01612195|health-related quality of life|health-related quality of life
5424183|NCT01612182|end-stage renal disease|end-stage renal disease
5424184|NCT01612182|renal replacement therapy|renal replacement therapy
5424185|NCT01612169|HIV patients|hiv patients
5424186|NCT01612169|Hospitalized patients|hospitalized patients
5424187|NCT01612169|Substance Users|substance users
5424188|NCT01612169|Drug Users|drug users
5424189|NCT01612156|Urodynamic testing|urodynamic testing
5424190|NCT01612156|pelvic floor examination|pelvic floor examination
5424191|NCT01612156|Lidocaine gel|lidocaine gel
5424192|NCT01612156|Surgical lubricant|surgical lubricant
5424193|NCT01612156|Pain|pain
5424194|NCT01612156|Embarrassment|embarrassment
5424195|NCT01612117|renal failure|renal failure
5424196|NCT01612117|cardiology|cardiology
5424197|NCT01612117|contrast-induced nephropathy|contrast-induced nephropathy
5424198|NCT01612104|Post Traumatic Stress Disorder|post traumatic stress disorder
5424199|NCT01612104|Anxiety symptoms|anxiety symptoms
5424200|NCT01612104|Depressive symptoms|depressive symptoms
5424201|NCT01612104|Externalizing behavior|externalizing behavior
5424202|NCT01612104|Reduced quality of life|reduced quality of life
5424203|NCT01612091|Expert System|expert system
5424204|NCT01612091|Intensive Care|intensive care
5544801|NCT01107951|ITP|itp
5424205|NCT01612091|Telemedicine|telemedicine
5411147|NCT01672762|hypoglycemic agents|hypoglycemic agents
5424206|NCT01612091|Equipment Design|equipment design
5424207|NCT01612065|Office hysteroscopy|office hysteroscopy
5424208|NCT01612065|Cervical priming|cervical priming
5424209|NCT01612065|Misoprostol|misoprostol
5424210|NCT01612052|Vascular Surgery|vascular surgery
5424211|NCT01612039|ulcerative colitis|ulcerative colitis
5424212|NCT01612013|N-acetylcysteine|n-acetylcysteine
5424213|NCT01612013|angiography|angiography
5424214|NCT01612013|contrast medium|contrast medium
5563125|NCT01034709|CMV|cmv
5424215|NCT01612013|contrast-induced nephropathy|contrast-induced nephropathy
5424216|NCT01612013|sodium bicarbonate|sodium bicarbonate
5424217|NCT01612000|Influenza|influenza
5424218|NCT01611974|transplant|transplant
5424219|NCT01611974|treatment|treatment
5424220|NCT01611974|resistant|resistant
5424221|NCT01611974|CMV|cmv
5424222|NCT01611974|refractory|refractory
5424223|NCT01611974|cytomegalovirus|cytomegalovirus
5424224|NCT01611961|Docetaxel|docetaxel
5424225|NCT01611961|Lipid Microsphere|lipid microsphere
5424226|NCT01611961|Neoplasms|neoplasms
5424227|NCT01611961|Antineoplastic Agents|antineoplastic agents
5424228|NCT01611961|Pharmacologic Actions|pharmacologic actions
5424229|NCT01611961|Therapeutic Uses|therapeutic uses
5424230|NCT01611935|trauma|trauma
5424231|NCT01611935|shock|shock
5424232|NCT01611935|vasopressin|vasopressin
5424233|NCT01611935|blood transfusion|blood transfusion
5424234|NCT01611922|eye|eye
5424235|NCT01611922|eyelid|eyelid
5424236|NCT01611922|contact lenses|contact lenses
5424237|NCT01611922|dry eye disease|dry eye disease
5424238|NCT01611909|p-menthane-3,8-diol oil extract|p-menthane-3,8-diol oil extract
5424239|NCT01611909|topical therapy|topical therapy
5424240|NCT01611896|Graves' hyperthyroidism|graves' hyperthyroidism
5424241|NCT01611896|Graves' disease|graves' disease
5424242|NCT01611896|Selenium|selenium
5424243|NCT01611896|Quality of Life|quality of life
5424244|NCT01611896|ThyPRO|thypro
5424245|NCT01611896|Autoimmunity|autoimmunity
5424246|NCT01611857|Advanced solid tumors|advanced solid tumors
5424247|NCT01611857|First-Line Metastatic GE cancer|first-line metastatic ge cancer
5424248|NCT01611857|c-Met Inhibitor|c-met inhibitor
5424249|NCT01611857|Tivantinib|tivantinib
5424250|NCT01611857|FOLFOX|folfox
5424251|NCT01611844|delayed-type hypersensitivity reaction to tuberculin intradermal injection|delayed-type hypersensitivity reaction to tuberculin intradermal injection
5424252|NCT01611844|tuberculosis skin test|tuberculosis skin test
5424253|NCT01611844|BD micro-needle|bd micro-needle
5424254|NCT01611844|medical device|medical device
5424255|NCT01611844|spectroscopy|spectroscopy
5424256|NCT01611831|fibromyalgia|fibromyalgia
5424257|NCT01611831|Acceptation & Commitment Therapy|acceptation & commitment therapy
5424258|NCT01611831|randomized controlled trial|randomized controlled trial
5424259|NCT01611818|Depression|depression
5424260|NCT01611818|Computer-delivered psychotherapy|computer-delivered psychotherapy
5424261|NCT01611818|Randomized-controlled trial|randomized-controlled trial
5424262|NCT01611792|Stabilization exercise|stabilization exercise
5424267|NCT01611779|tongue suspension|tongue suspension
5424268|NCT01611766|secondary cytoreductive surgery|secondary cytoreductive surgery
5424270|NCT01611766|surgery|surgery
5424271|NCT01611766|recurrence|recurrence
5424272|NCT01611753|Shock, Septic|shock, septic
5424273|NCT01611753|Erythrocyte Transfusion|erythrocyte transfusion
5424274|NCT01611753|Ischemia|ischemia
5424275|NCT01611740|Preterm infant|preterm infant
5424276|NCT01611740|Bacterial infection|bacterial infection
5424277|NCT01611740|Diagnosis of proven or suspected bacterial infection|diagnosis of proven or suspected bacterial infection
5424278|NCT01611727|BRCA1|brca1
5424279|NCT01611727|survival|survival
5424280|NCT01611727|metastatic disease|metastatic disease
5424281|NCT01611727|cisplatin|cisplatin
5424282|NCT01611714|Racial/ethnic disparities|racial/ethnic disparities
5424283|NCT01611714|Imaging|imaging
5424284|NCT01611714|Emergency|emergency
5424285|NCT01611714|Headache|headache
5424286|NCT01611675|Metastatic|metastatic
5424287|NCT01611675|Unresectable|unresectable
5424288|NCT01611675|Clearly progressive|clearly progressive
5424289|NCT01611675|BRAF mutation|braf mutation
5424290|NCT01611649|infant formula|infant formula
5424291|NCT01611649|dairy lipids|dairy lipids
5424292|NCT01611649|omega-3|omega-3
5424293|NCT01611636|allergy|allergy
5424294|NCT01611636|autoimmune diseases|autoimmune diseases
5424295|NCT01611636|rheumatic diseases|rheumatic diseases
5424296|NCT01611623|Solid tumor malignancy|solid tumor malignancy
5424297|NCT01611623|Hsp90|hsp90
5424300|NCT01611597|accelerometry|accelerometry
5424301|NCT01611597|neuromuscular disease|neuromuscular disease
5424302|NCT01611584|ALA|ala
5424303|NCT01611584|Florescence|florescence
5424304|NCT01611584|Lung cancer|lung cancer
5424305|NCT01611571|osteoporosis|osteoporosis
5424306|NCT01611571|male|male
5424307|NCT01611545|Pharmacogenomics|pharmacogenomics
5424308|NCT01611545|Pharmacogenetics|pharmacogenetics
5424309|NCT01611545|Clopidogrel|clopidogrel
5424310|NCT01611545|Plavix|plavix
5424311|NCT01611532|Acute pancreatitis|acute pancreatitis
5424312|NCT01611532|Intraabdominal pressure|intraabdominal pressure
5424313|NCT01611532|Critical illness|critical illness
5563225|NCT01034228|ORS|ors
5424314|NCT01611519|urinary bladder|urinary bladder
5424315|NCT01611519|urinary catheterization|urinary catheterization
5424316|NCT01611519|epidural analgesia|epidural analgesia
5424317|NCT01611519|catheters, indwelling|catheters, indwelling
5424318|NCT01611493|Dental Implants|dental implants
5424319|NCT01611493|Jaw, Edentulous, Partially/rehabilitation|jaw, edentulous, partially/rehabilitation
5424320|NCT01611493|Jaw, Edentulous, Partially/surgery|jaw, edentulous, partially/surgery
5424321|NCT01611493|randomised Clinical Trials|randomised clinical trials
5424322|NCT01611493|Humans|humans
5424323|NCT01611467|CC-223|cc-223
5424324|NCT01611467|safety|safety
5424325|NCT01611467|tolerability|tolerability
5424326|NCT01611467|pharmacokinetic|pharmacokinetic
5424327|NCT01611467|AME (Absorption, Metabolism, and Excretion)|ame (absorption, metabolism, and excretion)
5424328|NCT01611467|FE (Food Effect)|fe (food effect)
5424329|NCT01611454|Occupational Exposure to Radiation|occupational exposure to radiation
5424330|NCT01611441|Osteoarthritis of the knee|osteoarthritis of the knee
5424331|NCT01611441|Biomarkers|biomarkers
5424332|NCT01611428|Ipragliflozin|ipragliflozin
5424333|NCT01611428|Healthy|healthy
5424334|NCT01611428|Absolute Bioavailability|absolute bioavailability
5424335|NCT01611428|Pharmacokinetics|pharmacokinetics
5424336|NCT01611415|Phase 1|phase 1
5424337|NCT01611415|Ipragliflozin|ipragliflozin
5424338|NCT01611415|Furosemide|furosemide
5424339|NCT01611415|Pharmacokinetics|pharmacokinetics
5424340|NCT01611415|Pharmacodynamics|pharmacodynamics
5424341|NCT01611402|Tuberculosis|tuberculosis
5424342|NCT01611402|HIV Infection|hiv infection
5424343|NCT01611402|Transcriptional Signature|transcriptional signature
5424345|NCT01611376|impedance cardiography|impedance cardiography
5424346|NCT01611376|Flotrac/Vigileo|flotrac/vigileo
5424347|NCT01611376|cardiac output|cardiac output
5424348|NCT01611363|Ipragliflozin|ipragliflozin
5424349|NCT01611363|Phase 1|phase 1
5424350|NCT01611363|Healthy|healthy
5424351|NCT01611363|Diabetes Mellitus|diabetes mellitus
5424352|NCT01611363|Pharmacokinetics|pharmacokinetics
5424353|NCT01611363|Pharmacodynamics|pharmacodynamics
5424357|NCT01611337|schizophrenia, insight|schizophrenia, insight
5424358|NCT01611324|Varicose Veins|varicose veins
5424359|NCT01611324|Phlebectomy|phlebectomy
5424360|NCT01611324|Local Anesthesia|local anesthesia
5424361|NCT01611298|allogeneic stem cell transplant|allogeneic stem cell transplant
5424362|NCT01611298|malignant diseases|malignant diseases
5424363|NCT01611298|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5424364|NCT01611298|acute myelogenous leukemia|acute myelogenous leukemia
5424365|NCT01611298|Chronic myelogenous leukemia|chronic myelogenous leukemia
5424366|NCT01611298|myelodysplastic syndrome|myelodysplastic syndrome
5424367|NCT01611298|Hodgkin lymphoma|hodgkin lymphoma
5424368|NCT01611298|non-Hodgkin lymphoma|non-hodgkin lymphoma
5424369|NCT01611298|myeloproliferative disorder|myeloproliferative disorder
5424370|NCT01611298|non-malignant disease|non-malignant disease
5424371|NCT01611285|UPHOLD|uphold
5424372|NCT01611285|robotic surgery|robotic surgery
5424373|NCT01611285|decision analysis|decision analysis
5424374|NCT01611285|FDA|fda
5424375|NCT01611285|decision node|decision node
5424376|NCT01611285|outcome node|outcome node
5424377|NCT01611272|Unstable angina|unstable angina
5424378|NCT01611259|MALT Lymphoma|malt lymphoma
5424379|NCT01611259|Lenalidomide|lenalidomide
5424380|NCT01611259|Rituximab|rituximab
5424381|NCT01611259|AGMT|agmt
5424382|NCT01611233|metal on metal|metal on metal
5424383|NCT01611233|hip replacement|hip replacement
5424384|NCT01611233|ASR|asr
5424385|NCT01611233|DePuy|depuy
5424386|NCT01611220|Anorexia Nervosa|anorexia nervosa
5424387|NCT01611220|Relapse prevention|relapse prevention
5424388|NCT01611220|Cognitive Dissonance|cognitive dissonance
5424389|NCT01611220|Inpatient treatment|inpatient treatment
5424390|NCT01611220|Cognitive behavior therapy|cognitive behavior therapy
5424391|NCT01611207|wound healing impairments,|wound healing impairments,
5424392|NCT01611207|negative pressure wound therapy,|negative pressure wound therapy,
5424393|NCT01611207|health services research,|health services research,
5424394|NCT01611207|germany|germany
5424395|NCT01611194|HBO2|hbo2
5424396|NCT01611194|HBOT|hbot
5424397|NCT01611194|mTBI|mtbi
5424398|NCT01611194|Brain injury|brain injury
5424399|NCT01611194|PCS|pcs
5424402|NCT01611181|Iron supplementation|iron supplementation
5424403|NCT01611181|Iron deficiency|iron deficiency
5424404|NCT01611181|Hip arthroplasty|hip arthroplasty
5424405|NCT01611181|Knee arthroplasty|knee arthroplasty
5424406|NCT01611142|Monoclonal antibody|monoclonal antibody
5424407|NCT01611142|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5424408|NCT01611142|cancer|cancer
5680259|NCT00578461|Cancer|cancer
5424409|NCT01611142|hematologic malignancy|hematologic malignancy
5424410|NCT01611129|Disability Evaluation|disability evaluation
5424411|NCT01611103|Cognitive Enhancement|cognitive enhancement
5424412|NCT01611103|tDCS|tdcs
5424413|NCT01611103|stimulation|stimulation
5424414|NCT01611103|elderly|elderly
5424415|NCT01611103|older adults|older adults
5424416|NCT01611090|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5424417|NCT01611090|Small lymphocytic lymphoma|small lymphocytic lymphoma
5424418|NCT01611090|Relapsed or refractory chronic lymphocytic leukemia|relapsed or refractory chronic lymphocytic leukemia
5424419|NCT01611090|Relapsed or refractory small lymphocytic lymphoma|relapsed or refractory small lymphocytic lymphoma
5424420|NCT01611090|Ibrutinib|ibrutinib
5424421|NCT01611090|PCI-32765|pci-32765
5424422|NCT01611090|JNJ-54179060|jnj-54179060
5424423|NCT01611090|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5424424|NCT01611090|Bendamustine|bendamustine
5424425|NCT01611090|Rituximab|rituximab
5424426|NCT01611064|Hand|hand
5424427|NCT01611064|Surgery|surgery
5424428|NCT01611064|Tourniquet|tourniquet
5424429|NCT01611064|Pain|pain
5424430|NCT01611064|Oxygen|oxygen
5424431|NCT01611051|breast cancer|breast cancer
5424432|NCT01611051|neutropenia|neutropenia
5424433|NCT01611051|febrile neutropenia|febrile neutropenia
5424434|NCT01611012|Asthma|asthma
5424435|NCT01611012|Inflammation|inflammation
5424436|NCT01611012|Phenotype|phenotype
5424437|NCT01611012|Sputum|sputum
5424438|NCT01610986|Fructose|fructose
5424439|NCT01610986|Exercise|exercise
5424440|NCT01610986|Lactic acid|lactic acid
5424441|NCT01610986|Monocarboxylic Acid Transporters|monocarboxylic acid transporters
5424442|NCT01610973|Fuch's dystrophy|fuch's dystrophy
5424443|NCT01610973|Corneal graft|corneal graft
5424444|NCT01610960|Non invasive ventilation|non invasive ventilation
5424451|NCT01610947|Adalimumab|adalimumab
5424452|NCT01610947|Etanercept|etanercept
5424453|NCT01610947|Infliximab|infliximab
5424455|NCT01610934|Monogenic diabetes|monogenic diabetes
5424456|NCT01610934|Non-autoimmune diabetes|non-autoimmune diabetes
5424457|NCT01610934|MODY3|mody3
5424458|NCT01610921|asthma|asthma
5424459|NCT01610921|small airways disease|small airways disease
5424460|NCT01610921|inflammation|inflammation
5424461|NCT01610921|provocation|provocation
5424462|NCT01610921|adenosine|adenosine
5424469|NCT01610895|Colonoscopy|colonoscopy
5424470|NCT01610895|low fibre diet|low fibre diet
5424471|NCT01610895|clear fluids|clear fluids
5424472|NCT01610895|Bowel Preparation|bowel preparation
5424473|NCT01610869|Recurrence|recurrence
5424474|NCT01610869|Ovarian Neoplasms|ovarian neoplasms
5424475|NCT01610869|Ovarian Diseases|ovarian diseases
5424476|NCT01610869|Fallopian Tube Neoplasms|fallopian tube neoplasms
5424477|NCT01610869|Neoplasms|neoplasms
5424478|NCT01610869|Carcinoma|carcinoma
5424479|NCT01610869|Neoplasms by site|neoplasms by site
5424480|NCT01610856|bowel preparation|bowel preparation
5424481|NCT01610856|bowel purgative|bowel purgative
5424482|NCT01610856|bowel cleansing|bowel cleansing
5424483|NCT01610856|colonoscopy|colonoscopy
5424484|NCT01610843|Sarcoidosis|sarcoidosis
5424485|NCT01610843|WISE|wise
5424486|NCT01610843|Sarcoid Study|sarcoid study
5424487|NCT01610843|Worldwide Sarcoidosis Research Study|worldwide sarcoidosis research study
5424488|NCT01610830|Purpura, Schoenlein-Henoch|purpura, schoenlein-henoch
5424489|NCT01610830|adults|adults
5424490|NCT01610830|children|children
5424491|NCT01610830|pronostic factors|pronostic factors
5424492|NCT01610817|Patient information and active participation|patient information and active participation
5424493|NCT01610817|Patient safety|patient safety
5424494|NCT01610817|Health education|health education
5424495|NCT01610817|Adverse drug event|adverse drug event
5424496|NCT01610817|Primary care|primary care
5424497|NCT01610817|Antihypertensive drugs|antihypertensive drugs
5424499|NCT01610765|pharmacokinetics|pharmacokinetics
5424500|NCT01610765|herpes|herpes
5424501|NCT01610765|neonates|neonates
5424502|NCT01610752|Pregnancy|pregnancy
5424503|NCT01610752|Gestational weight gain|gestational weight gain
5424504|NCT01610726|colon|colon
5424505|NCT01610726|rectum|rectum
5424506|NCT01610726|recovery|recovery
5424507|NCT01610726|surgery|surgery
5424508|NCT01610674|Diabetes mellitus|diabetes mellitus
5424509|NCT01610674|Surgery|surgery
5424510|NCT01610674|Implementation|implementation
5424511|NCT01610674|Quality of care|quality of care
5424512|NCT01610674|Quality indicators|quality indicators
5424513|NCT01610661|carbohydrate|carbohydrate
5424514|NCT01610661|inflammation|inflammation
5424516|NCT01610661|gene expression|gene expression
5424517|NCT01610648|OSA|osa
5424518|NCT01610648|metabolic syndrome|metabolic syndrome
5424519|NCT01610648|Apnea-hypopnea index|apnea-hypopnea index
5424520|NCT01610648|Oxygen desaturation index|oxygen desaturation index
5424521|NCT01610635|RCT|rct
5680260|NCT00578461|Lymphoma|lymphoma
5424522|NCT01610635|blood donation frequency|blood donation frequency
5424523|NCT01610635|quality of life|quality of life
5424524|NCT01610635|iron deficiency|iron deficiency
5424525|NCT01610622|Cardiac Output|cardiac output
5424526|NCT01610622|Blood volumes|blood volumes
5424527|NCT01610622|Neonates|neonates
5424528|NCT01610609|Statin treatment|statin treatment
5424529|NCT01610609|Cardiovascular disease|cardiovascular disease
5424530|NCT01610609|High cholesterol|high cholesterol
5424531|NCT01610609|Care management|care management
5424532|NCT01610596|Psoriasis|psoriasis
5424533|NCT01610596|Skin Diseases|skin diseases
5424534|NCT01610596|Halobetasol|halobetasol
5424535|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents
5424536|NCT01610596|Therapeutic Uses|therapeutic uses
5424537|NCT01610596|Pharmacologic Actions|pharmacologic actions
5424538|NCT01610596|Anti-Inflammatory Agents|anti-inflammatory agents
5424539|NCT01610596|Physiological Effects of Drugs|physiological effects of drugs
5424540|NCT01610583|Genetic Literacy|genetic literacy
5424542|NCT01610570|Dose Limiting Toxicity|dose limiting toxicity
5424543|NCT01610570|Maximum Tolerated Dose|maximum tolerated dose
5424544|NCT01610570|Radiographic Response|radiographic response
5424545|NCT01610570|Time to Progression|time to progression
5424546|NCT01610570|Bone Tumors|bone tumors
5424547|NCT01610557|Diabetic Macular Edema|diabetic macular edema
5424548|NCT01610557|Ranibizumab|ranibizumab
5424549|NCT01610557|Bevacizumab|bevacizumab
5424550|NCT01610544|Thymoma|thymoma
5424551|NCT01610544|Insulin Growth Factor|insulin growth factor
5424552|NCT01610544|Cell Proliferation|cell proliferation
5424553|NCT01610544|Non Small Cell Lung Cancer|non small cell lung cancer
5424554|NCT01610544|PET/CT Imaging Sessions|pet/ct imaging sessions
5424555|NCT01610531|Cohort|cohort
5424556|NCT01610531|Melanoma|melanoma
5424557|NCT01610531|targeted screening|targeted screening
5424558|NCT01610531|risks function|risks function
5424559|NCT01610531|cost effectiveness|cost effectiveness
5424560|NCT01610518|postprandial blood glucose|postprandial blood glucose
5424561|NCT01610518|dietary fiber|dietary fiber
5424562|NCT01610518|beta-glucan|beta-glucan
5424563|NCT01610492|IMGN|imgn
5424564|NCT01610492|anti-PLA2R antibodies|anti-pla2r antibodies
5424565|NCT01610492|pharmacokinetics|pharmacokinetics
5424566|NCT01610492|belimumab|belimumab
5424567|NCT01610492|Benlysta|benlysta
5424568|NCT01610492|Idiopathic Membranous Glomerulonephropathy|idiopathic membranous glomerulonephropathy
5424569|NCT01610492|safety|safety
5424570|NCT01610492|GSK1550188|gsk1550188
5424571|NCT01610492|Lymphostat-B|lymphostat-b
5424572|NCT01610492|membrane attack complex|membrane attack complex
5424573|NCT01610466|Education|education
5424574|NCT01610466|Simulation|simulation
5424575|NCT01610466|Technical skills training|technical skills training
5424576|NCT01610466|Laparoscopy|laparoscopy
5424577|NCT01610466|Bariatric Surgery|bariatric surgery
5424578|NCT01610453|prolonged labor|prolonged labor
5424579|NCT01610453|cesarean section|cesarean section
5424580|NCT01610453|duration of labor|duration of labor
5424581|NCT01610440|Duchenne muscular dystrophy|duchenne muscular dystrophy
5424582|NCT01610440|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5424583|NCT01610427|CMI|cmi
5424584|NCT01610427|HIV|hiv
5424585|NCT01610427|Antiretroviral therapy-naïve|antiretroviral therapy-naïve
5424586|NCT01610414|Observer-blind|observer-blind
5424587|NCT01610414|Efficacy|efficacy
5424588|NCT01610414|Immunogenicity|immunogenicity
5424589|NCT01610414|Vaccination|vaccination
5424590|NCT01610414|Safety|safety
5424591|NCT01610414|Adult autologous haematopoietic cell transplant recipients|adult autologous haematopoietic cell transplant recipients
5424592|NCT01610414|Herpes Zoster|herpes zoster
5424593|NCT01610388|healthy subjects|healthy subjects
5424594|NCT01610388|double-blind|double-blind
5424595|NCT01610388|FTIH|ftih
5424596|NCT01610388|dose-escalation|dose-escalation
5424597|NCT01610388|absolute bioavailability|absolute bioavailability
5424598|NCT01610388|GSK1322322|gsk1322322
5424599|NCT01610388|BAL|bal
5424600|NCT01610375|Endometrial cancer|endometrial cancer
5424601|NCT01610362|rabies|rabies
5424602|NCT01610362|immunoglobulin|immunoglobulin
5424603|NCT01610362|dosage|dosage
5424604|NCT01610336|EGFR|egfr
5424605|NCT01610336|c-MET|c-met
5424606|NCT01610336|Lung cancer|lung cancer
5424607|NCT01610336|Gefitinib|gefitinib
5424608|NCT01610336|Erlotinib|erlotinib
5424609|NCT01610323|Pregnancy|pregnancy
5424610|NCT01610323|Obesity|obesity
5424611|NCT01610323|Physical activity|physical activity
5424612|NCT01610323|Cardiorespiratory fitness|cardiorespiratory fitness
5424613|NCT01610323|Muscular Fitness|muscular fitness
5424614|NCT01610323|Weight gain|weight gain
5424615|NCT01610323|Fetal growth|fetal growth
5424616|NCT01610310|SC|sc
5424617|NCT01610310|PEG|peg
5424618|NCT01610310|Inteferon|inteferon
5424619|NCT01610310|PK|pk
5424620|NCT01610310|Subcutaneous|subcutaneous
5424621|NCT01610310|PEGylated|pegylated
5424622|NCT01610310|Autoinjector|autoinjector
5424623|NCT01610310|Injectable|injectable
5424624|NCT01610310|MS|ms
5680261|NCT00578461|Lymphoma, Hodgkin|lymphoma, hodgkin
5545289|NCT01105845|HV|hv
5424625|NCT01610297|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload|hematopoietic stem cell transplantation, beta-thalassemia major, deferasirox, iron overload
5424626|NCT01610284|Breast cancer|breast cancer
5424627|NCT01610284|Hormone receptor positive|hormone receptor positive
5424628|NCT01610284|HER2-negative|her2-negative
5424629|NCT01610284|Metastatic|metastatic
5424630|NCT01610284|Locally advanced|locally advanced
5424631|NCT01610284|PI3K|pi3k
5424632|NCT01610284|Fulvestrant|fulvestrant
5424633|NCT01610284|Refractory|refractory
5424634|NCT01610284|Aromatase inhibitor|aromatase inhibitor
5424635|NCT01610271|Prevention|prevention
5424636|NCT01610271|Surgical Site Infection|surgical site infection
5424637|NCT01610271|Air Barrier System|air barrier system
5424638|NCT01610271|Implant Infection|implant infection
5424639|NCT01610258|pregnancy, chorioamnionitis, PPROM, Treg|pregnancy, chorioamnionitis, pprom, treg
5424640|NCT01610245|Influenza|influenza
5424641|NCT01610232|Infrared LED|infrared led
5424642|NCT01610232|Treadmill Training|treadmill training
5424643|NCT01610232|Strength Muscle|strength muscle
5424644|NCT01610232|Fatigue Muscle|fatigue muscle
5424645|NCT01610232|Aerobic Capacity|aerobic capacity
5424646|NCT01610232|Cellulite|cellulite
5424647|NCT01610232|Osteoporosis|osteoporosis
5424648|NCT01610206|recurrent|recurrent
5424649|NCT01610206|persistent|persistent
5424650|NCT01610193|Pancreatic Stone Protein|pancreatic stone protein
5424651|NCT01610193|Abdominal pain|abdominal pain
5424652|NCT01610193|Acute appendicitis|acute appendicitis
5424653|NCT01610193|Alvarado score|alvarado score
5424654|NCT01610193|Appendectomy|appendectomy
5424655|NCT01610193|Sensitivity and specificity|sensitivity and specificity
5424656|NCT01610180|Eltrombopag|eltrombopag
5424657|NCT01610180|ITP|itp
5424658|NCT01610180|LPD|lpd
5424659|NCT01610180|leukemia|leukemia
5424660|NCT01610180|Immune ThrombocytoPenia|immune thrombocytopenia
5424661|NCT01610154|glucagon|glucagon
5424662|NCT01610154|dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
5424663|NCT01610141|warfarin metabolism|warfarin metabolism
5424664|NCT01610141|pharmacogenetics|pharmacogenetics
5424665|NCT01610141|CYP2C9|cyp2c9
5424666|NCT01610141|genotyping|genotyping
5424667|NCT01610141|VKORC1|vkorc1
5424668|NCT01610141|CYP4F2|cyp4f2
5424669|NCT01610141|anticoagulation|anticoagulation
5424670|NCT01610141|atrial fibrillation|atrial fibrillation
5424671|NCT01610141|deep vein thrombosis|deep vein thrombosis
5424672|NCT01610141|pulmonary embolism|pulmonary embolism
5424673|NCT01610141|Artificial Heart Valve|artificial heart valve
5424674|NCT01610128|urticaria, patient reported outcome|urticaria, patient reported outcome
5424675|NCT01610115|Pregnancy|pregnancy
5424676|NCT01610102|clinical follow-up|clinical follow-up
5424677|NCT01610102|up to 7 years|up to 7 years
5424678|NCT01610102|all patients enrolled in the main study|all patients enrolled in the main study
5424679|NCT01610089|citrullinemia|citrullinemia
5424680|NCT01610089|argininosuccinate synthetase deficiency|argininosuccinate synthetase deficiency
5424685|NCT01610076|Do not intubate (DNI)|do not intubate (dni)
5424687|NCT01610076|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5424688|NCT01610076|video|video
5424689|NCT01610076|advanced directives|advanced directives
5424690|NCT01610063|Algorithm|algorithm
5424691|NCT01610063|Depression|depression
5424692|NCT01610063|Assurex|assurex
5424693|NCT01610063|GeneSight|genesight
5424694|NCT01610050|castration-resistant prostate cancer, advanced breast cancer|castration-resistant prostate cancer, advanced breast cancer
5424695|NCT01610037|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5424696|NCT01610037|COPD|copd
5424697|NCT01610037|QVA149|qva149
5424698|NCT01610037|QAB149|qab149
5424699|NCT01610037|NVA237|nva237
5424700|NCT01610037|Indacaterol maleate|indacaterol maleate
5424701|NCT01610037|Glycopyronnium bromide|glycopyronnium bromide
5424702|NCT01610011|Schizophrenia|schizophrenia
5424703|NCT01610011|Psychotic Disorders|psychotic disorders
5424704|NCT01610011|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5424705|NCT01610011|Glycine augmentation|glycine augmentation
5424706|NCT01610011|Glycine|glycine
5424707|NCT01610011|Glycine Pharmacodynamics|glycine pharmacodynamics
5424708|NCT01610011|Glycine Bioavailability|glycine bioavailability
5424709|NCT01610011|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5424710|NCT01610011|Glycine Decarboxylase|glycine decarboxylase
5424711|NCT01610011|Glycine Decarboxylase Mutation|glycine decarboxylase mutation
5424712|NCT01609998|Influenza A (H1)|influenza a (h1)
5424713|NCT01609998|Influenza A (H3)|influenza a (h3)
5424714|NCT01609998|Influenza B|influenza b
5424715|NCT01609998|DNA Vaccine|dna vaccine
5424716|NCT01609998|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
5424717|NCT01609998|Healthy Adolescents|healthy adolescents
5424718|NCT01609998|Healthy Children|healthy children
5424723|NCT01609959|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5424724|NCT01609959|Azilsartan|azilsartan
5424725|NCT01609959|Valsartan|valsartan
5424726|NCT01609946|presenting for FNAB or surgery|presenting for fnab or surgery
5424727|NCT01609933|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5424728|NCT01609933|Hepatitis C Genotype 1|hepatitis c genotype 1
5424729|NCT01609933|Chronic Hepatitis C|chronic hepatitis c
5424731|NCT01609920|MRI|mri
5424732|NCT01609920|lymph node metastases|lymph node metastases
5424733|NCT01609920|breast cancer|breast cancer
5424734|NCT01609920|gadofosveset|gadofosveset
5424735|NCT01609907|Drug interaction|drug interaction
5424736|NCT01609907|YH14700|yh14700
5424737|NCT01609907|Rosuvastatin|rosuvastatin
5424738|NCT01609907|Valsartan|valsartan
5424739|NCT01609907|Yuhan|yuhan
5424740|NCT01609894|Postnatal development|postnatal development
5424741|NCT01609894|Breast milk fortification|breast milk fortification
5424742|NCT01609894|Composition of breast milk|composition of breast milk
5424743|NCT01609881|Inflammation|inflammation
5424744|NCT01609868|premature infant feeding protein|premature infant feeding protein
5424745|NCT01609855|Adenoma Detection Rate|adenoma detection rate
5424746|NCT01609855|Anti-spasmotic drug|anti-spasmotic drug
5424747|NCT01609842|Acute Coronary Syndrome|acute coronary syndrome
5424748|NCT01609842|adherence|adherence
5424749|NCT01609816|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5424750|NCT01609816|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5424751|NCT01609816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5424752|NCT01609816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5424753|NCT01609816|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5424754|NCT01609816|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5424755|NCT01609816|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5424756|NCT01609816|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5424757|NCT01609816|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5424758|NCT01609816|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5424759|NCT01609816|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5424760|NCT01609816|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5424761|NCT01609816|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5424762|NCT01609816|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5427881|NCT01596933|echium oil|echium oil
5424764|NCT01609816|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5424765|NCT01609816|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5424766|NCT01609816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5424767|NCT01609816|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5424768|NCT01609816|intraocular lymphoma|intraocular lymphoma
5424769|NCT01609816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5424770|NCT01609816|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5424771|NCT01609816|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5424772|NCT01609816|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5424773|NCT01609816|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5424774|NCT01609816|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5424775|NCT01609816|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5424776|NCT01609816|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5424777|NCT01609816|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5424778|NCT01609816|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5424779|NCT01609816|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5424780|NCT01609816|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5424781|NCT01609816|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5424782|NCT01609816|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5424783|NCT01609816|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5424784|NCT01609816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5419571|NCT01633125|Depression|depression
5424785|NCT01609816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5424786|NCT01609816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5424787|NCT01609816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5424788|NCT01609816|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5424790|NCT01609816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5424791|NCT01609816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5424792|NCT01609816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5424793|NCT01609816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5424794|NCT01609816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5424795|NCT01609816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5424796|NCT01609816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5424797|NCT01609816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5685288|NCT00556751|Cardiovascular Risk Factors|cardiovascular risk factors
5424798|NCT01609816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5424799|NCT01609816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5424800|NCT01609816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5424801|NCT01609816|refractory hairy cell leukemia|refractory hairy cell leukemia
5424802|NCT01609816|refractory multiple myeloma|refractory multiple myeloma
5424803|NCT01609816|small intestine lymphoma|small intestine lymphoma
5424804|NCT01609816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5424805|NCT01609816|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5424806|NCT01609816|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5424807|NCT01609816|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5424808|NCT01609816|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5424809|NCT01609816|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5424810|NCT01609816|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5424811|NCT01609816|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5424812|NCT01609816|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5424813|NCT01609816|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5424814|NCT01609816|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5424815|NCT01609816|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5424816|NCT01609816|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5424817|NCT01609816|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5424818|NCT01609816|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5424819|NCT01609816|stage I multiple myeloma|stage i multiple myeloma
5424820|NCT01609816|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5407621|NCT01688232|CD8|cd8
5424821|NCT01609816|stage IA mycosis fungoides/Sezary syndrome|stage ia mycosis fungoides/sezary syndrome
5424822|NCT01609816|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
5424823|NCT01609816|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5424824|NCT01609816|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5424825|NCT01609816|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5424826|NCT01609816|stage II multiple myeloma|stage ii multiple myeloma
5424827|NCT01609816|stage IIA mycosis fungoides/Sezary syndrome|stage iia mycosis fungoides/sezary syndrome
5424828|NCT01609816|stage IIB mycosis fungoides/Sezary syndrome|stage iib mycosis fungoides/sezary syndrome
5424829|NCT01609816|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5424830|NCT01609816|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5424831|NCT01609816|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5424832|NCT01609816|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5424833|NCT01609816|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5424834|NCT01609816|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5424835|NCT01609816|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5424836|NCT01609816|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5424837|NCT01609816|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5424838|NCT01609816|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5424839|NCT01609816|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5424840|NCT01609816|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5424841|NCT01609816|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5424842|NCT01609816|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5424843|NCT01609816|stage III multiple myeloma|stage iii multiple myeloma
5424844|NCT01609816|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5424845|NCT01609816|stage IIIA mycosis fungoides/Sezary syndrome|stage iiia mycosis fungoides/sezary syndrome
5424846|NCT01609816|stage IIIB mycosis fungoides/Sezary syndrome|stage iiib mycosis fungoides/sezary syndrome
5424847|NCT01609816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5862843|NCT00001483|Re-Randomization|re-randomization
5424850|NCT01609816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5424852|NCT01609816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5424853|NCT01609816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5424854|NCT01609816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5424855|NCT01609816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5424856|NCT01609816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5424857|NCT01609816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5424858|NCT01609816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5424859|NCT01609816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5424860|NCT01609816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5424861|NCT01609816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5424862|NCT01609816|stage IVA mycosis fungoides/Sezary syndrome|stage iva mycosis fungoides/sezary syndrome
5685289|NCT00556751|Cholesterol|cholesterol
5424863|NCT01609816|stage IVB mycosis fungoides/Sezary syndrome|stage ivb mycosis fungoides/sezary syndrome
5424864|NCT01609816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5424865|NCT01609816|testicular lymphoma|testicular lymphoma
5424866|NCT01609816|Waldenström macroglobulinemia|waldenström macroglobulinemia
5424867|NCT01609751|probiotic|probiotic
5424868|NCT01609751|lactobacillus|lactobacillus
5424869|NCT01609751|colonic diseases|colonic diseases
5424870|NCT01609751|dietary fibre|dietary fibre
5424871|NCT01609738|Cardiac pacing|cardiac pacing
5424872|NCT01609738|Left ventricular septal pacing|left ventricular septal pacing
5424873|NCT01609738|Feasibility and safety|feasibility and safety
5424874|NCT01609738|Lead stability|lead stability
5424875|NCT01609738|Hemodynamics|hemodynamics
5424876|NCT01609738|Left ventricular dyssynchrony|left ventricular dyssynchrony
5424877|NCT01609738|Pacing for heart failure|pacing for heart failure
5424878|NCT01609738|Cardiac resynchronization therapy|cardiac resynchronization therapy
5424879|NCT01609725|Coronary artery disease|coronary artery disease
5424880|NCT01609725|C reactive protein|c reactive protein
5424882|NCT01609725|Periodontal therapy|periodontal therapy
5424883|NCT01609725|Flow-mediated dilation|flow-mediated dilation
5424884|NCT01609712|Improvement of lung function (FEV1, PEF)|improvement of lung function (fev1, pef)
5424885|NCT01609712|Visual Analog Scale|visual analog scale
5424886|NCT01609712|Oswestry Disability Index|oswestry disability index
5424887|NCT01609712|Radiographs pre and post Op|radiographs pre and post op
5424888|NCT01609699|body circumference|body circumference
5424889|NCT01609699|Non-Invasive Reduction|non-invasive reduction
5424890|NCT01609686|cardiac surgery|cardiac surgery
5424891|NCT01609686|renal dysfunction|renal dysfunction
5424892|NCT01609686|pharmacokinetics|pharmacokinetics
5424893|NCT01609686|tranexamic acid|tranexamic acid
5424894|NCT01609673|Immunosuppression|immunosuppression
5424895|NCT01609673|Chronic Kidney Disease|chronic kidney disease
5424896|NCT01609673|Renal Transplant|renal transplant
5424897|NCT01609660|probiotics|probiotics
5424898|NCT01609660|cytokine|cytokine
5424899|NCT01609660|short chain fatty acids|short chain fatty acids
5424900|NCT01609660|complications|complications
5424901|NCT01609660|colorectal surgery|colorectal surgery
5424902|NCT01609647|High plate reactivity unit after loading dose of clopidogrel|high plate reactivity unit after loading dose of clopidogrel
5424904|NCT01609634|Term infants|term infants
5424905|NCT01609634|Growth|growth
5424906|NCT01609634|Body composition|body composition
5424907|NCT01609595|Thalassemia|thalassemia
5424908|NCT01609595|Anemia|anemia
5424909|NCT01609595|Fetal hemoglobin|fetal hemoglobin
5424910|NCT01609582|Drug therapy|drug therapy
5424911|NCT01609556|FOLR solid tumors|folr solid tumors
5424912|NCT01609530|verruca vulgaris|verruca vulgaris
5424913|NCT01609530|hands|hands
5424914|NCT01609530|feet|feet
5424915|NCT01609530|Nd:YAG|nd:yag
5424916|NCT01609530|laser|laser
5424917|NCT01609530|cryotherapy|cryotherapy
5424918|NCT01609517|Spinal anesthesia|spinal anesthesia
5424919|NCT01609517|determinant|determinant
5424920|NCT01609517|duration|duration
5424921|NCT01609504|Rectal cancer|rectal cancer
5424922|NCT01609504|Radiochemotherapy|radiochemotherapy
5424923|NCT01609504|Transanal Endoscopic Microsurgery|transanal endoscopic microsurgery
5424924|NCT01609504|Laparoscopic Resection|laparoscopic resection
5424925|NCT01609478|asthma|asthma
5424927|NCT01609465|stable angina|stable angina
5424928|NCT01609465|STEMI|stemi
5424929|NCT01609465|NSTEMI|nstemi
5424931|NCT01609465|secondary prevention|secondary prevention
5424932|NCT01609452|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5424933|NCT01609452|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5424934|NCT01609452|Chronic ITP|chronic itp
5424935|NCT01609439|Permanent|permanent
5424936|NCT01609439|temporary|temporary
5424937|NCT01609439|hypocalcemia|hypocalcemia
5424938|NCT01609426|Proteinuria|proteinuria
5424939|NCT01609426|idiopathic|idiopathic
5424940|NCT01609426|nephrotic syndrome|nephrotic syndrome
5424941|NCT01609426|herpesvirus|herpesvirus
5424942|NCT01609426|epidemiology|epidemiology
5424943|NCT01609426|immune response|immune response
5424944|NCT01609426|interferon|interferon
5424945|NCT01609426|steroid dependency|steroid dependency
5424946|NCT01609426|nephrotic disease: Idiopathic nephrotic syndrome|nephrotic disease: idiopathic nephrotic syndrome
5545758|NCT01103726|FDG-PET|fdg-pet
5424947|NCT01609387|Vitamine|vitamine
5424948|NCT01609387|mineral|mineral
5424949|NCT01609387|obese patients|obese patients
5424950|NCT01609387|Vitamine en mineral shortage in obese patients|vitamine en mineral shortage in obese patients
5424951|NCT01609374|Spinal Kinetics|spinal kinetics
5424952|NCT01609374|artificial cervical disc|artificial cervical disc
5424953|NCT01609374|cervical radiculopathy|cervical radiculopathy
5424954|NCT01609374|ACDF|acdf
5424955|NCT01609374|neck pain|neck pain
5424956|NCT01609374|cervical spine|cervical spine
5424957|NCT01609374|degenerative disc disease|degenerative disc disease
5424958|NCT01609361|Rehabilitation program|rehabilitation program
5424959|NCT01609361|Fast track surgery|fast track surgery
5424960|NCT01609361|Laparoscopic colorectal resection|laparoscopic colorectal resection
5424961|NCT01609361|Colorectal cancer|colorectal cancer
5424963|NCT01609348|Depression|depression
5424964|NCT01609348|Alzheimer's Disease|alzheimer's disease
5424965|NCT01609322|fear of falling|fear of falling
5424966|NCT01609322|agoraphobia|agoraphobia
5424967|NCT01609309|Stomach Neoplasms|stomach neoplasms
5424968|NCT01609309|Laparoscopy|laparoscopy
5424969|NCT01609296|Peripheral Arterial Disease|peripheral arterial disease
5424970|NCT01609296|Drug coated balloon|drug coated balloon
5424971|NCT01609296|Superficial Femoral Artery|superficial femoral artery
5424972|NCT01609296|Popliteal Femoral Artery|popliteal femoral artery
5424973|NCT01609296|Atherosclerosis|atherosclerosis
5424974|NCT01609296|Drug eluting balloon|drug eluting balloon
5424975|NCT01609244|Sleep apnea|sleep apnea
5424976|NCT01609244|central sleep apnea|central sleep apnea
5424977|NCT01609244|bilevel|bilevel
5424978|NCT01609244|servoventilation|servoventilation
5424979|NCT01609244|CPAP|cpap
5424980|NCT01609192|sickle-cell anemia|sickle-cell anemia
5424981|NCT01609192|spermatogenesis|spermatogenesis
5424982|NCT01609192|hydroxyurea|hydroxyurea
5424983|NCT01609166|Hand-foot Syndrome|hand-foot syndrome
5424984|NCT01609166|capecitabine|capecitabine
5424985|NCT01609166|allopurinol|allopurinol
5424986|NCT01609153|schizophrenia|schizophrenia
5424987|NCT01609153|amisulpride|amisulpride
5424988|NCT01609153|olanzapine|olanzapine
5424989|NCT01609153|polypharmacy|polypharmacy
5424990|NCT01609140|Hyperlipidemia|hyperlipidemia
5424991|NCT01609140|Dyslipidemia|dyslipidemia
5424992|NCT01609114|phenomena and mechanism of RT-PK|phenomena and mechanism of rt-pk
5424993|NCT01609114|fact for different anticancer drugs|fact for different anticancer drugs
5424994|NCT01609114|different part in human|different part in human
5424995|NCT01609101|Videolaryngoscopy|videolaryngoscopy
5424996|NCT01609101|Palatopharyngeal distance|palatopharyngeal distance
5424999|NCT01609088|diabetes mellitus|diabetes mellitus
5425000|NCT01609088|oxidative stress|oxidative stress
5425001|NCT01609062|Mucopolysaccharidosis IVA Type A|mucopolysaccharidosis iva type a
5425002|NCT01609062|MPS IVA Type A|mps iva type a
5425003|NCT01609062|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5425004|NCT01609062|MPS IVA|mps iva
5425005|NCT01609062|Morquio A Syndrome|morquio a syndrome
5425006|NCT01609062|Lysosomal Storage Disorder|lysosomal storage disorder
5425007|NCT01609062|LSD|lsd
5425008|NCT01609062|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5425009|NCT01609062|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5425010|NCT01609062|sulfatase|sulfatase
5425011|NCT01609062|galactose-6-sulfatase|galactose-6-sulfatase
5425012|NCT01609062|GALNS|galns
5425013|NCT01609062|enzyme replacement therapy|enzyme replacement therapy
5425014|NCT01609062|ERT|ert
5425015|NCT01609062|MOR-008|mor-008
5425016|NCT01609062|CPET|cpet
5425017|NCT01609062|MST|mst
5425018|NCT01609062|muscle strength test|muscle strength test
5425019|NCT01609062|physiological effect|physiological effect
5425020|NCT01608984|remote ischemic preconditioning|remote ischemic preconditioning
5425021|NCT01608984|coronary artery bypass grafting|coronary artery bypass grafting
5425022|NCT01608984|myocardial injury|myocardial injury
5425023|NCT01608971|Protamine|protamine
5425024|NCT01608971|heparin level|heparin level
5425025|NCT01608971|haemostasis|haemostasis
5425026|NCT01608971|thromboelastometry|thromboelastometry
5425027|NCT01608971|cardiac surgery|cardiac surgery
5425028|NCT01608971|Patients undergoing cardiac surgery|patients undergoing cardiac surgery
5425029|NCT01608958|Postpartum hemorrhage|postpartum hemorrhage
5425030|NCT01608958|Oxytocin|oxytocin
5425031|NCT01608958|Third stage of labor|third stage of labor
5425032|NCT01608958|Hemoglobin|hemoglobin
5425033|NCT01608958|Prevention|prevention
5425034|NCT01608958|Intravenous|intravenous
5425035|NCT01608958|Intramuscular|intramuscular
5425037|NCT01608945|liver function|liver function
5425038|NCT01608945|prognosis|prognosis
5425039|NCT01608906|venous thrombosis|venous thrombosis
5425040|NCT01608906|heparin|heparin
5425041|NCT01608906|pulmonary embolism|pulmonary embolism
5425042|NCT01608906|ICU|icu
5425043|NCT01608867|Phase 1|phase 1
5425044|NCT01608867|dose escalation|dose escalation
5425045|NCT01608867|histologically confirmed|histologically confirmed
5425046|NCT01608867|malignancy|malignancy
5425047|NCT01608867|metastatic|metastatic
5425048|NCT01608854|surgical site infection|surgical site infection
5425049|NCT01608854|spinal surgery|spinal surgery
5425050|NCT01608854|prophylactic antibiotics|prophylactic antibiotics
5425051|NCT01608854|postoperative spinal drains|postoperative spinal drains
5425052|NCT01608815|Salmonella infections|salmonella infections
5425053|NCT01608815|Typhoid fever|typhoid fever
5425054|NCT01608815|Bacterial infections|bacterial infections
5425055|NCT01608815|Typhoid vaccine|typhoid vaccine
5425056|NCT01608802|HIV|hiv
5425057|NCT01608802|Antiretroviral therapy|antiretroviral therapy
5425058|NCT01608802|Palliative care|palliative care
5425059|NCT01608802|Pain|pain
5425060|NCT01608789|Male sling|male sling
5425061|NCT01608789|Stress Urinary Incontinence|stress urinary incontinence
5425062|NCT01608789|Urination Disorders|urination disorders
5425063|NCT01608789|Urologic Diseases|urologic diseases
5425065|NCT01608711|Gemcitabine|gemcitabine
5425066|NCT01608711|ASP6182|asp6182
5425067|NCT01608711|AGS-1C4D4|ags-1c4d4
5425068|NCT01608711|Pancreatic Cancer|pancreatic cancer
5425069|NCT01608698|chlormadinone acetate|chlormadinone acetate
5425070|NCT01608698|drospirenone|drospirenone
5425071|NCT01608698|contraceptive pills|contraceptive pills
5425072|NCT01608685|Tuberculosis|tuberculosis
5425073|NCT01608685|Latent tuberculosis infection|latent tuberculosis infection
5425074|NCT01608685|Immunosuppression|immunosuppression
5425075|NCT01608685|Renal transplant recipient|renal transplant recipient
5425076|NCT01608646|S-1|s-1
5425077|NCT01608646|Oxaliplatin|oxaliplatin
5425078|NCT01608646|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5425079|NCT01608620|Systematic review and meta-analysis|systematic review and meta-analysis
5425080|NCT01608620|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5425081|NCT01608620|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5425082|NCT01608620|Clinical practice guidelines|clinical practice guidelines
5425083|NCT01608620|Clinical trials|clinical trials
5425084|NCT01608620|Dietary sugars|dietary sugars
5425085|NCT01608620|Fructose|fructose
5425086|NCT01608620|High fructose corn syrup|high fructose corn syrup
5425087|NCT01608620|Fruit|fruit
5425088|NCT01608620|Isocaloric|isocaloric
5425089|NCT01608620|Hypercaloric|hypercaloric
5425090|NCT01608620|Cardiometabolic risk factors|cardiometabolic risk factors
5425091|NCT01608620|Triglycerides|triglycerides
5425092|NCT01608620|Cholesterol|cholesterol
5425093|NCT01608620|Glycemic control|glycemic control
5425094|NCT01608620|Insulin resistance|insulin resistance
5425095|NCT01608620|Body weight|body weight
5425096|NCT01608620|Uric acid|uric acid
5425097|NCT01608620|Blood pressure|blood pressure
5425098|NCT01608607|Systematic review and meta-analysis|systematic review and meta-analysis
5425099|NCT01608607|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5425100|NCT01608607|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5425101|NCT01608607|Clinical practice guidelines|clinical practice guidelines
5425103|NCT01608607|Dietary sugars|dietary sugars
5425104|NCT01608607|Fructose|fructose
5425105|NCT01608607|High fructose corn syrup|high fructose corn syrup
5425106|NCT01608607|sucrose|sucrose
5425107|NCT01608607|Isocaloric|isocaloric
5425108|NCT01608607|Hypercaloric|hypercaloric
5425109|NCT01608607|Glycemic control|glycemic control
5425110|NCT01608607|Insulin resistance|insulin resistance
5425111|NCT01608607|Body weight|body weight
5425112|NCT01608607|body mass index|body mass index
5425113|NCT01608607|waist circumference|waist circumference
5425114|NCT01608581|prevention|prevention
5425115|NCT01608581|burn|burn
5425116|NCT01608581|adult|adult
5425117|NCT01608581|health promotion|health promotion
5425118|NCT01608581|evaluation|evaluation
5425119|NCT01608581|media|media
5425120|NCT01608568|Sutures|sutures
5425121|NCT01608568|Pelvic Organ Prolapse|pelvic organ prolapse
5425122|NCT01608568|Sacrocolpopexy|sacrocolpopexy
5425123|NCT01608568|Robotic Assisted Laparoscopy|robotic assisted laparoscopy
5425124|NCT01608555|cystic fibrosis|cystic fibrosis
5425125|NCT01608555|bacterial load|bacterial load
5425126|NCT01608555|inhaled tobramycin|inhaled tobramycin
5425127|NCT01608542|fostamatinib|fostamatinib
5425128|NCT01608542|FosD|fosd
5425129|NCT01608542|Japanese Healthy volunteers|japanese healthy volunteers
5425130|NCT01608542|Phase 1|phase 1
5425131|NCT01608542|Single and Multiple Dose Study|single and multiple dose study
5425132|NCT01608529|Restriction device ventilatory nasal flow|restriction device ventilatory nasal flow
5425133|NCT01608529|oronasal breathing|oronasal breathing
5425134|NCT01608529|nasal breathing.|nasal breathing.
5425135|NCT01608516|PET/CT|pet/ct
5425136|NCT01608516|68Ga-NODAGA-RGD|68ga-nodaga-rgd
5425137|NCT01608516|18F-FDG|18f-fdg
5425138|NCT01608516|MRI|mri
5425139|NCT01608516|US ultrasound|us ultrasound
5425140|NCT01608516|inflammatory atheromatous plaque|inflammatory atheromatous plaque
5425141|NCT01608516|endarterectomy|endarterectomy
5425142|NCT01608503|subclavian vein|subclavian vein
5425143|NCT01608503|ultrasound|ultrasound
5425144|NCT01608503|distance between the subclavian vein and the lung|distance between the subclavian vein and the lung
5425145|NCT01608490|COPD|copd
5410394|NCT01675921|ACT|act
5425147|NCT01608477|Heart transplantation|heart transplantation
5425148|NCT01608477|Medication adherence|medication adherence
5425149|NCT01608477|Behavior system factor|behavior system factor
5425150|NCT01608464|Randomized trial,|randomized trial,
5425151|NCT01608464|Pre-operative chemo-RT with CDDP and 5-FU|pre-operative chemo-rt with cddp and 5-fu
5425152|NCT01608464|Multicenter study|multicenter study
5425153|NCT01608438|Body-machine interface|body-machine interface
5425154|NCT01608438|Customization|customization
5425155|NCT01608438|Upper-body motion|upper-body motion
5425156|NCT01608438|Motor learning|motor learning
5425157|NCT01608438|Assistive Devices|assistive devices
5425158|NCT01608438|Wheelchair|wheelchair
5425159|NCT01608438|Computer keyboard|computer keyboard
5425160|NCT01608425|diabetic foot ulcer|diabetic foot ulcer
5425161|NCT01608425|ulcer monitoring|ulcer monitoring
5425162|NCT01608425|telemedicine consultations|telemedicine consultations
5425163|NCT01608425|cross-sectoral collaboration|cross-sectoral collaboration
5425164|NCT01608412|renal transplantation|renal transplantation
5425165|NCT01608412|everolimus|everolimus
5425166|NCT01608412|tacrolimus|tacrolimus
5425167|NCT01608412|molecular evaluation|molecular evaluation
5425168|NCT01608399|major depressive disorder|major depressive disorder
5425169|NCT01608399|psychotherapy|psychotherapy
5425170|NCT01608399|metacognitive therapy|metacognitive therapy
5425171|NCT01608386|Anterior approach|anterior approach
5425172|NCT01608386|infrahepatic inferior vena cava clamping|infrahepatic inferior vena cava clamping
5425173|NCT01608386|hepatic resection|hepatic resection
5425174|NCT01608373|Pain|pain
5425175|NCT01608373|Lidocaine|lidocaine
5425176|NCT01608373|Intravenous|intravenous
5425177|NCT01608373|Intraperitoneum|intraperitoneum
5425178|NCT01608373|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5425179|NCT01608360|Pain|pain
5425180|NCT01608360|Lidocaine|lidocaine
5425181|NCT01608360|Intravenous|intravenous
5425182|NCT01608360|Thyroidectomy|thyroidectomy
5425183|NCT01608347|LMWH|lmwh
5425184|NCT01608347|enoxaparin|enoxaparin
5425185|NCT01608347|recurrent miscarriage|recurrent miscarriage
5425186|NCT01608347|continuing fetal viability beyond 20 weeks gestation|continuing fetal viability beyond 20 weeks gestation
5425187|NCT01608321|Chronic Pain|chronic pain
5425188|NCT01608321|Gulf War Illness|gulf war illness
5425189|NCT01608321|Gulf War Syndrome|gulf war syndrome
5425190|NCT01608321|Fibromyalgia|fibromyalgia
5425191|NCT01608321|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5425192|NCT01608321|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5425193|NCT01608321|Veterans|veterans
5425194|NCT01608308|Chronic Sinusitis|chronic sinusitis
5425195|NCT01608308|Pain Relief|pain relief
5425196|NCT01608308|Post-Operative Opioid Requirement|post-operative opioid requirement
5425197|NCT01608308|IV Acetaminophen|iv acetaminophen
5425198|NCT01608308|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5425199|NCT01608308|FESS|fess
5425200|NCT01608295|depressed|depressed
5425201|NCT01608295|geriatric|geriatric
5425202|NCT01608295|older adults|older adults
5425203|NCT01608295|antidepressants|antidepressants
5425204|NCT01608295|depression|depression
5425205|NCT01608295|anxious|anxious
5425206|NCT01608295|major depressive disorder|major depressive disorder
5425207|NCT01608295|MDD|mdd
5425208|NCT01608282|Osteoarthritis|osteoarthritis
5425209|NCT01608282|Arthritis|arthritis
5425210|NCT01608282|Knee|knee
5425211|NCT01608282|Exercise|exercise
5425212|NCT01608282|Physical Activity|physical activity
5425213|NCT01608282|Web-based|web-based
5425214|NCT01608256|mild cognitive impairment|mild cognitive impairment
5425215|NCT01608256|Automobile Driving|automobile driving
5425216|NCT01608256|cognitive aspects|cognitive aspects
5425217|NCT01608217|Behavioural disturbances|behavioural disturbances
5425218|NCT01608217|Pain|pain
5425219|NCT01608217|Dementia|dementia
5425220|NCT01608217|Alzheimer's dementia|alzheimer's dementia
5425221|NCT01608217|Vascular dementia|vascular dementia
5425222|NCT01608217|THC|thc
5425223|NCT01608217|Cannabis|cannabis
5425224|NCT01608204|Pharmacokinetics|pharmacokinetics
5425225|NCT01608204|Busulfan|busulfan
5425226|NCT01608204|Polymorphism|polymorphism
5425227|NCT01608204|GST|gst
5425228|NCT01608204|MDR-1(p-Glycoprotein)|mdr-1(p-glycoprotein)
5425229|NCT01608204|Acute Myeloid Leukemia adult patients|acute myeloid leukemia adult patients
5425230|NCT01608178|Pediatric Neurotransmitter Disorders|pediatric neurotransmitter disorders
5425231|NCT01608178|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
5425232|NCT01608178|GABA|gaba
5425233|NCT01608178|Epilepsy|epilepsy
5425234|NCT01608165|Small renal cancer mass|small renal cancer mass
5425235|NCT01608152|Leukemia|leukemia
5425236|NCT01608152|Lymphoma|lymphoma
5425237|NCT01608152|Game mechanics|game mechanics
5425238|NCT01608152|Stem cell transplant survivors|stem cell transplant survivors
5425239|NCT01608152|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5425240|NCT01608152|HSCT|hsct
5425241|NCT01608152|Internet-based|internet-based
5425242|NCT01608152|Interactive and personalized intervention|interactive and personalized intervention
5425243|NCT01608152|Questionnaires|questionnaires
5425244|NCT01608152|Focus groups|focus groups
5425245|NCT01608152|Interviews|interviews
5425246|NCT01608139|Advanced Cancers|advanced cancers
5425247|NCT01608139|Advanced Solid Tumors|advanced solid tumors
5425248|NCT01608139|Curcumin|curcumin
5425249|NCT01608139|Sorafenib|sorafenib
5425250|NCT01608139|Nexavar|nexavar
5425251|NCT01608139|Bay 43-9006|bay 43-9006
5425252|NCT01608139|Vorinostat|vorinostat
5425253|NCT01608139|SAHA|saha
5425254|NCT01608139|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5425255|NCT01608139|MSK-390|msk-390
5425256|NCT01608139|Zolinza|zolinza
5425257|NCT01608126|Ultrasound|ultrasound
5425258|NCT01608126|Cervical Plexus|cervical plexus
5425259|NCT01608126|Anesthesia, Conduction|anesthesia, conduction
5425260|NCT01608126|Surgical Procedures, Elective|surgical procedures, elective
5425261|NCT01608126|Atherectomy|atherectomy
5425262|NCT01608113|neovascular AMD|neovascular amd
5425263|NCT01608113|Optical coherence tomography|optical coherence tomography
5425264|NCT01608113|reading acuity|reading acuity
5425265|NCT01608113|contrast sensitivity|contrast sensitivity
5425266|NCT01608074|BRCA1|brca1
5425267|NCT01608074|BRCA2|brca2
5425268|NCT01608074|Prophylactic surgery|prophylactic surgery
5425269|NCT01608074|Salpingectomy|salpingectomy
5425270|NCT01608074|Fimbriectomy|fimbriectomy
5425271|NCT01608061|Mild probable Alzheimer's Disease|mild probable alzheimer's disease
5425272|NCT01608048|In-vitro Fertilization|in-vitro fertilization
5425273|NCT01608048|transcutaneous electrical acupoint stimulation|transcutaneous electrical acupoint stimulation
5425274|NCT01608035|sciatic catheter|sciatic catheter
5425275|NCT01608035|stump catheter|stump catheter
5425276|NCT01608035|below knee amputation|below knee amputation
5425277|NCT01608009|platinum resistant|platinum resistant
5425278|NCT01608009|ovarian cancer|ovarian cancer
5425279|NCT01607996|Epidural anesthesia|epidural anesthesia
5425280|NCT01607996|pancreatic perfusion|pancreatic perfusion
5425281|NCT01607996|pancreatic necrosectomy|pancreatic necrosectomy
5425282|NCT01607983|nitric oxide|nitric oxide
5425283|NCT01607983|ventricular-arterial coupling|ventricular-arterial coupling
5425284|NCT01607983|congenital heart disease|congenital heart disease
5425285|NCT01607970|Oxytocin|oxytocin
5425286|NCT01607970|Startle|startle
5425287|NCT01607970|moral dilemma|moral dilemma
5425288|NCT01607970|oxytocin receptor gene|oxytocin receptor gene
5425289|NCT01607957|Refractory, metastatic colorectal cancer|refractory, metastatic colorectal cancer
5425290|NCT01607931|Exercise|exercise
5425291|NCT01607931|Physical activity|physical activity
5425292|NCT01607931|Type 2 diabetes|type 2 diabetes
5425293|NCT01607931|Obesity|obesity
5425294|NCT01607931|Incretin effect|incretin effect
5425297|NCT01607931|Insulin secretion|insulin secretion
5425298|NCT01607931|Glucagon|glucagon
5425299|NCT01607931|Beta-cell function|beta-cell function
5425300|NCT01607931|Disposition Index|disposition index
5425301|NCT01607918|H pylori, eradication|h pylori, eradication
5425302|NCT01607905|Selinexor|selinexor
5425303|NCT01607905|KPT-330|kpt-330
5425304|NCT01607905|Squamous Cell Carcinoma|squamous cell carcinoma
5425305|NCT01607905|Glioblastoma multiforme|glioblastoma multiforme
5425306|NCT01607905|Adenocarcinoma|adenocarcinoma
5425307|NCT01607905|Melanoma|melanoma
5425308|NCT01607892|Selinexor|selinexor
5425309|NCT01607892|KPT-330|kpt-330
5425310|NCT01607892|Multiple Myeloma|multiple myeloma
5425311|NCT01607892|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5425312|NCT01607892|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5425313|NCT01607892|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5425314|NCT01607892|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5425315|NCT01607892|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5425316|NCT01607892|Chronic Myelocytic Leukemia|chronic myelocytic leukemia
5425317|NCT01607892|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5425318|NCT01607879|Prostate Cancer|prostate cancer
5425319|NCT01607879|Men|men
5425320|NCT01607879|Androgen Deprivation Therapy|androgen deprivation therapy
5425321|NCT01607879|Elderly|elderly
5425322|NCT01607879|Geriatric|geriatric
5425323|NCT01607879|Nutritional supplementation|nutritional supplementation
5425324|NCT01607840|Schizophrenia|schizophrenia
5425325|NCT01607840|Cognitive Improvement|cognitive improvement
5425326|NCT01607840|tDCS|tdcs
5425327|NCT01607840|stimulation|stimulation
5425328|NCT01607827|polypectomy|polypectomy
5425329|NCT01607827|colonoscopy|colonoscopy
5425330|NCT01607827|polyp miss rate|polyp miss rate
5425331|NCT01607827|surveillance|surveillance
5425332|NCT01607827|colorectal cancer|colorectal cancer
5425333|NCT01607814|cirrhosis|cirrhosis
5425334|NCT01607814|oxidative stress|oxidative stress
5425335|NCT01607814|NADPH oxidase|nadph oxidase
5425337|NCT01607814|PUFA balance|pufa balance
5425338|NCT01607814|platelet activation|platelet activation
5425339|NCT01607814|coagulation abnormalities|coagulation abnormalities
5425340|NCT01607801|umbilical hernia repair|umbilical hernia repair
5425341|NCT01607801|recurrence|recurrence
5425342|NCT01607801|choice of suture|choice of suture
5425343|NCT01607801|mesh|mesh
5425344|NCT01607801|mesh/non-mesh|mesh/non-mesh
5425345|NCT01607788|Selection criteria|selection criteria
5425346|NCT01607788|Liver transplantation|liver transplantation
5425347|NCT01607788|Hepatocellular carcinoma|hepatocellular carcinoma
5425348|NCT01607762|Healthy|healthy
5425349|NCT01607762|Antipsychotics|antipsychotics
5425350|NCT01607762|Aripiprazole|aripiprazole
5425351|NCT01607762|Paliperidone|paliperidone
5425352|NCT01607762|Risperidone|risperidone
5425353|NCT01607762|Quetiapine|quetiapine
5425354|NCT01607762|Olanzapine|olanzapine
5425355|NCT01607749|Asthma Control|asthma control
5425356|NCT01607749|Quality of life|quality of life
5425357|NCT01607749|Children|children
5425358|NCT01607749|Asthma education|asthma education
5425360|NCT01607736|walking|walking
5425361|NCT01607736|healthy older individuals|healthy older individuals
5425362|NCT01607736|virtual gait training|virtual gait training
5425363|NCT01607723|Sleep pattern|sleep pattern
5425364|NCT01607723|Mechanical ventilation|mechanical ventilation
5425365|NCT01607723|weaning|weaning
5425366|NCT01607723|Intensive Care|intensive care
5425367|NCT01607723|NAVA (Neurally Adjusted Ventilatory Assist)|nava (neurally adjusted ventilatory assist)
5425368|NCT01607723|PAV+ (Proportional Assist Ventilation Plus)|pav+ (proportional assist ventilation plus)
5425369|NCT01607710|fMRI|fmri
5425370|NCT01607710|Generalized Anxiety Disorder|generalized anxiety disorder
5425371|NCT01607697|Parkinson's Disease|parkinson's disease
5425372|NCT01607671|Ischemic|ischemic
5425373|NCT01607671|Optic Neuropathy|optic neuropathy
5425374|NCT01607671|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5425375|NCT01607671|NAION|naion
5425376|NCT01607671|Ischemic Optic Neuropathy|ischemic optic neuropathy
5425377|NCT01607671|Intraocular Pressure|intraocular pressure
5425378|NCT01607658|Testosterone|testosterone
5425580|NCT01606683|Infants|infants
5425379|NCT01607632|posttraumatic stress|posttraumatic stress
5425380|NCT01607632|depression|depression
5425382|NCT01607593|Retrospective|retrospective
5425383|NCT01607593|Sertraline|sertraline
5425384|NCT01607593|Posttraumatic stress disorder|posttraumatic stress disorder
5425385|NCT01607554|Lung|lung
5425386|NCT01607554|non small cell|non small cell
5425387|NCT01607554|NSCLC|nsclc
5425388|NCT01607554|Irinotecan|irinotecan
5425389|NCT01607541|HIV/AIDS|hiv/aids
5425390|NCT01607541|vulnerable populations|vulnerable populations
5425391|NCT01607541|heterosexuals at high risk|heterosexuals at high risk
5425392|NCT01607541|peer-driven intervention|peer-driven intervention
5425393|NCT01607541|tailored intervention|tailored intervention
5425394|NCT01607541|African-American|african-american
5425395|NCT01607541|Latino/Hispanic|latino/hispanic
5425396|NCT01607541|Seek, test, treat, and retain (STTR)|seek, test, treat, and retain (sttr)
5425397|NCT01607515|Pulmonary hypertension|pulmonary hypertension
5425398|NCT01607515|Cardiac index|cardiac index
5425399|NCT01607515|impedance cardiography|impedance cardiography
5425400|NCT01607502|Pulmonary hypertension|pulmonary hypertension
5425401|NCT01607502|database|database
5425402|NCT01607502|biomarker|biomarker
5425403|NCT01607489|Early diagnosis of pulmonary arterial hypertension|early diagnosis of pulmonary arterial hypertension
5425404|NCT01607489|dynamic dual-energy computed tomography|dynamic dual-energy computed tomography
5425405|NCT01607463|pain|pain
5425406|NCT01607463|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5425407|NCT01607450|Type 2 diabetes mellitus|type 2 diabetes mellitus
5425408|NCT01607450|lean healthy control|lean healthy control
5425409|NCT01607424|cognitive rehabilitation|cognitive rehabilitation
5425410|NCT01607424|schizophrenia|schizophrenia
5425411|NCT01607398|Japan|japan
5425412|NCT01607398|COPD|copd
5425414|NCT01607398|placebo|placebo
5425415|NCT01607398|serum|serum
5425416|NCT01607398|Adoair250|adoair250
5425417|NCT01607398|anti-inflammatory|anti-inflammatory
5425418|NCT01607398|sputum|sputum
5425419|NCT01607385|pharmacokinetic|pharmacokinetic
5425420|NCT01607385|intestinal bile acid transporter inhibitor|intestinal bile acid transporter inhibitor
5425421|NCT01607385|GSK2330672|gsk2330672
5425422|NCT01607385|pharmacodynamic|pharmacodynamic
5425423|NCT01607385|GSK1614235|gsk1614235
5425424|NCT01607385|dose escalation|dose escalation
5425425|NCT01607372|TLR7 agonist, Respiratory Allergies, Allergic Rhinitis, Mild Allergic Asthma, Repeat Dose Safety, Reduction of Allergic Reactivity|tlr7 agonist, respiratory allergies, allergic rhinitis, mild allergic asthma, repeat dose safety, reduction of allergic reactivity
5425426|NCT01607359|atrial fibrillation|atrial fibrillation
5425427|NCT01607359|catheter ablation|catheter ablation
5425428|NCT01607359|dabigatran|dabigatran
5425429|NCT01607359|warfarin|warfarin
5425430|NCT01607359|oral anticoagulation|oral anticoagulation
5425432|NCT01607333|Antiepileptics|antiepileptics
5425433|NCT01607333|suicidality|suicidality
5564676|NCT01028651|PAH|pah
5425434|NCT01607320|PCOS|pcos
5410707|NCT01674582|MRI|mri
5425435|NCT01607320|Infertility|infertility
5425436|NCT01607320|Anovulation|anovulation
5425437|NCT01607307|daikenchuto|daikenchuto
5425438|NCT01607307|postoperative ileus|postoperative ileus
5425439|NCT01607307|pancreaticoduodenectomy|pancreaticoduodenectomy
5425440|NCT01607281|anatomical landmark|anatomical landmark
5425441|NCT01607281|internal jugular vein canulation|internal jugular vein canulation
5425442|NCT01607268|autonomic failure|autonomic failure
5425443|NCT01607268|mangenetic resonance|mangenetic resonance
5425444|NCT01607268|neurochemistry|neurochemistry
5425445|NCT01607268|neurotransmitter|neurotransmitter
5425446|NCT01607268|glutamate|glutamate
5425447|NCT01607255|adenoma detection|adenoma detection
5425448|NCT01607255|screening colonoscopy|screening colonoscopy
5425449|NCT01607255|water exchange method|water exchange method
5425450|NCT01607255|chromoendoscopy|chromoendoscopy
5425451|NCT01607242|total thyroidectomy|total thyroidectomy
5425452|NCT01607242|voice handicap index|voice handicap index
5425453|NCT01607242|swallowing disorders|swallowing disorders
5425454|NCT01607242|thyroid surgery|thyroid surgery
5425455|NCT01607242|voice disorders|voice disorders
5425456|NCT01607229|multi-frequency|multi-frequency
5425457|NCT01607229|bioelectrical impedance|bioelectrical impedance
5425458|NCT01607229|body composition|body composition
5425459|NCT01607229|hydration|hydration
5425460|NCT01607216|Prematurity|prematurity
5425461|NCT01607216|Respiratory Illness|respiratory illness
5425462|NCT01607216|Lung Function|lung function
5425463|NCT01607216|Lung Disease|lung disease
5425464|NCT01607203|ovarian hyper stimulation syndrome (OHSS)|ovarian hyper stimulation syndrome (ohss)
5425465|NCT01607203|metaphase II oocytes (MII)|metaphase ii oocytes (mii)
5425466|NCT01607203|good quality embryo's|good quality embryo's
5425467|NCT01607203|implantation|implantation
5425468|NCT01607203|pregnancy|pregnancy
5425469|NCT01607190|type 2 diabetes mellitus|type 2 diabetes mellitus
5425470|NCT01607190|nonproliferative diabetic retinopathy|nonproliferative diabetic retinopathy
5425471|NCT01607164|Mood management|mood management
5425472|NCT01607164|self-help|self-help
5425473|NCT01607164|depression|depression
5425474|NCT01607164|prevention|prevention
5425475|NCT01607164|cognitive behavioral|cognitive behavioral
5425476|NCT01607151|hypothermia|hypothermia
5425477|NCT01607151|normothermia|normothermia
5425478|NCT01607151|hyperthermia|hyperthermia
5425479|NCT01607138|laryngectomy|laryngectomy
5425480|NCT01607138|swallowing disturbances|swallowing disturbances
5425481|NCT01607138|speech disturbances|speech disturbances
5425482|NCT01607138|speech intelligibility|speech intelligibility
5425483|NCT01607138|voice prothesis|voice prothesis
5425484|NCT01607112|Influenza|influenza
5425485|NCT01607112|Healthy|healthy
5425486|NCT01607112|Immunogenicity|immunogenicity
5425487|NCT01607112|Elderly|elderly
5425488|NCT01607112|Safety|safety
5425489|NCT01607112|Adults|adults
5425490|NCT01607099|colonoscopy|colonoscopy
5425491|NCT01607099|bowel cleansing|bowel cleansing
5425492|NCT01607099|bowel cleanness|bowel cleanness
5425493|NCT01607099|efficiency|efficiency
5425494|NCT01607099|compatibility|compatibility
5425495|NCT01607086|Lamotrigine|lamotrigine
5425496|NCT01607086|placebo|placebo
5425497|NCT01607086|properties|properties
5425498|NCT01607086|characteristics|characteristics
5425499|NCT01607073|Dravet|dravet
5425500|NCT01607073|seizures|seizures
5425501|NCT01607073|verapamil|verapamil
5425502|NCT01607060|Critically ill patients|critically ill patients
5425503|NCT01607060|intestinal failure|intestinal failure
5425504|NCT01607047|leptospirosis|leptospirosis
5425505|NCT01607047|qPCR|qpcr
5425506|NCT01607047|cohort|cohort
5425507|NCT01607047|french west indies|french west indies
5425508|NCT01607047|blood sample collection|blood sample collection
5425509|NCT01607047|pronostic|pronostic
5425510|NCT01607047|diagnosis|diagnosis
5425511|NCT01607021|Chronic hepatitis C|chronic hepatitis c
5425512|NCT01607021|interleukin 28|interleukin 28
5425513|NCT01607021|Children|children
5425514|NCT01606995|Stroke|stroke
5425515|NCT01606995|Embolism|embolism
5425516|NCT01606995|Atrial fibrillation|atrial fibrillation
5425517|NCT01606982|prostate|prostate
5425518|NCT01606982|MDV3100|mdv3100
5425519|NCT01606982|cancer|cancer
5425520|NCT01606969|Dexmedetomidine|dexmedetomidine
5425521|NCT01606969|epinephrine|epinephrine
5425522|NCT01606969|lidocaine|lidocaine
5425523|NCT01606969|scalp infiltration|scalp infiltration
5425524|NCT01606969|craniotomy|craniotomy
5425525|NCT01606943|Aortic dissection|aortic dissection
5425526|NCT01606943|Risk factor|risk factor
5425527|NCT01606943|Feature|feature
5425528|NCT01606943|Management|management
5425529|NCT01606943|Outcome|outcome
5425530|NCT01606930|Patient Satisfaction|patient satisfaction
5425531|NCT01606930|Patient Doctor Communication|patient doctor communication
5425532|NCT01606930|Shared Decision Making|shared decision making
5425533|NCT01606930|Patient Activation|patient activation
5425535|NCT01606891|community home visiting parents|community home visiting parents
5425536|NCT01606891|preschooler excess BMI gain|preschooler excess bmi gain
5425537|NCT01606891|multi-setting/component intervention|multi-setting/component intervention
5425538|NCT01606878|Crizotinib|crizotinib
5425539|NCT01606878|Chemotherapy|chemotherapy
5425540|NCT01606878|Solid Tumors|solid tumors
5425541|NCT01606878|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5425542|NCT01606852|sedation|sedation
5425543|NCT01606852|mechanical ventilation|mechanical ventilation
5425545|NCT01606852|respiratory failure|respiratory failure
5425546|NCT01606826|Severe|severe
5425547|NCT01606787|Kidney|kidney
5425548|NCT01606787|MANNITOL|mannitol
5425549|NCT01606787|PLACEBO|placebo
5425550|NCT01606787|Partial Nephrectomy|partial nephrectomy
5425551|NCT01606787|12-079|12-079
5425552|NCT01606761|Arthritis, Rheumatoid|arthritis, rheumatoid
5425553|NCT01606761|Active rheumatoid arthritis despite anti-TNF-alpha therapy|active rheumatoid arthritis despite anti-tnf-alpha therapy
5425554|NCT01606761|Sirukumab|sirukumab
5425555|NCT01606761|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
5425556|NCT01606748|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5425557|NCT01606748|Solid Cancers|solid cancers
5425558|NCT01606748|Non-small Cell Lung Cancer|non-small cell lung cancer
5425559|NCT01606748|NSCLC|nsclc
5425560|NCT01606748|Breast Cancer|breast cancer
5425561|NCT01606735|cataract surgery|cataract surgery
5425562|NCT01606735|ocular inflammation|ocular inflammation
5425563|NCT01606722|Antiretroviral therapy|antiretroviral therapy
5425564|NCT01606722|Boosted-Darunavir monotherapy|boosted-darunavir monotherapy
5425565|NCT01606722|Resistance|resistance
5425566|NCT01606722|Proviral DNA-HIV|proviral dna-hiv
5425567|NCT01606709|GnRHa trigger|gnrha trigger
5425568|NCT01606709|endometrial gene profile|endometrial gene profile
5425569|NCT01606709|quality of life|quality of life
5425571|NCT01606696|cardiac rehabilitation|cardiac rehabilitation
5425572|NCT01606696|fitness|fitness
5425573|NCT01606683|Acidified milk|acidified milk
5425574|NCT01606683|Beta-palmitate|beta-palmitate
5425575|NCT01606683|Bifidobacteria|bifidobacteria
5425576|NCT01606683|Breastfeeding|breastfeeding
5425577|NCT01606683|Infant formula|infant formula
5425578|NCT01606683|Galacto-oligosaccharides|galacto-oligosaccharides
5425579|NCT01606683|Growth|growth
5425581|NCT01606683|Metabolomics|metabolomics
5425582|NCT01606683|Prebiotics|prebiotics
5425583|NCT01606670|Rotigotine|rotigotine
5425584|NCT01606670|Neupro®|neupro®
5425585|NCT01606657|I&D|i&d
5425586|NCT01606657|Abscess|abscess
5425587|NCT01606657|Irrigation|irrigation
5425588|NCT01606657|Cutaneous Abscess|cutaneous abscess
5425589|NCT01606644|radiation sequelae|radiation sequelae
5425590|NCT01606644|hyperbaric oxygen|hyperbaric oxygen
5425591|NCT01606631|severe sepsis|severe sepsis
5425592|NCT01606631|toxic shock|toxic shock
5425593|NCT01606618|Self-esteem|self-esteem
5425594|NCT01606618|Spina Bifida|spina bifida
5425595|NCT01606618|Spinal cord injury|spinal cord injury
5425596|NCT01606605|Lymphoma|lymphoma
5425597|NCT01606605|Prognosis|prognosis
5425598|NCT01606605|Relapse|relapse
5425599|NCT01606605|Gene|gene
5425600|NCT01606605|microRNA|microrna
5425601|NCT01606579|Leukemia|leukemia
5425602|NCT01606579|acute myeloid leukemia|acute myeloid leukemia
5425603|NCT01606579|AML|aml
5425604|NCT01606579|chronic myeloid leukemia|chronic myeloid leukemia
5425605|NCT01606579|CML|cml
5425606|NCT01606579|MDS|mds
5425607|NCT01606579|myelodysplastic syndrome|myelodysplastic syndrome
5425608|NCT01606579|myeloproliferative neoplasia|myeloproliferative neoplasia
5425609|NCT01606579|MPN|mpn
5425610|NCT01606566|Recurrent|recurrent
5425611|NCT01606566|Head and Neck|head and neck
5425612|NCT01606566|Neoplasms|neoplasms
5425613|NCT01606566|Squamous Cell Carcinoma|squamous cell carcinoma
5425614|NCT01606566|Amphinex|amphinex
5425615|NCT01606566|Cancer|cancer
5425616|NCT01606566|Photodynamic therapy|photodynamic therapy
5425617|NCT01606566|Chemotherapy|chemotherapy
5425618|NCT01606566|Bleomycin|bleomycin
5425619|NCT01606553|chronic heart failure|chronic heart failure
5425620|NCT01606553|respiratory muscle weakness|respiratory muscle weakness
5425621|NCT01606553|inspiratory muscle training|inspiratory muscle training
5425622|NCT01606540|Colles fracture|colles fracture
5425623|NCT01606540|Non-steroid antiinflammatory drugs|non-steroid antiinflammatory drugs
5425624|NCT01606540|Bone healing|bone healing
5425625|NCT01606527|Spectrum of Altitude-associated acute mountain sickness|spectrum of altitude-associated acute mountain sickness
5425626|NCT01606527|hypoxia|hypoxia
5425627|NCT01606527|high altitude headache|high altitude headache
5425628|NCT01606527|high altitude cerebral edemat is.....|high altitude cerebral edemat is.....
5425629|NCT01606488|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5425630|NCT01606488|Postoperative Cognitive Decline|postoperative cognitive decline
5425631|NCT01606488|POCD|pocd
5425632|NCT01606488|Alzheimer's disease|alzheimer's disease
5425633|NCT01606488|Florbetapir F 18 (18F-AV-45)|florbetapir f 18 (18f-av-45)
5425634|NCT01606475|Islet transplant|islet transplant
5425635|NCT01606475|Diabetes Mellitus|diabetes mellitus
5410904|NCT01673646|SOM230|som230
5425636|NCT01606475|Hypoglycemia|hypoglycemia
5425637|NCT01606462|oxytocin|oxytocin
5425638|NCT01606462|social cognition|social cognition
5425639|NCT01606462|fMRI|fmri
5425640|NCT01606462|oxytocin receptor gene|oxytocin receptor gene
5425641|NCT01606449|Gastroesophageal reflux diseases|gastroesophageal reflux diseases
5425642|NCT01606449|Hiatal Hernia|hiatal hernia
5425643|NCT01606449|Paraesophageal Hernia|paraesophageal hernia
5425644|NCT01606358|Ovarian Cancer|ovarian cancer
5425645|NCT01606358|Patient with ovarian cancer|patient with ovarian cancer
5425646|NCT01606345|Upper Tract Urothelial Carcinoma|upper tract urothelial carcinoma
5425647|NCT01606345|UTUC|utuc
5425648|NCT01606345|Kidney|kidney
5425649|NCT01606345|Cancer|cancer
5425650|NCT01606345|Renal|renal
5425651|NCT01606319|Asthma|asthma
5425652|NCT01606319|Wheezing|wheezing
5425653|NCT01606319|Ibuprofen|ibuprofen
5425654|NCT01606319|Acetaminophen|acetaminophen
5425655|NCT01606319|exacerbations|exacerbations
5425656|NCT01606319|pain|pain
5425657|NCT01606319|fever|fever
5425658|NCT01606306|Asthma|asthma
5425659|NCT01606306|Wheezing|wheezing
5425660|NCT01606306|Fluticasone|fluticasone
5425661|NCT01606306|Montelukast|montelukast
5425662|NCT01606306|Preschool-age|preschool-age
5425663|NCT01606293|Small cell carcinomas of the cervix|small cell carcinomas of the cervix
5425664|NCT01606293|Large cell carcinomas of the cervix|large cell carcinomas of the cervix
5425665|NCT01606293|Online surveys|online surveys
5425666|NCT01606293|Electronic surveys|electronic surveys
5425667|NCT01606293|Questionnaires|questionnaires
5425668|NCT01606293|Facebook|facebook
5425669|NCT01606293|Social networking support groups|social networking support groups
5425670|NCT01606280|Amyloidosis|amyloidosis
5425671|NCT01606267|Integrated Community Case Management|integrated community case management
5425672|NCT01606267|Pneumonia|pneumonia
5425673|NCT01606267|Ethiopia|ethiopia
5425674|NCT01606254|Schizophrenia|schizophrenia
5425675|NCT01606254|Paliperidone Palmitate|paliperidone palmitate
5425676|NCT01606254|JNS010|jns010
5425677|NCT01606228|Schizophrenia|schizophrenia
5425678|NCT01606228|Paliperidone ER|paliperidone er
5425679|NCT01606228|Treatment naive patients|treatment naive patients
5425680|NCT01606228|Newly diagnosed patients|newly diagnosed patients
5425681|NCT01606215|multiple sclerosis|multiple sclerosis
5425682|NCT01606215|mesenchymal stem cells|mesenchymal stem cells
5425683|NCT01606215|bone marrow|bone marrow
5425684|NCT01606215|rapidly evolving|rapidly evolving
5425685|NCT01606150|neonate|neonate
5425686|NCT01606150|late preterm|late preterm
5425687|NCT01606150|lumbar puncture|lumbar puncture
5425688|NCT01606150|analgesia|analgesia
5425689|NCT01606150|pain|pain
5425690|NCT01606150|lidocaine|lidocaine
5425691|NCT01606098|Surgery|surgery
5425692|NCT01606098|Chemotherapy|chemotherapy
5425693|NCT01606085|Diabetes|diabetes
5425694|NCT01606085|Heart Failure|heart failure
5425695|NCT01606085|Quality of Life|quality of life
5425696|NCT01606085|Self Care|self care
5425697|NCT01606072|DDAVP|ddavp
5425698|NCT01606033|stress|stress
5425699|NCT01606033|Life quality|life quality
5425700|NCT01606033|adjustment strategy|adjustment strategy
5425701|NCT01606033|receiving an antitumor treatment|receiving an antitumor treatment
5425702|NCT01606033|within a clinical trial (case)|within a clinical trial (case)
5425703|NCT01606033|according to a standard treatment (control)|according to a standard treatment (control)
5425704|NCT01606020|effects of sleep deprivation|effects of sleep deprivation
5425705|NCT01606020|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5425706|NCT01606020|male, healthy volunteers|male, healthy volunteers
5425707|NCT01605981|Nilotinib|nilotinib
5425708|NCT01605981|CML patients|cml patients
5425709|NCT01605981|accelerated phase|accelerated phase
5425710|NCT01605968|Obstetrics|obstetrics
5425711|NCT01605968|Gynecology|gynecology
5425712|NCT01605968|Wound healing|wound healing
5425713|NCT01605955|SPO2|spo2
5425714|NCT01605929|Anesthetics, local/administration & dosage|anesthetics, local/administration & dosage
5425715|NCT01605929|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
5425716|NCT01605929|Humans|humans
5425717|NCT01605929|Nerve Block/methods|nerve block/methods
5425718|NCT01605929|Upper Extremity/surgery|upper extremity/surgery
5425719|NCT01605929|Catheters, Indwelling|catheters, indwelling
5425720|NCT01605929|Anesthesia, Conduction/methods|anesthesia, conduction/methods
5425721|NCT01605929|Analgesia/methods|analgesia/methods
5425722|NCT01605929|Nerve Block/adverse effects|nerve block/adverse effects
5425723|NCT01605916|Cancer,|cancer,
5425724|NCT01605916|Tumour,|tumour,
5425725|NCT01605916|Metastatic,|metastatic,
5425726|NCT01605916|Lung cancer,|lung cancer,
5425727|NCT01605916|Non-Small Cell Lung Cancer|non-small cell lung cancer
5425728|NCT01605903|Tonsillectomy|tonsillectomy
5425729|NCT01605903|adenoidectomy|adenoidectomy
5425730|NCT01605903|bleeding|bleeding
5425731|NCT01605903|bleeding rates|bleeding rates
5425732|NCT01605903|Tonsillectomy with and without adenoidectomy|tonsillectomy with and without adenoidectomy
5425733|NCT01605890|HIV-2|hiv-2
5411004|NCT01673243|Cancer|cancer
5425735|NCT01605877|Intraocular lens|intraocular lens
5425736|NCT01605877|Multifocal|multifocal
5425737|NCT01605877|Presbyopia|presbyopia
5425738|NCT01605864|pneumonia|pneumonia
5425739|NCT01605864|community acquired bacterial pneumonia|community acquired bacterial pneumonia
5425741|NCT01605864|CABP|cabp
5425742|NCT01605864|bacterial pneumonia|bacterial pneumonia
5425743|NCT01605851|PFO|pfo
5425744|NCT01605851|closure|closure
5425745|NCT01605838|TBI|tbi
5425746|NCT01605812|IOL;|iol;
5425747|NCT01605812|capsule；|capsule；
5425748|NCT01605812|PCO;|pco;
5425749|NCT01605812|OCT|oct
5425750|NCT01605799|PTSD|ptsd
5425751|NCT01605799|Mental Health|mental health
5425752|NCT01605799|War|war
5425753|NCT01605799|Veterans|veterans
5425754|NCT01605786|Malaria|malaria
5425755|NCT01605786|Plasmodium falciparum|plasmodium falciparum
5425756|NCT01605786|vaccine|vaccine
5425757|NCT01605786|ADCI|adci
5425758|NCT01605786|sporozoite challenge|sporozoite challenge
5425759|NCT01605786|pre-erythrocytic|pre-erythrocytic
5425760|NCT01605786|erythrocytic|erythrocytic
5425761|NCT01605760|immunotherapy|immunotherapy
5425763|NCT01605734|hepatocellular carcinoma|hepatocellular carcinoma
5425764|NCT01605734|transarterial chemoembolization|transarterial chemoembolization
5425765|NCT01605734|sorafenib|sorafenib
5425766|NCT01605721|Everolimus|everolimus
5425767|NCT01605721|XIENCE PRIME|xience prime
5425768|NCT01605721|Drug eluting stent|drug eluting stent
5425769|NCT01605708|Itching|itching
5425770|NCT01605695|reference range|reference range
5425771|NCT01605695|plasma|plasma
5425772|NCT01605695|inducible nitric oxide synthase|inducible nitric oxide synthase
5425773|NCT01605695|iNOS|inos
5425774|NCT01605695|healthy adults|healthy adults
5425775|NCT01605682|effect of different berry doses on mood and cognition|effect of different berry doses on mood and cognition
5425776|NCT01605682|adults|adults
5425777|NCT01605669|Auscultation|auscultation
5425778|NCT01605669|Aortic stenosis|aortic stenosis
5425779|NCT01605669|computer assisted auscultation|computer assisted auscultation
5425780|NCT01605669|Aortic Stenosis Acceleration Index|aortic stenosis acceleration index
5425781|NCT01605656|Cancer Prevention|cancer prevention
5425782|NCT01605656|Cervix|cervix
5425783|NCT01605656|Questionnaires|questionnaires
5425784|NCT01605656|Focus groups|focus groups
5425785|NCT01605656|Surveys|surveys
5425786|NCT01605656|Interviews|interviews
5425787|NCT01605643|cancer|cancer
5425788|NCT01605643|tobacco use|tobacco use
5425789|NCT01605643|pregnancy|pregnancy
5425790|NCT01605604|mindfulness EQ adolescents|mindfulness eq adolescents
5425791|NCT01605591|left-side double lumen bronchial tube|left-side double lumen bronchial tube
5425792|NCT01605591|bending type|bending type
5425793|NCT01605591|GlideScope videolaryngoscope|glidescope videolaryngoscope
5425794|NCT01605552|Depression|depression
5425795|NCT01605552|Depressive Symptoms|depressive symptoms
5425796|NCT01605552|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5425797|NCT01605552|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5425798|NCT01605552|Heart Disease|heart disease
5798666|NCT00111423|Clinical Trials|clinical trials
5425799|NCT01605513|recombinant interferon, tolerated, effective|recombinant interferon, tolerated, effective
5425800|NCT01605500|ICD|icd
5425801|NCT01605474|foley catheter|foley catheter
5425802|NCT01605474|foley bulb|foley bulb
5425803|NCT01605474|induction of labor|induction of labor
5425804|NCT01605474|labor|labor
5425805|NCT01605448|Mild Cognitive Impairment|mild cognitive impairment
5425806|NCT01605448|Alzheimer's disease|alzheimer's disease
5425807|NCT01605448|Meditation|meditation
5425808|NCT01605448|Default Mode Network|default mode network
5425809|NCT01605422|Systematic review and meta-analysis|systematic review and meta-analysis
5425810|NCT01605422|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5425811|NCT01605422|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5425812|NCT01605422|Clinical practice guidelines|clinical practice guidelines
5425813|NCT01605422|Clinical trials|clinical trials
5425814|NCT01605422|Dietary pulses|dietary pulses
5425815|NCT01605422|legumes|legumes
5425816|NCT01605422|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
5425817|NCT01605422|glycemic index|glycemic index
5425818|NCT01605422|postprandial glycemia|postprandial glycemia
5425819|NCT01605422|insulin resistance|insulin resistance
5425820|NCT01605422|body weight|body weight
5425821|NCT01605422|appetite|appetite
5425822|NCT01605422|food intake regulation|food intake regulation
5425823|NCT01605422|satiety|satiety
5425824|NCT01605422|satiation|satiation
5425825|NCT01605409|Refractory cardiac arrest|refractory cardiac arrest
5425826|NCT01605409|Emergency cardiopulmonary bypass|emergency cardiopulmonary bypass
5425827|NCT01605409|Extracorporeal life support in cardiac arrest|extracorporeal life support in cardiac arrest
5425828|NCT01605383|Avascular Necrosis of Femur Head|avascular necrosis of femur head
5425829|NCT01605383|Osteonecrosis of the hip|osteonecrosis of the hip
5425830|NCT01605383|Osteonecrosis of the femoral head|osteonecrosis of the femoral head
5425831|NCT01605383|Mesenchymal Stem Cells|mesenchymal stem cells
5425832|NCT01605383|Bone marrow|bone marrow
5425833|NCT01605383|Tissue engineering|tissue engineering
5425834|NCT01605383|Bone Diseases|bone diseases
5425835|NCT01605383|Musculoskeletal Diseases|musculoskeletal diseases
5425836|NCT01605370|Hypertension, Left Ventricular Mass|hypertension, left ventricular mass
5425837|NCT01605357|Brain Injuries|brain injuries
5425838|NCT01605357|Hematoma, subdural|hematoma, subdural
5425839|NCT01605357|Decompressive Craniectomy|decompressive craniectomy
5425840|NCT01605357|Saline solution, hypertonic|saline solution, hypertonic
5425841|NCT01605357|Hypernatremia|hypernatremia
5425842|NCT01605357|Intracranial hemorrhages|intracranial hemorrhages
5425843|NCT01605357|Head Injuries, closed|head injuries, closed
5425844|NCT01605357|Intracranial pressure|intracranial pressure
5425845|NCT01605357|Brain edema|brain edema
5425846|NCT01605357|Critical care|critical care
5425847|NCT01605357|Brain Diseases|brain diseases
5425848|NCT01605357|Central Nervous System Diseases|central nervous system diseases
5425849|NCT01605357|Nervous System Diseases|nervous system diseases
5425850|NCT01605357|Wounds and Injuries|wounds and injuries
5425851|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs
5425852|NCT01605357|Pharmacologic Actions|pharmacologic actions
5425853|NCT01605344|Advanced colon cancer|advanced colon cancer
5425854|NCT01605344|Advanced rectal cancer|advanced rectal cancer
5425855|NCT01605344|Metastatic colon cancer|metastatic colon cancer
5425856|NCT01605344|Metastatic rectal cancer|metastatic rectal cancer
5425857|NCT01605344|Lipitor|lipitor
5425858|NCT01605344|Atorvastatin|atorvastatin
5425859|NCT01605344|FOLFIRI|folfiri
5425860|NCT01605331|Adults|adults
5425861|NCT01605331|GH deficiency|gh deficiency
5425862|NCT01605318|metastatic colorectal cancer|metastatic colorectal cancer
5425863|NCT01605318|colon cancer|colon cancer
5425864|NCT01605318|rectal cancer|rectal cancer
5425865|NCT01605318|previously treated|previously treated
5425866|NCT01605292|Transradial catheterization|transradial catheterization
5425867|NCT01605292|Ultrasound|ultrasound
5425868|NCT01605292|Radial artery|radial artery
5425869|NCT01605279|Low superior vena cava flow|low superior vena cava flow
5425870|NCT01605279|Functional echocardiography|functional echocardiography
5425871|NCT01605266|pediatric|pediatric
5425872|NCT01605266|kidney disease|kidney disease
5425873|NCT01605266|minimal change disease|minimal change disease
5425874|NCT01605266|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5425875|NCT01605266|nephrotic syndrome|nephrotic syndrome
5425876|NCT01605253|Post-traumatic stress disorder|post-traumatic stress disorder
5425877|NCT01605253|sleep disturbance|sleep disturbance
5425878|NCT01605253|insomnia|insomnia
5425879|NCT01605253|cytokines|cytokines
5425880|NCT01605253|anxiety|anxiety
5425881|NCT01605253|traumatic event|traumatic event
5425882|NCT01605253|memory|memory
5425883|NCT01605240|Fracture pain|fracture pain
5425884|NCT01605240|Fracture reduction|fracture reduction
5425885|NCT01605240|Analgesia|analgesia
5425886|NCT01605240|Acetaminophen|acetaminophen
5425887|NCT01605240|Ibuprofen|ibuprofen
5425888|NCT01605240|Codeine|codeine
5425889|NCT01605240|Pediatric|pediatric
5425890|NCT01605240|Fracture Pain Analgesia in Pediatric population|fracture pain analgesia in pediatric population
5425891|NCT01605227|prostate cancer|prostate cancer
5846720|NCT00043654|Manic-Depressive Disorder|manic-depressive disorder
5425892|NCT01605227|castration resistant prostate cancer|castration resistant prostate cancer
5425893|NCT01605227|bone pain|bone pain
5425894|NCT01605227|CRPC|crpc
5425895|NCT01605214|Extravascular Lung Water|extravascular lung water
5425896|NCT01605214|Transpulmonary Thermodilution|transpulmonary thermodilution
5425897|NCT01605214|Primary Graft Dysfunction|primary graft dysfunction
5425898|NCT01605214|Ischemia Reperfusion Injury|ischemia reperfusion injury
5425899|NCT01605201|Chondral lesions in the knee after traumatic injury|chondral lesions in the knee after traumatic injury
5425900|NCT01605175|Inflammatory Bowel Disease|inflammatory bowel disease
5425901|NCT01605175|Predictors Mucosal Healing|predictors mucosal healing
5425902|NCT01605149|Diabetes|diabetes
5425903|NCT01605136|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5425904|NCT01605136|EPP|epp
5425905|NCT01605136|Afamelanotide|afamelanotide
5425906|NCT01605123|endothelial function|endothelial function
5425907|NCT01605123|children|children
5425908|NCT01605123|obesity|obesity
5425909|NCT01605123|cardiovascular dysfunction|cardiovascular dysfunction
5425910|NCT01605123|carotid intima media thickness|carotid intima media thickness
5425911|NCT01605123|blood pressure|blood pressure
5425912|NCT01605123|oral glucose tolerance test|oral glucose tolerance test
5425913|NCT01605110|blepharoplasty|blepharoplasty
5425914|NCT01605110|hyperbaric|hyperbaric
5425915|NCT01605110|oxygen|oxygen
5425916|NCT01605110|ecchymosis|ecchymosis
5425917|NCT01605110|edema|edema
5425918|NCT01605110|wound|wound
5425919|NCT01605110|healing|healing
5425920|NCT01605097|prostate neoplasms|prostate neoplasms
5425921|NCT01605097|interstitial radiation|interstitial radiation
5425922|NCT01605097|High dose rate prostate brachytherapy|high dose rate prostate brachytherapy
5425923|NCT01605097|dose escalation|dose escalation
5425924|NCT01605071|menopause|menopause
5425925|NCT01605071|estrogen|estrogen
5425926|NCT01605071|insulin sensitivity|insulin sensitivity
5425927|NCT01605071|estrogen receptors|estrogen receptors
5425929|NCT01605045|Radiation|radiation
5565303|NCT01025713|CF|cf
5425930|NCT01605019|Ventricular Assist Devices|ventricular assist devices
5425931|NCT01605019|Heart assist pumps|heart assist pumps
5425932|NCT01605019|heart pumps|heart pumps
5425933|NCT01605019|sealant agents|sealant agents
5425934|NCT01605006|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5425935|NCT01605006|ALS|als
5425936|NCT01605006|motor neuron disease|motor neuron disease
5425937|NCT01605006|diaphragm|diaphragm
5425938|NCT01605006|diaphragm pacing|diaphragm pacing
5425939|NCT01605006|diaphragmatic pacing|diaphragmatic pacing
5425940|NCT01605006|phrenic pacing|phrenic pacing
5425941|NCT01605006|phrenic nerve|phrenic nerve
5425942|NCT01605006|phrenic nerve stimulation|phrenic nerve stimulation
5425943|NCT01605006|NeuRx DPS|neurx dps
5425944|NCT01605006|DPS|dps
5425945|NCT01605006|chronic hypoventilation|chronic hypoventilation
5425946|NCT01605006|respiration|respiration
5425947|NCT01605006|ventilation|ventilation
5425948|NCT01605006|breathing|breathing
5425949|NCT01605006|Humanitarian Device Exemption|humanitarian device exemption
5425950|NCT01605006|HDE|hde
5425951|NCT01605006|post-approval study|post-approval study
5425952|NCT01604993|Dietary Nitrates|dietary nitrates
5425953|NCT01604993|Arterial Stiffness|arterial stiffness
5425954|NCT01604993|Vascular|vascular
5425955|NCT01604993|Blood pressure|blood pressure
5425956|NCT01604954|Food labeling|food labeling
5425957|NCT01604928|Overactive Bladder|overactive bladder
5425958|NCT01604928|YM178|ym178
5425959|NCT01604928|Mirabegron|mirabegron
5425960|NCT01604928|Frequency|frequency
5425961|NCT01604928|Urinary urge incontinence|urinary urge incontinence
5425962|NCT01604928|Urgency|urgency
5425963|NCT01604928|Urinary incontinence|urinary incontinence
5425964|NCT01604928|Micturition|micturition
5425965|NCT01604902|Psoriasis mRNA and miRNA|psoriasis mrna and mirna
5425966|NCT01604889|Melanoma, Skin Cancer, Oncology|melanoma, skin cancer, oncology
5425967|NCT01604876|Parkinson's disease|parkinson's disease
5425968|NCT01604876|depression|depression
5425969|NCT01604876|light therapy|light therapy
5425970|NCT01604876|sleeping problems|sleeping problems
5425971|NCT01604863|Solid Tumors|solid tumors
5425972|NCT01604863|Cancer|cancer
5425973|NCT01604863|Lung Cancer|lung cancer
5425974|NCT01604863|Prostate Cancer|prostate cancer
5425975|NCT01604863|Mesothelioma|mesothelioma
5425976|NCT01604863|Small Cell lung Cancer|small cell lung cancer
5425977|NCT01604850|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5425978|NCT01604850|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5425979|NCT01604850|HCV|hcv
5425980|NCT01604850|Sustained Virologic Response|sustained virologic response
5425981|NCT01604850|Direct Acting Antiviral|direct acting antiviral
5425982|NCT01604850|Combination Therapy|combination therapy
5425983|NCT01604850|Treatment Experienced|treatment experienced
5425984|NCT01604850|GS-7977|gs-7977
5425985|NCT01604850|Ribavirin|ribavirin
5425986|NCT01604837|superior hypogastric plexus block|superior hypogastric plexus block
5408823|NCT01682746|GBM|gbm
5425987|NCT01604837|pelvic malignancy|pelvic malignancy
5425988|NCT01604837|chronic pelvic pain|chronic pelvic pain
5425989|NCT01604798|proteomics|proteomics
5425990|NCT01604798|serum peptides|serum peptides
5425991|NCT01604798|colorectal cancer|colorectal cancer
5425992|NCT01604798|MALDI-TOF MS|maldi-tof ms
5425993|NCT01604785|Migraine Headache|migraine headache
5425994|NCT01604785|Pediatric|pediatric
5425995|NCT01604759|Mouth Neoplasms|mouth neoplasms
5425996|NCT01604759|Mouth Diseases|mouth diseases
5425997|NCT01604733|Multi-Center Survey|multi-center survey
5425998|NCT01604733|patients currently on lipid-lowering pharmacological treatment|patients currently on lipid-lowering pharmacological treatment
5425999|NCT01604733|level of Control of Hypercholesterolemia in Egypt|level of control of hypercholesterolemia in egypt
5426000|NCT01604720|sample size|sample size
5426001|NCT01604720|liver disease|liver disease
5426002|NCT01604707|stress|stress
5426003|NCT01604707|anxiety|anxiety
5426004|NCT01604707|depression|depression
5426005|NCT01604707|quality of life|quality of life
5426006|NCT01604694|Abdominoplasty|abdominoplasty
5426007|NCT01604694|Transversus Abdominis Plane (TAP) Block|transversus abdominis plane (tap) block
5426008|NCT01604694|levobupivacaine|levobupivacaine
5426009|NCT01604694|Placebo|placebo
5426010|NCT01604681|Linseed Oil|linseed oil
5426011|NCT01604681|Oxidative Stress|oxidative stress
5426012|NCT01604681|Polymorphism, Genetic|polymorphism, genetic
5426013|NCT01604681|Cardiovascular Diseases|cardiovascular diseases
5426014|NCT01604655|Chest pain|chest pain
5426015|NCT01604655|shortness of breath|shortness of breath
5426016|NCT01604655|suspected acute coronary syndrome|suspected acute coronary syndrome
5426017|NCT01604655|stress testing|stress testing
5426018|NCT01604655|coronary computed tomography angiography|coronary computed tomography angiography
5426019|NCT01604629|Spondylarthropathies|spondylarthropathies
5426020|NCT01604629|Persistent clinical remission with anti-TNF therapy|persistent clinical remission with anti-tnf therapy
5426021|NCT01604629|Standardized protocol for dose reduction anti-TNF therapy|standardized protocol for dose reduction anti-tnf therapy
5426022|NCT01604590|Glioblastoma|glioblastoma
5426023|NCT01604590|Imaging Biomarkers|imaging biomarkers
5426031|NCT01604564|IPAA|ipaa
5426032|NCT01604512|Brain tumor|brain tumor
5426033|NCT01604512|MRI Perfusion|mri perfusion
5426034|NCT01604512|FDG PET/CT|fdg pet/ct
5426035|NCT01604512|12-067|12-067
5426036|NCT01604499|Healthy eating|healthy eating
5426037|NCT01604499|Incentives|incentives
5426038|NCT01604499|Feedback|feedback
5426039|NCT01604486|Myocardial infarction|myocardial infarction
5426040|NCT01604486|Ischaemic preconditioning|ischaemic preconditioning
5426041|NCT01604486|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5426042|NCT01604486|General Practice Research Database|general practice research database
5426043|NCT01604486|Hospital Episode Statistics|hospital episode statistics
5426044|NCT01604486|Office for National Statistics|office for national statistics
5426045|NCT01604473|Chronic Kidney Disease|chronic kidney disease
5426046|NCT01604473|CKD|ckd
5426047|NCT01604473|ESRD|esrd
5426048|NCT01604473|AV Fistula|av fistula
5426049|NCT01604473|Arterio-venous fistula|arterio-venous fistula
5426050|NCT01604473|hemodialysis|hemodialysis
5426051|NCT01604460|Hypothermia|hypothermia
5426052|NCT01604460|Newborn|newborn
5426053|NCT01604460|Plastic bag|plastic bag
5426054|NCT01604460|Resuscitation|resuscitation
5426055|NCT01604447|Hypothermia|hypothermia
5426056|NCT01604447|Newborn|newborn
5426057|NCT01604447|Incubator|incubator
5426058|NCT01604447|Plastic bag|plastic bag
5426059|NCT01604447|Normothermia|normothermia
5426060|NCT01604434|Hypothermia|hypothermia
5426061|NCT01604434|Low birth Weight|low birth weight
5426062|NCT01604434|Newborn|newborn
5426063|NCT01604434|Incubator|incubator
5426064|NCT01604434|Plastic bag|plastic bag
5426065|NCT01604421|Hypothermia|hypothermia
5426066|NCT01604421|Low birth weight|low birth weight
5426067|NCT01604421|Newborn|newborn
5426068|NCT01604421|Plastic bag|plastic bag
5426069|NCT01604421|Thermoregulation|thermoregulation
5426070|NCT01604395|GHD|ghd
5426071|NCT01604395|TS|ts
5426072|NCT01604395|CRF|crf
5426073|NCT01604395|SGA|sga
5426074|NCT01604395|ISS|iss
5426075|NCT01604382|Total Knee Arthroplasty (TKA)|total knee arthroplasty (tka)
5426076|NCT01604369|Atrial flutter|atrial flutter
5426077|NCT01604369|Cryoablation|cryoablation
5426078|NCT01604369|Cavotricuspid isthmus|cavotricuspid isthmus
5426079|NCT01604369|Visual analogue scale|visual analogue scale
5426080|NCT01604356|retinitis pigmentosa|retinitis pigmentosa
5426081|NCT01604343|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
5426082|NCT01604343|Sirukumab|sirukumab
5426083|NCT01604343|Human Anti-IL-6 monoclonal antibody|human anti-il-6 monoclonal antibody
5426084|NCT01604330|High dose baclofen|high dose baclofen
5426085|NCT01604330|Alcoholism|alcoholism
5426086|NCT01604330|Abstinence|abstinence
5426087|NCT01604330|Low risk consumption|low risk consumption
5426088|NCT01604330|Craving|craving
5426089|NCT01604317|Hypothermia|hypothermia
5426090|NCT01604317|Low birth Weight|low birth weight
5426091|NCT01604317|Newborn|newborn
5426092|NCT01604317|Resuscitation|resuscitation
5426093|NCT01604317|Plastic bag|plastic bag
5426094|NCT01604304|stone|stone
5426095|NCT01604304|calculi|calculi
5426096|NCT01604304|kidney|kidney
5426097|NCT01604304|renal treatment|renal treatment
5426098|NCT01604304|flexible ureteroscopy|flexible ureteroscopy
5426099|NCT01604304|extracoporeal shockwave lithotripsy|extracoporeal shockwave lithotripsy
5426100|NCT01604304|retrograde intra renal surgery|retrograde intra renal surgery
5426101|NCT01604278|Indacaterol|indacaterol
5426102|NCT01604278|Glycopyrronium Bromide|glycopyrronium bromide
5426103|NCT01604278|COPD|copd
5426104|NCT01604278|bronchodilation|bronchodilation
5426105|NCT01604239|Osteoarthritis|osteoarthritis
5426106|NCT01604239|Shinbaro|shinbaro
5426107|NCT01604239|Herbal drug|herbal drug
5426108|NCT01604226|total intravenous anesthesia|total intravenous anesthesia
5426109|NCT01604226|Bispectral index monitoring|bispectral index monitoring
5426110|NCT01604226|propofol|propofol
5426111|NCT01604226|remifentanil|remifentanil
5426112|NCT01604213|Type 2 diabetes mellitus|type 2 diabetes mellitus
5426113|NCT01604213|vildagliptin|vildagliptin
5426114|NCT01604213|metformin|metformin
5426115|NCT01604213|atherosclerosis|atherosclerosis
5426116|NCT01604213|inflammation|inflammation
5426117|NCT01604213|interleukin-6|interleukin-6
5426118|NCT01604213|TNF|tnf
5426119|NCT01604213|atherothrombosis|atherothrombosis
5426120|NCT01604213|adiponectin|adiponectin
5426121|NCT01604213|MMP-9|mmp-9
5426122|NCT01604213|hs-CRP|hs-crp
5426124|NCT01604200|dentistry|dentistry
5426125|NCT01604200|blood pressure|blood pressure
5426126|NCT01604200|measurement|measurement
5426127|NCT01604200|screening|screening
5426128|NCT01604200|qualitative research|qualitative research
5426129|NCT01604187|sublingual fentanyl|sublingual fentanyl
5565541|NCT01024894|taiwan|taiwan
5426130|NCT01604187|pain in coloscopy|pain in coloscopy
5426131|NCT01604187|The efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.|the efficacy and safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
5426132|NCT01604174|knee|knee
5426133|NCT01604174|osteoarthritis|osteoarthritis
5426134|NCT01604174|arthroplasty|arthroplasty
5426135|NCT01604174|rehabilitation|rehabilitation
5426136|NCT01604148|Holmium Laser Enucleation of Prostate|holmium laser enucleation of prostate
5426137|NCT01604135|Collagen crosslinking|collagen crosslinking
5426138|NCT01604135|Keratoconus|keratoconus
5426139|NCT01604122|Survey|survey
5426140|NCT01604122|burden of illness|burden of illness
5426141|NCT01604122|caregivers|caregivers
5426142|NCT01604122|TTR-FAP|ttr-fap
5426143|NCT01604122|TTR-CM|ttr-cm
5426144|NCT01604122|familial amyloid polyneuropathy|familial amyloid polyneuropathy
5426145|NCT01604122|observational|observational
5426146|NCT01604122|transthyretin familial amyloidosis|transthyretin familial amyloidosis
5426147|NCT01604109|Caries detection/diagnosis/prevention|caries detection/diagnosis/prevention
5426148|NCT01604109|Preventive Dentistry|preventive dentistry
5426149|NCT01604109|Casien Phosphopeptide|casien phosphopeptide
5426150|NCT01604109|Remineralization|remineralization
5426151|NCT01604109|Clinical trial|clinical trial
5426152|NCT01604096|Information|information
5426153|NCT01604096|campaign|campaign
5426154|NCT01604096|antibiotics|antibiotics
5426155|NCT01604096|bacterial resistance|bacterial resistance
5426156|NCT01604096|primary care|primary care
5426157|NCT01604083|transfusion|transfusion
5426158|NCT01604083|packed red blood cells (PRBC)|packed red blood cells (prbc)
5426159|NCT01604083|Transfusion Practice|transfusion practice
5426160|NCT01604083|Transfusion habits|transfusion habits
5426161|NCT01604083|Outcome|outcome
5426162|NCT01604083|elective surgery|elective surgery
5426163|NCT01604083|ETPOS|etpos
5426165|NCT01604083|European Society of Anaesthesiology|european society of anaesthesiology
5426166|NCT01604070|Hammertoe deformity|hammertoe deformity
5426167|NCT01604070|podiatry|podiatry
5426168|NCT01604031|B-CLL|b-cll
5426169|NCT01604031|vaccine|vaccine
5426170|NCT01604031|Lenalidomide|lenalidomide
5426171|NCT01604031|CTL|ctl
5426172|NCT01604018|Cat Allergy|cat allergy
5426173|NCT01604018|Rhinoconjunctivitis|rhinoconjunctivitis
5426174|NCT01604005|Mesothelioma|mesothelioma
5426175|NCT01604005|radiotherapy|radiotherapy
5426302|NCT01603472|long-term PN|long-term pn
5426176|NCT01604005|prophylactic irradiation of tracts|prophylactic irradiation of tracts
5426177|NCT01603992|Cannabis|cannabis
5426178|NCT01603992|Craving|craving
5426179|NCT01603992|Questionnaire|questionnaire
5426180|NCT01603992|Non-Treatment|non-treatment
5426182|NCT01603979|AV203|av203
5426183|NCT01603979|Solid Tumors|solid tumors
5426184|NCT01603979|ERBB3|erbb3
5426185|NCT01603979|Monoclonal Antibody|monoclonal antibody
5426186|NCT01603979|HER3|her3
5426187|NCT01603966|platelet|platelet
5426188|NCT01603966|aggregation|aggregation
5426189|NCT01603966|aspirin|aspirin
5426190|NCT01603966|inhibition|inhibition
5426191|NCT01603966|reactivity|reactivity
5426192|NCT01603940|Hypertension|hypertension
5426193|NCT01603940|Diabetes Mellitus|diabetes mellitus
5426194|NCT01603940|Vascular stiffness|vascular stiffness
5426195|NCT01603940|Endothelial function|endothelial function
5426196|NCT01603914|burns, catheter related bacteremia,|burns, catheter related bacteremia,
5426197|NCT01603914|infection, central venous catheter,|infection, central venous catheter,
5426198|NCT01603914|catheter-related bloodstream, adult critically ill patients|catheter-related bloodstream, adult critically ill patients
5426199|NCT01603888|children with heart disease|children with heart disease
5426201|NCT01603888|healthy newborns|healthy newborns
5426202|NCT01603875|CPRV|cprv
5426203|NCT01603875|SPEEDA|speeda
5426204|NCT01603875|intradermal|intradermal
5426205|NCT01603875|pre-exposure|pre-exposure
5426206|NCT01603875|booster|booster
5426207|NCT01603849|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5426208|NCT01603849|Lung Cancer|lung cancer
5426209|NCT01603849|Non Small Cell Lung Cancer|non small cell lung cancer
5426210|NCT01603849|Carcinoembryonic Antigen|carcinoembryonic antigen
5426211|NCT01603836|Lumbar spine|lumbar spine
5426212|NCT01603836|Posterolateral fusion|posterolateral fusion
5426213|NCT01603836|Allograft|allograft
5426214|NCT01603836|Bone marrow concentrate|bone marrow concentrate
5426215|NCT01603836|Mesenchymal stem cells|mesenchymal stem cells
5426216|NCT01603836|Fusion rate|fusion rate
5426217|NCT01603784|exercise|exercise
5426218|NCT01603784|cognition|cognition
5426219|NCT01603784|memory|memory
5426220|NCT01603784|adult|adult
5426221|NCT01603771|Adult|adult
5426222|NCT01603771|Exercise|exercise
5426226|NCT01603758|Spectrometry, mass|spectrometry, mass
5426227|NCT01603758|Deuterium|deuterium
5426228|NCT01603758|Kinetics|kinetics
5426229|NCT01603758|Cholesterol absorption|cholesterol absorption
5426230|NCT01603758|Coronary Heart Disease|coronary heart disease
5426231|NCT01603732|Strep exposure and heart defects|strep exposure and heart defects
5426233|NCT01603719|prebiotics|prebiotics
5426234|NCT01603719|beta-palmitate|beta-palmitate
5426235|NCT01603719|stool flora|stool flora
5426236|NCT01603719|bifidogenic|bifidogenic
5426237|NCT01603563|Stepped Care|stepped care
5426238|NCT01603563|Trauma-Focused Cognitive Behavioral Therapy|trauma-focused cognitive behavioral therapy
5426239|NCT01603563|Preschool children|preschool children
5426240|NCT01603550|energy restriction|energy restriction
5426241|NCT01603550|sleep deprivation|sleep deprivation
5426242|NCT01603550|cognitive performance|cognitive performance
5426243|NCT01603550|brain function|brain function
5426244|NCT01603537|Traumatic injuries|traumatic injuries
5426245|NCT01603537|Prehospital Trauma Life Support|prehospital trauma life support
5426246|NCT01603537|Traffic accidents|traffic accidents
5426247|NCT01603524|Ottawa Model for Smoking Cessation|ottawa model for smoking cessation
5426248|NCT01603524|Primary Care|primary care
5426249|NCT01603511|rewarming|rewarming
5426250|NCT01603511|core cooling|core cooling
5426251|NCT01603511|afterdrop|afterdrop
5426252|NCT01603511|pre-hospital treatment|pre-hospital treatment
5426253|NCT01603511|hypothermia|hypothermia
5426254|NCT01603498|pain measurement,|pain measurement,
5426255|NCT01603498|edema,|edema,
5426256|NCT01603498|trismus|trismus
5426257|NCT01603407|prednisone|prednisone
5426258|NCT01603407|deflazacort|deflazacort
5426259|NCT01603407|muscular dystrophy|muscular dystrophy
5426260|NCT01603407|neuromuscular disease|neuromuscular disease
5426261|NCT01603407|multi-center|multi-center
5426262|NCT01603823|vitrectomy|vitrectomy
5426263|NCT01603823|cataract|cataract
5426264|NCT01603823|macular edema|macular edema
5426265|NCT01603810|Basal cell carcinoma|basal cell carcinoma
5426266|NCT01603810|Optical Coherence Tomography|optical coherence tomography
5426267|NCT01603797|internetdelivered CBT|internetdelivered cbt
5426268|NCT01603797|chronic pain|chronic pain
5426269|NCT01603797|acceptance and commitment therapy|acceptance and commitment therapy
5426270|NCT01603797|mindfulness|mindfulness
5426271|NCT01603797|guided self help|guided self help
5426272|NCT01603745|PCOS|pcos
5426273|NCT01603706|Heart failure|heart failure
5426274|NCT01603706|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5426275|NCT01603706|CRT|crt
5426276|NCT01603706|Radial strain echocardiography|radial strain echocardiography
5426277|NCT01603706|Ischemic cardiomyopathy|ischemic cardiomyopathy
5426278|NCT01603693|Guided bone regeneration|guided bone regeneration
5426279|NCT01603693|Bio Oss|bio oss
5426280|NCT01603693|BondBone|bondbone
5426281|NCT01603693|computerized tomography|computerized tomography
5426282|NCT01603693|histological examination|histological examination
5426284|NCT01603680|Block nerve|block nerve
5426285|NCT01603680|Anaesthesia|anaesthesia
5426286|NCT01603680|Carpal tunnel syndrome|carpal tunnel syndrome
5426287|NCT01603654|Colon preparation|colon preparation
5426288|NCT01603654|Colonoscopy|colonoscopy
5426289|NCT01603654|Polyethylene glycol|polyethylene glycol
5426290|NCT01603654|Sodium Picosulphate|sodium picosulphate
5426291|NCT01603589|coronary artery disease|coronary artery disease
5429484|NCT01590108|IPAH|ipah
5426292|NCT01603589|coronary artery bypass grafting|coronary artery bypass grafting
5426293|NCT01603589|cardiopulmonary bypass|cardiopulmonary bypass
5426294|NCT01603589|minimal extracorporeal circulation|minimal extracorporeal circulation
5426295|NCT01603485|Bioavailability|bioavailability
5426296|NCT01603485|Pharmacokinetics|pharmacokinetics
5409117|NCT01681589|TBI|tbi
5426297|NCT01603485|Lersivirine|lersivirine
5426298|NCT01603485|Modified-release|modified-release
5426299|NCT01603472|pediatric|pediatric
5426300|NCT01603472|parenteral nutrition|parenteral nutrition
5426301|NCT01603472|bone disease|bone disease
5426303|NCT01603446|pediatric|pediatric
5426304|NCT01603446|MELAS|melas
5426305|NCT01603446|mechanism of action of L-arginine|mechanism of action of l-arginine
5426306|NCT01603420|prostate|prostate
5426307|NCT01603420|cancer|cancer
5426308|NCT01603420|radiation|radiation
5426309|NCT01603420|proton|proton
5426310|NCT01603420|chemotherapy|chemotherapy
5426311|NCT01603420|high risk|high risk
5426312|NCT01603368|Probiotics|probiotics
5426313|NCT01603368|Lactobacillus reuteri|lactobacillus reuteri
5426314|NCT01603368|Prematures|prematures
5426315|NCT01603368|Enteral feeding|enteral feeding
5426316|NCT01603368|Motility|motility
5426317|NCT01603368|Necrotizing enterocolitis|necrotizing enterocolitis
5426318|NCT01603368|Sepsis|sepsis
5426319|NCT01603368|Weight|weight
5426320|NCT01603355|JIA|jia
5426321|NCT01603329|medication adherence|medication adherence
5426322|NCT01603329|diabetes|diabetes
5426323|NCT01603329|hypertension|hypertension
5426324|NCT01603329|cholesterol|cholesterol
5426325|NCT01603329|statins|statins
5426326|NCT01603316|Food pantry|food pantry
5426327|NCT01603316|Food voucher|food voucher
5426328|NCT01603316|Grocery delivery|grocery delivery
5426329|NCT01603316|12-099|12-099
5426330|NCT01603303|Breast Cancer|breast cancer
5426331|NCT01603303|Localized breast cancer|localized breast cancer
5426332|NCT01603303|Postmenopausal women|postmenopausal women
5426333|NCT01603303|Aromatase inhibitor|aromatase inhibitor
5426335|NCT01603303|Questionnaires|questionnaires
5426336|NCT01603303|Surveys|surveys
5426337|NCT01603303|Luvena|luvena
5426338|NCT01603303|Internet based website|internet based website
5426339|NCT01603303|Phone counseling|phone counseling
5426340|NCT01603303|Water-based vaginal lubricant|water-based vaginal lubricant
5426341|NCT01603303|Hyalo-Gyn|hyalo-gyn
5426342|NCT01603290|Acute leukemia,|acute leukemia,
5426343|NCT01603290|Chemotherapy,|chemotherapy,
5426344|NCT01603290|Cancer-Related Fatigue,|cancer-related fatigue,
5426345|NCT01603290|Physical Fitness|physical fitness
5426346|NCT01603277|Asthma|asthma
5426347|NCT01603277|GM-CSF|gm-csf
5426348|NCT01603277|Moderate-to-Severe Asthma|moderate-to-severe asthma
5426349|NCT01603264|Bioequivalence|bioequivalence
5426350|NCT01603264|Biosimilarity|biosimilarity
5426351|NCT01603264|Similarity|similarity
5426352|NCT01603264|PK|pk
5426353|NCT01603264|Phase I|phase i
5426354|NCT01603264|Trastuzumab|trastuzumab
5426355|NCT01603264|Healthy Male Volunteers|healthy male volunteers
5426356|NCT01603264|Single-dose|single-dose
5426357|NCT01603264|HER-2|her-2
5426358|NCT01603264|Oncology|oncology
5426359|NCT01603251|transmission|transmission
5426360|NCT01603251|anopheles|anopheles
5426361|NCT01603225|Autism|autism
5398832|NCT01727232|ITP|itp
5426362|NCT01603225|tDCS|tdcs
5426363|NCT01603212|Melanoma|melanoma
5426364|NCT01603212|Metastatic melanoma|metastatic melanoma
5426365|NCT01603212|Advanced melanoma|advanced melanoma
5426366|NCT01603212|Vemurafenib|vemurafenib
5426367|NCT01603212|PLX4032|plx4032
5426368|NCT01603212|RO5185426|ro5185426
5426369|NCT01603212|IL-2|il-2
5426370|NCT01603212|Interleukin-2|interleukin-2
5426371|NCT01603212|Aldesleukin|aldesleukin
5426372|NCT01603212|Proleukin|proleukin
5426373|NCT01603212|Interferon Alfa-2b|interferon alfa-2b
5426374|NCT01603212|Intron A|intron a
5426375|NCT01603160|Sickle Cell Disease|sickle cell disease
5426376|NCT01603160|Emergency Department|emergency department
5426377|NCT01603160|Quality Improvement|quality improvement
5426378|NCT01603147|methamphetamine|methamphetamine
5426379|NCT01603147|monoclonal antibody|monoclonal antibody
5426380|NCT01603121|lisofylline|lisofylline
5426381|NCT01603108|Liver Transplant Recipient|liver transplant recipient
5426382|NCT01603108|Recurrent Fibrosis|recurrent fibrosis
5426383|NCT01603095|Achondroplasia|achondroplasia
5426384|NCT01603095|dwarfism|dwarfism
5426385|NCT01603069|Parkinson's disease|parkinson's disease
5426386|NCT01603069|Safety|safety
5426387|NCT01603069|Tolerability|tolerability
5426388|NCT01603056|House dust mite induced allergic rhinitis.|house dust mite induced allergic rhinitis.
5426389|NCT01603043|Geographic Atrophy|geographic atrophy
5426390|NCT01603043|Age-Related Macular Degeneration|age-related macular degeneration
5426391|NCT01603043|Intravitreal injection|intravitreal injection
5426392|NCT01603030|Moxifloxacin|moxifloxacin
5426393|NCT01603030|Prednisolone|prednisolone
5426395|NCT01603017|Magnetic Resonance Therapy|magnetic resonance therapy
5426396|NCT01603017|Osteoarthrosis|osteoarthrosis
5426397|NCT01603017|Osteoarthritis|osteoarthritis
5426398|NCT01603004|MRI|mri
5426399|NCT01603004|CT|ct
5426400|NCT01603004|12-058|12-058
5426401|NCT01602991|Obesity|obesity
5426402|NCT01602991|Endoscopy|endoscopy
5426403|NCT01602991|Nasopharyngoesophagogastroscopy|nasopharyngoesophagogastroscopy
5426404|NCT01602991|Bariatric Surgery|bariatric surgery
5426405|NCT01602991|Gastric Bypass Surgery|gastric bypass surgery
5426406|NCT01602965|obesity|obesity
5426407|NCT01602965|counselling|counselling
5426408|NCT01602965|weight loss|weight loss
5426409|NCT01602952|Radotinib|radotinib
5426410|NCT01602952|CML-CP, AP|cml-cp, ap
5426411|NCT01602939|Mast cell|mast cell
5426412|NCT01602939|Mastocytosis|mastocytosis
5426413|NCT01602939|Mast cell disease|mast cell disease
5426414|NCT01602926|hallux valgus|hallux valgus
5426415|NCT01602913|Pravastatin|pravastatin
5426416|NCT01602913|Adverse Events|adverse events
5426417|NCT01602913|Type II Diabetes Mellitus|type ii diabetes mellitus
5426418|NCT01602913|Incidence|incidence
5426419|NCT01602913|Paroxetine|paroxetine
5426420|NCT01602887|BA/BE|ba/be
5426421|NCT01602887|PK|pk
5426422|NCT01602887|PD-0332991|pd-0332991
5426423|NCT01602887|PF-05089326|pf-05089326
5426424|NCT01602887|Breast Cancer|breast cancer
5426425|NCT01602874|children|children
5426426|NCT01602874|pediatry|pediatry
5426427|NCT01602874|pneumonia|pneumonia
5426428|NCT01602874|intra-abdominal|intra-abdominal
5426429|NCT01602874|infection|infection
5426430|NCT01602861|Fibrosis|fibrosis
5426431|NCT01602861|calcineurin inhibitor|calcineurin inhibitor
5426432|NCT01602861|kidney transplant|kidney transplant
5426433|NCT01602861|chronic rejection|chronic rejection
5426434|NCT01602848|Medicaid|medicaid
5421257|NCT01625260|TCR|tcr
5426435|NCT01602848|frequent users|frequent users
5426436|NCT01602848|heavy users|heavy users
5426437|NCT01602848|high risk|high risk
5426438|NCT01602848|high cost|high cost
5565920|NCT01023295|PCV|pcv
5426439|NCT01602848|intervention to improve care and reduce Medicaid expenditures|intervention to improve care and reduce medicaid expenditures
5426440|NCT01602835|Alport syndrome|alport syndrome
5426441|NCT01602835|proteinuria|proteinuria
5426442|NCT01602835|glomerular disease|glomerular disease
5426443|NCT01602835|hereditary nephropathy|hereditary nephropathy
5426444|NCT01602835|nephropathy|nephropathy
5426445|NCT01602822|HIV Prevention|hiv prevention
5426446|NCT01602822|NPEP|npep
5426447|NCT01602822|PEP|pep
5426448|NCT01602809|Perfusion|perfusion
5426449|NCT01602809|Microvessels|microvessels
5426450|NCT01602809|Ultrasound|ultrasound
5426451|NCT01602809|Sickle Cell Disease|sickle cell disease
5426452|NCT01602783|Radical Prostatectomy|radical prostatectomy
5426453|NCT01602770|Oral contraceptives|oral contraceptives
5426454|NCT01602770|Adverse events|adverse events
5426455|NCT01602770|Safety profile|safety profile
5426456|NCT01602770|Contraceptive Agents|contraceptive agents
5426457|NCT01602744|STOPP screening tool|stopp screening tool
5426458|NCT01602744|START screening tool|start screening tool
5426459|NCT01602744|MIP-medication inappropriate prescription|mip-medication inappropriate prescription
5426460|NCT01602744|PIM-Potentially inappropriate medication|pim-potentially inappropriate medication
5426461|NCT01602731|medication adherence|medication adherence
5426462|NCT01602718|physical activity|physical activity
5413541|NCT01661803|clonidine|clonidine
5426463|NCT01602718|physical performance|physical performance
5426464|NCT01602718|ESRD|esrd
5426465|NCT01602718|home dialysis|home dialysis
5426466|NCT01602705|Feedback (NOT MESH)|feedback (not mesh)
5426467|NCT01602705|Medication errors|medication errors
5426468|NCT01602705|Medication review|medication review
5426469|NCT01602705|Inappropriate medication|inappropriate medication
5426470|NCT01602705|Randomised controlled trial|randomised controlled trial
5426471|NCT01602705|Primary Health Care|primary health care
5426472|NCT01602705|Family Practice|family practice
5426473|NCT01602692|Pain, postoperative|pain, postoperative
5426474|NCT01602692|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5426475|NCT01602692|Patient Readmission|patient readmission
5426476|NCT01602692|Time to Discharge|time to discharge
5426477|NCT01602640|sedation|sedation
5426478|NCT01602640|critical care|critical care
5426479|NCT01602640|morphine|morphine
5426480|NCT01602640|fentanyl|fentanyl
5426481|NCT01602640|analgesic based sedation|analgesic based sedation
5426482|NCT01602601|Hunter syndrome, immunogenicity, antibodies|hunter syndrome, immunogenicity, antibodies
5426483|NCT01602575|IBS, FMRI, MBSR|ibs, fmri, mbsr
5426484|NCT01602562|Herpes simplex infection|herpes simplex infection
5426485|NCT01602562|valaciclovir|valaciclovir
5426486|NCT01602562|herpes simplex virus|herpes simplex virus
5426487|NCT01602562|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5426488|NCT01602536|twitter|twitter
5426489|NCT01602536|quit smoking|quit smoking
5426490|NCT01602536|smoking cessation|smoking cessation
5426491|NCT01602536|social media|social media
5426492|NCT01602536|peer support|peer support
5426493|NCT01602523|Emphysema|emphysema
5426494|NCT01602523|COPD|copd
5426495|NCT01602523|Sleep|sleep
5426496|NCT01602497|Borderline personality disorder|borderline personality disorder
5426497|NCT01602497|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5426498|NCT01602471|Endarterectomy|endarterectomy
5426499|NCT01602471|K5-C200|k5-c200
5426500|NCT01602471|RGD-K5|rgd-k5
5426501|NCT01602471|angiogenesis|angiogenesis
5426502|NCT01602471|Carotid CT Angiogram|carotid ct angiogram
5426503|NCT01602458|Preventative Scar Management|preventative scar management
5426504|NCT01602458|Skin Grafts|skin grafts
5426505|NCT01602458|Silicone Therapy|silicone therapy
5426506|NCT01602458|Silicone Pressure Garment Therapy|silicone pressure garment therapy
5426507|NCT01602445|Venous Thrombosis|venous thrombosis
5426508|NCT01602445|Coagulation factors|coagulation factors
5426509|NCT01602445|Cancer|cancer
5426510|NCT01602445|Blood|blood
5426511|NCT01602432|Venous Thrombosis|venous thrombosis
5426512|NCT01602432|Cancer|cancer
5426513|NCT01602432|Coagulation factors|coagulation factors
5426514|NCT01602432|Blood|blood
5426515|NCT01602406|Advanced HER2-positive Breast cancer or Gastric cancer|advanced her2-positive breast cancer or gastric cancer
5426516|NCT01602380|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5426517|NCT01602380|endocrine|endocrine
5426518|NCT01602380|no hormone therapy|no hormone therapy
5426519|NCT01602380|hormone|hormone
5426520|NCT01602380|breast|breast
5426521|NCT01602380|cancer|cancer
5426522|NCT01602380|neoplasm|neoplasm
5426523|NCT01602380|metastatic|metastatic
5426524|NCT01602380|tumour|tumour
5426525|NCT01602354|Endotoxin Activity Assay|endotoxin activity assay
5426526|NCT01602354|Gram negative|gram negative
5426527|NCT01602354|Septic Shock|septic shock
5426529|NCT01602341|atopic dermatitis|atopic dermatitis
5426530|NCT01602328|Acute Kidney Injury|acute kidney injury
5426531|NCT01602328|Acute renal failure|acute renal failure
5426532|NCT01602328|Human mesenchymal stem cells|human mesenchymal stem cells
5426535|NCT01602315|PI3K inhibitor|pi3k inhibitor
5426536|NCT01602315|PIK3CA|pik3ca
5426537|NCT01602315|cetuximab|cetuximab
5426538|NCT01602315|EGFR|egfr
5426539|NCT01602315|HNSCC|hnscc
5426540|NCT01602315|RM HNSCC|rm hnscc
5426541|NCT01602315|platinum-based chemotherapy|platinum-based chemotherapy
5426542|NCT01602315|(RM HNSCC) patients|(rm hnscc) patients
5426543|NCT01602315|resistant or ineligible/intolerant to platinum-based chemotherapy|resistant or ineligible/intolerant to platinum-based chemotherapy
5426544|NCT01602315|swallowing dysfunction|swallowing dysfunction
5426545|NCT01602315|G-tube|g-tube
5426546|NCT01602315|alpelisib|alpelisib
5426547|NCT01602302|rheumatoid arthritis|rheumatoid arthritis
5426548|NCT01602302|ultrasound|ultrasound
5426549|NCT01602302|remission|remission
5426550|NCT01602302|biological DMARD|biological dmard
5426551|NCT01602276|Parkinson's disease|parkinson's disease
5426552|NCT01602276|Lewy body dementia|lewy body dementia
5426553|NCT01602276|Korsakoff's syndrome|korsakoff's syndrome
5426554|NCT01602276|Subcortical Dementia|subcortical dementia
5426555|NCT01602276|Huntington's Disease|huntington's disease
5426556|NCT01602263|Normal cognitive function|normal cognitive function
5426557|NCT01602263|Aphasia|aphasia
5426558|NCT01602263|Autism|autism
5426559|NCT01602263|Schizophrenia|schizophrenia
5426560|NCT01602250|Anesthetics, local|anesthetics, local
5426561|NCT01602250|Toxicity|toxicity
5426562|NCT01602250|Adverse effects|adverse effects
5426563|NCT01602211|stem cell transplant|stem cell transplant
5426564|NCT01602211|cancer survivors|cancer survivors
5426565|NCT01602211|internet|internet
5426566|NCT01602211|social media|social media
5426567|NCT01602211|distress|distress
5426568|NCT01602211|health care adherence|health care adherence
5426569|NCT01602185|NMDA (N-Methyl-D-Aspartate) antagonists|nmda (n-methyl-d-aspartate) antagonists
5426570|NCT01602185|ketamine|ketamine
5426571|NCT01602185|memantine|memantine
5426572|NCT01602185|dextromethorphan|dextromethorphan
5426573|NCT01602185|Neuropathic pain|neuropathic pain
5426574|NCT01602172|alcohol consumption|alcohol consumption
5426575|NCT01602172|inpatients|inpatients
5426576|NCT01602172|risk reduction behavior|risk reduction behavior
5426577|NCT01602172|counseling|counseling
5426578|NCT01602172|nurses|nurses
5426579|NCT01602172|brief intervention|brief intervention
5426580|NCT01602159|Claudication|claudication
5426582|NCT01602159|Open Bypass|open bypass
5426583|NCT01602159|Angioplasty|angioplasty
5426584|NCT01602159|Stenting|stenting
5426585|NCT01602146|ultramarathon central fatigue,|ultramarathon central fatigue,
5426586|NCT01602133|venous puncture|venous puncture
5426587|NCT01602133|seldinger technique|seldinger technique
5426588|NCT01602133|ultrasound guidance|ultrasound guidance
5426589|NCT01602107|Stress|stress
5426590|NCT01602107|Urinary|urinary
5426591|NCT01602107|Incontinence|incontinence
5426592|NCT01602107|Pelvic|pelvic
5426593|NCT01602107|Physiotherapy|physiotherapy
5426594|NCT01602094|measles|measles
5426595|NCT01602094|antibody|antibody
5426596|NCT01602094|prevalence|prevalence
5426597|NCT01602094|predictors|predictors
5426598|NCT01602094|Donor of National Blood Centre, The Thai Red Cross Society who age 18-30 years old|donor of national blood centre, the thai red cross society who age 18-30 years old
5426599|NCT01602094|Measles antibody levels|measles antibody levels
5426600|NCT01602094|Predictors of adequate measles antibody levels and inadequate measles antibody levels|predictors of adequate measles antibody levels and inadequate measles antibody levels
5426601|NCT01602081|Anal fistula|anal fistula
5409402|NCT01680432|bifidobacterium|bifidobacterium
5426602|NCT01602081|Ligation of the intersphincteric fistula tract|ligation of the intersphincteric fistula tract
5426603|NCT01602081|LIFT|lift
5426604|NCT01602081|Tissue graft|tissue graft
5426605|NCT01602068|Iontophoresis|iontophoresis
5426606|NCT01602068|Cataract Surgery|cataract surgery
5426607|NCT01602068|Ophthalmology|ophthalmology
5426608|NCT01602068|Posterior Chamber Intraocular Lens Implant|posterior chamber intraocular lens implant
5426609|NCT01602042|essential tremor|essential tremor
5426610|NCT01602042|motion sensors|motion sensors
5426611|NCT01602042|tremor|tremor
5426612|NCT01602029|Anti inflammatory|anti inflammatory
5426613|NCT01602029|Schizophrenia|schizophrenia
5426614|NCT01602029|Simvastatin|simvastatin
5426615|NCT01602029|Ondansetron|ondansetron
5426617|NCT01602016|PDD-NOS|pdd-nos
5426618|NCT01601977|COPD|copd
5426619|NCT01601977|Respiratory failure|respiratory failure
5426620|NCT01601977|NIV|niv
5426621|NCT01601977|OSA|osa
5426622|NCT01601964|VEGF, ectopic pregnancy.|vegf, ectopic pregnancy.
5426623|NCT01601951|Osteoarthritis|osteoarthritis
5426624|NCT01601951|Stem Cell Injections|stem cell injections
5426625|NCT01601951|Bone Marrow|bone marrow
5426626|NCT01601951|Autologous|autologous
5426627|NCT01601938|Sepsis|sepsis
5426628|NCT01601938|Shock, Septic|shock, septic
5426629|NCT01601938|Selenium|selenium
5426630|NCT01601938|Survival|survival
5426631|NCT01601912|Whiplash Injuries|whiplash injuries
5426632|NCT01601912|Chronic Pain|chronic pain
5426634|NCT01601912|Cognition|cognition
5426635|NCT01601899|trial|trial
5426636|NCT01601899|stavudine|stavudine
5426637|NCT01601899|tenofovir|tenofovir
5426638|NCT01601899|mitochondria|mitochondria
5426639|NCT01601899|insulin resistance|insulin resistance
5426640|NCT01601899|lipids|lipids
5426641|NCT01601899|HOMA|homa
5426642|NCT01601886|Intubation, Intratracheal|intubation, intratracheal
5426643|NCT01601886|Continuous Positive Airway Pressure|continuous positive airway pressure
5426644|NCT01601886|Historical Cohort Studies|historical cohort studies
5426645|NCT01601886|Clinical Trial|clinical trial
5426646|NCT01601873|Arteriovenous graft|arteriovenous graft
5426647|NCT01601873|Propaten|propaten
5426648|NCT01601873|Heparin-bonded|heparin-bonded
5426649|NCT01601873|hemodialysis vascular access|hemodialysis vascular access
5426650|NCT01601873|Surgical|surgical
5426651|NCT01601873|Arteriovenous Shunt|arteriovenous shunt
5426652|NCT01601860|Labor|labor
5426653|NCT01601860|vaginal delivery|vaginal delivery
5426654|NCT01601860|pain|pain
5426655|NCT01601834|Phase 1|phase 1
5426656|NCT01601834|Single Dose|single dose
5426657|NCT01601834|Pharmacokinetics|pharmacokinetics
5426658|NCT01601834|Safety|safety
5426659|NCT01601834|Toleration|toleration
5426660|NCT01601795|Cardioprotection|cardioprotection
5426661|NCT01601769|Cervical preinvasive disease|cervical preinvasive disease
5426662|NCT01601769|Colposcopy|colposcopy
5426663|NCT01601769|Exocolposcopy|exocolposcopy
5426664|NCT01601769|Leep|leep
5426665|NCT01601756|revision knee arthroplasty|revision knee arthroplasty
5426666|NCT01601756|navigation|navigation
5426667|NCT01601756|joint line|joint line
5426668|NCT01601743|Cocaine|cocaine
5426669|NCT01601743|Exercise|exercise
5426670|NCT01601730|Cocaine|cocaine
5426671|NCT01601730|Modafinil|modafinil
5426672|NCT01601730|Escitalopram|escitalopram
5426673|NCT01601717|RTI-336|rti-336
5426674|NCT01601717|Methamphetamine|methamphetamine
5426675|NCT01601704|Body Weight|body weight
5426676|NCT01601704|Bupropion|bupropion
5426677|NCT01601704|Cardiovascular Diseases|cardiovascular diseases
5426678|NCT01601704|Diabetes Mellitus|diabetes mellitus
5426679|NCT01601704|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5426680|NCT01601704|Endocrine System Diseases|endocrine system diseases
5426681|NCT01601704|Glucose Metabolism Disorders|glucose metabolism disorders
5426682|NCT01601704|Heart Diseases|heart diseases
5426683|NCT01601704|Metabolic Diseases|metabolic diseases
5426684|NCT01601704|Narcotic Antagonists|narcotic antagonists
5426685|NCT01601704|Naltrexone|naltrexone
5426686|NCT01601704|Nutrition Disorders|nutrition disorders
5426687|NCT01601704|Obesity|obesity
5426688|NCT01601704|Overnutrition|overnutrition
5426689|NCT01601704|Overweight|overweight
5426690|NCT01601691|prostate cancer|prostate cancer
5426691|NCT01601691|brachytherapy|brachytherapy
5426692|NCT01601691|spacer|spacer
5426693|NCT01601691|side effect|side effect
5426694|NCT01601678|Achalasia|achalasia
5426695|NCT01601678|Heller Myotomy|heller myotomy
5426696|NCT01601678|Dysphagia|dysphagia
5426697|NCT01601678|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5426699|NCT01601678|POEM|poem
5426700|NCT01601665|Intraocular lens|intraocular lens
5426701|NCT01601665|Cataracts|cataracts
5426702|NCT01601665|Astigmatism|astigmatism
5426703|NCT01601665|Toric|toric
5426704|NCT01601652|cholestasis|cholestasis
5426705|NCT01601652|PNAC|pnac
5426706|NCT01601652|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
5426707|NCT01601652|PNALD|pnald
5846721|NCT00043654|Cortisol|cortisol
5426708|NCT01601652|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5426709|NCT01601639|Gastric Antral Vascular Ectasia|gastric antral vascular ectasia
5426710|NCT01601639|Argon plasma Coagulation|argon plasma coagulation
5426711|NCT01601639|Endoscopic Band Ligation|endoscopic band ligation
5426713|NCT01601587|Introductory Seminar|introductory seminar
5426714|NCT01601587|Waiting list|waiting list
5426715|NCT01601587|Community Mental Health Centre|community mental health centre
5426716|NCT01601574|Type 2 diabetes|type 2 diabetes
5426717|NCT01601574|HbA1c|hba1c
5426718|NCT01601574|Overweight|overweight
5426719|NCT01601574|Obesity|obesity
5426720|NCT01601561|Insulin|insulin
5426721|NCT01601561|Protein metabolism|protein metabolism
5426722|NCT01601561|Stress response|stress response
5426723|NCT01601483|AMD|amd
5426724|NCT01601483|Dry AMD|dry amd
5426725|NCT01601483|Nonexudative AMD|nonexudative amd
5426726|NCT01601483|MC-1101|mc-1101
5426727|NCT01601470|LCZ696, sildenafil, pharmacokinetics, mild to moderate hypertension|lcz696, sildenafil, pharmacokinetics, mild to moderate hypertension
5680262|NCT00578461|Lymphoma, non-Hodgkin|lymphoma, non-hodgkin
5426728|NCT01601444|To assess pleural effusion by measuring internal thoracic impedance|to assess pleural effusion by measuring internal thoracic impedance
5426729|NCT01601431|Screening colonoscopy|screening colonoscopy
5426731|NCT01601418|gastrin receptor antagonist|gastrin receptor antagonist
5426732|NCT01601418|pentagastrin|pentagastrin
5426733|NCT01601418|gastric acid|gastric acid
5426734|NCT01601418|healthy subjects|healthy subjects
5426735|NCT01601405|YF476|yf476
5426736|NCT01601405|gastrin receptor antagonist|gastrin receptor antagonist
5426737|NCT01601405|gastrin|gastrin
5426738|NCT01601405|gastric aspiration|gastric aspiration
5426739|NCT01601405|healthy subjects|healthy subjects
5426740|NCT01601392|Ischemic stroke|ischemic stroke
5426741|NCT01601392|direct current stimulation|direct current stimulation
5426742|NCT01601392|motor threshold|motor threshold
5426743|NCT01601392|National institutes of Health Stroke Scale|national institutes of health stroke scale
5426744|NCT01601392|Barthel index scale|barthel index scale
5426745|NCT01601392|Measurement of motor power improvement|measurement of motor power improvement
5426746|NCT01601379|Observational|observational
5426747|NCT01601379|GERD|gerd
5426748|NCT01601379|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5426749|NCT01601379|Gastro-oesophageal Reflux|gastro-oesophageal reflux
5426750|NCT01601379|Heartburn|heartburn
5426751|NCT01601366|Adenomyosis|adenomyosis
5426752|NCT01601366|Intrauterine levonorgestrel|intrauterine levonorgestrel
5426753|NCT01601366|Dysmenorrhea|dysmenorrhea
5426754|NCT01601366|Oral contraceptives|oral contraceptives
5426755|NCT01601366|Uterus|uterus
5426756|NCT01601353|Erectile Dysfunction|erectile dysfunction
5426757|NCT01601327|hypogonadism|hypogonadism
5426758|NCT01601327|treatment|treatment
5426759|NCT01601327|testis volume|testis volume
5426760|NCT01601301|Limb|limb
5426761|NCT01601301|Lengthening|lengthening
5426762|NCT01601301|PRECICE|precice
5426763|NCT01601301|Ellipse|ellipse
5426764|NCT01601301|Technologies|technologies
5426765|NCT01601301|Distraction|distraction
5426766|NCT01601301|Osteogenesis|osteogenesis
5426767|NCT01601301|Femur|femur
5426768|NCT01601301|Tibia|tibia
5426769|NCT01601301|Intramedullary|intramedullary
5426770|NCT01601301|Nail|nail
5426771|NCT01601301|Device|device
5426772|NCT01601301|Medical|medical
5426773|NCT01601301|Orthopedic|orthopedic
5426774|NCT01601301|Implant|implant
5426775|NCT01601288|obstructive lung disease|obstructive lung disease
5426776|NCT01601288|restrictive lung disease|restrictive lung disease
5426777|NCT01601288|cough|cough
5426778|NCT01601288|dyspnea|dyspnea
5426779|NCT01601275|tuberculosis|tuberculosis
5426781|NCT01601262|LI-ESWT|li-eswt
5426782|NCT01601249|IVF, embryo selection, polarized light|ivf, embryo selection, polarized light
5426783|NCT01601236|H.P. Acthar Gel|h.p. acthar gel
5426784|NCT01601236|Acthar|acthar
5426785|NCT01601236|diabetic nephropathy|diabetic nephropathy
5426786|NCT01601236|proteinuria|proteinuria
5426787|NCT01601236|nephrotic syndrome|nephrotic syndrome
5426788|NCT01601223|Ventilatory Management|ventilatory management
5426789|NCT01601223|Mechanical Ventilation|mechanical ventilation
5426790|NCT01601223|Post Operative pulmonary complications|post operative pulmonary complications
5426791|NCT01601223|Intra-operative complications|intra-operative complications
5426792|NCT01601223|General Anesthesia|general anesthesia
5426793|NCT01601223|Surgery|surgery
5426794|NCT01601223|LAS VEGAS|las vegas
5426795|NCT01601223|ESA (European Society of Anaesthesiology)|esa (european society of anaesthesiology)
5426796|NCT01601223|European Society of Anaesthesiology|european society of anaesthesiology
5426797|NCT01601197|immunization|immunization
5426798|NCT01601197|pain management|pain management
5426799|NCT01601197|infants|infants
5426800|NCT01601197|tactile stimulation|tactile stimulation
5426801|NCT01601184|medulloblastoma|medulloblastoma
5426802|NCT01601184|sonic hedgehog pathway|sonic hedgehog pathway
5426803|NCT01601184|vismodegib|vismodegib
5426804|NCT01601171|GnRH deficiency|gnrh deficiency
5426805|NCT01601171|hypogonadism|hypogonadism
5426806|NCT01601171|anosmia|anosmia
5426808|NCT01601171|cleft lip|cleft lip
5426809|NCT01601171|cleft palate|cleft palate
5426810|NCT01601171|cryptorchidism|cryptorchidism
5426811|NCT01601171|microphallus|microphallus
5409620|NCT01679340|S-1|s-1
5426812|NCT01601158|Global developmental delay|global developmental delay
5426813|NCT01601158|Umbilical cord blood|umbilical cord blood
5426814|NCT01601158|Rehabilitation|rehabilitation
5426815|NCT01601145|Lactobacillus Brevis CD2|lactobacillus brevis cd2
5426816|NCT01601145|schoolchildren|schoolchildren
5426817|NCT01601145|dental caries|dental caries
5426818|NCT01601145|Gingivatis|gingivatis
5426819|NCT01601132|pharmacokinetics|pharmacokinetics
5426820|NCT01601132|colchicine|colchicine
5426821|NCT01601132|theophylline|theophylline
5426822|NCT01601119|Multiple Sclerosis|multiple sclerosis
5426823|NCT01601119|Patient reported outcome|patient reported outcome
5426824|NCT01601119|Patient reported experience|patient reported experience
5426825|NCT01601106|Atherosclerosis, inflammation|atherosclerosis, inflammation
5426826|NCT01601093|Respiratory and urinary tract infections|respiratory and urinary tract infections
5426827|NCT01601093|Ceftazidime and Sulbactam Sodium for Injection (2:1)|ceftazidime and sulbactam sodium for injection (2:1)
5426828|NCT01601093|Phase Ⅱ|phase ⅱ
5426829|NCT01601080|Adherence|adherence
5426830|NCT01601080|Multiple Sclerosis|multiple sclerosis
5426831|NCT01601067|posttraumatic stress disorder|posttraumatic stress disorder
5426832|NCT01601067|psychotherapy|psychotherapy
5426833|NCT01601067|alcoholism|alcoholism
5426834|NCT01601054|spine|spine
5426835|NCT01601054|deformity|deformity
5426837|NCT01601054|ALIF|alif
5426838|NCT01601041|Urinary Tract Infection|urinary tract infection
5426839|NCT01601041|Bacteriuria|bacteriuria
5426840|NCT01601041|Pyuria|pyuria
5426841|NCT01601041|Prostatitis|prostatitis
5426842|NCT01601041|Intermittent Catheterization|intermittent catheterization
5426843|NCT01601041|Spinal Cord Injuries|spinal cord injuries
5426844|NCT01601041|Residual Urine|residual urine
5426845|NCT01601028|Autoimmune Diseases|autoimmune diseases
5426846|NCT01601028|Sjogren's Syndrome|sjogren's syndrome
5426847|NCT01601028|Hydroxychloroquine|hydroxychloroquine
5426848|NCT01601015|Tension-type headache, Effectiveness, Manual therapy|tension-type headache, effectiveness, manual therapy
5426849|NCT01601002|Mirtazapine|mirtazapine
5426850|NCT01600989|shock septic|shock septic
5426851|NCT01600989|monocytes|monocytes
5426852|NCT01600989|lymphocytes|lymphocytes
5426853|NCT01600989|mitochondria|mitochondria
5426854|NCT01600989|interleukins|interleukins
5426855|NCT01600989|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5426856|NCT01600989|Hypoxia-Inducible Factor 1, alpha Subunit|hypoxia-inducible factor 1, alpha subunit
5426857|NCT01600976|Hepatic impairment|hepatic impairment
5426858|NCT01600976|Hepatitis C|hepatitis c
5426859|NCT01600976|Telaprevir|telaprevir
5426860|NCT01600976|VX-950|vx-950
5426861|NCT01600976|Pharmacokinetics|pharmacokinetics
5426862|NCT01600976|Safety|safety
5413924|NCT01659866|Antibiotic resistance|antibiotic resistance
5426863|NCT01600976|Unbound plasma concentrations|unbound plasma concentrations
5426864|NCT01600976|Child-Pugh score|child-pugh score
5426865|NCT01600963|Multi-drug resistant tuberculosis|multi-drug resistant tuberculosis
5426866|NCT01600963|Pre-extensively drug resistant tuberculosis|pre-extensively drug resistant tuberculosis
5426867|NCT01600963|TMC207|tmc207
5426868|NCT01600963|Background regimen|background regimen
5426869|NCT01600937|diabetes mellitus|diabetes mellitus
5426870|NCT01600937|diabetes education|diabetes education
5426871|NCT01600937|behavioral therapy|behavioral therapy
5426872|NCT01600937|behavior modification|behavior modification
5426873|NCT01600937|physical activity|physical activity
5426874|NCT01600937|supervised exercise|supervised exercise
5426875|NCT01600937|physical fitness|physical fitness
5426876|NCT01600937|HbA1c|hba1c
5426877|NCT01600937|modifiable cardiovascular risk factors|modifiable cardiovascular risk factors
5426878|NCT01600937|quality of life|quality of life
5426879|NCT01600924|diabetes mellitus|diabetes mellitus
5426880|NCT01600924|muscle strength|muscle strength
5426881|NCT01600924|bone strength|bone strength
5426882|NCT01600924|cardiovascular risk factors|cardiovascular risk factors
5426883|NCT01600924|diabetic complications|diabetic complications
5426884|NCT01600911|metabolomics|metabolomics
5426885|NCT01600911|nutri-metabolomics|nutri-metabolomics
5426886|NCT01600911|plant food|plant food
5426887|NCT01600911|blood pressure|blood pressure
5426888|NCT01600898|Asymptomatic carriers of a BMPR2 mutation|asymptomatic carriers of a bmpr2 mutation
5426889|NCT01600898|follow up study|follow up study
5426890|NCT01600885|Guanfacine|guanfacine
5426891|NCT01600885|Ketamine|ketamine
5426892|NCT01600885|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5426893|NCT01600885|Prefrontal Cortex Activity|prefrontal cortex activity
5426894|NCT01600885|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5426895|NCT01600885|Receptors, Adrenergic, alpha-2|receptors, adrenergic, alpha-2
5426896|NCT01600885|Memory, Short-Term|memory, short-term
5426897|NCT01600885|Schizophrenia|schizophrenia
5426898|NCT01600872|EDCs|edcs
5426899|NCT01600872|PCOS|pcos
5426902|NCT01600872|ROS|ros
5798667|NCT00111410|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5426903|NCT01600872|Oxidative Stress, Endocrine-Disrupting Chemicals, Polycystic Ovary syndrome|oxidative stress, endocrine-disrupting chemicals, polycystic ovary syndrome
5426904|NCT01600846|Pharmacogenetic testing|pharmacogenetic testing
5426905|NCT01600846|pharmacokinetics|pharmacokinetics
5426906|NCT01600846|Pharmacogenomics|pharmacogenomics
5426907|NCT01600846|genetics|genetics
5426908|NCT01600846|pharmacy|pharmacy
5426909|NCT01600846|drug response|drug response
5426910|NCT01600833|PCOS|pcos
5426911|NCT01600833|Ferritin|ferritin
5426912|NCT01600833|Homocysteine|homocysteine
5426913|NCT01600833|Insulin Resistance|insulin resistance
5426914|NCT01600833|Metabolic Syndrome|metabolic syndrome
5426915|NCT01600820|Plant sterol|plant sterol
5426916|NCT01600820|Hypercholesterolemia|hypercholesterolemia
5426917|NCT01600820|diet|diet
5426918|NCT01600820|dairy|dairy
5426919|NCT01600820|LDL-C|ldl-c
5426920|NCT01600820|Mildly hypercholesterolemic subjects|mildly hypercholesterolemic subjects
5426921|NCT01600807|Metastatic|metastatic
5426922|NCT01600807|Pancreas|pancreas
5426923|NCT01600807|Cancer|cancer
5426924|NCT01600807|Adenocarcinoma|adenocarcinoma
5426925|NCT01600794|In Vitro Fertilization (IVF)|in vitro fertilization (ivf)
5426926|NCT01600794|androgens|androgens
5426927|NCT01600794|ovary function|ovary function
5426928|NCT01600794|This study include the patients who are evaluated by the doctors and are sure to process the In Vitro Fertilization cycle.|this study include the patients who are evaluated by the doctors and are sure to process the in vitro fertilization cycle.
5426929|NCT01600781|Improve the nutritional status|improve the nutritional status
5426931|NCT01600781|children|children
5426932|NCT01600781|enhance immune response|enhance immune response
5426933|NCT01600781|induction chemotherapy|induction chemotherapy
5426934|NCT01600781|fewer side effects|fewer side effects
5426935|NCT01600768|focus of study|focus of study
5426936|NCT01600755|Cell Therapy|cell therapy
5426937|NCT01600755|Autologous Cell Transplantation|autologous cell transplantation
5426938|NCT01600755|Muscle-derived Cell|muscle-derived cell
5426939|NCT01600755|Anal Incontinence|anal incontinence
5426940|NCT01600755|Rectal Diseases|rectal diseases
5426941|NCT01600755|Intestinal Diseases|intestinal diseases
5426942|NCT01600755|Gastrointestinal Diseases|gastrointestinal diseases
5426943|NCT01600755|Urinary Incontinence|urinary incontinence
5426944|NCT01600703|Intestinal lipoprotein|intestinal lipoprotein
5426945|NCT01600703|Apolipoprotein B48 and apolipoprotein B100|apolipoprotein b48 and apolipoprotein b100
5426946|NCT01600703|Pancreatic clamp|pancreatic clamp
5426947|NCT01600703|DPPIV inhibitor|dppiv inhibitor
5426948|NCT01600690|Stem cells|stem cells
5426949|NCT01600690|Regeneration|regeneration
5426950|NCT01600690|Inflammation|inflammation
5426951|NCT01600677|Experimental; Computerized medication delivery unit|experimental; computerized medication delivery unit
5426952|NCT01600664|Type 1 diabetes|type 1 diabetes
5426953|NCT01600664|"My Diabetic friend"|"my diabetic friend"
5426954|NCT01600664|interactive computer game|interactive computer game
5426955|NCT01600651|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5426956|NCT01600651|Soluble RAGE (sRAGE)|soluble rage (srage)
5426957|NCT01600651|Recruitment Maneuver|recruitment maneuver
5426958|NCT01600651|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5426959|NCT01600651|Alveolar epithelium|alveolar epithelium
5426960|NCT01600651|Electrical Impedance Tomography|electrical impedance tomography
5426961|NCT01600651|Mechanical ventilation|mechanical ventilation
5426962|NCT01600651|Intensive Care Unit (ICU)|intensive care unit (icu)
5426963|NCT01600638|Lipolysis|lipolysis
5426964|NCT01600638|Cryolipolysis|cryolipolysis
5426965|NCT01600638|Fat Reduction|fat reduction
5426966|NCT01600625|meibomian gland dysfunction|meibomian gland dysfunction
5426967|NCT01600625|inflammatory tear cytokine|inflammatory tear cytokine
5426968|NCT01600625|minocycline|minocycline
5426969|NCT01600612|postpartum hemorrhage, oxytocin, carbetocin, misopristol|postpartum hemorrhage, oxytocin, carbetocin, misopristol
5426970|NCT01600586|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
5426971|NCT01600586|Music therapy|music therapy
5426972|NCT01600586|Premature infant|premature infant
5426973|NCT01600586|Oral feeds|oral feeds
5426974|NCT01600586|Non-Nutritive Sucking|non-nutritive sucking
5426975|NCT01600586|Suck rate|suck rate
5426976|NCT01600586|Suck efficiency|suck efficiency
5426977|NCT01600586|Contingent music|contingent music
5426978|NCT01600586|Mother's voice|mother's voice
5426979|NCT01600573|ovarian cancer|ovarian cancer
5426980|NCT01600534|gestational diabetes|gestational diabetes
5426981|NCT01600508|stoma care|stoma care
5426982|NCT01600508|videoconference|videoconference
5426983|NCT01600508|costs|costs
5426984|NCT01600508|quality of life|quality of life
5426985|NCT01600495|pain|pain
5426986|NCT01600495|electric stimulation|electric stimulation
5426987|NCT01600495|nervous|nervous
5426988|NCT01600495|transcutaneous|transcutaneous
5426989|NCT01600495|humanized childbirth|humanized childbirth
5426990|NCT01600482|Hemostasis.|hemostasis.
5426991|NCT01600482|Percutaneous coronary interventions.|percutaneous coronary interventions.
5426992|NCT01600482|Closure Device|closure device
5426993|NCT01600469|Alzheimer's disease|alzheimer's disease
5426994|NCT01600469|mild cognitive impairment|mild cognitive impairment
5426996|NCT01600456|PTSD|ptsd
5426997|NCT01600456|Antidepressants|antidepressants
5426998|NCT01600456|Cognitive behavior therapy|cognitive behavior therapy
5426999|NCT01600430|Vitamin D|vitamin d
5427000|NCT01600430|Newborn|newborn
5427001|NCT01600430|Preterm|preterm
5427002|NCT01600430|Supplementation|supplementation
5427003|NCT01600430|Respiratory|respiratory
5427004|NCT01600417|low back pain|low back pain
5427005|NCT01600417|spine|spine
5427006|NCT01600417|lumbar spine|lumbar spine
5427007|NCT01600417|lumbar instability|lumbar instability
5427008|NCT01600417|radiology|radiology
5427009|NCT01600417|functional radiology|functional radiology
5427010|NCT01600404|Mild Cognitive Impairment|mild cognitive impairment
5427011|NCT01600404|Muscarinic Antagonists|muscarinic antagonists
5427012|NCT01600404|Spinal Cord Injuries|spinal cord injuries
5427013|NCT01600404|Urinary Bladder, Neurogenic|urinary bladder, neurogenic
5427014|NCT01600404|Urinary Bladder, Overactive|urinary bladder, overactive
5427015|NCT01600404|Overactive Detrusor|overactive detrusor
5427016|NCT01600391|Stroke|stroke
5427017|NCT01600391|Visual cues|visual cues
5427018|NCT01600391|Gait rehabilitation|gait rehabilitation
5427019|NCT01600391|Walking adaptability|walking adaptability
5427020|NCT01600391|Turning|turning
5427021|NCT01600391|Overground walking|overground walking
5427022|NCT01600391|Treadmill training|treadmill training
5427023|NCT01600378|diffuse parenchymal lung disease|diffuse parenchymal lung disease
5427024|NCT01600378|interstitial lung disease|interstitial lung disease
5427025|NCT01600378|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5427026|NCT01600365|Conjunctivitis|conjunctivitis
5427027|NCT01600365|adenovirus.|adenovirus.
5427028|NCT01600352|interstitial lung disease|interstitial lung disease
5427029|NCT01600352|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5427030|NCT01600313|rice bran oil|rice bran oil
5427031|NCT01600313|diet|diet
5427032|NCT01600313|cardiovascular disease|cardiovascular disease
5427033|NCT01600313|low density lipoprotein|low density lipoprotein
5427034|NCT01600313|total cholesterol|total cholesterol
5427035|NCT01600300|Age-related macular degeneration|age-related macular degeneration
5427036|NCT01600300|electrical stimulation|electrical stimulation
5427037|NCT01600300|randomized|randomized
5427038|NCT01600300|double blind|double blind
5427039|NCT01600287|bispectral index|bispectral index
5427040|NCT01600287|propofol|propofol
5427041|NCT01600287|paediatric cardiac surgery|paediatric cardiac surgery
5427042|NCT01600287|closed loop anaesthesia delivery system|closed loop anaesthesia delivery system
5427043|NCT01600261|without eye disease|without eye disease
5427044|NCT01600248|Chronic Pain|chronic pain
5427045|NCT01600248|Military|military
5427046|NCT01600248|Veteran|veteran
5427047|NCT01600248|Online|online
5427048|NCT01600248|Acceptance|acceptance
5427049|NCT01600235|Stroke, ischemic|stroke, ischemic
5427050|NCT01600235|Progression|progression
5427051|NCT01600235|Induced-hypertension|induced-hypertension
5427052|NCT01600235|Phenylephrine|phenylephrine
5427053|NCT01600209|Cancer|cancer
5427054|NCT01600209|Colorectal Cancer|colorectal cancer
5427055|NCT01600209|Neoplasm|neoplasm
5427056|NCT01600209|Colorectal Neoplasm|colorectal neoplasm
5427057|NCT01600209|Intestinal Neoplasms|intestinal neoplasms
5427058|NCT01600209|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5427059|NCT01600209|Digestive System Neoplasms|digestive system neoplasms
5427060|NCT01600209|Neoplasms by Site|neoplasms by site
5427061|NCT01600209|Neoplasms|neoplasms
5427062|NCT01600209|Digestive System Diseases|digestive system diseases
5427063|NCT01600209|Gastrointestinal Diseases|gastrointestinal diseases
5427064|NCT01600209|Colonic Diseases|colonic diseases
5427065|NCT01600209|Intestinal Diseases|intestinal diseases
5427066|NCT01600209|Rectal Diseases|rectal diseases
5427067|NCT01600196|Hepatectomy|hepatectomy
5427068|NCT01600196|Thrombectomy|thrombectomy
5427069|NCT01600196|Hepatocellular carcinoma|hepatocellular carcinoma
5427070|NCT01600196|Portal vein tumor thrombus|portal vein tumor thrombus
5427071|NCT01600183|MTA|mta
5427072|NCT01600183|metatarsus|metatarsus
5427073|NCT01600183|Metatarsus Adductus, also known as Metatarsus Varus|metatarsus adductus, also known as metatarsus varus
5427074|NCT01600170|HIV|hiv
5427075|NCT01600170|monocytes|monocytes
5427076|NCT01600170|CD16+|cd16+
5427077|NCT01600170|statins|statins
5427078|NCT01600170|mcp1|mcp1
5427079|NCT01600170|inflammation|inflammation
5427080|NCT01600144|data mammography|data mammography
5427081|NCT01600118|tooth mobility|tooth mobility
5427082|NCT01600118|periodontal status|periodontal status
5427083|NCT01600118|irregularity index|irregularity index
5427084|NCT01600118|pulpal blood flow|pulpal blood flow
5427085|NCT01600105|liver fibrosis|liver fibrosis
5427086|NCT01600105|liver cirrhosis|liver cirrhosis
5427087|NCT01600105|chronic hepatitis|chronic hepatitis
5427088|NCT01600105|magnetic resonance imaging|magnetic resonance imaging
5427089|NCT01600079|Varicella-zoster vaccine|varicella-zoster vaccine
5427090|NCT01600079|herpes zoster|herpes zoster
5427091|NCT01600079|shingles|shingles
5427092|NCT01600079|Varicella-zoster virus|varicella-zoster virus
5427093|NCT01600079|postherpetic neuralgia|postherpetic neuralgia
5427094|NCT01600079|Herpesviridae Infections|herpesviridae infections
5427095|NCT01600079|DNA Virus Infections|dna virus infections
5427096|NCT01600079|Virus Diseases|virus diseases
5427098|NCT01600053|Lymphocytic|lymphocytic
5427099|NCT01600053|Leukemia|leukemia
5427100|NCT01600040|metastatic|metastatic
5427101|NCT01600027|Fascia iliaca block|fascia iliaca block
5427102|NCT01600027|dexmetomidine|dexmetomidine
5427103|NCT01600027|fracture femur|fracture femur
5427104|NCT01600027|α2 agonist|α2 agonist
5427105|NCT01600001|Chronic Idiopathic Constipation (CIC)|chronic idiopathic constipation (cic)
5427106|NCT01600001|Constipation|constipation
5427107|NCT01600001|Functional gastrointestinal disorders|functional gastrointestinal disorders
5427108|NCT01599975|HAND|hand
5427109|NCT01599975|HIV Associated Neurocognitive Disorder|hiv associated neurocognitive disorder
5427110|NCT01599975|Methylphenidate|methylphenidate
5427111|NCT01599975|HIV Dementia|hiv dementia
5427112|NCT01599949|Mantle cell lymphoma|mantle cell lymphoma
5427113|NCT01599949|Ibrutinib|ibrutinib
5427114|NCT01599949|Bruton's tyrosine kinase inhibitor|bruton's tyrosine kinase inhibitor
5427115|NCT01599949|Rituximab|rituximab
5427116|NCT01599949|Bortezomib|bortezomib
5427117|NCT01599936|scorpion sting|scorpion sting
5427118|NCT01599936|envenomation|envenomation
5427119|NCT01599936|Anascorp|anascorp
5427120|NCT01599923|scorpion|scorpion
5427121|NCT01599923|envenomation|envenomation
5427122|NCT01599923|Alacramyn|alacramyn
5427123|NCT01599910|Scribes|scribes
5427124|NCT01599910|Physician Productivity|physician productivity
5427131|NCT01599884|Chronic bronchitis|chronic bronchitis
5427132|NCT01599884|N-acetylcysteine|n-acetylcysteine
5427133|NCT01599871|COPD|copd
5427134|NCT01599858|YF476|yf476
5427135|NCT01599858|gastrin receptor antagonist|gastrin receptor antagonist
5427136|NCT01599858|gastric pH|gastric ph
5427137|NCT01599858|healthy subjects|healthy subjects
5427138|NCT01599858|omeprazole|omeprazole
5427139|NCT01599845|Lung|lung
5427140|NCT01599845|Alveoli|alveoli
5427141|NCT01599845|Nanoparticles|nanoparticles
5427142|NCT01599845|Particulate matter|particulate matter
5427143|NCT01599845|Exhaled breath condensate|exhaled breath condensate
5427144|NCT01599845|Induced sputum|induced sputum
5427145|NCT01599845|Forced expiratory volume|forced expiratory volume
5427146|NCT01599845|Force vital capacity|force vital capacity
5427147|NCT01599806|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
5427148|NCT01599793|castrate resistant prostate cancer|castrate resistant prostate cancer
5427150|NCT01599793|cabozantinib|cabozantinib
5427151|NCT01599793|XL184|xl184
5427152|NCT01599780|preterm|preterm
5427153|NCT01599780|premature|premature
5427154|NCT01599780|prematurity|prematurity
5427155|NCT01599780|children|children
5427156|NCT01599780|child|child
5427157|NCT01599780|kid|kid
5427158|NCT01599780|toddler|toddler
5427159|NCT01599780|infant|infant
5427160|NCT01599780|baby|baby
5427161|NCT01599780|language|language
5427162|NCT01599780|development|development
5427163|NCT01599780|skills|skills
5427164|NCT01599780|listening|listening
5427165|NCT01599780|talking|talking
5427166|NCT01599780|communication|communication
5427167|NCT01599780|speech|speech
5427168|NCT01599780|processing|processing
5427169|NCT01599767|transcranial stimulation|transcranial stimulation
5427170|NCT01599767|direct current|direct current
5427171|NCT01599754|renal cell carcinoma|renal cell carcinoma
5427172|NCT01599754|axitinib|axitinib
5427173|NCT01599754|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5427174|NCT01599741|X-rays|x-rays
5427175|NCT01599741|Endovascular angiography|endovascular angiography
5427176|NCT01599741|Image processing|image processing
5427177|NCT01599728|Urocortin 2|urocortin 2
5427178|NCT01599728|Urocortin 3|urocortin 3
5427179|NCT01599728|Forearm venous occlusion plethysmography|forearm venous occlusion plethysmography
5427180|NCT01599728|Heart failure|heart failure
5427181|NCT01599728|Endothelium|endothelium
5427182|NCT01599728|Substance P|substance p
5427183|NCT01599715|Urinary Incontinence|urinary incontinence
5427184|NCT01599715|Weak bladder|weak bladder
5427185|NCT01599715|Frequent urination|frequent urination
5427186|NCT01599715|Overactive bladder|overactive bladder
5427187|NCT01599715|Urine leakage|urine leakage
5427188|NCT01599715|Stress incontinence|stress incontinence
5427189|NCT01599715|Urge Incontinence|urge incontinence
5427190|NCT01599715|Pelvic Floor weakness|pelvic floor weakness
5427191|NCT01599715|Pelvic Floor Muscle Exercises|pelvic floor muscle exercises
5427192|NCT01599715|Kegel exercises|kegel exercises
5427193|NCT01599715|Self-Care|self-care
5427194|NCT01599702|IBD|ibd
5427195|NCT01599702|IDA|ida
5427196|NCT01599702|Subjects|subjects
5427197|NCT01599702|diagnosis|diagnosis
5427198|NCT01599689|Delirium|delirium
5427199|NCT01599689|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5427200|NCT01599689|Confusion|confusion
5427201|NCT01599689|Neurobehavioral Manifestations|neurobehavioral manifestations
5427202|NCT01599689|Neurologic Manifestations|neurologic manifestations
5427203|NCT01599689|Nervous System Diseases|nervous system diseases
5427204|NCT01599689|Signs and Symptoms|signs and symptoms
5427205|NCT01599689|Mental Disorders|mental disorders
5427206|NCT01599689|Cardiac Surgery|cardiac surgery
5427207|NCT01599689|Mirrors|mirrors
5427208|NCT01599676|Citrulline|citrulline
5427209|NCT01599676|protein-energy malnutrition|protein-energy malnutrition
5427210|NCT01599676|amino acids|amino acids
5427211|NCT01599676|muscle strength|muscle strength
5427212|NCT01599676|resistance training|resistance training
5427213|NCT01599663|Pain management|pain management
5427214|NCT01599663|Pain assessment|pain assessment
5427215|NCT01599663|Intensive care unit|intensive care unit
5427216|NCT01599663|Adult|adult
5427217|NCT01599650|Macular Edema, Branch Retinal Vein Occlusion, visual impairment|macular edema, branch retinal vein occlusion, visual impairment
5422104|NCT01621347|HIV|hiv
5427218|NCT01599637|Chronic idiopathic urticaria|chronic idiopathic urticaria
5427221|NCT01599637|IGE025|ige025
5427222|NCT01599637|FcεRI|fcεri
5427224|NCT01599624|Resilience|resilience
5427225|NCT01599624|Perceived stress|perceived stress
5427226|NCT01599624|PTSD symptoms|ptsd symptoms
5427227|NCT01599624|Depression|depression
5427228|NCT01599624|Anxiety|anxiety
5427229|NCT01599624|Sleep quality|sleep quality
5427230|NCT01599624|United States Navy service members|united states navy service members
5427231|NCT01599611|Neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5427232|NCT01599611|Follow-up|follow-up
5427233|NCT01599611|Motor development|motor development
5427234|NCT01599611|Hearing|hearing
5427235|NCT01599611|Executive function|executive function
5427236|NCT01599598|perceived stress|perceived stress
5427237|NCT01599598|depression|depression
5427238|NCT01599598|anxiety|anxiety
5427239|NCT01599598|posttraumatic stress disorder|posttraumatic stress disorder
5427240|NCT01599598|military|military
5427241|NCT01599598|school|school
5427242|NCT01599598|training environment|training environment
5427243|NCT01599598|heart rate variability|heart rate variability
5427244|NCT01599598|progressive muscle relaxation|progressive muscle relaxation
5427245|NCT01599598|psychophysiological coherence|psychophysiological coherence
5427246|NCT01599598|coherence advantage|coherence advantage
5427247|NCT01599598|stress reduction|stress reduction
5427248|NCT01599598|stress regulation|stress regulation
5427249|NCT01599598|independent duty corpsmen|independent duty corpsmen
5427250|NCT01599585|Depression|depression
5427252|NCT01599585|Tele-medicine|tele-medicine
5427253|NCT01599572|zinc supplementation|zinc supplementation
5427254|NCT01599572|serum zinc concentration|serum zinc concentration
5427255|NCT01599572|lymphocyte proliferation|lymphocyte proliferation
5427256|NCT01599559|previously|previously
5427257|NCT01599559|untreated|untreated
5427258|NCT01599546|Preterm|preterm
5427259|NCT01599546|Full term|full term
5427260|NCT01599546|Reading|reading
5427261|NCT01599546|Dyslexia|dyslexia
5427262|NCT01599546|Brain|brain
5427263|NCT01599546|Diffusion tensor imaging|diffusion tensor imaging
5427264|NCT01599520|cancer|cancer
5427265|NCT01599520|stress|stress
5427266|NCT01599520|stress management|stress management
5427267|NCT01599520|Latinas|latinas
5427268|NCT01599520|Hispanics|hispanics
5427269|NCT01599507|Anemia|anemia
5427270|NCT01599507|Renal|renal
5427271|NCT01599481|Common mental illness|common mental illness
5427272|NCT01599481|Supported Employment|supported employment
5427273|NCT01599481|Anxiety|anxiety
5427274|NCT01599481|Depression|depression
5427275|NCT01599481|Sickness absence|sickness absence
5427276|NCT01599468|post partum hemorrhage|post partum hemorrhage
5427277|NCT01599468|transfusion|transfusion
5427278|NCT01599468|tranexamic acid|tranexamic acid
5427279|NCT01599455|pediatric spinal cord injury|pediatric spinal cord injury
5427280|NCT01599455|blood pressure|blood pressure
5427281|NCT01599455|heart rate|heart rate
5427282|NCT01599455|baseline|baseline
5427283|NCT01599429|AML / LMA|aml / lma
5427284|NCT01599416|Oral Probiotics|oral probiotics
5427285|NCT01599416|HPV DNA Index Test|hpv dna index test
5427286|NCT01599416|Vaginal infection|vaginal infection
5427287|NCT01599403|Rib Fracture|rib fracture
5427288|NCT01599403|Intercostal Nerve Block|intercostal nerve block
5427577|NCT01598194|EUS|eus
5427289|NCT01599403|Paravertebral Nerve Block|paravertebral nerve block
5427290|NCT01599390|United States|united states
5427291|NCT01599390|Burden of Disease|burden of disease
5427292|NCT01599390|Influenza|influenza
5427293|NCT01599364|HIV infection|hiv infection
5427294|NCT01599364|Atazanavir|atazanavir
5427295|NCT01599364|Lamivudine|lamivudine
5427296|NCT01599364|Ritonavir|ritonavir
5427297|NCT01599364|virological suppression|virological suppression
5427298|NCT01599364|non-inferiority|non-inferiority
5427299|NCT01599364|Combined antiretroviral therapy|combined antiretroviral therapy
5427300|NCT01599351|Radiation exposure|radiation exposure
5427301|NCT01599351|ERCP|ercp
5427302|NCT01599338|Liraglutide|liraglutide
5427303|NCT01599338|GLP-1 analogue|glp-1 analogue
5427304|NCT01599338|Food preference|food preference
5427305|NCT01599338|Gustative perception|gustative perception
5427306|NCT01599338|Liking|liking
5427307|NCT01599338|wanting|wanting
5427308|NCT01599338|T2DM|t2dm
5427309|NCT01599338|body mass composition|body mass composition
5427310|NCT01599338|leptin|leptin
5427311|NCT01599338|ghrelin|ghrelin
5427312|NCT01599312|Videolaryngoscopy|videolaryngoscopy
5427313|NCT01599312|Forces|forces
5427314|NCT01599312|Teeth|teeth
5427315|NCT01599299|ultrasound|ultrasound
5427316|NCT01599299|left and right jugular vein|left and right jugular vein
5427317|NCT01599299|comparison|comparison
5427318|NCT01599286|Hyperammonia|hyperammonia
5427319|NCT01599286|Propionic Acidemia (PA)|propionic acidemia (pa)
5427320|NCT01599286|Methylmalonic Acidemia (MMA)|methylmalonic acidemia (mma)
5427321|NCT01599286|Late-Onset CPS1 Deficiency (CPSD)|late-onset cps1 deficiency (cpsd)
5671966|NCT00613392|oxidant stress|oxidant stress
5427322|NCT01599286|Late-Onset Ornithine Transcarbamylase Deficiency (OTCD)|late-onset ornithine transcarbamylase deficiency (otcd)
5427324|NCT01599273|thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5427325|NCT01599273|triamcinolone|triamcinolone
5427326|NCT01599273|retraction|retraction
5427327|NCT01599273|swelling|swelling
5427329|NCT01599247|Optimism|optimism
5427330|NCT01599247|Hopelessness|hopelessness
5427331|NCT01599221|Femoral fractures|femoral fractures
5427332|NCT01599221|Nail|nail
5427333|NCT01599221|Implant|implant
5427334|NCT01599221|Elderly|elderly
5427335|NCT01599221|Orthopaedics|orthopaedics
5427336|NCT01599195|carotid stenosis|carotid stenosis
5427337|NCT01599195|femoral artery ischemia|femoral artery ischemia
5427338|NCT01599195|carotid bruit asymptomatic|carotid bruit asymptomatic
5427339|NCT01599195|carotid murmur|carotid murmur
5427340|NCT01599169|Burnout syndrome|burnout syndrome
5427341|NCT01599169|Depression work-related|depression work-related
5427342|NCT01599169|Food supplement|food supplement
5427343|NCT01599156|Chronic constipation|chronic constipation
5427344|NCT01599156|Reflexology|reflexology
5427345|NCT01599156|Complementary medicine|complementary medicine
5427346|NCT01599143|Mindfulness|mindfulness
5427347|NCT01599143|Pain Disorder (Chronic physical or mental health complaints:|pain disorder (chronic physical or mental health complaints:
5427348|NCT01599143|Fibromyalgia; Migraines; Back Pain; etc)|fibromyalgia; migraines; back pain; etc)
5427349|NCT01599143|Anxiety Disorder/Anxiety State|anxiety disorder/anxiety state
5427350|NCT01599130|Hepatitis B|hepatitis b
5427351|NCT01599130|sequential peg-interferon-2a to entecavir|sequential peg-interferon-2a to entecavir
5427352|NCT01599117|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5427353|NCT01599117|Diastolic Heart Failure|diastolic heart failure
5427354|NCT01599117|Exercise Capacity|exercise capacity
5427355|NCT01599117|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5427356|NCT01599117|Udenafil (Zydena)|udenafil (zydena)
5427357|NCT01599117|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5427358|NCT01599104|Essential hypertension|essential hypertension
5427359|NCT01599104|LCZ696|lcz696
5427360|NCT01599091|Fibroblasts|fibroblasts
5427361|NCT01599091|Periodontal ligament|periodontal ligament
5427362|NCT01599091|Gingiva|gingiva
5427363|NCT01599091|Porphyromonas gingivalis|porphyromonas gingivalis
5427364|NCT01599091|Chronic periodontitis|chronic periodontitis
5427365|NCT01599091|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)|( patients undergoing tooth extraction will be asked permission to use extracted tooth and gingiva for periodontal disease basic research)
5427366|NCT01599078|Restenosis|restenosis
5427367|NCT01599078|Angioplasty|angioplasty
5427368|NCT01599078|Stent|stent
5427369|NCT01599078|Atherectomy|atherectomy
5427370|NCT01599078|Femoral Artery|femoral artery
5427371|NCT01599078|Popliteal Artery|popliteal artery
5427372|NCT01599078|Paclitaxel|paclitaxel
5427373|NCT01599065|ICD|icd
5427374|NCT01599065|internal cardioverter defibrillator|internal cardioverter defibrillator
5427375|NCT01599065|electrocautery|electrocautery
5427376|NCT01599052|Social Cognition|social cognition
5427377|NCT01599052|Theory of Mind|theory of mind
5427378|NCT01599052|Emotion Recognition|emotion recognition
5427379|NCT01599052|Social competence|social competence
5427380|NCT01599052|Brain Tumour|brain tumour
5427381|NCT01599039|early diagnostics|early diagnostics
5427382|NCT01599039|lymphedema|lymphedema
5427383|NCT01599039|breast cancer|breast cancer
5427578|NCT01598194|guided|guided
5427384|NCT01599039|breast cancer related lymphedema|breast cancer related lymphedema
5427385|NCT01599039|measuring methods|measuring methods
5427386|NCT01599039|inverse water volumetry|inverse water volumetry
5427387|NCT01599039|prevention|prevention
5427388|NCT01599026|cardiology|cardiology
5427389|NCT01599026|fetus of diabetic mother|fetus of diabetic mother
5427390|NCT01599013|urothelial carcinoma|urothelial carcinoma
5427391|NCT01599013|bladder cancer|bladder cancer
5427392|NCT01599013|vinflunine|vinflunine
5427393|NCT01599013|transitional cell carcinoma|transitional cell carcinoma
5427394|NCT01599013|advanced or metastatic|advanced or metastatic
5427396|NCT01599013|ineligible to cisplatin|ineligible to cisplatin
5427397|NCT01599013|renal impairment|renal impairment
5427398|NCT01599013|renal insufficiency|renal insufficiency
5427399|NCT01599013|urologic neoplasms|urologic neoplasms
5427400|NCT01599013|urogenital neoplasm|urogenital neoplasm
5427401|NCT01599013|urinary neoplasms|urinary neoplasms
5427402|NCT01599013|cisplatin|cisplatin
5427403|NCT01599013|tubulin inhibitors|tubulin inhibitors
5427404|NCT01599000|malaria|malaria
5427405|NCT01599000|Plasmodium|plasmodium
5427406|NCT01599000|Papua New Guinea|papua new guinea
5427407|NCT01599000|artemether/lumefantrine|artemether/lumefantrine
5427408|NCT01598987|Paediatric liver transplantation|paediatric liver transplantation
5427409|NCT01598987|Everolimus|everolimus
5427410|NCT01598987|Reduced calcineurin inhibitor|reduced calcineurin inhibitor
5427411|NCT01598987|Cyclosporine, tacrolimus|cyclosporine, tacrolimus
5427412|NCT01598987|Renal function|renal function
5862844|NCT00001483|Continuation|continuation
5862845|NCT00001483|Ratings|ratings
5427413|NCT01598987|Composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)|composite efficacy endpoint (treated biopsy proven acute rejection death, graft loss)
5427414|NCT01598987|Liver transplant|liver transplant
5427415|NCT01598974|Lower Back Pain|lower back pain
5427416|NCT01598974|Acupuncture|acupuncture
5427417|NCT01598948|hypercholesterolemia|hypercholesterolemia
5427418|NCT01598948|apheresis|apheresis
5427419|NCT01598948|coronary heart disease|coronary heart disease
5427420|NCT01598948|cerebrovascular disease|cerebrovascular disease
5427421|NCT01598948|peripheral arterial disease|peripheral arterial disease
5427422|NCT01598922|Depression|depression
5427423|NCT01598922|Internet Cognitive Behavioral Therapy|internet cognitive behavioral therapy
5427424|NCT01598922|fMRI|fmri
5427425|NCT01598922|Neuroimaging|neuroimaging
5427426|NCT01598909|blepharoplasty|blepharoplasty
5427427|NCT01598909|arnica|arnica
5427428|NCT01598909|homeopathy|homeopathy
5427429|NCT01598896|Cannabis Dependence|cannabis dependence
5427430|NCT01598896|Marijuana Dependence|marijuana dependence
5427431|NCT01598896|Cannabis Use Disorders|cannabis use disorders
5427432|NCT01598896|Cannabis Withdrawal|cannabis withdrawal
5427433|NCT01598896|Dronabinol|dronabinol
5427434|NCT01598896|Clonidine|clonidine
5427435|NCT01598896|Schizophrenia|schizophrenia
5427436|NCT01598870|Spontaneous bacterial peritonitis.|spontaneous bacterial peritonitis.
5427437|NCT01598857|granulomatosis with polyangiitis|granulomatosis with polyangiitis
5427438|NCT01598857|microscopic polyangiitis|microscopic polyangiitis
5427439|NCT01598857|anti-neutrophil cytoplasmic antibodies|anti-neutrophil cytoplasmic antibodies
5414542|NCT01656889|ulcer|ulcer
5427440|NCT01598857|ANCA-associated vasculitis|anca-associated vasculitis
5427441|NCT01598857|Wegener Granulomatosis|wegener granulomatosis
5427442|NCT01598831|sepsis|sepsis
5427443|NCT01598818|Vision Nearsighted|vision nearsighted
5427444|NCT01598818|Vision Farsighted|vision farsighted
5427445|NCT01598805|venous thromboembolism/prevention & control|venous thromboembolism/prevention & control
5427446|NCT01598779|genital warts|genital warts
5427447|NCT01598779|HPV types|hpv types
5427448|NCT01598779|Sexually Transmitted Diseases|sexually transmitted diseases
5427449|NCT01598779|Skin Diseases, Viral|skin diseases, viral
5427450|NCT01598779|Tumor Virus Infections|tumor virus infections
5427451|NCT01598779|Skin Diseases, Infectious|skin diseases, infectious
5427452|NCT01598779|Skin Diseases|skin diseases
5427453|NCT01598779|Papillomavirus Infections|papillomavirus infections
5427454|NCT01598779|DNA Virus Infections|dna virus infections
5427455|NCT01598779|Virus Diseases|virus diseases
5427456|NCT01598779|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5427457|NCT01598727|parathyroid surgery|parathyroid surgery
5427458|NCT01598701|Acetaminophen|acetaminophen
5427459|NCT01598701|Intravenous Acetaminophen|intravenous acetaminophen
5427460|NCT01598701|Opioid Requirement|opioid requirement
5427461|NCT01598701|Pain|pain
5427462|NCT01598701|Post-Operative Pain|post-operative pain
5427463|NCT01598701|Craniotomy|craniotomy
5427464|NCT01598701|Post-Craniotomy Pain|post-craniotomy pain
5427465|NCT01598688|Bone marrow transplantation|bone marrow transplantation
5427466|NCT01598688|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5427467|NCT01598688|Medication management|medication management
5427468|NCT01598688|Nursing care|nursing care
5427469|NCT01598675|stroke|stroke
5427470|NCT01598675|Gait|gait
5427471|NCT01598675|walking|walking
5427472|NCT01598662|IUD placement|iud placement
5427473|NCT01598662|contraception|contraception
5427474|NCT01598662|postpartum|postpartum
5427475|NCT01598662|intrauterine device|intrauterine device
5427476|NCT01598662|expulsion|expulsion
5427477|NCT01598649|Dietary protein|dietary protein
5427478|NCT01598649|Lupin protein|lupin protein
5427479|NCT01598649|Cholesterol metabolism|cholesterol metabolism
5427480|NCT01598649|Protein metabolism|protein metabolism
5427481|NCT01598649|Hypercholesterolemia|hypercholesterolemia
5427482|NCT01598649|Protein-enriched foods|protein-enriched foods
5427483|NCT01598584|Mirtazapine|mirtazapine
5427484|NCT01598584|gemcitabine|gemcitabine
5427485|NCT01598584|placebo|placebo
5427487|NCT01598584|pancreatic cancer|pancreatic cancer
5427489|NCT01598571|Healthy male volunteers|healthy male volunteers
5427490|NCT01598571|pharmacokinetics|pharmacokinetics
5427491|NCT01598571|fostamatinib|fostamatinib
5427492|NCT01598571|Bioavailability|bioavailability
5427493|NCT01598571|R406 plasma AUC and Cmax|r406 plasma auc and cmax
5427494|NCT01598571|R406 plasma AUC0-t|r406 plasma auc0-t
5427495|NCT01598571|t1/2λz|t1/2λz
5427496|NCT01598571|tmax|tmax
5427497|NCT01598532|mild traumatic brain injury|mild traumatic brain injury
5427498|NCT01598532|mild TBI|mild tbi
5427499|NCT01598532|mTBI|mtbi
5427500|NCT01598519|school-based|school-based
5427501|NCT01598519|adolescent suicide|adolescent suicide
5427502|NCT01598519|intervention|intervention
5427504|NCT01598493|Burns|burns
5427505|NCT01598493|Wound Healing|wound healing
5427506|NCT01598480|Burns|burns
5427507|NCT01598480|Wound Healing|wound healing
5427508|NCT01598467|pelvic organ prolapse|pelvic organ prolapse
5427509|NCT01598467|POP|pop
5427510|NCT01598467|sacrocolpopexy|sacrocolpopexy
5427511|NCT01598467|sacrohysteropexy|sacrohysteropexy
5427512|NCT01598467|promontofixation|promontofixation
5427513|NCT01598467|colpopexy|colpopexy
5427514|NCT01598467|robotic surgery|robotic surgery
5427515|NCT01598467|surgical complications|surgical complications
5427516|NCT01598467|mesh|mesh
5427517|NCT01598467|prolapse repair|prolapse repair
5427518|NCT01598441|pulmonary hypertension, pulmonary hypertensive crisis|pulmonary hypertension, pulmonary hypertensive crisis
5427519|NCT01598428|age related cataract|age related cataract
5427520|NCT01598428|phacoemulsification|phacoemulsification
5427521|NCT01598428|anterior capsule polishing|anterior capsule polishing
5427522|NCT01598428|optical coherence tomography|optical coherence tomography
5427523|NCT01598428|anterior chamber depth|anterior chamber depth
5427524|NCT01598402|LAHNC|lahnc
5427525|NCT01598402|Locally Advanced Head and Neck Cancer|locally advanced head and neck cancer
5427526|NCT01598376|entropion|entropion
5427527|NCT01598376|suture|suture
5427528|NCT01598376|granuloma|granuloma
5427529|NCT01598376|tissue reaction|tissue reaction
5427530|NCT01598350|Gait|gait
5427531|NCT01598350|Orthoses|orthoses
5427532|NCT01598350|Down syndrome|down syndrome
5427533|NCT01598324|magnetic resonance imaging|magnetic resonance imaging
5427534|NCT01598324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5427535|NCT01598324|depression|depression
5427536|NCT01598324|escitalopram|escitalopram
5427537|NCT01598324|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5427538|NCT01598324|treatment-resistant depression|treatment-resistant depression
5427539|NCT01598324|ziprasidone|ziprasidone
5427540|NCT01598311|CDAD|cdad
5427541|NCT01598311|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5427543|NCT01598311|Clostridium difficile Infection|clostridium difficile infection
5427544|NCT01598311|Diarrhea|diarrhea
5427545|NCT01598298|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5427546|NCT01598298|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5427547|NCT01598298|stage IA breast cancer|stage ia breast cancer
5427548|NCT01598298|stage IB breast cancer|stage ib breast cancer
5427549|NCT01598298|stage II breast cancer|stage ii breast cancer
5427550|NCT01598298|stage IIIA breast cancer|stage iiia breast cancer
5427551|NCT01598298|stage IIIB breast cancer|stage iiib breast cancer
5427552|NCT01598298|stage IIIC breast cancer|stage iiic breast cancer
5427553|NCT01598298|pain|pain
5427554|NCT01598298|musculoskeletal complications|musculoskeletal complications
5427555|NCT01598285|Genome-Wide|genome-wide
5427556|NCT01598285|GWAS|gwas
5427557|NCT01598285|microRNA|microrna
5427558|NCT01598285|miRNA|mirna
5427559|NCT01598285|Bevacizumab Response Predictors|bevacizumab response predictors
5427560|NCT01598285|Metastatic Breast Cancer|metastatic breast cancer
5427561|NCT01598272|Ginseng|ginseng
5427562|NCT01598272|Cordyceps|cordyceps
5427563|NCT01598272|Pomegranate|pomegranate
5427564|NCT01598272|Red Orange|red orange
5427565|NCT01598272|Grape Seed|grape seed
5427566|NCT01598272|Broccoli Seed|broccoli seed
5427567|NCT01598246|Extubation failures|extubation failures
5427568|NCT01598246|Sedation|sedation
5427569|NCT01598220|schizophrenia|schizophrenia
5427570|NCT01598220|cognitive remediation therapy|cognitive remediation therapy
5427571|NCT01598220|cognition|cognition
5427572|NCT01598220|quality of life|quality of life
5427573|NCT01598194|solid pancreatic mass lesions|solid pancreatic mass lesions
5427574|NCT01598194|22-gauge core biopsy needle|22-gauge core biopsy needle
5427575|NCT01598194|reverse bevel design|reverse bevel design
5427576|NCT01598194|endoscopic ultrasound|endoscopic ultrasound
5427579|NCT01598194|fine needle aspiration|fine needle aspiration
5427580|NCT01598194|FNA|fna
5427581|NCT01598168|rivaroxaban|rivaroxaban
5427582|NCT01598168|treatment|treatment
5427583|NCT01598168|venous thromboembolism|venous thromboembolism
5427584|NCT01598168|arterial thromboembolism|arterial thromboembolism
5427585|NCT01598168|thrombocytopenia|thrombocytopenia
5427586|NCT01598155|dental biofilm|dental biofilm
5427587|NCT01598155|periodontitis|periodontitis
5427588|NCT01598155|maintenance|maintenance
5427589|NCT01598155|randomized clinical trial|randomized clinical trial
5427590|NCT01598155|biomarkers|biomarkers
5427591|NCT01598155|bacterias|bacterias
5427592|NCT01598155|gingival crevicular fluid|gingival crevicular fluid
5427593|NCT01598142|Endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
5427594|NCT01598142|Guidewires|guidewires
5427595|NCT01598142|Cannulation|cannulation
5427596|NCT01598142|Single-operator|single-operator
5427597|NCT01598142|C-Hook|c-hook
5427598|NCT01598129|Phase I|phase i
5427599|NCT01598129|Dose escalation|dose escalation
5427600|NCT01598129|oncolytic virus|oncolytic virus
5427601|NCT01598103|Neurogenic detrusor overactivity|neurogenic detrusor overactivity
5427602|NCT01598103|spinal cord lesions|spinal cord lesions
5427603|NCT01598103|spinal cord injury|spinal cord injury
5671215|NCT00616642|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5671216|NCT00616642|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5427604|NCT01598077|Breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma|breast cancer, gastric cancer, squamous cell carcinoma of head and neck, esophageal squamous cell carcinoma
5427605|NCT01598077|Breast cancer|breast cancer
5427607|NCT01598077|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5427608|NCT01598077|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5427609|NCT01598051|Xarelto|xarelto
5427610|NCT01598051|SPAF|spaf
5427611|NCT01598051|QOL|qol
5427612|NCT01598038|cancer|cancer
5427613|NCT01598038|renal|renal
5427614|NCT01598038|Afinitor|afinitor
5427615|NCT01598038|pharmacokinetics|pharmacokinetics
5427616|NCT01598025|ANTITHYMOCYTE GLOBULIN:ATG|antithymocyte globulin:atg
5427617|NCT01598025|FLUDARABINE|fludarabine
5427618|NCT01598025|THI0TEPA|thi0tepa
5427619|NCT01598025|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
5427620|NCT01598025|12-053|12-053
5427621|NCT01598012|Ayurved Siriraj Prasaplai|ayurved siriraj prasaplai
5427622|NCT01598012|primary dysmenorrhea|primary dysmenorrhea
5427623|NCT01597986|isavuconazole|isavuconazole
5427624|NCT01597986|ethinyl estradiol|ethinyl estradiol
5427625|NCT01597986|norethindrone|norethindrone
5427626|NCT01597986|contraceptive|contraceptive
5427627|NCT01597986|Healthy Volunteers|healthy volunteers
5427628|NCT01597986|BAL8557|bal8557
5427629|NCT01597986|BAL4815|bal4815
5427630|NCT01597934|Chronic hepatitis B|chronic hepatitis b
5427631|NCT01597934|Partial virologic response|partial virologic response
5427632|NCT01597934|YMDD mutation|ymdd mutation
5427633|NCT01597921|Breast conserving surgery|breast conserving surgery
5427634|NCT01597921|Radiation dermatitis|radiation dermatitis
5427635|NCT01597908|BRAF inhibitor|braf inhibitor
5427636|NCT01597908|Metastatic Melanoma|metastatic melanoma
5427637|NCT01597908|Cancer|cancer
5427638|NCT01597908|MEK inhibitor|mek inhibitor
5427639|NCT01597895|maraviroc|maraviroc
5427640|NCT01597895|boceprevir|boceprevir
5427641|NCT01597895|telaprevir|telaprevir
5427642|NCT01597895|drug interaction|drug interaction
5427643|NCT01597895|pharmacokinetics|pharmacokinetics
5427644|NCT01597895|HIV|hiv
5427645|NCT01597882|case management|case management
5427646|NCT01597882|long term conditions|long term conditions
5427647|NCT01597882|aged sixty five and over|aged sixty five and over
5427648|NCT01597843|education|education
5427649|NCT01597843|self care|self care
5427650|NCT01597843|peer group|peer group
5427651|NCT01597843|Computers|computers
5427652|NCT01597843|Attitude to computers|attitude to computers
5427653|NCT01597830|knee|knee
5427654|NCT01597830|osteoarthritis|osteoarthritis
5427655|NCT01597830|loading|loading
5427656|NCT01597817|Atopic dermatitis|atopic dermatitis
5427657|NCT01597817|Eczema|eczema
5427658|NCT01597817|Textiles|textiles
5427659|NCT01597791|Urinary Retention|urinary retention
5427660|NCT01597791|Urinary Catheter|urinary catheter
5427661|NCT01597791|Bacteriuria|bacteriuria
5427662|NCT01597778|Haplo identical transplant|haplo identical transplant
5427663|NCT01597778|Cord blood transplant|cord blood transplant
5427664|NCT01597778|Reduced intensity conditioning regimen|reduced intensity conditioning regimen
5427665|NCT01597778|Lymphoma|lymphoma
5427666|NCT01597778|Leukemia|leukemia
5427667|NCT01597765|Thalassemia|thalassemia
5427668|NCT01597765|Oxidative stress|oxidative stress
5427669|NCT01597765|antioxidant cocktail|antioxidant cocktail
5427670|NCT01597752|Immunotherapy|immunotherapy
5427671|NCT01597752|Skin prick test|skin prick test
5427672|NCT01597752|Standardization|standardization
5427673|NCT01597752|Blomia tropicalis|blomia tropicalis
5427674|NCT01597739|Active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy|active rheumatoid arthritis despite disease-modifying antirheumatic drug therapy
5427675|NCT01597739|Disease-modifying antirheumatic drugs|disease-modifying antirheumatic drugs
5427676|NCT01597726|Abortion, Induced|abortion, induced
5427677|NCT01597726|Laminaria|laminaria
5427678|NCT01597726|Misoprostol|misoprostol
5427679|NCT01597726|Pregnancy Trimester, Second|pregnancy trimester, second
5427680|NCT01597687|pertussis infection|pertussis infection
5427681|NCT01597687|Prevalence|prevalence
5427682|NCT01597687|health economic burden|health economic burden
5427683|NCT01597687|prolonged cough|prolonged cough
5427684|NCT01597674|YF476|yf476
5427685|NCT01597674|gastrin receptor antagonist|gastrin receptor antagonist
5427686|NCT01597674|gastric pH|gastric ph
5427687|NCT01597674|gastrin|gastrin
5427688|NCT01597674|healthy subjects|healthy subjects
5427689|NCT01597661|first trimester|first trimester
5427690|NCT01597661|left outflow tract obstruction|left outflow tract obstruction
5427691|NCT01597661|Bupropion|bupropion
5427692|NCT01597661|cardiovascular malformation|cardiovascular malformation
5427693|NCT01597661|antidepressants|antidepressants
5427694|NCT01597661|pregnancy|pregnancy
5427695|NCT01597661|cardiovascular defect|cardiovascular defect
5427696|NCT01597661|congenital malformation|congenital malformation
5671217|NCT00616616|appendectomy|appendectomy
5671218|NCT00616616|cholecystectomy|cholecystectomy
5671219|NCT00616616|gastric banding|gastric banding
5671220|NCT00616616|adrenalectomy|adrenalectomy
5427697|NCT01597648|Combivir™, HIV, bioequivalence, Combined Formulated Tablet, Combined Formulated Tablet, HIV, bioequivalence, Combivir, Selzentry™, Celsentri™, lamivudine, zidov|combivir™, hiv, bioequivalence, combined formulated tablet, combined formulated tablet, hiv, bioequivalence, combivir, selzentry™, celsentri™, lamivudine, zidov
5427698|NCT01597635|rhACE2|rhace2
5427699|NCT01597635|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5427700|NCT01597635|Acute Lung Injury|acute lung injury
5427701|NCT01597635|GSK2586881|gsk2586881
5427702|NCT01597635|critical care|critical care
5427703|NCT01597622|SELENA|selena
5427704|NCT01597622|belimumab|belimumab
5427705|NCT01597622|Lupus|lupus
5427706|NCT01597622|systemic lupus erythematosus|systemic lupus erythematosus
5427708|NCT01597622|BLys|blys
5427709|NCT01597622|SLE Flare Index|sle flare index
5427710|NCT01597622|continuation|continuation
5427711|NCT01597622|phase III|phase iii
5427712|NCT01597622|BILAG|bilag
5427713|NCT01597622|extension|extension
5427714|NCT01597622|efficacy|efficacy
5427715|NCT01597622|SRI|sri
5427716|NCT01597622|B cell|b cell
5427717|NCT01597622|SLEDAI|sledai
5427718|NCT01597622|safety|safety
5427719|NCT01597622|Asia|asia
5427720|NCT01597622|B lymphocyte|b lymphocyte
5427721|NCT01597557|Atrial Fibrillation|atrial fibrillation
5427722|NCT01597557|Electrical Cardioversion|electrical cardioversion
5427723|NCT01597557|Magnesium Sulfate|magnesium sulfate
5427724|NCT01597544|Voiding dysfunction|voiding dysfunction
5427725|NCT01597544|bladder catheter|bladder catheter
5427726|NCT01597544|prolapse surgery|prolapse surgery
5427727|NCT01597544|patient satisfaction|patient satisfaction
5427728|NCT01597531|Liraglutide|liraglutide
5427729|NCT01597531|Orlistat|orlistat
5427730|NCT01597518|Riluzole|riluzole
5427731|NCT01597518|spinal cord injury|spinal cord injury
5427732|NCT01597518|treatment|treatment
5427733|NCT01597505|CDAD|cdad
5427734|NCT01597505|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5427735|NCT01597505|CDI|cdi
5427736|NCT01597505|Clostridium difficile Infection|clostridium difficile infection
5427737|NCT01597505|Diarrhea|diarrhea
5427738|NCT01597492|Antibodies|antibodies
5427739|NCT01597492|Vaccines|vaccines
5427740|NCT01597492|SLE|sle
5427741|NCT01597492|Immune System Diseases|immune system diseases
5427742|NCT01597492|Biological Therapy|biological therapy
5427743|NCT01597492|Autoimmune Diseases|autoimmune diseases
5427744|NCT01597492|Pneumococcal Vaccines|pneumococcal vaccines
5427745|NCT01597492|Lupus|lupus
5427746|NCT01597492|Immunoglobulins|immunoglobulins
5427747|NCT01597492|Vaccination|vaccination
5427748|NCT01597492|Belimumab|belimumab
5427749|NCT01597492|Biological Agents|biological agents
5427750|NCT01597492|Immunization|immunization
5427751|NCT01597479|Ultrasound guided distal peripheral nerve blocks|ultrasound guided distal peripheral nerve blocks
5427752|NCT01597453|Young ischemic stroke|young ischemic stroke
5427753|NCT01597453|Families|families
5427754|NCT01597453|Long-term follow-up|long-term follow-up
5427755|NCT01597440|Propionic acidemia (PA)|propionic acidemia (pa)
5427756|NCT01597440|Methylmalonic acidemia (MMA)|methylmalonic acidemia (mma)
5427757|NCT01597440|Carbaglu NCG|carbaglu ncg
5427758|NCT01597440|Hyperammonia|hyperammonia
5427759|NCT01597427|Clonidine|clonidine
5427760|NCT01597427|Hypertension Pulmonary|hypertension pulmonary
5427761|NCT01597427|Cardiac Surgical Procedures|cardiac surgical procedures
5427762|NCT01597401|Antisickling Agents|antisickling agents
5427763|NCT01597388|Estrogen receptor positive|estrogen receptor positive
5427764|NCT01597388|Advanced metastatic breast cancer|advanced metastatic breast cancer
5427765|NCT01597388|Estrogen receptor positive advanced metastatic breast cancer|estrogen receptor positive advanced metastatic breast cancer
5427766|NCT01597375|Aspirin|aspirin
5427767|NCT01597375|Prasugrel|prasugrel
5427768|NCT01597375|Asthma|asthma
5427769|NCT01597375|AERD|aerd
5427770|NCT01597375|Aspirin challenge|aspirin challenge
5427771|NCT01597375|Aspirin desensitization|aspirin desensitization
5427772|NCT01597375|Aspirin induced asthma|aspirin induced asthma
5427773|NCT01597362|laparoscopy|laparoscopy
5427774|NCT01597362|trocars|trocars
5427775|NCT01597362|veress|veress
5427776|NCT01597362|open|open
5427778|NCT01597336|abscess|abscess
5427779|NCT01597336|tPA|tpa
5427780|NCT01597323|Wrinkle Reduction|wrinkle reduction
5427781|NCT01597323|Skin Resurfacing|skin resurfacing
5427782|NCT01597323|Skin Texture Improvement|skin texture improvement
5427783|NCT01597284|Oral therapies|oral therapies
5427784|NCT01597284|Cancer|cancer
5427785|NCT01597284|cognitive function|cognitive function
5427786|NCT01597284|compliance|compliance
5427787|NCT01597258|Safety|safety
5427788|NCT01597258|All cases surveillance in Japan|all cases surveillance in japan
5680263|NCT00578435|ERYTHROPOIESIS|erythropoiesis
5680264|NCT00578435|Genetic Disorders|genetic disorders
5427789|NCT01597258|ALK-positive unresectable advanced and/or recurrent non-small cell lung cancer|alk-positive unresectable advanced and/or recurrent non-small cell lung cancer
5427790|NCT01597232|Transfusion trigger|transfusion trigger
5427791|NCT01597232|Hemoglobin level|hemoglobin level
5427792|NCT01597219|Haploidentical transplant|haploidentical transplant
5427793|NCT01597219|Haematological malignancy|haematological malignancy
5427794|NCT01597219|Myeloablative|myeloablative
5427795|NCT01597219|Reduced intensity|reduced intensity
5427796|NCT01597206|randomized controlled trial|randomized controlled trial
5427797|NCT01597206|intervention|intervention
5427799|NCT01597206|patient satisfaction|patient satisfaction
5427800|NCT01597206|sequential sampling|sequential sampling
5427801|NCT01597193|enzalutamide|enzalutamide
5427803|NCT01597193|breast cancer|breast cancer
5427804|NCT01597180|contraception|contraception
5427806|NCT01597180|pharmacokinetics|pharmacokinetics
5427807|NCT01597180|pharmacodynamics|pharmacodynamics
5427808|NCT01597167|mild moderate treatment-resistant depression|mild moderate treatment-resistant depression
5427809|NCT01597167|magnesium sulfate|magnesium sulfate
5427810|NCT01597154|Adolescent|adolescent
5427811|NCT01597154|Type 2 Diabetes|type 2 diabetes
5427812|NCT01597154|Peer mentorship|peer mentorship
5427813|NCT01597141|Prodromal|prodromal
5427814|NCT01597141|Schizophrenia|schizophrenia
5427815|NCT01597141|Psychosis|psychosis
5427816|NCT01597141|Family psychoeducation|family psychoeducation
5427817|NCT01597141|Assertive community treatment|assertive community treatment
5427818|NCT01597141|Supported employment|supported employment
5427819|NCT01597141|Supported education|supported education
5427820|NCT01597128|Hernia|hernia
5427821|NCT01597128|human tissue|human tissue
5427822|NCT01597128|mesh|mesh
5427823|NCT01597115|duplex study|duplex study
5427824|NCT01597115|hemodialysis access|hemodialysis access
5427825|NCT01597115|maturation rate|maturation rate
5427826|NCT01597115|endovascular intervention|endovascular intervention
5427827|NCT01597102|encephalopathy, hepatic|encephalopathy, hepatic
5427828|NCT01597102|autoregulation, cerebrovascular|autoregulation, cerebrovascular
5427829|NCT01597102|liver failure|liver failure
5427830|NCT01597102|liver transplantation|liver transplantation
5427831|NCT01597089|Specificity|specificity
5427832|NCT01597089|Bronchoalveolar Lavage|bronchoalveolar lavage
5427833|NCT01597089|Film Array Assay|film array assay
5427834|NCT01597089|Nasopharyngeal Swab|nasopharyngeal swab
5427835|NCT01597089|Sensitivity|sensitivity
5427836|NCT01597076|Morinda citrifolia|morinda citrifolia
5427837|NCT01597076|noni|noni
5427838|NCT01597076|advanced glycation end products|advanced glycation end products
5427839|NCT01597076|oxidative stress|oxidative stress
5427840|NCT01597076|quality of life|quality of life
5427841|NCT01597076|metabolic syndrome|metabolic syndrome
5427842|NCT01597076|safety|safety
5427843|NCT01597050|Discoid Lupus Erythematosus|discoid lupus erythematosus
5427844|NCT01597050|Systemic Lupus Erythematosus|systemic lupus erythematosus
5427845|NCT01597037|Aphasia|aphasia
5427846|NCT01597037|Speech Rehabilitation|speech rehabilitation
5427847|NCT01597024|appetite|appetite
5427848|NCT01597024|food|food
5427849|NCT01597024|gut|gut
5427850|NCT01597024|brain|brain
5427851|NCT01597024|satiety|satiety
5427852|NCT01597024|hunger|hunger
5427853|NCT01597024|gut hormones|gut hormones
5427854|NCT01597011|Hernia, Inguinal|hernia, inguinal
5427855|NCT01597011|Hernia repair|hernia repair
5427856|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive
5427857|NCT01597011|Tisseel|tisseel
5427858|NCT01597011|Tissucol|tissucol
5427859|NCT01597011|Recurrence|recurrence
5427860|NCT01597011|Chronic Pain|chronic pain
5427861|NCT01597011|Dysejaculation|dysejaculation
5427862|NCT01596998|anesthesia, conduction|anesthesia, conduction
5427863|NCT01596998|transversus abdominis plane block|transversus abdominis plane block
5427864|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents
5427865|NCT01596998|Ultrasonography|ultrasonography
5427866|NCT01596985|Endometrioma|endometrioma
5427867|NCT01596985|Endometriosis|endometriosis
5427868|NCT01596985|Cystectomy|cystectomy
5427869|NCT01596985|Ablation|ablation
5427870|NCT01596985|Plasma energy|plasma energy
5427871|NCT01596959|atrial flutter|atrial flutter
5427872|NCT01596959|ablation|ablation
5427873|NCT01596959|irrigation|irrigation
5427874|NCT01596959|contact|contact
5427875|NCT01596959|ECI|eci
5427876|NCT01596946|contact tracing|contact tracing
5427877|NCT01596946|home sampling|home sampling
5427882|NCT01596933|weight loss|weight loss
5427884|NCT01596933|body composition|body composition
5427885|NCT01596933|biomarker|biomarker
5427886|NCT01596933|quality of life|quality of life
5427887|NCT01596920|Chronic DFUs|chronic dfus
5427888|NCT01596920|Diabetic Foot Ulcers|diabetic foot ulcers
5427889|NCT01596907|resting energy expenditure|resting energy expenditure
5427890|NCT01596907|fat free mass|fat free mass
5427891|NCT01596907|lean body mass|lean body mass
5427892|NCT01596907|bariatric surgery|bariatric surgery
5427893|NCT01596907|morbid obesity|morbid obesity
5427895|NCT01596907|caffeine|caffeine
5427896|NCT01596907|Low metabolic rate|low metabolic rate
5427897|NCT01596907|Low lean body mass|low lean body mass
5427898|NCT01596907|Weight loss rate|weight loss rate
5427899|NCT01596894|Pediatric|pediatric
5427900|NCT01596894|Crohn's disease|crohn's disease
5427901|NCT01596894|Azithromycin|azithromycin
5427902|NCT01596894|Metronidazole|metronidazole
5427903|NCT01596894|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5427904|NCT01596881|Multiple sclerosis|multiple sclerosis
5427905|NCT01596881|Blood flow|blood flow
5427906|NCT01596881|Optical Coherence Tomography|optical coherence tomography
5427908|NCT01596868|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
5427909|NCT01596868|treatment|treatment
5427910|NCT01596868|Northwest China|northwest china
5427911|NCT01596855|Anemia|anemia
5427912|NCT01596855|Renal|renal
5427913|NCT01596842|Omega-3 fatty acid|omega-3 fatty acid
5427914|NCT01596842|vitamin D|vitamin d
5427915|NCT01596842|ergocalciferol|ergocalciferol
5427916|NCT01596842|hemodialysis|hemodialysis
5427917|NCT01596829|antibiotic|antibiotic
5427918|NCT01596829|probiotic|probiotic
5427919|NCT01596829|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
5427920|NCT01596829|faecal microbiota|faecal microbiota
5427921|NCT01596816|prostate cancer|prostate cancer
5427922|NCT01596803|FSHD|fshd
5427923|NCT01596803|Antioxidants|antioxidants
5427924|NCT01596803|Oxidative stress|oxidative stress
5427925|NCT01596803|Muscle function|muscle function
5427926|NCT01596803|Quality of life|quality of life
5427927|NCT01596803|Activity|activity
5427928|NCT01596803|(FSHD;4q35)|(fshd;4q35)
5427929|NCT01596790|Bevacizumab|bevacizumab
5427930|NCT01596790|Circulating tumor cells|circulating tumor cells
5427931|NCT01596790|Treatment efficiency|treatment efficiency
5427932|NCT01596777|Loperamide-induced obstipation|loperamide-induced obstipation
5427933|NCT01596777|Methylnaltrexone|methylnaltrexone
5427934|NCT01596777|oro-cecal transit time|oro-cecal transit time
5427935|NCT01596777|whole gut transit time|whole gut transit time
5427936|NCT01596777|Pharmacokinetics|pharmacokinetics
5427937|NCT01596764|whole-gut transit time|whole-gut transit time
5427938|NCT01596764|oro-cecal transit time|oro-cecal transit time
5427939|NCT01596764|colon transit time|colon transit time
5427940|NCT01596764|loperamide-induced obstipation|loperamide-induced obstipation
5427941|NCT01596764|pharmacokinetics|pharmacokinetics
5427942|NCT01596764|Methylnaltrexone|methylnaltrexone
5427943|NCT01596764|Naloxone|naloxone
5427944|NCT01596751|metastatic|metastatic
5427945|NCT01596751|breast|breast
5427946|NCT01596751|cancer|cancer
5427947|NCT01596751|triple|triple
5427948|NCT01596751|negative|negative
5427950|NCT01596751|Eribulin|eribulin
5427951|NCT01596738|Coronary Artery Disease|coronary artery disease
5427952|NCT01596738|Coronary Artery Bypass Graft|coronary artery bypass graft
5427953|NCT01596738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5427954|NCT01596738|Tranexamic Acid|tranexamic acid
5427955|NCT01596712|Allergy,|allergy,
5427956|NCT01596712|Asthma,|asthma,
5427957|NCT01596712|Atopic dermatitis,|atopic dermatitis,
5427958|NCT01596712|Japanese,|japanese,
5427959|NCT01596712|QGE031,|qge031,
5427960|NCT01596712|IgE|ige
5427967|NCT01596660|Tap block|tap block
5427968|NCT01596660|laparoscopic hysterectomy|laparoscopic hysterectomy
5427969|NCT01596660|pain|pain
5427970|NCT01596647|cancer, tumors, phase I, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, CYP1A2, CYP2C9, CYP2C19, CYP3A4|cancer, tumors, phase i, drug-drug interaction, pharmacokinetic, probe drug, caffeine, diclofenac, omeprazole, midazolam, cyp1a2, cyp2c9, cyp2c19, cyp3a4
5427971|NCT01596621|Bendamustine hydrochloride|bendamustine hydrochloride
5427972|NCT01596621|CEP-18083|cep-18083
5427973|NCT01596621|Treanda®|treanda®
5427974|NCT01596621|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5427975|NCT01596608|Magnetic seizure therapy|magnetic seizure therapy
5427976|NCT01596608|Treatment resistance|treatment resistance
5428169|NCT01595867|snorting|snorting
5427979|NCT01596608|Treatment resistant schizophrenia|treatment resistant schizophrenia
5427980|NCT01596608|Treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
5427984|NCT01596582|Colorectal cancer screening|colorectal cancer screening
5427985|NCT01596582|Shared decision-making|shared decision-making
5427986|NCT01596582|Patient preferences|patient preferences
5427987|NCT01596582|Risk assessment|risk assessment
5427988|NCT01596582|Advanced colorectal neoplasia|advanced colorectal neoplasia
5431164|NCT01582828|pvi|pvi
5427993|NCT01596556|smoking|smoking
5427994|NCT01596556|exercise|exercise
5427995|NCT01596556|heat tolerance|heat tolerance
5427996|NCT01596556|heat stroke|heat stroke
5427997|NCT01596543|sleep|sleep
5427999|NCT01596543|heat illness|heat illness
5428000|NCT01596530|Breast Neoplasm|breast neoplasm
5428001|NCT01596530|Breast Cancer|breast cancer
5410833|NCT01674049|nutrition|nutrition
5428002|NCT01596530|Breast Tumour|breast tumour
5428003|NCT01596530|Cancer of Breast|cancer of breast
5428004|NCT01596530|Cancer of the Breast|cancer of the breast
5428005|NCT01596491|peripheral nerve injury|peripheral nerve injury
5428006|NCT01596491|postherpetic neuralgia|postherpetic neuralgia
5428007|NCT01596491|PNI|pni
5428008|NCT01596491|PHN|phn
5428009|NCT01596491|Capsaicin|capsaicin
5428010|NCT01596491|QST|qst
5428011|NCT01596491|quantitative sensory testing|quantitative sensory testing
5428012|NCT01596491|sensory profile|sensory profile
5428013|NCT01596491|neuropathic pain|neuropathic pain
5428014|NCT01596478|Gambling|gambling
5428015|NCT01596478|Pathological Gambling|pathological gambling
5428016|NCT01596439|Healthy women|healthy women
5422867|NCT01618292|splinting with defecation|splinting with defecation
5428017|NCT01596439|consisting of a friend or relative of the patient|consisting of a friend or relative of the patient
5428019|NCT01596413|CINV|cinv
5428020|NCT01596400|CINV|cinv
5428021|NCT01596387|anaesthetics iv|anaesthetics iv
5428022|NCT01596387|propofol|propofol
5428023|NCT01596387|pharmacokinetics|pharmacokinetics
5428024|NCT01596387|pharmacodynamic|pharmacodynamic
5428025|NCT01596348|Exercise|exercise
5428026|NCT01596348|Barriers|barriers
5428027|NCT01596348|Benefits|benefits
5428028|NCT01596348|Preferences|preferences
5428029|NCT01596348|Stages of change|stages of change
5428030|NCT01596335|Infliximab|infliximab
5428031|NCT01596335|REMICADE|remicade
5428032|NCT01596335|TA-650|ta-650
5428033|NCT01596335|intravenous immunoglobulin|intravenous immunoglobulin
5428034|NCT01596335|Kawasaki disease|kawasaki disease
5428035|NCT01596335|IVIG|ivig
5428036|NCT01596322|HIV/AIDS in resource limited setting|hiv/aids in resource limited setting
5428037|NCT01596322|HIV treatment outcomes in resource limited setting|hiv treatment outcomes in resource limited setting
5428038|NCT01596322|Adherence to HIV treatment in resource limited setting|adherence to hiv treatment in resource limited setting
5428039|NCT01596322|ART resistance in resource limited setting|art resistance in resource limited setting
5428040|NCT01596309|cardiovascular risk|cardiovascular risk
5428041|NCT01596309|Elderly population|elderly population
5428042|NCT01596309|cocoa extract|cocoa extract
5428043|NCT01596309|overweight and obesity|overweight and obesity
5428044|NCT01596309|Glycemic profile|glycemic profile
5428045|NCT01596309|lipid profile|lipid profile
5428046|NCT01596309|antioxidant status|antioxidant status
5428047|NCT01596309|inflammatory state|inflammatory state
5428048|NCT01596309|Cardiovascular Risk factors in elder population|cardiovascular risk factors in elder population
5428049|NCT01596296|labor induction|labor induction
5428050|NCT01596296|transcervical foley catheter|transcervical foley catheter
5428051|NCT01596296|dinoprostone|dinoprostone
5428052|NCT01596296|parous women|parous women
5428053|NCT01596283|Perioperative Fluid Management|perioperative fluid management
5428054|NCT01596283|liver resection|liver resection
5428055|NCT01596283|12-056|12-056
5428056|NCT01596257|CliniMACS-CD34 Reagent System|clinimacs-cd34 reagent system
5428057|NCT01596257|Acute Leukemia|acute leukemia
5428058|NCT01596257|Myelodysplastic syndrome|myelodysplastic syndrome
5428059|NCT01596257|Non Hodgkins Lymphoma|non hodgkins lymphoma
5428060|NCT01596257|Hodgkins Disease|hodgkins disease
5428061|NCT01596257|Multiple Myeloma|multiple myeloma
5428062|NCT01596257|12-016|12-016
5428063|NCT01596244|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5428064|NCT01596244|Disease management|disease management
5428065|NCT01596244|Chronic disease|chronic disease
5428066|NCT01596244|Prevention and control|prevention and control
5428067|NCT01596244|Education|education
5428068|NCT01596231|Alcohol consumption|alcohol consumption
5428069|NCT01596231|Kudzu extract|kudzu extract
5428070|NCT01596218|Steroid Refractory|steroid refractory
5428071|NCT01596218|Acute|acute
5428072|NCT01596205|cognitive therapy|cognitive therapy
5428266|NCT01595425|Japanese,|japanese,
5428073|NCT01596192|allogeneic transplantation, GVHD|allogeneic transplantation, gvhd
5428074|NCT01596192|Patients with acute GVHD after allogeneic hematopoietic cell transplantation|patients with acute gvhd after allogeneic hematopoietic cell transplantation
5428075|NCT01596179|treatment adherence|treatment adherence
5428076|NCT01596179|fatigue|fatigue
5428077|NCT01596179|symptom management|symptom management
5428078|NCT01596166|migraine|migraine
5428079|NCT01596166|pediatric|pediatric
5428080|NCT01596166|childhood|childhood
5428081|NCT01596166|emergency department|emergency department
5428082|NCT01596166|ketorolac|ketorolac
5428083|NCT01596166|metoclopramide|metoclopramide
5428084|NCT01596166|intravenous|intravenous
5428085|NCT01596140|Vemurafenib|vemurafenib
5428086|NCT01596140|Everolimus|everolimus
5428087|NCT01596140|Afinitor|afinitor
5428088|NCT01596140|RAD001|rad001
5428089|NCT01596140|temsirolimus|temsirolimus
5428090|NCT01596140|BRAF gene mutation|braf gene mutation
5428091|NCT01596140|solid tumor|solid tumor
5428092|NCT01596140|relapsed BRAF mutation positive malignant melanoma|relapsed braf mutation positive malignant melanoma
5428093|NCT01596140|refractory BRAF mutation positive malignant melanoma|refractory braf mutation positive malignant melanoma
5428094|NCT01596127|relapsed CD20+ lymphoid malignancies|relapsed cd20+ lymphoid malignancies
5428095|NCT01596127|refractory CD20+ lymphoid malignancies|refractory cd20+ lymphoid malignancies
5428096|NCT01596127|Rituximab|rituximab
5428097|NCT01596127|Intrathecal Rituximab|intrathecal rituximab
5428099|NCT01596127|Leptomeningeal disease|leptomeningeal disease
5428100|NCT01596127|LMD|lmd
5428101|NCT01596127|central nervous system disease|central nervous system disease
5428102|NCT01596127|Relapsed lymphoid malignancies|relapsed lymphoid malignancies
5428103|NCT01596127|refractory lymphoid malignancies|refractory lymphoid malignancies
5428104|NCT01596127|CNS leukemia|cns leukemia
5428105|NCT01596127|intrathecal chemotherapy|intrathecal chemotherapy
5428106|NCT01596127|cerebrospinal fluid|cerebrospinal fluid
5428107|NCT01596127|CSF|csf
5428108|NCT01596127|lumbar puncture|lumbar puncture
5428110|NCT01596114|TKI|tki
5428111|NCT01596114|CML|cml
5428112|NCT01596114|Stopping|stopping
5428113|NCT01596114|chronic phase|chronic phase
5428114|NCT01596114|in remission|in remission
5428115|NCT01596088|Extravasation|extravasation
5428116|NCT01596088|Anthracyclines|anthracyclines
5428117|NCT01596075|Cannabidiol|cannabidiol
5428118|NCT01596075|GVHD|gvhd
5428119|NCT01596075|Allogeneic transplantation|allogeneic transplantation
5428120|NCT01596062|Basiliximab|basiliximab
5428121|NCT01596062|renal transplantation|renal transplantation
5428122|NCT01596062|CNI-free|cni-free
5428123|NCT01596062|everolimus|everolimus
5428124|NCT01596036|cardiac rehabilitation|cardiac rehabilitation
5428125|NCT01596036|referral|referral
5428126|NCT01596036|enrollment|enrollment
5428127|NCT01596036|timing|timing
5428128|NCT01596023|COPD|copd
5428129|NCT01595997|safety tolerability and immunogenicity of two different doses of DLX105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients|safety tolerability and immunogenicity of two different doses of dlx105 applied intra-dermally into psoriatic lesion of mild-to-moderate psoriatic patients
5428130|NCT01595984|kidney|kidney
5428131|NCT01595984|transplantation|transplantation
5428132|NCT01595984|graft|graft
5428133|NCT01595984|creatinin|creatinin
5428134|NCT01595971|Asthma|asthma
5428135|NCT01595971|Continuing education|continuing education
5428136|NCT01595971|Primary health care|primary health care
5428138|NCT01595958|heart arrest|heart arrest
5428139|NCT01595958|cyclosporine A|cyclosporine a
5428140|NCT01595958|post cardiac arrest syndrome|post cardiac arrest syndrome
5428141|NCT01595958|protective agent|protective agent
5428142|NCT01595958|multiple organ failure|multiple organ failure
5428143|NCT01595958|mitochondrial permeability transition pore|mitochondrial permeability transition pore
5428144|NCT01595958|mitochondria|mitochondria
5428145|NCT01595958|cardio-pulmonary resuscitation|cardio-pulmonary resuscitation
5428146|NCT01595958|cardioprotection|cardioprotection
5428147|NCT01595958|ischemia reperfusion|ischemia reperfusion
5428148|NCT01595958|postconditioning|postconditioning
5428149|NCT01595945|Caloric restriction|caloric restriction
5428150|NCT01595945|Obesity|obesity
5428151|NCT01595945|Gastric bypass|gastric bypass
5428152|NCT01595945|Resting metabolic rate|resting metabolic rate
5428153|NCT01595932|irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5428154|NCT01595932|bloating|bloating
5428155|NCT01595932|abdominal distension|abdominal distension
5428156|NCT01595932|flatulence|flatulence
5428157|NCT01595932|α-Galactosidase|α-galactosidase
5428158|NCT01595906|Helmet|helmet
5428159|NCT01595906|Heat Tolerance Test|heat tolerance test
5428160|NCT01595906|ventilation System|ventilation system
5428161|NCT01595893|Polymorphic light eruption|polymorphic light eruption
5428162|NCT01595893|Vitamin D3|vitamin d3
5428163|NCT01595893|Photo provocation|photo provocation
5428164|NCT01595893|Immune function|immune function
5428165|NCT01595867|abuse liability|abuse liability
5428166|NCT01595867|abuse potential|abuse potential
5428167|NCT01595867|morphine|morphine
5428168|NCT01595867|intranasal administration|intranasal administration
5428170|NCT01595867|opioid abuse|opioid abuse
5428171|NCT01595867|pharmacodynamic|pharmacodynamic
5428172|NCT01595867|recreational drug use|recreational drug use
5428173|NCT01595841|hemodialysis|hemodialysis
5428174|NCT01595841|stenosis|stenosis
5428175|NCT01595841|angioplasty|angioplasty
5428176|NCT01595841|sirolimus|sirolimus
5846722|NCT00043654|Neuroendocrine|neuroendocrine
5428185|NCT01595763|Primary care|primary care
5428186|NCT01595763|Diagnosis|diagnosis
5428187|NCT01595763|Clinical model|clinical model
5428188|NCT01595750|Post-bronchodilator FEV1<70% reference|post-bronchodilator fev1<70% reference
5428189|NCT01595750|Chronic bronchitis|chronic bronchitis
5428190|NCT01595750|Presence of estavlished CVD,|presence of estavlished cvd,
5428191|NCT01595750|CVD equivalent or diabetes mellitus|cvd equivalent or diabetes mellitus
5428192|NCT01595724|Non-interventional study|non-interventional study
5428193|NCT01595724|Endometriosis,|endometriosis,
5428194|NCT01595724|Quality of life|quality of life
5428195|NCT01595698|Physical exercise|physical exercise
5428196|NCT01595698|IGF-1|igf-1
5428197|NCT01595698|Schizophrenia|schizophrenia
5428198|NCT01595698|neuroplasticity|neuroplasticity
5428199|NCT01595685|HBeAg-positive|hbeag-positive
5428200|NCT01595672|severe acute pancreatitis|severe acute pancreatitis
5428201|NCT01595672|organ failure|organ failure
5428202|NCT01595672|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5428203|NCT01595672|systemic complications|systemic complications
5428204|NCT01595672|continuous veno-venous hemofiltration|continuous veno-venous hemofiltration
5428205|NCT01595672|blood purification|blood purification
5428206|NCT01595672|continuous renal replacement therapy|continuous renal replacement therapy
5428207|NCT01595659|Risk|risk
5428208|NCT01595659|Young drivers|young drivers
5428209|NCT01595659|Alcohol|alcohol
5428210|NCT01595659|Passengers|passengers
5428211|NCT01595659|Gender|gender
5428212|NCT01595646|Memory|memory
5428213|NCT01595646|Intranasal insulin|intranasal insulin
5423106|NCT01617122|PID|pid
5428261|NCT01595438|Ceftazidime, Avibactam, Doripenem, Ciprofloxacin, sulfamethoxazole/trimethoprim, Anti-Infective Agents, Complicated Urinary Tract Infection,Acute Pyelonephritis|ceftazidime, avibactam, doripenem, ciprofloxacin, sulfamethoxazole/trimethoprim, anti-infective agents, complicated urinary tract infection,acute pyelonephritis
5428262|NCT01595425|Bioequivalence,|bioequivalence,
5428263|NCT01595425|pharmacokinetics,|pharmacokinetics,
5428264|NCT01595425|safety,|safety,
5428265|NCT01595425|esomeprazole,|esomeprazole,
5428267|NCT01595425|healthy subject,|healthy subject,
5428268|NCT01595425|homo-EM|homo-em
5428269|NCT01595412|Laparoscopic surgery|laparoscopic surgery
5428270|NCT01595412|Colorectal Surgery|colorectal surgery
5428271|NCT01595412|Quality of Life|quality of life
5431473|NCT01581398|HCV|hcv
5428272|NCT01595412|Rectal Prolapse|rectal prolapse
5428273|NCT01595412|Anorectal Physiology|anorectal physiology
5428274|NCT01595399|bradycardia|bradycardia
5428275|NCT01595399|hypoxemia|hypoxemia
5428276|NCT01595399|intubation|intubation
5428277|NCT01595399|premedication|premedication
5428279|NCT01595373|Microdialysis|microdialysis
5428280|NCT01595373|Controls|controls
5428281|NCT01595373|Metabolic effects of ghrelin|metabolic effects of ghrelin
5428282|NCT01595360|TT-173|tt-173
5428283|NCT01595360|Topical Hemostatics|topical hemostatics
5428284|NCT01595360|Hemostasis|hemostasis
5428285|NCT01595347|Pressure Ulcer|pressure ulcer
5428286|NCT01595347|Primary Prevention|primary prevention
5428287|NCT01595347|Fatty Acids|fatty acids
5428288|NCT01595347|Vegetable Fats|vegetable fats
5428289|NCT01595347|Olive oil|olive oil
5428290|NCT01595347|"Pressure Ulcer[prevention and control][Mesh]"|"pressure ulcer[prevention and control][mesh]"
5428291|NCT01595334|IVF-ET|ivf-et
5428292|NCT01595334|ICSI|icsi
5428293|NCT01595334|Gonadotrophins|gonadotrophins
5428294|NCT01595334|rFSH|rfsh
5428296|NCT01595334|Cetrorelix|cetrorelix
5428297|NCT01595334|Leuprolide acetate|leuprolide acetate
5428298|NCT01595321|Adjuvant therapy|adjuvant therapy
5428299|NCT01595321|Immunotherapy|immunotherapy
5428300|NCT01595321|Cytoxan|cytoxan
5428301|NCT01595321|Cyclophosphamide|cyclophosphamide
5428302|NCT01595321|Pancreatic Vaccine|pancreatic vaccine
5428303|NCT01595321|Stereotactic radiation therapy|stereotactic radiation therapy
5428304|NCT01595321|SBRT|sbrt
5428305|NCT01595321|FOLFIRINOX|folfirinox
5428306|NCT01595308|Male infertility|male infertility
5428307|NCT01595295|CMML|cmml
5428309|NCT01595295|AML|aml
5428310|NCT01595295|registry|registry
5428311|NCT01595295|Vidaza|vidaza
5428312|NCT01595282|pain|pain
5428313|NCT01595282|suction curettage|suction curettage
5428314|NCT01595269|Diabetes|diabetes
5428315|NCT01595269|eHealth|ehealth
5428316|NCT01595269|Type 2 Diabetes|type 2 diabetes
5428317|NCT01595269|Education|education
5428318|NCT01595269|Calgary Health Region|calgary health region
5428319|NCT01595256|colorectal cancer,fatigue,6-minute walking test|colorectal cancer,fatigue,6-minute walking test
5428320|NCT01595243|hepatocellular carcinoma|hepatocellular carcinoma
5428321|NCT01595243|Needs|needs
5428322|NCT01595243|Telephone consultation|telephone consultation
5428323|NCT01595230|Internal Hernias|internal hernias
5428324|NCT01595230|Clips|clips
5428325|NCT01595230|Gastric Bypass|gastric bypass
5428326|NCT01595230|Avoid|avoid
5428327|NCT01595217|Biliary Tract Neoplasm|biliary tract neoplasm
5428328|NCT01595217|Cholangiocarcinoma|cholangiocarcinoma
5428329|NCT01595217|Diffusion magnetic resonance imaging|diffusion magnetic resonance imaging
5428330|NCT01595217|Magnetic resonance imaging|magnetic resonance imaging
5428331|NCT01595217|Magnetic resonance Cholangiopancreatography|magnetic resonance cholangiopancreatography
5428332|NCT01595204|Cancer of Ovary, laparoscopy, operability , score.|cancer of ovary, laparoscopy, operability , score.
5428333|NCT01595178|smoking|smoking
5428334|NCT01595178|drinking|drinking
5428335|NCT01595178|SBIRT|sbirt
5428336|NCT01595178|BNI|bni
5428337|NCT01595178|counseling intervention|counseling intervention
5428338|NCT01595178|emergency department|emergency department
5428339|NCT01595178|adults|adults
5428340|NCT01595165|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5428341|NCT01595165|ultrasound|ultrasound
5428342|NCT01595165|transversus abdominis plane block|transversus abdominis plane block
5428343|NCT01595152|Urgency, urgency incontinence,USIQ|urgency, urgency incontinence,usiq
5428344|NCT01595100|Waist circumference|waist circumference
5428345|NCT01595100|Visceral adipose tissue|visceral adipose tissue
5428346|NCT01595100|Intra-abdominal fat|intra-abdominal fat
5428347|NCT01595100|Pediatrics|pediatrics
5428348|NCT01595087|CRPC|crpc
5428349|NCT01595035|Day surgery|day surgery
5428350|NCT01595035|Orthopedic surgery|orthopedic surgery
5428351|NCT01595035|Breast reconstruction surgery|breast reconstruction surgery
5428352|NCT01594996|Seroquel XR|seroquel xr
5428353|NCT01594996|Quetiapine XR|quetiapine xr
5428354|NCT01594996|Drug utilization|drug utilization
5428355|NCT01594996|Major depressive disorder (MDD)|major depressive disorder (mdd)
5428356|NCT01594983|hypertriglyceridemia|hypertriglyceridemia
5428357|NCT01594983|Non familial Chylocmicronemia Syndrome (non-FCS)|non familial chylocmicronemia syndrome (non-fcs)
5428358|NCT01594957|LCQ908,|lcq908,
5428359|NCT01594957|Hepatic Impairment,|hepatic impairment,
5789032|NCT00150163|Estrogens|estrogens
5428361|NCT01594931|malaria|malaria
5428362|NCT01594931|antimalarial|antimalarial
5428363|NCT01594931|artemisinin based combination therapy|artemisinin based combination therapy
5428364|NCT01594918|metastatic|metastatic
5428365|NCT01594918|CRPC|crpc
5428366|NCT01594918|prostate|prostate
5428367|NCT01594918|CAMP|camp
5428368|NCT01594905|To explore|to explore
5428369|NCT01594905|adequate management|adequate management
5428371|NCT01594905|Multidrug resistance|multidrug resistance
5428372|NCT01594892|Spinal metastases|spinal metastases
5428373|NCT01594892|Vertebral metastases|vertebral metastases
5428374|NCT01594892|Radiosurgery|radiosurgery
5428375|NCT01594892|Radiotherapy|radiotherapy
5428376|NCT01594892|Stereotactic body radiotherapy|stereotactic body radiotherapy
5428377|NCT01594892|Pain|pain
5428378|NCT01594879|Endometrial cancer|endometrial cancer
5428379|NCT01594879|LNG-IUS|lng-ius
5428380|NCT01594879|oral MPA|oral mpa
5428381|NCT01594866|Major depressive disorder, remission, escitalopram|major depressive disorder, remission, escitalopram
5428382|NCT01594853|exercise|exercise
5428383|NCT01594853|women|women
5428384|NCT01594853|training|training
5428385|NCT01594853|rehabilitation|rehabilitation
5428386|NCT01594853|leukodystrophy|leukodystrophy
5428387|NCT01594840|language development|language development
5428388|NCT01594840|parental interaction|parental interaction
5428389|NCT01594827|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5428390|NCT01594827|Vancomycin|vancomycin
5428391|NCT01594814|AVNRT|avnrt
5428392|NCT01594814|AVRT|avrt
5428393|NCT01594814|WPW|wpw
5428394|NCT01594801|DM|dm
5428395|NCT01594801|insulin|insulin
5428396|NCT01594801|injections|injections
5428397|NCT01594762|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
5428398|NCT01594749|NK-1 Receptor Antagonist, CINV, Emesis, MEC|nk-1 receptor antagonist, cinv, emesis, mec
5428399|NCT01594684|restenosis|restenosis
5428400|NCT01594684|stent|stent
5428401|NCT01594684|drug eltuing balloon|drug eltuing balloon
5428402|NCT01594684|peripheral arterial disease|peripheral arterial disease
5428403|NCT01594671|primary knee arthroplasty|primary knee arthroplasty
5428404|NCT01594671|tranexamic acid|tranexamic acid
5428405|NCT01594671|topical|topical
5428406|NCT01594658|Ultrasound-guided foam sclerotherapy; chronic venous ulcers|ultrasound-guided foam sclerotherapy; chronic venous ulcers
5428407|NCT01594632|AE adverse event|ae adverse event
5428408|NCT01594632|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5428409|NCT01594632|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5428410|NCT01594632|ART antiretroviral therapy|art antiretroviral therapy
5428411|NCT01594632|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5428412|NCT01594632|DCF data collection forms|dcf data collection forms
5428413|NCT01594632|DMC Data Monitoring Committee|dmc data monitoring committee
5428414|NCT01594632|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5428415|NCT01594632|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5428416|NCT01594632|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5428417|NCT01594632|ICH International Conference of Harmonization|ich international conference of harmonization
5428418|NCT01594632|IND Investigational New Drug Application|ind investigational new drug application
5428419|NCT01594632|IRB Institutional Review Board|irb institutional review board
5428420|NCT01594632|IU International units|iu international units
5428421|NCT01594632|mg milligram(s)|mg milligram(s)
5428422|NCT01594632|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5428423|NCT01594632|PCR polymerase chain reaction|pcr polymerase chain reaction
5428424|NCT01594632|SAE serious adverse event|sae serious adverse event
5428425|NCT01594632|µg microgram|µg microgram
5428426|NCT01594632|ULN upper limit of the normal range|uln upper limit of the normal range
5428427|NCT01594632|WB Western Blot|wb western blot
5428429|NCT01594619|Healthy male and female volunteers|healthy male and female volunteers
5428430|NCT01594619|Drug-drug interaction|drug-drug interaction
5428431|NCT01594619|Pharmacokinetics|pharmacokinetics
5428432|NCT01594619|Naloxegol|naloxegol
5428433|NCT01594606|Animal-assisted intervention|animal-assisted intervention
5428434|NCT01594606|adjudicated adolescents|adjudicated adolescents
5428435|NCT01594606|empathy|empathy
5428436|NCT01594593|prostate cancer|prostate cancer
5428437|NCT01594593|behavioral|behavioral
5428438|NCT01594593|acceptance and commitment therapy|acceptance and commitment therapy
5428439|NCT01594593|distress|distress
5428440|NCT01594567|Systematic review and meta-analysis|systematic review and meta-analysis
5428441|NCT01594567|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5428442|NCT01594567|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5428443|NCT01594567|Clinical practice guidelines|clinical practice guidelines
5428444|NCT01594567|Clinical trials|clinical trials
5428445|NCT01594567|Dietary pulses|dietary pulses
5428446|NCT01594567|legumes|legumes
5428447|NCT01594567|Beans, peas, chickpeas, lentils|beans, peas, chickpeas, lentils
5428448|NCT01594567|Cardiometabolic risk factors|cardiometabolic risk factors
5428449|NCT01594567|Triglycerides|triglycerides
5428450|NCT01594567|Cholesterol|cholesterol
5428451|NCT01594567|Glycemic control|glycemic control
5428460|NCT01594554|Follow-Up|follow-up
5428462|NCT01594554|RNA|rna
5428463|NCT01594554|China|china
5428464|NCT01594541|hyperhomocysteinemia|hyperhomocysteinemia
5428465|NCT01594541|dementia|dementia
5428466|NCT01594541|depression|depression
5428467|NCT01594541|vitamin B12|vitamin b12
5428476|NCT01594476|Postpartum|postpartum
5428477|NCT01594476|Contraception|contraception
5428478|NCT01594476|Intrauterine device|intrauterine device
5428479|NCT01594476|Intrauterine system|intrauterine system
5428480|NCT01594476|Mirena|mirena
5428481|NCT01594476|Paragard|paragard
5428482|NCT01594476|Uterine involution|uterine involution
5428483|NCT01594463|Intrauterine growth restriction|intrauterine growth restriction
5428484|NCT01594463|Screening|screening
5428485|NCT01594463|Ultrasound|ultrasound
5428486|NCT01594463|Perinatal morbidity|perinatal morbidity
5428487|NCT01594463|Maternal complications|maternal complications
5428488|NCT01594450|incisional ventral hernia|incisional ventral hernia
5428489|NCT01594450|infected field|infected field
5428490|NCT01594450|biological mesh|biological mesh
5400910|NCT01717742|tPA|tpa
5428491|NCT01594437|Cytomegalovirus|cytomegalovirus
5428492|NCT01594437|Monoclonal antibody|monoclonal antibody
5428493|NCT01594424|Donor-Specific Anti-HLA Antibodies|donor-specific anti-hla antibodies
5428494|NCT01594424|Kidney Transplantation|kidney transplantation
5428495|NCT01594411|Corus CAD|corus cad
5428496|NCT01594411|ASGES|asges
5428497|NCT01594411|Age/Sex/Gene Expression Score|age/sex/gene expression score
5428498|NCT01594411|Gene Expression|gene expression
5428499|NCT01594411|GES|ges
5428500|NCT01594411|CAD|cad
5428501|NCT01594411|CVD|cvd
5428502|NCT01594411|CHD|chd
5428503|NCT01594411|Clinical Utility|clinical utility
5428504|NCT01594411|Precision Medicine|precision medicine
5428505|NCT01594411|Primary care|primary care
5428506|NCT01594411|Coronary Artery Disease|coronary artery disease
5428507|NCT01594411|Angina Pectoris|angina pectoris
5428508|NCT01594411|Chest Pain|chest pain
5428509|NCT01594411|Cardiovascular Disease|cardiovascular disease
5428510|NCT01594411|Coronary Heart Disease|coronary heart disease
5428511|NCT01594411|IMPACT|impact
5428512|NCT01594411|IMPACT-PCP|impact-pcp
5428513|NCT01594398|carcinoma,non small cell lung|carcinoma,non small cell lung
5428514|NCT01594398|lung diseases|lung diseases
5428515|NCT01594398|lung neoplasms|lung neoplasms
5428517|NCT01594398|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5428518|NCT01594398|Bronchial Neoplasms|bronchial neoplasms
5428519|NCT01594398|Respiratory Tract Neoplasms|respiratory tract neoplasms
5428520|NCT01594398|Thoracic Neoplasms|thoracic neoplasms
5428521|NCT01594398|Neoplasms by Site|neoplasms by site
5428522|NCT01594398|Respiratory Tract Diseases|respiratory tract diseases
5428523|NCT01594398|Erlotinib|erlotinib
5428524|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors
5428525|NCT01594398|Breast Neoplasms|breast neoplasms
5428526|NCT01594398|Neoplasms|neoplasms
5428527|NCT01594398|Breast Diseases|breast diseases
5428528|NCT01594398|Exemestane|exemestane
5428529|NCT01594398|Aromatase Inhibitors|aromatase inhibitors
5428530|NCT01594385|Open Abdomen|open abdomen
5428531|NCT01594385|Damage Control|damage control
5428532|NCT01594385|Trauma|trauma
5428533|NCT01594385|Wound healing|wound healing
5428534|NCT01594385|Gun shot wounds|gun shot wounds
5428535|NCT01594385|Stab wounds|stab wounds
5428536|NCT01594385|Automobile accidents|automobile accidents
5428537|NCT01594385|Wounds and Injury|wounds and injury
5428538|NCT01594372|Uterine Prolapse|uterine prolapse
5428539|NCT01594372|Laparoscopy|laparoscopy
5428540|NCT01594372|Hysterectomy, vaginal|hysterectomy, vaginal
5428541|NCT01594359|Ferritin|ferritin
5428542|NCT01594346|Vitamin E|vitamin e
5428543|NCT01594346|alpha-tocopherol|alpha-tocopherol
5428544|NCT01594346|cognitive decline|cognitive decline
5428545|NCT01594346|Down syndrome|down syndrome
5428546|NCT01594346|Aging|aging
5428547|NCT01594346|Dementia|dementia
5428548|NCT01594333|Myocardial Infarction|myocardial infarction
5428549|NCT01594333|Stroke|stroke
5428550|NCT01594333|Cardiovascular death|cardiovascular death
5428551|NCT01594333|Type 2 Diabetes|type 2 diabetes
5428552|NCT01594333|Metabolic Syndrome|metabolic syndrome
5428553|NCT01594333|Cardiovascular Inflammation|cardiovascular inflammation
5428554|NCT01594333|Atherothrombosis|atherothrombosis
5428555|NCT01594307|BP|bp
5428556|NCT01594294|CLEAR CARE®|clear care®
5428557|NCT01594294|AOSEPT® Plus|aosept® plus
5428558|NCT01594294|ReNu MultiPlus®|renu multiplus®
5428559|NCT01594294|silicone hydrogel|silicone hydrogel
5428560|NCT01594294|hydrogel|hydrogel
5428561|NCT01594294|ACUVUE® 2®|acuvue® 2®
5428562|NCT01594294|AIR OPTIX® AQUA|air optix® aqua
5428563|NCT01594294|eyelid response|eyelid response
5428568|NCT01594281|Ranibizumab|ranibizumab
5428569|NCT01594268|kidney transplant|kidney transplant
5428570|NCT01594268|Certican|certican
5428571|NCT01594255|Healthy volunteer|healthy volunteer
5428572|NCT01594255|QT intervals|qt intervals
5428574|NCT01594255|QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs|qt/qtc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
5428575|NCT01594242|multiple myeloma|multiple myeloma
5428576|NCT01594242|bortezomib|bortezomib
5428577|NCT01594242|proteasome inhibitor|proteasome inhibitor
5428578|NCT01594229|Pharmacokinetics|pharmacokinetics
5428579|NCT01594229|Maximum Tolerated Dose|maximum tolerated dose
5428580|NCT01594229|Safety|safety
5428581|NCT01594229|Bendamustine|bendamustine
5428582|NCT01594229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5428583|NCT01594229|Rituximab|rituximab
5428584|NCT01594229|ABT-199|abt-199
5428585|NCT01594229|Cancer|cancer
5671967|NCT00613392|trauma|trauma
5428586|NCT01594229|Preliminary Efficacy|preliminary efficacy
5428587|NCT01594216|Postmenopausal female|postmenopausal female
5428589|NCT01594203|Pazopanib|pazopanib
5428590|NCT01594203|F18-FDG PET/CT|f18-fdg pet/ct
5428591|NCT01594177|DAFNE|dafne
5428592|NCT01594177|GBG 70|gbg 70
5428594|NCT01594177|German Breast Group|german breast group
5428595|NCT01594177|GBG Forschungs GmbH|gbg forschungs gmbh
5428596|NCT01594177|Afatinib|afatinib
5428597|NCT01594177|neo-adjuvant|neo-adjuvant
5534601|NCT01148459|HIV|hiv
5428598|NCT01594177|HER-2 positive breast cancer|her-2 positive breast cancer
5428599|NCT01594177|BIBW 2992|bibw 2992
5428600|NCT01594177|1200.159|1200.159
5428601|NCT01594164|High Resolution Computed Tomography|high resolution computed tomography
5428602|NCT01594164|Cone Beam Computed Tomography|cone beam computed tomography
5428603|NCT01594164|upper airway|upper airway
5428604|NCT01594164|geometry|geometry
5428605|NCT01594151|asthma|asthma
5428606|NCT01594151|controlled|controlled
5428607|NCT01594151|Cone Beam Computed Tomography|cone beam computed tomography
5428608|NCT01594151|upper airway|upper airway
5428609|NCT01594151|paediatric|paediatric
5428610|NCT01594112|Remote monitoring|remote monitoring
5428611|NCT01594112|Home monitoring|home monitoring
5428612|NCT01594112|Defibrillators, Implantable cardioverter-defibrillator|defibrillators, implantable cardioverter-defibrillator
5428613|NCT01594112|Shock|shock
5428614|NCT01594112|Inappropriate diagnoses and Therapies|inappropriate diagnoses and therapies
5428615|NCT01594112|Corrective actions|corrective actions
5428616|NCT01594112|ID recurrences|id recurrences
5428617|NCT01594112|Medical reaction time|medical reaction time
5428618|NCT01594099|cervical cancer|cervical cancer
5428619|NCT01594099|elderly women|elderly women
5428620|NCT01594099|concurrent chemotherapy|concurrent chemotherapy
5428621|NCT01594086|green tea|green tea
5428623|NCT01594086|atherosclerosis|atherosclerosis
5428624|NCT01594086|homocysteine|homocysteine
5428625|NCT01594086|cognitive impairment|cognitive impairment
5428626|NCT01594073|implantable defibrillator|implantable defibrillator
5428627|NCT01594073|ventricular arrhythmias|ventricular arrhythmias
5428628|NCT01594073|cardiac death|cardiac death
5428629|NCT01594047|hyperalgesia|hyperalgesia
5428630|NCT01594047|Patient controlled analgesia|patient controlled analgesia
5428631|NCT01594047|morphine|morphine
5428632|NCT01594047|methadone|methadone
5428633|NCT01594047|ketamine|ketamine
5428634|NCT01594021|propofol|propofol
5428635|NCT01594021|anesthesia, induction|anesthesia, induction
5428636|NCT01594021|hypotension|hypotension
5428637|NCT01594021|cardiac output|cardiac output
5428638|NCT01594008|Toll like receptors|toll like receptors
5428639|NCT01594008|Inflammation|inflammation
5428640|NCT01594008|Anthocyanins|anthocyanins
5428641|NCT01594008|Blueberries|blueberries
5428642|NCT01593995|Erlotinib|erlotinib
5428643|NCT01593995|Skin side effect|skin side effect
5428644|NCT01593995|EGF ointment|egf ointment
5428645|NCT01593982|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5428646|NCT01593982|Cocaine Dependence|cocaine dependence
5428647|NCT01593982|Cocaine Addicts|cocaine addicts
5428648|NCT01593982|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5428649|NCT01593982|Cognitive Function|cognitive function
5428650|NCT01593969|Essential Fatty Acid|essential fatty acid
5428651|NCT01593969|Seed oil|seed oil
5428652|NCT01593969|Fish oil|fish oil
5428653|NCT01593969|Dietary deficiency|dietary deficiency
5428654|NCT01593943|contraception|contraception
5428655|NCT01593943|india|india
5428656|NCT01593943|rural|rural
5428657|NCT01593930|Pulp Anesthesia|pulp anesthesia
5428658|NCT01593930|Articaine|articaine
5428659|NCT01593930|Lidocaine|lidocaine
5428660|NCT01593917|Aortic valve|aortic valve
5428661|NCT01593917|Heart valve|heart valve
5428662|NCT01593917|Tissue valve|tissue valve
5428663|NCT01593917|Bioprosthesis|bioprosthesis
5428664|NCT01593904|CCSVI, Flow, Perfusion in MS|ccsvi, flow, perfusion in ms
5428666|NCT01593865|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5428667|NCT01593865|Mammary Artery Grafts|mammary artery grafts
5428668|NCT01593865|Bilateral Mammary Artery Grafting|bilateral mammary artery grafting
5428669|NCT01593865|Clinical Outcomes|clinical outcomes
5428670|NCT01593852|X-rays|x-rays
5428671|NCT01593852|Cardiac Electrophysiology|cardiac electrophysiology
5428672|NCT01593852|Image Processing, Computer-Assisted|image processing, computer-assisted
5428673|NCT01593852|Catheter Ablation|catheter ablation
5428674|NCT01593813|Pronator quadratus|pronator quadratus
5428675|NCT01593813|distal radius fracture|distal radius fracture
5428676|NCT01593813|volar plating|volar plating
5428677|NCT01593800|Probiotics|probiotics
5428678|NCT01593800|Lactose|lactose
5428679|NCT01593787|Hypertension|hypertension
5428680|NCT01593787|Renal dysfunction|renal dysfunction
5428681|NCT01593787|LCZ696|lcz696
5428682|NCT01593774|Melatonin|melatonin
5428683|NCT01593774|Olanzapine|olanzapine
5428684|NCT01593774|Metabolic side effects|metabolic side effects
5428685|NCT01593774|Psychosis|psychosis
5428686|NCT01593774|Hyperlipidemia|hyperlipidemia
5428687|NCT01593774|Hyperglycemia|hyperglycemia
5428688|NCT01593774|Weight gain|weight gain
5428689|NCT01593774|Diabetes|diabetes
5428690|NCT01593761|cABSSSI|cabsssi
5428691|NCT01593761|MRSA|mrsa
5428692|NCT01593748|Sarcoma|sarcoma
5428693|NCT01593748|Soft Tissue Sarcoma|soft tissue sarcoma
5428694|NCT01593722|Loa loa|loa loa
5428695|NCT01593722|Immune Response|immune response
5428696|NCT01593722|Therapy|therapy
5428697|NCT01593709|Anti-infective agents|anti-infective agents
5428698|NCT01593709|ANTI-VIRAL AGENTS|anti-viral agents
5428699|NCT01593709|Healthy Volunteers|healthy volunteers
5428700|NCT01593696|CD 19 Expressing B Cells|cd 19 expressing b cells
5428701|NCT01593696|B Cell Lymphoma|b cell lymphoma
5428703|NCT01593696|Anti-CD19 Chimeric Antigen Receptor|anti-cd19 chimeric antigen receptor
5428704|NCT01593696|Adoptive Immunotherapy|adoptive immunotherapy
5428705|NCT01593683|Oncology service|oncology service
5428706|NCT01593683|Nursing staff|nursing staff
5428707|NCT01593683|Psychosocial intervention|psychosocial intervention
5428708|NCT01593683|Coping skills|coping skills
5428709|NCT01593670|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5428710|NCT01593670|natural killer cells|natural killer cells
5428711|NCT01593644|Dipyridamole/adenosine combination given intravenously|dipyridamole/adenosine combination given intravenously
5428712|NCT01593644|slow bolus and low doses|slow bolus and low doses
5428713|NCT01593644|coronary flow reserve assessment|coronary flow reserve assessment
5428714|NCT01593644|transthoracic echodoppler|transthoracic echodoppler
5428715|NCT01593644|Patients|patients
5428716|NCT01593644|stable|stable
5428717|NCT01593631|lactose malabsorption|lactose malabsorption
5428719|NCT01593631|lactose digestion|lactose digestion
5428720|NCT01593631|lactose maldigestion|lactose maldigestion
5428721|NCT01593631|acid lactase|acid lactase
5428722|NCT01593631|yoghurt bacteria|yoghurt bacteria
5428723|NCT01593618|cancer survivor|cancer survivor
5428724|NCT01593605|Impaired glucose tolerance, pre-diabetes,glycemic control,|impaired glucose tolerance, pre-diabetes,glycemic control,
5428725|NCT01593605|supplements|supplements
5428726|NCT01593592|Helicobacter pylori|helicobacter pylori
5428727|NCT01593592|Lactobacillus reuteri|lactobacillus reuteri
5428728|NCT01593592|dyspeptic patients|dyspeptic patients
5428729|NCT01593592|eradication|eradication
5428730|NCT01593579|melanoma|melanoma
5428731|NCT01593579|autonomic failure|autonomic failure
5428732|NCT01593579|hypotension|hypotension
5428733|NCT01593579|akt therapy|akt therapy
5428734|NCT01593566|femoral nerve block|femoral nerve block
5428735|NCT01593553|Screening|screening
5428736|NCT01593553|Stroke prevention|stroke prevention
5428737|NCT01593553|Cost effectiveness|cost effectiveness
5428738|NCT01593527|Frequent flares|frequent flares
5428739|NCT01593527|Frequent attacks|frequent attacks
5428740|NCT01593527|gout|gout
5428741|NCT01593527|gouty arthritis|gouty arthritis
5428742|NCT01593527|Chronic kidney disease|chronic kidney disease
5428743|NCT01593527|renal impairment|renal impairment
5428744|NCT01593527|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5428745|NCT01593527|anti-inflammatory therapy|anti-inflammatory therapy
5428746|NCT01593514|Vaccines|vaccines
5428747|NCT01593514|Meningitis|meningitis
5428748|NCT01593514|Meningococcal|meningococcal
5428749|NCT01593501|vitamin D|vitamin d
5428750|NCT01593501|cholecalciferol|cholecalciferol
5428751|NCT01593501|bone mineral density|bone mineral density
5428752|NCT01593501|Magnesium deficiency|magnesium deficiency
5428753|NCT01593501|Calcium metabolism disorders|calcium metabolism disorders
5428754|NCT01593488|recurrent|recurrent
5428755|NCT01593488|CNS disease|cns disease
5428756|NCT01593488|intrathecal therapy|intrathecal therapy
5846723|NCT00043654|Cognition|cognition
5428757|NCT01593436|insomnia,menopause, polysomnography, mindfulness|insomnia,menopause, polysomnography, mindfulness
5428758|NCT01593410|Efficacy/Safety|efficacy/safety
5411576|NCT01670981|Heart failure|heart failure
5428759|NCT01593410|Lenalidomide and Low-Dose Dexamethasone|lenalidomide and low-dose dexamethasone
5428764|NCT01593384|Breast Cancer|breast cancer
5428765|NCT01593384|Digital Breast Tomosynthesis (DBT)|digital breast tomosynthesis (dbt)
5428766|NCT01593384|Digital Mammography (DM)|digital mammography (dm)
5428767|NCT01593371|Adipokines|adipokines
5428768|NCT01593371|leptin|leptin
5428769|NCT01593371|chemerin|chemerin
5428770|NCT01593371|omentin|omentin
5428771|NCT01593371|metformin|metformin
5428772|NCT01593371|type 2 diabetes mellitus|type 2 diabetes mellitus
5428773|NCT01593358|CCSVI|ccsvi
5428774|NCT01593345|Elderly|elderly
5428775|NCT01593345|mobility limitations|mobility limitations
5428776|NCT01593345|self-management|self-management
5428777|NCT01593345|exercise|exercise
5428778|NCT01593332|Rituximab|rituximab
5428779|NCT01593332|Rheumatoid arthritis|rheumatoid arthritis
5428780|NCT01593332|Biologics|biologics
5428781|NCT01593332|Anti-tumour necrosis factor|anti-tumour necrosis factor
5428782|NCT01593332|Disease-modifying anti-rheumatic drugs|disease-modifying anti-rheumatic drugs
5428783|NCT01593332|DAS28|das28
5428784|NCT01593332|European League Against Rheumatism response|european league against rheumatism response
5428785|NCT01593293|Elderly patients|elderly patients
5428786|NCT01593293|Non-squamous Non-small Cell Lung Cancer|non-squamous non-small cell lung cancer
5428787|NCT01593293|Pemetrexed|pemetrexed
5428788|NCT01593293|Carboplatin|carboplatin
5428789|NCT01593280|anesthesia|anesthesia
5428790|NCT01593280|regional anesthetic techniques: transversus abdominis plane block,|regional anesthetic techniques: transversus abdominis plane block,
5428791|NCT01593280|pain, postoperative|pain, postoperative
5428792|NCT01593280|surgery, cesarean section|surgery, cesarean section
5428793|NCT01593280|quality of recovery|quality of recovery
5428794|NCT01593267|intracranial aneurysm|intracranial aneurysm
5428795|NCT01593267|subarachnoid hemorrhage|subarachnoid hemorrhage
5428796|NCT01593267|randomized trial|randomized trial
5428797|NCT01593267|coil embolization|coil embolization
5428798|NCT01593267|clip occlusion|clip occlusion
5428799|NCT01593267|vascular disorders|vascular disorders
5428800|NCT01593241|Seminoma IIA/B|seminoma iia/b
5428801|NCT01593241|Carboplatin|carboplatin
5428803|NCT01593215|genetics|genetics
5428804|NCT01593215|type 2 diabetes|type 2 diabetes
5428805|NCT01593215|insulin secretion|insulin secretion
5428806|NCT01593189|developmental disabilities|developmental disabilities
5428807|NCT01593189|school readiness|school readiness
5428808|NCT01593189|literacy|literacy
5428809|NCT01593189|social emotional skills|social emotional skills
5428810|NCT01593189|self regulation|self regulation
5428811|NCT01593189|caregiver involvement|caregiver involvement
5428812|NCT01593176|Femur|femur
5428813|NCT01593176|Fracture|fracture
5428814|NCT01593176|Radiostereometric Analysis|radiostereometric analysis
5428815|NCT01593163|Functional echocardiography|functional echocardiography
5428816|NCT01593163|power Doppler cranial ultrasonography|power doppler cranial ultrasonography
5428817|NCT01593163|N-terminal probrain natriuretic peptide|n-terminal probrain natriuretic peptide
5428818|NCT01593163|Patent ductus arteriosus|patent ductus arteriosus
5428819|NCT01593150|Atrial Fibrillation|atrial fibrillation
5428820|NCT01593150|TEE|tee
5428821|NCT01593150|Early versus late DC cardioversion.|early versus late dc cardioversion.
5428822|NCT01593124|Vaginal innate immune and inflammatory responses|vaginal innate immune and inflammatory responses
5428823|NCT01593111|Allergies|allergies
5428824|NCT01593111|Asthma|asthma
5428825|NCT01593111|Environmental|environmental
5428826|NCT01593111|NYC|nyc
5428827|NCT01593111|Manhattan|manhattan
5428828|NCT01593111|Harlem|harlem
5428829|NCT01593111|Bronx|bronx
5428830|NCT01593111|Brooklyn|brooklyn
5428831|NCT01593111|Breathing|breathing
5428832|NCT01593111|eNO|eno
5428833|NCT01593111|IgE|ige
5428834|NCT01593111|Allergens|allergens
5428835|NCT01593111|Cockroach|cockroach
5428836|NCT01593111|Dust mites|dust mites
5428837|NCT01593111|Pets|pets
5428838|NCT01593098|siblings|siblings
5428839|NCT01593098|advanced neoplasm|advanced neoplasm
5428840|NCT01593098|mRNA|mrna
5428841|NCT01593098|TaqMan microRNA expression assays|taqman microrna expression assays
5428842|NCT01593085|palliative cares|palliative cares
5428843|NCT01593085|cancer|cancer
5428844|NCT01593085|suicide risk|suicide risk
5428845|NCT01593072|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5428846|NCT01593072|Ebola Virus|ebola virus
5428847|NCT01593072|Post Exposure Prophylaxis|post exposure prophylaxis
5428848|NCT01593072|EHF|ehf
5428849|NCT01593059|International|international
5428850|NCT01593059|Multicenter|multicenter
5428851|NCT01593059|Observational registry|observational registry
5432076|NCT01578772|HIV|hiv
5428852|NCT01593059|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5428853|NCT01593059|Stenting|stenting
5428854|NCT01593059|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5789033|NCT00150163|Fat|fat
5428855|NCT01593059|Coronary revascularization|coronary revascularization
5428856|NCT01593059|Percutaneous Coronary Intervention|percutaneous coronary intervention
5428857|NCT01593059|STEMI|stemi
5428858|NCT01593059|NSTEMI|nstemi
5428859|NCT01593059|Ischemia|ischemia
5428860|NCT01593059|Angina|angina
5428861|NCT01593059|Subgroups|subgroups
5428862|NCT01593059|Acute Myocardial Infarction|acute myocardial infarction
5428863|NCT01593059|Diabetes|diabetes
5428864|NCT01593059|Small Vessels|small vessels
5428865|NCT01593059|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5428866|NCT01593046|GSK1265744 LAP|gsk1265744 lap
5428867|NCT01593046|integrase inhibitor|integrase inhibitor
5428868|NCT01593046|healthy subjects|healthy subjects
5428869|NCT01593046|TMC278 LA|tmc278 la
5428870|NCT01593046|GSK1265744LAP|gsk1265744lap
5428871|NCT01593046|long acting retroviral|long acting retroviral
5428872|NCT01593046|HIV-1 infection|hiv-1 infection
5428873|NCT01593020|Breast cancer|breast cancer
5428874|NCT01593020|Early Stage Breast Cancer Not Overexpressing HER-2|early stage breast cancer not overexpressing her-2
5568971|NCT01010438|OSA|osa
5428875|NCT01593020|Primary invasive adenocarcinoma of the breast|primary invasive adenocarcinoma of the breast
5428876|NCT01593020|Paclitaxel|paclitaxel
5428877|NCT01593020|Taxol|taxol
5428878|NCT01593020|Eribulin|eribulin
5428879|NCT01593020|E7389|e7389
5428880|NCT01593020|5-Fluorouracil|5-fluorouracil
5428881|NCT01593020|5-FU|5-fu
5428882|NCT01593020|Adrucil|adrucil
5428883|NCT01593020|Efudex|efudex
5428884|NCT01593020|Epirubicin|epirubicin
5428885|NCT01593020|Ellence|ellence
5428886|NCT01593020|Cyclophosphamide|cyclophosphamide
5428887|NCT01593020|Cytoxan|cytoxan
5428888|NCT01593020|Neosar|neosar
5428889|NCT01593020|Doxorubicin|doxorubicin
5428890|NCT01593020|Doxorubicin hydrochloride|doxorubicin hydrochloride
5428891|NCT01593020|Adriamycin PFS|adriamycin pfs
5428892|NCT01593020|Adriamycin RDF|adriamycin rdf
5428893|NCT01593020|Adriamycin|adriamycin
5428894|NCT01593020|Rubex|rubex
5428895|NCT01593007|Heart failure|heart failure
5428896|NCT01593007|respiratory muscles|respiratory muscles
5428897|NCT01593007|optoelectronic plethysmography|optoelectronic plethysmography
5428898|NCT01592994|HIV|hiv
5428899|NCT01592994|condom use|condom use
5428900|NCT01592994|India|india
5428901|NCT01592994|women|women
5428902|NCT01592981|Waldenstrom's macroglobulinaemia|waldenstrom's macroglobulinaemia
5428903|NCT01592981|bortezomib|bortezomib
5428904|NCT01592981|cyclophosphamide|cyclophosphamide
5428905|NCT01592981|rituximab|rituximab
5428906|NCT01592955|Glaucoma|glaucoma
5428907|NCT01592955|Cyclocoagulation|cyclocoagulation
5680265|NCT00578435|Sickle Cell Anemia|sickle cell anemia
5428908|NCT01592955|HIFU High Intensity Focused Ultrasound|hifu high intensity focused ultrasound
5428909|NCT01592942|inguinal hernia|inguinal hernia
5428910|NCT01592942|mesh fixation|mesh fixation
5428911|NCT01592942|glue|glue
5428912|NCT01592942|Lichtenstein|lichtenstein
5428913|NCT01592929|Functional Respiratory Imaging|functional respiratory imaging
5428914|NCT01592929|Magnetic Resonance Imaging|magnetic resonance imaging
5428915|NCT01592929|MRI|mri
5428916|NCT01592929|Pharyngometry|pharyngometry
5428917|NCT01592929|Upper Airway|upper airway
5428918|NCT01592929|Mouthpiece of Inhaler|mouthpiece of inhaler
5428919|NCT01592929|Cone Beam Computed Tomography|cone beam computed tomography
5428920|NCT01592929|CBCT|cbct
5428921|NCT01592929|Computed Tomography|computed tomography
5428922|NCT01592929|CT|ct
5428923|NCT01592916|Fibromyalgia|fibromyalgia
5428924|NCT01592916|Pain|pain
5428925|NCT01592916|Women|women
5428926|NCT01592916|Exercise|exercise
5428927|NCT01592916|IGF1|igf1
5428928|NCT01592903|Uterine fibroids|uterine fibroids
5428929|NCT01592903|somatic stem cell|somatic stem cell
5428930|NCT01592903|Side Population|side population
5428931|NCT01592877|UWB|uwb
5428932|NCT01592877|non-contact|non-contact
5428933|NCT01592877|patient monitor|patient monitor
5428934|NCT01592838|Belgium|belgium
5428935|NCT01592838|Quality of hospital care|quality of hospital care
5428936|NCT01592838|Rotavirus vaccination|rotavirus vaccination
5428937|NCT01592825|Breast Cancer|breast cancer
5428938|NCT01592825|Prognostic factor|prognostic factor
5428939|NCT01592825|uPA/PA-1|upa/pa-1
5428940|NCT01592825|cohort|cohort
5428941|NCT01592799|Influenza|influenza
5428942|NCT01592799|Children|children
5428943|NCT01592799|Hospitalizations|hospitalizations
5428944|NCT01592799|Spain|spain
5428945|NCT01592799|Burden|burden
5428946|NCT01592786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5428947|NCT01592786|Autism|autism
5428948|NCT01592786|Autistic Disorder|autistic disorder
5428949|NCT01592786|Asperger's Disorder|asperger's disorder
5428950|NCT01592786|Asperger's|asperger's
5428951|NCT01592786|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5428952|NCT01592786|Memantine|memantine
5428953|NCT01592786|Pediatric Disorder|pediatric disorder
5428954|NCT01592773|Autistic Disorder|autistic disorder
5428955|NCT01592773|Asperger's Disorder|asperger's disorder
5428956|NCT01592773|Asperger's|asperger's
5428957|NCT01592773|Pediatric Autism|pediatric autism
5428958|NCT01592773|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5428960|NCT01592760|air-Q SP|air-q sp
5428961|NCT01592760|air-Q|air-q
5411807|NCT01669954|HIV|hiv
5428962|NCT01592760|i-gel|i-gel
5428963|NCT01592760|supraglottic airway device|supraglottic airway device
5428964|NCT01592760|laryngeal mask airway|laryngeal mask airway
5428965|NCT01592747|Asperger's|asperger's
5428966|NCT01592747|Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)|pervasive developmental disorder not otherwise specified (pdd-nos)
5428967|NCT01592747|Memantine|memantine
5428968|NCT01592747|Pediatric Disorder|pediatric disorder
5428969|NCT01592747|Randomized Controlled Trial|randomized controlled trial
5428970|NCT01592734|chronic constipation|chronic constipation
5428971|NCT01592734|faecal impaction|faecal impaction
5428972|NCT01592734|PEG-only laxative|peg-only laxative
5428973|NCT01592721|Carcinoma|carcinoma
5428974|NCT01592721|Squamous cell carcinoma|squamous cell carcinoma
5569094|NCT01009866|GBM|gbm
5428975|NCT01592721|Head and neck neoplasms|head and neck neoplasms
5428976|NCT01592721|Cetuximab|cetuximab
5428977|NCT01592708|orthognathic surgery|orthognathic surgery
5428978|NCT01592708|maxillary osteotomy|maxillary osteotomy
5428979|NCT01592708|post operative nausea vomiting|post operative nausea vomiting
5428980|NCT01592708|post discharge nausea vomiting|post discharge nausea vomiting
5428981|NCT01592708|anesthesia|anesthesia
5428982|NCT01592695|Nicotine dependence|nicotine dependence
5428983|NCT01592695|Smoking cessation|smoking cessation
5428984|NCT01592695|Telehealth|telehealth
5428985|NCT01592695|Alcohol use|alcohol use
5428986|NCT01592695|Depression|depression
5428987|NCT01592695|Body weight|body weight
5428988|NCT01592682|tobacco|tobacco
5428989|NCT01592682|secondhand smoke|secondhand smoke
5428990|NCT01592682|Chinese|chinese
5416018|NCT01650116|PuCO2|puco2
5428991|NCT01592682|NNAL|nnal
5428992|NCT01592669|Passive leg raising, blood pressure, heart rate|passive leg raising, blood pressure, heart rate
5428993|NCT01592656|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5428994|NCT01592656|GOLD stages II, III and IV|gold stages ii, iii and iv
5428995|NCT01592656|Computed Tomography scan|computed tomography scan
5428996|NCT01592656|Functional Respiratory Imaging|functional respiratory imaging
5428997|NCT01592656|Non-Invasive Ventilation|non-invasive ventilation
5428998|NCT01592656|Arterial Blood Gas|arterial blood gas
5428999|NCT01592656|Hypercapnic|hypercapnic
5429000|NCT01592656|Health Related Quality of Life|health related quality of life
5414325|NCT01657838|BAL8557|bal8557
5429001|NCT01592656|Lung compliance|lung compliance
5429002|NCT01592643|Corneal shield|corneal shield
5429003|NCT01592643|PRK|prk
5429004|NCT01592643|Myopia|myopia
5429005|NCT01592643|Pain|pain
5429006|NCT01592643|Vision|vision
5429007|NCT01592617|cancer vaccine|cancer vaccine
5429008|NCT01592617|HLA-A*24:02|hla-a*24:02
5429009|NCT01592617|lung cancer|lung cancer
5429010|NCT01592617|CTL|ctl
5429011|NCT01592604|fracture|fracture
5429012|NCT01592604|fifth metatarsal|fifth metatarsal
5429013|NCT01592604|functioanl outcome|functioanl outcome
5429014|NCT01592578|gastroesophgeal variceal bleeding|gastroesophgeal variceal bleeding
5429015|NCT01592578|liver cirrhosis|liver cirrhosis
5429016|NCT01592578|portal hypertension|portal hypertension
5429017|NCT01592552|Alzheimer's Disease|alzheimer's disease
5429018|NCT01592552|Multiple Sclerosis|multiple sclerosis
5429019|NCT01592552|Parkinson's Disease|parkinson's disease
5429020|NCT01592552|Huntington's Disease|huntington's disease
5429021|NCT01592552|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5429022|NCT01592539|Type 1 Diabetes|type 1 diabetes
5429023|NCT01592539|Bone|bone
5429024|NCT01592526|Systemic inflammatory response.|systemic inflammatory response.
5429025|NCT01592526|Autonomic nervous regulation.|autonomic nervous regulation.
5429026|NCT01592526|Cholinergic antiinflammatory pathway|cholinergic antiinflammatory pathway
5429027|NCT01592500|GHD|ghd
5429028|NCT01592500|r-hGH|r-hgh
5429029|NCT01592500|Long-acting|long-acting
5429030|NCT01592474|Multiple Sclerosis|multiple sclerosis
5429031|NCT01592474|Avonex|avonex
5429032|NCT01592474|Brain atrophy|brain atrophy
5429033|NCT01592474|MRI|mri
5429034|NCT01592474|Interferon-beta 1a|interferon-beta 1a
5429035|NCT01592474|IFN Beta 1-a|ifn beta 1-a
5429036|NCT01592474|Clinically isolated syndrome|clinically isolated syndrome
5429037|NCT01592474|CIS|cis
5429038|NCT01592461|Substance abuse treatment outcomes|substance abuse treatment outcomes
5429039|NCT01592461|Opioid dependence|opioid dependence
5429040|NCT01592461|Suboxone|suboxone
5429041|NCT01592461|Methadone|methadone
5429042|NCT01592448|Acetaminophen|acetaminophen
5429043|NCT01592448|Patient Safety|patient safety
5429044|NCT01592448|Health Literacy|health literacy
5429045|NCT01592422|Small cell lung cancer|small cell lung cancer
5429046|NCT01592422|Maintenance therapy|maintenance therapy
5429047|NCT01592422|Immunotherapy|immunotherapy
5429048|NCT01592422|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
5846724|NCT00043654|Bipolar|bipolar
5429049|NCT01592409|cannabis impaired driving|cannabis impaired driving
5429050|NCT01592409|driving simulation|driving simulation
5429051|NCT01592409|acute psychopharmacologic effects of cannabis|acute psychopharmacologic effects of cannabis
5429052|NCT01592409|residual effects of cannabis|residual effects of cannabis
5429054|NCT01592396|Tralokinumab|tralokinumab
5429055|NCT01592396|CAT-354|cat-354
5429056|NCT01592396|Asthma|asthma
5429057|NCT01592357|cardiac rehabilitation|cardiac rehabilitation
5429058|NCT01592357|gait speed|gait speed
5429059|NCT01592357|mind body exercise|mind body exercise
5429060|NCT01592357|tai chi|tai chi
5429061|NCT01592357|cardiac disease|cardiac disease
5429062|NCT01592357|frail elderly|frail elderly
5429063|NCT01592344|Chronic pain|chronic pain
5429064|NCT01592344|peripheral nerve|peripheral nerve
5429065|NCT01592344|neuralgia|neuralgia
5429066|NCT01592344|somatosensory nervous system|somatosensory nervous system
5429067|NCT01592266|FLT|flt
5429068|NCT01592266|PET|pet
5429069|NCT01592266|bone marrow|bone marrow
5429070|NCT01592266|AML|aml
5429071|NCT01592240|PF-04950615|pf-04950615
5429072|NCT01592240|RN316|rn316
5429073|NCT01592227|healthy volunteer|healthy volunteer
5429074|NCT01592227|pharmacokinetics|pharmacokinetics
5429075|NCT01592227|paracetamol|paracetamol
5429076|NCT01592214|Staphylococcus aureus, nasal decolonization, XF-73, gel formulation|staphylococcus aureus, nasal decolonization, xf-73, gel formulation
5429077|NCT01592201|Schizophrenia|schizophrenia
5429078|NCT01592201|Paliperidone ER|paliperidone er
5429079|NCT01592201|Antipsychotics|antipsychotics
5429080|NCT01592201|Mental disorder|mental disorder
5429081|NCT01592201|Comparative study|comparative study
5429082|NCT01592188|meditation, inflammation, children, attention|meditation, inflammation, children, attention
5429083|NCT01592149|Appetite|appetite
5429084|NCT01592136|Ponatinib|ponatinib
5429085|NCT01592136|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5429086|NCT01592123|anxiety|anxiety
5429087|NCT01592123|septal surgery|septal surgery
5429088|NCT01592123|septum deviation|septum deviation
5429089|NCT01592123|sleep|sleep
5429090|NCT01592110|Schizophrenia|schizophrenia
5429091|NCT01592097|Multiple Sclerosis|multiple sclerosis
5429092|NCT01592097|MS|ms
5429093|NCT01592097|Autoimmune|autoimmune
5429094|NCT01592084|lipid lowering therapy|lipid lowering therapy
5429095|NCT01592084|survival|survival
5429096|NCT01592084|ALSFRS|alsfrs
5429097|NCT01592084|age|age
5429098|NCT01592084|BMI|bmi
5429099|NCT01592084|weight|weight
5429100|NCT01592071|food sensitivity|food sensitivity
5429101|NCT01592071|IgG|igg
5429102|NCT01592071|obesity|obesity
5429103|NCT01592071|overweight|overweight
5429104|NCT01592071|body composition|body composition
5429105|NCT01592071|reactive foods|reactive foods
5429106|NCT01592058|weight change|weight change
5429107|NCT01592058|contraception|contraception
5429108|NCT01592058|birth control|birth control
5429109|NCT01592058|progestin|progestin
5429110|NCT01592058|progestin only|progestin only
5429111|NCT01592058|weight gain|weight gain
5429112|NCT01592058|depo|depo
5429113|NCT01592058|Depo Provera|depo provera
5429114|NCT01592058|DMPA|dmpa
5429115|NCT01592058|IUD|iud
5429116|NCT01592058|IUC|iuc
5429117|NCT01592058|Mirena|mirena
5429118|NCT01592058|Paragard|paragard
5429119|NCT01592058|Implanon|implanon
5429120|NCT01592058|implant|implant
5429121|NCT01592032|Antibiotic-lock technique.|antibiotic-lock technique.
5429122|NCT01592032|In vivo antimicrobial concentration.|in vivo antimicrobial concentration.
5429123|NCT01592032|Antimicrobial bioactivity.|antimicrobial bioactivity.
5429124|NCT01592006|hepatitis C virus|hepatitis c virus
5429125|NCT01592006|liver transplant recipient|liver transplant recipient
5429126|NCT01591993|Sensitive skin|sensitive skin
5429127|NCT01591993|Lactic acid test|lactic acid test
5429128|NCT01591993|Transepidermal water loss|transepidermal water loss
5429129|NCT01591993|Colorimetry|colorimetry
5429130|NCT01591993|Capacitance|capacitance
5429131|NCT01591980|post-craniotomy pain|post-craniotomy pain
5429132|NCT01591980|pregabalin|pregabalin
5429133|NCT01591980|chronic post-craniotomy headache|chronic post-craniotomy headache
5429134|NCT01591980|Craniotomy|craniotomy
5429135|NCT01591967|Chiropractic|chiropractic
5429136|NCT01591967|Blood pressure|blood pressure
5429137|NCT01591967|Pulse Rate|pulse rate
5429138|NCT01591967|Thoracic|thoracic
5429139|NCT01591941|ACL, Knee , Injury,|acl, knee , injury,
5429140|NCT01591928|Pediatrics|pediatrics
5429141|NCT01591928|Congenital heart disease|congenital heart disease
5429142|NCT01591928|Heterotaxy syndrome|heterotaxy syndrome
5429143|NCT01591928|Intestinal malrotation|intestinal malrotation
5429144|NCT01591915|Breast cancer, Mindfulness Based Stress Reduction, RCT, mood, cooping, health related quality of life|breast cancer, mindfulness based stress reduction, rct, mood, cooping, health related quality of life
5429145|NCT01591876|exercise|exercise
5429146|NCT01591876|kidney disease|kidney disease
5429147|NCT01591876|vascular function|vascular function
5429148|NCT01591876|haemodialysis|haemodialysis
5411993|NCT01669031|fixation, ocular|fixation, ocular
5429149|NCT01591863|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5429150|NCT01591863|CDAD|cdad
5429151|NCT01591863|Pediatric|pediatric
5429152|NCT01591798|Rectal cancer|rectal cancer
5429159|NCT01591772|FALLOPIAN TUBE|fallopian tube
5429160|NCT01591772|OVARY|ovary
5429161|NCT01591772|PERITONEUM|peritoneum
5429162|NCT01591772|Quality of Life|quality of life
5429163|NCT01591772|structural MRI|structural mri
5429164|NCT01591772|functional MRI|functional mri
5429165|NCT01591772|neuropsychological assessment|neuropsychological assessment
5429166|NCT01591772|12-075|12-075
5429167|NCT01591759|citicoline|citicoline
5429168|NCT01591759|cognitive function|cognitive function
5429169|NCT01591759|function magnetic resonance imaging|function magnetic resonance imaging
5429170|NCT01591759|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5429171|NCT01591759|diffusion tensor imaging|diffusion tensor imaging
5429172|NCT01591746|Mastectomy|mastectomy
5429173|NCT01591746|Mammaplasty|mammaplasty
5429174|NCT01591746|Breast reconstruction|breast reconstruction
5429175|NCT01591746|Tissue expansion|tissue expansion
5429176|NCT01591746|Botulinum toxins, Type A|botulinum toxins, type a
5429177|NCT01591746|Quality of Life|quality of life
5429178|NCT01591746|Acellular dermal matrix|acellular dermal matrix
5429179|NCT01591733|Borderline resectable|borderline resectable
5429180|NCT01591707|autism spectrum disorders|autism spectrum disorders
5429182|NCT01591707|language|language
5429183|NCT01591707|social|social
5429184|NCT01591694|child trauma|child trauma
5429185|NCT01591694|maltreatment|maltreatment
5429186|NCT01591694|physical abuse|physical abuse
5429187|NCT01591694|sexual abuse|sexual abuse
5429188|NCT01591694|emotional abuse|emotional abuse
5429189|NCT01591694|abandonment|abandonment
5429190|NCT01591694|domestic violence|domestic violence
5429191|NCT01591694|community violence|community violence
5429192|NCT01591681|Type 1 Diabetes|type 1 diabetes
5429193|NCT01591681|Hypoglycemia|hypoglycemia
5429194|NCT01591681|Continuous Glucose Monitoring|continuous glucose monitoring
5429195|NCT01591681|Pump Suspension|pump suspension
5429196|NCT01591668|Hepatitis|hepatitis
5429197|NCT01591668|Hepatitis C|hepatitis c
5429198|NCT01591668|Chronic HCV|chronic hcv
5429200|NCT01591668|Treatment Naive|treatment naive
5429201|NCT01591668|Gilead|gilead
5429202|NCT01591668|GS-9620|gs-9620
5429203|NCT01591642|physical activity|physical activity
5429204|NCT01591642|functional fitness|functional fitness
5429205|NCT01591642|quality of life|quality of life
5429206|NCT01591629|Cannabis|cannabis
5429207|NCT01591629|Marijuana|marijuana
5429208|NCT01591629|Naloxone|naloxone
5429209|NCT01591629|THC|thc
5429210|NCT01591629|Psychotic Disorders|psychotic disorders
5429211|NCT01591590|Colorectal Cancer|colorectal cancer
5429212|NCT01591590|Cancer|cancer
5429213|NCT01591590|Colon Cancer|colon cancer
5429214|NCT01591590|Rectal Cancer|rectal cancer
5429215|NCT01591590|PET|pet
5429216|NCT01591590|PET-CT|pet-ct
5429217|NCT01591590|MRI|mri
5429218|NCT01591590|Diffusion MRI|diffusion mri
5429219|NCT01591590|Apparent Diffusion Coefficient|apparent diffusion coefficient
5429220|NCT01591590|ADC|adc
5429221|NCT01591590|Metabolic Progression Index|metabolic progression index
5429222|NCT01591564|interpersonal psychotherapy|interpersonal psychotherapy
5429223|NCT01591564|severe mood dysregulation|severe mood dysregulation
5429224|NCT01591538|Prevalence|prevalence
5429225|NCT01591538|MDRGNB|mdrgnb
5429226|NCT01591538|Acquisition|acquisition
5429227|NCT01591538|Middle stay|middle stay
5429228|NCT01591538|Endemic area|endemic area
5429229|NCT01591525|Type II Diabetes|type ii diabetes
5429230|NCT01591525|Minorities|minorities
5429231|NCT01591525|Diabetes Mellitus|diabetes mellitus
5429232|NCT01591525|Community based screening|community based screening
5429233|NCT01591512|Small Cell Lung Cancer|small cell lung cancer
5429234|NCT01591512|SCLC|sclc
5429235|NCT01591512|Lung Cancer|lung cancer
5429236|NCT01591512|Subjects diagnosed with SCLC who will undergo treatment|subjects diagnosed with sclc who will undergo treatment
5429237|NCT01591486|Helicobacter pylori (Hp)|helicobacter pylori (hp)
5429238|NCT01591486|ASA users|asa users
5429239|NCT01591486|peptic ulcer bleeding|peptic ulcer bleeding
5429240|NCT01591486|cohorts|cohorts
5429241|NCT01591473|Influenza|influenza
5429242|NCT01591473|Ampligen|ampligen
5429243|NCT01591473|Poly I:Poly C12U|poly i:poly c12u
5429244|NCT01591473|Rintatolimod|rintatolimod
5429245|NCT01591473|FluMist|flumist
5429246|NCT01591408|EEG biofeedback|eeg biofeedback
5429247|NCT01591408|neurofeedback|neurofeedback
5429248|NCT01591408|therapy|therapy
5429249|NCT01591408|adjunct|adjunct
5429250|NCT01591395|inguinal hernia|inguinal hernia
5429251|NCT01591395|laparoscopy|laparoscopy
5429252|NCT01591395|laparoendoscopic single-site surgery|laparoendoscopic single-site surgery
5429253|NCT01591382|Ketamine|ketamine
5429254|NCT01591382|Postoperative pain|postoperative pain
5429255|NCT01591382|Opioid dependent patients|opioid dependent patients
5429256|NCT01591382|Acute pain control|acute pain control
5429257|NCT01591343|Specific immunotherapy|specific immunotherapy
5429258|NCT01591343|Allergic rhinitis|allergic rhinitis
5412091|NCT01668550|Phase I|phase i
5429259|NCT01591343|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5429260|NCT01591343|Asthma|asthma
5429261|NCT01591304|Ulthera® System|ulthera® system
5429262|NCT01591304|Ultherapy™ Treatment|ultherapy™ treatment
5429263|NCT01591304|Ulthera, Inc.|ulthera, inc.
5429264|NCT01591291|alcohol dependence|alcohol dependence
5429265|NCT01591291|alcohol addiction|alcohol addiction
5429266|NCT01591265|Compensatory dental extraction|compensatory dental extraction
5429267|NCT01591265|Children 7-11 years old|children 7-11 years old
5429268|NCT01591252|HIV|hiv
5429269|NCT01591252|Bone mineral density|bone mineral density
5429270|NCT01591252|bone turnover|bone turnover
5429271|NCT01591252|fracture|fracture
5429272|NCT01591252|inflammation|inflammation
5429273|NCT01591239|Adolescent|adolescent
5429274|NCT01591239|Parent|parent
5429275|NCT01591239|Substance Abuse|substance abuse
5429276|NCT01591239|Parent Training|parent training
5429277|NCT01591239|Addiction|addiction
5429278|NCT01591239|Family Intervention|family intervention
5429279|NCT01591239|Brief Intervention|brief intervention
5429280|NCT01591239|Home Intervention|home intervention
5429281|NCT01591226|caffeine|caffeine
5429282|NCT01591226|sodium citrate|sodium citrate
5429283|NCT01591226|exercise performance|exercise performance
5429284|NCT01591226|wheelchair athletes|wheelchair athletes
5429285|NCT01591226|1500m|1500m
5429286|NCT01591213|Cancer education|cancer education
5429287|NCT01591213|Prevention education|prevention education
5429288|NCT01591213|Volunteers|volunteers
5429289|NCT01591200|Alcoholic|alcoholic
5429290|NCT01591200|Liver|liver
5429291|NCT01591200|Cirrhosis|cirrhosis
5429292|NCT01591200|Stem|stem
5429293|NCT01591200|Cells|cells
5429294|NCT01591187|Text messaging|text messaging
5429295|NCT01591187|Secondhand smoke exposure|secondhand smoke exposure
5429296|NCT01591174|Functional Dyspepsia|functional dyspepsia
5429297|NCT01591174|Postprandial Distress Syndrome|postprandial distress syndrome
5429298|NCT01591174|ghrelin|ghrelin
5429299|NCT01591174|C-13 acetate|c-13 acetate
5429300|NCT01591148|Pharmacokinetics|pharmacokinetics
5429301|NCT01591148|Pharmacodynamics|pharmacodynamics
5680266|NCT00578435|Thalassemia|thalassemia
5414645|NCT01656473|Caregiver Burden|caregiver burden
5429302|NCT01591135|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5429303|NCT01591135|chemoradiotherapy|chemoradiotherapy
5429304|NCT01591122|Prostate cancer|prostate cancer
5429305|NCT01591122|Metastatic Castration Resistant Prostate Cancer|metastatic castration resistant prostate cancer
5429306|NCT01591122|Abiraterone acetate|abiraterone acetate
5429307|NCT01591122|Prednisone|prednisone
5429308|NCT01591122|Zytiga|zytiga
5429309|NCT01591096|Stroke|stroke
5429310|NCT01591096|Childhood|childhood
5429311|NCT01591096|Thrombolysis|thrombolysis
5429312|NCT01591083|Peptic ulcer rebleeding, double dose of esomeprazole|peptic ulcer rebleeding, double dose of esomeprazole
5429313|NCT01591070|Facial seborrhoeic dermatitis, tacrolimus|facial seborrhoeic dermatitis, tacrolimus
5429314|NCT01591057|fruit|fruit
5429315|NCT01591057|vegetables|vegetables
5429316|NCT01591057|biomarkers|biomarkers
5429317|NCT01591057|randomised controlled feeding study|randomised controlled feeding study
5429318|NCT01591057|Fruit and vegetable intake biomarkers in healthy adults|fruit and vegetable intake biomarkers in healthy adults
5429319|NCT01591031|laryngeal injuries|laryngeal injuries
5429320|NCT01591031|vocal cord injuries|vocal cord injuries
5429321|NCT01591031|hoarseness|hoarseness
5429322|NCT01591031|sore throat|sore throat
5429323|NCT01591018|sonolysis, brain infarction, prevention, cardiac surgery|sonolysis, brain infarction, prevention, cardiac surgery
5429324|NCT01591005|sonolysis|sonolysis
5429325|NCT01591005|carotid|carotid
5429326|NCT01591005|endarterectomy|endarterectomy
5429327|NCT01591005|stenting|stenting
5429328|NCT01590992|Somatoform disorder|somatoform disorder
5429329|NCT01590992|Functional Somatic Syndrome|functional somatic syndrome
5429330|NCT01590992|Functional Somatic Symptoms|functional somatic symptoms
5429331|NCT01590992|Somatic Symptom Disorder|somatic symptom disorder
5429332|NCT01590992|globus sensation|globus sensation
5429333|NCT01590992|globus pharynges|globus pharynges
5429334|NCT01590992|globus hystericus|globus hystericus
5429335|NCT01590979|Atrial Fibrillation New Onset|atrial fibrillation new onset
5429336|NCT01590979|Ranolazine|ranolazine
5429337|NCT01590979|CABG|cabg
5429338|NCT01590979|valve repair/replacement|valve repair/replacement
5429339|NCT01590979|Cardiac Surgery|cardiac surgery
5429340|NCT01590966|spondyloarthritis|spondyloarthritis
5429341|NCT01590966|Rheumatoid arthritis|rheumatoid arthritis
5429342|NCT01590927|pelvic floor|pelvic floor
5429343|NCT01590927|ultrasonography|ultrasonography
5429344|NCT01590914|Roux-en-Y Bariatric surgery,|roux-en-y bariatric surgery,
5429345|NCT01590914|Gastric banding,|gastric banding,
5429346|NCT01590914|fMRI,|fmri,
5429347|NCT01590914|food cues|food cues
5429348|NCT01590901|Pharmacokinetics|pharmacokinetics
5429349|NCT01590901|Probucol|probucol
5429350|NCT01590901|healthy male subjects|healthy male subjects
5429351|NCT01590875|atrial fibrillation|atrial fibrillation
5429352|NCT01590875|ablation|ablation
5429353|NCT01590875|pulmonary veins|pulmonary veins
5429354|NCT01590875|adenosine|adenosine
5429355|NCT01590862|Obesessive Compulsive Disorder|obesessive compulsive disorder
5429356|NCT01590862|Major Depressive Disorder|major depressive disorder
5429357|NCT01590862|Deep Brain Stimulation|deep brain stimulation
5429358|NCT01590849|contraceptive agents|contraceptive agents
5429359|NCT01590849|autonomic nervous system|autonomic nervous system
5429360|NCT01590849|blood pressure|blood pressure
5429361|NCT01590849|risk|risk
5429362|NCT01590823|pharmacokinetics|pharmacokinetics
5429363|NCT01590784|Depression|depression
5429364|NCT01590784|Schizophrenia|schizophrenia
5429365|NCT01590758|Diabetic Foot Ulcer Infection|diabetic foot ulcer infection
5429366|NCT01590745|Ultrasound therapy|ultrasound therapy
5429367|NCT01590745|Nerve Conduction studies|nerve conduction studies
5429368|NCT01590745|Boston and Levine Questionnaire|boston and levine questionnaire
5429369|NCT01590745|Neutral Angle Wrist Splint|neutral angle wrist splint
5429370|NCT01590745|Canterbury CTS scale|canterbury cts scale
5429371|NCT01590706|Genotype-Phenotype Association|genotype-phenotype association
5429372|NCT01590706|Aged|aged
5429373|NCT01590706|Middle Aged|middle aged
5429374|NCT01590706|Mild Cognitive Impairment|mild cognitive impairment
5429375|NCT01590706|Heart Rate Control|heart rate control
5429376|NCT01590706|Biomarkers|biomarkers
5429377|NCT01590693|Gait|gait
5429378|NCT01590667|Fat excretion|fat excretion
5429379|NCT01590654|Hepatitis|hepatitis
5429380|NCT01590654|Hepatitis B|hepatitis b
5429381|NCT01590654|Hepatitis B Virus|hepatitis b virus
5429383|NCT01590654|GS-9620|gs-9620
5429384|NCT01590654|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
5429385|NCT01590641|Hepatitis|hepatitis
5429386|NCT01590641|Hepatitis B|hepatitis b
5429387|NCT01590641|Hepatitis B Virus|hepatitis b virus
5429389|NCT01590641|GS-9620|gs-9620
5429390|NCT01590641|Toll-like receptor (TLR)-7 Agonist|toll-like receptor (tlr)-7 agonist
5429391|NCT01590628|Sickle Cell Disease & Thalassemia|sickle cell disease & thalassemia
5429392|NCT01590628|Genetic disorder|genetic disorder
5429393|NCT01590615|Hepatitis|hepatitis
5429395|NCT01590615|HBV|hbv
5429397|NCT01590615|MELD|meld
5429398|NCT01590615|Renal Safety|renal safety
5429399|NCT01590615|Liver Transplant|liver transplant
5429400|NCT01590602|Huntington's Disease|huntington's disease
5429401|NCT01590602|European Huntington's Disease Network|european huntington's disease network
5429402|NCT01590602|Juvenile HD|juvenile hd
5429403|NCT01590602|EHDN|ehdn
5429404|NCT01590602|REGISTRY|registry
5429405|NCT01590589|Huntington Disease|huntington disease
5429406|NCT01590589|European HD Network|european hd network
5429407|NCT01590589|Cohort|cohort
5429408|NCT01590589|REGISTRY|registry
5429409|NCT01590589|EHDN|ehdn
5429410|NCT01590576|women|women
5429411|NCT01590550|Pediatric hemodialysis|pediatric hemodialysis
5429412|NCT01590550|Anticoagulation|anticoagulation
5429413|NCT01590537|non-interventional|non-interventional
5429414|NCT01590537|Mirena|mirena
5429415|NCT01590537|Contraception|contraception
5429416|NCT01590537|Russian Federation|russian federation
5429417|NCT01590524|Parent|parent
5429418|NCT01590524|childhood cancer|childhood cancer
5429419|NCT01590524|Complementary and Alternative|complementary and alternative
5429420|NCT01590511|mini fluid challenge|mini fluid challenge
5429421|NCT01590511|subaortic velocity time integral|subaortic velocity time integral
5429422|NCT01590498|Adenocarcinoma|adenocarcinoma
5429423|NCT01590498|Prostatic Neoplasms|prostatic neoplasms
5429424|NCT01590498|Carcinoma|carcinoma
5429425|NCT01590498|Prostatic Diseases|prostatic diseases
5429426|NCT01590485|pain|pain
5429427|NCT01590485|root canal therapy|root canal therapy
5429428|NCT01590472|Genetics of Mesothelioma|genetics of mesothelioma
5429429|NCT01590472|Mesothelioma Consortium|mesothelioma consortium
5429430|NCT01590472|GWAS|gwas
5429431|NCT01590472|Asbestos|asbestos
5429432|NCT01590446|Achondroplasia|achondroplasia
5429433|NCT01590433|Obesity|obesity
5429434|NCT01590433|Overweight|overweight
5429435|NCT01590433|Exenatide|exenatide
5429436|NCT01590433|Diet|diet
5429437|NCT01590433|Women|women
5429438|NCT01590420|OSA|osa
5429439|NCT01590420|Sleep|sleep
5429440|NCT01590420|CPAP|cpap
5429441|NCT01590420|Cost|cost
5429442|NCT01590394|obstruction|obstruction
5429443|NCT01590394|bile duct|bile duct
5429444|NCT01590394|malignant|malignant
5429445|NCT01590342|Pulmonary embolism|pulmonary embolism
5429446|NCT01590342|Right ventricular dysfunction|right ventricular dysfunction
5429447|NCT01590342|Prognosis|prognosis
5429448|NCT01590342|Inflammation|inflammation
5429449|NCT01590329|Skin surgery|skin surgery
5429450|NCT01590329|Micrografting|micrografting
5429451|NCT01590329|Hypo-pigmentation|hypo-pigmentation
5429452|NCT01590316|Brain Injuries|brain injuries
5429453|NCT01590316|Infant, Premature|infant, premature
5429454|NCT01590316|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5429455|NCT01590316|Randomized Controlled Trial|randomized controlled trial
5429456|NCT01590303|severe sepsis|severe sepsis
5429457|NCT01590264|tinnitus|tinnitus
5429458|NCT01590264|bimodal stimulation|bimodal stimulation
5429459|NCT01590264|rTMS|rtms
5429460|NCT01590264|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5429461|NCT01590251|Pain|pain
5429462|NCT01590251|Addiction|addiction
5429463|NCT01590251|Buprenorphine|buprenorphine
5429464|NCT01590251|Counseling|counseling
5429465|NCT01590251|Methadone|methadone
5429466|NCT01590251|Yoga|yoga
5429467|NCT01590238|alopecia|alopecia
5429468|NCT01590186|Pain|pain
5429469|NCT01590186|Front foot|front foot
5429470|NCT01590186|Flat foot|flat foot
5429471|NCT01590186|Metatarsalgia|metatarsalgia
5429472|NCT01590173|Low molecular weight heparin|low molecular weight heparin
5429473|NCT01590173|Prednisolone|prednisolone
5429474|NCT01590173|Glucocorticoids|glucocorticoids
5429475|NCT01590173|Recurrent implantation failure|recurrent implantation failure
5429476|NCT01590173|Pregnancy rate|pregnancy rate
5429477|NCT01590134|volunteers|volunteers
5429478|NCT01590134|Pilot study|pilot study
5429479|NCT01590134|There are no pre registration evaluations.|there are no pre registration evaluations.
5429480|NCT01590134|Inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.|inclusion criteria: to be a healthy, consenting volunteer not currently receiving iron supplements.
5429481|NCT01590134|Exclusion criteria: 1) Needle phobia; 2) Currently receiving iron supplements; 3) Unable to provide informed consent|exclusion criteria: 1) needle phobia; 2) currently receiving iron supplements; 3) unable to provide informed consent
5429482|NCT01590121|Previous flight by aeroplane|previous flight by aeroplane
5429483|NCT01590108|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5429485|NCT01590108|Apelin|apelin
5429486|NCT01590108|APJ receptor|apj receptor
5429487|NCT01590095|Chlorine water treatment|chlorine water treatment
5429488|NCT01590095|Point-of-use water treatment|point-of-use water treatment
5429489|NCT01590095|Household water treatment with safe storage|household water treatment with safe storage
5429490|NCT01590095|Hand washing with soap|hand washing with soap
5429491|NCT01590095|Hand hygiene|hand hygiene
5429492|NCT01590095|Latrines|latrines
5429493|NCT01590095|Child potties|child potties
5429494|NCT01590095|Point-of-use fortification|point-of-use fortification
5429495|NCT01590095|Lipid-based nutrient supplement|lipid-based nutrient supplement
5429496|NCT01590095|Environmental enteropathy|environmental enteropathy
5429497|NCT01590095|Tropical enteropathy|tropical enteropathy
5429498|NCT01590095|Gut function|gut function
5429499|NCT01590095|Intestinal parasitic infection|intestinal parasitic infection
5429500|NCT01590095|Soil transmitted helminths|soil transmitted helminths
5429501|NCT01590095|Intestinal protozoans|intestinal protozoans
5429502|NCT01590095|Antibody response|antibody response
5429503|NCT01590095|Water|water
5429504|NCT01590095|Sanitation|sanitation
5429505|NCT01590095|Hand washing|hand washing
5429506|NCT01590095|Breast Feeding|breast feeding
5429507|NCT01590095|Complementary Feeding|complementary feeding
5429508|NCT01590095|Micronutrients|micronutrients
5429509|NCT01590095|Malnutrition|malnutrition
5429510|NCT01590095|Nutrition Disorders|nutrition disorders
5429511|NCT01590095|Diarrhea|diarrhea
5429512|NCT01590095|Child Development|child development
5429513|NCT01590082|Melanoma|melanoma
5429514|NCT01590082|Metastatic Melanoma|metastatic melanoma
5429515|NCT01590082|Advanced melanoma|advanced melanoma
5429516|NCT01590082|Doxycycline|doxycycline
5429517|NCT01590082|Ipilimumab|ipilimumab
5429518|NCT01590082|Yervoy|yervoy
5429519|NCT01590082|MDX010|mdx010
5429520|NCT01590082|BMS-734016|bms-734016
5429521|NCT01590082|Temozolomide|temozolomide
5429522|NCT01590082|Temodar|temodar
5429523|NCT01590056|Mapping limbic areas of the STN|mapping limbic areas of the stn
5429524|NCT01590056|neuronal responses to stimuli during surgery|neuronal responses to stimuli during surgery
5429525|NCT01590017|stage IB cervical cancer|stage ib cervical cancer
5429526|NCT01590017|stage IIA cervical cancer|stage iia cervical cancer
5429527|NCT01590017|stage IIB cervical cancer|stage iib cervical cancer
5429528|NCT01590017|stage III cervical cancer|stage iii cervical cancer
5429529|NCT01590017|stage IVA cervical cancer|stage iva cervical cancer
5429530|NCT01590017|cervical adenocarcinoma|cervical adenocarcinoma
5429531|NCT01590017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5429532|NCT01590017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5429533|NCT01590017|HIV infection|hiv infection
5429534|NCT01590004|LumbarCool system|lumbarcool system
5429535|NCT01590004|Cooled radiofrequency medial ablation|cooled radiofrequency medial ablation
5429536|NCT01590004|Cooled-RF neurotomy|cooled-rf neurotomy
5429537|NCT01589991|toothpastes|toothpastes
5429538|NCT01589991|bioavailability|bioavailability
5429539|NCT01589991|sodium fluoride|sodium fluoride
5429540|NCT01589991|monofluorphosphate|monofluorphosphate
5429541|NCT01589991|low-fluoride|low-fluoride
5429542|NCT01589978|drug-eluting stent|drug-eluting stent
5429544|NCT01589978|atherosclerosis|atherosclerosis
5429545|NCT01589978|everolimus|everolimus
5429546|NCT01589965|HIV/AIDS|hiv/aids
5429547|NCT01589965|STIs|stis
5429548|NCT01589965|Lottery|lottery
5429553|NCT01589939|Calypso|calypso
5429554|NCT01589913|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5429555|NCT01589913|Heart Failure|heart failure
5429556|NCT01589913|Anxiety|anxiety
5429557|NCT01589913|Depression|depression
5429558|NCT01589913|Quality of Life|quality of life
5429559|NCT01589913|Remote Care|remote care
5429560|NCT01589913|Prevention|prevention
5429561|NCT01589900|colorectal cancer|colorectal cancer
5429562|NCT01589900|invasion|invasion
5429563|NCT01589900|metastasis|metastasis
5429564|NCT01589900|IHC|ihc
5429565|NCT01589874|hepcidin|hepcidin
5429566|NCT01589874|anemia|anemia
5429567|NCT01589874|acute inflammation|acute inflammation
5429568|NCT01589874|IL-6|il-6
5569860|NCT01007136|TMS|tms
5429569|NCT01589874|cytokines|cytokines
5429570|NCT01589848|vWD|vwd
5429571|NCT01589809|Congenital, familial and genetic disorders|congenital, familial and genetic disorders
5429572|NCT01589809|Nervous System Diseases|nervous system diseases
5429573|NCT01589796|anesthesia|anesthesia
5429574|NCT01589796|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block|regional anesthetic techniques: transversus abdominis plane block, ilioinguinal nerve block, iliohypogastric nerve block
5429575|NCT01589796|surgery, inguinal herniorrhaphy|surgery, inguinal herniorrhaphy
5429576|NCT01589796|pain, postoperative|pain, postoperative
5429577|NCT01589796|surgery, inguinal hernia repair|surgery, inguinal hernia repair
5429578|NCT01589783|Pregnancy|pregnancy
5429579|NCT01589783|Vitamin D|vitamin d
5429580|NCT01589770|rheumatoid arthritis|rheumatoid arthritis
5429581|NCT01589770|inflammation|inflammation
5429582|NCT01589757|"glycaemic index"|"glycaemic index"
5429583|NCT01589757|"glycemic index"|"glycemic index"
5429584|NCT01589757|hyperglycaemia|hyperglycaemia
5429585|NCT01589757|hyperglycemia|hyperglycemia
5429586|NCT01589757|pregnancy|pregnancy
5429587|NCT01589757|"dietary intervention"|"dietary intervention"
5429588|NCT01589757|"education evaluation"|"education evaluation"
5429589|NCT01589757|antioxidant|antioxidant
5429590|NCT01589757|"Impaired Glucose Tolerance of Pregnancy"|"impaired glucose tolerance of pregnancy"
5429591|NCT01589757|"Gestational Diabetes Mellitus"|"gestational diabetes mellitus"
5429593|NCT01589744|medical device|medical device
5429594|NCT01589731|Allergenicity|allergenicity
5429595|NCT01589731|Cow's milk allergy|cow's milk allergy
5429596|NCT01589731|Leukocyte adherence inhibition test|leukocyte adherence inhibition test
5429597|NCT01589731|Polymerization|polymerization
5429598|NCT01589718|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5429599|NCT01589718|Tractional Retinal Detachment|tractional retinal detachment
5429600|NCT01589718|Vitreous Hemorrhage|vitreous hemorrhage
5429601|NCT01589705|Uric acid|uric acid
5429602|NCT01589705|polycystic kidney disease|polycystic kidney disease
5429603|NCT01589692|WRIST|wrist
5429604|NCT01589692|Distal Radius Fracture|distal radius fracture
5429606|NCT01589692|elderly|elderly
5429607|NCT01589692|internal fixation|internal fixation
5429608|NCT01589692|VLPS|vlps
5429609|NCT01589692|External Fixation|external fixation
5429610|NCT01589692|Multi center randomized trial|multi center randomized trial
5429611|NCT01589666|Entegrion|entegrion
5429612|NCT01589666|Spray-dried Solvent/Detergent Plasma|spray-dried solvent/detergent plasma
5429613|NCT01589666|Fresh Frozen Plasma|fresh frozen plasma
5429614|NCT01589666|Transfusion|transfusion
5429615|NCT01589666|Resuscitation|resuscitation
5429616|NCT01589666|Hemorrhage|hemorrhage
5429617|NCT01589666|Coagulopathy|coagulopathy
5429618|NCT01589627|distal radius fracture|distal radius fracture
5429619|NCT01589627|wrist contracture|wrist contracture
5429620|NCT01589627|dynasplint|dynasplint
5429621|NCT01589601|Congestive Heart Failure|congestive heart failure
5429622|NCT01589601|Heart Failure|heart failure
5429623|NCT01589601|Palliative Care|palliative care
5429624|NCT01589601|Palliative Medicine|palliative medicine
5429625|NCT01589588|acute treatment|acute treatment
5429626|NCT01589575|Intensive Care Unit|intensive care unit
5429627|NCT01589549|Acute graft versus host disease|acute graft versus host disease
5429628|NCT01589549|Bone marrow transplantation|bone marrow transplantation
5429629|NCT01589549|Mesenchymal stromal cells|mesenchymal stromal cells
5429630|NCT01589536|psychocardiological|psychocardiological
5429631|NCT01589536|interval intervention|interval intervention
5429632|NCT01589536|disability pension|disability pension
5429633|NCT01589536|risk profile|risk profile
5429634|NCT01589536|mental comorbidity|mental comorbidity
5429635|NCT01589484|Tomography|tomography
5429636|NCT01589484|Urinary Lithiasis|urinary lithiasis
5429637|NCT01589484|Kidney Calculi|kidney calculi
5429638|NCT01589471|Low anterior resection syndrome|low anterior resection syndrome
5429639|NCT01589471|Botulinum toxin A|botulinum toxin a
5424682|NCT01610089|urea|urea
5429645|NCT01589458|saliva|saliva
5429646|NCT01589458|dental caries|dental caries
5429647|NCT01589458|fluoride|fluoride
5429648|NCT01589445|Bangladesh|bangladesh
5429649|NCT01589445|T2DM|t2dm
5429650|NCT01589445|Pioglitazone|pioglitazone
5429652|NCT01589445|Insulin secretion and Sensitivity|insulin secretion and sensitivity
5429653|NCT01589432|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5429654|NCT01589419|DLT|dlt
5429655|NCT01589419|radiation|radiation
5429656|NCT01589419|veliparib|veliparib
5429657|NCT01589419|locally advanced rectal cancer|locally advanced rectal cancer
5429658|NCT01589419|ABT-888|abt-888
5429659|NCT01589419|capecitabine|capecitabine
5429660|NCT01589419|MTD|mtd
5429661|NCT01589419|PARP|parp
5429662|NCT01589406|Gynaecological Cancer|gynaecological cancer
5429663|NCT01589406|Quality of Life|quality of life
5429664|NCT01589406|Sexuality|sexuality
5429665|NCT01589393|Trauma|trauma
5429666|NCT01589393|Thromboprophylaxis|thromboprophylaxis
5429667|NCT01589393|Intracranial haemorrhage|intracranial haemorrhage
5429668|NCT01589393|Deep vein Thrombosis|deep vein thrombosis
5429669|NCT01589380|Aortic stenosis|aortic stenosis
5429670|NCT01589380|Exercise performance|exercise performance
5429671|NCT01589380|cardiopulmonary exercise test|cardiopulmonary exercise test
5429672|NCT01589380|fimasartan|fimasartan
5429673|NCT01589367|neoadjuvant endocrine therapy|neoadjuvant endocrine therapy
5429674|NCT01589367|metformin|metformin
5429675|NCT01589367|postmenopausal breast cancer|postmenopausal breast cancer
5429676|NCT01589328|pancreatic cancer|pancreatic cancer
5429677|NCT01589328|biliary tract cancer|biliary tract cancer
5429678|NCT01589328|cancer pain|cancer pain
5429679|NCT01589328|depression|depression
5429680|NCT01589315|ECT|ect
5429681|NCT01589315|FEAST|feast
5429682|NCT01589315|brain stimulation|brain stimulation
5429683|NCT01589315|depression|depression
5429684|NCT01589302|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5429685|NCT01589302|CLL|cll
5429686|NCT01589302|SLL|sll
5429687|NCT01589302|B-PLL|b-pll
5429688|NCT01589289|Diagnostic research|diagnostic research
5429689|NCT01589289|Rapid diagnostic tests|rapid diagnostic tests
5429690|NCT01589289|Neurological disorders|neurological disorders
5429691|NCT01589289|Neglected Tropical Diseases|neglected tropical diseases
5429692|NCT01589289|Developing countries|developing countries
5429693|NCT01589263|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5429694|NCT01589263|Lower Urinary Track Symptoms|lower urinary track symptoms
5429695|NCT01589263|BPH|bph
5429696|NCT01589263|LUTS|luts
5429697|NCT01589237|Familial Chylomicronemia Syndrome (FCS) (HLP type I)|familial chylomicronemia syndrome (fcs) (hlp type i)
5429698|NCT01589237|LCQ908|lcq908
5429699|NCT01589211|smoking|smoking
5429700|NCT01589211|cessation|cessation
5429701|NCT01589211|intervention|intervention
5429702|NCT01589211|brief|brief
5429703|NCT01589198|Asthma|asthma
5429704|NCT01589185|Pneumonia|pneumonia
5429705|NCT01589185|Monoclonal antibody|monoclonal antibody
5429706|NCT01589185|Staphylococcus aureus|staphylococcus aureus
5429707|NCT01589146|colon-rectal cancer|colon-rectal cancer
5429708|NCT01589146|heparin|heparin
5429709|NCT01589146|prophylaxis|prophylaxis
5429710|NCT01589146|laparoscopy|laparoscopy
5429711|NCT01589133|Irregular antibody screening|irregular antibody screening
5429712|NCT01589120|CHF|chf
5429713|NCT01589120|video decision aid|video decision aid
5429714|NCT01589094|CISPLATIN|cisplatin
5429715|NCT01589094|GEMCITABINE|gemcitabine
5429716|NCT01589094|GM-CSF|gm-csf
5429717|NCT01589094|radical cystectomy|radical cystectomy
5429718|NCT01589094|12-071|12-071
5429719|NCT01589003|low GI milk mood behaviour cognitive function children|low gi milk mood behaviour cognitive function children
5429720|NCT01588964|HIPEC|hipec
5429721|NCT01588964|ovarian cancer|ovarian cancer
5429722|NCT01588964|recurrence|recurrence
5429723|NCT01588938|radiation therapy|radiation therapy
5429724|NCT01588938|Calypso|calypso
5429725|NCT01588925|Cochlear implantation|cochlear implantation
5429726|NCT01588925|Dexamethasone|dexamethasone
5429727|NCT01588925|Acid, Hyaluronic|acid, hyaluronic
5429728|NCT01588912|chronic hepatitis B|chronic hepatitis b
5429729|NCT01588912|HBeAg positive|hbeag positive
5429730|NCT01588912|telbivudine|telbivudine
5429731|NCT01588912|tenofovir|tenofovir
5429732|NCT01588912|entecavir|entecavir
5429733|NCT01588912|roadmap|roadmap
5429734|NCT01588899|Uterine Leiomyomas|uterine leiomyomas
5429735|NCT01588899|Fibroids|fibroids
5429736|NCT01588899|HIFU|hifu
5429737|NCT01588899|Ablation|ablation
5429738|NCT01588899|High Intensity Focused Ultrasound|high intensity focused ultrasound
5429739|NCT01588886|Proton pump inhibitors|proton pump inhibitors
5429740|NCT01588886|Pneumonia|pneumonia
5429741|NCT01588886|Retrospective cohort study|retrospective cohort study
5429742|NCT01588873|Oral contraceptive pill|oral contraceptive pill
5429743|NCT01588873|Hormonal contraceptive ring|hormonal contraceptive ring
5429744|NCT01588873|Polycystic ovary syndrome|polycystic ovary syndrome
5429745|NCT01588847|perioperative immunoediting|perioperative immunoediting
5429746|NCT01588847|potential predictive biomarkers|potential predictive biomarkers
5429747|NCT01588847|lymph node dissection|lymph node dissection
5429749|NCT01588821|Refractory|refractory
5429750|NCT01588821|Relapsed|relapsed
5429751|NCT01588808|Immobilization|immobilization
5429752|NCT01588808|Protein supplementation|protein supplementation
5429753|NCT01588795|Diabetic nephropathy|diabetic nephropathy
5429754|NCT01588795|renal denervation|renal denervation
5429755|NCT01588795|nephroprotection|nephroprotection
5429756|NCT01588795|Renal failure|renal failure
5429757|NCT01588795|Renal injury|renal injury
5429758|NCT01588795|End stage renal disease|end stage renal disease
5429759|NCT01588782|Healthy volunteers|healthy volunteers
5412623|NCT01666262|GPO|gpo
5429760|NCT01588782|Pharmacology|pharmacology
5429761|NCT01588782|Pharmacokinetics|pharmacokinetics
5429762|NCT01588782|Pharmacodynamics|pharmacodynamics
5429763|NCT01588782|Drug-drug interactions|drug-drug interactions
5429764|NCT01588782|CYP3A4|cyp3a4
5430062|NCT01587196|vivitrol|vivitrol
5429765|NCT01588782|Abiraterone acetate|abiraterone acetate
5429766|NCT01588782|JNJ-589485|jnj-589485
5429767|NCT01588782|JNJ-212082|jnj-212082
5429768|NCT01588782|Ketoconazole|ketoconazole
5429769|NCT01588769|Glioblastoma Multiforme|glioblastoma multiforme
5429770|NCT01588769|Brain cancer|brain cancer
5429771|NCT01588769|Immunotherapy|immunotherapy
5429772|NCT01588769|Cell based therapy|cell based therapy
5429773|NCT01588769|Autologous cell based therapy|autologous cell based therapy
5429774|NCT01588769|Adoptive immunotherapy|adoptive immunotherapy
5429775|NCT01588769|Cytotoxic T cells|cytotoxic t cells
5429776|NCT01588769|Natural Killer cells|natural killer cells
5429777|NCT01588756|Chronic kidney disease|chronic kidney disease
5429778|NCT01588756|GFR|gfr
5429779|NCT01588756|Inulin|inulin
5429780|NCT01588756|51Cr-EDTA|51cr-edta
5429781|NCT01588756|ASDKP-NH2|asdkp-nh2
5429782|NCT01588756|Healthy male 18-35 yrs old, non smokers, non allergic|healthy male 18-35 yrs old, non smokers, non allergic
5429783|NCT01588756|Or Male/female 18-80 yrs old with chronic Kidney disease|or male/female 18-80 yrs old with chronic kidney disease
5429784|NCT01588730|PF|pf
5429785|NCT01588730|Dynasplint|dynasplint
5429786|NCT01588730|ADFD|adfd
5429787|NCT01588730|AFD|afd
5429788|NCT01588730|Plantar Fasciitis|plantar fasciitis
5429789|NCT01588730|plantar Fasciopathy|plantar fasciopathy
5429790|NCT01588717|Hyperhydrosis|hyperhydrosis
5429791|NCT01588717|Excessive Sweating|excessive sweating
5429792|NCT01588717|Sweating|sweating
5429793|NCT01588717|Depression|depression
5429794|NCT01588717|Antidepressant|antidepressant
5429795|NCT01588704|lung cancer|lung cancer
5429796|NCT01588704|lung adenocarcinoma|lung adenocarcinoma
5429798|NCT01588704|adjuvant chemotherapy|adjuvant chemotherapy
5429799|NCT01588704|surgical resection rate|surgical resection rate
5429800|NCT01588704|safety|safety
5429801|NCT01588704|feasibility|feasibility
5429802|NCT01588691|Traumatic Brain Injury|traumatic brain injury
5429803|NCT01588678|endometrial|endometrial
5429804|NCT01588678|prostate|prostate
5429805|NCT01588678|breast|breast
5429806|NCT01588678|gastric|gastric
5429807|NCT01588678|cervical|cervical
5429808|NCT01588678|ovarian|ovarian
5429809|NCT01588678|neuroendocrine cancers|neuroendocrine cancers
5429810|NCT01588678|soft-tissue sarcoma|soft-tissue sarcoma
5429811|NCT01588678|squamous cell NSCLC|squamous cell nsclc
5429812|NCT01588678|renal cell carcinoma|renal cell carcinoma
5429813|NCT01588678|non-Hodgkin lymphoma|non-hodgkin lymphoma
5429814|NCT01588665|pregnancy|pregnancy
5429815|NCT01588665|stable isotopes|stable isotopes
5429816|NCT01588665|red blood cell catabolism|red blood cell catabolism
5429817|NCT01588639|Recombinant human insulin|recombinant human insulin
5429818|NCT01588639|T2DM|t2dm
5429819|NCT01588639|Safety|safety
5429820|NCT01588639|Efficacy|efficacy
5429821|NCT01588626|Healthy volunteer|healthy volunteer
5429822|NCT01588626|Japanese males|japanese males
5429823|NCT01588626|PK study|pk study
5429824|NCT01588600|food intake, satiety, fiber|food intake, satiety, fiber
5429825|NCT01588548|Advanced solid malignancies|advanced solid malignancies
5429826|NCT01588548|Malignant lymphoma|malignant lymphoma
5429827|NCT01588535|pain|pain
5429828|NCT01588535|pain measurement|pain measurement
5429829|NCT01588535|ear, middle|ear, middle
5429830|NCT01588535|otitis media|otitis media
5429831|NCT01588522|alopecia|alopecia
5429832|NCT01588509|AMG 785, bone mineral density, alendronate|amg 785, bone mineral density, alendronate
5429833|NCT01588496|hypercholesterolemia|hypercholesterolemia
5429834|NCT01588496|familial hypercholesterolemia|familial hypercholesterolemia
5429835|NCT01588496|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia
5429836|NCT01588470|diastolic function|diastolic function
5429837|NCT01588470|mitochondria|mitochondria
5429838|NCT01588470|pioglitazone|pioglitazone
5429839|NCT01588470|pericardial fat|pericardial fat
5429840|NCT01588444|tooth extraction|tooth extraction
5429841|NCT01588444|bone grafting|bone grafting
5429842|NCT01588431|Locally advanced head and neck cancer|locally advanced head and neck cancer
5429843|NCT01588431|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5429844|NCT01588418|Impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
5429845|NCT01588418|Diabetes|diabetes
5429846|NCT01588405|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5429852|NCT01588314|Fabry disease|fabry disease
5429853|NCT01588314|neuropathic pain|neuropathic pain
5429854|NCT01588314|gabapentin|gabapentin
5429855|NCT01588301|Cervical Cancer Screening|cervical cancer screening
5429856|NCT01588301|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5429857|NCT01588301|Self-collected vaginal sample|self-collected vaginal sample
5429858|NCT01588301|Cervical Smear|cervical smear
5429859|NCT01588288|Diagnosis|diagnosis
5429860|NCT01588288|Galectin 3|galectin 3
5429861|NCT01588288|Puncture|puncture
5429862|NCT01588288|Goiter, nodular|goiter, nodular
5429863|NCT01588288|Surgery|surgery
5429864|NCT01588275|cost-effectiveness|cost-effectiveness
5429865|NCT01588275|effectiveness|effectiveness
5429866|NCT01588275|treatment|treatment
5429867|NCT01588275|CPAP|cpap
5429869|NCT01588275|compliance|compliance
5429870|NCT01588210|caries|caries
5429871|NCT01588210|sealant|sealant
5429872|NCT01588210|fluoride|fluoride
5429873|NCT01588210|prevention|prevention
5429874|NCT01588210|community dentistry|community dentistry
5429875|NCT01588197|Pain|pain
5429876|NCT01588197|fMRI|fmri
5429877|NCT01588197|real time|real time
5429878|NCT01588171|Deep vein thrombosis|deep vein thrombosis
5429879|NCT01588171|Pulmonary embolism|pulmonary embolism
5429880|NCT01588171|Low molecular weight heparin|low molecular weight heparin
5429881|NCT01588171|Enoxaparin|enoxaparin
5429882|NCT01588171|Bemiparin|bemiparin
5429883|NCT01588158|carpal tunnel syndrome|carpal tunnel syndrome
5429884|NCT01588158|Tylenol|tylenol
5429885|NCT01588158|Vicodin|vicodin
5429886|NCT01588158|pain|pain
5429887|NCT01588145|NSCLC|nsclc
5429888|NCT01588145|HM61713|hm61713
5429889|NCT01588145|EGFR-TKI|egfr-tki
5429890|NCT01588145|Phase II|phase ii
5429891|NCT01588145|olmutinib|olmutinib
5429892|NCT01588041|Microscope mounted SDOCT|microscope mounted sdoct
5429893|NCT01587976|Health related quality of life|health related quality of life
5429894|NCT01587976|Colorectal liver metastasis|colorectal liver metastasis
5429895|NCT01587976|surveillance|surveillance
5429896|NCT01587963|hypovolemic or septic|hypovolemic or septic
5429897|NCT01587950|dentinal sensitivity|dentinal sensitivity
5429898|NCT01587950|potassium nitrate|potassium nitrate
5429899|NCT01587950|dental pain|dental pain
5429900|NCT01587937|Antibiotic stewardship.|antibiotic stewardship.
5429901|NCT01587937|Clostridium difficile infection.|clostridium difficile infection.
5429902|NCT01587937|Antibiotic resistance.|antibiotic resistance.
5429903|NCT01587924|Renal Impairment|renal impairment
5429904|NCT01587924|Anemia|anemia
5429905|NCT01587924|pharmacokinetics|pharmacokinetics
5429906|NCT01587924|hemodialysis|hemodialysis
5429907|NCT01587924|Chronic kidney disease|chronic kidney disease
5429908|NCT01587924|GSK1278863|gsk1278863
5429909|NCT01587924|hemoglobin|hemoglobin
5429910|NCT01587924|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5429911|NCT01587924|recombinant human erythropoietin|recombinant human erythropoietin
5429912|NCT01587924|erythropoiesis stimulating agents|erythropoiesis stimulating agents
5429913|NCT01587924|Dialysis, Renal|dialysis, renal
5429914|NCT01587911|Satiety|satiety
5429915|NCT01587911|Food intake regulation|food intake regulation
5429916|NCT01587911|Appetite regulation|appetite regulation
5429917|NCT01587911|Dairy Protein|dairy protein
5429918|NCT01587898|Anemia|anemia
5429919|NCT01587898|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5429920|NCT01587898|Hemoglobin|hemoglobin
5429921|NCT01587898|Chronic kidney disease|chronic kidney disease
5429922|NCT01587898|pharmacokinetics|pharmacokinetics
5429923|NCT01587898|recombinant human erythropoietin|recombinant human erythropoietin
5429924|NCT01587898|GSK1278863|gsk1278863
5429925|NCT01587885|Frequent Heartburn|frequent heartburn
5429926|NCT01587885|Omeprazole|omeprazole
5429927|NCT01587885|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination
5429928|NCT01587885|Gastrointestinal Agents|gastrointestinal agents
5429929|NCT01587885|Therapeutic Uses|therapeutic uses
5429930|NCT01587885|Pharmacologic Actions|pharmacologic actions
5429931|NCT01587885|Enzyme Inhibitors|enzyme inhibitors
5429932|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5429933|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors
5429934|NCT01587872|Colonoscopy|colonoscopy
5429935|NCT01587872|Colorectal cancer|colorectal cancer
5429936|NCT01587872|Screening colonoscopy|screening colonoscopy
5429937|NCT01587859|esophagus|esophagus
5429938|NCT01587859|gastro-esophageal reflux disease|gastro-esophageal reflux disease
5429939|NCT01587859|type II-IV hiatal hernia|type ii-iv hiatal hernia
5429940|NCT01587859|esophageal surgery|esophageal surgery
5429941|NCT01587859|minimally invasive surgery|minimally invasive surgery
5429942|NCT01587846|abdominal pain, constipation, Lactobacillus reuteri|abdominal pain, constipation, lactobacillus reuteri
5429944|NCT01587833|hip/femur fracture|hip/femur fracture
5429945|NCT01587820|cisplatin|cisplatin
5429946|NCT01587820|RADPLAT|radplat
5429947|NCT01587820|intra-arterial chemotherapy|intra-arterial chemotherapy
5429948|NCT01587820|head and neck cancer|head and neck cancer
5429949|NCT01587807|Infection, Quality of Life, lung injury|infection, quality of life, lung injury
5429950|NCT01587794|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5429951|NCT01587794|thickness of retinal layer|thickness of retinal layer
5429952|NCT01587794|outer nuclear layer|outer nuclear layer
5429953|NCT01587794|photoreceptor layer|photoreceptor layer
5548944|NCT01091480|LVH|lvh
5671221|NCT00616616|Gastric lap-band placement|gastric lap-band placement
5570337|NCT01005212|AAA|aaa
5429954|NCT01587781|Pharmacokinetics of enoxaparin|pharmacokinetics of enoxaparin
5429955|NCT01587768|Acute liver injury|acute liver injury
5429956|NCT01587768|antibiotics|antibiotics
5429957|NCT01587742|Calcium channel blockers|calcium channel blockers
5429958|NCT01587742|cancer|cancer
5429959|NCT01587729|Hip/femur fracture|hip/femur fracture
5429960|NCT01587729|antidepressants|antidepressants
5429961|NCT01587716|Safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (VGSC), anaesthesia|safety and tolerability, pharmacokinetics, cough, voltage gated sodium channels (vgsc), anaesthesia
5429963|NCT01587703|GSK525762|gsk525762
5429964|NCT01587703|NUT Midline Carcinoma|nut midline carcinoma
5429965|NCT01587703|MYCN-amplified Solid Tumor|mycn-amplified solid tumor
5429966|NCT01587703|BRD4|brd4
5429967|NCT01587703|BET inhibitor|bet inhibitor
5429968|NCT01587703|bromodomains|bromodomains
5429969|NCT01587703|NMC|nmc
5429970|NCT01587703|Colorectal C ancer|colorectal c ancer
5429971|NCT01587703|Small Cell Lung Cancer|small cell lung cancer
5429972|NCT01587703|Multiple Myeloma|multiple myeloma
5429973|NCT01587703|Neuroblastoma|neuroblastoma
5429974|NCT01587703|Oncology|oncology
5429975|NCT01587677|Tuberculosis|tuberculosis
5429976|NCT01587664|Swallowing disorders|swallowing disorders
5429977|NCT01587664|Aspiration|aspiration
5429978|NCT01587651|CAD|cad
5429979|NCT01587651|prasugrel|prasugrel
5429980|NCT01587651|ticagrelor|ticagrelor
5429981|NCT01587651|antiplatelet|antiplatelet
5429982|NCT01587651|thienopyridine|thienopyridine
5429983|NCT01587651|P2Y12 Inhibitors|p2y12 inhibitors
5429984|NCT01587638|new-onset diabetes|new-onset diabetes
5429985|NCT01587638|carvedilol|carvedilol
5429986|NCT01587638|claims analysis|claims analysis
5429987|NCT01587638|beta-blocker|beta-blocker
5429988|NCT01587638|Diabetes Mellitus|diabetes mellitus
5429989|NCT01587625|Delayed labour|delayed labour
5429990|NCT01587625|dystocia|dystocia
5429991|NCT01587625|oxytocin augmentation|oxytocin augmentation
5429992|NCT01587625|primiparous women|primiparous women
5429993|NCT01587625|childbirth|childbirth
5402379|NCT01711203|Rehabilitation|rehabilitation
5429994|NCT01587625|childbirth experience|childbirth experience
5429995|NCT01587625|progress|progress
5429996|NCT01587612|Pain|pain
5429997|NCT01587612|Foot|foot
5429998|NCT01587599|pharmaceutical care|pharmaceutical care
5429999|NCT01587599|drug-related problems|drug-related problems
5430000|NCT01587599|elderly|elderly
5430001|NCT01587599|Pharmaceutical care of elderly patients with diabetes|pharmaceutical care of elderly patients with diabetes
5430002|NCT01587586|Hepatitis C, Chronic|hepatitis c, chronic
5430003|NCT01587586|Interferon-alpha|interferon-alpha
5430004|NCT01587586|Hepatitis C Virus|hepatitis c virus
5430005|NCT01587573|salivary biomarkers|salivary biomarkers
5430006|NCT01587560|Shoulder|shoulder
5430007|NCT01587560|Arthroplasty|arthroplasty
5430008|NCT01587560|Pyrocarbon|pyrocarbon
5430009|NCT01587560|Randomized controlled trial|randomized controlled trial
5430010|NCT01587560|Shoulder resurfacing|shoulder resurfacing
5430011|NCT01587547|ART|art
5430012|NCT01587547|IVF|ivf
5430013|NCT01587547|ICSI|icsi
5430014|NCT01587547|embryo selection|embryo selection
5430015|NCT01587534|Unresectable Pancreatic cancer|unresectable pancreatic cancer
5430016|NCT01587521|Metabolic syndrome|metabolic syndrome
5430017|NCT01587521|Prevalence|prevalence
5430018|NCT01587521|Quality of life|quality of life
5430019|NCT01587521|Depression|depression
5430020|NCT01587521|Antipsychotics|antipsychotics
5430021|NCT01587482|Superficial femoral artery|superficial femoral artery
5430022|NCT01587482|endovascular|endovascular
5430023|NCT01587482|Drug eluting balloon|drug eluting balloon
5430024|NCT01587482|Paclitaxel|paclitaxel
5430025|NCT01587456|Osteoporosis|osteoporosis
5430026|NCT01587430|acute myeloid leukemia|acute myeloid leukemia
5430027|NCT01587430|anthracyclines|anthracyclines
5430028|NCT01587430|high dose cytarabine|high dose cytarabine
5430029|NCT01587430|maintenance|maintenance
5430030|NCT01587404|Atrial Fibrillation|atrial fibrillation
5430031|NCT01587404|Electrogram|electrogram
5430032|NCT01587404|Ablation|ablation
5430033|NCT01587404|Contact Force|contact force
5430034|NCT01587378|miscarriage|miscarriage
5430035|NCT01587378|preterm birth|preterm birth
5430036|NCT01587378|prevention|prevention
5430037|NCT01587326|cytokine, depression, escitalopram|cytokine, depression, escitalopram
5430038|NCT01587313|hydralazine|hydralazine
5430042|NCT01587313|pharmacokinetic profile|pharmacokinetic profile
5430043|NCT01587287|Anterior corneal power|anterior corneal power
5430044|NCT01587287|Placido topographer|placido topographer
5430045|NCT01587287|Scheimpﬂug|scheimpﬂug
5430046|NCT01587287|Precision|precision
5430047|NCT01587287|Agreement|agreement
5430048|NCT01587274|low back pain|low back pain
5430049|NCT01587261|Burns|burns
5430050|NCT01587261|Vitamin C|vitamin c
5430051|NCT01587261|Thermal Injury|thermal injury
5430052|NCT01587261|Fluid Resuscitation|fluid resuscitation
5430053|NCT01587248|Breast cancer,|breast cancer,
5430054|NCT01587248|Harmonic scalpel,|harmonic scalpel,
5430055|NCT01587248|Electrocautery,|electrocautery,
5430056|NCT01587248|Modified Radical Mastectomy,|modified radical mastectomy,
5430057|NCT01587248|Randomized Controlled Trial|randomized controlled trial
5430058|NCT01587209|decompression|decompression
5430059|NCT01587209|intravascular bubbles|intravascular bubbles
5430060|NCT01587209|neutrophil activation|neutrophil activation
5430061|NCT01587196|prescription opiates/medications|prescription opiates/medications
5430063|NCT01587196|brain imaging|brain imaging
5430064|NCT01587183|Running|running
5430065|NCT01587183|Blood pressure|blood pressure
5430066|NCT01587170|spasticity|spasticity
5430067|NCT01587170|spinal cord injury|spinal cord injury
5430068|NCT01587170|zolmitriptan|zolmitriptan
5430069|NCT01587144|GBM|gbm
5430070|NCT01587131|Universal Influenza|universal influenza
5430071|NCT01587131|Intradermal DNA-Based Vaccine|intradermal dna-based vaccine
5430072|NCT01587131|Senior|senior
5430073|NCT01587131|Electroporation|electroporation
5430074|NCT01587131|H1|h1
5430075|NCT01587131|Influenza|influenza
5430076|NCT01587131|FVH1|fvh1
5430077|NCT01587118|PTSD|ptsd
5430078|NCT01587118|Posttraumatic Stress Disorder|posttraumatic stress disorder
5430079|NCT01587118|Asenapine|asenapine
5430080|NCT01587118|Adjunctive|adjunctive
5430081|NCT01587118|antidepressant|antidepressant
5430082|NCT01587118|neuroleptic|neuroleptic
5430083|NCT01587092|walking|walking
5430084|NCT01587092|physical activity|physical activity
5430085|NCT01587092|sedentary behavior|sedentary behavior
5552137|NCT01078493|PRP|prp
5430086|NCT01587092|workplace|workplace
5430087|NCT01587079|COPD|copd
5430088|NCT01587027|Altitude Sickness|altitude sickness
5430089|NCT01587027|High Altitude Sickness|high altitude sickness
5430090|NCT01587001|Sarcoidosis|sarcoidosis
5430091|NCT01587001|oxidative stress|oxidative stress
5430092|NCT01587001|anti-oxidant|anti-oxidant
5430093|NCT01586988|HIV|hiv
5430094|NCT01586988|Parenting|parenting
5430095|NCT01586988|self-care|self-care
5430096|NCT01586988|disclosure|disclosure
5430097|NCT01586988|medication adherence|medication adherence
5430098|NCT01586988|mother|mother
5536470|NCT01140880|HIV|hiv
5430099|NCT01586988|child|child
5430100|NCT01586988|adolescent|adolescent
5430101|NCT01586962|paracetamol|paracetamol
5430102|NCT01586962|pseudoephedrine|pseudoephedrine
5430103|NCT01586962|syrup|syrup
5430104|NCT01586962|upper respiratory tract infection|upper respiratory tract infection
5430105|NCT01586949|well-being|well-being
5430106|NCT01586949|web-based intervention|web-based intervention
5430107|NCT01586949|social networks|social networks
5430108|NCT01586923|Anemia|anemia
5430109|NCT01586923|Transfusion|transfusion
5430110|NCT01586923|RBC storage age|rbc storage age
5430111|NCT01586923|Tissue oxygenation|tissue oxygenation
5430112|NCT01586923|Malaria|malaria
5430113|NCT01586897|health information technology|health information technology
5430114|NCT01586897|primary care|primary care
5430115|NCT01586897|visit-independent|visit-independent
5430116|NCT01586897|medication monitoring|medication monitoring
5430117|NCT01586884|LV Pacing|lv pacing
5430118|NCT01586884|LV Lead Placement|lv lead placement
5430119|NCT01586884|LV Pacing Site|lv pacing site
5430120|NCT01586884|CRT Device Placement|crt device placement
5430121|NCT01586871|MPS I|mps i
5430122|NCT01586871|MPS II|mps ii
5430123|NCT01586871|MPS VI|mps vi
5430124|NCT01586871|Mucopolysaccharidoses|mucopolysaccharidoses
5430125|NCT01586858|Vasculitis|vasculitis
5430126|NCT01586858|ANCA|anca
5430127|NCT01586858|Rituximab|rituximab
5430128|NCT01586858|Small vessel vasculitis|small vessel vasculitis
5430129|NCT01586845|Randomized Controlled Trials|randomized controlled trials
5430130|NCT01586845|Immunosuppression|immunosuppression
5430131|NCT01586845|Adult|adult
5430132|NCT01586845|Kidney Transplantation|kidney transplantation
5430133|NCT01586845|Treatment Outcome|treatment outcome
5430134|NCT01586832|Hospital Supplies|hospital supplies
5430135|NCT01586832|Stocking of Supplies|stocking of supplies
5430136|NCT01586806|Dexamethasone|dexamethasone
5430137|NCT01586806|Glucocorticoids|glucocorticoids
5430138|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs
5430139|NCT01586806|Therapeutic Uses|therapeutic uses
5430140|NCT01586806|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5430141|NCT01586806|Regional Anesthesia, nerve block|regional anesthesia, nerve block
5430142|NCT01586806|Ultrasonic Imaging|ultrasonic imaging
5430143|NCT01586806|Post-Operative Complications: muscle weakness, pain, nausea and vomiting|post-operative complications: muscle weakness, pain, nausea and vomiting
5430144|NCT01586806|Dexamethasone (as local anesthetic additive)|dexamethasone (as local anesthetic additive)
5430145|NCT01586793|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5430147|NCT01586793|Randomized trial|randomized trial
5430149|NCT01586793|Neuromodulation|neuromodulation
5430150|NCT01586780|Whey protein|whey protein
5430151|NCT01586780|Soy protein|soy protein
5430152|NCT01586780|Insulinogenic amino acids|insulinogenic amino acids
5430153|NCT01586780|Incretins|incretins
5430154|NCT01586780|Glycaemia|glycaemia
5430155|NCT01586780|Insulinaemia|insulinaemia
5430156|NCT01586767|Nasal cavity|nasal cavity
5430157|NCT01586767|Salivary gland tumors|salivary gland tumors
5430158|NCT01586767|Hard palate|hard palate
5430159|NCT01586767|Sinus|sinus
5430160|NCT01586767|Soft Palate|soft palate
5430161|NCT01586767|Lacrimal Apparatus|lacrimal apparatus
5430162|NCT01586754|metabolic syndrome|metabolic syndrome
5430163|NCT01586754|obesity|obesity
5430164|NCT01586754|endothelial damage|endothelial damage
5430165|NCT01586754|homocysteine|homocysteine
5430166|NCT01586754|microalbumin|microalbumin
5430167|NCT01586754|carotis intima-media thickness|carotis intima-media thickness
5430168|NCT01586728|Cystic fibrosis|cystic fibrosis
5430169|NCT01586728|oxygen therapy|oxygen therapy
5430170|NCT01586728|sleep|sleep
5430171|NCT01586715|Extremely complex perianal fistula|extremely complex perianal fistula
5430172|NCT01586715|Adipose Derived Stem Cells|adipose derived stem cells
5430173|NCT01586702|Stroke, TIA, secondary prevention, support program, multifactorial intervention|stroke, tia, secondary prevention, support program, multifactorial intervention
5430174|NCT01586689|Oxford House|oxford house
5430175|NCT01586689|recovery|recovery
5430176|NCT01586689|substance abuse|substance abuse
5430177|NCT01586689|alcohol abuse|alcohol abuse
5430178|NCT01586689|addiction|addiction
5430179|NCT01586676|supervision|supervision
5430180|NCT01586676|motivational interviewing|motivational interviewing
5430181|NCT01586676|substance abuse|substance abuse
5430182|NCT01586676|dissemination|dissemination
5430183|NCT01586663|Diffuse Systemic Sclerosis|diffuse systemic sclerosis
5430184|NCT01586663|Hand|hand
5430185|NCT01586663|Range of motion|range of motion
5430186|NCT01586663|Splint|splint
5430187|NCT01586650|ankylosing spondylitis|ankylosing spondylitis
5430188|NCT01586650|aerobic exercise|aerobic exercise
5430189|NCT01586637|Fibromyalgia|fibromyalgia
5430190|NCT01586637|Art Therapy|art therapy
5430191|NCT01586637|Pain|pain
5430192|NCT01586637|Quality of life|quality of life
5430193|NCT01586637|Body Image|body image
5430194|NCT01586624|Phase I|phase i
5430195|NCT01586624|Drug evaluation|drug evaluation
5430196|NCT01586624|Oncology|oncology
5430197|NCT01586624|Vandetanib|vandetanib
5430198|NCT01586624|Selumetinib|selumetinib
5430199|NCT01586624|Dose escalation|dose escalation
5430200|NCT01586624|Clinical trial|clinical trial
5430201|NCT01586624|Vascular Endothelial Growth Factor(VEGFR) inhibitor|vascular endothelial growth factor(vegfr) inhibitor
5430202|NCT01586624|Epidermal Growth Factor Receptor(EGFR)inhibitor|epidermal growth factor receptor(egfr)inhibitor
5430203|NCT01586624|Mitogen Activated Kinase (MEK) inhibitor|mitogen activated kinase (mek) inhibitor
5430204|NCT01586624|Non small cell lung cancer|non small cell lung cancer
5430205|NCT01586598|Mandibular Nerve|mandibular nerve
5430206|NCT01586598|Orthognathic Surgery|orthognathic surgery
5430207|NCT01586598|Sagittal Split Osteotomy|sagittal split osteotomy
5430208|NCT01586598|Sensory Retraining|sensory retraining
5430209|NCT01586572|Polio virus type 1,2,3|polio virus type 1,2,3
5430210|NCT01586572|Poliovaccine-Oral|poliovaccine-oral
5430211|NCT01586572|Poliovaccine|poliovaccine
5430212|NCT01586572|Trivalent Oral Polio vaccine|trivalent oral polio vaccine
5430213|NCT01586572|Monovalent oral polio vaccine|monovalent oral polio vaccine
5430214|NCT01586572|Bivalent Oral polio vaccine|bivalent oral polio vaccine
5430215|NCT01586546|Mind-body|mind-body
5430216|NCT01586546|Psychosocial|psychosocial
5430217|NCT01586546|Meditation|meditation
5430218|NCT01586546|Breathing Exercises|breathing exercises
5430219|NCT01586546|Guided Imagery|guided imagery
5430220|NCT01586546|Visualization|visualization
5430221|NCT01586533|ulcerative colitis|ulcerative colitis
5430223|NCT01586533|left-sided ulcerative colitis|left-sided ulcerative colitis
5430224|NCT01586533|distal ulcerative colitis|distal ulcerative colitis
5430225|NCT01586533|Zoenasa|zoenasa
5430226|NCT01586533|mesalamine|mesalamine
5430227|NCT01586533|mesalazine|mesalazine
5430228|NCT01586533|5-ASA|5-asa
5430229|NCT01586533|5-aminosalicylic acid|5-aminosalicylic acid
5430230|NCT01586533|N-acetylcysteine|n-acetylcysteine
5430231|NCT01586533|acetylcysteine|acetylcysteine
5430232|NCT01586533|NAC|nac
5430233|NCT01586533|enema|enema
5430234|NCT01586533|rectal gel|rectal gel
5430235|NCT01586520|thyroid cancer, papillary, follicular, proteomics, genetic markers|thyroid cancer, papillary, follicular, proteomics, genetic markers
5430236|NCT01586507|Pain|pain
5430237|NCT01586507|ULTRAM ER|ultram er
5430261|NCT01586416|Psychosocial Intervention|psychosocial intervention
5430262|NCT01586416|Chemotherapy adherence|chemotherapy adherence
5430264|NCT01586403|Gene Therapy|gene therapy
5430265|NCT01586403|Adoptive T-Cell Transfer|adoptive t-cell transfer
5430266|NCT01586403|IL-2|il-2
5430267|NCT01586390|Ankle Sprain|ankle sprain
5430268|NCT01586390|Ankle Distortion|ankle distortion
5430269|NCT01586390|Functional treatment|functional treatment
5430270|NCT01586390|Brace treatment|brace treatment
5430271|NCT01586377|Complex regional pain syndrome|complex regional pain syndrome
5413129|NCT01663701|Sepsis|sepsis
5430272|NCT01586377|Near Infrared Spectroscopy|near infrared spectroscopy
5430273|NCT01586377|Vascular Occlusion Test|vascular occlusion test
5430274|NCT01586364|Menopausal symptoms|menopausal symptoms
5430275|NCT01586364|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
5430276|NCT01586364|Vaginal atrophy|vaginal atrophy
5430277|NCT01586364|Urogenital atrophy|urogenital atrophy
5430278|NCT01586351|Rotator cuff tears|rotator cuff tears
5430279|NCT01586351|ACP|acp
5430280|NCT01586351|DX Reinforcement Matrix|dx reinforcement matrix
5430281|NCT01586325|Chronic hepatitis C infection|chronic hepatitis c infection
5430282|NCT01586325|Asian genotype 1 chronic hepatitis C infection|asian genotype 1 chronic hepatitis c infection
5430283|NCT01586325|JNJ-47910382|jnj-47910382
5430284|NCT01586325|Non-structural protein 5A (NS5A) inhibitor|non-structural protein 5a (ns5a) inhibitor
5430285|NCT01586312|Knee degenerative disease|knee degenerative disease
5430286|NCT01586312|osteoarthritis|osteoarthritis
5430287|NCT01586312|gonarthrosis|gonarthrosis
5430288|NCT01586312|stem cell|stem cell
5430289|NCT01586312|cellular therapy|cellular therapy
5430290|NCT01586312|regenerative therapy|regenerative therapy
5430291|NCT01586312|Mesenchymal stem cells|mesenchymal stem cells
5430292|NCT01586312|Bone marrow|bone marrow
5430293|NCT01586312|musculoskeletal Diseases|musculoskeletal diseases
5430294|NCT01586312|Mesenchymal Stromal Cells (allogenic)|mesenchymal stromal cells (allogenic)
5430295|NCT01586299|pleuropneumonia children|pleuropneumonia children
5430296|NCT01586299|non steroidal anti inflammatory drugs|non steroidal anti inflammatory drugs
5430297|NCT01586299|pleural effusion|pleural effusion
5430298|NCT01586299|severe pneumonia|severe pneumonia
5430299|NCT01586286|Levator Myalgia|levator myalgia
5430300|NCT01586286|Pelvic Pain|pelvic pain
5430301|NCT01586286|Vaginismus|vaginismus
5430302|NCT01586286|Myofascial pain syndromes|myofascial pain syndromes
5430303|NCT01586260|Neuroblastoma in remission|neuroblastoma in remission
5430304|NCT01586260|Relapsed Neuroblastoma|relapsed neuroblastoma
5430305|NCT01586260|Refractory Neuroblastoma|refractory neuroblastoma
5430306|NCT01586234|Fuchs' endothelial dystrophy|fuchs' endothelial dystrophy
5430307|NCT01586234|DSAEK|dsaek
5430308|NCT01586234|Descemet's stripping automated endothelial keratoplasty|descemet's stripping automated endothelial keratoplasty
5430309|NCT01586221|Rehabilitation|rehabilitation
5430310|NCT01586221|Fingers|fingers
5430311|NCT01586221|Grasp|grasp
5430312|NCT01586221|Strength|strength
5430313|NCT01586221|Brain Function|brain function
5430314|NCT01586221|Physiopathology|physiopathology
5430315|NCT01586221|Functional Laterality|functional laterality
5430316|NCT01586221|Psychomotor Performance|psychomotor performance
5430317|NCT01586221|Biomechanis|biomechanis
5430318|NCT01586221|Touch|touch
5430319|NCT01586221|Music Therapy|music therapy
5430320|NCT01586221|Weight-Bearing|weight-bearing
5430321|NCT01586208|refractory status epilepticus|refractory status epilepticus
5430322|NCT01586208|valproic acid|valproic acid
5430323|NCT01586208|phenytoin|phenytoin
5430324|NCT01586208|benzodiazepines|benzodiazepines
5430325|NCT01586208|Valproic acid initial dosage in status treatment|valproic acid initial dosage in status treatment
5430326|NCT01586182|poor prognosis|poor prognosis
5430327|NCT01586169|Albendazole|albendazole
5430328|NCT01586169|Ivermectin|ivermectin
5430329|NCT01586169|Azithromycin|azithromycin
5430330|NCT01586169|Lymphatic filariasis|lymphatic filariasis
5430331|NCT01586169|Trachoma|trachoma
5430332|NCT01586169|Safety|safety
5430333|NCT01586143|Paracetamol by permucosal route,|paracetamol by permucosal route,
5430334|NCT01586143|Paracetamol by intraveinous route,|paracetamol by intraveinous route,
5430335|NCT01586143|Pain.|pain.
5430336|NCT01586143|Patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).|patient with minor trauma of lower limb and/or superior limb (sprains, muscle contusions, …).
5430337|NCT01586130|Knee Osteoarthritis|knee osteoarthritis
5430338|NCT01586130|Exercise|exercise
5430339|NCT01586130|Isokinetic|isokinetic
5430340|NCT01586130|Muscle strength|muscle strength
5430341|NCT01586130|Rehabilitation|rehabilitation
5430342|NCT01586117|rectal cancer|rectal cancer
5430343|NCT01586117|amifostine|amifostine
5430344|NCT01586117|pre-operative chemo-radiation|pre-operative chemo-radiation
5430345|NCT01586065|type 1 diabetes|type 1 diabetes
5430346|NCT01586065|adolescents|adolescents
5430347|NCT01586065|poor control|poor control
5430348|NCT01586065|CGM|cgm
5430349|NCT01586052|Cerebral Palsy|cerebral palsy
5430350|NCT01586052|Erythropoietin|erythropoietin
5430351|NCT01586052|Rehabilitation|rehabilitation
5430352|NCT01586039|Melatonin|melatonin
5430353|NCT01586039|Sleep|sleep
5430354|NCT01586039|Light|light
5430355|NCT01586039|Alertness|alertness
5430358|NCT01586026|Catheters|catheters
5430359|NCT01586026|Distal Valved Catheters|distal valved catheters
5430360|NCT01586026|Maintenance Flush|maintenance flush
5430361|NCT01586026|subjects|subjects
5430362|NCT01586026|routine maintenance flushes|routine maintenance flushes
5430363|NCT01586013|propofol|propofol
5430364|NCT01586013|pharmacodynamic|pharmacodynamic
5430365|NCT01586013|age|age
5430366|NCT01586013|ke0|ke0
5430367|NCT01586000|vaginal ring|vaginal ring
5430368|NCT01585974|Renal Cell Carcinoma|renal cell carcinoma
5430369|NCT01585974|TKI|tki
5430370|NCT01585974|Turkey|turkey
5430371|NCT01585974|Observational|observational
5430372|NCT01585961|Symptomatic paroxysmal|symptomatic paroxysmal
5430373|NCT01585961|Atrial fibrillation|atrial fibrillation
5430374|NCT01585961|Observational|observational
5430375|NCT01585961|Acute procedural outcomes|acute procedural outcomes
5430376|NCT01585961|Ablation|ablation
5430377|NCT01585961|Drug refractory|drug refractory
5430378|NCT01585961|Arrhythmia Recurrent|arrhythmia recurrent
5430379|NCT01585961|Symptomatic|symptomatic
5430380|NCT01585935|Infant, Extremely Low Birth Weight|infant, extremely low birth weight
5430381|NCT01585935|Parenteral Nutrition|parenteral nutrition
5430382|NCT01585935|Fish Oils|fish oils
5430383|NCT01585935|Cholestasis|cholestasis
5430384|NCT01585935|Psychomotor Disorders, Developmental|psychomotor disorders, developmental
5430385|NCT01585922|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5430386|NCT01585896|Hoarding|hoarding
5430387|NCT01585896|Compulsive Hoarding|compulsive hoarding
5430388|NCT01585896|Self-Help|self-help
5430389|NCT01585883|Lung cancer|lung cancer
5430390|NCT01585883|Breathlessness|breathlessness
5430391|NCT01585883|Self-management|self-management
5430392|NCT01585870|Safety|safety
5430393|NCT01585870|Tolerability|tolerability
5430394|NCT01585870|Pharmacokinetics|pharmacokinetics
5430395|NCT01585870|Clinical benefit|clinical benefit
5430396|NCT01585870|Sorafenib|sorafenib
5430397|NCT01585870|Eribulin|eribulin
5430398|NCT01585870|advanced metastatic solid tumors|advanced metastatic solid tumors
5430399|NCT01585844|sleep apnea|sleep apnea
5430400|NCT01585844|pregnancy|pregnancy
5430401|NCT01585844|obesity|obesity
5430402|NCT01585831|Klinefelter syndrome|klinefelter syndrome
5430403|NCT01585831|XXY syndrome|xxy syndrome
5430404|NCT01585831|Sex Chromosome Abnormality|sex chromosome abnormality
5430405|NCT01585831|Testosterone replacement therapy|testosterone replacement therapy
5430406|NCT01585818|Glycemic Index|glycemic index
5430407|NCT01585818|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5430408|NCT01585818|Diet|diet
5430409|NCT01585818|Glucose Variability|glucose variability
5430410|NCT01585818|Metabolic Response|metabolic response
5430411|NCT01585818|Glucose Response|glucose response
5430412|NCT01585766|MAb, B cell, depletion, RMS|mab, b cell, depletion, rms
5430413|NCT01585753|cardiovascular function|cardiovascular function
5430415|NCT01585740|Hyperchloraemic metabolic acidosis|hyperchloraemic metabolic acidosis
5430416|NCT01585740|Neonatal acidosis|neonatal acidosis
5430417|NCT01585740|Neonatal hyperchloraemia|neonatal hyperchloraemia
5430418|NCT01585740|Base excess|base excess
5430419|NCT01585740|Metabolic acidosis|metabolic acidosis
5430420|NCT01585740|Caesarean section|caesarean section
5430421|NCT01585740|Normal saline|normal saline
5430422|NCT01585740|Ringer's Lactate|ringer's lactate
5430423|NCT01585740|Postoperative morbidity|postoperative morbidity
5430424|NCT01585727|Rectal cancer|rectal cancer
5430425|NCT01585727|total mesorectal excision|total mesorectal excision
5430426|NCT01585727|pelvic autonomic nerve preservation|pelvic autonomic nerve preservation
5430427|NCT01585727|neurostimulation|neurostimulation
5430428|NCT01585727|urogenital function|urogenital function
5430429|NCT01585727|quality of life|quality of life
5430430|NCT01585701|Phase I|phase i
5430431|NCT01585701|Oncology|oncology
5430432|NCT01585701|AGC Kinase inhibitor|agc kinase inhibitor
5430433|NCT01585701|Protein Kinase inhibitor|protein kinase inhibitor
5430434|NCT01585701|Clinical Trial|clinical trial
5430435|NCT01585701|Multiple protein kinases|multiple protein kinases
5430438|NCT01585675|Lung Cancer|lung cancer
5430439|NCT01585662|EUS|eus
5430440|NCT01585662|pancreatic pseudocyst|pancreatic pseudocyst
5430441|NCT01585662|drainage|drainage
5430442|NCT01585636|SQ109|sq109
5430443|NCT01585636|Tuberculosis|tuberculosis
5430444|NCT01585610|smoking|smoking
5430445|NCT01585610|smoking cessation|smoking cessation
5430446|NCT01585610|disabled persons|disabled persons
5430447|NCT01585610|behavioral research|behavioral research
5430448|NCT01585597|Ischemic Stoke|ischemic stoke
5430449|NCT01585597|Endovascular Reperfusion|endovascular reperfusion
5430450|NCT01585597|Reperfusion Injury|reperfusion injury
5430451|NCT01585597|Mild hypothermia|mild hypothermia
5430452|NCT01585584|Boceprevir|boceprevir
5430453|NCT01585584|Hepatitis C Genotype 3|hepatitis c genotype 3
5430454|NCT01585571|Balance|balance
5430455|NCT01585571|Posture|posture
5430456|NCT01585571|Virtual Environment|virtual environment
5430457|NCT01585571|Cerebral Palsy|cerebral palsy
5430458|NCT01585571|Adults|adults
5430658|NCT01584726|children|children
5430459|NCT01585558|Menopausal symptoms|menopausal symptoms
5430460|NCT01585558|Urogenital atrophy|urogenital atrophy
5430461|NCT01585558|Vulvar and vaginal atrophy in menopausal women|vulvar and vaginal atrophy in menopausal women
5430462|NCT01585558|Vaginal atrophy|vaginal atrophy
5430463|NCT01585545|CT|ct
5430464|NCT01585545|PET CT|pet ct
5430465|NCT01585545|MRI|mri
5430466|NCT01585545|cancer genomics|cancer genomics
5430467|NCT01585545|Radiomics|radiomics
5430468|NCT01585545|Radiogenomics|radiogenomics
5430469|NCT01585532|Tuberculosis|tuberculosis
5430470|NCT01585532|Urine|urine
5430471|NCT01585532|Nucleic acid|nucleic acid
5430472|NCT01585532|Alere|alere
5430473|NCT01585532|Borstel|borstel
5430474|NCT01585519|High Epicatechin Apples|high epicatechin apples
5430475|NCT01585519|Low Epicatechin Apples|low epicatechin apples
5430476|NCT01585519|Apple Extract|apple extract
5430477|NCT01585519|Apple Granules|apple granules
5430478|NCT01585519|Blood Pressure|blood pressure
5430479|NCT01585519|Cholesterol|cholesterol
5430480|NCT01585493|Lifestyle|lifestyle
5430481|NCT01585493|Smoking|smoking
5430482|NCT01585493|Dietary|dietary
5430483|NCT01585493|Exercise|exercise
5430484|NCT01585480|Obesity|obesity
5430485|NCT01585480|Weight Gain Prevention|weight gain prevention
5430486|NCT01585480|Workplace|workplace
5430487|NCT01585480|Intervention|intervention
5430488|NCT01585480|Diet|diet
5430489|NCT01585480|Exercise|exercise
5430490|NCT01585467|Anterior Shoulder Dislocation|anterior shoulder dislocation
5430491|NCT01585467|Shoulder Dislocation|shoulder dislocation
5430492|NCT01585467|Shoulder Pain|shoulder pain
5430493|NCT01585467|Shoulder Deformity|shoulder deformity
5430494|NCT01585454|Pregnancy|pregnancy
5430495|NCT01585454|Diabetes Mellitus|diabetes mellitus
5430496|NCT01585454|Weight Gain|weight gain
5430497|NCT01585454|Diabetes|diabetes
5430498|NCT01585441|Finasteride|finasteride
5430499|NCT01585441|Central Serous Chorioretinopathy|central serous chorioretinopathy
5430500|NCT01585428|Immunotherapy|immunotherapy
5430501|NCT01585428|HPV-Associated Cancers|hpv-associated cancers
5430502|NCT01585428|Cervical Cancer|cervical cancer
5430503|NCT01585428|Oropharyngeal Cancer|oropharyngeal cancer
5430505|NCT01585415|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5430506|NCT01585415|Immunotherapy|immunotherapy
5430507|NCT01585415|Adoptive Cell Therapy|adoptive cell therapy
5430508|NCT01585415|B Raf Inhibitor|b raf inhibitor
5430509|NCT01585402|NT5E|nt5e
5430510|NCT01585402|Biphosphonates|biphosphonates
5430511|NCT01585402|Vascular Calcifications|vascular calcifications
5430512|NCT01585402|Joint Capsule Calcifications|joint capsule calcifications
5430513|NCT01585402|Inherited Disease|inherited disease
5430514|NCT01585389|adult brain tumor|adult brain tumor
5430515|NCT01585389|childhood brain tumor|childhood brain tumor
5430516|NCT01585376|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5430517|NCT01585376|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5430518|NCT01585350|melanoma|melanoma
5430519|NCT01585350|peptide vaccine|peptide vaccine
5430520|NCT01585350|polyICLC|polyiclc
5430521|NCT01585350|lipopolysaccharide (LPS)|lipopolysaccharide (lps)
5430522|NCT01585350|immunotherapy|immunotherapy
5430523|NCT01585311|Subarachnoid Hemorrhage (SAH)|subarachnoid hemorrhage (sah)
5430524|NCT01585311|tachycardia|tachycardia
5430525|NCT01585311|Outcome|outcome
5430526|NCT01585298|Multiple Sclerosis|multiple sclerosis
5430528|NCT01585298|Fingolimod|fingolimod
5430529|NCT01585298|Gilenya|gilenya
5430530|NCT01585298|ECG|ecg
5430531|NCT01585298|Bradyarrythmia|bradyarrythmia
5430532|NCT01585298|conduction abnormalities|conduction abnormalities
5430533|NCT01585298|first dose observation|first dose observation
5430534|NCT01585285|Coronary artery bypass grafting|coronary artery bypass grafting
5430535|NCT01585285|Left internal mammary artery|left internal mammary artery
5430536|NCT01585285|Composite grafting|composite grafting
5430537|NCT01585285|Multislice Spiral Computed Tomography Scanner|multislice spiral computed tomography scanner
5430538|NCT01585285|Graft patency assessment|graft patency assessment
5430539|NCT01585272|Alzheimer's dementia, AD|alzheimer's dementia, ad
5430540|NCT01585259|anti-platelet;|anti-platelet;
5430541|NCT01585259|safety;|safety;
5430542|NCT01585259|efficacy|efficacy
5430543|NCT01585246|Prostate Cancer|prostate cancer
5430544|NCT01585246|Radiation Therapy|radiation therapy
5430545|NCT01585246|Quality of Life|quality of life
5430546|NCT01585246|Symptom Management|symptom management
5430547|NCT01585233|Moderate Psoriasis|moderate psoriasis
5430548|NCT01585233|Severe Psoriasis|severe psoriasis
5430549|NCT01585233|Skin disease|skin disease
5430550|NCT01585233|ASKP1240|askp1240
5430551|NCT01585233|CD40 antigen|cd40 antigen
5430552|NCT01585233|Anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
5430553|NCT01585220|WSRS|wsrs
5430554|NCT01585220|GAIS|gais
5430555|NCT01585220|HA filler|ha filler
5430556|NCT01585220|filler|filler
5430557|NCT01585207|Tourette's Disorder|tourette's disorder
5430558|NCT01585207|vigabatrin|vigabatrin
5863981|NCT00001147|Norepinephrine|norepinephrine
5430559|NCT01585181|Vaccine, Bacterial disease condition, Cholera|vaccine, bacterial disease condition, cholera
5430659|NCT01584726|pediatric|pediatric
5430560|NCT01585168|Reward Circuitry|reward circuitry
5430561|NCT01585168|Impulsivity|impulsivity
5430562|NCT01585168|Family History of Alcoholism|family history of alcoholism
5430563|NCT01585168|NMDA/DA Interactions|nmda/da interactions
5430564|NCT01585155|Infliximab|infliximab
5430565|NCT01585155|REMICADE|remicade
5430566|NCT01585155|TA-650|ta-650
5430567|NCT01585090|Ankle positions|ankle positions
5430568|NCT01585090|pelvic floor muscles strength|pelvic floor muscles strength
5430569|NCT01585090|relaxation of pelvic floor muscles syndrome|relaxation of pelvic floor muscles syndrome
5413436|NCT01662297|Quetiapine|quetiapine
5430570|NCT01585090|doing strengthening exercises of pelvic floor muscles|doing strengthening exercises of pelvic floor muscles
5430571|NCT01585077|Plasmodium vivax|plasmodium vivax
5430572|NCT01585077|Malaria|malaria
5430573|NCT01585077|Challenge|challenge
5430574|NCT01585077|Anopheles albimanus|anopheles albimanus
5430575|NCT01585064|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5430576|NCT01585064|Anti-TNF therapy|anti-tnf therapy
5430577|NCT01585064|Adalimumab|adalimumab
5430578|NCT01585064|Disease activity|disease activity
5430579|NCT01585064|Treating to target|treating to target
5430580|NCT01585051|vitamin D|vitamin d
5430581|NCT01585051|blood pressure|blood pressure
5430582|NCT01585051|typ 2 diabetes mellitus|typ 2 diabetes mellitus
5430583|NCT01585051|blood glucose|blood glucose
5430584|NCT01585051|HbA1c|hba1c
5430585|NCT01585038|endothelium|endothelium
5430586|NCT01585038|inflammation|inflammation
5430587|NCT01585038|oxidative stress|oxidative stress
5430588|NCT01585038|HIV-1|hiv-1
5430589|NCT01585025|Primary bile acid malabsorption|primary bile acid malabsorption
5430590|NCT01585025|Secondary bile acid malabsorption|secondary bile acid malabsorption
5430591|NCT01585025|Chronic diarrhoea|chronic diarrhoea
5430592|NCT01585025|Obeticholic acid|obeticholic acid
5430593|NCT01585025|SeHCAT|sehcat
5430595|NCT01585025|FGF19|fgf19
5430596|NCT01585012|Cervical cap insemination|cervical cap insemination
5430597|NCT01585012|Collection condom|collection condom
5430598|NCT01585012|Instructions for Use|instructions for use
5430599|NCT01585012|Safety during intercourse|safety during intercourse
5430600|NCT01585012|Acceptability of the cervical cap with condom sheath|acceptability of the cervical cap with condom sheath
5430602|NCT01585012|break|break
5430603|NCT01585012|ease of conversion|ease of conversion
5430604|NCT01585012|adequate sample collection|adequate sample collection
5430605|NCT01584947|Oral pain|oral pain
5430606|NCT01584947|Local anesthetic|local anesthetic
5430607|NCT01584947|Bupivacaine hydrochloride|bupivacaine hydrochloride
5430608|NCT01584934|fatigue|fatigue
5430609|NCT01584934|sleep quality|sleep quality
5430610|NCT01584934|Chronic, disabling, unexplained fatigue with at least 4 minor criteria for CFS, according to the 1994 Fukuda case definition|chronic, disabling, unexplained fatigue with at least 4 minor criteria for cfs, according to the 1994 fukuda case definition
5430611|NCT01584921|Erythropoietin|erythropoietin
5430612|NCT01584921|Glomerular filtration rate|glomerular filtration rate
5430613|NCT01584921|Tubular reabsorption|tubular reabsorption
5430614|NCT01584921|Renal function|renal function
5430615|NCT01584921|Renal perfusion|renal perfusion
5430616|NCT01584908|kidney transplant recipients|kidney transplant recipients
5430617|NCT01584882|Clinical decision support (CDS)|clinical decision support (cds)
5430619|NCT01584882|Behavioral|behavioral
5430620|NCT01584882|Dental hygienist|dental hygienist
5430622|NCT01584882|Smoking|smoking
5430623|NCT01584882|Electronic health record|electronic health record
5430624|NCT01584869|GI-bleeding|gi-bleeding
5430625|NCT01584869|capsule endoscopy|capsule endoscopy
5430626|NCT01584843|Neuromuscular Agents|neuromuscular agents
5430627|NCT01584843|Strabismus|strabismus
5430628|NCT01584843|Botulinum Toxin Type A|botulinum toxin type a
5430629|NCT01584830|Regorafenib|regorafenib
5430630|NCT01584830|Colorectal|colorectal
5430631|NCT01584830|Metastatic|metastatic
5430632|NCT01584817|colonoscopy|colonoscopy
5430633|NCT01584817|bowel preparation|bowel preparation
5430634|NCT01584817|education|education
5430635|NCT01584804|Su Huang antitussive capsule|su huang antitussive capsule
5430636|NCT01584804|Cough variant asthma|cough variant asthma
5430637|NCT01584804|Placebo|placebo
5430639|NCT01584791|PCI|pci
5430640|NCT01584791|Percutaneous Coronary Intervention|percutaneous coronary intervention
5430641|NCT01584778|Behçet's disease|behçet's disease
5430642|NCT01584778|Eosinophil cationic protein|eosinophil cationic protein
5430643|NCT01584778|Eosinophils|eosinophils
5430644|NCT01584765|liver injury|liver injury
5430645|NCT01584765|Rechallenge|rechallenge
5430646|NCT01584765|Kaiser Permanente California|kaiser permanente california
5430647|NCT01584739|Safety|safety
5430648|NCT01584739|tolerability|tolerability
5430649|NCT01584739|healthy|healthy
5430650|NCT01584739|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
5430651|NCT01584739|pharmacokinetic|pharmacokinetic
5430652|NCT01584739|pharmacodynamic|pharmacodynamic
5430653|NCT01584739|inhaled|inhaled
5430654|NCT01584726|magnesium|magnesium
5430655|NCT01584726|nebulization|nebulization
5430656|NCT01584726|asthma|asthma
5430657|NCT01584726|sulfate|sulfate
5430660|NCT01584713|Enterocutaneous fistula|enterocutaneous fistula
5430661|NCT01584713|Adipose Derived Stem Cells|adipose derived stem cells
5430662|NCT01584700|NYHA class III or IV|nyha class iii or iv
5430663|NCT01584700|Maximal medical therapy|maximal medical therapy
5430664|NCT01584700|Not eligible for CRT|not eligible for crt
5430665|NCT01584687|asthma|asthma
5430666|NCT01584687|difficult-to-control asthma|difficult-to-control asthma
5430667|NCT01584687|mRNA expression|mrna expression
5430668|NCT01584687|biomarker|biomarker
5430669|NCT01584687|real time PCR|real time pcr
5430670|NCT01584687|ACT|act
5430671|NCT01584687|ACQ|acq
5430672|NCT01584648|Randomized study|randomized study
5430673|NCT01584648|combination therapy|combination therapy
5430674|NCT01584648|BRAF inhibitor|braf inhibitor
5430675|NCT01584648|GSK1120212|gsk1120212
5430676|NCT01584648|BRAF V600E/K mutation-positive cutaneous melanoma|braf v600e/k mutation-positive cutaneous melanoma
5430677|NCT01584648|trametinib|trametinib
5430678|NCT01584648|GSK2118436|gsk2118436
5430679|NCT01584648|MEK inhibitor|mek inhibitor
5430680|NCT01584648|Phase III|phase iii
5430681|NCT01584648|dabrafenib|dabrafenib
5430682|NCT01584635|Less invasive treatment for Achalasia|less invasive treatment for achalasia
5430683|NCT01584609|ischemic stroke|ischemic stroke
5430684|NCT01584609|large vessel occlusion|large vessel occlusion
5430685|NCT01584609|mechanical thrombectomy|mechanical thrombectomy
5430686|NCT01584609|revascularization|revascularization
5430687|NCT01584609|Penumbra System|penumbra system
5430688|NCT01584609|Separator 3D|separator 3d
5430689|NCT01584596|physical activity|physical activity
5430690|NCT01584596|dietary|dietary
5430691|NCT01584596|adults|adults
5430692|NCT01584596|pedometer|pedometer
5430693|NCT01584596|education|education
5430694|NCT01584583|BP|bp
5430695|NCT01584570|dexmedetomidine|dexmedetomidine
5430696|NCT01584570|heart rate variability|heart rate variability
5430697|NCT01584570|QTc interval|qtc interval
5430698|NCT01584544|rectal neoplasms|rectal neoplasms
5430699|NCT01584544|aged|aged
5430700|NCT01584544|chemoradiotherapy|chemoradiotherapy
5430701|NCT01584544|clinical trials, phase I|clinical trials, phase i
5430702|NCT01584544|capecitabine|capecitabine
5430703|NCT01584531|rigosertib sodium|rigosertib sodium
5430704|NCT01584531|rigosertib|rigosertib
5430705|NCT01584531|ON 01910.Na|on 01910.na
5430706|NCT01584531|oral rigosertib|oral rigosertib
5430707|NCT01584505|COPD|copd
5430708|NCT01584479|periodontitis|periodontitis
5430709|NCT01584466|Schizophrenia|schizophrenia
5430710|NCT01584466|Substance Abuse|substance abuse
5430711|NCT01584427|Dietary fibers|dietary fibers
5430712|NCT01584427|Resistent Starch|resistent starch
5430713|NCT01584427|Arabinoxylans|arabinoxylans
5430714|NCT01584427|Postprandial lipaemia|postprandial lipaemia
5430715|NCT01584427|Insulin sensitivity|insulin sensitivity
5430716|NCT01584427|Body composition|body composition
5430717|NCT01584427|Gene expression|gene expression
5430718|NCT01584427|Metabolic rate|metabolic rate
5430719|NCT01584427|Blood pressure|blood pressure
5430720|NCT01584414|Zetiq CellDetect ® stain|zetiq celldetect ® stain
5430721|NCT01584414|distinct red/purple color to the cytoplasm of neoplastic|distinct red/purple color to the cytoplasm of neoplastic
5430722|NCT01584414|distinguishes green/blue stained non-neoplastic cells and tissues|distinguishes green/blue stained non-neoplastic cells and tissues
5430723|NCT01584401|Body temperature|body temperature
5430724|NCT01584401|Thermometers|thermometers
5430725|NCT01584401|Non invasive|non invasive
5430726|NCT01584401|Medisim's non invasive thermometers|medisim's non invasive thermometers
5430727|NCT01584388|Type 1 autoimmune pancreatitis|type 1 autoimmune pancreatitis
5430728|NCT01584388|IgG4-related sclerosing cholangitis|igg4-related sclerosing cholangitis
5430729|NCT01584388|Chronic sclerosing sialadenitis|chronic sclerosing sialadenitis
5430730|NCT01584388|Lacrimal glands|lacrimal glands
5430731|NCT01584388|Orbital pseudotumor|orbital pseudotumor
5430732|NCT01584388|IgG4-related tubulointerstitial nephritis|igg4-related tubulointerstitial nephritis
5430733|NCT01584388|Lymphadenopathy|lymphadenopathy
5430734|NCT01584388|Pachymeningitis|pachymeningitis
5430735|NCT01584388|Aorta|aorta
5430736|NCT01584388|Peri-aortitis|peri-aortitis
5430737|NCT01584388|Retroperitoneal fibrosis|retroperitoneal fibrosis
5430738|NCT01584388|Riedel's thyroiditis|riedel's thyroiditis
5430739|NCT01584375|Intraventricular hemorrhage|intraventricular hemorrhage
5430740|NCT01584375|Preterm infant|preterm infant
5430741|NCT01584375|Midline head position|midline head position
5430742|NCT01584375|Lateral head Position|lateral head position
5430743|NCT01584362|Taenia solium|taenia solium
5430744|NCT01584362|neurocysticercosis|neurocysticercosis
5430745|NCT01584362|oxfendazole|oxfendazole
5430746|NCT01584362|clinical trial, phase 1|clinical trial, phase 1
5430747|NCT01584362|safety|safety
5430748|NCT01584362|pharmacokinetics|pharmacokinetics
5430749|NCT01584336|Gastric cancer, laparoscopy-assisted total gastrectomy|gastric cancer, laparoscopy-assisted total gastrectomy
5430750|NCT01584323|Preterm premature rupture of membranes|preterm premature rupture of membranes
5430751|NCT01584323|pomgranate|pomgranate
5430752|NCT01584323|oxidative stress|oxidative stress
5430753|NCT01584323|pregnant women with Preterm premature rupture of membranes|pregnant women with preterm premature rupture of membranes
5430754|NCT01584310|Nutritional assessment|nutritional assessment
5430755|NCT01584310|children|children
5430756|NCT01584310|malnutrition|malnutrition
5430757|NCT01584297|Granulosa Cell Tumour|granulosa cell tumour
5430759|NCT01584284|Genelux Corporation|genelux corporation
5430760|NCT01584284|GL-ONC1|gl-onc1
5430761|NCT01584284|Vaccinia|vaccinia
5430762|NCT01584284|Vaccinia Virus|vaccinia virus
5430763|NCT01584284|Oncolytic virus|oncolytic virus
5430764|NCT01584284|Oncolytic Virotherapy|oncolytic virotherapy
5430765|NCT01584284|Head and Neck Cancer|head and neck cancer
5430766|NCT01584284|Squamous Cell Carcinoma|squamous cell carcinoma
5430767|NCT01584271|AOE|aoe
5430768|NCT01584271|Ear Comfort|ear comfort
5430769|NCT01584271|Dex Otic|dex otic
5430770|NCT01584271|Otidin|otidin
5430771|NCT01584258|Prostate cancer|prostate cancer
5430772|NCT01584258|Prostate adenocarcinoma|prostate adenocarcinoma
5430773|NCT01584258|Early stage prostate cancer|early stage prostate cancer
5430774|NCT01584258|Organ-confined prostate cancer|organ-confined prostate cancer
5430775|NCT01584258|Low-risk prostate cancer|low-risk prostate cancer
5430776|NCT01584258|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
5430777|NCT01584232|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5430778|NCT01584206|Sitosterolemia|sitosterolemia
5430779|NCT01584206|Ezetimibe|ezetimibe
5430780|NCT01584206|Plant sterol|plant sterol
5430781|NCT01584206|Cholesterol|cholesterol
5430782|NCT01584193|central venous access port|central venous access port
5430783|NCT01584193|ultrasound-guided venous puncture|ultrasound-guided venous puncture
5430784|NCT01584193|suclavian vein|suclavian vein
5430785|NCT01584193|cephalic vein|cephalic vein
5430786|NCT01584180|hypothermia|hypothermia
5430787|NCT01584180|induction of hypothermia|induction of hypothermia
5430788|NCT01584180|cold infusion|cold infusion
5430789|NCT01584180|local neck cooling|local neck cooling
5430790|NCT01584180|external cooling|external cooling
5430791|NCT01584180|surface cooling|surface cooling
5430792|NCT01584180|non invasive cooling|non invasive cooling
5430793|NCT01584180|stroke|stroke
5430794|NCT01584180|intracranial hemorrhage|intracranial hemorrhage
5430795|NCT01584180|cerebrovascular disease|cerebrovascular disease
5430796|NCT01584180|neuro intensive care|neuro intensive care
5430797|NCT01584167|hypothermia|hypothermia
5430798|NCT01584167|induction of hypothermia|induction of hypothermia
5430799|NCT01584167|cold infusion|cold infusion
5430800|NCT01584167|whole-body cooling|whole-body cooling
5430801|NCT01584167|external cooling|external cooling
5430802|NCT01584167|surface cooling|surface cooling
5430803|NCT01584167|non invasive cooling|non invasive cooling
5430804|NCT01584167|stroke|stroke
5430805|NCT01584167|intracranial hemorrhage|intracranial hemorrhage
5430806|NCT01584167|cerebrovascular disease|cerebrovascular disease
5430807|NCT01584167|neuro intensive care|neuro intensive care
5430808|NCT01584141|Leukemia|leukemia
5430809|NCT01584141|Lymphoma|lymphoma
5430810|NCT01584141|Occupational Epidemiology|occupational epidemiology
5430811|NCT01584141|Molecular Epidemiology|molecular epidemiology
5430812|NCT01584141|Genetic Polymorphisms|genetic polymorphisms
5430813|NCT01584115|Cancer.|cancer.
5430814|NCT01584115|Melanoma.|melanoma.
5430815|NCT01584115|Ovarian cancer.|ovarian cancer.
5430816|NCT01584115|Lung cancer.|lung cancer.
5430817|NCT01584115|NY-ESO-1.|ny-eso-1.
5430821|NCT01584102|Randomized controlled trial|randomized controlled trial
5430823|NCT01584102|community-based participatory research|community-based participatory research
5430824|NCT01584102|minority health|minority health
5430825|NCT01584102|rural health|rural health
5430826|NCT01584102|health promotion|health promotion
5430827|NCT01584076|Amblyopia|amblyopia
5430828|NCT01584076|Donepezil|donepezil
5430829|NCT01584063|Mexican Americans|mexican americans
5430830|NCT01584063|Pregnancy|pregnancy
5430831|NCT01584063|Diabetes Mellitus Type 2|diabetes mellitus type 2
5430832|NCT01584063|Prevention|prevention
5430833|NCT01584063|Community health workers|community health workers
5430834|NCT01584063|Community based participatory research|community based participatory research
5430835|NCT01584063|Behavioral Intervention|behavioral intervention
5430836|NCT01584063|Lifestyle Intervention|lifestyle intervention
5430837|NCT01584037|Adenovirus|adenovirus
5430838|NCT01584037|Adenovirus Type 4|adenovirus type 4
5430839|NCT01584037|Adenovirus Type 7|adenovirus type 7
5430840|NCT01584037|Adenovirus Type 4 and Type 7 Vaccine, Live, Oral|adenovirus type 4 and type 7 vaccine, live, oral
5430841|NCT01584024|Dental caries|dental caries
5430842|NCT01584024|Proximal surfaces|proximal surfaces
5430843|NCT01584024|Posterior teeth|posterior teeth
5430844|NCT01584024|Carious lesions|carious lesions
5430845|NCT01584024|Tooth diseases|tooth diseases
5430846|NCT01584024|Preventive therapy|preventive therapy
5430847|NCT01584011|Taste|taste
5430848|NCT01584011|Chorda tympani nerve|chorda tympani nerve
5430849|NCT01583998|Major Depressive Disorder|major depressive disorder
5430850|NCT01583998|MDD|mdd
5430851|NCT01583998|Depression|depression
5430852|NCT01583998|Measurement Based Care|measurement based care
5430853|NCT01583998|MBC|mbc
5430854|NCT01583998|electronic health records|electronic health records
5430855|NCT01583998|EHR|ehr
5430857|NCT01583998|EMR|emr
5430858|NCT01583985|opioid analgesics|opioid analgesics
5430859|NCT01583985|chronic pain|chronic pain
5430860|NCT01583985|musculoskeletal pain|musculoskeletal pain
5430861|NCT01583972|Vitamin A deficiency|vitamin a deficiency
5430862|NCT01583972|Vitamin A|vitamin a
5430863|NCT01583972|retinyl palmitate|retinyl palmitate
5430864|NCT01583972|malnutrition|malnutrition
5430865|NCT01583972|vaccine|vaccine
5430866|NCT01583972|vaccination|vaccination
5430867|NCT01583972|BCG|bcg
5430868|NCT01583972|tuberculosis|tuberculosis
5430869|NCT01583972|polio virus|polio virus
5430870|NCT01583972|tetanus toxoid|tetanus toxoid
5430871|NCT01583972|hepatitis B virus|hepatitis b virus
5430872|NCT01583972|thymus|thymus
5430873|NCT01583972|T lymphocyte|t lymphocyte
5430874|NCT01583972|B lymphocyte|b lymphocyte
5430875|NCT01583972|antibody|antibody
5430876|NCT01583972|bacterial translocation|bacterial translocation
5430877|NCT01583972|T-cell receptor excision circle|t-cell receptor excision circle
5430878|NCT01583959|rheumatoid arthritis|rheumatoid arthritis
5430879|NCT01583959|folic acid|folic acid
5430880|NCT01583959|methotrexate|methotrexate
5430881|NCT01583946|subjective well-being|subjective well-being
5430882|NCT01583946|life transitions|life transitions
5430883|NCT01583946|health-related quality of life|health-related quality of life
5430884|NCT01583946|health|health
5430885|NCT01583946|healthcare costs|healthcare costs
5430886|NCT01583933|Dental stability|dental stability
5430887|NCT01583933|Occlusal stability|occlusal stability
5430888|NCT01583933|Retainers|retainers
5430889|NCT01583920|prostatic neoplasms|prostatic neoplasms
5430890|NCT01583920|brachytherapy|brachytherapy
5430891|NCT01583920|salvage therapy|salvage therapy
5430892|NCT01583920|recurrent prostate cancer|recurrent prostate cancer
5430893|NCT01583907|cow's milk allergy|cow's milk allergy
5430894|NCT01583881|Patients with diastolic heart failure and hypertension|patients with diastolic heart failure and hypertension
5430895|NCT01583855|Remote catheter ablation|remote catheter ablation
5430896|NCT01583855|Atrial fibrillation|atrial fibrillation
5430897|NCT01583842|neuroblastoma|neuroblastoma
5430898|NCT01583842|imaging|imaging
5430899|NCT01583842|124I-MIBG|124i-mibg
5430900|NCT01583842|131I-MIBG|131i-mibg
5430901|NCT01583842|PET/CT|pet/ct
5430902|NCT01583829|ADHD|adhd
5430903|NCT01583829|neurofeedback|neurofeedback
5430904|NCT01583829|biofeedback|biofeedback
5430905|NCT01583829|computer attention training|computer attention training
5430906|NCT01583816|Actinic Keratosis|actinic keratosis
5430907|NCT01583816|Resiquimod|resiquimod
5430908|NCT01583790|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5430909|NCT01583790|Bariatric surgery|bariatric surgery
5430910|NCT01583790|Morbid Obesity|morbid obesity
5430911|NCT01583777|Belinostat|belinostat
5430912|NCT01583751|pilonidal sinus|pilonidal sinus
5430913|NCT01583751|new technique|new technique
5430914|NCT01583751|videoendoscopic|videoendoscopic
5430915|NCT01583725|Obesity|obesity
5430916|NCT01583725|Bariatric surgery|bariatric surgery
5430917|NCT01583725|Weight loss|weight loss
5430918|NCT01583725|fMRI|fmri
5430919|NCT01583725|gut peptides|gut peptides
5430920|NCT01583712|Confocal laser endomicroscopy|confocal laser endomicroscopy
5430921|NCT01583712|Small bowel imaging|small bowel imaging
5430922|NCT01583712|Graft-versus-host disease|graft-versus-host disease
5430923|NCT01583712|HSCT|hsct
5430924|NCT01583699|MALT-lymphoma|malt-lymphoma
5430925|NCT01583699|Confocal laser endomicroscopy|confocal laser endomicroscopy
5430926|NCT01583699|Gastrointestinal endoscopy|gastrointestinal endoscopy
5430927|NCT01583686|Metastatic Cancer|metastatic cancer
5430928|NCT01583686|Immunotherapy|immunotherapy
5430929|NCT01583686|Gene Therapy|gene therapy
5430930|NCT01583686|Mesothelioma|mesothelioma
5430931|NCT01583686|Pancreatic Cancer|pancreatic cancer
5430932|NCT01583660|NSAIDs|nsaids
5430933|NCT01583660|Anti-inflammatory|anti-inflammatory
5430934|NCT01583660|elderly hip fracture|elderly hip fracture
5430935|NCT01583660|mortality|mortality
5430936|NCT01583608|Drug eluting stent|drug eluting stent
5430937|NCT01583608|Bioabsorbable|bioabsorbable
5430938|NCT01583608|Bioresorbable|bioresorbable
5430939|NCT01583608|Coronary Stent|coronary stent
5430940|NCT01583608|Scaffold|scaffold
5430941|NCT01583608|Stents|stents
5430942|NCT01583608|Angioplasty|angioplasty
5430943|NCT01583608|Coronary Artery Disease|coronary artery disease
5430944|NCT01583608|Stentthrombosis|stentthrombosis
5430945|NCT01583595|Chronic Lung Disease|chronic lung disease
5430946|NCT01583595|Exercise|exercise
5430947|NCT01583595|Self-efficacy|self-efficacy
5430948|NCT01583582|randomized double-blind placebo-controlled study|randomized double-blind placebo-controlled study
5430949|NCT01583582|peptide concentrate|peptide concentrate
5430950|NCT01583582|Coldwater Shrimp|coldwater shrimp
5430951|NCT01583582|antihypertensive effect|antihypertensive effect
5430952|NCT01583582|mild hypertension|mild hypertension
5430953|NCT01583582|moderate hypertension|moderate hypertension
5430954|NCT01583582|blood pressure|blood pressure
5430955|NCT01583569|Complex Dynamic Systems|complex dynamic systems
5430957|NCT01583569|Mood Disorders|mood disorders
5430958|NCT01583556|Adult|adult
5430959|NCT01583556|English speaking|english speaking
5430960|NCT01583556|Fractures|fractures
5430961|NCT01583556|Excellent prognosis|excellent prognosis
5430962|NCT01583556|Upper Extremity|upper extremity
5430963|NCT01583543|Recurrent|recurrent
5430964|NCT01583543|Metastatic|metastatic
5430965|NCT01583530|Belimumab|belimumab
5430966|NCT01583530|Injections, Subcutaneous|injections, subcutaneous
5430967|NCT01583530|Drug Administration Routes|drug administration routes
5430968|NCT01583530|Injections|injections
5430969|NCT01583530|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5430970|NCT01583530|Lupus|lupus
5430971|NCT01583530|SLE|sle
5430972|NCT01583530|Systemic Lupus Erythematosus|systemic lupus erythematosus
5430973|NCT01583530|Antibodies|antibodies
5430974|NCT01583530|Autoimmune Disease|autoimmune disease
5430975|NCT01583530|Biological Therapy|biological therapy
5430976|NCT01583530|Immune System Diseases|immune system diseases
5430977|NCT01583530|Pharmacokinetics|pharmacokinetics
5430978|NCT01583530|Biological Availability|biological availability
5430979|NCT01583517|Acute pancreatitis|acute pancreatitis
5430980|NCT01583517|ERCP|ercp
5430981|NCT01583517|Sphincterotomy|sphincterotomy
5430982|NCT01583517|Manometry|manometry
5430983|NCT01583517|Sphincter of Oddi dysfunction|sphincter of oddi dysfunction
5430984|NCT01583504|Achilles|achilles
5430985|NCT01583504|Tendinopathy|tendinopathy
5430986|NCT01583504|Tendonitis|tendonitis
5430987|NCT01583504|Injection|injection
5430988|NCT01583491|platelet rich fibrin|platelet rich fibrin
5430989|NCT01583491|mandibular third molar|mandibular third molar
5430990|NCT01583491|periodontal problem|periodontal problem
5430991|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina
5430992|NCT01583478|wrinkles|wrinkles
5430993|NCT01583478|glabellar|glabellar
5430994|NCT01583478|rhytids|rhytids
5430995|NCT01583478|frown|frown
5430996|NCT01583478|lines|lines
5430997|NCT01583465|randomized controlled trial|randomized controlled trial
5430998|NCT01583465|Blood loss, surgical|blood loss, surgical
5430999|NCT01583465|Blood loss, postoperative|blood loss, postoperative
5431000|NCT01583465|Wound healing|wound healing
5431001|NCT01583452|Post operative ileus|post operative ileus
5431002|NCT01583452|Gastrointestinal surgery|gastrointestinal surgery
5431003|NCT01583452|Chewing gum|chewing gum
5431004|NCT01583439|HIV Infections|hiv infections
5431005|NCT01583439|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5431006|NCT01583439|Anti-HIV Agents|anti-hiv agents
5431007|NCT01583439|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5431008|NCT01583439|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5431009|NCT01583439|Immune System Diseases|immune system diseases
5431010|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents
5431011|NCT01583439|Antiviral Agents|antiviral agents
5431012|NCT01583426|GeparSepto|geparsepto
5431019|NCT01583426|Mucinous breast cancer stage II|mucinous breast cancer stage ii
5431020|NCT01583426|Invasive ductal breast cancer|invasive ductal breast cancer
5431021|NCT01583426|Tubular breast cancer stage III|tubular breast cancer stage iii
5431022|NCT01583426|HER-2 positive breast cancer|her-2 positive breast cancer
5431023|NCT01583426|Inflammatory breast cancer|inflammatory breast cancer
5431024|NCT01583413|Ventilator-associated pneumonia|ventilator-associated pneumonia
5431025|NCT01583400|Depressive Disorder, Major|depressive disorder, major
5431026|NCT01583400|Depressive Disorder, Minor|depressive disorder, minor
5431027|NCT01583400|Dysthymic Disorder|dysthymic disorder
5431029|NCT01583387|urinary adducts|urinary adducts
5431030|NCT01583387|water intake|water intake
5431031|NCT01583374|spondylitis|spondylitis
5431032|NCT01583374|spondyloarthritis|spondyloarthritis
5431033|NCT01583374|Spondyloarthropathy|spondyloarthropathy
5431034|NCT01583374|Oral preparation|oral preparation
5431035|NCT01583361|two arms|two arms
5431036|NCT01583361|D2 lymphadenectomy|d2 lymphadenectomy
5431037|NCT01583361|chemotherapy before and after surgery|chemotherapy before and after surgery
5431038|NCT01583361|disease free survival|disease free survival
5431039|NCT01583348|transvaginal|transvaginal
5431040|NCT01583348|NOTES|notes
5431041|NCT01583348|cholecystectomy|cholecystectomy
5431042|NCT01583348|cholangiography|cholangiography
5431043|NCT01583348|symptomatic gallstone disease|symptomatic gallstone disease
5431044|NCT01583335|Overweight|overweight
5431045|NCT01583335|Obesity|obesity
5431046|NCT01583335|Susceptibility|susceptibility
5431047|NCT01583335|Prevention|prevention
5431048|NCT01583335|Diet|diet
5431049|NCT01583335|Physical activity|physical activity
5431050|NCT01583335|Sleep|sleep
5431051|NCT01583335|Family stress|family stress
5431052|NCT01583322|ovarian cancer|ovarian cancer
5431053|NCT01583322|debulking surgery|debulking surgery
5431054|NCT01583322|interval debulking|interval debulking
5431055|NCT01583322|vargatef|vargatef
5431056|NCT01583322|nintedanib|nintedanib
5431057|NCT01583322|maintenance|maintenance
5431058|NCT01583322|first line|first line
5431059|NCT01583322|paclitaxel|paclitaxel
5431060|NCT01583322|carboplatin|carboplatin
5431061|NCT01583309|blood pressure|blood pressure
5431062|NCT01583309|cardiovascular instability|cardiovascular instability
5431063|NCT01583309|symptomatic hypotension|symptomatic hypotension
5431064|NCT01583309|online hemofiltration|online hemofiltration
5431065|NCT01583309|online hemodiafiltration|online hemodiafiltration
5431073|NCT01583270|Arabinxylan|arabinxylan
5431074|NCT01583270|Rye kernels|rye kernels
5431075|NCT01583270|whole grain|whole grain
5431076|NCT01583270|Dietary fibre|dietary fibre
5431077|NCT01583270|Metabolic syndrome|metabolic syndrome
5431078|NCT01583270|Glycemic response|glycemic response
5431079|NCT01583270|Colon fermentation|colon fermentation
5431080|NCT01583270|Second meal effekt|second meal effekt
5431081|NCT01583270|Satiety|satiety
5431082|NCT01583218|Phase III|phase iii
5431083|NCT01583205|ALS|als
5431084|NCT01583205|Coping Effectiveness Training|coping effectiveness training
5431085|NCT01583205|Distress|distress
5431086|NCT01583205|Care Giver|care giver
5431087|NCT01583192|infection|infection
5431088|NCT01583192|skin preparation|skin preparation
5431089|NCT01583192|fore-foot surgery|fore-foot surgery
5431090|NCT01583192|chloride-hexidine|chloride-hexidine
5431091|NCT01583192|povidine-jodine|povidine-jodine
5431092|NCT01583192|alcohol|alcohol
5431093|NCT01583179|nerve block|nerve block
5431094|NCT01583179|outpatient surgery|outpatient surgery
5431095|NCT01583140|physical activity|physical activity
5431096|NCT01583140|Latinas|latinas
5431097|NCT01583127|Problem Behavior|problem behavior
5431098|NCT01583114|dilated cardiomyopathy|dilated cardiomyopathy
5431099|NCT01583114|heart failure|heart failure
5431100|NCT01583114|genetics|genetics
5431101|NCT01583114|mutation carrier|mutation carrier
5431102|NCT01583114|ACE treatment|ace treatment
5431103|NCT01583114|preclinical|preclinical
5431104|NCT01583088|Amyotrophic lateral sclerosis,|amyotrophic lateral sclerosis,
5431105|NCT01583088|Diaphragm|diaphragm
5431106|NCT01583088|Mechanical ventilation|mechanical ventilation
5431107|NCT01583088|Phrenic nerve stimulation|phrenic nerve stimulation
5431108|NCT01583088|Respiratory insufficiency|respiratory insufficiency
5431109|NCT01583062|Surgical Wound Infection|surgical wound infection
5431110|NCT01583062|Facial Injuries|facial injuries
5431111|NCT01583062|Orbital Fractures|orbital fractures
5431112|NCT01583062|Zygomatic Fractures|zygomatic fractures
5431113|NCT01583062|Mandibular Fractures|mandibular fractures
5431114|NCT01583062|Jaw Injuries|jaw injuries
5431115|NCT01583023|bipolar disorder|bipolar disorder
5431116|NCT01583023|repetitive transcranial magnetic stimulation (rtms)|repetitive transcranial magnetic stimulation (rtms)
5431117|NCT01583023|bupropion|bupropion
5431118|NCT01583023|lithium a/o Epival|lithium a/o epival
5431119|NCT01583010|ultrasound guided regional anaesthesia needle visualization|ultrasound guided regional anaesthesia needle visualization
5418132|NCT01640314|Adults|adults
5431121|NCT01582997|Advance solid tumors|advance solid tumors
5431122|NCT01582984|consent|consent
5431123|NCT01582984|Patient Understanding|patient understanding
5431124|NCT01582984|Knee Arthroplasty|knee arthroplasty
5431125|NCT01582971|Breast Cancer|breast cancer
5431126|NCT01582971|Reflexology|reflexology
5431127|NCT01582971|Complementary|complementary
5431128|NCT01582958|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5431129|NCT01582958|Pulmonary Function Tests|pulmonary function tests
5431130|NCT01582958|Biochemical Alterations|biochemical alterations
5431131|NCT01582945|Treatment resistant|treatment resistant
5431132|NCT01582945|suicidal ideation|suicidal ideation
5431133|NCT01582945|major depressive disorder|major depressive disorder
5431134|NCT01582932|plaque psoriasis|plaque psoriasis
5431135|NCT01582932|pediatric|pediatric
5431136|NCT01582932|mild|mild
5431137|NCT01582932|moderate|moderate
5431138|NCT01582919|dementia|dementia
5431139|NCT01582919|Alzheimer's Disease|alzheimer's disease
5431140|NCT01582919|diagnostic|diagnostic
5431141|NCT01582919|biomarkers|biomarkers
5431142|NCT01582919|neuroimaging|neuroimaging
5431143|NCT01582919|PET|pet
5431144|NCT01582919|MRI|mri
5431145|NCT01582919|mild cognitive impairment|mild cognitive impairment
5431146|NCT01582893|inflammation|inflammation
5431147|NCT01582893|dialysis|dialysis
5431148|NCT01582880|Keratoprosthesis|keratoprosthesis
5431149|NCT01582880|sterile cornea ulcer|sterile cornea ulcer
5431150|NCT01582867|Hemodiafiltration|hemodiafiltration
5431151|NCT01582867|Hemodialysis|hemodialysis
5431152|NCT01582867|Sodium|sodium
5431153|NCT01582867|Artis|artis
5431154|NCT01582867|renal failure|renal failure
5431562|NCT01581021|randomized|randomized
5431155|NCT01582854|Post-Stroke Cognitive Impairment (PSCI)|post-stroke cognitive impairment (psci)
5431156|NCT01582854|Stroke|stroke
5431157|NCT01582854|Actovegin|actovegin
5431158|NCT01582854|Cognition disorders|cognition disorders
5431159|NCT01582841|Colon Cancer|colon cancer
5431160|NCT01582841|Lynch Syndrome|lynch syndrome
5431161|NCT01582841|Genetic Screening|genetic screening
5431162|NCT01582828|atrial|atrial
5431163|NCT01582828|fibrillation|fibrillation
5431165|NCT01582828|vats|vats
5431166|NCT01582828|ablation|ablation
5431167|NCT01582828|hybrid|hybrid
5431168|NCT01582815|Major Depressive Disorder|major depressive disorder
5431169|NCT01582815|Depression|depression
5431170|NCT01582815|Anxiety symptoms|anxiety symptoms
5431172|NCT01582763|Guillain-Barré syndrome|guillain-barré syndrome
5431173|NCT01582763|Polyneuropathy|polyneuropathy
5431174|NCT01582763|Autoimmune Diseases|autoimmune diseases
5431175|NCT01582763|Immune System Diseases|immune system diseases
5431176|NCT01582763|Neuromuscular Diseases|neuromuscular diseases
5431177|NCT01582763|Outcome|outcome
5431178|NCT01582763|Quality of life|quality of life
5431179|NCT01582763|Disability|disability
5431180|NCT01582763|Prognostic Determinants|prognostic determinants
5431181|NCT01582763|Treatment|treatment
5431182|NCT01582763|Immunoglobulins|immunoglobulins
5431183|NCT01582763|Prognosis|prognosis
5431184|NCT01582763|Infections|infections
5431185|NCT01582763|Anti-ganglioside antibodies|anti-ganglioside antibodies
5431186|NCT01582763|Genetic polymorphisms|genetic polymorphisms
5431187|NCT01582763|Electrophysiology|electrophysiology
5431188|NCT01582763|Cerebrospinal Fluid|cerebrospinal fluid
5431189|NCT01582763|Serum|serum
5431190|NCT01582750|endoscopic ultrasound|endoscopic ultrasound
5431191|NCT01582750|pre-operative concurrent chemoradiotherapy|pre-operative concurrent chemoradiotherapy
5431192|NCT01582737|Xarelto|xarelto
5431193|NCT01582737|SPAF|spaf
5431194|NCT01582724|Menstrual pain|menstrual pain
5431195|NCT01582724|Primary dysmenorrhea|primary dysmenorrhea
5431196|NCT01582724|Self-care acupressure|self-care acupressure
5431197|NCT01582711|LTBI|ltbi
5431198|NCT01582711|LTB|ltb
5431199|NCT01582711|Latent TB|latent tb
5431200|NCT01582711|TB infection|tb infection
5431201|NCT01582685|Breast Cancer|breast cancer
5431202|NCT01582685|Obesity|obesity
5431203|NCT01582685|Exercise|exercise
5431204|NCT01582685|Angiogenesis|angiogenesis
5431205|NCT01582672|RCC|rcc
5431206|NCT01582672|Kidney Cancer|kidney cancer
5431207|NCT01582659|constipation|constipation
5431208|NCT01582659|children|children
5431209|NCT01582659|outpatient|outpatient
5431210|NCT01582633|vaccine|vaccine
5431211|NCT01582633|influenza|influenza
5431212|NCT01582633|needle free jet injector|needle free jet injector
5431213|NCT01582633|Intradermal|intradermal
5431214|NCT01582633|sparing dose|sparing dose
5431215|NCT01582620|Cerebrovascular disorders|cerebrovascular disorders
5431223|NCT01582594|1000 residual serum/plasma samples|1000 residual serum/plasma samples
5431224|NCT01582594|anti-HCV seronegative or seropositive|anti-hcv seronegative or seropositive
5431226|NCT01582581|depression|depression
5431227|NCT01582581|behavioral health|behavioral health
5431228|NCT01582581|cognitive behavioral therapy|cognitive behavioral therapy
5431229|NCT01582581|CBT|cbt
5671222|NCT00616603|Total Knee Arthroplasty.|total knee arthroplasty.
5431230|NCT01582581|computer-assisted psychotherapy|computer-assisted psychotherapy
5431231|NCT01582555|mucolysis|mucolysis
5431233|NCT01582555|endoscopy|endoscopy
5431234|NCT01582555|sinus surgery|sinus surgery
5431235|NCT01582529|Developmental Outcomes|developmental outcomes
5431236|NCT01582529|Psychosocial Outcomes|psychosocial outcomes
5431237|NCT01582529|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5431238|NCT01582529|Congenital Heart Disease|congenital heart disease
5431239|NCT01582516|brain tumor|brain tumor
5431240|NCT01582516|virotherapy|virotherapy
5431241|NCT01582516|glioblastoma|glioblastoma
5431242|NCT01582516|replication competent adenovirus|replication competent adenovirus
5431243|NCT01582490|Mammoplasty|mammoplasty
5431244|NCT01582490|Postoperative pain|postoperative pain
5431245|NCT01582490|Analgesia|analgesia
5431246|NCT01582477|TAP, robot-assisted prostatectomy|tap, robot-assisted prostatectomy
5431247|NCT01582464|Protective Headwear|protective headwear
5431248|NCT01582464|Social Marketing|social marketing
5431249|NCT01582464|Theory of Planned Behavior|theory of planned behavior
5431250|NCT01582425|isavuconazole|isavuconazole
5431251|NCT01582425|methadone|methadone
5431252|NCT01582425|Healthy Volunteers|healthy volunteers
5431253|NCT01582425|BAL8557|bal8557
5431254|NCT01582412|Isavuconazole|isavuconazole
5431255|NCT01582412|Digoxin|digoxin
5431256|NCT01582412|Healthy Volunteers|healthy volunteers
5431257|NCT01582412|BAL8557|bal8557
5431263|NCT01582399|ASKP1240|askp1240
5431264|NCT01582360|critical illness|critical illness
5431265|NCT01582360|pharmacokinetics|pharmacokinetics
5431266|NCT01582360|CRRT|crrt
5431267|NCT01582360|CVVH|cvvh
5431268|NCT01582360|CVVHD|cvvhd
5431269|NCT01582360|CVVHDF|cvvhdf
5431270|NCT01582360|antiinfectives|antiinfectives
5431271|NCT01582360|antibiotics|antibiotics
5431272|NCT01582360|minimum inhibitory concentration|minimum inhibitory concentration
5431273|NCT01582360|bacterial killing|bacterial killing
5431274|NCT01582360|pharmacodynamics|pharmacodynamics
5431275|NCT01582360|PK/PD index|pk/pd index
5431276|NCT01582347|Opioid dependence|opioid dependence
5431277|NCT01582334|Growth disorders|growth disorders
5431278|NCT01582334|Saizen|saizen
5431279|NCT01582334|Easypod|easypod
5431280|NCT01582334|Growth hormone|growth hormone
5431281|NCT01582334|Pediatric subject|pediatric subject
5431282|NCT01582321|vascular ultrasound|vascular ultrasound
5431283|NCT01582321|flow cytometry|flow cytometry
5431284|NCT01582321|platelet aggregation|platelet aggregation
5431285|NCT01582295|Bone disease|bone disease
5431286|NCT01582282|Type II NIDDM|type ii niddm
5431287|NCT01582243|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5431288|NCT01582243|vildagliptin|vildagliptin
5431289|NCT01582230|Type 2 diabetes mellitus|type 2 diabetes mellitus
5431290|NCT01582230|Vildagliptin|vildagliptin
5431291|NCT01582217|Bleeding|bleeding
5431292|NCT01582217|Risk Score|risk score
5431293|NCT01582217|Outcomes|outcomes
5431294|NCT01582217|Prasugrel|prasugrel
5431295|NCT01582204|clear cell carcinoma|clear cell carcinoma
5431296|NCT01582204|Kidney|kidney
5431297|NCT01582204|MAB-124I-CG250|mab-124i-cg250
5431298|NCT01582204|PET scan|pet scan
5431299|NCT01582204|CT scan|ct scan
5431300|NCT01582204|sunitinib|sunitinib
5431301|NCT01582204|pazopanib|pazopanib
5431302|NCT01582204|11-134|11-134
5431303|NCT01582178|colonoscopy|colonoscopy
5431304|NCT01582178|warm water immersion|warm water immersion
5431305|NCT01582178|cool water immersion|cool water immersion
5431306|NCT01582152|Brain Neoplasms|brain neoplasms
5431307|NCT01582152|Central Nervous System Neoplasms|central nervous system neoplasms
5431308|NCT01582152|Recurrent Glioblastoma|recurrent glioblastoma
5431309|NCT01582152|Glioblastoma multiforme|glioblastoma multiforme
5431310|NCT01582152|GBM|gbm
5431311|NCT01582152|Gliosarcoma|gliosarcoma
5431312|NCT01582152|TPI287|tpi287
5431313|NCT01582152|Bevacizumab|bevacizumab
5431314|NCT01582152|Avastin|avastin
5431315|NCT01582152|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5431316|NCT01582152|rhuMAb-VEGF|rhumab-vegf
5431317|NCT01582139|Artificial Pancreas Project|artificial pancreas project
5431318|NCT01582139|AP Platform|ap platform
5431319|NCT01582139|Insulin Pump|insulin pump
5431320|NCT01582139|Continuous Glucose Monitor|continuous glucose monitor
5431321|NCT01582139|Closed-Loop Control|closed-loop control
5431322|NCT01582139|Control-to-Range|control-to-range
5431323|NCT01582126|multiple sclerosis|multiple sclerosis
5431324|NCT01582126|physical therapy|physical therapy
5431325|NCT01582126|postural control|postural control
5431326|NCT01582087|acute hepatic failure|acute hepatic failure
5431327|NCT01582087|chronic hepatic failure|chronic hepatic failure
5431328|NCT01582087|coma|coma
5431334|NCT01582061|Cushing's disease|cushing's disease
5431335|NCT01582061|Hormone disorder|hormone disorder
5431336|NCT01582061|Cortisol|cortisol
5431337|NCT01582061|Adrenocorticotropic hormone|adrenocorticotropic hormone
5431338|NCT01582061|Pituitary tumor|pituitary tumor
5431339|NCT01582061|SOM230|som230
5431340|NCT01582061|adult|adult
5431341|NCT01582035|Hepatitis C|hepatitis c
5431342|NCT01582035|TMC647055HPC1005|tmc647055hpc1005
5431343|NCT01582035|TMC647055|tmc647055
5431344|NCT01582035|telaprevir|telaprevir
5431345|NCT01581996|Chronic renal failure|chronic renal failure
5431346|NCT01581996|End-stage renal disease|end-stage renal disease
5431347|NCT01581996|Chronic peritoneal dialysis|chronic peritoneal dialysis
5431348|NCT01581996|Serum phosphorus|serum phosphorus
5431349|NCT01581996|Hyperphosphatemia|hyperphosphatemia
5431350|NCT01581996|Phosphate binders|phosphate binders
5431351|NCT01581996|Phosphate|phosphate
5431352|NCT01581970|head and neck cancer|head and neck cancer
5431353|NCT01581970|metastatic squamous cell cancer|metastatic squamous cell cancer
5431354|NCT01581957|Enteral nutrition, critically ill patients|enteral nutrition, critically ill patients
5431355|NCT01581944|myomectomy|myomectomy
5431356|NCT01581944|GnRH|gnrh
5431357|NCT01581944|blood loss|blood loss
5431358|NCT01581905|Hysterectomy|hysterectomy
5431359|NCT01581905|Laparoscopy|laparoscopy
5431360|NCT01581905|Robotics|robotics
5431361|NCT01581892|bone nonunion|bone nonunion
5431362|NCT01581892|bone marrow|bone marrow
5431363|NCT01581892|mononuclear|mononuclear
5431364|NCT01581892|fracture|fracture
5431365|NCT01581879|Bioequivalence|bioequivalence
5431366|NCT01581879|Ziprasidone hydrochloride|ziprasidone hydrochloride
5431367|NCT01581879|crossover|crossover
5431368|NCT01581866|Bioequivalence|bioequivalence
5431369|NCT01581866|Ziprasidone hydrochloride|ziprasidone hydrochloride
5431370|NCT01581866|crossover|crossover
5431371|NCT01581853|HIV|hiv
5431372|NCT01581853|AIDS|aids
5431373|NCT01581853|MONOTHERAPY|monotherapy
5431374|NCT01581853|PILOT|pilot
5431375|NCT01581853|LOPINAVIR/RITONAVIR|lopinavir/ritonavir
5431376|NCT01581840|anus|anus
5431377|NCT01581840|carcinoma|carcinoma
5431378|NCT01581840|panitumumab|panitumumab
5431379|NCT01581840|mitomycine|mitomycine
5431380|NCT01581840|5Fu|5fu
5431381|NCT01581840|radiotherapy|radiotherapy
5431382|NCT01581827|Heart Failure|heart failure
5431383|NCT01581827|BNP|bnp
5431384|NCT01581827|NT-proBNP|nt-probnp
5431385|NCT01581814|PCOS|pcos
5431386|NCT01581801|gastric bypass|gastric bypass
5431387|NCT01581801|sleeve gastrectomy|sleeve gastrectomy
5431388|NCT01581801|reactive hypoglycemia|reactive hypoglycemia
5431389|NCT01581788|Bioequivalence|bioequivalence
5431390|NCT01581788|Divalproex Sodium|divalproex sodium
5431391|NCT01581788|Crossover|crossover
5431392|NCT01581775|Bioequivalence|bioequivalence
5431393|NCT01581775|Divalproex Sodium|divalproex sodium
5431394|NCT01581775|Crossover|crossover
5431395|NCT01581762|EUS, FNA|eus, fna
5431396|NCT01581749|low risk prostate cancer|low risk prostate cancer
5431397|NCT01581749|intermediate risk prostate cancer|intermediate risk prostate cancer
5431398|NCT01581749|stereotactic radiosurgery|stereotactic radiosurgery
5431399|NCT01581736|insulin resistance|insulin resistance
5431400|NCT01581736|mitochondria|mitochondria
5431401|NCT01581723|urinary bladder tumor|urinary bladder tumor
5431402|NCT01581723|monopolar TURBT|monopolar turbt
5431403|NCT01581723|bipolar TURBT|bipolar turbt
5431404|NCT01581710|Leukotriene Antagonists|leukotriene antagonists
5431405|NCT01581710|Bronchodilator response|bronchodilator response
5431406|NCT01581697|oat|oat
5431407|NCT01581697|cholesterol|cholesterol
5431408|NCT01581697|children|children
5431409|NCT01581697|adolescent|adolescent
5431410|NCT01581697|Level reduction of ceric cholesterol|level reduction of ceric cholesterol
5431411|NCT01581645|Parkinson's disease|parkinson's disease
5431412|NCT01581645|Parkinsonism|parkinsonism
5431413|NCT01581645|Gait problems|gait problems
5431414|NCT01581645|Freezing gait|freezing gait
5431415|NCT01581632|atherosclerosis|atherosclerosis
5431416|NCT01581632|endothelial dysfunction|endothelial dysfunction
5431417|NCT01581632|coronary vasospasm|coronary vasospasm
5431418|NCT01581619|Early Invasive N0|early invasive n0
5431419|NCT01581619|Non-Invasive|non-invasive
5431420|NCT01581606|Age Related Macular Degeneration|age related macular degeneration
5431421|NCT01581606|Teleophthalmology|teleophthalmology
5431422|NCT01581606|Screening|screening
5431423|NCT01581606|Diagnosis|diagnosis
5431425|NCT01581606|Treatment|treatment
5431426|NCT01581593|Primary Immunodeficiency|primary immunodeficiency
5431427|NCT01581593|PID|pid
5431428|NCT01581593|Agammaglobulinemia|agammaglobulinemia
5431429|NCT01581593|Hypogammaglobulinemia|hypogammaglobulinemia
5431430|NCT01581593|Antibody deficiency|antibody deficiency
5431431|NCT01581580|Parkinson's Disease|parkinson's disease
5431432|NCT01581580|Deep Brain Stimulation|deep brain stimulation
5431433|NCT01581580|Neurophysiology|neurophysiology
5431434|NCT01581580|Movement Disorder|movement disorder
5431435|NCT01581580|Dystonia|dystonia
5431436|NCT01581580|Parkinson Disease|parkinson disease
5431437|NCT01581580|Essential Tremor|essential tremor
5431438|NCT01581554|Hepatitis B|hepatitis b
5431439|NCT01581554|Treatment|treatment
5431440|NCT01581554|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
5431441|NCT01581541|Targeted Therapy|targeted therapy
5431442|NCT01581541|Solid Tumors|solid tumors
5537972|NCT01135719|PRK|prk
5431443|NCT01581541|Lymphoma|lymphoma
5431444|NCT01581541|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5431445|NCT01581541|Solid Tumor|solid tumor
5431446|NCT01581528|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5431447|NCT01581528|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5431448|NCT01581528|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5431449|NCT01581528|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5431450|NCT01581502|Anticoagulation|anticoagulation
5431451|NCT01581502|Recurrent stroke|recurrent stroke
5431452|NCT01581502|Bleeding|bleeding
5431453|NCT01581489|Cord clamping|cord clamping
5431454|NCT01581489|iron deficiency|iron deficiency
5431455|NCT01581489|Neurodevelopment|neurodevelopment
5431456|NCT01581476|Adolescence|adolescence
5431457|NCT01581463|pharmacokinetics of oral T3|pharmacokinetics of oral t3
5431458|NCT01581450|Hyperalgesia and pain|hyperalgesia and pain
5431459|NCT01581437|atrial fibrillation|atrial fibrillation
5431460|NCT01581437|cardiac ablation|cardiac ablation
5431461|NCT01581424|Fabry disease|fabry disease
5431462|NCT01581424|kidney function|kidney function
5431463|NCT01581424|kidney structure morphometry|kidney structure morphometry
5431464|NCT01581424|Fabry kidney disease|fabry kidney disease
5431465|NCT01581424|Podocytes|podocytes
5431466|NCT01581411|central retinal vein occlusion|central retinal vein occlusion
5431467|NCT01581411|macular edema|macular edema
5431468|NCT01581411|vision loss|vision loss
5431469|NCT01581411|relative afferent papillary defect|relative afferent papillary defect
5431470|NCT01581398|Peginterferon|peginterferon
5431471|NCT01581398|Pegasys|pegasys
5431472|NCT01581398|Sustained virus response|sustained virus response
5431474|NCT01581385|atherosclerosis|atherosclerosis
5431475|NCT01581385|carotid artery|carotid artery
5431476|NCT01581385|carotid endarterectomy|carotid endarterectomy
5431477|NCT01581359|Endometriosis|endometriosis
5431478|NCT01581359|GnRH treatment|gnrh treatment
5431479|NCT01581359|Infertility|infertility
5431480|NCT01581359|IVF|ivf
5431481|NCT01581346|NSCLC|nsclc
5431482|NCT01581346|exercise intervention|exercise intervention
5431483|NCT01581346|quality of life|quality of life
5431484|NCT01581333|febrile neutropenia|febrile neutropenia
5431485|NCT01581333|antimicrobial treatment|antimicrobial treatment
5431486|NCT01581333|procalcitonin|procalcitonin
5431487|NCT01581307|liver|liver
5431488|NCT01581307|pancreas|pancreas
5431489|NCT01581307|chemotherapy|chemotherapy
5431490|NCT01581307|radiotherapy|radiotherapy
5431491|NCT01581294|Rheumatoid arthritis|rheumatoid arthritis
5431492|NCT01581294|Psoriatic arthritis|psoriatic arthritis
5431493|NCT01581294|Ankylosing spondylitis|ankylosing spondylitis
5431494|NCT01581294|Spondyloarthritis|spondyloarthritis
5431495|NCT01581281|Pediatric|pediatric
5431496|NCT01581281|Children|children
5431497|NCT01581281|Adolescent|adolescent
5431498|NCT01581281|Headache|headache
5431499|NCT01581281|Migraine|migraine
5431500|NCT01581255|acute respiratory distress syndrome|acute respiratory distress syndrome
5431501|NCT01581255|high frequency oscillation ventilation|high frequency oscillation ventilation
5431502|NCT01581255|ventilator-induced lung injury|ventilator-induced lung injury
5431503|NCT01581255|biomarkers|biomarkers
5431504|NCT01581242|Clevudine and Adefovir dipivoxil|clevudine and adefovir dipivoxil
5431505|NCT01581242|pharmacokinetic drug drug interaction|pharmacokinetic drug drug interaction
5431506|NCT01581242|oral administration|oral administration
5431507|NCT01581242|male subjects|male subjects
5431508|NCT01581229|ALI;noninvasive positive pressure ventilation|ali;noninvasive positive pressure ventilation
5431509|NCT01581216|Fatigue|fatigue
5431510|NCT01581216|Palliative Care|palliative care
5431511|NCT01581216|Exercise|exercise
5431512|NCT01581190|Bananas|bananas
5431513|NCT01581190|Exercise|exercise
5431514|NCT01581190|Metabolomics|metabolomics
5431515|NCT01581190|Oxidative stress|oxidative stress
5431516|NCT01581190|Inflammation|inflammation
5431517|NCT01581190|Immune function|immune function
5431518|NCT01581177|asthma|asthma
5431519|NCT01581177|mild-to-moderate persistent asthma|mild-to-moderate persistent asthma
5431520|NCT01581177|mild asthma|mild asthma
5431521|NCT01581177|moderate asthma|moderate asthma
5431522|NCT01581177|persistent asthma|persistent asthma
5431523|NCT01581164|blood|blood
5431524|NCT01581164|hematopoietic|hematopoietic
5431525|NCT01581164|stem|stem
5431526|NCT01581164|cell|cell
5431527|NCT01581164|transplant|transplant
5431528|NCT01581164|vaccine|vaccine
5431529|NCT01581164|vaccination|vaccination
5431530|NCT01581164|recovery|recovery
5431531|NCT01581164|immune|immune
5431532|NCT01581164|system|system
5431533|NCT01581151|retinal vein occlusion|retinal vein occlusion
5431534|NCT01581151|ozurdex|ozurdex
5431535|NCT01581151|lucentis|lucentis
5431536|NCT01581151|BCVA|bcva
5431537|NCT01581151|foveal thickness|foveal thickness
5431538|NCT01581125|Inpatients|inpatients
5431539|NCT01581125|Health Normalcy|health normalcy
5431540|NCT01581125|circadian rhythm|circadian rhythm
5431541|NCT01581099|Atherosclerosis|atherosclerosis
5431542|NCT01581099|Cardiovascular risk factors|cardiovascular risk factors
5431543|NCT01581099|Calorie restriction|calorie restriction
5431544|NCT01581099|Bariatric Surgery|bariatric surgery
5431545|NCT01581086|HIV|hiv
5431546|NCT01581086|COPD|copd
5431547|NCT01581086|Pulmonary disease|pulmonary disease
5431548|NCT01581073|renal anemia|renal anemia
5431549|NCT01581073|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5431550|NCT01581073|hemoglobin|hemoglobin
5431551|NCT01581073|non-diabetes|non-diabetes
5431552|NCT01581073|CKD|ckd
5431553|NCT01581073|Chronic Kidney Disease patients without diabetes|chronic kidney disease patients without diabetes
5431554|NCT01581047|amoxicillin|amoxicillin
5431555|NCT01581047|clavulanic acid|clavulanic acid
5431556|NCT01581047|cefuroxime|cefuroxime
5431557|NCT01581047|Patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime|patients in the intensive care unit, with an infection which requires amoxicillin/clavulanic acid or cefuroxime
5431558|NCT01581034|endothelial function|endothelial function
5431559|NCT01581034|biomarkers|biomarkers
5431560|NCT01581034|autonomic nervous system|autonomic nervous system
5431561|NCT01581034|coronary artery disease|coronary artery disease
5431563|NCT01581021|controlled|controlled
5431564|NCT01581021|hooks|hooks
5431565|NCT01581021|screws|screws
5431566|NCT01581008|palliative care|palliative care
5431567|NCT01581008|heart failure|heart failure
5431568|NCT01581008|delivery of health care|delivery of health care
5431569|NCT01580995|Chronic hepatitis C infection|chronic hepatitis c infection
5431570|NCT01580982|Oncogenes|oncogenes
5431571|NCT01580982|Lung and Other Thoracic Cancers|lung and other thoracic cancers
5431572|NCT01580969|glioma|glioma
5431573|NCT01580956|Acute respiratory failure|acute respiratory failure
5431574|NCT01580956|Critical illness|critical illness
5431575|NCT01580956|Mechanical ventilation|mechanical ventilation
5431576|NCT01580956|Ventilation weaning|ventilation weaning
5431577|NCT01580956|Intensive Care Unit|intensive care unit
5431578|NCT01580956|Variable (NOISY) PSV|variable (noisy) psv
5431579|NCT01580956|PSV|psv
5431580|NCT01580943|Chlorhexidine|chlorhexidine
5431581|NCT01580943|Cetyl pyridinium chloride|cetyl pyridinium chloride
5431582|NCT01580943|Mouth rinse|mouth rinse
5431583|NCT01580943|Antiplaque Efficacy|antiplaque efficacy
5431584|NCT01580943|Self Efficacy|self efficacy
5431585|NCT01580943|Taste Sweet|taste sweet
5431586|NCT01580943|Side Effects|side effects
5431587|NCT01580930|physical inactivity|physical inactivity
5431588|NCT01580930|exercise training|exercise training
5431589|NCT01580930|sedentary time|sedentary time
5431590|NCT01580930|habitual physical activity|habitual physical activity
5431591|NCT01580917|laser doppler anemometry|laser doppler anemometry
5431592|NCT01580917|dynamic testing of tissue mechanical property|dynamic testing of tissue mechanical property
5431593|NCT01580917|diabetic foot complications|diabetic foot complications
5431594|NCT01580917|ulcer genesis|ulcer genesis
5431595|NCT01580904|Pharmaceutical Care|pharmaceutical care
5431596|NCT01580904|Diabetics patients|diabetics patients
5431597|NCT01580904|Clinical trial|clinical trial
5431598|NCT01580891|Naftifine HCl Cream 1%|naftifine hcl cream 1%
5431599|NCT01580891|Naftin® (Naftifine HCl) Cream 1%|naftin® (naftifine hcl) cream 1%
5431600|NCT01580891|Tinea Pedis|tinea pedis
5431601|NCT01580891|Efficacy and safety|efficacy and safety
5431602|NCT01580878|Butenafine Hydrochloride Cream, 1%|butenafine hydrochloride cream, 1%
5431603|NCT01580878|Lotrimin Ultra® Cream, 1%|lotrimin ultra® cream, 1%
5431604|NCT01580878|Interdigital Tinea Pedis|interdigital tinea pedis
5431605|NCT01580878|Safety and Bioequivalence|safety and bioequivalence
5431606|NCT01580865|Lupus nephritis|lupus nephritis
5431607|NCT01580865|Tacrolimus|tacrolimus
5431608|NCT01580865|Mycophenolate mofetil|mycophenolate mofetil
5431609|NCT01580865|Complete remission|complete remission
5431610|NCT01580839|ischemic stroke|ischemic stroke
5431611|NCT01580839|ischemic penumbra|ischemic penumbra
5431612|NCT01580839|magnetic resonance imaging|magnetic resonance imaging
5431613|NCT01580839|MRI|mri
5431614|NCT01580839|diffusion imaging|diffusion imaging
5431615|NCT01580839|DWI|dwi
5431616|NCT01580839|perfusion imaging|perfusion imaging
5431617|NCT01580839|PWI|pwi
5431618|NCT01580839|thrombolysis|thrombolysis
5431619|NCT01580839|alteplase|alteplase
5431620|NCT01580839|tPA|tpa
5431621|NCT01580839|EPITHET|epithet
5431622|NCT01580826|pasteurization|pasteurization
5431623|NCT01580826|human milk|human milk
5431624|NCT01580826|very low birth weight infants|very low birth weight infants
5431625|NCT01580813|diabetes|diabetes
5431626|NCT01580813|exercise|exercise
5431627|NCT01580813|cardiovascular|cardiovascular
5431628|NCT01580813|heart|heart
5431629|NCT01580813|insulin sensitivity|insulin sensitivity
5431630|NCT01580787|Parkinson´s disease|parkinson´s disease
5431631|NCT01580787|Postural Balance|postural balance
5431632|NCT01580787|virtual reality|virtual reality
5431633|NCT01580735|NSCLC|nsclc
5431634|NCT01580735|c-MET|c-met
5431635|NCT01580735|EGFR mutation-positive|egfr mutation-positive
5431636|NCT01580735|gefitinib|gefitinib
5431637|NCT01580735|erlotinib|erlotinib
5431638|NCT01580735|EGFR-TKI resistance|egfr-tki resistance
5431639|NCT01580722|Anterior Cruciate Ligament,Early,Delay,Reconstruction|anterior cruciate ligament,early,delay,reconstruction
5431640|NCT01580709|stricture|stricture
5431641|NCT01580709|cholangiocarcinoma|cholangiocarcinoma
5431642|NCT01580709|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5431643|NCT01580709|bile duct|bile duct
5431645|NCT01580696|Folate binding protein|folate binding protein
5431646|NCT01580696|E39 vaccine|e39 vaccine
5431647|NCT01580696|Stage I-IV ovarian cancer|stage i-iv ovarian cancer
5431648|NCT01580696|Stage I-IV endometrial cancer|stage i-iv endometrial cancer
5431649|NCT01580683|Atrial Fibrillation|atrial fibrillation
5431650|NCT01580683|Ascorbic Acid|ascorbic acid
5431651|NCT01580683|Thoracic Surgery|thoracic surgery
5431652|NCT01580683|Cardiac Arrhythmias|cardiac arrhythmias
5431653|NCT01580683|Cardiac Surgery|cardiac surgery
5431654|NCT01580683|Vitamin C|vitamin c
5431655|NCT01580683|Postoperative Complications|postoperative complications
5431656|NCT01580683|Antioxidants|antioxidants
5431657|NCT01580683|Inflammation|inflammation
5431658|NCT01580670|Infliximab|infliximab
5431659|NCT01580670|REMICADE|remicade
5431660|NCT01580670|TA-650|ta-650
5431661|NCT01580670|pediatric Crohn's disease|pediatric crohn's disease
5431662|NCT01580657|HIV|hiv
5431663|NCT01580657|Prevention|prevention
5431664|NCT01580657|Methods|methods
5431665|NCT01580657|Assessment reactivity|assessment reactivity
5431666|NCT01580657|South Africa|south africa
5431667|NCT01580657|Youth|youth
5431668|NCT01580631|Narrow band imaging|narrow band imaging
5431669|NCT01580631|Barrett's esophagus|barrett's esophagus
5431670|NCT01580631|Gastroesophageal reflux disease|gastroesophageal reflux disease
5431671|NCT01580618|pleural effusion|pleural effusion
5431672|NCT01580618|malignancy|malignancy
5431673|NCT01580618|loculated|loculated
5431674|NCT01580579|Radiation pneumonitis|radiation pneumonitis
5431675|NCT01580579|locally advanced lung cancer|locally advanced lung cancer
5431676|NCT01580579|Respiratory function tests|respiratory function tests
5431677|NCT01580566|Myocardial Infarction (MI)|myocardial infarction (mi)
5431678|NCT01580566|Kidney function|kidney function
5431679|NCT01580566|bio-markers|bio-markers
5431680|NCT01580553|Heart failure|heart failure
5431681|NCT01580553|L-carnitine|l-carnitine
5431682|NCT01580553|injection|injection
5431683|NCT01580553|safety|safety
5431684|NCT01580553|efficacy|efficacy
5431685|NCT01580527|postoperative artificial nutrition|postoperative artificial nutrition
5431686|NCT01580527|parenteral nutrition|parenteral nutrition
5431687|NCT01580527|enteral nutrition|enteral nutrition
5431688|NCT01580527|postoperative complications|postoperative complications
5431689|NCT01580527|cephalic pancreatoduodenectomy|cephalic pancreatoduodenectomy
5431690|NCT01580514|myocardial infarction|myocardial infarction
5431691|NCT01580514|percutaneous coronary intervention|percutaneous coronary intervention
5431692|NCT01580514|exenatide|exenatide
5431693|NCT01580514|reperfusion injury|reperfusion injury
5863982|NCT00001147|Epinephrine|epinephrine
5431695|NCT01580475|glycemic control,|glycemic control,
5431696|NCT01580475|exercise training,|exercise training,
5431697|NCT01580475|detraining,|detraining,
5431698|NCT01580475|retraining,|retraining,
5431699|NCT01580475|body composition,|body composition,
5431700|NCT01580475|strength and fitness|strength and fitness
5431701|NCT01580462|continuous subcutaneous insulin infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5431702|NCT01580462|children|children
5431703|NCT01580462|adolescent|adolescent
5431704|NCT01580436|Tricuspid Valve Insufficiency|tricuspid valve insufficiency
5431705|NCT01580436|Cardiac Valve Annuloplasty|cardiac valve annuloplasty
5414628|NCT01656564|HIV|hiv
5431706|NCT01580436|Outcome Assessment (Health Care)|outcome assessment (health care)
5431707|NCT01580423|dyspnea|dyspnea
5431708|NCT01580397|Pancreatic cancer|pancreatic cancer
5431709|NCT01580397|INNO-206|inno-206
5431710|NCT01580397|Doxorubicin-EMCH|doxorubicin-emch
5431711|NCT01580358|cancer|cancer
5431712|NCT01580358|radiotherapy|radiotherapy
5431713|NCT01580358|chemotherapy|chemotherapy
5431714|NCT01580358|Traditional Chinese Medicine|traditional chinese medicine
5431715|NCT01580358|Safety|safety
5431716|NCT01580345|DHA|dha
5431717|NCT01580345|Omega 3 fatty acid|omega 3 fatty acid
5431718|NCT01580345|Decosa hexaenoic acid|decosa hexaenoic acid
5431719|NCT01580345|Pregnancy|pregnancy
5431720|NCT01580345|Newborn outcome|newborn outcome
5431721|NCT01580345|Supplementation|supplementation
5431722|NCT01580345|Birth size|birth size
5431723|NCT01580345|gestational age|gestational age
5431724|NCT01580345|India|india
5431725|NCT01580345|Randomized controlled trial|randomized controlled trial
5431727|NCT01580332|biomarkers|biomarkers
5431728|NCT01580332|lung cancer|lung cancer
5431729|NCT01580332|solitary pulmonary nodules|solitary pulmonary nodules
5431730|NCT01580332|SPN|spn
5431731|NCT01580332|breath analysis|breath analysis
5431732|NCT01580332|VOC|voc
5431733|NCT01580332|volatile organic compounds|volatile organic compounds
5431734|NCT01580332|sputum|sputum
5431735|NCT01580332|auto-antibodies|auto-antibodies
5431736|NCT01580319|obesity|obesity
5431737|NCT01580319|cholesterol|cholesterol
5431738|NCT01580319|cholesterol, LDL|cholesterol, ldl
5431739|NCT01580319|cholesterol, HDL|cholesterol, hdl
5431740|NCT01580319|blood glucose|blood glucose
5431741|NCT01580319|Triglyceride|triglyceride
5431742|NCT01580319|C-Reactive Protein - hs|c-reactive protein - hs
5431743|NCT01580319|blood pressure|blood pressure
5431744|NCT01580319|physical activity|physical activity
5431745|NCT01580319|Sedentary Lifestyle|sedentary lifestyle
5431746|NCT01580293|Hemophilia A, factor VIII, prophylaxis|hemophilia a, factor viii, prophylaxis
5431747|NCT01580280|Cervicogenic|cervicogenic
5431748|NCT01580280|Headache|headache
5431749|NCT01580280|Neck Pain|neck pain
5431750|NCT01580280|Manipulation|manipulation
5431751|NCT01580280|Mobilization|mobilization
5431752|NCT01580280|Exercise|exercise
5431753|NCT01580267|Anemia in trauma|anemia in trauma
5431754|NCT01580254|Latanoprost|latanoprost
5431755|NCT01580254|IOP|iop
5431756|NCT01580215|Valves|valves
5431757|NCT01580215|Endobronchial|endobronchial
5431758|NCT01580215|Endoscopic lung volume reduction|endoscopic lung volume reduction
5431759|NCT01580215|Pulmonx|pulmonx
5431760|NCT01580215|Zephyr|zephyr
5431761|NCT01580215|Chartis|chartis
5431762|NCT01580215|Emphysema|emphysema
5431763|NCT01580215|COPD|copd
5431764|NCT01580202|malignancy|malignancy
5431765|NCT01580202|hepatitis B|hepatitis b
5431773|NCT01580163|the opioid dependence in rehabilitation phase|the opioid dependence in rehabilitation phase
5431775|NCT01580150|Berries|berries
5431776|NCT01580150|Starch|starch
5431777|NCT01580150|Sucrose|sucrose
5431778|NCT01580150|Glucose|glucose
5431779|NCT01580150|Insulin|insulin
5431780|NCT01580150|Postprandial|postprandial
5431781|NCT01580137|acute respiratory tract infection|acute respiratory tract infection
5431782|NCT01580137|common cold|common cold
5431783|NCT01580137|acute bacterial rhinosinusitis|acute bacterial rhinosinusitis
5431784|NCT01580137|adult|adult
5431785|NCT01580137|conscript|conscript
5431786|NCT01580111|Blood|blood
5431787|NCT01580111|Storage|storage
5431788|NCT01580111|Age|age
5431789|NCT01580111|Transfusion|transfusion
5431790|NCT01580111|Lactic acidosis|lactic acidosis
5431791|NCT01580085|Sleep disordered breathing|sleep disordered breathing
5431792|NCT01580085|gender|gender
5431793|NCT01580085|hypercoagulability|hypercoagulability
5431794|NCT01580046|Chronic Kidney Disease|chronic kidney disease
5431795|NCT01580046|Coronary Angiography|coronary angiography
5431796|NCT01580046|Contrast Media|contrast media
5431797|NCT01580046|Percutaneous Coronary Intervention|percutaneous coronary intervention
5431798|NCT01580046|Serum Creatinine|serum creatinine
5431799|NCT01580046|Glomerular Filtration Rate|glomerular filtration rate
5431800|NCT01580046|Iodixanol|iodixanol
5431801|NCT01580046|Iopromide|iopromide
5431802|NCT01580033|immunogenicity|immunogenicity
5431803|NCT01580033|safety|safety
5431804|NCT01580033|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
5431805|NCT01580033|type b haemophilus Influenza|type b haemophilus influenza
5431807|NCT01580020|Macular Edema|macular edema
5431808|NCT01580020|Retinal Vein Occlusion|retinal vein occlusion
5431809|NCT01580020|Choroidal Neovascularization|choroidal neovascularization
5431810|NCT01580020|Signs and Symptoms|signs and symptoms
5431811|NCT01580020|Retinal Degeneration|retinal degeneration
5431812|NCT01580020|Retinal Diseases|retinal diseases
5431813|NCT01580020|Eye Diseases|eye diseases
5431814|NCT01580020|Venous Thrombosis Sensation Disorders|venous thrombosis sensation disorders
5431815|NCT01580020|Dexamethasone acetate|dexamethasone acetate
5431816|NCT01580020|Dexamethasone|dexamethasone
5431817|NCT01580020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate
5431818|NCT01580020|BB 1101|bb 1101
5431819|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents
5431820|NCT01580020|Therapeutic Uses|therapeutic uses
5431821|NCT01580020|Vision, Low|vision, low
5431822|NCT01580020|Signs|signs
5431823|NCT01580020|Vision Disorders|vision disorders
5431824|NCT01580007|tuberculosis|tuberculosis
5431825|NCT01580007|phenylbutyrate|phenylbutyrate
5431826|NCT01580007|vitamin D|vitamin d
5431827|NCT01580007|cathelicidin|cathelicidin
5431828|NCT01580007|antimicrobial peptide|antimicrobial peptide
5431829|NCT01580007|in adults|in adults
5431838|NCT01579981|RYGB|rygb
5431839|NCT01579981|Bariatric Surgery|bariatric surgery
5431840|NCT01579981|Glucagon-like-peptide 1|glucagon-like-peptide 1
5431841|NCT01579942|EEG|eeg
5431842|NCT01579942|Biomarker|biomarker
5431843|NCT01579942|Major Depressive Disorder|major depressive disorder
5431844|NCT01579942|Healthy Control|healthy control
5431845|NCT01579929|Extensive Stage Small Cell Lung Cancer (ES-SCLC)|extensive stage small cell lung cancer (es-sclc)
5431846|NCT01579929|CISPLATIN|cisplatin
5431847|NCT01579929|ETOPOSIDE (VP-16)|etoposide (vp-16)
5431848|NCT01579929|LDE-225|lde-225
5431849|NCT01579929|STAR|star
5431850|NCT01579929|Symptom Tracking and Reporting for Patients|symptom tracking and reporting for patients
5431851|NCT01579929|11-206|11-206
5431852|NCT01579916|Trivalent, Influenza, FluMist, Vaccine, Prevention|trivalent, influenza, flumist, vaccine, prevention
5431853|NCT01579903|Hemophilia A|hemophilia a
5431854|NCT01579903|moroctocog alfa (AF-CC)|moroctocog alfa (af-cc)
5431855|NCT01579903|ReFacto AF|refacto af
5431856|NCT01579903|dual-chamber syringe|dual-chamber syringe
5431857|NCT01579903|bioavailability|bioavailability
5431858|NCT01579877|Xerostomia|xerostomia
5431859|NCT01579877|Yukmijihwang-tang|yukmijihwang-tang
5431860|NCT01579877|Yin-Deficiency|yin-deficiency
5431861|NCT01579877|Visual analogue scale|visual analogue scale
5431862|NCT01579877|Dry mouth symptom questionnaire|dry mouth symptom questionnaire
5431863|NCT01579812|Ovarian, Fallopian Tube, and Primary Peritoneal Cancer|ovarian, fallopian tube, and primary peritoneal cancer
5431864|NCT01579786|post operative pain|post operative pain
5431865|NCT01579786|acupuncture|acupuncture
5431871|NCT01579760|aflibercept|aflibercept
5431872|NCT01579747|nerve stimulation|nerve stimulation
5431873|NCT01579747|ultrasound|ultrasound
5431874|NCT01579747|sciatic nerve block|sciatic nerve block
5431875|NCT01579747|popliteal block|popliteal block
5431876|NCT01579747|obese|obese
5431877|NCT01579734|breast cancer chemoprevention postmenopause|breast cancer chemoprevention postmenopause
5431878|NCT01579708|Diet|diet
5431879|NCT01579708|Physical activity|physical activity
5431880|NCT01579708|Knowledge|knowledge
5431881|NCT01579708|Attitudes|attitudes
5431882|NCT01579708|Habits|habits
5431883|NCT01579708|Lifestyle|lifestyle
5431884|NCT01579708|School-based|school-based
5431885|NCT01579695|HIV with lipohypertrophy|hiv with lipohypertrophy
5431886|NCT01579682|Eating Disorder|eating disorder
5431887|NCT01579682|Anorexia Nervosa|anorexia nervosa
5431888|NCT01579682|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5431889|NCT01579682|Maudsley|maudsley
5431890|NCT01579682|Family-Based Therapy|family-based therapy
5431891|NCT01579682|FBT|fbt
5431892|NCT01579682|Family Therapy|family therapy
5431893|NCT01579669|Autism Spectrum Disorder|autism spectrum disorder
5431894|NCT01579669|Primary Care Services|primary care services
5431895|NCT01579669|Patient-Provider Communication|patient-provider communication
5431896|NCT01579669|Adults|adults
5431897|NCT01579643|cornea|cornea
5431898|NCT01579643|opacity|opacity
5431899|NCT01579643|congenital|congenital
5431900|NCT01579630|NSCLC|nsclc
5431901|NCT01579630|Nonsquamous|nonsquamous
5431902|NCT01579630|Maintenance therapy|maintenance therapy
5431903|NCT01579617|pregnancy|pregnancy
5431904|NCT01579617|STI|sti
5431905|NCT01579617|STD|std
5431906|NCT01579604|Loss of upper extremities functions|loss of upper extremities functions
5431907|NCT01579604|Nerve transfer|nerve transfer
5431908|NCT01579578|Metastatic Gastric Cancer who progress following First Line Therapy and are Ineligible for Treatment with trastuzumab by HER2 Status|metastatic gastric cancer who progress following first line therapy and are ineligible for treatment with trastuzumab by her2 status
5431909|NCT01579565|cataract|cataract
5431910|NCT01579565|lens replacement|lens replacement
5431911|NCT01579552|Questionnaires|questionnaires
5431912|NCT01579552|telephone counseling session|telephone counseling session
5431913|NCT01579552|10-104|10-104
5431919|NCT01579526|Safety and Pharmacokinetics of FP01 in Healthy Volunteers|safety and pharmacokinetics of fp01 in healthy volunteers
5431920|NCT01579513|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5431921|NCT01579513|System Inflammatory Response|system inflammatory response
5431922|NCT01579513|inflammation|inflammation
5431923|NCT01579513|Methylprednisolone|methylprednisolone
5431924|NCT01579513|Neonates|neonates
5431925|NCT01579513|Steroid|steroid
5431926|NCT01579513|Cardiac Surgical Procedures|cardiac surgical procedures
5431927|NCT01579513|Children|children
5431928|NCT01579513|Infants|infants
5431929|NCT01579513|Pediatrics|pediatrics
5431930|NCT01579513|Glucocorticoid|glucocorticoid
5431931|NCT01579513|Heart Disease|heart disease
5431932|NCT01579513|Heart Defects, Congenital|heart defects, congenital
5431933|NCT01579513|Cardiovascular Diseases|cardiovascular diseases
5431934|NCT01579513|Cardiovascular Abnormalities|cardiovascular abnormalities
5431935|NCT01579513|Corticosteroid|corticosteroid
5431936|NCT01579513|methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate
5431937|NCT01579513|Hormones|hormones
5431938|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs
5431939|NCT01579513|Randomized Clinical Trial|randomized clinical trial
5431940|NCT01579487|Lipolysis|lipolysis
5431941|NCT01579487|Cryolipolysis|cryolipolysis
5431942|NCT01579487|Fat Reduction|fat reduction
5431943|NCT01579461|Pharmacokinetics|pharmacokinetics
5431944|NCT01579461|mirabegron|mirabegron
5431945|NCT01579461|hepatic impairment|hepatic impairment
5431947|NCT01579448|killed oral cholera vaccine|killed oral cholera vaccine
5431948|NCT01579448|boosting vaccine regimen|boosting vaccine regimen
5431949|NCT01579448|safety and immunogenicity|safety and immunogenicity
5431950|NCT01579435|essential tremor|essential tremor
5431951|NCT01579435|primary motor cortex|primary motor cortex
5431952|NCT01579435|cerebellum|cerebellum
5431953|NCT01579435|transcranial direct current stimulation|transcranial direct current stimulation
5431954|NCT01579435|electrophysiology|electrophysiology
5431955|NCT01579422|schizophrenia|schizophrenia
5431956|NCT01579422|treatment|treatment
5431957|NCT01579422|social cognition|social cognition
5431958|NCT01579409|Nutrition|nutrition
5431959|NCT01579409|Arterial stiffness|arterial stiffness
5431960|NCT01579409|Endothelial dysfunction|endothelial dysfunction
5431961|NCT01579409|Microcirculation|microcirculation
5431962|NCT01579409|Cardiac autonomic system.|cardiac autonomic system.
5431963|NCT01579396|septeX|septex
5431964|NCT01579396|high cut-off|high cut-off
5431965|NCT01579396|Thoracic Surgery|thoracic surgery
5431966|NCT01579396|Renal Replacement Therapy|renal replacement therapy
5431967|NCT01579383|Migraine Disorders|migraine disorders
5431968|NCT01579383|Phase 1|phase 1
5431969|NCT01579383|ALD403|ald403
5431970|NCT01579370|healthcare associated infections|healthcare associated infections
5431971|NCT01579370|multidrug resistant organisms|multidrug resistant organisms
5431972|NCT01579370|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
5431973|NCT01579370|vancomycin resistant enterococcus|vancomycin resistant enterococcus
5431974|NCT01579370|clostridium difficile|clostridium difficile
5431975|NCT01579370|acinetobacter|acinetobacter
5431976|NCT01579357|colorectal carcinoma|colorectal carcinoma
5431977|NCT01579357|K-ras wild type|k-ras wild type
5431978|NCT01579357|Capecitabine|capecitabine
5431979|NCT01579357|Cetuximab|cetuximab
5431980|NCT01579357|Oxaliplatin|oxaliplatin
5431981|NCT01579357|Pharmacokinetics|pharmacokinetics
5431982|NCT01579357|exclude a possible influence of CETUX|exclude a possible influence of cetux
5431983|NCT01579357|plasma disposition|plasma disposition
5431984|NCT01579357|metabolic activation|metabolic activation
5431985|NCT01579357|CCB|ccb
5431986|NCT01579357|OxPt|oxpt
5431987|NCT01579344|Iodine Radioisotopes|iodine radioisotopes
5431988|NCT01579344|Nasolacrimal Duct|nasolacrimal duct
5431989|NCT01579344|radiation effects|radiation effects
5431990|NCT01579331|IOP|iop
5431991|NCT01579331|Tonometry|tonometry
5431992|NCT01579331|Pascal|pascal
5431993|NCT01579331|Goldmann|goldmann
5431994|NCT01579331|DCT|dct
5431995|NCT01579331|Dynamic Contour|dynamic contour
5431996|NCT01579279|Diabetic neuropathic pain|diabetic neuropathic pain
5431997|NCT01579279|Active controlled phase 2 study|active controlled phase 2 study
5431998|NCT01579266|Writer's Cramp|writer's cramp
5431999|NCT01579266|Focal Hand Dystonia|focal hand dystonia
5432000|NCT01579266|Writer Cramp|writer cramp
5432001|NCT01579266|Dystonia|dystonia
5432002|NCT01579253|Recurrent glioblastoma|recurrent glioblastoma
5432003|NCT01579253|Radiotherapy|radiotherapy
5432004|NCT01579253|PET-MRI|pet-mri
5432005|NCT01579253|FET-PET|fet-pet
5432006|NCT01579240|physical activity|physical activity
5432007|NCT01579240|older adults|older adults
5432008|NCT01579240|Internet|internet
5432009|NCT01579240|sedentary|sedentary
5432010|NCT01579240|multi-week|multi-week
5432011|NCT01579240|internet intervention|internet intervention
5432012|NCT01579227|Healthy participants|healthy participants
5432013|NCT01579214|HIV|hiv
5432015|NCT01579214|Knowledge of results|knowledge of results
5432016|NCT01579214|Communication barriers|communication barriers
5432017|NCT01579214|Cellular Phones|cellular phones
5432018|NCT01579201|Postpartum Hemorrhage|postpartum hemorrhage
5432019|NCT01579201|Uterine Atony|uterine atony
5432020|NCT01579201|Obstetric Anesthesia|obstetric anesthesia
5432021|NCT01579201|Cesarean Section|cesarean section
5432022|NCT01579201|Carbetocin|carbetocin
5432023|NCT01579188|NSCLC|nsclc
5432024|NCT01579162|Hepatitis|hepatitis
5432025|NCT01579162|Fatty Liver|fatty liver
5432026|NCT01579123|Laser atherectomy|laser atherectomy
5432027|NCT01579123|Critical Limb Ischemia|critical limb ischemia
5432028|NCT01579123|Angioplasty|angioplasty
5432029|NCT01579110|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5432030|NCT01579110|hemolytic anemia|hemolytic anemia
5432031|NCT01579110|Levamisole|levamisole
5432032|NCT01579110|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
5432033|NCT01579110|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
5432034|NCT01579097|(PN) Parenteral nutrition|(pn) parenteral nutrition
5432035|NCT01579097|oral/enteral not possible|oral/enteral not possible
5432037|NCT01579058|beta-blocker|beta-blocker
5432038|NCT01579032|CKD,|ckd,
5432039|NCT01578980|Artificial Pancreas|artificial pancreas
5432040|NCT01578980|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5432041|NCT01578980|Control-to-Range|control-to-range
5432042|NCT01578980|Closed-Loop Control|closed-loop control
5432043|NCT01578980|Continuous Glucose Monitor|continuous glucose monitor
5432044|NCT01578967|Hodgkin's lymphoma|hodgkin's lymphoma
5432045|NCT01578967|Hodgkin lymphoma|hodgkin lymphoma
5432046|NCT01578954|Leukemia|leukemia
5432047|NCT01578954|Acute Myeloid Leukemia|acute myeloid leukemia
5432048|NCT01578941|menstrual migraine|menstrual migraine
5432049|NCT01578941|migraine|migraine
5432050|NCT01578941|treximet|treximet
5432051|NCT01578928|renal, impairment, endstage renal disease|renal, impairment, endstage renal disease
5432052|NCT01578928|renal|renal
5432053|NCT01578928|impairment|impairment
5432054|NCT01578928|endstage renal disease|endstage renal disease
5432055|NCT01578902|Prostatic Neoplasms|prostatic neoplasms
5432056|NCT01578902|Radiotherapy|radiotherapy
5432057|NCT01578902|Hypofractionation|hypofractionation
5419011|NCT01635972|BAL8557|bal8557
5432058|NCT01578902|Low Risk Prostate Cancer|low risk prostate cancer
5432059|NCT01578876|coronary artery disease|coronary artery disease
5432060|NCT01578876|angina pectoris|angina pectoris
5432061|NCT01578876|myocardial ischemia|myocardial ischemia
5432062|NCT01578876|cardiac shock wave therapy|cardiac shock wave therapy
5432063|NCT01578863|Childhood obesity|childhood obesity
5432064|NCT01578863|Adolescence|adolescence
5432065|NCT01578863|Predictors|predictors
5432067|NCT01578863|Intervention program|intervention program
5432068|NCT01578850|rheumatoid arthritis|rheumatoid arthritis
5432069|NCT01578850|etanercept|etanercept
5432070|NCT01578850|methotrexate|methotrexate
5432071|NCT01578850|DMARDs|dmards
5432072|NCT01578824|Rickets|rickets
5432073|NCT01578824|Vitamin D|vitamin d
5432074|NCT01578824|airway hyperreactivity|airway hyperreactivity
5432075|NCT01578824|Exhaled breath condensate|exhaled breath condensate
5432077|NCT01578772|Flow-mediated dialation (FMD)|flow-mediated dialation (fmd)
5432078|NCT01578772|Telmisartan|telmisartan
5432079|NCT01578772|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
5432080|NCT01578772|HIV+ men and women age > 50 at risk for heart disease|hiv+ men and women age > 50 at risk for heart disease
5432081|NCT01578759|ovarian function tests|ovarian function tests
5432082|NCT01578746|Coxarthrosis|coxarthrosis
5432083|NCT01578746|Hip arthroplasty|hip arthroplasty
5432084|NCT01578746|Anterior approach|anterior approach
5432085|NCT01578746|Direct lateral approach|direct lateral approach
5432086|NCT01578746|Hardinge approach|hardinge approach
5432087|NCT01578746|Smith-Petersen approach|smith-petersen approach
5432088|NCT01578746|Osteoarthrosis|osteoarthrosis
5432089|NCT01578733|protein requirement|protein requirement
5432090|NCT01578733|female elderly|female elderly
5432091|NCT01578733|healthy female subject's protein requirements|healthy female subject's protein requirements
5432092|NCT01578707|Chronic|chronic
5432093|NCT01578707|SLL|sll
5432094|NCT01578707|CLL|cll
5432095|NCT01578707|Ofatumumab|ofatumumab
5432096|NCT01578707|ibrutinib|ibrutinib
5432097|NCT01578707|RESONATE|resonate
5432098|NCT01578707|Phase III|phase iii
5432099|NCT01578707|Leukemia|leukemia
5432100|NCT01578707|Lymphoma|lymphoma
5432101|NCT01578681|bronchiectasis|bronchiectasis
5432102|NCT01578681|respiratory therapy|respiratory therapy
5432103|NCT01578681|airway clearance|airway clearance
5432104|NCT01578668|lung adenocarcinoma|lung adenocarcinoma
5432105|NCT01578668|brain metastases|brain metastases
5432106|NCT01578668|erlotinib|erlotinib
5432107|NCT01578668|pemetrexed|pemetrexed
5432108|NCT01578655|custirsen sodium|custirsen sodium
5432109|NCT01578655|prostate cancer|prostate cancer
5432110|NCT01578655|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5432111|NCT01578655|overall survival|overall survival
5432112|NCT01578642|GERD|gerd
5432113|NCT01578642|LES Pressure|les pressure
5432114|NCT01578642|Electrical Stimulation|electrical stimulation
5432116|NCT01578629|ischemia|ischemia
5432117|NCT01578629|TIA|tia
5432118|NCT01578616|Coronary artery disease|coronary artery disease
5432119|NCT01578616|Endothelial function|endothelial function
5414952|NCT01655160|Motor recovery|motor recovery
5432120|NCT01578616|Optical coherence tomography|optical coherence tomography
5432121|NCT01578616|Thin cap fibroatheroma|thin cap fibroatheroma
5432122|NCT01578603|prevention & control|prevention & control
5432123|NCT01578603|Xylitol|xylitol
5432124|NCT01578603|casein phosphopeptide amorphous calcium phosphate complex|casein phosphopeptide amorphous calcium phosphate complex
5432125|NCT01578603|Streptococcus mutans|streptococcus mutans
5432126|NCT01578603|saliva|saliva
5432127|NCT01578603|dental plaque|dental plaque
5432128|NCT01578603|gingivitis|gingivitis
5432129|NCT01578577|Medication Therapy Management|medication therapy management
5432130|NCT01578577|Hypertension|hypertension
5432131|NCT01578577|Health Literacy|health literacy
5432132|NCT01578577|Medication Reconciliation|medication reconciliation
5432133|NCT01578577|Medication Adherence|medication adherence
5432134|NCT01578564|Cancer|cancer
5432135|NCT01578564|Ovarian Cancer|ovarian cancer
5432136|NCT01578564|TRPV6 Calcium channel|trpv6 calcium channel
5432137|NCT01578551|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5432139|NCT01578538|hernia, abdominal, strangulation, emergency, wall|hernia, abdominal, strangulation, emergency, wall
5432140|NCT01578525|medication safety|medication safety
5432141|NCT01578525|elderly|elderly
5432142|NCT01578525|pharmaceutical care|pharmaceutical care
5432143|NCT01578525|hospital readmission|hospital readmission
5432144|NCT01578525|drug-related readmission|drug-related readmission
5432145|NCT01578525|Health Services for the Aged|health services for the aged
5432146|NCT01578499|Brentuximab vedotin|brentuximab vedotin
5432147|NCT01578499|ALCANZA|alcanza
5432148|NCT01578486|Schizophrenia|schizophrenia
5432149|NCT01578486|Cognition|cognition
5432150|NCT01578486|Metabolism|metabolism
5432151|NCT01578486|Antipsychotics|antipsychotics
5432152|NCT01578486|Psychopathology|psychopathology
5432153|NCT01578473|low testosterone|low testosterone
5432154|NCT01578473|penile curvature|penile curvature
5432155|NCT01578460|Pregnancy|pregnancy
5432156|NCT01578460|Gestational Diabetes|gestational diabetes
5432157|NCT01578460|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5432158|NCT01578460|Continuous Glucose Monitor|continuous glucose monitor
5432159|NCT01578460|Glucose|glucose
5432160|NCT01578447|injectable contraception|injectable contraception
5432161|NCT01578447|acceptability|acceptability
5432162|NCT01578447|intramuscular|intramuscular
5432163|NCT01578447|subcutaneous|subcutaneous
5432164|NCT01578434|Nutritional Rickets|nutritional rickets
5432165|NCT01578434|Calcium|calcium
5432166|NCT01578434|Vitamin D|vitamin d
5432167|NCT01578408|Femoral neck fractures|femoral neck fractures
5432168|NCT01578408|Uncemented|uncemented
5432169|NCT01578408|Hydroxyapatite|hydroxyapatite
5432170|NCT01578408|Coated|coated
5432171|NCT01578408|Femoral|femoral
5432172|NCT01578408|Stems|stems
5432173|NCT01578408|Hip fractures|hip fractures
5432174|NCT01578408|THA|tha
5432175|NCT01578408|THR|thr
5432176|NCT01578408|Cemented|cemented
5432177|NCT01578408|Fat embolism|fat embolism
5432178|NCT01578408|Cognition|cognition
5432179|NCT01578408|Inflammatory response|inflammatory response
5432180|NCT01578408|Mobilization|mobilization
5432181|NCT01578382|Martorell hypertensive ischemic leg ulcer|martorell hypertensive ischemic leg ulcer
5432182|NCT01578382|Calciphylaxis (calcific uremic arteriolopathy)|calciphylaxis (calcific uremic arteriolopathy)
5432183|NCT01578382|Ischemic subcutaneous arteriolosclerosis|ischemic subcutaneous arteriolosclerosis
5432184|NCT01578382|Hypertension|hypertension
5432185|NCT01578382|Diabetes|diabetes
5432186|NCT01578382|Medial calcinosis|medial calcinosis
5432187|NCT01578382|Wound healing|wound healing
5432188|NCT01578369|Urinary incontinence|urinary incontinence
5432189|NCT01578369|Pregnancy|pregnancy
5432190|NCT01578369|Pelvic floor muscle training|pelvic floor muscle training
5432191|NCT01578356|Prostate cancer|prostate cancer
5432192|NCT01578343|fludarabine|fludarabine
5432193|NCT01578343|mitoxantrone|mitoxantrone
5432194|NCT01578343|dexamethasone|dexamethasone
5432195|NCT01578343|relapsed or refractory mantle cell lymphoma|relapsed or refractory mantle cell lymphoma
5432196|NCT01578343|FND regimen|fnd regimen
5432197|NCT01578343|vorinostat|vorinostat
5432198|NCT01578343|autologous stem cell transplantation|autologous stem cell transplantation
5432199|NCT01578330|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5432200|NCT01578330|Fingolimod|fingolimod
5432201|NCT01578330|FTY720|fty720
5432202|NCT01578317|H5N1 Vaccine|h5n1 vaccine
5432203|NCT01578317|H5N1 Immunization|h5n1 immunization
5432204|NCT01578317|AS03 Adjuvant|as03 adjuvant
5432205|NCT01578317|Biologic Sample Collection|biologic sample collection
5432206|NCT01578317|Laboratory Research Specimens|laboratory research specimens
5432207|NCT01578317|Healthy Volunteer|healthy volunteer
5432208|NCT01578317|HV|hv
5432209|NCT01578304|Overactive bladder|overactive bladder
5432210|NCT01578291|Play therapy|play therapy
5432211|NCT01578291|Urinary tract infections|urinary tract infections
5432213|NCT01578291|Vesicoureteral reflux|vesicoureteral reflux
5432214|NCT01578239|Neuroendocrine tumour|neuroendocrine tumour
5432215|NCT01578239|177Lu-Dota0-Tyr3-octreotate|177lu-dota0-tyr3-octreotate
5432216|NCT01578226|Cirrhosis|cirrhosis
5432217|NCT01578226|Ascites|ascites
5432218|NCT01578226|Decompensation|decompensation
5432219|NCT01578226|Bacterial infection|bacterial infection
5432220|NCT01578226|Sepsis|sepsis
5432221|NCT01578226|Procalcitonin|procalcitonin
5432222|NCT01578226|PCT|pct
5432223|NCT01578200|CKD-MBD|ckd-mbd
5432224|NCT01578200|phosphate-binder|phosphate-binder
5432225|NCT01578200|vascular calcification|vascular calcification
5432226|NCT01578200|mortality|mortality
5432227|NCT01578200|dialysis|dialysis
5432228|NCT01578200|Hemodialysis patients with hyperphosphatemia|hemodialysis patients with hyperphosphatemia
5432229|NCT01578187|hair reduction|hair reduction
5432230|NCT01578187|hair removal|hair removal
5432231|NCT01578187|hair clearance|hair clearance
5432232|NCT01578148|Cervical pain|cervical pain
5432233|NCT01578148|Cervicalgia,|cervicalgia,
5432234|NCT01578148|Cervicodynia|cervicodynia
5432235|NCT01578148|Neck ache|neck ache
5432236|NCT01578148|Neckache|neckache
5432237|NCT01578148|Shoulder pain|shoulder pain
5432238|NCT01578148|Shoulder impingement syndrome|shoulder impingement syndrome
5432239|NCT01578122|post-thrombotic syndrome|post-thrombotic syndrome
5432240|NCT01578122|prevention|prevention
5432241|NCT01578122|deep vein thrombosis|deep vein thrombosis
5432242|NCT01578122|elastic compression stockings|elastic compression stockings
5432243|NCT01578122|compliance|compliance
5432244|NCT01578122|quality of life|quality of life
5432245|NCT01578096|Type 2 Diabetes|type 2 diabetes
5432246|NCT01578083|Chemotherapy|chemotherapy
5432247|NCT01578083|Breast Cancer|breast cancer
5432248|NCT01578083|Cognitive Impairment|cognitive impairment
5432249|NCT01578083|Chemo brain|chemo brain
5432250|NCT01578070|Other and Unspecified Vaccines and Biological Substances Causing Adverse Effects in Therapeutic Use|other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
5432252|NCT01578044|Anti-coagulation|anti-coagulation
5432253|NCT01578031|Sleep Apnea|sleep apnea
5432254|NCT01578031|Obesity|obesity
5432255|NCT01578018|lung cancer|lung cancer
5432256|NCT01578018|smoking|smoking
5432361|NCT01577628|Infant|infant
5432257|NCT01578005|acute coronary syndrome|acute coronary syndrome
5432258|NCT01578005|IVUS|ivus
5432259|NCT01578005|atherosclerotic plaque|atherosclerotic plaque
5432260|NCT01577992|subjective pain|subjective pain
5432261|NCT01577992|Multiple System Atrophy|multiple system atrophy
5432262|NCT01577979|Vaccination|vaccination
5432263|NCT01577979|Medical Home|medical home
5432264|NCT01577979|Adolescents|adolescents
5432265|NCT01577966|Patients with brain tumors associated with seizures|patients with brain tumors associated with seizures
5432266|NCT01577953|Antisense oligonucleotide|antisense oligonucleotide
5432267|NCT01577953|Asthma|asthma
5432268|NCT01577953|Patients with asthma|patients with asthma
5432269|NCT01577953|Phase 1b|phase 1b
5432270|NCT01577953|Transcription factor GATA-3|transcription factor gata-3
5432271|NCT01577953|Oral inhalation|oral inhalation
5432272|NCT01577940|Transversus abdominis plane block|transversus abdominis plane block
5432273|NCT01577940|postoperative pain|postoperative pain
5432274|NCT01577940|Postoperative pain management|postoperative pain management
5432275|NCT01577927|weaning|weaning
5432276|NCT01577927|severe chronic diseases|severe chronic diseases
5432277|NCT01577927|UTIR|utir
5432278|NCT01577901|Pregnancy|pregnancy
5432279|NCT01577862|ACINETOBACTER BAUMANNII|acinetobacter baumannii
5432280|NCT01577862|COLISTIN|colistin
5432281|NCT01577862|RIFAMPICIN|rifampicin
5432282|NCT01577862|THERAPY|therapy
5432283|NCT01577862|RESISTANCE|resistance
5432284|NCT01577836|Radical prostatectomie|radical prostatectomie
5432285|NCT01577836|Robotic assistance|robotic assistance
5432286|NCT01577836|Laparotomy|laparotomy
5432287|NCT01577810|NIRS|nirs
5432288|NCT01577810|near infrared spectroscopy|near infrared spectroscopy
5432289|NCT01577810|heart failure|heart failure
5432290|NCT01577810|cardiac output|cardiac output
5432291|NCT01577810|outpatient|outpatient
5432292|NCT01577810|pediatric|pediatric
5432293|NCT01577797|Methamphetamine|methamphetamine
5432294|NCT01577797|Drug Abuse|drug abuse
5432295|NCT01577797|Substance Abuse|substance abuse
5432296|NCT01577797|Amphetamine|amphetamine
5432297|NCT01577797|Dependence|dependence
5432298|NCT01577797|Addiction|addiction
5432299|NCT01577797|Craving|craving
5432300|NCT01577797|Cognitive Behavioral Therapy|cognitive behavioral therapy
5432301|NCT01577797|Text Messaging|text messaging
5432302|NCT01577784|Advanced renal cell carcinoma|advanced renal cell carcinoma
5432303|NCT01577784|second-line treatment with pazopanib|second-line treatment with pazopanib
5432304|NCT01577784|first line of treatment with a Tyrosine Kinase Inhibitor|first line of treatment with a tyrosine kinase inhibitor
5432305|NCT01577771|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5432306|NCT01577771|Immunogenicity|immunogenicity
5432307|NCT01577771|Reactogenicity|reactogenicity
5432308|NCT01577758|Phase 1,|phase 1,
5432309|NCT01577758|Advanced gastrointestinal malignancies,|advanced gastrointestinal malignancies,
5432310|NCT01577758|MLN0264,|mln0264,
5432311|NCT01577758|Guanylyl Cyclase C(GCC),|guanylyl cyclase c(gcc),
5432312|NCT01577758|Antibody Drug Conjugate(ADC)|antibody drug conjugate(adc)
5432313|NCT01577745|Cancer|cancer
5432314|NCT01577732|booster|booster
5432315|NCT01577732|Infanrix-IPV+HibTM|infanrix-ipv+hibtm
5432316|NCT01577732|DTPa-IPV/Hib|dtpa-ipv/hib
5432317|NCT01577732|Vietnamese toddlers|vietnamese toddlers
5432318|NCT01577719|Cardiovascular|cardiovascular
5432319|NCT01577719|Prevention|prevention
5432320|NCT01577719|Ethnicity|ethnicity
5432321|NCT01577719|Culture|culture
5432322|NCT01577719|Internet|internet
5432323|NCT01577719|Text Message|text message
5432324|NCT01577706|GABA|gaba
5432325|NCT01577706|glutamate|glutamate
5432326|NCT01577706|glutamine|glutamine
5432327|NCT01577706|spectroscopy|spectroscopy
5432328|NCT01577706|brain|brain
5432329|NCT01577706|imaging|imaging
5432330|NCT01577706|alprazolam|alprazolam
5432331|NCT01577706|dextroamphetamine|dextroamphetamine
5432332|NCT01577706|placebo|placebo
5432333|NCT01577693|dutasteride|dutasteride
5432334|NCT01577693|cross over study|cross over study
5432335|NCT01577693|bioavailability|bioavailability
5432341|NCT01577680|hepatic impairment|hepatic impairment
5432343|NCT01577680|GSK573719|gsk573719
5432344|NCT01577667|automation|automation
5432345|NCT01577667|closed loop|closed loop
5432346|NCT01577667|oxygenation|oxygenation
5432347|NCT01577667|ventilation|ventilation
5432348|NCT01577654|adenocarcinoma|adenocarcinoma
5432349|NCT01577654|squamous|squamous
5432350|NCT01577654|adenosquamous|adenosquamous
5432351|NCT01577654|adenocarcinoma with other NSCLC variants|adenocarcinoma with other nsclc variants
5432352|NCT01577654|EC145|ec145
5432353|NCT01577654|EC20|ec20
5432354|NCT01577654|Vintafolide|vintafolide
5432355|NCT01577654|Etarfolatide|etarfolatide
5432356|NCT01577628|Dermatitis|dermatitis
5432357|NCT01577628|Eczema|eczema
5432358|NCT01577628|Skin diseases|skin diseases
5432359|NCT01577628|Skin barrier|skin barrier
5432360|NCT01577628|Prevention|prevention
5432362|NCT01577628|Moisturizer|moisturizer
5432363|NCT01577628|Emollient|emollient
5432364|NCT01577628|Asthma|asthma
5432365|NCT01577628|Food allergy|food allergy
5432366|NCT01577628|Allergic rhinitis|allergic rhinitis
5432367|NCT01577615|Preterm Infant|preterm infant
5432368|NCT01577615|Neurobehavioral|neurobehavioral
5432369|NCT01577615|Development|development
5432370|NCT01577602|Medication reconciliation|medication reconciliation
5432371|NCT01577602|Self report|self report
5432372|NCT01577602|Electronic medical record medication list|electronic medical record medication list
5432373|NCT01577589|Phase 1|phase 1
5432374|NCT01577589|healthy volunteers|healthy volunteers
5432375|NCT01577589|cross-over study|cross-over study
5432376|NCT01577589|ceftaroline fosamil|ceftaroline fosamil
5432377|NCT01577589|various infusion volumes|various infusion volumes
5432378|NCT01577589|local tolerability|local tolerability
5432379|NCT01577589|Cmax|cmax
5432380|NCT01577589|tmax|tmax
5432382|NCT01577576|Athletes|athletes
5432383|NCT01577576|Sedentary volunteers|sedentary volunteers
5432384|NCT01577563|osteoarthritis (OA)|osteoarthritis (oa)
5432385|NCT01577563|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5432386|NCT01577563|ankylosing spondylitis (AS)|ankylosing spondylitis (as)
5432387|NCT01577563|gastrointestinal risk factors|gastrointestinal risk factors
5432388|NCT01577563|NSAIDs|nsaids
5432389|NCT01577550|ABBV-066|abbv-066
5432390|NCT01577550|BI 655066|bi 655066
5432391|NCT01577550|risankizumab|risankizumab
5432392|NCT01577537|SPL7013|spl7013
5432393|NCT01577537|VivaGel|vivagel
5432394|NCT01577537|bacterial vaginosis|bacterial vaginosis
5432395|NCT01577537|BV|bv
5432396|NCT01577511|invasive potential|invasive potential
5432397|NCT01577511|molecular characterisation of circulating cells|molecular characterisation of circulating cells
5432398|NCT01577498|Skeletal age|skeletal age
5432399|NCT01577498|Chronological age|chronological age
5432400|NCT01577498|Adolescent|adolescent
5432401|NCT01577472|female infertility|female infertility
5432402|NCT01577472|poor ovarian response|poor ovarian response
5432403|NCT01577472|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5432404|NCT01577472|IVF|ivf
5432405|NCT01577472|Antagonist protocol|antagonist protocol
5432406|NCT01577446|CRT|crt
5432407|NCT01577446|heart failure|heart failure
5432408|NCT01577446|narrow QRS|narrow qrs
5432409|NCT01577446|dyssynchrony|dyssynchrony
5432410|NCT01577433|HeartMate II|heartmate ii
5432411|NCT01577433|heart-assist device|heart-assist device
5432412|NCT01577433|left ventricular assist device|left ventricular assist device
5432413|NCT01577433|driveline infection|driveline infection
5432414|NCT01577433|LVAD|lvad
5432415|NCT01577433|HMII LVAS driveline|hmii lvas driveline
5432416|NCT01577433|silicone portion|silicone portion
5432417|NCT01577433|Thoratec Corporation|thoratec corporation
5432418|NCT01577420|Reflexology|reflexology
5432419|NCT01577420|Breast Cancer|breast cancer
5432420|NCT01577420|Complementary|complementary
5432421|NCT01577407|Dyspnea|dyspnea
5432423|NCT01577394|Alzheimer disease|alzheimer disease
5432424|NCT01577394|Lewy Body Disease|lewy body disease
5432425|NCT01577394|Cognitive Disorders|cognitive disorders
5432426|NCT01577394|Neurodegenerative Diseases|neurodegenerative diseases
5432427|NCT01577394|Differential diagnosis|differential diagnosis
5432428|NCT01577394|Eye movement|eye movement
5432429|NCT01577381|Phase 2|phase 2
5432430|NCT01577381|Advanced Dry Age-Related Macular Degeneration|advanced dry age-related macular degeneration
5432431|NCT01577381|Geographic Atrophy|geographic atrophy
5432432|NCT01577381|RN6G|rn6g
5432433|NCT01577368|Pseudomonas|pseudomonas
5432434|NCT01577368|Piperacillin|piperacillin
5432435|NCT01577368|Beta-lactams|beta-lactams
5432438|NCT01577368|Pharmacokinetics|pharmacokinetics
5432439|NCT01577329|meditation|meditation
5432440|NCT01577329|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5432441|NCT01577329|Mindfulness|mindfulness
5432442|NCT01577329|Anxiety|anxiety
5432443|NCT01577329|Breathing Patterns|breathing patterns
5432444|NCT01577316|vaccination|vaccination
5432445|NCT01577316|Influenza|influenza
5432446|NCT01577316|Immunogenicity|immunogenicity
5432447|NCT01577316|Safety|safety
5432448|NCT01577303|social phobia|social phobia
5432449|NCT01577303|social anxiety|social anxiety
5432450|NCT01577303|cognitive bias modification|cognitive bias modification
5432451|NCT01577290|Anxiety|anxiety
5432452|NCT01577290|Depression|depression
5432453|NCT01577290|Insomnia|insomnia
5432454|NCT01577290|Mindfulness|mindfulness
5432455|NCT01577290|Internet|internet
5432456|NCT01577277|Metabolic Syndrome X|metabolic syndrome x
5432457|NCT01577277|Fatty Acids, Omega-3|fatty acids, omega-3
5432458|NCT01577277|Learning|learning
5432459|NCT01577277|Attention|attention
5432460|NCT01577277|Nutritional Status|nutritional status
5432461|NCT01577277|Nutrition Assessments|nutrition assessments
5432462|NCT01577277|Body Weight|body weight
5432463|NCT01577277|Physical Activity|physical activity
5432464|NCT01577277|Sleep|sleep
5432846|NCT01575782|Phase I|phase i
5432465|NCT01577277|Child Nutrition Sciences|child nutrition sciences
5432466|NCT01577264|Certolizumab Pegol|certolizumab pegol
5432467|NCT01577264|Cimzia|cimzia
5432468|NCT01577238|SPL7013|spl7013
5432469|NCT01577238|VivaGel|vivagel
5432470|NCT01577238|bacterial vaginosis|bacterial vaginosis
5432472|NCT01577225|Clean surgery|clean surgery
5432473|NCT01577212|stage III NSCLC|stage iii nsclc
5432474|NCT01577212|(chemo)radiotherapy|(chemo)radiotherapy
5432475|NCT01577212|individualized dose-escalation|individualized dose-escalation
5432476|NCT01577199|IVF|ivf
5432477|NCT01577199|poor responder|poor responder
5432478|NCT01577199|low ovarian reserve|low ovarian reserve
5432479|NCT01577199|ART|art
5432480|NCT01577199|ovarian stimulation|ovarian stimulation
5432481|NCT01577199|IVF protocols|ivf protocols
5432482|NCT01577186|Schizophrenia|schizophrenia
5432483|NCT01577186|Paliperidone Extended Release|paliperidone extended release
5432484|NCT01577160|Schizophrenia|schizophrenia
5432485|NCT01577160|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5432486|NCT01577147|pregnancy|pregnancy
5432487|NCT01577134|multimorbidity|multimorbidity
5432488|NCT01577134|autonomy|autonomy
5432489|NCT01577134|older adults|older adults
5432490|NCT01577134|physical activity|physical activity
5432491|NCT01577134|intervention|intervention
5432492|NCT01577134|behavior change|behavior change
5432493|NCT01577121|Preterm labor|preterm labor
5432494|NCT01577108|31-32 Weeks of Gestation Completed|31-32 weeks of gestation completed
5432495|NCT01577108|Group B Streptococcal Infection|group b streptococcal infection
5432496|NCT01577108|Streptococcus Group B Infection of the Infant|streptococcus group b infection of the infant
5432497|NCT01577095|electroacupuncture|electroacupuncture
5432498|NCT01577095|rosiglitazone|rosiglitazone
5432499|NCT01577095|plasma glucose|plasma glucose
5432500|NCT01577095|insulin resistance|insulin resistance
5432501|NCT01577095|free fatty acid|free fatty acid
5432502|NCT01577082|Adults, not adequately controlled, pre-dose morning PEF|adults, not adequately controlled, pre-dose morning pef
5432503|NCT01577069|Hepatitis C|hepatitis c
5432504|NCT01577069|Direct Antiviral agent (DAA)|direct antiviral agent (daa)
5432505|NCT01577069|Ultra-deep pyrosequencing|ultra-deep pyrosequencing
5432506|NCT01577069|Single polynucleotide polymorphisms|single polynucleotide polymorphisms
5432507|NCT01577069|Treatment-resistant mutants|treatment-resistant mutants
5432508|NCT01577069|Hepatitis C Virus Protease Inhibitor|hepatitis c virus protease inhibitor
5432509|NCT01577056|Familial hypercholesterolaemia|familial hypercholesterolaemia
5432510|NCT01577056|Postprandial dyslipidaemia|postprandial dyslipidaemia
5432511|NCT01577056|Fish oil treatment|fish oil treatment
5432512|NCT01577056|Cardiovascular disease|cardiovascular disease
5432513|NCT01577043|acute diarrhea|acute diarrhea
5432514|NCT01577043|Racecadotril|racecadotril
5432515|NCT01577043|children|children
5432516|NCT01577017|ovulation induction, clomiphene citrate, letrozole|ovulation induction, clomiphene citrate, letrozole
5432517|NCT01576978|LUMBAR BACK pain|lumbar back pain
5432518|NCT01576978|PELVIC PAIN|pelvic pain
5432519|NCT01576978|PREGNANCY|pregnancy
5432520|NCT01576978|HATHA YOGA|hatha yoga
5427395|NCT01599013|unfit|unfit
5432521|NCT01576965|Laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep|laparoscopic hysterectomy,laparoscopic sacrocolpopexy,bowel prep
5432522|NCT01576926|Sleep apnea, obstructive|sleep apnea, obstructive
5432523|NCT01576926|Deglutition Disorders|deglutition disorders
5432525|NCT01576913|music|music
5432526|NCT01576913|VO2 max|vo2 max
5432527|NCT01576900|behavior therapy|behavior therapy
5432528|NCT01576900|nocturia|nocturia
5432529|NCT01576900|polyuria|polyuria
5432530|NCT01576874|nicotine dependence|nicotine dependence
5432532|NCT01576848|muscle metabolism|muscle metabolism
5432533|NCT01576848|intrinsically labeled protein|intrinsically labeled protein
5432534|NCT01576848|protein synthesis|protein synthesis
5432535|NCT01576848|insulin|insulin
5432536|NCT01576848|perfusion|perfusion
5432537|NCT01576835|Non-contrast|non-contrast
5432538|NCT01576822|Detoxification|detoxification
5432539|NCT01576822|Sauna|sauna
5432540|NCT01576809|Paracetamol|paracetamol
5432541|NCT01576809|acetaminophen|acetaminophen
5432542|NCT01576809|phenylephrine|phenylephrine
5432543|NCT01576809|guaifenesin|guaifenesin
5432544|NCT01576809|syrup|syrup
5432545|NCT01576809|URTI|urti
5432546|NCT01576809|productive cough|productive cough
5432547|NCT01576796|Radiotherapy|radiotherapy
5432548|NCT01576796|Fmiso|fmiso
5432549|NCT01576796|FDG PETSCAN|fdg petscan
5432550|NCT01576796|FMISO PETSCAN|fmiso petscan
5432551|NCT01576796|complement dose|complement dose
5432552|NCT01576796|lung cancer|lung cancer
5432553|NCT01576796|NSCLC|nsclc
5432554|NCT01576796|hypoxic lesion|hypoxic lesion
5432555|NCT01576770|propofol|propofol
5432556|NCT01576770|Pain|pain
5432557|NCT01576770|Synera Patch|synera patch
5432558|NCT01576770|Gebauer's Ethyl Chloride topical anesthetic|gebauer's ethyl chloride topical anesthetic
5432559|NCT01576757|Stem cell therapy|stem cell therapy
5432561|NCT01576744|IVF|ivf
5432562|NCT01576744|Biomarker|biomarker
5432563|NCT01576744|Ovarian cancer|ovarian cancer
5432564|NCT01576744|Infertility|infertility
5432565|NCT01576731|HIV Infection|hiv infection
5432566|NCT01576731|Postexposure prophylaxis|postexposure prophylaxis
5404975|NCT01700153|ICF|icf
5419494|NCT01633437|MAOI|maoi
5432567|NCT01576718|Dose ranging|dose ranging
5432568|NCT01576718|Fluticasone Propionate|fluticasone propionate
5432569|NCT01576718|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
5432570|NCT01576718|High Dose ICS|high dose ics
5432571|NCT01576718|Asthma|asthma
5432572|NCT01576705|Down syndrome|down syndrome
5432573|NCT01576705|Young children|young children
5432574|NCT01576705|Psychomotor development|psychomotor development
5432575|NCT01576705|Thyroid hormone|thyroid hormone
5432576|NCT01576705|Folinic acid|folinic acid
5432577|NCT01576705|Psychometric tests|psychometric tests
5432578|NCT01576705|GMDS|gmds
5432579|NCT01576705|Griffiths|griffiths
5432580|NCT01576705|Genetic factors|genetic factors
5432581|NCT01576705|Biochemical factors|biochemical factors
5432582|NCT01576692|recurrent neuroblastoma|recurrent neuroblastoma
5432583|NCT01576692|refractory neuroblastoma|refractory neuroblastoma
5432584|NCT01576692|natural killer cells|natural killer cells
5432585|NCT01576679|intra-abdominal|intra-abdominal
5432586|NCT01576679|abscess|abscess
5432587|NCT01576679|tPA|tpa
5432588|NCT01576679|alteplase|alteplase
5432589|NCT01576679|cathflo|cathflo
5432590|NCT01576666|Dose escalation|dose escalation
5432591|NCT01576666|Maximum Tolerated Dose|maximum tolerated dose
5432592|NCT01576666|MTD|mtd
5432593|NCT01576666|Safety Expansion|safety expansion
5432594|NCT01576666|Safety|safety
5432595|NCT01576666|Preliminary Efficacy|preliminary efficacy
5432596|NCT01576666|Objective Response Rate|objective response rate
5432597|NCT01576666|Early progression rate|early progression rate
5432598|NCT01576666|PI3K activation|pi3k activation
5432599|NCT01576666|Combination Treatment|combination treatment
5432600|NCT01576666|Hedgehog Signaling Pathway|hedgehog signaling pathway
5432601|NCT01576666|Smoothened inhibitor|smoothened inhibitor
5432602|NCT01576666|Phosphoinositide-3' kinase|phosphoinositide-3' kinase
5432603|NCT01576666|Phosphatase signaling pathway|phosphatase signaling pathway
5432604|NCT01576666|Advanced solid tumors|advanced solid tumors
5432605|NCT01576666|metastatic breast cancer|metastatic breast cancer
5432606|NCT01576666|advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
5432607|NCT01576666|metastatic colorectal cancer|metastatic colorectal cancer
5432608|NCT01576666|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5432609|NCT01576666|gastric cancer|gastric cancer
5432610|NCT01576666|gastroesophageal junction cancer|gastroesophageal junction cancer
5432611|NCT01576666|triple negative metastatic breast cancer|triple negative metastatic breast cancer
5432612|NCT01576666|hormone receptor positive (ER+/PR+, and Her2-) metastatic breast cancer|hormone receptor positive (er+/pr+, and her2-) metastatic breast cancer
5432613|NCT01576653|IFI|ifi
5432614|NCT01576640|Nicotine Dependence|nicotine dependence
5432615|NCT01576640|Smoking Cessation|smoking cessation
5432616|NCT01576640|Relapse Prevention|relapse prevention
5432617|NCT01576640|Cognitive Behavioral Therapy|cognitive behavioral therapy
5432618|NCT01576640|Schizophrenia|schizophrenia
5432619|NCT01576614|Comparing telephone VS RTP in SICU rounding practices|comparing telephone vs rtp in sicu rounding practices
5432620|NCT01576601|pediatrics|pediatrics
5432621|NCT01576601|acute pain|acute pain
5415462|NCT01652599|ITP|itp
5432622|NCT01576601|neurosurgery|neurosurgery
5432623|NCT01576601|Pediatric patients (0-18)|pediatric patients (0-18)
5432624|NCT01576601|postoperative management|postoperative management
5432625|NCT01576588|Chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab|chronic lymphocytic leukemia, relapsed, elderly or unfit patients, methylprednisolone, rituximab
5432626|NCT01576575|buprenorphine CYP3A|buprenorphine cyp3a
5432627|NCT01576562|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5432628|NCT01576562|Ventricular Assist Device|ventricular assist device
5432629|NCT01576536|Myocardial infarction|myocardial infarction
5417892|NCT01641224|Pinaverium|pinaverium
5432630|NCT01576536|Platelet aggregation|platelet aggregation
5432631|NCT01576536|cold pressor test|cold pressor test
5432632|NCT01576536|Genetics|genetics
5432633|NCT01576497|EUS, EUS-FNA, Pancreatic masses|eus, eus-fna, pancreatic masses
5432634|NCT01576471|T. suis ova|t. suis ova
5432635|NCT01576471|Trichuris suis ova|trichuris suis ova
5432636|NCT01576471|Inflammatory Bowel Disease|inflammatory bowel disease
5432637|NCT01576471|TRUST-I|trust-i
5432638|NCT01576471|TRUSTI|trusti
5432639|NCT01576471|TRUST-1|trust-1
5432640|NCT01576471|TRUST1|trust1
5432641|NCT01576458|ursodeoxycholic acid|ursodeoxycholic acid
5432642|NCT01576458|intrahepatic cholestasis|intrahepatic cholestasis
5432643|NCT01576458|pregnancy|pregnancy
5432644|NCT01576445|Total Knee Arthroplasty|total knee arthroplasty
5432645|NCT01576445|function|function
5432646|NCT01576432|Pain|pain
5432647|NCT01576432|Breastfeeding|breastfeeding
5432648|NCT01576432|Heel prick|heel prick
5432649|NCT01576432|Sucrose|sucrose
5432650|NCT01576432|Skin-to-skin contact|skin-to-skin contact
5432651|NCT01576432|Newborn|newborn
5432652|NCT01576419|PG201|pg201
5432653|NCT01576419|Non-inferiority|non-inferiority
5432654|NCT01576419|100mm pain VAS|100mm pain vas
5432655|NCT01576406|crizotinib|crizotinib
5432656|NCT01576406|xalkori|xalkori
5432657|NCT01576406|PF-02341066|pf-02341066
5432658|NCT01576406|hepatic impairment|hepatic impairment
5432659|NCT01576406|pharmacokinetics|pharmacokinetics
5432660|NCT01576406|advanced cancer|advanced cancer
5432661|NCT01576393|substance abuse|substance abuse
5432662|NCT01576393|treatment|treatment
5432663|NCT01576393|families|families
5432664|NCT01576380|Solid tumors|solid tumors
5432665|NCT01576380|Advanced scirrhous gastric carcinoma|advanced scirrhous gastric carcinoma
5432666|NCT01576380|Gastric Cancer|gastric cancer
5432667|NCT01576380|Second-line or third-line treatment|second-line or third-line treatment
5432668|NCT01576380|VEGF|vegf
5432669|NCT01576380|FGFR|fgfr
5432670|NCT01576380|Neoplasms|neoplasms
5432671|NCT01576380|Gastric Neoplasms|gastric neoplasms
5432672|NCT01576380|Cancer|cancer
5432673|NCT01576380|Carcinoma|carcinoma
5432674|NCT01576380|Gastric Diseases|gastric diseases
5432675|NCT01576380|Female Genital Diseases|female genital diseases
5432676|NCT01576380|Tumors|tumors
5432677|NCT01576380|Oral Administration|oral administration
5432678|NCT01576380|Capsules|capsules
5432679|NCT01576380|TKI258|tki258
5432680|NCT01576380|TKI-258|tki-258
5432681|NCT01576380|TKI 258|tki 258
5432682|NCT01576367|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
5432683|NCT01576367|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5432684|NCT01576367|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5432685|NCT01576367|Neonatal Onset Multisystem Inflammatory Disease (NOMID)|neonatal onset multisystem inflammatory disease (nomid)
5432686|NCT01576367|children, systemic autoinflammatory disease|children, systemic autoinflammatory disease
5432687|NCT01576367|CIAS-1 gene|cias-1 gene
5432688|NCT01576367|NALP-3|nalp-3
5432689|NCT01576367|NLRP3|nlrp3
5432690|NCT01576367|ACZ885|acz885
5432691|NCT01576367|canakinumab|canakinumab
5432692|NCT01576367|human monoclonal anti-human interleukin-1 antibody|human monoclonal anti-human interleukin-1 antibody
5432693|NCT01576367|autosomal dominant|autosomal dominant
5432694|NCT01576367|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5432695|NCT01576367|childhood immunizations vaccinations|childhood immunizations vaccinations
5432696|NCT01576354|Multiple Sclerosis|multiple sclerosis
5432697|NCT01576354|walking function|walking function
5432698|NCT01576354|fampridine|fampridine
5432699|NCT01576341|Epoetin alfa, ESA, HX575, CKD|epoetin alfa, esa, hx575, ckd
5432700|NCT01576315|cystic fibrosis|cystic fibrosis
5432701|NCT01576315|Aspergillus|aspergillus
5432702|NCT01576315|itraconazole|itraconazole
5432703|NCT01576315|voriconazole|voriconazole
5432704|NCT01576302|Rumination|rumination
5432705|NCT01576289|Esophagus|esophagus
5432706|NCT01576289|Gastroesophageal reflux|gastroesophageal reflux
5432707|NCT01576289|Reflux esophagitis|reflux esophagitis
5432708|NCT01576289|Barrett's esophagus|barrett's esophagus
5432709|NCT01576289|Stomach|stomach
5432710|NCT01576289|Intestinal metaplasia stomach|intestinal metaplasia stomach
5432711|NCT01576289|Helicobacter pylori infection|helicobacter pylori infection
5432712|NCT01576289|Proton pump inhibitor|proton pump inhibitor
5432713|NCT01576289|Duodenum|duodenum
5432714|NCT01576289|Duodenal bulb|duodenal bulb
5432715|NCT01576289|Celiac disease diagnosis|celiac disease diagnosis
5432717|NCT01576263|Infiltration|infiltration
5432718|NCT01576263|Blood transfusion|blood transfusion
5432719|NCT01576263|Autologous|autologous
5432720|NCT01576263|Arthroplasty|arthroplasty
5432721|NCT01576263|Replacement|replacement
5432722|NCT01576263|Ropivacaine|ropivacaine
5432723|NCT01576237|hemovigilance|hemovigilance
5432724|NCT01576237|hemapheresis|hemapheresis
5432725|NCT01576237|donor vigilance|donor vigilance
5432726|NCT01576237|plasmapheresis|plasmapheresis
5432727|NCT01576237|platelet apheresis|platelet apheresis
5417988|NCT01640847|Bone Cancer|bone cancer
5432728|NCT01576237|leukapheresis|leukapheresis
5432729|NCT01576237|stem cell apheresis|stem cell apheresis
5432730|NCT01576237|granulocyte apheresis|granulocyte apheresis
5432731|NCT01576237|monocyte apheresis|monocyte apheresis
5432732|NCT01576237|red cell apheresis|red cell apheresis
5432733|NCT01576224|Volar locking plate osteosynthesis|volar locking plate osteosynthesis
5432734|NCT01576224|Early mobilization|early mobilization
5432736|NCT01576211|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5432737|NCT01576198|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5432738|NCT01576159|Biochemical Marker|biochemical marker
5432739|NCT01576159|Fitness Exercises|fitness exercises
5432740|NCT01576159|Impact|impact
5432741|NCT01576159|Articular Cartilage|articular cartilage
5432742|NCT01576146|Clinical Trial, Phase 2|clinical trial, phase 2
5432743|NCT01576146|Renal Dialysis|renal dialysis
5432744|NCT01576146|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5432745|NCT01576146|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
5432746|NCT01576146|Parathyroid hormone|parathyroid hormone
5432747|NCT01576133|Quality of Life|quality of life
5432748|NCT01576120|Known, active Crohn's disease|known, active crohn's disease
5432749|NCT01576120|Iieocolonic or colonic involvement|iieocolonic or colonic involvement
5432750|NCT01576120|proven patency of the GI tract|proven patency of the gi tract
5432751|NCT01576107|Different cancer entities|different cancer entities
5432752|NCT01576094|congenital heart disease|congenital heart disease
5432753|NCT01576081|bone density|bone density
5432754|NCT01576081|weight bearing|weight bearing
5432755|NCT01576081|muscle atrophy|muscle atrophy
5432756|NCT01576081|vascular degeneration|vascular degeneration
5432757|NCT01576081|gravitational loading|gravitational loading
5432758|NCT01576081|muscular unloading|muscular unloading
5432759|NCT01576068|COPD|copd
5432760|NCT01576068|Pharmacy|pharmacy
5432761|NCT01576068|Spirometry|spirometry
5432762|NCT01576068|Case finding|case finding
5432763|NCT01576055|Peripheral Arterial Disease|peripheral arterial disease
5432764|NCT01576055|Superficial Femoral Artery|superficial femoral artery
5432765|NCT01576055|Proximal Popliteal Artery|proximal popliteal artery
5432766|NCT01576055|PAD|pad
5432767|NCT01576055|SFA|sfa
5432768|NCT01576055|PPA|ppa
5432769|NCT01576055|Stent|stent
5432770|NCT01576055|Gore|gore
5432771|NCT01576055|Bare Metal Stent|bare metal stent
5432772|NCT01576055|LifeStent|lifestent
5432773|NCT01576055|atherosclerosis|atherosclerosis
5432774|NCT01576055|Heparin|heparin
5432775|NCT01576055|claudication|claudication
5432776|NCT01576055|leg pain|leg pain
5432777|NCT01576042|Ischemic heart disease|ischemic heart disease
5432778|NCT01576042|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5432779|NCT01576042|Ventricular Tachycardia|ventricular tachycardia
5432780|NCT01576042|Patient with Implantable Cardioverter Defibrillator (ICD)|patient with implantable cardioverter defibrillator (icd)
5432781|NCT01576016|bradycardia|bradycardia
5432782|NCT01576016|MRI scans|mri scans
5432783|NCT01576003|Short Bowel Syndrome|short bowel syndrome
5432784|NCT01576003|Necrotizing Entercolitis (NEC)|necrotizing entercolitis (nec)
5432785|NCT01576003|Atresia|atresia
5432786|NCT01576003|Parenteral Nutrition|parenteral nutrition
5432787|NCT01576003|Biological Markers|biological markers
5432788|NCT01576003|Growth|growth
5432789|NCT01575990|Colon cancer screening|colon cancer screening
5432790|NCT01575990|Decision support interventions|decision support interventions
5432791|NCT01575990|Health status|health status
5432792|NCT01575990|Patient-centered care|patient-centered care
5432793|NCT01575990|Age|age
5432794|NCT01575990|Randomized controlled trial|randomized controlled trial
5432795|NCT01575990|Double blind|double blind
5432796|NCT01575990|UNC|unc
5432797|NCT01575938|HIV infection|hiv infection
5432798|NCT01575925|Pomalidomide for multiple myeloma|pomalidomide for multiple myeloma
5432799|NCT01575925|renal impairment|renal impairment
5432800|NCT01575925|multiple myeloma patients with renal impairment|multiple myeloma patients with renal impairment
5432801|NCT01575925|Pomalidomide for patients with renal impairment due to multiple myeloma|pomalidomide for patients with renal impairment due to multiple myeloma
5432802|NCT01575925|Pomalidomide|pomalidomide
5432803|NCT01575925|dexamethasone|dexamethasone
5432804|NCT01575925|RRMM|rrmm
5432805|NCT01575925|impaired renal function in multiple myeloma|impaired renal function in multiple myeloma
5432806|NCT01575925|hemodialysis|hemodialysis
5432807|NCT01575925|dialysis|dialysis
5432808|NCT01575925|POM|pom
5432810|NCT01575925|MM|mm
5432811|NCT01575925|severe renal impairment|severe renal impairment
5432812|NCT01575925|CrCl ≤ 30 mL/min|crcl ≤ 30 ml/min
5432813|NCT01575925|Creatinine less than 30|creatinine less than 30
5432814|NCT01575925|clinical trial in subjects with multiple myeloma with renal impairement|clinical trial in subjects with multiple myeloma with renal impairement
5432815|NCT01575912|Schizophrenia|schizophrenia
5432816|NCT01575912|Major depression|major depression
5432817|NCT01575912|Pain|pain
5432818|NCT01575912|Past pain experience|past pain experience
5432819|NCT01575899|Helicobacter pylori|helicobacter pylori
5432820|NCT01575899|Levofloxacin|levofloxacin
5432821|NCT01575899|Amoxicillin/clavulanate|amoxicillin/clavulanate
5432822|NCT01575899|Rabeprazole|rabeprazole
5432823|NCT01575899|Eastern Taiwan|eastern taiwan
5432824|NCT01575886|clinician patient communication|clinician patient communication
5432825|NCT01575886|smoking cessation|smoking cessation
5432826|NCT01575886|weight management|weight management
5432827|NCT01575886|primary care|primary care
5432828|NCT01575886|health behavior change advice|health behavior change advice
5432829|NCT01575873|GIOP, Glucocorticoid, osteporosis, denosumab, BMD, Bone Mineral Density|giop, glucocorticoid, osteporosis, denosumab, bmd, bone mineral density
5432830|NCT01575860|biopsy-proven diagnosis|biopsy-proven diagnosis
5432831|NCT01575860|completed at least 2 cycles of salvage chemotherapy|completed at least 2 cycles of salvage chemotherapy
5432832|NCT01575860|showing PET positive residual lesions|showing pet positive residual lesions
5432833|NCT01575847|Acetaminophen|acetaminophen
5432834|NCT01575847|Acetaminophen Toxicity|acetaminophen toxicity
5432835|NCT01575834|Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases|osteoporosis, osteoporosis-postmenopausal, bone diseases-metabolic, bone diseases, musculoskeletal diseases
5432836|NCT01575821|children, cough, honey|children, cough, honey
5432837|NCT01575808|Symptomatic PAD|symptomatic pad
5432838|NCT01575808|Stenosis|stenosis
5432839|NCT01575808|Occlusion|occlusion
5432840|NCT01575795|Ticagrelor|ticagrelor
5432841|NCT01575795|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5432842|NCT01575795|Platelet reactivity|platelet reactivity
5432843|NCT01575782|small cell lung cancer|small cell lung cancer
5432844|NCT01575782|stage I-III|stage i-iii
5432845|NCT01575782|chloroquine|chloroquine
5432847|NCT01575730|Peritoneal carcinomatosis from colorectal or appendiceal origin|peritoneal carcinomatosis from colorectal or appendiceal origin
5432848|NCT01575717|Vitamin D|vitamin d
5432849|NCT01575717|hepatocellular carcinoma|hepatocellular carcinoma
5432850|NCT01575717|liver neoplasms|liver neoplasms
5432851|NCT01575717|liver transplantation|liver transplantation
5432852|NCT01575704|Exercise|exercise
5432853|NCT01575704|Hematopoetic cell transplantation|hematopoetic cell transplantation
5432854|NCT01575704|Children|children
5432855|NCT01575678|enuresis|enuresis
5432856|NCT01575678|melatonin|melatonin
5432857|NCT01575678|circadian rhythm|circadian rhythm
5432858|NCT01575678|children|children
5432859|NCT01575678|blood pressure|blood pressure
5432860|NCT01575678|urine production|urine production
5432861|NCT01575678|activity|activity
5432862|NCT01575678|sleep|sleep
5432863|NCT01575665|Hyperventilation|hyperventilation
5432864|NCT01575665|Chronic Idiopathic Hyperventilation|chronic idiopathic hyperventilation
5432865|NCT01575665|Dysfunctional Breathing|dysfunctional breathing
5432866|NCT01575665|Respiratory Alkalosis|respiratory alkalosis
5432867|NCT01575665|Respiratory Acidosis|respiratory acidosis
5432868|NCT01575652|peritoneal dialysis|peritoneal dialysis
5432869|NCT01575652|protein losses|protein losses
5432870|NCT01575613|malaria|malaria
5432871|NCT01575613|heterogeneity|heterogeneity
5432872|NCT01575613|transmission|transmission
5432873|NCT01575613|elimination|elimination
5432874|NCT01575587|Pharmacology|pharmacology
5432875|NCT01575587|Pharmacokinetics|pharmacokinetics
5432876|NCT01575587|Pharmacodynamics|pharmacodynamics
5432877|NCT01575587|Abiraterone acetate|abiraterone acetate
5432878|NCT01575587|Food intake|food intake
5432879|NCT01575587|Caucasion|caucasion
5432880|NCT01575587|Japanese|japanese
5432881|NCT01575587|Healthy|healthy
5432882|NCT01575561|Lurasidone|lurasidone
5432883|NCT01575561|Latuda|latuda
5432884|NCT01575561|Bipolar Disorder|bipolar disorder
5432885|NCT01575535|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5432886|NCT01575535|adult acute basophilic leukemia|adult acute basophilic leukemia
5432887|NCT01575535|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5432888|NCT01575535|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5432889|NCT01575535|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5432890|NCT01575535|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5432891|NCT01575535|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5432892|NCT01575535|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5432893|NCT01575535|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5432894|NCT01575535|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5432895|NCT01575535|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5415736|NCT01651494|DAS181|das181
5432896|NCT01575535|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5432897|NCT01575535|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5432898|NCT01575535|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5432899|NCT01575535|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5432900|NCT01575535|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5432901|NCT01575535|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5432903|NCT01575496|Transcranial direct current stimulation|transcranial direct current stimulation
5432904|NCT01575496|Transcranial magnetic stimulation|transcranial magnetic stimulation
5432905|NCT01575470|Traumatic Brain Injury|traumatic brain injury
5432907|NCT01575470|stem cells|stem cells
5432908|NCT01575457|Adolescent Violence Prevention|adolescent violence prevention
5432909|NCT01575444|Pap test|pap test
5432910|NCT01575444|HPV testing|hpv testing
5432911|NCT01575444|cervical cancer|cervical cancer
5432912|NCT01575431|coronary artery disease|coronary artery disease
5432913|NCT01575431|endothelial progenitor cells|endothelial progenitor cells
5432914|NCT01575392|creatinine|creatinine
5432915|NCT01575392|chronic kidney disease|chronic kidney disease
5432916|NCT01575392|creatinine clearance|creatinine clearance
5432917|NCT01575392|estimated glomerular filtration rate|estimated glomerular filtration rate
5432918|NCT01575340|inflammatory markers|inflammatory markers
5432919|NCT01575340|colorectal cancer|colorectal cancer
5432920|NCT01575340|cytokines|cytokines
5432921|NCT01575340|fish oil|fish oil
5432922|NCT01575314|stapling device|stapling device
5432923|NCT01575314|lobectomy|lobectomy
5432924|NCT01575314|cost utility|cost utility
5432925|NCT01575301|GLP-1R agonist|glp-1r agonist
5432926|NCT01575301|biomarker|biomarker
5432927|NCT01575288|arterial function|arterial function
5432928|NCT01575288|cardiovascular|cardiovascular
5432929|NCT01575288|aging|aging
5432930|NCT01575288|endothelial function|endothelial function
5432931|NCT01575288|arterial stiffness|arterial stiffness
5432932|NCT01575288|vascular function|vascular function
5432933|NCT01575288|Trehalose|trehalose
5432934|NCT01575262|behaviour change|behaviour change
5432935|NCT01575262|incentives|incentives
5432936|NCT01575262|nudging|nudging
5432937|NCT01575262|physical activity|physical activity
5432938|NCT01575262|self-monitoring|self-monitoring
5432939|NCT01575249|progression|progression
5432940|NCT01575249|moderate aortic stenosis|moderate aortic stenosis
5432941|NCT01575249|asymptomatic|asymptomatic
5432942|NCT01575249|symptomatic|symptomatic
5432943|NCT01575223|saline irrigation|saline irrigation
5432944|NCT01575223|chronic rhinosinusitis|chronic rhinosinusitis
5432945|NCT01575223|endoscopic sinus surgery|endoscopic sinus surgery
5432946|NCT01575223|high volume saline irrigation|high volume saline irrigation
5432947|NCT01575184|internal jugular vein cannulation|internal jugular vein cannulation
5432948|NCT01575184|common carotid artery|common carotid artery
5432949|NCT01575184|infants|infants
5432950|NCT01575132|Parkinson's Disease|parkinson's disease
5432951|NCT01575132|Stimulation, Deep Brain|stimulation, deep brain
5432952|NCT01575132|Study, Follow-Up|study, follow-up
5432953|NCT01575132|Adverse Effects|adverse effects
5432954|NCT01575119|Cigarette smoker|cigarette smoker
5432955|NCT01575119|Elective surgery|elective surgery
5432956|NCT01575093|Healthy volunteers|healthy volunteers
5432958|NCT01575041|sodium|sodium
5432959|NCT01575041|salt|salt
5432960|NCT01575041|potassium|potassium
5432961|NCT01575041|blood pressure|blood pressure
5432962|NCT01575041|flow-mediated dilatation|flow-mediated dilatation
5432963|NCT01575041|endothelial function|endothelial function
5432964|NCT01575041|renal function|renal function
5432965|NCT01575041|controlled feeding study|controlled feeding study
5432966|NCT01575041|dietary intervention|dietary intervention
5432967|NCT01575028|Transversus abdominis plane block|transversus abdominis plane block
5432968|NCT01575028|TAP block|tap block
5432969|NCT01575028|Local anesthetic infiltration|local anesthetic infiltration
5432970|NCT01575028|Appendectomy|appendectomy
5432971|NCT01575028|Laparoscopic appendectomy|laparoscopic appendectomy
5432972|NCT01575015|Liver transplantation (E04.210.650)|liver transplantation (e04.210.650)
5432973|NCT01575015|Renal replacement therapy (E05.196.353)|renal replacement therapy (e05.196.353)
5432974|NCT01575015|Intra-operative period (E04.614.374)|intra-operative period (e04.614.374)
5432975|NCT01575015|Safety (N06.850.135.060.075)|safety (n06.850.135.060.075)
5432976|NCT01575015|Efficacy|efficacy
5432977|NCT01575002|transcranial stimulation|transcranial stimulation
5432978|NCT01575002|direct current stimulation|direct current stimulation
5432979|NCT01574989|direct current stimulation|direct current stimulation
5432980|NCT01574989|magnetic stimulation|magnetic stimulation
5432981|NCT01574989|transcranial stimulation|transcranial stimulation
5432982|NCT01574976|ADHD|adhd
5432983|NCT01574976|probabilistic|probabilistic
5432984|NCT01574976|choice|choice
5432985|NCT01574976|feedback|feedback
5432986|NCT01574976|practice|practice
5432987|NCT01574963|Coronary artery disease|coronary artery disease
5432995|NCT01574924|Perfectionism|perfectionism
5432997|NCT01574924|Medical Specialty|medical specialty
5432998|NCT01574924|Medical Residency|medical residency
5432999|NCT01574911|volumetry 3D|volumetry 3d
5433000|NCT01574911|Displacement of water|displacement of water
5433001|NCT01574911|lymphoedema|lymphoedema
5433002|NCT01574911|Venous chronic insufficiency|venous chronic insufficiency
5433003|NCT01574898|Smoking cessation|smoking cessation
5433004|NCT01574898|Nicotine|nicotine
5433005|NCT01574898|Tobacco Use Disorder|tobacco use disorder
5433006|NCT01574898|Central Nervous System Agents|central nervous system agents
5433007|NCT01574885|sleep apnea|sleep apnea
5433008|NCT01574885|adenotonsillar hypertrophy|adenotonsillar hypertrophy
5433009|NCT01574885|salt|salt
5433010|NCT01574885|sodium chloride|sodium chloride
5433011|NCT01574872|psoriasis|psoriasis
5433012|NCT01574872|salt|salt
5433013|NCT01574872|sodium chloride|sodium chloride
5433014|NCT01574859|central hypothyroidism|central hypothyroidism
5433015|NCT01574859|hypopituitarism|hypopituitarism
5433016|NCT01574859|levothyroxine replacement|levothyroxine replacement
5433018|NCT01574859|body composition|body composition
5433019|NCT01574820|prediabetes|prediabetes
5433020|NCT01574820|coronary artery disease|coronary artery disease
5433021|NCT01574820|insulin resistance|insulin resistance
5433022|NCT01574820|glucose intolerance|glucose intolerance
5433023|NCT01574807|mepivacaine|mepivacaine
5433024|NCT01574807|lidocaine|lidocaine
5433025|NCT01574807|inferior alveolar nerve block|inferior alveolar nerve block
5433026|NCT01574807|pulpal anesthesia|pulpal anesthesia
5433027|NCT01574807|pain of injection|pain of injection
5433028|NCT01574807|mepivacaine/lidocaine|mepivacaine/lidocaine
5433029|NCT01574807|lidocaine/lidocaine|lidocaine/lidocaine
5433030|NCT01574781|Down syndrome|down syndrome
5433031|NCT01574781|Trisomy 13|trisomy 13
5433032|NCT01574781|Trisomy 18|trisomy 18
5433033|NCT01574781|Microdeletions|microdeletions
5433034|NCT01574781|Pregnancy|pregnancy
5433035|NCT01574781|Non-invasive|non-invasive
5433036|NCT01574755|gastric inlet patches|gastric inlet patches
5433037|NCT01574755|argon plasma coagulation|argon plasma coagulation
5433038|NCT01574755|globus sensations|globus sensations
5433039|NCT01574729|p53 gene therapy|p53 gene therapy
5433040|NCT01574729|non-small cell lung cancer|non-small cell lung cancer
5433041|NCT01574729|post-surgery|post-surgery
5433042|NCT01574729|chemotherapy|chemotherapy
5433043|NCT01574703|smoking cessation|smoking cessation
5433044|NCT01574703|psychiatric disease|psychiatric disease
5433045|NCT01574703|cardiovascular events|cardiovascular events
5433046|NCT01574690|central venous pressure|central venous pressure
5433047|NCT01574690|right heart catheter (RHC)|right heart catheter (rhc)
5433048|NCT01574690|non-invasive monitor|non-invasive monitor
5433049|NCT01574690|physical exam of jugular venous pressure|physical exam of jugular venous pressure
5433050|NCT01574690|heart failure (HF)|heart failure (hf)
5433051|NCT01574677|Colorectal cancer|colorectal cancer
5433052|NCT01574677|fecal immunochemical test|fecal immunochemical test
5433053|NCT01574677|Septin 9|septin 9
5433054|NCT01574677|screening|screening
5433055|NCT01574651|QVA149|qva149
5433056|NCT01574651|Health related quality of life|health related quality of life
5433057|NCT01574651|Formoterol|formoterol
5433058|NCT01574651|Tiotropium|tiotropium
5433059|NCT01574651|COPD|copd
5433060|NCT01574612|Xerese|xerese
5433061|NCT01574612|acyclovir hydrocortisone cream|acyclovir hydrocortisone cream
5433062|NCT01574612|herpes labialis|herpes labialis
5433063|NCT01574612|pediatric|pediatric
5433064|NCT01574599|Stroke|stroke
5433065|NCT01574599|weakness|weakness
5433066|NCT01574599|rehabilitation|rehabilitation
5433067|NCT01574599|chronic stroke|chronic stroke
5433068|NCT01574586|True Bifurcation stenosis|true bifurcation stenosis
5433069|NCT01574573|Obesity|obesity
5433070|NCT01574573|GERD|gerd
5433071|NCT01574573|Weight loss|weight loss
5433072|NCT01574560|smoke-free|smoke-free
5433073|NCT01574560|tobacco exposure|tobacco exposure
5433074|NCT01574560|biomarker feedback|biomarker feedback
5433075|NCT01574560|nicotine|nicotine
5433076|NCT01574560|cotinine|cotinine
5433077|NCT01574560|secondhand smoke|secondhand smoke
5433078|NCT01574547|Cat Scratch Colon.|cat scratch colon.
5433079|NCT01574547|Mucosal tears.|mucosal tears.
5433080|NCT01574547|Mucosal erosion.|mucosal erosion.
5433081|NCT01574547|Colonoscopy.|colonoscopy.
5433082|NCT01574508|efficacy|efficacy
5433083|NCT01574508|safety|safety
5433084|NCT01574508|intensive insulin therapy|intensive insulin therapy
5433085|NCT01574495|stroke|stroke
5433086|NCT01574495|error augmentation|error augmentation
5433087|NCT01574495|arm recovery|arm recovery
5433088|NCT01574495|massed practice|massed practice
5433089|NCT01574482|Plant sterol - Hypercholesterolemia - diet - dairy|plant sterol - hypercholesterolemia - diet - dairy
5415929|NCT01650545|Lung function|lung function
5433090|NCT01574469|Plant sterol - Cholesterol absorption - diet - dairy - LDL|plant sterol - cholesterol absorption - diet - dairy - ldl
5433091|NCT01574443|Epilepsy|epilepsy
5433092|NCT01574417|Plant stanols|plant stanols
5433093|NCT01574417|Gene expression profile|gene expression profile
5433094|NCT01574417|Microbiota|microbiota
5433095|NCT01574404|PGS,PGD, IVF, Polar Body Biopsy, FISH, Microarray analysis|pgs,pgd, ivf, polar body biopsy, fish, microarray analysis
5433096|NCT01574378|Abdominoplasty|abdominoplasty
5433097|NCT01574365|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
5433098|NCT01574352|Children|children
5433099|NCT01574352|Overweight|overweight
5433102|NCT01574352|Physical activity|physical activity
5433103|NCT01574352|Cognitive function|cognitive function
5433104|NCT01574352|Intervention study|intervention study
5433105|NCT01574352|Randomized controlled trial|randomized controlled trial
5433106|NCT01574352|Day camp|day camp
5433107|NCT01574352|Risk factors|risk factors
5433108|NCT01574339|GERD|gerd
5433109|NCT01574339|LES Pressure|les pressure
5433110|NCT01574339|Electrical Stimulation|electrical stimulation
5433111|NCT01574326|Chronic Kidney Disease|chronic kidney disease
5433112|NCT01574326|Pediatric|pediatric
5433113|NCT01574326|Sevelamer Carbonate|sevelamer carbonate
5433114|NCT01574326|Hyperphosphatemia|hyperphosphatemia
5433115|NCT01574313|stellate ganglion block.|stellate ganglion block.
5433116|NCT01574313|Meniere's disease.|meniere's disease.
5433117|NCT01574313|electrocochleography.|electrocochleography.
5433118|NCT01574313|vertigo.|vertigo.
5433119|NCT01574313|hearing impairment.|hearing impairment.
5433120|NCT01574300|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5433121|NCT01574300|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5433122|NCT01574300|M1A or B NSCLC|m1a or b nsclc
5433123|NCT01574261|Polycystic Ovary Syndrome|polycystic ovary syndrome
5433124|NCT01574261|Cardiovascular risk|cardiovascular risk
5433125|NCT01574261|Metabolic Syndrome|metabolic syndrome
5433126|NCT01574248|ACE inhibitor|ace inhibitor
5433127|NCT01574248|Angioedema|angioedema
5433128|NCT01574248|Bradykinin|bradykinin
5433129|NCT01574248|Swelling|swelling
5433130|NCT01574222|Stages IIIB, IV, and recurrent NSCLC|stages iiib, iv, and recurrent nsclc
5433131|NCT01574222|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
5433137|NCT01574222|Lung Diseases|lung diseases
5433138|NCT01574209|Celiac disease|celiac disease
5433140|NCT01574209|Intestinal barrier|intestinal barrier
5433141|NCT01574209|Intestinal permeability|intestinal permeability
5433142|NCT01574209|GI peptides|gi peptides
5433143|NCT01574196|Childhood cancer|childhood cancer
5433144|NCT01574196|Cancer|cancer
5433145|NCT01574196|Sequels|sequels
5433146|NCT01574196|Complications|complications
5433147|NCT01574196|Chemotherapy|chemotherapy
5433148|NCT01574196|Radiotherapy|radiotherapy
5433149|NCT01574196|Surgery|surgery
5433150|NCT01574196|Autonomic nervous system|autonomic nervous system
5433151|NCT01574196|Parasympathetic Nervous System|parasympathetic nervous system
5433152|NCT01574196|Sympathetic Nervous System|sympathetic nervous system
5433153|NCT01574183|Marijuana|marijuana
5433154|NCT01574183|Vilazodone|vilazodone
5433155|NCT01574183|Contingency management|contingency management
5433156|NCT01574183|Motivational enhancement therapy|motivational enhancement therapy
5433157|NCT01574170|Breast cancer,|breast cancer,
5433158|NCT01574170|Third line metastatic|third line metastatic
5433159|NCT01574170|Chemotherapy,|chemotherapy,
5433160|NCT01574170|Overall survival,|overall survival,
5433161|NCT01574170|Quality of life.|quality of life.
5433162|NCT01574144|Heart Failure|heart failure
5433163|NCT01574131|Burn|burn
5433164|NCT01574131|Fenofibrate|fenofibrate
5433165|NCT01574131|PPAR alpha agonist|ppar alpha agonist
5433166|NCT01574131|insulin sensitivity|insulin sensitivity
5433167|NCT01574131|mitochondrial|mitochondrial
5433168|NCT01574118|PTSD|ptsd
5433169|NCT01574118|Posttraumatic Stress Disorder|posttraumatic stress disorder
5433170|NCT01574118|Exposure Therapy|exposure therapy
5433171|NCT01574118|Prolonged Exposure|prolonged exposure
5433172|NCT01574118|Fear Memory Retrieval|fear memory retrieval
5433173|NCT01574118|Compound extinction|compound extinction
5433174|NCT01574118|Deepened extinction|deepened extinction
5433175|NCT01574118|Psychotherapy|psychotherapy
5433176|NCT01574105|Heparin Dose|heparin dose
5433177|NCT01574105|Heparin Resistance|heparin resistance
5433178|NCT01574105|Chest Tube Losses|chest tube losses
5433179|NCT01574105|Transfusion Events|transfusion events
5433180|NCT01574092|Pediatric|pediatric
5433181|NCT01574092|Pediatrics|pediatrics
5433182|NCT01574092|Gliomas|gliomas
5433183|NCT01574092|Glioma|glioma
5433184|NCT01574092|Brain tumor|brain tumor
5433185|NCT01574092|Brain cancer|brain cancer
5433186|NCT01574092|Cisplatin|cisplatin
5433187|NCT01574092|Cisplatino|cisplatino
5433188|NCT01574092|Irinotecan|irinotecan
5433189|NCT01574092|Brain stem tumor|brain stem tumor
5433205|NCT01574040|Lifestyle modification|lifestyle modification
5433207|NCT01574040|Primary prevention|primary prevention
5433208|NCT01574040|Healthy staff and visitors of an Academic Hospital|healthy staff and visitors of an academic hospital
5445475|NCT01521572|forced oscillation technique,|forced oscillation technique,
5433209|NCT01574027|Assess the efficacy of vitamin D for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin D-based therapy.|assess the efficacy of vitamin d for preventing colorectal cancer and identifying the populations likely (or unlikely) to benefit from vitamin d-based therapy.
5433210|NCT01574027|Evaluate the ability of Vitamin D3 (cholecalciferol) to reduce ACF's in humans.|evaluate the ability of vitamin d3 (cholecalciferol) to reduce acf's in humans.
5433211|NCT01574014|Anxiety Disorder|anxiety disorder
5433212|NCT01574014|Phobic Disorders|phobic disorders
5433213|NCT01574001|ischemic stroke|ischemic stroke
5433214|NCT01574001|smoking cessation|smoking cessation
5433215|NCT01574001|antismoking interventions|antismoking interventions
5433216|NCT01573988|Nutrition|nutrition
5433218|NCT01573988|Food intake|food intake
5433219|NCT01573988|Eating behavior|eating behavior
5433220|NCT01573988|Satiety|satiety
5433221|NCT01573988|Ghrelin|ghrelin
5433222|NCT01573975|Helicobacter pylori|helicobacter pylori
5433223|NCT01573975|antibiotic resistance|antibiotic resistance
5433224|NCT01573975|sequential therapy|sequential therapy
5433225|NCT01573975|Taiwan|taiwan
5433226|NCT01573962|Kidney Renal|kidney renal
5433227|NCT01573949|Heart Failure|heart failure
5433228|NCT01573949|Diabetes|diabetes
5433229|NCT01573949|Pre-diabetes|pre-diabetes
5433230|NCT01573949|Early type II diabetes|early type ii diabetes
5433231|NCT01573949|Metformin|metformin
5433232|NCT01573949|Pharmacotherapy with metformin for prevention of DM in HF patients with pre-diabetes (pre-DM) and glycemic control in HF patients with early type II DM|pharmacotherapy with metformin for prevention of dm in hf patients with pre-diabetes (pre-dm) and glycemic control in hf patients with early type ii dm
5433233|NCT01573936|acquired brain injury|acquired brain injury
5433234|NCT01573936|health-related quality of life|health-related quality of life
5433235|NCT01573936|poliomyelitis survivor|poliomyelitis survivor
5433236|NCT01573936|rehabilitation|rehabilitation
5433237|NCT01573936|spinal cord injury|spinal cord injury
5433238|NCT01573936|completed the WHOQOL-BREF|completed the whoqol-bref
5433239|NCT01573923|Umbilical Mesenchymal Stem Cells; Liver cirrhosis|umbilical mesenchymal stem cells; liver cirrhosis
5433240|NCT01573910|Bacterial conjunctivitis|bacterial conjunctivitis
5433241|NCT01573910|Anti-infective|anti-infective
5433242|NCT01573910|Antibiotics|antibiotics
5433243|NCT01573897|Diabetes|diabetes
5433244|NCT01573897|Sleep apnea|sleep apnea
5433245|NCT01573897|Diabetic foot|diabetic foot
5433246|NCT01573897|Microcirculation|microcirculation
5433247|NCT01573858|Infertility|infertility
5433248|NCT01573858|Polycystic Ovary Syndrome|polycystic ovary syndrome
5433249|NCT01573858|Clomiphene citrate|clomiphene citrate
5433250|NCT01573858|Acupuncture|acupuncture
5433251|NCT01573845|child|child
5433252|NCT01573845|communication|communication
5433253|NCT01573845|diet|diet
5433254|NCT01573845|food|food
5433255|NCT01573845|health communication|health communication
5433256|NCT01573845|nutrition|nutrition
5433257|NCT01573845|parents|parents
5433258|NCT01573845|primary schools|primary schools
5433259|NCT01573845|school age population|school age population
5433260|NCT01573845|school health|school health
5433261|NCT01573819|repeat dose|repeat dose
5433262|NCT01573819|PDE4|pde4
5433263|NCT01573819|healthy volunteers|healthy volunteers
5433264|NCT01573819|GSK356278|gsk356278
5433265|NCT01573806|sepsis|sepsis
5433266|NCT01573806|septic shock|septic shock
5433267|NCT01573806|children|children
5433268|NCT01573806|incretins|incretins
5433269|NCT01573806|exenatide|exenatide
5433270|NCT01573806|pharmacokinetics|pharmacokinetics
5433271|NCT01573806|pharmacodynamics|pharmacodynamics
5433272|NCT01573806|glucose homeostasis|glucose homeostasis
5433273|NCT01573806|inflammation|inflammation
5433274|NCT01573806|cytokines|cytokines
5433275|NCT01573806|health-related quality of life|health-related quality of life
5433276|NCT01573806|functional status|functional status
5428178|NCT01595802|Cerebral vasospasm|cerebral vasospasm
5433277|NCT01573754|Porphyria, rare disease, orphan disease, iron metabolism|porphyria, rare disease, orphan disease, iron metabolism
5433278|NCT01573741|depressive ketamine antidepressant|depressive ketamine antidepressant
5433280|NCT01573728|Biomarkers|biomarkers
5433281|NCT01573728|Exercise|exercise
5433282|NCT01573702|Non small cell lung cancer|non small cell lung cancer
5433283|NCT01573702|EGFR mutant|egfr mutant
5433284|NCT01573702|Phase II|phase ii
5433285|NCT01573702|erlotinib|erlotinib
5433286|NCT01573702|tarceva|tarceva
5433287|NCT01573702|cyberknife|cyberknife
5433288|NCT01573702|Lineberger|lineberger
5433289|NCT01573689|bereaved children, mutual aid group, death, group intervention.|bereaved children, mutual aid group, death, group intervention.
5433290|NCT01573676|bariatric surgery|bariatric surgery
5433291|NCT01573676|sleep apnea|sleep apnea
5433292|NCT01573676|overweight|overweight
5433293|NCT01573663|Ambroxol|ambroxol
5433294|NCT01573663|Levodropropizine|levodropropizine
5433295|NCT01573663|Drug-drug interaction|drug-drug interaction
5433297|NCT01573637|negative schizophrenia|negative schizophrenia
5433298|NCT01573637|schizophrenia in post-menopausal women|schizophrenia in post-menopausal women
5433299|NCT01573637|schizophrenia in women|schizophrenia in women
5433300|NCT01573637|ralixifene|ralixifene
5433301|NCT01573637|raloxifen|raloxifen
5433302|NCT01573637|raloxifeno|raloxifeno
5433303|NCT01573637|negative symptoms of schizophrenia|negative symptoms of schizophrenia
5433304|NCT01573637|negative symptoms in schizophrenia|negative symptoms in schizophrenia
5433305|NCT01573637|schizophrenia symptoms|schizophrenia symptoms
5433306|NCT01573637|negative symptoms of psychosis|negative symptoms of psychosis
5433307|NCT01573624|Fluticasone Furoate|fluticasone furoate
5433308|NCT01573624|Vilanterol|vilanterol
5433309|NCT01573624|Adults|adults
5433310|NCT01573624|GSK573719|gsk573719
5433311|NCT01573624|Asthma|asthma
5433312|NCT01573611|mild cognitive impairment|mild cognitive impairment
5433313|NCT01573611|dementia|dementia
5433314|NCT01573611|positron emission tomography (PET)|positron emission tomography (pet)
5433315|NCT01573611|F-18 Fluorodeoxyglucose (FDG)|f-18 fluorodeoxyglucose (fdg)
5433316|NCT01573611|cerebral metabolism|cerebral metabolism
5433317|NCT01573611|dietary supplement|dietary supplement
5433318|NCT01573598|Major Depressive Disorder|major depressive disorder
5433319|NCT01573598|Depression|depression
5433320|NCT01573585|Physical Therapy|physical therapy
5433321|NCT01573585|Exercise therapy|exercise therapy
5433322|NCT01573559|Ambulatory adults with no apparent health conditions|ambulatory adults with no apparent health conditions
5433323|NCT01573533|Treatment Resistant Idiopathic FSGS|treatment resistant idiopathic fsgs
5433324|NCT01573533|Glomerulosclerosis|glomerulosclerosis
5433325|NCT01573533|Proteinuria|proteinuria
5433326|NCT01573533|Rituximab|rituximab
5433327|NCT01573520|compliance|compliance
5433328|NCT01573520|dialysis|dialysis
5433329|NCT01573520|hyperparathyroidism|hyperparathyroidism
5433330|NCT01573507|traumatic brain injury|traumatic brain injury
5433331|NCT01573507|lactate|lactate
5433332|NCT01573507|brain metabolism|brain metabolism
5433333|NCT01573507|cerebral microdialysis|cerebral microdialysis
5433334|NCT01573507|subarachnoid hemorrhage|subarachnoid hemorrhage
5433335|NCT01573507|transcranial doppler|transcranial doppler
5433336|NCT01573494|Cancer|cancer
5433337|NCT01573494|Melanoma|melanoma
5433338|NCT01573494|Circulating Tumor Cells|circulating tumor cells
5433339|NCT01573481|WEANING|weaning
5433340|NCT01573481|PRESSURE CONTROLLED CONTINOUS VENTILATION|pressure controlled continous ventilation
5433341|NCT01573481|PRESSURE VENTILATION SUPPORT|pressure ventilation support
5433343|NCT01573481|POLYGRAPHIC RECORD|polygraphic record
5433344|NCT01573442|hot flashes|hot flashes
5433345|NCT01573442|musculoskeletal complications|musculoskeletal complications
5433346|NCT01573442|sexual dysfunction|sexual dysfunction
5433347|NCT01573442|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5433348|NCT01573442|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5433349|NCT01573442|arthralgia|arthralgia
5433350|NCT01573442|stage IA breast cancer|stage ia breast cancer
5433351|NCT01573442|stage IB breast cancer|stage ib breast cancer
5433352|NCT01573442|stage II breast cancer|stage ii breast cancer
5433353|NCT01573442|stage IIIA breast cancer|stage iiia breast cancer
5433354|NCT01573442|stage IIIB breast cancer|stage iiib breast cancer
5433355|NCT01573442|stage IIIC breast cancer|stage iiic breast cancer
5433356|NCT01573429|Biologic Sample Collection|biologic sample collection
5433357|NCT01573429|Metabolism|metabolism
5433358|NCT01573429|Healthy Volunteer|healthy volunteer
5433359|NCT01573429|HV|hv
5433360|NCT01573416|Alcohol|alcohol
5433361|NCT01573416|Abuse|abuse
5433362|NCT01573416|Drugs|drugs
5433363|NCT01573416|Brief intervention|brief intervention
5433364|NCT01573416|ASSIST|assist
5433365|NCT01573403|Proton pump inhibitor (PPI)|proton pump inhibitor (ppi)
5433366|NCT01573403|DLBS2411|dlbs2411
5433367|NCT01573403|gastric pH|gastric ph
5433368|NCT01573390|Non-invasive|non-invasive
5433369|NCT01573390|tissue-oxygenation|tissue-oxygenation
5433370|NCT01573390|hyperspectral|hyperspectral
5433371|NCT01573390|CWC imaging system|cwc imaging system
5433372|NCT01573377|polycystic ovary syndrome|polycystic ovary syndrome
5433373|NCT01573377|insulin resistance|insulin resistance
5433375|NCT01573364|Hyperinflation|hyperinflation
5433376|NCT01573364|Reversibility|reversibility
5433377|NCT01573338|Cyclin dependent kinases|cyclin dependent kinases
5433378|NCT01573338|Drug therapy, combination|drug therapy, combination
5433379|NCT01573338|Small cell lung carcinoma|small cell lung carcinoma
5433380|NCT01573338|Etoposide|etoposide
5433381|NCT01573338|Cisplatin|cisplatin
5433382|NCT01573338|Carboplatin|carboplatin
5433383|NCT01573325|Cirrhosis of the liver|cirrhosis of the liver
5433384|NCT01573325|Pre-liver transplant Candidate|pre-liver transplant candidate
5433385|NCT01573325|Depression|depression
5433386|NCT01573325|Poor social support|poor social support
5433387|NCT01573325|Liver disease symptoms|liver disease symptoms
5433388|NCT01573325|Health releated quality of life|health releated quality of life
5433389|NCT01573312|influenza, vaccine, H5N1, monovalent, adjuvant, ASO3|influenza, vaccine, h5n1, monovalent, adjuvant, aso3
5433390|NCT01573299|Cerebral Infarction, Mobilization, Recovery|cerebral infarction, mobilization, recovery
5433391|NCT01573286|Infant Nutrition Disorders|infant nutrition disorders
5433392|NCT01573286|Childhood nutrition disorders|childhood nutrition disorders
5433393|NCT01573286|malnutrition|malnutrition
5433394|NCT01573286|post surgical syndromes|post surgical syndromes
5433397|NCT01573286|gastroschisis|gastroschisis
5433398|NCT01573273|cocaine|cocaine
5433399|NCT01573273|substance abuse|substance abuse
5433400|NCT01573273|drug abuse|drug abuse
5433401|NCT01573273|cocaine dependence|cocaine dependence
5433402|NCT01573273|drug addiction|drug addiction
5433403|NCT01573260|Parkinson's Disease|parkinson's disease
5433404|NCT01573260|Tango|tango
5433405|NCT01573247|Acute myeloid leukemia|acute myeloid leukemia
5433406|NCT01573247|Refractory Acute myeloid leukemia|refractory acute myeloid leukemia
5433407|NCT01573247|FLT3 inhibitor|flt3 inhibitor
5433408|NCT01573247|kinase inhibitor|kinase inhibitor
5433409|NCT01573234|MySkin patch|myskin patch
5433410|NCT01573234|Hydrogel bandage|hydrogel bandage
5433411|NCT01573234|Occlusive dressing|occlusive dressing
5433412|NCT01573208|Knee osteoarthritis|knee osteoarthritis
5433413|NCT01573195|deescalation|deescalation
5433414|NCT01573195|best practice alert|best practice alert
5433415|NCT01573195|antimicrobial stewardship|antimicrobial stewardship
5433416|NCT01573182|Zostavax|zostavax
5433417|NCT01573182|Herpes Zoster|herpes zoster
5433418|NCT01573182|VZV vaccination|vzv vaccination
5433419|NCT01573182|Allogeneic haemopoietic stem cell transplantation|allogeneic haemopoietic stem cell transplantation
5433420|NCT01573169|hemorrhagic stroke|hemorrhagic stroke
5433421|NCT01573169|venous thromboembolism|venous thromboembolism
5433423|NCT01573156|renal cancer|renal cancer
5433424|NCT01573156|photodynamic therapy|photodynamic therapy
5433425|NCT01573156|wst 11|wst 11
5433426|NCT01573143|Surgical Procedures, Cardiac|surgical procedures, cardiac
5433427|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5433428|NCT01573143|Rosuvastatin|rosuvastatin
5433429|NCT01573143|Post operative atrial fibrillation|post operative atrial fibrillation
5433430|NCT01573130|Depression|depression
5433431|NCT01573130|Physical exercise|physical exercise
5433432|NCT01573130|Internet|internet
5433433|NCT01573117|hypothermia|hypothermia
5433434|NCT01573117|induction of hypothermia|induction of hypothermia
5433435|NCT01573117|cold infusion|cold infusion
5433436|NCT01573117|nasopharyngeal cooling|nasopharyngeal cooling
5433437|NCT01573117|stroke|stroke
5433438|NCT01573117|intracranial hemorrhage|intracranial hemorrhage
5433439|NCT01573117|cerebrovascular disease|cerebrovascular disease
5433440|NCT01573117|neuro intensive care|neuro intensive care
5433441|NCT01573104|Diagnosis|diagnosis
5433442|NCT01573104|Acute Kidney Injury|acute kidney injury
5433443|NCT01573091|Cardiac resynchronization therapy|cardiac resynchronization therapy
5433444|NCT01573091|Heart failure|heart failure
5433445|NCT01573078|Crohn's disease|crohn's disease
5433447|NCT01573078|Dissociation|dissociation
5433448|NCT01573078|Emotional processing|emotional processing
5433449|NCT01573065|alcohol consumption|alcohol consumption
5433450|NCT01573065|sexual risk behaviors|sexual risk behaviors
5433451|NCT01573065|young, unhealthy drinkers|young, unhealthy drinkers
5433452|NCT01573039|Kidney transplantation|kidney transplantation
5433453|NCT01573039|PCR quantitative|pcr quantitative
5433454|NCT01573039|cytomegalovirus|cytomegalovirus
5433455|NCT01573039|antigenemia|antigenemia
5433456|NCT01573026|Dental Implants|dental implants
5433457|NCT01573026|Dental Implantation|dental implantation
5433458|NCT01573026|Osseointegration|osseointegration
5433459|NCT01573013|iron deficiency|iron deficiency
5433460|NCT01573013|Lead poisoning|lead poisoning
5433461|NCT01573013|cognitive development|cognitive development
5433462|NCT01573013|motor activity|motor activity
5433463|NCT01573000|Bexxar|bexxar
5433464|NCT01573000|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5433465|NCT01573000|Tositumomab|tositumomab
5433466|NCT01573000|Anti-B1 Antibody|anti-b1 antibody
5433467|NCT01573000|Radioimmunotherapy|radioimmunotherapy
5433468|NCT01573000|Iodine I-131|iodine i-131
5433469|NCT01573000|Iodine-131|iodine-131
5433476|NCT01572974|Quality of life|quality of life
5433477|NCT01572961|Laser Doppler flowmetry, skin, microcirculation|laser doppler flowmetry, skin, microcirculation
5433478|NCT01572935|childhood obesity prevalence|childhood obesity prevalence
5433479|NCT01572922|Sickle cell disease|sickle cell disease
5433480|NCT01572922|Thalassemia|thalassemia
5433481|NCT01572922|Hemochromatosis|hemochromatosis
5433483|NCT01572909|Myocardial Reperfusion|myocardial reperfusion
5433484|NCT01572909|Primary PCI|primary pci
5433485|NCT01572909|Stenting for ST-segment Elevation Myocardial Infarction|stenting for st-segment elevation myocardial infarction
5433486|NCT01572896|adoloescent|adoloescent
5433487|NCT01572896|internet self-management|internet self-management
5433488|NCT01572896|managing JIA|managing jia
5436716|NCT01558986|surgical site infection|surgical site infection
5433489|NCT01572883|adjuvant treatment with Radiotherapy and trastuzumab|adjuvant treatment with radiotherapy and trastuzumab
5433491|NCT01572870|Cystic Fibrosis|cystic fibrosis
5433492|NCT01572870|Allergic Bronchopulmonary Aspergillosis (ABPA)|allergic bronchopulmonary aspergillosis (abpa)
5433493|NCT01572870|Aspergillus|aspergillus
5433494|NCT01572857|multiple myeloma|multiple myeloma
5433495|NCT01572857|Proteinuria|proteinuria
5433496|NCT01572857|Albuminuria|albuminuria
5433497|NCT01572857|Urinary FLC|urinary flc
5433498|NCT01572857|Urine creatinine|urine creatinine
5433499|NCT01572844|Dermatomyositis|dermatomyositis
5433500|NCT01572844|Superficial calcinosis|superficial calcinosis
5433501|NCT01572844|Fractional carbon dioxide laser|fractional carbon dioxide laser
5433502|NCT01572844|Sodium thiosulfate|sodium thiosulfate
5433503|NCT01572831|antibiotic cessation rules|antibiotic cessation rules
5433504|NCT01572831|procalcitonin|procalcitonin
5433505|NCT01572831|infection|infection
5433506|NCT01572831|critical care|critical care
5433507|NCT01572818|Phlebotomy|phlebotomy
5433508|NCT01572818|Insulin Resistance|insulin resistance
5433509|NCT01572818|Iron Overload|iron overload
5433510|NCT01572805|Post partum haemorrhage|post partum haemorrhage
5433511|NCT01572805|Cesarean|cesarean
5433512|NCT01572805|Pain|pain
5433513|NCT01572792|COPD|copd
5433520|NCT01572792|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5433522|NCT01572779|vimove|vimove
5433523|NCT01572779|biofeedback|biofeedback
5433524|NCT01572779|objective movement data|objective movement data
5433525|NCT01572779|back pain|back pain
5433526|NCT01572766|Osteoporosis|osteoporosis
5433527|NCT01572766|Pharmacist|pharmacist
5433528|NCT01572766|Behavior Change|behavior change
5433529|NCT01572766|FRAX|frax
5433530|NCT01572766|Osteopenia|osteopenia
5433531|NCT01572727|BKM120|bkm120
5433532|NCT01572727|paclitaxel|paclitaxel
5433533|NCT01572727|breast cancer|breast cancer
5433534|NCT01572727|metastatic|metastatic
5433535|NCT01572727|locally advanced|locally advanced
5433536|NCT01572727|PI3K|pi3k
5433537|NCT01572727|PIK3CA|pik3ca
5433538|NCT01572727|PTEN|pten
5433539|NCT01572714|Exercise|exercise
5433540|NCT01572714|Self Care|self care
5433541|NCT01572714|Fatigue|fatigue
5433542|NCT01572675|Pharmacoepidemiological|pharmacoepidemiological
5433543|NCT01572675|Longitudinal|longitudinal
5433544|NCT01572675|Observational|observational
5433545|NCT01572662|Leukemia|leukemia
5433546|NCT01572662|Acute myeloid leukemia|acute myeloid leukemia
5433547|NCT01572662|Acute lymphocytic leukemia|acute lymphocytic leukemia
5433548|NCT01572662|Chronic myeloid leukemia|chronic myeloid leukemia
5685290|NCT00556751|Blood Pressure|blood pressure
5433549|NCT01572662|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5433550|NCT01572662|Myeloproliferative Diseases|myeloproliferative diseases
5433552|NCT01572662|Hodgkins lymphoma|hodgkins lymphoma
5433553|NCT01572662|Multiple myeloma|multiple myeloma
5433554|NCT01572662|Myelodysplastic syndrome|myelodysplastic syndrome
5433555|NCT01572662|MDS|mds
5433556|NCT01572662|Fludarabine monophosphate|fludarabine monophosphate
5433557|NCT01572662|Fludarabine phosphate|fludarabine phosphate
5433558|NCT01572662|Fludara|fludara
5433559|NCT01572662|Busulfan|busulfan
5433560|NCT01572662|Busulfex|busulfex
5433561|NCT01572662|Myleran|myleran
5433562|NCT01572662|Tacrolimus|tacrolimus
5433563|NCT01572662|Prograf|prograf
5433564|NCT01572662|Methotrexate|methotrexate
5433565|NCT01572662|G-CSF|g-csf
5433566|NCT01572662|Filgrastim|filgrastim
5433567|NCT01572662|Neupogen|neupogen
5433568|NCT01572662|Stem cell transplant|stem cell transplant
5433572|NCT01572610|CKD patients with type 2 diabetes|ckd patients with type 2 diabetes
5433573|NCT01572597|Helicobacter pylori|helicobacter pylori
5433574|NCT01572597|antibiotic resistance|antibiotic resistance
5433575|NCT01572597|N-acetylcystein|n-acetylcystein
5433576|NCT01572597|biofilm|biofilm
5433577|NCT01572597|second-line eradication treatment|second-line eradication treatment
5433578|NCT01572584|Pneumothorax|pneumothorax
5433579|NCT01572584|Lung ultrasound|lung ultrasound
5433580|NCT01572584|Chest sonography|chest sonography
5433581|NCT01572571|Emergency ultrasound|emergency ultrasound
5433582|NCT01572571|Focused ultrasound|focused ultrasound
5433583|NCT01572571|Point-of-care ultrasound|point-of-care ultrasound
5433584|NCT01572571|Undifferentiated hypotension|undifferentiated hypotension
5433585|NCT01572558|Appendectomy|appendectomy
5433586|NCT01572558|Nonsurgical treatment with antibiotics|nonsurgical treatment with antibiotics
5433587|NCT01572545|bone turnover|bone turnover
5433588|NCT01572545|denosumab|denosumab
5433589|NCT01572545|postmenopausal osteoporosis|postmenopausal osteoporosis
5433591|NCT01572545|zolendronic acid|zolendronic acid
5433592|NCT01572532|Adverse Perinatal Outcomes|adverse perinatal outcomes
5433593|NCT01572532|Treatment of abnormal vaginal flora|treatment of abnormal vaginal flora
5433594|NCT01572519|Relapsed Hodgkin lymphoma|relapsed hodgkin lymphoma
5433595|NCT01572519|Refractory Hodgkin lymphoma|refractory hodgkin lymphoma
5433596|NCT01572519|JNJ-40346527|jnj-40346527
5433597|NCT01572519|Dose-escalation|dose-escalation
5433598|NCT01572519|Pharmacokinetics|pharmacokinetics
5433603|NCT01572493|Pharmacokinetics of lL-15|pharmacokinetics of ll-15
5433604|NCT01572493|Cytokine Therapy|cytokine therapy
5433605|NCT01572493|Effects of rhlL-15 on T-cells and NK cells|effects of rhll-15 on t-cells and nk cells
5433606|NCT01572493|Immunotherapy|immunotherapy
5433613|NCT01572467|Leydig cell tumor|leydig cell tumor
5433614|NCT01572467|ovarian stromal cancer|ovarian stromal cancer
5433615|NCT01572467|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5433616|NCT01572467|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5433617|NCT01572454|coronary artery bypass graft|coronary artery bypass graft
5433619|NCT01572454|cardiac arrhythmia|cardiac arrhythmia
5433620|NCT01572454|dexmedetomidine|dexmedetomidine
5433621|NCT01572454|remifentanil|remifentanil
5433622|NCT01572428|Proximal Colon Cancer|proximal colon cancer
5433623|NCT01572428|Serrated Colon Lesions|serrated colon lesions
5433624|NCT01572428|Narrow Band Imaging|narrow band imaging
5433625|NCT01572415|Screening for Type 2 diabetes|screening for type 2 diabetes
5433626|NCT01572402|Diet|diet
5433627|NCT01572402|Gastrointestinal peptides|gastrointestinal peptides
5433628|NCT01572402|Insulin secretion|insulin secretion
5433629|NCT01572402|Oxidative stress|oxidative stress
5433630|NCT01572402|Plasma lipids|plasma lipids
5433631|NCT01572402|Postprandial|postprandial
5433632|NCT01572402|Type 2 diabetes|type 2 diabetes
5433633|NCT01572389|Diabetes Mellitus|diabetes mellitus
5433634|NCT01572389|Depression|depression
5433635|NCT01572389|Affective Symptoms|affective symptoms
5433636|NCT01572389|Self Care|self care
5433637|NCT01572389|Telemedicine|telemedicine
5433638|NCT01572389|Psychotherapy|psychotherapy
5433639|NCT01572376|Pressure ulcers|pressure ulcers
5433640|NCT01572376|Chronic wounds|chronic wounds
5433641|NCT01572376|Spinal cord injury patients|spinal cord injury patients
5433642|NCT01572376|Bone marrow|bone marrow
5433643|NCT01572376|Mononuclear|mononuclear
5433644|NCT01572376|Debridement|debridement
5433645|NCT01572363|Fontan|fontan
5433646|NCT01572363|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5433647|NCT01572363|Sildenafil|sildenafil
5433649|NCT01572337|acute respiratory failure|acute respiratory failure
5433650|NCT01572337|hypoxia|hypoxia
5433651|NCT01572337|hypercapnia|hypercapnia
5433652|NCT01572337|non-invasive ventilation|non-invasive ventilation
5433653|NCT01572337|hospital ward|hospital ward
5433654|NCT01572324|Cholangiocarcinoma|cholangiocarcinoma
5433655|NCT01572324|gallbladder cancer|gallbladder cancer
5433656|NCT01572324|Infusions|infusions
5433657|NCT01572324|Intra-Arterial|intra-arterial
5685291|NCT00556751|Diabetes|diabetes
5433658|NCT01572311|Aerobic exercise|aerobic exercise
5433659|NCT01572311|Cognition|cognition
5433660|NCT01572311|Dual Task|dual task
5433661|NCT01572311|Gait Training|gait training
5433662|NCT01572311|Group-based exercise|group-based exercise
5433663|NCT01572311|Older adults|older adults
5433664|NCT01572285|Hemiplegic|hemiplegic
5433665|NCT01572285|Shoulder Pain|shoulder pain
5433666|NCT01572285|Transforaminal|transforaminal
5433667|NCT01572285|Treatment|treatment
5433668|NCT01572285|Interventional|interventional
5433669|NCT01572272|Distal Capnography|distal capnography
5433670|NCT01572272|CO2|co2
5433671|NCT01572272|neonates|neonates
5433672|NCT01572272|conventional ventilation|conventional ventilation
5433673|NCT01572246|electrosurgery|electrosurgery
5433674|NCT01572246|Cardiac surgical procedures|cardiac surgical procedures
5433675|NCT01572246|Surgical procedures, operative|surgical procedures, operative
5433676|NCT01572246|Defibrillators|defibrillators
5433677|NCT01572233|Fatigue,Physical Activity,Hepatitis C Virus Infection|fatigue,physical activity,hepatitis c virus infection
5433678|NCT01572220|Hospitalized patients|hospitalized patients
5433679|NCT01572207|Multiple Sclerosis|multiple sclerosis
5433680|NCT01572207|Exercise|exercise
5433681|NCT01572207|Physical activity|physical activity
5433682|NCT01572207|Quality of life|quality of life
5433683|NCT01572194|CF|cf
5433684|NCT01572168|Fatigue|fatigue
5433685|NCT01572142|Parkinson disease|parkinson disease
5433686|NCT01572142|smell|smell
5433687|NCT01572142|cognitive|cognitive
5433688|NCT01572116|sufentanil|sufentanil
5433689|NCT01572116|irreversible pulpitis|irreversible pulpitis
5433690|NCT01572116|intra ligament injection|intra ligament injection
5433691|NCT01572090|Body mass index|body mass index
5433692|NCT01572090|Body fat|body fat
5433693|NCT01572090|Obesity|obesity
5433694|NCT01572090|Bariatric surgery|bariatric surgery
5433695|NCT01572090|Conventional dietary treatment|conventional dietary treatment
5433696|NCT01572090|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5433697|NCT01572090|Cardiometabolic risk factors|cardiometabolic risk factors
5433698|NCT01572090|Inflammation|inflammation
5433699|NCT01572090|Adipokines|adipokines
5433700|NCT01572090|Gastrointestinal hormones|gastrointestinal hormones
5433701|NCT01572090|Comorbidity improvement|comorbidity improvement
5433702|NCT01572090|Energy intake|energy intake
5433709|NCT01572051|knee osteoarthritis|knee osteoarthritis
5433710|NCT01572051|education|education
5433711|NCT01572012|Pharmacokinetics|pharmacokinetics
5433712|NCT01572012|Safety|safety
5433713|NCT01572012|Healthy Volunteers|healthy volunteers
5433714|NCT01572012|tolerability|tolerability
5433715|NCT01571999|pharmacokinetics|pharmacokinetics
5433716|NCT01571999|GW642444|gw642444
5433717|NCT01571999|GSK573719|gsk573719
5433718|NCT01571999|vilanterol|vilanterol
5433719|NCT01571999|renal impairment|renal impairment
5433720|NCT01571999|safety|safety
5433721|NCT01571999|COPD|copd
5433722|NCT01571986|NIV|niv
5433723|NCT01571986|acute respiratory failure|acute respiratory failure
5433724|NCT01571986|hypoxia|hypoxia
5433725|NCT01571986|hypercapnia|hypercapnia
5433726|NCT01571986|non-invasive ventilation|non-invasive ventilation
5433727|NCT01571986|hospital ward|hospital ward
5433728|NCT01571973|pharmaceutical care|pharmaceutical care
5433729|NCT01571973|depression|depression
5433730|NCT01571973|compliance|compliance
5433731|NCT01571973|pharmacist's intervention|pharmacist's intervention
5433732|NCT01571973|Dáder|dáder
5433733|NCT01571947|Insulinaemia|insulinaemia
5433734|NCT01571947|inflammatory markers|inflammatory markers
5433735|NCT01571947|gastrointestinal peptides|gastrointestinal peptides
5433736|NCT01571947|SFA|sfa
5433737|NCT01571947|dietary fats|dietary fats
5433738|NCT01571947|carbohydrate|carbohydrate
5433739|NCT01571947|insulin sensitivity|insulin sensitivity
5433740|NCT01571934|Hemophilia A|hemophilia a
5433741|NCT01571908|rocuronium|rocuronium
5433742|NCT01571908|succinylcholine|succinylcholine
5433743|NCT01571908|magnesiumsulphate|magnesiumsulphate
5433744|NCT01571908|intubation conditions|intubation conditions
5433745|NCT01571895|Autoimmune inflammatory blistering disorder|autoimmune inflammatory blistering disorder
5433746|NCT01571882|Plant sterol - Policosanols - Hypercholesterolemia - Dairy|plant sterol - policosanols - hypercholesterolemia - dairy
5433747|NCT01571869|Plant sterol - hypercholesterolemia - dairy - meal|plant sterol - hypercholesterolemia - dairy - meal
5433748|NCT01571856|Acute Diarrhea|acute diarrhea
5433749|NCT01571856|Zinc|zinc
5433750|NCT01571856|Children|children
5433751|NCT01571843|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5433752|NCT01571843|Bone Diseases, Metabolic|bone diseases, metabolic
5433753|NCT01571843|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5433754|NCT01571843|Bone Loss, Postmenopausal|bone loss, postmenopausal
5433755|NCT01571830|food allergy|food allergy
5433756|NCT01571830|nutrient intake|nutrient intake
5433757|NCT01571830|growth|growth
5433758|NCT01571817|Insulin Dependent|insulin dependent
5433759|NCT01571804|Anesthesia|anesthesia
5433760|NCT01571804|pregabalin|pregabalin
5433761|NCT01571804|sevoflurane|sevoflurane
5685292|NCT00556738|HFPV|hfpv
5433762|NCT01571804|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5433763|NCT01571791|Ketorolac|ketorolac
5433764|NCT01571791|lidocaine|lidocaine
5433765|NCT01571791|valvular hear diseases|valvular hear diseases
5433766|NCT01571791|cesarean section|cesarean section
5433767|NCT01571778|Hand Hygiene|hand hygiene
5433768|NCT01571778|Non-sterile Glove Use|non-sterile glove use
5433769|NCT01571765|maternal|maternal
5433770|NCT01571765|newborn|newborn
5433771|NCT01571765|child|child
5433778|NCT01571739|Biomarker|biomarker
5433779|NCT01571739|Latent Tuberculosis|latent tuberculosis
5433780|NCT01571739|IGRA|igra
5433781|NCT01571739|Isoniazid|isoniazid
5433782|NCT01571739|TB Lymphadenopathy|tb lymphadenopathy
5428702|NCT01593696|ALL|all
5433784|NCT01571739|TB|tb
5433785|NCT01571726|(18)-Fluciclatide PET/CT|(18)-fluciclatide pet/ct
5433786|NCT01571726|Serum M-Protein|serum m-protein
5433787|NCT01571726|Percentage of Plasma Cells in the Bone Marrow|percentage of plasma cells in the bone marrow
5433788|NCT01571726|Ratio of Normal/Abnormal Percentage of Plasma Cells in the Bone Marrow|ratio of normal/abnormal percentage of plasma cells in the bone marrow
5433789|NCT01571726|Multiple Myeloma|multiple myeloma
5433790|NCT01571700|Mechanical Dysynchrony|mechanical dysynchrony
5433791|NCT01571700|Electrical Dysynchrony|electrical dysynchrony
5433792|NCT01571687|expedition|expedition
5433793|NCT01571687|hypoxia|hypoxia
5433794|NCT01571687|blood coagulation disorders|blood coagulation disorders
5433795|NCT01571687|cell-derived microparticles|cell-derived microparticles
5433796|NCT01571687|oxidative stress|oxidative stress
5433797|NCT01571687|N-Acetylcystein|n-acetylcystein
5433798|NCT01571687|vitamins|vitamins
5433799|NCT01571674|Cervical|cervical
5433800|NCT01571674|Clinical Prediction Rule|clinical prediction rule
5433801|NCT01571674|Exercise|exercise
5433802|NCT01571674|Manipulation|manipulation
5433808|NCT01571674|Thoracic|thoracic
5433809|NCT01571661|KGT-1142|kgt-1142
5433811|NCT01571661|pharmacokinetics|pharmacokinetics
5433812|NCT01571661|single-dose escalation|single-dose escalation
5433813|NCT01571661|tolerability|tolerability
5433814|NCT01571635|Beta-Thalassaemia|beta-thalassaemia
5433815|NCT01571622|Whey protein|whey protein
5433816|NCT01571622|type 2 diabetes|type 2 diabetes
5433818|NCT01571583|Chronic HCV infection|chronic hcv infection
5433819|NCT01571583|Genotype 1 chronic HCV|genotype 1 chronic hcv
5433820|NCT01571583|Liver transplantation|liver transplantation
5433821|NCT01571583|Hepatitis C|hepatitis c
5433822|NCT01571583|Hep C|hep c
5433823|NCT01571583|HCV|hcv
5433824|NCT01571583|Telaprevir|telaprevir
5433825|NCT01571583|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
5433826|NCT01571583|Ribavirin|ribavirin
5433827|NCT01571570|Healthy volunteers|healthy volunteers
5433828|NCT01571570|Food effect|food effect
5433829|NCT01571570|Capsule|capsule
5433830|NCT01571570|Formulations|formulations
5433831|NCT01571570|Liquid formulation|liquid formulation
5433832|NCT01571570|Concept K|concept k
5433833|NCT01571570|Concept L|concept l
5433834|NCT01571570|Oral suspension|oral suspension
5433835|NCT01571570|Oral solution|oral solution
5433836|NCT01571570|TMC435HPC1002|tmc435hpc1002
5433837|NCT01571570|TMC435|tmc435
5433838|NCT01571570|HPC|hpc
5433839|NCT01571518|G-CSF|g-csf
5433840|NCT01571518|neutropenia|neutropenia
5433841|NCT01571518|TAC|tac
5433842|NCT01571505|Oral vaccines|oral vaccines
5433843|NCT01571505|Vaccine Responsiveness|vaccine responsiveness
5433844|NCT01571505|Tropical Enteropathy|tropical enteropathy
5433845|NCT01571492|Postoperative Pain|postoperative pain
5433846|NCT01571492|Nerve block|nerve block
5433847|NCT01571492|Total Hip Arthroplasty|total hip arthroplasty
5433848|NCT01571492|Postoperative analgesia|postoperative analgesia
5433849|NCT01571492|Lumbar Plexus Catheters|lumbar plexus catheters
5433850|NCT01571492|L2 Paravertebral Catheters|l2 paravertebral catheters
5433851|NCT01571479|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5433852|NCT01571479|mini-instrument|mini-instrument
5433853|NCT01571466|HIV Seronegativity|hiv seronegativity
5433854|NCT01571466|HIV Preventive Vaccine|hiv preventive vaccine
5433855|NCT01571453|MDD|mdd
5433856|NCT01571440|Bone|bone
5433857|NCT01571440|adolescents|adolescents
5433858|NCT01571440|fiber|fiber
5433859|NCT01571440|healthy|healthy
5433860|NCT01571440|boys|boys
5433861|NCT01571440|girls|girls
5433862|NCT01571440|camp|camp
5433863|NCT01571440|calcium|calcium
5433864|NCT01571427|Behavioral intervention|behavioral intervention
5433865|NCT01571427|Social engagement|social engagement
5433866|NCT01571427|Conversational engagement|conversational engagement
5433867|NCT01571427|Social network|social network
5433868|NCT01571427|Cognitive Reserve|cognitive reserve
5433869|NCT01571427|Alzheimer's disease|alzheimer's disease
5433870|NCT01571401|Kidney cancer survivors|kidney cancer survivors
5433871|NCT01571401|Randomized Controlled Trial|randomized controlled trial
5433872|NCT01571401|Physical Activity|physical activity
5433873|NCT01571401|Theory of Planned Behaviour|theory of planned behaviour
5433874|NCT01571401|Quality of life|quality of life
5433875|NCT01571388|dacomitinib|dacomitinib
5433876|NCT01571388|PF-00299804|pf-00299804
5433877|NCT01571388|hepatic impairment|hepatic impairment
5433878|NCT01571388|pharmacokinetics|pharmacokinetics
5433879|NCT01571375|Traumatic Brain Injury|traumatic brain injury
5433880|NCT01571375|HEMS|hems
5433881|NCT01571375|Out-of-hospital|out-of-hospital
5433882|NCT01571375|Finland|finland
5433883|NCT01571362|oxycodone|oxycodone
5433884|NCT01571362|naltrexone|naltrexone
5433885|NCT01571362|chronic pain|chronic pain
5433886|NCT01571362|low back pain|low back pain
5433887|NCT01571349|rebalanced hemostasis|rebalanced hemostasis
5433888|NCT01571349|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5433889|NCT01571349|coagulation status|coagulation status
5433890|NCT01571323|post partum haemorrhage at cesarean section|post partum haemorrhage at cesarean section
5433891|NCT01571297|Diabetes Mellitus|diabetes mellitus
5433892|NCT01571297|Delayed Gastric Emptying|delayed gastric emptying
5433893|NCT01571297|Gastroparesis|gastroparesis
5433894|NCT01571297|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
5433895|NCT01571271|biliary|biliary
5433896|NCT01571271|lithotripsy|lithotripsy
5433897|NCT01571271|gall stones|gall stones
5433898|NCT01571271|bile duct|bile duct
5433899|NCT01571271|Biliary stones|biliary stones
5433900|NCT01571258|SMS|sms
5433901|NCT01571258|Obesity|obesity
5433902|NCT01571258|Text Messaging|text messaging
5433903|NCT01571258|Intervention|intervention
5433904|NCT01571258|Mobile Phone|mobile phone
5433905|NCT01571245|Heart rate variability|heart rate variability
5433906|NCT01571245|Attentional Bias|attentional bias
5433907|NCT01571232|Macular Edema|macular edema
5433908|NCT01571232|DME|dme
5433909|NCT01571232|PDR|pdr
5433910|NCT01571232|NPDR|npdr
5433911|NCT01571232|Ozurdex|ozurdex
5433912|NCT01571232|Dexamethasone|dexamethasone
5433913|NCT01571232|Avastin|avastin
5433914|NCT01571232|Bevacizumab|bevacizumab
5433917|NCT01571206|AS|as
5433918|NCT01571206|Biosimilar|biosimilar
5433919|NCT01571180|Obesity|obesity
5433920|NCT01571180|Gastric bypass|gastric bypass
5433921|NCT01571180|Medication|medication
5433922|NCT01571180|Medication counseling|medication counseling
5433923|NCT01571180|Dietary pattern|dietary pattern
5433924|NCT01571180|Follow-up of patients|follow-up of patients
5433925|NCT01571167|Methamphetamine|methamphetamine
5433926|NCT01571167|Chantix|chantix
5433927|NCT01571167|Varenicline|varenicline
5433929|NCT01571141|polyhexamethylene biguanide|polyhexamethylene biguanide
5433930|NCT01571141|intraepithelial lesions|intraepithelial lesions
5433931|NCT01571141|regression rate|regression rate
5433932|NCT01571128|HIV|hiv
5433933|NCT01571128|Prevention & Control|prevention & control
5433934|NCT01571128|Intervention Studies|intervention studies
5433935|NCT01571128|Adolescent|adolescent
5433936|NCT01571128|Gender|gender
5433937|NCT01571128|Combination prevention|combination prevention
5433938|NCT01571128|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5433939|NCT01571128|Cash Transfer|cash transfer
5433940|NCT01571128|Medical Male Circumcision|medical male circumcision
5433941|NCT01571128|HIV Testing|hiv testing
5433942|NCT01571128|Mobile Health|mobile health
5433943|NCT01571115|insomnia|insomnia
5433944|NCT01571115|resistance physical exercise|resistance physical exercise
5433945|NCT01571115|stretching|stretching
5433946|NCT01571089|Dialectical behavior therapy|dialectical behavior therapy
5433947|NCT01571089|cognitive behavioral therapy|cognitive behavioral therapy
5433948|NCT01571089|emotion regulation|emotion regulation
5433949|NCT01571089|emotion dysregulation|emotion dysregulation
5433950|NCT01571089|anxiety disorders|anxiety disorders
5433951|NCT01571089|skills training|skills training
5433952|NCT01571076|PGS|pgs
5433953|NCT01571076|CGH|cgh
5433954|NCT01571076|Aneuploidy|aneuploidy
5433955|NCT01571076|Advanced maternal age|advanced maternal age
5433956|NCT01571076|Male factor|male factor
5433957|NCT01571050|toothpastes|toothpastes
5433958|NCT01571050|dental fluorosis|dental fluorosis
5433959|NCT01571050|fluoride|fluoride
5433960|NCT01571050|bioavailability|bioavailability
5433961|NCT01571037|mechanical circulatory assist device|mechanical circulatory assist device
5433962|NCT01571024|FOLFOX6|folfox6
5433963|NCT01571024|BKM120|bkm120
5433964|NCT01571024|Advanced Solid Tumors|advanced solid tumors
5433965|NCT01571024|Metastatic|metastatic
5433966|NCT01571024|Colorectal Cancer|colorectal cancer
5433967|NCT01571024|Pancreatic Cancer|pancreatic cancer
5433968|NCT01571011|Adolescent|adolescent
5433969|NCT01571011|Randomized Trial|randomized trial
5433970|NCT01571011|Internet|internet
5433971|NCT01571011|Depressive Disorder|depressive disorder
5433972|NCT01571011|Primary Care|primary care
5433973|NCT01571011|Prevention|prevention
5433974|NCT01570985|shoulder capsulitis|shoulder capsulitis
5433975|NCT01570985|frozen shoulder|frozen shoulder
5433976|NCT01570985|adhesive capsulitis|adhesive capsulitis
5433977|NCT01570985|distension|distension
5433978|NCT01570985|corticosteroid injection|corticosteroid injection
5433979|NCT01570985|intraarticular injection|intraarticular injection
5433980|NCT01570972|schizophrenia|schizophrenia
5433981|NCT01570972|schizoaffective disorder|schizoaffective disorder
5433982|NCT01570972|bipolar disorder with psychotic features|bipolar disorder with psychotic features
5433983|NCT01570972|major depression with psychotic features|major depression with psychotic features
5433984|NCT01570972|recent-onset psychosis|recent-onset psychosis
5433985|NCT01570972|first-episode psychosis|first-episode psychosis
5433986|NCT01570972|cognitive behavioral therapy|cognitive behavioral therapy
5433987|NCT01570972|multifamily group psychoeducation|multifamily group psychoeducation
5433988|NCT01570946|Lifestyle changes to prevent type 2 diabetes|lifestyle changes to prevent type 2 diabetes
5433989|NCT01570933|cardio-pulmonary bypass|cardio-pulmonary bypass
5433990|NCT01570920|Activity limitations|activity limitations
5433991|NCT01570920|restriction of participation|restriction of participation
5433992|NCT01570920|chronic stroke survival|chronic stroke survival
5433993|NCT01570920|physical activity|physical activity
5433995|NCT01570881|postoperative delirium|postoperative delirium
5433996|NCT01570881|melatonin|melatonin
5433997|NCT01570881|sevoflurane|sevoflurane
5433998|NCT01570868|Leukemia|leukemia
5433999|NCT01570868|Chronic Myeloid Leukemia|chronic myeloid leukemia
5434001|NCT01570868|Chronic Phase|chronic phase
5434002|NCT01570868|Cytogenetic response|cytogenetic response
5434003|NCT01570868|CCyR|ccyr
5434004|NCT01570868|Major molecular response|major molecular response
5434005|NCT01570868|MMR|mmr
5434006|NCT01570868|Complete molecular response|complete molecular response
5434008|NCT01570868|Ponatinib|ponatinib
5434009|NCT01570868|AP24534|ap24534
5434010|NCT01570855|Lung cancer|lung cancer
5434011|NCT01570855|chemosensitivity|chemosensitivity
5434012|NCT01570842|Gastroesophageal reflux disease|gastroesophageal reflux disease
5434013|NCT01570842|GERD|gerd
5434014|NCT01570842|Barrett's esophagus|barrett's esophagus
5434015|NCT01570816|stroke|stroke
5434016|NCT01570816|partial paralysis|partial paralysis
5434017|NCT01570816|gait correction|gait correction
5434018|NCT01570816|functional electrical stimulation|functional electrical stimulation
5434019|NCT01570816|paraplegia|paraplegia
5434020|NCT01570816|tetraplegia|tetraplegia
5434021|NCT01570816|spinal cord injury|spinal cord injury
5434022|NCT01570803|peripheral arterial disease,|peripheral arterial disease,
5434023|NCT01570803|atherosclerosis,|atherosclerosis,
5434024|NCT01570803|nitinol,|nitinol,
5434025|NCT01570803|stents|stents
5434026|NCT01570777|Resistant hypertension|resistant hypertension
5434027|NCT01570777|Renal denervation|renal denervation
5434028|NCT01570777|Standardized medication regimen|standardized medication regimen
5434029|NCT01570777|Endovascular|endovascular
5434030|NCT01570777|Primary hypertension|primary hypertension
5434031|NCT01570777|Cardiovascular diseases|cardiovascular diseases
5434032|NCT01570777|Vascular diseases|vascular diseases
5434033|NCT01570764|Systemic sclerosis|systemic sclerosis
5434034|NCT01570764|Interstitial lung disease|interstitial lung disease
5434035|NCT01570764|Worsening|worsening
5434036|NCT01570764|Cyclophosphamide|cyclophosphamide
5434037|NCT01570764|Intravenous|intravenous
5434038|NCT01570738|sleep disorders|sleep disorders
5434039|NCT01570738|sleep apnea|sleep apnea
5434040|NCT01570738|ambulatory device|ambulatory device
5434041|NCT01570738|polysomnography|polysomnography
5434042|NCT01570738|WatchPAT|watchpat
5434043|NCT01570725|Immersive virtual reality|immersive virtual reality
5434044|NCT01570725|e-health|e-health
5434045|NCT01570725|surgery|surgery
5434046|NCT01570725|anxiety|anxiety
5434047|NCT01570725|relaxation|relaxation
5434048|NCT01570725|Patients who undergo ambulatory surgical operations|patients who undergo ambulatory surgical operations
5434049|NCT01570699|Cross-sectional observational study|cross-sectional observational study
5434050|NCT01570699|COMT polymorphism|comt polymorphism
5434051|NCT01570699|Opiate-users|opiate-users
5434052|NCT01570699|Opiate dependence|opiate dependence
5434053|NCT01570686|Food effect, hypertension, aliskiren|food effect, hypertension, aliskiren
5434054|NCT01570673|quality of life|quality of life
5434055|NCT01570673|urinary bladder|urinary bladder
5434056|NCT01570673|symptoms|symptoms
5434057|NCT01570673|children|children
5434058|NCT01570634|Clostridium difficile|clostridium difficile
5434059|NCT01570634|infection|infection
5434060|NCT01570634|diarrhea|diarrhea
5434061|NCT01570634|cramping|cramping
5434062|NCT01570621|achalasia|achalasia
5434063|NCT01570621|peroral endoscopic myotomy|peroral endoscopic myotomy
5434064|NCT01570621|LES pressure|les pressure
5434065|NCT01570621|postoperative complication|postoperative complication
5434066|NCT01570621|symptom relief|symptom relief
5434067|NCT01570621|esophageal barium|esophageal barium
5434068|NCT01570608|Ranibizumab|ranibizumab
5434069|NCT01570608|Bevacizumab|bevacizumab
5434070|NCT01570608|Verteporfin|verteporfin
5434071|NCT01570608|age-related macular degeneration|age-related macular degeneration
5434072|NCT01570595|Tobacco Use Cessation|tobacco use cessation
5434073|NCT01570595|Tobacco Cessation|tobacco cessation
5434074|NCT01570595|Tobacco Use Disorder|tobacco use disorder
5434075|NCT01570595|Tobacco Dependence|tobacco dependence
5434076|NCT01570595|Tobacco-Use Disorder|tobacco-use disorder
5434077|NCT01570595|Virus, Human Immunodeficiency|virus, human immunodeficiency
5434078|NCT01570582|recurrent ovarian|recurrent ovarian
5434080|NCT01570582|GOG performance|gog performance
5434081|NCT01570582|Hematologic g|hematologic g
5434082|NCT01570582|Blood chemistry and urinalysis h|blood chemistry and urinalysis h
5434083|NCT01570569|Volunteers|volunteers
5434084|NCT01570556|Hemodialysis|hemodialysis
5434085|NCT01570556|Inflammation|inflammation
5434086|NCT01570556|Bacteriuria|bacteriuria
5434087|NCT01570556|Interleukin 6|interleukin 6
5434088|NCT01570556|C reactive protein|c reactive protein
5434089|NCT01570543|implants|implants
5434090|NCT01570543|knee implants|knee implants
5434091|NCT01570543|hip implants|hip implants
5434092|NCT01570543|metallic implants|metallic implants
5434093|NCT01570504|Strongyloidiasis|strongyloidiasis
5434094|NCT01570504|Strongyloides stercoralis|strongyloides stercoralis
5434095|NCT01570504|Ivermectin|ivermectin
5434096|NCT01570465|AML|aml
5434097|NCT01570465|adult|adult
5434098|NCT01570465|AML1310 GIMEMA study|aml1310 gimema study
5434099|NCT01570452|matrilysin|matrilysin
5434100|NCT01570452|MMP-7|mmp-7
5434101|NCT01570452|colorectal cancer|colorectal cancer
5434102|NCT01570452|adenoma|adenoma
5434103|NCT01570452|lymph nodes|lymph nodes
5434104|NCT01570426|Bipolar disorder|bipolar disorder
5434105|NCT01570426|Mood disorders|mood disorders
5434106|NCT01570426|ADHD|adhd
5434107|NCT01570426|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5434108|NCT01570426|Attention Deficit Disorder without Hyperactivity|attention deficit disorder without hyperactivity
5434109|NCT01570426|Anxiety disorders|anxiety disorders
5434110|NCT01570426|Generalized anxiety disorder|generalized anxiety disorder
5434111|NCT01570426|Magnetic resonance imaging|magnetic resonance imaging
5434112|NCT01570426|Mental disorders|mental disorders
5434113|NCT01570426|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
5434114|NCT01570426|affective neuroscience|affective neuroscience
5434115|NCT01570426|emotion|emotion
5434117|NCT01570426|fMRI|fmri
5434118|NCT01570426|neurocognitive tasks|neurocognitive tasks
5434123|NCT01570400|social anxiety|social anxiety
5434124|NCT01570400|cognitive bias modification|cognitive bias modification
5434125|NCT01570374|Cognitive behavioral therapy|cognitive behavioral therapy
5434126|NCT01570374|Internet|internet
5434127|NCT01570374|Anxiety|anxiety
5434128|NCT01570374|Generalized anxiety disorder|generalized anxiety disorder
5434129|NCT01570361|Atrial Fibrillation|atrial fibrillation
5434130|NCT01570361|Arrhythmias, Cardiac|arrhythmias, cardiac
5434131|NCT01570361|Heart Diseases|heart diseases
5434132|NCT01570361|Cardiovascular Diseases|cardiovascular diseases
5434133|NCT01570361|Pathologic Processes|pathologic processes
5434137|NCT01570335|SBAR,|sbar,
5434138|NCT01570335|SAQ,|saq,
5434139|NCT01570335|Team Resource Management|team resource management
5434140|NCT01570322|Dementia - Alzheimer - Quality of life|dementia - alzheimer - quality of life
5434141|NCT01570309|vitamin D,|vitamin d,
5434142|NCT01570309|vitamin D deficiency|vitamin d deficiency
5434143|NCT01570309|coronary artery disease|coronary artery disease
5434144|NCT01570309|ergocalciferol|ergocalciferol
5434145|NCT01570309|endothelial function|endothelial function
5434146|NCT01570309|adhesion molecules|adhesion molecules
5434147|NCT01570309|inflammation|inflammation
5434148|NCT01570309|IL-12|il-12
5434149|NCT01570309|interferon-gamma|interferon-gamma
5434150|NCT01570309|CXCL-10|cxcl-10
5434151|NCT01570309|reactive hyperemia peripheral arterial tonometry|reactive hyperemia peripheral arterial tonometry
5434152|NCT01570309|endothelial dysfunction|endothelial dysfunction
5434153|NCT01570309|cytokines|cytokines
5434154|NCT01570309|chemokines|chemokines
5434155|NCT01570296|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5434156|NCT01570296|tumors harbor molecular|tumors harbor molecular
5434157|NCT01570296|alterations of PI3K pathway|alterations of pi3k pathway
5434158|NCT01570296|known to overexpress EGFR|known to overexpress egfr
5434159|NCT01570283|post allogeneic hematopoietic stem cell transplant|post allogeneic hematopoietic stem cell transplant
5434160|NCT01570283|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5434161|NCT01570283|Cytomegalovirus|cytomegalovirus
5434162|NCT01570283|CMV|cmv
5434163|NCT01570283|adenovirus|adenovirus
5434164|NCT01570283|Epstein-Barr virus|epstein-barr virus
5434165|NCT01570283|EBV|ebv
5434166|NCT01570283|Human polyomavirus type I|human polyomavirus type i
5434167|NCT01570283|BK virus|bk virus
5434168|NCT01570283|Human herpesvirus 6|human herpesvirus 6
5434169|NCT01570283|HHV6|hhv6
5434170|NCT01570270|Hypercholesterolemia|hypercholesterolemia
5434171|NCT01570270|Endocannabinoids|endocannabinoids
5434172|NCT01570257|normal pressure hydrocephalus|normal pressure hydrocephalus
5434173|NCT01570257|ventriculoperitoneal shunt|ventriculoperitoneal shunt
5434174|NCT01570257|overdrainage|overdrainage
5434175|NCT01570257|subdural effusion|subdural effusion
5434176|NCT01570231|remote ischemic preconditioning|remote ischemic preconditioning
5434177|NCT01570231|octogenarian|octogenarian
5434178|NCT01570231|intracranial arterial stenosis|intracranial arterial stenosis
5434179|NCT01570231|stroke recurrence|stroke recurrence
5434180|NCT01570218|breast cancer|breast cancer
5434181|NCT01570218|gynecological cancer|gynecological cancer
5434182|NCT01570218|radiotherapy|radiotherapy
5434184|NCT01570218|musicotherapy|musicotherapy
5434185|NCT01570192|gram negative pathogens|gram negative pathogens
5434186|NCT01570192|Pseudomonas aeruginosa|pseudomonas aeruginosa
5434187|NCT01570192|Acinetobacter|acinetobacter
5434188|NCT01570192|HCAP|hcap
5434189|NCT01570192|VABP|vabp
5434190|NCT01570192|HABP|habp
5434191|NCT01570179|bariatric surgery|bariatric surgery
5434192|NCT01570179|residual paralysis|residual paralysis
5434193|NCT01570179|surgical conditions|surgical conditions
5434194|NCT01570166|Hepatocellular Carcinoma|hepatocellular carcinoma
5434195|NCT01570166|RFA|rfa
5434196|NCT01570166|HR|hr
5434197|NCT01570127|Individualized Acupuncture|individualized acupuncture
5434198|NCT01570127|Standardized Acupuncture|standardized acupuncture
5434199|NCT01570127|Low Back Pain|low back pain
5434200|NCT01570127|Randomized Controlled Trial|randomized controlled trial
5434201|NCT01570114|Covered metallic stent|covered metallic stent
5434203|NCT01570114|benign stricture|benign stricture
5434204|NCT01570075|Hepatocellular Carcinoma|hepatocellular carcinoma
5434205|NCT01570075|RFA|rfa
5434206|NCT01570075|HR|hr
5434207|NCT01570062|Inflammation|inflammation
5434208|NCT01570062|Pathologic Processes|pathologic processes
5434209|NCT01570049|Single arm|single arm
5434211|NCT01570049|Bendamustine HCl|bendamustine hcl
5434212|NCT01570049|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
5434213|NCT01570036|stage I breast cancer|stage i breast cancer
5434214|NCT01570036|stage II breast cancer|stage ii breast cancer
5434215|NCT01570036|stage IIIA breast cancer|stage iiia breast cancer
5434216|NCT01570036|stage IIIB breast cancer|stage iiib breast cancer
5434217|NCT01570036|stage IIIC breast cancer|stage iiic breast cancer
5434218|NCT01570036|male breast cancer|male breast cancer
5434219|NCT01570023|Deglutition|deglutition
5434220|NCT01570023|Exercise|exercise
5434221|NCT01569997|Dementia|dementia
5434222|NCT01569997|emergency hospitalization|emergency hospitalization
5434223|NCT01569997|nursing home|nursing home
5434224|NCT01569997|multidisciplinary meeting|multidisciplinary meeting
5434225|NCT01569997|cognitive decline|cognitive decline
5434226|NCT01569997|disability|disability
5434227|NCT01569997|residents|residents
5434228|NCT01569997|facilities|facilities
5434229|NCT01569997|long term care unit|long term care unit
5434230|NCT01569997|health policy|health policy
5434231|NCT01569997|general practitioner|general practitioner
5434232|NCT01569997|prevention|prevention
5434233|NCT01569984|Colorectal|colorectal
5434234|NCT01569971|Transition Program|transition program
5434235|NCT01569971|Perspectives|perspectives
5434236|NCT01569932|chemobrain, chemotherapy, cognitive impairments, fcMRI, neurocognitive Assessments|chemobrain, chemotherapy, cognitive impairments, fcmri, neurocognitive assessments
5434237|NCT01569919|Phase II|phase ii
5434238|NCT01569919|Single arm|single arm
5434239|NCT01569919|Vaccine|vaccine
5434240|NCT01569906|Atopic Dermatitis|atopic dermatitis
5434241|NCT01569893|Telemonitoring|telemonitoring
5434242|NCT01569893|Telemedicine|telemedicine
5434243|NCT01569893|Diabetes mellitus|diabetes mellitus
5434244|NCT01569880|Blood gas response|blood gas response
5434245|NCT01569880|Exercise|exercise
5434246|NCT01569880|Gas exchange|gas exchange
5434247|NCT01569880|Hypoxia altitude simulation test|hypoxia altitude simulation test
5434248|NCT01569880|Pulmonary function|pulmonary function
5434249|NCT01569828|LCZ696|lcz696
5434250|NCT01569828|pharmacokinetics|pharmacokinetics
5434251|NCT01569815|Renal Impairment,|renal impairment,
5434252|NCT01569815|LCZ696|lcz696
5434253|NCT01569802|breast cancer screening|breast cancer screening
5434254|NCT01569802|tomosynthesis|tomosynthesis
5434255|NCT01569802|FFDM|ffdm
5434256|NCT01569789|cytokines|cytokines
5434257|NCT01569789|inflammation|inflammation
5434258|NCT01569789|vagus nerve|vagus nerve
5434259|NCT01569789|TNF|tnf
5434260|NCT01569776|Cow milk allergy|cow milk allergy
5434261|NCT01569776|CMA|cma
5434262|NCT01569763|endometrial ablation|endometrial ablation
5434263|NCT01569750|CD20-positive B-cell non-Hodgkin lymphoma|cd20-positive b-cell non-hodgkin lymphoma
5434264|NCT01569750|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5434265|NCT01569750|Mantle cell lymphoma|mantle cell lymphoma
5434266|NCT01569750|Follicular lymphoma|follicular lymphoma
5434267|NCT01569750|Ibrutinib|ibrutinib
5434268|NCT01569750|R-CHOP|r-chop
5434269|NCT01569750|Rituximab|rituximab
5434270|NCT01569750|Cyclophosphamide|cyclophosphamide
5434271|NCT01569750|Doxorubicin|doxorubicin
5434272|NCT01569750|Vincristine|vincristine
5434273|NCT01569750|Prednisone|prednisone
5434274|NCT01569737|ella|ella
5434275|NCT01569737|ulipristal acetate|ulipristal acetate
5434276|NCT01569737|pregnancy|pregnancy
5434277|NCT01569737|emergency contraception|emergency contraception
5434278|NCT01569724|hypertriglyceridemia|hypertriglyceridemia
5434279|NCT01569724|bexarotene|bexarotene
5434280|NCT01569711|chronic and resistant major depressive disorder|chronic and resistant major depressive disorder
5434281|NCT01569711|deep brain stimulation|deep brain stimulation
5434282|NCT01569698|pediatric|pediatric
5434283|NCT01569698|acute renal failure|acute renal failure
5434284|NCT01569698|acute extra renal replacement therapy|acute extra renal replacement therapy
5434285|NCT01569698|Intermittent Hemodialysis|intermittent hemodialysis
5434286|NCT01569698|Continuous Renal Replacement Therapies|continuous renal replacement therapies
5434287|NCT01569698|Peritoneal Dialysis|peritoneal dialysis
5434288|NCT01569685|PTSD|ptsd
5434289|NCT01569685|Traumatic Stress|traumatic stress
5434290|NCT01569685|Depressions|depressions
5434291|NCT01569685|Refugees|refugees
5434292|NCT01569672|Navigator|navigator
5434293|NCT01569659|Schizophrenia|schizophrenia
5434294|NCT01569659|Refractory|refractory
5434295|NCT01569659|Treatment resistant|treatment resistant
5434296|NCT01569659|Lurasidone|lurasidone
5434297|NCT01569646|monocytes|monocytes
5434298|NCT01569646|culprit vessels|culprit vessels
5434299|NCT01569620|Colorectal Cancer Screening|colorectal cancer screening
5434300|NCT01569620|CRC|crc
5434301|NCT01569620|Screening Colonoscopy|screening colonoscopy
5434302|NCT01569620|Hispanics|hispanics
5434303|NCT01569620|Latinos|latinos
5434304|NCT01569607|Neurophysiology|neurophysiology
5434305|NCT01569607|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5434306|NCT01569607|Neurology|neurology
5434307|NCT01569607|Stroke|stroke
5434308|NCT01569607|Physical Medicine and Rehabilitation|physical medicine and rehabilitation
5434309|NCT01569581|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5671223|NCT00616603|Sciatic nerve Blocks.|sciatic nerve blocks.
5434310|NCT01569581|Hand, Foot and Mouth Disease (HFMD)|hand, foot and mouth disease (hfmd)
5434311|NCT01569581|Inactivated Vaccine|inactivated vaccine
5434312|NCT01569581|Human Diploid cell (KMB17)|human diploid cell (kmb17)
5680267|NCT00578435|Diamond Blackfan Anemia|diamond blackfan anemia
5434313|NCT01569581|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5434314|NCT01569581|Efficacy|efficacy
5434315|NCT01569568|Neuroimaging|neuroimaging
5434317|NCT01569568|Urea cycle|urea cycle
5434318|NCT01569568|hyperammonemia|hyperammonemia
5434319|NCT01569568|cognitive function|cognitive function
5434320|NCT01569568|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
5434321|NCT01569516|Alzheimer's Disease|alzheimer's disease
5434322|NCT01569516|Octohydroaminoacridine Succinate|octohydroaminoacridine succinate
5434323|NCT01569503|Crohn's Disease|crohn's disease
5434325|NCT01569503|vagus nerve stimulation|vagus nerve stimulation
5434326|NCT01569503|inflammation|inflammation
5434327|NCT01569503|Inflammatory bowel diseases|inflammatory bowel diseases
5434328|NCT01569503|TNF|tnf
5434329|NCT01569464|Rotigotine|rotigotine
5434330|NCT01569464|Restless Legs Syndrome|restless legs syndrome
5434331|NCT01569464|Neupro®|neupro®
5434332|NCT01569451|Multiple Sclerosis|multiple sclerosis
5434333|NCT01569451|Glatiramer Acetate|glatiramer acetate
5434334|NCT01569451|Rituximab|rituximab
5434335|NCT01569451|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5434336|NCT01569451|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5434337|NCT01569425|PCOS|pcos
5434338|NCT01569399|Alcohol dependance|alcohol dependance
5434339|NCT01569399|rTMS|rtms
5434340|NCT01569399|craving|craving
5434341|NCT01569399|alcohol consumption|alcohol consumption
5434342|NCT01569386|pulse wave velocity|pulse wave velocity
5434343|NCT01569386|low intensity physical activity|low intensity physical activity
5434344|NCT01569386|hemiplegia|hemiplegia
5434345|NCT01569373|Allogeneic stem cell transplant|allogeneic stem cell transplant
5434346|NCT01569373|Graft versus Host Disease|graft versus host disease
5434347|NCT01569373|GVHD|gvhd
5434348|NCT01569360|Spinal cord injury|spinal cord injury
5434349|NCT01569360|Tetraplegia|tetraplegia
5434350|NCT01569360|Paraplegia|paraplegia
5434351|NCT01569360|Respiratory function|respiratory function
5434352|NCT01569360|Corset|corset
5434353|NCT01569347|Cocaine|cocaine
5434354|NCT01569347|Cocaine-induced psychosis|cocaine-induced psychosis
5434355|NCT01569347|Genetic|genetic
5434356|NCT01569347|Clinical|clinical
5434357|NCT01569347|Biological|biological
5434358|NCT01569334|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with CAV in heart transplanted recipients (HTR)|identify early non invasive markers that index the endothelial lesion/ regeneration potential in association with cav in heart transplanted recipients (htr)
5434359|NCT01569308|Cardiac output|cardiac output
5434360|NCT01569308|Pulse pressure variation|pulse pressure variation
5434361|NCT01569308|Fluid responsiveness|fluid responsiveness
5434362|NCT01569308|Low tidal volume|low tidal volume
5434363|NCT01569295|Zydelig|zydelig
5434364|NCT01569295|CLL|cll
5434365|NCT01569295|CAL 101|cal 101
5434366|NCT01569295|CAL-101|cal-101
5434367|NCT01569295|GS 1101|gs 1101
5434368|NCT01569295|GS-1101|gs-1101
5434369|NCT01569295|PI3K|pi3k
5434370|NCT01569295|Rituxan|rituxan
5434371|NCT01569295|Rituximab|rituximab
5434372|NCT01569295|Bendamustine|bendamustine
5434373|NCT01569295|Leukemia|leukemia
5434374|NCT01569295|idelalisib|idelalisib
5434375|NCT01569282|Surgical bypass|surgical bypass
5434376|NCT01569282|Hepaticojejunostomy|hepaticojejunostomy
5434377|NCT01569282|Gastrojejunostomy|gastrojejunostomy
5434378|NCT01569282|Biliary stent|biliary stent
5434379|NCT01569282|Enteral stent|enteral stent
5434380|NCT01569269|chemotherapy induced peripheral neuropathy|chemotherapy induced peripheral neuropathy
5434381|NCT01569269|cancer|cancer
5434382|NCT01569269|psychological distress|psychological distress
5434383|NCT01569269|mindfulness|mindfulness
5434384|NCT01569269|complementary and alternative|complementary and alternative
5434385|NCT01569243|Diabetes mellitus|diabetes mellitus
5434386|NCT01569243|Text messaging|text messaging
5434387|NCT01569243|Physical activity|physical activity
5434388|NCT01569230|Knee osteoarthritis|knee osteoarthritis
5434389|NCT01569230|acupuncture|acupuncture
5434390|NCT01569230|sham acupuncture|sham acupuncture
5434391|NCT01569217|Diaphragm|diaphragm
5434392|NCT01569217|Abdomen|abdomen
5434393|NCT01569217|Breathing pattern|breathing pattern
5434394|NCT01569217|dyspnea|dyspnea
5434395|NCT01569191|Ocular allergy|ocular allergy
5434396|NCT01569191|Tear supplement|tear supplement
5434397|NCT01569191|Cold compress|cold compress
5434398|NCT01569178|stem cells|stem cells
5434399|NCT01569178|acute myocardial infarction|acute myocardial infarction
5434400|NCT01569178|heart failure|heart failure
5434401|NCT01569178|heart attack|heart attack
5434402|NCT01569178|bone marrow|bone marrow
5434403|NCT01569178|intracoronary reinfusion|intracoronary reinfusion
5434404|NCT01569178|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
5434405|NCT01569178|Left ventricular function improvement|left ventricular function improvement
5434409|NCT01569165|dental plaque|dental plaque
5434410|NCT01569165|water rinsing|water rinsing
5434412|NCT01569139|Concordance|concordance
5434413|NCT01569139|Myocardial infarction|myocardial infarction
5434802|NCT01567488|Advanced|advanced
5434414|NCT01569139|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5434415|NCT01569139|General Practice Research Database|general practice research database
5434416|NCT01569139|Hospital Episode Statistics|hospital episode statistics
5434417|NCT01569139|ONS mortality|ons mortality
5434418|NCT01569113|ella|ella
5434419|NCT01569113|ellaOne|ellaone
5434420|NCT01569113|quickstart|quickstart
5434421|NCT01569113|contraception|contraception
5434422|NCT01569113|combined oral pill|combined oral pill
5434423|NCT01569113|microgynon|microgynon
5434424|NCT01569087|empegfilgrastim|empegfilgrastim
5434425|NCT01569087|pegylated filgrastim|pegylated filgrastim
5434426|NCT01569087|neutropenia|neutropenia
5434427|NCT01569087|febrile neutropenia|febrile neutropenia
5434428|NCT01569087|chemotherapy-associated neutropenia|chemotherapy-associated neutropenia
5434429|NCT01569087|breast cancer|breast cancer
5434430|NCT01569087|docetaxel|docetaxel
5434431|NCT01569087|doxorubicin|doxorubicin
5434432|NCT01569074|Rheumatoid Arthritis|rheumatoid arthritis
5434433|NCT01569061|overactive bladder|overactive bladder
5434434|NCT01569061|laser therapy|laser therapy
5434435|NCT01569061|urinary incontinence|urinary incontinence
5434436|NCT01569061|urinary urgency|urinary urgency
5434437|NCT01569035|oligohudramnios|oligohudramnios
5434438|NCT01569035|oral anti coagulant|oral anti coagulant
5434439|NCT01569035|Dopplar ultrasound|dopplar ultrasound
5434440|NCT01569022|post traumatic stress disorder|post traumatic stress disorder
5434441|NCT01569022|continuous positive airway pressure|continuous positive airway pressure
5434442|NCT01569022|oral appliance|oral appliance
5434443|NCT01569009|Bronchiectasis|bronchiectasis
5434444|NCT01569009|Physical activity|physical activity
5434445|NCT01569009|Activity monitor|activity monitor
5434446|NCT01569009|Pedometer|pedometer
5434447|NCT01568996|atypical nevi|atypical nevi
5434448|NCT01568996|melanoma|melanoma
5434449|NCT01568996|sulforaphane|sulforaphane
5434450|NCT01568996|broccoli|broccoli
5434451|NCT01568996|lesions|lesions
5434452|NCT01568996|STAT1|stat1
5434453|NCT01568996|STAT3|stat3
5434454|NCT01568970|rehabilitation|rehabilitation
5434455|NCT01568970|return to work|return to work
5434456|NCT01568970|sick leave|sick leave
5434457|NCT01568957|Gait|gait
5434458|NCT01568957|Dual-task|dual-task
5434459|NCT01568957|Obstacle avoidance|obstacle avoidance
5434460|NCT01568957|Attention allocation|attention allocation
5434461|NCT01568944|periodontal|periodontal
5434462|NCT01568944|disease|disease
5434463|NCT01568944|dendritic|dendritic
5434464|NCT01568944|cells|cells
5434465|NCT01568944|antibiotics|antibiotics
5434466|NCT01568931|thrombectomy|thrombectomy
5434467|NCT01568905|smoker|smoker
5434468|NCT01568905|smoking|smoking
5434469|NCT01568905|nicotine levels|nicotine levels
5434470|NCT01568905|tobacco|tobacco
5434471|NCT01568905|nicotine|nicotine
5434472|NCT01568892|ART-experienced|art-experienced
5434473|NCT01568892|GSK1349572|gsk1349572
5434474|NCT01568892|Integrase inhibitor resistance|integrase inhibitor resistance
5434475|NCT01568892|Dolutegravir|dolutegravir
5434476|NCT01568879|Recurrent gout|recurrent gout
5434477|NCT01568879|Tophaceous gout|tophaceous gout
5434478|NCT01568879|Gout flares|gout flares
5434479|NCT01568879|Arthritis|arthritis
5434480|NCT01568879|Joint Diseases|joint diseases
5434481|NCT01568879|Rheumatic Diseases|rheumatic diseases
5434482|NCT01568866|multiple myeloma|multiple myeloma
5434483|NCT01568866|relapsed multiple myeloma|relapsed multiple myeloma
5434484|NCT01568840|Physical Therapy Modalities|physical therapy modalities
5434485|NCT01568840|Posture|posture
5434486|NCT01568840|Muscle Stretching Exercises|muscle stretching exercises
5434487|NCT01568840|Dyskinesias|dyskinesias
5434488|NCT01568840|Neck pain|neck pain
5434489|NCT01568814|colonoscopy|colonoscopy
5434490|NCT01568814|bowel preparation|bowel preparation
5434491|NCT01568814|polyethylene glycol|polyethylene glycol
5434492|NCT01568814|low residue meal|low residue meal
5434493|NCT01568801|Integrated Services|integrated services
5434494|NCT01568801|Health Services for the Elderly|health services for the elderly
5434495|NCT01568801|Community Services|community services
5434496|NCT01568788|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
5434497|NCT01568775|End Stage Renal Disease|end stage renal disease
5434498|NCT01568775|Dialysis|dialysis
5434499|NCT01568775|aliskiren|aliskiren
5434500|NCT01568775|SPP100A|spp100a
5434501|NCT01568762|Asthma|asthma
5434502|NCT01568762|VAK694|vak694
5434503|NCT01568762|QAX576|qax576
5434504|NCT01568762|QBX258|qbx258
5434505|NCT01568762|pharmacokinetics|pharmacokinetics
5434507|NCT01568749|Analgesia|analgesia
5434508|NCT01568749|Paracetamol|paracetamol
5434509|NCT01568736|Hyper IgD Syndrome (HIDS)|hyper igd syndrome (hids)
5434510|NCT01568736|Mevalonate Kinase Deficiency (MKD)|mevalonate kinase deficiency (mkd)
5434511|NCT01568723|Barrett's esophagus|barrett's esophagus
5434512|NCT01568723|high grade dysplasia|high grade dysplasia
5434513|NCT01568723|ablation|ablation
5434514|NCT01568723|radiofrequency ablation|radiofrequency ablation
5434515|NCT01568723|esophageal cancer|esophageal cancer
5434516|NCT01568710|Blood Flow|blood flow
5434517|NCT01568710|Endothelium|endothelium
5434534|NCT01568684|Major Depression|major depression
5434535|NCT01568684|Unipolar Depression|unipolar depression
5434537|NCT01568671|Body Fat Distribution|body fat distribution
5434538|NCT01568671|Accelerometry|accelerometry
5434539|NCT01568671|Healthy Volunteers|healthy volunteers
5434540|NCT01568671|Thermoregulation|thermoregulation
5434541|NCT01568671|Healthy Volunteer|healthy volunteer
5434543|NCT01568658|Hereditary Myopathies|hereditary myopathies
5434544|NCT01568658|Neuropathology|neuropathology
5434545|NCT01568658|Muscular Dystrophy|muscular dystrophy
5434546|NCT01568658|Inherited Neuromuscular Condition|inherited neuromuscular condition
5434547|NCT01568658|Inherited Neuropathy|inherited neuropathy
5434548|NCT01568658|Inherited Myopathy|inherited myopathy
5434549|NCT01568658|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5434550|NCT01568658|Healthy Volunteer|healthy volunteer
5434551|NCT01568658|HV|hv
5434552|NCT01568645|Sickle Cell Anemia|sickle cell anemia
5434553|NCT01568645|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5434554|NCT01568645|Platelet Derived Growth Factor|platelet derived growth factor
5434555|NCT01568645|Beta Adrenergic Receptor Blocker|beta adrenergic receptor blocker
5434556|NCT01568645|Pulmonary Vascular Disease|pulmonary vascular disease
5434557|NCT01568645|Sickle Cell Disease|sickle cell disease
5434558|NCT01568645|Pulmonary Hypertension|pulmonary hypertension
5434559|NCT01568632|Dose Limiting Toxicity|dose limiting toxicity
5434560|NCT01568632|Maximum Tolerated Dose|maximum tolerated dose
5434561|NCT01568632|Telomerase Inhibitor|telomerase inhibitor
5434562|NCT01568632|Safety|safety
5434563|NCT01568632|Solid Tumor|solid tumor
5434564|NCT01568632|Lymphoma|lymphoma
5434565|NCT01568619|cardiopulmonary exercise test|cardiopulmonary exercise test
5434566|NCT01568619|cardiac output|cardiac output
5434567|NCT01568606|Heart Failure|heart failure
5434568|NCT01568606|Obesity|obesity
5434569|NCT01568606|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5434570|NCT01568580|Hemophilia A|hemophilia a
5434571|NCT01568580|Factor VIII|factor viii
5434572|NCT01568580|Recombinant|recombinant
5434573|NCT01568567|safety|safety
5434574|NCT01568567|tolerance|tolerance
5434575|NCT01568567|lactobacillus Reuteri|lactobacillus reuteri
5434576|NCT01568541|children|children
5434577|NCT01568541|dentifrice|dentifrice
5434578|NCT01568541|fluoride|fluoride
5434579|NCT01568541|dental fluorosis|dental fluorosis
5434580|NCT01568515|HPV vaccine|hpv vaccine
5434581|NCT01568515|Vaccine adherence|vaccine adherence
5434582|NCT01568515|Vaccine utilization|vaccine utilization
5434583|NCT01568515|Electronic Messaging|electronic messaging
5434584|NCT01568502|dobutamine stress|dobutamine stress
5434585|NCT01568502|inducible ischemia|inducible ischemia
5434586|NCT01568502|CAD|cad
5434587|NCT01568476|Regional anesthesia|regional anesthesia
5434588|NCT01568476|Sciatic nerve block|sciatic nerve block
5434589|NCT01568476|foot surgery|foot surgery
5434590|NCT01568476|ankle surgery|ankle surgery
5434591|NCT01568476|Interneural local anesthetic|interneural local anesthetic
5434592|NCT01568463|Inter-scalene Block|inter-scalene block
5434593|NCT01568463|Regional Anesthesia|regional anesthesia
5434594|NCT01568463|shoulder surgeries|shoulder surgeries
5434595|NCT01568450|Oxycodone, controlled release formulation|oxycodone, controlled release formulation
5434596|NCT01568437|Laparoscopic gastric-bypass surgery|laparoscopic gastric-bypass surgery
5434597|NCT01568437|TAP block|tap block
5434598|NCT01568424|Heart Failure|heart failure
5434599|NCT01568424|Right Ventricular Failure|right ventricular failure
5434600|NCT01568424|Levitronix|levitronix
5434601|NCT01568424|Thoratec Corporation|thoratec corporation
5434602|NCT01568411|None - normal volunteers|none - normal volunteers
5434603|NCT01568398|Gastric or duodenal ulcer|gastric or duodenal ulcer
5434604|NCT01568385|Gastric or duodenal ulcer|gastric or duodenal ulcer
5434605|NCT01568372|pediatric|pediatric
5434606|NCT01568372|tonsillectomy|tonsillectomy
5434607|NCT01568372|pain management|pain management
5434608|NCT01568372|nurse follow-up|nurse follow-up
5434609|NCT01568346|Newly diagnosed|newly diagnosed
5434610|NCT01568346|Early stage|early stage
5434611|NCT01568333|Decitabine|decitabine
5434612|NCT01568333|Immune thrombocytopenia|immune thrombocytopenia
5434613|NCT01568320|Aorta|aorta
5434614|NCT01568320|Thoracic|thoracic
5434615|NCT01568320|Aortic dissection|aortic dissection
5434616|NCT01568320|Rupture|rupture
5434617|NCT01568320|Type B|type b
5434618|NCT01568320|DeBakey type III|debakey type iii
5434619|NCT01568320|Endovascular|endovascular
5434620|NCT01568307|Major depressive disorder|major depressive disorder
5434621|NCT01568307|Serotonin transporter|serotonin transporter
5434622|NCT01568307|Sympathetic nervous system activation|sympathetic nervous system activation
5434623|NCT01568307|Cardiovascular risk factors|cardiovascular risk factors
5434624|NCT01568307|Serotonin re-uptake inhibitor|serotonin re-uptake inhibitor
5434626|NCT01568281|pharmacokinetics|pharmacokinetics
5434627|NCT01568281|safety|safety
5434628|NCT01568281|anastrozole|anastrozole
5434629|NCT01568281|Arimidex|arimidex
5434630|NCT01568281|Japanese|japanese
5434631|NCT01568281|healthy subject|healthy subject
5434632|NCT01568268|palonosetron|palonosetron
5434633|NCT01568268|postoperative nausea and vomiting|postoperative nausea and vomiting
5434634|NCT01568255|myopathic symptoms|myopathic symptoms
5434635|NCT01568242|Cataract|cataract
5434636|NCT01568242|Phacoemulsification|phacoemulsification
5434637|NCT01568242|Temperature|temperature
5434638|NCT01568242|Vitreous|vitreous
5434639|NCT01568229|schizophrenia negative symptoms|schizophrenia negative symptoms
5434640|NCT01568216|schizophrenia negative symptoms|schizophrenia negative symptoms
5434641|NCT01568203|single dose, safety, healthy subjects, schizoaffective disorder, AMG 579|single dose, safety, healthy subjects, schizoaffective disorder, amg 579
5434642|NCT01568190|House dust mites sensitisation|house dust mites sensitisation
5434644|NCT01568164|Epicardial Catheter-based Restoration|epicardial catheter-based restoration
5434645|NCT01568164|Surgical/Left Ventricular Reconstruction|surgical/left ventricular reconstruction
5434646|NCT01568164|Ventricular Remodeling|ventricular remodeling
5434648|NCT01568151|Colorectal Cancer|colorectal cancer
5434649|NCT01568151|Screening|screening
5434650|NCT01568151|Education|education
5434651|NCT01568151|Testing|testing
5434652|NCT01568138|Ventricular Remodeling|ventricular remodeling
5434653|NCT01568112|BG00012|bg00012
5434654|NCT01568112|gastrointestinal events|gastrointestinal events
5434655|NCT01568112|flushing events|flushing events
5434656|NCT01568112|dose titration|dose titration
5434657|NCT01568112|pre-medication|pre-medication
5434658|NCT01568112|aspirin|aspirin
5434659|NCT01568073|Parkinson|parkinson
5434661|NCT01568073|Wearing-off|wearing-off
5434662|NCT01568073|Levodopa/DDCI|levodopa/ddci
5434663|NCT01568060|Safety|safety
5434664|NCT01568060|Infanrix-IPV|infanrix-ipv
5434665|NCT01568060|Post-marketing surveillance|post-marketing surveillance
5434666|NCT01568060|Diphtheria, tetanus, pertussis and poliomyelitis|diphtheria, tetanus, pertussis and poliomyelitis
5434667|NCT01568047|Parkinson Disease|parkinson disease
5434668|NCT01568047|BIA 9-1067|bia 9-1067
5434669|NCT01568034|Parkinson's Disease|parkinson's disease
5434670|NCT01568034|BIA 9-1067|bia 9-1067
5434671|NCT01567995|eczematous|eczematous
5434672|NCT01567995|dermatitis|dermatitis
5434673|NCT01567982|tDCS|tdcs
5434674|NCT01567982|brain stimulation|brain stimulation
5434675|NCT01567982|addiction|addiction
5434676|NCT01567982|substance dependence|substance dependence
5434677|NCT01567982|craving|craving
5434678|NCT01567982|cognition|cognition
5434679|NCT01567969|mental health services|mental health services
5434680|NCT01567969|child behavior disorders|child behavior disorders
5434681|NCT01567969|child psychiatry|child psychiatry
5434682|NCT01567956|Ulcerative colitis|ulcerative colitis
5434683|NCT01567943|alcohol abuse|alcohol abuse
5434684|NCT01567943|drug abuse|drug abuse
5434685|NCT01567943|schizophrenia|schizophrenia
5434686|NCT01567943|bipolar disorder|bipolar disorder
5434687|NCT01567943|major depressive disorder|major depressive disorder
5434688|NCT01567943|contingency management|contingency management
5434689|NCT01567943|psychosocial treatment|psychosocial treatment
5434690|NCT01567930|Temsirolimus|temsirolimus
5434691|NCT01567930|HCC|hcc
5434692|NCT01567930|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5434693|NCT01567917|Venous thromboembolism|venous thromboembolism
5434694|NCT01567917|Colorectal cancer|colorectal cancer
5434695|NCT01567917|Postoperative period|postoperative period
5434696|NCT01567917|detected on 5th~14th days after surgery (by doppler US) or the follow-up period of postoperative 1 month|detected on 5th~14th days after surgery (by doppler us) or the follow-up period of postoperative 1 month
5434697|NCT01567904|thrombosis|thrombosis
5434698|NCT01567904|Central Venous Line|central venous line
5434699|NCT01567904|CVL|cvl
5434700|NCT01567891|Ovarian Cancer|ovarian cancer
5434701|NCT01567891|Cell Therapy|cell therapy
5434702|NCT01567891|T Cell Therapy|t cell therapy
5434703|NCT01567891|NY-ESO-1|ny-eso-1
5434704|NCT01567891|Immuno-oncology|immuno-oncology
5434705|NCT01567891|Metastatic|metastatic
5434706|NCT01567891|Previously treated|previously treated
5434707|NCT01567891|T Cell Receptor|t cell receptor
5434708|NCT01567878|ultrasound|ultrasound
5434709|NCT01567878|MASEI index|masei index
5434710|NCT01567878|clinical and ultrasound correlation|clinical and ultrasound correlation
5434711|NCT01567878|enthesis ultrasound|enthesis ultrasound
5434712|NCT01567878|articular ultrasound|articular ultrasound
5434713|NCT01567878|ankylosing spondylitis ultrasound|ankylosing spondylitis ultrasound
5434714|NCT01567878|radiographic and ultrasound correlation|radiographic and ultrasound correlation
5434715|NCT01567852|orientation|orientation
5434726|NCT01567826|Coronary artery disease|coronary artery disease
5434728|NCT01567813|Warts|warts
5434729|NCT01567813|Papillomavirus infections|papillomavirus infections
5434730|NCT01567813|DNA virus infections|dna virus infections
5434731|NCT01567813|Virus diseases|virus diseases
5434732|NCT01567813|Skin diseases, viral|skin diseases, viral
5434733|NCT01567813|Tumor virus infections|tumor virus infections
5434734|NCT01567813|Skin diseases, infectious|skin diseases, infectious
5434735|NCT01567813|Skin diseases|skin diseases
5434736|NCT01567800|Procedure/Surgery: 18F-Fluoroazomycin Arabinoside (18F-FAZA)|procedure/surgery: 18f-fluoroazomycin arabinoside (18f-faza)
5434737|NCT01567787|Proton Radiation Therapy|proton radiation therapy
5434738|NCT01567787|Spinal tumors|spinal tumors
5434739|NCT01567787|Neurofibroma(NF1)|neurofibroma(nf1)
5434740|NCT01567787|Malignant peripheral nerve sheath tumor(MPNST)|malignant peripheral nerve sheath tumor(mpnst)
5434741|NCT01567774|Coronary artery disease|coronary artery disease
5434742|NCT01567774|dual antiplatelet therapy|dual antiplatelet therapy
5434743|NCT01567774|atorvastatin|atorvastatin
5434744|NCT01567774|rosuvastatin|rosuvastatin
5434746|NCT01567748|CABG|cabg
5434747|NCT01567748|Coronary Artery Bypass|coronary artery bypass
5434748|NCT01567748|Central Aortic Pressure|central aortic pressure
5434749|NCT01567748|Peripheral Arterial Waveform|peripheral arterial waveform
5434750|NCT01567735|Hepatitis C|hepatitis c
5434751|NCT01567735|TMC435HPC3011|tmc435hpc3011
5434752|NCT01567735|TMC435|tmc435
5434753|NCT01567722|HIV infection|hiv infection
5434754|NCT01567722|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5434755|NCT01567722|anal cancer|anal cancer
5434756|NCT01567722|cervical cancer|cervical cancer
5434757|NCT01567722|non-small cell lung cancer|non-small cell lung cancer
5434758|NCT01567722|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5434759|NCT01567696|Revision,|revision,
5434760|NCT01567683|Safety and Tolerability of Limtop and vehicle|safety and tolerability of limtop and vehicle
5434761|NCT01567683|of Limtop and vehicle|of limtop and vehicle
5434762|NCT01567657|Sedation in TEE|sedation in tee
5434763|NCT01567657|Blood pressure drop during TEE|blood pressure drop during tee
5434764|NCT01567657|Safety of sedation in TEE|safety of sedation in tee
5434765|NCT01567644|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5434766|NCT01567644|Myocardial Ischemia|myocardial ischemia
5434767|NCT01567644|Refractory Angina|refractory angina
5434768|NCT01567631|Classical Procedure|classical procedure
5434769|NCT01567631|Intrahepatic Glisson's Approach|intrahepatic glisson's approach
5434770|NCT01567631|laparoscopic hepatectomy|laparoscopic hepatectomy
5434771|NCT01567631|Minimal invasive surgery|minimal invasive surgery
5434772|NCT01567631|Endoscopic stapling devices|endoscopic stapling devices
5434773|NCT01567618|Docetaxel|docetaxel
5434774|NCT01567618|Fluorouracil|fluorouracil
5434775|NCT01567618|First line therapy|first line therapy
5434776|NCT01567618|Gastric cancer|gastric cancer
5434777|NCT01567605|spinal cord injury|spinal cord injury
5434778|NCT01567605|autonomic dysreflexia|autonomic dysreflexia
5434779|NCT01567605|blood pressure|blood pressure
5434780|NCT01567605|bowel care management|bowel care management
5434781|NCT01567605|defecation|defecation
5434782|NCT01567592|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5434783|NCT01567592|Myocardial Ischemia|myocardial ischemia
5434784|NCT01567592|Refractory Angina|refractory angina
5434785|NCT01567579|congenital heart defects|congenital heart defects
5434786|NCT01567566|home based daily exercise program|home based daily exercise program
5434787|NCT01567566|local lumbopelvic stabilizer muscles|local lumbopelvic stabilizer muscles
5434788|NCT01567566|hip stabilizer muscles|hip stabilizer muscles
5434789|NCT01567566|real time ultrasound imaging|real time ultrasound imaging
5434790|NCT01567553|inflammatory disease of the central nervous system|inflammatory disease of the central nervous system
5434791|NCT01567553|early clinical deficit|early clinical deficit
5434792|NCT01567553|multiple sclerosis (MS)|multiple sclerosis (ms)
5434793|NCT01567540|Chronic Hepatitis C|chronic hepatitis c
5434794|NCT01567540|Interferon protein 10|interferon protein 10
5434795|NCT01567540|Chemokine gradients|chemokine gradients
5434796|NCT01567540|Sitagliptin|sitagliptin
5434798|NCT01567527|Intramuscular (IM) Depot|intramuscular (im) depot
5434799|NCT01567527|Bipolar|bipolar
5434800|NCT01567514|Deep occlusal caries restored with resin composite|deep occlusal caries restored with resin composite
5434801|NCT01567514|on Pit and Fissure Surface Penetrating Into Dentin|on pit and fissure surface penetrating into dentin
5434803|NCT01567488|Non functioning|non functioning
5434804|NCT01567488|Well differentiated|well differentiated
5434805|NCT01567462|bladder cancer|bladder cancer
5434806|NCT01567462|transurethral resection of bladder tumors|transurethral resection of bladder tumors
5434807|NCT01567423|Malaria|malaria
5434808|NCT01567423|Plasmodium falciparum|plasmodium falciparum
5434809|NCT01567423|Children|children
5434810|NCT01567423|Efficacy|efficacy
5434811|NCT01567423|Uncomplicated malaria|uncomplicated malaria
5434812|NCT01567410|e-learning|e-learning
5434813|NCT01567410|education|education
5434814|NCT01567384|cancer|cancer
5434815|NCT01567384|neoplasms|neoplasms
5434816|NCT01567384|tumors|tumors
5434818|NCT01567345|cancer|cancer
5434819|NCT01567345|Intrathecal|intrathecal
5434820|NCT01567345|analgesia|analgesia
5434821|NCT01567345|Morphine|morphine
5434822|NCT01567345|Implantable pump|implantable pump
5434823|NCT01567319|Sensitization|sensitization
5434824|NCT01567319|Skin Prick Test|skin prick test
5434825|NCT01567319|Standardization|standardization
5434826|NCT01567319|sources of: D. glomerata, L. perenne, S. cereale and O. europaea|sources of: d. glomerata, l. perenne, s. cereale and o. europaea
5434827|NCT01567306|Allergy|allergy
5434828|NCT01567306|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5434829|NCT01567306|Subcutaneous Immunotherapy|subcutaneous immunotherapy
5434830|NCT01567306|Phleum pratense pollen extract|phleum pratense pollen extract
5434831|NCT01567267|Evidence-based Medicine|evidence-based medicine
5417630|NCT01642485|TQT bridging|tqt bridging
5434832|NCT01567267|Good Scientific Practice|good scientific practice
5434833|NCT01567267|Problem-based Learning|problem-based learning
5434834|NCT01567267|Critical health literacy|critical health literacy
5434835|NCT01567267|Educational intervention|educational intervention
5434836|NCT01567254|guided imaginary|guided imaginary
5434837|NCT01567241|clinical hypnosis|clinical hypnosis
5434838|NCT01567241|relaxation music|relaxation music
5434839|NCT01567241|reproduction techniques|reproduction techniques
5434840|NCT01567241|insemination|insemination
5434841|NCT01567241|embryo transfer|embryo transfer
5434842|NCT01567241|pregnancy rate|pregnancy rate
5434843|NCT01567228|obesity|obesity
5434844|NCT01567228|overweight|overweight
5434845|NCT01567228|dental caries|dental caries
5434846|NCT01567228|school problems|school problems
5434847|NCT01567228|school failure|school failure
5434848|NCT01567228|child BMI > 85th percentile|child bmi > 85th percentile
5434849|NCT01567228|Needing dental preventive services|needing dental preventive services
5434850|NCT01567228|Needing academic support for school problems|needing academic support for school problems
5434851|NCT01567215|granuloma umbilical|granuloma umbilical
5434852|NCT01567202|Brain tumor|brain tumor
5434853|NCT01567202|Glioma|glioma
5434854|NCT01567202|Glioblastoma|glioblastoma
5434855|NCT01567202|Tumor stem cells|tumor stem cells
5434856|NCT01567202|Immunotherapy|immunotherapy
5434857|NCT01567202|Vaccine|vaccine
5434858|NCT01567189|Exercise therapy|exercise therapy
5434859|NCT01567189|cost effectiveness|cost effectiveness
5434860|NCT01567189|cardiac rehabilitation|cardiac rehabilitation
5434861|NCT01567189|home-based exercise|home-based exercise
5434862|NCT01567176|Sirtuins|sirtuins
5434863|NCT01567176|Aging|aging
5434864|NCT01567176|Metabolic disease|metabolic disease
5434865|NCT01567163|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5434866|NCT01567124|Schizophrenia|schizophrenia
5434867|NCT01567124|Moxonidine|moxonidine
5434868|NCT01567124|Sympathetic nervous system activation|sympathetic nervous system activation
5434869|NCT01567124|Cardiometabolic side effects of antipsychotics|cardiometabolic side effects of antipsychotics
5434870|NCT01567111|Primary aldosteronism|primary aldosteronism
5434871|NCT01567111|Aldosterone producing adenoma|aldosterone producing adenoma
5434872|NCT01567111|Bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
5434873|NCT01567111|Metomidate-Positron emission tomography|metomidate-positron emission tomography
5434874|NCT01567072|NSAID|nsaid
5434875|NCT01567072|bone fracture|bone fracture
5434876|NCT01567072|heal|heal
5434877|NCT01567033|Diabetes|diabetes
5434878|NCT01567033|Obesity|obesity
5434879|NCT01567033|Home visiting|home visiting
5434880|NCT01567020|Central Auditory Processing|central auditory processing
5434881|NCT01567020|Traumatic Brain Injury|traumatic brain injury
5434882|NCT01567020|Hearing Loss|hearing loss
5434883|NCT01567007|pedometer|pedometer
5421799|NCT01622699|Newborn|newborn
5434884|NCT01567007|physical activity|physical activity
5434885|NCT01567007|workplace|workplace
5434886|NCT01566994|smoking cessation|smoking cessation
5434887|NCT01566981|Diabetes mellitus tip II|diabetes mellitus tip ii
5434888|NCT01566981|eHealth solution|ehealth solution
5434889|NCT01566981|Health Information Technology|health information technology
5434890|NCT01566981|quality of life|quality of life
5434891|NCT01566981|family medicine|family medicine
5438140|NCT01553188|Ang 1|ang 1
5434892|NCT01566981|satisfaction with e-health care|satisfaction with e-health care
5434893|NCT01566981|primary care|primary care
5434895|NCT01566968|Asthma|asthma
5434896|NCT01566968|Healthy volunteers|healthy volunteers
5434897|NCT01566968|Chronic cough|chronic cough
5434898|NCT01566968|Smokers|smokers
5434899|NCT01566968|Cough challenge|cough challenge
5434900|NCT01566968|Cough challenge testing.|cough challenge testing.
5434901|NCT01566955|transgastric|transgastric
5434902|NCT01566955|NOTES|notes
5434903|NCT01566955|Gastrotomy|gastrotomy
5434904|NCT01566955|BRCA 1/2|brca 1/2
5434905|NCT01566942|FOLFIRI|folfiri
5434906|NCT01566942|FOLFOX|folfox
5434907|NCT01566942|adjuvant chemotherapy|adjuvant chemotherapy
5434908|NCT01566942|advanced colorectal cancer|advanced colorectal cancer
5434909|NCT01566929|Obesity|obesity
5434910|NCT01566929|In vitro fertilization|in vitro fertilization
5434911|NCT01566929|Low calorie diet (LCD)|low calorie diet (lcd)
5434912|NCT01566929|Obstetric outcome|obstetric outcome
5434913|NCT01566929|Weight reduction|weight reduction
5434919|NCT01566890|sickle cell pain crisis|sickle cell pain crisis
5434920|NCT01566890|vaso-occlusive crisis|vaso-occlusive crisis
5434921|NCT01566890|vaso-occlusion|vaso-occlusion
5434922|NCT01566890|sickle cell anemia|sickle cell anemia
5434923|NCT01566890|sickle cell disease|sickle cell disease
5434924|NCT01566890|genetic diseases|genetic diseases
5434925|NCT01566890|adenosine 2A Receptor Agonists|adenosine 2a receptor agonists
5434927|NCT01566890|Regadenoson|regadenoson
5434928|NCT01566890|contrast-enhanced ultrasound|contrast-enhanced ultrasound
5434929|NCT01566890|Hydroxyurea|hydroxyurea
5417724|NCT01641887|GERD|gerd
5434930|NCT01566877|Multiple Ascending Dose (MAD)|multiple ascending dose (mad)
5434931|NCT01566877|Marburg Virus|marburg virus
5434932|NCT01566877|Post Exposure Prophylaxis|post exposure prophylaxis
5434933|NCT01566864|hypertension|hypertension
5434934|NCT01566864|disparities|disparities
5434935|NCT01566864|care management|care management
5434936|NCT01566864|provider education|provider education
5434937|NCT01566864|audit and feedback|audit and feedback
5434938|NCT01566864|Omron|omron
5434939|NCT01566864|African Americans|african americans
5434940|NCT01566864|organizational change|organizational change
5434941|NCT01566864|implementation research|implementation research
5434942|NCT01566838|Visual analog pain score|visual analog pain score
5434943|NCT01566838|Length of stay|length of stay
5434944|NCT01566838|Hospital Cost|hospital cost
5434945|NCT01566838|Subpleural pain catheter|subpleural pain catheter
5434946|NCT01566838|Bupivacaine|bupivacaine
5434947|NCT01566825|amitriptyline|amitriptyline
5434948|NCT01566825|sleep dependent memory consolidation|sleep dependent memory consolidation
5434949|NCT01566812|Breast Feeding|breast feeding
5434950|NCT01566812|Cardiovascular Risk|cardiovascular risk
5434951|NCT01566799|Locally advanced breast cancer|locally advanced breast cancer
5434952|NCT01566799|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5434953|NCT01566799|Metformin|metformin
5434954|NCT01566799|Pathologic Complete Response|pathologic complete response
5434955|NCT01566773|COPD|copd
5434956|NCT01566760|food effect|food effect
5434957|NCT01566760|bioavailability|bioavailability
5434958|NCT01566760|pharmacokinetics|pharmacokinetics
5434959|NCT01566760|fesoterodine|fesoterodine
5434960|NCT01566760|5-hydroxymethyl tolterodine|5-hydroxymethyl tolterodine
5434961|NCT01566760|treatment of overactive bladder|treatment of overactive bladder
5434962|NCT01566734|Surgical Wound Infection|surgical wound infection
5434963|NCT01566734|cefazolin|cefazolin
5434964|NCT01566734|Cesarean Section|cesarean section
5434965|NCT01566708|Acute Tinnitus|acute tinnitus
5434966|NCT01566708|Recent Onset Tinnitus|recent onset tinnitus
5434967|NCT01566708|Music Therapy|music therapy
5434968|NCT01566708|fMRI|fmri
5434969|NCT01566708|Therapy Evaluation|therapy evaluation
5434970|NCT01566682|Lung Lesion|lung lesion
5434971|NCT01566682|Lung Mass|lung mass
5434972|NCT01566682|Lung Nodule|lung nodule
5434973|NCT01566682|Lung Cancer|lung cancer
5434974|NCT01566682|Low-Dose CT|low-dose ct
5434975|NCT01566682|CT|ct
5434976|NCT01566682|Diagnostic|diagnostic
5434977|NCT01566682|Evaluation|evaluation
5434978|NCT01566682|Bioconductance|bioconductance
5434979|NCT01566682|ProLung|prolung
5434980|NCT01566669|Cyclooxygenase inhibitors|cyclooxygenase inhibitors
5434981|NCT01566669|Morphine|morphine
5434982|NCT01566669|Analgesia|analgesia
5434983|NCT01566669|patient-controlled|patient-controlled
5434984|NCT01566669|Gynecologic surgical procedures|gynecologic surgical procedures
5434985|NCT01566656|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5434986|NCT01566656|Non-myeloablative preparative regimen|non-myeloablative preparative regimen
5407317|NCT01689571|Asthma|asthma
5434987|NCT01566656|Total lymphoid irradiation|total lymphoid irradiation
5434988|NCT01566656|Anti-thymocyte globulin|anti-thymocyte globulin
5434989|NCT01566656|Lymphoid malignancies|lymphoid malignancies
5434990|NCT01566643|Helicobacter pylori|helicobacter pylori
5434991|NCT01566643|antibiotic resistance|antibiotic resistance
5434992|NCT01566643|sequential-concomitant hybrid therapy|sequential-concomitant hybrid therapy
5434993|NCT01566630|human recombinant RLX030|human recombinant rlx030
5434994|NCT01566630|Pre-eclampsia|pre-eclampsia
5434995|NCT01566630|hemodynamics|hemodynamics
5434996|NCT01566630|Pharmacokinetics|pharmacokinetics
5434997|NCT01566604|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5434999|NCT01566591|Bipolar Depression|bipolar depression
5576543|NCT00981721|China|china
5435000|NCT01566552|AMBISOME|ambisome
5435001|NCT01566552|VISCERAL LEISHMANIASIS|visceral leishmaniasis
5435002|NCT01566552|SINGLE DOSE|single dose
5435003|NCT01566539|Social cooperation|social cooperation
5435006|NCT01566539|Prisoner's Dilemma game|prisoner's dilemma game
5435007|NCT01566539|Empathy|empathy
5435008|NCT01566539|fMRI|fmri
5435009|NCT01566513|Peer Support|peer support
5435010|NCT01566513|Cost Effectiveness|cost effectiveness
5435011|NCT01566513|Reducing Hospital use|reducing hospital use
5435012|NCT01566513|Serious Mental Illness|serious mental illness
5435013|NCT01566500|Epilepsy|epilepsy
5435014|NCT01566500|Medication Adherence|medication adherence
5435015|NCT01566487|Bioequivalence|bioequivalence
5435016|NCT01566487|Quetiapine fumarate|quetiapine fumarate
5435017|NCT01566487|crossover|crossover
5435018|NCT01566461|Drug-Coated Angioplasty Balloon|drug-coated angioplasty balloon
5435019|NCT01566461|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5435020|NCT01566461|Peripheral Artery Disease|peripheral artery disease
5435021|NCT01566461|Experimental|experimental
5435022|NCT01566461|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5435024|NCT01566448|Mucositis|mucositis
5435025|NCT01566448|Oral ketamine rinse|oral ketamine rinse
5435026|NCT01566409|Constipation|constipation
5435027|NCT01566409|Maintenance treatment|maintenance treatment
5435028|NCT01566409|Ultrasound of rectum|ultrasound of rectum
5435029|NCT01566396|Fractional,|fractional,
5435030|NCT01566396|RF,|rf,
5435031|NCT01566396|Wrinkles|wrinkles
5435032|NCT01566396|Safety|safety
5435033|NCT01566396|Efficacy|efficacy
5435034|NCT01566396|treatment|treatment
5435035|NCT01566370|alcoholism|alcoholism
5435036|NCT01566370|alcohol use disorder|alcohol use disorder
5435037|NCT01566370|alcohol dependence|alcohol dependence
5435038|NCT01566370|alcohol abuse|alcohol abuse
5435039|NCT01566370|bipolar|bipolar
5435040|NCT01566370|anticonvulsant|anticonvulsant
5435041|NCT01566370|zonisamide|zonisamide
5435042|NCT01566357|dental erosion|dental erosion
5435043|NCT01566357|enamel|enamel
5435044|NCT01566357|dentin|dentin
5435045|NCT01566344|Premature Ventricular Complex|premature ventricular complex
5435046|NCT01566344|Cardiomyopathy|cardiomyopathy
5435047|NCT01566344|Left ventricular dysfunction|left ventricular dysfunction
5435048|NCT01566344|Catheter Ablation|catheter ablation
5435049|NCT01566344|Anti-Arrhythmic Agents|anti-arrhythmic agents
5435050|NCT01566344|Randomized Clinical Trial|randomized clinical trial
5435051|NCT01566331|Safe Delivery|safe delivery
5435052|NCT01566331|reduction of pain|reduction of pain
5435053|NCT01566331|reduction stage of labor|reduction stage of labor
5435054|NCT01566318|Depression|depression
5435056|NCT01566318|Geriatric mental health|geriatric mental health
5435057|NCT01566279|solid tumors|solid tumors
5435058|NCT01566279|all comers|all comers
5435059|NCT01566279|everolimus|everolimus
5435060|NCT01566279|biomarker|biomarker
5435061|NCT01566279|next generation sequencing|next generation sequencing
5435062|NCT01566266|gut flora|gut flora
5435063|NCT01566266|antibiotics|antibiotics
5435064|NCT01566266|lipid metabolism|lipid metabolism
5435065|NCT01566266|LDL cholesterol|ldl cholesterol
5435066|NCT01566253|planned caesarian section, analgesic, PCOA|planned caesarian section, analgesic, pcoa
5435067|NCT01566240|Cervical Cancer|cervical cancer
5435068|NCT01566240|Chemotherapy|chemotherapy
5435069|NCT01566240|Paclitaxel|paclitaxel
5435070|NCT01566240|Carboplatin|carboplatin
5435071|NCT01566240|Cisplatin|cisplatin
5435072|NCT01566240|Radiotherapy|radiotherapy
5435073|NCT01566240|Chemoradiation|chemoradiation
5435074|NCT01566240|Brachytherapy|brachytherapy
5435075|NCT01566240|Stage IB2 Cervical Cancer|stage ib2 cervical cancer
5435076|NCT01566240|Stage IIA Cervical Cancer|stage iia cervical cancer
5435077|NCT01566240|Stage IIB Cervical Cancer|stage iib cervical cancer
5435078|NCT01566240|Stage IIIB Cervical Cancer|stage iiib cervical cancer
5435079|NCT01566240|Stage IVA Cervical Cancer|stage iva cervical cancer
5435080|NCT01566227|overdenture|overdenture
5435081|NCT01566227|implant|implant
5435082|NCT01566227|edentulism|edentulism
5435083|NCT01566214|coronary heart disease (CHD)|coronary heart disease (chd)
5435084|NCT01566214|myocardial infarction (MI)|myocardial infarction (mi)
5435085|NCT01566214|acute coronary syndromes (ACS)|acute coronary syndromes (acs)
5435086|NCT01566201|Arterial stiffness|arterial stiffness
5435087|NCT01566201|Endothelial function|endothelial function
5435088|NCT01566201|Left ventricular function|left ventricular function
5435089|NCT01566201|Apoptosis|apoptosis
5435090|NCT01566201|Nitrooxidative stress|nitrooxidative stress
5435091|NCT01566175|Neovasc Reducer|neovasc reducer
5435092|NCT01566175|Coronary Sinus|coronary sinus
5435093|NCT01566175|Refractory Angina Pectoris|refractory angina pectoris
5435094|NCT01566175|angina class 3-4|angina class 3-4
5435095|NCT01566162|Lurasidone|lurasidone
5435096|NCT01566162|Latuda|latuda
5435097|NCT01566162|Schizophrenia|schizophrenia
5435098|NCT01566136|hip fracture patients|hip fracture patients
5435099|NCT01566136|cognitive impairment|cognitive impairment
5435100|NCT01566136|rehabilitation model of care|rehabilitation model of care
5435101|NCT01566123|retroperitoneal soft tissue sarcoma|retroperitoneal soft tissue sarcoma
5435102|NCT01566123|IMRT|imrt
5435103|NCT01566123|IORT|iort
5435105|NCT01566110|dietary treatment|dietary treatment
5435106|NCT01566110|celiac disease|celiac disease
5435107|NCT01566110|T1D|t1d
5435108|NCT01566097|Cluster randomized trial|cluster randomized trial
5435109|NCT01566097|Decision aids|decision aids
5435110|NCT01566097|Culturally-appropriate decision aids|culturally-appropriate decision aids
5435111|NCT01566058|Post partum|post partum
5435112|NCT01566058|mother-child relationships|mother-child relationships
5435113|NCT01566045|Prostate Cancer|prostate cancer
5435115|NCT01566032|pulmonary air leak|pulmonary air leak
5435116|NCT01566032|Thopaz|thopaz
5435117|NCT01566032|analog|analog
5435118|NCT01566032|digital|digital
5435119|NCT01566006|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5435120|NCT01566006|Diabetic Nephropathy|diabetic nephropathy
5435121|NCT01566006|proteinuria|proteinuria
5435122|NCT01566006|Diabetic Nephropathy in Chronic Kidney Disease patients stages 2-4|diabetic nephropathy in chronic kidney disease patients stages 2-4
5435123|NCT01565980|Lung cancer|lung cancer
5435124|NCT01565980|mindfulness therapy|mindfulness therapy
5435125|NCT01565980|active treatment (radiation and/or chemotherapy)|active treatment (radiation and/or chemotherapy)
5435126|NCT01565967|AutoLog|autolog
5435127|NCT01565967|Post market release|post market release
5435128|NCT01565967|Non-interventional|non-interventional
5435129|NCT01565954|Sickle Cell Disease|sickle cell disease
5435130|NCT01565954|Respiration Disorders|respiration disorders
5435131|NCT01565954|Polysomnography|polysomnography
5435132|NCT01565941|Cardiovascular|cardiovascular
5435133|NCT01565941|Respiratory|respiratory
5435134|NCT01565941|Failure|failure
5435135|NCT01565941|Heart|heart
5435136|NCT01565941|Lung|lung
5435137|NCT01565941|Continuous glucose monitoring|continuous glucose monitoring
5435138|NCT01565941|Tight glycemic control|tight glycemic control
5435139|NCT01565941|Subcutaneous|subcutaneous
5435140|NCT01565941|Insulin|insulin
5435141|NCT01565941|Algorithm|algorithm
5435142|NCT01565928|Prostate cancer|prostate cancer
5435143|NCT01565928|docetaxel|docetaxel
5435144|NCT01565928|MDV3100|mdv3100
5435145|NCT01565928|enzalutamide|enzalutamide
5435146|NCT01565928|Xtandi|xtandi
5435147|NCT01565902|BAF312|baf312
5435148|NCT01565902|Pharmacokinetics|pharmacokinetics
5435149|NCT01565902|Hepatic impairment|hepatic impairment
5435150|NCT01565876|weight bearing|weight bearing
5435151|NCT01565876|physiological load|physiological load
5435152|NCT01565863|Perceived Disability|perceived disability
5435153|NCT01565863|Mental Wellness|mental wellness
5435154|NCT01565863|Employment|employment
5435155|NCT01565863|Social Integration and Engagement|social integration and engagement
5435156|NCT01565863|Goal Achievement|goal achievement
5435157|NCT01565850|HIV-1|hiv-1
5435158|NCT01565850|HIV|hiv
5435159|NCT01565850|Treatment-Naive|treatment-naive
5435160|NCT01565837|Melanoma|melanoma
5435161|NCT01565837|Malignant Melanoma|malignant melanoma
5435162|NCT01565837|Metastatic|metastatic
5435163|NCT01565837|Oligometastatic|oligometastatic
5435164|NCT01565837|Radiosurgery|radiosurgery
5435165|NCT01565837|Radiosurgery, Stereotactic|radiosurgery, stereotactic
5435166|NCT01565837|Stereotactic Radiosurgery|stereotactic radiosurgery
5435167|NCT01565837|Ipilimumab|ipilimumab
5435168|NCT01565837|Yervoy|yervoy
5435169|NCT01565837|MDX-010|mdx-010
5435170|NCT01565837|Circulating Tumor Cells|circulating tumor cells
5435171|NCT01565811|colon neoplasm, rectal neoplasm, liver metastasis|colon neoplasm, rectal neoplasm, liver metastasis
5435172|NCT01565798|healthcare-acquired infections|healthcare-acquired infections
5435173|NCT01565798|colonization|colonization
5435174|NCT01565798|copper-alloy surfaces|copper-alloy surfaces
5435175|NCT01565785|Child parent home self-management|child parent home self-management
5435176|NCT01565772|Lung cancer|lung cancer
5435177|NCT01565772|Stage III|stage iii
5435178|NCT01565759|Gene expression|gene expression
5435179|NCT01565759|Lithium|lithium
5435180|NCT01565759|Healthy volunteers|healthy volunteers
5435181|NCT01565759|Lymphoblastoid cell lines|lymphoblastoid cell lines
5435182|NCT01565746|BAY88-8223|bay88-8223
5435183|NCT01565746|radium-223 dichloride|radium-223 dichloride
5435184|NCT01565746|prostate cancer|prostate cancer
5435185|NCT01565720|Isavuconazole|isavuconazole
5435186|NCT01565720|Healthy Volunteers|healthy volunteers
5435187|NCT01565720|BAL8557|bal8557
5435188|NCT01565707|Pediatric|pediatric
5435189|NCT01565707|Solifenacin succinate suspension|solifenacin succinate suspension
5435190|NCT01565707|Phase 3|phase 3
5435191|NCT01565707|Pharmacokinetics|pharmacokinetics
5435192|NCT01565707|Overactive bladder (OAB)|overactive bladder (oab)
5435193|NCT01565694|Cognitive Function|cognitive function
5435194|NCT01565694|Phase 3|phase 3
5435195|NCT01565694|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5435196|NCT01565694|Pharmacokinetics|pharmacokinetics
5435197|NCT01565694|Ocular Accommodation|ocular accommodation
5435198|NCT01565694|Urodynamics|urodynamics
5435199|NCT01565681|Healthy Volunteers|healthy volunteers
5435200|NCT01565681|B cell CD40 receptor occupancy|b cell cd40 receptor occupancy
5435201|NCT01565681|anti-CD40 monoclonal antibody|anti-cd40 monoclonal antibody
5435202|NCT01565668|FLT3-ITD positive Acute Myeloid Leukemia (AML)|flt3-itd positive acute myeloid leukemia (aml)
5435204|NCT01565668|Relapse|relapse
5435205|NCT01565668|Refractory|refractory
5435206|NCT01565655|Rheumatoid Arthritis|rheumatoid arthritis
5435207|NCT01565655|ASP015K|asp015k
5435208|NCT01565642|Dementia, decision making|dementia, decision making
5435209|NCT01565629|Autism|autism
5435210|NCT01565629|Asperger's Syndrome|asperger's syndrome
5435211|NCT01565629|Treatment|treatment
5435212|NCT01565629|Cognitive-behavioral therapy|cognitive-behavioral therapy
5435213|NCT01565629|Anxiety|anxiety
5435214|NCT01565629|Children|children
5435215|NCT01565629|Therapy|therapy
5435216|NCT01565616|Severe Sickle Cell Disease|severe sickle cell disease
5435217|NCT01565616|Hematopoietic cell transplantation (HCT)|hematopoietic cell transplantation (hct)
5435218|NCT01565616|Hematopoietic Stem Cell Therapy|hematopoietic stem cell therapy
5435219|NCT01565616|Bone Marrow Transplant|bone marrow transplant
5435220|NCT01565616|Hematologic Diseases|hematologic diseases
5435221|NCT01565616|Genetic Diseases|genetic diseases
5435222|NCT01565616|Anemia|anemia
5435223|NCT01565616|Hemolytic|hemolytic
5435224|NCT01565616|Congenital|congenital
5435225|NCT01565616|Human Leukocyte Antigen|human leukocyte antigen
5435227|NCT01565603|Hypoxia|hypoxia
5435228|NCT01565603|Exercise|exercise
5435229|NCT01565603|Sleep|sleep
5435230|NCT01565603|Brain|brain
5435231|NCT01565603|Neuromuscular function|neuromuscular function
5435232|NCT01565603|Heart|heart
5435233|NCT01565590|aneurysmal subarachnoid hemorrhage|aneurysmal subarachnoid hemorrhage
5435234|NCT01565590|dexmedetomidine|dexmedetomidine
5435235|NCT01565590|cytokines|cytokines
5435236|NCT01565577|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5435237|NCT01565577|Serum bactericidal activity|serum bactericidal activity
5435238|NCT01565577|Menbvac|menbvac
5435239|NCT01565564|Gestational diabetes mellitus|gestational diabetes mellitus
5435240|NCT01565564|intervention|intervention
5435241|NCT01565564|shared care|shared care
5435242|NCT01565564|pregnancy outcome|pregnancy outcome
5435243|NCT01565564|macrosomia|macrosomia
5435244|NCT01565564|pregnancy-induced hypertension|pregnancy-induced hypertension
5435245|NCT01565551|Traumatic Brain Injury|traumatic brain injury
5435246|NCT01565551|Common Data Elements|common data elements
5435247|NCT01565551|Prognostic Models|prognostic models
5435248|NCT01565551|Neuroimaging|neuroimaging
5435249|NCT01565551|Biomarkers|biomarkers
5435250|NCT01565551|Genetic Variants|genetic variants
5435251|NCT01565551|Concussion|concussion
5435252|NCT01565551|Psychological Health|psychological health
5435253|NCT01565538|Cancer|cancer
5435254|NCT01565538|Non-small-cell lung cancer|non-small-cell lung cancer
5435255|NCT01565538|Adenocarcinoma|adenocarcinoma
5435256|NCT01565538|EGFR gene mutation|egfr gene mutation
5435257|NCT01565538|Chemotherapy|chemotherapy
5435258|NCT01565538|Pemetrexed|pemetrexed
5435259|NCT01565538|Erlotinib|erlotinib
5435260|NCT01565525|well child visit|well child visit
5435261|NCT01565525|anticipatory guidance|anticipatory guidance
5435262|NCT01565525|obesity prevention|obesity prevention
5435263|NCT01565525|infant feeding|infant feeding
5435264|NCT01565512|randomized trial|randomized trial
5435265|NCT01565512|robotic prostatectomy|robotic prostatectomy
5435266|NCT01565512|prostate cancer|prostate cancer
5435267|NCT01565512|foley catheter discomfort|foley catheter discomfort
5435268|NCT01565499|Neoadjuvant nab-paclitaxel luminal breast cancer|neoadjuvant nab-paclitaxel luminal breast cancer
5435269|NCT01565486|operation time|operation time
5435270|NCT01565486|complication rate|complication rate
5435271|NCT01565486|costs|costs
5435272|NCT01565486|admission time|admission time
5435274|NCT01565486|OS|os
5435275|NCT01565473|non-motor symptoms|non-motor symptoms
5435276|NCT01565460|pancreas|pancreas
5435277|NCT01565460|biliary|biliary
5435278|NCT01565460|stricture|stricture
5435279|NCT01565395|ALS|als
5435280|NCT01565395|PD|pd
5435281|NCT01565382|Amyloid imaging|amyloid imaging
5435282|NCT01565382|Positron Emission Tomography|positron emission tomography
5435283|NCT01565382|18F-AV-45|18f-av-45
5435284|NCT01565382|florbetapir F 18|florbetapir f 18
5435285|NCT01565382|Diagnostic imaging|diagnostic imaging
5435286|NCT01565369|Amyloid imaging|amyloid imaging
5435287|NCT01565369|Positron Emission Tomography|positron emission tomography
5435288|NCT01565369|18F-AV-45|18f-av-45
5435289|NCT01565369|florbetapir F 18|florbetapir f 18
5435290|NCT01565369|Diagnostic imaging|diagnostic imaging
5435291|NCT01565356|Amyloid imaging|amyloid imaging
5435292|NCT01565356|Positron Emission Tomography|positron emission tomography
5435293|NCT01565356|18F-AV-45|18f-av-45
5435294|NCT01565356|florbetapir F 18|florbetapir f 18
5435295|NCT01565356|Diagnostic imaging|diagnostic imaging
5435296|NCT01565343|Amyloid imaging|amyloid imaging
5435297|NCT01565343|Positron Emission Tomography|positron emission tomography
5435298|NCT01565343|18F-AV-45|18f-av-45
5435299|NCT01565343|florbetapir F 18|florbetapir f 18
5435300|NCT01565343|Diagnostic imaging|diagnostic imaging
5435301|NCT01565330|Amyloid imaging|amyloid imaging
5435302|NCT01565330|Positron Emission Tomography|positron emission tomography
5435303|NCT01565330|18F-AV-45|18f-av-45
5435304|NCT01565330|florbetapir F 18|florbetapir f 18
5435321|NCT01565265|ovarian hyperstimulation|ovarian hyperstimulation
5435322|NCT01565265|GnRH antagonist|gnrh antagonist
5435323|NCT01565265|GnRH agonist|gnrh agonist
5435324|NCT01565265|assisted reproduction|assisted reproduction
5435327|NCT01565252|Egg,Omega 3, Omega 6|egg,omega 3, omega 6
5435328|NCT01565239|Warfarin|warfarin
5435329|NCT01565239|Monitoring|monitoring
5435330|NCT01565239|prothrombin time|prothrombin time
5435331|NCT01565239|Fiix prothrombin time|fiix prothrombin time
5435332|NCT01565239|international normalized ratio (INR)|international normalized ratio (inr)
5435333|NCT01565239|new test|new test
5435334|NCT01565226|Capnography|capnography
5435335|NCT01565226|CO2|co2
5435336|NCT01565226|neonates|neonates
5435337|NCT01565226|High Frequency ventilation (HFV)|high frequency ventilation (hfv)
5435338|NCT01565213|primary health care,common mental disorders,|primary health care,common mental disorders,
5435339|NCT01565213|group therapy|group therapy
5435340|NCT01565200|HER2|her2
5435341|NCT01565200|Metastatic Breast Cancer|metastatic breast cancer
5435342|NCT01565187|Hand Transplantation|hand transplantation
5435343|NCT01565174|cannabis|cannabis
5435344|NCT01565174|THC|thc
5435345|NCT01565174|COMT|comt
5435346|NCT01565174|psychosis|psychosis
5435347|NCT01565174|D2|d2
5435348|NCT01565161|Obesity|obesity
5435349|NCT01565161|Overweight|overweight
5435350|NCT01565148|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5435351|NCT01565109|NESC|nesc
5435352|NCT01565109|NEOADJUVANT|neoadjuvant
5435353|NCT01565109|GASTRIC|gastric
5435354|NCT01565070|Osteoarthritis|osteoarthritis
5435355|NCT01565070|Pain|pain
5435356|NCT01565070|Quality of life|quality of life
5435357|NCT01565057|emulsion|emulsion
5435358|NCT01565057|emptying|emptying
5435359|NCT01565057|protein|protein
5435360|NCT01565057|layering|layering
5435361|NCT01565044|Stroke|stroke
5435362|NCT01565044|hemiplegia|hemiplegia
5435363|NCT01565044|automatic pilot|automatic pilot
5435364|NCT01565044|upper-limb rehabilitation|upper-limb rehabilitation
5435365|NCT01565031|Asthma|asthma
5435366|NCT01565018|Rotigotine|rotigotine
5435367|NCT01565018|Neupro®|neupro®
5435368|NCT01565018|Transdermal Patch|transdermal patch
5435369|NCT01565018|Bioequivalence|bioequivalence
5435370|NCT01565005|MCPH|mcph
5435371|NCT01565005|FANCONI ANEMIA|fanconi anemia
5435372|NCT01564992|Parkinson's disease|parkinson's disease
5435373|NCT01564992|Pharmacogenetics|pharmacogenetics
5435374|NCT01564992|Genetics|genetics
5435375|NCT01564979|botulinum toxin|botulinum toxin
5435376|NCT01564979|facial nerve|facial nerve
5435377|NCT01564979|hemifacial spasm|hemifacial spasm
5435378|NCT01564979|tears|tears
5435379|NCT01564966|transplantation|transplantation
5435380|NCT01564966|inflammation|inflammation
5435381|NCT01564966|endothelial dysfunction|endothelial dysfunction
5435382|NCT01564953|vitamin D|vitamin d
5435383|NCT01564953|calcium|calcium
5435384|NCT01564953|magnesium|magnesium
5435385|NCT01564953|COPD|copd
5435386|NCT01564953|QoL|qol
5435387|NCT01564940|Cervical cap insemination|cervical cap insemination
5435388|NCT01564940|Usability Study|usability study
5435389|NCT01564927|deqi electroacupuncture|deqi electroacupuncture
5435390|NCT01564927|BP HR HRV|bp hr hrv
5435391|NCT01564875|Simvast CR|simvast cr
5435392|NCT01564875|Zocor|zocor
5435393|NCT01564862|Drug Therapy|drug therapy
5435394|NCT01564849|Pomegranate fruit extract|pomegranate fruit extract
5435395|NCT01564849|Sinusitis|sinusitis
5435397|NCT01564849|nasal polyps|nasal polyps
5435398|NCT01564823|Crohn´s disease|crohn´s disease
5435399|NCT01564823|Metronidazole|metronidazole
5435400|NCT01564823|Azathioprine|azathioprine
5435401|NCT01564823|Adalimumab|adalimumab
5435402|NCT01564823|post-chirurgic recurrence|post-chirurgic recurrence
5435403|NCT01564810|liver metastasis|liver metastasis
5435404|NCT01564810|colorectal cancer|colorectal cancer
5435406|NCT01564810|chemotherapy|chemotherapy
5435407|NCT01564797|Diabetes|diabetes
5435408|NCT01564797|haemoglobin A1C|haemoglobin a1c
5435409|NCT01564797|Hispanic|hispanic
5435410|NCT01564797|Behavioural Intervention|behavioural intervention
5435411|NCT01564771|Pneumococcal serotypes|pneumococcal serotypes
5435412|NCT01564771|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5435413|NCT01564758|non-interventional|non-interventional
5435415|NCT01564758|open-label study|open-label study
5435416|NCT01564758|safety|safety
5435417|NCT01564758|Linezolid|linezolid
5435418|NCT01564758|gram positive infections|gram positive infections
5435419|NCT01564758|Filipino|filipino
5435420|NCT01564732|morbid obesity|morbid obesity
5435421|NCT01564732|gastric band|gastric band
5435422|NCT01564719|clergy|clergy
5435423|NCT01564719|weight loss|weight loss
5435424|NCT01564719|holistic|holistic
5435425|NCT01564719|stress|stress
5435426|NCT01564719|spiritual|spiritual
5435427|NCT01564706|Amyloid imaging|amyloid imaging
5435428|NCT01564706|Positron Emission Tomography|positron emission tomography
5435429|NCT01564706|18F-AV-45|18f-av-45
5435430|NCT01564706|florbetapir F 18|florbetapir f 18
5435431|NCT01564706|Diagnostic imaging|diagnostic imaging
5435432|NCT01564693|anorexia|anorexia
5435433|NCT01564693|cancer|cancer
5435434|NCT01564693|hypothalamus|hypothalamus
5435435|NCT01564693|inflammation|inflammation
5435436|NCT01564680|Lower abdominal surgery|lower abdominal surgery
5435437|NCT01564680|Paracetamol|paracetamol
5435438|NCT01564680|Lornoxicam|lornoxicam
5435439|NCT01564680|Morphine|morphine
5435440|NCT01564667|PTSD|ptsd
5435441|NCT01564667|Posttraumatic Stress|posttraumatic stress
5435442|NCT01564667|Post Traumatic Stress|post traumatic stress
5435443|NCT01564667|Attention Bias|attention bias
5435444|NCT01564667|Threat Bias|threat bias
5435445|NCT01564667|Combat|combat
5435446|NCT01564667|Warzone|warzone
5435447|NCT01564641|knee|knee
5435448|NCT01564641|osteoarthritis|osteoarthritis
5435449|NCT01564641|bicompartmental|bicompartmental
5435450|NCT01564641|arthroplasty|arthroplasty
5435451|NCT01564641|joint diseases|joint diseases
5435453|NCT01564615|Catheter related bloodstream infection|catheter related bloodstream infection
5435454|NCT01564615|Umbilical venous catheter|umbilical venous catheter
5435455|NCT01564615|Silver|silver
5435456|NCT01564615|Preterm infants|preterm infants
5435457|NCT01564602|2-channel single port laparoscopy|2-channel single port laparoscopy
5435458|NCT01564602|multiple-channel port laparoscopy|multiple-channel port laparoscopy
5435459|NCT01564576|Laparoscopic surgery|laparoscopic surgery
5435460|NCT01564576|Anesthesiology|anesthesiology
5435461|NCT01564576|Neuromuscular blockade|neuromuscular blockade
5435462|NCT01564550|Type 2 diabetes|type 2 diabetes
5435463|NCT01564550|Very-low-density-lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
5435464|NCT01564550|VLDL1|vldl1
5435465|NCT01564550|VLDL2|vldl2
5435466|NCT01564550|hyperinsulinemia|hyperinsulinemia
5435467|NCT01564550|diet|diet
5435468|NCT01564537|Drug therapy|drug therapy
5435469|NCT01564524|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5435470|NCT01564524|Facial Trauma|facial trauma
5435471|NCT01564524|Fat Grafts|fat grafts
5435472|NCT01564524|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5435473|NCT01564524|Wounded warriors|wounded warriors
5435474|NCT01564511|Multiple Sclerosis|multiple sclerosis
5435475|NCT01564511|Robotic Rahabilitation|robotic rahabilitation
5435476|NCT01564511|Fatigue|fatigue
5435477|NCT01564511|Gait disorder|gait disorder
5435478|NCT01564498|anthocyanins|anthocyanins
5435479|NCT01564498|antioxidant|antioxidant
5435480|NCT01564498|polyphenols|polyphenols
5435481|NCT01564498|bioavailability|bioavailability
5435482|NCT01564498|cholesterol|cholesterol
5435483|NCT01564498|insulin sensitivity|insulin sensitivity
5435484|NCT01564498|glucose tolerance|glucose tolerance
5435485|NCT01564498|atherosclerosis|atherosclerosis
5435486|NCT01564498|metabolic syndrome|metabolic syndrome
5435487|NCT01564446|medication|medication
5435488|NCT01564446|discharge|discharge
5435489|NCT01564446|adherence|adherence
5435490|NCT01564446|compliance|compliance
5435491|NCT01564446|secure message|secure message
5435492|NCT01564433|robotics|robotics
5435493|NCT01564433|rehabilitation|rehabilitation
5435494|NCT01564433|gait|gait
5435495|NCT01564433|cerebral palsy|cerebral palsy
5435496|NCT01564420|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
5435497|NCT01564420|intrathecal morphine|intrathecal morphine
5435498|NCT01564420|postoperative analgesia|postoperative analgesia
5846725|NCT00043654|Bipolar Disorder|bipolar disorder
5435499|NCT01564420|patient-controlled analgesia device|patient-controlled analgesia device
5435500|NCT01564407|ICX‐RHY‐013|icx‐rhy‐013
5435501|NCT01564407|Restrictive scar contracture|restrictive scar contracture
5435502|NCT01564407|Restrictive hypertrophic scar|restrictive hypertrophic scar
5435503|NCT01564407|Burn Scar|burn scar
5435504|NCT01564407|Burn Scar contractures|burn scar contractures
5435505|NCT01564407|Scar|scar
5435506|NCT01564394|qigong|qigong
5435507|NCT01564394|mindfulness meditation|mindfulness meditation
5435508|NCT01564394|fatigue|fatigue
5435509|NCT01564394|prostate cancer|prostate cancer
5435510|NCT01564381|Cardiovascular disease|cardiovascular disease
5435511|NCT01564368|stage II breast cancer|stage ii breast cancer
5435512|NCT01564368|stage IIIA breast cancer|stage iiia breast cancer
5435513|NCT01564368|stage IIIB breast cancer|stage iiib breast cancer
5435514|NCT01564368|stage IIIC breast cancer|stage iiic breast cancer
5435515|NCT01564368|stage IV breast cancer|stage iv breast cancer
5435516|NCT01564368|HER2-negative breast cancer|her2-negative breast cancer
5435517|NCT01564368|HER2-positive breast cancer|her2-positive breast cancer
5435518|NCT01564342|wound irrigation|wound irrigation
5435519|NCT01564342|tap water irrigation|tap water irrigation
5435520|NCT01564342|wound infection|wound infection
5435521|NCT01564342|wound irrigation solution|wound irrigation solution
5435522|NCT01564329|endostar|endostar
5435523|NCT01564329|CT Perfusion|ct perfusion
5435524|NCT01564329|Advanced Primary Lung Adenocarcinoma|advanced primary lung adenocarcinoma
5435525|NCT01564303|Carnitine|carnitine
5435526|NCT01564303|Phosphodiesterase type 5 (PDE5) inhibitor|phosphodiesterase type 5 (pde5) inhibitor
5435527|NCT01564303|Contrast Media-induced Nephropathy (CMN)|contrast media-induced nephropathy (cmn)
5435528|NCT01564290|acute diarrhea|acute diarrhea
5435529|NCT01564290|probiotics|probiotics
5435530|NCT01564290|children|children
5435531|NCT01564264|Uterine Neoplasms|uterine neoplasms
5435532|NCT01564264|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5435533|NCT01564238|calcium retention|calcium retention
5435534|NCT01564238|sodium retention|sodium retention
5435535|NCT01564225|XLHED|xlhed
5435536|NCT01564212|heat loss|heat loss
5435537|NCT01564212|laminar airflow|laminar airflow
5435538|NCT01564212|operating rooms|operating rooms
5435539|NCT01564160|Fish Oil|fish oil
5435542|NCT01564160|Omega-Score|omega-score
5435543|NCT01564160|Omega-3 Fatty Acids|omega-3 fatty acids
5435544|NCT01564160|Green-Lipped Mussel|green-lipped mussel
5435545|NCT01564160|Omega-score < 5.2%|omega-score < 5.2%
5435546|NCT01564147|Therapeutic Education, Rheumatoid Arthritis|therapeutic education, rheumatoid arthritis
5435547|NCT01564134|response vaccination|response vaccination
5435548|NCT01564108|Intravitreal Ranibizumab|intravitreal ranibizumab
5435549|NCT01564108|Non-infectious uveitis|non-infectious uveitis
5435550|NCT01564108|Refractory Cystoid Macular Oedema|refractory cystoid macular oedema
5435551|NCT01564108|Lucentis|lucentis
5435552|NCT01564108|LIMO|limo
5435553|NCT01564095|Liver transplantation|liver transplantation
5435554|NCT01564095|EDC|edc
5435555|NCT01564095|IRI|iri
5435556|NCT01564095|graft survival|graft survival
5435557|NCT01564095|graft function|graft function
5435558|NCT01564095|graft preconditioning|graft preconditioning
5435559|NCT01564095|Tacrolimus rinse|tacrolimus rinse
5435560|NCT01564095|randomised multicenter trial|randomised multicenter trial
5435561|NCT01564082|endotracheal intubation|endotracheal intubation
5435562|NCT01564082|GlideScope|glidescope
5435563|NCT01564069|Chronic pain|chronic pain
5435564|NCT01564069|Intrathecal pain management|intrathecal pain management
5435565|NCT01564056|Adjuvant systemic treatment|adjuvant systemic treatment
5435566|NCT01564056|Breast cancer|breast cancer
5435567|NCT01564056|Elderly patients|elderly patients
5435568|NCT01564030|Pregnancy|pregnancy
5435569|NCT01564030|Respiratory aspiration|respiratory aspiration
5435570|NCT01564030|Gastric contents|gastric contents
5435571|NCT01564030|Ultrasound|ultrasound
5435572|NCT01564017|Allergy|allergy
5435573|NCT01564017|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5435574|NCT01564017|Immunotherapy|immunotherapy
5435575|NCT01564017|D. pteronyssinus|d. pteronyssinus
5435576|NCT01564017|house dust allergy|house dust allergy
5435577|NCT01564004|breech presentation at term|breech presentation at term
5435578|NCT01564004|pregnancy|pregnancy
5435579|NCT01564004|external cephalic version (ECV)|external cephalic version (ecv)
5435580|NCT01564004|clinical hypnosis|clinical hypnosis
5435581|NCT01564004|neuro-linguistic programming (NLP)|neuro-linguistic programming (nlp)
5435582|NCT01563991|surgery|surgery
5435583|NCT01563991|fluid|fluid
5435584|NCT01563991|morbidity|morbidity
5435585|NCT01563978|Rheumatoid Arthritis|rheumatoid arthritis
5435586|NCT01563965|Preoperative fasting|preoperative fasting
5435587|NCT01563965|Acute phase proteins|acute phase proteins
5435588|NCT01563965|Carbohydrates|carbohydrates
5435589|NCT01563965|Protein hydrolizate|protein hydrolizate
5435590|NCT01563965|Inflammatory response|inflammatory response
5435591|NCT01563965|Surgery|surgery
5435592|NCT01563939|Labour analgesia|labour analgesia
5435593|NCT01563939|Pregnancy|pregnancy
5435594|NCT01563939|IVPCA|ivpca
5435595|NCT01563913|Parkinsons disease|parkinsons disease
5435597|NCT01563913|DHA|dha
5435598|NCT01563913|dyskinesia|dyskinesia
5435599|NCT01563913|abnormal movements|abnormal movements
5435600|NCT01563900|fatigue|fatigue
5435601|NCT01563900|multiple sclerosis|multiple sclerosis
5435602|NCT01563900|sleep apnea|sleep apnea
5435603|NCT01563900|CPAP|cpap
5435604|NCT01563887|Type 1 Diabetes|type 1 diabetes
5435605|NCT01563887|Hypoglycemia|hypoglycemia
5435606|NCT01563887|Driving|driving
5435618|NCT01563861|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5435619|NCT01563861|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5435620|NCT01563861|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5422501|NCT01619592|schemes|schemes
5435621|NCT01563861|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5435623|NCT01563835|Epidural|epidural
5435624|NCT01563835|IV PCA|iv pca
5435625|NCT01563822|Follicular Fluid|follicular fluid
5435626|NCT01563822|uterine cavity|uterine cavity
5435627|NCT01563822|Implantation rates|implantation rates
5435628|NCT01563822|ICSI|icsi
5435629|NCT01563796|bladder cancer|bladder cancer
5435630|NCT01563796|TCC|tcc
5435631|NCT01563796|urine|urine
5435632|NCT01563796|protein ELISA|protein elisa
5435633|NCT01563783|Fibroids|fibroids
5435634|NCT01563783|Myomas|myomas
5435635|NCT01563783|leiomyomata|leiomyomata
5435636|NCT01563783|menorrhagia|menorrhagia
5435637|NCT01563783|Acessa Procedure|acessa procedure
5435638|NCT01563783|Radiofrequency Ablation|radiofrequency ablation
5435639|NCT01563783|RFA|rfa
5435640|NCT01563770|Hyperlipidemia|hyperlipidemia
5435641|NCT01563770|Hypertension|hypertension
5435642|NCT01563770|Vasodilation|vasodilation
5435643|NCT01563770|Oxidative stress|oxidative stress
5435644|NCT01563770|Inflammation|inflammation
5435645|NCT01563770|Hemostasis|hemostasis
5435646|NCT01563770|Hemorheology|hemorheology
5435647|NCT01563770|Cardiovascular diseases|cardiovascular diseases
5435648|NCT01563770|Cardiovascular agents|cardiovascular agents
5435649|NCT01563770|Salvia miltiorrhiza|salvia miltiorrhiza
5435650|NCT01563770|Danshen|danshen
5435651|NCT01563770|Danshen root extract|danshen root extract
5435652|NCT01563770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5435653|NCT01563770|Therapeutic Uses|therapeutic uses
5435654|NCT01563744|colonoscopy|colonoscopy
5435655|NCT01563744|bowel preparation|bowel preparation
5435656|NCT01563744|tolerability|tolerability
5435657|NCT01563744|EGD-assisted|egd-assisted
5435658|NCT01563731|Blood pressure medicines|blood pressure medicines
5435659|NCT01563731|Lipid lowering medicines|lipid lowering medicines
5435660|NCT01563731|Hypertension|hypertension
5435661|NCT01563731|Stroke|stroke
5435662|NCT01563731|Dementia|dementia
5435663|NCT01563731|Heart attack|heart attack
5435664|NCT01563731|Heart failure|heart failure
5435665|NCT01563705|Neuromuscular Disorders|neuromuscular disorders
5435666|NCT01563705|GSD III|gsd iii
5435667|NCT01563705|glycogen storage disease|glycogen storage disease
5435668|NCT01563692|RSV|rsv
5435669|NCT01563692|Immune response|immune response
5435670|NCT01563679|cancer|cancer
5435671|NCT01563679|locoregional therapies|locoregional therapies
5435672|NCT01563679|RFA|rfa
5435673|NCT01563679|Cryoablation|cryoablation
5435674|NCT01563679|Microwave ablation|microwave ablation
5435675|NCT01563679|chemical ablation|chemical ablation
5435676|NCT01563679|Irreversible electroporation|irreversible electroporation
5435677|NCT01563653|predicting surgical success|predicting surgical success
5435678|NCT01563653|simple diagnostic test device|simple diagnostic test device
5435679|NCT01563640|dengue|dengue
5435680|NCT01563588|breast cancer|breast cancer
5435681|NCT01563588|chemotherapy|chemotherapy
5435682|NCT01563588|first line treatment|first line treatment
5435683|NCT01563588|treatments include a chemotherapy|treatments include a chemotherapy
5435684|NCT01563588|last treatment not performed more than 9 months earlier|last treatment not performed more than 9 months earlier
5435685|NCT01563575|Recognition Process|recognition process
5435686|NCT01563575|Health Promotion|health promotion
5435688|NCT01563575|WHO|who
5435689|NCT01563575|Hospitals|hospitals
5435690|NCT01563575|Health Services|health services
5435691|NCT01563575|Health Gain|health gain
5435692|NCT01563575|Service Delivery|service delivery
5435693|NCT01563575|Quality Management|quality management
5435694|NCT01563536|Hepatitis C,Genotype 1|hepatitis c,genotype 1
5435695|NCT01563510|Hepatolithiasis|hepatolithiasis
5435696|NCT01563510|Minimal invasive surgery|minimal invasive surgery
5435697|NCT01563510|Laparoscopic hepatectomy|laparoscopic hepatectomy
5435698|NCT01563510|Choledochoscope|choledochoscope
5435699|NCT01563484|Primary Hepatocellular Carcinoma(HCC)|primary hepatocellular carcinoma(hcc)
5435700|NCT01563484|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5435701|NCT01563484|Liver function|liver function
5435702|NCT01563484|Renal function|renal function
5435703|NCT01563432|crossover|crossover
5435704|NCT01563432|pharmacokinetic|pharmacokinetic
5435705|NCT01563432|hyperuricemia|hyperuricemia
5435706|NCT01563432|gout|gout
5430527|NCT01585298|MS|ms
5435710|NCT01563406|Needleless connectors|needleless connectors
5435711|NCT01563406|catheter hubs|catheter hubs
5435712|NCT01563393|tool for nutritional evaluation|tool for nutritional evaluation
5435713|NCT01563393|children|children
5435714|NCT01563393|malnutrition|malnutrition
5435715|NCT01563380|total knee arthroplasty|total knee arthroplasty
5435716|NCT01563380|osteoarthritis|osteoarthritis
5435717|NCT01563380|autologous Platelet rich plasma|autologous platelet rich plasma
5435718|NCT01563380|complications|complications
5435719|NCT01563380|blood loss|blood loss
5435720|NCT01563380|Pain|pain
5435721|NCT01563380|functional outcome|functional outcome
5435722|NCT01563367|Anaemia|anaemia
5423141|NCT01617044|Leg|leg
5435723|NCT01563367|Cardiac surgery|cardiac surgery
5435725|NCT01563328|Dolutegravir, GSK1349572, DTG, BCV, TVR, drug interaction|dolutegravir, gsk1349572, dtg, bcv, tvr, drug interaction
5435726|NCT01563315|Community-Acquired Infections|community-acquired infections
5435727|NCT01563315|Pneumonia/microbiology|pneumonia/microbiology
5435728|NCT01563315|Pneumonia/diagnosis|pneumonia/diagnosis
5435729|NCT01563315|Prognosis|prognosis
5435730|NCT01563315|Prospective Studies|prospective studies
5435731|NCT01563302|Advanced Cancers|advanced cancers
5435732|NCT01563302|DLBCL|dlbcl
5435733|NCT01563302|Advanced Lymphoma|advanced lymphoma
5435734|NCT01563276|Progressive Supranuclear Palsy|progressive supranuclear palsy
5435736|NCT01563276|Falls|falls
5435737|NCT01563276|Gait|gait
5435738|NCT01563276|Balance|balance
5435739|NCT01563276|Parkinson's Disease|parkinson's disease
5435740|NCT01563276|PD|pd
5435741|NCT01563263|IC43|ic43
5435742|NCT01563263|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5435743|NCT01563263|mechanically ventilated ICU patients|mechanically ventilated icu patients
5435744|NCT01563263|ICU patients|icu patients
5435745|NCT01563250|Acute Coronary Syndrome|acute coronary syndrome
5435746|NCT01563250|Cardiac Biomarkers|cardiac biomarkers
5435747|NCT01563250|point of care testing|point of care testing
5435748|NCT01563224|GABA-B|gaba-b
5435749|NCT01563211|breast cancer therapy|breast cancer therapy
5435750|NCT01563211|toxicity|toxicity
5435751|NCT01563211|side effect profile|side effect profile
5435752|NCT01563198|MRI departments and facilities|mri departments and facilities
5403929|NCT01704521|HCV|hcv
5435753|NCT01563198|Noncompletion of MRI|noncompletion of mri
5435754|NCT01563185|JIA|jia
5435755|NCT01563185|ibuprofen|ibuprofen
5435756|NCT01563185|famotidine|famotidine
5435757|NCT01563185|pediatrics|pediatrics
5435758|NCT01563185|for > 1 month|for > 1 month
5435759|NCT01563159|Belgium|belgium
5435760|NCT01563159|hospitals|hospitals
5435761|NCT01563159|Rotavirus|rotavirus
5435762|NCT01563146|Rotavirus|rotavirus
5435763|NCT01563146|hospitals|hospitals
5435764|NCT01563146|Belgium|belgium
5435765|NCT01563133|endomicroscopy|endomicroscopy
5435766|NCT01563133|needle-based|needle-based
5435767|NCT01563133|pancreatic|pancreatic
5435768|NCT01563133|cyst|cyst
5435769|NCT01563133|mass|mass
5435770|NCT01563133|EUSFNA|eusfna
5435771|NCT01563107|Orthostatic Intolerance|orthostatic intolerance
5435772|NCT01563107|Tachycardia|tachycardia
5435773|NCT01563107|Orthostatic Hypotension|orthostatic hypotension
5435774|NCT01563107|Sodium|sodium
5435775|NCT01563094|Bone Density|bone density
5435776|NCT01563094|Lactation|lactation
5435777|NCT01563094|Bone Turnover Markers|bone turnover markers
5435778|NCT01563081|Allergic rhinitis|allergic rhinitis
5435779|NCT01563081|Pediatric|pediatric
5435780|NCT01563081|Pruritus|pruritus
5435781|NCT01563081|Levocetirizine|levocetirizine
5435782|NCT01563068|plaque psoriasis|plaque psoriasis
5435783|NCT01563068|pediatric|pediatric
5435784|NCT01563068|adolescent|adolescent
5435785|NCT01563042|immunogenicity|immunogenicity
5435786|NCT01563042|GSK2434735|gsk2434735
5435787|NCT01563042|pharmacokinetics (PK)|pharmacokinetics (pk)
5435788|NCT01563042|PK|pk
5435789|NCT01563042|biospecific antibody|biospecific antibody
5435790|NCT01563016|schizophrenia|schizophrenia
5435791|NCT01563016|Psychotic Disorders|psychotic disorders
5435792|NCT01563016|Psychoses|psychoses
5435793|NCT01563003|Autism|autism
5435794|NCT01563003|Asperger's Syndrome|asperger's syndrome
5435795|NCT01563003|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
5435796|NCT01563003|Treatment|treatment
5435797|NCT01563003|Cognitive-behavioral therapy|cognitive-behavioral therapy
5435798|NCT01563003|Anxiety|anxiety
5435799|NCT01563003|Children|children
5435800|NCT01563003|Therapy|therapy
5435801|NCT01562951|Crohn's disease|crohn's disease
5435802|NCT01562951|mucosal inflammation|mucosal inflammation
5435803|NCT01562951|lesions|lesions
5435804|NCT01562938|Respiratory Syncytial Virus|respiratory syncytial virus
5435805|NCT01562912|radiofrequency|radiofrequency
5435806|NCT01562912|ablation|ablation
5435807|NCT01562912|atrial fibrillation|atrial fibrillation
5435808|NCT01562912|PVAC|pvac
5435809|NCT01562899|MEK162|mek162
5435810|NCT01562899|AMG 479|amg 479
5435811|NCT01562899|Ganitumab|ganitumab
5435812|NCT01562899|colorectal adenocarcinoma|colorectal adenocarcinoma
5435813|NCT01562899|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5435814|NCT01562899|melanoma|melanoma
5435816|NCT01562899|BRAF|braf
5435817|NCT01562886|Rilpivirine CSF pharmacokinetics|rilpivirine csf pharmacokinetics
5435818|NCT01562873|pSTAT3+|pstat3+
5435819|NCT01562860|median nerve|median nerve
5435820|NCT01562860|carpal tunnel syndrome|carpal tunnel syndrome
5435821|NCT01562860|Pronator Teres Release|pronator teres release
5435822|NCT01562782|Elevated triglycerides|elevated triglycerides
5435823|NCT01562782|Diabetes Mellitus|diabetes mellitus
5435824|NCT01562782|Dyslipidemia|dyslipidemia
5435825|NCT01562782|Lipid Metabolic Disorders|lipid metabolic disorders
5435826|NCT01562782|Body Weight|body weight
5435827|NCT01562730|Coronary Artery Disease|coronary artery disease
5435828|NCT01562730|Myocardial Ischemia|myocardial ischemia
5435829|NCT01562730|Coronary Disease|coronary disease
5435830|NCT01562730|Heart Diseases|heart diseases
5435831|NCT01562730|Cardiovascular Diseases|cardiovascular diseases
5435832|NCT01562730|Arteriosclerosis|arteriosclerosis
5435833|NCT01562730|Arterial Occlusive Diseases|arterial occlusive diseases
5435834|NCT01562730|Vascular Diseases|vascular diseases
5435836|NCT01562730|12 leads ECG|12 leads ecg
5435837|NCT01562704|mechanism of action of paracetamol in the brain structures|mechanism of action of paracetamol in the brain structures
5435838|NCT01562691|nasal packing|nasal packing
5435839|NCT01562691|nasal airway|nasal airway
5435841|NCT01562691|oxygen saturation|oxygen saturation
5435842|NCT01562691|postoperative pain|postoperative pain
5435843|NCT01562678|fMRI|fmri
5435844|NCT01562678|Liraglutide|liraglutide
5435845|NCT01562678|diabetes|diabetes
5435846|NCT01562678|GLP-1|glp-1
5435847|NCT01562665|All patients with NSCLC attending participating hospitals|all patients with nsclc attending participating hospitals
5435848|NCT01562639|maintenance therapy,|maintenance therapy,
5435849|NCT01562639|repeatedly recurring,|repeatedly recurring,
5435850|NCT01562639|relapsing reflux oesophagitis,|relapsing reflux oesophagitis,
5435851|NCT01562639|Nexium|nexium
5435852|NCT01562613|Stroke|stroke
5435853|NCT01562613|Hypertension|hypertension
5435854|NCT01562600|NSAIDs|nsaids
5435855|NCT01562600|Gastric ulcer or duodenal ulcer|gastric ulcer or duodenal ulcer
5435856|NCT01562600|Nexium|nexium
5435857|NCT01562548|upper back/neck/shoulder muscle spasm|upper back/neck/shoulder muscle spasm
5435858|NCT01562535|pulled elbow|pulled elbow
5435859|NCT01562535|nursemaid elbow|nursemaid elbow
5435860|NCT01562509|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5435861|NCT01562509|Quality of health care|quality of health care
5435862|NCT01562509|Oncology Service Hospital|oncology service hospital
5435863|NCT01562509|Patient-centredness|patient-centredness
5435864|NCT01562509|PROMs|proms
5435865|NCT01562496|Parkinson's disease|parkinson's disease
5435866|NCT01562496|Neuroprotective|neuroprotective
5435867|NCT01562496|Intensive exercise|intensive exercise
5435868|NCT01562483|postsurgical pain|postsurgical pain
5435869|NCT01562483|abdominal pain|abdominal pain
5435870|NCT01562483|visceral pain|visceral pain
5435871|NCT01562483|chronic pain|chronic pain
5435872|NCT01562470|cellulite|cellulite
5435873|NCT01562470|reduction|reduction
5435874|NCT01562470|cream|cream
5435875|NCT01562470|thighs|thighs
5435876|NCT01562470|women|women
5435877|NCT01562444|Long term immunogenicity study|long term immunogenicity study
5435878|NCT01562418|Ergonomics|ergonomics
5435879|NCT01562418|musculoskeletal symptoms|musculoskeletal symptoms
5435880|NCT01562418|kinematics|kinematics
5435881|NCT01562405|Relapsed|relapsed
5435882|NCT01562405|Refractory|refractory
5435883|NCT01562392|dietary prevention|dietary prevention
5435884|NCT01562392|cognitive performance|cognitive performance
5435885|NCT01562392|metabolic syndrome|metabolic syndrome
5435886|NCT01562392|colonic fermentation|colonic fermentation
5435887|NCT01562392|sub clinical inflammation|sub clinical inflammation
5435888|NCT01562392|cognition and metabolism|cognition and metabolism
5435889|NCT01562379|complementary food supplements|complementary food supplements
5435890|NCT01562379|stunting|stunting
5435891|NCT01562379|wasting|wasting
5435892|NCT01562379|growth|growth
5435893|NCT01562379|Bangladesh|bangladesh
5435894|NCT01562379|infant feeding|infant feeding
5435895|NCT01562366|Iliotibial Band Release|iliotibial band release
5435896|NCT01562366|Trochanteric Bursectomy|trochanteric bursectomy
5435897|NCT01562366|Micro debridement|micro debridement
5435898|NCT01562353|Opioid Dependence|opioid dependence
5435899|NCT01562353|Opioids for the treatment of pain|opioids for the treatment of pain
5435900|NCT01562340|Hemodialysis|hemodialysis
5435901|NCT01562340|End stage renal disease|end stage renal disease
5435902|NCT01562340|Oxidative stress|oxidative stress
5435903|NCT01562340|Inflammation|inflammation
5435904|NCT01562340|Endothelial dysfunction|endothelial dysfunction
5435905|NCT01562340|Cardiovascular disease|cardiovascular disease
5435906|NCT01562340|Antioxidants|antioxidants
5435907|NCT01562340|Flavonoids|flavonoids
5435908|NCT01562314|Mild to Moderate Ulcerative Colitis|mild to moderate ulcerative colitis
5435909|NCT01562314|GWP42003|gwp42003
5435910|NCT01562301|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5435911|NCT01562301|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5435912|NCT01562301|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5435916|NCT01562301|Paraplatin|paraplatin
5435917|NCT01562301|docetaxel|docetaxel
5435918|NCT01562301|Taxotere|taxotere
5435919|NCT01562301|Anvirzel|anvirzel
5435920|NCT01562301|nerium oleander|nerium oleander
5435921|NCT01562301|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5435922|NCT01562301|NSCLC|nsclc
5435923|NCT01562288|HER2-positive breast cancer|her2-positive breast cancer
5435924|NCT01562288|HER2-negative breast cancer|her2-negative breast cancer
5435925|NCT01562288|stage IA breast cancer|stage ia breast cancer
5435926|NCT01562288|stage IB breast cancer|stage ib breast cancer
5435927|NCT01562288|stage II breast cancer|stage ii breast cancer
5435928|NCT01562288|stage IIIA breast cancer|stage iiia breast cancer
5435929|NCT01562275|GDC0973|gdc0973
5435930|NCT01562275|MEK|mek
5435931|NCT01562275|MEK inhibitor|mek inhibitor
5435932|NCT01562275|GDC0068|gdc0068
5435933|NCT01562275|Akt|akt
5435934|NCT01562275|Akt inhibitor|akt inhibitor
5435935|NCT01562262|Apnea|apnea
5435936|NCT01562262|PVT|pvt
5435937|NCT01562262|Reaction Time|reaction time
5435938|NCT01562249|clinical evaluation|clinical evaluation
5435939|NCT01562249|controlled clinical trial|controlled clinical trial
5435940|NCT01562249|electromyography|electromyography
5435941|NCT01562249|exercise program|exercise program
5435942|NCT01562249|motor control|motor control
5435943|NCT01562223|stage IIA prostate cancer|stage iia prostate cancer
5435944|NCT01562223|stage IIB prostate cancer|stage iib prostate cancer
5435945|NCT01562223|stage III prostate cancer|stage iii prostate cancer
5435946|NCT01562223|stage IV prostate cancer|stage iv prostate cancer
5435947|NCT01562223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5435948|NCT01562210|NSCLC|nsclc
5435949|NCT01562210|Olaparib|olaparib
5435950|NCT01562210|CCRT|ccrt
5435951|NCT01562197|axitinib|axitinib
5435952|NCT01562197|glioblastoma|glioblastoma
5435953|NCT01562197|recurrent|recurrent
5435954|NCT01562171|Overweight|overweight
5435955|NCT01562171|Obese|obese
5435956|NCT01562171|Obesity|obesity
5435957|NCT01562171|Cholesterol|cholesterol
5435958|NCT01562171|Hypercholesterolemia|hypercholesterolemia
5435959|NCT01562171|LDL-Cholesterol|ldl-cholesterol
5435960|NCT01562145|Rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.|rotator cuff tear, matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, partial-thickness tear, full-thickness tear, plasma.
5435961|NCT01562132|cryptococcus|cryptococcus
5435962|NCT01562132|HIV|hiv
5435963|NCT01562119|Burns|burns
5435964|NCT01562119|Wound repair|wound repair
5435965|NCT01562119|Skin substitutes|skin substitutes
5435966|NCT01562106|Cancer of Endometrium|cancer of endometrium
5435967|NCT01562106|Cancer of the Endometrium|cancer of the endometrium
5435968|NCT01562106|Carcinoma of Endometrium|carcinoma of endometrium
5435969|NCT01562106|Endometrial Carcinoma|endometrial carcinoma
5435970|NCT01562106|Endometrium Cancer|endometrium cancer
5435971|NCT01562106|Neoplasms, Endometrial|neoplasms, endometrial
5435972|NCT01562093|Adrenal Cortex Hormones|adrenal cortex hormones
5435973|NCT01562093|Spirometry|spirometry
5435974|NCT01562093|Administration, Intranasal|administration, intranasal
5435975|NCT01562093|Nasal blockage|nasal blockage
5435976|NCT01562093|Nasal sprays|nasal sprays
5435977|NCT01562080|hyperlipidemia|hyperlipidemia
5435978|NCT01562080|metabolic syndrome|metabolic syndrome
5435979|NCT01562080|yeast red|yeast red
5435980|NCT01562080|berberine|berberine
5435981|NCT01562080|policosanol|policosanol
5435982|NCT01562080|astaxanthin|astaxanthin
5435983|NCT01562067|Cervical tumors,vascular changes,Sonographic characteristics|cervical tumors,vascular changes,sonographic characteristics
5435984|NCT01562041|Cardiovascular disease|cardiovascular disease
5435985|NCT01562041|Exercise Treadmill Test|exercise treadmill test
5435986|NCT01562041|Ranolazine|ranolazine
5435987|NCT01562041|Angina|angina
5435988|NCT01562041|Myocardial ischemia|myocardial ischemia
5435989|NCT01562028|non small cell lung cancer|non small cell lung cancer
5435990|NCT01562028|advanced|advanced
5435991|NCT01562028|non-squamous|non-squamous
5435992|NCT01562028|EGFR|egfr
5435993|NCT01562028|mutations|mutations
5435994|NCT01562002|limbus|limbus
5435995|NCT01562002|cornea|cornea
5435996|NCT01562002|insufficiency syndrome|insufficiency syndrome
5435997|NCT01562002|stem cell transplant|stem cell transplant
5435998|NCT01561963|Apremilast|apremilast
5435999|NCT01561963|drug interaction|drug interaction
5436000|NCT01561963|pharmacokinetics|pharmacokinetics
5436001|NCT01561911|Clinical Trial|clinical trial
5436002|NCT01561911|Phase I|phase i
5436003|NCT01561911|Antibodies|antibodies
5436004|NCT01561911|Monoclonal|monoclonal
5436005|NCT01561898|Schizophrenia|schizophrenia
5436006|NCT01561898|JNS007ER|jns007er
5430819|NCT01584115|Tumor antigen.|tumor antigen.
5436007|NCT01561898|Paliperidone extended-release|paliperidone extended-release
5436008|NCT01561885|Clinical Pathways|clinical pathways
5436009|NCT01561885|Length of Stay|length of stay
5436010|NCT01561885|Patient-Centered Care|patient-centered care
5671224|NCT00616603|Dexamethasone.|dexamethasone.
5436011|NCT01561885|Pragmatic Randomized Controlled Trial|pragmatic randomized controlled trial
5436012|NCT01561859|Early Course Schizophrenia|early course schizophrenia
5436013|NCT01561859|Cognitive Enhancement Therapy|cognitive enhancement therapy
5436014|NCT01561859|Enriched Supportive Therapy|enriched supportive therapy
5436015|NCT01561846|Conjugated Linoleic Acid|conjugated linoleic acid
5436016|NCT01561846|LDL-cholesterol|ldl-cholesterol
5436017|NCT01561846|Endocannabinoids|endocannabinoids
5436018|NCT01561833|relapsed or refractory T cell lymphoma|relapsed or refractory t cell lymphoma
5436019|NCT01561820|mild cognitive impairment|mild cognitive impairment
5436020|NCT01561820|cognitive disorders|cognitive disorders
5436021|NCT01561820|exercise|exercise
5436022|NCT01561794|Ciprofloxacin|ciprofloxacin
5436023|NCT01561794|Bacterial pneumonia|bacterial pneumonia
5436024|NCT01561794|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5436025|NCT01561794|Hospital Acquired Pneumonia (HAP)|hospital acquired pneumonia (hap)
5436026|NCT01561794|Secondary infection of chronic respiratory disease|secondary infection of chronic respiratory disease
5436027|NCT01561794|400 mg BID/TID|400 mg bid/tid
5436028|NCT01561781|Phase 1|phase 1
5436029|NCT01561781|healthy volunteers|healthy volunteers
5436030|NCT01561781|pharmacokinetics|pharmacokinetics
5436031|NCT01561781|vandetanib|vandetanib
5436032|NCT01561781|digoxin|digoxin
5436033|NCT01561755|HIV associated myelopathy|hiv associated myelopathy
5436034|NCT01561742|minocycline, augmentation, schizophrenia|minocycline, augmentation, schizophrenia
5436035|NCT01561729|nasogastric tube|nasogastric tube
5436036|NCT01561729|orogastric tube|orogastric tube
5436037|NCT01561729|RightSpot pH Indicator|rightspot ph indicator
5436038|NCT01561729|suction tube|suction tube
5436039|NCT01561729|RightBio Metrics|rightbio metrics
5436040|NCT01561729|RightLevel|rightlevel
5436041|NCT01561729|RightSpot Infant|rightspot infant
5436042|NCT01561729|NG Tube|ng tube
5436043|NCT01561729|pH|ph
5436044|NCT01561729|Gastric Acidity|gastric acidity
5436045|NCT01561716|video games|video games
5436046|NCT01561716|energy expenditure|energy expenditure
5436047|NCT01561716|physical activity|physical activity
5436048|NCT01561716|exercise physiology|exercise physiology
5436049|NCT01561703|Healthcare utilization|healthcare utilization
5436050|NCT01561703|Tonsillectomy|tonsillectomy
5436051|NCT01561703|Adenoidectomy/Tonsillectomy|adenoidectomy/tonsillectomy
5436052|NCT01561703|Antibiotics|antibiotics
5436053|NCT01561677|obstructive sleep apnea|obstructive sleep apnea
5436054|NCT01561677|syndrome survival|syndrome survival
5436055|NCT01561677|ischemic stroke|ischemic stroke
5436056|NCT01561677|continuous positive airway pressure|continuous positive airway pressure
5436057|NCT01561677|handicap|handicap
5436058|NCT01561664|obesity|obesity
5436059|NCT01561664|insulin resistance|insulin resistance
5436060|NCT01561651|cardiac surgery|cardiac surgery
5436061|NCT01561651|left atrial appendage|left atrial appendage
5436062|NCT01561651|atrial fibrillation|atrial fibrillation
5436063|NCT01561651|stroke|stroke
5436064|NCT01561651|non-CNS systemic embolism|non-cns systemic embolism
5436065|NCT01561638|Pulsed|pulsed
5436066|NCT01561638|radiofrequency|radiofrequency
5436067|NCT01561638|single-dose|single-dose
5436068|NCT01561638|shoulder pain|shoulder pain
5436069|NCT01561638|Pain lasts more than one month|pain lasts more than one month
5436070|NCT01561638|patients referred to the pain clinic from the shoulder clinic|patients referred to the pain clinic from the shoulder clinic
5436071|NCT01561638|Failed all conservative therapies available|failed all conservative therapies available
5436072|NCT01561625|COPD|copd
5436073|NCT01561625|exercise training|exercise training
5436074|NCT01561612|Breastfeeding|breastfeeding
5436075|NCT01561612|Child Health|child health
5436076|NCT01561612|Obesity|obesity
5436077|NCT01561612|Blood Pressure|blood pressure
5436078|NCT01561612|Asthma|asthma
5436079|NCT01561612|Cognitive Development|cognitive development
5436080|NCT01561612|Behavior|behavior
5436081|NCT01561612|Eczema|eczema
5436082|NCT01561612|Lung Function|lung function
5436083|NCT01561612|Spirometry|spirometry
5436084|NCT01561599|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
5436085|NCT01561599|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
5436086|NCT01561599|Delayed Graft Function (DGF)|delayed graft function (dgf)
5436087|NCT01561599|Kidney transplantation|kidney transplantation
5436088|NCT01561586|Cervical cancer|cervical cancer
5436089|NCT01561586|Concurrent chemoradiation|concurrent chemoradiation
5436090|NCT01561586|Cisplatin|cisplatin
5436091|NCT01561573|Point of Care Ultrasound|point of care ultrasound
5436092|NCT01561573|Emergency Ultrasound|emergency ultrasound
5436093|NCT01561573|Colles Fracture|colles fracture
5436094|NCT01561573|Fracture Reduction|fracture reduction
5436095|NCT01561573|Bedside Ultrasound|bedside ultrasound
5436096|NCT01561560|DAILIES TOTAL1|dailies total1
5436097|NCT01561560|contact lenses|contact lenses
5436098|NCT01561560|myopia|myopia
5436099|NCT01561547|pain|pain
5436100|NCT01561547|preterm neonate|preterm neonate
5436107|NCT01561508|children|children
5436108|NCT01561495|scheduled to receive RT either pre- or postoperatively|scheduled to receive rt either pre- or postoperatively
5436109|NCT01561482|Prostate carcinoma|prostate carcinoma
5436110|NCT01561482|Prostate cancer|prostate cancer
5436111|NCT01561482|Prostate Specific Antigen|prostate specific antigen
5436112|NCT01561482|PSA|psa
5436113|NCT01561482|Metformin|metformin
5436114|NCT01561482|Simvastatin|simvastatin
5436115|NCT01561482|Radiation therapy|radiation therapy
5436116|NCT01561482|Prostatectomy|prostatectomy
5436117|NCT01561469|Linezolid|linezolid
5436118|NCT01561469|Vancomycin|vancomycin
5436119|NCT01561469|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5436120|NCT01561469|Respiratory Tract Infections|respiratory tract infections
5436121|NCT01561456|non-small-cell lung cancer|non-small-cell lung cancer
5436122|NCT01561456|squamous cell carcinoma|squamous cell carcinoma
5423004|NCT01617590|RA|ra
5436123|NCT01561456|adenocarcinoma of the lung|adenocarcinoma of the lung
5436124|NCT01561456|IGF-1 inhibitor|igf-1 inhibitor
5436125|NCT01561456|docetaxel|docetaxel
5436126|NCT01561456|AXL1717|axl1717
5436127|NCT01561456|NSCLC|nsclc
5436128|NCT01561456|SCC|scc
5436129|NCT01561456|AC|ac
5436130|NCT01561443|Breast cancer,|breast cancer,
5436131|NCT01561443|hormone positive,|hormone positive,
5436132|NCT01561430|beta-secretase inhibitor|beta-secretase inhibitor
5436133|NCT01561326|cervical cancer|cervical cancer
5436134|NCT01561326|follow-up|follow-up
5436135|NCT01561326|Pap test|pap test
5436136|NCT01561326|Medical management|medical management
5436137|NCT01561326|Colposcopy|colposcopy
5436138|NCT01561313|On label Humira users|on label humira users
5436139|NCT01561313|Pain|pain
5436140|NCT01561313|Rheumatoid Arthritis,|rheumatoid arthritis,
5436141|NCT01561300|Black tea|black tea
5436142|NCT01561300|Flow Mediated Dilation|flow mediated dilation
5436143|NCT01561300|Vascular function|vascular function
5436144|NCT01561300|India|india
5436145|NCT01561261|fasciotomy|fasciotomy
5436146|NCT01561261|ACS|acs
5436147|NCT01561248|EHEC|ehec
5436148|NCT01561248|O104:H4|o104:h4
5436149|NCT01561248|German|german
5436150|NCT01561248|outbreak|outbreak
5436151|NCT01561248|polyethylene glycol|polyethylene glycol
5436152|NCT01561248|Bowel lavage|bowel lavage
5436153|NCT01561235|Protein|protein
5436154|NCT01561235|Appetite|appetite
5436155|NCT01561235|Satiety|satiety
5436156|NCT01561235|Energi intake|energi intake
5436157|NCT01561235|Appetite regulating hormones|appetite regulating hormones
5436158|NCT01561235|Dose-response|dose-response
5436159|NCT01561222|calcitrol|calcitrol
5436160|NCT01561222|Bone mineral density|bone mineral density
5436161|NCT01561222|Osteoprotegin|osteoprotegin
5436162|NCT01561222|Vascular calcification|vascular calcification
5436163|NCT01561209|amitryptiline|amitryptiline
5436164|NCT01561209|Chronic pain|chronic pain
5436165|NCT01561209|Neck pain|neck pain
5436166|NCT01561196|arteria cannulation|arteria cannulation
5436167|NCT01561196|Ultrasound|ultrasound
5436168|NCT01561196|pain|pain
5436169|NCT01561196|complications|complications
5436170|NCT01561183|Vital pulp therapy|vital pulp therapy
5436171|NCT01561183|Pulp cap|pulp cap
5436172|NCT01561183|pulpotomy|pulpotomy
5436173|NCT01561183|calcium enriched mixture|calcium enriched mixture
5436174|NCT01561183|CEM cement|cem cement
5436175|NCT01561183|Endodontic|endodontic
5436176|NCT01561170|Electromagnetic|electromagnetic
5436177|NCT01561170|Field therapy|field therapy
5436178|NCT01561170|Chronically venous ulcer|chronically venous ulcer
5436179|NCT01561170|Venous insufficiens|venous insufficiens
5436180|NCT01561157|porphyria|porphyria
5436181|NCT01561157|acute intermittent|acute intermittent
5436182|NCT01561157|coproporphyria|coproporphyria
5436183|NCT01561157|variegate|variegate
5436184|NCT01561157|erythropoietic|erythropoietic
5436185|NCT01561157|protoporphyria|protoporphyria
5436186|NCT01561157|hepatoerythropoietic|hepatoerythropoietic
5436187|NCT01561157|cutanea tarda|cutanea tarda
5436188|NCT01561157|AIP|aip
5436189|NCT01561157|HCP|hcp
5436190|NCT01561157|VP|vp
5436191|NCT01561157|ADP|adp
5436192|NCT01561157|ALAD|alad
5436193|NCT01561157|PCT|pct
5436194|NCT01561157|HEP|hep
5436195|NCT01561157|CEP|cep
5436196|NCT01561157|EPP|epp
5436197|NCT01561157|XLP|xlp
5436198|NCT01561144|Defibrillators, Implantable|defibrillators, implantable
5436199|NCT01561144|Cardiac arrhythmias|cardiac arrhythmias
5436200|NCT01561144|Heart Disease|heart disease
5436201|NCT01561131|Obesity|obesity
5436202|NCT01561131|Protein intake|protein intake
5436203|NCT01561131|Calcium intake|calcium intake
5436205|NCT01561131|Weight maintenance|weight maintenance
5436206|NCT01561131|Blood lipid profile|blood lipid profile
5436207|NCT01561131|Diet induced thermogenesis|diet induced thermogenesis
5436208|NCT01561118|hemodialysis|hemodialysis
5436209|NCT01561118|dialysis efficacy|dialysis efficacy
5436210|NCT01561118|cardiorespiratory capacity|cardiorespiratory capacity
5436211|NCT01561118|exercise capacity|exercise capacity
5436212|NCT01561118|children and adolescents|children and adolescents
5436214|NCT01561092|RCT|rct
5436215|NCT01561092|SSRI|ssri
5439435|NCT01547754|HV|hv
5436216|NCT01561092|Outcome|outcome
5436217|NCT01561079|Buprenorphine|buprenorphine
5436218|NCT01561079|Methadone|methadone
5436219|NCT01561079|Fetal neurobehavior|fetal neurobehavior
5436220|NCT01561079|Infant neurobehavior|infant neurobehavior
5436221|NCT01561066|Fibrin glue|fibrin glue
5436222|NCT01561066|Platelet|platelet
5436223|NCT01561066|Autologous derivation|autologous derivation
5436224|NCT01561066|Prospective randomized trial|prospective randomized trial
5436226|NCT01561053|Alzheimer's disease|alzheimer's disease
5436227|NCT01561053|Amyloid Beta (AB) peptide|amyloid beta (ab) peptide
5436228|NCT01561053|Albumin|albumin
5436229|NCT01561053|Intravenous immunoglobulin|intravenous immunoglobulin
5436230|NCT01561053|IVIG|ivig
5436231|NCT01561040|Dry Eye syndrome|dry eye syndrome
5436233|NCT01561040|Essential Fatty Acid nutritional supplements|essential fatty acid nutritional supplements
5436234|NCT01561040|Omega three supplements|omega three supplements
5436235|NCT01560988|Asthma|asthma
5436236|NCT01560988|Borage|borage
5436237|NCT01560988|Echium|echium
5436238|NCT01560988|Botanical|botanical
5436239|NCT01560949|Pancreatic Cancer|pancreatic cancer
5436240|NCT01560949|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5436241|NCT01560949|High Risk Resectable|high risk resectable
5436242|NCT01560949|Borderline Resectable|borderline resectable
5436243|NCT01560949|Chemotherapy|chemotherapy
5436244|NCT01560949|Chemoradiation therapy|chemoradiation therapy
5436245|NCT01560949|Oxaliplatin|oxaliplatin
5436246|NCT01560949|Eloxatin|eloxatin
5436247|NCT01560949|Irinotecan|irinotecan
5436248|NCT01560949|CPT-11|cpt-11
5436249|NCT01560949|Camptosar|camptosar
5436250|NCT01560949|5-FU|5-fu
5436251|NCT01560949|5-Fluorouracil|5-fluorouracil
5436252|NCT01560949|Adrucil|adrucil
5436253|NCT01560949|Efudex|efudex
5436254|NCT01560949|Gemcitabine|gemcitabine
5436255|NCT01560949|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5436256|NCT01560949|Gemzar|gemzar
5436257|NCT01560949|Radiation Therapy|radiation therapy
5436259|NCT01560949|RT|rt
5436260|NCT01560949|External Beam Radiation Therapy|external beam radiation therapy
5436261|NCT01560936|bacterial contamination|bacterial contamination
5436262|NCT01560923|hormone refractory prostate cancer|hormone refractory prostate cancer
5436263|NCT01560910|with or without GERD symptoms|with or without gerd symptoms
5445476|NCT01521572|plethysmography,|plethysmography,
5436264|NCT01560910|presenting to gastrointestinal clinic of Maharaj Nakorn Chiangmai Hospital|presenting to gastrointestinal clinic of maharaj nakorn chiangmai hospital
5436265|NCT01560910|November 2009 to November 2010|november 2009 to november 2010
5436266|NCT01560910|GERD|gerd
5436267|NCT01560910|NERD|nerd
5436268|NCT01560871|Heart failure|heart failure
5436269|NCT01560871|inspiratory muscle training|inspiratory muscle training
5436270|NCT01560871|physical activity|physical activity
5436271|NCT01560845|autologous bone marrow stem cells|autologous bone marrow stem cells
5436272|NCT01560845|portal hypertension|portal hypertension
5436273|NCT01560845|surgery|surgery
5436274|NCT01560845|liver cirrhosis|liver cirrhosis
5436275|NCT01560819|ulcerative colitis, gut microbial transplantation|ulcerative colitis, gut microbial transplantation
5436276|NCT01560806|hypertension|hypertension
5436277|NCT01560806|cardiovascular risk factor|cardiovascular risk factor
5436278|NCT01560806|lifestyle|lifestyle
5436279|NCT01560793|Influenza|influenza
5436280|NCT01560793|Vaccines|vaccines
5436281|NCT01560793|H5N1|h5n1
5436282|NCT01560780|Coronary Artery Bypass|coronary artery bypass
5436283|NCT01560780|thrombosis|thrombosis
5436284|NCT01560780|prasugrel|prasugrel
5436285|NCT01560767|Pain relief|pain relief
5436286|NCT01560767|Arthroplasty|arthroplasty
5436287|NCT01560767|periarticular knee infiltration|periarticular knee infiltration
5436288|NCT01560754|Randomized|randomized
5436289|NCT01560754|Placebo-controlled|placebo-controlled
5436290|NCT01560754|Double-blind|double-blind
5436291|NCT01560754|Multi-center|multi-center
5436292|NCT01560754|Disease-modifying potential|disease-modifying potential
5436293|NCT01560754|transdermal nicotine|transdermal nicotine
5436294|NCT01560741|Chronic respiratory failure|chronic respiratory failure
5436295|NCT01560741|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
5436296|NCT01560741|Home-care|home-care
5436297|NCT01560741|Telemedicine|telemedicine
5436298|NCT01560741|COPD|copd
5436299|NCT01560728|Post Traumatic Stress Disorder|post traumatic stress disorder
5436300|NCT01560728|Major Depressive Disorder|major depressive disorder
5436301|NCT01560728|Dysthymia|dysthymia
5436310|NCT01560702|epinephrine|epinephrine
5436311|NCT01560702|endoscopy|endoscopy
5436312|NCT01560702|ulcer|ulcer
5436313|NCT01560702|hemostasis|hemostasis
5436314|NCT01560689|bone marrow transplantation|bone marrow transplantation
5436315|NCT01560689|obstructive lung disease|obstructive lung disease
5436316|NCT01560689|bronchodilators|bronchodilators
5436317|NCT01560689|inhaled steroids|inhaled steroids
5436318|NCT01560689|late-onset pulmonary complication|late-onset pulmonary complication
5436319|NCT01560676|Internet|internet
5436320|NCT01560676|School based|school based
5436321|NCT01560676|Obesity Prevention Program|obesity prevention program
5436322|NCT01560676|Adolescents|adolescents
5436323|NCT01560663|Breast Cancer|breast cancer
5436324|NCT01560663|Neoadjuvant therapy|neoadjuvant therapy
5436325|NCT01560663|Triple negative|triple negative
5436326|NCT01560663|predictor of response|predictor of response
5436327|NCT01560663|predictor of resistance|predictor of resistance
5436328|NCT01560663|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5436330|NCT01560650|cardiac surgery associated acute kidney injury|cardiac surgery associated acute kidney injury
5436331|NCT01560650|Intensity|intensity
5436332|NCT01560637|PAH|pah
5436333|NCT01560637|PH|ph
5436334|NCT01560637|FREEDOM|freedom
5436335|NCT01560637|6 minute walk test|6 minute walk test
5436336|NCT01560637|treprostinil|treprostinil
5436337|NCT01560637|open label|open label
5436338|NCT01560624|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
5436339|NCT01560624|Pulmonary hypertension (PH)|pulmonary hypertension (ph)
5436340|NCT01560624|Clinical Worsening|clinical worsening
5436341|NCT01560624|Freedom|freedom
5436342|NCT01560624|Freedom-EV|freedom-ev
5436343|NCT01560624|Treprostinil|treprostinil
5436344|NCT01560624|UT-15C|ut-15c
5436345|NCT01560624|6 Minute walk test|6 minute walk test
5436346|NCT01560598|GERD|gerd
5436347|NCT01560598|reflux esophagitis|reflux esophagitis
5436348|NCT01560598|adipokine|adipokine
5436349|NCT01560598|especially|especially
5436350|NCT01560598|endoscopically proven|endoscopically proven
5436351|NCT01560585|Isotretinoin|isotretinoin
5436352|NCT01560585|Alzheimer's disease|alzheimer's disease
5436353|NCT01560585|Dementia|dementia
5436354|NCT01560585|Retinoid|retinoid
5436355|NCT01560572|kidney transplantation|kidney transplantation
5436356|NCT01560572|immunosuppression|immunosuppression
5436357|NCT01560572|steroids|steroids
5436358|NCT01560572|tacrolimus OD|tacrolimus od
5436359|NCT01560559|Primary esophageal achalasia|primary esophageal achalasia
5436360|NCT01560559|endoscopic myotomy|endoscopic myotomy
5436361|NCT01560559|high resolution manometry|high resolution manometry
5436362|NCT01560520|acute ischemic stroke|acute ischemic stroke
5436363|NCT01560520|accelerometer|accelerometer
5436364|NCT01560481|metformin glycinate|metformin glycinate
5436365|NCT01560481|pharmacokinetics|pharmacokinetics
5436366|NCT01560481|pharmacodynamics|pharmacodynamics
5436367|NCT01560468|Hepatitis C Virus Infection|hepatitis c virus infection
5436368|NCT01560468|Liver Transplantation|liver transplantation
5436369|NCT01560455|stent|stent
5436370|NCT01560455|bifurcation|bifurcation
5436371|NCT01560455|coronary|coronary
5436372|NCT01560442|Analgesics, opioids|analgesics, opioids
5436373|NCT01560442|Opiate substitution treatment|opiate substitution treatment
5436374|NCT01560442|Methadone|methadone
5436375|NCT01560442|Buprenorphine|buprenorphine
5436376|NCT01560442|Hyperalgesia|hyperalgesia
5436377|NCT01560442|Pupil|pupil
5436378|NCT01560442|Pain|pain
5436379|NCT01560442|Psychophysics|psychophysics
5436380|NCT01560442|previous illicit drug intake, under a substitution program|previous illicit drug intake, under a substitution program
5436381|NCT01560429|anesthesia and analgesia|anesthesia and analgesia
5436382|NCT01560429|Epidural Anesthesia|epidural anesthesia
5436383|NCT01560429|administration schedules, drug|administration schedules, drug
5436384|NCT01560416|Metastatic|metastatic
5436385|NCT01560416|HR positive|hr positive
5436386|NCT01560416|ER positive|er positive
5436387|NCT01560403|Parenteral nutrition|parenteral nutrition
5436388|NCT01560403|TPN|tpn
5436389|NCT01560403|HPN|hpn
5436390|NCT01560403|PN|pn
5436391|NCT01560403|SBS|sbs
5436392|NCT01560403|Short bowel syndrome|short bowel syndrome
5436393|NCT01560390|Sedation|sedation
5436394|NCT01560390|ICU|icu
5436395|NCT01560390|Ketamine|ketamine
5436396|NCT01560390|Confusion|confusion
5436397|NCT01560390|Hyperalgesia|hyperalgesia
5436398|NCT01560377|Laparoscopic low anterior colon resection|laparoscopic low anterior colon resection
5436399|NCT01560377|Laparoscopic left colectomy|laparoscopic left colectomy
5436400|NCT01560377|Colectomy|colectomy
5436401|NCT01560377|Rectal cancer|rectal cancer
5436402|NCT01560377|Colon cancer|colon cancer
5436403|NCT01560377|Crohn's Disease|crohn's disease
5436404|NCT01560377|Polyp|polyp
5436405|NCT01560377|Procidentia|procidentia
5436406|NCT01560377|Diverticulitis|diverticulitis
5436407|NCT01560364|Renal replacement therapy|renal replacement therapy
5436408|NCT01560364|Hemofilter clotting|hemofilter clotting
5436409|NCT01560364|Clotting risk factor|clotting risk factor
5436410|NCT01560364|Hemofilter clotting prevention|hemofilter clotting prevention
5436411|NCT01560351|Pathological gambling|pathological gambling
5436412|NCT01560351|craving|craving
5436413|NCT01560351|repeated Transcranial Magnetic Stimulation|repeated transcranial magnetic stimulation
5436414|NCT01560351|craving cues|craving cues
5436415|NCT01560338|Pharmacokinetics|pharmacokinetics
5436416|NCT01560338|Midazolam|midazolam
5436417|NCT01560338|Morphine|morphine
5436418|NCT01560338|Cardiac Arrest|cardiac arrest
5436419|NCT01560338|Hypothermia|hypothermia
5436420|NCT01560325|Solid Tumor, Tubulin inhibitor|solid tumor, tubulin inhibitor
5436421|NCT01560312|Renal denervation|renal denervation
5436422|NCT01560312|Resistant hypertension|resistant hypertension
5436423|NCT01560312|Spironolactone|spironolactone
5436424|NCT01560312|Long-term Outcome|long-term outcome
5436425|NCT01560299|hyperthyroidism|hyperthyroidism
5436426|NCT01560299|radio-iodine|radio-iodine
5436427|NCT01560299|I-131|i-131
5436428|NCT01560299|methimazole|methimazole
5436429|NCT01560299|graves disease|graves disease
5436430|NCT01560286|PKU|pku
5436431|NCT01560286|Injections|injections
5436432|NCT01560286|PEG-PAL|peg-pal
5436433|NCT01560286|PAL|pal
5436434|NCT01560247|Stroke|stroke
5436435|NCT01560247|Ischemic Stroke|ischemic stroke
5436436|NCT01560247|Revascularization|revascularization
5436437|NCT01560247|Mechanical thrombectomy|mechanical thrombectomy
5436439|NCT01560234|Safety|safety
5436440|NCT01560234|tolerability|tolerability
5436441|NCT01560234|healthy|healthy
5436442|NCT01560234|pharmacokinetic|pharmacokinetic
5436443|NCT01560234|pharmacodynamic|pharmacodynamic
5436444|NCT01560234|inhaled|inhaled
5436445|NCT01560208|infectious keratitis|infectious keratitis
5436446|NCT01560208|infective keratitis|infective keratitis
5436447|NCT01560208|prospective multicentre study|prospective multicentre study
5436448|NCT01560208|Asia|asia
5436449|NCT01560195|neutropenia|neutropenia
5436450|NCT01560195|febrile neutropenia|febrile neutropenia
5436451|NCT01560195|chemotherapy|chemotherapy
5436452|NCT01560182|OTL-200|otl-200
5436453|NCT01560182|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5436454|NCT01560182|Gene Therapy|gene therapy
5436455|NCT01560182|MLD|mld
5436456|NCT01560182|Previously GSK2696274|previously gsk2696274
5436457|NCT01560169|Celiac Disease|celiac disease
5436458|NCT01560169|Coeliac Disease|coeliac disease
5436459|NCT01560169|Celiac Sprue|celiac sprue
5436460|NCT01560169|Keilakia Disease|keilakia disease
5436461|NCT01560117|AGMT|agmt
5436462|NCT01560117|NHL|nhl
5436463|NCT01560104|Randomized|randomized
5436464|NCT01560104|metastatic|metastatic
5436465|NCT01560104|ABT-888|abt-888
5436466|NCT01560104|paclitaxel|paclitaxel
5436467|NCT01560104|non-small cell lung cancer|non-small cell lung cancer
5436468|NCT01560104|PARP|parp
5436469|NCT01560104|veliparib|veliparib
5436470|NCT01560104|progression free survival|progression free survival
5436471|NCT01560104|carboplatin|carboplatin
5436472|NCT01560091|clearance rate|clearance rate
5436473|NCT01560078|Tuberculosis|tuberculosis
5436474|NCT01560078|Pleural effusion|pleural effusion
5436475|NCT01560078|Category 3|category 3
5436476|NCT01560052|end stage kidney disease|end stage kidney disease
5436477|NCT01560052|IgA nephropathy|iga nephropathy
5436478|NCT01560039|Neuropathic pain|neuropathic pain
5436479|NCT01560039|neurostimulation|neurostimulation
5436480|NCT01560026|ovarian preservation|ovarian preservation
5436481|NCT01560013|Alcohol|alcohol
5436482|NCT01560013|naltrexone|naltrexone
5436483|NCT01560013|cue reactivity|cue reactivity
5436484|NCT01560013|PET|pet
5436485|NCT01560000|The focus of this study is to determine satiety|the focus of this study is to determine satiety
5436486|NCT01559987|plaque removal methods|plaque removal methods
5436487|NCT01559987|oral hygiene devices|oral hygiene devices
5436488|NCT01559974|Peripheral arterial disease|peripheral arterial disease
5436489|NCT01559974|PAOD|paod
5436490|NCT01559974|Vitamin D|vitamin d
5436491|NCT01559974|Walking impairment|walking impairment
5436492|NCT01559961|bladder|bladder
5436493|NCT01559961|cystitis|cystitis
5436494|NCT01559961|frequency|frequency
5436495|NCT01559961|nocturia|nocturia
5436496|NCT01559961|pain|pain
5436497|NCT01559961|urgency|urgency
5436498|NCT01559948|Low back pain|low back pain
5436499|NCT01559948|Sacroiliac joint pain|sacroiliac joint pain
5436500|NCT01559948|Lumbopelvic stabilization program|lumbopelvic stabilization program
5436501|NCT01559948|Pelvic compression belt|pelvic compression belt
5436502|NCT01559948|Deep abdominal muscles|deep abdominal muscles
5436503|NCT01559935|Multiple Myeloma|multiple myeloma
5436504|NCT01559922|Acne|acne
5436505|NCT01559909|Lower limb loss|lower limb loss
5436506|NCT01559909|Leg amputation|leg amputation
5436507|NCT01559909|walking study|walking study
5436508|NCT01559909|socket technology|socket technology
5436509|NCT01559896|egg protein hydrolysate|egg protein hydrolysate
5436510|NCT01559883|cancer|cancer
5436511|NCT01559883|thrombosis|thrombosis
5436512|NCT01559883|pulmonary embolism|pulmonary embolism
5436513|NCT01559883|anticoagulation|anticoagulation
5436514|NCT01559883|low molecular weight heparin|low molecular weight heparin
5436515|NCT01559870|cardiac surgery|cardiac surgery
5436516|NCT01559870|cytokine|cytokine
5436517|NCT01559870|clinical scoring system|clinical scoring system
5436518|NCT01559870|risk factor|risk factor
5436519|NCT01559857|Depression|depression
5436520|NCT01559857|Insulin resistance|insulin resistance
5436521|NCT01559857|Mood disorder|mood disorder
5436522|NCT01559844|Hepatitis|hepatitis
5436523|NCT01559844|Chronic|chronic
5436524|NCT01559844|hepatocellular carcinoma|hepatocellular carcinoma
5436526|NCT01559844|transplant|transplant
5436527|NCT01559831|Japanese Encephalitis|japanese encephalitis
5436528|NCT01559831|IXIARO|ixiaro
5436529|NCT01559831|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5436531|NCT01559805|Viral Load|viral load
5436532|NCT01559805|Risk|risk
5436533|NCT01559805|Patient Compliance|patient compliance
5436534|NCT01559805|Homosexuality, Male|homosexuality, male
5436535|NCT01559805|Anti-Retroviral Agents|anti-retroviral agents
5436536|NCT01559779|Obesity|obesity
5436537|NCT01559779|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5436538|NCT01559779|Incretin hormones|incretin hormones
5436539|NCT01559779|Beta cell function|beta cell function
5436540|NCT01559766|Vitamin A|vitamin a
5436541|NCT01559766|Dietary requirement|dietary requirement
5436542|NCT01559766|Dietary records|dietary records
5436543|NCT01559766|Deuterated retinol dilution technique|deuterated retinol dilution technique
5436544|NCT01559766|Chinese children|chinese children
5436545|NCT01559766|Dietary intake of vitamin A|dietary intake of vitamin a
5436546|NCT01559766|Vitamin A liver reserves|vitamin a liver reserves
5436547|NCT01559753|Antibiotic|antibiotic
5436548|NCT01559753|treatment|treatment
5436549|NCT01559753|ventilator associated pneumonia|ventilator associated pneumonia
5436550|NCT01559753|duration|duration
5436551|NCT01559740|regional anesthesia|regional anesthesia
5436552|NCT01559740|children|children
5436553|NCT01559740|postoperative pain relief|postoperative pain relief
5436554|NCT01559727|heart failure|heart failure
5436555|NCT01559727|diuresis|diuresis
5436556|NCT01559727|prednisone|prednisone
5436557|NCT01559714|Troponin|troponin
5436558|NCT01559714|Exercise|exercise
5436559|NCT01559714|MRI|mri
5436560|NCT01559701|Safety|safety
5436561|NCT01559701|PF-00345439|pf-00345439
5436562|NCT01559701|Remoxy|remoxy
5436563|NCT01559701|PTI-821|pti-821
5436564|NCT01559675|Corticosteroids|corticosteroids
5436565|NCT01559675|perioperative|perioperative
5436566|NCT01559675|colorectal surgery|colorectal surgery
5436567|NCT01559662|chewing gum|chewing gum
5436568|NCT01559662|ileus|ileus
5436569|NCT01559662|gastrointestinal function|gastrointestinal function
5436570|NCT01559662|colorectal surgery|colorectal surgery
5436571|NCT01559662|abdominal surgery|abdominal surgery
5436572|NCT01559649|Stroke|stroke
5436573|NCT01559649|Deglutition|deglutition
5436574|NCT01559649|Deglutition Disorders|deglutition disorders
5436575|NCT01559649|Nurse Screening|nurse screening
5436576|NCT01559636|seroconversion|seroconversion
5436577|NCT01559636|oral polio vaccine|oral polio vaccine
5436579|NCT01559636|poliomyelitis|poliomyelitis
5436580|NCT01559636|diarrhea|diarrhea
5436581|NCT01559636|seroimmunity|seroimmunity
5436582|NCT01559610|cardiac surgery|cardiac surgery
5436583|NCT01559610|orientation|orientation
5436584|NCT01559610|nursing|nursing
5436585|NCT01559597|controlled temperature chain|controlled temperature chain
5436586|NCT01559597|outside the cold chain|outside the cold chain
5436587|NCT01559597|vaccination|vaccination
5436588|NCT01559597|prevention of mother to child transmission|prevention of mother to child transmission
5436589|NCT01559584|Alopecia|alopecia
5436590|NCT01559584|Areata|areata
5436591|NCT01559584|Phototherapy|phototherapy
5436592|NCT01559584|Phototoxic|phototoxic
5436593|NCT01559584|Ultraviolet A|ultraviolet a
5436594|NCT01559584|Randomized controlled trial|randomized controlled trial
5436595|NCT01559584|Interferon gamma|interferon gamma
5436596|NCT01559584|Transforming growth factor beta-1|transforming growth factor beta-1
5436597|NCT01559584|Insulin like growth factor-1|insulin like growth factor-1
5436598|NCT01559571|Retinopathy of Prematurity|retinopathy of prematurity
5436599|NCT01559545|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5436600|NCT01559545|Metronidazole|metronidazole
5436601|NCT01559545|CDAD|cdad
5436602|NCT01559532|Deep vein thrombosis|deep vein thrombosis
5436603|NCT01559532|Thromboembolism|thromboembolism
5436604|NCT01559532|Tourniquet|tourniquet
5436605|NCT01559532|Knee prosthesis.|knee prosthesis.
5436607|NCT01559519|albumin|albumin
5436608|NCT01559519|hepatic encephalopathy|hepatic encephalopathy
5436609|NCT01559519|hyponatremia|hyponatremia
5436610|NCT01559519|hypovolemia|hypovolemia
5436611|NCT01559519|cirrhosis|cirrhosis
5436612|NCT01559506|CFU|cfu
5436613|NCT01559506|surgery site|surgery site
5436614|NCT01559493|atherosclerotic lesion assessment|atherosclerotic lesion assessment
5436615|NCT01559480|Endometriosis|endometriosis
5436616|NCT01559480|Desogestrel|desogestrel
5436617|NCT01559480|Placebo|placebo
5436618|NCT01559467|Myocardial infarction|myocardial infarction
5437120|NCT01557400|Ataluren|ataluren
5436619|NCT01559467|Randomized Controlled Trial|randomized controlled trial
5436620|NCT01559467|Magnetic Resonance Imaging|magnetic resonance imaging
5436621|NCT01559467|Coronary Angiography|coronary angiography
5436622|NCT01559467|Tomography, X-Ray Computed|tomography, x-ray computed
5436623|NCT01559467|Mortality|mortality
5436624|NCT01559467|Complications|complications
5436625|NCT01559467|Quality of Life|quality of life
5436626|NCT01559467|Cost-Benefit Analysis|cost-benefit analysis
5436627|NCT01559454|chronic pain|chronic pain
5436628|NCT01559454|opioid dependence|opioid dependence
5436629|NCT01559454|methadone|methadone
5436630|NCT01559454|buprenorphine|buprenorphine
5436631|NCT01559454|substance use disorder|substance use disorder
5436632|NCT01559441|beetroot juice|beetroot juice
5436633|NCT01559441|nitrate|nitrate
5436634|NCT01559441|vascular activity|vascular activity
5436635|NCT01559441|postprandial state|postprandial state
5436636|NCT01559428|Plant sterols|plant sterols
5436637|NCT01559428|Plant stanols|plant stanols
5436638|NCT01559428|Oxyphytosterols|oxyphytosterols
5436639|NCT01559428|Cardiovascular Disease|cardiovascular disease
5436640|NCT01559415|Adipocytes|adipocytes
5436641|NCT01559389|Urge Urinary Incontinence|urge urinary incontinence
5436642|NCT01559389|Vesicare|vesicare
5436643|NCT01559389|Urinary Incontinence|urinary incontinence
5436644|NCT01559389|Sexual function|sexual function
5436645|NCT01559389|solifenacin|solifenacin
5436646|NCT01559350|OPCAB|opcab
5436647|NCT01559337|defect|defect
5436648|NCT01559337|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5436649|NCT01559337|proper digital nerve|proper digital nerve
5436650|NCT01559337|nerve transfer|nerve transfer
5436651|NCT01559337|finger sensory reconstruction|finger sensory reconstruction
5436652|NCT01559311|Bradycardia|bradycardia
5436653|NCT01559298|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5436654|NCT01559298|Antithrombotic treatment|antithrombotic treatment
5436655|NCT01559298|Clopidogrel|clopidogrel
5436656|NCT01559298|Aspirin|aspirin
5436657|NCT01559298|Myocardial Infarction|myocardial infarction
5436658|NCT01559298|Ischemic stroke|ischemic stroke
5436659|NCT01559298|Major bleeding|major bleeding
5436660|NCT01559285|epidural, local, ropivacaine|epidural, local, ropivacaine
5436661|NCT01559285|epidural administration|epidural administration
5436662|NCT01559285|stroke volume variability|stroke volume variability
5436663|NCT01559272|Schizophrenia|schizophrenia
5436664|NCT01559272|Paliperidone palmitate|paliperidone palmitate
5436665|NCT01559272|R092670|r092670
5436666|NCT01559272|Paliperidone|paliperidone
5436667|NCT01559272|3-month formulation|3-month formulation
5436668|NCT01559272|Pharmacokinetics|pharmacokinetics
5436669|NCT01559259|ibuprofen|ibuprofen
5436670|NCT01559259|acetaminophen|acetaminophen
5436671|NCT01559259|pain|pain
5436672|NCT01559259|molar extraction|molar extraction
5436673|NCT01559246|Cardiac Arrhythmia Monitoring|cardiac arrhythmia monitoring
5436674|NCT01559246|Holter Monitoring|holter monitoring
5436675|NCT01559246|Continuous ECG monitoring|continuous ecg monitoring
5436676|NCT01559246|Event monitoring|event monitoring
5436677|NCT01559246|Observational|observational
5436678|NCT01559207|nucleosome|nucleosome
5436679|NCT01559207|plasma nucleosome concentrations|plasma nucleosome concentrations
5436680|NCT01559207|free DNA|free dna
5436681|NCT01559207|plasma free DNA concentrations|plasma free dna concentrations
5436682|NCT01559181|Offspring of mothers with type 1 diabetes|offspring of mothers with type 1 diabetes
5436683|NCT01559181|Pregnancy and programing|pregnancy and programing
5436684|NCT01559181|Intrauterine hyperglycaemia|intrauterine hyperglycaemia
5436685|NCT01559181|Study focuses on offspring of mothers with type 1 diabetes|study focuses on offspring of mothers with type 1 diabetes
5436686|NCT01559155|proteasomes|proteasomes
5436687|NCT01559155|proteasome concentration|proteasome concentration
5436688|NCT01559155|disease activity|disease activity
5436689|NCT01559155|proteolytic activity|proteolytic activity
5436690|NCT01559155|autoantibodies|autoantibodies
5436691|NCT01559155|proteasome autoantibody|proteasome autoantibody
5436692|NCT01559142|Crohn Disease|crohn disease
5436693|NCT01559142|infliximab|infliximab
5436694|NCT01559142|azathioprine|azathioprine
5436695|NCT01559103|Rheumatoid Arthritis|rheumatoid arthritis
5436696|NCT01559103|Phase I|phase i
5436697|NCT01559103|Biologic|biologic
5436698|NCT01559090|Japan|japan
5436699|NCT01559090|Phase2|phase2
5436700|NCT01559090|Safety|safety
5436701|NCT01559090|Tolerability|tolerability
5436702|NCT01559090|Systemic Lupus Erythematosus|systemic lupus erythematosus
5436703|NCT01559090|SLE, MEDI-546|sle, medi-546
5436705|NCT01559051|COPD|copd
5436706|NCT01559051|Pulmonary|pulmonary
5436707|NCT01559051|Lungs|lungs
5436708|NCT01559038|Assessing Effectiveness in Psoriatic Arthritis|assessing effectiveness in psoriatic arthritis
5436709|NCT01559025|Type 1 diabetes|type 1 diabetes
5436710|NCT01559025|Vildagliptin|vildagliptin
5436711|NCT01559025|Galvus|galvus
5436712|NCT01559012|Hyperemesis Gravidarum|hyperemesis gravidarum
5436713|NCT01559012|treatment|treatment
5436714|NCT01559012|transdermal clonidine|transdermal clonidine
5436715|NCT01558986|Antibiotic prophylaxis|antibiotic prophylaxis
5437121|NCT01557400|PTC124|ptc124
5436718|NCT01558986|Prevention of surgical site infection (SSI) in patients undergoing MRM for breast cancer|prevention of surgical site infection (ssi) in patients undergoing mrm for breast cancer
5436719|NCT01558960|Retinoblastoma|retinoblastoma
5436720|NCT01558947|gastric cancer|gastric cancer
5436722|NCT01558934|lofexidine|lofexidine
5436723|NCT01558934|methadone|methadone
5436724|NCT01558934|interaction|interaction
5436725|NCT01558934|pharmacodynamic|pharmacodynamic
5436727|NCT01558934|QTc|qtc
5436728|NCT01558921|rectal cancer|rectal cancer
5436729|NCT01558921|radiotherapy|radiotherapy
5436730|NCT01558921|chemotherapy|chemotherapy
5436731|NCT01558921|5x5|5x5
5436732|NCT01558921|capecitbine|capecitbine
5436733|NCT01558921|oxaliplatin|oxaliplatin
5436734|NCT01558921|CAPOX|capox
5436735|NCT01558921|FOLFOX|folfox
5436736|NCT01558921|folinic acid|folinic acid
5436737|NCT01558921|fluorouracil|fluorouracil
5436738|NCT01558908|critical limb ischemia|critical limb ischemia
5436739|NCT01558895|Infrared ray heat treatment|infrared ray heat treatment
5436740|NCT01558895|liver cirrhosis|liver cirrhosis
5436741|NCT01558895|refractory ascites|refractory ascites
5436742|NCT01558882|Essure|essure
5436743|NCT01558882|Change in uterine cytokines|change in uterine cytokines
5436744|NCT01558882|Change in uterine natural killer cells|change in uterine natural killer cells
5436745|NCT01558882|cytokine|cytokine
5436746|NCT01558882|natural killer cell|natural killer cell
5436747|NCT01558856|refractory overactive bladder|refractory overactive bladder
5436748|NCT01558856|neuromodulation|neuromodulation
5436749|NCT01558856|sacral nerves|sacral nerves
5436750|NCT01558843|Sodium Management|sodium management
5436751|NCT01558843|Neurointensive Care|neurointensive care
5436752|NCT01558843|Hyponatremia|hyponatremia
5436753|NCT01558830|amiodarone|amiodarone
5436754|NCT01558830|ranolazine|ranolazine
5436755|NCT01558830|safety|safety
5436756|NCT01558830|arrhythmia|arrhythmia
5436757|NCT01558817|CPR|cpr
5436758|NCT01558817|Palliative|palliative
5436759|NCT01558817|Outcome|outcome
5436762|NCT01558791|PTSD|ptsd
5436763|NCT01558791|patient education handout|patient education handout
5436764|NCT01558765|Rehabilitation|rehabilitation
5436765|NCT01558765|Integrated rehabilitation programme|integrated rehabilitation programme
5436766|NCT01558765|Exercise training|exercise training
5436767|NCT01558765|Psycho-educational care|psycho-educational care
5436768|NCT01558752|Total hip replacement|total hip replacement
5436769|NCT01558752|Bone mineral density (BMD)|bone mineral density (bmd)
5436770|NCT01558739|Ruxolitinib|ruxolitinib
5436771|NCT01558739|INC424|inc424
5436772|NCT01558739|myelofibrosis|myelofibrosis
5436773|NCT01558739|PMF|pmf
5436774|NCT01558739|post polycythemia myelofibrosis|post polycythemia myelofibrosis
5436775|NCT01558739|PPV MF|ppv mf
5436776|NCT01558739|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5436777|NCT01558739|PET-MF|pet-mf
5436778|NCT01558739|Primary Myelofibrosis|primary myelofibrosis
5436779|NCT01558739|Polycythemia|polycythemia
5436780|NCT01558739|Thrombocythemia|thrombocythemia
5436781|NCT01558739|Essential Thrombocytosis|essential thrombocytosis
5436782|NCT01558739|myeloproliferative Disorders|myeloproliferative disorders
5436783|NCT01558739|Bone Marrow Diseases|bone marrow diseases
5419481|NCT01633567|LGBT|lgbt
5436784|NCT01558739|Haematologic Diseases|haematologic diseases
5436785|NCT01558739|Blood Coagulation Disorders|blood coagulation disorders
5436786|NCT01558739|Blood Platelet Disorders|blood platelet disorders
5436787|NCT01558739|Haemorrhagic Disorders|haemorrhagic disorders
5436788|NCT01558726|Case Management|case management
5436789|NCT01558726|Crack abuse/dependents|crack abuse/dependents
5436790|NCT01558726|Evaluation|evaluation
5436791|NCT01558726|Inpatient|inpatient
5436792|NCT01558726|ASI|asi
5436793|NCT01558726|Treatment retention|treatment retention
5436794|NCT01558726|Abstinence|abstinence
5436795|NCT01558713|parturient|parturient
5436796|NCT01558700|osteoarthritis|osteoarthritis
5436797|NCT01558700|pain|pain
5436798|NCT01558700|brain|brain
5436799|NCT01558700|gray matter|gray matter
5436800|NCT01558687|Oncology|oncology
5436801|NCT01558687|newly diagnosed inoperable glioblastoma|newly diagnosed inoperable glioblastoma
5436802|NCT01558687|temolozomide|temolozomide
5436803|NCT01558687|radiotherapy|radiotherapy
5436804|NCT01558687|dynamic MRI|dynamic mri
5436805|NCT01558687|Positron emission tomography|positron emission tomography
5436806|NCT01558687|[18]FET tracer|[18]fet tracer
5436807|NCT01558687|cilengitide|cilengitide
5436808|NCT01558687|World Health Organization [WHO] Grade IV|world health organization [who] grade iv
5436809|NCT01558661|axitinib (AG-013736)|axitinib (ag-013736)
5436810|NCT01558661|recurrent|recurrent
5436811|NCT01558661|metastatic|metastatic
5436812|NCT01558661|12-004|12-004
5436813|NCT01558648|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5436814|NCT01558648|Open Esophagectomy|open esophagectomy
5436815|NCT01558648|Quality of Life|quality of life
5436817|NCT01558635|Atrial Fibrillation|atrial fibrillation
5436818|NCT01558635|Surgical Ablation|surgical ablation
5436819|NCT01558635|Maze Procedure|maze procedure
5436821|NCT01558622|postoperative analgesia|postoperative analgesia
5436822|NCT01558622|dexketoprofen trometamol|dexketoprofen trometamol
5436823|NCT01558622|tramadol hydrochloride|tramadol hydrochloride
5436824|NCT01558622|pethidine|pethidine
5439993|NCT01545518|IVIG|ivig
5436825|NCT01558622|laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5436826|NCT01558583|Colon|colon
5436827|NCT01558583|Prostate|prostate
5436828|NCT01558583|Cancer|cancer
5436829|NCT01558544|Ovarian tissue cryopreservation|ovarian tissue cryopreservation
5436830|NCT01558544|Ovarian tissue transplantation|ovarian tissue transplantation
5436831|NCT01558544|Fertility preservation|fertility preservation
5436832|NCT01558544|Risk of premature ovarian failure|risk of premature ovarian failure
5436833|NCT01558531|peripheral arterial disease|peripheral arterial disease
5436834|NCT01558531|drug-eluting balloon|drug-eluting balloon
5436835|NCT01558531|restenosis|restenosis
5436836|NCT01558518|Handheld echocardiography|handheld echocardiography
5436837|NCT01558518|V-scan|v-scan
5436838|NCT01558518|Handheld ultrasound|handheld ultrasound
5436839|NCT01558518|Portable ultrasound|portable ultrasound
5436840|NCT01558505|critical limb ischemia|critical limb ischemia
5436841|NCT01558505|drug-eluting balloon|drug-eluting balloon
5436842|NCT01558505|restenosis|restenosis
5436843|NCT01558492|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
5436845|NCT01558479|Parkinson's Disease|parkinson's disease
5436846|NCT01558479|Genetics|genetics
5436847|NCT01558479|Family Research|family research
5436848|NCT01558479|Hereditary Neurodegenerative Diseases|hereditary neurodegenerative diseases
5436849|NCT01558466|newborn|newborn
5436850|NCT01558466|INO|ino
5436851|NCT01558466|Sildenafil|sildenafil
5436852|NCT01558466|PPHN|pphn
5436853|NCT01558440|Nutrition rehabilitation|nutrition rehabilitation
5436854|NCT01558440|severe malnutrition|severe malnutrition
5436855|NCT01558440|infant formula|infant formula
5436856|NCT01558440|F-100|f-100
5436857|NCT01558414|Cholecystectomy|cholecystectomy
5436858|NCT01558414|Minimally invasive surgery|minimally invasive surgery
5436859|NCT01558414|Laparoscopic surgery|laparoscopic surgery
5436860|NCT01558414|Single incision surgery|single incision surgery
5436861|NCT01558401|physical activity|physical activity
5436862|NCT01558401|elderly|elderly
5436863|NCT01558401|women|women
5436864|NCT01558401|efficiency|efficiency
5436865|NCT01558362|myocardial perfusion imaging|myocardial perfusion imaging
5436866|NCT01558362|single photon emission tomography|single photon emission tomography
5436867|NCT01558362|Coronary artery disease|coronary artery disease
5436868|NCT01558362|gamma camera imaging|gamma camera imaging
5436869|NCT01558362|Phase 1 clinical trial|phase 1 clinical trial
5436870|NCT01558362|cyclotron|cyclotron
5436871|NCT01558349|Epispot|epispot
5436872|NCT01558349|CellSearch|cellsearch
5436873|NCT01558349|Circulating melanoma cells|circulating melanoma cells
5436874|NCT01558349|circulating cells|circulating cells
5436875|NCT01558336|Schistosoma haematobium|schistosoma haematobium
5436876|NCT01558336|schoolchildren|schoolchildren
5436877|NCT01558336|Central Sudan|central sudan
5436878|NCT01558336|Praziquantel|praziquantel
5436879|NCT01558323|LCQ908, Renal Impairment, Pharmacokinetics|lcq908, renal impairment, pharmacokinetics
5436880|NCT01558284|Irritable bowel syndrome|irritable bowel syndrome
5436881|NCT01558284|Neu-P11|neu-p11
5436882|NCT01558284|Melatonin|melatonin
5436883|NCT01558284|D-IBS|d-ibs
5436884|NCT01558271|GLP-1|glp-1
5436885|NCT01558245|ischemic stroke; in-stent restenosis; tissue kallikrein;|ischemic stroke; in-stent restenosis; tissue kallikrein;
5436886|NCT01558245|the middle cerebral artery; atherosclerotic stenosis|the middle cerebral artery; atherosclerotic stenosis
5436887|NCT01558232|Stroke|stroke
5436888|NCT01558232|Tibion|tibion
5436889|NCT01558232|Bionics|bionics
5436890|NCT01558232|Rehab|rehab
5436891|NCT01558232|Therapy|therapy
5436892|NCT01558232|Robotics|robotics
5436893|NCT01558232|Intention|intention
5436894|NCT01558219|Metastatic prostate cancer|metastatic prostate cancer
5436895|NCT01558206|PTE|pte
5436896|NCT01558206|Emergency bedside ultrasonography|emergency bedside ultrasonography
5436897|NCT01558206|pulmonary CT Angiography|pulmonary ct angiography
5436898|NCT01558206|Pulmonary Wedge infarction|pulmonary wedge infarction
5436899|NCT01558206|Pulmonary Thromboembolism|pulmonary thromboembolism
5436900|NCT01558193|Aggression DHA|aggression dha
5436901|NCT01558193|Docosahexaenoic acid|docosahexaenoic acid
5436902|NCT01558193|Impulsivity|impulsivity
5436903|NCT01558193|Minerals|minerals
5431726|NCT01580345|RCT|rct
5436905|NCT01558167|Dose limiting toxicity of Lenalidomide|dose limiting toxicity of lenalidomide
5436906|NCT01558167|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5436907|NCT01558154|depression|depression
5436908|NCT01558154|Chinese herb|chinese herb
5436909|NCT01558154|acupuncture|acupuncture
5436910|NCT01558154|Psychotherapy|psychotherapy
5436911|NCT01558154|Transcranial magnetic stimulation|transcranial magnetic stimulation
5436912|NCT01558141|IVF stimulation.|ivf stimulation.
5436913|NCT01558141|Poor responders.|poor responders.
5436914|NCT01558141|IVF patients with poor response to stimulation|ivf patients with poor response to stimulation
5436915|NCT01558115|Columbia University|columbia university
5436916|NCT01558115|Primary hyperparathyroidism|primary hyperparathyroidism
5436917|NCT01558115|Low bone density|low bone density
5436918|NCT01558115|Denosumab|denosumab
5436919|NCT01558115|Prolia|prolia
5436920|NCT01558102|brain aneurysm PED Pipeline|brain aneurysm ped pipeline
5436921|NCT01558076|Sickle cell anemia|sickle cell anemia
5436922|NCT01558076|exercise testing|exercise testing
5436923|NCT01558076|cardiopulmonary disease|cardiopulmonary disease
5436924|NCT01558063|Ketamine|ketamine
5436925|NCT01558063|Major Depressive Disorder|major depressive disorder
5436926|NCT01558063|Treatment|treatment
5436927|NCT01558063|Depression|depression
5436928|NCT01558037|transplant|transplant
5436929|NCT01558037|solid organ transplant|solid organ transplant
5436930|NCT01558037|kidney transplant|kidney transplant
5436931|NCT01558037|liver transplant|liver transplant
5436932|NCT01558037|pancreas transplant|pancreas transplant
5436933|NCT01558037|heart transplant|heart transplant
5436934|NCT01558037|CMV|cmv
5436935|NCT01558037|Cytomegalovirus|cytomegalovirus
5436936|NCT01558024|compression stockings|compression stockings
5436937|NCT01558024|physiopathology|physiopathology
5436938|NCT01558011|gastric adenocarcinoma|gastric adenocarcinoma
5436939|NCT01558011|Capecitabine and oxaliplatin (XELOX)|capecitabine and oxaliplatin (xelox)
5436940|NCT01558011|Docetaxel and capecitabine (TX)|docetaxel and capecitabine (tx)
5436941|NCT01558011|Using genetic polymorphisms|using genetic polymorphisms
5436942|NCT01558011|drug metabolism and immunohistochemical stain|drug metabolism and immunohistochemical stain
5436943|NCT01558011|predict the efficacy|predict the efficacy
5436944|NCT01557998|Test and linkage to care|test and linkage to care
5436945|NCT01557998|Injecting drug user (IDU)|injecting drug user (idu)
5436946|NCT01557998|Prevention with positives|prevention with positives
5436947|NCT01557998|ART adherence|art adherence
5436948|NCT01557998|point of care CD4 counts|point of care cd4 counts
5436949|NCT01557998|Peer case management|peer case management
5436950|NCT01557998|Conditional cash transfer|conditional cash transfer
5436952|NCT01557985|regional anesthesia|regional anesthesia
5436953|NCT01557985|postoperative pain management|postoperative pain management
5436954|NCT01557985|local anesthetic solution|local anesthetic solution
5436955|NCT01557985|toxicity|toxicity
5436956|NCT01557933|ECT|ect
5436957|NCT01557933|Bipolar Disorder|bipolar disorder
5436958|NCT01557920|apnea|apnea
5436959|NCT01557920|airway collapsibility|airway collapsibility
5436960|NCT01557920|healthy|healthy
5436961|NCT01557920|hypercapnia|hypercapnia
5436962|NCT01557920|general anesthesia|general anesthesia
5436963|NCT01557920|breathing-swallow coordination|breathing-swallow coordination
5436964|NCT01557920|aspiration|aspiration
5436965|NCT01557907|Diabetes|diabetes
5436966|NCT01557907|Diabetes Mellitus|diabetes mellitus
5436967|NCT01557907|Type 1 diabetes|type 1 diabetes
5436968|NCT01557907|Insulin Pump users|insulin pump users
5436969|NCT01557907|Intradermal insulin|intradermal insulin
5436970|NCT01557894|Social anxiety disorders|social anxiety disorders
5436971|NCT01557894|Social phobia|social phobia
5436972|NCT01557894|Anxiety sensitivity|anxiety sensitivity
5436973|NCT01557894|Irrational thinking|irrational thinking
5436974|NCT01557894|Guided self-help|guided self-help
5436975|NCT01557894|Internet-delivered treatment|internet-delivered treatment
5436976|NCT01557855|Corus CAD|corus cad
5436977|NCT01557855|ASGES|asges
5436978|NCT01557855|Age/Sex/Gene Expression Score|age/sex/gene expression score
5436979|NCT01557855|Gene Expression|gene expression
5436980|NCT01557855|GES|ges
5436981|NCT01557855|CAD|cad
5436982|NCT01557855|CVD|cvd
5436983|NCT01557855|CHD|chd
5436984|NCT01557855|Precision Medicine|precision medicine
5436985|NCT01557855|Clinical Utility|clinical utility
5436986|NCT01557855|Registry|registry
5436987|NCT01557855|Coronary Artery Disease|coronary artery disease
5436988|NCT01557855|Coronary Heart Disease|coronary heart disease
5436989|NCT01557855|Cardiovascular Disease|cardiovascular disease
5436990|NCT01557855|Angina Pectoris|angina pectoris
5436991|NCT01557855|Chest Pain|chest pain
5436992|NCT01557855|Registry I|registry i
5436993|NCT01557855|Registry-I|registry-i
5436994|NCT01557842|Ischemic|ischemic
5436995|NCT01557842|Ventricular Tachycardia|ventricular tachycardia
5436996|NCT01557842|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5436997|NCT01557842|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5436998|NCT01557842|Ablation|ablation
5436999|NCT01557842|Electrophysiology|electrophysiology
5437000|NCT01557829|spondylolisthesis|spondylolisthesis
5437001|NCT01557829|disc degeneration|disc degeneration
5437002|NCT01557829|lumbar interbody fusion|lumbar interbody fusion
5437003|NCT01557829|randomized controlled trial|randomized controlled trial
5437004|NCT01557829|ceramic interbody spacer|ceramic interbody spacer
5437005|NCT01557816|osteoarthritis|osteoarthritis
5437007|NCT01557816|Naproxen|naproxen
5437008|NCT01557803|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5437009|NCT01557803|Biomarkers|biomarkers
5437010|NCT01557803|HIV|hiv
5437011|NCT01557803|ART|art
5437012|NCT01557803|predictive factors|predictive factors
5437013|NCT01557803|epidemiological pattern|epidemiological pattern
5437014|NCT01557803|Gabon|gabon
5437015|NCT01557790|Adult male|adult male
5437016|NCT01557790|18 years or older|18 years or older
5437017|NCT01557790|clinical diagnosis|clinical diagnosis
5437018|NCT01557751|Total knee arthroplasty|total knee arthroplasty
5846728|NCT00043641|RT PCR|rt pcr
5437019|NCT01557751|Total knee replacement|total knee replacement
5437020|NCT01557751|Genetics of pain|genetics of pain
5437022|NCT01557738|Blood Flow|blood flow
5437023|NCT01557738|Nitric Oxide|nitric oxide
5437024|NCT01557738|Aging|aging
5437025|NCT01557738|Antioxidant|antioxidant
5437026|NCT01557738|Flavanol|flavanol
5437027|NCT01557738|Young (18-30 yrs)|young (18-30 yrs)
5437028|NCT01557738|Aging (60 - 80 yrs)|aging (60 - 80 yrs)
5437029|NCT01557725|Knee Replacement, Total|knee replacement, total
5437030|NCT01557725|Hip Replacement, Total|hip replacement, total
5437031|NCT01557725|Thromboembolism, Venous|thromboembolism, venous
5437032|NCT01557725|prophylaxis|prophylaxis
5437033|NCT01557725|Enhanced recovery|enhanced recovery
5437034|NCT01557686|Cancer Related fatigue|cancer related fatigue
5437035|NCT01557686|Quality of Life|quality of life
5437036|NCT01557686|Psychosocial Intervention|psychosocial intervention
5437037|NCT01557686|Rehabilitation|rehabilitation
5437038|NCT01557686|Physical Fitness|physical fitness
5437039|NCT01557686|Physical Activity|physical activity
5437040|NCT01557686|Exercise Therapy|exercise therapy
5437041|NCT01557686|Exercise|exercise
5437042|NCT01557686|Hematologic|hematologic
5437043|NCT01557686|Hematological|hematological
5437044|NCT01557686|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5437045|NCT01557686|Acute Myeloid Leukemia|acute myeloid leukemia
5437046|NCT01557686|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5437047|NCT01557686|Acute Leukemia|acute leukemia
5437048|NCT01557673|Nasogastric|nasogastric
5437049|NCT01557673|Small bowel water|small bowel water
5437050|NCT01557673|Diarrhoea|diarrhoea
5437051|NCT01557673|Mesenteric blood flow|mesenteric blood flow
5437052|NCT01557673|Enteral feeding|enteral feeding
5437053|NCT01557621|Immunization reminder/recall|immunization reminder/recall
5437054|NCT01557621|Reminder/Recall systems|reminder/recall systems
5437055|NCT01557621|Population based Recall|population based recall
5437056|NCT01557621|Practice based Recall|practice based recall
5437057|NCT01557608|cancer|cancer
5437058|NCT01557608|chemotherapy|chemotherapy
5437059|NCT01557608|photon stimulation|photon stimulation
5437060|NCT01557608|neuropathy|neuropathy
5437061|NCT01557608|pain|pain
5437062|NCT01557582|IPAH|ipah
5437063|NCT01557582|HPAH|hpah
5437064|NCT01557582|APAH CTD|apah ctd
5437065|NCT01557582|APAH HIV|apah hiv
5437066|NCT01557582|APAH PoPH|apah poph
5437067|NCT01557582|APAH Drugs/Toxins|apah drugs/toxins
5437068|NCT01557582|APAH CHD repaired|apah chd repaired
5437069|NCT01557582|APAH CHD unrepaired|apah chd unrepaired
5437070|NCT01557569|methamphetamine|methamphetamine
5437071|NCT01557569|addiction|addiction
5437072|NCT01557569|relapse|relapse
5437073|NCT01557569|atomoxetine|atomoxetine
5437074|NCT01557556|CRH Antagonist|crh antagonist
5437075|NCT01557556|Nicotine|nicotine
5437076|NCT01557556|Nicotine Dependence|nicotine dependence
5437077|NCT01557556|Smoking|smoking
5437078|NCT01557556|Stress|stress
5437079|NCT01557543|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5437080|NCT01557543|Coronary Artery Disease|coronary artery disease
5437081|NCT01557543|Transmyocardial Revascularization|transmyocardial revascularization
5445477|NCT01521572|spirometry|spirometry
5437082|NCT01557543|Bone Marrow Stromal Cells|bone marrow stromal cells
5437083|NCT01557517|cGVHD|cgvhd
5437084|NCT01557517|Oral cGVHD|oral cgvhd
5437085|NCT01557517|Topical|topical
5437086|NCT01557517|Oral Rinse|oral rinse
5437087|NCT01557517|Clobetasol|clobetasol
5437088|NCT01557517|Oral Graft-Versus-Host Disease|oral graft-versus-host disease
5437089|NCT01557517|GVHD|gvhd
5437090|NCT01557491|Alopecia|alopecia
5437091|NCT01557491|Coronal Incision|coronal incision
5437092|NCT01557491|Scar Quality|scar quality
5437093|NCT01557478|breast cancer|breast cancer
5437094|NCT01557478|melatonin|melatonin
5437095|NCT01557478|adjuvant therapy|adjuvant therapy
5437096|NCT01557478|quality of life|quality of life
5437097|NCT01557478|pain|pain
5437098|NCT01557478|sleep|sleep
5437099|NCT01557478|survival|survival
5437100|NCT01557478|adverse events|adverse events
5437101|NCT01557452|JIA|jia
5437102|NCT01557426|skin|skin
5437103|NCT01557426|soft tissue|soft tissue
5437104|NCT01557426|infection|infection
5437105|NCT01557426|cellulitis|cellulitis
5437106|NCT01557426|abscess|abscess
5437107|NCT01557413|Humerus|humerus
5437108|NCT01557413|fracture|fracture
5437109|NCT01557413|nail|nail
5437110|NCT01557413|plate|plate
5437111|NCT01557413|tuberosity|tuberosity
5437112|NCT01557400|Duchenne muscular dystrophy|duchenne muscular dystrophy
5437113|NCT01557400|Becker muscular dystrophy|becker muscular dystrophy
5437114|NCT01557400|Nonsense mutation|nonsense mutation
5437115|NCT01557400|Premature stop codon|premature stop codon
5437117|NCT01557400|BMD|bmd
5437127|NCT01557374|Lowest Effective DOse|lowest effective dose
5437128|NCT01557374|Abatacept Tocilizumab|abatacept tocilizumab
5437129|NCT01557374|ACR-EULAR 2010|acr-eular 2010
5437130|NCT01557361|renal replacement therapy|renal replacement therapy
5437131|NCT01557361|dialysis|dialysis
5437132|NCT01557361|acute kidney injury|acute kidney injury
5437133|NCT01557361|hemodialysis|hemodialysis
5437136|NCT01557309|traumatic rotator cuff tear|traumatic rotator cuff tear
5437137|NCT01557309|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5437138|NCT01557309|age|age
5437139|NCT01557309|early rotator cuff repair|early rotator cuff repair
5437140|NCT01557296|Diet|diet
5437141|NCT01557296|Dietary treatment|dietary treatment
5437142|NCT01557296|Particle size|particle size
5437143|NCT01557296|Gastroparesis|gastroparesis
5437144|NCT01557296|Diabetes Mellitus|diabetes mellitus
5437145|NCT01557257|single- and multiple-dose pharmacokinetics|single- and multiple-dose pharmacokinetics
5437146|NCT01557257|ALO-02|alo-02
5437147|NCT01557257|OxyContin|oxycontin
5437153|NCT01557231|OA|oa
5437154|NCT01557231|osteoarthritis|osteoarthritis
5437155|NCT01557231|pain|pain
5437156|NCT01557231|variability|variability
5437157|NCT01557231|activity|activity
5437158|NCT01557231|treatment|treatment
5437159|NCT01557218|Dietary variety|dietary variety
5437160|NCT01557218|Vegetable intake|vegetable intake
5437161|NCT01557218|Fruit intake|fruit intake
5437162|NCT01557205|optical coherence tomography|optical coherence tomography
5437163|NCT01557205|cell imaging|cell imaging
5437164|NCT01557192|Depression|depression
5437165|NCT01557192|Bipolar Depression|bipolar depression
5437166|NCT01557192|LFMS|lfms
5437167|NCT01557192|Electromagnetic Stimulation|electromagnetic stimulation
5437168|NCT01557166|OSA|osa
5437169|NCT01557153|Late-life Unremitted Depression|late-life unremitted depression
5437170|NCT01557140|Chagas cardiomyopathy,|chagas cardiomyopathy,
5437171|NCT01557140|Renin-angiotensin system,|renin-angiotensin system,
5437172|NCT01557140|Beta-blockers,|beta-blockers,
5437173|NCT01557140|Enalapril,|enalapril,
5437174|NCT01557140|Carvedilol,|carvedilol,
5437175|NCT01557140|Renin-angiotensin system inhibitors,|renin-angiotensin system inhibitors,
5437176|NCT01557140|Brain natriuretic peptide level,|brain natriuretic peptide level,
5437177|NCT01557140|Left ventricular ejection fraction,|left ventricular ejection fraction,
5437178|NCT01557140|Chemokines|chemokines
5437179|NCT01557127|Renal cell carcinoma,|renal cell carcinoma,
5437180|NCT01557127|Sorafenib|sorafenib
5437181|NCT01557127|Dosing|dosing
5437182|NCT01557114|unresectable Stage III or stage IV advanced malignant melanoma|unresectable stage iii or stage iv advanced malignant melanoma
5437183|NCT01557088|coronary artery disease|coronary artery disease
5437184|NCT01557088|coronary artery spasm|coronary artery spasm
5437185|NCT01557088|small vessel coronary artery disease|small vessel coronary artery disease
5437186|NCT01557075|High dose statin|high dose statin
5437187|NCT01557062|Fibromyalgia|fibromyalgia
5437188|NCT01557062|Hydrotherapy|hydrotherapy
5437189|NCT01557062|Sleep|sleep
5437190|NCT01557062|Pain|pain
5437191|NCT01557062|Body Temperature|body temperature
5437192|NCT01557049|chronic low back pain|chronic low back pain
5437193|NCT01557049|Postural global reeducation|postural global reeducation
5437194|NCT01557049|randomized|randomized
5437195|NCT01557049|physical rehabilitation|physical rehabilitation
5437196|NCT01557036|Brain Aneurysm|brain aneurysm
5437197|NCT01556997|Hypertension|hypertension
5437198|NCT01556997|Essential Hypertension|essential hypertension
5437199|NCT01556984|diabetic foot|diabetic foot
5445766|NCT01520389|Phase I|phase i
5437200|NCT01556984|digital subtraction angiography|digital subtraction angiography
5437201|NCT01556984|endothelial function|endothelial function
5437202|NCT01556984|Patients with diabetes|patients with diabetes
5437203|NCT01556984|Age 40 to 70 years old|age 40 to 70 years old
5437204|NCT01556984|Endothelial function are determined|endothelial function are determined
5437205|NCT01556945|P. falciparum|p. falciparum
5437206|NCT01556945|vaccine|vaccine
5437207|NCT01556945|healthy volunteers|healthy volunteers
5437208|NCT01556919|GERD|gerd
5437209|NCT01556919|Esophagitis|esophagitis
5437210|NCT01556893|Flap Creation|flap creation
5437211|NCT01556893|Femtosecond Laser|femtosecond laser
5437212|NCT01556893|corneal flap prior to LASIK procedure|corneal flap prior to lasik procedure
5437213|NCT01556880|Drivers|drivers
5437214|NCT01556880|Chinese|chinese
5437215|NCT01556880|Short Message Service|short message service
5437216|NCT01556880|Cellular Phone|cellular phone
5437217|NCT01556867|Umbilical cord care|umbilical cord care
5437218|NCT01556867|dry cord care|dry cord care
5437219|NCT01556867|antiseptic|antiseptic
5437221|NCT01556867|umbilical cord drop|umbilical cord drop
5437222|NCT01556867|hospitalized in maternity hospital|hospitalized in maternity hospital
5437223|NCT01556854|ginkgo leaves|ginkgo leaves
5437224|NCT01556854|butylphthalide|butylphthalide
5437225|NCT01556854|edaravone|edaravone
5437226|NCT01556854|citicoline|citicoline
5437227|NCT01556854|cerebrolysin|cerebrolysin
5437228|NCT01556854|piracetam|piracetam
5437229|NCT01556854|Neuroprotectants|neuroprotectants
5437230|NCT01556841|Randomised|randomised
5437231|NCT01556841|Controlled|controlled
5437232|NCT01556841|Trovax|trovax
5437233|NCT01556841|MVA-5T4|mva-5t4
5437234|NCT01556841|5T4|5t4
5437235|NCT01556841|Immunotherapy|immunotherapy
5437236|NCT01556841|Relapsed|relapsed
5437237|NCT01556841|Asymptomatic|asymptomatic
5437238|NCT01556841|Epithelial|epithelial
5437239|NCT01556841|Ovarian|ovarian
5437240|NCT01556841|Fallopian|fallopian
5437241|NCT01556841|Peritoneal|peritoneal
5437242|NCT01556815|Hepatocellular Carcinoma|hepatocellular carcinoma
5437243|NCT01556815|Sorafenib|sorafenib
5437244|NCT01556815|Transarterial Chemoembolization|transarterial chemoembolization
5437245|NCT01556815|HBV|hbv
5437246|NCT01556802|stroke|stroke
5437247|NCT01556802|sequelaes|sequelaes
5437248|NCT01556802|minocicline|minocicline
5437249|NCT01556789|ONT-10|ont-10
5437250|NCT01556789|MUC1|muc1
5437251|NCT01556789|Vaccine|vaccine
5437252|NCT01556789|Phase 1|phase 1
5437253|NCT01556789|Solid Tumors|solid tumors
5437254|NCT01556789|Dose escalation|dose escalation
5437255|NCT01556776|CLL|cll
5437256|NCT01556776|High Risk|high risk
5437257|NCT01556776|Maintenance|maintenance
5437258|NCT01556763|Schizophrenia|schizophrenia
5437259|NCT01556763|Schizoaffective|schizoaffective
5437260|NCT01556763|CNS|cns
5437261|NCT01556737|isoflavone|isoflavone
5437262|NCT01556737|supplement|supplement
5437263|NCT01556737|daidzein|daidzein
5437264|NCT01556737|genistein|genistein
5437265|NCT01556737|gene expression|gene expression
5437266|NCT01556724|Peripheral nerve blocks|peripheral nerve blocks
5437267|NCT01556724|Ropivacaine concentrations in lumbar plexus catheters|ropivacaine concentrations in lumbar plexus catheters
5437268|NCT01556724|Postoperative pain|postoperative pain
5437269|NCT01556724|Total hip replacement|total hip replacement
5437270|NCT01556711|Head Injury|head injury
5437271|NCT01556711|Head Trauma|head trauma
5437272|NCT01556711|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5437273|NCT01556711|Emergency Department|emergency department
5437274|NCT01556698|Acne Vulgaris|acne vulgaris
5437275|NCT01556698|Acne|acne
5437276|NCT01556672|small bowel lesions|small bowel lesions
5437277|NCT01556672|Crohn's Disease|crohn's disease
5437278|NCT01556672|Plaque psoriasis|plaque psoriasis
5437279|NCT01556672|adalimumab|adalimumab
5437280|NCT01556672|capsule endoscopy|capsule endoscopy
5437281|NCT01556659|Left ventricular thrombus|left ventricular thrombus
5437282|NCT01556659|Acute myocardial infarction|acute myocardial infarction
5437283|NCT01556659|Anticoagulation|anticoagulation
5437284|NCT01556646|Cirrhosis|cirrhosis
5437285|NCT01556646|Hepatic Encephalopathy|hepatic encephalopathy
5437286|NCT01556646|Hyponatremia|hyponatremia
5437287|NCT01556646|Brain MRI|brain mri
5437288|NCT01556646|Health-related quality of life|health-related quality of life
5437289|NCT01556646|cognitive function|cognitive function
5437290|NCT01556620|PtiO2|ptio2
5437291|NCT01556620|NIRS|nirs
5437292|NCT01556607|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5437293|NCT01556607|RSV|rsv
5437294|NCT01556594|Hypoglycemia|hypoglycemia
5437295|NCT01556594|Diabetes mellitus|diabetes mellitus
5437296|NCT01556581|back pain|back pain
5437297|NCT01556581|primary care|primary care
5437298|NCT01556581|physical therapy|physical therapy
5437299|NCT01556568|Noonan Syndrome, hypertrophic cardiomyopathy.|noonan syndrome, hypertrophic cardiomyopathy.
5437300|NCT01556555|Sclerosing cholangitis|sclerosing cholangitis
5437301|NCT01556555|Spyglass|spyglass
5437302|NCT01556555|Endoscopic retrograde cholangiopancreaticography|endoscopic retrograde cholangiopancreaticography
5419986|NCT01631188|Catheter|catheter
5437303|NCT01556542|peripheral arterial disease|peripheral arterial disease
5437304|NCT01556542|drug-eluting balloon|drug-eluting balloon
5437305|NCT01556542|restenosis|restenosis
5437306|NCT01556477|MDS|mds
5437307|NCT01556477|AML|aml
5437308|NCT01556477|Azacitidine|azacitidine
5437309|NCT01556477|Lenalidomide|lenalidomide
5437310|NCT01556477|del5q|del5q
5437311|NCT01556464|Obstructive sleep apnea|obstructive sleep apnea
5437312|NCT01556464|CPAP|cpap
5437313|NCT01556425|opioid use disorder|opioid use disorder
5437314|NCT01556425|treatment|treatment
5437315|NCT01556425|heroin|heroin
5437316|NCT01556425|extended-release naltrexone|extended-release naltrexone
5437317|NCT01556425|incentives|incentives
5437318|NCT01556425|cotningency management|cotningency management
5437319|NCT01556425|employment-based reinforcement|employment-based reinforcement
5437320|NCT01556425|therapeutic workplace|therapeutic workplace
5437321|NCT01556412|endoscopic ultrasound|endoscopic ultrasound
5437322|NCT01556412|primary sclerosing cholangitis|primary sclerosing cholangitis
5437323|NCT01556412|EUS|eus
5437325|NCT01556399|Duodenal adenoma|duodenal adenoma
5437326|NCT01556399|Ampullary adenoma|ampullary adenoma
5437455|NCT01555892|Hodgkin's Lymphoma|hodgkin's lymphoma
5437327|NCT01556386|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5437328|NCT01556386|single nucleotide polymorphism|single nucleotide polymorphism
5437329|NCT01556373|acute systemic inflammation|acute systemic inflammation
5437330|NCT01556373|arterial stiffness|arterial stiffness
5437331|NCT01556373|Carotid-femoral pulse wave velocity|carotid-femoral pulse wave velocity
5437332|NCT01556360|genetic hemochromatosis|genetic hemochromatosis
5437333|NCT01556360|Iron overload|iron overload
5437334|NCT01556360|C282 homozygosity|c282 homozygosity
5437335|NCT01556347|alloantibody|alloantibody
5437336|NCT01556347|immunologic|immunologic
5437338|NCT01556347|heart|heart
5437339|NCT01556347|transplant|transplant
5437340|NCT01556347|desensitization|desensitization
5437341|NCT01556334|premature ruptured membranes|premature ruptured membranes
5437342|NCT01556334|azithromycin|azithromycin
5437343|NCT01556334|erythromycin|erythromycin
5437344|NCT01556334|latency|latency
5437345|NCT01556334|antibiotics|antibiotics
5437346|NCT01556321|Obesity|obesity
5437347|NCT01556321|Body weight|body weight
5437348|NCT01556321|Gut flora|gut flora
5437349|NCT01556321|Fat absorption|fat absorption
5437350|NCT01556308|Dowling Meara|dowling meara
5437351|NCT01556308|Epidermolysis bullosa|epidermolysis bullosa
5437352|NCT01556308|inflammation|inflammation
5437353|NCT01556295|Nurses|nurses
5437354|NCT01556295|Low back pain|low back pain
5437355|NCT01556295|Gesture behavior|gesture behavior
5437356|NCT01556295|Knowlegde|knowlegde
5437357|NCT01556282|Hepatocellular Carcinoma|hepatocellular carcinoma
5437358|NCT01556282|portal vein thrombosis|portal vein thrombosis
5437359|NCT01556282|HCC|hcc
5437360|NCT01556243|stage IA breast cancer|stage ia breast cancer
5545050|NCT01106794|BSG|bsg
5437361|NCT01556243|stage IB breast cancer|stage ib breast cancer
5437362|NCT01556243|stage II breast cancer|stage ii breast cancer
5437363|NCT01556243|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5437364|NCT01556243|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5437365|NCT01556230|pituitary gland|pituitary gland
5437366|NCT01556230|pituitary adenoma|pituitary adenoma
5437367|NCT01556230|pituitary tumor|pituitary tumor
5437368|NCT01556230|hypophysis|hypophysis
5437369|NCT01556230|endocrine|endocrine
5437370|NCT01556230|neuroendocrine|neuroendocrine
5437371|NCT01556230|hormone|hormone
5437372|NCT01556217|Healthy volunteers|healthy volunteers
5437373|NCT01556217|JNJ-39393406-aaa|jnj-39393406-aaa
5437374|NCT01556217|Pharmacokinetics|pharmacokinetics
5437375|NCT01556217|Central brain penetrance|central brain penetrance
5437376|NCT01556217|Cerebral spinal fluid|cerebral spinal fluid
5437377|NCT01556204|Endometriosis|endometriosis
5437378|NCT01556191|lung cancer|lung cancer
5437379|NCT01556191|women|women
5437380|NCT01556178|Hydrocephalus|hydrocephalus
5437381|NCT01556178|Survivin|survivin
5437382|NCT01556178|miRNA|mirna
5437383|NCT01556165|Rasagiline|rasagiline
5437384|NCT01556165|Azilect|azilect
5437385|NCT01556165|Parkinson´s Disease|parkinson´s disease
5437386|NCT01556165|Motor fluctuations|motor fluctuations
5437387|NCT01556139|Endurance|endurance
5437388|NCT01556139|exercise training|exercise training
5437389|NCT01556139|6-min walking test|6-min walking test
5437390|NCT01556126|Coronary artery disease|coronary artery disease
5437391|NCT01556126|Drug Eluting Stent|drug eluting stent
5437392|NCT01556126|All comers patients|all comers patients
5437393|NCT01556113|fatty liver|fatty liver
5437394|NCT01556113|hypertriglyceridemia|hypertriglyceridemia
5437395|NCT01556113|elevated liver enzymes|elevated liver enzymes
5437396|NCT01556100|18F-DTBZ AV-133 imaging|18f-dtbz av-133 imaging
5437397|NCT01556087|opioids|opioids
5437398|NCT01556087|distress tolerance|distress tolerance
5437399|NCT01556087|buprenorphine|buprenorphine
5437400|NCT01556074|Post traumatic stress disorder|post traumatic stress disorder
5437401|NCT01556074|PTSD|ptsd
5437402|NCT01556074|Insomnia|insomnia
5437403|NCT01556074|Sleep|sleep
5437404|NCT01556074|Yoga|yoga
5437405|NCT01556074|Meditation|meditation
5437406|NCT01556074|Mental Health|mental health
5437407|NCT01556074|Sleep Quality|sleep quality
5437408|NCT01556074|Actigraphy|actigraphy
5437409|NCT01556074|Sleep Diaries|sleep diaries
5437410|NCT01556074|Autonomic|autonomic
5437411|NCT01556074|Social Health|social health
5437412|NCT01556074|Interoception|interoception
5437413|NCT01556074|Attention Regulation|attention regulation
5437414|NCT01556074|Emotion Regulation|emotion regulation
5437415|NCT01556061|Laryngoscopy|laryngoscopy
5437416|NCT01556061|Airway Management|airway management
5437417|NCT01556061|Intubation|intubation
5437418|NCT01556048|Behavior therapy|behavior therapy
5437419|NCT01556048|Bereavement|bereavement
5437420|NCT01556048|Complicated grief|complicated grief
5437421|NCT01556048|Depression|depression
5437422|NCT01556048|Posttraumatic Stress Disorder|posttraumatic stress disorder
5437423|NCT01556035|oncodermatology|oncodermatology
5437425|NCT01556035|cutaneous B cell lymphoma|cutaneous b cell lymphoma
5437431|NCT01556022|Adult stem cells|adult stem cells
5437432|NCT01556022|Adipose derived regenerative cells|adipose derived regenerative cells
5437433|NCT01556009|Basal Cell Carcinoma|basal cell carcinoma
5437434|NCT01556009|Photodynamic Therapy|photodynamic therapy
5437435|NCT01555996|older|older
5437436|NCT01555996|delirium|delirium
5437437|NCT01555996|cognitive status|cognitive status
5437438|NCT01555996|occupational therapy|occupational therapy
5437439|NCT01555996|critically ill patients|critically ill patients
5437440|NCT01555983|cannabis|cannabis
5437441|NCT01555983|central neuropathic pain|central neuropathic pain
5437442|NCT01555983|analgesia|analgesia
5437443|NCT01555970|Obsessive-compulsive disorder|obsessive-compulsive disorder
5437444|NCT01555970|Treatment|treatment
5437445|NCT01555970|Glutamate|glutamate
5437446|NCT01555970|N-Acetylcysteine|n-acetylcysteine
5437447|NCT01555918|Pharmacokinetics|pharmacokinetics
5437448|NCT01555918|Healthy volunteers|healthy volunteers
5437449|NCT01555918|Isavuconazole|isavuconazole
5437450|NCT01555918|BAL4815|bal4815
5437451|NCT01555918|BAL8728|bal8728
5437452|NCT01555918|BAL8557|bal8557
5437453|NCT01555905|Respiratory Muscle Strength|respiratory muscle strength
5437454|NCT01555892|EBV|ebv
5437456|NCT01555892|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5437457|NCT01555892|Lymphoma Relapse|lymphoma relapse
5437458|NCT01555892|Autologous or Syngeneic Stem Cell Transplant|autologous or syngeneic stem cell transplant
5437459|NCT01555892|T/NK-lymphoproliferative disease|t/nk-lymphoproliferative disease
5437461|NCT01555892|BARF1|barf1
5437462|NCT01555892|EBNA1|ebna1
5437463|NCT01555879|Retrospective|retrospective
5437464|NCT01555879|Database|database
5437465|NCT01555879|Data warehouse|data warehouse
5437466|NCT01555879|Data mining|data mining
5437467|NCT01555879|Collaborative effectiveness|collaborative effectiveness
5437468|NCT01555879|Comparative effectiveness|comparative effectiveness
5437469|NCT01555879|Outcome based medicine|outcome based medicine
5437470|NCT01555879|Evidence based medicine|evidence based medicine
5437471|NCT01555866|isavuconazole|isavuconazole
5437472|NCT01555866|BAL4815|bal4815
5437473|NCT01555866|BAL8557|bal8557
5437474|NCT01555866|BAL8728|bal8728
5437475|NCT01555840|Magnetically guided capsule endoscopy (MGCE)|magnetically guided capsule endoscopy (mgce)
5437476|NCT01555840|Gastroscopy|gastroscopy
5437477|NCT01555827|Retina|retina
5437478|NCT01555827|ALzheimer's disease|alzheimer's disease
5437479|NCT01555827|neurodegenerative signs|neurodegenerative signs
5437480|NCT01555814|dopamine|dopamine
5437481|NCT01555814|first episode|first episode
5437482|NCT01555814|reward|reward
5437483|NCT01555814|cognition|cognition
5437484|NCT01555814|MRI|mri
5437485|NCT01555814|fMRI|fmri
5437486|NCT01555814|PPI|ppi
5437487|NCT01555814|P300|p300
5437488|NCT01555814|P50 gating|p50 gating
5437489|NCT01555814|endophenotypes|endophenotypes
5437490|NCT01555801|esophageal cancer|esophageal cancer
5437491|NCT01555801|early cancer|early cancer
5437492|NCT01555801|ultrasonography (EUS)|ultrasonography (eus)
5437493|NCT01555801|stage|stage
5437494|NCT01555788|type 1 diabetes,|type 1 diabetes,
5437495|NCT01555788|diaport,|diaport,
5437496|NCT01555788|artificial pancreas,|artificial pancreas,
5437497|NCT01555788|zone mpc algorithm,|zone mpc algorithm,
5437498|NCT01555788|ap system,|ap system,
5437499|NCT01555788|intraperitoneal insulin|intraperitoneal insulin
5437500|NCT01555775|exercise-induced muscle damage|exercise-induced muscle damage
5437501|NCT01555775|nutritional recovery|nutritional recovery
5437502|NCT01555775|nutritional supplement|nutritional supplement
5437503|NCT01555775|natural food|natural food
5437504|NCT01555736|allergic rhinitis|allergic rhinitis
5437505|NCT01555736|perennial immunotherapy|perennial immunotherapy
5437506|NCT01555736|preseasonal immunotherapy|preseasonal immunotherapy
5437507|NCT01555697|Schizophrenia|schizophrenia
5437508|NCT01555697|prepulse inhibition|prepulse inhibition
5437509|NCT01555697|neurocognition|neurocognition
5437510|NCT01555697|working memory|working memory
5437511|NCT01555697|memantine|memantine
5437512|NCT01555697|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
5437513|NCT01555684|MS|ms
5437514|NCT01555684|CCSVI|ccsvi
5437515|NCT01555671|labor,|labor,
5437516|NCT01555671|meperidine,|meperidine,
5437517|NCT01555671|active phase,|active phase,
5437518|NCT01555671|duration of labor|duration of labor
5437519|NCT01555658|Long Lesions|long lesions
5437520|NCT01555658|Stent Implantation|stent implantation
5437521|NCT01555645|Breast cancer|breast cancer
5437522|NCT01555645|Stress management|stress management
5437523|NCT01555645|Stepped care|stepped care
5437526|NCT01555619|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5437528|NCT01555619|Quadripolar pacing|quadripolar pacing
5437529|NCT01555606|Psoriasis|psoriasis
5437530|NCT01555606|Patient-reported outcome|patient-reported outcome
5437531|NCT01555606|Quality of Life|quality of life
5437532|NCT01555593|COPD|copd
5437533|NCT01555593|FeNO|feno
5437534|NCT01555593|Bronchial inflammation|bronchial inflammation
5437535|NCT01555593|Small airways|small airways
5437536|NCT01555593|Decubitus|decubitus
5437537|NCT01555580|myasthenia gravis|myasthenia gravis
5437538|NCT01555580|autoimmune|autoimmune
5437539|NCT01555580|GM-CSF|gm-csf
5437540|NCT01555567|ACL|acl
5437541|NCT01555567|muscle|muscle
5437542|NCT01555567|quadriceps|quadriceps
5437543|NCT01555567|strength|strength
5437548|NCT01555541|relapsed|relapsed
5437549|NCT01555541|refractory|refractory
5437551|NCT01555541|lymphoma|lymphoma
5437553|NCT01555541|diffuse|diffuse
5437554|NCT01555528|Growth disorders|growth disorders
5437555|NCT01555528|Saizen|saizen
5437556|NCT01555528|Easypod|easypod
5437557|NCT01555528|Growth hormone|growth hormone
5437558|NCT01555528|Pediatric subject|pediatric subject
5437559|NCT01555489|Pancreatic Neoplasms|pancreatic neoplasms
5437560|NCT01555489|Pancreatic Cancer cells|pancreatic cancer cells
5437561|NCT01555489|Digestive System Neoplasms|digestive system neoplasms
5437562|NCT01555489|Neoplasms by Site|neoplasms by site
5437563|NCT01555489|Neoplasms|neoplasms
5437564|NCT01555489|Endocrine Gland Neoplasms|endocrine gland neoplasms
5437565|NCT01555489|Digestive System Diseases|digestive system diseases
5437566|NCT01555489|Pancreatic Diseases|pancreatic diseases
5437567|NCT01555489|Endocrine System Diseases|endocrine system diseases
5437568|NCT01555489|Ascorbic Acid|ascorbic acid
5437569|NCT01555489|Gemcitabine Vitamins|gemcitabine vitamins
5437570|NCT01555489|Vitamin C|vitamin c
5437571|NCT01555489|Antioxidants|antioxidants
5437572|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5437573|NCT01555489|Pharmacologic Actions|pharmacologic actions
5437574|NCT01555489|Protective Agents|protective agents
5437575|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs
5437576|NCT01555489|Micronutrients|micronutrients
5437577|NCT01555489|Growth Substances|growth substances
5437578|NCT01555489|Erlotinib|erlotinib
5437579|NCT01555489|Integrative Medicine|integrative medicine
5437580|NCT01555489|Alternative Medicine|alternative medicine
5437581|NCT01555489|Complementary Medicine|complementary medicine
5437582|NCT01555476|Pharmacokinetics|pharmacokinetics
5437583|NCT01555463|Rosacea|rosacea
5437584|NCT01555450|Colorectal cancer screening|colorectal cancer screening
5437585|NCT01555450|Social inequalities|social inequalities
5437586|NCT01555450|Patient Navigator|patient navigator
5437587|NCT01555437|capsule endoscopy scoring index|capsule endoscopy scoring index
5437588|NCT01555437|Harvey-Bradshaw index|harvey-bradshaw index
5437589|NCT01555437|C-reactive protein|c-reactive protein
5437590|NCT01555437|serum albumin|serum albumin
5437591|NCT01555437|hemoglobin|hemoglobin
5437592|NCT01555424|25-hydroxyvitamin D|25-hydroxyvitamin d
5437593|NCT01555424|Institutionalized seniors|institutionalized seniors
5437594|NCT01555424|SF-36 survey|sf-36 survey
5437595|NCT01555424|Winter|winter
5437596|NCT01555411|Cardiovascular epidemiology|cardiovascular epidemiology
5437597|NCT01555411|Prospective, observational cohort study|prospective, observational cohort study
5437598|NCT01555411|Biomarkers|biomarkers
5437599|NCT01555411|Cardio- and cerebrovascular imaging|cardio- and cerebrovascular imaging
5437600|NCT01555398|Fenofibric acid|fenofibric acid
5437601|NCT01555398|HIP0901|hip0901
5437602|NCT01555398|food effect|food effect
5437603|NCT01555385|Mental workload|mental workload
5437604|NCT01555385|Multitasking|multitasking
5437605|NCT01555385|Protein|protein
5437606|NCT01555385|Tryptophan|tryptophan
5437607|NCT01555372|unstable distal clavicular fractures (Neer 2b)|unstable distal clavicular fractures (neer 2b)
5437608|NCT01555372|Study Protocol|study protocol
5437609|NCT01555372|Fracture Fixation|fracture fixation
5437610|NCT01555346|Down syndrome|down syndrome
5437611|NCT01555346|fetal aneuploidy|fetal aneuploidy
5437612|NCT01555346|trisomy|trisomy
5437613|NCT01555346|noninvasive prenatal test|noninvasive prenatal test
5437614|NCT01555307|total hip arthroplasty|total hip arthroplasty
5437615|NCT01555307|total knee arthroplasty|total knee arthroplasty
5437616|NCT01555307|balance exercises|balance exercises
5437617|NCT01555307|force plate|force plate
5437618|NCT01555307|berg balance scale|berg balance scale
5437619|NCT01555307|timed up and go test|timed up and go test
5437620|NCT01555294|(subclinical)atherosclerosis|(subclinical)atherosclerosis
5437621|NCT01555294|non-invasive measurements|non-invasive measurements
5437622|NCT01555294|intima-media thickness|intima-media thickness
5437623|NCT01555294|flow-mediated dilation|flow-mediated dilation
5437624|NCT01555294|pulse wave velocity and analysis|pulse wave velocity and analysis
5437625|NCT01555294|fatal and non-fatal cardiovascular events|fatal and non-fatal cardiovascular events
5437626|NCT01555294|ankle-brachial index (at rest and after exercise)|ankle-brachial index (at rest and after exercise)
5437627|NCT01555294|general population|general population
5437628|NCT01555294|Familial Combined Hyperlipidemia|familial combined hyperlipidemia
5437629|NCT01555281|Multiple Myeloma|multiple myeloma
5437630|NCT01555281|Kahler Disease|kahler disease
5437631|NCT01555281|Lenalidomide|lenalidomide
5437632|NCT01555281|Revlimid|revlimid
5437633|NCT01555281|Nelfinavir|nelfinavir
5437634|NCT01555281|Viracept|viracept
5437637|NCT01555255|pregnancy|pregnancy
5437638|NCT01555255|placental malaria|placental malaria
5437639|NCT01555255|malaria in pregnancy|malaria in pregnancy
5437640|NCT01555255|birth weight|birth weight
5437641|NCT01555255|anemia|anemia
5437642|NCT01555242|Advanced Cancer|advanced cancer
5437643|NCT01555242|Lymphoma|lymphoma
5437644|NCT01555242|Refractory|refractory
5437645|NCT01555229|Secretion drainage|secretion drainage
5437646|NCT01555229|Ventilator-associated pneumonia|ventilator-associated pneumonia
5437647|NCT01555229|Tracheal fibroscopy|tracheal fibroscopy
5437648|NCT01555216|Forefoot surgery|forefoot surgery
5437649|NCT01555190|myo-inositol|myo-inositol
5437650|NCT01555190|folic acid|folic acid
5437651|NCT01555177|Peri-operative myocardial infarction|peri-operative myocardial infarction
5437652|NCT01555177|Non-ST elevation myocardial infarction|non-st elevation myocardial infarction
5437653|NCT01555177|Optical coherence tomography|optical coherence tomography
5437654|NCT01555151|Asthma|asthma
5437655|NCT01555138|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5437656|NCT01555138|Indacaterol|indacaterol
5437657|NCT01555138|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5437658|NCT01555125|Psoriasis|psoriasis
5437659|NCT01555099|COPD, FEV1, AZD5423|copd, fev1, azd5423
5437660|NCT01555086|Lymphadenectomy|lymphadenectomy
5437661|NCT01555086|Prostate cancer|prostate cancer
5437662|NCT01555060|hemoglobin recovery|hemoglobin recovery
5437663|NCT01555060|iron recovery|iron recovery
5437664|NCT01555060|iron supplements|iron supplements
5437665|NCT01555034|obesity|obesity
5437666|NCT01555034|movement therapy|movement therapy
5437667|NCT01555034|exercise|exercise
5437668|NCT01555034|behaviour|behaviour
5437669|NCT01554995|LCB01-0371|lcb01-0371
5437670|NCT01554982|Participation Limited|participation limited
5437671|NCT01554982|Long Term|long term
5437672|NCT01554982|Safety Extension|safety extension
5437673|NCT01554956|Plasminogen Deficiency|plasminogen deficiency
5437674|NCT01554956|Ligneous Conjunctivitis|ligneous conjunctivitis
5437675|NCT01554956|Plasminogen|plasminogen
5437676|NCT01554956|Ligneous Conjunctivitis in Plasminogen Deficient Patients|ligneous conjunctivitis in plasminogen deficient patients
5437679|NCT01554943|EC|ec
5437680|NCT01554943|node positive|node positive
5437681|NCT01554943|breast cancer|breast cancer
5437682|NCT01554930|HFMD|hfmd
5437683|NCT01554930|Traditional Chinese Medicine|traditional chinese medicine
5437684|NCT01554930|Xiyanping|xiyanping
5437685|NCT01554917|Rheumatoid Arthritis|rheumatoid arthritis
5437686|NCT01554917|Iguratimod|iguratimod
5437687|NCT01554904|Sleep Study|sleep study
5437688|NCT01554904|Snoring|snoring
5437689|NCT01554904|Sleep Apnea|sleep apnea
5437690|NCT01554904|Muscle Laxity|muscle laxity
5437691|NCT01554904|Oral Appliance|oral appliance
5437692|NCT01554904|Facial Muscles|facial muscles
5437693|NCT01554904|Neck Muscles|neck muscles
5437694|NCT01554904|Upper Airway|upper airway
5437695|NCT01554904|Muscle Strength|muscle strength
5437696|NCT01554904|Dynamic Resistance|dynamic resistance
5437697|NCT01554904|Oral Exercise|oral exercise
5437698|NCT01554904|Facial Toning|facial toning
5437699|NCT01554904|Facial Muscle Strength|facial muscle strength
5437700|NCT01554904|Strap Muscles of the Neck|strap muscles of the neck
5437701|NCT01554904|Apnea-Hypopnea|apnea-hypopnea
5437702|NCT01554891|brain injuries, traumatic|brain injuries, traumatic
5437703|NCT01554891|military personnel|military personnel
5437704|NCT01554891|classification|classification
5437705|NCT01554891|diagnosis|diagnosis
5437706|NCT01554891|instrumentation|instrumentation
5437707|NCT01554878|osteochondral defect of the knee|osteochondral defect of the knee
5437708|NCT01554865|obesity|obesity
5437709|NCT01554865|men|men
5437710|NCT01554865|sexual function|sexual function
5437711|NCT01554865|urinary tract symptoms|urinary tract symptoms
5437712|NCT01554865|endothelial function|endothelial function
5437713|NCT01554865|inflammation|inflammation
5437714|NCT01554865|quality of life|quality of life
5437715|NCT01554852|myeloma|myeloma
5437716|NCT01554852|lenalidomide|lenalidomide
5437717|NCT01554852|Revlimid|revlimid
5437718|NCT01554852|cyclophosphamide|cyclophosphamide
5437719|NCT01554852|dexamethasone|dexamethasone
5437720|NCT01554852|bortezomib|bortezomib
5437721|NCT01554852|Velcade|velcade
5437723|NCT01554852|Zolinza|zolinza
5437724|NCT01554852|stem cell|stem cell
5437725|NCT01554852|carfilzomib|carfilzomib
5437726|NCT01554852|Kyprolis|kyprolis
5437727|NCT01554826|Pediatric influenza vaccine|pediatric influenza vaccine
5437731|NCT01554800|rhLCAT|rhlcat
5437732|NCT01554800|Enzyme replacement therapy|enzyme replacement therapy
5437733|NCT01554800|High-Density Lipoprotein (HDL)|high-density lipoprotein (hdl)
5437734|NCT01554800|Cholesterol|cholesterol
5437735|NCT01554800|Cholesterol ester|cholesterol ester
5437736|NCT01554800|LCAT Deficiency|lcat deficiency
5437737|NCT01554787|After stroke with fatigue|after stroke with fatigue
5437738|NCT01554774|COPD|copd
5437740|NCT01554761|astigmatism|astigmatism
5437741|NCT01554761|pseudophakia|pseudophakia
5437742|NCT01554748|total joint arthroplasty|total joint arthroplasty
5437744|NCT01554748|trapeziometacarpal joint|trapeziometacarpal joint
5437745|NCT01554748|osteoarthritis|osteoarthritis
5437746|NCT01554735|obesity|obesity
5437747|NCT01554735|men|men
5437748|NCT01554735|sexual function|sexual function
5437749|NCT01554735|urinary tract symptoms|urinary tract symptoms
5437750|NCT01554735|endothelial function|endothelial function
5437751|NCT01554735|inflammation|inflammation
5437752|NCT01554735|quality of life|quality of life
5437753|NCT01554722|Ultrasound guidance|ultrasound guidance
5437754|NCT01554722|Femoral nerve block|femoral nerve block
5437755|NCT01554722|Needle placement|needle placement
5437756|NCT01554722|Intraneural needle insertion|intraneural needle insertion
5437757|NCT01554709|bypass|bypass
5437758|NCT01554709|cannula|cannula
5437759|NCT01554696|ASP015K|asp015k
5437760|NCT01554696|Rheumatoid Arthritis|rheumatoid arthritis
5437761|NCT01554683|Alzheimer's Disease|alzheimer's disease
5437762|NCT01554683|Seizures|seizures
5437763|NCT01554683|Memory|memory
5437764|NCT01554683|Executive|executive
5437765|NCT01554670|Arthroscopic subacromial decompression|arthroscopic subacromial decompression
5437766|NCT01554670|Bipolar radiofrequency|bipolar radiofrequency
5437767|NCT01554670|Tendon debridement|tendon debridement
5437768|NCT01554670|Shoulder surgery|shoulder surgery
5437769|NCT01554657|Pneumonia, Bacterial|pneumonia, bacterial
5437770|NCT01554644|Cleansing|cleansing
5437771|NCT01554644|Chronic Leg Ulcers|chronic leg ulcers
5437772|NCT01554644|Diabetic Patients|diabetic patients
5437773|NCT01554631|Bioequivalence|bioequivalence
5437774|NCT01554631|Acarbose|acarbose
5437775|NCT01554631|ODT|odt
5437779|NCT01554592|Heart Failure|heart failure
5437780|NCT01554592|Statin withdrawal|statin withdrawal
5437781|NCT01554566|honey|honey
5437782|NCT01554566|diabetes|diabetes
5437783|NCT01554566|lipids|lipids
5437784|NCT01554566|c-peptide|c-peptide
5437785|NCT01554553|Sleeve gastrectomy|sleeve gastrectomy
5437786|NCT01554553|Posterior crural repair|posterior crural repair
5437787|NCT01554540|Treprostinil|treprostinil
5437788|NCT01554540|Scleroderma|scleroderma
5437789|NCT01554540|Iontophoresis|iontophoresis
5437790|NCT01554527|polysomnography|polysomnography
5437791|NCT01554527|child|child
5437792|NCT01554527|continuous positive airway pressure|continuous positive airway pressure
5437793|NCT01554527|tonsillectomy|tonsillectomy
5437794|NCT01554527|neuropsychological tests|neuropsychological tests
5437795|NCT01554527|cognition|cognition
5437796|NCT01554527|sleepiness|sleepiness
5437797|NCT01554527|behavior|behavior
5437798|NCT01554514|ADAMTS13|adamts13
5437799|NCT01554514|Rituximab|rituximab
5437800|NCT01554514|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5437801|NCT01554514|TTP|ttp
5437802|NCT01554514|Plasma exchange|plasma exchange
5437803|NCT01554501|stress|stress
5437804|NCT01554501|self-control|self-control
5437805|NCT01554501|emotion regulation|emotion regulation
5437806|NCT01554501|health|health
5437807|NCT01554488|asthma|asthma
5437808|NCT01554488|COPD|copd
5437809|NCT01554488|sleep apnea, obstructive|sleep apnea, obstructive
5437810|NCT01554475|herbal drugs|herbal drugs
5437811|NCT01554475|dietary supplements|dietary supplements
5437812|NCT01554475|drug interactions|drug interactions
5437813|NCT01554462|Attention|attention
5437814|NCT01554462|Cognitive control|cognitive control
5437815|NCT01554462|ADHD|adhd
5437816|NCT01554462|Healthy|healthy
5437817|NCT01554462|EPA|epa
5437818|NCT01554462|Eicosapentaenoic acid|eicosapentaenoic acid
5437819|NCT01554462|DHA|dha
5437820|NCT01554462|Docosahexaenoic acid|docosahexaenoic acid
5437821|NCT01554462|PUFA|pufa
5437822|NCT01554462|Omega-3|omega-3
5437823|NCT01554449|Stroke|stroke
5437824|NCT01554449|Upper arm|upper arm
5437825|NCT01554449|Rehabilitation|rehabilitation
5437826|NCT01554449|Motor function|motor function
5437827|NCT01554449|Video games|video games
5437828|NCT01554449|Virtual reality|virtual reality
5437829|NCT01554449|Occupational Therapy|occupational therapy
5437830|NCT01554449|Functional MRI|functional mri
5437831|NCT01554436|Smoking|smoking
5437832|NCT01554436|Neuropsychology|neuropsychology
5437833|NCT01554436|Abstinence|abstinence
5437835|NCT01554436|Nicotine Dependence, Cigarettes, with Other Nicotine-induced Disorders|nicotine dependence, cigarettes, with other nicotine-induced disorders
5437836|NCT01554423|HIV Prevention Intervention|hiv prevention intervention
5437838|NCT01554410|Carcinoma|carcinoma
5437839|NCT01554410|Gemcitabine|gemcitabine
5437840|NCT01554410|Gemzar|gemzar
5437841|NCT01554410|Cisplatin|cisplatin
5437843|NCT01554410|Radiation|radiation
5437844|NCT01554410|External Beam|external beam
5437845|NCT01554410|Brachytherapy|brachytherapy
5437846|NCT01554397|Cervical|cervical
5437847|NCT01554397|Carcinoma|carcinoma
5437848|NCT01554397|Cisplatin|cisplatin
5437849|NCT01554397|IMRT|imrt
5437850|NCT01554397|Radiation|radiation
5437851|NCT01554397|INTERTECC|intertecc
5437852|NCT01554397|International|international
5437853|NCT01554397|External Beam|external beam
5437854|NCT01554397|Brachytherapy|brachytherapy
5437856|NCT01554397|HDR|hdr
5437857|NCT01554397|IGRT|igrt
5437858|NCT01554397|CBCT|cbct
5437859|NCT01554384|Tuberculosis|tuberculosis
5437860|NCT01554384|diagnosis|diagnosis
5437861|NCT01554384|Xpert MTB/RIF|xpert mtb/rif
5437862|NCT01554384|point-of-treatment|point-of-treatment
5437863|NCT01554384|randomized controlled trial|randomized controlled trial
5437864|NCT01554371|Solid tumor|solid tumor
5437865|NCT01554371|Metastatic breast cancer|metastatic breast cancer
5437866|NCT01554371|Unresectable or metastatic carcinoma|unresectable or metastatic carcinoma
5437867|NCT01554371|Neuropathy|neuropathy
5437868|NCT01554371|Eribulin|eribulin
5437869|NCT01554371|Cyclophosphamide|cyclophosphamide
5437870|NCT01554358|Gestational diabetes mellitus|gestational diabetes mellitus
5437871|NCT01554358|Lifestyle intervention|lifestyle intervention
5437872|NCT01554332|Motor Cortex Stimulation|motor cortex stimulation
5437873|NCT01554332|Neuropathic pain|neuropathic pain
5437874|NCT01554319|Antisense oligonucleotide|antisense oligonucleotide
5437875|NCT01554319|Asthma|asthma
5437876|NCT01554319|Healthy subjects|healthy subjects
5437877|NCT01554319|Phase 1|phase 1
5437878|NCT01554319|Transcription factor GATA-3|transcription factor gata-3
5437879|NCT01554319|Oral inhalation|oral inhalation
5437880|NCT01554280|Stricture|stricture
5437881|NCT01554280|Dysphagia|dysphagia
5437882|NCT01554267|Mastectomy skin flap necrosis|mastectomy skin flap necrosis
5437883|NCT01554267|Breast reconstruction|breast reconstruction
5437884|NCT01554267|Indocyanine Green Dye|indocyanine green dye
5437885|NCT01554254|Cord blood transplant|cord blood transplant
5437886|NCT01554254|hematological malignancy|hematological malignancy
5437887|NCT01554254|inherited metabolic disease|inherited metabolic disease
5437888|NCT01554254|Mucositis|mucositis
5437889|NCT01554254|Neutrophil engraftment|neutrophil engraftment
5437890|NCT01554254|Platelet recovery|platelet recovery
5437891|NCT01554254|Immune reconstitution|immune reconstitution
5437892|NCT01554241|vitamin D3|vitamin d3
5437893|NCT01554241|D3|d3
5437894|NCT01554241|cholecalciferol|cholecalciferol
5437895|NCT01554241|25-OH vitamin D|25-oh vitamin d
5437896|NCT01554241|elderly|elderly
5437897|NCT01554241|nursing home resident|nursing home resident
5437898|NCT01554215|parenting|parenting
5437899|NCT01554215|child behavior|child behavior
5437900|NCT01554215|attachment|attachment
5437901|NCT01554202|Alzheimer's disease|alzheimer's disease
5437902|NCT01554202|MCI|mci
5437903|NCT01554202|genetic|genetic
5437904|NCT01554202|AV45-PET|av45-pet
5437905|NCT01554176|Current depressive episode|current depressive episode
5437906|NCT01554176|moderate to severe|moderate to severe
5437907|NCT01554163|Osteoarthritis|osteoarthritis
5437908|NCT01554163|Celecoxib|celecoxib
5437909|NCT01554163|Etoricoxib|etoricoxib
5437910|NCT01554150|Primary Health Care|primary health care
5437911|NCT01554150|Mental Health|mental health
5437912|NCT01554150|Cognitive Therapy|cognitive therapy
5437913|NCT01554124|Meningitis|meningitis
5437914|NCT01554124|Neonates|neonates
5437915|NCT01554124|Meropenem|meropenem
5437916|NCT01554111|Bowel Evacuants|bowel evacuants
5437917|NCT01554111|Purgatives|purgatives
5437918|NCT01554098|Polyp detection|polyp detection
5437919|NCT01554098|Supine|supine
5437920|NCT01554098|Colonoscope withdrawal|colonoscope withdrawal
5437921|NCT01554098|Patient position|patient position
5437922|NCT01554098|Dynamic position change|dynamic position change
5437923|NCT01554072|home-based|home-based
5437924|NCT01554072|pulmonary rehabilitation|pulmonary rehabilitation
5437925|NCT01554072|COPD|copd
5437926|NCT01554059|Rectal cancer|rectal cancer
5437927|NCT01554059|Adenocarcinoma|adenocarcinoma
5437928|NCT01554059|Bevacizumab|bevacizumab
5437929|NCT01554059|Chemoradiation|chemoradiation
5437930|NCT01554046|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5437931|NCT01554046|Methylphenidate- RITALIN IR (Immediate Release)|methylphenidate- ritalin ir (immediate release)
5437932|NCT01554033|European Huntington's Disease Network|european huntington's disease network
5437933|NCT01554033|Huntington patients in KOREA|huntington patients in korea
5437934|NCT01554020|Blood glucose|blood glucose
5437935|NCT01554020|Insulin sensitivity|insulin sensitivity
5437936|NCT01554020|Oral glucose tolerance|oral glucose tolerance
5437937|NCT01554007|Crohn's disease|crohn's disease
5437938|NCT01553981|Interstitial lung disease|interstitial lung disease
5437939|NCT01553981|Scleroderma|scleroderma
5437940|NCT01553955|PRP,|prp,
5437941|NCT01553955|Platelet|platelet
5437942|NCT01553955|Manual|manual
5437943|NCT01553942|NSCLC|nsclc
5437944|NCT01553929|MCI|mci
5437946|NCT01553903|Breast Cancer|breast cancer
5437947|NCT01553903|AEBS|aebs
5437948|NCT01553903|Oxysterols|oxysterols
5437949|NCT01553890|SSc= scleroderma|ssc= scleroderma
5437950|NCT01553890|ICF+ informed consent form|icf+ informed consent form
5437951|NCT01553890|age 18 to 85|age 18 to 85
5437952|NCT01553890|healthy|healthy
5437953|NCT01553838|prostate biopsy|prostate biopsy
5437954|NCT01553838|MRI guided biopsy|mri guided biopsy
5437955|NCT01553838|TRUS guided biopsy|trus guided biopsy
5437956|NCT01553812|forced oscillation technique|forced oscillation technique
5437957|NCT01553812|COPD|copd
5437958|NCT01553812|elderly|elderly
5437959|NCT01553812|airway resistance|airway resistance
5437961|NCT01553786|T-cell lymphoma|t-cell lymphoma
5437962|NCT01553786|CHOp|chop
5437963|NCT01553786|lenalidomide|lenalidomide
5437964|NCT01553773|Hyaluroic acid|hyaluroic acid
5437965|NCT01553773|Estradiol|estradiol
5437966|NCT01553773|Isoflavone|isoflavone
5437967|NCT01553773|Skin|skin
5437968|NCT01553773|Postmenopause|postmenopause
5437969|NCT01553760|Cataract|cataract
5437970|NCT01553760|TRI-MICS|tri-mics
5437972|NCT01553760|MICS|mics
5437973|NCT01553760|phacoemulsification|phacoemulsification
5437974|NCT01553747|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5437975|NCT01553747|Irritable bowel syndrome|irritable bowel syndrome
5437976|NCT01553747|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5437977|NCT01553747|Colonic diseases|colonic diseases
5437978|NCT01553747|Colonic diseases, functional|colonic diseases, functional
5437979|NCT01553747|Digestive system disease|digestive system disease
5437980|NCT01553747|Gastrointestinal disease|gastrointestinal disease
5437981|NCT01553747|Intestinal disease|intestinal disease
5437982|NCT01553747|Colonic pseudo-obstruction|colonic pseudo-obstruction
5437983|NCT01553747|Diarrhea|diarrhea
5437984|NCT01553747|Signs and symptoms, Digestive|signs and symptoms, digestive
5437985|NCT01553734|QT prolongation|qt prolongation
5437986|NCT01553734|Azithromycin|azithromycin
5437987|NCT01553734|macrolide|macrolide
5437988|NCT01553734|pneumonia|pneumonia
5437989|NCT01553734|ECG changes|ecg changes
5437990|NCT01553708|Wound healing|wound healing
5437991|NCT01553708|Epithelialization|epithelialization
5437992|NCT01553708|Safety|safety
5437993|NCT01553695|Touble|touble
5437994|NCT01553695|deficit|deficit
5437995|NCT01553695|attention|attention
5437996|NCT01553695|hyperactivity|hyperactivity
5437997|NCT01553695|Touble deficit attention with hyperactivity|touble deficit attention with hyperactivity
5437998|NCT01553682|HIV|hiv
5438000|NCT01553682|African American Females|african american females
5438001|NCT01553682|Alcohol|alcohol
5438002|NCT01553656|Advanced cancer|advanced cancer
5438003|NCT01553656|Metastatic|metastatic
5438004|NCT01553656|NSCLC|nsclc
5438005|NCT01553643|Huang-Chi-Wu-Wu-Tang|huang-chi-wu-wu-tang
5438006|NCT01553643|Intracranial arterial prominent stenosis|intracranial arterial prominent stenosis
5438007|NCT01553630|Fractures|fractures
5438008|NCT01553630|distal femur fractures|distal femur fractures
5438009|NCT01553630|distal tibial fracures|distal tibial fracures
5438010|NCT01553604|breast prosthesis implantation|breast prosthesis implantation
5438011|NCT01553604|bandages|bandages
5438012|NCT01553604|skin colonization|skin colonization
5438013|NCT01553604|surgical site infection|surgical site infection
5438014|NCT01553604|augmentation mammaplasty|augmentation mammaplasty
5438015|NCT01553604|dressing wear time|dressing wear time
5438016|NCT01553565|10 mm in diameter|10 mm in diameter
5438017|NCT01553565|antithrombotic agents|antithrombotic agents
5438018|NCT01553552|Schistosoma haematobium|schistosoma haematobium
5438019|NCT01553552|schistosoma mansoni|schistosoma mansoni
5438020|NCT01553552|Anemia|anemia
5438021|NCT01553552|Underweight|underweight
5438022|NCT01553552|stunting|stunting
5438023|NCT01553552|Blastocystis|blastocystis
5438024|NCT01553526|International|international
5438025|NCT01553526|Multicenter|multicenter
5438026|NCT01553526|Observational registry|observational registry
5438027|NCT01553526|All-comers open label registry|all-comers open label registry
5438028|NCT01553526|Orsiro Drug Eluting Stent (DES)|orsiro drug eluting stent (des)
5438029|NCT01553526|Stenting|stenting
5438030|NCT01553526|Treatment of Coronary Artery Disease|treatment of coronary artery disease
5438031|NCT01553526|Coronary revascularization|coronary revascularization
5438032|NCT01553526|Percutaneous Coronary Intervention|percutaneous coronary intervention
5438033|NCT01553526|STEMI|stemi
5438034|NCT01553526|NSTEMI|nstemi
5438035|NCT01553526|Ischemia|ischemia
5438036|NCT01553526|Angina|angina
5438037|NCT01553526|Subgroups|subgroups
5438038|NCT01553526|Acute Myocardial Infarction|acute myocardial infarction
5438050|NCT01553487|vibration|vibration
5438051|NCT01553487|muscle strength|muscle strength
5438052|NCT01553487|bone loss|bone loss
5438053|NCT01553487|immobilization|immobilization
5438054|NCT01553487|fracture|fracture
5438055|NCT01553474|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5438056|NCT01553474|Eye Diseases|eye diseases
5438061|NCT01553448|disseminated neuroblastoma|disseminated neuroblastoma
5438062|NCT01553448|hereditary neuroblastoma|hereditary neuroblastoma
5438063|NCT01553448|localized resectable neuroblastoma|localized resectable neuroblastoma
5438064|NCT01553448|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5438065|NCT01553448|stage 4S neuroblastoma|stage 4s neuroblastoma
5438066|NCT01553435|Dextromethorphan|dextromethorphan
5438068|NCT01553435|Fentanyl|fentanyl
5438069|NCT01553435|Opioid|opioid
5438071|NCT01553435|Efficacy|efficacy
5438072|NCT01553422|Intrabdominal Pressure|intrabdominal pressure
5438073|NCT01553422|Emergency Bedside Ultrasonography|emergency bedside ultrasonography
5438074|NCT01553422|Abdominal Compartment Syndrome|abdominal compartment syndrome
5438075|NCT01553409|Hypertension|hypertension
5438076|NCT01553409|Ferritin|ferritin
5438077|NCT01553409|Phlebotomy|phlebotomy
5438078|NCT01553409|Blood donation|blood donation
5438079|NCT01553383|OSA|osa
5438080|NCT01553357|Plasma cell leukemia|plasma cell leukemia
5438081|NCT01553357|Lenalidomide|lenalidomide
5438082|NCT01553357|Dexamethasone|dexamethasone
5438083|NCT01553357|Multiple myeloma|multiple myeloma
5438084|NCT01553357|Bortezomib|bortezomib
5438085|NCT01553357|Stem cell transplantation|stem cell transplantation
5438086|NCT01553344|sclerostin|sclerostin
5438087|NCT01553344|osteomalacia|osteomalacia
5438088|NCT01553344|vitamin D deficiency|vitamin d deficiency
5438089|NCT01553331|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5438090|NCT01553318|Fibromyalgia|fibromyalgia
5438091|NCT01553318|FMS|fms
5438092|NCT01553305|exercise programme|exercise programme
5438093|NCT01553292|Respiratory distress syndrome|respiratory distress syndrome
5438094|NCT01553292|Preterm infants|preterm infants
5438095|NCT01553292|Vascular catheter|vascular catheter
5438096|NCT01553292|Surfactant|surfactant
5438097|NCT01553292|CPAP|cpap
5438098|NCT01553292|ECALMIST|ecalmist
5438099|NCT01553266|Diabetes Mellitus|diabetes mellitus
5438100|NCT01553266|diabetes care|diabetes care
5438101|NCT01553266|diabetes self-management education|diabetes self-management education
5438102|NCT01553266|primary care physicians|primary care physicians
5438103|NCT01553266|interprofessional collaboration|interprofessional collaboration
5438104|NCT01553266|diabetes education programs|diabetes education programs
5438105|NCT01553266|qualitative|qualitative
5438106|NCT01553266|quantitative|quantitative
5438107|NCT01553266|implementation|implementation
5438108|NCT01553266|evaluation|evaluation
5438109|NCT01553266|health services|health services
5438110|NCT01553266|coordinated care|coordinated care
5438111|NCT01553266|integrated care|integrated care
5438112|NCT01553266|patient care processes|patient care processes
5438113|NCT01553253|Postcholecystectomy Pain|postcholecystectomy pain
5438114|NCT01553253|Chronic Postoperative Pain|chronic postoperative pain
5438115|NCT01553253|Visceral Pain|visceral pain
5438116|NCT01553253|Referred pain|referred pain
5438117|NCT01553253|Somatic pain|somatic pain
5438118|NCT01553253|Quantitative Sensory Testing|quantitative sensory testing
5438119|NCT01553240|TMS|tms
5438120|NCT01553240|functional MRI|functional mri
5438121|NCT01553240|Supplementary motor cortex|supplementary motor cortex
5438122|NCT01553240|Right Temporoparietal junction( RTPJ)|right temporoparietal junction( rtpj)
5438123|NCT01553227|OSAHS: Obstructive Sleep Apnea hypopnea Syndrome|osahs: obstructive sleep apnea hypopnea syndrome
5438124|NCT01553227|OHS: Obesity Hypoventilation Syndrome|ohs: obesity hypoventilation syndrome
5438125|NCT01553227|Auto-trilevel ventilation|auto-trilevel ventilation
5438126|NCT01553227|BiPAP ventilation|bipap ventilation
5438134|NCT01553201|Quality of Life|quality of life
5438135|NCT01553201|Endometriosis|endometriosis
5438136|NCT01553201|Botulinum Toxin A|botulinum toxin a
5438137|NCT01553201|Pelvic Pain Spasm|pelvic pain spasm
5438138|NCT01553201|Chronic Pelvic Pain|chronic pelvic pain
5438139|NCT01553188|Anti-Angiogenesis|anti-angiogenesis
5438141|NCT01553188|Ang 2|ang 2
5438142|NCT01553188|Peptide-Fc fusion protein|peptide-fc fusion protein
5438143|NCT01553188|Small Molecule|small molecule
5438144|NCT01553175|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5438145|NCT01553175|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5438146|NCT01553162|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5438147|NCT01553162|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5438148|NCT01553136|alcohol-related disorders|alcohol-related disorders
5438149|NCT01553136|Cholinergic Drugs|cholinergic drugs
5438150|NCT01553136|varenicline|varenicline
5438152|NCT01553123|Leiomyomas|leiomyomas
5438153|NCT01553110|Cold|cold
5438154|NCT01553110|Acute Rhinosinusitis|acute rhinosinusitis
5438155|NCT01553110|Allergic Rhinitis|allergic rhinitis
5438156|NCT01553097|Breast Cancer|breast cancer
5438157|NCT01553097|Neurocognitive Impairment|neurocognitive impairment
5438158|NCT01553097|Quality of Life|quality of life
5438159|NCT01553097|Cytokines|cytokines
5438160|NCT01553084|Smoking Cessation|smoking cessation
5438161|NCT01553084|Smoking|smoking
5438162|NCT01553084|Nicotine|nicotine
5438163|NCT01553071|Malignancy, Relapsed|malignancy, relapsed
5574003|NCT00991419|PET|pet
5438164|NCT01553071|Chemotherapy, Intravenous|chemotherapy, intravenous
5438165|NCT01553058|Psoriasis|psoriasis
5438166|NCT01553058|Cardiovascular Disease|cardiovascular disease
5438167|NCT01553058|FDG/PET-CT|fdg/pet-ct
5438168|NCT01553058|NB-UVB Phototherapy|nb-uvb phototherapy
5438169|NCT01553058|Vascular Inflammation|vascular inflammation
5438170|NCT01553058|Lipid Biomarkers|lipid biomarkers
5438171|NCT01553045|symptom burden|symptom burden
5438172|NCT01553045|atrial fibrillation|atrial fibrillation
5438173|NCT01553045|biomarkers|biomarkers
5438174|NCT01553045|intracardiac pressures|intracardiac pressures
5680269|NCT00578422|Peripheral Artery Disease|peripheral artery disease
5438175|NCT01553032|Immuno-(Chemo-)and Radiotherapy|immuno-(chemo-)and radiotherapy
5438177|NCT01553032|Skin changes in Head and neck cancer|skin changes in head and neck cancer
5438178|NCT01553019|Proton radiation|proton radiation
5438179|NCT01553019|Chemotherapy|chemotherapy
5438180|NCT01553019|Pancreatic cancer|pancreatic cancer
5438181|NCT01553019|Postoperative|postoperative
5438182|NCT01553006|rhinosinusitis|rhinosinusitis
5438183|NCT01553006|cefditoren pivoxil|cefditoren pivoxil
5438184|NCT01552993|prematurity|prematurity
5438185|NCT01552993|retinopathy|retinopathy
5438186|NCT01552993|pain|pain
5438187|NCT01552993|acetaminophen|acetaminophen
5438188|NCT01552980|Gastric cancer|gastric cancer
5438189|NCT01552980|Adenocarcinoma|adenocarcinoma
5438190|NCT01552980|SOX|sox
5438191|NCT01552967|Colorectal cancer|colorectal cancer
5438192|NCT01552967|Adenocarcinoma|adenocarcinoma
5438193|NCT01552967|XELOX|xelox
5438194|NCT01552954|hypertension|hypertension
5438195|NCT01552954|Chronic kidney disease|chronic kidney disease
5438196|NCT01552954|albuminuria|albuminuria
5438197|NCT01552954|low salt diet|low salt diet
5438198|NCT01552954|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5438199|NCT01552941|Vagus Nerve|vagus nerve
5438200|NCT01552941|Vagal Nerve Stimulation|vagal nerve stimulation
5438201|NCT01552941|Rheumatoid Arthritis|rheumatoid arthritis
5438202|NCT01552941|Implantable Medical Device|implantable medical device
5438203|NCT01552915|ADHD|adhd
5438204|NCT01552902|ADHD|adhd
5438205|NCT01552863|pharmacokinetics|pharmacokinetics
5438206|NCT01552863|bioavailability|bioavailability
5438207|NCT01552863|oxycodone.|oxycodone.
5438208|NCT01552850|pharmacokinetics|pharmacokinetics
5438209|NCT01552850|relative bioavailability|relative bioavailability
5438210|NCT01552850|oxycodone|oxycodone
5438211|NCT01552837|Diffusion Tensor Imaging,|diffusion tensor imaging,
5438212|NCT01552837|quetiapine|quetiapine
5438213|NCT01552837|Bipolar Disorder|bipolar disorder
5438214|NCT01552837|hippocampus|hippocampus
5438215|NCT01552837|Volume Brain Morphometry|volume brain morphometry
5438216|NCT01552837|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5438345|NCT01552369|prophylaxis|prophylaxis
5438217|NCT01552837|effect of quetiapine on hippocampal neurogenesis|effect of quetiapine on hippocampal neurogenesis
5438218|NCT01552824|LUTO|luto
5438219|NCT01552824|posterior urethral valves|posterior urethral valves
5438220|NCT01552824|urethral atresia|urethral atresia
5438221|NCT01552772|Safety|safety
5438222|NCT01552772|Tolerability|tolerability
5438223|NCT01552772|Schizophrenia|schizophrenia
5438224|NCT01552772|Aripiprazole|aripiprazole
5438225|NCT01552759|Appetite Hormones|appetite hormones
5438226|NCT01552759|Binge Eating Disorder|binge eating disorder
5438227|NCT01552759|Obesity|obesity
5438228|NCT01552759|Cortisol|cortisol
5438229|NCT01552759|Stress|stress
5438230|NCT01552746|Postoperative shoulder pain|postoperative shoulder pain
5438231|NCT01552746|Persisting postoperative pain|persisting postoperative pain
5438232|NCT01552720|aorta|aorta
5438233|NCT01552720|dissection|dissection
5438234|NCT01552720|feature|feature
5438235|NCT01552707|Spondylolisthesis|spondylolisthesis
5438236|NCT01552707|Degenerative discopathy|degenerative discopathy
5438237|NCT01552707|Mesenchymal Stem Cells|mesenchymal stem cells
5438238|NCT01552707|Bone marrow|bone marrow
5438239|NCT01552707|Tissue engineering|tissue engineering
5438240|NCT01552707|Spinal fusion|spinal fusion
5438241|NCT01552694|cardiometabolic complications|cardiometabolic complications
5438242|NCT01552681|baminercept treatment|baminercept treatment
5438243|NCT01552668|Clostridium difficile infection|clostridium difficile infection
5438244|NCT01552668|fidaxomicin|fidaxomicin
5438245|NCT01552655|Dual-time PET/CT|dual-time pet/ct
5438246|NCT01552655|Breast cancer recurrence|breast cancer recurrence
5438247|NCT01552655|Bone scintigraphy|bone scintigraphy
5438248|NCT01552655|CT thorax upper abdomen|ct thorax upper abdomen
5580481|NCT00966485|MACE|mace
5438249|NCT01552642|Comprehensive Health Enhancement Support System (CHESS)|comprehensive health enhancement support system (chess)
5438250|NCT01552629|Atopic dermatitis|atopic dermatitis
5438251|NCT01552629|Atopic eczema|atopic eczema
5438252|NCT01552629|Skin Diseases|skin diseases
5438253|NCT01552629|QGE031|qge031
5438254|NCT01552603|glucose sensors|glucose sensors
5438255|NCT01552603|artificial pancreas|artificial pancreas
5438256|NCT01552603|Diabetes Mellitus|diabetes mellitus
5438257|NCT01552577|Post-Concussion Syndrome|post-concussion syndrome
5438258|NCT01552577|Concussion|concussion
5438259|NCT01552577|Brain Injury|brain injury
5438261|NCT01552577|Military Personnel|military personnel
5438264|NCT01552577|Assessment|assessment
5438265|NCT01552551|Falls|falls
5438266|NCT01552551|exercise|exercise
5438267|NCT01552551|safety|safety
5438268|NCT01552551|injury|injury
5438269|NCT01552551|Older adults|older adults
5438270|NCT01552538|Rheumatoid Arthritis|rheumatoid arthritis
5438271|NCT01552538|Vagus Nerve|vagus nerve
5438272|NCT01552538|Vagal Nerve Stimulation|vagal nerve stimulation
5438274|NCT01552525|asymmetric dimethylarginine|asymmetric dimethylarginine
5438275|NCT01552525|symmetric dimethylarginine|symmetric dimethylarginine
5438276|NCT01552525|l-arginine|l-arginine
5438277|NCT01552525|arterial stiffness|arterial stiffness
5438278|NCT01552525|augmentation index|augmentation index
5438279|NCT01552525|pulse wave velocity|pulse wave velocity
5438280|NCT01552512|Stunting|stunting
5438281|NCT01552512|Hidden Hunger|hidden hunger
5438282|NCT01552512|Diarrhea|diarrhea
5438283|NCT01552512|Vitamin A Deficiency|vitamin a deficiency
5438284|NCT01552486|chiropractic|chiropractic
5438285|NCT01552486|manipulation|manipulation
5438286|NCT01552486|radiculopathy|radiculopathy
5438287|NCT01552486|sciatica|sciatica
5438288|NCT01552486|lumbar|lumbar
5438289|NCT01552486|disc|disc
5438290|NCT01552486|herniation|herniation
5438291|NCT01552486|protrusion|protrusion
5438292|NCT01552473|TBI|tbi
5438293|NCT01552473|Traumatic Brain Injury|traumatic brain injury
5438294|NCT01552473|combat related injury|combat related injury
5438295|NCT01552473|blast injury|blast injury
5438296|NCT01552473|concussion|concussion
5438297|NCT01552473|sleep problems|sleep problems
5438298|NCT01552473|attention problems|attention problems
5438299|NCT01552473|memory problems|memory problems
5438300|NCT01552473|headaches|headaches
5438301|NCT01552473|dizziness|dizziness
5438302|NCT01552473|OEF|oef
5438303|NCT01552473|OIF|oif
5438304|NCT01552473|Veterans|veterans
5438305|NCT01552473|Civilian|civilian
5438306|NCT01552460|Autism Spectrum Disorders|autism spectrum disorders
5438307|NCT01552460|Brain Imaging|brain imaging
5438308|NCT01552460|Genetics|genetics
5438309|NCT01552434|Temsirolimus|temsirolimus
5438310|NCT01552434|CCI-779|cci-779
5438311|NCT01552434|Torisel|torisel
5438312|NCT01552434|Bevacizumab|bevacizumab
5438313|NCT01552434|Avastin|avastin
5438314|NCT01552434|rhuMAb-VEGF|rhumab-vegf
5438315|NCT01552434|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5438316|NCT01552434|Advanced Cancers|advanced cancers
5438317|NCT01552434|Advanced Malignancy|advanced malignancy
5425296|NCT01607931|GIP|gip
5438318|NCT01552434|Metastatic|metastatic
5438319|NCT01552434|cancer|cancer
5438320|NCT01552434|Cetuximab|cetuximab
5438321|NCT01552434|C225|c225
5438322|NCT01552434|Erbitux|erbitux
5438323|NCT01552434|IMC-C225|imc-c225
5438324|NCT01552434|Valproic Acid|valproic acid
5438325|NCT01552421|Cholecystectomy|cholecystectomy
5438326|NCT01552421|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5438327|NCT01552421|Transvaginal cholecystectomy|transvaginal cholecystectomy
5438328|NCT01552421|Postoperative outcome|postoperative outcome
5438329|NCT01552408|Non Proliferative Diabetic Retinopathy|non proliferative diabetic retinopathy
5438330|NCT01552408|Diabetic Retinopathy|diabetic retinopathy
5438331|NCT01552408|Macular Edema|macular edema
5438332|NCT01552408|Background Diabetic Retinopathy|background diabetic retinopathy
5438333|NCT01552408|Pre Proliferative Diabetic Retinopathy|pre proliferative diabetic retinopathy
5438334|NCT01552382|vitamin D|vitamin d
5438335|NCT01552382|25-hydroxyvitamin D|25-hydroxyvitamin d
5438336|NCT01552382|MACCE|macce
5438337|NCT01552382|mortality|mortality
5438338|NCT01552382|cardiac|cardiac
5438339|NCT01552382|cerebrovascular|cerebrovascular
5438340|NCT01552369|CMV|cmv
5438341|NCT01552369|cytomegalovirus infections|cytomegalovirus infections
5438342|NCT01552369|ganciclovir|ganciclovir
5438343|NCT01552369|liver transplant|liver transplant
5438344|NCT01552369|preemptive therapy|preemptive therapy
5438346|NCT01552369|valganciclovir|valganciclovir
5438347|NCT01552330|Primaquine|primaquine
5438348|NCT01552330|Pyronaridine-artesunate|pyronaridine-artesunate
5438349|NCT01552317|chronic kidney disease|chronic kidney disease
5438350|NCT01552304|Obstructive sleep apnea|obstructive sleep apnea
5580607|NCT00965861|Breast|breast
5438351|NCT01552304|Oxygen therapy|oxygen therapy
5438352|NCT01552304|Surgery|surgery
5438353|NCT01552304|Anesthesia|anesthesia
5438354|NCT01552291|Malnourishment|malnourishment
5438355|NCT01552291|Gastrointestinal tumors|gastrointestinal tumors
5438356|NCT01552291|Immunocompetence|immunocompetence
5438357|NCT01552265|Mild Cognitive Impairment|mild cognitive impairment
5438358|NCT01552265|Alzheimer's Disease|alzheimer's disease
5438359|NCT01552252|POs-Ca|pos-ca
5438360|NCT01552252|calcium additives|calcium additives
5438361|NCT01552252|drink|drink
5438362|NCT01552239|Soft tissue sarcoma|soft tissue sarcoma
5438363|NCT01552239|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
5438364|NCT01552239|Tomotherapy|tomotherapy
5438365|NCT01552239|Safety Margins|safety margins
5438367|NCT01552239|Brachytherapy|brachytherapy
5438368|NCT01552239|interstitial|interstitial
5438369|NCT01552200|Colorectal Cancer|colorectal cancer
5438370|NCT01552200|Polyp|polyp
5438371|NCT01552200|Adenoma|adenoma
5438372|NCT01552200|Detection Rate|detection rate
5438373|NCT01552200|Colonoscopy|colonoscopy
5438374|NCT01552200|NaviAid™ G-Eye procedure|naviaid™ g-eye procedure
5438375|NCT01552200|NaviAid™ G-Eye system|naviaid™ g-eye system
5438377|NCT01552200|G-Eye system|g-eye system
5438378|NCT01552187|cardiac surgery|cardiac surgery
5438379|NCT01552187|post-pericardiotomy syndrome|post-pericardiotomy syndrome
5438380|NCT01552187|atrial fibrillation|atrial fibrillation
5438381|NCT01552187|pericardial effusion|pericardial effusion
5438382|NCT01552187|pleural effusion|pleural effusion
5438383|NCT01552187|prevention|prevention
5438384|NCT01552187|colchicine|colchicine
5438386|NCT01552174|ocular surface pathologies|ocular surface pathologies
5438387|NCT01552161|Angiography|angiography
5438388|NCT01552161|Atherosclerosis|atherosclerosis
5438389|NCT01552161|Asthma|asthma
5438390|NCT01552161|Tryptase|tryptase
5438391|NCT01552161|Eosinophil cationic protein|eosinophil cationic protein
5438392|NCT01552135|titanium dioxide|titanium dioxide
5438393|NCT01552135|nanoparticles|nanoparticles
5438394|NCT01552135|skin|skin
5438395|NCT01552135|penetrate|penetrate
5438396|NCT01552109|symptomatic stable angina|symptomatic stable angina
5438397|NCT01552109|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria|subjects with symptomatic stable angina visiting non-interventional consulting physicians for treatment and meets the inclusion/exclusion criteria
5438398|NCT01552096|Anaesthesia|anaesthesia
5438399|NCT01552096|tonsillectomy|tonsillectomy
5438400|NCT01552096|inflammatory response|inflammatory response
5438401|NCT01552096|stress response|stress response
5438402|NCT01552096|tramadol|tramadol
5438403|NCT01552096|lidocaine|lidocaine
5438404|NCT01552083|sleep apnea|sleep apnea
5438405|NCT01552083|screening|screening
5438406|NCT01552083|community pharmacy|community pharmacy
5438407|NCT01552044|retina|retina
5438408|NCT01552031|COPD exacerbations|copd exacerbations
5438409|NCT01552031|FOT variability|fot variability
5438410|NCT01551992|Sutures|sutures
5438411|NCT01551992|Pelvic Organ Prolapse|pelvic organ prolapse
5438412|NCT01551992|Sacrocolpopexy|sacrocolpopexy
5438413|NCT01551992|Laparoscopy|laparoscopy
5438414|NCT01551979|Schizophrenia|schizophrenia
5438415|NCT01551979|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5438416|NCT01551966|Esophageal varices|esophageal varices
5410576|NCT01675102|cll|cll
5438417|NCT01551966|Portal hypertension in children|portal hypertension in children
5438418|NCT01551966|Wireless capsule endoscopy|wireless capsule endoscopy
5438419|NCT01551953|chronic bronchitis|chronic bronchitis
5438420|NCT01551953|emphysema|emphysema
5438421|NCT01551953|pulmonary|pulmonary
5438422|NCT01551953|COPD|copd
5438423|NCT01551940|Sialorrhea|sialorrhea
5438424|NCT01551940|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5438425|NCT01551940|Botulinum toxin|botulinum toxin
5438426|NCT01551927|expectations|expectations
5438427|NCT01551914|Ultrasonic scissors|ultrasonic scissors
5438428|NCT01551914|thyroidectomy|thyroidectomy
5438429|NCT01551901|Back pain|back pain
5438430|NCT01551901|Spinal fusion|spinal fusion
5438431|NCT01551901|Degenerative disc disease (DDD)|degenerative disc disease (ddd)
5438432|NCT01551901|Lower back pain|lower back pain
5438433|NCT01551901|Fusion|fusion
5438434|NCT01551888|COPD|copd
5438435|NCT01551888|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5438436|NCT01551888|Chronic Bronchitis|chronic bronchitis
5438437|NCT01551888|Emphysema|emphysema
5438833|NCT01550198|newborn|newborn
5438438|NCT01551888|Airflow Obstruction, Chronic|airflow obstruction, chronic
5438439|NCT01551888|Chronic Airflow Obstruction|chronic airflow obstruction
5438440|NCT01551888|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5438441|NCT01551888|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5438442|NCT01551875|CIMT|cimt
5438443|NCT01551875|cardiovascular disease|cardiovascular disease
5438444|NCT01551875|correlation with cardiovascular Risk factors|correlation with cardiovascular risk factors
5438445|NCT01551862|lower body lift|lower body lift
5438446|NCT01551862|body contouring surgery|body contouring surgery
5438447|NCT01551862|massive weight loss|massive weight loss
5438448|NCT01551836|pharmacokinetics|pharmacokinetics
5438449|NCT01551836|paracetamol|paracetamol
5438450|NCT01551823|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
5438451|NCT01551823|Influenza|influenza
5438452|NCT01551810|Influenza Virus Vaccine (Split Virion, Inactivated)|influenza virus vaccine (split virion, inactivated)
5438453|NCT01551810|Influenza|influenza
5421092|NCT01625962|PTSD|ptsd
5438454|NCT01551784|Statin treatment|statin treatment
5438455|NCT01551784|Cardiovascular disease|cardiovascular disease
5438456|NCT01551784|Statin treatment induced HDL changes and the effect on cardiovascular disease|statin treatment induced hdl changes and the effect on cardiovascular disease
5438457|NCT01551771|CCR3 antagonist|ccr3 antagonist
5438458|NCT01551758|Exacerbation|exacerbation
5438459|NCT01551758|Adult|adult
5438460|NCT01551758|COPD|copd
5438461|NCT01551758|Respiratory|respiratory
5438462|NCT01551745|Papillary Serous Ovarian Cancer|papillary serous ovarian cancer
5438463|NCT01551745|Endometrioid Ovarian Cancer|endometrioid ovarian cancer
5438464|NCT01551745|Epithelial Ovarian Cancer|epithelial ovarian cancer
5438465|NCT01551732|Anger|anger
5438466|NCT01551732|Aggression|aggression
5438467|NCT01551732|Biofeedback|biofeedback
5438468|NCT01551732|Videogame|videogame
5438469|NCT01551719|Bacterial infection of skin or soft tissues|bacterial infection of skin or soft tissues
5438470|NCT01551706|Total antioxidant capacity|total antioxidant capacity
5438472|NCT01551706|8-OHdG|8-ohdg
5438473|NCT01551706|8-isoprostane|8-isoprostane
5438474|NCT01551706|oxLDL|oxldl
5438475|NCT01551693|Stage III|stage iii
5438476|NCT01551693|Stage IV|stage iv
5438477|NCT01551693|Unresectable|unresectable
5438478|NCT01551693|Metastatic|metastatic
5438479|NCT01551667|S. aureus|s. aureus
5438480|NCT01551654|Pain|pain
5438481|NCT01551654|Colonoscopy|colonoscopy
5438482|NCT01551654|TENS|tens
5438483|NCT01551654|Acupuncture|acupuncture
5438484|NCT01551641|Esophageal Cancer|esophageal cancer
5438485|NCT01551641|Chemoradiotherapy|chemoradiotherapy
5438486|NCT01551641|VEGF|vegf
5438487|NCT01551641|Thalidomide|thalidomide
5438488|NCT01551615|Phase 1|phase 1
5438489|NCT01551615|healthy volunteers|healthy volunteers
5438490|NCT01551615|pharmacokinetics|pharmacokinetics
5438491|NCT01551615|vandetanib|vandetanib
5438492|NCT01551615|metformin|metformin
5438493|NCT01551615|AUC(0-t)|auc(0-t)
5438494|NCT01551615|t1/2|t1/2
5438495|NCT01551615|tmax|tmax
5438496|NCT01551615|CL/F|cl/f
5438497|NCT01551615|Vz/F|vz/f
5438498|NCT01551615|Cmax|cmax
5438499|NCT01551602|AK159|ak159
5438500|NCT01551602|teriparatide acetate|teriparatide acetate
5438501|NCT01551589|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5438502|NCT01551589|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5438503|NCT01551589|Clinical target volume|clinical target volume
5438504|NCT01551589|Safety|safety
5438505|NCT01551589|Prognosis|prognosis
5438506|NCT01551550|Glaucoma Drainage Device, Tube Exposure, Amniotic Membrane|glaucoma drainage device, tube exposure, amniotic membrane
5438507|NCT01551537|Healthy females|healthy females
5438508|NCT01551537|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
5438509|NCT01551537|Human papillomavirus vaccine|human papillomavirus vaccine
5438510|NCT01551537|Sri Lanka|sri lanka
5438511|NCT01551537|Cervarix|cervarix
5438512|NCT01551524|Leukemia|leukemia
5438513|NCT01551524|Lymphoma|lymphoma
5438514|NCT01551524|C240588.448|c240588.448
5438515|NCT01551524|C115.378.400|c115.378.400
5438516|NCT01551511|chronic pancreatitis|chronic pancreatitis
5438517|NCT01551511|abdominal pain|abdominal pain
5438518|NCT01551511|visceral pain|visceral pain
5438519|NCT01551511|chronic pain|chronic pain
5438520|NCT01551498|Hashimoto Disease|hashimoto disease
5438521|NCT01551498|Thyroiditis|thyroiditis
5438522|NCT01551459|Uveal|uveal
5438523|NCT01551459|Melanoma|melanoma
5438524|NCT01551459|Metastatic|metastatic
5438525|NCT01551459|Sunitinib|sunitinib
5438526|NCT01551433|esophagectomy|esophagectomy
5438527|NCT01551433|ESOPHAGUS|esophagus
5438528|NCT01551433|Wipox instrument|wipox instrument
5438529|NCT01551433|Tissue Oxygenation|tissue oxygenation
5438530|NCT01551433|Anastomotic Leak|anastomotic leak
5438531|NCT01551433|11-192|11-192
5438532|NCT01551420|Amputation|amputation
5438533|NCT01551420|Prosthetic Design|prosthetic design
5438534|NCT01551420|Upper Extremity|upper extremity
5438535|NCT01551407|Hexvix|hexvix
5438536|NCT01551407|bladder cancer|bladder cancer
5438537|NCT01551407|cystoscopy|cystoscopy
5438834|NCT01550198|shock|shock
5438538|NCT01551407|Patients with known or suspicion of bladder cancer|patients with known or suspicion of bladder cancer
5438539|NCT01551394|sepsis|sepsis
5438540|NCT01551394|neonates|neonates
5438541|NCT01551394|meropenem|meropenem
5438542|NCT01551381|Safety|safety
5438543|NCT01551381|Tolerability|tolerability
5438544|NCT01551381|Pharmacokinetics|pharmacokinetics
5438545|NCT01551381|Pharmacodynamics|pharmacodynamics
5438546|NCT01551368|male factor|male factor
5438547|NCT01551368|intrauterine insemination|intrauterine insemination
5438548|NCT01551368|LH surge|lh surge
5438549|NCT01551368|controlled ovarian stimulation|controlled ovarian stimulation
5438550|NCT01551368|clomiphene citrate|clomiphene citrate
5438551|NCT01551368|letrozole|letrozole
5438552|NCT01551368|human menopausal gonadotropins|human menopausal gonadotropins
5438553|NCT01551355|behavioral modification|behavioral modification
5438554|NCT01551355|health communication|health communication
5438555|NCT01551355|prevention|prevention
5438556|NCT01551342|bladder cancer|bladder cancer
5438557|NCT01551342|Transitional cell carcinoma (TCC)|transitional cell carcinoma (tcc)
5438558|NCT01551329|depression|depression
5438560|NCT01551329|comorbidity|comorbidity
5438561|NCT01551329|ketamine|ketamine
5438562|NCT01551329|glutamate|glutamate
5438563|NCT01551329|NMDA|nmda
5438564|NCT01551316|safety|safety
5438565|NCT01551316|pharmacokinetics|pharmacokinetics
5438568|NCT01551290|UC|uc
5438569|NCT01551290|Remicade|remicade
5438571|NCT01551290|Chinese patients|chinese patients
5438572|NCT01551290|Mayo score|mayo score
5438573|NCT01551290|Mucosal healing|mucosal healing
5438574|NCT01551290|Rectal bleeding|rectal bleeding
5438575|NCT01551290|Inflammatory bowel disease|inflammatory bowel disease
5438576|NCT01551290|IBD|ibd
5438577|NCT01551238|Energy expenditure|energy expenditure
5438578|NCT01551238|Sleep|sleep
5438579|NCT01551238|Protein|protein
5438580|NCT01551238|Carbohydrate|carbohydrate
5438581|NCT01551225|Randomized controlled trial|randomized controlled trial
5438582|NCT01551225|Escitalopram|escitalopram
5438583|NCT01551225|Irritable bowel syndrome|irritable bowel syndrome
5438584|NCT01551225|Panic disorder|panic disorder
5438585|NCT01551212|Liver transplantation|liver transplantation
5438586|NCT01551212|Everolimus|everolimus
5438587|NCT01551212|Tacrolimus|tacrolimus
5438588|NCT01551212|Renal function|renal function
5438589|NCT01551186|Probiotics|probiotics
5438590|NCT01551173|Dyslipidemias|dyslipidemias
5438591|NCT01551173|Fluvastatin sodium|fluvastatin sodium
5438592|NCT01551173|Chinese|chinese
5438593|NCT01551160|Non-technical skills|non-technical skills
5438594|NCT01551160|Crisis resource management|crisis resource management
5438595|NCT01551160|Medical Emergency Team|medical emergency team
5438596|NCT01551160|Rapid Response Team|rapid response team
5438597|NCT01551147|asthma|asthma
5438598|NCT01551147|ONO-6950|ono-6950
5438599|NCT01551147|asthma in adult patients|asthma in adult patients
5438600|NCT01551134|Gastroesophageal Reflux|gastroesophageal reflux
5438601|NCT01551134|Fundoplication|fundoplication
5438602|NCT01551134|Randomized Controlled Trial|randomized controlled trial
5438603|NCT01551134|General Surgery|general surgery
5438604|NCT01551134|Child|child
5438605|NCT01551134|Laparoscopy|laparoscopy
5438606|NCT01551108|Children|children
5438607|NCT01551108|physical activity|physical activity
5438608|NCT01551095|PEGJ|pegj
5438609|NCT01551095|PEG-J|peg-j
5438610|NCT01551095|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5438611|NCT01551095|feeding tube|feeding tube
5438612|NCT01551095|gastroparesis|gastroparesis
5438613|NCT01551095|acute pancreatitis|acute pancreatitis
5438614|NCT01551095|stroke|stroke
5438615|NCT01551095|respiratory failure|respiratory failure
5438616|NCT01551095|GERD|gerd
5438617|NCT01551095|balloon|balloon
5438618|NCT01551095|self-propelled|self-propelled
5438619|NCT01551043|adult patients|adult patients
5438620|NCT01551043|aged 18|aged 18
5438621|NCT01551043|CD19+ ALL relapsed|cd19+ all relapsed
5438622|NCT01551043|after allogeneic SCT|after allogeneic sct
5438623|NCT01551030|KIDNEY|kidney
5438624|NCT01551030|URETER|ureter
5438625|NCT01551030|URINARY BLADDER|urinary bladder
5438626|NCT01551030|Buparlisib|buparlisib
5438627|NCT01551030|11-060|11-060
5438628|NCT01551017|total knee endoprostheses|total knee endoprostheses
5438629|NCT01551017|swelling|swelling
5438630|NCT01551017|mobilisation|mobilisation
5438631|NCT01551004|C. diff|c. diff
5438632|NCT01551004|C. difficile|c. difficile
5438633|NCT01551004|Clostridium difficile|clostridium difficile
5438634|NCT01551004|CRS3123|crs3123
5438635|NCT01550965|Quality of Life|quality of life
5438636|NCT01550965|Costs of Ulcerative Colitis|costs of ulcerative colitis
5438637|NCT01550965|Health Care Utilization|health care utilization
5438638|NCT01550939|Biometry of the Eye|biometry of the eye
5438639|NCT01550939|Intraocular Lens Implantation|intraocular lens implantation
5438640|NCT01550939|IOL|iol
5438641|NCT01550926|orlistat|orlistat
5438642|NCT01550926|overweight|overweight
5438940|NCT01549847|L-Carnitine|l-carnitine
5438643|NCT01550926|bioequivalence|bioequivalence
5438644|NCT01550913|Substance use|substance use
5438645|NCT01550913|perinatal depression|perinatal depression
5438646|NCT01550913|pregnant|pregnant
5438647|NCT01550900|Colorectum|colorectum
5438648|NCT01550900|Metachronous ctalColonic Neoplastic Polyps|metachronous ctalcolonic neoplastic polyps
5438649|NCT01550900|Chemoprevention|chemoprevention
5580949|NCT00964795|AMD|amd
5438650|NCT01550900|Colonic adenoma(s)|colonic adenoma(s)
5438651|NCT01550900|Pre-cancerous tumor(s) on the colon|pre-cancerous tumor(s) on the colon
5438652|NCT01550900|Metformin ER|metformin er
5438653|NCT01550900|Extended Release|extended release
5438654|NCT01550900|Placebo|placebo
5438655|NCT01550900|Sugar pill|sugar pill
5438656|NCT01550874|Physical Activity|physical activity
5438657|NCT01550874|Epilepsy|epilepsy
5438658|NCT01550874|Children|children
5438659|NCT01550874|Motivation|motivation
5438660|NCT01550861|infertility|infertility
5438661|NCT01550861|in vitro maturation (IVM)|in vitro maturation (ivm)
5438662|NCT01550861|in vitro fertilization (IVF)|in vitro fertilization (ivf)
5438663|NCT01550861|natural cycle|natural cycle
5438664|NCT01550835|Symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
5438665|NCT01550822|stroke, lifestyle habits|stroke, lifestyle habits
5438666|NCT01550809|T1DM|t1dm
5438667|NCT01550809|CSII|csii
5438669|NCT01550809|postprandial control|postprandial control
5438670|NCT01550809|glycemic variability|glycemic variability
5438671|NCT01550809|Prandial insulin dosing in Type 1 diabetes treated with continuous subcutaneous insulin infusion|prandial insulin dosing in type 1 diabetes treated with continuous subcutaneous insulin infusion
5438673|NCT01550796|Brain Fitness Program|brain fitness program
5438674|NCT01550796|Posit Science|posit science
5438675|NCT01550796|D-cycloserine|d-cycloserine
5438676|NCT01550796|Cognitive Training|cognitive training
5438677|NCT01550783|Cervical cancer|cervical cancer
5438678|NCT01550783|Atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5438679|NCT01550783|Stage 0 cervical cancer|stage 0 cervical cancer
5438680|NCT01550783|Cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5438681|NCT01550783|Cervical|cervical
5438682|NCT01550783|intraepithelial neoplasia grade 2|intraepithelial neoplasia grade 2
5438683|NCT01550783|Cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5438684|NCT01550783|Human papillomavirus|human papillomavirus
5438686|NCT01550744|Psoriasis|psoriasis
5438687|NCT01550744|Ustekinumab|ustekinumab
5438688|NCT01550744|STELARA|stelara
5438689|NCT01550744|Skin disease|skin disease
5438690|NCT01550744|Monoclonal|monoclonal
5438691|NCT01550731|advance care planning|advance care planning
5438692|NCT01550731|health communication|health communication
5438693|NCT01550731|aging|aging
5438694|NCT01550718|Aerobic Exercise|aerobic exercise
5438695|NCT01550718|Alzheimer's Disease|alzheimer's disease
5438696|NCT01550718|Burden and Stress|burden and stress
5438697|NCT01550718|Caregiving Issues|caregiving issues
5438698|NCT01550718|Quality of Life|quality of life
5438699|NCT01550718|Early Stage Memory Loss|early stage memory loss
5438700|NCT01550705|Protoporphyria|protoporphyria
5438701|NCT01550705|Porphyria|porphyria
5438702|NCT01550705|Porphyrins|porphyrins
5438703|NCT01550666|negative symptoms|negative symptoms
5438704|NCT01550653|Memory|memory
5438705|NCT01550653|GLP-1|glp-1
5438706|NCT01550653|Liraglutide|liraglutide
5438707|NCT01550653|energy output|energy output
5438708|NCT01550653|Memory facilitation|memory facilitation
5438709|NCT01550653|GLP-1 analogue|glp-1 analogue
5438710|NCT01550640|remifentanil|remifentanil
5438711|NCT01550640|Caesarean operation|caesarean operation
5438712|NCT01550640|general anaesthesia|general anaesthesia
5438713|NCT01550640|hypertension|hypertension
5438714|NCT01550640|newborn's adaptation|newborn's adaptation
5438715|NCT01550640|pharmacogenetics|pharmacogenetics
5438716|NCT01550627|preterm infants < 32 weeks of gestation|preterm infants < 32 weeks of gestation
5438717|NCT01550614|Angina Pectoris|angina pectoris
5438718|NCT01550614|Myocardial Ischemia|myocardial ischemia
5438719|NCT01550614|Chest Pain|chest pain
5438720|NCT01550614|Coronary Artery Disease|coronary artery disease
5438721|NCT01550614|Heart Diseases|heart diseases
5438722|NCT01550614|Cardiovascular Diseases|cardiovascular diseases
5438723|NCT01550614|Myocardial Perfusion|myocardial perfusion
5438724|NCT01550614|Reversible Perfusion Defect Size|reversible perfusion defect size
5438725|NCT01550614|SPECT-MIBI|spect-mibi
5438726|NCT01550614|Anti-Anginal Medication|anti-anginal medication
5438727|NCT01550614|Quality of Life|quality of life
5438728|NCT01550601|morbid obesity|morbid obesity
5438729|NCT01550601|gastrectomy|gastrectomy
5438730|NCT01550601|gastrinaemia|gastrinaemia
5438731|NCT01550601|comorbidity|comorbidity
5438732|NCT01550601|gastric antrum|gastric antrum
5438733|NCT01550588|PFO|pfo
5438734|NCT01550588|Stroke|stroke
5438735|NCT01550549|Amyloid imaging|amyloid imaging
5438736|NCT01550549|Positron Emission Tomography|positron emission tomography
5438737|NCT01550549|18F-AV-45|18f-av-45
5438738|NCT01550549|florbetapir F 18|florbetapir f 18
5438739|NCT01550549|Diagnostic imaging|diagnostic imaging
5438941|NCT01549808|ADL|adl
5438740|NCT01550536|basal metabolic rate|basal metabolic rate
5438741|NCT01550536|resting energy expenditure|resting energy expenditure
5438742|NCT01550536|menopause|menopause
5438743|NCT01550536|physical activity|physical activity
5438744|NCT01550536|metabolic syndrome|metabolic syndrome
5438745|NCT01550523|Brain Tumor|brain tumor
5438746|NCT01550510|Stage IV Colorectal cancer|stage iv colorectal cancer
5438747|NCT01550510|Colorectal Neoplasms|colorectal neoplasms
5438748|NCT01550510|Intestinal Neoplasms|intestinal neoplasms
5438749|NCT01550510|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5438750|NCT01550510|Digestive System Neoplasms|digestive system neoplasms
5438751|NCT01550510|Neoplasms by Site|neoplasms by site
5438752|NCT01550510|Neoplasms|neoplasms
5438753|NCT01550510|Digestive System Diseases|digestive system diseases
5438754|NCT01550510|Gastrointestinal Diseases|gastrointestinal diseases
5438755|NCT01550510|Colonic Diseases|colonic diseases
5438756|NCT01550510|Intestinal Diseases|intestinal diseases
5438757|NCT01550510|Rectal Diseases|rectal diseases
5438758|NCT01550510|Ascorbic Acid|ascorbic acid
5438759|NCT01550510|Vitamins|vitamins
5438760|NCT01550510|Irinotecan|irinotecan
5438761|NCT01550510|Integrative Medicine|integrative medicine
5438762|NCT01550510|Complementary Medicine|complementary medicine
5438763|NCT01550510|Alternative Medicine Antioxidants|alternative medicine antioxidants
5438764|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5438765|NCT01550510|Pharmacologic Actions|pharmacologic actions
5438766|NCT01550510|Protective Agents|protective agents
5438767|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs
5438769|NCT01550510|Growth Substances|growth substances
5438770|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5438771|NCT01550510|Antineoplastic Agents|antineoplastic agents
5438772|NCT01550510|Therapeutic Uses|therapeutic uses
5438773|NCT01550510|Radiation-Sensitizing Agents|radiation-sensitizing agents
5438774|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors
5438775|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors
5438776|NCT01550510|Enzyme Inhibitors|enzyme inhibitors
5438777|NCT01550497|back pain|back pain
5438778|NCT01550497|scoliosis|scoliosis
5438779|NCT01550497|home exercise program|home exercise program
5438780|NCT01550471|Mild asthma and allergic rhinitis|mild asthma and allergic rhinitis
5438781|NCT01550458|Clinical Trial, Phase I|clinical trial, phase i
5438782|NCT01550458|Human Volunteers|human volunteers
5438783|NCT01550458|Healthy Volunteers|healthy volunteers
5438784|NCT01550458|mibefradil|mibefradil
5438785|NCT01550458|Posicor®|posicor®
5438786|NCT01550445|Steroid withdrawal, Kidney transplantation|steroid withdrawal, kidney transplantation
5438787|NCT01550419|Ventilator-associated pneumonia|ventilator-associated pneumonia
5438788|NCT01550419|Ischemic stroke|ischemic stroke
5438789|NCT01550419|Atorvastatin|atorvastatin
5438790|NCT01550419|Morbidity|morbidity
5438791|NCT01550419|Mortality|mortality
5438792|NCT01550406|Pancreatic fistula|pancreatic fistula
5438793|NCT01550406|distal Pancreatectomy|distal pancreatectomy
5438794|NCT01550393|stage II Wilms tumor|stage ii wilms tumor
5438795|NCT01550393|stage III Wilms tumor|stage iii wilms tumor
5438796|NCT01550393|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5438797|NCT01550380|Endometrial cancer|endometrial cancer
5438798|NCT01550341|HIV|hiv
5438799|NCT01550341|AIDS|aids
5438800|NCT01550341|Opiate Addiction|opiate addiction
5438801|NCT01550341|Drug Dependence|drug dependence
5438802|NCT01550341|Buprenorphine|buprenorphine
5438803|NCT01550328|Screening for Type 2 diabetes|screening for type 2 diabetes
5438804|NCT01550315|POTS|pots
5438805|NCT01550315|endothelial function|endothelial function
5438806|NCT01550315|high salt vs low salt diet|high salt vs low salt diet
5438807|NCT01550315|PAT protocol|pat protocol
5438808|NCT01550315|Calf blood flow|calf blood flow
5438809|NCT01550315|forearm mediated dilation|forearm mediated dilation
5438810|NCT01550302|Superficial Cervical Plexus Block|superficial cervical plexus block
5438811|NCT01550302|Thoracic Surgery|thoracic surgery
5438812|NCT01550302|Thoracotomy|thoracotomy
5438813|NCT01550302|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5438814|NCT01550289|Dengue Fever|dengue fever
5438815|NCT01550289|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5438816|NCT01550289|CYD Dengue Vaccine|cyd dengue vaccine
5438817|NCT01550289|Dengue Virus|dengue virus
5438818|NCT01550289|Flavivirus|flavivirus
5438819|NCT01550276|Effectiveness|effectiveness
5438820|NCT01550276|Tension-type headache|tension-type headache
5438821|NCT01550276|Manual therapy|manual therapy
5438822|NCT01550263|Hip Preservation|hip preservation
5438823|NCT01550263|Hip Arthroscopy|hip arthroscopy
5438824|NCT01550263|Hip Pain|hip pain
5438825|NCT01550263|Psychological distress|psychological distress
5438826|NCT01550250|Breast cancer|breast cancer
5438827|NCT01550250|Arm lymphedema|arm lymphedema
5438828|NCT01550250|Compression therapy|compression therapy
5438829|NCT01550237|radiotherapy, image-guided|radiotherapy, image-guided
5438830|NCT01550237|adverse effects|adverse effects
5438831|NCT01550237|position verification|position verification
5438832|NCT01550237|safety margins|safety margins
5438835|NCT01550198|hemodynamics|hemodynamics
5438836|NCT01550198|cardiac output|cardiac output
5438837|NCT01550198|blood pressure|blood pressure
5438838|NCT01550172|dementia caregivers|dementia caregivers
5438839|NCT01550172|caregivers|caregivers
5438840|NCT01550172|Alzheimer's caregivers|alzheimer's caregivers
5438841|NCT01550172|caregiver sleep|caregiver sleep
5438842|NCT01550172|heart disease risk|heart disease risk
5438843|NCT01550172|dementia|dementia
5438844|NCT01550172|Alzheimer's Disease|alzheimer's disease
5438845|NCT01550159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5438846|NCT01550159|Cardiac Surgery|cardiac surgery
5438847|NCT01550159|General Anesthesia|general anesthesia
5438848|NCT01550159|Neuropsychological Tests|neuropsychological tests
5438849|NCT01550146|Fractured neck of femur|fractured neck of femur
5438850|NCT01550146|Dexamethasone|dexamethasone
5438851|NCT01550133|Peptides|peptides
5438852|NCT01550133|Hormones|hormones
5438853|NCT01550133|Appetite|appetite
5438854|NCT01550133|Humans|humans
5438855|NCT01550133|Obese|obese
5438856|NCT01550133|Beverage|beverage
5438857|NCT01550133|Solid food|solid food
5438858|NCT01550133|cephalic phase|cephalic phase
5438859|NCT01550120|taste|taste
5438867|NCT01550107|MR Spectroscopy|mr spectroscopy
5438868|NCT01550094|obese|obese
5438869|NCT01550094|regional anesthesia|regional anesthesia
5438870|NCT01550094|anesthesia|anesthesia
5438871|NCT01550094|anesthesiology|anesthesiology
5438872|NCT01550094|surgery|surgery
5438873|NCT01550094|foot|foot
5438874|NCT01550094|foot surgery|foot surgery
5438875|NCT01550094|ankle|ankle
5438876|NCT01550094|ankle surgery|ankle surgery
5438877|NCT01550094|orthopedics|orthopedics
5438878|NCT01550094|orthopedic surgery|orthopedic surgery
5438879|NCT01550094|sports medicine|sports medicine
5438880|NCT01550094|sports medicine surgery|sports medicine surgery
5438881|NCT01550094|Ochsner Hospital|ochsner hospital
5438882|NCT01550094|Ochsner Clinic|ochsner clinic
5438883|NCT01550094|New Orleans|new orleans
5438884|NCT01550094|Louisiana|louisiana
5438885|NCT01550094|Jefferson|jefferson
5438886|NCT01550094|Soberon|soberon
5438887|NCT01550081|exercise intensity|exercise intensity
5438888|NCT01550081|aerobic interval training|aerobic interval training
5438889|NCT01550081|cardiac rehabilitation|cardiac rehabilitation
5438890|NCT01550081|group exercise|group exercise
5438891|NCT01550068|Rheumatic Heart Disease|rheumatic heart disease
5438892|NCT01550055|KRAS wild-type|kras wild-type
5438893|NCT01550055|Metastatic Colorectal Cancer|metastatic colorectal cancer
5438894|NCT01550055|CMAB009 Plus Irinotecan|cmab009 plus irinotecan
5438895|NCT01550055|Phase II/III|phase ii/iii
5438896|NCT01550029|Smoking|smoking
5438897|NCT01550029|Tobacco|tobacco
5438898|NCT01550029|Nicotine|nicotine
5438899|NCT01550029|Bipolar|bipolar
5438900|NCT01550016|dengue warning signs|dengue warning signs
5438901|NCT01550016|latin america|latin america
5438902|NCT01550016|south east asia|south east asia
5438903|NCT01550016|other febrile illnesses|other febrile illnesses
5438904|NCT01550016|dengue classification|dengue classification
5438905|NCT01550003|Cimzia|cimzia
5438906|NCT01550003|JIA|jia
5438907|NCT01550003|Polyarticular|polyarticular
5438908|NCT01550003|Oligoarticular|oligoarticular
5438909|NCT01550003|Enthesitis-related-Arthritis|enthesitis-related-arthritis
5438910|NCT01550003|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5438911|NCT01550003|Juvenile Psoriatic Arthritis|juvenile psoriatic arthritis
5438912|NCT01550003|Certolizumab Pegol|certolizumab pegol
5438913|NCT01550003|PASCAL|pascal
5438914|NCT01550003|CDP870|cdp870
5438915|NCT01549977|Drug Therapy|drug therapy
5438916|NCT01549964|Drug Therapy|drug therapy
5685293|NCT00556738|neonatal respiratory distress|neonatal respiratory distress
5438917|NCT01549951|Metastatic castrate resistant prostate cancer, mCRPC, orteronel, TAK-700, Phase 2, QT, QTc|metastatic castrate resistant prostate cancer, mcrpc, orteronel, tak-700, phase 2, qt, qtc
5438918|NCT01549938|Vitamin D|vitamin d
5438919|NCT01549938|Cholecalciferol|cholecalciferol
5438920|NCT01549938|Respiratory tract infection|respiratory tract infection
5438921|NCT01549912|Rotator Cuff Tears|rotator cuff tears
5438922|NCT01549912|Dislocation|dislocation
5438923|NCT01549912|Shoulder Dislocation|shoulder dislocation
5438924|NCT01549899|Insomnia|insomnia
5438925|NCT01549899|Cognitive|cognitive
5438926|NCT01549899|Behavioral|behavioral
5438927|NCT01549899|Therapy|therapy
5438928|NCT01549899|Internet|internet
5438929|NCT01549899|Depression|depression
5438930|NCT01549899|Substance Use|substance use
5438931|NCT01549899|Post-Tramatic Stress Disorder|post-tramatic stress disorder
5438932|NCT01549886|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5438933|NCT01549886|Zevalin|zevalin
5438934|NCT01549886|Motexafin Gadolinium|motexafin gadolinium
5438935|NCT01549860|Venous Insufficiency|venous insufficiency
5438936|NCT01549860|Reflux|reflux
5438937|NCT01549860|Lower Extremity Ulcer|lower extremity ulcer
5438938|NCT01549847|Postpoliomyelitis Syndrome|postpoliomyelitis syndrome
5438939|NCT01549847|Piracetam|piracetam
5438942|NCT01549808|activities of daily living|activities of daily living
5438943|NCT01549808|level of function|level of function
5438944|NCT01549795|Liver transplantation|liver transplantation
5438945|NCT01549795|Neoadjuvant radio- chemo-therapy|neoadjuvant radio- chemo-therapy
5438946|NCT01549782|Prebiotics|prebiotics
5438947|NCT01549782|Microbiota|microbiota
5438948|NCT01549782|Radiotherapy|radiotherapy
5438949|NCT01549782|Gynaecological Cancer|gynaecological cancer
5438950|NCT01549756|stage 4 stomach cancer|stage 4 stomach cancer
5438951|NCT01549756|stage 4 gastric cancer|stage 4 gastric cancer
5438952|NCT01549717|Early warning score|early warning score
5438953|NCT01549717|Physiological score|physiological score
5438954|NCT01549717|Track and trigger score|track and trigger score
5438955|NCT01549717|Scoring system|scoring system
5438956|NCT01549717|Physiological model|physiological model
5438957|NCT01549717|Monitoring|monitoring
5438962|NCT01549704|Adductor canal blockade (ACB)|adductor canal blockade (acb)
5438964|NCT01549704|US-guided nerve block|us-guided nerve block
5438965|NCT01549691|Premedication|premedication
5438966|NCT01549691|Benzodiazepine|benzodiazepine
5438967|NCT01549691|Anti-anxiety agents|anti-anxiety agents
5438968|NCT01549691|Anxiety|anxiety
5438969|NCT01549691|Surgery|surgery
5438970|NCT01549691|Adult|adult
5438971|NCT01549691|Human|human
5438972|NCT01549678|Plantar fasciitis|plantar fasciitis
5438973|NCT01549678|foot pain|foot pain
5438974|NCT01549678|insoles|insoles
5438975|NCT01549678|foot function|foot function
5438976|NCT01549678|electronic baropodometer|electronic baropodometer
5438977|NCT01549678|plantar pressure|plantar pressure
5438978|NCT01549678|gait analysis|gait analysis
5438979|NCT01549665|Graft-Versus-Host Disease|graft-versus-host disease
5438980|NCT01549665|GVHD|gvhd
5438981|NCT01549665|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5438982|NCT01549665|Stem Cell Transplantation|stem cell transplantation
5438983|NCT01549665|Allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
5438984|NCT01549665|Mesenchymal Stem Cells|mesenchymal stem cells
5438985|NCT01549665|Unrelated Donors|unrelated donors
5438986|NCT01549665|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5438987|NCT01549639|Propofol|propofol
5438988|NCT01549639|Target controlled infusion|target controlled infusion
5438989|NCT01549639|General anaesthesia|general anaesthesia
5438990|NCT01549626|Flaxseed|flaxseed
5438991|NCT01549626|Women|women
5438992|NCT01549626|Obesity|obesity
5438993|NCT01549626|No smokers|no smokers
5438994|NCT01549574|crizotinib|crizotinib
5438995|NCT01549574|pharmacokinetics|pharmacokinetics
5438996|NCT01549574|esomeprazole|esomeprazole
5438997|NCT01549574|proton pump inhibitor|proton pump inhibitor
5438998|NCT01549574|drug drug interaction|drug drug interaction
5438999|NCT01549574|healthy volunteers|healthy volunteers
5439000|NCT01549561|behavior problems|behavior problems
5439001|NCT01549561|foster care|foster care
5439002|NCT01549561|parent training|parent training
5439003|NCT01549561|youth skills training|youth skills training
5439004|NCT01549548|CML|cml
5439005|NCT01549522|patients or caregivers|patients or caregivers
5439006|NCT01549522|for caregivers, loved one must still be living|for caregivers, loved one must still be living
5439007|NCT01549496|HCV|hcv
5439008|NCT01549496|pharmacokinetics|pharmacokinetics
5439009|NCT01549496|boceprevir|boceprevir
5439010|NCT01549496|hypertension|hypertension
5439011|NCT01549496|amlodipine|amlodipine
5439012|NCT01549496|diltiazem|diltiazem
5439013|NCT01549483|asthma|asthma
5439014|NCT01549483|airway hyperresponsiveness|airway hyperresponsiveness
5439015|NCT01549483|asymptomatic airway hyperresponsiveness|asymptomatic airway hyperresponsiveness
5439016|NCT01549483|small airways|small airways
5439017|NCT01549457|latent tuberculosis|latent tuberculosis
5439018|NCT01549457|text message interventions|text message interventions
5439019|NCT01549457|medication adherence|medication adherence
5439020|NCT01549444|renin|renin
5439021|NCT01549444|aldosterone|aldosterone
5439022|NCT01549444|neonate|neonate
5439023|NCT01549431|Multiple Myeloma|multiple myeloma
5439024|NCT01549418|Gastrointestinal bleeding|gastrointestinal bleeding
5439025|NCT01549418|Lower gastrointestinal bleeding (LGIB)|lower gastrointestinal bleeding (lgib)
5439026|NCT01549418|Polypectomy|polypectomy
5439027|NCT01549418|Large colorectal polyps|large colorectal polyps
5439028|NCT01549418|ASA|asa
5439029|NCT01549418|Aspirin|aspirin
5439030|NCT01549418|Acetylsalicylic acid|acetylsalicylic acid
5439031|NCT01549418|Colorectal Neoplasms|colorectal neoplasms
5439032|NCT01549418|Intestinal Neoplasms|intestinal neoplasms
5439033|NCT01549418|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5439034|NCT01549418|Digestive System Neoplasms|digestive system neoplasms
5439035|NCT01549418|Neoplasms by Site|neoplasms by site
5439036|NCT01549418|Neoplasms|neoplasms
5439037|NCT01549418|Digestive System Diseases|digestive system diseases
5439038|NCT01549418|Gastrointestinal Diseases|gastrointestinal diseases
5439039|NCT01549418|Colonic Diseases|colonic diseases
5439040|NCT01549418|Intestinal Diseases|intestinal diseases
5439042|NCT01549405|percutanous nephrolitotomy,intercostal nerve block, Ultrasound|percutanous nephrolitotomy,intercostal nerve block, ultrasound
5439043|NCT01549392|dynamic enhanced ct scan|dynamic enhanced ct scan
5439044|NCT01549392|mri spectroscopy|mri spectroscopy
5439045|NCT01549392|recurrent gliomas|recurrent gliomas
5439046|NCT01549379|Head and neck cancer|head and neck cancer
5439047|NCT01549379|Radiation|radiation
5439048|NCT01549379|Chemotherapy|chemotherapy
5439049|NCT01549379|Surgery|surgery
5433817|NCT01571596|XLH|xlh
5439050|NCT01549379|Dynamic contrast enhanced computed tomography|dynamic contrast enhanced computed tomography
5439051|NCT01549340|Rhinitis|rhinitis
5439052|NCT01549340|Allergen immunotherapy|allergen immunotherapy
5439053|NCT01549327|Virtual Patient Navigation|virtual patient navigation
5439054|NCT01549327|Randomized Clinical Trial|randomized clinical trial
5439055|NCT01549327|Empowerment|empowerment
5439056|NCT01549327|Cost-Effectiveness|cost-effectiveness
5439057|NCT01549327|Cancer Information Preferences|cancer information preferences
5439058|NCT01549314|Cystic fibrosis related bone disease|cystic fibrosis related bone disease
5439059|NCT01549314|Cystic fibrosis|cystic fibrosis
5439060|NCT01549314|Ivacaftor|ivacaftor
5439061|NCT01549249|cone outer segment tips line|cone outer segment tips line
5439062|NCT01549249|inner segment/outer segment junction line|inner segment/outer segment junction line
5439063|NCT01549249|optical coherence tomography|optical coherence tomography
5439064|NCT01549249|epiretinal membrane|epiretinal membrane
5439065|NCT01549236|Chagas Disease|chagas disease
5439066|NCT01549236|Trypanosoma Cruzi|trypanosoma cruzi
5439067|NCT01549236|T.Cruzi|t.cruzi
5439068|NCT01549223|Uterine Atony|uterine atony
5439069|NCT01549223|Hypotension|hypotension
5439071|NCT01549223|Hemorrhage|hemorrhage
5439072|NCT01549223|Phenylephrine|phenylephrine
5439073|NCT01549223|Ephedrine|ephedrine
5439074|NCT01549210|gout|gout
5439075|NCT01549210|gouty arthritis|gouty arthritis
5439076|NCT01549197|PTSD|ptsd
5439077|NCT01549184|secondary ITP|secondary itp
5439078|NCT01549184|hydroxychloroquine|hydroxychloroquine
5439079|NCT01549184|Systemic Lupus Erythematosus|systemic lupus erythematosus
5439080|NCT01549171|Human ART|human art
5439081|NCT01549171|Prostacyclin|prostacyclin
5439082|NCT01549171|Iloprost|iloprost
5439083|NCT01549171|Pregnancy|pregnancy
5439084|NCT01549158|loop diuretics|loop diuretics
5439085|NCT01549158|torasemide prolonged release|torasemide prolonged release
5439086|NCT01549158|torasemide immediate release|torasemide immediate release
5439087|NCT01549158|Sutril Neo|sutril neo
5439088|NCT01549158|pharmacodynamic profile of Torasemide-PR|pharmacodynamic profile of torasemide-pr
5439089|NCT01549145|Severe|severe
5439090|NCT01549145|Ongoing|ongoing
5439091|NCT01549145|Unilateral|unilateral
5439092|NCT01549145|present for more than 6 months|present for more than 6 months
5439093|NCT01549132|Clinically significant macular oedema|clinically significant macular oedema
5439094|NCT01549132|Retinal Oximetry|retinal oximetry
5439095|NCT01549132|Spectral imaging|spectral imaging
5439096|NCT01549132|Retinal Laser therapy|retinal laser therapy
5439097|NCT01549132|Intravitreal Anti-VEGF Injection therapy|intravitreal anti-vegf injection therapy
5439098|NCT01549119|HIV-1|hiv-1
5439100|NCT01549119|immunotherapy|immunotherapy
5439101|NCT01549119|active immunotherapy|active immunotherapy
5439102|NCT01549119|vaccine|vaccine
5439103|NCT01549119|virulence|virulence
5439104|NCT01549119|innate immunity|innate immunity
5439105|NCT01549119|NK cells|nk cells
5439106|NCT01549093|Non-small cell lung cancer|non-small cell lung cancer
5439107|NCT01549093|Endostar|endostar
5439108|NCT01549093|Continued Pumping into|continued pumping into
5439109|NCT01549093|Gemcitabine|gemcitabine
5439110|NCT01549093|Carboplatin|carboplatin
5439111|NCT01549080|traditional chinese medicine and thalassemia|traditional chinese medicine and thalassemia
5439112|NCT01549067|Advanced|advanced
5439113|NCT01549067|Colorectal Cancer|colorectal cancer
5439114|NCT01549067|Targeted chemotherapy|targeted chemotherapy
5547081|NCT01098773|BNP|bnp
5439115|NCT01549067|Surgery|surgery
5439116|NCT01549067|Radiotherapy|radiotherapy
5439117|NCT01549041|schizophrenia|schizophrenia
5439118|NCT01549041|asenapine|asenapine
5439119|NCT01549041|Once daily|once daily
5439120|NCT01549041|twice daily|twice daily
5439121|NCT01549015|Urea Cycle Defects|urea cycle defects
5439122|NCT01549015|CPSD|cpsd
5439123|NCT01549015|OTCD|otcd
5439124|NCT01549015|ASSD|assd
5439125|NCT01549015|ASLD|asld
5439126|NCT01549002|Abscess|abscess
5439127|NCT01549002|Pain|pain
5439128|NCT01549002|Administration intranasal|administration intranasal
5439129|NCT01549002|Infusions intravenous|infusions intravenous
5439130|NCT01548989|linguistic validation of a new questionnaire|linguistic validation of a new questionnaire
5439131|NCT01548976|linguistic validation of the PISQ-R questionnaire|linguistic validation of the pisq-r questionnaire
5439132|NCT01548963|Tight glycemia control|tight glycemia control
5439133|NCT01548963|Model Predictive Control algorithm|model predictive control algorithm
5439134|NCT01548963|Cardiac surgery patients|cardiac surgery patients
5439135|NCT01548950|Congenital heart disease|congenital heart disease
5439136|NCT01548950|Pulmonary arterial hypertension|pulmonary arterial hypertension
5439137|NCT01548950|Sildenafil|sildenafil
5439138|NCT01548950|Bosentan|bosentan
5439139|NCT01548950|Pediatric cardiac surgery|pediatric cardiac surgery
5439140|NCT01548937|I-123 ADAM Serotonin transporter imaging|i-123 adam serotonin transporter imaging
5439141|NCT01548924|Patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available|patients with malignant solid tumors of any histologically confirmed, not susceptible of cure, which have received the standard treatment available
5439142|NCT01548872|HTk solution|htk solution
5439144|NCT01548872|myocardial protection|myocardial protection
5439145|NCT01548872|pediatric cardiac surgery|pediatric cardiac surgery
5439146|NCT01548859|Myocardial protection|myocardial protection
5439147|NCT01548859|Myocardial injury|myocardial injury
5439148|NCT01548859|Anaesthetic preconditioning|anaesthetic preconditioning
5439149|NCT01548859|Pediatric cardiac surgery|pediatric cardiac surgery
5439150|NCT01548859|Troponin I|troponin i
5439151|NCT01548859|Sevoflurane|sevoflurane
5439152|NCT01548859|Midazolam|midazolam
5439153|NCT01548846|tomotherapy|tomotherapy
5439154|NCT01548846|xerostomy|xerostomy
5439155|NCT01548846|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5439156|NCT01548833|Myopia|myopia
5439157|NCT01548833|Contact Lenses|contact lenses
5439158|NCT01548820|Hepatitis B virus|hepatitis b virus
5439159|NCT01548820|Lamivudine|lamivudine
5439160|NCT01548820|Resistance to treatment|resistance to treatment
5439161|NCT01548794|spinal anesthesia|spinal anesthesia
5439162|NCT01548794|bupivacaine|bupivacaine
5439163|NCT01548794|lidocaine|lidocaine
5439164|NCT01548794|local infiltration anesthesia|local infiltration anesthesia
5439165|NCT01548794|recovery|recovery
5439166|NCT01548794|duration of anesthesia|duration of anesthesia
5439167|NCT01548794|outpatient herniorrhaphy|outpatient herniorrhaphy
5439168|NCT01548781|arm|arm
5439169|NCT01548781|strength|strength
5439170|NCT01548781|coordination|coordination
5439171|NCT01548781|physical therapy|physical therapy
5439172|NCT01548781|robotics|robotics
5439173|NCT01548781|stroke|stroke
5439174|NCT01548781|synergy|synergy
5439175|NCT01548768|Rheumatoid Arthritis|rheumatoid arthritis
5439176|NCT01548768|Cardiovascular disease|cardiovascular disease
5439177|NCT01548768|Myocardium|myocardium
5439178|NCT01548768|TNF-alpha inhibitors|tnf-alpha inhibitors
5439179|NCT01548768|ESCAPE|escape
5439180|NCT01548768|Co-morbidities|co-morbidities
5439181|NCT01548768|RHYTHM|rhythm
5439182|NCT01548755|Home monitoring|home monitoring
5439183|NCT01548755|cardiomessenger|cardiomessenger
5439184|NCT01548755|ICD|icd
5439185|NCT01548742|Meditation|meditation
5439186|NCT01548729|Cystic Fibrosis|cystic fibrosis
5439187|NCT01548729|Diabetes Related Cystic Fibrosis|diabetes related cystic fibrosis
5439188|NCT01548729|Lung transplantation|lung transplantation
5439189|NCT01548729|Pancreatic islets|pancreatic islets
5439190|NCT01548716|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
5439191|NCT01548716|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
5439192|NCT01548703|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
5439193|NCT01548703|antagonist|antagonist
5439194|NCT01548703|mGluR|mglur
5439195|NCT01548703|ketamine|ketamine
5439196|NCT01548703|BDNF|bdnf
5439197|NCT01548703|Depression|depression
5439198|NCT01548703|Major Depressive Disorder|major depressive disorder
5439199|NCT01548703|Treatment Resistant Depression|treatment resistant depression
5439200|NCT01548703|Mood Disorder|mood disorder
5439201|NCT01548703|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
5439202|NCT01548690|ornithine|ornithine
5439203|NCT01548690|phenylacetate|phenylacetate
5439204|NCT01548690|acetaminophen toxicity|acetaminophen toxicity
5439205|NCT01548690|acute liver failure|acute liver failure
5439206|NCT01548690|hepatitis B|hepatitis b
5439207|NCT01548690|autoimmune hepatitis|autoimmune hepatitis
5439208|NCT01548690|drug-induced liver injury|drug-induced liver injury
5439209|NCT01548677|Circulating Tumour Cells|circulating tumour cells
5439210|NCT01548677|HER2 negative primary breast cancer|her2 negative primary breast cancer
5439211|NCT01548677|HER2 positive CTC|her2 positive ctc
5439212|NCT01548677|Trastuzumab|trastuzumab
5439213|NCT01548664|Total knee replacement|total knee replacement
5439214|NCT01548664|Outpatient|outpatient
5439215|NCT01548664|Randomized controlled trial|randomized controlled trial
5439216|NCT01548664|Video games|video games
5439217|NCT01548638|Tobacco|tobacco
5439218|NCT01548638|Smoking|smoking
5439219|NCT01548638|Galantamine|galantamine
5439220|NCT01548625|risk of cardiovascular events|risk of cardiovascular events
5439221|NCT01548612|Schizophrenia|schizophrenia
5439222|NCT01548612|Nitric oxide|nitric oxide
5439223|NCT01548612|Sodium nitroprusside|sodium nitroprusside
5439225|NCT01548599|Malnutrition|malnutrition
5439226|NCT01548599|Food Security|food security
5439227|NCT01548599|Kenya|kenya
5439228|NCT01548586|tDCS|tdcs
5439229|NCT01548586|Diaphragm|diaphragm
5439230|NCT01548586|Cortical Excitability|cortical excitability
5439231|NCT01548586|MEPs|meps
5439233|NCT01548573|multiple myeloma|multiple myeloma
5439234|NCT01548573|POEMS (Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)|poems (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes)
5439235|NCT01548573|amyloidosis|amyloidosis
5439236|NCT01548573|bone marrow transplant|bone marrow transplant
5439237|NCT01548573|autologous|autologous
5439238|NCT01548560|HIV Infections|hiv infections
5439239|NCT01548560|Anti-HIV agents|anti-hiv agents
5439240|NCT01548560|HIV-1|hiv-1
5439241|NCT01548547|intravenous line|intravenous line
5439242|NCT01548547|simulation education|simulation education
5439243|NCT01548534|Metastatic Breast Cancer|metastatic breast cancer
5439244|NCT01548534|First-Line chemotherapy|first-line chemotherapy
5439245|NCT01548534|Taxane or Anthracycline|taxane or anthracycline
5439246|NCT01548534|DHA|dha
5439247|NCT01548534|PUFA|pufa
5439248|NCT01548534|Dietary supplementation|dietary supplementation
5680272|NCT00578409|castration resistant prostate cancer|castration resistant prostate cancer
5439249|NCT01548534|First-Line Taxane or Anthracycline based chemotherapy|first-line taxane or anthracycline based chemotherapy
5439250|NCT01548521|Prader-Willi, neonates, poor suckling|prader-willi, neonates, poor suckling
5439251|NCT01548508|Advanced Chronic Heart Failure, physical therapy, Exercise|advanced chronic heart failure, physical therapy, exercise
5439252|NCT01548495|MDS|mds
5439253|NCT01548495|Autoantibodies|autoantibodies
5439254|NCT01548495|Erythropoietin|erythropoietin
5439255|NCT01548495|Autoantibodies in MDS patients treated with EPO|autoantibodies in mds patients treated with epo
5439256|NCT01548469|Mild periodontitis|mild periodontitis
5439257|NCT01548469|Bio Mineral toothpaste|bio mineral toothpaste
5439258|NCT01548469|Geumjin Thermal Water|geumjin thermal water
5439259|NCT01548456|femur fracture|femur fracture
5439260|NCT01548456|internal fixation|internal fixation
5439267|NCT01548443|Mild Acute Trauma|mild acute trauma
5439268|NCT01548417|Alcohol|alcohol
5439269|NCT01548417|Relapse|relapse
5439270|NCT01548378|HGF|hgf
5439271|NCT01548378|Gene|gene
5439272|NCT01548378|Critical Limb Ischemia|critical limb ischemia
5439273|NCT01548365|Nursing Services|nursing services
5439274|NCT01548365|Catheterization, Central Venous|catheterization, central venous
5439275|NCT01548365|Catheters Indwelling|catheters indwelling
5439276|NCT01548365|Catheterization, Peripheral|catheterization, peripheral
5439277|NCT01548352|Syncope|syncope
5439278|NCT01548352|Unconsciousness|unconsciousness
5439279|NCT01548352|Syncope, vasovagal, neurally-mediated|syncope, vasovagal, neurally-mediated
5439280|NCT01548352|Syncope, cardiogenic|syncope, cardiogenic
5439281|NCT01548352|Cardiac arrhythmia|cardiac arrhythmia
5439282|NCT01548352|Sudden cardiac death|sudden cardiac death
5439283|NCT01548352|Syncopal episode|syncopal episode
5439284|NCT01548326|Vaccination Failure|vaccination failure
5439285|NCT01548326|Nonresponder|nonresponder
5439286|NCT01548326|Hepatitis B virus|hepatitis b virus
5439287|NCT01548326|Atorvastatin|atorvastatin
5439288|NCT01548326|Immunization against viral Hepatitis|immunization against viral hepatitis
5439289|NCT01548313|human milk|human milk
5439290|NCT01548313|nutrition|nutrition
5439291|NCT01548313|breastfed child|breastfed child
5439292|NCT01548313|microbiota|microbiota
5439293|NCT01548313|fatty acids|fatty acids
5439294|NCT01548313|intestinal microbiota|intestinal microbiota
5439295|NCT01548313|probiotics|probiotics
5439296|NCT01548300|cardiometabolic disease|cardiometabolic disease
5439297|NCT01548287|Mild Cognitive Impairment|mild cognitive impairment
5439298|NCT01548287|Mild Alzheimer's disease|mild alzheimer's disease
5439299|NCT01548287|Safety|safety
5439300|NCT01548287|Tolerability|tolerability
5439301|NCT01548274|endothelial progenitor cells|endothelial progenitor cells
5439302|NCT01548261|obtain the oral mucosal tissue from healthy donors|obtain the oral mucosal tissue from healthy donors
5439303|NCT01548222|type 2 diabetes|type 2 diabetes
5439304|NCT01548222|continuous glucose|continuous glucose
5439305|NCT01548222|basal insulin|basal insulin
5439306|NCT01548196|nephrolithotomy|nephrolithotomy
5426224|NCT01603771|MRI|mri
5439307|NCT01548170|Pharmacokinetic|pharmacokinetic
5439308|NCT01548170|Sunitinib|sunitinib
5439309|NCT01548170|Ketoconazol|ketoconazol
5439310|NCT01548170|interaction, Phase I|interaction, phase i
5439311|NCT01548157|HCP1007|hcp1007
5439312|NCT01548157|Rosuvastatin|rosuvastatin
5439313|NCT01548157|Omega-3|omega-3
5439314|NCT01548144|Advanced Cancers|advanced cancers
5439315|NCT01548144|Advanced Malignancies|advanced malignancies
5439316|NCT01548144|Crizotinib|crizotinib
5439317|NCT01548144|PF-02341066|pf-02341066
5439318|NCT01548144|Pazopanib|pazopanib
5439319|NCT01548144|Gw786034|gw786034
5439320|NCT01548144|Pemetrexed|pemetrexed
5439321|NCT01548144|LY231514|ly231514
5439322|NCT01548144|Alimta|alimta
5439323|NCT01548144|MTA|mta
5439324|NCT01548144|Multitargeted Antifolate|multitargeted antifolate
5439325|NCT01548144|NSC-698037|nsc-698037
5439326|NCT01548131|fear of childbirth|fear of childbirth
5439327|NCT01548131|delivery mode|delivery mode
5439328|NCT01548131|delivery satisfaction|delivery satisfaction
5439329|NCT01548118|Human papillomavirus|human papillomavirus
5439330|NCT01548118|vaccine|vaccine
5439331|NCT01548118|cervical infection|cervical infection
5439332|NCT01548118|cervical cancer|cervical cancer
5439333|NCT01548105|Pelvic organ prolapse|pelvic organ prolapse
5439334|NCT01548105|smoking and collagen metabolism|smoking and collagen metabolism
5439335|NCT01548092|Recto-vaginal fistula|recto-vaginal fistula
5439336|NCT01548092|Adipose Derived Stem Cells|adipose derived stem cells
5439337|NCT01548079|ursodeoxycholic acid|ursodeoxycholic acid
5439338|NCT01548079|fatty liver disease|fatty liver disease
5439339|NCT01548079|morbid obesity|morbid obesity
5439340|NCT01548079|bariatric surgery|bariatric surgery
5439341|NCT01548079|NAFLD|nafld
5439342|NCT01548053|Primary care|primary care
5439343|NCT01548053|Dementia|dementia
5439344|NCT01548053|Knowledge translation|knowledge translation
5439346|NCT01548053|Qualitative methods|qualitative methods
5439347|NCT01548053|Alzheimer's disease|alzheimer's disease
5439348|NCT01548040|NMES|nmes
5439349|NCT01548040|Muscle|muscle
5422003|NCT01621724|WT1 TCR|wt1 tcr
5439350|NCT01548040|strength|strength
5439351|NCT01548040|TKA|tka
5439352|NCT01548040|Focus to show shorter muscle recovery after Knee operation|focus to show shorter muscle recovery after knee operation
5439353|NCT01548027|TAP block|tap block
5439354|NCT01548027|postoperative analgesia|postoperative analgesia
5442470|NCT01534923|survey|survey
5439358|NCT01548001|Rheumatoid Arthritis|rheumatoid arthritis
5439360|NCT01548001|Methotrexate|methotrexate
5439361|NCT01547988|Aging|aging
5439362|NCT01547988|Falls|falls
5439363|NCT01547988|Balance Control|balance control
5439364|NCT01547988|Voluntary Step Execution Test|voluntary step execution test
5439365|NCT01547988|Dual-Task|dual-task
5439366|NCT01547988|Self-reported function|self-reported function
5439367|NCT01547975|surgical outcomes after corneal transplantation|surgical outcomes after corneal transplantation
5439368|NCT01547975|Retrospective analysis|retrospective analysis
5439369|NCT01547975|corneal transplantation|corneal transplantation
5439370|NCT01547949|pain|pain
5439371|NCT01547949|inflammation|inflammation
5439372|NCT01547949|muscle damage|muscle damage
5439373|NCT01547923|Colorectal Cancer|colorectal cancer
5439374|NCT01547923|DihydroPyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5439375|NCT01547923|Lethal toxicity|lethal toxicity
5439376|NCT01547923|Fluoropyrimidine|fluoropyrimidine
5439377|NCT01547910|fatty liver|fatty liver
5439378|NCT01547910|hepatitis|hepatitis
5439379|NCT01547910|insulin resistance|insulin resistance
5439380|NCT01547910|unsaturated fatty acids|unsaturated fatty acids
5439381|NCT01547910|NAFLD, children|nafld, children
5439382|NCT01547884|T Cells|t cells
5439383|NCT01547884|Immune Responses|immune responses
5439384|NCT01547884|Mycobacterial Antigens|mycobacterial antigens
5439385|NCT01547884|Tissue-invasive Helminth Parasites|tissue-invasive helminth parasites
5439386|NCT01547884|Cytokines|cytokines
5439387|NCT01547871|Natural History Study|natural history study
5439388|NCT01547871|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5439389|NCT01547871|Natural History|natural history
5439390|NCT01547858|Hematotoxicity|hematotoxicity
5439391|NCT01547858|Formaldehyde|formaldehyde
5439392|NCT01547858|Cross-Sectional Study|cross-sectional study
5439393|NCT01547858|Occupational Exposure|occupational exposure
5439394|NCT01547845|Disparities|disparities
5439395|NCT01547845|Patient Reported Outcomes|patient reported outcomes
5439396|NCT01547845|Symptoms|symptoms
5439397|NCT01547845|Symptom Surveillance|symptom surveillance
5439398|NCT01547832|Cholesterol|cholesterol
5439399|NCT01547832|Early Onset Parkinson's Disease|early onset parkinson's disease
5439400|NCT01547832|Fat Metabolism|fat metabolism
5439401|NCT01547832|Insulin Resistance|insulin resistance
5439402|NCT01547832|PARK2 Mutations|park2 mutations
5439403|NCT01547819|TBI|tbi
5439404|NCT01547819|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5439405|NCT01547819|PTSD|ptsd
5439406|NCT01547819|PET Imaging|pet imaging
5439407|NCT01547819|11C-Flumazenil|11c-flumazenil
5439408|NCT01547806|Autologous Hematopoietic Cell Transplantation|autologous hematopoietic cell transplantation
5439409|NCT01547806|Plasma Cell Myeloma|plasma cell myeloma
5439410|NCT01547806|Mobilization|mobilization
5439411|NCT01547806|Apheresis|apheresis
5439412|NCT01547806|Plerixafor|plerixafor
5439413|NCT01547793|Hemolytic Severity|hemolytic severity
5439414|NCT01547793|Erythrocyte|erythrocyte
5439415|NCT01547793|Sickle Cell Disease|sickle cell disease
5439416|NCT01547793|SD|sd
5439417|NCT01547780|MRI|mri
5439418|NCT01547780|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5439419|NCT01547780|Inflammation|inflammation
5439420|NCT01547780|Microglial Activation|microglial activation
5439421|NCT01547780|Traumatic Brain Injury|traumatic brain injury
5439422|NCT01547780|TBI|tbi
5439423|NCT01547767|Metabolism|metabolism
5439424|NCT01547767|Muscle|muscle
5439425|NCT01547767|Mutation|mutation
5439426|NCT01547767|ISCU Myopathy|iscu myopathy
5439427|NCT01547767|Myopathy|myopathy
5439428|NCT01547754|Neuroinflammation|neuroinflammation
5439429|NCT01547754|HIV|hiv
5439532|NCT01547429|secondary intraocular lens|secondary intraocular lens
5439430|NCT01547754|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5439431|NCT01547754|Mild Neurocognitive Disorder|mild neurocognitive disorder
5439432|NCT01547754|P-Glycoprotein|p-glycoprotein
5439433|NCT01547754|Mild Cognitive Disorder|mild cognitive disorder
5439434|NCT01547754|Healthy Volunteer|healthy volunteer
5439436|NCT01547741|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5439437|NCT01547741|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5439438|NCT01547741|HER2-negative breast cancer|her2-negative breast cancer
5439439|NCT01547741|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5439440|NCT01547741|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5439441|NCT01547741|stage IA breast cancer|stage ia breast cancer
5434210|NCT01570049|Open label|open label
5439442|NCT01547741|stage IB breast cancer|stage ib breast cancer
5439443|NCT01547741|stage II breast cancer|stage ii breast cancer
5422115|NCT01621269|MS|ms
5439444|NCT01547741|stage IIIA breast cancer|stage iiia breast cancer
5439445|NCT01547741|stage IIIC breast cancer|stage iiic breast cancer
5439446|NCT01547728|antithrombin|antithrombin
5439447|NCT01547728|Heparin Resistant|heparin resistant
5439448|NCT01547728|Cardiac Surgery|cardiac surgery
5439449|NCT01547715|Meningococcal,|meningococcal,
5439450|NCT01547715|ACWY,|acwy,
5439451|NCT01547715|bacterial meningitis,|bacterial meningitis,
5439452|NCT01547715|conjugate vaccine,|conjugate vaccine,
5439453|NCT01547715|healthy, children,|healthy, children,
5439454|NCT01547715|adolescents,|adolescents,
5439455|NCT01547715|adults,|adults,
5439456|NCT01547715|India|india
5439457|NCT01547702|ADHD|adhd
5439458|NCT01547702|attention|attention
5439459|NCT01547702|inattention|inattention
5439460|NCT01547702|hyperactivity|hyperactivity
5439461|NCT01547702|classroom intervention|classroom intervention
5439462|NCT01547702|teacher education|teacher education
5439463|NCT01547702|web-based intervention|web-based intervention
5439464|NCT01547663|pain scale|pain scale
5439465|NCT01547663|craniotomy|craniotomy
5439466|NCT01547637|Obturator nerve block|obturator nerve block
5439467|NCT01547637|Regional anesthesia|regional anesthesia
5439468|NCT01547637|TURBT|turbt
5439469|NCT01547624|Neck|neck
5439470|NCT01547624|Spine|spine
5439471|NCT01547624|Muscles|muscles
5439472|NCT01547624|Activity|activity
5439473|NCT01547624|Coordination|coordination
5439474|NCT01547611|Rehabilitation|rehabilitation
5439475|NCT01547611|Cervical Spine|cervical spine
5439476|NCT01547611|Radiculopathy|radiculopathy
5439477|NCT01547611|Disc|disc
5439478|NCT01547611|Surgery|surgery
5439479|NCT01547585|Cholesterol|cholesterol
5439480|NCT01547585|Cardiovascular disease|cardiovascular disease
5439482|NCT01547585|Dose-response|dose-response
5439483|NCT01547572|Video education|video education
5439484|NCT01547572|Enhanced recovery|enhanced recovery
5439485|NCT01547572|Reducing hospital stay|reducing hospital stay
5439486|NCT01547572|Improving patient satisfaction|improving patient satisfaction
5439487|NCT01547533|Chagas disease|chagas disease
5439488|NCT01547533|lactation|lactation
5439489|NCT01547533|breastmilk|breastmilk
5439490|NCT01547533|postpartum period|postpartum period
5439491|NCT01547533|infants|infants
5439492|NCT01547533|pediatric clinical pharmacology|pediatric clinical pharmacology
5439493|NCT01547533|developmental clinical pharmacology|developmental clinical pharmacology
5439494|NCT01547533|parasitology|parasitology
5439495|NCT01547533|trypanosoma cruzi|trypanosoma cruzi
5439496|NCT01547520|meperidine|meperidine
5439497|NCT01547520|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5439498|NCT01547520|unsedated|unsedated
5439499|NCT01547520|minimal sedation|minimal sedation
5439500|NCT01547507|hemodynamics|hemodynamics
5439501|NCT01547507|respiratory|respiratory
5439502|NCT01547494|Migraines|migraines
5439503|NCT01547494|Diet, Vegetarian|diet, vegetarian
5439504|NCT01547494|Diet, Fat-Restricted|diet, fat-restricted
5439505|NCT01547494|Pain|pain
5439506|NCT01547468|hip fracture|hip fracture
5439507|NCT01547468|elderly|elderly
5547583|NCT01096602|CT-011|ct-011
5439508|NCT01547468|delirium|delirium
5439509|NCT01547468|broken hip|broken hip
5439510|NCT01547468|hip|hip
5439511|NCT01547468|surgery|surgery
5439512|NCT01547468|orthopedic|orthopedic
5439513|NCT01547468|orthopedic surgery|orthopedic surgery
5439514|NCT01547468|pain|pain
5439515|NCT01547468|anesthesia|anesthesia
5439516|NCT01547468|Ochsner Clinic|ochsner clinic
5439517|NCT01547468|Ochsner Hospital|ochsner hospital
5439518|NCT01547468|Leslie Thomas MD|leslie thomas md
5439519|NCT01547468|New Orleans|new orleans
5439520|NCT01547468|Louisiana|louisiana
5439521|NCT01547455|Statin|statin
5439522|NCT01547455|kidney function|kidney function
5439523|NCT01547455|antiinflammatory effect|antiinflammatory effect
5439524|NCT01547442|aphakia|aphakia
5439525|NCT01547442|secondary intraocular lens|secondary intraocular lens
5439526|NCT01547442|congenital cataract|congenital cataract
5439527|NCT01547442|marfan syndrome|marfan syndrome
5439528|NCT01547442|pediatric cataract|pediatric cataract
5439529|NCT01547442|ectopia lentis|ectopia lentis
5439530|NCT01547442|subluxated lens|subluxated lens
5439531|NCT01547429|aphakia|aphakia
5439533|NCT01547416|Diaphragmatic dysfunction|diaphragmatic dysfunction
5439534|NCT01547416|General anesthesia|general anesthesia
5439535|NCT01547416|Epidural Anesthesia|epidural anesthesia
5439536|NCT01547403|Screening for Type 2 Diabetes|screening for type 2 diabetes
5439537|NCT01547390|preeclampsia|preeclampsia
5439538|NCT01547390|Aspirin|aspirin
5439539|NCT01547377|atherosclerosis|atherosclerosis
5439540|NCT01547377|zinc and selenium status|zinc and selenium status
5439541|NCT01547377|rosuvastatin|rosuvastatin
5439542|NCT01547377|oxidative stress biomarkers|oxidative stress biomarkers
5439543|NCT01547377|inflammation biomarkers|inflammation biomarkers
5439544|NCT01547364|Caudal|caudal
5439545|NCT01547364|Epidural|epidural
5439546|NCT01547364|Dextrose|dextrose
5439547|NCT01547364|Analgesia|analgesia
5439548|NCT01547364|TRVP1|trvp1
5863983|NCT00001147|Catecholamines|catecholamines
5422224|NCT01620801|AAV|aav
5439551|NCT01547351|Evaluation of ARMS questionnaire|evaluation of arms questionnaire
5439553|NCT01547338|Reconstruction|reconstruction
5439555|NCT01547299|prostatectomy|prostatectomy
5439557|NCT01547286|Asthma|asthma
5439558|NCT01547286|Allergen Challenge|allergen challenge
5439559|NCT01547286|Cat allergen|cat allergen
5439560|NCT01547286|Dust mite allergen|dust mite allergen
5439561|NCT01547286|Airway Hyper-responsiveness|airway hyper-responsiveness
5439562|NCT01547286|Positron Emission Tomography - Computed Tomography|positron emission tomography - computed tomography
5439563|NCT01547286|Nitrogen isotopes|nitrogen isotopes
5439564|NCT01547286|Blood flow|blood flow
5439565|NCT01547247|colonoscopy|colonoscopy
5439566|NCT01547247|cap-assisted colonoscopy|cap-assisted colonoscopy
5439567|NCT01547247|water immersion colonoscopy|water immersion colonoscopy
5439568|NCT01547234|Multiple Sclerosis|multiple sclerosis
5439569|NCT01547234|ambulation|ambulation
5439570|NCT01547234|manual function|manual function
5439571|NCT01547234|Fampridine|fampridine
5439572|NCT01547221|otomycosis|otomycosis
5439573|NCT01547221|3% boric acid|3% boric acid
5439574|NCT01547221|1% clotrimazole ear drop|1% clotrimazole ear drop
5439575|NCT01547208|ICD shocks|icd shocks
5439576|NCT01547208|Ventricular tachycardias ablation|ventricular tachycardias ablation
5439577|NCT01547208|Timing of ablation|timing of ablation
5439578|NCT01547208|Electrical storm|electrical storm
5439579|NCT01547208|Arrhythmic storm|arrhythmic storm
5439580|NCT01547195|fibromyalgia|fibromyalgia
5439581|NCT01547195|swimming|swimming
5439582|NCT01547169|memory|memory
5439583|NCT01547169|intranasal insulin|intranasal insulin
5439584|NCT01547169|Alzheimer's disease|alzheimer's disease
5439585|NCT01547156|patient decision support|patient decision support
5439586|NCT01547156|telemonitoring|telemonitoring
5439587|NCT01547156|self-management|self-management
5439588|NCT01547156|remote patient monitoring|remote patient monitoring
5439589|NCT01547156|active assistance technology|active assistance technology
5439590|NCT01547156|selfcare|selfcare
5439591|NCT01547143|Secondary hemophagocytic lymphohistiocytosis of adults|secondary hemophagocytic lymphohistiocytosis of adults
5439592|NCT01547130|Colonoscopy|colonoscopy
5439593|NCT01547130|Yoga|yoga
5439594|NCT01547130|Complementary and alternative medicine|complementary and alternative medicine
5439595|NCT01547130|Bowel cleansing|bowel cleansing
5439596|NCT01547130|Large bowel preparation|large bowel preparation
5439597|NCT01547130|Cancer screening|cancer screening
5439598|NCT01547130|Colorectal cancer|colorectal cancer
5439599|NCT01547117|POTS|pots
5439600|NCT01547117|Orthostatic Intolerance|orthostatic intolerance
5439601|NCT01547117|Orthostatic Tachycardia|orthostatic tachycardia
5439602|NCT01547091|Mesenchymal Stem Cells|mesenchymal stem cells
5439603|NCT01547091|Rheumatoid Arthritis|rheumatoid arthritis
5439604|NCT01547065|TEE and renal resistive index|tee and renal resistive index
5439605|NCT01547052|DBT, child, emotion regulation, behavior problems|dbt, child, emotion regulation, behavior problems
5439606|NCT01547039|Carotid endarterectomy|carotid endarterectomy
5439607|NCT01547039|Transcranial doppler|transcranial doppler
5439608|NCT01547039|Micro embolic signals|micro embolic signals
5439609|NCT01547039|Platelets|platelets
5439610|NCT01547039|Aspirin|aspirin
5439611|NCT01547026|schizophrenia|schizophrenia
5439612|NCT01547026|exercise|exercise
5439613|NCT01547026|sport|sport
5439614|NCT01547026|weight control|weight control
5439615|NCT01547026|fitness|fitness
5439616|NCT01547000|Tourette Syndrome|tourette syndrome
5439617|NCT01547000|Tourette Disorder|tourette disorder
5439618|NCT01547000|Tics|tics
5439619|NCT01547000|Motor tics|motor tics
5439620|NCT01547000|Vocal tics|vocal tics
5439622|NCT01547000|Guanfacine|guanfacine
5439623|NCT01547000|Medication|medication
5439624|NCT01547000|Drug|drug
5439625|NCT01547000|Placebo|placebo
5439626|NCT01547000|Child|child
5439627|NCT01547000|Children|children
5439628|NCT01547000|Adolescent|adolescent
5439629|NCT01546987|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5439630|NCT01546987|stage I prostate cancer|stage i prostate cancer
5439631|NCT01546987|stage IIA prostate cancer|stage iia prostate cancer
5439632|NCT01546987|stage IIB prostate cancer|stage iib prostate cancer
5439633|NCT01546987|stage III prostate cancer|stage iii prostate cancer
5439634|NCT01546987|stage IV prostate cancer|stage iv prostate cancer
5439635|NCT01546974|Mechanical Ventilation|mechanical ventilation
5439636|NCT01546974|Humidification system|humidification system
5439637|NCT01546974|Patients submitted to mechanical ventilation for at least 48 hours|patients submitted to mechanical ventilation for at least 48 hours
5439638|NCT01546961|Chloroquine|chloroquine
5439639|NCT01546961|Uncomplicated vivax malaria|uncomplicated vivax malaria
5439640|NCT01546948|Methadone|methadone
5439641|NCT01546948|Hydromorphone|hydromorphone
5439642|NCT01546948|Hepatobiliary surgery|hepatobiliary surgery
5439643|NCT01546948|Postoperative pain|postoperative pain
5439644|NCT01546935|Influenza|influenza
5439645|NCT01546935|Oseltamivir|oseltamivir
5422314|NCT01620268|Polyoma BK Nephropathy|polyoma bk nephropathy
5439646|NCT01546935|Lower tract respiratory infection|lower tract respiratory infection
5439647|NCT01546922|Hydrocortisone|hydrocortisone
5439648|NCT01546922|Cognition|cognition
5439649|NCT01546922|Adrenal insufficiency|adrenal insufficiency
5439650|NCT01546922|Quality of Life|quality of life
5439651|NCT01546922|Common Somatic Complaints|common somatic complaints
5439652|NCT01546922|Cardiovascular/Metabolic Profile|cardiovascular/metabolic profile
5439653|NCT01546922|Somatosensation|somatosensation
5439654|NCT01546883|Atrial fibrillation|atrial fibrillation
5439656|NCT01546857|orthopedic pain|orthopedic pain
5439657|NCT01546844|SMS|sms
5439658|NCT01546844|text|text
5439659|NCT01546844|text messages|text messages
5439660|NCT01546844|text messaging|text messaging
5439661|NCT01546844|diabetes|diabetes
5439662|NCT01546844|diabetes mellitus|diabetes mellitus
5439663|NCT01546844|type II diabetes|type ii diabetes
5439664|NCT01546844|type II diabetes mellitus|type ii diabetes mellitus
5439665|NCT01546844|type 2 diabetes|type 2 diabetes
5439666|NCT01546844|type 2 diabetes mellitus|type 2 diabetes mellitus
5439667|NCT01546844|Beacon|beacon
5439668|NCT01546818|HIV|hiv
5439669|NCT01546818|Vaccine|vaccine
5439670|NCT01546818|HIV-1 infections|hiv-1 infections
5439671|NCT01546805|Blepharospasm|blepharospasm
5439672|NCT01546805|Hemifacial spasm|hemifacial spasm
5439673|NCT01546805|Botox|botox
5439674|NCT01546805|Zinc|zinc
5439675|NCT01546792|exercise|exercise
5439676|NCT01546792|diet|diet
5439677|NCT01546792|lifestyle|lifestyle
5439678|NCT01546792|sleep apnoea|sleep apnoea
5439679|NCT01546792|obesity|obesity
5439680|NCT01546766|Diabetes|diabetes
5439681|NCT01546766|Pupillary response|pupillary response
5439682|NCT01546766|Retinal disorders|retinal disorders
5439683|NCT01546766|Midperipheral ischemia|midperipheral ischemia
5439684|NCT01546766|Fundus photography|fundus photography
5439685|NCT01546766|Optical coherence tomography|optical coherence tomography
5439686|NCT01546753|Walnut hypersensitivity|walnut hypersensitivity
5439687|NCT01546753|Tree nut hypersensitivity|tree nut hypersensitivity
5439688|NCT01546753|Oral immunotherapy|oral immunotherapy
5439689|NCT01546753|Food allergy|food allergy
5439690|NCT01546753|Walnut allergy|walnut allergy
5439691|NCT01546753|tree nut allergy|tree nut allergy
5439692|NCT01546740|Glaucoma, Compliance, Prevalence|glaucoma, compliance, prevalence
5439693|NCT01546727|Preschoolers|preschoolers
5439694|NCT01546727|Obesity|obesity
5439695|NCT01546727|Behavioral Treatment|behavioral treatment
5439696|NCT01546675|Amputation|amputation
5439697|NCT01546675|Prosthesis Design|prosthesis design
5439698|NCT01546675|Biomechanics|biomechanics
5439699|NCT01546662|Rhinitis|rhinitis
5439700|NCT01546636|Cerebral desaturation events|cerebral desaturation events
5439701|NCT01546636|Cerebral oximetry|cerebral oximetry
5439702|NCT01546636|Beach chair position|beach chair position
5439703|NCT01546610|Rheumatoid foot|rheumatoid foot
5439704|NCT01546610|foot pain|foot pain
5439705|NCT01546610|insoles|insoles
5439706|NCT01546610|foot function|foot function
5439707|NCT01546610|electronic baropodometer|electronic baropodometer
5439708|NCT01546610|plantar pressure|plantar pressure
5439709|NCT01546610|gait analysis|gait analysis
5439710|NCT01546597|Metformin|metformin
5439711|NCT01546597|Ranolazine|ranolazine
5439712|NCT01546597|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5439713|NCT01546558|Metformin|metformin
5439714|NCT01546558|Ranolazine|ranolazine
5439715|NCT01546558|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5439716|NCT01546532|Heart failure|heart failure
5439717|NCT01546532|RLX030|rlx030
5439718|NCT01546532|hemodynamics|hemodynamics
5439719|NCT01546532|cardiovascular diseases|cardiovascular diseases
5439720|NCT01546480|Chronic postoperative pain|chronic postoperative pain
5439721|NCT01546480|Postcholecystectomy pain|postcholecystectomy pain
5439722|NCT01546480|Inflammation|inflammation
5439723|NCT01546480|Interleukines|interleukines
5439724|NCT01546467|Schizophrenia|schizophrenia
5439725|NCT01546467|Schizoaffective disorder|schizoaffective disorder
5439726|NCT01546467|Psychosis|psychosis
5439727|NCT01546467|Early phase|early phase
5439728|NCT01546467|Cognitive remediation|cognitive remediation
5439729|NCT01546467|Functional outcome|functional outcome
5439730|NCT01546454|Premenopausal women|premenopausal women
5439731|NCT01546454|coronary heart disease|coronary heart disease
5439732|NCT01546454|menstrual cycle|menstrual cycle
5439733|NCT01546454|lipids|lipids
5439734|NCT01546441|primary care|primary care
5439735|NCT01546441|aging|aging
5439736|NCT01546441|interprofessional care|interprofessional care
5439737|NCT01546441|multimorbidity|multimorbidity
5439738|NCT01546428|c-MET|c-met
5439739|NCT01546428|Advanced solid tumor|advanced solid tumor
5439740|NCT01546415|Phase 4|phase 4
5439741|NCT01546415|Desferasirox|desferasirox
5439742|NCT01546415|Iron Overload|iron overload
5439743|NCT01546415|Aplastic Anemia|aplastic anemia
5439744|NCT01546389|Malaria, vaccine, PfSPZ, challenge|malaria, vaccine, pfspz, challenge
5439745|NCT01546350|infertility, recurrent pregnancy loss, miscarriage|infertility, recurrent pregnancy loss, miscarriage
5439747|NCT01546337|non-myeloid haemopathy|non-myeloid haemopathy
5422438|NCT01619722|PKU|pku
5439748|NCT01546337|myelodysplastic syndrome|myelodysplastic syndrome
5439749|NCT01546337|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5439750|NCT01546337|predictive markers|predictive markers
5439751|NCT01546324|Maternal Blood|maternal blood
5439752|NCT01546324|PGD|pgd
5439754|NCT01546324|Natera|natera
5439755|NCT01546324|Gene Security Network|gene security network
5439756|NCT01546324|Non-invasive prenatal diagnosis|non-invasive prenatal diagnosis
5439757|NCT01546311|prosthetic socket|prosthetic socket
5439758|NCT01546311|residual limb volume fluctuation|residual limb volume fluctuation
5439759|NCT01546311|instantaneous bladder|instantaneous bladder
5439760|NCT01546298|Contact Dermatitis|contact dermatitis
5439761|NCT01546285|The focus of this study is to demonstrate that DINAMAP® SuperSTATTM NIBP algorithm has been implemented correctly without performance losses to the B40 monitor|the focus of this study is to demonstrate that dinamap® superstattm nibp algorithm has been implemented correctly without performance losses to the b40 monitor
5439762|NCT01546272|Subcutaneous resorbable sutures|subcutaneous resorbable sutures
5439763|NCT01546272|Tolerance / effectiveness of subcutaneous suture|tolerance / effectiveness of subcutaneous suture
5439764|NCT01546272|Reduced operative time and anesthesia time|reduced operative time and anesthesia time
5439765|NCT01546272|Medico-economic evaluation|medico-economic evaluation
5439766|NCT01546272|Accidental exposure to blood|accidental exposure to blood
5439767|NCT01546259|colonoscopy|colonoscopy
5439768|NCT01546259|water|water
5439769|NCT01546259|female|female
5439770|NCT01546259|BMI|bmi
5439771|NCT01546259|unsedated|unsedated
5439772|NCT01546259|low BMI female patients|low bmi female patients
5439773|NCT01546259|Intubation|intubation
5439774|NCT01546246|colonoscopy|colonoscopy
5439775|NCT01546246|water|water
5439776|NCT01546246|incomplete|incomplete
5439777|NCT01546246|failed|failed
5439778|NCT01546246|unsedated|unsedated
5439779|NCT01546233|Lung cancer|lung cancer
5439780|NCT01546233|Chemotherapy|chemotherapy
5439781|NCT01546233|Multidisciplinary self care programme|multidisciplinary self care programme
5439782|NCT01546233|Fatigue|fatigue
5439783|NCT01546220|colonoscopy|colonoscopy
5439784|NCT01546220|elder patient|elder patient
5439785|NCT01546220|water|water
5439786|NCT01546220|unsedated|unsedated
5439787|NCT01546207|ventricular tachycardia|ventricular tachycardia
5439788|NCT01546207|catheter ablation|catheter ablation
5439789|NCT01546207|VT|vt
5439790|NCT01546194|Informed consent|informed consent
5439791|NCT01546194|Perioperative period|perioperative period
5439792|NCT01546194|Morning of surgery|morning of surgery
5439793|NCT01546194|Anesthesiology|anesthesiology
5439794|NCT01546181|photoreceptors|photoreceptors
5439795|NCT01546181|retinal pigment epithelium|retinal pigment epithelium
5439796|NCT01546181|adaptive optics|adaptive optics
5439797|NCT01546168|Atrial Fibrillation ablation|atrial fibrillation ablation
5439798|NCT01546168|Esophageal Deviation|esophageal deviation
5439799|NCT01546168|AF|af
5439800|NCT01546116|adefovir|adefovir
5439801|NCT01546116|lamivudine|lamivudine
5439802|NCT01546116|entecavir resistance|entecavir resistance
5439803|NCT01546103|Vitamin D deficiency|vitamin d deficiency
5439804|NCT01546090|Alprazolam|alprazolam
5439805|NCT01546090|benzodiazepines|benzodiazepines
5439806|NCT01546090|Inferior alveolar nerve block|inferior alveolar nerve block
5685295|NCT00556699|Rituxan|rituxan
5439807|NCT01546090|irreversible pulpitis|irreversible pulpitis
5439808|NCT01546090|local anesthesia|local anesthesia
5439809|NCT01546064|Bile duct anastomosis|bile duct anastomosis
5439810|NCT01546064|Biliary complications|biliary complications
5439811|NCT01546051|metabotropic glutamate receptors 2 and 3|metabotropic glutamate receptors 2 and 3
5439812|NCT01546051|antagonist|antagonist
5439813|NCT01546051|mGluR|mglur
5439814|NCT01546051|ketamine|ketamine
5439815|NCT01546051|BDNF|bdnf
5439816|NCT01546051|Depression|depression
5439817|NCT01546051|Major Depressive Disorder|major depressive disorder
5439818|NCT01546051|Mood Disorder|mood disorder
5439819|NCT01546051|Treatment Resistant Depression|treatment resistant depression
5439820|NCT01546051|Phase 1 safety, tolerability and pharmacokinetics study|phase 1 safety, tolerability and pharmacokinetics study
5439821|NCT01546038|Hedgehog Inhibitor|hedgehog inhibitor
5439822|NCT01546038|Acute Myeloid Leukemia|acute myeloid leukemia
5439823|NCT01546038|Myelodysplastic syndrome|myelodysplastic syndrome
5439824|NCT01546038|Intensive chemotherapy|intensive chemotherapy
5439825|NCT01546038|LDAC|ldac
5439826|NCT01546038|glasdegib|glasdegib
5439827|NCT01545999|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5439828|NCT01545999|Dorsolateral Prefrontal Cortex (DLPFC)|dorsolateral prefrontal cortex (dlpfc)
5439829|NCT01545999|Schizophrenia|schizophrenia
5439830|NCT01545999|Working Memory|working memory
5439831|NCT01545999|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
5439832|NCT01545999|Electroencephalography (EEG)|electroencephalography (eeg)
5439833|NCT01545999|Cognition|cognition
5439834|NCT01545986|Joint Replacement|joint replacement
5439835|NCT01545986|Exercise|exercise
5439836|NCT01545986|Power training|power training
5439847|NCT01545934|Weight Gain|weight gain
5439848|NCT01545921|Quality Of Life|quality of life
5439849|NCT01545921|Cancer|cancer
5439850|NCT01545921|End of life|end of life
5439851|NCT01545921|palliative setting|palliative setting
5439852|NCT01545908|Fecal transplant|fecal transplant
5439853|NCT01545908|induction of remission|induction of remission
5439854|NCT01545908|active ulcerative colitis|active ulcerative colitis
5439855|NCT01545882|prostate|prostate
5439856|NCT01545882|hormone-resistant|hormone-resistant
5439857|NCT01545882|degarelix|degarelix
5439858|NCT01545882|firmagon|firmagon
5439859|NCT01545882|anti-androgens|anti-androgens
5439860|NCT01545882|total androgen blockade|total androgen blockade
5439861|NCT01545882|injection|injection
5439862|NCT01545869|carbon dioxide laser|carbon dioxide laser
5439863|NCT01545869|fractional resurfacing|fractional resurfacing
5439864|NCT01545869|freckles|freckles
5439865|NCT01545869|melanosis|melanosis
5439866|NCT01545856|Parkinson's Disease|parkinson's disease
5439867|NCT01545856|cardiovascular events|cardiovascular events
5439868|NCT01545856|Levodopa|levodopa
5439869|NCT01545843|depression|depression
5439870|NCT01545843|sleep|sleep
5439871|NCT01545843|treatment|treatment
5439872|NCT01545830|Metabolic syndrome|metabolic syndrome
5439873|NCT01545830|Insulin resistance|insulin resistance
5439874|NCT01545830|Vitamin D deficiency|vitamin d deficiency
5439875|NCT01545817|Renal cell carcinoma (RCC), GW786034, Everolimus, Pazopanib, renal cancer, cancer, kidney cancer, hypernephroma, Grawitz tumor, renal adenocarcinoma.|renal cell carcinoma (rcc), gw786034, everolimus, pazopanib, renal cancer, cancer, kidney cancer, hypernephroma, grawitz tumor, renal adenocarcinoma.
5439876|NCT01545804|Hepatocellular carcinoma|hepatocellular carcinoma
5439877|NCT01545778|Substance abuse detection|substance abuse detection
5439878|NCT01545778|Opioids abuse|opioids abuse
5439879|NCT01545778|Tapentadol immediate-release (IR)|tapentadol immediate-release (ir)
5439880|NCT01545778|Oxycodone immediate-release (IR)|oxycodone immediate-release (ir)
5439881|NCT01545765|Healthy volunteers|healthy volunteers
5439882|NCT01545752|elearning|elearning
5439883|NCT01545752|CD-based education|cd-based education
5439884|NCT01545739|Pacemaker therapy|pacemaker therapy
5439885|NCT01545739|Cardiac resynchronisation therapy (CRT)|cardiac resynchronisation therapy (crt)
5439886|NCT01545726|Asthma|asthma
5439887|NCT01545726|Sputum eosinophilia|sputum eosinophilia
5439888|NCT01545726|CRTH2 receptor|crth2 receptor
5439889|NCT01545726|PGD2 antagonist|pgd2 antagonist
5439890|NCT01545713|renal|renal
5439891|NCT01545713|kidney|kidney
5439892|NCT01545713|transplant|transplant
5439893|NCT01545713|living donor|living donor
5439894|NCT01545700|dexamethasone|dexamethasone
5439895|NCT01545700|hyperglycemia|hyperglycemia
5439896|NCT01545700|gynecologic surgery|gynecologic surgery
5439897|NCT01545687|pain|pain
5439898|NCT01545687|oral complications of radiation therapy|oral complications of radiation therapy
5439899|NCT01545687|weight changes|weight changes
5439900|NCT01545687|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5439901|NCT01545687|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5439902|NCT01545687|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5439903|NCT01545687|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5685296|NCT00556699|anti-CD40|anti-cd40
5439904|NCT01545687|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5439905|NCT01545687|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5439906|NCT01545687|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5439907|NCT01545687|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5439908|NCT01545687|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5439909|NCT01545687|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5439910|NCT01545687|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5439911|NCT01545687|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5439912|NCT01545687|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5439913|NCT01545687|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5439915|NCT01545687|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5439916|NCT01545687|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5439917|NCT01545687|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5439918|NCT01545687|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5439919|NCT01545687|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5439920|NCT01545687|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5439921|NCT01545687|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5439922|NCT01545687|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5439923|NCT01545687|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5439924|NCT01545687|stage IVA verrucous carcinoma of the larynx|stage iva verrucous carcinoma of the larynx
5422596|NCT01619228|ontogeny of neonatal skin maturation|ontogeny of neonatal skin maturation
5439925|NCT01545687|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5439926|NCT01545687|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5439927|NCT01545687|stage IVB verrucous carcinoma of the larynx|stage ivb verrucous carcinoma of the larynx
5439928|NCT01545687|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5439929|NCT01545687|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5439930|NCT01545687|stage IVC verrucous carcinoma of the larynx|stage ivc verrucous carcinoma of the larynx
5439931|NCT01545687|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5439932|NCT01545687|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5439933|NCT01545687|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5439934|NCT01545687|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5439935|NCT01545687|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5439936|NCT01545687|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5439937|NCT01545687|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5439938|NCT01545687|stage IVA verrucous carcinoma of the oral cavity|stage iva verrucous carcinoma of the oral cavity
5439939|NCT01545687|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5439940|NCT01545687|stage IVB verrucous carcinoma of the oral cavity|stage ivb verrucous carcinoma of the oral cavity
5439941|NCT01545687|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5439942|NCT01545687|stage IVC verrucous carcinoma of the oral cavity|stage ivc verrucous carcinoma of the oral cavity
5439943|NCT01545687|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5439944|NCT01545687|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5439946|NCT01545674|Non-invasive Prenatal Diagnosis|non-invasive prenatal diagnosis
5439947|NCT01545674|Prenatal Blood Test|prenatal blood test
5439948|NCT01545674|Prenatal Aneuploidy Screening|prenatal aneuploidy screening
5439949|NCT01545674|Trisomy 13|trisomy 13
5439950|NCT01545674|Trisomy 18|trisomy 18
5439951|NCT01545674|Trisomy 21|trisomy 21
5439953|NCT01545674|Down Syndrome|down syndrome
5439954|NCT01545674|Turner Syndrome|turner syndrome
5439955|NCT01545674|Edwards Syndrome|edwards syndrome
5439956|NCT01545661|Tuberculosis|tuberculosis
5439957|NCT01545661|diagnosis|diagnosis
5439958|NCT01545661|sputum induction|sputum induction
5439959|NCT01545661|primary care|primary care
5439961|NCT01545648|cancer|cancer
5439962|NCT01545648|early|early
5439963|NCT01545648|DTC|dtc
5439964|NCT01545648|disseminated|disseminated
5439965|NCT01545648|tumor|tumor
5439966|NCT01545648|cells|cells
5439967|NCT01545635|Major trauma|major trauma
5439968|NCT01545635|Injury Severity Score|injury severity score
5439969|NCT01545635|ISS > 15|iss > 15
5439970|NCT01545635|clinical signs|clinical signs
5439971|NCT01545635|risk of blood loss|risk of blood loss
5439972|NCT01545635|coagulopathy|coagulopathy
5439973|NCT01545635|rotational thrombelastometry|rotational thrombelastometry
5439974|NCT01545635|ROTEM|rotem
5439975|NCT01545609|Text messaging|text messaging
5439976|NCT01545609|birth control|birth control
5439977|NCT01545609|adolescents|adolescents
5439978|NCT01545596|Intraoperative Monitoring|intraoperative monitoring
5439979|NCT01545596|Decision Support Systems|decision support systems
5439980|NCT01545596|anesthesia outcomes|anesthesia outcomes
5439981|NCT01545557|Volume loss|volume loss
5439982|NCT01545544|B-Cell Non Hodgkin Lymphomas|b-cell non hodgkin lymphomas
5439983|NCT01545544|Hepatitis C|hepatitis c
5439984|NCT01545531|glomerular filtration rate|glomerular filtration rate
5439985|NCT01545531|iohexol|iohexol
5439986|NCT01545531|hematopoietic cell transplant|hematopoietic cell transplant
5439987|NCT01545531|kidney function|kidney function
5439989|NCT01545531|cystatin C.|cystatin c.
5439990|NCT01545518|Refractory epilepsy|refractory epilepsy
5439991|NCT01545518|Cryptogenic epilepsy|cryptogenic epilepsy
5439992|NCT01545518|Autoimmune disorders|autoimmune disorders
5439994|NCT01545518|Immunomodulatory therapy|immunomodulatory therapy
5439995|NCT01545518|Autoantibodies|autoantibodies
5439996|NCT01545492|CHIPS|chips
5439997|NCT01545492|famine|famine
5439998|NCT01545492|reprogramming|reprogramming
5439999|NCT01545492|developmental|developmental
5440000|NCT01545492|blood|blood
5425146|NCT01608490|RePneu|repneu
5440001|NCT01545492|pressure|pressure
5440002|NCT01545492|randomised|randomised
5440003|NCT01545492|randomized|randomized
5440004|NCT01545492|hypertension|hypertension
5440005|NCT01545492|anthropometry|anthropometry
5440006|NCT01545492|measurement|measurement
5440007|NCT01545492|genetics|genetics
5440008|NCT01545492|epigenetics|epigenetics
5440009|NCT01545492|methylation|methylation
5440010|NCT01545492|cortisol|cortisol
5440011|NCT01545492|stress|stress
5440013|NCT01545492|growth|growth
5440014|NCT01545492|weight|weight
5440015|NCT01545492|length|length
5440016|NCT01545492|height|height
5440017|NCT01545479|ECA|eca
5440018|NCT01545479|BOLD-MRI|bold-mri
5440019|NCT01545479|kidney|kidney
5440020|NCT01545466|Migraines|migraines
5440021|NCT01545466|Behavioral|behavioral
5440022|NCT01545466|Complementary and Alternative Medicine|complementary and alternative medicine
5440023|NCT01545466|Mindfulness Meditation|mindfulness meditation
5440024|NCT01545466|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5440025|NCT01545427|Scleroderma|scleroderma
5440026|NCT01545427|Randomized controled trial|randomized controled trial
5440027|NCT01545427|Pilot study|pilot study
5440028|NCT01545427|Gleevec (imatinib)|gleevec (imatinib)
5440029|NCT01545427|Biomarkers|biomarkers
5440030|NCT01545414|Self-help treatment|self-help treatment
5440031|NCT01545414|Internet treatment|internet treatment
5440032|NCT01545414|Cognitive Behavioral Therapy|cognitive behavioral therapy
5440033|NCT01545414|Internet-based Cognitive Behavioral Therapy|internet-based cognitive behavioral therapy
5440034|NCT01545401|chronic disease management|chronic disease management
5440035|NCT01545401|Chronic Care Model|chronic care model
5440036|NCT01545401|multifaceted intervention|multifaceted intervention
5440037|NCT01545401|primary care|primary care
5440038|NCT01545401|type 2 diabetes mellitus|type 2 diabetes mellitus
5440039|NCT01545401|hypertension|hypertension
5440040|NCT01545375|nasopharyngeal carriage|nasopharyngeal carriage
5440041|NCT01545375|safety|safety
5440042|NCT01545375|immunogenicity|immunogenicity
5440043|NCT01545375|US|us
5440044|NCT01545375|Pneumococcal vaccine|pneumococcal vaccine
5440045|NCT01545375|efficacy|efficacy
5440046|NCT01545375|Streptococcus pneumoniae|streptococcus pneumoniae
5440047|NCT01545375|infants|infants
5440048|NCT01545349|LGG|lgg
5440049|NCT01545349|Immune response|immune response
5440050|NCT01545349|Influenza vaccine|influenza vaccine
5440051|NCT01545349|Elderly|elderly
5440052|NCT01545349|Healthy|healthy
5440053|NCT01545349|Microbiome|microbiome
5440054|NCT01545323|Netherton syndrome|netherton syndrome
5440055|NCT01545323|Gene therapy|gene therapy
5440056|NCT01545323|SPINK5|spink5
5440057|NCT01545297|dexmedetomidine|dexmedetomidine
5440058|NCT01545297|conscious sedation|conscious sedation
5440059|NCT01545297|awake craniotomy|awake craniotomy
5440060|NCT01545297|brain mapping|brain mapping
5440061|NCT01545284|chronic hand dermatitis|chronic hand dermatitis
5440062|NCT01545284|acitretin|acitretin
5440063|NCT01545284|PGA|pga
5440064|NCT01545271|Xenon|xenon
5440065|NCT01545271|Hypothermia|hypothermia
5440066|NCT01545271|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5440067|NCT01545271|Newborn|newborn
5440068|NCT01545271|Term|term
5440069|NCT01545271|Neuroprotection|neuroprotection
5440070|NCT01545271|Cooling|cooling
5440071|NCT01545271|HIE|hie
5440072|NCT01545245|atopic asthma|atopic asthma
5440073|NCT01545245|recurrent wheezing|recurrent wheezing
5440074|NCT01545245|preterm infants|preterm infants
5440075|NCT01545245|palivizumab|palivizumab
5440076|NCT01545245|respiratory syncytial virus|respiratory syncytial virus
5440077|NCT01545245|RSV|rsv
5440078|NCT01545232|Massive Transfusion|massive transfusion
5440079|NCT01545232|Trauma|trauma
5440080|NCT01545232|Coagulopathy|coagulopathy
5440081|NCT01545232|Trauma Induced Coagulopathy|trauma induced coagulopathy
5440082|NCT01545232|Plasma|plasma
5440083|NCT01545232|Platelets|platelets
5440084|NCT01545232|Red Blood Cells|red blood cells
5440085|NCT01545232|Mortality|mortality
5440086|NCT01545232|Wounds and Injuries|wounds and injuries
5440087|NCT01545232|Shock, Hemorrhagic|shock, hemorrhagic
5440088|NCT01545232|Shock|shock
5440089|NCT01545232|Pathologic Processes|pathologic processes
5440090|NCT01545232|Hemorrhage|hemorrhage
5440091|NCT01545232|Hemostatics|hemostatics
5440092|NCT01545232|Coagulation|coagulation
5440093|NCT01545232|Transfusion-related acute lung injury (TRALI)|transfusion-related acute lung injury (trali)
5440094|NCT01545232|Inflammation|inflammation
5440096|NCT01545193|Residual neuromuscular blockade|residual neuromuscular blockade
5440097|NCT01545180|Observatory|observatory
5440098|NCT01545180|Heart failure|heart failure
5440099|NCT01545180|Post-capillary pulmonary hypertension|post-capillary pulmonary hypertension
5440100|NCT01545180|HTPcap|htpcap
5440101|NCT01545167|African Americans|african americans
5440102|NCT01545167|pancreatitis|pancreatitis
5440103|NCT01545167|controls|controls
5440104|NCT01545141|metastatic|metastatic
5440105|NCT01545141|recurrent|recurrent
5440106|NCT01545141|peritoneal metastasis|peritoneal metastasis
5440107|NCT01545141|cytoreductive surgery|cytoreductive surgery
5440108|NCT01545141|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
5440110|NCT01545141|hepatic metastasis|hepatic metastasis
5440111|NCT01545141|extrahepatic metastasis|extrahepatic metastasis
5440112|NCT01545141|vaccine|vaccine
5440113|NCT01545128|COPD|copd
5440114|NCT01545128|Pulmonary rehabilitation|pulmonary rehabilitation
5440115|NCT01545115|Children|children
5440116|NCT01545115|Immunity|immunity
5440117|NCT01545115|Sub-Saharan|sub-saharan
5440118|NCT01545115|Pertussis|pertussis
5440119|NCT01545115|Malaria|malaria
5440120|NCT01545115|Nutrition|nutrition
5440121|NCT01545115|antibodies|antibodies
5440122|NCT01545011|Inspiratory muscle training|inspiratory muscle training
5440123|NCT01545011|COPD|copd
5440124|NCT01545011|Conventional respiratory rehabilitation|conventional respiratory rehabilitation
5440125|NCT01545011|Dyspnea scale|dyspnea scale
5440126|NCT01544985|pediatrics|pediatrics
5440127|NCT01544985|emergency medicine|emergency medicine
5440128|NCT01544985|pain|pain
5440129|NCT01544985|bladder catheterization|bladder catheterization
5440130|NCT01544972|Patent Ductus Arteriosus|patent ductus arteriosus
5440131|NCT01544972|Paracetamol|paracetamol
5440132|NCT01544972|Ibuprofen|ibuprofen
5440133|NCT01544972|Serum levels|serum levels
5440134|NCT01544972|Preterm infant|preterm infant
5440135|NCT01544959|Narcotic|narcotic
5440136|NCT01544959|Opioid|opioid
5440137|NCT01544959|betablocking drug|betablocking drug
5440138|NCT01544959|postoperative pain|postoperative pain
5440139|NCT01544959|postoperative nausea and vomiting|postoperative nausea and vomiting
5440140|NCT01544959|breast cancer|breast cancer
5440141|NCT01544959|hyperalgesia|hyperalgesia
5440142|NCT01544959|cancer recurrence|cancer recurrence
5440143|NCT01544959|anesthesia|anesthesia
5440144|NCT01544959|mastectomy|mastectomy
5440145|NCT01544959|chronic postsurgical pain syndrome|chronic postsurgical pain syndrome
5440146|NCT01544959|acute postoperative pain|acute postoperative pain
5440147|NCT01544959|postmastectomy pain syndrome|postmastectomy pain syndrome
5440148|NCT01544959|pain|pain
5440149|NCT01544959|ambulatory surgery|ambulatory surgery
5440150|NCT01544946|pediatrics|pediatrics
5440151|NCT01544946|emergency medicine|emergency medicine
5440152|NCT01544946|pain|pain
5440153|NCT01544946|nasopharyngeal aspiration|nasopharyngeal aspiration
5440154|NCT01544933|spinal fractures|spinal fractures
5440155|NCT01544933|Thoracic vertebrae|thoracic vertebrae
5440156|NCT01544933|spinal canal|spinal canal
5440157|NCT01544933|kyphosis|kyphosis
5440158|NCT01544907|Drug Eluting Balloon|drug eluting balloon
5440159|NCT01544907|Arteriovenous fistula or graft stenosis|arteriovenous fistula or graft stenosis
5440160|NCT01544894|Postmenopausal osteoporosis|postmenopausal osteoporosis
5440161|NCT01544894|Compliance|compliance
5440162|NCT01544894|Bone mineral density|bone mineral density
5440163|NCT01544894|Bonemarkers|bonemarkers
5440164|NCT01544881|Pharmacokinetics|pharmacokinetics
5440165|NCT01544881|Pharmacodynamics|pharmacodynamics
5440166|NCT01544881|Hyperglycemia|hyperglycemia
5440167|NCT01544881|Insulin|insulin
5440168|NCT01544868|Total Energy Expenditure|total energy expenditure
5440169|NCT01544868|Protein Balance|protein balance
5440170|NCT01544868|Burns|burns
5440171|NCT01544855|Health young participants|health young participants
5440172|NCT01544842|Oral lichen planus|oral lichen planus
5440173|NCT01544842|Tacrolimus ointment|tacrolimus ointment
5440174|NCT01544842|Triamcinolone paste|triamcinolone paste
5440175|NCT01544829|theobromine|theobromine
5440176|NCT01544829|heart rate|heart rate
5440177|NCT01544829|blood lipids|blood lipids
5440178|NCT01544803|Randomized Controlled Trial|randomized controlled trial
5440179|NCT01544803|Alcohol|alcohol
5440180|NCT01544803|Internet|internet
5440181|NCT01544803|Screening|screening
5440182|NCT01544803|Brief intervention|brief intervention
5440183|NCT01544803|Personalized feedback|personalized feedback
5440184|NCT01544790|Esophageal carcinoma|esophageal carcinoma
5440185|NCT01544790|Esophageal cancer|esophageal cancer
5440186|NCT01544790|Robotic surgery|robotic surgery
5440187|NCT01544790|Esophagectomy|esophagectomy
5440188|NCT01544790|Minimally invasive|minimally invasive
5440189|NCT01544777|Aphakia|aphakia
5440190|NCT01544777|Cataract|cataract
5440191|NCT01544764|Diphtheria-Tetanus-Pertussis Vaccine|diphtheria-tetanus-pertussis vaccine
5440192|NCT01544764|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5440193|NCT01544764|Meningococcal Vaccines|meningococcal vaccines
5440490|NCT01543516|Sputum|sputum
5440194|NCT01544764|Hepatitis B Vaccines|hepatitis b vaccines
5440195|NCT01544764|Chickenpox Vaccine|chickenpox vaccine
5440196|NCT01544764|Papillomavirus Vaccines|papillomavirus vaccines
5440198|NCT01544751|metformin|metformin
5440199|NCT01544751|atorvastatin|atorvastatin
5440200|NCT01544751|metabolic syndrome|metabolic syndrome
5440201|NCT01544738|Parkinson Disease|parkinson disease
5440202|NCT01544738|sensory stimulation|sensory stimulation
5440203|NCT01544738|Bradykinesia|bradykinesia
5440204|NCT01544725|Procedural sedation|procedural sedation
5440205|NCT01544725|Ketamine-propofol|ketamine-propofol
5440206|NCT01544725|Ketamine|ketamine
5440207|NCT01544712|osteonecrosis|osteonecrosis
5440208|NCT01544712|cell-based therapy|cell-based therapy
5440209|NCT01544712|bone marrow|bone marrow
5440210|NCT01544712|mesenchymal stem cell|mesenchymal stem cell
5440211|NCT01544712|hip|hip
5440212|NCT01544712|core decompression|core decompression
5440213|NCT01544699|stroke|stroke
5440214|NCT01544686|neutropenia|neutropenia
5440215|NCT01544686|cancer|cancer
5440216|NCT01544686|fever|fever
5440217|NCT01544686|central venous catheter|central venous catheter
5440218|NCT01544686|infection|infection
5440219|NCT01544660|spine and hip scan|spine and hip scan
5440220|NCT01544660|BMD|bmd
5440221|NCT01544647|Knee osteoarthritis|knee osteoarthritis
5440222|NCT01544647|spa therapy|spa therapy
5440223|NCT01544647|spa modalities|spa modalities
5440224|NCT01544634|Asthma|asthma
5440225|NCT01544634|Propranolol|propranolol
5440226|NCT01544634|Inhaled corticosteroids|inhaled corticosteroids
5440227|NCT01544634|Steroid sparing agent|steroid sparing agent
5440228|NCT01544634|Airway hyper-responsiveness|airway hyper-responsiveness
5440229|NCT01544621|Real life smoking cessation. NON-drug NON-intervention study|real life smoking cessation. non-drug non-intervention study
5440230|NCT01544608|Acute psychotic episode of Schizophrenia|acute psychotic episode of schizophrenia
5440231|NCT01544595|Psoriasis, inflammatory skin disease|psoriasis, inflammatory skin disease
5440232|NCT01544595|scaly patches|scaly patches
5440233|NCT01544595|secukinumab (AIN457)|secukinumab (ain457)
5440234|NCT01544595|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
5440235|NCT01544595|Investigator Global Assessment (IGA) mod 2011|investigator global assessment (iga) mod 2011
5440236|NCT01544582|Pegylated Interferon|pegylated interferon
5440237|NCT01544582|boceprevir|boceprevir
5440238|NCT01544582|telaprevir|telaprevir
5440239|NCT01544569|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5440240|NCT01544556|abdominoplasty|abdominoplasty
5440241|NCT01544543|COPD|copd
5440242|NCT01544530|Brain-death|brain-death
5440243|NCT01544530|organ donation|organ donation
5440244|NCT01544517|Helicobacter pylori|helicobacter pylori
5440245|NCT01544517|Concomitant therapy|concomitant therapy
5440246|NCT01544517|Sequential therapy|sequential therapy
5440247|NCT01544517|levofloxacin|levofloxacin
5440248|NCT01544504|Radiodermatitis|radiodermatitis
5440249|NCT01544504|Prevention|prevention
5440250|NCT01544504|Radiotherapy|radiotherapy
5440251|NCT01544504|Breast|breast
5440252|NCT01544504|Radiation Dermatitis|radiation dermatitis
5440253|NCT01544491|Paediatric kidney transplantation|paediatric kidney transplantation
5440254|NCT01544491|Early MMF to everolimus conversion|early mmf to everolimus conversion
5440255|NCT01544491|Composite efficacy (biopsy-proven acute rejection, graft loss or death)|composite efficacy (biopsy-proven acute rejection, graft loss or death)
5440256|NCT01544491|Renal function|renal function
5440257|NCT01544465|Parkinson's disease|parkinson's disease
5440258|NCT01544465|Sleep Quality|sleep quality
5440259|NCT01544465|Daytime sleepiness|daytime sleepiness
5440260|NCT01544465|physical therapy|physical therapy
5440261|NCT01544465|exercise|exercise
5440262|NCT01544452|MR|mr
5440263|NCT01544452|CT|ct
5440264|NCT01544452|ultrasonography|ultrasonography
5440265|NCT01544452|MR colonography|mr colonography
5440266|NCT01544452|MR rectum|mr rectum
5440267|NCT01544452|MR liver|mr liver
5440268|NCT01544439|Temporomandibular joint disorders|temporomandibular joint disorders
5440269|NCT01544439|Stress psychological|stress psychological
5440270|NCT01544439|Depression|depression
5440271|NCT01544439|Quality of Life|quality of life
5440272|NCT01544426|Office hysteroscopy,|office hysteroscopy,
5440273|NCT01544426|intrauterine insemination|intrauterine insemination
5440274|NCT01544426|endometrial scrap|endometrial scrap
5440275|NCT01544413|laparoscopic sentinel lymph node biopsy|laparoscopic sentinel lymph node biopsy
5440276|NCT01544413|quality control study|quality control study
5440277|NCT01544413|early gastric cancer|early gastric cancer
5440278|NCT01544400|reverse anorexia,|reverse anorexia,
5440279|NCT01544400|anorexia athletics|anorexia athletics
5440280|NCT01544387|Preterm Premature Rupture Of Membranes|preterm premature rupture of membranes
5440281|NCT01544387|PPROM|pprom
5440282|NCT01544387|Pregnancy|pregnancy
5440283|NCT01544387|Bed rest.|bed rest.
5440284|NCT01544374|Breast Cancer|breast cancer
5440285|NCT01544374|Treatment Disparities|treatment disparities
5440286|NCT01544374|Tracking and Feedback|tracking and feedback
5440287|NCT01544374|Registry|registry
5440288|NCT01544374|Cancer Therapy Disparities|cancer therapy disparities
5440289|NCT01544374|Adjuvant Treatment|adjuvant treatment
5440290|NCT01544374|Racial Disparities|racial disparities
5440291|NCT01544374|Underuse of Adjuvant Treatment|underuse of adjuvant treatment
5440292|NCT01544361|Healthy subjects|healthy subjects
5440293|NCT01544361|MEDI7814|medi7814
5440295|NCT01544348|Allergic|allergic
5440296|NCT01544348|Atopic Dermatitis|atopic dermatitis
5440297|NCT01544348|MEDI4212|medi4212
5440298|NCT01544322|solid tumors|solid tumors
5440299|NCT01544322|recurrent|recurrent
5440300|NCT01544322|advanced|advanced
5440301|NCT01544322|metastatic|metastatic
5440302|NCT01544322|refractory|refractory
5440303|NCT01544283|Shoulder Pain|shoulder pain
5440304|NCT01544283|Shoulder Impingement Syndrome|shoulder impingement syndrome
5440305|NCT01544270|milk protein|milk protein
5440306|NCT01544270|probiotics|probiotics
5440307|NCT01544270|stress|stress
5440308|NCT01544270|cortisol|cortisol
5440309|NCT01544270|heart beat|heart beat
5440310|NCT01544257|Osteopathic manipulative treatment|osteopathic manipulative treatment
5440311|NCT01544257|alternative medicine|alternative medicine
5440312|NCT01544257|complementary medicine|complementary medicine
5440313|NCT01544257|neonatology|neonatology
5440314|NCT01544257|neonatal care|neonatal care
5440315|NCT01544257|prematurity|prematurity
5440316|NCT01544257|allied health care|allied health care
5440317|NCT01544244|comparison of physical therapy strategies|comparison of physical therapy strategies
5440318|NCT01544231|Neutrophil Gelatinase Associated Lipocalin|neutrophil gelatinase associated lipocalin
5440319|NCT01544231|predicting acute kidney failure|predicting acute kidney failure
5440320|NCT01544231|emergency room|emergency room
5440321|NCT01544218|Alcohol related disorders|alcohol related disorders
5440322|NCT01544192|Antioxidant|antioxidant
5440323|NCT01544192|α−tocopherol|α−tocopherol
5440324|NCT01544192|Vitamin E|vitamin e
5440325|NCT01544192|Gingko Biloba|gingko biloba
5440326|NCT01544192|Glaucoma|glaucoma
5440327|NCT01544192|Neuroprotection|neuroprotection
5440328|NCT01544192|Retina|retina
5440329|NCT01544179|Non Small Cell Lung Cancer|non small cell lung cancer
5440330|NCT01544179|Gefitinib|gefitinib
5440331|NCT01544179|Pemetrexed|pemetrexed
5440332|NCT01544179|Treatment Beyond Progression|treatment beyond progression
5440333|NCT01544166|Gadolinium, Pediatrics, MRI, contrast|gadolinium, pediatrics, mri, contrast
5440334|NCT01544153|Web based behavioral intervention|web based behavioral intervention
5440335|NCT01544153|Adherence|adherence
5440336|NCT01544153|Smoking cessation|smoking cessation
5440337|NCT01544153|Social network|social network
5440338|NCT01544153|Nicotine replacement therapy|nicotine replacement therapy
5440339|NCT01544153|Social support|social support
5440340|NCT01544140|Phase 1|phase 1
5440341|NCT01544140|healthy volunteers|healthy volunteers
5440342|NCT01544140|pharmacokinetics|pharmacokinetics
5440343|NCT01544140|vandetanib|vandetanib
5440344|NCT01544140|midazolam|midazolam
5440345|NCT01544127|Veterans|veterans
5440346|NCT01544127|Motivational Interviewing|motivational interviewing
5440347|NCT01544127|Inpatients|inpatients
5440348|NCT01544127|Suicide, Attempted|suicide, attempted
5440349|NCT01544101|Rheumatoid Arthritis|rheumatoid arthritis
5440350|NCT01544101|Diet, Vegetarian|diet, vegetarian
5440351|NCT01544101|Diet, Fat-Restricted|diet, fat-restricted
5440352|NCT01544101|Pain|pain
5440353|NCT01544088|randomized controlled trial|randomized controlled trial
5440354|NCT01544088|PTSD|ptsd
5440355|NCT01544088|cognitive behavioral treatment|cognitive behavioral treatment
5440356|NCT01544088|group treatment|group treatment
5440357|NCT01544062|Cardiac surgery|cardiac surgery
5440358|NCT01544062|Acute Pain|acute pain
5440359|NCT01544062|Wound Hyperalgesia|wound hyperalgesia
5440360|NCT01544062|Intravenous Acetaminophen|intravenous acetaminophen
5440361|NCT01544062|Patient Satisfaction|patient satisfaction
5440362|NCT01544049|fallopian tube removal|fallopian tube removal
5440363|NCT01544049|salpingectomy|salpingectomy
5440364|NCT01544049|ovarian cancer prevention|ovarian cancer prevention
5440366|NCT01544036|contrast nephropathy|contrast nephropathy
5440367|NCT01544036|renal blood flow|renal blood flow
5440368|NCT01544023|breast reconstruction|breast reconstruction
5440369|NCT01544023|mesh|mesh
5440371|NCT01544023|acellular dermal matrix|acellular dermal matrix
5440372|NCT01544023|titanized polypropylene mesh|titanized polypropylene mesh
5440373|NCT01544023|TiLOOP Bra|tiloop bra
5440374|NCT01544023|TiLOOP|tiloop
5440375|NCT01544023|implant based breast reconstruction|implant based breast reconstruction
5440376|NCT01544010|Transtheoretical Model|transtheoretical model
5427328|NCT01599247|Suicide|suicide
5440377|NCT01544010|Tailored Print Intervention|tailored print intervention
5440378|NCT01544010|Population-based|population-based
5440379|NCT01544010|Behavioral Intervention|behavioral intervention
5440380|NCT01543984|health care workers|health care workers
5440381|NCT01543984|tailored physical activity|tailored physical activity
5440382|NCT01543984|prevention|prevention
5440383|NCT01543984|spine|spine
5440384|NCT01543984|upper body|upper body
5440385|NCT01543984|pain related to Spine or Upper body|pain related to spine or upper body
5440386|NCT01543971|Peripheral blood stem cell mobilization|peripheral blood stem cell mobilization
5440387|NCT01543971|CD34+ count|cd34+ count
5440491|NCT01543516|Blood|blood
5440390|NCT01543945|Gynecologic laparoscopy|gynecologic laparoscopy
5440391|NCT01543945|Incidence of postoperative nausea and vomiting.|incidence of postoperative nausea and vomiting.
5440393|NCT01543932|prasugrel|prasugrel
5440394|NCT01543932|clopidogrel|clopidogrel
5440395|NCT01543932|stable angina|stable angina
5440396|NCT01543893|neck pain|neck pain
5440397|NCT01543893|shoulder pain|shoulder pain
5440398|NCT01543893|resistance training|resistance training
5440399|NCT01543854|Heart failure|heart failure
5440401|NCT01543854|Hemodynamics|hemodynamics
5440402|NCT01543854|Cardiovascular Diseases|cardiovascular diseases
5440403|NCT01543841|advanced cancer|advanced cancer
5440404|NCT01543841|healthy|healthy
5440405|NCT01543841|blood sample|blood sample
5440406|NCT01543841|TEM|tem
5440407|NCT01543841|TIE-2 expressing monocytes|tie-2 expressing monocytes
5440408|NCT01543841|ANG1|ang1
5440409|NCT01543841|ANG2|ang2
5440410|NCT01543828|COPD|copd
5440411|NCT01543828|Indacatarol|indacatarol
5440412|NCT01543828|placebo|placebo
5440413|NCT01543828|crossover|crossover
5440414|NCT01543828|patient perception|patient perception
5440415|NCT01543815|Psychological Distress|psychological distress
5440416|NCT01543815|Depression|depression
5440417|NCT01543815|Anxiety|anxiety
5440418|NCT01543815|Well-Being Therapy|well-being therapy
5440419|NCT01543815|Heart Failure|heart failure
5440420|NCT01543815|Quality of Life|quality of life
5440421|NCT01543815|Adherence|adherence
5440422|NCT01543802|soft-tissue sarcoma|soft-tissue sarcoma
5440423|NCT01543802|pazopanib|pazopanib
5440424|NCT01543802|antiangiogenetic treatment|antiangiogenetic treatment
5440425|NCT01543802|endothelial progenitor cells|endothelial progenitor cells
5440426|NCT01543802|preoperative therapy|preoperative therapy
5440427|NCT01543789|Umbilical Hernia|umbilical hernia
5440428|NCT01543763|metastatic|metastatic
5440429|NCT01543763|solid|solid
5440430|NCT01543763|sarcoma|sarcoma
5440431|NCT01543763|progression|progression
5440432|NCT01543750|episodic ataxia|episodic ataxia
5440433|NCT01543750|CACNA1A mutations|cacna1a mutations
5440434|NCT01543724|Lithium|lithium
5440435|NCT01543724|Bipolar disorder|bipolar disorder
5440436|NCT01543724|Multimodal Brain Imaging|multimodal brain imaging
5440437|NCT01543711|Breast cancer|breast cancer
5440438|NCT01543711|persistent pain|persistent pain
5440439|NCT01543711|neuropathic pain|neuropathic pain
5440440|NCT01543711|lymphedema|lymphedema
5440441|NCT01543698|Advanced solid tumor,|advanced solid tumor,
5440442|NCT01543698|BRAF V600 mutation|braf v600 mutation
5440443|NCT01543672|lung|lung
5440444|NCT01543672|SBRT|sbrt
5440445|NCT01543672|MLD|mld
5440446|NCT01543672|toxicity|toxicity
5440451|NCT01543646|Hepatology|hepatology
5440452|NCT01543646|Liver Cirrhosis|liver cirrhosis
5440453|NCT01543646|Fatty Liver|fatty liver
5440454|NCT01543620|kidney safety|kidney safety
5440455|NCT01543620|biomarkers|biomarkers
5440456|NCT01543620|serum creatinine|serum creatinine
5440457|NCT01543620|BUN|bun
5440458|NCT01543620|cystic fibrosis|cystic fibrosis
5440459|NCT01543620|head and neck cancer|head and neck cancer
5440460|NCT01543620|renal injury|renal injury
5440461|NCT01543620|drug induced acute kidney injury|drug induced acute kidney injury
5440462|NCT01543620|aminoglycoside|aminoglycoside
5440463|NCT01543620|cisplatin|cisplatin
5440464|NCT01543620|nephrotoxicity|nephrotoxicity
5440465|NCT01543620|biomarker qualification|biomarker qualification
5440466|NCT01543607|Bile duct|bile duct
5440467|NCT01543607|Cholangiocarcinoma|cholangiocarcinoma
5440468|NCT01543607|Bile duct stenosis|bile duct stenosis
5440469|NCT01543607|Malignant bile duct obstruction|malignant bile duct obstruction
5440470|NCT01543607|Malignant bile duct stricture|malignant bile duct stricture
5440471|NCT01543607|Radiofrequency ablation|radiofrequency ablation
5440472|NCT01543607|RFA|rfa
5440473|NCT01543607|Endoscopic RFA catheter|endoscopic rfa catheter
5440474|NCT01543607|EndoHPB|endohpb
5440475|NCT01543594|Rheumatoid arthritis|rheumatoid arthritis
5440476|NCT01543594|Seronegative polyarthritis|seronegative polyarthritis
5440477|NCT01543594|Biologic drugs|biologic drugs
5440478|NCT01543594|Safety efficacy biologics polyarthritis|safety efficacy biologics polyarthritis
5440479|NCT01543581|Basal Cell Carcinoma|basal cell carcinoma
5440480|NCT01543581|Treatment of Skin Cancer|treatment of skin cancer
5440481|NCT01543568|Age related Macular Degeneration|age related macular degeneration
5685509|NCT00555802|Randomized Controlled trial.|randomized controlled trial.
5427486|NCT01598584|RCT|rct
5440482|NCT01543568|Recalcitrant Age Related Macular Degeneration|recalcitrant age related macular degeneration
5440483|NCT01543555|myocardial infarction|myocardial infarction
5440485|NCT01543555|perioperative care|perioperative care
5440486|NCT01543555|peripheral vascular diseases|peripheral vascular diseases
5440487|NCT01543555|anesthesiology|anesthesiology
5440488|NCT01543542|1-3 brain metastases from any primary cancer|1-3 brain metastases from any primary cancer
5440489|NCT01543516|Asthma|asthma
5440492|NCT01543516|Inflammation|inflammation
5440493|NCT01543516|adaptive immune system|adaptive immune system
5440494|NCT01543516|innate immune system|innate immune system
5440495|NCT01543464|Indeolamine 2,3 dioxygenase|indeolamine 2,3 dioxygenase
5440496|NCT01543464|Survivin|survivin
5440497|NCT01543464|Montanide|montanide
5440498|NCT01543464|Imiquimod|imiquimod
5440499|NCT01543464|GMCSF|gmcsf
5440500|NCT01543438|ED utilization|ed utilization
5440501|NCT01543438|video education|video education
5440502|NCT01543438|mobile health|mobile health
5440503|NCT01543438|streaming media|streaming media
5440504|NCT01543438|underserved populations|underserved populations
5440505|NCT01543425|Neuropathic Pain|neuropathic pain
5440506|NCT01543425|Adenocorticotrophic axis|adenocorticotrophic axis
5440507|NCT01543425|Psychological state|psychological state
5440508|NCT01543412|FOLFIRI|folfiri
5440509|NCT01543412|Metastases|metastases
5440510|NCT01543412|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5440511|NCT01543412|locally advanced or metastatic pancreatic adenocarcinoma|locally advanced or metastatic pancreatic adenocarcinoma
5440512|NCT01543399|Tibolone|tibolone
5440513|NCT01543399|climacteric|climacteric
5440514|NCT01543399|Doppler|doppler
5440515|NCT01543399|hormone replacement therapy|hormone replacement therapy
5440516|NCT01543386|Polyphenol|polyphenol
5440517|NCT01543386|Curcumin|curcumin
5440518|NCT01543386|Endothelium, vascular|endothelium, vascular
5440519|NCT01543386|Endothelium-dependant relaxing factor|endothelium-dependant relaxing factor
5440520|NCT01543386|Smoking|smoking
5440521|NCT01543386|Transcriptome|transcriptome
5440522|NCT01543373|Coronary artery disease|coronary artery disease
5440523|NCT01543373|Optical Coherence Tomography|optical coherence tomography
5440524|NCT01543373|Tissue coverage|tissue coverage
5440525|NCT01543373|DES|des
5440526|NCT01543360|axillary vein|axillary vein
5440527|NCT01543360|sub clavian vein|sub clavian vein
5440528|NCT01543360|comparison of strategies|comparison of strategies
5440529|NCT01543347|UTI|uti
5440530|NCT01543347|ESBL|esbl
5440531|NCT01543347|AmpC Enterobacteriaceae|ampc enterobacteriaceae
5440532|NCT01543334|intensive care|intensive care
5440533|NCT01543334|antibiotic levels in blood samples|antibiotic levels in blood samples
5440534|NCT01543321|tetrabenazine|tetrabenazine
5440535|NCT01543321|movement disorders|movement disorders
5440536|NCT01543321|tardive disorders|tardive disorders
5440537|NCT01543295|Non-Treponemal|non-treponemal
5440538|NCT01543295|Treponemal|treponemal
5440539|NCT01543282|endoscopic ultrasonography|endoscopic ultrasonography
5440540|NCT01543282|fine needle aspiration cytology|fine needle aspiration cytology
5440541|NCT01543282|22 gauge|22 gauge
5440542|NCT01543282|25 gauge|25 gauge
5440543|NCT01543269|Obesity|obesity
5440544|NCT01543269|Lipid disorders|lipid disorders
5440545|NCT01543256|benign biliary strictures secondary to chronic pancreatitis|benign biliary strictures secondary to chronic pancreatitis
5440546|NCT01543243|postural balance|postural balance
5440547|NCT01543243|strength|strength
5440548|NCT01543230|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5440549|NCT01543217|COPD|copd
5440550|NCT01543204|plaque psoriasis|plaque psoriasis
5440551|NCT01543204|etanercept|etanercept
5440552|NCT01543204|adalimumab|adalimumab
5440553|NCT01543191|Lung Diseases|lung diseases
5440554|NCT01543191|Respiratory Tract Diseases|respiratory tract diseases
5440555|NCT01543191|Fibrosis|fibrosis
5440556|NCT01543178|IBS|ibs
5440557|NCT01543178|IBS-D|ibs-d
5440558|NCT01543178|IBS with diarrhea|ibs with diarrhea
5440559|NCT01543178|Diarrhea|diarrhea
5440560|NCT01543178|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5440561|NCT01543165|Renal colic|renal colic
5440562|NCT01543165|Analgesia|analgesia
5440563|NCT01543165|Nefopam|nefopam
5440564|NCT01543165|Ketorolac|ketorolac
5440565|NCT01543152|HIV|hiv
5440566|NCT01543152|autologous cell therapy|autologous cell therapy
5440567|NCT01543152|cyclophosphamide|cyclophosphamide
5440568|NCT01543139|Bipolar Depression|bipolar depression
5440569|NCT01543139|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5440570|NCT01543139|Cytidine-|cytidine-
5440571|NCT01543139|Creatine-|creatine-
5440572|NCT01543113|melanoma|melanoma
5440573|NCT01543113|white-caucasian population|white-caucasian population
5440574|NCT01543100|MGUS|mgus
5440575|NCT01543074|HDAC|hdac
5440576|NCT01543074|histone acetylation|histone acetylation
5440577|NCT01543074|broccoli sprout extract|broccoli sprout extract
5440578|NCT01543074|garlic oil|garlic oil
5440579|NCT01543074|PBMCs|pbmcs
5440580|NCT01543048|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5427503|NCT01598519|screening|screening
5440581|NCT01543048|Virological tests|virological tests
5440583|NCT01543048|Cervical cancer|cervical cancer
5440584|NCT01543048|Conization|conization
5440585|NCT01543048|within women treated by conization for a CIN3|within women treated by conization for a cin3
5440586|NCT01543035|HIV infection|hiv infection
5440587|NCT01543035|lipid lowering drugs|lipid lowering drugs
5440588|NCT01543035|etravirine|etravirine
5440589|NCT01543035|patient|patient
5440590|NCT01543035|statin treatment|statin treatment
5440591|NCT01543035|EFV or boosted PI antiretroviral treatment|efv or boosted pi antiretroviral treatment
5440592|NCT01543009|child|child
5440593|NCT01543009|venipuncture|venipuncture
5440594|NCT01543009|pain|pain
5440595|NCT01542983|breast cancer|breast cancer
5440596|NCT01542983|bright light|bright light
5440597|NCT01542983|insomnia|insomnia
5440598|NCT01542983|fatigue|fatigue
5440599|NCT01542970|intervention|intervention
5440600|NCT01542970|lactobacillus reuteri|lactobacillus reuteri
5440601|NCT01542970|omega-3 fatty acids|omega-3 fatty acids
5440602|NCT01542970|pregnancy|pregnancy
5440603|NCT01542970|lactation|lactation
5440604|NCT01542970|allergic symptoms|allergic symptoms
5440605|NCT01542970|IgE associated disease|ige associated disease
5440606|NCT01542970|gastrointestinal function|gastrointestinal function
5440607|NCT01542957|Major Depressive Disorder|major depressive disorder
5440608|NCT01542957|Dysthymic Disorder|dysthymic disorder
5440609|NCT01542957|Depression|depression
5440610|NCT01542957|Cognitive Behavior Therapy|cognitive behavior therapy
5440611|NCT01542957|Personal Construct Theory|personal construct theory
5440612|NCT01542957|Repertory Grid Technique|repertory grid technique
5440613|NCT01542957|Cognitive Conflicts|cognitive conflicts
5440614|NCT01542957|Personal dilemmas|personal dilemmas
5440615|NCT01542944|Acute myeloid leukemia|acute myeloid leukemia
5440616|NCT01542944|Myelodysplastic syndrome|myelodysplastic syndrome
5440617|NCT01542944|Stem Cell Mobilization|stem cell mobilization
5440618|NCT01542944|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5846729|NCT00043641|Antiretrovial Therapy|antiretrovial therapy
5440619|NCT01542931|Oral squamous cell carcinoma|oral squamous cell carcinoma
5440620|NCT01542931|Induction chemotherapy|induction chemotherapy
5440621|NCT01542931|Surgery|surgery
5440622|NCT01542931|Radiotherapy|radiotherapy
5440623|NCT01542918|Recurrent|recurrent
5440624|NCT01542918|Refractory|refractory
5440625|NCT01542918|CNS|cns
5440626|NCT01542918|Intraocular|intraocular
5440627|NCT01542918|Lymphoma|lymphoma
5440628|NCT01542892|Sarcopenia|sarcopenia
5440629|NCT01542892|Nutrition|nutrition
5440630|NCT01542892|Vitamin D|vitamin d
5440631|NCT01542892|Exercise|exercise
5440632|NCT01542866|ranibizumab|ranibizumab
5440633|NCT01542866|Age related Macular Degeneration|age related macular degeneration
5440634|NCT01542866|AMD|amd
5440635|NCT01542866|Health Management Tool|health management tool
5440636|NCT01542866|HMT|hmt
5440637|NCT01542866|Best Corrected Visual Acuity|best corrected visual acuity
5440638|NCT01542866|Investigator's Clinical Judgement of Change|investigator's clinical judgement of change
5440639|NCT01542866|Choroidal Neovascularization|choroidal neovascularization
5440640|NCT01542866|Central Retinal Subfield Thickness|central retinal subfield thickness
5440641|NCT01542866|visual function self test|visual function self test
5440642|NCT01542840|surgery|surgery
5440643|NCT01542840|orthopedic surgery|orthopedic surgery
5440644|NCT01542840|foot surgery|foot surgery
5440645|NCT01542840|leg surgery|leg surgery
5440646|NCT01542840|ankle surgery|ankle surgery
5440647|NCT01542840|leg|leg
5440648|NCT01542840|foot|foot
5440649|NCT01542840|ankle|ankle
5440650|NCT01542840|anesthesia|anesthesia
5440651|NCT01542840|local anesthesia|local anesthesia
5440652|NCT01542840|regional anesthesia|regional anesthesia
5440653|NCT01542840|Ochsner Clinic|ochsner clinic
5440654|NCT01542840|Ochsner Hospital|ochsner hospital
5440655|NCT01542840|New Orleans|new orleans
5440656|NCT01542840|Louisiana|louisiana
5440657|NCT01542840|Kristie Osteen, MD|kristie osteen, md
5440658|NCT01542827|neck pain|neck pain
5440659|NCT01542827|menthol|menthol
5440660|NCT01542814|Screening Mammogram|screening mammogram
5440661|NCT01542814|Diagnostic Mammogram|diagnostic mammogram
5440662|NCT01542814|Benign|benign
5440663|NCT01542814|Malignant|malignant
5440664|NCT01542814|BI-RADS Categories|bi-rads categories
5440665|NCT01542801|Effect of Preventive Antibiotics|effect of preventive antibiotics
5440666|NCT01542788|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5440667|NCT01542788|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5440668|NCT01542788|HCV|hcv
5440669|NCT01542788|Sustained Virologic Response|sustained virologic response
5440670|NCT01542788|Direct Acting Antiviral|direct acting antiviral
5440671|NCT01542788|Combination Therapy|combination therapy
5440672|NCT01542788|Interferon intolerant|interferon intolerant
5440673|NCT01542788|Interferon ineligible|interferon ineligible
5440674|NCT01542788|GS-7977|gs-7977
5440675|NCT01542788|Ribavirin|ribavirin
5440676|NCT01542762|Deep venous thrombosis|deep venous thrombosis
5440677|NCT01542762|Pulmonary Embolism|pulmonary embolism
5440678|NCT01542762|Lower leg Cast immobilization|lower leg cast immobilization
5440679|NCT01542749|BVA-100 Blood volume analyzer|bva-100 blood volume analyzer
5440680|NCT01542749|Human serum albumin labeled with Iodine 131|human serum albumin labeled with iodine 131
5440681|NCT01542723|Deep venous thrombosis|deep venous thrombosis
5440682|NCT01542723|Pulmonary Embolism|pulmonary embolism
5440683|NCT01542723|Arthroscopy of the knee|arthroscopy of the knee
5440684|NCT01542697|magnesium sulpahate|magnesium sulpahate
5440685|NCT01542697|postoperative analgesia|postoperative analgesia
5440686|NCT01542684|Leukemia|leukemia
5440687|NCT01542684|Myelodysplastic Syndrome|myelodysplastic syndrome
5440688|NCT01542684|MDS|mds
5440689|NCT01542684|Azacytidine|azacytidine
5440690|NCT01542684|5-Azacytidine|5-azacytidine
5440691|NCT01542684|5-AZA|5-aza
5440692|NCT01542684|Vidaza|vidaza
5440693|NCT01542684|5-AZC|5-azc
5440694|NCT01542684|Aza-CR|aza-cr
5440695|NCT01542684|Ladakamycin|ladakamycin
5440696|NCT01542684|NSC-102816|nsc-102816
5440697|NCT01542684|GM-CSF|gm-csf
5440698|NCT01542684|Sargramostim|sargramostim
5440699|NCT01542684|Leukine|leukine
5440700|NCT01542671|lifestyle change|lifestyle change
5440701|NCT01542671|obesity treatment|obesity treatment
5440702|NCT01542671|physical activity|physical activity
5440704|NCT01542671|quality of life|quality of life
5440705|NCT01542645|Fentanyl|fentanyl
5440706|NCT01542645|Methadone|methadone
5440707|NCT01542645|Thoracic Surgery|thoracic surgery
5440708|NCT01542632|safety and immunogenicity of dengue vaccine|safety and immunogenicity of dengue vaccine
5440709|NCT01542606|PH|ph
5440710|NCT01542606|SCREENING|screening
5440711|NCT01542606|EARLY WARNING|early warning
5423632|NCT01614847|dry eye|dry eye
5440712|NCT01542606|VAGINAL HEALTH|vaginal health
5440713|NCT01542606|VAGINAL SECRETION|vaginal secretion
5440714|NCT01542606|VAGINAL PH|vaginal ph
5440715|NCT01542580|Revision surgery|revision surgery
5440716|NCT01542567|Diclofenac|diclofenac
5440717|NCT01542567|BCG|bcg
5440718|NCT01542567|BLADDER IRRIGATIONS|bladder irrigations
5440719|NCT01542554|Diabetes mellitus|diabetes mellitus
5440720|NCT01542554|Chinese|chinese
5440721|NCT01542554|Glycaemic index|glycaemic index
5440722|NCT01542528|ADHD|adhd
5440726|NCT01542528|Sports activities|sports activities
5440727|NCT01542528|Good Behavior Game|good behavior game
5440728|NCT01542515|Allograft|allograft
5440729|NCT01542515|Arthroplasty|arthroplasty
5440730|NCT01542515|Basal Joint|basal joint
5440731|NCT01542515|carpometacarpal joint|carpometacarpal joint
5440732|NCT01542515|Thumb|thumb
5440733|NCT01542515|meniscus|meniscus
5440734|NCT01542515|osteoarthritis|osteoarthritis
5440735|NCT01542515|Patients with Stages I - III arthritis of the the thumb carpometacarpal joint|patients with stages i - iii arthritis of the the thumb carpometacarpal joint
5440736|NCT01542502|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5440737|NCT01542502|Diastolic heart failure|diastolic heart failure
5440738|NCT01542502|Aerobic exercise performance|aerobic exercise performance
5440739|NCT01542437|Non-Small Cell Lung Cancer|non-small cell lung cancer
5440740|NCT01542398|community-based|community-based
5440741|NCT01542398|war-affected|war-affected
5440742|NCT01542398|psychosocial support|psychosocial support
5440743|NCT01542398|family-focused|family-focused
5440744|NCT01542398|psychological distress|psychological distress
5440745|NCT01542398|adolescents|adolescents
5440746|NCT01542398|Democratic Republic of Congo|democratic republic of congo
5440747|NCT01542398|family functioning|family functioning
5440748|NCT01542398|community functioning|community functioning
5440749|NCT01542398|daily functioning|daily functioning
5440750|NCT01542385|Delayed stenting|delayed stenting
5440751|NCT01542385|Deferred stenting|deferred stenting
5440752|NCT01542385|Late stenting|late stenting
5440753|NCT01542385|postponed stenting|postponed stenting
5440754|NCT01542385|Thrombectomy|thrombectomy
5440755|NCT01542385|Percutaneous coronary intervention|percutaneous coronary intervention
5440756|NCT01542385|PCI|pci
5440757|NCT01542385|Angioplasty|angioplasty
5440758|NCT01542385|STEMI|stemi
5440759|NCT01542385|acute myocardial infarction|acute myocardial infarction
5440760|NCT01542372|PTSD|ptsd
5440761|NCT01542372|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5440762|NCT01542372|Medication augmentation|medication augmentation
5440763|NCT01542372|Treatment-resistant PTSD|treatment-resistant ptsd
5440764|NCT01542372|Cambodian refugees|cambodian refugees
5440765|NCT01542372|Culturally sensitive treatment|culturally sensitive treatment
5440766|NCT01542359|Yoga, Hypertension|yoga, hypertension
5440767|NCT01542359|Blood Pressure|blood pressure
5440768|NCT01542359|Autonomic Nervous system|autonomic nervous system
5440769|NCT01542346|Wound closure|wound closure
5440770|NCT01542346|cosmetic outcome|cosmetic outcome
5440771|NCT01542333|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5440772|NCT01542333|stage I Wilms tumor|stage i wilms tumor
5440773|NCT01542333|stage II Wilms tumor|stage ii wilms tumor
5440774|NCT01542333|stage III Wilms tumor|stage iii wilms tumor
5440775|NCT01542333|stage IV Wilms tumor|stage iv wilms tumor
5440776|NCT01542333|stage V Wilms tumor|stage v wilms tumor
5440777|NCT01542320|probiotic|probiotic
5440778|NCT01542320|Lactobacillus reuteri DSM 17938|lactobacillus reuteri dsm 17938
5440779|NCT01542320|healthy infants|healthy infants
5440780|NCT01542307|migraine|migraine
5440781|NCT01542307|oxygen therapy|oxygen therapy
5440782|NCT01542294|gastric cancer|gastric cancer
5440783|NCT01542294|S-1|s-1
5440784|NCT01542294|oxaliplatin|oxaliplatin
5440785|NCT01542294|adjuvant chemotherapy|adjuvant chemotherapy
5440786|NCT01542281|liver resection|liver resection
5440787|NCT01542281|hepatectomy|hepatectomy
5440788|NCT01542281|pre-habilitation|pre-habilitation
5440789|NCT01542268|pentoxifylline|pentoxifylline
5440790|NCT01542268|tight junction signalling|tight junction signalling
5440794|NCT01542255|Metastatic Melanoma|metastatic melanoma
5440795|NCT01542255|Vinblastine|vinblastine
5440796|NCT01542255|Cyclophosphamide|cyclophosphamide
5440797|NCT01542255|Dacarbazine|dacarbazine
5440798|NCT01542242|Diabetes Mellitus Type 2|diabetes mellitus type 2
5440799|NCT01542242|Prader Willi Syndrome|prader willi syndrome
5440800|NCT01542229|Post Traumatic Stress Disorder|post traumatic stress disorder
5440801|NCT01542229|Severe Mental Illness|severe mental illness
5440802|NCT01542203|doxorubicin|doxorubicin
5440803|NCT01542203|cyclophosphamide|cyclophosphamide
5440805|NCT01542203|BMI|bmi
5440806|NCT01542190|cataract surgery|cataract surgery
5440807|NCT01542190|cystoid macular edema|cystoid macular edema
5440808|NCT01542190|angiography|angiography
5440809|NCT01542177|hypoxia|hypoxia
5440810|NCT01542177|pancreas|pancreas
5440811|NCT01542177|cancer|cancer
5440812|NCT01542177|pancreatic cancer|pancreatic cancer
5440813|NCT01542177|18F-FAZA|18f-faza
5440814|NCT01542177|18F-Fluoroazomycin Arabinoside|18f-fluoroazomycin arabinoside
5440815|NCT01542177|Positron Emission Tomography|positron emission tomography
5440816|NCT01542177|PET|pet
5440817|NCT01542164|Calcium intake|calcium intake
5440818|NCT01542164|Fat excretion|fat excretion
5440819|NCT01542164|Energy excretion|energy excretion
5440820|NCT01542164|Gut micro flora|gut micro flora
5440821|NCT01542151|Labor, induced|labor, induced
5440822|NCT01542151|Sleep|sleep
5440823|NCT01542151|Fatigue|fatigue
5440824|NCT01542151|Patient satisfaction|patient satisfaction
5440825|NCT01542151|Circadian rhythm|circadian rhythm
5440826|NCT01542138|Inflammatory hyperpigmentation, axillar pigmentation|inflammatory hyperpigmentation, axillar pigmentation
5440827|NCT01542125|Patients aged 3 to 16 years presenting for|patients aged 3 to 16 years presenting for
5440828|NCT01542125|removal of smooth percutaneous interosseus pins|removal of smooth percutaneous interosseus pins
5440829|NCT01542125|after orthopeadic surgery|after orthopeadic surgery
5440830|NCT01542112|Patient-Centered Care|patient-centered care
5440831|NCT01542112|Patient Satisfaction|patient satisfaction
5440832|NCT01542112|Interventional study|interventional study
5440833|NCT01542112|Patient Expectations|patient expectations
5440834|NCT01542112|Hospitalization|hospitalization
5440835|NCT01542086|intermediate pre-test|intermediate pre-test
5440836|NCT01542086|probability of significant coronary heart disease|probability of significant coronary heart disease
5440837|NCT01542073|myocardial infarction|myocardial infarction
5440838|NCT01542073|angiogenesis|angiogenesis
5440839|NCT01542073|integrin receptor imaging|integrin receptor imaging
5440840|NCT01542073|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5440841|NCT01542047|Metastatic|metastatic
5440842|NCT01542047|Solid tumors|solid tumors
5440843|NCT01542047|carboplatin|carboplatin
5440844|NCT01542047|Paraplatin|paraplatin
5440845|NCT01542047|Pazopanib|pazopanib
5440846|NCT01542047|Votrient|votrient
5440847|NCT01542047|Alkylating agent|alkylating agent
5440848|NCT01542047|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5440849|NCT01542047|Metastatic disease|metastatic disease
5440855|NCT01541995|contrast medium enhanced post mortem CT|contrast medium enhanced post mortem ct
5440856|NCT01541995|virtual autopsy|virtual autopsy
5440857|NCT01541995|To evaluate the value of contrast medium enhanced post-mortem CT in virtual autopsy focussing on thromboembolic and vascular conditions|to evaluate the value of contrast medium enhanced post-mortem ct in virtual autopsy focussing on thromboembolic and vascular conditions
5440858|NCT01541969|Ear|ear
5440859|NCT01541969|Hearing|hearing
5440860|NCT01541956|type 2 diabetes;|type 2 diabetes;
5440861|NCT01541956|vildagliptin;|vildagliptin;
5440862|NCT01541956|metformin;|metformin;
5440863|NCT01541943|Atorvastatin|atorvastatin
5440864|NCT01541943|Losartan|losartan
5440865|NCT01541943|Essential Hypertension|essential hypertension
5440866|NCT01541943|Hyperlipidemia|hyperlipidemia
5440867|NCT01541904|Ocular Allergy.|ocular allergy.
5440868|NCT01541904|Seasonal Allergic Conjunctivitis|seasonal allergic conjunctivitis
5440869|NCT01541904|Perennial Allergic Conjunctivitis|perennial allergic conjunctivitis
5440870|NCT01541904|Conjunctivitis, Allergic|conjunctivitis, allergic
5440871|NCT01541904|Ocular Antihistamines.|ocular antihistamines.
5440872|NCT01541891|PRO-148|pro-148
5440873|NCT01541891|Dry eye syndrome|dry eye syndrome
5440874|NCT01541865|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension|hypertension, renal denervation, uncontrolled hypertension, medication resistant hypertension
5440875|NCT01541852|Vascular Inflammation|vascular inflammation
5440876|NCT01541852|FDG PET-CT|fdg pet-ct
5440878|NCT01541852|Atherosclerosis|atherosclerosis
5440879|NCT01541852|p38 MAP kinase inhibitor|p38 map kinase inhibitor
5440880|NCT01541839|Nasal septum|nasal septum
5440881|NCT01541839|Nasal surgical procedures|nasal surgical procedures
5440882|NCT01541826|aronia|aronia
5440984|NCT01541293|Laminaria|laminaria
5440883|NCT01541826|LDL cholesterol|ldl cholesterol
5440884|NCT01541826|polyphenols|polyphenols
5440885|NCT01541826|bioavailability|bioavailability
5440886|NCT01541826|oxidative stress|oxidative stress
5440887|NCT01541813|Rare iron overload|rare iron overload
5440888|NCT01541813|hepcidin|hepcidin
5440889|NCT01541774|Atherectomy|atherectomy
5440890|NCT01541774|Atherosclerosis|atherosclerosis
5440891|NCT01541774|Peripheral artery disease|peripheral artery disease
5440892|NCT01541761|Obesity|obesity
5440893|NCT01541761|Child|child
5440894|NCT01541761|Hispanic|hispanic
5440895|NCT01541761|Prevention|prevention
5440896|NCT01541761|Nutrition|nutrition
5440897|NCT01541761|Parenting|parenting
5440898|NCT01541735|Diabetes|diabetes
5440899|NCT01541735|Insulin|insulin
5440900|NCT01541735|Pantoprazole|pantoprazole
5440901|NCT01541722|Urea cycle disorders|urea cycle disorders
5440902|NCT01541709|This is a single-center|this is a single-center
5440903|NCT01541709|prospective|prospective
5440904|NCT01541709|single-arm|single-arm
5440905|NCT01541709|open-label phase II study|open-label phase ii study
5440906|NCT01541696|zinc|zinc
5440907|NCT01541696|zn|zn
5440908|NCT01541696|EZP (exchangeable zinc pools)multivitamin MN|ezp (exchangeable zinc pools)multivitamin mn
5440909|NCT01541683|PEG-electrolyte solution|peg-electrolyte solution
5440910|NCT01541683|bowel cleansing|bowel cleansing
5440911|NCT01541683|Mentholyptus drops|mentholyptus drops
5440912|NCT01541683|Palatability|palatability
5440913|NCT01541657|Ankle Instability|ankle instability
5440914|NCT01541657|Sensorimotor Control|sensorimotor control
5440915|NCT01541657|Sensory|sensory
5440916|NCT01541657|Postural Control|postural control
5440918|NCT01541657|Gait|gait
5440919|NCT01541644|Acupuncture Therapy|acupuncture therapy
5440920|NCT01541644|bortezomib-induced peripheral neuropathy|bortezomib-induced peripheral neuropathy
5440921|NCT01541631|Human Immunodeficiency Virus-1|human immunodeficiency virus-1
5440922|NCT01541631|Schistosoma mansoni|schistosoma mansoni
5440923|NCT01541631|Anemia|anemia
5440924|NCT01541631|Immune response|immune response
5440925|NCT01541631|Opportunistic infections|opportunistic infections
5440926|NCT01541631|Tanzania|tanzania
5440927|NCT01541618|MS|ms
5440928|NCT01541618|RRMS|rrms
5440929|NCT01541618|RR Multiple Sclerosis|rr multiple sclerosis
5440930|NCT01541592|Insulin resistance|insulin resistance
5440931|NCT01541592|Endothelial dysfunction|endothelial dysfunction
5440932|NCT01541592|saturated fat|saturated fat
5440933|NCT01541592|monounsaturated fat|monounsaturated fat
5440934|NCT01541592|polyunsaturated fat|polyunsaturated fat
5440935|NCT01541579|Perianal fistulising Crohn's disease.|perianal fistulising crohn's disease.
5440936|NCT01541566|arterial hypertension|arterial hypertension
5440937|NCT01541566|metabolic syndrome|metabolic syndrome
5440938|NCT01541566|home blood pressure|home blood pressure
5440939|NCT01541566|ambulatory blood pressure|ambulatory blood pressure
5440940|NCT01541566|office blood pressure|office blood pressure
5440941|NCT01541566|telemedicine|telemedicine
5440942|NCT01541527|non neutralizing antibody|non neutralizing antibody
5440943|NCT01541527|Epitopic profile|epitopic profile
5440944|NCT01541527|Clinical relevance|clinical relevance
5440945|NCT01541501|Central Corneal Thickness|central corneal thickness
5440946|NCT01541501|Pachymetry|pachymetry
5440947|NCT01541462|mechanical ventilation|mechanical ventilation
5440948|NCT01541462|weaning|weaning
5440949|NCT01541462|pressure support|pressure support
5440950|NCT01541462|spontaneous breathing|spontaneous breathing
5440951|NCT01541462|Long-term acute care facility|long-term acute care facility
5440952|NCT01541462|mortality|mortality
5440953|NCT01541449|AMD|amd
5440954|NCT01541449|PLAQUENIL|plaquenil
5440955|NCT01541449|CNV|cnv
5440956|NCT01541436|Remote Ischemic Preconditioning|remote ischemic preconditioning
5440957|NCT01541436|Nociception|nociception
5440958|NCT01541436|Central Sensitization|central sensitization
5440959|NCT01541436|Peripheral Sensitization|peripheral sensitization
5440960|NCT01541397|Hyperphenylalaninemia|hyperphenylalaninemia
5440961|NCT01541397|Phenylketonuria|phenylketonuria
5440962|NCT01541397|Adults|adults
5440963|NCT01541397|Bone Mineral Density|bone mineral density
5440964|NCT01541384|Kidney transplant|kidney transplant
5440965|NCT01541384|Adherence|adherence
5440966|NCT01541384|Electronic pill bottles|electronic pill bottles
5440967|NCT01541371|Schizophrenia|schizophrenia
5440968|NCT01541371|Paliperidone extended-release tablets|paliperidone extended-release tablets
5440969|NCT01541332|relapsed refractory|relapsed refractory
5440970|NCT01541332|multiple myeloma|multiple myeloma
5440971|NCT01541332|pomalidomide|pomalidomide
5440972|NCT01541332|Doxil|doxil
5440973|NCT01541332|dexamethasone|dexamethasone
5440974|NCT01541332|Oncotherapeutics|oncotherapeutics
5440975|NCT01541319|Cardiac Surgery|cardiac surgery
5440976|NCT01541319|Erythrocyte Transfusion|erythrocyte transfusion
5427894|NCT01596907|ephedrine|ephedrine
5440977|NCT01541306|C-type natriuretic peptide|c-type natriuretic peptide
5440978|NCT01541306|dwarfism|dwarfism
5440979|NCT01541306|growth|growth
5440980|NCT01541306|achondroplasia|achondroplasia
5440981|NCT01541306|hypochondroplasia|hypochondroplasia
5440982|NCT01541306|biomarker|biomarker
5440983|NCT01541293|Abortion, Induced|abortion, induced
5440985|NCT01541293|Pain management|pain management
5440986|NCT01541293|Cervical preparation|cervical preparation
5440987|NCT01541293|Dilation and Evacuation|dilation and evacuation
5440988|NCT01541280|Allogreffe, LAM , MDS|allogreffe, lam , mds
5440989|NCT01541280|Azacitidine (VidazaÒ)|azacitidine (vidazaò)
5440990|NCT01541280|Injection de lymphocytes de donneur (DLI)|injection de lymphocytes de donneur (dli)
5440991|NCT01541267|aliskiren|aliskiren
5440992|NCT01541267|eplerenon|eplerenon
5440993|NCT01541267|telmisartan|telmisartan
5440994|NCT01541267|direct renin inhibitor|direct renin inhibitor
5440995|NCT01541267|ACE inhibitor|ace inhibitor
5440996|NCT01541267|mineralocorticoid inhibitor|mineralocorticoid inhibitor
5440997|NCT01541267|proteinuria|proteinuria
5440998|NCT01541267|chronic kidney diseases|chronic kidney diseases
5440999|NCT01541267|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5441000|NCT01541254|intracranial aneurysm|intracranial aneurysm
5441001|NCT01541254|wide-neck|wide-neck
5441002|NCT01541254|saccular|saccular
5441003|NCT01541254|endovascular treatment|endovascular treatment
5441004|NCT01541254|coil embolization|coil embolization
5441005|NCT01541254|stent|stent
5441006|NCT01541254|bare platinum|bare platinum
5441007|NCT01541241|Intrauterine contraceptive device (IUD) is one of the most frequently used methods of birth control around the world|intrauterine contraceptive device (iud) is one of the most frequently used methods of birth control around the world
5441008|NCT01541241|Uterine Hemodynamic changes|uterine hemodynamic changes
5441009|NCT01541228|actinic keratosis|actinic keratosis
5441010|NCT01541228|photodynamic therapy|photodynamic therapy
5441011|NCT01541228|5-aminolevulinic acid|5-aminolevulinic acid
5441013|NCT01541202|neuregulin|neuregulin
5441014|NCT01541202|mortality|mortality
5441015|NCT01541189|hypertension|hypertension
5441016|NCT01541189|valsartan|valsartan
5441017|NCT01541176|Corticotherapy|corticotherapy
5441018|NCT01541176|Fibrosis|fibrosis
5441019|NCT01541176|Numerical reading|numerical reading
5441020|NCT01541176|18-70 years|18-70 years
5441021|NCT01541176|first renal transplant was lost due to rejection|first renal transplant was lost due to rejection
5441022|NCT01541176|first or second renal transplant|first or second renal transplant
5441023|NCT01541163|Ischemia|ischemia
5441024|NCT01541163|Brain Infarction|brain infarction
5441025|NCT01541163|Acute Stroke|acute stroke
5441026|NCT01541163|Heart Diseases|heart diseases
5441027|NCT01541163|Myocardial Infarction|myocardial infarction
5441028|NCT01541150|Pedophilia|pedophilia
5441029|NCT01541150|Impaired Decision making|impaired decision making
5441030|NCT01541150|Insight|insight
5441031|NCT01541150|Cognitive Distorsions|cognitive distorsions
5441032|NCT01541150|Impulsiveness|impulsiveness
5441033|NCT01541137|thoracotomy|thoracotomy
5441034|NCT01541137|pain|pain
5441035|NCT01541137|NSAID|nsaid
5441036|NCT01541137|PCA|pca
5441037|NCT01541137|TEA|tea
5441038|NCT01541137|chronic|chronic
5441039|NCT01541124|cancer pain|cancer pain
5441040|NCT01541124|analgesia|analgesia
5441041|NCT01541124|morphine|morphine
5441042|NCT01541111|Cancer pain|cancer pain
5441043|NCT01541111|Magnesiun|magnesiun
5441044|NCT01541085|Human Immunodeficiency Virus; HIV; Highly Active Antiretroviral Therapy; HAART; Darunavir; Ritonavir; Efavirenz; Kinetics; Immunological Recovery|human immunodeficiency virus; hiv; highly active antiretroviral therapy; haart; darunavir; ritonavir; efavirenz; kinetics; immunological recovery
5441045|NCT01541072|Lymphoma, B-cell|lymphoma, b-cell
5441046|NCT01541072|Lymphocyte reconstitution|lymphocyte reconstitution
5441047|NCT01541072|Lymphocyte subsets|lymphocyte subsets
5441048|NCT01541072|Peripheral stem cell transplantation|peripheral stem cell transplantation
5441049|NCT01541072|Induction chemotherapy|induction chemotherapy
5441050|NCT01541072|growth factor|growth factor
5441051|NCT01541072|Granulocyte Colony-stimulating factor|granulocyte colony-stimulating factor
5441052|NCT01541072|Pegfilgrastim|pegfilgrastim
5441053|NCT01541072|Filgrastim|filgrastim
5441054|NCT01541059|Third molar extraction|third molar extraction
5441055|NCT01541059|local anesthesia|local anesthesia
5441056|NCT01541059|ropivacaine|ropivacaine
5441057|NCT01541046|pediatric|pediatric
5441058|NCT01541046|infantile colic|infantile colic
5441059|NCT01541046|probiotic treatment|probiotic treatment
5441060|NCT01541033|autism|autism
5441061|NCT01541033|children|children
5441062|NCT01541007|Prostate Cancer|prostate cancer
5441063|NCT01541007|Metastatic|metastatic
5441064|NCT01541007|Castration Resistant|castration resistant
5441065|NCT01540994|Neoplasms|neoplasms
5441066|NCT01540994|Urogenital neoplasm|urogenital neoplasm
5441067|NCT01540994|Genital neoplasms, male|genital neoplasms, male
5441068|NCT01540955|Reduce Cognitive Complaints|reduce cognitive complaints
5441069|NCT01540955|improve cognitive function|improve cognitive function
5441070|NCT01540955|post-treatment breast cancer patients|post-treatment breast cancer patients
5441071|NCT01540942|Crohn's disease|crohn's disease
5441072|NCT01540942|Nutrition|nutrition
5441073|NCT01540942|Bowel resection|bowel resection
5441074|NCT01540942|Postoperative recurrence|postoperative recurrence
5441075|NCT01540942|complication|complication
5441076|NCT01540942|Active disease|active disease
5441077|NCT01540929|Smallpox|smallpox
5441078|NCT01540929|ACAM2000®|acam2000®
5441079|NCT01540929|Smallpox vaccine|smallpox vaccine
5441080|NCT01540916|acid-base equilibrium|acid-base equilibrium
5441081|NCT01540916|renal system|renal system
5441082|NCT01540916|urinary electrolytes|urinary electrolytes
5441083|NCT01540903|Malaria Challenge|malaria challenge
5441084|NCT01540903|Plasmodium falciparum|plasmodium falciparum
5441085|NCT01540903|PfSPZ Challenge|pfspz challenge
5441086|NCT01540903|Controlled|controlled
5441087|NCT01540903|human|human
5441088|NCT01540903|malaria infection|malaria infection
5441089|NCT01540864|Obesity|obesity
5441090|NCT01540864|Overweight|overweight
5441091|NCT01540864|Body Mass Index|body mass index
5441092|NCT01540851|Osteoarthritis|osteoarthritis
5426232|NCT01603719|infant formula|infant formula
5441093|NCT01540851|Total Knee Replacement|total knee replacement
5441094|NCT01540851|total Knee Arthroplasty|total knee arthroplasty
5863984|NCT00001147|Tyrosine Hydroxylase|tyrosine hydroxylase
5441095|NCT01540851|Post operative recovery, TKA|post operative recovery, tka
5441096|NCT01540851|Post-operative recovery TKR|post-operative recovery tkr
5441097|NCT01540851|Care Navigator|care navigator
5424084|NCT01612689|EMU|emu
5441098|NCT01540838|Bacterial meningitis|bacterial meningitis
5441099|NCT01540838|infusion|infusion
5441100|NCT01540838|bolus|bolus
5441101|NCT01540838|paracetamol|paracetamol
5441102|NCT01540812|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5441103|NCT01540799|Migraine|migraine
5441104|NCT01540799|High disability migraine|high disability migraine
5441105|NCT01540799|Sphenopalatine ganglion|sphenopalatine ganglion
5441106|NCT01540799|Neuromodulation|neuromodulation
5441107|NCT01540799|Neurostimulation|neurostimulation
5441108|NCT01540799|Autonomic nervous system|autonomic nervous system
5441110|NCT01540786|High Resolution Urodynamics|high resolution urodynamics
5441111|NCT01540773|growth hormone|growth hormone
5441112|NCT01540747|intrafollicular melatonin|intrafollicular melatonin
5441113|NCT01540747|PCOS|pcos
5441114|NCT01540747|embryos quality|embryos quality
5441115|NCT01540747|oocytes quality|oocytes quality
5441116|NCT01540734|paracetamol|paracetamol
5441117|NCT01540734|pharmacokinetic|pharmacokinetic
5441118|NCT01540721|paracetamol|paracetamol
5441119|NCT01540721|pharmacokinetics|pharmacokinetics
5441120|NCT01540708|Asthma|asthma
5441121|NCT01540708|Respiratory|respiratory
5441122|NCT01540708|COPD|copd
5441123|NCT01540695|Any patient with a routine basal cell or squamous cell carcinoma|any patient with a routine basal cell or squamous cell carcinoma
5441124|NCT01540695|of the skin diagnosed on frozen histology during a Mohs procedure|of the skin diagnosed on frozen histology during a mohs procedure
5441125|NCT01540682|Male and female patients with HNSCC of the oral cavity, oropharynx, hypopharynx, larynx,|male and female patients with hnscc of the oral cavity, oropharynx, hypopharynx, larynx,
5441126|NCT01540682|nasopharynx or paranasal sinuses that is considered appropriate|nasopharynx or paranasal sinuses that is considered appropriate
5441127|NCT01540682|for definitive cetuximab-based radiation therapy.|for definitive cetuximab-based radiation therapy.
5441128|NCT01540669|constipation|constipation
5441129|NCT01540669|functional constipation|functional constipation
5441130|NCT01540669|polydextrose|polydextrose
5441131|NCT01540669|whole gut transit time|whole gut transit time
5441132|NCT01540656|Stress incontinence|stress incontinence
5441133|NCT01540656|Incontinence|incontinence
5441134|NCT01540656|prostate cancer|prostate cancer
5441135|NCT01540656|Radical Prostatectomy vibration|radical prostatectomy vibration
5441136|NCT01540656|nerve stimulation|nerve stimulation
5441137|NCT01540643|abdominal aortic aneurysm|abdominal aortic aneurysm
5441138|NCT01540643|iliac leg graft|iliac leg graft
5441139|NCT01540617|Low back pain|low back pain
5441140|NCT01540617|Proprioception|proprioception
5441141|NCT01540617|Postural control|postural control
5441142|NCT01540617|Spine|spine
5441143|NCT01540617|Variability|variability
5441144|NCT01540617|MRI|mri
5441145|NCT01540617|Vibration|vibration
5441146|NCT01540617|Brain|brain
5441147|NCT01540604|DMD|dmd
5441148|NCT01540604|BMD|bmd
5441149|NCT01540604|symptomatic carriers|symptomatic carriers
5441150|NCT01540591|repeated implantation failure|repeated implantation failure
5441151|NCT01540591|intralipid|intralipid
5441152|NCT01540552|lung cancer|lung cancer
5441153|NCT01540552|precancerous condition|precancerous condition
5441154|NCT01540552|lung nodules|lung nodules
5441155|NCT01540552|CT Scan|ct scan
5441156|NCT01540500|Pharmacokinetics|pharmacokinetics
5441157|NCT01540500|Drug Interaction|drug interaction
5671225|NCT00616590|sleep disorders|sleep disorders
5441158|NCT01540474|Interference of malaria infection|interference of malaria infection
5441160|NCT01540435|Colorectal cancer|colorectal cancer
5441161|NCT01540435|Liver metastases|liver metastases
5441162|NCT01540435|Perioperative treatment|perioperative treatment
5441163|NCT01540435|Liver resection|liver resection
5441164|NCT01540422|vein grafts|vein grafts
5441165|NCT01540422|coronary bypass|coronary bypass
5441166|NCT01540422|endoscopic harvest|endoscopic harvest
5441167|NCT01540422|endoscopic vein harvest|endoscopic vein harvest
5441168|NCT01540409|DMD, Duchenne, Eteplirsen, dystrophy, dystrophin, exon 51|dmd, duchenne, eteplirsen, dystrophy, dystrophin, exon 51
5441169|NCT01540396|Gestational Diabetes|gestational diabetes
5441170|NCT01540383|Communication|communication
5441171|NCT01540383|Language|language
5441172|NCT01540383|Treatment|treatment
5441173|NCT01540383|Intervention|intervention
5441174|NCT01540383|Therapy|therapy
5441175|NCT01540383|Efficacy|efficacy
5441176|NCT01540383|Maintenance|maintenance
5441177|NCT01540383|Recovery|recovery
5441178|NCT01540383|Outcome|outcome
5441179|NCT01540383|Rehabilitation|rehabilitation
5441180|NCT01540383|Treatment Intensity|treatment intensity
5441181|NCT01540383|Language Impairment|language impairment
5441182|NCT01540383|Intensive Language Therapy|intensive language therapy
5441183|NCT01540383|Functional Communication|functional communication
5441184|NCT01540383|Functional Improvement|functional improvement
5441185|NCT01540383|Evidence-Based Intervention|evidence-based intervention
5441186|NCT01540383|High-Frequency|high-frequency
5441187|NCT01540357|mindfulness-based therapy|mindfulness-based therapy
5441188|NCT01540357|chronic tinnitus;|chronic tinnitus;
5441189|NCT01540344|peritoneal carcinomatosis|peritoneal carcinomatosis
5441190|NCT01540344|cytoreductive surgery|cytoreductive surgery
5441191|NCT01540344|HIPEC|hipec
5441192|NCT01540344|colorectal cancer|colorectal cancer
5441193|NCT01540318|ultrasonography|ultrasonography
5441194|NCT01540318|Abdominal Injuries|abdominal injuries
5441196|NCT01540305|Obsessive Compulsive Disorder|obsessive compulsive disorder
5441197|NCT01540305|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5441198|NCT01540305|Treatment|treatment
5441199|NCT01540292|Crohn's disease|crohn's disease
5441200|NCT01540292|Mesenchymal Stem Cell|mesenchymal stem cell
5441201|NCT01540292|Cell therapy|cell therapy
5441202|NCT01540292|Allogeneic|allogeneic
5441203|NCT01540292|Inflammatory disorders|inflammatory disorders
5441204|NCT01540292|Autoimmune disorders|autoimmune disorders
5441205|NCT01540266|physician-patient communication|physician-patient communication
5441206|NCT01540266|information structuring|information structuring
5441207|NCT01540266|emergency department|emergency department
5441209|NCT01540240|zidovudine|zidovudine
5441210|NCT01540240|dose reduction|dose reduction
5441211|NCT01540240|anaemia|anaemia
5441212|NCT01540240|safety and efficacy comparison|safety and efficacy comparison
5441213|NCT01540227|Syphilis|syphilis
5441214|NCT01540227|Penicillin|penicillin
5441215|NCT01540214|Urinary Bladder, Overactive|urinary bladder, overactive
5441216|NCT01540214|Pelvic Organ Prolapse|pelvic organ prolapse
5441217|NCT01540214|Gynecologic Surgical Procedures|gynecologic surgical procedures
5441218|NCT01540214|Urodynamics|urodynamics
5441219|NCT01540201|one lung ventilation|one lung ventilation
5441220|NCT01540201|gas exchange|gas exchange
5441221|NCT01540201|inverse-ratio ventilation|inverse-ratio ventilation
5441222|NCT01540188|Drug user|drug user
5441223|NCT01540188|Family member|family member
5441224|NCT01540188|Intervention|intervention
5441225|NCT01540188|Community|community
5441226|NCT01540188|Support|support
5441227|NCT01540175|Autologous stem cell transplant|autologous stem cell transplant
5441228|NCT01540175|Immune reconstitution|immune reconstitution
5441229|NCT01540162|preterm newborn|preterm newborn
5441230|NCT01540162|neonatology|neonatology
5441231|NCT01540162|EcN|ecn
5441232|NCT01540162|Nissle|nissle
5441233|NCT01540162|Mutaflor|mutaflor
5441234|NCT01540162|prophylaxis|prophylaxis
5441235|NCT01540162|infection|infection
5441236|NCT01540110|Locally Advanced or Node Positive Primary Breast Cancer|locally advanced or node positive primary breast cancer
5441237|NCT01540084|Cocktail sedation|cocktail sedation
5441238|NCT01540084|ERCP|ercp
5441239|NCT01540071|Hormone refractory prostate cancer|hormone refractory prostate cancer
5441240|NCT01540071|HRPC|hrpc
5441241|NCT01540071|Androgen independent prostate cancer|androgen independent prostate cancer
5441242|NCT01540071|CRPC|crpc
5441243|NCT01540071|Castration and Taxane Resistant Prostate Cancer|castration and taxane resistant prostate cancer
5441244|NCT01540045|Non-Small Cell Lung Cancer|non-small cell lung cancer
5441245|NCT01540045|Dysgeusia|dysgeusia
5441246|NCT01540045|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5441247|NCT01540045|Paclitaxel|paclitaxel
5441248|NCT01540045|Cisplatin|cisplatin
5441249|NCT01540019|anorexia|anorexia
5441250|NCT01540019|Paullinia cupana|paullinia cupana
5441251|NCT01540019|loss of weight|loss of weight
5441252|NCT01539993|Hepatocellular carcinoma|hepatocellular carcinoma
5441253|NCT01539993|Liver metastases|liver metastases
5584168|NCT00952237|IL-2|il-2
5441254|NCT01539993|Cholangiocarcinoma|cholangiocarcinoma
5441255|NCT01539993|Percutaneous treatments|percutaneous treatments
5441256|NCT01539993|RFA|rfa
5441257|NCT01539993|TACE|tace
5441258|NCT01539993|DEB|deb
5441259|NCT01539980|Sericin scaffold|sericin scaffold
5441260|NCT01539980|Wound healing|wound healing
5441261|NCT01539980|Skin graft donor|skin graft donor
5441262|NCT01539967|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5441263|NCT01539967|Obesity follow-up|obesity follow-up
5441264|NCT01539954|Alcohol related disorders|alcohol related disorders
5441265|NCT01539941|Co-occurring adolescent substance use and ADHD|co-occurring adolescent substance use and adhd
5441266|NCT01539928|Dual time PET/CT|dual time pet/ct
5441267|NCT01539928|glucose-6-phosphatase|glucose-6-phosphatase
5441269|NCT01539915|Stable plaque psoriasis|stable plaque psoriasis
5441270|NCT01539915|lesions|lesions
5441271|NCT01539915|TNF-alpha|tnf-alpha
5441272|NCT01539915|BCT194|bct194
5441273|NCT01539902|MSC for the treatment of Lupus Nephritis|msc for the treatment of lupus nephritis
5441274|NCT01539876|locally advanced breast cancer patients|locally advanced breast cancer patients
5441275|NCT01539850|obesity|obesity
5441276|NCT01539850|gastric stimulation|gastric stimulation
5441277|NCT01539850|morbid obesity|morbid obesity
5441278|NCT01539837|Parkinson's disease|parkinson's disease
5441279|NCT01539837|Brain Iron|brain iron
5441281|NCT01539837|Oxidative stress|oxidative stress
5441282|NCT01539811|Foot Infections|foot infections
5441283|NCT01539811|Diabetes|diabetes
5441284|NCT01539811|Antibiotic|antibiotic
5441285|NCT01539798|Saline solution|saline solution
5441286|NCT01539798|Sodium Chloride|sodium chloride
5441287|NCT01539798|Hypoalbuminemia|hypoalbuminemia
5441288|NCT01539798|Weight Gain|weight gain
5441289|NCT01539785|HIPEC|hipec
5441293|NCT01539759|Postpartum Contraception|postpartum contraception
5441294|NCT01539759|Intrauterine Devices|intrauterine devices
5441295|NCT01539746|Aortic stenosis|aortic stenosis
5441296|NCT01539746|Transcatheter aortic valve implantation|transcatheter aortic valve implantation
5441297|NCT01539746|TAVI|tavi
5441298|NCT01539746|Predilation|predilation
5441299|NCT01539746|Balloon valvuloplasty|balloon valvuloplasty
5441300|NCT01539746|BAV|bav
5441301|NCT01539746|CoreValve|corevalve
5444509|NCT01526044|CGM|cgm
5441302|NCT01539720|emergency contraception|emergency contraception
5441303|NCT01539720|Ella|ella
5441304|NCT01539720|Mirena IUD|mirena iud
5441305|NCT01539720|post-coital contraception|post-coital contraception
5441306|NCT01539720|Liletta IUD|liletta iud
5441307|NCT01539707|Solifenacin succinate suspension|solifenacin succinate suspension
5441308|NCT01539707|Pharmacokinetics|pharmacokinetics
5441309|NCT01539707|Phase 1|phase 1
5441310|NCT01539707|Neurogenic Detrusor Overactivity|neurogenic detrusor overactivity
5441311|NCT01539681|Hepatocellular Carcinoma|hepatocellular carcinoma
5441312|NCT01539681|Cancer, Liver|cancer, liver
5441313|NCT01539681|Sorafenib|sorafenib
5441314|NCT01539681|Nexavar|nexavar
5441315|NCT01539668|Cervical Cancer|cervical cancer
5441316|NCT01539668|HPV|hpv
5441317|NCT01539668|Secondary prevention|secondary prevention
5441318|NCT01539655|Phase 1|phase 1
5441319|NCT01539655|healthy volunteers|healthy volunteers
5441320|NCT01539655|pharmacokinetics|pharmacokinetics
5441321|NCT01539655|vandetanib|vandetanib
5441322|NCT01539655|omeprazole|omeprazole
5441323|NCT01539655|ranitidine|ranitidine
5441324|NCT01539642|In patient, post operative pain|in patient, post operative pain
5441325|NCT01539642|Adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery|adult post-operative inpatients who are expected to require parenteral opioid analgesia for at least 48 hours after open abdominal surgery
5441326|NCT01539629|Heart failure|heart failure
5441327|NCT01539629|Autothreshold|autothreshold
5441329|NCT01539629|CRT-D recipients|crt-d recipients
5441330|NCT01539629|Left Ventricular evoked response signals|left ventricular evoked response signals
5441331|NCT01539616|Hypertriglyceridemia|hypertriglyceridemia
5441332|NCT01539616|Dyslipidemia|dyslipidemia
5441333|NCT01539603|drug eluting balloon|drug eluting balloon
5441334|NCT01539603|bare metal stent|bare metal stent
5441335|NCT01539603|drug eluting stent|drug eluting stent
5441336|NCT01539603|coronary artery disease|coronary artery disease
5441337|NCT01539590|hepatocyte growth factor mimetic|hepatocyte growth factor mimetic
5441338|NCT01539590|hepatocyte growth factor(HGF)|hepatocyte growth factor(hgf)
5441339|NCT01539590|Myocardial Infarction|myocardial infarction
5441340|NCT01539590|Acute ST Segment Elevation Myocardial Infarction (STEMI)|acute st segment elevation myocardial infarction (stemi)
5441341|NCT01539590|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5441342|NCT01539538|Adult post-operative inpatients who|adult post-operative inpatients who
5441343|NCT01539538|are expected to require parenteral|are expected to require parenteral
5441344|NCT01539538|opioid analgesia for at least 48|opioid analgesia for at least 48
5441345|NCT01539538|hours after open abdominal surgery|hours after open abdominal surgery
5441346|NCT01539538|or hip/knee replacement surgery|or hip/knee replacement surgery
5441347|NCT01539512|CLL|cll
5441348|NCT01539512|CAL-101|cal-101
5441349|NCT01539512|GS 1101|gs 1101
5441350|NCT01539512|PI3K|pi3k
5441351|NCT01539512|GS-US-312-0117|gs-us-312-0117
5441352|NCT01539512|idelalisib|idelalisib
5441353|NCT01539460|Axillary osmidrosis|axillary osmidrosis
5441354|NCT01539460|liposuction|liposuction
5441355|NCT01539460|minimally invasive surgery|minimally invasive surgery
5441356|NCT01539447|Hip arthroscopy|hip arthroscopy
5441357|NCT01539447|Femoroacetabular impingement|femoroacetabular impingement
5441358|NCT01539447|Heterotopic ossification|heterotopic ossification
5441359|NCT01539447|Heterotopic bone formation|heterotopic bone formation
5441360|NCT01539434|COPD|copd
5441361|NCT01539434|Behavioral intervention|behavioral intervention
5441362|NCT01539434|Physical capacity|physical capacity
5441363|NCT01539434|Physical activity|physical activity
5441364|NCT01539421|COPD|copd
5441365|NCT01539421|exercise endurance|exercise endurance
5441366|NCT01539395|Relapsing Remitting|relapsing remitting
5441367|NCT01539395|MS|ms
5441368|NCT01539382|cardiac surgery|cardiac surgery
5441576|NCT01538745|Morphine|morphine
5441369|NCT01539382|neurocognitive assessment|neurocognitive assessment
5441370|NCT01539382|neurocognitive function|neurocognitive function
5441371|NCT01539369|dietary intervention|dietary intervention
5441372|NCT01539369|dietary fibre|dietary fibre
5441373|NCT01539369|weight loss|weight loss
5441374|NCT01539369|weight maintenance|weight maintenance
5441375|NCT01539356|Hepcidin|hepcidin
5441376|NCT01539356|Preterm Infants|preterm infants
5441377|NCT01539356|Anemia|anemia
5441378|NCT01539356|Sepsis|sepsis
5441379|NCT01539356|Ferritin|ferritin
5441380|NCT01539343|Infection|infection
5441381|NCT01539343|Catheter-related bloodstream infection|catheter-related bloodstream infection
5441383|NCT01539343|Antimicrobial Lock Therapy|antimicrobial lock therapy
5441384|NCT01539343|ALT|alt
5441385|NCT01539343|Central Line Associated Bloodstream Infection|central line associated bloodstream infection
5441386|NCT01539343|CLABSI|clabsi
5441387|NCT01539343|Central Venous Catheter|central venous catheter
5441388|NCT01539343|CVC|cvc
5441389|NCT01539343|Quantitative blood cultures|quantitative blood cultures
5441390|NCT01539343|QBC|qbc
5441391|NCT01539330|voriconazole|voriconazole
5441392|NCT01539330|microdialysis|microdialysis
5441393|NCT01539330|sequence therapy|sequence therapy
5441395|NCT01539330|Target Site Pharmacokinetics|target site pharmacokinetics
5441396|NCT01539317|Vulvodynia|vulvodynia
5441397|NCT01539317|Dyspareunia|dyspareunia
5441398|NCT01539317|Breast Cancer|breast cancer
5441399|NCT01539317|Menopause|menopause
5441400|NCT01539317|Vaginal dryness|vaginal dryness
5441401|NCT01539317|Painful intercourse|painful intercourse
5441403|NCT01539291|CAL-101|cal-101
5441404|NCT01539291|CAL 101|cal 101
5441405|NCT01539291|GS-1101|gs-1101
5441406|NCT01539291|GS 1101|gs 1101
5441407|NCT01539291|PI3K|pi3k
5441408|NCT01539291|Leukemia|leukemia
5441409|NCT01539291|GS-US-312-0116|gs-us-312-0116
5441410|NCT01539291|idelalisib|idelalisib
5441411|NCT01539278|Sleep Apnea, Obstructive|sleep apnea, obstructive
5441412|NCT01539278|Child|child
5441413|NCT01539278|Tonsillectomy|tonsillectomy
5441414|NCT01539278|Adenoidectomy|adenoidectomy
5441415|NCT01539265|urinary calculus|urinary calculus
5441416|NCT01539265|ureteral stones|ureteral stones
5441417|NCT01539265|medical expulsive therapy|medical expulsive therapy
5441418|NCT01539252|hemodialysis|hemodialysis
5441419|NCT01539252|adequacy|adequacy
5441420|NCT01539252|phosphate clearance|phosphate clearance
5441421|NCT01539252|double dialyzer|double dialyzer
5441422|NCT01539252|two dialyzers in parallel|two dialyzers in parallel
5441423|NCT01539239|Glaucoma|glaucoma
5441424|NCT01539239|POAG|poag
5441425|NCT01539239|Cataract|cataract
5441426|NCT01539226|HIV Infections|hiv infections
5441427|NCT01539226|Anti-HIV agents|anti-hiv agents
5441428|NCT01539226|HIV-1|hiv-1
5441429|NCT01539213|Psoriasis|psoriasis
5441430|NCT01539213|interstitial fluid|interstitial fluid
5441431|NCT01539213|open flow microperfusion|open flow microperfusion
5441432|NCT01539213|IL-17|il-17
5441433|NCT01539213|inflammatory skin disease|inflammatory skin disease
5441434|NCT01539213|scaly patches|scaly patches
5441435|NCT01539213|Healthy volunteers and psoriasis patients|healthy volunteers and psoriasis patients
5441436|NCT01539187|uterine fibroid RF ablation|uterine fibroid rf ablation
5441437|NCT01539187|intrauterine ultrasound|intrauterine ultrasound
5441438|NCT01539187|VizAblate|vizablate
5441439|NCT01539161|Chagas Disease|chagas disease
5441440|NCT01539161|Chagasic|chagasic
5441441|NCT01539161|Reveal XT|reveal xt
5441442|NCT01539161|Implantable Cardiac Monitor|implantable cardiac monitor
5441443|NCT01539161|ICM|icm
5441444|NCT01539148|Quality of Life|quality of life
5441445|NCT01539148|Qol|qol
5441446|NCT01539148|Questionnaire|questionnaire
5441447|NCT01539148|Survey|survey
5671968|NCT00613392|free radical|free radical
5441448|NCT01539148|Insulin Potentiation Targeted Low Dose Chemotherapy|insulin potentiation targeted low dose chemotherapy
5441449|NCT01539148|IPTLD|iptld
5441450|NCT01539148|Nutritional Therapy|nutritional therapy
5441451|NCT01539148|Chemotherapy|chemotherapy
5441452|NCT01539148|Cancer Treatment|cancer treatment
5441453|NCT01539148|Kotsanis Institute|kotsanis institute
5441454|NCT01539148|The Best Answer for Cancer Foundation|the best answer for cancer foundation
5441455|NCT01539148|Liberty IRB|liberty irb
5441456|NCT01539148|Texas|texas
5441457|NCT01539135|Aspiration, Respiratory|aspiration, respiratory
5428428|NCT01594619|Phase 1|phase 1
5441458|NCT01539122|osteoarthritis|osteoarthritis
5441459|NCT01539122|shoulder replacement|shoulder replacement
5441460|NCT01539109|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5441461|NCT01539109|Quadriplegia|quadriplegia
5441462|NCT01539109|Tetraplegia|tetraplegia
5441463|NCT01539109|SCI|sci
5441464|NCT01539109|Spinal Cord Disease|spinal cord disease
5441465|NCT01539109|Spinal Cord Injury|spinal cord injury
5441466|NCT01539109|iSCI|isci
5441467|NCT01539109|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5441468|NCT01539109|tDCS|tdcs
5441469|NCT01539109|SCI recovery|sci recovery
5441470|NCT01539109|brain stimulation|brain stimulation
5441471|NCT01539109|rehabilitation|rehabilitation
5441472|NCT01539096|Stroke|stroke
5441473|NCT01539096|Rehabilitation|rehabilitation
5441474|NCT01539096|Paresis|paresis
5441475|NCT01539096|Paralysis|paralysis
5441476|NCT01539096|Recovery|recovery
5441477|NCT01539096|tDCS|tdcs
5441478|NCT01539096|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5441479|NCT01539096|CIMT|cimt
5441480|NCT01539096|Constraint Induced Movement Therapy|constraint induced movement therapy
5441481|NCT01539096|Stroke therapy|stroke therapy
5441482|NCT01539096|MRI|mri
5441483|NCT01539096|Hand|hand
5441484|NCT01539096|CVA|cva
5436329|NCT01560650|CRRT|crrt
5441485|NCT01539096|Cerebrovascular accident|cerebrovascular accident
5441486|NCT01539083|Multiple Myeloma|multiple myeloma
5441487|NCT01539083|Bortezomib|bortezomib
5441489|NCT01539083|Consolidation therapy|consolidation therapy
5424400|NCT01611194|PTSD|ptsd
5441490|NCT01539083|Subcutaneous|subcutaneous
5441491|NCT01539083|Thalidomide|thalidomide
5441492|NCT01539083|Prednisolone|prednisolone
5441493|NCT01539083|Autologous stem cell transplant (ASCT)|autologous stem cell transplant (asct)
5441494|NCT01539083|VELCADE, cyclophosphamide, dexamethasone (VCD) induction therapy|velcade, cyclophosphamide, dexamethasone (vcd) induction therapy
5441499|NCT01539057|Liver|liver
5441500|NCT01539057|Surgery|surgery
5441501|NCT01539057|hemostasis|hemostasis
5441502|NCT01539057|coagulation|coagulation
5441503|NCT01539057|Fibrinogen|fibrinogen
5441504|NCT01539044|reversal|reversal
5441505|NCT01539044|muscle relaxant|muscle relaxant
5441506|NCT01539044|sugammadex|sugammadex
5441507|NCT01539031|Alzheimer Disease|alzheimer disease
5441508|NCT01539031|Dementia|dementia
5441509|NCT01539031|Delirium|delirium
5441510|NCT01539031|Amnestic|amnestic
5441511|NCT01539031|Cognitive Disorders|cognitive disorders
5441512|NCT01539031|Donepezil|donepezil
5441513|NCT01539031|Brain Diseases|brain diseases
5441514|NCT01539031|Central Nervous System Diseases|central nervous system diseases
5441515|NCT01539031|Nervous System Diseases|nervous system diseases
5441516|NCT01539031|Tauopathies|tauopathies
5441517|NCT01539031|Neurodegenerative Diseases|neurodegenerative diseases
5441518|NCT01539031|Mental Disorders|mental disorders
5441519|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors
5441520|NCT01539031|Enzy|enzy
5441521|NCT01539005|Recurrence|recurrence
5441522|NCT01539005|Tuberculosis|tuberculosis
5441523|NCT01538992|renal denervation|renal denervation
5441524|NCT01538992|heart failure|heart failure
5441525|NCT01538979|Grass pollen allergy|grass pollen allergy
5441526|NCT01538979|Immunotherapy|immunotherapy
5441527|NCT01538979|Recombinant vaccine|recombinant vaccine
5441528|NCT01538979|Rhinitis, allergic, seasonal|rhinitis, allergic, seasonal
5441529|NCT01538966|acromegaly|acromegaly
5441530|NCT01538966|pituitary|pituitary
5441531|NCT01538966|pegvisomant|pegvisomant
5441532|NCT01538966|somavert|somavert
5441533|NCT01538966|lanreotide|lanreotide
5441534|NCT01538966|octreotide|octreotide
5441535|NCT01538953|diarrhea|diarrhea
5441536|NCT01538953|handwashing|handwashing
5441537|NCT01538953|point-of-use water treatment|point-of-use water treatment
5441538|NCT01538953|diarrhea longitudinal prevalence|diarrhea longitudinal prevalence
5441539|NCT01538940|Influenza|influenza
5441540|NCT01538940|Vaccine|vaccine
5441541|NCT01538940|Thailand|thailand
5441542|NCT01538927|fibrin sealant|fibrin sealant
5441543|NCT01538927|tissue adhesive|tissue adhesive
5441544|NCT01538927|wound healing|wound healing
5441545|NCT01538927|interleukin 1 beta|interleukin 1 beta
5441546|NCT01538927|interleukin 8|interleukin 8
5441547|NCT01538901|actinic keratoses|actinic keratoses
5441548|NCT01538901|organ transplant recipients|organ transplant recipients
5441549|NCT01538901|photodynamic therapy|photodynamic therapy
5441550|NCT01538901|imiquimod|imiquimod
5441551|NCT01538888|WHOLE BODY VIBRATION|whole body vibration
5441552|NCT01538888|AGED|aged
5441553|NCT01538888|VO2|vo2
5441554|NCT01538888|muscle strength|muscle strength
5441555|NCT01538875|Hypertension, pregnancy induced|hypertension, pregnancy induced
5441556|NCT01538875|Hydralazine|hydralazine
5441557|NCT01538875|Labetalol|labetalol
5441558|NCT01538823|Surgery, Renal Cell Cancer|surgery, renal cell cancer
5441559|NCT01538810|CT imaging|ct imaging
5441560|NCT01538797|YF476|yf476
5441561|NCT01538797|gastrin receptor antagonist|gastrin receptor antagonist
5441562|NCT01538797|gastric pH|gastric ph
5428516|NCT01594398|Respiratory|respiratory
5441563|NCT01538797|healthy subjects|healthy subjects
5441564|NCT01538797|ranitidine|ranitidine
5441565|NCT01538784|YF476|yf476
5441566|NCT01538784|gastrin receptor antagonist|gastrin receptor antagonist
5441567|NCT01538784|gastric pH|gastric ph
5441568|NCT01538784|healthy subjects|healthy subjects
5441569|NCT01538771|Myocardial infarction|myocardial infarction
5441570|NCT01538771|Erythropoietin|erythropoietin
5441571|NCT01538771|Myocardial reperfusion injury|myocardial reperfusion injury
5441572|NCT01538758|calcifying tendinitis|calcifying tendinitis
5441573|NCT01538758|rotator cuff|rotator cuff
5441574|NCT01538745|Pain|pain
5441575|NCT01538745|Emergency Department|emergency department
5441577|NCT01538745|Ketamine|ketamine
5441578|NCT01538706|Hospital-based home care|hospital-based home care
5441579|NCT01538706|Pediatric oncology|pediatric oncology
5441580|NCT01538693|BDNF|bdnf
5441581|NCT01538693|serotonin|serotonin
5441582|NCT01538693|high-intensity|high-intensity
5441583|NCT01538693|exercise|exercise
5441584|NCT01538667|Lung|lung
5441585|NCT01538667|Scintigraphy|scintigraphy
5441586|NCT01538667|Pharmacokinetics|pharmacokinetics
5441587|NCT01538667|Inhalation|inhalation
5441588|NCT01538667|Ciprofloxacin|ciprofloxacin
5441589|NCT01538654|obesity|obesity
5441590|NCT01538654|PSMF ( protein sparing modified fast)|psmf ( protein sparing modified fast)
5441591|NCT01538654|Enteral nutrition|enteral nutrition
5441592|NCT01538654|Tube feeding|tube feeding
5441593|NCT01538654|VLCD ( very low calorie diet)|vlcd ( very low calorie diet)
5444774|NCT01524653|Advanced|advanced
5441594|NCT01538654|Pulmonary function tests|pulmonary function tests
5441595|NCT01538654|body composition|body composition
5441596|NCT01538654|FFM ( fat free mass)|ffm ( fat free mass)
5441597|NCT01538654|Body fat|body fat
5441598|NCT01538654|Handgripstregth|handgripstregth
5441599|NCT01538628|Prostate cancer|prostate cancer
5441600|NCT01538628|Spacer|spacer
5441601|NCT01538615|Family meals|family meals
5441602|NCT01538615|Home food environment|home food environment
5441603|NCT01538615|Electronic media|electronic media
5441604|NCT01538602|PCOS|pcos
5441605|NCT01538602|cardiovascular disorders|cardiovascular disorders
5441606|NCT01538563|ON 01910.Na|on 01910.na
5441607|NCT01538563|rigosertib sodium|rigosertib sodium
5441608|NCT01538563|rogosertib|rogosertib
5441609|NCT01538550|cancer|cancer
5441610|NCT01538550|colon|colon
5441611|NCT01538550|rectum|rectum
5441612|NCT01538550|adenoma|adenoma
5441613|NCT01538550|screening|screening
5441614|NCT01538550|iFOBT|ifobt
5441615|NCT01538550|flexible sigmoidoscopy|flexible sigmoidoscopy
5441616|NCT01538550|randomized trial|randomized trial
5441617|NCT01538537|ON 01910.Na|on 01910.na
5441618|NCT01538537|rigosertib Sodium|rigosertib sodium
5441619|NCT01538537|rigosertib|rigosertib
5441621|NCT01538498|Ovarian cancer|ovarian cancer
5441622|NCT01538485|Vitamin D|vitamin d
5441623|NCT01538485|regulatory T cells|regulatory t cells
5441624|NCT01538485|GUT|gut
5441625|NCT01538472|Lymphoma|lymphoma
5441626|NCT01538472|Relapse B-cell CD20+ non-Hodgkin's lymphoma|relapse b-cell cd20+ non-hodgkin's lymphoma
5441627|NCT01538472|High-dose BEAM chemotherapy|high-dose beam chemotherapy
5441628|NCT01538472|Y Zevalin|y zevalin
5441629|NCT01538472|In Zevalin|in zevalin
5441630|NCT01538472|Rituxan|rituxan
5441631|NCT01538472|Rituximab|rituximab
5441632|NCT01538472|BCNU|bcnu
5441633|NCT01538472|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea|1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea
5441634|NCT01538472|Carmustine|carmustine
5441635|NCT01538472|BiCNU|bicnu
5441636|NCT01538472|VP-16|vp-16
5441637|NCT01538472|Ara-C|ara-c
5441638|NCT01538472|Cytarabine|cytarabine
5441639|NCT01538472|Cytosar|cytosar
5441640|NCT01538472|DepoCyt|depocyt
5441641|NCT01538472|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5441642|NCT01538472|Melphalan|melphalan
5441643|NCT01538472|Alkeran|alkeran
5441644|NCT01538472|G-CSF|g-csf
5441645|NCT01538472|Filgrastim|filgrastim
5441646|NCT01538472|Neupogen|neupogen
5441647|NCT01538472|Stem cell infusion|stem cell infusion
5441648|NCT01538472|Autologous stem cell transplantation|autologous stem cell transplantation
5441649|NCT01538459|Blood Glucose|blood glucose
5441650|NCT01538459|Bupivacaine|bupivacaine
5441651|NCT01538459|Interscalene Nerve Block|interscalene nerve block
5441652|NCT01538459|Regional Anesthesia|regional anesthesia
5441653|NCT01538459|Pain Blockade|pain blockade
5441654|NCT01538459|Arthroscopic Surgery|arthroscopic surgery
5441655|NCT01538459|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5441656|NCT01538459|Dexamethasone|dexamethasone
5441657|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents
5441658|NCT01538459|Therapeutic Uses|therapeutic uses
5441659|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs
5441660|NCT01538459|Glucocorticoids|glucocorticoids
5441661|NCT01538459|Anesthetics, Local|anesthetics, local
5441662|NCT01538459|Anesthetics|anesthetics
5441663|NCT01538459|Sensory System Agents|sensory system agents
5428622|NCT01594086|aging|aging
5441664|NCT01538459|Adjuvants, Anesthesia|adjuvants, anesthesia
5441665|NCT01538459|Anesthesiology|anesthesiology
5441666|NCT01538459|Injections|injections
5441668|NCT01538459|Analgesia/methods|analgesia/methods
5441669|NCT01538459|Brachial Plexus/drug effects|brachial plexus/drug effects
5441670|NCT01538459|Brachial Plexus/surgery|brachial plexus/surgery
5441671|NCT01538459|Brachial Plexus/ultrasonography|brachial plexus/ultrasonography
5441672|NCT01538459|Bupivacaine/administration & dosage|bupivacaine/administration & dosage
5441673|NCT01538459|Dexamethasone/administration & dosage|dexamethasone/administration & dosage
5441674|NCT01538459|Drug Therapy, Combination|drug therapy, combination
5441675|NCT01538459|Female|female
5441676|NCT01538459|Humans|humans
5441677|NCT01538459|Male|male
5441678|NCT01538459|Nerve Block/methods|nerve block/methods
5442071|NCT01536483|Preterms|preterms
5441679|NCT01538459|Pain, Postoperative/etiology|pain, postoperative/etiology
5441680|NCT01538459|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
5441681|NCT01538459|Prospective Studies|prospective studies
5441682|NCT01538459|Time Factors|time factors
5441683|NCT01538446|Elderly|elderly
5441684|NCT01538446|Acute coronary syndrome|acute coronary syndrome
5441685|NCT01538446|Percutaneous coronary intervention|percutaneous coronary intervention
5441686|NCT01538446|Prasugrel|prasugrel
5441687|NCT01538446|Platelet function test|platelet function test
5441688|NCT01538433|diagnosis|diagnosis
5441689|NCT01538433|IgA nephropathy|iga nephropathy
5441690|NCT01538420|Safety|safety
5441691|NCT01538420|Tolerability|tolerability
5441692|NCT01538420|Pharmacokinetics|pharmacokinetics
5441693|NCT01538420|Pharmacodynamics|pharmacodynamics
5441694|NCT01538407|Strength training|strength training
5441695|NCT01538407|Biomechanics|biomechanics
5441696|NCT01538407|Quadriceps|quadriceps
5441697|NCT01538407|Gait|gait
5441698|NCT01538394|smoking cessation|smoking cessation
5441699|NCT01538394|abstinence|abstinence
5441700|NCT01538394|clinical trial|clinical trial
5441701|NCT01538394|varenicline|varenicline
5441702|NCT01538394|nicotine|nicotine
5441703|NCT01538381|Neoadjuvant targeted therapy|neoadjuvant targeted therapy
5441704|NCT01538381|Preoperative targeted therapy|preoperative targeted therapy
5441705|NCT01538381|Afatinib|afatinib
5441706|NCT01538368|MRCP|mrcp
5441707|NCT01538368|ERCP|ercp
5441709|NCT01538368|Image interpretation|image interpretation
5441710|NCT01538368|MRCP findings|mrcp findings
5441711|NCT01538368|endoscopic intervention(s)|endoscopic intervention(s)
5441712|NCT01538355|multiple sclerosis|multiple sclerosis
5441713|NCT01538355|diet|diet
5441714|NCT01538355|prolonged fasting|prolonged fasting
5441715|NCT01538355|caloric restriction|caloric restriction
5441716|NCT01538355|ketogenic low glycemic load treatment|ketogenic low glycemic load treatment
5441717|NCT01538355|health related quality of life|health related quality of life
5441718|NCT01538355|ketogenic diet|ketogenic diet
5441719|NCT01538355|neurodegeneration|neurodegeneration
5441720|NCT01538355|neuroinflammation|neuroinflammation
5441721|NCT01538329|Dyskinesia|dyskinesia
5441722|NCT01538329|L-DOPA|l-dopa
5441723|NCT01538329|Early introduced treatment|early introduced treatment
5441724|NCT01538329|Amantadine|amantadine
5441725|NCT01538316|Prostate cancer|prostate cancer
5441726|NCT01538316|dietary supplements|dietary supplements
5441727|NCT01538316|quercetin|quercetin
5441728|NCT01538316|genistein|genistein
5441729|NCT01538316|prostate-specific antigen|prostate-specific antigen
5441730|NCT01538316|oxidative Status|oxidative status
5441731|NCT01538303|STEMI|stemi
5441732|NCT01538303|absolute flow|absolute flow
5441733|NCT01538303|microvascular resistance|microvascular resistance
5441734|NCT01538290|Calibration|calibration
5441735|NCT01538290|Validation|validation
5441736|NCT01538290|Transfer function|transfer function
5441737|NCT01538290|SphygmoCor|sphygmocor
5441738|NCT01538290|Arteriograph|arteriograph
5441739|NCT01538277|contact force catheter|contact force catheter
5441740|NCT01538277|loop recorder|loop recorder
5441741|NCT01538251|ulcerative colitis|ulcerative colitis
5441742|NCT01538251|propionyl-l-carnitine|propionyl-l-carnitine
5441743|NCT01538225|Spasticity|spasticity
5441744|NCT01538212|Alzheimer's disease|alzheimer's disease
5441745|NCT01538212|retrospective|retrospective
5441746|NCT01538212|Axona|axona
5441747|NCT01538199|Device study|device study
5441748|NCT01538199|Depression|depression
5441749|NCT01538199|Major Depression|major depression
5441750|NCT01538199|Major Depressive Disorder|major depressive disorder
5441751|NCT01538199|MDD|mdd
5441752|NCT01538199|Device for depression|device for depression
5441753|NCT01538199|Alternatives to medication for depression|alternatives to medication for depression
5441754|NCT01538199|Massachusetts General Hospital|massachusetts general hospital
5441755|NCT01538199|Boston|boston
5441756|NCT01538186|Coronary intervention|coronary intervention
5441757|NCT01538186|PCI of the side branch|pci of the side branch
5441758|NCT01538173|surgical side infection|surgical side infection
5441759|NCT01538173|breast reduction|breast reduction
5428718|NCT01593631|lactose intolerance|lactose intolerance
5441760|NCT01538173|reduction mammaplasty|reduction mammaplasty
5441761|NCT01538173|prospective trial|prospective trial
5441762|NCT01538173|microcirculation|microcirculation
5441763|NCT01538173|breast surgery|breast surgery
5441764|NCT01538160|recombinant factor VIIa|recombinant factor viia
5441765|NCT01538160|factor XI deficiency|factor xi deficiency
5441766|NCT01538147|Restless Leg Syndrome|restless leg syndrome
5441767|NCT01538147|Severe Preeclampsia|severe preeclampsia
5441768|NCT01538134|Antibodies, anticardiolipin|antibodies, anticardiolipin
5441769|NCT01538134|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
5441770|NCT01538134|Lupus Anticoagulant|lupus anticoagulant
5441771|NCT01538134|Fetal Growth Restriction|fetal growth restriction
5441772|NCT01538121|Antibodies, anticardiolipin|antibodies, anticardiolipin
5441773|NCT01538121|Antibodies, B2 Glycoprotein I|antibodies, b2 glycoprotein i
5441774|NCT01538121|Lupus Anticoagulant|lupus anticoagulant
5441775|NCT01538121|Severe Preeclampsia|severe preeclampsia
5441776|NCT01538082|Anxiety disorders|anxiety disorders
5441777|NCT01538082|Depressive disorders|depressive disorders
5441778|NCT01538082|Metabolic syndrome|metabolic syndrome
5441779|NCT01538082|Stress disorders|stress disorders
5441780|NCT01538082|Primary care|primary care
5441781|NCT01538069|Heart failure|heart failure
5441782|NCT01538069|Sleep apnea syndromes|sleep apnea syndromes
5441783|NCT01538069|Exercise|exercise
5441784|NCT01538069|Continuous Positive Airway Pressure|continuous positive airway pressure
5441786|NCT01538043|Cost-effectiveness analysis|cost-effectiveness analysis
5441787|NCT01538043|Cost-utility analysis|cost-utility analysis
5441788|NCT01538043|Osteoarthritis|osteoarthritis
5441789|NCT01538043|Spa therapy|spa therapy
5441790|NCT01538043|Randomized clinical trial|randomized clinical trial
5441791|NCT01538043|Mechanisms of action|mechanisms of action
5441793|NCT01538030|Cesarean section|cesarean section
5441794|NCT01538030|Perinatal mortality|perinatal mortality
5441795|NCT01538030|Neonatal sepsis|neonatal sepsis
5441796|NCT01538030|Amniotic Fluid Volume|amniotic fluid volume
5441797|NCT01538004|Blood pressure determination|blood pressure determination
5441798|NCT01538004|Primary health care|primary health care
5441799|NCT01538004|Office visits|office visits
5441800|NCT01538004|Reproducibility of results|reproducibility of results
5441801|NCT01537991|radiotherapy|radiotherapy
5441802|NCT01537991|non small cell lung cancer|non small cell lung cancer
5441804|NCT01537978|spinal cord injury, video gaming, functional improvement|spinal cord injury, video gaming, functional improvement
5441805|NCT01537965|hepatitis|hepatitis
5441806|NCT01537965|fibrosis|fibrosis
5441807|NCT01537965|elastography|elastography
5441808|NCT01537952|facial paralysis, facial nerve, borreliosis, Bell's palsy|facial paralysis, facial nerve, borreliosis, bell's palsy
5441809|NCT01537939|Physical Activity|physical activity
5441810|NCT01537939|Walking|walking
5441811|NCT01537939|Pedometer|pedometer
5441812|NCT01537939|Body Composition|body composition
5441813|NCT01537939|Aerobic Fitness|aerobic fitness
5441814|NCT01537926|HALT|halt
5441815|NCT01537926|HCM|hcm
5441816|NCT01537874|Secondhand smoke|secondhand smoke
5441817|NCT01537874|Pediatric disease|pediatric disease
5441818|NCT01537848|EUS|eus
5441819|NCT01537848|Endoscopic ultrasound|endoscopic ultrasound
5441820|NCT01537848|abdominal collection|abdominal collection
5441821|NCT01537848|post-operative|post-operative
5441822|NCT01537848|post-surgical|post-surgical
5441823|NCT01537835|healthcare|healthcare
5441824|NCT01537835|worker|worker
5441825|NCT01537835|uniforms|uniforms
5441826|NCT01537835|bacterial|bacterial
5441827|NCT01537835|contamination|contamination
5441828|NCT01537822|intrauterine polyps|intrauterine polyps
5441829|NCT01537822|myomas|myomas
5441830|NCT01537822|residual placental tissue|residual placental tissue
5441831|NCT01537809|Vitamin D|vitamin d
5441832|NCT01537809|Vitamin D Deficiency|vitamin d deficiency
5441833|NCT01537809|Avitaminosis|avitaminosis
5441834|NCT01537809|Deficiency Diseases|deficiency diseases
5441835|NCT01537809|Blood lipids|blood lipids
5441836|NCT01537796|Obesity|obesity
5441837|NCT01537796|Exercise|exercise
5441838|NCT01537783|abscess|abscess
5441839|NCT01537770|Vertebroplasty|vertebroplasty
5441840|NCT01537770|Low energy osteoporotic vertebral fractures|low energy osteoporotic vertebral fractures
5441841|NCT01537770|of the thoracic and/or lumbar spine|of the thoracic and/or lumbar spine
5441842|NCT01537744|expansion cohort|expansion cohort
5441843|NCT01537705|Medical food|medical food
5441844|NCT01537705|Neuropathy|neuropathy
5441845|NCT01537705|Diabetes|diabetes
5441846|NCT01537705|Neuropathic Pain|neuropathic pain
5441847|NCT01537679|Caregiver|caregiver
5441848|NCT01537679|meditation|meditation
5441849|NCT01537679|relaxation|relaxation
5441850|NCT01537679|stress|stress
5441851|NCT01537627|Motor activity|motor activity
5441852|NCT01537627|Exercise|exercise
5441853|NCT01537627|Rehabilitation|rehabilitation
5441854|NCT01537601|Posterior urethral valves|posterior urethral valves
5441855|NCT01537601|Febrile urinary tract infection|febrile urinary tract infection
5441856|NCT01537601|Circumcision|circumcision
5550488|NCT01085253|MRI|mri
5441857|NCT01537601|Antibioprophylaxis|antibioprophylaxis
5441858|NCT01537601|Impact on family|impact on family
5441859|NCT01537588|anterior cruciate ligament|anterior cruciate ligament
5441860|NCT01537588|hamstring|hamstring
5441861|NCT01537588|semitendinosus|semitendinosus
5441862|NCT01537588|gracilis|gracilis
5441863|NCT01537588|graft|graft
5441864|NCT01537562|Copper IUD|copper iud
5441865|NCT01537562|LNG-IUS|lng-ius
5441866|NCT01537562|intrauterine contraception|intrauterine contraception
5441867|NCT01537562|medical abortion|medical abortion
5441868|NCT01537562|postabortion contraception|postabortion contraception
5441869|NCT01537549|Progressive supranuclear palsy|progressive supranuclear palsy
5441870|NCT01537549|alpha-lipoic acid|alpha-lipoic acid
5441871|NCT01537549|L-acetyl carnitine|l-acetyl carnitine
5441872|NCT01537549|antioxidant|antioxidant
5441873|NCT01537549|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5441874|NCT01537549|neurodegeneration|neurodegeneration
5441876|NCT01537536|Breast cancer|breast cancer
5441877|NCT01537536|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5441878|NCT01537536|EndoTAG-1|endotag-1
5441879|NCT01537523|physical|physical
5441880|NCT01537523|psychological|psychological
5441881|NCT01537523|fracture hip|fracture hip
5441882|NCT01537497|Phase 1|phase 1
5441883|NCT01537497|Single Doses|single doses
5441884|NCT01537497|Pharmacodynamics|pharmacodynamics
5441885|NCT01537497|Healthy Volunteers|healthy volunteers
5441886|NCT01537484|massage|massage
5441887|NCT01537484|osteoarthritis|osteoarthritis
5441888|NCT01537484|light touch|light touch
5441889|NCT01537484|Swedish|swedish
5441890|NCT01537471|PPI|ppi
5441891|NCT01537471|Meclizine|meclizine
5441892|NCT01537471|Startle|startle
5441893|NCT01537471|Sensory processing|sensory processing
5441894|NCT01537471|antihistamines|antihistamines
5441895|NCT01537445|Diabetes Mellitus|diabetes mellitus
5441896|NCT01537445|Pancreas|pancreas
5441897|NCT01537445|Renal failure|renal failure
5441898|NCT01537445|Transplantation|transplantation
5441899|NCT01537432|Psoriasis, Plaque-type psoriasis|psoriasis, plaque-type psoriasis
5441900|NCT01537432|Plaque|plaque
5441901|NCT01537432|Secukinumab|secukinumab
5441902|NCT01537432|AIN457A|ain457a
5441903|NCT01537432|PASI|pasi
5441904|NCT01537432|DLQI|dlqi
5441905|NCT01537432|IGA|iga
5441906|NCT01537419|Suicide|suicide
5441907|NCT01537419|Depression|depression
5441908|NCT01537419|Family Relationships|family relationships
5441909|NCT01537406|BREAST IRRADIATION USING INTENSITY MODULATED RADIATION THERAPY|breast irradiation using intensity modulated radiation therapy
5441910|NCT01537393|cornea|cornea
5441911|NCT01537393|transplant|transplant
5441912|NCT01537393|preservation|preservation
5441913|NCT01537393|endothelial keratoplasty|endothelial keratoplasty
5441914|NCT01537367|Human immunodeficiency virus|human immunodeficiency virus
5441915|NCT01537367|HIV primary care|hiv primary care
5441916|NCT01537328|Total knee arthroplasty|total knee arthroplasty
5441917|NCT01537328|quadriceps|quadriceps
5441918|NCT01537328|muscle|muscle
5441919|NCT01537328|arthroplasty|arthroplasty
5441920|NCT01537328|joint diseases|joint diseases
5441921|NCT01537328|musculoskeletal diseases|musculoskeletal diseases
5441922|NCT01537315|Kidney Failure, Chronic|kidney failure, chronic
5441923|NCT01537315|Cardiovascular Disease|cardiovascular disease
5441924|NCT01537315|Arteriosclerosis|arteriosclerosis
5441925|NCT01537302|Chronic Total Occlusion|chronic total occlusion
5441926|NCT01537302|Optimal Coherence Tomography|optimal coherence tomography
5441927|NCT01537302|Lumivascular|lumivascular
5441928|NCT01537289|Trauma|trauma
5441929|NCT01537289|Pneumothorax|pneumothorax
5441930|NCT01537276|hysterosalpingography|hysterosalpingography
5441931|NCT01537276|Fluoroscopy|fluoroscopy
5441932|NCT01537276|diagnostic accuracy|diagnostic accuracy
5441933|NCT01537263|Aneurysmal Subarachnoid Hemorrhage|aneurysmal subarachnoid hemorrhage
5441934|NCT01537263|SAB|sab
5441935|NCT01537263|SAH|sah
5441936|NCT01537263|Ultrasound|ultrasound
5441937|NCT01537263|Perfusion imaging|perfusion imaging
5441938|NCT01537250|CAP|cap
5441939|NCT01537237|Atrial Fibrillation|atrial fibrillation
5441940|NCT01537237|Catheter-based ablation|catheter-based ablation
5441941|NCT01537237|Pulmonary vein isolation|pulmonary vein isolation
5441942|NCT01537237|Electro-anatomical mapping|electro-anatomical mapping
5441943|NCT01537237|Rotational angiography|rotational angiography
5441944|NCT01537224|Electrophysiology|electrophysiology
5441945|NCT01537224|Subthalamic nucleus|subthalamic nucleus
5441946|NCT01537224|Parkinson|parkinson
5441947|NCT01537211|Dysvascular|dysvascular
5441948|NCT01537211|amputation|amputation
5441949|NCT01537211|above knee|above knee
5441950|NCT01537211|ambulation|ambulation
5441951|NCT01537198|Postmarketing Drug Surveillance|postmarketing drug surveillance
5441952|NCT01537172|ONO-4053 healthy subjects|ono-4053 healthy subjects
5441953|NCT01537172|3 part adaptive design|3 part adaptive design
5441954|NCT01537159|AML|aml
5441955|NCT01537146|unicompartmental|unicompartmental
5441956|NCT01537146|osteoarthritis|osteoarthritis
5441957|NCT01537146|varus|varus
5441958|NCT01537146|malalignment|malalignment
5441959|NCT01537146|opening wedge|opening wedge
5441960|NCT01537146|HTO|hto
5441961|NCT01537146|high|high
5441962|NCT01537146|tibia|tibia
5441963|NCT01537146|osteotomy|osteotomy
5441964|NCT01537094|low vitamin c|low vitamin c
5441965|NCT01537094|reduced growth hormone secretion|reduced growth hormone secretion
5441966|NCT01537068|Dysthymic disorder|dysthymic disorder
5441967|NCT01537068|Dysthymia|dysthymia
5441968|NCT01537068|Chronic non-major depression|chronic non-major depression
5441969|NCT01537068|Non-major chronic depression|non-major chronic depression
5441970|NCT01537068|Chronic depressive disorder|chronic depressive disorder
5441971|NCT01537068|Antidepressant treatment|antidepressant treatment
5441972|NCT01537055|H pylori eradication|h pylori eradication
5441973|NCT01537042|Rotigotine|rotigotine
5441974|NCT01537042|Neupro|neupro
5441975|NCT01537042|Restless Legs Syndrome|restless legs syndrome
5441976|NCT01537042|RLS|rls
5441977|NCT01537042|End-Stage Renal Disease|end-stage renal disease
5441978|NCT01537029|Breast cancer|breast cancer
5442168|NCT01536119|Coparenting|coparenting
5441979|NCT01537029|Pharmacokinetics|pharmacokinetics
5441980|NCT01537029|Obesity|obesity
5441981|NCT01537029|Doxorubicin|doxorubicin
5441982|NCT01537029|Cyclophosphamide|cyclophosphamide
5441983|NCT01537029|Weight|weight
5441984|NCT01536977|quality of life|quality of life
5441985|NCT01536925|Behavioral Economics|behavioral economics
5441986|NCT01536925|Drug self administration|drug self administration
5441987|NCT01536925|Opioid|opioid
5441988|NCT01536912|HIV positive|hiv positive
5441989|NCT01536899|HIV positive|hiv positive
5441990|NCT01536899|Medical Marijuana|medical marijuana
5441991|NCT01536873|treatment experienced patients|treatment experienced patients
5441992|NCT01536873|Integrase resistance|integrase resistance
5441993|NCT01536834|Verruca|verruca
5441994|NCT01536834|Plantar Wart|plantar wart
5441995|NCT01536834|Medical Device|medical device
5441996|NCT01536834|Podiatry|podiatry
5441997|NCT01536834|Footcare|footcare
5441998|NCT01536821|Parkinson disease|parkinson disease
5441999|NCT01536821|Parkinson's Disease|parkinson's disease
5442000|NCT01536821|PD|pd
5442001|NCT01536821|LRRK2|lrrk2
5442002|NCT01536821|genetics|genetics
5442003|NCT01536821|genes|genes
5442004|NCT01536808|Diabetes mellitus|diabetes mellitus
5442005|NCT01536808|accelerated aging|accelerated aging
5442006|NCT01536808|cellular senescence|cellular senescence
5442007|NCT01536808|diabetic cardiomyopathy|diabetic cardiomyopathy
5442008|NCT01536808|strain imaging|strain imaging
5442009|NCT01536808|strain rate imaging,|strain rate imaging,
5442010|NCT01536808|echocardiography|echocardiography
5442011|NCT01536795|Ointment to treat leishmania skin lesions|ointment to treat leishmania skin lesions
5442012|NCT01536782|head and neck cancer|head and neck cancer
5442013|NCT01536782|chemoradiation therapy|chemoradiation therapy
5442014|NCT01536782|bolus feeding|bolus feeding
5442015|NCT01536782|gravity feeding|gravity feeding
5442016|NCT01536782|pump feeding|pump feeding
5442017|NCT01536782|optimal enteral feeding method|optimal enteral feeding method
5442018|NCT01536782|To determine the optimal tube feeding method by analyzing percent weigtht loss.|to determine the optimal tube feeding method by analyzing percent weigtht loss.
5442019|NCT01536782|To determine the optimal tube feeding method by analyzing tolerance of enteral feeds.|to determine the optimal tube feeding method by analyzing tolerance of enteral feeds.
5442020|NCT01536782|To determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.|to determine the optimal tube feeding method by analyzing percent met of estimated calories and protein.
5442021|NCT01536769|Metagenomic analysis|metagenomic analysis
5442022|NCT01536769|Microbiota|microbiota
5442023|NCT01536756|Depressive disorder|depressive disorder
5442024|NCT01536756|exercise|exercise
5442025|NCT01536756|pain|pain
5442026|NCT01536756|physical|physical
5442027|NCT01536756|psychological|psychological
5442028|NCT01536756|Chinese|chinese
5442029|NCT01536756|mild to severe depressive disorders|mild to severe depressive disorders
5442030|NCT01536717|atrial septal defect|atrial septal defect
5442031|NCT01536717|mitral valve annuloplasty|mitral valve annuloplasty
5442032|NCT01536717|aortic valve annuloplasty|aortic valve annuloplasty
5442033|NCT01536717|open heart surgery|open heart surgery
5442034|NCT01536717|oxycodone consumption|oxycodone consumption
5442035|NCT01536717|articain|articain
5442036|NCT01536717|bupivacaine|bupivacaine
5442037|NCT01536717|pain after sternotomy|pain after sternotomy
5442038|NCT01536717|postoperative pain|postoperative pain
5442039|NCT01536717|wound infusion|wound infusion
5442040|NCT01536704|nicotine lozenge|nicotine lozenge
5442041|NCT01536704|nicotine|nicotine
5442042|NCT01536704|nicotine replacement therapy|nicotine replacement therapy
5442043|NCT01536691|ramosetron|ramosetron
5442044|NCT01536691|ondansetron|ondansetron
5442045|NCT01536691|aprepitant|aprepitant
5442046|NCT01536691|chemotherapy induced nausea & vomiting|chemotherapy induced nausea & vomiting
5442047|NCT01536587|influence of bronchodilatation with salmeterol on the autonomic nervous systems in COPD patients will be measured using MSNA.|influence of bronchodilatation with salmeterol on the autonomic nervous systems in copd patients will be measured using msna.
5442048|NCT01536587|Relation of COPD and sympathetic nerve activity is to be evaluated,|relation of copd and sympathetic nerve activity is to be evaluated,
5442049|NCT01536561|Tositumomab and/or Iodine I 131 Tositumomab|tositumomab and/or iodine i 131 tositumomab
5442050|NCT01536561|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5442051|NCT01536561|Dose-limiting toxicity|dose-limiting toxicity
5442052|NCT01536561|Bexxar|bexxar
5442053|NCT01536548|hemodialysis|hemodialysis
5442054|NCT01536548|cannulation|cannulation
5442055|NCT01536548|AV-fistula|av-fistula
5442056|NCT01536548|buttonhole technique|buttonhole technique
5442057|NCT01536535|Ulcerative Colitis|ulcerative colitis
5442058|NCT01536535|mesalamine|mesalamine
5442059|NCT01536535|corticosteroids|corticosteroids
5442060|NCT01536535|PROTECT|protect
5442061|NCT01536522|Asthma|asthma
5442062|NCT01536522|Allergic Asthma|allergic asthma
5442063|NCT01536522|Non-allergic Asthma|non-allergic asthma
5442064|NCT01536496|trauma|trauma
5442065|NCT01536496|hemorrhagic shock|hemorrhagic shock
5442066|NCT01536496|thrombelastography|thrombelastography
5442067|NCT01536496|coagulopathy|coagulopathy
5442068|NCT01536496|transfusion|transfusion
5442069|NCT01536496|resuscitation|resuscitation
5442070|NCT01536483|Butyrate|butyrate
5442072|NCT01536483|Very Low Birth Weight (<1250g)|very low birth weight (<1250g)
5442073|NCT01536483|Rectocolonic enemas|rectocolonic enemas
5442074|NCT01536483|Digestive maturation|digestive maturation
5442075|NCT01536483|Parenteral nutrition weaning|parenteral nutrition weaning
5442076|NCT01536483|ECUN|ecun
5442077|NCT01536483|Whole gut transit time|whole gut transit time
5442078|NCT01536470|Intraoperative hemodynamic|intraoperative hemodynamic
5442079|NCT01536470|Arterial pressure|arterial pressure
5442080|NCT01536470|Postoperative complications|postoperative complications
5442081|NCT01536470|Intraoperative fluids|intraoperative fluids
5442082|NCT01536470|Noradrenaline|noradrenaline
5442083|NCT01536457|asthma|asthma
5442084|NCT01536457|children|children
5442085|NCT01536457|gastroesophageal reflux|gastroesophageal reflux
5442087|NCT01536457|data analysis|data analysis
5442088|NCT01536444|Mohs surgery|mohs surgery
5442089|NCT01536444|Excisional skin surgery|excisional skin surgery
5442090|NCT01536444|Micrografting|micrografting
5442091|NCT01536431|Diabetes|diabetes
5442092|NCT01536418|Crohn's disease, chemokine receptor 9 antagonist, Crohn's Disease Activity Index|crohn's disease, chemokine receptor 9 antagonist, crohn's disease activity index
5442093|NCT01536418|active treatment|active treatment
5442094|NCT01536392|Cancer of the Cervix|cancer of the cervix
5442095|NCT01536392|Anti-emetic therapy|anti-emetic therapy
5442096|NCT01536392|Granisetron|granisetron
5442097|NCT01536392|Transdermal patch|transdermal patch
5442098|NCT01536392|Ondansetron|ondansetron
5442099|NCT01536392|Zofran|zofran
5442100|NCT01536392|Questionnaires|questionnaires
5442101|NCT01536392|Surveys|surveys
5442102|NCT01536392|Study Drug Diary|study drug diary
5442103|NCT01536379|Infection|infection
5442104|NCT01536379|Quality of Life|quality of life
5442105|NCT01536366|Parkinson Disease|parkinson disease
5442106|NCT01536366|BIA 9-1067|bia 9-1067
5442107|NCT01536340|post discharge adverse events|post discharge adverse events
5442108|NCT01536340|discontinuities in care|discontinuities in care
5442109|NCT01536340|medical injury|medical injury
5442110|NCT01536327|leukodystrophies|leukodystrophies
5442111|NCT01536327|Metachromatic Leukodystrophy Disease|metachromatic leukodystrophy disease
5442112|NCT01536314|Pre-emptive administration|pre-emptive administration
5442113|NCT01536314|Post-operative administration|post-operative administration
5442114|NCT01536314|Prophylaxis|prophylaxis
5442115|NCT01536314|Memantine|memantine
5442116|NCT01536314|Post-mastectomy/tumorectomy|post-mastectomy/tumorectomy
5442117|NCT01536314|Neuropathic pain|neuropathic pain
5442118|NCT01536301|oxycodone|oxycodone
5442119|NCT01536301|morphine|morphine
5442120|NCT01536301|hip replacement|hip replacement
5442121|NCT01536301|analgesia|analgesia
5442122|NCT01536301|post operative analgesia|post operative analgesia
5442123|NCT01536288|acute mountain sickness|acute mountain sickness
5442125|NCT01536288|Rhodiola Crenulata|rhodiola crenulata
5442126|NCT01536288|mountaineering|mountaineering
5442127|NCT01536288|pulse oximetry|pulse oximetry
5442128|NCT01536288|oxygen saturation|oxygen saturation
5442129|NCT01536275|critical illness|critical illness
5442130|NCT01536275|children|children
5442131|NCT01536275|nutrition|nutrition
5442132|NCT01536275|metabolism|metabolism
5442133|NCT01536236|Diabetes|diabetes
5442134|NCT01536236|Polyneuropathy|polyneuropathy
5442135|NCT01536236|Spinal cord stimulation|spinal cord stimulation
5671969|NCT00613379|HIV|hiv
5442136|NCT01536223|Nasopharyngeal Carcinoma (NPC)|nasopharyngeal carcinoma (npc)
5442137|NCT01536223|cisplatin and 5-fluorouracil (PF)|cisplatin and 5-fluorouracil (pf)
5442138|NCT01536223|docetaxel,cisplatin and 5-fluorouracil(TPF)|docetaxel,cisplatin and 5-fluorouracil(tpf)
5442139|NCT01536223|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5442140|NCT01536223|intensity modulated radiotherapy(IMRT)|intensity modulated radiotherapy(imrt)
5442141|NCT01536210|ADHD(attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
5442142|NCT01536197|obesity|obesity
5442143|NCT01536197|gastric bypass|gastric bypass
5442144|NCT01536197|gastric banding|gastric banding
5442145|NCT01536197|sleeve gastrectomy|sleeve gastrectomy
5442146|NCT01536197|weight loss|weight loss
5442147|NCT01536197|taste perception|taste perception
5442148|NCT01536184|Fetal Alcohol Spectrum Disorder|fetal alcohol spectrum disorder
5442149|NCT01536184|FASD|fasd
5442150|NCT01536171|runners|runners
5442151|NCT01536171|mid-foot strike|mid-foot strike
5442152|NCT01536171|fore foot strike|fore foot strike
5442153|NCT01536171|metabolic costs|metabolic costs
5442154|NCT01536171|trained runners (men,women) with a FM strike|trained runners (men,women) with a fm strike
5442155|NCT01536171|shod running|shod running
5442156|NCT01536171|barefoot running|barefoot running
5442157|NCT01536158|Patent Ductus Arteriosus|patent ductus arteriosus
5442158|NCT01536158|Paracetamol|paracetamol
5442159|NCT01536158|Ibuprofen|ibuprofen
5442160|NCT01536158|Preterm infant|preterm infant
5442161|NCT01536145|IGF-1R inhibitor|igf-1r inhibitor
5442163|NCT01536145|multiple myeloma|multiple myeloma
5442164|NCT01536132|Levosimendan|levosimendan
5442165|NCT01536132|chronic heart failure|chronic heart failure
5442166|NCT01536132|inotropic drug|inotropic drug
5442167|NCT01536119|Breastfeeding|breastfeeding
5442169|NCT01536119|Infant feeding|infant feeding
5442170|NCT01536119|Fathers' support|fathers' support
5442171|NCT01536119|Breastfeeding support|breastfeeding support
5442172|NCT01536119|Breastfeeding support intervention|breastfeeding support intervention
5442173|NCT01536119|clinical trial|clinical trial
5442174|NCT01536106|Cell therapy, Bone marrow stem cells, cardiac cell therapy|cell therapy, bone marrow stem cells, cardiac cell therapy
5442175|NCT01536041|asthma|asthma
5442176|NCT01536041|Adult|adult
5442177|NCT01536015|Rotigotine|rotigotine
5442178|NCT01536015|Neupro®|neupro®
5442179|NCT01536015|Levodopa|levodopa
5442180|NCT01536015|Gastrointestinal Dysfunction|gastrointestinal dysfunction
5442181|NCT01536002|Bariatric surgery|bariatric surgery
5437021|NCT01557738|Exercise|exercise
5442185|NCT01535989|B-cell Non Hodgkin's Lymphomas|b-cell non hodgkin's lymphomas
5442186|NCT01535989|CD22 positive|cd22 positive
5442187|NCT01535950|Age-related macular degeneration|age-related macular degeneration
5442188|NCT01535950|intravitreal, neovascular|intravitreal, neovascular
5442189|NCT01535950|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5442191|NCT01535950|Age-related|age-related
5442192|NCT01535950|Macular degeneration|macular degeneration
5442193|NCT01535950|Intravitreal|intravitreal
5442194|NCT01535950|Neovascular|neovascular
5442195|NCT01535924|Hodgkin's Lymphoma|hodgkin's lymphoma
5442196|NCT01535924|relapsed|relapsed
5442197|NCT01535924|refractory|refractory
5442198|NCT01535911|ketogenic diet|ketogenic diet
5442199|NCT01535911|brain tumors|brain tumors
5442201|NCT01535898|MR imaging Pulse Sequence|mr imaging pulse sequence
5442202|NCT01535898|High Resolution Diffusion-weighted|high resolution diffusion-weighted
5442203|NCT01535898|Questionnaire|questionnaire
5442204|NCT01535898|12-033|12-033
5442205|NCT01535885|Cytoxic T Lymphocytes(CTL)|cytoxic t lymphocytes(ctl)
5442206|NCT01535885|T-cell Depleted|t-cell depleted
5442207|NCT01535885|Allogeneic Transplant|allogeneic transplant
5442208|NCT01535885|Epstein Barr Virus|epstein barr virus
5442209|NCT01535885|Adenovirus|adenovirus
5442210|NCT01535885|Cytomegalovirus|cytomegalovirus
5442211|NCT01535885|Hematopoietic progenitor cell transplantation|hematopoietic progenitor cell transplantation
5442212|NCT01535846|taste|taste
5442213|NCT01535846|mindful eating|mindful eating
5442214|NCT01535846|intuitive eating|intuitive eating
5442215|NCT01535846|attitude|attitude
5442216|NCT01535846|behavior|behavior
5442217|NCT01535833|robotic sacral colpopexy|robotic sacral colpopexy
5442218|NCT01535833|Learning curve|learning curve
5442219|NCT01535833|Pelvic Organ Prolapse|pelvic organ prolapse
5442220|NCT01535833|Robotic Surgery|robotic surgery
5442221|NCT01535820|Healthy volunteers|healthy volunteers
5442222|NCT01535820|ORTHO EVRA|ortho evra
5442223|NCT01535820|Contraceptive hormones|contraceptive hormones
5442224|NCT01535820|Transdermal patch|transdermal patch
5442225|NCT01535820|Progestin norelgestromin (NGMN)|progestin norelgestromin (ngmn)
5442226|NCT01535820|Estrogen ethinyl estradiol (EE)|estrogen ethinyl estradiol (ee)
5442227|NCT01535820|JNJ-93964|jnj-93964
5442228|NCT01535820|JNJ-622206|jnj-622206
5442229|NCT01535807|Atrial Fibrillation|atrial fibrillation
5442230|NCT01535807|Cardiac surgery|cardiac surgery
5442231|NCT01535807|Coronary Artery Bypass Graft|coronary artery bypass graft
5442232|NCT01535807|CorMatrix extra cellular matrix|cormatrix extra cellular matrix
5442233|NCT01535807|Heart surgery|heart surgery
5442234|NCT01535807|Inflammatory Biomarkers|inflammatory biomarkers
5442235|NCT01535807|Myocardial Infarction|myocardial infarction
5442236|NCT01535807|identify proteomic inflammatory biomarkers|identify proteomic inflammatory biomarkers
5442237|NCT01535794|HPV vaccine|hpv vaccine
5442238|NCT01535794|acceptability|acceptability
5442239|NCT01535794|males|males
5442240|NCT01535794|men who have sex with men|men who have sex with men
5442241|NCT01535781|pertrochanteric fracture|pertrochanteric fracture
5442242|NCT01535781|tranexamic acid|tranexamic acid
5442243|NCT01535781|postoperative blood loss|postoperative blood loss
5442244|NCT01535781|blood loss|blood loss
5442245|NCT01535781|hidden blood loss|hidden blood loss
5442246|NCT01535781|blood transfusions|blood transfusions
5442247|NCT01535755|noninvasive mechanical ventilation|noninvasive mechanical ventilation
5442248|NCT01535755|ventilator weaning|ventilator weaning
5442249|NCT01535742|laryngeal mask airway|laryngeal mask airway
5442250|NCT01535742|children|children
5442251|NCT01535742|tracheal intubation|tracheal intubation
5442252|NCT01535742|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5442253|NCT01535690|Laser|laser
5442254|NCT01535690|Clinical trial|clinical trial
5442255|NCT01535690|Non-surgical periodontal therapy|non-surgical periodontal therapy
5442256|NCT01535690|Periodontitis|periodontitis
5442257|NCT01535690|bleeding on probing and radiographic bone loss|bleeding on probing and radiographic bone loss
5442258|NCT01535690|minimum of 2 teeth with probing depth (PD) ≥ 7 mm and|minimum of 2 teeth with probing depth (pd) ≥ 7 mm and
5442259|NCT01535690|2 other teeth with PD ≥ 5 mm|2 other teeth with pd ≥ 5 mm
5442260|NCT01535690|mininum 16 teeth in both jaws|mininum 16 teeth in both jaws
5442261|NCT01535677|Phase 1|phase 1
5442262|NCT01535677|healthy volunteers|healthy volunteers
5442263|NCT01535677|cross-over study|cross-over study
5442264|NCT01535677|Bioavailability|bioavailability
5442265|NCT01535677|Bioequivalence|bioequivalence
5442266|NCT01535677|Cmax|cmax
5442267|NCT01535677|tmax|tmax
5442269|NCT01535677|AUC(0-t)|auc(0-t)
5442271|NCT01535677|tlast|tlast
5442272|NCT01535664|Multiple Sclerosis|multiple sclerosis
5442273|NCT01535664|MS|ms
5442274|NCT01535625|Coronary artery disease|coronary artery disease
5442275|NCT01535625|Atherosclerosis|atherosclerosis
5442276|NCT01535625|CAD|cad
5442277|NCT01535599|Acute Otitis Externa|acute otitis externa
5442278|NCT01535586|CPAP|cpap
5442279|NCT01535586|MAD|mad
5442280|NCT01535586|sleep apnea|sleep apnea
5442281|NCT01535586|PTSD|ptsd
5442282|NCT01535573|Cocaine|cocaine
5442283|NCT01535573|citalopram|citalopram
5442284|NCT01535573|treatment|treatment
5442285|NCT01535573|serotonin|serotonin
5442286|NCT01535560|Acute otitis externa|acute otitis externa
5442287|NCT01535547|isavuconazole|isavuconazole
5442288|NCT01535547|tacrolimus|tacrolimus
5442289|NCT01535547|Healthy Volunteers|healthy volunteers
5442290|NCT01535547|BAL8557|bal8557
5442291|NCT01535534|sepsis|sepsis
5442292|NCT01535534|inflammation|inflammation
5442293|NCT01535534|diagnosis|diagnosis
5442294|NCT01535534|prognosis|prognosis
5442295|NCT01535534|survival|survival
5442296|NCT01535534|mortality|mortality
5442297|NCT01535495|beta-antagonist|beta-antagonist
5442298|NCT01535495|propranolol|propranolol
5442299|NCT01535495|diabetic retinopathy|diabetic retinopathy
5442300|NCT01535495|diabetes|diabetes
5442301|NCT01535495|angiogenesis|angiogenesis
5442302|NCT01535495|neovascularization|neovascularization
5442303|NCT01535482|Cognitive therapy|cognitive therapy
5442304|NCT01535482|Suicide|suicide
5442305|NCT01535482|Older men|older men
5442306|NCT01535482|suicide ideation|suicide ideation
5442307|NCT01535469|cryptococcal meningitis|cryptococcal meningitis
5442308|NCT01535469|hiv|hiv
5442309|NCT01535469|aids|aids
5442310|NCT01535469|implementation science|implementation science
5442311|NCT01535469|stepped wedge design|stepped wedge design
5442312|NCT01535469|retention-in-care|retention-in-care
5442313|NCT01535456|MDS|mds
5442314|NCT01535456|AML|aml
5442315|NCT01535456|5 azacitidine|5 azacitidine
5442316|NCT01535456|FLT PET|flt pet
5442317|NCT01535443|PRO-155|pro-155
5442318|NCT01535443|Ocular NSAIDs|ocular nsaids
5442319|NCT01535443|Safety and tolerability|safety and tolerability
5442320|NCT01535443|Ocular Inflammation|ocular inflammation
5442321|NCT01535443|Ocular Paint|ocular paint
5442322|NCT01535430|brain mapping|brain mapping
5442323|NCT01535430|brain tumor|brain tumor
5442324|NCT01535417|Osteoarthritis|osteoarthritis
5442325|NCT01535391|Chronic Myeloid Leukemia,|chronic myeloid leukemia,
5442326|NCT01535391|Nilotinib,|nilotinib,
5442327|NCT01535391|Philadelphia positive,|philadelphia positive,
5442328|NCT01535391|BCR-ABL+|bcr-abl+
5442329|NCT01535391|Early chronic phase|early chronic phase
5442330|NCT01535365|muscular sprain|muscular sprain
5442331|NCT01535365|acute back pain|acute back pain
5442332|NCT01535365|acute neck pain|acute neck pain
5442333|NCT01535365|heat treatment|heat treatment
5442334|NCT01535365|cold treatment|cold treatment
5442335|NCT01535339|mild Traumatic Brain Injury|mild traumatic brain injury
5442336|NCT01535339|mTBI|mtbi
5442337|NCT01535339|Concussion|concussion
5442338|NCT01535326|colonoscopy|colonoscopy
5442339|NCT01535300|Ultrasound|ultrasound
5442340|NCT01535300|Minimal transverse tracheal diameter|minimal transverse tracheal diameter
5442341|NCT01535300|Endotracheal tube size|endotracheal tube size
5442342|NCT01535300|Paediatric age-based formulas|paediatric age-based formulas
5442343|NCT01535300|Sonographic measurement of the trachea|sonographic measurement of the trachea
5442344|NCT01535287|Dexmedetomidine|dexmedetomidine
5442345|NCT01535287|Emergence Agitation|emergence agitation
5442346|NCT01535287|Myringotomy|myringotomy
5442347|NCT01535287|Children|children
5442348|NCT01535287|General Anesthesia|general anesthesia
5442349|NCT01535274|Cerebral oxygenation|cerebral oxygenation
5442350|NCT01535274|Beach chair position|beach chair position
5442351|NCT01535274|General anesthetic technique|general anesthetic technique
5442352|NCT01535274|Inspired oxygen fraction|inspired oxygen fraction
5442353|NCT01535274|End tidal carbon dioxide|end tidal carbon dioxide
5442354|NCT01535261|Ophthalmology|ophthalmology
5442355|NCT01535261|Ranibizumab|ranibizumab
5442356|NCT01535261|Central Retinal Vein Occlusion|central retinal vein occlusion
5442357|NCT01535248|ERCP|ercp
5442358|NCT01535248|Transthoracic Echocardiography|transthoracic echocardiography
5442359|NCT01535248|Air Embolus|air embolus
5442360|NCT01535248|ERCP associated air embolus|ercp associated air embolus
5442362|NCT01535235|Lymphoid fibrosis|lymphoid fibrosis
5442363|NCT01535222|cardiac surgery|cardiac surgery
5442364|NCT01535222|coronary artery bypass graft|coronary artery bypass graft
5442365|NCT01535222|cardiopulmonary bypass|cardiopulmonary bypass
5442366|NCT01535222|haemostasis modulator|haemostasis modulator
5442367|NCT01535222|blood loss|blood loss
5442368|NCT01535222|direct inhibitor of plasmin and plasma kallikrein|direct inhibitor of plasmin and plasma kallikrein
5442369|NCT01535222|CABG|cabg
5442371|NCT01535209|Stereotactic radiotherapy|stereotactic radiotherapy
5442372|NCT01535209|Whole-brain radiotherapy|whole-brain radiotherapy
5442373|NCT01535209|Resection cavity|resection cavity
5442374|NCT01535196|vitamin D|vitamin d
5442375|NCT01535196|heart failure|heart failure
5442376|NCT01535183|irinotecan|irinotecan
5442377|NCT01535183|brain tumor|brain tumor
5442378|NCT01535183|pediatrics|pediatrics
5442379|NCT01535183|salvage therapy|salvage therapy
5442380|NCT01535183|chemotherapy|chemotherapy
5442381|NCT01535170|lactoferrin|lactoferrin
5442382|NCT01535170|selective decontamination of digestive tract|selective decontamination of digestive tract
5442383|NCT01535170|antimicrobial activity|antimicrobial activity
5846730|NCT00043641|Drug Intensification|drug intensification
5442384|NCT01535170|prolonged mechanical ventilation|prolonged mechanical ventilation
5442385|NCT01535170|respiratory care center|respiratory care center
5442386|NCT01535157|Chemotherapy|chemotherapy
5442387|NCT01535131|otitis media|otitis media
5442388|NCT01535131|cleft palate|cleft palate
5442389|NCT01535118|Allergies|allergies
5442390|NCT01535118|Immunotherapy|immunotherapy
5442391|NCT01535092|HCV recurrence|hcv recurrence
5442392|NCT01535092|HCV reinfection|hcv reinfection
5442393|NCT01535092|Liver transplantation|liver transplantation
5442394|NCT01535092|Legalon SIL|legalon sil
5442395|NCT01535092|silibinin|silibinin
5442396|NCT01535092|viral load|viral load
5442397|NCT01535079|sore throat pain|sore throat pain
5442398|NCT01535079|tonsillopharyngitis|tonsillopharyngitis
5442399|NCT01535079|upper respiratory tract infection|upper respiratory tract infection
5442400|NCT01535066|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5442401|NCT01535066|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5442402|NCT01535066|stage IA breast cancer|stage ia breast cancer
5442403|NCT01535066|stage IB breast cancer|stage ib breast cancer
5442404|NCT01535066|stage II breast cancer|stage ii breast cancer
5442405|NCT01535066|stage IIIA breast cancer|stage iiia breast cancer
5442406|NCT01535066|stage IIIB breast cancer|stage iiib breast cancer
5442407|NCT01535066|stage IIIC breast cancer|stage iiic breast cancer
5442408|NCT01535066|pain|pain
5442409|NCT01535040|cancer survivor|cancer survivor
5442410|NCT01535040|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5442411|NCT01535040|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5442412|NCT01535040|tobacco use disorder|tobacco use disorder
5442413|NCT01535040|stage IA breast cancer|stage ia breast cancer
5442414|NCT01535040|stage IB breast cancer|stage ib breast cancer
5442415|NCT01535040|stage II breast cancer|stage ii breast cancer
5442416|NCT01535040|stage IIIA breast cancer|stage iiia breast cancer
5442417|NCT01535040|stage IIIB breast cancer|stage iiib breast cancer
5442418|NCT01535040|stage IIIC breast cancer|stage iiic breast cancer
5442419|NCT01535040|stage I prostate cancer|stage i prostate cancer
5442420|NCT01535040|stage IIA prostate cancer|stage iia prostate cancer
5442421|NCT01535040|stage IIB prostate cancer|stage iib prostate cancer
5442422|NCT01535040|stage III prostate cancer|stage iii prostate cancer
5442423|NCT01535040|stage I colon cancer|stage i colon cancer
5442424|NCT01535040|stage IIA colon cancer|stage iia colon cancer
5442425|NCT01535040|stage IIB colon cancer|stage iib colon cancer
5442426|NCT01535040|stage IIC colon cancer|stage iic colon cancer
5442427|NCT01535040|stage IIIA colon cancer|stage iiia colon cancer
5442428|NCT01535040|stage IIIB colon cancer|stage iiib colon cancer
5442429|NCT01535040|stage IIIC colon cancer|stage iiic colon cancer
5442430|NCT01535040|stage I rectal cancer|stage i rectal cancer
5442431|NCT01535040|stage IIA rectal cancer|stage iia rectal cancer
5442432|NCT01535040|stage IIB rectal cancer|stage iib rectal cancer
5442433|NCT01535040|stage IIC rectal cancer|stage iic rectal cancer
5442434|NCT01535040|stage IIIA rectal cancer|stage iiia rectal cancer
5442435|NCT01535040|stage IIIB rectal cancer|stage iiib rectal cancer
5442436|NCT01535040|stage IIIC rectal cancer|stage iiic rectal cancer
5442437|NCT01535027|teriparatide|teriparatide
5442438|NCT01535027|alendronate|alendronate
5442439|NCT01535027|raloxifene|raloxifene
5442440|NCT01535027|bone mineral density|bone mineral density
5442441|NCT01535001|Osteoarthritis, Knee|osteoarthritis, knee
5442442|NCT01535001|Treatment Outcome|treatment outcome
5442443|NCT01535001|Time Factors|time factors
5442444|NCT01535001|Rehabilitation|rehabilitation
5442445|NCT01535001|Combined Modality Therapy|combined modality therapy
5442446|NCT01535001|Middle Aged|middle aged
5442447|NCT01535001|Aged|aged
5442448|NCT01535001|Aged, 80 and over|aged, 80 and over
5442449|NCT01535001|Male|male
5442450|NCT01535001|Female|female
5442451|NCT01535001|Humans|humans
5442452|NCT01535001|Analysis of Variance|analysis of variance
5442453|NCT01534975|cardiac CT|cardiac ct
5442454|NCT01534975|enhancement|enhancement
5442455|NCT01534975|contrast|contrast
5442456|NCT01534975|safety|safety
5442457|NCT01534975|image quality|image quality
5442458|NCT01534962|Atrial Fibrillation|atrial fibrillation
5442459|NCT01534962|Ranolazine|ranolazine
5442460|NCT01534962|Arrhythmias, Cardiac|arrhythmias, cardiac
5442461|NCT01534962|Antiarrhythmic Agents|antiarrhythmic agents
5442462|NCT01534962|Cardiac Electroversion|cardiac electroversion
5442463|NCT01534962|Ranexa|ranexa
5442469|NCT01534923|questionnaire|questionnaire
5442471|NCT01534923|12-017|12-017
5442472|NCT01534910|garlic|garlic
5442473|NCT01534910|ct angiography|ct angiography
5442474|NCT01534910|atherosclerosis|atherosclerosis
5442475|NCT01534910|carotid IMT|carotid imt
5442476|NCT01534897|thyroid cancer|thyroid cancer
5442477|NCT01534897|Tall cell PTC|tall cell ptc
5442478|NCT01534897|Poorly differentiated thyroid carcinoma|poorly differentiated thyroid carcinoma
5442479|NCT01534897|metastatic|metastatic
5442480|NCT01534884|RA, Biosimilar|ra, biosimilar
5442481|NCT01534871|Cardiac rehabilitation|cardiac rehabilitation
5442482|NCT01534871|Exercise|exercise
5442483|NCT01534871|Systemic inflammation|systemic inflammation
5442484|NCT01534871|Cardiovascular disease risk|cardiovascular disease risk
5442485|NCT01534858|polyhexanide, polihexanide, PHMB, Prontosan, burns, wounds|polyhexanide, polihexanide, phmb, prontosan, burns, wounds
5442486|NCT01534832|surgical smoke|surgical smoke
5442487|NCT01534832|laparoscopic surgery|laparoscopic surgery
5442488|NCT01534832|impaired vision|impaired vision
5442489|NCT01534819|Endograft|endograft
5442490|NCT01534819|Endurant|endurant
5442491|NCT01534819|Heli-FX™|heli-fx™
5442492|NCT01534819|EndoAnchor™|endoanchor™
5442493|NCT01534819|Short neck|short neck
5442494|NCT01534819|Endovascular treatment|endovascular treatment
5442495|NCT01534819|Interventional treatment of aortic aneurysm|interventional treatment of aortic aneurysm
5442496|NCT01534819|Abdominal aortic aneurysm|abdominal aortic aneurysm
5442497|NCT01534819|AAA|aaa
5442498|NCT01534819|Thoracic aortic aneurysm|thoracic aortic aneurysm
5442499|NCT01534819|TAA|taa
5442500|NCT01534819|Advanced disease|advanced disease
5442501|NCT01534806|Migraine|migraine
5442502|NCT01534793|Quality assessment|quality assessment
5442503|NCT01534793|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5442504|NCT01534793|Enucleation of the prostate|enucleation of the prostate
5442505|NCT01534793|LUMENIS|lumenis
5442506|NCT01534793|Laser|laser
5442507|NCT01534793|Learning Curve|learning curve
5442508|NCT01534728|Hepatitis C|hepatitis c
5442509|NCT01534728|CD8 epitopes|cd8 epitopes
5442510|NCT01534702|Acute Myeloid Leukemia|acute myeloid leukemia
5442511|NCT01534702|chemotherapy|chemotherapy
5442512|NCT01534702|clofarabine|clofarabine
5442513|NCT01534676|iron|iron
5442514|NCT01534676|transfusion|transfusion
5442515|NCT01534676|red blood cells|red blood cells
5442516|NCT01534676|sickle cell disease|sickle cell disease
5442517|NCT01534676|thalassemia|thalassemia
5442518|NCT01534676|blood donors|blood donors
5442519|NCT01534663|Heart Failure|heart failure
5442520|NCT01534663|Skeletal Muscle Function|skeletal muscle function
5442521|NCT01534663|Metabolism|metabolism
5442522|NCT01534663|Inflammation|inflammation
5442523|NCT01534663|Glutamine|glutamine
5442524|NCT01534663|Fish oil|fish oil
5442525|NCT01534663|Muscle Function|muscle function
5442526|NCT01534650|motion sensors|motion sensors
5442527|NCT01534650|tremor|tremor
5442528|NCT01534650|bradykinesia|bradykinesia
5442529|NCT01534650|gait|gait
5442530|NCT01534650|balance|balance
5442531|NCT01534650|dyskinesia|dyskinesia
5442532|NCT01534624|Induced Pluripotent Stem Cell (iPS) Cell Lines|induced pluripotent stem cell (ips) cell lines
5442533|NCT01534624|Addiction|addiction
5442534|NCT01534624|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
5442535|NCT01534624|Dopamine Transporter|dopamine transporter
5442543|NCT01534585|nasopharyngeal carcinoma(NPC)|nasopharyngeal carcinoma(npc)
5442544|NCT01534585|Icotinib|icotinib
5442545|NCT01534585|Intensity Modulation Radiation Therapy(IMRT)|intensity modulation radiation therapy(imrt)
5442546|NCT01534546|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5442547|NCT01534546|adjuvant chemotherapy|adjuvant chemotherapy
5442548|NCT01534546|DFS|dfs
5442549|NCT01534546|OS|os
5442550|NCT01534546|safety|safety
5442551|NCT01534546|resectable locally advanced gastric carcinoma|resectable locally advanced gastric carcinoma
5442552|NCT01534546|potentially resectable locally advanced gastric carcinoma|potentially resectable locally advanced gastric carcinoma
5442553|NCT01534533|early atherosclerosis|early atherosclerosis
5442554|NCT01534533|serum lutein|serum lutein
5442555|NCT01534533|serum lycopene|serum lycopene
5442556|NCT01534533|intima-media thickness|intima-media thickness
5442557|NCT01534533|arterial stiffness|arterial stiffness
5442558|NCT01534533|combined effect|combined effect
5442559|NCT01534520|Intrauterine Device|intrauterine device
5442560|NCT01534520|Pain|pain
5442561|NCT01534520|Lidocaine|lidocaine
5442562|NCT01534494|alcohol dependence|alcohol dependence
5442563|NCT01534494|psilocybin|psilocybin
5442566|NCT01534481|NICHD Neonatal Research Network|nichd neonatal research network
5442567|NCT01534481|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5442569|NCT01534481|Neurodevelopmental Impairment|neurodevelopmental impairment
5442570|NCT01534481|Donor Breast Milk|donor breast milk
5442571|NCT01534481|Preterm Formula|preterm formula
5442572|NCT01534455|German Breast Group|german breast group
5442573|NCT01534455|GBG Forschungs GmbH|gbg forschungs gmbh
5442575|NCT01534455|GBG 64|gbg 64
5442576|NCT01534455|E-VITA|e-vita
5442577|NCT01534455|Breast Cancer|breast cancer
5442578|NCT01534455|Metastatic Breast Cancer|metastatic breast cancer
5442579|NCT01534455|Eribulin|eribulin
5442580|NCT01534455|Lapatinib|lapatinib
5442581|NCT01534455|Halaven|halaven
5442582|NCT01534455|Tyverb|tyverb
5442583|NCT01534429|pain|pain
5442584|NCT01534416|Paracervical Block|paracervical block
5442585|NCT01534416|Laparoscopic Surgery|laparoscopic surgery
5442586|NCT01534416|Postoperative Pain|postoperative pain
5442587|NCT01534416|Bupivacaine|bupivacaine
5442588|NCT01534416|Hysterectomy|hysterectomy
5442589|NCT01534416|Myomectomy|myomectomy
5442590|NCT01534416|Randomized Trial|randomized trial
5442602|NCT01534377|Adolescents|adolescents
5442603|NCT01534364|acute renal failure|acute renal failure
5442604|NCT01534364|acute kidney injury|acute kidney injury
5442605|NCT01534364|diet|diet
5442606|NCT01534364|caloric restriction|caloric restriction
5442607|NCT01534364|cardiac surgery|cardiac surgery
5442608|NCT01534364|cardiothoracic surgery|cardiothoracic surgery
5442609|NCT01534338|Sleep|sleep
5442610|NCT01534338|inflammation|inflammation
5442611|NCT01534338|mindfulness|mindfulness
5442612|NCT01534338|meditation|meditation
5442613|NCT01534338|randomized controlled trial|randomized controlled trial
5442614|NCT01534312|Glycopeptides|glycopeptides
5442615|NCT01534312|Dietary proteins|dietary proteins
5442616|NCT01534286|Prescription Medical Food|prescription medical food
5442617|NCT01534286|Theramine|theramine
5442618|NCT01534286|Knee surgery|knee surgery
5442619|NCT01534273|Mild Cognitive Impairment|mild cognitive impairment
5442620|NCT01534247|Phase I|phase i
5442621|NCT01534247|drug to drug|drug to drug
5442622|NCT01534247|CAZ-AVI|caz-avi
5442623|NCT01534247|Healthy volunteer|healthy volunteer
5442624|NCT01534247|pharmacokinetics|pharmacokinetics
5442625|NCT01534247|open label|open label
5442626|NCT01534247|metronidazole|metronidazole
5442627|NCT01534247|safety|safety
5442628|NCT01534234|CRT-D device|crt-d device
5442629|NCT01534234|Severe HF (NYHA Class III or ambulatory IV)|severe hf (nyha class iii or ambulatory iv)
5442630|NCT01534234|stable, optimal drug regimen|stable, optimal drug regimen
5442631|NCT01534234|sinus rhythm|sinus rhythm
5442632|NCT01534221|Ischemic Heart Disease|ischemic heart disease
5442633|NCT01534182|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5442634|NCT01534182|Fingolimod|fingolimod
5442635|NCT01534182|Disease Modifying Therapy (DMT)|disease modifying therapy (dmt)
5442636|NCT01534182|TSQM-9|tsqm-9
5442637|NCT01534169|Graves' disease|graves' disease
5442638|NCT01534169|Dexamethasone|dexamethasone
5442639|NCT01534169|Function of regulatory T cells|function of regulatory t cells
5442640|NCT01534169|The proportion of Th1 and Th2 cells|the proportion of th1 and th2 cells
5442645|NCT01534104|DTI|dti
5442646|NCT01534104|DSI|dsi
5442647|NCT01534104|tractography|tractography
5442648|NCT01534104|neurological/physical testing|neurological/physical testing
5442649|NCT01534104|Motor and Language Pathways|motor and language pathways
5442650|NCT01534104|resting state fMRI|resting state fmri
5442651|NCT01534104|12-008|12-008
5442652|NCT01534091|overweight|overweight
5442653|NCT01534091|obese|obese
5442654|NCT01534091|children|children
5442655|NCT01534091|exercise|exercise
5442656|NCT01534091|physical activity|physical activity
5442657|NCT01534091|pedometer|pedometer
5442658|NCT01534078|non-bulky|non-bulky
5442659|NCT01534078|limited stage|limited stage
5442660|NCT01534065|Hernia|hernia
5442661|NCT01534065|Intervertebral Disk Displacement|intervertebral disk displacement
5429605|NCT01589692|DRF|drf
5442662|NCT01534065|Pathological Conditions, Anatomical|pathological conditions, anatomical
5442663|NCT01534065|Spinal Diseases|spinal diseases
5442664|NCT01534065|Bone Diseases|bone diseases
5442961|NCT01532635|MMF|mmf
5442665|NCT01534065|Musculoskeletal Diseases|musculoskeletal diseases
5442666|NCT01534052|Prostate Cancer|prostate cancer
5442667|NCT01534052|Castration-Resistant Prostate Cancer (CRPC)|castration-resistant prostate cancer (crpc)
5442668|NCT01534052|MDV3100|mdv3100
5442669|NCT01534052|Androgen receptor signaling inhibitor|androgen receptor signaling inhibitor
5442670|NCT01534013|Closed loop insulin delivery|closed loop insulin delivery
5442671|NCT01534000|Cardiac CT|cardiac ct
5442672|NCT01534000|Ischemic heat disease|ischemic heat disease
5442673|NCT01534000|Stress test|stress test
5442674|NCT01533987|Male|male
5442675|NCT01533987|Overweight|overweight
5442676|NCT01533987|Juice Plus|juice plus
5442677|NCT01533961|neglected disease|neglected disease
5442678|NCT01533961|africa|africa
5442679|NCT01533961|new drug|new drug
5442680|NCT01533961|oral drug|oral drug
5442681|NCT01533961|parasite|parasite
5442682|NCT01533896|Obesity prevention|obesity prevention
5442683|NCT01533896|Primary care|primary care
5442684|NCT01533896|Education|education
5442685|NCT01533870|Phase 1|phase 1
5442686|NCT01533870|Healthy male and female volunteers|healthy male and female volunteers
5442687|NCT01533870|Drug-drug interaction|drug-drug interaction
5442688|NCT01533870|Pharmacokinetics|pharmacokinetics
5442689|NCT01533870|NKTR-118|nktr-118
5442690|NCT01533870|Bioavailability|bioavailability
5442691|NCT01533870|Plasma AUC and Cmax|plasma auc and cmax
5442692|NCT01533870|Plasma AUC0-t and t1/2λz and tmax|plasma auc0-t and t1/2λz and tmax
5442693|NCT01533857|Black tea|black tea
5442694|NCT01533857|phenolic acids|phenolic acids
5442696|NCT01533844|Neonates|neonates
5437545|NCT01555554|Propranolol|propranolol
5442698|NCT01533818|Fast breathing|fast breathing
5442699|NCT01533818|Young infants|young infants
5442700|NCT01533818|Management|management
5442701|NCT01533818|Amoxicillin|amoxicillin
5442702|NCT01533818|Placebo|placebo
5442703|NCT01533805|Lumbago|lumbago
5442704|NCT01533805|Exercise therapy|exercise therapy
5442705|NCT01533805|Spine|spine
5442706|NCT01533792|Treatment|treatment
5442707|NCT01533792|pregnant women|pregnant women
5442708|NCT01533792|periodontitis|periodontitis
5442709|NCT01533792|dental scaling|dental scaling
5442710|NCT01533792|dental plaque|dental plaque
5442711|NCT01533779|children|children
5442712|NCT01533779|malignancy|malignancy
5442713|NCT01533779|neutrophil|neutrophil
5442714|NCT01533779|neutrophil extracellular traps|neutrophil extracellular traps
5442715|NCT01533779|superoxide production|superoxide production
5442716|NCT01533779|hydrogen peroxide production|hydrogen peroxide production
5442717|NCT01533779|chemotaxis|chemotaxis
5442718|NCT01533779|myeloperoxidase|myeloperoxidase
5442719|NCT01533779|immunosurveillance|immunosurveillance
5442720|NCT01533779|cancer cell lines|cancer cell lines
5442721|NCT01533753|hot flashes|hot flashes
5442722|NCT01533753|prostate cancer|prostate cancer
5442723|NCT01533727|Cytokine-Induced Killer Cell|cytokine-induced killer cell
5442724|NCT01533727|NSCLC|nsclc
5442725|NCT01533727|adjuvant therapy|adjuvant therapy
5442726|NCT01533714|Rheumatoid Arthritis|rheumatoid arthritis
5442727|NCT01533714|Monoclonal antibody|monoclonal antibody
5442728|NCT01533714|Interleukin-6|interleukin-6
5442729|NCT01533714|Olokizumab|olokizumab
5442730|NCT01533714|CDP6038|cdp6038
5442731|NCT01533701|Hypoxia|hypoxia
5442732|NCT01533701|Fetal blood sampling|fetal blood sampling
5442733|NCT01533701|Lactate|lactate
5442734|NCT01533701|pH|ph
5442735|NCT01533701|base deficit|base deficit
5442736|NCT01533701|angiogenic factors|angiogenic factors
5442737|NCT01533701|suspected fetal hypoxia|suspected fetal hypoxia
5442738|NCT01533675|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics|suture, tensile strength, wound care, saline, hydrogen peroxide, skin closure, wounds, wound healing, wound cleansing, antiseptics
5442739|NCT01533662|phenylephrine|phenylephrine
5442740|NCT01533662|hypotension|hypotension
5442741|NCT01533662|spinal anesthesia|spinal anesthesia
5442742|NCT01533662|lower limb orthopedic surgery|lower limb orthopedic surgery
5442743|NCT01533649|Behavioral intervention|behavioral intervention
5442744|NCT01533649|Seizure self-efficacy|seizure self-efficacy
5442745|NCT01533649|Psychosocial outcomes|psychosocial outcomes
5442746|NCT01533649|Quality of Life in Epilepsy|quality of life in epilepsy
5442747|NCT01533636|Cystic Fibrosis, Healthy|cystic fibrosis, healthy
5442748|NCT01533610|Post-Traumatic Stress disorder|post-traumatic stress disorder
5442749|NCT01533610|Stellate ganglion|stellate ganglion
5442750|NCT01533610|cervical plexus|cervical plexus
5442751|NCT01533610|local anesthesia|local anesthesia
5442752|NCT01533610|anxiety|anxiety
5442753|NCT01533597|Overactive bladder|overactive bladder
5442754|NCT01533597|Solifenacin succinate|solifenacin succinate
5442755|NCT01533597|Tamsulosin|tamsulosin
5442756|NCT01533571|Guided Bone Regeneration|guided bone regeneration
5442757|NCT01533571|Dental Implant|dental implant
5442758|NCT01533571|Alveolar Ridge Augmentation|alveolar ridge augmentation
5442759|NCT01533571|Socket graft|socket graft
5442760|NCT01533558|caspofungin|caspofungin
5442761|NCT01533558|pharmacokinetics|pharmacokinetics
5442762|NCT01533558|invasive fungal infection|invasive fungal infection
5442763|NCT01533558|candidiasis|candidiasis
5442764|NCT01533558|aspergillosis|aspergillosis
5442765|NCT01533558|intensive care|intensive care
5442766|NCT01533545|Mepivacaine|mepivacaine
5442767|NCT01533545|Epinephrine|epinephrine
5442768|NCT01533545|Brachial plexus block|brachial plexus block
5442769|NCT01533545|Renal insufficiency|renal insufficiency
5442770|NCT01533532|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5442771|NCT01533519|Neuropeptide Y|neuropeptide y
5442772|NCT01533519|Intranasal Administration|intranasal administration
5442773|NCT01533519|PTSD|ptsd
5427949|NCT01596751|PLX|plx
5442774|NCT01533519|Trauma|trauma
5442775|NCT01533506|treatment with stiripentol|treatment with stiripentol
5442776|NCT01533493|ADHD|adhd
5442777|NCT01533493|Executive Function|executive function
5442778|NCT01533493|Namenda|namenda
5442779|NCT01533493|Concerta|concerta
5442780|NCT01533480|Adenovirus|adenovirus
5442781|NCT01533480|Conjunctivitis|conjunctivitis
5442782|NCT01533480|keratoconjunctivitis|keratoconjunctivitis
5442783|NCT01533480|viral shedding|viral shedding
5442784|NCT01533480|subepithelial infiltrate|subepithelial infiltrate
5442785|NCT01533480|bulbar injection|bulbar injection
5442786|NCT01533467|Delivery rupture|delivery rupture
5442787|NCT01533467|perineal protection device|perineal protection device
5442788|NCT01533467|reduce perineal tears|reduce perineal tears
5442789|NCT01533454|Obesity|obesity
5442790|NCT01533454|Weight loss|weight loss
5442791|NCT01533454|Incentives|incentives
5442792|NCT01533454|Motivation|motivation
5442793|NCT01533441|anticoagulant therapy|anticoagulant therapy
5442795|NCT01533441|vitamin K2|vitamin k2
5442796|NCT01533441|vitamin K antagonist|vitamin k antagonist
5442797|NCT01533428|Painful Diabetic Peripheral Neuropathy,|painful diabetic peripheral neuropathy,
5442798|NCT01533428|Capsaicin 8% transdermal delivery system|capsaicin 8% transdermal delivery system
5442799|NCT01533415|Anxiety|anxiety
5442800|NCT01533415|Anxiety Disorders|anxiety disorders
5442801|NCT01533402|Cognitive behavior therapy|cognitive behavior therapy
5442802|NCT01533402|Internet|internet
5442803|NCT01533402|Anxiety disorders|anxiety disorders
5442804|NCT01533402|Children|children
5442805|NCT01533376|Sturge Weber|sturge weber
5442806|NCT01533376|SWS|sws
5442807|NCT01533376|Timolol|timolol
5442808|NCT01533376|Port wine mark|port wine mark
5442809|NCT01533363|Hemorrhoids|hemorrhoids
5442810|NCT01533363|Surgery|surgery
5442811|NCT01533363|Hemorrhoidopexy|hemorrhoidopexy
5442812|NCT01533363|Milligan Morgan|milligan morgan
5442813|NCT01533350|Ultrasonography|ultrasonography
5442814|NCT01533350|late follicle phase|late follicle phase
5442815|NCT01533350|homogeneous endometrium|homogeneous endometrium
5442816|NCT01533350|receptivity|receptivity
5442817|NCT01533350|biochemical factor|biochemical factor
5442818|NCT01533350|ultrastructure|ultrastructure
5442819|NCT01533350|endometrial echo pattern|endometrial echo pattern
5442820|NCT01533337|dorsal digital free flap|dorsal digital free flap
5442821|NCT01533337|dorsal branch of proper digital nerve|dorsal branch of proper digital nerve
5442822|NCT01533337|dorsal branch of proper digital artery|dorsal branch of proper digital artery
5442823|NCT01533337|proper digital artery|proper digital artery
5442824|NCT01533324|hepatocellular carcinoma|hepatocellular carcinoma
5442825|NCT01533324|S-1|s-1
5442826|NCT01533324|Leucovorin|leucovorin
5442827|NCT01533324|fluorouracil|fluorouracil
5442828|NCT01533311|nonpolypoid colorectal neoplasms(NP-CRN)|nonpolypoid colorectal neoplasms(np-crn)
5442829|NCT01533311|prevalence|prevalence
5442830|NCT01533311|histology|histology
5442831|NCT01533285|Major depressive disorder|major depressive disorder
5442832|NCT01533285|MDD|mdd
5442833|NCT01533285|Psychiatry disorders|psychiatry disorders
5442834|NCT01533285|Psychosocial stressor|psychosocial stressor
5442835|NCT01533285|Psychosocial stress|psychosocial stress
5442836|NCT01533285|Typhoid vaccination|typhoid vaccination
5442837|NCT01533285|Typhoid vaccine|typhoid vaccine
5442838|NCT01533272|HIV infection|hiv infection
5442839|NCT01533272|Postexposure prophylaxis|postexposure prophylaxis
5442840|NCT01533259|HIV-1|hiv-1
5442841|NCT01533259|HIV|hiv
5442842|NCT01533259|Treatment Experienced|treatment experienced
5442843|NCT01533233|thoracoscopy|thoracoscopy
5442844|NCT01533233|lung cancer|lung cancer
5442845|NCT01533233|lobectomy|lobectomy
5442846|NCT01533233|epidural anesthesia|epidural anesthesia
5442847|NCT01533220|nasal and nasopharyngeal congestion|nasal and nasopharyngeal congestion
5442848|NCT01533168|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5442849|NCT01533168|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5442850|NCT01533168|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5442851|NCT01533155|Phase 1|phase 1
5685510|NCT00555789|kidney transplantation|kidney transplantation
5442852|NCT01533155|Healthy male and female volunteers|healthy male and female volunteers
5442853|NCT01533155|Drug-drug interaction|drug-drug interaction
5442854|NCT01533155|Pharmacokinetics|pharmacokinetics
5442855|NCT01533155|NKTR-118|nktr-118
5442856|NCT01533142|lipids|lipids
5442857|NCT01533129|Hypogonadism|hypogonadism
5442858|NCT01533129|Endothelial dysfunction|endothelial dysfunction
5442859|NCT01533129|Inflammation|inflammation
5442860|NCT01533129|Insulin resistance|insulin resistance
5443169|NCT01531738|Taste|taste
5442861|NCT01533129|Testosterone replacement therapy|testosterone replacement therapy
5442862|NCT01533116|Parkinson Disease|parkinson disease
5442863|NCT01533116|BIA 9-1067|bia 9-1067
5442864|NCT01533077|Parkinson Disease|parkinson disease
5442865|NCT01533077|BIA 9-1067|bia 9-1067
5442866|NCT01533051|Chronic hepatitis B|chronic hepatitis b
5442867|NCT01533051|Nucleos(t)ide analogue|nucleos(t)ide analogue
5442868|NCT01533051|Antiviral treatment|antiviral treatment
5442870|NCT01533025|anterior cruciate ligament|anterior cruciate ligament
5442871|NCT01533025|Achilles|achilles
5442872|NCT01533025|free tendon|free tendon
5442873|NCT01533025|bone-tendon|bone-tendon
5442874|NCT01533025|free tendon Achilles allograft|free tendon achilles allograft
5442875|NCT01533025|Achilles allograft with calcaneal bone block on its end|achilles allograft with calcaneal bone block on its end
5442876|NCT01532999|Posttraumatic Stress Disorder|posttraumatic stress disorder
5442877|NCT01532999|Meditation|meditation
5442878|NCT01532999|Present Centered Group Therapy|present centered group therapy
5442879|NCT01532999|mindfulness|mindfulness
5442880|NCT01532999|MBSR|mbsr
5442881|NCT01532999|complementary alternative medicine|complementary alternative medicine
5442882|NCT01532986|Quality of Health Care|quality of health care
5442883|NCT01532986|Nursing Care Management|nursing care management
5442884|NCT01532986|Care Coordination|care coordination
5442885|NCT01532986|Randomized Trials|randomized trials
5442886|NCT01532960|breast cancer|breast cancer
5442887|NCT01532960|peptide vaccine|peptide vaccine
5442888|NCT01532960|immunotherapy|immunotherapy
5442889|NCT01532934|substance use|substance use
5442890|NCT01532934|psychopathy|psychopathy
5442891|NCT01532934|motivational enhancement|motivational enhancement
5442892|NCT01532934|criminal recidivism|criminal recidivism
5442893|NCT01532908|Liver Transplantation|liver transplantation
5442895|NCT01532895|Cancer pain|cancer pain
5442896|NCT01532895|Hydromorphone|hydromorphone
5442897|NCT01532895|Hydromorphone OROS|hydromorphone oros
5442898|NCT01532895|Narcotic analgesics|narcotic analgesics
5442899|NCT01532895|Opioid-naive|opioid-naive
5442900|NCT01532856|multiple myeloma|multiple myeloma
5442901|NCT01532856|thalidomide|thalidomide
5442902|NCT01532856|comparative|comparative
5442903|NCT01532856|elderly|elderly
5442904|NCT01532843|Hepatitis B|hepatitis b
5442905|NCT01532843|sustained response|sustained response
5442906|NCT01532843|peginterferon|peginterferon
5442907|NCT01532843|nucleos(t)ide analogues|nucleos(t)ide analogues
5442908|NCT01532830|vagus nerve stimulation|vagus nerve stimulation
5442909|NCT01532830|vagal nerve stimulation|vagal nerve stimulation
5442910|NCT01532830|nVNS|nvns
5442911|NCT01532830|VNS|vns
5442912|NCT01532830|migraine|migraine
5442913|NCT01532830|non invasive|non invasive
5442914|NCT01532830|gammacore|gammacore
5442915|NCT01532804|Unresectable metastases|unresectable metastases
5442916|NCT01532791|MELAS|melas
5442917|NCT01532791|mitochondrial DNA mutation|mitochondrial dna mutation
5442918|NCT01532791|mtDNA mutation|mtdna mutation
5442919|NCT01532791|mitochondrial DNA|mitochondrial dna
5442920|NCT01532791|mitochondria|mitochondria
5442921|NCT01532791|m.3243A>G mutation|m.3243a>g mutation
5442922|NCT01532765|Internal limiting membrane|internal limiting membrane
5442923|NCT01532765|Indocyanine green dye|indocyanine green dye
5442924|NCT01532739|Mild Cognitive Impairment|mild cognitive impairment
5442925|NCT01532739|Aging|aging
5442926|NCT01532739|Memory|memory
5442927|NCT01532739|Executive Function|executive function
5442928|NCT01532739|Cognitive Intervention|cognitive intervention
5442929|NCT01532739|Memory Training|memory training
5442930|NCT01532739|Mental Health|mental health
5442931|NCT01532726|Partial-Onset Seizures|partial-onset seizures
5442932|NCT01532726|Eslicarbazepine Acetate|eslicarbazepine acetate
5442933|NCT01532726|ESL|esl
5442934|NCT01532726|BIA 2-093|bia 2-093
5442935|NCT01532726|BIAL|bial
5442936|NCT01532661|TRAUMA|trauma
5442938|NCT01532661|rVIIa|rviia
5442939|NCT01532661|Complication of Trauma hemorrhage|complication of trauma hemorrhage
5442940|NCT01532661|bleeding|bleeding
5442941|NCT01532661|rFVIIa administration for hemorrhage after trauma|rfviia administration for hemorrhage after trauma
5442942|NCT01532648|Ulcerative Colitis|ulcerative colitis
5442943|NCT01532635|hematologic malignancy|hematologic malignancy
5442944|NCT01532635|leukemia|leukemia
5442945|NCT01532635|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5442946|NCT01532635|ALL|all
5442947|NCT01532635|Acute myelogenous leukemia|acute myelogenous leukemia
5442948|NCT01532635|AML|aml
5442949|NCT01532635|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5442950|NCT01532635|CLL|cll
5442951|NCT01532635|lymphoma|lymphoma
5442952|NCT01532635|hodgkin's lymphoma|hodgkin's lymphoma
5442953|NCT01532635|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5442954|NCT01532635|myeloma|myeloma
5442955|NCT01532635|allogeneic stem cell transplant|allogeneic stem cell transplant
5442956|NCT01532635|TJU 2-step|tju 2-step
5442957|NCT01532635|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5442958|NCT01532635|HSCT|hsct
5442959|NCT01532635|bone marrow transplant|bone marrow transplant
5442960|NCT01532635|Cyclophosphamide|cyclophosphamide
5442962|NCT01532635|Mycophenolate Mofetil|mycophenolate mofetil
5442963|NCT01532622|Blueberry|blueberry
5442964|NCT01532609|Methadone maintenance therapy|methadone maintenance therapy
5442965|NCT01532609|Behavioral intervention|behavioral intervention
5442966|NCT01532609|Service provider|service provider
5442967|NCT01532609|Drug use|drug use
5568059|NCT01014481|HIV|hiv
5442968|NCT01532570|Behcet's disease|behcet's disease
5442969|NCT01532570|intestinal Behcet's disease|intestinal behcet's disease
5442970|NCT01532570|neuro-Behcet's disease|neuro-behcet's disease
5442971|NCT01532570|vascular Behcet's disease|vascular behcet's disease
5442972|NCT01532544|Severe pneumonia|severe pneumonia
5442973|NCT01532531|Collateral Meridian Therapy|collateral meridian therapy
5442974|NCT01532531|Knee Osteoarthritis|knee osteoarthritis
5442975|NCT01532518|Feeding intolerance|feeding intolerance
5442976|NCT01532518|Infant|infant
5442977|NCT01532518|tachykinin antagonist|tachykinin antagonist
5442978|NCT01532518|Infant colic|infant colic
5442979|NCT01532518|Nepadutant|nepadutant
5442980|NCT01532505|cardiopulmonary bypass|cardiopulmonary bypass
5442981|NCT01532505|Postcardiotomy vasodilatory shock|postcardiotomy vasodilatory shock
5442982|NCT01532505|Microcirculation|microcirculation
5442983|NCT01532505|Catecholamines|catecholamines
5442984|NCT01532505|Vasopressin|vasopressin
5442985|NCT01532492|Questionnaire|questionnaire
5442986|NCT01532492|WORC|worc
5442987|NCT01532492|Rotator cuff|rotator cuff
5442988|NCT01532492|Reliability|reliability
5442989|NCT01532492|Validity|validity
5442991|NCT01532479|Osteoradionecrosis|osteoradionecrosis
5442992|NCT01532479|Xerostomia|xerostomia
5442993|NCT01532466|fentanyl-induced coughing, rocuronium|fentanyl-induced coughing, rocuronium
5442994|NCT01532401|Blood pressure|blood pressure
5442995|NCT01532388|Randomized Controlled Trial|randomized controlled trial
5442996|NCT01532388|Alcohol|alcohol
5442997|NCT01532388|Drugs|drugs
5442998|NCT01532388|Internet|internet
5442999|NCT01532388|Screening|screening
5443000|NCT01532388|Brief intervention|brief intervention
5443001|NCT01532375|Kochujang,|kochujang,
5443002|NCT01532375|visceral fat|visceral fat
5443003|NCT01532375|population|population
5443004|NCT01532349|chronic kidney disease|chronic kidney disease
5443005|NCT01532349|anemia|anemia
5443006|NCT01532336|adenovirus|adenovirus
5443007|NCT01532336|conjunctivitis|conjunctivitis
5443008|NCT01532336|pinkeye|pinkeye
5443009|NCT01532323|Oral disorders|oral disorders
5443010|NCT01532310|systemic lupus erythematosus|systemic lupus erythematosus
5443011|NCT01532310|belimumab|belimumab
5443012|NCT01532310|pregnancy|pregnancy
5443013|NCT01532297|citrate dialysate|citrate dialysate
5443014|NCT01532297|dialysis|dialysis
5443015|NCT01532297|calcium|calcium
5443016|NCT01532284|aneuploid oocytes|aneuploid oocytes
5443017|NCT01532284|ICSI|icsi
5443019|NCT01532284|Polar Body Biopsy|polar body biopsy
5443020|NCT01532271|mild Traumatic Brain Injury|mild traumatic brain injury
5443021|NCT01532271|mTBI|mtbi
5443022|NCT01532271|Concussion|concussion
5443023|NCT01532258|BMI|bmi
5443024|NCT01532258|Weight loss|weight loss
5443025|NCT01532258|Nutrition|nutrition
5443026|NCT01532258|Diet|diet
5443027|NCT01532258|Mediterranean diet|mediterranean diet
5443028|NCT01532258|Online program|online program
5443029|NCT01532258|web-based program|web-based program
5443030|NCT01532258|Oxidative stress|oxidative stress
5443031|NCT01532258|F2 isoprostanes|f2 isoprostanes
5443032|NCT01532232|PLACEBO|placebo
5443033|NCT01532232|VARENICLINE (CHANTIX)|varenicline (chantix)
5443034|NCT01532232|Self-reported cigarettes smokers|self-reported cigarettes smokers
5443035|NCT01532232|Smoking Cessation|smoking cessation
5443036|NCT01532232|11-136|11-136
5443037|NCT01532206|Remote ischemic preconditioning|remote ischemic preconditioning
5443038|NCT01532206|inflammation|inflammation
5443039|NCT01532180|Obstructive sleep apnea, neurostimulation, hypoglossal nerve|obstructive sleep apnea, neurostimulation, hypoglossal nerve
5443040|NCT01532141|Parkinson Disease|parkinson disease
5443041|NCT01532141|BIA 9-1067|bia 9-1067
5443042|NCT01532128|Parkinson Disease|parkinson disease
5443043|NCT01532128|BIA 9-1067|bia 9-1067
5443044|NCT01532115|Parkinson Disease|parkinson disease
5443045|NCT01532115|BIA 9-1067|bia 9-1067
5443046|NCT01532102|Genital warts|genital warts
5443047|NCT01532102|Anogenital warts|anogenital warts
5443048|NCT01532102|HPV|hpv
5443049|NCT01532102|Human papillomavirus|human papillomavirus
5443050|NCT01532102|Antiviral|antiviral
5443051|NCT01532076|osteoporosis|osteoporosis
5443052|NCT01532076|prox. humeral fracture|prox. humeral fracture
5443053|NCT01532076|geriatric trauma|geriatric trauma
5443054|NCT01532076|mesenchymal stem cells|mesenchymal stem cells
5443055|NCT01532063|Difficult intubation|difficult intubation
5443056|NCT01532063|Intensive care units|intensive care units
5443057|NCT01532063|Risk factors|risk factors
5443058|NCT01532063|Incidence|incidence
5443059|NCT01532063|Complications|complications
5443060|NCT01532063|Intubation in Intensive Care Unit|intubation in intensive care unit
5443061|NCT01532063|More than 2 attempts of intubation|more than 2 attempts of intubation
5443168|NCT01531751|Light Chain Amyloidosis|light chain amyloidosis
5443062|NCT01532063|Intubation attempts lasting more than 10 minutes|intubation attempts lasting more than 10 minutes
5443063|NCT01532050|OSAS|osas
5443064|NCT01532050|American Academy of Sleep Medicine Task Force|american academy of sleep medicine task force
5443065|NCT01532037|Randomised controlled trial|randomised controlled trial
5443066|NCT01532037|Multiple Sclerosis|multiple sclerosis
5443067|NCT01532037|Fatigue|fatigue
5443068|NCT01532037|Cognitive Behavioural Therapy|cognitive behavioural therapy
5443069|NCT01532037|Self Help|self help
5443070|NCT01532024|Optical Imaging|optical imaging
5443071|NCT01532024|Neutrophil|neutrophil
5443072|NCT01532024|Elastase|elastase
5443073|NCT01532024|Molecular Imaging|molecular imaging
5443074|NCT01532024|Acute Lung Injury|acute lung injury
5443075|NCT01532024|ARDS|ards
5443076|NCT01532011|Advanced Cancers|advanced cancers
5443077|NCT01532011|Solid Tumors|solid tumors
5443078|NCT01532011|Erlotinib|erlotinib
5443079|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride
5443080|NCT01532011|OSI-774|osi-774
5443081|NCT01532011|Tarceva|tarceva
5443082|NCT01532011|Pralatrexate|pralatrexate
5443083|NCT01532011|Folotyn|folotyn
5443084|NCT01532011|PDX-010|pdx-010
5443085|NCT01531998|Myeloma|myeloma
5443086|NCT01531998|Multiple Myeloma|multiple myeloma
5443087|NCT01531998|MM|mm
5443088|NCT01531998|Newly diagnosed|newly diagnosed
5443089|NCT01531998|Lenalidomide|lenalidomide
5443090|NCT01531998|CC-5013|cc-5013
5443091|NCT01531998|Revlimid|revlimid
5443095|NCT01531998|MLN341|mln341
5443096|NCT01531998|PS-341|ps-341
5443097|NCT01531998|Siltuximab|siltuximab
5443098|NCT01531998|CNTO 328|cnto 328
5443099|NCT01531998|Anti-IL-6 Antibody|anti-il-6 antibody
5443100|NCT01531998|Dexamethasone|dexamethasone
5443101|NCT01531998|Decadron|decadron
5443102|NCT01531998|M. D. Anderson Symptom Inventory Module|m. d. anderson symptom inventory module
5443103|NCT01531998|MDASI-MM|mdasi-mm
5443104|NCT01531998|Questionnaires|questionnaires
5443105|NCT01531998|Surveys|surveys
5443106|NCT01531985|Congenital Heart Disease|congenital heart disease
5443107|NCT01531985|Acute Kidney Injury|acute kidney injury
5443108|NCT01531985|Cardiopulmonary Bypass|cardiopulmonary bypass
5443109|NCT01531985|Biomarkers|biomarkers
5443110|NCT01531972|Single-photon Emission Computed Tomography|single-photon emission computed tomography
5443111|NCT01531972|Healthy Volunteers|healthy volunteers
5443112|NCT01531972|Tomography|tomography
5443113|NCT01531959|Midodrine|midodrine
5443114|NCT01531959|Hypotension|hypotension
5443115|NCT01531959|Intensive care unit|intensive care unit
5443116|NCT01531959|IV vasopressors|iv vasopressors
5443117|NCT01531959|ICU discharge|icu discharge
5443118|NCT01531946|Diffusion Tensor Imaging|diffusion tensor imaging
5443119|NCT01531933|Prediabetic|prediabetic
5443120|NCT01531933|Primary prevention|primary prevention
5443121|NCT01531933|Type 2 diabetes mellitus|type 2 diabetes mellitus
5443122|NCT01531907|GLP2|glp2
5443123|NCT01531907|Obesity|obesity
5443124|NCT01531907|Premenopausal|premenopausal
5443125|NCT01531907|Bone|bone
5443126|NCT01531907|Formation|formation
5443127|NCT01531907|Resorption|resorption
5443128|NCT01531894|solid tumor|solid tumor
5443129|NCT01531894|GSK2110183|gsk2110183
5443130|NCT01531894|hematologic malignancy|hematologic malignancy
5443131|NCT01531894|AKT inhibitor|akt inhibitor
5443132|NCT01531894|cancer|cancer
5443133|NCT01531894|safety|safety
5443134|NCT01531868|Decision making|decision making
5443135|NCT01531868|Carotid stenosis|carotid stenosis
5443136|NCT01531855|T1DM, Exercise|t1dm, exercise
5443137|NCT01531842|Conjunctival bacterial flora|conjunctival bacterial flora
5443138|NCT01531842|prophylactic topical antibiotic|prophylactic topical antibiotic
5443139|NCT01531842|injection|injection
5443140|NCT01531842|intravitreal injection|intravitreal injection
5443141|NCT01531842|bacterial resistance|bacterial resistance
5443142|NCT01531842|serial injection|serial injection
5443143|NCT01531842|serial intravitreal injections|serial intravitreal injections
5443144|NCT01531842|CNV|cnv
5443145|NCT01531842|CRVO|crvo
5443146|NCT01531842|AMD|amd
5443147|NCT01531842|BRVO|brvo
5443148|NCT01531829|pulmonary embolism|pulmonary embolism
5443149|NCT01531829|right ventricular dysfunction|right ventricular dysfunction
5443150|NCT01531829|Thrombolysis|thrombolysis
5443151|NCT01531829|Heparin|heparin
5443152|NCT01531816|Pediatrics,|pediatrics,
5443153|NCT01531816|Critically ill Children|critically ill children
5443154|NCT01531816|immobility|immobility
5443155|NCT01531790|Endostar|endostar
5443156|NCT01531790|Carboplatin|carboplatin
5443157|NCT01531790|Pemetrexed|pemetrexed
5443158|NCT01531790|NSCLC|nsclc
5443159|NCT01531790|Phase I|phase i
5443160|NCT01531777|Advanced Colorectal Cancer|advanced colorectal cancer
5443161|NCT01531764|Metastatic breast cancer|metastatic breast cancer
5443162|NCT01531764|intermediate HER2 expression|intermediate her2 expression
5443163|NCT01531764|Afatinib|afatinib
5443164|NCT01531751|HCO-HD|hco-hd
5443165|NCT01531751|survival|survival
5443166|NCT01531751|cardiac biomarkers|cardiac biomarkers
5443167|NCT01531751|AL amyloidosis|al amyloidosis
5443170|NCT01531738|bariatric surgery|bariatric surgery
5443171|NCT01531738|food preferences|food preferences
5443172|NCT01531738|reward|reward
5443173|NCT01531738|progressive ratio task|progressive ratio task
5443174|NCT01531725|Stents|stents
5443175|NCT01531712|neoadjuvant treatment|neoadjuvant treatment
5443176|NCT01531712|borderline resectability|borderline resectability
5443177|NCT01531686|intraosseous vascular access|intraosseous vascular access
5443178|NCT01531686|CT examination|ct examination
5443179|NCT01531634|Borderline Personality Disorder|borderline personality disorder
5443180|NCT01531634|Women|women
5443181|NCT01531634|Dynamic Cognitive Intervention|dynamic cognitive intervention
5443182|NCT01531634|Recovery|recovery
5443183|NCT01531634|Hope Scale|hope scale
5443184|NCT01531621|metastatic colorectal cancer|metastatic colorectal cancer
5443185|NCT01531608|melanoma|melanoma
5443186|NCT01531608|imaging|imaging
5443187|NCT01531608|sentinel node|sentinel node
5443188|NCT01531608|biopsy|biopsy
5443189|NCT01531595|metastatic colorectal cancer|metastatic colorectal cancer
5443190|NCT01531582|Angelman|angelman
5443191|NCT01531582|Minocycline|minocycline
5443192|NCT01531582|cognitive|cognitive
5443193|NCT01531582|children|children
5443194|NCT01531582|tetracycline|tetracycline
5443195|NCT01531569|Flaxseed|flaxseed
5443196|NCT01531569|Lignans|lignans
5443197|NCT01531569|Pharmacokinetics|pharmacokinetics
5443198|NCT01531543|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5443199|NCT01531543|Laparostomy|laparostomy
5443200|NCT01531543|Severe peritonitis|severe peritonitis
5443201|NCT01531530|Shigella|shigella
5443202|NCT01531530|Vaccine|vaccine
5443203|NCT01531530|Mucosal immunity|mucosal immunity
5443204|NCT01531517|Pedyphar|pedyphar
5443205|NCT01531517|Ointment|ointment
5443206|NCT01531517|Healing|healing
5443207|NCT01531517|Diabetic|diabetic
5443208|NCT01531517|Foot Ulcer|foot ulcer
5443209|NCT01531504|hysterectomies|hysterectomies
5443210|NCT01531504|uterine manipulator|uterine manipulator
5443211|NCT01531491|Emergence|emergence
5443212|NCT01531491|Hypercapnia|hypercapnia
5443213|NCT01531491|Hypocapnia|hypocapnia
5443214|NCT01531491|Propofol|propofol
5443215|NCT01531478|Childhood cancer|childhood cancer
5443216|NCT01531478|Cancer|cancer
5443217|NCT01531478|Sequels|sequels
5443218|NCT01531478|Complications|complications
5443219|NCT01531478|Chemotherapy|chemotherapy
5443220|NCT01531478|Radiotherapy|radiotherapy
5443221|NCT01531478|Surgery|surgery
5443222|NCT01531465|Respiratory insufficiency|respiratory insufficiency
5443223|NCT01531465|Infants|infants
5443224|NCT01531465|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
5443225|NCT01531465|Nasal Continuous Positive Airway Pressure (NCPAP)|nasal continuous positive airway pressure (ncpap)
5443226|NCT01531452|Stomach Neoplasms|stomach neoplasms
5443227|NCT01531452|drug therapy|drug therapy
5443228|NCT01531452|oxaliplatin|oxaliplatin
5443230|NCT01531439|Narcotic Antagonists|narcotic antagonists
5443231|NCT01531439|Naloxone infusion|naloxone infusion
5443232|NCT01531439|Postoperative pruritis|postoperative pruritis
5443233|NCT01531439|Patient controlled analgesia|patient controlled analgesia
5443234|NCT01531439|Pediatric|pediatric
5443235|NCT01531439|Children|children
5443236|NCT01531426|resuscitation|resuscitation
5443237|NCT01531426|hypothermia|hypothermia
5443238|NCT01531426|outcome|outcome
5443239|NCT01531387|Phase III|phase iii
5443240|NCT01531387|Sickle cell anemia|sickle cell anemia
5443241|NCT01531387|Conditional transcranial doppler velocities|conditional transcranial doppler velocities
5671342|NCT00616499|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5586492|NCT00944879|HIV|hiv
5443242|NCT01531387|Reduce risk of conversion to abnormally high transcranial doppler velocities|reduce risk of conversion to abnormally high transcranial doppler velocities
5443243|NCT01531387|Pediatric patients|pediatric patients
5443244|NCT01531374|Valvular Heart Disease|valvular heart disease
5443245|NCT01531374|Critical Aortic Stenosis|critical aortic stenosis
5443246|NCT01531374|Severe Aortic Stenosis|severe aortic stenosis
5443247|NCT01531374|Extreme Risk|extreme risk
5443248|NCT01531374|High Risk|high risk
5443249|NCT01531374|Aortic Valve Replacement|aortic valve replacement
5443250|NCT01531348|Retinitis pigmentosa|retinitis pigmentosa
5443251|NCT01531348|Bone marrow-derived mesenchymal stem cells|bone marrow-derived mesenchymal stem cells
5443252|NCT01531348|Intravitreal injection|intravitreal injection
5443253|NCT01531335|adults|adults
5443254|NCT01531322|13vPnC|13vpnc
5443255|NCT01531322|Healthy subjects|healthy subjects
5443256|NCT01531322|China|china
5443257|NCT01531309|Liver impairment|liver impairment
5443258|NCT01531309|Major Depression Disorder|major depression disorder
5443259|NCT01531309|Sublingual tablet|sublingual tablet
5443261|NCT01531296|Lower Extremity Rotational|lower extremity rotational
5443262|NCT01531296|Femoral Version|femoral version
5443263|NCT01531296|Tibial Torsion|tibial torsion
5443264|NCT01531283|unacylated ghrelin|unacylated ghrelin
5443265|NCT01531283|beta cell function|beta cell function
5443266|NCT01531231|heart disease|heart disease
5443267|NCT01531231|unstable angina|unstable angina
5443268|NCT01531231|myocardial infarction|myocardial infarction
5443269|NCT01531231|behavioral|behavioral
5443270|NCT01531231|cardiovascular|cardiovascular
5443271|NCT01531231|emotions|emotions
5443272|NCT01531218|Campylobacter|campylobacter
5443273|NCT01531218|concisus|concisus
5443274|NCT01531218|diarrhea|diarrhea
5443275|NCT01531218|fever|fever
5443276|NCT01531218|abdominal pain|abdominal pain
5443277|NCT01531218|vomiting|vomiting
5443278|NCT01531205|recurrent|recurrent
5443279|NCT01531205|high risk|high risk
5443280|NCT01531192|Lactobacillus reuteri|lactobacillus reuteri
5443281|NCT01531192|Nystatin|nystatin
5443282|NCT01531192|Very Low Birth Weight Infants|very low birth weight infants
5443283|NCT01531192|Candida Colonization|candida colonization
5443284|NCT01531166|Chronic hepatitis B|chronic hepatitis b
5443285|NCT01531166|pegylated Interferon-alpha 2a|pegylated interferon-alpha 2a
5443286|NCT01531166|Korean|korean
5443287|NCT01531153|Cocaine use decreases, increases or stays the same|cocaine use decreases, increases or stays the same
5443288|NCT01531140|colonoscopy cleansing|colonoscopy cleansing
5443289|NCT01531140|PEG|peg
5443290|NCT01531140|sennosides|sennosides
5443291|NCT01531140|children|children
5443292|NCT01531114|Diabetes mellitus|diabetes mellitus
5443293|NCT01531114|antiplatelet effect|antiplatelet effect
5443294|NCT01531114|prasugrel|prasugrel
5443306|NCT01531062|dyslipidemia|dyslipidemia
5443307|NCT01531062|elderly|elderly
5443308|NCT01531049|smoking cessation|smoking cessation
5443309|NCT01531049|young adults|young adults
5443310|NCT01531049|motivational counselling|motivational counselling
5443311|NCT01531049|smoking|smoking
5426164|NCT01604083|ESA|esa
5443312|NCT01531049|nicotine replacement therapy|nicotine replacement therapy
5443313|NCT01531049|therapy|therapy
5443314|NCT01531023|Extended-Spectrum Beta-lactamase Producing Bacteria|extended-spectrum beta-lactamase producing bacteria
5443315|NCT01531010|Neonate|neonate
5443316|NCT01531010|Premature|premature
5443317|NCT01531010|Pressure limited ventilation|pressure limited ventilation
5443318|NCT01531010|Volume ventilation|volume ventilation
5443319|NCT01530997|Human Papilloma Virus|human papilloma virus
5443320|NCT01530997|Oropharynx|oropharynx
5443321|NCT01530997|Oropharyngeal Squamous Cell Carcinoma|oropharyngeal squamous cell carcinoma
5443322|NCT01530997|Squamous Cell Carcinoma|squamous cell carcinoma
5443323|NCT01530997|Radiation Therapy|radiation therapy
5443324|NCT01530997|Chemotherapy|chemotherapy
5443326|NCT01530984|prostate cancer|prostate cancer
5443327|NCT01530984|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5443328|NCT01530984|Chemotherapy-naïve patients|chemotherapy-naïve patients
5443329|NCT01530984|Anti-CTLA4 blockade|anti-ctla4 blockade
5443330|NCT01530984|systemic GM-CSF|systemic gm-csf
5443331|NCT01530984|Ipilimumab|ipilimumab
5443332|NCT01530971|oxygen|oxygen
5443333|NCT01530971|pregnancy|pregnancy
5443334|NCT01530971|caesarean section|caesarean section
5443335|NCT01530971|anesthetic techniques|anesthetic techniques
5443336|NCT01530958|CKD|ckd
5443337|NCT01530958|Automated Telephone Self Management|automated telephone self management
5443338|NCT01530958|Registry|registry
5443339|NCT01530958|CKD awareness|ckd awareness
5443340|NCT01530958|Self efficacy|self efficacy
5443341|NCT01530932|sepsis|sepsis
5443342|NCT01530932|tissue oxygenation|tissue oxygenation
5443343|NCT01530932|tissue perfusion|tissue perfusion
5443344|NCT01530932|immune reaction|immune reaction
5443345|NCT01530906|Eating disorders|eating disorders
5443346|NCT01530906|Bulimia|bulimia
5443347|NCT01530906|rTMS|rtms
5443348|NCT01530906|Treatment|treatment
5443349|NCT01530893|flavonoids|flavonoids
5443350|NCT01530893|vascular function|vascular function
5443351|NCT01530893|randomised controlled trial|randomised controlled trial
5443352|NCT01530893|placebo controlled|placebo controlled
5443353|NCT01530880|Fever reduction|fever reduction
5443354|NCT01530880|Fever burden|fever burden
5443355|NCT01530880|intravenous ibuprofen|intravenous ibuprofen
5443356|NCT01530867|Dietary Supplements|dietary supplements
5443357|NCT01530867|Physician-patient communication|physician-patient communication
5443358|NCT01530867|Qualitative study|qualitative study
5443359|NCT01530867|Audio recorded office visits|audio recorded office visits
5443360|NCT01530854|sepsis|sepsis
5443361|NCT01530854|free fatty acids|free fatty acids
5443362|NCT01530854|emergency department|emergency department
5443363|NCT01530841|Myotonic dystrophy type 1|myotonic dystrophy type 1
5443364|NCT01530841|Home ventilation|home ventilation
5443365|NCT01530841|Respiratory insufficiency|respiratory insufficiency
5443366|NCT01530841|Neuromuscular|neuromuscular
5443367|NCT01530828|Immunoreactive Trypsinogen|immunoreactive trypsinogen
5443368|NCT01530828|Nectrotizing Enterocolitis|nectrotizing enterocolitis
5443369|NCT01530828|Premature Infants|premature infants
5443370|NCT01530828|Serial IRT|serial irt
5443371|NCT01530802|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery|laparoscopic myomectomy, leiomyoma, blood loss, uterine artery
5443372|NCT01530789|Telemedecine|telemedecine
5443373|NCT01530789|Telemedecine nurse|telemedecine nurse
5443374|NCT01530789|Delegation of tasks|delegation of tasks
5443375|NCT01530789|Type 1 diabetes|type 1 diabetes
5443376|NCT01530776|Pregnancy|pregnancy
5443377|NCT01530776|Postpartum|postpartum
5443378|NCT01530776|Weight Retention|weight retention
5443379|NCT01530776|Behavioral|behavioral
5443380|NCT01530776|Electronically-mediated|electronically-mediated
5443381|NCT01530763|Infections|infections
5443382|NCT01530763|Pediatrics|pediatrics
5443383|NCT01530763|Teflaro|teflaro
5443384|NCT01530763|cephalosporin|cephalosporin
5443385|NCT01530750|postoperative atrial fibrillation|postoperative atrial fibrillation
5443386|NCT01530750|internal loop recorder|internal loop recorder
5443387|NCT01530750|risk factors|risk factors
5443388|NCT01530750|coronary artery bypass surgery|coronary artery bypass surgery
5443389|NCT01530737|pediatric|pediatric
5443390|NCT01530737|Antithrombin|antithrombin
5443391|NCT01530737|anticoagulation efficiency|anticoagulation efficiency
5443392|NCT01530737|cardiac surgery|cardiac surgery
5443393|NCT01530724|abdominal obesity|abdominal obesity
5443394|NCT01530698|dendritic cell vaccination|dendritic cell vaccination
5443395|NCT01530698|melanoma|melanoma
5443396|NCT01530698|toll like receptor ligands|toll like receptor ligands
5443397|NCT01530698|mRNA electroporation|mrna electroporation
5443398|NCT01530698|vaccines|vaccines
5443399|NCT01530685|cinnamon|cinnamon
5443400|NCT01530685|chromium|chromium
5443401|NCT01530685|prediabete|prediabete
5443402|NCT01530685|overweight|overweight
5443404|NCT01530672|Syphilis|syphilis
5443405|NCT01530672|Combination|combination
5443407|NCT01530672|point-of-care|point-of-care
5443408|NCT01530672|MBIO|mbio
5443409|NCT01530659|Retinitis pigmentosa|retinitis pigmentosa
5443410|NCT01530659|Usher syndrome type 2|usher syndrome type 2
5443411|NCT01530659|Usher syndrome type 3|usher syndrome type 3
5443412|NCT01530659|Cone photoreceptor|cone photoreceptor
5443413|NCT01530659|Vision|vision
5443414|NCT01530659|Blind|blind
5443415|NCT01530646|obesity|obesity
5443416|NCT01530646|overweight|overweight
5443417|NCT01530646|muscle|muscle
5443418|NCT01530646|protein|protein
5443419|NCT01530646|muscle protein synthesis|muscle protein synthesis
5443420|NCT01530646|muscle protein breakdown|muscle protein breakdown
5443421|NCT01530646|whey|whey
5443422|NCT01530646|soy|soy
5443423|NCT01530646|caloric restriction|caloric restriction
5443424|NCT01530620|Antimuscarinics|antimuscarinics
5443425|NCT01530620|Neurogenic bladder|neurogenic bladder
5443426|NCT01530620|Propiverine|propiverine
5443427|NCT01530620|Urodynamics|urodynamics
5443428|NCT01530607|Early Stage Breast Cancer|early stage breast cancer
5443429|NCT01530607|Reduce Ovarian Failure Following Chemotherapy|reduce ovarian failure following chemotherapy
5443430|NCT01530594|Untreated|untreated
5443431|NCT01530594|Without intent for immediate autologous stem cell transplant|without intent for immediate autologous stem cell transplant
5443432|NCT01530568|Intensive care, TB, tracheal aspirates, Gene Xpert|intensive care, tb, tracheal aspirates, gene xpert
5443433|NCT01530542|bioavailability|bioavailability
5443434|NCT01530542|food effect|food effect
5443435|NCT01530542|oxycodone|oxycodone
5443436|NCT01530542|management of acute and chronic moderate to severe pain|management of acute and chronic moderate to severe pain
5443437|NCT01530529|PF-05180999|pf-05180999
5443438|NCT01530529|safety|safety
5443439|NCT01530529|pharmacokinetics|pharmacokinetics
5443440|NCT01530529|relative bioavailability|relative bioavailability
5443441|NCT01530529|Mental Disorders|mental disorders
5443442|NCT01530529|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5443443|NCT01530529|Schizophrenia|schizophrenia
5443444|NCT01530516|Malocclusion, Angle Class II|malocclusion, angle class ii
5443445|NCT01530503|biliary tract cancer|biliary tract cancer
5443446|NCT01530503|advanced disease|advanced disease
5443447|NCT01530503|chemotherapy|chemotherapy
5443448|NCT01530490|IVF|ivf
5443449|NCT01530490|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5443450|NCT01530490|cabergoline|cabergoline
5443451|NCT01530490|hydroxyethyl starch|hydroxyethyl starch
5443452|NCT01530490|prevention|prevention
5443453|NCT01530477|Bone mineral density|bone mineral density
5443454|NCT01530477|weight|weight
5443455|NCT01530477|body composition|body composition
5443456|NCT01530477|DEXA|dexa
5443457|NCT01530477|DXA|dxa
5443458|NCT01530464|High altitude induced fatigue|high altitude induced fatigue
5443459|NCT01530464|High altitude induced pulmonary Hypertension|high altitude induced pulmonary hypertension
5443460|NCT01530451|Nocturia|nocturia
5443461|NCT01530451|Obstructive sleep Apnoea|obstructive sleep apnoea
5443462|NCT01530451|Desmopressin|desmopressin
5443463|NCT01530438|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5443464|NCT01530425|pediatric wheelchairs|pediatric wheelchairs
5443465|NCT01530425|low-income|low-income
5443466|NCT01530425|comparisons|comparisons
5443467|NCT01530412|Quality of Life|quality of life
5443468|NCT01530412|Free-living activity|free-living activity
5443469|NCT01530412|Exacerbation|exacerbation
5428588|NCT01594203|Soft Tissue Sarcoma|soft tissue sarcoma
5443470|NCT01530412|Rehabilitation|rehabilitation
5443471|NCT01530386|Lacosamide|lacosamide
5443472|NCT01530386|Vimpat|vimpat
5443473|NCT01530373|hot flashes|hot flashes
5443474|NCT01530373|breast cancer|breast cancer
5443475|NCT01530373|aromatase inhibitors|aromatase inhibitors
5443476|NCT01530373|solifenacin|solifenacin
5443477|NCT01530373|clonidine|clonidine
5443478|NCT01530373|quality of life|quality of life
5443479|NCT01530347|Glucose monitoring|glucose monitoring
5443480|NCT01530347|non-invasive glucometer|non-invasive glucometer
5443481|NCT01530347|Self glucose monitoring|self glucose monitoring
5443482|NCT01530321|cervicogenic headache|cervicogenic headache
5846731|NCT00043641|Ultra-low|ultra-low
5443483|NCT01530321|spinal manipulation|spinal manipulation
5443484|NCT01530321|chiropractic|chiropractic
5443485|NCT01530321|randomized controlled trial|randomized controlled trial
5443486|NCT01530321|dose-response|dose-response
5443487|NCT01530321|efficacy|efficacy
5443488|NCT01530308|Delirium|delirium
5443489|NCT01530282|Respiratory Insufficiency [C08.618.846]|respiratory insufficiency [c08.618.846]
5443490|NCT01530269|intermediate|intermediate
5443491|NCT01530269|high|high
5443492|NCT01530269|risk|risk
5443493|NCT01530269|radiation|radiation
5443494|NCT01530269|therapy|therapy
5443495|NCT01530269|planning|planning
5443496|NCT01530269|surgical|surgical
5443497|NCT01530269|immunotherapy|immunotherapy
5443499|NCT01530269|hormone|hormone
5443500|NCT01530256|allograph|allograph
5443501|NCT01530256|steroid refractory|steroid refractory
5443502|NCT01530230|cesarean section|cesarean section
5443503|NCT01530230|electrocardiography|electrocardiography
5443504|NCT01530230|heart|heart
5443505|NCT01530230|hypotension|hypotension
5443506|NCT01530230|ischemia|ischemia
5443507|NCT01530230|oxytocin|oxytocin
5443508|NCT01530230|preeclampsia|preeclampsia
5443509|NCT01530230|regional anesthesia|regional anesthesia
5443510|NCT01530230|ECG changes suggestive of myocardial ischemia|ecg changes suggestive of myocardial ischemia
5443511|NCT01530217|Analgesics|analgesics
5443512|NCT01530217|Ibuprofen|ibuprofen
5443513|NCT01530217|Inflammation|inflammation
5443514|NCT01530217|Tooth Bleaching|tooth bleaching
5443515|NCT01530204|knee arthritis|knee arthritis
5443516|NCT01530204|knee osteoarthritis|knee osteoarthritis
5443517|NCT01530204|knee pain|knee pain
5443518|NCT01530204|cognitive behavioral therapy|cognitive behavioral therapy
5443519|NCT01530204|physical therapy|physical therapy
5443520|NCT01530204|depression prevention|depression prevention
5443521|NCT01530191|depression|depression
5443522|NCT01530191|anxiety|anxiety
5443523|NCT01530191|pelvic organ prolapse|pelvic organ prolapse
5443524|NCT01530191|POP|pop
5443525|NCT01530178|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5443526|NCT01530165|IFG|ifg
5443527|NCT01530165|IGTT|igtt
5443528|NCT01530152|Truwiev PCD laryngoscope|truwiev pcd laryngoscope
5443529|NCT01530152|Macintosh laryngoscope|macintosh laryngoscope
5443530|NCT01530126|periodontitis|periodontitis
5443531|NCT01530113|Childhood sexual abuse|childhood sexual abuse
5443532|NCT01530113|Vaginismus|vaginismus
5443533|NCT01530113|Partial vaginismus|partial vaginismus
5443534|NCT01530113|Labor dystocia|labor dystocia
5586858|NCT00943345|GI|gi
5443535|NCT01530113|Depression|depression
5443536|NCT01530100|Edema|edema
5443537|NCT01530100|Pain|pain
5443538|NCT01530100|Lower laser therapy|lower laser therapy
5443539|NCT01530100|orthognathics surgery|orthognathics surgery
5443540|NCT01530087|colostomy|colostomy
5443541|NCT01530087|ileostomy|ileostomy
5443542|NCT01530087|irritant dermatitis|irritant dermatitis
5443543|NCT01530087|two piece barrier|two piece barrier
5443544|NCT01530074|Mandibular nerve|mandibular nerve
5443545|NCT01530074|Mental nerve|mental nerve
5443546|NCT01530074|Mandibular incisive nerve|mandibular incisive nerve
5443547|NCT01530074|Local anesthesia|local anesthesia
5443548|NCT01530074|None, only healthy subjects will be enrolled in this study|none, only healthy subjects will be enrolled in this study
5443549|NCT01530035|cardiac|cardiac
5443550|NCT01530035|vascular|vascular
5443551|NCT01530035|muscular|muscular
5443552|NCT01530035|adaptations|adaptations
5443553|NCT01530035|soccer training|soccer training
5443554|NCT01530035|strength training|strength training
5443555|NCT01530022|Lacosamide|lacosamide
5443556|NCT01530022|Vimpat|vimpat
5443557|NCT01530022|Cognition|cognition
5443558|NCT01530022|Mental Processes|mental processes
5443559|NCT01530022|Adverse Effects|adverse effects
5443560|NCT01530009|Antroduodenal manometry|antroduodenal manometry
5443561|NCT01530009|Child|child
5443562|NCT01530009|Adolescent|adolescent
5443563|NCT01530009|Amoxicillin|amoxicillin
5443564|NCT01530009|Gastrointestinal Motility|gastrointestinal motility
5443565|NCT01529957|Volunteers|volunteers
5443566|NCT01529918|Diabetes|diabetes
5443567|NCT01529918|Self-screening|self-screening
5443568|NCT01529918|Web-based technology|web-based technology
5430504|NCT01585428|HPV Infection|hpv infection
5443569|NCT01529918|follow-up clinical care|follow-up clinical care
5443570|NCT01529918|randomized control trial|randomized control trial
5443571|NCT01529905|depression|depression
5443572|NCT01529905|mania|mania
5443573|NCT01529905|bipolar|bipolar
5443574|NCT01529905|outcome|outcome
5443575|NCT01529905|cognitive|cognitive
5443576|NCT01529879|edentulism|edentulism
5443577|NCT01529879|dental implants|dental implants
5443578|NCT01529879|clinical study|clinical study
5443579|NCT01529879|Nanotite Certain Tapered implant|nanotite certain tapered implant
5443580|NCT01529879|randomized|randomized
5443581|NCT01529879|crestal bone level|crestal bone level
5443582|NCT01529866|clinical study|clinical study
5443583|NCT01529866|edentulism|edentulism
5443584|NCT01529866|dental implants|dental implants
5443585|NCT01529866|Nanotite Certain Tapered implant|nanotite certain tapered implant
5443586|NCT01529866|randomized|randomized
5443587|NCT01529866|crestal bone level|crestal bone level
5443588|NCT01529866|immediate loading|immediate loading
5443589|NCT01529814|edentulism|edentulism
5443590|NCT01529814|dental implants|dental implants
5443591|NCT01529814|clinical study|clinical study
5443592|NCT01529814|Nanotite Certain Tapered implant|nanotite certain tapered implant
5443593|NCT01529814|randomized|randomized
5443594|NCT01529814|crestal bone level|crestal bone level
5443595|NCT01529814|early loading|early loading
5443596|NCT01529801|edentulism|edentulism
5443597|NCT01529801|dental implants|dental implants
5443598|NCT01529801|clinical study|clinical study
5443599|NCT01529801|randomized|randomized
5438471|NCT01551706|SOD|sod
5443601|NCT01529801|Crestal bone level|crestal bone level
5443602|NCT01529788|abobotulinum toxin lateral orbital lines|abobotulinum toxin lateral orbital lines
5443603|NCT01529788|BotoxCosmetic|botoxcosmetic
5443604|NCT01529788|Dysport|dysport
5443605|NCT01529788|onabotulinum toxin|onabotulinum toxin
5443606|NCT01529788|wrinkles|wrinkles
5443607|NCT01529788|lateral orbital lines|lateral orbital lines
5443608|NCT01529775|partial edentulism|partial edentulism
5443609|NCT01529775|dental implants|dental implants
5443610|NCT01529775|Osseotite Certain Prevail Tapered|osseotite certain prevail tapered
5443611|NCT01529775|Osseotite Certain Tapered|osseotite certain tapered
5443612|NCT01529775|Crestal bone level|crestal bone level
5443613|NCT01529775|randomized|randomized
5443614|NCT01529775|clinical study|clinical study
5443615|NCT01529762|edentulism|edentulism
5443616|NCT01529762|dental implants|dental implants
5443617|NCT01529762|Osseotite Certain Tapered|osseotite certain tapered
5443618|NCT01529762|randomized|randomized
5443619|NCT01529762|clinical study|clinical study
5443620|NCT01529762|partial edentulism|partial edentulism
5443621|NCT01529762|immediate loading|immediate loading
5443622|NCT01529762|crestal bone level|crestal bone level
5443623|NCT01529736|edentulism|edentulism
5443624|NCT01529736|dental implants|dental implants
5443625|NCT01529736|early loading|early loading
5443626|NCT01529736|crestal bone level|crestal bone level
5443627|NCT01529736|high torque insertion|high torque insertion
5443628|NCT01529736|low torque insertion|low torque insertion
5443629|NCT01529736|randomized|randomized
5443630|NCT01529736|Osseotite|osseotite
5443631|NCT01529736|clinical study|clinical study
5443632|NCT01529723|Stroke|stroke
5443633|NCT01529723|Dysphagia screening|dysphagia screening
5443634|NCT01529710|Schistosomiasis hematobium|schistosomiasis hematobium
5443635|NCT01529710|Schistosomiasis mansoni|schistosomiasis mansoni
5443636|NCT01529697|Asthma|asthma
5443637|NCT01529697|Inhaler use|inhaler use
5443638|NCT01529684|oncology patients|oncology patients
5443639|NCT01529684|Metabolic profile of 906|metabolic profile of 906
5443640|NCT01529684|OSI-906|osi-906
5443641|NCT01529684|mass balance|mass balance
5443642|NCT01529684|Pharmacokinetics of 14C-OSI-906|pharmacokinetics of 14c-osi-906
5443643|NCT01529684|Cancer, solid tumors|cancer, solid tumors
5443644|NCT01529684|Absorption, Metabolism, and Excretion of OSI-906|absorption, metabolism, and excretion of osi-906
5443645|NCT01529658|Renal function|renal function
5443646|NCT01529658|Renal hypothermia|renal hypothermia
5443647|NCT01529658|Nephrology|nephrology
5443648|NCT01529658|Nephrectomy|nephrectomy
5443649|NCT01529658|Renal tumor|renal tumor
5443650|NCT01529658|Urology|urology
5443651|NCT01529658|Kidney|kidney
5443652|NCT01529645|pertussis|pertussis
5443653|NCT01529645|booster vaccine|booster vaccine
5443654|NCT01529645|tetanus|tetanus
5443655|NCT01529645|diphtheria in adults|diphtheria in adults
5443656|NCT01529632|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5443657|NCT01529632|COPD|copd
5443658|NCT01529632|QVA149|qva149
5443659|NCT01529632|QAB149|qab149
5443660|NCT01529632|NVA237|nva237
5443661|NCT01529632|indacaterol|indacaterol
5443662|NCT01529632|glycopyrronium bromide|glycopyrronium bromide
5443663|NCT01529619|Rivastigmine|rivastigmine
5443664|NCT01529619|Alzheimer's disease|alzheimer's disease
5443665|NCT01529619|Transdermal patch|transdermal patch
5443666|NCT01529606|dental restoration|dental restoration
5443667|NCT01529606|dental caries|dental caries
5685511|NCT00555789|rejection|rejection
5430601|NCT01585012|slip|slip
5443668|NCT01529606|tooth cavity|tooth cavity
5443669|NCT01529593|Advanced Cancers|advanced cancers
5443670|NCT01529593|Metastatic cancer|metastatic cancer
5443671|NCT01529593|Tumor response|tumor response
5443672|NCT01529593|Dose limiting toxicity|dose limiting toxicity
5443674|NCT01529593|Maximum tolerated dose|maximum tolerated dose
5443675|NCT01529593|MTD|mtd
5443676|NCT01529593|Temsirolimus|temsirolimus
5443677|NCT01529593|CCI-779|cci-779
5443678|NCT01529593|Torisel|torisel
5443679|NCT01529593|Metformin|metformin
5443680|NCT01529580|Autism Spectrum Disorder|autism spectrum disorder
5443681|NCT01529580|language|language
5443682|NCT01529580|intervention|intervention
5443683|NCT01529580|school-age|school-age
5443684|NCT01529554|Acute Coronary Syndromes|acute coronary syndromes
5443685|NCT01529554|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5443686|NCT01529554|Infarct size|infarct size
5443687|NCT01529554|inflammation|inflammation
5443688|NCT01529554|everolimus|everolimus
5443689|NCT01529541|CWP-0403|cwp-0403
5443690|NCT01529541|Sitagliptin|sitagliptin
5443691|NCT01529541|Metformin|metformin
5443692|NCT01529541|type 2 DM|type 2 dm
5443693|NCT01529528|CWP-0403|cwp-0403
5443694|NCT01529528|type 2 DM|type 2 dm
5443695|NCT01529528|Efficacy|efficacy
5443696|NCT01529528|Safety|safety
5443697|NCT01529528|Phase 3|phase 3
5443698|NCT01529515|Schizophrenia|schizophrenia
5443699|NCT01529515|R092670|r092670
5443700|NCT01529515|Paliperidone Palmitate|paliperidone palmitate
5443701|NCT01529515|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
5443702|NCT01529502|Blood Transfusion, Autologous|blood transfusion, autologous
5443703|NCT01529502|Blood Preservation/adverse effects|blood preservation/adverse effects
5443704|NCT01529502|Blood Transfusion/adverse effects|blood transfusion/adverse effects
5443705|NCT01529502|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
5443706|NCT01529502|Hemoglobins|hemoglobins
5443707|NCT01529502|Nitric Oxide|nitric oxide
5443708|NCT01529502|Pulmonary Hypertension|pulmonary hypertension
5426534|NCT01602315|BYL719|byl719
5443709|NCT01529489|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5443710|NCT01529489|Physical training|physical training
5443711|NCT01529489|Oxygen uptake kinetic|oxygen uptake kinetic
5443712|NCT01529489|Heart rate kinetic|heart rate kinetic
5443713|NCT01529476|Ofloxacin|ofloxacin
5443714|NCT01529476|Levofloxacin|levofloxacin
5443715|NCT01529476|Ofloxacin hydrochloride|ofloxacin hydrochloride
5443716|NCT01529463|Congestive Heart Failure|congestive heart failure
5443717|NCT01529450|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog|basal cell carcinoma, sonidegib, smoothened inhibitor, hedgehog
5443718|NCT01529437|allergy|allergy
5443719|NCT01529437|immunology|immunology
5443720|NCT01529437|immune tolerance|immune tolerance
5443721|NCT01529437|immunotherapy|immunotherapy
5443722|NCT01529424|Hypertriglyceridemia|hypertriglyceridemia
5443723|NCT01529411|urothelium|urothelium
5443724|NCT01529411|transitional|transitional
5443725|NCT01529411|carcinoma|carcinoma
5443726|NCT01529411|cancer|cancer
5443727|NCT01529411|metastatic|metastatic
5443728|NCT01529411|tract|tract
5443729|NCT01529398|knee osteoarthritis|knee osteoarthritis
5443730|NCT01529398|exercise therapy|exercise therapy
5443731|NCT01529398|resistance training|resistance training
5443732|NCT01529398|proprioception|proprioception
5443733|NCT01529385|swollen leg|swollen leg
5443734|NCT01529385|diabetes|diabetes
5443735|NCT01529385|compression stockings|compression stockings
5443736|NCT01529385|edema|edema
5443737|NCT01529372|Hypertension|hypertension
5443738|NCT01529372|Blood pressure|blood pressure
5443739|NCT01529372|Renal denervation|renal denervation
5443740|NCT01529359|Irritable Bowel Syndrome|irritable bowel syndrome
5443741|NCT01529359|Probiotics|probiotics
5443742|NCT01529346|Postoperative dental pain|postoperative dental pain
5443743|NCT01529307|Biologic,|biologic,
5443744|NCT01529307|solid tumors,|solid tumors,
5443745|NCT01529307|Death Receptor 5 agonist,|death receptor 5 agonist,
5443746|NCT01529307|caspase-8|caspase-8
5443747|NCT01529294|Hepatic impairment|hepatic impairment
5443748|NCT01529294|Iloperidone|iloperidone
5443749|NCT01529294|ILO522D|ilo522d
5443750|NCT01529294|Pharmacokinetics|pharmacokinetics
5443751|NCT01529268|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5443752|NCT01529268|Cysteamine bitartrate delayed release|cysteamine bitartrate delayed release
5443753|NCT01529268|Children|children
5443754|NCT01529255|Chronic Hepatitis B|chronic hepatitis b
5443755|NCT01529255|Compensated Chronic hepatitis B|compensated chronic hepatitis b
5443756|NCT01529216|DIAMOND System|diamond system
5443757|NCT01529216|T2DM|t2dm
5443758|NCT01529216|Randomized study|randomized study
5443759|NCT01529216|Electrical stimulation|electrical stimulation
5443760|NCT01529216|Fundus|fundus
5443761|NCT01529190|pregabalin|pregabalin
5443762|NCT01529190|postoperative pain control|postoperative pain control
5443763|NCT01529190|interleukin-6|interleukin-6
5443764|NCT01529190|acute pain|acute pain
5443765|NCT01529177|Metformin|metformin
5433928|NCT01571141|HPV|hpv
5443766|NCT01529177|Insulin resistance|insulin resistance
5443767|NCT01529177|male infertility|male infertility
5443768|NCT01529177|unexplained Oligozspermia|unexplained oligozspermia
5443769|NCT01529177|Clomiphene citrate|clomiphene citrate
5443770|NCT01529177|Unexplained azoospermia|unexplained azoospermia
5443771|NCT01529164|endostatin|endostatin
5443772|NCT01529164|chemotherapy|chemotherapy
5443773|NCT01529164|antiangiogenesis agent|antiangiogenesis agent
5443774|NCT01529164|colorectal cancer|colorectal cancer
5443775|NCT01529151|Dizziness|dizziness
5443776|NCT01529151|Vertigo|vertigo
5443777|NCT01529151|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5443778|NCT01529151|Labyrinthitis|labyrinthitis
5443779|NCT01529151|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5443780|NCT01529151|Vestibular Rehabilitation Therapy|vestibular rehabilitation therapy
5443781|NCT01529138|Cancer|cancer
5443782|NCT01529112|Locally Advanced|locally advanced
5443783|NCT01529112|Metastatic Non-Squamous Non-Small Cell Lung Cancer|metastatic non-squamous non-small cell lung cancer
5443784|NCT01529099|Osteoarthritis|osteoarthritis
5443788|NCT01529099|Knee arthroplasty|knee arthroplasty
5443789|NCT01529099|Unicompartmental|unicompartmental
5443790|NCT01529099|Primary|primary
5443791|NCT01529099|Partial|partial
5443792|NCT01529099|Patellofemoral|patellofemoral
5443793|NCT01529099|Medial|medial
5443794|NCT01529099|Lateral|lateral
5443795|NCT01529099|Bicompartmental|bicompartmental
5443796|NCT01529099|Cemented|cemented
5443797|NCT01529099|Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces|post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces
5443798|NCT01529099|History of Gout or pseudo-gout.|history of gout or pseudo-gout.
5443799|NCT01529086|prostate cancer|prostate cancer
5443800|NCT01529086|dutasteride|dutasteride
5443801|NCT01529086|for cause prostate biopsy|for cause prostate biopsy
5443803|NCT01529073|genotype 4 HCV|genotype 4 hcv
5443804|NCT01529073|pegylated interferon|pegylated interferon
5443805|NCT01529073|ribavirin|ribavirin
5443806|NCT01529073|nitazoxanide|nitazoxanide
5443807|NCT01529060|phenylbutyrate|phenylbutyrate
5443808|NCT01529060|MSUD|msud
5443809|NCT01529060|Buphenyl-TM|buphenyl-tm
5443810|NCT01529034|Epilepsy|epilepsy
5443811|NCT01529034|seizure clusters|seizure clusters
5443812|NCT01529034|acute repetitive seizures|acute repetitive seizures
5443813|NCT01529034|rescue treatment|rescue treatment
5443814|NCT01529021|Pain management|pain management
5443815|NCT01529021|vaccination|vaccination
5443816|NCT01529021|immunization|immunization
5443817|NCT01529021|pediatric|pediatric
5443818|NCT01529021|robotics|robotics
5443819|NCT01529021|human-robot interaction|human-robot interaction
5443820|NCT01529008|Osteonecrosis|osteonecrosis
5443821|NCT01529008|Femoral Head|femoral head
5443823|NCT01529008|Orthopedics|orthopedics
5443824|NCT01529008|Bone|bone
5443825|NCT01529008|Musculoskeletal Disorders|musculoskeletal disorders
5443826|NCT01528995|fecal incontinence|fecal incontinence
5443827|NCT01528995|anal incontinence|anal incontinence
5443828|NCT01528995|obstetric sphincter injuries|obstetric sphincter injuries
5443829|NCT01528995|OASIS|oasis
5443830|NCT01528995|double incontinence|double incontinence
5443831|NCT01528995|urinary incontinence|urinary incontinence
5443832|NCT01528995|sexual function|sexual function
5443833|NCT01528995|sacral nerve modulation|sacral nerve modulation
5443834|NCT01528995|sacral nerve stimulation|sacral nerve stimulation
5443835|NCT01528995|Interstim|interstim
5443836|NCT01528995|anal bulking injections|anal bulking injections
5443837|NCT01528995|Permacol|permacol
5443838|NCT01528969|oral microbiota|oral microbiota
5443839|NCT01528969|mutans streptococci|mutans streptococci
5443840|NCT01528969|xylitol|xylitol
5443841|NCT01528956|adrenocortical carcinoma|adrenocortical carcinoma
5443842|NCT01528943|prostacycline, endothel integrity and abdominal surgery|prostacycline, endothel integrity and abdominal surgery
5443843|NCT01528930|Lung Diseases|lung diseases
5443844|NCT01528930|Anti-Infective Agents|anti-infective agents
5443845|NCT01528930|Therapeutic Uses|therapeutic uses
5443846|NCT01528930|Amikacin|amikacin
5443847|NCT01528917|Lysosomal Storage Disease|lysosomal storage disease
5443848|NCT01528917|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
5443849|NCT01528917|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5443850|NCT01528917|Acid lipase disease|acid lipase disease
5443851|NCT01528917|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5443852|NCT01528917|LAL Deficiency|lal deficiency
5443853|NCT01528917|LIPA Deficiency|lipa deficiency
5443854|NCT01528917|Wolman disease|wolman disease
5443855|NCT01528904|pregnancy|pregnancy
5443856|NCT01528904|autoimmune thyroid disease|autoimmune thyroid disease
5443857|NCT01528904|fetal thyroid hormones|fetal thyroid hormones
5443858|NCT01528904|antithyroid antibodies|antithyroid antibodies
5443859|NCT01528904|ultrasound parameters|ultrasound parameters
5443860|NCT01528891|tonsillectomy|tonsillectomy
5443861|NCT01528891|emergence agitation|emergence agitation
5443862|NCT01528878|Liver Cancer|liver cancer
5443863|NCT01528878|Hepatocellular Carcinoma|hepatocellular carcinoma
5443865|NCT01528878|Metastatic Cancer to Liver|metastatic cancer to liver
5443866|NCT01528878|Metastatic Colon Cancer|metastatic colon cancer
5443867|NCT01528878|Metastatic Colo-rectal Cancer|metastatic colo-rectal cancer
5443868|NCT01528878|mCRC|mcrc
5443869|NCT01528878|Liver Function|liver function
5443870|NCT01528878|Child-Pugh|child-pugh
5443871|NCT01528865|virus|virus
5443872|NCT01528865|K(HML2)[HERV-K(HML2)]|k(hml2)[herv-k(hml2)]
5443873|NCT01528865|Lymphoma|lymphoma
5443874|NCT01528865|Human endogenous retrovirus-K(HLM2)[HERV-K(HML2)]|human endogenous retrovirus-k(hlm2)[herv-k(hml2)]
5443875|NCT01528852|neonatal Mortality|neonatal mortality
5443876|NCT01528852|chlorhexidine cord care|chlorhexidine cord care
5443877|NCT01528852|cord infections|cord infections
5443878|NCT01528852|african settings|african settings
5443879|NCT01528852|clinical trials|clinical trials
5443880|NCT01528839|Bipolar disorder|bipolar disorder
5443881|NCT01528839|Bipolar depression|bipolar depression
5443882|NCT01528839|Thyroid abnormality|thyroid abnormality
5443883|NCT01528839|mood stabilizer|mood stabilizer
5443884|NCT01528839|antidepressants|antidepressants
5443885|NCT01528839|currently depressed|currently depressed
5443886|NCT01528826|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer
5443887|NCT01528826|vinorebine|vinorebine
5443888|NCT01528826|oxaliplatin|oxaliplatin
5443889|NCT01528813|Erbium-doped yttrium aluminium garnet laser|erbium-doped yttrium aluminium garnet laser
5443891|NCT01528813|Amorolfine lacquer|amorolfine lacquer
5443892|NCT01528813|Dermatophytes|dermatophytes
5443893|NCT01528813|Subungual distal lateral onychomycosis|subungual distal lateral onychomycosis
5443894|NCT01528813|Drug delivery|drug delivery
5443895|NCT01528800|Vitamin K|vitamin k
5443896|NCT01528800|Chronic Kidney Disease|chronic kidney disease
5443897|NCT01528800|Vascular Calcification|vascular calcification
5443898|NCT01528800|Hemodialysis|hemodialysis
5443899|NCT01528800|Coronary Artery Calcification|coronary artery calcification
5443900|NCT01528787|Intraocular pressure|intraocular pressure
5443901|NCT01528787|visual field|visual field
5443902|NCT01528787|Ocular hypertension or open angle glaucoma|ocular hypertension or open angle glaucoma
5443903|NCT01528774|Melanoma|melanoma
5426780|NCT01601262|ED|ed
5443904|NCT01528774|Circulating Tumor Cells|circulating tumor cells
5443905|NCT01528774|Prostate cancer|prostate cancer
5443906|NCT01528774|Sarcoma|sarcoma
5443907|NCT01528774|Renal Cancer|renal cancer
5443908|NCT01528774|Pancreatic neuroendocrine cancer|pancreatic neuroendocrine cancer
5443909|NCT01528774|Other solid tumor|other solid tumor
5443910|NCT01528761|physical activity|physical activity
5443911|NCT01528761|older adults|older adults
5443912|NCT01528761|physical function|physical function
5443913|NCT01528761|health-related quality of life|health-related quality of life
5443914|NCT01528761|prosocial behavior|prosocial behavior
5443915|NCT01528761|social cognitive theory|social cognitive theory
5443916|NCT01528722|Emergency laparoscopic cholecystectomy|emergency laparoscopic cholecystectomy
5443917|NCT01528722|Pain scores|pain scores
5443918|NCT01528722|Intraperitoneal local anaesthesia|intraperitoneal local anaesthesia
5443919|NCT01528722|Cholecystitis|cholecystitis
5443920|NCT01528709|Statin,|statin,
5443921|NCT01528709|CABG,|cabg,
5443922|NCT01528709|saphenous vein graft,|saphenous vein graft,
5443923|NCT01528709|graft occlusion,|graft occlusion,
5443924|NCT01528709|lipids|lipids
5443925|NCT01528696|Obesity|obesity
5443926|NCT01528696|Cesarean Section|cesarean section
5443927|NCT01528696|Wound care|wound care
5443928|NCT01528657|Sick Sinus Syndrome|sick sinus syndrome
5443929|NCT01528657|Ventricular pacing|ventricular pacing
5443930|NCT01528657|Minimal ventricular pacing|minimal ventricular pacing
5443931|NCT01528657|Ventricular pacing suppression|ventricular pacing suppression
5443932|NCT01528657|Intrinsic rhythm support|intrinsic rhythm support
5443933|NCT01528657|Long term AV|long term av
5443934|NCT01528644|iron|iron
5443935|NCT01528644|fortification|fortification
5443936|NCT01528644|alginate|alginate
5443937|NCT01528644|iron deficiency|iron deficiency
5443938|NCT01528618|Advanced Nasopharyngeal Carcinoma|advanced nasopharyngeal carcinoma
5443939|NCT01528618|treatment|treatment
5443940|NCT01528605|lutein|lutein
5443941|NCT01528605|zeaxanthin|zeaxanthin
5443942|NCT01528605|age-related macular degeneration|age-related macular degeneration
5443943|NCT01528605|supplementation|supplementation
5443944|NCT01528605|macular pigment optical density|macular pigment optical density
5443945|NCT01528605|visual function|visual function
5443946|NCT01528605|serum concentration|serum concentration
5443947|NCT01528579|Whiplash|whiplash
5443948|NCT01528579|Rehabilitation|rehabilitation
5443949|NCT01528579|Physiotherapy|physiotherapy
5443950|NCT01528579|Exercises|exercises
5443951|NCT01528566|osteoarthritis, knee|osteoarthritis, knee
5443952|NCT01528566|Cognitive impairment|cognitive impairment
5443953|NCT01528566|Tai Chi|tai chi
5443954|NCT01528553|genu valgus|genu valgus
5443955|NCT01528553|lower limb|lower limb
5443956|NCT01528553|paediatric|paediatric
5443957|NCT01528553|epiphysiodesis|epiphysiodesis
5443958|NCT01528540|chronic pancreatitis|chronic pancreatitis
5443959|NCT01528540|pregabalin|pregabalin
5443960|NCT01528540|antioxidant|antioxidant
5443961|NCT01528514|Myocardial infarction|myocardial infarction
5569273|NCT01009294|DMD|dmd
5443962|NCT01528514|Coronary artery bypass grafting|coronary artery bypass grafting
5443963|NCT01528514|Anti-oxidant|anti-oxidant
5443964|NCT01528514|Curcuminoids|curcuminoids
5443965|NCT01528475|Therapeutic Hypothermia|therapeutic hypothermia
5443966|NCT01528475|Cardiac arrest|cardiac arrest
5443967|NCT01528462|Stroke|stroke
5443968|NCT01528462|Ischemic Attack, Transient|ischemic attack, transient
5443972|NCT01528462|Chronobiology Disorders|chronobiology disorders
5443973|NCT01528449|babesia|babesia
5443974|NCT01528449|blood donation|blood donation
5443975|NCT01528449|transfusion transmitted babesiosis|transfusion transmitted babesiosis
5443976|NCT01528436|Cerebral Palsy|cerebral palsy
5443977|NCT01528436|Umbilical Cord Blood|umbilical cord blood
5443978|NCT01528436|Rehabilitation|rehabilitation
5443979|NCT01528423|XtremeCT|xtremect
5443980|NCT01528423|Density|density
5443981|NCT01528423|pQCT|pqct
5443982|NCT01528423|Turnover|turnover
5443983|NCT01528423|Bone|bone
5443984|NCT01528423|short-term reproducibility|short-term reproducibility
5443985|NCT01528397|defect|defect
5443986|NCT01528397|dorsal branch of the proper digital nerve|dorsal branch of the proper digital nerve
5443987|NCT01528397|proper digital nerve|proper digital nerve
5443988|NCT01528397|second dorsal metacarpal artery|second dorsal metacarpal artery
5443989|NCT01528397|pedicled nerve graft.|pedicled nerve graft.
5443990|NCT01528384|Arginine|arginine
5443991|NCT01528384|Arginine deiminase|arginine deiminase
5443992|NCT01528384|Argininosuccinate synthetase|argininosuccinate synthetase
5443993|NCT01528384|Phase 1|phase 1
5443994|NCT01528384|Pediatric|pediatric
5443995|NCT01528384|Failed other treatments|failed other treatments
5443996|NCT01528384|Pediatric patients|pediatric patients
5443997|NCT01528371|Intravenous sedation|intravenous sedation
5443998|NCT01528371|Midazolam|midazolam
5443999|NCT01528371|Dental treatment|dental treatment
5444000|NCT01528371|White-coat hypertension|white-coat hypertension
5444001|NCT01528371|STAI|stai
5444002|NCT01528371|Dental patients|dental patients
5444003|NCT01528371|Transient hypertension|transient hypertension
5444004|NCT01528358|sepsis|sepsis
5444005|NCT01528358|tissue oximetry|tissue oximetry
5444006|NCT01528358|NIRS|nirs
5444007|NCT01528358|VOT|vot
5444008|NCT01528345|Breast Cancer|breast cancer
5444009|NCT01528345|HER2-, HR+|her2-, hr+
5444010|NCT01528345|post-menopausal|post-menopausal
5444011|NCT01528345|Locally advanced or metastatic Breast Cancer (HER2-, HR+)|locally advanced or metastatic breast cancer (her2-, hr+)
5444012|NCT01528332|Musculoskeletal pain|musculoskeletal pain
5444013|NCT01528332|Back pain|back pain
5444014|NCT01528332|Chronic pain|chronic pain
5444015|NCT01528319|Arthroscopic Bankart repair|arthroscopic bankart repair
5444016|NCT01528319|Suture anchor|suture anchor
5444017|NCT01528319|Shoulder dislocation|shoulder dislocation
5444018|NCT01528306|HP802-247|hp802-247
5444019|NCT01528306|EB (epidermolysis bullosa)|eb (epidermolysis bullosa)
5444020|NCT01528280|Shift work|shift work
5444021|NCT01528280|Hepatitis A vaccination|hepatitis a vaccination
5444022|NCT01528280|humoral response|humoral response
5444023|NCT01528280|cellular response|cellular response
5444024|NCT01528267|Emphysema, lung volume reduction, autologous blood|emphysema, lung volume reduction, autologous blood
5444028|NCT01528241|ABP688|abp688
5587484|NCT00941109|MDS|mds
5444029|NCT01528241|Tracer|tracer
5444030|NCT01528241|Depression|depression
5444031|NCT01528202|Sleep, circadian cycle, melatonin|sleep, circadian cycle, melatonin
5444032|NCT01528189|Insulin, surgery, infection|insulin, surgery, infection
5444033|NCT01528176|FGF-23, CKD, Cyp24, 24,25(OH)2D, vitamin D metabolism|fgf-23, ckd, cyp24, 24,25(oh)2d, vitamin d metabolism
5444034|NCT01528163|Head and neck|head and neck
5444035|NCT01528163|Squamous cell carcinoma|squamous cell carcinoma
5444036|NCT01528163|Randomized|randomized
5444037|NCT01528163|palliative treatment|palliative treatment
5444038|NCT01528098|polyethylene glycol|polyethylene glycol
5444039|NCT01528098|bisacodyl|bisacodyl
5444040|NCT01528085|Philadelphia chromsome|philadelphia chromsome
5444041|NCT01528085|BCR-ABL|bcr-abl
5444042|NCT01528085|ALL|all
5444043|NCT01528085|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5444044|NCT01528085|Nilotinib|nilotinib
5444045|NCT01528085|Tasigna|tasigna
5444046|NCT01528072|Dynesys Dynamic Stabilization System|dynesys dynamic stabilization system
5444047|NCT01528072|Spondylolithesis|spondylolithesis
5444048|NCT01528072|pseudoarthrosis|pseudoarthrosis
5444049|NCT01528072|neurologic impairment|neurologic impairment
5444050|NCT01528072|failed fusion|failed fusion
5444051|NCT01528059|Diabetes|diabetes
5444052|NCT01528059|Gastric cancer|gastric cancer
5444053|NCT01528059|Gastric bypass|gastric bypass
5444054|NCT01528046|central nervous system (CNS)|central nervous system (cns)
5444055|NCT01528046|malignancy|malignancy
5444056|NCT01528046|relapsed|relapsed
5444057|NCT01528046|refractory|refractory
5444058|NCT01528046|pediatric|pediatric
5444059|NCT01528046|recurrent|recurrent
5444060|NCT01528033|surgical wound|surgical wound
5444061|NCT01528033|wound healing disorder|wound healing disorder
5444062|NCT01528033|Wound healing impairment|wound healing impairment
5444063|NCT01528033|post surgical wound healing disorder|post surgical wound healing disorder
5444064|NCT01528033|abdominal wound healing impairment|abdominal wound healing impairment
5444065|NCT01528033|Vacuum Assisted Closure|vacuum assisted closure
5444066|NCT01528033|negative pressure wound therapy|negative pressure wound therapy
5444067|NCT01528007|Pathological gambling|pathological gambling
5444068|NCT01528007|Treatment intervention|treatment intervention
5444069|NCT01527994|Aprepitant|aprepitant
5444070|NCT01527994|Intravenous heroin dependence|intravenous heroin dependence
5444071|NCT01527981|Depression|depression
5444072|NCT01527981|Diabetes|diabetes
5444073|NCT01527981|Adherence|adherence
5444074|NCT01527981|Medication|medication
5444075|NCT01527981|Glucose|glucose
5444076|NCT01527981|Insulin|insulin
5444077|NCT01527955|Kelee|kelee
5444078|NCT01527955|Meditation|meditation
5444079|NCT01527955|Stress|stress
5444081|NCT01527955|Depression|depression
5444082|NCT01527955|Brain|brain
5444083|NCT01527955|Mind|mind
5444084|NCT01527942|Pain Management|pain management
5444085|NCT01527903|propofol|propofol
5444086|NCT01527903|midazolam|midazolam
5444087|NCT01527903|sedation|sedation
5444088|NCT01527903|ICU|icu
5444089|NCT01527890|intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
5444090|NCT01527890|IV PCA|iv pca
5444091|NCT01527877|BKM120|bkm120
5444092|NCT01527877|head and neck cancer|head and neck cancer
5444093|NCT01527877|squamous cell carcinoma|squamous cell carcinoma
5444094|NCT01527864|NSCLC|nsclc
5444095|NCT01527851|Post-bariatric surgery|post-bariatric surgery
5444096|NCT01527851|Excess skin|excess skin
5444097|NCT01527851|Physical fitness|physical fitness
5444098|NCT01527851|Physical activity|physical activity
5444099|NCT01527851|Barriers to physical activity|barriers to physical activity
5444100|NCT01527851|Plastic surgery|plastic surgery
5444101|NCT01527851|Quality of life|quality of life
5444102|NCT01527851|Self-esteem|self-esteem
5444105|NCT01527799|Exercise testing|exercise testing
5444106|NCT01527799|Cardiopulmonary disease|cardiopulmonary disease
5444107|NCT01527786|Major Depressive Disorder, Postpartum Onset|major depressive disorder, postpartum onset
5444108|NCT01527773|COPD|copd
5444109|NCT01527773|Cardiovascular disease|cardiovascular disease
5444110|NCT01527773|Phenotypes|phenotypes
5444111|NCT01527760|Essential Hypertension|essential hypertension
5444112|NCT01527760|Viscum album mother tincture|viscum album mother tincture
5444113|NCT01527760|one group pretest post-test study|one group pretest post-test study
5444114|NCT01527747|Type 2 Diabetes|type 2 diabetes
5444115|NCT01527747|Hypertriglyceridemia|hypertriglyceridemia
5444116|NCT01527747|dipeptidyl peptidase-4 (DPP-4)|dipeptidyl peptidase-4 (dpp-4)
5444117|NCT01527747|glucagon-like peptide-1 (glp-1)|glucagon-like peptide-1 (glp-1)
5444118|NCT01527734|Comparison study|comparison study
5444119|NCT01527721|keratoconus|keratoconus
5444120|NCT01527721|CxL|cxl
5444121|NCT01527721|CxL combined with t-PRK|cxl combined with t-prk
5444122|NCT01527695|Phase IIa|phase iia
5444123|NCT01527695|AZD3241|azd3241
5444124|NCT01527695|microglia activation|microglia activation
5444125|NCT01527695|safety|safety
5444126|NCT01527695|Pharmacodynamics and pharmacokinetics analyses|pharmacodynamics and pharmacokinetics analyses
5444127|NCT01527695|Parkinson patients|parkinson patients
5444128|NCT01527682|Intraocular pressure|intraocular pressure
5444129|NCT01527682|Latanoprost|latanoprost
5444130|NCT01527682|Dorzolamide|dorzolamide
5444131|NCT01527669|Red yeast rice|red yeast rice
5444132|NCT01527669|lovastatin|lovastatin
5444133|NCT01527669|Pharmacokinetics|pharmacokinetics
5444134|NCT01527578|Healthy children|healthy children
5444135|NCT01527578|Healthy adults|healthy adults
5444136|NCT01527578|individuals ages 7-60|individuals ages 7-60
5444137|NCT01527526|DMPA|dmpa
5444138|NCT01527526|insulin resistance|insulin resistance
5444139|NCT01527526|cardiovascular disease|cardiovascular disease
5444140|NCT01527526|BMI|bmi
5444141|NCT01527526|weight gain|weight gain
5444142|NCT01527526|thrombosis|thrombosis
5444143|NCT01527513|Partial Epilepsy|partial epilepsy
5444144|NCT01527513|eslicarbazepine acetate|eslicarbazepine acetate
5444145|NCT01527513|Children|children
5444146|NCT01527500|AMD|amd
5444147|NCT01527500|Age-related Macular Degeneration|age-related macular degeneration
5444148|NCT01527500|geographic atrophy|geographic atrophy
5444149|NCT01527500|GA|ga
5444150|NCT01527500|Dry AMD|dry amd
5444151|NCT01527500|Blindness|blindness
5444152|NCT01527500|Drusen|drusen
5444153|NCT01527500|GA lesion|ga lesion
5444154|NCT01527487|breast cancer|breast cancer
5444155|NCT01527487|eribulin|eribulin
5444156|NCT01527487|Halaven|halaven
5444157|NCT01527487|taxotere|taxotere
5444158|NCT01527474|postpartum|postpartum
5444159|NCT01527474|postpartum depression|postpartum depression
5444160|NCT01527474|PPD|ppd
5444161|NCT01527474|escitalopram|escitalopram
5444162|NCT01527461|lung neoplasms|lung neoplasms
5444163|NCT01527461|dogs|dogs
5444164|NCT01527461|sweat|sweat
5444165|NCT01527461|smell|smell
5444166|NCT01527448|postpartum|postpartum
5685512|NCT00555789|AEB071|aeb071
5444167|NCT01527448|postpartum depression|postpartum depression
5444169|NCT01527448|quetiapine XR|quetiapine xr
5444170|NCT01527448|quetiapine|quetiapine
5444171|NCT01527448|seroquel|seroquel
5444172|NCT01527448|bipolar|bipolar
5444173|NCT01527448|bipolar disorder|bipolar disorder
5444174|NCT01527448|bipolar disorder, type II|bipolar disorder, type ii
5444175|NCT01527435|Best corrected visual acuity|best corrected visual acuity
5444176|NCT01527435|Slit lamp examination|slit lamp examination
5444177|NCT01527435|Ophthalmoscopy with contact lens/indirect ophthalmoscope|ophthalmoscopy with contact lens/indirect ophthalmoscope
5444178|NCT01527435|OCT assessment|oct assessment
5444179|NCT01527435|Fundus photos, fluorescein angiogram, ICG angiogram|fundus photos, fluorescein angiogram, icg angiogram
5447363|NCT01513655|COPD|copd
5444180|NCT01527422|Aggressive Non-Hodgkin's Lymphoma|aggressive non-hodgkin's lymphoma
5444181|NCT01527409|Exercise|exercise
5444182|NCT01527409|Diet|diet
5444183|NCT01527409|Posttraumatic growth|posttraumatic growth
5444184|NCT01527396|endometrial cancer|endometrial cancer
5444185|NCT01527396|lymph node metastasis|lymph node metastasis
5444186|NCT01527396|lymphadenectomy|lymphadenectomy
5444187|NCT01527396|risk criteria|risk criteria
5444188|NCT01527383|Shingles|shingles
5444189|NCT01527357|fibrin sealant|fibrin sealant
5444190|NCT01527357|thrombin|thrombin
5444191|NCT01527357|fibrinogen|fibrinogen
5444192|NCT01527357|hemostasis|hemostasis
5444194|NCT01527344|IVUS|ivus
5444196|NCT01527318|NLSDM|nlsdm
5444197|NCT01527318|Lipid accumulation|lipid accumulation
5444198|NCT01527305|Schizophrenia|schizophrenia
5444199|NCT01527305|Antipsychotics|antipsychotics
5444200|NCT01527305|Paliperidone Palmitate|paliperidone palmitate
5444201|NCT01527305|Paliperidone|paliperidone
5444202|NCT01527305|Invega|invega
5444203|NCT01527305|Sustenna|sustenna
5444204|NCT01527305|Psychotic disorder|psychotic disorder
5444205|NCT01527305|Psychosis|psychosis
5444206|NCT01527292|Vertebral Metastasis|vertebral metastasis
5444207|NCT01527292|pain control|pain control
5444209|NCT01527292|SRT+VAP|srt+vap
5444210|NCT01527279|atrial fibrillation|atrial fibrillation
5444211|NCT01527279|paroxysmal|paroxysmal
5444212|NCT01527279|cardioversion|cardioversion
5444213|NCT01527279|antazoline|antazoline
5444214|NCT01527266|carbohydrate|carbohydrate
5444215|NCT01527266|performance|performance
5444216|NCT01527266|cycling|cycling
5444217|NCT01527253|Cardiometabolic risk|cardiometabolic risk
5444218|NCT01527253|Metabolic syndrome|metabolic syndrome
5444219|NCT01527253|Prebiotics|prebiotics
5444220|NCT01527253|Legumes|legumes
5444221|NCT01527253|Wholegrain cereal|wholegrain cereal
5444222|NCT01527253|Functional diet|functional diet
5444223|NCT01527253|Low glycemic index diet|low glycemic index diet
5444224|NCT01527240|Volume of cerebral infarction|volume of cerebral infarction
5444225|NCT01527240|Stroke|stroke
5444226|NCT01527240|CsA|csa
5444227|NCT01527240|NIHSS|nihss
5444228|NCT01527227|Children of mentally ill|children of mentally ill
5444229|NCT01527214|Lung cancer|lung cancer
5444230|NCT01527214|early detection|early detection
5444231|NCT01527214|CT scan|ct scan
5444232|NCT01527214|General Practice|general practice
5444233|NCT01527214|Effect of Computed Tomography scans|effect of computed tomography scans
5444234|NCT01527214|Clinical medical education|clinical medical education
5444235|NCT01527201|Arthroscopy|arthroscopy
5444236|NCT01527201|Debridement|debridement
5444237|NCT01527188|HDM|hdm
5444238|NCT01527188|allergic rhinitis|allergic rhinitis
5444239|NCT01527162|Cerebral palsy|cerebral palsy
5444240|NCT01527162|orthotics|orthotics
5444241|NCT01527162|solid ankle foot orthoses|solid ankle foot orthoses
5444242|NCT01527123|GSK2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics|gsk2585823, benzoic acid, hippuric acid, acne vulgaris, pharmacokinetics
5444243|NCT01527110|zanamivir|zanamivir
5444244|NCT01527110|Seasonal Influenza|seasonal influenza
5444245|NCT01527110|H1N1|h1n1
5444246|NCT01527110|intravenous|intravenous
5444247|NCT01527110|neuraminidase inhibitor|neuraminidase inhibitor
5444248|NCT01527110|Pandemic|pandemic
5444249|NCT01527110|Relenza|relenza
5444250|NCT01527110|Influenza B virus|influenza b virus
5444251|NCT01527110|Influenza A virus|influenza a virus
5444252|NCT01527097|Cardiovascular Diseases|cardiovascular diseases
5444253|NCT01527097|Pharmacologic Actions|pharmacologic actions
5444254|NCT01527097|Endothelial Function|endothelial function
5444255|NCT01527097|Dermatology|dermatology
5444256|NCT01527097|Inflammatory Disease|inflammatory disease
5444257|NCT01527097|Skin Disease|skin disease
5444258|NCT01527058|lung cancer|lung cancer
5444259|NCT01527058|integrin receptor|integrin receptor
5444260|NCT01527058|68Ga-BNOTA-PRGD2|68ga-bnota-prgd2
5444261|NCT01527058|PET/CT|pet/ct
5444262|NCT01527058|efficacy and safety|efficacy and safety
5444263|NCT01527032|amyloidosis|amyloidosis
5444264|NCT01527032|stem cell transplant|stem cell transplant
5444265|NCT01527019|Acute Cystitis|acute cystitis
5444266|NCT01526967|ostomy|ostomy
5444267|NCT01526967|peristomal skin breakdown|peristomal skin breakdown
5444268|NCT01526967|ConvaTec Moldable Skin Barriers|convatec moldable skin barriers
5444269|NCT01526928|cancer|cancer
5444270|NCT01526928|metastatic|metastatic
5444271|NCT01526928|locally advanced|locally advanced
5444272|NCT01526928|lung|lung
5444273|NCT01526928|non-small cell lung cancer|non-small cell lung cancer
5444274|NCT01526928|NSCLC|nsclc
5444275|NCT01526928|epidermal growth factor receptor|epidermal growth factor receptor
5444276|NCT01526928|EGFR|egfr
5444277|NCT01526928|T790M|t790m
5444278|NCT01526928|CO-1686|co-1686
5444279|NCT01526928|unresectable|unresectable
5444280|NCT01526928|recurrent|recurrent
5444281|NCT01526928|EGFR-directed therapy|egfr-directed therapy
5444282|NCT01526928|irreversible EGFR inhibitor|irreversible egfr inhibitor
5444283|NCT01526928|TIGER|tiger
5444284|NCT01526928|Rociletinib|rociletinib
5444285|NCT01526915|PRF|prf
5444286|NCT01526915|PLATELET RICH FIBRIN|platelet rich fibrin
5444287|NCT01526915|BISPHOSPHONATES|bisphosphonates
5444288|NCT01526902|contact lenses|contact lenses
5444289|NCT01526889|Non-infectious uveitis|non-infectious uveitis
5444290|NCT01526889|Panuveitis|panuveitis
5444291|NCT01526889|Visual acuity|visual acuity
5444292|NCT01526889|Vitreous Haze|vitreous haze
5444293|NCT01526889|Inflammation of the uvea|inflammation of the uvea
5444294|NCT01526889|inflammation of the middle, pigmented vascular structures of the eye, iris, ciliary body, choroid plexus|inflammation of the middle, pigmented vascular structures of the eye, iris, ciliary body, choroid plexus
5444295|NCT01526876|Intracranial Pressure|intracranial pressure
5444296|NCT01526876|Cerebral Perfusion Pressure|cerebral perfusion pressure
5444297|NCT01526876|Clevidipine Butyrate|clevidipine butyrate
5444298|NCT01526863|Allergy|allergy
5444299|NCT01526863|Egg|egg
5444300|NCT01526850|cGVHD|cgvhd
5444301|NCT01526837|Brain tumor|brain tumor
5444302|NCT01526837|GBM|gbm
5444303|NCT01526837|Brain cancer|brain cancer
5444304|NCT01526811|Endurant|endurant
5444305|NCT01526811|Stent Graft|stent graft
5444306|NCT01526811|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5444313|NCT01526772|Transnasal|transnasal
5444314|NCT01526772|Transoral|transoral
5444315|NCT01526772|Roux en Y gastric bypass|roux en y gastric bypass
5444316|NCT01526772|Upper Endoscopy|upper endoscopy
5444317|NCT01526772|Obesity|obesity
5444318|NCT01526759|dietary fiber|dietary fiber
5444319|NCT01526759|energy intake|energy intake
5444320|NCT01526759|satiety|satiety
5444321|NCT01526759|physicochemical properties|physicochemical properties
5444322|NCT01526759|men and women|men and women
5444323|NCT01526759|Healthy adults|healthy adults
5444324|NCT01526746|End stage renal disease|end stage renal disease
5444325|NCT01526746|ESRD|esrd
5444326|NCT01526746|kidney disease|kidney disease
5444327|NCT01526746|renal impairment|renal impairment
5444328|NCT01526746|renal|renal
5444329|NCT01526733|Type 1 Diabetes|type 1 diabetes
5444330|NCT01526733|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5444331|NCT01526720|Type 2 diabetes mellitus|type 2 diabetes mellitus
5444332|NCT01526720|Beta cell function|beta cell function
5444333|NCT01526720|Insulin sensitivity|insulin sensitivity
5444334|NCT01526720|Genetics of diabetes|genetics of diabetes
5444335|NCT01526707|To identify changes in FKBP51 expression with inhaled steroid treatment in asthma|to identify changes in fkbp51 expression with inhaled steroid treatment in asthma
5444336|NCT01526694|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5444337|NCT01526681|Sensory Nerve|sensory nerve
5444338|NCT01526681|Mixed Nerve|mixed nerve
5444339|NCT01526681|Motor Nerve|motor nerve
5444340|NCT01526681|Neurotization|neurotization
5444341|NCT01526681|Nerve Injury|nerve injury
5444342|NCT01526681|Peripheral Nerve Injury|peripheral nerve injury
5444343|NCT01526668|Benign gynecological disease|benign gynecological disease
5444344|NCT01526668|Surgery|surgery
5444345|NCT01526668|Postoperative follow-up strategy|postoperative follow-up strategy
5444346|NCT01526668|Pain threshold|pain threshold
5444347|NCT01526668|Chronic pelvic pain|chronic pelvic pain
5444348|NCT01526668|[E04.950.300.399]|[e04.950.300.399]
5444349|NCT01526668|[C13.351.500]|[c13.351.500]
5444350|NCT01526668|[F02.463.593.710.560]|[f02.463.593.710.560]
5444351|NCT01526668|[N02.421.585.722.700]|[n02.421.585.722.700]
5444352|NCT01526668|Postoperative Care|postoperative care
5444353|NCT01526655|Endometrial cancer|endometrial cancer
5444354|NCT01526655|Robot assisted laparoscopy|robot assisted laparoscopy
5444355|NCT01526655|Abdominal hysterectomy|abdominal hysterectomy
5444356|NCT01526655|Fast track program|fast track program
5444357|NCT01526629|ICD|icd
5444358|NCT01526629|Remote follow-up|remote follow-up
5444359|NCT01526616|PCOS|pcos
5429543|NCT01589978|DES|des
5444360|NCT01526616|metformin|metformin
5444361|NCT01526616|spironolactone|spironolactone
5444362|NCT01526616|metabolic syndrome|metabolic syndrome
5444363|NCT01526616|hyperandrogenism|hyperandrogenism
5444364|NCT01526603|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5444365|NCT01526603|autologous stem cell transplant|autologous stem cell transplant
5444366|NCT01526577|phase1|phase1
5444367|NCT01526577|healthy subjects|healthy subjects
5444368|NCT01526577|antiplatelet agent|antiplatelet agent
5444369|NCT01526564|Chemotherapy-induced peripheral neuropathy (CIPN)|chemotherapy-induced peripheral neuropathy (cipn)
5685513|NCT00555789|tacrolimus|tacrolimus
5444370|NCT01526551|Human Papillomavirus|human papillomavirus
5444371|NCT01526525|tramadol|tramadol
5444372|NCT01526525|ketamine|ketamine
5444373|NCT01526525|parecoxib|parecoxib
5444374|NCT01526525|paracetamol|paracetamol
5444375|NCT01526525|numerical rating scale (NRS)|numerical rating scale (nrs)
5444376|NCT01526525|McGill (SF-MPQ)|mcgill (sf-mpq)
5444377|NCT01526525|electronic pressure algometer|electronic pressure algometer
5444378|NCT01526525|Spielberger State Trait Anxiety Inventory STAI Y-6 item|spielberger state trait anxiety inventory stai y-6 item
5444379|NCT01526512|Metronomic cyclophosphamide|metronomic cyclophosphamide
5444380|NCT01526512|Metronomic capecitabine|metronomic capecitabine
5444381|NCT01526512|HER2-negative breast cancer|her2-negative breast cancer
5444382|NCT01526499|Metronomic cyclophosphamide|metronomic cyclophosphamide
5444383|NCT01526499|metastatic breast cancer|metastatic breast cancer
5444384|NCT01526499|first line|first line
5444385|NCT01526499|docetaxel|docetaxel
5444386|NCT01526486|melanoma|melanoma
5444387|NCT01526486|urology|urology
5444388|NCT01526486|inguinal|inguinal
5444389|NCT01526486|lymph nodes|lymph nodes
5444390|NCT01526486|groin|groin
5444391|NCT01526486|lymphadenectomy|lymphadenectomy
5444392|NCT01526486|groin dissection|groin dissection
5444393|NCT01526486|skin cancer|skin cancer
5444394|NCT01526486|penile cancer|penile cancer
5444398|NCT01526473|Alphavirus|alphavirus
5444400|NCT01526473|Immunotherapy|immunotherapy
5444401|NCT01526473|HER2|her2
5444402|NCT01526460|Platelet|platelet
5444403|NCT01526460|Atorvastatin|atorvastatin
5444404|NCT01526460|Rosuvastatin|rosuvastatin
5444405|NCT01526460|Multiplate|multiplate
5444406|NCT01526460|reactivity|reactivity
5444407|NCT01526447|Neck Pain|neck pain
5444408|NCT01526447|Craniosacral Manipulation|craniosacral manipulation
5444409|NCT01526447|Complementary Therapies|complementary therapies
5444410|NCT01526447|Randomized Controlled Trial|randomized controlled trial
5444411|NCT01526447|Sensory Thresholds|sensory thresholds
5444412|NCT01526447|Quality of Life|quality of life
5444413|NCT01526434|Cimzia|cimzia
5444414|NCT01526434|Non-interventional|non-interventional
5444415|NCT01526434|Multicenter|multicenter
5444416|NCT01526434|Postmarketing|postmarketing
5444417|NCT01526434|Local|local
5444418|NCT01526421|HIV|hiv
5444419|NCT01526421|Antiretroviral therapy, highly active|antiretroviral therapy, highly active
5444420|NCT01526408|Meniere's Disease|meniere's disease
5444421|NCT01526408|Vertigo|vertigo
5444422|NCT01526408|Hearing loss|hearing loss
5444423|NCT01526408|Tinnitus|tinnitus
5444424|NCT01526408|Anti-viral|anti-viral
5444425|NCT01526408|Famciclovir|famciclovir
5444426|NCT01526395|electroconvulsive therapy|electroconvulsive therapy
5444427|NCT01526395|ECT|ect
5444428|NCT01526395|unmodified|unmodified
5444429|NCT01526395|anesthesia|anesthesia
5444430|NCT01526395|propofol|propofol
5444431|NCT01526382|septic shock|septic shock
5444432|NCT01526382|acute respiratory distress syndrome|acute respiratory distress syndrome
5444433|NCT01526382|transpulmonary thermodilution technique|transpulmonary thermodilution technique
5444434|NCT01526382|mortality|mortality
5444435|NCT01526369|HER2-positive metastatic breast cancer.|her2-positive metastatic breast cancer.
5444436|NCT01526356|Angiofibroma|angiofibroma
5444437|NCT01526356|Tuberous Sclerosis|tuberous sclerosis
5444438|NCT01526356|Rapamycin|rapamycin
5444439|NCT01526356|Sirolimus|sirolimus
5444440|NCT01526356|mTOR|mtor
5444441|NCT01526343|Patients|patients
5444442|NCT01526330|Degenerative disc disease|degenerative disc disease
5444443|NCT01526330|YH14618|yh14618
5444444|NCT01526330|Penial 2000|penial 2000
5444445|NCT01526330|Penial 2K|penial 2k
5444446|NCT01526317|Drug interaction|drug interaction
5444447|NCT01526317|Rosuvastatin|rosuvastatin
5444448|NCT01526317|Metformin SR|metformin sr
5444449|NCT01526317|Pharmacokinetic|pharmacokinetic
5444450|NCT01526291|Myopia|myopia
5444451|NCT01526291|Hyperopia|hyperopia
5444452|NCT01526291|Astigmatism|astigmatism
5444453|NCT01526291|Patient-reported outcomes|patient-reported outcomes
5444454|NCT01526291|Patient satisfaction|patient satisfaction
5444455|NCT01526291|Refractive Error|refractive error
5444456|NCT01526291|Emmetropia|emmetropia
5444457|NCT01526291|Dry eyes|dry eyes
5444458|NCT01526291|glare|glare
5444459|NCT01526291|halos|halos
5444460|NCT01526291|patient expectations|patient expectations
5444461|NCT01526278|alendronate|alendronate
5444462|NCT01526278|Maxmarvil®|maxmarvil®
5444463|NCT01526265|Smoking Cessation|smoking cessation
5444464|NCT01526265|Work-site|work-site
5444465|NCT01526265|Incentives|incentives
5444466|NCT01526265|Health Behavior|health behavior
5444467|NCT01526265|Smoking|smoking
5444468|NCT01526252|speckle tracking echocardiography|speckle tracking echocardiography
5444469|NCT01526252|database|database
5444470|NCT01526239|Colorectal cancer screening|colorectal cancer screening
5444471|NCT01526239|colon cancer screening|colon cancer screening
5444472|NCT01526239|colonoscopy|colonoscopy
5444473|NCT01526226|High flow nasal cannula|high flow nasal cannula
5444474|NCT01526226|Discomfort|discomfort
5444475|NCT01526200|CLM|clm
5444476|NCT01526187|Public Health and Epidemiology|public health and epidemiology
5444477|NCT01526187|Bacteriology|bacteriology
5444478|NCT01526187|Infectious and Tropical|infectious and tropical
5444479|NCT01526174|autoimmune|autoimmune
5444480|NCT01526174|hearing loss|hearing loss
5444481|NCT01526174|bilateral hearing loss|bilateral hearing loss
5444482|NCT01526174|steroid-dependent|steroid-dependent
5444483|NCT01526161|Asthma|asthma
5444484|NCT01526161|Children|children
5444486|NCT01526161|Fluticasone|fluticasone
5444487|NCT01526161|Salmeterol|salmeterol
5444488|NCT01526161|Montelukast|montelukast
5444489|NCT01526135|National multicentric phase III superiority trial|national multicentric phase iii superiority trial
5444490|NCT01526122|Clopidogrel|clopidogrel
5444491|NCT01526122|Aspirin|aspirin
5444492|NCT01526122|coadministration|coadministration
5444493|NCT01526109|elderly|elderly
5444494|NCT01526109|quality of life|quality of life
5444495|NCT01526109|functional capacity|functional capacity
5444496|NCT01526109|cognitive function|cognitive function
5444497|NCT01526109|physical exercise|physical exercise
5444498|NCT01526083|Male Healthy Volunteers|male healthy volunteers
5444499|NCT01526057|rheumatoid arthritis|rheumatoid arthritis
5444500|NCT01526057|rituximab|rituximab
5444501|NCT01526057|methotrexate|methotrexate
5444502|NCT01526057|anti-TNF|anti-tnf
5444503|NCT01526044|hyperglycemia|hyperglycemia
5444504|NCT01526044|hypoglycemia|hypoglycemia
5444506|NCT01526044|critical illness|critical illness
5444507|NCT01526044|intensive insulin therapy|intensive insulin therapy
5444508|NCT01526044|continuous glucose monitoring|continuous glucose monitoring
5444510|NCT01526044|interstitial fluid glucose|interstitial fluid glucose
5444511|NCT01526044|intensive care unit|intensive care unit
5444512|NCT01526044|Blood glucose|blood glucose
5444513|NCT01526031|frozen shoulder|frozen shoulder
5444514|NCT01526031|bee venom acupuncture|bee venom acupuncture
5444515|NCT01526018|Intake|intake
5444516|NCT01526018|Formula feeding|formula feeding
5444517|NCT01525992|Community Pharmacy Services|community pharmacy services
5444518|NCT01525992|Pharmacists|pharmacists
5444519|NCT01525992|Diabetes Mellitus|diabetes mellitus
5444520|NCT01525992|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5444521|NCT01525992|Self Care|self care
5444522|NCT01525992|Randomized Controlled Trial|randomized controlled trial
5444523|NCT01525979|Stroke rehabilitation|stroke rehabilitation
5444524|NCT01525979|Unilateral arm training|unilateral arm training
5444525|NCT01525979|Bilateral arm training|bilateral arm training
5444526|NCT01525979|Robot-assisted arm training|robot-assisted arm training
5444527|NCT01525979|Kinematic analysis|kinematic analysis
5444528|NCT01525979|Functional magnetic resonance image|functional magnetic resonance image
5444529|NCT01525979|Motor recovery|motor recovery
5444530|NCT01525979|Quality of life|quality of life
5444531|NCT01525953|esophageal cancer|esophageal cancer
5444532|NCT01525953|radiochemotherapy|radiochemotherapy
5444533|NCT01525953|prognosis|prognosis
5444534|NCT01525940|colon capsule endoscopy|colon capsule endoscopy
5444535|NCT01525940|CT-colonography|ct-colonography
5444536|NCT01525940|Patients|patients
5444537|NCT01525940|incomplete colonoscopy|incomplete colonoscopy
5444538|NCT01525927|Oropharyngeal Neoplasms|oropharyngeal neoplasms
5444539|NCT01525927|Neoplasms, Oropharyngeal|neoplasms, oropharyngeal
5444540|NCT01525927|Oropharynx Neoplasms|oropharynx neoplasms
5444541|NCT01525914|prostate cancer|prostate cancer
5444542|NCT01525914|PSA kinetics|psa kinetics
5444543|NCT01525914|PSA doubling time|psa doubling time
5444544|NCT01525914|active surveillance|active surveillance
5444545|NCT01525901|SHANK3|shank3
5444546|NCT01525901|IGF-1|igf-1
5444547|NCT01525901|Autism|autism
5444548|NCT01525888|Contrast induced nephropathy|contrast induced nephropathy
5444549|NCT01525875|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5444550|NCT01525875|calcification|calcification
5444551|NCT01525836|Purpura|purpura
5444552|NCT01525836|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5444553|NCT01525797|Liver Transplant|liver transplant
5444554|NCT01525784|rtCGMS|rtcgms
5444555|NCT01525784|glycemic control|glycemic control
5444556|NCT01525784|type 1 diabetes mellitus|type 1 diabetes mellitus
5444557|NCT01525784|youth|youth
5444558|NCT01525771|Advanced Gastric cancer|advanced gastric cancer
5444559|NCT01525771|Xeloda (Capecitabine)|xeloda (capecitabine)
5444560|NCT01525771|Cisplatin|cisplatin
5444561|NCT01525771|Taxotere (Docetaxel)|taxotere (docetaxel)
5444562|NCT01525732|Achalasia, Hypertensive LES|achalasia, hypertensive les
5444563|NCT01525719|cholangiocarcinoma|cholangiocarcinoma
5444565|NCT01525719|everolimus|everolimus
5444566|NCT01525706|Endoscopic Ultrasound|endoscopic ultrasound
5444567|NCT01525706|Pancreatic Mucinous Cystic Neoplasm|pancreatic mucinous cystic neoplasm
5444568|NCT01525706|Fine Needle Injection|fine needle injection
5444569|NCT01525706|Ethanol Ablation|ethanol ablation
5444570|NCT01525706|Paclitaxel Ablation|paclitaxel ablation
5444571|NCT01525693|diabetes|diabetes
5444572|NCT01525693|diabetics|diabetics
5444573|NCT01525693|high glucose|high glucose
5444574|NCT01525693|Chinese patients|chinese patients
5444575|NCT01525680|PTSD|ptsd
5444577|NCT01525667|Muscle injury|muscle injury
5444578|NCT01525654|Rheumatoid Arthritis|rheumatoid arthritis
5444579|NCT01525654|peer support|peer support
5444580|NCT01525654|self-efficacy|self-efficacy
5444581|NCT01525654|medication adherence|medication adherence
5444582|NCT01525602|advanced, incurable solid tumors|advanced, incurable solid tumors
5444583|NCT01525589|Breast cancer|breast cancer
5444584|NCT01525589|PM01183|pm01183
5444585|NCT01525589|lurbinectedin|lurbinectedin
5444586|NCT01525589|Pharma Mar|pharma mar
5444587|NCT01525576|booster program|booster program
5444588|NCT01525576|internet|internet
5444589|NCT01525576|cbt|cbt
5444590|NCT01525576|Study the specific effects of adding a booster program|study the specific effects of adding a booster program
5444591|NCT01525563|Duphaston Study|duphaston study
5444592|NCT01525550|neuroendocrine tumors|neuroendocrine tumors
5444593|NCT01525550|adenoma islet cells|adenoma islet cells
5444594|NCT01525550|carcinoma islet cells|carcinoma islet cells
5444595|NCT01525550|pancreatic neoplasms|pancreatic neoplasms
5444596|NCT01525550|angiogenesis inhibitors|angiogenesis inhibitors
5444599|NCT01525550|carcinoma|carcinoma
5444600|NCT01525550|adenoma|adenoma
5444601|NCT01525537|Anesthesia General|anesthesia general
5444602|NCT01525537|Anesthetics Inhalation|anesthetics inhalation
5444603|NCT01525537|Diagnostic techniques and procedures|diagnostic techniques and procedures
5444604|NCT01525524|tDCS|tdcs
5444605|NCT01525524|Major Depression|major depression
5444606|NCT01525524|Stroke|stroke
5444607|NCT01525498|Pelvic Organ Prolapse|pelvic organ prolapse
5444608|NCT01525498|Catheterization|catheterization
5444609|NCT01525498|Urinary tract infection|urinary tract infection
5444610|NCT01525498|Urinary retention|urinary retention
5444611|NCT01525472|obesity|obesity
5444612|NCT01525472|adipose tissue|adipose tissue
5444613|NCT01525472|angiogenesis|angiogenesis
5444614|NCT01525472|senecence|senecence
5444615|NCT01525459|Glioma|glioma
5444616|NCT01525459|PBMC subpopulations|pbmc subpopulations
5444617|NCT01525459|Gene expression|gene expression
5444618|NCT01525459|Metabolomics|metabolomics
5444619|NCT01525459|Immunological status|immunological status
5444620|NCT01525459|miRNA|mirna
5444621|NCT01525459|Proteomics|proteomics
5444622|NCT01525446|NSCLC|nsclc
5444623|NCT01525446|Lung Cancer|lung cancer
5444624|NCT01525394|lymphomas|lymphomas
5444625|NCT01525394|Refractory solid tumors|refractory solid tumors
5444626|NCT01525368|mild cognitive impairment|mild cognitive impairment
5444627|NCT01525368|Alzheimer's disease|alzheimer's disease
5444628|NCT01525368|cognitive intervention|cognitive intervention
5444629|NCT01525368|cognitive reserve|cognitive reserve
5444631|NCT01525355|ERCP|ercp
5444632|NCT01525355|Intraoperative cholangiogram|intraoperative cholangiogram
5444633|NCT01525355|Cholecystectomy|cholecystectomy
5444634|NCT01525355|Common Bile Duct Stones|common bile duct stones
5444635|NCT01525355|Strictures|strictures
5444636|NCT01525355|Stenosis|stenosis
5444637|NCT01525355|Duodenum|duodenum
5444638|NCT01525355|Dilated Bile duct|dilated bile duct
5444639|NCT01525355|Non-filling of the duodenum by contrast|non-filling of the duodenum by contrast
5444640|NCT01525329|Actinic Keratosis|actinic keratosis
5444641|NCT01525329|Photodynamic Therapy|photodynamic therapy
5444642|NCT01525316|Late Onset Neonatal Sepsis|late onset neonatal sepsis
5444643|NCT01525316|Neonates|neonates
5444644|NCT01525316|Lactoferrin|lactoferrin
5444645|NCT01525316|Infections|infections
5444646|NCT01525316|Prevention|prevention
5444647|NCT01525316|Neurodevelopment|neurodevelopment
5444648|NCT01525303|headaches|headaches
5444649|NCT01525303|behavioral treatment|behavioral treatment
5444650|NCT01525303|physical activity|physical activity
5444651|NCT01525290|wake-up stroke|wake-up stroke
5444652|NCT01525290|thrombolysis|thrombolysis
5444653|NCT01525290|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5444654|NCT01525290|diffusion weighted imaging (DWI)|diffusion weighted imaging (dwi)
5444655|NCT01525290|fluid attenuated inversion recovery (FLAIR)|fluid attenuated inversion recovery (flair)
5444656|NCT01525264|Mammography|mammography
5444657|NCT01525251|primary caregiver|primary caregiver
5444658|NCT01525251|neuroblastoma|neuroblastoma
5444659|NCT01525251|support group|support group
5444660|NCT01525251|posttraumatic stress|posttraumatic stress
5444661|NCT01525251|uncertainty|uncertainty
5444662|NCT01525199|Non-Small Cell Lung Cancer,|non-small cell lung cancer,
5444663|NCT01525199|Epidermal Growth Factor Receptor mutation,|epidermal growth factor receptor mutation,
5444664|NCT01525199|Lung cancer,|lung cancer,
5444665|NCT01525199|Lung adenocarcinoma|lung adenocarcinoma
5444666|NCT01525186|Weight|weight
5444667|NCT01525186|Food intakes|food intakes
5444668|NCT01525186|Feeding|feeding
5444669|NCT01525160|Clot structure|clot structure
5444670|NCT01525160|Haemostasis|haemostasis
5444671|NCT01525160|Gel point|gel point
5444672|NCT01525160|Fractal dimension|fractal dimension
5444673|NCT01525160|serum amyloid A|serum amyloid a
5444674|NCT01525160|C-reactive protein|c-reactive protein
5444773|NCT01524653|Metastatic|metastatic
5685514|NCT00555789|mycophenolic acid|mycophenolic acid
5444676|NCT01525160|intercellular adhesion molecule-1|intercellular adhesion molecule-1
5444677|NCT01525134|Tests, Diagnostic|tests, diagnostic
5444678|NCT01525134|Mycobacterium tuberculosis|mycobacterium tuberculosis
5444679|NCT01525134|Mycobacterium tuberculosis antigens|mycobacterium tuberculosis antigens
5444680|NCT01525134|TB|tb
5444681|NCT01525134|Tuberculosis|tuberculosis
5444682|NCT01525134|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5444683|NCT01525134|Tuberculosis, Miliary|tuberculosis, miliary
5444689|NCT01525121|Mechanically ventilated patients with pulmonary infection.|mechanically ventilated patients with pulmonary infection.
5444690|NCT01525108|Medication adherence|medication adherence
5444691|NCT01525108|Blood pressure|blood pressure
5444692|NCT01525108|Home-based blood pressure measurement|home-based blood pressure measurement
5444693|NCT01525108|Blood Pressure Determination|blood pressure determination
5444694|NCT01525108|Blood Pressure Monitors|blood pressure monitors
5444695|NCT01525108|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5444697|NCT01525095|Diagnostic Assay|diagnostic assay
5444698|NCT01525095|Blood culture|blood culture
5444699|NCT01525095|Sepsis|sepsis
5444700|NCT01525095|T2 Magnetic Relaxation|t2 magnetic relaxation
5444701|NCT01525056|rectal cancer|rectal cancer
5444702|NCT01525056|imaging|imaging
5444703|NCT01525056|PET|pet
5444704|NCT01525056|MRI|mri
5444705|NCT01525043|Epicondylitis|epicondylitis
5444706|NCT01525004|Solid organ transplant|solid organ transplant
5444707|NCT01525004|Flu vaccine|flu vaccine
5444708|NCT01524965|Locking Plate|locking plate
5444709|NCT01524965|Physiotherapy|physiotherapy
5444710|NCT01524926|Phase 2|phase 2
5444711|NCT01524926|Crizotinib|crizotinib
5444712|NCT01524926|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5444713|NCT01524926|Inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
5444714|NCT01524926|Papillary renal cell carcinoma type 1|papillary renal cell carcinoma type 1
5444715|NCT01524926|Alveolar soft part sarcoma|alveolar soft part sarcoma
5444716|NCT01524926|Clear cell sarcoma|clear cell sarcoma
5444717|NCT01524926|Alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
5444718|NCT01524874|vitamin d|vitamin d
5444719|NCT01524874|cholecalciferol|cholecalciferol
5444720|NCT01524874|nutritional supplements|nutritional supplements
5444721|NCT01524874|hypovitaminosis d|hypovitaminosis d
5444722|NCT01524874|klotho|klotho
5444723|NCT01524874|toll like receptor 4|toll like receptor 4
5444724|NCT01524861|Tako-Tsubo|tako-tsubo
5444725|NCT01524861|Sympathetic heart innervation|sympathetic heart innervation
5444726|NCT01524861|MIBG|mibg
5444727|NCT01524861|Alpha-lipoic acid|alpha-lipoic acid
5444728|NCT01524861|L-acetyl carnitine|l-acetyl carnitine
5444729|NCT01524848|Clinical trial|clinical trial
5444730|NCT01524848|Investigational drugs|investigational drugs
5444731|NCT01524848|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5444732|NCT01524848|Pazopanib|pazopanib
5444733|NCT01524835|Tissue Donors|tissue donors
5444734|NCT01524835|Lung|lung
5444735|NCT01524835|Transplants|transplants
5444736|NCT01524835|Transplantation|transplantation
5444742|NCT01524796|Real-life|real-life
5444743|NCT01524796|non-interventional|non-interventional
5444744|NCT01524796|observational|observational
5444745|NCT01524796|peripheral neuropathic pain|peripheral neuropathic pain
5444746|NCT01524796|Lyrica|lyrica
5444747|NCT01524796|pregabalin|pregabalin
5444748|NCT01524783|Neuroendocrine tumor|neuroendocrine tumor
5444749|NCT01524783|NET|net
5444750|NCT01524783|progressive|progressive
5444751|NCT01524783|advanced|advanced
5444752|NCT01524783|gastrointestinal|gastrointestinal
5444753|NCT01524783|GI or lung origin|gi or lung origin
5444754|NCT01524783|nonfunctional|nonfunctional
5444755|NCT01524783|everolimus|everolimus
5444756|NCT01524783|Advanced NET of GI origin|advanced net of gi origin
5444757|NCT01524783|Advanced NET of lung origin|advanced net of lung origin
5444758|NCT01524744|oral lichen planus treatment pimecrolimus|oral lichen planus treatment pimecrolimus
5444759|NCT01524718|radiation|radiation
5444760|NCT01524718|time surgery|time surgery
5444761|NCT01524705|Pilot Study|pilot study
5444762|NCT01524705|Prospective Randomized Trial|prospective randomized trial
5444763|NCT01524705|Comparative Effectiveness|comparative effectiveness
5444764|NCT01524705|Glycemic Variability|glycemic variability
5444765|NCT01524705|insulin glargine|insulin glargine
5444766|NCT01524705|exenatide|exenatide
5444767|NCT01524705|basal insulin|basal insulin
5444768|NCT01524705|bolus insulin|bolus insulin
5444770|NCT01524653|VTE|vte
5444771|NCT01524653|DVT|dvt
5444772|NCT01524653|Chemo|chemo
5444779|NCT01524640|safety and immunogenicity|safety and immunogenicity
5444780|NCT01524640|bridging study|bridging study
5444781|NCT01524640|ethiopia|ethiopia
5444782|NCT01524627|Smokers|smokers
5444783|NCT01524627|fMRI|fmri
5444784|NCT01524627|varenicline|varenicline
5444785|NCT01524614|continuous positive airway pressure|continuous positive airway pressure
5444786|NCT01524614|nasal mask|nasal mask
5444787|NCT01524614|upper airway obstruction|upper airway obstruction
5444788|NCT01524601|Immunosuppression|immunosuppression
5444789|NCT01524601|Everolimus|everolimus
5444790|NCT01524601|rosuvastatin|rosuvastatin
5417094|NCT01644747|tDCS|tdcs
5444791|NCT01524601|fluvastatin|fluvastatin
5444792|NCT01524601|Lipid lowering|lipid lowering
5444793|NCT01524588|Genotype|genotype
5444794|NCT01524588|Phenotype|phenotype
5444795|NCT01524588|Genotypic Variation Between Patients|genotypic variation between patients
5444796|NCT01524588|Genotypic Phenotypic Relationships|genotypic phenotypic relationships
5444797|NCT01524575|pancreatic cancer|pancreatic cancer
5444798|NCT01524575|ERCC1|ercc1
5444799|NCT01524575|oxaliplatin|oxaliplatin
5444800|NCT01524575|gemcitabine|gemcitabine
5444801|NCT01524562|Fibrosis|fibrosis
5444802|NCT01524562|Cirrhosis|cirrhosis
5444803|NCT01524562|Africa|africa
5444804|NCT01524562|Schistosomiasis|schistosomiasis
5444805|NCT01524562|Aflatoxin|aflatoxin
5444806|NCT01524562|Liver Disease|liver disease
5444807|NCT01524549|Cardiovascular|cardiovascular
5444808|NCT01524549|P450s|p450s
5444809|NCT01524549|Flow-Mediated Dilatation|flow-mediated dilatation
5444810|NCT01524549|Brachial Artery Ultrasound|brachial artery ultrasound
5444811|NCT01524549|Endothelial Cell Function|endothelial cell function
5444812|NCT01524549|Healthy Volunteer|healthy volunteer
5444813|NCT01524549|HV|hv
5444819|NCT01524523|Gene Expression|gene expression
5444821|NCT01524523|Nitric Oxide|nitric oxide
5444822|NCT01524523|Pain|pain
5444823|NCT01524523|Bone Marrow|bone marrow
5444824|NCT01524510|OSAS|osas
5444825|NCT01524510|AHI|ahi
5444826|NCT01524510|MRA|mra
5444827|NCT01524510|CFD|cfd
5444828|NCT01524497|losing interest and feelings of guilt|losing interest and feelings of guilt
5444829|NCT01524497|poor concentration|poor concentration
5444830|NCT01524497|loss of appetite|loss of appetite
5444831|NCT01524497|suicide|suicide
5444832|NCT01524484|Data quality|data quality
5444833|NCT01524484|Anesthesia|anesthesia
5444834|NCT01524484|Quality assurance|quality assurance
5444835|NCT01524471|Hypertensive LES|hypertensive les
5444836|NCT01524445|Bortezomib|bortezomib
5444837|NCT01524445|Velcade|velcade
5444838|NCT01524445|multiple myeloma|multiple myeloma
5444839|NCT01524445|retrospective study, response rate, medical resource utilization|retrospective study, response rate, medical resource utilization
5444840|NCT01524432|Clotrimazole|clotrimazole
5444841|NCT01524432|Microcapsules|microcapsules
5444842|NCT01524419|spontaneous labor|spontaneous labor
5444843|NCT01524419|term|term
5444844|NCT01524419|surgical|surgical
5444845|NCT01524419|mechanical|mechanical
5444846|NCT01524419|fetal or maternal complications|fetal or maternal complications
5444847|NCT01524406|Muscle Atrophy|muscle atrophy
5444848|NCT01524393|Assisted Reproductive Techniques|assisted reproductive techniques
5444849|NCT01524393|Pregnancy|pregnancy
5444850|NCT01524393|Pulmonary Embolism|pulmonary embolism
5444851|NCT01524393|Venous Thromboembolism|venous thromboembolism
5444852|NCT01524380|Schizophrenia|schizophrenia
5444853|NCT01524380|clinical trial|clinical trial
5444854|NCT01524380|risperidone|risperidone
5444855|NCT01524380|ginkgo biloba extract|ginkgo biloba extract
5444856|NCT01524380|antioxidant|antioxidant
5444857|NCT01524354|depth of anesthesia|depth of anesthesia
5444858|NCT01524354|valve surgery|valve surgery
5444859|NCT01524341|Acute malaria|acute malaria
5444860|NCT01524341|KAE609|kae609
5444861|NCT01524328|Complementary and alternative medicine|complementary and alternative medicine
5444862|NCT01524328|HRQoL, Inflammatory bowel disease|hrqol, inflammatory bowel disease
5444863|NCT01524315|Thiamine|thiamine
5444864|NCT01524315|Vitamin B1|vitamin b1
5444865|NCT01524315|Thiamine Deficiency|thiamine deficiency
5444866|NCT01524315|Thiamine supplementation|thiamine supplementation
5444867|NCT01524315|Cardiac surgery|cardiac surgery
5444868|NCT01524315|Lactic Acid|lactic acid
5444869|NCT01524302|pneumonia|pneumonia
5444870|NCT01524302|ceftaroline|ceftaroline
5444871|NCT01524302|community-aquired|community-aquired
5444872|NCT01524250|Multiple Sclerosis|multiple sclerosis
5444873|NCT01524250|relapse|relapse
5444874|NCT01524250|demyelination|demyelination
5444875|NCT01524250|treatment|treatment
5444876|NCT01524250|corticosteroids|corticosteroids
5444877|NCT01524224|Metastases|metastases
5444878|NCT01524224|Neoplasm|neoplasm
5444879|NCT01524224|Advanced Cancer|advanced cancer
5444880|NCT01524224|Metastatic Cancer|metastatic cancer
5444881|NCT01524211|Aortic Aneurysms|aortic aneurysms
5444882|NCT01524185|childhood trauma|childhood trauma
5444883|NCT01524185|intergenerational trauma|intergenerational trauma
5444884|NCT01524185|child neglect|child neglect
5444885|NCT01524185|child maltreatment|child maltreatment
5444886|NCT01524185|mental health|mental health
5444887|NCT01524172|child trauma exposure|child trauma exposure
5444888|NCT01524172|mental health|mental health
5444890|NCT01524172|mood regulation|mood regulation
5444891|NCT01524172|child maltreatment|child maltreatment
5444892|NCT01524159|cardiovascular disease|cardiovascular disease
5444893|NCT01524146|Unresectable Cholangiocarcinoma|unresectable cholangiocarcinoma
5444894|NCT01524146|Biliary obstruction|biliary obstruction
5444895|NCT01524146|Stent obstruction|stent obstruction
5444896|NCT01524146|Biliary stricture|biliary stricture
5417211|NCT01643993|IVF|ivf
5444897|NCT01524146|Photodynamic therapy|photodynamic therapy
5444900|NCT01524133|combat-related PTSD|combat-related ptsd
5444901|NCT01524133|Posttraumatic stress disorder|posttraumatic stress disorder
5444902|NCT01524133|prolonged exposure therapy|prolonged exposure therapy
5444903|NCT01524133|sertraline|sertraline
5444904|NCT01524133|military|military
5444905|NCT01524133|veterans|veterans
5444906|NCT01524133|VA hospital|va hospital
5444907|NCT01524133|mental illness|mental illness
5444908|NCT01524120|Mucosal healing|mucosal healing
5444909|NCT01524107|Prophylaxis Antibiotics|prophylaxis antibiotics
5444910|NCT01524107|Maternal Complications|maternal complications
5444911|NCT01524107|Neonatal Complications|neonatal complications
5444912|NCT01524107|Cord Prolapse|cord prolapse
5444913|NCT01524107|Elective Caesarian Section|elective caesarian section
5444914|NCT01524107|Maternal Morbidity|maternal morbidity
5444915|NCT01524107|Neonatal Morbidity|neonatal morbidity
5444916|NCT01524094|colorectal cancer|colorectal cancer
5444917|NCT01524094|cytoreductive surgery|cytoreductive surgery
5444918|NCT01524094|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5444919|NCT01524094|systemic chemotherapy|systemic chemotherapy
5444920|NCT01524094|Peritoneal Metastatic Disease From the Colon or Rectum|peritoneal metastatic disease from the colon or rectum
5439753|NCT01546324|PGS|pgs
5444921|NCT01524081|antibiotic prophylaxis|antibiotic prophylaxis
5444922|NCT01524081|emergent surgery|emergent surgery
5444923|NCT01524081|surgical site infection|surgical site infection
5444924|NCT01524068|Acute Idiopathic Pulmonary Fibrosis Exacerbations|acute idiopathic pulmonary fibrosis exacerbations
5444925|NCT01524068|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5444927|NCT01524042|Satisfaction|satisfaction
5444928|NCT01524042|colonoscopy|colonoscopy
5444929|NCT01524042|double pants|double pants
5444930|NCT01524042|single pants|single pants
5444931|NCT01524029|Digital Breast Tomosynthesis|digital breast tomosynthesis
5444932|NCT01524029|Digital Mammography|digital mammography
5444933|NCT01524029|Breast cancer detection|breast cancer detection
5444934|NCT01524016|Oncogenic osteomalacia|oncogenic osteomalacia
5444935|NCT01524016|mesenchymal tumor|mesenchymal tumor
5444936|NCT01524016|Somatostatin receptor|somatostatin receptor
5444937|NCT01524016|68Ga-DOTATATE|68ga-dotatate
5444939|NCT01524003|community based participatory research|community based participatory research
5444940|NCT01523977|ALL|all
5444941|NCT01523977|pediatric|pediatric
5444942|NCT01523977|relapse|relapse
5444943|NCT01523964|DMD|dmd
5444944|NCT01523964|EIM|eim
5444945|NCT01523964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5444946|NCT01523964|electrical impedance myography|electrical impedance myography
5444947|NCT01523951|topical local anaesthesia|topical local anaesthesia
5444948|NCT01523951|cooling|cooling
5444949|NCT01523951|capsaicin 8%|capsaicin 8%
5444950|NCT01523951|epidermal nerve fiber density|epidermal nerve fiber density
5444951|NCT01523951|treatment pain|treatment pain
5444952|NCT01523925|Functional electrical therapy|functional electrical therapy
5444953|NCT01523925|Bilateral arm training|bilateral arm training
5444954|NCT01523925|Constraint induced therapy|constraint induced therapy
5444955|NCT01523925|Stroke rehabilitation|stroke rehabilitation
5444956|NCT01523925|Clinical evaluation|clinical evaluation
5444957|NCT01523925|Kinematic analysis|kinematic analysis
5444958|NCT01523912|radiofrequency ablation|radiofrequency ablation
5444959|NCT01523912|gastric dysplasia|gastric dysplasia
5444960|NCT01523912|gastric neoplasia|gastric neoplasia
5444961|NCT01523899|SSTI|ssti
5444962|NCT01523899|cutaneous abscess|cutaneous abscess
5444963|NCT01523899|boil|boil
5444964|NCT01523847|Hodgkin Lymphoma|hodgkin lymphoma
5444965|NCT01523847|Cardiopathic|cardiopathic
5444966|NCT01523847|elderly|elderly
5444967|NCT01523847|Myocet|myocet
5444968|NCT01523834|Diffuse Large B-cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5444969|NCT01523834|Panobinostat|panobinostat
5444970|NCT01523834|Patients with relapsed/refractory DLBCL.|patients with relapsed/refractory dlbcl.
5444971|NCT01523808|pancreatic cancer|pancreatic cancer
5444972|NCT01523808|asparaginase|asparaginase
5444973|NCT01523795|Energy intake|energy intake
5444974|NCT01523795|Video games|video games
5444975|NCT01523795|Television|television
5444976|NCT01523795|Physical activity|physical activity
5444977|NCT01523795|Obesity|obesity
5444978|NCT01523782|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5444979|NCT01523782|Elderly patient|elderly patient
5444980|NCT01523782|Asparaginase|asparaginase
5444981|NCT01523769|prematurity|prematurity
5444982|NCT01523769|umbilical cord milking|umbilical cord milking
5444983|NCT01523769|delayed cord clamping|delayed cord clamping
5444984|NCT01523769|neonatal transfusion|neonatal transfusion
5444985|NCT01523730|Schizophrenia|schizophrenia
5444986|NCT01523730|Nicotine|nicotine
5444987|NCT01523730|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5444988|NCT01523730|Cognition|cognition
5444989|NCT01523730|EEG|eeg
5444990|NCT01523717|procalcitonin|procalcitonin
5444991|NCT01523717|decrease over 72 hours|decrease over 72 hours
5444992|NCT01523717|severe sepsis|severe sepsis
5444993|NCT01523717|septic shock|septic shock
5444994|NCT01523691|Healthy individuals|healthy individuals
5444995|NCT01523678|Ovarian Cancer|ovarian cancer
5444996|NCT01523678|Endometrial Cancer|endometrial cancer
5444997|NCT01523678|Endometrial Carcinoma|endometrial carcinoma
5444998|NCT01523678|Uterine Cervical Cancer|uterine cervical cancer
5444999|NCT01523678|Paclitaxel|paclitaxel
5445000|NCT01523678|Carboplatin|carboplatin
5445001|NCT01523678|Neupogen|neupogen
5445002|NCT01523678|Filgrastim|filgrastim
5445003|NCT01523678|Ovarian Diseases|ovarian diseases
5445004|NCT01523678|Peritoneal Diseases|peritoneal diseases
5445005|NCT01523678|Fallopian Tube Diseases|fallopian tube diseases
5445006|NCT01523678|Endocrine System Diseases|endocrine system diseases
5445007|NCT01523678|Endometrial Diseases|endometrial diseases
5445008|NCT01523678|Uterine Cervical Diseases|uterine cervical diseases
5445009|NCT01523678|Neoplasms|neoplasms
5445010|NCT01523678|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5445011|NCT01523678|Ovarian Neoplasms|ovarian neoplasms
5445012|NCT01523678|Peritoneal Neoplasms|peritoneal neoplasms
5445013|NCT01523678|Fallopian Tube Neoplasms|fallopian tube neoplasms
5445014|NCT01523678|Neoplasms, Endometrial|neoplasms, endometrial
5445015|NCT01523678|Cervical Neoplasms|cervical neoplasms
5445016|NCT01523678|Genital Neoplasms, Female|genital neoplasms, female
5445017|NCT01523678|Urogenital Neoplasms|urogenital neoplasms
5445018|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5445019|NCT01523678|Genital Diseases, Female|genital diseases, female
5445020|NCT01523639|liver injury|liver injury
5445021|NCT01523639|steatosis|steatosis
5445022|NCT01523639|KRAS-Wild-Type|kras-wild-type
5445023|NCT01523639|metastatic colorectal cancer|metastatic colorectal cancer
5445024|NCT01523639|metformin|metformin
5445025|NCT01523639|placebo|placebo
5445026|NCT01523639|chemotherapy|chemotherapy
5445027|NCT01523626|Trauma|trauma
5445028|NCT01523626|Injur*|injur*
5445029|NCT01523626|Emergen*|emergen*
5445030|NCT01523626|Computed Tomography|computed tomography
5445031|NCT01523626|Total body|total body
5445033|NCT01523626|Whole body|whole body
5445034|NCT01523626|WBCT|wbct
5445035|NCT01523626|Full body|full body
5445036|NCT01523626|Pan CT|pan ct
5445037|NCT01523613|Dental caries|dental caries
5445038|NCT01523613|Proximal surfaces|proximal surfaces
5445039|NCT01523613|Posterior teeth|posterior teeth
5445040|NCT01523613|Carious lesions|carious lesions
5445041|NCT01523613|Tooth diseases|tooth diseases
5445042|NCT01523613|Dental restorations|dental restorations
5445043|NCT01523613|Glass-ionomer|glass-ionomer
5445044|NCT01523600|whole body vibration|whole body vibration
5445045|NCT01523600|physical functioning|physical functioning
5445046|NCT01523600|falls|falls
5445047|NCT01523600|older people|older people
5445048|NCT01523600|prevention|prevention
5445049|NCT01523574|oxaliplatin|oxaliplatin
5445050|NCT01523574|vitamin e|vitamin e
5445051|NCT01523574|neuropathy|neuropathy
5445052|NCT01523574|peripheral|peripheral
5445053|NCT01523574|prophylaxis|prophylaxis
5445054|NCT01523561|dance|dance
5445055|NCT01523561|intervention|intervention
5445056|NCT01523561|adolescent|adolescent
5445057|NCT01523561|girls|girls
5445058|NCT01523548|Carbon Monoxide|carbon monoxide
5445059|NCT01523548|Hypertension, Pulmonary|hypertension, pulmonary
5445060|NCT01523522|Fecal incontinence|fecal incontinence
5445061|NCT01523522|Myoblast|myoblast
5445062|NCT01523522|Surgery|surgery
5445063|NCT01523509|Dental Caries|dental caries
5445064|NCT01523509|Radiography, Dental|radiography, dental
5445065|NCT01523509|Contrast media|contrast media
5445066|NCT01523509|Tooth|tooth
5445067|NCT01523496|HIV|hiv
5445068|NCT01523496|Vitamin D Deficiency|vitamin d deficiency
5445069|NCT01523483|preterm birth|preterm birth
5445070|NCT01523483|preterm labor|preterm labor
5445071|NCT01523483|progesterone|progesterone
5445072|NCT01523483|uterine electromyography|uterine electromyography
5445073|NCT01523483|cervical length|cervical length
5445074|NCT01523470|non-invasive ventilator|non-invasive ventilator
5445075|NCT01523457|metastatic pancreatic cancer|metastatic pancreatic cancer
5445076|NCT01523457|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5445077|NCT01523457|FOLFIRINOX|folfirinox
5445078|NCT01523457|phase II|phase ii
5445079|NCT01523457|progression free survival|progression free survival
5445080|NCT01523444|Adolescents|adolescents
5445081|NCT01523444|Screening|screening
5570621|NCT01004029|17P|17p
5445082|NCT01523444|Advice|advice
5445083|NCT01523444|Referral|referral
5445084|NCT01523431|Colorectal cancer|colorectal cancer
5445085|NCT01523431|Irinotecan|irinotecan
5445086|NCT01523431|UGT1A1 genotype|ugt1a1 genotype
5445087|NCT01523431|Neutropenia|neutropenia
5445088|NCT01523431|diarrhea|diarrhea
5445089|NCT01523431|response|response
5445090|NCT01523431|pharmacokinetic|pharmacokinetic
5445091|NCT01523418|Xarelto|xarelto
5445092|NCT01523418|Thromboembolism, Venous|thromboembolism, venous
5445093|NCT01523418|Orthopedic surgery|orthopedic surgery
5445094|NCT01523418|Factor Xa inhibitor|factor xa inhibitor
5445095|NCT01523418|Observational study|observational study
5432036|NCT01579058|aortic stenosis|aortic stenosis
5445096|NCT01523405|Non Interventional Study, Type II Diabetes Mellitus, Quality of Life|non interventional study, type ii diabetes mellitus, quality of life
5445097|NCT01523392|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
5448249|NCT01510067|CLE|cle
5445098|NCT01523379|Causalgia|causalgia
5445100|NCT01523379|complex regional pain syndrome|complex regional pain syndrome
5445101|NCT01523379|Dynastat|dynastat
5445102|NCT01523379|Parecoxib|parecoxib
5445103|NCT01523366|Stable Coronary Artery Disease, CAD|stable coronary artery disease, cad
5445104|NCT01523353|Prehabilitation|prehabilitation
5445105|NCT01523353|Exercise|exercise
5445106|NCT01523353|Colorectal Cancer|colorectal cancer
5445107|NCT01523353|Surgery|surgery
5445108|NCT01523327|Uric acid|uric acid
5445109|NCT01523314|diabetic macular edema|diabetic macular edema
5445110|NCT01523314|intravitreal injection|intravitreal injection
5445111|NCT01523314|dexamethasone|dexamethasone
5445112|NCT01523314|Cyclodextrin|cyclodextrin
5445113|NCT01523314|eye drops|eye drops
5445114|NCT01523314|bevacizumab|bevacizumab
5445115|NCT01523314|macular laser|macular laser
5445116|NCT01523301|Rotigotine|rotigotine
5445117|NCT01523301|Neupro|neupro
5445118|NCT01523301|Depressive Symptom|depressive symptom
5445119|NCT01523301|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5445120|NCT01523275|mitomycin-C|mitomycin-c
5445121|NCT01523275|laryngotracheal stenosis|laryngotracheal stenosis
5445122|NCT01523275|subglottic stenosis|subglottic stenosis
5445123|NCT01523275|tracheal stenosis|tracheal stenosis
5445124|NCT01523275|endoscopic airway surgery|endoscopic airway surgery
5445126|NCT01523262|aortic aneurysm|aortic aneurysm
5445127|NCT01523249|3D ultrasonography|3d ultrasonography
5445128|NCT01523249|epidural|epidural
5445129|NCT01523249|neuraxial anesthesia|neuraxial anesthesia
5445130|NCT01523249|neuraxial analgesia|neuraxial analgesia
5445131|NCT01523249|pregnant woman|pregnant woman
5445132|NCT01523249|parturients|parturients
5445133|NCT01523236|Allergic Rhinitis|allergic rhinitis
5445134|NCT01523236|Bioequivalence|bioequivalence
5445135|NCT01523210|spasticity|spasticity
5445136|NCT01523210|Diffusor tensor imaging|diffusor tensor imaging
5445137|NCT01523210|distribution|distribution
5445138|NCT01523210|botulinum toxin|botulinum toxin
5445139|NCT01523210|physiotherapy|physiotherapy
5445140|NCT01523197|Obstructive Sleep Apnea hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
5445141|NCT01523197|COPD|copd
5445142|NCT01523197|overlap syndrome|overlap syndrome
5445143|NCT01523197|Auto-trilevel ventilation|auto-trilevel ventilation
5445144|NCT01523197|BiPAP ventilation|bipap ventilation
5445145|NCT01523184|Chronic constipation (CC)|chronic constipation (cc)
5445146|NCT01523184|Functional Constipation (FC)|functional constipation (fc)
5445147|NCT01523184|Gastric Emptying|gastric emptying
5445148|NCT01523184|Colon Transit|colon transit
5445149|NCT01523184|multiple doses of YKP10811|multiple doses of ykp10811
5445150|NCT01523184|gastrointestinal transit|gastrointestinal transit
5445151|NCT01523184|colonic transit|colonic transit
5445152|NCT01523158|Allergic Rhinitis|allergic rhinitis
5445153|NCT01523158|Immunotherapy|immunotherapy
5445154|NCT01523145|Atrial fibrillation|atrial fibrillation
5445155|NCT01523145|Radio Frequency Ablation|radio frequency ablation
5445156|NCT01523145|Rehabilitation|rehabilitation
5445157|NCT01523145|Physical capacity|physical capacity
5445158|NCT01523145|Quality of life|quality of life
5445159|NCT01523145|Integrated rehabilitation|integrated rehabilitation
5445160|NCT01523106|Crohn's disease|crohn's disease
5445161|NCT01523106|carnitine|carnitine
5445162|NCT01523067|Vasomera|vasomera
5445163|NCT01523067|PB1046|pb1046
5445164|NCT01523067|Hypertension|hypertension
5445165|NCT01523054|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics|metoprolol, acute myocardial infarction, pharmacokinetics, pharmacodynamics
5445166|NCT01523015|Adenocarcinoma|adenocarcinoma
5445167|NCT01523015|esophago-gastric cancer|esophago-gastric cancer
5445168|NCT01523015|chemotherapy|chemotherapy
5445169|NCT01523015|chemoradiotherapy|chemoradiotherapy
5445170|NCT01523015|surgery|surgery
5445171|NCT01522989|Cancer|cancer
5445172|NCT01522989|Advanced|advanced
5445173|NCT01522989|Refractory|refractory
5445174|NCT01522950|hypertension|hypertension
5445175|NCT01522950|prevention|prevention
5445276|NCT01522534|injuries|injuries
5445176|NCT01522950|endothelial function|endothelial function
5445177|NCT01522924|tobacco cessation treatment|tobacco cessation treatment
5445178|NCT01522924|standardized patients|standardized patients
5445179|NCT01522924|dental students|dental students
5445180|NCT01522924|tobacco cessation treatment education|tobacco cessation treatment education
5445181|NCT01522898|Heart Failure|heart failure
5445182|NCT01522898|Atrial Fibrillation|atrial fibrillation
5445183|NCT01522885|Chest tube|chest tube
5445184|NCT01522885|placement|placement
5445185|NCT01522885|mal positioning|mal positioning
5445186|NCT01522872|TH-302|th-302
5445187|NCT01522872|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5445188|NCT01522872|Bortezomib|bortezomib
5445189|NCT01522872|Phase 1/2|phase 1/2
5445190|NCT01522872|Hypoxia|hypoxia
5445191|NCT01522872|Myeloma|myeloma
5445192|NCT01522872|Evofosfamide|evofosfamide
5445193|NCT01522872|Pomalidomide|pomalidomide
5445194|NCT01522872|Pimonidazole|pimonidazole
5445195|NCT01522859|COPD|copd
5448374|NCT01509508|HIV|hiv
5445196|NCT01522859|Telehealth|telehealth
5445197|NCT01522859|health related quality of life|health related quality of life
5445198|NCT01522833|NSLCL|nslcl
5445199|NCT01522833|Erlotinib|erlotinib
5445200|NCT01522833|Tarceva|tarceva
5445201|NCT01522807|Phase 1|phase 1
5445202|NCT01522807|Single Doses|single doses
5445203|NCT01522807|Biocomparison|biocomparison
5445204|NCT01522807|Pharmacokinetics|pharmacokinetics
5445205|NCT01522807|Healthy Volunteers|healthy volunteers
5445206|NCT01522768|ESOPHAGUS|esophagus
5445207|NCT01522768|STOMACH|stomach
5445208|NCT01522768|Afatinib|afatinib
5445209|NCT01522768|paclitaxel|paclitaxel
5445210|NCT01522768|trastuzumab|trastuzumab
5445211|NCT01522768|11-166|11-166
5445212|NCT01522755|Pacing lead|pacing lead
5445213|NCT01522755|implant|implant
5445214|NCT01522755|pacemaker|pacemaker
5445215|NCT01522742|psoriasis|psoriasis
5445340|NCT01522248|influenza vaccine|influenza vaccine
5445216|NCT01522742|cardiovascular disease risk|cardiovascular disease risk
5445217|NCT01522742|atherosclerosis|atherosclerosis
5445218|NCT01522742|etanercept (enbrel)|etanercept (enbrel)
5445219|NCT01522729|Chronic pulmonary obstructive disease|chronic pulmonary obstructive disease
5445220|NCT01522729|Muscle dysfunction|muscle dysfunction
5445221|NCT01522729|Exercise intolerance|exercise intolerance
5445222|NCT01522729|Muscle afferents|muscle afferents
5445223|NCT01522729|Ventilation|ventilation
5445224|NCT01522703|asthma|asthma
5445225|NCT01522703|allergic rhinitis|allergic rhinitis
5445226|NCT01522703|dietary interventions|dietary interventions
5445227|NCT01522703|mouse allergy|mouse allergy
5445228|NCT01522690|Accelerometer|accelerometer
5445229|NCT01522690|gait analysis|gait analysis
5445230|NCT01522690|Healthy subjects|healthy subjects
5445231|NCT01522677|tumor immunology|tumor immunology
5445232|NCT01522677|neoadjuvant|neoadjuvant
5445233|NCT01522677|colonoscopy|colonoscopy
5445234|NCT01522677|photosensitization|photosensitization
5445235|NCT01522651|Atrial Fibrillation|atrial fibrillation
5445236|NCT01522651|Ranolazine|ranolazine
5445237|NCT01522651|Dronedarone|dronedarone
5445238|NCT01522651|Dual Chamber Pacemakers|dual chamber pacemakers
5445239|NCT01522625|chronic hepatitis B|chronic hepatitis b
5445240|NCT01522625|hepatitis B viral DNA|hepatitis b viral dna
5428018|NCT01596426|CINV|cinv
5445241|NCT01522625|antiviral therapy|antiviral therapy
5445242|NCT01522625|Tenofovir|tenofovir
5445243|NCT01522612|KRAS Wild Type|kras wild type
5445244|NCT01522612|Frail Elderly|frail elderly
5445245|NCT01522612|QLQ-C30|qlq-c30
5445246|NCT01522612|QLQ-ELD14|qlq-eld14
5445248|NCT01522612|EGFR|egfr
5445249|NCT01522612|Cetuximab|cetuximab
5445250|NCT01522612|5-FU|5-fu
5445251|NCT01522599|ARDS: Acute Respiratory Distress Syndrome|ards: acute respiratory distress syndrome
5445252|NCT01522599|LOW FLOW ECCO2-R: EXTRA-CORPOREAL CO2 REMOVAL|low flow ecco2-r: extra-corporeal co2 removal
5445253|NCT01522599|VILI: Ventilator Induced Lung Injury|vili: ventilator induced lung injury
5445254|NCT01522573|Cholangiocarcinoma|cholangiocarcinoma
5445255|NCT01522573|Pancreatic Cancer|pancreatic cancer
5445256|NCT01522573|Bile Duct Cancer|bile duct cancer
5445257|NCT01522573|Biliary Stricture|biliary stricture
5445258|NCT01522573|Biliary obstruction|biliary obstruction
5445259|NCT01522573|Stent obstruction|stent obstruction
5445260|NCT01522573|Proximal duct stricture|proximal duct stricture
5445261|NCT01522573|Distal duct stricture|distal duct stricture
5445262|NCT01522573|Ampullary Cancer|ampullary cancer
5445263|NCT01522573|Biliary sphincter stenosis|biliary sphincter stenosis
5445264|NCT01522573|Impacted stones|impacted stones
5445265|NCT01522573|Chronic pancreatitis|chronic pancreatitis
5445266|NCT01522573|Peri-ampullary diverticula|peri-ampullary diverticula
5445267|NCT01522573|Altered anatomy|altered anatomy
5445268|NCT01522573|Endoscopic ultrasound|endoscopic ultrasound
5445269|NCT01522573|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5445270|NCT01522573|Multicenter|multicenter
5445271|NCT01522560|CA2 and CA3 residents|ca2 and ca3 residents
5445272|NCT01522560|Pediatric Anesthesia|pediatric anesthesia
5445273|NCT01522547|Pomalidomide|pomalidomide
5445274|NCT01522547|Sickle Cell Disease|sickle cell disease
5445275|NCT01522547|Fetal Hemoglobin|fetal hemoglobin
5445277|NCT01522534|pain|pain
5445278|NCT01522534|Block, Nerve|block, nerve
5445279|NCT01522534|morphine|morphine
5445280|NCT01522534|Prehospital Emergency Care|prehospital emergency care
5445281|NCT01522521|AK156|ak156
5445282|NCT01522508|Analgesia|analgesia
5445283|NCT01522508|Anesthetics|anesthetics
5445284|NCT01522508|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5445285|NCT01522482|fatty acids|fatty acids
5445286|NCT01522482|cardiovascular disease|cardiovascular disease
5445287|NCT01522482|genotype|genotype
5445288|NCT01522482|apoE|apoe
5445289|NCT01522469|FLT3|flt3
5445290|NCT01522469|Crenolanib|crenolanib
5445291|NCT01522469|Acute|acute
5445292|NCT01522469|myeloid|myeloid
5445293|NCT01522469|leukemia|leukemia
5445294|NCT01522469|relapsed|relapsed
5445295|NCT01522469|refractory|refractory
5445296|NCT01522443|prostate cancer|prostate cancer
5445297|NCT01522443|castration resistant prostate cancer|castration resistant prostate cancer
5445298|NCT01522443|bone pain|bone pain
5445299|NCT01522443|CRPC|crpc
5445300|NCT01522430|Resistant hypertension|resistant hypertension
5445301|NCT01522430|Renal denervation|renal denervation
5445302|NCT01522430|Ambulatory blood pressure|ambulatory blood pressure
5445303|NCT01522430|Renal function|renal function
5445304|NCT01522430|Simplicity catheter|simplicity catheter
5445305|NCT01522430|Sham procedure|sham procedure
5445306|NCT01522404|Mild Cognitive Impairment|mild cognitive impairment
5445307|NCT01522404|Memory Loss|memory loss
5445308|NCT01522404|Alzheimer's Disease|alzheimer's disease
5445309|NCT01522378|cardiac resynchronization therapy|cardiac resynchronization therapy
5445310|NCT01522365|Dental implants|dental implants
5445311|NCT01522365|XiVE CAD/CAM bridge|xive cad/cam bridge
5445312|NCT01522352|Bioprosthesis,|bioprosthesis,
5445313|NCT01522352|aortic valve replacement|aortic valve replacement
5445314|NCT01522352|Magna Ease|magna ease
5445315|NCT01522352|Mitroflow|mitroflow
5445316|NCT01522352|Trifecta|trifecta
5445317|NCT01522339|NICU|nicu
5445318|NCT01522339|MRI|mri
5445319|NCT01522339|Neonatal|neonatal
5445320|NCT01522339|Safety|safety
5445321|NCT01522339|Efficacy|efficacy
5445322|NCT01522339|Cincinnati|cincinnati
5445323|NCT01522326|Acute Mountain Sickness|acute mountain sickness
5445324|NCT01522326|High Altitude Headache|high altitude headache
5445325|NCT01522326|Lake Louise AMS Score|lake louise ams score
5445326|NCT01522326|Visual Analog Scale|visual analog scale
5445327|NCT01522326|Ibuprofen|ibuprofen
5445328|NCT01522326|Metoclopramide|metoclopramide
5445329|NCT01522326|Nepal|nepal
5445330|NCT01522300|Tomosynthesis|tomosynthesis
5445331|NCT01522300|breast cancer|breast cancer
5445332|NCT01522300|specificity|specificity
5445333|NCT01522300|sensitivity|sensitivity
5671226|NCT00616590|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5445334|NCT01522300|To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor|to assess efficacy of tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor
5445335|NCT01522287|Obsessive Compulsive Disorder|obsessive compulsive disorder
5445336|NCT01522287|Computer Assisted Therapy|computer assisted therapy
5445337|NCT01522287|Cognitive Behavior Therapy|cognitive behavior therapy
5445488|NCT01521533|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5445489|NCT01521533|CXCL12|cxcl12
5445490|NCT01521520|type 1 diabetes|type 1 diabetes
5445491|NCT01521520|magnetic resonance imaging|magnetic resonance imaging
5445492|NCT01521520|insulitis|insulitis
5445493|NCT01521520|ferumoxytol|ferumoxytol
5445494|NCT01521494|Hemodialysis|hemodialysis
5445495|NCT01521494|Hyperphosphatemia|hyperphosphatemia
5445496|NCT01521468|Coronary artery disease|coronary artery disease
5445497|NCT01521468|Diagnostic accuracy|diagnostic accuracy
5445498|NCT01521468|CT coronary angiography|ct coronary angiography
5445499|NCT01521468|Positron emission tomography|positron emission tomography
5445500|NCT01521468|Single photon emission tomography|single photon emission tomography
5445501|NCT01521468|Noninvasive techniques|noninvasive techniques
5445502|NCT01521468|Cardiac catheterization|cardiac catheterization
5445503|NCT01521468|Fractional flow reserve|fractional flow reserve
5445504|NCT01521442|PTSD|ptsd
5445505|NCT01521442|Yoga|yoga
5445506|NCT01521442|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
5445507|NCT01521416|Illness|illness
5445508|NCT01521416|Influenza|influenza
5445509|NCT01521416|Cost|cost
5445511|NCT01521403|Blastocystis hominis|blastocystis hominis
5445512|NCT01521403|Metronidazole|metronidazole
5445513|NCT01521377|LAMA|lama
5445514|NCT01521377|Respiratory|respiratory
5445515|NCT01521377|COPD|copd
5445516|NCT01521377|Tolerability|tolerability
5445517|NCT01521377|Beta-2 Agonist|beta-2 agonist
5445518|NCT01521377|Safety|safety
5445519|NCT01521377|Pharmacokinetics|pharmacokinetics
5445520|NCT01521377|Pharmacodynamics|pharmacodynamics
5445521|NCT01521377|LABA|laba
5445522|NCT01521377|Muscarinic Receptor Agonist|muscarinic receptor agonist
5445523|NCT01521377|Healthy subjects|healthy subjects
5445524|NCT01521377|Moxifloxacin|moxifloxacin
5445525|NCT01521377|Anticholinergic|anticholinergic
5445526|NCT01521377|GW642444|gw642444
5445527|NCT01521377|GSK573719|gsk573719
5445529|NCT01521364|pharmacokinetic|pharmacokinetic
5445530|NCT01521364|drug-interaction|drug-interaction
5445531|NCT01521364|linezolid|linezolid
5445532|NCT01521364|clarithromycin|clarithromycin
5445533|NCT01521364|Mycobacterium tuberculosis|mycobacterium tuberculosis
5445534|NCT01521351|microwave radiometry|microwave radiometry
5445535|NCT01521351|cardiovascular events|cardiovascular events
5445536|NCT01521351|carotid artery disease|carotid artery disease
5445537|NCT01521351|stroke|stroke
5445538|NCT01521351|myocardial infarction|myocardial infarction
5445539|NCT01521338|Cystic Fibrosis|cystic fibrosis
5445540|NCT01521338|G551D|g551d
5445541|NCT01521338|G551D Mutation|g551d mutation
5445542|NCT01521312|Impaired glucose tolerance|impaired glucose tolerance
5445543|NCT01521312|Saxagliptin|saxagliptin
5445544|NCT01521312|Cardiovascular risk integrators|cardiovascular risk integrators
5445545|NCT01521312|Vago-sympathetic activity|vago-sympathetic activity
5445546|NCT01521312|Arterial stiffness|arterial stiffness
5445547|NCT01521312|Endothelial function|endothelial function
5445548|NCT01521299|hydroxyurea|hydroxyurea
5445549|NCT01521299|S phase|s phase
5445550|NCT01521299|G2 phase|g2 phase
5445551|NCT01521299|pharmacokinetics|pharmacokinetics
5445552|NCT01521286|Spain|spain
5445553|NCT01521286|cost|cost
5445554|NCT01521286|complications|complications
5445555|NCT01521286|incidence|incidence
5445556|NCT01521286|adults|adults
5445557|NCT01521286|quality of life|quality of life
5445558|NCT01521286|Herpes Zoster|herpes zoster
5445559|NCT01521286|Surveillance|surveillance
5445560|NCT01521273|beans|beans
5445561|NCT01521273|biofortification|biofortification
5445562|NCT01521273|phytic acid|phytic acid
5445563|NCT01521273|iron|iron
5445564|NCT01521273|iron isotopes|iron isotopes
5445565|NCT01521273|different phytic acid concentrations|different phytic acid concentrations
5445566|NCT01521260|dental implants|dental implants
5445567|NCT01521260|microbiology|microbiology
5445568|NCT01521260|chlorhexidine|chlorhexidine
5445569|NCT01521247|Asthma|asthma
5445570|NCT01521247|Transition program|transition program
5445571|NCT01521247|Pediatric|pediatric
5445572|NCT01521247|Adult|adult
5430638|NCT01584791|CAD|cad
5445573|NCT01521208|Out-of-Hospital cardiac arrest (OHCA)|out-of-hospital cardiac arrest (ohca)
5445574|NCT01521208|Chest compressions|chest compressions
5445575|NCT01521208|LUCAS device|lucas device
5445576|NCT01521195|pediatric|pediatric
5445577|NCT01521195|ECMO|ecmo
5445578|NCT01521195|extracorporeal blood flow|extracorporeal blood flow
5445579|NCT01521195|VO2|vo2
5445673|NCT01520714|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5445580|NCT01521182|Probiotic - dairy product - influenza vaccination - healthy elderly|probiotic - dairy product - influenza vaccination - healthy elderly
5445581|NCT01521169|Plant sterol - Hypercholesterolemia - Diet - Dairy|plant sterol - hypercholesterolemia - diet - dairy
5417802|NCT01641588|eeg|eeg
5445582|NCT01521156|Plant sterols - Hypercholesterolemia - Diet - Dairy|plant sterols - hypercholesterolemia - diet - dairy
5445583|NCT01521143|EOC|eoc
5445584|NCT01521130|Benign Childhood Epilepsy With Centrotemporal Spikes|benign childhood epilepsy with centrotemporal spikes
5445585|NCT01521130|Benign Rolandic Epilepsy|benign rolandic epilepsy
5445586|NCT01521117|donepezil|donepezil
5445587|NCT01521117|parkinson's disease|parkinson's disease
5445588|NCT01521117|balance|balance
5445589|NCT01521117|cholinesterase inhibitor|cholinesterase inhibitor
5445590|NCT01521104|narrow band imaging（NBI）|narrow band imaging（nbi）
5445591|NCT01521104|colorectal lesions|colorectal lesions
5445592|NCT01521104|predicting histology|predicting histology
5846732|NCT00043641|Sequence|sequence
5445593|NCT01521091|narrow band imaging（NBI）|narrow band imaging（nbi）
5445594|NCT01521091|indigo carmine|indigo carmine
5445595|NCT01521091|acetic acid|acetic acid
5445596|NCT01521091|colorectal lesions|colorectal lesions
5445597|NCT01521091|predicting histology|predicting histology
5445598|NCT01521065|AMD|amd
5445599|NCT01521065|Wet AMD|wet amd
5445600|NCT01521039|aGVHD|agvhd
5445601|NCT01521039|Acute Graft-versus-Host Disease|acute graft-versus-host disease
5445602|NCT01521039|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5445603|NCT01521039|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5445604|NCT01521039|MicroRNA Expression|microrna expression
5445605|NCT01521000|Breast Cancer|breast cancer
5445606|NCT01521000|Lymphedema|lymphedema
5445607|NCT01521000|Sentinel Node Biopsy|sentinel node biopsy
5445608|NCT01521000|Axillary Dissection|axillary dissection
5445609|NCT01520987|Parkinson Disease|parkinson disease
5445610|NCT01520987|BIA 9-1067|bia 9-1067
5445611|NCT01520961|Partial Hip Arthroplasty|partial hip arthroplasty
5445612|NCT01520948|Parkinson disease|parkinson disease
5445613|NCT01520948|Incontinence|incontinence
5445614|NCT01520935|Office of National Statistics|office of national statistics
5445615|NCT01520935|Burden of Disease|burden of disease
5445616|NCT01520935|Influenza|influenza
5445617|NCT01520935|Hospital Episode Statistics|hospital episode statistics
5445618|NCT01520935|General Practitioners Research Database|general practitioners research database
5445619|NCT01520922|Relapsed or Refractory Chronic Lymphocytic Leukemia|relapsed or refractory chronic lymphocytic leukemia
5445620|NCT01520922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5445621|NCT01520922|CLL|cll
5445622|NCT01520922|Cancer|cancer
5445623|NCT01520922|Lymphoid leukemia|lymphoid leukemia
5445624|NCT01520922|Lymphoblastic leukemia|lymphoblastic leukemia
5445625|NCT01520909|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5445626|NCT01520909|pediatrics|pediatrics
5445627|NCT01520909|chronic ITP|chronic itp
5445628|NCT01520909|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5445629|NCT01520909|eltrombopag|eltrombopag
5445630|NCT01520909|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
5445631|NCT01520909|platelet disorder|platelet disorder
5445632|NCT01520909|thrombocytopenia|thrombocytopenia
5445633|NCT01520896|Phase 1|phase 1
5445634|NCT01520896|Healthy male and female volunteers|healthy male and female volunteers
5445635|NCT01520896|Drug-drug interaction|drug-drug interaction
5445636|NCT01520896|Pharmacokinetics|pharmacokinetics
5445637|NCT01520896|NKTR-118|nktr-118
5445638|NCT01520870|Dacomitinib|dacomitinib
5445639|NCT01520870|PF-299804|pf-299804
5445640|NCT01520870|Glioblastoma, Recurrent|glioblastoma, recurrent
5445641|NCT01520870|EGFR|egfr
5445642|NCT01520857|Laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5445643|NCT01520857|TAPP|tapp
5445644|NCT01520857|Spinal Anesthesia|spinal anesthesia
5445645|NCT01520857|General Anesthesia|general anesthesia
5445646|NCT01520805|acute myeloid leukemia|acute myeloid leukemia
5445647|NCT01520805|myelodysplastic syndrome|myelodysplastic syndrome
5445648|NCT01520805|refractory|refractory
5445649|NCT01520805|relapsed|relapsed
5445650|NCT01520805|hypomethylating agents|hypomethylating agents
5445651|NCT01520792|pharmacogenetic of paracetamol|pharmacogenetic of paracetamol
5445652|NCT01520792|Pain threshold|pain threshold
5445653|NCT01520779|Hepatocellular cacinoma|hepatocellular cacinoma
5445654|NCT01520779|Radiofrequancy ablation|radiofrequancy ablation
5445655|NCT01520779|Intrahepatic recurrence|intrahepatic recurrence
5445656|NCT01520766|glass fiber posts|glass fiber posts
5445657|NCT01520766|titanium posts|titanium posts
5445658|NCT01520766|postendodontic restoration|postendodontic restoration
5445659|NCT01520766|self-adhesive resin cement|self-adhesive resin cement
5445660|NCT01520740|Gold Stage III|gold stage iii
5445661|NCT01520740|Gold Stage IV|gold stage iv
5445662|NCT01520740|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5445663|NCT01520740|COPD|copd
5445664|NCT01520740|Lung Volume Reduction Surgery|lung volume reduction surgery
5445665|NCT01520740|LVRS|lvrs
5445666|NCT01520740|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5445667|NCT01520740|BLVR|blvr
5445668|NCT01520740|Upper Lobe Predominant|upper lobe predominant
5445669|NCT01520740|ULP|ulp
5445670|NCT01520740|Heterogeneous|heterogeneous
5445671|NCT01520740|Homogeneous|homogeneous
5445674|NCT01520714|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5445675|NCT01520714|BiVentricular Implantable Cardioverter Defibrillator (BiVICD)|biventricular implantable cardioverter defibrillator (bivicd)
5445676|NCT01520714|Fraction|fraction
5445677|NCT01520701|head and neck cancer|head and neck cancer
5445678|NCT01520701|Hydrotac®|hydrotac®
5445679|NCT01520701|radiodermatitis|radiodermatitis
5445680|NCT01520701|algia|algia
5445681|NCT01520701|radiotherapy|radiotherapy
5445682|NCT01520688|Mild persistent or mild intermittent asthma|mild persistent or mild intermittent asthma
5445683|NCT01520675|chronic pancreatitis|chronic pancreatitis
5445684|NCT01520675|randomized controlled trial|randomized controlled trial
5445685|NCT01520675|endoscopic therapy|endoscopic therapy
5445686|NCT01520675|surgery|surgery
5445687|NCT01520675|ESWL|eswl
5445688|NCT01520662|patient-centered care|patient-centered care
5445690|NCT01520662|preventive services|preventive services
5445691|NCT01520662|primary care|primary care
5445692|NCT01520662|To accomplish Aim 2, we will conduct a nine-month pre-post|to accomplish aim 2, we will conduct a nine-month pre-post
5445693|NCT01520662|randomized controlled trial (RCT) in four primary care|randomized controlled trial (rct) in four primary care
5445694|NCT01520662|practices. The study will focus on the impact of a patient|practices. the study will focus on the impact of a patient
5445695|NCT01520662|Wellness Portal on the quantity and quality of preventive|wellness portal on the quantity and quality of preventive
5445696|NCT01520662|care patients receive in primary care practices.|care patients receive in primary care practices.
5445697|NCT01520649|Neurogenesis|neurogenesis
5445698|NCT01520649|hippocampal stem cells|hippocampal stem cells
5445699|NCT01520649|depression|depression
5445700|NCT01520649|stroke|stroke
5445701|NCT01520636|stroke|stroke
5445702|NCT01520636|early rehabilitation|early rehabilitation
5445703|NCT01520636|motor recovery|motor recovery
5445704|NCT01520636|functional recovery|functional recovery
5445705|NCT01520623|Allogeneic haematopoietic stem cell transplantation (HSCT)|allogeneic haematopoietic stem cell transplantation (hsct)
5789034|NCT00150163|Lipid and glucose metabolism|lipid and glucose metabolism
5445706|NCT01520623|Myeloablative conditioning for an haematological malignancy|myeloablative conditioning for an haematological malignancy
5445708|NCT01520623|Activation of complement system|activation of complement system
5445709|NCT01520623|Gut GVHD|gut gvhd
5445710|NCT01520610|Tako-TSUBO Cardiomyopathy|tako-tsubo cardiomyopathy
5445711|NCT01520610|Stress Cardiomyopathy|stress cardiomyopathy
5445712|NCT01520610|Myocardiopathies|myocardiopathies
5445713|NCT01520610|Acute Coronary Syndrome|acute coronary syndrome
5445714|NCT01520610|Gene|gene
5445715|NCT01520597|Multicentric|multicentric
5445716|NCT01520597|National|national
5445717|NCT01520597|Prospective on|prospective on
5445718|NCT01520597|Listeriosis|listeriosis
5445719|NCT01520597|Listeria|listeria
5445720|NCT01520571|Computer Assistance|computer assistance
5445721|NCT01520571|Total Knee Arthroplasty|total knee arthroplasty
5445722|NCT01520571|conventional|conventional
5445723|NCT01520558|Acute Myeloid Leukemia|acute myeloid leukemia
5445724|NCT01520558|High Risk Relapse|high risk relapse
5445725|NCT01520558|Complete Remission|complete remission
5445726|NCT01520558|Allogeneic Natural Killer Cells|allogeneic natural killer cells
5445727|NCT01520545|Gablofen|gablofen
5445728|NCT01520545|baclofen injection|baclofen injection
5445729|NCT01520519|Leukemia|leukemia
5445730|NCT01520519|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5445732|NCT01520519|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5445734|NCT01520519|Rituximab|rituximab
5445735|NCT01520519|Rituxan|rituxan
5445736|NCT01520519|PCI-32765|pci-32765
5445737|NCT01520506|Hypertension|hypertension
5445738|NCT01520506|Kidney Diseases|kidney diseases
5445739|NCT01520506|Kidney Failure, Chronic|kidney failure, chronic
5445740|NCT01520506|Vascular Diseases|vascular diseases
5445741|NCT01520506|Cardiovascular Diseases|cardiovascular diseases
5445742|NCT01520506|Urologic Diseases|urologic diseases
5445743|NCT01520506|Renal Insufficiency, Chronic|renal insufficiency, chronic
5445744|NCT01520506|Renal Insufficiency|renal insufficiency
5445745|NCT01520493|pulmonary arterial hypertension|pulmonary arterial hypertension
5445746|NCT01520493|skeletal muscle microcirculation|skeletal muscle microcirculation
5445747|NCT01520493|exercise induced blood flow|exercise induced blood flow
5445748|NCT01520480|survival after surgery|survival after surgery
5445749|NCT01520480|Pathological Subtrochanteric Fractures|pathological subtrochanteric fractures
5445750|NCT01520467|SRS|srs
5445751|NCT01520467|PWS|pws
5445752|NCT01520467|pathological adrenarche|pathological adrenarche
5445753|NCT01520467|aromatase inhibitor|aromatase inhibitor
5445754|NCT01520467|Children|children
5445755|NCT01520454|Leptin resistance|leptin resistance
5445756|NCT01520454|Free fatty acids|free fatty acids
5445757|NCT01520454|Lipotoxicity|lipotoxicity
5445758|NCT01520441|Botulinum Toxin|botulinum toxin
5445759|NCT01520441|Prostate Cancer|prostate cancer
5445760|NCT01520441|BPH|bph
5445761|NCT01520441|LUTS|luts
5445762|NCT01520402|Genetic Determinants of Warfarin Dose Variability|genetic determinants of warfarin dose variability
5445763|NCT01520389|cancer|cancer
5445764|NCT01520389|solid tumors|solid tumors
5445765|NCT01520389|oncology|oncology
5445767|NCT01520389|EGFR|egfr
5445768|NCT01520389|EGF receptor (ErbB1)|egf receptor (erbb1)
5445769|NCT01520389|irinotecan|irinotecan
5445770|NCT01520363|Rett syndrome|rett syndrome
5445771|NCT01520363|RTT|rtt
5445772|NCT01520363|MECP2|mecp2
5445773|NCT01520363|dextromethorphan|dextromethorphan
5445774|NCT01520363|DM|dm
5445775|NCT01520311|Coronary Artery Disease|coronary artery disease
5445776|NCT01520311|Myocardial Ischemia|myocardial ischemia
5445777|NCT01520311|Coronary Disease|coronary disease
5445778|NCT01520311|Heart Diseases|heart diseases
5445779|NCT01520311|Cardiovascular Diseases|cardiovascular diseases
5445780|NCT01520311|Arteriosclerosis|arteriosclerosis
5445781|NCT01520311|Arterial Occlusive Diseases|arterial occlusive diseases
5445782|NCT01520311|Vascular Diseases|vascular diseases
5445783|NCT01520311|CABG|cabg
5445784|NCT01520311|SVG|svg
5445785|NCT01520311|eSVS Mesh|esvs mesh
5445786|NCT01520311|Bypass Grafting|bypass grafting
5445787|NCT01520285|hypertension|hypertension
5445788|NCT01520285|Blood pressure decrease|blood pressure decrease
5445789|NCT01520285|efficacy|efficacy
5445790|NCT01520272|HPV18 Immunogenicity|hpv18 immunogenicity
5445791|NCT01520272|HPV16 Immunogenicity|hpv16 immunogenicity
5445792|NCT01520272|Bivalent HPV16/18 Vaccine|bivalent hpv16/18 vaccine
5445793|NCT01520272|Less than 3 Dosed of the Bivalent HPV Vaccine|less than 3 dosed of the bivalent hpv vaccine
5445794|NCT01520272|HP Vaccine|hp vaccine
5445795|NCT01520259|Gallbaldder|gallbaldder
5445796|NCT01520259|Gallstones|gallstones
5445797|NCT01520259|Inflammation|inflammation
5445798|NCT01520259|Cholecystectomy|cholecystectomy
5445799|NCT01520259|Cancer|cancer
5445800|NCT01520259|Gallbaldder Cancer|gallbaldder cancer
5445801|NCT01520246|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5445802|NCT01520246|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5445803|NCT01520246|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5445806|NCT01520233|recurrent neuroblastoma|recurrent neuroblastoma
5445807|NCT01520233|regional neuroblastoma|regional neuroblastoma
5445808|NCT01520233|stage 4S neuroblastoma|stage 4s neuroblastoma
5445809|NCT01520194|genital warts|genital warts
5445811|NCT01520194|psychosocial burden|psychosocial burden
5445812|NCT01520194|economic burden|economic burden
5445813|NCT01520194|female genital warts|female genital warts
5445814|NCT01520168|Incisional hernia|incisional hernia
5445815|NCT01520168|Mesh|mesh
5445816|NCT01520168|Surgery|surgery
5445817|NCT01520168|Composix Kugel|composix kugel
5445818|NCT01520168|IPOM technique|ipom technique
5445819|NCT01520155|lupus erythematosus|lupus erythematosus
5445820|NCT01520155|cardiovascular risk|cardiovascular risk
5445821|NCT01520142|Healthy participants|healthy participants
5445822|NCT01520142|Pharmacodynamic|pharmacodynamic
5445823|NCT01520142|Pharmacokinetics|pharmacokinetics
5445824|NCT01520142|Intravenous Endotoxin-Induced Model|intravenous endotoxin-induced model
5445825|NCT01520142|Acute Inflammation|acute inflammation
5445826|NCT01520142|JNJ-26528398|jnj-26528398
5445827|NCT01520142|Anti-inflammatory|anti-inflammatory
5445828|NCT01520129|Bipolar Disorder|bipolar disorder
5445829|NCT01520129|Bipolar NOS|bipolar nos
5445830|NCT01520129|Bipolar Depression|bipolar depression
5445831|NCT01520103|Metastatic breast cancer|metastatic breast cancer
5445832|NCT01520103|locally advanced breast cancer|locally advanced breast cancer
5445833|NCT01520103|Her2/new negative|her2/new negative
5445834|NCT01520103|HER2 negative|her2 negative
5445835|NCT01520090|contraception|contraception
5445836|NCT01520090|family planning|family planning
5445837|NCT01520090|egyptian|egyptian
5445838|NCT01520090|knowledge|knowledge
5445839|NCT01520077|alopecia areata|alopecia areata
5445840|NCT01520077|vytorin|vytorin
5445841|NCT01520077|statin|statin
5445842|NCT01520077|hair growth|hair growth
5445843|NCT01520064|Emphysema|emphysema
5445844|NCT01520064|GOLD Stage III|gold stage iii
5445845|NCT01520064|GOLD Stage IV|gold stage iv
5445846|NCT01520064|AeriSeal System|aeriseal system
5445847|NCT01520064|Homogeneous|homogeneous
5445848|NCT01520064|Heterogeneous|heterogeneous
5445849|NCT01520064|Upper Lobe Predominant|upper lobe predominant
5445850|NCT01520064|ULP|ulp
5445851|NCT01520064|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5445852|NCT01520064|COPD|copd
5445853|NCT01520064|Lung Volume Reduction Surgery|lung volume reduction surgery
5445854|NCT01520064|LVRS|lvrs
5445855|NCT01520064|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5445856|NCT01520064|BLVR|blvr
5445857|NCT01520051|Asthma|asthma
5445858|NCT01520051|Viral|viral
5445859|NCT01520051|Infection|infection
5445860|NCT01520051|Inflammation|inflammation
5445861|NCT01520051|Mepolizumab|mepolizumab
5445862|NCT01520051|Eosinophilia|eosinophilia
5445863|NCT01520025|Radiopharmaceutical|radiopharmaceutical
5445864|NCT01520025|18FDG PET|18fdg pet
5445865|NCT01520025|CTA|cta
5445866|NCT01520025|Multi-modality imaging|multi-modality imaging
5445867|NCT01520025|Metabolic Imaging of Ischemia|metabolic imaging of ischemia
5418077|NCT01640431|TENS|tens
5446755|NCT01516502|acupoint|acupoint
5445872|NCT01519999|Patient-Centered Care|patient-centered care
5428593|NCT01594177|GBG|gbg
5445873|NCT01519999|Community-wide intervention|community-wide intervention
5445874|NCT01519999|Intervention Study|intervention study
5445875|NCT01519999|Longitudinal Studies|longitudinal studies
5445877|NCT01519986|Cholecalciferol|cholecalciferol
5445878|NCT01519986|Supplementation|supplementation
5445879|NCT01519986|Dietary Supplements|dietary supplements
5445880|NCT01519986|Dietary Fats|dietary fats
5445881|NCT01519986|25-hydroxyvitamin D|25-hydroxyvitamin d
5445882|NCT01519973|Diagnostic imaging|diagnostic imaging
5445883|NCT01519973|Single Photon Emission Computed Tomography|single photon emission computed tomography
5445884|NCT01519973|Positron emission tomography|positron emission tomography
5846733|NCT00043641|HIV|hiv
5445885|NCT01519973|Computed tomography|computed tomography
5445886|NCT01519973|Attenuation|attenuation
5445887|NCT01519973|Resolution|resolution
5445888|NCT01519973|Scatter|scatter
5445889|NCT01519973|Radiopharmaceutical|radiopharmaceutical
5445890|NCT01519934|Ulthera® System|ulthera® system
5445891|NCT01519934|Ultherapy™ Treatment|ultherapy™ treatment
5445892|NCT01519934|Ulthera, Inc.|ulthera, inc.
5445893|NCT01519934|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5445894|NCT01519908|cardiac resynchronization therapy|cardiac resynchronization therapy
5445895|NCT01519908|biomarkers|biomarkers
5445896|NCT01519908|response|response
5445897|NCT01519895|quality of life|quality of life
5445898|NCT01519895|anxiety|anxiety
5445899|NCT01519895|stress|stress
5445900|NCT01519895|carers|carers
5445901|NCT01519895|colorectal or colon cancer|colorectal or colon cancer
5445902|NCT01519882|Rotigotine|rotigotine
5445903|NCT01519882|Neupro|neupro
5445904|NCT01519882|Polysomnography|polysomnography
5445905|NCT01519882|Sleep efficiency|sleep efficiency
5445906|NCT01519882|Advanced Idiopathic Parkinson's Disease|advanced idiopathic parkinson's disease
5445907|NCT01519882|Sleep Disorder|sleep disorder
5445914|NCT01519856|open|open
5445915|NCT01519856|non-intervention|non-intervention
5445916|NCT01519856|observational|observational
5445917|NCT01519843|stroke|stroke
5445918|NCT01519830|Anemia, Iron-Deficiency|anemia, iron-deficiency
5445919|NCT01519830|Blood Donors|blood donors
5445920|NCT01519817|Vaccine Therapy|vaccine therapy
5445921|NCT01519817|Dose-Limiting Toxicity|dose-limiting toxicity
5445922|NCT01519817|Maximum Tolerated Dose|maximum tolerated dose
5445923|NCT01519817|Clinical Response|clinical response
5445924|NCT01519817|Immune Response|immune response
5445925|NCT01519817|Cancer|cancer
5445926|NCT01519817|Solid Tumor|solid tumor
5445927|NCT01519791|Certolizumab Pegol - Cimzia|certolizumab pegol - cimzia
5445928|NCT01519791|Methotrexate|methotrexate
5445929|NCT01519791|Rheumatoid Arthritis|rheumatoid arthritis
5445930|NCT01519752|Tinea Pedis|tinea pedis
5445931|NCT01519713|Meningitis|meningitis
5445932|NCT01519713|Meningococcal Meningitis|meningococcal meningitis
5445933|NCT01519713|Meningococcal Infections|meningococcal infections
5445934|NCT01519713|Meningococcal conjugate Vaccine|meningococcal conjugate vaccine
5445935|NCT01519713|Menactra®|menactra®
5445936|NCT01519700|Filgrastim|filgrastim
5445937|NCT01519700|G-CSF, neutropenia|g-csf, neutropenia
5445938|NCT01519700|supportive care|supportive care
5445939|NCT01519700|breast cancer|breast cancer
5445940|NCT01519687|hyperuricemia|hyperuricemia
5445941|NCT01519687|gout|gout
5445942|NCT01519687|levotofisopam|levotofisopam
5445943|NCT01519661|Tobramycin Inhalation powder|tobramycin inhalation powder
5445944|NCT01519661|Cystic fibrosis|cystic fibrosis
5445945|NCT01519661|Lung disease|lung disease
5445946|NCT01519661|Anti-bacterial agents|anti-bacterial agents
5445947|NCT01519648|Invasive fungal infection|invasive fungal infection
5445948|NCT01519648|Acute leukemia (AL)|acute leukemia (al)
5445949|NCT01519648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5445950|NCT01519648|Antifungal stewardship|antifungal stewardship
5445951|NCT01519648|Neutropenia|neutropenia
5445952|NCT01519648|Hematological malignancies|hematological malignancies
5445953|NCT01519635|Kidney oxygenation|kidney oxygenation
5445954|NCT01519635|Stage 1 or 2 hypertension|stage 1 or 2 hypertension
5445955|NCT01519635|BOLD-IRM|bold-irm
5445956|NCT01519622|End of life decisions|end of life decisions
5445957|NCT01519622|Perception of illness|perception of illness
5445958|NCT01519609|Bowel prep|bowel prep
5445959|NCT01519609|Safety|safety
5445960|NCT01519609|Efficacy|efficacy
5445961|NCT01519583|walking|walking
5445962|NCT01519583|physical activity|physical activity
5445963|NCT01519583|sedentary behavior|sedentary behavior
5445964|NCT01519570|Herpes Zoster vaccine|herpes zoster vaccine
5445965|NCT01519570|Electronic patient portal|electronic patient portal
5447154|NCT01514695|narcotic|narcotic
5445966|NCT01519570|Electronic medical record|electronic medical record
5445967|NCT01519570|Primary care|primary care
5445968|NCT01519570|Immunizations|immunizations
5445969|NCT01519544|Sleep|sleep
5445970|NCT01519544|High Altitude|high altitude
5445971|NCT01519544|High-altitude Sleep Disturbance|high-altitude sleep disturbance
5445972|NCT01519544|Acute Mountain Sickness|acute mountain sickness
5445973|NCT01519544|Difficulty Sleeping at High Altitude|difficulty sleeping at high altitude
5445974|NCT01519544|Periodic Breathing|periodic breathing
5445976|NCT01519544|Acetazolamide|acetazolamide
5445977|NCT01519544|Temazepam|temazepam
5445978|NCT01519544|Groningen Sleep Quality Questionnaire survey|groningen sleep quality questionnaire survey
5445979|NCT01519544|Stanford Sleepiness Scale|stanford sleepiness scale
5445980|NCT01519544|Lake Louise Acute Mountain Sickness Score|lake louise acute mountain sickness score
5445981|NCT01519518|ST elevation myocardial infarction|st elevation myocardial infarction
5445982|NCT01519518|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5445983|NCT01519518|Unfractionated heparin|unfractionated heparin
5445984|NCT01519518|Bivalirudin|bivalirudin
5445985|NCT01519518|primary angioplasty|primary angioplasty
5445986|NCT01519505|Prevention|prevention
5445987|NCT01519505|Diabetes mellitus|diabetes mellitus
5445988|NCT01519505|Lifestyle changes|lifestyle changes
5445989|NCT01519505|Cardiovascular risk|cardiovascular risk
5445990|NCT01519505|Cost-effectiveness|cost-effectiveness
5445991|NCT01519492|Skin and Subcutaneous Tissue Bacterial Infections|skin and subcutaneous tissue bacterial infections
5445992|NCT01519479|Congestive Heart Failure|congestive heart failure
5445993|NCT01519479|Heart Failure|heart failure
5445994|NCT01519479|Palliative Care|palliative care
5445995|NCT01519479|Palliative Medicine|palliative medicine
5445996|NCT01519466|Diabetes|diabetes
5445997|NCT01519466|SMBG|smbg
5445998|NCT01519466|Insulin calculator|insulin calculator
5445999|NCT01519453|Asthma|asthma
5446000|NCT01519453|Preschool|preschool
5446001|NCT01519453|Health Disparities|health disparities
5446002|NCT01519453|Implementation|implementation
5446003|NCT01519440|unintended extension|unintended extension
5446004|NCT01519440|blunt|blunt
5446005|NCT01519440|sharp|sharp
5446008|NCT01519401|drospirenone ethinylestradiol|drospirenone ethinylestradiol
5446009|NCT01519401|androgens|androgens
5446010|NCT01519401|metabolism|metabolism
5446011|NCT01519388|Neuromuscular disorder|neuromuscular disorder
5446012|NCT01519388|Respiratory failure|respiratory failure
5446013|NCT01519388|Swallowing|swallowing
5446014|NCT01519388|Mechanical ventilation|mechanical ventilation
5446015|NCT01519375|Osteoarthritis|osteoarthritis
5446016|NCT01519375|Rheumatoid Arthritis|rheumatoid arthritis
5446017|NCT01519375|Ankylosing Spondylitis|ankylosing spondylitis
5446018|NCT01519362|Polyacrylamide hydrogel|polyacrylamide hydrogel
5446019|NCT01519362|leukocytopenia|leukocytopenia
5446020|NCT01519362|migration|migration
5446021|NCT01519362|complication|complication
5446022|NCT01519362|epicranial aponeurosis|epicranial aponeurosis
5446023|NCT01519362|PAAG injection|paag injection
5446024|NCT01519349|Becker muscular dystrophy|becker muscular dystrophy
5446025|NCT01519349|BMD|bmd
5446026|NCT01519349|muscular dystrophy|muscular dystrophy
5446027|NCT01519349|inclusion body myositis|inclusion body myositis
5446028|NCT01519349|IBM|ibm
5446029|NCT01519349|Follistatin|follistatin
5446030|NCT01519310|choline metabolism|choline metabolism
5446031|NCT01519310|gut flora|gut flora
5446032|NCT01519310|phosphatidylcholine|phosphatidylcholine
5446033|NCT01519310|lecithin|lecithin
5446034|NCT01519297|Preeclampsia|preeclampsia
5446035|NCT01519297|Pregnancy Induced Hypertension|pregnancy induced hypertension
5446036|NCT01519284|Parkinson Disease|parkinson disease
5446037|NCT01519284|BIA 9-1067|bia 9-1067
5446038|NCT01519271|Parkinson's Disease|parkinson's disease
5446039|NCT01519271|Mild Cognitive Impairment|mild cognitive impairment
5446040|NCT01519271|Cognition|cognition
5446041|NCT01519271|Memory|memory
5446042|NCT01519271|Attention|attention
5446043|NCT01519271|Exelon|exelon
5446044|NCT01519271|Rivastigmine|rivastigmine
5446045|NCT01519258|ARDS|ards
5446046|NCT01519245|coronary artery bypass grafting|coronary artery bypass grafting
5446047|NCT01519245|tranexamic acid|tranexamic acid
5446048|NCT01519245|antifibrinolytic|antifibrinolytic
5446049|NCT01519245|administration, topical|administration, topical
5446050|NCT01519245|operative blood salvage|operative blood salvage
5446051|NCT01519232|hepatocellular carcinoma|hepatocellular carcinoma
5446052|NCT01519219|hepatic irradiation|hepatic irradiation
5446053|NCT01519219|IC-GREEN|ic-green
5446055|NCT01519206|Ultherapy™ Treatment|ultherapy™ treatment
5446056|NCT01519206|Ulthera, Inc.|ulthera, inc.
5446057|NCT01519193|Aggressive Behavior|aggressive behavior
5446058|NCT01519193|Appetitive Aggression|appetitive aggression
5446059|NCT01519193|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5446060|NCT01519180|gastroparesis|gastroparesis
5446061|NCT01519180|gastric emptying|gastric emptying
5446062|NCT01519180|antro-duodenal manometry|antro-duodenal manometry
5447258|NCT01514149|diabetes|diabetes
5446063|NCT01519154|deep sedation|deep sedation
5446064|NCT01519154|propofol|propofol
5446065|NCT01519154|ketamine|ketamine
5446066|NCT01519154|child|child
5446067|NCT01519154|preschool child|preschool child
5446068|NCT01519154|infant|infant
5446069|NCT01519154|recovery and quality of sedation|recovery and quality of sedation
5446070|NCT01519141|Human Immunodeficiency Virus|human immunodeficiency virus
5446071|NCT01519141|Atherosclerosis|atherosclerosis
5446072|NCT01519141|Inflammation|inflammation
5446073|NCT01519141|Endothelial Function|endothelial function
5446074|NCT01519141|Thrombosis|thrombosis
5446075|NCT01519128|Healthy|healthy
5446076|NCT01519128|TMC278|tmc278
5446077|NCT01519128|TMC278IFD1001|tmc278ifd1001
5446078|NCT01519128|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
5446079|NCT01519128|Pharmacokinetics|pharmacokinetics
5446080|NCT01519128|Digoxin|digoxin
5446081|NCT01519115|deep cervical flexors|deep cervical flexors
5446082|NCT01519115|spine stabilization|spine stabilization
5446083|NCT01519115|posture|posture
5446084|NCT01519115|function|function
5446085|NCT01519115|neck pain|neck pain
5449328|NCT01505660|HIV|hiv
5446086|NCT01519089|chronic|chronic
5446087|NCT01519089|severe|severe
5446088|NCT01519089|moderate|moderate
5446089|NCT01519089|treatment|treatment
5446091|NCT01519089|efficacy|efficacy
5446092|NCT01519089|CP-690|cp-690
5446094|NCT01519089|Plaque psoriasis|plaque psoriasis
5446095|NCT01519089|Psoriasis Vulgaris|psoriasis vulgaris
5446096|NCT01519089|Psoriatic Arthritis|psoriatic arthritis
5446097|NCT01519089|tofacitinib|tofacitinib
5446098|NCT01519089|Xeljanz|xeljanz
5446099|NCT01519076|stroke|stroke
5446100|NCT01519063|Alcohol|alcohol
5446101|NCT01519063|Drinking|drinking
5446102|NCT01519063|Drinkers|drinkers
5446103|NCT01519063|Alcohol Drinking|alcohol drinking
5446104|NCT01519063|Memantine|memantine
5446105|NCT01519063|Naltrexone|naltrexone
5446106|NCT01519063|Alcohol Dependence|alcohol dependence
5446107|NCT01519063|Alcohol Abuse|alcohol abuse
5446108|NCT01519063|Alcohol-Related Disorders|alcohol-related disorders
5446109|NCT01519063|Ethanol|ethanol
5446112|NCT01519037|RAAS|raas
5446113|NCT01519037|renin|renin
5446114|NCT01519037|aldosterone|aldosterone
5446115|NCT01519024|hypertrophy|hypertrophy
5446116|NCT01519024|breast|breast
5446117|NCT01519024|postural balance|postural balance
5446118|NCT01519011|Myelodysplastic Syndromes|myelodysplastic syndromes
5446119|NCT01519011|MDS|mds
5446120|NCT01519011|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5446121|NCT01519011|CMML|cmml
5590010|NCT00930670|stent|stent
5446122|NCT01519011|Acute Myeloid Leukemia|acute myeloid leukemia
5446123|NCT01519011|AML|aml
5446124|NCT01519011|Vidaza|vidaza
5446125|NCT01519011|oral azacitidine|oral azacitidine
5446126|NCT01519011|aza|aza
5446127|NCT01519011|oral aza|oral aza
5446128|NCT01519011|pharmacokinetics|pharmacokinetics
5446129|NCT01519011|hematology|hematology
5446130|NCT01519011|myeloid disease|myeloid disease
5446131|NCT01519011|PK|pk
5446132|NCT01518998|Fimasartan|fimasartan
5446133|NCT01518998|Amlodipine|amlodipine
5446134|NCT01518998|antihypertension|antihypertension
5446135|NCT01518972|Alcohol|alcohol
5446136|NCT01518972|Abuse|abuse
5446137|NCT01518972|Use|use
5446138|NCT01518972|Disorder|disorder
5446139|NCT01518972|Dependence|dependence
5446140|NCT01518972|Symptoms|symptoms
5446141|NCT01518972|Alcoholic|alcoholic
5446142|NCT01518972|Alcoholism|alcoholism
5446143|NCT01518972|Prazosin|prazosin
5446144|NCT01518972|Drug|drug
5446145|NCT01518972|Medicine|medicine
5446146|NCT01518972|Medication|medication
5446147|NCT01518972|Treatment|treatment
5446148|NCT01518972|Study|study
5446149|NCT01518972|Placebo|placebo
5446150|NCT01518972|Medical|medical
5446151|NCT01518972|Management|management
5446152|NCT01518972|Craving|craving
5446153|NCT01518972|Consumption|consumption
5446154|NCT01518972|Binge|binge
5446155|NCT01518972|Drinking|drinking
5446156|NCT01518972|Drink|drink
5446157|NCT01518972|Heavy|heavy
5446158|NCT01518972|PTSD|ptsd
5446159|NCT01518972|Trauma|trauma
5446160|NCT01518972|Post|post
5446161|NCT01518972|Posttraumatic|posttraumatic
5446162|NCT01518946|Symptomatic Orthostatic Hypotension|symptomatic orthostatic hypotension
5446163|NCT01518933|HCV recurrence|hcv recurrence
5446164|NCT01518933|stable liver transplanted patients|stable liver transplanted patients
5446165|NCT01518920|Age related sensorineural hearing loss|age related sensorineural hearing loss
5446166|NCT01518920|PF-04958242|pf-04958242
5446167|NCT01518907|cellulite|cellulite
5446168|NCT01518907|Xiaflex|xiaflex
5446169|NCT01518894|PF-04958242|pf-04958242
5446170|NCT01518894|multiple dose|multiple dose
5446171|NCT01518894|Safety|safety
5446172|NCT01518894|schizophrenia|schizophrenia
5446173|NCT01518842|ischemic retinopathy, stem cell,bone marrow|ischemic retinopathy, stem cell,bone marrow
5446174|NCT01518829|hepatocellular carcinom|hepatocellular carcinom
5446175|NCT01518829|postablation syndrom|postablation syndrom
5446176|NCT01518829|procalcitonin|procalcitonin
5446177|NCT01518816|antioxidant preterm labor|antioxidant preterm labor
5446178|NCT01518803|Obesity|obesity
5446179|NCT01518803|Adolescence|adolescence
5446180|NCT01518803|Lipid metabolism|lipid metabolism
5446181|NCT01518803|Mediterranean diet|mediterranean diet
5446182|NCT01518803|Chylomicron|chylomicron
5446183|NCT01518803|Macrophages|macrophages
5446184|NCT01518790|PEG 3350|peg 3350
5446185|NCT01518790|boston bowel preparation scale|boston bowel preparation scale
5446186|NCT01518790|colonoscopy cleanout|colonoscopy cleanout
5446187|NCT01518790|bowel preparation|bowel preparation
5446188|NCT01518790|miralax|miralax
5446189|NCT01518790|gatorade|gatorade
5446190|NCT01518790|cleanout efficacy|cleanout efficacy
5446191|NCT01518790|Focus of study is efficacy of PEG 3350 cleanout for improving diagnostic yield of colonoscopy.|focus of study is efficacy of peg 3350 cleanout for improving diagnostic yield of colonoscopy.
5446192|NCT01518777|Coronary Artery Disease|coronary artery disease
5446193|NCT01518725|Muscle Power|muscle power
5446194|NCT01518725|Vitamin D|vitamin d
5446195|NCT01518725|Vitamins|vitamins
5446199|NCT01518712|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5446201|NCT01518686|Norm values|norm values
5446202|NCT01518686|semi-automated kinetic perimetry|semi-automated kinetic perimetry
5446203|NCT01518686|isopters|isopters
5446204|NCT01518686|mathematical model|mathematical model
5446205|NCT01518686|luminance|luminance
5446206|NCT01518686|test-retest reliability|test-retest reliability
5446207|NCT01518686|deviation|deviation
5446208|NCT01518686|age dependance|age dependance
5446209|NCT01518686|different age groups|different age groups
5446210|NCT01518686|Healthy subjects|healthy subjects
5446211|NCT01518660|Resistance Training|resistance training
5446212|NCT01518660|Strength Training|strength training
5446213|NCT01518647|Bodily Distress Syndrome|bodily distress syndrome
5446214|NCT01518647|Medically unexplained symptoms|medically unexplained symptoms
5446215|NCT01518647|Functional somatic symptoms|functional somatic symptoms
5446216|NCT01518647|Functional somatic syndromes|functional somatic syndromes
5446218|NCT01518647|Acceptance and Commitment Therapy|acceptance and commitment therapy
5446220|NCT01518634|Medically unexplained symptoms|medically unexplained symptoms
5446221|NCT01518634|Functional somatic symptoms|functional somatic symptoms
5446222|NCT01518634|Functional somatic syndromes|functional somatic syndromes
5446223|NCT01518634|Treatment|treatment
5446224|NCT01518634|Imipramine|imipramine
5446225|NCT01518634|Tricyclic antidepressant|tricyclic antidepressant
5446226|NCT01518608|Alfentanil|alfentanil
5446227|NCT01518608|Tracheal intubation|tracheal intubation
5446228|NCT01518608|Rapid sequence induction|rapid sequence induction
5446229|NCT01518595|patients|patients
5446230|NCT01518582|Cervicobrachial|cervicobrachial
5446231|NCT01518582|neuralgia|neuralgia
5446232|NCT01518582|symptomatic cervical discopathy|symptomatic cervical discopathy
5446233|NCT01518569|ulinastatin|ulinastatin
5446234|NCT01518569|systemic inflammation|systemic inflammation
5446235|NCT01518569|cardiac surgery|cardiac surgery
5446236|NCT01518569|cardiopulmonary bypass|cardiopulmonary bypass
5446237|NCT01518556|Idarubicin|idarubicin
5446238|NCT01518556|Remission Induction|remission induction
5446239|NCT01518556|Maximum Tolerated Dose|maximum tolerated dose
5446240|NCT01518556|Survival|survival
5446241|NCT01518543|arthrodesis|arthrodesis
5446242|NCT01518543|arthrodesis in the following joints:Ankle, 1st MTP, Metatarso - Cuneiform (1st), Navicular - Cuneiform, Talo-Navicular, Calcaneum - Cuboid;|arthrodesis in the following joints:ankle, 1st mtp, metatarso - cuneiform (1st), navicular - cuneiform, talo-navicular, calcaneum - cuboid;
5446243|NCT01518530|Chronic Neck Pain, Occiflex, Computerized Mobilization|chronic neck pain, occiflex, computerized mobilization
5446244|NCT01518517|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5446245|NCT01518517|relapse|relapse
5446246|NCT01518517|asparaginase|asparaginase
5446247|NCT01518504|Thoracic|thoracic
5446248|NCT01518504|Manipulation|manipulation
5446249|NCT01518504|Manual Therapy|manual therapy
5446250|NCT01518504|Mobilization|mobilization
5446251|NCT01518504|Shoulder|shoulder
5446252|NCT01518504|Range of Motion|range of motion
5446253|NCT01518452|working memory training, computerized|working memory training, computerized
5446254|NCT01518452|clinical assessment|clinical assessment
5446255|NCT01518452|quantitative EEG|quantitative eeg
5446256|NCT01518452|child, preschool|child, preschool
5446257|NCT01518439|neuromuscular|neuromuscular
5446259|NCT01518439|restrictive|restrictive
5446260|NCT01518426|Brain computer interface|brain computer interface
5446261|NCT01518426|EEG recording|eeg recording
5446262|NCT01518426|Electrodes|electrodes
5446263|NCT01518413|Sora./Irino. combination therapy|sora./irino. combination therapy
5446264|NCT01518400|Pediatric Cancer|pediatric cancer
5446265|NCT01518400|Cancer Late Effects|cancer late effects
5446266|NCT01518400|Cancer Survivor|cancer survivor
5446267|NCT01518400|Cancer Survivorship|cancer survivorship
5447259|NCT01514149|ConjuChem|conjuchem
5446268|NCT01518387|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
5446269|NCT01518374|Male or female subjects at least 18 years of age|male or female subjects at least 18 years of age
5446271|NCT01518374|MCI|mci
5446272|NCT01518348|Patch Test|patch test
5446273|NCT01518348|Contact Dermatitis|contact dermatitis
5446274|NCT01518348|Allergy|allergy
5446275|NCT01518348|Children|children
5446276|NCT01518348|PREA|prea
5446277|NCT01518335|platelet rich plasma|platelet rich plasma
5446278|NCT01518335|ankle|ankle
5446279|NCT01518335|sprain|sprain
5446280|NCT01518335|injection|injection
5446281|NCT01518335|Platelet Rich Plasma therapy|platelet rich plasma therapy
5446282|NCT01518335|focal, invasive therapy for sprains|focal, invasive therapy for sprains
5446283|NCT01518322|Asthma|asthma
5446284|NCT01518322|Fractional Exhaled Nitric Oxide|fractional exhaled nitric oxide
5446285|NCT01518322|Respiratory Symptoms|respiratory symptoms
5446286|NCT01518322|NIOX MINO|niox mino
5446287|NCT01518322|Inhaled corticosteroids|inhaled corticosteroids
5446288|NCT01518322|Nitric Oxide|nitric oxide
5446289|NCT01518296|Pelvic Organ Prolapse Quantification (POPQ)|pelvic organ prolapse quantification (popq)
5446290|NCT01518296|POPQ|popq
5446291|NCT01518296|Urodynamic test|urodynamic test
5446292|NCT01518283|Weekly cabazitaxel.|weekly cabazitaxel.
5446293|NCT01518283|Advanced Hormone-refractory prostate Cancer.|advanced hormone-refractory prostate cancer.
5446294|NCT01518283|Unfit patients.|unfit patients.
5446295|NCT01518244|Primary open angle-glaucoma|primary open angle-glaucoma
5446296|NCT01518244|Ocular hypertension|ocular hypertension
5446297|NCT01518244|Pigment dispersion glaucoma|pigment dispersion glaucoma
5446298|NCT01518231|stroke|stroke
5446299|NCT01518231|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5446300|NCT01518218|Sickle cell disease|sickle cell disease
5446301|NCT01518218|laying-on-of-hands|laying-on-of-hands
5446302|NCT01518218|morbidity|morbidity
5446303|NCT01518218|mortality|mortality
5446304|NCT01518205|diabetic foot ulcers,|diabetic foot ulcers,
5446305|NCT01518205|peripheral arterial disease,|peripheral arterial disease,
5789035|NCT00150150|Interventional ultrasound|interventional ultrasound
5446307|NCT01518205|inflammatory markers|inflammatory markers
5446308|NCT01518205|type 2 diabetes|type 2 diabetes
5446309|NCT01518205|LDL-cholesterol|ldl-cholesterol
5446310|NCT01518192|erythema migrans|erythema migrans
5446311|NCT01518192|doxycycline|doxycycline
5446312|NCT01518192|cefuroxime axetil|cefuroxime axetil
5446313|NCT01518192|post-Lyme disease symptoms|post-lyme disease symptoms
5446314|NCT01518192|background symptoms in general population|background symptoms in general population
5446315|NCT01518179|Colles' Fracture|colles' fracture
5446316|NCT01518179|Compression Bandages|compression bandages
5446317|NCT01518179|Occupational therapy|occupational therapy
5446318|NCT01518179|Rehabilitation|rehabilitation
5446319|NCT01518179|Smith's fracture|smith's fracture
5446320|NCT01518153|Blood and Marrow Transplantation|blood and marrow transplantation
5446321|NCT01518153|Lymphoma|lymphoma
5446322|NCT01518153|Myeloma|myeloma
5446323|NCT01518153|Myeloproliferative Diseases|myeloproliferative diseases
5446324|NCT01518153|Leukemia|leukemia
5446325|NCT01518153|Myelodysplastic syndrome|myelodysplastic syndrome
5446326|NCT01518153|MDS|mds
5446327|NCT01518153|Hodgkin disease|hodgkin disease
5446328|NCT01518153|Multiple myeloma|multiple myeloma
5446329|NCT01518153|Fludarabine|fludarabine
5446330|NCT01518153|Fludarabine Phosphate|fludarabine phosphate
5446331|NCT01518153|Fludara|fludara
5446332|NCT01518153|Melphalan|melphalan
5446333|NCT01518153|Alkeran|alkeran
5446334|NCT01518153|Tacrolimus|tacrolimus
5446335|NCT01518153|Prograf|prograf
5446336|NCT01518153|Methotrexate|methotrexate
5446337|NCT01518153|G-CSF|g-csf
5446338|NCT01518153|Filgrastim|filgrastim
5446339|NCT01518153|NeupogenTM|neupogentm
5446340|NCT01518153|Donor Lymphocyte Infusion|donor lymphocyte infusion
5446341|NCT01518153|DLI|dli
5446342|NCT01518153|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5446343|NCT01518153|Graft-vs-host disease|graft-vs-host disease
5446344|NCT01518153|GvHD|gvhd
5446345|NCT01518153|T-lymphocytes|t-lymphocytes
5446346|NCT01518153|T-cells|t-cells
5446347|NCT01518153|Alemtuzumab|alemtuzumab
5446348|NCT01518153|CAMPATH-1H|campath-1h
5446349|NCT01518153|Campath|campath
5446350|NCT01518140|Advanced Cancers|advanced cancers
5446351|NCT01518140|Locally advanced|locally advanced
5446352|NCT01518140|Recurrent|recurrent
5446353|NCT01518140|Metastatic disease|metastatic disease
5446354|NCT01518140|Oxygen Delivery Modalities|oxygen delivery modalities
5446355|NCT01518140|Shortness of breath|shortness of breath
5446356|NCT01518140|Dyspnea|dyspnea
5446357|NCT01518140|VapoTherm|vapotherm
5446358|NCT01518140|Bilevel positive airway pressure|bilevel positive airway pressure
5446359|NCT01518140|BiPAP|bipap
5446360|NCT01518140|Non-rebreather mask|non-rebreather mask
5446361|NCT01518127|Macular Degeneration|macular degeneration
5446362|NCT01518114|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5446363|NCT01518114|Exercise Training|exercise training
5446364|NCT01518114|Cardiac Rehabilitation|cardiac rehabilitation
5446365|NCT01518114|Heart Failure|heart failure
5446366|NCT01518101|patient preference|patient preference
5446367|NCT01518101|vildagliptin|vildagliptin
5446368|NCT01518101|liraglutide|liraglutide
5446369|NCT01518075|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5446370|NCT01518075|Non invasive mechanical ventilation|non invasive mechanical ventilation
5446371|NCT01518075|Breathing-swallowing interaction|breathing-swallowing interaction
5446372|NCT01518075|Intensive Care Unit|intensive care unit
5446373|NCT01518049|Affective Disorders, Psychotic|affective disorders, psychotic
5446374|NCT01518049|Psychometrics|psychometrics
5446375|NCT01518049|Biological Markers|biological markers
5446376|NCT01518023|diabetes mellitus|diabetes mellitus
5446377|NCT01518023|prediabetes|prediabetes
5446378|NCT01518023|fasting blood glucose|fasting blood glucose
5446380|NCT01518023|Roux en Y gastric bypass|roux en y gastric bypass
5446381|NCT01518023|Cancer gastrectomy|cancer gastrectomy
5446382|NCT01518023|Cancer colorectal surgery|cancer colorectal surgery
5446383|NCT01518010|Brain injury|brain injury
5446384|NCT01518010|Cognitive rehabilitation|cognitive rehabilitation
5446385|NCT01518010|Video game|video game
5446386|NCT01517997|Drug coated balloons|drug coated balloons
5446387|NCT01517997|Drug eluting stents|drug eluting stents
5446388|NCT01517984|recipients of living-donor kidney allografts|recipients of living-donor kidney allografts
5446389|NCT01517984|antithymocyte globulin (ATG) induction|antithymocyte globulin (atg) induction
5446390|NCT01517984|calcineurin inhibitors (CNIs)|calcineurin inhibitors (cnis)
5446391|NCT01517984|CNI withdrawal|cni withdrawal
5446392|NCT01517971|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5446393|NCT01517971|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5446394|NCT01517971|adenocarcinoma of the lung|adenocarcinoma of the lung
5446395|NCT01517971|squamous cell lung cancer|squamous cell lung cancer
5446396|NCT01517958|Transient tachypnea of the newborn|transient tachypnea of the newborn
5446397|NCT01517958|Respiratory Distress Syndrome|respiratory distress syndrome
5446398|NCT01517958|Lung Ultrasound|lung ultrasound
5446399|NCT01517958|Neonates|neonates
5446400|NCT01517945|Survivors|survivors
5446401|NCT01517945|Quality of Life|quality of life
5446402|NCT01517945|Questionnaire|questionnaire
5446403|NCT01517945|11-204|11-204
5446404|NCT01517919|peer support|peer support
5446405|NCT01517919|peer leader|peer leader
5446406|NCT01517919|community health worker|community health worker
5446407|NCT01517919|empowerment|empowerment
5446408|NCT01517919|self-management|self-management
5446409|NCT01517906|eating disorder behaviors|eating disorder behaviors
5446410|NCT01517906|well being|well being
5446411|NCT01517906|functional health|functional health
5446412|NCT01517893|vitiligo|vitiligo
5446413|NCT01517893|simvastatin|simvastatin
5446414|NCT01517880|Hereditary Inclusion Body Myopathy (HIBM)|hereditary inclusion body myopathy (hibm)
5446415|NCT01517880|GNE myopathies|gne myopathies
5446416|NCT01517880|distal myopathy with rimmed vacuoles [DMRV]|distal myopathy with rimmed vacuoles [dmrv]
5446417|NCT01517880|Nonaka disease|nonaka disease
5446418|NCT01517867|preschool children behavior problems|preschool children behavior problems
5446419|NCT01517867|child between 2 and 5 years old|child between 2 and 5 years old
5446420|NCT01517841|peritoneal dialysis|peritoneal dialysis
5446421|NCT01517841|modality choice|modality choice
5446422|NCT01517841|kidney disease|kidney disease
5446423|NCT01517828|Intubation|intubation
5446424|NCT01517828|Delivery room|delivery room
5446425|NCT01517828|Sedation|sedation
5446426|NCT01517828|Analgesia|analgesia
5446427|NCT01517815|Septic shock|septic shock
5446428|NCT01517815|overweight|overweight
5446429|NCT01517815|critically ill|critically ill
5446430|NCT01517815|pharmacokinetic|pharmacokinetic
5446431|NCT01517815|doripenem|doripenem
5446432|NCT01517815|piperacillin-tazobactam|piperacillin-tazobactam
5446433|NCT01517802|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5446434|NCT01517802|Metastatic breast cancer|metastatic breast cancer
5446435|NCT01517802|Abiraterone acetate|abiraterone acetate
5446436|NCT01517802|Low-dose corticosteroid treatment|low-dose corticosteroid treatment
5446437|NCT01517802|Long-term access|long-term access
5446439|NCT01517789|Optic Nerve and Pathway Injury|optic nerve and pathway injury
5446440|NCT01517789|visual event-related potential|visual event-related potential
5446441|NCT01517776|High grade glioma|high grade glioma
5446442|NCT01517776|Glioblastoma multiforme|glioblastoma multiforme
5446443|NCT01517776|Anaplastic astrocytoma|anaplastic astrocytoma
5446444|NCT01517776|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5446445|NCT01517776|Relapse|relapse
5446446|NCT01517776|refractory tumour disease|refractory tumour disease
5446447|NCT01517776|Relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas|relapsed or refractory high grade gliomas and diffuse intrinsic pontine gliomas
5446448|NCT01517763|Obstructive Sleep Apnea|obstructive sleep apnea
5446449|NCT01517763|Humidification|humidification
5446450|NCT01517763|Continuous Positive Airway Pressure|continuous positive airway pressure
5446451|NCT01517763|ICON|icon
5446452|NCT01517763|ThermoSmart|thermosmart
5446453|NCT01517763|SensAwake|sensawake
5446454|NCT01517750|Obstructive Sleep Apnea|obstructive sleep apnea
5446455|NCT01517750|Humidification|humidification
5446756|NCT01516502|trigger point|trigger point
5446456|NCT01517750|Continuous Positive Airway Pressure|continuous positive airway pressure
5446457|NCT01517750|ICON|icon
5446458|NCT01517750|ThermoSmart|thermosmart
5446459|NCT01517724|MM|mm
5446460|NCT01517724|HDT|hdt
5446461|NCT01517724|ASCT|asct
5446462|NCT01517724|consolidation|consolidation
5446463|NCT01517724|bortezomib|bortezomib
5446464|NCT01517711|pharmacotherapy|pharmacotherapy
5446465|NCT01517711|combat disorders|combat disorders
5446466|NCT01517685|Eicosapentaenoic acid|eicosapentaenoic acid
5446468|NCT01517685|Docosahexaenoic acid|docosahexaenoic acid
5446469|NCT01517685|DHA|dha
5446470|NCT01517685|Omega 3 fat|omega 3 fat
5446471|NCT01517685|alpha-linoleic acid|alpha-linoleic acid
5446472|NCT01517685|ALA|ala
5446473|NCT01517685|fish oil|fish oil
5446474|NCT01517685|flax seed oil|flax seed oil
5446475|NCT01517672|PTSD|ptsd
5446476|NCT01517672|domestic violence|domestic violence
5446477|NCT01517672|intimate partner violence|intimate partner violence
5446478|NCT01517672|functional MRI|functional mri
5446479|NCT01517672|neuroimaging|neuroimaging
5446480|NCT01517659|Lipolysis|lipolysis
5446481|NCT01517659|Cryolipolysis|cryolipolysis
5446482|NCT01517659|Fat Reduction|fat reduction
5446483|NCT01517646|Lipolysis|lipolysis
5446484|NCT01517646|Cryolipolysis|cryolipolysis
5446485|NCT01517646|Fat Reduction|fat reduction
5446486|NCT01517633|Amniotic fluid leakage|amniotic fluid leakage
5446487|NCT01517633|Urinary incontinence|urinary incontinence
5446488|NCT01517581|Brown adipose tissue|brown adipose tissue
5446489|NCT01517542|diet|diet
5446490|NCT01517542|DASH|dash
5446491|NCT01517542|Stroke|stroke
5446492|NCT01517542|Nutritional counseling|nutritional counseling
5446493|NCT01517529|Hepatitis C|hepatitis c
5446494|NCT01517529|HCV|hcv
5446495|NCT01517516|fMRI|fmri
5446496|NCT01517516|resting state|resting state
5446497|NCT01517516|structural MRI|structural mri
5446498|NCT01517516|functional MRI|functional mri
5446499|NCT01517477|Open angle|open angle
5446500|NCT01517477|Glaucoma|glaucoma
5446502|NCT01517477|Glaucoma, Open-Angle|glaucoma, open-angle
5446503|NCT01517477|Ocular Hypertension|ocular hypertension
5446505|NCT01517464|neoplasm|neoplasm
5446506|NCT01517464|bladder cancer|bladder cancer
5446507|NCT01517464|advances solid tumors|advances solid tumors
5446508|NCT01517438|agitation, desflurane, children|agitation, desflurane, children
5446509|NCT01517399|Oncology|oncology
5446510|NCT01517399|pharmacokinetics|pharmacokinetics
5446511|NCT01517399|PK interaction in advanced solid tumors with our drug and other drugs|pk interaction in advanced solid tumors with our drug and other drugs
5446512|NCT01517386|paravertebral space|paravertebral space
5446513|NCT01517386|needle placement|needle placement
5446514|NCT01517386|tissue identification|tissue identification
5446515|NCT01517386|regional|regional
5446516|NCT01517373|T2DM|t2dm
5446517|NCT01517373|PF-04937319|pf-04937319
5446518|NCT01517373|Phase 2|phase 2
5446519|NCT01517360|Schizophrenia|schizophrenia
5446520|NCT01517360|Social Cognition|social cognition
5446521|NCT01517360|Oxytocin|oxytocin
5446522|NCT01517347|IL2|il2
5446523|NCT01517347|relapse|relapse
5446524|NCT01517347|GVHD|gvhd
5446525|NCT01517347|survival|survival
5446526|NCT01517347|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5446527|NCT01517347|MRD|mrd
5446528|NCT01517347|CR|cr
5446529|NCT01517308|HCV|hcv
5446530|NCT01517308|Hepatitis|hepatitis
5446531|NCT01517308|Genotype 2 or 3|genotype 2 or 3
5446532|NCT01517308|Pegylated Interferon|pegylated interferon
5446533|NCT01517308|Duration|duration
5446534|NCT01517295|Pharmacokinetics|pharmacokinetics
5446535|NCT01517295|Hydromorphone|hydromorphone
5446536|NCT01517295|Hydrocodone|hydrocodone
5446537|NCT01517295|APAP|apap
5446538|NCT01517269|Parent education|parent education
5446539|NCT01517256|Chronic pain|chronic pain
5446540|NCT01517256|Primary care|primary care
5446541|NCT01517256|Multidisciplinary group therapy|multidisciplinary group therapy
5446542|NCT01517256|Embedded mixed-methods study|embedded mixed-methods study
5446543|NCT01517243|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5446544|NCT01517243|sunitinib|sunitinib
5446545|NCT01517243|alternating|alternating
5446546|NCT01517243|temsirolimus|temsirolimus
5446547|NCT01517230|Cluster-randomised trial|cluster-randomised trial
5446548|NCT01517230|Comprehensive mass media campaign|comprehensive mass media campaign
5446549|NCT01517230|Rural community radio|rural community radio
5446550|NCT01517230|Under-five child mortality|under-five child mortality
5446551|NCT01517230|Preventive and curative behaviours|preventive and curative behaviours
5446552|NCT01517230|Burkina Faso|burkina faso
5446553|NCT01517230|Health care seeking behavior|health care seeking behavior
5446554|NCT01517230|Childbirth|childbirth
5446555|NCT01517217|girdle|girdle
5446556|NCT01517217|laparotomy|laparotomy
5446557|NCT01517217|pulmonary function|pulmonary function
5446558|NCT01517217|postoperative pain|postoperative pain
5446559|NCT01517217|mobilisation|mobilisation
5446560|NCT01517204|Trachway(R) intubating stylet|trachway(r) intubating stylet
5446569|NCT01517152|Symptoms|symptoms
5446570|NCT01517152|Patient-Reported Outcomes|patient-reported outcomes
5446571|NCT01517152|Linguistic Validation|linguistic validation
5446572|NCT01517152|Toxicity|toxicity
5446573|NCT01517152|PRO-CTCAE|pro-ctcae
5446574|NCT01517152|Adverse Events|adverse events
5446576|NCT01517152|Questionnaire|questionnaire
5446577|NCT01517139|Diet and Nutrition|diet and nutrition
5446578|NCT01517139|Pregnancy Folic Acid|pregnancy folic acid
5446579|NCT01517139|In Utero Exposure|in utero exposure
5446580|NCT01517139|DNA Methylation|dna methylation
5446581|NCT01517139|Physical Activity|physical activity
5446582|NCT01517126|Youth Suicide|youth suicide
5446583|NCT01517126|Suicide Screening|suicide screening
5446585|NCT01517126|Intellectual Disability|intellectual disability
5446586|NCT01517126|Assessment Instrument|assessment instrument
5446587|NCT01517126|Mental Retardation|mental retardation
5446588|NCT01517126|Suicidal Thoughts|suicidal thoughts
5446589|NCT01517126|Suicidal Behavior|suicidal behavior
5446590|NCT01517113|Endothelial Dysfunction|endothelial dysfunction
5446591|NCT01517113|Hepatic|hepatic
5446592|NCT01517113|Adiposity|adiposity
5446593|NCT01517113|Cytokines|cytokines
5446594|NCT01517113|Muscle Mass|muscle mass
5446595|NCT01517113|Coronary Artery Disease|coronary artery disease
5446596|NCT01517113|Aging|aging
5446597|NCT01517113|Inflammation|inflammation
5446598|NCT01517100|Glucose|glucose
5446599|NCT01517100|Insulin Secretion|insulin secretion
5446600|NCT01517100|Insulin Action|insulin action
5446601|NCT01517100|Endocannabinoids|endocannabinoids
5446602|NCT01517100|Insulin|insulin
5446603|NCT01517100|Metabolism|metabolism
5446611|NCT01517074|Sirolimus|sirolimus
5446612|NCT01517074|Scleritis|scleritis
5446613|NCT01517074|Autoimmune Scleritis|autoimmune scleritis
5446614|NCT01517061|Phantom Limb Pain|phantom limb pain
5446615|NCT01517061|Genetic Polymorphisms|genetic polymorphisms
5441394|NCT01539330|pharmacokinetics|pharmacokinetics
5446620|NCT01517048|Overweight|overweight
5446621|NCT01517048|Energy Homeostasis|energy homeostasis
5446622|NCT01517048|Nociception|nociception
5446623|NCT01517048|Prader-Willi Syndrome|prader-willi syndrome
5446624|NCT01517048|Genetic Disorder|genetic disorder
5446625|NCT01517048|Healthy Volunteer|healthy volunteer
5446627|NCT01517035|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5446628|NCT01517035|Stem Cell Transplant|stem cell transplant
5446629|NCT01517035|Transplant|transplant
5446630|NCT01517035|Myelodyplastic Syndrome|myelodyplastic syndrome
5446632|NCT01517035|Leukemia|leukemia
5446633|NCT01517022|smoking cessation|smoking cessation
5446634|NCT01517022|early sputum smear conversion|early sputum smear conversion
5446635|NCT01517009|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5446636|NCT01517009|D1extra-resection|d1extra-resection
5446637|NCT01516996|Neoadjuvant|neoadjuvant
5446638|NCT01516996|Concurrent Chemoradiotherapy,CCRT|concurrent chemoradiotherapy,ccrt
5446639|NCT01516996|Nimotuzumab|nimotuzumab
5446640|NCT01516996|Locoregionally Advanced Oropharynx|locoregionally advanced oropharynx
5446641|NCT01516996|Hypopharynx cancer|hypopharynx cancer
5446642|NCT01516996|Randomized|randomized
5446643|NCT01516996|Multicenter|multicenter
5446644|NCT01516983|Safety|safety
5446645|NCT01516983|EGFR-TKI|egfr-tki
5446646|NCT01516983|NSCLC|nsclc
5446647|NCT01516983|Icotinib|icotinib
5446648|NCT01516983|WBRT|wbrt
5446649|NCT01516970|Human Immunodeficiency Virus (HIV) Post exposure prophylaxis|human immunodeficiency virus (hiv) post exposure prophylaxis
5446650|NCT01516970|DRV/r|drv/r
5446651|NCT01516970|Occupational injury|occupational injury
5446652|NCT01516970|Non-occupational exposure|non-occupational exposure
5446653|NCT01516970|Prezista|prezista
5446654|NCT01516970|Darunavir/r|darunavir/r
5446655|NCT01516957|Psoriatic Arthritis|psoriatic arthritis
5446656|NCT01516957|IL-17|il-17
5446657|NCT01516957|AMG 827|amg 827
5446658|NCT01516957|AMG827|amg827
5446659|NCT01516957|Musculoskeletal Disease|musculoskeletal disease
5446660|NCT01516957|Spondylarthropathy|spondylarthropathy
5446661|NCT01516944|Tegafur，Gimeracil and Oteracil Potassium Capsules|tegafur，gimeracil and oteracil potassium capsules
5446662|NCT01516944|Capecitabine|capecitabine
5446663|NCT01516944|Oxaliplatin|oxaliplatin
5446664|NCT01516944|perioperative Chemotherapy|perioperative chemotherapy
5446665|NCT01516944|Gastric Cancer|gastric cancer
5446666|NCT01516931|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5446667|NCT01516931|Depression|depression
5446668|NCT01516931|Venlafaxine|venlafaxine
5446669|NCT01516931|Relapse|relapse
5446670|NCT01516879|Cholesterol|cholesterol
5446671|NCT01516879|High Cholesterol|high cholesterol
5446672|NCT01516879|Elevated Cholesterol|elevated cholesterol
5446673|NCT01516879|Raised Cholesterol|raised cholesterol
5446674|NCT01516866|Androgen receptor-directed therapy|androgen receptor-directed therapy
5446675|NCT01516866|NaF PET/CT|naf pet/ct
5446676|NCT01516866|antimicrotubule directed chemotherapy|antimicrotubule directed chemotherapy
5446677|NCT01516840|acute symptomatic deep vein thrombosis|acute symptomatic deep vein thrombosis
5446678|NCT01516827|PTSD|ptsd
5446679|NCT01516827|Children and Adolescents|children and adolescents
5446680|NCT01516827|Post-Traumatic Stress Disorder in Children and Adolescents|post-traumatic stress disorder in children and adolescents
5446681|NCT01516814|acute symptomatic pulmonary embolism|acute symptomatic pulmonary embolism
5446682|NCT01516801|Prostate Cancer Screening|prostate cancer screening
5446683|NCT01516801|Pragmatic Trial|pragmatic trial
5446684|NCT01516801|Health Literacy|health literacy
5446685|NCT01516775|preoperative care|preoperative care
5446686|NCT01516775|preoperative period|preoperative period
5446687|NCT01516775|fasting|fasting
5446689|NCT01516762|Alpharadin|alpharadin
5446690|NCT01516762|Prostate Cancer|prostate cancer
5446691|NCT01516762|Bone metastases|bone metastases
5429388|NCT01590641|HBV|hbv
5446692|NCT01516762|Castrate resistant prostate cancer|castrate resistant prostate cancer
5446693|NCT01516762|Hormone refractory prostate cancer|hormone refractory prostate cancer
5446694|NCT01516749|hidradenitis suppurativa|hidradenitis suppurativa
5446695|NCT01516749|anakinra|anakinra
5446696|NCT01516736|Pegfilgrastim|pegfilgrastim
5446697|NCT01516736|G-CSF|g-csf
5446698|NCT01516736|neutropenia|neutropenia
5446699|NCT01516736|breast cancer|breast cancer
5446700|NCT01516736|myelosuppressive chemotherapy|myelosuppressive chemotherapy
5446701|NCT01516723|drug-eluting stent|drug-eluting stent
5446702|NCT01516723|chronic total occlusion|chronic total occlusion
5446703|NCT01516723|hybrid sirolimus-eluting stent|hybrid sirolimus-eluting stent
5446704|NCT01516723|everolimus-eluting stent|everolimus-eluting stent
5446705|NCT01516710|Open liver resection|open liver resection
5446706|NCT01516710|Laparoscopic liver resection|laparoscopic liver resection
5441495|NCT01539070|Nutritional intervention|nutritional intervention
5446707|NCT01516710|Colorectal cancer liver metastases|colorectal cancer liver metastases
5446708|NCT01516697|thoracic electric bioimpedance|thoracic electric bioimpedance
5446709|NCT01516697|cardiac output monitoring|cardiac output monitoring
5446710|NCT01516697|cesarean section|cesarean section
5446711|NCT01516697|spinal anesthesia|spinal anesthesia
5446712|NCT01516671|Subarachnoid hemorrhage|subarachnoid hemorrhage
5446713|NCT01516671|Cerebral vasospasm|cerebral vasospasm
5446714|NCT01516671|Neuroinflammation|neuroinflammation
5446715|NCT01516671|Bilateral Bispectral Index|bilateral bispectral index
5446716|NCT01516658|intracranial aneurysm|intracranial aneurysm
5446717|NCT01516658|endovascular therapy|endovascular therapy
5446718|NCT01516658|detachable coil|detachable coil
5446719|NCT01516658|recanalization|recanalization
5446720|NCT01516645|Squamous cell type tumor|squamous cell type tumor
5446721|NCT01516632|Cellular Phone|cellular phone
5446722|NCT01516632|Mobile Phone|mobile phone
5446723|NCT01516632|Cognitive Behavior Therapy|cognitive behavior therapy
5446724|NCT01516632|Technology|technology
5446725|NCT01516632|Smoking cessation|smoking cessation
5446726|NCT01516632|young adults|young adults
5446728|NCT01516619|chemotherapy-induced grade-4 thrombocytopenia|chemotherapy-induced grade-4 thrombocytopenia
5446729|NCT01516606|MALT|malt
5446730|NCT01516606|refractory|refractory
5446731|NCT01516606|relapsed|relapsed
5446732|NCT01516606|extranodal|extranodal
5446733|NCT01516606|relapsed or refractory extranodal marginal zone lymphoma|relapsed or refractory extranodal marginal zone lymphoma
5446734|NCT01516593|HIV|hiv
5446735|NCT01516593|Burkitt's lymphoma|burkitt's lymphoma
5446736|NCT01516593|intensive|intensive
5446737|NCT01516593|short term|short term
5446738|NCT01516593|immuno-chemotherapy|immuno-chemotherapy
5446739|NCT01516593|HIV-positive patients with Burkitt's lymphoma|hiv-positive patients with burkitt's lymphoma
5446740|NCT01516554|Multiple Sclerosis|multiple sclerosis
5446741|NCT01516554|Fatigue|fatigue
5446742|NCT01516528|COPD|copd
5446743|NCT01516528|exacerbation|exacerbation
5446744|NCT01516528|comorbidities|comorbidities
5446745|NCT01516528|lung function|lung function
5446746|NCT01516528|burden|burden
5446747|NCT01516528|chronic bronchitis|chronic bronchitis
5446748|NCT01516528|emphysema|emphysema
5446749|NCT01516528|prevalence|prevalence
5446750|NCT01516528|cardiovascular disease|cardiovascular disease
5446751|NCT01516515|Actinic Keratosis|actinic keratosis
5446752|NCT01516515|AK|ak
5446753|NCT01516502|laser therapy|laser therapy
5446754|NCT01516502|myofascial pain syndrome|myofascial pain syndrome
5446757|NCT01516502|range of motion|range of motion
5446758|NCT01516489|screening|screening
5446759|NCT01516489|colon cancer|colon cancer
5446760|NCT01516489|incentives|incentives
5446761|NCT01516489|behavioral economics|behavioral economics
5446763|NCT01516463|partial thickness burn|partial thickness burn
5446764|NCT01516463|second degree burn|second degree burn
5446765|NCT01516463|minor burn|minor burn
5446766|NCT01516463|scar|scar
5446767|NCT01516463|Santyl|santyl
5446768|NCT01516463|Bacitracin|bacitracin
5446769|NCT01516463|outpatient burn center|outpatient burn center
5446770|NCT01516463|scar appearance|scar appearance
5446771|NCT01516463|Kansas City|kansas city
5446772|NCT01516463|University of Kansas Medical Center|university of kansas medical center
5446773|NCT01516463|KUMC|kumc
5446774|NCT01516450|GSK1550188, belimumab, SLE, healthy, Japanese, pharmacokinetics, safety|gsk1550188, belimumab, sle, healthy, japanese, pharmacokinetics, safety
5446775|NCT01516437|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5446776|NCT01516424|Blonanserin|blonanserin
5446777|NCT01516411|Health Promotion|health promotion
5446778|NCT01516411|Physical Activity|physical activity
5446779|NCT01516411|Sedentary Time|sedentary time
5446780|NCT01516411|Smartphones|smartphones
5446781|NCT01516385|spinal cord injury|spinal cord injury
5446782|NCT01516385|biomarkers|biomarkers
5446783|NCT01516385|rehabilitation|rehabilitation
5446784|NCT01516385|functional independence|functional independence
5446785|NCT01516385|prognosis|prognosis
5446786|NCT01516372|GEn, moxifloxacin, cardiac repolarisation, QT/QTc|gen, moxifloxacin, cardiac repolarisation, qt/qtc
5446787|NCT01516346|Heart Failure|heart failure
5446788|NCT01516346|Heart failure with preserved ejection fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5446789|NCT01516346|Vasodilators|vasodilators
5446790|NCT01516346|Isosorbide dinitrate|isosorbide dinitrate
5446791|NCT01516346|Hydralazine|hydralazine
5446792|NCT01516346|wave reflections|wave reflections
5446793|NCT01516346|arterial stiffness|arterial stiffness
5446794|NCT01516346|hemodynamics|hemodynamics
5446795|NCT01516333|glycemic Index|glycemic index
5446796|NCT01516320|Type 2 Diabetes|type 2 diabetes
5446797|NCT01516320|Gastric Bypass|gastric bypass
5446798|NCT01516320|Laparoscopic Banding|laparoscopic banding
5446799|NCT01516320|Vertical Sleeve Gastrectomy|vertical sleeve gastrectomy
5446801|NCT01516294|PCV|pcv
5446802|NCT01516294|Iray|iray
5446803|NCT01516294|radiation|radiation
5446804|NCT01516294|retina|retina
5446805|NCT01516294|macula|macula
5446806|NCT01516294|radiotherapy|radiotherapy
5446809|NCT01516268|Cesarean Delivery|cesarean delivery
5446810|NCT01516268|TAP block|tap block
5446811|NCT01516268|sufentanyl|sufentanyl
5446812|NCT01516268|Narcotic dosages|narcotic dosages
5446813|NCT01516216|previously untreated|previously untreated
5446814|NCT01516203|AZD5847|azd5847
5446815|NCT01516203|dose-ranging|dose-ranging
5446816|NCT01516203|Mycobacterium tuberculosis|mycobacterium tuberculosis
5446817|NCT01516203|Rifafour|rifafour
5446818|NCT01516203|tuberculosis|tuberculosis
5446819|NCT01516190|stage I-III breast cancer|stage i-iii breast cancer
5446820|NCT01516177|Kidney Transplantation|kidney transplantation
5446821|NCT01516177|kidney transplant|kidney transplant
5446822|NCT01516177|renal transplant|renal transplant
5446823|NCT01516177|immunosuppression|immunosuppression
5446824|NCT01516164|Laryngoscopy|laryngoscopy
5446825|NCT01516164|Videolaryngoscopy|videolaryngoscopy
5446826|NCT01516164|Ease of Intubation|ease of intubation
5446827|NCT01516151|Hypertriglyceridemia|hypertriglyceridemia
5446828|NCT01516138|Glucose-insulin-potassium|glucose-insulin-potassium
5446829|NCT01516138|Cardiac surgery|cardiac surgery
5446830|NCT01516125|healthy adult|healthy adult
5446831|NCT01516125|genetic variation|genetic variation
5446832|NCT01516125|botanical oils|botanical oils
5446833|NCT01516125|polyunsaturated fatty acid|polyunsaturated fatty acid
5446834|NCT01516125|fish oil|fish oil
5446835|NCT01516125|fat metabolism|fat metabolism
5446836|NCT01516125|Genetic variation of fat metabolism in healthy adults|genetic variation of fat metabolism in healthy adults
5446837|NCT01516112|ICD, home monitoring, cardiomessenger, implant|icd, home monitoring, cardiomessenger, implant
5446838|NCT01516099|Physical activity counselor|physical activity counselor
5446839|NCT01516099|Active and healthy lifestyle|active and healthy lifestyle
5446840|NCT01516099|General Practitioner|general practitioner
5446841|NCT01516099|Social-cultural Organization|social-cultural organization
5446842|NCT01516086|Controlled|controlled
5446843|NCT01516086|uncontrolled|uncontrolled
5446844|NCT01516073|partially controlled|partially controlled
5446845|NCT01516073|uncontrolled|uncontrolled
5446846|NCT01516047|Hepatic impairment|hepatic impairment
5446847|NCT01516047|Pharmacology|pharmacology
5446848|NCT01516047|Pharmacokinetics|pharmacokinetics
5446849|NCT01516047|Pharmacodynamics|pharmacodynamics
5446850|NCT01516047|Abiraterone acetate suspension|abiraterone acetate suspension
5446851|NCT01516047|JNJ-212082|jnj-212082
5446852|NCT01516034|Tattoo removal|tattoo removal
5446853|NCT01516034|ultrasound|ultrasound
5446854|NCT01516021|Fat ingestion|fat ingestion
5446855|NCT01516021|hypothalamus|hypothalamus
5446857|NCT01516021|fMRI|fmri
5446859|NCT01516008|Hallux Valgus|hallux valgus
5446860|NCT01516008|Bunionectomy|bunionectomy
5446861|NCT01516008|Bunion|bunion
5446862|NCT01516008|Acute pain|acute pain
5446863|NCT01516008|Tapentadol|tapentadol
5446864|NCT01516008|Tapentadol IR|tapentadol ir
5446865|NCT01515995|Magnesium sulfate|magnesium sulfate
5446866|NCT01515995|Childhood asthma|childhood asthma
5446867|NCT01515995|Emergency department|emergency department
5446868|NCT01515982|Alzheimer's disease|alzheimer's disease
5446869|NCT01515982|Aerobic exercise|aerobic exercise
5446870|NCT01515982|Physical training|physical training
5446871|NCT01515982|Cognitive function|cognitive function
5446872|NCT01515982|Functional capacity.|functional capacity.
5446873|NCT01515956|Mucopolysaccharidosis IVA type A|mucopolysaccharidosis iva type a
5446874|NCT01515956|MPS IVA Type A|mps iva type a
5446875|NCT01515956|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5446876|NCT01515956|MPS IVA|mps iva
5446877|NCT01515956|Morquio A Syndrome|morquio a syndrome
5446878|NCT01515956|Lysosomal Storage Disorder|lysosomal storage disorder
5446880|NCT01515956|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5446881|NCT01515956|N-acetylgalactosamine-6-sulfate|n-acetylgalactosamine-6-sulfate
5446882|NCT01515956|sulfatase|sulfatase
5446883|NCT01515956|galactose-6-sulfatase|galactose-6-sulfatase
5446884|NCT01515956|GALNS|galns
5446885|NCT01515956|enzyme replacement therapy|enzyme replacement therapy
5446886|NCT01515956|ERT|ert
5446887|NCT01515943|Convergence insufficiency|convergence insufficiency
5446888|NCT01515930|Parenting|parenting
5446889|NCT01515930|Parental Monitoring|parental monitoring
5446890|NCT01515930|Diabetes|diabetes
5446891|NCT01515930|Care|care
5446892|NCT01515917|Veterans|veterans
5446893|NCT01515917|Traumatic Brain Injury|traumatic brain injury
5446894|NCT01515917|TBI|tbi
5446895|NCT01515917|Substance Abuse|substance abuse
5446896|NCT01515917|Substance Dependence|substance dependence
5446897|NCT01515917|Veterans with traumatic brain injury (TBI)|veterans with traumatic brain injury (tbi)
5446898|NCT01515917|Veterans with substance abuse or dependence|veterans with substance abuse or dependence
5446899|NCT01515904|obesity management|obesity management
5446900|NCT01515904|adolescents|adolescents
5446901|NCT01515904|body mass index|body mass index
5446902|NCT01515904|treatment outcomes|treatment outcomes
5446903|NCT01515904|program evaluation|program evaluation
5446904|NCT01515891|Parkinson Disease|parkinson disease
5446906|NCT01515852|stress level|stress level
5446907|NCT01515852|stereotactic biopsy|stereotactic biopsy
5446908|NCT01515852|brain lesion|brain lesion
5446909|NCT01515852|general anesthesia|general anesthesia
5446910|NCT01515852|local anesthesia|local anesthesia
5446911|NCT01515839|SPECT|spect
5446912|NCT01515839|Imaging|imaging
5446913|NCT01515839|Football|football
5446914|NCT01515839|Traumatic brain injury|traumatic brain injury
5446915|NCT01515839|Regional cerebral blood flow|regional cerebral blood flow
5446916|NCT01515826|Cataract surgery|cataract surgery
5446917|NCT01515826|Topical therapy|topical therapy
5446918|NCT01515826|Prevention of inflammation|prevention of inflammation
5446919|NCT01515826|Inflammation of infection|inflammation of infection
5446920|NCT01515800|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5446921|NCT01515800|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5446922|NCT01515800|stage IA breast cancer|stage ia breast cancer
5446923|NCT01515800|stage IB breast cancer|stage ib breast cancer
5446924|NCT01515800|stage II breast cancer|stage ii breast cancer
5446925|NCT01515800|stage IIIA breast cancer|stage iiia breast cancer
5446926|NCT01515787|stage IIA rectal cancer|stage iia rectal cancer
5446927|NCT01515787|stage IIIA rectal cancer|stage iiia rectal cancer
5446928|NCT01515787|stage IIIB rectal cancer|stage iiib rectal cancer
5446929|NCT01515774|Parkinson's disease|parkinson's disease
5446930|NCT01515774|Pramipexole|pramipexole
5446931|NCT01515722|Medication Persistence|medication persistence
5446932|NCT01515722|Compliance|compliance
5446933|NCT01515722|Health Education Intervention (HEI)|health education intervention (hei)
5446934|NCT01515709|Cohort Studies|cohort studies
5446935|NCT01515709|Longitudinal Studies|longitudinal studies
5446936|NCT01515696|VLBW infant|vlbw infant
5446937|NCT01515696|Meconium|meconium
5446938|NCT01515696|Enteral nutrition|enteral nutrition
5446939|NCT01515696|Meconium passage|meconium passage
5446940|NCT01515683|Nervousness before anesthesia|nervousness before anesthesia
5446941|NCT01515670|THA|tha
5446942|NCT01515670|TKA|tka
5446943|NCT01515670|Fast-track|fast-track
5446944|NCT01515670|Enhanced recovery|enhanced recovery
5446945|NCT01515670|preoperative co-morbidity|preoperative co-morbidity
5446946|NCT01515670|postoperative morbidity|postoperative morbidity
5446947|NCT01515670|Arthroplasty|arthroplasty
5446948|NCT01515670|Replacement|replacement
5446949|NCT01515670|Hip|hip
5446950|NCT01515670|Knee|knee
5446951|NCT01515670|Morbidity|morbidity
5446952|NCT01515644|Healthy infants|healthy infants
5446953|NCT01515644|Infant formula|infant formula
5446954|NCT01515644|Prebiotics|prebiotics
5446955|NCT01515566|Advanced Cancer|advanced cancer
5446956|NCT01515566|Dyspnea|dyspnea
5446957|NCT01515566|Exercise-induced breakthrough dyspnea|exercise-induced breakthrough dyspnea
5446958|NCT01515566|Shortness of breath|shortness of breath
5446959|NCT01515566|Fentanyl|fentanyl
5446960|NCT01515566|Sublimaze|sublimaze
5446961|NCT01515566|Placebo|placebo
5446962|NCT01515566|Normal saline|normal saline
5446963|NCT01515566|NS|ns
5446964|NCT01515566|Questionnaires|questionnaires
5446965|NCT01515566|Surveys|surveys
5446966|NCT01515566|Walk test|walk test
5446967|NCT01515540|chronic back pain|chronic back pain
5446968|NCT01515540|placebo|placebo
5446969|NCT01515540|fmri|fmri
5446970|NCT01515540|brain imaging|brain imaging
5446971|NCT01515527|Leukemia|leukemia
5446972|NCT01515527|Acute myeloid leukemia|acute myeloid leukemia
5446973|NCT01515527|AML|aml
5446974|NCT01515527|myelodysplastic syndrome|myelodysplastic syndrome
5446975|NCT01515527|MDS|mds
5446976|NCT01515527|Cytarabine|cytarabine
5446977|NCT01515527|Ara-C|ara-c
5433916|NCT01571219|Biosimilar|biosimilar
5446978|NCT01515527|Cytosar|cytosar
5446979|NCT01515527|DepoCyt|depocyt
5446980|NCT01515527|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5446981|NCT01515527|Decitabine|decitabine
5446982|NCT01515527|Dacogen|dacogen
5446983|NCT01515527|Cladribine|cladribine
5446984|NCT01515527|Leustatin|leustatin
5446985|NCT01515527|2-CdA|2-cda
5446986|NCT01515514|polyps|polyps
5446987|NCT01515514|inflammatory bowel disease|inflammatory bowel disease
5446988|NCT01515514|associated neoplasia|associated neoplasia
5446989|NCT01515501|Constipation|constipation
5446990|NCT01515501|Hirschsprung Disease|hirschsprung disease
5446991|NCT01515488|Triage|triage
5446992|NCT01515488|Automated|automated
5446993|NCT01515488|Admitting|admitting
5446994|NCT01515488|Pediatric ED|pediatric ed
5446995|NCT01515475|Hyperopia|hyperopia
5446996|NCT01515475|Glasses|glasses
5446997|NCT01515462|Lentiviral vector|lentiviral vector
5446998|NCT01515462|Gene therapy|gene therapy
5446999|NCT01515462|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5447000|NCT01515462|OTL-103|otl-103
5447001|NCT01515462|Previously GSK2696275|previously gsk2696275
5447002|NCT01515436|Rolandic Epilepsy|rolandic epilepsy
5447003|NCT01515436|Benign Childhood Epilepsy with Centrotemporal Spikes (BCECTS)|benign childhood epilepsy with centrotemporal spikes (bcects)
5447004|NCT01515436|Epilepsy|epilepsy
5447005|NCT01515436|Seizures|seizures
5447006|NCT01515436|Music|music
5447008|NCT01515436|Beethoven|beethoven
5447009|NCT01515423|Schizophrenia|schizophrenia
5447010|NCT01515423|R092670|r092670
5591122|NCT00926146|HIV|hiv
5447011|NCT01515423|Paliperidone Palmitate|paliperidone palmitate
5447012|NCT01515423|Paliperidone palmitate 1 month formulation (PP1M)|paliperidone palmitate 1 month formulation (pp1m)
5447013|NCT01515423|Paliperidone palmitate 3 month formulation (PP3M)|paliperidone palmitate 3 month formulation (pp3m)
5447014|NCT01515410|Parkinson's disease|parkinson's disease
5447015|NCT01515410|PD|pd
5447016|NCT01515410|stage2/3Parkinson's|stage2/3parkinson's
5447017|NCT01515410|Advanced Parkinson's Disease with Motor Fluctuations|advanced parkinson's disease with motor fluctuations
5447018|NCT01515345|clopidogrel-nonresponder|clopidogrel-nonresponder
5447019|NCT01515345|stent thrombosis|stent thrombosis
5447020|NCT01515319|Obesity|obesity
5447021|NCT01515319|Peptide YY|peptide yy
5447022|NCT01515319|Food intake|food intake
5447023|NCT01515319|Safety|safety
5447024|NCT01515319|Pharmacokinetics|pharmacokinetics
5447025|NCT01515306|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5447026|NCT01515280|chronic cough|chronic cough
5447027|NCT01515267|EF|ef
5447028|NCT01515267|EDV|edv
5447029|NCT01515267|ESV|esv
5447030|NCT01515267|Biplane|biplane
5447031|NCT01515267|Echocardiography|echocardiography
5447032|NCT01515254|Children|children
5447033|NCT01515254|Obesity Prevention|obesity prevention
5447034|NCT01515254|Child Overweight|child overweight
5447035|NCT01515254|Energy Compensation|energy compensation
5447036|NCT01515254|Eating Behavior|eating behavior
5447037|NCT01515254|Food Intake|food intake
5447038|NCT01515254|Parenting Behavior|parenting behavior
5447039|NCT01515241|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5447040|NCT01515241|Familial Hypercholesterolemia|familial hypercholesterolemia
5447041|NCT01515241|HDL mimetic|hdl mimetic
5447042|NCT01515241|ApoA-1|apoa-1
5447043|NCT01515228|requiring drug eluting stents|requiring drug eluting stents
5447044|NCT01515215|Major Depression Disorder|major depression disorder
5447045|NCT01515215|Treatment Resistance|treatment resistance
5447046|NCT01515215|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5447047|NCT01515150|diverticulitis|diverticulitis
5447048|NCT01515150|Out-patient management|out-patient management
5447049|NCT01515150|Antibiotics|antibiotics
5447050|NCT01515137|Head and Neck|head and neck
5447051|NCT01515137|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
5447052|NCT01515124|Lymphedema|lymphedema
5447053|NCT01515124|Strength training intervention|strength training intervention
5447054|NCT01515124|Weight loss intervention|weight loss intervention
5447055|NCT01515124|Breast cancer recurrence|breast cancer recurrence
5447059|NCT01515111|Medical education|medical education
5447060|NCT01515111|Guatemala|guatemala
5447061|NCT01515072|Remote Ischemic Preconditioning|remote ischemic preconditioning
5447062|NCT01515072|Brain death organ donors|brain death organ donors
5447063|NCT01515072|Delayed graft function|delayed graft function
5447064|NCT01515072|Donor management|donor management
5447065|NCT01515072|Pulsatile perfusion|pulsatile perfusion
5447066|NCT01515059|obesity|obesity
5447067|NCT01515059|diabetes|diabetes
5447068|NCT01515059|bariatric surgery|bariatric surgery
5447069|NCT01515059|gastric bypass|gastric bypass
5447070|NCT01515059|insulin|insulin
5447071|NCT01515059|glucose|glucose
5447072|NCT01515059|incretins|incretins
5447073|NCT01515059|leptin|leptin
5447074|NCT01515059|ghrelin|ghrelin
5447075|NCT01515046|Vitamins|vitamins
5447076|NCT01515046|Complementary medicine|complementary medicine
5447077|NCT01515046|Pancreatic cancer|pancreatic cancer
5447078|NCT01515046|Ascorbate|ascorbate
5447079|NCT01515046|Ascorbic Acid|ascorbic acid
5447080|NCT01515046|Antioxidants|antioxidants
5447081|NCT01515046|Gemcitabine|gemcitabine
5447082|NCT01515046|Pharmacologic actions|pharmacologic actions
5447083|NCT01515033|Coronary artery disease|coronary artery disease
5447084|NCT01515033|Exercise|exercise
5447085|NCT01515033|Ventilatory efficiency|ventilatory efficiency
5447086|NCT01515020|bacteremia|bacteremia
5429748|NCT01588821|Metastatic|metastatic
5447087|NCT01515020|meticillin-resistant Staphylococcus aureus|meticillin-resistant staphylococcus aureus
5447088|NCT01515020|nosocomial infection|nosocomial infection
5447089|NCT01515020|healthcare-associated infection|healthcare-associated infection
5447090|NCT01515020|rapid molecular diagnostic test|rapid molecular diagnostic test
5447091|NCT01515007|Bronchiectasis, non-CF, Ciprofloxacin, Liposome|bronchiectasis, non-cf, ciprofloxacin, liposome
5447092|NCT01514981|Asthma|asthma
5447093|NCT01514942|PCOS|pcos
5447094|NCT01514942|Insulin resistance|insulin resistance
5447095|NCT01514942|Myo-inositol|myo-inositol
5447096|NCT01514942|D-chiro-inositol|d-chiro-inositol
5447097|NCT01514929|Thorough QT|thorough qt
5447098|NCT01514903|anti erectile dysfunction agent|anti erectile dysfunction agent
5447099|NCT01514877|tumors metastatic to brain|tumors metastatic to brain
5447100|NCT01514877|non-small cell lung cancer|non-small cell lung cancer
5447101|NCT01514877|Icotinib|icotinib
5447102|NCT01514851|Hyperphosphatemia in ESRD (End Stage Renal Disease) patients on dialysis|hyperphosphatemia in esrd (end stage renal disease) patients on dialysis
5447105|NCT01514838|plasma glucose|plasma glucose
5447106|NCT01514838|ASP1941|asp1941
5447107|NCT01514825|YM150|ym150
5447108|NCT01514825|Plasma concentration|plasma concentration
5447109|NCT01514825|darexaban|darexaban
5447110|NCT01514825|Healthy elderly subject|healthy elderly subject
5447111|NCT01514825|Pharmacokinetics of YM150|pharmacokinetics of ym150
5447112|NCT01514812|YM150|ym150
5447113|NCT01514812|digoxin|digoxin
5447114|NCT01514812|drug-drug interaction|drug-drug interaction
5447115|NCT01514812|Plasma concentration|plasma concentration
5447116|NCT01514812|darexaban|darexaban
5447117|NCT01514812|Pharmacokinetics of digoxin|pharmacokinetics of digoxin
5447122|NCT01514786|Colorectal Cancer|colorectal cancer
5447123|NCT01514786|Screening|screening
5447124|NCT01514786|Prevention|prevention
5447125|NCT01514773|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5447126|NCT01514773|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5447127|NCT01514773|systolic heart failure|systolic heart failure
5447128|NCT01514773|congestive heart failure|congestive heart failure
5447129|NCT01514773|Ischemic cardiomyopathy|ischemic cardiomyopathy
5447130|NCT01514773|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
5447132|NCT01514773|ICD utilization|icd utilization
5447133|NCT01514773|ICD implantation|icd implantation
5447134|NCT01514773|defibrillator|defibrillator
5447135|NCT01514773|defibrillator therapy|defibrillator therapy
5447136|NCT01514773|sudden cardiac death|sudden cardiac death
5447137|NCT01514760|Adolescents|adolescents
5447138|NCT01514760|Mobile based applications|mobile based applications
5447139|NCT01514760|Asthma action plan|asthma action plan
5447140|NCT01514760|Self Efficacy|self efficacy
5447141|NCT01514734|Primary open-angle glaucoma|primary open-angle glaucoma
5447142|NCT01514734|Ocular hypertension|ocular hypertension
5447143|NCT01514734|Pigment dispersion glaucoma|pigment dispersion glaucoma
5447144|NCT01514721|Open-angle glaucoma|open-angle glaucoma
5447145|NCT01514721|Ocular hypertension|ocular hypertension
5447146|NCT01514721|Pigment dispersion glaucoma|pigment dispersion glaucoma
5447147|NCT01514708|Influenza|influenza
5447148|NCT01514708|Vaccination|vaccination
5447149|NCT01514708|Vaccine|vaccine
5447150|NCT01514708|Pregnancy|pregnancy
5447151|NCT01514695|endoscopy|endoscopy
5447152|NCT01514695|sedation|sedation
5447153|NCT01514695|opioid|opioid
5447155|NCT01514682|schizophrenia|schizophrenia
5447156|NCT01514682|anti-inflammatory|anti-inflammatory
5447157|NCT01514682|salsalate|salsalate
5447158|NCT01514682|statins|statins
5447159|NCT01514682|omega-3-fatty acids|omega-3-fatty acids
5447160|NCT01514643|tibial plateau fracture|tibial plateau fracture
5447161|NCT01514643|tibial plafond fracture|tibial plafond fracture
5447162|NCT01514643|inflammatory cytokine profile|inflammatory cytokine profile
5447163|NCT01514643|synovial fluid|synovial fluid
5447164|NCT01514643|blood serum|blood serum
5447165|NCT01514643|Post-traumatic osteoarthritis (PTOA)|post-traumatic osteoarthritis (ptoa)
5447166|NCT01514617|Leiomyoma|leiomyoma
5447167|NCT01514617|Diffusion weighted MRI|diffusion weighted mri
5447168|NCT01514617|Perfusion MRI|perfusion mri
5447169|NCT01514617|Uterine artery embolization|uterine artery embolization
5447170|NCT01514617|Volumetric Response|volumetric response
5447171|NCT01514617|Women with symptomatic leiomyomas|women with symptomatic leiomyomas
5447172|NCT01514604|Anesthesia and analgesia|anesthesia and analgesia
5447173|NCT01514604|ultrasonography|ultrasonography
5447174|NCT01514604|education|education
5447175|NCT01514578|safety|safety
5447176|NCT01514578|tolerability|tolerability
5447177|NCT01514578|TRV130A|trv130a
5447178|NCT01514565|Triple negative Breast Cancer|triple negative breast cancer
5447179|NCT01514565|RB|rb
5447180|NCT01514565|PTEN|pten
5447181|NCT01514565|Chemotherapy|chemotherapy
5447182|NCT01514565|Neoadjuvant|neoadjuvant
5447183|NCT01514552|Functional food|functional food
5447184|NCT01514552|Strawberries|strawberries
5447185|NCT01514552|Gummies|gummies
5447186|NCT01514552|Smoker|smoker
5447187|NCT01514552|Nonsmoker|nonsmoker
5447188|NCT01514539|Human milk, Ghrelin,PYY and maternal obesity.|human milk, ghrelin,pyy and maternal obesity.
5447189|NCT01514526|Adrenocortical carcinoma|adrenocortical carcinoma
5447190|NCT01514461|Hyperlipoproteinemia (HLP Type I)|hyperlipoproteinemia (hlp type i)
5447191|NCT01514461|Fasting Triglycerides|fasting triglycerides
5447192|NCT01514448|Kidney cancer|kidney cancer
5447193|NCT01514448|mRCC|mrcc
5447194|NCT01514448|metastic renal cell carcinoma|metastic renal cell carcinoma
5447195|NCT01514448|everolimus|everolimus
5447196|NCT01514448|sunitinib|sunitinib
5447197|NCT01514448|pazopanib|pazopanib
5447198|NCT01514435|depression|depression
5447199|NCT01514435|FDG-PET|fdg-pet
5447200|NCT01514435|Electroconvulsive therapy|electroconvulsive therapy
5447201|NCT01514435|glucose metabolism|glucose metabolism
5447202|NCT01514422|Bipolar disorder|bipolar disorder
5447203|NCT01514422|depression|depression
5447204|NCT01514422|minocycline|minocycline
5447205|NCT01514422|mood disorders|mood disorders
5447206|NCT01514422|bipolar depression|bipolar depression
5447207|NCT01514409|5-hydroxytryptophan|5-hydroxytryptophan
5447209|NCT01514409|Emotional Processing|emotional processing
5447210|NCT01514409|Emotional Cognition|emotional cognition
5447211|NCT01514409|Nutritional Supplement|nutritional supplement
5447213|NCT01514396|Pediatric|pediatric
5447214|NCT01514396|Wounds|wounds
5447215|NCT01514383|wounds|wounds
5447216|NCT01514370|Multiple Sclerosis|multiple sclerosis
5447217|NCT01514370|Relapsing|relapsing
5447218|NCT01514370|Interferon beta 1a|interferon beta 1a
5447219|NCT01514370|Curcumin|curcumin
5447220|NCT01514344|OAL|oal
5447221|NCT01514344|MALT|malt
5447222|NCT01514344|conjunctiva|conjunctiva
5447223|NCT01514344|indolent|indolent
5447224|NCT01514344|CD20+|cd20+
5447225|NCT01514331|Ventilator Induced Lung Injury|ventilator induced lung injury
5447226|NCT01514331|Neonatal respiratory distress|neonatal respiratory distress
5447227|NCT01514331|Mechanical ventilation|mechanical ventilation
5447228|NCT01514279|Overweight|overweight
5447229|NCT01514279|Obese|obese
5447230|NCT01514279|Over Nutrition|over nutrition
5447231|NCT01514279|Nutrition Disorders|nutrition disorders
5447232|NCT01514279|Body weight|body weight
5447233|NCT01514279|Signs and Symptoms|signs and symptoms
5447234|NCT01514266|proven diagnosis|proven diagnosis
5447235|NCT01514266|COPD|copd
5447236|NCT01514266|sputum|sputum
5447237|NCT01514253|glucose|glucose
5447238|NCT01514253|analgesic|analgesic
5447239|NCT01514253|newborns|newborns
5447240|NCT01514240|mild to moderate active Crohn's disease|mild to moderate active crohn's disease
5447241|NCT01514240|affecting ileum|affecting ileum
5447242|NCT01514240|ileocecal region|ileocecal region
5447243|NCT01514240|ascending colon|ascending colon
5447244|NCT01514240|score of 180-400 on the CDAI|score of 180-400 on the cdai
5447245|NCT01514214|ERCP|ercp
5447246|NCT01514214|biliary stricture|biliary stricture
5447247|NCT01514214|viaduct|viaduct
5447248|NCT01514214|cancer|cancer
5447249|NCT01514188|sarcoma|sarcoma
5447250|NCT01514188|soft-tissue sarcoma|soft-tissue sarcoma
5680273|NCT00578409|progressive castrate metastatic prostate cancer|progressive castrate metastatic prostate cancer
5447251|NCT01514188|Metastatic,locally advanced, or unresectable soft tissue sarcoma|metastatic,locally advanced, or unresectable soft tissue sarcoma
5447253|NCT01514175|Caldolor|caldolor
5447254|NCT01514175|Chronic Pelvic Pain|chronic pelvic pain
5447255|NCT01514162|Trifecta Valve|trifecta valve
5447256|NCT01514149|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5447257|NCT01514149|T2DM|t2dm
5447260|NCT01514149|GLP-1|glp-1
5447261|NCT01514149|Glucagon-like peptide-1|glucagon-like peptide-1
5447262|NCT01514149|exendin-4|exendin-4
5447263|NCT01514149|modified exendin-4|modified exendin-4
5447264|NCT01514123|VGX-100|vgx-100
5447265|NCT01514123|Bevacizumab|bevacizumab
5447266|NCT01514123|VEGF-C|vegf-c
5447267|NCT01514123|First-In-Human|first-in-human
5447268|NCT01514123|Dose Escalation|dose escalation
5447269|NCT01514123|Advanced Solid Tumors|advanced solid tumors
5447270|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors
5447271|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents
5447272|NCT01514123|Pharmacologic Actions|pharmacologic actions
5447273|NCT01514123|Antibodies, Monoclonal|antibodies, monoclonal
5447274|NCT01514123|Phase 1|phase 1
5447275|NCT01514123|Oncology|oncology
5447276|NCT01514123|Advanced malignancy|advanced malignancy
5447277|NCT01514097|emergency|emergency
5447278|NCT01514097|pediatric|pediatric
5447279|NCT01514097|fracture|fracture
5447280|NCT01514097|pain|pain
5447281|NCT01514084|laceration|laceration
5447282|NCT01514084|emergency|emergency
5447283|NCT01514084|cosmetic outcomes|cosmetic outcomes
5447284|NCT01514084|patient satisfaction|patient satisfaction
5447286|NCT01514071|head injury|head injury
5447287|NCT01514071|CT|ct
5447288|NCT01514071|emergency|emergency
5447289|NCT01514071|radiation|radiation
5447290|NCT01514045|Quality of Life|quality of life
5447291|NCT01514019|SLCO2B1 genotype|slco2b1 genotype
5447292|NCT01514019|effect of apple juice|effect of apple juice
5447293|NCT01514006|Primary hip arthroplasty|primary hip arthroplasty
5447294|NCT01514006|postoperative anemia|postoperative anemia
5447300|NCT01513967|Alzheimer,|alzheimer,
5447301|NCT01513967|dementia|dementia
5447302|NCT01513954|Infertility|infertility
5447303|NCT01513941|Chronic hepatitis C|chronic hepatitis c
5447304|NCT01513941|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
5447305|NCT01513941|Treatment experienced with HCV-1/HIV-1 coinfection|treatment experienced with hcv-1/hiv-1 coinfection
5447306|NCT01513941|Telaprevir|telaprevir
5447307|NCT01513941|Pegylated-Interferon-alfa-2a|pegylated-interferon-alfa-2a
5447308|NCT01513941|Ribavirin|ribavirin
5447309|NCT01513941|HCV-1/HIV-1 coinfection|hcv-1/hiv-1 coinfection
5447310|NCT01513941|Hepatitis C|hepatitis c
5447311|NCT01513928|pharmacokinetics|pharmacokinetics
5447312|NCT01513928|relative bioavailability|relative bioavailability
5447313|NCT01513928|formulation comparison|formulation comparison
5447314|NCT01513915|parents|parents
5447315|NCT01513915|group cognitive behavioral intervention|group cognitive behavioral intervention
5447316|NCT01513915|anxiety disorder|anxiety disorder
5447318|NCT01513915|FRIENDS program|friends program
5447319|NCT01513902|Arthritis|arthritis
5447320|NCT01513902|Pediatric|pediatric
5447321|NCT01513902|Tofacitinib|tofacitinib
5447322|NCT01513902|JIA|jia
5447323|NCT01513850|Liver Transplantation|liver transplantation
5447324|NCT01513850|HBV|hbv
5447325|NCT01513850|HBV Recurrence|hbv recurrence
5447326|NCT01513850|HBsAg Positive|hbsag positive
5447327|NCT01513824|stress|stress
5447328|NCT01513824|biofeed back guided treatment|biofeed back guided treatment
5447329|NCT01513824|acupressure|acupressure
5447330|NCT01513824|ischemic heart disease|ischemic heart disease
5447331|NCT01513811|bowel preparation|bowel preparation
5447332|NCT01513811|constipation|constipation
5447333|NCT01513811|polyethylene glycol|polyethylene glycol
5447334|NCT01513811|itopride|itopride
5447335|NCT01513798|Diet Therapy|diet therapy
5447336|NCT01513798|Exercise Therapy|exercise therapy
5447337|NCT01513798|Insulin Resistance|insulin resistance
5447338|NCT01513785|H. pylori|h. pylori
5447339|NCT01513785|Dual therapy|dual therapy
5447340|NCT01513785|Amoxicillin|amoxicillin
5447341|NCT01513785|Rabeprazole|rabeprazole
5447342|NCT01513759|Fibrinolysis|fibrinolysis
5447343|NCT01513759|catheter directed fibrinolysis|catheter directed fibrinolysis
5447344|NCT01513759|ultrasound accelerated fibrinolysis|ultrasound accelerated fibrinolysis
5447345|NCT01513759|recombinant t-PA|recombinant t-pa
5447346|NCT01513759|Activase|activase
5447347|NCT01513746|Type 1 Diabetes|type 1 diabetes
5447348|NCT01513746|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5447349|NCT01513746|Eating Disorders|eating disorders
5447350|NCT01513746|Insulin Omission|insulin omission
5447351|NCT01513720|Bioequivalence|bioequivalence
5447352|NCT01513720|Lamotrigine|lamotrigine
5447353|NCT01513720|crossover|crossover
5447354|NCT01513707|kidney transplantation|kidney transplantation
5447355|NCT01513707|hemodialysis|hemodialysis
5447356|NCT01513707|peritoneal dialysis|peritoneal dialysis
5447357|NCT01513694|Mesenchymal Stem Cells|mesenchymal stem cells
5447358|NCT01513694|Stem Cells|stem cells
5447359|NCT01513694|Intervertebral disc disease|intervertebral disc disease
5447360|NCT01513681|Bioequivalence|bioequivalence
5447361|NCT01513681|Lamotrigine|lamotrigine
5447362|NCT01513681|crossover|crossover
5447364|NCT01513655|Home NIV|home niv
5447365|NCT01513655|NIV|niv
5447366|NCT01513642|physiotherapy|physiotherapy
5447367|NCT01513642|cardiac surgery|cardiac surgery
5447368|NCT01513642|breath Stacking|breath stacking
5447369|NCT01513629|Autism spectrum disorders|autism spectrum disorders
5447370|NCT01513629|structural connectivity|structural connectivity
5447371|NCT01513629|diffusion spectrum imaging|diffusion spectrum imaging
5447372|NCT01513629|sibling|sibling
5447373|NCT01513629|endophenotype|endophenotype
5447374|NCT01513616|COPD|copd
5447375|NCT01513616|dyspnea|dyspnea
5447376|NCT01513616|exercise|exercise
5447377|NCT01513616|measurement|measurement
5447378|NCT01513616|respiratory physiology|respiratory physiology
5447379|NCT01513577|Lumbar fusion|lumbar fusion
5447380|NCT01513577|Pedicular screws|pedicular screws
5447381|NCT01513577|Minimal invasive technique|minimal invasive technique
5447382|NCT01513577|Randomized controlled trial|randomized controlled trial
5447383|NCT01513564|Disc disease|disc disease
5447384|NCT01513564|Spondylolisthesis|spondylolisthesis
5447385|NCT01513551|Pneumococcal vaccines|pneumococcal vaccines
5447386|NCT01513538|Pacemaker programming|pacemaker programming
5447387|NCT01513538|Bradyarrhythmia|bradyarrhythmia
5447388|NCT01513499|Eating behavior|eating behavior
5447389|NCT01513499|Appetite|appetite
5447390|NCT01513499|Oxytocin|oxytocin
5447391|NCT01513499|Neuropeptide|neuropeptide
5447392|NCT01513460|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
5447393|NCT01513460|NVA 237,|nva 237,
5447394|NCT01513460|glycopyrronium,|glycopyrronium,
5447395|NCT01513460|COPD|copd
5447396|NCT01513447|sterile water injections|sterile water injections
5447397|NCT01513447|back labor|back labor
5447398|NCT01513421|Infected|infected
5447399|NCT01513421|Intra-abdominal|intra-abdominal
5447400|NCT01513421|Collection|collection
5447401|NCT01513421|Drainage|drainage
5447402|NCT01513421|Percutaneous|percutaneous
5447403|NCT01513408|breast cancer|breast cancer
5447404|NCT01513408|CD8+|cd8+
5447405|NCT01513408|Foxp3|foxp3
5447406|NCT01513408|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5447407|NCT01513395|Cervical assessment|cervical assessment
5447408|NCT01513395|Focal myometrial contractions|focal myometrial contractions
5447409|NCT01513382|Pilonidal sinus|pilonidal sinus
5447410|NCT01513382|Methylene blue|methylene blue
5447411|NCT01513382|Histopathology|histopathology
5447412|NCT01513382|Surgery|surgery
5447413|NCT01513369|Diabetes|diabetes
5447414|NCT01513369|iron deficiency|iron deficiency
5447415|NCT01513356|breast|breast
5447416|NCT01513356|cancer|cancer
5447417|NCT01513356|BKM120|bkm120
5447418|NCT01513317|Myelodysplastic Syndrome|myelodysplastic syndrome
5447419|NCT01513317|MDS|mds
5447420|NCT01513317|Blood and lymphatic diseases|blood and lymphatic diseases
5447421|NCT01513317|Siltuximab|siltuximab
5447422|NCT01513317|Anemic|anemic
5447423|NCT01513265|reduction polypharmacy|reduction polypharmacy
5447424|NCT01513265|clinical outcomes|clinical outcomes
5447425|NCT01513265|pharmaceutical care|pharmaceutical care
5447426|NCT01513265|clinical pharmacy|clinical pharmacy
5447427|NCT01513265|geriatrics|geriatrics
5447428|NCT01513265|medication review|medication review
5447429|NCT01513265|potentially inappropriate drugs|potentially inappropriate drugs
5447430|NCT01513252|Cognitive decline|cognitive decline
5447431|NCT01513252|prevention|prevention
5447432|NCT01513252|omega-3 fatty acids|omega-3 fatty acids
5447433|NCT01513252|nutrition exercise|nutrition exercise
5447434|NCT01513252|cognitive training|cognitive training
5447435|NCT01513252|social activities|social activities
5447436|NCT01513252|frailty|frailty
5447437|NCT01513239|Clostridium difficile|clostridium difficile
5447438|NCT01513239|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
5447439|NCT01513239|recurrent Clostridium difficile|recurrent clostridium difficile
5447440|NCT01513239|vancomycin|vancomycin
5447441|NCT01513239|metronidazole|metronidazole
5447442|NCT01513239|monoclonal antibody|monoclonal antibody
5447443|NCT01513226|cycled light|cycled light
5447444|NCT01513226|dim light|dim light
5447445|NCT01513226|circadian rhythm|circadian rhythm
5447446|NCT01513226|actigraphy, sleep|actigraphy, sleep
5447447|NCT01513226|premature infant|premature infant
5447448|NCT01513213|Arterial cannulation|arterial cannulation
5447449|NCT01513213|Blood gas|blood gas
5447450|NCT01513213|Carbon dioxide|carbon dioxide
5447451|NCT01513213|Arterial blood|arterial blood
5447452|NCT01513213|Oxygen|oxygen
5447453|NCT01513213|Oxygen fractions|oxygen fractions
5447454|NCT01513187|Advanced renal cell carcinoma|advanced renal cell carcinoma
5447455|NCT01513187|SOGUG|sogug
5447456|NCT01513187|Pazopanib|pazopanib
5447457|NCT01513187|Pazopanib in combination with interferon alpha 2A|pazopanib in combination with interferon alpha 2a
5447458|NCT01513174|GOAL|goal
5447459|NCT01513174|Lung|lung
5447460|NCT01513174|Non small cell lung cancer|non small cell lung cancer
5447461|NCT01513174|EGFR mutations|egfr mutations
5447462|NCT01513161|pruritus|pruritus
5447463|NCT01513135|HIV,|hiv,
5447464|NCT01513135|HAART-treated|haart-treated
5447465|NCT01513135|participants|participants
5447466|NCT01513135|Tat protein,|tat protein,
5447467|NCT01513135|Therapeutic immunization|therapeutic immunization
5447468|NCT01513109|WT1 positive Acute Myeloid Leukemia|wt1 positive acute myeloid leukemia
5447469|NCT01513109|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
5447470|NCT01513109|Ex vivo regulatory T cell depletion|ex vivo regulatory t cell depletion
5447471|NCT01513109|In vivo regulatory T cell depletion|in vivo regulatory t cell depletion
5447472|NCT01513096|colonoscopy|colonoscopy
5447473|NCT01513096|bowel preparation|bowel preparation
5447475|NCT01513096|Prokinetics|prokinetics
5447476|NCT01513070|Quick-Acting Heart Reliever|quick-acting heart reliever
5447477|NCT01513070|Coronary Artery Stenosis|coronary artery stenosis
5447478|NCT01513070|Coronary Heart Disease|coronary heart disease
5447479|NCT01513070|Suxiao Jiuxin Pill|suxiao jiuxin pill
5447480|NCT01513070|Chinese Herbal Drugs|chinese herbal drugs
5447481|NCT01513070|Traditional Chinese Medicine|traditional chinese medicine
5447482|NCT01513070|Chinese Medicine|chinese medicine
5447483|NCT01513070|Angina Pectoris|angina pectoris
5447484|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate
5447485|NCT01513070|Myocardial Perfusion Imaging|myocardial perfusion imaging
5447486|NCT01513070|Clinical Trial|clinical trial
5447487|NCT01513057|bioequivalence|bioequivalence
5447488|NCT01513057|Mycophenolate Mofetil|mycophenolate mofetil
5447489|NCT01513057|crossover|crossover
5447490|NCT01513044|bioequivalence|bioequivalence
5447491|NCT01513044|Mycophenolate Mofetil|mycophenolate mofetil
5447492|NCT01513044|crossover|crossover
5447493|NCT01513031|Atrial fibrillation|atrial fibrillation
5447494|NCT01513031|Anti-arrhythmic medication|anti-arrhythmic medication
5447495|NCT01513031|Medication adherence|medication adherence
5447496|NCT01513018|OLV|olv
5447497|NCT01513018|one lung ventilation|one lung ventilation
5447498|NCT01513005|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5447499|NCT01513005|obesity management|obesity management
5447500|NCT01512966|Diabetic Macular Edema|diabetic macular edema
5447501|NCT01512966|DME|dme
5447502|NCT01512966|VEGF Trap-Eye|vegf trap-eye
5447503|NCT01512966|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
5447504|NCT01512953|PPI|ppi
5447505|NCT01512953|clopidogrel|clopidogrel
5447506|NCT01512953|2C19|2c19
5447507|NCT01512953|Lansoprazole|lansoprazole
5447508|NCT01512940|obesity|obesity
5447509|NCT01512940|Laparoscopic Greater Curvature Plication|laparoscopic greater curvature plication
5447510|NCT01512940|Percent Excess weight Loss|percent excess weight loss
5447511|NCT01512940|comorbidities|comorbidities
5447512|NCT01512940|BMI|bmi
5447513|NCT01512940|Bariatric Surgery|bariatric surgery
5447514|NCT01512927|electronic stethoscope|electronic stethoscope
5447515|NCT01512927|arteriovenous fistula|arteriovenous fistula
5447516|NCT01512927|hemodialysis,|hemodialysis,
5447517|NCT01512914|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5447518|NCT01512914|Postoperative pain|postoperative pain
5447519|NCT01512914|Nebulization|nebulization
5447520|NCT01512914|Ropivacaine|ropivacaine
5447521|NCT01512888|SCID|scid
5447522|NCT01512888|SCID-X1|scid-x1
5447523|NCT01512888|X-linked SCID|x-linked scid
5447524|NCT01512888|immunodeficiency|immunodeficiency
5447525|NCT01512888|gene therapy|gene therapy
5447526|NCT01512875|Helicobacter pylori|helicobacter pylori
5447527|NCT01512875|water contamination|water contamination
5447528|NCT01512875|Lima, Peru|lima, peru
5447529|NCT01512862|Calcitriol|calcitriol
5447530|NCT01512862|Off-label|off-label
5447531|NCT01512849|TA-7284|ta-7284
5447532|NCT01512849|JNJ-28431754|jnj-28431754
5447533|NCT01512849|Canagliflozin|canagliflozin
5447534|NCT01512849|Renal Impairment|renal impairment
5447535|NCT01512849|Sodium Glucose Co-transporter2 (SGLT2) inhibitor|sodium glucose co-transporter2 (sglt2) inhibitor
5447536|NCT01512836|COPD|copd
5447537|NCT01512836|Case management|case management
5447538|NCT01512836|CEA|cea
5447539|NCT01512836|Health economy|health economy
5447540|NCT01512836|Quality of Life|quality of life
5447541|NCT01512823|randomised controlled trial|randomised controlled trial
5447542|NCT01512823|educational intervention|educational intervention
5447543|NCT01512823|occupational therapy|occupational therapy
5447544|NCT01512810|Endometrial|endometrial
5447545|NCT01512810|Cancer|cancer
5447546|NCT01512810|Intraoperative Consultation|intraoperative consultation
5447547|NCT01512797|Januvia|januvia
5447548|NCT01512797|Sitagliptin|sitagliptin
5447549|NCT01512797|Diabetes|diabetes
5447550|NCT01512797|Gastric-Bypass|gastric-bypass
5447551|NCT01512784|Quadrivalent Human Papillomavirus Vaccine (HPV) Gardasil|quadrivalent human papillomavirus vaccine (hpv) gardasil
5447552|NCT01512784|HIV infection|hiv infection
5447553|NCT01512784|Evaluation of quadrivalent HPV vaccine in adolescents and young adults.|evaluation of quadrivalent hpv vaccine in adolescents and young adults.
5447554|NCT01512758|East Asian Patients|east asian patients
5447555|NCT01512758|Advanced solid tumors|advanced solid tumors
5447556|NCT01512758|Lymphomas|lymphomas
5447557|NCT01512758|MLN8237|mln8237
5447558|NCT01512758|Alisertib|alisertib
5447559|NCT01512758|Aurora A Kinase Inhibitor|aurora a kinase inhibitor
5447560|NCT01512758|Drug therapy|drug therapy
5447561|NCT01512706|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5447562|NCT01512706|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5447563|NCT01512706|Inactivated Vaccine|inactivated vaccine
5447564|NCT01512706|Human Diploid cell|human diploid cell
5447565|NCT01512706|Safety|safety
5447566|NCT01512706|Immunogenicity|immunogenicity
5447567|NCT01512706|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5447568|NCT01512680|Functional Insulin Thearpy|functional insulin thearpy
5447569|NCT01512680|Carbs counting|carbs counting
5447570|NCT01512680|Type 1 diabetes mellitus|type 1 diabetes mellitus
5447571|NCT01512680|Insulin pump|insulin pump
5447572|NCT01512680|Treatment by external insulin pump|treatment by external insulin pump
5447573|NCT01512654|diabetes|diabetes
5447574|NCT01512654|diadvisor|diadvisor
5447575|NCT01512654|type 1 diabetes|type 1 diabetes
5447576|NCT01512654|type 2 diabetes|type 2 diabetes
5447577|NCT01512654|glucose prediction|glucose prediction
5447578|NCT01512654|cgm prediction|cgm prediction
5447579|NCT01512654|algorithm|algorithm
5447580|NCT01512654|therapy advices|therapy advices
5447581|NCT01512641|children dissociative disorders schizophrenia|children dissociative disorders schizophrenia
5447582|NCT01512615|Rehabilitation|rehabilitation
5447583|NCT01512615|Exercise training|exercise training
5447584|NCT01512615|Psycho-educational care|psycho-educational care
5447585|NCT01512602|Borderline Personality Disorder traits|borderline personality disorder traits
5447587|NCT01512602|Self-harm|self-harm
5447588|NCT01512602|Dialectical Behavior Therapy|dialectical behavior therapy
5447589|NCT01512602|DBT|dbt
5447590|NCT01512602|Collaborative Assessment and Management of Suicidology|collaborative assessment and management of suicidology
5447591|NCT01512602|CAMS|cams
5447592|NCT01512589|Proton Beam Therapy|proton beam therapy
5447593|NCT01512589|PBT|pbt
5447594|NCT01512589|Intensity-Modulated Radiation Therapy|intensity-modulated radiation therapy
5447595|NCT01512589|IMRT|imrt
5447596|NCT01512589|Esophageal cancer|esophageal cancer
5447597|NCT01512589|Adenocarcinoma|adenocarcinoma
5447598|NCT01512589|Squamous cell carcinoma|squamous cell carcinoma
5447599|NCT01512589|Cervical esophagus|cervical esophagus
5447600|NCT01512589|Thoracic esophagus|thoracic esophagus
5447601|NCT01512589|Gastroesophageal junction|gastroesophageal junction
5447602|NCT01512589|Cardia of stomach|cardia of stomach
5447603|NCT01512589|Questionnaires|questionnaires
5447604|NCT01512589|Surveys|surveys
5447605|NCT01512589|Symptom scores|symptom scores
5447606|NCT01512589|Quality of life|quality of life
5447607|NCT01512589|QOL|qol
5447608|NCT01512576|whiplash|whiplash
5447609|NCT01512576|chronic pain|chronic pain
5447610|NCT01512576|sensitization|sensitization
5447612|NCT01512576|acupuncture|acupuncture
5447613|NCT01512576|relaxation|relaxation
5447614|NCT01512563|paclitaxel|paclitaxel
5447615|NCT01512563|drug eluting stent|drug eluting stent
5447616|NCT01512550|Radiostereometric Analysis (RSA)|radiostereometric analysis (rsa)
5447617|NCT01512550|Total hip arthroplasty (THA)|total hip arthroplasty (tha)
5447618|NCT01512550|Hip anatomy|hip anatomy
5447619|NCT01512550|Hip biomechanics|hip biomechanics
5447620|NCT01512537|Vitamin D|vitamin d
5447621|NCT01512537|UVB|uvb
5447622|NCT01512537|Vitamin D supplementation|vitamin d supplementation
5447623|NCT01512524|Traumatic Brain Injury|traumatic brain injury
5447624|NCT01512524|Quality of Life (QoL)|quality of life (qol)
5447625|NCT01512524|hypopituitarism,GH|hypopituitarism,gh
5447626|NCT01512511|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5447627|NCT01512511|pneumoperitoneum|pneumoperitoneum
5447628|NCT01512511|nitrous oxide|nitrous oxide
5447629|NCT01512511|carbon dioxide|carbon dioxide
5447630|NCT01512498|VV GVHD|vv gvhd
5447631|NCT01512498|girls|girls
5447632|NCT01512498|adolescents|adolescents
5447633|NCT01512498|HSCT|hsct
5447634|NCT01512485|Bioequivalence|bioequivalence
5447635|NCT01512485|Clopidogrel|clopidogrel
5447636|NCT01512485|crossover|crossover
5447637|NCT01512472|localized prostate cancer|localized prostate cancer
5447638|NCT01512472|degarelix|degarelix
5447639|NCT01512472|intermittent androgen deprivation therapy|intermittent androgen deprivation therapy
5447640|NCT01512459|Bioavailability|bioavailability
5447641|NCT01512459|Venlafaxine|venlafaxine
5447642|NCT01512459|two way crossover|two way crossover
5447643|NCT01512446|Osteoporosis|osteoporosis
5447644|NCT01512446|Osteoporotic fractures|osteoporotic fractures
5447645|NCT01512446|Bisphosphonate|bisphosphonate
5447646|NCT01512446|Pretreatment with bisphosphonates|pretreatment with bisphosphonates
5447647|NCT01512433|acupuncture|acupuncture
5447648|NCT01512433|methadone|methadone
5447649|NCT01512407|Hepatocellular Carcinoma|hepatocellular carcinoma
5447650|NCT01512407|Randomised controlled trial|randomised controlled trial
5447651|NCT01512407|Transarterial chemoembolisation|transarterial chemoembolisation
5447652|NCT01512394|bowel preparation|bowel preparation
5447653|NCT01512381|heart failure|heart failure
5447654|NCT01512381|CRT|crt
5447655|NCT01512381|atrial fibrillation|atrial fibrillation
5447656|NCT01512381|AV junction ablation|av junction ablation
5447657|NCT01512368|Fibroblast growth factor 21 (FGF21)|fibroblast growth factor 21 (fgf21)
5447658|NCT01512368|Exercise|exercise
5447659|NCT01512368|Metabolic equivalents (METs)|metabolic equivalents (mets)
5447660|NCT01512368|Lipolysis|lipolysis
5447661|NCT01512368|Glucose|glucose
5447662|NCT01512368|Free fatty acids (FFAs)|free fatty acids (ffas)
5447663|NCT01512368|Epinephrine|epinephrine
5447664|NCT01512342|pacing|pacing
5447665|NCT01512342|activity management|activity management
5447666|NCT01512342|relaxation|relaxation
5447667|NCT01512342|physiotherapy|physiotherapy
5447668|NCT01512342|occupational therapy|occupational therapy
5447669|NCT01512342|autonomic nervous system|autonomic nervous system
5447670|NCT01512329|neurology|neurology
5447671|NCT01512329|physiotherapy|physiotherapy
5447672|NCT01512329|physical therapy|physical therapy
5447673|NCT01512329|occupational therapy|occupational therapy
5447674|NCT01512329|stress management|stress management
5447675|NCT01512329|activity management|activity management
5447676|NCT01512329|treatment|treatment
5447677|NCT01512316|Fear|fear
5447678|NCT01512316|Cycloserine|cycloserine
5447679|NCT01512316|Conditioning|conditioning
5447680|NCT01512316|Functional neuroimaging|functional neuroimaging
5447681|NCT01512316|Anxiety disorders|anxiety disorders
5447682|NCT01512303|PTSD|ptsd
5447683|NCT01512303|Veterans' Health|veterans' health
5447684|NCT01512303|Meditation|meditation
5447685|NCT01512303|MRI, Functional|mri, functional
5447686|NCT01512290|Auditory verbal hallucinations|auditory verbal hallucinations
5447687|NCT01512290|Transcranial Magnetic stimulation|transcranial magnetic stimulation
5447688|NCT01512290|Theta Burst frequency|theta burst frequency
5447689|NCT01512277|vaccines|vaccines
5447690|NCT01512277|safety|safety
5447691|NCT01512277|drug tolerance|drug tolerance
5447692|NCT01512277|immunogenic protein|immunogenic protein
5447693|NCT01512277|antibody response|antibody response
5447694|NCT01512277|cytokine|cytokine
5447695|NCT01512264|Aphasia|aphasia
5447696|NCT01512264|Stroke|stroke
5447697|NCT01512264|functional Magnetic resonance imaging|functional magnetic resonance imaging
5447698|NCT01512264|fMRI|fmri
5447699|NCT01512264|Language recovery after stroke|language recovery after stroke
5430357|NCT01586026|Ports|ports
5447700|NCT01512264|constraint induced aphasia therapy|constraint induced aphasia therapy
5447701|NCT01512264|CIAT|ciat
5447702|NCT01512264|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5447703|NCT01512264|rTMS|rtms
5447704|NCT01512251|BKM120|bkm120
5447705|NCT01512251|BRAF|braf
5447706|NCT01512251|Melanoma|melanoma
5447707|NCT01512251|PI3K|pi3k
5447708|NCT01512238|Medicine adherence|medicine adherence
5447709|NCT01512238|Drug substitution|drug substitution
5447710|NCT01512238|Herb-drug interaction|herb-drug interaction
5447712|NCT01512238|Dietary supplements|dietary supplements
5447713|NCT01512238|Over-the-counter products|over-the-counter products
5447714|NCT01512238|On-line prescription records|on-line prescription records
5447715|NCT01512238|Personal electronic medicine profile|personal electronic medicine profile
5447716|NCT01512238|Intentional non-adherence|intentional non-adherence
5447717|NCT01512238|Unintentional non-adherence|unintentional non-adherence
5447725|NCT01512212|biopsy|biopsy
5447726|NCT01512212|new|new
5447727|NCT01512212|technique|technique
5447728|NCT01512199|U3-1287|u3-1287
5447729|NCT01512199|Trastuzumab|trastuzumab
5447730|NCT01512199|Paclitaxel|paclitaxel
5447731|NCT01512199|newly diagnosed HER-2 positive|newly diagnosed her-2 positive
5447732|NCT01512199|breast cancer|breast cancer
5447733|NCT01512199|metastatic|metastatic
5447734|NCT01512186|Clear cell renal cancer|clear cell renal cancer
5447735|NCT01512173|Propranolol gel|propranolol gel
5447736|NCT01512173|Hemangioma|hemangioma
5447737|NCT01512173|capillary neoplasm|capillary neoplasm
5447738|NCT01512173|vascular tissue|vascular tissue
5447739|NCT01512173|neoplasm by histologic type|neoplasm by histologic type
5447740|NCT01512173|neoplasm|neoplasm
5447741|NCT01512173|therapeutic uses|therapeutic uses
5447742|NCT01512173|pharmacologic actions|pharmacologic actions
5447743|NCT01512173|adrenergic beta-antagonists|adrenergic beta-antagonists
5447744|NCT01512173|adrenergic antagonist|adrenergic antagonist
5447745|NCT01512173|adrenergics agent|adrenergics agent
5447746|NCT01512173|neurotransmitter agent|neurotransmitter agent
5447747|NCT01512173|molecular mechanism of pharmacological action|molecular mechanism of pharmacological action
5447748|NCT01512173|physiological effects of drugs|physiological effects of drugs
5447749|NCT01512160|Post-surgical dental pain|post-surgical dental pain
5447750|NCT01512147|SSEP measurements|ssep measurements
5447751|NCT01512147|MEP measurements|mep measurements
5447752|NCT01512147|Pediatric Patients|pediatric patients
5447753|NCT01512147|Neurosurgery|neurosurgery
5447754|NCT01512147|General Anesthesia|general anesthesia
5447755|NCT01512134|Obesity|obesity
5432906|NCT01575470|TBI|tbi
5447756|NCT01512134|DBS|dbs
5447757|NCT01512082|Pain|pain
5447758|NCT01512082|Delayed onset muscle soreness|delayed onset muscle soreness
5447759|NCT01512082|Pulsed electromagnetic field|pulsed electromagnetic field
5447760|NCT01512082|Marathon|marathon
5447761|NCT01512069|randomized controlled trial|randomized controlled trial
5447762|NCT01512069|internet|internet
5447764|NCT01512069|exercise|exercise
5447765|NCT01512069|health planning|health planning
5447766|NCT01512069|the TTM|the ttm
5447767|NCT01512056|Influenza vaccine|influenza vaccine
5447768|NCT01512056|dialysis|dialysis
5447769|NCT01512056|vaccine|vaccine
5447770|NCT01512056|Seroprotection|seroprotection
5447771|NCT01512056|Seroresponse|seroresponse
5447772|NCT01512056|Seroconversion|seroconversion
5447773|NCT01512056|Safety of the vaccine|safety of the vaccine
5447774|NCT01512043|Breathlessness|breathlessness
5447775|NCT01512043|Symptoms|symptoms
5447776|NCT01512043|Quality of life|quality of life
5447777|NCT01512017|skin lesions or defects|skin lesions or defects
5447778|NCT01512004|Overactive Bladder|overactive bladder
5447779|NCT01512004|urgent micturition|urgent micturition
5447780|NCT01512004|frequent micturition|frequent micturition
5447781|NCT01512004|urge urinary incontinence|urge urinary incontinence
5447782|NCT01511991|cardiac surgery|cardiac surgery
5447783|NCT01511991|sevoflurane|sevoflurane
5447784|NCT01511991|tissue Doppler|tissue doppler
5447785|NCT01511978|Lambert-Eaton|lambert-eaton
5447786|NCT01511978|Eaton-Lambert|eaton-lambert
5447787|NCT01511978|myasthenia|myasthenia
5447788|NCT01511978|myasthenic|myasthenic
5447789|NCT01511978|LEMS|lems
5447790|NCT01511978|LES|les
5447791|NCT01511978|DAP|dap
5447792|NCT01511978|diaminopyridine|diaminopyridine
5447793|NCT01511978|3,4-diaminopyridine|3,4-diaminopyridine
5447794|NCT01511978|3,4-DAP|3,4-dap
5447795|NCT01511952|music therapy|music therapy
5447810|NCT01511913|Unresectable or metastatic cutaneous melanoma|unresectable or metastatic cutaneous melanoma
5447811|NCT01511887|Patent Ductus Arteriosus|patent ductus arteriosus
5447812|NCT01511887|PDA|pda
5447813|NCT01511887|Term newborns|term newborns
5447814|NCT01511887|Ibuprofen|ibuprofen
5447815|NCT01511874|ELIGARD|eligard
5447816|NCT01511874|Prostate cancer|prostate cancer
5447817|NCT01511848|Iron chelation|iron chelation
5447818|NCT01511848|Iron balance|iron balance
5447819|NCT01511848|Secondary iron overload|secondary iron overload
5447820|NCT01511848|deferoxamine|deferoxamine
5447821|NCT01511848|deferasirox|deferasirox
5447822|NCT01511848|Deferiprone|deferiprone
5447823|NCT01511848|1- Beta-thalassemia major patients;|1- beta-thalassemia major patients;
5447824|NCT01511848|Patients with high iron stores|patients with high iron stores
5447825|NCT01511848|Serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months|serum ferritin consistently > 2500 mcg/l and or increasing trend over previous 12 months
5447826|NCT01511848|Liver iron >14 mg/g dry weight- by R2 MRI|liver iron >14 mg/g dry weight- by r2 mri
5442600|NCT01534390|adult|adult
5447827|NCT01511848|2- Sickle cell disease|2- sickle cell disease
5447828|NCT01511848|3- Other causes of transfusional iron hemosiderosis|3- other causes of transfusional iron hemosiderosis
5447830|NCT01511835|pregnancy|pregnancy
5447831|NCT01511835|myo-inositol|myo-inositol
5447832|NCT01511822|PCOS|pcos
5447833|NCT01511822|Insulin resistance|insulin resistance
5447834|NCT01511822|Hyperandrogenism|hyperandrogenism
5447835|NCT01511822|Myo-inositol|myo-inositol
5447836|NCT01511809|HIV-1|hiv-1
5447837|NCT01511796|stroke|stroke
5447838|NCT01511796|upper limb rehabilitation function|upper limb rehabilitation function
5447839|NCT01511770|Bioequivalence|bioequivalence
5447840|NCT01511770|Fluconazole|fluconazole
5447841|NCT01511770|Crossover|crossover
5447842|NCT01511757|Bioequivalence|bioequivalence
5447843|NCT01511757|Fluconazole|fluconazole
5447844|NCT01511757|Crossover|crossover
5447845|NCT01511744|Respiratory Tract Infections; Orthomyxoviridae Infections|respiratory tract infections; orthomyxoviridae infections
5447846|NCT01511731|Bioequivalence|bioequivalence
5447847|NCT01511731|famotidine|famotidine
5447848|NCT01511731|Crossover|crossover
5447849|NCT01511718|Bioequivalence|bioequivalence
5447850|NCT01511718|Ondansetron|ondansetron
5447851|NCT01511718|crossover|crossover
5447852|NCT01511705|Bioequivalence|bioequivalence
5447853|NCT01511705|Ondansetron|ondansetron
5447854|NCT01511705|crossover|crossover
5447855|NCT01511679|Alcohol abuse|alcohol abuse
5447856|NCT01511666|cardiac arrest|cardiac arrest
5447857|NCT01511666|mechanical chest compressions|mechanical chest compressions
5447858|NCT01511666|intraarrest cooling|intraarrest cooling
5447859|NCT01511666|ECLS|ecls
5447860|NCT01511653|screening colonoscopy|screening colonoscopy
5447861|NCT01511653|colon cancer early detection|colon cancer early detection
5447862|NCT01511653|rectal cancer early detection|rectal cancer early detection
5447863|NCT01511653|colorectal cancer prevention|colorectal cancer prevention
5447864|NCT01511653|biomarker validation|biomarker validation
5447865|NCT01511640|marijuana|marijuana
5447866|NCT01511640|addiction|addiction
5447867|NCT01511640|treatment|treatment
5447868|NCT01511640|pharmacotherapy|pharmacotherapy
5447869|NCT01511640|cannabinoid|cannabinoid
5447870|NCT01511614|fMRI|fmri
5447871|NCT01511614|tDCS|tdcs
5447872|NCT01511601|Apheresis|apheresis
5447873|NCT01511601|Leukocytes|leukocytes
5447874|NCT01511601|Plasma|plasma
5447875|NCT01511601|Plamodium Falciparum Malaria|plamodium falciparum malaria
5447876|NCT01511601|Immunology|immunology
5447877|NCT01511588|Kallmann Syndrome|kallmann syndrome
5451010|NCT01498458|GBG|gbg
5447878|NCT01511588|Delayed Puberty|delayed puberty
5447879|NCT01511588|GnRH Deficiency|gnrh deficiency
5447881|NCT01511588|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5447882|NCT01511588|Amenorrhea|amenorrhea
5447883|NCT01511588|Hypogonadism|hypogonadism
5447884|NCT01511575|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5447885|NCT01511575|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5447886|NCT01511575|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5447887|NCT01511562|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5447888|NCT01511562|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5447889|NCT01511562|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5447890|NCT01511562|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5447891|NCT01511562|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5447892|NCT01511562|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5447893|NCT01511523|Liver|liver
5447894|NCT01511523|Fatty|fatty
5447895|NCT01511523|Non Alcoholic|non alcoholic
5447896|NCT01511523|Vitamin E|vitamin e
5447897|NCT01511523|Silymarin|silymarin
5447898|NCT01511523|Carnitine|carnitine
5447899|NCT01511523|Supplement|supplement
5447900|NCT01511523|NAFLD|nafld
5447901|NCT01511510|PF-04958242|pf-04958242
5447902|NCT01511510|multiple dose|multiple dose
5447904|NCT01511510|schizophrenia|schizophrenia
5447905|NCT01511497|Phase 1|phase 1
5447906|NCT01511497|PF-04427429|pf-04427429
5447907|NCT01511484|fruit|fruit
5447908|NCT01511484|vegetables|vegetables
5447909|NCT01511484|appearance|appearance
5447910|NCT01511484|skin color|skin color
5447911|NCT01511484|carotenoids|carotenoids
5447912|NCT01511484|diet|diet
5447913|NCT01511471|Ticagrelor|ticagrelor
5447914|NCT01511471|platelet reactivity|platelet reactivity
5447915|NCT01511471|clopidogrel|clopidogrel
5447916|NCT01511471|haemodialysis|haemodialysis
5447917|NCT01511458|Pregnancy|pregnancy
5447918|NCT01511458|Fetal aneuploidy|fetal aneuploidy
5447919|NCT01511458|Trisomy 21|trisomy 21
5447920|NCT01511458|Down Syndrome|down syndrome
5447921|NCT01511458|Prenatal screening|prenatal screening
5447922|NCT01511458|Non-invasive prenatal testing|non-invasive prenatal testing
5447923|NCT01511458|First trimester|first trimester
5447924|NCT01511458|Combined screening|combined screening
5442695|NCT01533844|CDAD|cdad
5447925|NCT01511458|Nuchal translucency|nuchal translucency
5447926|NCT01511458|PAPP-A|papp-a
5447927|NCT01511458|hCG|hcg
5447928|NCT01511458|cell free DNA|cell free dna
5447929|NCT01511458|cf DNA|cf dna
5447930|NCT01511458|DNA|dna
5447931|NCT01511458|Performance characteristics of non-invasive first trimester screening|performance characteristics of non-invasive first trimester screening
5447932|NCT01511458|Harmony Prenatal Test|harmony prenatal test
5447933|NCT01511445|Cervicobrachial pain|cervicobrachial pain
5447934|NCT01511445|radicular pain|radicular pain
5447935|NCT01511445|arm pain|arm pain
5447936|NCT01511445|myelopathy|myelopathy
5447937|NCT01511445|radiculitis|radiculitis
5447938|NCT01511445|Radiating pain with or without signs of myelopathy.|radiating pain with or without signs of myelopathy.
5447939|NCT01511432|Relative bioavailability|relative bioavailability
5447940|NCT01511432|telaprevir formulations|telaprevir formulations
5447941|NCT01511419|Influenza|influenza
5447942|NCT01511419|Vaccine|vaccine
5447943|NCT01511419|Pandemic|pandemic
5447944|NCT01511419|H7N3|h7n3
5447945|NCT01511406|Psychosis|psychosis
5447946|NCT01511406|Schizophrenia|schizophrenia
5447947|NCT01511406|Cognitive behavioral therapy|cognitive behavioral therapy
5447948|NCT01511406|Self esteem|self esteem
5447949|NCT01511406|Depression|depression
5447950|NCT01511393|GLP1|glp1
5447951|NCT01511393|Glucagon like peptide|glucagon like peptide
5447952|NCT01511393|liraglutide|liraglutide
5447953|NCT01511393|exenatide extended release|exenatide extended release
5447954|NCT01511393|albiglutide|albiglutide
5447955|NCT01511393|dulaglutide|dulaglutide
5447956|NCT01511380|juvenile|juvenile
5447957|NCT01511380|randomized trial|randomized trial
5447958|NCT01511380|substance abuse|substance abuse
5447959|NCT01511380|sexual risk|sexual risk
5447960|NCT01511380|contingency management|contingency management
5447961|NCT01511367|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
5447962|NCT01511354|critically ill children|critically ill children
5447964|NCT01511354|24hr protein balance|24hr protein balance
5447965|NCT01511354|stable isotopes|stable isotopes
5447966|NCT01511354|fed state|fed state
5433017|NCT01574859|lipids|lipids
5447967|NCT01511341|Telenursing|telenursing
5447968|NCT01511341|Children|children
5447969|NCT01511341|Chronic Illness|chronic illness
5447970|NCT01511341|Nursing|nursing
5447971|NCT01511328|HPV testing|hpv testing
5447972|NCT01511328|Primary screening|primary screening
5447973|NCT01511328|Cervical Cancer|cervical cancer
5447974|NCT01511315|Moderate to severe psoriasis|moderate to severe psoriasis
5447975|NCT01511289|Radotinib|radotinib
5447976|NCT01511289|CML-CP|cml-cp
5447977|NCT01511289|Chronic Myeloid Leukemia, chronic phase|chronic myeloid leukemia, chronic phase
5447978|NCT01511276|Breast cancer|breast cancer
5447979|NCT01511276|Sex hormones|sex hormones
5447980|NCT01511276|Physical activity|physical activity
5447981|NCT01511263|Epigallocatechin gallate|epigallocatechin gallate
5447982|NCT01511263|AL amyloidosis|al amyloidosis
5447983|NCT01511250|Normal healthy adults and children|normal healthy adults and children
5447984|NCT01511250|Safety and tolerability|safety and tolerability
5447985|NCT01511250|Active vaccine|active vaccine
5447987|NCT01511250|Dengue virus vaccine|dengue virus vaccine
5447988|NCT01511250|Immune response|immune response
5447989|NCT01511237|HIV-1 infection|hiv-1 infection
5447990|NCT01511237|Prophylaxis|prophylaxis
5447991|NCT01511237|Mother-to-child transmission HIV-1|mother-to-child transmission hiv-1
5447992|NCT01511237|Thailand|thailand
5447993|NCT01511237|Developing Countries|developing countries
5447994|NCT01511224|Bloodstream infections|bloodstream infections
5447995|NCT01511224|Acinetobacter|acinetobacter
5447996|NCT01511224|Drug resistant Acinetobacter baumannii bacteremia|drug resistant acinetobacter baumannii bacteremia
5447997|NCT01511211|Dexamethasone|dexamethasone
5447998|NCT01511211|lower limb block|lower limb block
5447999|NCT01511211|ultrasound guided femoral nerve block|ultrasound guided femoral nerve block
5448000|NCT01511211|ultrasound guided obturator nerve block|ultrasound guided obturator nerve block
5448001|NCT01511211|ultrasound guided sciatic nerve block|ultrasound guided sciatic nerve block
5448002|NCT01511211|ropivacaine|ropivacaine
5448003|NCT01511211|total knee arthroplasty|total knee arthroplasty
5448004|NCT01511211|Post surgical pain after total knee arthroplasty|post surgical pain after total knee arthroplasty
5448005|NCT01511146|oxaliplatin|oxaliplatin
5448006|NCT01511146|mitomycin|mitomycin
5448007|NCT01511146|gemcitabine|gemcitabine
5448008|NCT01511146|intrahepatic|intrahepatic
5448009|NCT01511146|liver metastasis|liver metastasis
5448010|NCT01511146|response in liver metastasis|response in liver metastasis
5448011|NCT01511146|downsized to operation|downsized to operation
5448012|NCT01511133|Laboratory evaluations|laboratory evaluations
5448013|NCT01511133|infants|infants
5448014|NCT01511133|Porcine circovirus type 1 (PCV-1)|porcine circovirus type 1 (pcv-1)
5448015|NCT01511133|serologic response|serologic response
5448016|NCT01511133|human rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
5448017|NCT01511107|acute otitis media|acute otitis media
5448018|NCT01511107|ear infection|ear infection
5448019|NCT01511107|antimicrobial therapy|antimicrobial therapy
5448020|NCT01511107|antimicrobial resistance|antimicrobial resistance
5448021|NCT01511094|ab-interno trabeculectomy,|ab-interno trabeculectomy,
5448022|NCT01511094|intraocular pressure,|intraocular pressure,
5448023|NCT01511094|open angle glaucoma|open angle glaucoma
5448024|NCT01511094|trabeculectomy|trabeculectomy
5448025|NCT01511094|Goniocurettage|goniocurettage
5448026|NCT01511094|Non-Filtering Surgery|non-filtering surgery
5448027|NCT01511081|Non-small-cell lung cancer|non-small-cell lung cancer
5448029|NCT01511081|Centrally-located|centrally-located
5448030|NCT01511081|Recurrent|recurrent
5448031|NCT01511081|Squamous cell carcinoma|squamous cell carcinoma
5448032|NCT01511081|Adenocarcinoma|adenocarcinoma
5448033|NCT01511081|Large cell carcinoma|large cell carcinoma
5448034|NCT01511081|Bronchioloalveolar cell carcinoma|bronchioloalveolar cell carcinoma
5448035|NCT01511081|Non-small cell carcinoma not otherwise specified|non-small cell carcinoma not otherwise specified
5448036|NCT01511081|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5448037|NCT01511081|SBRT|sbrt
5448038|NCT01511081|Stereotactic Body Proton Therapy|stereotactic body proton therapy
5448039|NCT01511081|SBPT|sbpt
5448041|NCT01511055|Ovarian Cancer|ovarian cancer
5448042|NCT01511016|lipid kinetics|lipid kinetics
5448043|NCT01511016|fat oxidation|fat oxidation
5448044|NCT01511003|calcineurin inhibitor|calcineurin inhibitor
5448045|NCT01511003|Prograf|prograf
5448046|NCT01511003|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5448047|NCT01511003|Tacrolimus|tacrolimus
5448048|NCT01510990|Non-small cell lung cancer|non-small cell lung cancer
5448049|NCT01510990|Gefitinib|gefitinib
5448050|NCT01510990|FDG-PET|fdg-pet
5448051|NCT01510977|colonoscopy|colonoscopy
5448052|NCT01510977|bowel preparation|bowel preparation
5448053|NCT01510964|Breast cancer|breast cancer
5448054|NCT01510964|Patient involvement|patient involvement
5448055|NCT01510964|Question prompt-sheet|question prompt-sheet
5448056|NCT01510964|Doctor-patient communication|doctor-patient communication
5448057|NCT01510964|RCT|rct
5448058|NCT01510951|AMGEN|amgen
5448059|NCT01510951|PSORIASIS|psoriasis
5448060|NCT01510951|SAFETY|safety
5448061|NCT01510938|Children|children
5448062|NCT01510938|Respiratory Tract Infections|respiratory tract infections
5448063|NCT01510938|Prevention|prevention
5448064|NCT01510886|MDD, management, Andalusia, Database, PismaEP|mdd, management, andalusia, database, pismaep
5448065|NCT01510873|Health-related quality of life|health-related quality of life
5448066|NCT01510873|Fatigue|fatigue
5448067|NCT01510873|pITO|pito
5448068|NCT01510873|Primary Immune Thrombocytopenic Purpura|primary immune thrombocytopenic purpura
5451215|NCT01497665|GRN1005|grn1005
5448069|NCT01510834|Computerized Tailored Intervention|computerized tailored intervention
5448071|NCT01510834|Post Traumatic Stress Disorder|post traumatic stress disorder
5448072|NCT01510834|PTSD|ptsd
5448073|NCT01510834|Smoking|smoking
5448074|NCT01510834|Anxiety|anxiety
5448075|NCT01510834|Depression|depression
5448076|NCT01510821|endoscopic vein harvest|endoscopic vein harvest
5448077|NCT01510821|saphenous vein graft|saphenous vein graft
5448078|NCT01510821|endothelial function|endothelial function
5448079|NCT01510808|aggressive periodontitis orthodontic stability|aggressive periodontitis orthodontic stability
5448080|NCT01510795|Kidney transplantation|kidney transplantation
5448081|NCT01510795|Mineralocorticoid receptors|mineralocorticoid receptors
5448082|NCT01510795|Spironolactone|spironolactone
5448083|NCT01510743|open heart surgery|open heart surgery
5448084|NCT01510743|lung surgery|lung surgery
5448085|NCT01510743|spine surgery|spine surgery
5448086|NCT01510743|hepatobiliary surgery|hepatobiliary surgery
5448087|NCT01510730|gastric tumor|gastric tumor
5448088|NCT01510730|Helicobacter pylori|helicobacter pylori
5448089|NCT01510730|endoscopic resection|endoscopic resection
5448090|NCT01510730|metachronous neoplasms|metachronous neoplasms
5435023|NCT01566448|Ketamine|ketamine
5448091|NCT01510717|Intraocular Lens|intraocular lens
5448092|NCT01510717|Monofocal|monofocal
5448093|NCT01510717|Multifocal|multifocal
5448094|NCT01510691|Oxygenation of the retinal vessels|oxygenation of the retinal vessels
5448095|NCT01510691|vitroretinal surgery|vitroretinal surgery
5448096|NCT01510678|Diet Quality|diet quality
5448097|NCT01510665|Weight gain in pregnancy|weight gain in pregnancy
5448098|NCT01510665|Metabolic and Inflammatory markers|metabolic and inflammatory markers
5448099|NCT01510652|Cardiac Resynchronization therapy,|cardiac resynchronization therapy,
5448100|NCT01510652|Heart Failure,|heart failure,
5448101|NCT01510652|Left Ventricular Lead,|left ventricular lead,
5448102|NCT01510652|Quadripolar Left ventricular Lead,|quadripolar left ventricular lead,
5448103|NCT01510652|Phrenic Nerve Stimulation,|phrenic nerve stimulation,
5448104|NCT01510652|Intra and post operative related complications|intra and post operative related complications
5448105|NCT01510626|Multiple food allergies|multiple food allergies
5448106|NCT01510613|Pomalidomide|pomalidomide
5448107|NCT01510613|Dexamethasone|dexamethasone
5448108|NCT01510613|treatment|treatment
5448109|NCT01510613|AL amyloidosis|al amyloidosis
5448110|NCT01510600|stage 4S neuroblastoma|stage 4s neuroblastoma
5448111|NCT01510600|localized resectable neuroblastoma|localized resectable neuroblastoma
5448112|NCT01510600|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5448113|NCT01510600|recurrent neuroblastoma|recurrent neuroblastoma
5448114|NCT01510600|regional neuroblastoma|regional neuroblastoma
5448116|NCT01510587|prevention|prevention
5448117|NCT01510587|preteen|preteen
5448118|NCT01510587|nutrition|nutrition
5448119|NCT01510587|physical activity|physical activity
5448120|NCT01510587|body image|body image
5448121|NCT01510587|family dynamics|family dynamics
5448122|NCT01510574|postpartum hemorrhage, PPH, misoprostol|postpartum hemorrhage, pph, misoprostol
5448123|NCT01510561|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5448124|NCT01510561|pancreatic cancer|pancreatic cancer
5448125|NCT01510561|metastatic pancreatic cancer|metastatic pancreatic cancer
5448126|NCT01510548|Disc prolapse|disc prolapse
5448127|NCT01510548|Pain|pain
5448128|NCT01510548|Disability|disability
5448129|NCT01510535|Osteoartritis|osteoartritis
5448130|NCT01510535|Knee|knee
5448131|NCT01510535|LBSA0103|lbsa0103
5448132|NCT01510535|Hyruan Plus Inj.|hyruan plus inj.
5448133|NCT01510522|Diabetes|diabetes
5448134|NCT01510522|Glucophage|glucophage
5448135|NCT01510522|Metformin|metformin
5448136|NCT01510522|sachets|sachets
5448137|NCT01510522|tablets|tablets
5448138|NCT01510509|Drug Eluting Stent|drug eluting stent
5448139|NCT01510509|Bioactive Bare Metal Stent|bioactive bare metal stent
5448140|NCT01510496|Chronic pain|chronic pain
5448141|NCT01510496|genetic polymorphisms|genetic polymorphisms
5448142|NCT01510496|postoperative pain|postoperative pain
5448143|NCT01510483|obesity prevention|obesity prevention
5448144|NCT01510483|tobacco prevention|tobacco prevention
5448145|NCT01510483|nutrition|nutrition
5448146|NCT01510483|physical activity|physical activity
5448147|NCT01510483|sedentary activity|sedentary activity
5448148|NCT01510483|tobacco use|tobacco use
5448149|NCT01510483|tobacco exposure|tobacco exposure
5448150|NCT01510483|prevention|prevention
5448151|NCT01510483|clinician intervention|clinician intervention
5448153|NCT01510483|adolescents|adolescents
5448154|NCT01510470|AstraTech Osseospeed Profile Implant|astratech osseospeed profile implant
5448155|NCT01510470|Marginal bone level|marginal bone level
5448156|NCT01510470|soft tissue|soft tissue
5448157|NCT01510470|soft tissue responds|soft tissue responds
5448158|NCT01510457|Knee Osteoarthritis|knee osteoarthritis
5448159|NCT01510457|Degenerative Joint Disease|degenerative joint disease
5448160|NCT01510457|Chronic Pain|chronic pain
5448161|NCT01510457|Knee Pain|knee pain
5448162|NCT01510418|Hemophilia|hemophilia
5448163|NCT01510418|Spouse|spouse
5448164|NCT01510418|Significant Other|significant other
5448165|NCT01510418|Quality of Life|quality of life
5448167|NCT01510405|The following procedures are allowed: Wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.|the following procedures are allowed: wedge resection, lobectomy, bilobectomy, segmentectomy and pneumonectomy thoracic surgical operations are permitted.
5448171|NCT01510392|Keratoconus|keratoconus
5448172|NCT01510392|Screening|screening
5448173|NCT01510379|nausea|nausea
5448174|NCT01510379|vomiting|vomiting
5448175|NCT01510379|post-operative|post-operative
5448176|NCT01510379|foregut surgery|foregut surgery
5448177|NCT01510366|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5448178|NCT01510366|Sabin Strains|sabin strains
5448179|NCT01510366|poliomyelitis|poliomyelitis
5448180|NCT01510340|adherence|adherence
5448181|NCT01510340|HIV|hiv
5448182|NCT01510340|antiretroviral therapy|antiretroviral therapy
5448183|NCT01510340|tailored web intervention|tailored web intervention
5448184|NCT01510327|drug-eluting stents|drug-eluting stents
5448185|NCT01510327|DES|des
5448186|NCT01510327|atherosclerotic|atherosclerotic
5592623|NCT00920725|DKA|dka
5448187|NCT01510301|Self-report|self-report
5448188|NCT01510301|Self-management|self-management
5448189|NCT01510301|Hypertension|hypertension
5448190|NCT01510301|Adherence|adherence
5448191|NCT01510301|Cell phone|cell phone
5448192|NCT01510301|Drug treatment|drug treatment
5448193|NCT01510301|Medical Adherence|medical adherence
5448194|NCT01510288|GVAX|gvax
5448195|NCT01510288|Ipilimumab|ipilimumab
5448196|NCT01510288|prostate cancer|prostate cancer
5448197|NCT01510275|cardio-thoracic surgery|cardio-thoracic surgery
5448198|NCT01510275|patients|patients
5448199|NCT01510275|pulmonary volume|pulmonary volume
5448200|NCT01510275|respiratory muscle performance|respiratory muscle performance
5448201|NCT01510262|Repeat STI patients|repeat sti patients
5448202|NCT01510262|HIV|hiv
5448203|NCT01510262|Cost effectiveness|cost effectiveness
5448204|NCT01510262|Resource scarce|resource scarce
5448205|NCT01510262|Urban clinics|urban clinics
5448206|NCT01510249|calcaneal spur|calcaneal spur
5448207|NCT01510249|shock wave therapy|shock wave therapy
5448208|NCT01510249|ultrasound therapy|ultrasound therapy
5448209|NCT01510236|Adolescence|adolescence
5448210|NCT01510236|Cancer|cancer
5448211|NCT01510236|Depression|depression
5448212|NCT01510236|Anxiety|anxiety
5448213|NCT01510236|Self-help via internet|self-help via internet
5448214|NCT01510223|Fats|fats
5448215|NCT01510223|Macronutrients|macronutrients
5448216|NCT01510223|appetite|appetite
5448217|NCT01510223|gastric emptying|gastric emptying
5448218|NCT01510223|Gastrointestinal transit|gastrointestinal transit
5448220|NCT01510210|Arrhythmia|arrhythmia
5448221|NCT01510210|Rhythm control|rhythm control
5448222|NCT01510197|Atrial Fibrillation|atrial fibrillation
5448223|NCT01510197|Arrhythmia|arrhythmia
5448224|NCT01510197|Rhythm control|rhythm control
5448225|NCT01510171|platelet inhibitor|platelet inhibitor
5448226|NCT01510171|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5448227|NCT01510171|stent|stent
5448228|NCT01510171|prasugrel|prasugrel
5448229|NCT01510171|ticagrelor|ticagrelor
5448230|NCT01510145|Glaucoma|glaucoma
5448231|NCT01510145|Open-angle glaucoma|open-angle glaucoma
5448232|NCT01510145|Ocular hypertension|ocular hypertension
5448233|NCT01510145|Hypertension|hypertension
5448234|NCT01510145|Eye Diseases|eye diseases
5448235|NCT01510145|Vascular Diseases|vascular diseases
5448236|NCT01510145|Cardiovascular Diseases|cardiovascular diseases
5448237|NCT01510145|Travoprost|travoprost
5448238|NCT01510145|Antihypertensive Agents|antihypertensive agents
5448239|NCT01510145|Cardiovascular Agents|cardiovascular agents
5448240|NCT01510145|Therapeutic Uses|therapeutic uses
5448241|NCT01510145|Pharmacologic Actions|pharmacologic actions
5448243|NCT01510132|OHT|oht
5448244|NCT01510093|type 2 diabetes mellitus, endogenous insulin|type 2 diabetes mellitus, endogenous insulin
5448245|NCT01510080|Computer-assisted live supervision|computer-assisted live supervision
5448246|NCT01510080|"Bug-in-the-eye supervision"|"bug-in-the-eye supervision"
5448247|NCT01510080|Delayed video-based supervision|delayed video-based supervision
5448248|NCT01510080|Cognitive behavioral therapy supervision|cognitive behavioral therapy supervision
5448250|NCT01510067|Lupus|lupus
5448251|NCT01510067|Lupus Erythematosus|lupus erythematosus
5448252|NCT01510054|miRNA in endometrium|mirna in endometrium
5448253|NCT01510041|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5448254|NCT01510041|Physical therapy|physical therapy
5448255|NCT01510041|Dyspnea|dyspnea
5448256|NCT01510041|Inspiratory muscle training|inspiratory muscle training
5448257|NCT01510041|Activities of daily living|activities of daily living
5448258|NCT01510028|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
5448259|NCT01510028|Recombinant human arylsulfatase A (rhASA)|recombinant human arylsulfatase a (rhasa)
5448260|NCT01510028|Metachromatic Leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5448261|NCT01510015|cannabis|cannabis
5448262|NCT01510015|psychostimulants|psychostimulants
5448263|NCT01510015|psychosis|psychosis
5448264|NCT01510002|papillary thyroid cancer|papillary thyroid cancer
5448265|NCT01510002|central neck dissection|central neck dissection
5448266|NCT01510002|survival|survival
5448267|NCT01510002|locoregional control|locoregional control
5448268|NCT01510002|morbidity|morbidity
5448269|NCT01509989|Adherence|adherence
5448270|NCT01509989|Compliance|compliance
5448271|NCT01509989|Systemic Lupus Erythematosus|systemic lupus erythematosus
5448272|NCT01509989|Hydroxychloroquine|hydroxychloroquine
5448273|NCT01509989|Blood monitoring|blood monitoring
5448274|NCT01509989|Flares|flares
5448275|NCT01509976|Triclosan|triclosan
5448276|NCT01509976|Triclocarban|triclocarban
5448277|NCT01509976|Microbial flora|microbial flora
5448278|NCT01509976|Obesity|obesity
5448279|NCT01509963|MSKCC nomogram|mskcc nomogram
5448280|NCT01509963|Tenon score|tenon score
5448281|NCT01509963|metastatic SN|metastatic sn
5448282|NCT01509963|low risk of metastatic non-SN|low risk of metastatic non-sn
5448283|NCT01509963|additional ALND|additional alnd
5448284|NCT01509937|end stage renal disease|end stage renal disease
5448285|NCT01509937|maintenance hemodialysis|maintenance hemodialysis
5448286|NCT01509937|dry weight|dry weight
5448287|NCT01509937|bioimpedance spectroscopy analysis|bioimpedance spectroscopy analysis
5448288|NCT01509937|body composition monitor|body composition monitor
5448289|NCT01509937|Fresenius BCM|fresenius bcm
5448290|NCT01509937|Ultrafiltration|ultrafiltration
5448291|NCT01509924|Walking capacity|walking capacity
5448292|NCT01509924|Mental Fatigue|mental fatigue
5448293|NCT01509924|Quality of Life|quality of life
5448294|NCT01509924|Cognition|cognition
5448295|NCT01509924|Motor activity|motor activity
5448296|NCT01509924|Exercise|exercise
5448297|NCT01509872|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
5448298|NCT01509872|War-affected Children|war-affected children
5448299|NCT01509872|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
5448300|NCT01509872|Psychosocial Distress|psychosocial distress
5448301|NCT01509859|proximal femur nail|proximal femur nail
5448302|NCT01509859|pfna|pfna
5448303|NCT01509859|intertan|intertan
5448304|NCT01509859|weight bearing|weight bearing
5448305|NCT01509859|pertrochanteric fracture|pertrochanteric fracture
5448306|NCT01509859|femur neck fracture|femur neck fracture
5448307|NCT01509846|Shigella|shigella
5448308|NCT01509846|vaccine|vaccine
5448309|NCT01509846|shigellosis|shigellosis
5448310|NCT01509846|dysentery|dysentery
5448311|NCT01509846|whole cell|whole cell
5448312|NCT01509833|ICSI Ovarian stimulation|icsi ovarian stimulation
5448313|NCT01509833|hCG low dose|hcg low dose
5448314|NCT01509833|Oocyte maturity|oocyte maturity
5448315|NCT01509833|poor respond|poor respond
5448316|NCT01509807|Ileostomy reversal|ileostomy reversal
5448317|NCT01509794|CME|cme
5448318|NCT01509794|Simulation|simulation
5448319|NCT01509794|Affective engagement|affective engagement
5448320|NCT01509794|Cognitive performance|cognitive performance
5448321|NCT01509781|simple mastectomy|simple mastectomy
5448322|NCT01509781|modified radical mastectomy|modified radical mastectomy
5448323|NCT01509781|wound care|wound care
5448324|NCT01509781|suction drain|suction drain
5448325|NCT01509781|adaptive suture|adaptive suture
5448326|NCT01509768|MPS IIIB|mps iiib
5448327|NCT01509729|Knee|knee
5448328|NCT01509729|Arthroscopy|arthroscopy
5448329|NCT01509729|Lidocaine patch|lidocaine patch
5448330|NCT01509729|Pain management after knee arthroscopy|pain management after knee arthroscopy
5448331|NCT01509716|Predialysis|predialysis
5448332|NCT01509703|COPD|copd
5448333|NCT01509703|Nasal High Flow Therapy|nasal high flow therapy
5448334|NCT01509703|tracheotomy stent|tracheotomy stent
5448335|NCT01509703|tracheotomy|tracheotomy
5448336|NCT01509690|Incident|incident
5448337|NCT01509690|Hemodialysis|hemodialysis
5448338|NCT01509677|Roflumilast|roflumilast
5448339|NCT01509677|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5448340|NCT01509677|COPD|copd
5448341|NCT01509651|antagonists neuromuscular block|antagonists neuromuscular block
5448342|NCT01509651|neuromuscular block, monitoring|neuromuscular block, monitoring
5448343|NCT01509651|neuromuscular function|neuromuscular function
5448344|NCT01509638|Ileostomy reversal|ileostomy reversal
5448345|NCT01509625|Fulvestrant|fulvestrant
5448346|NCT01509625|Faslodex|faslodex
5448347|NCT01509612|cancer|cancer
5448348|NCT01509612|additive homeopathy|additive homeopathy
5448349|NCT01509612|patients with advanced malignant tumors|patients with advanced malignant tumors
5448350|NCT01509599|Venous disease|venous disease
5448351|NCT01509599|Venous disorders|venous disorders
5448352|NCT01509599|Venous insufficiency|venous insufficiency
5448353|NCT01509599|Venous ulcers|venous ulcers
5448354|NCT01509599|Cryotherapy|cryotherapy
5448356|NCT01509586|smoking cessation|smoking cessation
5448357|NCT01509586|Potentially Reduced Exposure Products (PREPs)|potentially reduced exposure products (preps)
5448358|NCT01509573|prevention therapy|prevention therapy
5448359|NCT01509573|depressive symptoms|depressive symptoms
5448360|NCT01509573|anxiety|anxiety
5448361|NCT01509573|parenting|parenting
5448362|NCT01509573|family functioning|family functioning
5448363|NCT01509573|resilience, psychological|resilience, psychological
5448364|NCT01509573|Developing countries|developing countries
5448365|NCT01509573|Rwanda|rwanda
5448366|NCT01509573|HIV/AIDS|hiv/aids
5448367|NCT01509534|pacemaker|pacemaker
5448368|NCT01509534|implantable loop recorder|implantable loop recorder
5448369|NCT01509534|syncope|syncope
5448370|NCT01509521|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5448371|NCT01509521|Fetal heartrate|fetal heartrate
5448372|NCT01509521|Ephedrine|ephedrine
5448373|NCT01509521|Phenylephrine|phenylephrine
5448375|NCT01509508|Prevention|prevention
5448376|NCT01509508|Treatment|treatment
5448377|NCT01509508|South Africa|south africa
5448378|NCT01509495|Heart Failure|heart failure
5448379|NCT01509495|HF|hf
5448380|NCT01509482|insulin resistance|insulin resistance
5448381|NCT01509482|unexplained azoospermia|unexplained azoospermia
5448382|NCT01509482|unexplained oligospermia|unexplained oligospermia
5448383|NCT01509469|Ileal brake|ileal brake
5448384|NCT01509469|Casein|casein
5448386|NCT01509469|Ileal infusion|ileal infusion
5448387|NCT01509456|bone metabolism|bone metabolism
5448388|NCT01509456|potassium bicarbonate|potassium bicarbonate
5448389|NCT01509456|alkaline salt|alkaline salt
5448390|NCT01509456|acid base balance|acid base balance
5448391|NCT01509456|bed rest|bed rest
5448392|NCT01509443|Asthma|asthma
5448393|NCT01509443|Obesity|obesity
5448394|NCT01509443|Breathing exercise|breathing exercise
5448395|NCT01509417|pyloric stenosis|pyloric stenosis
5448396|NCT01509404|CMV|cmv
5448397|NCT01509404|cytomegalovirus|cytomegalovirus
5448398|NCT01509404|transplant|transplant
5448399|NCT01509378|ICD|icd
5448400|NCT01509378|ATP therapy|atp therapy
5448401|NCT01509378|Rescue Shock therapy|rescue shock therapy
5448402|NCT01509365|cardiovascular disease|cardiovascular disease
5448403|NCT01509365|maintenance dose|maintenance dose
5448404|NCT01509365|clopidogrel|clopidogrel
5448405|NCT01509365|overweight|overweight
5448406|NCT01509365|antiplatelet agents|antiplatelet agents
5448407|NCT01509352|fundoplication|fundoplication
5448408|NCT01509352|gastric reflux|gastric reflux
5448409|NCT01509339|Vancomycin|vancomycin
5448410|NCT01509339|Inhalation|inhalation
5448411|NCT01509339|Nebulization|nebulization
5448412|NCT01509339|Pharmacokinetics|pharmacokinetics
5448413|NCT01509326|headache|headache
5448414|NCT01509326|chiropractic|chiropractic
5448415|NCT01509326|manipulation|manipulation
5448416|NCT01509326|acupressure|acupressure
5448417|NCT01509326|self-care|self-care
5448418|NCT01509313|endometrial polyps|endometrial polyps
5448419|NCT01509313|uterine polyps|uterine polyps
5448420|NCT01509313|morcellator|morcellator
5448421|NCT01509313|hysteroscopy|hysteroscopy
5448422|NCT01509300|TBI|tbi
5448430|NCT01509287|genetic|genetic
5448431|NCT01509274|Plantar fasciitis|plantar fasciitis
5448432|NCT01509274|Plasma|plasma
5448434|NCT01509274|Heel pain|heel pain
5448435|NCT01509261|Erosive Esophagitis|erosive esophagitis
5448436|NCT01509261|Ilaprazole|ilaprazole
5448437|NCT01509261|GERD|gerd
5448438|NCT01509248|Theophylline|theophylline
5448439|NCT01509235|cystic fibrosis|cystic fibrosis
5448440|NCT01509235|Lung function|lung function
5448441|NCT01509235|physical exercise|physical exercise
5448442|NCT01509222|Health promotion|health promotion
5448443|NCT01509222|Dietary Counseling|dietary counseling
5448444|NCT01509209|vasomotor|vasomotor
5448445|NCT01509209|pseudoephedrine|pseudoephedrine
5448446|NCT01509209|levocetirizine|levocetirizine
5448447|NCT01509196|Fenofibric acid|fenofibric acid
5448448|NCT01509196|HIP0901|hip0901
5448449|NCT01509196|Lipidilsupra|lipidilsupra
5448450|NCT01509183|asthma|asthma
5448451|NCT01509183|healthcare utilization costs|healthcare utilization costs
5448452|NCT01509157|Type 1 diabetes|type 1 diabetes
5448453|NCT01509157|Continuous Glucose Monitoring|continuous glucose monitoring
5448454|NCT01509157|Nocturnal Hypoglycemia|nocturnal hypoglycemia
5448455|NCT01509144|Safety of this HIV vaccine|safety of this hiv vaccine
5448456|NCT01509092|traumatic macular hole|traumatic macular hole
5448457|NCT01509092|vitrectomy|vitrectomy
5448458|NCT01509092|observation|observation
5448459|NCT01509066|vegetarian|vegetarian
5448460|NCT01509066|vegan|vegan
5448465|NCT01509040|Resuscitated from Out-of-Hospital Cardiac Arrest|resuscitated from out-of-hospital cardiac arrest
5448467|NCT01509027|hyperphoshatemia|hyperphoshatemia
5448468|NCT01509027|compliance|compliance
5448469|NCT01509014|Statins|statins
5448470|NCT01509014|Adherence|adherence
5448471|NCT01509014|Pharmacists|pharmacists
5448472|NCT01509001|type 2 diabetes|type 2 diabetes
5448473|NCT01509001|metformin|metformin
5448474|NCT01509001|glimepiride|glimepiride
5448475|NCT01509001|glucose control|glucose control
5448476|NCT01509001|vascular reactivity|vascular reactivity
5448477|NCT01509001|Adverse Reaction to Other Drugs and Medicines|adverse reaction to other drugs and medicines
5448478|NCT01508988|ONO-9054|ono-9054
5448479|NCT01508988|adult healthy volunteers|adult healthy volunteers
5448480|NCT01508988|single dose|single dose
5448481|NCT01508988|phase 1|phase 1
5448482|NCT01508975|satiety|satiety
5448483|NCT01508975|obesity|obesity
5448484|NCT01508975|food intake|food intake
5448485|NCT01508962|Disease onset|disease onset
5448486|NCT01508962|Disease progression|disease progression
5448487|NCT01508884|intradermal|intradermal
5448488|NCT01508884|influenza|influenza
5448489|NCT01508884|vaccination|vaccination
5448490|NCT01508845|vitamin D|vitamin d
5448491|NCT01508845|vitamin D absorption|vitamin d absorption
5448492|NCT01508845|vitamin D deficiency|vitamin d deficiency
5448493|NCT01508819|Patients over 75|patients over 75
5448494|NCT01508819|acute pathology|acute pathology
5448495|NCT01508819|ICU admission|icu admission
5448497|NCT01508793|Obesity|obesity
5448498|NCT01508793|Children|children
5448499|NCT01508793|Eating behaviors|eating behaviors
5448500|NCT01508793|Activity|activity
5448501|NCT01508754|Continuous positive airway pressure|continuous positive airway pressure
5448502|NCT01508754|Ambulatory blood pressures|ambulatory blood pressures
5448503|NCT01508741|Insomnia|insomnia
5448504|NCT01508741|Frequent Nocturnal Awakening|frequent nocturnal awakening
5448505|NCT01508741|Irritability|irritability
5448506|NCT01508741|Moody|moody
5448507|NCT01508741|Moodiness|moodiness
5448508|NCT01508741|Coping Ability|coping ability
5448509|NCT01508741|Coping Behavior|coping behavior
5448510|NCT01508741|Stress|stress
5448511|NCT01508741|Feeling Overwhelmed|feeling overwhelmed
5448512|NCT01508728|unoperated severe sprain of the knee with partial or total rupture of the anterior|unoperated severe sprain of the knee with partial or total rupture of the anterior
5448513|NCT01508728|cruciate ligament and medial or lateral collateral ligament|cruciate ligament and medial or lateral collateral ligament
5448514|NCT01508715|subacromial|subacromial
5448515|NCT01508715|rotator cuff|rotator cuff
5448516|NCT01508715|impingement|impingement
5448517|NCT01508715|physical therapy|physical therapy
5448518|NCT01508715|eccentric exercise|eccentric exercise
5448519|NCT01508715|concentric exercise|concentric exercise
5448520|NCT01508702|Gout|gout
5448521|NCT01508689|Cereal bar|cereal bar
5448522|NCT01508689|Calcium-fortified|calcium-fortified
5448523|NCT01508689|Calcium intake|calcium intake
5448524|NCT01508676|neuropathic pain|neuropathic pain
5448525|NCT01508676|postherpetic neuralgia|postherpetic neuralgia
5448526|NCT01508676|complex regional pain syndrome|complex regional pain syndrome
5448527|NCT01508676|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5448528|NCT01508663|Coronary artery disease 75years of age or older|coronary artery disease 75years of age or older
5448529|NCT01508650|heart failure|heart failure
5448530|NCT01508637|air pollution|air pollution
5448531|NCT01508637|vasoconstriction|vasoconstriction
5448532|NCT01508637|blood pressure|blood pressure
5448533|NCT01508637|diesel exhaust|diesel exhaust
5448534|NCT01508624|Randomised controlled trial|randomised controlled trial
5448535|NCT01508624|Pain|pain
5448536|NCT01508624|Recovery|recovery
5448537|NCT01508624|Office based surgery|office based surgery
5448538|NCT01508611|dental caries|dental caries
5448539|NCT01508611|permanent teeth|permanent teeth
5448540|NCT01508611|silver diamine fluoride|silver diamine fluoride
5448541|NCT01508611|tooth eruption|tooth eruption
5448542|NCT01508598|Pediatric|pediatric
5448543|NCT01508598|Obesity|obesity
5448544|NCT01508598|Bariatric surgery|bariatric surgery
5448545|NCT01508598|Cardiovascular disease|cardiovascular disease
5448546|NCT01508585|Bariatric surgery|bariatric surgery
5448547|NCT01508585|Cognitive Behavioral Therapy|cognitive behavioral therapy
5448548|NCT01508585|Telephone based CBT|telephone based cbt
5448549|NCT01508585|Obesity|obesity
5448550|NCT01508572|breast cancer|breast cancer
5448551|NCT01508572|VEGF|vegf
5448552|NCT01508572|optical imaging|optical imaging
5448553|NCT01508559|HIV|hiv
5448554|NCT01508559|Neurocognitive|neurocognitive
5448555|NCT01508546|breast cancer|breast cancer
5448556|NCT01508546|axillary dissection|axillary dissection
5448557|NCT01508533|Disease burden|disease burden
5448558|NCT01508533|Rotavirus gastroenteritis|rotavirus gastroenteritis
5448559|NCT01508520|early gastric cancer|early gastric cancer
5448560|NCT01508520|stomach neoplasms|stomach neoplasms
5448561|NCT01508520|magnifying endoscopy|magnifying endoscopy
5448562|NCT01508520|narrow band imaging|narrow band imaging
5448563|NCT01508507|Oral|oral
5448564|NCT01508507|Cholera|cholera
5448565|NCT01508507|Vaccine|vaccine
5448566|NCT01508507|Herd|herd
5448567|NCT01508507|Risk|risk
5448568|NCT01508507|population|population
5448569|NCT01508507|Matched|matched
5448570|NCT01508507|Control|control
5448571|NCT01508507|Case|case
5448572|NCT01508507|Bias|bias
5448573|NCT01508494|modification of fMRI maps after galantamine/placebo|modification of fmri maps after galantamine/placebo
5448574|NCT01508481|Vitamin D|vitamin d
5448575|NCT01508481|Diabetes|diabetes
5448576|NCT01508481|pancreas beta cell function|pancreas beta cell function
5448577|NCT01508481|insulin resistance|insulin resistance
5448578|NCT01508481|Deficiency of Vitamin D3|deficiency of vitamin d3
5448579|NCT01508468|Rituximab|rituximab
5448580|NCT01508468|membranous nephropathy|membranous nephropathy
5448581|NCT01508468|anti-PLA2R antibody|anti-pla2r antibody
5448582|NCT01508429|Postpartum hemorrhage|postpartum hemorrhage
5448583|NCT01508429|PPH|pph
5448584|NCT01508429|misoprostol|misoprostol
5448585|NCT01508429|home deliveries|home deliveries
5448586|NCT01508416|Multiple Myeloma|multiple myeloma
5448587|NCT01508416|Newly diagnosed|newly diagnosed
5448588|NCT01508416|Thrombin generation|thrombin generation
5448589|NCT01508416|TFPI|tfpi
5448590|NCT01508416|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
5448591|NCT01508416|Protein S|protein s
5448592|NCT01508416|Thrombosis|thrombosis
5448593|NCT01508416|Chemotherapy|chemotherapy
5448594|NCT01508390|prostate|prostate
5448595|NCT01508377|posttraumatic stress disorder|posttraumatic stress disorder
5448596|NCT01508377|internet-based psychotherapy|internet-based psychotherapy
5448597|NCT01508377|cognitive restructuring|cognitive restructuring
5448598|NCT01508377|exposure|exposure
5448599|NCT01508364|renal cell carcinoma, first targeted therapy, observational study|renal cell carcinoma, first targeted therapy, observational study
5448600|NCT01508351|Propofol|propofol
5448601|NCT01508351|Induction|induction
5448602|NCT01508351|Hypotension|hypotension
5448603|NCT01508351|General population|general population
5448604|NCT01508338|HMB beta-hydroxy-beta-methylbutyrate|hmb beta-hydroxy-beta-methylbutyrate
5448605|NCT01508338|ATP (adenosine-triphosphate)|atp (adenosine-triphosphate)
5448606|NCT01508338|trained athletes|trained athletes
5448607|NCT01508325|Bisoprolol|bisoprolol
5448608|NCT01508325|Hypertension|hypertension
5448609|NCT01508325|Blood pressure|blood pressure
5448610|NCT01508325|Heart rate|heart rate
5448611|NCT01508312|CARBOPLATIN|carboplatin
5448612|NCT01508312|ETOPOSIDE (VP-16)|etoposide (vp-16)
5448613|NCT01508312|IFOSFAMIDE|ifosfamide
5448614|NCT01508312|SGN-35 (BRENTUXIMAB VEDOTIN)|sgn-35 (brentuximab vedotin)
5448615|NCT01508312|11-142|11-142
5448616|NCT01508299|skin test|skin test
5448617|NCT01508299|raw food|raw food
5448618|NCT01508299|commercial extract|commercial extract
5448619|NCT01508286|telaprevir|telaprevir
5448620|NCT01508286|hepatitis C|hepatitis c
5448621|NCT01508286|early access program|early access program
5448622|NCT01508273|Breast Cancer|breast cancer
5448623|NCT01508273|Breast Cancer Survivors|breast cancer survivors
5448624|NCT01508273|High risk cancer survivors|high risk cancer survivors
5448625|NCT01508273|Stage II to IIIC breast cancer|stage ii to iiic breast cancer
5448626|NCT01508273|African American|african american
5448628|NCT01508273|Hispanic|hispanic
5448629|NCT01508273|Non-Hispanic White|non-hispanic white
5448630|NCT01508273|Operable invasive breast carcinoma|operable invasive breast carcinoma
5448631|NCT01508273|Aerobic and resistance training|aerobic and resistance training
5448632|NCT01508273|Pedometer|pedometer
5448633|NCT01508273|Telephone Counseling Calls|telephone counseling calls
5448634|NCT01508273|Physical activity report|physical activity report
5448635|NCT01508273|PAR|par
5448636|NCT01508273|Functional Assessment of Cancer Therapy-Breast|functional assessment of cancer therapy-breast
5448637|NCT01508273|FACT-B|fact-b
5448638|NCT01508273|Health related quality of life|health related quality of life
5448639|NCT01508273|HRQOL|hrqol
5448640|NCT01508260|Leukemia|leukemia
5448641|NCT01508260|Aquapheresis|aquapheresis
5448642|NCT01508260|Ultrafiltration|ultrafiltration
5448643|NCT01508260|Aquadex pump|aquadex pump
5448644|NCT01508260|Severe Fluid Overload|severe fluid overload
5448645|NCT01508260|Diuretic therapy|diuretic therapy
5448646|NCT01508260|Dyspnea|dyspnea
5448647|NCT01508260|Orthopnea|orthopnea
5448648|NCT01508260|Paroxysmal nocturnal dyspnea|paroxysmal nocturnal dyspnea
5448649|NCT01508260|PND|pnd
5448650|NCT01508260|Peripheral edema|peripheral edema
5448651|NCT01508260|Rales|rales
5448652|NCT01508260|Jugular venous distension|jugular venous distension
5448653|NCT01508260|JVD|jvd
5448654|NCT01508260|Hypoxia|hypoxia
5448655|NCT01508260|Pulmonary edema by chest X-ray|pulmonary edema by chest x-ray
5448656|NCT01508260|Furosemide|furosemide
5448657|NCT01508260|Lasix|lasix
5448658|NCT01508247|efficacy|efficacy
5448659|NCT01508247|safety|safety
5448660|NCT01508247|inactivated vaccine (Vero Cell) against EV71|inactivated vaccine (vero cell) against ev71
5448661|NCT01508247|EV71-associated diseases|ev71-associated diseases
5448662|NCT01508221|brain metastasis|brain metastasis
5448663|NCT01508208|Hypertension|hypertension
5448664|NCT01508208|24 hour urine protein|24 hour urine protein
5448665|NCT01508208|Protein/creatinine ratio|protein/creatinine ratio
5448666|NCT01508195|Healthy Volunteers|healthy volunteers
5448667|NCT01508195|Bioequivalence|bioequivalence
5448668|NCT01508195|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5448669|NCT01508195|Metformin IR|metformin ir
5448670|NCT01508182|Healthy Volunteers|healthy volunteers
5448671|NCT01508182|Bioequivalence|bioequivalence
5448672|NCT01508182|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5448673|NCT01508182|Metformin IR|metformin ir
5448674|NCT01508169|elderly|elderly
5448675|NCT01508169|balance|balance
5448676|NCT01508169|insole|insole
5448677|NCT01508169|foot orthosis|foot orthosis
5448678|NCT01508169|orthotics|orthotics
5448679|NCT01508156|Hepatitis C|hepatitis c
5448681|NCT01508156|treatment-naive|treatment-naive
5448682|NCT01508143|Abortion|abortion
5448683|NCT01508143|Pregnancy|pregnancy
5448684|NCT01508143|Termination|termination
5448685|NCT01508143|Misoprostol|misoprostol
5448686|NCT01508117|GBM|gbm
5448687|NCT01508117|brain tumor|brain tumor
5448688|NCT01508104|solid tumor|solid tumor
5448689|NCT01508104|glioblastoma multiforme|glioblastoma multiforme
5448690|NCT01508104|GBM|gbm
5448691|NCT01508104|brain tumor|brain tumor
5448692|NCT01508104|neuroendocrine tumor|neuroendocrine tumor
5448693|NCT01508091|Obesity|obesity
5448694|NCT01508091|ageing|ageing
5448695|NCT01508052|core temperature|core temperature
5448696|NCT01508052|sequential compression device|sequential compression device
5448697|NCT01508052|total intravenous anesthesia|total intravenous anesthesia
5448698|NCT01508039|Intranasal|intranasal
5448699|NCT01508039|Chitin Micro-particles|chitin micro-particles
5448700|NCT01508039|Immunological Effects|immunological effects
5448701|NCT01508039|Nasal mucosa|nasal mucosa
5448702|NCT01508039|Cytokines|cytokines
5448703|NCT01508039|Immunological Effects from Intranasal Chitin Micro-Particles|immunological effects from intranasal chitin micro-particles
5448704|NCT01508026|Stage 1|stage 1
5448705|NCT01508026|Stage 2|stage 2
5448706|NCT01508026|Hypertension|hypertension
5448707|NCT01508013|Melanoma|melanoma
5448708|NCT01508013|Basal Cell Carcinoma|basal cell carcinoma
5448709|NCT01508013|Squamous Cell Carcinoma|squamous cell carcinoma
5448710|NCT01508000|Liver metastases|liver metastases
5448711|NCT01508000|Colorectal Cancer|colorectal cancer
5448712|NCT01508000|KRAS wild type|kras wild type
5448713|NCT01508000|FOLFOX|folfox
5448714|NCT01508000|Bevacizumab|bevacizumab
5448715|NCT01508000|Panitumumab|panitumumab
5448716|NCT01508000|Randomized|randomized
5448717|NCT01508000|Phase II|phase ii
5448718|NCT01508000|Perioperative treatment|perioperative treatment
5448719|NCT01508000|Adjuvant|adjuvant
5448720|NCT01508000|Neo-adjuvant|neo-adjuvant
5448721|NCT01508000|Surgery|surgery
5448722|NCT01508000|Progression Free Survival|progression free survival
5448723|NCT01507987|Externalized Conductors, visual lead an|externalized conductors, visual lead an
5448724|NCT01507974|preventive|preventive
5448725|NCT01507974|antibiotic treatment|antibiotic treatment
5448726|NCT01507974|urinary tract infection|urinary tract infection
5448727|NCT01507974|pregnancy|pregnancy
5448728|NCT01507974|puerperium|puerperium
5448729|NCT01507948|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5448730|NCT01507948|Psychotherapy|psychotherapy
5448731|NCT01507948|non-medication treatment|non-medication treatment
5448732|NCT01507948|Prolonged Exposure|prolonged exposure
5448733|NCT01507948|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5448734|NCT01507948|Anxiety Disorders|anxiety disorders
5448735|NCT01507948|emotion|emotion
5448736|NCT01507948|emotion regulation|emotion regulation
5448737|NCT01507948|functional MRI|functional mri
5448738|NCT01507948|Affective Symptoms|affective symptoms
5448739|NCT01507935|Healthy infants|healthy infants
5448740|NCT01507935|Infant formula|infant formula
5448741|NCT01507935|Prebiotics oligosaccharides|prebiotics oligosaccharides
5448742|NCT01507935|Colonisation Resistance|colonisation resistance
5448743|NCT01507935|Gut Microbiota|gut microbiota
5448744|NCT01507922|Fenoverine|fenoverine
5448745|NCT01507922|Irritable Bowel Syndrome|irritable bowel syndrome
5448746|NCT01507922|Abdominal pain|abdominal pain
5448747|NCT01507922|BSS|bss
5448748|NCT01507909|EEG|eeg
5448749|NCT01507909|related visual|related visual
5448750|NCT01507909|and verbal cues|and verbal cues
5448751|NCT01507883|Supervision|supervision
5448752|NCT01507883|embryos|embryos
5448753|NCT01507883|Resulting|resulting
5448754|NCT01507870|body mass index|body mass index
5448755|NCT01507857|EV71 vaccine|ev71 vaccine
5448756|NCT01507857|HFMD|hfmd
5448757|NCT01507857|efficacy|efficacy
5448758|NCT01507857|EV71 associated disease|ev71 associated disease
5448759|NCT01507844|COPD|copd
5448760|NCT01507844|CPAP|cpap
5448761|NCT01507844|Sham|sham
5448762|NCT01507844|FEV1|fev1
5448763|NCT01507844|IC|ic
5448764|NCT01507844|RV/TLC|rv/tlc
5448765|NCT01507818|Arthroscopic Rotator Cuff Repair|arthroscopic rotator cuff repair
5448766|NCT01507818|Electromagnetic field treatment|electromagnetic field treatment
5448767|NCT01507818|Pulsed Radio Frequency treatment|pulsed radio frequency treatment
5448768|NCT01507818|Non-invasive|non-invasive
5448769|NCT01507818|Non-thermal|non-thermal
5448770|NCT01507805|Electroacupuncture|electroacupuncture
5448771|NCT01507805|preconditioning|preconditioning
5448772|NCT01507805|Non-cardiac surgery|non-cardiac surgery
5448773|NCT01507805|Coronary heart disease|coronary heart disease
5448774|NCT01507792|Cough|cough
5448775|NCT01507792|Laryngismus|laryngismus
5448776|NCT01507792|Bronchial spasm|bronchial spasm
5448777|NCT01507792|Deficiency diseases|deficiency diseases
5448778|NCT01507766|severe acute pancreatitis|severe acute pancreatitis
5448779|NCT01507766|intra-abdominal pressure|intra-abdominal pressure
5448780|NCT01507766|enteral nutrition|enteral nutrition
5448781|NCT01507753|childhood bipolar disorder|childhood bipolar disorder
5448782|NCT01507727|hyponatremia|hyponatremia
5448783|NCT01507727|Non-hypovolemic and Non-acute hyponatremia|non-hypovolemic and non-acute hyponatremia
5448784|NCT01507727|Tolvaptan|tolvaptan
5448785|NCT01507714|Preventive|preventive
5448786|NCT01507714|tvt-o|tvt-o
5448787|NCT01507714|stress incontinence|stress incontinence
5448788|NCT01507701|adolescents|adolescents
5448789|NCT01507688|Stroke|stroke
5448790|NCT01507688|Self-Management|self-management
5448791|NCT01507688|Transient ischemic attack|transient ischemic attack
5448792|NCT01507688|Self-Efficacy|self-efficacy
5448793|NCT01507675|suicide|suicide
5448794|NCT01507675|psychometric properties|psychometric properties
5448795|NCT01507675|military|military
5448796|NCT01507675|veterans|veterans
5448797|NCT01507675|Interpersonal needs questionnaire|interpersonal needs questionnaire
5448798|NCT01507675|Acquired capability for suicide|acquired capability for suicide
5448799|NCT01507675|mental health|mental health
5448800|NCT01507675|Survey of Life Principles|survey of life principles
5448801|NCT01507675|Risk assessment|risk assessment
5448802|NCT01507662|Bone Density|bone density
5448803|NCT01507662|Absorptiometry, Photon|absorptiometry, photon
5448804|NCT01507662|Osteoporosis|osteoporosis
5448805|NCT01507662|Bone, Diseases, Metabolic|bone, diseases, metabolic
5448806|NCT01507662|Patient Education as Topic|patient education as topic
5448807|NCT01507662|Fractures, Bone/Prevention and Control|fractures, bone/prevention and control
5448808|NCT01507649|postnatal depression|postnatal depression
5448809|NCT01507649|quality of life|quality of life
5448810|NCT01507636|apraxia|apraxia
5448811|NCT01507636|occupational therapy|occupational therapy
5448812|NCT01507636|multiple sclerosis|multiple sclerosis
5448813|NCT01507636|manual dexterity|manual dexterity
5448814|NCT01507623|NAPS|naps
5448815|NCT01507623|Hypoxia|hypoxia
5448816|NCT01507623|Propofol|propofol
5448817|NCT01507623|capnography|capnography
5448818|NCT01507623|endoscopy|endoscopy
5448819|NCT01507623|Sedation|sedation
5448820|NCT01507610|sumatriptan|sumatriptan
5448821|NCT01507610|bioavailability|bioavailability
5448822|NCT01507597|Glucagon-like peptide-1|glucagon-like peptide-1
5448823|NCT01507597|Glucagon|glucagon
5448824|NCT01507597|Normal physiology|normal physiology
5448825|NCT01507597|T2DM|t2dm
5448827|NCT01507571|Incurable cancer|incurable cancer
5448828|NCT01507571|Palliative care|palliative care
5448829|NCT01507571|Dignity Therapy|dignity therapy
5448830|NCT01507571|Loss of dignity|loss of dignity
5448831|NCT01507571|Patient Dignity Intventory|patient dignity intventory
5448832|NCT01507571|Eortc QLQ-C15-PAL|eortc qlq-c15-pal
5448833|NCT01507571|Structured Interview for Symptoms and Concerns|structured interview for symptoms and concerns
5448834|NCT01507571|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
5448835|NCT01507558|Peripheral Arterial Disease|peripheral arterial disease
5448836|NCT01507558|Femoral popliteal lesions|femoral popliteal lesions
5448837|NCT01507545|mCRC|mcrc
5448838|NCT01507545|chemorefractory metastatic colorectal cancer|chemorefractory metastatic colorectal cancer
5448839|NCT01507506|Glioblastoma|glioblastoma
5448840|NCT01507506|Radiotherapy|radiotherapy
5448841|NCT01507506|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5448842|NCT01507506|Magnetic resonance spectroscopic imaging (MRSI)|magnetic resonance spectroscopic imaging (mrsi)
5448843|NCT01507493|gene polymorphism|gene polymorphism
5448844|NCT01507493|SCN9A|scn9a
5448845|NCT01507493|pain perception|pain perception
5448846|NCT01507493|postoperative pain|postoperative pain
5448847|NCT01507480|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5448848|NCT01507480|Antiangiogenic therapies|antiangiogenic therapies
5448849|NCT01507480|Bevacizumab|bevacizumab
5448850|NCT01507467|Head and neck carcinoma|head and neck carcinoma
5448851|NCT01507467|Accelerated radiotherapy|accelerated radiotherapy
5448852|NCT01507467|Hypoxic modification with Nimorazole|hypoxic modification with nimorazole
5448853|NCT01507441|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5448854|NCT01507441|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5846734|NCT00043641|Treatment Experienced|treatment experienced
5448855|NCT01507441|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5448857|NCT01507415|Longitudinal Studies|longitudinal studies
5448858|NCT01507415|Patient Readmission|patient readmission
5448859|NCT01507415|Hospitalization|hospitalization
5448860|NCT01507415|Disability Evaluation|disability evaluation
5448861|NCT01507376|Ovulation induction|ovulation induction
5448862|NCT01507376|urinary|urinary
5448864|NCT01507376|recombinant hCG|recombinant hcg
5448865|NCT01507350|obesity related glmerulopathy|obesity related glmerulopathy
5448866|NCT01507350|51 Cr-EDTA clearance|51 cr-edta clearance
5448867|NCT01507350|impaired renal function|impaired renal function
5448868|NCT01507350|gastric band|gastric band
5448869|NCT01507350|GFR measurement|gfr measurement
5448870|NCT01507350|gastric bypass|gastric bypass
5448871|NCT01507350|sleeve gastrectomy|sleeve gastrectomy
5448872|NCT01507298|Physical activity|physical activity
5448873|NCT01507298|Accelerometry|accelerometry
5448874|NCT01507298|Oesophageal pH|oesophageal ph
5448875|NCT01507298|Capsule endoscopy|capsule endoscopy
5448876|NCT01507259|Determine effect on cerebral vasculature|determine effect on cerebral vasculature
5448877|NCT01507246|open colectomy|open colectomy
5448878|NCT01507233|open colectomy|open colectomy
5448879|NCT01507233|colectomy|colectomy
5448880|NCT01507220|open colectomy|open colectomy
5448881|NCT01507207|Dysphagia|dysphagia
5448882|NCT01507207|aspiration|aspiration
5448883|NCT01507207|pediatric|pediatric
5448884|NCT01507207|injection laryngoplasty|injection laryngoplasty
5448885|NCT01507181|suicidal ideation|suicidal ideation
5448886|NCT01507181|major depression|major depression
5448887|NCT01507181|treatment resistant|treatment resistant
5448888|NCT01507181|ketamine|ketamine
5448889|NCT01507181|glutamate|glutamate
5448890|NCT01507155|Major|major
5448891|NCT01507155|Depressive|depressive
5448892|NCT01507155|Disorder|disorder
5448893|NCT01507155|Depression|depression
5448894|NCT01507155|MDD|mdd
5448895|NCT01507155|Treatment Resistant|treatment resistant
5448896|NCT01507155|Anxiety|anxiety
5448897|NCT01507155|GAD|gad
5448898|NCT01507142|saliva|saliva
5435840|NCT01562691|septoplasty|septoplasty
5448899|NCT01507142|diagnostics|diagnostics
5448900|NCT01507142|HIV|hiv
5448901|NCT01507142|AIDS|aids
5448902|NCT01507129|dehydration|dehydration
5448903|NCT01507129|plasma|plasma
5448904|NCT01507129|osmolality|osmolality
5448905|NCT01507129|saliva|saliva
5448906|NCT01507129|urine|urine
5448907|NCT01507129|biomarkers|biomarkers
5448908|NCT01507129|hypertonic|hypertonic
5448909|NCT01507129|isotonic|isotonic
5448910|NCT01507129|hydration|hydration
5448911|NCT01507103|Tecemotide (L-BLP25)|tecemotide (l-blp25)
5448912|NCT01507103|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
5448913|NCT01507103|Mode of action|mode of action
5448914|NCT01507103|Neoplasms|neoplasms
5448915|NCT01507103|Neoplasms by Site|neoplasms by site
5448916|NCT01507103|Carcinomas|carcinomas
5448917|NCT01507103|Antineoplastic Agents|antineoplastic agents
5448918|NCT01507103|Neoadjuvant|neoadjuvant
5448919|NCT01507103|Radiotherapy Pharmacologic Actions|radiotherapy pharmacologic actions
5448920|NCT01507103|Immunosuppressive Agents|immunosuppressive agents
5448921|NCT01507103|Immunologic Function|immunologic function
5448922|NCT01507103|Therapeutic Uses|therapeutic uses
5448925|NCT01507077|Obese|obese
5448926|NCT01507077|Obesity|obesity
5448927|NCT01507077|Overweight|overweight
5448928|NCT01507064|hepatocellular carcinoma|hepatocellular carcinoma
5448929|NCT01507064|sorafenib|sorafenib
5448930|NCT01507064|laser ablation|laser ablation
5448931|NCT01507051|Rivaroxaban|rivaroxaban
5448932|NCT01507051|Xa-Factors|xa-factors
5448933|NCT01507051|Warfarin|warfarin
5448934|NCT01507051|Thrombosis|thrombosis
5448935|NCT01507051|Embolism|embolism
5448936|NCT01507038|Diabetes Mellitus|diabetes mellitus
5448937|NCT01507038|YH14617|yh14617
5448938|NCT01507038|Exenatide|exenatide
5448939|NCT01507038|Yuhan|yuhan
5448940|NCT01507025|hinge position|hinge position
5448941|NCT01507025|dry eye|dry eye
5448942|NCT01507012|Berry phenolics|berry phenolics
5448943|NCT01507012|mood|mood
5448944|NCT01507012|cognition|cognition
5448945|NCT01507012|adults|adults
5448946|NCT01506999|Angina Pectoris|angina pectoris
5448947|NCT01506999|SNPs|snps
5448948|NCT01506999|Genetic|genetic
5448949|NCT01506999|Myocardial Infarction|myocardial infarction
5448950|NCT01506999|Cardiovascular Risk Factors|cardiovascular risk factors
5448951|NCT01506986|Ulcer bleeding|ulcer bleeding
5448952|NCT01506986|Aspirin|aspirin
5448953|NCT01506986|Helicobacter pylori|helicobacter pylori
5448954|NCT01506986|H. pylori|h. pylori
5448955|NCT01506986|Hospitalisation for ulcer bleeding|hospitalisation for ulcer bleeding
5448956|NCT01506973|histologically or cytologically documented|histologically or cytologically documented
5448957|NCT01506947|Hemodialysis|hemodialysis
5448958|NCT01506947|Chronic kidney disease|chronic kidney disease
5452124|NCT01493804|EEG|eeg
5448959|NCT01506947|Secondary hyperparathyroidism,|secondary hyperparathyroidism,
5448960|NCT01506921|racemic ketamine|racemic ketamine
5448961|NCT01506921|S-ketamine|s-ketamine
5448962|NCT01506921|Cerebral blood flow|cerebral blood flow
5448963|NCT01506921|Magnetic resonance imaging|magnetic resonance imaging
5448964|NCT01506921|arterial spin labeling|arterial spin labeling
5448965|NCT01506921|healthy volunteers|healthy volunteers
5448966|NCT01506908|craving|craving
5448967|NCT01506895|Diabetic Macular Edema|diabetic macular edema
5448968|NCT01506856|Epithelial ovarian cancer|epithelial ovarian cancer
5448969|NCT01506856|Fallopian tube cancer|fallopian tube cancer
5448970|NCT01506856|peritoneal cancer|peritoneal cancer
5448971|NCT01506856|intraperitoneal therapy|intraperitoneal therapy
5448972|NCT01506856|Carboplatin|carboplatin
5448973|NCT01506856|Paclitaxel|paclitaxel
5448974|NCT01506843|IgA antibody|iga antibody
5448975|NCT01506843|IgE antibody|ige antibody
5448976|NCT01506843|IgG1/IgG4 subclasses|igg1/igg4 subclasses
5448977|NCT01506843|Mite allergy|mite allergy
5448978|NCT01506843|Sublingual immunotherapy|sublingual immunotherapy
5448979|NCT01506843|Saliva|saliva
5448980|NCT01506830|Adhesives.|adhesives.
5448981|NCT01506830|Composites.|composites.
5448982|NCT01506830|Noncarious cervical lesions.|noncarious cervical lesions.
5448983|NCT01506830|Clinical performance.|clinical performance.
5448984|NCT01506830|Treatment|treatment
5448985|NCT01506817|fibromyalgia|fibromyalgia
5448986|NCT01506817|DCE-MRI|dce-mri
5448987|NCT01506817|neurogenic inflammation|neurogenic inflammation
5448988|NCT01506817|contrast-enhancement patterns|contrast-enhancement patterns
5448989|NCT01506804|Shoulder|shoulder
5448990|NCT01506804|Impingement|impingement
5448991|NCT01506804|Ultrasound|ultrasound
5448992|NCT01506804|injection of glucocorticosteroid|injection of glucocorticosteroid
5448993|NCT01506804|exercise|exercise
5448994|NCT01506791|Bioequivalence|bioequivalence
5448995|NCT01506791|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
5448996|NCT01506791|crossover|crossover
5448997|NCT01506778|Endometrial Sampling Procedure|endometrial sampling procedure
5448998|NCT01506778|Likert Scala|likert scala
5448999|NCT01506778|Pipelle|pipelle
5449000|NCT01506778|Tenaculum|tenaculum
5449001|NCT01506778|Visual Analog Pain Scala|visual analog pain scala
5449002|NCT01506765|Schizophrenia|schizophrenia
5449003|NCT01506765|glutathione|glutathione
5449005|NCT01506765|Neurological scales|neurological scales
5449006|NCT01506765|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5449007|NCT01506765|EEG/evoked potentials|eeg/evoked potentials
5449008|NCT01506765|fibroblasts|fibroblasts
5449009|NCT01506765|patients who receive NAC|patients who receive nac
5449010|NCT01506765|patients who receive placebo|patients who receive placebo
5449011|NCT01506752|Bioequivalence|bioequivalence
5449012|NCT01506752|Healthy Subjects|healthy subjects
5449013|NCT01506752|Donepezil|donepezil
5449014|NCT01506739|Bioequivalence|bioequivalence
5449015|NCT01506739|Healthy Subjects|healthy subjects
5449016|NCT01506739|Donepezil|donepezil
5449017|NCT01506726|anemia|anemia
5449018|NCT01506726|unexplained anemia|unexplained anemia
5443802|NCT01529073|HIV|hiv
5449020|NCT01506726|geriatric|geriatric
5449021|NCT01506726|older adults|older adults
5449022|NCT01506726|UAE|uae
5449023|NCT01506726|over 65|over 65
5449024|NCT01506726|salsalate|salsalate
5449025|NCT01506726|PACTTE|pactte
5449026|NCT01506726|pactee|pactee
5449027|NCT01506726|aging|aging
5449028|NCT01506726|aged|aged
5449029|NCT01506726|old|old
5449030|NCT01506726|older|older
5449031|NCT01506687|Colorectal cancer screening|colorectal cancer screening
5449032|NCT01506687|50 years or older|50 years or older
5449033|NCT01506661|Rheumatoid arthritis|rheumatoid arthritis
5449034|NCT01506661|vaccination|vaccination
5449035|NCT01506661|immune response|immune response
5449036|NCT01506661|varicella zoster|varicella zoster
5449037|NCT01506609|PARP|parp
5449038|NCT01506609|TMZ|tmz
5449039|NCT01506609|Temodal|temodal
5449040|NCT01506609|Carboplatin|carboplatin
5449041|NCT01506609|veliparib|veliparib
5449042|NCT01506609|BRCA2 mutation carrier|brca2 mutation carrier
5449043|NCT01506609|Breast cancer|breast cancer
5449044|NCT01506609|Metastatic breast cancer|metastatic breast cancer
5449045|NCT01506609|temozolomide|temozolomide
5449046|NCT01506609|BRCA1 mutation carrier|brca1 mutation carrier
5449047|NCT01506609|ABT-888|abt-888
5449048|NCT01506609|Paclitaxel|paclitaxel
5449049|NCT01506609|Recurrent breast cancer|recurrent breast cancer
5449050|NCT01506609|Temodar|temodar
5449051|NCT01506609|Locally recurrent|locally recurrent
5449052|NCT01506596|Liposarcoma|liposarcoma
5449053|NCT01506583|cough|cough
5449054|NCT01506583|myalgia|myalgia
5449055|NCT01506583|nasal obstruction|nasal obstruction
5449056|NCT01506583|sore throat|sore throat
5449057|NCT01506583|headache|headache
5449058|NCT01506583|fatigue|fatigue
5449059|NCT01506583|feverishness|feverishness
5449155|NCT01506271|Complicated Intra-abdominal Infections|complicated intra-abdominal infections
5798668|NCT00111410|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
5798669|NCT00111410|Autoimmune, Kineret®|autoimmune, kineret®
5449065|NCT01506557|bone mineral content|bone mineral content
5449066|NCT01506544|HU|hu
5449067|NCT01506544|Hydroxyurea|hydroxyurea
5449068|NCT01506544|Sickle cell|sickle cell
5449069|NCT01506544|Pediatric|pediatric
5449070|NCT01506531|gastroschisis|gastroschisis
5449071|NCT01506531|silo|silo
5449072|NCT01506531|primary closure|primary closure
5449073|NCT01506518|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
5449074|NCT01506518|Ultrasound|ultrasound
5449075|NCT01506518|Imaging|imaging
5449076|NCT01506518|Acoustic Radiation Force|acoustic radiation force
5449077|NCT01506518|Double Push|double push
5449078|NCT01506505|Cardiovascular prevention|cardiovascular prevention
5449079|NCT01506505|Polypill|polypill
5449080|NCT01506505|Combination therapy|combination therapy
5449081|NCT01506492|Randomized controlled trial|randomized controlled trial
5449082|NCT01506492|Depression|depression
5449083|NCT01506492|Cancer|cancer
5449084|NCT01506492|Psychotherapy|psychotherapy
5449085|NCT01506492|Quality of life|quality of life
5449086|NCT01506479|Parkinson Disease|parkinson disease
5449087|NCT01506479|Basal Ganglia Disease|basal ganglia disease
5449088|NCT01506479|Central Nervous System Diseases|central nervous system diseases
5449089|NCT01506479|Nervous System Diseases|nervous system diseases
5449090|NCT01506479|Movement Disorders|movement disorders
5449091|NCT01506479|Neurodegenerative Diseases|neurodegenerative diseases
5449092|NCT01506479|Brain Diseases|brain diseases
5449093|NCT01506466|chemotherapy|chemotherapy
5449094|NCT01506466|metabolism|metabolism
5449095|NCT01506466|weight|weight
5449096|NCT01506466|body composition|body composition
5449097|NCT01506453|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5449098|NCT01506453|Neuropathy|neuropathy
5449099|NCT01506453|Neuropathic Pain|neuropathic pain
5449100|NCT01506453|Vincristine|vincristine
5449101|NCT01506453|TOTAL XVI Protocol|total xvi protocol
5449102|NCT01506427|Newly Diagnosed|newly diagnosed
5449103|NCT01506427|Head and Neck Cancer|head and neck cancer
5449104|NCT01506427|PET Imaging|pet imaging
5449105|NCT01506414|Purpura|purpura
5449106|NCT01506414|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5449107|NCT01506401|ARDS|ards
5449108|NCT01506401|ventilator-induced lung injury|ventilator-induced lung injury
5449109|NCT01506401|lung protective ventilation|lung protective ventilation
5449110|NCT01506401|high frequency oscillation|high frequency oscillation
5449111|NCT01506388|labour induction|labour induction
5449112|NCT01506388|Foley catheter|foley catheter
5449113|NCT01506388|misoprostol|misoprostol
5449114|NCT01506388|isosorbide mononitrate|isosorbide mononitrate
5449115|NCT01506375|seasonal allergic rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5449116|NCT01506375|grass pollen|grass pollen
5449117|NCT01506375|allergen specific immunotherapy|allergen specific immunotherapy
5449118|NCT01506362|Ulcerative Colitis|ulcerative colitis
5449119|NCT01506362|IBD|ibd
5449120|NCT01506349|celiac disease|celiac disease
5449121|NCT01506349|gluten|gluten
5449122|NCT01506349|fog|fog
5449123|NCT01506349|attention|attention
5449124|NCT01506336|GIST|gist
5449125|NCT01506336|resistant|resistant
5449127|NCT01506336|gastro intestinal stromal tumor resistant to imatinib|gastro intestinal stromal tumor resistant to imatinib
5449128|NCT01506323|Complementary Therapy|complementary therapy
5449129|NCT01506323|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5449130|NCT01506323|Veterans Health|veterans health
5449131|NCT01506323|Clinical Trials, Randomized|clinical trials, randomized
5449132|NCT01506323|Mindfulness|mindfulness
5449133|NCT01506323|Spirituality|spirituality
5449134|NCT01506323|Meditation|meditation
5449135|NCT01506323|Mind-body therapy|mind-body therapy
5449136|NCT01506310|gestational diabetes mellitus|gestational diabetes mellitus
5449137|NCT01506310|fasting glucose|fasting glucose
5449138|NCT01506310|insulin resistance|insulin resistance
5449139|NCT01506310|birth-weight|birth-weight
5449140|NCT01506310|Glucose values|glucose values
5449141|NCT01506310|Insulin concentrations|insulin concentrations
5449142|NCT01506310|Cesarean sections|cesarean sections
5449143|NCT01506297|obesity|obesity
5449144|NCT01506297|satiety|satiety
5449145|NCT01506297|body weight management|body weight management
5452303|NCT01492829|community health worker|community health worker
5449146|NCT01506284|Forced oscillatory technique|forced oscillatory technique
5449147|NCT01506284|Laser interferometry|laser interferometry
5449148|NCT01506284|Intravenous anesthesia|intravenous anesthesia
5449149|NCT01506284|Mechanical ventilation|mechanical ventilation
5449150|NCT01506284|Pressure controlled ventilation|pressure controlled ventilation
5449151|NCT01506284|Airways mechanical properties|airways mechanical properties
5449152|NCT01506284|Respiratory system reactance|respiratory system reactance
5449153|NCT01506284|Oscillatory mechanics|oscillatory mechanics
5449154|NCT01506284|Atelectasis|atelectasis
5449156|NCT01506258|CD34+|cd34+
5449157|NCT01506258|perinatal hypoxia|perinatal hypoxia
5449158|NCT01506258|autologous hematopoietic stem cells|autologous hematopoietic stem cells
5449159|NCT01506258|cord and placental blood|cord and placental blood
5449160|NCT01506258|cerebral palsy|cerebral palsy
5449161|NCT01506245|Obesity|obesity
5449162|NCT01506245|Children|children
5449163|NCT01506245|Behavior|behavior
5449164|NCT01506245|Family|family
5449165|NCT01506245|Exercise|exercise
5449166|NCT01506232|ADHD|adhd
5449167|NCT01506232|Pediatric Bipolar Disorder|pediatric bipolar disorder
5449168|NCT01506232|Autism|autism
5449169|NCT01506232|Autism Spectrum Disorders|autism spectrum disorders
5449170|NCT01506232|EEG|eeg
5449171|NCT01506232|Brain Flow Analyses|brain flow analyses
5449172|NCT01506219|Randomized controlled trial|randomized controlled trial
5449173|NCT01506219|Comprehensive geriatric care|comprehensive geriatric care
5449174|NCT01506219|Activity of daily living|activity of daily living
5449175|NCT01506219|Quality of life|quality of life
5449176|NCT01506219|Healthcare utilization|healthcare utilization
5449177|NCT01506219|Community rehabilitation unit|community rehabilitation unit
5449178|NCT01506219|Medication adjustment|medication adjustment
5449179|NCT01506206|Deep Brain Stimulation|deep brain stimulation
5449180|NCT01506206|Impulsivity|impulsivity
5449181|NCT01506193|safety|safety
5449182|NCT01506193|healthy|healthy
5449183|NCT01506193|conjugated|conjugated
5449184|NCT01506193|immunogenicity|immunogenicity
5449185|NCT01506193|children|children
5449186|NCT01506193|MenC vaccine|menc vaccine
5449187|NCT01506193|MMRV vaccine|mmrv vaccine
5449188|NCT01506180|acute medical care|acute medical care
5449189|NCT01506180|comprehensive geriatric assessment|comprehensive geriatric assessment
5449190|NCT01506180|Health Services for the Aged|health services for the aged
5449191|NCT01506180|Geriatric Assessment|geriatric assessment
5449192|NCT01506180|Geriatrics|geriatrics
5449194|NCT01506154|bursitis/tendonitis and/or subdeltoid bursitis|bursitis/tendonitis and/or subdeltoid bursitis
5449195|NCT01506141|MPS II|mps ii
5449196|NCT01506141|MPS 2|mps 2
5449197|NCT01506141|lysosomal storage disorder|lysosomal storage disorder
5449198|NCT01506141|mps symptoms|mps symptoms
5449199|NCT01506141|enlarged adenoids|enlarged adenoids
5449200|NCT01506141|elaprase|elaprase
5449201|NCT01506141|hunter's syndrome|hunter's syndrome
5449202|NCT01506141|MPS2|mps2
5449203|NCT01506141|hunters disease|hunters disease
5421328|NCT01625013|Active|active
5449204|NCT01506141|hunter's disease treatment|hunter's disease treatment
5449205|NCT01506141|hunter syndrome therapy|hunter syndrome therapy
5449206|NCT01506141|iduronate sulfatase|iduronate sulfatase
5449207|NCT01506141|mps society|mps society
5449208|NCT01506141|MPSII|mpsii
5449209|NCT01506141|hunter syndrome treatment|hunter syndrome treatment
5449210|NCT01506141|hunter's disease|hunter's disease
5449211|NCT01506141|iduronate 2 sulfatase|iduronate 2 sulfatase
5449212|NCT01506141|mucopolysaccharides|mucopolysaccharides
5449213|NCT01506141|mps diagnosis|mps diagnosis
5449214|NCT01506141|chronic ear infection|chronic ear infection
5449215|NCT01506141|hunters syndrome|hunters syndrome
5449216|NCT01506141|ert treatment|ert treatment
5449217|NCT01506141|lysosomal storage disease|lysosomal storage disease
5449218|NCT01506141|hunter disease|hunter disease
5449219|NCT01506141|enzyme replacement therapy|enzyme replacement therapy
5449220|NCT01506141|idursulfase|idursulfase
5449221|NCT01506141|hunter's syndrome treatment|hunter's syndrome treatment
5449222|NCT01506128|HPV|hpv
5449224|NCT01506128|HPV detection using menstrual blood|hpv detection using menstrual blood
5449225|NCT01506115|Hepatocellular carcinoma|hepatocellular carcinoma
5449226|NCT01506115|Obstructive jaundice|obstructive jaundice
5449227|NCT01506115|Photodynamic therapy|photodynamic therapy
5449228|NCT01506089|IVF|ivf
5449229|NCT01506089|infertility|infertility
5449230|NCT01506089|PGD|pgd
5449231|NCT01506089|embryo|embryo
5449232|NCT01506089|temperature|temperature
5449233|NCT01506089|incubator|incubator
5449234|NCT01506089|CCS|ccs
5449235|NCT01506089|culture|culture
5449236|NCT01506089|incubator-36 degrees Celsius|incubator-36 degrees celsius
5449237|NCT01506089|incubator-37 degrees Celsius|incubator-37 degrees celsius
5449238|NCT01506063|Bioequivalence|bioequivalence
5449239|NCT01506063|Levocetirizine|levocetirizine
5449240|NCT01506063|Crossover|crossover
5449241|NCT01506050|Bioequivalence|bioequivalence
5449242|NCT01506050|Desloratadine|desloratadine
5449243|NCT01506050|crossover|crossover
5449244|NCT01506037|Bioequivalence|bioequivalence
5449245|NCT01506037|Desloratadine|desloratadine
5449246|NCT01506037|crossover|crossover
5449252|NCT01505985|Functional recovery|functional recovery
5449253|NCT01505972|screening colonoscopy|screening colonoscopy
5449254|NCT01505972|attendance|attendance
5449255|NCT01505972|response|response
5449256|NCT01505972|colorectal cancer|colorectal cancer
5449257|NCT01505959|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5449258|NCT01505959|Apnea|apnea
5449259|NCT01505959|Sleep Apnea|sleep apnea
5449260|NCT01505959|Telemedicine|telemedicine
5449261|NCT01505959|CPAP compliance|cpap compliance
5449262|NCT01505946|Thrombin|thrombin
5449263|NCT01505946|Hemophilia|hemophilia
5449264|NCT01505946|Inhibitors|inhibitors
5449265|NCT01505946|Immunotolerance|immunotolerance
5449266|NCT01505946|Haemostatic|haemostatic
5449267|NCT01505946|FVIII|fviii
5449268|NCT01505946|Epitopes|epitopes
5449269|NCT01505946|Moderately severe Hemophilia A with inhibitor|moderately severe hemophilia a with inhibitor
5449270|NCT01505933|upper|upper
5449271|NCT01505933|airway|airway
5449272|NCT01505933|dimensions|dimensions
5449273|NCT01505933|propofol|propofol
5449274|NCT01505933|dexmedetomidine|dexmedetomidine
5449275|NCT01505907|Pharmacokinetics|pharmacokinetics
5449276|NCT01505907|Safety|safety
5449277|NCT01505907|Healthy Males|healthy males
5449278|NCT01505855|Crohn's disease|crohn's disease
5449279|NCT01505855|Pneumococcal vaccination|pneumococcal vaccination
5449280|NCT01505842|Ulcerative colitis|ulcerative colitis
5449281|NCT01505842|Crohn's disease|crohn's disease
5449282|NCT01505842|Chromoendoscopy|chromoendoscopy
5449283|NCT01505842|Dysplasia|dysplasia
5449284|NCT01505842|Neoplasia|neoplasia
5449285|NCT01505842|Inflammatory Bowel Disease|inflammatory bowel disease
5449286|NCT01505816|Cataract|cataract
5449287|NCT01505816|Vision|vision
5449288|NCT01505816|Intraocular lens|intraocular lens
5449289|NCT01505816|Multifocal|multifocal
5449290|NCT01505816|Toric|toric
5449291|NCT01505803|Type 2 diabetes mellitus|type 2 diabetes mellitus
5449292|NCT01505803|Dietary supplements|dietary supplements
5449293|NCT01505803|Hyperglycemia|hyperglycemia
5449294|NCT01505803|Insulin resistance|insulin resistance
5449295|NCT01505803|Dyslipidemia|dyslipidemia
5449296|NCT01505803|Inflammation|inflammation
5449297|NCT01505803|Oxidative stress|oxidative stress
5449298|NCT01505803|Zinc|zinc
5449299|NCT01505803|Omega 3|omega 3
5449300|NCT01505777|irritable bowel syndrome without predominant diarrhea|irritable bowel syndrome without predominant diarrhea
5449301|NCT01505777|Probiotics(Medirac) 10/mosapride 10mg|probiotics(medirac) 10/mosapride 10mg
5449302|NCT01505777|Probiotics(Medirac) 15/mosapride 10mg|probiotics(medirac) 15/mosapride 10mg
5449303|NCT01505777|Probiotics(Medirac) 15/mosapride 15mg|probiotics(medirac) 15/mosapride 15mg
5449304|NCT01505777|Probiotics(Medirac) 30/mosapride 15mg|probiotics(medirac) 30/mosapride 15mg
5449305|NCT01505777|Probiotics(Medirac) placebo/mosapride placebo|probiotics(medirac) placebo/mosapride placebo
5449306|NCT01505764|Cachexia|cachexia
5436225|NCT01561066|Fistulas|fistulas
5449307|NCT01505751|Outcome of cervical cancer|outcome of cervical cancer
5449308|NCT01505725|Nicotine Reinforcement|nicotine reinforcement
5449309|NCT01505725|Tobacco Craving|tobacco craving
5449310|NCT01505725|Behavior Genetics|behavior genetics
5449311|NCT01505725|Smoking|smoking
5449312|NCT01505712|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5449313|NCT01505712|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5449314|NCT01505712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5449315|NCT01505712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5449316|NCT01505699|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5449317|NCT01505699|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5449318|NCT01505673|Insulin|insulin
5449319|NCT01505673|Glucagon-like peptide|glucagon-like peptide
5449320|NCT01505673|Liraglutide|liraglutide
5449321|NCT01505673|Beta-Cell|beta-cell
5449322|NCT01505673|pancreatic steatosis|pancreatic steatosis
5449323|NCT01505673|hepatic steatosis|hepatic steatosis
5449324|NCT01505660|Adherence|adherence
5449325|NCT01505660|Depression|depression
5449327|NCT01505660|Stepped care|stepped care
5449329|NCT01505660|Patient reported outcomes|patient reported outcomes
5449330|NCT01505660|Antiretroviral medication adherence|antiretroviral medication adherence
5449331|NCT01505634|Relebactam; MK-7655; Imipenem; Urinary Tract Infections; Pyelonephritis; Urologic Diseases; beta-Lactamase Inhibitors; Anti-Bacterial and Anti-Infective Agent|relebactam; mk-7655; imipenem; urinary tract infections; pyelonephritis; urologic diseases; beta-lactamase inhibitors; anti-bacterial and anti-infective agent
5449332|NCT01505621|Aging|aging
5452512|NCT01492088|Relapsed|relapsed
5449333|NCT01505621|Protein accumulation|protein accumulation
5449335|NCT01505569|autologous transplantation|autologous transplantation
5449336|NCT01505569|high risk solid tumor|high risk solid tumor
5449337|NCT01505569|relapsed solid tumor|relapsed solid tumor
5449338|NCT01505478|Sepsis|sepsis
5449339|NCT01505478|Clinical Prediction Rule|clinical prediction rule
5449340|NCT01505478|Clinical Informatics|clinical informatics
5449341|NCT01505478|Machine Learning|machine learning
5449342|NCT01505465|Total Knee Replacement|total knee replacement
5449343|NCT01505465|Pain|pain
5449344|NCT01505465|Confusion|confusion
5449345|NCT01505465|Sleep|sleep
5449346|NCT01505439|solifenacin|solifenacin
5449347|NCT01505439|bladder symptom|bladder symptom
5449348|NCT01505426|ASP1941|asp1941
5449349|NCT01505426|ipragliflozin|ipragliflozin
5449350|NCT01505426|urine glucose|urine glucose
5449351|NCT01505426|metformin|metformin
5449352|NCT01505426|plasma glucose|plasma glucose
5449353|NCT01505413|advanced unresectable or metastatic Pancreatic Cancer|advanced unresectable or metastatic pancreatic cancer
5449354|NCT01505400|Molecular profiling|molecular profiling
5449355|NCT01505400|Advanced cancer|advanced cancer
5449356|NCT01505400|Breast cancer|breast cancer
5449357|NCT01505400|Non-small cell lung cancer|non-small cell lung cancer
5449358|NCT01505400|Colorectal cancer|colorectal cancer
5449359|NCT01505400|Genitourinary cancer|genitourinary cancer
5449360|NCT01505400|Pancreatobiliary gastrointestinal cancer|pancreatobiliary gastrointestinal cancer
5449361|NCT01505400|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
5449362|NCT01505400|Gynecological cancers|gynecological cancers
5449363|NCT01505400|Phase I|phase i
5449364|NCT01505400|Phase I Clinical Trial Candidates|phase i clinical trial candidates
5449365|NCT01505400|melanoma cancer|melanoma cancer
5449366|NCT01505400|rare cancer|rare cancer
5449367|NCT01505400|unknown primary cancer|unknown primary cancer
5449368|NCT01505387|Weight maintenance|weight maintenance
5449369|NCT01505387|Overweight|overweight
5449370|NCT01505387|Obese|obese
5449371|NCT01505387|Weight management|weight management
5449372|NCT01505374|Bilateral total knee replacement|bilateral total knee replacement
5449373|NCT01505374|Femoral Nerve Block|femoral nerve block
5449374|NCT01505374|Saphenous Nerve Block|saphenous nerve block
5449375|NCT01505361|probiotic|probiotic
5449376|NCT01505361|Lactobacillus salivarius|lactobacillus salivarius
5449377|NCT01505361|mastitis|mastitis
5449378|NCT01505361|prevention|prevention
5449379|NCT01505361|group B streptococci|group b streptococci
5449380|NCT01505361|intrapartum prophylaxis|intrapartum prophylaxis
5449381|NCT01505348|feeding patterns|feeding patterns
5449382|NCT01505348|aerobic exercise|aerobic exercise
5449383|NCT01505348|osteoclasts|osteoclasts
5449384|NCT01505335|alveolar nerve, inferior|alveolar nerve, inferior
5449385|NCT01505335|ultrasound|ultrasound
5449386|NCT01505335|digital radiography, dental|digital radiography, dental
5449387|NCT01505335|nerve injury|nerve injury
5449388|NCT01505322|daily activities|daily activities
5449389|NCT01505309|Aortic Diseases|aortic diseases
5449390|NCT01505309|Vascular Diseases|vascular diseases
5449391|NCT01505309|Cardiovascular Diseases|cardiovascular diseases
5449392|NCT01505309|Treatment Outcome|treatment outcome
5449393|NCT01505309|Aorta Dissection|aorta dissection
5449394|NCT01505309|Aorta Aneurysm|aorta aneurysm
5449395|NCT01505309|Aorta pseudoaneurysm|aorta pseudoaneurysm
5449396|NCT01505309|Endovascular aortic repair|endovascular aortic repair
5449397|NCT01505296|Catheter ablation|catheter ablation
5449398|NCT01505257|Delirium|delirium
5449399|NCT01505257|Dementia|dementia
5449400|NCT01505257|Confusion Assessment Method|confusion assessment method
5449401|NCT01505231|Shock|shock
5449402|NCT01505231|norepinephrine|norepinephrine
5449403|NCT01505231|vasopressin|vasopressin
5449404|NCT01505231|cardiac surgery|cardiac surgery
5449405|NCT01505218|Sedation|sedation
5449406|NCT01505218|propofol|propofol
5449407|NCT01505218|patient-controlled|patient-controlled
5449408|NCT01505218|safety|safety
5449409|NCT01505205|Gist,c-KIT,PDGFRA,DOG1,mutation|gist,c-kit,pdgfra,dog1,mutation
5449410|NCT01505192|Those in Labor, Delivery and the Puerperium|those in labor, delivery and the puerperium
5449411|NCT01505179|HFPEF|hfpef
5449412|NCT01505179|Heart Failure|heart failure
5449413|NCT01505179|HF w/ preserved EF|hf w/ preserved ef
5449414|NCT01505179|Preserved EF|preserved ef
5449415|NCT01505179|Preserved Ejection Fraction|preserved ejection fraction
5449416|NCT01505179|Diastolic Dysfunction|diastolic dysfunction
5449417|NCT01505166|colorectal carcinoma|colorectal carcinoma
5449418|NCT01505166|colon cancer|colon cancer
5444193|NCT01527344|OCT|oct
5449419|NCT01505166|liver metastases|liver metastases
5449420|NCT01505153|Advanced cancer|advanced cancer
5449421|NCT01505153|Metastatic cancer|metastatic cancer
5449422|NCT01505153|solid tumors|solid tumors
5449423|NCT01505153|Melanoma|melanoma
5449424|NCT01505140|Andrology|andrology
5449425|NCT01505140|Fertility|fertility
5449426|NCT01505140|Reproduction|reproduction
5449427|NCT01505140|Diet|diet
5449428|NCT01505140|Nutritional Sciences|nutritional sciences
5449429|NCT01505140|Fatty Acids|fatty acids
5449430|NCT01505140|Antioxidants|antioxidants
5449431|NCT01505140|Body weight changes|body weight changes
5449432|NCT01505127|Drug Therapy|drug therapy
5449433|NCT01505114|HIV Prevention|hiv prevention
5449434|NCT01505114|PrEP|prep
5449435|NCT01505114|Maraviroc|maraviroc
5449436|NCT01505088|Iontophoresis|iontophoresis
5449437|NCT01505088|Non-Infectious Anterior Segment Uveitis|non-infectious anterior segment uveitis
5449438|NCT01505088|Ophthalmology|ophthalmology
5449439|NCT01505075|prostatic neoplasms|prostatic neoplasms
5449440|NCT01505075|radiotherapy|radiotherapy
5449441|NCT01505075|hypofractionated|hypofractionated
5449442|NCT01505075|high risk prostate cancer|high risk prostate cancer
5449443|NCT01505062|Usher Syndrome Retinitis Pigmentosa|usher syndrome retinitis pigmentosa
5449444|NCT01505062|Usher Syndrome associated Retinitis Pigmentosa|usher syndrome associated retinitis pigmentosa
5449445|NCT01505049|immunology|immunology
5449446|NCT01505049|vaccination|vaccination
5449447|NCT01505049|human papillomavirus|human papillomavirus
5449451|NCT01505010|Treatment-resistant hypertension|treatment-resistant hypertension
5449452|NCT01505010|Renal denervation|renal denervation
5449453|NCT01505010|Sympathetic nervous system|sympathetic nervous system
5449455|NCT01504997|Robot assisted surgery|robot assisted surgery
5449456|NCT01504997|Gastrectomy|gastrectomy
5449457|NCT01504997|Safety|safety
5449458|NCT01504997|Gastric Cancer|gastric cancer
5449459|NCT01504984|Evaluation of the pharmacokinetics equivalence|evaluation of the pharmacokinetics equivalence
5449460|NCT01504984|Healthy volunteers|healthy volunteers
5449461|NCT01504984|Single dose over the period I and II(crossover)|single dose over the period i and ii(crossover)
5449462|NCT01504984|Healthy male volunteers|healthy male volunteers
5449463|NCT01504971|Gastroesophageal Reflux;|gastroesophageal reflux;
5449464|NCT01504971|Endoscopy;|endoscopy;
5449465|NCT01504971|Esophageal pH monitoring;|esophageal ph monitoring;
5449466|NCT01504971|Narrow band imaging;|narrow band imaging;
5449467|NCT01504971|Autofluorescence imaging;|autofluorescence imaging;
5449468|NCT01504971|White light imaging;|white light imaging;
5449469|NCT01504958|Alzheimer's disease|alzheimer's disease
5449470|NCT01504958|Cognitive Training|cognitive training
5449471|NCT01504958|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5449472|NCT01504945|chronic coronary artery disease|chronic coronary artery disease
5449477|NCT01504919|Psychosocial|psychosocial
5449478|NCT01504919|Behavioral intervention|behavioral intervention
5449479|NCT01504919|Nicotine patch|nicotine patch
5449480|NCT01504919|Latinos|latinos
5449481|NCT01504919|Mexican American|mexican american
5449482|NCT01504919|Motivation and Problem Solving|motivation and problem solving
5449483|NCT01504919|MAPS|maps
5449484|NCT01504919|Cancer risk reduction|cancer risk reduction
5449485|NCT01504919|Smoking cessation|smoking cessation
5449486|NCT01504919|Overweight/obese smokers|overweight/obese smokers
5449487|NCT01504919|BMI greater than or equal to 25|bmi greater than or equal to 25
5449488|NCT01504919|Wellness program|wellness program
5449489|NCT01504919|Questionnaires|questionnaires
5449490|NCT01504919|Surveys|surveys
5449491|NCT01504919|Self-help materials|self-help materials
5449492|NCT01504919|Pamphlets|pamphlets
5449493|NCT01504906|Phase 1|phase 1
5449494|NCT01504906|Healthy male volunteers|healthy male volunteers
5449495|NCT01504906|pharmacokinetics|pharmacokinetics
5449496|NCT01504906|cyclosporine|cyclosporine
5449497|NCT01504906|ticagrelor|ticagrelor
5449498|NCT01504906|Bioavailability (plasma AUC, Cmax, plasma AUC0-t, t1/2λz, tmax)|bioavailability (plasma auc, cmax, plasma auc0-t, t1/2λz, tmax)
5449500|NCT01504893|PEEP|peep
5449501|NCT01504893|Acute Lung Injury|acute lung injury
5449502|NCT01504893|pneumonectomy|pneumonectomy
5449503|NCT01504893|ARDS|ards
5449504|NCT01504880|Mitral Regurgitation|mitral regurgitation
5449505|NCT01504880|Tricuspid Regurgitation|tricuspid regurgitation
5449506|NCT01504880|Vena Contracta|vena contracta
5449507|NCT01504867|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5449508|NCT01504867|Acute Lung Injury|acute lung injury
5449509|NCT01504867|ARDS|ards
5449511|NCT01504867|aspirin|aspirin
5449512|NCT01504867|prevention|prevention
5449513|NCT01504854|Alzheimer's disease|alzheimer's disease
5449514|NCT01504854|Dementia|dementia
5449515|NCT01504854|Brain diseases|brain diseases
5449516|NCT01504854|Resveratrol|resveratrol
5449517|NCT01504854|Memory problems|memory problems
5449518|NCT01504854|Mental disorders|mental disorders
5449519|NCT01504854|Cognitive disorders|cognitive disorders
5449520|NCT01504828|Energy Metabolism|energy metabolism
5449521|NCT01504828|Ageing|ageing
5449522|NCT01504828|left ventricle|left ventricle
5449523|NCT01504828|energetics|energetics
5449525|NCT01504815|advanced head and neck cancer|advanced head and neck cancer
5449526|NCT01504815|adaptive radiotherapy|adaptive radiotherapy
5449527|NCT01504815|cisplatinum|cisplatinum
5449528|NCT01504802|Growth hormone|growth hormone
5449529|NCT01504802|C-type natriuretic peptide|c-type natriuretic peptide
5449530|NCT01504802|amino-terminal propeptide of C-type natriuretic peptide|amino-terminal propeptide of c-type natriuretic peptide
5449531|NCT01504802|insulin-like growth factor-I|insulin-like growth factor-i
5449532|NCT01504802|bone specific alkaline phosphatase|bone specific alkaline phosphatase
5449538|NCT01504789|Breast Cancer|breast cancer
5449539|NCT01504789|Breast Cancer Survivors|breast cancer survivors
5449540|NCT01504789|Exercise|exercise
5449541|NCT01504789|Hispanic|hispanic
5449542|NCT01504789|Mexican-American|mexican-american
5449543|NCT01504789|Puerto Rican|puerto rican
5449544|NCT01504789|Culturally tailored exercise|culturally tailored exercise
5449545|NCT01504789|Fitness tests|fitness tests
5449546|NCT01504789|Questionnaires|questionnaires
5449547|NCT01504789|Surveys|surveys
5449548|NCT01504789|Culturally tailored written material|culturally tailored written material
5449550|NCT01504776|Lymphoma|lymphoma
5449551|NCT01504776|Panobinostat|panobinostat
5449552|NCT01504763|Massage|massage
5449553|NCT01504763|Chair massage|chair massage
5449554|NCT01504763|Relaxation|relaxation
5449555|NCT01504763|Nurses|nurses
5449556|NCT01504750|Length of Stay [E02.760.400.480]|length of stay [e02.760.400.480]
5449557|NCT01504750|Activities of Daily Living [I03.050]|activities of daily living [i03.050]
5449558|NCT01504737|Exercise|exercise
5449559|NCT01504737|Physical Activity|physical activity
5449560|NCT01504737|Physiotherapy|physiotherapy
5449561|NCT01504737|Exercise test|exercise test
5449562|NCT01504737|Quality of Life|quality of life
5449563|NCT01504737|Aortic Valve Replacement|aortic valve replacement
5449564|NCT01504724|central macular thickness|central macular thickness
5449565|NCT01504698|Manipulative treatment|manipulative treatment
5449566|NCT01504698|Children|children
5449567|NCT01504698|Neck pain|neck pain
5449568|NCT01504698|Back pain|back pain
5449570|NCT01504698|Adolescence|adolescence
5449571|NCT01504698|Advise|advise
5449572|NCT01504698|Exercise|exercise
5449573|NCT01504685|Morbid obesity|morbid obesity
5449574|NCT01504685|Obesity surgery|obesity surgery
5449575|NCT01504685|Gastric bypass|gastric bypass
5449576|NCT01504685|Banded gastric bypass|banded gastric bypass
5449577|NCT01504672|Drug related problems|drug related problems
5449578|NCT01504659|bipolar disorder|bipolar disorder
5449579|NCT01504659|treatment resistance|treatment resistance
5449580|NCT01504659|depression|depression
5449581|NCT01504659|ketamine|ketamine
5449582|NCT01504659|intranasal|intranasal
5449583|NCT01504659|child|child
5449584|NCT01504646|Asthma|asthma
5449585|NCT01504646|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5449586|NCT01504646|lipids|lipids
5449587|NCT01504646|n-3 PUFA|n-3 pufa
5449588|NCT01504646|airway inflammation|airway inflammation
5449589|NCT01504646|Bronchoconstriction|bronchoconstriction
5449590|NCT01504633|cognitive function|cognitive function
5449591|NCT01504633|omega-3 PUFA (DHA)|omega-3 pufa (dha)
5449592|NCT01504633|iron|iron
5449593|NCT01504633|nutrigenomics|nutrigenomics
5449594|NCT01504633|under-two year old children|under-two year old children
5449595|NCT01504633|Indonesia|indonesia
5449596|NCT01504620|diabetes mellitus|diabetes mellitus
5449597|NCT01504620|blood glucose self-assessment|blood glucose self-assessment
5449598|NCT01504620|Accuracy|accuracy
5449599|NCT01504620|Intra-Assay precision|intra-assay precision
5449600|NCT01504620|Hematocrit interference|hematocrit interference
5449601|NCT01504607|corneal endothelium|corneal endothelium
5449602|NCT01504607|congenital cataract surgery|congenital cataract surgery
5449603|NCT01504607|IOL implantation|iol implantation
5449604|NCT01504594|Dilated cardiomyopathy|dilated cardiomyopathy
5449605|NCT01504594|Idiopathic|idiopathic
5449606|NCT01504594|Bone Marrow|bone marrow
5449607|NCT01504594|Stem Cells|stem cells
5449608|NCT01504594|CD34 +|cd34 +
5449609|NCT01504594|Autologous|autologous
5449610|NCT01504555|hypercortisolism, dexamethasone, alcoholism,obesity.|hypercortisolism, dexamethasone, alcoholism,obesity.
5449611|NCT01504542|Immunotherapy|immunotherapy
5449612|NCT01504529|Rotigotine (Neupro)|rotigotine (neupro)
5449613|NCT01504529|Non-Motor Symptoms|non-motor symptoms
5449614|NCT01504529|Advanced Parkinson's Disease|advanced parkinson's disease
5449615|NCT01504529|Local study|local study
5449616|NCT01504529|Spain|spain
5449617|NCT01504529|Observational study|observational study
5449618|NCT01504529|Non-interventional study|non-interventional study
5449619|NCT01504529|Retrospective study|retrospective study
5449620|NCT01504529|Post-marketing study|post-marketing study
5449621|NCT01504529|Multicenter study|multicenter study
5449622|NCT01504516|Bioequivalence|bioequivalence
5449623|NCT01504516|Donepezil|donepezil
5449624|NCT01504516|crossover|crossover
5449625|NCT01504503|Bioequivalence|bioequivalence
5449626|NCT01504503|Donepezil|donepezil
5449627|NCT01504503|crossover|crossover
5452813|NCT01490957|HD|hd
5449629|NCT01504477|colorectal cancer|colorectal cancer
5449630|NCT01504477|relapsed|relapsed
5449631|NCT01504477|refractory|refractory
5449632|NCT01504477|Kras wild type|kras wild type
5449633|NCT01504464|knee joint osteoarthritis mesenchymal stem cell|knee joint osteoarthritis mesenchymal stem cell
5449634|NCT01504451|Atrial fibrillation|atrial fibrillation
5449635|NCT01504451|Ablation|ablation
5449636|NCT01504451|Implantable loop recorder|implantable loop recorder
5449638|NCT01504412|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5449639|NCT01504399|Pituitary surgery|pituitary surgery
5449640|NCT01504399|Transsphenoidal surgery|transsphenoidal surgery
5449641|NCT01504399|Anterior skull base surgery|anterior skull base surgery
5449642|NCT01504399|Endoscopic surgery|endoscopic surgery
5449643|NCT01504399|Patient survey|patient survey
5449644|NCT01504399|Nasal complications|nasal complications
5449645|NCT01504373|NAVA|nava
5449646|NCT01504373|neurally adjusted ventilatory support|neurally adjusted ventilatory support
5449647|NCT01504373|lung injury|lung injury
5449648|NCT01504373|ventilation|ventilation
5449649|NCT01504373|lung volume distribution|lung volume distribution
5449650|NCT01504373|oxygen cost of breathing|oxygen cost of breathing
5449652|NCT01504360|radiation therapy|radiation therapy
5449653|NCT01504360|predictive essay|predictive essay
5449654|NCT01504321|Polycystic Ovary syndrome|polycystic ovary syndrome
5449655|NCT01504321|PCOS|pcos
5449656|NCT01504321|sympathetic nervous system|sympathetic nervous system
5449657|NCT01504321|moxonidine|moxonidine
5449658|NCT01504308|uterine fibroids|uterine fibroids
5449659|NCT01504308|uterine leiomyomas|uterine leiomyomas
5449660|NCT01504308|magnetic resonance imaging|magnetic resonance imaging
5449661|NCT01504308|focused ultrasound|focused ultrasound
5449662|NCT01504256|Adenocarcinoma|adenocarcinoma
5449663|NCT01504256|Esophagogastric Junction|esophagogastric junction
5449664|NCT01504256|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5449665|NCT01504256|Catumaxomab|catumaxomab
5449666|NCT01504256|AIO-STO-0110|aio-sto-0110
5449667|NCT01504243|CD163;|cd163;
5449668|NCT01504243|SNPs;|snps;
5449669|NCT01504243|prognosis;|prognosis;
5449670|NCT01504243|control（normal person）|control（normal person）
5449671|NCT01504230|To ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.|to ascertain the mechanisms for effectively controlling balance in seniors with osteoporosis and to provide a basis for developing fall prevention programs.
5449672|NCT01504230|To develop biomechanical models that control the entire body's center of mass (CoM) during upright quiet stance in seniors with osteoporosis.|to develop biomechanical models that control the entire body's center of mass (com) during upright quiet stance in seniors with osteoporosis.
5449673|NCT01504230|To identify the mechanism to control the entire body's CoM after receiving a balance perturbation in seniors with osteoporosis.|to identify the mechanism to control the entire body's com after receiving a balance perturbation in seniors with osteoporosis.
5449674|NCT01504217|Healthy older people over 65 years old|healthy older people over 65 years old
5449675|NCT01504204|adherence|adherence
5449676|NCT01504204|adapalene|adapalene
5449677|NCT01504204|benzoyl peroxide|benzoyl peroxide
5449678|NCT01504204|sample|sample
5449679|NCT01504204|topical treatment|topical treatment
5449680|NCT01504191|myocardial infarction|myocardial infarction
5449681|NCT01504191|depression|depression
5449682|NCT01504191|anxiety|anxiety
5449683|NCT01504191|Internet‐based CBT|internet‐based cbt
5449684|NCT01504191|genetic disposition|genetic disposition
5449685|NCT01504178|Noradrenergic system and pain in Parkinson's disease|noradrenergic system and pain in parkinson's disease
5449686|NCT01504165|Renal impairment|renal impairment
5449687|NCT01504165|Pharmacokinetic|pharmacokinetic
5449688|NCT01504165|cilengitide|cilengitide
5449689|NCT01504165|subjects with mild|subjects with mild
5685515|NCT00555789|immunosuppression|immunosuppression
5685516|NCT00555776|tinnitus|tinnitus
5449690|NCT01504165|moderate or severe renal impairment compared to subjects with normal renal function|moderate or severe renal impairment compared to subjects with normal renal function
5449691|NCT01504152|International travel|international travel
5449692|NCT01504152|cancer patients|cancer patients
5449693|NCT01504152|HSCT|hsct
5449694|NCT01504152|Quality of Life|quality of life
5449695|NCT01504152|questionnaire|questionnaire
5449696|NCT01504152|11-176|11-176
5449697|NCT01504113|Target therapy|target therapy
5449698|NCT01504113|Biologics|biologics
5449699|NCT01504113|Psoriasis|psoriasis
5449700|NCT01504113|Latent virus|latent virus
5449701|NCT01504113|Human papillomaviruses|human papillomaviruses
5449702|NCT01504113|Cytomegalovirus|cytomegalovirus
5449703|NCT01504113|Epstein-Barr virus|epstein-barr virus
5449704|NCT01504113|Tumor necrosis factor|tumor necrosis factor
5449705|NCT01504087|patient in critical care|patient in critical care
5449706|NCT01504074|Irvine Gass syndrome|irvine gass syndrome
5449707|NCT01504074|multimodal imaging|multimodal imaging
5449708|NCT01504074|SD-OCT|sd-oct
5449709|NCT01504074|CME secondary to cataract surgery|cme secondary to cataract surgery
5449710|NCT01504074|in vivo correlation of morphology and function|in vivo correlation of morphology and function
5449711|NCT01504061|surgical|surgical
5449712|NCT01504061|scars|scars
5449713|NCT01504061|Mederma|mederma
5449714|NCT01504048|Microscopic colitis|microscopic colitis
5449715|NCT01504048|Intestinal Diseases|intestinal diseases
5449716|NCT01504048|Inflammatory Bowel Diseases|inflammatory bowel diseases
5449717|NCT01504035|Donor site pain|donor site pain
5449718|NCT01504035|Iliac crest|iliac crest
5449719|NCT01504035|Bone graft|bone graft
5449720|NCT01504035|Hemostatic putty|hemostatic putty
5449721|NCT01504035|lidocaine|lidocaine
5449722|NCT01504035|Donor site pain following harvest of iliac crest bone grafts|donor site pain following harvest of iliac crest bone grafts
5449723|NCT01504022|Hypertension|hypertension
5449724|NCT01504022|self-monitoring|self-monitoring
5449725|NCT01504022|internet|internet
5449726|NCT01504022|lifestyle modification|lifestyle modification
5449727|NCT01504009|Nervous System Disease|nervous system disease
5449728|NCT01504009|Neurodegenerative Disease|neurodegenerative disease
5449729|NCT01504009|Motor Neuron Disease|motor neuron disease
5449730|NCT01504009|ALS|als
5449731|NCT01504009|Muscle training|muscle training
5449732|NCT01504009|Muscle atrophy|muscle atrophy
5449733|NCT01503996|dehydration|dehydration
5449734|NCT01503996|risk factor|risk factor
5449735|NCT01503996|glaucoma|glaucoma
5449736|NCT01503996|Controls|controls
5449737|NCT01503983|Gastric Cancer with Metastasis|gastric cancer with metastasis
5449738|NCT01503983|HER2-positive|her2-positive
5449740|NCT01503970|knee|knee
5449741|NCT01503957|Allergic rhinitis|allergic rhinitis
5449742|NCT01503957|Allergen|allergen
5449743|NCT01503957|Allergy|allergy
5449744|NCT01503957|Dustmite|dustmite
5449745|NCT01503931|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,|alcohol dependence, functional magnetic resonance imaging, genetics, endophenotypes, dopamine,
5449746|NCT01503931|glutamate|glutamate
5449747|NCT01503918|Critical Illness|critical illness
5449748|NCT01503918|Critical Care|critical care
5449749|NCT01503918|Valganciclovir|valganciclovir
5449750|NCT01503918|Ganciclovir|ganciclovir
5449751|NCT01503918|Aciclovir|aciclovir
5449752|NCT01503918|Valaciclovir|valaciclovir
5449753|NCT01503918|Cytomegalovirus|cytomegalovirus
5449754|NCT01503905|breast cancer|breast cancer
5449755|NCT01503905|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5449756|NCT01503905|amenorrhea|amenorrhea
5449757|NCT01503892|Small Fiber Neuropathy|small fiber neuropathy
5449758|NCT01503892|Metanx Effect on Small Fiber Neuropathy|metanx effect on small fiber neuropathy
5449759|NCT01503892|Metanx Effect on Diabetic Peripheral Neuropathy|metanx effect on diabetic peripheral neuropathy
5449760|NCT01503879|general anaesthesia|general anaesthesia
5449761|NCT01503879|invasive mechanical ventilation|invasive mechanical ventilation
5449762|NCT01503879|DLCO|dlco
5449763|NCT01503879|SPB|spb
5449764|NCT01503853|Medical Costs|medical costs
5449765|NCT01503853|Health Care|health care
5449766|NCT01503853|Focus Groups|focus groups
5449767|NCT01503827|Whole Brain Radiotherapy|whole brain radiotherapy
5449768|NCT01503827|Brain metastases|brain metastases
5449769|NCT01503827|Melanoma|melanoma
5449770|NCT01503827|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
5449771|NCT01503827|Neurocognitive function|neurocognitive function
5449772|NCT01503827|Quality of life|quality of life
5449773|NCT01503814|hypertension|hypertension
5449774|NCT01503814|primary care|primary care
5449775|NCT01503814|cardiovascular disease prevention|cardiovascular disease prevention
5449776|NCT01503814|high cardiovascular risk|high cardiovascular risk
5449777|NCT01503814|diuretics|diuretics
5449778|NCT01503814|aspirin|aspirin
5449779|NCT01503814|smoking cessation|smoking cessation
5449780|NCT01503814|salt reduction|salt reduction
5449781|NCT01503814|Tibet|tibet
5449782|NCT01503801|Preterm neonates|preterm neonates
5449783|NCT01503801|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5685517|NCT00555776|gabapentin|gabapentin
5449784|NCT01503801|Chronic lung disease|chronic lung disease
5449785|NCT01503801|Inhaled nitric oxide|inhaled nitric oxide
5449786|NCT01503801|Respiratory therapy|respiratory therapy
5449787|NCT01503775|intracranial|intracranial
5449788|NCT01503775|ruptured|ruptured
5449789|NCT01503775|non-ruptured|non-ruptured
5449790|NCT01503775|aneurysms|aneurysms
5449791|NCT01503775|Intracranial ruptured or non-ruptured aneurysms|intracranial ruptured or non-ruptured aneurysms
5449792|NCT01503762|Hand Flexor tendon Injuries|hand flexor tendon injuries
5449793|NCT01503762|hand Extensor Tendon Injuries|hand extensor tendon injuries
5449794|NCT01503762|Hand Joint Dislocations and subluxation|hand joint dislocations and subluxation
5449795|NCT01503736|Kidney Diseases|kidney diseases
5449796|NCT01503736|Kidney Failure, Chronic|kidney failure, chronic
5449797|NCT01503736|Hyperphosphatemia|hyperphosphatemia
5449798|NCT01503736|Urologic Diseases|urologic diseases
5449799|NCT01503736|Renal Insufficiency, Chronic|renal insufficiency, chronic
5449800|NCT01503736|Renal Insufficiency|renal insufficiency
5449801|NCT01503736|Phosphorus Metabolism Disorders|phosphorus metabolism disorders
5449802|NCT01503710|Proteinuria predict outcome|proteinuria predict outcome
5449803|NCT01503710|BNP and NGAL predict outcome|bnp and ngal predict outcome
5449804|NCT01503710|Pre-operative GFR and proteinuria|pre-operative gfr and proteinuria
5449805|NCT01503697|Breast Cancer|breast cancer
5449806|NCT01503697|High Risk|high risk
5449807|NCT01503697|Imaging|imaging
5449808|NCT01503697|Angiogenesis|angiogenesis
5449809|NCT01503684|sepsis|sepsis
5798670|NCT00111410|Anakinra, Immunex|anakinra, immunex
5449816|NCT01503658|Pharmacogenomics|pharmacogenomics
5449817|NCT01503645|kidney diseases|kidney diseases
5449818|NCT01503645|drugs, Chinese herbal|drugs, chinese herbal
5449819|NCT01503645|aristolochic acid|aristolochic acid
5449820|NCT01503645|polymorphism, genetic|polymorphism, genetic
5449821|NCT01503619|small cell lung cancer|small cell lung cancer
5449822|NCT01503606|preterm premature rupture of membrane|preterm premature rupture of membrane
5449823|NCT01503606|antibiotics|antibiotics
5449824|NCT01503606|duration|duration
5449825|NCT01503606|cefazolin|cefazolin
5449826|NCT01503606|clarithromycin|clarithromycin
5450015|NCT01502748|Magnesium|magnesium
5449827|NCT01503541|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5449828|NCT01503541|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5449829|NCT01503541|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5449830|NCT01503541|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5449831|NCT01503541|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5449832|NCT01503541|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5449833|NCT01503541|adult acute myeloid leukemia|adult acute myeloid leukemia
5449835|NCT01503528|wound|wound
5449836|NCT01503528|catheter|catheter
5449837|NCT01503528|local|local
5449838|NCT01503528|anesthesia|anesthesia
5449839|NCT01503528|infiltration|infiltration
5449840|NCT01503528|Total Knee Arthroplasty|total knee arthroplasty
5449841|NCT01503502|Myelogenous Leukemia|myelogenous leukemia
5449842|NCT01503502|chronce|chronce
5449843|NCT01503502|Philadelphia Chromosome Positive|philadelphia chromosome positive
5449844|NCT01503502|Flumatinib|flumatinib
5449845|NCT01503489|Switch.|switch.
5449846|NCT01503476|gastro esophageal reflux disease|gastro esophageal reflux disease
5449847|NCT01503463|Congestive Heart Failure|congestive heart failure
5449848|NCT01503463|Telemedicine|telemedicine
5449849|NCT01503385|Celecoxib|celecoxib
5449850|NCT01503385|phase II|phase ii
5449851|NCT01503359|glutamic acid|glutamic acid
5449852|NCT01503359|sarcosine|sarcosine
5449853|NCT01503359|NMDA|nmda
5449854|NCT01503359|schizophrenia|schizophrenia
5449856|NCT01503333|exercise|exercise
5449857|NCT01503333|adolescent|adolescent
5449858|NCT01503333|intervention|intervention
5449859|NCT01503333|female|female
5449860|NCT01503333|counseling|counseling
5449861|NCT01503320|To evaluate|to evaluate
5449862|NCT01503320|efficacy|efficacy
5449863|NCT01503320|enteral glutamine|enteral glutamine
5449864|NCT01503307|prenatal chd diagnosis|prenatal chd diagnosis
5449865|NCT01503307|postpartum chd diagnosis|postpartum chd diagnosis
5449866|NCT01503307|parenting|parenting
5449867|NCT01503307|internal working models|internal working models
5449868|NCT01503294|Temporal artery thermometer|temporal artery thermometer
5449869|NCT01503294|Pulmonary artery thermistor|pulmonary artery thermistor
5449870|NCT01503281|Children|children
5449871|NCT01503281|Physical activity|physical activity
5449872|NCT01503281|Home-based treatment|home-based treatment
5449873|NCT01503281|Body mass index (z-BMI)|body mass index (z-bmi)
5449874|NCT01503281|Percentage body fat|percentage body fat
5449875|NCT01503281|Waist circumference|waist circumference
5449876|NCT01503268|Atrial fibrillation|atrial fibrillation
5449877|NCT01503268|Ablation|ablation
5449878|NCT01503268|Percutaneous ablation|percutaneous ablation
5449879|NCT01503268|Minimally-invasive thoracoscopic ablation|minimally-invasive thoracoscopic ablation
5449880|NCT01503268|Implantable loop recorder|implantable loop recorder
5449881|NCT01503255|CBT|cbt
5449882|NCT01503255|alcohol|alcohol
5449883|NCT01503255|HIV|hiv
5449884|NCT01503255|Kenya|kenya
5449885|NCT01503255|paraprofessional|paraprofessional
5449886|NCT01503216|randomized controlled trial|randomized controlled trial
5449887|NCT01503216|vitamin D|vitamin d
5449888|NCT01503216|bioavailability|bioavailability
5449889|NCT01503203|Older|older
5449890|NCT01503203|virtual systems|virtual systems
5449891|NCT01503203|low back pain|low back pain
5449892|NCT01503203|postural balance|postural balance
5449893|NCT01503190|Breast Cancer|breast cancer
5449894|NCT01503190|Young Women|young women
5449895|NCT01503190|Pregnancy Associated Breast Cancer|pregnancy associated breast cancer
5449896|NCT01503190|Pregnancy|pregnancy
5449897|NCT01503190|Premenopausal Breast Cancer|premenopausal breast cancer
5449898|NCT01503164|Obstructive sleep apnea|obstructive sleep apnea
5449899|NCT01503164|Sleep Apnea|sleep apnea
5449900|NCT01503164|Sleep-disordered breathing|sleep-disordered breathing
5444696|NCT01525095|Candida|candida
5449901|NCT01503164|Insulin sensitivity|insulin sensitivity
5449902|NCT01503164|Glucose tolerance|glucose tolerance
5449903|NCT01503164|Type 2 diabetes|type 2 diabetes
5453127|NCT01489826|Cancer|cancer
5449904|NCT01503151|attention bias modification treatment|attention bias modification treatment
5449905|NCT01503151|interpretive bias modification|interpretive bias modification
5449906|NCT01503151|cognitive bias modification|cognitive bias modification
5449907|NCT01503151|attention training|attention training
5449908|NCT01503151|social anxiety|social anxiety
5449909|NCT01503138|Intimate Partner Violence|intimate partner violence
5449910|NCT01503138|Depressive Symptoms|depressive symptoms
5449911|NCT01503138|Intervention|intervention
5449912|NCT01503138|Randomized Controlled Trial|randomized controlled trial
5449913|NCT01503138|Mainland Chinese|mainland chinese
5449915|NCT01503138|Women|women
5449917|NCT01503125|Giant Axonal Neuropathy|giant axonal neuropathy
5449918|NCT01503125|Neuromuscular Disease|neuromuscular disease
5449919|NCT01503125|Natural History Study|natural history study
5449920|NCT01503125|Observational Study|observational study
5450016|NCT01502748|Endovascular|endovascular
5450017|NCT01502735|dengue|dengue
5680274|NCT00578396|Grapes and colon cancer prevention|grapes and colon cancer prevention
5680275|NCT00578383|Depression|depression
5449921|NCT01503112|Glucagon-Like Peptide 1, DPP4 protein, Therapeutics, Hypoglycemic Agents, C-Peptide, Type 2 Diabetes Mellitus,|glucagon-like peptide 1, dpp4 protein, therapeutics, hypoglycemic agents, c-peptide, type 2 diabetes mellitus,
5449923|NCT01503099|PTB|ptb
5449924|NCT01503099|CD|cd
5449925|NCT01503073|stroke|stroke
5449926|NCT01503060|pediatrics|pediatrics
5449927|NCT01503060|Pain|pain
5449928|NCT01503060|Immunization|immunization
5449929|NCT01503034|Pregnant women|pregnant women
5449930|NCT01503021|Soluble ferric pyrophosphate|soluble ferric pyrophosphate
5449931|NCT01503021|Chronic kidney disease|chronic kidney disease
5449932|NCT01503021|Chronic hemodialysis|chronic hemodialysis
5449933|NCT01503021|Ferric pyrophosphate citrate|ferric pyrophosphate citrate
5449934|NCT01502995|Assistive devices|assistive devices
5449935|NCT01502995|Freezing of gait|freezing of gait
5449936|NCT01502995|Gait disorders|gait disorders
5449937|NCT01502995|Gait hesitation|gait hesitation
5449938|NCT01502995|Gait ignition failure|gait ignition failure
5449939|NCT01502995|Laser light|laser light
5449940|NCT01502995|Parkinson's disease|parkinson's disease
5449941|NCT01502995|Rolling walker|rolling walker
5449942|NCT01502995|Visual Cue|visual cue
5449943|NCT01502995|Walker|walker
5449944|NCT01502982|DLBCL|dlbcl
5449945|NCT01502982|high risk|high risk
5449946|NCT01502982|young|young
5449947|NCT01502969|diarrhea|diarrhea
5449948|NCT01502969|fever|fever
5594834|NCT00911612|IBS|ibs
5449949|NCT01502969|nausea|nausea
5449950|NCT01502969|vomit|vomit
5449951|NCT01502969|irritability|irritability
5449952|NCT01502956|Refractory Urinary Urge Incontinence|refractory urinary urge incontinence
5449953|NCT01502956|Botox A®|botox a®
5449954|NCT01502956|Interstim® Device|interstim® device
5449955|NCT01502943|Complementary Therapies|complementary therapies
5449956|NCT01502943|Traditional Chinese Medicine|traditional chinese medicine
5449957|NCT01502943|Quality of life|quality of life
5449958|NCT01502943|Seattle angina questionnaire (SAQ)|seattle angina questionnaire (saq)
5449959|NCT01502943|SF-12|sf-12
5449960|NCT01502943|Measure Your Medical Outcome Profile (MYMOP)|measure your medical outcome profile (mymop)
5449961|NCT01502943|Phlegm and blood stasis Syndrome|phlegm and blood stasis syndrome
5449962|NCT01502943|Qi deficiency and blood stasis Syndrome|qi deficiency and blood stasis syndrome
5449963|NCT01502943|Invigorating Spleen to Remove Phlegm or replenish Qi|invigorating spleen to remove phlegm or replenish qi
5449964|NCT01502943|Activating blood and dissolving stasis|activating blood and dissolving stasis
5449965|NCT01502943|Traditional Chinese medicine SYndrome Scale (TCMsys)|traditional chinese medicine syndrome scale (tcmsys)
5449966|NCT01502943|Patients Report Outcomes(PRO)|patients report outcomes(pro)
5449967|NCT01502943|clinical efficacy|clinical efficacy
5449968|NCT01502943|evaluative index|evaluative index
5449969|NCT01502917|Brain stem glioma|brain stem glioma
5449970|NCT01502917|CNS|cns
5449971|NCT01502917|MAB 124I-8H9|mab 124i-8h9
5449972|NCT01502917|infusion cannula|infusion cannula
5449973|NCT01502917|DIPG|dipg
5449974|NCT01502917|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5449975|NCT01502917|11-011|11-011
5449976|NCT01502904|SES vs BES|ses vs bes
5449977|NCT01502891|Comparative Effectiveness Research|comparative effectiveness research
5449978|NCT01502891|Decision Support Techniques|decision support techniques
5449979|NCT01502891|Decision Making|decision making
5449980|NCT01502878|Nut allergy|nut allergy
5449981|NCT01502878|Double-blind placebo-controlled (DBPC) oral nut challenge|double-blind placebo-controlled (dbpc) oral nut challenge
5449982|NCT01502878|Nut oral immunotherapy (OIT)|nut oral immunotherapy (oit)
5449983|NCT01502878|Nut oral desensitization|nut oral desensitization
5449984|NCT01502852|OEF/OIF Veterans|oef/oif veterans
5449985|NCT01502852|Traumatic Brain Injury|traumatic brain injury
5449986|NCT01502852|Community Mental Health|community mental health
5449987|NCT01502826|Childhood obesity|childhood obesity
5449988|NCT01502826|Endothelial dysfunction|endothelial dysfunction
5449990|NCT01502826|Insulin resistance|insulin resistance
5449991|NCT01502813|Neuropsychological testing|neuropsychological testing
5449992|NCT01502813|Dietary supplements|dietary supplements
5449993|NCT01502800|Metastatic|metastatic
5449995|NCT01502800|Recurrent advanced|recurrent advanced
5449996|NCT01502787|hypertension|hypertension
5449997|NCT01502787|blood pressure|blood pressure
5449998|NCT01502787|blood pressure medications|blood pressure medications
5449999|NCT01502787|metoprolol|metoprolol
5450000|NCT01502787|nebivolol|nebivolol
5450001|NCT01502787|handgrip exercise|handgrip exercise
5450002|NCT01502787|lower body negative pressure|lower body negative pressure
5450003|NCT01502787|angiotensin II|angiotensin ii
5450004|NCT01502787|sympathetic nerve activity|sympathetic nerve activity
5450005|NCT01502787|flow mediated dilation|flow mediated dilation
5450006|NCT01502787|nitric oxide|nitric oxide
5450007|NCT01502787|microneurography|microneurography
5450008|NCT01502774|STEMI|stemi
5450009|NCT01502774|cyclosporine|cyclosporine
5450010|NCT01502774|reperfusion injury|reperfusion injury
5450011|NCT01502761|stroke|stroke
5450012|NCT01502761|Magnesium|magnesium
5450013|NCT01502761|endovascular|endovascular
5450014|NCT01502748|stroke|stroke
5450018|NCT01502735|dengue fever|dengue fever
5450019|NCT01502735|monovalent dengue vaccine|monovalent dengue vaccine
5450020|NCT01502709|Single blind|single blind
5450021|NCT01502709|Randomized|randomized
5450022|NCT01502709|Controlled clinical trial|controlled clinical trial
5450023|NCT01502696|ulcerated primary cutaneous melanoma|ulcerated primary cutaneous melanoma
5450024|NCT01502696|Stage II|stage ii
5450025|NCT01502696|PEG IFN alfa-2b|peg ifn alfa-2b
5450026|NCT01502696|T(2-4)bN0M0|t(2-4)bn0m0
5450027|NCT01502683|Stroke|stroke
5450028|NCT01502683|neurocognitive dysfunction|neurocognitive dysfunction
5450029|NCT01502683|cerebral embolic events|cerebral embolic events
5450030|NCT01502670|Pulmonary nodules|pulmonary nodules
5450031|NCT01502657|percutaneous tracheostomy|percutaneous tracheostomy
5450032|NCT01502657|ultrasonography|ultrasonography
5450033|NCT01502657|echography|echography
5450034|NCT01502657|critical care|critical care
5450035|NCT01502644|low back pain|low back pain
5450036|NCT01502644|opioids|opioids
5450037|NCT01502644|mood symptoms|mood symptoms
5450038|NCT01502618|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
5450039|NCT01502618|Human Immunodeficiency Virus|human immunodeficiency virus
5450040|NCT01502605|5-ALA|5-ala
5450041|NCT01502605|Aminolevulinic Acid|aminolevulinic acid
5903963|NCT00092222|HHV-8|hhv-8
5450042|NCT01502605|Craniotomy|craniotomy
5450043|NCT01502605|Brain Tumor|brain tumor
5450044|NCT01502605|Surgical Resection|surgical resection
5450045|NCT01502605|Neurosurgery|neurosurgery
5450046|NCT01502592|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
5450047|NCT01502592|Cryoablation|cryoablation
5450048|NCT01502592|Total mastectomy planned|total mastectomy planned
5450049|NCT01502592|11-202|11-202
5450050|NCT01502579|IgA nephropathy|iga nephropathy
5450051|NCT01502566|educational intervention|educational intervention
5450052|NCT01502566|dentals caries|dentals caries
5450053|NCT01502566|population|population
5450054|NCT01502566|new populational caries prevention strategies.|new populational caries prevention strategies.
5450055|NCT01502553|blood pressure|blood pressure
5450056|NCT01502553|heart rate|heart rate
5450057|NCT01502540|pain|pain
5450058|NCT01502540|craniotomy|craniotomy
5450059|NCT01502527|Vulvo vaginal atrophy|vulvo vaginal atrophy
5450060|NCT01502527|Femarelle|femarelle
5450061|NCT01502514|CHF|chf
5450062|NCT01502514|ischemia|ischemia
5450063|NCT01502514|Heart Failure|heart failure
5450064|NCT01502501|CHF|chf
5450065|NCT01502501|Heart Failure|heart failure
5450066|NCT01502501|Non-Ischemic|non-ischemic
5450067|NCT01502501|nonischemic|nonischemic
5450068|NCT01502501|nonischemia|nonischemia
5450069|NCT01502488|Autistic|autistic
5450070|NCT01502488|ASC therapy|asc therapy
5450071|NCT01502488|ADSC|adsc
5685518|NCT00555763|Intraocular pressure|intraocular pressure
5450072|NCT01502475|Complementary Alternative Medicine|complementary alternative medicine
5450073|NCT01502475|Veteran|veteran
5450074|NCT01502475|Attitudes|attitudes
5450075|NCT01502475|Beliefs|beliefs
5450076|NCT01502462|Clinical course and prognostic factors in patients with severe isolated TR|clinical course and prognostic factors in patients with severe isolated tr
5450077|NCT01502449|telemedicine, telephonic, PTSD|telemedicine, telephonic, ptsd
5450078|NCT01502436|posttraumatic stress disorder|posttraumatic stress disorder
5450079|NCT01502436|traumatic brain injury|traumatic brain injury
5450080|NCT01502436|Suicide Attempt|suicide attempt
5450081|NCT01502436|Veterans|veterans
5450082|NCT01502423|On label Humira users|on label humira users
5450083|NCT01502423|Rheumatoid Arthritis|rheumatoid arthritis
5450084|NCT01502423|Pain|pain
5450085|NCT01502397|hepatitis B|hepatitis b
5450086|NCT01502397|anti-HBc|anti-hbc
5450087|NCT01502397|HBsAg|hbsag
5450088|NCT01502397|rituximab|rituximab
5450089|NCT01502397|occult HBV|occult hbv
5450090|NCT01502384|healthy 1st degree relatives of pd patients|healthy 1st degree relatives of pd patients
5450091|NCT01502371|Asthma|asthma
5450092|NCT01502371|Children|children
5450093|NCT01502371|Persistent|persistent
5450095|NCT01502358|dengue fever|dengue fever
5450096|NCT01502358|dengue disease|dengue disease
5450097|NCT01502358|tetravalent dengue vaccine|tetravalent dengue vaccine
5450098|NCT01502358|Vaxfectin®|vaxfectin®
5450099|NCT01502345|HFRS|hfrs
5450100|NCT01502332|Mechanical ventilation|mechanical ventilation
5450101|NCT01502332|Open lung approach|open lung approach
5450102|NCT01502332|Blood gases|blood gases
5450103|NCT01502332|Cardiac surgery|cardiac surgery
5450104|NCT01502332|Pulmonary complications|pulmonary complications
5450105|NCT01502306|Smoking cessation|smoking cessation
5450106|NCT01502306|Telephone|telephone
5450107|NCT01502306|Self-help|self-help
5450108|NCT01502306|Smoking abstinence|smoking abstinence
5450109|NCT01502306|Incentives|incentives
5450110|NCT01502306|Nicotine-replacement therapy|nicotine-replacement therapy
5450111|NCT01502306|Medi-Cal|medi-cal
5450112|NCT01502306|Medicaid|medicaid
5450113|NCT01502280|extent of resection|extent of resection
5450114|NCT01502280|Glioma|glioma
5450115|NCT01502280|5-ALA|5-ala
5450116|NCT01502280|tumor fluorescence|tumor fluorescence
5450117|NCT01502280|confocal microscopy|confocal microscopy
5450118|NCT01502267|Waiting list|waiting list
5450218|NCT01501968|ascorbic acid|ascorbic acid
5450119|NCT01502267|Deceased donor kidney transplantation|deceased donor kidney transplantation
5450120|NCT01502267|Desensitization|desensitization
5432809|NCT01575925|Pomalyst|pomalyst
5450121|NCT01502267|anti HLA antibody|anti hla antibody
5450122|NCT01502254|Informed consent|informed consent
5450123|NCT01502254|Cancer clinical trials|cancer clinical trials
5450124|NCT01502254|Patient information|patient information
5450125|NCT01502254|Knowledge|knowledge
5450126|NCT01502254|Questionnaire|questionnaire
5450127|NCT01502254|Patient Eligible for a Phase II or III Cancer Clinical Trial|patient eligible for a phase ii or iii cancer clinical trial
5450128|NCT01502254|Scheduled Clinical Visit for Information About a Trial|scheduled clinical visit for information about a trial
5450129|NCT01502241|elderly|elderly
5450130|NCT01502241|brain tumors|brain tumors
5450131|NCT01502241|MGMT|mgmt
5450132|NCT01502241|chemotherapy|chemotherapy
5450133|NCT01502241|Newly diagnosed|newly diagnosed
5450134|NCT01502241|patients > 65 years|patients > 65 years
5450135|NCT01502202|lung adenocarcinoma|lung adenocarcinoma
5450136|NCT01502202|never smoker|never smoker
5450137|NCT01502202|1st line treatment|1st line treatment
5450138|NCT01502202|Intercalation administration|intercalation administration
5450139|NCT01502202|Gefitinib|gefitinib
5450140|NCT01502202|never smokers|never smokers
5450141|NCT01502189|patient education as topic|patient education as topic
5450142|NCT01502189|representational approach|representational approach
5450144|NCT01502189|childhood cancer|childhood cancer
5450145|NCT01502189|paediatric oncology|paediatric oncology
5450146|NCT01502189|nursing|nursing
5450147|NCT01502189|parents of children with cancer|parents of children with cancer
5450148|NCT01502189|Stress|stress
5450149|NCT01502189|Health Knowledge|health knowledge
5450150|NCT01502189|Attitudes|attitudes
5450151|NCT01502189|Practice|practice
5450152|NCT01502176|atrial fibrillation|atrial fibrillation
5450153|NCT01502176|registry|registry
5450154|NCT01502163|perioperative hypothermia|perioperative hypothermia
5450155|NCT01502163|prewarming|prewarming
5450156|NCT01502163|forced air warming|forced air warming
5450157|NCT01502163|insulation|insulation
5450158|NCT01502150|Pediatric Cancer|pediatric cancer
5450159|NCT01502150|Proton Radiation Therapy|proton radiation therapy
5450160|NCT01502150|Proton beam radiotherapy|proton beam radiotherapy
5450161|NCT01502150|PBT|pbt
5450162|NCT01502150|Data Collection|data collection
5450163|NCT01502150|Database|database
5450164|NCT01502150|Acute and late normal tissue toxicities|acute and late normal tissue toxicities
5450165|NCT01502150|Dosimetric data|dosimetric data
5450166|NCT01502150|Toxicity data|toxicity data
5450167|NCT01502111|decreased level of consciousness|decreased level of consciousness
5450168|NCT01502111|hypoxemia|hypoxemia
5450169|NCT01502111|ineffective ventilation|ineffective ventilation
5450170|NCT01502111|airway obstruction|airway obstruction
5450171|NCT01502111|combative or unresponsive|combative or unresponsive
5450172|NCT01502111|relief of pain or distress|relief of pain or distress
5450173|NCT01502111|cardiopulmonary arrest|cardiopulmonary arrest
5450174|NCT01502085|multiple myeloma lenalidomide|multiple myeloma lenalidomide
5450175|NCT01502072|Ribavirin|ribavirin
5450176|NCT01502072|Ribavirin Aerosol|ribavirin aerosol
5450177|NCT01502072|Respiratory Syncytial Virus|respiratory syncytial virus
5450178|NCT01502072|RSV|rsv
5450179|NCT01502072|upper respiratory tract infection|upper respiratory tract infection
5450180|NCT01502072|URI|uri
5450181|NCT01502072|Lower respiratory tract Infection|lower respiratory tract infection
5450182|NCT01502072|LRI|lri
5450183|NCT01502072|pneumonia|pneumonia
5450184|NCT01502072|aerosolized ribavirin|aerosolized ribavirin
5450185|NCT01502072|HSCT|hsct
5450186|NCT01502072|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5450187|NCT01502072|oral ribavirin therapy|oral ribavirin therapy
5450188|NCT01502059|Pilates|pilates
5450189|NCT01502059|Exercise|exercise
5450191|NCT01502059|Low back pain|low back pain
5450192|NCT01502059|Pain|pain
5450193|NCT01502059|Function|function
5450194|NCT01502046|Huntington's disease, cannabinoids|huntington's disease, cannabinoids
5450195|NCT01502033|Adolescent Depression|adolescent depression
5450196|NCT01502033|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5450197|NCT01502020|actinic keratoses|actinic keratoses
5450198|NCT01502020|actinic keratosis|actinic keratosis
5450199|NCT01502020|imiquimod, 3.75%|imiquimod, 3.75%
5450200|NCT01502020|imiquimod|imiquimod
5450202|NCT01502020|Actinic keratoses of the face or balding scalp|actinic keratoses of the face or balding scalp
5450203|NCT01502007|Activity Level|activity level
5450204|NCT01502007|Overweight|overweight
5450205|NCT01502007|Obesity|obesity
5450206|NCT01501994|Activity level|activity level
5450207|NCT01501994|Weight|weight
5450208|NCT01501994|Body Fat|body fat
5450209|NCT01501994|Well Being|well being
5450210|NCT01501981|heart failure|heart failure
5450211|NCT01501981|MR-proANP|mr-proanp
5450212|NCT01501981|MR-proADM|mr-proadm
5450213|NCT01501981|decompensation|decompensation
5450214|NCT01501981|Copeptin|copeptin
5450215|NCT01501981|CT-proET1|ct-proet1
5450217|NCT01501968|Colistin|colistin
5450219|NCT01501968|renal toxicity|renal toxicity
5450220|NCT01501955|Osteoarthritis|osteoarthritis
5450221|NCT01501942|Asthma|asthma
5450222|NCT01501942|Allergen induced asthma|allergen induced asthma
5450223|NCT01501942|ATS Criteria (1)|ats criteria (1)
5450224|NCT01501929|hypertension|hypertension
5450225|NCT01501929|blood pressure|blood pressure
5450226|NCT01501929|blood pressure medications|blood pressure medications
5450227|NCT01501929|metoprolol|metoprolol
5450228|NCT01501929|nebivolol|nebivolol
5450229|NCT01501929|vascular oxidative stress|vascular oxidative stress
5450230|NCT01501929|nitric oxide|nitric oxide
5450231|NCT01501929|nitric oxide synthase (eNOS)|nitric oxide synthase (enos)
5450232|NCT01501929|endothelium|endothelium
5450233|NCT01501929|endothelial dysfunction|endothelial dysfunction
5450234|NCT01501929|endothelial cell protein expression|endothelial cell protein expression
5450235|NCT01501929|microvascular blood flow|microvascular blood flow
5450236|NCT01501929|flow mediated dilation|flow mediated dilation
5450237|NCT01501929|handgrip exercise|handgrip exercise
5450238|NCT01501929|endothelial cell collection|endothelial cell collection
5450239|NCT01501929|microbubbles|microbubbles
5450240|NCT01501929|Definity|definity
5450241|NCT01501890|Threatened Abortion|threatened abortion
5450242|NCT01501890|Progesterone|progesterone
5450243|NCT01501890|Subchorionic Hematoma|subchorionic hematoma
5450244|NCT01501890|Pre-Eclampsia|pre-eclampsia
5450245|NCT01501890|Abruptio Placentae|abruptio placentae
5450246|NCT01501890|Fetal Growth Retardation|fetal growth retardation
5450247|NCT01501890|Premature Birth|premature birth
5450249|NCT01501877|Type 2 Diabetes|type 2 diabetes
5450250|NCT01501877|Smoking cessation|smoking cessation
5450251|NCT01501864|HIV prevention|hiv prevention
5450252|NCT01501864|HSV-2|hsv-2
5450253|NCT01501864|Schooling|schooling
5450254|NCT01501864|Kenya|kenya
5450255|NCT01501864|Orphans|orphans
5450256|NCT01501864|School support|school support
5450257|NCT01501799|acne|acne
5450258|NCT01501799|adapalene/benzoyl peroxide|adapalene/benzoyl peroxide
5450259|NCT01501799|Epiduo|epiduo
5450260|NCT01501799|Mild to severe acne vulgaris|mild to severe acne vulgaris
5450261|NCT01501786|children|children
5450262|NCT01501786|sedation|sedation
5450263|NCT01501786|propofol|propofol
5450264|NCT01501786|ketamine|ketamine
5450265|NCT01501773|Acute ischemic stroke|acute ischemic stroke
5450266|NCT01501747|Placebo effect|placebo effect
5450267|NCT01501747|drug half life|drug half life
5450268|NCT01501747|pharmacokinetics|pharmacokinetics
5450269|NCT01501734|CHF|chf
5450270|NCT01501734|watch-pat|watch-pat
5450271|NCT01501734|embletta x|embletta x
5450272|NCT01501734|endothelial function|endothelial function
5450273|NCT01501721|prevention|prevention
5450274|NCT01501721|workers|workers
5450275|NCT01501721|clinical trials|clinical trials
5450276|NCT01501721|obesity|obesity
5450277|NCT01501708|caspofungin|caspofungin
5450278|NCT01501708|IFI|ifi
5450279|NCT01501708|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5450280|NCT01501695|tic disorder|tic disorder
5450281|NCT01501695|pediatric|pediatric
5450282|NCT01501682|ventralex|ventralex
5450283|NCT01501682|ventral hernia|ventral hernia
5450284|NCT01501669|irinotecan|irinotecan
5450285|NCT01501669|capecitabine|capecitabine
5450286|NCT01501669|metastatic breast cancer|metastatic breast cancer
5450287|NCT01501643|Non invasive positive pressure ventilation|non invasive positive pressure ventilation
5450288|NCT01501643|Spirometry|spirometry
5450289|NCT01501643|Acute chest syndrome|acute chest syndrome
5450290|NCT01501643|Sickle cell disease|sickle cell disease
5450291|NCT01501643|Vaso-occlusive crisis|vaso-occlusive crisis
5450292|NCT01501630|Comparison of imaging modalities|comparison of imaging modalities
5450293|NCT01501630|Impact on patient management|impact on patient management
5445099|NCT01523379|CRPS|crps
5450294|NCT01501630|Optimisation of cost of the diagnostic strategy|optimisation of cost of the diagnostic strategy
5450296|NCT01501617|Androgenetic Alopecia|androgenetic alopecia
5450297|NCT01501617|Baldness|baldness
5450298|NCT01501617|Male pattern baldness|male pattern baldness
5450299|NCT01501617|Male pattern hair loss|male pattern hair loss
5450300|NCT01501617|Hair Regrowth|hair regrowth
5450301|NCT01501617|Alopecia|alopecia
5450302|NCT01501617|Hair growth|hair growth
5450303|NCT01501617|Regrow Hair|regrow hair
5450304|NCT01501604|PIK3CA mutation|pik3ca mutation
5450305|NCT01501604|Advanced solid tumors|advanced solid tumors
5450306|NCT01501591|Placebo effect|placebo effect
5450307|NCT01501591|placebo drug interaction|placebo drug interaction
5450308|NCT01501591|placebo -controlled clinical trials|placebo -controlled clinical trials
5450309|NCT01501578|Pulmonary fibrosis|pulmonary fibrosis
5450310|NCT01501578|Telomerase mutation|telomerase mutation
5450311|NCT01501565|Postoperative pain|postoperative pain
5450312|NCT01501565|Transverse abdominal blockade|transverse abdominal blockade
5450313|NCT01501565|Efficacy|efficacy
5450315|NCT01501565|Urology|urology
5450316|NCT01501552|Primary health care|primary health care
5450317|NCT01501552|Identification and Brief Intervention Programmes|identification and brief intervention programmes
5450415|NCT01501136|RR|rr
5450318|NCT01501552|Hazardous and harmful alcohol consumption|hazardous and harmful alcohol consumption
5450319|NCT01501539|Hypergranulation tissue|hypergranulation tissue
5450320|NCT01501539|Gastrostomy tube|gastrostomy tube
5450321|NCT01501539|Hydrocolloid dressing|hydrocolloid dressing
5450322|NCT01501539|Silver hydrocolloid dressing|silver hydrocolloid dressing
5450323|NCT01501539|Gastrostomy tube dislodgement|gastrostomy tube dislodgement
5450324|NCT01501539|Wound infection|wound infection
5450325|NCT01501539|Peristomal skin breakdown|peristomal skin breakdown
5450326|NCT01501526|herpes esophagitis|herpes esophagitis
5450327|NCT01501526|dysphagia|dysphagia
5450328|NCT01501526|vocal fold palsy|vocal fold palsy
5450329|NCT01501526|immunocompetent|immunocompetent
5450330|NCT01501526|husky voice|husky voice
5450331|NCT01501513|colonoscopy|colonoscopy
5450332|NCT01501513|bowel preparation|bowel preparation
5450333|NCT01501513|endoscopy|endoscopy
5450334|NCT01501500|botulinum toxin type A|botulinum toxin type a
5450335|NCT01501500|hallux valgus angle|hallux valgus angle
5450336|NCT01501500|foot function index|foot function index
5450337|NCT01501500|VAS pain scale|vas pain scale
5450338|NCT01501487|breast cancer|breast cancer
5450339|NCT01501487|neo adjuvant therapy|neo adjuvant therapy
5450340|NCT01501474|Confocal|confocal
5450341|NCT01501474|malignant biliary stricture|malignant biliary stricture
5450342|NCT01501474|Sensitivity, specificity and accuracy of CholangioFlex in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of cholangioflex in malignant biliary stricture diagnosis
5450343|NCT01501474|sensitivity, specificity and accuracy of Fluorescent in situ Hybridization(FISH) in malignant biliary stricture diagnosis|sensitivity, specificity and accuracy of fluorescent in situ hybridization(fish) in malignant biliary stricture diagnosis
5450345|NCT01501435|Pharmacokinetics|pharmacokinetics
5450346|NCT01501422|postmenopause|postmenopause
5450347|NCT01501422|sleep quality|sleep quality
5450348|NCT01501422|estrogen|estrogen
5450349|NCT01501422|objective sleep quality|objective sleep quality
5450350|NCT01501422|actigraph|actigraph
5450351|NCT01501409|Sodium lauryl sulfate (SLS)|sodium lauryl sulfate (sls)
5450352|NCT01501409|recurrent aphthous stomatitis (RAS)|recurrent aphthous stomatitis (ras)
5450353|NCT01501409|dentifrice|dentifrice
5450354|NCT01501409|pain|pain
5450355|NCT01501370|Myeloma|myeloma
5450356|NCT01501370|Biochemical relapse|biochemical relapse
5450357|NCT01501357|caries|caries
5450358|NCT01501357|primary molars|primary molars
5450359|NCT01501357|plaque|plaque
5450360|NCT01501357|toothbrushing|toothbrushing
5450361|NCT01501344|osteoporosis|osteoporosis
5450362|NCT01501344|postmenopausal women|postmenopausal women
5450363|NCT01501344|bone remodelling|bone remodelling
5450364|NCT01501344|bone turnover markers|bone turnover markers
5450365|NCT01501331|Congestive Heart Failure|congestive heart failure
5450366|NCT01501331|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5450367|NCT01501331|Internal Cardioverter Defibrillators|internal cardioverter defibrillators
5450368|NCT01501318|SBIRT|sbirt
5450369|NCT01501318|brief intervention|brief intervention
5450370|NCT01501318|alcohol|alcohol
5450371|NCT01501318|drug abuse|drug abuse
5450372|NCT01501305|influence|influence
5450373|NCT01501305|carob powder|carob powder
5450374|NCT01501305|probiotics|probiotics
5450375|NCT01501305|duration|duration
5450376|NCT01501279|pudendal nerve block|pudendal nerve block
5450377|NCT01501279|postoperative pain|postoperative pain
5450378|NCT01501279|bladder spasm|bladder spasm
5450379|NCT01501266|postmenopausal breast cancer|postmenopausal breast cancer
5450380|NCT01501266|Faslodex|faslodex
5450381|NCT01501266|cohort|cohort
5450382|NCT01501253|CKD-828|ckd-828
5450383|NCT01501253|Hypertension|hypertension
5450384|NCT01501253|Primary Hypertension|primary hypertension
5450385|NCT01501253|S-Amlodipine|s-amlodipine
5450386|NCT01501253|Telmisartan|telmisartan
5450387|NCT01501253|Non-Responder|non-responder
5450388|NCT01501240|Magnetic resonance image|magnetic resonance image
5450389|NCT01501240|gadoxetic acid|gadoxetic acid
5450390|NCT01501240|hepatocellular carcinoma|hepatocellular carcinoma
5450391|NCT01501240|liver cirrhosis|liver cirrhosis
5450392|NCT01501227|ventilator associated pneumonia|ventilator associated pneumonia
5450393|NCT01501214|atosiban|atosiban
5450394|NCT01501214|in vitro fertilization|in vitro fertilization
5450395|NCT01501214|subfertility|subfertility
5450396|NCT01501201|Obesity|obesity
5450397|NCT01501201|Diabetes|diabetes
5450398|NCT01501201|Bariatric Surgery|bariatric surgery
5450399|NCT01501188|Chronic Venous Insufficiency|chronic venous insufficiency
5450400|NCT01501188|Kinesio Taping|kinesio taping
5450401|NCT01501188|Electromyography|electromyography
5450402|NCT01501188|Range of ankle motion|range of ankle motion
5450403|NCT01501175|superficial vein thrombosis|superficial vein thrombosis
5450404|NCT01501175|Saint Etienne region|saint etienne region
5450405|NCT01501162|hepatitis, alcohol|hepatitis, alcohol
5450406|NCT01501149|NK/T cell lymphoma|nk/t cell lymphoma
5450407|NCT01501149|chemotherapy|chemotherapy
5450408|NCT01501149|clinical trial|clinical trial
5450410|NCT01501149|PFS|pfs
5450411|NCT01501149|OS|os
5450412|NCT01501136|NK/T cell lymphoma|nk/t cell lymphoma
5450413|NCT01501136|chemotherapy|chemotherapy
5450414|NCT01501136|clinical trial|clinical trial
5450416|NCT01501136|PFS|pfs
5450417|NCT01501136|OS|os
5450418|NCT01501123|Time to sedation of agitated patients|time to sedation of agitated patients
5450419|NCT01501110|Euthyroid Sick Syndrome|euthyroid sick syndrome
5450420|NCT01501110|low T3 syndrome|low t3 syndrome
5450421|NCT01501110|deiodases|deiodases
5450422|NCT01501110|oxidative stress|oxidative stress
5450423|NCT01501110|ischemic heart disease|ischemic heart disease
5450424|NCT01501084|functional MRI|functional mri
5450425|NCT01501084|Structural MRI|structural mri
5450426|NCT01501084|obesity|obesity
5450427|NCT01501084|resting state networks|resting state networks
5450428|NCT01501071|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5450429|NCT01501071|Esophageal calibration|esophageal calibration
5450430|NCT01501071|Postoperative dysphagia|postoperative dysphagia
5450431|NCT01501045|TMS|tms
5450432|NCT01501045|CPM|cpm
5450433|NCT01501045|headache|headache
5450434|NCT01501045|migraine|migraine
5450435|NCT01501045|EEG|eeg
5450436|NCT01501045|psychophysics|psychophysics
5450437|NCT01501032|Diabetes Type 1|diabetes type 1
5450438|NCT01501032|Artificial Pancreas|artificial pancreas
5450439|NCT01501006|Physicians|physicians
5450440|NCT01500993|Rectal cancer|rectal cancer
5450441|NCT01500993|Chemoradiotherapy|chemoradiotherapy
5450442|NCT01500993|Capecitabine|capecitabine
5450443|NCT01500993|phase-III trial|phase-iii trial
5450444|NCT01500980|malaria|malaria
5450445|NCT01500980|challenge|challenge
5450446|NCT01500980|P. falciparum|p. falciparum
5450447|NCT01500980|prevention|prevention
5450448|NCT01500928|Insulin Pump|insulin pump
5450449|NCT01500928|Glycemic Control|glycemic control
5450450|NCT01500928|Type 1 Diabetes|type 1 diabetes
5450452|NCT01500915|ranibizumab|ranibizumab
5450453|NCT01500915|antiVEGF|antivegf
5450454|NCT01500915|regimen of injections|regimen of injections
5450455|NCT01500915|anti VEGF regimen|anti vegf regimen
5450456|NCT01500915|PRN|prn
5450457|NCT01500915|treat and extend|treat and extend
5450458|NCT01500902|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5450459|NCT01500902|Percutaneous Intervention (PCI)|percutaneous intervention (pci)
5450460|NCT01500902|Coronary Stent (CStent)|coronary stent (cstent)
5450461|NCT01500902|Percutaneous Transluminal Coronary Angioplasty (PTCA)|percutaneous transluminal coronary angioplasty (ptca)
5450462|NCT01500902|stent placement|stent placement
5450463|NCT01500902|balloon angioplasty|balloon angioplasty
5450464|NCT01500889|Anal fissure|anal fissure
5450465|NCT01500889|Advancement flap|advancement flap
5450466|NCT01500889|Internal sphincterotomy|internal sphincterotomy
5450467|NCT01500876|lung cancer|lung cancer
5450468|NCT01500863|endometrial receptivity|endometrial receptivity
5450469|NCT01500863|gene arrays|gene arrays
5450470|NCT01500863|agonist triggering|agonist triggering
5450471|NCT01500863|Endometrial gene expression|endometrial gene expression
5450472|NCT01500863|OHSS|ohss
5450473|NCT01500850|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5450474|NCT01500850|NPH insulin|nph insulin
5450475|NCT01500850|Insulin Glargine|insulin glargine
5450476|NCT01500850|cardiovascular biomarkers|cardiovascular biomarkers
5450477|NCT01500850|hsCRP, adiponectin|hscrp, adiponectin
5450478|NCT01500850|intact proinsulin|intact proinsulin
5450479|NCT01500850|cardiovascular risk|cardiovascular risk
5450480|NCT01500837|Staphylococcus aureus|staphylococcus aureus
5450481|NCT01500837|osteoarticular infection|osteoarticular infection
5450482|NCT01500837|clindamycin|clindamycin
5450483|NCT01500837|serum concentration|serum concentration
5450484|NCT01500837|orthopedic surgery|orthopedic surgery
5450485|NCT01500824|Crizotinib|crizotinib
5450487|NCT01500824|NSCLC|nsclc
5450488|NCT01500824|Non-Small Cell Lung Cancer|non-small cell lung cancer
5450489|NCT01500824|Asian|asian
5450490|NCT01500811|chondrocyte hip osteoarthritis intra articular injection|chondrocyte hip osteoarthritis intra articular injection
5450491|NCT01500772|Hepatitis C|hepatitis c
5450492|NCT01500772|PI treatment failure|pi treatment failure
5450493|NCT01500759|chronic heart failure|chronic heart failure
5450494|NCT01500759|heart failure|heart failure
5450495|NCT01500759|hf|hf
5450496|NCT01500759|sleep-disordered breathing|sleep-disordered breathing
5450497|NCT01500759|sdb|sdb
5450498|NCT01500759|nyha|nyha
5450499|NCT01500759|lvef|lvef
5450500|NCT01500759|cheyne stokes|cheyne stokes
5450501|NCT01500759|central sleep apnoea|central sleep apnoea
5450502|NCT01500759|sleep apnoea|sleep apnoea
5450503|NCT01500746|chronic wound treatment|chronic wound treatment
5450504|NCT01500746|pulse lavage|pulse lavage
5450505|NCT01500746|serial pulse lavage|serial pulse lavage
5450506|NCT01500746|wounds|wounds
5450507|NCT01500746|bacterial colonization of wounds|bacterial colonization of wounds
5450508|NCT01500733|Treatment|treatment
5450509|NCT01500733|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5450510|NCT01500733|SLL (Small Lymphocytic Lymphoma)|sll (small lymphocytic lymphoma)
5450512|NCT01500733|Lymphocytic Leukemia|lymphocytic leukemia
5450513|NCT01500733|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5450514|NCT01500733|CLL|cll
5450515|NCT01500733|Small Lymphocytic Leukemia|small lymphocytic leukemia
5450516|NCT01500733|SLL|sll
5450517|NCT01500668|Botox|botox
5450524|NCT01500655|skin graft donor site|skin graft donor site
5450525|NCT01500655|analgesia for donor site|analgesia for donor site
5450526|NCT01500629|Allergic Rhinitis|allergic rhinitis
5450527|NCT01500629|Hayfever|hayfever
5450528|NCT01500629|Pollen Allergy|pollen allergy
5450529|NCT01500616|Chronic Hepatitis C Infection|chronic hepatitis c infection
5450530|NCT01500616|Chronic Hepatitis C Co-Infected Patients|chronic hepatitis c co-infected patients
5450531|NCT01500616|Hepatitis C|hepatitis c
5450532|NCT01500616|Severe Fibrosis|severe fibrosis
5450533|NCT01500616|Compensated Cirrhosis|compensated cirrhosis
5450534|NCT01500616|VX-950HPC3005|vx-950hpc3005
5450535|NCT01500603|post-radical prostatectomy|post-radical prostatectomy
5450536|NCT01500603|stress urinary incontinence|stress urinary incontinence
5450537|NCT01500603|periurethral Pro-ACT balloons|periurethral pro-act balloons
5450538|NCT01500603|AdvanceXP retrourethral male sling|advancexp retrourethral male sling
5450539|NCT01500590|Diabetes|diabetes
5450540|NCT01500590|hypertensive|hypertensive
5450541|NCT01500590|without albuminuria|without albuminuria
5450542|NCT01500577|Prevention|prevention
5450543|NCT01500577|Breast Cancer|breast cancer
5450544|NCT01500577|Proliferation|proliferation
5450545|NCT01500577|Breast Cancer Prevention|breast cancer prevention
5450546|NCT01500564|Stroke|stroke
5450547|NCT01500564|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5450548|NCT01500564|motor function|motor function
5450549|NCT01500551|Arthritis|arthritis
5450550|NCT01500551|Pediatric|pediatric
5450551|NCT01500551|Tofacitinib|tofacitinib
5450552|NCT01500551|Long-term|long-term
5450553|NCT01500551|JIA|jia
5450554|NCT01500551|CP-690,550|cp-690,550
5450555|NCT01500551|Xeljanz|xeljanz
5450556|NCT01500538|Follicular lymphoma|follicular lymphoma
5450557|NCT01500538|Marginal zone lymphoma|marginal zone lymphoma
5450558|NCT01500538|Mantle cell lymphoma|mantle cell lymphoma
5450559|NCT01500538|thrombocytopenia|thrombocytopenia
5450560|NCT01500538|eltrombopag|eltrombopag
5450561|NCT01500538|vorinostat|vorinostat
5450562|NCT01500538|lymphoma|lymphoma
5450563|NCT01500525|asthma|asthma
5450564|NCT01500525|children|children
5450565|NCT01500525|accuracy of bronchodilator response|accuracy of bronchodilator response
5450566|NCT01500499|adult acute myeloid leukemia|adult acute myeloid leukemia
5450567|NCT01500499|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5450573|NCT01500434|drug-eluting stents|drug-eluting stents
5450574|NCT01500434|DES|des
5450575|NCT01500434|atherosclerotic|atherosclerotic
5450576|NCT01500421|Hypothermia, Induced|hypothermia, induced
5450577|NCT01500395|Aortic Diseases|aortic diseases
5450578|NCT01500395|Vascular Diseases|vascular diseases
5422715|NCT01618786|Wounds|wounds
5437552|NCT01555541|B-cell|b-cell
5450579|NCT01500395|Cardiovascular Diseases|cardiovascular diseases
5450580|NCT01500395|Treatment Outcome|treatment outcome
5450581|NCT01500395|Aorta Dissection|aorta dissection
5450582|NCT01500395|Aorta Aneurysm|aorta aneurysm
5450583|NCT01500395|Aorta pseudoaneurysm|aorta pseudoaneurysm
5450584|NCT01500395|Endovascular aortic repair|endovascular aortic repair
5450585|NCT01500395|Hybrid operation|hybrid operation
5450586|NCT01500395|Debranching|debranching
5450587|NCT01500369|atrial fibrillation|atrial fibrillation
5450588|NCT01500369|remote ischemic conditioning|remote ischemic conditioning
5450589|NCT01500356|cardiovascular disease|cardiovascular disease
5450590|NCT01500356|obesity|obesity
5450591|NCT01500356|exercise|exercise
5450592|NCT01500343|heart failure|heart failure
5450593|NCT01500343|probiotics|probiotics
5450594|NCT01500343|Saccharomyces boulardii|saccharomyces boulardii
5450595|NCT01500343|cardio-intestinal syndrome|cardio-intestinal syndrome
5450596|NCT01500343|gut|gut
5450597|NCT01500343|inflammation|inflammation
5450598|NCT01500317|tapentadol|tapentadol
5450599|NCT01500317|oxycodone|oxycodone
5450600|NCT01500317|mu-opiate|mu-opiate
5450601|NCT01500317|stomach|stomach
5450602|NCT01500317|small intestine|small intestine
5450603|NCT01500317|colon|colon
5450604|NCT01500317|motility|motility
5450605|NCT01500317|nausea|nausea
5450606|NCT01500317|constipation|constipation
5450607|NCT01500304|Melanoma|melanoma
5450608|NCT01500304|Lymph Nodes|lymph nodes
5450609|NCT01500304|Lymph Node Dissection|lymph node dissection
5450610|NCT01500304|Minimally invasive|minimally invasive
5450611|NCT01500291|anesthesia stress|anesthesia stress
5450612|NCT01500278|Certolizumab Pegol|certolizumab pegol
5450614|NCT01500278|Adalimumab|adalimumab
5450615|NCT01500278|Humira|humira
5450616|NCT01500278|Rheumatoid Arthritis|rheumatoid arthritis
5450617|NCT01500265|hepatitis B virus|hepatitis b virus
5450618|NCT01500265|early screening tools|early screening tools
5450619|NCT01500265|renal proximal tubular tolerance|renal proximal tubular tolerance
5450620|NCT01500252|Total Knee Replacement|total knee replacement
5450621|NCT01500252|Patellar Resurfacing|patellar resurfacing
5450622|NCT01500252|Health Related Quality of Life|health related quality of life
5450624|NCT01500226|Nausea|nausea
5450625|NCT01500226|Vomiting|vomiting
5450626|NCT01500226|CINV|cinv
5450627|NCT01500226|Chemotherapy|chemotherapy
5450628|NCT01500213|Rolapitant|rolapitant
5450629|NCT01500213|Nausea|nausea
5450630|NCT01500213|Vomiting|vomiting
5450631|NCT01500213|CINV|cinv
5450632|NCT01500213|Chemotherapy|chemotherapy
5450633|NCT01500187|white spot lesions|white spot lesions
5450634|NCT01500187|fixed orthodontic brackets|fixed orthodontic brackets
5450635|NCT01500187|fluoride varnish|fluoride varnish
5450636|NCT01500187|fluoride gel|fluoride gel
5450637|NCT01500174|skin|skin
5450638|NCT01500174|decubitus|decubitus
5450639|NCT01500174|pressure|pressure
5450640|NCT01500174|sore|sore
5450641|NCT01500174|spinal cord injury|spinal cord injury
5450642|NCT01500161|Leukemia|leukemia
5450643|NCT01500161|Lymphoma|lymphoma
5450644|NCT01500161|Myeloma|myeloma
5450645|NCT01500161|Aplastic Anemia|aplastic anemia
5450646|NCT01500161|Myelodysplasia|myelodysplasia
5450647|NCT01500161|AML|aml
5450649|NCT01500161|CLL|cll
5450650|NCT01500161|CML|cml
5450651|NCT01500148|Mitral Valve Prolapse|mitral valve prolapse
5450652|NCT01500148|Mitral Valve Disease|mitral valve disease
5450653|NCT01500148|Mitral Valve Regurgitation|mitral valve regurgitation
5450654|NCT01500148|Mitral Valve Insufficiency|mitral valve insufficiency
5450655|NCT01500148|Mitral Valve Incompetence|mitral valve incompetence
5450656|NCT01500148|Percutaneous Mitral Valve Repair|percutaneous mitral valve repair
5450657|NCT01500148|Posterior leaflet prolapse|posterior leaflet prolapse
5450658|NCT01500148|Mitral valve degeneration|mitral valve degeneration
5450659|NCT01500135|Vascular Surgery|vascular surgery
5450660|NCT01500135|Secondary treatment of needle hole bleeding|secondary treatment of needle hole bleeding
5450661|NCT01500135|Subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding|subjects undergoing vascular surgery and who need supportive treatment in order to control bleeding
5450662|NCT01500109|cleft palate surgery|cleft palate surgery
5450663|NCT01500109|post-operative pain management|post-operative pain management
5450664|NCT01500109|Acetaminophen|acetaminophen
5450665|NCT01500096|Fatigue|fatigue
5450666|NCT01500096|HIV/AIDS|hiv/aids
5450667|NCT01500096|American ginseng|american ginseng
5450668|NCT01500096|Panax quinquefolius|panax quinquefolius
5450669|NCT01500096|Fatigue Severity Scale|fatigue severity scale
5450670|NCT01500096|CD4 count|cd4 count
5450671|NCT01500096|plasma HIV RNA|plasma hiv rna
5450672|NCT01500096|cytokines|cytokines
5450673|NCT01500096|IL-6|il-6
5450674|NCT01500096|sTNFR1|stnfr1
5450675|NCT01500096|sTNFR2|stnfr2
5450676|NCT01500083|iNHL|inhl
5450677|NCT01500083|CLL|cll
5450678|NCT01500070|Peripheral Arterial Disease|peripheral arterial disease
5450679|NCT01500070|Claudication|claudication
5450680|NCT01500070|Drug-Eluting Stent|drug-eluting stent
5450681|NCT01500070|BTK|btk
5450682|NCT01500070|Everolimus|everolimus
5450683|NCT01500070|CLI|cli
5450684|NCT01500057|enlarged prostate|enlarged prostate
5450685|NCT01500044|Radiculopathy|radiculopathy
5450686|NCT01500044|Rehabilitation|rehabilitation
5450687|NCT01500044|Mobilization|mobilization
5450688|NCT01500044|Exercise|exercise
5450689|NCT01500044|Physical Therapy|physical therapy
5450690|NCT01500018|Phase I|phase i
5450691|NCT01500018|healthy recreational polydrug users|healthy recreational polydrug users
5450692|NCT01500018|abuse liability|abuse liability
5450693|NCT01500018|TC-5214|tc-5214
5450694|NCT01500018|Single dose crossover study to evaluate the abuse potential of TC-5214|single dose crossover study to evaluate the abuse potential of tc-5214
5450695|NCT01499992|Shoulder rehabilitation|shoulder rehabilitation
5450696|NCT01499992|Rotator cuff tear|rotator cuff tear
5450697|NCT01499992|Physiotherapy|physiotherapy
5450698|NCT01499992|aqua therapy|aqua therapy
5450699|NCT01499992|Therapy dosage|therapy dosage
5450700|NCT01499992|adjunctive aquatic physical therapy|adjunctive aquatic physical therapy
5450701|NCT01499979|Ischemia-reperfusion injury|ischemia-reperfusion injury
5450702|NCT01499979|In situ hypothermic perfusion|in situ hypothermic perfusion
5450703|NCT01499979|In situ hypothermic preservation|in situ hypothermic preservation
5450704|NCT01499966|Lateral Ankle Sprain|lateral ankle sprain
5450705|NCT01499966|Plaster of Paris|plaster of paris
5453889|NCT01486537|samples|samples
5450706|NCT01499966|Tubigrip|tubigrip
5450707|NCT01499953|superficial vein thrombosis|superficial vein thrombosis
5450708|NCT01499953|thrombosis|thrombosis
5450710|NCT01499940|peripheral neuropathy|peripheral neuropathy
5450711|NCT01499940|vitamin D status|vitamin d status
5450712|NCT01499940|oxaliplatin|oxaliplatin
5450713|NCT01499927|Early reassessment of intravenous antiinfective therapy|early reassessment of intravenous antiinfective therapy
5450714|NCT01499914|vaccination H1N1|vaccination h1n1
5450715|NCT01499914|cystic fibrosis|cystic fibrosis
5450716|NCT01499901|deafness|deafness
5450717|NCT01499901|unilateral implantation|unilateral implantation
5450718|NCT01499901|bilateral|bilateral
5450719|NCT01499901|auditory perception|auditory perception
5450720|NCT01499888|Sickle Cell Disease|sickle cell disease
5450721|NCT01499888|Subtype Hgb SS|subtype hgb ss
5450722|NCT01499888|Subtype Hgb SC|subtype hgb sc
5450723|NCT01499888|Subtype Hgb SB|subtype hgb sb
5450724|NCT01499888|Chronic Transfusion Therapy|chronic transfusion therapy
5450725|NCT01499888|Prior Stroke|prior stroke
5450726|NCT01499888|Allogeneic|allogeneic
5450727|NCT01499888|Stem Cell Transplantation|stem cell transplantation
5450728|NCT01499888|Alemtuzumab|alemtuzumab
5450729|NCT01499888|Sirolimus|sirolimus
5450730|NCT01499888|Total Body Irradiation|total body irradiation
5450731|NCT01499888|Hydroxyurea Intolerant|hydroxyurea intolerant
5450732|NCT01499875|Pharmacokinetic|pharmacokinetic
5450733|NCT01499875|Pharmacodynamic|pharmacodynamic
5450734|NCT01499875|Phenoxymethylpenicillin|phenoxymethylpenicillin
5450735|NCT01499875|Children|children
5450736|NCT01499862|Stroke|stroke
5450737|NCT01499862|Tibion|tibion
5450738|NCT01499862|Bionics|bionics
5450739|NCT01499862|Rehab|rehab
5450740|NCT01499862|Therapy|therapy
5450741|NCT01499862|Robotics|robotics
5450742|NCT01499862|Intention|intention
5450743|NCT01499849|Rolapitant|rolapitant
5450744|NCT01499849|Nausea|nausea
5450745|NCT01499849|Vomiting|vomiting
5450746|NCT01499849|CINV|cinv
5450747|NCT01499849|Chemotherapy|chemotherapy
5450748|NCT01499823|Permeability Map|permeability map
5450749|NCT01499823|High-Grade Glioma|high-grade glioma
5450750|NCT01499810|Hypertension|hypertension
5450751|NCT01499810|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5450752|NCT01499810|Renal Artery|renal artery
5450753|NCT01499810|Sympathetic Nerve Block|sympathetic nerve block
5450754|NCT01499797|frailty|frailty
5450755|NCT01499797|frail elders|frail elders
5450756|NCT01499797|multicomponent intervention|multicomponent intervention
5450757|NCT01499797|overall functioning|overall functioning
5450758|NCT01499797|cost-effectiveness|cost-effectiveness
5450759|NCT01499797|integrated care|integrated care
5450760|NCT01499797|primary care|primary care
5450761|NCT01499797|community dwelling|community dwelling
5450762|NCT01499745|Idiopathic pulmonary fibrosis (IPF) patients|idiopathic pulmonary fibrosis (ipf) patients
5450763|NCT01499732|Premature endothelial dysfunction|premature endothelial dysfunction
5450764|NCT01499732|Early Rheumatoid Arthritis|early rheumatoid arthritis
5450765|NCT01499732|established rheumatoid arthritis|established rheumatoid arthritis
5450766|NCT01499732|Premature endothelial dysfunction in early rheumatoid arthritis|premature endothelial dysfunction in early rheumatoid arthritis
5450767|NCT01499732|Premature endothelial dysfunction in established rheumatoid arthritis|premature endothelial dysfunction in established rheumatoid arthritis
5450768|NCT01499732|Endothelial function in healthy subjects|endothelial function in healthy subjects
5450769|NCT01499719|Sinusitis|sinusitis
5450770|NCT01499719|Disease|disease
5450771|NCT01499719|Chronic|chronic
5450772|NCT01499719|Sinonasal|sinonasal
5561523|NCT01041612|CBD|cbd
5450773|NCT01499706|Motivational Interviewing|motivational interviewing
5450774|NCT01499706|Telephone|telephone
5450775|NCT01499706|HIV|hiv
5450776|NCT01499706|AIDS|aids
5450777|NCT01499706|Older Adults|older adults
5450778|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors
5450779|NCT01499693|gastric pH|gastric ph
5450780|NCT01499680|Degenerative Lumbar Conditions|degenerative lumbar conditions
5450781|NCT01499667|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5450782|NCT01499667|multiple sclerosis (MS)|multiple sclerosis (ms)
5450783|NCT01499667|safety|safety
5450784|NCT01499667|tolerability|tolerability
5450785|NCT01499667|health outcomes|health outcomes
5450786|NCT01499667|fingolimod|fingolimod
5450787|NCT01499667|disease control|disease control
5450788|NCT01499667|MRI|mri
5450789|NCT01499654|SPECT MPI|spect mpi
5450790|NCT01499654|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5450791|NCT01499654|Wide Beam Reconstruction|wide beam reconstruction
5450792|NCT01499641|discectomy|discectomy
5450793|NCT01499641|methylprednisolone|methylprednisolone
5450794|NCT01499641|randomized control trial|randomized control trial
5450795|NCT01499615|adverse events|adverse events
5450796|NCT01499615|adverse cardiovascular events|adverse cardiovascular events
5450797|NCT01499615|early warning|early warning
5450798|NCT01499602|Endometrial hyperplasia,|endometrial hyperplasia,
5450799|NCT01499602|LNG-IUS,|lng-ius,
5450800|NCT01499602|Progestin|progestin
5450801|NCT01499589|anesthesia-controlled time|anesthesia-controlled time
5450803|NCT01499576|Mass Screening|mass screening
5450804|NCT01499576|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5450805|NCT01499576|Stomach Neoplasms|stomach neoplasms
5450806|NCT01499576|Metaplasia|metaplasia
5450807|NCT01499576|Diagnosis|diagnosis
5450808|NCT01499576|Acetic acid|acetic acid
5450809|NCT01499576|Chromoendoscopy|chromoendoscopy
5450810|NCT01499550|transnasal high flow therapy|transnasal high flow therapy
5450812|NCT01499537|Stenosis of biliary ways|stenosis of biliary ways
5450813|NCT01499524|ICP, GDM|icp, gdm
5450814|NCT01499511|Hypertension|hypertension
5450815|NCT01499511|Mortality|mortality
5450816|NCT01499511|Morbidity|morbidity
5450817|NCT01499511|Coronary Heart Disease|coronary heart disease
5450818|NCT01499511|Stroke|stroke
5450819|NCT01499511|Diabetes|diabetes
5450820|NCT01499498|Healthy volunteers|healthy volunteers
5450821|NCT01499485|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5450822|NCT01499485|Obesity Hypoventilation Syndrome|obesity hypoventilation syndrome
5450823|NCT01499485|Alkalosis|alkalosis
5450824|NCT01499485|Respiration, Artificial|respiration, artificial
5450825|NCT01499485|Acetazolamide|acetazolamide
5450826|NCT01499485|Intensive care|intensive care
5450827|NCT01499485|Adult|adult
5450828|NCT01499459|liver cirrhosis|liver cirrhosis
5450829|NCT01499459|autologous mesenchymal stem cell transplantation|autologous mesenchymal stem cell transplantation
5450830|NCT01499342|Stent|stent
5450831|NCT01499342|Atherosclerotic occlusive disease|atherosclerotic occlusive disease
5450832|NCT01499342|Peripheral arterial disease|peripheral arterial disease
5450833|NCT01499342|Superficial femoral artery|superficial femoral artery
5450835|NCT01499329|Stent therapy|stent therapy
5450836|NCT01499316|Coronary artery disease|coronary artery disease
5450837|NCT01499316|Fractional flow reserve|fractional flow reserve
5450838|NCT01499303|lymphoma|lymphoma
5450839|NCT01499303|DLBCL|dlbcl
5450840|NCT01499303|fostamatinib|fostamatinib
5450841|NCT01499303|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5450842|NCT01499290|Ceftazidime|ceftazidime
5450843|NCT01499290|Meropenem|meropenem
5450844|NCT01499290|Metronidazole|metronidazole
5450845|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents
5450846|NCT01499290|Anti-Infective Agents|anti-infective agents
5450847|NCT01499290|Antiprotozoal Agents|antiprotozoal agents
5450848|NCT01499290|Antiparasitic Agents|antiparasitic agents
5450849|NCT01499290|cIAI, Complicated Intra-Abdominal Infection|ciai, complicated intra-abdominal infection
5450850|NCT01499277|complicated skin and soft tissue infections (cSSTI)|complicated skin and soft tissue infections (cssti)
5450851|NCT01499277|skin infection|skin infection
5450852|NCT01499277|ceftaroline|ceftaroline
5450853|NCT01499277|wound infection|wound infection
5450854|NCT01499277|cellulitis|cellulitis
5450855|NCT01499277|burn infection|burn infection
5450856|NCT01499277|bacterial infection|bacterial infection
5450857|NCT01499277|vancomycin|vancomycin
5450858|NCT01499264|MySkin patch|myskin patch
5450859|NCT01499251|glioblastoma|glioblastoma
5450860|NCT01499238|Efficacy|efficacy
5450861|NCT01499238|safety|safety
5450862|NCT01499238|nasal SIMV|nasal simv
5450863|NCT01499238|nasal CPAP|nasal cpap
5450864|NCT01499238|infants who are >35 gestational week with wet lung|infants who are >35 gestational week with wet lung
5450865|NCT01499199|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5450866|NCT01499199|ART-naive|art-naive
5450867|NCT01499199|integrase inhibitor|integrase inhibitor
5450868|NCT01499199|dolutegravir|dolutegravir
5450869|NCT01499199|antiretroviral therapy naive|antiretroviral therapy naive
5561610|NCT01041300|TMS|tms
5450870|NCT01499186|Local vibration, elderly, bone, muscle, functionality|local vibration, elderly, bone, muscle, functionality
5450871|NCT01499160|endocrine resistant|endocrine resistant
5450872|NCT01499160|everolimus|everolimus
5450873|NCT01499160|lapatinib|lapatinib
5450874|NCT01499160|letrozole|letrozole
5450875|NCT01499147|Acute myeloid leukemia|acute myeloid leukemia
5450876|NCT01499147|First remission|first remission
5450877|NCT01499147|Acute lymphocytic leukemia|acute lymphocytic leukemia
5450878|NCT01499147|Acute leukemia|acute leukemia
5450879|NCT01499147|Second remission|second remission
5450880|NCT01499147|Early relapse|early relapse
5450881|NCT01499147|Partial remission|partial remission
5450882|NCT01499147|Accelerated phase|accelerated phase
5450883|NCT01499147|Blast-crisis|blast-crisis
5450884|NCT01499147|Chronic myelogenous leukemia|chronic myelogenous leukemia
5450885|NCT01499147|Chronic phase|chronic phase
5450886|NCT01499147|Recurrent malignant lymphoma|recurrent malignant lymphoma
5450887|NCT01499147|Refractory malignant lymphoma|refractory malignant lymphoma
5450888|NCT01499147|Hodgkin's disease|hodgkin's disease
5450889|NCT01499147|Multiple myeloma.|multiple myeloma.
5450890|NCT01499147|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5450891|NCT01499147|Myeloproliferative disorder|myeloproliferative disorder
5450892|NCT01499147|Polycythemia vera|polycythemia vera
5450893|NCT01499147|Myelofibrosis|myelofibrosis
5450894|NCT01499147|Severe aplastic anemia|severe aplastic anemia
5450895|NCT01499108|type 2 diabetes|type 2 diabetes
5450896|NCT01499108|hypertension|hypertension
5450897|NCT01499108|liraglutide|liraglutide
5450898|NCT01499108|kidney function|kidney function
5450899|NCT01499056|osteoarthritis|osteoarthritis
5450900|NCT01499056|hip joint|hip joint
5450901|NCT01499056|mesenchymal stem cell|mesenchymal stem cell
5450902|NCT01499043|CRPC|crpc
5450903|NCT01499043|Prostate Cancer|prostate cancer
5450904|NCT01499043|Bone metastasis|bone metastasis
5450905|NCT01499043|Advanced Castration-Resistant Prostate Cancer (CRPC)|advanced castration-resistant prostate cancer (crpc)
5450906|NCT01499017|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
5450907|NCT01499004|tofacitinib|tofacitinib
5450908|NCT01499004|CP-690|cp-690
5450910|NCT01499004|relative bioavailability|relative bioavailability
5450911|NCT01499004|modified release|modified release
5450912|NCT01499004|Phase 1|phase 1
5450913|NCT01498991|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5450914|NCT01498991|Rehabilitation|rehabilitation
5450915|NCT01498991|AMES device|ames device
5450916|NCT01498991|Lower Extremity|lower extremity
5450917|NCT01498991|Gait|gait
5450918|NCT01498991|Paraplegia|paraplegia
5450919|NCT01498965|food allergy|food allergy
5450920|NCT01498965|eczema|eczema
5450921|NCT01498965|Vitamin D status|vitamin d status
5450922|NCT01498965|body composition|body composition
5450923|NCT01498965|obesity|obesity
5450924|NCT01498965|neurodevelopmental and behavioural outcome|neurodevelopmental and behavioural outcome
5450925|NCT01498952|HCC, liver cancer, hepatocellular carcinoma, MEDI-573, anti-IGF|hcc, liver cancer, hepatocellular carcinoma, medi-573, anti-igf
5450926|NCT01498887|Multiple Sclerosis|multiple sclerosis
5450927|NCT01498887|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5450928|NCT01498887|Fingolimod|fingolimod
5450929|NCT01498887|Early multiple sclerosis|early multiple sclerosis
5450930|NCT01498887|Naive patients|naive patients
5450931|NCT01498874|Acne|acne
5596113|NCT00906399|MS|ms
5450932|NCT01498874|Acne Vulgaris|acne vulgaris
5450933|NCT01498835|Soft tissue sarcoma|soft tissue sarcoma
5450934|NCT01498835|Radiation therapy|radiation therapy
5450935|NCT01498835|Sunitinib|sunitinib
5450936|NCT01498822|Levetiracetam|levetiracetam
5450937|NCT01498822|Oxcarbazepine|oxcarbazepine
5450938|NCT01498822|treatment failure|treatment failure
5450939|NCT01498822|partial epilepsy|partial epilepsy
5450940|NCT01498809|Orthostatic intolerance in people with spinal cord injury|orthostatic intolerance in people with spinal cord injury
5450941|NCT01498744|Skin and Soft Tissue Abscess|skin and soft tissue abscess
5450942|NCT01498744|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5450943|NCT01498744|Incision and Drainage|incision and drainage
5450944|NCT01498744|Clindamycin|clindamycin
5450945|NCT01498744|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5450946|NCT01498744|Skin Infection|skin infection
5450947|NCT01498731|Copeptin|copeptin
5450948|NCT01498731|Troponin|troponin
5450949|NCT01498731|Acute Coronary Syndrome|acute coronary syndrome
5450950|NCT01498731|Rule-out of acute myocardial infarction|rule-out of acute myocardial infarction
5450951|NCT01498731|Emergency Medicine|emergency medicine
5450952|NCT01498718|Influenza A (H1N1)|influenza a (h1n1)
5450953|NCT01498718|Influenza A (H3N2)|influenza a (h3n2)
5450954|NCT01498718|Influenza B|influenza b
5450955|NCT01498718|Trivalent Inactivated Vaccine (TIV)|trivalent inactivated vaccine (tiv)
5450956|NCT01498718|Healthy Adults|healthy adults
5450957|NCT01498705|Intraventricular Hemorrhage|intraventricular hemorrhage
5450958|NCT01498705|Intracerebral Hemorrhage|intracerebral hemorrhage
5450959|NCT01498705|Cerebrovascular Disorders|cerebrovascular disorders
5437960|NCT01553812|airtrapping|airtrapping
5450960|NCT01498705|Brain Diseases|brain diseases
5450961|NCT01498705|Central Nervous System Diseases|central nervous system diseases
5450962|NCT01498705|Nervous System Diseases|nervous system diseases
5450963|NCT01498705|Vascular Diseases|vascular diseases
5450964|NCT01498705|Procalcitonin Level|procalcitonin level
5450965|NCT01498692|drug-eluting stents|drug-eluting stents
5450967|NCT01498692|atherosclerotic|atherosclerotic
5450968|NCT01498640|XIAFLEX|xiaflex
5450969|NCT01498640|XIAPEX|xiapex
5450970|NCT01498640|Dupuytren's disease|dupuytren's disease
5450971|NCT01498640|contracture|contracture
5450972|NCT01498627|Autoimmune diseases (AIDs)|autoimmune diseases (aids)
5450973|NCT01498627|Cervarix|cervarix
5450974|NCT01498627|PGRx information system|pgrx information system
5450975|NCT01498614|Diabetes mellitus|diabetes mellitus
5450976|NCT01498614|depression|depression
5450977|NCT01498614|anxiety|anxiety
5450978|NCT01498614|negative self image|negative self image
5450979|NCT01498614|alexithymia|alexithymia
5450980|NCT01498614|metabolic control|metabolic control
5450981|NCT01498614|diabetes complications|diabetes complications
5450982|NCT01498601|oral hygiene|oral hygiene
5450983|NCT01498601|tracheostomy|tracheostomy
5450984|NCT01498601|deglutition disorders|deglutition disorders
5450985|NCT01498601|enteral nutrition|enteral nutrition
5450986|NCT01498601|brain injury|brain injury
5450987|NCT01498601|coma|coma
5450988|NCT01498588|Breast Neoplasms|breast neoplasms
5450989|NCT01498588|Breast Cancer|breast cancer
5450990|NCT01498588|Breast Tumors|breast tumors
5450991|NCT01498588|Cancer of the Breast|cancer of the breast
5450992|NCT01498588|Neoplasms, Breast|neoplasms, breast
5450993|NCT01498588|Tumors, Breast|tumors, breast
5450994|NCT01498575|Teen driving|teen driving
5450995|NCT01498575|Behind the wheel practice driving|behind the wheel practice driving
5450996|NCT01498575|Parent supervision|parent supervision
5450997|NCT01498549|Abstinent cocaine users|abstinent cocaine users
5450998|NCT01498549|cognitive testing|cognitive testing
5450999|NCT01498523|Camel milk|camel milk
5451000|NCT01498523|Postprandial glycaemic response|postprandial glycaemic response
5451001|NCT01498523|postprandial insulinaemic response|postprandial insulinaemic response
5451002|NCT01498523|Glycaemic index|glycaemic index
5451003|NCT01498510|chronic pain|chronic pain
5451004|NCT01498510|cognitive behavior therapy|cognitive behavior therapy
5451005|NCT01498510|web-based intervention|web-based intervention
5451006|NCT01498484|EBV-specific T-cell lines|ebv-specific t-cell lines
5451007|NCT01498484|11-130|11-130
5451024|NCT01498445|Blastic phase|blastic phase
5451025|NCT01498445|Dasatinib|dasatinib
5451026|NCT01498445|BMS-354825|bms-354825
5451027|NCT01498445|Sprycel|sprycel
5451028|NCT01498445|Decitabine|decitabine
5451029|NCT01498445|Dacogen|dacogen
5451030|NCT01498419|Tuberculosis|tuberculosis
5451031|NCT01498419|Serial Sputum Colony Counts|serial sputum colony counts
5451032|NCT01498419|Colony Forming Units|colony forming units
5451033|NCT01498419|Time to Sputum Culture Positivity|time to sputum culture positivity
5451034|NCT01498419|PA824|pa824
5451035|NCT01498419|pretomanid|pretomanid
5451036|NCT01498406|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5451037|NCT01498406|vitamin D|vitamin d
5451038|NCT01498406|quality of life|quality of life
5451039|NCT01498393|fungal nail|fungal nail
5451040|NCT01498380|Dexmedetomidine|dexmedetomidine
5451041|NCT01498380|Precedex|precedex
5451042|NCT01498380|TIVA|tiva
5451043|NCT01498380|Rapid bolus|rapid bolus
5451044|NCT01498367|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5451045|NCT01498367|Telemedicine|telemedicine
5451046|NCT01498354|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5451047|NCT01498354|Transanal endoscopic operations|transanal endoscopic operations
5451048|NCT01498354|Rectal adenomas|rectal adenomas
5451049|NCT01498354|Transanal endoscopic surgery|transanal endoscopic surgery
5451050|NCT01498354|"Rectal adenocarcinomas in situ"|"rectal adenocarcinomas in situ"
5451051|NCT01498341|Hypoparathyroidism|hypoparathyroidism
5451052|NCT01498341|Epidemiology|epidemiology
5451053|NCT01498341|Prognosis|prognosis
5451054|NCT01498341|Symptoms|symptoms
5451073|NCT01498302|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5451074|NCT01498289|recurrent esophageal cancer|recurrent esophageal cancer
5451075|NCT01498289|stage IV esophageal cancer|stage iv esophageal cancer
5451076|NCT01498289|recurrent gastric cancer|recurrent gastric cancer
5451077|NCT01498289|stage IV gastric cancer|stage iv gastric cancer
5451078|NCT01498289|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5451079|NCT01498289|stage IIIB gastric cancer|stage iiib gastric cancer
5451080|NCT01498289|stage IIIC gastric cancer|stage iiic gastric cancer
5451081|NCT01498289|stage IIIB esophageal cancer|stage iiib esophageal cancer
5451082|NCT01498289|stage IIIC esophageal cancer|stage iiic esophageal cancer
5451083|NCT01498289|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5451084|NCT01498289|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5451085|NCT01498276|FHH (Family Health History)|fhh (family health history)
5451086|NCT01498276|Family Health History|family health history
5451087|NCT01498276|Disease Risk Assessment|disease risk assessment
5451088|NCT01498263|Genetic Condition|genetic condition
5451089|NCT01498263|Family Network|family network
5451090|NCT01498263|Social Support|social support
5451091|NCT01498263|Alzheimer's Disease|alzheimer's disease
5451092|NCT01498263|AD|ad
5451093|NCT01498263|Family Systems|family systems
5451094|NCT01498237|Photoacoustic endoscopy|photoacoustic endoscopy
5451095|NCT01498224|Cataract surgery|cataract surgery
5451096|NCT01498211|volunteer|volunteer
5451097|NCT01498198|Rotator Cuff|rotator cuff
5451098|NCT01498198|WCB|wcb
5451099|NCT01498172|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
5451100|NCT01498159|Diabetes Mellitus|diabetes mellitus
5451101|NCT01498159|Pharmacists|pharmacists
5451102|NCT01498159|Community Health Aides|community health aides
5451103|NCT01498146|cryptogenic stroke|cryptogenic stroke
5451104|NCT01498146|atrial fibrillation|atrial fibrillation
5451105|NCT01498146|longterm monitoring|longterm monitoring
5451106|NCT01498146|loop recorder|loop recorder
5451703|NCT01495637|critical|critical
5451107|NCT01498133|Skin-to-skin contact|skin-to-skin contact
5451108|NCT01498133|Decolonization|decolonization
5451109|NCT01498133|MRSA|mrsa
5451110|NCT01498120|Rotigotine|rotigotine
5451111|NCT01498120|Restless Legs Syndrome|restless legs syndrome
5451112|NCT01498120|RLS|rls
5451113|NCT01498120|Long-term|long-term
5451114|NCT01498120|Adolescents|adolescents
5451115|NCT01498107|online intervention|online intervention
5451116|NCT01498107|computerized CBT|computerized cbt
5451117|NCT01498107|e-health|e-health
5451118|NCT01498094|Bronchiolitis|bronchiolitis
5451119|NCT01498094|High|high
5451120|NCT01498094|Flow|flow
5451121|NCT01498094|Oxygen|oxygen
5451122|NCT01498094|Therapy|therapy
5451123|NCT01498094|Nasal|nasal
5451124|NCT01498094|Cannulae|cannulae
5451125|NCT01498094|Prongs|prongs
5451126|NCT01498081|COPD, pulmonary disease|copd, pulmonary disease
5451127|NCT01498068|Genotype 1 chronic Hepatitis C|genotype 1 chronic hepatitis c
5451128|NCT01498068|VX-950HPC3007|vx-950hpc3007
5451129|NCT01498068|VX-950|vx-950
5451130|NCT01498068|Hepatitis C|hepatitis c
5451131|NCT01498068|Telaprevir|telaprevir
5451132|NCT01498068|HCV|hcv
5451133|NCT01498055|lung cancer|lung cancer
5451134|NCT01498055|CIK cells|cik cells
5451135|NCT01498055|therapy|therapy
5451136|NCT01498029|Cartilage, Articular|cartilage, articular
5451137|NCT01498016|acute leukemia|acute leukemia
5451138|NCT01498016|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5451139|NCT01498016|busulfan|busulfan
5451140|NCT01498003|coronary disease|coronary disease
5451141|NCT01498003|stents|stents
5451142|NCT01498003|thrombosis|thrombosis
5451143|NCT01498003|myocardial infarction|myocardial infarction
5451144|NCT01498003|prognosis|prognosis
5451145|NCT01497990|Burns|burns
5451146|NCT01497990|Ertapenem|ertapenem
5451147|NCT01497990|Pharmacokinetics|pharmacokinetics
5451148|NCT01497977|phytoestrogens|phytoestrogens
5451149|NCT01497977|postmenopause|postmenopause
5451150|NCT01497977|serum lipids|serum lipids
5451151|NCT01497925|Arginine deiminase|arginine deiminase
5451152|NCT01497925|Arginine|arginine
5451153|NCT01497925|Solid tumors|solid tumors
5451154|NCT01497925|Prostate cancer|prostate cancer
5451155|NCT01497925|Phase 1 study|phase 1 study
5451156|NCT01497899|HIV-1|hiv-1
5451157|NCT01497899|HIV|hiv
5451158|NCT01497899|Treatment-Naive|treatment-naive
5451159|NCT01497886|Stroke|stroke
5451160|NCT01497886|Children|children
5451161|NCT01497886|Hip Hop Stroke|hip hop stroke
5451162|NCT01497886|New York City|new york city
5451163|NCT01497873|Small Cell Lung Cancer|small cell lung cancer
5451164|NCT01497873|Belotecan|belotecan
5451165|NCT01497873|Topotecan|topotecan
5451166|NCT01497860|pediatric|pediatric
5451167|NCT01497860|children|children
5451168|NCT01497860|glioma|glioma
5451169|NCT01497860|low-grade|low-grade
5451170|NCT01497860|vinorelbine|vinorelbine
5451171|NCT01497860|recurrent|recurrent
5451172|NCT01497860|progressive|progressive
5451173|NCT01497847|Post-Infectious Irritable Bowel Syndrome|post-infectious irritable bowel syndrome
5451174|NCT01497847|PI-IBS|pi-ibs
5451175|NCT01497834|Hepatitis C Virus Infection|hepatitis c virus infection
5451176|NCT01497821|Amgen|amgen
5451177|NCT01497821|Phase 1|phase 1
5451178|NCT01497821|First in Human|first in human
5451179|NCT01497821|Relapsed / Refractory Renal Cell Carcinoma (RCC)|relapsed / refractory renal cell carcinoma (rcc)
5451180|NCT01497821|Kidney Cancer|kidney cancer
5451181|NCT01497821|Clinical Trial|clinical trial
5451182|NCT01497821|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5451183|NCT01497821|Open-label|open-label
5451184|NCT01497821|Oncology|oncology
5451185|NCT01497808|previously untreated|previously untreated
5451186|NCT01497808|previously treated|previously treated
5451187|NCT01497808|bone, lung, liver or subcutaneous involvement|bone, lung, liver or subcutaneous involvement
5451188|NCT01497808|nodal involvement|nodal involvement
5451189|NCT01497808|without evidence of brain involvement|without evidence of brain involvement
5438176|NCT01553032|Erbitux®|erbitux®
5451190|NCT01497782|virtual reality, simulator, feedback, laparoscopy, training|virtual reality, simulator, feedback, laparoscopy, training
5451191|NCT01497769|vaccine|vaccine
5451192|NCT01497769|immunogenicity|immunogenicity
5451193|NCT01497743|Scleroderma|scleroderma
5451194|NCT01497743|gastrointestinal|gastrointestinal
5451195|NCT01497743|bloating|bloating
5451196|NCT01497743|reflux|reflux
5451197|NCT01497730|Arthroplasty, Replacement, Knee,|arthroplasty, replacement, knee,
5451198|NCT01497704|Cancer|cancer
5451199|NCT01497704|Tumor|tumor
5451200|NCT01497704|Oncology|oncology
5451201|NCT01497704|Antiangiogenesis|antiangiogenesis
5451202|NCT01497691|Asthma|asthma
5451203|NCT01497691|Pediatrics|pediatrics
5451204|NCT01497691|BiPAP|bipap
5451205|NCT01497691|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5451206|NCT01497678|MTURR|mturr
5451207|NCT01497678|ECM|ecm
5451208|NCT01497678|Muscle Loss|muscle loss
5451209|NCT01497678|Tendon|tendon
5451210|NCT01497678|Tendon Repair|tendon repair
5451211|NCT01497678|Muscle Repair|muscle repair
5451212|NCT01497678|Soft Tissue Repair|soft tissue repair
5451213|NCT01497678|Scaffold|scaffold
5451214|NCT01497678|Extracellular Matrix|extracellular matrix
5451216|NCT01497665|ANG1005|ang1005
5451217|NCT01497665|LRP-1|lrp-1
5451218|NCT01497665|Targeted Therapy|targeted therapy
5451219|NCT01497665|Brain Tumor|brain tumor
5451220|NCT01497665|Blood Brain Barrier|blood brain barrier
5451221|NCT01497665|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
5451222|NCT01497665|Brain Metastases|brain metastases
5451223|NCT01497665|Paclitaxel|paclitaxel
5451224|NCT01497665|Taxol|taxol
5451225|NCT01497665|NSCLC|nsclc
5451226|NCT01497665|Non-Small Cell Lung Cancer|non-small cell lung cancer
5451227|NCT01497652|Parkinson's Disease|parkinson's disease
5451228|NCT01497652|Cognition|cognition
5451229|NCT01497652|Rasagiline|rasagiline
5451231|NCT01497652|Mild Cognitive Impairment in Parkinson's Disease|mild cognitive impairment in parkinson's disease
5451233|NCT01497639|pallidal stimulation|pallidal stimulation
5451234|NCT01497639|deep brain stimulation|deep brain stimulation
5451235|NCT01497639|deep brain stimulation of GPi|deep brain stimulation of gpi
5451237|NCT01497639|interleaving stimulation|interleaving stimulation
5451238|NCT01497626|Advanced cancer|advanced cancer
5451239|NCT01497626|Solid tumor|solid tumor
5451240|NCT01497613|Socialization|socialization
5451241|NCT01497613|Well-being|well-being
5451242|NCT01497613|Quality of Life|quality of life
5451243|NCT01497613|Connectivity|connectivity
5451244|NCT01497548|Depression|depression
5451245|NCT01497548|cancer|cancer
5451246|NCT01497548|methylphenidate|methylphenidate
5451247|NCT01497548|pharmacotherapy|pharmacotherapy
5451248|NCT01497522|Vildagliptin|vildagliptin
5451249|NCT01497522|Type 2 diabetes|type 2 diabetes
5451250|NCT01497522|HbA1c|hba1c
5451251|NCT01497522|Fasting plasma glucose|fasting plasma glucose
5451252|NCT01497496|leukemia|leukemia
5451253|NCT01497496|lymphoma|lymphoma
5451254|NCT01497496|consolidative therapy|consolidative therapy
5451255|NCT01497496|combination regimen|combination regimen
5451256|NCT01497496|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5451257|NCT01497496|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5451258|NCT01497470|paclitaxel|paclitaxel
5451259|NCT01497470|carboplatin|carboplatin
5451260|NCT01497470|custirsen|custirsen
5903965|NCT00092222|Malignancy|malignancy
5451261|NCT01497470|drug-drug interaction|drug-drug interaction
5451262|NCT01497470|pharmacokinetics|pharmacokinetics
5451263|NCT01497470|cancer|cancer
5451264|NCT01497444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5451265|NCT01497444|recurrent renal cell cancer|recurrent renal cell cancer
5451266|NCT01497444|advanced adult primary liver cancer|advanced adult primary liver cancer
5451267|NCT01497444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5451268|NCT01497444|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5451269|NCT01497405|Gender-based Violence|gender-based violence
5451270|NCT01497405|HIV|hiv
5451271|NCT01497405|Randomized Controlled Trial|randomized controlled trial
5451272|NCT01497405|Sexually Transmitted Diseases|sexually transmitted diseases
5451273|NCT01497405|Substance Abuse Detection|substance abuse detection
5451274|NCT01497405|Test, Treat and Retain|test, treat and retain
5451275|NCT01497379|Hereditary retinal|hereditary retinal
5451276|NCT01497379|degeneration outer|degeneration outer
5451277|NCT01497379|retinal layers|retinal layers
5451278|NCT01497379|photoreceptor rods cones|photoreceptor rods cones
5451279|NCT01497379|Retinitis pigmentosa|retinitis pigmentosa
5451280|NCT01497379|blindness|blindness
5451281|NCT01497379|reading ability|reading ability
5451282|NCT01497379|retina implant|retina implant
5451283|NCT01497379|subretinal|subretinal
5451284|NCT01497366|HCV genotype 2 (GT-2)|hcv genotype 2 (gt-2)
5451285|NCT01497366|HCV genotype 3 (GT-3)|hcv genotype 3 (gt-3)
5451286|NCT01497353|Cord clamping|cord clamping
5451287|NCT01497353|newborn|newborn
5451288|NCT01497353|Skin contact|skin contact
5438273|NCT01552525|acute kidney injury|acute kidney injury
5451289|NCT01497353|Placental transfusion|placental transfusion
5451291|NCT01497340|Cord clamping|cord clamping
5451292|NCT01497340|newborn|newborn
5451293|NCT01497340|Placental trasfusion|placental trasfusion
5451294|NCT01497340|Delivery room|delivery room
5451295|NCT01497327|HEPATITIS C, CHRONIC|hepatitis c, chronic
5451296|NCT01497327|HCV|hcv
5451297|NCT01497327|hepatic impairment|hepatic impairment
5451298|NCT01497314|healthy term infants|healthy term infants
5451299|NCT01497314|growth|growth
5451300|NCT01497314|infant formula|infant formula
5451301|NCT01497301|Diabetes|diabetes
5451302|NCT01497301|Group Visit|group visit
5451303|NCT01497301|Shared Medical Appointment|shared medical appointment
5451304|NCT01497288|Intranasal fentanyl spray|intranasal fentanyl spray
5451305|NCT01497288|Population PK|population pk
5451306|NCT01497262|Multiple Sclerosis|multiple sclerosis
5451307|NCT01497262|Relapsing-Remitting|relapsing-remitting
5451308|NCT01497249|Dietary Fiber|dietary fiber
5451309|NCT01497249|Blood glucose control|blood glucose control
5451310|NCT01497249|Fermentability|fermentability
5451311|NCT01497249|Tolerability|tolerability
5451312|NCT01497223|Phase II|phase ii
5451313|NCT01497223|Double-Blind|double-blind
5451314|NCT01497223|Placebo-Controlled|placebo-controlled
5451315|NCT01497223|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5451316|NCT01497223|Moderate to Severe|moderate to severe
5451317|NCT01497223|Acute|acute
5451318|NCT01497223|Treatment of Moderate to Severe Vulvovaginal Candidiasis|treatment of moderate to severe vulvovaginal candidiasis
5451319|NCT01497197|Reproduction Techniques|reproduction techniques
5451320|NCT01497197|Reproductive Medicine|reproductive medicine
5451321|NCT01497197|Assisted Reproductive Technics|assisted reproductive technics
5451322|NCT01497197|Pregnancy Rate|pregnancy rate
5451323|NCT01497197|Ovulation Induction|ovulation induction
5451324|NCT01497197|Ovarian Stimulation|ovarian stimulation
5446093|NCT01519089|550|550
5451333|NCT01497184|Bone marrow transplant|bone marrow transplant
5451334|NCT01497184|CD19-specific T cells|cd19-specific t cells
5451335|NCT01497184|T cell infusion|t cell infusion
5451336|NCT01497184|B-Lineage lymphoid malignancies|b-lineage lymphoid malignancies
5451337|NCT01497184|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
5451338|NCT01497184|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5451339|NCT01497184|ALL|all
5451340|NCT01497184|Biphenotypic leukemia CD19+ in advanced remission|biphenotypic leukemia cd19+ in advanced remission
5451341|NCT01497184|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5451342|NCT01497184|NHL|nhl
5451343|NCT01497184|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5451344|NCT01497184|Small lymphocytic lymphoma|small lymphocytic lymphoma
5451345|NCT01497184|Follicular lymphoma|follicular lymphoma
5451346|NCT01497184|Mantle cell lymphoma with active disease at time of transplant|mantle cell lymphoma with active disease at time of transplant
5451347|NCT01497171|Cystocele|cystocele
5451348|NCT01497171|Bladder prolapse|bladder prolapse
5451349|NCT01497171|Anterior prolapse|anterior prolapse
5451350|NCT01497171|Vaginal prolapse|vaginal prolapse
5451351|NCT01497171|Uterine prolapse|uterine prolapse
5451352|NCT01497171|Urinary incontinence|urinary incontinence
5451353|NCT01497158|tobacco cessation|tobacco cessation
5451354|NCT01497119|Moderate atopic dermatitis|moderate atopic dermatitis
5451355|NCT01497119|JNJ-39758979|jnj-39758979
5451356|NCT01497119|Japanese patients|japanese patients
5451357|NCT01497106|Insulin resistance|insulin resistance
5451358|NCT01497106|Abdominal obesity|abdominal obesity
5451359|NCT01497106|Calorie restriction|calorie restriction
5451361|NCT01497093|Multiple Myeloma|multiple myeloma
5451362|NCT01497093|Relapsed Multiple Myeloma|relapsed multiple myeloma
5451363|NCT01497093|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5451364|NCT01497093|Refractory Myeloma|refractory myeloma
5451365|NCT01497093|Resistant Multiple Myeloma|resistant multiple myeloma
5451366|NCT01497093|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5451367|NCT01497093|Pomalidomide|pomalidomide
5451368|NCT01497093|Lenalidomide-resistant|lenalidomide-resistant
5451369|NCT01497080|distal radius fracture|distal radius fracture
5451370|NCT01497080|Condition|condition
5451371|NCT01497080|risk factors|risk factors
5451372|NCT01497080|adverse activity transitions following DRF|adverse activity transitions following drf
5451373|NCT01497080|optimal assessment approach|optimal assessment approach
5451374|NCT01497067|Phakic Lens|phakic lens
5451375|NCT01497067|Intraocular Lens (IOL)|intraocular lens (iol)
5451376|NCT01497054|B type natriuretic peptide|b type natriuretic peptide
5451377|NCT01497054|Patent Ductus Arteriosus|patent ductus arteriosus
5451378|NCT01497054|Preterm infant|preterm infant
5451379|NCT01497028|Co-morbid disease resolution|co-morbid disease resolution
5451380|NCT01497002|AML|aml
5451381|NCT01496989|HIV|hiv
5451382|NCT01496989|AIDS|aids
5451383|NCT01496989|HIV vaccine|hiv vaccine
5451384|NCT01496989|HIV prevention|hiv prevention
5451385|NCT01496976|leukemia|leukemia
5451386|NCT01496976|lymphoma|lymphoma
5438376|NCT01552200|G-Eye procedure|g-eye procedure
5451387|NCT01496976|consolidative therapy|consolidative therapy
5451388|NCT01496976|combination regimen|combination regimen
5451389|NCT01496976|CLL|cll
5451390|NCT01496976|SLL|sll
5451391|NCT01496963|Thalassemia|thalassemia
5451392|NCT01496963|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5451393|NCT01496950|migraine|migraine
5451394|NCT01496924|Dysphagia|dysphagia
5451395|NCT01496924|Intensive care units|intensive care units
5451396|NCT01496924|Deglutition disorders|deglutition disorders
5451397|NCT01496924|Rehabilitation|rehabilitation
5451398|NCT01496911|Diving|diving
5451399|NCT01496911|Drugs|drugs
5451400|NCT01496911|Antihistamines|antihistamines
5451401|NCT01496911|Performance|performance
5451402|NCT01496898|Microflora|microflora
5451403|NCT01496898|Vaginal|vaginal
5451404|NCT01496898|Cervical|cervical
5451405|NCT01496898|Uterine|uterine
5451406|NCT01496898|Inflammation|inflammation
5451407|NCT01496898|Cytokine|cytokine
5451408|NCT01496898|Intrauterine Device|intrauterine device
5451414|NCT01496872|Cranial strain pattern|cranial strain pattern
5451415|NCT01496872|Osteopathy|osteopathy
5451416|NCT01496859|Baska mask|baska mask
5451417|NCT01496859|supraglottic airway|supraglottic airway
5451418|NCT01496859|airway management|airway management
5451419|NCT01496846|Articaine|articaine
5451420|NCT01496846|Lidocaine|lidocaine
5451421|NCT01496846|Anesthesia, Local|anesthesia, local
5451422|NCT01496846|Endodontics|endodontics
5451424|NCT01496846|Dental Pulp Diseases|dental pulp diseases
5451425|NCT01496833|Aortic Diseases|aortic diseases
5454594|NCT01483599|Psoriasis|psoriasis
5451426|NCT01496833|Vascular Diseases|vascular diseases
5451427|NCT01496833|Cardiovascular Diseases|cardiovascular diseases
5451428|NCT01496833|Treatment Outcome|treatment outcome
5451429|NCT01496833|Aorta Dissection|aorta dissection
5451431|NCT01496833|Aorta pseudoaneurysm|aorta pseudoaneurysm
5451432|NCT01496833|Endovascular aortic repair|endovascular aortic repair
5451433|NCT01496807|unresectable|unresectable
5451435|NCT01496807|stage 4|stage 4
5451436|NCT01496807|autoimmune|autoimmune
5451437|NCT01496807|antibodies|antibodies
5451438|NCT01496781|Endoscopic Hemostasis|endoscopic hemostasis
5451439|NCT01496781|metallic hemoclip|metallic hemoclip
5451440|NCT01496781|EndoClot Absorbable Polysaccharide Hemostat|endoclot absorbable polysaccharide hemostat
5451441|NCT01496781|Colonic Polyps|colonic polyps
5451442|NCT01496729|Kidney transplantation|kidney transplantation
5451443|NCT01496729|Transversus abdominis plane (TAP) block|transversus abdominis plane (tap) block
5451444|NCT01496716|Osteoarthritis|osteoarthritis
5451445|NCT01496716|obesity|obesity
5451446|NCT01496716|quality of life|quality of life
5451447|NCT01496703|reasons for MMF dose reduction|reasons for mmf dose reduction
5451448|NCT01496690|Anxiety-comorbidity to schizophrenia|anxiety-comorbidity to schizophrenia
5451449|NCT01496690|Double-blinded randomized placebo controlled trial|double-blinded randomized placebo controlled trial
5451450|NCT01496690|Pregabalin|pregabalin
5451451|NCT01496677|volunteer|volunteer
5451452|NCT01496651|Percutaneous coronary intervention|percutaneous coronary intervention
5451453|NCT01496651|Coronary artery bypass graft operation|coronary artery bypass graft operation
5451454|NCT01496651|Left Main|left main
5451455|NCT01496638|PCI|pci
5451456|NCT01496638|Bifurcation lesion|bifurcation lesion
5596712|NCT00904332|HV|hv
5451457|NCT01496625|Biological Specimens|biological specimens
5451458|NCT01496625|Retinal Disease|retinal disease
5451459|NCT01496625|Phenotype|phenotype
5451460|NCT01496625|Phenotype-Genotype correlation|phenotype-genotype correlation
5451461|NCT01496625|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5451462|NCT01496625|AMD|amd
5451463|NCT01496625|Diabetic Retinopathy|diabetic retinopathy
5451464|NCT01496625|Healthy Volunteer|healthy volunteer
5451465|NCT01496625|HV|hv
5451466|NCT01496612|Epilepsy|epilepsy
5451467|NCT01496612|Temporal Lobe Epilepsy|temporal lobe epilepsy
5451468|NCT01496612|Serotonin 1A Receptor|serotonin 1a receptor
5451469|NCT01496612|Seizures|seizures
5451477|NCT01496586|Fatigue|fatigue
5451478|NCT01496586|Traumatic Brain Injury|traumatic brain injury
5451479|NCT01496586|Motivational Incentive|motivational incentive
5451480|NCT01496586|TBI|tbi
5451481|NCT01496560|colonoscopy|colonoscopy
5451482|NCT01496560|pain|pain
5451483|NCT01496560|rectal balloon|rectal balloon
5451484|NCT01496547|feasibility, effective and safety|feasibility, effective and safety
5451485|NCT01496547|intensive chemotherapy|intensive chemotherapy
5451486|NCT01496547|RIC regimen|ric regimen
5451487|NCT01496547|refractory or relapse leukemia|refractory or relapse leukemia
5451488|NCT01496547|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5451489|NCT01496534|advanced solid tumors|advanced solid tumors
5451490|NCT01496534|bladder cancer|bladder cancer
5451491|NCT01496534|gemcitabine|gemcitabine
5451492|NCT01496534|cisplatin|cisplatin
5451493|NCT01496534|carboplatin|carboplatin
5451494|NCT01496534|solid tumors|solid tumors
5451495|NCT01496521|Aspirin|aspirin
5451496|NCT01496521|polyphenols|polyphenols
5451497|NCT01496521|Chemoprevention|chemoprevention
5451498|NCT01496508|high-frequency oscillatory ventilation|high-frequency oscillatory ventilation
5451499|NCT01496508|respiratory distress syndrome|respiratory distress syndrome
5451500|NCT01496508|preterm infants|preterm infants
5451501|NCT01496508|neurodevelopment|neurodevelopment
5451502|NCT01496508|preterm infants with severe respiratory distress syndrome|preterm infants with severe respiratory distress syndrome
5451503|NCT01496482|Dry eye Syndromes|dry eye syndromes
5451504|NCT01496469|Drug Therapy|drug therapy
5451505|NCT01496456|Dental caries|dental caries
5451704|NCT01495637|GM-CSF|gm-csf
5451506|NCT01496456|Proximal surfaces|proximal surfaces
5451507|NCT01496456|Posterior teeth|posterior teeth
5451508|NCT01496456|Carious lesions|carious lesions
5451509|NCT01496456|Tooth diseases|tooth diseases
5451510|NCT01496456|Preventive therapy|preventive therapy
5451511|NCT01496443|Drug Therapy|drug therapy
5451512|NCT01496430|Drug Therapy|drug therapy
5451513|NCT01496430|Hypertension and Diabetes|hypertension and diabetes
5451514|NCT01496417|Kidney Transplantation|kidney transplantation
5451515|NCT01496417|Biopsy|biopsy
5451516|NCT01496417|Belatacept|belatacept
5451517|NCT01496404|Electrocautery|electrocautery
5451518|NCT01496391|imaging|imaging
5451519|NCT01496391|renal function|renal function
5451520|NCT01496391|I-123 OIH|i-123 oih
5451521|NCT01496391|Tc-99m MAG 3|tc-99m mag 3
5451522|NCT01496378|Chronic Pain|chronic pain
5451523|NCT01496378|Abdominal Pain|abdominal pain
5451524|NCT01496378|Headache|headache
5451525|NCT01496378|Adolescents|adolescents
5451526|NCT01496378|Children|children
5451527|NCT01496378|Parents|parents
5451528|NCT01496378|Problem-Solving Skills Training|problem-solving skills training
5451529|NCT01496365|Keywords: pain, diabetes, neuropathy|keywords: pain, diabetes, neuropathy
5451530|NCT01496352|Surgical site infection|surgical site infection
5451532|NCT01496326|Osteoarthritis|osteoarthritis
5451533|NCT01496326|knee pain|knee pain
5451534|NCT01496313|medullary thyroid cancer|medullary thyroid cancer
5451535|NCT01496313|metastatic|metastatic
5451536|NCT01496313|thyroid cancer|thyroid cancer
5451537|NCT01496313|carcinoma of the thyroid|carcinoma of the thyroid
5451538|NCT01496313|receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5451539|NCT01496313|VEGFR|vegfr
5451540|NCT01496313|Unresectable locally advanced thyroid cancer|unresectable locally advanced thyroid cancer
5451541|NCT01496300|Navigation OrthoPilot Hip TEP THA|navigation orthopilot hip tep tha
5451542|NCT01496261|Clopidogrel|clopidogrel
5451543|NCT01496261|Aspirin|aspirin
5451544|NCT01496261|Combination|combination
5451545|NCT01496261|Pharmacokinetics|pharmacokinetics
5451546|NCT01496261|Phase 1|phase 1
5451547|NCT01496248|Major depressive disorder|major depressive disorder
5451548|NCT01496248|Residual symptoms|residual symptoms
5451549|NCT01496248|Korean red ginseng|korean red ginseng
5451550|NCT01496222|mild cognitive impairment|mild cognitive impairment
5451551|NCT01496222|Montreal Cognitive Assessment test|montreal cognitive assessment test
5451552|NCT01496209|Infarction|infarction
5451553|NCT01496209|Myocardial Infarction|myocardial infarction
5451554|NCT01496209|Ventricular Dysfunction, Left|ventricular dysfunction, left
5451555|NCT01496209|Heart Disease|heart disease
5451556|NCT01496209|Cardiovascular Disease|cardiovascular disease
5451557|NCT01496209|Chronic Ischemia|chronic ischemia
5451558|NCT01496196|hemoptisis|hemoptisis
5903966|NCT00092222|Lymphoproliferation|lymphoproliferation
5451559|NCT01496196|bleeding|bleeding
5451560|NCT01496196|tranexamic acid|tranexamic acid
5451561|NCT01496157|Primary Prostate Cancer|primary prostate cancer
5451562|NCT01496144|Chronic non specific low back pain|chronic non specific low back pain
5451563|NCT01496144|Manual therapy|manual therapy
5451564|NCT01496144|Active exercises|active exercises
5451565|NCT01496144|Pain|pain
5451566|NCT01496144|Disability|disability
5451567|NCT01496131|Tecemotide|tecemotide
5451568|NCT01496131|Prostate Cancer|prostate cancer
5451569|NCT01496131|Goserelin|goserelin
5451570|NCT01496131|Cyclophosphamide|cyclophosphamide
5451571|NCT01496131|Radiotherapy|radiotherapy
5451572|NCT01496118|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5451573|NCT01496118|carfilzomib|carfilzomib
5451574|NCT01496118|panobinostat|panobinostat
5451575|NCT01496092|Keto Acid|keto acid
5451576|NCT01496092|Peritoneal dialysis|peritoneal dialysis
5451577|NCT01496092|Insulin resistance|insulin resistance
5451578|NCT01496079|Maternal immunization|maternal immunization
5451579|NCT01496079|Infant immunization|infant immunization
5451580|NCT01496079|Influenza vaccine|influenza vaccine
5451581|NCT01496079|Passive transfer of immunity|passive transfer of immunity
5451582|NCT01496053|Cytokine levels in blood|cytokine levels in blood
5451583|NCT01496053|Calprotectin in feces|calprotectin in feces
5451584|NCT01496053|Clinical symptom score.|clinical symptom score.
5451585|NCT01496027|cerebral oxygenation|cerebral oxygenation
5451586|NCT01496027|NIRS|nirs
5451587|NCT01496027|tissue oximeters|tissue oximeters
5451588|NCT01496027|near infrared spectroscopy|near infrared spectroscopy
5451589|NCT01496027|newborn|newborn
5451590|NCT01496014|open fracture wounds|open fracture wounds
5451591|NCT01496014|infections|infections
5438570|NCT01551290|Infliximab|infliximab
5451592|NCT01496014|tibia fractures|tibia fractures
5451593|NCT01496014|antibiotic therapies in severe fractures|antibiotic therapies in severe fractures
5451594|NCT01496014|All severe open fracture of the tibia bone|all severe open fracture of the tibia bone
5451595|NCT01496001|Early unilateral breast cancer|early unilateral breast cancer
5451596|NCT01495988|Metastatic melanoma|metastatic melanoma
5451597|NCT01495988|BRAF-mutant|braf-mutant
5451598|NCT01495988|Stage IV melanoma|stage iv melanoma
5451599|NCT01495988|Vemurafenib|vemurafenib
5451600|NCT01495988|Bevacizumab|bevacizumab
5451601|NCT01495988|Cobimetinib|cobimetinib
5451602|NCT01495975|Diabetes Mellitus|diabetes mellitus
5451705|NCT01495637|immune|immune
5451603|NCT01495975|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5451604|NCT01495975|Hospitalization|hospitalization
5451605|NCT01495975|Patient Discharge|patient discharge
5451606|NCT01495962|Damage Control Laparotomy|damage control laparotomy
5451607|NCT01495962|Open Abdomen|open abdomen
5451608|NCT01495962|Botulinum Toxin A|botulinum toxin a
5451609|NCT01495962|Primary Fascial Closure|primary fascial closure
5451610|NCT01495949|etomidate|etomidate
5451611|NCT01495949|cortisol level|cortisol level
5451612|NCT01495949|inotrope|inotrope
5451613|NCT01495949|cardiac patients|cardiac patients
5451614|NCT01495936|One Lung Ventilation (OLV)|one lung ventilation (olv)
5451615|NCT01495936|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5451616|NCT01495936|Positive End Expiratory Pressure (PEEP)|positive end expiratory pressure (peep)
5451617|NCT01495936|Lung recruitment maneuver|lung recruitment maneuver
5451618|NCT01495936|Hypoxia|hypoxia
5451619|NCT01495923|low back pain|low back pain
5451620|NCT01495923|radiculopathy|radiculopathy
5451621|NCT01495923|injection|injection
5451622|NCT01495910|21-hydroxylase deficiency|21-hydroxylase deficiency
5451623|NCT01495910|Androstenedione|androstenedione
5451624|NCT01495910|Abiraterone acetate|abiraterone acetate
5451625|NCT01495910|Pharmacokinetics|pharmacokinetics
5451626|NCT01495910|Pharmacodynamics|pharmacodynamics
5451627|NCT01495910|Dose-finding|dose-finding
5451628|NCT01495897|Dystonia|dystonia
5451629|NCT01495897|Cerebellar|cerebellar
5451630|NCT01495897|ocular movements|ocular movements
5451632|NCT01495897|sensorimotor integration|sensorimotor integration
5451633|NCT01495858|Naproxen sodium|naproxen sodium
5451634|NCT01495858|Diphenhydramine|diphenhydramine
5451635|NCT01495845|pharmacogenomics|pharmacogenomics
5451636|NCT01495845|feasibility|feasibility
5451637|NCT01495845|community pharmacy|community pharmacy
5451638|NCT01495845|personalized medicine|personalized medicine
5451639|NCT01495845|clopidogrel|clopidogrel
5451640|NCT01495845|Plavix|plavix
5451641|NCT01495832|Adult Obesity|adult obesity
5451642|NCT01495832|Cardiometabolic health|cardiometabolic health
5451643|NCT01495832|Pulse Foods|pulse foods
5451644|NCT01495832|Beans, Peas, Lentils|beans, peas, lentils
5451645|NCT01495832|Cognitive Function|cognitive function
5451646|NCT01495819|Nicotine|nicotine
5451647|NCT01495819|smokers|smokers
5451648|NCT01495819|vitals associated with smoking|vitals associated with smoking
5451649|NCT01495806|functional dyspepsia|functional dyspepsia
5451650|NCT01495806|irritable bowel syndrome|irritable bowel syndrome
5451651|NCT01495806|functional abdominal pain|functional abdominal pain
5451652|NCT01495793|Rotigotine|rotigotine
5451653|NCT01495793|Restless Legs Syndrome|restless legs syndrome
5451655|NCT01495793|Children|children
5451656|NCT01495793|Adolescents|adolescents
5451657|NCT01495780|Behavioral|behavioral
5451658|NCT01495780|Remote monitoring|remote monitoring
5451659|NCT01495767|childhood uveitis|childhood uveitis
5451660|NCT01495767|health-related quality of life|health-related quality of life
5451661|NCT01495767|gender|gender
5451662|NCT01495754|coffee|coffee
5451663|NCT01495754|overweight/obese|overweight/obese
5451664|NCT01495754|appetite|appetite
5451665|NCT01495754|energy intake|energy intake
5451666|NCT01495754|inflammation|inflammation
5451667|NCT01495754|glucose metabolism|glucose metabolism
5451668|NCT01495754|randomized controlled trial|randomized controlled trial
5451669|NCT01495741|Mania|mania
5451670|NCT01495741|Manic|manic
5451671|NCT01495741|Depressive|depressive
5451672|NCT01495741|Manic Depressive|manic depressive
5451673|NCT01495728|Cervical Radiculopathy|cervical radiculopathy
5451674|NCT01495728|Neck Pain|neck pain
5451675|NCT01495728|Manipulation|manipulation
5451676|NCT01495702|HIV-1|hiv-1
5451678|NCT01495702|Treatment Experienced|treatment experienced
5451679|NCT01495689|Smoking Cessation|smoking cessation
5451680|NCT01495689|respirology Out-patient setting|respirology out-patient setting
5451681|NCT01495689|SmartCard|smartcard
5451682|NCT01495676|Bladder cancer|bladder cancer
5451683|NCT01495676|Organ-conserving strategy|organ-conserving strategy
5451684|NCT01495676|Radiochemotherapy|radiochemotherapy
5451685|NCT01495676|non metastatic|non metastatic
5451686|NCT01495663|refractory|refractory
5451687|NCT01495663|relapsed|relapsed
5451688|NCT01495663|non-small cell lung cancer|non-small cell lung cancer
5451689|NCT01495663|triple-negative breast cancer|triple-negative breast cancer
5451690|NCT01495663|soft tissue sarcoma|soft tissue sarcoma
5451691|NCT01495663|colorectal cancer|colorectal cancer
5451692|NCT01495663|esophageal cancer|esophageal cancer
5451693|NCT01495663|prostate cancer|prostate cancer
5451694|NCT01495663|ovarian cancer|ovarian cancer
5451695|NCT01495650|Comprehensive Adjuvant Care|comprehensive adjuvant care
5451696|NCT01495650|Cancer-related fatigue|cancer-related fatigue
5451697|NCT01495650|Therapeutic patient education|therapeutic patient education
5451698|NCT01495650|Physical Activity|physical activity
5451699|NCT01495650|Nutritional counselling|nutritional counselling
5451700|NCT01495650|Rehabilitation|rehabilitation
5451701|NCT01495637|pediatric|pediatric
5451702|NCT01495637|trauma|trauma
5451710|NCT01495624|18 and 75 years|18 and 75 years
5451711|NCT01495611|postoperative,|postoperative,
5451712|NCT01495611|pediatric|pediatric
5451713|NCT01495611|pharmacogenetic|pharmacogenetic
5451714|NCT01495611|opioid|opioid
5451715|NCT01495611|morphine|morphine
5451716|NCT01495611|perioperative|perioperative
5451717|NCT01495611|respiratory depression|respiratory depression
5451723|NCT01495585|Hepatitis|hepatitis
5451724|NCT01495585|Delta|delta
5451725|NCT01495585|Treatment|treatment
5451726|NCT01495585|Lonafarnib|lonafarnib
5451727|NCT01495585|Hepatitis D|hepatitis d
5451728|NCT01495572|Malignant Melanoma|malignant melanoma
5451729|NCT01495572|Immunotherapy|immunotherapy
5451730|NCT01495572|Cell Therapy|cell therapy
5451731|NCT01495572|HLA-A2 Positive|hla-a2 positive
5451732|NCT01495572|Skin Cancer|skin cancer
5451733|NCT01495546|total hip arthroplasty|total hip arthroplasty
5451734|NCT01495546|THA|tha
5451735|NCT01495546|prosthesis type Lepine|prosthesis type lepine
5451736|NCT01495520|Arrhythmias|arrhythmias
5451737|NCT01495520|palpitations|palpitations
5451739|NCT01495481|Supraventricular Tachycardia|supraventricular tachycardia
5451740|NCT01495481|SVT|svt
5451741|NCT01495481|Reentrant Tachycardia|reentrant tachycardia
5451743|NCT01495481|Adenosine|adenosine
5451744|NCT01495468|pegylated somatropin|pegylated somatropin
5451745|NCT01495468|PEG-rhGH|peg-rhgh
5451746|NCT01495468|growth hormone|growth hormone
5451747|NCT01495468|Growth Hormone Deficiency|growth hormone deficiency
5451748|NCT01495468|phase III study|phase iii study
5451749|NCT01495429|catheter related large vein thrombosis|catheter related large vein thrombosis
5451750|NCT01495429|upper extremity deep venous thrombosis|upper extremity deep venous thrombosis
5451751|NCT01495429|central venous catheters|central venous catheters
5451752|NCT01495429|upper extremity catheter related large vein thrombosis|upper extremity catheter related large vein thrombosis
5451753|NCT01495403|liver cirrhosis|liver cirrhosis
5451754|NCT01495403|muscle cramps|muscle cramps
5451755|NCT01495390|Biomarkers|biomarkers
5451756|NCT01495390|Biological Markers|biological markers
5451757|NCT01495390|Surrogate Markers|surrogate markers
5451758|NCT01495390|Clinical Markers|clinical markers
5451759|NCT01495390|Plasma|plasma
5451760|NCT01495390|Cerebrospinal Fluid|cerebrospinal fluid
5451761|NCT01495390|DNA|dna
5451762|NCT01495390|Serum|serum
5451763|NCT01495390|RNA|rna
5451764|NCT01495377|swallowing difficulties|swallowing difficulties
5451765|NCT01495377|remifentanil|remifentanil
5451766|NCT01495377|pulmonary aspiration|pulmonary aspiration
5451767|NCT01495377|scintigraphy|scintigraphy
5451768|NCT01495364|STEMI|stemi
5451769|NCT01495325|Firefighter|firefighter
5451770|NCT01495325|Woodsmoke|woodsmoke
5451771|NCT01495325|Vascular function|vascular function
5451772|NCT01495325|Air Pollution|air pollution
5451773|NCT01495325|Endothelial function|endothelial function
5451774|NCT01495325|Thrombosis|thrombosis
5451775|NCT01495312|IOP fluctuations|iop fluctuations
5451776|NCT01495312|during two 24-hour periods|during two 24-hour periods
5451777|NCT01495299|relationship|relationship
5451778|NCT01495299|IOP fluctuations|iop fluctuations
5451779|NCT01495299|glaucoma|glaucoma
5451780|NCT01495299|cataract surgery|cataract surgery
5451781|NCT01495299|SENSIMED Triggerfish|sensimed triggerfish
5451782|NCT01495286|newborn infant|newborn infant
5451783|NCT01495286|acupuncture|acupuncture
5451784|NCT01495286|safety|safety
5451785|NCT01495286|pain|pain
5451786|NCT01495260|XALD|xald
5451787|NCT01495260|AMN|amn
5451788|NCT01495247|Locally advanced|locally advanced
5451789|NCT01495247|metastatic|metastatic
5451790|NCT01495247|breast cancer|breast cancer
5451791|NCT01495247|HER2 negative|her2 negative
5451792|NCT01495247|PI3K pathway|pi3k pathway
5451793|NCT01495247|paclitaxel|paclitaxel
5451794|NCT01495247|mTOR inhibitor|mtor inhibitor
5451795|NCT01495234|Spinal degeneration|spinal degeneration
5451796|NCT01495195|Acetylcholine|acetylcholine
5451797|NCT01495195|Cholinesterases|cholinesterases
5451798|NCT01495195|Cocaine|cocaine
5451799|NCT01495195|Self-Administration|self-administration
5451800|NCT01495182|Dietary fiber|dietary fiber
5451801|NCT01495182|Gastrointestinal toleration|gastrointestinal toleration
5451802|NCT01495182|Fecal weight|fecal weight
5451803|NCT01495169|Antipsychotic|antipsychotic
5451804|NCT01495169|Schizophrenia|schizophrenia
5451805|NCT01495169|Bipolar disorder|bipolar disorder
5451806|NCT01495169|Iloperidone|iloperidone
5451807|NCT01495143|Glucose|glucose
5451808|NCT01495143|Lactate pyruvate ratio|lactate pyruvate ratio
5451809|NCT01495143|Glycerol|glycerol
5451810|NCT01495143|Paraspinal muscle|paraspinal muscle
5451811|NCT01495143|Microdialysis|microdialysis
5451812|NCT01495117|surgical site infection|surgical site infection
5451813|NCT01495117|chlorhexidine gluconate|chlorhexidine gluconate
5451814|NCT01495117|povidone iodine|povidone iodine
5451815|NCT01495091|coronary artery disease|coronary artery disease
5451816|NCT01495091|cardiovascular disease|cardiovascular disease
5451817|NCT01495091|exercise stress testing|exercise stress testing
5451818|NCT01495091|biomarkers|biomarkers
5451819|NCT01495091|NT-pro-BNP|nt-pro-bnp
5451820|NCT01495078|telemonitoring|telemonitoring
5451821|NCT01495078|heart failure|heart failure
5451822|NCT01495065|GSK2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single|gsk2251052, healthy volunteer, safety, tolerability, pharmacokinetics, single
5451823|NCT01495052|naked oat (Avena nuda L.)|naked oat (avena nuda l.)
5451824|NCT01495052|diabetes mellitus|diabetes mellitus
5451825|NCT01495052|RCT|rct
5451826|NCT01495026|Healthy male subjects|healthy male subjects
5451827|NCT01495026|North-East Asian ancestry|north-east asian ancestry
5451828|NCT01495026|Bioequivalence|bioequivalence
5451829|NCT01495026|Food effect|food effect
5451830|NCT01495026|Tamsulosin hydrochloride|tamsulosin hydrochloride
5451831|NCT01495026|Cross-over design|cross-over design
5451832|NCT01495026|Pilot bioequivalence|pilot bioequivalence
5451833|NCT01495026|Dutasteride (GI198745)|dutasteride (gi198745)
5451834|NCT01495013|non-inferiority|non-inferiority
5451835|NCT01495013|glimepiride|glimepiride
5451836|NCT01495013|LDL cholesterol|ldl cholesterol
5451837|NCT01495013|fixed dose combination|fixed dose combination
5451838|NCT01495013|atorvastatin|atorvastatin
5451839|NCT01495013|Diabetes Mellitus|diabetes mellitus
5451841|NCT01495000|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5451843|NCT01495000|denosumab|denosumab
5451844|NCT01494987|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5451845|NCT01494974|Glaucoma|glaucoma
5451846|NCT01494974|Pediatric|pediatric
5451847|NCT01494974|Ahmed|ahmed
5451848|NCT01494974|Congenital|congenital
5451849|NCT01494974|FP7|fp7
5451850|NCT01494974|FP8|fp8
5434542|NCT01568671|HV|hv
5451851|NCT01494961|Partner HIV testing|partner hiv testing
5451852|NCT01494961|Couple HIV counseling|couple hiv counseling
5451853|NCT01494961|Couple communication on sexual and reproductive health|couple communication on sexual and reproductive health
5451854|NCT01494961|HIV incidence|hiv incidence
5451855|NCT01494961|Incidence of pregnancies|incidence of pregnancies
5451856|NCT01494961|Disclosure|disclosure
5451857|NCT01494961|Condom use|condom use
5451858|NCT01494922|Skin scarring|skin scarring
5451859|NCT01494922|cicatrix|cicatrix
5451860|NCT01494922|hypertrophic scar|hypertrophic scar
5451861|NCT01494922|hypertrophic scar prevention|hypertrophic scar prevention
5451862|NCT01494909|protein digestion|protein digestion
5451863|NCT01494909|fat absorption|fat absorption
5451864|NCT01494909|gut function|gut function
5451865|NCT01494909|glucose absorption|glucose absorption
5451866|NCT01494909|CF|cf
5451867|NCT01494909|pancreatic intake|pancreatic intake
5451868|NCT01494909|feeding|feeding
5903967|NCT00092222|Lymph Node Hyperplasia|lymph node hyperplasia
5451869|NCT01494896|Pulmonary Hypertension|pulmonary hypertension
5451870|NCT01494896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5451872|NCT01494896|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5451873|NCT01494896|Tyvaso|tyvaso
5451874|NCT01494896|Inhaled Treprostinil Sodium|inhaled treprostinil sodium
5451875|NCT01494896|Ventilation Perfusion Matching|ventilation perfusion matching
5451876|NCT01494896|HO Group 1 Pulmonary Arterial Hypertension|ho group 1 pulmonary arterial hypertension
5451877|NCT01494896|Concomitant Chronic Obstructive Pulmonary Disease|concomitant chronic obstructive pulmonary disease
5451878|NCT01494883|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5451879|NCT01494883|lung cancer|lung cancer
5451880|NCT01494883|psychological distress|psychological distress
5451881|NCT01494883|caretakers|caretakers
5451882|NCT01494870|acute coronary syndrome|acute coronary syndrome
5451883|NCT01494870|percutaneous coronary intervention|percutaneous coronary intervention
5451884|NCT01494870|left bundle branch block|left bundle branch block
5451885|NCT01494857|Ulcerative colitis|ulcerative colitis
5451886|NCT01494857|biological treatment|biological treatment
5451887|NCT01494857|anti-TNF|anti-tnf
5451888|NCT01494844|Patient Monitoring|patient monitoring
5451889|NCT01494844|Capnography|capnography
5451890|NCT01494844|Human Engineering|human engineering
5451891|NCT01494818|Contact lenses|contact lenses
5451892|NCT01494818|Contact lens solutions|contact lens solutions
5451893|NCT01494805|Age-related Macular Degeneration|age-related macular degeneration
5451894|NCT01494805|AAV|aav
5451895|NCT01494805|AMD|amd
5451896|NCT01494805|Wet AMD|wet amd
5451897|NCT01494805|Neovascular AMD|neovascular amd
5451898|NCT01494805|Gene Therapy|gene therapy
5451899|NCT01494805|Ocular|ocular
5451900|NCT01494805|Ocular Gene Therapy|ocular gene therapy
5451901|NCT01494805|Eye diseases|eye diseases
5451902|NCT01494805|Macular Degeneration|macular degeneration
5451903|NCT01494805|Retinal Degeneration|retinal degeneration
5451904|NCT01494805|Retinal Neovascularization|retinal neovascularization
5451905|NCT01494805|Wet Macular Degeneration|wet macular degeneration
5451906|NCT01494805|Retinal Diseases|retinal diseases
5451907|NCT01494779|children|children
5451909|NCT01494740|H1N1|h1n1
5451910|NCT01494740|Vaccine|vaccine
5451911|NCT01494740|Immunogenicity|immunogenicity
5451912|NCT01494740|Safety|safety
5451913|NCT01494740|infants|infants
5451914|NCT01494727|Safety|safety
5451915|NCT01494727|Pharmacokinetics|pharmacokinetics
5451916|NCT01494714|Healthy volunteers|healthy volunteers
5451917|NCT01494714|JNJ 10229570-AAA|jnj 10229570-aaa
5451918|NCT01494714|Skin irritation|skin irritation
5451919|NCT01494714|Skin photo irritation|skin photo irritation
5451920|NCT01494701|Spinal Muscular Atrophy|spinal muscular atrophy
5451921|NCT01494701|SMA|sma
5451922|NCT01494701|SMN|smn
5451923|NCT01494701|SMNRx|smnrx
5451924|NCT01494701|ISIS-SMNRx|isis-smnrx
5451925|NCT01494701|ISIS-SMN Rx|isis-smn rx
5451926|NCT01494701|ISIS 396443|isis 396443
5451927|NCT01494701|IONIS-SMNRx|ionis-smnrx
5451928|NCT01494701|IONIS-SMN Rx|ionis-smn rx
5451929|NCT01494701|Spinraza|spinraza
5451930|NCT01494675|procalcitonin|procalcitonin
5451931|NCT01494675|duration of the antibiotic therapy|duration of the antibiotic therapy
5451932|NCT01494675|sepsis|sepsis
5451933|NCT01494662|HER2 Positive|her2 positive
5451934|NCT01494662|BrCa|brca
5451935|NCT01494649|dentinal|dentinal
5451936|NCT01494649|hypersensitivity|hypersensitivity
5451937|NCT01494636|Capsaicin Challenge|capsaicin challenge
5451938|NCT01494636|Pharmacodynamics|pharmacodynamics
5451940|NCT01494636|Pharmacokinetics|pharmacokinetics
5451941|NCT01494636|Oral GSK2339345|oral gsk2339345
5451942|NCT01494636|Tolerability|tolerability
5451943|NCT01494636|FTIH|ftih
5451944|NCT01494636|Chronic Cough|chronic cough
5451945|NCT01494623|working memory|working memory
5451946|NCT01494623|schizophrenia|schizophrenia
5451947|NCT01494623|cognition|cognition
5451948|NCT01494623|rTMS|rtms
5451949|NCT01494610|safety|safety
5451950|NCT01494610|replicated cross-over design|replicated cross-over design
5451951|NCT01494610|pharmacodynamics|pharmacodynamics
5434647|NCT01568164|Dor|dor
5451952|NCT01494610|Fluticasone propionate/Salmeterol|fluticasone propionate/salmeterol
5451953|NCT01494610|capsule-based inhaler|capsule-based inhaler
5451954|NCT01494610|COPD|copd
5451955|NCT01494610|asthma|asthma
5451956|NCT01494610|multi dose dry powder inhaler|multi dose dry powder inhaler
5451957|NCT01494610|bioavailability|bioavailability
5451958|NCT01494610|pharmacokinetics|pharmacokinetics
5451959|NCT01494597|Isavuconazole|isavuconazole
5451960|NCT01494597|Cyclosporine|cyclosporine
5451961|NCT01494597|Healthy Volunteers|healthy volunteers
5451962|NCT01494597|BAL8557|bal8557
5451963|NCT01494597|Pharmacokinetics of isavuconazole|pharmacokinetics of isavuconazole
5451964|NCT01494597|Pharmacokinetics of cyclosporine|pharmacokinetics of cyclosporine
5451965|NCT01494558|Overall survival|overall survival
5451966|NCT01494545|DAILIES TOTAL1|dailies total1
5451967|NCT01494545|Alcon|alcon
5451968|NCT01494545|contact lens|contact lens
5451969|NCT01494519|External ring fixation|external ring fixation
5451971|NCT01494519|traumatic tibia fracture|traumatic tibia fracture
5451972|NCT01494506|Pancreatic cancer|pancreatic cancer
5451973|NCT01494506|MM-398|mm-398
5451974|NCT01494506|PEP02|pep02
5451975|NCT01494506|Metastatic pancreatic cancer|metastatic pancreatic cancer
5451976|NCT01494506|Gemcitabine refractory pancreatic cancer|gemcitabine refractory pancreatic cancer
5451977|NCT01494506|Second line pancreatic cancer treatment|second line pancreatic cancer treatment
5451978|NCT01494506|Pancreatic cancer post gemcitabine therapy|pancreatic cancer post gemcitabine therapy
5451979|NCT01494493|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5451981|NCT01494480|stem cell|stem cell
5451982|NCT01494467|PPR|ppr
5451983|NCT01494454|Lumbar degenerative disc disease|lumbar degenerative disc disease
5451984|NCT01494441|lumbar degenerative disc disease|lumbar degenerative disc disease
5451985|NCT01494428|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5451986|NCT01494415|Squamous Cell Lung Cancer|squamous cell lung cancer
5451987|NCT01494415|radiation therapy|radiation therapy
5451988|NCT01494415|chemotherapy|chemotherapy
5451989|NCT01494402|Healthy volunteer, Japanese males, homo-EM|healthy volunteer, japanese males, homo-em
5451990|NCT01494389|CD4+T lymphocyte subsets|cd4+t lymphocyte subsets
5451991|NCT01494389|sepsis|sepsis
5451992|NCT01494389|immunoparalysis|immunoparalysis
5451993|NCT01494350|cutaneous leishmaniasis|cutaneous leishmaniasis
5451994|NCT01494350|topical treatment|topical treatment
5451995|NCT01494350|Tunisia|tunisia
5451996|NCT01494337|LASER|laser
5451997|NCT01494337|BPH|bph
5451998|NCT01494337|Prostate surgery|prostate surgery
5451999|NCT01494337|HOLEP|holep
5452000|NCT01494337|Green light PVP|green light pvp
5452001|NCT01494324|Liver|liver
5452002|NCT01494324|Thermal Ablation|thermal ablation
5452003|NCT01494324|Dynamic CT|dynamic ct
5452004|NCT01494324|09-122|09-122
5452005|NCT01494311|Arterial catheter|arterial catheter
5452006|NCT01494311|arterial cannula|arterial cannula
5452007|NCT01494311|Rapydan|rapydan
5452008|NCT01494311|lidocaine/tetracaine patch|lidocaine/tetracaine patch
5452009|NCT01494311|topical anaesthesia|topical anaesthesia
5452010|NCT01494298|Type 2 diabetes|type 2 diabetes
5452011|NCT01494298|African American|african american
5452012|NCT01494298|cholesterol|cholesterol
5452013|NCT01494298|lipoprotein|lipoprotein
5452014|NCT01494298|apolipoprotein|apolipoprotein
5452015|NCT01494285|Acne Vulgaris|acne vulgaris
5452016|NCT01494285|Topical|topical
5452017|NCT01494285|Foam|foam
5452018|NCT01494272|caudal epidural analgesia|caudal epidural analgesia
5452019|NCT01494272|elective circumcision|elective circumcision
5452020|NCT01494272|elective inguinal herniorrhaphy|elective inguinal herniorrhaphy
5452021|NCT01494259|immediate breast reconstruction|immediate breast reconstruction
5452022|NCT01494259|pain control|pain control
5452023|NCT01494259|post mastectomy pain control|post mastectomy pain control
5452024|NCT01494246|Adult|adult
5452025|NCT01494246|computer-assisted instruction|computer-assisted instruction
5452026|NCT01494246|electronic mail|electronic mail
5452027|NCT01494246|program evaluation|program evaluation
5452028|NCT01494246|smoking cessation/methods|smoking cessation/methods
5452029|NCT01494246|continued abstinence|continued abstinence
5452030|NCT01494220|Bispectral index; anesthesia|bispectral index; anesthesia
5452031|NCT01494220|liver transplantation|liver transplantation
5452032|NCT01494220|independent factors|independent factors
5452033|NCT01494220|outcome|outcome
5452034|NCT01494220|Living donor liver transplantation|living donor liver transplantation
5452035|NCT01494207|worksite|worksite
5452036|NCT01494207|interventions|interventions
5452037|NCT01494207|motivational interviewing|motivational interviewing
5452038|NCT01494207|physical activity|physical activity
5452039|NCT01494194|Mold sensitized|mold sensitized
5452040|NCT01494181|obstructive sleep apnea|obstructive sleep apnea
5452041|NCT01494181|vascular events|vascular events
5452042|NCT01494168|Hypertension|hypertension
5452043|NCT01494168|Arterial stiffness|arterial stiffness
5452045|NCT01494168|Bariatric surgery|bariatric surgery
5452046|NCT01494155|resectable pancreatic cancer|resectable pancreatic cancer
5452047|NCT01494155|pancreaticoduodenectomy|pancreaticoduodenectomy
5452048|NCT01494142|Registry|registry
5452049|NCT01494142|Atopic Dermatitis|atopic dermatitis
5452050|NCT01494142|Eczema Herpeticum|eczema herpeticum
5452051|NCT01494142|GWAS|gwas
5452052|NCT01494142|Staphylococcus aureus|staphylococcus aureus
5452053|NCT01494116|Pediatrics|pediatrics
5452054|NCT01494116|Fluid|fluid
5452055|NCT01494116|Bolus|bolus
5452056|NCT01494116|Resuscitation|resuscitation
5452057|NCT01494116|Shock|shock
5452058|NCT01494103|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5452059|NCT01494103|Myelodysplastic syndrome|myelodysplastic syndrome
5452060|NCT01494103|Acute myeloid leukemia|acute myeloid leukemia
5452061|NCT01494103|Chronic myelogenous leukemia|chronic myelogenous leukemia
5452062|NCT01494103|Non Hodgkin lymphoma|non hodgkin lymphoma
5452063|NCT01494103|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5452064|NCT01494103|Familial hemophagocytic lymphohistiocytosis|familial hemophagocytic lymphohistiocytosis
5452065|NCT01494103|Hemophagocytic syndrome|hemophagocytic syndrome
5452066|NCT01494103|Epstein Barr virus infection|epstein barr virus infection
5452067|NCT01494103|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
5452068|NCT01494090|Venous thromboembolism|venous thromboembolism
5452069|NCT01494090|Hip fracture|hip fracture
5452070|NCT01494090|Cardiovascular events|cardiovascular events
5452071|NCT01494090|Statin|statin
5452072|NCT01494077|Pancreatic Cyst Fluid|pancreatic cyst fluid
5452073|NCT01494077|Dilution|dilution
5452074|NCT01494077|Carcinoembryonic Antigen (CEA)|carcinoembryonic antigen (cea)
5452075|NCT01494051|fatty acid oxidation disorders|fatty acid oxidation disorders
5452076|NCT01494025|Diabetes|diabetes
5452077|NCT01494025|Pre-diabetes|pre-diabetes
5452078|NCT01494025|Obese|obese
5452079|NCT01493999|Clopidogrel|clopidogrel
5452080|NCT01493999|prasugrel|prasugrel
5452082|NCT01493999|loading dose|loading dose
5452083|NCT01493999|maintenance dose|maintenance dose
5452084|NCT01493999|stent thrombosis|stent thrombosis
5452085|NCT01493999|platelet reactivity|platelet reactivity
5452086|NCT01493999|Coronary intervention|coronary intervention
5452087|NCT01493999|stent implantation|stent implantation
5452088|NCT01493986|Ropivacaine|ropivacaine
5452089|NCT01493986|Brachial plexus|brachial plexus
5452090|NCT01493973|Erythropoietin|erythropoietin
5452092|NCT01493973|Friedreich|friedreich
5452093|NCT01493973|Ataxia|ataxia
5452094|NCT01493973|Epoetin alfa|epoetin alfa
5452095|NCT01493973|VO2 max|vo2 max
5452096|NCT01493973|SARA|sara
5452097|NCT01493973|EQ-5D|eq-5d
5452098|NCT01493973|frataxin|frataxin
5452099|NCT01493960|Colitis, Ulcerative|colitis, ulcerative
5452100|NCT01493960|Gastrointestinal Diseases|gastrointestinal diseases
5452101|NCT01493960|Inflammatory Bowel Diseases|inflammatory bowel diseases
5452102|NCT01493960|Immunomodulatory Therapy|immunomodulatory therapy
5452103|NCT01493960|Glucocorticoids|glucocorticoids
5452104|NCT01493960|Anti-Inflammatory Agents|anti-inflammatory agents
5452105|NCT01493960|Therapeutic uses|therapeutic uses
5452106|NCT01493934|metabolic syndrome|metabolic syndrome
5452107|NCT01493934|type 2 diabetes mellitus|type 2 diabetes mellitus
5452108|NCT01493934|insulin resistance|insulin resistance
5452109|NCT01493934|Scintigraphy|scintigraphy
5452110|NCT01493921|SR-T100 Clinical treatment against Actinic Keratosis|sr-t100 clinical treatment against actinic keratosis
5452111|NCT01493921|Actinic keratosis skin lesion treatment with SR-T100 gel|actinic keratosis skin lesion treatment with sr-t100 gel
5452112|NCT01493921|Skin lesion treatment with SR-T100 gel|skin lesion treatment with sr-t100 gel
5452113|NCT01493921|SR-T100 gel treatment against skin lesion|sr-t100 gel treatment against skin lesion
5452114|NCT01493921|Clinical efficacy study of SR-T100 gel|clinical efficacy study of sr-t100 gel
5452115|NCT01493908|Placebo effect;|placebo effect;
5452116|NCT01493908|Pain; Analgesic;|pain; analgesic;
5452117|NCT01493908|Electrical shock|electrical shock
5452118|NCT01493908|control in healthy volunteers|control in healthy volunteers
5452119|NCT01493882|Uncontrolled Persistent Asthma, Dyspnea, Wheezing|uncontrolled persistent asthma, dyspnea, wheezing
5452120|NCT01493869|Normal healthy adult subjects|normal healthy adult subjects
5452121|NCT01493869|Adult subjects with hepatic impairment|adult subjects with hepatic impairment
5452122|NCT01493830|neuroblastoma|neuroblastoma
5452123|NCT01493804|Near Infrared Spectroscopy|near infrared spectroscopy
5452125|NCT01493804|Brain Connectivity|brain connectivity
5452126|NCT01493804|Healthy Volunteer|healthy volunteer
5452127|NCT01493804|HV|hv
5452128|NCT01493791|CDB-2914|cdb-2914
5452129|NCT01493791|Abnormal Urine Bleeding|abnormal urine bleeding
5452130|NCT01493791|Abnormal Uterine Bleeding|abnormal uterine bleeding
5452131|NCT01493700|heated circuit|heated circuit
5452132|NCT01493700|body temperature|body temperature
5452134|NCT01493674|homocysteine|homocysteine
5452135|NCT01493674|cognitive function|cognitive function
5452136|NCT01493674|eating disorders|eating disorders
5452137|NCT01493674|depression.|depression.
5452138|NCT01493661|Sleep|sleep
5452139|NCT01493661|Polysomnography|polysomnography
5452140|NCT01493661|Reaction Time|reaction time
5452141|NCT01493661|Sleep Deprivation|sleep deprivation
5452142|NCT01493661|Psychophysiology|psychophysiology
5452143|NCT01493661|Chronic sleep restriction|chronic sleep restriction
5452144|NCT01493661|healthy|healthy
5434817|NCT01567345|Pain|pain
5452145|NCT01493661|without sleep complaints|without sleep complaints
5452146|NCT01493648|statins|statins
5452147|NCT01493648|side effects|side effects
5452148|NCT01493648|muscle|muscle
5452149|NCT01493648|vitamin D|vitamin d
5452150|NCT01493648|biopsy|biopsy
5452151|NCT01493648|strength|strength
5452152|NCT01493648|fatigue|fatigue
5452153|NCT01493622|Schizophrenia minocycline cognition|schizophrenia minocycline cognition
5452154|NCT01493596|Safety|safety
5452155|NCT01493596|Tolerability|tolerability
5452156|NCT01493583|severely obese|severely obese
5671343|NCT00616499|large cell lung cancer|large cell lung cancer
5452157|NCT01493583|Roux-en Y gastric bypass surgery (RYGB)|roux-en y gastric bypass surgery (rygb)
5452158|NCT01493583|brain activity by fMRI|brain activity by fmri
5452159|NCT01493583|visual presentation of food and non-food-related pictures|visual presentation of food and non-food-related pictures
5452160|NCT01493544|COPD|copd
5452161|NCT01493544|smokers|smokers
5452162|NCT01493544|primary care|primary care
5452163|NCT01493531|Gout|gout
5452164|NCT01493518|SAFETY|safety
5452165|NCT01493518|ADULT|adult
5452166|NCT01493518|PSORIASIS|psoriasis
5452167|NCT01493518|INFLAMMATION|inflammation
5452168|NCT01493505|Primary Peritoneal Cancer|primary peritoneal cancer
5452169|NCT01493492|proteomics,urinary,sepsis,prognosis|proteomics,urinary,sepsis,prognosis
5452170|NCT01493466|proteomics,|proteomics,
5452171|NCT01493466|serum,|serum,
5452172|NCT01493466|sepsis,|sepsis,
5452173|NCT01493466|potential biomarkers,|potential biomarkers,
5452174|NCT01493466|dynamic changes|dynamic changes
5452175|NCT01493466|normal|normal
5452176|NCT01493440|atosiban|atosiban
5452177|NCT01493440|clinical pregnancy|clinical pregnancy
5452178|NCT01493440|implantation rate|implantation rate
5452179|NCT01493440|uterine contractility|uterine contractility
5452180|NCT01493440|IVF-ET|ivf-et
5452181|NCT01493427|Glaucoma|glaucoma
5452182|NCT01493427|OAG|oag
5452183|NCT01493427|OHT|oht
5452184|NCT01493414|Myelofibrosis|myelofibrosis
5452185|NCT01493414|Primary myelofibrosis|primary myelofibrosis
5452186|NCT01493414|PMF|pmf
5452187|NCT01493414|Post polycythemia myelofibrosis|post polycythemia myelofibrosis
5452188|NCT01493414|PPV MF|ppv mf
5452189|NCT01493414|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5452190|NCT01493414|PET-MF|pet-mf
5452191|NCT01493414|INC424|inc424
5452192|NCT01493414|Ruxolitinib|ruxolitinib
5452193|NCT01493375|Contamination, hip operation, knee operation|contamination, hip operation, knee operation
5452194|NCT01493362|Bulimia Nervosa|bulimia nervosa
5452195|NCT01493362|PET Imaging|pet imaging
5452196|NCT01493362|Dopamine|dopamine
5452197|NCT01493349|Colonic diverticula|colonic diverticula
5452198|NCT01493349|Diverticulitis|diverticulitis
5452199|NCT01493323|Psychic pain|psychic pain
5452200|NCT01493323|Social exclusion|social exclusion
5452201|NCT01493323|Mood disorders|mood disorders
5452202|NCT01493323|Suicide, attempted|suicide, attempted
5452203|NCT01493323|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5452205|NCT01493323|Physic pain|physic pain
5452206|NCT01493297|Retinyl palmitate, beta-carotene, stable isotopes, radio isotopes|retinyl palmitate, beta-carotene, stable isotopes, radio isotopes
5452207|NCT01493284|aortic stenosis|aortic stenosis
5452208|NCT01493284|aortic valve stenosis|aortic valve stenosis
5452209|NCT01493284|valvular heart disease|valvular heart disease
5452210|NCT01493284|aortic valve replacement|aortic valve replacement
5452211|NCT01493284|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5452212|NCT01493284|TAVI|tavi
5452213|NCT01493258|Diabetes|diabetes
5452214|NCT01493258|Comparative Effectiveness Research|comparative effectiveness research
5452215|NCT01493258|Interactive computer-assisted education|interactive computer-assisted education
5452216|NCT01493258|Informatics|informatics
5452217|NCT01493245|Chronic Pain|chronic pain
5452218|NCT01493245|JNS020QD|jns020qd
5452219|NCT01493245|Fentanyl|fentanyl
5452220|NCT01493245|Opioid analgesics|opioid analgesics
5452221|NCT01493232|Lingualized occlusion|lingualized occlusion
5452222|NCT01493232|Complete denture occlusion|complete denture occlusion
5452223|NCT01493232|Fully bilateral balanced occlusion|fully bilateral balanced occlusion
5452224|NCT01493232|Patient satisfaction of complete denture|patient satisfaction of complete denture
5452225|NCT01493219|Glioblastoma|glioblastoma
5452226|NCT01493219|Glioblastoma Multiforme|glioblastoma multiforme
5452227|NCT01493219|Astrocytoma|astrocytoma
5452228|NCT01493219|Gliosarcoma|gliosarcoma
5452229|NCT01493219|Glioma WHO grade IV|glioma who grade iv
5452230|NCT01493206|intraoperative radiotherapy|intraoperative radiotherapy
5452231|NCT01493167|cast|cast
5452232|NCT01493167|splint|splint
5452233|NCT01493167|circumferential casting|circumferential casting
5452234|NCT01493167|casting techniques|casting techniques
5452235|NCT01493167|fracture in extremity|fracture in extremity
5452237|NCT01493154|Head and Neck Cancer|head and neck cancer
5452238|NCT01493154|Vaccine|vaccine
5452239|NCT01493154|Immunotherapy|immunotherapy
5452240|NCT01493154|Cyclophosphamide|cyclophosphamide
5452241|NCT01493154|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5452242|NCT01493141|MOMHR|momhr
5452243|NCT01493141|THA|tha
5452244|NCT01493141|Osteoarthritis|osteoarthritis
5452245|NCT01493128|atrial fibrillation|atrial fibrillation
5452246|NCT01493128|atrial cells|atrial cells
5452247|NCT01493128|myocardial tissue|myocardial tissue
5452248|NCT01493128|t-tubules|t-tubules
5452249|NCT01493128|immunofluorescence|immunofluorescence
5452250|NCT01493102|septic shock|septic shock
5452251|NCT01493102|norepinephrine|norepinephrine
5452252|NCT01493102|vasopressin|vasopressin
5452253|NCT01493102|hypotension|hypotension
5452254|NCT01493076|ERCP|ercp
5452255|NCT01493076|Cannulation|cannulation
5452256|NCT01493076|Precut|precut
5452257|NCT01493076|Mini-spincterotome|mini-spincterotome
5452258|NCT01493063|preterm infant|preterm infant
5452259|NCT01493050|Diabetic Nephropathy|diabetic nephropathy
5452260|NCT01493050|Sevelamer Carbonate|sevelamer carbonate
5452261|NCT01493037|STEMI|stemi
5452262|NCT01493037|PICSO|picso
5452263|NCT01493037|Coronary Sinus|coronary sinus
5452264|NCT01493037|Involving Left Anterior Descending Coronary Artery|involving left anterior descending coronary artery
5452265|NCT01492998|Hepatitis C virus|hepatitis c virus
5452266|NCT01492998|Biliary salts|biliary salts
5452267|NCT01492998|Farnesoid X receptor|farnesoid x receptor
5452268|NCT01492998|Guggulsterone|guggulsterone
5452269|NCT01492972|Prostate|prostate
5452270|NCT01492972|proton|proton
5452271|NCT01492972|radiation|radiation
5452272|NCT01492972|intermediate risk|intermediate risk
5452273|NCT01492946|Malnutrition|malnutrition
5452274|NCT01492946|Post-operative outcome|post-operative outcome
5452275|NCT01492946|Phase angle|phase angle
5452276|NCT01492946|MUST|must
5452277|NCT01492946|Clavien Dindo classification|clavien dindo classification
5452278|NCT01492946|Bioelectrical impedance analysis|bioelectrical impedance analysis
5452279|NCT01492933|Ethanol|ethanol
5452280|NCT01492933|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5452281|NCT01492933|Spectroscopy|spectroscopy
5452282|NCT01492933|Alcohol Use|alcohol use
5452283|NCT01492907|Heterocyclic amine carcinogens|heterocyclic amine carcinogens
5452284|NCT01492907|meat-borne carcinogens|meat-borne carcinogens
5452285|NCT01492881|relapsed multiple myeloma|relapsed multiple myeloma
5452286|NCT01492881|refractory multiple myeloma|refractory multiple myeloma
5452287|NCT01492881|vorinostat|vorinostat
5452288|NCT01492881|bortezomib|bortezomib
5452289|NCT01492881|doxil|doxil
5452290|NCT01492868|sinusitis|sinusitis
5452291|NCT01492868|upper respiratory infection|upper respiratory infection
5452292|NCT01492855|Meniscal lesions|meniscal lesions
5452294|NCT01492855|arthroscopic treatment|arthroscopic treatment
5452295|NCT01492829|HIV prevention|hiv prevention
5685519|NCT00555763|Goldmann tonometry|goldmann tonometry
5452296|NCT01492829|sexually transmitted infection prevention|sexually transmitted infection prevention
5452297|NCT01492829|HIV knowledge|hiv knowledge
5452298|NCT01492829|relationship power|relationship power
5452299|NCT01492829|depression|depression
5452300|NCT01492829|coping|coping
5452301|NCT01492829|social support|social support
5452302|NCT01492829|internally displaced persons|internally displaced persons
5452311|NCT01492764|Ventricular Tachyarrhythmia|ventricular tachyarrhythmia
5452313|NCT01492764|Electrophysiology|electrophysiology
5452314|NCT01492764|Human|human
5452315|NCT01492764|Mapping|mapping
5452325|NCT01492738|Acupuncture|acupuncture
5452326|NCT01492738|anxiety|anxiety
5452327|NCT01492738|memory|memory
5452328|NCT01492712|Propofol|propofol
5452329|NCT01492712|Pharmacokinetics|pharmacokinetics
5452330|NCT01492712|Pharmacodynamics|pharmacodynamics
5452331|NCT01492712|Infusion Pumps|infusion pumps
5452332|NCT01492699|PTSD|ptsd
5452333|NCT01492699|Post Traumatic Stress Disorder|post traumatic stress disorder
5452334|NCT01492686|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5452335|NCT01492673|Ewing's sarcoma|ewing's sarcoma
5452336|NCT01492673|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5452337|NCT01492673|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5452338|NCT01492673|TOPOTECAN|topotecan
5452339|NCT01492673|11-183|11-183
5452340|NCT01492673|POETIC|poetic
5452341|NCT01492660|Ultrasonography|ultrasonography
5452342|NCT01492660|nerve block|nerve block
5452343|NCT01492660|catheters|catheters
5452344|NCT01492660|needle|needle
5452345|NCT01492660|anesthesia|anesthesia
5452346|NCT01492647|Acne vulgaris|acne vulgaris
5452347|NCT01492647|JNJ 10229570-AAA|jnj 10229570-aaa
5452348|NCT01492647|Japanese patients|japanese patients
5452349|NCT01492647|Topical treatment|topical treatment
5452350|NCT01492634|bioimpedance|bioimpedance
5452351|NCT01492634|overhydration|overhydration
5452352|NCT01492634|dry weight|dry weight
5452353|NCT01492621|major depression|major depression
5452355|NCT01492621|inflammatory markers|inflammatory markers
5452356|NCT01492621|cognition|cognition
5452357|NCT01492608|magnesium sulphate|magnesium sulphate
5452358|NCT01492608|preterm birth|preterm birth
5452359|NCT01492608|cerebral palsy|cerebral palsy
5452361|NCT01492556|Recurrent|recurrent
5452362|NCT01492556|Metastatic|metastatic
5452363|NCT01492556|Breast cancer|breast cancer
5452364|NCT01492543|Advanced|advanced
5452365|NCT01492543|Metastatic|metastatic
5452366|NCT01492543|Breast cancer|breast cancer
5452367|NCT01492530|Men who have sex with Men and Women|men who have sex with men and women
5452368|NCT01492530|HIV Prevention|hiv prevention
5452369|NCT01492530|Behavioral Intervention|behavioral intervention
5452370|NCT01492530|Condom use|condom use
5452371|NCT01492530|African American MSMW|african american msmw
5452372|NCT01492517|Controlled Human exposure study|controlled human exposure study
5452373|NCT01492517|Air Pollution|air pollution
5452374|NCT01492517|Gene expression|gene expression
5452375|NCT01492517|Epigenetic|epigenetic
5452376|NCT01492517|Cardiovascular|cardiovascular
5452377|NCT01492491|SUPRA-HFR|supra-hfr
5452378|NCT01492491|adsorpition|adsorpition
5452379|NCT01492491|vitamins|vitamins
5452380|NCT01492491|large toxins|large toxins
5452381|NCT01492465|Type 2 diabetes|type 2 diabetes
5452382|NCT01492452|guidelines for nursing|guidelines for nursing
5452383|NCT01492452|anxiety|anxiety
5452384|NCT01492452|cardiac surgery|cardiac surgery
5452385|NCT01492452|pediatrics|pediatrics
5452386|NCT01492439|Psychosis|psychosis
5452387|NCT01492439|Psychosis NOS|psychosis nos
5452388|NCT01492439|Schizophrenia|schizophrenia
5452389|NCT01492439|Schizoaffective Disorder|schizoaffective disorder
5452390|NCT01492439|Bipolar Disorder|bipolar disorder
5452391|NCT01492426|Hepatitis C Virus|hepatitis c virus
5452392|NCT01492413|Overweight|overweight
5452393|NCT01492413|Obesity|obesity
5452394|NCT01492387|community-acquired pneumonia|community-acquired pneumonia
5452395|NCT01492387|healthcare-associated pneumonia|healthcare-associated pneumonia
5452396|NCT01492387|antibiotic therapy|antibiotic therapy
5452397|NCT01492387|Duration of therapy|duration of therapy
5452398|NCT01492361|Coronary Artery Disease|coronary artery disease
5452399|NCT01492361|Myocardial Ischemia|myocardial ischemia
5452400|NCT01492361|Coronary Disease|coronary disease
5452401|NCT01492361|Heart Diseases|heart diseases
5452402|NCT01492361|Acute Coronary Syndrome|acute coronary syndrome
5452403|NCT01492361|Cardiovascular Diseases|cardiovascular diseases
5452404|NCT01492361|Arteriosclerosis|arteriosclerosis
5452405|NCT01492361|Arterial Occlusive Diseases|arterial occlusive diseases
5452406|NCT01492361|Vascular Diseases|vascular diseases
5452407|NCT01492361|Angina Pectoris|angina pectoris
5452408|NCT01492361|Chest Pain|chest pain
5452409|NCT01492361|Anticholesteremic Agents|anticholesteremic agents
5452410|NCT01492361|Hypolipidemic Agents|hypolipidemic agents
5452411|NCT01492361|Lipid Regulating Agents|lipid regulating agents
5452412|NCT01492361|Hypertriglyceridemia|hypertriglyceridemia
5452413|NCT01492361|Omega-3 Fatty Acids|omega-3 fatty acids
5452414|NCT01492361|Statin|statin
5452415|NCT01492361|Triglycerides|triglycerides
5452416|NCT01492361|EPA|epa
5452417|NCT01492361|Docosahexaenoic Acid|docosahexaenoic acid
5452419|NCT01492361|Fatty acids|fatty acids
5452420|NCT01492361|Fibrates|fibrates
5452421|NCT01492361|Niacin|niacin
5452422|NCT01492361|Lipids|lipids
5452423|NCT01492361|Lipoprotein|lipoprotein
5452424|NCT01492361|Atorvastatin|atorvastatin
5452425|NCT01492361|Lovaza|lovaza
5452426|NCT01492361|Simvastatin|simvastatin
5452427|NCT01492361|Lovastatin|lovastatin
5452428|NCT01492361|Pravastatin|pravastatin
5452429|NCT01492361|Fluvastatin|fluvastatin
5452430|NCT01492361|Rosuvastatin|rosuvastatin
5452431|NCT01492361|Trilipix|trilipix
5452432|NCT01492361|Vytorin|vytorin
5452433|NCT01492361|Simcor|simcor
5452434|NCT01492361|Ezetimibe|ezetimibe
5452435|NCT01492361|Zetia|zetia
5452436|NCT01492361|Ethyl-EPA|ethyl-epa
5452437|NCT01492361|Ethyl Icosapentate|ethyl icosapentate
5452438|NCT01492361|Crestor|crestor
5452439|NCT01492361|Zocor|zocor
5452440|NCT01492361|Lipitor|lipitor
5452441|NCT01492361|LDL|ldl
5452442|NCT01492361|HDL|hdl
5452443|NCT01492361|Cholesterol|cholesterol
5452444|NCT01492361|Dyslipidemia|dyslipidemia
5452445|NCT01492361|AMR101|amr101
5452446|NCT01492361|Cardiovascular Disease, Unspecified|cardiovascular disease, unspecified
5452447|NCT01492361|VASCEPA|vascepa
5452448|NCT01492361|Icosapent Ethyl|icosapent ethyl
5452449|NCT01492348|collaborative care|collaborative care
5452450|NCT01492348|PTSD|ptsd
5452451|NCT01492348|military|military
5452452|NCT01492348|Depression|depression
5452453|NCT01492348|primary care|primary care
5452454|NCT01492348|care management|care management
5452455|NCT01492348|stepped care|stepped care
5452456|NCT01492348|telehealth|telehealth
5452457|NCT01492348|OIF|oif
5452458|NCT01492348|OEF|oef
5452459|NCT01492348|preference-based treatment|preference-based treatment
5452460|NCT01492348|cost effectiveness|cost effectiveness
5452461|NCT01492348|web-based treatment|web-based treatment
5452462|NCT01492348|telephonic CBT|telephonic cbt
5452463|NCT01492348|evidence-based treatment|evidence-based treatment
5452464|NCT01492335|Cognitive decline|cognitive decline
5452465|NCT01492335|Cognitive impairment|cognitive impairment
5452467|NCT01492322|SPECT|spect
5452468|NCT01492322|Dopamine|dopamine
5452469|NCT01492322|Nicotine Sated condition|nicotine sated condition
5452474|NCT01492309|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5452475|NCT01492283|NAFLD|nafld
5452476|NCT01492283|Incretin hormones|incretin hormones
5452477|NCT01492270|Prostate Cancer|prostate cancer
5452478|NCT01492270|Multi parametric MRI|multi parametric mri
5452479|NCT01492270|Prostate HistoScanning|prostate histoscanning
5452480|NCT01492270|Transperineal prostate mapping biopsy|transperineal prostate mapping biopsy
5671344|NCT00616460|safety|safety
5452481|NCT01492257|shared decision making|shared decision making
5452482|NCT01492257|decision aids|decision aids
5452483|NCT01492257|total joint arthroplasty|total joint arthroplasty
5452484|NCT01492257|osteoarthritis|osteoarthritis
5452485|NCT01492244|Knee pain|knee pain
5452487|NCT01492244|questionnaire|questionnaire
5452488|NCT01492244|survey|survey
5452489|NCT01492231|gastroenterology|gastroenterology
5452490|NCT01492231|Endoscopy, Digestive System|endoscopy, digestive system
5452491|NCT01492231|Endosonography|endosonography
5452492|NCT01492231|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5452493|NCT01492231|gastrointestinal endoscopy|gastrointestinal endoscopy
5452494|NCT01492192|Angiogenesis|angiogenesis
5452495|NCT01492192|PET-CT|pet-ct
5452496|NCT01492192|Perfusion-CT|perfusion-ct
5452497|NCT01492179|Surgery: Abdominal hysterectomy|surgery: abdominal hysterectomy
5452498|NCT01492179|Anesthetics: Local|anesthetics: local
5452499|NCT01492179|Postoperative: Pain|postoperative: pain
5452500|NCT01492179|Drugs: Morphine|drugs: morphine
5452501|NCT01492127|Hepatocellular carcinoma|hepatocellular carcinoma
5452502|NCT01492127|cirrhosis|cirrhosis
5452503|NCT01492127|proteasome|proteasome
5452504|NCT01492127|alpha-fetoprotein|alpha-fetoprotein
5452505|NCT01492114|C-reactive protein|c-reactive protein
5452506|NCT01492114|Resveratrol|resveratrol
5452507|NCT01492114|Redox index|redox index
5452508|NCT01492088|Pediatric|pediatric
5452509|NCT01492088|Lymphoma|lymphoma
5452510|NCT01492088|Hodgkin|hodgkin
5452511|NCT01492088|Anaplastic Large-cell|anaplastic large-cell
5452518|NCT01492062|Type 1 diabetes mellitus|type 1 diabetes mellitus
5452519|NCT01492062|artificial pancreas|artificial pancreas
5452520|NCT01492062|closed-loop|closed-loop
5452521|NCT01492049|Colorectal Neoplasms|colorectal neoplasms
5452522|NCT01492049|Promoting Health Literacy|promoting health literacy
5452523|NCT01492049|Patient education program|patient education program
5452524|NCT01492049|Colorectal Cancer Screening|colorectal cancer screening
5452525|NCT01492049|CRCS|crcs
5452526|NCT01492049|Patient decision aid|patient decision aid
5452527|NCT01492049|PtDA|ptda
5452528|NCT01492049|Video|video
5452529|NCT01492049|Questionnaires|questionnaires
5452530|NCT01492049|Surveys|surveys
5452531|NCT01492036|Replication-Competent Retrovirus|replication-competent retrovirus
5452532|NCT01492036|RCR|rcr
5452533|NCT01492036|Gene transfer therapy|gene transfer therapy
5452534|NCT01492036|Registry|registry
5452535|NCT01492036|Medical information database|medical information database
5452536|NCT01492036|Vector or vector-treated cells|vector or vector-treated cells
5452537|NCT01492036|Blood draw|blood draw
5452538|NCT01492036|Computed tomography|computed tomography
5452539|NCT01492036|CT|ct
5452540|NCT01492036|Questionnaires|questionnaires
5452541|NCT01492036|Surveys|surveys
5452542|NCT01492036|Gene Transfer Research|gene transfer research
5452543|NCT01492036|National Gene Vector Biorepository and Coordinating Center|national gene vector biorepository and coordinating center
5452544|NCT01492036|NGVB|ngvb
5452545|NCT01492023|neuropsychological|neuropsychological
5452546|NCT01492023|rehabilitation|rehabilitation
5452547|NCT01492023|multiple sclerosis|multiple sclerosis
5452548|NCT01492023|RCT study|rct study
5452554|NCT01491958|Leukemia|leukemia
5452555|NCT01491958|AML|aml
5452556|NCT01491958|ALL|all
5452557|NCT01491958|MDS|mds
5452558|NCT01491945|Abdominal aortic aneurysm|abdominal aortic aneurysm
5452559|NCT01491945|Renal stent|renal stent
5452560|NCT01491945|Juxtarenal|juxtarenal
5452561|NCT01491945|Pararenal|pararenal
5452562|NCT01491945|Endovascular|endovascular
5452563|NCT01491932|Parkinson Disease|parkinson disease
5452564|NCT01491932|L-dopa|l-dopa
5452565|NCT01491932|Levodopa|levodopa
5452566|NCT01491932|Dyskinesia|dyskinesia
5452567|NCT01491919|High Blood Pressure|high blood pressure
5452568|NCT01491919|Hypertension|hypertension
5452569|NCT01491919|Renal Transplantation|renal transplantation
5452570|NCT01491919|Kidney Transplantation|kidney transplantation
5452571|NCT01491893|GBM|gbm
5452572|NCT01491893|Brain Tumor|brain tumor
5452573|NCT01491893|Poliovirus Vaccine|poliovirus vaccine
5452574|NCT01491893|WHO Grade IV Malignant Glioma|who grade iv malignant glioma
5447296|NCT01513993|CHF|chf
5452575|NCT01491880|cognitive behavior therapy|cognitive behavior therapy
5452576|NCT01491880|telemedicine|telemedicine
5452577|NCT01491880|rural|rural
5452578|NCT01491880|Latinos|latinos
5452579|NCT01491880|children|children
5452580|NCT01491867|intraocular pressure|intraocular pressure
5452581|NCT01491854|Long-term|long-term
5452582|NCT01491854|safety|safety
5452583|NCT01491854|follow-up|follow-up
5452584|NCT01491854|growth hormone treatment|growth hormone treatment
5452585|NCT01491854|short children|short children
5452586|NCT01491854|Small for Gestational Age|small for gestational age
5452587|NCT01491854|Somatropin|somatropin
5452588|NCT01491828|Apnea|apnea
5452589|NCT01491828|Sleep apnea|sleep apnea
5452590|NCT01491828|Snoring|snoring
5452591|NCT01491828|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
5452592|NCT01491828|Laynx stimulation|laynx stimulation
5452593|NCT01491802|COPD|copd
5452594|NCT01491802|Combination therapy|combination therapy
5452595|NCT01491802|Anticholinergic|anticholinergic
5452596|NCT01491802|Beta2-agonist|beta2-agonist
5452597|NCT01491802|Exercise|exercise
5452599|NCT01491802|Respiratory mechanics|respiratory mechanics
5452603|NCT01491776|Group A Streptococcus|group a streptococcus
5452604|NCT01491776|Strep A|strep a
5452605|NCT01491776|Rapid Test|rapid test
5452606|NCT01491776|Pharyngitis|pharyngitis
5452607|NCT01491750|SURGERY|surgery
5452608|NCT01491750|TOTAL JOINT REPLACEMENT|total joint replacement
5452609|NCT01491750|TOTAL KNEE REPLACEMENT|total knee replacement
5452610|NCT01491750|GUIDED IMAGERY|guided imagery
5452611|NCT01491750|COMPLEMENTARY AND ALTERNATIVE THERAPY|complementary and alternative therapy
5452612|NCT01491711|Superficial basal cell carcinoma|superficial basal cell carcinoma
5452613|NCT01491711|Carcinoma, Basal Cell|carcinoma, basal cell
5452614|NCT01491711|Skin diseases|skin diseases
5452615|NCT01491711|Connective tissue diseases|connective tissue diseases
5452616|NCT01491711|Treatment|treatment
5452617|NCT01491711|Drug therapy|drug therapy
5452618|NCT01491711|Efficacy|efficacy
5452619|NCT01491711|Photodynamic therapy|photodynamic therapy
5452620|NCT01491711|Photosensitizing Agents/therapeutic use|photosensitizing agents/therapeutic use
5452621|NCT01491711|Aminolevulinic acid|aminolevulinic acid
5452622|NCT01491711|Methylaminolevulinate|methylaminolevulinate
5452623|NCT01491711|Pain measurement|pain measurement
5452624|NCT01491711|Health Care Economics and Organizations|health care economics and organizations
5452625|NCT01491698|stomach|stomach
5452626|NCT01491698|surgery|surgery
5452627|NCT01491698|Total Gastrectomy|total gastrectomy
5452628|NCT01491698|Roux-En-Y Pouch Reconstruction|roux-en-y pouch reconstruction
5452629|NCT01491698|Conventional Roux-En-Y Reconstruction|conventional roux-en-y reconstruction
5452630|NCT01491698|Quality of Life|quality of life
5452631|NCT01491698|11-170|11-170
5452632|NCT01491672|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5452633|NCT01491672|Second Line|second line
5452634|NCT01491672|Everolimus|everolimus
5452635|NCT01491672|RAD001|rad001
5452636|NCT01491646|pulmonary hypertension|pulmonary hypertension
5452637|NCT01491646|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5685520|NCT00555763|applanation tonometry|applanation tonometry
5452638|NCT01491646|Characterize and quantify RV vortex flow|characterize and quantify rv vortex flow
5452639|NCT01491646|Assess feasibility of cardiac MR for RVDD diagnosis|assess feasibility of cardiac mr for rvdd diagnosis
5452640|NCT01491646|Biomarker information to help diagnose|biomarker information to help diagnose
5452641|NCT01491633|Lung cancer|lung cancer
5452642|NCT01491633|NSCLC|nsclc
5452643|NCT01491633|Stage IIIB|stage iiib
5452644|NCT01491633|Stage IV|stage iv
5452645|NCT01491620|poikiloderma of Civatte|poikiloderma of civatte
5452646|NCT01491620|red dyschromia|red dyschromia
5452647|NCT01491620|brown dyschromia|brown dyschromia
5452648|NCT01491620|sun damage|sun damage
5452649|NCT01491620|neck|neck
5452650|NCT01491620|chest|chest
5452651|NCT01491620|dyschromia|dyschromia
5452652|NCT01491620|pigmentation disorders|pigmentation disorders
5452653|NCT01491620|erythema|erythema
5452654|NCT01491620|photosensitivity disorders|photosensitivity disorders
5452655|NCT01491620|sun exposure|sun exposure
5452656|NCT01491620|telangiectasia|telangiectasia
5452657|NCT01491620|hyperpigmentation|hyperpigmentation
5452658|NCT01491620|hypopigmentation|hypopigmentation
5452659|NCT01491607|post-exposure prophylaxis|post-exposure prophylaxis
5452660|NCT01491607|toxin neutralization assay|toxin neutralization assay
5452661|NCT01491594|Metastatic sarcoma|metastatic sarcoma
5452662|NCT01491594|Bone sarcoma|bone sarcoma
5452663|NCT01491581|anthropometry|anthropometry
5452664|NCT01491581|zinc|zinc
5452665|NCT01491581|iodine|iodine
5452666|NCT01491581|vitamin D|vitamin d
5452667|NCT01491581|calcium|calcium
5452668|NCT01491581|school children|school children
5452669|NCT01491581|food supplement|food supplement
5452670|NCT01491568|symptomatic degenerative disc disease at two levels|symptomatic degenerative disc disease at two levels
5452671|NCT01491555|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5452672|NCT01491555|DMD|dmd
5452673|NCT01491555|controls|controls
5452675|NCT01491555|QUS|qus
5452676|NCT01491542|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
5452677|NCT01491529|Parkinson Disease|parkinson disease
5452678|NCT01491529|L-dopa|l-dopa
5452680|NCT01491529|Dyskinesia|dyskinesia
5452681|NCT01491529|Amantadine|amantadine
5452682|NCT01491516|Lumbar degenerative disc disease|lumbar degenerative disc disease
5452683|NCT01491503|montelukast|montelukast
5452684|NCT01491503|levocetirizine|levocetirizine
5452685|NCT01491503|interaction|interaction
5452686|NCT01491490|Schizophrenia|schizophrenia
5452687|NCT01491490|Functional psychosis|functional psychosis
5452688|NCT01491490|Schizophreniform|schizophreniform
5452689|NCT01491490|Acute psychosis|acute psychosis
5452690|NCT01491464|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5452691|NCT01491451|Degenerative lumbar disc disease|degenerative lumbar disc disease
5452692|NCT01491425|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5452693|NCT01491412|Schizophrenia|schizophrenia
5452694|NCT01491412|antipsychotics|antipsychotics
5452695|NCT01491412|real life treatment|real life treatment
5452696|NCT01491412|non-interventional|non-interventional
5452697|NCT01491386|symptomatic degenerative disc disease|symptomatic degenerative disc disease
5452698|NCT01491373|Degenerative Disc Disease|degenerative disc disease
5452699|NCT01491373|Symptomatic Degenerative Disc Disease|symptomatic degenerative disc disease
5452700|NCT01491360|Presbyopia|presbyopia
5452701|NCT01491360|sclera|sclera
5452702|NCT01491360|LaserACE|laserace
5452703|NCT01491347|BDNF|bdnf
5452704|NCT01491347|withdrawal|withdrawal
5452705|NCT01491347|alcohol|alcohol
5452706|NCT01491347|psychiatry|psychiatry
5452707|NCT01491334|POP|pop
5452708|NCT01491334|Pelvic Floor|pelvic floor
5452709|NCT01491334|Pelvic Organ Prolapse|pelvic organ prolapse
5452710|NCT01491321|chronic low back pain|chronic low back pain
5452711|NCT01491321|bee venom acupuncture|bee venom acupuncture
5452712|NCT01491295|Lamivudine|lamivudine
5452713|NCT01491295|adefovir add on treatment|adefovir add on treatment
5452714|NCT01491295|tenofovir|tenofovir
5452715|NCT01491295|chronic hepatitis B|chronic hepatitis b
5452716|NCT01491282|human brown adipose tissue activity|human brown adipose tissue activity
5452717|NCT01491282|obesity|obesity
5452718|NCT01491282|energy metabolism|energy metabolism
5452719|NCT01491282|adaptive thermogenesis|adaptive thermogenesis
5452720|NCT01491269|chronic pain|chronic pain
5452721|NCT01491269|internet delivered CBT|internet delivered cbt
5452722|NCT01491269|tertiary intervention|tertiary intervention
5452723|NCT01491269|mindfulness|mindfulness
5452724|NCT01491269|applied relaxation|applied relaxation
5452725|NCT01491269|guided self help|guided self help
5452726|NCT01491256|Index of microcirculatory resistance|index of microcirculatory resistance
5452727|NCT01491256|atorvastatin|atorvastatin
5452728|NCT01491256|drug-eluting stent|drug-eluting stent
5452729|NCT01491256|acute coronary syndrome|acute coronary syndrome
5452730|NCT01491243|contrast-induced nephropathy|contrast-induced nephropathy
5452731|NCT01491230|cancer|cancer
5452732|NCT01491230|neutrophil extracellular traps|neutrophil extracellular traps
5452733|NCT01491230|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5452734|NCT01491230|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5452735|NCT01491230|chemotaxis|chemotaxis
5452736|NCT01491230|superoxide production|superoxide production
5452737|NCT01491230|hydrogen peroxide production|hydrogen peroxide production
5452738|NCT01491230|myeloperoxidase|myeloperoxidase
5452739|NCT01491217|Oraxol®|oraxol®
5452740|NCT01491217|oral paclitaxel|oral paclitaxel
5452741|NCT01491217|paclitaxel|paclitaxel
5452742|NCT01491217|HM30181A|hm30181a
5452743|NCT01491217|MTD|mtd
5452744|NCT01491217|DLT|dlt
5452745|NCT01491217|RD|rd
5452746|NCT01491191|surgical pain|surgical pain
5452747|NCT01491191|chronic pain|chronic pain
5452748|NCT01491191|prevention|prevention
5452749|NCT01491191|palmitoylethanolamide|palmitoylethanolamide
5452750|NCT01491165|umbilical cord mesenchyma stem cell|umbilical cord mesenchyma stem cell
5452751|NCT01491152|Cerebral Palsy|cerebral palsy
5452752|NCT01491152|Whole Body Vibration|whole body vibration
5452753|NCT01491152|Infant|infant
5452754|NCT01491152|Motor development|motor development
5452755|NCT01491152|Physiotherapy|physiotherapy
5452756|NCT01491139|Radiotherapy|radiotherapy
5452757|NCT01491139|Biomarkers, pharmacological|biomarkers, pharmacological
5452758|NCT01491139|Pharmacokinetics|pharmacokinetics
5452759|NCT01491139|Genetic Markers|genetic markers
5452760|NCT01491139|Cisplatin|cisplatin
5452761|NCT01491139|Poly(ADP-ribose) Polymerases|poly(adp-ribose) polymerases
5452762|NCT01491139|AZD 2281|azd 2281
5680276|NCT00578383|Major depression|major depression
5452763|NCT01491139|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
5452764|NCT01491139|Head and Neck|head and neck
5452765|NCT01491139|Chemoradiotherapy|chemoradiotherapy
5452766|NCT01491139|SCC|scc
5452767|NCT01491126|Gastroscopy|gastroscopy
5452768|NCT01491126|Colonoscopy|colonoscopy
5452769|NCT01491126|Anesthesia|anesthesia
5452770|NCT01491126|Recovery|recovery
5452771|NCT01491113|Levetiracetam|levetiracetam
5452772|NCT01491113|Oral administration|oral administration
5452773|NCT01491113|Japanese|japanese
5452774|NCT01491113|Non-epileptic|non-epileptic
5452775|NCT01491113|Healthy|healthy
5452776|NCT01491113|Renal impaired subjects|renal impaired subjects
5452778|NCT01491100|Physical Activity|physical activity
5452779|NCT01491100|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5452780|NCT01491087|Pentaxim®|pentaxim®
5452781|NCT01491087|Whole-cell Pertussis vaccine|whole-cell pertussis vaccine
5452782|NCT01491087|Acellular Pertussis vaccine|acellular pertussis vaccine
5452783|NCT01491087|Haemophilus influenzae type b polysaccharide|haemophilus influenzae type b polysaccharide
5452784|NCT01491087|Inactivated Polio vaccine|inactivated polio vaccine
5452785|NCT01491087|Pentavac®|pentavac®
5452786|NCT01491061|periprocedural myocardial infarction|periprocedural myocardial infarction
5452787|NCT01491061|ranolazine|ranolazine
5452788|NCT01491048|Hip osteoarthritis|hip osteoarthritis
5452789|NCT01491048|Physiotherapy|physiotherapy
5452790|NCT01491048|THA|tha
5452791|NCT01491035|Children|children
5452792|NCT01491035|Adolescents|adolescents
5452793|NCT01491035|Pharmacokinetic|pharmacokinetic
5452794|NCT01491035|Pharmacodynamic|pharmacodynamic
5452795|NCT01491022|parkinson's|parkinson's
5452796|NCT01491022|gait dysfunction|gait dysfunction
5452797|NCT01491022|ampyra|ampyra
5452798|NCT01491022|4-aminopyridine|4-aminopyridine
5452799|NCT01491009|Dexmedetomidine|dexmedetomidine
5452800|NCT01491009|midazolam|midazolam
5452801|NCT01491009|remifentanil|remifentanil
5452802|NCT01491009|mini-mental state examination|mini-mental state examination
5452803|NCT01491009|monitored anaesthesia care|monitored anaesthesia care
5452804|NCT01491009|cystoscopy|cystoscopy
5452805|NCT01491009|sedation|sedation
5452806|NCT01490996|Curcumin|curcumin
5452807|NCT01490996|Colorectal cancer|colorectal cancer
5452808|NCT01490996|metastases|metastases
5452809|NCT01490996|FOLFOX|folfox
5452810|NCT01490983|Chronic Myeloid Leukemia|chronic myeloid leukemia
5452811|NCT01490983|Chronic Phase CML|chronic phase cml
5452812|NCT01490970|Sarcoma Database|sarcoma database
5452818|NCT01490931|dental implant surgery|dental implant surgery
5452819|NCT01490918|Type-II diabetes mellitus|type-ii diabetes mellitus
5452820|NCT01490918|Acarbose|acarbose
5452821|NCT01490918|ACADEMIC|academic
5452822|NCT01490905|Medical food|medical food
5452823|NCT01490905|Theramine|theramine
5452824|NCT01490905|Ibuprofen|ibuprofen
5452825|NCT01490905|Amino acids|amino acids
5452826|NCT01490905|Convenience Pack Kit|convenience pack kit
5452832|NCT01490879|Diabetic Foot Ulcer|diabetic foot ulcer
5452833|NCT01490879|Ulcers|ulcers
5452834|NCT01490879|Foot Ulcers|foot ulcers
5452835|NCT01490879|chronic wound|chronic wound
5452836|NCT01490879|wounds|wounds
5452837|NCT01490879|Nexagon|nexagon
5452838|NCT01490879|CoDa|coda
5452839|NCT01490866|Colorectal Cancer|colorectal cancer
5452840|NCT01490866|Axitinib|axitinib
5452841|NCT01490866|FOLFOX/Bevacizumab|folfox/bevacizumab
5452842|NCT01490853|Ph pos CML|ph pos cml
5452843|NCT01490853|Philadelphia positive Chronic Myeloid Leukemia|philadelphia positive chronic myeloid leukemia
5452844|NCT01490840|Fatigue|fatigue
5452845|NCT01490840|MS|ms
5452846|NCT01490840|Multiple Sclerosis|multiple sclerosis
5452847|NCT01490840|Exercise|exercise
5452848|NCT01490840|Physical activity|physical activity
5452849|NCT01490840|Physical training|physical training
5452850|NCT01490840|Fingolimod|fingolimod
5452851|NCT01490814|PAF|paf
5452852|NCT01490814|two episodes within the last twelve months one episode documented|two episodes within the last twelve months one episode documented
5452853|NCT01490814|Documented treatment failure of at least one antiarrhythmic|documented treatment failure of at least one antiarrhythmic
5452854|NCT01490814|drug AAD Type I or III including β-blocker and AAD intolerance|drug aad type i or iii including β-blocker and aad intolerance
5452855|NCT01490801|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5452856|NCT01490801|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5452857|NCT01490801|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5452858|NCT01490801|Epstein-Barr virus infection|epstein-barr virus infection
5452859|NCT01490775|Chronic Myeloid Leukemia|chronic myeloid leukemia
5452860|NCT01490762|PK|pk
5452861|NCT01490762|PD|pd
5452862|NCT01490749|Esophageal Cancer|esophageal cancer
5452863|NCT01490749|Neoplasms, Esophageal|neoplasms, esophageal
5452864|NCT01490736|Acne|acne
5452865|NCT01490736|Sebum gland disease|sebum gland disease
5452866|NCT01490723|Leukemia|leukemia
5452867|NCT01490723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5452868|NCT01490723|Lymphoma|lymphoma
5452869|NCT01490723|CD20+ lymphoid malignancies|cd20+ lymphoid malignancies
5452870|NCT01490723|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5452871|NCT01490723|Allogeneic transplantation|allogeneic transplantation
5435541|NCT01564160|DHA|dha
5452872|NCT01490723|Rituximab|rituximab
5452874|NCT01490723|In ibritumomab|in ibritumomab
5452875|NCT01490723|Y ibritumomab|y ibritumomab
5452876|NCT01490723|Zevalin|zevalin
5452877|NCT01490723|Fludarabine Phosphate|fludarabine phosphate
5452878|NCT01490723|Fludara|fludara
5452879|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride
5452880|NCT01490723|Bendamustine HCL|bendamustine hcl
5452881|NCT01490723|CEP-18083|cep-18083
5452882|NCT01490723|SDX-105|sdx-105
5452883|NCT01490723|Treanda|treanda
5452884|NCT01490723|Stem Cell Transplantation|stem cell transplantation
5452885|NCT01490723|Planar Scintigraphy|planar scintigraphy
5452886|NCT01490723|Spect Scan|spect scan
5452887|NCT01490723|Single Photon Emission-Computed Tomography|single photon emission-computed tomography
5452888|NCT01490723|CT Scan|ct scan
5452889|NCT01490723|Computed Tomography|computed tomography
5452890|NCT01490723|G-CSF|g-csf
5452891|NCT01490723|Filgrastim|filgrastim
5452892|NCT01490723|Neupogen|neupogen
5452893|NCT01490723|Thymoglobulin|thymoglobulin
5452895|NCT01490723|Antithymocyte Globulin|antithymocyte globulin
5452896|NCT01490723|Methotrexate|methotrexate
5452897|NCT01490723|Mycophenolate|mycophenolate
5452898|NCT01490723|MMF|mmf
5452899|NCT01490723|Mycophenolate Mofetil|mycophenolate mofetil
5452900|NCT01490723|CellCept|cellcept
5452901|NCT01490723|Tacrolimus|tacrolimus
5452902|NCT01490723|Prograf|prograf
5452903|NCT01490710|NAVA|nava
5452904|NCT01490710|Hemodynamic|hemodynamic
5452905|NCT01490710|Cardiac Index|cardiac index
5452906|NCT01490710|Children with admission weight > 5kg|children with admission weight > 5kg
5452907|NCT01490697|stress disorders|stress disorders
5452908|NCT01490697|posttraumatic|posttraumatic
5452909|NCT01490697|memory|memory
5452910|NCT01490697|mifepristone|mifepristone
5452911|NCT01490697|d-cycloserine|d-cycloserine
5452912|NCT01490697|psychophysiology|psychophysiology
5452913|NCT01490684|candidiasis|candidiasis
5452914|NCT01490684|critically ill|critically ill
5452915|NCT01490684|outcomes|outcomes
5452916|NCT01490645|ACS patients participating in a SCP|acs patients participating in a scp
5452917|NCT01490645|QoL after ACS|qol after acs
5452918|NCT01490645|ASC Patients's needs|asc patients's needs
5452919|NCT01490632|Moderate|moderate
5452920|NCT01490632|Severe|severe
5452921|NCT01490632|Plaque|plaque
5452922|NCT01490632|Chronic|chronic
5452923|NCT01490619|Type 1 diabetes|type 1 diabetes
5452924|NCT01490619|Adolescent|adolescent
5452925|NCT01490619|Resilience|resilience
5452926|NCT01490619|Prevention|prevention
5452927|NCT01490619|Depression|depression
5452928|NCT01490593|Canadian|canadian
5452929|NCT01490593|Eye|eye
5452930|NCT01490593|Injury|injury
5452931|NCT01490593|Registry|registry
5452932|NCT01490580|Pain|pain
5452933|NCT01490580|Newborn|newborn
5452934|NCT01490580|Anaesthesia|anaesthesia
5452935|NCT01490580|opioids|opioids
5452936|NCT01490580|propofol|propofol
5452937|NCT01490580|neuromuscular blocker|neuromuscular blocker
5452938|NCT01490580|atropine|atropine
5452939|NCT01490567|Impaired Cognition Schizophrenia|impaired cognition schizophrenia
5452940|NCT01490554|Skin aging|skin aging
5452941|NCT01490554|fibroblasts|fibroblasts
5452942|NCT01490554|transplantation|transplantation
5452943|NCT01490554|autologous|autologous
5452944|NCT01490541|Gastric intestinal metaplasia|gastric intestinal metaplasia
5452945|NCT01490528|Pediatric IBD|pediatric ibd
5452946|NCT01490515|non-invasive,|non-invasive,
5452947|NCT01490515|metabolomics,|metabolomics,
5452948|NCT01490515|morphology,|morphology,
5452949|NCT01490515|embryo selection,|embryo selection,
5452950|NCT01490515|implantation rates|implantation rates
5452951|NCT01490489|EG-VEGF|eg-vegf
5452952|NCT01490489|Endocrine Gland-derived Vascular Endothelial Growth Factor|endocrine gland-derived vascular endothelial growth factor
5452953|NCT01490489|Pre-eclampsia|pre-eclampsia
5452954|NCT01490489|intra-uterine growth retardation|intra-uterine growth retardation
5452955|NCT01490489|prognosis|prognosis
5452956|NCT01490476|Neurofibromatosis Type 2 with Vestibular Schwannoma|neurofibromatosis type 2 with vestibular schwannoma
5452957|NCT01490476|Vestibular Schwannoma|vestibular schwannoma
5452958|NCT01490476|Peripheral Nervous System Diseases|peripheral nervous system diseases
5452959|NCT01490476|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5452960|NCT01490476|Vestibulocochlear Nerve Diseases|vestibulocochlear nerve diseases
5452961|NCT01490463|Treatment of|treatment of
5452962|NCT01490437|Advanced urothelial carcinoma|advanced urothelial carcinoma
5452963|NCT01490424|TREM-1;|trem-1;
5452964|NCT01490424|SNPs;|snps;
5452965|NCT01490424|prognosis|prognosis
5452966|NCT01490424|control（normal person）|control（normal person）
5452967|NCT01490411|Specific immunotherapy|specific immunotherapy
5452969|NCT01490411|SCIT|scit
5452970|NCT01490411|recombinant|recombinant
5452971|NCT01490398|Hypertension|hypertension
5452972|NCT01490398|Rosuvastatin|rosuvastatin
5452973|NCT01490398|Coronary flow reserve|coronary flow reserve
5452974|NCT01490359|human immunodeficiency virus|human immunodeficiency virus
5452975|NCT01490359|randomized controlled trial|randomized controlled trial
5452976|NCT01490359|intervention studies|intervention studies
5452977|NCT01490359|South Africa|south africa
5452978|NCT01490359|men|men
5452979|NCT01490359|sexually behavior|sexually behavior
5452980|NCT01490359|social cognitive theory|social cognitive theory
5452981|NCT01490346|HIV 1|hiv 1
5452982|NCT01490346|Pharmacokinetics|pharmacokinetics
5452983|NCT01490346|Drug levels|drug levels
5452984|NCT01490346|Treatment naive|treatment naive
5452985|NCT01490320|Violence prevention|violence prevention
5452986|NCT01490320|Media|media
5452987|NCT01490320|Primary care|primary care
5453002|NCT01490281|Fibromyalgia|fibromyalgia
5453003|NCT01490281|exercise|exercise
5453004|NCT01490281|physical activity|physical activity
5453005|NCT01490281|pain|pain
5671345|NCT00616460|efficacy|efficacy
5453006|NCT01490268|Pharmacokinetic-pharmacodynamic modeling|pharmacokinetic-pharmacodynamic modeling
5453007|NCT01490268|Patient-controlled analgesia|patient-controlled analgesia
5453008|NCT01490268|Target-controlled infusion|target-controlled infusion
5453009|NCT01490268|Hydromorphone|hydromorphone
5453010|NCT01490268|Sufentanil|sufentanil
5453011|NCT01490268|after thoracotomy|after thoracotomy
5453012|NCT01490268|cardiac surgery|cardiac surgery
5453013|NCT01490255|platelet reactivity|platelet reactivity
5453014|NCT01490255|aspirin|aspirin
5453015|NCT01490255|clopidogrel|clopidogrel
5453016|NCT01490229|nutraceuticals|nutraceuticals
5453017|NCT01490229|statin|statin
5453018|NCT01490216|cocaine|cocaine
5453019|NCT01490216|lisdexamfetamine|lisdexamfetamine
5453020|NCT01490216|vyvanse|vyvanse
5453021|NCT01490203|Gd-EOB-DTPA|gd-eob-dtpa
5453023|NCT01490203|Hepatectomy|hepatectomy
5453024|NCT01490203|Hepatocellular Carcinoma|hepatocellular carcinoma
5453025|NCT01490203|Liver Function Tests|liver function tests
5453026|NCT01490177|Multiple food allergies|multiple food allergies
5453027|NCT01490151|Hormone|hormone
5453028|NCT01490151|Diabetes|diabetes
5453029|NCT01490151|Mellitus|mellitus
5453030|NCT01490151|Type 1|type 1
5453031|NCT01490151|Immune|immune
5453032|NCT01490151|Metabolic disorder|metabolic disorder
5453033|NCT01490138|β-D-Glucan test|β-d-glucan test
5453035|NCT01490125|COPD|copd
5453036|NCT01490125|Dyspnea|dyspnea
5453037|NCT01490125|QVA149|qva149
5453038|NCT01490125|tiotropium|tiotropium
5453039|NCT01490073|Intrauterine device|intrauterine device
5453040|NCT01490073|Pain|pain
5453041|NCT01490073|Contraception|contraception
5453042|NCT01490073|Nitroglycerin|nitroglycerin
5453043|NCT01490073|Nitric oxide donor|nitric oxide donor
5453044|NCT01490073|Intrauterine device insertion|intrauterine device insertion
5453045|NCT01490060|cancer|cancer
5453046|NCT01490060|fosaprepitant|fosaprepitant
5453047|NCT01490060|Ifosfamide-based Multi-day Chemotherapy|ifosfamide-based multi-day chemotherapy
5453048|NCT01490060|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5453049|NCT01490060|CINV|cinv
5453050|NCT01490060|multi-day chemotherapy regimens|multi-day chemotherapy regimens
5453051|NCT01490060|antiemetics|antiemetics
5453052|NCT01490060|adverse effect|adverse effect
5453053|NCT01490060|doxorubicin plus ifosfamide|doxorubicin plus ifosfamide
5453054|NCT01490060|AI|ai
5453055|NCT01490060|AI and vincristine|ai and vincristine
5453056|NCT01490060|VAI|vai
5453057|NCT01490060|aprepitant|aprepitant
5453058|NCT01490060|prevention|prevention
5453059|NCT01490060|nausea|nausea
5453060|NCT01490060|vomiting|vomiting
5453061|NCT01490060|emetogenic chemotherapy|emetogenic chemotherapy
5453062|NCT01490034|obesity|obesity
5453063|NCT01490034|energy intake|energy intake
5453064|NCT01490034|appetite|appetite
5453065|NCT01490034|food form|food form
5453066|NCT01490034|beverage|beverage
5453067|NCT01490034|learning|learning
5453068|NCT01490034|dietary compensation|dietary compensation
5453069|NCT01490021|Healthy young men|healthy young men
5453070|NCT01489995|Food effect|food effect
5453071|NCT01489995|GR181413A|gr181413a
5453072|NCT01489995|AT1001|at1001
5453073|NCT01489995|migalastat hydrochloride|migalastat hydrochloride
5453074|NCT01489995|Lysosomal storage disorders|lysosomal storage disorders
5453075|NCT01489995|Pharmacokinetics|pharmacokinetics
5453076|NCT01489982|Parkinson's disease|parkinson's disease
5453078|NCT01489969|sleep latency|sleep latency
5453079|NCT01489969|Sleep maintenance|sleep maintenance
5453080|NCT01489969|Sleep fragmentation|sleep fragmentation
5453081|NCT01489969|Polysomnography|polysomnography
5453082|NCT01489956|Keyhole Limpet Hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
5453083|NCT01489956|Immucothel|immucothel
5453084|NCT01489956|Native KLH|native klh
5453085|NCT01489956|Healthy volunteers|healthy volunteers
5453086|NCT01489956|Oral tolerance|oral tolerance
5453087|NCT01489956|Immunogenicity|immunogenicity
5453088|NCT01489956|Autoimmune diseases|autoimmune diseases
5453089|NCT01489930|Exercise|exercise
5453090|NCT01489930|Aging|aging
5453091|NCT01489930|Sarcopenia|sarcopenia
5453092|NCT01489930|Mitochondria|mitochondria
5453093|NCT01489917|radial artery occlusion|radial artery occlusion
5453094|NCT01489917|hemostasis|hemostasis
5453095|NCT01489917|coronary intervention|coronary intervention
5453096|NCT01489917|radial approach|radial approach
5453097|NCT01489904|drooling|drooling
5846726|NCT00043654|BPD|bpd
5453098|NCT01489904|cerebral palsy|cerebral palsy
5453099|NCT01489891|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5453100|NCT01489891|Lidocaine|lidocaine
5453101|NCT01489891|Propofol|propofol
5453102|NCT01489878|Coagulase-negative staphylococci|coagulase-negative staphylococci
5453103|NCT01489878|Staphylococcus epidermidis|staphylococcus epidermidis
5453104|NCT01489878|Staphylococcus aureus|staphylococcus aureus
5453105|NCT01489878|Anti-bacterial agents|anti-bacterial agents
5453106|NCT01489878|Drug resistance, Microbial|drug resistance, microbial
5453107|NCT01489878|Methicillin resistance|methicillin resistance
5453108|NCT01489878|Β-lactams|β-lactams
5453109|NCT01489878|Fluoroquinolones|fluoroquinolones
5453110|NCT01489878|Macrolides|macrolides
5453111|NCT01489878|Synergistin|synergistin
5453112|NCT01489878|General practitioners|general practitioners
5453113|NCT01489878|Antibiotic selection pressure|antibiotic selection pressure
5453114|NCT01489878|Ambulatory antibiotherapy|ambulatory antibiotherapy
5453115|NCT01489878|Community patients|community patients
5453116|NCT01489865|Pancreas cancer|pancreas cancer
5453117|NCT01489865|Veliparib|veliparib
5453118|NCT01489865|oxaliplatin|oxaliplatin
5453119|NCT01489852|Assisted reproductive treatment|assisted reproductive treatment
5453219|NCT01489345|ONO-2952|ono-2952
5453120|NCT01489852|GnRH antagonist|gnrh antagonist
5453121|NCT01489852|Estrogen pre-treatment|estrogen pre-treatment
5453122|NCT01489852|Ovarian stimulation|ovarian stimulation
5453123|NCT01489839|periodontal disease|periodontal disease
5453124|NCT01489839|biomarkers|biomarkers
5453125|NCT01489839|periodontal treatment|periodontal treatment
5453126|NCT01489839|clinical attachment level|clinical attachment level
5453128|NCT01489800|feeding|feeding
5453129|NCT01489800|complications|complications
5453130|NCT01489800|radical cystectomy|radical cystectomy
5453131|NCT01489787|Surgery|surgery
5453132|NCT01489787|Ultrasonic therapy|ultrasonic therapy
5453133|NCT01489787|Liver|liver
5453134|NCT01489761|long lesions|long lesions
5453135|NCT01489761|drug eluting stents|drug eluting stents
5453136|NCT01489735|GERD|gerd
5453137|NCT01489735|GERD Q QUESTIONNAIRE|gerd q questionnaire
5453138|NCT01489722|Leukemia|leukemia
5453139|NCT01489722|AML|aml
5453140|NCT01489722|AZD1208|azd1208
5453141|NCT01489709|overactive bladder|overactive bladder
5453142|NCT01489709|solifenacin|solifenacin
5453143|NCT01489709|Overactive bladder questionnaire|overactive bladder questionnaire
5453144|NCT01489709|Overactive Bladder Symptom Score|overactive bladder symptom score
5453145|NCT01489709|satisfaction score|satisfaction score
5453146|NCT01489696|Pharmacokinetics|pharmacokinetics
5453147|NCT01489696|Mirabegron|mirabegron
5453148|NCT01489696|Tamsulosin|tamsulosin
5453149|NCT01489696|Phase 1|phase 1
5453150|NCT01489683|intubating conditions|intubating conditions
5453151|NCT01489683|propofol|propofol
5453152|NCT01489683|remifentanil|remifentanil
5453153|NCT01489683|topical lidocaine|topical lidocaine
5453154|NCT01489657|Obesity|obesity
5453155|NCT01489657|Bariatric Surgery|bariatric surgery
5453156|NCT01489657|Sleeve Gastrectomy|sleeve gastrectomy
5453157|NCT01489657|Metabolite Profiling|metabolite profiling
5453158|NCT01489631|Epidural|epidural
5453159|NCT01489631|Local infiltration|local infiltration
5453160|NCT01489631|Knee|knee
5453161|NCT01489631|Arthroplasty|arthroplasty
5453162|NCT01489618|Common variable immunodeficiency|common variable immunodeficiency
5453163|NCT01489618|pneumococcal vaccine|pneumococcal vaccine
5453164|NCT01489618|prime boost|prime boost
5453165|NCT01489605|Orotracheal intubation, videolaryngoscopy|orotracheal intubation, videolaryngoscopy
5453166|NCT01489566|Hepatocellular,Carcinoma,recurrence|hepatocellular,carcinoma,recurrence
5453167|NCT01489553|Egg hypersensitivity|egg hypersensitivity
5453168|NCT01489553|egg allergy|egg allergy
5453169|NCT01489553|egg protein allergy|egg protein allergy
5453170|NCT01489540|Burn|burn
5453171|NCT01489540|Depth|depth
5453172|NCT01489540|Diagnosis|diagnosis
5453173|NCT01489540|Laser Doppler Imaging|laser doppler imaging
5453174|NCT01489527|Vaccine|vaccine
5453175|NCT01489527|Placebo|placebo
5453176|NCT01489527|sexually transmitted infection (STI)|sexually transmitted infection (sti)
5453178|NCT01489527|Human Immunodeficiency|human immunodeficiency
5453179|NCT01489527|Gardasil|gardasil
5453180|NCT01489527|HPV|hpv
5453181|NCT01489527|human papillomavirus|human papillomavirus
5453182|NCT01489514|peanut allergy|peanut allergy
5453183|NCT01489514|hypoallergenic peanut extracts|hypoallergenic peanut extracts
5453184|NCT01489514|epicutaneous skin prick testing|epicutaneous skin prick testing
5453185|NCT01489501|Caomecs, Transplantation, Limbal stem cell deficiency,|caomecs, transplantation, limbal stem cell deficiency,
5453186|NCT01489488|Relative bioavailability study|relative bioavailability study
5453187|NCT01489475|children|children
5453188|NCT01489475|congenital heart defects|congenital heart defects
5453189|NCT01489475|cardiopulmonary bypass|cardiopulmonary bypass
5453190|NCT01489475|modified ultrafiltration|modified ultrafiltration
5453191|NCT01489475|angiopoietins|angiopoietins
5453192|NCT01489475|cytokines|cytokines
5453193|NCT01489462|Arthritis|arthritis
5453194|NCT01489462|Osteoarthritis|osteoarthritis
5453195|NCT01489462|Strength Training|strength training
5435815|NCT01562899|KRAS|kras
5453196|NCT01489449|drug coated balloon|drug coated balloon
5453197|NCT01489449|NSTEMI|nstemi
5453198|NCT01489436|gallstone disease|gallstone disease
5453199|NCT01489436|cholecystectomy|cholecystectomy
5453200|NCT01489436|minimally invasive|minimally invasive
5453201|NCT01489436|surgical|surgical
5453202|NCT01489436|laparoscopic|laparoscopic
5453203|NCT01489436|single port|single port
5453204|NCT01489436|cytokine|cytokine
5453205|NCT01489423|stage IIIC melanoma|stage iiic melanoma
5453206|NCT01489423|stage IV melanoma|stage iv melanoma
5453207|NCT01489423|recurrent melanoma|recurrent melanoma
5453208|NCT01489397|Confocol laser endomicroscopy|confocol laser endomicroscopy
5671346|NCT00616421|vaccine|vaccine
5453209|NCT01489397|Feasibility of Confocol laser endomicroscopy|feasibility of confocol laser endomicroscopy
5453210|NCT01489384|Rheumatoid arthritis|rheumatoid arthritis
5453211|NCT01489384|DAS28|das28
5453212|NCT01489358|Vaccine-Mediated Protection|vaccine-mediated protection
5453213|NCT01489358|Antibody Response|antibody response
5453214|NCT01489358|Chikungunya Virus|chikungunya virus
5453215|NCT01489358|Immune Response|immune response
5453216|NCT01489358|Healthy Volunteer|healthy volunteer
5453217|NCT01489358|Humoral Inmunity|humoral inmunity
5453218|NCT01489358|Virus-like Particles|virus-like particles
5453220|NCT01489345|Healthy adult subjects|healthy adult subjects
5453221|NCT01489345|Multiple dose|multiple dose
5453223|NCT01489345|Tolerability|tolerability
5453224|NCT01489345|Pharmacokinetics|pharmacokinetics
5453225|NCT01489332|rectal cancer|rectal cancer
5453226|NCT01489332|capecitabine|capecitabine
5453227|NCT01489332|radiotherapy|radiotherapy
5453228|NCT01489332|locally advanced rectal cancer|locally advanced rectal cancer
5453229|NCT01489319|inflammation|inflammation
5453230|NCT01489319|body composition|body composition
5453231|NCT01489319|hyperandrogenism|hyperandrogenism
5453232|NCT01489319|insulin resistance|insulin resistance
5453233|NCT01489306|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5453234|NCT01489306|RSV|rsv
5453235|NCT01489280|Temple Touch Pro|temple touch pro
5453236|NCT01489280|Medisim|medisim
5453237|NCT01489280|temperature|temperature
5453238|NCT01489280|surgery|surgery
5453239|NCT01489267|cerebellar ataxia|cerebellar ataxia
5453240|NCT01489267|hereditary disease|hereditary disease
5453241|NCT01489267|stem cell|stem cell
5453242|NCT01489254|Multiple Sclerosis,|multiple sclerosis,
5453243|NCT01489254|Relapsing-Remitting Multiple Sclerosis,|relapsing-remitting multiple sclerosis,
5453244|NCT01489254|glatiramer acetate,|glatiramer acetate,
5453245|NCT01489254|MRI,|mri,
5453246|NCT01489254|lesions,|lesions,
5453247|NCT01489254|MS relapse rate,|ms relapse rate,
5453248|NCT01489254|Copaxone|copaxone
5453249|NCT01489241|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5453250|NCT01489241|Telemedicine|telemedicine
5453251|NCT01489228|Chagas Disease|chagas disease
5453252|NCT01489202|drug-eluting stent|drug-eluting stent
5453253|NCT01489202|percutaneous coronary intervention|percutaneous coronary intervention
5453254|NCT01489176|Stress Echocardiography|stress echocardiography
5453255|NCT01489176|Real-Time Perfusion Imaging|real-time perfusion imaging
5453256|NCT01489176|Regadenoson|regadenoson
5453257|NCT01489176|Optison|optison
5453258|NCT01489163|Gestational Diabetes|gestational diabetes
5453259|NCT01489163|Weight Loss|weight loss
5453260|NCT01489163|Physical Activity|physical activity
5453261|NCT01489163|Pregnancy|pregnancy
5453262|NCT01489163|Postpartum|postpartum
5453263|NCT01489163|Intervention|intervention
5453264|NCT01489150|Acute respiratory failure|acute respiratory failure
5453265|NCT01489150|Hypercapnia|hypercapnia
5453266|NCT01489150|Non invasive ventilation|non invasive ventilation
5453267|NCT01489150|End-tidal CO2|end-tidal co2
5453268|NCT01489124|Infection|infection
5453269|NCT01489124|Imipenem|imipenem
5453270|NCT01489124|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5453271|NCT01489124|pharmacokinetic|pharmacokinetic
5453272|NCT01489124|pharmacodynamic|pharmacodynamic
5453273|NCT01489098|Body composition|body composition
5453274|NCT01489098|Protein Metabolism|protein metabolism
5447986|NCT01511250|Placebo|placebo
5453275|NCT01489085|ventilation|ventilation
5453276|NCT01489085|automated|automated
5453277|NCT01489033|Allergic rhinitis|allergic rhinitis
5453278|NCT01489033|Phleum pratense|phleum pratense
5453279|NCT01489033|Timothy grass pollen allergy|timothy grass pollen allergy
5453280|NCT01489033|subcutaneous immunotherapy|subcutaneous immunotherapy
5453281|NCT01489020|Allergy|allergy
5453282|NCT01489020|Immunotherapy|immunotherapy
5453283|NCT01489020|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5453284|NCT01489020|D. pteronyssinus|d. pteronyssinus
5453285|NCT01489020|house dust allergy|house dust allergy
5453286|NCT01489007|vegetarian|vegetarian
5453287|NCT01489007|children|children
5453288|NCT01489007|iron|iron
5453289|NCT01489007|iron absorption|iron absorption
5453290|NCT01488981|Radio Frequency Microstimulator|radio frequency microstimulator
5435915|NCT01562301|carboplatin|carboplatin
5453291|NCT01488981|Traumatic Brain Injury|traumatic brain injury
5453293|NCT01488981|Arm Rehabilitation|arm rehabilitation
5453294|NCT01488981|electrical stimulation|electrical stimulation
5453296|NCT01488968|high risk prostate cancer|high risk prostate cancer
5453297|NCT01488968|hypofractionated radiation treatment|hypofractionated radiation treatment
5453298|NCT01488968|higher biological doses|higher biological doses
5453299|NCT01488968|acceptable rectal toxicity|acceptable rectal toxicity
5453300|NCT01488968|Radiation Treatment|radiation treatment
5453301|NCT01488955|bacterial infection|bacterial infection
5453302|NCT01488942|HIV|hiv
5453303|NCT01488942|reinforcement|reinforcement
5453304|NCT01488942|medication adherence|medication adherence
5453305|NCT01488942|patient compliance|patient compliance
5453306|NCT01488942|antiretroviral therapy, highly active|antiretroviral therapy, highly active
5453307|NCT01488916|Vitamin D|vitamin d
5453308|NCT01488916|Postprandial Glucose|postprandial glucose
5453309|NCT01488916|Type 2 Diabetes|type 2 diabetes
5453310|NCT01488903|genetic susceptibility|genetic susceptibility
5453311|NCT01488903|obesity|obesity
5453312|NCT01488903|body composition|body composition
5453313|NCT01488903|the metabolic syndrome|the metabolic syndrome
5453314|NCT01488903|women|women
5453315|NCT01488890|Dengue fever|dengue fever
5453316|NCT01488890|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5453317|NCT01488890|CYD dengue vaccine|cyd dengue vaccine
5453318|NCT01488890|Yellow Fever|yellow fever
5453319|NCT01488890|Flavivirus|flavivirus
5453320|NCT01488877|Type 2 diabetes mellitus. albuminuria.|type 2 diabetes mellitus. albuminuria.
5453321|NCT01488864|Hot flashes|hot flashes
5453322|NCT01488864|Vasomotor symptoms|vasomotor symptoms
5453323|NCT01488864|Menopause|menopause
5453324|NCT01488864|Applied Relaxation|applied relaxation
5453325|NCT01488864|Health Related Quality of Life|health related quality of life
5453326|NCT01488864|Salivary cortisol|salivary cortisol
5453327|NCT01488851|Osteo necrosis of the Jaw|osteo necrosis of the jaw
5453328|NCT01488812|Hip-fracture|hip-fracture
5453329|NCT01488799|Anxiety|anxiety
5453330|NCT01488799|Generalized Anxiety Disorder|generalized anxiety disorder
5453331|NCT01488799|Motivational Interviewing|motivational interviewing
5453332|NCT01488799|Cognitive Behavioural Therapy|cognitive behavioural therapy
5453333|NCT01488799|Psychotherapy|psychotherapy
5453334|NCT01488786|Assistive Technology|assistive technology
5453335|NCT01488786|Non-Surgical Visual Prosthetic|non-surgical visual prosthetic
5453336|NCT01488786|Sensory Substitution|sensory substitution
5453337|NCT01488773|asthma|asthma
5453338|NCT01488773|asthma control|asthma control
5453339|NCT01488773|inhaled glucocorticosteroid|inhaled glucocorticosteroid
5453340|NCT01488773|ICS|ics
5453341|NCT01488773|leukotriene antagonist|leukotriene antagonist
5453342|NCT01488773|LTRA|ltra
5453343|NCT01488773|montelukast|montelukast
5453344|NCT01488773|fluticasone|fluticasone
5453345|NCT01488773|salmeterol|salmeterol
5453346|NCT01488773|observational study|observational study
5453347|NCT01488773|repeated measures|repeated measures
5453348|NCT01488773|retrospective|retrospective
5453349|NCT01488747|Omega-3 fatty acids|omega-3 fatty acids
5453350|NCT01488747|Phospholipid fatty acids|phospholipid fatty acids
5453351|NCT01488747|chymlomicron fatty acids|chymlomicron fatty acids
5685521|NCT00555763|Tonometry, Ocular|tonometry, ocular
5685522|NCT00555750|sleep|sleep
5453352|NCT01488747|Bioavailability fo fish oil supplements in healthy adults|bioavailability fo fish oil supplements in healthy adults
5453353|NCT01488734|Vitamin D|vitamin d
5453354|NCT01488734|Mushroom|mushroom
5453355|NCT01488734|Cholecalciferol|cholecalciferol
5453356|NCT01488734|Prediabetes|prediabetes
5453357|NCT01488734|Metabolic Syndrome|metabolic syndrome
5453358|NCT01488708|Lupus|lupus
5453359|NCT01488708|SLE|sle
5453360|NCT01488708|Systemic Lupus Erythematosus|systemic lupus erythematosus
5453361|NCT01488708|Immune System Disease|immune system disease
5453362|NCT01488695|intubation|intubation
5453363|NCT01488695|double lumen tube|double lumen tube
5453364|NCT01488682|Head and neck cancer|head and neck cancer
5453365|NCT01488682|Neck dissection|neck dissection
5453366|NCT01488682|Harmonic scalpel|harmonic scalpel
5453367|NCT01488669|head and neck neoplasms|head and neck neoplasms
5453368|NCT01488669|neck dissection|neck dissection
5453369|NCT01488669|robotics|robotics
5453370|NCT01488656|Antioxidants|antioxidants
5453371|NCT01488656|Dietary supplements|dietary supplements
5453372|NCT01488656|Forced vital lung capacity|forced vital lung capacity
5453379|NCT01488630|alcohol|alcohol
5453380|NCT01488630|drug|drug
5453381|NCT01488630|smoking|smoking
5453382|NCT01488630|HIV screening|hiv screening
5453383|NCT01488617|Surgery|surgery
5453384|NCT01488617|Psychosocial Factors|psychosocial factors
5453385|NCT01488617|Psychological Distress|psychological distress
5453386|NCT01488617|Outcome Assessment (Health Care)|outcome assessment (health care)
5453395|NCT01488552|Stage IV pancreatic cancer|stage iv pancreatic cancer
5453396|NCT01488552|pancreas|pancreas
5453397|NCT01488552|pancreatic|pancreatic
5453398|NCT01488539|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5453399|NCT01488539|PTSD|ptsd
5453400|NCT01488539|Adult Survivors of Child Abuse|adult survivors of child abuse
5453401|NCT01488539|Women|women
5453402|NCT01488539|Interpersonal violence|interpersonal violence
5453403|NCT01488539|psychological trauma|psychological trauma
5453404|NCT01488526|Hepatitis B|hepatitis b
5453405|NCT01488526|Vertical transmission|vertical transmission
5453406|NCT01488526|Pregnancy|pregnancy
5453407|NCT01488526|Antiviral treatment|antiviral treatment
5453408|NCT01488513|ABC294640|abc294640
5453409|NCT01488513|RedHill Biopharma, Ltd.|redhill biopharma, ltd.
5453410|NCT01488513|ABC-101|abc-101
5453411|NCT01488513|Medical University of South Carolina|medical university of south carolina
5453412|NCT01488513|Apogee Biotechnology Corporation|apogee biotechnology corporation
5453413|NCT01488500|Wood smoke|wood smoke
5453414|NCT01488500|inflammation|inflammation
5453415|NCT01488500|lung function|lung function
5453416|NCT01488500|arterial stiffness|arterial stiffness
5453682|NCT01487603|Patients|patients
5453417|NCT01488500|heart rate variability|heart rate variability
5453418|NCT01488500|Respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers|respiratory and systemic inflammation following exposure to woodsmoke in healthy volunteers
5453419|NCT01488487|HCC|hcc
5453420|NCT01488487|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5453421|NCT01488487|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5453422|NCT01488487|Liver Cancer|liver cancer
5453423|NCT01488474|regional anesthesia|regional anesthesia
5453424|NCT01488474|peripheral nerve stimulation|peripheral nerve stimulation
5453425|NCT01488474|diabetes|diabetes
5453426|NCT01488474|diabetic neuropathy|diabetic neuropathy
5453427|NCT01488461|Congenital cerebellar ataxias|congenital cerebellar ataxias
5453428|NCT01488461|Genetics|genetics
5453429|NCT01488461|Gene ATCAY|gene atcay
5453430|NCT01488461|Gene ABC7|gene abc7
5453431|NCT01488461|Cerebellar atrophy|cerebellar atrophy
5453432|NCT01488448|Hypertonic saline|hypertonic saline
5453433|NCT01488448|Bronchiolitis|bronchiolitis
5453434|NCT01488448|Infants|infants
5453435|NCT01488448|Wheezing|wheezing
5453436|NCT01488448|Nebulized|nebulized
5453437|NCT01488448|Bronchodilator|bronchodilator
5453438|NCT01488396|Cyclosporin|cyclosporin
5453439|NCT01488396|Stevens-Johnson syndrome|stevens-johnson syndrome
5453440|NCT01488396|Dry eye|dry eye
5453441|NCT01488383|Hyperglycemia|hyperglycemia
5453442|NCT01488383|Diabetes|diabetes
5453443|NCT01488383|Blood glucose|blood glucose
5453444|NCT01488383|Hypertension|hypertension
5453445|NCT01488383|Anti hypertensive agents|anti hypertensive agents
5453446|NCT01488383|Anti hypertensive drugs|anti hypertensive drugs
5453447|NCT01488383|Anti hypertensive|anti hypertensive
5453448|NCT01488370|breathing tube placement|breathing tube placement
5453449|NCT01488357|Breast cancer|breast cancer
5453450|NCT01488357|UNC|unc
5453451|NCT01488357|Lineberger|lineberger
5453452|NCT01488357|Breast Reconstruction|breast reconstruction
5453453|NCT01488357|Mastectomy|mastectomy
5453454|NCT01488318|Cetuximab|cetuximab
5453455|NCT01488318|Dasatinib|dasatinib
5453456|NCT01488318|Squamous Cell|squamous cell
5453457|NCT01488318|Head and Neck|head and neck
5453458|NCT01488318|After Cetuximab Containing Chemoradiotherapy|after cetuximab containing chemoradiotherapy
5453459|NCT01488318|Recurrent|recurrent
5453460|NCT01488318|Metastatic|metastatic
5453461|NCT01488305|MNP|mnp
5453462|NCT01488305|AAMA program|aama program
5453463|NCT01488305|Nepal|nepal
5453464|NCT01488305|HFP|hfp
5453465|NCT01488305|IYCF|iycf
5453466|NCT01488305|BCC|bcc
5453467|NCT01488292|mental health|mental health
5453468|NCT01488292|social skills|social skills
5453469|NCT01488279|Pre-diabetes|pre-diabetes
5453470|NCT01488279|Impaired fasting glucose|impaired fasting glucose
5453471|NCT01488279|Impaired glucose tolerance|impaired glucose tolerance
5453472|NCT01488279|Steroid-induced hyperglycemia|steroid-induced hyperglycemia
5453473|NCT01488266|depression|depression
5453474|NCT01488266|depressive|depressive
5453475|NCT01488266|major|major
5453476|NCT01488266|aripiprazole|aripiprazole
5453477|NCT01488266|switching|switching
5453478|NCT01488266|augmentation|augmentation
5453479|NCT01488266|antidepressant|antidepressant
5453480|NCT01488253|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5453481|NCT01488253|Graft vs Host disease|graft vs host disease
5453482|NCT01488253|Prevention|prevention
5453483|NCT01488253|Sirolimus|sirolimus
5453484|NCT01488253|Tacrolimus|tacrolimus
5453485|NCT01488240|burn|burn
5453486|NCT01488240|scar|scar
5453487|NCT01488240|laser|laser
5453488|NCT01488227|Vitamin D status in athletes|vitamin d status in athletes
5453489|NCT01488227|Vitamin D|vitamin d
5453490|NCT01488227|25(OH)D|25(oh)d
5453491|NCT01488227|athletes|athletes
5453492|NCT01488227|body composition|body composition
5453493|NCT01488227|inflammatory markers|inflammatory markers
5453494|NCT01488227|illness|illness
5453495|NCT01488227|injury|injury
5453496|NCT01488214|Systemic Sclerosis|systemic sclerosis
5453497|NCT01488214|neuropsychiatric manifestations|neuropsychiatric manifestations
5453498|NCT01488214|magnetic resonance imaging|magnetic resonance imaging
5453499|NCT01488201|Psoriasis|psoriasis
5453500|NCT01488188|Influenza vaccine|influenza vaccine
5453501|NCT01488188|nasal route|nasal route
5453502|NCT01488188|sublingual route|sublingual route
5453503|NCT01488188|immunogenicity|immunogenicity
5453504|NCT01488188|safety|safety
5453505|NCT01488175|TKA|tka
5453506|NCT01488175|RSA|rsa
5453507|NCT01488175|Tourniquet|tourniquet
5453508|NCT01488175|Arthroplasty|arthroplasty
5453509|NCT01488175|Knee|knee
5453510|NCT01488149|Fentanyl|fentanyl
5453511|NCT01488149|Bupivacaine|bupivacaine
5453512|NCT01488149|Nalbuphine|nalbuphine
5453513|NCT01488136|Type 1 diabetes|type 1 diabetes
5453514|NCT01488136|Hypoglycaemia|hypoglycaemia
5453515|NCT01488136|Diazoxide|diazoxide
5453516|NCT01488123|Breast, Cancer, Survivorship, Integrative, Complementary|breast, cancer, survivorship, integrative, complementary
5453517|NCT01488097|Enzyme replacement therapy (ERT)|enzyme replacement therapy (ert)
5453518|NCT01488097|Lysosomal storage disease|lysosomal storage disease
5454186|NCT01485406|Safety|safety
5453519|NCT01488097|Late onset lysosomal acid lipase (LAL) deficiency|late onset lysosomal acid lipase (lal) deficiency
5453520|NCT01488097|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5453521|NCT01488097|Acid lipase disease|acid lipase disease
5453522|NCT01488097|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5453523|NCT01488097|LAL deficiency|lal deficiency
5453524|NCT01488097|LIPA enzyme deficiency|lipa enzyme deficiency
5453525|NCT01488084|Saphenous vein graft patency|saphenous vein graft patency
5453526|NCT01488084|Coronary artery bypass surgery|coronary artery bypass surgery
5453527|NCT01488084|Coronary artery disease|coronary artery disease
5453528|NCT01488071|Depression|depression
5453529|NCT01488071|Multimodal antidepressant|multimodal antidepressant
5453530|NCT01488045|Colonoscopy|colonoscopy
5453531|NCT01488045|Propofol|propofol
5453532|NCT01488045|Cancer Screening|cancer screening
5453533|NCT01488006|Primary Glenohumeral Osteoarthritis|primary glenohumeral osteoarthritis
5453534|NCT01488006|Total shoulder arthroplasty|total shoulder arthroplasty
5453535|NCT01488006|Total shoulder replacement|total shoulder replacement
5453536|NCT01488006|Osteoarthritis|osteoarthritis
5453537|NCT01488006|Multicenter study|multicenter study
5453538|NCT01487993|Obesity|obesity
5453539|NCT01487993|Children|children
5453540|NCT01487993|Adolescents|adolescents
5453541|NCT01487993|Metformin|metformin
5453542|NCT01487993|Insulin resistance|insulin resistance
5453543|NCT01487967|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5453544|NCT01487967|ADHD|adhd
5453545|NCT01487967|Preferences|preferences
5453546|NCT01487967|Goals|goals
5453547|NCT01487967|Decision Making|decision making
5453548|NCT01487954|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5453549|NCT01487928|breastfed|breastfed
5453550|NCT01487928|human milk cream|human milk cream
5453551|NCT01487928|human milk fat|human milk fat
5453552|NCT01487928|caloric supplement|caloric supplement
5453553|NCT01487915|Cisplatin-unfit condition|cisplatin-unfit condition
5453554|NCT01487902|Chemotherapy-naive|chemotherapy-naive
5453555|NCT01487876|DNA vaccine|dna vaccine
5453557|NCT01487876|Chronic hepatitis B (CHB)|chronic hepatitis b (chb)
5453558|NCT01487876|T-cell|t-cell
5453559|NCT01487863|prostate cancer|prostate cancer
5453560|NCT01487863|prostate|prostate
5453561|NCT01487863|androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
5453562|NCT01487863|androgen-independent|androgen-independent
5453563|NCT01487863|androgen independent|androgen independent
5453564|NCT01487863|hormone insensitive|hormone insensitive
5453565|NCT01487863|hormone-insensitive|hormone-insensitive
5453566|NCT01487863|prostate specific antigen (PSA)|prostate specific antigen (psa)
5453567|NCT01487863|prostatic adenocarcinoma|prostatic adenocarcinoma
5453568|NCT01487863|hormone-refractory|hormone-refractory
5453569|NCT01487863|hormone refractory|hormone refractory
5453570|NCT01487863|hormone refractory prostate cancer (HRPC)|hormone refractory prostate cancer (hrpc)
5453571|NCT01487863|immune therapy|immune therapy
5453572|NCT01487863|immunotherapy|immunotherapy
5453573|NCT01487863|vaccine|vaccine
5453574|NCT01487863|dendritic cells|dendritic cells
5453575|NCT01487863|antigen-presenting cells|antigen-presenting cells
5453576|NCT01487863|antigen presenting cells|antigen presenting cells
5453577|NCT01487863|cancer vaccine|cancer vaccine
5453578|NCT01487863|therapeutic vaccine|therapeutic vaccine
5453579|NCT01487863|therapeutic cancer vaccine|therapeutic cancer vaccine
5453580|NCT01487863|recombinant|recombinant
5453581|NCT01487863|biological|biological
5453582|NCT01487863|biopharmaceutical|biopharmaceutical
5453583|NCT01487863|biotechnology|biotechnology
5453584|NCT01487863|biotech|biotech
5453585|NCT01487863|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
5453586|NCT01487863|castration-resistant prostate cancer (CRPC)|castration-resistant prostate cancer (crpc)
5453587|NCT01487863|castration-resistance|castration-resistance
5453588|NCT01487863|sipuleucel-T|sipuleucel-t
5453589|NCT01487863|abiraterone|abiraterone
5453590|NCT01487863|prednisone|prednisone
5453591|NCT01487863|sequence|sequence
5453592|NCT01487863|sequencing|sequencing
5453593|NCT01487850|wind instruments|wind instruments
5453594|NCT01487850|molds|molds
5453595|NCT01487850|hypersensitivity pneumonitis|hypersensitivity pneumonitis
5453596|NCT01487850|fungal contamination of wind instruments|fungal contamination of wind instruments
5453597|NCT01487850|specific antibodies against molds in musicians' sera|specific antibodies against molds in musicians' sera
5453598|NCT01487850|musicians|musicians
5453599|NCT01487837|Fibrinogen|fibrinogen
5453600|NCT01487837|Blood coagulation disorders|blood coagulation disorders
5671347|NCT00616421|children|children
5453601|NCT01487837|Postoperative bleeding|postoperative bleeding
5453602|NCT01487837|Transfusions|transfusions
5453603|NCT01487785|metastatic pancreatic cancer|metastatic pancreatic cancer
5453604|NCT01487785|LDE225|lde225
5453605|NCT01487785|gemcitabine|gemcitabine
5453606|NCT01487785|locally advanced|locally advanced
5453607|NCT01487785|adenocarcinoma|adenocarcinoma
5453608|NCT01487746|APLA|apla
5453609|NCT01487746|APS|aps
5453610|NCT01487746|Stroke|stroke
5453611|NCT01487746|minor anti body|minor anti body
5453612|NCT01487746|major anti body|major anti body
5453613|NCT01487746|APLA antibodies in Serum|apla antibodies in serum
5453614|NCT01487733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5453615|NCT01487733|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5453616|NCT01487733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5453617|NCT01487733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5453618|NCT01487733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5453619|NCT01487733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5453620|NCT01487733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5453621|NCT01487733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5453622|NCT01487733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5453623|NCT01487733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5453624|NCT01487733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5453625|NCT01487733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5453626|NCT01487733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5453627|NCT01487733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5453628|NCT01487733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5453629|NCT01487733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5453630|NCT01487733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5453631|NCT01487733|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5453632|NCT01487733|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5685523|NCT00555750|metabolism|metabolism
5453633|NCT01487733|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5453634|NCT01487733|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5453635|NCT01487733|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5453636|NCT01487733|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5453637|NCT01487733|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5453638|NCT01487733|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5453639|NCT01487733|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5453640|NCT01487733|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5453642|NCT01487733|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5453644|NCT01487733|stage III salivary gland cancer|stage iii salivary gland cancer
5453645|NCT01487733|stage IVA salivary gland cancer|stage iva salivary gland cancer
5453646|NCT01487733|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5453647|NCT01487733|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5453648|NCT01487720|Castration-resistant prostate cancer|castration-resistant prostate cancer
5436306|NCT01560715|stem cell|stem cell
5453649|NCT01487720|Docetaxel-refractory status|docetaxel-refractory status
5453651|NCT01487707|maternal mortality|maternal mortality
5453652|NCT01487707|neonatal mortality|neonatal mortality
5453653|NCT01487707|community intervention|community intervention
5453654|NCT01487707|voluntary health worker|voluntary health worker
5453655|NCT01487707|safe birth kit|safe birth kit
5453656|NCT01487707|maternal child health|maternal child health
5453658|NCT01487694|cimicifuga racemosa|cimicifuga racemosa
5453659|NCT01487694|menopausal symptoms|menopausal symptoms
5453660|NCT01487694|hot flashes|hot flashes
5453661|NCT01487694|Kupperman index|kupperman index
5453663|NCT01487668|chronic mental disorders|chronic mental disorders
5453664|NCT01487668|cardiovascular disease|cardiovascular disease
5453665|NCT01487668|behavior change|behavior change
5453666|NCT01487655|Open-angle glaucoma|open-angle glaucoma
5453667|NCT01487655|Low tension glaucoma|low tension glaucoma
5453668|NCT01487655|Color Doppler Imaging|color doppler imaging
5453669|NCT01487629|Diabetic Retinopathy|diabetic retinopathy
5453670|NCT01487629|Macular Edema|macular edema
5453671|NCT01487629|Bevacizumab|bevacizumab
5453672|NCT01487629|Ranibizumab|ranibizumab
5453673|NCT01487616|Mullerian anomalies|mullerian anomalies
5453674|NCT01487616|Congenital uterine malformations or anomalies|congenital uterine malformations or anomalies
5453675|NCT01487616|Arcuate|arcuate
5453676|NCT01487616|Septate|septate
5453677|NCT01487616|Subseptate|subseptate
5453678|NCT01487616|Bicornuate|bicornuate
5453679|NCT01487616|Unicornuate|unicornuate
5453680|NCT01487616|Didelphys|didelphys
5453681|NCT01487616|T-shaped|t-shaped
5453683|NCT01487603|undiagnosed enlarged|undiagnosed enlarged
5453684|NCT01487603|lymph nodes|lymph nodes
5453685|NCT01487590|pregnancy|pregnancy
5453686|NCT01487590|breech|breech
5453687|NCT01487590|acupuncture|acupuncture
5453688|NCT01487590|moxibustion|moxibustion
5453689|NCT01487590|version|version
5453690|NCT01487577|Allogeneic blood and marrow transplantation (BMT)|allogeneic blood and marrow transplantation (bmt)
5453691|NCT01487577|Graft versus host disease|graft versus host disease
5453692|NCT01487577|Mycophenolate mofetil|mycophenolate mofetil
5453693|NCT01487577|Pharmacokinetics|pharmacokinetics
5453694|NCT01487564|Healthy volunteers|healthy volunteers
5453695|NCT01487564|Pharmacokinetics|pharmacokinetics
5453696|NCT01487564|OROS Hydromorphone|oros hydromorphone
5453697|NCT01487564|Hydromorphone|hydromorphone
5453698|NCT01487564|Taiwan|taiwan
5453699|NCT01487564|UGT2B7 Gene|ugt2b7 gene
5453700|NCT01487551|Systemic sclerosis|systemic sclerosis
5453701|NCT01487551|Biomarkers|biomarkers
5453702|NCT01487525|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5453703|NCT01487525|partial blood flow restriction|partial blood flow restriction
5453704|NCT01487525|knee extensor strength|knee extensor strength
5453705|NCT01487512|Healthy Volunteers|healthy volunteers
5453706|NCT01487512|Dose Proportionality|dose proportionality
5453707|NCT01487512|Pharmacokinetics|pharmacokinetics
5453708|NCT01487512|OROS Hydromorphone|oros hydromorphone
5453709|NCT01487512|Hydromorphone|hydromorphone
5453710|NCT01487512|Taiwan|taiwan
5453711|NCT01487486|Polycystic Ovary Syndrome|polycystic ovary syndrome
5453712|NCT01487486|PCOS|pcos
5453713|NCT01487486|Follicular Fluid|follicular fluid
5453714|NCT01487486|Proteomics|proteomics
5453715|NCT01487486|Glyco-proteomics|glyco-proteomics
5453716|NCT01487473|Meditation|meditation
5453717|NCT01487473|Mindfulness|mindfulness
5453718|NCT01487473|Attention|attention
5453719|NCT01487473|Chronic Pain|chronic pain
5453720|NCT01487473|Depression|depression
5453721|NCT01487473|Anxiety|anxiety
5453722|NCT01487473|Stress|stress
5453723|NCT01487473|Acceptance|acceptance
5685524|NCT00555750|insulin|insulin
5453724|NCT01487473|Pain intensity|pain intensity
5453725|NCT01487473|Pain disability|pain disability
5453726|NCT01487460|High cholesterol levels|high cholesterol levels
5453727|NCT01487460|Hyperlipidemia|hyperlipidemia
5453728|NCT01487460|High-density Lipoprotein|high-density lipoprotein
5453729|NCT01487460|Low-density Lipoprotein|low-density lipoprotein
5453730|NCT01487460|Simvastatin|simvastatin
5453731|NCT01487434|Attendance|attendance
5453732|NCT01487434|Truancy|truancy
5453733|NCT01487434|Student engagement|student engagement
5453734|NCT01487434|Mentoring|mentoring
5453735|NCT01487434|Monitoring|monitoring
5453736|NCT01487434|Case management|case management
5453737|NCT01487395|Alzheimer|alzheimer
5453738|NCT01487395|Donepezil|donepezil
5453739|NCT01487395|biomarkers|biomarkers
5453740|NCT01487395|battery|battery
5453741|NCT01487395|cognition|cognition
5453742|NCT01487395|imaging|imaging
5453743|NCT01487395|neurophysiological|neurophysiological
5453744|NCT01487356|Colonoscopy|colonoscopy
5453745|NCT01487356|quality assurance|quality assurance
5453746|NCT01487356|withdrawal time|withdrawal time
5453747|NCT01487356|polyp detection rate|polyp detection rate
5453748|NCT01487343|Oral Chemotherapy|oral chemotherapy
5453749|NCT01487343|capecitabine|capecitabine
5453750|NCT01487343|questionnaire|questionnaire
5453751|NCT01487343|breast|breast
5453752|NCT01487343|gastric|gastric
5453753|NCT01487343|11-194|11-194
5453754|NCT01487330|aortic stenosis|aortic stenosis
5453755|NCT01487330|aortic valve stenosis|aortic valve stenosis
5453756|NCT01487330|valvular heart disease|valvular heart disease
5453757|NCT01487330|aortic valve replacement|aortic valve replacement
5453758|NCT01487330|transcatheter aortic valve implantation|transcatheter aortic valve implantation
5453759|NCT01487330|TAVI|tavi
5453760|NCT01487330|TAVR|tavr
5453761|NCT01487317|Delirium|delirium
5453762|NCT01487317|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5453763|NCT01487317|Elderly|elderly
5453764|NCT01487317|Emergency department|emergency department
5453765|NCT01487291|Thrombophilia tests|thrombophilia tests
5453766|NCT01487291|Hypofibrinolysis|hypofibrinolysis
5453767|NCT01487291|Fibrinolysis|fibrinolysis
5453768|NCT01487278|postpartum hemorrhage|postpartum hemorrhage
5453769|NCT01487278|prevention|prevention
5453770|NCT01487278|misoprostol|misoprostol
5453771|NCT01487278|Uniject|uniject
5453772|NCT01487278|oxytocin|oxytocin
5453773|NCT01487265|Erlotinib|erlotinib
5453774|NCT01487265|BKM120|bkm120
5453775|NCT01487265|NSCLC|nsclc
5453776|NCT01487226|Cervical cancer|cervical cancer
5453777|NCT01487213|Medical abortion|medical abortion
5453778|NCT01487213|Termination of pregnancy|termination of pregnancy
5453779|NCT01487213|Mifepristone|mifepristone
5453780|NCT01487213|Misoprostol|misoprostol
5453781|NCT01487213|Urine hCG|urine hcg
5453782|NCT01487213|Follow Up|follow up
5453783|NCT01487213|Termination of unwanted pregnancy. Self assessment (follow up) after medical abortion|termination of unwanted pregnancy. self assessment (follow up) after medical abortion
5453784|NCT01487200|osteoarthritis|osteoarthritis
5453785|NCT01487200|knee|knee
5453786|NCT01487200|corticosteroid|corticosteroid
5453787|NCT01487200|intra-articular|intra-articular
5453788|NCT01487200|injection|injection
5453789|NCT01487187|Cord-milking|cord-milking
5453790|NCT01487187|hemodynamic|hemodynamic
5453791|NCT01487187|preterm infants|preterm infants
5453792|NCT01487161|osteoarthritis|osteoarthritis
5453793|NCT01487161|knee|knee
5453794|NCT01487161|pain|pain
5453795|NCT01487161|corticosteroid|corticosteroid
5453796|NCT01487161|intra-articular|intra-articular
5453797|NCT01487161|injection|injection
5453798|NCT01487135|Thorough QT (TQT)|thorough qt (tqt)
5453799|NCT01487135|EVP-6124|evp-6124
5453800|NCT01487122|Diathermy|diathermy
5453801|NCT01487122|Neck Pain|neck pain
5453802|NCT01487109|Type 2 diabetes|type 2 diabetes
5453803|NCT01487109|chronic kidney disease|chronic kidney disease
5453804|NCT01487083|schizophrenia|schizophrenia
5453805|NCT01487083|LY2140023|ly2140023
5453806|NCT01487083|pomaglumetad methionil|pomaglumetad methionil
5453807|NCT01487057|thyroid cancer|thyroid cancer
5453808|NCT01487057|dislipidemia|dislipidemia
5453809|NCT01487057|cardiovascular risk|cardiovascular risk
5453811|NCT01487031|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5453812|NCT01487031|multiple myeloma|multiple myeloma
5453813|NCT01487031|non-Hodgkin|non-hodgkin
5453814|NCT01487031|Hodgkin lymphoma|hodgkin lymphoma
5453815|NCT01487031|Music Therapy|music therapy
5453816|NCT01487031|Nausea|nausea
5453817|NCT01487031|Pain|pain
5453818|NCT01487018|Zygomatic Fractures|zygomatic fractures
5453819|NCT01487018|Surgery, Computer-Assisted|surgery, computer-assisted
5453820|NCT01487018|Facial Asymmetry|facial asymmetry
5453821|NCT01487005|ozone|ozone
5453822|NCT01487005|air pollution|air pollution
5453823|NCT01487005|vascular function|vascular function
5453824|NCT01487005|cardiac function|cardiac function
5453825|NCT01487005|inflammation|inflammation
5453826|NCT01486953|respiratory resistance|respiratory resistance
5453827|NCT01486953|lung compliance|lung compliance
5453828|NCT01486953|desflurane|desflurane
5453829|NCT01486953|sevoflurane|sevoflurane
5453830|NCT01486836|Cardiac disease (ICD indication)|cardiac disease (icd indication)
5453831|NCT01486810|cocaine|cocaine
5453832|NCT01486810|lisdexamfetamine|lisdexamfetamine
5453833|NCT01486797|Relapsed Chronic Lymphocytic Leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
5453834|NCT01486797|NOX-A12|nox-a12
5453835|NCT01486797|Bendamustine|bendamustine
5453836|NCT01486797|Rituximab|rituximab
5453837|NCT01486797|Spiegelmer|spiegelmer
5453838|NCT01486797|Chemosensitization|chemosensitization
5453839|NCT01486797|Stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5453840|NCT01486797|CXCL12|cxcl12
5453841|NCT01486784|equal to or greater than age 60 years|equal to or greater than age 60 years
5453842|NCT01486784|non-M3 AML|non-m3 aml
5453843|NCT01486784|relapsed disease|relapsed disease
5453844|NCT01486784|primary refractory disease|primary refractory disease
5798673|NCT00111397|Interferon|interferon
5798674|NCT00111397|GM-CSF|gm-csf
5453845|NCT01486784|not appropriate or willing candidates for aggressive therapy|not appropriate or willing candidates for aggressive therapy
5453847|NCT01486771|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5453848|NCT01486732|Cerebral Palsy|cerebral palsy
5453849|NCT01486732|Umbilical Cord Blood|umbilical cord blood
5453850|NCT01486732|FLT-PET|flt-pet
5453851|NCT01486719|Finger pulp reconstruction|finger pulp reconstruction
5453852|NCT01486719|dorsal branch|dorsal branch
5453853|NCT01486719|proper digital nerve|proper digital nerve
5453854|NCT01486719|palmar arterial arch|palmar arterial arch
5453855|NCT01486719|dorsal digital island flap|dorsal digital island flap
5453856|NCT01486706|Overactive Bladder|overactive bladder
5453857|NCT01486706|Gabapentin|gabapentin
5453858|NCT01486706|Quality of Life|quality of life
5453859|NCT01486706|Urodynamic|urodynamic
5453860|NCT01486706|safety|safety
5453861|NCT01486706|Efficacy|efficacy
5453862|NCT01486693|cytomegalovirus|cytomegalovirus
5453863|NCT01486693|uveitis|uveitis
5453864|NCT01486680|Gastric bypass|gastric bypass
5453865|NCT01486680|Silastic ring gastric bypass|silastic ring gastric bypass
5453866|NCT01486680|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5453867|NCT01486680|Sleeve gastrectomy|sleeve gastrectomy
5453868|NCT01486680|Body composition analysis|body composition analysis
5453869|NCT01486667|focus of study instead|focus of study instead
5453870|NCT01486654|Cortical stimulation|cortical stimulation
5453871|NCT01486654|Ischemic Stroke|ischemic stroke
5453872|NCT01486654|Aphasia|aphasia
5453873|NCT01486654|Speech and Language Rehabilitation|speech and language rehabilitation
5453874|NCT01486641|femoral neck fracture|femoral neck fracture
5453875|NCT01486641|arthroplasty|arthroplasty
5453876|NCT01486641|surgical approach|surgical approach
5453877|NCT01486641|anterolateral|anterolateral
5453878|NCT01486641|posterolateral|posterolateral
5453879|NCT01486615|premedication|premedication
5453880|NCT01486615|premedicants|premedicants
5453881|NCT01486615|preoperative anxiety|preoperative anxiety
5453882|NCT01486615|melatonin|melatonin
5453883|NCT01486615|alprazolam|alprazolam
5453884|NCT01486602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5453885|NCT01486602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5454493|NCT01484093|RITUXIMAB|rituximab
5453886|NCT01486589|emergency care|emergency care
5453887|NCT01486589|cardiac autonomic function|cardiac autonomic function
5453888|NCT01486589|deceleration capacity|deceleration capacity
5453890|NCT01486537|children|children
5453891|NCT01486537|the age group 3-13 years|the age group 3-13 years
5453892|NCT01486524|pharmacogenomic biomarker|pharmacogenomic biomarker
5453893|NCT01486524|predictive marker|predictive marker
5453894|NCT01486524|prospective-retrospective|prospective-retrospective
5453895|NCT01486524|propensity score|propensity score
5453896|NCT01486524|matched-patients trial|matched-patients trial
5453897|NCT01486511|Liver disease|liver disease
5453898|NCT01486511|Pulmonary embolism|pulmonary embolism
5453899|NCT01486511|Thrombophilia|thrombophilia
5453900|NCT01486511|Death|death
5453901|NCT01486485|renal replacement therapy|renal replacement therapy
5453902|NCT01486472|Adjuvant chemotherapy|adjuvant chemotherapy
5453903|NCT01486446|IEM|iem
5453904|NCT01486446|EM|em
5453905|NCT01486446|Erythromelalgia|erythromelalgia
5453906|NCT01486446|Erythermalgia|erythermalgia
5453907|NCT01486446|Red neuralgia|red neuralgia
5453908|NCT01486446|Peripheral Vascular Disease|peripheral vascular disease
5453909|NCT01486446|Vascular Disease|vascular disease
5453910|NCT01486446|Cardiovascular Disease|cardiovascular disease
5453911|NCT01486433|eicosapentaenoic acid|eicosapentaenoic acid
5453912|NCT01486433|docosapentaenoic acid|docosapentaenoic acid
5453913|NCT01486433|arachidonic acid|arachidonic acid
5453914|NCT01486433|hypertriglyceridemia|hypertriglyceridemia
5453915|NCT01486433|simvastatin|simvastatin
5453916|NCT01486420|Quinell grade|quinell grade
5453917|NCT01486420|Open surgery|open surgery
5453918|NCT01486420|corticosteroid injections|corticosteroid injections
5453919|NCT01486420|randomized controlled trial|randomized controlled trial
5453920|NCT01486420|Trigger finger|trigger finger
5453921|NCT01486407|Airway management|airway management
5453922|NCT01486355|Mortality|mortality
5453923|NCT01486355|Morbidity|morbidity
5453924|NCT01486355|Hospitalisations/consultations|hospitalisations/consultations
5453925|NCT01486355|Growth|growth
5453926|NCT01486355|Measles infection|measles infection
5453927|NCT01486329|Pancreatic cancer|pancreatic cancer
5453928|NCT01486329|Cancer vaccine|cancer vaccine
5453929|NCT01486329|Gemcitabine|gemcitabine
5453930|NCT01486329|Inoperable|inoperable
5453931|NCT01486329|Gemcitabine chemotherapy|gemcitabine chemotherapy
5453932|NCT01486329|Locally advanced|locally advanced
5453933|NCT01486303|Facial Cosmetic acupuncture|facial cosmetic acupuncture
5453934|NCT01486303|Skin Rejuvenation|skin rejuvenation
5453935|NCT01486303|Skin Aging|skin aging
5453936|NCT01486290|Intervention|intervention
5453937|NCT01486290|Cost Effective|cost effective
5453938|NCT01486290|Elderly|elderly
5453939|NCT01486290|Glycemic Control|glycemic control
5453940|NCT01486277|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5453941|NCT01486277|T-cell lymphoma|t-cell lymphoma
5453942|NCT01486277|Lymphoma|lymphoma
5453943|NCT01486277|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5453944|NCT01486277|JNJ-26481585|jnj-26481585
5453945|NCT01486238|Diabetic Macular Edema|diabetic macular edema
5453946|NCT01486212|Ischemia-reperfusion injury|ischemia-reperfusion injury
5453947|NCT01486212|Oxidative markers|oxidative markers
5453948|NCT01486212|Inflammatory markers|inflammatory markers
5453949|NCT01486199|cystic fibrosis|cystic fibrosis
5453950|NCT01486199|mucociliary clearance|mucociliary clearance
5453951|NCT01486199|airway surface liquid|airway surface liquid
5453952|NCT01486199|nuclear medicine|nuclear medicine
5453953|NCT01486186|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5453954|NCT01486186|Double-Blind Method|double-blind method
5453955|NCT01486186|Medicine, Chinese Traditional|medicine, chinese traditional
5453957|NCT01486186|Treatment Outcome|treatment outcome
5453958|NCT01486173|PUFA|pufa
5453959|NCT01486173|Iron|iron
5453960|NCT01486173|Neurological development|neurological development
5453961|NCT01486173|Premature infant|premature infant
5453962|NCT01486147|Food labeling|food labeling
5453963|NCT01486147|Nutrition|nutrition
5453964|NCT01486147|Memory|memory
5453965|NCT01486147|Diet|diet
5453966|NCT01486134|Hepatocellular carcinoma|hepatocellular carcinoma
5453967|NCT01486134|Radiofrequency ablation|radiofrequency ablation
5453968|NCT01486134|Multipolar mode|multipolar mode
5453969|NCT01486134|Recurrence|recurrence
5453970|NCT01486134|Cirrhosis|cirrhosis
5453971|NCT01486134|MR temperature monitoring|mr temperature monitoring
5453972|NCT01486134|large tumor|large tumor
5453973|NCT01486121|Surgery|surgery
5453974|NCT01486121|Critical illness|critical illness
5453975|NCT01486121|Mechanical ventilation|mechanical ventilation
5453976|NCT01486121|Organ dysfunction syndrome|organ dysfunction syndrome
5453977|NCT01486121|Intensive Care Units Sedation|intensive care units sedation
5453978|NCT01486121|Analgesia|analgesia
5453979|NCT01486121|Treatment protocol|treatment protocol
5453980|NCT01486121|Nursing protocol|nursing protocol
5453981|NCT01486121|Outcome|outcome
5453982|NCT01486121|Pain|pain
5453983|NCT01486121|Neurological disorders|neurological disorders
5453984|NCT01486121|Delirium|delirium
5453985|NCT01486121|Muscular weakness|muscular weakness
5453986|NCT01486121|Psychological disorders|psychological disorders
5453987|NCT01486121|Anxiety|anxiety
5453988|NCT01486121|Depression|depression
5453989|NCT01486121|Stress disorders|stress disorders
5453990|NCT01486121|Post-Traumatic|post-traumatic
5453991|NCT01486108|tonic, burst and placebo stimulation|tonic, burst and placebo stimulation
5453992|NCT01486082|OCA 10|oca 10
5453993|NCT01486082|Antibiogram|antibiogram
5453994|NCT01486082|Eradication|eradication
5453995|NCT01486069|Dentofacial Deformity|dentofacial deformity
5453996|NCT01486069|Orthognathic Surgery|orthognathic surgery
5453997|NCT01486069|Mandible|mandible
5453998|NCT01486069|Orthognathic Surgical Procedures|orthognathic surgical procedures
5453999|NCT01486056|epilepsy|epilepsy
5454001|NCT01486056|device placement|device placement
5454002|NCT01486043|Induction chemotherapy|induction chemotherapy
5454003|NCT01486043|Transient hyperglycemia|transient hyperglycemia
5454004|NCT01486043|Metformin|metformin
5454005|NCT01486043|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5454006|NCT01486043|Insulin resistance|insulin resistance
5454007|NCT01486043|Hyperglycemia|hyperglycemia
5454008|NCT01486043|Insulin|insulin
5454009|NCT01486030|Atherosclerosis|atherosclerosis
5454010|NCT01486030|Corus CAD|corus cad
5454011|NCT01486030|Age/Sex/Gene Expression Score|age/sex/gene expression score
5454012|NCT01486030|ASGES|asges
5454013|NCT01486030|Gene Expression|gene expression
5454014|NCT01486030|GES|ges
5454015|NCT01486030|CAD|cad
5454016|NCT01486030|CVD|cvd
5454017|NCT01486030|CHD|chd
5454018|NCT01486030|Precision Medicine|precision medicine
5454019|NCT01486030|Exercise Stress Test|exercise stress test
5454020|NCT01486030|Coronary Artery Disease|coronary artery disease
5454021|NCT01486030|Angina Pectoris|angina pectoris
5454022|NCT01486030|Chest Pain|chest pain
5454023|NCT01486030|Cardiovascular Disease|cardiovascular disease
5454024|NCT01486030|Coronary Heart Disease|coronary heart disease
5454025|NCT01486030|EXERCISE|exercise
5454026|NCT01486017|ASP015K|asp015k
5454027|NCT01486017|healthy subjects|healthy subjects
5454028|NCT01486017|bioavailability|bioavailability
5454029|NCT01486017|rheumatoid arthritis|rheumatoid arthritis
5454030|NCT01486017|psoriasis|psoriasis
5454031|NCT01486017|transplantation|transplantation
5454032|NCT01486004|Hepatitis C Virus|hepatitis c virus
5454033|NCT01486004|TMC435|tmc435
5454034|NCT01486004|TMC435-TiDP16-C124|tmc435-tidp16-c124
5454035|NCT01486004|TMC435-C124|tmc435-c124
5454037|NCT01486004|Hepatitis C|hepatitis c
5454038|NCT01486004|Hep C|hep c
5454039|NCT01486004|Healthy participants|healthy participants
5454040|NCT01485991|Hepatitis C|hepatitis c
5454041|NCT01485991|TMC435HPC3001|tmc435hpc3001
5454042|NCT01485991|TMC435|tmc435
5454043|NCT01485991|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5454044|NCT01485991|HEP C|hep c
5454045|NCT01485991|Genotype 1|genotype 1
5454046|NCT01485991|Treatment experienced|treatment experienced
5454047|NCT01485991|Null responders|null responders
5454048|NCT01485991|Partial responders|partial responders
5454049|NCT01485978|Alport Syndrome|alport syndrome
5454050|NCT01485978|chronic kidney disease|chronic kidney disease
5454051|NCT01485978|renal fibrosis|renal fibrosis
5454052|NCT01485978|nephroprotection|nephroprotection
5454053|NCT01485978|pediatric study|pediatric study
5454054|NCT01485965|Huntington Disease|huntington disease
5454055|NCT01485965|Basal Ganglia Diseases|basal ganglia diseases
5454056|NCT01485965|Brain Diseases|brain diseases
5436704|NCT01559077|ATTR|attr
5454057|NCT01485965|Central Nervous System Diseases|central nervous system diseases
5454058|NCT01485965|Nervous System Diseases|nervous system diseases
5454059|NCT01485965|Dementia|dementia
5454060|NCT01485965|Chorea|chorea
5454061|NCT01485965|Dyskinesias|dyskinesias
5454062|NCT01485965|Movement Disorders|movement disorders
5454063|NCT01485965|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5454064|NCT01485965|Neurodegenerative Diseases|neurodegenerative diseases
5454065|NCT01485965|Genetic Diseases, Inborn|genetic diseases, inborn
5454066|NCT01485965|Cognition Disorders|cognition disorders
5454067|NCT01485965|Mental Disorders|mental disorders
5454068|NCT01485952|Huntington Disease|huntington disease
5454069|NCT01485952|Basal Ganglia Diseases|basal ganglia diseases
5454070|NCT01485952|Brain Diseases|brain diseases
5454071|NCT01485952|Central Nervous System Diseases|central nervous system diseases
5454072|NCT01485952|Nervous System Diseases|nervous system diseases
5454073|NCT01485952|Dementia|dementia
5454074|NCT01485952|Chorea|chorea
5454075|NCT01485952|Dyskinesias|dyskinesias
5454076|NCT01485952|Movement Disorders|movement disorders
5671348|NCT00616421|healthy|healthy
5454077|NCT01485952|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5454078|NCT01485952|Neurodegenerative Diseases|neurodegenerative diseases
5454079|NCT01485952|Genetic Diseases, Inborn|genetic diseases, inborn
5454080|NCT01485952|Cognition Disorders|cognition disorders
5454081|NCT01485952|Mental Disorders|mental disorders
5454082|NCT01485939|lidocaine patch|lidocaine patch
5454083|NCT01485939|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5454084|NCT01485913|Education|education
5454085|NCT01485913|Diabetes|diabetes
5454592|NCT01483612|Weight Loss|weight loss
5454086|NCT01485913|Prevention complications|prevention complications
5454087|NCT01485913|Prevention of complications of diabetes|prevention of complications of diabetes
5454088|NCT01485887|Venlafaxine ER|venlafaxine er
5454089|NCT01485887|long-term extension|long-term extension
5454090|NCT01485887|Japan|japan
5454091|NCT01485874|BIBF 1120|bibf 1120
5454092|NCT01485835|Multiple Myeloma|multiple myeloma
5454093|NCT01485835|Bortezomib|bortezomib
5454094|NCT01485835|Velcade|velcade
5454095|NCT01485835|Ganetespib|ganetespib
5454096|NCT01485822|Glaucoma|glaucoma
5454097|NCT01485822|Travatan|travatan
5454098|NCT01485822|Trabeculectomy|trabeculectomy
5454099|NCT01485796|PIDD|pidd
5454100|NCT01485783|Hypertension|hypertension
5454101|NCT01485757|patients|patients
5454102|NCT01485744|metastatic|metastatic
5454103|NCT01485744|untreated|untreated
5454104|NCT01485744|advanced|advanced
5454105|NCT01485731|Cervical|cervical
5454106|NCT01485731|Cancer|cancer
5454107|NCT01485731|Uterine Cervix|uterine cervix
5454108|NCT01485731|Squamous Cell|squamous cell
5454109|NCT01485731|Adenocarcinoma|adenocarcinoma
5454110|NCT01485718|Obesity|obesity
5454111|NCT01485718|Overweight|overweight
5454112|NCT01485718|Weight loss|weight loss
5454113|NCT01485705|severe bacterial infection|severe bacterial infection
5454114|NCT01485692|Violence|violence
5454115|NCT01485692|Aggression|aggression
5454116|NCT01485692|Psychiatric emergencies|psychiatric emergencies
5454117|NCT01485692|Psychomotor agitation|psychomotor agitation
5454118|NCT01485692|Violent patient|violent patient
5685297|NCT00556673|Asthma, QMF149, fixed combination of indacaterol and mometasone furoate|asthma, qmf149, fixed combination of indacaterol and mometasone furoate
5454119|NCT01485679|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,|18 fluoro deoxy glucose positrons emission tomography combined with computed tomography,
5454120|NCT01485679|Patients with intraductal papillary mucinous tumor of the pancreas|patients with intraductal papillary mucinous tumor of the pancreas
5454121|NCT01485679|intraductal papillary mucinous|intraductal papillary mucinous
5454122|NCT01485679|pancreas|pancreas
5454123|NCT01485666|Thoratec|thoratec
5454124|NCT01485666|HeartMate II|heartmate ii
5454125|NCT01485666|heart-assist devices|heart-assist devices
5454126|NCT01485666|driveline or percutaneous lead management|driveline or percutaneous lead management
5454127|NCT01485666|HeartMate II Percutaneous Lead Management|heartmate ii percutaneous lead management
5454128|NCT01485653|Brachial Plexus|brachial plexus
5454130|NCT01485653|Ultrasound|ultrasound
5454131|NCT01485653|Axillary|axillary
5454133|NCT01485640|Schizophrenia|schizophrenia
5454134|NCT01485640|bipolar disorder|bipolar disorder
5454135|NCT01485640|Lurasidone|lurasidone
5454136|NCT01485640|Latuda|latuda
5454137|NCT01485627|Cancer|cancer
5454138|NCT01485627|Communication|communication
5454139|NCT01485627|prognosis|prognosis
5454140|NCT01485575|Chromovitrectomy|chromovitrectomy
5454141|NCT01485575|Indocyanine green|indocyanine green
5454143|NCT01485575|Brilliant Blue G|brilliant blue g
5454144|NCT01485575|BBG|bbg
5454145|NCT01485575|Trypan blue|trypan blue
5454146|NCT01485575|TB|tb
5454147|NCT01485575|Internal limiting membrane|internal limiting membrane
5454148|NCT01485575|ILM|ilm
5454149|NCT01485562|postpartum haemorrhage|postpartum haemorrhage
5454150|NCT01485562|misoprostol|misoprostol
5454151|NCT01485562|treatment|treatment
5454152|NCT01485562|prophylaxis|prophylaxis
5454153|NCT01485562|home births|home births
5454154|NCT01485549|Multiple system atrophy (MSA)|multiple system atrophy (msa)
5454155|NCT01485549|alpha-synucleinopathies|alpha-synucleinopathies
5454156|NCT01485549|biological markers|biological markers
5454157|NCT01485549|cerebrospinal fluid|cerebrospinal fluid
5454158|NCT01485549|plasma|plasma
5454159|NCT01485536|Lymphoma|lymphoma
5454160|NCT01485536|Relapsed/refractory lymphoma|relapsed/refractory lymphoma
5454161|NCT01485536|AUY922|auy922
5454162|NCT01485523|Allergic rhinitis|allergic rhinitis
5454163|NCT01485523|Nasal provocation test|nasal provocation test
5454164|NCT01485510|Maltreatment|maltreatment
5454165|NCT01485510|Infant Mental Health|infant mental health
5454166|NCT01485510|Infant mental health in maltreated children|infant mental health in maltreated children
5454167|NCT01485497|APNEA|apnea
5454168|NCT01485471|Middle Ear Infection|middle ear infection
5454169|NCT01485458|Incomplete spinal cord injury|incomplete spinal cord injury
5454170|NCT01485458|Cervical canal stenosis|cervical canal stenosis
5454171|NCT01485458|Ossification of the posterior longitudinal ligament|ossification of the posterior longitudinal ligament
5454172|NCT01485458|Surgery|surgery
5454173|NCT01485458|Decompression|decompression
5454174|NCT01485445|bioequivalence|bioequivalence
5454175|NCT01485445|pharmacokinetics|pharmacokinetics
5454176|NCT01485445|Fluticasone Furoate|fluticasone furoate
5454177|NCT01485445|Vilanterol|vilanterol
5454178|NCT01485432|Renal transplant surgery|renal transplant surgery
5454179|NCT01485432|hemodynamic management|hemodynamic management
5454180|NCT01485432|PiCCO|picco
5454181|NCT01485432|delayed graft function|delayed graft function
5454182|NCT01485419|Sex hormones|sex hormones
5454183|NCT01485419|Testosterone|testosterone
5454184|NCT01485419|Estradiol|estradiol
5454185|NCT01485406|Haemophilus influenzae|haemophilus influenzae
5454187|NCT01485406|Pneumococcal vaccine|pneumococcal vaccine
5454188|NCT01485406|Streptococcus pneumoniae|streptococcus pneumoniae
5454189|NCT01485406|Immunogenicity|immunogenicity
5454190|NCT01485406|Toddlers|toddlers
5454191|NCT01485380|Dexmedetomidine|dexmedetomidine
5454192|NCT01485380|Sleep|sleep
5454193|NCT01485380|MRI-PET|mri-pet
5454194|NCT01485380|EEG|eeg
5454195|NCT01485367|Senile Purpura|senile purpura
5454196|NCT01485367|Adapalene 0.3%|adapalene 0.3%
5454197|NCT01485354|Stroke|stroke
5454198|NCT01485354|Rehabilitation|rehabilitation
5454199|NCT01485341|gluten sensitivity|gluten sensitivity
5454200|NCT01485328|Dyspepsia|dyspepsia
5454201|NCT01485328|Flatulence|flatulence
5454202|NCT01485328|Aerophagia|aerophagia
5454203|NCT01485328|Constipation|constipation
5454204|NCT01485302|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5454205|NCT01485276|Parkinson's Disease|parkinson's disease
5454206|NCT01485276|Deep Brain Stimulation|deep brain stimulation
5454207|NCT01485276|Gait|gait
5454208|NCT01485276|Electrophysiology|electrophysiology
5454209|NCT01485276|Parkinson Disease|parkinson disease
5454211|NCT01485263|Deep Brain Stimulation|deep brain stimulation
5454212|NCT01485263|OCD|ocd
5454213|NCT01485250|Healthy Volunteers|healthy volunteers
5454214|NCT01485250|Motivations|motivations
5454215|NCT01485250|Decision Making|decision making
5454216|NCT01485250|Motivation|motivation
5454217|NCT01485224|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5454218|NCT01485224|Epistaxis|epistaxis
5454219|NCT01485224|Thalidomide|thalidomide
5454220|NCT01485211|progressive keratoconus|progressive keratoconus
5454221|NCT01485211|thin corneas|thin corneas
5454222|NCT01485211|cross-linking|cross-linking
5454223|NCT01485211|hypo-osmolar riboflavin|hypo-osmolar riboflavin
5454224|NCT01485198|osteoarthritis|osteoarthritis
5454226|NCT01485198|stem cell therapy|stem cell therapy
5454227|NCT01485198|bone marrow|bone marrow
5454228|NCT01485198|G-CSF|g-csf
5454229|NCT01485185|Donepezil|donepezil
5454230|NCT01485185|allodynia|allodynia
5454231|NCT01485185|Gabapentin|gabapentin
5454232|NCT01485185|Sural nerve stimulation|sural nerve stimulation
5454233|NCT01485185|Electrical hyperalgesia|electrical hyperalgesia
5454234|NCT01485159|prevalence|prevalence
5454236|NCT01485159|emphysema|emphysema
5454237|NCT01485159|co-morbidities|co-morbidities
5454238|NCT01485159|ischemic heart disease|ischemic heart disease
5454239|NCT01485159|chronic bronchitis|chronic bronchitis
5454249|NCT01485107|Ulthera, Inc.|ulthera, inc.
5454250|NCT01485107|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5454251|NCT01485094|neuralgia|neuralgia
5454252|NCT01485094|postherpetic|postherpetic
5454253|NCT01485081|Bifurcation|bifurcation
5454254|NCT01485081|Drug-eluting balloon|drug-eluting balloon
5454255|NCT01485081|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
5454256|NCT01485081|Angioplasty|angioplasty
5454257|NCT01485081|Coronary artery disease|coronary artery disease
5454258|NCT01485081|Coronary artery stenosis|coronary artery stenosis
5454259|NCT01485068|Restenosis|restenosis
5454260|NCT01485068|Paclitaxel-eluting balloon|paclitaxel-eluting balloon
5454261|NCT01485068|Angioplasty|angioplasty
5454262|NCT01485068|Coronary artery disease|coronary artery disease
5454263|NCT01485068|Coronary artery stenosis|coronary artery stenosis
5454264|NCT01485055|aGVHD|agvhd
5454265|NCT01485055|GVHD|gvhd
5436904|NCT01558193|Vitamins|vitamins
5454266|NCT01485055|Graft versus host disease|graft versus host disease
5454267|NCT01485055|Acute graft versus host disease|acute graft versus host disease
5454268|NCT01485055|Steroid refractory graft versus host disease|steroid refractory graft versus host disease
5454269|NCT01485055|Bone marrow transplant|bone marrow transplant
5454270|NCT01485055|BMT|bmt
5454271|NCT01485055|HSCT|hsct
5454272|NCT01485055|infliximab|infliximab
5454273|NCT01485055|basiliximab|basiliximab
5454274|NCT01485055|Monoclonal antibody treatment|monoclonal antibody treatment
5454275|NCT01485042|Phase 1|phase 1
5454276|NCT01485042|pazopanib|pazopanib
5454277|NCT01485042|TH-302|th-302
5454278|NCT01485042|advanced solid tumors|advanced solid tumors
5454279|NCT01485016|epilepsy|epilepsy
5454280|NCT01485016|ECG|ecg
5454281|NCT01485016|accelerometer|accelerometer
5454282|NCT01484990|Parkinson's Disease|parkinson's disease
5454283|NCT01484990|levodopa|levodopa
5454284|NCT01484990|carbidopa|carbidopa
5454285|NCT01484990|Duodopa|duodopa
5454286|NCT01484990|intestinal gel|intestinal gel
5454287|NCT01484977|Lacosamide|lacosamide
5454288|NCT01484977|Epilepsy|epilepsy
5454289|NCT01484977|Levetiracetam|levetiracetam
5454290|NCT01484977|Sodium Channel Blockers|sodium channel blockers
5454291|NCT01484964|ASP015K|asp015k
5454292|NCT01484964|healthy subjects|healthy subjects
5454293|NCT01484964|bioavailability|bioavailability
5454294|NCT01484964|food effect|food effect
5454295|NCT01484964|rheumatoid arthritis|rheumatoid arthritis
5454296|NCT01484964|psoriasis|psoriasis
5454297|NCT01484964|transplantation|transplantation
5454298|NCT01484951|Open-angle glaucoma|open-angle glaucoma
5454299|NCT01484951|Ocular hypertension|ocular hypertension
5454300|NCT01484951|Pigment dispersion glaucoma|pigment dispersion glaucoma
5454301|NCT01484938|Soft contact lenses|soft contact lenses
5454302|NCT01484938|Multi-purpose solution|multi-purpose solution
5454303|NCT01484938|Corneal staining|corneal staining
5454304|NCT01484925|Barrett's esophagus|barrett's esophagus
5454305|NCT01484912|Green tea polyphenols|green tea polyphenols
5454306|NCT01484912|Chronic Stable Angina|chronic stable angina
5454307|NCT01484899|Pulmonary arterial Hypertension|pulmonary arterial hypertension
5454308|NCT01484899|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5454309|NCT01484899|smoking|smoking
5454310|NCT01484886|Hemoglobin|hemoglobin
5454311|NCT01484886|Congenital heart disease|congenital heart disease
5454312|NCT01484886|Cardiac surgery|cardiac surgery
5454313|NCT01484886|Red blood cell transfusion|red blood cell transfusion
5454314|NCT01484886|Number of red blood cell transfusions|number of red blood cell transfusions
5454315|NCT01484873|Exenatide|exenatide
5454316|NCT01484873|Byetta|byetta
5454317|NCT01484873|Hypothalamic Obesity|hypothalamic obesity
5454318|NCT01484873|Obesity|obesity
5454319|NCT01484873|Craniopharyngioma|craniopharyngioma
5454320|NCT01484860|AUY922|auy922
5454321|NCT01484860|Pancreas|pancreas
5454322|NCT01484860|Pancreatic cancer|pancreatic cancer
5454323|NCT01484860|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5454324|NCT01484860|Cancer of the pancreas|cancer of the pancreas
5454325|NCT01484860|Metastatic|metastatic
5454326|NCT01484860|Advanced|advanced
5454327|NCT01484860|Advanced disease|advanced disease
5426334|NCT01603303|AI|ai
5454328|NCT01484860|Prior systemic anticancer therapy|prior systemic anticancer therapy
5454329|NCT01484847|advanced|advanced
5454330|NCT01484847|PF-00299804|pf-00299804
5454331|NCT01484847|head and neck|head and neck
5454332|NCT01484847|pharmacokinetic|pharmacokinetic
5454333|NCT01484847|squamous cell carcinoma|squamous cell carcinoma
5454334|NCT01484847|gastrojejunostomy|gastrojejunostomy
5454335|NCT01484847|feeding tube|feeding tube
5454336|NCT01484834|Physical Activity|physical activity
5454337|NCT01484834|Occupational Health|occupational health
5454338|NCT01484834|Quality of Life|quality of life
5454339|NCT01484834|Health Promotion|health promotion
5454340|NCT01484821|Sarcopenia|sarcopenia
5454341|NCT01484821|ARFI|arfi
5454342|NCT01484821|DEXA|dexa
5454343|NCT01484821|Cancer|cancer
5454344|NCT01484808|PSA Density|psa density
5454345|NCT01484808|Prostate Cancer|prostate cancer
5454346|NCT01484808|Prostate Biopsy|prostate biopsy
5454348|NCT01484795|noninvasive ventilation|noninvasive ventilation
5454349|NCT01484795|autonomic nervous system|autonomic nervous system
5454350|NCT01484782|Hypertension|hypertension
5454351|NCT01484782|Telephone Care Management|telephone care management
5454352|NCT01484782|Blood pressure|blood pressure
5454353|NCT01484782|Medication adherence|medication adherence
5454354|NCT01484782|Interactive Voice Response (IVR)|interactive voice response (ivr)
5454355|NCT01484782|Cloud computing|cloud computing
5454356|NCT01484756|respiratory infection|respiratory infection
5454357|NCT01484756|independent elderly|independent elderly
5454358|NCT01484756|zinc|zinc
5454359|NCT01484756|vitamins|vitamins
5454360|NCT01484743|recurrence|recurrence
5454361|NCT01484743|readmission|readmission
5454362|NCT01484743|reoperation|reoperation
5454363|NCT01484743|mortality|mortality
5454364|NCT01484743|morbidity|morbidity
5454365|NCT01484704|Carcinoma ductale mammae|carcinoma ductale mammae
5437006|NCT01557816|knee|knee
5454366|NCT01484678|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5454367|NCT01484678|Magnetic Resonance Imaging|magnetic resonance imaging
5454368|NCT01484678|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5454369|NCT01484678|Muscle|muscle
5454370|NCT01484665|PSA screening|psa screening
5454371|NCT01484665|Decision aids|decision aids
5454372|NCT01484652|Moderate Post-Operative Pain|moderate post-operative pain
5454373|NCT01484652|Severe Post-Operative Pain|severe post-operative pain
5454374|NCT01484652|Bunionectomy|bunionectomy
5454375|NCT01484639|transfusion|transfusion
5454376|NCT01484639|cardiac surgery|cardiac surgery
5454377|NCT01484626|Relapsed Multiple Myeloma|relapsed multiple myeloma
5454378|NCT01484626|Refractory Multiple Myeloma|refractory multiple myeloma
5454379|NCT01484626|Bendamustine|bendamustine
5454380|NCT01484626|Bortezomib|bortezomib
5454381|NCT01484626|Lenalidomide|lenalidomide
5671349|NCT00616421|meningitis|meningitis
5454382|NCT01484626|Dexamethasone|dexamethasone
5454383|NCT01484626|Treanda|treanda
5454384|NCT01484626|Velcade|velcade
5454385|NCT01484626|Revlimid|revlimid
5454386|NCT01484613|Hear Failure|hear failure
5454387|NCT01484613|Cardiac resynchronization|cardiac resynchronization
5454388|NCT01484613|CRT-D|crt-d
5454389|NCT01484613|quadripolar|quadripolar
5454390|NCT01484600|Volunteers|volunteers
5454391|NCT01484587|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5454392|NCT01484587|Psoriasis|psoriasis
5454393|NCT01484587|Plaque-type psoriasis|plaque-type psoriasis
5454394|NCT01484587|CNTO 1959|cnto 1959
5454395|NCT01484587|Japanese participants|japanese participants
5454396|NCT01484574|Critical limb ischemia|critical limb ischemia
5454397|NCT01484574|Buerger's disease|buerger's disease
5454398|NCT01484574|Critical limb ischemia due to Buerger's disease|critical limb ischemia due to buerger's disease
5454399|NCT01484561|Phase 1|phase 1
5454400|NCT01484522|Influenza|influenza
5454401|NCT01484522|Perinatal|perinatal
5454402|NCT01484522|immunogenicity|immunogenicity
5454403|NCT01484522|Monovalent vaccine|monovalent vaccine
5454404|NCT01484522|Children|children
5454405|NCT01484522|Youth|youth
5454406|NCT01484522|H1N1|h1n1
5454407|NCT01484522|Adolescent|adolescent
5454408|NCT01484522|Flu|flu
5454409|NCT01484509|walking impairment|walking impairment
5454410|NCT01484509|claudication|claudication
5454411|NCT01484509|treadmill|treadmill
5454412|NCT01484509|questionnaire|questionnaire
5454413|NCT01484496|Subcutaneous|subcutaneous
5454414|NCT01484496|Lupus|lupus
5454415|NCT01484496|Systemic Lupus Erythematosus|systemic lupus erythematosus
5454416|NCT01484496|SLE|sle
5454417|NCT01484496|Belimumab|belimumab
5454418|NCT01484496|Autoimmune Disease|autoimmune disease
5454419|NCT01484496|Antibodies|antibodies
5454420|NCT01484470|Stem cell transplantation|stem cell transplantation
5454421|NCT01484470|Stem Cell expansion|stem cell expansion
5454422|NCT01484470|Elderly|elderly
5454423|NCT01484457|Diabetes Mellitus|diabetes mellitus
5454424|NCT01484457|Closed Loop|closed loop
5454425|NCT01484457|Artificial Pancreas|artificial pancreas
5454426|NCT01484418|Chronic Low Back Pain|chronic low back pain
5454427|NCT01484418|Cognitive Behavioural Therapy|cognitive behavioural therapy
5454428|NCT01484418|Exposure|exposure
5454429|NCT01484418|Fear avoidance|fear avoidance
5454430|NCT01484418|Cognitive Behavioural Therapy in chronic low back pain|cognitive behavioural therapy in chronic low back pain
5454436|NCT01484379|Primary Hyperparathyroidism|primary hyperparathyroidism
5454437|NCT01484379|multigland disease|multigland disease
5454438|NCT01484379|neck exploration|neck exploration
5454439|NCT01484379|elderly|elderly
5454440|NCT01484366|fractures of both radius and ulna|fractures of both radius and ulna
5454441|NCT01484353|Diabetes|diabetes
5454442|NCT01484340|smoking|smoking
5454443|NCT01484340|administration, cutaneous|administration, cutaneous
5454444|NCT01484327|Heart Failure|heart failure
5454445|NCT01484327|Acute Myocardial Infarction|acute myocardial infarction
5454450|NCT01484301|Tolerability|tolerability
5454451|NCT01484275|High-risk smoldering multiple myeloma|high-risk smoldering multiple myeloma
5454452|NCT01484275|Multiple myeloma|multiple myeloma
5454453|NCT01484275|Siltuximab|siltuximab
5454454|NCT01484249|embolic|embolic
5454455|NCT01484249|filters|filters
5454456|NCT01484249|brachiocephalic|brachiocephalic
5454457|NCT01484249|neurovasculature|neurovasculature
5454458|NCT01484249|debris|debris
5454459|NCT01484236|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5454460|NCT01484223|Primary Health Care|primary health care
5454461|NCT01484223|Somatization symptoms|somatization symptoms
5454462|NCT01484223|Cognitive Behavioral Therapy|cognitive behavioral therapy
5454463|NCT01484223|Nursing intervention|nursing intervention
5454464|NCT01484197|Asthma|asthma
5454465|NCT01484197|Indacaterol|indacaterol
5454466|NCT01484197|QAB149|qab149
5454467|NCT01484184|Completely paralyzed|completely paralyzed
5454468|NCT01484184|Chronically injured|chronically injured
5454469|NCT01484184|Central Pattern Generator|central pattern generator
5454470|NCT01484184|Locomotion|locomotion
5454471|NCT01484184|Secondary complications|secondary complications
5454472|NCT01484184|Activity-based training|activity-based training
5454473|NCT01484184|Treadmill training|treadmill training
5454474|NCT01484184|Spinal cord injury|spinal cord injury
5454475|NCT01484184|Paraplegia|paraplegia
5454476|NCT01484184|Tetraplegia|tetraplegia
5454477|NCT01484171|Acute Myeloid Leukemia|acute myeloid leukemia
5454478|NCT01484171|idarubicin|idarubicin
5454479|NCT01484171|Microtransplantation|microtransplantation
5454480|NCT01484158|Myocardial Infarction|myocardial infarction
5454481|NCT01484145|Onychomycosis|onychomycosis
5454482|NCT01484145|Nail fungus|nail fungus
5454483|NCT01484145|Tinea Unguium|tinea unguium
5454484|NCT01484132|Dental Caries|dental caries
5454485|NCT01484132|Dental Restorative Materials|dental restorative materials
5454486|NCT01484132|Dental Composite|dental composite
5454487|NCT01484132|Bisphenol-A|bisphenol-a
5454488|NCT01484119|seasonal allergic rhinitis|seasonal allergic rhinitis
5454489|NCT01484093|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5454490|NCT01484093|CYTARABINE (ARA-C)|cytarabine (ara-c)
5454491|NCT01484093|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5454492|NCT01484093|PREDNISONE|prednisone
5454494|NCT01484093|TOSITUMOMAB (BEXXAR)|tositumomab (bexxar)
5454496|NCT01484093|VINCRISTIN|vincristin
5454497|NCT01484093|Lymphoma|lymphoma
5454498|NCT01484093|Chemo-Radioimmunotherapy|chemo-radioimmunotherapy
5454499|NCT01484093|Autologous Transplantation|autologous transplantation
5454500|NCT01484093|Untreated|untreated
5454501|NCT01484093|11-095|11-095
5454502|NCT01484067|Herpes Simplex Virus|herpes simplex virus
5454503|NCT01484041|Breast cancer|breast cancer
5454504|NCT01484041|postmenopausal|postmenopausal
5454505|NCT01484002|Hip replacement|hip replacement
5454506|NCT01484002|Crosslinked and conventional polyethylene|crosslinked and conventional polyethylene
5454507|NCT01484002|Oxidation|oxidation
5454508|NCT01484002|Crosslink density|crosslink density
5454509|NCT01484002|Outcome|outcome
5454510|NCT01483989|Dry Eye|dry eye
5454511|NCT01483989|Epithelial changes|epithelial changes
5454512|NCT01483950|Dyslipidemia|dyslipidemia
5454513|NCT01483950|Statins|statins
5454514|NCT01483950|Total Cholesterol|total cholesterol
5454515|NCT01483950|Low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
5454516|NCT01483950|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
5454517|NCT01483937|Keywords provided by BalanceSense, LLC:|keywords provided by balancesense, llc:
5454518|NCT01483937|Physical Therapy|physical therapy
5454519|NCT01483937|Rehabilitation|rehabilitation
5454520|NCT01483937|Disequilibrium|disequilibrium
5454521|NCT01483937|Balance dysfunction or disorder|balance dysfunction or disorder
5454522|NCT01483937|Vestibular|vestibular
5454523|NCT01483937|Mild Traumatic Brain Injury (mTBI)|mild traumatic brain injury (mtbi)
5454524|NCT01483937|Vibrotactile|vibrotactile
5454525|NCT01483924|Mild to Moderate Chronic Plaque Psoriasis|mild to moderate chronic plaque psoriasis
5454527|NCT01483898|REVIVE|revive
5439621|NCT01547000|Intuniv|intuniv
5454528|NCT01483898|peripheral vascular disease|peripheral vascular disease
5454529|NCT01483898|CLI|cli
5454530|NCT01483898|PAD|pad
5454531|NCT01483898|MSC|msc
5454532|NCT01483898|stem cells|stem cells
5685298|NCT00556660|Alzheimer|alzheimer
5454533|NCT01483898|cell therapy|cell therapy
5454534|NCT01483872|salvage infected hemodialysis catheters|salvage infected hemodialysis catheters
5454535|NCT01483872|novel catheter lock solution|novel catheter lock solution
5454536|NCT01483846|Neuropathic Pain|neuropathic pain
5454537|NCT01483846|Capsaicin Induced Pain|capsaicin induced pain
5454538|NCT01483807|speech|speech
5454539|NCT01483807|speech therapy|speech therapy
5454540|NCT01483807|apraxia of speech|apraxia of speech
5454541|NCT01483794|genital warts|genital warts
5457717|NCT01470833|Achilles tendon|achilles tendon
5454542|NCT01483781|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5454543|NCT01483781|Plasma Volume|plasma volume
5454544|NCT01483781|Canagliflozin|canagliflozin
5454545|NCT01483781|Metformin|metformin
5454546|NCT01483781|Hemoglobin A1c|hemoglobin a1c
5454547|NCT01483781|Hypertension|hypertension
5454548|NCT01483781|Angiotensin-Converting Enzyme Inhibitors (ACEIs)|angiotensin-converting enzyme inhibitors (aceis)
5454549|NCT01483781|Angiotensin Receptor Blockers (ARBs)|angiotensin receptor blockers (arbs)
5454550|NCT01483781|Pharmacodynamics|pharmacodynamics
5454551|NCT01483781|Pharmacokinetics|pharmacokinetics
5454552|NCT01483768|Sleeve gastrectomy|sleeve gastrectomy
5454553|NCT01483768|Obesity surgery|obesity surgery
5454554|NCT01483768|Iron deficiency|iron deficiency
5454555|NCT01483768|HEPCIDINE|hepcidine
5454556|NCT01483755|Myocardial infarction|myocardial infarction
5454557|NCT01483755|Postconditioning|postconditioning
5454558|NCT01483690|Relapse|relapse
5454559|NCT01483690|Lymphoblastic|lymphoblastic
5454560|NCT01483690|Leukemia|leukemia
5454561|NCT01483690|Decitabine|decitabine
5454562|NCT01483690|Vorinostat|vorinostat
5454563|NCT01483690|Refractory|refractory
5454564|NCT01483690|Acute|acute
5454565|NCT01483690|Childhood|childhood
5454566|NCT01483690|Pediatric|pediatric
5454567|NCT01483690|ALL|all
5454568|NCT01483677|Laparoscopy|laparoscopy
5454569|NCT01483677|video games|video games
5454570|NCT01483677|Nintendo Wii|nintendo wii
5454571|NCT01483677|Playstation|playstation
5454572|NCT01483664|patient outcomes|patient outcomes
5454573|NCT01483664|Survivorship|survivorship
5454574|NCT01483664|Communication Skills|communication skills
5454575|NCT01483664|Communication strategies|communication strategies
5454576|NCT01483664|Physicians communication|physicians communication
5454577|NCT01483664|11-180|11-180
5454578|NCT01483651|diabetes|diabetes
5454579|NCT01483651|glucagon|glucagon
5454580|NCT01483651|insulin|insulin
5454581|NCT01483651|dideuterated glucose|dideuterated glucose
5454582|NCT01483638|duration of disease response|duration of disease response
5454583|NCT01483638|axitinib|axitinib
5454584|NCT01483612|Body Weight|body weight
5454585|NCT01483612|Female|female
5454710|NCT01483040|PeerScope B System™|peerscope b system™
5454586|NCT01483612|Infertility, Female/therapy|infertility, female/therapy
5454587|NCT01483612|Infertility, Female/physiopathology|infertility, female/physiopathology
5454588|NCT01483612|Obesity/physiopathology|obesity/physiopathology
5454589|NCT01483612|Polycystic ovary syndrome|polycystic ovary syndrome
5454590|NCT01483612|Pregnancy|pregnancy
5454591|NCT01483612|Pregnancy Outcome|pregnancy outcome
5454595|NCT01483599|Plaque-type psoriasis|plaque-type psoriasis
5454596|NCT01483599|CNTO 1959|cnto 1959
5454597|NCT01483599|adalimumab|adalimumab
5454598|NCT01483573|low back pain|low back pain
5454599|NCT01483573|straight leg raise|straight leg raise
5454601|NCT01483560|metformin|metformin
5454602|NCT01483560|carotid IMT|carotid imt
5454603|NCT01483560|LDL Cholesterol|ldl cholesterol
5454604|NCT01483560|endothelial function|endothelial function
5454605|NCT01483560|retinopathy|retinopathy
5454607|NCT01483534|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5454608|NCT01483534|Pulmonary|pulmonary
5454609|NCT01483534|Intervention|intervention
5454610|NCT01483534|Device|device
5454611|NCT01483534|Denervation|denervation
5454612|NCT01483534|Lung|lung
5454613|NCT01483534|Holaira, Inc.|holaira, inc.
5454614|NCT01483534|Innovative Pulmonary Solutions, Inc.|innovative pulmonary solutions, inc.
5454615|NCT01483521|Randomized|randomized
5454616|NCT01483521|Home visitation|home visitation
5454617|NCT01483521|Externalizing disorder|externalizing disorder
5454618|NCT01483521|Parenting stress|parenting stress
5454619|NCT01483521|Childhood externalizing disorders|childhood externalizing disorders
5454620|NCT01483521|Positional defiant|positional defiant
5454621|NCT01483508|flavanols|flavanols
5454622|NCT01483508|procyanidins|procyanidins
5454623|NCT01483508|absorption|absorption
5454624|NCT01483508|cocoa polyphenols|cocoa polyphenols
5454625|NCT01483508|Flavanol and procyanidin absorption in healthy volunteers|flavanol and procyanidin absorption in healthy volunteers
5454626|NCT01483482|clavicle fractures|clavicle fractures
5454627|NCT01483482|midshaft clavicle fractures|midshaft clavicle fractures
5454628|NCT01483482|conservative treatment|conservative treatment
5454629|NCT01483482|surgical treatment|surgical treatment
5454630|NCT01483482|functional outcome|functional outcome
5454631|NCT01483482|clinical assessment|clinical assessment
5454632|NCT01483482|adults|adults
5454633|NCT01483456|Accidental falls|accidental falls
5454634|NCT01483456|safety management|safety management
5454636|NCT01483456|inpatient|inpatient
5454637|NCT01483456|stepped wedge design|stepped wedge design
5454638|NCT01483443|oophrectomy|oophrectomy
5454639|NCT01483443|survival|survival
5454640|NCT01483430|Blood pressure|blood pressure
5454641|NCT01483430|Korea red ginseng|korea red ginseng
5454642|NCT01483430|Ambulatory blood pressure|ambulatory blood pressure
5454643|NCT01483430|Pulse wave velocity|pulse wave velocity
5454644|NCT01483417|SILS|sils
5454645|NCT01483417|Laparoscopic hysterectomy|laparoscopic hysterectomy
5798676|NCT00111397|Proteomics|proteomics
5454647|NCT01483417|Pain|pain
5454648|NCT01483404|microcirculation|microcirculation
5454649|NCT01483404|caput femoris|caput femoris
5454650|NCT01483391|Bipolar disorder|bipolar disorder
5454651|NCT01483391|Major depressive disorder|major depressive disorder
5454652|NCT01483391|Mania|mania
5454653|NCT01483391|Depression|depression
5454654|NCT01483391|Cyclothymic Disorder|cyclothymic disorder
5454655|NCT01483313|Anesthestics|anesthestics
5454656|NCT01483313|Minor surgery|minor surgery
5454657|NCT01483313|Wechsler Intelligence Scale for Children|wechsler intelligence scale for children
5454658|NCT01483313|Cognitiion|cognitiion
5454659|NCT01483300|breast cancer|breast cancer
5454660|NCT01483300|gemcitabine|gemcitabine
5454661|NCT01483300|lobaplatin|lobaplatin
5454662|NCT01483300|cisplatin|cisplatin
5454663|NCT01483287|Gastrointestinal Symptoms|gastrointestinal symptoms
5454664|NCT01483287|Bloating|bloating
5454665|NCT01483287|Distention|distention
5454667|NCT01483274|vaccine|vaccine
5454668|NCT01483261|Trauma-Focused Cognitive Behavior Therapy|trauma-focused cognitive behavior therapy
5454669|NCT01483261|Sexually Exploited Girls|sexually exploited girls
5454670|NCT01483261|Post-traumatic Stress Symptoms|post-traumatic stress symptoms
5454671|NCT01483261|Psychosocial Distress|psychosocial distress
5454672|NCT01483248|Menstrual blood|menstrual blood
5454673|NCT01483248|Mesenchymal stem cell|mesenchymal stem cell
5454674|NCT01483248|Liver cirrhosis|liver cirrhosis
5454675|NCT01483235|cardiac rehabilitation|cardiac rehabilitation
5454676|NCT01483235|prevention|prevention
5454677|NCT01483235|exercise capacity|exercise capacity
5454678|NCT01483222|Low Back Pain|low back pain
5454679|NCT01483222|Braces|braces
5454680|NCT01483222|Prevention|prevention
5454681|NCT01483209|Digital ischemia|digital ischemia
5454682|NCT01483209|Vasopressor|vasopressor
5454683|NCT01483183|Atrial fibrillation|atrial fibrillation
5454684|NCT01483183|Paroxysmal Atrial fibrillation|paroxysmal atrial fibrillation
5454685|NCT01483183|Persistent Atrial fibrillation|persistent atrial fibrillation
5454686|NCT01483183|A-fib|a-fib
5454690|NCT01483118|PCOS|pcos
5454691|NCT01483118|Insulin resistance|insulin resistance
5454692|NCT01483118|Cinnamon extract|cinnamon extract
5455192|NCT01480999|Laparotomy|laparotomy
5454693|NCT01483118|Irregular menstrual cycles|irregular menstrual cycles
5454694|NCT01483118|Ovarian cysts|ovarian cysts
5454695|NCT01483105|VCUG|vcug
5454696|NCT01483105|Child|child
5454697|NCT01483105|Hypnosis|hypnosis
5454698|NCT01483105|Relaxation|relaxation
5454699|NCT01483105|Voiding cystourethrography|voiding cystourethrography
5454700|NCT01483079|donor human milk products|donor human milk products
5454701|NCT01483079|post-discharge|post-discharge
5454702|NCT01483079|growth|growth
5454703|NCT01483079|development|development
5454704|NCT01483053|Major depressive disorder|major depressive disorder
5454705|NCT01483053|Sympathetic nervous system activation|sympathetic nervous system activation
5454706|NCT01483053|Cardiovascular risk factors|cardiovascular risk factors
5454707|NCT01483053|Agomelatine|agomelatine
5454708|NCT01483053|Escitalopram|escitalopram
5454709|NCT01483040|wide angle view colonoscopy|wide angle view colonoscopy
5454711|NCT01483014|Gastrointestinal,|gastrointestinal,
5454712|NCT01483014|stromal,|stromal,
5454713|NCT01483014|neoadjuvant,|neoadjuvant,
5454714|NCT01483014|imatinib,|imatinib,
5454715|NCT01483014|mesylate,|mesylate,
5454716|NCT01483014|pre-operatory|pre-operatory
5454717|NCT01483001|Cancer Stem Cells|cancer stem cells
5454718|NCT01483001|Chemo-Sensitivity Assay|chemo-sensitivity assay
5454719|NCT01483001|Cancer Treatment|cancer treatment
5454720|NCT01482988|prevalence of the Dectin-1 polymorphism (Tyr238X)|prevalence of the dectin-1 polymorphism (tyr238x)
5454721|NCT01482975|tobacco|tobacco
5454722|NCT01482975|alcohol|alcohol
5454723|NCT01482975|diet|diet
5454724|NCT01482975|exercise|exercise
5454725|NCT01482962|Drug Therapy|drug therapy
5454726|NCT01482949|RCC|rcc
5454727|NCT01482949|Kidney Cancer|kidney cancer
5454728|NCT01482949|Renal Cancer|renal cancer
5454729|NCT01482949|Arcelis|arcelis
5454730|NCT01482923|Tobacco Use Assessment|tobacco use assessment
5454731|NCT01482923|smoke tobacco|smoke tobacco
5454732|NCT01482923|quit smoking|quit smoking
5454733|NCT01482923|tobacco cessation|tobacco cessation
5454737|NCT01482923|Low-Income Persons Living with HIV/AIDS|low-income persons living with hiv/aids
5454739|NCT01482897|Subjects|subjects
5454740|NCT01482897|evolving|evolving
5454742|NCT01482884|inflammatory bowel disease|inflammatory bowel disease
5454743|NCT01482884|moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5454744|NCT01482871|Diabetic Macular Edema|diabetic macular edema
5454745|NCT01482832|Randomized trial|randomized trial
5454746|NCT01482832|Postpartum depression|postpartum depression
5454747|NCT01482832|Adolescent pregnancy|adolescent pregnancy
5457922|NCT01469897|JIA|jia
5454750|NCT01482806|Anxiety|anxiety
5454751|NCT01482806|Primary care|primary care
5454752|NCT01482806|Cognitive Behavioral Therapy|cognitive behavioral therapy
5454753|NCT01482806|Internet|internet
5454754|NCT01482806|Support groups|support groups
5454755|NCT01482806|Technology assisted|technology assisted
5454756|NCT01482741|Quality of Life|quality of life
5454757|NCT01482741|Focus groups|focus groups
5454758|NCT01482741|Risks of Ionizing Radiation|risks of ionizing radiation
5454759|NCT01482741|Risk of medical imaging|risk of medical imaging
5454760|NCT01482741|11-185|11-185
5454761|NCT01482715|gBRCA ovarian cancer|gbrca ovarian cancer
5454762|NCT01482715|platinum sensitive|platinum sensitive
5454763|NCT01482715|PARP Inhibitor|parp inhibitor
5454764|NCT01482715|Rucaparib|rucaparib
5454765|NCT01482715|CO-338|co-338
5454766|NCT01482715|PF 01367338|pf 01367338
5454767|NCT01482715|AG 14699|ag 14699
5454768|NCT01482715|BRCA1|brca1
5454769|NCT01482715|BRCA2|brca2
5454770|NCT01482715|platinum sensitive ovarian cancer|platinum sensitive ovarian cancer
5454771|NCT01482715|platinum sensitive gBRCA ovarian cancer|platinum sensitive gbrca ovarian cancer
5454772|NCT01482715|gynecological cancer|gynecological cancer
5454773|NCT01482715|relapsed disease|relapsed disease
5454774|NCT01482715|homologous recombination deficiency|homologous recombination deficiency
5454775|NCT01482715|HRD|hrd
5454776|NCT01482702|breast cancer survivor|breast cancer survivor
5454777|NCT01482702|weight loss|weight loss
5454778|NCT01482702|postmenopausal|postmenopausal
5437426|NCT01556035|lenalidomide|lenalidomide
5454779|NCT01482702|Weight loss for overweight postmenopausal breast cancer survivors|weight loss for overweight postmenopausal breast cancer survivors
5454780|NCT01482689|Bioavailability|bioavailability
5454781|NCT01482689|Vitamin D metabolism|vitamin d metabolism
5454782|NCT01482689|Bone turnover|bone turnover
5454783|NCT01482663|Hand eczema|hand eczema
5454784|NCT01482663|Hand dermatitis|hand dermatitis
5454785|NCT01482663|Chronic hand eczema|chronic hand eczema
5454786|NCT01482663|Chronic hand dermatitis|chronic hand dermatitis
5454787|NCT01482663|Contact dermatitis|contact dermatitis
5454788|NCT01482663|Skin disease|skin disease
5454789|NCT01482663|Self-management|self-management
5454790|NCT01482650|Baska mask|baska mask
5454791|NCT01482650|LMA|lma
5454792|NCT01482650|laryngeal mask airway|laryngeal mask airway
5454793|NCT01482650|supraglottic airway device|supraglottic airway device
5454794|NCT01482624|hyaluronan|hyaluronan
5454795|NCT01482624|hyaluronic acid|hyaluronic acid
5454796|NCT01482611|Hepatitis C Virus|hepatitis c virus
5454797|NCT01482611|JNJ-47910382|jnj-47910382
5454798|NCT01482611|47910382HPC1001|47910382hpc1001
5454799|NCT01482611|HCV|hcv
5454800|NCT01482611|Hepatitis C|hepatitis c
5454801|NCT01482611|Hep C|hep c
5454802|NCT01482611|Healthy participants|healthy participants
5454803|NCT01482611|Japanese|japanese
5454804|NCT01482611|Caucasians|caucasians
5454805|NCT01482598|Heart Failure|heart failure
5454806|NCT01482598|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5454807|NCT01482598|Remote Care|remote care
5454808|NCT01482598|Disease Management|disease management
5454809|NCT01482585|lung adenocarcinoma|lung adenocarcinoma
5454810|NCT01482585|prognosis|prognosis
5454811|NCT01482585|tumor aggressiveness|tumor aggressiveness
5454812|NCT01482585|imaging biomarker|imaging biomarker
5454813|NCT01482585|genetic biomarker|genetic biomarker
5454814|NCT01482572|biopsy|biopsy
5454815|NCT01482572|needle aspiration|needle aspiration
5454816|NCT01482572|mutational analysis|mutational analysis
5454817|NCT01482559|Dopamine|dopamine
5454818|NCT01482559|Intraventricular haemorrhage|intraventricular haemorrhage
5454819|NCT01482559|Periventricular Leukomalacia|periventricular leukomalacia
5454820|NCT01482559|Neurodisability|neurodisability
5454821|NCT01482559|Infant|infant
5454822|NCT01482546|colonoscopy|colonoscopy
5454823|NCT01482546|trainees|trainees
5454824|NCT01482546|water|water
5454825|NCT01482546|adenoma detection rate|adenoma detection rate
5454826|NCT01482546|cecal intubation rate|cecal intubation rate
5454827|NCT01482494|Myopathies|myopathies
5454828|NCT01482494|Pompe disease|pompe disease
5454829|NCT01482494|Polymyositis|polymyositis
5454830|NCT01482494|Respiratory Insufficiency|respiratory insufficiency
5454831|NCT01482481|Patient Care Planning|patient care planning
5454832|NCT01482481|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5454833|NCT01482481|Cardiovascular Risk Factors|cardiovascular risk factors
5454834|NCT01482481|Primary Health Care|primary health care
5454836|NCT01482455|Insulin resistance|insulin resistance
5454837|NCT01482455|vascular impairment|vascular impairment
5454838|NCT01482455|diabetes|diabetes
5454839|NCT01482442|Liver, HCC|liver, hcc
5685299|NCT00556660|SPECT|spect
5454840|NCT01482442|Liver, interventional procedures|liver, interventional procedures
5454841|NCT01482442|Liver, randomized studies|liver, randomized studies
5454842|NCT01482442|Liver, targeted therapy|liver, targeted therapy
5454843|NCT01482442|Liver, RADIOEMBOLIZATION|liver, radioembolization
5454844|NCT01482429|ventilator weaning|ventilator weaning
5454845|NCT01482429|protocol|protocol
5454860|NCT01482338|Low-dose combine contraceptives pills|low-dose combine contraceptives pills
5454862|NCT01482299|pS6 Ser 240/4|ps6 ser 240/4
5454863|NCT01482299|RAD001 (everolimus)|rad001 (everolimus)
5454864|NCT01482299|second-line treatment|second-line treatment
5454865|NCT01482299|advanced gastric cancer|advanced gastric cancer
5454867|NCT01482286|Diet|diet
5454868|NCT01482286|Insulin resistance|insulin resistance
5454869|NCT01482286|Weight|weight
5454870|NCT01482273|catheter-directed thrombolysis|catheter-directed thrombolysis
5454871|NCT01482273|ilio-femoral deep vein thrombosis|ilio-femoral deep vein thrombosis
5454872|NCT01482273|Postthrombotic syndrome|postthrombotic syndrome
5454873|NCT01482273|Phlebographic scores|phlebographic scores
5454874|NCT01482273|Phlebography|phlebography
5454875|NCT01482273|Catheters|catheters
5454876|NCT01482234|physical activity|physical activity
5454877|NCT01482234|exercise|exercise
5454878|NCT01482234|walking|walking
5454879|NCT01482234|pedometers|pedometers
5454880|NCT01482234|goal setting|goal setting
5454881|NCT01482234|text messages|text messages
5454882|NCT01482234|motivation|motivation
5454883|NCT01482234|intrinsic motivation|intrinsic motivation
5454884|NCT01482234|extrinsic motivation|extrinsic motivation
5454885|NCT01482234|self determination theory|self determination theory
5454886|NCT01482234|prompts|prompts
5454887|NCT01482221|Major Depressive Disorder|major depressive disorder
5454888|NCT01482221|MDD|mdd
5454889|NCT01482221|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
5454890|NCT01482221|Channel blocker of the NMDA class of glutamate receptors|channel blocker of the nmda class of glutamate receptors
5454891|NCT01482208|Dehydration|dehydration
5454892|NCT01482208|Hydration|hydration
5454893|NCT01482208|Muscle composition|muscle composition
5454894|NCT01482208|Diarrhea|diarrhea
5454895|NCT01482208|Pediatrics|pediatrics
5454896|NCT01482208|Neonatology|neonatology
5454897|NCT01482208|Ultrasound|ultrasound
5454898|NCT01482195|Retinal Disease|retinal disease
5454899|NCT01482182|Non-small cell lung cancer|non-small cell lung cancer
5454900|NCT01482182|Diffusion-weighted MRI|diffusion-weighted mri
5454901|NCT01482182|18F-FDG PET|18f-fdg pet
5454902|NCT01482182|Treatment response|treatment response
5454903|NCT01482182|Prognosis|prognosis
5454904|NCT01482169|Left heart catheterization|left heart catheterization
5454905|NCT01482169|Fractional flow reserve|fractional flow reserve
5454906|NCT01482169|Adenoscan®|adenoscan®
5454907|NCT01482169|Regadenoson|regadenoson
5454908|NCT01482156|Advanced solid tumors|advanced solid tumors
5454909|NCT01482156|Metastatic renal cell carcinoma (mRCC)|metastatic renal cell carcinoma (mrcc)
5454910|NCT01482156|ER+/HER2-Metastatic breast cancer (MBC)|er+/her2-metastatic breast cancer (mbc)
5454911|NCT01482156|Dose finding study|dose finding study
5454913|NCT01482156|Pl3K|pl3k
5454914|NCT01482156|BEZ235|bez235
5454915|NCT01482156|RAD001|rad001
5454916|NCT01482156|Everolimus|everolimus
5454917|NCT01482156|Afinitor®|afinitor®
5454918|NCT01482156|ER+/HER2- metastatic breast cancer|er+/her2- metastatic breast cancer
5454919|NCT01482143|Fragile X Syndrome|fragile x syndrome
5454920|NCT01482143|pharmacokinetics|pharmacokinetics
5454921|NCT01482143|safety and tolerability|safety and tolerability
5454922|NCT01482130|Exercise|exercise
5454923|NCT01482130|osteoporosis|osteoporosis
5454924|NCT01482130|prevention|prevention
5454925|NCT01482117|CYP2C19|cyp2c19
5454926|NCT01482117|CYP3A5|cyp3a5
5454927|NCT01482117|Clopidogrel|clopidogrel
5454928|NCT01482117|Cilostazol|cilostazol
5454929|NCT01482117|Healthy|healthy
5454930|NCT01482104|Photochemotherapy|photochemotherapy
5454931|NCT01482104|methyl 5-aminolevulinate|methyl 5-aminolevulinate
5454932|NCT01482091|fentanyl|fentanyl
5454933|NCT01482091|intranasal|intranasal
5454934|NCT01482091|sickle cell|sickle cell
5454935|NCT01482091|vasoocclusive crisis|vasoocclusive crisis
5454936|NCT01482091|pain crisis|pain crisis
5454937|NCT01482091|pediatrics|pediatrics
5454938|NCT01482078|Magnesium Sulphate|magnesium sulphate
5454939|NCT01482078|Neuroprotection|neuroprotection
5454940|NCT01482078|Neuraxial Anesthesia|neuraxial anesthesia
5454941|NCT01482078|Sedation|sedation
5454942|NCT01482078|Respiratory function|respiratory function
5454943|NCT01482078|Cesarean Section|cesarean section
5454944|NCT01482078|Obstetrical Anesthesia|obstetrical anesthesia
5454945|NCT01482065|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5454946|NCT01482065|NAFLD|nafld
5454947|NCT01482065|Continuous Positive Airway Pressure|continuous positive airway pressure
5454948|NCT01482065|CPAP|cpap
5454949|NCT01482065|CPAP Therapy|cpap therapy
5454950|NCT01482065|Apnea Hypopnea Index|apnea hypopnea index
5454951|NCT01482065|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
5454952|NCT01482065|NASH|nash
5454953|NCT01482065|OSA|osa
5454954|NCT01482065|Obstructive Sleep Apnea|obstructive sleep apnea
5454955|NCT01482065|AHI|ahi
5454956|NCT01482052|Central Nervous System Infections|central nervous system infections
5454957|NCT01482052|Meningitis|meningitis
5454958|NCT01482052|toxoid|toxoid
5454959|NCT01482052|Meningococcal vaccine|meningococcal vaccine
5454960|NCT01482052|conjugate vaccines|conjugate vaccines
5454961|NCT01482039|short cervix|short cervix
5454962|NCT01482039|cervical shortening|cervical shortening
5454963|NCT01482039|preterm birth|preterm birth
5454964|NCT01482026|Epilepsy|epilepsy
5454965|NCT01482026|Attention deficit|attention deficit
5454966|NCT01482026|ADHD rating scale IV|adhd rating scale iv
5454967|NCT01482000|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5454968|NCT01482000|Adult|adult
5454969|NCT01482000|therapeutic use|therapeutic use
5454970|NCT01482000|Humans|humans
5454971|NCT01482000|Treatment Outcome|treatment outcome
5454972|NCT01482000|daoyin therapy|daoyin therapy
5454973|NCT01481987|Microperimetry|microperimetry
5454974|NCT01481987|OCT|oct
5454975|NCT01481987|idiopathic epiretinal membrane|idiopathic epiretinal membrane
5454976|NCT01481974|liver transplantation|liver transplantation
5454977|NCT01481974|treprostinil|treprostinil
5454978|NCT01481961|Alzheimer's disease|alzheimer's disease
5454979|NCT01481961|rTMS|rtms
5454980|NCT01481961|cognition|cognition
5454981|NCT01481948|physical activity|physical activity
5454982|NCT01481948|fruit and vegetable|fruit and vegetable
5454983|NCT01481948|water|water
5454984|NCT01481948|girls|girls
5454985|NCT01481948|African American|african american
5454986|NCT01481948|online|online
5454987|NCT01481935|Antibiotic resistant bacteria|antibiotic resistant bacteria
5454988|NCT01481935|Colonization|colonization
5454989|NCT01481935|Hospital cleaning|hospital cleaning
5454990|NCT01481935|Environmental cleaning|environmental cleaning
5454991|NCT01481935|Infection Control|infection control
5454992|NCT01481922|Lumbar puncture|lumbar puncture
5454993|NCT01481922|Flow rate|flow rate
5454994|NCT01481922|Backache|backache
5454995|NCT01481922|Pain|pain
5454996|NCT01481922|Undifferentiated headache|undifferentiated headache
5454997|NCT01481922|Post-lumbar puncture headache|post-lumbar puncture headache
5454998|NCT01481909|Assessment of wheal and flare development|assessment of wheal and flare development
5454999|NCT01481909|Assessment of life quality|assessment of life quality
5455000|NCT01481896|Hip replacement|hip replacement
5455001|NCT01481896|Metal-on-metal bearings|metal-on-metal bearings
5455002|NCT01481896|Osteolysis|osteolysis
5455003|NCT01481896|Metal ion levels|metal ion levels
5455004|NCT01481896|Outcome|outcome
5455005|NCT01481883|Schizophrenia|schizophrenia
5455006|NCT01481883|Mental Illness|mental illness
5455007|NCT01481883|SERM|serm
5455008|NCT01481883|Raloxifene|raloxifene
5455009|NCT01481870|renal cell carcinoma|renal cell carcinoma
5455010|NCT01481870|sorafenib|sorafenib
5455011|NCT01481870|sunitinib|sunitinib
5455012|NCT01481870|crossover|crossover
5455013|NCT01481844|sequential therapy|sequential therapy
5455014|NCT01481844|second line treatment|second line treatment
5455015|NCT01481844|H pylori|h pylori
5455016|NCT01481792|Keratorefractive Surgical Procedures|keratorefractive surgical procedures
5455017|NCT01481766|child development|child development
5455018|NCT01481766|screening|screening
5455019|NCT01481766|Non-anemic iron deficiency|non-anemic iron deficiency
5455020|NCT01481766|primary care pediatrics|primary care pediatrics
5455021|NCT01481766|prevention and health promotion|prevention and health promotion
5455022|NCT01481740|spinal induced hypotension|spinal induced hypotension
5455023|NCT01481740|nausea and vomiting|nausea and vomiting
5455024|NCT01481740|cesarean delivery|cesarean delivery
5455025|NCT01481727|acute exacerbation of COPD number|acute exacerbation of copd number
5455026|NCT01481727|acute exacerbation of COPD severity|acute exacerbation of copd severity
5455027|NCT01481714|Sodium picosulphate|sodium picosulphate
5455028|NCT01481714|Split-dose|split-dose
5455029|NCT01481714|Bowel cleansing|bowel cleansing
5455030|NCT01481714|colonoscopy|colonoscopy
5455031|NCT01481714|Degree of bowel cleansing during colonoscopy|degree of bowel cleansing during colonoscopy
5455032|NCT01481701|ovarian carcinoma|ovarian carcinoma
5455033|NCT01481701|Bordet|bordet
5455034|NCT01481701|relapse|relapse
5455035|NCT01481688|Dialysis adequacy|dialysis adequacy
5455036|NCT01481688|Urea clearance|urea clearance
5455037|NCT01481688|Phosphate clearance|phosphate clearance
5455038|NCT01481688|Beta 2 microglobulin clearance|beta 2 microglobulin clearance
5455039|NCT01481688|Intradialytic exercise|intradialytic exercise
5455040|NCT01481688|Haemodialysis patients|haemodialysis patients
5455041|NCT01481675|biliopancreatic diversion|biliopancreatic diversion
5455042|NCT01481675|sleeve gastrectomy|sleeve gastrectomy
5455047|NCT01481675|GLP-1|glp-1
5455048|NCT01481662|SUSAC's Syndrome|susac's syndrome
5455049|NCT01481662|encephalopathy|encephalopathy
5455050|NCT01481662|hearing loss|hearing loss
5455051|NCT01481662|retinal artery branch occlusions|retinal artery branch occlusions
5455052|NCT01481662|Diffusion tensor MRI|diffusion tensor mri
5455053|NCT01481649|hepatitis B|hepatitis b
5455054|NCT01481649|anti-HBc|anti-hbc
5455055|NCT01481649|HBsAg|hbsag
5455056|NCT01481649|HSCT|hsct
5455057|NCT01481649|recipients|recipients
5455058|NCT01481636|Obstructive sleep apnea|obstructive sleep apnea
5455059|NCT01481636|correlation|correlation
5455061|NCT01481636|symptoms|symptoms
5455062|NCT01481636|mechanisms|mechanisms
5455063|NCT01481623|Diabetes|diabetes
5455064|NCT01481623|neonatal|neonatal
5455065|NCT01481623|consanguinity|consanguinity
5455066|NCT01481623|monogenic|monogenic
5455067|NCT01481623|metabolism|metabolism
5455068|NCT01481610|Kidney Failure, Chronic|kidney failure, chronic
5455069|NCT01481610|Arthralgia|arthralgia
5455070|NCT01481610|NSAID|nsaid
5455071|NCT01481610|Diclofenac|diclofenac
5455072|NCT01481610|Lumiracoxib|lumiracoxib
5455073|NCT01481610|Safety|safety
5455074|NCT01481597|deuteporfin|deuteporfin
5455075|NCT01481597|safety|safety
5455076|NCT01481597|tolerability|tolerability
5455077|NCT01481597|pharmacokinetics|pharmacokinetics
5455078|NCT01481597|healthy volunteers|healthy volunteers
5455079|NCT01481584|Dietary protein|dietary protein
5455080|NCT01481584|Canola protein|canola protein
5455081|NCT01481584|Protein metabolism|protein metabolism
5455082|NCT01481584|Protein-enriched drinks|protein-enriched drinks
5455083|NCT01481584|Nitrogen balance|nitrogen balance
5455084|NCT01481571|Media for vitrification/warming of human oocytes|media for vitrification/warming of human oocytes
5455085|NCT01481558|Apathy|apathy
5455086|NCT01481558|Alzheimer's Disease|alzheimer's disease
5455087|NCT01481558|Dementia|dementia
5455088|NCT01481545|locally advanced|locally advanced
5455089|NCT01481545|high risk|high risk
5455090|NCT01481545|preoperative therapy|preoperative therapy
5455091|NCT01481532|Antineoplastic agent|antineoplastic agent
5455092|NCT01481519|Conjunctivitis|conjunctivitis
5455093|NCT01481519|Ocular diseases|ocular diseases
5455094|NCT01481519|Artificial tears|artificial tears
5455095|NCT01481493|rheumatoid arthritis|rheumatoid arthritis
5455096|NCT01481480|shoulder|shoulder
5455097|NCT01481480|rotator cuff|rotator cuff
5455098|NCT01481480|tendon transfer|tendon transfer
5455099|NCT01481480|arthroscopic repair|arthroscopic repair
5455100|NCT01481467|influenza vaccination|influenza vaccination
5455101|NCT01481467|intervention mapping|intervention mapping
5455102|NCT01481467|hospital care|hospital care
5455103|NCT01481467|respiratory infections|respiratory infections
5455104|NCT01481467|vaccination|vaccination
5455105|NCT01481454|Influenza|influenza
5455106|NCT01481454|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5455107|NCT01481454|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5455108|NCT01481441|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5455109|NCT01481441|Prostate cancer|prostate cancer
5455110|NCT01481441|Quantification|quantification
5455111|NCT01481441|Prostate biopsies|prostate biopsies
5455112|NCT01481441|Transrectal ultrasound (TRUS)|transrectal ultrasound (trus)
5455113|NCT01481441|Microbubbles|microbubbles
5455114|NCT01481428|High risk behavior|high risk behavior
5455115|NCT01481428|Drug court clients|drug court clients
5455116|NCT01481428|Substance abuse|substance abuse
5455117|NCT01481428|HIV intervention|hiv intervention
5455118|NCT01481428|Treatment Court Clients|treatment court clients
5455119|NCT01481415|left atrial|left atrial
5455120|NCT01481415|three-dimensional echocardioraphy|three-dimensional echocardioraphy
5455121|NCT01481415|left atrial function|left atrial function
5455122|NCT01481402|Heart failure|heart failure
5455123|NCT01481402|Liothyronine|liothyronine
5455124|NCT01481402|Low T3 syndrome|low t3 syndrome
5455125|NCT01481389|Blood lipids|blood lipids
5455126|NCT01481389|risk factor for cardiovascular diseases|risk factor for cardiovascular diseases
5455127|NCT01481376|Parietex™ ProGrip™|parietex™ progrip™
5455128|NCT01481376|Laparoscopic Transabdominal preperitoneal|laparoscopic transabdominal preperitoneal
5455130|NCT01481376|Inguinal hernia repair|inguinal hernia repair
5455131|NCT01481363|dementia|dementia
5455132|NCT01481363|communication|communication
5455133|NCT01481363|carers|carers
5455134|NCT01481363|caregivers|caregivers
5455135|NCT01481363|psychosocial support systems|psychosocial support systems
5455136|NCT01481363|education|education
5455137|NCT01481337|colon|colon
5455138|NCT01481337|endoscopy|endoscopy
5455139|NCT01481337|resection|resection
5455140|NCT01481324|Clubfoot|clubfoot
5455141|NCT01481324|Compliance|compliance
5455142|NCT01481324|Brace wear|brace wear
5455143|NCT01481285|Bioelectrical Impedance Measurement|bioelectrical impedance measurement
5455144|NCT01481285|Adults|adults
5455146|NCT01481259|Nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer
5455147|NCT01481259|Maintenance therapy|maintenance therapy
5455148|NCT01481259|Immunotherapy|immunotherapy
5455149|NCT01481259|Autologous cytokine-induced killer cell|autologous cytokine-induced killer cell
5455150|NCT01481259|Pemetrexed|pemetrexed
5455151|NCT01481246|neurorehabilitation|neurorehabilitation
5455152|NCT01481246|cognition|cognition
5455155|NCT01481246|cognitive decline|cognitive decline
5455156|NCT01481233|oral colchicine|oral colchicine
5455157|NCT01481233|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5455158|NCT01481233|failed taxotere based chemotherapy|failed taxotere based chemotherapy
5455159|NCT01481220|Myelodysplastic syndrome|myelodysplastic syndrome
5455160|NCT01481220|azacitidine|azacitidine
5455161|NCT01481220|Eltrombopag|eltrombopag
5455162|NCT01481220|Thrombopoietin-receptor agonist|thrombopoietin-receptor agonist
5455163|NCT01481220|Thrombocytopenia|thrombocytopenia
5455164|NCT01481220|Transfusion dependency|transfusion dependency
5455165|NCT01481220|Safety study|safety study
5455166|NCT01481207|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5455167|NCT01481207|magnetic resonance imaging|magnetic resonance imaging
5455168|NCT01481194|Multiple Myeloma|multiple myeloma
5455169|NCT01481181|zinc water diarrhoea growth preschool children|zinc water diarrhoea growth preschool children
5455170|NCT01481155|actinic keratosis|actinic keratosis
5455171|NCT01481155|field cancerisation|field cancerisation
5455172|NCT01481116|Drug Therapy|drug therapy
5455173|NCT01481103|Over the counter medication|over the counter medication
5455174|NCT01481103|Acupuncture|acupuncture
5455175|NCT01481090|Infertility|infertility
5455176|NCT01481090|acupuncture|acupuncture
5455177|NCT01481090|frozen embryos|frozen embryos
5455178|NCT01481090|endometrium|endometrium
5455179|NCT01481090|TCM|tcm
5455180|NCT01481064|Patient centredness|patient centredness
5455181|NCT01481064|Quality of life|quality of life
5455182|NCT01481064|Multifaceted approach|multifaceted approach
5455183|NCT01481064|Fertility care|fertility care
5455184|NCT01481038|early detection|early detection
5455185|NCT01481038|CRBSI|crbsi
5455186|NCT01481025|Climacteric|climacteric
5455187|NCT01481025|Depression|depression
5455188|NCT01481025|Herbal treatment|herbal treatment
5455189|NCT01481012|Heart transplantation|heart transplantation
5455190|NCT01481012|Coronary artery bypass graft (CABG) surgery|coronary artery bypass graft (cabg) surgery
5455191|NCT01481012|Left ventricular assist device implantation surgeries|left ventricular assist device implantation surgeries
5437842|NCT01554410|IMRT|imrt
5455193|NCT01480999|Open Surgery|open surgery
5455194|NCT01480999|Laparoscopy|laparoscopy
5455195|NCT01480999|Robotic surgery|robotic surgery
5455196|NCT01480960|lung transplantation|lung transplantation
5455197|NCT01480960|whole body vibration|whole body vibration
5455198|NCT01480960|exercise training|exercise training
5455199|NCT01480960|pulmonary rehabilitation|pulmonary rehabilitation
5455200|NCT01480947|probiotics|probiotics
5455201|NCT01480947|pediatric|pediatric
5455202|NCT01480947|salmonella|salmonella
5455203|NCT01480947|rotavirus|rotavirus
5455204|NCT01480947|gastroenteritis|gastroenteritis
5455205|NCT01480934|Diabetes,posterior capsule opacification,case control study|diabetes,posterior capsule opacification,case control study
5455206|NCT01480921|heart failure|heart failure
5455207|NCT01480921|health related quality of life|health related quality of life
5455208|NCT01480921|exercise capacity|exercise capacity
5455209|NCT01480921|home based exercise training|home based exercise training
5455210|NCT01480921|supervised exercise training|supervised exercise training
5455211|NCT01480908|Right bundle branch block|right bundle branch block
5455212|NCT01480908|Ventricular septal defect|ventricular septal defect
5455213|NCT01480908|Echocardiography|echocardiography
5455214|NCT01480908|MRI|mri
5455215|NCT01480908|Exercise testing|exercise testing
5455216|NCT01480895|Diabetes Mellitus Type 2|diabetes mellitus type 2
5455217|NCT01480895|Gestational Diabetes Mellitus|gestational diabetes mellitus
5455218|NCT01480895|Glucose Intolerance|glucose intolerance
5455219|NCT01480895|Physical exercise|physical exercise
5455220|NCT01480895|Nutritional Habits|nutritional habits
5455221|NCT01480895|Dyslipidemia|dyslipidemia
5455222|NCT01480882|Manual percussion|manual percussion
5455223|NCT01480882|Mechanical percussion|mechanical percussion
5455224|NCT01480882|Chronic bronchiectasis|chronic bronchiectasis
5455225|NCT01480882|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5455226|NCT01480882|Wet sputum weight|wet sputum weight
5455227|NCT01480882|Dry sputum weight|dry sputum weight
5455228|NCT01480869|Breast cancer|breast cancer
5455229|NCT01480869|Vitamin D supplementation|vitamin d supplementation
5455230|NCT01480869|in neoadjuvant|in neoadjuvant
5455231|NCT01480869|adjuvant setting|adjuvant setting
5455232|NCT01480843|simplification|simplification
5455234|NCT01480843|elderly|elderly
5455235|NCT01480830|Quality|quality
5455236|NCT01480830|indicators|indicators
5455237|NCT01480804|Barriers|barriers
5455238|NCT01480804|Intervention|intervention
5455239|NCT01480804|Elderly|elderly
5455240|NCT01480804|glycemic control|glycemic control
5455241|NCT01480791|resistance arteries|resistance arteries
5455243|NCT01480791|aortic stiffness|aortic stiffness
5455244|NCT01480778|hormonal response, levonorgestrel, ethinyl estradiol|hormonal response, levonorgestrel, ethinyl estradiol
5455245|NCT01480752|In the patients with symptomatic Irreversible Pulpitis|in the patients with symptomatic irreversible pulpitis
5455246|NCT01480739|Phase 1, AZD5069, safety and tolerability, healthy volunteer,|phase 1, azd5069, safety and tolerability, healthy volunteer,
5455247|NCT01480713|HIV-1|hiv-1
5455248|NCT01480713|protease inhibitors|protease inhibitors
5455249|NCT01480713|integrase inhibitors|integrase inhibitors
5455250|NCT01480713|raltegravir|raltegravir
5455251|NCT01480713|viral replication|viral replication
5455252|NCT01480713|treatment intensification|treatment intensification
5455253|NCT01480713|viral pathogenesis|viral pathogenesis
5455254|NCT01480713|immune activation|immune activation
5455255|NCT01480700|eggs|eggs
5455256|NCT01480700|Optical Macular Pigment|optical macular pigment
5455257|NCT01480700|Age Macular Degeneration|age macular degeneration
5455258|NCT01480700|study for the Age Macular Degeneration prevention|study for the age macular degeneration prevention
5455259|NCT01480687|Hypertension|hypertension
5455260|NCT01480687|Endothelial dysfunction|endothelial dysfunction
5455261|NCT01480687|Vascular stiffness|vascular stiffness
5455262|NCT01480661|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5455263|NCT01480661|Computed Tomography scan|computed tomography scan
5455264|NCT01480661|Functional Respiratory Imaging|functional respiratory imaging
5455265|NCT01480661|Roflumilast|roflumilast
5455266|NCT01480661|Health Related Quality of Life|health related quality of life
5455267|NCT01480635|Incomplete Colonoscopy|incomplete colonoscopy
5455268|NCT01480635|Efficacy of PillCam Colon2|efficacy of pillcam colon2
5455269|NCT01480622|healthy subjects|healthy subjects
5455270|NCT01480622|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5455271|NCT01480622|hepatitis|hepatitis
5455272|NCT01480622|pharmacokinetics|pharmacokinetics
5455273|NCT01480583|GRN1005|grn1005
5455274|NCT01480583|ANG1005|ang1005
5455275|NCT01480583|Peptide-Drug Conjugate (PDC)|peptide-drug conjugate (pdc)
5455276|NCT01480583|LRP-1|lrp-1
5455277|NCT01480583|Targeted Therapy|targeted therapy
5455278|NCT01480583|Breast Cancer|breast cancer
5455279|NCT01480583|Brain Metastases|brain metastases
5455281|NCT01480583|Blood Brain Barrier|blood brain barrier
5455282|NCT01480583|Trastuzumab|trastuzumab
5455283|NCT01480583|Herceptin|herceptin
5455284|NCT01480583|Paclitaxel|paclitaxel
5455285|NCT01480583|Taxol|taxol
5455791|NCT01478763|vitrectomy|vitrectomy
5455286|NCT01480583|Breast cancer with brain metastases|breast cancer with brain metastases
5455287|NCT01480557|cataract|cataract
5455288|NCT01480557|phacoemulsification|phacoemulsification
5455289|NCT01480557|liquefaction|liquefaction
5455290|NCT01480557|torsional ip|torsional ip
5455291|NCT01480557|endothelial cell count|endothelial cell count
5455292|NCT01480557|central corneal edema|central corneal edema
5455293|NCT01480557|central corneal sensitivity|central corneal sensitivity
5455294|NCT01480544|Institutional Deliveries|institutional deliveries
5455295|NCT01480544|Maternal Health|maternal health
5455296|NCT01480544|Infant Health|infant health
5455297|NCT01480544|Private Medical Providers|private medical providers
5455298|NCT01480544|Provider Incentives|provider incentives
5455299|NCT01480544|Randomized Control Trial|randomized control trial
5455300|NCT01480531|aorta|aorta
5455301|NCT01480531|aneurysm|aneurysm
5455302|NCT01480531|dissection|dissection
5455303|NCT01480518|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5455304|NCT01480505|Retinal detachment|retinal detachment
5455305|NCT01480505|high myopia|high myopia
5455306|NCT01480505|macular hole|macular hole
5455307|NCT01480505|axial length|axial length
5455308|NCT01480505|Scleral buckling|scleral buckling
5455309|NCT01480505|Vitrectomy|vitrectomy
5455310|NCT01480505|Visual acuity|visual acuity
5455311|NCT01480505|fundus examination results|fundus examination results
5455312|NCT01480492|HBV|hbv
5455313|NCT01480492|Immune|immune
5455314|NCT01480492|antiviral therapy|antiviral therapy
5455315|NCT01480479|EGFRvIII|egfrviii
5455316|NCT01480479|Glioblastoma|glioblastoma
5455317|NCT01480479|Small cell|small cell
5455318|NCT01480479|Giant cell|giant cell
5455319|NCT01480479|Gliosarcoma|gliosarcoma
5455320|NCT01480479|oligodendroglial|oligodendroglial
5455321|NCT01480479|Brain Cancer|brain cancer
5455322|NCT01480479|Brain Tumor|brain tumor
5455323|NCT01480479|radiotherapy|radiotherapy
5455324|NCT01480479|chemoradiation|chemoradiation
5455325|NCT01480479|Tumor|tumor
5455326|NCT01480479|temozolomide|temozolomide
5455327|NCT01480479|EGFR variant III|egfr variant iii
5455328|NCT01480466|Overweight|overweight
5455329|NCT01480466|Obesity|obesity
5455330|NCT01480466|Body mass index|body mass index
5455331|NCT01480466|Weight|weight
5455332|NCT01480466|Primary care|primary care
5455333|NCT01480453|Osteoarthritis|osteoarthritis
5455334|NCT01480453|Rheumatoid arthritis|rheumatoid arthritis
5455335|NCT01480453|Post-traumatic arthritis|post-traumatic arthritis
5449994|NCT01502800|Unresectable|unresectable
5455336|NCT01480453|Ununited humeral head fracture|ununited humeral head fracture
5455337|NCT01480453|Irreducible 3- and 4-part proximal humeral fractures|irreducible 3- and 4-part proximal humeral fractures
5455338|NCT01480453|Avascular necrosis|avascular necrosis
5455339|NCT01480440|Reverse Total Shoulder Arthroplasty|reverse total shoulder arthroplasty
5455340|NCT01480440|Reverse TSA|reverse tsa
5455341|NCT01480440|Osteoarthritis|osteoarthritis
5455342|NCT01480440|Rheumatoid Arthritis|rheumatoid arthritis
5455343|NCT01480440|Post-traumatic arthritis|post-traumatic arthritis
5455344|NCT01480440|Ununited humeral head fracture|ununited humeral head fracture
5455345|NCT01480440|Irreducible 3-and 4-part proximal humeral fractures|irreducible 3-and 4-part proximal humeral fractures
5455346|NCT01480440|Avascular necrosis|avascular necrosis
5455347|NCT01480440|Gross rotator cuff deficiency|gross rotator cuff deficiency
5455348|NCT01480440|Failed total shoulder arthroplasty (glenoid & humeral components require revision)|failed total shoulder arthroplasty (glenoid & humeral components require revision)
5455349|NCT01480427|Children aged 0-12 years|children aged 0-12 years
5455350|NCT01480427|IgE mediated food allergy|ige mediated food allergy
5455351|NCT01480414|bone marrow mono nuclear stem cell ischemic ulcer|bone marrow mono nuclear stem cell ischemic ulcer
5455352|NCT01480401|Patients with stable heart failure|patients with stable heart failure
5455353|NCT01480388|Rheumatoid arthritis|rheumatoid arthritis
5455354|NCT01480388|Swollen and tender joints|swollen and tender joints
5455355|NCT01480388|Dose range finding study|dose range finding study
5455356|NCT01480388|Concurrent treatment with methotrexate|concurrent treatment with methotrexate
5455357|NCT01480375|prostate cancer detection|prostate cancer detection
5455358|NCT01480375|prostate biopsy|prostate biopsy
5455359|NCT01480375|3d navigation|3d navigation
5455360|NCT01480375|trans rectal ultrasound|trans rectal ultrasound
5455361|NCT01480362|Diabetic foot wound|diabetic foot wound
5455362|NCT01480362|Amputation wound|amputation wound
5455363|NCT01480362|Chronic wound|chronic wound
5455364|NCT01480349|Post-Hemorrhagic Hydrocephalus|post-hemorrhagic hydrocephalus
5455365|NCT01480349|Intraventricular Hemorrhage|intraventricular hemorrhage
5455366|NCT01480349|Low Birth Weight Premature Infants|low birth weight premature infants
5455367|NCT01480336|Arrhythmia|arrhythmia
5455368|NCT01480323|Malignant melanoma|malignant melanoma
5455369|NCT01480297|Pain|pain
5455370|NCT01480297|Neuropathy|neuropathy
5455371|NCT01480297|Diabetes type 1|diabetes type 1
5455372|NCT01480284|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5455373|NCT01480284|Chronic Hepatitis B|chronic hepatitis b
5455374|NCT01480271|Allergic Rhinitis|allergic rhinitis
5455375|NCT01480271|Healthy Volunteers|healthy volunteers
5455376|NCT01480271|Single Dose Escalation|single dose escalation
5455377|NCT01480271|TLR7 agonist|tlr7 agonist
5455378|NCT01480271|First Time in Human Study|first time in human study
5455379|NCT01480258|combination vaccine|combination vaccine
5455380|NCT01480258|diphtheria|diphtheria
5455381|NCT01480258|pertussis|pertussis
5455383|NCT01480258|hepatitis B|hepatitis b
5455384|NCT01480258|Hep B|hep b
5455385|NCT01480258|Haemophilus influenzae b|haemophilus influenzae b
5455386|NCT01480258|Hib|hib
5455387|NCT01480258|polio|polio
5455388|NCT01480258|poliovirus|poliovirus
5455389|NCT01480245|968|968
5455390|NCT01480245|Duchenne|duchenne
5455391|NCT01480245|DMD|dmd
5455392|NCT01480245|drisapersen|drisapersen
5455393|NCT01480219|voriconazole|voriconazole
5455394|NCT01480219|non-melanoma skin cancer|non-melanoma skin cancer
5455395|NCT01480219|confounding|confounding
5455396|NCT01480219|statistical adjustment|statistical adjustment
5455397|NCT01480219|risk adjustment|risk adjustment
5455398|NCT01480219|lung transplant|lung transplant
5455399|NCT01480219|heart/lung transplant|heart/lung transplant
5455400|NCT01480219|immunosuppression|immunosuppression
5455401|NCT01480193|Tinnitus|tinnitus
5455402|NCT01480167|VCF|vcf
5455403|NCT01480167|Osteoporosis|osteoporosis
5455404|NCT01480167|Minimally Invasive|minimally invasive
5455405|NCT01480167|Non-operative management|non-operative management
5455406|NCT01480167|Medical Management|medical management
5455407|NCT01480128|Single-port|single-port
5455408|NCT01480128|Laparoscopy|laparoscopy
5455409|NCT01480128|colectomy|colectomy
5455410|NCT01480128|Single port|single port
5455411|NCT01480128|colon cancer|colon cancer
5455412|NCT01480128|minimally invasive surgery|minimally invasive surgery
5455413|NCT01480115|antral follicle count|antral follicle count
5455414|NCT01480115|automated antral follicle count|automated antral follicle count
5455415|NCT01480115|ovarian reserve|ovarian reserve
5455416|NCT01480102|Percutaneous nephrolithotomy|percutaneous nephrolithotomy
5455417|NCT01480102|Paravertebral block|paravertebral block
5455418|NCT01480102|bupivacaine|bupivacaine
5455419|NCT01480089|Surgical Pain Management|surgical pain management
5455420|NCT01480089|Robotic surgery|robotic surgery
5455421|NCT01480089|Ropivacaine|ropivacaine
5455422|NCT01480076|Quality of Life|quality of life
5455423|NCT01480076|Multiple Sclerosis|multiple sclerosis
5455424|NCT01480050|adult giant cell glioblastoma|adult giant cell glioblastoma
5455425|NCT01480050|adult glioblastoma|adult glioblastoma
5455426|NCT01480050|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5455427|NCT01480050|adult anaplastic ependymoma|adult anaplastic ependymoma
5789036|NCT00150150|interstitial laser theraphy|interstitial laser theraphy
5455428|NCT01480050|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5455429|NCT01480050|adult mixed glioma|adult mixed glioma
5455430|NCT01480050|recurrent adult brain tumor|recurrent adult brain tumor
5455431|NCT01480024|healthy women|healthy women
5455433|NCT01480024|in vitro fertilization|in vitro fertilization
5455434|NCT01480024|pregnancy|pregnancy
5685525|NCT00555750|glucose|glucose
5455435|NCT01480024|childbearing-age|childbearing-age
5455436|NCT01480011|Lactobacillus CD2 lozenges|lactobacillus cd2 lozenges
5455437|NCT01480011|high-dose chemotherapy induced|high-dose chemotherapy induced
5455438|NCT01480011|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5455439|NCT01479998|smoking cessation|smoking cessation
5455440|NCT01479998|NRT nicotine replacement therapy|nrt nicotine replacement therapy
5455441|NCT01479998|CBT cognitive behavioral therapy|cbt cognitive behavioral therapy
5455442|NCT01479998|contingency management|contingency management
5455443|NCT01479972|Tuberculosis|tuberculosis
5455444|NCT01479972|Vaccine|vaccine
5455445|NCT01479972|Live vaccine|live vaccine
5455446|NCT01479972|rBCG|rbcg
5455447|NCT01479959|Tracheostomy|tracheostomy
5455448|NCT01479959|positive end expiratory pressure|positive end expiratory pressure
5455449|NCT01479959|speech|speech
5455450|NCT01479959|respiratory failure|respiratory failure
5455451|NCT01479959|ventilation|ventilation
5455452|NCT01479959|neuromuscular disorders|neuromuscular disorders
5455453|NCT01479933|vitamin D|vitamin d
5455454|NCT01479933|cholecalciferol|cholecalciferol
5455455|NCT01479933|supplementation|supplementation
5455456|NCT01479933|prediabetic state|prediabetic state
5455457|NCT01479933|obesity|obesity
5455458|NCT01479933|glucose metabolism|glucose metabolism
5455459|NCT01479933|gene expression|gene expression
5455460|NCT01479933|transcriptomics|transcriptomics
5455461|NCT01479933|epigenomics|epigenomics
5455462|NCT01479933|immunological function|immunological function
5455463|NCT01479933|insulin sensitivity|insulin sensitivity
5455464|NCT01479933|peripheral mononuclear cells|peripheral mononuclear cells
5455465|NCT01479920|Depressive Disorder|depressive disorder
5455466|NCT01479920|Depressive Symptoms|depressive symptoms
5455467|NCT01479920|Depressive Syndrome|depressive syndrome
5455468|NCT01479920|Emotional Depression|emotional depression
5455469|NCT01479881|Hepatitis C Virus|hepatitis c virus
5455470|NCT01479881|TMC435|tmc435
5455471|NCT01479881|TMC435-TiDP16-C120|tmc435-tidp16-c120
5455472|NCT01479881|TMC435-C120|tmc435-c120
5455474|NCT01479881|Hepatitis C|hepatitis c
5455475|NCT01479881|Hep C|hep c
5455476|NCT01479881|Healthy participants|healthy participants
5455477|NCT01479868|Hepatitis C virus genotype-1|hepatitis c virus genotype-1
5455478|NCT01479868|Human immunodeficiency virus-type 1|human immunodeficiency virus-type 1
5455479|NCT01479868|HCV-1|hcv-1
5455480|NCT01479868|HIV-1|hiv-1
5455481|NCT01479868|TMC435|tmc435
5455482|NCT01479868|Pegylated interferon alpha-2a|pegylated interferon alpha-2a
5455483|NCT01479868|PegIFNα-2a|pegifnα-2a
5455484|NCT01479868|Pegasys|pegasys
5455485|NCT01479868|Ribavirin|ribavirin
5455487|NCT01479868|Copegus|copegus
5455488|NCT01479855|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5455489|NCT01479855|Alzheimers disease|alzheimers disease
5455490|NCT01479855|Vitamines|vitamines
5455491|NCT01479855|Nutrients|nutrients
5455492|NCT01479829|Bipolar depression|bipolar depression
5455493|NCT01479829|Celecoxib|celecoxib
5455494|NCT01479829|Escitalopram|escitalopram
5455495|NCT01479829|Inflammation|inflammation
5455496|NCT01479816|continence|continence
5455497|NCT01479816|index|index
5455498|NCT01479790|Visante AS-OCT|visante as-oct
5455499|NCT01479790|Cirrus AS-OCT|cirrus as-oct
5455500|NCT01479790|Thermography|thermography
5455501|NCT01479790|Tear evaporation|tear evaporation
5455502|NCT01479790|Tear evaporimetry|tear evaporimetry
5455503|NCT01479777|Spinal Cord Injury|spinal cord injury
5455504|NCT01479777|Functional electrical stimulation|functional electrical stimulation
5455505|NCT01479777|Rehabilitation|rehabilitation
5455506|NCT01479751|Rocuronium|rocuronium
5455507|NCT01479751|magnesium|magnesium
5455508|NCT01479751|priming|priming
5455509|NCT01479751|ketamine|ketamine
5455510|NCT01479751|intubation|intubation
5455511|NCT01479738|arthroplasty|arthroplasty
5455512|NCT01479738|graft|graft
5455513|NCT01479738|capitate|capitate
5455514|NCT01479738|artery|artery
5455515|NCT01479725|interstitial cystitis|interstitial cystitis
5455516|NCT01479712|Irrigation|irrigation
5455517|NCT01479712|Cesarean Section|cesarean section
5455518|NCT01479712|Nausea|nausea
5455519|NCT01479712|Infection|infection
5455520|NCT01479699|Olive leaf extract|olive leaf extract
5455521|NCT01479699|Polyphenols|polyphenols
5455522|NCT01479699|Vascular function|vascular function
5455523|NCT01479699|Bioavailability|bioavailability
5455524|NCT01479699|Cytokines|cytokines
5455525|NCT01479686|GLIOMA|glioma
5455526|NCT01479686|NEURONAVIGATION|neuronavigation
5455527|NCT01479686|INTERVENTIONAL MRI|interventional mri
5455528|NCT01479673|Enteral Nutrition|enteral nutrition
5455529|NCT01479673|Parenteral Nutrition|parenteral nutrition
5455530|NCT01479673|Indirect Calorimetry|indirect calorimetry
5455532|NCT01479660|Probiotics|probiotics
5455533|NCT01479660|ulcerative colitis|ulcerative colitis
5455534|NCT01479660|inflammatory bowel disease|inflammatory bowel disease
5455535|NCT01479634|HIV|hiv
5455536|NCT01479634|ART|art
5455537|NCT01479621|Dose Ranging|dose ranging
5455538|NCT01479621|Fluticasone Propionate|fluticasone propionate
5455539|NCT01479621|Dry Powder Inhaler (DPI)|dry powder inhaler (dpi)
5455540|NCT01479621|Non-steroidal|non-steroidal
5455541|NCT01479621|Asthma|asthma
5455542|NCT01479595|Asthma|asthma
5455543|NCT01479595|Interleukin|interleukin
5455544|NCT01479595|QBX258|qbx258
5455545|NCT01479595|QAX576|qax576
5455546|NCT01479595|VAK694|vak694
5455547|NCT01479582|Adult and Pediatric|adult and pediatric
5455548|NCT01479582|Unlicensed Cord Blood Unit IND|unlicensed cord blood unit ind
5455549|NCT01479582|NMDP|nmdp
5455550|NCT01479582|Transplant|transplant
5455551|NCT01479582|Hematologic Malignancies|hematologic malignancies
5455552|NCT01479582|Leukemia|leukemia
5455553|NCT01479582|Multiple Myeloma|multiple myeloma
5455554|NCT01479582|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5455555|NCT01479582|CML|cml
5455556|NCT01479582|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5455557|NCT01479582|Myelodyplastic Syndrome|myelodyplastic syndrome
5455558|NCT01479582|MDS|mds
5455559|NCT01479582|Thalassemia|thalassemia
5455560|NCT01479582|Lysosomal Storage Diseases|lysosomal storage diseases
5455561|NCT01479569|MRI Catheterization|mri catheterization
5455562|NCT01479569|Pericardiocentesis|pericardiocentesis
5455563|NCT01479569|MRI Safety|mri safety
5455564|NCT01479569|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5455565|NCT01479556|Pregabalin|pregabalin
5455566|NCT01479556|Neuropathic pain|neuropathic pain
5455567|NCT01479556|At-level neuropathic pain|at-level neuropathic pain
5455568|NCT01479556|Non-evoked neuropathic pain|non-evoked neuropathic pain
5455569|NCT01479556|Evoked neuropathic pain|evoked neuropathic pain
5455570|NCT01479556|Sub-acute spinal cord injury|sub-acute spinal cord injury
5455571|NCT01479543|Probiotic|probiotic
5455572|NCT01479543|Immunity|immunity
5455573|NCT01479543|Gastrointestinal symptoms|gastrointestinal symptoms
5455574|NCT01479530|Rasagiline|rasagiline
5455575|NCT01479530|Azilect|azilect
5455576|NCT01479530|Parkinson´s Disease|parkinson´s disease
5455577|NCT01479530|Motor fluctuations|motor fluctuations
5455578|NCT01479517|operative|operative
5455579|NCT01479517|dental procedure|dental procedure
5455580|NCT01479504|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5455581|NCT01479504|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5455688|NCT01479166|innate immune system|innate immune system
5455582|NCT01479504|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5455583|NCT01479504|Nedaplatin|nedaplatin
5455584|NCT01479491|Japan|japan
5455585|NCT01479491|Retrospective|retrospective
5455586|NCT01479491|Observational|observational
5455587|NCT01479491|Epidemiological study|epidemiological study
5455588|NCT01479491|Children aged < 12 months|children aged < 12 months
5455589|NCT01479491|Intussusception|intussusception
5455590|NCT01479465|GSI|gsi
5455591|NCT01479465|Gilead|gilead
5455592|NCT01479465|Gilead Sciences|gilead sciences
5455593|NCT01479465|GS-6624|gs-6624
5455594|NCT01479465|Colorectal Cancer|colorectal cancer
5455595|NCT01479465|KRAS|kras
5455596|NCT01479465|Oncology|oncology
5455597|NCT01479465|monoclonal antibody|monoclonal antibody
5455598|NCT01479452|obesity|obesity
5455599|NCT01479452|bariatric surgery|bariatric surgery
5455600|NCT01479452|weight loss|weight loss
5455601|NCT01479426|Erectile dysfunction|erectile dysfunction
5455602|NCT01479426|Korean Red Ginseng|korean red ginseng
5455603|NCT01479426|IIEF(International Index of Erectile Function)|iief(international index of erectile function)
5455604|NCT01479426|MSHQ(Male Sexual Health Questionnaire,)|mshq(male sexual health questionnaire,)
5455605|NCT01479413|Schizophrenia|schizophrenia
5455606|NCT01479413|Oxidative stress|oxidative stress
5455607|NCT01479413|Mitochondria|mitochondria
5455608|NCT01479400|antipsychotic|antipsychotic
5455609|NCT01479400|schizophrenia|schizophrenia
5455610|NCT01479400|infant development|infant development
5455611|NCT01479387|Zevalin|zevalin
5455612|NCT01479387|CD20+|cd20+
5455613|NCT01479387|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5455614|NCT01479387|Mantle cell lymphoma|mantle cell lymphoma
5455615|NCT01479374|Allergic Conjunctivitis|allergic conjunctivitis
5455616|NCT01479374|Ocular Allergy|ocular allergy
5455617|NCT01479361|Atovaquone|atovaquone
5455618|NCT01479361|Drug Interaction|drug interaction
5455619|NCT01479361|Pharmacokinetics|pharmacokinetics
5455620|NCT01479361|Efavirenz|efavirenz
5455621|NCT01479361|Atazanavir-Ritonavir|atazanavir-ritonavir
5455622|NCT01479361|HIV|hiv
5455623|NCT01479348|Imaging|imaging
5455625|NCT01479348|Safety|safety
5455626|NCT01479348|Dosimetry|dosimetry
5455627|NCT01479348|Drug Distribution|drug distribution
5455628|NCT01479348|Cancer|cancer
5455629|NCT01479322|Intima-media thickness|intima-media thickness
5455630|NCT01479322|Ghrelin|ghrelin
5455631|NCT01479322|Prader-Willi syndrome|prader-willi syndrome
5455632|NCT01479283|Infection|infection
5455633|NCT01479283|Bone Neoplasms|bone neoplasms
5455634|NCT01479283|Prosthesis|prosthesis
5455635|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents
5455636|NCT01479283|Randomized|randomized
5455637|NCT01479270|recovery|recovery
5455638|NCT01479270|postoperative|postoperative
5455639|NCT01479270|pain|pain
5455640|NCT01479270|laparoscopy|laparoscopy
5455641|NCT01479270|hysterectomy|hysterectomy
5455642|NCT01479270|ropivacaine|ropivacaine
5455643|NCT01479270|TAP block|tap block
5455644|NCT01479270|local anesthesia|local anesthesia
5455645|NCT01479257|Cancer|cancer
5455646|NCT01479257|Risk factors|risk factors
5455647|NCT01479257|Latinos|latinos
5455648|NCT01479257|Hispanic Americans|hispanic americans
5455649|NCT01479257|Hispanics|hispanics
5455650|NCT01479257|Latino resident|latino resident
5455651|NCT01479257|Houston metropolitan area|houston metropolitan area
5455652|NCT01479257|Spanish speaking|spanish speaking
5455653|NCT01479257|Cancer risk behaviors|cancer risk behaviors
5455654|NCT01479257|Questionnaires|questionnaires
5455655|NCT01479257|Surveys|surveys
5455656|NCT01479257|Accelerometer|accelerometer
5455657|NCT01479244|HER2|her2
5455658|NCT01479244|low or intermediate|low or intermediate
5455659|NCT01479244|breast cancer|breast cancer
5455660|NCT01479244|node-positive tumors|node-positive tumors
5455661|NCT01479231|GERD|gerd
5455662|NCT01479231|Eosinophilic esophagitis|eosinophilic esophagitis
5455663|NCT01479231|Proton pump inhibitor|proton pump inhibitor
5455664|NCT01479231|dysphagia|dysphagia
5455665|NCT01479205|specific immunotherapy|specific immunotherapy
5455666|NCT01479205|bronchial allergen provocation|bronchial allergen provocation
5455667|NCT01479205|specific IgE|specific ige
5455668|NCT01479205|specific IgG|specific igg
5455669|NCT01479205|specific IgG4|specific igg4
5455670|NCT01479205|SIT|sit
5455671|NCT01479192|breast|breast
5455672|NCT01479192|cancer|cancer
5455673|NCT01479192|prevention|prevention
5455674|NCT01479192|fenretinide|fenretinide
5455675|NCT01479179|Breast Cancer|breast cancer
5455676|NCT01479179|Metastatic Breast Cancer|metastatic breast cancer
5455677|NCT01479179|HER-2-overexpressing breast cancer|her-2-overexpressing breast cancer
5455678|NCT01479179|Human epidermal growth factor receptor|human epidermal growth factor receptor
5455679|NCT01479179|AMG 479|amg 479
5455680|NCT01479179|Trastuzumab|trastuzumab
5455681|NCT01479179|Herceptin|herceptin
5455682|NCT01479166|cystic fibrosis|cystic fibrosis
5455683|NCT01479166|HRCT|hrct
5455684|NCT01479166|Sputum|sputum
5455685|NCT01479166|Blood|blood
5455686|NCT01479166|Inflammation|inflammation
5455687|NCT01479166|adaptive immune system|adaptive immune system
5455689|NCT01479153|Central venous catheterization|central venous catheterization
5455690|NCT01479153|Major complications|major complications
5455691|NCT01479153|Internal Jugular|internal jugular
5455692|NCT01479153|Femoral|femoral
5455693|NCT01479153|Subclavian|subclavian
5455694|NCT01479140|myocardial infarction|myocardial infarction
5455695|NCT01479140|dissection|dissection
5455696|NCT01479140|coronary Fibromuscular Dysplasia|coronary fibromuscular dysplasia
5455697|NCT01479140|coronary ectasia|coronary ectasia
5455698|NCT01479140|atherosclerotic Coronary Artery Disease|atherosclerotic coronary artery disease
5455699|NCT01479140|coronary vasculitis|coronary vasculitis
5455700|NCT01479140|coronary embolism|coronary embolism
5455701|NCT01479140|congenital coronary anomaly|congenital coronary anomaly
5455702|NCT01479127|Levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5455703|NCT01479127|Advanced Parkinson's disease|advanced parkinson's disease
5455704|NCT01479127|Severe motor fluctuations|severe motor fluctuations
5455705|NCT01479127|Dyskinesia|dyskinesia
5455706|NCT01479101|neo adjuvant, breast cancer|neo adjuvant, breast cancer
5455707|NCT01479088|Cinacalcet|cinacalcet
5455708|NCT01479088|PK|pk
5455709|NCT01479088|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5455710|NCT01479088|Paediatric|paediatric
5455711|NCT01479088|Chronic Kidney Disease|chronic kidney disease
5455712|NCT01479088|Dialysis|dialysis
5455713|NCT01479075|central insulin|central insulin
5455714|NCT01479075|insulin resistance|insulin resistance
5455715|NCT01479075|energy metabolism|energy metabolism
5455716|NCT01479062|behavior change|behavior change
5455717|NCT01479062|pre-diabetes|pre-diabetes
5455718|NCT01479062|prevention|prevention
5455719|NCT01479062|diabetes prevention|diabetes prevention
5455720|NCT01479062|Hemoglobin A1c|hemoglobin a1c
5455721|NCT01479062|glucose|glucose
5455722|NCT01479062|physical activity|physical activity
5455723|NCT01479062|nutrition|nutrition
5455724|NCT01479062|email|email
5455725|NCT01479062|web|web
5455726|NCT01479062|obesity|obesity
5455727|NCT01479049|congenital heart disease|congenital heart disease
5455729|NCT01479049|cardiopulmonary bypass|cardiopulmonary bypass
5455730|NCT01479049|cardioplegia|cardioplegia
5455731|NCT01479036|breast cancer|breast cancer
5455732|NCT01479036|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5455733|NCT01479036|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
5455734|NCT01479036|docetaxel|docetaxel
5455735|NCT01479036|epirubicin|epirubicin
5455736|NCT01478984|NSTEMI|nstemi
5455737|NCT01478984|PCI|pci
5455739|NCT01478984|multistaged|multistaged
5455740|NCT01478971|Anemia|anemia
5455741|NCT01478971|Chronic Renal Failure|chronic renal failure
5455742|NCT01478971|CRF|crf
5455743|NCT01478971|Chronic Kidney Disease|chronic kidney disease
5455744|NCT01478971|CKD|ckd
5455745|NCT01478971|Erythropoietin|erythropoietin
5455746|NCT01478971|Hematide|hematide
5455747|NCT01478971|Peginesatide|peginesatide
5455748|NCT01478971|Hemoglobin|hemoglobin
5455749|NCT01478971|Hgb|hgb
5455750|NCT01478971|Red Blood Cell|red blood cell
5455751|NCT01478971|Red Blood Cell Production|red blood cell production
5455752|NCT01478971|Dialysis|dialysis
5455753|NCT01478958|fatty acids|fatty acids
5455754|NCT01478958|cardiovascular disease|cardiovascular disease
5455755|NCT01478958|vascular function|vascular function
5455756|NCT01478958|microparticles|microparticles
5455757|NCT01478945|vitiligo|vitiligo
5455758|NCT01478945|early vitiligo|early vitiligo
5455759|NCT01478945|focal vitiligo|focal vitiligo
5455760|NCT01478932|dyspnea|dyspnea
5455761|NCT01478932|diaphragmatic breathing|diaphragmatic breathing
5455762|NCT01478932|Heart failure|heart failure
5455763|NCT01478919|Endoscopic Mucosal Resection|endoscopic mucosal resection
5455764|NCT01478919|Laterally Spreading Tumor|laterally spreading tumor
5455765|NCT01478919|Local Residual Neoplasia|local residual neoplasia
5455766|NCT01478919|Colonoscopy|colonoscopy
5455767|NCT01478919|Therapy|therapy
5455768|NCT01478893|nicotine vaccine|nicotine vaccine
5455769|NCT01478893|smoking vaccine|smoking vaccine
5455770|NCT01478893|smoking cessation|smoking cessation
5455771|NCT01478893|SEL-068|sel-068
5455772|NCT01478867|celiac disease|celiac disease
5455773|NCT01478867|gluten-free diet|gluten-free diet
5455774|NCT01478867|gluten peptides|gluten peptides
5455775|NCT01478867|feces|feces
5455776|NCT01478841|insulin resistance|insulin resistance
5455777|NCT01478841|type 2 diabetes (T2D)|type 2 diabetes (t2d)
5455778|NCT01478841|cardiovascular complications|cardiovascular complications
5455779|NCT01478841|polyphenolic compounds derived from red grape marc extracts|polyphenolic compounds derived from red grape marc extracts
5455780|NCT01478841|oxidative stress|oxidative stress
5455781|NCT01478802|Mechanical Ventilation|mechanical ventilation
5455782|NCT01478802|High frequency oscillation|high frequency oscillation
5455783|NCT01478802|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
5455784|NCT01478776|ASP|asp
5455785|NCT01478776|LCN2|lcn2
5455786|NCT01478776|RBP4|rbp4
5455787|NCT01478776|C5L2|c5l2
5455788|NCT01478763|PDRP|pdrp
5455789|NCT01478763|vitreous|vitreous
5455790|NCT01478763|protein|protein
5455792|NCT01478750|obesity|obesity
5455793|NCT01478750|fat|fat
5455794|NCT01478750|appetite|appetite
5455795|NCT01478750|digestion|digestion
5455796|NCT01478737|PDRP|pdrp
5455797|NCT01478737|vitreous hemorrhage|vitreous hemorrhage
5455798|NCT01478737|vitrectomy|vitrectomy
5455799|NCT01478698|peritoneal dialysis|peritoneal dialysis
5455800|NCT01478698|peritoneal dialysis, continuous ambulatory|peritoneal dialysis, continuous ambulatory
5455801|NCT01478698|peritonitis|peritonitis
5455802|NCT01478685|Relapsed or Refractory Solid Tumors|relapsed or refractory solid tumors
5455803|NCT01478672|Promotion health|promotion health
5455804|NCT01478659|Diet|diet
5455805|NCT01478659|Fiber|fiber
5455806|NCT01478659|Adult|adult
5455807|NCT01478659|Fructooligosaccharide|fructooligosaccharide
5455808|NCT01478646|breathing therapy|breathing therapy
5455809|NCT01478646|reflective breathing therapy|reflective breathing therapy
5455810|NCT01478646|COPD|copd
5455811|NCT01478646|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5455812|NCT01478633|Alzheimer's disease|alzheimer's disease
5455813|NCT01478633|Dementia|dementia
5455814|NCT01478633|Galantamine|galantamine
5455815|NCT01478633|Donepezil|donepezil
5455816|NCT01478607|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
5455817|NCT01478607|Qutenza|qutenza
5455818|NCT01478594|metastatic colorectal cancer|metastatic colorectal cancer
5455819|NCT01478594|Avastin|avastin
5455820|NCT01478594|bevacizumab|bevacizumab
5455821|NCT01478594|tivozanib|tivozanib
5455822|NCT01478594|mFOLFOX6|mfolfox6
5455823|NCT01478594|BATON-CRC|baton-crc
5455824|NCT01478594|AV951|av951
5455825|NCT01478594|ASP4130|asp4130
5455826|NCT01478581|PCI-32765|pci-32765
5455827|NCT01478581|Multiple Myeloma|multiple myeloma
5455828|NCT01478581|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5455829|NCT01478581|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5455830|NCT01478568|Pharmacokinetics|pharmacokinetics
5455831|NCT01478568|Mirabegron|mirabegron
5455832|NCT01478568|Phase 1|phase 1
5455833|NCT01478555|Dry Eye|dry eye
5455834|NCT01478542|DLBCL|dlbcl
5455835|NCT01478542|Liposomal Vincristine (Marqibo)|liposomal vincristine (marqibo)
5455836|NCT01478542|Optimised Rituximab|optimised rituximab
5455837|NCT01478542|Toxicity|toxicity
5455838|NCT01478542|Elderly Patients|elderly patients
5455839|NCT01478542|FDG-PET|fdg-pet
5455840|NCT01478542|Bulky Disease|bulky disease
5455841|NCT01478542|Radiation|radiation
5455842|NCT01478542|age >60 years|age >60 years
5455844|NCT01478542|Vitamin D|vitamin d
5455845|NCT01478529|Pharmacokinetics|pharmacokinetics
5455846|NCT01478529|Mirabegron|mirabegron
5455847|NCT01478529|Phase 1|phase 1
5455848|NCT01478516|autologous plasmin|autologous plasmin
5455849|NCT01478516|macular edema|macular edema
5455850|NCT01478516|vitreous|vitreous
5455851|NCT01478503|Pharmacokinetics|pharmacokinetics
5455852|NCT01478503|Mirabegron|mirabegron
5455853|NCT01478503|Phase 1|phase 1
5455854|NCT01478503|Dose-Escalation|dose-escalation
5455855|NCT01478490|Pharmacokinetics,|pharmacokinetics,
5455856|NCT01478490|Mirabegron|mirabegron
5455857|NCT01478490|Metoprolol|metoprolol
5455858|NCT01478490|CYP2D6|cyp2d6
5455859|NCT01478490|Phase 1|phase 1
5455860|NCT01478477|Breast Cancer|breast cancer
5455861|NCT01478451|DOMS|doms
5455862|NCT01478438|Unifocal|unifocal
5455863|NCT01478438|20mm in diameter|20mm in diameter
5455864|NCT01478438|measures|measures
5455865|NCT01478438|5mm away from the skin and chest|5mm away from the skin and chest
5455866|NCT01478425|Prevention|prevention
5455867|NCT01478425|Pollen|pollen
5455868|NCT01478425|Allergy|allergy
5455869|NCT01478425|Rhinitis|rhinitis
5455870|NCT01478412|Prostate cancer|prostate cancer
5455871|NCT01478412|Low risk|low risk
5455872|NCT01478412|Intermediate risk|intermediate risk
5455873|NCT01478412|T1|t1
5455874|NCT01478412|T2a|t2a
5455875|NCT01478412|T2b|t2b
5455876|NCT01478412|Gleason 6|gleason 6
5455877|NCT01478412|Gleason 7|gleason 7
5455878|NCT01478412|PSA 10|psa 10
5455879|NCT01478412|PSA 20|psa 20
5455880|NCT01478373|GIST|gist
5455881|NCT01478373|Dovitinib|dovitinib
5455882|NCT01478360|Asthma|asthma
5455883|NCT01478360|Secukinumab|secukinumab
5455884|NCT01478360|Therapeutic Uses|therapeutic uses
5601290|NCT00892632|ERCP|ercp
5455885|NCT01478360|Respiratory|respiratory
5455886|NCT01478360|Lung|lung
5455887|NCT01478360|Pulmonary|pulmonary
5455888|NCT01478360|inhaled|inhaled
5455889|NCT01478360|corticosteroids|corticosteroids
5455890|NCT01478347|Neisseria, Meningitis, Group B, Vaccine, At-risk, Adults|neisseria, meningitis, group b, vaccine, at-risk, adults
5455891|NCT01478334|High intensity exercise|high intensity exercise
5455892|NCT01478334|cardiovascular risk factors|cardiovascular risk factors
5455893|NCT01478321|Information Not Provided|information not provided
5455894|NCT01478308|prostate|prostate
5455895|NCT01478308|castration resistant|castration resistant
5438566|NCT01551316|spirometry|spirometry
5455896|NCT01478308|hormone resistant|hormone resistant
5455897|NCT01478308|CRPC|crpc
5455898|NCT01478295|Nursing intervention|nursing intervention
5455899|NCT01478295|Primary Health care|primary health care
5455900|NCT01478295|caregiver|caregiver
5455901|NCT01478295|strain|strain
5455902|NCT01478282|dabigatran|dabigatran
5455903|NCT01478282|rivaroxaban|rivaroxaban
5455904|NCT01478282|oral anticoagulants|oral anticoagulants
5455905|NCT01478282|coagulation|coagulation
5455906|NCT01478282|bleeding|bleeding
5455907|NCT01478282|plasma concentrates|plasma concentrates
5455908|NCT01478269|Aggressive B-cell lymphoma|aggressive b-cell lymphoma
5455909|NCT01478269|R-CHOP|r-chop
5455910|NCT01478256|blepharitis|blepharitis
5455911|NCT01478256|topical erythromycin|topical erythromycin
5455912|NCT01478256|topical besifloxocin|topical besifloxocin
5455913|NCT01478243|Keloid|keloid
5455914|NCT01478230|Pharmacokinetics|pharmacokinetics
5455915|NCT01478217|lung ultrasonography|lung ultrasonography
5455916|NCT01478217|pressure-volume loops|pressure-volume loops
5455917|NCT01478217|ARDS|ards
5455918|NCT01478204|Alzheimer's disease|alzheimer's disease
5455919|NCT01478204|Sleep quality|sleep quality
5455920|NCT01478204|Anticholinesterase drugs|anticholinesterase drugs
5455921|NCT01478191|Hodgkin's Lymphoma|hodgkin's lymphoma
5455922|NCT01478191|Ifosfamide, Gemcitabine and Vinorelbine (IGEV)|ifosfamide, gemcitabine and vinorelbine (igev)
5455923|NCT01478191|High Dose Chemotherapy (HDCT)|high dose chemotherapy (hdct)
5455924|NCT01478191|Autologous Hematopoietic Stem Cells Transplantation (AHSCT)|autologous hematopoietic stem cells transplantation (ahsct)
5455925|NCT01478178|Glioma|glioma
5455926|NCT01478178|Glioblastoma|glioblastoma
5455927|NCT01478178|Glioblastoma multiforme|glioblastoma multiforme
5455928|NCT01478178|GBM|gbm
5455929|NCT01478178|brain tumor|brain tumor
5455930|NCT01478178|brain cancer|brain cancer
5455931|NCT01478178|recurrent brain tumor|recurrent brain tumor
5455932|NCT01478178|recurrent brain cancer|recurrent brain cancer
5455933|NCT01478178|refractory brain tumor|refractory brain tumor
5455934|NCT01478178|refractory brain cancer|refractory brain cancer
5455935|NCT01478178|recurrent GBM|recurrent gbm
5455936|NCT01478178|refractory GBM|refractory gbm
5455937|NCT01478178|recurrent glioma|recurrent glioma
5455938|NCT01478178|refractory glioma|refractory glioma
5455939|NCT01478178|recurrent glioblastoma|recurrent glioblastoma
5455940|NCT01478178|refractory glioblastoma|refractory glioblastoma
5455941|NCT01478178|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5455942|NCT01478178|refractory glioblastoma multiforme|refractory glioblastoma multiforme
5455943|NCT01478178|failed temodar|failed temodar
5455944|NCT01478178|failed temozolomide|failed temozolomide
5455945|NCT01478178|temodar refractory|temodar refractory
5455946|NCT01478178|temozolomide refractory|temozolomide refractory
5455947|NCT01478178|failed avastin|failed avastin
5455948|NCT01478178|avastin refractory|avastin refractory
5455949|NCT01478178|failed bevacizumab|failed bevacizumab
5455951|NCT01478178|avastin failure|avastin failure
5455952|NCT01478178|bevacizumab failure|bevacizumab failure
5455953|NCT01478178|temodar failure|temodar failure
5455954|NCT01478178|temozolomide failure|temozolomide failure
5455955|NCT01478165|Palonosetron|palonosetron
5455956|NCT01478165|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
5455957|NCT01478165|TIVA(Total intravenous anesthesia)|tiva(total intravenous anesthesia)
5455960|NCT01478152|Ectoine|ectoine
5455961|NCT01478152|FeNO|feno
5455962|NCT01478152|Metacholin|metacholin
5455963|NCT01478152|sRaw|sraw
5455964|NCT01478139|anorectal fistula|anorectal fistula
5455965|NCT01478139|acellular dermal matrix|acellular dermal matrix
5455966|NCT01478139|ligation of intersphincteric fistula tract|ligation of intersphincteric fistula tract
5455967|NCT01478139|ligation of intersphincteric fistula tract and plug|ligation of intersphincteric fistula tract and plug
5455968|NCT01478139|complications of treatment|complications of treatment
5455969|NCT01478139|recurrence|recurrence
5455970|NCT01478113|Major Depressive Disorder|major depressive disorder
5455971|NCT01478113|Therapy|therapy
5455972|NCT01478113|Medication study|medication study
5455973|NCT01478113|Depression|depression
5455974|NCT01478113|Therapy study|therapy study
5455975|NCT01478100|Coronary artery disease|coronary artery disease
5455976|NCT01478100|CT|ct
5455977|NCT01478100|Computational flow dynamics|computational flow dynamics
5903968|NCT00092222|Multicentric Castleman DIsease|multicentric castleman disease
5455978|NCT01478074|Acute Myeloid Leukemia|acute myeloid leukemia
5455979|NCT01478074|Relapsed leukemia|relapsed leukemia
5455980|NCT01478074|Refractory leukemia|refractory leukemia
5455981|NCT01478074|Natural Killer Cells|natural killer cells
5455982|NCT01478074|Adoptive immunotherapy|adoptive immunotherapy
5455983|NCT01478074|NK cell infusion|nk cell infusion
5455984|NCT01478074|Haploidentical|haploidentical
5455985|NCT01478074|KIR mismatch|kir mismatch
5455986|NCT01478074|Fludarabine|fludarabine
5455987|NCT01478074|Cytarabine|cytarabine
5455988|NCT01478074|Ara-C|ara-c
5455989|NCT01478074|ALT-801|alt-801
5455990|NCT01478048|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5455991|NCT01478035|Phenytoin prophylaxis|phenytoin prophylaxis
5438668|NCT01550809|CGM|cgm
5455992|NCT01478035|Pneumococcal meningitis|pneumococcal meningitis
5455993|NCT01478035|Randomized|randomized
5455994|NCT01478035|Placebo-controlled|placebo-controlled
5455995|NCT01478035|Double blind|double blind
5455996|NCT01478035|Patient 50 years or older|patient 50 years or older
5455997|NCT01478022|DMD|dmd
5455998|NCT01478022|Duchenne|duchenne
5455999|NCT01478022|Muscular Dystrophy|muscular dystrophy
5456000|NCT01477996|intravitreal therapy|intravitreal therapy
5456001|NCT01477996|pain scales|pain scales
5456002|NCT01477996|gauge|gauge
5456003|NCT01477996|Pain Scores|pain scores
5456004|NCT01477996|Visual Analog Scale|visual analog scale
5456005|NCT01477983|atrial fibrillation|atrial fibrillation
5456006|NCT01477983|catheter ablation|catheter ablation
5456007|NCT01477983|adenosine triphosphate|adenosine triphosphate
5456008|NCT01477983|antiarrhythmic drugs|antiarrhythmic drugs
5456009|NCT01477970|GnRH antagonists|gnrh antagonists
5456010|NCT01477970|OHSS|ohss
5456011|NCT01477970|ovarian stimulation|ovarian stimulation
5456012|NCT01477957|weight loss after bariatric surgery|weight loss after bariatric surgery
5456013|NCT01477957|Insulin sensitivity|insulin sensitivity
5456014|NCT01477957|insulin resistance|insulin resistance
5456015|NCT01477944|Statins pattern of use|statins pattern of use
5456016|NCT01477944|Hypercholesterolemic patients|hypercholesterolemic patients
5456017|NCT01477944|Statins|statins
5456018|NCT01477931|Bupropion hydrochloride extended release|bupropion hydrochloride extended release
5456019|NCT01477931|Wellbutrin XL|wellbutrin xl
5456020|NCT01477931|Major Depressive Disorder with Atypical Features|major depressive disorder with atypical features
5456021|NCT01477918|prevalence|prevalence
5456022|NCT01477918|Korea|korea
5456023|NCT01477905|priming|priming
5456024|NCT01477905|remifentanil|remifentanil
5456025|NCT01477905|target-controlled infusion|target-controlled infusion
5456026|NCT01477840|Misoprostol|misoprostol
5456027|NCT01477840|Oxytocin|oxytocin
5456028|NCT01477840|Cesarean Delivery|cesarean delivery
5456029|NCT01477840|Blood Loss|blood loss
5456030|NCT01477814|colorectal cancer|colorectal cancer
5456031|NCT01477814|screening|screening
5456032|NCT01477814|colonoscopy|colonoscopy
5456049|NCT01477749|immune therapy|immune therapy
5456050|NCT01477749|immunotherapy|immunotherapy
5456051|NCT01477749|vaccine|vaccine
5456052|NCT01477749|dendritic cells|dendritic cells
5456053|NCT01477749|antigen-presenting cells|antigen-presenting cells
5456054|NCT01477749|antigen presenting cells|antigen presenting cells
5456055|NCT01477749|cancer vaccine|cancer vaccine
5456057|NCT01477749|prostatic adenocarcinoma|prostatic adenocarcinoma
5456058|NCT01477736|Neurogenic bladder|neurogenic bladder
5456060|NCT01477736|Quality of life|quality of life
5456061|NCT01477710|Mechanical ventilation|mechanical ventilation
5456062|NCT01477710|Tidal volume|tidal volume
5456063|NCT01477710|Respiratory rate|respiratory rate
5456064|NCT01477697|Trauma|trauma
5456065|NCT01477671|Dengue|dengue
5456066|NCT01477671|Dengue Fever|dengue fever
5456067|NCT01477671|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5456068|NCT01477658|Congenital Complete Atrioventricular Heart Block|congenital complete atrioventricular heart block
5456069|NCT01477658|Pacemaker|pacemaker
5456070|NCT01477658|Cardiac pacing|cardiac pacing
5456071|NCT01477658|Children|children
5456072|NCT01477658|Heart failure|heart failure
5456073|NCT01477658|Ventricular dyssynchrony|ventricular dyssynchrony
5456074|NCT01477658|Echocardiography|echocardiography
5456075|NCT01477658|Quality of life|quality of life
5456076|NCT01477658|Six-minute walk test|six-minute walk test
5456077|NCT01477658|Young adults|young adults
5456078|NCT01477619|Pharmacokinetics|pharmacokinetics
5456079|NCT01477606|Acute myeloid leukemia|acute myeloid leukemia
5456080|NCT01477606|FLT3-ITD|flt3-itd
5456081|NCT01477606|midostaurin (PKC412)|midostaurin (pkc412)
5456082|NCT01477593|circumcision, chinese children, pain|circumcision, chinese children, pain
5456084|NCT01477554|Maternal morbidity|maternal morbidity
5456085|NCT01477554|Maternal mortality|maternal mortality
5456086|NCT01477554|Perinatal mortality|perinatal mortality
5456087|NCT01477554|Perinatal morbidity|perinatal morbidity
5456088|NCT01477554|Training|training
5456089|NCT01477554|Obstetric Emergency|obstetric emergency
5456090|NCT01477554|Medical team|medical team
5456091|NCT01477554|Simulation|simulation
5456092|NCT01477541|Prenatal care|prenatal care
5456093|NCT01477541|Maternal mortality|maternal mortality
5456094|NCT01477541|Perinatal mortality|perinatal mortality
5456095|NCT01477541|Perinatal|perinatal
5456096|NCT01477541|Puerperium|puerperium
5456097|NCT01477541|Puerperium care|puerperium care
5456098|NCT01477541|Midwives|midwives
5456099|NCT01477541|Midwife|midwife
5456100|NCT01477541|Obstetric|obstetric
5456101|NCT01477541|Nurse|nurse
5456102|NCT01477541|Integration|integration
5456103|NCT01477541|Alternative personnel|alternative personnel
5456104|NCT01477541|Skilled attendant|skilled attendant
5456105|NCT01477541|Birth attendant|birth attendant
5456106|NCT01477541|Delivery|delivery
5456107|NCT01477541|Delivery services|delivery services
5456108|NCT01477541|Best practices|best practices
5456109|NCT01477541|Rural|rural
5456110|NCT01477528|HeartMate II|heartmate ii
5456111|NCT01477528|Anticoagulation|anticoagulation
5456112|NCT01477528|Thoratec Corporation|thoratec corporation
5456113|NCT01477502|urinary tract infection|urinary tract infection
5456114|NCT01477502|spinal cord injury|spinal cord injury
5456115|NCT01477502|homeopathy|homeopathy
5456116|NCT01477502|prevention|prevention
5459282|NCT01464398|stress|stress
5456118|NCT01477476|Diabetes|diabetes
5456119|NCT01477476|Type I Diabetes|type i diabetes
5456120|NCT01477463|quality of life|quality of life
5456121|NCT01477450|Hypobaric hypoxemia|hypobaric hypoxemia
5456122|NCT01477450|Altitude|altitude
5456124|NCT01477450|oxygen concentrator|oxygen concentrator
5456125|NCT01477437|teens|teens
5456126|NCT01477437|adolescents|adolescents
5456127|NCT01477437|Internet intervention|internet intervention
5456128|NCT01477437|Hemophilia|hemophilia
5456129|NCT01477424|Drug-drug interaction|drug-drug interaction
5456130|NCT01477424|Pharmacokinetics|pharmacokinetics
5456131|NCT01477424|PA21|pa21
5456132|NCT01477411|Drug-drug interaction|drug-drug interaction
5456133|NCT01477411|Pharmacokinetics|pharmacokinetics
5456134|NCT01477411|PA21|pa21
5456135|NCT01477385|dental caries|dental caries
5456136|NCT01477385|primary teeth|primary teeth
5456137|NCT01477385|permanent teeth|permanent teeth
5456138|NCT01477385|silver diamine fluoride|silver diamine fluoride
5456139|NCT01477372|Pregnancy|pregnancy
5456140|NCT01477372|Exercise|exercise
5456141|NCT01477372|Excessive weight gain|excessive weight gain
5456142|NCT01477372|Outcomes|outcomes
5456143|NCT01477372|Urinary incontinence|urinary incontinence
5456144|NCT01477359|Sarcoidosis|sarcoidosis
5456145|NCT01477333|Tyvaso|tyvaso
5456146|NCT01477333|UT-15C SR|ut-15c sr
5456147|NCT01477333|PAH|pah
5456148|NCT01477320|Enteral Nutrition|enteral nutrition
5456149|NCT01477320|Stress Ulcer Prophylaxis|stress ulcer prophylaxis
5456150|NCT01477320|Critically Ill Patients|critically ill patients
5456151|NCT01477320|Overt and significant GI bleeding|overt and significant gi bleeding
5456152|NCT01477320|Stress gastropathy|stress gastropathy
5456153|NCT01477320|Clostridium Difficile pseudomembranous colitis|clostridium difficile pseudomembranous colitis
5456154|NCT01477320|Vital AF|vital af
5456155|NCT01477320|Small peptide fish oil structured lipids|small peptide fish oil structured lipids
5456156|NCT01477320|Fructose oligosaccharide|fructose oligosaccharide
5456157|NCT01477307|obesity|obesity
5456158|NCT01477307|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5456159|NCT01477294|Total|total
5456160|NCT01477294|Intra and Extracellular Water|intra and extracellular water
5456161|NCT01477294|Energy Expenditure, Physical Activity|energy expenditure, physical activity
5456162|NCT01477294|Body Composition|body composition
5456164|NCT01477281|chronic venous insufficiency|chronic venous insufficiency
5456165|NCT01477281|Daflon|daflon
5456166|NCT01477281|Venaflon|venaflon
5456167|NCT01477268|antidepressants|antidepressants
5456168|NCT01477268|depression|depression
5456169|NCT01477268|zoloft|zoloft
5456170|NCT01477268|psychiatry|psychiatry
5456171|NCT01477268|psychology|psychology
5456172|NCT01477255|daily assessment|daily assessment
5456173|NCT01477255|electronic diary|electronic diary
5456174|NCT01477255|coping strategies|coping strategies
5456175|NCT01477255|resiliency of cancer patients|resiliency of cancer patients
5456176|NCT01477255|psychology|psychology
5456177|NCT01477242|vomiting|vomiting
5456178|NCT01477242|anti-emetics|anti-emetics
5456179|NCT01477242|ketamine|ketamine
5456180|NCT01477242|sedation|sedation
5456181|NCT01477229|Rectal cancer|rectal cancer
5456182|NCT01477229|Quality of Life|quality of life
5456183|NCT01477229|Abdominoperineal Resection|abdominoperineal resection
5456184|NCT01477229|Anterior Resection|anterior resection
5456185|NCT01477229|Palliative cancer treatment|palliative cancer treatment
5456186|NCT01477229|Radio chemotherapy|radio chemotherapy
5456187|NCT01477216|Glycemic index|glycemic index
5456188|NCT01477216|Glycemic responses|glycemic responses
5456189|NCT01477216|Insulin responses|insulin responses
5456190|NCT01477216|Insulinemic index|insulinemic index
5456191|NCT01477216|Carbohydrates|carbohydrates
5456192|NCT01477216|Methodology|methodology
5456193|NCT01477216|Glucose metabolism|glucose metabolism
5456194|NCT01477177|Barrett's esophagus dysplasia|barrett's esophagus dysplasia
5456195|NCT01477164|Exercise|exercise
5456196|NCT01477164|Aging|aging
5456197|NCT01477164|Sarcopenia|sarcopenia
5456198|NCT01477164|Muscle function|muscle function
5456199|NCT01477151|isoflurane|isoflurane
5456200|NCT01477151|sevoflurane|sevoflurane
5456201|NCT01477151|troponin|troponin
5456202|NCT01477151|anesthesia|anesthesia
5456203|NCT01477151|cardioprotection|cardioprotection
5456204|NCT01477151|preconditioning|preconditioning
5456205|NCT01477151|cardiac surgery|cardiac surgery
5456206|NCT01477151|cardiac anesthesia|cardiac anesthesia
5456207|NCT01477138|Sick Sinus Syndrome|sick sinus syndrome
5438861|NCT01550120|threshold|threshold
5456208|NCT01477138|Cardiac Pacing, Artificial|cardiac pacing, artificial
5456209|NCT01477138|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5456210|NCT01477138|Pacemaker, Artificial|pacemaker, artificial
5456212|NCT01477125|adhd|adhd
5456213|NCT01477125|adults|adults
5456214|NCT01477125|working memory|working memory
5456215|NCT01477125|training|training
5456216|NCT01477125|RCT|rct
5456217|NCT01477112|Type 2 diabetes|type 2 diabetes
5456218|NCT01477112|β-carotene|β-carotene
5456219|NCT01477112|Oxidative balance|oxidative balance
5456228|NCT01477034|Obesity|obesity
5456229|NCT01477034|Inflammation|inflammation
5456230|NCT01477034|Low-grade, chronic inflammation|low-grade, chronic inflammation
5456231|NCT01477034|Adipose tissue inflammation|adipose tissue inflammation
5456232|NCT01477034|Diabetes|diabetes
5456233|NCT01477034|Type 2 diabetes mellitus|type 2 diabetes mellitus
5456234|NCT01477034|Insulin resistance|insulin resistance
5456235|NCT01477034|Intestinal permeability|intestinal permeability
5456236|NCT01477008|Knee|knee
5456237|NCT01477008|Cartilage repair|cartilage repair
5456238|NCT01477008|Cartilage regeneration|cartilage regeneration
5456239|NCT01477008|Chondral|chondral
5456240|NCT01477008|Osteochondral|osteochondral
5456241|NCT01477008|Biphasic scaffold|biphasic scaffold
5456242|NCT01477008|Medical device|medical device
5456243|NCT01477008|Autologous|autologous
5456244|NCT01477008|Synthetic|synthetic
5456245|NCT01477008|Medial condyle|medial condyle
5456246|NCT01477008|Lateral condyle|lateral condyle
5456247|NCT01477008|Trochlea|trochlea
5456248|NCT01476995|Cardiovascular system|cardiovascular system
5456249|NCT01476995|gastrointestinal system|gastrointestinal system
5456250|NCT01476995|kidneys|kidneys
5456251|NCT01476995|liver|liver
5456252|NCT01476995|lungs|lungs
5456253|NCT01476969|Ischemia reperfusion injury|ischemia reperfusion injury
5456254|NCT01476969|Cardiopulmonary bypass|cardiopulmonary bypass
5456255|NCT01476969|Remote Ischemic Postconditioning|remote ischemic postconditioning
5456256|NCT01476969|Other Functional Disturbances Following Cardiac Surgery|other functional disturbances following cardiac surgery
5456257|NCT01476930|migraine|migraine
5456258|NCT01476930|prophylactic treatment|prophylactic treatment
5456259|NCT01476930|cupping|cupping
5456260|NCT01476930|serkangabin|serkangabin
5456261|NCT01476904|Asthma|asthma
5456262|NCT01476904|Bronchial Asthma|bronchial asthma
5456263|NCT01476904|Shortness of breath|shortness of breath
5456264|NCT01476891|MBSR|mbsr
5456265|NCT01476891|Cancer|cancer
5456266|NCT01476891|Online|online
5456267|NCT01476891|Mindfulness Meditation|mindfulness meditation
5456268|NCT01476891|Randomized Waitlist Controlled Trial|randomized waitlist controlled trial
5456269|NCT01476878|Radiosurgery|radiosurgery
5456270|NCT01476878|Frameless radiosurgery|frameless radiosurgery
5456271|NCT01476878|Accuracy|accuracy
5685526|NCT00555750|actigraphy|actigraphy
5456272|NCT01476800|Drugs, Investigational|drugs, investigational
5456273|NCT01476800|pharmacokinetics|pharmacokinetics
5456274|NCT01476800|Urinary Bladder, Overactive|urinary bladder, overactive
5456275|NCT01476800|YM178|ym178
5456276|NCT01476800|Mirabegron|mirabegron
5456277|NCT01476787|Follicular lymphoma|follicular lymphoma
5456278|NCT01476787|Non-Hodgkins Follicular Lymphoma|non-hodgkins follicular lymphoma
5671350|NCT00616421|meningococcal|meningococcal
5456279|NCT01476787|treatment for Follicular Lymphoma|treatment for follicular lymphoma
5456280|NCT01476787|rituximab treatment|rituximab treatment
5456281|NCT01476787|rituximab and lenalidomide treatment|rituximab and lenalidomide treatment
5456282|NCT01476761|Surgical tissue resection|surgical tissue resection
5456283|NCT01476761|Tissue dissection|tissue dissection
5456284|NCT01476761|Tissue transection|tissue transection
5456285|NCT01476761|Anastomosis of gastrointestina tissue|anastomosis of gastrointestina tissue
5456286|NCT01476722|Silicone Hydrogel|silicone hydrogel
5456287|NCT01476722|Soft Contact Lenses|soft contact lenses
5456288|NCT01476722|Multi-Purpose Solution|multi-purpose solution
5456289|NCT01476709|Puncture; Instrument|puncture; instrument
5456290|NCT01476709|Optics and Photonics|optics and photonics
5456291|NCT01476709|Pain|pain
5456292|NCT01476696|Sickle cell disease|sickle cell disease
5456293|NCT01476696|pediatrics|pediatrics
5456294|NCT01476696|SCD|scd
5456295|NCT01476696|children|children
5456296|NCT01476696|child|child
5456297|NCT01476696|kids|kids
5456298|NCT01476696|pain crisis|pain crisis
5456299|NCT01476696|sickle cell anemia|sickle cell anemia
5456300|NCT01476696|sickle cell pain|sickle cell pain
5456301|NCT01476683|Antidiarrheals|antidiarrheals
5456302|NCT01476670|Posterior fossa brain tumor|posterior fossa brain tumor
5456303|NCT01476670|Cerebral blood flow|cerebral blood flow
5456304|NCT01476670|Cerebral autoregulation|cerebral autoregulation
5456305|NCT01476670|Carbon dioxide reactivity|carbon dioxide reactivity
5456306|NCT01476670|Transcranial Doppler|transcranial doppler
5456307|NCT01476657|Phase 1|phase 1
5456308|NCT01476644|Health related quality of life|health related quality of life
5459481|NCT01463514|cerebral blood flow|cerebral blood flow
5456309|NCT01476644|Clinical measures of vision|clinical measures of vision
5456310|NCT01476618|Provider Perspectives|provider perspectives
5456311|NCT01476618|Barriers|barriers
5456312|NCT01476618|OIF/OEF Veterans|oif/oef veterans
5456313|NCT01476605|prolotherapy|prolotherapy
5456314|NCT01476605|Platelet rich plasma|platelet rich plasma
5456315|NCT01476605|tennis elbow|tennis elbow
5456316|NCT01476605|lateral epicondylosis|lateral epicondylosis
5456317|NCT01476592|gastrointestinal neuroendocrine tumor|gastrointestinal neuroendocrine tumor
5456318|NCT01476579|Coronary CT|coronary ct
5456319|NCT01476579|Sensitivity|sensitivity
5456320|NCT01476579|Specificity|specificity
5456321|NCT01476579|Radiation|radiation
5456322|NCT01476579|Tomography, X-Ray Computed|tomography, x-ray computed
5456323|NCT01476579|Coronary angiography|coronary angiography
5456324|NCT01476566|aged|aged
5456325|NCT01476566|family practice|family practice
5456326|NCT01476553|gastric cancer|gastric cancer
5456327|NCT01476553|extensive intraperitoneal lavage|extensive intraperitoneal lavage
5456328|NCT01476553|EIPL|eipl
5456329|NCT01476553|intraperitoneal tumor cells|intraperitoneal tumor cells
5456330|NCT01476553|peritoneal carcinomatosis|peritoneal carcinomatosis
5456331|NCT01476514|Hyperekplexia|hyperekplexia
5456332|NCT01476514|Pain modulation|pain modulation
5456333|NCT01476514|Glycine receptors|glycine receptors
5456334|NCT01476514|Hyperalgesia|hyperalgesia
5456335|NCT01476514|Spinal inhibitory interneurons|spinal inhibitory interneurons
5456336|NCT01476501|vitamin D|vitamin d
5456337|NCT01476501|bone health|bone health
5456338|NCT01476501|diabetes|diabetes
5456339|NCT01476501|nephropathy|nephropathy
5456340|NCT01476462|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5456341|NCT01476462|Ponte-di-Legno consortium|ponte-di-legno consortium
5456342|NCT01476462|Second cancer|second cancer
5456343|NCT01476462|Survival|survival
5456344|NCT01476449|Diabetic Macular Edema|diabetic macular edema
5456473|NCT01475773|malocclusion|malocclusion
5456345|NCT01476449|Diabetic Retinal Swelling|diabetic retinal swelling
5456346|NCT01476449|DIabetic Eye Disease|diabetic eye disease
5456347|NCT01476436|Cardio vascular risk factors|cardio vascular risk factors
5456348|NCT01476423|Glanzmann's Thrombasthenia|glanzmann's thrombasthenia
5456349|NCT01476397|full-term|full-term
5456350|NCT01476397|formula-fed infants|formula-fed infants
5456351|NCT01476384|Glucose|glucose
5456352|NCT01476384|insulin|insulin
5456353|NCT01476384|Glycocalyx|glycocalyx
5456354|NCT01476384|Muscle|muscle
5456355|NCT01476384|Vascularisation|vascularisation
5456356|NCT01476384|young|young
5456357|NCT01476384|elderly|elderly
5456358|NCT01476371|Group treatment|group treatment
5456359|NCT01476371|Mindfulness|mindfulness
5456360|NCT01476371|Minor mental disorders|minor mental disorders
5456361|NCT01476371|Inflammation|inflammation
5456362|NCT01476332|eyes|eyes
5456363|NCT01476332|cis-urocanic acid|cis-urocanic acid
5456364|NCT01476332|safety|safety
5456365|NCT01476332|tolerability|tolerability
5456366|NCT01476332|pharmacokinetics|pharmacokinetics
5456367|NCT01476306|feasibility|feasibility
5456368|NCT01476306|effectiveness|effectiveness
5456369|NCT01476306|Parkinson disease care|parkinson disease care
5456370|NCT01476306|care via telemedicine|care via telemedicine
5456371|NCT01476293|Infiltration|infiltration
5456372|NCT01476293|Extravasation|extravasation
5456373|NCT01476293|Leaking|leaking
5456374|NCT01476293|PIV Infiltration|piv infiltration
5456375|NCT01476293|IV Infiltration|iv infiltration
5671453|NCT00615979|Department of Defense|department of defense
5601900|NCT00890656|ALL|all
5456376|NCT01476293|Optical Detection of Infiltration|optical detection of infiltration
5456377|NCT01476293|Optical Monitoring|optical monitoring
5456378|NCT01476280|antiemetics|antiemetics
5456379|NCT01476280|ramosetron|ramosetron
5456380|NCT01476280|palonosetron|palonosetron
5456381|NCT01476280|PONV(postoperative nausea and vomiting)|ponv(postoperative nausea and vomiting)
5456382|NCT01476254|Postoperative pulmonary complications|postoperative pulmonary complications
5456383|NCT01476254|Laparoscopic surgery|laparoscopic surgery
5456384|NCT01476215|paracetamol|paracetamol
5456385|NCT01476202|craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT|craving, provoked craving, smoking cessation, nicotine replacement therapy, nrt
5456386|NCT01476189|pharmacokinetic|pharmacokinetic
5456387|NCT01476189|paracetamol|paracetamol
5456388|NCT01476189|Healthy volunteer|healthy volunteer
5456389|NCT01476189|steady state|steady state
5456390|NCT01476176|Bioequivalence|bioequivalence
5456391|NCT01476176|Pharmacokinetics|pharmacokinetics
5456392|NCT01476176|Healthy volunteers|healthy volunteers
5456393|NCT01476176|paracetamol|paracetamol
5456394|NCT01476176|caffeine|caffeine
5456395|NCT01476163|AT1001|at1001
5456396|NCT01476163|Lysosomal storage disease|lysosomal storage disease
5456397|NCT01476163|Lysosomal Storage Disorder|lysosomal storage disorder
5456398|NCT01476163|migalastat|migalastat
5456399|NCT01476163|Fabry disease|fabry disease
5456400|NCT01476163|Fabry|fabry
5456401|NCT01476163|Amicus|amicus
5456402|NCT01476137|oncology|oncology
5456403|NCT01476137|solid tumors|solid tumors
5456404|NCT01476137|multiple myeloma|multiple myeloma
5456405|NCT01476137|AKT inhibitor|akt inhibitor
5456406|NCT01476137|MEK inhibitor|mek inhibitor
5456407|NCT01476111|tumor antigens|tumor antigens
5456408|NCT01476111|observational|observational
5456409|NCT01476111|breast cancer|breast cancer
5456410|NCT01476111|biomarkers|biomarkers
5456411|NCT01476111|Neoadjuvant|neoadjuvant
5456412|NCT01476059|Treatment compliance|treatment compliance
5456413|NCT01476059|Pediatric|pediatric
5456414|NCT01476059|Asthma|asthma
5456415|NCT01476046|Acute Lung Injury (ALI)|acute lung injury (ali)
5456416|NCT01476046|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5456417|NCT01476033|Oxidative stress|oxidative stress
5456418|NCT01476033|inflammation|inflammation
5456419|NCT01476033|blood flow|blood flow
5456420|NCT01476020|Drug eluting stent|drug eluting stent
5456421|NCT01476020|Dual antiplatelet therapy|dual antiplatelet therapy
5456422|NCT01476020|bleeding|bleeding
5456423|NCT01476020|stent thrombosis|stent thrombosis
5456424|NCT01476020|follow-up of the drug eluting stent|follow-up of the drug eluting stent
5456425|NCT01476007|primary health care|primary health care
5456426|NCT01476007|Vitamin B 12 Deficiency|vitamin b 12 deficiency
5456427|NCT01475981|JTK-853|jtk-853
5456428|NCT01475981|single dose|single dose
5456429|NCT01475942|elderly|elderly
5456430|NCT01475942|probiotic|probiotic
5456431|NCT01475942|bowel function|bowel function
5456432|NCT01475942|pathogen|pathogen
5456433|NCT01475942|constipation|constipation
5456434|NCT01475942|diarrhoea|diarrhoea
5456435|NCT01475942|Subclinical levels|subclinical levels
5456436|NCT01475929|irritable bowel syndrome|irritable bowel syndrome
5456437|NCT01475929|probiotic|probiotic
5456438|NCT01475916|Asthma|asthma
5456439|NCT01475916|Educational program|educational program
5456440|NCT01475916|Quality of life|quality of life
5456441|NCT01475916|School-aged children|school-aged children
5456442|NCT01475903|Obesity|obesity
5456443|NCT01475903|Sleeve gastrectomy|sleeve gastrectomy
5456444|NCT01475903|Nutritional impact|nutritional impact
5456445|NCT01475903|Vitamin deficiency|vitamin deficiency
5456446|NCT01475890|HIV/AIDS|hiv/aids
5456447|NCT01475890|Nutrition|nutrition
5456448|NCT01475877|bromfenac|bromfenac
5456449|NCT01475877|nepafenac|nepafenac
5456450|NCT01475877|PRK|prk
5456451|NCT01475877|epithelial healing,|epithelial healing,
5456452|NCT01475864|Choledocholithiasis|choledocholithiasis
5456453|NCT01475864|metal stents|metal stents
5456454|NCT01475864|biliary duct stent|biliary duct stent
5456455|NCT01475851|Tenofovir disoproxil fumarate, compensated chronic hepatitis B|tenofovir disoproxil fumarate, compensated chronic hepatitis b
5456456|NCT01475838|HIV-1|hiv-1
5456457|NCT01475838|HIV|hiv
5456458|NCT01475838|Treatment Experienced|treatment experienced
5456459|NCT01475812|COPD|copd
5456460|NCT01475812|activities of daily living|activities of daily living
5456461|NCT01475812|pulmonary hyperinflation|pulmonary hyperinflation
5456462|NCT01475812|exercise|exercise
5456463|NCT01475786|nerve pain|nerve pain
5456464|NCT01475786|diabetic nerve pain|diabetic nerve pain
5456465|NCT01475786|throbbing|throbbing
5456467|NCT01475786|painful feet|painful feet
5456468|NCT01475786|tingling|tingling
5456469|NCT01475786|numbness|numbness
5456470|NCT01475773|self-esteem|self-esteem
5456471|NCT01475773|personality|personality
5456472|NCT01475773|quality of life|quality of life
5456474|NCT01475773|orthodontics|orthodontics
5456475|NCT01475760|chronic kidney disease|chronic kidney disease
5456476|NCT01475760|serum phosphorus|serum phosphorus
5456477|NCT01475760|salivary phosphorus|salivary phosphorus
5456478|NCT01475760|FGF23|fgf23
5456479|NCT01475734|glucose clamp|glucose clamp
5456480|NCT01475734|hypoglycemia|hypoglycemia
5456481|NCT01475721|ADVAIR|advair
5456482|NCT01475721|Asthma|asthma
5456483|NCT01475721|safety|safety
5456484|NCT01475721|FLOVENT|flovent
5456485|NCT01475708|Lyme borreliosis|lyme borreliosis
5456486|NCT01475708|Erythema migrans|erythema migrans
5456487|NCT01475708|Doxycycline|doxycycline
5456488|NCT01475708|Subjective symptoms|subjective symptoms
5456489|NCT01475708|Outcome|outcome
5456490|NCT01475695|Mass balance|mass balance
5456491|NCT01475695|intravenous|intravenous
5456492|NCT01475695|GSK2251052|gsk2251052
5456493|NCT01475695|Healthy volunteer|healthy volunteer
5456494|NCT01475695|Antimicrobial|antimicrobial
5456495|NCT01475695|Radiolabel|radiolabel
5456496|NCT01475682|Obstructive sleep apnea|obstructive sleep apnea
5456497|NCT01475682|cardiometabolic complications|cardiometabolic complications
5456498|NCT01475682|Effects of CPAP treatment|effects of cpap treatment
5456499|NCT01475643|Pediatric cataract|pediatric cataract
5456500|NCT01475630|temporomandibular joint|temporomandibular joint
5456501|NCT01475630|rehabilitation medicine|rehabilitation medicine
5456502|NCT01475630|joint diseases|joint diseases
5456503|NCT01475630|physical therapy|physical therapy
5456504|NCT01475604|Pulsed Radio Frequency, Electromagnetic Field therapy|pulsed radio frequency, electromagnetic field therapy
5456505|NCT01475591|persistent neuromusculoskeletal pain|persistent neuromusculoskeletal pain
5456506|NCT01475591|neck|neck
5456507|NCT01475591|shoulder|shoulder
5456508|NCT01475591|back-area|back-area
5456509|NCT01475591|risk|risk
5456510|NCT01475591|longlasting|longlasting
5456511|NCT01475591|pain syndrome|pain syndrome
5456512|NCT01475578|Vascular Dementia|vascular dementia
5456513|NCT01475565|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5456514|NCT01475565|insulin sensitivity|insulin sensitivity
5456515|NCT01475565|insulin resistance|insulin resistance
5456516|NCT01475565|gestational diabetes|gestational diabetes
5456517|NCT01475565|pregnancy|pregnancy
5456518|NCT01475565|estrogen|estrogen
5456519|NCT01475565|glucose intolerance|glucose intolerance
5456520|NCT01475565|obesity|obesity
5456521|NCT01475565|ovulatory disorder|ovulatory disorder
5456522|NCT01475565|racial differences|racial differences
5456523|NCT01475565|hyperandrogenism|hyperandrogenism
5456524|NCT01475552|platelet reactivity|platelet reactivity
5456525|NCT01475552|platelet function assay|platelet function assay
5456526|NCT01475552|abciximab|abciximab
5456527|NCT01475552|tailored therapy|tailored therapy
5456528|NCT01475539|Polio|polio
5456529|NCT01475539|Poliovirus|poliovirus
5456530|NCT01475539|Oral poliovirus vaccine|oral poliovirus vaccine
5456531|NCT01475539|IMOVAX Polio®|imovax polio®
5456532|NCT01475526|grocery store|grocery store
5456533|NCT01475526|nutrition|nutrition
5456534|NCT01475526|Latino|latino
5456535|NCT01475526|Hispanic|hispanic
5456536|NCT01475513|oral contraceptive|oral contraceptive
5456537|NCT01475513|birth control pill|birth control pill
5456538|NCT01475513|women|women
5456539|NCT01475513|healthy volunteer|healthy volunteer
5456540|NCT01475513|insulin sensitivity|insulin sensitivity
5456541|NCT01475513|insulin resistance|insulin resistance
5456542|NCT01475513|cardiovascular risk factors|cardiovascular risk factors
5456543|NCT01475513|endothelial function|endothelial function
5456544|NCT01475513|estrogen metabolism|estrogen metabolism
5456545|NCT01475513|racial difference|racial difference
5456546|NCT01475513|glucose intolerance|glucose intolerance
5456547|NCT01475474|incontinence|incontinence
5456548|NCT01475474|bowel|bowel
5456549|NCT01475474|movement|movement
5456550|NCT01475474|fecal|fecal
5456551|NCT01475474|anal|anal
5456552|NCT01475474|diarrhea|diarrhea
5456553|NCT01475474|stool|stool
5456554|NCT01475474|rectal|rectal
5456555|NCT01475474|feces|feces
5456556|NCT01475474|uncontrolled|uncontrolled
5456557|NCT01475474|loose|loose
5456558|NCT01475474|leakage|leakage
5456559|NCT01475474|rectum|rectum
5456561|NCT01475474|watery|watery
5456562|NCT01475474|urgent|urgent
5456563|NCT01475474|flatulence|flatulence
5456564|NCT01475474|gas|gas
5456565|NCT01475461|Phase 2|phase 2
5456566|NCT01475461|type 2 diabetes mellitus|type 2 diabetes mellitus
5456567|NCT01475461|PF-04937319|pf-04937319
5456568|NCT01475448|biomechanics|biomechanics
5456569|NCT01475448|motor control|motor control
5456570|NCT01475448|movement|movement
5456571|NCT01475448|walking|walking
5456572|NCT01475448|running|running
5456576|NCT01475409|tuberculosis|tuberculosis
5456577|NCT01475409|QuantiFERON-TB Gold In-Tube|quantiferon-tb gold in-tube
5456578|NCT01475409|tuberculin skin test|tuberculin skin test
5456579|NCT01475409|rheumatoid arthritis|rheumatoid arthritis
5456580|NCT01475409|spondyloarthritis|spondyloarthritis
5456581|NCT01475396|exercise|exercise
5456582|NCT01475396|physical activity|physical activity
5456583|NCT01475396|cognition|cognition
5456585|NCT01475396|aging|aging
5456586|NCT01475396|BDNF|bdnf
5456587|NCT01475383|Tourette's Syndrome in adults|tourette's syndrome in adults
5456588|NCT01475383|Safety and Efficacy|safety and efficacy
5456589|NCT01475383|Randomized|randomized
5456590|NCT01475383|Placebo Control|placebo control
5456591|NCT01475383|Cross-over|cross-over
5456592|NCT01475370|Acute myeloid leukemia|acute myeloid leukemia
5456593|NCT01475370|WT1|wt1
5456594|NCT01475357|congenital heart defects|congenital heart defects
5456595|NCT01475357|growth failure|growth failure
5456596|NCT01475344|Trauma patient with major bleeding|trauma patient with major bleeding
5456597|NCT01475331|pancreatic cyst|pancreatic cyst
5456598|NCT01475331|chemotherapy|chemotherapy
5456599|NCT01475331|ethanol|ethanol
5456600|NCT01475331|ablation|ablation
5456601|NCT01475318|complete abortion rate|complete abortion rate
5456602|NCT01475318|side effects|side effects
5456603|NCT01475318|induction-to-abortion interval|induction-to-abortion interval
5456850|NCT01474356|side effects|side effects
5456604|NCT01475305|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5456605|NCT01475305|Healthy adults|healthy adults
5456606|NCT01475305|MEDI-557|medi-557
5456607|NCT01475305|Intranasal challenge|intranasal challenge
5456608|NCT01475305|Human model|human model
5456618|NCT01475266|Apaziquone|apaziquone
5456619|NCT01475266|EOquin|eoquin
5456620|NCT01475266|Immediate instillation|immediate instillation
5456621|NCT01475240|HIV|hiv
5456622|NCT01475227|HIV|hiv
5456623|NCT01475227|Bilirubin|bilirubin
5456624|NCT01475214|potassium bicarbonate|potassium bicarbonate
5456625|NCT01475214|urinary N-telopeptide|urinary n-telopeptide
5456627|NCT01475214|net acid excretion|net acid excretion
5456628|NCT01475201|Type 2 diabetes|type 2 diabetes
5456629|NCT01475201|Hypertension|hypertension
5456630|NCT01475201|Primary Care|primary care
5456631|NCT01475201|Physical Activity|physical activity
5456632|NCT01475201|Behavioural Intervention|behavioural intervention
5456633|NCT01475201|Pedometer|pedometer
5456634|NCT01475201|Accelerometer|accelerometer
5456635|NCT01475201|Arterial Stiffness|arterial stiffness
5456636|NCT01475201|Carotid femoral pulse wave velocity|carotid femoral pulse wave velocity
5456637|NCT01475201|Vascular disease risk|vascular disease risk
5456638|NCT01475201|Vascular disease prevention|vascular disease prevention
5456639|NCT01475201|Intervention|intervention
5456640|NCT01475188|specific subcutaneous immunotherapy|specific subcutaneous immunotherapy
5456641|NCT01475188|seasonal allergic rhinitis|seasonal allergic rhinitis
5456642|NCT01475188|regulatory lymphocytes|regulatory lymphocytes
5456643|NCT01475188|signal transduction|signal transduction
5456644|NCT01475188|histamine receptor|histamine receptor
5456650|NCT01475149|Antiphospholipid syndrome|antiphospholipid syndrome
5456651|NCT01475149|Antiphospholipid antibodies|antiphospholipid antibodies
5456652|NCT01475149|Systemic lupus erythematosus|systemic lupus erythematosus
5456653|NCT01475149|Annexin A5 and Annexin A5 resistance assay|annexin a5 and annexin a5 resistance assay
5456654|NCT01475123|Nicorandil|nicorandil
5456655|NCT01475123|Randomized control study|randomized control study
5456656|NCT01475123|Hemodialysis|hemodialysis
5456657|NCT01475123|Coronary Artery Disease|coronary artery disease
5456658|NCT01475110|Imatinib|imatinib
5456659|NCT01475110|Chronic Myeloid Leukaemia|chronic myeloid leukaemia
5456660|NCT01475110|Nilotinib|nilotinib
5456661|NCT01475110|Adult patients|adult patients
5456662|NCT01475110|Imatinib resistant|imatinib resistant
5456663|NCT01475097|AE - Adverse event|ae - adverse event
5456664|NCT01475097|Arteriography|arteriography
5456665|NCT01475097|IA - Intra-arterial|ia - intra-arterial
5456666|NCT01475097|IOCM - Iso-Osmolar Contrast Medium|iocm - iso-osmolar contrast medium
5456667|NCT01475097|LOCM - Low-Osmolar Contrast Medium|locm - low-osmolar contrast medium
5456668|NCT01475097|Patient Comfort|patient comfort
5456669|NCT01475097|Body Image Disturbance|body image disturbance
5456670|NCT01475097|Patient|patient
5456671|NCT01475084|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5456672|NCT01475084|cryobiopsy|cryobiopsy
5456673|NCT01475084|pleural biopsy|pleural biopsy
5456674|NCT01475084|pleural effusion|pleural effusion
5456675|NCT01475084|safety|safety
5456676|NCT01475084|thoracoscopy|thoracoscopy
5456677|NCT01475045|COPD|copd
5456678|NCT01475032|Asthma|asthma
5456679|NCT01475032|children|children
5456680|NCT01475032|chronic treatment|chronic treatment
5456681|NCT01475019|Obesity|obesity
5456682|NCT01475019|Polycystic Ovaries Syndrome|polycystic ovaries syndrome
5456684|NCT01475019|Sibutramine|sibutramine
5456685|NCT01475019|Androgen levels|androgen levels
5456686|NCT01475019|Insulin resistance|insulin resistance
5685300|NCT00556647|fast-track diagnosis|fast-track diagnosis
5456687|NCT01475006|Epidermal Growth Factor Receptor Variant III|epidermal growth factor receptor variant iii
5456688|NCT01475006|EGFRvIII|egfrviii
5456689|NCT01475006|Glioma|glioma
5456690|NCT01475006|Anaplastic Astrocytomas|anaplastic astrocytomas
5456691|NCT01475006|Glioblastoma Multiforme|glioblastoma multiforme
5456692|NCT01475006|Antibody drug conjugate|antibody drug conjugate
5456693|NCT01475006|brain tumor|brain tumor
5456694|NCT01474980|Congenital Myasthenic Syndrome|congenital myasthenic syndrome
5456695|NCT01474980|Pregnancy|pregnancy
5456696|NCT01474980|Outcome|outcome
5456697|NCT01474967|polycystic ovary syndrome|polycystic ovary syndrome
5456698|NCT01474967|lipid profile|lipid profile
5456699|NCT01474967|metformin|metformin
5456700|NCT01474954|HIV|hiv
5456701|NCT01474954|Antiretroviral Medication|antiretroviral medication
5456702|NCT01474954|Cardiovascular Disease Risk|cardiovascular disease risk
5456703|NCT01474941|Multiple Dose Study Overweight Healthy Subjects Body Weight Modified-Release Formulation|multiple dose study overweight healthy subjects body weight modified-release formulation
5456704|NCT01474928|Asthma|asthma
5456705|NCT01474928|Community-based participatory research|community-based participatory research
5456706|NCT01474928|Educational intervention|educational intervention
5456707|NCT01474928|Ethno-cultural community|ethno-cultural community
5456708|NCT01474928|Video recording|video recording
5456709|NCT01474928|Patient education handout|patient education handout
5456710|NCT01474915|Neurosurgery|neurosurgery
5456711|NCT01474902|pediatric|pediatric
5456712|NCT01474902|asymptotic venous thrombosis|asymptotic venous thrombosis
5456713|NCT01474902|Enoxaparin|enoxaparin
5456714|NCT01474902|pediatric cardiac surgery|pediatric cardiac surgery
5456715|NCT01474889|Hypoglycemia, Unawareness, RT-CGM, Type 1 Diabetes|hypoglycemia, unawareness, rt-cgm, type 1 diabetes
5456716|NCT01474876|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
5456717|NCT01474876|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
5456718|NCT01474876|Psoriatic Arthritis|psoriatic arthritis
5456719|NCT01474876|Ankylosing Spondylitis|ankylosing spondylitis
5456720|NCT01474850|mechanical ventilation|mechanical ventilation
5459891|NCT01461811|toric|toric
5456972|NCT01473836|Metronidazole|metronidazole
5439345|NCT01548053|Quality of care|quality of care
5456723|NCT01474850|positive end expiratory pressure|positive end expiratory pressure
5456724|NCT01474850|opto-electronic plethysmography|opto-electronic plethysmography
5456725|NCT01474850|chest wall volume variation|chest wall volume variation
5456726|NCT01474850|intravenous anesthesia|intravenous anesthesia
5456727|NCT01474837|depressive disorders|depressive disorders
5456728|NCT01474837|exercise therapy|exercise therapy
5456729|NCT01474824|Cardiac output|cardiac output
5456730|NCT01474824|Stroke volume|stroke volume
5456731|NCT01474811|Hepatitis|hepatitis
5456732|NCT01474811|Hepatitis C|hepatitis c
5456733|NCT01474811|HCV-TARGET|hcv-target
5456735|NCT01474811|Observational Study|observational study
5456736|NCT01474798|Acne Vulgaris|acne vulgaris
5456737|NCT01474785|Obesity|obesity
5456738|NCT01474785|Bariatric surgery|bariatric surgery
5456739|NCT01474785|Nashville, Tennessee|nashville, tennessee
5456740|NCT01474772|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5456741|NCT01474772|Pain on Walking|pain on walking
5456742|NCT01474772|Pregabalin|pregabalin
5456743|NCT01474746|Fragile X Syndrome|fragile x syndrome
5456744|NCT01474746|Pediatrics|pediatrics
5456745|NCT01474746|sertraline|sertraline
5456746|NCT01474746|autism|autism
5456747|NCT01474733|resident education|resident education
5456748|NCT01474733|health literacy|health literacy
5456749|NCT01474733|curriculum|curriculum
5456750|NCT01474720|Systemic Lupus Erythematosus|systemic lupus erythematosus
5456751|NCT01474720|Lupus|lupus
5456752|NCT01474720|SLE|sle
5456753|NCT01474720|Zostavax|zostavax
5456754|NCT01474720|shingles|shingles
5456755|NCT01474707|COPD|copd
5456756|NCT01474707|Educational materials|educational materials
5456757|NCT01474707|Cultural background|cultural background
5456758|NCT01474707|Instructional videos|instructional videos
5456759|NCT01474707|Patient education handouts|patient education handouts
5456760|NCT01474707|Lung age|lung age
5456761|NCT01474694|prospective study|prospective study
5456762|NCT01474694|multicenter trial|multicenter trial
5456763|NCT01474694|analysis, computer assisted image|analysis, computer assisted image
5456764|NCT01474694|CE marked|ce marked
5456765|NCT01474694|medical devices|medical devices
5456766|NCT01474694|catheter ablation|catheter ablation
5456767|NCT01474681|hematologic malignancies|hematologic malignancies
5456768|NCT01474681|leukemia|leukemia
5456769|NCT01474681|lymphoma|lymphoma
5456770|NCT01474655|epiretinal membrane|epiretinal membrane
5456771|NCT01474655|visual acuity|visual acuity
5456772|NCT01474655|metamorphopsia|metamorphopsia
5456773|NCT01474655|thickness of retinal layers|thickness of retinal layers
5456774|NCT01474655|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5456775|NCT01474642|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
5451434|NCT01496807|stage 3|stage 3
5685301|NCT00556647|PET-CT|pet-ct
5456776|NCT01474642|Randomizes phase II trial|randomizes phase ii trial
5456778|NCT01474642|Cisplatin|cisplatin
5456779|NCT01474642|Genexol|genexol
5456780|NCT01474629|oxidative stress|oxidative stress
5456781|NCT01474629|inflammation|inflammation
5456782|NCT01474629|endotoxemia|endotoxemia
5456783|NCT01474629|strenuous exercise|strenuous exercise
5456784|NCT01474616|Aging|aging
5456785|NCT01474616|Health Services|health services
5903970|NCT00092222|KSHV-MCD|kshv-mcd
5602333|NCT00889226|PWV|pwv
5456786|NCT01474616|Knowledge Translation|knowledge translation
5456787|NCT01474616|Long-Term Care Facilities|long-term care facilities
5456788|NCT01474616|Mobility|mobility
5456789|NCT01474616|Psychosocial And Health Behaviours|psychosocial and health behaviours
5456790|NCT01474603|observational study|observational study
5456791|NCT01474577|stress test|stress test
5456792|NCT01474577|cardiac issues|cardiac issues
5456793|NCT01474577|Rb-82 PET Myocardial Perfusion Imaging|rb-82 pet myocardial perfusion imaging
5456794|NCT01474577|11-150|11-150
5456795|NCT01474577|one or more 82Rb myocardial perfusion stress tests|one or more 82rb myocardial perfusion stress tests
5456796|NCT01474564|Blood draw|blood draw
5456797|NCT01474564|pancreas|pancreas
5456798|NCT01474564|Tumorigenic Cells|tumorigenic cells
5456799|NCT01474564|11-141|11-141
5456800|NCT01474551|Vemurafenib|vemurafenib
5456801|NCT01474551|skin cancer|skin cancer
5456802|NCT01474551|Stage IV|stage iv
5456803|NCT01474551|advanced stage III|advanced stage iii
5456804|NCT01474551|11-091|11-091
5456805|NCT01474538|diabetes|diabetes
5456806|NCT01474538|type 2 diabetes|type 2 diabetes
5456807|NCT01474538|insulin pump|insulin pump
5456808|NCT01474538|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5456809|NCT01474538|CSII|csii
5456810|NCT01474538|A1C|a1c
5456811|NCT01474486|thiamin|thiamin
5456812|NCT01474486|pyridoxine|pyridoxine
5456813|NCT01474486|vitamin D|vitamin d
5456814|NCT01474486|zinc|zinc
5846735|NCT00043628|Progenitor Cells|progenitor cells
5456816|NCT01474486|ischemic cardiomyopathy|ischemic cardiomyopathy
5456817|NCT01474486|nutritional injury|nutritional injury
5456818|NCT01474486|quality of life|quality of life
5456819|NCT01474473|CACIPLIQ20|cacipliq20
5456820|NCT01474473|Matrix Therapy|matrix therapy
5456821|NCT01474473|Diabetic foot|diabetic foot
5456822|NCT01474460|warfarin|warfarin
5456823|NCT01474460|phytonadione|phytonadione
5456824|NCT01474460|INR|inr
5456825|NCT01474447|low back pain|low back pain
5456826|NCT01474434|coronary artery disease,|coronary artery disease,
5456827|NCT01474434|LCQ908,|lcq908,
5456828|NCT01474434|hyperlipidemia,|hyperlipidemia,
5456829|NCT01474434|hypertriglyceridemia,|hypertriglyceridemia,
5456830|NCT01474434|pradigastat|pradigastat
5456831|NCT01474421|Parkinson's disease|parkinson's disease
5456832|NCT01474421|Dyskinesia|dyskinesia
5456833|NCT01474421|Movement disorders|movement disorders
5456834|NCT01474421|L-dopa|l-dopa
5456835|NCT01474408|Coronary artery bypass|coronary artery bypass
5456836|NCT01474408|Exercise therapy|exercise therapy
5456837|NCT01474408|Revascularization (PCI)|revascularization (pci)
5456838|NCT01474395|schizophrenia|schizophrenia
5456839|NCT01474395|cognitive remediation|cognitive remediation
5456840|NCT01474395|NMDA|nmda
5456841|NCT01474382|OraVerse|oraverse
5456842|NCT01474382|Safety|safety
5456843|NCT01474382|Efficacy|efficacy
5456844|NCT01474382|Pediatric|pediatric
5456845|NCT01474382|Reversal of dental anesthesia|reversal of dental anesthesia
5456846|NCT01474369|Drug Therapy|drug therapy
5456847|NCT01474356|brachytherapy|brachytherapy
5456848|NCT01474356|interstitial hyperthermia|interstitial hyperthermia
5456849|NCT01474356|cervical cancer|cervical cancer
5456851|NCT01474356|Locally advanced cervical cancer patients|locally advanced cervical cancer patients
5456852|NCT01474343|Neurodegenerative Diseases|neurodegenerative diseases
5456853|NCT01474343|Nervous System Diseases|nervous system diseases
5456854|NCT01474343|Genetic Diseases, Inborn|genetic diseases, inborn
5456855|NCT01474343|Metabolic Diseases|metabolic diseases
5456856|NCT01474343|Gene Therapy|gene therapy
5456857|NCT01474343|Adenovirus Associated Vector|adenovirus associated vector
5456858|NCT01474330|Pomalidomide|pomalidomide
5456859|NCT01474330|safety|safety
5456860|NCT01474330|tolerability|tolerability
5456861|NCT01474330|pharmacokinetics|pharmacokinetics
5456862|NCT01474304|craniotomy|craniotomy
5456863|NCT01474304|tumor resection|tumor resection
5456864|NCT01474304|aneurysm|aneurysm
5456865|NCT01474304|revascularization|revascularization
5456866|NCT01474304|opioid|opioid
5456867|NCT01474304|nausea|nausea
5456868|NCT01474304|vomiting|vomiting
5456869|NCT01474304|acetaminophen|acetaminophen
5456870|NCT01474265|smoking cessation|smoking cessation
5456871|NCT01474265|varenicline|varenicline
5456872|NCT01474265|sympathovagal balance|sympathovagal balance
5456873|NCT01474265|quit attempts|quit attempts
5456875|NCT01474226|lysine|lysine
5456876|NCT01474226|rice|rice
5456877|NCT01474226|bioavailability|bioavailability
5456878|NCT01474213|dexmedetomidine|dexmedetomidine
5456879|NCT01474213|remifentanil|remifentanil
5685527|NCT00555750|diary|diary
5456880|NCT01474213|awake nasotracheal fibreoptic intubation|awake nasotracheal fibreoptic intubation
5456881|NCT01474213|oral maxillofacial surgery|oral maxillofacial surgery
5456882|NCT01474213|difficult airway|difficult airway
5456884|NCT01474200|Ultrafiltration|ultrafiltration
5456885|NCT01474200|Aquapheresis|aquapheresis
5456886|NCT01474200|Diuretics|diuretics
5903971|NCT00092222|KSHV Associated MCD|kshv associated mcd
5602463|NCT00888589|MBI|mbi
5456887|NCT01474200|Loop Diuretics|loop diuretics
5456888|NCT01474200|Aquadex Flexflow System|aquadex flexflow system
5456889|NCT01474200|Gambro UF Solutions|gambro uf solutions
5456890|NCT01474187|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5456891|NCT01474187|rectal cancer|rectal cancer
5456892|NCT01474187|phase I study|phase i study
5456893|NCT01474187|irinotecan|irinotecan
5456894|NCT01474148|paraplegia|paraplegia
5456895|NCT01474148|tetraplegia|tetraplegia
5456896|NCT01474148|Spinal cord injured|spinal cord injured
5456897|NCT01474148|FES|fes
5456898|NCT01474135|Glaucoma|glaucoma
5456899|NCT01474135|Ocular Hypertension|ocular hypertension
5456900|NCT01474122|digital ulcers|digital ulcers
5456901|NCT01474122|systemic sclerosis|systemic sclerosis
5456902|NCT01474109|systemic sclerosis|systemic sclerosis
5456903|NCT01474109|digital ulcers|digital ulcers
5456904|NCT01474096|clinical practice guideline-primary health care|clinical practice guideline-primary health care
5456905|NCT01474083|Type 2 diabetes mellitus|type 2 diabetes mellitus
5456906|NCT01474083|pharmacokinetics|pharmacokinetics
5456907|NCT01474083|pharmacodynamics|pharmacodynamics
5456908|NCT01474070|Glaucoma|glaucoma
5456909|NCT01474070|Goldmann Tonometry|goldmann tonometry
5456910|NCT01474070|Dynamic Contour Tonometry|dynamic contour tonometry
5456911|NCT01474057|PTSD|ptsd
5456912|NCT01474057|combat trauma|combat trauma
5456913|NCT01474057|telemedicine|telemedicine
5460081|NCT01460992|Pacemaker therapy|pacemaker therapy
5456914|NCT01474057|primary care interventions|primary care interventions
5456915|NCT01474057|CBT|cbt
5456916|NCT01474057|self-managed treatment|self-managed treatment
5456917|NCT01474057|web-based intervention|web-based intervention
5439552|NCT01547338|Breast|breast
5456918|NCT01474057|internet treatment|internet treatment
5456919|NCT01474031|total hip arthroplasty|total hip arthroplasty
5456920|NCT01474031|biomechanics|biomechanics
5456921|NCT01474031|direct anterior approach|direct anterior approach
5456922|NCT01474005|laryngectomy|laryngectomy
5456923|NCT01474005|artificial larynx|artificial larynx
5456924|NCT01474005|breathing|breathing
5456925|NCT01474005|swallowing|swallowing
5456926|NCT01474005|upper airway|upper airway
5456927|NCT01473979|cardiac surgery|cardiac surgery
5456928|NCT01473979|poststernotomy wound infections|poststernotomy wound infections
5456929|NCT01473979|delayed secondary closure of sternum|delayed secondary closure of sternum
5456930|NCT01473927|Inflammatory bowel diseases|inflammatory bowel diseases
5456931|NCT01473927|Crohn disease|crohn disease
5456932|NCT01473927|Ficolin-2|ficolin-2
5456933|NCT01473927|C-Reactive Protein|c-reactive protein
5456934|NCT01473927|Calprotectin|calprotectin
5456935|NCT01473927|Inflammatory markers|inflammatory markers
5456936|NCT01473927|SES-CD|ses-cd
5456937|NCT01473901|BKM120|bkm120
5456938|NCT01473901|temozolomide|temozolomide
5456939|NCT01473901|glioblastoma multiforme|glioblastoma multiforme
5456940|NCT01473901|GBM|gbm
5456941|NCT01473901|Newly diagnosed|newly diagnosed
5456942|NCT01473888|T89(Dantonic®)|t89(dantonic®)
5456943|NCT01473888|Cooperstown 5+1 cocktail probes|cooperstown 5+1 cocktail probes
5456944|NCT01473888|CYP450|cyp450
5456945|NCT01473875|LIPA|lipa
5456946|NCT01473875|Wolman Disease|wolman disease
5456947|NCT01473875|Wolman Phenotype|wolman phenotype
5456948|NCT01473875|Acid Lipase Deficiency|acid lipase deficiency
5456949|NCT01473875|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
5456950|NCT01473875|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
5456951|NCT01473875|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
5456952|NCT01473875|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
5456953|NCT01473875|Early Onset LAL-Deficiency (Wolman Disease)|early onset lal-deficiency (wolman disease)
5456954|NCT01473875|LAL Deficiency|lal deficiency
5456955|NCT01473875|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
5456956|NCT01473875|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
5456957|NCT01473875|Related Disorders:|related disorders:
5456958|NCT01473875|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5456959|NCT01473875|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5456960|NCT01473875|Alcoholic Liver Disease|alcoholic liver disease
5456961|NCT01473875|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5456962|NCT01473875|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
5456963|NCT01473875|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
5456964|NCT01473862|adolescent|adolescent
5456965|NCT01473862|bereavement|bereavement
5456966|NCT01473862|cancer|cancer
5456967|NCT01473862|coping skills|coping skills
5456968|NCT01473849|Cytomegalovirus|cytomegalovirus
5685528|NCT00555750|volumetry|volumetry
5456969|NCT01473849|Liver transplantation|liver transplantation
5451631|NCT01495897|DYT 11|dyt 11
5456970|NCT01473849|Hepatitis C virus|hepatitis c virus
5456971|NCT01473849|Patients who underwent first liver transplantation due to hepatopathy caused by HCV,confirmed by detection of HCV RNA previously to transplantation|patients who underwent first liver transplantation due to hepatopathy caused by hcv,confirmed by detection of hcv rna previously to transplantation
5456973|NCT01473836|intra-abdominal infection|intra-abdominal infection
5456974|NCT01473836|pelvic inflammatory disease|pelvic inflammatory disease
5456975|NCT01473836|anaerobe|anaerobe
5903972|NCT00092222|HIV Infections|hiv infections
5456976|NCT01473823|food allergy|food allergy
5456977|NCT01473823|eczema|eczema
5456978|NCT01473823|sensitisation|sensitisation
5456979|NCT01473823|omega-3 long chain polyunsaturated fatty acids|omega-3 long chain polyunsaturated fatty acids
5456980|NCT01473823|prevention|prevention
5456981|NCT01473823|asthma|asthma
5456982|NCT01473810|HIV|hiv
5456983|NCT01473810|vaccination|vaccination
5456984|NCT01473810|T cells|t cells
5456985|NCT01473810|mucosal immunity|mucosal immunity
5456986|NCT01473810|safety|safety
5456987|NCT01473810|nasal administration|nasal administration
5456988|NCT01473810|DTH skin test|dth skin test
5456989|NCT01473771|Suicide|suicide
5456990|NCT01473771|Suicide, Attempted|suicide, attempted
5456991|NCT01473758|COPD|copd
5456992|NCT01473758|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5456993|NCT01473758|Roflumilast|roflumilast
5456994|NCT01473745|Alar Base Suture; Nasolabial Change; 3D stereogrammetry|alar base suture; nasolabial change; 3d stereogrammetry
5456995|NCT01473732|CNI toxicity|cni toxicity
5456996|NCT01473732|CAI|cai
5456997|NCT01473719|alcohol use|alcohol use
5456998|NCT01473719|marijuana use|marijuana use
5456999|NCT01473719|STI|sti
5457000|NCT01473706|Malnutrition|malnutrition
5457001|NCT01473706|Nutrition status|nutrition status
5457002|NCT01473706|Elderly|elderly
5457003|NCT01473706|Nutrition screening|nutrition screening
5457004|NCT01473693|Quality of Life|quality of life
5457005|NCT01473693|Lung cancer|lung cancer
5457006|NCT01473693|MRI|mri
5457007|NCT01473693|Surgery|surgery
5457008|NCT01473693|induction chemotherapy|induction chemotherapy
5457009|NCT01473693|11-145|11-145
5457010|NCT01473680|minority breast cancer patients|minority breast cancer patients
5457011|NCT01473680|EEG|eeg
5457012|NCT01473680|Evaluation|evaluation
5457013|NCT01473680|Questionnaires|questionnaires
5457014|NCT01473680|11-139|11-139
5457015|NCT01473641|Etonogestrel|etonogestrel
5457016|NCT01473641|Contraceptive implant|contraceptive implant
5457017|NCT01473641|Safety|safety
5457018|NCT01473576|type II diabetes|type ii diabetes
5457019|NCT01473576|protein synthesis|protein synthesis
5457020|NCT01473576|nitrate|nitrate
5457021|NCT01473576|elderly|elderly
5457022|NCT01473550|Mental Health|mental health
5457023|NCT01473550|Smart Technology|smart technology
5457024|NCT01473550|Mood disorder|mood disorder
5457025|NCT01473550|Psychotic disorder|psychotic disorder
5457026|NCT01473537|dental caries/prevention and control|dental caries/prevention and control
5457027|NCT01473537|oral health|oral health
5457028|NCT01473537|cariostatic agents|cariostatic agents
5457029|NCT01473524|Primary Biliary Cholangitis|primary biliary cholangitis
5457030|NCT01473524|Primary Biliary Cirrhosis|primary biliary cirrhosis
5457031|NCT01473524|PBC|pbc
5457032|NCT01473524|Cirrhosis|cirrhosis
5457033|NCT01473524|Liver|liver
5457034|NCT01473511|Behavioural intervention|behavioural intervention
5457035|NCT01473511|Distance intervention|distance intervention
5457036|NCT01473511|Parenting intervention|parenting intervention
5457037|NCT01473498|Sepsis|sepsis
5457038|NCT01473498|Acute kidney injury|acute kidney injury
5457039|NCT01473498|Mean arterial pressure|mean arterial pressure
5457040|NCT01473498|Catecholamines|catecholamines
5457041|NCT01473498|Renal doppler|renal doppler
5457042|NCT01473485|Brain Tumor|brain tumor
5457043|NCT01473485|Glioma|glioma
5457044|NCT01473485|Brain Cancer|brain cancer
5457045|NCT01473485|Metastatic Brain Cancer|metastatic brain cancer
5457046|NCT01473472|Prophylaxis|prophylaxis
5457047|NCT01473472|HIV infection|hiv infection
5457048|NCT01473472|tenofovir|tenofovir
5457049|NCT01473472|emtricitabine|emtricitabine
5457050|NCT01473472|men who have sex with men|men who have sex with men
5457051|NCT01473459|best fertility protocol|best fertility protocol
5457052|NCT01473459|(BMI > 30)|(bmi > 30)
5457053|NCT01473459|women|women
5457054|NCT01473459|PCOS|pcos
5457055|NCT01473446|Goal directed fluid therapy|goal directed fluid therapy
5457056|NCT01473446|perioperative fluid therapy|perioperative fluid therapy
5457057|NCT01473446|LiDCOrapid|lidcorapid
5457058|NCT01473446|Postoperative outcome|postoperative outcome
5457059|NCT01473446|Open abdominal surgery|open abdominal surgery
5457060|NCT01473433|Regenerative medicine|regenerative medicine
5457061|NCT01473433|Myocardial infarction|myocardial infarction
5457062|NCT01473394|Major depressive disorder|major depressive disorder
5457063|NCT01473394|Depression|depression
5457064|NCT01473381|Major Depressive Disorder|major depressive disorder
5457065|NCT01473381|Depression|depression
5457066|NCT01473368|human Gut Microbiota|human gut microbiota
5457067|NCT01473368|gut microbiota|gut microbiota
5451738|NCT01495494|Nasal Strip|nasal strip
5457069|NCT01473368|probiotic|probiotic
5457070|NCT01473368|antibiotic|antibiotic
5457071|NCT01473368|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5457072|NCT01473368|intestinal bacterial overgrowth|intestinal bacterial overgrowth
5457073|NCT01473342|Healthy survivorship|healthy survivorship
5457074|NCT01473342|Smartphones|smartphones
5457075|NCT01473342|Treatment|treatment
5457076|NCT01473329|diabetes care|diabetes care
5903973|NCT00092222|Herpes Viruses|herpes viruses
5457077|NCT01473329|diabetes education|diabetes education
5457078|NCT01473329|diabetes control|diabetes control
5457079|NCT01473303|stage IV pancreatic cancer|stage iv pancreatic cancer
5457080|NCT01473303|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5457081|NCT01473290|diarrhea|diarrhea
5457082|NCT01473290|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5457083|NCT01473290|gastrointestinal complications|gastrointestinal complications
5457084|NCT01473290|fatigue|fatigue
5457085|NCT01473290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5457086|NCT01473290|cognitive/functional effects|cognitive/functional effects
5457087|NCT01473290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5457088|NCT01473277|Hemiplegic shoulder pain|hemiplegic shoulder pain
5457089|NCT01473277|Botulinum toxin type A (BT-A)|botulinum toxin type a (bt-a)
5457090|NCT01473277|Steroid|steroid
5457091|NCT01473277|Intra-articular injection|intra-articular injection
5457092|NCT01473277|Pain score of 45 or greater on a 0-100 mm VAS|pain score of 45 or greater on a 0-100 mm vas
5457093|NCT01473277|Duration of HSP for at least one month|duration of hsp for at least one month
5457094|NCT01473277|Pain refractoriness to conventional treatment|pain refractoriness to conventional treatment
5457095|NCT01473264|CC10|cc10
5457097|NCT01473264|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5457098|NCT01473264|premature infants|premature infants
5457099|NCT01473264|neonates|neonates
5457100|NCT01473264|pulmonary inflammation|pulmonary inflammation
5457101|NCT01473264|lung function|lung function
5457103|NCT01473238|Desktop computer|desktop computer
5457104|NCT01473238|Mobile|mobile
5457105|NCT01473238|iPad|ipad
5457106|NCT01473238|Evaluation|evaluation
5457107|NCT01473238|User experience|user experience
5457108|NCT01473238|Benefits|benefits
5457109|NCT01473238|Cost analysis|cost analysis
5457110|NCT01473199|focal defect|focal defect
5457111|NCT01473199|focal lesion|focal lesion
5457112|NCT01473199|chondral lesion|chondral lesion
5457113|NCT01473199|osteochondral lesion|osteochondral lesion
5457114|NCT01473186|morbid obesity|morbid obesity
5457115|NCT01473186|endometrial pathology|endometrial pathology
5457116|NCT01473186|menstrual irregularities|menstrual irregularities
5457117|NCT01473173|Safety|safety
5457118|NCT01473173|Tolerability|tolerability
5457119|NCT01473173|Pharmacokinetics|pharmacokinetics
5457120|NCT01473173|Pharmacodynamics|pharmacodynamics
5457121|NCT01473147|GLP-1 analogue|glp-1 analogue
5457122|NCT01473147|CSII|csii
5457123|NCT01473147|insulin|insulin
5457124|NCT01473147|type 2 diabetes mellitus|type 2 diabetes mellitus
5457125|NCT01473121|Hepatocellular carcinoma|hepatocellular carcinoma
5457126|NCT01473121|Registry|registry
5457127|NCT01473121|Turkey|turkey
5457128|NCT01473108|Healthy volunteers, proof-of-concept trial, PK and PD|healthy volunteers, proof-of-concept trial, pk and pd
5457129|NCT01473095|AKT|akt
5457130|NCT01473095|ARQ 092|arq 092
5457131|NCT01473095|Targeted therapy|targeted therapy
5457132|NCT01473095|Molecular therapy|molecular therapy
5457133|NCT01473095|Biomarker|biomarker
5457134|NCT01473095|Phase 1|phase 1
5457135|NCT01473095|Phase I|phase i
5457136|NCT01473095|Endometrial cancer|endometrial cancer
5457137|NCT01473095|Lymphoma|lymphoma
5457138|NCT01473095|AKT pathway|akt pathway
5457139|NCT01473095|AKT signaling|akt signaling
5457140|NCT01473095|AKT inhibitor|akt inhibitor
5457141|NCT01473095|AKT pan inhibitor|akt pan inhibitor
5457142|NCT01473095|AKT1|akt1
5457143|NCT01473095|AKT2|akt2
5457144|NCT01473095|AKT3|akt3
5457145|NCT01473095|AKT1 mutation|akt1 mutation
5457146|NCT01473095|AKT1-E17K|akt1-e17k
5457147|NCT01473095|AKT1-E17K mutation|akt1-e17k mutation
5457148|NCT01473095|AKT 2 inhibitor|akt 2 inhibitor
5457149|NCT01473095|AKT 3 inhibitor|akt 3 inhibitor
5457150|NCT01473095|AKT 3 amplification|akt 3 amplification
5680277|NCT00578383|Bipolar Disorder|bipolar disorder
5457151|NCT01473095|PI3K AKT mTOR signalling pathway|pi3k akt mtor signalling pathway
5457152|NCT01473095|mTOR inhibitor|mtor inhibitor
5457153|NCT01473095|PI3K inhibitor|pi3k inhibitor
5457154|NCT01473095|Clinical oncology|clinical oncology
5457156|NCT01473095|Tumour|tumour
5457157|NCT01473095|PIK3CA H1047R mutation|pik3ca h1047r mutation
5457158|NCT01473069|JTK-853|jtk-853
5457159|NCT01473069|Healthy subjects|healthy subjects
5457160|NCT01473056|Hepatitis C|hepatitis c
5457161|NCT01473056|JTK-853|jtk-853
5457162|NCT01473043|Axitinib|axitinib
5457163|NCT01473043|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5457164|NCT01473030|Benign prostate|benign prostate
5457166|NCT01473030|Dutasteride|dutasteride
5457167|NCT01473030|PSA|psa
5457168|NCT01473030|Avodart|avodart
5457169|NCT01473004|Sir-spheres|sir-spheres
5457170|NCT01473004|Liver Metastases|liver metastases
5457171|NCT01473004|Selective internal radiation|selective internal radiation
5457172|NCT01473004|Yttrium-90|yttrium-90
5457173|NCT01473004|Uveal|uveal
5457174|NCT01473004|Melanoma|melanoma
5457175|NCT01473004|Ocular melanoma|ocular melanoma
5457177|NCT01472978|C. difficile|c. difficile
5457178|NCT01472965|central line|central line
5457179|NCT01472965|adolescents|adolescents
5457180|NCT01472965|children|children
5457181|NCT01472965|bloodstream infection|bloodstream infection
5457182|NCT01472965|antibiotic lock therapy|antibiotic lock therapy
5457183|NCT01472965|catheter lock therapy|catheter lock therapy
5457184|NCT01472965|ethanol lock therapy|ethanol lock therapy
5457185|NCT01472952|sepsis|sepsis
5457186|NCT01472952|immune cells|immune cells
5457187|NCT01472952|immune reaction|immune reaction
5457188|NCT01472952|trauma|trauma
5457189|NCT01472952|Immune activation|immune activation
5457190|NCT01472926|acute ischaemic stroke|acute ischaemic stroke
5457191|NCT01472926|stroke|stroke
5457192|NCT01472926|thrombolysis|thrombolysis
5457193|NCT01472926|thrombolytic drug therapy|thrombolytic drug therapy
5457194|NCT01472926|CT perfusion|ct perfusion
5457195|NCT01472926|CT angiography|ct angiography
5457196|NCT01472926|brain imaging|brain imaging
5457197|NCT01472913|Prospective randomised double-blind study|prospective randomised double-blind study
5457198|NCT01472913|Fibrin sealant|fibrin sealant
5457304|NCT01472458|Cardiac arrest|cardiac arrest
5457199|NCT01472913|Bilateral simultaneous total knee arthroplasty|bilateral simultaneous total knee arthroplasty
5457200|NCT01472913|Blood loss|blood loss
5457201|NCT01472913|Postoperative pain|postoperative pain
5457202|NCT01472913|Complications|complications
5457203|NCT01472900|acne vulgaris|acne vulgaris
5457204|NCT01472874|Wilson Disease|wilson disease
5457205|NCT01472874|Trientine|trientine
5457206|NCT01472874|One Daily Dosage|one daily dosage
5457207|NCT01472861|coculture|coculture
5457208|NCT01472861|endometrial biopsy|endometrial biopsy
5457209|NCT01472861|IVF poor responders|ivf poor responders
5457210|NCT01472835|sedation|sedation
5457211|NCT01472835|sensitivity|sensitivity
5457212|NCT01472835|specificity|specificity
5457213|NCT01472835|validity|validity
5457214|NCT01472835|diagnostic injection|diagnostic injection
5457215|NCT01472822|Omija|omija
5457216|NCT01472822|knee osteoarthritis|knee osteoarthritis
5457217|NCT01472809|ZYGK1|zygk1
5457218|NCT01472809|Cadila|cadila
5457219|NCT01472809|Zydus|zydus
5457220|NCT01472809|ZRC|zrc
5457221|NCT01472809|Zydus Research Center|zydus research center
5457222|NCT01472809|Phase 1|phase 1
5457223|NCT01472809|Diabetes|diabetes
5457224|NCT01472796|African American|african american
5457225|NCT01472796|Vitamin D deficient|vitamin d deficient
5457226|NCT01472783|BRCA1 mutation|brca1 mutation
5457227|NCT01472783|BRCA2 mutation|brca2 mutation
5457228|NCT01472783|Ovarian cancer|ovarian cancer
5457229|NCT01472783|PARP inhibitor|parp inhibitor
5457230|NCT01472770|Colorectal cancer|colorectal cancer
5457231|NCT01472770|Metastatic|metastatic
5457232|NCT01472770|Treatment resistant|treatment resistant
5457233|NCT01472744|Executive function|executive function
5457234|NCT01472744|Aging|aging
5457235|NCT01472744|Physical activity|physical activity
5457236|NCT01472731|GC1008|gc1008
5457237|NCT01472731|PET imaging|pet imaging
5457238|NCT01472731|primary brain tumors|primary brain tumors
5457239|NCT01472731|recurrent high grade glioma's|recurrent high grade glioma's
5457240|NCT01472705|drug-eluting coronary stent|drug-eluting coronary stent
5457241|NCT01472705|percutaneous coronary intervention|percutaneous coronary intervention
5457242|NCT01472692|Prehypertension|prehypertension
5457243|NCT01472692|Gout|gout
5457244|NCT01472692|Puls Wave Velocity|puls wave velocity
5457245|NCT01472692|Hypertension|hypertension
5457246|NCT01472692|24 hour blood pressure|24 hour blood pressure
5457247|NCT01472679|fat mass|fat mass
5457248|NCT01472679|fat free mass|fat free mass
5457249|NCT01472679|body mass index|body mass index
5457250|NCT01472666|Medium chain fatty acids|medium chain fatty acids
5457251|NCT01472666|Saturated fatty acids|saturated fatty acids
5457252|NCT01472666|Whey protein|whey protein
5457253|NCT01472666|Casein protein|casein protein
5457254|NCT01472666|Metabolic syndrome|metabolic syndrome
5457256|NCT01472666|Cardiovascular disease|cardiovascular disease
5457257|NCT01472666|Dairy products|dairy products
5457258|NCT01472666|Dietary intervention|dietary intervention
5457259|NCT01472653|Head and neck Cancer|head and neck cancer
5457260|NCT01472653|Radiochemotherapy|radiochemotherapy
5457261|NCT01472653|Radioimmunotherapy|radioimmunotherapy
5457262|NCT01472653|Skin rush|skin rush
5457263|NCT01472653|locoregional control|locoregional control
5457264|NCT01472653|Survival|survival
5457265|NCT01472653|Toxicity|toxicity
5429181|NCT01591707|school|school
5457266|NCT01472640|CHF, Diabetes; Liraglutid, Ecco|chf, diabetes; liraglutid, ecco
5457267|NCT01472627|MM|mm
5457268|NCT01472627|Bortezomib|bortezomib
5457270|NCT01472614|Type-2 diabetes mellitus|type-2 diabetes mellitus
5457271|NCT01472614|Add-on therapy|add-on therapy
5457272|NCT01472575|rotavirus|rotavirus
5457273|NCT01472575|gastroenteritis|gastroenteritis
5457274|NCT01472575|vaccination|vaccination
5457275|NCT01472575|hospitalisation|hospitalisation
5457276|NCT01472562|mantle cell lymphoma|mantle cell lymphoma
5457277|NCT01472549|Preoperative|preoperative
5457278|NCT01472549|Antiseptics|antiseptics
5457279|NCT01472549|Comparative|comparative
5457280|NCT01472549|Cost|cost
5457281|NCT01472549|Effectiveness|effectiveness
5457282|NCT01472536|Influenza|influenza
5457283|NCT01472536|Non pharmaceutical intervention|non pharmaceutical intervention
5457284|NCT01472536|Sequestration|sequestration
5457285|NCT01472536|Social network|social network
5457286|NCT01472510|Diabetic|diabetic
5457287|NCT01472510|Macular|macular
5457288|NCT01472510|Edema|edema
5457289|NCT01472510|Ranibizumab|ranibizumab
5457290|NCT01472510|anti-VEGF|anti-vegf
5457291|NCT01472497|hypertension|hypertension
5457292|NCT01472497|insulin resistance|insulin resistance
5457293|NCT01472497|oral glucose tolerance test|oral glucose tolerance test
5457294|NCT01472497|AGE|age
5457295|NCT01472497|inflammatory cytokine|inflammatory cytokine
5457296|NCT01472484|beans|beans
5457297|NCT01472484|lpa mutant|lpa mutant
5457298|NCT01472484|polyphenols|polyphenols
5457299|NCT01472484|phytic acid|phytic acid
5457300|NCT01472484|stable iron isotopes|stable iron isotopes
5457301|NCT01472471|Childhood Asthma|childhood asthma
5457302|NCT01472471|Oxidative stress|oxidative stress
5457303|NCT01472471|Urinary 8-isoprostane|urinary 8-isoprostane
5457305|NCT01472458|Hypothermia|hypothermia
5457306|NCT01472458|Post Cardiac Arrest Care|post cardiac arrest care
5457307|NCT01472458|Survivors of cardiac arrest|survivors of cardiac arrest
5457308|NCT01472445|Vitamin D|vitamin d
5457309|NCT01472445|Obesity|obesity
5457310|NCT01472432|type 2 diabetes|type 2 diabetes
5457311|NCT01472432|healing|healing
5457312|NCT01472432|foot ulcers|foot ulcers
5457313|NCT01472432|vildagliptin|vildagliptin
5846736|NCT00043628|MRI|mri
5457314|NCT01472419|metastatic esophageal squamous cell carcinoma|metastatic esophageal squamous cell carcinoma
5457315|NCT01472419|Fluoropyrimidine/platinum-based first-line chemotherapy|fluoropyrimidine/platinum-based first-line chemotherapy
5457317|NCT01472406|type 1 diabetes mellitus|type 1 diabetes mellitus
5457318|NCT01472406|closed-loop artificial pancreas|closed-loop artificial pancreas
5457319|NCT01472393|creatine supplementation|creatine supplementation
5457320|NCT01472393|bone mass|bone mass
5457321|NCT01472393|postmenopausal women|postmenopausal women
5457322|NCT01472393|muscle function|muscle function
5457323|NCT01472393|bone markers|bone markers
5457324|NCT01472354|HIV|hiv
5457325|NCT01472354|Hepatitis C|hepatitis c
5457326|NCT01472354|Decision-Making|decision-making
5457327|NCT01472354|chronic|chronic
5457328|NCT01472328|Oxidative stress|oxidative stress
5457329|NCT01472328|Insulin resistance|insulin resistance
5457330|NCT01472315|sleep apnea|sleep apnea
5457331|NCT01472315|women|women
5457332|NCT01472315|postmenopause|postmenopause
5457333|NCT01472315|hormone treatment|hormone treatment
5457334|NCT01472289|CLI|cli
5457335|NCT01472289|Peripheral arterial disease|peripheral arterial disease
5457336|NCT01472276|Behaviour change|behaviour change
5457337|NCT01472276|Weight loss|weight loss
5457338|NCT01472276|Cardiovascular risk|cardiovascular risk
5457339|NCT01472276|Diet|diet
5457340|NCT01472276|Physical activity|physical activity
5457341|NCT01472276|Overweight|overweight
5457342|NCT01472276|Obesity|obesity
5457343|NCT01472276|Internet|internet
5457344|NCT01472263|HTLV-1|htlv-1
5457345|NCT01472263|tropical spastic paraparesis|tropical spastic paraparesis
5457346|NCT01472263|Immune System Diseases|immune system diseases
5457347|NCT01472263|Physical disability|physical disability
5457348|NCT01472263|pentoxifylline|pentoxifylline
5457349|NCT01472250|Advanced Gastric Cancer|advanced gastric cancer
5457350|NCT01472250|chemotherapy|chemotherapy
5457351|NCT01472250|quality of life|quality of life
5457352|NCT01472250|treatment expense|treatment expense
5457353|NCT01472250|patients accepted first-line chemotherapy|patients accepted first-line chemotherapy
5457354|NCT01472224|Transcranial ultrasound|transcranial ultrasound
5457355|NCT01472224|Haematoma expansion|haematoma expansion
5457356|NCT01472198|GSI|gsi
5457357|NCT01472198|Gilead|gilead
5457358|NCT01472198|Gilead Sciences|gilead sciences
5457359|NCT01472198|Pancreatic Cancer|pancreatic cancer
5457361|NCT01472198|Gemcitabine|gemcitabine
5457362|NCT01472198|Phase 2|phase 2
5457363|NCT01472198|Phase II|phase ii
5457364|NCT01472198|GS-6624|gs-6624
5457365|NCT01472198|Oncology|oncology
5457366|NCT01472198|Monoclonal Antibody|monoclonal antibody
5457367|NCT01472185|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5457368|NCT01472172|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5457369|NCT01472172|cryobiopsy|cryobiopsy
5685529|NCT00555750|GABA|gaba
5457370|NCT01472172|pleural biopsy|pleural biopsy
5457371|NCT01472172|pleural effusion|pleural effusion
5457373|NCT01472172|thoracoscopy|thoracoscopy
5457374|NCT01472146|Neoadjuvant therapy|neoadjuvant therapy
5457375|NCT01472146|Breast cancer HER2 positive|breast cancer her2 positive
5457376|NCT01472146|zolendronic acid|zolendronic acid
5457377|NCT01472133|Respiration Rate|respiration rate
5457379|NCT01472133|Pulse oximetry|pulse oximetry
5457380|NCT01472133|Photoplethysmograph|photoplethysmograph
5457381|NCT01472133|PPG|ppg
5457382|NCT01472133|Physiology|physiology
5457383|NCT01472107|Pregnancy|pregnancy
5457384|NCT01472107|APL female patients|apl female patients
5457385|NCT01472068|Incontinence|incontinence
5457386|NCT01472068|NMES|nmes
5457387|NCT01472055|Hematopoietic stem cell transplantation with fludarabine based conditioning|hematopoietic stem cell transplantation with fludarabine based conditioning
5457388|NCT01472042|Traumatic Brain Injury|traumatic brain injury
5457389|NCT01472042|Sport Concussion|sport concussion
5457390|NCT01472042|Head Injury|head injury
5457391|NCT01472042|Sports Injury|sports injury
5457392|NCT01472029|Adenocarcinoma|adenocarcinoma
5457393|NCT01472029|Gastroesophageal junction|gastroesophageal junction
5457394|NCT01472029|Stomach|stomach
5457395|NCT01472029|HER2|her2
5457396|NCT01472016|c-Met overexpression|c-met overexpression
5457397|NCT01472016|MET amplification|met amplification
5457398|NCT01472016|Neoplasms|neoplasms
5457399|NCT01472016|h224G11|h224g11
5457400|NCT01471990|PACAP38|pacap38
5457401|NCT01471990|MMA|mma
5457402|NCT01471990|migraine|migraine
5457403|NCT01471990|angiography|angiography
5457404|NCT01471990|VIP|vip
5457405|NCT01471990|vasodilatation|vasodilatation
5457406|NCT01471912|Macular Holes|macular holes
5457407|NCT01471912|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5457408|NCT01471912|elongation of foveal tissue|elongation of foveal tissue
5457409|NCT01471912|M-score|m-score
5457410|NCT01471873|Posterior corneal surface elevation|posterior corneal surface elevation
5457411|NCT01471873|Pentacam-Scheimpflung imaging|pentacam-scheimpflung imaging
5457412|NCT01471873|variability|variability
5457413|NCT01471873|progressive keratoconus|progressive keratoconus
5457414|NCT01471873|corneal cross-linking|corneal cross-linking
5457415|NCT01471847|Locally advanced|locally advanced
5457416|NCT01471847|metastatic|metastatic
5457417|NCT01471847|breast cancer|breast cancer
5457418|NCT01471847|HER2 positive|her2 positive
5457419|NCT01471847|PI3K|pi3k
5457420|NCT01471847|mTOR|mtor
5457421|NCT01471847|trastuzumab|trastuzumab
5457422|NCT01471847|targeted therapy|targeted therapy
5457423|NCT01471847|LABC|labc
5457424|NCT01471847|MBC|mbc
5457425|NCT01471782|ALL|all
5457426|NCT01471782|relapsed, refractory B-precursor ALL|relapsed, refractory b-precursor all
5457427|NCT01471782|Leukemia|leukemia
5457428|NCT01471782|Leukemia, Lymphoid|leukemia, lymphoid
5457429|NCT01471782|Precursor Cell Lymphoblastic Leukemia|precursor cell lymphoblastic leukemia
5457430|NCT01471782|Neoplasms by Histologic Type|neoplasms by histologic type
5457431|NCT01471782|Neoplasms|neoplasms
5457432|NCT01471782|Lymphoproliferative Disorders|lymphoproliferative disorders
5457433|NCT01471782|Lymphatic Diseases|lymphatic diseases
5457434|NCT01471782|Immunoproliferative Disorders|immunoproliferative disorders
5457435|NCT01471782|Antibodies, Bispecific|antibodies, bispecific
5457436|NCT01471769|pediatric|pediatric
5457437|NCT01471769|pain|pain
5457438|NCT01471756|sessile neoplasms|sessile neoplasms
5457439|NCT01471756|flat neoplasms|flat neoplasms
5457440|NCT01471756|gastric cancer|gastric cancer
5457441|NCT01471743|nutrition|nutrition
5457442|NCT01471743|surgery|surgery
5457443|NCT01471743|immune|immune
5457444|NCT01471730|Transfusions|transfusions
5457445|NCT01471730|Fresh Frozen Plasma|fresh frozen plasma
5457446|NCT01471730|Fibrinogen|fibrinogen
5457447|NCT01471730|Prothrombin complex|prothrombin complex
5457448|NCT01471717|PK|pk
5457449|NCT01471717|pharmacokinetics|pharmacokinetics
5457450|NCT01471717|INX08189|inx08189
5457451|NCT01471717|Victrelis|victrelis
5457452|NCT01471717|Inhibitex|inhibitex
5457453|NCT01471704|Pharmacokinetics|pharmacokinetics
5457454|NCT01471704|PK|pk
5457455|NCT01471704|INX08189|inx08189
5457456|NCT01471704|Verapamil|verapamil
5457457|NCT01471704|Inhibitex|inhibitex
5457458|NCT01471678|Cross-over design|cross-over design
5457459|NCT01471678|Pilot bioequivalence|pilot bioequivalence
5457460|NCT01471678|North east Asian ancestry|north east asian ancestry
5457461|NCT01471678|GI198745|gi198745
5457462|NCT01471678|Tamsulosin hydrochloride|tamsulosin hydrochloride
5457463|NCT01471678|healthy male subjects|healthy male subjects
5457464|NCT01471678|Bioequivalence|bioequivalence
5457465|NCT01471678|Dutasteride|dutasteride
5457466|NCT01471561|Osmolarity|osmolarity
5457467|NCT01471561|Cataract|cataract
5457468|NCT01471561|Dry Eye|dry eye
5457469|NCT01471548|tumor|tumor
5457470|NCT01471548|cancer|cancer
5457471|NCT01471548|phase1|phase1
5457472|NCT01471548|TKI258|tki258
5457474|NCT01471418|orofacial pain|orofacial pain
5457475|NCT01471418|synovitis|synovitis
5457476|NCT01471418|arthroscopy|arthroscopy
5457477|NCT01471379|Irritable Bowel Syndrome|irritable bowel syndrome
5457479|NCT01471379|Savella|savella
5457480|NCT01471379|Milnacipran|milnacipran
5457481|NCT01471379|Abdominal Pain|abdominal pain
5457482|NCT01471366|Hyperlipidemias|hyperlipidemias
5457483|NCT01471366|Dyslipidemias|dyslipidemias
5457484|NCT01471366|Fatty Acids, Omega-3|fatty acids, omega-3
5457485|NCT01471366|Fish Oils|fish oils
5457486|NCT01471353|Metastatic|metastatic
5457487|NCT01471353|Colon Cancer|colon cancer
5457488|NCT01471353|Rectal Cancer|rectal cancer
5457489|NCT01471652|myalgic encephalopathy|myalgic encephalopathy
5457490|NCT01471652|chronic fatigue syndrome|chronic fatigue syndrome
5457491|NCT01471652|post viral infection|post viral infection
5457492|NCT01471652|fatigue|fatigue
5457493|NCT01471652|muscle pain|muscle pain
5457494|NCT01471652|unrefreshing sleep|unrefreshing sleep
5457495|NCT01471652|fuzzy thought|fuzzy thought
5457496|NCT01471652|poor memory|poor memory
5457497|NCT01471652|forgetfulness|forgetfulness
5457498|NCT01471639|18 years and older,|18 years and older,
5457499|NCT01471639|previously healthy|previously healthy
5457500|NCT01471639|men and nonpregnant women|men and nonpregnant women
5457501|NCT01471639|emergency department|emergency department
5457502|NCT01471626|sleep apnea|sleep apnea
5457503|NCT01471626|polysomnography|polysomnography
5457504|NCT01471626|telemedicine|telemedicine
5457505|NCT01471613|spinal cord injury|spinal cord injury
5457506|NCT01471613|umbilical cord blood cell|umbilical cord blood cell
5457507|NCT01471613|cell transplant|cell transplant
5457508|NCT01471613|lithium carbonate|lithium carbonate
5457509|NCT01471600|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5457510|NCT01471600|general anesthesia|general anesthesia
5457511|NCT01471535|chronic hepatitis B|chronic hepatitis b
5457512|NCT01471509|Glycemic Index|glycemic index
5457513|NCT01471509|LoBAG Diet|lobag diet
5457514|NCT01471509|Insulin|insulin
5457515|NCT01471509|Glucagon|glucagon
5457516|NCT01471496|duodenal ulcer|duodenal ulcer
5457517|NCT01471496|upper gastrointestinal system bleeding|upper gastrointestinal system bleeding
5457518|NCT01471496|injection therapy|injection therapy
5457519|NCT01471483|Geriatric Assessment|geriatric assessment
5457520|NCT01471483|Quality of Life|quality of life
5457522|NCT01471483|Fallopian Tubes|fallopian tubes
5457523|NCT01471470|Advanced gastric cancer|advanced gastric cancer
5457524|NCT01471470|Neoadjuvant|neoadjuvant
5457525|NCT01471470|Bevacizumab|bevacizumab
5457526|NCT01471457|bacterial|bacterial
5457527|NCT01471457|vaginosis|vaginosis
5457528|NCT01471457|pessary|pessary
5457529|NCT01471457|discharge|discharge
5457530|NCT01471444|Blood And Marrow Transplantation|blood and marrow transplantation
5457531|NCT01471444|Leukemia|leukemia
5457532|NCT01471444|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5457533|NCT01471444|Acute myeloid leukemia|acute myeloid leukemia
5457535|NCT01471444|Myelodysplastic syndrome|myelodysplastic syndrome
5457536|NCT01471444|MDS|mds
5457537|NCT01471444|Progression free survival|progression free survival
5457538|NCT01471444|Rate of engraftment|rate of engraftment
5457539|NCT01471444|Toxicity|toxicity
5457540|NCT01471444|Relapse rate|relapse rate
5457541|NCT01471444|Graft-vs-host disease|graft-vs-host disease
5457542|NCT01471444|GvHD|gvhd
5457543|NCT01471444|Progression-free survival|progression-free survival
5457544|NCT01471444|PFS|pfs
5457545|NCT01471444|Overall survival|overall survival
5457546|NCT01471444|OS|os
5457547|NCT01471444|Fludarabine|fludarabine
5457548|NCT01471444|Fludarabine Phosphate|fludarabine phosphate
5457549|NCT01471444|Fludara|fludara
5457550|NCT01471444|Clofarabine|clofarabine
5457551|NCT01471444|Clofarex|clofarex
5457552|NCT01471444|Clolar|clolar
5457553|NCT01471444|Busulfan|busulfan
5457554|NCT01471444|Busulfex|busulfex
5457555|NCT01471444|Myleran|myleran
5457556|NCT01471444|Thymoglobulin|thymoglobulin
5457557|NCT01471444|ATG|atg
5457558|NCT01471444|Antithymocyte Globulin|antithymocyte globulin
5457559|NCT01471444|Methotrexate|methotrexate
5457560|NCT01471444|Tacrolimus|tacrolimus
5457561|NCT01471444|Prograf|prograf
5457562|NCT01471392|Identigene|identigene
5457563|NCT01471392|STD Test|std test
5457564|NCT01471392|Chlamydia|chlamydia
5457565|NCT01471392|Gonorrhoeae|gonorrhoeae
5457566|NCT01471392|APTIMA|aptima
5457567|NCT01471392|Sexually Transmitted Disease|sexually transmitted disease
5457568|NCT01471301|systemic lupus erythematosus|systemic lupus erythematosus
5457569|NCT01471301|rheumatoid arthritis|rheumatoid arthritis
5457570|NCT01471288|well differentiated thyroid cancer|well differentiated thyroid cancer
5457572|NCT01471288|Normal controls|normal controls
5457573|NCT01471275|type 2 diabetes|type 2 diabetes
5457574|NCT01471275|obesity|obesity
5457575|NCT01471275|hypertriglyceridemia|hypertriglyceridemia
5457576|NCT01471262|Complications|complications
5457577|NCT01471262|Mortality|mortality
5457579|NCT01471262|Failure|failure
5457580|NCT01471249|esophageal stenting|esophageal stenting
5457581|NCT01471249|palliative|palliative
5457582|NCT01471249|dysphagia|dysphagia
5457583|NCT01471236|cartilage|cartilage
5457584|NCT01471236|bone|bone
5457585|NCT01471184|Allergic Rhinitis|allergic rhinitis
5457586|NCT01471184|Conjunctivitis|conjunctivitis
5457587|NCT01471184|Bitop|bitop
5457588|NCT01471184|Eye|eye
5457590|NCT01471184|Nasal Spray|nasal spray
5457591|NCT01471184|Total Nasal Symptom Score|total nasal symptom score
5457592|NCT01471184|Total Ocular Symptom Score|total ocular symptom score
5457593|NCT01471184|AUC|auc
5457594|NCT01471171|COPD|copd
5457595|NCT01471171|Antimuscarinic|antimuscarinic
5457596|NCT01471158|Primary open-angle glaucoma|primary open-angle glaucoma
5457597|NCT01471158|ocular hypertension|ocular hypertension
5457598|NCT01471158|pigment dispersion glaucoma|pigment dispersion glaucoma
5457599|NCT01471145|opioid dependence|opioid dependence
5457600|NCT01471145|heroin dependence|heroin dependence
5457601|NCT01471145|extended release depot naltrexone|extended release depot naltrexone
5457602|NCT01471145|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5457603|NCT01471145|dopamine transporter|dopamine transporter
5457604|NCT01471145|Single Photon Emission Computed Tomography|single photon emission computed tomography
5457605|NCT01471119|sublingual immunotherapy|sublingual immunotherapy
5457606|NCT01471119|atopic dermatitis|atopic dermatitis
5457607|NCT01471119|Dermatophagoides Farinae Drops|dermatophagoides farinae drops
5457608|NCT01471106|Breast Cancer|breast cancer
5457609|NCT01471106|Estrogen Receptor Negative Breast Cancer|estrogen receptor negative breast cancer
5457610|NCT01471106|Biomarker studies|biomarker studies
5457611|NCT01471106|Ki-67|ki-67
5457612|NCT01471106|Dasatinib|dasatinib
5457613|NCT01471106|BMS-354825|bms-354825
5457614|NCT01471106|Sprycel|sprycel
5457615|NCT01471080|laparoscopic hepatectomy|laparoscopic hepatectomy
5458020|NCT01469520|Treatment|treatment
5457616|NCT01471080|radio-frequency ablation|radio-frequency ablation
5457617|NCT01471080|giant cavernous hemangiomas|giant cavernous hemangiomas
5457618|NCT01471080|liver|liver
5457619|NCT01471067|Blood And Marrow Transplantation|blood and marrow transplantation
5440197|NCT01544751|NAFLD|nafld
5457620|NCT01471067|Leukemia|leukemia
5457621|NCT01471067|Lymphoma|lymphoma
5457622|NCT01471067|Pediatrics|pediatrics
5457623|NCT01471067|Cord blood transplant|cord blood transplant
5457624|NCT01471067|Cord Blood Fucosylation|cord blood fucosylation
5457625|NCT01471067|Hematologic Malignancies|hematologic malignancies
5457626|NCT01471067|Acute Myelogenous Leukemia|acute myelogenous leukemia
5457628|NCT01471067|Myelodysplastic Syndrome|myelodysplastic syndrome
5457629|NCT01471067|MDS|mds
5457630|NCT01471067|High-risk cytogenetics|high-risk cytogenetics
5457631|NCT01471067|Secondary leukemia from prior chemotherapy|secondary leukemia from prior chemotherapy
5457632|NCT01471067|Langerhan's cell histiocytosis|langerhan's cell histiocytosis
5457633|NCT01471067|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5457634|NCT01471067|ALL|all
5457635|NCT01471067|complete remission|complete remission
5457636|NCT01471067|Philadelphia chromosome|philadelphia chromosome
5457637|NCT01471067|translocation 4;11|translocation 4;11
5457638|NCT01471067|Hypodiploidy|hypodiploidy
5457639|NCT01471067|Chronic Myeloid Leukemia|chronic myeloid leukemia
5457640|NCT01471067|CML|cml
5457641|NCT01471067|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5457642|NCT01471067|NHL|nhl
5457643|NCT01471067|Hodgkin's Disease|hodgkin's disease
5457644|NCT01471067|HD|hd
5457645|NCT01471067|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5457646|NCT01471067|CLL|cll
5457647|NCT01471067|Melphalan|melphalan
5457648|NCT01471067|Alkeran|alkeran
5457649|NCT01471067|Thiotepa|thiotepa
5457650|NCT01471067|Fludarabine|fludarabine
5457651|NCT01471067|Fludarabine Phosphate|fludarabine phosphate
5457652|NCT01471067|Fludara|fludara
5457653|NCT01471067|Mycophenolate Mofetil|mycophenolate mofetil
5457654|NCT01471067|MMF|mmf
5457655|NCT01471067|CellCept|cellcept
5457656|NCT01471067|Tacrolimus|tacrolimus
5457657|NCT01471067|Prograf|prograf
5457658|NCT01471067|Rituximab|rituximab
5457659|NCT01471067|Rituxan|rituxan
5457660|NCT01471067|ATG|atg
5457661|NCT01471067|Antithymocyte Globulin|antithymocyte globulin
5457662|NCT01471067|Thymoglobulin|thymoglobulin
5457663|NCT01471054|Plaque radiotherapy|plaque radiotherapy
5457664|NCT01471054|Brachytherapy|brachytherapy
5457665|NCT01471054|Macular edema|macular edema
5457666|NCT01471054|Cystoid macular edema|cystoid macular edema
5457667|NCT01471054|Uveal melanoma|uveal melanoma
5457668|NCT01471054|Radiation maculopathy|radiation maculopathy
5457669|NCT01471054|Radiation retinopathy|radiation retinopathy
5457670|NCT01471054|Ozurdex|ozurdex
5457671|NCT01471054|Dexamethasone intravitreal implant|dexamethasone intravitreal implant
5457672|NCT01471041|End Stage Renal Disease|end stage renal disease
5457673|NCT01471041|Hemodialysis|hemodialysis
5457674|NCT01471041|AV fistula|av fistula
5457675|NCT01471041|Kidney failure|kidney failure
5457676|NCT01471028|Acute alcoholic hepatitis|acute alcoholic hepatitis
5457677|NCT01471028|alcoholic|alcoholic
5457678|NCT01471028|hepatitis|hepatitis
5457679|NCT01471028|liver|liver
5457680|NCT01471015|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5457681|NCT01471015|Cooling Therapy|cooling therapy
5457682|NCT01471015|HIE|hie
5457683|NCT01470989|gouty arthritis|gouty arthritis
5457684|NCT01470976|Goal-directed therapy|goal-directed therapy
5457685|NCT01470976|Hemodynamic optimization|hemodynamic optimization
5457686|NCT01470976|Cardiac surgery|cardiac surgery
5457688|NCT01470963|Quality of Health Care|quality of health care
5457689|NCT01470950|Functional Electrical Stimulation|functional electrical stimulation
5457690|NCT01470950|Signalling Pathways|signalling pathways
5457691|NCT01470937|diabetes acarbose alphaglucosidase prevention|diabetes acarbose alphaglucosidase prevention
5457692|NCT01470924|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5457694|NCT01470924|salvage|salvage
5457695|NCT01470924|prognostic|prognostic
5457696|NCT01470911|Antisense oligonucleotide|antisense oligonucleotide
5457697|NCT01470911|Asthma|asthma
5457698|NCT01470911|Healthy subjects|healthy subjects
5457699|NCT01470911|Phase 1|phase 1
5457700|NCT01470911|Transcription factor GATA-3|transcription factor gata-3
5457701|NCT01470911|Oral inhalation|oral inhalation
5457702|NCT01470898|bispectral index monitoring|bispectral index monitoring
5457703|NCT01470898|extubation|extubation
5457704|NCT01470898|analgesia|analgesia
5457705|NCT01470898|abdominal surgery|abdominal surgery
5457706|NCT01470885|glucose|glucose
5457707|NCT01470885|prognosis|prognosis
5457708|NCT01470885|glycated hemoglobin|glycated hemoglobin
5457709|NCT01470859|De Novo parkinson's disease|de novo parkinson's disease
5457710|NCT01470859|initial treatment|initial treatment
5457711|NCT01470859|pramipexole|pramipexole
5457712|NCT01470859|Levodopa|levodopa
5457713|NCT01470859|Parkinson's disease-related spatial covariance pattern|parkinson's disease-related spatial covariance pattern
5457714|NCT01470846|epidural analgesia|epidural analgesia
5457715|NCT01470846|morphin analgesia|morphin analgesia
5457716|NCT01470846|laparotomy|laparotomy
5457721|NCT01470820|Neonates|neonates
5457722|NCT01470820|Hyperbilirubinemia|hyperbilirubinemia
5457723|NCT01470820|Phototherapy|phototherapy
5457724|NCT01470820|Light irradiance|light irradiance
5457725|NCT01470820|Saturation point|saturation point
5440294|NCT01544361|FTiH|ftih
5457726|NCT01470807|Artificial Pancreas|artificial pancreas
5457727|NCT01470807|Insulin Pump|insulin pump
5457728|NCT01470807|Continuous Glucose Monitor|continuous glucose monitor
5457729|NCT01470807|Closed Loop|closed loop
5457730|NCT01470794|GBM|gbm
5457731|NCT01470794|HGG|hgg
5457732|NCT01470794|High grade glioma|high grade glioma
5457733|NCT01470794|Malignant glioma|malignant glioma
5457734|NCT01470794|Grade III glioma|grade iii glioma
5457735|NCT01470794|Grad IV glioma|grad iv glioma
5457736|NCT01470794|glioma|glioma
5457737|NCT01470794|glioblastoma|glioblastoma
5457738|NCT01470794|Grade IV astrocytoma|grade iv astrocytoma
5457739|NCT01470794|brain cancer|brain cancer
5457740|NCT01470794|recurrent glioblastoma|recurrent glioblastoma
5457741|NCT01470794|AA|aa
5457743|NCT01470794|anaplastic astrocytoma|anaplastic astrocytoma
5457744|NCT01470794|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5457745|NCT01470794|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5457750|NCT01470755|Pediatrics|pediatrics
5457751|NCT01470755|Bronchial wheeze|bronchial wheeze
5457752|NCT01470755|bronchodilator|bronchodilator
5457753|NCT01470755|lung function|lung function
5457754|NCT01470755|airway resistance|airway resistance
5457755|NCT01470729|Spinocerebellar ataxia, energy metabolism, NMR spectroscopy|spinocerebellar ataxia, energy metabolism, nmr spectroscopy
5457756|NCT01470716|EGFR mutation|egfr mutation
5457757|NCT01470716|NSCLC|nsclc
5457758|NCT01470703|Acute Respiratory Distress Syndrome,|acute respiratory distress syndrome,
5457759|NCT01470703|ECMO, Extracorporeal Membrane Oxygenation|ecmo, extracorporeal membrane oxygenation
5457760|NCT01470703|Randomized controlled trial|randomized controlled trial
5457761|NCT01470703|Positive-Pressure ventilation|positive-pressure ventilation
5457762|NCT01470703|Survival Rate|survival rate
5457763|NCT01470690|HVC infection|hvc infection
5457764|NCT01470690|gastric acid-related disorders|gastric acid-related disorders
5457765|NCT01470690|proton pump inhibitor|proton pump inhibitor
5457766|NCT01470690|interaction|interaction
5457767|NCT01470690|pharmacokinetics|pharmacokinetics
5457768|NCT01470690|boceprevir|boceprevir
5457769|NCT01470690|omeprazole|omeprazole
5457770|NCT01470677|lymph cyst|lymph cyst
5457771|NCT01470677|lymphocele|lymphocele
5457772|NCT01470677|fibrin|fibrin
5457773|NCT01470677|collagen|collagen
5457774|NCT01470677|prevention|prevention
5457775|NCT01470677|cancer|cancer
5457776|NCT01470651|HCV+|hcv+
5457777|NCT01470651|HCV treatment|hcv treatment
5457778|NCT01470651|Fatigue|fatigue
5457779|NCT01470651|patients starting alpha interferon/ribavirin treatment|patients starting alpha interferon/ribavirin treatment
5457780|NCT01470638|Flt3-L|flt3-l
5457781|NCT01470638|CSF|csf
5457782|NCT01470625|Dying|dying
5457783|NCT01470625|Patients|patients
5457784|NCT01470625|Hospice|hospice
5457785|NCT01470625|Liverpool Care Pathways|liverpool care pathways
5457786|NCT01470612|Ulcerative colitis|ulcerative colitis
5457787|NCT01470612|open-label|open-label
5457788|NCT01470612|long term treatment|long term treatment
5457789|NCT01470586|Colorectal cancer|colorectal cancer
5457790|NCT01470586|Surgical resection|surgical resection
5457791|NCT01470586|Oxidative Stress Markers|oxidative stress markers
5457792|NCT01470586|Controls|controls
5457794|NCT01470560|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5457795|NCT01470560|Meditation|meditation
5457796|NCT01470560|Yoga|yoga
5457797|NCT01470547|Liver Cirrhosis|liver cirrhosis
5457798|NCT01470547|Portal Vein Thrombosis|portal vein thrombosis
5457799|NCT01470547|Cirrhosis Complications|cirrhosis complications
5457800|NCT01470547|Registry|registry
5457801|NCT01470547|Italian|italian
5457802|NCT01470534|Dietary supplement|dietary supplement
5457803|NCT01470534|Carbohydrate loading|carbohydrate loading
5457804|NCT01470534|Insulin resistance|insulin resistance
5457805|NCT01470534|Surgery|surgery
5457806|NCT01470521|Multiple sclerosis|multiple sclerosis
5457807|NCT01470521|Hookworm larvae|hookworm larvae
5457808|NCT01470521|Necator americanus|necator americanus
5457809|NCT01470521|Treg cells|treg cells
5457810|NCT01470508|Bulimia|bulimia
5457811|NCT01470508|Binge-Eating Disorder|binge-eating disorder
5457812|NCT01470508|Eating Disorders|eating disorders
5457813|NCT01470482|Total knee|total knee
5457814|NCT01470482|Tourniquet|tourniquet
5457815|NCT01470482|Blood loss|blood loss
5457816|NCT01470482|pain|pain
5457817|NCT01470482|range of motion|range of motion
5457818|NCT01470391|Adductor-Canal-Blockade|adductor-canal-blockade
5457819|NCT01470391|Femoral Nerve Block|femoral nerve block
5457820|NCT01470391|Postoperative Pain|postoperative pain
5457821|NCT01470391|Total Knee Arthroplasty|total knee arthroplasty
5457822|NCT01470378|Lymphedema|lymphedema
5457823|NCT01470378|Magnetic Resonance Imaging|magnetic resonance imaging
5457824|NCT01470378|Plastic Surgery|plastic surgery
5457825|NCT01470352|migraine|migraine
5457826|NCT01470352|pain|pain
5457828|NCT01470352|offset analgesia|offset analgesia
5457829|NCT01470352|fMRI|fmri
5457830|NCT01470339|endogenous pain modulation|endogenous pain modulation
5457831|NCT01470339|migraine|migraine
5457832|NCT01470339|fMRI|fmri
5457833|NCT01470339|duloxetine|duloxetine
5440400|NCT01543854|RLX030|rlx030
5457834|NCT01470339|preventive migraine treatment|preventive migraine treatment
5457835|NCT01470326|Osteoporosis|osteoporosis
5457836|NCT01470326|Post menopausal women|post menopausal women
5457837|NCT01470326|SERM|serm
5457838|NCT01470326|Japanese|japanese
5457839|NCT01470326|Viviant|viviant
5457840|NCT01470326|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5457841|NCT01470326|Long term treatment|long term treatment
5457842|NCT01470313|Safety and tolerability|safety and tolerability
5457843|NCT01470313|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5457844|NCT01470313|efficacy|efficacy
5457845|NCT01470287|Infants,|infants,
5457846|NCT01470287|Immunogenicity,|immunogenicity,
5457847|NCT01470287|Safety|safety
5457848|NCT01470274|Blood volume|blood volume
5457849|NCT01470274|CO-rebreathing|co-rebreathing
5457850|NCT01470274|COPD|copd
5457851|NCT01470274|CVD|cvd
5457852|NCT01470261|methylphenidate|methylphenidate
5457853|NCT01470261|ritalin|ritalin
5457854|NCT01470261|Attention Deficit Disorder|attention deficit disorder
5457855|NCT01470248|Lung Cancer|lung cancer
5457856|NCT01470248|Carcinoma, small cell|carcinoma, small cell
5457857|NCT01470248|Trisenox|trisenox
5457858|NCT01470248|Arsenic trioxide|arsenic trioxide
5457859|NCT01470248|phase II trial|phase ii trial
5457860|NCT01470235|screening|screening
5457861|NCT01470235|genetic|genetic
5457862|NCT01470235|cancer|cancer
5457863|NCT01470222|Worksite|worksite
5457864|NCT01470222|group weight loss|group weight loss
5457865|NCT01470222|behavioral components|behavioral components
5457866|NCT01470209|lung cancer with activated mTOR/PI3K pathway|lung cancer with activated mtor/pi3k pathway
5457867|NCT01470209|alterations in PIK3CA, NF1, TSC1/TSC2, mTOR, KRAS, LKB1, PTEN|alterations in pik3ca, nf1, tsc1/tsc2, mtor, kras, lkb1, pten
5457868|NCT01470196|WM|wm
5457869|NCT01470196|untreated|untreated
5457870|NCT01470196|symptomatic|symptomatic
5457871|NCT01470183|Lupus Nephritis|lupus nephritis
5457872|NCT01470170|Sedative bronchoscope|sedative bronchoscope
5457873|NCT01470170|Alfentanil doses|alfentanil doses
5457874|NCT01470170|Propofol|propofol
5457875|NCT01470170|Targeted controlled infusion|targeted controlled infusion
5457876|NCT01470170|Hypoxemia|hypoxemia
5457877|NCT01470131|multiple myeloma|multiple myeloma
5457879|NCT01470131|second line therapy|second line therapy
5457880|NCT01470131|bortezomib|bortezomib
5457881|NCT01470131|dexamethasone|dexamethasone
5457882|NCT01470105|questionnaire|questionnaire
5457883|NCT01470105|11-121|11-121
5457884|NCT01470092|Menopause|menopause
5457885|NCT01470092|Depression|depression
5457886|NCT01470066|peripheral T cell lymphomas|peripheral t cell lymphomas
5457887|NCT01470066|interim PET/CT|interim pet/ct
5457888|NCT01470066|prognosis|prognosis
5685302|NCT00556647|endoscopic techniques|endoscopic techniques
5457889|NCT01470066|Positron-emission tomography/Computerized tomography|positron-emission tomography/computerized tomography
5457890|NCT01470053|mometasone furoate|mometasone furoate
5457891|NCT01470053|azelastine HCl|azelastine hcl
5457892|NCT01470053|perennial allergic rhinitis|perennial allergic rhinitis
5457893|NCT01470040|traumatic brain injury|traumatic brain injury
5457894|NCT01470040|chronic subdural hematoma|chronic subdural hematoma
5457896|NCT01470040|antiplatelet therapy|antiplatelet therapy
5457897|NCT01470027|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5457898|NCT01470027|N-acetylcysteine|n-acetylcysteine
5457899|NCT01470027|antioxidant|antioxidant
5457900|NCT01470027|glutathione|glutathione
5457901|NCT01470014|isolated left ventricular non-compaction|isolated left ventricular non-compaction
5457902|NCT01470014|cardiac computed tomography|cardiac computed tomography
5457903|NCT01470014|cardiac magnet resonance imaging|cardiac magnet resonance imaging
5457904|NCT01470014|echocardiography|echocardiography
5457905|NCT01469975|cancer|cancer
5457906|NCT01469975|relapse or refractory|relapse or refractory
5457907|NCT01469962|morbid obesity|morbid obesity
5457908|NCT01469962|bariatric surgery|bariatric surgery
5457909|NCT01469962|NASH|nash
5457910|NCT01469962|Liver fibrosis|liver fibrosis
5457911|NCT01469962|Fibrotest|fibrotest
5457912|NCT01469949|Improvement of the accuracy of Lumbar repositioning|improvement of the accuracy of lumbar repositioning
5457913|NCT01469936|Fibromyalgia|fibromyalgia
5457914|NCT01469936|Irritable Bowel Syndrome|irritable bowel syndrome
5457915|NCT01469923|Phase 1|phase 1
5457916|NCT01469923|obese|obese
5457917|NCT01469923|healthy male volunteers|healthy male volunteers
5457918|NCT01469923|multiple doses|multiple doses
5457919|NCT01469923|dose escalation|dose escalation
5457920|NCT01469923|pharmacokinetics|pharmacokinetics
5457921|NCT01469923|pharmakodynamics|pharmakodynamics
5457923|NCT01469897|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5457924|NCT01469897|Cost of Care|cost of care
5457925|NCT01469897|Quality of Life|quality of life
5457927|NCT01469884|Renal allograft recipients|renal allograft recipients
5457928|NCT01469884|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5457929|NCT01469884|Certican|certican
5457930|NCT01469884|Calcineurin inhibitor(tacrolimus or cyclosporin)|calcineurin inhibitor(tacrolimus or cyclosporin)
5457931|NCT01469871|Dressing|dressing
5457932|NCT01469871|Blisters|blisters
5457933|NCT01469871|Silicone|silicone
5457934|NCT01469845|hospital admissions|hospital admissions
5457935|NCT01469845|acute bronchiolitis|acute bronchiolitis
5457936|NCT01469845|under one year old|under one year old
5457937|NCT01469845|requiring oxygen therapy|requiring oxygen therapy
5457938|NCT01469832|fundus flavimaculatus|fundus flavimaculatus
5457939|NCT01469832|Retinal Diseases|retinal diseases
5457940|NCT01469832|Macular Degeneration|macular degeneration
5457941|NCT01469832|SMD|smd
5457942|NCT01469832|juvenile macular dystrophy|juvenile macular dystrophy
5457943|NCT01469819|chronic constipation|chronic constipation
5457944|NCT01469819|constipation|constipation
5457945|NCT01469819|idiopathic constipation|idiopathic constipation
5457946|NCT01469819|SmartPill|smartpill
5457947|NCT01469819|Wireless Motility Capsule|wireless motility capsule
5457948|NCT01469819|lubiprostone (Amitiza)|lubiprostone (amitiza)
5457949|NCT01469819|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
5457950|NCT01469780|Pain|pain
5457951|NCT01469780|Health behavior change|health behavior change
5457952|NCT01469780|Coronary angioplasty|coronary angioplasty
5457953|NCT01469780|Cardiovascular disease|cardiovascular disease
5457954|NCT01469780|Outcomes|outcomes
5457955|NCT01469780|Morbidity|morbidity
5457956|NCT01469780|Mortality|mortality
5457957|NCT01469767|eczema|eczema
5457958|NCT01469767|itch|itch
5457959|NCT01469767|scratching|scratching
5457960|NCT01469767|actigraphy|actigraphy
5457961|NCT01469767|adherence|adherence
5457962|NCT01469754|lymphoma|lymphoma
5457963|NCT01469754|survivors|survivors
5457964|NCT01469754|posttraumatic growth|posttraumatic growth
5457965|NCT01469754|posttraumatic stress|posttraumatic stress
5457966|NCT01469754|longitudinal|longitudinal
5457967|NCT01469728|VATS|vats
5457968|NCT01469728|awake thoracic surgery|awake thoracic surgery
5457969|NCT01469728|pleurodesis|pleurodesis
5457970|NCT01469728|talc|talc
5457971|NCT01469728|TEA|tea
5457972|NCT01469728|epidural anesthesia|epidural anesthesia
5457973|NCT01469728|Video-Assisted|video-assisted
5457974|NCT01469728|Anesthesia Epidural|anesthesia epidural
5457975|NCT01469715|Continuous Glucose Monitor|continuous glucose monitor
5457976|NCT01469702|cat-scratch disease|cat-scratch disease
5457977|NCT01469702|Bartonella henselae|bartonella henselae
5457978|NCT01469702|corticosteroids|corticosteroids
5457979|NCT01469702|treatment|treatment
5457980|NCT01469689|People|people
5457981|NCT01469689|living|living
5457982|NCT01469689|community|community
5457983|NCT01469676|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5457984|NCT01469676|Cardiopulmonary Bypass|cardiopulmonary bypass
5457985|NCT01469676|Leukocyte Reduction Filtrations|leukocyte reduction filtrations
5457986|NCT01469676|Pulmonary Function|pulmonary function
5457987|NCT01469676|Systemic Inflammatory Response|systemic inflammatory response
5457988|NCT01469663|Borderline Personality Disorder|borderline personality disorder
5457989|NCT01469663|Major Depression|major depression
5457990|NCT01469663|Electroencephalogram|electroencephalogram
5457991|NCT01469663|N2|n2
5457992|NCT01469663|Error Related Negativity|error related negativity
5457993|NCT01469663|Emotional Processing|emotional processing
5457995|NCT01469650|vitamin D3|vitamin d3
5457996|NCT01469650|prematurity|prematurity
5457997|NCT01469650|parathyroid hormone|parathyroid hormone
5457998|NCT01469650|25(OH)D|25(oh)d
5457999|NCT01469650|NICU hospitalization|nicu hospitalization
5458000|NCT01469624|Contrast Induced Nephropathy|contrast induced nephropathy
5458001|NCT01469624|Pentoxifylline|pentoxifylline
5458002|NCT01469624|PCI|pci
5458003|NCT01469611|advanced/metastatic colorectal carcinoma|advanced/metastatic colorectal carcinoma
5458004|NCT01469585|continuous oral contraceptives|continuous oral contraceptives
5458005|NCT01469585|MMP expression|mmp expression
5458006|NCT01469572|Neuroendocrine hepatic tumors|neuroendocrine hepatic tumors
5458007|NCT01469572|Liver cancer|liver cancer
5458008|NCT01469572|Metastatic liver cancer|metastatic liver cancer
5458009|NCT01469559|Insulin|insulin
5458010|NCT01469559|Diabetic neuropathy|diabetic neuropathy
5458011|NCT01469559|Intranasal administration|intranasal administration
5458012|NCT01469559|Pilot project|pilot project
5458013|NCT01469546|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5458014|NCT01469533|Spine|spine
5458015|NCT01469533|Manipulation|manipulation
5458016|NCT01469533|Pain Threshold|pain threshold
5458017|NCT01469533|Electromyography.|electromyography.
5458018|NCT01469520|HIV|hiv
5458019|NCT01469520|AIDS|aids
5458022|NCT01469494|SIEA flap|siea flap
5458023|NCT01469494|breast reconstruction|breast reconstruction
5458024|NCT01469494|objective isokinetic abdominal strength testing|objective isokinetic abdominal strength testing
5458025|NCT01469494|fat necrosis|fat necrosis
5458026|NCT01469494|flap loss|flap loss
5458027|NCT01469494|seroma rate|seroma rate
5458028|NCT01469494|abdominal wound breakdown|abdominal wound breakdown
5458029|NCT01469494|Breast-Q|breast-q
5458030|NCT01469494|abdominal wall outcome questionnaire|abdominal wall outcome questionnaire
5458031|NCT01469481|diabetes mellitus|diabetes mellitus
5458033|NCT01469455|Local metastatic melanoma|local metastatic melanoma
5458034|NCT01469455|relapsed cutaneous/subcutaneous tumors|relapsed cutaneous/subcutaneous tumors
5458035|NCT01469455|melanoma-in-transit|melanoma-in-transit
5458036|NCT01469442|Biliary fistula|biliary fistula
5458037|NCT01469442|prevention|prevention
5458038|NCT01469442|hepatectomy|hepatectomy
5458039|NCT01469442|external stent|external stent
5458040|NCT01469442|Hepatectomy of more 2 segments|hepatectomy of more 2 segments
5458041|NCT01469442|Not emergency or laparoscopy surgery|not emergency or laparoscopy surgery
5458043|NCT01469416|rosuvastatin|rosuvastatin
5458044|NCT01469416|clopidogrel|clopidogrel
5458045|NCT01469416|pharmacokinetics|pharmacokinetics
5458046|NCT01469416|drug interaction|drug interaction
5458047|NCT01469416|healthy volunteer|healthy volunteer
5458048|NCT01469416|drug transporter|drug transporter
5458049|NCT01469403|Osteoarthritis, knee|osteoarthritis, knee
5458050|NCT01469403|Obesity|obesity
5458051|NCT01469403|Weight Loss|weight loss
5458052|NCT01469403|Arthroplasty|arthroplasty
5458053|NCT01469377|Major depressive disorder|major depressive disorder
5458054|NCT01469377|Depression|depression
5458055|NCT01469364|Lung Transplant|lung transplant
5458056|NCT01469364|Lung Transplant Recipient|lung transplant recipient
5458057|NCT01469351|Alzheimers disease|alzheimers disease
5458058|NCT01469325|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5458059|NCT01469325|Depression|depression
5458060|NCT01469325|left prefrontal|left prefrontal
5458061|NCT01469312|Low Biologically Available Glucose Diet (LoBAG diet)|low biologically available glucose diet (lobag diet)
5458062|NCT01469312|Diabetes|diabetes
5458063|NCT01469312|Glycemic Index|glycemic index
5680278|NCT00578383|Bipolar depression|bipolar depression
5680279|NCT00578383|LFMS|lfms
5458064|NCT01469299|Ligament Balance, Total Knee Arthroplasty, Intra-operative Sensors|ligament balance, total knee arthroplasty, intra-operative sensors
5458065|NCT01469286|delayed gastric emptying|delayed gastric emptying
5458066|NCT01469286|nausea|nausea
5458067|NCT01469286|vomiting|vomiting
5458068|NCT01469286|abdominal discomfort|abdominal discomfort
5458069|NCT01469273|Diarrhea|diarrhea
5458071|NCT01469273|E. coli strain Nissle 1917|e. coli strain nissle 1917
5458072|NCT01469273|Gastrointestinal infection|gastrointestinal infection
5458073|NCT01469273|Infant|infant
5458074|NCT01469273|Newborn|newborn
5458075|NCT01469273|Probiotic drug|probiotic drug
5458076|NCT01469273|Prevention|prevention
5458077|NCT01469273|Prophylaxis|prophylaxis
5458078|NCT01469260|Overweight|overweight
5458079|NCT01469260|Obesity|obesity
5458080|NCT01469260|Pregnancy|pregnancy
5458081|NCT01469260|Weight gain|weight gain
5458082|NCT01469260|Pedometer|pedometer
5458083|NCT01469260|Exercise|exercise
5458084|NCT01469247|Brain cancer|brain cancer
5458085|NCT01469247|Recurrent or progressive brainstem glioma|recurrent or progressive brainstem glioma
5458086|NCT01469247|Diffuse Intrinsic Pontine Glioma|diffuse intrinsic pontine glioma
5458087|NCT01469247|DIPG|dipg
5458088|NCT01469247|Reirradiation|reirradiation
5458089|NCT01469247|ReRT|rert
5458090|NCT01469247|Photon radiation therapy|photon radiation therapy
5458091|NCT01469247|XRT|xrt
5458092|NCT01469221|Bladder Cancer|bladder cancer
5458093|NCT01469221|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5458094|NCT01469221|NMIBC|nmibc
5458095|NCT01469221|Apaziquone|apaziquone
5458096|NCT01469221|EOquin|eoquin
5458097|NCT01469221|GU Cancer|gu cancer
5458098|NCT01469221|TURBT|turbt
5458099|NCT01469208|Gastroschisis|gastroschisis
5458100|NCT01469208|NICU inpatients|nicu inpatients
5458101|NCT01469208|Post surgical repair|post surgical repair
5458102|NCT01469208|Music Therapy|music therapy
5458103|NCT01469195|lead rectangle|lead rectangle
5458104|NCT01469195|radiation exposure|radiation exposure
5458105|NCT01469195|operators|operators
5458106|NCT01469195|radial approach|radial approach
5458107|NCT01469195|coronary procedures|coronary procedures
5458108|NCT01469195|percutaneous coronary intervention|percutaneous coronary intervention
5458109|NCT01469182|Immunology|immunology
5458110|NCT01469169|Iloprost|iloprost
5458111|NCT01469169|Inhalation|inhalation
5458112|NCT01469169|Pulmonary Hypertension|pulmonary hypertension
5458113|NCT01469169|Pulmonary Artery Hypertension|pulmonary artery hypertension
5458114|NCT01469169|Japanese Patients|japanese patients
5458115|NCT01469156|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5458116|NCT01469156|choroidal neovascularization|choroidal neovascularization
5458117|NCT01469156|ranibizumab|ranibizumab
5458118|NCT01469156|Lucentis|lucentis
5458134|NCT01469039|schizophrenia|schizophrenia
5458135|NCT01469039|ALKS 9072|alks 9072
5458136|NCT01469039|ALKS 9070|alks 9070
5458137|NCT01469039|aripiprazole lauroxil|aripiprazole lauroxil
5458138|NCT01468948|Essential Tremor|essential tremor
5458139|NCT01468948|Tremor|tremor
5458140|NCT01468948|Octanol|octanol
5458141|NCT01468948|Octanoic Acid|octanoic acid
5458142|NCT01468935|Uterus|uterus
5458143|NCT01468935|Endometrium|endometrium
5458144|NCT01468935|Bone Marrow Transplant|bone marrow transplant
5458145|NCT01468935|Gynecology|gynecology
5458146|NCT01468935|Healthy Volunteer|healthy volunteer
5458147|NCT01468935|HV|hv
5458148|NCT01468935|Stem Cell Transplant|stem cell transplant
5458149|NCT01468935|Endometriosis|endometriosis
5458161|NCT01468857|Clinical Stress Markers|clinical stress markers
5458162|NCT01468857|Chronic Stress|chronic stress
5458163|NCT01468857|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5458164|NCT01468857|HSCT Caregivers|hsct caregivers
5458165|NCT01468857|Cancer Caregivers|cancer caregivers
5458166|NCT01468857|Stress|stress
5458167|NCT01468857|Family Caregivers|family caregivers
5458174|NCT01468818|Metastatic Melanoma|metastatic melanoma
5458175|NCT01468818|Adoptive Cell Therapy|adoptive cell therapy
5458176|NCT01468818|Skin Cancer|skin cancer
5458177|NCT01468805|Environmental Intervention|environmental intervention
5458178|NCT01468805|Indoor Allergens|indoor allergens
5458179|NCT01468805|Cockroach|cockroach
5458180|NCT01468805|Health Disparities|health disparities
5458181|NCT01468805|Multi-Center|multi-center
5458182|NCT01468805|Asthma|asthma
5458183|NCT01468805|Environment|environment
5458184|NCT01468792|systemic sclerosis|systemic sclerosis
5458185|NCT01468792|pulmonary arterial hypertension|pulmonary arterial hypertension
5458186|NCT01468779|Periampullary cancer|periampullary cancer
5458187|NCT01468779|Surgery|surgery
5458188|NCT01468779|Dietary supplementation|dietary supplementation
5458189|NCT01468779|Nutritional assessment|nutritional assessment
5458190|NCT01468753|Conception in HIV Discordant Couples|conception in hiv discordant couples
5458191|NCT01468753|Reproduction in HIV Discordant Couples|reproduction in hiv discordant couples
5458192|NCT01468753|Vaginal Insemination|vaginal insemination
5458193|NCT01468727|dental caries|dental caries
5458194|NCT01468727|mutans streptococci|mutans streptococci
5458195|NCT01468727|lactobacilli|lactobacilli
5458196|NCT01468727|bacterial transmission|bacterial transmission
5458197|NCT01468727|bacterial colonization|bacterial colonization
5458198|NCT01468714|Drug Interaction|drug interaction
5458199|NCT01468714|pharmacokinetics|pharmacokinetics
5458200|NCT01468714|ketoconazole|ketoconazole
5458201|NCT01468714|CYP3A|cyp3a
5458202|NCT01468688|Imatinib mesylate|imatinib mesylate
5458203|NCT01468688|BKM120|bkm120
5458204|NCT01468688|GIST|gist
5458205|NCT01468649|Breast Cancer|breast cancer
5458206|NCT01468649|Sentinel Lymph Node Mapping|sentinel lymph node mapping
5458207|NCT01468649|Intraoperative Imaging|intraoperative imaging
5458208|NCT01468636|Warts|warts
5458210|NCT01468636|Zinc|zinc
5458211|NCT01468623|Colorectal cancer, metastatic|colorectal cancer, metastatic
5458212|NCT01468623|FOLFOX6|folfox6
5458213|NCT01468623|5-FU|5-fu
5458214|NCT01468623|First line|first line
5458215|NCT01468623|bevacizumab|bevacizumab
5458216|NCT01468610|depression|depression
5458217|NCT01468610|cognition|cognition
5685303|NCT00556647|lung cancer|lung cancer
5458218|NCT01468610|occupational functioning|occupational functioning
5458219|NCT01468610|productivity|productivity
5458220|NCT01468610|neuropsychology|neuropsychology
5458221|NCT01468610|desvenlafaxine|desvenlafaxine
5458222|NCT01468610|antidepressants|antidepressants
5458223|NCT01468597|Emergent|emergent
5458224|NCT01468597|Cardiac surgery|cardiac surgery
5458225|NCT01468597|On-pump|on-pump
5458226|NCT01468597|Platelet function|platelet function
5458227|NCT01468584|Genotype 2|genotype 2
5458228|NCT01468571|Potassium Sparing Diuretics|potassium sparing diuretics
5458229|NCT01468571|Right-sided heart failure|right-sided heart failure
5458230|NCT01468571|Edema|edema
5458231|NCT01468558|Drug Drug Interaction Study in Normal Healthy Volunteers|drug drug interaction study in normal healthy volunteers
5458232|NCT01468545|Education|education
5458233|NCT01468545|Ventavis|ventavis
5458234|NCT01468545|Adherence|adherence
5458236|NCT01468545|Pulmonary artery hypertension|pulmonary artery hypertension
5458237|NCT01468519|Diabetes mellitus, type 2|diabetes mellitus, type 2
5458238|NCT01468519|Erectile dysfunction|erectile dysfunction
5458239|NCT01468519|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5458240|NCT01468519|CSII|csii
5458241|NCT01468519|insulin|insulin
5458242|NCT01468506|Chronic Kidney Disease|chronic kidney disease
5458243|NCT01468506|arteriovenous fistula|arteriovenous fistula
5458244|NCT01468493|FSGS|fsgs
5458245|NCT01468493|suPAR|supar
5458246|NCT01468480|direct pulp capping|direct pulp capping
5458247|NCT01468480|MTA|mta
5458248|NCT01468480|Single visit pulp cap|single visit pulp cap
5458249|NCT01468480|Multical|multical
5458250|NCT01468467|AC220|ac220
5458251|NCT01468467|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5458252|NCT01468467|Transplantation|transplantation
5458253|NCT01468467|Stem Cell Transplantation|stem cell transplantation
5458254|NCT01468467|Allogeneic Transplantation|allogeneic transplantation
5458255|NCT01468467|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
5458256|NCT01468467|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
5458257|NCT01468467|Kinase|kinase
5458258|NCT01468467|Kinase Inhibitor|kinase inhibitor
5458259|NCT01468467|Pharmacokinetics|pharmacokinetics
5458260|NCT01468467|ASP2689|asp2689
5458261|NCT01468467|quizartinib|quizartinib
5458262|NCT01468454|Congenital Hyperinsulinism (CHI)|congenital hyperinsulinism (chi)
5458263|NCT01468454|hyperinsulinism|hyperinsulinism
5458264|NCT01468454|Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)|persistent hyperinsulinemic hypoglycemia of infancy (phhi)
5458266|NCT01468454|PHHI|phhi
5458267|NCT01468454|Pancreatectomy|pancreatectomy
5458268|NCT01468454|18F-DOPA|18f-dopa
5458269|NCT01468454|PET/CT scan|pet/ct scan
5458270|NCT01468441|ovarian stimulation|ovarian stimulation
5458271|NCT01468441|GnRH agonist|gnrh agonist
5458272|NCT01468441|GnRH antagonist|gnrh antagonist
5458273|NCT01468441|hCG microdose|hcg microdose
5458274|NCT01468441|ICSI|icsi
5458275|NCT01468415|Methylprednisolone|methylprednisolone
5458276|NCT01468415|trans sacral block|trans sacral block
5458277|NCT01468415|phenol|phenol
5458278|NCT01468402|Leiomyoma|leiomyoma
5458279|NCT01468402|uterine artery embolization|uterine artery embolization
5458280|NCT01468402|magnetic resonance imaging|magnetic resonance imaging
5458281|NCT01468389|Gastric Cancer|gastric cancer
5458282|NCT01468389|capecitabine|capecitabine
5458283|NCT01468389|maintenance treatment|maintenance treatment
5458284|NCT01468376|impaired glucose tolerance|impaired glucose tolerance
5458285|NCT01468376|pre-diabetes|pre-diabetes
5458286|NCT01468363|Dry weight|dry weight
5458287|NCT01468363|Body composition monitor|body composition monitor
5458288|NCT01468363|Hemodialysis|hemodialysis
5458289|NCT01468363|Zonguldak|zonguldak
5458290|NCT01468337|Central Serous Chorioretinopathy|central serous chorioretinopathy
5458291|NCT01468337|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5458292|NCT01468337|Jakstat|jakstat
5458293|NCT01468337|Retinal Eye Disease|retinal eye disease
5458294|NCT01468337|Macular Eye Disease|macular eye disease
5458296|NCT01468324|Brain|brain
5458297|NCT01468324|Angiogenesis|angiogenesis
5458298|NCT01468324|Radiotherapy|radiotherapy
5458299|NCT01468324|Malignant|malignant
5458300|NCT01468324|Tumor|tumor
5458301|NCT01468324|Glioma|glioma
5458302|NCT01468324|Glioblastoma Multiforme|glioblastoma multiforme
5458303|NCT01468324|Brain Tumor|brain tumor
5458304|NCT01468311|Immunotherapy|immunotherapy
5458305|NCT01468311|Resistant Hodgkins Lymphoma|resistant hodgkins lymphoma
5458306|NCT01468311|Auto Stem Cell Transplant|auto stem cell transplant
5458307|NCT01468311|Combination Chemo and Radiolabeled Monoclonal Antibody|combination chemo and radiolabeled monoclonal antibody
5458308|NCT01468311|Hodgkin Lymphoma|hodgkin lymphoma
5458309|NCT01468298|back pain|back pain
5458310|NCT01468298|physical therapy|physical therapy
5458311|NCT01468298|spine|spine
5458312|NCT01468298|rehabilitation|rehabilitation
5458313|NCT01468298|exercise|exercise
5458314|NCT01468285|interventional,placebo controlled|interventional,placebo controlled
5458315|NCT01468272|asthma children NEXT DPI LABA ICS inhalation|asthma children next dpi laba ics inhalation
5458317|NCT01468246|Cohort|cohort
5458318|NCT01468246|Young Women|young women
5458319|NCT01468246|Survivorship|survivorship
5458320|NCT01468246|Fertility|fertility
5458321|NCT01468233|placebo controlled|placebo controlled
5458322|NCT01468233|double blind|double blind
5458323|NCT01468233|adalimumab|adalimumab
5458324|NCT01468233|TNF|tnf
5458325|NCT01468233|psoriasis|psoriasis
5458326|NCT01468233|HS|hs
5458327|NCT01468233|PIONEER II|pioneer ii
5458328|NCT01468233|hidradenitis suppurativa|hidradenitis suppurativa
5458329|NCT01468233|acne inversa|acne inversa
5458331|NCT01468233|acne|acne
5458332|NCT01468220|tissue metabolism|tissue metabolism
5458333|NCT01468220|skeletal muscle|skeletal muscle
5458334|NCT01468220|adipose tissue|adipose tissue
5458335|NCT01468220|HIF|hif
5458336|NCT01468207|acne|acne
5458337|NCT01468207|psoriasis|psoriasis
5458338|NCT01468207|hidradenitis suppurativa|hidradenitis suppurativa
5458339|NCT01468207|TNF|tnf
5458340|NCT01468207|HS|hs
5458341|NCT01468207|PIONEER I|pioneer i
5458342|NCT01468207|acne inversa|acne inversa
5458343|NCT01468207|boil|boil
5458344|NCT01468207|placebo controlled|placebo controlled
5458345|NCT01468207|Double blind|double blind
5458346|NCT01468207|adalimumab|adalimumab
5458347|NCT01468194|AMS|ams
5458348|NCT01468194|HAPE|hape
5458349|NCT01468194|high altitude|high altitude
5458350|NCT01468194|oxygen|oxygen
5458351|NCT01468194|saturation|saturation
5458352|NCT01468194|mountain|mountain
5458353|NCT01468194|climbing|climbing
5458354|NCT01468194|breathing|breathing
5458355|NCT01468181|Type 2 diabetes mellitus|type 2 diabetes mellitus
5458356|NCT01468181|Oral antihyperglycemic medications|oral antihyperglycemic medications
5458357|NCT01468181|Long-Term Safety|long-term safety
5458358|NCT01468181|GLP 1|glp 1
5458359|NCT01468181|Glucagon like peptide 1|glucagon like peptide 1
5458360|NCT01468155|PVA|pva
5458361|NCT01468155|peri procedural bleeding complications|peri procedural bleeding complications
5458362|NCT01468116|Type 2 diabetes|type 2 diabetes
5458363|NCT01468116|Gastric bypass surgery|gastric bypass surgery
5458364|NCT01468116|Obesity|obesity
5458365|NCT01468116|Mitochondrial function|mitochondrial function
5458366|NCT01468103|intraocular pressure|intraocular pressure
5458367|NCT01468103|Peripheral anterior synechiae|peripheral anterior synechiae
5458368|NCT01468090|Inflammatory bowel disease|inflammatory bowel disease
5458369|NCT01468090|Crohn's disease|crohn's disease
5458370|NCT01468090|Ulcerative colitis|ulcerative colitis
5458371|NCT01468090|Disease course|disease course
5458372|NCT01468090|Phenotype|phenotype
5458373|NCT01468090|Biological treatment|biological treatment
5458374|NCT01468064|Central Nervous System Diseases|central nervous system diseases
5458375|NCT01468064|Stroke|stroke
5458376|NCT01468064|Infarction, Middle Cerebral Artery|infarction, middle cerebral artery
5458377|NCT01468064|Cerebral Infarction|cerebral infarction
5458378|NCT01468064|Cerebrovascular Accident|cerebrovascular accident
5458379|NCT01468064|Stem Cell Transplantation|stem cell transplantation
5458380|NCT01468064|Mesenchymal Stem Cell Transplantation|mesenchymal stem cell transplantation
5458381|NCT01468064|Bone marrow stromal cells|bone marrow stromal cells
5458382|NCT01468064|Mesenchymal Stem Cells|mesenchymal stem cells
5458383|NCT01468064|Endothelial progenitor cells|endothelial progenitor cells
5458384|NCT01468064|Adult Stem Cells|adult stem cells
5458385|NCT01468064|Cell Therapy|cell therapy
5458386|NCT01468051|predialysed|predialysed
5458387|NCT01468051|chronic|chronic
5458388|NCT01468051|renal failure patients|renal failure patients
5458389|NCT01468025|NSAIDs|nsaids
5458390|NCT01468025|Theramine|theramine
5458391|NCT01468025|naproxen|naproxen
5458392|NCT01468025|Low back pain|low back pain
5458393|NCT01468025|amino acids|amino acids
5458394|NCT01468025|CRP|crp
5458395|NCT01468025|Medical Food|medical food
5458396|NCT01468012|cocaine dependence|cocaine dependence
5458397|NCT01468012|levodopa|levodopa
5458398|NCT01468012|carbidopa|carbidopa
5458399|NCT01468012|entacapone|entacapone
5458400|NCT01467999|cannabis dependence|cannabis dependence
5458401|NCT01467999|marijuana dependence|marijuana dependence
5458402|NCT01467999|guanfacine|guanfacine
5458403|NCT01467986|neuroblastoma|neuroblastoma
5458404|NCT01467986|molecular targeted therapy|molecular targeted therapy
5458405|NCT01467986|protein kinase inhibitor|protein kinase inhibitor
5458406|NCT01467986|mTOR Inhibitor|mtor inhibitor
5458407|NCT01467986|cytostatic topoisomerase-I-inhibitor|cytostatic topoisomerase-i-inhibitor
5458408|NCT01467986|temozolomide|temozolomide
5458409|NCT01467986|irinotecan|irinotecan
5458410|NCT01467986|dasatinib|dasatinib
5458411|NCT01467986|rapamycin|rapamycin
5458412|NCT01467973|Heart Failure|heart failure
5458413|NCT01467973|Heart Failure, Diastolic|heart failure, diastolic
5458414|NCT01467973|Heart Failure, Systolic|heart failure, systolic
5458415|NCT01467973|Middle-East|middle-east
5458416|NCT01467908|Diagnosed vegetative state after stroke or traumatic brain injury|diagnosed vegetative state after stroke or traumatic brain injury
5685304|NCT00556634|HIV|hiv
5458418|NCT01467869|assisted conception|assisted conception
5458419|NCT01467856|Tetraplegia|tetraplegia
5458420|NCT01467843|Cognitive Behavioral Therapy|cognitive behavioral therapy
5458421|NCT01467843|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5458422|NCT01467830|absorbable sutures efficacy|absorbable sutures efficacy
5458736|NCT01466439|rTMS|rtms
5458423|NCT01467830|reducing Adverse effect to be caused from surgery|reducing adverse effect to be caused from surgery
5458424|NCT01467830|Inguinal Hernia repair with mesh|inguinal hernia repair with mesh
5458425|NCT01467817|body mass|body mass
5458426|NCT01467817|abdominal fat|abdominal fat
5458427|NCT01467817|whole body lean mass|whole body lean mass
5458428|NCT01467817|insulin resistance|insulin resistance
5458429|NCT01467817|caloric intake|caloric intake
5458430|NCT01467817|expenditure|expenditure
5458431|NCT01467817|endurance|endurance
5458432|NCT01467817|Strength|strength
5458433|NCT01467817|TC:HDL ratio|tc:hdl ratio
5458434|NCT01467817|LDL:HDL ratio|ldl:hdl ratio
5458435|NCT01467817|area under the TG response curve|area under the tg response curve
5458436|NCT01467817|feeding challenge|feeding challenge
5458437|NCT01467817|fasting and post-prandial whole body fat oxidation|fasting and post-prandial whole body fat oxidation
5458438|NCT01467817|HRQoL|hrqol
5458439|NCT01467804|efficacy,|efficacy,
5458440|NCT01467804|safety,|safety,
5458441|NCT01467804|JWXYJN|jwxyjn
5458442|NCT01467791|ambrisentan|ambrisentan
5458443|NCT01467791|Bosentan|bosentan
5458444|NCT01467791|Iloprost|iloprost
5458445|NCT01467778|skin|skin
5458446|NCT01467752|reconstruction|reconstruction
5458447|NCT01467752|metacarpophalangeal joint|metacarpophalangeal joint
5458448|NCT01467752|bone graft|bone graft
5458449|NCT01467752|MCP joint|mcp joint
5458450|NCT01467726|Alzheimer's disease|alzheimer's disease
5458451|NCT01467726|Elderly|elderly
5458452|NCT01467713|Drug Therapy|drug therapy
5458453|NCT01467700|Drug Therapy|drug therapy
5458454|NCT01467674|Diabetes mellitus|diabetes mellitus
5458455|NCT01467674|Chronic periodontitis|chronic periodontitis
5458456|NCT01467674|Malondialdehyde|malondialdehyde
5458457|NCT01467674|Glutathione peroxidase|glutathione peroxidase
5458458|NCT01467674|Paraoxonase|paraoxonase
5458459|NCT01467648|Infection|infection
5458460|NCT01467648|Doripenem|doripenem
5458461|NCT01467648|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5458462|NCT01467648|pharmacokinetic|pharmacokinetic
5458463|NCT01467648|pharmacodynamic|pharmacodynamic
5458464|NCT01467635|Endobronchial ultrasound|endobronchial ultrasound
5458465|NCT01467635|Transbronchial needle aspiration|transbronchial needle aspiration
5458466|NCT01467635|Transbronchial biopsy forceps|transbronchial biopsy forceps
5458467|NCT01467635|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5458468|NCT01467635|Hilar lymphadenopathy|hilar lymphadenopathy
5458469|NCT01467622|chest tube drainage|chest tube drainage
5458470|NCT01467622|pulmonary air leak|pulmonary air leak
5458471|NCT01467622|lung resection|lung resection
5458472|NCT01467609|Pillcam colon capsule endoscopy|pillcam colon capsule endoscopy
5458473|NCT01467609|conventional colonoscopy|conventional colonoscopy
5458474|NCT01467609|ulcerative colitis|ulcerative colitis
5458475|NCT01467609|endoscopic manifestation|endoscopic manifestation
5458476|NCT01467609|colonoscopy|colonoscopy
5458477|NCT01467596|Ultrasound|ultrasound
5458478|NCT01467596|Brachial block|brachial block
5458479|NCT01467596|Levobupivacaine|levobupivacaine
5458480|NCT01467596|Minimum|minimum
5458481|NCT01467596|Volume|volume
5458482|NCT01467596|Minimum volume of Levobupivacaine 0,5%|minimum volume of levobupivacaine 0,5%
5458483|NCT01467583|Fondaparinux|fondaparinux
5458484|NCT01467583|Renal Failure|renal failure
5458485|NCT01467583|Critically Ill|critically ill
5458486|NCT01467570|diarrhea|diarrhea
5458487|NCT01467557|adverse events|adverse events
5458488|NCT01467544|Tai Chi|tai chi
5458489|NCT01467531|HIV, GSK1265744, GSK1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics|hiv, gsk1265744, gsk1349572, dolutegravir, rilpivirine, drug interaction, pharmacokinetics
5458490|NCT01467518|methadone|methadone
5458491|NCT01467518|Opiate-dependent|opiate-dependent
5458492|NCT01467492|VX-950, Incivek|vx-950, incivek
5458493|NCT01467466|renal|renal
5458494|NCT01467466|cardiovascular|cardiovascular
5458495|NCT01467466|kidney|kidney
5458496|NCT01467466|heart|heart
5458497|NCT01467466|clinical trial|clinical trial
5458498|NCT01467466|double-blind|double-blind
5458499|NCT01467466|multi-site trial|multi-site trial
5458500|NCT01467466|randomized|randomized
5458501|NCT01467466|drug treatment|drug treatment
5458502|NCT01467466|IV solutions|iv solutions
5458503|NCT01467466|antioxidant|antioxidant
5458504|NCT01467440|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
5458505|NCT01467388|patients with glaucoma or ocular hypertension|patients with glaucoma or ocular hypertension
5458506|NCT01467362|xerosis|xerosis
5458507|NCT01467362|dry skin|dry skin
5458508|NCT01467362|dermatitis|dermatitis
5458509|NCT01467362|pruritus|pruritus
5458510|NCT01467362|eczema|eczema
5458511|NCT01467362|emollient|emollient
5685305|NCT00556634|efavirenz|efavirenz
5458512|NCT01467362|corticosteroid|corticosteroid
5458513|NCT01467349|Raltegravir|raltegravir
5458514|NCT01467349|efficacy|efficacy
5458515|NCT01467349|safety|safety
5458516|NCT01467349|raltegravir-containing regimens|raltegravir-containing regimens
5458517|NCT01467349|HIV urban clinic setting|hiv urban clinic setting
5458518|NCT01467310|GSK1120212|gsk1120212
5458519|NCT01467310|TNBC|tnbc
5458520|NCT01467310|Triple Negative Breast Cancer|triple negative breast cancer
5458521|NCT01467310|Surgical Resection|surgical resection
5458522|NCT01467297|Chronic bronchitis|chronic bronchitis
5458523|NCT01467297|exacerbations|exacerbations
5458524|NCT01467297|treatment|treatment
5458525|NCT01467297|ceftidoren|ceftidoren
5458526|NCT01467297|levofloxacin|levofloxacin
5458527|NCT01467297|inflammation|inflammation
5458528|NCT01467284|Obesity|obesity
5458529|NCT01467284|Workplace|workplace
5458530|NCT01467284|Intervention|intervention
5458531|NCT01467284|Diet|diet
5458532|NCT01467284|Exercise|exercise
5458533|NCT01467245|Thoracoscopy|thoracoscopy
5458534|NCT01467245|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5458535|NCT01467245|oesophageal atresia|oesophageal atresia
5458536|NCT01467245|hypercapnia|hypercapnia
5458537|NCT01467245|acidosis|acidosis
5458538|NCT01467245|cerebral oxygenation|cerebral oxygenation
5458539|NCT01467245|neonates|neonates
5458540|NCT01467219|early|early
5458541|NCT01467219|high risk|high risk
5458542|NCT01467206|Stroke|stroke
5458543|NCT01467206|Physiotherapy|physiotherapy
5458544|NCT01467206|Motor training|motor training
5458545|NCT01467206|Rehabilitation|rehabilitation
5458546|NCT01467180|septeX|septex
5458547|NCT01467180|CVVH|cvvh
5458548|NCT01467180|CVHD|cvhd
5458549|NCT01467180|myoglobin|myoglobin
5458550|NCT01467167|Anesthesia|anesthesia
5458551|NCT01467167|Smart Pilot View|smart pilot view
5458552|NCT01467167|Pain control|pain control
5458553|NCT01467167|Recovery|recovery
5458554|NCT01467128|Elderly|elderly
5458555|NCT01467128|Hospital|hospital
5458556|NCT01467128|Adverse Drug|adverse drug
5458557|NCT01467128|Pharmacist|pharmacist
5458558|NCT01467128|Prevention|prevention
5458559|NCT01467115|loco regionally advanced|loco regionally advanced
5458560|NCT01467115|head and neck cancer|head and neck cancer
5458561|NCT01467115|chemotherapy|chemotherapy
5458562|NCT01467115|radiation|radiation
5458563|NCT01467102|chronic post surgical pain|chronic post surgical pain
5458564|NCT01467102|Pain|pain
5458565|NCT01467102|Risk factors of chronic post surgical pain|risk factors of chronic post surgical pain
5458566|NCT01467102|predictive risk factors|predictive risk factors
5458567|NCT01467102|chronic post-surgical pain (CPSP)|chronic post-surgical pain (cpsp)
5458568|NCT01467102|international level|international level
5458569|NCT01467102|epidemiology of CPSP|epidemiology of cpsp
5458570|NCT01467102|Europe|europe
5458571|NCT01467102|observational|observational
5458572|NCT01467102|prospective|prospective
5458573|NCT01467089|Schizophrenia|schizophrenia
5458574|NCT01467089|Extrapyramidal symptoms|extrapyramidal symptoms
5458575|NCT01467089|Tardive dyskinesia|tardive dyskinesia
5458576|NCT01467089|Two Way Video Assessment|two way video assessment
5458577|NCT01467063|Type I Diabetes|type i diabetes
5458578|NCT01467063|Insulin Resistance|insulin resistance
5458579|NCT01467063|Glutamine|glutamine
5458580|NCT01467063|Amino Acids|amino acids
5458581|NCT01467063|Glucagon like peptide 1|glucagon like peptide 1
5458582|NCT01467063|Glutathione|glutathione
5458583|NCT01467063|Citrulline|citrulline
5458584|NCT01467063|Arginine|arginine
5458585|NCT01467063|Nitric Oxide|nitric oxide
5458586|NCT01467050|Adverse drug event|adverse drug event
5458587|NCT01467050|Adverse drug reaction|adverse drug reaction
5458588|NCT01467050|Inappropriate prescribing|inappropriate prescribing
5458589|NCT01467050|Elderly|elderly
5458590|NCT01467050|Hospital-acquired|hospital-acquired
5458591|NCT01467037|Rotavirus|rotavirus
5458592|NCT01467037|Gastroenteritis|gastroenteritis
5458593|NCT01467037|Vaccination|vaccination
5458594|NCT01467037|Pediatrics|pediatrics
5458595|NCT01467024|HTLV|htlv
5458596|NCT01467024|Confirmatory|confirmatory
5458597|NCT01467024|Supplemental|supplemental
5458598|NCT01467024|Blot|blot
5458599|NCT01467024|HTLV-I|htlv-i
5458600|NCT01467024|HTLV-II|htlv-ii
5458601|NCT01467011|Myfortic|myfortic
5458602|NCT01467011|Mycophenolic acid|mycophenolic acid
5458603|NCT01467011|Prograf|prograf
5458604|NCT01467011|Tacrolimus|tacrolimus
5458605|NCT01467011|Liver transplantation|liver transplantation
5458606|NCT01466972|Advanced|advanced
5458607|NCT01466972|Breast|breast
5458608|NCT01466972|Cancer|cancer
5458609|NCT01466972|Hormone Resistance|hormone resistance
5458610|NCT01466972|Pazopanib|pazopanib
5458611|NCT01466972|anastrozole|anastrozole
5458612|NCT01466972|arimidex|arimidex
5458613|NCT01466972|letrozole|letrozole
5458614|NCT01466972|femara|femara
5458615|NCT01466959|hemodialysis|hemodialysis
5458616|NCT01466959|dialysate|dialysate
5458617|NCT01466959|acetate based dialysate|acetate based dialysate
5458618|NCT01466959|citrasate dialysate|citrasate dialysate
5458619|NCT01466959|heparin anticoagulation|heparin anticoagulation
5458620|NCT01466959|hemodynamic stability|hemodynamic stability
5458621|NCT01466946|lung cancer|lung cancer
5458622|NCT01466946|Hispanic/Latino patients|hispanic/latino patients
5458623|NCT01466946|interviews|interviews
5458624|NCT01466946|11-109|11-109
5458625|NCT01466933|parenting intervention|parenting intervention
5458626|NCT01466933|child development|child development
5458627|NCT01466933|low and middle income countries|low and middle income countries
5458628|NCT01466920|Total knee arthroplasty|total knee arthroplasty
5458629|NCT01466907|complication|complication
5458630|NCT01466907|depression|depression
5458631|NCT01466907|follow-up|follow-up
5458632|NCT01466907|intervention|intervention
5458633|NCT01466907|nurse-led|nurse-led
5458644|NCT01466868|objective response rate|objective response rate
5458645|NCT01466868|progression free survival|progression free survival
5458646|NCT01466868|overall survival|overall survival
5458647|NCT01466868|safety|safety
5458648|NCT01466855|Retinoblastoma|retinoblastoma
5458649|NCT01466829|sternotomy|sternotomy
5458650|NCT01466829|parathyroid hormone|parathyroid hormone
5458651|NCT01466829|bone healing|bone healing
5458652|NCT01466816|Lipid metabolism|lipid metabolism
5458653|NCT01466803|Buprenorphine|buprenorphine
5458654|NCT01466803|Vorikonazole|vorikonazole
5458655|NCT01466803|Interactions|interactions
5458656|NCT01466803|Pharmacokinetics|pharmacokinetics
5458657|NCT01466803|Pharmacodynamics|pharmacodynamics
5458658|NCT01466803|Voriconazole|voriconazole
5458659|NCT01466790|Hepatitis C|hepatitis c
5458660|NCT01466790|TMC435|tmc435
5458661|NCT01466790|PSI-7977|psi-7977
5458662|NCT01466790|GS7977|gs7977
5458663|NCT01466790|Ribavirin|ribavirin
5458665|NCT01466790|Hep C|hep c
5458666|NCT01466790|Genotype 1|genotype 1
5458667|NCT01466777|Endometrium cancer|endometrium cancer
5458668|NCT01466777|Robotic-assisted laparoscopy|robotic-assisted laparoscopy
5458669|NCT01466777|Traditional laparoscopy|traditional laparoscopy
5458670|NCT01466777|Laparoscopic surgery|laparoscopic surgery
5458671|NCT01466777|Treatment|treatment
5458672|NCT01466777|Operation time|operation time
5458673|NCT01466777|Bleeding|bleeding
5458674|NCT01466777|Complications|complications
5458675|NCT01466777|Conversions|conversions
5458676|NCT01466777|Pelvic lymph node|pelvic lymph node
5458677|NCT01466764|biomarkers|biomarkers
5458678|NCT01466751|Computerized neurobehavioral intervention|computerized neurobehavioral intervention
5458679|NCT01466738|Healthy volunteer|healthy volunteer
5458680|NCT01466738|Rhinovirus|rhinovirus
5458681|NCT01466738|Cold virus|cold virus
5458682|NCT01466738|HRV-16|hrv-16
5458683|NCT01466725|Lupus|lupus
5458684|NCT01466725|Discoid Lupus|discoid lupus
5458685|NCT01466725|DLE|dle
5458686|NCT01466725|Cutaneous Lupus|cutaneous lupus
5458687|NCT01466686|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5458688|NCT01466686|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
5458689|NCT01466686|Surgery|surgery
5458690|NCT01466686|Adjuvant Radiation|adjuvant radiation
5458691|NCT01466686|Adjuvant Temozolomide|adjuvant temozolomide
5458692|NCT01466673|Acne Vulgaris|acne vulgaris
5458693|NCT01466673|Ethinyl estradiol|ethinyl estradiol
5458694|NCT01466673|Norgestimate|norgestimate
5458695|NCT01466673|Desogestrel|desogestrel
5458696|NCT01466673|Tricilest|tricilest
5458697|NCT01466673|Oilezz|oilezz
5458698|NCT01466647|NSCLC|nsclc
5458699|NCT01466621|cardiac resynchronization therapy|cardiac resynchronization therapy
5458700|NCT01466621|heart failure|heart failure
5458701|NCT01466621|mortality|mortality
5458702|NCT01466608|OATP1B1|oatp1b1
5458704|NCT01466608|lipidomics|lipidomics
5458705|NCT01466608|pharmacodynamics|pharmacodynamics
5458706|NCT01466582|HIV-1-infection|hiv-1-infection
5458707|NCT01466582|comorbidity|comorbidity
5458708|NCT01466582|ageing|ageing
5458709|NCT01466569|Advanced Solid Tumor|advanced solid tumor
5458710|NCT01466569|Gastric Cancer|gastric cancer
5458711|NCT01466569|Oncology|oncology
5458712|NCT01466569|monoclonal Antibody|monoclonal antibody
5458713|NCT01466543|Vascular dementia|vascular dementia
5458714|NCT01466543|Subcortical vascular dementia|subcortical vascular dementia
5458715|NCT01466543|Phosphodiesterase 5|phosphodiesterase 5
5458716|NCT01466543|Udenafil|udenafil
5458717|NCT01466530|Full term pregnancy > 36 weeks|full term pregnancy > 36 weeks
5458718|NCT01466530|Cesarean delivery|cesarean delivery
5458719|NCT01466530|General anesthesia|general anesthesia
5458720|NCT01466517|Relative Bioavailability Study|relative bioavailability study
5458721|NCT01466517|Ibuprofen|ibuprofen
5458722|NCT01466517|Alivium|alivium
5458723|NCT01466504|P63|p63
5458724|NCT01466504|Sorafenib|sorafenib
5458725|NCT01466504|Regorafenib|regorafenib
5458726|NCT01466504|rash|rash
5458727|NCT01466504|skin toxicity|skin toxicity
5458728|NCT01466504|RCC|rcc
5458729|NCT01466504|HCC|hcc
5458730|NCT01466504|colorectal carcinoma|colorectal carcinoma
5458731|NCT01466491|Pain during first-trimester surgical abortion|pain during first-trimester surgical abortion
5458733|NCT01466465|SIT|sit
5458734|NCT01466465|Grass pollen|grass pollen
5458735|NCT01466465|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5458738|NCT01466439|inhibitory|inhibitory
5458739|NCT01466439|facilitatory|facilitatory
5458740|NCT01466439|physiological process|physiological process
5458741|NCT01466439|brain changes|brain changes
5458742|NCT01466426|Venous thromboembolic disease|venous thromboembolic disease
5458743|NCT01466426|Deep veinous thrombosis|deep veinous thrombosis
5458744|NCT01466426|Pulmonary embolism|pulmonary embolism
5458745|NCT01466413|Intrinsic Aging of Skin|intrinsic aging of skin
5458746|NCT01466400|health benefits of infant formula|health benefits of infant formula
5458747|NCT01466387|Adults|adults
5458748|NCT01466387|international travel vaccination|international travel vaccination
5458749|NCT01466387|Meningococcal disease|meningococcal disease
5458750|NCT01466387|meningococcal meningitis|meningococcal meningitis
5458751|NCT01466387|typhoid|typhoid
5458752|NCT01466387|yellow fever|yellow fever
5458753|NCT01466387|rabies|rabies
5458754|NCT01466387|Japanese encephalitis|japanese encephalitis
5458755|NCT01466309|AHI|ahi
5458756|NCT01466309|ESS|ess
5458757|NCT01466309|VAS|vas
5458758|NCT01466309|FOSQ|fosq
5458759|NCT01466309|SF-36|sf-36
5458760|NCT01466140|Patient Satisfaction|patient satisfaction
5458761|NCT01466140|Request for help|request for help
5458762|NCT01466140|General practice|general practice
5458763|NCT01466010|osteoma, osteoid|osteoma, osteoid
5458764|NCT01466010|surgical procedures, operative|surgical procedures, operative
5458765|NCT01466010|bone neoplasms|bone neoplasms
5458766|NCT01465932|Nursing staff|nursing staff
5458767|NCT01465932|Physical Therapy (Specialty)|physical therapy (specialty)
5458768|NCT01465737|epidemiology|epidemiology
5458769|NCT01465737|uterine cancer|uterine cancer
5458770|NCT01465737|Taiwan|taiwan
5458771|NCT01465646|levothyroxine|levothyroxine
5458772|NCT01465646|bioavailability|bioavailability
5458773|NCT01465633|bioavailability|bioavailability
5458774|NCT01465633|levothyroxine|levothyroxine
5458775|NCT01466361|Nicotine|nicotine
5458776|NCT01466361|Nicotine craving|nicotine craving
5458777|NCT01466348|Paracetomol|paracetomol
5458778|NCT01466348|Caffeine|caffeine
5458779|NCT01466348|Common cold|common cold
5458780|NCT01466322|Healthy volunteers|healthy volunteers
5458781|NCT01466322|GSK2018682|gsk2018682
5458782|NCT01466322|Pharmacokinetics|pharmacokinetics
5458783|NCT01466322|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5458784|NCT01466322|Pharmacodynamics|pharmacodynamics
5458785|NCT01466296|CERBRAL PALSY|cerbral palsy
5458786|NCT01466296|Poststroke/CVA Paresis|poststroke/cva paresis
5458787|NCT01466296|REHABILITATION|rehabilitation
5458788|NCT01466296|WALKING|walking
5458789|NCT01466296|PERUTURBATION|peruturbation
5458790|NCT01466283|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5458791|NCT01466270|fatigue|fatigue
5458792|NCT01466270|sleep disorders|sleep disorders
5458793|NCT01466270|depression|depression
5441292|NCT01539785|recurrence|recurrence
5458794|NCT01466270|anxiety disorder|anxiety disorder
5458795|NCT01466270|cognitive/functional effects|cognitive/functional effects
5458796|NCT01466270|breast cancer|breast cancer
5458797|NCT01466270|cancer survivor|cancer survivor
5458798|NCT01466257|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5458799|NCT01466257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5458800|NCT01466257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5458801|NCT01466257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5458802|NCT01466257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5458803|NCT01466257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5458804|NCT01466257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5458805|NCT01466257|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5458806|NCT01466257|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5458807|NCT01466257|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5458808|NCT01466257|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5458809|NCT01466257|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5458810|NCT01466257|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5458811|NCT01466257|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5458812|NCT01466257|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5458813|NCT01466257|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5458814|NCT01466257|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5685306|NCT00556634|central nervous system|central nervous system
5458815|NCT01466257|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5458816|NCT01466257|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5458817|NCT01466257|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5458985|NCT01465685|Mechanism of action of MDMA|mechanism of action of mdma
5458818|NCT01466257|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5458819|NCT01466257|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5458820|NCT01466257|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5458821|NCT01466257|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5458822|NCT01466257|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5458823|NCT01466257|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5458824|NCT01466244|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5458825|NCT01466244|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5458826|NCT01466244|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5458827|NCT01466244|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5458828|NCT01466244|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5458829|NCT01466244|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5458830|NCT01466244|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5458831|NCT01466244|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5458832|NCT01466244|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5458833|NCT01466244|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5458834|NCT01466244|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5458835|NCT01466244|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5846737|NCT00043628|Coronary Blood Flow|coronary blood flow
5458836|NCT01466244|stage IVA squamous cell carcinoma of the larynx|stage iva squamous cell carcinoma of the larynx
5458837|NCT01466244|stage IVA squamous cell carcinoma of the lip and oral cavity|stage iva squamous cell carcinoma of the lip and oral cavity
5458838|NCT01466244|stage IVA squamous cell carcinoma of the oropharynx|stage iva squamous cell carcinoma of the oropharynx
5458839|NCT01466244|stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iva squamous cell carcinoma of the paranasal sinus and nasal cavity
5458840|NCT01466244|stage IVB squamous cell carcinoma of the larynx|stage ivb squamous cell carcinoma of the larynx
5458841|NCT01466244|stage IVB squamous cell carcinoma of the lip and oral cavity|stage ivb squamous cell carcinoma of the lip and oral cavity
5458842|NCT01466244|stage IVB squamous cell carcinoma of the oropharynx|stage ivb squamous cell carcinoma of the oropharynx
5458843|NCT01466244|stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivb squamous cell carcinoma of the paranasal sinus and nasal cavity
5458844|NCT01466244|stage IVC squamous cell carcinoma of the larynx|stage ivc squamous cell carcinoma of the larynx
5458845|NCT01466244|stage IVC squamous cell carcinoma of the lip and oral cavity|stage ivc squamous cell carcinoma of the lip and oral cavity
5458846|NCT01466244|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5458847|NCT01466244|stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ivc squamous cell carcinoma of the paranasal sinus and nasal cavity
5458848|NCT01466244|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5458849|NCT01466231|refractory germ cell cancer|refractory germ cell cancer
5458850|NCT01466231|everolimus|everolimus
5458851|NCT01466218|pulmonary function abnormalities|pulmonary function abnormalities
5458852|NCT01466218|pulmonary disease|pulmonary disease
5458853|NCT01466218|cardiac disease|cardiac disease
5458854|NCT01466218|cardiopulmonary disease|cardiopulmonary disease
5458855|NCT01466218|obstructive sleep apnea|obstructive sleep apnea
5458857|NCT01466218|cardiovascular disease|cardiovascular disease
5458858|NCT01466218|CVD|cvd
5458859|NCT01466218|particulate matter|particulate matter
5458860|NCT01466205|schizotypal personality disorder|schizotypal personality disorder
5458861|NCT01466205|cognitive impairment|cognitive impairment
5458862|NCT01466205|working memory|working memory
5458863|NCT01466192|Genotype 2|genotype 2
5458864|NCT01466179|B-ALL|b-all
5458865|NCT01466179|relapsed ALL|relapsed all
5458866|NCT01466179|refractory ALL|refractory all
5458867|NCT01466179|adult ALL|adult all
5458868|NCT01466179|Leukemia|leukemia
5458869|NCT01466179|Leukemia, Lymphoid|leukemia, lymphoid
5458870|NCT01466179|precursor cell lymphoblastic leukemia-lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5458871|NCT01466179|Lymphatic diseases|lymphatic diseases
5458872|NCT01466179|Lymphoproliferative disorders|lymphoproliferative disorders
5458873|NCT01466179|bispecific antibody|bispecific antibody
5458874|NCT01466179|anti-CD19|anti-cd19
5458875|NCT01466179|Immunotherapeutic treatment|immunotherapeutic treatment
5458876|NCT01466179|immunoproliferative disorders|immunoproliferative disorders
5458877|NCT01466153|Chronic lymphocytic leukemia; leukemia; B-Cell malignancy; anti-CD19; monoclonal antibody; CLL; Refractory; Relapse; Non-Hodgkin's Lymphoma|chronic lymphocytic leukemia; leukemia; b-cell malignancy; anti-cd19; monoclonal antibody; cll; refractory; relapse; non-hodgkin's lymphoma
5458878|NCT01466127|Effect of oxytocin on learning|effect of oxytocin on learning
5458879|NCT01466114|multiple sclerosis|multiple sclerosis
5458881|NCT01466114|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5458882|NCT01466114|RRMS|rrms
5458883|NCT01466114|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5458884|NCT01466114|SPMS|spms
5458885|NCT01466114|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5458886|NCT01466114|estrogen|estrogen
5458887|NCT01466114|estriol|estriol
5458888|NCT01466101|Hysterectomy|hysterectomy
5458889|NCT01466101|Pain|pain
5458890|NCT01466101|Pregabalin|pregabalin
5458891|NCT01466088|Alzheimer's Disease|alzheimer's disease
5458893|NCT01466088|Dementia|dementia
5458894|NCT01466062|Immunocompromised medical conditions|immunocompromised medical conditions
5458895|NCT01466062|Respiratory Syncytial Virus Infection|respiratory syncytial virus infection
5458896|NCT01466062|Infant|infant
5458897|NCT01466062|Newborn|newborn
5458898|NCT01466062|Young children|young children
5458899|NCT01466049|Ovarian Cancer|ovarian cancer
5458900|NCT01466049|Adnexal Mass|adnexal mass
5458901|NCT01466049|Pelvic Mass|pelvic mass
5458902|NCT01466036|metastatic|metastatic
5458903|NCT01466023|thyroid metabolism during pregnancy|thyroid metabolism during pregnancy
5458904|NCT01466023|impact on neonate|impact on neonate
5458905|NCT01465997|Lacosamide|lacosamide
5458906|NCT01465984|Paracetamol|paracetamol
5458907|NCT01465984|Morphine sulfates|morphine sulfates
5458908|NCT01465984|Acute pain|acute pain
5458909|NCT01465971|high|high
5458910|NCT01465971|altitude|altitude
5458911|NCT01465971|acute|acute
5458912|NCT01465971|mountain|mountain
5458913|NCT01465971|sickness|sickness
5458914|NCT01465971|sleep|sleep
5458915|NCT01465971|disorder|disorder
5458916|NCT01465971|periodic|periodic
5458917|NCT01465971|breathing|breathing
5458918|NCT01465971|hyperventilation|hyperventilation
5458919|NCT01465971|apnea|apnea
5458920|NCT01465945|TEM for rectal lesions|tem for rectal lesions
5458921|NCT01465945|Sutured defect|sutured defect
5458922|NCT01465945|Unsutured defect|unsutured defect
5458923|NCT01465919|depression|depression
5458924|NCT01465919|interferon|interferon
5458925|NCT01465919|chronic hepatitis C|chronic hepatitis c
5458926|NCT01465919|mirtazapine|mirtazapine
5458927|NCT01465906|COPD|copd
5458928|NCT01465893|vitamin d|vitamin d
5458929|NCT01465880|Smoking research study|smoking research study
5458930|NCT01465867|Selenium|selenium
5458931|NCT01465867|Pregnancy|pregnancy
5458932|NCT01465867|Auto-immune thyroiditis|auto-immune thyroiditis
5441488|NCT01539083|VELCADE|velcade
5458933|NCT01465867|Post-partum thyroiditis|post-partum thyroiditis
5458934|NCT01465867|Miscarriage|miscarriage
5458935|NCT01465867|Pre-eclampsia|pre-eclampsia
5458936|NCT01465867|Implantation and Pregnancy rate|implantation and pregnancy rate
5458937|NCT01465867|Infertility|infertility
5458938|NCT01465854|lung cancer|lung cancer
5458939|NCT01465854|smoking|smoking
5458940|NCT01465854|molecular epidemiology|molecular epidemiology
5458941|NCT01465854|genetic polymorphism|genetic polymorphism
5458942|NCT01465854|risk factors|risk factors
5458943|NCT01465854|never smokers|never smokers
5458944|NCT01465854|histologically/cytologically confirmed|histologically/cytologically confirmed
5458945|NCT01465841|intracranial aneurysms|intracranial aneurysms
5458946|NCT01465841|Peripheral aneurysms|peripheral aneurysms
5458947|NCT01465841|acute treatment|acute treatment
5458948|NCT01465841|PC 400 System|pc 400 system
5458949|NCT01465841|packing density|packing density
5458950|NCT01465828|antiplatelet effect|antiplatelet effect
5458951|NCT01465828|prasugrel|prasugrel
5458952|NCT01465828|clopidogrel|clopidogrel
5458954|NCT01465802|non-small cell lung cancer|non-small cell lung cancer
5458955|NCT01465802|advanced|advanced
5458956|NCT01465802|previously treated|previously treated
5458957|NCT01465776|SCC of the oral cavity|scc of the oral cavity
5458958|NCT01465776|black raspberries|black raspberries
5458959|NCT01465763|tofacitinib|tofacitinib
5458960|NCT01465763|CP-690|cp-690
5458961|NCT01465763|550|550
5458962|NCT01465763|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5458963|NCT01465763|phase 3 clinical trial|phase 3 clinical trial
5458964|NCT01465763|Mayo score|mayo score
5458965|NCT01465724|Insulin resistance|insulin resistance
5458966|NCT01465724|Insulin sensitivity|insulin sensitivity
5458967|NCT01465724|HOMA-IR|homa-ir
5458968|NCT01465724|blood pressure|blood pressure
5458969|NCT01465724|Renal denervation|renal denervation
5458970|NCT01465724|renal sympathetic denervation|renal sympathetic denervation
5458971|NCT01465724|renal ablation|renal ablation
5605064|NCT00877968|Sensory|sensory
5458972|NCT01465711|Peritonitis|peritonitis
5458973|NCT01465711|Sepsis|sepsis
5458974|NCT01465711|General Surgery|general surgery
5458975|NCT01465711|Intensive Care Units|intensive care units
5458976|NCT01465711|Sensitivity and Specificity|sensitivity and specificity
5458977|NCT01465698|exercise|exercise
5458978|NCT01465698|counseling|counseling
5458979|NCT01465698|movement control|movement control
5458980|NCT01465698|fear avoidance|fear avoidance
5458981|NCT01465685|MDMA|mdma
5458982|NCT01465685|pharmacokinetics|pharmacokinetics
5458983|NCT01465685|pharmacodynamics|pharmacodynamics
5458984|NCT01465685|emotions|emotions
5458986|NCT01465685|Interaction study|interaction study
5458987|NCT01465685|Effect of MDMA and methylphenidate on emotions|effect of mdma and methylphenidate on emotions
5458988|NCT01465672|copeptin|copeptin
5458990|NCT01465672|Diabetes insipidus|diabetes insipidus
5458991|NCT01465672|transphenoidal pituitary adenoma resection|transphenoidal pituitary adenoma resection
5458992|NCT01465672|pituitary adenoma|pituitary adenoma
5458993|NCT01465672|tumors close to pituitary gland|tumors close to pituitary gland
5458994|NCT01465672|tumors close to hypothalamus|tumors close to hypothalamus
5458995|NCT01465620|Peripheral Nervous System Diseases|peripheral nervous system diseases
5458996|NCT01465620|Diabetic Polyneuropathy|diabetic polyneuropathy
5458997|NCT01465620|Metabolic Syndrome X|metabolic syndrome x
5458998|NCT01465607|Condom use|condom use
5458999|NCT01465594|Pain Measurement|pain measurement
5459000|NCT01465581|incontinence|incontinence
5459001|NCT01465581|dysfunctional voiding|dysfunctional voiding
5459002|NCT01465581|neurogenic bladder disturbance|neurogenic bladder disturbance
5459003|NCT01465581|filum terminale|filum terminale
5459004|NCT01465581|spinal cord tethering|spinal cord tethering
5459005|NCT01465581|conus|conus
5459006|NCT01465568|osteoporosis|osteoporosis
5459007|NCT01465568|denosumab|denosumab
5459008|NCT01465568|RANKL|rankl
5459009|NCT01465568|glucocorticoids|glucocorticoids
5459010|NCT01465555|Clinical Alert|clinical alert
5459011|NCT01465555|Cognitive Behavioral Intervention|cognitive behavioral intervention
5459012|NCT01465555|Web-based|web-based
5459013|NCT01465555|Substance Abuse Treatment|substance abuse treatment
5459014|NCT01465542|Acetaminophen Toxicity|acetaminophen toxicity
5459015|NCT01465542|Acetaminophen Overdose|acetaminophen overdose
5459016|NCT01465542|N-acetylcysteine|n-acetylcysteine
5459017|NCT01465542|Liver Toxicity|liver toxicity
5459018|NCT01465503|bleeding|bleeding
5459019|NCT01465503|percutaneous coronary intervention|percutaneous coronary intervention
5459020|NCT01465503|heparin|heparin
5459021|NCT01465503|bivalirudin|bivalirudin
5459022|NCT01465490|Monitoring|monitoring
5459024|NCT01465490|Substance Abuse Treatment|substance abuse treatment
5459025|NCT01465477|Fibromyalgia|fibromyalgia
5459026|NCT01465477|Influenza vaccination|influenza vaccination
5459027|NCT01465451|colorectal cancer|colorectal cancer
5459028|NCT01465451|curative resection|curative resection
5459029|NCT01465451|intra-operative chemotherapy|intra-operative chemotherapy
5459030|NCT01465451|5-fluorouracil|5-fluorouracil
5459031|NCT01465451|chemotherapy|chemotherapy
5459032|NCT01465425|extracolonic findings|extracolonic findings
5459033|NCT01465425|ECFs|ecfs
5459034|NCT01465425|CT colonography|ct colonography
5459035|NCT01465425|computed tomography colonography|computed tomography colonography
5459036|NCT01465425|National CT Colonography Trial|national ct colonography trial
5459037|NCT01465425|ACRIN 6664|acrin 6664
5459038|NCT01465412|Parkinson disease|parkinson disease
5459039|NCT01465373|In-Vitro Fertilization|in-vitro fertilization
5459040|NCT01465373|Donor Egg IVF|donor egg ivf
5459041|NCT01465360|Alzheimer's disease|alzheimer's disease
5459043|NCT01465360|Non AD dementia|non ad dementia
5459044|NCT01465360|Mild Cognitive Impairment|mild cognitive impairment
5459046|NCT01465360|Vascular dementia|vascular dementia
5459047|NCT01465360|Fronto-temporal dementia|fronto-temporal dementia
5459048|NCT01465360|Primary progressive aphasia|primary progressive aphasia
5459049|NCT01465360|Parkinson's Disease dementia|parkinson's disease dementia
5459050|NCT01465360|Mixed dementia|mixed dementia
5459051|NCT01465360|Blood signature|blood signature
5459053|NCT01465360|AclarusDx|aclarusdx
5459054|NCT01465360|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
5459055|NCT01465360|Exonhit|exonhit
5459056|NCT01465347|Primary brain tumor|primary brain tumor
5459057|NCT01465347|Glioblastoma|glioblastoma
5459058|NCT01465347|Glioma|glioma
5459059|NCT01465347|GBM|gbm
5459060|NCT01465347|Radiation therapy|radiation therapy
5459061|NCT01465334|17p Deletion CLL|17p deletion cll
5459062|NCT01465308|head and neck cancer|head and neck cancer
5459063|NCT01465308|radiotherapy induced xerostomia|radiotherapy induced xerostomia
5459064|NCT01465308|radiotherapy induced oral mucositis|radiotherapy induced oral mucositis
5459065|NCT01465308|RCT|rct
5459066|NCT01465308|symptom management|symptom management
5459067|NCT01465295|Scoliosis|scoliosis
5903980|NCT00086567|Testing|testing
5459068|NCT01465295|Adolescent Idiopathic Scoliosis (AIS)|adolescent idiopathic scoliosis (ais)
5459069|NCT01465295|Scoliosis treatment|scoliosis treatment
5459070|NCT01465295|Fusionless spinal surgery|fusionless spinal surgery
5459071|NCT01465295|Vertebral stapling|vertebral stapling
5459072|NCT01465295|Spinal stapling|spinal stapling
5459073|NCT01465295|Non-fusion|non-fusion
5459074|NCT01465295|Spinal curvature|spinal curvature
5459075|NCT01465295|Curvature of the spine|curvature of the spine
5459076|NCT01465295|Spinal bracing alternative|spinal bracing alternative
5459077|NCT01465295|HemiBridge|hemibridge
5459078|NCT01465295|SpineForm|spineform
5459079|NCT01465295|Dr. Eric Wall|dr. eric wall
5459080|NCT01465295|Dr. George Thompson|dr. george thompson
5459081|NCT01465295|Spinal clip|spinal clip
5459082|NCT01465295|Cincinnati Children's Hospital Medical Center|cincinnati children's hospital medical center
5459083|NCT01465295|University Hospitals Case Medical Center, Rainbow Babies|university hospitals case medical center, rainbow babies
5459084|NCT01465282|psoriasis vulgaris|psoriasis vulgaris
5459085|NCT01465282|topical ointment|topical ointment
5459087|NCT01465269|Social Competence|social competence
5459088|NCT01465256|Aspirin|aspirin
5459089|NCT01465256|Colon polypectomy|colon polypectomy
5459090|NCT01465256|Bleeding|bleeding
5459091|NCT01465243|Efficacy|efficacy
5459092|NCT01465243|Safety|safety
5459093|NCT01465243|EGFR-TKI|egfr-tki
5459094|NCT01465243|phase IV|phase iv
5459095|NCT01465243|NSCLC|nsclc
5459096|NCT01465243|Dose escalation|dose escalation
5459097|NCT01465230|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5459098|NCT01465230|maintenance therapy|maintenance therapy
5459099|NCT01465217|medication adherence|medication adherence
5459100|NCT01465217|African Americans|african americans
5459101|NCT01465204|Behavior Change|behavior change
5459102|NCT01465204|Hygiene & Sanitation Marketing|hygiene & sanitation marketing
5459103|NCT01465191|cesarean|cesarean
5459104|NCT01465191|postoperative|postoperative
5459105|NCT01465191|morphine|morphine
5459106|NCT01465191|genetics|genetics
5459107|NCT01465191|opioid|opioid
5459108|NCT01465178|hypovitaminosis D|hypovitaminosis d
5459109|NCT01465178|vitamin D insufficiency|vitamin d insufficiency
5459110|NCT01465178|low vitamin D|low vitamin d
5459111|NCT01465165|Depression|depression
5459112|NCT01465165|Positron emission tomography|positron emission tomography
5459113|NCT01465165|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5459114|NCT01465165|glucose metabolism|glucose metabolism
5459115|NCT01465165|ATP|atp
5459116|NCT01465165|phosphocreatine|phosphocreatine
5459117|NCT01465113|Barrett's Esophagus|barrett's esophagus
5459118|NCT01465113|Vitamin D3|vitamin d3
5459119|NCT01465113|cholecalciferol|cholecalciferol
5462286|NCT01451788|Surgery|surgery
5459120|NCT01465113|15-Prostaglandin Dehydrogenase Expression|15-prostaglandin dehydrogenase expression
5459121|NCT01465113|metformin|metformin
5459122|NCT01465100|phenylketonuria|phenylketonuria
5459123|NCT01465100|hepatocyte|hepatocyte
5459124|NCT01465087|Multiple Sclerosis|multiple sclerosis
5459125|NCT01465087|Breath|breath
5459126|NCT01465087|Diagnosis|diagnosis
5459127|NCT01465087|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
5459128|NCT01465087|Discrimination MS/other neurological and autoimmune diseases|discrimination ms/other neurological and autoimmune diseases
5459129|NCT01465074|nicotine|nicotine
5459130|NCT01465074|memory|memory
5459131|NCT01465074|plasticity|plasticity
5459132|NCT01465074|TMS|tms
5459133|NCT01465074|Paired Associative Stimulation|paired associative stimulation
5459134|NCT01465061|Online social network|online social network
5459135|NCT01465061|Psoriasis|psoriasis
5459136|NCT01465061|Filipino|filipino
5459137|NCT01465048|Malaria|malaria
5459138|NCT01465048|Protozoan Infections|protozoan infections
5459139|NCT01465048|Parasitic Diseases|parasitic diseases
5459140|NCT01465048|Malaria Challenge|malaria challenge
5459141|NCT01465022|Breastfeeding rates|breastfeeding rates
5459142|NCT01465022|Contraceptive continuation|contraceptive continuation
5459143|NCT01465022|Birth control pills|birth control pills
5459144|NCT01465022|Lactation|lactation
5459145|NCT01465009|Sore Throat|sore throat
5459146|NCT01464996|non-carious cervical lesions|non-carious cervical lesions
5459147|NCT01464996|bonded restorations|bonded restorations
5459148|NCT01464996|composites|composites
5459149|NCT01464996|adhesives|adhesives
5459150|NCT01464970|DIEP perfusion|diep perfusion
5459151|NCT01464970|Zone IV|zone iv
5459152|NCT01464970|Free Flap|free flap
5459153|NCT01464970|Breast Cancer Reconstruction|breast cancer reconstruction
5459154|NCT01464970|Perfusion of Zone IV of DIEP flaps|perfusion of zone iv of diep flaps
5459155|NCT01464957|skin cancer prevention|skin cancer prevention
5459156|NCT01464957|precaution adoption process model|precaution adoption process model
5459157|NCT01464957|semi-tailored newsletter|semi-tailored newsletter
5459158|NCT01464957|pediatric|pediatric
5459159|NCT01464957|behavioral intervention|behavioral intervention
5459160|NCT01464944|Upper Respiratory Tract Infections|upper respiratory tract infections
5459161|NCT01464918|gastric cancer|gastric cancer
5459162|NCT01464918|colon cancer|colon cancer
5459163|NCT01464918|endoscopic submucosal dissection|endoscopic submucosal dissection
5459164|NCT01464905|RRMS|rrms
5459165|NCT01464892|Imagery rescripting|imagery rescripting
5459166|NCT01464892|Imagery rescripting and reprocessing therapy|imagery rescripting and reprocessing therapy
5459167|NCT01464892|Skills Training in affective and interpersonal regulation|skills training in affective and interpersonal regulation
5459168|NCT01464892|Post-traumatic Stress Disorder|post-traumatic stress disorder
5459169|NCT01464892|Childhood abuse|childhood abuse
5459170|NCT01464892|Childhood sexual abuse|childhood sexual abuse
5459172|NCT01464840|Cesarean section|cesarean section
5459173|NCT01464840|Antibiotic|antibiotic
5459175|NCT01464827|Hepatitis C|hepatitis c
5459176|NCT01464827|Interferon-Free|interferon-free
5459177|NCT01464827|HCV|hcv
5459178|NCT01464827|Chronic Hepatitis C|chronic hepatitis c
5459179|NCT01464814|probiotic|probiotic
5459180|NCT01464814|fish oil|fish oil
5459181|NCT01464814|digestion|digestion
5459182|NCT01464814|viability|viability
5459183|NCT01464801|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5459184|NCT01464801|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5459185|NCT01464801|Resveratrol|resveratrol
5459186|NCT01464801|Human study|human study
5459187|NCT01464788|stroke|stroke
5459188|NCT01464788|Argatroban|argatroban
5459189|NCT01464788|thrombin-inhibition|thrombin-inhibition
5459190|NCT01464788|thrombolysis|thrombolysis
5459191|NCT01464788|anticoagulation|anticoagulation
5459192|NCT01464775|Endometriosis|endometriosis
5459193|NCT01464775|Laparoscopy|laparoscopy
5459194|NCT01464775|Narrow Band Imaging|narrow band imaging
5459195|NCT01464762|Tuberculosis|tuberculosis
5459196|NCT01464762|TMC207TBC3001|tmc207tbc3001
5459197|NCT01464762|TMC207|tmc207
5459198|NCT01464762|Early access|early access
5459199|NCT01464762|TB|tb
5459200|NCT01464762|Drug resistant|drug resistant
5459201|NCT01464762|Multi drug-resistant|multi drug-resistant
5459202|NCT01464762|Extensively drug-resistant|extensively drug-resistant
5459203|NCT01464749|multiple sclerosis|multiple sclerosis
5459204|NCT01464749|gait rehabilitation|gait rehabilitation
5459205|NCT01464736|aerobic exercise|aerobic exercise
5459206|NCT01464736|noninvasive ventilation|noninvasive ventilation
5459207|NCT01464736|functionality|functionality
5459208|NCT01464697|hot flushes/hot flashes|hot flushes/hot flashes
5459209|NCT01464697|night sweats|night sweats
5459210|NCT01464697|sleep problems|sleep problems
5459211|NCT01464697|negative mood|negative mood
5459212|NCT01464697|anxiety|anxiety
5459213|NCT01464697|perimenopause|perimenopause
5459214|NCT01464697|progesterone|progesterone
5459215|NCT01464697|vasomotor symptoms|vasomotor symptoms
5459216|NCT01464697|depression|depression
5459217|NCT01464697|women's perceived change|women's perceived change
5459218|NCT01464697|perimenopause interference questionnaire|perimenopause interference questionnaire
5459219|NCT01464671|Coronary Artery Disease|coronary artery disease
5459220|NCT01464671|Stable Angina|stable angina
5459221|NCT01464671|Percutaneous Coronary Intervention|percutaneous coronary intervention
5459222|NCT01464658|panniculitis|panniculitis
5459223|NCT01464658|panniculectomy|panniculectomy
5459224|NCT01464632|medial knee replacement|medial knee replacement
5459225|NCT01464619|Parenting|parenting
5459226|NCT01464619|Early Child Development|early child development
5459227|NCT01464606|pleuropulmonary blastoma|pleuropulmonary blastoma
5459228|NCT01464606|pediatric|pediatric
5459229|NCT01464606|lung cysts|lung cysts
5459230|NCT01464593|Colorectal Liver Metastasis|colorectal liver metastasis
5459231|NCT01464593|Colon Cancer|colon cancer
5459232|NCT01464593|Liver Cancer|liver cancer
5459233|NCT01464593|Liver Metastasis|liver metastasis
5459234|NCT01464593|Liver metastases|liver metastases
5459235|NCT01464567|Weaning|weaning
5459236|NCT01464567|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5459237|NCT01464567|Spontaneous Breathing Trial|spontaneous breathing trial
5459238|NCT01464554|adolescents|adolescents
5459239|NCT01464554|alcohol|alcohol
5459240|NCT01464554|drugs|drugs
5459241|NCT01464554|delinquency|delinquency
5459242|NCT01464554|intervention|intervention
5459243|NCT01464541|Orbit|orbit
5459244|NCT01464541|Fracture|fracture
5459245|NCT01464541|measurement|measurement
5459246|NCT01464541|CT|ct
5459247|NCT01464541|intraoperative|intraoperative
5459248|NCT01464528|hysteroscopy|hysteroscopy
5459249|NCT01464528|postoperative complications|postoperative complications
5459250|NCT01464528|adhesions|adhesions
5459251|NCT01464528|hyaluronic gel|hyaluronic gel
5459252|NCT01464528|prevention|prevention
5459253|NCT01464515|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
5459254|NCT01464515|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5459255|NCT01464502|Heart failure|heart failure
5459256|NCT01464502|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5459257|NCT01464502|Acute haemodynamic response|acute haemodynamic response
5459258|NCT01464502|Responder|responder
5459259|NCT01464489|Intubation time|intubation time
5459260|NCT01464489|Atropine|atropine
5459261|NCT01464489|Propofol anesthesia|propofol anesthesia
5459262|NCT01464463|Depression|depression
5459263|NCT01464463|Exercise|exercise
5459264|NCT01464463|Psychoneuroimmunology|psychoneuroimmunology
5459265|NCT01464463|Cognitive Behavioral Therapy|cognitive behavioral therapy
5459266|NCT01464463|CBASP|cbasp
5446054|NCT01519206|Ulthera® System|ulthera® system
5459267|NCT01464450|Pharmacokinetics|pharmacokinetics
5459268|NCT01464450|Bioavailability|bioavailability
5459269|NCT01464450|Healthy Participants|healthy participants
5459270|NCT01464437|diabetes|diabetes
5459271|NCT01464437|mellitus|mellitus
5459272|NCT01464437|metformin|metformin
5459273|NCT01464424|Glaucoma|glaucoma
5459274|NCT01464424|Ocular Hypertension|ocular hypertension
5459275|NCT01464424|Open-Angle Glaucoma|open-angle glaucoma
5459276|NCT01464424|Intraocular Pressure|intraocular pressure
5459277|NCT01464411|chronic myelogenous leukemia|chronic myelogenous leukemia
5459278|NCT01464411|chronic phase|chronic phase
5459297|NCT01464320|Type 2 diabetes|type 2 diabetes
5459298|NCT01464320|Kidney disease|kidney disease
5459299|NCT01464294|CAD/CAM|cad/cam
5459300|NCT01464294|crowns|crowns
5459301|NCT01464294|onlays|onlays
5459302|NCT01464294|composite block|composite block
5459303|NCT01464294|milled restorations|milled restorations
5459304|NCT01464281|nucleoside|nucleoside
5459305|NCT01464281|peginterferon alfa-2a|peginterferon alfa-2a
5459306|NCT01464268|Keratoconus|keratoconus
5459307|NCT01464268|Corneal Ectasia|corneal ectasia
5459308|NCT01464268|Collagen Crosslinking|collagen crosslinking
5459309|NCT01464268|Riboflavin|riboflavin
5459310|NCT01464255|contact lenses|contact lenses
5459311|NCT01464242|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5459312|NCT01464242|pentoxifylline|pentoxifylline
5459313|NCT01464242|immunomodulation|immunomodulation
5459314|NCT01464216|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5459315|NCT01464216|Prostate cancer|prostate cancer
5459316|NCT01464216|FACBC PET|facbc pet
5459317|NCT01464216|Hypoxia imaging|hypoxia imaging
5459318|NCT01464203|Computed tomographic coronary angiography|computed tomographic coronary angiography
5459319|NCT01464203|multi-slice CT|multi-slice ct
5459320|NCT01464203|angina|angina
5459321|NCT01464203|cost-effectiveness|cost-effectiveness
5459322|NCT01464190|PA21|pa21
5459323|NCT01464190|Phosphate Binder|phosphate binder
5459324|NCT01464177|malignant glioma|malignant glioma
5459325|NCT01464177|glioblastoma|glioblastoma
5459326|NCT01464177|radiotherapy|radiotherapy
5459327|NCT01464177|randomized|randomized
5459343|NCT01464151|IBD|ibd
5459344|NCT01464151|colitis|colitis
5459345|NCT01464151|dysplasia|dysplasia
5459346|NCT01464151|colorectal cancer|colorectal cancer
5459347|NCT01464138|Malaria|malaria
5459348|NCT01464125|Malaria|malaria
5459349|NCT01464125|Plasmodium falciparum|plasmodium falciparum
5459350|NCT01464125|acute uncomplicated|acute uncomplicated
5798677|NCT00111397|Mycobacterium Avium Complex Infection|mycobacterium avium complex infection
5798678|NCT00111397|MAC|mac
5459351|NCT01464112|Multiple myeloma that has relapsed or is progressive following prior therapy|multiple myeloma that has relapsed or is progressive following prior therapy
5459352|NCT01464112|Relapsed Multiple Myeloma|relapsed multiple myeloma
5459353|NCT01464112|JNJ 26481585|jnj 26481585
5459354|NCT01464112|VELCADE|velcade
5459355|NCT01464112|Bortezomib|bortezomib
5459356|NCT01464112|Dexamethasone|dexamethasone
5459357|NCT01464086|patients with Li Fraumeni syndrome|patients with li fraumeni syndrome
5459358|NCT01464073|NIDDM|niddm
5459359|NCT01464073|obesity|obesity
5459360|NCT01464073|lifestyle intervention|lifestyle intervention
5459361|NCT01464073|physical exercise|physical exercise
5459362|NCT01464073|diet|diet
5459363|NCT01464073|LIPOXmax|lipoxmax
5459364|NCT01464073|FATmax|fatmax
5459365|NCT01464073|fat oxydation rate|fat oxydation rate
5459366|NCT01464060|Helicobacter pylori|helicobacter pylori
5459367|NCT01464060|Quadruple therapy|quadruple therapy
5459368|NCT01464060|Clarithromycin resistance|clarithromycin resistance
5459369|NCT01464021|Study|study
5459370|NCT01464021|prospective|prospective
5459371|NCT01464021|Rheumatoid|rheumatoid
5459372|NCT01464021|Observational study|observational study
5459373|NCT01464021|Arthritis|arthritis
5459374|NCT01464021|Adalimumab|adalimumab
5459375|NCT01463995|severe neurological diseases|severe neurological diseases
5459376|NCT01463995|neurological intensive care unit|neurological intensive care unit
5459377|NCT01463995|prediction|prediction
5459378|NCT01463995|long-term outcome|long-term outcome
5459379|NCT01463995|biomarkers|biomarkers
5459380|NCT01463995|prediction of long-term outcome|prediction of long-term outcome
5459381|NCT01463982|Advanced solid cancer|advanced solid cancer
5459382|NCT01463969|PCOS and PTX3 levels|pcos and ptx3 levels
5459383|NCT01463956|Boceprevir|boceprevir
5459384|NCT01463956|HCV infection|hcv infection
5459385|NCT01463956|Antiviral therapy|antiviral therapy
5459386|NCT01463956|Liver transplantation|liver transplantation
5459387|NCT01463930|Total Knee Replacement|total knee replacement
5459388|NCT01463930|Expectations|expectations
5459389|NCT01463930|Audiovisual videodisc|audiovisual videodisc
5459390|NCT01463917|Coronary Artery Bypass|coronary artery bypass
5459391|NCT01463917|Off-Pump|off-pump
5459392|NCT01463917|Saline Solution|saline solution
5459393|NCT01463917|Hypertonic|hypertonic
5459394|NCT01463904|Morbid obesity|morbid obesity
5459395|NCT01463904|duodenal switch|duodenal switch
5459396|NCT01463904|diabetes|diabetes
5459397|NCT01463904|decrease in cardiac risk|decrease in cardiac risk
5459398|NCT01463904|remission of T2DM|remission of t2dm
5459399|NCT01463891|Eribulin Mesylate|eribulin mesylate
5459400|NCT01463891|inoperable or recurrent breast cancer|inoperable or recurrent breast cancer
5459401|NCT01463878|glycemic control|glycemic control
5459402|NCT01463878|glycemic variability|glycemic variability
5459403|NCT01463878|mean blood glucose level|mean blood glucose level
5459404|NCT01463852|vincristine|vincristine
5459406|NCT01463852|phosphorylation|phosphorylation
5459407|NCT01463852|cll|cll
5459408|NCT01463852|vinca alkaloid|vinca alkaloid
5459409|NCT01463852|apoptosis|apoptosis
5459410|NCT01463839|sleep disorder|sleep disorder
5459411|NCT01463839|malocclusion|malocclusion
5459412|NCT01463839|children|children
5459413|NCT01463826|bruxism|bruxism
5459414|NCT01463826|children|children
5459415|NCT01463826|oral breathing|oral breathing
5459416|NCT01463826|dental caries|dental caries
5459417|NCT01463813|bone density conservation agents|bone density conservation agents
5459418|NCT01463813|cancer|cancer
5459419|NCT01463813|cardiovascular disease|cardiovascular disease
5459420|NCT01463813|cholecalciferol|cholecalciferol
5459421|NCT01463813|diabetes mellitus, type 2|diabetes mellitus, type 2
5459422|NCT01463813|dietary supplements|dietary supplements
5459423|NCT01463813|primary prevention|primary prevention
5459424|NCT01463813|vitamin D|vitamin d
5459425|NCT01463800|Heart Defects, congenital|heart defects, congenital
5459426|NCT01463787|Infertility|infertility
5459427|NCT01463787|varicocelectomy|varicocelectomy
5459428|NCT01463787|microsurgery|microsurgery
5459429|NCT01463787|Chinese men|chinese men
5459430|NCT01463787|pregnancy rate|pregnancy rate
5459431|NCT01463774|Healthy Volunteers|healthy volunteers
5459432|NCT01463774|Bioequivalence|bioequivalence
5459433|NCT01463774|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5459434|NCT01463774|Metformin|metformin
5459435|NCT01463761|High-level athlete|high-level athlete
5459436|NCT01463761|ANS activity|ans activity
5459437|NCT01463761|Overtraining|overtraining
5459438|NCT01463735|Cirrhotic patients|cirrhotic patients
5459439|NCT01463722|Respiratory distress syndrome|respiratory distress syndrome
5459440|NCT01463722|Lung maturity|lung maturity
5459441|NCT01463722|lamellar body|lamellar body
5459442|NCT01463709|basal cell carcinoma|basal cell carcinoma
5459443|NCT01463709|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5459444|NCT01463709|Electric Field|electric field
5459445|NCT01463709|Nanosecond pulse|nanosecond pulse
5459446|NCT01463670|LENALIDOMIDE (CC-5013)|lenalidomide (cc-5013)
5459447|NCT01463670|BONE MARROW|bone marrow
5459448|NCT01463670|11-107|11-107
5459449|NCT01463657|Aging|aging
5459450|NCT01463644|Mepolizumab|mepolizumab
5459452|NCT01463644|eosinophilic bronchitis|eosinophilic bronchitis
5459453|NCT01463644|exacerbation|exacerbation
5459454|NCT01463644|anti-interleukin 5 (IL5)|anti-interleukin 5 (il5)
5459455|NCT01463605|radiotherapy|radiotherapy
5459456|NCT01463605|targeted therapy|targeted therapy
5459457|NCT01463605|esophageal cancer|esophageal cancer
5459459|NCT01463592|Renessans|renessans
5459460|NCT01463592|HCV|hcv
5459461|NCT01463579|Intensive Care Unit|intensive care unit
5459462|NCT01463579|Critical Illness|critical illness
5459463|NCT01463579|Rehabilitation|rehabilitation
5459464|NCT01463579|Exercise Programme|exercise programme
5459465|NCT01463566|arthritis|arthritis
5459466|NCT01463553|primary spontaneous pneumothorax|primary spontaneous pneumothorax
5459467|NCT01463553|VATS|vats
5459468|NCT01463553|pleurodesis|pleurodesis
5459470|NCT01463540|Enteral nutrition|enteral nutrition
5459471|NCT01463540|Gastrostomy, adverse effects|gastrostomy, adverse effects
5459472|NCT01463540|Gastrostomy, nursing|gastrostomy, nursing
5459473|NCT01463540|Endoscopy,gastrointestinal|endoscopy,gastrointestinal
5459474|NCT01463540|Surgical wound infection|surgical wound infection
5459475|NCT01463527|Hypoventilation during sedation|hypoventilation during sedation
5459476|NCT01463527|Hypoxia associated with hypoventilation|hypoxia associated with hypoventilation
5459477|NCT01463514|Pulmonary Hypertension,|pulmonary hypertension,
5459478|NCT01463514|NIRS,|nirs,
5459479|NCT01463514|Near-infrared spectroscopy,|near-infrared spectroscopy,
5459488|NCT01463475|Bone marrow cells|bone marrow cells
5459489|NCT01463475|Healthy subject donors|healthy subject donors
5459490|NCT01463475|Collection of MSC from bone marrow aspirate|collection of msc from bone marrow aspirate
5459491|NCT01463475|Bronchiolitis obliterans syndrome (BOS)|bronchiolitis obliterans syndrome (bos)
5459492|NCT01463449|Obesity|obesity
5459493|NCT01463449|Soluble-CD163|soluble-cd163
5459494|NCT01463449|Macrophage|macrophage
5459495|NCT01463449|Inflammation|inflammation
5459496|NCT01463436|endothelial function|endothelial function
5459497|NCT01463436|postmenopausal|postmenopausal
5459498|NCT01463436|soy isoflavone supplementation|soy isoflavone supplementation
5459499|NCT01463436|osteoporosis|osteoporosis
5459500|NCT01463384|Magnetic Resonance Imaging|magnetic resonance imaging
5459501|NCT01463384|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5459502|NCT01463384|Neuroinflammation|neuroinflammation
5459503|NCT01463384|Mild Cognitive Impairment|mild cognitive impairment
5459504|NCT01463384|Alzheimer's Disease|alzheimer's disease
5459505|NCT01463384|Minocycline|minocycline
5459506|NCT01463371|Bronchiectasis|bronchiectasis
5459507|NCT01463371|Oxidative stress markers|oxidative stress markers
5459508|NCT01463371|Airway inflammation|airway inflammation
5459509|NCT01463358|Syncope|syncope
5459510|NCT01463358|Bifascicular block|bifascicular block
5459511|NCT01463358|Bradycardia pacing|bradycardia pacing
5459512|NCT01463345|Blood conservation|blood conservation
5459513|NCT01463345|Transfusion|transfusion
5459514|NCT01463345|Hemoglobin trigger|hemoglobin trigger
5459515|NCT01463345|Transfusion trigger|transfusion trigger
5459516|NCT01463345|Cardiac surgery|cardiac surgery
5459517|NCT01463345|Transfusion triggers post cardiac surgery|transfusion triggers post cardiac surgery
5459518|NCT01463332|Propofol|propofol
5459519|NCT01463332|Pain|pain
5459520|NCT01463332|Dexmedetomidine|dexmedetomidine
5459521|NCT01463319|colonoscopy|colonoscopy
5459522|NCT01463319|warm water method|warm water method
5459523|NCT01463319|hydrocolonoscopy|hydrocolonoscopy
5459524|NCT01463319|unsedated colonoscopy|unsedated colonoscopy
5459533|NCT01463293|constipation|constipation
5459534|NCT01463293|probiotic|probiotic
5459535|NCT01463293|functional constipation|functional constipation
5459536|NCT01463293|IBS-C|ibs-c
5459537|NCT01463280|Platelets|platelets
5459538|NCT01463280|Inhibition|inhibition
5459539|NCT01463280|Lidocaine|lidocaine
5459540|NCT01463280|Thromboembolism|thromboembolism
5459541|NCT01463280|Prevention|prevention
5459542|NCT01463280|Lidocaine effects on platelets|lidocaine effects on platelets
5459543|NCT01463267|Heart Failure|heart failure
5459544|NCT01463254|Femplant|femplant
5459545|NCT01463254|AE adverse event|ae adverse event
5459546|NCT01463254|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5459547|NCT01463254|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5459548|NCT01463254|ART antiretroviral therapy|art antiretroviral therapy
5459549|NCT01463254|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5459550|NCT01463254|DCF data collection forms|dcf data collection forms
5459551|NCT01463254|DMC Data Monitoring Committee|dmc data monitoring committee
5459552|NCT01463254|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5459553|NCT01463254|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5459554|NCT01463254|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5459555|NCT01463254|ICH International Conference of Harmonisation|ich international conference of harmonisation
5459556|NCT01463254|IND Investigational New Drug Application|ind investigational new drug application
5798686|NCT00111371|artificial grammar learning|artificial grammar learning
5459557|NCT01463254|IRB Institutional Review Board|irb institutional review board
5459558|NCT01463254|IU international units|iu international units
5459559|NCT01463254|mg milligram(s)|mg milligram(s)
5459560|NCT01463254|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5459561|NCT01463254|PCR polymerase chain reaction|pcr polymerase chain reaction
5459562|NCT01463254|SAE serious adverse event|sae serious adverse event
5459563|NCT01463254|µg microgram|µg microgram
5459564|NCT01463254|ULN upper limit of the normal range|uln upper limit of the normal range
5459565|NCT01463254|WB Western Blot|wb western blot
5459566|NCT01463228|Healthy Volunteers|healthy volunteers
5459567|NCT01463228|Bioequivalence|bioequivalence
5459568|NCT01463228|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5459569|NCT01463228|Metformin IR|metformin ir
5459570|NCT01463215|Ambroxol|ambroxol
5459571|NCT01463215|Type I Gaucher Disease|type i gaucher disease
5459572|NCT01463202|Postpartum contraception|postpartum contraception
5459573|NCT01463202|Contraceptive continuation|contraceptive continuation
5459574|NCT01463202|Breastfeeding|breastfeeding
5459575|NCT01463202|Postpartum depression|postpartum depression
5459576|NCT01463202|Progestins|progestins
5459577|NCT01463189|arthritis|arthritis
5459578|NCT01463189|self management|self management
5459579|NCT01463176|Music Therapy|music therapy
5459580|NCT01463176|Child Psychology|child psychology
5459581|NCT01463176|Vaccination|vaccination
5459582|NCT01463163|Platelet reactivity|platelet reactivity
5459583|NCT01463163|Ticagrelor|ticagrelor
5459584|NCT01463163|Prasugrel|prasugrel
5459585|NCT01463150|Platelet reactivity|platelet reactivity
5459586|NCT01463150|Clopidogrel|clopidogrel
5459587|NCT01463150|Prasugrel|prasugrel
5459588|NCT01463137|social phobia|social phobia
5459589|NCT01463137|anxiety|anxiety
5459590|NCT01463124|School Nurse|school nurse
5459591|NCT01463124|Overweight|overweight
5459592|NCT01463124|Obesity|obesity
5459593|NCT01463124|Counseling|counseling
5459594|NCT01463124|Intervention|intervention
5459595|NCT01463124|Exercise|exercise
5459596|NCT01463111|Bipolar|bipolar
5459597|NCT01463111|Manic depression|manic depression
5459598|NCT01463111|Mood stabilizer|mood stabilizer
5459599|NCT01463111|Decision|decision
5459600|NCT01463111|Neuroeconomics|neuroeconomics
5459601|NCT01463059|Rheumatoid Arthritis|rheumatoid arthritis
5903981|NCT00086567|Gynecologic|gynecologic
5459602|NCT01463059|Monoclonal Antibody|monoclonal antibody
5459603|NCT01463059|Interleukin-6|interleukin-6
5459604|NCT01463059|Olokizumab|olokizumab
5459605|NCT01463059|CDP6038|cdp6038
5459606|NCT01463046|leukemia|leukemia
5459607|NCT01463046|AML|aml
5459608|NCT01463046|AMS|ams
5459609|NCT01463046|panobinostat|panobinostat
5459610|NCT01463046|cytarabine|cytarabine
5459611|NCT01463046|daunorubicin|daunorubicin
5459612|NCT01463046|HDAC|hdac
5459613|NCT01463033|Post-Traumatic epilepsy|post-traumatic epilepsy
5459614|NCT01463033|Traumatic brain injury|traumatic brain injury
5459615|NCT01463033|Epilepsy prevention|epilepsy prevention
5459616|NCT01463033|Levetiracetam|levetiracetam
5459617|NCT01463020|Depression|depression
5459618|NCT01463020|Smartphone|smartphone
5459619|NCT01463020|Behavioural activation|behavioural activation
5459620|NCT01463020|Mindfulness|mindfulness
5459621|NCT01463007|invasive ductal cancer|invasive ductal cancer
5459622|NCT01463007|tubular breast cancer|tubular breast cancer
5459623|NCT01463007|breast cancer|breast cancer
5459625|NCT01463007|ER positive|er positive
5459626|NCT01463007|radiation|radiation
5459627|NCT01462994|Patients with GIST treated with standard therapy harboring activating mutations of CKIT and PDGFRA|patients with gist treated with standard therapy harboring activating mutations of ckit and pdgfra
5459628|NCT01462968|Heparin treatment during cardiac surgery|heparin treatment during cardiac surgery
5459629|NCT01462968|Heparin reversal after cardiac surgery|heparin reversal after cardiac surgery
5459630|NCT01462968|Thrombin generation|thrombin generation
5459631|NCT01462968|Endogenous Thrombin potential|endogenous thrombin potential
5459632|NCT01462942|COPD|copd
5459633|NCT01462942|Bronchitis|bronchitis
5459634|NCT01462942|Chronic|chronic
5459635|NCT01462942|Emphysema|emphysema
5459636|NCT01462929|COPD|copd
5459637|NCT01462929|antimuscarinic|antimuscarinic
5459638|NCT01462916|honey|honey
5459639|NCT01462916|mucositis|mucositis
5459640|NCT01462916|bee products|bee products
5459641|NCT01462903|TIL|til
5459642|NCT01462903|NPC|npc
5459643|NCT01462903|hepatocellular carcinoma|hepatocellular carcinoma
5459644|NCT01462903|immunotherapy|immunotherapy
5459645|NCT01462890|Ovarian Carcinoma|ovarian carcinoma
5459646|NCT01462890|Bevacizumab|bevacizumab
5459647|NCT01462890|Paclitaxel|paclitaxel
5459648|NCT01462890|Carboplatin|carboplatin
5459649|NCT01462877|Lipid Regulating Agents|lipid regulating agents
5459650|NCT01462877|Drug Therapy|drug therapy
5459651|NCT01462877|cardiovascular diseases|cardiovascular diseases
5459652|NCT01462877|hypertriglyceridemia|hypertriglyceridemia
5459653|NCT01462877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5459654|NCT01462877|fenofibrate|fenofibrate
5459655|NCT01462877|Dyslipidemias|dyslipidemias
5459656|NCT01462877|Combination|combination
5798687|NCT00111371|dyslexia|dyslexia
5459657|NCT01462864|Polycystic Ovary Syndrome|polycystic ovary syndrome
5459659|NCT01462864|Structured Education|structured education
5459660|NCT01462864|Walking Activity|walking activity
5459661|NCT01462864|Exercise|exercise
5459662|NCT01462864|Overweight|overweight
5459663|NCT01462864|Impaired Glucose Regulation|impaired glucose regulation
5459664|NCT01462864|Diabetes Prevention|diabetes prevention
5459665|NCT01462851|healthy volunteer|healthy volunteer
5459666|NCT01462851|safety|safety
5459667|NCT01462851|pharmacokinetic|pharmacokinetic
5459668|NCT01462851|pharmacodynamic|pharmacodynamic
5442183|NCT01536002|Propofol|propofol
5459669|NCT01462838|advanced HPV-|advanced hpv-
5459670|NCT01462838|p16INK4a-positive|p16ink4a-positive
5459671|NCT01462838|cervical|cervical
5459672|NCT01462838|vulvar,|vulvar,
5459673|NCT01462838|vaginal|vaginal
5459674|NCT01462838|penile|penile
5459675|NCT01462838|anal|anal
5459676|NCT01462838|head|head
5459677|NCT01462838|neck|neck
5459774|NCT01462383|Phase I|phase i
5459678|NCT01462825|Inflammation|inflammation
5459679|NCT01462825|cytokines|cytokines
5459680|NCT01462825|chemotaxis|chemotaxis
5459681|NCT01462825|tomatoes|tomatoes
5459682|NCT01462825|cardiovascular disease|cardiovascular disease
5459683|NCT01462812|Migraine|migraine
5459684|NCT01462812|Headache|headache
5459685|NCT01462812|Sumatriptan|sumatriptan
5459686|NCT01462799|PBL|pbl
5459687|NCT01462799|patient education|patient education
5459688|NCT01462799|coronary heart disease|coronary heart disease
5459689|NCT01462799|empowerment|empowerment
5459690|NCT01462799|self-efficacy|self-efficacy
5459691|NCT01462799|self-care|self-care
5459692|NCT01462799|Focus on to determine the long term effectiveness of PBL in patient education by comparison of standardized homesent information in patients with CHD.|focus on to determine the long term effectiveness of pbl in patient education by comparison of standardized homesent information in patients with chd.
5459693|NCT01462799|Further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.|further focus is on patients' self-care goals, beliefs, self-efficacy and empowerment to make lifestyle changes.
5459694|NCT01462773|malignant|malignant
5459695|NCT01462773|melanoma|melanoma
5459696|NCT01462708|Parkinson Disease|parkinson disease
5459697|NCT01462708|Molecular NeuroImaging|molecular neuroimaging
5459698|NCT01462682|focus group study|focus group study
5459699|NCT01462682|sleep deprivation|sleep deprivation
5459700|NCT01462682|surgery|surgery
5459701|NCT01462669|Ezogabine|ezogabine
5459702|NCT01462669|Pharmacokinetics|pharmacokinetics
5459704|NCT01462656|anti-epileptic drug|anti-epileptic drug
5459705|NCT01462656|ezogabine|ezogabine
5459706|NCT01462656|AED polytherapy|aed polytherapy
5459707|NCT01462656|epilepsy|epilepsy
5459708|NCT01462656|AED monotherapy|aed monotherapy
5459709|NCT01462656|retigabine|retigabine
5459710|NCT01462656|urinary retention|urinary retention
5459711|NCT01462643|Psoriasis Plaque Test|psoriasis plaque test
5459712|NCT01462643|topical|topical
5459713|NCT01462643|ointment|ointment
5459714|NCT01462591|wave reflection|wave reflection
5459715|NCT01462591|augmentation Index|augmentation index
5459716|NCT01462591|heart rate variability|heart rate variability
5459719|NCT01462578|Acute myeloid leukemia|acute myeloid leukemia
5459721|NCT01462578|Myelodysplastic syndrome|myelodysplastic syndrome
5459722|NCT01462578|MDS|mds
5459723|NCT01462565|flolan|flolan
5459724|NCT01462565|pulmonary arterial hypertension|pulmonary arterial hypertension
5459725|NCT01462565|thermo stable formulation|thermo stable formulation
5459726|NCT01462565|epoprostenol sodium|epoprostenol sodium
5459727|NCT01462565|modified sterile diluent|modified sterile diluent
5459728|NCT01462552|liver function testing|liver function testing
5459729|NCT01462552|Breast cancer|breast cancer
5459730|NCT01462552|lapatanib|lapatanib
5459731|NCT01462513|Colon carcinoma|colon carcinoma
5459732|NCT01462513|Rectum carcinoma|rectum carcinoma
5459733|NCT01462513|Liver metastases|liver metastases
5459734|NCT01462500|Miltefosine|miltefosine
5459735|NCT01462500|pharmacokinetics|pharmacokinetics
5459736|NCT01462500|cutaneous leishmaniasis|cutaneous leishmaniasis
5459737|NCT01462487|Pregnancy safety|pregnancy safety
5459738|NCT01462487|zanamivir|zanamivir
5459739|NCT01462487|influenza|influenza
5459740|NCT01462474|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5459741|NCT01462461|Phantom Limb|phantom limb
5459742|NCT01462461|Amputation, Traumatic|amputation, traumatic
5459743|NCT01462461|Electromyography|electromyography
5459744|NCT01462461|Visual Analog Pain Scale|visual analog pain scale
5459745|NCT01462448|Phantom Limb|phantom limb
5459746|NCT01462448|Genetic Variation|genetic variation
5459747|NCT01462448|DNA Sequence Analysis|dna sequence analysis
5459748|NCT01462448|Amputation, Traumatic|amputation, traumatic
5459749|NCT01462448|Single Nucleotide Polymorphism|single nucleotide polymorphism
5459750|NCT01462448|Visual Analog Pain Scale|visual analog pain scale
5459751|NCT01462448|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5459752|NCT01462448|Inflammatory Antibody|inflammatory antibody
5459753|NCT01462448|Peripheral Nerve Damage|peripheral nerve damage
5459754|NCT01462422|Postpartum hemorrhage|postpartum hemorrhage
5459756|NCT01462422|Misoprostol|misoprostol
5459757|NCT01462422|Developing countries|developing countries
5459758|NCT01462422|Nurse midwife|nurse midwife
5459759|NCT01462409|obstructive sleep apnea|obstructive sleep apnea
5459760|NCT01462409|humidification|humidification
5459761|NCT01462409|mask|mask
5459762|NCT01462409|heated tubing|heated tubing
5459763|NCT01462396|Neuroblastoma|neuroblastoma
5459764|NCT01462396|Relapsed|relapsed
5459765|NCT01462396|Refractory|refractory
5459766|NCT01462383|Advanced Cancer|advanced cancer
5459767|NCT01462383|Malignancy|malignancy
5459768|NCT01462383|Cardiac complications|cardiac complications
5459769|NCT01462383|Electrocardiograms|electrocardiograms
5459770|NCT01462383|ECG|ecg
5459771|NCT01462383|Chart Review|chart review
5459772|NCT01462383|Data Review|data review
5459773|NCT01462383|Data Analysis|data analysis
5459775|NCT01462383|Clinical Research Study|clinical research study
5459776|NCT01462357|Human papillomavirus|human papillomavirus
5459777|NCT01462357|Safety|safety
5459778|NCT01462357|HPV vaccine|hpv vaccine
5459779|NCT01462357|Immune response|immune response
5459780|NCT01462344|pediatric|pediatric
5459781|NCT01462344|ADVAIR|advair
5459782|NCT01462344|FLOVENT|flovent
5459783|NCT01462344|asthma|asthma
5459784|NCT01462331|Isomaltooligosaccharide|isomaltooligosaccharide
5459785|NCT01462331|Human Consumption|human consumption
5459786|NCT01462331|Dose tolerance|dose tolerance
5459787|NCT01462331|Prebiotic|prebiotic
5459788|NCT01462331|Short chain fatty acids|short chain fatty acids
5459789|NCT01462331|Blood glucose|blood glucose
5459790|NCT01462331|Dose tolerance and prebiotic effect|dose tolerance and prebiotic effect
5459791|NCT01462318|Pre-filled syringe|pre-filled syringe
5459792|NCT01462318|Pharmacokinetic|pharmacokinetic
5459793|NCT01462318|Daclizumab High Yield Process|daclizumab high yield process
5459794|NCT01462318|immunogenicity|immunogenicity
5459795|NCT01462305|SAD|sad
5459796|NCT01462305|Seasonal Affective Disorder|seasonal affective disorder
5459797|NCT01462305|Winter Blues|winter blues
5459798|NCT01462305|Seasonal Depression|seasonal depression
5459799|NCT01462292|968|968
5459800|NCT01462292|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5459801|NCT01462292|GSK2402968|gsk2402968
5459802|NCT01462292|DMD|dmd
5459803|NCT01462292|Duchenne|duchenne
5459804|NCT01462292|GSK|gsk
5459805|NCT01462279|acute respiratory failure|acute respiratory failure
5459806|NCT01462279|thiamine|thiamine
5446626|NCT01517048|HV|hv
5459807|NCT01462279|oxygen consumption|oxygen consumption
5459808|NCT01462279|VO2|vo2
5459809|NCT01462253|Adult patients|adult patients
5459810|NCT01462253|Refractory|refractory
5459811|NCT01462253|Relapsed|relapsed
5459812|NCT01462253|clofarabine|clofarabine
5459813|NCT01462253|cyclophosphamide|cyclophosphamide
5459814|NCT01462253|refractory and relapsed acute lymphoblastic leukemia|refractory and relapsed acute lymphoblastic leukemia
5459815|NCT01462253|ALL|all
5459816|NCT01462240|arthritis|arthritis
5459817|NCT01462227|Hypoglycemia|hypoglycemia
5459818|NCT01462227|Type 1 diabetes|type 1 diabetes
5459819|NCT01462201|focused ultrasound|focused ultrasound
5459820|NCT01462201|mechanical fat destruction|mechanical fat destruction
5459821|NCT01462201|Body Sculpting|body sculpting
5459822|NCT01462188|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5459823|NCT01462188|Primary angioplasty|primary angioplasty
5459824|NCT01462188|stent|stent
5459825|NCT01462136|PK study|pk study
5459826|NCT01462097|Chronic kidney disease|chronic kidney disease
5459827|NCT01462097|Exercise|exercise
5459828|NCT01462097|Aerobic capacity|aerobic capacity
5459829|NCT01462097|Learning and memory|learning and memory
5459830|NCT01462097|Executive function|executive function
5459831|NCT01462097|Endothelial function|endothelial function
5459832|NCT01462084|sleeping|sleeping
5459833|NCT01462084|opioid medications|opioid medications
5459834|NCT01462084|positive airway pressure|positive airway pressure
5459835|NCT01462058|SPAQ|spaq
5459836|NCT01462058|Sigh-SAD|sigh-sad
5459837|NCT01462058|Hamilton 29|hamilton 29
5459838|NCT01462058|Vitamin D3|vitamin d3
5459839|NCT01462058|p25(OH)D|p25(oh)d
5459840|NCT01462045|Exercise|exercise
5459841|NCT01462045|Stress|stress
5459842|NCT01462045|PTSD|ptsd
5459843|NCT01462045|Mindfulness|mindfulness
5459844|NCT01462045|Breathing|breathing
5459845|NCT01462045|Cortisol|cortisol
5459846|NCT01462032|Preschool Children|preschool children
5459847|NCT01462032|ADHD|adhd
5459848|NCT01462032|Treatment|treatment
5459849|NCT01462032|Non-pharmacological|non-pharmacological
5459850|NCT01462019|nipple trauma|nipple trauma
5459851|NCT01462019|breast feeding|breast feeding
5459852|NCT01462019|phototherapy|phototherapy
5459853|NCT01462019|wound healing|wound healing
5459854|NCT01461993|vaccine|vaccine
5459855|NCT01461993|rLP2086|rlp2086
5459856|NCT01461993|Gardasil|gardasil
5459857|NCT01461993|HPV|hpv
5459858|NCT01461993|meningitis B|meningitis b
5459859|NCT01461993|N. meningitidis serogroup B|n. meningitidis serogroup b
5459860|NCT01461993|adolescents|adolescents
5459861|NCT01461993|single-blind|single-blind
5459862|NCT01461993|Meningococcal Vaccines|meningococcal vaccines
5459863|NCT01461980|vaccine|vaccine
5459864|NCT01461980|rLP2086|rlp2086
5459865|NCT01461980|MCV4|mcv4
5459866|NCT01461980|Tdap|tdap
5459867|NCT01461980|meningitis B|meningitis b
5459868|NCT01461980|N. meningitidis serogroup B|n. meningitidis serogroup b
5459869|NCT01461980|adolescents|adolescents
5459870|NCT01461980|observer-blind|observer-blind
5459871|NCT01461941|Dermatitis|dermatitis
5459872|NCT01461941|Atopic|atopic
5459873|NCT01461915|Pancreatic Cancer|pancreatic cancer
5459874|NCT01461902|traumatic brain injury|traumatic brain injury
5459875|NCT01461902|brain injury|brain injury
5459876|NCT01461902|head injury|head injury
5459877|NCT01461902|vasospasm|vasospasm
5459878|NCT01461889|transfusion-related acute lung injury|transfusion-related acute lung injury
5459879|NCT01461889|Blood Component Transfusion|blood component transfusion
5459880|NCT01461889|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5459881|NCT01461889|Cirrhosis|cirrhosis
5459882|NCT01461889|Fresh frozen plasma|fresh frozen plasma
5459883|NCT01461837|sickle cell disease|sickle cell disease
5459884|NCT01461837|stem cell transplantation|stem cell transplantation
5459885|NCT01461837|haploidentical|haploidentical
5459886|NCT01461824|Birth Control|birth control
5459887|NCT01461824|Contraceptive Methods|contraceptive methods
5459888|NCT01461824|Female Contraception|female contraception
5459889|NCT01461824|Weight Gain|weight gain
5459890|NCT01461824|Bone Density|bone density
5459892|NCT01461811|contact lenses|contact lenses
5459893|NCT01461811|daily disposable contact lenses|daily disposable contact lenses
5459894|NCT01461811|astigmatism|astigmatism
5459895|NCT01461811|soft contact lenses|soft contact lenses
5459896|NCT01461811|contact lens comfort|contact lens comfort
5459897|NCT01461798|plant stanols|plant stanols
5459898|NCT01461798|lipids|lipids
5459899|NCT01461798|cardiovascular disease|cardiovascular disease
5459900|NCT01461785|Platelet rich plasma|platelet rich plasma
5459901|NCT01461785|Dermal improvement|dermal improvement
5459902|NCT01461785|Graft survival|graft survival
5459903|NCT01461733|atrial fibrillation|atrial fibrillation
5459904|NCT01461733|amiodarone|amiodarone
5459905|NCT01461720|Bone marrow|bone marrow
5459906|NCT01461720|Autologous|autologous
5459907|NCT01461720|Mesenchymal stem cells|mesenchymal stem cells
5459908|NCT01461720|Unilateral middle cerebral artery infarct|unilateral middle cerebral artery infarct
5459909|NCT01461707|Cellular phone|cellular phone
5459910|NCT01461707|exercise|exercise
5459911|NCT01461707|pregnant women|pregnant women
5459912|NCT01461707|obesity|obesity
5459913|NCT01461707|overweight|overweight
5459914|NCT01461707|physical activity|physical activity
5459915|NCT01461694|Hirsutism|hirsutism
5459916|NCT01461694|Laser|laser
5459917|NCT01461694|Hair Reduction|hair reduction
5459918|NCT01461694|IPL|ipl
5459919|NCT01461694|Intense Pulsed Light|intense pulsed light
5459920|NCT01461681|Palliative care|palliative care
5459921|NCT01461681|Symptom management|symptom management
5459923|NCT01461668|MRSA|mrsa
5459924|NCT01461668|MRSA resistant to mupirocin|mrsa resistant to mupirocin
5459925|NCT01461642|Asthma|asthma
5459926|NCT01461642|ICT Support|ict support
5459928|NCT01461642|PEF|pef
5459929|NCT01461629|cognitive impairment|cognitive impairment
5459930|NCT01461629|cognitive function|cognitive function
5459931|NCT01461629|hospitalization|hospitalization
5459932|NCT01461629|self-management|self-management
5459933|NCT01461629|cardiac disease|cardiac disease
5459934|NCT01461629|heart failure|heart failure
5459935|NCT01461616|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5459936|NCT01461603|critical illness|critical illness
5459937|NCT01461603|protein metabolism|protein metabolism
5459938|NCT01461603|pharmaconutrients|pharmaconutrients
5459939|NCT01461564|screening|screening
5459940|NCT01461564|colonoscopy|colonoscopy
5459941|NCT01461564|carbon dioxide|carbon dioxide
5459942|NCT01461564|air|air
5459943|NCT01461564|pain score|pain score
5459944|NCT01461564|complications|complications
5459945|NCT01461551|troponin I|troponin i
5459946|NCT01461551|creatine kinase mb|creatine kinase mb
5459947|NCT01461551|hospital days|hospital days
5459948|NCT01461551|lymphocyte apoptosis|lymphocyte apoptosis
5459949|NCT01461551|intensive care unit days|intensive care unit days
5459950|NCT01461538|Acute Lymphoid Leukemia|acute lymphoid leukemia
5459951|NCT01461538|Myelodysplastic Syndrome|myelodysplastic syndrome
5459952|NCT01461538|Acute Myeloid Leukemia|acute myeloid leukemia
5459953|NCT01461538|Solid Tumors|solid tumors
5459954|NCT01461538|Anemia, Refractory, with Excess of Blasts|anemia, refractory, with excess of blasts
5459955|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal
5459956|NCT01461538|Antibody-Drug Conjugate|antibody-drug conjugate
5459957|NCT01461538|Antigens, CD30|antigens, cd30
5459958|NCT01461538|Drug Therapy|drug therapy
5459959|NCT01461538|Hematologic Diseases|hematologic diseases
5459960|NCT01461538|Immunotherapy|immunotherapy
5459961|NCT01461538|Monomethyl Auristatin E|monomethyl auristatin e
5459962|NCT01461525|Low Rectal Cancer|low rectal cancer
5459963|NCT01461525|Sphincter preservation|sphincter preservation
5459964|NCT01461525|Abdominoperineal resection|abdominoperineal resection
5459965|NCT01461525|Quality of life|quality of life
5459966|NCT01461525|Sexual function|sexual function
5459967|NCT01461525|Urinary function|urinary function
5459968|NCT01461525|Oncologic outcome|oncologic outcome
5459969|NCT01461499|Hypertension|hypertension
5459970|NCT01461499|Albuminuria|albuminuria
5459971|NCT01461499|Direct renin inhibitor|direct renin inhibitor
5459972|NCT01461499|Angiotensin receptor blocker|angiotensin receptor blocker
5459973|NCT01461499|Type 2 diabetes|type 2 diabetes
5459974|NCT01461486|Continuous positive airway pressure|continuous positive airway pressure
5459975|NCT01461486|Oral appliance|oral appliance
5459976|NCT01461486|mild Obstructive Sleep Apnea Syndrome|mild obstructive sleep apnea syndrome
5459977|NCT01461473|Obstructive Sleep Apnea|obstructive sleep apnea
5459978|NCT01461473|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5459979|NCT01461473|Sleep Apnea Syndrome, Obstructive|sleep apnea syndrome, obstructive
5459982|NCT01461473|Syndrome, Upper Airway Resistance, Sleep Apnea|syndrome, upper airway resistance, sleep apnea
5459983|NCT01461473|Upper Airway Resistance Sleep Apnea Syndrome|upper airway resistance sleep apnea syndrome
5459984|NCT01461460|volunteer|volunteer
5459985|NCT01461434|atrial fibrillation|atrial fibrillation
5459986|NCT01461434|biomarkers|biomarkers
5459987|NCT01461434|stroke prevention|stroke prevention
5459988|NCT01461434|implantable loop recorder|implantable loop recorder
5459989|NCT01461421|Obesity|obesity
5459990|NCT01461421|Primary Care|primary care
5459991|NCT01461421|Behavior Modification|behavior modification
5459992|NCT01461408|HPV Vaccination|hpv vaccination
5459993|NCT01461408|Beauty Salons|beauty salons
5459994|NCT01461408|Health Education|health education
5459995|NCT01461408|Sexual Health|sexual health
5459996|NCT01461395|IVF|ivf
5459997|NCT01461343|pulmonary hypertension, PET imaging, CT/PET|pulmonary hypertension, pet imaging, ct/pet
5459998|NCT01461330|diabetes|diabetes
5459999|NCT01461330|exercise|exercise
5460000|NCT01461330|DASH diet|dash diet
5460001|NCT01461330|ABPM|abpm
5460002|NCT01461304|fatty acid oxidation|fatty acid oxidation
5460003|NCT01461304|triheptanoin|triheptanoin
5460004|NCT01461304|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
5460005|NCT01461304|LCHADD|lchadd
5460006|NCT01461304|VLCADD|vlcadd
5460007|NCT01461304|CPT1|cpt1
5460008|NCT01461304|CPT2|cpt2
5460009|NCT01461304|TFP|tfp
5460010|NCT01461304|Glycogen Storage Disorders|glycogen storage disorders
5460011|NCT01461304|GSD|gsd
5446762|NCT01516463|burn|burn
5460012|NCT01461304|Pyruvate Carboxylase|pyruvate carboxylase
5460013|NCT01461304|PC|pc
5460014|NCT01461304|ACAD9|acad9
5460015|NCT01461304|Barth|barth
5460016|NCT01461291|Primary open-angle glaucoma|primary open-angle glaucoma
5460017|NCT01461291|POAG|poag
5460018|NCT01461291|Trabecular meshwork|trabecular meshwork
5460019|NCT01461291|iStent inject|istent inject
5460020|NCT01461278|Primary open-angle glaucoma|primary open-angle glaucoma
5460021|NCT01461278|POAG|poag
5460024|NCT01461278|Suprachoroidal stent|suprachoroidal stent
5460025|NCT01461278|iStent supra|istent supra
5460026|NCT01461265|Painful bone metastases|painful bone metastases
5460027|NCT01461265|Bone metastases|bone metastases
5460028|NCT01461265|Metastatic bone tumors|metastatic bone tumors
5460029|NCT01461265|Metastatic bone pain|metastatic bone pain
5460030|NCT01461265|Cryoablation|cryoablation
5460031|NCT01461265|Cryotherapy|cryotherapy
5460032|NCT01461265|Cryosurgery|cryosurgery
5460033|NCT01461252|Painful bone metastases|painful bone metastases
5460034|NCT01461252|Bone metastases|bone metastases
5460035|NCT01461252|Metastatic bone tumors|metastatic bone tumors
5460036|NCT01461252|Metastatic bone pain|metastatic bone pain
5460037|NCT01461252|Cryoablation|cryoablation
5460038|NCT01461252|Cryotherapy|cryotherapy
5460039|NCT01461252|Cryosurgery|cryosurgery
5460040|NCT01461252|Radiation therapy|radiation therapy
5460041|NCT01461252|Radiotherapy|radiotherapy
5460042|NCT01461239|survival|survival
5460043|NCT01461239|debonding|debonding
5460044|NCT01461239|endodontic treated teeth|endodontic treated teeth
5460045|NCT01461226|overweight|overweight
5460046|NCT01461226|cardiovascular risk factors|cardiovascular risk factors
5460047|NCT01461226|exercise training|exercise training
5460048|NCT01461226|endothelial function|endothelial function
5460049|NCT01461226|endothelium|endothelium
5460050|NCT01461226|endothelial progenitor cells|endothelial progenitor cells
5460051|NCT01461213|Tapetoretinal degeneration, choroideraemia, X-linked|tapetoretinal degeneration, choroideraemia, x-linked
5460052|NCT01461213|retinitis pigmentosa|retinitis pigmentosa
5460053|NCT01461187|Exercise|exercise
5460054|NCT01461187|Pregnancy|pregnancy
5460055|NCT01461187|Childbirth|childbirth
5460056|NCT01461187|Vaginal|vaginal
5460057|NCT01461187|Cesarean section|cesarean section
5460058|NCT01461174|Sleep deprivation|sleep deprivation
5460059|NCT01461174|Cognitive Functions|cognitive functions
5460060|NCT01461174|young male|young male
5460061|NCT01461148|UICC stage III/IV MSI-H colorectal cancer|uicc stage iii/iv msi-h colorectal cancer
5460065|NCT01461109|GlyT1|glyt1
5460066|NCT01461083|Parkinson Disease|parkinson disease
5460067|NCT01461083|[18F]MPPF|[18f]mppf
5460068|NCT01461070|Breast Cancer|breast cancer
5460069|NCT01461070|Post Menopausal Estrogens|post menopausal estrogens
5460070|NCT01461070|Fecal Microbes|fecal microbes
5460071|NCT01461031|pain|pain
5460072|NCT01461031|orthognathic|orthognathic
5460073|NCT01461018|Immune globulin subcutaneous|immune globulin subcutaneous
5460074|NCT01461018|SCIG|scig
5460075|NCT01461018|Primary immunodeficiency|primary immunodeficiency
5460076|NCT01461018|PID|pid
5460082|NCT01460992|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5460083|NCT01460992|EVIA/ENTOVIS|evia/entovis
5460084|NCT01460979|Ovarian Cancer|ovarian cancer
5442591|NCT01534403|Lupus|lupus
5460085|NCT01460979|Endometrial Carcinoma|endometrial carcinoma
5460086|NCT01460979|Temsirolimus|temsirolimus
5460087|NCT01460966|Distal protection device|distal protection device
5460088|NCT01460966|Thrombus aspiration|thrombus aspiration
5460089|NCT01460966|Coronary Artery Disease|coronary artery disease
5460090|NCT01460966|Coronary Disease|coronary disease
5460091|NCT01460966|Acute Coronary Syndrome|acute coronary syndrome
5460092|NCT01460953|curriculum|curriculum
5460093|NCT01460953|training|training
5460094|NCT01460953|Medical student Knowledge|medical student knowledge
5460095|NCT01460940|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
5460096|NCT01460940|panobinostat|panobinostat
5460097|NCT01460940|lenalidomide|lenalidomide
5460099|NCT01460914|CTCL|ctcl
5460100|NCT01460914|Extracorporeal photopheresis|extracorporeal photopheresis
5460101|NCT01460914|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5460102|NCT01460914|GVHD|gvhd
5460103|NCT01460914|Graft versus host disease|graft versus host disease
5460104|NCT01460901|Neuroblastoma|neuroblastoma
5460105|NCT01460901|Relapsed|relapsed
5460106|NCT01460901|Refractory|refractory
5460107|NCT01460875|high risk melanoma|high risk melanoma
5460108|NCT01460875|lymph node disease|lymph node disease
5460109|NCT01460862|Asthma|asthma
5460110|NCT01460862|Omalizumab|omalizumab
5460111|NCT01460849|Cystic fibrosis|cystic fibrosis
5460112|NCT01460836|Cystic fibrosis|cystic fibrosis
5460113|NCT01460823|Hearing loss|hearing loss
5460114|NCT01460823|Cochlear Implantation|cochlear implantation
5460115|NCT01460823|Image guided surgery|image guided surgery
5460116|NCT01460797|Glycemic index|glycemic index
5460117|NCT01460797|Caloric restriction|caloric restriction
5460118|NCT01460797|Energy intake|energy intake
5460119|NCT01460797|Glucose|glucose
5460120|NCT01460797|Lipid Metabolism|lipid metabolism
5460121|NCT01460797|Cholesterol|cholesterol
5460122|NCT01460797|HDL Cholesterol|hdl cholesterol
5460123|NCT01460797|LDL Cholesterol|ldl cholesterol
5460124|NCT01460797|Obesity|obesity
5460125|NCT01460797|Metformin|metformin
5460126|NCT01460784|Metabolic dysfunction|metabolic dysfunction
5460127|NCT01460784|Insulin resistance|insulin resistance
5454749|NCT01482806|Depression|depression
5460143|NCT01460732|Nocturnal BP dipping|nocturnal bp dipping
5460144|NCT01460732|Home Blood pressure Monitoring|home blood pressure monitoring
5460145|NCT01460732|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5460147|NCT01460706|68Ga-DOTATOC|68ga-dotatoc
5460148|NCT01460706|PET/CT|pet/ct
5460149|NCT01460706|Somatostatin receptor|somatostatin receptor
5460150|NCT01460693|Leukemia|leukemia
5460151|NCT01460693|Myeloid|myeloid
5460152|NCT01460693|Chronic|chronic
5460153|NCT01460693|Chronic-Phase|chronic-phase
5460154|NCT01460693|CML|cml
5460155|NCT01460680|Fibromyalgia|fibromyalgia
5460156|NCT01460680|Systemic Lupus Erythematosus|systemic lupus erythematosus
5460157|NCT01460680|Omega-3 Fatty acids|omega-3 fatty acids
5460158|NCT01460680|Magnesium|magnesium
5460159|NCT01460667|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
5460160|NCT01460667|Post-Operative Pain|post-operative pain
5460161|NCT01460667|IV Acetaminophen|iv acetaminophen
5460162|NCT01460667|Post-Operative Nausea and Vomiting|post-operative nausea and vomiting
5460163|NCT01460628|fatigue|fatigue
5460164|NCT01460628|menopausal symptoms|menopausal symptoms
5460165|NCT01460628|hot flashes|hot flashes
5460166|NCT01460628|Vasomotor symptoms|vasomotor symptoms
5460167|NCT01460628|perimenopause|perimenopause
5460168|NCT01460628|related Quality of life|related quality of life
5460169|NCT01460615|Postoperative pancreatitis|postoperative pancreatitis
5460170|NCT01460615|Postoperative complications|postoperative complications
5460171|NCT01460615|Delayed gastric emptying|delayed gastric emptying
5460172|NCT01460615|Leakage|leakage
5460173|NCT01460615|Fistula|fistula
5460174|NCT01460615|Acinar cell|acinar cell
5460175|NCT01460615|Risk patient|risk patient
5460176|NCT01460615|Pancreaticoduodenectomy|pancreaticoduodenectomy
5460177|NCT01460615|Whipple|whipple
5460178|NCT01460615|Cortisone|cortisone
5460179|NCT01460602|Lymphoma|lymphoma
5460180|NCT01460602|Follicular|follicular
5460181|NCT01460602|Marginal Zone|marginal zone
5460183|NCT01460602|Velcade|velcade
5460184|NCT01460602|bortezomib|bortezomib
5460185|NCT01460602|Nipent|nipent
5460186|NCT01460602|pentastatin|pentastatin
5460187|NCT01460602|Rituxan|rituxan
5460188|NCT01460602|rituximab|rituximab
5460189|NCT01460602|Turturro|turturro
5460190|NCT01460602|Shreveport|shreveport
5460191|NCT01460589|colon cancer|colon cancer
5460192|NCT01460589|Chemotherapy|chemotherapy
5460193|NCT01460589|adjuvant|adjuvant
5460194|NCT01460576|prematurity|prematurity
5460195|NCT01460576|respiratory disease|respiratory disease
5460196|NCT01460576|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5460197|NCT01460563|craniotomy|craniotomy
5460198|NCT01460563|sodium valproate|sodium valproate
5460199|NCT01460563|rocuronium|rocuronium
5460200|NCT01460550|delayed gastric emptying(DGE)|delayed gastric emptying(dge)
5460201|NCT01460550|pancreaticoduodenectomy(PD)|pancreaticoduodenectomy(pd)
5460202|NCT01460550|randomized controlled trial(RCT)|randomized controlled trial(rct)
5460203|NCT01460550|gastro- or duodeno- jejunostomy reconstruction|gastro- or duodeno- jejunostomy reconstruction
5460204|NCT01460550|morbidity|morbidity
5460205|NCT01460537|phase I|phase i
5460206|NCT01460537|phosphatidylinositol-3 kinase inhibitor|phosphatidylinositol-3 kinase inhibitor
5460207|NCT01460537|gemcitabine|gemcitabine
5460208|NCT01460537|cisplatin|cisplatin
5460209|NCT01460537|maximum tolerated dose|maximum tolerated dose
5460210|NCT01460524|bronchiolitis|bronchiolitis
5460211|NCT01460524|saline|saline
5460212|NCT01460524|nebulization|nebulization
5460213|NCT01460524|hypertonic|hypertonic
5460214|NCT01460511|Mild bronchial asthma|mild bronchial asthma
5460215|NCT01460498|Leukemia|leukemia
5454849|NCT01482416|menopause|menopause
5460216|NCT01460498|Chronic Myeloid Leukemia|chronic myeloid leukemia
5460217|NCT01460498|CML|cml
5460218|NCT01460498|Complete cytogenetic remission|complete cytogenetic remission
5460219|NCT01460498|CCyR|ccyr
5460220|NCT01460498|Minimal residual disease|minimal residual disease
5460221|NCT01460498|Philadelphia chromosome (Ph)-|philadelphia chromosome (ph)-
5460222|NCT01460498|BCR/ABL-positive|bcr/abl-positive
5460223|NCT01460498|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5460224|NCT01460498|TKI|tki
5460225|NCT01460498|Azacitidine|azacitidine
5460226|NCT01460498|5-Azacytidine|5-azacytidine
5460227|NCT01460498|5-AZA|5-aza
5460228|NCT01460498|Vidaza|vidaza
5460229|NCT01460498|5-AZC|5-azc
5460230|NCT01460498|AZA-CR|aza-cr
5460231|NCT01460498|Ladakamycin|ladakamycin
5460232|NCT01460498|NSC-102816|nsc-102816
5460233|NCT01460472|NSCLC|nsclc
5460234|NCT01460472|Lung cancer, small-cell|lung cancer, small-cell
5460235|NCT01460472|advanced lung cancer|advanced lung cancer
5460236|NCT01460472|therapeutic vaccine|therapeutic vaccine
5432066|NCT01578863|Success|success
5460237|NCT01460472|anti-idiotypic vaccine|anti-idiotypic vaccine
5460238|NCT01460472|1E10|1e10
5460239|NCT01460459|diabetes|diabetes
5460240|NCT01460459|self-monitoring of blood glucose|self-monitoring of blood glucose
5460241|NCT01460459|frequency|frequency
5460242|NCT01460433|HIV 1|hiv 1
5460243|NCT01460433|Herpes Simplex Type 2|herpes simplex type 2
5460244|NCT01460433|Treatment experienced|treatment experienced
5460245|NCT01460420|Allogeneic transplantation|allogeneic transplantation
5460246|NCT01460420|Hematologic malignancies|hematologic malignancies
5460247|NCT01460420|Multiple myeloma|multiple myeloma
5460248|NCT01460420|RIC (Reduced Intensity Conditioning)|ric (reduced intensity conditioning)
5460249|NCT01460394|Healthy|healthy
5460250|NCT01460394|Control|control
5460251|NCT01460355|strabismus surgery|strabismus surgery
5460252|NCT01460355|botulinum toxin|botulinum toxin
5460253|NCT01460355|esotropia|esotropia
5460254|NCT01460355|exotropia|exotropia
5460255|NCT01460355|blepharoptosis|blepharoptosis
5460256|NCT01460342|Prostatic hyperplasia|prostatic hyperplasia
5460257|NCT01460342|Benign prostatic hyperplasia|benign prostatic hyperplasia
5460258|NCT01460342|Lower urinary tract|lower urinary tract
5460259|NCT01460329|intensive care units|intensive care units
5460260|NCT01460329|pediatric|pediatric
5460261|NCT01460329|cardiac index|cardiac index
5460262|NCT01460329|Doppler Ultrasonography|doppler ultrasonography
5460263|NCT01460316|Conotruncal cardiac defects|conotruncal cardiac defects
5460264|NCT01460316|methylation|methylation
5460265|NCT01460316|genotype|genotype
5460266|NCT01460316|cobalamin|cobalamin
5460267|NCT01460316|folates|folates
5460268|NCT01460316|nutrition|nutrition
5460269|NCT01460303|Transurethral catheterization|transurethral catheterization
5460270|NCT01460303|Urinary retention|urinary retention
5460271|NCT01460303|Bladder dysfunction|bladder dysfunction
5460272|NCT01460303|Patient comfort|patient comfort
5460273|NCT01460303|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
5460274|NCT01460303|Postoperative bladder dysfunction|postoperative bladder dysfunction
5460275|NCT01460303|Postoperative urinary retention|postoperative urinary retention
5460276|NCT01460277|hemiplegic|hemiplegic
5460277|NCT01460277|balance|balance
5460278|NCT01460277|hydrotherapy|hydrotherapy
5460279|NCT01460264|Prospective Cohort Study|prospective cohort study
5460280|NCT01460264|Respiratory Function Tests|respiratory function tests
5460281|NCT01460264|Computed Tomography|computed tomography
5460282|NCT01460264|Electrocardiography|electrocardiography
5460283|NCT01460264|Peripheral Arterial Disease|peripheral arterial disease
5460284|NCT01460251|type 1 diabetes|type 1 diabetes
5460285|NCT01460251|beta cell|beta cell
5460286|NCT01460251|immunomodulation|immunomodulation
5460287|NCT01460251|immunointervention|immunointervention
5460288|NCT01460238|Lipoprotein Lipase|lipoprotein lipase
5460289|NCT01460238|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5460290|NCT01460238|CLL|cll
5460291|NCT01460225|constipation|constipation
5460292|NCT01460225|chronic idiopathic constipation|chronic idiopathic constipation
5460293|NCT01460225|no prior history of surgery to the colon|no prior history of surgery to the colon
5460294|NCT01460225|not on any type of medication that could alter gastrointestinal motility or transit|not on any type of medication that could alter gastrointestinal motility or transit
5460295|NCT01460212|Cognitive-Behavior Therapy|cognitive-behavior therapy
5460296|NCT01460212|Magnetic Resonance Imaging|magnetic resonance imaging
5460297|NCT01460212|major depressive disorder|major depressive disorder
5460298|NCT01460186|Germ line polymorphisms|germ line polymorphisms
5460299|NCT01460173|alertness test|alertness test
5460300|NCT01460173|sleepiness|sleepiness
5460301|NCT01460173|vigilance|vigilance
5460302|NCT01460173|Sleep Apnea, Obstructive|sleep apnea, obstructive
5460303|NCT01460147|Hemophilia|hemophilia
5460304|NCT01460134|CD27 expressing Hematologic Malignancies|cd27 expressing hematologic malignancies
5460305|NCT01460134|CD27 expressing Solid Tumors|cd27 expressing solid tumors
5903982|NCT00086567|Urine|urine
5460306|NCT01460134|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5460307|NCT01460134|Burkett's lymphoma|burkett's lymphoma
5460308|NCT01460134|mantle cell lymphoma|mantle cell lymphoma
5460309|NCT01460134|primary lymphoma of the central nervous system|primary lymphoma of the central nervous system
5460310|NCT01460134|marginal zone B cell lymphoma|marginal zone b cell lymphoma
5460311|NCT01460134|solid tumor|solid tumor
5460312|NCT01460134|metastatic melanoma|metastatic melanoma
5460313|NCT01460134|renal (clear) cell carcinoma|renal (clear) cell carcinoma
5460314|NCT01460134|hormone-refractory prostate adenocarcinoma|hormone-refractory prostate adenocarcinoma
5460315|NCT01460134|ovarian cancer|ovarian cancer
5460316|NCT01460134|colorectal adenocarcinoma|colorectal adenocarcinoma
5460317|NCT01460134|non-small cell lung cancer|non-small cell lung cancer
5460318|NCT01460121|Phobic Postural Vertigo|phobic postural vertigo
5460319|NCT01460121|Visual Vertigo|visual vertigo
5460320|NCT01460121|Chronic Subjective Dizziness|chronic subjective dizziness
5460321|NCT01460121|Motion and Space Discomfort|motion and space discomfort
5460322|NCT01460121|SpotOn|spoton
5460323|NCT01460108|PLVR|plvr
5460324|NCT01460108|AeriSeal|aeriseal
5447131|NCT01514773|ICD|icd
5460325|NCT01460108|Treatment|treatment
5460326|NCT01460108|Device|device
5460327|NCT01460108|Breathing|breathing
5460328|NCT01460108|COPD|copd
5460329|NCT01460108|emphysema|emphysema
5460330|NCT01460108|polymeric lung volume reduction|polymeric lung volume reduction
5460331|NCT01460108|heterogeneous|heterogeneous
5460332|NCT01460108|homogeneous|homogeneous
5460333|NCT01460108|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5460334|NCT01460095|diabetes|diabetes
5460335|NCT01460095|translational research|translational research
5460336|NCT01460095|HbA1c|hba1c
5460337|NCT01460095|education|education
5460338|NCT01460082|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5460339|NCT01460082|acute exacerbation|acute exacerbation
5460340|NCT01460082|endothelial dysfunction|endothelial dysfunction
5460341|NCT01460082|flow mediated dilation|flow mediated dilation
5460342|NCT01460082|systemic inflammation|systemic inflammation
5460343|NCT01460069|psoriasis|psoriasis
5460344|NCT01460069|liraglutide|liraglutide
5460345|NCT01460069|morbidity|morbidity
5460346|NCT01460069|PASI|pasi
5460347|NCT01460069|DLQI|dlqi
5460348|NCT01460056|peritoneal dialysis|peritoneal dialysis
5460349|NCT01460056|endotoxin-associated sterile peritonitis|endotoxin-associated sterile peritonitis
5460350|NCT01460030|Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT|hypercalcemia in patients with parathyroid carcinoma or intractable phpt
5460351|NCT01460004|patellar tendinopathy|patellar tendinopathy
5460352|NCT01460004|jumper's knee|jumper's knee
5460353|NCT01459991|walnut|walnut
5460354|NCT01459991|mediterranean|mediterranean
5460355|NCT01459978|CUmulative SUM (CUSUM)|cumulative sum (cusum)
5460356|NCT01459978|quality indicators|quality indicators
5460357|NCT01459978|obstetrics|obstetrics
5460358|NCT01459965|Jaundice|jaundice
5460359|NCT01459965|Biliary stents|biliary stents
5460360|NCT01459965|Palliation|palliation
5460361|NCT01459965|Quality of Life|quality of life
5460362|NCT01459965|Endoscopic Retrograde Cholangiography|endoscopic retrograde cholangiography
5460363|NCT01459952|occurences of flu|occurences of flu
5460364|NCT01459952|occurences of common cold|occurences of common cold
5460365|NCT01459939|Osteoarthritis|osteoarthritis
5460366|NCT01459926|Opioid induced constipation|opioid induced constipation
5460368|NCT01459926|Constipation|constipation
5460369|NCT01459926|Opioid side effects|opioid side effects
5460370|NCT01459926|Morphine induced constipation|morphine induced constipation
5460371|NCT01459926|Opioid therapy|opioid therapy
5460372|NCT01459913|VX-950|vx-950
5460373|NCT01459913|INCIVEK|incivek
5460374|NCT01459913|INCIVO|incivo
5460473|NCT01459445|metformin|metformin
5460375|NCT01459900|Treatment Resistant Hypertension|treatment resistant hypertension
5460376|NCT01459887|untreated, CD20-positive|untreated, cd20-positive
5460377|NCT01459874|Home Monitoring|home monitoring
5460378|NCT01459874|Remote monitoring|remote monitoring
5460379|NCT01459874|Telecardiology|telecardiology
5460380|NCT01459874|Organizational model|organizational model
5460381|NCT01459874|Patient indicated for pacemaker, ICD, CRT-P, or CRT-D|patient indicated for pacemaker, icd, crt-p, or crt-d
5460382|NCT01459861|early ambulation|early ambulation
5460383|NCT01459861|knee arthroplasty|knee arthroplasty
5460384|NCT01459848|Salivary cortisol measured after DVD watching or block play|salivary cortisol measured after dvd watching or block play
5460385|NCT01459835|TV|tv
5460386|NCT01459835|Violence|violence
5460387|NCT01459835|DVDs|dvds
5460388|NCT01459835|Behavior|behavior
5460389|NCT01459835|Preschool children|preschool children
5460390|NCT01459822|sepsis|sepsis
5460391|NCT01459822|miRNA|mirna
5460392|NCT01459783|Caregivers|caregivers
5460393|NCT01459783|Comparative Effectiveness Research|comparative effectiveness research
5460394|NCT01459783|Cost Effectiveness|cost effectiveness
5460395|NCT01459783|Patient Care Management|patient care management
5460396|NCT01459783|Social Work|social work
5460397|NCT01459770|glomerular filtration rate|glomerular filtration rate
5460398|NCT01459770|albuminuria|albuminuria
5460399|NCT01459770|medical therapy|medical therapy
5460400|NCT01459770|hospital discharge|hospital discharge
5460401|NCT01459770|hospital readmission|hospital readmission
5460402|NCT01459770|CKD complications|ckd complications
5460403|NCT01459770|CKD risk factors|ckd risk factors
5460404|NCT01459757|Retrospective|retrospective
5460405|NCT01459757|GIST|gist
5460406|NCT01459757|sunitinib|sunitinib
5460407|NCT01459757|mutational|mutational
5460408|NCT01459744|Heart failure|heart failure
5460409|NCT01459744|Palliative care|palliative care
5460410|NCT01459744|Communication|communication
5460411|NCT01459718|Severe cardiac iron overload|severe cardiac iron overload
5460412|NCT01459718|deferasirox|deferasirox
5460413|NCT01459718|β-thalassaemia|β-thalassaemia
5460414|NCT01459718|cardiac dysfunction|cardiac dysfunction
5460415|NCT01459705|Combat Disorders|combat disorders
5460416|NCT01459705|Exposure Therapy|exposure therapy
5460417|NCT01459705|Army Personnel|army personnel
5460418|NCT01459692|Seizures|seizures
5460419|NCT01459692|Epilepsy|epilepsy
5460420|NCT01459692|Auditory Stimulation|auditory stimulation
5460421|NCT01459692|Music|music
5460422|NCT01459666|Scar|scar
5460423|NCT01459666|Forehead|forehead
5460424|NCT01459666|Skin Cancer|skin cancer
5460425|NCT01459666|MOHS Surgery|mohs surgery
5460426|NCT01459666|Dermatology|dermatology
5460427|NCT01459653|Febrile neutropenia|febrile neutropenia
5460428|NCT01459653|cancer|cancer
5460429|NCT01459653|chemotherapy,|chemotherapy,
5460430|NCT01459653|primary prophylaxis|primary prophylaxis
5460431|NCT01459653|secondary prophylaxis|secondary prophylaxis
5460432|NCT01459653|filgrastim|filgrastim
5460433|NCT01459653|granulocyte colony stimulating factor|granulocyte colony stimulating factor
5460434|NCT01459653|observational study|observational study
5460435|NCT01459653|noninterventional study|noninterventional study
5460436|NCT01459640|Osteoarthritis|osteoarthritis
5460437|NCT01459640|Bone marrow|bone marrow
5460438|NCT01459640|Mesenchymal stem cells|mesenchymal stem cells
5460439|NCT01459640|Autologous|autologous
5460440|NCT01459640|Mild osteoarthritis|mild osteoarthritis
5460441|NCT01459640|Moderate osteoarthritis|moderate osteoarthritis
5460442|NCT01459627|DAPT- Dual Antiplatelet Therapy|dapt- dual antiplatelet therapy
5460443|NCT01459627|STEMI|stemi
5460444|NCT01459601|diabetes mellitus|diabetes mellitus
5460445|NCT01459601|FBS|fbs
5460446|NCT01459601|HbA1C|hba1c
5460447|NCT01459601|Cabergoline|cabergoline
5460448|NCT01459575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5460449|NCT01459575|antiretroviral therapy|antiretroviral therapy
5460450|NCT01459575|China|china
5460451|NCT01459549|hepatolithiasis|hepatolithiasis
5460452|NCT01459549|sphincter of oddi laxity|sphincter of oddi laxity
5460453|NCT01459549|choledochojejunostomy|choledochojejunostomy
5460454|NCT01459536|Aging|aging
5460455|NCT01459523|Peripheral Nerve Block|peripheral nerve block
5460456|NCT01459523|Perineural Catheter|perineural catheter
5460457|NCT01459523|Orthopedic Surgery|orthopedic surgery
5460458|NCT01459523|Ultrasound|ultrasound
5460459|NCT01459510|Violence prevention|violence prevention
5460460|NCT01459510|Parenting|parenting
5460461|NCT01459510|Discipline|discipline
5460462|NCT01459497|non-small cell lung cancer|non-small cell lung cancer
5460463|NCT01459497|Stages II or III non-small cell lung cancer|stages ii or iii non-small cell lung cancer
5460464|NCT01459484|Non metastatic extremities high grade osteosarcoma|non metastatic extremities high grade osteosarcoma
5460465|NCT01459458|intimate partner violence|intimate partner violence
5460466|NCT01459458|gender-based violence|gender-based violence
5460467|NCT01459458|domestic violence|domestic violence
5460468|NCT01459458|unintended pregnancy|unintended pregnancy
5460469|NCT01459445|ethinylestradiol 30µg-drospirenone|ethinylestradiol 30µg-drospirenone
5460470|NCT01459445|flow-mediated dilatation|flow-mediated dilatation
5460471|NCT01459445|endothelial dysfunction|endothelial dysfunction
5460474|NCT01459445|polycystic ovary syndrome|polycystic ovary syndrome
5460475|NCT01459406|Gastrointestinal physiology|gastrointestinal physiology
5460476|NCT01459406|Gastrointestinal response to sugars|gastrointestinal response to sugars
5460477|NCT01459406|MRI|mri
5460478|NCT01459406|gastrointestinal|gastrointestinal
5460480|NCT01459406|small bowel|small bowel
5460481|NCT01459406|colon|colon
5460482|NCT01459406|glucose|glucose
5460483|NCT01459406|fructose|fructose
5460484|NCT01459406|fructan|fructan
5460485|NCT01459406|FODMAP|fodmap
5460486|NCT01459393|Actinic keratosis|actinic keratosis
5460487|NCT01459393|Photodynamic therapy|photodynamic therapy
5460488|NCT01459393|5-aminolevulinic acid|5-aminolevulinic acid
5460489|NCT01459393|Cryotherapy|cryotherapy
5460490|NCT01459367|Drug Therapy|drug therapy
5460491|NCT01459341|CLI Critical limb ischemia|cli critical limb ischemia
5460492|NCT01459341|PVD peripheral vascular disease|pvd peripheral vascular disease
5460493|NCT01459341|NIRS near infrared spectroscopy|nirs near infrared spectroscopy
5460494|NCT01459341|TCPO2 - transcutaneous oxygen pressure|tcpo2 - transcutaneous oxygen pressure
5460495|NCT01459328|rectal carcinoma|rectal carcinoma
5460496|NCT01459328|long course chemo-radiation|long course chemo-radiation
5460497|NCT01459328|short course chemo-rdiation|short course chemo-rdiation
5460498|NCT01459328|Locally Advanced Rectal Carcinoma|locally advanced rectal carcinoma
5460499|NCT01459315|Healthy|healthy
5460500|NCT01459315|Male|male
5460501|NCT01459315|GSK1349572|gsk1349572
5460502|NCT01459315|Dolutegravir|dolutegravir
5460503|NCT01459315|DTG|dtg
5460504|NCT01459315|Integrase|integrase
5460505|NCT01459315|HIV|hiv
5460506|NCT01459302|FALS|fals
5460507|NCT01459302|ALS|als
5460509|NCT01459302|MND|mnd
5460510|NCT01459302|SOD1|sod1
5460511|NCT01459302|ALS GENES|als genes
5460512|NCT01459302|PLS|pls
5460513|NCT01459302|PMA|pma
5460514|NCT01459302|ALS/FTD|als/ftd
5460515|NCT01459302|FAMILIAL ALS|familial als
5460516|NCT01459302|SPORADIC ALS|sporadic als
5460517|NCT01459302|GENETICS|genetics
5460518|NCT01459302|FTD|ftd
5460519|NCT01459302|Miyoshi myopathy|miyoshi myopathy
5460520|NCT01459276|seasonal|seasonal
5460521|NCT01459276|prevention|prevention
5460522|NCT01459276|influenza|influenza
5460523|NCT01459276|infection|infection
5460524|NCT01459276|influenza vaccine|influenza vaccine
5460525|NCT01459276|vaccine|vaccine
5447252|NCT01514175|Ketorolac|ketorolac
5460526|NCT01459276|influenza in humans|influenza in humans
5460528|NCT01459263|insufficiency|insufficiency
5460529|NCT01459263|ClariVein device|clarivein device
5460530|NCT01459263|safety|safety
5460531|NCT01459263|efficacy|efficacy
5460532|NCT01459263|QOL|qol
5460533|NCT01459250|AGO178C,|ago178c,
5460534|NCT01459250|renal impairment,|renal impairment,
5460535|NCT01459250|ESRD,|esrd,
5460536|NCT01459250|pharmacokinetics|pharmacokinetics
5460537|NCT01459237|Cushing's Disease|cushing's disease
5460538|NCT01459237|Microadenoma|microadenoma
5460539|NCT01459237|PET Imaging|pet imaging
5460540|NCT01459237|Cushing Disease Tumor|cushing disease tumor
5460541|NCT01459237|Pituitary Tumors|pituitary tumors
5460542|NCT01459211|CLL|cll
5460543|NCT01459185|Non-small cell lung cancer|non-small cell lung cancer
5460544|NCT01459185|Adjuvant chemotherapy|adjuvant chemotherapy
5460545|NCT01459185|oral fluoropyrimidine|oral fluoropyrimidine
5460546|NCT01459185|S-1|s-1
5460547|NCT01459185|Feasibility study|feasibility study
5460548|NCT01459185|Surgery|surgery
5460549|NCT01459172|breast cancer prevention|breast cancer prevention
5460550|NCT01459159|Hematology|hematology
5460551|NCT01459159|MDS|mds
5460552|NCT01459159|Myelodysplastic Syndrome|myelodysplastic syndrome
5460553|NCT01459159|Low risk MDS|low risk mds
5460554|NCT01459159|Int-1 risk MDS|int-1 risk mds
5460555|NCT01459159|Transfusion dependence|transfusion dependence
5460556|NCT01459159|Telintra|telintra
5460557|NCT01459159|ezatiostat|ezatiostat
5460558|NCT01459159|ezatiostat hydrochloride|ezatiostat hydrochloride
5460559|NCT01459159|TLK199|tlk199
5460560|NCT01459159|Glutathione|glutathione
5460561|NCT01459159|Glutathione analog|glutathione analog
5460562|NCT01459159|Glutathione Transferase|glutathione transferase
5460563|NCT01459159|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5460564|NCT01459159|GST P1-1 inhibitor|gst p1-1 inhibitor
5460565|NCT01459159|Apoptosis|apoptosis
5460566|NCT01459159|Differentiation|differentiation
5460584|NCT01459120|Community based testing|community based testing
5460585|NCT01459120|HIV/AIDS|hiv/aids
5460586|NCT01459120|Lesotho|lesotho
5460587|NCT01459107|Hand Transplant|hand transplant
5460588|NCT01459107|Composite Tissue Allotransplantation (CTA)|composite tissue allotransplantation (cta)
5460589|NCT01459107|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
5460590|NCT01459107|Composite Tissue|composite tissue
5460591|NCT01459107|Amputation|amputation
5460592|NCT01459107|Upper limb|upper limb
5460593|NCT01459107|Immunosuppression|immunosuppression
5460594|NCT01459094|Healthy Volunteers|healthy volunteers
5460595|NCT01459094|Oral bioavailability|oral bioavailability
5460596|NCT01459094|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5460597|NCT01459094|Metformin IR|metformin ir
5460598|NCT01459029|Schizophrenia|schizophrenia
5460599|NCT01459029|NMDA receptor|nmda receptor
5460601|NCT01459029|Recent onset|recent onset
5460602|NCT01459029|Negative symptoms|negative symptoms
5460603|NCT01459029|Cognition|cognition
5460604|NCT01459016|Mild Cognitive Impairment|mild cognitive impairment
5460605|NCT01459016|Brain Imaging Biomarkers|brain imaging biomarkers
5460606|NCT01459016|Magnetic resonance imaging biomarker|magnetic resonance imaging biomarker
5460607|NCT01459016|Positron Emission Tomography|positron emission tomography
5460608|NCT01458977|Lípid-lowering effect|lípid-lowering effect
5443093|NCT01531998|Velcade|velcade
5460609|NCT01458977|Tenofovir|tenofovir
5460610|NCT01458977|Dyslipidemia|dyslipidemia
5460611|NCT01458964|Fibromyalgia|fibromyalgia
5460612|NCT01458951|Tofacitinib|tofacitinib
5460613|NCT01458951|CP-690|cp-690
5460614|NCT01458951|550|550
5460615|NCT01458951|Moderate to severe ulcerative colitis|moderate to severe ulcerative colitis
5460616|NCT01458951|phase 3 clinical trial|phase 3 clinical trial
5460617|NCT01458951|Mayo score|mayo score
5460618|NCT01458925|Colorectal cancer|colorectal cancer
5460619|NCT01458925|Colonic polyps|colonic polyps
5460620|NCT01458899|Phase 1|phase 1
5460621|NCT01458899|healthy male|healthy male
5460622|NCT01458899|nonpregnant female|nonpregnant female
5460623|NCT01458899|volunteers|volunteers
5460624|NCT01458899|pharmacokinetics|pharmacokinetics
5460625|NCT01458899|TC 5214|tc 5214
5460626|NCT01458899|The effect of food on the pharmacokinetics of TC-5214|the effect of food on the pharmacokinetics of tc-5214
5460627|NCT01458873|infiltration|infiltration
5460628|NCT01458873|extravasation|extravasation
5460629|NCT01458847|bladder cancer|bladder cancer
5460630|NCT01458847|cis-urocanic acid|cis-urocanic acid
5460632|NCT01458847|recurrent|recurrent
5460633|NCT01458847|non-muscle|non-muscle
5460634|NCT01458834|Smoking|smoking
5460635|NCT01458834|Attentional bias|attentional bias
5460636|NCT01458834|Craving|craving
5460637|NCT01458821|Tinnitus|tinnitus
5460638|NCT01458808|salt|salt
5460639|NCT01458808|inflammation|inflammation
5460640|NCT01458808|hypervolemia|hypervolemia
5460641|NCT01458808|diet|diet
5460642|NCT01458782|Cartilage repair|cartilage repair
5460643|NCT01458782|Chondrocytes|chondrocytes
5460644|NCT01458782|Stemcells|stemcells
5460645|NCT01458756|liver transplant patients|liver transplant patients
5460646|NCT01458756|hepatic transplantation|hepatic transplantation
5460647|NCT01458743|pharmacokinetics|pharmacokinetics
5460648|NCT01458730|PCNSL|pcnsl
5460649|NCT01458730|Immunochemotherapy|immunochemotherapy
5460650|NCT01458730|Intraspinal Depocyt|intraspinal depocyt
5463777|NCT01445691|Surgery|surgery
5460663|NCT01458717|recurrence|recurrence
5460664|NCT01458717|response rate|response rate
5460665|NCT01458652|AST-120|ast-120
5460666|NCT01458652|HDF|hdf
5460667|NCT01458652|Replacement Volume described above|replacement volume described above
5460668|NCT01458639|Pulmonary embolism|pulmonary embolism
5460669|NCT01458639|PE|pe
5460670|NCT01458626|mirtazapine|mirtazapine
5460671|NCT01458626|paroxetine|paroxetine
5460672|NCT01458626|major depression|major depression
5460673|NCT01458626|early improvement|early improvement
5460674|NCT01458613|Maroteaux-Lamy Disease|maroteaux-lamy disease
5460675|NCT01458613|Biomarker|biomarker
5460676|NCT01458600|ophthalmopathy|ophthalmopathy
5460677|NCT01458600|prevention|prevention
5460678|NCT01458600|diclofenac|diclofenac
5460679|NCT01458587|Actinic keratosis|actinic keratosis
5460680|NCT01458574|Janus kinase inhibitor|janus kinase inhibitor
5460681|NCT01458574|JAK 3 inhibitor|jak 3 inhibitor
5460682|NCT01458574|inflammatory bowel disease|inflammatory bowel disease
5460683|NCT01458574|ulcerative colitis|ulcerative colitis
5460684|NCT01458574|OCTAVE|octave
5460685|NCT01458574|CP-690|cp-690
5460686|NCT01458574|550|550
5460687|NCT01458574|tofacitinib|tofacitinib
5460688|NCT01458574|Xeljanz|xeljanz
5460689|NCT01458561|Hemostatic agent|hemostatic agent
5460690|NCT01458561|Liver surgery|liver surgery
5460691|NCT01458561|Hemostasis|hemostasis
5460692|NCT01458548|1st-line therapy|1st-line therapy
5460693|NCT01458548|single agent rituximab|single agent rituximab
5460694|NCT01458548|CHOP|chop
5460695|NCT01458548|PTLD|ptld
5460696|NCT01458535|Genotype 1|genotype 1
5460697|NCT01458535|Genotype 2|genotype 2
5460698|NCT01458535|Genotype 3|genotype 3
5460699|NCT01458535|Hepatitis C Virus|hepatitis c virus
5460700|NCT01458535|ABT-450/r|abt-450/r
5460701|NCT01458535|Ribavirin|ribavirin
5460702|NCT01458535|ABT-267|abt-267
5460703|NCT01458535|Ombitasvir|ombitasvir
5460704|NCT01458535|Paritaprevir|paritaprevir
5460705|NCT01458522|Nonconvulsive Seizures|nonconvulsive seizures
5460706|NCT01458509|Quality of Life|quality of life
5460707|NCT01458509|patient outcomes|patient outcomes
5460708|NCT01458509|questionaires|questionaires
5460709|NCT01458509|11-101|11-101
5460710|NCT01458470|huntington|huntington
5460711|NCT01458470|huntingtin|huntingtin
5460712|NCT01458470|memantine|memantine
5460713|NCT01458470|ebixa|ebixa
5460714|NCT01458470|namenda|namenda
5460715|NCT01458444|Respiratory Insufficiency|respiratory insufficiency
5460716|NCT01458444|Cardiothoracic Surgery|cardiothoracic surgery
5460717|NCT01458444|Ventilation system|ventilation system
5460718|NCT01458431|cesarean section|cesarean section
5460719|NCT01458431|wound infusion|wound infusion
5460720|NCT01458431|Local anesthetic levobupivacaine|local anesthetic levobupivacaine
5460721|NCT01458431|Pain management|pain management
5460722|NCT01458418|Eosinophil|eosinophil
5460723|NCT01458418|Esophagitis|esophagitis
5460724|NCT01458405|Myocardial Infarction|myocardial infarction
5460725|NCT01458405|Heart Attack|heart attack
5460726|NCT01458405|Stem cell|stem cell
5460727|NCT01458405|Left ventricular dysfunction|left ventricular dysfunction
5460728|NCT01458405|Congestive heart failure|congestive heart failure
5460729|NCT01458366|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5460730|NCT01458366|Lymphoma|lymphoma
5460731|NCT01458366|B-Cell Lymphoma|b-cell lymphoma
5460732|NCT01458353|Right-sided colon cancer|right-sided colon cancer
5460733|NCT01458353|Ileocolonic anastomosis|ileocolonic anastomosis
5460734|NCT01458353|stapled anastomosis|stapled anastomosis
5460735|NCT01458353|handsewn anastomosis|handsewn anastomosis
5460736|NCT01458353|peritoneal contamination|peritoneal contamination
5460737|NCT01458353|microbiological spectrum|microbiological spectrum
5460738|NCT01458340|Adult ADHD|adult adhd
5460739|NCT01458340|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5460740|NCT01458327|MDMA|mdma
5460741|NCT01458327|PTSD|ptsd
5460742|NCT01458327|psychotherapy|psychotherapy
5460743|NCT01458314|Physical exercise|physical exercise
5460744|NCT01458314|Rehabilitation|rehabilitation
5460745|NCT01458314|NIV|niv
5460747|NCT01458275|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5460748|NCT01458275|Ciclesonide|ciclesonide
5460749|NCT01458275|Ciclesonide Nasal Aerosol|ciclesonide nasal aerosol
5460750|NCT01458262|cerebral oxymetry|cerebral oxymetry
5460751|NCT01458262|systemic oxymetry|systemic oxymetry
5460752|NCT01458262|hepatic surgery|hepatic surgery
5460753|NCT01458262|liver transplantation|liver transplantation
5460754|NCT01458249|Soft Tissue Sarcoma|soft tissue sarcoma
5460755|NCT01458223|spine surgery|spine surgery
5460756|NCT01458223|postoperative infection|postoperative infection
5460757|NCT01458223|postoperative antibiotics|postoperative antibiotics
5460758|NCT01458197|Overactive Bladder|overactive bladder
5460759|NCT01458197|Tarafenacin|tarafenacin
5460760|NCT01458184|risk factors for complications|risk factors for complications
5460761|NCT01458184|precarious medical situations|precarious medical situations
5460762|NCT01458171|Immune globulin subcutaneous|immune globulin subcutaneous
5460763|NCT01458171|SCIG|scig
5460764|NCT01458171|Primary immunodeficiency|primary immunodeficiency
5460765|NCT01458171|PID|pid
5460766|NCT01458158|Gelatinases|gelatinases
5460767|NCT01458158|kidney disease|kidney disease
5460768|NCT01458158|diabetes mellitus type 2|diabetes mellitus type 2
5460769|NCT01458132|subject follow-up|subject follow-up
5460770|NCT01458132|HIV infection|hiv infection
5460771|NCT01458132|registry|registry
5460772|NCT01458132|seizures|seizures
5460773|NCT01458132|GSK2248761|gsk2248761
5460774|NCT01458119|Amicus Therapeutics|amicus therapeutics
5460775|NCT01458119|AT1001|at1001
5460776|NCT01458119|Galafold|galafold
5460777|NCT01458119|Migalastat|migalastat
5460778|NCT01458080|ENABLE|enable
5460779|NCT01458080|invasive procedures|invasive procedures
5460780|NCT01458080|Thrombocytopenia|thrombocytopenia
5460781|NCT01458080|Thromboembolic events|thromboembolic events
5460782|NCT01458080|Eltrombopag|eltrombopag
5460783|NCT01458080|Hepatitis C|hepatitis c
5460784|NCT01458080|HCV|hcv
5460785|NCT01458054|pharmacokinetics|pharmacokinetics
5460786|NCT01458054|omeprazole|omeprazole
5460787|NCT01458054|ritonavir|ritonavir
5460788|NCT01458054|healthy subjects|healthy subjects
5460789|NCT01458054|drug interaction|drug interaction
5460790|NCT01458041|Critical limb ischaemia|critical limb ischaemia
5460791|NCT01458041|Iloprost|iloprost
5460792|NCT01458041|Quality of life|quality of life
5460793|NCT01458041|Visual analogue scale|visual analogue scale
5460794|NCT01458028|BAY85-3934|bay85-3934
5460795|NCT01458028|pharmacokinetics|pharmacokinetics
5460797|NCT01458028|gender|gender
5460798|NCT01458015|QST|qst
5460799|NCT01458015|neuropathic pain|neuropathic pain
5460800|NCT01458015|tapentadol pr|tapentadol pr
5460801|NCT01458015|oxycodone|oxycodone
5460802|NCT01457989|retention rate|retention rate
5460803|NCT01457989|epilepsy|epilepsy
5460804|NCT01457989|responder rate|responder rate
5460805|NCT01457989|seizure freedom|seizure freedom
5460806|NCT01457989|discontinuation rate|discontinuation rate
5460807|NCT01457989|safety assessment|safety assessment
5460808|NCT01457989|reduction in seizure frequency|reduction in seizure frequency
5460809|NCT01457989|open-label|open-label
5460811|NCT01457976|obesity|obesity
5460812|NCT01457976|personal responsibility|personal responsibility
5460813|NCT01457950|denosumab|denosumab
5460814|NCT01457950|Republic of Korea|republic of korea
5460815|NCT01457950|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5460816|NCT01457937|HCV|hcv
5460817|NCT01457937|Menopause|menopause
5460818|NCT01457937|Peg IFN|peg ifn
5460819|NCT01457937|Ribavirin|ribavirin
5460820|NCT01457937|Boceprevir|boceprevir
5460821|NCT01457924|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5460822|NCT01457924|Ofatumumab|ofatumumab
5460823|NCT01457898|Cardiac surgery|cardiac surgery
5460824|NCT01457898|Non-invasive ventilation|non-invasive ventilation
5460825|NCT01457885|AML|aml
5460826|NCT01457872|Heroin addiction|heroin addiction
5460827|NCT01457872|Substance use disorders|substance use disorders
5460828|NCT01457872|Substitution treatment|substitution treatment
5460829|NCT01457872|Syringe exchange|syringe exchange
5460830|NCT01457846|gastro-oesophageal junction cancer|gastro-oesophageal junction cancer
5460831|NCT01457846|gastric cancer|gastric cancer
5460832|NCT01457846|lower third oesophageal cancer|lower third oesophageal cancer
5460833|NCT01457846|polysomy|polysomy
5460834|NCT01457846|amplification|amplification
5460835|NCT01457846|FGFR|fgfr
5460836|NCT01457820|Allopurinol|allopurinol
5460837|NCT01457820|Angina|angina
5460838|NCT01457820|Acute coronary syndrome|acute coronary syndrome
5460839|NCT01457807|Phase 1|phase 1
5460840|NCT01457807|Parkinson's disease|parkinson's disease
5460841|NCT01457807|pharmacodynamic|pharmacodynamic
5460842|NCT01457807|biomarkers|biomarkers
5460843|NCT01457807|pharmacokinetics|pharmacokinetics
5460844|NCT01457807|extended release formulation|extended release formulation
5460845|NCT01457794|Metabolic Syndrome X|metabolic syndrome x
5460846|NCT01457794|Fatty Acids, Omega-3|fatty acids, omega-3
5460847|NCT01457794|Learning|learning
5460848|NCT01457794|Attention|attention
5460849|NCT01457794|Nutritional Status|nutritional status
5460850|NCT01457794|Nutrition Assessments|nutrition assessments
5460851|NCT01457794|Body Weight|body weight
5460852|NCT01457794|Physical Activity|physical activity
5460853|NCT01457794|Sleep|sleep
5460854|NCT01457794|Child Nutrition Sciences|child nutrition sciences
5460855|NCT01457781|Inhaled nitric oxide|inhaled nitric oxide
5460856|NCT01457781|pulmonary arterial hypertension|pulmonary arterial hypertension
5460857|NCT01457781|pulmonary hypertension|pulmonary hypertension
5460858|NCT01457781|PAH|pah
5460859|NCT01457768|Hepatitis C|hepatitis c
5460860|NCT01457768|HCV|hcv
5460861|NCT01457768|Sustained Virologic Response|sustained virologic response
5460862|NCT01457768|Direct Acting Antiviral|direct acting antiviral
5460863|NCT01457768|Combination Therapy|combination therapy
5460864|NCT01457768|Tegobuvir|tegobuvir
5460865|NCT01457768|Registry|registry
5460866|NCT01457768|HCV RNA|hcv rna
5460867|NCT01457768|Treatment experienced|treatment experienced
5460868|NCT01457768|Treatment naive|treatment naive
5460869|NCT01457768|GS 9451|gs 9451
5460870|NCT01457768|GS 5885|gs 5885
5460871|NCT01457768|Sequence|sequence
5460872|NCT01457768|GS 5816|gs 5816
5460873|NCT01457768|GS 7977|gs 7977
5460874|NCT01457768|Sofosbuvir|sofosbuvir
5460875|NCT01457768|Sovaldi™|sovaldi™
5460876|NCT01457768|SOF|sof
5460877|NCT01457768|Ledipasvir|ledipasvir
5460878|NCT01457768|LDV|ldv
5460879|NCT01457755|Hepatitis C|hepatitis c
5460880|NCT01457755|HCV|hcv
5460881|NCT01457755|Sustained Virologic Response|sustained virologic response
5460882|NCT01457755|Direct Acting Antiviral|direct acting antiviral
5460883|NCT01457755|Combination Therapy|combination therapy
5460884|NCT01457755|Tegobuvir|tegobuvir
5460885|NCT01457755|Registry|registry
5460886|NCT01457755|HCV RNA|hcv rna
5460887|NCT01457755|Treatment experienced|treatment experienced
5460888|NCT01457755|Treatment naive|treatment naive
5460889|NCT01457755|GS 9451|gs 9451
5460890|NCT01457755|GS 5885|gs 5885
5460891|NCT01457755|GS 7977|gs 7977
5460892|NCT01457755|GS 5816|gs 5816
5460893|NCT01457755|Sofosbuvir|sofosbuvir
5460894|NCT01457755|Sovaldi™|sovaldi™
5460895|NCT01457755|SOF|sof
5460896|NCT01457755|Ledipasvir|ledipasvir
5460898|NCT01457742|Osteoarthritis|osteoarthritis
5460899|NCT01457729|ergometer|ergometer
5460900|NCT01457729|training|training
5460901|NCT01457729|motivation|motivation
5460902|NCT01457729|telemonitoring|telemonitoring
5460903|NCT01457729|sleep apnea|sleep apnea
5460904|NCT01457716|Healthy volunteer study|healthy volunteer study
5460905|NCT01457703|LH pulsatility|lh pulsatility
5460906|NCT01457703|Obesity|obesity
5460907|NCT01457703|Reproduction|reproduction
5460908|NCT01457690|Vitamin E pegylated|vitamin e pegylated
5460909|NCT01457690|chylomicron retention|chylomicron retention
5460910|NCT01457690|Familial Hypocholesterolemia|familial hypocholesterolemia
5460911|NCT01457690|Hypobetalipoproteinemias|hypobetalipoproteinemias
5460912|NCT01457651|Recruitment|recruitment
5460913|NCT01457651|Coronary artery bypass grafting|coronary artery bypass grafting
5460914|NCT01457651|Postoperative period|postoperative period
5460915|NCT01457638|nasal obstruction|nasal obstruction
5460916|NCT01457638|rhinoplasty|rhinoplasty
5460917|NCT01457638|turbinate surgery|turbinate surgery
5460918|NCT01457638|quality of life|quality of life
5460919|NCT01457638|acoustic rhinometry|acoustic rhinometry
5460920|NCT01457625|fetuin A liver fat content visceral obesity mortality|fetuin a liver fat content visceral obesity mortality
5460921|NCT01457612|Insulin Resistant|insulin resistant
5460922|NCT01457612|Dietary Supplements|dietary supplements
5460923|NCT01457612|Nutrition|nutrition
5460924|NCT01457612|Antioxidant|antioxidant
5460925|NCT01457612|Inflammation|inflammation
5460926|NCT01457599|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response|liver-colorectal metastases-computertomography-guided-wire-chemotherapy-complete response
5460927|NCT01457599|Feasibility, safety|feasibility, safety
5460928|NCT01457586|Heart Surgery|heart surgery
5460929|NCT01457586|Blood Transfusion|blood transfusion
5460930|NCT01457586|Postoperative Complications|postoperative complications
5460931|NCT01457560|Oral polio vaccine (OPV)|oral polio vaccine (opv)
5460932|NCT01457560|DTPa-HBV-IPV/Hib vaccine|dtpa-hbv-ipv/hib vaccine
5460933|NCT01457547|HEXAVACTM|hexavactm
5460934|NCT01457547|InfanrixTM HEXA|infanrixtm hexa
5460935|NCT01457547|DTPa-HBV-IPV-Hib|dtpa-hbv-ipv-hib
5460936|NCT01457547|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5460937|NCT01457521|pain|pain
5460938|NCT01457521|medical abortion|medical abortion
5460939|NCT01457508|combination vaccine|combination vaccine
5460940|NCT01457508|DTPa-HBV-IPV|dtpa-hbv-ipv
5460941|NCT01457508|Hib|hib
5460942|NCT01457495|Infants|infants
5460943|NCT01457495|combined vaccine|combined vaccine
5460944|NCT01457495|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5460945|NCT01457495|DTPa-IPV/Hib|dtpa-ipv/hib
5460946|NCT01457495|safety|safety
5460947|NCT01457495|Immunogenicity|immunogenicity
5460948|NCT01457495|HBV|hbv
5460949|NCT01457482|Fear|fear
5460950|NCT01457482|Childbirth|childbirth
5460951|NCT01457482|Art therapy|art therapy
5460952|NCT01457482|Therapeutic conversations|therapeutic conversations
5460953|NCT01457482|W-DEQ|w-deq
5460954|NCT01457456|Biomarker|biomarker
5460955|NCT01457456|Morquio Disease|morquio disease
5460957|NCT01457443|Biomarker|biomarker
5460958|NCT01457417|Cancer|cancer
5460959|NCT01457417|Oncology|oncology
5460960|NCT01457404|integrated cognitive behavioral therapy|integrated cognitive behavioral therapy
5460961|NCT01457404|cognitive behavioral therapy|cognitive behavioral therapy
5460962|NCT01457404|addiction|addiction
5460963|NCT01457404|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5460964|NCT01457391|cognitive behavioral therapy|cognitive behavioral therapy
5460965|NCT01457391|addiction|addiction
5460966|NCT01457391|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5460967|NCT01457378|Gastrointestinal symptoms|gastrointestinal symptoms
5460968|NCT01457378|healthy subjects|healthy subjects
5460969|NCT01457378|IBS|ibs
5460970|NCT01457378|HRQoL|hrqol
5460971|NCT01457378|questionnaires|questionnaires
5460972|NCT01457352|spasticity|spasticity
5460973|NCT01457339|Schizophrenia|schizophrenia
5460974|NCT01457326|Immersion therapy|immersion therapy
5460975|NCT01457326|early weight bearing physical therapy|early weight bearing physical therapy
5460976|NCT01457300|Rehabilitation outcome|rehabilitation outcome
5460977|NCT01457300|Aged|aged
5460978|NCT01457300|Aged, 80 and over|aged, 80 and over
5460979|NCT01457300|Activities of daily living|activities of daily living
5460980|NCT01457274|AMBULATORY CARE|ambulatory care
5460981|NCT01457274|AWARENESS AND RECALL|awareness and recall
5460982|NCT01457274|Propofol|propofol
5460983|NCT01457274|Patient Safety and Satisfaction|patient safety and satisfaction
5460984|NCT01457274|Colonoscopy|colonoscopy
5460985|NCT01457274|Elective outpatient colonoscopy|elective outpatient colonoscopy
5460986|NCT01457274|Procedural sedation|procedural sedation
5460987|NCT01457261|interstitial lung disease|interstitial lung disease
5460988|NCT01457261|drug deposition|drug deposition
5460989|NCT01457261|lung imaging|lung imaging
5460990|NCT01457261|respiratory|respiratory
5460991|NCT01457248|after aortic surgery|after aortic surgery
5460992|NCT01457235|Bipolar disorder|bipolar disorder
5460993|NCT01457235|Cognitive Remediation|cognitive remediation
5460994|NCT01457235|Cognition|cognition
5460995|NCT01457235|Cognitive function|cognitive function
5460996|NCT01457235|Mood disorders|mood disorders
5460997|NCT01457235|Affective disorders|affective disorders
5460998|NCT01457222|Mindfulness|mindfulness
5461000|NCT01457222|Cognition|cognition
5461001|NCT01457222|Psychological health|psychological health
5461002|NCT01457222|Primary prevention|primary prevention
5461003|NCT01457209|PCOS|pcos
5461004|NCT01457209|Insulin resistance|insulin resistance
5461005|NCT01457209|Acupuncture|acupuncture
5461006|NCT01457196|Cancer Genetics|cancer genetics
5461007|NCT01457183|pulsed lavage|pulsed lavage
5461008|NCT01457183|evaluate containment|evaluate containment
5461009|NCT01457183|evaluate tolerability|evaluate tolerability
5461010|NCT01457170|Pulmonary Hypertension|pulmonary hypertension
5461011|NCT01457170|Heart Failure|heart failure
5461012|NCT01457170|Apelin|apelin
5461013|NCT01457170|Haemodynamics|haemodynamics
5461014|NCT01457170|pulmonary vascular resistance|pulmonary vascular resistance
5903983|NCT00086567|CA125|ca125
5461015|NCT01457170|cardiac output|cardiac output
5461016|NCT01457144|Mantle cell lymphoma|mantle cell lymphoma
5461017|NCT01457144|Rituximab|rituximab
5461018|NCT01457144|bendamustine|bendamustine
5461019|NCT01457144|Velcade|velcade
5461020|NCT01457144|Dexamethasone|dexamethasone
5461021|NCT01457131|Metastatic Cancer|metastatic cancer
5461022|NCT01457131|Immunotherapy|immunotherapy
5461023|NCT01457131|Gene Therapy|gene therapy
5461024|NCT01457131|Metastatic Melanoma|metastatic melanoma
5461025|NCT01457131|Metastatic Kidney Cancer|metastatic kidney cancer
5461026|NCT01457118|Open Label multicenter extension study advanced solid tumors|open label multicenter extension study advanced solid tumors
5461027|NCT01457105|Malignant strictures of the main biliary duct|malignant strictures of the main biliary duct
5461028|NCT01457092|benign biliary strictures|benign biliary strictures
5461029|NCT01457092|chronic pancreatitis|chronic pancreatitis
5461030|NCT01457079|Keloid|keloid
5461031|NCT01457079|Radiation Therapy|radiation therapy
5461032|NCT01457079|Hypertrophic Scar|hypertrophic scar
5461033|NCT01457053|Acute decompensated heart failure|acute decompensated heart failure
5461034|NCT01457053|Myocardial blood flow|myocardial blood flow
5461035|NCT01457053|Coronary flow reserve|coronary flow reserve
5461036|NCT01457053|Ultrafiltration|ultrafiltration
5461037|NCT01457053|Diuretics|diuretics
5461038|NCT01457040|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5461039|NCT01457040|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5461040|NCT01457027|Influenza|influenza
5461041|NCT01457027|Virus|virus
5461042|NCT01457027|Vaccination|vaccination
5461043|NCT01457027|Immunisation|immunisation
5461044|NCT01457014|chronic pain|chronic pain
5461045|NCT01457014|sleep disordered breathing|sleep disordered breathing
5461046|NCT01457014|Opioids|opioids
5461047|NCT01457001|chronic haemodialysis|chronic haemodialysis
5461048|NCT01457001|25-OH-D vitamin|25-oh-d vitamin
5461049|NCT01456975|Ascending aorta aneurism|ascending aorta aneurism
5461050|NCT01456975|Aortic insufficiency|aortic insufficiency
5461051|NCT01456962|Immune reconstitution|immune reconstitution
5461053|NCT01456949|Atrial fibrillation (AF)|atrial fibrillation (af)
5461054|NCT01456949|Paroxysmal atrial fibrillation (PAF)|paroxysmal atrial fibrillation (paf)
5461055|NCT01456949|Arrythmias|arrythmias
5461056|NCT01456949|Cardiac Arrythmias|cardiac arrythmias
5461057|NCT01456949|Cardiac ablation|cardiac ablation
5461058|NCT01456949|Cryoablation|cryoablation
5461059|NCT01456936|smoking cessation|smoking cessation
5461060|NCT01456936|psychiatric disease|psychiatric disease
5461061|NCT01456923|DNA damaging agents|dna damaging agents
5461062|NCT01456910|Physical education|physical education
5461063|NCT01456910|People with mental disabilities|people with mental disabilities
5461064|NCT01456910|muscular strength dynamometer|muscular strength dynamometer
5461065|NCT01456910|Performance Evaluation|performance evaluation
5461066|NCT01456910|Occupational health|occupational health
5461067|NCT01456884|Music therapy|music therapy
5461069|NCT01456884|Children|children
5461070|NCT01456884|Adolescents|adolescents
5461071|NCT01456884|pediatric|pediatric
5461072|NCT01456884|palliative care|palliative care
5461073|NCT01456884|neurological impairment|neurological impairment
5461074|NCT01456884|metabolic condition|metabolic condition
5461075|NCT01456884|pain management|pain management
5461076|NCT01456871|Mechanoreceptors|mechanoreceptors
5461077|NCT01456871|PIP joint|pip joint
5461078|NCT01456871|Ligamento-muscular reflexes|ligamento-muscular reflexes
5461079|NCT01456858|Malaria Prevention Refugee Emergency|malaria prevention refugee emergency
5461080|NCT01456858|Malaria, Falciparum C03.752.530.650|malaria, falciparum c03.752.530.650
5461081|NCT01456845|Plasma levels|plasma levels
5461082|NCT01456845|isoniazid|isoniazid
5461083|NCT01456845|rifampicin|rifampicin
5461084|NCT01456845|pyrazinamide|pyrazinamide
5461085|NCT01456845|hepatoxicity|hepatoxicity
5461086|NCT01456832|hyponatremia|hyponatremia
5461087|NCT01456832|renal transplant|renal transplant
5461088|NCT01456819|autologous|autologous
5461089|NCT01456819|bone marrow|bone marrow
5461090|NCT01456819|critical limb ischemia|critical limb ischemia
5461091|NCT01456819|efficacy|efficacy
5461092|NCT01456819|mesenchymal stem cells|mesenchymal stem cells
5461093|NCT01456819|mononuclear cells|mononuclear cells
5461094|NCT01456806|T2DM|t2dm
5461095|NCT01456806|Cardiovascular risk factors|cardiovascular risk factors
5461096|NCT01456806|Metabolic control|metabolic control
5461097|NCT01456806|Well-being|well-being
5461098|NCT01456806|Cost|cost
5461099|NCT01456806|Cost-consequence|cost-consequence
5461100|NCT01456793|Pregnancy prevention|pregnancy prevention
5461101|NCT01456793|Pregnancy|pregnancy
5461102|NCT01456793|Birth|birth
5461103|NCT01456793|Contraceptive use|contraceptive use
5461104|NCT01456793|Adolescents|adolescents
5461105|NCT01456780|Meibomian gland dysfunction|meibomian gland dysfunction
5461106|NCT01456780|Blepharitis|blepharitis
5461107|NCT01456780|Dry Eye|dry eye
5461108|NCT01456780|Ocular Inflammation|ocular inflammation
5461109|NCT01456780|MGD|mgd
5461110|NCT01456780|Zylet|zylet
5461111|NCT01456780|Lotemax|lotemax
5461112|NCT01456780|Artificial Tear|artificial tear
5461113|NCT01456754|Insulin Metabolism|insulin metabolism
5461114|NCT01456754|Glucose Metabolism|glucose metabolism
5461115|NCT01456754|Substrate Partitioning|substrate partitioning
5461116|NCT01456754|Muscle Biopsies|muscle biopsies
5461117|NCT01456754|Feeding Frequency|feeding frequency
5461119|NCT01456741|endobronchial needle aspiration (EBNA)|endobronchial needle aspiration (ebna)
5461120|NCT01456741|transbronchial needle aspiration (TBNA)|transbronchial needle aspiration (tbna)
5461121|NCT01456741|rapid on-site evaluation (ROSE)|rapid on-site evaluation (rose)
5461122|NCT01456741|lung cancer|lung cancer
5461123|NCT01456728|Helicobacter pylori|helicobacter pylori
5461124|NCT01456728|Progastria|progastria
5461125|NCT01456728|Lactobacillus reuteri|lactobacillus reuteri
5461126|NCT01456728|omeprazole|omeprazole
5461127|NCT01456728|triple therapy|triple therapy
5461128|NCT01456728|probiotic|probiotic
5461129|NCT01456715|Human Papillomavirus Vaccines|human papillomavirus vaccines
5461130|NCT01456715|Immunogenicity Gardasil Cervarix|immunogenicity gardasil cervarix
5461131|NCT01456715|Booster dose|booster dose
5461132|NCT01456702|SVV|svv
5461133|NCT01456702|hemodynamic monitoring|hemodynamic monitoring
5461134|NCT01456702|goal-directed volume therapie|goal-directed volume therapie
5461135|NCT01456689|Myeloma|myeloma
5461136|NCT01456689|Multiple Myeloma|multiple myeloma
5461137|NCT01456689|MM|mm
5461138|NCT01456676|LDE225|lde225
5461139|NCT01456676|nilotinib|nilotinib
5461140|NCT01456676|Chronic myeloid leukemia|chronic myeloid leukemia
5461141|NCT01456676|CML|cml
5461142|NCT01456676|Philadelphia positive|philadelphia positive
5461143|NCT01456676|Ph+|ph+
5461144|NCT01456676|resistant|resistant
5461145|NCT01456676|Resistant Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)|resistant philadelphia chromosome positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp)
5461146|NCT01456663|AFQ056|afq056
5461147|NCT01456663|Hepatic impairment|hepatic impairment
5461148|NCT01456663|Hepatic impaired|hepatic impaired
5461149|NCT01456650|Type 2 diabetes|type 2 diabetes
5461150|NCT01456650|ABCA1 alleles|abca1 alleles
5461151|NCT01456650|Glyburide|glyburide
5461152|NCT01456637|Insomnia|insomnia
5461153|NCT01456637|Intervention|intervention
5461154|NCT01456637|Self-help|self-help
5461155|NCT01456637|Internet|internet
5461156|NCT01456598|Stomach neoplasm|stomach neoplasm
5461157|NCT01456598|Laparoscopy|laparoscopy
5461158|NCT01456585|Histological documentation|histological documentation
5461159|NCT01456585|primary adenocarcinoma of the pancreas|primary adenocarcinoma of the pancreas
5461160|NCT01456585|surgically eligible|surgically eligible
5461161|NCT01456585|tumor resection|tumor resection
5461162|NCT01456585|curative intent|curative intent
5461163|NCT01456572|glucagon-like peptide-1|glucagon-like peptide-1
5461164|NCT01456572|peptide tyrosine tyrosine|peptide tyrosine tyrosine
5461167|NCT01456572|small intestine|small intestine
5461168|NCT01456572|gastric emptying|gastric emptying
5461169|NCT01456559|Hypovolemia|hypovolemia
5461170|NCT01456559|Lower body negative pressure|lower body negative pressure
5461171|NCT01456559|Photoplethysmography|photoplethysmography
5461172|NCT01456546|CYP2C19*17|cyp2c19*17
5461173|NCT01456546|Pharmacokinetics|pharmacokinetics
5461174|NCT01456546|Pharmacodynamics|pharmacodynamics
5461175|NCT01456533|hyponatremia|hyponatremia
5461176|NCT01456533|hypernatremia|hypernatremia
5461177|NCT01456520|pharmacokinetics|pharmacokinetics
5461178|NCT01456520|bioequivalence|bioequivalence
5461179|NCT01456520|hydrocodone|hydrocodone
5461180|NCT01456520|acetaminophen|acetaminophen
5461181|NCT01456520|moderate to moderately severe pain|moderate to moderately severe pain
5461182|NCT01456507|Food effect|food effect
5461183|NCT01456507|bioavailability|bioavailability
5461184|NCT01456507|oxycodone|oxycodone
5461185|NCT01456507|sequestered Naltrexone|sequestered naltrexone
5461186|NCT01456507|management of moderate to severe pain|management of moderate to severe pain
5461187|NCT01456494|Obstructive Lung Disease|obstructive lung disease
5461188|NCT01456494|COPD|copd
5461189|NCT01456494|Asthma|asthma
5461190|NCT01456494|Inhaler|inhaler
5461191|NCT01456494|Metered-Dose Inhaler|metered-dose inhaler
5461192|NCT01456494|Education|education
5461193|NCT01456494|Hospital-based education|hospital-based education
5461194|NCT01456481|reflex fainting|reflex fainting
5461195|NCT01456481|vasovagal syncope|vasovagal syncope
5461196|NCT01456481|midodrine|midodrine
5461197|NCT01456468|Cholangitis, Sclerosing|cholangitis, sclerosing
5461198|NCT01456468|Tretinoin|tretinoin
5461199|NCT01456468|Ursodeoxycholic Acid|ursodeoxycholic acid
5461200|NCT01456455|Central nervous system|central nervous system
5461201|NCT01456455|pathological markers|pathological markers
5461202|NCT01456429|invasive staging|invasive staging
5461203|NCT01456429|mediastinal lymph nodes|mediastinal lymph nodes
5461204|NCT01456429|endosonography|endosonography
5461205|NCT01456429|surgical staging|surgical staging
5461206|NCT01456429|lung cancer|lung cancer
5461207|NCT01456416|RRMS|rrms
5461208|NCT01456416|Multiple Sclerosis|multiple sclerosis
5461209|NCT01456416|Glatiramer Acetate|glatiramer acetate
5461210|NCT01456416|Autoimmune Comorbidities|autoimmune comorbidities
5461211|NCT01456416|Psoriasis|psoriasis
5461212|NCT01456416|Autoimmune Thyroiditis|autoimmune thyroiditis
5461213|NCT01456416|Vasculitis|vasculitis
5461214|NCT01456416|Rheumatoid Arthritis|rheumatoid arthritis
5461216|NCT01456403|endarterectomy|endarterectomy
5461217|NCT01456403|vulnerable plaque|vulnerable plaque
5461218|NCT01456403|Ultrasound|ultrasound
5461220|NCT01456403|PET/CT|pet/ct
5461221|NCT01456390|Open angle glaucoma|open angle glaucoma
5461222|NCT01456390|Prior trabeculectomy|prior trabeculectomy
5461223|NCT01456377|lumbar stenosis|lumbar stenosis
5461224|NCT01456377|systemic corticosteroids|systemic corticosteroids
5461225|NCT01456377|outcome|outcome
5461226|NCT01456377|security|security
5461227|NCT01456364|clopidogrel low response|clopidogrel low response
5461228|NCT01456364|ticagrelor|ticagrelor
5461229|NCT01456364|prasugrel|prasugrel
5461230|NCT01456364|platelet aggregation|platelet aggregation
5461231|NCT01456351|Event free survival|event free survival
5461232|NCT01456351|Remission rates|remission rates
5461233|NCT01456351|Toxicity|toxicity
5461234|NCT01456351|Overall survival|overall survival
5461235|NCT01456351|Efficiency costs|efficiency costs
5461236|NCT01456351|Recurrent low grade|recurrent low grade
5461237|NCT01456338|cognitive behavior therapy|cognitive behavior therapy
5461238|NCT01456338|addiction|addiction
5461239|NCT01456338|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5461240|NCT01456312|Peginterferon alfa 2a|peginterferon alfa 2a
5461241|NCT01456312|Entecavir|entecavir
5461242|NCT01456312|Response Guided Therapy|response guided therapy
5461243|NCT01456312|Chronic Hepatitis B|chronic hepatitis b
5461244|NCT01456299|laryngeal mask airway|laryngeal mask airway
5461245|NCT01456299|insertion|insertion
5461246|NCT01456299|sevoflurane|sevoflurane
5461247|NCT01456299|remifentanil|remifentanil
5461248|NCT01456273|biopsychosocial model|biopsychosocial model
5461249|NCT01456273|biomedical model|biomedical model
5461250|NCT01456273|functional dyspepsia|functional dyspepsia
5461251|NCT01456260|Drug Therapy|drug therapy
5461252|NCT01456247|Drug Therapy|drug therapy
5461254|NCT01456221|Insulin resistance|insulin resistance
5461255|NCT01456221|Omega3 long chain polyunsaturated fatty acids|omega3 long chain polyunsaturated fatty acids
5461256|NCT01456195|Drug Therapy|drug therapy
5461257|NCT01456169|High Blood Pressure|high blood pressure
5461258|NCT01456169|Drug Therapy|drug therapy
5461259|NCT01456156|hepatocellular carcinoma|hepatocellular carcinoma
5461260|NCT01456156|postoperative radiotherapy|postoperative radiotherapy
5461261|NCT01456143|Squamous Cell Carcinoma|squamous cell carcinoma
5461263|NCT01456143|Optical imaging|optical imaging
5461264|NCT01456143|Head and Neck Cancer|head and neck cancer
5461265|NCT01456143|Oropharynx|oropharynx
5461266|NCT01456143|Larynx|larynx
5461267|NCT01456143|Oral Cavity|oral cavity
5461268|NCT01456117|Drug Therapy|drug therapy
5461269|NCT01456117|pharmacodynamics|pharmacodynamics
5461270|NCT01456117|pharmacokinetics|pharmacokinetics
5461271|NCT01456104|vaccine|vaccine
5461272|NCT01456104|stage IIB|stage iib
5461273|NCT01456104|stage IIC|stage iic
5461274|NCT01456104|stage III|stage iii
5461275|NCT01456104|stage IV (MIa)|stage iv (mia)
5461276|NCT01456104|Langerhans-type dendritic cells|langerhans-type dendritic cells
5461277|NCT01456104|Immune Responses|immune responses
5461278|NCT01456104|10-229|10-229
5461279|NCT01456091|adolescent pregnancy|adolescent pregnancy
5461280|NCT01456091|adolescent birth|adolescent birth
5461281|NCT01456091|rapid repeat pregnancy|rapid repeat pregnancy
5461282|NCT01456091|rapid repeat birth|rapid repeat birth
5461283|NCT01456091|youth development|youth development
5461284|NCT01456091|Pregnancy in Adolescence|pregnancy in adolescence
5461285|NCT01456078|Neuroendocrine tumor|neuroendocrine tumor
5461286|NCT01456078|Liver metastases|liver metastases
5461287|NCT01456078|177Lu-DOTA-TATE|177lu-dota-tate
5461288|NCT01456078|Safety|safety
5461289|NCT01456078|Kidney dosimetry|kidney dosimetry
5461290|NCT01456078|Dose escalation|dose escalation
5461291|NCT01456078|Neuroendocrine tumors, with liver metastases.|neuroendocrine tumors, with liver metastases.
5461292|NCT01456026|Diabetes|diabetes
5461293|NCT01456026|Advanced glycation endproducts|advanced glycation endproducts
5461294|NCT01456026|Endothelium|endothelium
5461295|NCT01456000|atrial fibrillation|atrial fibrillation
5461296|NCT01456000|AF|af
5461297|NCT01456000|PAF|paf
5461298|NCT01456000|PVI|pvi
5461299|NCT01456000|ablation|ablation
5461300|NCT01456000|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5461301|NCT01456000|pulmonary vein isolation|pulmonary vein isolation
5461302|NCT01455987|Osteochondritis dissecans|osteochondritis dissecans
5461303|NCT01455987|Juvenile osteochondritis dissecans|juvenile osteochondritis dissecans
5461304|NCT01455987|Knee|knee
5461305|NCT01455987|Osteochondral|osteochondral
5461306|NCT01455987|Outcome|outcome
5461307|NCT01455974|hypertension|hypertension
5461308|NCT01455974|arterial stiffness|arterial stiffness
5461309|NCT01455974|left ventricular hypertrophy|left ventricular hypertrophy
5461310|NCT01455961|Real life setting|real life setting
5461311|NCT01455961|Bipolar Disorder|bipolar disorder
5461312|NCT01455961|Registry based Data Base Audit|registry based data base audit
5461313|NCT01455948|sinusitis|sinusitis
5461314|NCT01455948|chronic|chronic
5461315|NCT01455948|Functional endoscopic sinus surgery|functional endoscopic sinus surgery
5461316|NCT01455948|balloon sinuplasty|balloon sinuplasty
5461317|NCT01455844|Hypertriglyceridemia|hypertriglyceridemia
5461318|NCT01455792|Biopsy|biopsy
5461319|NCT01455792|MRI and ultrasound soft image fusion|mri and ultrasound soft image fusion
5461320|NCT01455792|Gold standard TRUS biopsy|gold standard trus biopsy
5461321|NCT01455779|Stress Urinary Incontinence|stress urinary incontinence
5461322|NCT01455779|Incontinence|incontinence
5461323|NCT01455779|SUI|sui
5461324|NCT01455779|Renessa|renessa
5461325|NCT01455766|postpneumonectomy pulmonary edema|postpneumonectomy pulmonary edema
5461326|NCT01455766|extravascular lung water|extravascular lung water
5461327|NCT01455753|Influenza|influenza
5461328|NCT01455753|Proximity|proximity
5461329|NCT01455740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5461330|NCT01455740|HIV|hiv
5461331|NCT01455740|Commitment|commitment
5461332|NCT01455740|Financial Incentives|financial incentives
5461333|NCT01455727|Pharmaceutical care|pharmaceutical care
5461334|NCT01455727|Diabetes Mellitus|diabetes mellitus
5461335|NCT01455714|hypertenion|hypertenion
5461336|NCT01455714|exertional dyspnoea|exertional dyspnoea
5461337|NCT01455714|heart failure|heart failure
5461338|NCT01455714|biomarkers|biomarkers
5461339|NCT01455688|critically ill patients|critically ill patients
5461340|NCT01455688|HIV infection|hiv infection
5461341|NCT01455688|HAART|haart
5461342|NCT01455688|mortality|mortality
5461343|NCT01455675|cystic fibrosis|cystic fibrosis
5461344|NCT01455662|cardiac arrest|cardiac arrest
5461345|NCT01455649|Kidney|kidney
5461346|NCT01455649|Transplant|transplant
5461347|NCT01455649|Immunosuppression|immunosuppression
5461348|NCT01455649|Everolimus|everolimus
5461349|NCT01455649|Graft function|graft function
5461350|NCT01455636|pediatric|pediatric
5461351|NCT01455636|micronutrient powder|micronutrient powder
5461353|NCT01455636|low birth weight|low birth weight
5461354|NCT01455636|infant feeding|infant feeding
5461371|NCT01455519|Low Back Pain|low back pain
5461372|NCT01455519|Back Pain|back pain
5461373|NCT01455519|Chronic back pain|chronic back pain
5461374|NCT01455506|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5461375|NCT01455506|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5461376|NCT01455506|Bone Marrow Transplant|bone marrow transplant
5461377|NCT01455506|Stem Cell Transplant|stem cell transplant
5461378|NCT01455480|Second Degree Burn|second degree burn
5461379|NCT01455480|partial thickness burns|partial thickness burns
5461380|NCT01455467|Open angle glaucoma|open angle glaucoma
5461381|NCT01455467|Pigmentary glaucoma|pigmentary glaucoma
5461382|NCT01455467|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5461383|NCT01455441|GLP-1|glp-1
5461384|NCT01455441|Training|training
5461385|NCT01455441|Exercise|exercise
5461386|NCT01455441|Type 2 Diabetes|type 2 diabetes
5461387|NCT01455428|Pregabalin|pregabalin
5461388|NCT01455428|Postherpetic Neuralgia ( PHN )|postherpetic neuralgia ( phn )
5461389|NCT01455402|Respiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Observational|respiratory syncytial virus, chronic obstructive pulmonary disease, congestive heart failure, observational
5461390|NCT01455389|Lung Cancer|lung cancer
5461490|NCT01455012|Neupro|neupro
5461391|NCT01455389|Non-small cell lung cancer|non-small cell lung cancer
5461392|NCT01455389|NSCLC|nsclc
5461393|NCT01455389|FUS1-nanoparticles|fus1-nanoparticles
5461394|NCT01455389|DOTAP:Chol-TUSC2|dotap:chol-tusc2
5461395|NCT01455389|DOTAP:Cholesterol-TUSC2 Liposome Complex|dotap:cholesterol-tusc2 liposome complex
5461396|NCT01455389|Erlotinib|erlotinib
5461397|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride
5461398|NCT01455389|OSI-774|osi-774
5461399|NCT01455389|Tarceva|tarceva
5461400|NCT01455389|Dexamethasone|dexamethasone
5461401|NCT01455389|Decadron|decadron
5461402|NCT01455389|Diphenhydramine|diphenhydramine
5461403|NCT01455389|Benadryl|benadryl
5461404|NCT01455389|Benylin Cough SyrupPharmacokinetic|benylin cough syruppharmacokinetic
5461405|NCT01455389|PK|pk
5461406|NCT01455376|brain injury|brain injury
5461407|NCT01455376|cognitive function|cognitive function
5461408|NCT01455376|sodium lactate|sodium lactate
5461409|NCT01455376|MMSE score|mmse score
5461410|NCT01455350|provoked vestibulodynia|provoked vestibulodynia
5461411|NCT01455350|multimodal physiotherapy|multimodal physiotherapy
5461412|NCT01455350|lidocaine|lidocaine
5461413|NCT01455337|severe alcoholic hepatitis|severe alcoholic hepatitis
5461414|NCT01455324|prosthetic socket|prosthetic socket
5461415|NCT01455324|residual limb volume fluctuation|residual limb volume fluctuation
5461416|NCT01455324|conformable socket liner|conformable socket liner
5461417|NCT01455311|cystic pancreatic tumors|cystic pancreatic tumors
5461418|NCT01455311|cystic pancreatic lesions|cystic pancreatic lesions
5461419|NCT01455311|gastrointestinal|gastrointestinal
5461420|NCT01455311|GI|gi
5461421|NCT01455311|EUS-FNA|eus-fna
5461422|NCT01455311|EchoBrush®|echobrush®
5461423|NCT01455311|cytology brush|cytology brush
5461424|NCT01455311|endoscopic|endoscopic
5461425|NCT01455298|Alpha-1 AT deficiency|alpha-1 at deficiency
5461426|NCT01455298|liver injury|liver injury
5461427|NCT01455298|Transient Elastography|transient elastography
5461428|NCT01455298|FibroTest|fibrotest
5461429|NCT01455285|dysmenorrhea|dysmenorrhea
5461430|NCT01455285|transcutaneous electrical nerve stimulation (TENS|transcutaneous electrical nerve stimulation (tens
5461431|NCT01455285|analgesia|analgesia
5461432|NCT01455285|pain visual analog scale|pain visual analog scale
5461433|NCT01455285|McGill pain questionnaire|mcgill pain questionnaire
5461435|NCT01455259|Adenoviral vector|adenoviral vector
5461436|NCT01455259|CD40L|cd40l
5461437|NCT01455259|CD154|cd154
5461438|NCT01455259|malignant melanoma|malignant melanoma
5461439|NCT01455246|Cirrhosis|cirrhosis
5461440|NCT01455246|Nosocomial Spontaneous Bacterial Peritonitis|nosocomial spontaneous bacterial peritonitis
5461441|NCT01455246|Ascites|ascites
5461442|NCT01455246|Daptomycin|daptomycin
5461443|NCT01455246|Meropenem|meropenem
5461444|NCT01455246|Ceftazidime|ceftazidime
5461445|NCT01455246|Nosocomial infection|nosocomial infection
5464578|NCT01442467|LVEDP|lvedp
5461452|NCT01455220|Multiple Sclerosis|multiple sclerosis
5461453|NCT01455220|Sexual Dysfunction|sexual dysfunction
5461454|NCT01455220|Quality of Life|quality of life
5461455|NCT01455207|Magnetic Resonance Imaging|magnetic resonance imaging
5461456|NCT01455207|Positon Emission Tomography|positon emission tomography
5461457|NCT01455207|Behavior|behavior
5461458|NCT01455194|ciclesonide|ciclesonide
5461459|NCT01455194|asthma|asthma
5461460|NCT01455181|PTH 1-84|pth 1-84
5461461|NCT01455181|Hypoparathyroidism|hypoparathyroidism
5461462|NCT01455181|NPSP558|npsp558
5461463|NCT01455181|Parathyroid Hormone 1-84|parathyroid hormone 1-84
5461464|NCT01455168|anterior capsule shrinkage|anterior capsule shrinkage
5461465|NCT01455168|capsular tension ring|capsular tension ring
5461466|NCT01455168|exfoliation syndrome|exfoliation syndrome
5461467|NCT01455168|phacoemulsification and aspiration|phacoemulsification and aspiration
5461468|NCT01455155|stroke|stroke
5461469|NCT01455155|Art therapy|art therapy
5461470|NCT01455155|Music therapy|music therapy
5461471|NCT01455155|Creative therapy|creative therapy
5461472|NCT01455155|Efficacy|efficacy
5461473|NCT01455129|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5461474|NCT01455129|COPD|copd
5461475|NCT01455129|COPD exacerbation|copd exacerbation
5461476|NCT01455129|treatment|treatment
5433217|NCT01573988|Eating frequency|eating frequency
5461477|NCT01455129|tiotropium|tiotropium
5461478|NCT01455129|anticholinergic|anticholinergic
5461479|NCT01455129|acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
5461480|NCT01455116|Sepsis|sepsis
5461481|NCT01455116|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5461482|NCT01455116|Mild Induced Hypothermia|mild induced hypothermia
5461483|NCT01455077|obesity|obesity
5461484|NCT01455077|sleep apnea|sleep apnea
5461485|NCT01455077|portable monitoring|portable monitoring
5461486|NCT01455025|Plerixafor granulocyte-colony stimulating factor|plerixafor granulocyte-colony stimulating factor
5461487|NCT01455025|Chemotherapy in relapse|chemotherapy in relapse
5461488|NCT01455025|Acute Myeloid Leukemia|acute myeloid leukemia
5461489|NCT01455012|Rotigotine|rotigotine
5461491|NCT01455012|RLS|rls
5461492|NCT01455012|Cardiovascular Risk|cardiovascular risk
5461493|NCT01455012|Nocturnal Blood Pressure|nocturnal blood pressure
5461494|NCT01454999|veteran|veteran
5461495|NCT01454999|smoking|smoking
5461496|NCT01454999|stage of change|stage of change
5461497|NCT01454999|cell phone|cell phone
5461498|NCT01454999|computerized tailored intervention|computerized tailored intervention
5461499|NCT01454986|Healthy subjects|healthy subjects
5461500|NCT01454973|type 2 diabetes|type 2 diabetes
5461501|NCT01454973|beta cell function|beta cell function
5461502|NCT01454973|meal tolerance test|meal tolerance test
5461503|NCT01454973|maximum stimulation test|maximum stimulation test
5461504|NCT01454973|method standardization|method standardization
5461505|NCT01454973|insulin secretion|insulin secretion
5461506|NCT01454960|Antibiotics|antibiotics
5461507|NCT01454960|Inappropriate Prescribing|inappropriate prescribing
5461508|NCT01454960|Respiratory Tract Infections|respiratory tract infections
5461509|NCT01454960|Behavioral Research|behavioral research
5461510|NCT01454947|Antibiotics|antibiotics
5461511|NCT01454947|Inappropriate Prescribing|inappropriate prescribing
5461512|NCT01454947|Respiratory Tract Infections|respiratory tract infections
5461513|NCT01454947|Behavioral Research|behavioral research
5461515|NCT01454921|Adolescent Trials Network|adolescent trials network
5461516|NCT01454908|partial knee arthroplasty|partial knee arthroplasty
5461517|NCT01454895|noise-induced hearing loss|noise-induced hearing loss
5461518|NCT01454895|prevention|prevention
5461519|NCT01454895|farmers|farmers
5461520|NCT01454882|Direct calorimetry|direct calorimetry
5461521|NCT01454882|Indirect calorimetry|indirect calorimetry
5461522|NCT01454882|Energy Expenditure|energy expenditure
5461523|NCT01454869|heparin|heparin
5461524|NCT01454843|Myopia|myopia
5461525|NCT01454843|Astigmatism|astigmatism
5461526|NCT01454843|Aberrations|aberrations
5461527|NCT01454843|Wavefront|wavefront
5461528|NCT01454843|LASIK|lasik
5461529|NCT01454843|Wavefront LASIK|wavefront lasik
5461530|NCT01454830|Social support|social support
5461531|NCT01454830|Cognition|cognition
5461532|NCT01454830|Adaptation, psychological|adaptation, psychological
5461533|NCT01454830|Health behavior|health behavior
5461534|NCT01454830|Patient education|patient education
5461535|NCT01454817|Quality of Life|quality of life
5461536|NCT01454817|Implantable Cardiac Defibrillators|implantable cardiac defibrillators
5461537|NCT01454817|ICDs|icds
5461538|NCT01454804|Advanced Cancers|advanced cancers
5461539|NCT01454804|Solid Tumors|solid tumors
5461549|NCT01454791|subcutaneous injection|subcutaneous injection
5461550|NCT01454791|glatiramer acetate|glatiramer acetate
5461551|NCT01454791|Copaxone|copaxone
5461552|NCT01454778|restenosis|restenosis
5461553|NCT01454778|peripheral vascular disease|peripheral vascular disease
5461554|NCT01454778|lower extremity ischemia|lower extremity ischemia
5461555|NCT01454778|claudication|claudication
5461556|NCT01454752|malaria|malaria
5461557|NCT01454752|anaemia|anaemia
5461558|NCT01454752|cognition|cognition
5461559|NCT01454752|intermittent preventive treatment|intermittent preventive treatment
5461560|NCT01454752|children|children
5461561|NCT01454752|schools|schools
5461562|NCT01454752|insecticide-treated nets|insecticide-treated nets
5461563|NCT01454739|rFVIIIFc|rfviiifc
5461564|NCT01454739|A-LONG Extension|a-long extension
5461565|NCT01454726|Dizziness|dizziness
5461566|NCT01454726|Meniere's disease|meniere's disease
5461567|NCT01454726|Diaoshi Jifa therapy|diaoshi jifa therapy
5461568|NCT01454700|Type 1 diabetes mellitus|type 1 diabetes mellitus
5461569|NCT01454700|Albuminuria|albuminuria
5461570|NCT01454700|Late diabetes complications|late diabetes complications
5461571|NCT01454700|CSII|csii
5461573|NCT01454700|Glycaemic control|glycaemic control
5461574|NCT01454661|Probiotics|probiotics
5461575|NCT01454661|Premature infant|premature infant
5461576|NCT01454661|Intestinal microbiota|intestinal microbiota
5461577|NCT01454661|Intestinal immunity|intestinal immunity
5461578|NCT01454661|Breastfeeding|breastfeeding
5461579|NCT01454648|Traumatic Brain Injury|traumatic brain injury
5461581|NCT01454648|Out-of-Hospital|out-of-hospital
5461582|NCT01454635|depression|depression
5461583|NCT01454635|treatment response|treatment response
5685307|NCT00556634|adverse effects|adverse effects
5461584|NCT01454635|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5461585|NCT01454622|Healthy Volunteers|healthy volunteers
5461586|NCT01454622|Bioequivalence|bioequivalence
5461587|NCT01454622|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5461588|NCT01454622|Metformin IR|metformin ir
5461589|NCT01454609|cervical plexus block|cervical plexus block
5461590|NCT01454609|thyroidectomy|thyroidectomy
5461591|NCT01454609|postoperative analgesia|postoperative analgesia
5461592|NCT01454596|Cell Therapy|cell therapy
5461593|NCT01454596|Gene Therapy|gene therapy
5461594|NCT01454596|Immunotherapy|immunotherapy
5461595|NCT01454596|Brain Cancer|brain cancer
5461596|NCT01454596|Glioma|glioma
5461597|NCT01454596|Glioblastoma|glioblastoma
5461598|NCT01454583|renin inhibitor|renin inhibitor
5461599|NCT01454583|ACE inhibitor|ace inhibitor
5461600|NCT01454583|ARB (AT1 receptor blockers)|arb (at1 receptor blockers)
5461601|NCT01454583|RAS blockade|ras blockade
5461602|NCT01454570|exoskeleton walking system|exoskeleton walking system
5461603|NCT01454570|paraplegia|paraplegia
5461604|NCT01454570|paralysis|paralysis
5461605|NCT01454557|Acquired Brain Injury|acquired brain injury
5461606|NCT01454557|Heart Rate Variability (HRV)|heart rate variability (hrv)
5461607|NCT01454557|Auditory Stimuli|auditory stimuli
5461608|NCT01454557|Physical Activity|physical activity
5461609|NCT01454518|hip arthroscopy|hip arthroscopy
5461610|NCT01454518|post operative analgesia|post operative analgesia
5461611|NCT01454505|Healthy subjects|healthy subjects
5461612|NCT01454505|Nasal allergies|nasal allergies
5461613|NCT01454505|Allergies|allergies
5461614|NCT01454505|Environmental Exposure Chamber|environmental exposure chamber
5461615|NCT01454505|EEC|eec
5461616|NCT01454505|Ragweed|ragweed
5461617|NCT01454492|Allergy rhinitis|allergy rhinitis
5461618|NCT01454492|Geographic tongue|geographic tongue
5461619|NCT01454479|Lapatinib|lapatinib
5461620|NCT01454479|Ixabepilone|ixabepilone
5461621|NCT01454479|HER-2|her-2
5461622|NCT01454479|Endometrial Carcinoma|endometrial carcinoma
5461623|NCT01454466|prevention|prevention
5461624|NCT01454466|retinal break|retinal break
5461625|NCT01454466|vitrectomy|vitrectomy
5461626|NCT01454466|partial posterior hyaloidectomy|partial posterior hyaloidectomy
5461627|NCT01454453|amisulpride|amisulpride
5461628|NCT01454453|receptor occupancy|receptor occupancy
5461629|NCT01454453|antipsychotic sensitivity|antipsychotic sensitivity
5461630|NCT01454440|Coronary artery disease|coronary artery disease
5461631|NCT01454440|Eptifibatide|eptifibatide
5461632|NCT01454440|Percutaneous coronary intervention|percutaneous coronary intervention
5461633|NCT01454440|stable coronary artery disease|stable coronary artery disease
5456220|NCT01477112|Oxidants|oxidants
5461634|NCT01454440|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5461636|NCT01454375|Smoking|smoking
5461637|NCT01454362|nicotine|nicotine
5461638|NCT01454362|inhalator|inhalator
5461639|NCT01454362|electronic cigarette|electronic cigarette
5461640|NCT01454362|tobacco|tobacco
5461641|NCT01454349|Benign prostatic hyperplasia|benign prostatic hyperplasia
5461642|NCT01454349|BPH|bph
5461643|NCT01454349|Enlarged prostate|enlarged prostate
5461644|NCT01454349|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5461645|NCT01454336|MSCs|mscs
5461646|NCT01454336|Pioglitazon|pioglitazon
5461647|NCT01454336|fibrosis|fibrosis
5461648|NCT01454336|liver|liver
5461649|NCT01454323|Chronic Myocardial Ischemia|chronic myocardial ischemia
5461650|NCT01454323|Cell therapy|cell therapy
5461651|NCT01454323|Bone marrow mononuclear cells|bone marrow mononuclear cells
5461652|NCT01454310|Skin substitutes|skin substitutes
5461653|NCT01454310|Split-thickness skin graft|split-thickness skin graft
5461654|NCT01454310|Burn wound|burn wound
5461655|NCT01454310|Scar formation|scar formation
5461656|NCT01454310|Skin quality|skin quality
5461657|NCT01454297|Myeloma|myeloma
5461658|NCT01454297|Multiple Myeloma|multiple myeloma
5461659|NCT01454297|Observational|observational
5461660|NCT01454297|Longitudinal|longitudinal
5461661|NCT01454271|Total Hip arthroplasty|total hip arthroplasty
5461662|NCT01454271|Hip Osteoarthritis|hip osteoarthritis
5461663|NCT01454271|Infection after Total Hip Arthroplasty|infection after total hip arthroplasty
5461664|NCT01454245|39439335EDI1013|39439335edi1013
5461665|NCT01454245|Bioavailability|bioavailability
5461666|NCT01454245|Pharmacokinetics|pharmacokinetics
5461667|NCT01454232|Obesity|obesity
5461668|NCT01454232|adipose tissue inflammation|adipose tissue inflammation
5461669|NCT01454232|Low grade systemic inflammation|low grade systemic inflammation
5461670|NCT01454232|gut microbiota|gut microbiota
5461671|NCT01454232|Bariatric surgery|bariatric surgery
5461672|NCT01454206|cannabis abuse|cannabis abuse
5461673|NCT01454206|alcohol abuse|alcohol abuse
5461674|NCT01454206|substance abuse|substance abuse
5461675|NCT01454180|Therapeutic targets in Pancreas|therapeutic targets in pancreas
5461676|NCT01454167|vacum drains|vacum drains
5461677|NCT01454167|operational wounds|operational wounds
5461678|NCT01454167|infections|infections
5461679|NCT01454167|seroma|seroma
5461680|NCT01454167|acid base|acid base
5461681|NCT01454167|glucose|glucose
5461682|NCT01454167|lactate|lactate
5461683|NCT01454154|TBI|tbi
5461684|NCT01454154|Traumatic Brain Injury|traumatic brain injury
5461685|NCT01454141|Depressed mood|depressed mood
5461686|NCT01454128|exercise base rehabilitation|exercise base rehabilitation
5461687|NCT01454128|heart failure|heart failure
5461688|NCT01454128|periodic breathing|periodic breathing
5461689|NCT01454128|aerobic fitness|aerobic fitness
5461690|NCT01454089|bladder|bladder
5461691|NCT01454089|urinary tract|urinary tract
5461692|NCT01454089|transitional cell carcinoma|transitional cell carcinoma
5461693|NCT01454089|metastatic bladder cancer|metastatic bladder cancer
5461694|NCT01454089|chemotherapy|chemotherapy
5461695|NCT01454076|Cmax: maximum plasma concentration|cmax: maximum plasma concentration
5461696|NCT01454076|AUC0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration|auc0-tlast: area under the plasma concentration-time curve from time zero to the time of the last quantifiable concentration
5461697|NCT01454063|cataract|cataract
5461698|NCT01454063|lens replacement|lens replacement
5461699|NCT01454050|ICD therapy|icd therapy
5461700|NCT01454050|RV/LV Capture Control|rv/lv capture control
5461701|NCT01454050|Safety and Efficacy|safety and efficacy
5461702|NCT01454011|hypogonadism|hypogonadism
5461703|NCT01454011|testosterone|testosterone
5461704|NCT01454011|HDL cholesterol subgroups|hdl cholesterol subgroups
5461706|NCT01454011|HOMA-IR|homa-ir
5461707|NCT01453972|Exercise|exercise
5461708|NCT01453972|High-intensity|high-intensity
5461709|NCT01453972|Interval training|interval training
5461710|NCT01453959|hypertension|hypertension
5461711|NCT01453959|salt sensitivity|salt sensitivity
5461712|NCT01453959|fludrocortisone|fludrocortisone
5461713|NCT01453946|Crohn's Disease|crohn's disease
5461714|NCT01453933|Anti-HIV Agents|anti-hiv agents
5461715|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents
5461716|NCT01453933|Antiviral Agents|antiviral agents
5461717|NCT01453933|Anti-Infective Agents|anti-infective agents
5461718|NCT01453933|Lopinavir/ritonavir|lopinavir/ritonavir
5461719|NCT01453920|Age Related Macular Degeneration|age related macular degeneration
5461720|NCT01453920|Choroidal Neovascular Membrane|choroidal neovascular membrane
5461721|NCT01453894|Colorectal Cancer Screening|colorectal cancer screening
5461722|NCT01453894|Fecal Occult Blood Testing|fecal occult blood testing
5461723|NCT01453881|Asthma|asthma
5461724|NCT01453881|pMDI|pmdi
5461725|NCT01453881|Beclomethasone|beclomethasone
5461726|NCT01453881|Formoterol|formoterol
5461727|NCT01453881|Efficacy|efficacy
5461728|NCT01453868|Multiple Sclerosis|multiple sclerosis
5461729|NCT01453868|non impact aerobics|non impact aerobics
5461730|NCT01453855|Open-Angle Glaucoma|open-angle glaucoma
5461731|NCT01453855|Ocular Hypertension|ocular hypertension
5461732|NCT01453842|Glucagon-like peptide-1|glucagon-like peptide-1
5461733|NCT01453842|Glucose-dependant insulinotropic polypeptide|glucose-dependant insulinotropic polypeptide
5461735|NCT01453842|Peptide PYY|peptide pyy
5461736|NCT01453842|2-oleyl glycerol|2-oleyl glycerol
5461737|NCT01453816|Renal insufficiency|renal insufficiency
5461738|NCT01453816|kidney failure|kidney failure
5461739|NCT01453803|Liposuction|liposuction
5461740|NCT01453803|ADSC|adsc
5461742|NCT01453803|stem cell|stem cell
5461743|NCT01453803|Parkinson's Disease|parkinson's disease
5461744|NCT01453803|Parkinson's|parkinson's
5461746|NCT01453790|depression|depression
5461747|NCT01453790|treatment|treatment
5461748|NCT01453790|motivation to seek follow up|motivation to seek follow up
5461749|NCT01453777|diffuse brain lesion|diffuse brain lesion
5461750|NCT01453751|Diabetes|diabetes
5461751|NCT01453751|Type 2 Diabetes|type 2 diabetes
5461752|NCT01453738|Osteoarthritis|osteoarthritis
5461753|NCT01453738|Knee|knee
5461754|NCT01453738|Stem cells|stem cells
5461755|NCT01453738|Mesenchymal Stem Cells|mesenchymal stem cells
5461756|NCT01453712|coronary artery disease|coronary artery disease
5461757|NCT01453712|coronary CT angiography|coronary ct angiography
5461758|NCT01453712|radiation dose|radiation dose
5461759|NCT01453712|iterative image reconstruction|iterative image reconstruction
5461760|NCT01453712|detection|detection
5461761|NCT01453699|Bereavement|bereavement
5461762|NCT01453699|early parental death|early parental death
5461763|NCT01453699|grief|grief
5461764|NCT01453699|affective disorders|affective disorders
5461765|NCT01453699|depression, depressive symptoms|depression, depressive symptoms
5461766|NCT01453699|socioeconomic factors|socioeconomic factors
5461767|NCT01453699|suicide|suicide
5461768|NCT01453699|attempted suicide|attempted suicide
5461769|NCT01453699|antidepressive agents|antidepressive agents
5461770|NCT01453699|cardiovascular diseases|cardiovascular diseases
5461771|NCT01453699|quality of life|quality of life
5461772|NCT01453699|Long-term health effects|long-term health effects
5461773|NCT01453699|Socioeconomic outcomes|socioeconomic outcomes
5461774|NCT01453699|Psychosocial well-being|psychosocial well-being
5461775|NCT01453686|Alopecia Areata|alopecia areata
5461776|NCT01453686|Hydrocortisone|hydrocortisone
5461777|NCT01453686|Clobetasol Propionate|clobetasol propionate
5574735|NCT00988429|partial|partial
5451654|NCT01495793|RLS|rls
5461778|NCT01453686|Randomized Controlled Trial|randomized controlled trial
5461779|NCT01453673|knee|knee
5461780|NCT01453673|Cruciate Ligament|cruciate ligament
5461781|NCT01453673|Meniscus|meniscus
5461782|NCT01453660|Endothelial Function|endothelial function
5461783|NCT01453660|Endo-PAT2000 system|endo-pat2000 system
5461784|NCT01453660|11-140|11-140
5461785|NCT01453647|Fibromyalgia|fibromyalgia
5461786|NCT01453647|self-efficacy|self-efficacy
5461787|NCT01453647|fatigue|fatigue
5461788|NCT01453647|stress|stress
5461789|NCT01453647|cytokine|cytokine
5461790|NCT01453634|chronic kidney disease (CKD)|chronic kidney disease (ckd)
5461791|NCT01453634|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5461792|NCT01453634|hemodialysis (HD)|hemodialysis (hd)
5461793|NCT01453621|prediction rules|prediction rules
5461794|NCT01453621|computerized clinical decision support|computerized clinical decision support
5461795|NCT01453621|traumatic brain injury|traumatic brain injury
5461796|NCT01453621|blunt head trauma|blunt head trauma
5461797|NCT01453595|Kidney|kidney
5461798|NCT01453595|renal cell carcinoma|renal cell carcinoma
5461799|NCT01453595|BEZ235|bez235
5461800|NCT01453595|11-080|11-080
5461801|NCT01453582|Chest stuffiness of TCM|chest stuffiness of tcm
5461802|NCT01453582|Qi deficiency and blood stasis of TCM|qi deficiency and blood stasis of tcm
5461803|NCT01453556|Laparoscopic surgery|laparoscopic surgery
5461804|NCT01453556|Right colectomy|right colectomy
5461805|NCT01453556|Mechanical anastomosis|mechanical anastomosis
5461806|NCT01453556|Post-operative ileum|post-operative ileum
5461808|NCT01453530|Street fitness|street fitness
5461809|NCT01453530|Sugammadex|sugammadex
5461810|NCT01453530|Alertness|alertness
5461811|NCT01453530|Ambulatory surgery|ambulatory surgery
5461812|NCT01453517|bariatric|bariatric
5461813|NCT01453517|obesity|obesity
5461814|NCT01453517|post-surgery|post-surgery
5461815|NCT01453517|intervention|intervention
5461816|NCT01453452|weight changes|weight changes
5461817|NCT01453452|fatigue|fatigue
5461818|NCT01453452|depression|depression
5461819|NCT01453452|anxiety disorder|anxiety disorder
5461820|NCT01453452|pain|pain
5461821|NCT01453452|cognitive/functional effects|cognitive/functional effects
5461822|NCT01453452|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5461823|NCT01453452|cancer survivor|cancer survivor
5461824|NCT01453452|stage IA breast cancer|stage ia breast cancer
5461825|NCT01453452|stage IB breast cancer|stage ib breast cancer
5461826|NCT01453452|stage II breast cancer|stage ii breast cancer
5461827|NCT01453452|stage IIIA breast cancer|stage iiia breast cancer
5461828|NCT01453452|stage IIIB breast cancer|stage iiib breast cancer
5461829|NCT01453452|stage IIIC breast cancer|stage iiic breast cancer
5461830|NCT01453452|stage I colon cancer|stage i colon cancer
5461831|NCT01453452|stage IIA colon cancer|stage iia colon cancer
5461832|NCT01453452|stage IIB colon cancer|stage iib colon cancer
5461833|NCT01453452|stage IIC colon cancer|stage iic colon cancer
5461834|NCT01453452|stage IIIA colon cancer|stage iiia colon cancer
5461835|NCT01453452|stage IIIB colon cancer|stage iiib colon cancer
5461836|NCT01453452|stage IIIC colon cancer|stage iiic colon cancer
5461837|NCT01453452|stage I rectal cancer|stage i rectal cancer
5461838|NCT01453452|stage IIA rectal cancer|stage iia rectal cancer
5461839|NCT01453452|stage IIB rectal cancer|stage iib rectal cancer
5461840|NCT01453452|stage IIC rectal cancer|stage iic rectal cancer
5461841|NCT01453452|stage IIIA rectal cancer|stage iiia rectal cancer
5461842|NCT01453452|stage IIIB rectal cancer|stage iiib rectal cancer
5461843|NCT01453452|stage IIIC rectal cancer|stage iiic rectal cancer
5461844|NCT01453439|Body dysmorphic disorder|body dysmorphic disorder
5461845|NCT01453439|Obsessive compulsive spectrum disorder|obsessive compulsive spectrum disorder
5461846|NCT01453439|Body image|body image
5461847|NCT01453439|Appearance concerns|appearance concerns
5461848|NCT01453400|aspirin|aspirin
5461849|NCT01453400|acetylsalicylic acid|acetylsalicylic acid
5461850|NCT01453400|pharyngitis|pharyngitis
5461851|NCT01453400|sore throat|sore throat
5461852|NCT01453387|MEK inhibitor|mek inhibitor
5461853|NCT01453387|Solid Tumor|solid tumor
5461854|NCT01453387|Phase I|phase i
5461855|NCT01453374|opioid dependence|opioid dependence
5461856|NCT01453374|VIVITROL|vivitrol
5461857|NCT01453374|criminal justice|criminal justice
5461858|NCT01453361|FANG|fang
5461859|NCT01453361|Melanoma|melanoma
5461860|NCT01453361|Vigil|vigil
5461861|NCT01453348|meningococcal|meningococcal
5461862|NCT01453348|conjugate|conjugate
5461863|NCT01453348|vaccine|vaccine
5461864|NCT01453348|adults|adults
5461865|NCT01453335|Veins|veins
5461866|NCT01453335|Catheter Segments|catheter segments
5461867|NCT01453335|Vascular Access|vascular access
5461868|NCT01453335|VeinViewer Vision|veinviewer vision
5461869|NCT01453322|Veins|veins
5461870|NCT01453322|Vascular Access|vascular access
5461871|NCT01453322|IV complications|iv complications
5461872|NCT01453322|VeinViewer Vision|veinviewer vision
5461873|NCT01453309|lumbar fusion|lumbar fusion
5461874|NCT01453309|transfusion|transfusion
5461875|NCT01453309|cell-saver|cell-saver
5461876|NCT01453309|cost-effectiveness|cost-effectiveness
5461877|NCT01453296|Asthma|asthma
5461878|NCT01453296|Tolerability|tolerability
5461879|NCT01453296|Safety|safety
5461880|NCT01453296|Pharmacokinetics|pharmacokinetics
5461881|NCT01453296|GW642444|gw642444
5461882|NCT01453283|DNA Repair|dna repair
5461883|NCT01453283|Nucleotide Excision Repair|nucleotide excision repair
5461884|NCT01453283|Trabectedine|trabectedine
5461885|NCT01453283|Phase I|phase i
5461886|NCT01453283|Sarcoma|sarcoma
5461887|NCT01453283|Cytotoxic|cytotoxic
5461888|NCT01453283|Chemotherapy|chemotherapy
5461889|NCT01453283|Solid Tumor|solid tumor
5461890|NCT01453283|Malignant Tumor|malignant tumor
5461891|NCT01453283|Rhabdomyosarcoma|rhabdomyosarcoma
5461892|NCT01453283|Ewing Sarcoma|ewing sarcoma
5461893|NCT01453283|Neuroblastoma|neuroblastoma
5461894|NCT01453283|Wilm's Tumor|wilm's tumor
5461895|NCT01453283|Hepatic Tumor|hepatic tumor
5461896|NCT01453283|Brain Tumor|brain tumor
5461897|NCT01453270|Sepsis|sepsis
5461898|NCT01453270|Emergency medicine|emergency medicine
5461899|NCT01453270|Cardiac output|cardiac output
5461900|NCT01453270|Stroke volume|stroke volume
5461901|NCT01453270|Lactate|lactate
5461902|NCT01453257|Molecular Targets|molecular targets
5461903|NCT01453257|Personalize Treatment|personalize treatment
5461904|NCT01453257|Colon Cancer|colon cancer
5461905|NCT01453257|Complete Response Rate|complete response rate
5461906|NCT01453244|Chronic hepatitis C|chronic hepatitis c
5461907|NCT01453244|Pharmacogenomics|pharmacogenomics
5461909|NCT01453244|ITPA|itpa
5461910|NCT01453231|bariatric surgery|bariatric surgery
5461911|NCT01453231|plastic surgery|plastic surgery
5461912|NCT01453231|thigh|thigh
5461913|NCT01453231|obesity|obesity
5461914|NCT01453231|body image|body image
5461915|NCT01453231|quality of life|quality of life
5461916|NCT01453218|Renal insufficiency|renal insufficiency
5461917|NCT01453218|Liver transplant|liver transplant
5461918|NCT01453218|Acute rejection|acute rejection
5461919|NCT01453218|Infections|infections
5461920|NCT01453218|Hepatitis C recurrence|hepatitis c recurrence
5461921|NCT01453205|Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, B-Cell Malignancy, anti-CD19, monoclonal antibody, second line, ASCT, Refractory|lymphoma, non-hodgkin's lymphoma, diffuse large b-cell lymphoma, dlbcl, b-cell malignancy, anti-cd19, monoclonal antibody, second line, asct, refractory
5461922|NCT01453192|Raltegravir|raltegravir
5461923|NCT01453192|Renal transplantation|renal transplantation
5461924|NCT01453192|HIV-1|hiv-1
5461925|NCT01453192|Acute renal graft rejection|acute renal graft rejection
5461926|NCT01453179|actinic keratosis|actinic keratosis
5461927|NCT01453179|invasive SCC|invasive scc
5461928|NCT01453179|in situ SCC|in situ scc
5461929|NCT01453179|histological classification|histological classification
5461930|NCT01453179|histological progression|histological progression
5461931|NCT01453179|clinical clearance|clinical clearance
5461932|NCT01453179|cryotherapy|cryotherapy
5461933|NCT01453153|pancreatic|pancreatic
5461935|NCT01453153|Stage IV|stage iv
5461936|NCT01453153|untreated|untreated
5461937|NCT01453127|dementia|dementia
5461938|NCT01453127|parkinsonism|parkinsonism
5461939|NCT01453127|mild cognitive impairment|mild cognitive impairment
5461940|NCT01453127|REM sleep behavior disorder|rem sleep behavior disorder
5461941|NCT01453114|Cognitive Behavioral Therapy|cognitive behavioral therapy
5461944|NCT01453114|postpartum depression|postpartum depression
5461945|NCT01453114|depression recurrence|depression recurrence
5461946|NCT01453114|depression relapse|depression relapse
5461947|NCT01453101|Multiple Myeloma|multiple myeloma
5461948|NCT01453101|Transplant|transplant
5461949|NCT01453088|multiple myeloma|multiple myeloma
5461950|NCT01453088|transplant|transplant
5461951|NCT01453075|hepatitis C|hepatitis c
5461952|NCT01453075|herpes simplex type 2|herpes simplex type 2
5461953|NCT01453075|veterans|veterans
5444399|NCT01526473|Vaccine|vaccine
5461954|NCT01453062|Ofatumumab|ofatumumab
5461955|NCT01453062|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5461956|NCT01453062|Arzerra|arzerra
5461957|NCT01453049|rosiglitazone/glimepiride, fix dose, type 2 diabetes|rosiglitazone/glimepiride, fix dose, type 2 diabetes
5461958|NCT01453036|Peptic ulcer|peptic ulcer
5461959|NCT01453036|Helicobacter pylori|helicobacter pylori
5461960|NCT01453036|Clarithromycin|clarithromycin
5461961|NCT01453036|23S rRNA|23s rrna
5461962|NCT01453036|Resistance|resistance
5461963|NCT01453023|pediatric ages 5 to 11 years|pediatric ages 5 to 11 years
5461964|NCT01453010|SaeboFlex|saeboflex
5461965|NCT01453010|Stroke rehabilitation|stroke rehabilitation
5461966|NCT01453010|Upper Limb Rehabilitation|upper limb rehabilitation
5461967|NCT01453010|Acute Stroke|acute stroke
5461968|NCT01452997|mosquito|mosquito
5461969|NCT01452997|allergy|allergy
5461970|NCT01452997|bite|bite
5461971|NCT01452997|ant-inflammatory|ant-inflammatory
5461972|NCT01452997|Aedes aegypti mosquito bite|aedes aegypti mosquito bite
5461973|NCT01452984|Non-Melanoma skin cancer patients who have undergone or about to undergo Mohs surgery|non-melanoma skin cancer patients who have undergone or about to undergo mohs surgery
5461974|NCT01452984|who are treated within the University of Pennsylvania Health System|who are treated within the university of pennsylvania health system
5461975|NCT01452971|tumor susceptibility gene|tumor susceptibility gene
5461976|NCT01452971|glycine N-methyltransferase (GNMT)|glycine n-methyltransferase (gnmt)
5461977|NCT01452971|polycyclic aromatic hydrocarbons (PAHs)|polycyclic aromatic hydrocarbons (pahs)
5461979|NCT01452958|Endotoxin|endotoxin
5461980|NCT01452958|LPS|lps
5461981|NCT01452958|TNF-α|tnf-α
5461982|NCT01452958|insulin resistance|insulin resistance
5461983|NCT01452958|metabolism|metabolism
5461984|NCT01452932|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5461985|NCT01452932|Dyspnea|dyspnea
5461986|NCT01452932|Exercise test|exercise test
5461987|NCT01452932|Endurance training|endurance training
5461988|NCT01452919|schizophrenia, LY2140023, pomaglumetad methionil|schizophrenia, ly2140023, pomaglumetad methionil
5461989|NCT01452906|Drug-drug interaction|drug-drug interaction
5461990|NCT01452906|Pharmacokinetics|pharmacokinetics
5461992|NCT01452906|Drug Interaction Potentiation|drug interaction potentiation
5461993|NCT01452880|Remifentanil|remifentanil
5461994|NCT01452880|Lithotripsy|lithotripsy
5461995|NCT01452880|Conscious Sedation|conscious sedation
5461996|NCT01452867|Airway|airway
5461997|NCT01452867|Bag-Valve -Mask- Ventilation|bag-valve -mask- ventilation
5461998|NCT01452867|Laryngeal Mask - Ventilation|laryngeal mask - ventilation
5461999|NCT01452867|Laryngeal Tube - Ventilation|laryngeal tube - ventilation
5462000|NCT01452854|LGG|lgg
5462001|NCT01452854|Temozolomide|temozolomide
5462002|NCT01452854|Temodar|temodar
5462003|NCT01452854|Ovarian Aging|ovarian aging
5462004|NCT01452854|Infertility|infertility
5462005|NCT01452854|Chemotherapy|chemotherapy
5462006|NCT01452841|grapefruit|grapefruit
5462007|NCT01452841|weight loss|weight loss
5462008|NCT01452841|blood pressure|blood pressure
5462009|NCT01452841|lipids|lipids
5462010|NCT01452841|inflammation|inflammation
5462011|NCT01452828|Renal Impairment|renal impairment
5462012|NCT01452815|diabetic gastroparesis|diabetic gastroparesis
5462013|NCT01452815|delayed gastric emptying|delayed gastric emptying
5462014|NCT01452815|gastroparesis|gastroparesis
5462015|NCT01452815|diabetes mellitus, Type 1|diabetes mellitus, type 1
5462016|NCT01452815|diabetes mellitus, Type 2|diabetes mellitus, type 2
5462017|NCT01452802|HeartMate II|heartmate ii
5462018|NCT01452802|heart-assist device|heart-assist device
5462019|NCT01452802|medical management|medical management
5462020|NCT01452802|optimal medical management|optimal medical management
5462021|NCT01452802|Heart Failure NYHA Class IIIB/IV|heart failure nyha class iiib/iv
5462022|NCT01452802|Thoratec Corporation|thoratec corporation
5462023|NCT01452789|neonatal abstinence syndrome|neonatal abstinence syndrome
5462024|NCT01452789|buprenorphine|buprenorphine
5462025|NCT01452789|morphine|morphine
5462026|NCT01452789|pharmacokinetics|pharmacokinetics
5462027|NCT01452776|Drug Therapy|drug therapy
5462028|NCT01452763|Drug Therapy|drug therapy
5462029|NCT01452750|Drug Therapy|drug therapy
5462033|NCT01452724|Drug Therapy|drug therapy
5462034|NCT01452711|Drug Therapy|drug therapy
5462035|NCT01452698|Drug Therapy|drug therapy
5462036|NCT01452685|Drug Therapy|drug therapy
5462037|NCT01452672|Breast cancer|breast cancer
5462038|NCT01452672|Radiotherapy|radiotherapy
5462039|NCT01452672|Post-mastectomy|post-mastectomy
5462040|NCT01452672|Molecular characterization|molecular characterization
5462041|NCT01452659|Drug Therapy|drug therapy
5462042|NCT01452646|acute myeloid leukemia|acute myeloid leukemia
5462043|NCT01452646|risk-adapted therapy|risk-adapted therapy
5462044|NCT01452646|MRD-directed therapy|mrd-directed therapy
5462045|NCT01452646|young adults|young adults
5462047|NCT01452633|laparoscopy|laparoscopy
5462048|NCT01452633|reduction|reduction
5462049|NCT01452620|Endovascular Abdominal Aortic Aneurysm Repair (EVAR)|endovascular abdominal aortic aneurysm repair (evar)
5462050|NCT01452620|Abdominal Aortic aneurysm (AAA)|abdominal aortic aneurysm (aaa)
5462051|NCT01452607|Ebselen|ebselen
5444505|NCT01526044|insulin|insulin
5462052|NCT01452581|Transfusion|transfusion
5462053|NCT01452581|Red blood cells|red blood cells
5462054|NCT01452581|Postoperative|postoperative
5462055|NCT01452581|Dizziness|dizziness
5462056|NCT01452581|Hip Arthroplasty|hip arthroplasty
5462057|NCT01452568|Thromboembolic complications|thromboembolic complications
5462058|NCT01452568|Bleeding complications|bleeding complications
5462059|NCT01452568|Haemorrhagic complications|haemorrhagic complications
5462060|NCT01452568|Anticoagulant therapy|anticoagulant therapy
5462061|NCT01452568|Aspirin|aspirin
5462062|NCT01452568|biological Aorta Valve|biological aorta valve
5462063|NCT01452555|HIV|hiv
5462064|NCT01452555|HIV Prevention|hiv prevention
5462065|NCT01452555|HIV testing|hiv testing
5462066|NCT01452555|HIV Rapid Test|hiv rapid test
5462067|NCT01452542|Genz-112638|genz-112638
5462068|NCT01452529|Pain|pain
5462069|NCT01452529|Opioid|opioid
5462070|NCT01452516|PLF|plf
5462071|NCT01452516|lumbar fusion|lumbar fusion
5462072|NCT01452516|bone graft|bone graft
5462073|NCT01452516|biologics|biologics
5462074|NCT01452503|AE adverse event|ae adverse event
5462075|NCT01452503|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5462076|NCT01452503|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5462077|NCT01452503|ART antiretroviral therapy|art antiretroviral therapy
5462078|NCT01452503|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5462079|NCT01452503|DCF data collection forms|dcf data collection forms
5462080|NCT01452503|DMC Data Monitoring Committee|dmc data monitoring committee
5462081|NCT01452503|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5462082|NCT01452503|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5462083|NCT01452503|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5462084|NCT01452503|ICH International Conference of Harmonization|ich international conference of harmonization
5462789|NCT01449669|cefazolin|cefazolin
5462085|NCT01452503|IND Investigational New Drug Application|ind investigational new drug application
5462086|NCT01452503|IRB Institutional Review Board|irb institutional review board
5462087|NCT01452503|IU International units|iu international units
5462088|NCT01452503|mg milligram(s)|mg milligram(s)
5462089|NCT01452503|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5462090|NCT01452503|PCR polymerase chain reaction|pcr polymerase chain reaction
5462091|NCT01452503|SAE serious adverse event|sae serious adverse event
5462092|NCT01452503|µg microgram|µg microgram
5462093|NCT01452503|ULN upper limit of the normal range|uln upper limit of the normal range
5462094|NCT01452503|WB Western Blot|wb western blot
5462095|NCT01452490|Onychomycosis|onychomycosis
5462096|NCT01452490|Toenail Fungus|toenail fungus
5462097|NCT01452477|Polycystic Ovary Syndrome|polycystic ovary syndrome
5462098|NCT01452477|Cryptotanshinone|cryptotanshinone
5462099|NCT01452464|observational|observational
5462100|NCT01452464|serogroup A, B, Y, W|serogroup a, b, y, w
5462101|NCT01452464|meningococcal meningitis|meningococcal meningitis
5462102|NCT01452464|meningococcal vaccines|meningococcal vaccines
5462103|NCT01452464|safety|safety
5462104|NCT01452464|MenACYW-CRM|menacyw-crm
5462105|NCT01452464|post-marketing|post-marketing
5462106|NCT01452464|adolescents|adolescents
5462107|NCT01452438|observational|observational
5462108|NCT01452438|serogroup A, B, Y, W|serogroup a, b, y, w
5462109|NCT01452438|meningococcal meningitis|meningococcal meningitis
5462110|NCT01452438|meningococcal vaccines|meningococcal vaccines
5462111|NCT01452438|safety|safety
5462112|NCT01452438|MenACYW-CRM|menacyw-crm
5462113|NCT01452438|post-marketing|post-marketing
5462114|NCT01452438|children|children
5462115|NCT01452425|Human volunteers|human volunteers
5462116|NCT01452412|Alkali|alkali
5462117|NCT01452412|Sodium bicarbonate|sodium bicarbonate
5462118|NCT01452412|Kidney disease|kidney disease
5462119|NCT01452412|Acidosis|acidosis
5462120|NCT01452386|Constipation|constipation
5462121|NCT01452386|Stimulation Treatment|stimulation treatment
5456734|NCT01474811|HCV|hcv
5462124|NCT01452373|Vasomotor symptoms|vasomotor symptoms
5462125|NCT01452373|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5462126|NCT01452373|Prasterone|prasterone
5462127|NCT01452373|Acolbifene|acolbifene
5462128|NCT01452373|Selective estrogen receptor modulator (SERM)|selective estrogen receptor modulator (serm)
5462129|NCT01452373|Antiestrogen|antiestrogen
5462130|NCT01452373|Menopause|menopause
5462131|NCT01452373|Postmenopausal women|postmenopausal women
5462132|NCT01452360|chronic kidney disease|chronic kidney disease
5462133|NCT01452321|Transcranial Magnetic Stimulation;|transcranial magnetic stimulation;
5462134|NCT01452321|Postpartum Depression;|postpartum depression;
5462135|NCT01452321|Clinical Performance;|clinical performance;
5462136|NCT01452321|Cognitive Performance;|cognitive performance;
5462137|NCT01452321|Social Performance|social performance
5462139|NCT01452308|Gilead Sciences|gilead sciences
5462140|NCT01452308|GSI|gsi
5462141|NCT01452308|Liver Fibrosis|liver fibrosis
5462142|NCT01452308|Liver|liver
5462143|NCT01452308|Fibrosis|fibrosis
5462144|NCT01452295|liver|liver
5462145|NCT01452295|liver failure|liver failure
5462146|NCT01452295|acute liver failure|acute liver failure
5462147|NCT01452295|ELAD|elad
5462148|NCT01452295|alcoholic hepatitis|alcoholic hepatitis
5462149|NCT01452295|acute on chronic hepatitis|acute on chronic hepatitis
5462150|NCT01452282|Ankle Brachial Index|ankle brachial index
5462151|NCT01452282|Perioperative care|perioperative care
5462152|NCT01452282|General Surgery|general surgery
5462153|NCT01452282|Acute Coronary Syndromes|acute coronary syndromes
5462154|NCT01452282|Cardiovascular Complications|cardiovascular complications
5462155|NCT01452243|Vitamin D|vitamin d
5462156|NCT01452243|Calcium|calcium
5462157|NCT01452243|Elderly|elderly
5462158|NCT01452230|Bariatric Surgery Candidate|bariatric surgery candidate
5462159|NCT01452230|Severely obese|severely obese
5462160|NCT01452230|Bariatric surgery|bariatric surgery
5462161|NCT01452230|Physical activity|physical activity
5462162|NCT01452230|Physical fitness|physical fitness
5462163|NCT01452230|Comorbidities|comorbidities
5462164|NCT01452230|Quality of life|quality of life
5462165|NCT01452230|Surgical complications|surgical complications
5462166|NCT01452217|Pancreas|pancreas
5462167|NCT01452217|Chronic pancreatitis|chronic pancreatitis
5462168|NCT01452217|Perfusion|perfusion
5433915|NCT01571219|RA|ra
5462169|NCT01452217|Blood flow|blood flow
5462170|NCT01452217|Magnetic resonance imaging|magnetic resonance imaging
5462171|NCT01452204|PEMF|pemf
5462172|NCT01452204|magneto|magneto
5462173|NCT01452204|shoulder|shoulder
5462174|NCT01452204|impingement|impingement
5462175|NCT01452191|Cluster Randomised Controlled Trial|cluster randomised controlled trial
5462176|NCT01452191|Community Health Services|community health services
5462177|NCT01452191|prevention & control|prevention & control
5462178|NCT01452191|Accidents, Home|accidents, home
5462179|NCT01452191|Child Health Services|child health services
5462180|NCT01452178|Cardiovascular diseases|cardiovascular diseases
5462181|NCT01452178|Glucometabolic disorders|glucometabolic disorders
5462182|NCT01452178|Type-D personality|type-d personality
5462183|NCT01452165|Cardiovascular diseases|cardiovascular diseases
5462184|NCT01452165|Hypertrophy, Left ventricle|hypertrophy, left ventricle
5462185|NCT01452165|Echocardiography|echocardiography
5462186|NCT01452165|Prognosis|prognosis
5462187|NCT01452152|Pharmacogenomics|pharmacogenomics
5462188|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5462189|NCT01452139|STEMI|stemi
5462190|NCT01452139|Pharmacogenetics|pharmacogenetics
5462191|NCT01452139|Prasugrel|prasugrel
5462192|NCT01452139|Clopidogrel|clopidogrel
5462193|NCT01452139|Percutaneous Coronary Intervention|percutaneous coronary intervention
5462194|NCT01452113|Diabetes Mellitus|diabetes mellitus
5462195|NCT01452113|DPP-IV protein|dpp-iv protein
5462196|NCT01452113|Glucagon-Like Peptide 1|glucagon-like peptide 1
5462197|NCT01452113|autonomic neuropathy|autonomic neuropathy
5462198|NCT01452100|embolism|embolism
5462199|NCT01452100|cholesterol cristal|cholesterol cristal
5462200|NCT01452100|creatinine|creatinine
5462201|NCT01452100|renal insufficiency|renal insufficiency
5462202|NCT01452100|prednisone|prednisone
5462203|NCT01452100|systemic atheroembolism|systemic atheroembolism
5462204|NCT01452087|insulin sensitivity|insulin sensitivity
5462205|NCT01452087|exercise|exercise
5462206|NCT01452074|Insulin Sensitivity|insulin sensitivity
5462207|NCT01452074|Exercise Training|exercise training
5462208|NCT01452074|Weight Loss|weight loss
5462209|NCT01452074|Fat Metabolism|fat metabolism
5462210|NCT01452061|Autism Spectrum Disorder|autism spectrum disorder
5462211|NCT01452061|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5462212|NCT01452061|Developmental Delay|developmental delay
5462213|NCT01452048|insulin sensitivity|insulin sensitivity
5462214|NCT01452048|fatty acid metabolism|fatty acid metabolism
5462215|NCT01452035|insulin sensitivity|insulin sensitivity
5462216|NCT01452035|fatty acid metabolism|fatty acid metabolism
5462217|NCT01452035|exercise|exercise
5462218|NCT01452022|inductigraft|inductigraft
5462219|NCT01452022|osteoinductive|osteoinductive
5462220|NCT01452022|synthetic bone graft|synthetic bone graft
5462221|NCT01452022|posterolateral lumbar fusion|posterolateral lumbar fusion
5462222|NCT01452022|post market|post market
5462223|NCT01452022|lumbar spinal stenosis|lumbar spinal stenosis
5462224|NCT01452009|open angle glaucoma|open angle glaucoma
5462225|NCT01452009|ocular hypertension|ocular hypertension
5462226|NCT01451996|direct-to-consumer advertising|direct-to-consumer advertising
5462228|NCT01451983|PTEN|pten
5462229|NCT01451983|macrocephaly|macrocephaly
5462230|NCT01451970|high fat diet treatment|high fat diet treatment
5462231|NCT01451970|insulin sensitivity|insulin sensitivity
5462232|NCT01451957|exercise|exercise
5462233|NCT01451957|fatty acid metabolism|fatty acid metabolism
5462234|NCT01451957|insulin sensitivity|insulin sensitivity
5462235|NCT01451944|Asthma|asthma
5462236|NCT01451944|Home Health Nursing|home health nursing
5462237|NCT01451944|Patient education|patient education
5462238|NCT01451931|kidney stone|kidney stone
5462239|NCT01451931|urolithiasis|urolithiasis
5462240|NCT01451931|urinary tract infection|urinary tract infection
5462241|NCT01451931|ultrasound|ultrasound
5462242|NCT01451931|computed tomography|computed tomography
5462243|NCT01451931|safety|safety
5462244|NCT01451931|cost|cost
5462245|NCT01451931|accuracy|accuracy
5462246|NCT01451918|Dyslipidaemia|dyslipidaemia
5462247|NCT01451918|Insulin resistance|insulin resistance
5462248|NCT01451918|Type 2 Diabetes|type 2 diabetes
5462249|NCT01451892|Obesity|obesity
5462250|NCT01451892|dance|dance
5462251|NCT01451892|gait|gait
5462252|NCT01451892|balance|balance
5462253|NCT01451892|posture|posture
5462254|NCT01451892|dance therapy|dance therapy
5462255|NCT01451879|Pompe Disease|pompe disease
5462256|NCT01451879|Infusion Associated Reaction|infusion associated reaction
5462257|NCT01451879|Immune-modulation regimen|immune-modulation regimen
5462258|NCT01451866|resistance training|resistance training
5462259|NCT01451866|Healthy People Programs|healthy people programs
5462260|NCT01451853|Lung Cancer|lung cancer
5462261|NCT01451853|Head and Neck Cancer|head and neck cancer
5462262|NCT01451853|Hearing Loss|hearing loss
5462263|NCT01451853|Ototoxicity|ototoxicity
5462264|NCT01451853|Tinnitus|tinnitus
5462265|NCT01451853|Deafness|deafness
5462266|NCT01451853|SPI-1005|spi-1005
5462267|NCT01451853|Cisplatin|cisplatin
5462268|NCT01451853|Carboplatin|carboplatin
5462269|NCT01451853|Ebselen|ebselen
5462270|NCT01451827|Kidney Disease|kidney disease
5462271|NCT01451827|Polycystic Kidney Disease|polycystic kidney disease
5462272|NCT01451827|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5462273|NCT01451827|PKD|pkd
5462274|NCT01451827|ADPKD|adpkd
5462275|NCT01451814|smoking cessation|smoking cessation
5462276|NCT01451801|Hepatitis B|hepatitis b
5462277|NCT01451801|non responders|non responders
5462278|NCT01451801|cellular immune response|cellular immune response
5462279|NCT01451801|cytokines|cytokines
5462280|NCT01451801|predictors|predictors
5462281|NCT01451801|HBsAg|hbsag
5462282|NCT01451788|RCT|rct
5462283|NCT01451788|Gelatin matrix|gelatin matrix
5462284|NCT01451788|thrombin|thrombin
5462892|NCT01449188|Zofran|zofran
5462285|NCT01451788|idiopathic scoliosis|idiopathic scoliosis
5462287|NCT01451762|pain|pain
5462288|NCT01451762|anesthesia|anesthesia
5462289|NCT01451762|surgery|surgery
5462290|NCT01451762|postoperative|postoperative
5462291|NCT01451749|Mild cognitive impairment|mild cognitive impairment
5462292|NCT01451736|First-episode Schizophrenia|first-episode schizophrenia
5680280|NCT00578383|low field magnetic stimulation|low field magnetic stimulation
5462293|NCT01451736|Schizoaffective Disorder, Depressed Type (recent-onset)|schizoaffective disorder, depressed type (recent-onset)
5462294|NCT01451736|Schizophreniform Disorder|schizophreniform disorder
5462295|NCT01451736|oral risperidone|oral risperidone
5462296|NCT01451736|long-acting injectable paliperidone palmitate|long-acting injectable paliperidone palmitate
5462297|NCT01451736|functional outcome|functional outcome
5462298|NCT01451723|Multiple Sclerosis|multiple sclerosis
5462299|NCT01451723|Polyphenon E|polyphenon e
5462300|NCT01451723|Green tea|green tea
5462301|NCT01451723|EGCG|egcg
5462302|NCT01451723|Epigallocatechin-galleate|epigallocatechin-galleate
5462303|NCT01451723|Placebo|placebo
5462304|NCT01451723|Randomized controlled trial|randomized controlled trial
5462305|NCT01451710|enough steroids|enough steroids
5462306|NCT01451710|MCD|mcd
5462307|NCT01451710|efficacy|efficacy
5462308|NCT01451684|pregnancy|pregnancy
5462309|NCT01451684|fetus|fetus
5462310|NCT01451684|euploid|euploid
5462311|NCT01451671|fetal|fetal
5462312|NCT01451671|aneuploidy|aneuploidy
5462313|NCT01451671|non-invasive|non-invasive
5462314|NCT01451671|prenatal|prenatal
5462315|NCT01451671|cell free DNA|cell free dna
5462316|NCT01451658|Variceal bleeding|variceal bleeding
5462317|NCT01451658|portal hypertension|portal hypertension
5462318|NCT01451658|hepatocellular carcinoma|hepatocellular carcinoma
5462319|NCT01451658|endoscopic variceal ligation|endoscopic variceal ligation
5462320|NCT01451658|non-selective beta-blocker|non-selective beta-blocker
5462321|NCT01451658|rebleeding|rebleeding
5462322|NCT01451645|Gout|gout
5462323|NCT01451632|Metastatic Colorectal cancer|metastatic colorectal cancer
5462324|NCT01451632|Kras wild-type|kras wild-type
5462325|NCT01451632|Squamous cell head and neck cancer|squamous cell head and neck cancer
5462326|NCT01451632|Non-small cell lung cancer|non-small cell lung cancer
5462327|NCT01451632|Triple negative breast cancer|triple negative breast cancer
5462328|NCT01451632|EGFR|egfr
5462329|NCT01451632|ErbB3|erbb3
5462330|NCT01451632|MM-121|mm-121
5462331|NCT01451632|Cetuximab|cetuximab
5462332|NCT01451632|Irinotecan|irinotecan
5462333|NCT01451606|Chronic Pelvic Pain (CPP)|chronic pelvic pain (cpp)
5462344|NCT01451580|Phase II|phase ii
5462345|NCT01451580|Metastatic Breast Cancer|metastatic breast cancer
5462346|NCT01451567|Nurses, Workload, Musculoskeletal System, Intervention|nurses, workload, musculoskeletal system, intervention
5462347|NCT01451554|weight|weight
5462348|NCT01451554|body mass index|body mass index
5462349|NCT01451554|obesity|obesity
5462350|NCT01451554|portion control plate|portion control plate
5462351|NCT01451554|diet|diet
5462352|NCT01451554|exercise|exercise
5462353|NCT01451528|Umbilical Cord Blood|umbilical cord blood
5462354|NCT01451528|Allogeneic|allogeneic
5462355|NCT01451528|Traumatic Brain Injury|traumatic brain injury
5462356|NCT01451515|Lymphoblastic lymphoma|lymphoblastic lymphoma
5444820|NCT01524523|Acute Pain|acute pain
5462357|NCT01451502|umbilical cord blood|umbilical cord blood
5462358|NCT01451489|FSGS|fsgs
5462359|NCT01451489|FK506|fk506
5462360|NCT01451489|CTX|ctx
5462361|NCT01451476|Ageing|ageing
5462362|NCT01451463|Huntington's Disease|huntington's disease
5462363|NCT01451463|Chorea|chorea
5462364|NCT01451463|Gait|gait
5462365|NCT01451463|Balance|balance
5462366|NCT01451450|Peanut Allergy|peanut allergy
5462367|NCT01451411|Serum Sodium|serum sodium
5462368|NCT01451411|Euvolemia|euvolemia
5462369|NCT01451411|Hypervolemia|hypervolemia
5462370|NCT01451411|Vaprisol®|vaprisol®
5462371|NCT01451411|Conivaptan|conivaptan
5462372|NCT01451411|YM087|ym087
5462373|NCT01451372|Diabetes|diabetes
5462374|NCT01451372|CGM|cgm
5462375|NCT01451372|CSII|csii
5462376|NCT01451346|Pilot study|pilot study
5462377|NCT01451333|HIV|hiv
5462378|NCT01451333|Efavirenz|efavirenz
5462379|NCT01451333|Central Nervous System (CNS)|central nervous system (cns)
5462380|NCT01451333|Lumbar puncture|lumbar puncture
5462381|NCT01451333|Dose reduction|dose reduction
5462382|NCT01451320|Prosthetic valve|prosthetic valve
5462383|NCT01451320|thrombosis|thrombosis
5462384|NCT01451320|TROIA|troia
5462385|NCT01451320|tPA|tpa
5462386|NCT01451320|TEE|tee
5462387|NCT01451307|Congenital abnormalities|congenital abnormalities
5462388|NCT01451307|Digestive system abnormalities|digestive system abnormalities
5462389|NCT01451307|Neonatal surgery|neonatal surgery
5462390|NCT01451307|Neonatal anesthesia|neonatal anesthesia
5462391|NCT01451307|Bayley Scales of Infant Development II|bayley scales of infant development ii
5462392|NCT01451294|Cerebral autoregulation|cerebral autoregulation
5462393|NCT01451281|Ultrasonography|ultrasonography
5462394|NCT01451281|Muscular Dystrophy|muscular dystrophy
5462395|NCT01451281|Neuromuscular Disease|neuromuscular disease
5462396|NCT01451281|Oligonucleotide|oligonucleotide
5462397|NCT01451281|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5462398|NCT01451281|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5462399|NCT01451281|DND|dnd
5462400|NCT01451268|60 to 150 Days After Allogeneic Stem Cell Transplantation|60 to 150 days after allogeneic stem cell transplantation
5462401|NCT01451268|High Risk MDS|high risk mds
5462402|NCT01451268|MDS|mds
5462403|NCT01451268|AML|aml
5462404|NCT01451255|pulsatility|pulsatility
5462405|NCT01451255|normal subjects|normal subjects
5462406|NCT01451255|mild pulmonary hypertension|mild pulmonary hypertension
5462407|NCT01451255|exercise-associated pulmonary hypertension|exercise-associated pulmonary hypertension
5462408|NCT01451242|Heart Rate Variability|heart rate variability
5462409|NCT01451242|Acquired Brain Injury|acquired brain injury
5462410|NCT01451242|Physical Activity|physical activity
5462411|NCT01451229|pharmacokinetics|pharmacokinetics
5462412|NCT01451229|pharmacodynamics|pharmacodynamics
5462413|NCT01451216|Acquired brain injury|acquired brain injury
5462414|NCT01451216|Balance control|balance control
5462415|NCT01451216|Functional reach|functional reach
5462416|NCT01451203|Cimzia|cimzia
5462417|NCT01451203|Early RA|early ra
5462418|NCT01451203|Certolizumab Pegol|certolizumab pegol
5462419|NCT01451190|Androgenetic Alopecia|androgenetic alopecia
5462420|NCT01451190|Male Pattern Baldness|male pattern baldness
5462421|NCT01451190|Female Pattern Baldness|female pattern baldness
5462422|NCT01451190|Hair Loss|hair loss
5462423|NCT01451190|Baldness|baldness
5462424|NCT01451177|Androgenetic Alopecia|androgenetic alopecia
5462425|NCT01451177|Male Pattern Baldness|male pattern baldness
5462426|NCT01451177|Female Pattern Baldness|female pattern baldness
5462427|NCT01451177|Hair Loss|hair loss
5462428|NCT01451177|Baldness|baldness
5462429|NCT01451151|Androgenetic Alopecia|androgenetic alopecia
5462430|NCT01451151|Male Pattern Baldness|male pattern baldness
5462431|NCT01451151|Female Pattern Baldness|female pattern baldness
5462432|NCT01451151|Hair Loss|hair loss
5462433|NCT01451151|Baldness|baldness
5462434|NCT01451138|Androgenetic Alopecia|androgenetic alopecia
5462435|NCT01451138|Male Pattern Baldness|male pattern baldness
5462436|NCT01451138|Female Pattern Baldness|female pattern baldness
5462437|NCT01451138|Hair Loss|hair loss
5462438|NCT01451138|Baldness|baldness
5462439|NCT01451125|Androgenetic Alopecia|androgenetic alopecia
5462440|NCT01451125|Male Pattern Baldness|male pattern baldness
5462441|NCT01451125|Female Pattern Baldness|female pattern baldness
5462442|NCT01451125|Hair Loss Baldness|hair loss baldness
5462443|NCT01451112|Androgenetic Alopecia|androgenetic alopecia
5462444|NCT01451112|Male Pattern Baldness|male pattern baldness
5462445|NCT01451112|Female Pattern Baldness|female pattern baldness
5462446|NCT01451112|Hair Loss|hair loss
5462447|NCT01451112|Baldness|baldness
5462448|NCT01451099|Androgenetic Alopecia|androgenetic alopecia
5462449|NCT01451099|Male Pattern Baldness|male pattern baldness
5462450|NCT01451099|Female Pattern Baldness|female pattern baldness
5462451|NCT01451099|Hair Loss|hair loss
5462452|NCT01451099|Baldness|baldness
5462453|NCT01451086|Safety|safety
5462454|NCT01451086|Immunogenicity|immunogenicity
5462455|NCT01451086|Pneumococcal vaccine|pneumococcal vaccine
5462456|NCT01451073|Androgenetic Alopecia|androgenetic alopecia
5462457|NCT01451073|Male Pattern Baldness|male pattern baldness
5462458|NCT01451073|Female Pattern Baldness|female pattern baldness
5462459|NCT01451073|Hair Loss|hair loss
5462460|NCT01451073|Baldness|baldness
5462461|NCT01451060|vasopressors|vasopressors
5462462|NCT01451060|cesarean anesthesia|cesarean anesthesia
5462463|NCT01451060|hypotension|hypotension
5462464|NCT01451047|Androgenetic Alopecia|androgenetic alopecia
5462465|NCT01451047|Male Pattern Baldness|male pattern baldness
5462466|NCT01451047|Female Pattern Baldness|female pattern baldness
5462467|NCT01451047|Hair Loss|hair loss
5462468|NCT01451047|Baldness|baldness
5462469|NCT01451034|WHYX lesion|whyx lesion
5462470|NCT01451034|endoscopic resection|endoscopic resection
5462471|NCT01451034|complete resection|complete resection
5462472|NCT01451034|complete resection rate|complete resection rate
5462473|NCT01451034|endoscopic feature|endoscopic feature
5462474|NCT01451034|Average size discrepancy|average size discrepancy
5462475|NCT01451021|Androgenetic Alopecia|androgenetic alopecia
5462476|NCT01451021|Male Pattern Baldness|male pattern baldness
5462477|NCT01451021|Female Pattern Baldness|female pattern baldness
5462479|NCT01451021|Baldness|baldness
5462480|NCT01451008|Anastomosis|anastomosis
5462481|NCT01451008|Compression|compression
5462483|NCT01450995|Migraine|migraine
5462484|NCT01450995|Headache, Migraine|headache, migraine
5462485|NCT01450982|Rheumatoid Arthritis|rheumatoid arthritis
5462486|NCT01450982|JNJ-38518168|jnj-38518168
5462487|NCT01450982|Methotrexate|methotrexate
5462488|NCT01450969|Operator Comfort Assessment|operator comfort assessment
5462489|NCT01450969|Radiation protection|radiation protection
5462490|NCT01450969|Measurement of Radiation Exposure|measurement of radiation exposure
5462491|NCT01450969|Endovascular Interventional Radiology|endovascular interventional radiology
5462492|NCT01450956|congenital heart diseases|congenital heart diseases
5462493|NCT01450956|cardiopulmonary bypass|cardiopulmonary bypass
5462494|NCT01450956|Pediatric|pediatric
5462495|NCT01450956|sevoflurane|sevoflurane
5462496|NCT01450943|Diabetic Foot Ulcer|diabetic foot ulcer
5462497|NCT01450943|Chronic wounds|chronic wounds
5462498|NCT01450943|Chronic ulcers|chronic ulcers
5462499|NCT01450943|Oasis|oasis
5462501|NCT01450943|Adaptic|adaptic
5462502|NCT01450930|Adrenal insufficiency|adrenal insufficiency
5462503|NCT01450930|Addison's disease|addison's disease
5462504|NCT01450891|Alzheimer's disease|alzheimer's disease
5462505|NCT01450891|Diagnosis|diagnosis
5462506|NCT01450891|Costs|costs
5462507|NCT01450891|Benefits|benefits
5462508|NCT01450891|subjective and/or objective memory complaints|subjective and/or objective memory complaints
5462509|NCT01450878|high dose of EPO|high dose of epo
5462510|NCT01450878|transplant kidney|transplant kidney
5462511|NCT01450878|cadaveric organ donor|cadaveric organ donor
5462512|NCT01450878|mono-organ (kidney) retrieval|mono-organ (kidney) retrieval
5462513|NCT01450878|patient|patient
5462514|NCT01450878|kidney graft|kidney graft
5462515|NCT01450865|neuropathy|neuropathy
5462516|NCT01450865|axonal excitability|axonal excitability
5462517|NCT01450865|myelinated nerve|myelinated nerve
5462518|NCT01450865|human|human
5462519|NCT01450865|ectopic discharge|ectopic discharge
5462520|NCT01450865|flupirtine|flupirtine
5462521|NCT01450852|Melanocortin Receptor|melanocortin receptor
5462522|NCT01450852|Monocyte|monocyte
5462523|NCT01450852|Resistance Training|resistance training
5462524|NCT01450852|Inflammation|inflammation
5462525|NCT01450852|Markers of Inflammation|markers of inflammation
5462531|NCT01450826|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5462532|NCT01450826|CINV|cinv
5462533|NCT01450826|Glioma|glioma
5462534|NCT01450826|Temozolomide|temozolomide
5462535|NCT01450826|Temodar|temodar
5462536|NCT01450826|Aprepitant|aprepitant
5462537|NCT01450826|Emend|emend
5462538|NCT01450826|Ondansetron|ondansetron
5462539|NCT01450826|Zofran|zofran
5462540|NCT01450826|Pro00031206|pro00031206
5462541|NCT01450826|Affronti|affronti
5462542|NCT01450826|Peters|peters
5462543|NCT01450826|Duke|duke
5462544|NCT01450826|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
5462545|NCT01450800|urinary tract infection|urinary tract infection
5462546|NCT01450800|gynecologic surgery|gynecologic surgery
5462547|NCT01450800|post-operative complications|post-operative complications
5462548|NCT01450800|nitrofurantoin|nitrofurantoin
5462549|NCT01450787|dry eyes|dry eyes
5462550|NCT01450787|diabetes|diabetes
5462551|NCT01450748|sodium alginate|sodium alginate
5462552|NCT01450748|laryngopharyngeal reflux|laryngopharyngeal reflux
5462553|NCT01450748|combined impedance-pH monitoring|combined impedance-ph monitoring
5462554|NCT01450722|Chronic lower limb ischemia|chronic lower limb ischemia
5462555|NCT01450722|claudication|claudication
5462556|NCT01450722|chronic critical ischemia|chronic critical ischemia
5462557|NCT01450709|Probiotics|probiotics
5462558|NCT01450709|Kibow Biotics|kibow biotics
5462559|NCT01450709|Dialysis|dialysis
5462560|NCT01450709|Gut based uremic toxin removal|gut based uremic toxin removal
5462561|NCT01450670|Probiotics|probiotics
5462562|NCT01450670|Kibow Biotics|kibow biotics
5462563|NCT01450670|Dialysis|dialysis
5462564|NCT01450670|Gut based uremic toxin removal|gut based uremic toxin removal
5462565|NCT01450657|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
5462566|NCT01450657|Probiotics|probiotics
5462567|NCT01450657|Kibow Biotics|kibow biotics
5462568|NCT01450657|Dialysis|dialysis
5462569|NCT01450657|Gut based uremic toxin removal|gut based uremic toxin removal
5462570|NCT01450644|Advanced|advanced
5462571|NCT01450644|Progressive|progressive
5462572|NCT01450644|Idiopathic Fibrotic Interstitial Lung Disease|idiopathic fibrotic interstitial lung disease
5462573|NCT01450644|Palliative Care|palliative care
5462574|NCT01450644|Randomised|randomised
5462575|NCT01450644|Controlled|controlled
5462576|NCT01450631|surgical site infection|surgical site infection
5462577|NCT01450631|nosocomial infection|nosocomial infection
5462578|NCT01450631|post-operative complication|post-operative complication
5462579|NCT01450631|surgical incision risk|surgical incision risk
5462580|NCT01450631|surgical incision infection|surgical incision infection
5462581|NCT01450631|negative pressure wound therapy|negative pressure wound therapy
5462582|NCT01450631|wound management|wound management
5462583|NCT01450631|cesarean section surgery|cesarean section surgery
5462584|NCT01450631|wound dehiscence|wound dehiscence
5463289|NCT01447602|Dysthymia|dysthymia
5462585|NCT01450631|wound infection|wound infection
5462586|NCT01450631|surgical closure|surgical closure
5462587|NCT01450631|wound disruption|wound disruption
5462588|NCT01450631|subcutaneous approximation|subcutaneous approximation
5462589|NCT01450631|wound separation|wound separation
5462590|NCT01450631|seroma|seroma
5462591|NCT01450631|hematoma|hematoma
5462592|NCT01450631|subcutaneous closure|subcutaneous closure
5462593|NCT01450631|obesity|obesity
5462594|NCT01450631|cesarean|cesarean
5462595|NCT01450631|incision|incision
5462596|NCT01450631|massive obesity|massive obesity
5462597|NCT01450631|obese|obese
5462598|NCT01450631|pregnancy|pregnancy
5462599|NCT01450631|cesarean delivery|cesarean delivery
5462600|NCT01450631|superobesity|superobesity
5462601|NCT01450631|wound complication|wound complication
5462602|NCT01450592|Carbohydrate, Dietary|carbohydrate, dietary
5462603|NCT01450579|Recombinant Influenza HA vaccine|recombinant influenza ha vaccine
5462604|NCT01450579|Immunogenicity of ASP7373|immunogenicity of asp7373
5462605|NCT01450566|ureteroscopy (URS)|ureteroscopy (urs)
5462606|NCT01450566|ureteral stent placement|ureteral stent placement
5462607|NCT01450566|Ureteral Calculi|ureteral calculi
5462608|NCT01450566|Renal Calculi|renal calculi
5462609|NCT01450553|Tissue Collection|tissue collection
5462610|NCT01450553|Lung Cancer|lung cancer
5462611|NCT01450553|Non-Small Cell Lung Cancer|non-small cell lung cancer
5462612|NCT01450553|Early Stage Lung Cancer|early stage lung cancer
5462613|NCT01450527|Etiology and outcomes of ARDS|etiology and outcomes of ards
5462614|NCT01450488|primary progressive multiple sclerosis|primary progressive multiple sclerosis
5462615|NCT01450488|relapse-free secondary progressive multiple sclerosis|relapse-free secondary progressive multiple sclerosis
5462616|NCT01450449|GBM, fractionation, short course, standard course|gbm, fractionation, short course, standard course
5462617|NCT01450423|Epilepsy|epilepsy
5462618|NCT01450423|Physical activity|physical activity
5462619|NCT01450423|Cardio exercise|cardio exercise
5462620|NCT01450423|Physical fitness|physical fitness
5462621|NCT01450423|Cognitive function|cognitive function
5462622|NCT01450410|Dyslipemia, HDL composition|dyslipemia, hdl composition
5462623|NCT01450397|Dupuytren's Contracture|dupuytren's contracture
5462624|NCT01450384|protocol specific|protocol specific
5462625|NCT01450371|Autonomic Nervous System|autonomic nervous system
5462626|NCT01450371|Neuromodulation|neuromodulation
5462627|NCT01450371|Blood flow control|blood flow control
5462628|NCT01450371|Exercise|exercise
5462629|NCT01450358|Sepsis|sepsis
5462630|NCT01450358|Real time PCR|real time pcr
5462631|NCT01450358|Blood culture|blood culture
5462632|NCT01450358|Bacteremia diagnosis|bacteremia diagnosis
5462633|NCT01450358|Fungemia diagnosis|fungemia diagnosis
5462634|NCT01450345|Clinical diagnosis of inguinal hernia|clinical diagnosis of inguinal hernia
5462635|NCT01450345|Patient undergo operation under daycare basis|patient undergo operation under daycare basis
5462637|NCT01450345|Written consent|written consent
5462639|NCT01450332|arthroscopy|arthroscopy
5462640|NCT01450332|ligament|ligament
5462641|NCT01450332|rupture|rupture
5462642|NCT01450332|reconstruction|reconstruction
5462643|NCT01450332|ACLR|aclr
5462644|NCT01450332|accelerated rehabilitation program|accelerated rehabilitation program
5462645|NCT01450319|K-RAS|k-ras
5462646|NCT01450319|FcγRII/IIIa genotypes|fcγrii/iiia genotypes
5462648|NCT01450319|Colorectal cancer|colorectal cancer
5462649|NCT01450293|Immune response|immune response
5462650|NCT01450267|Cystic Fibrosis|cystic fibrosis
5462651|NCT01450267|Glutathione|glutathione
5462652|NCT01450254|Hip Osteoarthritis|hip osteoarthritis
5462653|NCT01450254|Gait Patterns|gait patterns
5462654|NCT01450254|Neuromuscular retraining|neuromuscular retraining
5462655|NCT01450241|Febrile neutropenia|febrile neutropenia
5462656|NCT01450241|Unexplained fever|unexplained fever
5462657|NCT01450241|Duration|duration
5462658|NCT01450241|Short-term antibiotic treatment|short-term antibiotic treatment
5462659|NCT01450228|primary insomnia|primary insomnia
5462660|NCT01450215|Relapsed and refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5462661|NCT01450202|Carbon dioxide insufflation|carbon dioxide insufflation
5462662|NCT01450202|Colonoscopy|colonoscopy
5462663|NCT01450202|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5462664|NCT01450202|Bowel insufflation|bowel insufflation
5462665|NCT01450202|Postprocedure pain|postprocedure pain
5462666|NCT01450202|Pain Due to Certain Specified Procedures|pain due to certain specified procedures
5462667|NCT01450189|Acute HIV|acute hiv
5462668|NCT01450189|Transmission Prevention|transmission prevention
5462669|NCT01450189|Randomized Pilot study|randomized pilot study
5462670|NCT01450176|eye|eye
5462671|NCT01450176|itching|itching
5462672|NCT01450176|allergies|allergies
5462673|NCT01450163|Neuropathic pain|neuropathic pain
5462674|NCT01450163|prevention|prevention
5462675|NCT01450163|prophylaxis|prophylaxis
5462676|NCT01450163|chemotherapy|chemotherapy
5462677|NCT01450163|neuropathy|neuropathy
5462678|NCT01450163|Oxaliplatin|oxaliplatin
5462679|NCT01450163|pregabalin|pregabalin
5462680|NCT01450150|Major Depression|major depression
5462681|NCT01450150|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5462683|NCT01450150|tDCS|tdcs
5462684|NCT01450137|Giant Cell Arteritis|giant cell arteritis
5462685|NCT01450137|Tocilizumab|tocilizumab
5462686|NCT01450137|Antibodies, Monoclonal|antibodies, monoclonal
5462687|NCT01450137|Glucocorticoids|glucocorticoids
5462688|NCT01450111|Lacosamide|lacosamide
5462689|NCT01450059|Human Immunodeficiency Virus|human immunodeficiency virus
5462690|NCT01450059|Microchimerism|microchimerism
5462691|NCT01450059|Maternal-Fetal Exchange|maternal-fetal exchange
5462692|NCT01450059|Gestation|gestation
5462693|NCT01450059|HiV-vertical transmission|hiv-vertical transmission
5462694|NCT01450046|pancreas|pancreas
5462695|NCT01450046|gastrointestinal|gastrointestinal
5462696|NCT01450046|GI|gi
5462697|NCT01450046|prevention|prevention
5462698|NCT01450046|vitamin E|vitamin e
5462700|NCT01450033|renal|renal
5462701|NCT01450033|transplant|transplant
5462702|NCT01450033|transplantation|transplantation
5462703|NCT01450033|adolescent|adolescent
5462704|NCT01450033|pediatric|pediatric
5462705|NCT01450033|mentor|mentor
5462706|NCT01450033|mentoring|mentoring
5462707|NCT01450033|medication|medication
5462708|NCT01450033|adherence|adherence
5462709|NCT01450033|immunosuppressant|immunosuppressant
5462710|NCT01450033|heart|heart
5462711|NCT01450033|liver|liver
5462713|NCT01450007|Pain blockade|pain blockade
5462714|NCT01450007|Ropivacaine|ropivacaine
5462715|NCT01450007|Dexamethasone|dexamethasone
5462716|NCT01449994|knee|knee
5462717|NCT01449994|hip|hip
5462718|NCT01449994|ankle|ankle
5462719|NCT01449994|foot|foot
5462720|NCT01449994|pain|pain
5462721|NCT01449994|lower limb|lower limb
5462722|NCT01449994|activator|activator
5462723|NCT01449994|instrumental|instrumental
5462725|NCT01449994|Painful functional conditions of the lower extremity|painful functional conditions of the lower extremity
5462726|NCT01449981|Adolescents|adolescents
5462727|NCT01449981|Alcohol Abuse|alcohol abuse
5462728|NCT01449981|Alcohol Dependence|alcohol dependence
5462729|NCT01449981|Drug Abuse|drug abuse
5462730|NCT01449981|Drug Dependence|drug dependence
5462731|NCT01449981|Substance Use Disorder|substance use disorder
5462732|NCT01449981|Alcoholics Anonymous|alcoholics anonymous
5462733|NCT01449981|Motivational Enhancement Therapy|motivational enhancement therapy
5462734|NCT01449981|Cognitive Behavioral Therapy|cognitive behavioral therapy
5462735|NCT01449955|PTSD|ptsd
5462736|NCT01449942|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5462737|NCT01449942|EBV|ebv
5462738|NCT01449942|LMP1|lmp1
5462739|NCT01449929|ritonavir|ritonavir
5462740|NCT01449929|HIV|hiv
5462741|NCT01449929|HAART|haart
5462742|NCT01449929|darunavir|darunavir
5462743|NCT01449929|antiretroviral|antiretroviral
5462744|NCT01449929|dolutegravir|dolutegravir
5462745|NCT01449929|GSK1349572|gsk1349572
5462746|NCT01449916|Sepsis|sepsis
5462747|NCT01449916|Severe Sepsis|severe sepsis
5462748|NCT01449916|Protocol|protocol
5462749|NCT01449916|Zambia|zambia
5462750|NCT01449890|follow up care|follow up care
5462751|NCT01449890|e-mail|e-mail
5462752|NCT01449890|effectiveness|effectiveness
5462753|NCT01449890|depressive disorders|depressive disorders
5462754|NCT01449877|Ocular Toxoplasmosis|ocular toxoplasmosis
5462755|NCT01449877|Retinochoroiditis|retinochoroiditis
5462756|NCT01449877|Prophylaxis|prophylaxis
5462757|NCT01449864|upper GI malignancies|upper gi malignancies
5462758|NCT01449864|concurrent chemoradiation with continuous infusion 5-Fluorouracil chemotherapy|concurrent chemoradiation with continuous infusion 5-fluorouracil chemotherapy
5462759|NCT01449825|hepatic safety|hepatic safety
5462760|NCT01449825|prescriber compliance|prescriber compliance
5462761|NCT01449825|pazopanib|pazopanib
5462762|NCT01449825|epidemiology|epidemiology
5462763|NCT01449812|combination vaccine|combination vaccine
5462764|NCT01449812|booster vaccination|booster vaccination
5462765|NCT01449786|Mal d 1, Bet v 1, sublingual immunotherapy,|mal d 1, bet v 1, sublingual immunotherapy,
5462766|NCT01449760|Ankle sprain|ankle sprain
5462767|NCT01449760|Balance|balance
5462768|NCT01449760|Gait|gait
5462769|NCT01449747|Type 2 diabetes mellitus|type 2 diabetes mellitus
5462770|NCT01449747|Dipeptidyl peptidase IV inhibitors|dipeptidyl peptidase iv inhibitors
5462771|NCT01449747|Glucagon-like peptide 1|glucagon-like peptide 1
5462772|NCT01449721|Sepsis|sepsis
5462773|NCT01449721|Multiple organ failure|multiple organ failure
5462774|NCT01449721|Resuscitation|resuscitation
5462775|NCT01449708|Bariatric Surgery|bariatric surgery
5462776|NCT01449708|TIVA|tiva
5462777|NCT01449708|PONV|ponv
5462778|NCT01449708|non-opioid|non-opioid
5462779|NCT01449708|OSA|osa
5462781|NCT01449695|CVA|cva
5462782|NCT01449695|ACS|acs
5462783|NCT01449682|BRVO|brvo
5462784|NCT01449682|CRVO|crvo
5462785|NCT01449682|Macular Edema|macular edema
5462786|NCT01449682|Anti-VEGF|anti-vegf
5462787|NCT01449682|Ozurdex|ozurdex
5462788|NCT01449669|pharmacokinetics|pharmacokinetics
5462790|NCT01449669|microdialysis sampling|microdialysis sampling
5462791|NCT01449669|interstitial fluid|interstitial fluid
5462792|NCT01449669|skeletal muscle|skeletal muscle
5462793|NCT01449669|plasma|plasma
5462794|NCT01449669|children|children
5462795|NCT01449643|Obesity|obesity
5462796|NCT01449643|Diaphragm|diaphragm
5462797|NCT01449643|Inspiratory muscular training|inspiratory muscular training
5462798|NCT01449617|Carotid stenosis|carotid stenosis
5462799|NCT01449617|Aspirin plus Clopidogrel|aspirin plus clopidogrel
5462800|NCT01449617|Residual platelet reactivity|residual platelet reactivity
5462801|NCT01449604|Stereotactic radiotherapy|stereotactic radiotherapy
5462802|NCT01449604|SRS|srs
5462803|NCT01449604|SRT|srt
5462804|NCT01449604|vestibular schwannoma|vestibular schwannoma
5462805|NCT01449591|BFH772|bfh772
5462806|NCT01449591|rosacea|rosacea
5447711|NCT01512238|Herbal medicine|herbal medicine
5462807|NCT01449591|erythemato-telangiectatic rosacea|erythemato-telangiectatic rosacea
5462808|NCT01449565|methamphetamine|methamphetamine
5462809|NCT01449565|high-risk sexual behavior|high-risk sexual behavior
5462810|NCT01449565|HIV prevention|hiv prevention
5462811|NCT01449539|Hyperbaric oxygen|hyperbaric oxygen
5462812|NCT01449539|mobilize|mobilize
5462813|NCT01449539|stem cells|stem cells
5462814|NCT01449539|growth factor|growth factor
5462815|NCT01449526|contact lens|contact lens
5462816|NCT01449500|Dyspeptic H.pylori-infection|dyspeptic h.pylori-infection
5462817|NCT01449487|Experimental pain|experimental pain
5462818|NCT01449487|IBS|ibs
5462819|NCT01449487|Rectum|rectum
5462820|NCT01449448|pain relief|pain relief
5462821|NCT01449448|Hypermobility, Joint|hypermobility, joint
5462822|NCT01449448|increased strength|increased strength
5462823|NCT01449448|increased patient satisfaction|increased patient satisfaction
5462824|NCT01449435|Asthma|asthma
5462825|NCT01449435|children|children
5462826|NCT01449435|predictors of exacerbation|predictors of exacerbation
5462827|NCT01449435|Methacholine challenge|methacholine challenge
5462828|NCT01449435|Pulmonary function testing|pulmonary function testing
5462829|NCT01449409|Uncontrolled asthma|uncontrolled asthma
5462830|NCT01449409|Asthma risk|asthma risk
5462831|NCT01449409|Asthma impairment|asthma impairment
5462832|NCT01449409|Real time asthma outreach program|real time asthma outreach program
5462833|NCT01449396|acupuncture|acupuncture
5462834|NCT01449396|in vitro fertilization|in vitro fertilization
5462835|NCT01449396|embryo transfer|embryo transfer
5462836|NCT01449383|cross over|cross over
5462837|NCT01449383|dietary intervention|dietary intervention
5462838|NCT01449383|fibre|fibre
5462839|NCT01449383|red meat|red meat
5462840|NCT01449383|microbiota|microbiota
5462841|NCT01449370|INK1117|ink1117
5462842|NCT01449370|PIK3CA|pik3ca
5462843|NCT01449370|KINASE|kinase
5462844|NCT01449370|TUMOR|tumor
5462845|NCT01449370|CANCER|cancer
5789037|NCT00150150|tumor ablation|tumor ablation
5462846|NCT01449370|Locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
5462847|NCT01449370|not eligible for standard of care therapy|not eligible for standard of care therapy
5462849|NCT01449357|Zalutumumab|zalutumumab
5462850|NCT01449357|Efficacy|efficacy
5462851|NCT01449357|Safety|safety
5462852|NCT01449344|relapsed|relapsed
5462853|NCT01449344|refractory|refractory
5462854|NCT01449318|Pain|pain
5462855|NCT01449318|quantitative sensory testing|quantitative sensory testing
5462856|NCT01449292|PLVR|plvr
5462857|NCT01449292|ELVR|elvr
5462858|NCT01449292|AeriSeal System|aeriseal system
5462859|NCT01449292|foam sealant|foam sealant
5462860|NCT01449292|emphysematous lung sealant|emphysematous lung sealant
5462861|NCT01449292|ELS|els
5462862|NCT01449292|COPD|copd
5462863|NCT01449292|emphysema|emphysema
5462864|NCT01449292|polymeric lung volume reduction|polymeric lung volume reduction
5462865|NCT01449292|heterogeneous|heterogeneous
5462866|NCT01449292|Respiratory Tract Diseases|respiratory tract diseases
5462867|NCT01449292|Lung Diseases|lung diseases
5462868|NCT01449292|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5462869|NCT01449266|Dotarem|dotarem
5462870|NCT01449266|Dialyses|dialyses
5462871|NCT01449266|Dialysed|dialysed
5462872|NCT01449266|Safety|safety
5789974|NCT00146302|immunisation|immunisation
5462873|NCT01449266|Safety and dialysability of Dotarem in dialysed patients|safety and dialysability of dotarem in dialysed patients
5462874|NCT01449240|Hunter syndrome|hunter syndrome
5462875|NCT01449240|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5462876|NCT01449240|Iduronate 2-Sulfatase Deficiency|iduronate 2-sulfatase deficiency
5462877|NCT01449240|Lumbar puncture|lumbar puncture
5462878|NCT01449240|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5462879|NCT01449240|Pediatric|pediatric
5462880|NCT01449240|Adult|adult
5462881|NCT01449240|Biomarkers|biomarkers
5462882|NCT01449227|adhesive capsulitis|adhesive capsulitis
5462883|NCT01449227|hip|hip
5462884|NCT01449214|Thoracic epidural|thoracic epidural
5462885|NCT01449214|Epidural anesthesia|epidural anesthesia
5462886|NCT01449214|Ultrasound|ultrasound
5462887|NCT01449214|Palpation|palpation
5462888|NCT01449214|Thoracic spine|thoracic spine
5462889|NCT01449201|PF-00299804, head and neck cancer, squamous cell carcinoma|pf-00299804, head and neck cancer, squamous cell carcinoma
5462890|NCT01449188|ondansetron|ondansetron
5462891|NCT01449188|moxifloxacin|moxifloxacin
5462893|NCT01449188|thorough QT study|thorough qt study
5462894|NCT01449188|IV|iv
5462895|NCT01449175|AeriSeal|aeriseal
5462896|NCT01449175|treatment|treatment
5462897|NCT01449175|device|device
5462898|NCT01449175|breathing|breathing
5462899|NCT01449175|COPD|copd
5462900|NCT01449175|emphysema|emphysema
5462901|NCT01449175|polymeric lung volume reduction (PLVR)|polymeric lung volume reduction (plvr)
5462902|NCT01449175|biologic lung volume reduction (BLVR)|biologic lung volume reduction (blvr)
5462903|NCT01449175|heterogeneous|heterogeneous
5462904|NCT01449175|homogeneous|homogeneous
5462905|NCT01449175|Respiratory Tract Diseases|respiratory tract diseases
5462906|NCT01449175|Lung Diseases|lung diseases
5462907|NCT01449175|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5462908|NCT01449162|severe persistent asthma|severe persistent asthma
5462909|NCT01449162|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5462910|NCT01449149|Age 18 or greater|age 18 or greater
5462911|NCT01449149|No prior radiation|no prior radiation
5462912|NCT01449136|Antibacterial agents|antibacterial agents
5462913|NCT01449136|Deciduous Teeth|deciduous teeth
5462914|NCT01449136|Clinical Trial|clinical trial
5462915|NCT01449123|Asthma|asthma
5462916|NCT01449123|mannitol challenge test|mannitol challenge test
5462917|NCT01449123|Sweden|sweden
5462918|NCT01449123|primary care|primary care
5462919|NCT01449110|Primary prevention|primary prevention
5462920|NCT01449110|Secondary prevention|secondary prevention
5462921|NCT01449110|Resveratrol|resveratrol
5462922|NCT01449110|Grape|grape
5462923|NCT01449110|Cardiovascular|cardiovascular
5462924|NCT01449110|Nutraceutical|nutraceutical
5462925|NCT01449110|Food complement|food complement
5462926|NCT01449097|Adductor-Canal-blockade,|adductor-canal-blockade,
5462927|NCT01449097|human volunteers,|human volunteers,
5462928|NCT01449097|US-guided nerve block|us-guided nerve block
5462929|NCT01449097|femoral nerve block|femoral nerve block
5462930|NCT01449084|Pancreatic duct stenting|pancreatic duct stenting
5462931|NCT01449084|Post-endoscopic pancreatitis|post-endoscopic pancreatitis
5462932|NCT01449071|Lupus|lupus
5462933|NCT01449071|Monoclonal antibody|monoclonal antibody
5462934|NCT01449071|B-cell immunotherapy|b-cell immunotherapy
5462935|NCT01449071|Epratuzumab|epratuzumab
5462936|NCT01449058|Advanced solid tumor,|advanced solid tumor,
5462938|NCT01449058|high risk and very high risk MDS|high risk and very high risk mds
5462939|NCT01449058|dose escalation,|dose escalation,
5462940|NCT01449058|RAS/BRAF mutation,|ras/braf mutation,
5462941|NCT01449058|PI3K inhibitor,|pi3k inhibitor,
5462942|NCT01449058|MEK inhibitor,|mek inhibitor,
5462943|NCT01449058|BYL719,|byl719,
5462944|NCT01449058|MEK162|mek162
5462945|NCT01449045|IPTc|iptc
5457521|NCT01471483|11-164|11-164
5462946|NCT01449045|Community Case Management|community case management
5462947|NCT01449045|Home Management for malaria|home management for malaria
5462949|NCT01449019|GLP-1|glp-1
5462950|NCT01449019|Exendin(9-39)|exendin(9-39)
5462951|NCT01449019|Insulin|insulin
5462952|NCT01449019|Glucagon|glucagon
5462953|NCT01449019|T2DM|t2dm
5462954|NCT01449019|incretin effect|incretin effect
5462955|NCT01449019|human physiology|human physiology
5462956|NCT01449006|HIV|hiv
5462957|NCT01449006|HAND|hand
5462958|NCT01449006|Maraviroc|maraviroc
5462959|NCT01449006|Neurocognitive|neurocognitive
5462960|NCT01449006|Neurology|neurology
5462961|NCT01449006|Human Immunodeficiency Virus|human immunodeficiency virus
5462962|NCT01449006|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
5462963|NCT01448980|massage|massage
5462964|NCT01448980|stroke spasticity|stroke spasticity
5462965|NCT01448928|Zevalin|zevalin
5462966|NCT01448928|CD20+|cd20+
5462967|NCT01448928|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5462968|NCT01448928|Mantle Cell Lymphoma|mantle cell lymphoma
5462969|NCT01448915|HIV|hiv
5462970|NCT01448915|Human immunodeficiency virus|human immunodeficiency virus
5462971|NCT01448915|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5462972|NCT01448915|AIDS virus|aids virus
5462973|NCT01448915|Immunodeficiency Virus, Human|immunodeficiency virus, human
5462974|NCT01448915|Virus, Human Immunodeficiency|virus, human immunodeficiency
5462975|NCT01448915|Hepatitis C|hepatitis c
5462976|NCT01448915|Hepatitis C, chronic|hepatitis c, chronic
5462977|NCT01448915|Hepatitis C virus|hepatitis c virus
5462978|NCT01448915|Hepatitis C antibodies|hepatitis c antibodies
5462979|NCT01448915|Hepatitis C antigens|hepatitis c antigens
5462980|NCT01448902|Allergic rhinitis|allergic rhinitis
5462981|NCT01448902|CRTH2|crth2
5903984|NCT00086567|Epithelial Ovarian Cancer|epithelial ovarian cancer
5462982|NCT01448889|contrast induced nephropathy|contrast induced nephropathy
5462983|NCT01448889|oxigen|oxigen
5462984|NCT01448889|coronary angiography|coronary angiography
5462985|NCT01448876|Chlamydia trachomatis|chlamydia trachomatis
5462986|NCT01448876|anorectal|anorectal
5462987|NCT01448876|cervicovaginal|cervicovaginal
5462988|NCT01448876|MSM|msm
5462989|NCT01448876|women|women
5462990|NCT01448876|treatment|treatment
5462991|NCT01448876|RNA|rna
5462992|NCT01448876|bacterial load|bacterial load
5462993|NCT01448876|sexual behaviour|sexual behaviour
5462994|NCT01448876|Azythromycin treated|azythromycin treated
5462995|NCT01448850|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5462996|NCT01448850|MEDI8968|medi8968
5462997|NCT01448824|Low High-density Lipoprotein (HDL)|low high-density lipoprotein (hdl)
5462998|NCT01448824|Cholesterol (HDL-C)|cholesterol (hdl-c)
5462999|NCT01448798|radical prostatectomy|radical prostatectomy
5463000|NCT01448798|robotic surgery|robotic surgery
5463001|NCT01448798|erectile dysfunction|erectile dysfunction
5463002|NCT01448798|continence|continence
5463004|NCT01448785|gastric stimulation|gastric stimulation
5463005|NCT01448785|morbid obesity|morbid obesity
5463006|NCT01448772|Dronabinol|dronabinol
5463007|NCT01448772|fasting|fasting
5463008|NCT01448759|Patients receiving docetaxel or paclitaxel. All tumors.|patients receiving docetaxel or paclitaxel. all tumors.
5463009|NCT01448746|gastric cancer|gastric cancer
5463010|NCT01448746|VTE|vte
5463011|NCT01448746|incidence|incidence
5463012|NCT01448733|acne vulgaris|acne vulgaris
5463013|NCT01448720|Schizophrenia|schizophrenia
5463014|NCT01448720|Paliperidone palmitate|paliperidone palmitate
5463015|NCT01448720|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5463016|NCT01448707|Darunavir (DRV)|darunavir (drv)
5463017|NCT01448707|TMC114|tmc114
5463018|NCT01448707|Prezista|prezista
5463019|NCT01448707|HIV|hiv
5463020|NCT01448707|virologic response|virologic response
5463021|NCT01448707|neurocognitive function|neurocognitive function
5463022|NCT01448694|Hemorrhage|hemorrhage
5463023|NCT01448681|Intracranial Hypertension|intracranial hypertension
5463024|NCT01448681|Elevated ICP (Intracranial Pressure)|elevated icp (intracranial pressure)
5463025|NCT01448668|pancreatic cancer|pancreatic cancer
5463026|NCT01448668|mistletoe|mistletoe
5463027|NCT01448668|supportive treatment|supportive treatment
5463028|NCT01448668|long-term study|long-term study
5798688|NCT00111371|healthy subjects|healthy subjects
5463029|NCT01448668|non-interventional cohort study|non-interventional cohort study
5463030|NCT01448668|controlled study with parallel groups|controlled study with parallel groups
5463031|NCT01448655|colorectal cancer|colorectal cancer
5463032|NCT01448655|mistletoe|mistletoe
5463033|NCT01448655|supportive treatment|supportive treatment
5463034|NCT01448655|long-term study|long-term study
5463035|NCT01448655|non-interventional cohort study|non-interventional cohort study
5463036|NCT01448655|controlled study with parallel groups|controlled study with parallel groups
5463037|NCT01448603|Ragweed allergy|ragweed allergy
5463038|NCT01448603|ToleroMune ragweed|toleromune ragweed
5463039|NCT01448603|immunotherapy|immunotherapy
5463040|NCT01448590|post dural puncture headache|post dural puncture headache
5457627|NCT01471067|AML|aml
5463041|NCT01448590|accidental dural puncture|accidental dural puncture
5463042|NCT01448590|PDPH|pdph
5463043|NCT01448590|ADP|adp
5463044|NCT01448590|spinal catheter|spinal catheter
5463045|NCT01448590|epidural catheter|epidural catheter
5463046|NCT01448590|intrathecal catheter|intrathecal catheter
5463047|NCT01448590|dural puncture|dural puncture
5463048|NCT01448590|systemic review|systemic review
5463049|NCT01448564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5463050|NCT01448564|Fatigue|fatigue
5463051|NCT01448564|laser therapy|laser therapy
5463052|NCT01448551|Obesity|obesity
5463053|NCT01448551|Treatment|treatment
5463054|NCT01448551|Adolescents|adolescents
5463055|NCT01448551|Text Messages|text messages
5463056|NCT01448551|Mobile phones|mobile phones
5463057|NCT01448551|Multidisciplinary|multidisciplinary
5463058|NCT01448538|Medication Non-Adherence|medication non-adherence
5463059|NCT01448538|Medication Persistence|medication persistence
5463060|NCT01448538|wet macular degeneration|wet macular degeneration
5463061|NCT01448512|HIV|hiv
5463062|NCT01448512|Pregnancy|pregnancy
5463063|NCT01448512|Prevention|prevention
5463064|NCT01448512|Couples|couples
5463065|NCT01448499|schizophrenia|schizophrenia
5463066|NCT01448499|clozapine|clozapine
5463067|NCT01448499|amisulpride|amisulpride
5463068|NCT01448499|combination|combination
5463069|NCT01448499|treatment resistant|treatment resistant
5463070|NCT01448486|HIV|hiv
5463071|NCT01448486|HAND|hand
5463072|NCT01448486|Human Immunodeficiency Virus|human immunodeficiency virus
5463073|NCT01448486|Raltegravir|raltegravir
5463074|NCT01448486|HIV Associated Neurocognitive Disorders|hiv associated neurocognitive disorders
5463075|NCT01448486|Neuro-HAART|neuro-haart
5463076|NCT01448486|Neurocognitive|neurocognitive
5463077|NCT01448486|Neurology|neurology
5463078|NCT01448473|Head trauma|head trauma
5463079|NCT01448473|Children|children
5463080|NCT01448473|Radiography|radiography
5463081|NCT01448434|Osteoarthritis|osteoarthritis
5463082|NCT01448434|Knee|knee
5463083|NCT01448434|Stem cell|stem cell
5449739|NCT01503970|chondral lesions|chondral lesions
5463085|NCT01448421|TAVR|tavr
5463086|NCT01448408|Forme Fruste Keratoconus|forme fruste keratoconus
5463087|NCT01448408|Corneal Biomechanical properties|corneal biomechanical properties
5463088|NCT01448408|Anterior Segment Parameters|anterior segment parameters
5463089|NCT01448408|Diagnostic Capacity|diagnostic capacity
5463090|NCT01448395|Mass Balance|mass balance
5463091|NCT01448395|Metabolite Identification and Profiling|metabolite identification and profiling
5463092|NCT01448395|Metabolite profile and Identification of [14C]NXL104|metabolite profile and identification of [14c]nxl104
5463093|NCT01448395|Mass Balance Recovery|mass balance recovery
5463094|NCT01448369|meibomian gland dysfunction|meibomian gland dysfunction
5463095|NCT01448369|hot compress|hot compress
5463096|NCT01448369|eyelid warming|eyelid warming
5463097|NCT01448369|meibum|meibum
5463098|NCT01448356|Controlled adverse chamber|controlled adverse chamber
5463099|NCT01448356|tear film stability|tear film stability
5463100|NCT01448356|tear film evaporation|tear film evaporation
5463101|NCT01448356|tear film break up time|tear film break up time
5463102|NCT01448356|humidity|humidity
5463103|NCT01448356|temperature|temperature
5463104|NCT01448343|transfusion|transfusion
5463105|NCT01448343|potassium|potassium
5463106|NCT01448330|clopidogrel|clopidogrel
5463107|NCT01448330|aspinin|aspinin
5463108|NCT01448330|combination|combination
5463109|NCT01448291|Contraception|contraception
5463110|NCT01448291|Nuvaring|nuvaring
5463111|NCT01448291|Vaginal inflammation|vaginal inflammation
5463112|NCT01448291|Bacterial vaginosis|bacterial vaginosis
5463113|NCT01448291|Nugent score|nugent score
5463114|NCT01448278|Anterior cruciate ligament|anterior cruciate ligament
5463115|NCT01448278|Arthroscopy|arthroscopy
5463116|NCT01448278|Incomplete bone tunnels|incomplete bone tunnels
5463117|NCT01448278|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5463118|NCT01448265|atrial fibrillation|atrial fibrillation
5463119|NCT01448265|catheter ablation|catheter ablation
5463120|NCT01448265|circular mapping catheter|circular mapping catheter
5463121|NCT01448265|cryoballoon|cryoballoon
5463122|NCT01448252|T cell vaccination|t cell vaccination
5463123|NCT01448252|Immunotherapy|immunotherapy
5463124|NCT01448252|Tolerance|tolerance
5463125|NCT01448252|safety|safety
5463126|NCT01448252|clinical efficacy|clinical efficacy
5463127|NCT01448213|DMEK|dmek
5463128|NCT01448213|Rejection|rejection
5463129|NCT01448213|Corticosteroid|corticosteroid
5463130|NCT01448200|hepatitis C|hepatitis c
5463131|NCT01448200|NS5A inhibitor|ns5a inhibitor
5463132|NCT01448200|Phase 1|phase 1
5463133|NCT01448200|genotype-1|genotype-1
5463134|NCT01448200|genotype-2|genotype-2
5463135|NCT01448200|genotype-3|genotype-3
5463136|NCT01448187|Lung cancer, France|lung cancer, france
5463137|NCT01448174|salusin-alpha|salusin-alpha
5463138|NCT01448174|atorvastatin|atorvastatin
5463139|NCT01448174|CD36|cd36
5463140|NCT01448174|Hemodialysis|hemodialysis
5463141|NCT01448161|Pediatric|pediatric
5463142|NCT01448161|Adult|adult
5463143|NCT01448161|ICU|icu
5463144|NCT01448148|Mild cognitive impairment|mild cognitive impairment
5463145|NCT01448122|Prevention of pigmentation|prevention of pigmentation
5463147|NCT01448109|Corticosteroid|corticosteroid
5463148|NCT01448096|primary breast diffuse large B cell lymphoma|primary breast diffuse large b cell lymphoma
5463149|NCT01448096|rituximab|rituximab
5463150|NCT01448096|prophylactic intrathecal chemotherapy|prophylactic intrathecal chemotherapy
5463151|NCT01448096|CNS recurrence|cns recurrence
5463152|NCT01448083|I-131 MIBG therapy|i-131 mibg therapy
5463153|NCT01448083|whole body I-123 MIBG scintigraphy|whole body i-123 mibg scintigraphy
5463154|NCT01448057|Paracetamol|paracetamol
5463155|NCT01448057|dimethindene maleate|dimethindene maleate
5463156|NCT01448057|phenylephrine hydrochloride|phenylephrine hydrochloride
5463157|NCT01448057|cold and flu symptoms|cold and flu symptoms
5463158|NCT01448044|hepatitis C virus|hepatitis c virus
5463159|NCT01448031|Acetyl Salicylic Acid|acetyl salicylic acid
5463160|NCT01448031|Bioavailability|bioavailability
5463161|NCT01448031|Healthy Volunteers|healthy volunteers
5463162|NCT01448005|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5463163|NCT01448005|Resuscitation|resuscitation
5463164|NCT01448005|Sudden Cardiac Death|sudden cardiac death
5463165|NCT01448005|Ventricular Dysfunction|ventricular dysfunction
5463166|NCT01447992|Artificial Pancreas|artificial pancreas
5463167|NCT01447992|Insulin Pump|insulin pump
5463168|NCT01447992|Continuous Glucose Monitor|continuous glucose monitor
5463169|NCT01447992|Closed Loop|closed loop
5463170|NCT01447979|Artificial Pancreas|artificial pancreas
5463171|NCT01447979|Insulin Pump|insulin pump
5463172|NCT01447979|Continuous Glucose Monitor|continuous glucose monitor
5463173|NCT01447979|Closed Loop|closed loop
5463174|NCT01447966|OCD|ocd
5463175|NCT01447966|Obsessive Compulsive Disorder|obsessive compulsive disorder
5463176|NCT01447966|Child|child
5463177|NCT01447966|Pediatric|pediatric
5463178|NCT01447966|CBT|cbt
5463179|NCT01447966|Therapy|therapy
5463180|NCT01447966|ERP|erp
5463181|NCT01447966|Exposure Response Prevention|exposure response prevention
5576414|NCT00982241|OAB|oab
5463182|NCT01447966|Preschool|preschool
5463183|NCT01447966|Cognitive Behavioral|cognitive behavioral
5463184|NCT01447953|Activity|activity
5463185|NCT01447953|disability|disability
5463186|NCT01447953|life-role|life-role
5463187|NCT01447953|multimodal rehabilitation|multimodal rehabilitation
5463188|NCT01447953|primary health care|primary health care
5463189|NCT01447953|persistent pain|persistent pain
5463190|NCT01447953|randomized controlled trial|randomized controlled trial
5463191|NCT01447953|Musculoskeletal back pain|musculoskeletal back pain
5463192|NCT01447940|Telemedicine|telemedicine
5463193|NCT01447940|Type 1 diabetes|type 1 diabetes
5463775|NCT01445691|Gliomas|gliomas
5463194|NCT01447940|economic cost of Type 1 diabetes|economic cost of type 1 diabetes
5463195|NCT01447940|ePortal Meos|eportal meos
5463196|NCT01447914|c-Met Inhibitor ARQ-197|c-met inhibitor arq-197
5463197|NCT01447914|tivantinib|tivantinib
5463198|NCT01447914|multiple myeloma|multiple myeloma
5463199|NCT01447914|plasma cell proliferative disorder|plasma cell proliferative disorder
5463200|NCT01447914|Hypercalcemia|hypercalcemia
5463201|NCT01447914|hematologic malignancy|hematologic malignancy
5463202|NCT01447914|plasma cell dyscrasia|plasma cell dyscrasia
5463203|NCT01447914|cast nephropathy|cast nephropathy
5463204|NCT01447914|amyloidosis|amyloidosis
5463205|NCT01447914|osteolysis|osteolysis
5463206|NCT01447914|Renal insufficiency|renal insufficiency
5463207|NCT01447914|Anemia|anemia
5463208|NCT01447914|Bone lytic lesions|bone lytic lesions
5463209|NCT01447914|severe osteopenia|severe osteopenia
5463210|NCT01447914|pathologic fractures|pathologic fractures
5463211|NCT01447914|biopsy-proven plasmacytoma|biopsy-proven plasmacytoma
5463212|NCT01447901|Hyperlipoproteinemia Type I|hyperlipoproteinemia type i
5463213|NCT01447888|Spine surgery|spine surgery
5463214|NCT01447888|Chronic pain|chronic pain
5463215|NCT01447888|Opioid tolerant|opioid tolerant
5463216|NCT01447888|Pain management in spine surgery patients|pain management in spine surgery patients
5463217|NCT01447862|recent-onset|recent-onset
5463218|NCT01447849|Chronic Constipation|chronic constipation
5463219|NCT01447836|indocyanine green|indocyanine green
5463220|NCT01447836|sepsis|sepsis
5463221|NCT01447836|liver injury|liver injury
5463222|NCT01447836|abdominal perfusion pressure|abdominal perfusion pressure
5463223|NCT01447823|Oesophageal bolus obstruction|oesophageal bolus obstruction
5463224|NCT01447823|Gastroscopy|gastroscopy
5463225|NCT01447823|phmetry|phmetry
5463226|NCT01447810|Constraint-Induced Movement therapy|constraint-induced movement therapy
5463227|NCT01447810|Pediatric|pediatric
5463232|NCT01447797|Atorvastatin|atorvastatin
5463233|NCT01447797|combination|combination
5463234|NCT01447784|HDM allergy|hdm allergy
5463235|NCT01447784|Rhinoconunctivitis|rhinoconunctivitis
5463236|NCT01447784|Environmental Exposure Chamber|environmental exposure chamber
5463237|NCT01447784|Immunotherapy|immunotherapy
5463238|NCT01447784|ToleroMune HDM|toleromune hdm
5463239|NCT01447771|Decision making|decision making
5463240|NCT01447771|Decisional aide|decisional aide
5463241|NCT01447745|Visceral obesity|visceral obesity
5463242|NCT01447745|Cardiometabolic risk|cardiometabolic risk
5463243|NCT01447745|Atherosclerosis|atherosclerosis
5463244|NCT01447745|Ectopic fat|ectopic fat
5463245|NCT01447745|Carotid plaque|carotid plaque
5463246|NCT01447745|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5463247|NCT01447745|Computed tomography (CT)|computed tomography (ct)
5463248|NCT01447732|Monoclonal antibody (Mab)|monoclonal antibody (mab)
5463249|NCT01447732|Antibody dependent cellular cytotoxicity (ADCC)|antibody dependent cellular cytotoxicity (adcc)
5463250|NCT01447732|Complement-dependent toxicity (CDC)|complement-dependent toxicity (cdc)
5463251|NCT01447732|Non-fucosylated immunoglobulin G|non-fucosylated immunoglobulin g
5463252|NCT01447706|Ovarian Cancer|ovarian cancer
5463253|NCT01447706|Platinum-resistant|platinum-resistant
5463254|NCT01447706|Platinum-refractory|platinum-refractory
5463255|NCT01447706|Fallopian tube cancer|fallopian tube cancer
5463256|NCT01447706|Peritoneal Cancer|peritoneal cancer
5463257|NCT01447706|Paclitaxel|paclitaxel
5463258|NCT01447706|ErbB3|erbb3
5463259|NCT01447706|Phase II|phase ii
5463260|NCT01447706|locally advanced/metastatic or recurrent|locally advanced/metastatic or recurrent
5463261|NCT01447693|uremia|uremia
5463262|NCT01447693|pruritus|pruritus
5463263|NCT01447693|oliva-omega 3|oliva-omega 3
5463264|NCT01447680|HIV infection|hiv infection
5463265|NCT01447680|HCV infection|hcv infection
5463266|NCT01447680|SMARTube|smartube
5463267|NCT01447680|SMARTplasma|smartplasma
5463268|NCT01447667|Hepatic fibrosis|hepatic fibrosis
5463269|NCT01447667|Magnetic resonance elastography|magnetic resonance elastography
5463270|NCT01447667|Hepatocellular carcinoma|hepatocellular carcinoma
5463271|NCT01447667|Recurrence|recurrence
5463272|NCT01447654|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5463273|NCT01447654|Hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy
5463274|NCT01447654|Hypertrophy|hypertrophy
5463275|NCT01447654|Losartan|losartan
5463276|NCT01447654|Angiotensin II receptor antagonist|angiotensin ii receptor antagonist
5463277|NCT01447641|Cluster Headache|cluster headache
5463278|NCT01447641|Trigeminal Autonomic Cephalalgias|trigeminal autonomic cephalalgias
5463279|NCT01447641|Sleep|sleep
5463280|NCT01447641|Circadian Rhythms|circadian rhythms
5463281|NCT01447628|Idiopathic pulmonary arterial hypertension (IPAH)|idiopathic pulmonary arterial hypertension (ipah)
5463282|NCT01447628|Iron deficiency|iron deficiency
5463283|NCT01447615|Orphaned children and youth|orphaned children and youth
5463284|NCT01447615|Economic empowerment|economic empowerment
5463285|NCT01447615|Uganda|uganda
5463286|NCT01447615|HIV/AIDS|hiv/aids
5463287|NCT01447615|Sub-Saharan Africa|sub-saharan africa
5463288|NCT01447602|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5463292|NCT01447563|Bioequivalence|bioequivalence
5463293|NCT01447563|Bioavailability|bioavailability
5463294|NCT01447550|Bosentan|bosentan
5463295|NCT01447550|Buerguer disease|buerguer disease
5463296|NCT01447537|Cirrhosis|cirrhosis
5463297|NCT01447537|Exercise|exercise
5463298|NCT01447537|Relaxation|relaxation
5463300|NCT01447537|Effort tolerance|effort tolerance
5463301|NCT01447511|Drug Interactions|drug interactions
5463302|NCT01447511|Warfarin|warfarin
5463303|NCT01447511|Genetics|genetics
5463304|NCT01447511|CYP2C9|cyp2c9
5463305|NCT01447511|Healthy Volunteers|healthy volunteers
5463306|NCT01447485|Hypertension, chronic kidney disease|hypertension, chronic kidney disease
5463307|NCT01447485|nephrotic syndrome|nephrotic syndrome
5463308|NCT01447485|pharmacokinetics|pharmacokinetics
5463309|NCT01447472|MDMA,|mdma,
5463310|NCT01447472|pharmacokinetics,|pharmacokinetics,
5463311|NCT01447472|pharmacodynamics,|pharmacodynamics,
5463312|NCT01447472|CYP2D6, COMT,|cyp2d6, comt,
5463313|NCT01447472|SERT, 5-HTTLPR, gender,|sert, 5-httlpr, gender,
5463314|NCT01447472|dextromethorphan,|dextromethorphan,
5463315|NCT01447472|caffeine.|caffeine.
5463316|NCT01447459|Asthma|asthma
5463317|NCT01447459|Asthma Education|asthma education
5463318|NCT01447433|Calcium Carbonate|calcium carbonate
5463319|NCT01447433|Vitamin D|vitamin d
5463320|NCT01447433|Body weight|body weight
5463321|NCT01447433|Body fat|body fat
5463322|NCT01447433|Metabolic parameters|metabolic parameters
5463323|NCT01447433|Energy restriction|energy restriction
5463324|NCT01447433|Very-low calcium consumers|very-low calcium consumers
5463325|NCT01447433|Obesity|obesity
5463326|NCT01447433|Overweight|overweight
5463327|NCT01447407|Staphylococcal infections|staphylococcal infections
5463328|NCT01447407|Yeast infections|yeast infections
5463329|NCT01447407|Candidiasis|candidiasis
5463330|NCT01447368|chronic kidney disease|chronic kidney disease
5463331|NCT01447368|peritoneal dialysis|peritoneal dialysis
5463332|NCT01447368|secondary hyperparathyroidism|secondary hyperparathyroidism
5463333|NCT01447368|parathyroidectomy|parathyroidectomy
5463334|NCT01447368|vascular calcification|vascular calcification
5463335|NCT01447368|cinacalcet|cinacalcet
5463336|NCT01447329|pain|pain
5463337|NCT01447329|acupuncture|acupuncture
5463338|NCT01447329|knee|knee
5463339|NCT01447329|debridement|debridement
5463340|NCT01447329|surgery|surgery
5463341|NCT01447329|arthroscopic knee surgery debridement|arthroscopic knee surgery debridement
5463342|NCT01447316|body composition|body composition
5463343|NCT01447316|gait|gait
5463344|NCT01447316|quality of life|quality of life
5463345|NCT01447316|Patients|patients
5463346|NCT01447316|undergoing|undergoing
5463347|NCT01447316|bariatric surgery.|bariatric surgery.
5463348|NCT01447303|knee|knee
5463349|NCT01447303|osteoarthritis|osteoarthritis
5463350|NCT01447303|hyaluronic acid|hyaluronic acid
5463351|NCT01447303|viscosupplementation|viscosupplementation
5463352|NCT01447290|preeclampsia|preeclampsia
5463353|NCT01447290|protein|protein
5463354|NCT01447290|creatinine|creatinine
5463355|NCT01447290|protein:creatinine ratio|protein:creatinine ratio
5463359|NCT01447264|Rheumatoid arthritis|rheumatoid arthritis
5463360|NCT01447264|Muscle strength|muscle strength
5463361|NCT01447264|Body composition|body composition
5463362|NCT01447264|Physical activity|physical activity
5463363|NCT01447264|Water exercises|water exercises
5463364|NCT01447264|Hydrotherapy|hydrotherapy
5463365|NCT01447264|Randomized controlled clinical trial|randomized controlled clinical trial
5463366|NCT01447251|Obstructive Sleep Apnea|obstructive sleep apnea
5463367|NCT01447251|Diabetes Mellitus type 2|diabetes mellitus type 2
5463369|NCT01447251|OSA|osa
5463370|NCT01447251|CPAP|cpap
5463371|NCT01447251|continuous positive airway pressure|continuous positive airway pressure
5463372|NCT01447238|pancreatic cysts|pancreatic cysts
5463373|NCT01447238|EUS/FNA|eus/fna
5445810|NCT01520194|HPV|hpv
5463374|NCT01447238|Needle-based Confocal Laser Endomicroscopy (nCLE)|needle-based confocal laser endomicroscopy (ncle)
5463375|NCT01447238|fiber optic imaging|fiber optic imaging
5463376|NCT01447238|EUS/FNA of pancreatic cysts|eus/fna of pancreatic cysts
5463377|NCT01447225|Advanced-stage|advanced-stage
5463378|NCT01447225|Solid Tumors|solid tumors
5463379|NCT01447225|MM-121|mm-121
5463380|NCT01447225|Carboplatin|carboplatin
5463381|NCT01447225|Pemetrexed|pemetrexed
5463382|NCT01447225|Gemcitabine|gemcitabine
5463383|NCT01447225|Cabazitaxel|cabazitaxel
5463384|NCT01447225|ErbB3|erbb3
5463385|NCT01447225|Phase I|phase i
5463386|NCT01447225|Cancer|cancer
5463387|NCT01447212|Opioid Dependence|opioid dependence
5463388|NCT01447212|Long-term Opioid Injectors|long-term opioid injectors
5463389|NCT01447212|Opioid Substitution Treatment|opioid substitution treatment
5463390|NCT01447212|Hydromorphone|hydromorphone
5463391|NCT01447212|Diamorphine|diamorphine
5463984|NCT01444898|Adolescents|adolescents
5463392|NCT01447212|Diacetylmorphine|diacetylmorphine
5463393|NCT01447199|Bladder cancer|bladder cancer
5463394|NCT01447199|Colorectal cancer|colorectal cancer
5463395|NCT01447199|Endometrial cancer|endometrial cancer
5463396|NCT01447199|Kidney cancer|kidney cancer
5463397|NCT01447199|Skin cancer|skin cancer
5463398|NCT01447199|Uterus cancer|uterus cancer
5463399|NCT01447199|Molecular Predisposition|molecular predisposition
5463400|NCT01447199|Hereditary Nonpolyposis Colon Cancer|hereditary nonpolyposis colon cancer
5463401|NCT01447199|HNPCC|hnpcc
5463402|NCT01447199|Molecular genetic testing|molecular genetic testing
5463403|NCT01447199|Gene mutations|gene mutations
5463404|NCT01447199|Mutation analyses|mutation analyses
5463405|NCT01447199|Genetic polymorphisms|genetic polymorphisms
5463406|NCT01447199|Family history of cancer|family history of cancer
5463407|NCT01447199|Early age of cancer onset|early age of cancer onset
5463408|NCT01447199|Little/no personal or family history of cancer|little/no personal or family history of cancer
5463409|NCT01447199|Spouses|spouses
5463410|NCT01447199|Questionnaires|questionnaires
5463411|NCT01447199|Blood sample|blood sample
5463412|NCT01447199|Saliva Sample|saliva sample
5463413|NCT01447186|Prostate cancer screening|prostate cancer screening
5463414|NCT01447186|Prostate Cancer|prostate cancer
5463415|NCT01447186|Patient Decision Aid|patient decision aid
5463416|NCT01447186|Spanish Speaking Men|spanish speaking men
5463417|NCT01447186|Spanish-language slide set|spanish-language slide set
5463418|NCT01447186|Focus group|focus group
5463419|NCT01447186|Interview|interview
5463420|NCT01447186|Survey|survey
5463421|NCT01447173|Asthma|asthma
5463422|NCT01447173|Pulmonary Function Test|pulmonary function test
5463423|NCT01447173|Vitamin D|vitamin d
5463424|NCT01447160|facet joint|facet joint
5463425|NCT01447160|back pain|back pain
5463426|NCT01447160|osteoarthritis|osteoarthritis
5463427|NCT01447160|infiltration|infiltration
5463428|NCT01447108|Trigeminal Neuralgia|trigeminal neuralgia
5463429|NCT01447108|Tic Douloureux|tic douloureux
5463430|NCT01447108|Low Intensity Low Frequency Surface Acoustic Wave Ultrasound|low intensity low frequency surface acoustic wave ultrasound
5463431|NCT01447095|Subarachnoid hemorrhage|subarachnoid hemorrhage
5463432|NCT01447095|vasospasm|vasospasm
5463433|NCT01447095|prostacyclin|prostacyclin
5463434|NCT01447082|atypical|atypical
5463435|NCT01447082|antipsychotics|antipsychotics
5463436|NCT01447082|quetiapine|quetiapine
5463437|NCT01447069|heart failure stage 3|heart failure stage 3
5463438|NCT01447069|beta 2 agonist|beta 2 agonist
5463439|NCT01447069|N-terminal pro-brain natriuretic peptide|n-terminal pro-brain natriuretic peptide
5463440|NCT01447069|ejection fraction <35%|ejection fraction <35%
5463441|NCT01447056|Hodgkin lymphoma|hodgkin lymphoma
5463442|NCT01447056|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5463443|NCT01447056|Lymphoproliferative disorder|lymphoproliferative disorder
5463444|NCT01447056|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5463445|NCT01447056|Leiomyosarcoma|leiomyosarcoma
5463446|NCT01447056|EBV Cytotoxic T Lymphocytes|ebv cytotoxic t lymphocytes
5458070|NCT01469273|EcN|ecn
5463447|NCT01447043|retrospective studies|retrospective studies
5463448|NCT01447030|Biliary strictur|biliary strictur
5463449|NCT01447030|Hepatojejunostomy|hepatojejunostomy
5463450|NCT01447030|Iatrogenic major bile duct injury|iatrogenic major bile duct injury
5463451|NCT01446991|prostate neoplasm|prostate neoplasm
5463452|NCT01446991|brachytherapy|brachytherapy
5463453|NCT01446991|androgen ablation|androgen ablation
5463454|NCT01446991|benign prostatic hypertrophy|benign prostatic hypertrophy
5463455|NCT01446991|prostate size reduction|prostate size reduction
5463456|NCT01446991|localized prostate cancer with prostate volume > 40 cc|localized prostate cancer with prostate volume > 40 cc
5463457|NCT01446978|hepatitis A vaccine|hepatitis a vaccine
5463458|NCT01446978|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
5463459|NCT01446978|Rheumatoid arthritis|rheumatoid arthritis
5463460|NCT01446978|methotrexate|methotrexate
5463461|NCT01446965|myocardial infarction, acute|myocardial infarction, acute
5463462|NCT01446965|myocardial infarction|myocardial infarction
5463463|NCT01446965|ventricular dysfunction|ventricular dysfunction
5463464|NCT01446965|death, sudden, cardiac|death, sudden, cardiac
5463465|NCT01446965|death, sudden|death, sudden
5463467|NCT01446965|ventricular tachycardia|ventricular tachycardia
5463468|NCT01446965|ventricular fibrillation|ventricular fibrillation
5463469|NCT01446965|defibrillation, electric|defibrillation, electric
5463470|NCT01446965|cardioversion, electric|cardioversion, electric
5463471|NCT01446965|electric countershock|electric countershock
5463472|NCT01446965|defibrillators, external|defibrillators, external
5463473|NCT01446952|prevention|prevention
5463474|NCT01446952|pancreas|pancreas
5463475|NCT01446939|MRI|mri
5463476|NCT01446939|Parkinson's disease|parkinson's disease
5463477|NCT01446939|Essential tremor|essential tremor
5463478|NCT01446939|Ultrasonography|ultrasonography
5463480|NCT01446926|Pneumonia|pneumonia
5463481|NCT01446926|Pneumococcal Infections|pneumococcal infections
5463482|NCT01446926|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
5463483|NCT01446926|Pneumococcal vaccines|pneumococcal vaccines
5463484|NCT01446913|Sleep Apnea|sleep apnea
5463485|NCT01446913|CPAP adherence|cpap adherence
5463486|NCT01446913|behavioral adherence|behavioral adherence
5463487|NCT01446913|stroke|stroke
5463488|NCT01446900|Rituximab|rituximab
5463489|NCT01446900|Cladribine|cladribine
5463490|NCT01446900|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
5463491|NCT01446900|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5463492|NCT01446887|Deep Vein Thrombosis|deep vein thrombosis
5463493|NCT01446887|total hip arthroplasty|total hip arthroplasty
5463494|NCT01446887|prophylactic anticoagulation|prophylactic anticoagulation
5463495|NCT01446887|randomized study|randomized study
5463496|NCT01446874|Incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer|incidence of post-operative pneumonia in patients undergoing surgery for primary lung cancer or primary esophageal cancer
5463497|NCT01446861|Cystic fibrosis|cystic fibrosis
5463498|NCT01446861|Pancreas|pancreas
5463499|NCT01446861|Exocrine function|exocrine function
5463500|NCT01446861|Ultrasound|ultrasound
5463501|NCT01446861|Contrast ultrasound|contrast ultrasound
5463502|NCT01446848|iron deficiency|iron deficiency
5463503|NCT01446848|pulmonary hypertension|pulmonary hypertension
5463504|NCT01446848|iron supplements|iron supplements
5463505|NCT01446848|ferrous sulfate|ferrous sulfate
5463506|NCT01446822|urinary bladder neoplasm|urinary bladder neoplasm
5463507|NCT01446822|bipolar transurethral resection|bipolar transurethral resection
5463508|NCT01446822|monopolar transurethral resection|monopolar transurethral resection
5463509|NCT01446822|obturator nerve|obturator nerve
5463510|NCT01446796|Ventricular assist device|ventricular assist device
5463511|NCT01446783|COL5A1|col5a1
5463512|NCT01446783|Collagen disorders|collagen disorders
5463513|NCT01446783|IGF-I|igf-i
5463514|NCT01446783|Collagen synthesis|collagen synthesis
5463515|NCT01446757|quality of life|quality of life
5463516|NCT01446757|feeling of security|feeling of security
5463517|NCT01446757|costs|costs
5463518|NCT01446757|multiprofessional team|multiprofessional team
5798689|NCT00111371|levodopa|levodopa
5463521|NCT01446718|quadrivalent vaccine|quadrivalent vaccine
5463522|NCT01446718|Human Papillomavirus|human papillomavirus
5463523|NCT01446692|Major depressive disorder|major depressive disorder
5463524|NCT01446692|primary care|primary care
5463525|NCT01446692|real-world evidence|real-world evidence
5463526|NCT01446692|database|database
5463527|NCT01446679|Lipitor|lipitor
5463528|NCT01446679|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5463529|NCT01446666|hepatocellular carcinoma|hepatocellular carcinoma
5463530|NCT01446666|surveillance|surveillance
5463531|NCT01446666|gadoxetic acid|gadoxetic acid
5463532|NCT01446666|MRI|mri
5463533|NCT01446653|Fetal Alcohol Spectrum Disorders|fetal alcohol spectrum disorders
5463534|NCT01446653|FASDs|fasds
5463535|NCT01446653|AEP risk|aep risk
5463536|NCT01446653|binge drinking|binge drinking
5463537|NCT01446653|ineffective contraception|ineffective contraception
5463538|NCT01446627|Absorbable vicryl subcuticular staples|absorbable vicryl subcuticular staples
5463539|NCT01446627|metal staples|metal staples
5463541|NCT01446627|cesarean section|cesarean section
5463542|NCT01446601|Apnea|apnea
5463543|NCT01446601|OSA|osa
5463544|NCT01446601|Sleep Apnea Syndromes|sleep apnea syndromes
5463545|NCT01446601|Sleep Apnea, Obstructive|sleep apnea, obstructive
5463546|NCT01446601|Hypoglossal Nerve Stimulation|hypoglossal nerve stimulation
5463547|NCT01446601|Sleep Disorders|sleep disorders
5463548|NCT01446601|Tongue|tongue
5463549|NCT01446536|Quality|quality
5463550|NCT01446536|Improvement|improvement
5463551|NCT01446523|endotoxins HE|endotoxins he
5463552|NCT01446510|VTE|vte
5463553|NCT01446510|DVT|dvt
5463554|NCT01446510|PE|pe
5463555|NCT01446510|Risk assessment|risk assessment
5463556|NCT01446510|risk score|risk score
5463557|NCT01446510|risk analysis|risk analysis
5463558|NCT01446510|Venous thromboembolism risk|venous thromboembolism risk
5463559|NCT01446497|Normal tension glaucoma|normal tension glaucoma
5463560|NCT01446497|Antiglaucoma ophthalmic solution|antiglaucoma ophthalmic solution
5463561|NCT01446497|Brimonidine|brimonidine
5463562|NCT01446497|Timolol|timolol
5463563|NCT01446497|Combination drugs|combination drugs
5463564|NCT01446484|Renal transplantation|renal transplantation
5463565|NCT01446484|Kidney transplantation|kidney transplantation
5463566|NCT01446484|CD4+CD25+CD127lowFoxP3+ T Regulatory Cells|cd4+cd25+cd127lowfoxp3+ t regulatory cells
5463567|NCT01446484|T reg|t reg
5463568|NCT01446484|Campath|campath
5463569|NCT01446471|Bedside Ultrasound|bedside ultrasound
5463570|NCT01446471|Point of care ultrasound|point of care ultrasound
5463571|NCT01446471|cardiac arrest|cardiac arrest
5463572|NCT01446458|Cancer of Pancreas|cancer of pancreas
5463573|NCT01446458|Cancer of the Pancreas|cancer of the pancreas
5463574|NCT01446458|Neoplasms, Pancreatic|neoplasms, pancreatic
5450216|NCT01501981|NT-proBNP|nt-probnp
5463575|NCT01446458|Pancreas Cancer|pancreas cancer
5463576|NCT01446458|Pancreas Neoplasms|pancreas neoplasms
5463577|NCT01446458|Entry Term Pancreatic Cancer|entry term pancreatic cancer
5463578|NCT01446445|Cytomegalovirus|cytomegalovirus
5463579|NCT01446445|renal transplant|renal transplant
5463580|NCT01446432|Dupuytren's Contracture|dupuytren's contracture
5463581|NCT01446419|chronic axial low back pain|chronic axial low back pain
5463582|NCT01446419|vertebrogenic pain|vertebrogenic pain
5463583|NCT01446419|Radio frequency ablation|radio frequency ablation
5463584|NCT01446406|Bipolar disorder|bipolar disorder
5463585|NCT01446406|Electronic daily monitoring|electronic daily monitoring
5463586|NCT01446406|Affective episodes|affective episodes
5463587|NCT01446354|Blood component transfusion|blood component transfusion
5463588|NCT01446354|Hypothermic|hypothermic
5463589|NCT01446341|Ankle sprain|ankle sprain
5463590|NCT01446341|Functional rehabilitation|functional rehabilitation
5463591|NCT01446341|Immobilization|immobilization
5463592|NCT01446328|Antipsychotic Drugs|antipsychotic drugs
5463593|NCT01446328|Randomized Controlled Trial|randomized controlled trial
5463594|NCT01446328|Treatment Effectiveness|treatment effectiveness
5463595|NCT01446328|Translational Research|translational research
5463596|NCT01446315|asthma|asthma
5463597|NCT01446315|asthma care system|asthma care system
5463598|NCT01446315|effectiveness|effectiveness
5463599|NCT01446315|primary care|primary care
5463600|NCT01446315|practice based research network|practice based research network
5463601|NCT01446302|Dialysis|dialysis
5463602|NCT01446302|Protein-energy wasting|protein-energy wasting
5463603|NCT01446302|Insulin-Like Growth Factor I|insulin-like growth factor i
5463604|NCT01446302|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
5463605|NCT01446302|Inflammation|inflammation
5463606|NCT01446289|Group B streptococcus|group b streptococcus
5463607|NCT01446289|GBS|gbs
5463608|NCT01446289|Vaccine|vaccine
5463609|NCT01446289|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5463610|NCT01446276|Obesity|obesity
5463611|NCT01446276|Resveratrol|resveratrol
5463612|NCT01446276|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5463613|NCT01446276|Insulin sensitivity|insulin sensitivity
5463614|NCT01446276|Lipid turnover|lipid turnover
5463615|NCT01446276|Liver fat content|liver fat content
5463616|NCT01446263|Radial access|radial access
5463617|NCT01446263|Femoral access|femoral access
5463618|NCT01446263|Coronary angiography|coronary angiography
5463619|NCT01446263|Coronary artery bypass graft|coronary artery bypass graft
5463620|NCT01446250|Chronic hepatitis C|chronic hepatitis c
5463621|NCT01446250|Cyclophilin inhibitor|cyclophilin inhibitor
5463622|NCT01446224|adverse events|adverse events
5463623|NCT01446224|pazopanib|pazopanib
5463624|NCT01446224|Torsades des Pointes|torsades des pointes
5463625|NCT01446224|renal cell carcinoma|renal cell carcinoma
5463626|NCT01446224|anti-VEGF agents|anti-vegf agents
5463627|NCT01446224|observational data|observational data
5463628|NCT01446224|cardiac ischemia|cardiac ischemia
5463629|NCT01446211|gusperimus|gusperimus
5463630|NCT01446211|Wegeners granulomatosis|wegeners granulomatosis
5463631|NCT01446211|relapse|relapse
5463632|NCT01446198|HPV|hpv
5463633|NCT01446185|HR+, N- or pN1(mi), Her2- breast cancer adjuvant population|hr+, n- or pn1(mi), her2- breast cancer adjuvant population
5463634|NCT01446185|Early Breast cancer|early breast cancer
5463635|NCT01446185|Gene Expression|gene expression
5463636|NCT01446185|Node-Negative|node-negative
5463637|NCT01446185|treatment options|treatment options
5463638|NCT01446185|Hormone receptor positive|hormone receptor positive
5463639|NCT01446172|Long term outcome|long term outcome
5463640|NCT01446159|MEDI-573, breast cancer, metastatic, aromatase inhibitor, anti-IGF|medi-573, breast cancer, metastatic, aromatase inhibitor, anti-igf
5463641|NCT01446146|Posttraumatic Stress Disorder|posttraumatic stress disorder
5463642|NCT01446146|PTSD Treatment|ptsd treatment
5463643|NCT01446146|Decision making|decision making
5463644|NCT01446146|Veterans|veterans
5463645|NCT01446133|Leukemia|leukemia
5463646|NCT01446133|Lymphoma|lymphoma
5463647|NCT01446133|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5463648|NCT01446133|CLL|cll
5463649|NCT01446133|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5463650|NCT01446133|SLL|sll
5463651|NCT01446133|Initial Treatment|initial treatment
5463652|NCT01446133|Subsequent Therapy|subsequent therapy
5463653|NCT01446133|Rituximab|rituximab
5463654|NCT01446133|Rituxan|rituxan
5463655|NCT01446133|Lenalidomide|lenalidomide
5463656|NCT01446133|CC-5013|cc-5013
5463657|NCT01446133|Revlimid|revlimid
5463658|NCT01446120|this is phase one study. The study population are healthy volunteers.|this is phase one study. the study population are healthy volunteers.
5463659|NCT01446107|tooth decay|tooth decay
5463660|NCT01446107|fluoride|fluoride
5463661|NCT01446107|sealant|sealant
5463662|NCT01446107|prevention|prevention
5463663|NCT01446094|Coronary artery disease|coronary artery disease
5463664|NCT01446081|chemotherapy|chemotherapy
5463665|NCT01446081|exercise|exercise
5463666|NCT01446081|quality of life|quality of life
5435405|NCT01564810|cetuximab|cetuximab
5463667|NCT01446081|cancer-related fatigue|cancer-related fatigue
5463668|NCT01446081|elderly|elderly
5463669|NCT01446081|physical fitness|physical fitness
5463670|NCT01446055|Peripheral arterial disease|peripheral arterial disease
5463671|NCT01446055|Buerger's disease|buerger's disease
5463672|NCT01446055|atherosclerotic arterial occlusion|atherosclerotic arterial occlusion
5463673|NCT01446055|bone marrow mononuclear cell|bone marrow mononuclear cell
5463674|NCT01446055|chronic limb ischemia|chronic limb ischemia
5463675|NCT01446029|Telemonitoring|telemonitoring
5463676|NCT01446029|Chronic Kidney Disease|chronic kidney disease
5463677|NCT01446016|Breast Cancer|breast cancer
5463678|NCT01446016|Breast Tumors|breast tumors
5463679|NCT01446016|Cancer of Breast|cancer of breast
5463680|NCT01446016|Cancer of the Breast|cancer of the breast
5463681|NCT01446016|Human Mammary Carcinoma|human mammary carcinoma
5463682|NCT01446016|Mammary Carcinoma, Human|mammary carcinoma, human
5463683|NCT01446016|Mammary Neoplasm, Human|mammary neoplasm, human
5463684|NCT01446016|Mammary Neoplasms, Human|mammary neoplasms, human
5463685|NCT01446016|Neoplasms, Breast|neoplasms, breast
5463686|NCT01446016|Tumors, Breast|tumors, breast
5463688|NCT01446016|Paclitaxel|paclitaxel
5463689|NCT01446016|Taxol|taxol
5463690|NCT01446016|Ixabepilone|ixabepilone
5463691|NCT01446016|Abraxane|abraxane
5463692|NCT01446016|Metastatic Breast Cancer|metastatic breast cancer
5463693|NCT01446016|Advanced Breast Cancer|advanced breast cancer
5463694|NCT01446016|Anthracycline|anthracycline
5463695|NCT01445990|free tissue flaps|free tissue flaps
5463696|NCT01445990|lactic acid|lactic acid
5463697|NCT01445990|glucose|glucose
5463698|NCT01445990|thrombosis|thrombosis
5463699|NCT01445990|diagnostic test|diagnostic test
5463700|NCT01445990|Pedicle postoperative complications diagnosis|pedicle postoperative complications diagnosis
5463701|NCT01445977|Sonitus Medical|sonitus medical
5463702|NCT01445977|SoundBite|soundbite
5463703|NCT01445977|Single Sided Deafness|single sided deafness
5463704|NCT01445977|Conductive Hearing Loss|conductive hearing loss
5463705|NCT01445977|Unilateral Hearing Loss|unilateral hearing loss
5463706|NCT01445964|SLCO2B1 genotype|slco2b1 genotype
5463707|NCT01445964|effect of apple juice|effect of apple juice
5463708|NCT01445886|Nail Psoriasis|nail psoriasis
5463709|NCT01445886|Indigo Naturalis|indigo naturalis
5463710|NCT01445886|Indirubin|indirubin
5463718|NCT01445847|Laryngospasm|laryngospasm
5463719|NCT01445847|Lidocaine|lidocaine
5463720|NCT01445834|outcome of pelvic floor muscle physiotherapy|outcome of pelvic floor muscle physiotherapy
5463721|NCT01445834|female|female
5463722|NCT01445834|stress urinary incontinence|stress urinary incontinence
5463723|NCT01445834|urgency urinary incontinence|urgency urinary incontinence
5463724|NCT01445834|mixed urinary incontinence|mixed urinary incontinence
5463725|NCT01445821|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5463726|NCT01445808|psychodynamic psychotherapy|psychodynamic psychotherapy
5463727|NCT01445808|coronary heart disease|coronary heart disease
5463728|NCT01445808|physical activity|physical activity
5463729|NCT01445808|secondary prevention|secondary prevention
5463730|NCT01445795|Inhibitex|inhibitex
5463731|NCT01445795|Chronic Hepatitis|chronic hepatitis
5463732|NCT01445795|Hepatitis C Virus|hepatitis c virus
5463733|NCT01445782|Safety|safety
5463734|NCT01445782|tolerability|tolerability
5463735|NCT01445782|healthy|healthy
5463736|NCT01445782|inhaled|inhaled
5463737|NCT01445769|Myelofibrosis|myelofibrosis
5463738|NCT01445769|Primary Myelofibrosis|primary myelofibrosis
5789038|NCT00150150|nodule reduction|nodule reduction
5463740|NCT01445769|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5463742|NCT01445769|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5463743|NCT01445769|PET-MF|pet-mf
5463744|NCT01445769|Open label|open label
5463745|NCT01445769|Ruxolitinib|ruxolitinib
5463746|NCT01445769|18424|18424
5463747|NCT01445769|Jak inhibitor|jak inhibitor
5463748|NCT01445756|Intrauterine Device|intrauterine device
5463749|NCT01445743|Tdap Vaccine|tdap vaccine
5463750|NCT01445743|Pregnant woman|pregnant woman
5463751|NCT01445743|Pertussis|pertussis
5463752|NCT01445730|fructose|fructose
5463753|NCT01445730|hypertriglyceridemia|hypertriglyceridemia
5463754|NCT01445730|postprandial lipids|postprandial lipids
5463755|NCT01445730|de novo lipogenesis|de novo lipogenesis
5463756|NCT01445730|stable isotopes|stable isotopes
5463757|NCT01445717|GBS, Streptococcus, .|gbs, streptococcus, .
5463758|NCT01445717|Group B|group b
5463759|NCT01445704|Weight loss|weight loss
5463760|NCT01445704|Probiotics|probiotics
5463761|NCT01445704|Gastric Bypass|gastric bypass
5463762|NCT01445691|Benign Neoplasms, Brain|benign neoplasms, brain
5463763|NCT01445691|Brain Cancer|brain cancer
5463764|NCT01445691|Brain Neoplasms, Benign|brain neoplasms, benign
5463765|NCT01445691|Brain Neoplasms, Malignant|brain neoplasms, malignant
5463766|NCT01445691|Brain Tumor, Primary|brain tumor, primary
5463767|NCT01445691|Brain Tumor, Recurrent|brain tumor, recurrent
5463768|NCT01445691|Brain Tumors|brain tumors
5463769|NCT01445691|Intracranial Neoplasms|intracranial neoplasms
5463770|NCT01445691|Neoplasms, Brain|neoplasms, brain
5463771|NCT01445691|Neoplasms, Intracranial|neoplasms, intracranial
5463772|NCT01445691|Primary Brain Neoplasms|primary brain neoplasms
5463773|NCT01445691|Primary Malignant Brain Neoplasms|primary malignant brain neoplasms
5463774|NCT01445691|Primary Malignant Brain Tumors|primary malignant brain tumors
5463793|NCT01445587|AKT inhibitor|akt inhibitor
5463794|NCT01445587|multiple myeloma|multiple myeloma
5463795|NCT01445587|GSK2110183|gsk2110183
5463796|NCT01445587|hematologic malignancies|hematologic malignancies
5463804|NCT01445548|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5463805|NCT01445548|Geographic Atrophy|geographic atrophy
5463806|NCT01445548|Bilateral Geographic Atrophy|bilateral geographic atrophy
5463807|NCT01445548|Sirolimus|sirolimus
5463808|NCT01445548|Age Related Macular Degeneration|age related macular degeneration
5463810|NCT01445535|CD2 Positive|cd2 positive
5463811|NCT01445535|Toxicity|toxicity
5463812|NCT01445535|EBV Lymphoma|ebv lymphoma
5463813|NCT01445535|Chemotherapy Naive|chemotherapy naive
5463814|NCT01445535|Maximum Tolerated Dose|maximum tolerated dose
5463815|NCT01445535|Lymphoma|lymphoma
5463816|NCT01445535|T-Cell Lymphoma|t-cell lymphoma
5463817|NCT01445535|NK T-Cell Lymphoma|nk t-cell lymphoma
5463818|NCT01445522|PARP Inhibitor|parp inhibitor
5463819|NCT01445522|DNA Damage|dna damage
5463820|NCT01445522|Chemotherapy|chemotherapy
5463821|NCT01445522|Advanced Cancer|advanced cancer
5463822|NCT01445522|DNA Repair|dna repair
5463835|NCT01445444|Habit Reversal Training|habit reversal training
5463836|NCT01445444|Hair Pulling|hair pulling
5463837|NCT01445444|Children|children
5463838|NCT01445444|Trich|trich
5466975|NCT01433003|plasma exchange|plasma exchange
5463839|NCT01445444|cognitive behavioral therapy|cognitive behavioral therapy
5463840|NCT01445444|TTM|ttm
5463841|NCT01445444|psychotherapy|psychotherapy
5463842|NCT01445418|Genetic|genetic
5463843|NCT01445418|BRCA|brca
5463844|NCT01445418|Ovarian Cancer, sporadic epithelial ovarian cancer|ovarian cancer, sporadic epithelial ovarian cancer
5463845|NCT01445418|Breast Cancer, triple negative breast cancer|breast cancer, triple negative breast cancer
5463846|NCT01445418|Metastatic|metastatic
5463847|NCT01445418|Breast Cancer|breast cancer
5463848|NCT01445418|Ovarian Cancer|ovarian cancer
5463849|NCT01445405|Proteasome|proteasome
5463850|NCT01445405|Bortezomib|bortezomib
5463851|NCT01445405|NF-kappaB|nf-kappab
5463852|NCT01445405|Cetuximab|cetuximab
5463853|NCT01445405|Epidermal Growth Factor|epidermal growth factor
5463854|NCT01445405|Head and Neck Cancer|head and neck cancer
5463855|NCT01445405|Squamous Cell Carcinoma|squamous cell carcinoma
5463856|NCT01445405|Oral Cancer|oral cancer
5463857|NCT01445392|Recombinant Immunotoxin|recombinant immunotoxin
5463858|NCT01445392|Monoclonal Antibody|monoclonal antibody
5463859|NCT01445392|Pseudomonas Exotoxin|pseudomonas exotoxin
5463860|NCT01445392|Targeted Therapy|targeted therapy
5463861|NCT01445392|Pleural Mesothelioma|pleural mesothelioma
5463862|NCT01445392|Mesothelioma|mesothelioma
5463863|NCT01445392|Epithelial Pleural Mesothelioma|epithelial pleural mesothelioma
5463864|NCT01445379|Solid Tumor|solid tumor
5463865|NCT01445379|Monoclonal Antibody|monoclonal antibody
5463866|NCT01445379|Pediatrics|pediatrics
5463867|NCT01445379|Pharmacokinetics|pharmacokinetics
5463868|NCT01445379|Immunotherapy|immunotherapy
5463869|NCT01445379|Sarcoma|sarcoma
5463870|NCT01445379|Lymphoma|lymphoma
5463871|NCT01445379|Neuroblastoma|neuroblastoma
5463872|NCT01445340|Topical Depsi|topical depsi
5463873|NCT01445340|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5463874|NCT01445340|CTCL|ctcl
5463876|NCT01445327|Blood|blood
5463877|NCT01445327|Urine|urine
5463878|NCT01445327|Stool|stool
5463879|NCT01445327|Tumor Marker|tumor marker
5463880|NCT01445327|Radiation Therapy|radiation therapy
5463896|NCT01445301|acne vulgaris|acne vulgaris
5463904|NCT01445249|regional anaesthetic techniques|regional anaesthetic techniques
5463905|NCT01445249|surgery orthopaedic|surgery orthopaedic
5463906|NCT01445236|Operational tolerance|operational tolerance
5463907|NCT01445236|Biomarkers|biomarkers
5463908|NCT01445236|Liver Transplantation|liver transplantation
5463909|NCT01445223|HIV|hiv
5463910|NCT01445223|Antiretroviral therapy|antiretroviral therapy
5463911|NCT01445223|efavirenz|efavirenz
5463912|NCT01445223|lopinavir|lopinavir
5463913|NCT01445223|atazanavir|atazanavir
5463914|NCT01445223|randomised controlled clinical trial|randomised controlled clinical trial
5463915|NCT01445210|Postoperative pain|postoperative pain
5463916|NCT01445210|Major ankle surgery|major ankle surgery
5463917|NCT01445210|Continuous nerve block|continuous nerve block
5463918|NCT01445210|Saphenous nerve|saphenous nerve
5463919|NCT01445210|Ropivacaine|ropivacaine
5463921|NCT01445158|ShopTalk|shoptalk
5463922|NCT01445158|Comprehension|comprehension
5463923|NCT01445158|Donors|donors
5463924|NCT01445158|Education|education
5463925|NCT01445158|Stem Cell Transplant|stem cell transplant
5463926|NCT01445158|Sibling Donor|sibling donor
5463927|NCT01445145|End-of-Life|end-of-life
5463928|NCT01445145|Advance Directive|advance directive
5463929|NCT01445145|Pediatric Cancer|pediatric cancer
5463930|NCT01445145|Adolescents|adolescents
5463931|NCT01445145|Young Adults|young adults
5463932|NCT01445132|Adoptive Immunotherapy|adoptive immunotherapy
5463933|NCT01445132|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5463934|NCT01445132|Refractory Tumor|refractory tumor
5463935|NCT01445132|Resection|resection
5463936|NCT01445132|B-Cell Malignancies|b-cell malignancies
5463937|NCT01445132|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5463938|NCT01445132|BCL|bcl
5463939|NCT01445132|B-Cell Lymphoid Malignancy|b-cell lymphoid malignancy
5463940|NCT01445119|Brain|brain
5463941|NCT01445119|Tumor|tumor
5463942|NCT01445119|Radiation|radiation
5463943|NCT01445119|Antiangiogenesis|antiangiogenesis
5463944|NCT01445119|Chemotherapy|chemotherapy
5463945|NCT01445119|Brain Tumor|brain tumor
5463946|NCT01445119|Glioma|glioma
5463947|NCT01445106|HIV Protease Inhibitor|hiv protease inhibitor
5593360|NCT00917813|HIV|hiv
5463948|NCT01445106|Drug Repositioning|drug repositioning
5463949|NCT01445106|Akt/Mtor Inhibitor|akt/mtor inhibitor
5463950|NCT01445106|Targeted Therapy|targeted therapy
5463951|NCT01445106|Off - Label Drugs|off - label drugs
5463952|NCT01445106|Nelfinavir|nelfinavir
5463953|NCT01445106|Protease Inhibitor|protease inhibitor
5463954|NCT01445106|Solid Tumor|solid tumor
5463955|NCT01445106|Phase I|phase i
5463956|NCT01445106|Malignant Tumor|malignant tumor
5463957|NCT01445054|111 Indium Trastuzumab Imaging|111 indium trastuzumab imaging
5463958|NCT01445054|PET|pet
5463959|NCT01445054|Optimal Scanning Strategy|optimal scanning strategy
5463960|NCT01445054|Breast Cancer|breast cancer
5463961|NCT01445041|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5463962|NCT01445041|Autologous Umbilical Cord Blood|autologous umbilical cord blood
5463963|NCT01445041|Newborn Infants|newborn infants
5463964|NCT01445015|adolescents|adolescents
5463965|NCT01445002|grass pollen allergy|grass pollen allergy
5463966|NCT01445002|immunotherapy|immunotherapy
5463967|NCT01445002|recombinant vaccine|recombinant vaccine
5463968|NCT01444989|"Sun spots"|"sun spots"
5463969|NCT01444989|"Pre-cancerous skin lesion"|"pre-cancerous skin lesion"
5463970|NCT01444976|age range of 18-83|age range of 18-83
5463971|NCT01444924|Pain control|pain control
5463972|NCT01444924|Gynecologic Oncology|gynecologic oncology
5463973|NCT01444924|Surgery|surgery
5463974|NCT01444911|Sexual Dysfunction|sexual dysfunction
5463975|NCT01444911|Gynecologic cancer|gynecologic cancer
5463976|NCT01444911|Cancer survivor|cancer survivor
5463977|NCT01444911|Vaginal dilator|vaginal dilator
5463978|NCT01444898|Prader-Willi Syndrome|prader-willi syndrome
5463979|NCT01444898|Obesity|obesity
5463980|NCT01444898|Weight|weight
5463981|NCT01444898|Exenatide|exenatide
5463982|NCT01444898|Byetta|byetta
5463983|NCT01444898|Pediatrics|pediatrics
5463985|NCT01444885|Variant angina|variant angina
5463986|NCT01444885|Cilostazol|cilostazol
5463987|NCT01444846|Temporary Auditory Threshold Shift|temporary auditory threshold shift
5463988|NCT01444846|Hearing Loss|hearing loss
5463989|NCT01444846|Deafness|deafness
5463990|NCT01444846|SPI-1005|spi-1005
5463991|NCT01444846|Ebselen|ebselen
5463992|NCT01444833|hypertension|hypertension
5463993|NCT01444833|obesity|obesity
5463994|NCT01444833|metabolism|metabolism
5463995|NCT01444833|angiotensin|angiotensin
5463996|NCT01444820|radiation therapy|radiation therapy
5463997|NCT01444820|hypofractionation|hypofractionation
5463998|NCT01444820|hormonal therapy|hormonal therapy
5463999|NCT01444820|high risk adenocarcinoma of the prostate|high risk adenocarcinoma of the prostate
5464000|NCT01444807|sorafenib|sorafenib
5464001|NCT01444807|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5464002|NCT01444807|metastasectomy|metastasectomy
5464003|NCT01444794|Lower limb spasticity|lower limb spasticity
5464005|NCT01444781|Tetanus|tetanus
5464006|NCT01444781|Whooping Cough|whooping cough
5464007|NCT01444781|Hepatitis B|hepatitis b
5464008|NCT01444781|Poliomyelitis|poliomyelitis
5464009|NCT01444781|Pediatric combined vaccine|pediatric combined vaccine
5464010|NCT01444781|Invasive Hib infections|invasive hib infections
5464011|NCT01444768|Alert Systems, Medication|alert systems, medication
5464012|NCT01444768|Computerized Physician Order Entry System|computerized physician order entry system
5464013|NCT01444768|CPOE|cpoe
5464014|NCT01444768|Medication Alert Systems|medication alert systems
5464015|NCT01444768|Medical Order Entry Systems|medical order entry systems
5464016|NCT01444755|Locally advanced gastric cancer|locally advanced gastric cancer
5464017|NCT01444755|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5464018|NCT01444742|Leukemia|leukemia
5903985|NCT00086567|Peritoneal Cancer|peritoneal cancer
5464019|NCT01444742|Myeloproliferative Diseases|myeloproliferative diseases
5464020|NCT01444742|Myelodysplastic Syndrome|myelodysplastic syndrome
5464021|NCT01444742|(MDS)|(mds)
5464022|NCT01444742|Relapsing|relapsing
5464023|NCT01444742|Refractory|refractory
5464024|NCT01444742|Clofarabine|clofarabine
5464025|NCT01444742|Clofarex|clofarex
5464026|NCT01444742|Clolar|clolar
5464027|NCT01444742|Cytarabine|cytarabine
5464028|NCT01444742|Ara-C|ara-c
5464029|NCT01444742|Cytosar|cytosar
5464030|NCT01444742|DepoCyt|depocyt
5464031|NCT01444742|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5464032|NCT01444729|'Dupuytren's contracture'|'dupuytren's contracture'
5464033|NCT01444729|'xiapex'|'xiapex'
5464034|NCT01444729|'surgery'|'surgery'
5464035|NCT01444703|Thoracic surgery|thoracic surgery
5464036|NCT01444703|double-lumen endotracheal tube|double-lumen endotracheal tube
5464037|NCT01444703|intubation|intubation
5464038|NCT01444703|extubation|extubation
5464039|NCT01444703|sore throat|sore throat
5464040|NCT01444703|prevention of post-extubation sore throat|prevention of post-extubation sore throat
5464041|NCT01444690|Antiretroviral therapy|antiretroviral therapy
5464042|NCT01444690|Acquired Immunodeficiency Syndrome/complications*|acquired immunodeficiency syndrome/complications*
5464043|NCT01444690|Anti-HIV Agents/adverse effects|anti-hiv agents/adverse effects
5464044|NCT01444677|Safety|safety
5464045|NCT01444677|Tolerability|tolerability
5464046|NCT01444677|Pharmacokinetic|pharmacokinetic
5464047|NCT01444651|Tadalafil|tadalafil
5464048|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors
5464049|NCT01444651|Cyclic Guanylyl Monophosphate Pathway|cyclic guanylyl monophosphate pathway
5464050|NCT01444651|Pharmacologic Actions|pharmacologic actions
5464051|NCT01444651|Vasodilator Agents|vasodilator agents
5464052|NCT01444651|Cardiovascular Agents|cardiovascular agents
5464053|NCT01444651|Obesity|obesity
5464054|NCT01444651|Glycemic Traits|glycemic traits
5464055|NCT01444651|Insulin Resistance|insulin resistance
5464056|NCT01444651|Glucose Metabolism|glucose metabolism
5464057|NCT01444638|pregnancy|pregnancy
5464058|NCT01444638|Caesarian|caesarian
5464059|NCT01444638|section|section
5464060|NCT01444638|spinal|spinal
5464061|NCT01444625|UV radiation|uv radiation
5464062|NCT01444625|photoprotection|photoprotection
5464063|NCT01444625|flavanols rich chocolate|flavanols rich chocolate
5464065|NCT01444612|venous thromboembolism|venous thromboembolism
5464066|NCT01444612|hospitalization|hospitalization
5464067|NCT01444612|anticoagulants|anticoagulants
5464068|NCT01444612|costs and cost analysis|costs and cost analysis
5464069|NCT01444612|thromboprophylaxis|thromboprophylaxis
5464070|NCT01444599|coronary atherosclerosis|coronary atherosclerosis
5464071|NCT01444599|virtual histology intravascular ultrasound|virtual histology intravascular ultrasound
5464072|NCT01444599|fractional flow reserve|fractional flow reserve
5464073|NCT01444586|non-interventional|non-interventional
5464074|NCT01444586|Xarelto|xarelto
5464075|NCT01444586|knee replacement|knee replacement
5464076|NCT01444586|hip replecement|hip replecement
5464077|NCT01444586|Russia|russia
5464078|NCT01444573|Rate control|rate control
5464079|NCT01444573|ILR|ilr
5464080|NCT01444547|esophageal cancer|esophageal cancer
5464081|NCT01444547|paclitaxel|paclitaxel
5464082|NCT01444547|cisplatin|cisplatin
5464083|NCT01444534|mobile phone application|mobile phone application
5464084|NCT01444534|diabetes type 1|diabetes type 1
5464085|NCT01444534|self-management|self-management
5464086|NCT01444534|telemedicin|telemedicin
5464087|NCT01444521|advanced gastric cancer|advanced gastric cancer
5464088|NCT01444521|irinotecan|irinotecan
5464089|NCT01444521|cisplatin|cisplatin
5464090|NCT01444495|rectal cancer|rectal cancer
5464091|NCT01444495|radiotherapy|radiotherapy
5464092|NCT01444495|overall survival|overall survival
5464093|NCT01444495|recurrence rate|recurrence rate
5464094|NCT01444495|downstaging|downstaging
5464095|NCT01444469|Asthma exacerbations|asthma exacerbations
5464096|NCT01444469|Respiratory disease|respiratory disease
5464097|NCT01444469|Viral infection|viral infection
5464098|NCT01444469|Macrolide/ketolide antibiotics|macrolide/ketolide antibiotics
5464099|NCT01444469|Mycoplasma pneumoniae (M. pneumoniae)|mycoplasma pneumoniae (m. pneumoniae)
5464100|NCT01444469|Chlamydophila pneumoniae (C. pneumoniae)|chlamydophila pneumoniae (c. pneumoniae)
5464101|NCT01444456|Breast Cancer|breast cancer
5464103|NCT01444456|Ovarian Cancer|ovarian cancer
5464104|NCT01444456|Prostate Cancer|prostate cancer
5464105|NCT01444456|Colorectal Cancer|colorectal cancer
5464106|NCT01444456|Aranesp|aranesp
5464107|NCT01444456|Chemotherapy induced anaemia|chemotherapy induced anaemia
5464108|NCT01444456|Chemotherapy|chemotherapy
5464109|NCT01444456|Bladder Cancer|bladder cancer
5464110|NCT01444456|Endometrial Cancer|endometrial cancer
5464111|NCT01444456|Renal Cancer|renal cancer
5464112|NCT01444456|Pancreatic Cancer|pancreatic cancer
5464113|NCT01444456|Esophageal Cancer|esophageal cancer
5464114|NCT01444456|Gastric Cancer|gastric cancer
5464115|NCT01444443|Type 1 diabetes|type 1 diabetes
5464116|NCT01444443|Glucose control|glucose control
5464117|NCT01444443|Closed-loop|closed-loop
5464118|NCT01444443|Insulin pump|insulin pump
5464119|NCT01444443|Glucose sensor|glucose sensor
5464120|NCT01444430|Symbicort pMDI|symbicort pmdi
5464121|NCT01444430|Asthma|asthma
5464122|NCT01444430|safety|safety
5464123|NCT01444430|budesonide|budesonide
5464124|NCT01444417|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
5685308|NCT00556621|stage II bladder cancer|stage ii bladder cancer
5464125|NCT01444417|Pediatric Immune (Idiopathic) Thrombocytopenic Purpura|pediatric immune (idiopathic) thrombocytopenic purpura
5464126|NCT01444417|Immune Thrombocytopenia|immune thrombocytopenia
5464127|NCT01444404|Solid Tumors|solid tumors
5464128|NCT01444404|Phase 1|phase 1
5464129|NCT01444404|Clinical Trial|clinical trial
5464130|NCT01444391|Tympanostomy tube placement|tympanostomy tube placement
5464131|NCT01444391|iontophoresis|iontophoresis
5464132|NCT01444378|Atherosclerosis|atherosclerosis
5464133|NCT01444378|Claudication|claudication
5464134|NCT01444378|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5464135|NCT01444378|Stent|stent
5464136|NCT01444365|Osteoarthritis of the knee|osteoarthritis of the knee
5464137|NCT01444352|Pneumococcal infections|pneumococcal infections
5464138|NCT01444352|Streptococcus pneumoniae Infections|streptococcus pneumoniae infections
5464139|NCT01444352|Pneumococcal Vaccines|pneumococcal vaccines
5464140|NCT01444339|Pneumococcal Infections|pneumococcal infections
5464141|NCT01444339|Streptococcus Pneumoniae Infections|streptococcus pneumoniae infections
5464142|NCT01444339|Pneumococcal Vaccine|pneumococcal vaccine
5464143|NCT01444326|Keywords;|keywords;
5464144|NCT01444326|Cardiovascular disease|cardiovascular disease
5464145|NCT01444326|Dairy|dairy
5464146|NCT01444326|Inflammation|inflammation
5464147|NCT01444326|Blood lipids|blood lipids
5464148|NCT01444300|multiple sclerosis|multiple sclerosis
5464149|NCT01444300|postural balance|postural balance
5464150|NCT01444300|gait|gait
5464151|NCT01444300|fatigue|fatigue
5464152|NCT01444261|iron deficiency|iron deficiency
5464153|NCT01444261|anemia|anemia
5464154|NCT01444248|Amaryl MEX|amaryl mex
5464155|NCT01444235|CAD, ACVB|cad, acvb
5464156|NCT01444222|Myocardial contractility|myocardial contractility
5464157|NCT01444222|Quantification of regurgitant flow|quantification of regurgitant flow
5464158|NCT01444222|exercise capacity|exercise capacity
5464159|NCT01444209|pituitary gland|pituitary gland
5464161|NCT01444196|acquired cold urticaria|acquired cold urticaria
5464164|NCT01444183|stress reduction|stress reduction
5464165|NCT01444170|eccentric exercise|eccentric exercise
5464166|NCT01444170|exercise induce muscle damage|exercise induce muscle damage
5464167|NCT01444170|isometric strength|isometric strength
5464168|NCT01444170|range of motion|range of motion
5464169|NCT01444170|self report symptoms|self report symptoms
5464170|NCT01444170|mechanical pain threshold|mechanical pain threshold
5464171|NCT01444144|Ankle|ankle
5464172|NCT01444144|Fracture|fracture
5464173|NCT01444144|Elderly|elderly
5464174|NCT01444144|At-risk Population|at-risk population
5464175|NCT01444144|Ankle Fracture in at-risk elderly population|ankle fracture in at-risk elderly population
5464176|NCT01444131|Smoking|smoking
5464177|NCT01444131|Smoking cessation|smoking cessation
5464178|NCT01444131|Pharmaceutical aids|pharmaceutical aids
5464179|NCT01444105|Open angle glaucoma|open angle glaucoma
5464180|NCT01444105|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5464181|NCT01444079|Liver transplantation|liver transplantation
5464182|NCT01444079|Rejection|rejection
5464183|NCT01444079|Tolerance|tolerance
5464184|NCT01444040|Open angle glaucoma|open angle glaucoma
5464185|NCT01444040|POAG|poag
5464186|NCT01444040|Ocular hypertension|ocular hypertension
5464187|NCT01444040|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5464188|NCT01444040|Naïve to treatment|naïve to treatment
5464189|NCT01444014|YF476|yf476
5464190|NCT01444014|netazepide|netazepide
5464191|NCT01444014|hypergastrinaemia|hypergastrinaemia
5464192|NCT01444014|gastric carcinoids|gastric carcinoids
5464193|NCT01444001|Pneumococcal Infections|pneumococcal infections
5464194|NCT01444001|Pneumococcal Vaccines|pneumococcal vaccines
5464195|NCT01444001|pneumococcal protein|pneumococcal protein
5464196|NCT01443988|Open angle glaucoma|open angle glaucoma
5464197|NCT01443988|POAG|poag
5464198|NCT01443988|Ocular hypertension|ocular hypertension
5464199|NCT01443988|Pseudoexfoliative glaucoma|pseudoexfoliative glaucoma
5464200|NCT01443988|Naïve to treatment|naïve to treatment
5464201|NCT01443975|Total Hip Arthroplasty|total hip arthroplasty
5464202|NCT01443975|Osteoarthritis|osteoarthritis
5464203|NCT01443962|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5464204|NCT01443962|PEEP|peep
5464205|NCT01443962|rSO2|rso2
5464206|NCT01443949|fMRI|fmri
5464207|NCT01443949|Reward|reward
5464208|NCT01443949|Adolescents|adolescents
5464209|NCT01443949|Impulse Control|impulse control
5464210|NCT01443949|Cabergoline|cabergoline
5464211|NCT01443936|Influenza Vaccine|influenza vaccine
5464212|NCT01443936|H5N1 Influenza|h5n1 influenza
5464213|NCT01443936|Normal Volunteer|normal volunteer
5464214|NCT01443936|Adenovirus|adenovirus
5464215|NCT01443936|Live Virus Vaccine|live virus vaccine
5464216|NCT01443936|Healthy Volunteer|healthy volunteer
5464217|NCT01443936|HV|hv
5464218|NCT01443923|Hepatitis|hepatitis
5464219|NCT01443923|Immunological Response|immunological response
5464220|NCT01443923|Virological Response|virological response
5464221|NCT01443923|Resistance Mutations|resistance mutations
5464222|NCT01443923|Viral Kinetics|viral kinetics
5464223|NCT01443923|Hepatitis C|hepatitis c
5464224|NCT01443923|HCV|hcv
5464227|NCT01443897|Vitamin D|vitamin d
5464228|NCT01443871|Volunteer|volunteer
5464229|NCT01443858|Smoking Cessation|smoking cessation
5464230|NCT01443858|Cigarette Smoking|cigarette smoking
5464231|NCT01443858|Meclizine|meclizine
5464232|NCT01443858|Nicotine Patch|nicotine patch
5464233|NCT01443845|COPD|copd
5464234|NCT01443845|Exacerbations|exacerbations
5464235|NCT01443845|Roflumilast|roflumilast
5464236|NCT01443845|Daliresp|daliresp
5464237|NCT01443832|ferrous sulfate|ferrous sulfate
5464238|NCT01443832|iron absorption|iron absorption
5464239|NCT01443832|Beninese women|beninese women
5464240|NCT01443832|fonio|fonio
5464241|NCT01443819|Radiculopathy|radiculopathy
5464242|NCT01443819|Transforaminal|transforaminal
5464243|NCT01443819|Disc Protrusion|disc protrusion
5464244|NCT01443806|oseltamivir metabolism|oseltamivir metabolism
5464245|NCT01443806|Carboxylesterase 1|carboxylesterase 1
5464246|NCT01443780|Selenium|selenium
5464247|NCT01443780|Q10|q10
5464248|NCT01443780|dietary supplement|dietary supplement
5464249|NCT01443780|elderly population|elderly population
5464250|NCT01443780|intervention|intervention
5464251|NCT01443780|All-cause mortality|all-cause mortality
5464252|NCT01443780|cardiac function|cardiac function
5464253|NCT01443767|Cardiac Output|cardiac output
5464255|NCT01443767|Pulse Wave Transit Time|pulse wave transit time
5464256|NCT01443767|PiCCO|picco
5464257|NCT01443767|Pulse Contour Analysis|pulse contour analysis
5464258|NCT01443767|Non-invasive Monitoring|non-invasive monitoring
5464259|NCT01443767|Partial Liver Resection|partial liver resection
5464260|NCT01443741|FIT Therapy|fit therapy
5464261|NCT01443741|Diabetes mellitus|diabetes mellitus
5464262|NCT01443741|Insulin pump|insulin pump
5464263|NCT01443741|Pediatric|pediatric
5464264|NCT01443728|sickle cell disease|sickle cell disease
5464265|NCT01443728|acute chest syndrome|acute chest syndrome
5464266|NCT01443728|respiratory complications|respiratory complications
5464267|NCT01443728|vitamin D|vitamin d
5464268|NCT01443715|MDD|mdd
5464269|NCT01443715|Dysthymia|dysthymia
5464270|NCT01443715|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
5464271|NCT01443702|Kidney Calculi|kidney calculi
5464272|NCT01443702|Iranian traditional medicine|iranian traditional medicine
5464273|NCT01443702|Lapis judaicus|lapis judaicus
5464274|NCT01443689|Extensive Burn|extensive burn
5464275|NCT01443689|Human Cord Blood Mononuclear Cells|human cord blood mononuclear cells
5464276|NCT01443689|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5464277|NCT01443637|Coronary Artery Disease|coronary artery disease
5464278|NCT01443637|CAD|cad
5464279|NCT01443637|Atherosclerosis|atherosclerosis
5464280|NCT01443637|Myocardial Infarction|myocardial infarction
5464281|NCT01443637|MI|mi
5464282|NCT01443637|CONFIRM|confirm
5464283|NCT01443637|Coronary Computed Tomographic Angiography|coronary computed tomographic angiography
5464284|NCT01443637|CCTA|ccta
5464285|NCT01443624|iron|iron
5464286|NCT01443624|critical illness|critical illness
5464287|NCT01443624|oxidative stress|oxidative stress
5464288|NCT01443611|Infants|infants
5464289|NCT01443598|Pulmonary arterial hypertension,|pulmonary arterial hypertension,
5464290|NCT01443598|Interstitial lung disease at HRCT|interstitial lung disease at hrct
5464291|NCT01443585|Progressive Addition Lens|progressive addition lens
5464292|NCT01443585|Multifocal|multifocal
5464293|NCT01443585|Presbyopia|presbyopia
5464294|NCT01443572|Kasai operation under general anesthesia|kasai operation under general anesthesia
5464295|NCT01443559|Xenogenic|xenogenic
5464296|NCT01443546|oocyte donor|oocyte donor
5464297|NCT01443546|oocyte recipient|oocyte recipient
5464298|NCT01443546|ovulation trigger|ovulation trigger
5464299|NCT01443533|Contraception|contraception
5464300|NCT01443533|Contraception behavior|contraception behavior
5464301|NCT01443533|Postnatal care|postnatal care
5464302|NCT01443533|Health education|health education
5464303|NCT01443533|Randomized controlled trial|randomized controlled trial
5464304|NCT01443520|Pharmacokinetics|pharmacokinetics
5464305|NCT01443520|Pharmacodynamics|pharmacodynamics
5464306|NCT01443507|aerobic capacity|aerobic capacity
5464307|NCT01443507|maximal oxygen uptake|maximal oxygen uptake
5464308|NCT01443507|aerobic endurance|aerobic endurance
5464309|NCT01443507|work economy|work economy
5464310|NCT01443507|lactate threshold|lactate threshold
5464311|NCT01443507|endurance training|endurance training
5464312|NCT01443507|exercise intensity|exercise intensity
5464313|NCT01443494|septic shock|septic shock
5464314|NCT01443494|microcirculation|microcirculation
5464315|NCT01443494|norepinephrine|norepinephrine
5611654|NCT00851383|HIV|hiv
5464316|NCT01443494|fluid|fluid
5590812|NCT00927550|RCT|rct
5464317|NCT01443481|solid tumors|solid tumors
5464318|NCT01443481|hepatic impairment|hepatic impairment
5464319|NCT01443481|Child-Pugh classification|child-pugh classification
5464320|NCT01443481|pharmacokinetics|pharmacokinetics
5464321|NCT01443481|PK|pk
5464322|NCT01443481|RECIST 1.1|recist 1.1
5464323|NCT01443468|Tp53|tp53
5464324|NCT01443468|Cancer|cancer
5464325|NCT01443468|Hereditary|hereditary
5464326|NCT01443468|Genetic Testing|genetic testing
5464328|NCT01443455|menopause|menopause
5464329|NCT01443455|sedentary|sedentary
5464330|NCT01443455|overweight|overweight
5464331|NCT01443442|Conjunctivitis|conjunctivitis
5464332|NCT01443442|Allergic|allergic
5464333|NCT01443442|Bepotastine besilate|bepotastine besilate
5464334|NCT01443442|Loteprednol etabonate|loteprednol etabonate
5464335|NCT01443429|TRK-100STP|trk-100stp
5464336|NCT01443429|PK|pk
5464337|NCT01443429|beraprost sodium|beraprost sodium
5464338|NCT01443429|Japanese males and females|japanese males and females
5464339|NCT01443429|Subjects with mild/moderate/severe patients|subjects with mild/moderate/severe patients
5464340|NCT01443429|renal impairment|renal impairment
5464341|NCT01443416|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5464342|NCT01443416|invasive pneumococcal disease|invasive pneumococcal disease
5464343|NCT01443416|vaccination|vaccination
5464344|NCT01443416|children|children
5464345|NCT01443403|Opioid Therapy|opioid therapy
5449193|NCT01506180|Aged|aged
5464346|NCT01443403|Non-Malignant Chronic Pain|non-malignant chronic pain
5464347|NCT01443403|Opioid-Induced Constipation|opioid-induced constipation
5464348|NCT01443390|Whole genome sequencing|whole genome sequencing
5464349|NCT01443390|Advanced Refractory Cancer|advanced refractory cancer
5464350|NCT01443377|Neorec|neorec
5464351|NCT01443377|rectal cancer|rectal cancer
5464352|NCT01443377|KRAS|kras
5464353|NCT01443377|Panitumumab|panitumumab
5464354|NCT01443377|neoadjuvant|neoadjuvant
5464355|NCT01443377|Radiochemotherapy|radiochemotherapy
5464356|NCT01443377|antibody|antibody
5464357|NCT01443377|locally advanced KRAS wild type rectal cancer|locally advanced kras wild type rectal cancer
5464358|NCT01443364|Certolizumab pegol - Cimzia|certolizumab pegol - cimzia
5464359|NCT01443364|Rheumatoid Arthritis|rheumatoid arthritis
5464360|NCT01443364|Power Doppler Ultrasonography|power doppler ultrasonography
5464361|NCT01443364|Italy|italy
5464362|NCT01443364|Moderate-severe Rheumatoid Arthritis|moderate-severe rheumatoid arthritis
5464364|NCT01443351|romiplostim|romiplostim
5464365|NCT01443351|eltrombopag|eltrombopag
5464366|NCT01443351|bone marrow fibrosis|bone marrow fibrosis
5464367|NCT01443351|long-term safety|long-term safety
5464368|NCT01443338|Triptergium wilfordii|triptergium wilfordii
5464369|NCT01443338|Acitretin|acitretin
5464370|NCT01443338|psoriasis vulgaris|psoriasis vulgaris
5464371|NCT01443325|Persistent Postherniorrhaphy inguinal Pain|persistent postherniorrhaphy inguinal pain
5464372|NCT01443312|Beta globin gene|beta globin gene
5464373|NCT01443312|Alfa globin gene|alfa globin gene
5464374|NCT01443312|xmn1 polymorphism|xmn1 polymorphism
5464375|NCT01443273|Newborns|newborns
5464376|NCT01443260|oncolytic virus|oncolytic virus
5464377|NCT01443260|oncolytic|oncolytic
5464378|NCT01443260|GL-ONC1|gl-onc1
5464379|NCT01443260|Vaccinia|vaccinia
5464380|NCT01443260|Vaccinia virus|vaccinia virus
5464381|NCT01443260|Genelux|genelux
5464382|NCT01443260|Genelux GmbH|genelux gmbh
5464383|NCT01443260|peritoneal|peritoneal
5464384|NCT01443260|peritoneal carcinomatosis|peritoneal carcinomatosis
5464385|NCT01443260|cancer|cancer
5464386|NCT01443260|abdominal cancer|abdominal cancer
5464387|NCT01443260|imaging|imaging
5464388|NCT01443234|Depression|depression
5464389|NCT01443234|Cognitive Bias|cognitive bias
5464390|NCT01443234|Internet|internet
5464391|NCT01443221|mitiglinide|mitiglinide
5464392|NCT01443221|metformin|metformin
5464393|NCT01443221|Pharmacokinetics|pharmacokinetics
5464394|NCT01443221|Safety|safety
5464395|NCT01443208|pharmacokinetics|pharmacokinetics
5464396|NCT01443208|safety|safety
5464397|NCT01443208|desvenlafaxine|desvenlafaxine
5464398|NCT01443208|Korean healthy subjects|korean healthy subjects
5464399|NCT01443169|Pharmacokinetic|pharmacokinetic
5464400|NCT01443169|relative oral bioavailability|relative oral bioavailability
5464401|NCT01443169|pregabalin|pregabalin
5464402|NCT01443156|Diet|diet
5464403|NCT01443156|Sleep deficiency|sleep deficiency
5464404|NCT01443156|Cancer|cancer
5464405|NCT01443156|Obesity|obesity
5464408|NCT01443156|Work schedule|work schedule
5464409|NCT01443156|Cardiovascular disease|cardiovascular disease
5464410|NCT01443156|Body composition|body composition
5464411|NCT01443156|Body mass index|body mass index
5464412|NCT01443156|Body fat percentage|body fat percentage
5464414|NCT01443143|Obesity|obesity
5464415|NCT01443143|Glycemic|glycemic
5464416|NCT01443143|Portion-control|portion-control
5464417|NCT01443143|Commercial diet|commercial diet
5903986|NCT00086567|Fallopian Tube Cancer|fallopian tube cancer
5464418|NCT01443130|malaria,Malawi,pregnancy|malaria,malawi,pregnancy
5464419|NCT01443104|coronary artery disease|coronary artery disease
5446807|NCT01516281|TBI|tbi
5464420|NCT01443104|drug-eluting stents|drug-eluting stents
5464421|NCT01443104|polymers|polymers
5464422|NCT01443091|very low birth weight infants|very low birth weight infants
5464423|NCT01443091|VLBW infants|vlbw infants
5464424|NCT01443091|colostrum|colostrum
5464425|NCT01443078|Carboplatin|carboplatin
5464426|NCT01443078|Cisplatin|cisplatin
5464427|NCT01443078|Pemetrexed (Altima)|pemetrexed (altima)
5464428|NCT01443078|Taxotere (Docetaxel)|taxotere (docetaxel)
5464429|NCT01443078|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
5464430|NCT01443078|Stage IB-III|stage ib-iii
5464431|NCT01443078|non squamous|non squamous
5464432|NCT01443078|non-small cell lung cancer|non-small cell lung cancer
5464433|NCT01443078|11-106|11-106
5464434|NCT01443065|Adenocarcinoma|adenocarcinoma
5464435|NCT01443065|Locally advanced (non operable) or metastatic|locally advanced (non operable) or metastatic
5464436|NCT01443065|First line treatment|first line treatment
5464437|NCT01443052|Gait stability|gait stability
5464438|NCT01443052|Spatiotemporal parameters|spatiotemporal parameters
5464439|NCT01443052|Walking|walking
5464440|NCT01443052|Elderly people|elderly people
5464441|NCT01443052|Stroke|stroke
5464442|NCT01443052|Fallers|fallers
5464443|NCT01443039|drug metabolizing enzymes and drug transporter|drug metabolizing enzymes and drug transporter
5464444|NCT01443039|Roux-en Y-Gastric Bypass|roux-en y-gastric bypass
5464445|NCT01443039|Obesity|obesity
5464446|NCT01443039|Drug Availability|drug availability
5464447|NCT01443039|BMI over 35kg/m² and comorbidities or >40kg/m²|bmi over 35kg/m² and comorbidities or >40kg/m²
5464448|NCT01443026|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
5464449|NCT01443026|Prostatic neoplasms|prostatic neoplasms
5464450|NCT01443026|Male urogenital disease|male urogenital disease
5464451|NCT01443026|Prostate|prostate
5464452|NCT01443013|Tolerance|tolerance
5464453|NCT01443013|Renal Transplantation|renal transplantation
5464454|NCT01443013|Chronic allograft nephropathy|chronic allograft nephropathy
5464455|NCT01443000|Observational study|observational study
5464456|NCT01443000|IOIS|iois
5464457|NCT01443000|Orbital Pseudotumor|orbital pseudotumor
5464458|NCT01443000|Outcome|outcome
5464459|NCT01443000|Treatment|treatment
5464460|NCT01442987|Irbesartan|irbesartan
5464461|NCT01442987|Atorvastatin|atorvastatin
5464462|NCT01442987|Hypertension|hypertension
5464463|NCT01442987|Hyperlipidemia|hyperlipidemia
5464464|NCT01442974|nab-paclitaxel|nab-paclitaxel
5464465|NCT01442974|neoadjuvant treatment|neoadjuvant treatment
5464466|NCT01442974|SPARC|sparc
5464467|NCT01442974|Pancreatic Cancer|pancreatic cancer
5464468|NCT01442961|pain, postoperative|pain, postoperative
5464469|NCT01442961|hysterectomy, vaginal|hysterectomy, vaginal
5464470|NCT01442961|surgery, gynecological|surgery, gynecological
5464471|NCT01442948|-CD16+ monocytes|-cd16+ monocytes
5464472|NCT01442935|Adenocarcinoma|adenocarcinoma
5464473|NCT01442935|Non-resectable hepatic metastases|non-resectable hepatic metastases
5464474|NCT01442935|First-line treatment|first-line treatment
5464475|NCT01442922|L3-L4|l3-l4
5464476|NCT01442922|L4-L5|l4-l5
5464477|NCT01442922|L5-S1|l5-s1
5464478|NCT01442922|Human Meniscus Allograft|human meniscus allograft
5464479|NCT01442922|Nucleus pulposus|nucleus pulposus
5464480|NCT01442922|Minimally invasive surgery|minimally invasive surgery
5464481|NCT01442922|Degeneration of L3-L4 Intervertebral Disc|degeneration of l3-l4 intervertebral disc
5464482|NCT01442922|Degeneration of L4-L5 Intervertebral Disc|degeneration of l4-l5 intervertebral disc
5464483|NCT01442922|Degeneration of L5-S1 Intervertebral Disc|degeneration of l5-s1 intervertebral disc
5464484|NCT01442909|lung cancer|lung cancer
5464485|NCT01442909|docetaxel|docetaxel
5464486|NCT01442909|pemetrexed|pemetrexed
5464487|NCT01442883|Treatment Resistant|treatment resistant
5464488|NCT01442857|Magnetic Resonance Imaging|magnetic resonance imaging
5464489|NCT01442857|Nerve Net|nerve net
5464490|NCT01442857|Brachial Plexus|brachial plexus
5464491|NCT01442857|Nerve block|nerve block
5464492|NCT01442844|Mohs|mohs
5464493|NCT01442844|Scalp|scalp
5464494|NCT01442831|metabolic profile of TR-700 in plasma urine|metabolic profile of tr-700 in plasma urine
5464495|NCT01442818|vaginal reconstructive surgery|vaginal reconstructive surgery
5464496|NCT01442805|Cognitive Behavior Therapy|cognitive behavior therapy
5464497|NCT01442805|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5459023|NCT01465490|Feedback|feedback
5464498|NCT01442805|Psychophysiological Measures|psychophysiological measures
5464499|NCT01442805|Driving Phobia|driving phobia
5464500|NCT01442805|Flying Phobia|flying phobia
5464501|NCT01442792|Angioplasty, Balloon, Coronary|angioplasty, balloon, coronary
5464502|NCT01442779|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5464503|NCT01442779|Interferon alpha|interferon alpha
5464504|NCT01442766|cholinesterase inhibitor|cholinesterase inhibitor
5464505|NCT01442766|donepezil|donepezil
5464506|NCT01442766|motor|motor
5464507|NCT01442766|stroke|stroke
5464508|NCT01442753|Spanish speaking|spanish speaking
5464509|NCT01442740|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5464510|NCT01442740|Reverse Trendelenburg Position|reverse trendelenburg position
5464511|NCT01442727|arsenical melanosis|arsenical melanosis
5446905|NCT01515891|BIA 9-1067|bia 9-1067
5464512|NCT01442727|arsenical melanoses|arsenical melanoses
5464513|NCT01442727|arsenical keratosis|arsenical keratosis
5464514|NCT01442727|arsenical keratoses|arsenical keratoses
5464515|NCT01442727|arsenical cancer|arsenical cancer
5464516|NCT01442727|arsenic cancers|arsenic cancers
5464517|NCT01442727|arsenic|arsenic
5464518|NCT01442727|arsenicosis|arsenicosis
5464519|NCT01442727|arsenic exposure|arsenic exposure
5464520|NCT01442727|arsenic toxicity|arsenic toxicity
5464521|NCT01442727|arsenic poisoning|arsenic poisoning
5464522|NCT01442727|drinking water|drinking water
5464523|NCT01442727|selenium|selenium
5464524|NCT01442727|selenite|selenite
5464525|NCT01442727|sodium selenite|sodium selenite
5464526|NCT01442675|Meningitis|meningitis
5464527|NCT01442675|Meningococcal Infection|meningococcal infection
5464528|NCT01442675|Menactra®|menactra®
5464529|NCT01442662|Metastatic or relapsed uterine or soft tissue leiomyosarcoma|metastatic or relapsed uterine or soft tissue leiomyosarcoma
5464530|NCT01442649|Adenocarcinoma|adenocarcinoma
5464531|NCT01442649|Metastatic|metastatic
5464532|NCT01442649|Second-line treatment|second-line treatment
5464533|NCT01442649|Progressive disease after first-line treatment with bevacizumab|progressive disease after first-line treatment with bevacizumab
5464534|NCT01442649|Non-mutated (wild-type) KRAS.|non-mutated (wild-type) kras.
5464535|NCT01442623|Vestibular Rehabilitation|vestibular rehabilitation
5464536|NCT01442623|Balance|balance
5464537|NCT01442623|Virtual Reality|virtual reality
5464538|NCT01442623|Gait|gait
5464539|NCT01442623|Dizziness|dizziness
5464540|NCT01442610|Rasagiline|rasagiline
5464541|NCT01442610|Sleep disorder|sleep disorder
5464542|NCT01442610|Parkinson's disease|parkinson's disease
5464543|NCT01442610|Sleep Disturbances in patients with parkinsons's disease|sleep disturbances in patients with parkinsons's disease
5464544|NCT01442597|cognitive behavior therapy|cognitive behavior therapy
5464545|NCT01442597|computer assisted instruction|computer assisted instruction
5464546|NCT01442597|drug abuse therapy|drug abuse therapy
5464547|NCT01442597|educational resource design and development|educational resource design and development
5464548|NCT01442584|ovary|ovary
5464549|NCT01442584|cortex|cortex
5464550|NCT01442584|transplantation|transplantation
5464551|NCT01442571|Adult Men and Women, who underwent arthroscopy of the knee with cartilage injury of ICRS grade 2 or higher|adult men and women, who underwent arthroscopy of the knee with cartilage injury of icrs grade 2 or higher
5464552|NCT01442558|relief|relief
5464553|NCT01442558|Intra-operative|intra-operative
5798690|NCT00111371|drug|drug
5464554|NCT01442545|Rheumatoid Arthritis|rheumatoid arthritis
5464555|NCT01442545|JNJ-39758979|jnj-39758979
5464556|NCT01442545|Methotrexate|methotrexate
5464557|NCT01442532|Healthy male volunteer|healthy male volunteer
5464558|NCT01442532|JNJ-38518168|jnj-38518168
5464559|NCT01442532|Midazolam|midazolam
5464560|NCT01442519|non-muscle invasive urothelial bladder cancer|non-muscle invasive urothelial bladder cancer
5464561|NCT01442519|intravesical therapy|intravesical therapy
5464562|NCT01442519|BCG|bcg
5464563|NCT01442519|mitomycin|mitomycin
5464564|NCT01442519|electromotive drug administration|electromotive drug administration
5464565|NCT01442519|Bladder Cancer Stage 0, Without Cancer in Situ|bladder cancer stage 0, without cancer in situ
5464566|NCT01442506|acetic acid|acetic acid
5464567|NCT01442506|virtual chromoendosopy|virtual chromoendosopy
5464568|NCT01442493|Methadone Treatment|methadone treatment
5464569|NCT01442493|Opiate dependence|opiate dependence
5464570|NCT01442493|Services research|services research
5464571|NCT01442480|air pollution|air pollution
5464572|NCT01442480|fatty acid supplementation|fatty acid supplementation
5464573|NCT01442467|mitral annular calcification|mitral annular calcification
5464574|NCT01442467|MAC|mac
5464575|NCT01442467|left atrial pressure|left atrial pressure
5464576|NCT01442467|LAP|lap
5464777|NCT01441609|Th9 cells|th9 cells
5464577|NCT01442467|left ventricular end diastolic pressure|left ventricular end diastolic pressure
5464579|NCT01442467|Echocardiogram|echocardiogram
5464580|NCT01442454|chronic pancreatitis|chronic pancreatitis
5464581|NCT01442441|chronic pancreatitis|chronic pancreatitis
5464582|NCT01442428|TB|tb
5464583|NCT01442428|AIDS|aids
5464584|NCT01442428|HIV|hiv
5464585|NCT01442428|IRIS|iris
5464586|NCT01442428|immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5464587|NCT01442428|anti-inflammatory|anti-inflammatory
5464588|NCT01442428|treatment|treatment
5789040|NCT00150150|patient satesfaction|patient satesfaction
5464589|NCT01442376|Prevention of Chemotherapy-Induced Nausea and Vomiting|prevention of chemotherapy-induced nausea and vomiting
5464590|NCT01442376|Palonosetron|palonosetron
5464591|NCT01442376|Ondansetron|ondansetron
5464592|NCT01442376|Pediatric|pediatric
5464593|NCT01442363|Crohn's disease|crohn's disease
5464594|NCT01442363|perianal|perianal
5464595|NCT01442363|inflammatory bowel disease|inflammatory bowel disease
5464596|NCT01442363|fistula|fistula
5464597|NCT01442350|Fabry disease|fabry disease
5464598|NCT01442350|annexin 5|annexin 5
5464599|NCT01442350|miosin|miosin
5464600|NCT01442350|sarcoma|sarcoma
5464601|NCT01442350|alfa-galactosidase|alfa-galactosidase
5464602|NCT01442350|fibrosis|fibrosis
5464603|NCT01442350|apoptosis|apoptosis
5447007|NCT01515436|Mozart|mozart
5464604|NCT01442350|biomarkers|biomarkers
5464605|NCT01442350|NT-proBNP|nt-probnp
5464606|NCT01442337|de novo kidney transplant|de novo kidney transplant
5464607|NCT01442337|kidney transplant|kidney transplant
5464608|NCT01442337|ASP8597|asp8597
5464609|NCT01442337|diannexin|diannexin
5464610|NCT01442337|ischemia-reperfusion injury|ischemia-reperfusion injury
5464611|NCT01442324|Laparotomic surgery|laparotomic surgery
5464612|NCT01442324|Laparoscopic surgery|laparoscopic surgery
5464613|NCT01442324|Percutaneos tumour ablation|percutaneos tumour ablation
5464614|NCT01442324|Irreversible electroporation (IRE)|irreversible electroporation (ire)
5464615|NCT01442311|Hepatitis C Virus|hepatitis c virus
5464616|NCT01442311|Chronic Hepatitis C|chronic hepatitis c
5464617|NCT01442311|Methadone|methadone
5464618|NCT01442311|Injection Drug User|injection drug user
5464619|NCT01442311|Adherence|adherence
5464620|NCT01442311|Directly Observed Treatment|directly observed treatment
5464621|NCT01442298|bloodless field|bloodless field
5464622|NCT01442298|cuff pressure|cuff pressure
5464623|NCT01442298|limb occlusion pressure|limb occlusion pressure
5464624|NCT01442259|Renal impairment,|renal impairment,
5464625|NCT01442259|pharmacokinetics,|pharmacokinetics,
5464626|NCT01442259|safety|safety
5464627|NCT01442246|Benefit of|benefit of
5464628|NCT01442246|adjuvant|adjuvant
5464629|NCT01442246|treatment|treatment
5464630|NCT01442246|prostatectomy|prostatectomy
5464631|NCT01442233|multiple sclerosis|multiple sclerosis
5464632|NCT01442233|plasma exchange|plasma exchange
5464633|NCT01442207|Premature Birth|premature birth
5464634|NCT01442207|Placenta Previa|placenta previa
5464635|NCT01442194|Multiple sclerosis|multiple sclerosis
5464636|NCT01442194|fingolimod|fingolimod
5464637|NCT01442194|observational study|observational study
5464638|NCT01442168|Uncomplicated Falciparum Malaria|uncomplicated falciparum malaria
5464639|NCT01442168|Plasmodium falciparum|plasmodium falciparum
5464640|NCT01442168|Antimalarial treatment|antimalarial treatment
5464641|NCT01442168|Sevuparin/DF02|sevuparin/df02
5464642|NCT01442168|Adjuvant therapy|adjuvant therapy
5464643|NCT01442168|Malanil|malanil
5464644|NCT01442168|Peripheral blood parasitemia|peripheral blood parasitemia
5464645|NCT01442168|Rosette formation|rosette formation
5464646|NCT01442168|Maximum tolerated dose|maximum tolerated dose
5464647|NCT01442155|Colorectal cancer|colorectal cancer
5464648|NCT01442155|Adjuvant setting|adjuvant setting
5464649|NCT01442155|Capecitabine|capecitabine
5464650|NCT01442155|Oxaliplatin|oxaliplatin
5464651|NCT01442142|obesity|obesity
5464652|NCT01442142|pediatric|pediatric
5464653|NCT01442142|childhood|childhood
5464654|NCT01442142|overweight|overweight
5464655|NCT01442129|Heart Failure|heart failure
5464656|NCT01442129|Left Ventricular Assist Device|left ventricular assist device
5464657|NCT01442129|Heart Transplantation|heart transplantation
5464658|NCT01442129|Cardiomyopathy|cardiomyopathy
5464659|NCT01442129|Destination Therapy|destination therapy
5464660|NCT01442129|Cell Therapy|cell therapy
5464661|NCT01442064|CNV|cnv
5464662|NCT01442064|Lucentis|lucentis
5464663|NCT01442064|AMD|amd
5464664|NCT01442064|Age-related macular degeneration|age-related macular degeneration
5464665|NCT01442064|RVO|rvo
5464666|NCT01442064|Macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
5464667|NCT01442051|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
5464668|NCT01442051|Cytoreductive Surgery|cytoreductive surgery
5464669|NCT01442051|laparotomy|laparotomy
5464670|NCT01442051|11-149|11-149
5464671|NCT01442051|advanced primary epithelial ovarian cancer|advanced primary epithelial ovarian cancer
5464672|NCT01442025|Crohn's Disease|crohn's disease
5464673|NCT01442025|IFX trough level|ifx trough level
5464674|NCT01442012|PONV|ponv
5464675|NCT01442012|ACUPUNCTURE|acupuncture
5464676|NCT01441999|Rigid rods|rigid rods
5464677|NCT01441999|less rigid rods|less rigid rods
5464683|NCT01441986|oral glucose tolerance test|oral glucose tolerance test
5464684|NCT01441960|Succinylcholine|succinylcholine
5464685|NCT01441960|Rocuronium|rocuronium
5464686|NCT01441960|ECT|ect
5464687|NCT01441947|ER+|er+
5464688|NCT01441947|PR+|pr+
5464689|NCT01441947|Human Epidermal Growth Factor Receptor (HER) 2 negative|human epidermal growth factor receptor (her) 2 negative
5464690|NCT01441947|metastatic|metastatic
5464691|NCT01441921|pistachio intake|pistachio intake
5464692|NCT01441921|insulin resistance|insulin resistance
5464693|NCT01441921|type 2 diabetes mellitus|type 2 diabetes mellitus
5464694|NCT01441908|Cardiovascular|cardiovascular
5464696|NCT01441908|Statin|statin
5464697|NCT01441908|Dyslipidemia|dyslipidemia
5464698|NCT01441895|Refractive Cataract Extraction|refractive cataract extraction
5464699|NCT01441895|Femtosecond laser|femtosecond laser
5464700|NCT01441895|arcuate relaxing incisions|arcuate relaxing incisions
5464701|NCT01441895|Dry Eye post cataract refraction|dry eye post cataract refraction
5464702|NCT01441869|Phase 1, Healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , Diabex|phase 1, healthy male volunteers, pharmacokinetics, saxagliptin/ metformin , diabex
5464709|NCT01441843|quality of life|quality of life
5464710|NCT01441843|lorazepam|lorazepam
5464711|NCT01441843|anxiety|anxiety
5464712|NCT01441843|premedication|premedication
5464713|NCT01441843|surgery|surgery
5464714|NCT01441843|Adult patients|adult patients
5464715|NCT01441843|Ambulatory Surgical Procedures|ambulatory surgical procedures
5464716|NCT01441843|Postoperative Period|postoperative period
5464717|NCT01441830|shoulder|shoulder
5464718|NCT01441830|subacromial|subacromial
5464719|NCT01441830|impingement|impingement
5464720|NCT01441830|tendinopathy|tendinopathy
5464721|NCT01441830|rESWT|reswt
5464722|NCT01441830|shock wave|shock wave
5464723|NCT01441830|ESWT|eswt
5464724|NCT01441830|RSWT|rswt
5464725|NCT01441791|PEEP|peep
5464726|NCT01441791|Positive end-expiratory pressure|positive end-expiratory pressure
5464727|NCT01441791|Recruitment maneuver|recruitment maneuver
5464728|NCT01441791|Open lung approach|open lung approach
5464729|NCT01441791|Post-operative complications|post-operative complications
5464730|NCT01441791|Open abdominal surgery|open abdominal surgery
5464731|NCT01441778|nasal irrigation|nasal irrigation
5464732|NCT01441778|allergic rhinitis|allergic rhinitis
5464733|NCT01441778|children|children
5464734|NCT01441765|Kidney|kidney
5464735|NCT01441765|Metastatic|metastatic
5464736|NCT01441765|Stage IV|stage iv
5464737|NCT01441726|Advanced dementia|advanced dementia
5464738|NCT01441726|Quality|quality
5464739|NCT01441726|Terminal care|terminal care
5464740|NCT01441713|Hormone treatment|hormone treatment
5464741|NCT01441713|castration|castration
5464742|NCT01441713|Orchiectomy|orchiectomy
5464743|NCT01441713|treatment frequency|treatment frequency
5464744|NCT01441713|treatment satisfaction|treatment satisfaction
5464745|NCT01441713|side effects|side effects
5464746|NCT01441700|Prone emergence|prone emergence
5464747|NCT01441700|supine emergence|supine emergence
5464748|NCT01441700|coughing|coughing
5464749|NCT01441700|haemodynamic stimulation|haemodynamic stimulation
5464750|NCT01441700|lumbar surgery|lumbar surgery
5464751|NCT01441687|Health status unknown|health status unknown
5464752|NCT01441687|healthy,no evidence of disease|healthy,no evidence of disease
5464753|NCT01441674|Occupational Therapy|occupational therapy
5464754|NCT01441661|Sunitinib|sunitinib
5464755|NCT01441661|kidney diseases|kidney diseases
5464756|NCT01441661|urogenital neoplasms|urogenital neoplasms
5464757|NCT01441661|kidney cancer|kidney cancer
5464758|NCT01441648|conjunctival injection|conjunctival injection
5464759|NCT01441648|conjunctival papillary hypertrophy|conjunctival papillary hypertrophy
5464760|NCT01441648|pannus formation|pannus formation
5464761|NCT01441648|corneal epitheliopathy|corneal epitheliopathy
5464762|NCT01441648|Schirmer test|schirmer test
5464763|NCT01441648|Impression cytology|impression cytology
5464764|NCT01441648|confocal microscopy|confocal microscopy
5464765|NCT01441648|Scanning electronmicroscopy (SEM)|scanning electronmicroscopy (sem)
5464766|NCT01441648|bacterial adhesion determination|bacterial adhesion determination
5464767|NCT01441635|Elagolix|elagolix
5464768|NCT01441635|Uterine Fibroids|uterine fibroids
5464769|NCT01441635|Elagolix sodium|elagolix sodium
5464770|NCT01441635|Leiomyomata|leiomyomata
5464771|NCT01441635|Heavy Uterine Bleeding|heavy uterine bleeding
5464772|NCT01441635|Menorrhagia|menorrhagia
5464773|NCT01441635|ABT-620|abt-620
5464774|NCT01441622|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5464775|NCT01441622|AL539|al539
5464776|NCT01441622|Home-monitoring|home-monitoring
5464778|NCT01441609|IL9|il9
5464779|NCT01441609|non/poor responsiveness to hepatitis B|non/poor responsiveness to hepatitis b
5464780|NCT01441609|collect blood samples after vaccination|collect blood samples after vaccination
5464781|NCT01441583|pacemaker, CRT-P, auto threshold|pacemaker, crt-p, auto threshold
5464782|NCT01441570|kidney|kidney
5464783|NCT01441570|transplant|transplant
5464784|NCT01441570|hypertension|hypertension
5464785|NCT01441570|nebivolol|nebivolol
5464786|NCT01441570|metoprolol|metoprolol
5464787|NCT01441570|bystolic|bystolic
5464788|NCT01441570|toprol|toprol
5464789|NCT01441557|mechanical ventilation|mechanical ventilation
5464790|NCT01441544|active video games|active video games
5464791|NCT01441544|Energy expenditure|energy expenditure
5464792|NCT01441531|narcotic use|narcotic use
5464793|NCT01441531|Other Acute Pain|other acute pain
5464794|NCT01441492|Distal pancreatectomy|distal pancreatectomy
5464795|NCT01441492|Pancreas resection|pancreas resection
5464796|NCT01441466|bronchiolitis|bronchiolitis
5464797|NCT01441466|RSV|rsv
5464798|NCT01441453|Hepatocellular carcinoma|hepatocellular carcinoma
5464799|NCT01441453|Cirrhosis|cirrhosis
5464801|NCT01441453|FibroScan|fibroscan
5464802|NCT01441440|venlafaxine ER|venlafaxine er
5464803|NCT01441440|Major depressive disorder|major depressive disorder
5464804|NCT01441440|Japan|japan
5464805|NCT01441440|placebo-controlled|placebo-controlled
5464806|NCT01441427|feeding intolerance|feeding intolerance
5464807|NCT01441427|recombinant growth factors|recombinant growth factors
5464808|NCT01441427|G-CSF|g-csf
5464809|NCT01441427|EPO|epo
5464810|NCT01441427|necrotizing enterocolitis|necrotizing enterocolitis
5464812|NCT01441414|PF-04856884|pf-04856884
5464813|NCT01441414|AG-013736|ag-013736
5464814|NCT01441414|axitinib|axitinib
5464815|NCT01441414|mRCC|mrcc
5447208|NCT01514409|Mood|mood
5464816|NCT01441414|metastatic renal cell cancer|metastatic renal cell cancer
5464817|NCT01441414|second line|second line
5464818|NCT01441414|anti-angiogenic|anti-angiogenic
5464819|NCT01441414|Ang-2|ang-2
5464820|NCT01441401|Gabapentin|gabapentin
5464821|NCT01441401|Epilepsies|epilepsies
5464822|NCT01441401|safety|safety
5464823|NCT01441388|Phase 1b|phase 1b
5464824|NCT01441388|crizotinib|crizotinib
5464825|NCT01441388|sunitinib|sunitinib
5464826|NCT01441388|axitinib|axitinib
5464827|NCT01441388|sorafenib|sorafenib
5464828|NCT01441388|bevacizumab|bevacizumab
5464829|NCT01441388|cMET inhibitor|cmet inhibitor
5464830|NCT01441388|VEGF inhibitor|vegf inhibitor
5464831|NCT01441388|crizotinib combination|crizotinib combination
5464832|NCT01441375|Sickle cell anemia|sickle cell anemia
5464833|NCT01441362|during double-lumen|during double-lumen
5464834|NCT01441362|tube intubation|tube intubation
5464835|NCT01441349|Simvastatin|simvastatin
5464836|NCT01441349|SCLC|sclc
5464837|NCT01441349|Extensive Disease|extensive disease
5464838|NCT01441323|Obesity|obesity
5464839|NCT01441323|Type 2 Diabetes|type 2 diabetes
5464840|NCT01441323|Cardiovascular Risk|cardiovascular risk
5464841|NCT01441323|Cancer|cancer
5464842|NCT01441323|African American|african american
5464843|NCT01441323|Adolescents|adolescents
5464844|NCT01441323|Strength Training|strength training
5464845|NCT01441323|Nutrition|nutrition
5464846|NCT01441310|Gastric cancer|gastric cancer
5464847|NCT01441310|Sentinel node navigation surgery|sentinel node navigation surgery
5464848|NCT01441310|Dual method|dual method
5464849|NCT01441310|Recurrence|recurrence
5464850|NCT01441297|recurrent small cell lung cancer|recurrent small cell lung cancer
5464851|NCT01441284|pramipexole|pramipexole
5464852|NCT01441284|essential tremor|essential tremor
5464853|NCT01441284|cross-over|cross-over
5464854|NCT01441245|acute heart failure|acute heart failure
5464855|NCT01441245|diuretics|diuretics
5464857|NCT01441245|Renal function|renal function
5464858|NCT01441245|acute decompensated Heart Failure,|acute decompensated heart failure,
5464859|NCT01441245|volume overload|volume overload
5464860|NCT01441206|rifampin|rifampin
5464861|NCT01441206|infants|infants
5464862|NCT01441193|HIV|hiv
5464863|NCT01441193|preventive vaccine|preventive vaccine
5464864|NCT01441193|Tat|tat
5464865|NCT01441193|Env|env
5464866|NCT01441180|Direct Acting Antiviral|direct acting antiviral
5464867|NCT01441180|Liver|liver
5464868|NCT01441180|Hepatitis C|hepatitis c
5464869|NCT01441180|HCV|hcv
5464870|NCT01441167|Healthy Subjects|healthy subjects
5464871|NCT01441167|Immunogenicity|immunogenicity
5464872|NCT01441167|Vaccine-Mediated Protection|vaccine-mediated protection
5464874|NCT01441167|Parasitemia|parasitemia
5464875|NCT01441167|Healthy Volunteer|healthy volunteer
5464876|NCT01441167|HV|hv
5464877|NCT01441154|Hypothyroidism|hypothyroidism
5464878|NCT01441154|Thyroid Cancer|thyroid cancer
5464879|NCT01441154|Triiodothyronine (T3)|triiodothyronine (t3)
5464880|NCT01441154|Energy Expenditure|energy expenditure
5464881|NCT01441154|Thyroid Hormone|thyroid hormone
5464882|NCT01441141|GCH1|gch1
5464883|NCT01441141|Pain Sensitivity|pain sensitivity
5464884|NCT01441141|Quantitative Sensory Testing (QST)|quantitative sensory testing (qst)
5464885|NCT01441141|Genetic Variation|genetic variation
5464886|NCT01441141|Sickle Cell Anemia|sickle cell anemia
5464887|NCT01441128|Lung Neoplasms|lung neoplasms
5464888|NCT01441128|Epithelial-Mesenchymal Transition Factor (c-Met)|epithelial-mesenchymal transition factor (c-met)
5464889|NCT01441128|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5464890|NCT01441128|Hepatocyte Growth Factor Receptor|hepatocyte growth factor receptor
5464891|NCT01441128|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5464892|NCT01441128|Non Small Cell Lung Cancer|non small cell lung cancer
5464893|NCT01441128|NSCLC|nsclc
5464894|NCT01441115|Metastasis|metastasis
5464895|NCT01441115|Cancer|cancer
5464896|NCT01441115|Radiation Therapy|radiation therapy
5464897|NCT01441115|Locally Advanced|locally advanced
5464898|NCT01441115|Palliation|palliation
5464899|NCT01441115|Metastatic Cancer|metastatic cancer
5464900|NCT01441102|Diabetic Macular Edema|diabetic macular edema
5464901|NCT01441102|Microglia|microglia
5464902|NCT01441102|Dextromethorphan|dextromethorphan
5464903|NCT01441089|Pharmacogenetics|pharmacogenetics
5464904|NCT01441089|Pharmacokinetics|pharmacokinetics
5459451|NCT01463644|COPD|copd
5464905|NCT01441089|Pharmacodynamics|pharmacodynamics
5464906|NCT01441089|Clinical Outcome|clinical outcome
5464907|NCT01441089|Drug Metabolism and Transport|drug metabolism and transport
5464909|NCT01441076|Behcet's Disease|behcet's disease
5464910|NCT01441076|Aphthous Ulcer|aphthous ulcer
5464911|NCT01441076|Uveitis|uveitis
5464912|NCT01441076|IL-1|il-1
5464913|NCT01441076|Autoinflammation|autoinflammation
5464914|NCT01441076|BD|bd
5464915|NCT01441063|Kaposi Sarcoma Herpesvirus|kaposi sarcoma herpesvirus
5464916|NCT01441063|Human Immunodeficiency Virus|human immunodeficiency virus
5464917|NCT01441063|Tocilizumab|tocilizumab
5464918|NCT01441063|Multicentric Castleman Disease|multicentric castleman disease
5464919|NCT01441063|Interleukin-6|interleukin-6
5447317|NCT01513915|children|children
5464920|NCT01441063|Castleman Disease|castleman disease
5464921|NCT01441037|Aplastic Anemia|aplastic anemia
5464922|NCT01441037|Androgen|androgen
5464923|NCT01441037|Telomeres|telomeres
5464924|NCT01441037|Sex hormone|sex hormone
5464925|NCT01441037|Pulmonary fibrosis|pulmonary fibrosis
5464926|NCT01441037|Liver cirrhosis|liver cirrhosis
5464927|NCT01441024|Immunocompromised|immunocompromised
5464928|NCT01441024|Respiratory Tract Disease|respiratory tract disease
5464929|NCT01441024|Viral Shedding|viral shedding
5464930|NCT01441024|Fever|fever
5464931|NCT01441024|Pharmacokinetics|pharmacokinetics
5464932|NCT01441024|Parainfluenza Infection|parainfluenza infection
5464933|NCT01441024|Flu|flu
5464934|NCT01441011|weight loss|weight loss
5464935|NCT01441011|breast cancer|breast cancer
5464936|NCT01441011|obesity|obesity
5464937|NCT01441011|overweight|overweight
5464938|NCT01441011|rural women|rural women
5464939|NCT01441011|community based|community based
5464940|NCT01441011|Secondary Prevention|secondary prevention
5464941|NCT01440985|Tooth Staining|tooth staining
5464942|NCT01440972|knee osteoarthritis|knee osteoarthritis
5464943|NCT01440972|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5464944|NCT01440972|isotonic leg-press strength|isotonic leg-press strength
5464945|NCT01440972|isokinetic knee extensor strength|isokinetic knee extensor strength
5464946|NCT01440972|quadriceps volume|quadriceps volume
5464947|NCT01440959|This is a single-center|this is a single-center
5464948|NCT01440959|prospective|prospective
5464949|NCT01440959|single-arm|single-arm
5464950|NCT01440959|open-label phase II study|open-label phase ii study
5464951|NCT01440933|sugammadex|sugammadex
5464952|NCT01440933|rocuronium|rocuronium
5464953|NCT01440933|magnesiumsulphate|magnesiumsulphate
5464954|NCT01440933|neuromuscular monitoring|neuromuscular monitoring
5464955|NCT01440920|Acute myeloid leukemia|acute myeloid leukemia
5464956|NCT01440920|WT1|wt1
5464957|NCT01440907|Health Information Technology|health information technology
5464958|NCT01440907|Health Records, Personal|health records, personal
5464959|NCT01440907|Hospital Information Systems|hospital information systems
5464960|NCT01440907|Patient Access to Records|patient access to records
5464961|NCT01440907|Medical Records|medical records
5464962|NCT01440907|Medical Record Systems, Computerized|medical record systems, computerized
5464963|NCT01440894|weight|weight
5464964|NCT01440894|body fat|body fat
5464965|NCT01440894|total body water|total body water
5464966|NCT01440894|bone mass|bone mass
5464967|NCT01440894|muscle mass|muscle mass
5464968|NCT01440881|renal failure|renal failure
5464969|NCT01440881|cardiopulmonary bypass|cardiopulmonary bypass
5464970|NCT01440868|Respiratory Distress Syndrome, Newborn|respiratory distress syndrome, newborn
5464972|NCT01440868|Resuscitation|resuscitation
5464973|NCT01440868|Premature Birth|premature birth
5464974|NCT01440868|Infant, Newborn|infant, newborn
5464975|NCT01440868|Respiration, Artificial|respiration, artificial
5464976|NCT01440855|Survivorship|survivorship
5464977|NCT01440855|cancer control|cancer control
5464978|NCT01440855|psychosocial interventions|psychosocial interventions
5464979|NCT01440855|Facing Forward|facing forward
5464980|NCT01440842|Stress hyperglycaemia|stress hyperglycaemia
5464981|NCT01440829|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5464982|NCT01440829|TIPS|tips
5464983|NCT01440829|Liver Cirrhosis|liver cirrhosis
5464984|NCT01440829|LOLA|lola
5464985|NCT01440829|L-ornithine-L-aspartate|l-ornithine-l-aspartate
5464986|NCT01440829|Refractory Ascites|refractory ascites
5464987|NCT01440803|osteoporosis|osteoporosis
5464988|NCT01440803|premenopausal|premenopausal
5464989|NCT01440803|forteo|forteo
5464990|NCT01440803|idiopathic|idiopathic
5464991|NCT01440803|Idiopathic Osteoporosis in Premenopausal Women|idiopathic osteoporosis in premenopausal women
5464992|NCT01440777|Insomnia|insomnia
5464993|NCT01440777|Sleep|sleep
5464994|NCT01440777|Stress|stress
5464995|NCT01440777|Online program|online program
5464996|NCT01440777|Web-based program|web-based program
5464997|NCT01440777|Cognitive Behavioral Therapy for Insomnia (CBT-i)|cognitive behavioral therapy for insomnia (cbt-i)
5464998|NCT01440764|dyspnea|dyspnea
5464999|NCT01440764|Laboratory model of dyspnea in healthy subjects|laboratory model of dyspnea in healthy subjects
5465000|NCT01440751|ologen collagen matrix|ologen collagen matrix
5465001|NCT01440751|mitomycin-C|mitomycin-c
5465002|NCT01440751|trabeculectomy|trabeculectomy
5465003|NCT01440751|glaucoma|glaucoma
5465005|NCT01440738|general population|general population
5465006|NCT01440725|muscle|muscle
5465007|NCT01440725|injuries|injuries
5465008|NCT01440725|platelet-rich plasma|platelet-rich plasma
5465009|NCT01440725|autologous|autologous
5465010|NCT01440725|haematoma|haematoma
5465011|NCT01440712|Gastrografin|gastrografin
5465012|NCT01440712|Postoperative ileus|postoperative ileus
5465013|NCT01440712|Colo-rectal surgery|colo-rectal surgery
5465014|NCT01440712|Effects on morbidity and mortality of postoperative ileus|effects on morbidity and mortality of postoperative ileus
5465016|NCT01440686|Pharmacokinetics|pharmacokinetics
5465017|NCT01440686|Pharmacodynamics|pharmacodynamics
5465019|NCT01440686|Male|male
5465020|NCT01440673|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5465021|NCT01440647|Respiration, Artificial|respiration, artificial
5465022|NCT01440647|Infant, Premature|infant, premature
5465023|NCT01440647|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5465024|NCT01440647|Continuous Positive Airway Pressure|continuous positive airway pressure
5465025|NCT01440647|Non-Invasive Positive-Pressure Ventilation|non-invasive positive-pressure ventilation
5465026|NCT01440647|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5465027|NCT01440647|High-Frequency Ventilation|high-frequency ventilation
5465028|NCT01440634|Peripheral arterial disease|peripheral arterial disease
5465029|NCT01440634|Community Medicine|community medicine
5465030|NCT01440634|Exercise Test|exercise test
5465031|NCT01440634|Exercise Therapy|exercise therapy
5465032|NCT01440621|Cancer related fatigue|cancer related fatigue
5465033|NCT01440621|Quality of life|quality of life
5465035|NCT01440621|Radiation therapy|radiation therapy
5465036|NCT01440621|Radiotherapy|radiotherapy
5465037|NCT01440582|Myeloma|myeloma
5465038|NCT01440582|Multiple Myeloma|multiple myeloma
5465039|NCT01440582|MM|mm
5465040|NCT01440582|Newly diagnosed|newly diagnosed
5465041|NCT01440582|Transplant eligible|transplant eligible
5465042|NCT01440582|Panobinostat|panobinostat
5465043|NCT01440582|LBH589B|lbh589b
5465044|NCT01440582|Bortezomib|bortezomib
5465045|NCT01440582|Velcade|velcade
5465046|NCT01440582|LDP-341|ldp-341
5465047|NCT01440582|MLN341|mln341
5465048|NCT01440582|PS-341|ps-341
5465049|NCT01440582|Lenalidomide|lenalidomide
5465050|NCT01440582|CC-5013|cc-5013
5465051|NCT01440582|Revlimid|revlimid
5465052|NCT01440582|Dexamethasone|dexamethasone
5465053|NCT01440582|Decadron|decadron
5465054|NCT01440582|Symptom questionnaire|symptom questionnaire
5465055|NCT01440582|Survey|survey
5465056|NCT01440569|HIV-1|hiv-1
5465057|NCT01440569|HIV|hiv
5465058|NCT01440569|Treatment Naïve|treatment naïve
5465059|NCT01440569|Treatment Experienced|treatment experienced
5465060|NCT01440556|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5465061|NCT01440556|Multiple myeloma|multiple myeloma
5465062|NCT01440543|colonoscopy|colonoscopy
5465063|NCT01440543|water immersion|water immersion
5465064|NCT01440543|CO2 insufflation|co2 insufflation
5465065|NCT01440543|patients referred for diagnostic outpatient colonoscopy|patients referred for diagnostic outpatient colonoscopy
5465066|NCT01440543|(screening, surveillance, symptoms)|(screening, surveillance, symptoms)
5468226|NCT01428154|CKD|ckd
5798691|NCT00111371|treatment|treatment
5465067|NCT01440543|patient discomfort associated with diagnostic colonoscopy|patient discomfort associated with diagnostic colonoscopy
5465068|NCT01440530|Diabetes Internet Education|diabetes internet education
5465069|NCT01440530|Diabetes Education|diabetes education
5465070|NCT01440530|Diabetes Self-Care|diabetes self-care
5465071|NCT01440530|Diabetes Self-Management|diabetes self-management
5465072|NCT01440530|Diabetes Behavior Intervention|diabetes behavior intervention
5465073|NCT01440517|CE-MRI - Contrast-enhanced magnetic resonance imaging|ce-mri - contrast-enhanced magnetic resonance imaging
5465074|NCT01440517|DM - Diabetes mellitus|dm - diabetes mellitus
5465075|NCT01440517|EKG - Echocardiography|ekg - echocardiography
5465076|NCT01440517|HFPEF - Heart failure preserved left ventricular ejection fraction|hfpef - heart failure preserved left ventricular ejection fraction
5465077|NCT01440517|LVEF - Left Ventricular Ejection Fraction|lvef - left ventricular ejection fraction
5465078|NCT01440504|Cancer|cancer
5465079|NCT01440504|Ovarian|ovarian
5465080|NCT01440504|chemotherapy|chemotherapy
5465081|NCT01440504|BH3-mimetic|bh3-mimetic
5465082|NCT01440504|platin|platin
5465083|NCT01440504|ex-vivo|ex-vivo
5465084|NCT01440491|low back pain|low back pain
5465085|NCT01440491|exercise|exercise
5465086|NCT01440491|booklet|booklet
5465087|NCT01440465|chemotherapy|chemotherapy
5465088|NCT01440465|cancer|cancer
5465089|NCT01440465|nausea|nausea
5465090|NCT01440465|vomiting|vomiting
5465091|NCT01440452|TM|tm
5465092|NCT01440452|MS|ms
5465093|NCT01440452|Spinal Cord Injury|spinal cord injury
5465094|NCT01440452|Functional electrical stimulation|functional electrical stimulation
5465095|NCT01440452|Rehabilitation|rehabilitation
5465096|NCT01440452|Growth factors|growth factors
5465097|NCT01440452|Cytokines|cytokines
5465098|NCT01440439|insulin glargine|insulin glargine
5465099|NCT01440439|insulin detemir|insulin detemir
5465101|NCT01440439|metabolism|metabolism
5465102|NCT01440439|Exercise|exercise
5465103|NCT01440426|gingival recession|gingival recession
5465104|NCT01440426|root coverage|root coverage
5465105|NCT01440426|periodontal surgery|periodontal surgery
5465106|NCT01440426|collagen matrix|collagen matrix
5465107|NCT01440426|mucograft|mucograft
5465108|NCT01440426|multiple exposed teeth|multiple exposed teeth
5465109|NCT01440413|anti-tumor immune response|anti-tumor immune response
5465110|NCT01440413|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5465111|NCT01440413|relapse|relapse
5465112|NCT01440413|long term survival|long term survival
5465113|NCT01440413|histo-pathological response|histo-pathological response
5465114|NCT01440413|tumor cell death|tumor cell death
5465115|NCT01440413|tumor associated antigens|tumor associated antigens
5465116|NCT01440413|Calreticulin|calreticulin
5465117|NCT01440413|Localized breast cancer|localized breast cancer
5465118|NCT01440400|Ultrasound|ultrasound
5465119|NCT01440400|Spinal anesthesia|spinal anesthesia
5465120|NCT01440400|Cesarean section|cesarean section
5465121|NCT01440387|Influenza|influenza
5465122|NCT01440387|Phase III|phase iii
5465123|NCT01440387|Seasonal influenza|seasonal influenza
5465124|NCT01440374|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5465125|NCT01440374|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5465126|NCT01440374|acute non lymphocytic leukemia (ANLL)|acute non lymphocytic leukemia (anll)
5465127|NCT01440374|myeloproliferative disease (MDS)|myeloproliferative disease (mds)
5465128|NCT01440374|myelodysplastic syndrome ( secondary acute myeloid leukemia)|myelodysplastic syndrome ( secondary acute myeloid leukemia)
5465129|NCT01440374|refractory acute myeloid leukemia|refractory acute myeloid leukemia
5465130|NCT01440348|Achilles allograft|achilles allograft
5465131|NCT01440348|cruciate ligament|cruciate ligament
5465132|NCT01440348|reconstruction|reconstruction
5465133|NCT01440335|Fenoterol|fenoterol
5465134|NCT01440335|Pharmacodynamics|pharmacodynamics
5465135|NCT01440335|Pharmacokinetics|pharmacokinetics
5465136|NCT01440335|Safety|safety
5465137|NCT01440335|Beta Adrenergic Agonist|beta adrenergic agonist
5465138|NCT01440322|Myopia|myopia
5465139|NCT01440322|Contact lenses|contact lenses
5465140|NCT01440309|biliary cirrhosis|biliary cirrhosis
5465141|NCT01440283|Neuroblastoma|neuroblastoma
5465142|NCT01440283|Radiation Therapy|radiation therapy
5465143|NCT01440270|Oral cancer|oral cancer
5465144|NCT01440270|Oropharyngeal cancer|oropharyngeal cancer
5465145|NCT01440270|Induction chemotherapy|induction chemotherapy
5465146|NCT01440270|Targeted chemotherapy|targeted chemotherapy
5465147|NCT01440270|Surgery|surgery
5465148|NCT01440270|Radiotherapy|radiotherapy
5465149|NCT01440270|Effects of Chemotherapy|effects of chemotherapy
5465150|NCT01440244|mediastinoscopy|mediastinoscopy
5465151|NCT01440244|pleural evaluation|pleural evaluation
5465152|NCT01440244|pleural biopsy|pleural biopsy
5465153|NCT01440244|pleurodesis|pleurodesis
5465154|NCT01440231|Rheumatology|rheumatology
5465155|NCT01440231|Double-Blind|double-blind
5465156|NCT01440231|Placebo-Controlled|placebo-controlled
5465157|NCT01440231|Multidose|multidose
5465158|NCT01440231|Dose-Response|dose-response
5465159|NCT01440231|Phase II|phase ii
5465160|NCT01440231|Systemic Lupus Erythematosus|systemic lupus erythematosus
5465162|NCT01440231|Atacicept|atacicept
5465163|NCT01440218|Idiopathic diseases|idiopathic diseases
5465164|NCT01440218|family member of the affected individual|family member of the affected individual
5465165|NCT01440218|unknown etiology|unknown etiology
5465166|NCT01440205|Flu Shot|flu shot
5465167|NCT01440192|Sarcoidosis|sarcoidosis
5465168|NCT01440192|Stem cells|stem cells
5465169|NCT01440192|PDA001|pda001
5465170|NCT01440192|Celgene|celgene
5465171|NCT01440192|Human Placenta-Derived cells|human placenta-derived cells
5465172|NCT01440192|Cenplacel-L|cenplacel-l
5465173|NCT01440166|Human healthy volunteers|human healthy volunteers
5465174|NCT01440153|Dance|dance
5465175|NCT01440153|Injury|injury
5465176|NCT01440153|Physical condition|physical condition
5465177|NCT01440153|Exercise|exercise
5465178|NCT01440114|emergence agitation|emergence agitation
5465179|NCT01440114|pediatric patient|pediatric patient
5465180|NCT01440114|fentanyl|fentanyl
5465181|NCT01440114|incidence of emergence agitation|incidence of emergence agitation
5465182|NCT01440114|severity of emergence agitation|severity of emergence agitation
5465183|NCT01440114|adverse outcome from intervention|adverse outcome from intervention
5465184|NCT01440088|TH-302|th-302
5465185|NCT01440088|TH-CR-406|th-cr-406
5465186|NCT01440088|SARC021|sarc021
5465187|NCT01440088|Locally Advanced Soft Tissue Sarcoma|locally advanced soft tissue sarcoma
5465188|NCT01440088|Metastatic Soft Tissue Sarcoma|metastatic soft tissue sarcoma
5465189|NCT01440088|Sarcoma|sarcoma
5465190|NCT01440088|Doxorubicin|doxorubicin
5465191|NCT01440088|Evofosfamide|evofosfamide
5465192|NCT01440075|Kawasaki disease|kawasaki disease
5465193|NCT01440049|patients with MI- on top of treatment add Eplerenone - assess LVEF and BP|patients with mi- on top of treatment add eplerenone - assess lvef and bp
5465194|NCT01440036|carotid artery|carotid artery
5465195|NCT01440036|Atherosclerotic plaque|atherosclerotic plaque
5465196|NCT01440036|paraoxygenase 1 PON1|paraoxygenase 1 pon1
5465197|NCT01440036|Patients undergoing carotid artery endarterectomy CEA for carotid artery stenosis|patients undergoing carotid artery endarterectomy cea for carotid artery stenosis
5465198|NCT01440023|tic disorder|tic disorder
5465199|NCT01440023|tourette syndrome|tourette syndrome
5465200|NCT01440023|habit reversal|habit reversal
5465201|NCT01440023|response inhibition|response inhibition
5465202|NCT01440023|cognitive retraining|cognitive retraining
5465203|NCT01440010|IORT|iort
5465204|NCT01440010|Boost|boost
5465205|NCT01440010|Breast cancer|breast cancer
5465206|NCT01440010|Local recurrence|local recurrence
5465207|NCT01440010|Toxicity|toxicity
5465208|NCT01440010|LENT SOMA|lent soma
5465209|NCT01440010|TARGIT|targit
5465210|NCT01440010|Quality Control Registry|quality control registry
5465211|NCT01439997|Nocturnal polyuria|nocturnal polyuria
5465212|NCT01439984|PE|pe
5465213|NCT01439984|IELT|ielt
5465214|NCT01439984|DCIT|dcit
5465215|NCT01439971|Phase 1|phase 1
5465216|NCT01439971|Safety|safety
5465217|NCT01439971|Pharmacokinetic|pharmacokinetic
5465218|NCT01439971|Pharmacodynamic|pharmacodynamic
5465219|NCT01439958|Inhalation|inhalation
5465220|NCT01439958|Lung Transplantation|lung transplantation
5465221|NCT01439958|Cyclosporine|cyclosporine
5465222|NCT01439945|hot flashes|hot flashes
5465223|NCT01439945|cancer survivor|cancer survivor
5465224|NCT01439945|breast cancer|breast cancer
5465225|NCT01439932|plantar fasciitis|plantar fasciitis
5465226|NCT01439932|heel pain|heel pain
5465227|NCT01439932|manual treatment|manual treatment
5465228|NCT01439932|dorsi flexion|dorsi flexion
5465229|NCT01439906|Degenerative scoliosis|degenerative scoliosis
5465230|NCT01439906|Pain|pain
5465231|NCT01439906|Deformity correction|deformity correction
5465232|NCT01439906|Instrumented arthrodesis|instrumented arthrodesis
5465233|NCT01439893|Chronic heart failure|chronic heart failure
5465234|NCT01439893|rhNRG-1|rhnrg-1
5465235|NCT01439893|Cardiac remodeling|cardiac remodeling
5465236|NCT01439880|High cholesterol|high cholesterol
5465237|NCT01439880|Raised cholesterol|raised cholesterol
5465238|NCT01439880|Cholesterol|cholesterol
5465239|NCT01439880|Elevated Cholesterol|elevated cholesterol
5465240|NCT01439867|Dialysis|dialysis
5465241|NCT01439867|Sensipar|sensipar
5465242|NCT01439867|Mimpara|mimpara
5465243|NCT01439867|Hemodialysis|hemodialysis
5465244|NCT01439867|Peritoneal Dialysis|peritoneal dialysis
5465245|NCT01439867|Renal|renal
5465246|NCT01439867|Parathyroid hormone|parathyroid hormone
5465247|NCT01439867|Pediatric|pediatric
5465248|NCT01439854|Insulin sensitivity|insulin sensitivity
5465249|NCT01439854|Mitochondrial function|mitochondrial function
5465250|NCT01439854|Glucose toxicity|glucose toxicity
5465251|NCT01439854|Glucosuria|glucosuria
5465252|NCT01439841|HIV|hiv
5465253|NCT01439841|microbial translocation|microbial translocation
5465254|NCT01439841|immune activation|immune activation
5465255|NCT01439841|probiotics|probiotics
5465256|NCT01439828|Cannabis|cannabis
5465257|NCT01439828|N-Acetylcystein|n-acetylcystein
5465258|NCT01439828|Dependence|dependence
5465259|NCT01439828|Abuse|abuse
5465260|NCT01439828|Craving|craving
5465261|NCT01439828|Genetic|genetic
5465262|NCT01439802|Postpartum IUD|postpartum iud
5465263|NCT01439802|Cesarean Delivery|cesarean delivery
5465264|NCT01439802|6 months postpartum|6 months postpartum
5465265|NCT01439802|satisfaction|satisfaction
5465269|NCT01439776|chronic hepatitis C|chronic hepatitis c
5465271|NCT01439776|Vit D|vit d
5465272|NCT01439776|Peginterferon alfa 2a|peginterferon alfa 2a
5465273|NCT01439776|Ribavirin|ribavirin
5465274|NCT01439763|Bullies|bullies
5465275|NCT01439763|Bully victims|bully victims
5465276|NCT01439763|Psychiatric symptoms|psychiatric symptoms
5465277|NCT01439750|mantle cell lymphoma|mantle cell lymphoma
5465278|NCT01439750|lymphoma|lymphoma
5465279|NCT01439737|Asthma|asthma
5465280|NCT01439737|metabolomics|metabolomics
5465281|NCT01439737|exhaled breath condensate|exhaled breath condensate
5465282|NCT01439724|Oral mucositis|oral mucositis
5465388|NCT01439347|ALL|all
5465283|NCT01439724|Low Level Laser Therapy|low level laser therapy
5465284|NCT01439724|Head and neck cancer|head and neck cancer
5465285|NCT01439711|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5465286|NCT01439711|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5465287|NCT01439698|Cholangiocarcinoma|cholangiocarcinoma
5465288|NCT01439698|Pancreatic Cancer|pancreatic cancer
5465289|NCT01439698|Bile Duct Cancer|bile duct cancer
5465290|NCT01439698|Biliary Stricture|biliary stricture
5465291|NCT01439698|Bile duct obstruction|bile duct obstruction
5465292|NCT01439698|ENDOHPB|endohpb
5465293|NCT01439698|Radio Frequency Ablation|radio frequency ablation
5465294|NCT01439698|RFA|rfa
5465295|NCT01439698|ERCP|ercp
5465296|NCT01439698|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5465297|NCT01439698|Registry|registry
5465298|NCT01439698|Multicenter|multicenter
5465299|NCT01439685|Cholangiocarcinoma|cholangiocarcinoma
5465300|NCT01439685|PDT|pdt
5465301|NCT01439685|Photodynamic Therapy|photodynamic therapy
5465302|NCT01439685|Bile Duct|bile duct
5465303|NCT01439685|Bile Duct Obstruction|bile duct obstruction
5465304|NCT01439685|Jaundice|jaundice
5465305|NCT01439685|Biliary Stent|biliary stent
5465306|NCT01439685|ERCP|ercp
5465307|NCT01439685|Obstructive Jaundice|obstructive jaundice
5465308|NCT01439672|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5465309|NCT01439659|Ovarian Cancer|ovarian cancer
5465310|NCT01439659|Epithelial ovarian cancer|epithelial ovarian cancer
5465311|NCT01439659|First clinical remission|first clinical remission
5465312|NCT01439659|Nutritional Supplements|nutritional supplements
5465313|NCT01439659|Juice Plus +|juice plus +
5465314|NCT01439659|Juice Plus + Complete|juice plus + complete
5465315|NCT01439659|Dietary counseling|dietary counseling
5465316|NCT01439646|empirical|empirical
5465317|NCT01439646|ICU|icu
5465318|NCT01439646|high risk patient|high risk patient
5465319|NCT01439633|Barrett's Esophagus|barrett's esophagus
5465320|NCT01439633|Esophagus|esophagus
5465321|NCT01439633|OCT|oct
5465322|NCT01439633|Imaging|imaging
5465323|NCT01439620|Biliary Stricture|biliary stricture
5465324|NCT01439620|OCT|oct
5465325|NCT01439620|Imaging|imaging
5465326|NCT01439607|Gaucher disease|gaucher disease
5465327|NCT01439594|Barrett's Esophagus|barrett's esophagus
5465328|NCT01439594|Esophagus|esophagus
5465329|NCT01439594|OCT|oct
5465330|NCT01439594|Imaging|imaging
5465331|NCT01439594|Radiofrequency Ablation|radiofrequency ablation
5465332|NCT01439594|BARRX|barrx
5465333|NCT01439581|patients|patients
5465334|NCT01439581|susceptible to|susceptible to
5465335|NCT01439581|hospital|hospital
5465336|NCT01439581|acquired pressure|acquired pressure
5465337|NCT01439568|Cancer|cancer
5465338|NCT01439568|Lung|lung
5465339|NCT01439568|Metastasis|metastasis
5465340|NCT01439555|Early Alzheimer|early alzheimer
5465341|NCT01439555|Mild Cognitive Impairment|mild cognitive impairment
5465342|NCT01439555|Drug treatment|drug treatment
5450143|NCT01502189|parents|parents
5465343|NCT01439555|Cerebral blood flow|cerebral blood flow
5465344|NCT01439555|Endothelial facilitation|endothelial facilitation
5465345|NCT01439555|Cognitive improvement|cognitive improvement
5465346|NCT01439542|High risk prostate cancer|high risk prostate cancer
5465347|NCT01439529|Cardiac|cardiac
5465348|NCT01439529|Resynchronization|resynchronization
5465349|NCT01439529|Therapy|therapy
5465350|NCT01439477|exercise|exercise
5465351|NCT01439477|healthy eating|healthy eating
5465352|NCT01439477|heart disease|heart disease
5465353|NCT01439477|prevention & control|prevention & control
5465354|NCT01439477|Middle aged|middle aged
5465355|NCT01439477|Women|women
5465356|NCT01439477|Health promotion|health promotion
5465357|NCT01439451|Balance control|balance control
5465358|NCT01439451|Aging|aging
5465359|NCT01439451|Balance reactions|balance reactions
5465360|NCT01439451|Perturbation|perturbation
5465361|NCT01439451|above seventy years old|above seventy years old
5465362|NCT01439425|psoriasis|psoriasis
5465363|NCT01439425|obesity|obesity
5465364|NCT01439425|body mass index|body mass index
5465365|NCT01439425|disease remission|disease remission
5465366|NCT01439425|diet|diet
5465367|NCT01439412|Low back pain|low back pain
5465369|NCT01439412|General practice|general practice
5465370|NCT01439399|postoperative pain|postoperative pain
5465371|NCT01439399|postoperative care|postoperative care
5465372|NCT01439399|intravenous lidocaine|intravenous lidocaine
5465373|NCT01439399|intravenous ketamine|intravenous ketamine
5465374|NCT01439399|morphine consumption|morphine consumption
5465375|NCT01439373|chronic hepatitis C|chronic hepatitis c
5465376|NCT01439373|NS5A inhibitor|ns5a inhibitor
5465377|NCT01439373|ribavirin|ribavirin
5465378|NCT01439373|pegylated interferon|pegylated interferon
5465379|NCT01439373|GSK2336805|gsk2336805
5465380|NCT01439360|Vaccine|vaccine
5465381|NCT01439360|Seasonal Flu|seasonal flu
5465382|NCT01439360|Efficacy|efficacy
5465383|NCT01439360|Children|children
5465384|NCT01439347|Marqibo|marqibo
5465385|NCT01439347|HALLMARQ|hallmarq
5465386|NCT01439347|leukemia|leukemia
5465387|NCT01439347|front-line|front-line
5465389|NCT01439347|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5465390|NCT01439334|Brief|brief
5465391|NCT01439334|Online|online
5465392|NCT01439334|Image|image
5465393|NCT01439334|Interactive|interactive
5465394|NCT01439334|Young Adult|young adult
5465395|NCT01439334|Primary Care|primary care
5465396|NCT01439321|treatment satisfaction|treatment satisfaction
5465397|NCT01439321|romiplostim|romiplostim
5465398|NCT01439321|eltrombopag|eltrombopag
5465399|NCT01439321|chronic immune thrombocytopenic pupura|chronic immune thrombocytopenic pupura
5465401|NCT01439308|Capsaicin challenge|capsaicin challenge
5465402|NCT01439295|Ascorbyl peroxide|ascorbyl peroxide
5465403|NCT01439295|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5465404|NCT01439295|Redox status|redox status
5465405|NCT01439295|Necrotising entercolitis|necrotising entercolitis
5465406|NCT01439295|Retinopathy of prematurity|retinopathy of prematurity
5465407|NCT01439295|Patent ductus arteriosus|patent ductus arteriosus
5465408|NCT01439295|Intraventricular hemorrhage|intraventricular hemorrhage
5465409|NCT01439295|Periventricular leucomalacia|periventricular leucomalacia
5465412|NCT01439269|Family Nurture|family nurture
5465413|NCT01439269|Maternal Confidence|maternal confidence
5465414|NCT01439269|Maternal Competence|maternal competence
5465415|NCT01439269|Calming Cycle|calming cycle
5465416|NCT01439269|Kangaroo Care|kangaroo care
5465417|NCT01439269|Infant Neurodevelopment|infant neurodevelopment
5465418|NCT01439269|Infant Psychological Development|infant psychological development
5465419|NCT01439269|Post-partum depression|post-partum depression
5465420|NCT01439269|Mother-infant Co-regulation|mother-infant co-regulation
5465421|NCT01439243|Bioequivalence|bioequivalence
5465422|NCT01439243|Healthy Subjects|healthy subjects
5465423|NCT01439243|Donepezil|donepezil
5465424|NCT01439230|Bioequivalence|bioequivalence
5465425|NCT01439230|Healthy Subjects|healthy subjects
5465426|NCT01439230|Donepezil|donepezil
5465427|NCT01439217|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5465428|NCT01439217|Survivor|survivor
5465429|NCT01439217|Sibling control|sibling control
5465430|NCT01439191|HER2-Overexpressed|her2-overexpressed
5465431|NCT01439165|Adacel vaccine|adacel vaccine
5465433|NCT01439165|Diphtheria|diphtheria
5465434|NCT01439165|whooping cough|whooping cough
5465435|NCT01439152|Oncology|oncology
5465436|NCT01439152|Solid tumors|solid tumors
5465437|NCT01439152|Antibody drug conjugate (ADC)|antibody drug conjugate (adc)
5465438|NCT01439152|Treatment Emergent Adverse Events|treatment emergent adverse events
5465439|NCT01439152|Mesothelin|mesothelin
5465440|NCT01439139|Osteoporosis|osteoporosis
5465441|NCT01439139|ultrasound|ultrasound
5465442|NCT01439139|sonometer|sonometer
5465444|NCT01439126|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5465445|NCT01439113|Ultrasound, Difficult access|ultrasound, difficult access
5465446|NCT01439100|Parkinson's disease|parkinson's disease
5465447|NCT01439100|severe pain|severe pain
5465448|NCT01439100|OXN PR|oxn pr
5465449|NCT01439100|randomised|randomised
5465450|NCT01439087|Colonic Polyps|colonic polyps
5465451|NCT01439087|OCT|oct
5465452|NCT01439087|Imaging|imaging
5465453|NCT01439087|Colon|colon
5465454|NCT01439087|Polyp|polyp
5465455|NCT01439074|Burn injuries|burn injuries
5465456|NCT01439074|Mepilex Ag|mepilex ag
5465457|NCT01439074|SSD Ag|ssd ag
5465458|NCT01439074|Partial thickness|partial thickness
5465459|NCT01439061|Growth disorders|growth disorders
5465460|NCT01439061|Saizen|saizen
5465461|NCT01439061|Easypod|easypod
5465462|NCT01439061|Growth hormone|growth hormone
5465463|NCT01439061|Pediatric subject|pediatric subject
5465464|NCT01439048|Placenta|placenta
5465465|NCT01439048|Cord Blood|cord blood
5465466|NCT01439048|PAH|pah
5465467|NCT01439048|Environmental Markers|environmental markers
5465468|NCT01439048|Toll-Like Receptors|toll-like receptors
5465469|NCT01439035|Celiac Disease|celiac disease
5465470|NCT01439035|Duodenal|duodenal
5465471|NCT01439035|OCT|oct
5465472|NCT01439035|Imaging|imaging
5465478|NCT01439009|Volume overload|volume overload
5465479|NCT01439009|Tolvaptan|tolvaptan
5465480|NCT01439009|loop diuretics|loop diuretics
5465481|NCT01438996|Typhoid fever|typhoid fever
5465482|NCT01438996|Glycoconjugate vaccine|glycoconjugate vaccine
5465483|NCT01438996|Vi polysaccharide|vi polysaccharide
5465484|NCT01438996|Immunogenicity|immunogenicity
5465485|NCT01438957|Dexmedetomidine|dexmedetomidine
5465486|NCT01438957|Sedation|sedation
5465487|NCT01438957|Non-intubation|non-intubation
5465488|NCT01438957|epidural anesthesia|epidural anesthesia
5465489|NCT01438957|spinal anesthesia|spinal anesthesia
5465490|NCT01438944|NRT|nrt
5465491|NCT01438944|Patch|patch
5465492|NCT01438944|smoking|smoking
5465493|NCT01438944|addiction|addiction
5465494|NCT01438931|Dexmedetomidine|dexmedetomidine
5465495|NCT01438931|Sedation|sedation
5465496|NCT01438931|Non-intubation|non-intubation
5465497|NCT01438931|local anesthesia|local anesthesia
5465498|NCT01438918|Knee|knee
5465499|NCT01438918|Osteoarthritis|osteoarthritis
5465500|NCT01438918|X-ray|x-ray
5465501|NCT01438918|Joint Space Narrowing|joint space narrowing
5465502|NCT01438905|Ankle Sprain|ankle sprain
5465503|NCT01438905|Chronic Ankle Instability|chronic ankle instability
5465504|NCT01438905|Ankle Mobilization|ankle mobilization
5465505|NCT01438905|Talocrural Joint Mobilization|talocrural joint mobilization
5465506|NCT01438905|Cortical Muscle Activation|cortical muscle activation
5465507|NCT01438905|Spinal Muscle Activation|spinal muscle activation
5465508|NCT01438892|rheumatoid arthritis|rheumatoid arthritis
5465509|NCT01438892|therapy compliance|therapy compliance
5465510|NCT01438879|CSF|csf
5465511|NCT01438879|PCR|pcr
5465512|NCT01438879|lymphocytic herpesvirus|lymphocytic herpesvirus
5465513|NCT01438879|CNS|cns
5465514|NCT01438866|Dental caries|dental caries
5465515|NCT01438866|Fissure sealant|fissure sealant
5465516|NCT01438866|Fluoride varnish|fluoride varnish
5465517|NCT01438866|Primary molar|primary molar
5465518|NCT01438853|Sepsis|sepsis
5465519|NCT01438853|Acute Lung Injury|acute lung injury
5465520|NCT01438853|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5465521|NCT01438853|ALI/ARDS|ali/ards
5465522|NCT01438853|Lung Disease|lung disease
5465523|NCT01438840|Chronic Immune Thrombocytopenia|chronic immune thrombocytopenia
5465524|NCT01438788|Bethlem myopathy|bethlem myopathy
5465525|NCT01438788|Ullrich congenital muscular dystrophy|ullrich congenital muscular dystrophy
5465526|NCT01438788|Low protein diet|low protein diet
5465527|NCT01438788|Autophagy|autophagy
5465528|NCT01438788|Pilot clinical trial|pilot clinical trial
5465529|NCT01438775|Benign prostatic hyperplasia|benign prostatic hyperplasia
5465531|NCT01438775|Enlarged prostate|enlarged prostate
5465532|NCT01438775|Lower urinary tract symptoms|lower urinary tract symptoms
5465533|NCT01438775|LUTS|luts
5465534|NCT01438775|LUTS secondary to BPH|luts secondary to bph
5465535|NCT01438775|LUTS/BPH|luts/bph
5465536|NCT01438775|Benign prostatic obstruction|benign prostatic obstruction
5465537|NCT01438775|BPO|bpo
5465538|NCT01438775|Bladder outlet obstruction|bladder outlet obstruction
5465539|NCT01438775|BOO|boo
5465540|NCT01438762|Anterior Knee Pain|anterior knee pain
5465541|NCT01438736|Focus:|focus:
5465542|NCT01438736|preceding|preceding
5465543|NCT01438736|desogestrel predicts|desogestrel predicts
5465544|NCT01438736|pattern of following|pattern of following
5465545|NCT01438736|etonogestrel implant|etonogestrel implant
5465546|NCT01438723|ischemia reperfusion injury|ischemia reperfusion injury
5465547|NCT01438723|CABG|cabg
5465548|NCT01438723|metformin|metformin
5465549|NCT01438723|Hs-troponin-I|hs-troponin-i
5465550|NCT01438697|sleep|sleep
5465551|NCT01438697|insomnia|insomnia
5465552|NCT01438697|internet|internet
5465553|NCT01438697|CBT|cbt
5465554|NCT01438684|chronic vegetative state|chronic vegetative state
5465555|NCT01438684|functional MRI|functional mri
5465556|NCT01438671|WiiFit|wiifit
5465557|NCT01438671|Standing Balance|standing balance
5465558|NCT01438671|Neurological Population|neurological population
5465559|NCT01438658|uveal melanoma|uveal melanoma
5465560|NCT01438658|metastatic uveal melanoma|metastatic uveal melanoma
5465561|NCT01438645|Colonoscopy|colonoscopy
5465562|NCT01438645|Colon cancer screening|colon cancer screening
5465563|NCT01438632|Insulin action|insulin action
5465564|NCT01438632|Jet injector|jet injector
5465565|NCT01438632|Diabetes Mellitus|diabetes mellitus
5465566|NCT01438632|Pharmacodynamics|pharmacodynamics
5465567|NCT01438632|Pharmacokinetics|pharmacokinetics
5465568|NCT01438632|Insulin analogs|insulin analogs
5465569|NCT01438632|Insulin aspart|insulin aspart
5465570|NCT01438619|sodium|sodium
5468663|NCT01426256|immunity|immunity
5465571|NCT01438619|blood pressure|blood pressure
5465572|NCT01438619|pulse wave velocity|pulse wave velocity
5465573|NCT01438619|random digit dialling|random digit dialling
5465574|NCT01438593|Stroke|stroke
5465575|NCT01438593|Brain disease|brain disease
5465576|NCT01438593|Ischemia|ischemia
5465577|NCT01438593|Cerebral infraction|cerebral infraction
5465578|NCT01438593|Cord Blood|cord blood
5465579|NCT01438580|atrial ﬁbrillation|atrial ﬁbrillation
5465580|NCT01438580|stroke|stroke
5465581|NCT01438580|warfarin|warfarin
5465582|NCT01438580|aspirin|aspirin
5465583|NCT01438567|oxycodone naloxone combination|oxycodone naloxone combination
5465584|NCT01438567|severe chronic and non-malignant pain|severe chronic and non-malignant pain
5465585|NCT01438567|Malignant and non-malignant pain that requires around-the clock opioid therapy|malignant and non-malignant pain that requires around-the clock opioid therapy
5465586|NCT01438567|Opioid related constipation|opioid related constipation
5465587|NCT01438541|No skin breakdown|no skin breakdown
5465588|NCT01438541|Prevention|prevention
5465589|NCT01438541|protection of the skin|protection of the skin
5465590|NCT01438528|Growth disorders|growth disorders
5465591|NCT01438528|Saizen|saizen
5465592|NCT01438528|Easypod|easypod
5465593|NCT01438528|Growth hormone|growth hormone
5465611|NCT01438476|Intravenous patient-controlled analgesia|intravenous patient-controlled analgesia
5465612|NCT01438476|IVPCA|ivpca
5465613|NCT01438476|Pain control|pain control
5465614|NCT01438476|Quality of life|quality of life
5465615|NCT01438476|QOL|qol
5465616|NCT01438476|Surgical resection|surgical resection
5465617|NCT01438463|non-seasonal allergy|non-seasonal allergy
5465618|NCT01438463|house dust mite|house dust mite
5465619|NCT01438463|immunotherapy|immunotherapy
5465620|NCT01438463|dose response|dose response
5465621|NCT01438450|Thalidomide|thalidomide
5465622|NCT01438450|Capecitabine|capecitabine
5465623|NCT01438450|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5465624|NCT01438450|Therapy|therapy
5465625|NCT01438450|Supportive care|supportive care
5465626|NCT01438437|Hepatocellular carcinoma|hepatocellular carcinoma
5465627|NCT01438437|Radiofrequency ablation|radiofrequency ablation
5465628|NCT01438437|Percutaneous acetic acid ablation|percutaneous acetic acid ablation
5465629|NCT01438437|Tumour response|tumour response
5465630|NCT01438411|Cholic Acid|cholic acid
5465631|NCT01438411|Inborn Error|inborn error
5465632|NCT01438411|Bile Acid Metabolism|bile acid metabolism
5465633|NCT01438411|Inborn Error of Bile Acid Synthesis|inborn error of bile acid synthesis
5465634|NCT01438398|Submucosal endoscopic myotomy|submucosal endoscopic myotomy
5465635|NCT01438398|Per Oral Endoscopic Myotomy|per oral endoscopic myotomy
5465636|NCT01438398|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5465637|NCT01438385|Pancreatico-biliary|pancreatico-biliary
5465639|NCT01438385|Bile Duct|bile duct
5465640|NCT01438385|Gastrointestinal disorder|gastrointestinal disorder
5465641|NCT01438385|Esophageal disorder|esophageal disorder
5465642|NCT01438372|Iron Deficiency Anemia|iron deficiency anemia
5465643|NCT01438372|Inflammatory Bowel Disease|inflammatory bowel disease
5465644|NCT01438372|Children|children
5465645|NCT01438359|Drug-drug interaction|drug-drug interaction
5465646|NCT01438359|Pharmacokinetics|pharmacokinetics
5465648|NCT01438359|Drug Interaction Potentiation|drug interaction potentiation
5465649|NCT01438346|Substance Abuse|substance abuse
5465650|NCT01438346|Substance Addiction|substance addiction
5465651|NCT01438346|Substance Dependence|substance dependence
5448028|NCT01511081|NSCLC|nsclc
5465652|NCT01438346|Treatment program|treatment program
5465653|NCT01438333|Chronic Peridodontitis|chronic peridodontitis
5465654|NCT01438333|probiotics|probiotics
5465655|NCT01438333|lactobacillus brevis|lactobacillus brevis
5465656|NCT01438333|full mouth disinfection|full mouth disinfection
5465657|NCT01438320|Treatment naive|treatment naive
5465658|NCT01438320|Contraindications to standard therapies|contraindications to standard therapies
5465659|NCT01438320|Alternative hepatitis C therapy|alternative hepatitis c therapy
5465660|NCT01438307|Non-small cell lung cancer|non-small cell lung cancer
5465661|NCT01438307|Cabazitaxel-XRP6258|cabazitaxel-xrp6258
5465662|NCT01438307|P-glycoprotein|p-glycoprotein
5465663|NCT01438307|taxane|taxane
5465664|NCT01438307|Advanced NSCLC|advanced nsclc
5465665|NCT01438294|Asthma|asthma
5465666|NCT01438294|childhood|childhood
5465667|NCT01438294|exercise|exercise
5465668|NCT01438281|ocular pain|ocular pain
5465669|NCT01438281|dry eye|dry eye
5465670|NCT01438281|siRNA|sirna
5465671|NCT01438242|Major|major
5465672|NCT01438242|Depressive|depressive
5465673|NCT01438242|Disorder|disorder
5465674|NCT01438242|Depression|depression
5465675|NCT01438242|Treatment Resistant|treatment resistant
5465676|NCT01438229|Catheter-based renal artery ablation|catheter-based renal artery ablation
5465677|NCT01438229|Hypertension|hypertension
5465678|NCT01438229|Resistant to Conventional Therapy|resistant to conventional therapy
5465679|NCT01438216|Pharmacokinetics|pharmacokinetics
5465680|NCT01438216|Intensive Care|intensive care
5465681|NCT01438216|Candidemia|candidemia
5465682|NCT01438216|Invasive candidiasis|invasive candidiasis
5465683|NCT01438216|Anidulafungin|anidulafungin
5465684|NCT01438203|manipulation|manipulation
5465685|NCT01438203|mobilization|mobilization
5465686|NCT01438203|low back pain|low back pain
5465692|NCT01438164|FDG-PET|fdg-pet
5465693|NCT01438164|cancer|cancer
5465694|NCT01438164|staging|staging
5465695|NCT01438164|Evaluate the cost impact in the evaluation of oncologic patients.|evaluate the cost impact in the evaluation of oncologic patients.
5465696|NCT01438151|Crohn's disease|crohn's disease
5465697|NCT01438151|Remicade|remicade
5465698|NCT01438151|infliximab|infliximab
5465699|NCT01438138|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5465700|NCT01438138|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5465701|NCT01438138|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5465702|NCT01438138|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5465703|NCT01438138|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5465704|NCT01438138|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5465705|NCT01438138|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5465706|NCT01438138|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5465707|NCT01438138|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5465708|NCT01438138|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5465709|NCT01438138|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5465710|NCT01438138|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5465711|NCT01438138|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5465712|NCT01438112|cancer|cancer
5465713|NCT01438112|bladder cancer|bladder cancer
5465714|NCT01438112|transitional cell|transitional cell
5465715|NCT01438112|virus|virus
5465716|NCT01438112|oncolytic|oncolytic
5465717|NCT01438112|GM-CSF|gm-csf
5465718|NCT01438112|adenovirus|adenovirus
5465719|NCT01438112|intravesical|intravesical
5465720|NCT01438112|neoadjuvant|neoadjuvant
5465721|NCT01438112|cystectomy|cystectomy
5465722|NCT01438112|gene therapy|gene therapy
5465723|NCT01438112|oncolytic virus|oncolytic virus
5465724|NCT01438112|carcinoma in situ|carcinoma in situ
5465725|NCT01438112|carcinoma in situ concurrent with papillary tumors|carcinoma in situ concurrent with papillary tumors
5465726|NCT01438099|epidural analgesia|epidural analgesia
5465727|NCT01438099|ultrasound|ultrasound
5465728|NCT01438099|labor analgesia|labor analgesia
5465729|NCT01438099|labor|labor
5465730|NCT01438086|Heart Failure|heart failure
5465731|NCT01438086|Myocardial Infarction|myocardial infarction
5465732|NCT01438047|Port Wine Stain|port wine stain
5465733|NCT01438021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5465734|NCT01438008|Sucrose|sucrose
5465735|NCT01438008|Pain|pain
5465736|NCT01437995|Asthma|asthma
5465737|NCT01437995|Step down therapy|step down therapy
5465738|NCT01437995|Inhaled corticosteroids|inhaled corticosteroids
5465739|NCT01437995|Long-acting beta agonists|long-acting beta agonists
5465740|NCT01437995|Fluticasone Salmeterol|fluticasone salmeterol
5465741|NCT01437982|post-operative inflammation|post-operative inflammation
5465742|NCT01437982|conjunctivitis|conjunctivitis
5437424|NCT01556035|hematology|hematology
5452360|NCT01492595|contact|contact
5465743|NCT01437982|safety|safety
5465744|NCT01437982|Seasonal allergic conjunctivitis|seasonal allergic conjunctivitis
5465745|NCT01437982|Giant papillary conjunctivitis|giant papillary conjunctivitis
5465746|NCT01437969|Possible association|possible association
5465747|NCT01437969|between severity|between severity
5465748|NCT01437969|IL28B genetic variants|il28b genetic variants
5465749|NCT01437969|patients|patients
5465750|NCT01437969|different HCV genotypes|different hcv genotypes
5465751|NCT01437956|Calcineurin|calcineurin
5465752|NCT01437956|Bronchiolitis|bronchiolitis
5465753|NCT01437956|Epithelial lung injury|epithelial lung injury
5465754|NCT01437956|Rhinovirus|rhinovirus
5465755|NCT01437956|Respiratory Syncytial Virus|respiratory syncytial virus
5465756|NCT01437956|Asthma|asthma
5465757|NCT01437943|Transplant|transplant
5465758|NCT01437943|Failure|failure
5465759|NCT01437943|Kidney|kidney
5465760|NCT01437930|n-3 LC-PUFA|n-3 lc-pufa
5465761|NCT01437930|hypertriglyceridemic|hypertriglyceridemic
5465764|NCT01437917|glycemic index|glycemic index
5465765|NCT01437904|Renal Calculi|renal calculi
5465766|NCT01437904|Percutaneous nephrolithotomy (PCNL)|percutaneous nephrolithotomy (pcnl)
5465767|NCT01437891|PTSD|ptsd
5465768|NCT01437891|Military veteran|military veteran
5465769|NCT01437891|Gulf War|gulf war
5465770|NCT01437891|Fibromyalgia|fibromyalgia
5465771|NCT01437891|Gulf War Syndrome|gulf war syndrome
5465772|NCT01437878|PH|ph
5465773|NCT01437878|COPD|copd
5465774|NCT01437865|MRI|mri
5465775|NCT01437865|lymph node metastases|lymph node metastases
5465776|NCT01437865|breast cancer|breast cancer
5465777|NCT01437865|gadofosveset|gadofosveset
5465778|NCT01437839|Food effect study|food effect study
5465779|NCT01437839|Pharmacokinetics|pharmacokinetics
5465780|NCT01437839|Apixaban|apixaban
5465781|NCT01437826|chemoprevention|chemoprevention
5465782|NCT01437826|colorectal cancer|colorectal cancer
5465783|NCT01437826|metachronous adenoma|metachronous adenoma
5465784|NCT01437826|randomized trial|randomized trial
5465790|NCT01437800|metformin extended release|metformin extended release
5465791|NCT01437774|Acute ischemic stroke|acute ischemic stroke
5465792|NCT01437748|Small Airways|small airways
5465793|NCT01437748|Closing volume|closing volume
5465794|NCT01437748|Closing Capacity|closing capacity
5465795|NCT01437748|Tiotropium|tiotropium
5465796|NCT01437748|Indacaterol|indacaterol
5465797|NCT01437748|COPD|copd
5465798|NCT01437735|Asthma|asthma
5465799|NCT01437735|QAW039|qaw039
5465800|NCT01437722|BV|bv
5465801|NCT01437722|Bacterial vaginosis|bacterial vaginosis
5465802|NCT01437722|recurrent|recurrent
5465803|NCT01437722|SPL7013 Gel|spl7013 gel
5465804|NCT01437722|VivaGel|vivagel
5465805|NCT01437709|Bendamustine HCL|bendamustine hcl
5465806|NCT01437709|Ofatumumab (GSK 1841157)|ofatumumab (gsk 1841157)
5465807|NCT01437709|Immunotherapy|immunotherapy
5465808|NCT01437709|Chemoimmunotherapy|chemoimmunotherapy
5465809|NCT01437709|11-050|11-050
5465810|NCT01437696|Aging|aging
5465811|NCT01437696|Vitamin D|vitamin d
5465812|NCT01437696|Bone health|bone health
5465813|NCT01437696|Inflammation|inflammation
5465814|NCT01437696|Men|men
5465815|NCT01437683|Craniocerebral Trauma|craniocerebral trauma
5465816|NCT01437683|Quality of life|quality of life
5465817|NCT01437683|Long term outcome|long term outcome
5465818|NCT01437683|Activities of Daily Living|activities of daily living
5465819|NCT01437683|Cognitive Deficiency|cognitive deficiency
5465820|NCT01437683|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5465821|NCT01437644|Cerebral Palsy|cerebral palsy
5465822|NCT01437644|Hip displacement|hip displacement
5465823|NCT01437644|Hip surgery|hip surgery
5465824|NCT01437644|Post-operative pain|post-operative pain
5465825|NCT01437644|Botulinum Toxin|botulinum toxin
5465830|NCT01437605|Resected|resected
5465831|NCT01437605|Skin|skin
5465832|NCT01437605|Stage IV|stage iv
5465833|NCT01437579|interstitial cystitis|interstitial cystitis
5465834|NCT01437579|bladder pain syndrome|bladder pain syndrome
5465835|NCT01437579|intratrigonal injection|intratrigonal injection
5465836|NCT01437579|botulinum toxin|botulinum toxin
5465837|NCT01437553|IVUS|ivus
5465838|NCT01437553|iMAP|imap
5465839|NCT01437553|Catheterization|catheterization
5465840|NCT01437553|Acute Coronary Syndrome|acute coronary syndrome
5465841|NCT01437540|COPD|copd
5465842|NCT01437540|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5465843|NCT01437540|Chronic Bronchitis|chronic bronchitis
5465844|NCT01437540|Emphysema|emphysema
5465845|NCT01437540|Airflow Obstruction, Chronic|airflow obstruction, chronic
5465846|NCT01437540|Chronic Airflow Obstruction|chronic airflow obstruction
5465847|NCT01437540|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5465848|NCT01437540|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5465849|NCT01437527|anorexia nervosa|anorexia nervosa
5465850|NCT01437527|CMME-TCA Unit|cmme-tca unit
5452466|NCT01492322|Smoker|smoker
5465851|NCT01437527|Centre Hospitalier Sainte Anne|centre hospitalier sainte anne
5465852|NCT01437514|rectal cancer|rectal cancer
5465853|NCT01437514|Endosonography|endosonography
5465854|NCT01437514|preoperative short-course radiotherapy|preoperative short-course radiotherapy
5465855|NCT01437514|preoperative adjuvant therapy|preoperative adjuvant therapy
5465856|NCT01437514|neoadjuvant therapy|neoadjuvant therapy
5465857|NCT01437514|short-term high-dose preoperative radiotherapy|short-term high-dose preoperative radiotherapy
5465858|NCT01437514|total mesorectal excision|total mesorectal excision
5465859|NCT01437514|circumferential resection margin|circumferential resection margin
5465860|NCT01437514|local recurrence|local recurrence
5465861|NCT01437514|overall survival|overall survival
5465862|NCT01437514|metastasis|metastasis
5465863|NCT01437514|complication|complication
5465864|NCT01437501|glucoraphanin|glucoraphanin
5465865|NCT01437501|sulforaphane|sulforaphane
5465866|NCT01437501|pharmacokinetics|pharmacokinetics
5465867|NCT01437501|pharmacodynamics|pharmacodynamics
5465868|NCT01437501|broccoli sprout|broccoli sprout
5465869|NCT01437501|carcinogens, environment|carcinogens, environment
5465870|NCT01437488|Urothelial carcinoma|urothelial carcinoma
5465871|NCT01437488|Urothelial cancer|urothelial cancer
5465874|NCT01437475|Immunization|immunization
5465875|NCT01437475|HBV Immunization rate among HIV positive individuals|hbv immunization rate among hiv positive individuals
5465876|NCT01437462|Pain, Postoperative|pain, postoperative
5465877|NCT01437462|Anesthetics, intravenous|anesthetics, intravenous
5465878|NCT01437462|Anesthetics, inhalation|anesthetics, inhalation
5465879|NCT01437462|Otherwise healthy adults undergoing general anesthesia for gynecological disease.|otherwise healthy adults undergoing general anesthesia for gynecological disease.
5465880|NCT01437449|Quality of Life|quality of life
5465881|NCT01437436|otitis media|otitis media
5465882|NCT01437436|obesity|obesity
5465883|NCT01437436|ventilation tube|ventilation tube
5465884|NCT01437423|Diphtheria|diphtheria
5465885|NCT01437423|Tetanus|tetanus
5465886|NCT01437423|Pertussis|pertussis
5465887|NCT01437423|Poliomyelitis|poliomyelitis
5465888|NCT01437423|TETRAXIM™|tetraxim™
5465889|NCT01437397|COPD|copd
5465890|NCT01437397|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5465891|NCT01437397|Chronic Bronchitis|chronic bronchitis
5465892|NCT01437397|Emphysema|emphysema
5465893|NCT01437397|Airflow Obstruction, Chronic|airflow obstruction, chronic
5465894|NCT01437397|Chronic Airflow Obstruction|chronic airflow obstruction
5465895|NCT01437397|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5465896|NCT01437397|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5465897|NCT01437371|Heart failure|heart failure
5465898|NCT01437371|Aged and over 80|aged and over 80
5465899|NCT01437371|clinical trial|clinical trial
5465900|NCT01437371|quality of life|quality of life
5465901|NCT01437358|Epidural catheter|epidural catheter
5465902|NCT01437358|Epidural analgesia|epidural analgesia
5465903|NCT01437358|Intensive care unit|intensive care unit
5465904|NCT01437358|Safety|safety
5465905|NCT01437306|lofexidine|lofexidine
5465906|NCT01437306|food effect|food effect
5465907|NCT01437306|pharmacokinetics|pharmacokinetics
5465908|NCT01437306|healthy volunteer|healthy volunteer
5465909|NCT01437293|cocaine|cocaine
5465910|NCT01437280|Tumors|tumors
5465911|NCT01437280|Solid Tumors|solid tumors
5465912|NCT01437254|99mTc Pertechnetate|99mtc pertechnetate
5465913|NCT01437254|thyroidectomy|thyroidectomy
5465914|NCT01437241|HIV-infection|hiv-infection
5465915|NCT01437241|Etravirine|etravirine
5465916|NCT01437241|Treatment|treatment
5465917|NCT01437241|Non-nucleoside reverse-transcriptase inhibitor|non-nucleoside reverse-transcriptase inhibitor
5465918|NCT01437215|aneurysm|aneurysm
5465919|NCT01437215|renal stent|renal stent
5465920|NCT01437215|juxtarenal|juxtarenal
5465921|NCT01437215|pararenal|pararenal
5465922|NCT01437202|imatinib|imatinib
5465923|NCT01437202|drug resistance|drug resistance
5465924|NCT01437202|pharmacogenetics|pharmacogenetics
5465925|NCT01437189|Parkinson's disease|parkinson's disease
5465926|NCT01437189|depression|depression
5465928|NCT01437189|intervention|intervention
5465929|NCT01437176|surgery|surgery
5465930|NCT01437176|fixation|fixation
5465931|NCT01437176|intramedullary nail|intramedullary nail
5465932|NCT01437150|surgery|surgery
5465933|NCT01437150|fixation|fixation
5465934|NCT01437150|bone plate|bone plate
5465935|NCT01437137|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway|elective surgery of short duration (less than 2 hr) undergoing general anesthesia using supraglottic airway
5465952|NCT01437020|Leishmaniasis|leishmaniasis
5465953|NCT01437020|Immunotherapy|immunotherapy
5465954|NCT01437007|SNALP|snalp
5465955|NCT01437007|Regional Therapy|regional therapy
5465956|NCT01437007|Stage IV Disease|stage iv disease
5465957|NCT01437007|Adenocarcinoma|adenocarcinoma
5465958|NCT01437007|Unresectable|unresectable
5465959|NCT01437007|Liver Metastases|liver metastases
5465960|NCT01437007|Colorectal Cancer|colorectal cancer
5465961|NCT01437007|Stomach Cancer|stomach cancer
5465962|NCT01437007|Gastric Cancer|gastric cancer
5465963|NCT01437007|Breast Cancer|breast cancer
5465964|NCT01437007|Ovarian Cancer|ovarian cancer
5465965|NCT01437007|Pancreatic Cancer|pancreatic cancer
5465966|NCT01437007|Liver Cancer|liver cancer
5465967|NCT01436994|thyrotoxic|thyrotoxic
5465968|NCT01436994|thyrotoxicosis|thyrotoxicosis
5465969|NCT01436994|paediatric|paediatric
5465970|NCT01436994|endocrinology|endocrinology
5465971|NCT01436994|block and replace|block and replace
5465972|NCT01436994|dose titration|dose titration
5465973|NCT01436994|carbimazole|carbimazole
5465974|NCT01436981|papaverine|papaverine
5465975|NCT01436981|pharmacokinetic|pharmacokinetic
5465976|NCT01436981|CABG|cabg
5465977|NCT01436981|Injury of Internal Mammary Artery|injury of internal mammary artery
5465978|NCT01436981|Complications Due to Coronary Artery Bypass Graft|complications due to coronary artery bypass graft
5465979|NCT01436968|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy|immunotherapy, cytotoxicity, tumor vaccine, prostate cancer, radiotherapy
5465980|NCT01436929|silymarin|silymarin
5465981|NCT01436929|hepatotoxicity|hepatotoxicity
5465982|NCT01436929|tuberculosis|tuberculosis
5465983|NCT01436929|HREZ|hrez
5465984|NCT01436916|prediabetes|prediabetes
5465985|NCT01436916|oral cholecalciferol|oral cholecalciferol
5465986|NCT01436903|menorrhagia|menorrhagia
5465987|NCT01436903|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5465988|NCT01436903|endometrial ablation|endometrial ablation
5465997|NCT01436864|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5465998|NCT01436864|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5465999|NCT01436864|intravitreal injection|intravitreal injection
5466000|NCT01436864|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
5466001|NCT01436864|central retinal thickness|central retinal thickness
5466002|NCT01436851|rhinitis|rhinitis
5466003|NCT01436851|allergy|allergy
5466004|NCT01436851|occupational|occupational
5466005|NCT01436851|storage mites|storage mites
5466006|NCT01436851|nasal lavage|nasal lavage
5466007|NCT01436851|challenge test|challenge test
5466009|NCT01436851|alfa2Macroglobuline|alfa2macroglobuline
5466010|NCT01436838|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5466138|NCT01436318|Respiratory|respiratory
5466011|NCT01436838|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5466012|NCT01436825|Haemophilia A|haemophilia a
5466013|NCT01436825|Factor VIII|factor viii
5466014|NCT01436825|Pharmacokinetic|pharmacokinetic
5466015|NCT01436825|Computer Tool validation|computer tool validation
5466016|NCT01436812|cerebral oxymetry|cerebral oxymetry
5466017|NCT01436812|laparoscopy|laparoscopy
5466018|NCT01436812|PEEP|peep
5466019|NCT01436799|propofol|propofol
5466020|NCT01436799|desflurane|desflurane
5466021|NCT01436799|cerebrovascular circulation|cerebrovascular circulation
5466023|NCT01436786|cytokines|cytokines
5466024|NCT01436786|Guided imagery|guided imagery
5466025|NCT01436760|IBS|ibs
5466026|NCT01436747|Kidney transplantation|kidney transplantation
5466039|NCT01436656|BRAF mutant,|braf mutant,
5466040|NCT01436656|BRAF mutated,|braf mutated,
5466041|NCT01436656|melanoma,|melanoma,
5466042|NCT01436656|metastatic,|metastatic,
5466043|NCT01436656|advanced,|advanced,
5466044|NCT01436656|RAF kinase inhibitor|raf kinase inhibitor
5466045|NCT01436656|BRAF V600 mutation|braf v600 mutation
5466046|NCT01436643|Depression|depression
5466047|NCT01436643|Multiple Sclerosis|multiple sclerosis
5466048|NCT01436643|Fingolimod|fingolimod
5466049|NCT01436643|Venlafaxine|venlafaxine
5466050|NCT01436643|Fluoxetine|fluoxetine
5466051|NCT01436630|Exercise Tolerance|exercise tolerance
5466052|NCT01436630|Step Test|step test
5466053|NCT01436630|Stroke|stroke
5466054|NCT01436630|Walking|walking
5466055|NCT01436617|cancer|cancer
5466056|NCT01436617|colon|colon
5466057|NCT01436617|Head and neck|head and neck
5466058|NCT01436617|cetuximab|cetuximab
5466059|NCT01436617|anti-cetuximab dosage|anti-cetuximab dosage
5466060|NCT01436604|cardiac MRI|cardiac mri
5466061|NCT01436604|Cancer|cancer
5466062|NCT01436604|Breast|breast
5466063|NCT01436604|Herceptin|herceptin
5466064|NCT01436604|LV dysfunction|lv dysfunction
5466065|NCT01436591|Cancer|cancer
5466066|NCT01436591|Breast|breast
5466067|NCT01436591|18FDG|18fdg
5466068|NCT01436591|Axillary|axillary
5466069|NCT01436591|Positron Emission Tomography|positron emission tomography
5466070|NCT01436552|MCI|mci
5466071|NCT01436552|Depression|depression
5466072|NCT01436552|Alzheimer|alzheimer
5466073|NCT01436552|Life events|life events
5466074|NCT01436526|Bioequivalence|bioequivalence
5466075|NCT01436513|bioequivalence|bioequivalence
5466076|NCT01436513|menometrorrhagia|menometrorrhagia
5466077|NCT01436513|climacteric disturbance|climacteric disturbance
5466078|NCT01436513|Estrogen Replacement Therapy|estrogen replacement therapy
5466079|NCT01436513|Estrogens Conjugated|estrogens conjugated
5466080|NCT01436500|Hepatorenal Syndrome|hepatorenal syndrome
5466082|NCT01436500|ifetroban|ifetroban
5466091|NCT01436448|glucose intolerance|glucose intolerance
5466092|NCT01436448|feasibility|feasibility
5466093|NCT01436448|compliance and safety|compliance and safety
5448423|NCT01509300|Fludarabine|fludarabine
5466094|NCT01436448|reducing glucose intolerance during and after pregnancy|reducing glucose intolerance during and after pregnancy
5466095|NCT01436435|PAD|pad
5466096|NCT01436435|peripheral artery disease|peripheral artery disease
5466097|NCT01436435|atherectomy|atherectomy
5466098|NCT01436422|Dengue Virus|dengue virus
5466099|NCT01436422|Dengue Fever|dengue fever
5466100|NCT01436422|Dengue Vaccine|dengue vaccine
5466101|NCT01436422|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5466102|NCT01436422|Dengue Shock Syndrome|dengue shock syndrome
5466103|NCT01436409|vaginal touch|vaginal touch
5466104|NCT01436409|deliveries assisted|deliveries assisted
5466105|NCT01436409|echography|echography
5466106|NCT01436409|assisted delivery|assisted delivery
5466107|NCT01436396|Dengue|dengue
5466108|NCT01436396|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5466109|NCT01436396|CYD Dengue Vaccines|cyd dengue vaccines
5466110|NCT01436396|Yellow Fever|yellow fever
5466111|NCT01436396|Stamaril®|stamaril®
5466112|NCT01436396|Flavivirus Infections|flavivirus infections
5466113|NCT01436383|high altitude|high altitude
5466114|NCT01436383|hypobaric hypoxia|hypobaric hypoxia
5466115|NCT01436383|metabolomics|metabolomics
5466116|NCT01436383|oxidative stress|oxidative stress
5466117|NCT01436383|acute mountain sickness|acute mountain sickness
5466118|NCT01436370|influenza, rheumatoid arthritis, TNF-alpha-inhibitor, Fluzone®, Fluzone® High Dose|influenza, rheumatoid arthritis, tnf-alpha-inhibitor, fluzone®, fluzone® high dose
5466119|NCT01436357|AdCh3NSmut1|adch3nsmut1
5466120|NCT01436357|Hepatitis C|hepatitis c
5466121|NCT01436357|MVA-NSmut|mva-nsmut
5466122|NCT01436357|vaccine|vaccine
5466123|NCT01436344|esophageal electrocardiography|esophageal electrocardiography
5466124|NCT01436344|electrocardiography|electrocardiography
5466125|NCT01436344|atrial electrogram|atrial electrogram
5466126|NCT01436344|atrial function, left|atrial function, left
5466127|NCT01436331|First episode psychosis|first episode psychosis
5466128|NCT01436331|Early Psychosis|early psychosis
5466129|NCT01436331|Cognitive Behavioural therapy|cognitive behavioural therapy
5466130|NCT01436331|Psychosocial Intervention|psychosocial intervention
5466131|NCT01436331|Assertive Community treatment|assertive community treatment
5466132|NCT01436331|Family Intervention|family intervention
5466133|NCT01436331|Mental Disorders|mental disorders
5466134|NCT01436331|Psychotic Disorders|psychotic disorders
5466135|NCT01436331|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5466136|NCT01436331|Affective Disorders, Psychotic|affective disorders, psychotic
5466137|NCT01436318|Healthy Kids|healthy kids
5466139|NCT01436318|Volunteers|volunteers
5466140|NCT01436305|immunosuppressive (IS) regimens|immunosuppressive (is) regimens
5466141|NCT01436305|long-term graft function|long-term graft function
5466142|NCT01436305|CNI (calcineurin Inhibitor )-free IS regimen|cni (calcineurin inhibitor )-free is regimen
5466143|NCT01436305|CNI (calcineurin Inhibitor ) IS regimen|cni (calcineurin inhibitor ) is regimen
5466144|NCT01436305|corticosteroids|corticosteroids
5466145|NCT01436292|Hypoalbuminemia|hypoalbuminemia
5466147|NCT01436292|Albumin|albumin
5466148|NCT01436292|Organ dysfunction|organ dysfunction
5466149|NCT01436292|Outcome|outcome
5466150|NCT01436240|Patient-Reported Outcomes|patient-reported outcomes
5466151|NCT01436240|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
5466152|NCT01436240|PRO-CTCAE|pro-ctcae
5466153|NCT01436240|Native Spanish Speaking|native spanish speaking
5466154|NCT01436240|Spanish Translation|spanish translation
5466155|NCT01436240|Cognitive Interview|cognitive interview
5466156|NCT01436240|Questionnaire|questionnaire
5466157|NCT01436240|11-133|11-133
5466158|NCT01436240|Adverse Events|adverse events
5466159|NCT01436240|chemotherapy|chemotherapy
5466160|NCT01436240|radiation therapy|radiation therapy
5466161|NCT01436240|treatment in previous 6 months|treatment in previous 6 months
5466162|NCT01436227|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5466163|NCT01436227|VHL|vhl
5466164|NCT01436227|Von Hippel-Lindau related lesion|von hippel-lindau related lesion
5466165|NCT01436227|Pazopanib|pazopanib
5466166|NCT01436227|GW786034|gw786034
5466167|NCT01436188|Biological Markers|biological markers
5466168|NCT01436188|Healthy Volunteer|healthy volunteer
5469261|NCT01423838|Overactive bladder|overactive bladder
5466169|NCT01436188|Alzheimer's Disease (AD)|alzheimer's disease (ad)
5466170|NCT01436188|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5466171|NCT01436188|Cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5466172|NCT01436188|CSF proteins|csf proteins
5466173|NCT01436136|Cardiovascular disease|cardiovascular disease
5466174|NCT01436136|HIV|hiv
5466175|NCT01436136|Antiretroviral treatment|antiretroviral treatment
5466176|NCT01436136|team interventions|team interventions
5466177|NCT01436136|Framingham risk score|framingham risk score
5466178|NCT01436123|Plasmonic Photothermal Therapy|plasmonic photothermal therapy
5466280|NCT01435681|DYT1|dyt1
5466179|NCT01436123|Nanoparticles|nanoparticles
5466180|NCT01436123|Stem cells|stem cells
5466181|NCT01436123|Atherosclerosis|atherosclerosis
5466182|NCT01436123|Bioengineering|bioengineering
5466183|NCT01436123|Biodegradable stenting|biodegradable stenting
5466184|NCT01436123|Repair disease|repair disease
5466185|NCT01436097|Healthy Eating|healthy eating
5466186|NCT01436097|Health Behavior|health behavior
5466187|NCT01436097|Incentive|incentive
5466188|NCT01436097|Work-site|work-site
5466189|NCT01436084|Leukemia|leukemia
5466190|NCT01436084|Myelodysplastic syndrome|myelodysplastic syndrome
5466191|NCT01436084|MDS|mds
5466192|NCT01436084|SB1518|sb1518
5466193|NCT01436058|side effect|side effect
5466194|NCT01436058|mesenchymal stem cell|mesenchymal stem cell
5466195|NCT01436058|ankle|ankle
5466196|NCT01436058|osteoarthritis|osteoarthritis
5466197|NCT01436045|Memory|memory
5466198|NCT01436045|Insulin glulisine|insulin glulisine
5466199|NCT01436045|Alzheimer's Disease|alzheimer's disease
5466200|NCT01436019|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5466201|NCT01436019|Rheumatic diseases|rheumatic diseases
5466202|NCT01436019|Antibodies|antibodies
5466203|NCT01436019|Biological therapy|biological therapy
5466204|NCT01436006|MDCT|mdct
5466205|NCT01436006|radiation|radiation
5466206|NCT01436006|dose|dose
5466207|NCT01435993|Multiple Sclerosis, Secondary-Progressive with relapses|multiple sclerosis, secondary-progressive with relapses
5466208|NCT01435980|type 2 diabetes|type 2 diabetes
5466209|NCT01435980|Gastric Bypass|gastric bypass
5466210|NCT01435980|GLP-1|glp-1
5466211|NCT01435980|adiponectin|adiponectin
5466212|NCT01435967|Rotarix™|rotarix™
5466213|NCT01435967|Observational|observational
5466214|NCT01435967|ecological|ecological
5466215|NCT01435954|benign prostatic hyperplasia|benign prostatic hyperplasia
5466216|NCT01435954|surgery|surgery
5466217|NCT01435954|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5466218|NCT01435954|enlarged prostate|enlarged prostate
5466219|NCT01435954|acute urinary retention|acute urinary retention
5466220|NCT01435941|mailed survey|mailed survey
5466221|NCT01435941|non-steroidal anti-inflammatory drug|non-steroidal anti-inflammatory drug
5466222|NCT01435941|migraine disorders|migraine disorders
5466223|NCT01435941|headache|headache
5466224|NCT01435928|Schizophrenia|schizophrenia
5466225|NCT01435928|Lurasidone|lurasidone
5466226|NCT01435928|Latuda|latuda
5466227|NCT01435902|exercise-induced bronchospasm|exercise-induced bronchospasm
5466228|NCT01435902|Activity/Exercise induced bronchospasm|activity/exercise induced bronchospasm
5466229|NCT01435902|asthma|asthma
5466230|NCT01435889|Acute respiratory distress syndrome|acute respiratory distress syndrome
5466231|NCT01435889|Children|children
5466232|NCT01435889|Long term respiratory sequelae|long term respiratory sequelae
5466233|NCT01435889|Pulmonary function tests|pulmonary function tests
5466234|NCT01435889|Computed tomography, lung|computed tomography, lung
5466235|NCT01435850|hip arthroplasty|hip arthroplasty
5466236|NCT01435850|primary stability|primary stability
5466237|NCT01435850|secondary stability|secondary stability
5466238|NCT01435850|EBRA|ebra
5466239|NCT01435837|Voice|voice
5466240|NCT01435837|aerodynamics|aerodynamics
5466241|NCT01435837|acoustics|acoustics
5466242|NCT01435824|healthy adult volunteers|healthy adult volunteers
5466243|NCT01435824|comparative bioavailability|comparative bioavailability
5466244|NCT01435824|amoxicillin|amoxicillin
5466245|NCT01435824|breast milk|breast milk
5466246|NCT01435824|Amoxicillin Bioavailability in breast milk|amoxicillin bioavailability in breast milk
5466247|NCT01435811|Norovirus|norovirus
5466248|NCT01435798|chronic pain|chronic pain
5466249|NCT01435798|central neuropathic pain|central neuropathic pain
5466250|NCT01435798|spinal cord injury|spinal cord injury
5466251|NCT01435798|dextromethorphan|dextromethorphan
5466252|NCT01435798|lidocaine|lidocaine
5466253|NCT01435798|combination therapy|combination therapy
5466254|NCT01435798|analgesia|analgesia
5466255|NCT01435785|PKPD|pkpd
5466256|NCT01435785|Propofol|propofol
5466258|NCT01435785|Elderly patients|elderly patients
5466259|NCT01435746|liver transplantation|liver transplantation
5466260|NCT01435746|intensive care|intensive care
5466261|NCT01435746|red blood cell transfusion|red blood cell transfusion
5466262|NCT01435733|ASD|asd
5466263|NCT01435733|Divorce|divorce
5466264|NCT01435720|Multiple myeloma|multiple myeloma
5466265|NCT01435720|B cell lymphoma|b cell lymphoma
5466266|NCT01435720|Hematologic disease|hematologic disease
5466267|NCT01435720|Blood protein disorder|blood protein disorder
5466268|NCT01435720|Neoplasm, plasma cell|neoplasm, plasma cell
5466273|NCT01435707|epidural steroid injection|epidural steroid injection
5466274|NCT01435707|triamcinolone|triamcinolone
5466275|NCT01435707|fasting blood glucose|fasting blood glucose
5466276|NCT01435707|diabetes mellitus|diabetes mellitus
5466277|NCT01435694|multiple sclerosis|multiple sclerosis
5466278|NCT01435694|gait rehabilitation|gait rehabilitation
5466279|NCT01435681|DYT-1|dyt-1
5466281|NCT01435681|DYT 1|dyt 1
5466282|NCT01435681|dystonia|dystonia
5466283|NCT01435681|DBS|dbs
5466284|NCT01435681|deep brain stimulation|deep brain stimulation
5466285|NCT01435681|TMS|tms
5466286|NCT01435681|transcranial magnetic stimulation|transcranial magnetic stimulation
5466287|NCT01435668|alcohol|alcohol
5466288|NCT01435668|hazardous or harmful drinking|hazardous or harmful drinking
5466289|NCT01435668|emergency department (ED)|emergency department (ed)
5466290|NCT01435616|diabetes mellitus|diabetes mellitus
5466291|NCT01435616|type 2 diabetes mellitus|type 2 diabetes mellitus
5466292|NCT01435616|insulin naive|insulin naive
5466293|NCT01435616|insulin treatment|insulin treatment
5466294|NCT01435603|Prevention & Control|prevention & control
5466295|NCT01435603|Hyperglycemia|hyperglycemia
5466296|NCT01435603|Obesity|obesity
5466297|NCT01435603|Diabetes Mellitus|diabetes mellitus
5466298|NCT01435603|Cost Benefit Analysis|cost benefit analysis
5466299|NCT01435577|Bunionectomy|bunionectomy
5466300|NCT01435577|Postsurgical Pain|postsurgical pain
5466301|NCT01435577|Acute Pain|acute pain
5466302|NCT01435564|Mobile phone|mobile phone
5466303|NCT01435564|Sedentary lifestyle|sedentary lifestyle
5466304|NCT01435564|Physical activity|physical activity
5466305|NCT01435564|Prevention|prevention
5466306|NCT01435564|Health Promotion|health promotion
5466307|NCT01435564|Exercise|exercise
5466308|NCT01435564|eHealth|ehealth
5466309|NCT01435564|Electronic diary|electronic diary
5466310|NCT01435551|Alzheimer|alzheimer
5466311|NCT01435551|Dementia|dementia
5466312|NCT01435538|interprofessional teamwork|interprofessional teamwork
5466313|NCT01435538|care pathways|care pathways
5466314|NCT01435538|team communication|team communication
5466315|NCT01435538|team coordination|team coordination
5466316|NCT01435538|Chronic Obstructive Pulmonary Disease Teams|chronic obstructive pulmonary disease teams
5466317|NCT01435538|Proximal Femur Fracture Teams|proximal femur fracture teams
5466318|NCT01435525|triple therapy|triple therapy
5466319|NCT01435525|Helicobacter pylori|helicobacter pylori
5466320|NCT01435525|eradication|eradication
5466321|NCT01435525|Nexium|nexium
5466322|NCT01435512|PTSD|ptsd
5466323|NCT01435512|CBT|cbt
5466324|NCT01435512|Intimate Partner Violence|intimate partner violence
5466325|NCT01435512|Treatment|treatment
5466326|NCT01435499|immunotherapy|immunotherapy
5466327|NCT01435499|vaccine|vaccine
5466328|NCT01435499|GVAX|gvax
5466329|NCT01435499|GM-CSF|gm-csf
5466330|NCT01435486|caffeine|caffeine
5466331|NCT01435486|apnea|apnea
5466332|NCT01435486|bronchiolitis|bronchiolitis
5466333|NCT01435473|pediatrics|pediatrics
5466334|NCT01435473|thrombosis|thrombosis
5466335|NCT01435473|thromboembolic complications|thromboembolic complications
5466336|NCT01435473|pediatric cardiac surgery|pediatric cardiac surgery
5466337|NCT01435460|ocular allergy|ocular allergy
5466338|NCT01435447|efficacy|efficacy
5466339|NCT01435447|safety|safety
5466340|NCT01435447|conditioning|conditioning
5466341|NCT01435447|fludarabine|fludarabine
5466342|NCT01435447|busulfan|busulfan
5466343|NCT01435447|cyclophosphamide|cyclophosphamide
5466344|NCT01435447|adult|adult
5466345|NCT01435434|subjects sustaining Non union/delayed fractures and requiring surgical intervention for treatment|subjects sustaining non union/delayed fractures and requiring surgical intervention for treatment
5466346|NCT01435408|STEMI|stemi
5466347|NCT01435408|Ischemic postconditioning|ischemic postconditioning
5466348|NCT01435408|Deferred stenting|deferred stenting
5466349|NCT01435408|Primary PCI|primary pci
5466350|NCT01435382|PF-04950615|pf-04950615
5466351|NCT01435382|RN316|rn316
5466352|NCT01435356|Urinary Bladder neoplasms|urinary bladder neoplasms
5466353|NCT01435356|Lymphoproliferative Disorders|lymphoproliferative disorders
5466354|NCT01435356|Immune System Diseases|immune system diseases
5466355|NCT01435356|Cystectomy|cystectomy
5466356|NCT01435356|Adjuvants, Immunologic|adjuvants, immunologic
5466357|NCT01435356|Immunologic Factors|immunologic factors
5466358|NCT01435330|Safety|safety
5466359|NCT01435330|BVS857|bvs857
5466360|NCT01435330|insulin resistance|insulin resistance
5466361|NCT01435317|Acoustic CR®-neuromodulation|acoustic cr®-neuromodulation
5466362|NCT01435317|ANM T30 CR®-System|anm t30 cr®-system
5466363|NCT01435278|Weight maintenance|weight maintenance
5466364|NCT01435278|BMI|bmi
5466365|NCT01435278|Body weight|body weight
5466367|NCT01435278|Obesity|obesity
5466368|NCT01435278|Satiety|satiety
5466369|NCT01435265|Psoriasis|psoriasis
5466370|NCT01435265|Dermatology|dermatology
5466371|NCT01435265|Phase IV|phase iv
5466372|NCT01435265|Nurse Education|nurse education
5466373|NCT01435265|Adalimumab|adalimumab
5466374|NCT01435265|Humira|humira
5466375|NCT01435226|Hepatitis C|hepatitis c
5466376|NCT01435226|HCV|hcv
5466377|NCT01435226|Rapid Virologic Response|rapid virologic response
5466378|NCT01435226|Sustained Virologic Response|sustained virologic response
5466379|NCT01435226|Direct Acting Antiviral|direct acting antiviral
5466380|NCT01435226|Combination Therapy|combination therapy
5466381|NCT01435226|Tegobuvir|tegobuvir
5466382|NCT01435226|Treatment Experienced|treatment experienced
5466383|NCT01435226|HCV RNA|hcv rna
5467076|NCT01432587|Familial|familial
5466384|NCT01435226|Polymerase inhibitor|polymerase inhibitor
5466385|NCT01435226|Protease inhibitor|protease inhibitor
5466386|NCT01435226|Interferon intolerant|interferon intolerant
5466387|NCT01435226|Interferon ineligible|interferon ineligible
5466388|NCT01435226|GS-9190|gs-9190
5466389|NCT01435226|GS-9451|gs-9451
5466390|NCT01435226|GS-5885|gs-5885
5466517|NCT01434706|acute infection|acute infection
5466391|NCT01435226|Chronic Genotype 1a or 1b|chronic genotype 1a or 1b
5466392|NCT01435213|alpha2-adrenoceptor|alpha2-adrenoceptor
5466393|NCT01435213|receptor occupancy|receptor occupancy
5466394|NCT01435213|positron emission tomography|positron emission tomography
5466395|NCT01435213|[11C]ORM-13070|[11c]orm-13070
5466396|NCT01435213|striatum|striatum
5466397|NCT01435213|brain|brain
5466398|NCT01435213|noradrenaline|noradrenaline
5466399|NCT01435213|norepinephrine|norepinephrine
5466400|NCT01435213|endogenous|endogenous
5466401|NCT01435213|binding|binding
5466402|NCT01435213|Validation studies|validation studies
5466403|NCT01435200|Intravenous iron|intravenous iron
5466404|NCT01435200|gynecologic cancer blood transfusion|gynecologic cancer blood transfusion
5466405|NCT01435174|ranolazine|ranolazine
5466406|NCT01435174|end-stage renal disease|end-stage renal disease
5466407|NCT01435174|pharmacokinetics|pharmacokinetics
5466408|NCT01435174|cardiovascular disease|cardiovascular disease
5466409|NCT01435161|paroxysmal atrial fibrillation, hypertension|paroxysmal atrial fibrillation, hypertension
5466410|NCT01435148|Deep Brain Stimulation|deep brain stimulation
5466411|NCT01435148|Treatment Resistant Depression|treatment resistant depression
5466412|NCT01435122|progressive advanced carcinoid tumors|progressive advanced carcinoid tumors
5466413|NCT01435122|advanced|advanced
5466414|NCT01435122|unresectable|unresectable
5466415|NCT01435122|metastatic|metastatic
5466416|NCT01435122|cancerous tumors|cancerous tumors
5466417|NCT01435122|neuroendocrine|neuroendocrine
5466418|NCT01435122|digestive tract|digestive tract
5466419|NCT01435122|lungs|lungs
5466420|NCT01435122|renal|renal
5466421|NCT01435122|ovarian|ovarian
5466422|NCT01435122|thymic|thymic
5466423|NCT01435122|hepatic|hepatic
5466424|NCT01435109|Osteoarthritis|osteoarthritis
5466425|NCT01435109|Exercise|exercise
5466426|NCT01435109|Diet|diet
5466427|NCT01435109|Coping Skills|coping skills
5466428|NCT01435109|Education, Medical|education, medical
5466429|NCT01435083|Nocturia|nocturia
5466431|NCT01435070|Radius fracture|radius fracture
5466432|NCT01435070|grip strength|grip strength
5466433|NCT01435070|pinch strength|pinch strength
5466434|NCT01435070|range of movement|range of movement
5466435|NCT01435070|PRWE|prwe
5466436|NCT01435070|DASH|dash
5466437|NCT01435070|EQ-5D|eq-5d
5466438|NCT01435070|Kirschner wire|kirschner wire
5466439|NCT01435070|Volar locking plate|volar locking plate
5466440|NCT01435057|Abdominal Obesity|abdominal obesity
5466441|NCT01435057|training|training
5466442|NCT01435057|fat|fat
5466443|NCT01435057|insulin|insulin
5466444|NCT01435057|glucose|glucose
5466445|NCT01435057|diet|diet
5466446|NCT01435044|Hepatitis C|hepatitis c
5466447|NCT01435044|Chronic|chronic
5466448|NCT01435044|HCV|hcv
5466449|NCT01435031|Angioplasty|angioplasty
5466450|NCT01435031|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5466451|NCT01435031|Chronic total coronary occlusions|chronic total coronary occlusions
5466452|NCT01435031|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5466453|NCT01435031|Coronary artery stenosis|coronary artery stenosis
5466454|NCT01435031|Total coronary occlusion|total coronary occlusion
5466455|NCT01435005|Prevention and control|prevention and control
5466456|NCT01435005|Exercise|exercise
5466457|NCT01435005|Sedentary lifestyle|sedentary lifestyle
5466458|NCT01435005|Biological markers|biological markers
5466459|NCT01434966|Lumbopelvic Manipulation|lumbopelvic manipulation
5466460|NCT01434966|Lumbosacral Manipulation|lumbosacral manipulation
5466461|NCT01434966|Sacroiliac Manipulation|sacroiliac manipulation
5466462|NCT01434966|TENS Spine|tens spine
5466463|NCT01434966|TENS Knee|tens knee
5466464|NCT01434966|Knee Pain|knee pain
5466465|NCT01434966|Chronic Knee Pain|chronic knee pain
5466466|NCT01434953|Prehypertension|prehypertension
5466467|NCT01434953|Blood pressure screening|blood pressure screening
5466468|NCT01434953|White coat effect|white coat effect
5466469|NCT01434940|Alzheimer disease|alzheimer disease
5466470|NCT01434940|Depression|depression
5466471|NCT01434940|Differential diagnosis|differential diagnosis
5466472|NCT01434940|Eye movement|eye movement
5466473|NCT01434914|Ulcus cruris|ulcus cruris
5466474|NCT01434914|chronic wounds|chronic wounds
5466475|NCT01434914|octenisept®|octenisept®
5466476|NCT01434901|Diabetes|diabetes
5466477|NCT01434901|Blood Sugar|blood sugar
5466478|NCT01434901|Xenin-25|xenin-25
5466479|NCT01434901|GIP|gip
5466480|NCT01434901|Muscarinic|muscarinic
5466481|NCT01434888|pharmacokinetics|pharmacokinetics
5466482|NCT01434862|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5466483|NCT01434849|infantile hemangioma|infantile hemangioma
5466484|NCT01434849|very low birth weight infants|very low birth weight infants
5466485|NCT01434849|premature infants|premature infants
5466489|NCT01434823|intensivist coverage|intensivist coverage
5466490|NCT01434823|ICU patient-centered outcomes|icu patient-centered outcomes
5466491|NCT01434823|ICU resource utilization|icu resource utilization
5466492|NCT01434823|patients admitted to the medical intensive care unit|patients admitted to the medical intensive care unit
5466493|NCT01434823|Sleep Deprivation|sleep deprivation
5466494|NCT01434823|Inattention|inattention
5466495|NCT01434823|Work Hours|work hours
5466496|NCT01434810|Hyperbilirubinemia, Neonatal|hyperbilirubinemia, neonatal
5466497|NCT01434797|Infection|infection
5466498|NCT01434797|Permanent central venous catheter|permanent central venous catheter
5466499|NCT01434797|Device Related|device related
5466500|NCT01434784|lung cancer|lung cancer
5466501|NCT01434784|quality of life|quality of life
5466502|NCT01434758|Mycobacterium tuberculosis|mycobacterium tuberculosis
5466503|NCT01434758|Culture yield|culture yield
5466504|NCT01434745|SLOS|slos
5466505|NCT01434745|Cholesterol Supplementation|cholesterol supplementation
5466506|NCT01434745|Simvastatin|simvastatin
5466507|NCT01434732|Superior vena cava flow|superior vena cava flow
5466508|NCT01434732|umbilical cord milking|umbilical cord milking
5466509|NCT01434732|hemodynamics|hemodynamics
5466510|NCT01434732|systemic blood flow|systemic blood flow
5466511|NCT01434719|Streptococcus suis|streptococcus suis
5466512|NCT01434719|Sepsis|sepsis
5466513|NCT01434719|Porcine Respiratory and Reproductive System virus|porcine respiratory and reproductive system virus
5466514|NCT01434719|Pig disease|pig disease
5466515|NCT01434719|Epidemiology|epidemiology
5466516|NCT01434706|HIV|hiv
5466518|NCT01434706|primary infection|primary infection
5466519|NCT01434706|seroconverters|seroconverters
5614345|NCT00840658|HIV|hiv
5466520|NCT01434693|T. suis ova|t. suis ova
5466521|NCT01434693|Crohn's disease|crohn's disease
5466522|NCT01434680|Meningococcal disease|meningococcal disease
5466523|NCT01434680|vaccines|vaccines
5466524|NCT01434680|toddlers|toddlers
5466525|NCT01434680|prevention|prevention
5466526|NCT01434680|Meningitis|meningitis
5466527|NCT01434667|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5466528|NCT01434667|Alzheimer's disease (AD)|alzheimer's disease (ad)
5466529|NCT01434667|APOE|apoe
5466530|NCT01434667|genetics|genetics
5466531|NCT01434667|risk assessment|risk assessment
5466532|NCT01434667|education|education
5466534|NCT01434667|Mild Cognitive Impairment, So Stated|mild cognitive impairment, so stated
5466537|NCT01434654|Neurology|neurology
5466538|NCT01434654|Neurocognitive|neurocognitive
5466539|NCT01434654|Neuro-HAART|neuro-haart
5466540|NCT01434654|HIV Associated Neurocognitive Disorders (HAND)|hiv associated neurocognitive disorders (hand)
5466541|NCT01434641|myocardial perfusion SPECT|myocardial perfusion spect
5466542|NCT01434641|wide beam reconstruction|wide beam reconstruction
5466543|NCT01434641|Tc-99m sestamibi|tc-99m sestamibi
5466544|NCT01434628|Male Circumcision|male circumcision
5466545|NCT01434628|HIV Prevention|hiv prevention
5466546|NCT01434628|HIV Infections|hiv infections
5466547|NCT01434615|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5466548|NCT01434615|Moderate to advanced|moderate to advanced
5466549|NCT01434615|patients|patients
5466550|NCT01434615|current consensus guidelines|current consensus guidelines
5466555|NCT01434589|internet addiction|internet addiction
5466556|NCT01434589|computer game addiction|computer game addiction
5466557|NCT01434589|STICA|stica
5466558|NCT01434589|short-term treatment|short-term treatment
5466559|NCT01434589|psychotherapy|psychotherapy
5466560|NCT01434589|internet and computer game addiction|internet and computer game addiction
5466561|NCT01434563|HIV|hiv
5466562|NCT01434563|neurocognitive disorder|neurocognitive disorder
5466563|NCT01434563|primary care|primary care
5466564|NCT01434563|HIV negative|hiv negative
5466565|NCT01434563|HAND|hand
5466566|NCT01434563|CNS|cns
5466567|NCT01434550|pancreas|pancreas
5466568|NCT01434550|pancreatic cancer|pancreatic cancer
5466569|NCT01434550|SBRT|sbrt
5466570|NCT01434550|stereotactic body radiation|stereotactic body radiation
5466571|NCT01434550|radiation therapy|radiation therapy
5466573|NCT01434550|non-metastatic|non-metastatic
5466574|NCT01434550|tissue, blood, research imaging|tissue, blood, research imaging
5466575|NCT01434550|TBRI|tbri
5466576|NCT01434537|pediatric anesthesia|pediatric anesthesia
5466577|NCT01434537|venepuncture|venepuncture
5466578|NCT01434537|peripheral venous access|peripheral venous access
5466579|NCT01434511|hemophilia A|hemophilia a
5466580|NCT01434511|haemophilia A|haemophilia a
5466581|NCT01434511|blood coagulation disorders|blood coagulation disorders
5466582|NCT01434511|hemorrhagic disorders|hemorrhagic disorders
5466583|NCT01434511|coagulation protein disorder|coagulation protein disorder
5467077|NCT01432574|HPV|hpv
5466584|NCT01434511|hematologic diseases|hematologic diseases
5466585|NCT01434511|congenital hemophilia A|congenital hemophilia a
5466586|NCT01434498|Hepatitis C|hepatitis c
5466587|NCT01434498|HCV|hcv
5466588|NCT01434498|Rapid Virologic Response|rapid virologic response
5466589|NCT01434498|Sustained Virologic Response|sustained virologic response
5466590|NCT01434498|Direct Acting Antiviral|direct acting antiviral
5466591|NCT01434498|Combination Therapy|combination therapy
5438260|NCT01552577|TBI|tbi
5466592|NCT01434498|Tegobuvir|tegobuvir
5466593|NCT01434498|Treatment naïve|treatment naïve
5466594|NCT01434498|HCV RNA|hcv rna
5466595|NCT01434498|Polymerase inhibitor|polymerase inhibitor
5466596|NCT01434498|Protease inhibitor|protease inhibitor
5466597|NCT01434498|Interferon intolerant|interferon intolerant
5466598|NCT01434498|Interferon ineligible|interferon ineligible
5466599|NCT01434498|GS-9190|gs-9190
5466600|NCT01434498|GS-9451|gs-9451
5466601|NCT01434498|GS-5885|gs-5885
5466602|NCT01434485|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome, Nexium|gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, zollinger-ellison syndrome, nexium
5466603|NCT01434459|Pancreatic neoplasms|pancreatic neoplasms
5466604|NCT01434459|Cholangiocarcinoma|cholangiocarcinoma
5466605|NCT01434420|triple negative breast cancer|triple negative breast cancer
5466606|NCT01434407|Advanced glycation endproducts|advanced glycation endproducts
5466607|NCT01434407|Satiety|satiety
5466608|NCT01434407|Obesity|obesity
5466609|NCT01434407|Inflammation|inflammation
5466610|NCT01434407|Insulin resistance|insulin resistance
5466611|NCT01434394|Oral cancer|oral cancer
5466612|NCT01434394|Oropharyngeal cancer|oropharyngeal cancer
5466613|NCT01434394|Induction chemotherapy|induction chemotherapy
5466614|NCT01434394|Targeted chemotherapy|targeted chemotherapy
5466615|NCT01434394|Surgery|surgery
5466616|NCT01434394|Radiotherapy|radiotherapy
5466617|NCT01434381|Recombinant|recombinant
5466618|NCT01434381|Proteins|proteins
5466619|NCT01434381|Antigen|antigen
5466620|NCT01434381|Membrane|membrane
5466621|NCT01434381|Assay|assay
5466622|NCT01434381|Malaria|malaria
5466623|NCT01434368|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5466624|NCT01434368|Normal Development|normal development
5466625|NCT01434368|Puberty|puberty
5466626|NCT01434368|Brain Function|brain function
5466627|NCT01434368|Gonadal Steroids|gonadal steroids
5466628|NCT01434368|Brain Structure|brain structure
5466629|NCT01434368|Healthy Volunteer|healthy volunteer
5466631|NCT01434342|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5466632|NCT01434342|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5466633|NCT01434342|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5466634|NCT01434342|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5466635|NCT01434342|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5466636|NCT01434342|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5466637|NCT01434342|limited stage small cell lung cancer|limited stage small cell lung cancer
5466638|NCT01434342|tobacco use disorder|tobacco use disorder
5466639|NCT01434342|Breast Cancer|breast cancer
5466640|NCT01434342|Cervical Cancer|cervical cancer
5466641|NCT01434342|head & neck cancer|head & neck cancer
5466642|NCT01434342|Prostate Cancer|prostate cancer
5466643|NCT01434342|All histologies|all histologies
5466644|NCT01434329|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5466645|NCT01434290|radiation toxicity|radiation toxicity
5466646|NCT01434290|sexual dysfunction|sexual dysfunction
5466647|NCT01434290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5466648|NCT01434290|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5466649|NCT01434290|stage I prostate cancer|stage i prostate cancer
5466650|NCT01434290|stage IIA prostate cancer|stage iia prostate cancer
5466651|NCT01434277|Preservative|preservative
5466653|NCT01434264|rehabilitation|rehabilitation
5466654|NCT01434251|Hypotension|hypotension
5466655|NCT01434251|premature infants|premature infants
5466656|NCT01434251|near infrared spectroscopy|near infrared spectroscopy
5466657|NCT01434238|infant feeding|infant feeding
5466658|NCT01434238|HIV|hiv
5466659|NCT01434238|growth|growth
5466660|NCT01434238|anemia|anemia
5466661|NCT01434225|Neonatal seizures|neonatal seizures
5466662|NCT01434225|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5466663|NCT01434225|Electroencephalography|electroencephalography
5466664|NCT01434225|Bumetanide|bumetanide
5466665|NCT01434212|HCV dynamics|hcv dynamics
5466666|NCT01434212|Mathematical model|mathematical model
5466667|NCT01434212|Interferon|interferon
5466668|NCT01434212|Predict|predict
5466669|NCT01434212|Hepatitis C Virus|hepatitis c virus
5466670|NCT01434199|magnetic endoscope imaging|magnetic endoscope imaging
5466671|NCT01434199|colonoscopy|colonoscopy
5466672|NCT01434199|caecal intubation|caecal intubation
5466673|NCT01434173|Liver Diseases|liver diseases
5466674|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents
5466675|NCT01434173|Fluoroquinolones|fluoroquinolones
5466676|NCT01434173|Amoxicillin|amoxicillin
5466878|NCT01433302|Inflammatory proteins|inflammatory proteins
5466677|NCT01434173|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
5466678|NCT01434173|Clarithromycin|clarithromycin
5466679|NCT01434173|Doxycycline|doxycycline
5466680|NCT01434173|Cefuroxime|cefuroxime
5466681|NCT01434173|Case-Control Studies|case-control studies
5466682|NCT01434173|Retrospective Studies|retrospective studies
5466683|NCT01434173|Cohort Studies|cohort studies
5466684|NCT01434173|Epidemiologic Research Design|epidemiologic research design
5466685|NCT01434173|Epidemiologic Studies|epidemiologic studies
5466686|NCT01434173|HealthCore Integrated Research Database (non-MESH)|healthcore integrated research database (non-mesh)
5466687|NCT01434173|United States|united states
5466688|NCT01434173|Human|human
5466689|NCT01434173|Insurance Claim Review|insurance claim review
5466690|NCT01434160|Intrauterine|intrauterine
5466691|NCT01434160|contraception|contraception
5466692|NCT01434160|adolescent|adolescent
5466693|NCT01434147|locally advanced rectal cancer|locally advanced rectal cancer
5466694|NCT01434147|preoperative induction chemotherapy chemoradiotherapy|preoperative induction chemotherapy chemoradiotherapy
5466695|NCT01434134|Anthracyclines|anthracyclines
5466696|NCT01434134|Trastuzumab|trastuzumab
5466697|NCT01434108|cirrhosis, gastrointestinal bleeding|cirrhosis, gastrointestinal bleeding
5466698|NCT01434095|microperimetry|microperimetry
5466699|NCT01434095|fixation point|fixation point
5466700|NCT01434095|retinal sensitivity|retinal sensitivity
5466701|NCT01434095|photodynamic therapy|photodynamic therapy
5466702|NCT01434095|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5466703|NCT01434082|sleep|sleep
5466704|NCT01434082|school-age children|school-age children
5466705|NCT01434082|Children with and without arthritis|children with and without arthritis
5466706|NCT01434069|colon|colon
5466707|NCT01434069|rectum|rectum
5466708|NCT01434069|small bowel|small bowel
5466709|NCT01434069|pancreas|pancreas
5466710|NCT01434069|gastric|gastric
5466711|NCT01434069|esophageal|esophageal
5466712|NCT01434069|metastatic|metastatic
5466713|NCT01434069|unresectable|unresectable
5466714|NCT01434069|GI|gi
5466715|NCT01434069|combination therapy|combination therapy
5466716|NCT01434069|dose escalation|dose escalation
5466717|NCT01434069|solid tumor|solid tumor
5466718|NCT01434056|Liver disease|liver disease
5466719|NCT01434056|Hepatic encephalopathy|hepatic encephalopathy
5466720|NCT01434056|MELD|meld
5466721|NCT01434056|Liver transplantation|liver transplantation
5466722|NCT01434043|Cardiac CT perfusion|cardiac ct perfusion
5466723|NCT01434043|Positron emission tomography perfusion|positron emission tomography perfusion
5466725|NCT01434017|PONV|ponv
5466726|NCT01434017|Dexamethasone|dexamethasone
5466727|NCT01434017|Droperidol|droperidol
5466728|NCT01434017|Ondansetron|ondansetron
5466729|NCT01434017|Tonsillectomy|tonsillectomy
5466730|NCT01434004|prostate cancer|prostate cancer
5466731|NCT01433965|Bone marrow transplantation|bone marrow transplantation
5466732|NCT01433965|Maintenance lenalidomide|maintenance lenalidomide
5466733|NCT01433939|colonoscopy|colonoscopy
5466734|NCT01433939|position changes|position changes
5466735|NCT01433939|patient comfort|patient comfort
5466736|NCT01433926|Breast cancer.|breast cancer.
5466737|NCT01433926|Trastuzumab.|trastuzumab.
5466738|NCT01433926|Complete remission.|complete remission.
5466739|NCT01433900|glaucoma|glaucoma
5466740|NCT01433900|intraocular pressure|intraocular pressure
5466741|NCT01433900|ocular surface|ocular surface
5466742|NCT01433900|benzalkonium chloride|benzalkonium chloride
5466743|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a
5466744|NCT01433887|ribavirin|ribavirin
5466745|NCT01433874|Shoulder pain|shoulder pain
5466746|NCT01433874|Upper abdominal pain|upper abdominal pain
5466747|NCT01433874|Laparoscopic surgery|laparoscopic surgery
5466748|NCT01433874|Abdominal fullness|abdominal fullness
5466749|NCT01433861|gastric cancer|gastric cancer
5466750|NCT01433861|proximal gastrectomy|proximal gastrectomy
5466751|NCT01433861|total gastrectomy|total gastrectomy
5466752|NCT01433861|laparoscopy|laparoscopy
5466753|NCT01433861|reflux esophagitis|reflux esophagitis
5466754|NCT01433861|double tract reconstruction|double tract reconstruction
5466755|NCT01433835|Cytomegalovirus|cytomegalovirus
5466756|NCT01433835|Antiviral|antiviral
5466757|NCT01433835|Safety|safety
5466758|NCT01433835|Healthy|healthy
5466759|NCT01433809|thyroid cancer|thyroid cancer
5466760|NCT01433809|thyroid neoplasm|thyroid neoplasm
5466761|NCT01433809|thyroid adenoma|thyroid adenoma
5466762|NCT01433796|antiretroviral therapy|antiretroviral therapy
5466763|NCT01433796|tuberculosis|tuberculosis
5466764|NCT01433796|health centres|health centres
5466765|NCT01433796|Ethiopia|ethiopia
5466766|NCT01433757|dystonia|dystonia
5466767|NCT01433757|DYT-1|dyt-1
5466768|NCT01433757|AMPICILLIN|ampicillin
5466769|NCT01433744|C-Reactive protein|c-reactive protein
5466770|NCT01433744|risk|risk
5466771|NCT01433731|CTCL|ctcl
5466772|NCT01433731|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5466773|NCT01433718|Effectivness|effectivness
5466774|NCT01433718|Neuromuscular Training|neuromuscular training
5466775|NCT01433718|Resistance Training|resistance training
5466776|NCT01433718|Modification|modification
5466778|NCT01433718|Drop-Jump|drop-jump
5466779|NCT01433718|Knee Separation|knee separation
5466780|NCT01433718|Resistance training program|resistance training program
5466781|NCT01433705|heart|heart
5466782|NCT01433705|perfusion|perfusion
5466783|NCT01433705|glucose|glucose
5466784|NCT01433692|Addictions|addictions
5466785|NCT01433692|Adolescents|adolescents
5466786|NCT01433692|Primary Health Care|primary health care
5466787|NCT01433692|Brief Intervention|brief intervention
5466788|NCT01433679|Health Behavior|health behavior
5466789|NCT01433679|Exercise|exercise
5466790|NCT01433679|Adolescent Behavior|adolescent behavior
5466791|NCT01433679|Motivation|motivation
5466792|NCT01433679|Biological Markers|biological markers
5466793|NCT01433653|Comorbid|comorbid
5466794|NCT01433653|Complicated|complicated
5466795|NCT01433640|image on multi-modalities|image on multi-modalities
5449126|NCT01506336|imatinib|imatinib
5466796|NCT01433640|visualize cancer lesions|visualize cancer lesions
5466797|NCT01433640|highly suspicious lesions|highly suspicious lesions
5466798|NCT01433627|acute coronary syndromes|acute coronary syndromes
5466799|NCT01433627|myocardial infarction|myocardial infarction
5466800|NCT01433627|access site|access site
5466801|NCT01433627|bivalirudin|bivalirudin
5466802|NCT01433627|bleedings|bleedings
5466803|NCT01433601|Adherence|adherence
5466804|NCT01433601|Peer support|peer support
5466805|NCT01433601|Treatment failure|treatment failure
5466806|NCT01433588|Managing infant pain|managing infant pain
5466807|NCT01433588|27 - 36+6 weeks gestation|27 - 36+6 weeks gestation
5466808|NCT01433588|Preterm infants|preterm infants
5466809|NCT01433562|breast cancer|breast cancer
5466810|NCT01433562|neoadjuvant therapy|neoadjuvant therapy
5466811|NCT01433562|Stage II/III|stage ii/iii
5466812|NCT01433536|cranial trauma with or without high velocity fracture to inferior limb|cranial trauma with or without high velocity fracture to inferior limb
5466813|NCT01433536|spinal trauma with or without high velocity fracture to inferior limb|spinal trauma with or without high velocity fracture to inferior limb
5466814|NCT01433536|high velocity fracture to inferior limb|high velocity fracture to inferior limb
5466817|NCT01433523|asthma|asthma
5466818|NCT01433523|asthma exacerbation|asthma exacerbation
5466819|NCT01433523|House dust mite induced asthma|house dust mite induced asthma
5466820|NCT01433510|Allergic|allergic
5466821|NCT01433510|Rhinoconjunctivitis|rhinoconjunctivitis
5466822|NCT01433510|Immunotherapy|immunotherapy
5466823|NCT01433497|multiple sclerosis|multiple sclerosis
5466824|NCT01433497|primary progressive|primary progressive
5466830|NCT01433484|weight loss|weight loss
5466831|NCT01433484|genomics|genomics
5466832|NCT01433471|Ulcerative Colitis|ulcerative colitis
5466833|NCT01433471|Trichuris Suis Ova|trichuris suis ova
5466834|NCT01433471|Inflammatory Bowel Disease|inflammatory bowel disease
5466836|NCT01433458|Hepatic impairment|hepatic impairment
5466837|NCT01433458|healthy volunteers|healthy volunteers
5466838|NCT01433458|RLX030|rlx030
5466839|NCT01433458|pharmacokinetics|pharmacokinetics
5466840|NCT01433445|Myelofibrosis|myelofibrosis
5466841|NCT01433445|Panobinostat|panobinostat
5466842|NCT01433445|Ruxolitinib|ruxolitinib
5466843|NCT01433445|MF|mf
5466844|NCT01433445|PMF|pmf
5466845|NCT01433445|PPV|ppv
5466846|NCT01433445|PPV-MF|ppv-mf
5466847|NCT01433445|PET|pet
5466848|NCT01433445|PET-MF|pet-mf
5466849|NCT01433445|JAK2|jak2
5466850|NCT01433445|DACi|daci
5466851|NCT01433432|Crohn's Disease|crohn's disease
5466852|NCT01433419|Drug Therapy|drug therapy
5466853|NCT01433406|Drug Therapy|drug therapy
5466854|NCT01433393|Drug Therapy|drug therapy
5466855|NCT01433380|Phase 1|phase 1
5466856|NCT01433380|Single Doses|single doses
5466857|NCT01433380|Pharmacodynamics|pharmacodynamics
5466858|NCT01433380|Healthy Volunteers|healthy volunteers
5466859|NCT01433367|total disc replacement|total disc replacement
5466860|NCT01433367|cervical disc disease|cervical disc disease
5466861|NCT01433354|Fragile X Syndrome|fragile x syndrome
5466862|NCT01433354|Martin-Bell Syndrome|martin-bell syndrome
5466863|NCT01433354|Genetic Diseases|genetic diseases
5466864|NCT01433354|X-Linked|x-linked
5466865|NCT01433354|Escalante's syndrome|escalante's syndrome
5466866|NCT01433341|Normal young athletes|normal young athletes
5466867|NCT01433328|Remodulin|remodulin
5466868|NCT01433328|Treprostinil|treprostinil
5466871|NCT01433302|Breast cancer|breast cancer
5466872|NCT01433302|Genitourinary cancer|genitourinary cancer
5466873|NCT01433302|Gynecological cancer|gynecological cancer
5466874|NCT01433302|Malignant Female Reproductive System Neoplasm|malignant female reproductive system neoplasm
5466875|NCT01433302|Melanoma|melanoma
5466876|NCT01433302|Sarcoma|sarcoma
5466877|NCT01433302|Inflammatory Response|inflammatory response
5466879|NCT01433302|Tissue Fibrosis|tissue fibrosis
5466880|NCT01433302|Lymphatico-venous Bypass Surgery|lymphatico-venous bypass surgery
5466881|NCT01433302|Punch biopsy|punch biopsy
5466882|NCT01433302|Lab collections|lab collections
5466883|NCT01433302|Th2 immune phenotype|th2 immune phenotype
5466885|NCT01433289|HIV|hiv
5466886|NCT01433289|safety|safety
5466887|NCT01433289|toxicity|toxicity
5466888|NCT01433289|pharmacokinetics|pharmacokinetics
5466889|NCT01433289|Polyphenon E|polyphenon e
5466890|NCT01433289|EGCG|egcg
5466891|NCT01433289|green tea|green tea
5466892|NCT01433289|CD4|cd4
5466893|NCT01433289|viral load|viral load
5466894|NCT01433276|Fluid resuscitation|fluid resuscitation
5466895|NCT01433276|hemorrhagic shock|hemorrhagic shock
5438559|NCT01551329|alcohol|alcohol
5466896|NCT01433276|Totilac|totilac
5466897|NCT01433276|Ringer's|ringer's
5466898|NCT01433276|trauma|trauma
5466899|NCT01433263|Wasting syndrome|wasting syndrome
5466900|NCT01433263|emaciation|emaciation
5466901|NCT01433263|lung cancer|lung cancer
5466902|NCT01433263|adenocarcinoma|adenocarcinoma
5466903|NCT01433263|pancreatic cancer|pancreatic cancer
5466904|NCT01433250|Multiple Sclerosis,|multiple sclerosis,
5466905|NCT01433250|demyelinating autoimmune diseases,|demyelinating autoimmune diseases,
5466906|NCT01433250|interleukin-17,|interleukin-17,
5466907|NCT01433250|monoclonal human antibody|monoclonal human antibody
5466908|NCT01433237|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5466909|NCT01433237|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5466910|NCT01433237|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5466911|NCT01433237|adult soft tissue sarcoma|adult soft tissue sarcoma
5466912|NCT01433237|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5466913|NCT01433224|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5903990|NCT00085930|Neuroblastoma|neuroblastoma
5466914|NCT01433224|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5466915|NCT01433224|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5466916|NCT01433224|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5466917|NCT01433185|PMTCT|pmtct
5466918|NCT01433185|SMS|sms
5466919|NCT01433185|HIV Infections|hiv infections
5466920|NCT01433185|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5466921|NCT01433185|Prevention & Control|prevention & control
5466922|NCT01433185|Patient Compliance|patient compliance
5466924|NCT01433185|Randomized Controlled Trial|randomized controlled trial
5466926|NCT01433172|adenocarcinoma|adenocarcinoma
5466927|NCT01433172|vaccine therapy|vaccine therapy
5466928|NCT01433172|immunology|immunology
5466929|NCT01433172|tumor vaccine|tumor vaccine
5466930|NCT01433172|colony stimulating factor(CSF)|colony stimulating factor(csf)
5466931|NCT01433172|granulocyte-macrophage colony-stimulating factor (GM-CSF)|granulocyte-macrophage colony-stimulating factor (gm-csf)
5466932|NCT01433172|CC chemokine ligand 21 (CCL21)|cc chemokine ligand 21 (ccl21)
5466933|NCT01433172|Chemokine [C-C motif] ligand 21 (CCL21)|chemokine [c-c motif] ligand 21 (ccl21)
5466934|NCT01433172|human leukocyte antigen serotype (HLA)|human leukocyte antigen serotype (hla)
5466935|NCT01433159|Pressure Ulcers|pressure ulcers
5466936|NCT01433159|Spinal Cord Injury|spinal cord injury
5466937|NCT01433159|Healthpoint|healthpoint
5466938|NCT01433159|Xenaderm|xenaderm
5466939|NCT01433159|011-101|011-101
5466940|NCT01433146|Temperament|temperament
5466941|NCT01433146|Anxiety|anxiety
5466942|NCT01433146|Depression|depression
5466943|NCT01433146|Colorectal Cancer|colorectal cancer
5466944|NCT01433120|Obesity|obesity
5466945|NCT01433120|Insulin resistance|insulin resistance
5466946|NCT01433120|Microbiota|microbiota
5466947|NCT01433120|Probiotic|probiotic
5466948|NCT01433120|Prebiotic|prebiotic
5466949|NCT01433107|Tinea pedis|tinea pedis
5466950|NCT01433107|Terbinafine film forming solution|terbinafine film forming solution
5466951|NCT01433094|Adherence|adherence
5466952|NCT01433094|Psychoeducation|psychoeducation
5466953|NCT01433094|Pharmacotherapy|pharmacotherapy
5466954|NCT01433094|Schizophrenia|schizophrenia
5466955|NCT01433094|Family support|family support
5466956|NCT01433068|Adult Soft Tissue Sarcoma of the extremities and Trunk wall|adult soft tissue sarcoma of the extremities and trunk wall
5466957|NCT01433055|Schizophrenia|schizophrenia
5466958|NCT01433055|Cognitive Symptoms|cognitive symptoms
5466959|NCT01433055|Clozapine|clozapine
5466960|NCT01433042|small bowel disease|small bowel disease
5466961|NCT01433029|Surgical Procedure|surgical procedure
5466962|NCT01433029|Assessment|assessment
5466963|NCT01433029|Cardiothoracic Surgery|cardiothoracic surgery
5466964|NCT01433029|Coronary artery bypass|coronary artery bypass
5466966|NCT01433029|Video recordings|video recordings
5466967|NCT01433029|Global rating scale|global rating scale
5466968|NCT01433029|GRS|grs
5466969|NCT01433029|Cardiothoracic surgeon|cardiothoracic surgeon
5466970|NCT01433029|Surgical trainees|surgical trainees
5466971|NCT01433016|HCC Hepatocellular carcinoma|hcc hepatocellular carcinoma
5466972|NCT01433016|OBT Octanoate Breath Test|obt octanoate breath test
5466973|NCT01433003|Thrombotic thrombocytopenia purpura|thrombotic thrombocytopenia purpura
5466974|NCT01433003|hemolytic uremic syndrome|hemolytic uremic syndrome
5466983|NCT01432964|Fracture Fixation|fracture fixation
5466984|NCT01432964|Blow-out Fractures|blow-out fractures
5466985|NCT01432964|Surgical Mesh|surgical mesh
5466986|NCT01432964|Titanium|titanium
5466987|NCT01432964|Computer-assisted Image Processing|computer-assisted image processing
5466988|NCT01432925|Buruli ulcer|buruli ulcer
5466989|NCT01432925|Mycobacterium ulcerans|mycobacterium ulcerans
5466990|NCT01432925|Streptomycin|streptomycin
5466991|NCT01432925|Rifampicin|rifampicin
5466992|NCT01432925|Functional limitations|functional limitations
5466993|NCT01432925|surgery|surgery
5466994|NCT01432925|Bénin|bénin
5466995|NCT01432899|Neurophysiology|neurophysiology
5466996|NCT01432899|Hemidystonia|hemidystonia
5466997|NCT01432899|Childhood-onset|childhood-onset
5466998|NCT01432899|Motion Analysis|motion analysis
5466999|NCT01432899|Neuroimaging|neuroimaging
5467000|NCT01432899|Childhood Onset Hemidystonia|childhood onset hemidystonia
5467001|NCT01432899|Healthy Volunteer|healthy volunteer
5467002|NCT01432899|HV|hv
5467003|NCT01432886|Breast Cancer|breast cancer
5467004|NCT01432873|BMT|bmt
5467005|NCT01432873|HSCT|hsct
5467006|NCT01432860|Skin Self Examination|skin self examination
5467013|NCT01432834|non-anterior astigmatism correction|non-anterior astigmatism correction
5467014|NCT01432834|Allegretto Wave excimer laser|allegretto wave excimer laser
5467015|NCT01432834|wavefront optimized ablation profile (WFO)|wavefront optimized ablation profile (wfo)
5467016|NCT01432834|LASIK|lasik
5467017|NCT01432834|PRK|prk
5467018|NCT01432821|Epilepsy,|epilepsy,
5467019|NCT01432821|dopamine|dopamine
5467020|NCT01432821|yawning,|yawning,
5467021|NCT01432821|blinking eyelids,|blinking eyelids,
5467022|NCT01432821|electroencephalography|electroencephalography
5467023|NCT01432795|chronic venous insufficiency|chronic venous insufficiency
5467024|NCT01432795|post-thrombotic syndrome|post-thrombotic syndrome
5467025|NCT01432795|medical compression therapy|medical compression therapy
5467026|NCT01432795|compression stocking|compression stocking
5467027|NCT01432795|gliding aid|gliding aid
5467028|NCT01432795|stocking butler|stocking butler
5467029|NCT01432795|adherence to treatment|adherence to treatment
5467030|NCT01432782|Weight loss|weight loss
5467031|NCT01432782|Dysphagia|dysphagia
5467032|NCT01432782|Esophageal hypermotility|esophageal hypermotility
5467033|NCT01432782|Chest Pain|chest pain
5467034|NCT01432769|enteral nutrition|enteral nutrition
5467035|NCT01432769|malnutrition|malnutrition
5467036|NCT01432769|cardiac surgery|cardiac surgery
5467037|NCT01432756|HIV|hiv
5467038|NCT01432743|3D mapping|3d mapping
5467039|NCT01432743|Image integration|image integration
5467040|NCT01432743|Atrial fibrillation|atrial fibrillation
5467041|NCT01432743|Catheter Ablation|catheter ablation
5467042|NCT01432704|MS|ms
5467043|NCT01432704|vitamin D|vitamin d
5467044|NCT01432704|environment|environment
5467045|NCT01432691|Hip-fracture|hip-fracture
5467046|NCT01432691|RSA|rsa
5467047|NCT01432678|vitamin D|vitamin d
5467048|NCT01432678|asthma|asthma
5467049|NCT01432665|HSDD|hsdd
5467050|NCT01432639|Myocardial infarction|myocardial infarction
5467051|NCT01432639|Autonomic function|autonomic function
5467052|NCT01432639|Arterial Stiffness|arterial stiffness
5467053|NCT01432639|Endothelial function|endothelial function
5467054|NCT01432639|Inflammation|inflammation
5467055|NCT01432639|Rehabilitation program|rehabilitation program
5467056|NCT01432639|Exercise|exercise
5467057|NCT01432626|stress induced cardiomyopathy|stress induced cardiomyopathy
5467058|NCT01432626|broken heart syndrome|broken heart syndrome
5467059|NCT01432626|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5467060|NCT01432626|transient apical ballooning syndrome|transient apical ballooning syndrome
5467061|NCT01432626|apical ballooning cardiomyopathy|apical ballooning cardiomyopathy
5467062|NCT01432626|stress cardiomyopathy|stress cardiomyopathy
5467063|NCT01432626|non-ischemic cardiomyopathy|non-ischemic cardiomyopathy
5467064|NCT01432613|Myositis|myositis
5467065|NCT01432613|Magnetic Resonance Imaging|magnetic resonance imaging
5467066|NCT01432613|Muscle biopsy|muscle biopsy
5467067|NCT01432613|Sensitivity and Specificity|sensitivity and specificity
5467068|NCT01432600|Multiple Myeloma|multiple myeloma
5467069|NCT01432600|Relapsed|relapsed
5467070|NCT01432600|Refractory|refractory
5467071|NCT01432600|Corticosteroids|corticosteroids
5467072|NCT01432587|Amyloidosis|amyloidosis
5467073|NCT01432587|Transthyretin|transthyretin
5467074|NCT01432587|Neuropathies|neuropathies
5467075|NCT01432587|Diflunisal|diflunisal
5467078|NCT01432561|Lysosomal Storage Diseases|lysosomal storage diseases
5467079|NCT01432561|Metabolic Diseases|metabolic diseases
5467080|NCT01432561|Metabolism, Inborn Errors|metabolism, inborn errors
5467081|NCT01432548|Ischemic|ischemic
5467082|NCT01432548|preconditioning|preconditioning
5467083|NCT01432548|liver|liver
5467084|NCT01432548|resection|resection
5467085|NCT01432522|Intranasal epinephrine|intranasal epinephrine
5467086|NCT01432522|Plasma epinephrine level|plasma epinephrine level
5467087|NCT01432509|Pre-diabetes|pre-diabetes
5467088|NCT01432509|Type 2 diabetes|type 2 diabetes
5467089|NCT01432509|Biomarkers|biomarkers
5467090|NCT01432509|Cohort|cohort
5467091|NCT01432509|Diabetes Risk Score|diabetes risk score
5467092|NCT01432509|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5467093|NCT01432509|Glucose Intolerance|glucose intolerance
5467094|NCT01432509|Prediabetic State|prediabetic state
5467095|NCT01432509|Glucose Metabolism Disorders|glucose metabolism disorders
5467096|NCT01432509|Metabolic Diseases|metabolic diseases
5467097|NCT01432509|Endocrine System Diseases|endocrine system diseases
5467098|NCT01432509|Hyperglycemia|hyperglycemia
5467099|NCT01432496|Laparoscopic|laparoscopic
5467100|NCT01432496|Colectomy|colectomy
5467101|NCT01432496|Nebulization|nebulization
5467102|NCT01432496|Ropivacaine|ropivacaine
5467103|NCT01432483|Cancer|cancer
5467104|NCT01432483|ONTAK|ontak
5467105|NCT01432483|Denileukin diftitox|denileukin diftitox
5453650|NCT01487707|pregnancy|pregnancy
5467106|NCT01432483|persistent or recurrent disease|persistent or recurrent disease
5467107|NCT01432483|requiring continued delivery of essential cancer therapy|requiring continued delivery of essential cancer therapy
5467108|NCT01432470|vaginal atrophy|vaginal atrophy
5467109|NCT01432444|Schizophrenia|schizophrenia
5467110|NCT01432418|rehabilitation|rehabilitation
5467111|NCT01432418|wheelchairs|wheelchairs
5467112|NCT01432418|safety|safety
5467113|NCT01432418|disability evaluation|disability evaluation
5467114|NCT01432418|motor skills|motor skills
5467115|NCT01432405|Diabetes|diabetes
5467116|NCT01432392|gastroesophageal reflux disease|gastroesophageal reflux disease
5467117|NCT01432392|GERD questionnaire|gerd questionnaire
5467118|NCT01432392|primary care setting|primary care setting
5467119|NCT01432340|Influenza|influenza
5467120|NCT01432340|Influenza vaccine|influenza vaccine
5467121|NCT01432340|Influenza vaccine effectiveness study|influenza vaccine effectiveness study
5467122|NCT01432327|motor activity|motor activity
5467123|NCT01432327|randomized controlled trial|randomized controlled trial
5467124|NCT01432327|feedback|feedback
5467125|NCT01432314|patient's survival|patient's survival
5467126|NCT01432314|tumor response|tumor response
5467127|NCT01432314|safety|safety
5467128|NCT01432301|fluorouracil overdose|fluorouracil overdose
5467129|NCT01432301|fluorouracil toxicity|fluorouracil toxicity
5467130|NCT01432301|capecitabine overdose|capecitabine overdose
5467131|NCT01432301|capecitabine toxicity|capecitabine toxicity
5467132|NCT01432275|Diabetes|diabetes
5467133|NCT01432275|SMBG|smbg
5467134|NCT01432275|Insulin calculator|insulin calculator
5789041|NCT00150137|Radioiodine therapy|radioiodine therapy
5467135|NCT01432262|prevention of pneumococcal diseases|prevention of pneumococcal diseases
5467136|NCT01432249|pediatric psoriasis|pediatric psoriasis
5467138|NCT01432249|safety|safety
5467139|NCT01432249|efficacy|efficacy
5467140|NCT01432236|Pregabalin|pregabalin
5467141|NCT01432236|Lyrica|lyrica
5467142|NCT01432236|depression|depression
5467143|NCT01432223|Trastuzumab|trastuzumab
5467144|NCT01432223|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5467145|NCT01432223|Primary chemotherapy|primary chemotherapy
5467146|NCT01432210|post-prandial absorption|post-prandial absorption
5467147|NCT01432210|provitamin A carotenoids|provitamin a carotenoids
5467148|NCT01432210|vitamin A|vitamin a
5467149|NCT01432210|avocado|avocado
5467150|NCT01432210|tomato|tomato
5467151|NCT01432210|carrot|carrot
5467152|NCT01432197|HRQOL|hrqol
5467153|NCT01432197|Occupational therapy|occupational therapy
5467154|NCT01432197|ADL intervention|adl intervention
5467155|NCT01432197|Cancer patients|cancer patients
5467156|NCT01432184|cerebral|cerebral
5467157|NCT01432184|hypoxia|hypoxia
5467158|NCT01432158|Invasive pneumococcal disease|invasive pneumococcal disease
5467159|NCT01432145|BRCA defective|brca defective
5467160|NCT01432132|Head and Neck Cancer|head and neck cancer
5467161|NCT01432132|Body Image Adaptation|body image adaptation
5467162|NCT01432132|Post surgical body image|post surgical body image
5467163|NCT01432132|Audio-recorded interview|audio-recorded interview
5467164|NCT01432132|Questionnaire|questionnaire
5467165|NCT01432132|Survey|survey
5467166|NCT01432119|Advanced Cancers|advanced cancers
5467167|NCT01432119|Advanced Malignancies|advanced malignancies
5467168|NCT01432119|Liver Metastases|liver metastases
5467169|NCT01432119|SIR-Spheres|sir-spheres
5467170|NCT01432119|Selective internal radiation|selective internal radiation
5467171|NCT01432119|Yttrium-90|yttrium-90
5467172|NCT01432119|Cetuximab|cetuximab
5467173|NCT01432119|C225|c225
5467174|NCT01432119|Erbitux|erbitux
5467175|NCT01432119|Erlotinib|erlotinib
5467176|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride
5467177|NCT01432119|Tarceva|tarceva
5467178|NCT01432119|OSI-774|osi-774
5467180|NCT01432106|Metabolic Syndrome|metabolic syndrome
5467181|NCT01432106|African American|african american
5467182|NCT01432093|liver transplant|liver transplant
5467183|NCT01432093|high blood sugars|high blood sugars
5467184|NCT01432093|hospital hyperglycemia|hospital hyperglycemia
5467185|NCT01432093|post-transplant hyperglycemia|post-transplant hyperglycemia
5467186|NCT01432093|post liver transplant|post liver transplant
5451970|NCT01494519|internal fixation|internal fixation
5467187|NCT01432093|post liver-kidney transplant|post liver-kidney transplant
5467188|NCT01432080|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5467189|NCT01432080|Viral respiratory tract infections|viral respiratory tract infections
5467190|NCT01432080|Respiratory syncytial viruses|respiratory syncytial viruses
5467191|NCT01432080|Influenza virus A|influenza virus a
5467192|NCT01432080|Influenza virus B|influenza virus b
5467193|NCT01432080|Transplantation, Allogeneic|transplantation, allogeneic
5467194|NCT01432067|cancer|cancer
5467195|NCT01432067|geriatry|geriatry
5467196|NCT01432067|curative care|curative care
5467197|NCT01432067|physical activity|physical activity
5467198|NCT01432054|Human Tissue Repository|human tissue repository
5467199|NCT01432041|Injury prevention|injury prevention
5467200|NCT01432041|smoke alarms|smoke alarms
5467201|NCT01432041|car seats|car seats
5467202|NCT01432015|aprepitant|aprepitant
5467203|NCT01432015|fosaprepitant|fosaprepitant
5467204|NCT01432015|gynecologic cancer|gynecologic cancer
5467205|NCT01432015|emesis|emesis
5467206|NCT01432002|breast carcinoma|breast carcinoma
5467208|NCT01432002|PET/CT|pet/ct
5467209|NCT01432002|PET/IRM|pet/irm
5467210|NCT01431950|fluticasone furoate|fluticasone furoate
5467211|NCT01431937|Pharmacodynamics|pharmacodynamics
5467212|NCT01431937|Pharmacokinetics|pharmacokinetics
5467213|NCT01431924|outcomes|outcomes
5467214|NCT01431924|observational|observational
5449549|NCT01504776|MCL|mcl
5467215|NCT01431924|retrospective|retrospective
5467216|NCT01431924|database|database
5467217|NCT01431924|asthma|asthma
5467218|NCT01431898|HCV RNA|hcv rna
5467219|NCT01431898|Polymerase inhibitor|polymerase inhibitor
5467220|NCT01431898|Treatment naïve and Treatment experienced|treatment naïve and treatment experienced
5467221|NCT01431898|GS-9669|gs-9669
5467222|NCT01431898|Hepatitis C|hepatitis c
5467223|NCT01431898|HCV|hcv
5467224|NCT01431885|fibronectin|fibronectin
5467225|NCT01431885|cervical length|cervical length
5467226|NCT01431872|Aromatase Inhibitors|aromatase inhibitors
5467227|NCT01431859|pollen|pollen
5467228|NCT01431859|allergy|allergy
5467229|NCT01431859|food|food
5467230|NCT01431859|immunotherapy|immunotherapy
5467231|NCT01431833|Hepatic Impairment|hepatic impairment
5467232|NCT01431833|Matched control subjects|matched control subjects
5467233|NCT01431820|Onychomycosis|onychomycosis
5467234|NCT01431820|Toenail Fungus|toenail fungus
5467235|NCT01431820|luliconazole|luliconazole
5467236|NCT01431820|Antifungal|antifungal
5467237|NCT01431820|Topical|topical
5461745|NCT01453803|therapy|therapy
5467238|NCT01431794|Pancreatic ductal adenocarcinoma (PDA)Neoplasms|pancreatic ductal adenocarcinoma (pda)neoplasms
5467239|NCT01431794|LDE225|lde225
5467240|NCT01431794|nab-paclitaxel|nab-paclitaxel
5467241|NCT01431794|abraxane|abraxane
5467242|NCT01431794|gemcitabine|gemcitabine
5467243|NCT01431794|neoadjuvant|neoadjuvant
5467244|NCT01431794|cytotoxic|cytotoxic
5467245|NCT01431794|hedgehog inhibitor|hedgehog inhibitor
5467246|NCT01431794|stromal cells|stromal cells
5467247|NCT01431794|resectable PDA|resectable pda
5467248|NCT01431794|Pancreatic Diseases|pancreatic diseases
5467249|NCT01431794|Carcinoma|carcinoma
5467250|NCT01431794|Sonidegib|sonidegib
5467251|NCT01431768|Influenza|influenza
5467252|NCT01431768|Human|human
5467253|NCT01431768|Orthomyxoviridae infections|orthomyxoviridae infections
5467254|NCT01431768|RNA Virus Infections|rna virus infections
5467255|NCT01431768|Virus Diseases|virus diseases
5467256|NCT01431768|Respiratory Tract infections|respiratory tract infections
5467257|NCT01431768|Respiratory Tract Diseases|respiratory tract diseases
5467258|NCT01431742|buccal soluble film|buccal soluble film
5467259|NCT01431742|Pain|pain
5467260|NCT01431742|Back Pain|back pain
5467261|NCT01431742|Low Back Pain|low back pain
5467262|NCT01431742|Buprenorphine|buprenorphine
5467263|NCT01431742|Analgesics, Opioid|analgesics, opioid
5467264|NCT01431742|Analgesics|analgesics
5467265|NCT01431703|narrow band imaging|narrow band imaging
5467266|NCT01431703|learning curve|learning curve
5467267|NCT01431703|colorectal|colorectal
5467268|NCT01431703|differential diagnosis|differential diagnosis
5467269|NCT01431703|with colorectal lesion|with colorectal lesion
5467270|NCT01431703|NBI with magnification|nbi with magnification
5467271|NCT01431690|Eicosapentaenoic Acid|eicosapentaenoic acid
5467272|NCT01431690|Docosahexaenoic Acid|docosahexaenoic acid
5467273|NCT01431690|Warfarin|warfarin
5467274|NCT01431690|Hypertriglyceridemia|hypertriglyceridemia
5467275|NCT01431690|Omega-3 free fatty acids|omega-3 free fatty acids
5467276|NCT01431690|Omega-3 ethyl ester acids|omega-3 ethyl ester acids
5467277|NCT01431690|Epanova|epanova
5467278|NCT01431690|Lovaza|lovaza
5467279|NCT01431690|pharmacokinetics|pharmacokinetics
5467280|NCT01431690|low-fat meal|low-fat meal
5467283|NCT01431677|Energetics|energetics
5467284|NCT01431677|Sarcopenia|sarcopenia
5467285|NCT01431677|Frailty|frailty
5467286|NCT01431664|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5467287|NCT01431664|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5467288|NCT01431664|acute leukemias of ambiguous lineage|acute leukemias of ambiguous lineage
5467289|NCT01431664|acute undifferentiated leukemia|acute undifferentiated leukemia
5467290|NCT01431664|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5467291|NCT01431651|Food and beverages|food and beverages
5467292|NCT01431651|Food|food
5467293|NCT01431651|Dietary supplements|dietary supplements
5467294|NCT01431638|Gout|gout
5467295|NCT01431638|arthritis|arthritis
5467296|NCT01431638|gout flare|gout flare
5467297|NCT01431638|acute gout|acute gout
5467298|NCT01431638|gouty|gouty
5467299|NCT01431638|rheumatic disease|rheumatic disease
5467300|NCT01431638|uric acid|uric acid
5467301|NCT01431638|podagra|podagra
5467302|NCT01431625|COPD|copd
5467303|NCT01431625|Exercise Training|exercise training
5467304|NCT01431612|Pharmacokinetics, kidney;|pharmacokinetics, kidney;
5467305|NCT01431612|Receptors, adrenergic;|receptors, adrenergic;
5467306|NCT01431612|Fluids, i.v.;|fluids, i.v.;
5467307|NCT01431612|Sympathetic nervous system, esmolol;|sympathetic nervous system, esmolol;
5467308|NCT01431612|Sympathetic nervous system, phenylephrine|sympathetic nervous system, phenylephrine
5467309|NCT01431599|Locally advanced rectal cancer|locally advanced rectal cancer
5467310|NCT01431586|JDTic|jdtic
5467311|NCT01431586|cocaine dependence|cocaine dependence
5467312|NCT01431586|kappa-opioid antagonist|kappa-opioid antagonist
5467313|NCT01431573|Depression|depression
5467314|NCT01431560|ankle|ankle
5467315|NCT01431560|metallic|metallic
5467316|NCT01431560|biodegradable|biodegradable
5467317|NCT01431560|Freedom|freedom
5467318|NCT01431508|Hypertension|hypertension
5467319|NCT01431495|platelet agregation|platelet agregation
5467320|NCT01431495|clopidogrel|clopidogrel
5467321|NCT01431495|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5467322|NCT01431482|skin symptoms|skin symptoms
5467323|NCT01431456|Prevention|prevention
5467324|NCT01431456|venous thromboembolism after knee arthroplasty|venous thromboembolism after knee arthroplasty
5467325|NCT01431443|Randomized double blind trial|randomized double blind trial
5467326|NCT01431443|Cocoa flavonoids|cocoa flavonoids
5467327|NCT01431443|Endothelial function|endothelial function
5467328|NCT01431443|Blood pressure|blood pressure
5467329|NCT01431443|Pregnant women|pregnant women
5467330|NCT01431443|Preeclampsia|preeclampsia
5467331|NCT01431443|Uterine artery flow|uterine artery flow
5467332|NCT01431443|Pulsatility index|pulsatility index
5467333|NCT01431430|Vitamine D|vitamine d
5467334|NCT01431430|renal transplantation|renal transplantation
5467335|NCT01431430|diabetes mellitus|diabetes mellitus
5467336|NCT01431430|cancer|cancer
5467337|NCT01431430|cardiovascular complications|cardiovascular complications
5467338|NCT01431417|Shoulder|shoulder
5467339|NCT01431417|Outcome treatment|outcome treatment
5467340|NCT01431417|Validation Studies as topic|validation studies as topic
5467341|NCT01431417|Biomechanics|biomechanics
5467342|NCT01431417|Shoulder, Joint Instability|shoulder, joint instability
5467343|NCT01431391|Immune therapy|immune therapy
5467344|NCT01431391|Cancer vaccine|cancer vaccine
5467345|NCT01431391|Therapeutic vaccine|therapeutic vaccine
5467346|NCT01431391|Therapeutic cancer vaccine|therapeutic cancer vaccine
5467348|NCT01431391|Dendritic cells|dendritic cells
5467349|NCT01431391|PSA|psa
5467350|NCT01431391|Androgen deprivation therapy|androgen deprivation therapy
5467351|NCT01431391|Prostatic Neoplasms|prostatic neoplasms
5467352|NCT01431391|Genital Neoplasms, Male|genital neoplasms, male
5467353|NCT01431391|Urogenital Neoplasms|urogenital neoplasms
5467354|NCT01431391|Neoplasms|neoplasms
5467355|NCT01431391|Prostatic Diseases|prostatic diseases
5467356|NCT01431391|Androgens|androgens
5467357|NCT01431391|Hormones|hormones
5467358|NCT01431391|Adenocarcinoma|adenocarcinoma
5467359|NCT01431391|Carcinoma|carcinoma
5467360|NCT01431391|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5467361|NCT01431391|Immunology|immunology
5467362|NCT01431391|Hormone therapy|hormone therapy
5467363|NCT01431391|Immunotherapy|immunotherapy
5467364|NCT01431391|Luteinizing hormone-releasing hormone (LHRH)|luteinizing hormone-releasing hormone (lhrh)
5467365|NCT01431378|CT scan|ct scan
5467366|NCT01431378|CNS|cns
5467367|NCT01431378|Thorax|thorax
5467368|NCT01431378|Abdomen|abdomen
5467369|NCT01431378|staging of a known or suspected lung cancer|staging of a known or suspected lung cancer
5467370|NCT01431378|suspected urolithiasis|suspected urolithiasis
5467371|NCT01431378|known or suspected focal liver lesion|known or suspected focal liver lesion
5467372|NCT01431365|exercise|exercise
5467373|NCT01431365|topography|topography
5467374|NCT01431365|cravings|cravings
5467375|NCT01431365|smoking behaviour|smoking behaviour
5467376|NCT01431352|Polycystic ovary syndrome|polycystic ovary syndrome
5467377|NCT01431352|Randomized controlled trial|randomized controlled trial
5467378|NCT01431352|Chinese herbal medicine|chinese herbal medicine
5467379|NCT01431352|Chinese herbal medicine granules|chinese herbal medicine granules
5467380|NCT01431352|Letrozole|letrozole
5467381|NCT01431352|Live birth|live birth
5467382|NCT01431326|adenovirus|adenovirus
5467383|NCT01431326|anaesthetic|anaesthetic
5467384|NCT01431326|anesthesia|anesthesia
5467385|NCT01431326|anticoagulant|anticoagulant
5467386|NCT01431326|anti-epileptic|anti-epileptic
5467387|NCT01431326|anti-inflammatory|anti-inflammatory
5467388|NCT01431326|antimicrobial|antimicrobial
5467389|NCT01431326|anti-psychotic|anti-psychotic
5467390|NCT01431326|antiviral|antiviral
5467392|NCT01431326|anxiolysis|anxiolysis
5467393|NCT01431326|anxiolytic|anxiolytic
5467394|NCT01431326|autism|autism
5467395|NCT01431326|autistic disorder|autistic disorder
5467396|NCT01431326|benzodiazepine|benzodiazepine
5467397|NCT01431326|bipolar disorder|bipolar disorder
5467398|NCT01431326|convulsions|convulsions
5467399|NCT01431326|epilepsy|epilepsy
5467400|NCT01431326|headaches|headaches
5467401|NCT01431326|herpes simplex virus|herpes simplex virus
5467402|NCT01431326|herpes simplex virus (HSV)|herpes simplex virus (hsv)
5467403|NCT01431326|hypertension|hypertension
5467404|NCT01431326|infantile hemangioma|infantile hemangioma
5467405|NCT01431326|infection|infection
5439041|NCT01549418|Rectal Diseases|rectal diseases
5467406|NCT01431326|inflammation|inflammation
5467407|NCT01431326|influenza|influenza
5467408|NCT01431326|lower respiratory tract infection (LRTI)|lower respiratory tract infection (lrti)
5467409|NCT01431326|meningitis|meningitis
5467410|NCT01431326|migraines|migraines
5467411|NCT01431326|muscle spasms|muscle spasms
5467412|NCT01431326|pain|pain
5467413|NCT01431326|pneumonia|pneumonia
5467414|NCT01431326|prophylaxis|prophylaxis
5467415|NCT01431326|retinitis|retinitis
5467416|NCT01431326|schizophrenia|schizophrenia
5467417|NCT01431326|sedation|sedation
5467418|NCT01431326|sedative|sedative
5467419|NCT01431326|seizures|seizures
5467420|NCT01431326|septicemia|septicemia
5467421|NCT01431326|swelling|swelling
5467422|NCT01431326|urinary tract infection|urinary tract infection
5467423|NCT01431326|urinary tract infection (UTI)|urinary tract infection (uti)
5467424|NCT01431326|withdrawal|withdrawal
5467425|NCT01431326|empiric therapy|empiric therapy
5615455|NCT00836160|NSCLC|nsclc
5467426|NCT01431326|staphylococci|staphylococci
5467427|NCT01431326|Fibrinolytic Bleeding|fibrinolytic bleeding
5467428|NCT01431326|pulmonary arterial hypertension|pulmonary arterial hypertension
5467429|NCT01431326|CMV retinitis|cmv retinitis
5467430|NCT01431326|control of serum phosphorus|control of serum phosphorus
5467431|NCT01431326|Hyperaldosteronism|hyperaldosteronism
5467432|NCT01431326|hypokalemia|hypokalemia
5467433|NCT01431326|heart failure|heart failure
5467434|NCT01431326|hemophilia|hemophilia
5467435|NCT01431326|Heavy Menstrual Bleeding|heavy menstrual bleeding
5467436|NCT01431326|insomnia|insomnia
5467437|NCT01431313|pulmonary hypertension|pulmonary hypertension
5467438|NCT01431313|heart failure|heart failure
5461943|NCT01453114|relapse|relapse
5467441|NCT01431300|superior vena cava|superior vena cava
5467442|NCT01431300|Central vein imaging|central vein imaging
5467443|NCT01431261|Chronic neck pain|chronic neck pain
5467444|NCT01431261|Whiplash|whiplash
5467445|NCT01431261|Whiplash Associated Disorders|whiplash associated disorders
5467446|NCT01431261|Chronic Pain|chronic pain
5467447|NCT01431261|Neck exercises|neck exercises
5467448|NCT01431261|Training|training
5467450|NCT01431261|Patient Education|patient education
5467451|NCT01431261|Pain Management|pain management
5467452|NCT01431261|Whiplash Injuries|whiplash injuries
5467453|NCT01431261|Musculoskeletal|musculoskeletal
5467454|NCT01431248|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
5467455|NCT01431248|Erythromycin|erythromycin
5467456|NCT01431248|Azithromycin|azithromycin
5467457|NCT01431235|ADHD|adhd
5467459|NCT01431235|cognitive behavioral therapy|cognitive behavioral therapy
5467460|NCT01431222|severe mitral regurgitation|severe mitral regurgitation
5467461|NCT01431222|interventional mitral valve reconstruction|interventional mitral valve reconstruction
5467462|NCT01431222|inoperable|inoperable
5467463|NCT01431222|EuroSCORE|euroscore
5467464|NCT01431222|STS Risk Score|sts risk score
5467465|NCT01431222|MitraClip|mitraclip
5467466|NCT01431222|fluoroscopy|fluoroscopy
5467467|NCT01431222|echocardiography|echocardiography
5467468|NCT01431222|percutaneous treatment of mitral regurgitation|percutaneous treatment of mitral regurgitation
5467469|NCT01431196|breast cancer|breast cancer
5467470|NCT01431196|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5467471|NCT01431196|autologous dendritic cell vaccination|autologous dendritic cell vaccination
5467472|NCT01431183|influenza|influenza
5467473|NCT01431183|vaccine|vaccine
5467474|NCT01431183|reminder / recall|reminder / recall
5467475|NCT01431183|immunization registry|immunization registry
5467476|NCT01431183|immunization information systems|immunization information systems
5467477|NCT01431157|Sleep Apnea Syndrome|sleep apnea syndrome
5467478|NCT01431157|Heart Failure|heart failure
5467479|NCT01431157|Oxygen Inhalation Therapy|oxygen inhalation therapy
5467487|NCT01431118|hepcidin|hepcidin
5467488|NCT01431118|dragon boating|dragon boating
5467489|NCT01431118|sport-specific stress|sport-specific stress
5467490|NCT01431118|iron|iron
5467491|NCT01431118|anaemia|anaemia
5467492|NCT01431118|sport|sport
5452293|NCT01492855|MRI|mri
5467493|NCT01431105|Kawasaki disease|kawasaki disease
5467494|NCT01431079|HPV|hpv
5467495|NCT01431079|College men|college men
5467496|NCT01431079|HPV vaccine|hpv vaccine
5467497|NCT01431079|Health belief model|health belief model
5467498|NCT01431079|HPV vaccine acceptance|hpv vaccine acceptance
5467499|NCT01431053|exemestane|exemestane
5467500|NCT01431053|aspirin|aspirin
5467501|NCT01431053|quality of life|quality of life
5467502|NCT01431040|Bowel Prep|bowel prep
5467503|NCT01431040|No bowel prep|no bowel prep
5467504|NCT01431040|Vaginal reconstructive or obliterative surgery|vaginal reconstructive or obliterative surgery
5467505|NCT01431027|Heart Failure|heart failure
5467506|NCT01431027|Diastolic Heart Failure|diastolic heart failure
5467507|NCT01431027|Heart Failure with Normal Ejection Fraction|heart failure with normal ejection fraction
5467508|NCT01431014|orthognathic surgery|orthognathic surgery
5467509|NCT01431014|steroid|steroid
5467510|NCT01431014|swelling|swelling
5581539|NCT00962715|CLL|cll
5467511|NCT01431014|3-dimensional photogrammetry|3-dimensional photogrammetry
5467512|NCT01431001|Depression|depression
5467513|NCT01431001|MDD|mdd
5467514|NCT01431001|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5467515|NCT01431001|Depressive Disorder|depressive disorder
5467516|NCT01431001|TMS|tms
5467517|NCT01430988|Head Injuries|head injuries
5467518|NCT01430988|Head Trauma|head trauma
5467519|NCT01430988|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5467520|NCT01430988|Emergency Department|emergency department
5467521|NCT01430988|Accident & Emergency|accident & emergency
5467522|NCT01430975|Radiation Exposure|radiation exposure
5467523|NCT01430975|Rubidium 82|rubidium 82
5467524|NCT01430975|Strontium 82|strontium 82
5467525|NCT01430975|Strontium 85|strontium 85
5467526|NCT01430962|EBUS|ebus
5467527|NCT01430962|mediastinal lymph nodes|mediastinal lymph nodes
5467528|NCT01430962|mediastinal masses|mediastinal masses
5467529|NCT01430962|anesthesia|anesthesia
5467530|NCT01430962|moderate sedation|moderate sedation
5467531|NCT01430949|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5467532|NCT01430949|Catheter Ablation|catheter ablation
5467533|NCT01430949|Pulmonary Vein Isolation|pulmonary vein isolation
5467534|NCT01430949|Radio Frequency Ablation|radio frequency ablation
5467535|NCT01430936|Vascular Diseases|vascular diseases
5467536|NCT01430936|Hypertension|hypertension
5467537|NCT01430936|Chronic Kidney Disease|chronic kidney disease
5467538|NCT01430936|COPD|copd
5467539|NCT01430923|Refrigeration free latanoprost|refrigeration free latanoprost
5467540|NCT01430910|Phase 1|phase 1
5467541|NCT01430910|open label|open label
5467542|NCT01430910|ceftazidime|ceftazidime
5467544|NCT01430910|urinary tract infection|urinary tract infection
5467545|NCT01430910|intra-abdominal infection|intra-abdominal infection
5467546|NCT01430897|d-TGA|d-tga
5467547|NCT01430897|dextro Transposition of the great arteries|dextro transposition of the great arteries
5467548|NCT01430897|systemic right ventricle|systemic right ventricle
5467549|NCT01430897|right ventricular failure|right ventricular failure
5467550|NCT01430897|Atrial switch procedure|atrial switch procedure
5467551|NCT01430884|coronary aspirate blood|coronary aspirate blood
5467552|NCT01430884|particular debris / microemboli|particular debris / microemboli
5467553|NCT01430884|distal occlusion device|distal occlusion device
5467554|NCT01430858|Fracture|fracture
5467555|NCT01430858|Anabolic|anabolic
5467556|NCT01430858|Vibration|vibration
5467557|NCT01430858|Strain Gauge|strain gauge
5467558|NCT01430858|Focus - Osteoporosis|focus - osteoporosis
5467559|NCT01430845|GDD|gdd
5467560|NCT01430845|CP|cp
5467561|NCT01430845|MR|mr
5467562|NCT01430845|PDD|pdd
5467563|NCT01430845|ASD|asd
5467564|NCT01430845|BSID|bsid
5467565|NCT01430832|PTSD|ptsd
5467566|NCT01430832|Preterm|preterm
5467567|NCT01430832|Premature|premature
5467568|NCT01430832|VLBW|vlbw
5467569|NCT01430819|Influenza|influenza
5467570|NCT01430819|Influenza Virus Vaccine|influenza virus vaccine
5470647|NCT01418378|retaining|retaining
5467572|NCT01430819|Fluzone® High-Dose 2011-2012 Formulation|fluzone® high-dose 2011-2012 formulation
5467573|NCT01430819|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5467574|NCT01430780|Coronary artery disease|coronary artery disease
5467575|NCT01430780|nitrate|nitrate
5467576|NCT01430780|endothelium|endothelium
5467577|NCT01430767|adherence|adherence
5467578|NCT01430754|Blindness|blindness
5467579|NCT01430754|Eye Diseases|eye diseases
5467580|NCT01430754|Nap Disorders|nap disorders
5467864|NCT01429545|atosiban|atosiban
5467581|NCT01430754|Circadian Rhythm Disorders|circadian rhythm disorders
5467582|NCT01430754|Sleep Disorders|sleep disorders
5467583|NCT01430754|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5467584|NCT01430754|Dyssomnias|dyssomnias
5467585|NCT01430754|Nervous System Diseases|nervous system diseases
5467586|NCT01430741|Implementation Science|implementation science
5467587|NCT01430741|Supportive Housing|supportive housing
5467588|NCT01430741|Co-occurring disorders|co-occurring disorders
5467589|NCT01430741|Cluster randomized controlled trial|cluster randomized controlled trial
5467590|NCT01430741|Hybrid implementation-effectiveness trial|hybrid implementation-effectiveness trial
5467591|NCT01430715|active video game|active video game
5467592|NCT01430715|video gaming|video gaming
5467593|NCT01430715|accelerometery|accelerometery
5467594|NCT01430715|MVPA|mvpa
5467595|NCT01430715|outdoor play|outdoor play
5467596|NCT01430715|children|children
5467597|NCT01430715|unstructured|unstructured
5467598|NCT01430715|energy expenditure|energy expenditure
5467599|NCT01430689|Influenza|influenza
5467600|NCT01430689|Pregnancy|pregnancy
5467601|NCT01430689|Neonates|neonates
5467602|NCT01430676|Incisional hernia|incisional hernia
5467603|NCT01430676|recurrence|recurrence
5467604|NCT01430676|longterm|longterm
5467605|NCT01430663|aspergillosis|aspergillosis
5467606|NCT01430663|bronchoalveolar lavage|bronchoalveolar lavage
5467607|NCT01430663|galactomannan|galactomannan
5467608|NCT01430663|pcr|pcr
5467609|NCT01430663|hematological patients|hematological patients
5454129|NCT01485653|Mepivacaine|mepivacaine
5467610|NCT01430650|Oral estrogens|oral estrogens
5467611|NCT01430650|transdermal estrogens|transdermal estrogens
5467612|NCT01430650|endometrial priming|endometrial priming
5467613|NCT01430637|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5467614|NCT01430637|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5467615|NCT01430637|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5467616|NCT01430637|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5467617|NCT01430637|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5467618|NCT01430637|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5467619|NCT01430637|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5467620|NCT01430637|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5467621|NCT01430637|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5467622|NCT01430637|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5467623|NCT01430624|Rape|rape
5467624|NCT01430624|Secondary prevention|secondary prevention
5467625|NCT01430624|Intervention|intervention
5467626|NCT01430611|Meningitis|meningitis
5467627|NCT01430611|Neisseria meningitidis|neisseria meningitidis
5467628|NCT01430611|Meningo A+C®|meningo a+c®
5467629|NCT01430611|Meng Ling Kang®|meng ling kang®
5467630|NCT01430598|Full Thickness Rotator Cuff Tear and Acromial Spur|full thickness rotator cuff tear and acromial spur
5467631|NCT01430585|Ki-67|ki-67
5467632|NCT01430585|postmenopausal early breast cancer|postmenopausal early breast cancer
5467633|NCT01430585|ER positive/HER2 negative early breast cancer|er positive/her2 negative early breast cancer
5467634|NCT01430572|Advanced Cancers|advanced cancers
5467635|NCT01430572|Solid Tumors|solid tumors
5467636|NCT01430572|PI3KCA Mutation Positive/PTEN|pi3kca mutation positive/pten
5467637|NCT01430572|Refractory to standard therapy|refractory to standard therapy
5467638|NCT01430572|Relapsed after standard therapy|relapsed after standard therapy
5467639|NCT01430572|Pazopanib|pazopanib
5467640|NCT01430572|GW786034|gw786034
5467641|NCT01430572|Everolimus|everolimus
5467642|NCT01430572|Afinitor|afinitor
5467643|NCT01430572|RAD001|rad001
5467644|NCT01430559|Validation of the WOMAC in Chinese subjects with osteoarthritis of the knee|validation of the womac in chinese subjects with osteoarthritis of the knee
5467645|NCT01430546|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5467646|NCT01430533|dermal sensitization potential|dermal sensitization potential
5467647|NCT01430507|Anti-inflammatory drugs, DMARD|anti-inflammatory drugs, dmard
5467648|NCT01430481|rosehip|rosehip
5467649|NCT01430481|osteoarthritis|osteoarthritis
5467650|NCT01430481|pain|pain
5467651|NCT01430481|knee|knee
5467653|NCT01430468|Glenoid component position|glenoid component position
5467654|NCT01430468|patient specific instruments|patient specific instruments
5467655|NCT01430455|Major Depressive Episode|major depressive episode
5467656|NCT01430455|Depression NOS|depression nos
5467657|NCT01430455|Bipolar Disorder|bipolar disorder
5467658|NCT01430455|Bipolar Disorder I|bipolar disorder i
5467659|NCT01430455|Bipolar Disorder II|bipolar disorder ii
5467660|NCT01430455|Bipolar Depression|bipolar depression
5467661|NCT01430455|Major Depression|major depression
5467662|NCT01430416|Uveal melanoma|uveal melanoma
5467663|NCT01430416|phase 1|phase 1
5467664|NCT01430416|AEB071|aeb071
5467665|NCT01430416|Metastatic|metastatic
5467666|NCT01430403|persistent allergic asthma|persistent allergic asthma
5467667|NCT01430403|asthma exacerbations reduction|asthma exacerbations reduction
5467668|NCT01430403|Xolair® (omalizumab)|xolair® (omalizumab)
5467669|NCT01430403|Flovent® Diskus® (fluticasone)|flovent® diskus® (fluticasone)
5467670|NCT01430403|placebo|placebo
5467671|NCT01430403|inhaled corticosteroid therapy|inhaled corticosteroid therapy
5467672|NCT01430403|anti-immunoglobulin E therapy|anti-immunoglobulin e therapy
5467673|NCT01430403|anti-IgE therapy|anti-ige therapy
5467674|NCT01430390|In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic|in vitro expanded allogeneic epstein-barr virus specific cytotoxic
5467675|NCT01430390|T-Lymphocytes (EBV-CTLs)|t-lymphocytes (ebv-ctls)
5467676|NCT01430390|CD19 specific T-cells|cd19 specific t-cells
5467677|NCT01430390|11-038|11-038
5452486|NCT01492244|map|map
5467678|NCT01430377|periprocedural myonecrosis|periprocedural myonecrosis
5467679|NCT01430377|procedure time|procedure time
5467680|NCT01430377|fluoroscopy time|fluoroscopy time
5467681|NCT01430364|coronary bifurcation stenosis|coronary bifurcation stenosis
5467682|NCT01430364|dedicated bifurcation stent|dedicated bifurcation stent
5467683|NCT01430364|sirolymus|sirolymus
5467684|NCT01430364|PTS|pts
5467685|NCT01430364|BiOSS Lym|bioss lym
5467686|NCT01430325|Hyperbaric oxygen|hyperbaric oxygen
5467687|NCT01430312|dermal irritative potential|dermal irritative potential
5467688|NCT01430286|Caregivers|caregivers
5467689|NCT01430286|Alzheimer Disease|alzheimer disease
5467690|NCT01430286|Psychological stress|psychological stress
5467691|NCT01430286|Psychological adaptation|psychological adaptation
5467692|NCT01430286|Self-efficacy|self-efficacy
5467693|NCT01430286|Randomized controlled trial|randomized controlled trial
5454235|NCT01485159|COPD|copd
5467694|NCT01430273|Antiplatelet therapy|antiplatelet therapy
5467695|NCT01430273|Surgery|surgery
5467696|NCT01430273|Bleeding|bleeding
5467697|NCT01430273|Platelet aggregation|platelet aggregation
5467698|NCT01430260|efficacy|efficacy
5467699|NCT01430260|ciclesonide|ciclesonide
5467700|NCT01430260|levocetirizine|levocetirizine
5467701|NCT01430260|allergic rhinitis|allergic rhinitis
5467702|NCT01430247|amblyopia|amblyopia
5467703|NCT01430247|amblyogenic factors|amblyogenic factors
5467704|NCT01430247|screening|screening
5467705|NCT01430247|preschool children|preschool children
5467706|NCT01430247|visual acuity|visual acuity
5467707|NCT01430247|prevalence|prevalence
5467708|NCT01430234|Chronic pancreatitis|chronic pancreatitis
5467709|NCT01430234|Exocrine insufficiency|exocrine insufficiency
5467710|NCT01430234|Pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5467711|NCT01430234|Self-administration|self-administration
5467712|NCT01430221|prediabetes|prediabetes
5467713|NCT01430221|severity of depressive symptoms|severity of depressive symptoms
5467714|NCT01430221|mindfulness|mindfulness
5467715|NCT01430221|personalized health planning|personalized health planning
5467716|NCT01430221|cardiometabolic diseases prevention|cardiometabolic diseases prevention
5467717|NCT01430208|endometrial pathology|endometrial pathology
5467718|NCT01430195|vitiligo|vitiligo
5467719|NCT01430195|depigmentation|depigmentation
5467720|NCT01430195|phototherapy|phototherapy
5467721|NCT01430195|non-segmental vitiligo|non-segmental vitiligo
5467722|NCT01430182|Adult|adult
5467723|NCT01430182|Female|female
5467724|NCT01430182|Humans|humans
5467725|NCT01430182|Intraoperative Care/methods|intraoperative care/methods
5467726|NCT01430182|Male|male
5467727|NCT01430182|Methadone/administration & dosage|methadone/administration & dosage
5467728|NCT01430182|Analgesics/therapeutic use|analgesics/therapeutic use
5467737|NCT01430182|Tibial Fractures/surgery|tibial fractures/surgery
5467738|NCT01430182|Young Adult|young adult
5467739|NCT01430182|Orthopedics|orthopedics
5467740|NCT01430169|Xiaflex|xiaflex
5467741|NCT01430169|Xiapex|xiapex
5467742|NCT01430169|Collagenase clostridium histolyticum|collagenase clostridium histolyticum
5467743|NCT01430156|Renal Transplantation|renal transplantation
5467744|NCT01430156|Ischemia-reperfusion injury|ischemia-reperfusion injury
5467745|NCT01430156|Heme-oxygenase 1|heme-oxygenase 1
5467746|NCT01430156|Heme arginate|heme arginate
5467747|NCT01430143|Exercise|exercise
5467748|NCT01430130|scar|scar
5467749|NCT01430130|incision|incision
5467750|NCT01430130|wound healing|wound healing
5467751|NCT01430130|scarring|scarring
5467752|NCT01430130|scar revision|scar revision
5467753|NCT01430117|Immunotherapy|immunotherapy
5467754|NCT01430117|Skin prick test|skin prick test
5467755|NCT01430117|Standardization|standardization
5467756|NCT01430117|Poa pratensis|poa pratensis
5467757|NCT01430078|ASP015K|asp015k
5467758|NCT01430078|Healthy subjects|healthy subjects
5467759|NCT01430078|Pharmacokinetics of ASP015K|pharmacokinetics of asp015k
5467760|NCT01430065|transplant|transplant
5467761|NCT01430065|ASP015K|asp015k
5467762|NCT01430065|tacrolimus|tacrolimus
5467763|NCT01430065|Prograf|prograf
5467764|NCT01430065|healthy volunteers|healthy volunteers
5467765|NCT01430039|Crohn's disease|crohn's disease
5467766|NCT01430039|ulcerative colitis|ulcerative colitis
5467767|NCT01430039|Syndecan-1|syndecan-1
5467768|NCT01430026|chronic sinusitis|chronic sinusitis
5467865|NCT01429545|nifedipine|nifedipine
5467769|NCT01430026|gentamicin nasal irrigation|gentamicin nasal irrigation
5467770|NCT01429987|Chronic Idiopathic Constipation|chronic idiopathic constipation
5467771|NCT01429987|Constipation|constipation
5467772|NCT01429987|Sign and Symptoms: Digestive|sign and symptoms: digestive
5467773|NCT01429974|amniotic fluid|amniotic fluid
5452598|NCT01491802|Dyspnea|dyspnea
5467774|NCT01429974|post term pregnancies|post term pregnancies
5467775|NCT01429948|Stroke, Ischemic|stroke, ischemic
5467776|NCT01429948|Patent foramen ovale|patent foramen ovale
5467777|NCT01429948|Magnetic resonance imaging|magnetic resonance imaging
5467778|NCT01429948|Paradoxical embolism|paradoxical embolism
5467779|NCT01429948|Transcranial Doppler|transcranial doppler
5467780|NCT01429948|Silent cerebral infarct|silent cerebral infarct
5467781|NCT01429935|dental pain model|dental pain model
5467782|NCT01429935|Ginger powder|ginger powder
5467783|NCT01429935|CRP|crp
5467784|NCT01429909|Functional magnetic resonance imaging|functional magnetic resonance imaging
5467785|NCT01429909|T2*|t2*
5467786|NCT01429909|cortex and basal ganglia|cortex and basal ganglia
5467787|NCT01429909|Parkinson's disease|parkinson's disease
5467788|NCT01429896|peanut allergy|peanut allergy
5467789|NCT01429896|food allergy|food allergy
5467790|NCT01429896|thresholds|thresholds
5467791|NCT01429896|anaphylaxis|anaphylaxis
5467792|NCT01429896|food labelling|food labelling
5467793|NCT01429896|food challenges|food challenges
5467794|NCT01429896|peanut challenges|peanut challenges
5467795|NCT01429857|Troponin concentration in heart failure|troponin concentration in heart failure
5467796|NCT01429844|Calcineurin inhibitors|calcineurin inhibitors
5467797|NCT01429844|Bronchiolitis obliterans|bronchiolitis obliterans
5467798|NCT01429844|Lung transplantation|lung transplantation
5467799|NCT01429844|Cyclosporine|cyclosporine
5467800|NCT01429844|Tacrolimus|tacrolimus
5467801|NCT01429844|Mycophenolate|mycophenolate
5467802|NCT01429844|Steroids|steroids
5467803|NCT01429844|Chronic rejection|chronic rejection
5467805|NCT01429844|Obliterative bronchiolitis|obliterative bronchiolitis
5467806|NCT01429818|Endothelial dysfunction|endothelial dysfunction
5467807|NCT01429818|Diabetes mellitus|diabetes mellitus
5467808|NCT01429818|glimepiride|glimepiride
5467809|NCT01429818|metformin|metformin
5467810|NCT01429805|Hip arthroscopy|hip arthroscopy
5450094|NCT01502358|dengue|dengue
5467811|NCT01429779|General surgery|general surgery
5467812|NCT01429766|Breath holding times|breath holding times
5467813|NCT01429766|Phases of respiration|phases of respiration
5467814|NCT01429766|Radiotherapy|radiotherapy
5467815|NCT01429753|Cardiac resychronisation therapy|cardiac resychronisation therapy
5467816|NCT01429753|Heart failure|heart failure
5467817|NCT01429753|Imaging guided LV lead placement|imaging guided lv lead placement
5467818|NCT01429740|PF 05180999|pf 05180999
5467819|NCT01429740|safety|safety
5467820|NCT01429740|pharmacokinetics|pharmacokinetics
5467821|NCT01429727|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
5467822|NCT01429727|SCAD|scad
5467823|NCT01429727|coronary artery disease|coronary artery disease
5467824|NCT01429727|myocardial infarction|myocardial infarction
5467825|NCT01429727|coronary dissection|coronary dissection
5467826|NCT01429714|Elastic Compression Stockings|elastic compression stockings
5467827|NCT01429714|Deep Venous Thrombosis|deep venous thrombosis
5467828|NCT01429714|Post Thrombotic Syndrome|post thrombotic syndrome
5467829|NCT01429701|Dermatitis|dermatitis
5467830|NCT01429701|Dermatitis, Atopic|dermatitis, atopic
5467831|NCT01429662|postmenopause|postmenopause
5467832|NCT01429662|hypertension|hypertension
5467833|NCT01429662|relaxation|relaxation
5467834|NCT01429662|SBP 140-159 mmHg|sbp 140-159 mmhg
5467835|NCT01429662|DBP 90-99 mmHg|dbp 90-99 mmhg
5467836|NCT01429662|stage 1 or mild hypertension|stage 1 or mild hypertension
5467837|NCT01429649|pure pulmonary ground glass opacity|pure pulmonary ground glass opacity
5467838|NCT01429636|perimenopause|perimenopause
5467839|NCT01429636|postmenopause|postmenopause
5467840|NCT01429636|vasomotor symptoms|vasomotor symptoms
5467841|NCT01429636|relaxation|relaxation
5467842|NCT01429623|Mild Cognitive Impairment|mild cognitive impairment
5467843|NCT01429623|Early Stage Dementia|early stage dementia
5467844|NCT01429623|Conversion to Alzheimer's disease|conversion to alzheimer's disease
5467845|NCT01429623|Memory Impairment|memory impairment
5467846|NCT01429610|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5467847|NCT01429610|rituximab|rituximab
5467848|NCT01429610|VPDL|vpdl
5467849|NCT01429610|CD20|cd20
5467850|NCT01429597|Cerebrovascular Accident|cerebrovascular accident
5467851|NCT01429597|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5467852|NCT01429597|Fabry Disease|fabry disease
5467853|NCT01429597|Fabry´s Disease|fabry´s disease
5467854|NCT01429597|Anderson-Fabry Disease|anderson-fabry disease
5467855|NCT01429597|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5467856|NCT01429597|Stroke, Acute|stroke, acute
5467857|NCT01429597|Cerebral Stroke|cerebral stroke
5467858|NCT01429584|bupivacaine concentration|bupivacaine concentration
5467859|NCT01429584|interscalene nerve block|interscalene nerve block
5467860|NCT01429584|diaphragm function|diaphragm function
5467861|NCT01429584|diaphragm weakness|diaphragm weakness
5467862|NCT01429558|treatment resistant obsessive-compulsive disorder|treatment resistant obsessive-compulsive disorder
5467866|NCT01429545|combination|combination
5467867|NCT01429532|Cataract|cataract
5467868|NCT01429519|chronic wound|chronic wound
5467869|NCT01429519|ulcerated wound|ulcerated wound
5467870|NCT01429519|venous insufficiency|venous insufficiency
5467871|NCT01429519|lymphatic insufficiency|lymphatic insufficiency
5467872|NCT01429519|neuropathic wound|neuropathic wound
5467873|NCT01429519|diabetic ulcer|diabetic ulcer
5467874|NCT01429519|post- operative|post- operative
5467875|NCT01429519|post-traumatic chronic wound|post-traumatic chronic wound
5467876|NCT01429506|Sleeve gastrectomy|sleeve gastrectomy
5467877|NCT01429506|Intensive medical management|intensive medical management
5467878|NCT01429480|Analgesia, postoperative|analgesia, postoperative
5467879|NCT01429467|Glucose Variability|glucose variability
5467880|NCT01429467|Continuous Glucose Monitoring|continuous glucose monitoring
5467881|NCT01429467|Hypoxia-inducible Factor (HIF)|hypoxia-inducible factor (hif)
5467882|NCT01429467|Vascular Endothelial Growth Factor (VEGF)|vascular endothelial growth factor (vegf)
5467883|NCT01429467|Erythropoietin|erythropoietin
5467885|NCT01429454|Prodromal|prodromal
5467886|NCT01429454|Schizophrenia|schizophrenia
5467887|NCT01429454|Psychosis|psychosis
5467888|NCT01429454|Omega|omega
5467889|NCT01429428|Cellulitis|cellulitis
5467890|NCT01429428|Skin ultra-sound images|skin ultra-sound images
5467891|NCT01429428|Treatment|treatment
5467892|NCT01429428|Infra-red light|infra-red light
5467893|NCT01429415|pediatric|pediatric
5467894|NCT01429415|Acute Asthma|acute asthma
5467895|NCT01429415|Inhaled Magnesium|inhaled magnesium
5467896|NCT01429402|Botulinum toxin A.|botulinum toxin a.
5467897|NCT01429402|Cleft lip scar|cleft lip scar
5467898|NCT01429389|Down syndrome|down syndrome
5467899|NCT01429389|fetal aneuploidy|fetal aneuploidy
5467900|NCT01429389|trisomy|trisomy
5467901|NCT01429389|noninvasive screening test|noninvasive screening test
5467902|NCT01429376|Chronic heart failure|chronic heart failure
5467903|NCT01429376|Pulmonary function abnormalities/impairment|pulmonary function abnormalities/impairment
5467904|NCT01429376|Restriction|restriction
5467905|NCT01429376|Airway obstruction|airway obstruction
5467906|NCT01429376|Diffusion impairment|diffusion impairment
5450190|NCT01502059|Treatment|treatment
5467907|NCT01429376|Pulmonary function tests|pulmonary function tests
5467908|NCT01429376|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5467909|NCT01429376|Prevalence|prevalence
5467910|NCT01429376|Overdiagnosis|overdiagnosis
5467911|NCT01429376|Underdiagnosis|underdiagnosis
5467912|NCT01429376|Systemic inflammation|systemic inflammation
5467913|NCT01429376|Diagnostic Errors|diagnostic errors
5467918|NCT01429350|ischemic stroke|ischemic stroke
5467919|NCT01429350|acute intervention|acute intervention
5467920|NCT01429350|thrombolysis|thrombolysis
5467922|NCT01429350|internal carotid artery|internal carotid artery
5467923|NCT01429350|middle cerebral artery|middle cerebral artery
5467924|NCT01429350|mechanical thrombectomy|mechanical thrombectomy
5467925|NCT01429350|Penumbra System|penumbra system
5467926|NCT01429350|clot length|clot length
5467927|NCT01429350|mRS|mrs
5467928|NCT01429350|NIHSS|nihss
5467929|NCT01429337|Pharmacokinetics|pharmacokinetics
5467930|NCT01429337|Hepatic impaired patients|hepatic impaired patients
5467931|NCT01429337|Healthy volunteers|healthy volunteers
5467932|NCT01429337|Varying degrees of hepatic impairment|varying degrees of hepatic impairment
5467933|NCT01429324|Near infrared spectroscopy|near infrared spectroscopy
5467934|NCT01429324|neuromonitoring|neuromonitoring
5467935|NCT01429324|aortic arch surgery|aortic arch surgery
5467936|NCT01429311|Atopic Dermatitis|atopic dermatitis
5467937|NCT01429311|Eczema herpeticum|eczema herpeticum
5467938|NCT01429311|Interferon gamma|interferon gamma
5467939|NCT01429311|IFNγ|ifnγ
5467940|NCT01429298|Acute|acute
5467941|NCT01429298|Pain|pain
5467942|NCT01429298|Emergency Department|emergency department
5467943|NCT01429298|Hydromorphone|hydromorphone
5467944|NCT01429298|Protocol|protocol
5467945|NCT01429285|Pain|pain
5467946|NCT01429285|Hydromorphone|hydromorphone
5467947|NCT01429285|Acute|acute
5467948|NCT01429285|Emergency Department|emergency department
5467949|NCT01429272|Bipolar Disorder|bipolar disorder
5467950|NCT01429272|Minocycline|minocycline
5467951|NCT01429259|Cystic Fibrosis|cystic fibrosis
5467952|NCT01429259|Acute Pulmonary Exacerbations|acute pulmonary exacerbations
5467953|NCT01429259|Pseudomonas aeruginosa|pseudomonas aeruginosa
5467954|NCT01429246|Hypertension|hypertension
5467955|NCT01429246|Diet Therapy|diet therapy
5467956|NCT01429246|Sodium Chloride, Dietary|sodium chloride, dietary
5467957|NCT01429246|Tibet|tibet
5467958|NCT01429246|Aged|aged
5467959|NCT01429233|Observational|observational
5467960|NCT01429233|Colombia|colombia
5467961|NCT01429220|deep brain stimulation|deep brain stimulation
5467962|NCT01429220|monopolar review|monopolar review
5467963|NCT01429220|motion sensors|motion sensors
5467964|NCT01429220|tremor|tremor
5467965|NCT01429220|bradykinesia|bradykinesia
5467966|NCT01429207|levodopa|levodopa
5467967|NCT01429207|tremor|tremor
5467968|NCT01429207|bradykinesia|bradykinesia
5467969|NCT01429207|motion sensors|motion sensors
5467970|NCT01429194|Weight Loss|weight loss
5467971|NCT01429194|Trans-oral Endoscopic Procedure|trans-oral endoscopic procedure
5467972|NCT01429194|Gastric Plication|gastric plication
5467973|NCT01429181|Peripheral Neuropathic Pain|peripheral neuropathic pain
5467974|NCT01429155|End stage liver disease|end stage liver disease
5467975|NCT01429155|Living donor liver transplantation|living donor liver transplantation
5467976|NCT01429155|Hepatitis C|hepatitis c
5467977|NCT01429155|Interleukin 28B|interleukin 28b
5467978|NCT01429129|Smoking|smoking
5467979|NCT01429129|Nicotine|nicotine
5467980|NCT01429129|Nicotine Replacement Therapy|nicotine replacement therapy
5467981|NCT01429129|Nicotine Patch|nicotine patch
5467982|NCT01429129|Nicoderm|nicoderm
5467983|NCT01429129|Mass Distribution|mass distribution
5467984|NCT01429129|Tobacco Control|tobacco control
5467985|NCT01429129|Randomized Controlled Trial|randomized controlled trial
5467986|NCT01429116|Blindness|blindness
5467987|NCT01429116|Eye Diseases|eye diseases
5467988|NCT01429116|Nap Disorders|nap disorders
5467989|NCT01429116|Circadian Rhythm Disorders|circadian rhythm disorders
5467990|NCT01429116|Sleep Disorders|sleep disorders
5467991|NCT01429116|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5467992|NCT01429116|Dyssomnias|dyssomnias
5467993|NCT01429116|Nervous System Diseases|nervous system diseases
5467994|NCT01429090|Pharmacokinetics|pharmacokinetics
5467995|NCT01429090|Accommodation, Ocular|accommodation, ocular
5467997|NCT01429090|Salivation|salivation
5467998|NCT01429077|Levodopa|levodopa
5467999|NCT01429077|Ischemic Stroke|ischemic stroke
5468001|NCT01429077|Speech Rehabilitation|speech rehabilitation
5468002|NCT01429051|Break through pain|break through pain
5468003|NCT01429051|BTP|btp
5468004|NCT01429051|Cancer|cancer
5468005|NCT01429051|Intranasal Fentanyl Spray|intranasal fentanyl spray
5468006|NCT01429051|INFS|infs
5468007|NCT01429051|cancer patients|cancer patients
5468008|NCT01429038|end-stage|end-stage
5468009|NCT01429038|liver diseases|liver diseases
5468010|NCT01429038|cirrhosis|cirrhosis
5468011|NCT01429038|cancer|cancer
5468012|NCT01429038|fulminant hepatic failure|fulminant hepatic failure
5462528|NCT01450839|elderly|elderly
5468013|NCT01429038|metabolic hepatic diseases|metabolic hepatic diseases
5468014|NCT01429038|congenital hepatic diseases|congenital hepatic diseases
5468015|NCT01429038|renal diseases|renal diseases
5468016|NCT01429025|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5468017|NCT01429025|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5468018|NCT01429025|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5468019|NCT01429025|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5468020|NCT01429025|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5468021|NCT01429025|Waldenström macroglobulinemia|waldenström macroglobulinemia
5468022|NCT01429025|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5468023|NCT01429025|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5468024|NCT01429012|bone|bone
5468025|NCT01429012|nonunion fracture|nonunion fracture
5468026|NCT01429012|atrophic nonunion fracture|atrophic nonunion fracture
5468027|NCT01429012|callus|callus
5468028|NCT01429012|mesenchymal stem cells|mesenchymal stem cells
5468029|NCT01429012|cell therapy|cell therapy
5468030|NCT01429012|autologous|autologous
5468031|NCT01429012|indium|indium
5468032|NCT01429012|Pet-scan|pet-scan
5468033|NCT01428999|probiotics|probiotics
5468034|NCT01428999|gastrointestinal function|gastrointestinal function
5468035|NCT01428999|intestinal bacteria flora|intestinal bacteria flora
5468036|NCT01428986|maraviroc|maraviroc
5468037|NCT01428986|osteoclasts|osteoclasts
5468038|NCT01428986|Receptors, CCR5|receptors, ccr5
5468039|NCT01428986|Chemokine CCL5|chemokine ccl5
5468040|NCT01428973|Allogeneic hematopoeitic cell transplantation|allogeneic hematopoeitic cell transplantation
5468041|NCT01428973|Graft-Versus-Host Disease|graft-versus-host disease
5468042|NCT01428973|Prophylaxis|prophylaxis
5468043|NCT01428973|Reduced-intensity conditioning|reduced-intensity conditioning
5468044|NCT01428973|Immunosuppressive regimen|immunosuppressive regimen
5468045|NCT01428973|HLA-matched donor|hla-matched donor
5468046|NCT01428973|Progression free survival|progression free survival
5468047|NCT01428973|Overall survival|overall survival
5468048|NCT01428960|Palm mid fraction|palm mid fraction
5468049|NCT01428960|Shea butter|shea butter
5468050|NCT01428960|sn-1, sn-3 fatty acids|sn-1, sn-3 fatty acids
5468051|NCT01428960|Cholesterol|cholesterol
5468052|NCT01428960|Postprandial lipemia,|postprandial lipemia,
5468053|NCT01428960|Inflammatory markers|inflammatory markers
5468054|NCT01428960|Satiety|satiety
5468055|NCT01428960|Gut hormone|gut hormone
5468056|NCT01428960|Insulin|insulin
5468057|NCT01428921|Long-term efficacy|long-term efficacy
5468058|NCT01428921|Education programme|education programme
5468059|NCT01428921|Adherence|adherence
5468060|NCT01428921|OSA|osa
5468061|NCT01428921|CPAP|cpap
5468062|NCT01428908|immunogenicity|immunogenicity
5468064|NCT01428908|group A, C polysaccharide meningitis|group a, c polysaccharide meningitis
5468065|NCT01428908|type b haemophilus Influenza|type b haemophilus influenza
5468066|NCT01428908|conjugate vaccine|conjugate vaccine
5468067|NCT01428895|Bone Metastases|bone metastases
5468068|NCT01428895|Femoral Metastases|femoral metastases
5468069|NCT01428882|Propofol|propofol
5468070|NCT01428882|Midazolam|midazolam
5468071|NCT01428882|Moderate sedation|moderate sedation
5468072|NCT01428882|Deep sedation|deep sedation
5468073|NCT01428882|Colonoscopy|colonoscopy
5468074|NCT01428869|Statins|statins
5468075|NCT01428869|acetylsalicylic acid|acetylsalicylic acid
5468076|NCT01428869|dutasteride|dutasteride
5468077|NCT01428869|Prostate Cancer|prostate cancer
5468078|NCT01428869|Lower urinary tract symptoms|lower urinary tract symptoms
5468079|NCT01428869|prevention|prevention
5468080|NCT01428869|drug interactions|drug interactions
5468081|NCT01428843|Inflammatory Bowel Disease|inflammatory bowel disease
5468082|NCT01428843|Anemia|anemia
5468083|NCT01428843|Anti-TNF alpha theray|anti-tnf alpha theray
5468084|NCT01428843|Ferrisat perfusion|ferrisat perfusion
5468085|NCT01428830|fistula|fistula
5468086|NCT01428830|catheter|catheter
5468087|NCT01428830|surgery|surgery
5468088|NCT01428830|obstetrics|obstetrics
5468089|NCT01428830|gynecology|gynecology
5468090|NCT01428830|urology|urology
5468091|NCT01428817|pregnancy|pregnancy
5468092|NCT01428817|postpartum hemorrhage|postpartum hemorrhage
5468093|NCT01428817|Cesarean delivery|cesarean delivery
5468094|NCT01428817|carbetocin|carbetocin
5468095|NCT01428804|Resistant Major Depression|resistant major depression
5468096|NCT01428804|Mood disorders|mood disorders
5468098|NCT01428791|Geriatrics|geriatrics
5468099|NCT01428791|Older adults|older adults
5468100|NCT01428791|Health Disparities|health disparities
5468101|NCT01428791|Health Services for the Aged|health services for the aged
5468102|NCT01428791|Interdisciplinary Health Team|interdisciplinary health team
5468103|NCT01428791|Depressive symptoms|depressive symptoms
5468104|NCT01428791|Metabolic Syndrome X|metabolic syndrome x
5468105|NCT01428791|Overweight|overweight
5468106|NCT01428791|Obesity|obesity
5468107|NCT01428791|Hypertension|hypertension
5468108|NCT01428791|Hyperglycemia|hyperglycemia
5468109|NCT01428791|Dyslipidemias|dyslipidemias
5468110|NCT01428778|Marathon running|marathon running
5468112|NCT01428778|ECG recording|ecg recording
5468113|NCT01428778|Blood tests|blood tests
5468114|NCT01428752|colonoscopy|colonoscopy
5468115|NCT01428752|colorectal neoplasms|colorectal neoplasms
5468116|NCT01428752|screening|screening
5468117|NCT01428752|family history|family history
5468118|NCT01428739|cancer|cancer
5468119|NCT01428739|MRS|mrs
5468120|NCT01428739|Treatment response|treatment response
5468121|NCT01428726|NT-KO-003|nt-ko-003
5468122|NCT01428726|RRMS|rrms
5468123|NCT01428726|efficacy|efficacy
5468124|NCT01428726|safety|safety
5468125|NCT01428726|Phase IIa|phase iia
5468126|NCT01428713|menorrhagia|menorrhagia
5468127|NCT01428713|oral contraceptives|oral contraceptives
5468128|NCT01428713|oral tranexamic acid|oral tranexamic acid
5468129|NCT01428687|Weight loss|weight loss
5468130|NCT01428687|Sleep duration|sleep duration
5468131|NCT01428674|Interpersonal mindful compassion|interpersonal mindful compassion
5468132|NCT01428674|Loving kindness meditation|loving kindness meditation
5468133|NCT01428674|Autonomic Nervous System|autonomic nervous system
5468134|NCT01428674|Heart rate variability|heart rate variability
5468135|NCT01428674|Respiratory rate|respiratory rate
5468136|NCT01428674|Relaxation|relaxation
5468137|NCT01428661|tasimelteon|tasimelteon
5468138|NCT01428661|Major Depressive Disorder|major depressive disorder
5468140|NCT01428661|depression|depression
5468141|NCT01428648|Parkinson|parkinson
5468142|NCT01428648|ballroom dancing|ballroom dancing
5468143|NCT01428609|Amalgam|amalgam
5468144|NCT01428609|Mercury|mercury
5468145|NCT01428609|Endodontics|endodontics
5468146|NCT01428609|Apicoectomy|apicoectomy
5468147|NCT01428596|HIV-1|hiv-1
5468148|NCT01428596|therapeutic vaccine|therapeutic vaccine
5468149|NCT01428596|immunotherapy|immunotherapy
5468150|NCT01428596|AIDS|aids
5468151|NCT01428583|Chronic noncancer pain|chronic noncancer pain
5468152|NCT01428583|oxycodone|oxycodone
5468153|NCT01428583|naltrexone|naltrexone
5468154|NCT01428570|sleep apnea, obstructive|sleep apnea, obstructive
5468155|NCT01428570|intubation|intubation
5468156|NCT01428557|Heart Failure|heart failure
5468157|NCT01428557|Epidemiology|epidemiology
5468158|NCT01428557|Evidence-Based Practice|evidence-based practice
5468159|NCT01428492|AKT Inhibitor|akt inhibitor
5468160|NCT01428492|hematologic malignancies|hematologic malignancies
5468161|NCT01428492|GSK2110183|gsk2110183
5468162|NCT01428492|bortezomib|bortezomib
5468163|NCT01428492|multiple myeloma|multiple myeloma
5468164|NCT01428492|dexamethasone|dexamethasone
5468165|NCT01428453|Alzheimer's disease|alzheimer's disease
5468166|NCT01428427|Gemcitabine|gemcitabine
5468167|NCT01428427|MEK inhibitor|mek inhibitor
5468168|NCT01428427|GSK1120212|gsk1120212
5468169|NCT01428414|HER2|her2
5468170|NCT01428414|Breast cancer|breast cancer
5468171|NCT01428414|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5468172|NCT01428414|efficacy|efficacy
5468173|NCT01428414|safety|safety
5468174|NCT01428401|Complementary therapies|complementary therapies
5468175|NCT01428401|Acute hemorrhagic stroke|acute hemorrhagic stroke
5468176|NCT01428388|macular edema|macular edema
5468177|NCT01428388|vein occlusion|vein occlusion
5468178|NCT01428388|bevacizumab|bevacizumab
5468179|NCT01428388|ranibizumab|ranibizumab
5468180|NCT01428388|vascular endothelial growth factor|vascular endothelial growth factor
5468181|NCT01428375|intravenous paracetamol|intravenous paracetamol
5468182|NCT01428375|intrapartum analgesia|intrapartum analgesia
5468183|NCT01428375|labor pain|labor pain
5468184|NCT01428375|intrapartum pains|intrapartum pains
5468185|NCT01428362|donepezil|donepezil
5468186|NCT01428362|VI-1121|vi-1121
5468187|NCT01428349|Incarcerated offenders|incarcerated offenders
5468188|NCT01428349|emotionally reactive|emotionally reactive
5468189|NCT01428349|emotionally stable|emotionally stable
5468190|NCT01428349|psychopathy|psychopathy
5468191|NCT01428310|dietary supplement|dietary supplement
5468192|NCT01428310|nutraceutical|nutraceutical
5468193|NCT01428297|Atopic dermatitis|atopic dermatitis
5468194|NCT01428297|Eczema|eczema
5468195|NCT01428297|Skin Diseases, Eczematous|skin diseases, eczematous
5468196|NCT01428297|Netherton syndrome|netherton syndrome
5468197|NCT01428297|Skin Diseases, Genetic|skin diseases, genetic
5468198|NCT01428297|BPR277|bpr277
5468199|NCT01428284|Healthy Volunteers|healthy volunteers
5468200|NCT01428284|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5468202|NCT01428284|Probenecid|probenecid
5468203|NCT01428258|Diet therapy|diet therapy
5468204|NCT01428258|Low phenylalanine diet|low phenylalanine diet
5468205|NCT01428258|Attention|attention
5468206|NCT01428258|Executive function|executive function
5468207|NCT01428232|Breastfeeding|breastfeeding
5468208|NCT01428232|Baby Friendly Hospital Initiative|baby friendly hospital initiative
5468209|NCT01428232|Well-child clinics|well-child clinics
5468210|NCT01428219|Prostate|prostate
5468211|NCT01428219|Cancer|cancer
5468212|NCT01428219|Metastatic|metastatic
5468213|NCT01428206|palliative care|palliative care
5468214|NCT01428206|nursing homes|nursing homes
5462724|NCT01449994|chiropractic|chiropractic
5468215|NCT01428206|Liverpool care pathway|liverpool care pathway
5468216|NCT01428193|PCOS|pcos
5468217|NCT01428193|hyperandrogenemia|hyperandrogenemia
5468218|NCT01428180|preterm neonates|preterm neonates
5468219|NCT01428180|hemodynamically relevant patent ductus arteriosus|hemodynamically relevant patent ductus arteriosus
5468220|NCT01428167|Thyroid cancer|thyroid cancer
5468221|NCT01428167|Hashimotos thyroiditis|hashimotos thyroiditis
5468222|NCT01428167|Thyroidectomy|thyroidectomy
5468223|NCT01428167|Anti-inflammatory factors|anti-inflammatory factors
5468224|NCT01428154|paediatric|paediatric
5468225|NCT01428154|dialysis|dialysis
5468227|NCT01428154|pediatric|pediatric
5468228|NCT01428141|Cancer|cancer
5468229|NCT01428141|Gastrointestinal Cancer|gastrointestinal cancer
5468230|NCT01428115|monoclonal|monoclonal
5468231|NCT01428115|anxiety|anxiety
5468232|NCT01428115|antibodies|antibodies
5468233|NCT01428115|adalimumab|adalimumab
5468234|NCT01428115|severe crohn's disease|severe crohn's disease
5468235|NCT01428115|quality of life|quality of life
5468236|NCT01428115|biological products|biological products
5468237|NCT01428102|Thromboelastography|thromboelastography
5468238|NCT01428102|TEG|teg
5468239|NCT01428102|Coagulation|coagulation
5468240|NCT01428102|RapidTEG|rapidteg
5468241|NCT01428102|Kaolin|kaolin
5468242|NCT01428089|hyperandrogenemia|hyperandrogenemia
5468243|NCT01428076|Varicose Veins|varicose veins
5468244|NCT01428076|SFJ Reflux|sfj reflux
5468245|NCT01428050|whipple|whipple
5468246|NCT01428050|hypertonic saline|hypertonic saline
5468247|NCT01428050|pancreaticoduodenectomy|pancreaticoduodenectomy
5468248|NCT01428050|fluid restriction|fluid restriction
5468249|NCT01428050|resuscitation strategy|resuscitation strategy
5468250|NCT01428037|Vaginal Misoprostol|vaginal misoprostol
5468251|NCT01428037|Cervical Ripening|cervical ripening
5468252|NCT01428037|Labor Induced|labor induced
5468253|NCT01428024|efficacy|efficacy
5468254|NCT01428024|safety|safety
5468255|NCT01428024|Restylane|restylane
5468256|NCT01428024|Lip products|lip products
5468257|NCT01428024|injection techniques|injection techniques
5468258|NCT01428011|Hypertension|hypertension
5468259|NCT01428011|Patient-Provider Communication|patient-provider communication
5468260|NCT01428011|Medication Adherence|medication adherence
5468261|NCT01428011|Race Concordance|race concordance
5468262|NCT01427998|diabetes|diabetes
5468264|NCT01427998|olive leaf extract|olive leaf extract
5468265|NCT01427946|KRAS mutant|kras mutant
5468266|NCT01427946|Non-Small Cell Lung Cancer|non-small cell lung cancer
5468267|NCT01427946|NSCLC|nsclc
5468268|NCT01427933|Breast Cancer|breast cancer
5468269|NCT01427907|Serum phosphorus levels|serum phosphorus levels
5468270|NCT01427894|Prematurity|prematurity
5468271|NCT01427894|Music|music
5468272|NCT01427894|Kangaroo Care|kangaroo care
5468273|NCT01427894|Bonding Mother infant|bonding mother infant
5468274|NCT01427868|LB80380|lb80380
5468275|NCT01427868|bioequivalence|bioequivalence
5468276|NCT01427855|Dietary Protein|dietary protein
5468277|NCT01427855|Red Meat|red meat
5468278|NCT01427855|White Meat|white meat
5468279|NCT01427855|Vegetable Protein|vegetable protein
5468280|NCT01427855|Saturated Fat|saturated fat
5468281|NCT01427855|LDL Subclasses|ldl subclasses
5468282|NCT01427855|Cholesterol|cholesterol
5468283|NCT01427855|Atherogenic Dyslipidemia|atherogenic dyslipidemia
5468284|NCT01427842|Trough concentration|trough concentration
5468285|NCT01427842|Vancomycin|vancomycin
5468286|NCT01427842|Pharmacokinetics|pharmacokinetics
5468287|NCT01427829|pilot|pilot
5468288|NCT01427829|randomized controlled trial|randomized controlled trial
5468289|NCT01427829|RCT|rct
5468290|NCT01427829|computer|computer
5468291|NCT01427829|screening|screening
5468292|NCT01427829|community heath center|community heath center
5468293|NCT01427829|psychosocial|psychosocial
5468294|NCT01427829|immigrant|immigrant
5468295|NCT01427816|Dry eye syndromes|dry eye syndromes
5468296|NCT01427816|Corneal diseases|corneal diseases
5468297|NCT01427816|Conjunctival diseases|conjunctival diseases
5468298|NCT01427803|Actual Use Trial|actual use trial
5468299|NCT01427764|Dentin sensitivity|dentin sensitivity
5468300|NCT01427764|Dental scaling|dental scaling
5468301|NCT01427764|Ultrasonic|ultrasonic
5685309|NCT00556621|stage III bladder cancer|stage iii bladder cancer
5468302|NCT01427764|manual and ultrasonic instrumentation|manual and ultrasonic instrumentation
5468303|NCT01427725|Digestive System Diseases|digestive system diseases
5468304|NCT01427725|Therapeutic Uses|therapeutic uses
5468305|NCT01427725|Pancreatectomy|pancreatectomy
5468306|NCT01427725|Gastrointestinal Agents|gastrointestinal agents
5468307|NCT01427725|Pancreatic Diseases|pancreatic diseases
5468308|NCT01427725|Pancrelipase|pancrelipase
5468309|NCT01427725|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5468310|NCT01427712|Digestive System Diseases|digestive system diseases
5468311|NCT01427712|Cystic Fibrosis|cystic fibrosis
5468312|NCT01427712|Therapeutic Uses|therapeutic uses
5468313|NCT01427712|Gastrointestinal Agents|gastrointestinal agents
5468314|NCT01427712|Pancreatic Diseases|pancreatic diseases
5468315|NCT01427712|Pancrelipase|pancrelipase
5468316|NCT01427712|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5468317|NCT01427673|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5468318|NCT01427673|Obstructive Sleep Apnea|obstructive sleep apnea
5468319|NCT01427673|Overlap Syndrome|overlap syndrome
5468320|NCT01427673|COPD|copd
5468321|NCT01427673|OSA|osa
5468322|NCT01427660|Diabetes|diabetes
5468323|NCT01427660|Decision Aid|decision aid
5468324|NCT01427660|AntiHyperglycemic Medication|antihyperglycemic medication
5468325|NCT01427660|Tailored health information|tailored health information
5468326|NCT01427660|Medication information|medication information
5468327|NCT01427647|Laparoscopy|laparoscopy
5468328|NCT01427647|Anesthesia, Epidural|anesthesia, epidural
5468329|NCT01427634|Heart Failure|heart failure
5468330|NCT01427634|Ventricular Assist Device|ventricular assist device
5468331|NCT01427634|Palliative Care|palliative care
5468332|NCT01427595|hyperandrogenemia|hyperandrogenemia
5468333|NCT01427569|Diabetes|diabetes
5468334|NCT01427569|Chronic wound|chronic wound
5468335|NCT01427556|Food intake|food intake
5468336|NCT01427556|Breakfast eating|breakfast eating
5468337|NCT01427543|behavioral intervention|behavioral intervention
5468338|NCT01427543|HIV risk reduction|hiv risk reduction
5468339|NCT01427543|African Americans|african americans
5468340|NCT01427543|incarceration|incarceration
5468341|NCT01427543|bisexual|bisexual
5468342|NCT01427543|reduce risk behaviors|reduce risk behaviors
5468343|NCT01427530|brain activity|brain activity
5468344|NCT01427530|implanted with DBS electrodes|implanted with dbs electrodes
5468345|NCT01427517|Parkinson's disease|parkinson's disease
5468346|NCT01427517|Gaucher's disease|gaucher's disease
5468347|NCT01427517|Control|control
5468348|NCT01427504|HCV|hcv
5468349|NCT01427504|HIV|hiv
5468350|NCT01427478|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5468351|NCT01427478|Post operative radio-chemotherapy|post operative radio-chemotherapy
5468352|NCT01427478|Randomisation|randomisation
5468353|NCT01427478|Maintenance treatment|maintenance treatment
5468354|NCT01427478|Afatinib|afatinib
5468355|NCT01427465|Brief|brief
5468356|NCT01427465|Image|image
5468357|NCT01427465|Intervention|intervention
5468358|NCT01427465|Adolescents|adolescents
5468359|NCT01427465|School|school
5468360|NCT01427452|Live Donor|live donor
5468361|NCT01427452|Kidney Donation|kidney donation
5468362|NCT01427452|Living Donation|living donation
5468363|NCT01427452|Live Donor Kidney Transplantation|live donor kidney transplantation
5468364|NCT01427452|Donor Nephrectomy|donor nephrectomy
5468366|NCT01427439|Non-interventional study|non-interventional study
5468367|NCT01427439|Observational study|observational study
5468368|NCT01427426|Health|health
5468369|NCT01427426|Vitality|vitality
5468370|NCT01427426|Well-being|well-being
5468371|NCT01427426|Nutritional Supplement|nutritional supplement
5468372|NCT01427426|Phytonutrient|phytonutrient
5468373|NCT01427426|Greens|greens
5468374|NCT01427413|blastocoele fluid|blastocoele fluid
5468375|NCT01427413|mass spectrometry|mass spectrometry
5468376|NCT01427413|metabolomics|metabolomics
5468377|NCT01427400|Breast expander|breast expander
5468378|NCT01427400|Breast reconstruction|breast reconstruction
5468379|NCT01427400|Implants|implants
5468380|NCT01427400|Botox|botox
5468381|NCT01427387|ASP0456|asp0456
5468382|NCT01427387|Pharmacokinetics|pharmacokinetics
5468383|NCT01427387|safety|safety
5468384|NCT01427387|tolerability|tolerability
5468385|NCT01427387|food effect|food effect
5468386|NCT01427374|hemodialysis|hemodialysis
5468387|NCT01427374|peritoneal dialysis|peritoneal dialysis
5468388|NCT01427374|chronic kidney disease|chronic kidney disease
5468389|NCT01427374|cardiovascular risk factors|cardiovascular risk factors
5468390|NCT01427374|cardiac imaging|cardiac imaging
5468391|NCT01427374|dialysis|dialysis
5468392|NCT01427374|parathyroid hormone|parathyroid hormone
5468393|NCT01427374|vitamin D|vitamin d
5468394|NCT01427374|coronary artery calcification|coronary artery calcification
5468395|NCT01427374|left ventricular hypertrophy|left ventricular hypertrophy
5468396|NCT01427374|genetic predisposition|genetic predisposition
5468397|NCT01427374|biochemical markers|biochemical markers
5468398|NCT01427374|infection|infection
5468399|NCT01427374|pharmacogenomics|pharmacogenomics
5616753|NCT00830401|IVF|ivf
5468401|NCT01427335|ICSI|icsi
5468402|NCT01427335|calcium injection|calcium injection
5468403|NCT01427322|lapatinib|lapatinib
5468404|NCT01427322|radiation therapy|radiation therapy
5468405|NCT01427322|metastases|metastases
5468406|NCT01427309|Influenza|influenza
5468407|NCT01427309|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5468408|NCT01427309|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
5468409|NCT01427309|Fluzone® High-Dose|fluzone® high-dose
5468410|NCT01427309|Influenza vaccines|influenza vaccines
5468411|NCT01427296|Colon Cleansing|colon cleansing
5468412|NCT01427296|Bowel Prep|bowel prep
5468413|NCT01427296|Colonoscopy|colonoscopy
5468414|NCT01427283|Low back pain|low back pain
5468415|NCT01427283|Chronic pain|chronic pain
5468416|NCT01427283|Opioid|opioid
5468417|NCT01427283|Constipation|constipation
5468418|NCT01427283|Moderate to severe|moderate to severe
5468419|NCT01427270|Low back pain|low back pain
5468420|NCT01427270|Chronic pain|chronic pain
5468423|NCT01427270|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5468424|NCT01427244|HER2+|her2+
5468425|NCT01427244|Histologic confirmation|histologic confirmation
5468426|NCT01427244|measurable disease|measurable disease
5468427|NCT01427244|HER2 positive|her2 positive
5468428|NCT01427244|HER2 overexpression|her2 overexpression
5468429|NCT01427244|persistent vulvar Paget's disease|persistent vulvar paget's disease
5468430|NCT01427244|recurrent vulvar Paget's disease|recurrent vulvar paget's disease
5468431|NCT01427231|Cognitive performance|cognitive performance
5468432|NCT01427231|Attention|attention
5468433|NCT01427231|Memory|memory
5468434|NCT01427231|Glucose|glucose
5468435|NCT01427231|Sacharose|sacharose
5468436|NCT01427231|Elderly|elderly
5468437|NCT01427231|Memory complaints|memory complaints
5468438|NCT01427218|pharmacist|pharmacist
5468439|NCT01427218|medication therapy management|medication therapy management
5468440|NCT01427218|evidence based medicine|evidence based medicine
5468441|NCT01427205|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5468442|NCT01427205|HNSCC|hnscc
5468443|NCT01427205|recurrent|recurrent
5468444|NCT01427205|metastatic|metastatic
5468445|NCT01427205|oral cavity|oral cavity
5468446|NCT01427205|Cetuximab|cetuximab
5468447|NCT01427205|C225|c225
5468448|NCT01427205|Erbitux|erbitux
5468449|NCT01427205|IMC-C225|imc-c225
5468450|NCT01427205|OSI-906|osi-906
5468451|NCT01427205|Placebo|placebo
5468452|NCT01427205|sugar pill|sugar pill
5468453|NCT01427205|oropharynx|oropharynx
5468454|NCT01427205|larynx|larynx
5468455|NCT01427205|hypopharynx|hypopharynx
5468456|NCT01427192|Breathing-Related Sleep Disorder|breathing-related sleep disorder
5468457|NCT01427192|Pulmonary Hypertension|pulmonary hypertension
5468458|NCT01427179|Spontaneous coronary artery dissection|spontaneous coronary artery dissection
5468459|NCT01427179|SCAD|scad
5468460|NCT01427166|Breast Cancer|breast cancer
5468461|NCT01427166|Cording|cording
5468462|NCT01427166|Lymphedema|lymphedema
5468463|NCT01427166|upper extremity cording|upper extremity cording
5468464|NCT01427166|following treatment|following treatment
5468465|NCT01427153|knee osteoarthritis|knee osteoarthritis
5468466|NCT01427153|physical therapy|physical therapy
5468467|NCT01427153|corticosteroid|corticosteroid
5468468|NCT01427153|treatment|treatment
5468469|NCT01427140|Liver fat|liver fat
5468470|NCT01427140|Polyunsaturated fatty acids (PUFA)|polyunsaturated fatty acids (pufa)
5468471|NCT01427140|Saturated fatty acids (SFA)|saturated fatty acids (sfa)
5468472|NCT01427140|Weight gain|weight gain
5468473|NCT01427140|Overfeed|overfeed
5468474|NCT01427140|Dietary fatty acids|dietary fatty acids
5468478|NCT01427114|ocular adnexal lymphoma|ocular adnexal lymphoma
5468479|NCT01427114|mucosa associated lymphoid tissue|mucosa associated lymphoid tissue
5468480|NCT01427114|cyclophosphamide|cyclophosphamide
5468481|NCT01427114|vincristine|vincristine
5468482|NCT01427114|prednisolone|prednisolone
5468483|NCT01427101|Pseudomyxoma Peritonei|pseudomyxoma peritonei
5468484|NCT01427101|Cytoreductive surgery|cytoreductive surgery
5468485|NCT01427101|Debulking surgery|debulking surgery
5468486|NCT01427101|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5468487|NCT01427088|rTMS-induced cumulative pattern of sBDNF|rtms-induced cumulative pattern of sbdnf
5468488|NCT01427075|Magnetic Resonance Imaging|magnetic resonance imaging
5468489|NCT01427075|Sleep Apnea, Obstructive|sleep apnea, obstructive
5468490|NCT01427075|Pharyngeal Muscles|pharyngeal muscles
5468491|NCT01427062|parkinson's disease|parkinson's disease
5468493|NCT01427062|anticipatory postural adjustment|anticipatory postural adjustment
5468494|NCT01427062|componsatory postural adjustment|componsatory postural adjustment
5468495|NCT01427062|falls|falls
5468496|NCT01427049|renal denervation|renal denervation
5468497|NCT01427049|renal sympathetic denervation|renal sympathetic denervation
5468498|NCT01427049|renal ablation|renal ablation
5468499|NCT01427049|resistant hypertension|resistant hypertension
5468500|NCT01427049|hypertension|hypertension
5468501|NCT01427049|renal oxygenation|renal oxygenation
5468502|NCT01427049|renal perfusion|renal perfusion
5468503|NCT01427023|APTIMA Trichomonas vaginalis Assay|aptima trichomonas vaginalis assay
5468505|NCT01427023|trichomonas|trichomonas
5468506|NCT01427023|trichomonas vaginalis|trichomonas vaginalis
5468507|NCT01426997|Major Depressive Disorder|major depressive disorder
5468508|NCT01426997|Depression|depression
5468509|NCT01426971|Migraine|migraine
5468510|NCT01426945|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5468511|NCT01426945|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5468512|NCT01426945|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5468513|NCT01426945|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5468514|NCT01426945|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5468515|NCT01426932|Vestibular Function Tests|vestibular function tests
5468516|NCT01426932|Caloric Test|caloric test
5468517|NCT01426932|Electronystagmography|electronystagmography
5468518|NCT01426932|Prediction|prediction
5468519|NCT01426919|Traumatic Brain Injury|traumatic brain injury
5468520|NCT01426919|Head Injury|head injury
5468521|NCT01426893|Respiratory disease|respiratory disease
5468522|NCT01426893|COPD|copd
5468523|NCT01426880|GBG|gbg
5468524|NCT01426880|German Breast Group|german breast group
5468525|NCT01426880|neo-adjuvant|neo-adjuvant
5468526|NCT01426880|GBG Forschungs GmbH|gbg forschungs gmbh
5468527|NCT01426880|Tubular breast cancer stage II|tubular breast cancer stage ii
5468528|NCT01426880|Mucinous breast cancer stage II|mucinous breast cancer stage ii
5468529|NCT01426880|Invasive ductal breast cancer|invasive ductal breast cancer
5468530|NCT01426880|Tubular breast cancer stage III|tubular breast cancer stage iii
5468531|NCT01426880|HER-2 positive breast cancer|her-2 positive breast cancer
5468532|NCT01426880|Inflammatory breast cancer stage IV|inflammatory breast cancer stage iv
5468533|NCT01426880|Inflammatory breast cancer|inflammatory breast cancer
5468534|NCT01426867|Open-Angle Glaucoma|open-angle glaucoma
5468535|NCT01426867|Ocular Hypertension|ocular hypertension
5468536|NCT01426867|Intraocular Pressure|intraocular pressure
5468537|NCT01426867|Brinzolamide|brinzolamide
5468538|NCT01426867|Brimonidine|brimonidine
5468539|NCT01426854|Cataract Surgery|cataract surgery
5468540|NCT01426854|Anti-ocular Inflammation|anti-ocular inflammation
5468541|NCT01426854|Anti-ocular Pain|anti-ocular pain
5468542|NCT01426841|Small cell lung cancer|small cell lung cancer
5468543|NCT01426841|Adaptive radiotherapy|adaptive radiotherapy
5468544|NCT01426841|Thoracic radiotherapy|thoracic radiotherapy
5468545|NCT01426828|adult|adult
5468546|NCT01426828|symptomatic multiple myeloma|symptomatic multiple myeloma
5468547|NCT01426828|myeloma|myeloma
5468548|NCT01426828|diagnosis within 12 months of initiation of systemic therapy|diagnosis within 12 months of initiation of systemic therapy
5468549|NCT01426815|Peripheral spondylarthritis according to ASAS- criteria|peripheral spondylarthritis according to asas- criteria
5468550|NCT01426802|metformin|metformin
5468551|NCT01426802|vildagliptin|vildagliptin
5468552|NCT01426802|T2DM|t2dm
5468553|NCT01426789|Rheumatoid Arthritis|rheumatoid arthritis
5468554|NCT01426789|IgG1K monoclonal antibody|igg1k monoclonal antibody
5468555|NCT01426789|Interleukin-17A neutralizing|interleukin-17a neutralizing
5468559|NCT01426763|HAE|hae
5468560|NCT01426763|C1 esterase inhibitor|c1 esterase inhibitor
5468561|NCT01426763|C1 INH|c1 inh
5468562|NCT01426763|Subcutaneous|subcutaneous
5468563|NCT01426763|hyaluronidase|hyaluronidase
5468564|NCT01426763|rHuPH20|rhuph20
5468565|NCT01426750|Nutritional support.|nutritional support.
5468566|NCT01426750|Cancer.|cancer.
5468567|NCT01426750|Malnutrition.|malnutrition.
5468568|NCT01426750|Child.|child.
5468569|NCT01426750|Adolescent|adolescent
5468570|NCT01426724|Vitamin D|vitamin d
5468571|NCT01426724|Chronic Kidney Disease|chronic kidney disease
5468572|NCT01426724|Hyperparathyroidism|hyperparathyroidism
5468573|NCT01426724|Renal Blood Flow|renal blood flow
5468574|NCT01426724|Proteinuria|proteinuria
5468575|NCT01426724|Inflammation|inflammation
5468576|NCT01426724|Renin Angiotensin System|renin angiotensin system
5468577|NCT01426698|delayed cord clamping|delayed cord clamping
5468578|NCT01426698|developmental delay|developmental delay
5468580|NCT01426685|coronary artery disease|coronary artery disease
5468581|NCT01426685|diabetes|diabetes
5468582|NCT01426672|Strabismic deviation less than 12 prism diopeters|strabismic deviation less than 12 prism diopeters
5468583|NCT01426659|language|language
5468584|NCT01426659|constraints|constraints
5468585|NCT01426659|premature|premature
5468586|NCT01426659|phonology|phonology
5468587|NCT01426659|implied|implied
5468588|NCT01426659|early development (< 5 years)|early development (< 5 years)
5468589|NCT01426646|gastric cancer|gastric cancer
5468590|NCT01426646|S-1|s-1
5468591|NCT01426646|cisplatin|cisplatin
5468592|NCT01426646|adjuvant chemotherapy|adjuvant chemotherapy
5468593|NCT01426633|L-sarcomas|l-sarcomas
5468594|NCT01426620|NSCLC|nsclc
5468595|NCT01426620|blueberry|blueberry
5468596|NCT01426620|salvage therapy|salvage therapy
5468597|NCT01426620|docetaxel|docetaxel
5468598|NCT01426620|non-small cell lung cancer|non-small cell lung cancer
5468599|NCT01426620|second-line|second-line
5468601|NCT01426594|Observational|observational
5468602|NCT01426594|Colombia|colombia
5468603|NCT01426594|Metpure XL|metpure xl
5468604|NCT01426581|Asthma|asthma
5468605|NCT01426581|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5468606|NCT01426581|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5468607|NCT01426581|Lung Disease, Obstructive|lung disease, obstructive
5468608|NCT01426581|Self-management|self-management
5468609|NCT01426581|Health Literacy|health literacy
5468610|NCT01426568|Multi-Convergent Therapy|multi-convergent therapy
5468611|NCT01426568|Mindfulness Meditation|mindfulness meditation
5468612|NCT01426568|Functional Abdominal Symptoms|functional abdominal symptoms
5468613|NCT01426568|Irritable Bowel Syndrome|irritable bowel syndrome
5468614|NCT01426568|Inflammatory Bowel Disease|inflammatory bowel disease
5468615|NCT01426568|Psychological Stress|psychological stress
5468616|NCT01426555|Disorder of Bone Density and Structure, Unspecified|disorder of bone density and structure, unspecified
5468617|NCT01426555|Weakening of the bone structure|weakening of the bone structure
5468622|NCT01426516|Treatment Resistant|treatment resistant
5468623|NCT01426516|Depression|depression
5468624|NCT01426477|Ventral hernia|ventral hernia
5468625|NCT01426477|Abdominal wall hernia|abdominal wall hernia
5450909|NCT01499004|550|550
5468626|NCT01426477|Incisional hernia|incisional hernia
5468627|NCT01426477|Biologic mesh|biologic mesh
5468628|NCT01426477|Veritas Collagen Matrix|veritas collagen matrix
5468629|NCT01426477|Veritas|veritas
5468630|NCT01426464|Glaucoma|glaucoma
5468631|NCT01426464|Xalatan|xalatan
5468632|NCT01426464|Transdermal|transdermal
5468633|NCT01426451|Dramatherapy|dramatherapy
5468634|NCT01426451|Group tutoring activities|group tutoring activities
5468635|NCT01426451|Impairment|impairment
5468636|NCT01426451|Emotional and behavioural problems|emotional and behavioural problems
5468637|NCT01426451|Learning difficulties|learning difficulties
5468638|NCT01426425|Cardiac cryoablation|cardiac cryoablation
5468639|NCT01426425|AVNRT|avnrt
5468640|NCT01426425|heart disease|heart disease
5468641|NCT01426425|tachycardia|tachycardia
5468764|NCT01425866|Adult learning|adult learning
5468642|NCT01426425|AtrioVentricular Nodal Reentrant Tachycardia|atrioventricular nodal reentrant tachycardia
5468643|NCT01426425|Supraventricular tachycardia|supraventricular tachycardia
5468644|NCT01426425|SVT|svt
5468645|NCT01426360|dentifrice|dentifrice
5468646|NCT01426360|potassium nitrate|potassium nitrate
5468647|NCT01426360|strontium chloride|strontium chloride
5468648|NCT01426347|Rheumatoid Arthritis|rheumatoid arthritis
5468649|NCT01426347|Vitamin D deficiency|vitamin d deficiency
5468650|NCT01426347|Disability|disability
5468651|NCT01426321|Cardiac resynchronization therapy|cardiac resynchronization therapy
5468652|NCT01426321|Echocardiography|echocardiography
5468653|NCT01426321|Cardiac computed tomography|cardiac computed tomography
5468654|NCT01426295|hematologic disease candidates for autologous or allogeneic bone marrow|hematologic disease candidates for autologous or allogeneic bone marrow
5468655|NCT01426282|Out-patient Compliance|out-patient compliance
5468656|NCT01426282|Nurse, Heath Education|nurse, heath education
5468657|NCT01426282|Cardiovascular Diseases|cardiovascular diseases
5468658|NCT01426282|Treatment and Prevention|treatment and prevention
5468659|NCT01426256|vitamin D|vitamin d
5468660|NCT01426256|cholecalciferol|cholecalciferol
5468666|NCT01426256|dietary supplements|dietary supplements
5468667|NCT01426256|alpha-Defensins|alpha-defensins
5468668|NCT01426256|Cytokines|cytokines
5468669|NCT01426256|mortality|mortality
5468670|NCT01426256|biological markers|biological markers
5468671|NCT01426256|Biomedical Research|biomedical research
5468672|NCT01426230|PHN|phn
5468673|NCT01426230|Post Herpetic Neuralgia|post herpetic neuralgia
5468674|NCT01426230|Shingles|shingles
5468675|NCT01426230|HZ roster|hz roster
5468676|NCT01426217|IV contamination|iv contamination
5468677|NCT01426217|intravenous contamination|intravenous contamination
5468679|NCT01426217|surgical site infection|surgical site infection
5468680|NCT01426204|Hepatitis C|hepatitis c
5468681|NCT01426204|Retreatment|retreatment
5468682|NCT01426204|Failures|failures
5468683|NCT01426204|Infergen|infergen
5468684|NCT01426204|Interferon Alfacon-1|interferon alfacon-1
5468685|NCT01426191|Cefotaxime sulbactam sodium|cefotaxime sulbactam sodium
5468686|NCT01426191|Phase IV clinical studies|phase iv clinical studies
5468687|NCT01426191|Respiratory and urinary tract infections|respiratory and urinary tract infections
5468688|NCT01426178|Respiratory Insufficiency|respiratory insufficiency
5468689|NCT01426178|Respiration, Artificial|respiration, artificial
5468690|NCT01426178|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5468691|NCT01426178|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5468692|NCT01426178|Non Invasive Ventilation|non invasive ventilation
5468693|NCT01426165|hypomagnesemia|hypomagnesemia
5468694|NCT01426165|magnesium|magnesium
5468695|NCT01426165|magnesium sulfate|magnesium sulfate
5468696|NCT01426152|IVF|ivf
5468697|NCT01426152|progesterone|progesterone
5468698|NCT01426152|ovulation induction|ovulation induction
5468699|NCT01426152|pregnancy rates|pregnancy rates
5468700|NCT01426152|Female Infertility Due to Nonimplantation|female infertility due to nonimplantation
5468701|NCT01426126|urothelial carcinoma|urothelial carcinoma
5468702|NCT01426126|gemcitabine|gemcitabine
5468703|NCT01426126|platinum|platinum
5468704|NCT01426126|refractory|refractory
5468705|NCT01426126|salvage chemotherapy|salvage chemotherapy
5468706|NCT01426100|CKD-828|ckd-828
5468707|NCT01426100|Hypertension|hypertension
5468708|NCT01426100|Primary Hypertension|primary hypertension
5468709|NCT01426100|S-Amlodipine|s-amlodipine
5468710|NCT01426100|Telmisartan|telmisartan
5468711|NCT01426100|Amlodipine|amlodipine
5468712|NCT01426100|Non-Responder|non-responder
5468713|NCT01426061|Complementary and alternative medicine|complementary and alternative medicine
5468714|NCT01426061|Reflexology|reflexology
5468715|NCT01426061|Homeopathy|homeopathy
5468716|NCT01426061|Asthma|asthma
5468718|NCT01426035|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
5468719|NCT01426022|alcohol|alcohol
5468720|NCT01426022|mood|mood
5468721|NCT01426022|postprandial|postprandial
5468722|NCT01426009|COPD|copd
5468723|NCT01425996|HCC|hcc
5468724|NCT01425996|PVTT|pvtt
5468725|NCT01425983|stress|stress
5468726|NCT01425983|lability and irritative disturbances|lability and irritative disturbances
5468727|NCT01425983|dietary supplement|dietary supplement
5468728|NCT01425983|amino acid composition|amino acid composition
5468729|NCT01425983|psychological neurological questionnaire (PNF)|psychological neurological questionnaire (pnf)
5468730|NCT01425970|Inhibitex|inhibitex
5468731|NCT01425970|Chronic Hepatitis|chronic hepatitis
5468732|NCT01425970|Hepatitis C Virus|hepatitis c virus
5468733|NCT01425957|MEMORY and COGNITIVE IMPAIRMENT|memory and cognitive impairment
5468734|NCT01425957|ALZHEIMER DISEASE CONVERSION|alzheimer disease conversion
5468735|NCT01425957|Amyloid beta-Peptides|amyloid beta-peptides
5468736|NCT01425944|Sturge Weber Syndrome|sturge weber syndrome
5468737|NCT01425944|Biomarkers|biomarkers
5468738|NCT01425944|DNA arrays|dna arrays
5468739|NCT01425944|brain vessel malformations|brain vessel malformations
5468740|NCT01425918|Autism Spectrum Disorder|autism spectrum disorder
5468741|NCT01425918|language|language
5468742|NCT01425918|social|social
5468743|NCT01425918|toddlers|toddlers
5468744|NCT01425905|Female|female
5468745|NCT01425905|Depression|depression
5468746|NCT01425905|Obesity|obesity
5468747|NCT01425905|Insulin Resistance|insulin resistance
5468748|NCT01425905|Adolescents|adolescents
5468749|NCT01425905|Overweight|overweight
5468750|NCT01425905|Type 2 Diabetes Risk|type 2 diabetes risk
5468751|NCT01425905|Mood|mood
5468757|NCT01425866|Diabetes Mellitus|diabetes mellitus
5468758|NCT01425866|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5468859|NCT01425385|liver transplantation|liver transplantation
5468759|NCT01425866|Structured self-management education|structured self-management education
5468760|NCT01425866|Therapeutic patient education|therapeutic patient education
5468761|NCT01425866|Lifestyle changes|lifestyle changes
5468762|NCT01425866|Self-management Blood glucose|self-management blood glucose
5468763|NCT01425866|Empowerment|empowerment
5468765|NCT01425866|Socio-constructivism|socio-constructivism
5468766|NCT01425866|Health management network|health management network
5468767|NCT01425866|Reunion island|reunion island
5468768|NCT01425840|Lidocaine,|lidocaine,
5468769|NCT01425840|liposome encapsulation,|liposome encapsulation,
5468770|NCT01425840|topical anesthesia,|topical anesthesia,
5468771|NCT01425840|palatal mucosa|palatal mucosa
5468772|NCT01425827|duloxetine|duloxetine
5468773|NCT01425827|osteoarthritis|osteoarthritis
5468774|NCT01425827|pain|pain
5468775|NCT01425827|function|function
5468776|NCT01425814|COPD|copd
5468777|NCT01425801|COPD|copd
5468778|NCT01425788|Grass pollen induced allergic rhinoconjunctivitis|grass pollen induced allergic rhinoconjunctivitis
5468779|NCT01425775|SLE|sle
5468780|NCT01425775|disease activity markers|disease activity markers
5468782|NCT01425749|melanoma|melanoma
5468783|NCT01425749|MAGE-A3|mage-a3
5468784|NCT01425749|immunotherapy|immunotherapy
5468785|NCT01425749|adjuvant|adjuvant
5468786|NCT01425749|skin cancer|skin cancer
5468787|NCT01425749|skin diseases|skin diseases
5468788|NCT01425749|immunology|immunology
5468789|NCT01425736|Nimotuzumab|nimotuzumab
5468790|NCT01425736|Chemotherapy|chemotherapy
5468791|NCT01425736|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5468792|NCT01425723|B-LONG|b-long
5468793|NCT01425723|B-YOND|b-yond
5468794|NCT01425723|B-LONG Extension|b-long extension
5468795|NCT01425723|rFIXFc|rfixfc
5468796|NCT01425723|Severe Hemophilia B|severe hemophilia b
5468797|NCT01425710|Pheochromocytoma|pheochromocytoma
5468798|NCT01425710|Adrenalectomy|adrenalectomy
5468799|NCT01425710|Cardiac output|cardiac output
5468800|NCT01425710|Fluid managment|fluid managment
5468801|NCT01425710|Esopagheal doppler sonography|esopagheal doppler sonography
5468802|NCT01425697|Adult Cardiac surgery|adult cardiac surgery
5468803|NCT01425697|Surgery site infections|surgery site infections
5468805|NCT01425684|Smoking|smoking
5468806|NCT01425684|Schizophrenia|schizophrenia
5468807|NCT01425671|Schizophrenia|schizophrenia
5440370|NCT01544023|implant reconstruction|implant reconstruction
5468808|NCT01425671|Family|family
5468809|NCT01425671|Psychosis|psychosis
5468810|NCT01425658|Fentanyl|fentanyl
5468811|NCT01425658|clonidine|clonidine
5468812|NCT01425658|intrathcal|intrathcal
5468813|NCT01425658|bupivacaine|bupivacaine
5468814|NCT01425645|gestational diabetes|gestational diabetes
5468815|NCT01425645|GDM|gdm
5468816|NCT01425645|prevention|prevention
5468817|NCT01425632|TAU-284|tau-284
5468818|NCT01425632|Bepotastine besilate|bepotastine besilate
5468819|NCT01425632|Histamine H1 receptor antagonists|histamine h1 receptor antagonists
5468820|NCT01425619|Anxiety Disorder due to Allergy Skin Testing|anxiety disorder due to allergy skin testing
5468821|NCT01425580|Congestive Heart Failure|congestive heart failure
5468822|NCT01425580|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5468823|NCT01425580|GLP-1|glp-1
5468824|NCT01425580|Liraglutide|liraglutide
5468825|NCT01425567|cholestasis|cholestasis
5468826|NCT01425567|parenteral nutrition|parenteral nutrition
5468827|NCT01425554|Vascular malformations in the internal jugular veins|vascular malformations in the internal jugular veins
5468828|NCT01425515|hypertension|hypertension
5468829|NCT01425515|genomics|genomics
5468830|NCT01425502|High risk prescribing|high risk prescribing
5468831|NCT01425502|Primary care|primary care
5468832|NCT01425502|Non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5468833|NCT01425502|Anti-platelet agents|anti-platelet agents
5468834|NCT01425502|Stepped wedge design|stepped wedge design
5468835|NCT01425502|Cluster randomised controlled trial|cluster randomised controlled trial
5468836|NCT01425502|United Kingdom|united kingdom
5468837|NCT01425489|Krabbe Disease|krabbe disease
5468838|NCT01425489|Biomarker|biomarker
5468840|NCT01425476|high risk women|high risk women
5468841|NCT01425476|biomarkers|biomarkers
5468842|NCT01425476|vitamin D|vitamin d
5468843|NCT01425463|Ferrous (II) Glycine Sulphate Complex|ferrous (ii) glycine sulphate complex
5468844|NCT01425463|Polyferose|polyferose
5468845|NCT01425463|Ferro Sanol duodenal|ferro sanol duodenal
5468846|NCT01425463|Niferex|niferex
5468847|NCT01425463|Iron Deficiency Anemia|iron deficiency anemia
5468848|NCT01425437|Keloid|keloid
5468849|NCT01425424|Vitamin D|vitamin d
5468850|NCT01425424|Prediabetes|prediabetes
5468851|NCT01425424|Prehypertension|prehypertension
5468852|NCT01425411|hypertension|hypertension
5468853|NCT01425411|left ventricular hypertrophy|left ventricular hypertrophy
5468854|NCT01425411|angiotensin receptor blocker|angiotensin receptor blocker
5468855|NCT01425411|midwall mechanics|midwall mechanics
5468856|NCT01425411|tissue Doppler imaging|tissue doppler imaging
5468857|NCT01425411|Hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy
5468858|NCT01425385|liver failure|liver failure
5468860|NCT01425372|vaccine|vaccine
5468861|NCT01425372|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5468862|NCT01425372|immune responses|immune responses
5468863|NCT01425372|primary immunisation|primary immunisation
5798692|NCT00111371|intervention|intervention
5468864|NCT01425372|Vaccine responses to primary immunisation in the UK|vaccine responses to primary immunisation in the uk
5468865|NCT01425359|Chronic angina|chronic angina
5468866|NCT01425359|Angina pectoris|angina pectoris
5468867|NCT01425359|Coronary artery disease|coronary artery disease
5468868|NCT01425359|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5468869|NCT01425346|Ophthalmic, healthy eye, fluorescence, lens|ophthalmic, healthy eye, fluorescence, lens
5468870|NCT01425333|Ovarian endometriomas|ovarian endometriomas
5468871|NCT01425333|Laparoscopy|laparoscopy
5468872|NCT01425333|Cystectomy|cystectomy
5468873|NCT01425333|Ablation|ablation
5468874|NCT01425307|Phase III|phase iii
5468875|NCT01425307|Sickle cell anemia|sickle cell anemia
5468876|NCT01425307|Abnormally high Transcranial Doppler velocities.|abnormally high transcranial doppler velocities.
5468877|NCT01425307|Reduce risk of primary stroke|reduce risk of primary stroke
5468878|NCT01425307|Pediatric patients|pediatric patients
5468879|NCT01425307|Chelation therapy|chelation therapy
5468880|NCT01425294|Chinese post-menopausal women|chinese post-menopausal women
5468881|NCT01425294|oestrogen receptor-positive locally advanced|oestrogen receptor-positive locally advanced
5468882|NCT01425294|metastatic breast cancer|metastatic breast cancer
5468883|NCT01425294|fulvestrant 250 mg|fulvestrant 250 mg
5468884|NCT01425294|failure to adjuvant anti-oestrogen therapy|failure to adjuvant anti-oestrogen therapy
5468885|NCT01425281|Bioabsorbable|bioabsorbable
5468886|NCT01425281|Coronary scaffold|coronary scaffold
5468887|NCT01425281|Coronary Stent|coronary stent
5468888|NCT01425281|Everolimus|everolimus
5468889|NCT01425281|Drug eluting stents|drug eluting stents
5468890|NCT01425281|Angioplasty|angioplasty
5468891|NCT01425281|Coronary artery disease|coronary artery disease
5468892|NCT01425281|Total coronary occlusion|total coronary occlusion
5468893|NCT01425281|Coronary artery restenosis|coronary artery restenosis
5468894|NCT01425281|Stent thrombosis|stent thrombosis
5468895|NCT01425281|Myocardial ischemia|myocardial ischemia
5468896|NCT01425281|Coronary artery stenosis|coronary artery stenosis
5468897|NCT01425268|Tissue Expansion|tissue expansion
5468898|NCT01425268|Tissue Expander|tissue expander
5468899|NCT01425268|Breast Tissue Expansion|breast tissue expansion
5468900|NCT01425268|Breast Tissue Expander|breast tissue expander
5468901|NCT01425268|Breast Reconstruction|breast reconstruction
5468902|NCT01425268|Two Stage Breast Reconstruction|two stage breast reconstruction
5468903|NCT01425268|2 Stage Breast Reconstruction|2 stage breast reconstruction
5468904|NCT01425255|Type 1 diabetes|type 1 diabetes
5468905|NCT01425255|Sleep quality|sleep quality
5468906|NCT01425255|Parents|parents
5468907|NCT01425242|inflammation|inflammation
5468908|NCT01425242|aneurysm|aneurysm
5468909|NCT01425242|hypertension|hypertension
5468910|NCT01425242|aliskiren|aliskiren
5468911|NCT01425229|steady state|steady state
5468912|NCT01425229|bosentan|bosentan
5468913|NCT01425229|clarithromycin|clarithromycin
5468914|NCT01425216|Keloid|keloid
5468915|NCT01425216|Patient who have extensive or massive keloids|patient who have extensive or massive keloids
5468918|NCT01425164|hemodialysis|hemodialysis
5468919|NCT01425164|coronary heart disease|coronary heart disease
5468920|NCT01425164|angina|angina
5468921|NCT01425164|betablocker|betablocker
5468922|NCT01425164|carvedilol|carvedilol
5468923|NCT01425164|ivabradine|ivabradine
5468924|NCT01425138|psoriasis|psoriasis
5468925|NCT01425138|systematic review|systematic review
5468926|NCT01425138|meta-analyses|meta-analyses
5468927|NCT01425125|nonedematous hyponatremia|nonedematous hyponatremia
5468928|NCT01425125|fractional urate excretion|fractional urate excretion
5451232|NCT01497639|dystonia|dystonia
5468929|NCT01425112|trabeculectomy|trabeculectomy
5468930|NCT01425112|bevacizumab|bevacizumab
5468931|NCT01425112|anti-VEGF|anti-vegf
5468932|NCT01425112|Efficacy|efficacy
5468933|NCT01425086|Incubator,|incubator,
5468934|NCT01425086|hypothermia,|hypothermia,
5468935|NCT01425086|preterm,|preterm,
5468936|NCT01425086|low-birthweight infants,|low-birthweight infants,
5468937|NCT01425086|embrace device,|embrace device,
5468938|NCT01425086|phase change materials|phase change materials
5468940|NCT01425073|HIV|hiv
5468941|NCT01425073|Co-Infections|co-infections
5468942|NCT01425073|Malaria|malaria
5468943|NCT01425073|Pneumonia|pneumonia
5468944|NCT01425073|Diarrhea|diarrhea
5468945|NCT01425060|Contraception|contraception
5468946|NCT01425060|Unintended pregnancy|unintended pregnancy
5468947|NCT01425060|HIV|hiv
5468948|NCT01425060|HIV Risk|hiv risk
5468949|NCT01425060|Sexually Transmitted Infections|sexually transmitted infections
5468950|NCT01425060|Women|women
5468951|NCT01425060|Pregnancy|pregnancy
5468952|NCT01425060|Neonatal Health|neonatal health
5468953|NCT01425060|Drug Use|drug use
5468954|NCT01425060|Drug Treatment|drug treatment
5468955|NCT01425060|Opioids|opioids
5468956|NCT01425047|mangosteen|mangosteen
5468957|NCT01425047|xanthones|xanthones
5468958|NCT01425047|dietary supplement|dietary supplement
5468959|NCT01425047|botanical supplement|botanical supplement
5468960|NCT01425047|bioavailability|bioavailability
5468961|NCT01425047|Determine bioavailability of mangosteen xanthones in adults|determine bioavailability of mangosteen xanthones in adults
5468963|NCT01425034|motion|motion
5468964|NCT01425034|thumb CMC arthritis|thumb cmc arthritis
5468965|NCT01425034|Collateral Ligament of Metacarpophalangeal Joint|collateral ligament of metacarpophalangeal joint
5468966|NCT01424995|trigger thumb|trigger thumb
5468967|NCT01424995|flexor pollicis longus tendon of the thumb|flexor pollicis longus tendon of the thumb
5468968|NCT01424995|stenosis tenosynovitis|stenosis tenosynovitis
5468969|NCT01424969|rotator cuff repair|rotator cuff repair
5468970|NCT01424969|arthroscopic|arthroscopic
5468971|NCT01424969|platelet-rich plasma|platelet-rich plasma
5468972|NCT01424969|platelet-rich fibrin matrix|platelet-rich fibrin matrix
5468973|NCT01424969|outcomes|outcomes
5468974|NCT01424969|tendon healing|tendon healing
5468975|NCT01424969|magnetic resonance imaging|magnetic resonance imaging
5468976|NCT01424956|breast|breast
5468977|NCT01424956|breast cancer|breast cancer
5468978|NCT01424956|breast screening|breast screening
5468979|NCT01424956|breast cancer screening|breast cancer screening
5468980|NCT01424956|ultrasound|ultrasound
5468981|NCT01424956|ultrasonography|ultrasonography
5468982|NCT01424956|mammogram|mammogram
5468983|NCT01424956|mammography|mammography
5468984|NCT01424956|breast density|breast density
5468985|NCT01424956|dense breasts|dense breasts
5468986|NCT01424956|early detection|early detection
5468987|NCT01424956|somo v|somo v
5468988|NCT01424956|somo•v|somo•v
5468989|NCT01424956|U-Systems|u-systems
5468990|NCT01424956|Automated Breast Ultrasound|automated breast ultrasound
5468991|NCT01424956|Ultrasonography, Mammary|ultrasonography, mammary
5617425|NCT00827801|HF|hf
5468992|NCT01424956|Breast Neoplasms|breast neoplasms
5468993|NCT01424956|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
5468994|NCT01424943|prevention|prevention
5468995|NCT01424943|evidence-based parenting intervention|evidence-based parenting intervention
5468996|NCT01424943|children|children
5468997|NCT01424943|disabilities|disabilities
5468998|NCT01424943|IDEA Part C|idea part c
5468999|NCT01424943|Stepping Stones Triple P|stepping stones triple p
5685310|NCT00556621|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5583329|NCT00956137|hip|hip
5469000|NCT01424930|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5469001|NCT01424930|CRPC|crpc
5469002|NCT01424930|Abiraterone Acetate|abiraterone acetate
5469003|NCT01424930|Prednisone|prednisone
5469004|NCT01424930|Food Safety|food safety
5469005|NCT01424917|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5469006|NCT01424904|Ergogenic aid|ergogenic aid
5469007|NCT01424904|Exercise endurance|exercise endurance
5469008|NCT01424904|High performance|high performance
5469009|NCT01424904|Time trial performance|time trial performance
5469010|NCT01424904|Glutathione|glutathione
5469011|NCT01424878|Molecular Analysis of Medullary Thyroid Carcinoma Tissues|molecular analysis of medullary thyroid carcinoma tissues
5469012|NCT01424865|HER2-positive breast cancer|her2-positive breast cancer
5469013|NCT01424865|stage II breast cancer|stage ii breast cancer
5469015|NCT01424852|Probiotics|probiotics
5469016|NCT01424852|Caries|caries
5469017|NCT01424852|Oral flora|oral flora
5469018|NCT01424839|SIOP CNS GCT II|siop cns gct ii
5469019|NCT01424839|Patients with the primary disease of an Intracranial Germ Cell Tumors|patients with the primary disease of an intracranial germ cell tumors
5469020|NCT01424826|Healthy volunteers|healthy volunteers
5469021|NCT01424813|Asthma|asthma
5469022|NCT01424813|dry powder inhaler|dry powder inhaler
5469023|NCT01424813|short-acting beta2-agonist|short-acting beta2-agonist
5469024|NCT01424813|SABA|saba
5469025|NCT01424813|bronchoconstriction|bronchoconstriction
5469026|NCT01424813|bronchodilation|bronchodilation
5469027|NCT01424813|bronchodilator|bronchodilator
5469028|NCT01424813|metered dose inhaler|metered dose inhaler
5469029|NCT01424774|Radiation Exposure|radiation exposure
5469030|NCT01424774|Rubidium 82|rubidium 82
5469031|NCT01424774|Strontium 82|strontium 82
5469032|NCT01424774|Strontium 85|strontium 85
5469033|NCT01424748|Noni juice|noni juice
5469034|NCT01424748|Safety|safety
5469035|NCT01424735|Best corrected Visual Acuity|best corrected visual acuity
5469036|NCT01424735|Pupillary Reaction|pupillary reaction
5469037|NCT01424735|Colour vision|colour vision
5469038|NCT01424735|Disc edema|disc edema
5469039|NCT01424722|ICD Indicated patients|icd indicated patients
5469040|NCT01424722|documented CAD|documented cad
5469041|NCT01424709|Chemotherapy|chemotherapy
5469042|NCT01424709|Individual therapy|individual therapy
5469043|NCT01424709|RRM1|rrm1
5469044|NCT01424709|BRCA1|brca1
5469045|NCT01424696|growth measures|growth measures
5469046|NCT01424696|nutritional status|nutritional status
5469047|NCT01424696|pulmonary infection|pulmonary infection
5469048|NCT01424696|inflammatory markers|inflammatory markers
5469049|NCT01424696|pancreatic enzyme replacement therapy|pancreatic enzyme replacement therapy
5469050|NCT01424683|Qol|qol
5469051|NCT01424683|Quality of life|quality of life
5469052|NCT01424683|VAS|vas
5469053|NCT01424683|Visual Analogue Scale|visual analogue scale
5469054|NCT01424683|CABG|cabg
5469359|NCT01423448|wellbeing|wellbeing
5469055|NCT01424683|Coronary Artery Bypass Graft|coronary artery bypass graft
5469056|NCT01424683|Qol conversion|qol conversion
5469057|NCT01424683|post hoc HTA|post hoc hta
5469058|NCT01424670|Multidrug-resistant tuberculosis|multidrug-resistant tuberculosis
5469059|NCT01424657|MRCP|mrcp
5469060|NCT01424657|ERCP|ercp
5469061|NCT01424657|BILIARY OBSTRUCTION|biliary obstruction
5469062|NCT01424657|EFFECTIVENESS|effectiveness
5469063|NCT01424644|meningitis|meningitis
5469064|NCT01424644|human papillomavirus|human papillomavirus
5469065|NCT01424644|tetanus|tetanus
5469066|NCT01424644|diptheria|diptheria
5469067|NCT01424644|pertussis|pertussis
5469068|NCT01424618|Donor eggs|donor eggs
5469069|NCT01424618|Donor oocytes|donor oocytes
5469070|NCT01424618|Pregnancy|pregnancy
5469071|NCT01424618|Embryo Implantation|embryo implantation
5469072|NCT01424618|Infertility|infertility
5469073|NCT01424618|IVF|ivf
5680281|NCT00578383|mood disorders|mood disorders
5469074|NCT01424605|left-sided double lumen bronchial tube|left-sided double lumen bronchial tube
5469075|NCT01424605|GlideScope videolaryngoscope|glidescope videolaryngoscope
5469076|NCT01424605|direct laryngoscope|direct laryngoscope
5469077|NCT01424592|Portable sleep apnea testing|portable sleep apnea testing
5469078|NCT01424592|Positive airway pressure therapy|positive airway pressure therapy
5469079|NCT01424592|Polysomnography|polysomnography
5469080|NCT01424566|Cancer pain|cancer pain
5469081|NCT01424566|Opioid therapy|opioid therapy
5469082|NCT01424566|Inadequate analgesia|inadequate analgesia
5469083|NCT01424566|Optimized chronic opioid therapy|optimized chronic opioid therapy
5469084|NCT01424553|Low birthweight|low birthweight
5469085|NCT01424553|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5469086|NCT01424553|Lung development|lung development
5469087|NCT01424553|Airway obstruction|airway obstruction
5469088|NCT01424553|Asthma|asthma
5469089|NCT01424527|Chronic Obstructive Pulmonary Disease(COPD)|chronic obstructive pulmonary disease(copd)
5469090|NCT01424527|COPD Assessment Test(CAT)|copd assessment test(cat)
5469091|NCT01424501|Tuberculosis vaccine|tuberculosis vaccine
5469092|NCT01424501|HIV-negative|hiv-negative
5469093|NCT01424501|tuberculosis treatment|tuberculosis treatment
5469094|NCT01424488|sugammadex|sugammadex
5469095|NCT01424488|reversal|reversal
5469096|NCT01424488|pipecuronium-induced neuromuscular blockade|pipecuronium-induced neuromuscular blockade
5469097|NCT01424462|healthy volunteers|healthy volunteers
5469098|NCT01424462|firategrast|firategrast
5469099|NCT01424462|Pharmacokinetics|pharmacokinetics
5469100|NCT01424462|modified release|modified release
5469101|NCT01424436|CSF sampling|csf sampling
5469102|NCT01424436|Alzheimer's disease|alzheimer's disease
5469103|NCT01424436|Amyloid beta levels|amyloid beta levels
5469104|NCT01424423|Safety|safety
5469105|NCT01424423|GSK1223249|gsk1223249
5469106|NCT01424423|Pharmacokinetics|pharmacokinetics
5469107|NCT01424423|Single dose escalation|single dose escalation
5469108|NCT01424423|anti-GSK1223249 antibodies|anti-gsk1223249 antibodies
5469109|NCT01424423|Multiple Sclerosis|multiple sclerosis
5469115|NCT01424345|Immunosuppression|immunosuppression
5469116|NCT01424345|Immune monitoring|immune monitoring
5469117|NCT01424332|Pharmacodynamics|pharmacodynamics
5469118|NCT01424332|pharmacokinetics|pharmacokinetics
5469120|NCT01424332|Acetyl Salicylic Acid|acetyl salicylic acid
5469121|NCT01424332|darexaban glucuronide|darexaban glucuronide
5469122|NCT01424332|YM150|ym150
5469123|NCT01424332|YM-222714|ym-222714
5469124|NCT01424332|Phase 1|phase 1
5469125|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists
5469126|NCT01424319|Proteinuria|proteinuria
5469127|NCT01424306|Inflammation|inflammation
5469128|NCT01424306|Intestinal permeability|intestinal permeability
5469129|NCT01424306|Type 2 diabetes mellitus|type 2 diabetes mellitus
5469130|NCT01424306|Cardiovascular disease|cardiovascular disease
5469131|NCT01424306|Obesity|obesity
5469132|NCT01424306|Sweetened beverages|sweetened beverages
5469133|NCT01424306|Sugar|sugar
5469134|NCT01424306|Fructose|fructose
5469135|NCT01424306|Glucose|glucose
5469136|NCT01424306|High-fructose corn syrup|high-fructose corn syrup
5469137|NCT01424293|Rectal Cancer|rectal cancer
5469138|NCT01424293|Colon Cancer|colon cancer
5469139|NCT01424293|Diverticulitis|diverticulitis
5469140|NCT01424293|Anastamosis|anastamosis
5469141|NCT01424293|colectomy|colectomy
5469142|NCT01424293|low anterior resection|low anterior resection
5469143|NCT01424267|low profile|low profile
5469144|NCT01424267|endovascular graft|endovascular graft
5469145|NCT01424267|endovascular procedure|endovascular procedure
5469146|NCT01424267|aortic aneurysm, abdominal aortic aneurysm|aortic aneurysm, abdominal aortic aneurysm
5469147|NCT01424254|Gastrointestinal Bleeding of Obscure Origin|gastrointestinal bleeding of obscure origin
5469148|NCT01424241|Sandostatin LAR|sandostatin lar
5469149|NCT01424228|Long term|long term
5469150|NCT01424228|Constipation|constipation
5469151|NCT01424228|Digestive signs and symptoms|digestive signs and symptoms
5469161|NCT01424150|fluid|fluid
5469171|NCT01424059|labor|labor
5469172|NCT01424059|induction|induction
5469173|NCT01424059|amniotomy|amniotomy
5469174|NCT01424059|WEDQ-B|wedq-b
5469175|NCT01424059|parous|parous
5469176|NCT01424059|cesarean section|cesarean section
5469177|NCT01424046|type 1 diabetes|type 1 diabetes
5469178|NCT01424046|basal insulin|basal insulin
5469179|NCT01424046|developing world|developing world
5469180|NCT01424046|comparative effectiveness|comparative effectiveness
5469181|NCT01424033|Interstitial lung disease|interstitial lung disease
5469182|NCT01424033|Connective tissue disease|connective tissue disease
5469183|NCT01424033|Scleroderma|scleroderma
5469184|NCT01424033|Rheumatoid arthritis|rheumatoid arthritis
5469185|NCT01424033|Sjogren's syndrome|sjogren's syndrome
5680282|NCT00578383|affective disorders|affective disorders
5469186|NCT01424033|Mixed connective tissue disease|mixed connective tissue disease
5469187|NCT01424033|Dermatomyositis|dermatomyositis
5469188|NCT01424033|Polymyositis|polymyositis
5469189|NCT01424033|Systemic lupus erythematosis|systemic lupus erythematosis
5469190|NCT01424020|Questionnaire|questionnaire
5469191|NCT01424020|peripheral artery disease|peripheral artery disease
5469192|NCT01424020|execise|execise
5469193|NCT01424007|Obese|obese
5469194|NCT01424007|Women|women
5469195|NCT01424007|Weight loss|weight loss
5469196|NCT01424007|Exercise|exercise
5469197|NCT01424007|Physical activity|physical activity
5469198|NCT01424007|Diet|diet
5469199|NCT01424007|Female|female
5469200|NCT01423994|syncope|syncope
5469201|NCT01423994|fainting|fainting
5469202|NCT01423994|implantable loop recorder|implantable loop recorder
5469203|NCT01423994|pacemaker|pacemaker
5469204|NCT01423994|heart block|heart block
5469205|NCT01423994|bifascicular heart block|bifascicular heart block
5469206|NCT01423981|Keloid|keloid
5469207|NCT01423981|Scar|scar
5469208|NCT01423981|hypertrophic scar|hypertrophic scar
5469209|NCT01423981|familial keloid|familial keloid
5469210|NCT01423968|Sepsis|sepsis
5469211|NCT01423968|Inflammation|inflammation
5469212|NCT01423968|Lipopolysaccharide|lipopolysaccharide
5469213|NCT01423968|Muscle protein turnover|muscle protein turnover
5469214|NCT01423968|Insulin resistance|insulin resistance
5469215|NCT01423955|Erythropoietin|erythropoietin
5469216|NCT01423955|Erythropoetin|erythropoetin
5469217|NCT01423955|Cardiac surgery|cardiac surgery
5469218|NCT01423955|Ischemia|ischemia
5469219|NCT01423955|Reperfusion|reperfusion
5469220|NCT01423955|Renal function|renal function
5469221|NCT01423955|Cystatin C|cystatin c
5469222|NCT01423955|Creatinine|creatinine
5469224|NCT01423929|Oxygen|oxygen
5469225|NCT01423929|Myocardial infarction|myocardial infarction
5469226|NCT01423929|Ambulance|ambulance
5469227|NCT01423929|Percutaneous coronary intervention|percutaneous coronary intervention
5469228|NCT01423929|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5469229|NCT01423916|Schizophrenia|schizophrenia
5469230|NCT01423916|QTc Interval|qtc interval
5469231|NCT01423903|Phase I|phase i
5469232|NCT01423903|STAT-3 inhibitor|stat-3 inhibitor
5469233|NCT01423903|solid tumors|solid tumors
5469234|NCT01423890|Breast Cancer|breast cancer
5469235|NCT01423890|Oncotype DX|oncotype dx
5469236|NCT01423890|Adjuvant! Online|adjuvant! online
5469237|NCT01423890|Decisional Conflict Scale|decisional conflict scale
5469238|NCT01423877|bariatric surgery|bariatric surgery
5469239|NCT01423877|diabetes|diabetes
5469240|NCT01423877|sleeve gastrectomy|sleeve gastrectomy
5469241|NCT01423877|gastric bypass|gastric bypass
5469242|NCT01423877|gastric banding|gastric banding
5469243|NCT01423864|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5469244|NCT01423864|Multi-organ Dysfunction Syndrome|multi-organ dysfunction syndrome
5469245|NCT01423864|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5469270|NCT01423799|Cancer|cancer
5469271|NCT01423799|Immunonutrition|immunonutrition
5469272|NCT01423760|Vaccine|vaccine
5469273|NCT01423760|Stimuvax|stimuvax
5469274|NCT01423760|Tecemotide|tecemotide
5469275|NCT01423760|L-BLP25|l-blp25
5469276|NCT01423760|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5469277|NCT01423760|Multiple Myeloma|multiple myeloma
5469279|NCT01423747|HSCT|hsct
5469280|NCT01423747|children|children
5469281|NCT01423747|adolescents|adolescents
5469282|NCT01423734|ADRENAL GLAND|adrenal gland
5469283|NCT01423734|MRI|mri
5469284|NCT01423734|11-122|11-122
5469285|NCT01423708|Liver Transplantation|liver transplantation
5469286|NCT01423708|Graft Rejection|graft rejection
5469287|NCT01423708|Graft Survival|graft survival
5469288|NCT01423708|Transplantation Immunology|transplantation immunology
5469289|NCT01423708|Anti-Rejection Therapy|anti-rejection therapy
5469290|NCT01423708|Immunosuppression|immunosuppression
5469291|NCT01423708|Organ Transplantation|organ transplantation
5469292|NCT01423708|Host vs Graft Reaction|host vs graft reaction
5469293|NCT01423708|Gastroenterology|gastroenterology
5469294|NCT01423708|Hepatology|hepatology
5469295|NCT01423669|Psychotic Disorders|psychotic disorders
5469296|NCT01423643|HIV|hiv
5469297|NCT01423643|Human immunodeficiency virus|human immunodeficiency virus
5469298|NCT01423643|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5469299|NCT01423643|AIDS Virus|aids virus
5469300|NCT01423643|Immunodeficiency Virus, Human|immunodeficiency virus, human
5469301|NCT01423643|Virus, Human Immunodeficiency|virus, human immunodeficiency
5469302|NCT01423643|Hepatitis C|hepatitis c
5469303|NCT01423643|Hepatitis C, chronic|hepatitis c, chronic
5469304|NCT01423643|Hepatitis C virus|hepatitis c virus
5469305|NCT01423643|Hepatitis C antibodies|hepatitis c antibodies
5469306|NCT01423643|Hepatitis C antigens|hepatitis c antigens
5469307|NCT01423630|fatty liver|fatty liver
5469308|NCT01423630|probiotics|probiotics
5469309|NCT01423630|Lactobacillus|lactobacillus
5469310|NCT01423630|fruit|fruit
5469311|NCT01423630|fibre|fibre
5469312|NCT01423630|dietary intervention|dietary intervention
5469313|NCT01423630|obesity|obesity
5469314|NCT01423617|overweight|overweight
5469315|NCT01423617|weight loss|weight loss
5469316|NCT01423617|body fat|body fat
5469317|NCT01423617|waist circumference|waist circumference
5469318|NCT01423617|satiety|satiety
5469319|NCT01423617|appetite|appetite
5469320|NCT01423604|Metastatic pancreatic cancer|metastatic pancreatic cancer
5469321|NCT01423591|Infliximab|infliximab
5469322|NCT01423591|polymyalgia rheumatica|polymyalgia rheumatica
5469323|NCT01423591|refractory|refractory
5469324|NCT01423591|double blind|double blind
5469325|NCT01423591|placebo controlled|placebo controlled
5469326|NCT01423591|trial|trial
5469327|NCT01423578|craving|craving
5469328|NCT01423578|mood|mood
5469329|NCT01423578|cue reactivity|cue reactivity
5469330|NCT01423578|smoking behavior|smoking behavior
5469331|NCT01423578|quit smoking|quit smoking
5469332|NCT01423578|prevention|prevention
5469333|NCT01423578|Hatha yoga|hatha yoga
5469334|NCT01423578|cardiovascular exercise|cardiovascular exercise
5469335|NCT01423565|Deep Brain Stimulation|deep brain stimulation
5469336|NCT01423565|Parkinson's Disease|parkinson's disease
5469337|NCT01423565|Subthalamic Nucleus|subthalamic nucleus
5469338|NCT01423565|Constant Current|constant current
5469339|NCT01423552|Heart transplantation|heart transplantation
5469340|NCT01423552|Immunosuppression|immunosuppression
5469341|NCT01423552|Pharmacokinetics|pharmacokinetics
5469342|NCT01423552|Pharmacogenetics|pharmacogenetics
5469343|NCT01423513|ankle tape|ankle tape
5440877|NCT01541852|COPD|copd
5469344|NCT01423513|Hoffmann reflex|hoffmann reflex
5469345|NCT01423513|Balance|balance
5469347|NCT01423500|HSCT|hsct
5469348|NCT01423500|children|children
5469349|NCT01423500|adolescents|adolescents
5469350|NCT01423487|Metformin|metformin
5469351|NCT01423487|Risperidone|risperidone
5469352|NCT01423487|Prevention|prevention
5469353|NCT01423487|weight gain|weight gain
5469354|NCT01423487|Amenorrhea|amenorrhea
5469355|NCT01423474|Radiotherapy|radiotherapy
5469356|NCT01423474|Hypofractionation|hypofractionation
5469357|NCT01423448|Depression|depression
5469358|NCT01423448|mental health|mental health
5469360|NCT01423448|online bulletin board|online bulletin board
5469361|NCT01423448|online support group|online support group
5469362|NCT01423435|TRK-100STP|trk-100stp
5469363|NCT01423435|PK|pk
5469364|NCT01423435|beraprost sodium|beraprost sodium
5469365|NCT01423422|Exercise stress test|exercise stress test
5469366|NCT01423422|Effort Angina|effort angina
5469367|NCT01423422|Exercise induced angina|exercise induced angina
5469368|NCT01423409|visual analog pain scale|visual analog pain scale
5469369|NCT01423409|Deaf persons|deaf persons
5469370|NCT01423409|clinical trial|clinical trial
5469371|NCT01423409|multicentric|multicentric
5469372|NCT01423396|Alzheimer's disease|alzheimer's disease
5469373|NCT01423396|cardiovascular risk factors|cardiovascular risk factors
5469374|NCT01423383|Keloid|keloid
5469375|NCT01423370|Erectile Dysfunction|erectile dysfunction
5469376|NCT01423370|YHD1023|yhd1023
5469377|NCT01423370|YCD190|ycd190
5469378|NCT01423370|Cialis|cialis
5469379|NCT01423370|Yuhan|yuhan
5469380|NCT01423357|HIV prevention|hiv prevention
5469381|NCT01423357|condom distribution|condom distribution
5469382|NCT01423357|youth peer education|youth peer education
5469383|NCT01423357|high risk places|high risk places
5469384|NCT01423357|condom use|condom use
5469385|NCT01423357|prevention through increased condom use|prevention through increased condom use
5469386|NCT01423344|multiple myeloma|multiple myeloma
5469387|NCT01423344|Free light chains|free light chains
5469388|NCT01423331|Postpartum depression|postpartum depression
5469389|NCT01423331|maternal mental health|maternal mental health
5469390|NCT01423305|Asthma|asthma
5469391|NCT01423266|High Protein Diet in heart failure|high protein diet in heart failure
5469392|NCT01423266|obesity and heart failure|obesity and heart failure
5469393|NCT01423266|Weight management in Heart failure|weight management in heart failure
5469394|NCT01423266|heart failure, diabetes and obesity|heart failure, diabetes and obesity
5469395|NCT01423253|Depression|depression
5469396|NCT01423253|Lurasidone|lurasidone
5469397|NCT01423253|Latuda|latuda
5469398|NCT01423240|Depression|depression
5469399|NCT01423240|Lurasidone|lurasidone
5469400|NCT01423240|Latuda|latuda
5469401|NCT01423227|COPD|copd
5469402|NCT01423227|exercise|exercise
5469403|NCT01423227|rehabilitation|rehabilitation
5469404|NCT01423227|dyspnea|dyspnea
5469405|NCT01423227|quality of life|quality of life
5469406|NCT01423227|economic evaluation|economic evaluation
5469407|NCT01423214|rectal cancer|rectal cancer
5469408|NCT01423214|robot|robot
5469409|NCT01423214|laparoscopy|laparoscopy
5469410|NCT01423214|total mesorectal excision|total mesorectal excision
5469411|NCT01423214|robotic surgery|robotic surgery
5469413|NCT01423201|triage|triage
5469414|NCT01423201|Lp-PLA2|lp-pla2
5469415|NCT01423201|Proteomic|proteomic
5469416|NCT01423201|Genomic|genomic
5469417|NCT01423188|ApolipoproteinA1|apolipoproteina1
5469418|NCT01423188|HDL-C|hdl-c
5469419|NCT01423188|Atherosclerosis|atherosclerosis
5469420|NCT01423175|high risk acute myeloid leukemia|high risk acute myeloid leukemia
5469421|NCT01423175|advanced myelodysplastic syndrome|advanced myelodysplastic syndrome
5469422|NCT01423175|allogenic stem cell transplantation|allogenic stem cell transplantation
5469423|NCT01423175|clofarabine|clofarabine
5469424|NCT01423162|Iron absorption|iron absorption
5469425|NCT01423162|Oats|oats
5469426|NCT01423162|fortified oat beverages|fortified oat beverages
5469427|NCT01423149|subfoveal choroidal neovascularization|subfoveal choroidal neovascularization
5469428|NCT01423149|pathologic myopia|pathologic myopia
5469429|NCT01423136|Patients undergoing non-cardiac Surgery|patients undergoing non-cardiac surgery
5469430|NCT01423123|Paclitaxel|paclitaxel
5469431|NCT01423123|Trastuzumab|trastuzumab
5469432|NCT01423123|Neratinib|neratinib
5469433|NCT01423123|Breast Cancer|breast cancer
5469434|NCT01423123|HER2-positive|her2-positive
5469435|NCT01423110|sporadic Inclusion Body Myositis|sporadic inclusion body myositis
5469436|NCT01423097|osteoarthritis symptoms|osteoarthritis symptoms
5469437|NCT01423084|Meningococcal Meningitis|meningococcal meningitis
5469438|NCT01423084|prevention, vaccination|prevention, vaccination
5469439|NCT01423084|adolescents|adolescents
5469440|NCT01423071|Pulmonary Hypertension|pulmonary hypertension
5469441|NCT01423071|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5469442|NCT01423071|Prevalence|prevalence
5469443|NCT01423071|Quality of life|quality of life
5469444|NCT01423045|Chronic kidney disease|chronic kidney disease
5455958|NCT01478152|Asthma|asthma
5469445|NCT01423045|Urine osmolarity|urine osmolarity
5469446|NCT01423045|Glomerular filtration rate|glomerular filtration rate
5469447|NCT01423032|relapsed|relapsed
5469448|NCT01423019|Weight Loss|weight loss
5469449|NCT01423019|Body Composition|body composition
5469450|NCT01423019|Fat Free Mass|fat free mass
5469451|NCT01423019|Bone Mineral Density|bone mineral density
5469454|NCT01423019|Body Fat|body fat
5469455|NCT01423019|Eating and appetite control|eating and appetite control
5469456|NCT01423019|Basal Metabolic Rate|basal metabolic rate
5469457|NCT01423006|Pilot|pilot
5469458|NCT01423006|Ablation|ablation
5469459|NCT01423006|Low Risk|low risk
5469465|NCT01422993|Peripheral Neuropathy|peripheral neuropathy
5469466|NCT01422993|Strength|strength
5469467|NCT01422993|Balance|balance
5469468|NCT01422993|Training Program|training program
5469469|NCT01422993|Colon|colon
5469470|NCT01422993|Rectal|rectal
5469471|NCT01422980|dairy product|dairy product
5469472|NCT01422980|upper gastric discomfort|upper gastric discomfort
5469473|NCT01422980|adult|adult
5469474|NCT01422967|Osteoarthritis|osteoarthritis
5469475|NCT01422967|Sleep|sleep
5469476|NCT01422967|muscle strength|muscle strength
5469477|NCT01422967|balance|balance
5469478|NCT01422928|Radiotherapy|radiotherapy
5469479|NCT01422928|Acupuncture|acupuncture
5469480|NCT01422928|Immune System|immune system
5469481|NCT01422915|Sorbent|sorbent
5469482|NCT01422915|Resin|resin
5469484|NCT01422915|Cutaneous porphyria|cutaneous porphyria
5469485|NCT01422915|Adult|adult
5469486|NCT01422915|over age 21|over age 21
5469487|NCT01422915|without intercurrent illness|without intercurrent illness
5469488|NCT01422915|not pregnant|not pregnant
5469489|NCT01422915|willing to participate|willing to participate
5469490|NCT01422902|Schizophrenia|schizophrenia
5469491|NCT01422902|Cognitive deficits|cognitive deficits
5469492|NCT01422902|Cognitive remediation|cognitive remediation
5469493|NCT01422902|Software|software
5469494|NCT01422902|Brain Plasticity|brain plasticity
5469495|NCT01422889|Atherosclerosis|atherosclerosis
5469496|NCT01422889|Coronary Artery Disease|coronary artery disease
5469497|NCT01422863|weight loss|weight loss
5469498|NCT01422863|exercise|exercise
5469499|NCT01422863|diet|diet
5469500|NCT01422863|sleep apnea|sleep apnea
5469501|NCT01422863|aging|aging
5469502|NCT01422850|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5469503|NCT01422850|Immunotherapy|immunotherapy
5469504|NCT01422837|opioid|opioid
5469505|NCT01422837|dependence|dependence
5469506|NCT01422837|VIVITROL|vivitrol
5469507|NCT01422811|Public health|public health
5469508|NCT01422811|Policy|policy
5469509|NCT01422811|Training|training
5469510|NCT01422785|Acne Vulgaris|acne vulgaris
5469511|NCT01422720|Epilepsy|epilepsy
5469512|NCT01422720|ESL|esl
5469513|NCT01422720|Eslicarbazepine Acetate|eslicarbazepine acetate
5469514|NCT01422720|BIAL|bial
5469515|NCT01422720|BIA|bia
5469516|NCT01422720|Partial-onset Seizures|partial-onset seizures
5469522|NCT01422681|COPD|copd
5469523|NCT01422668|Glycemic index|glycemic index
5469524|NCT01422668|Dates|dates
5469525|NCT01422668|Diabetes|diabetes
5469526|NCT01422668|Coffee|coffee
5469527|NCT01422629|Breast Fibroadenoma|breast fibroadenoma
5469528|NCT01422629|High Intensity Focused Ultrasound|high intensity focused ultrasound
5469529|NCT01422616|Ischemic stroke|ischemic stroke
5469530|NCT01422616|High blood pressure|high blood pressure
5469531|NCT01422616|Thrombolysis|thrombolysis
5469532|NCT01422616|Antihypertensive drugs|antihypertensive drugs
5469533|NCT01422616|Disability|disability
5469534|NCT01422616|Clinical trial|clinical trial
5469535|NCT01422603|High risk|high risk
5469537|NCT01422603|MDS|mds
5469538|NCT01422590|sitagliptin|sitagliptin
5469539|NCT01422590|mitiglinide|mitiglinide
5469540|NCT01422590|type 2 diabetes mellitus|type 2 diabetes mellitus
5469541|NCT01422590|Pharmacodynamics|pharmacodynamics
5469542|NCT01422590|Safety|safety
5469543|NCT01422551|stress management intervention|stress management intervention
5469544|NCT01422551|breast cancer|breast cancer
5469545|NCT01422551|quality of life|quality of life
5469546|NCT01422551|psychosocial adaptation|psychosocial adaptation
5469547|NCT01422538|Ulthera® System|ulthera® system
5469548|NCT01422538|Ultherapy™ treatment|ultherapy™ treatment
5469549|NCT01422538|Ulthera, Inc.|ulthera, inc.
5469550|NCT01422538|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5469551|NCT01422538|Skin laxity on the face and neck.|skin laxity on the face and neck.
5469552|NCT01422512|seasonal influenza|seasonal influenza
5469553|NCT01422512|vaccine|vaccine
5469554|NCT01422499|pediatric oncology|pediatric oncology
5469555|NCT01422499|relapsed solid tumor|relapsed solid tumor
5469556|NCT01422499|lymphoma|lymphoma
5469557|NCT01422499|leukemia|leukemia
5469558|NCT01422499|vorinostat|vorinostat
5469559|NCT01422486|Hematology|hematology
5469560|NCT01422486|MDS|mds
5469561|NCT01422486|Myelodysplastic Syndrome|myelodysplastic syndrome
5469562|NCT01422486|Low risk MDS|low risk mds
5469563|NCT01422486|Intermediate-1 risk MDS|intermediate-1 risk mds
5469564|NCT01422486|Int-1 risk MDS|int-1 risk mds
5469565|NCT01422486|Transfusion dependence|transfusion dependence
5469566|NCT01422486|Lenalidomide refractory|lenalidomide refractory
5469568|NCT01422486|Lenalidomide resistant|lenalidomide resistant
5469569|NCT01422486|Revlimid resistant|revlimid resistant
5469571|NCT01422486|ezatiostat|ezatiostat
5469572|NCT01422486|ezatiostat hydrochloride|ezatiostat hydrochloride
5469573|NCT01422486|TLK199|tlk199
5469574|NCT01422486|Glutathione|glutathione
5469575|NCT01422486|Glutathione analog|glutathione analog
5469576|NCT01422486|Glutathione Transferase|glutathione transferase
5469577|NCT01422486|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5469578|NCT01422486|GST P1-1 inhibitor|gst p1-1 inhibitor
5469579|NCT01422486|Apoptosis|apoptosis
5469580|NCT01422486|Differentiation|differentiation
5469581|NCT01422486|Enzyme inhibitor|enzyme inhibitor
5469582|NCT01422473|Hemorrhoids|hemorrhoids
5469583|NCT01422473|Rectal Diseases|rectal diseases
5469584|NCT01422473|Intestinal Diseases|intestinal diseases
5469585|NCT01422473|Gastrointestinal Diseases|gastrointestinal diseases
5469586|NCT01422473|Digestive System Diseases|digestive system diseases
5469587|NCT01422460|Osteoarthritis|osteoarthritis
5469589|NCT01422460|PRGF|prgf
5469590|NCT01422447|mental health education|mental health education
5469591|NCT01422447|community-based|community-based
5469592|NCT01422434|A national|a national
5469593|NCT01422434|multi-centre|multi-centre
5469594|NCT01422434|prospective|prospective
5469595|NCT01422434|randomised|randomised
5469596|NCT01422434|double-blind|double-blind
5469597|NCT01422434|active-controlled|active-controlled
5469598|NCT01422434|3-arm|3-arm
5469599|NCT01422434|parallel group|parallel group
5469600|NCT01422434|4 week study|4 week study
5469601|NCT01422421|type 2 diabetes|type 2 diabetes
5469602|NCT01422421|coronary artery disease|coronary artery disease
5469603|NCT01422421|hypertension|hypertension
5469604|NCT01422421|dyslipidemia|dyslipidemia
5469605|NCT01422395|Vitrification|vitrification
5469606|NCT01422395|Egg Freezing|egg freezing
5469607|NCT01422395|Oocyte Cryopreservation|oocyte cryopreservation
5469608|NCT01422382|Healthy Volunteers|healthy volunteers
5469609|NCT01422369|Healthy Volunteers|healthy volunteers
5469610|NCT01422356|cohort study|cohort study
5469611|NCT01422356|men who have sex with men|men who have sex with men
5469612|NCT01422343|peripheral arterial disease|peripheral arterial disease
5469613|NCT01422343|cell-derived microparticles|cell-derived microparticles
5469614|NCT01422343|immunity, innate|immunity, innate
5469615|NCT01422343|blood coagulation|blood coagulation
5469616|NCT01422330|Human Immunodeficiency Virus (HIV) infection|human immunodeficiency virus (hiv) infection
5469617|NCT01422330|TMC125IFD3002|tmc125ifd3002
5469618|NCT01422330|TMC125|tmc125
5469619|NCT01422330|Intelence|intelence
5469620|NCT01422330|HIV|hiv
5469621|NCT01422317|n-3 fatty acids|n-3 fatty acids
5469622|NCT01422317|randomized double-blind study|randomized double-blind study
5469623|NCT01422317|coronary events|coronary events
5469624|NCT01422317|serum lipids|serum lipids
5469625|NCT01422317|antithrombotic effects of omega-3 fatty acids|antithrombotic effects of omega-3 fatty acids
5469626|NCT01422317|anti-inflammatory effects of omega-3 fatty acids|anti-inflammatory effects of omega-3 fatty acids
5469627|NCT01422317|prognostic biomarkers in myocardial infarction (MI)-patients|prognostic biomarkers in myocardial infarction (mi)-patients
5469628|NCT01422291|Low back pain|low back pain
5469629|NCT01422291|paracetamol|paracetamol
5469630|NCT01422291|dexketoprofen|dexketoprofen
5469631|NCT01422291|morphine|morphine
5469632|NCT01422252|Falls Elderly persons|falls elderly persons
5469633|NCT01422252|Isolated At risk for falls|isolated at risk for falls
5469634|NCT01422252|Fall detection device|fall detection device
5671454|NCT00615966|kidney transplantation|kidney transplantation
5469635|NCT01422252|Precocious detection Vigi'Fall®|precocious detection vigi'fall®
5469636|NCT01422239|smoking|smoking
5469637|NCT01422239|treatment|treatment
5469638|NCT01422239|perceived risks|perceived risks
5469639|NCT01422226|IUD|iud
5469640|NCT01422226|contraception|contraception
5469641|NCT01422226|nulliparous|nulliparous
5469642|NCT01422226|women|women
5469643|NCT01422213|MDD|mdd
5469644|NCT01422213|Cognitive dysfunction|cognitive dysfunction
5469645|NCT01422200|DMD|dmd
5469646|NCT01422200|SMA|sma
5469647|NCT01422200|CMD|cmd
5469648|NCT01422200|flu vaccine|flu vaccine
5469649|NCT01422187|enzyme replacement therapy|enzyme replacement therapy
5469650|NCT01422174|Primary prevention|primary prevention
5469651|NCT01422174|Latin America|latin america
5469652|NCT01422174|Sudden death|sudden death
5469653|NCT01422174|Myocardial infarction|myocardial infarction
5469654|NCT01422174|Ejection Fraction|ejection fraction
5469655|NCT01422174|ICD|icd
5469656|NCT01422161|Rehabilitation|rehabilitation
5469657|NCT01422161|Fingers|fingers
5469658|NCT01422161|Grasp|grasp
5469659|NCT01422161|Hand|hand
5469660|NCT01422161|Strength|strength
5469661|NCT01422161|Brain Infraction|brain infraction
5469662|NCT01422161|Pathology|pathology
5469663|NCT01422161|Physiopathology|physiopathology
5469664|NCT01422161|Functional Laterality|functional laterality
5469665|NCT01422161|Neuronal Plasticity|neuronal plasticity
5469666|NCT01422161|Psychomotor Performance|psychomotor performance
5469667|NCT01422161|Biomechanics|biomechanics
5469668|NCT01422161|Touch|touch
5469669|NCT01422161|Weight-Bearing|weight-bearing
5469670|NCT01422148|cardiac surgery|cardiac surgery
5469671|NCT01422148|atrial fibrillation|atrial fibrillation
5469672|NCT01422148|minocycline|minocycline
5469673|NCT01422148|amiodarone|amiodarone
5469674|NCT01422135|PK and safety|pk and safety
5469675|NCT01422135|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
5469676|NCT01422122|vitamin D|vitamin d
5469677|NCT01422122|pregnancy|pregnancy
5469678|NCT01422122|periodontal health|periodontal health
5469679|NCT01422122|biomarkers|biomarkers
5469680|NCT01422109|YH14659|yh14659
5469681|NCT01422109|Aspirin|aspirin
5469682|NCT01422109|Clopidogrel|clopidogrel
5469683|NCT01422109|Yuhan|yuhan
5469684|NCT01422070|mortality|mortality
5469685|NCT01422070|intensive care|intensive care
5469686|NCT01422070|critical care|critical care
5469687|NCT01422070|intermediate care|intermediate care
5469688|NCT01422057|diabetes|diabetes
5469689|NCT01422057|coronary artery disease|coronary artery disease
5469690|NCT01422057|ischemic heart disease|ischemic heart disease
5469691|NCT01422057|autonomic function|autonomic function
5469692|NCT01422057|heart rate turbulence|heart rate turbulence
5469693|NCT01422057|deceleration capacity|deceleration capacity
5469694|NCT01422057|severe autonomic failure|severe autonomic failure
5469695|NCT01422044|aortic stenosis|aortic stenosis
5469696|NCT01422044|autonomic function|autonomic function
5469697|NCT01422031|Primary care|primary care
5469698|NCT01422031|Family doctor|family doctor
5469699|NCT01422031|Consultation|consultation
5469700|NCT01422031|utilization|utilization
5469701|NCT01422031|Non-drug managements|non-drug managements
5469702|NCT01422031|Patient enablement index|patient enablement index
5469703|NCT01422018|clinically significant macular edema|clinically significant macular edema
5469704|NCT01422018|diabetic macular edema|diabetic macular edema
5469705|NCT01422018|focal edema|focal edema
5469706|NCT01422018|focal laser photocoagulation|focal laser photocoagulation
5469707|NCT01422018|hard exudates|hard exudates
5469708|NCT01422018|intravitreal bevacizumab|intravitreal bevacizumab
5469709|NCT01422005|Rehabilitation|rehabilitation
5469710|NCT01422005|Fingers|fingers
5469711|NCT01422005|Grasp|grasp
5469712|NCT01422005|Hand|hand
5469713|NCT01422005|Strength|strength
5469714|NCT01422005|Brain Infraction|brain infraction
5469715|NCT01422005|Hand Function|hand function
5469716|NCT01422005|Post Stroke|post stroke
5469717|NCT01422005|Neural mechanisms|neural mechanisms
5469718|NCT01422005|Motor Control|motor control
5469719|NCT01422005|Motor Function|motor function
5469720|NCT01421992|randomized|randomized
5469721|NCT01421992|double-blind|double-blind
5469722|NCT01421992|crossover|crossover
5469723|NCT01421992|methylphenidate|methylphenidate
5469724|NCT01421992|excessive daytime sleepiness|excessive daytime sleepiness
5469725|NCT01421966|chronic ulcers|chronic ulcers
5469726|NCT01421966|diabetic foot ulcers|diabetic foot ulcers
5469727|NCT01421953|Positron Emission Tomography|positron emission tomography
5469728|NCT01421953|Computed Tomography|computed tomography
5469729|NCT01421953|Lung cancer|lung cancer
5469730|NCT01421940|Udenafil|udenafil
5469731|NCT01421940|rectal cancer|rectal cancer
5469732|NCT01421940|penile rehabilitation|penile rehabilitation
5469733|NCT01421940|total mesorectal excision|total mesorectal excision
5469734|NCT01421927|lenalidomide|lenalidomide
5469735|NCT01421914|Ultrasound|ultrasound
5469736|NCT01421914|Axillary block|axillary block
5469737|NCT01421914|Bupivacaine|bupivacaine
5469738|NCT01421914|Minimum|minimum
5469739|NCT01421914|Volume|volume
5469740|NCT01421914|Minimum volume of bupivacaine 0,5%|minimum volume of bupivacaine 0,5%
5469741|NCT01421901|Acute appendicitis|acute appendicitis
5469743|NCT01421901|Antibiotics|antibiotics
5469744|NCT01421901|comparison surgery and antibiotics|comparison surgery and antibiotics
5469745|NCT01421901|resolutions of symptoms|resolutions of symptoms
5469746|NCT01421888|Immunity|immunity
5469747|NCT01421888|Urea Cycle Disorder|urea cycle disorder
5469748|NCT01421888|Nutrition|nutrition
5469749|NCT01421888|Vaccination|vaccination
5469750|NCT01421888|Influenza|influenza
5469751|NCT01421875|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5469752|NCT01421875|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5469753|NCT01421875|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5469754|NCT01421875|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5469755|NCT01421875|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5469756|NCT01421875|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5685311|NCT00556595|atrial fibrillation|atrial fibrillation
5469757|NCT01421875|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5469758|NCT01421875|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5469759|NCT01421875|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5469760|NCT01421875|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5469761|NCT01421875|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5469762|NCT01421875|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5469763|NCT01421875|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5469764|NCT01421875|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5469765|NCT01421875|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5469766|NCT01421862|adult acute basophilic leukemia|adult acute basophilic leukemia
5469767|NCT01421862|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5469768|NCT01421862|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5469769|NCT01421862|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5469770|NCT01421862|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5469771|NCT01421862|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5469772|NCT01421862|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5469773|NCT01421862|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5469774|NCT01421862|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5469775|NCT01421862|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5469776|NCT01421862|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5469777|NCT01421862|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5469778|NCT01421862|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5469779|NCT01421862|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5469780|NCT01421862|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5469781|NCT01421862|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5469782|NCT01421862|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5469783|NCT01421849|single implant denture|single implant denture
5469784|NCT01421849|Elderly with an unstable mandibular denture|elderly with an unstable mandibular denture
5469786|NCT01421836|EUS guided insertion|eus guided insertion
5469787|NCT01421836|ERCP guided insertion|ercp guided insertion
5469788|NCT01421823|Fecal Incontinence|fecal incontinence
5469789|NCT01421823|Alpha agonist|alpha agonist
5469790|NCT01421732|Dengue fever|dengue fever
5469791|NCT01421732|severe dengue fever|severe dengue fever
5469792|NCT01421732|NS1 detection assay|ns1 detection assay
5469793|NCT01421732|Prognosis|prognosis
5469794|NCT01421732|Diagnosis|diagnosis
5469795|NCT01421719|Parkinson's Disease|parkinson's disease
5469796|NCT01421719|Neurogenic Bladder|neurogenic bladder
5469797|NCT01421719|Urinary Incontinence|urinary incontinence
5469798|NCT01421719|botulinum toxin|botulinum toxin
5469799|NCT01421719|cystoscopy|cystoscopy
5469800|NCT01421719|Effect of Other Parasympatholytics [Anticholinergics and Antimuscarinics] and Spasmolytics|effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics
5469801|NCT01421706|clarithromycin|clarithromycin
5469802|NCT01421706|sibutramine|sibutramine
5469803|NCT01421706|clopidogrel|clopidogrel
5469804|NCT01421693|Gatifloxacin|gatifloxacin
5469805|NCT01421693|Ceftriaxone|ceftriaxone
5469806|NCT01421693|Enteric fever|enteric fever
5469807|NCT01421693|Typhoid fever|typhoid fever
5469808|NCT01421667|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5469809|NCT01421667|Antigens, CD30|antigens, cd30
5469810|NCT01421667|Antibody-Drug Conjugate|antibody-drug conjugate
5469811|NCT01421667|Antibodies, Monoclonal|antibodies, monoclonal
5469812|NCT01421667|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5469813|NCT01421667|Monomethyl auristatin E|monomethyl auristatin e
5469814|NCT01421667|Drug Therapy|drug therapy
5469815|NCT01421667|Immunotherapy|immunotherapy
5469816|NCT01421667|Hematologic Diseases|hematologic diseases
5469817|NCT01421667|Lymphoma|lymphoma
5469818|NCT01421667|Lymphoma, B-Cell|lymphoma, b-cell
5469819|NCT01421667|Lymphoma, T-Cell|lymphoma, t-cell
5469820|NCT01421654|OSA|osa
5469821|NCT01421654|Sleep Apnea|sleep apnea
5469822|NCT01421654|PAP|pap
5469823|NCT01421654|positive airway pressure|positive airway pressure
5469824|NCT01421641|Tenaculum|tenaculum
5469825|NCT01421641|Pain|pain
5469826|NCT01421641|Lidocaine|lidocaine
5469827|NCT01421628|older adults|older adults
5469828|NCT01421628|exercise|exercise
5469829|NCT01421628|stretching|stretching
5469830|NCT01421628|mobility|mobility
5469831|NCT01421615|Bacterial vaginosis|bacterial vaginosis
5469832|NCT01421615|Probiotics|probiotics
5469833|NCT01421615|Lactobacilli|lactobacilli
5469834|NCT01421615|Pregnancy outcome|pregnancy outcome
5469835|NCT01421615|Randomized controlled trial|randomized controlled trial
5469836|NCT01421602|Inguinal Hernia|inguinal hernia
5469837|NCT01421602|Self-fixating mesh|self-fixating mesh
5469838|NCT01421602|Progrip|progrip
5469839|NCT01421602|Hernia Recurrence|hernia recurrence
5584333|NCT00952172|OSAS|osas
5469840|NCT01421602|Mesh, Surgical|mesh, surgical
5469841|NCT01421602|Recurrence|recurrence
5469842|NCT01421589|Growth hormone|growth hormone
5469843|NCT01421589|GH|gh
5469844|NCT01421589|Obesity|obesity
5469845|NCT01421589|Mitochondrial function|mitochondrial function
5469846|NCT01421589|reduced growth hormone secretion|reduced growth hormone secretion
5469847|NCT01421550|umbilical|umbilical
5469848|NCT01421550|hernia|hernia
5469849|NCT01421550|cirrhosis|cirrhosis
5469850|NCT01421550|ascites|ascites
5469851|NCT01421550|conservative|conservative
5469852|NCT01421550|surgery|surgery
5469853|NCT01421550|optimal management|optimal management
5469854|NCT01421537|Thromboprophylaxis|thromboprophylaxis
5469855|NCT01421537|enoxaparin|enoxaparin
5469856|NCT01421524|Neoplasm|neoplasm
5469857|NCT01421524|Malignancy|malignancy
5469858|NCT01421524|Carcinoma|carcinoma
5469859|NCT01421524|Lymphoma|lymphoma
5469860|NCT01421524|Multiple Myeloma|multiple myeloma
5469861|NCT01421524|DNA-PK inhibitor|dna-pk inhibitor
5469862|NCT01421524|Advanced Solid Tumors|advanced solid tumors
5469863|NCT01421524|Glioblastoma multiforme|glioblastoma multiforme
5469864|NCT01421524|Hepatocellular Carcinoma|hepatocellular carcinoma
5469865|NCT01421524|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5469866|NCT01421524|Mantel Cell Lymphoma|mantel cell lymphoma
5469867|NCT01421524|Advanced unresectable Solid Tumors|advanced unresectable solid tumors
5469868|NCT01421524|Primary CNS Lymphoma|primary cns lymphoma
5469869|NCT01421511|ABSSSI|absssi
5469870|NCT01421511|Tedizolid Phosphate|tedizolid phosphate
5469871|NCT01421511|TR-701|tr-701
5469872|NCT01421511|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
5469873|NCT01421498|ophthalmic delivery|ophthalmic delivery
5469874|NCT01421498|Dry Eye|dry eye
5469875|NCT01421472|Breast Cancer|breast cancer
5469876|NCT01421472|Neoadjuvant|neoadjuvant
5469877|NCT01421472|Her2 negative|her2 negative
5469878|NCT01421472|Her2 non-overexpressing|her2 non-overexpressing
5469879|NCT01421472|Estrogen Receptor Positive|estrogen receptor positive
5469880|NCT01421472|Triple Negative|triple negative
5469881|NCT01421472|MM-121|mm-121
5469882|NCT01421472|Paclitaxel|paclitaxel
5469883|NCT01421459|Diabetes|diabetes
5469884|NCT01421459|Type 2 Diabetes|type 2 diabetes
5469885|NCT01421446|Neuropsychology|neuropsychology
5469886|NCT01421433|Clonixin|clonixin
5469887|NCT01421433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5469888|NCT01421433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5469889|NCT01421433|Lysine|lysine
5469890|NCT01421433|L-Lysine|l-lysine
5469891|NCT01421433|Lysine Acetate|lysine acetate
5469892|NCT01421433|Lysine Hydrochloride|lysine hydrochloride
5469893|NCT01421433|Amitriptyline|amitriptyline
5469894|NCT01421420|Alzheimer's|alzheimer's
5469895|NCT01421420|Dementia|dementia
5469896|NCT01421420|Mild Cognitive Impairment|mild cognitive impairment
5469897|NCT01421407|Secondary hyperparathyroidism|secondary hyperparathyroidism
5469898|NCT01421407|End stage renal disease|end stage renal disease
5469899|NCT01421407|Parathyroid hyperplasia|parathyroid hyperplasia
5469900|NCT01421407|High Intensity Focused Ultrasound|high intensity focused ultrasound
5469901|NCT01421394|spinal cord injury(SCI)|spinal cord injury(sci)
5469902|NCT01421394|diffusion tensor imaging(DTI)|diffusion tensor imaging(dti)
5469903|NCT01421394|tractography|tractography
5469904|NCT01421381|leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
5469905|NCT01421381|idebenone|idebenone
5469906|NCT01421342|Mood Disorder|mood disorder
5469907|NCT01421342|Depression|depression
5469908|NCT01421342|Depressive Disorder|depressive disorder
5469909|NCT01421342|Depressive Disorder, Major|depressive disorder, major
5469910|NCT01421342|Bupropion|bupropion
5469911|NCT01421342|Aripiprazole|aripiprazole
5469912|NCT01421342|Remission|remission
5469913|NCT01421342|Relapse|relapse
5469914|NCT01421342|Cost-Effectiveness|cost-effectiveness
5469915|NCT01421342|Atypical Antipsychotic|atypical antipsychotic
5469916|NCT01421342|Antidepressant|antidepressant
5469917|NCT01421342|Augmentation|augmentation
5469918|NCT01421342|Veterans|veterans
5469919|NCT01421342|Mental Health|mental health
5469920|NCT01421316|Patients treated with whole brain radiotherapy in the setting of brain metastases|patients treated with whole brain radiotherapy in the setting of brain metastases
5469921|NCT01421316|Patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).|patients treated with whole brain radiotherapy in the prophylactic treatment for small cell lung cancer (extended disease).
5469922|NCT01421290|Cartilage lesions in the knee joint|cartilage lesions in the knee joint
5469923|NCT01421264|concussion|concussion
5469924|NCT01421264|gabapentin|gabapentin
5469925|NCT01421264|neurontin|neurontin
5469926|NCT01421264|insomnia|insomnia
5469927|NCT01421251|H1N1|h1n1
5469928|NCT01421251|Flu|flu
5469929|NCT01421251|Influenza|influenza
5469930|NCT01421251|Vaccine|vaccine
5469931|NCT01421251|Manitoba|manitoba
5469932|NCT01421251|Canada|canada
5469933|NCT01421251|Safety|safety
5469934|NCT01421238|Decision Making|decision making
5469935|NCT01421238|Premature infant|premature infant
5469936|NCT01421238|Informed consent|informed consent
5469937|NCT01421238|Prematurity|prematurity
5469938|NCT01421238|Framing|framing
5469939|NCT01421238|Negotiation Model|negotiation model
5469940|NCT01421225|Closed Loop Insulin Delivery|closed loop insulin delivery
5469941|NCT01421225|Diabetes|diabetes
5469942|NCT01421225|Type 1 Diabetes|type 1 diabetes
5469943|NCT01421225|Artificial pancreas|artificial pancreas
5469944|NCT01421212|Liver Transplantation|liver transplantation
5469945|NCT01421212|Liver Disease|liver disease
5469946|NCT01421212|Hepatitis B|hepatitis b
5469947|NCT01421212|Hepatitis B Infection|hepatitis b infection
5469948|NCT01421212|Hepatitis B Associated Liver Disease|hepatitis b associated liver disease
5469950|NCT01421199|Otitis Media with Effusion|otitis media with effusion
5469951|NCT01421199|Middle Ear Effusion|middle ear effusion
5469952|NCT01421186|Multiple Myeloma|multiple myeloma
5469953|NCT01421186|MOR03087 (MOR202)|mor03087 (mor202)
5469954|NCT01421186|Lenalidomide|lenalidomide
5469955|NCT01421186|Pomalidomide|pomalidomide
5469956|NCT01421186|CD38|cd38
5469957|NCT01421173|Lymphoma|lymphoma
5469958|NCT01421173|Lymphoid malignancies|lymphoid malignancies
5469959|NCT01421173|Relapsed|relapsed
5469960|NCT01421173|Refractory|refractory
5469961|NCT01421173|Autologous hematopoietic cell support|autologous hematopoietic cell support
5469962|NCT01421173|Stem cell infusion|stem cell infusion
5469963|NCT01421173|Hodgkin's lymphoma|hodgkin's lymphoma
5469964|NCT01421173|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5469965|NCT01421173|Vorinostat|vorinostat
5469966|NCT01421173|SAHA|saha
5469967|NCT01421173|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5469968|NCT01421173|MSK-390|msk-390
5469969|NCT01421173|Zolinza|zolinza
5469970|NCT01421173|Busulfan|busulfan
5469971|NCT01421173|Busulfex|busulfex
5469972|NCT01421173|Myleran|myleran
5469973|NCT01421173|Gemcitabine|gemcitabine
5469974|NCT01421173|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5469975|NCT01421173|Gemzar|gemzar
5469976|NCT01421173|Melphalan|melphalan
5469977|NCT01421173|Alkeran|alkeran
5469978|NCT01421173|Rituximab|rituximab
5469979|NCT01421173|Rituxan|rituxan
5469980|NCT01421173|Dexamethasone|dexamethasone
5469981|NCT01421173|Decadron|decadron
5469982|NCT01421173|G-CSF|g-csf
5469983|NCT01421173|Filgrastim|filgrastim
5469985|NCT01421173|Palifermin|palifermin
5469986|NCT01421173|Kepivance|kepivance
5469987|NCT01421160|Chronic|chronic
5469988|NCT01421160|Inflammatory|inflammatory
5469989|NCT01421160|Joint|joint
5469990|NCT01421160|Pain|pain
5469991|NCT01421147|Diabetes|diabetes
5469992|NCT01421147|Type 1 Diabetes|type 1 diabetes
5469993|NCT01421147|Diabetes Mellitus|diabetes mellitus
5469994|NCT01421134|depression|depression
5469995|NCT01421134|Lurasidone|lurasidone
5469996|NCT01421134|Latuda|latuda
5469997|NCT01421108|oral health|oral health
5469998|NCT01421108|dental brushing|dental brushing
5469999|NCT01421108|dental flossing|dental flossing
5470000|NCT01421095|Fertility|fertility
5470001|NCT01421095|adolescent|adolescent
5470002|NCT01421095|young adult|young adult
5470003|NCT01421095|cancer survivors|cancer survivors
5470004|NCT01421082|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
5470005|NCT01421082|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
5470006|NCT01421082|Emphysema|emphysema
5470007|NCT01421082|coil|coil
5470008|NCT01421082|RePneu|repneu
5470009|NCT01421069|Use of etanercept to treat pediatric subjects with extended oligoarticular JIA|use of etanercept to treat pediatric subjects with extended oligoarticular jia
5470010|NCT01421069|enthestitis related arthritis (ERA)|enthestitis related arthritis (era)
5470011|NCT01421069|or psoriatic arthritis (PsA).|or psoriatic arthritis (psa).
5470012|NCT01421043|bioequivalence study|bioequivalence study
5470013|NCT01421043|triazolam|triazolam
5470014|NCT01421043|liquid oral drops|liquid oral drops
5470015|NCT01421043|tablet|tablet
5470016|NCT01421030|quality of life|quality of life
5470017|NCT01421030|congenital heart disease|congenital heart disease
5470018|NCT01421030|open heart surgery|open heart surgery
5470019|NCT01421030|percutaneous pulmonary valve implantation|percutaneous pulmonary valve implantation
5470020|NCT01421030|costs|costs
5470021|NCT01421017|radiation therapy|radiation therapy
5470022|NCT01421017|combination therapy|combination therapy
5470023|NCT01421017|immunotherapy|immunotherapy
5470024|NCT01421017|immune response modifier|immune response modifier
5470025|NCT01421017|immunostimulatory|immunostimulatory
5470026|NCT01421017|immunomodulator|immunomodulator
5470027|NCT01421004|cancer|cancer
5470028|NCT01421004|tumors|tumors
5470029|NCT01421004|phase I|phase i
5470030|NCT01421004|crossover|crossover
5470031|NCT01421004|bioequivalence|bioequivalence
5470032|NCT01420965|Anti PD-1 Monoclonal Antibody|anti pd-1 monoclonal antibody
5470033|NCT01420965|Vaccine|vaccine
5470034|NCT01420965|Autologous Cellular Immunotherapy|autologous cellular immunotherapy
5470035|NCT01420965|Prostate Cancer|prostate cancer
5470036|NCT01420952|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5470037|NCT01420952|Metabolic Glutamate Receptors|metabolic glutamate receptors
5470038|NCT01420952|Brain|brain
5470040|NCT01420939|Brain|brain
5470041|NCT01420939|Traumatic Brain Injury|traumatic brain injury
5470042|NCT01420939|Biomarkers|biomarkers
5470043|NCT01420939|Healthy Volunteer|healthy volunteer
5470045|NCT01420913|To evaluate the pharmacokinetic characteristics of Lyrica, YHD1119 A,B,C|to evaluate the pharmacokinetic characteristics of lyrica, yhd1119 a,b,c
5470046|NCT01420887|CPM|cpm
5470047|NCT01420887|elbow joint surgery|elbow joint surgery
5470048|NCT01420887|continuous passive motion|continuous passive motion
5470049|NCT01420887|Recovery after surgery to restore elbow motion|recovery after surgery to restore elbow motion
5470050|NCT01420861|castrate resistant|castrate resistant
5470051|NCT01420848|stress disorders|stress disorders
5470052|NCT01420848|anxiety disorders|anxiety disorders
5470053|NCT01420835|Stress|stress
5470054|NCT01420835|Quality of life|quality of life
5470055|NCT01420796|Parkinson's disease|parkinson's disease
5470056|NCT01420796|dysphagia|dysphagia
5470057|NCT01420796|swallowing treatment|swallowing treatment
5470058|NCT01420757|operation time|operation time
5470059|NCT01420757|length of hospital stay|length of hospital stay
5470060|NCT01420744|Endotracheal ventilation|endotracheal ventilation
5470061|NCT01420744|Bacterial pneumonia|bacterial pneumonia
5470062|NCT01420731|sexual life, back pain|sexual life, back pain
5470063|NCT01420718|partial pulpotomy|partial pulpotomy
5470064|NCT01420718|Cvek pulpotomy|cvek pulpotomy
5470065|NCT01420718|MTA|mta
5470066|NCT01420718|iRootBP|irootbp
5470067|NCT01420718|dentin bridge|dentin bridge
5470068|NCT01420705|Bacille Calmette-Guérin|bacille calmette-guérin
5470069|NCT01420705|DTP|dtp
5470070|NCT01420705|Vaccination|vaccination
5470071|NCT01420705|Allergy|allergy
5470072|NCT01420705|Atopy|atopy
5470073|NCT01420705|Guinea-Bissau|guinea-bissau
5470074|NCT01420692|Tip 2 DM|tip 2 dm
5470075|NCT01420692|Endothelium|endothelium
5470076|NCT01420692|Gliclazide|gliclazide
5470077|NCT01420692|Insulin detemir|insulin detemir
5470078|NCT01420679|Lymphoproliferative Disorders|lymphoproliferative disorders
5470079|NCT01420679|Lymphoma|lymphoma
5470080|NCT01420679|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5470081|NCT01420679|T-cell Lymphoma|t-cell lymphoma
5470082|NCT01420640|Fibromyalgia|fibromyalgia
5470083|NCT01420640|Tai Chi|tai chi
5470084|NCT01420640|mind-body exercise|mind-body exercise
5470085|NCT01420640|aerobic exercise|aerobic exercise
5470087|NCT01420640|pain|pain
5470088|NCT01420614|radial access|radial access
5470089|NCT01420614|primary angioplasty|primary angioplasty
5470090|NCT01420614|trial|trial
5470091|NCT01420614|randomization|randomization
5470092|NCT01420614|outcome|outcome
5470093|NCT01420588|Oncologic Investigations|oncologic investigations
5470094|NCT01420588|Gastric Diseases|gastric diseases
5470095|NCT01420588|Gastric Cancer|gastric cancer
5470096|NCT01420588|Gastric Ulcer|gastric ulcer
5470097|NCT01420588|Breath Analysis|breath analysis
5470098|NCT01420588|Volatile Biomarkers|volatile biomarkers
5470099|NCT01420588|Nanosensors Array|nanosensors array
5470100|NCT01420588|Discriminant Factor Analysis|discriminant factor analysis
5470101|NCT01420588|GC-MS|gc-ms
5470102|NCT01420588|Breath Tests|breath tests
5470103|NCT01420575|Schizophrenia|schizophrenia
5470104|NCT01420575|Schizoaffective Disorder|schizoaffective disorder
5470105|NCT01420575|Shared Decision|shared decision
5470106|NCT01420575|Decision Aid|decision aid
5470107|NCT01420575|Antipsychotic|antipsychotic
5470108|NCT01420575|Weight Gain|weight gain
5470109|NCT01420575|Olanzapine|olanzapine
5470110|NCT01420575|Lexapro|lexapro
5470111|NCT01420575|Perphenazine|perphenazine
5470112|NCT01420562|allogeneic HSCT|allogeneic hsct
5470113|NCT01420562|posaconazole|posaconazole
5470114|NCT01420562|prophylaxis|prophylaxis
5470115|NCT01420562|mucositis|mucositis
5470116|NCT01420562|pharmacokinetics|pharmacokinetics
5470117|NCT01420549|Hypercholesterolemia|hypercholesterolemia
5470118|NCT01420549|Dyslipidemia|dyslipidemia
5470119|NCT01420536|Bilateral Balanced Occlusion|bilateral balanced occlusion
5470120|NCT01420536|Canine Guidance|canine guidance
5470121|NCT01420536|Complete Denture|complete denture
5470122|NCT01420536|Denture Retention|denture retention
5470123|NCT01420536|Dental Occlusion|dental occlusion
5470124|NCT01420536|Edentulous|edentulous
5470125|NCT01420536|Edentulism|edentulism
5470126|NCT01420536|Mandibular movement|mandibular movement
5470127|NCT01420536|Mastication|mastication
5470128|NCT01420536|Patient Acceptance of Health Care|patient acceptance of health care
5470129|NCT01420536|Patient Satisfaction|patient satisfaction
5470130|NCT01420523|HIV|hiv
5470131|NCT01420523|Lipohypertrophy|lipohypertrophy
5470132|NCT01420510|Patients satisfaction|patients satisfaction
5470133|NCT01420510|Side effects|side effects
5470134|NCT01420497|methylprednisolone|methylprednisolone
5470135|NCT01420497|intra articular infiltration|intra articular infiltration
5470136|NCT01420497|glycemia|glycemia
5470137|NCT01420497|epidural infiltration|epidural infiltration
5470138|NCT01420497|diabetes|diabetes
5470139|NCT01420484|CNAP|cnap
5470140|NCT01420484|continuous non-invasive arterial pressure|continuous non-invasive arterial pressure
5470141|NCT01420484|IAP|iap
5470142|NCT01420484|blood pressure|blood pressure
5470143|NCT01420484|analgosedation|analgosedation
5470144|NCT01420484|high-risk patients|high-risk patients
5470145|NCT01420484|rapid-pacing|rapid-pacing
5470146|NCT01420471|Endoscopic Sinus Surgery|endoscopic sinus surgery
5470147|NCT01420471|Triamcinolone|triamcinolone
5470148|NCT01420471|Merocel Middle Meatus Spacers|merocel middle meatus spacers
5470149|NCT01420458|bioequivalence|bioequivalence
5470359|NCT01419639|ependymomas|ependymomas
5470151|NCT01420432|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5470152|NCT01420432|Transplantation|transplantation
5470153|NCT01420419|nipple pain|nipple pain
5470154|NCT01420419|breastfeeding|breastfeeding
5470155|NCT01420419|nipple damage|nipple damage
5470157|NCT01420419|clinical trial|clinical trial
5470158|NCT01420406|lactation|lactation
5470159|NCT01420406|cryptoxanthin|cryptoxanthin
5470160|NCT01420406|beta-carotene|beta-carotene
5470161|NCT01420406|vitamin A|vitamin a
5470162|NCT01420393|Heart Failure|heart failure
5470163|NCT01420393|Atrial Fibrillation|atrial fibrillation
5470164|NCT01420393|Catheter Ablation|catheter ablation
5470165|NCT01420393|Anti-arrhythmic Medications|anti-arrhythmic medications
5470166|NCT01420393|Cardiovascular Mortality|cardiovascular mortality
5470167|NCT01420367|Paediatric|paediatric
5470169|NCT01420367|Non-perforated|non-perforated
5470170|NCT01420354|Metabolic stones|metabolic stones
5470171|NCT01420354|kidney stones|kidney stones
5470172|NCT01420354|renal calculi|renal calculi
5470173|NCT01420354|metabolic evaluation|metabolic evaluation
5470174|NCT01420341|Meliodosis|meliodosis
5470175|NCT01420341|Co-trimoxazole|co-trimoxazole
5470176|NCT01420341|Relapse|relapse
5470177|NCT01420315|vitamin D|vitamin d
5470178|NCT01420315|deficiency|deficiency
5470179|NCT01420315|alzheimer's disease|alzheimer's disease
5470180|NCT01420302|critical illness|critical illness
5470181|NCT01420302|intensive care|intensive care
5470182|NCT01420302|insulin|insulin
5470183|NCT01420302|glucose|glucose
5470184|NCT01420302|algorithm|algorithm
5470185|NCT01420302|blood glucose control|blood glucose control
5470186|NCT01420289|Ischemic ulcers|ischemic ulcers
5470187|NCT01420289|PAD|pad
5470188|NCT01420289|Intermittent Claudication Pain|intermittent claudication pain
5470189|NCT01420276|Female sexual function|female sexual function
5470190|NCT01420263|premature infant|premature infant
5470191|NCT01420263|feeding|feeding
5470192|NCT01420263|residuals|residuals
5470193|NCT01420263|fresh feeds|fresh feeds
5470194|NCT01420263|full feeds|full feeds
5470195|NCT01420263|digestive system|digestive system
5470196|NCT01420250|Prostate cancer|prostate cancer
5470197|NCT01420250|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5470198|NCT01420237|Noninflammatory joint disease of the hip.|noninflammatory joint disease of the hip.
5470199|NCT01420224|Air travel|air travel
5470200|NCT01420224|Aircraft cabin hypoxia|aircraft cabin hypoxia
5470201|NCT01420224|Pulmonary artery pressure|pulmonary artery pressure
5470202|NCT01420224|Hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5470203|NCT01420224|Pulmonary hypertension|pulmonary hypertension
5470204|NCT01420211|pharmacokinetics|pharmacokinetics
5470205|NCT01420211|MRI|mri
5470206|NCT01420211|liver|liver
5470207|NCT01420211|drug transporter|drug transporter
5470208|NCT01420211|Gd-EOB-DTPA|gd-eob-dtpa
5470209|NCT01420198|Diabetes type 2|diabetes type 2
5470210|NCT01420198|Lifestyle intervention|lifestyle intervention
5470211|NCT01420198|QALY|qaly
5470212|NCT01420198|Ethnic group|ethnic group
5470213|NCT01420198|Impaired glucose tolerance|impaired glucose tolerance
5470214|NCT01420198|Impaired fasting glucose|impaired fasting glucose
5470215|NCT01420185|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5470216|NCT01420185|stage II breast cancer|stage ii breast cancer
5470217|NCT01420185|stage IIIA breast cancer|stage iiia breast cancer
5470218|NCT01420159|Pain|pain
5470219|NCT01420159|Trauma|trauma
5470220|NCT01420159|Analgesia|analgesia
5470221|NCT01420133|Corticosteroids|corticosteroids
5470222|NCT01420133|Diet low in sugar and salt|diet low in sugar and salt
5470223|NCT01420133|Dermatological disease|dermatological disease
5470224|NCT01420133|Corticosteroids Allergy|corticosteroids allergy
5470225|NCT01420133|3 Months|3 months
5470226|NCT01420120|Biodegradable stent, PAD|biodegradable stent, pad
5470227|NCT01420107|Infant, Premature|infant, premature
5470228|NCT01420107|Delivery Rooms|delivery rooms
5470229|NCT01420107|Video Recording|video recording
5470230|NCT01420107|Outcome Assessment (Health Care)|outcome assessment (health care)
5470231|NCT01420094|Drugs, Investigational|drugs, investigational
5470232|NCT01420094|Acetylsalicylic Acid|acetylsalicylic acid
5470233|NCT01420094|Aspirin|aspirin
5470234|NCT01420094|dental pain|dental pain
5470235|NCT01420081|uterine neoplasms|uterine neoplasms
5470236|NCT01420081|endometrial|endometrial
5470237|NCT01420081|uterine|uterine
5470238|NCT01420081|cancer|cancer
5470239|NCT01420081|PI3K|pi3k
5470240|NCT01420081|mTOR|mtor
5470241|NCT01420081|PI3K/mTOR|pi3k/mtor
5470242|NCT01420081|recurrent|recurrent
5470243|NCT01420081|metastatic|metastatic
5470244|NCT01420068|Pediatric|pediatric
5470245|NCT01420068|hypertension|hypertension
5470246|NCT01420068|aliskiren|aliskiren
5470247|NCT01420055|Multiple sclerosis|multiple sclerosis
5470248|NCT01420055|Fingolimod|fingolimod
5470249|NCT01420055|Coping|coping
5470250|NCT01420055|Anxiety|anxiety
5470251|NCT01420055|France|france
5789042|NCT00150137|Graves’ disease|graves’ disease
5470252|NCT01420055|Treatment Satisfaction Questionnaire for Medication-9 items (TSQM 9)|treatment satisfaction questionnaire for medication-9 items (tsqm 9)
5470254|NCT01420029|Low birth weight neonates|low birth weight neonates
5470255|NCT01420029|Neurodevelopmental outcome|neurodevelopmental outcome
5470256|NCT01420029|Thyroid dysfunction|thyroid dysfunction
5470257|NCT01420029|Extrauterine growth|extrauterine growth
5470258|NCT01420029|Plasticizers|plasticizers
5470259|NCT01420016|Cardiovascular risk|cardiovascular risk
5470260|NCT01420016|Clinical Decision Support|clinical decision support
5470261|NCT01420016|Electronic Health Records|electronic health records
5470262|NCT01420016|Primary Care|primary care
5470263|NCT01420016|Quality of Care|quality of care
5470264|NCT01420003|Allergen Challenge|allergen challenge
5470265|NCT01420003|B cell activation|b cell activation
5470266|NCT01420003|M1 prime related biomarkers|m1 prime related biomarkers
5470267|NCT01419977|sickle cell disease|sickle cell disease
5470268|NCT01419977|vaso-occlusive crisis|vaso-occlusive crisis
5470269|NCT01419977|anticoagulation|anticoagulation
5470270|NCT01419964|Vitiligo|vitiligo
5470271|NCT01419964|Macular depigmentation|macular depigmentation
5470272|NCT01419964|Stachytarpheta cayensensis|stachytarpheta cayensensis
5470273|NCT01419951|Behavioral treatment|behavioral treatment
5470274|NCT01419951|Preschool aged children|preschool aged children
5470275|NCT01419951|Obesity|obesity
5470276|NCT01419938|Light therapy|light therapy
5470277|NCT01419938|circadian rhythm|circadian rhythm
5470278|NCT01419938|CBT|cbt
5470279|NCT01419925|influenza vaccine|influenza vaccine
5470280|NCT01419925|peptide|peptide
5470281|NCT01419925|universal|universal
5470282|NCT01419925|prime|prime
5470283|NCT01419925|boost|boost
5470284|NCT01419925|TIV|tiv
5470285|NCT01419925|HAI|hai
5470286|NCT01419925|Hemagglutination Inhibition|hemagglutination inhibition
5470287|NCT01419925|elderly|elderly
5470293|NCT01419860|Microcirculation|microcirculation
5470294|NCT01419860|Colon|colon
5470295|NCT01419860|Anastomosis|anastomosis
5470296|NCT01419860|ICG|icg
5470297|NCT01419860|Gastro surgery|gastro surgery
5470298|NCT01419860|benign colon diseases requiring resection|benign colon diseases requiring resection
5470299|NCT01419834|CNS|cns
5470300|NCT01419834|Brain|brain
5470301|NCT01419834|MAB 3F8|mab 3f8
5470302|NCT01419834|Hu3F8|hu3f8
5470303|NCT01419834|11-009|11-009
5470304|NCT01419821|Vitamin D|vitamin d
5470305|NCT01419821|Bone densitometry|bone densitometry
5470306|NCT01419821|Vitamin D supplementation|vitamin d supplementation
5470307|NCT01419821|Growth|growth
5470308|NCT01419808|Scaphoid|scaphoid
5470309|NCT01419808|Non-Union|non-union
5470310|NCT01419808|Proximal pole|proximal pole
5470311|NCT01419808|Bone Graft|bone graft
5470312|NCT01419808|Vascularized|vascularized
5470313|NCT01419808|Non-Vascularized|non-vascularized
5470314|NCT01419808|PREE|pree
5470315|NCT01419782|bone|bone
5470316|NCT01419782|osteocyte|osteocyte
5470317|NCT01419782|rest muscle electrical activity|rest muscle electrical activity
5470318|NCT01419782|whole-body vibration|whole-body vibration
5470319|NCT01419782|sclerostin|sclerostin
5470320|NCT01419769|symptomatic pancreatic pseudocyst|symptomatic pancreatic pseudocyst
5470321|NCT01419769|pancreatic pseudocyst|pancreatic pseudocyst
5470322|NCT01419769|transluminal drainage|transluminal drainage
5470323|NCT01419769|minimally invasive|minimally invasive
5470324|NCT01419769|Nitinol stent|nitinol stent
5470325|NCT01419769|transmural endoscopic drainage|transmural endoscopic drainage
5470326|NCT01419769|catheter based|catheter based
5470327|NCT01419743|Vitamin D deficiency|vitamin d deficiency
5470328|NCT01419743|Supplementation|supplementation
5470329|NCT01419743|Infertility|infertility
5470330|NCT01419743|Clinical pregnancy rates|clinical pregnancy rates
5470331|NCT01419717|cancer|cancer
5470332|NCT01419717|bone metastases|bone metastases
5470333|NCT01419717|breast cancer|breast cancer
5470334|NCT01419717|prostate cancer|prostate cancer
5470335|NCT01419704|other hemoglobinopathies|other hemoglobinopathies
5470336|NCT01419704|chimerism|chimerism
5470337|NCT01419704|sickle cell|sickle cell
5470338|NCT01419704|thalassemia|thalassemia
5470339|NCT01419704|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
5470340|NCT01419691|auranofin|auranofin
5470341|NCT01419691|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5470342|NCT01419691|relapsed|relapsed
5470343|NCT01419691|refractory|refractory
5470344|NCT01419691|CLL|cll
5470345|NCT01419691|SLL|sll
5470346|NCT01419691|PLL|pll
5470347|NCT01419678|posaconazole|posaconazole
5470348|NCT01419678|PK blood sampling|pk blood sampling
5470349|NCT01419665|Follicular Lymphoma|follicular lymphoma
5470350|NCT01419665|Biosimilar|biosimilar
5584854|NCT00950430|PET|pet
5456874|NCT01474265|MSNA|msna
5470351|NCT01419665|GP13-301|gp13-301
5470352|NCT01419665|rituximab|rituximab
5470353|NCT01419665|Antibodies|antibodies
5470354|NCT01419665|CD20|cd20
5470355|NCT01419652|percutaneous coronary intervention|percutaneous coronary intervention
5470356|NCT01419639|Neurofibromatosis Type II|neurofibromatosis type ii
5470357|NCT01419639|cranial nerve schwannomas|cranial nerve schwannomas
5464873|NCT01441167|Sporozoites|sporozoites
5470361|NCT01419626|Interdental Cleaning Device|interdental cleaning device
5470362|NCT01419613|healthy lifestyle|healthy lifestyle
5470363|NCT01419613|physical activity|physical activity
5470364|NCT01419613|behavior|behavior
5470365|NCT01419613|motivational|motivational
5470366|NCT01419613|interview|interview
5470367|NCT01419613|breast cancer survivor|breast cancer survivor
5470369|NCT01419600|healthy volunteers|healthy volunteers
5470371|NCT01419600|tolerability|tolerability
5470372|NCT01419600|pharmacokinetics|pharmacokinetics
5470373|NCT01419600|single ascending dose study|single ascending dose study
5470374|NCT01419587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5470375|NCT01419587|Non small cell lung cancer|non small cell lung cancer
5470376|NCT01419587|NSCLC|nsclc
5470377|NCT01419587|Ketogenic Diet|ketogenic diet
5470378|NCT01419587|radiotherapy|radiotherapy
5470379|NCT01419587|paclitaxel|paclitaxel
5470380|NCT01419587|carboplatin|carboplatin
5470381|NCT01419574|Carotid Artery Plaque|carotid artery plaque
5470382|NCT01419574|Contrast Agents|contrast agents
5470383|NCT01419574|Vasa Vasorum|vasa vasorum
5470384|NCT01419574|MRI|mri
5470385|NCT01419574|Intraplaque Hemorrhage|intraplaque hemorrhage
5470386|NCT01419574|Solid Tumor|solid tumor
5470387|NCT01419574|Metastatic Solid Tumor|metastatic solid tumor
5470388|NCT01419561|KSHV|kshv
5470389|NCT01419561|KICS|kics
5470390|NCT01419561|HIV|hiv
5470391|NCT01419561|Cytokines|cytokines
5470392|NCT01419561|HHV-8|hhv-8
5470393|NCT01419561|KSHV Inflammatory Cytokine Syndrome|kshv inflammatory cytokine syndrome
5470394|NCT01419561|Kaposi Sarcoma Heres Virus|kaposi sarcoma heres virus
5470395|NCT01419548|ABT-888|abt-888
5470396|NCT01419548|Liver Dysfunction|liver dysfunction
5470397|NCT01419548|Kidney Dysfunction|kidney dysfunction
5470398|NCT01419548|PARP Inhibitor|parp inhibitor
5470399|NCT01419548|Pharmacokinetics|pharmacokinetics
5470400|NCT01419548|Cancer|cancer
5470401|NCT01419535|Metabolism|metabolism
5470402|NCT01419535|Cortisol|cortisol
5470403|NCT01419535|Hypercortisolism|hypercortisolism
5470404|NCT01419535|Glucose Intolerance|glucose intolerance
5470405|NCT01419522|Traumatic Brain Injury|traumatic brain injury
5470406|NCT01419522|Walking Impairment|walking impairment
5470407|NCT01419522|Gait Training|gait training
5470408|NCT01419522|TBI|tbi
5470409|NCT01419509|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5470410|NCT01419509|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5470411|NCT01419509|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5470412|NCT01419509|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5470413|NCT01419509|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5470414|NCT01419509|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5470415|NCT01419509|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5470416|NCT01419496|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5470417|NCT01419496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5470418|NCT01419496|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5470419|NCT01419496|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5470420|NCT01419496|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5600417|NCT00896272|XXY|xxy
5470421|NCT01419496|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5470422|NCT01419496|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5470423|NCT01419496|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5470424|NCT01419483|Pancreatic neoplasms|pancreatic neoplasms
5470425|NCT01419483|Pancreatic cancer|pancreatic cancer
5470426|NCT01419483|Ketogenic Diet|ketogenic diet
5470427|NCT01419483|radiotherapy|radiotherapy
5470428|NCT01419483|gemcitabine|gemcitabine
5470429|NCT01419457|Healthy|healthy
5470430|NCT01419457|hepatic impairment|hepatic impairment
5470431|NCT01419457|T-705a|t-705a
5470432|NCT01419457|Favipiravir|favipiravir
5470433|NCT01419444|Voice|voice
5470434|NCT01419444|Muscle Tension Dysphonia|muscle tension dysphonia
5470435|NCT01419444|Hyperfunction|hyperfunction
5470436|NCT01419444|Treatment|treatment
5470437|NCT01419431|Colon cancer|colon cancer
5470438|NCT01419418|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5470439|NCT01419418|Qualitative analysis|qualitative analysis
5470440|NCT01419418|Patients' perspective|patients' perspective
5470441|NCT01419405|analgesia|analgesia
5685312|NCT00556595|paroxysmal|paroxysmal
5470442|NCT01419405|acute experimental pain|acute experimental pain
5470443|NCT01419405|cold pressor test|cold pressor test
5470444|NCT01419405|pregabalin|pregabalin
5470445|NCT01419405|remifentanil|remifentanil
5470446|NCT01419392|sildenafil citrate|sildenafil citrate
5470447|NCT01419392|Doppler Ultrasonography|doppler ultrasonography
5470448|NCT01419392|nitric oxide|nitric oxide
5470449|NCT01419392|total antioxidant capacity|total antioxidant capacity
5464971|NCT01440868|Delivery Rooms|delivery rooms
5470451|NCT01419353|Infertility, IVF, Estrogen|infertility, ivf, estrogen
5470452|NCT01419327|Fosrenol|fosrenol
5470453|NCT01419327|Hyperphosphatemia|hyperphosphatemia
5470454|NCT01419327|Hemodialysis|hemodialysis
5470455|NCT01419314|Physical Therapy|physical therapy
5470457|NCT01419314|Sleep|sleep
5470458|NCT01419314|Pain|pain
5470459|NCT01419314|6 min walk|6 min walk
5470460|NCT01419314|forward reach|forward reach
5470461|NCT01419314|Function|function
5470462|NCT01419301|multiple sclerosis|multiple sclerosis
5470463|NCT01419301|glatiramer acetate|glatiramer acetate
5470464|NCT01419301|stress reduction|stress reduction
5470465|NCT01419301|medication adherence|medication adherence
5470466|NCT01419288|Amputees|amputees
5470467|NCT01419262|Vitamin D|vitamin d
5470468|NCT01419262|Randomized Controlled Trial|randomized controlled trial
5470469|NCT01419262|Child, Preschool|child, preschool
5470470|NCT01419262|Dietary Supplements|dietary supplements
5470471|NCT01419262|Respiratory Tract Infections|respiratory tract infections
5470472|NCT01419262|Asthma|asthma
5470473|NCT01419249|Growth Hormone Deficiency|growth hormone deficiency
5470474|NCT01419249|Turner syndrome|turner syndrome
5470475|NCT01419249|Pharmacogenetics|pharmacogenetics
5470476|NCT01419249|Recombinant Human Growth Hormone therapy|recombinant human growth hormone therapy
5470477|NCT01419236|Ejaculatory Dysfunction|ejaculatory dysfunction
5452777|NCT01491100|Cognition|cognition
5470478|NCT01419236|Orgasmic Dysfunction|orgasmic dysfunction
5470479|NCT01419236|Sexual Dysfunction|sexual dysfunction
5470480|NCT01419236|Climax Dysfunction|climax dysfunction
5470481|NCT01419236|Erectile Dysfunction|erectile dysfunction
5470482|NCT01419236|Impotence|impotence
5470483|NCT01419236|Hypogonadism|hypogonadism
5470484|NCT01419236|Low testosterone|low testosterone
5470485|NCT01419236|Low t|low t
5470486|NCT01419223|Qualitative research|qualitative research
5470487|NCT01419223|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5470488|NCT01419223|Refusal to Participate|refusal to participate
5470489|NCT01419210|Complementary Medicine|complementary medicine
5470490|NCT01419210|Traditional Medicine|traditional medicine
5470491|NCT01419184|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5470492|NCT01419184|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5470493|NCT01419184|Daptomycin|daptomycin
5470494|NCT01419184|Vancomycin|vancomycin
5470495|NCT01419184|Antibiotics|antibiotics
5470496|NCT01419158|Alpha-1 antitrypsin|alpha-1 antitrypsin
5470497|NCT01419158|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5470498|NCT01419158|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5470499|NCT01419145|cachexia|cachexia
5470500|NCT01419145|neoplasms|neoplasms
5470501|NCT01419145|complications|complications
5470502|NCT01419145|combined modality therapy|combined modality therapy
5470503|NCT01419145|exercise therapy|exercise therapy
5470504|NCT01419145|diet therapy|diet therapy
5470505|NCT01419145|anti-inflammatory agents|anti-inflammatory agents
5470506|NCT01419132|furosemide|furosemide
5470507|NCT01419132|hypertonic saline solution|hypertonic saline solution
5470508|NCT01419132|troponin I|troponin i
5470509|NCT01419119|vitamin D insufficiency|vitamin d insufficiency
5470510|NCT01419119|Cholecalciferol|cholecalciferol
5470511|NCT01419119|D3|d3
5455280|NCT01480583|Brain Tumor|brain tumor
5470512|NCT01419119|Parathyroid Hormone|parathyroid hormone
5470513|NCT01419119|25-hydroxyvitamin D3|25-hydroxyvitamin d3
5470514|NCT01419119|RDA, recommended daily intake (nutrition policy)|rda, recommended daily intake (nutrition policy)
5470515|NCT01419119|Vitamin D|vitamin d
5470516|NCT01419119|Hypovitaminosis-D|hypovitaminosis-d
5470517|NCT01419119|Pharmacologic treatment|pharmacologic treatment
5470518|NCT01419106|Hypotension|hypotension
5470519|NCT01419106|Emergency care|emergency care
5470520|NCT01419106|Point of care Ultrasound|point of care ultrasound
5470521|NCT01419106|Shock|shock
5470522|NCT01419093|Physical Activity|physical activity
5470523|NCT01419093|Exercise|exercise
5470524|NCT01419080|Peripheral Arterial Disease|peripheral arterial disease
5470525|NCT01419080|Quality of Life|quality of life
5470526|NCT01419080|Quality of Care|quality of care
5470527|NCT01419067|Proton Therapy|proton therapy
5470528|NCT01419067|Radical resection|radical resection
5470529|NCT01419041|renal impairment|renal impairment
5470530|NCT01419041|crizotinib|crizotinib
5470531|NCT01419041|pharmacokinetics|pharmacokinetics
5470532|NCT01419028|Hypophosphatasia|hypophosphatasia
5470534|NCT01419028|Bone disease|bone disease
5470535|NCT01419028|Soft bones|soft bones
5470536|NCT01419028|Low alkaline phosphatase|low alkaline phosphatase
5685313|NCT00556595|symptomatic|symptomatic
5470537|NCT01419028|Genetic metabolic disorder|genetic metabolic disorder
5470538|NCT01419028|Alkaline phosphatase|alkaline phosphatase
5470539|NCT01419028|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5470540|NCT01419028|Rickets|rickets
5470541|NCT01419028|Osteomalacia|osteomalacia
5470542|NCT01419015|SAPIEN XT Valve (20mm)|sapien xt valve (20mm)
5470543|NCT01419015|Cardiovascular Disease|cardiovascular disease
5470544|NCT01419015|Valvular Heart Disease|valvular heart disease
5470546|NCT01419015|Heart Valve Therapy|heart valve therapy
5470547|NCT01419015|Transcatheter|transcatheter
5470548|NCT01419015|Transfemoral|transfemoral
5470549|NCT01419015|Efficacy endpoints|efficacy endpoints
5470550|NCT01419015|Indexed Aortic Valve Area|indexed aortic valve area
5470551|NCT01419015|NYHA|nyha
5470552|NCT01419002|Pancreatic Cancer|pancreatic cancer
5470553|NCT01419002|Adenocarcinoma|adenocarcinoma
5470554|NCT01419002|Neoadjuvant Radiotherapy|neoadjuvant radiotherapy
5470555|NCT01418976|physical therapy techniques|physical therapy techniques
5470556|NCT01418976|brain injuries, traumatic|brain injuries, traumatic
5470557|NCT01418976|walking|walking
5470558|NCT01418976|gait|gait
5470559|NCT01418976|postural balance|postural balance
5470560|NCT01418950|Prematurity Counseling for pregnant women and their family|prematurity counseling for pregnant women and their family
5470561|NCT01418937|HPV vaccine|hpv vaccine
5470562|NCT01418937|serious adverse events (SAEs)|serious adverse events (saes)
5470563|NCT01418937|medically significant conditions|medically significant conditions
5470564|NCT01418937|cervical neoplasia|cervical neoplasia
5470565|NCT01418924|sclerostin|sclerostin
5470566|NCT01418924|estradiol|estradiol
5470567|NCT01418924|progesterone|progesterone
5470568|NCT01418924|testosteron|testosteron
5470569|NCT01418924|sex hormones|sex hormones
5470570|NCT01418898|Iron deficiency anemia|iron deficiency anemia
5470571|NCT01418898|iron|iron
5470572|NCT01418898|zinc|zinc
5470573|NCT01418898|vitamin A|vitamin a
5470574|NCT01418898|vitamin C|vitamin c
5470575|NCT01418898|oats|oats
5470576|NCT01418885|subcortical ischemic vascular disease|subcortical ischemic vascular disease
5470577|NCT01418872|Obesity|obesity
5470578|NCT01418872|Cardiovascular Diseases Prevention|cardiovascular diseases prevention
5470579|NCT01418872|Paediatrics|paediatrics
5470580|NCT01418859|cervical cancer|cervical cancer
5470581|NCT01418859|postoperation|postoperation
5470582|NCT01418859|chemotherapy|chemotherapy
5470583|NCT01418859|radiotherapy|radiotherapy
5470584|NCT01418846|voriconazole|voriconazole
5470585|NCT01418846|saliva|saliva
5470586|NCT01418846|pharmacokinetics|pharmacokinetics
5470587|NCT01418833|voriconazole|voriconazole
5470588|NCT01418833|therapeutic drug monitoring|therapeutic drug monitoring
5470589|NCT01418833|plasma levels|plasma levels
5470590|NCT01418833|dose adjustment|dose adjustment
5470591|NCT01418820|hemianopia|hemianopia
5470592|NCT01418820|visual field defect|visual field defect
5470593|NCT01418820|stroke|stroke
5470594|NCT01418820|non-invasive brain stimulation|non-invasive brain stimulation
5470595|NCT01418820|alternating current stimulation|alternating current stimulation
5470596|NCT01418794|Acute Coronary Syndromes|acute coronary syndromes
5470597|NCT01418794|Drug eluting stent|drug eluting stent
5470598|NCT01418794|Diffused lesion|diffused lesion
5470599|NCT01418781|gout|gout
5470600|NCT01418781|cost|cost
5470601|NCT01418781|utilization|utilization
5470602|NCT01418768|COPD|copd
5470603|NCT01418768|CAT|cat
5470604|NCT01418768|Rehabilitation|rehabilitation
5671455|NCT00615966|ischemia-reperfusion injury|ischemia-reperfusion injury
5470605|NCT01418768|chronic obstructive pulmonary disease GOLD III/IV|chronic obstructive pulmonary disease gold iii/iv
5470606|NCT01418755|Platelet-Rich Plasma|platelet-rich plasma
5470607|NCT01418755|Knee|knee
5470608|NCT01418755|Tibiofemoral Chondromalacia|tibiofemoral chondromalacia
5470609|NCT01418755|Injection|injection
5470610|NCT01418742|skin toxicity|skin toxicity
5470611|NCT01418716|Disease Management|disease management
5470612|NCT01418716|Quality Improvement|quality improvement
5470613|NCT01418716|Cooperative Behavior (collaboration)|cooperative behavior (collaboration)
5470614|NCT01418677|Unspecified Advance Solid Tumor, Protocol Specific|unspecified advance solid tumor, protocol specific
5470615|NCT01418664|vitamin D|vitamin d
5470616|NCT01418664|adverse pregnancy outcome|adverse pregnancy outcome
5470617|NCT01418664|Pakistan|pakistan
5470618|NCT01418638|Major Depressive Disorder|major depressive disorder
5470619|NCT01418638|Antidepressants|antidepressants
5470620|NCT01418573|glucose, insulin, post prandial|glucose, insulin, post prandial
5470621|NCT01418560|renal artery|renal artery
5470622|NCT01418560|sympathetic nerves|sympathetic nerves
5470623|NCT01418560|modification|modification
5470624|NCT01418560|chronic renal failure|chronic renal failure
5470625|NCT01418521|Cardiac surgery|cardiac surgery
5470626|NCT01418521|Balanced 3rd generation Hydroxyethyl starch|balanced 3rd generation hydroxyethyl starch
5470627|NCT01418521|Tetraspan|tetraspan
5470628|NCT01418521|Ringer-albumin|ringer-albumin
5470629|NCT01418469|COPD|copd
5470630|NCT01418469|protein metabolism|protein metabolism
5457155|NCT01473095|Tumor|tumor
5470631|NCT01418469|branched-chain amino acid metabolism|branched-chain amino acid metabolism
5470632|NCT01418469|exercise|exercise
5470633|NCT01418469|protein feeding|protein feeding
5470634|NCT01418456|diabetes|diabetes
5470635|NCT01418456|antibiotics|antibiotics
5470636|NCT01418456|clean foot ulcers|clean foot ulcers
5470637|NCT01418404|Stroke|stroke
5470638|NCT01418404|Effects of TS in U/E motor recovery|effects of ts in u/e motor recovery
5470639|NCT01418404|Brain mapping|brain mapping
5470643|NCT01418391|morphine consumption|morphine consumption
5470644|NCT01418391|post-operative analgesia|post-operative analgesia
5470646|NCT01418378|cruciate|cruciate
5470656|NCT01418352|tic disorders|tic disorders
5470657|NCT01418339|Tourette's Disorder|tourette's disorder
5470658|NCT01418339|tic disorders|tic disorders
5470659|NCT01418326|Cancer - breast|cancer - breast
5470660|NCT01418326|colo-rectal|colo-rectal
5470671|NCT01418261|uncontrolled hypertension|uncontrolled hypertension
5470672|NCT01418261|renal denervation|renal denervation
5470673|NCT01418248|cardiac catheterization|cardiac catheterization
5470674|NCT01418248|echocardiography|echocardiography
5470675|NCT01418235|HIV Infections|hiv infections
5470676|NCT01418235|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5470677|NCT01418235|Lentivirus Infections|lentivirus infections
5470678|NCT01418235|Retroviridae Infections|retroviridae infections
5470679|NCT01418235|RNA Virus Infections|rna virus infections
5470680|NCT01418235|Virus Diseases|virus diseases
5470681|NCT01418235|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5470682|NCT01418235|Sexually Transmitted Diseases|sexually transmitted diseases
5470683|NCT01418235|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5470684|NCT01418235|Immune System Diseases|immune system diseases
5470685|NCT01418235|Slow Virus Diseases|slow virus diseases
5470686|NCT01418209|Menopause|menopause
5470687|NCT01418209|Vasomotor|vasomotor
5470688|NCT01418209|Symptoms|symptoms
5470689|NCT01418209|Estradiol|estradiol
5470690|NCT01418209|Venlafaxine|venlafaxine
5470691|NCT01418196|TMAO|tmao
5470692|NCT01418196|Children|children
5470693|NCT01418196|Dietary choline|dietary choline
5470694|NCT01418196|Cardiovascular disease risk|cardiovascular disease risk
5470695|NCT01418196|Atherogenic dyslipidemia|atherogenic dyslipidemia
5470696|NCT01418183|Orthognathic surgery|orthognathic surgery
5470697|NCT01418183|Pain control|pain control
5470698|NCT01418183|Trigeminal nerve|trigeminal nerve
5470699|NCT01418183|Levobupivacaine|levobupivacaine
5470700|NCT01418170|myofascial pain syndrome|myofascial pain syndrome
5470701|NCT01418170|myofascial trigger points|myofascial trigger points
5470702|NCT01418170|spinal manipulative therapy|spinal manipulative therapy
5470703|NCT01418170|algometer|algometer
5470704|NCT01418170|pressure pain thresholds|pressure pain thresholds
5470705|NCT01418157|Acute mountain sickness|acute mountain sickness
5470706|NCT01418157|Rapid ascent|rapid ascent
5470707|NCT01418157|High altitude headache|high altitude headache
5470708|NCT01418157|Mountain Medicine Society Nepal|mountain medicine society nepal
5470709|NCT01418131|Proctitis|proctitis
5470710|NCT01418131|resistant|resistant
5470711|NCT01418131|ulcerative colitis|ulcerative colitis
5470712|NCT01418131|inflammatory bowel disease|inflammatory bowel disease
5470713|NCT01418118|noradrenaline|noradrenaline
5470714|NCT01418118|norepinephrine|norepinephrine
5470715|NCT01418118|epinephrine|epinephrine
5470716|NCT01418118|adrenaline|adrenaline
5470717|NCT01418118|dobutamine|dobutamine
5470718|NCT01418118|dopexamine|dopexamine
5470719|NCT01418118|inotrope|inotrope
5470720|NCT01418118|pressor|pressor
5680283|NCT00578370|Ciclosporin|ciclosporin
5455473|NCT01479881|HCV|hcv
5470721|NCT01418118|sympathomimetic|sympathomimetic
5470722|NCT01418118|free flap|free flap
5470723|NCT01418118|transplantation|transplantation
5470724|NCT01418118|free tissue transfer|free tissue transfer
5470725|NCT01418118|microsurgery|microsurgery
5470726|NCT01418118|survival|survival
5470727|NCT01418105|spine injuries|spine injuries
5470728|NCT01418105|brain lesions|brain lesions
5470729|NCT01418105|dysphagia|dysphagia
5470730|NCT01418079|Spectroscopy, near infrared|spectroscopy, near infrared
5470731|NCT01418079|cerebral oxygenation|cerebral oxygenation
5470732|NCT01418027|NAFLD|nafld
5470733|NCT01418027|exercise|exercise
5470734|NCT01418027|hepatic triglycerides|hepatic triglycerides
5470735|NCT01418001|GEMCITABINE|gemcitabine
5470736|NCT01418001|GW786034 (PAZOPANIB)|gw786034 (pazopanib)
5470737|NCT01418001|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5470738|NCT01418001|11-104|11-104
5470739|NCT01417988|TB|tb
5470740|NCT01417975|exercise|exercise
5470741|NCT01417975|smoking satisfaction|smoking satisfaction
5470742|NCT01417975|topography|topography
5470743|NCT01417975|cravings|cravings
5470744|NCT01417962|Autopsy|autopsy
5470745|NCT01417962|MRI|mri
5470746|NCT01417962|Stillbirths|stillbirths
5470747|NCT01417962|Neonatal death|neonatal death
5470748|NCT01417962|Sudden Infant death|sudden infant death
5470749|NCT01417923|chronic musculo-skeletal pain|chronic musculo-skeletal pain
5685314|NCT00556595|drug-refractory|drug-refractory
5470750|NCT01417923|therapeutic&serology effects of vitamin D|therapeutic&serology effects of vitamin d
5470751|NCT01417923|CRP, IL-6, IL-8, TNF and prostaglandin E2|crp, il-6, il-8, tnf and prostaglandin e2
5465266|NCT01439789|Chronic Heart Failure|chronic heart failure
5470752|NCT01417923|patients suffering from chronic musculo-skeletal pain|patients suffering from chronic musculo-skeletal pain
5470755|NCT01417884|platelets|platelets
5470756|NCT01417884|cardiovascular disease|cardiovascular disease
5470757|NCT01417858|intra-ocular pressure|intra-ocular pressure
5470758|NCT01417858|iridectomy|iridectomy
5470759|NCT01417858|gonioscopy|gonioscopy
5470760|NCT01417858|ocular tonometry|ocular tonometry
5470761|NCT01417832|Dental caries|dental caries
5470762|NCT01417832|Proximal surfaces|proximal surfaces
5470763|NCT01417832|Preventive therapy|preventive therapy
5470764|NCT01417832|Dental radiography|dental radiography
5470765|NCT01417832|Treatment efficacy|treatment efficacy
5470766|NCT01417832|Young adults|young adults
5470767|NCT01417806|small cell lung cancer|small cell lung cancer
5470768|NCT01417806|somatostatin|somatostatin
5470769|NCT01417806|topotecan|topotecan
5470770|NCT01417793|Smoking cessation rate|smoking cessation rate
5470771|NCT01417767|myelodysplastic syndromes|myelodysplastic syndromes
5470772|NCT01417767|Decitabine|decitabine
5470773|NCT01417767|homoharringtonine|homoharringtonine
5470774|NCT01417767|cytarabine|cytarabine
5470775|NCT01417767|G-CSF|g-csf
5470776|NCT01417754|toremifene|toremifene
5470777|NCT01417728|endomicroscopy|endomicroscopy
5470778|NCT01417728|inflammatory bowel disease|inflammatory bowel disease
5470779|NCT01417728|mucosal healing|mucosal healing
5470780|NCT01417728|infliximab|infliximab
5470781|NCT01417689|glaucoma|glaucoma
5470782|NCT01417689|randomized controlled trial|randomized controlled trial
5470783|NCT01417689|eye drops|eye drops
5470784|NCT01417689|instillation|instillation
5470785|NCT01417689|compliance|compliance
5470786|NCT01417676|prostate cancer|prostate cancer
5470787|NCT01417676|locally advanced|locally advanced
5470788|NCT01417676|lymph node positive|lymph node positive
5470789|NCT01417676|radiation therapy|radiation therapy
5470790|NCT01417676|morbidity|morbidity
5470791|NCT01417676|early morbidity|early morbidity
5470797|NCT01417663|Advanced Glycation Endproducts|advanced glycation endproducts
5470798|NCT01417663|AGE crosslink breakers|age crosslink breakers
5470799|NCT01417650|temporomandibular disorder|temporomandibular disorder
5470800|NCT01417650|laser therapy|laser therapy
5470801|NCT01417650|osteoarthritis|osteoarthritis
5470802|NCT01417637|TMD|tmd
5470803|NCT01417637|myofacial pain syndrome|myofacial pain syndrome
5470804|NCT01417637|low level laser therapy|low level laser therapy
5470805|NCT01417637|LLLT|lllt
5470806|NCT01417624|Heart Failure|heart failure
5470807|NCT01417624|Cardiac Resynchronisation Therapy|cardiac resynchronisation therapy
5470808|NCT01417611|screening colonoscopy|screening colonoscopy
5470809|NCT01417598|Balance|balance
5470810|NCT01417598|Gait|gait
5470811|NCT01417598|Physical activity|physical activity
5470812|NCT01417585|Activities of daily living|activities of daily living
5470813|NCT01417585|Caregiver burden|caregiver burden
5470814|NCT01417585|Client centered|client centered
5470815|NCT01417585|Life satisfaction|life satisfaction
5470816|NCT01417585|Participation|participation
5470817|NCT01417585|Patient satisfaction|patient satisfaction
5470818|NCT01417585|Rehabilitation|rehabilitation
5619611|NCT00819832|VCF|vcf
5470819|NCT01417585|Self rated impact of stroke|self rated impact of stroke
5470820|NCT01417585|Stroke|stroke
5470821|NCT01417546|Dose-Limiting Toxicity|dose-limiting toxicity
5470822|NCT01417546|Maximum Tolerated Dose|maximum tolerated dose
5470823|NCT01417546|Immune Response|immune response
5470824|NCT01417546|Pharmacokinetics|pharmacokinetics
5470825|NCT01417546|Dose Escalation|dose escalation
5470826|NCT01417546|Cancer|cancer
5470827|NCT01417546|Metastatic Solid Tumor|metastatic solid tumor
5470828|NCT01417546|Solid Tumor|solid tumor
5470830|NCT01417520|ECD|ecd
5470831|NCT01417520|Erdheim-Chester Disease|erdheim-chester disease
5470832|NCT01417494|adenocarcinoma of the colon|adenocarcinoma of the colon
5470833|NCT01417494|stage IVA colon cancer|stage iva colon cancer
5470834|NCT01417494|stage IVB colon cancer|stage ivb colon cancer
5470835|NCT01417494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5470836|NCT01417494|stage IVA rectal cancer|stage iva rectal cancer
5470837|NCT01417494|stage IVB rectal cancer|stage ivb rectal cancer
5470838|NCT01417481|cystic fibrosis|cystic fibrosis
5470839|NCT01417481|glycine|glycine
5470840|NCT01417481|airway inflammation|airway inflammation
5470841|NCT01417468|Cognitive Rehabilitation|cognitive rehabilitation
5470842|NCT01417468|Learning Styles|learning styles
5470843|NCT01417468|Learning Modes|learning modes
5470844|NCT01417468|Learning Modalities|learning modalities
5470845|NCT01417468|Multiple Intelligences|multiple intelligences
5470846|NCT01417468|Educational Intervention|educational intervention
5471530|NCT01414621|CABG|cabg
5470847|NCT01417468|Instructional Design|instructional design
5470848|NCT01417455|Rheumatoid arthritis|rheumatoid arthritis
5470849|NCT01417455|Ankylosing spondylitis|ankylosing spondylitis
5470850|NCT01417455|Osteoclasts|osteoclasts
5442370|NCT01535222|CPB|cpb
5457360|NCT01472198|PC|pc
5470851|NCT01417455|TNF antagonists|tnf antagonists
5470852|NCT01417442|papillary thyroid carcinoma|papillary thyroid carcinoma
5470853|NCT01417442|BRAF V600E|braf v600e
5470854|NCT01417442|poor prognosis|poor prognosis
5470861|NCT01417364|Sarcopenia|sarcopenia
5470862|NCT01417364|Aging muscle|aging muscle
5470863|NCT01417364|Testosterone administration|testosterone administration
5470864|NCT01417364|Bone metabolism|bone metabolism
5470865|NCT01417351|pregnancy|pregnancy
5470866|NCT01417351|immune function|immune function
5470867|NCT01417338|Hypertension,pulmonary|hypertension,pulmonary
5470868|NCT01417338|Mortality|mortality
5470869|NCT01417338|Risk factors|risk factors
5470870|NCT01417312|Multiple sclerosis|multiple sclerosis
5470871|NCT01417312|Green tea extract|green tea extract
5470872|NCT01417312|Metabolism|metabolism
5470873|NCT01417299|chronic vegetative state|chronic vegetative state
5470874|NCT01417299|RPh201|rph201
5470875|NCT01417299|functional MRI|functional mri
5470876|NCT01417273|Multiple sclerosis|multiple sclerosis
5470877|NCT01417273|immune system|immune system
5470878|NCT01417273|vitamin A|vitamin a
5470879|NCT01417273|(MSFC)Multiple Sclerosis Functional Composite|(msfc)multiple sclerosis functional composite
5453177|NCT01489527|HIV|hiv
5470880|NCT01417273|(EDSS)Expanded Disability Status Scale|(edss)expanded disability status scale
5470881|NCT01417273|(MRI)Magnetic resonance imaging|(mri)magnetic resonance imaging
5470882|NCT01417247|renal artery|renal artery
5473942|NCT01405170|suspension|suspension
5470886|NCT01417221|renal artery|renal artery
5470887|NCT01417221|sympathetic nerves|sympathetic nerves
5470888|NCT01417221|modification|modification
5470889|NCT01417221|essential hypertension|essential hypertension
5470890|NCT01417221|primary hypertension|primary hypertension
5470891|NCT01417195|Assisted Reproductive Technology|assisted reproductive technology
5470892|NCT01417182|Patients with Advanced Prostate Cancer|patients with advanced prostate cancer
5470893|NCT01417143|dovitinib|dovitinib
5470894|NCT01417130|Naproxen|naproxen
5470895|NCT01417130|Celecoxib|celecoxib
5470896|NCT01417130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5470897|NCT01417117|Intracerebral Hemorrhage|intracerebral hemorrhage
5470898|NCT01417117|Ischemic Stroke|ischemic stroke
5470899|NCT01417117|Diffusion Weight Imaging Abnormalities|diffusion weight imaging abnormalities
5470900|NCT01417117|Neurologic Outcome|neurologic outcome
5470902|NCT01417104|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5470903|NCT01417104|high blood pressure|high blood pressure
5470905|NCT01417104|heart attack|heart attack
5470906|NCT01417104|CVA|cva
5470907|NCT01417104|stroke|stroke
5470908|NCT01417104|PAD|pad
5470909|NCT01417091|Brittle bone disease|brittle bone disease
5470910|NCT01417091|inherited|inherited
5470911|NCT01417091|connective tissue disorder|connective tissue disorder
5470912|NCT01417091|fracture|fracture
5470913|NCT01417065|Cancer|cancer
5470914|NCT01417065|mTOR inhibitor Temsirolimus|mtor inhibitor temsirolimus
5470915|NCT01417065|Torisel|torisel
5470916|NCT01417065|CCI-779|cci-779
5470917|NCT01417065|pharmacodynamic targets|pharmacodynamic targets
5470918|NCT01417026|Autism Spectrum Disorders|autism spectrum disorders
5470919|NCT01417026|Oxytocin|oxytocin
5470920|NCT01417026|Clinical Trial|clinical trial
5470921|NCT01417026|Computer-based Intervention|computer-based intervention
5470922|NCT01417026|Social Perception|social perception
5470923|NCT01417026|Social Motivation|social motivation
5470924|NCT01417026|Social Cognition|social cognition
5470925|NCT01417013|Dry eye or lubricant eye drops|dry eye or lubricant eye drops
5470926|NCT01417000|Cancer|cancer
5470927|NCT01417000|Cancer vaccine|cancer vaccine
5470928|NCT01417000|Listeria monocytogenes|listeria monocytogenes
5470929|NCT01417000|Listeria-based vaccines|listeria-based vaccines
5470930|NCT01417000|GVAX|gvax
5470931|NCT01417000|Cyclophosphamide|cyclophosphamide
5470932|NCT01417000|Cytoxan|cytoxan
5470933|NCT01417000|T regulatory cells|t regulatory cells
5470934|NCT01417000|Heterologous Prime-Boost|heterologous prime-boost
5470935|NCT01417000|Immunotherapy|immunotherapy
5470936|NCT01417000|Mesothelin|mesothelin
5470937|NCT01417000|Pancreatic cancer|pancreatic cancer
5470938|NCT01416974|19-28Z RETROVIRUS|19-28z retrovirus
5470939|NCT01416974|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5470940|NCT01416974|autologous T cells|autologous t cells
5470941|NCT01416974|Leukapheresis|leukapheresis
5470942|NCT01416974|11-048|11-048
5470943|NCT01416961|Squamous Cell|squamous cell
5470944|NCT01416961|Non-squamous cell|non-squamous cell
5470945|NCT01416948|Cognitive Complaints, TBI, PTSD|cognitive complaints, tbi, ptsd
5470946|NCT01416935|Atrial Fibrillation|atrial fibrillation
5470947|NCT01416935|Anti-Arrhythmic Medication|anti-arrhythmic medication
5470948|NCT01416909|Medication-induced|medication-induced
5470949|NCT01416909|Constipation in Cancer|constipation in cancer
5470950|NCT01416896|End stage Renal Disease|end stage renal disease
5470951|NCT01416896|Hemodialysis|hemodialysis
5470952|NCT01416896|Oxidative Stress|oxidative stress
5470953|NCT01416896|Inflammation|inflammation
5470954|NCT01416883|oral mucosal absorption|oral mucosal absorption
5470955|NCT01416883|pharmacokinetics|pharmacokinetics
5470956|NCT01416883|safety|safety
5470957|NCT01416883|bicalutamide|bicalutamide
5470958|NCT01416883|Japanese|japanese
5470959|NCT01416883|healthy subject|healthy subject
5470960|NCT01416870|Bioequivalence|bioequivalence
5470961|NCT01416870|pharmacokinetics|pharmacokinetics
5470962|NCT01416870|safety|safety
5470963|NCT01416870|bicalutamide|bicalutamide
5470964|NCT01416870|Casodex|casodex
5470965|NCT01416870|Japanese|japanese
5470966|NCT01416870|healthy subject|healthy subject
5470967|NCT01416857|Medicare|medicare
5470968|NCT01416844|Metastatic melanoma|metastatic melanoma
5470969|NCT01416844|anti-OX40|anti-ox40
5470970|NCT01416844|Immunostimulatory|immunostimulatory
5470971|NCT01416831|metastatic melanoma|metastatic melanoma
5470972|NCT01416831|IL-2|il-2
5470973|NCT01416831|Interleukin 2|interleukin 2
5470974|NCT01416831|Radiation|radiation
5470975|NCT01416831|Stereotactic Body Radiation Treatment|stereotactic body radiation treatment
5470976|NCT01416831|SBRT|sbrt
5470977|NCT01416831|Immunotherapy|immunotherapy
5470978|NCT01416818|Depression;|depression;
5474051|NCT01404871|genetics|genetics
5470979|NCT01416818|Parkinson's disease;|parkinson's disease;
5470980|NCT01416818|antidepressant|antidepressant
5470981|NCT01416805|childhood anxiety disorders|childhood anxiety disorders
5470982|NCT01416805|cognitive behavioral therapy|cognitive behavioral therapy
5470983|NCT01416805|CBT|cbt
5470984|NCT01416805|Generalized Anxiety Disorder|generalized anxiety disorder
5470985|NCT01416805|Social Phobia|social phobia
5470986|NCT01416805|Separation Anxiety Disorder|separation anxiety disorder
5470987|NCT01416805|Psychotherapy|psychotherapy
5470988|NCT01416805|Counseling|counseling
5470989|NCT01416805|Social Anxiety Disorder|social anxiety disorder
5470990|NCT01416779|Writing Intervention|writing intervention
5470991|NCT01416779|Bereaved Caregivers|bereaved caregivers
5470992|NCT01416779|Older Adults|older adults
5470993|NCT01416779|hope|hope
5470994|NCT01416779|inventory of daily widowed life|inventory of daily widowed life
5470995|NCT01416766|Blood Pressure Monitors|blood pressure monitors
5470996|NCT01416766|Medical Informatics|medical informatics
5470997|NCT01416766|Disease Management|disease management
5470998|NCT01416766|Comparative Effectiveness Research|comparative effectiveness research
5470999|NCT01416753|hemodialysis|hemodialysis
5471000|NCT01416753|blood volume monitoring|blood volume monitoring
5471001|NCT01416740|Indirect magnetic resonance arthrogram|indirect magnetic resonance arthrogram
5471002|NCT01416740|Direct magnetic resonance arthrogram|direct magnetic resonance arthrogram
5471003|NCT01416740|Diagnostic tests for shoulder pain|diagnostic tests for shoulder pain
5471004|NCT01416727|Patient Simulation|patient simulation
5471005|NCT01416727|Education, Medical, Graduate|education, medical, graduate
5471006|NCT01416727|Internship and Residency|internship and residency
5471007|NCT01416727|Psychiatry|psychiatry
5471008|NCT01416701|COPD|copd
5471009|NCT01416701|Vitamin D|vitamin d
5471010|NCT01416701|Pulmonary rehabilitation|pulmonary rehabilitation
5471011|NCT01416688|therapy-related toxicity|therapy-related toxicity
5471012|NCT01416688|dermatologic complications|dermatologic complications
5471013|NCT01416688|stage I colon cancer|stage i colon cancer
5471014|NCT01416688|stage IIA colon cancer|stage iia colon cancer
5471015|NCT01416688|stage IIB colon cancer|stage iib colon cancer
5471016|NCT01416688|stage IIC colon cancer|stage iic colon cancer
5471017|NCT01416688|stage IIIA colon cancer|stage iiia colon cancer
5471018|NCT01416688|stage IIIB colon cancer|stage iiib colon cancer
5471019|NCT01416688|stage IIIC colon cancer|stage iiic colon cancer
5471020|NCT01416688|stage IVA colon cancer|stage iva colon cancer
5471021|NCT01416688|stage IVB colon cancer|stage ivb colon cancer
5471022|NCT01416688|stage I rectal cancer|stage i rectal cancer
5471023|NCT01416688|stage IIA rectal cancer|stage iia rectal cancer
5471024|NCT01416688|stage IIB rectal cancer|stage iib rectal cancer
5471025|NCT01416688|stage IIC rectal cancer|stage iic rectal cancer
5471026|NCT01416688|stage IIIA rectal cancer|stage iiia rectal cancer
5471027|NCT01416688|stage IIIB rectal cancer|stage iiib rectal cancer
5471028|NCT01416688|stage IIIC rectal cancer|stage iiic rectal cancer
5471029|NCT01416688|stage IVA rectal cancer|stage iva rectal cancer
5471030|NCT01416688|stage IVB rectal cancer|stage ivb rectal cancer
5471031|NCT01416688|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5471032|NCT01416688|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5471033|NCT01416688|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5471034|NCT01416688|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5471035|NCT01416688|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5471036|NCT01416688|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5471037|NCT01416688|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5471038|NCT01416688|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5471039|NCT01416688|limited stage small cell lung cancer|limited stage small cell lung cancer
5471040|NCT01416688|recurrent small cell lung cancer|recurrent small cell lung cancer
5471042|NCT01416688|recurrent rectal cancer|recurrent rectal cancer
5471043|NCT01416688|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5471044|NCT01416662|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5471045|NCT01416662|stage IA pancreatic cancer|stage ia pancreatic cancer
5471046|NCT01416662|stage IB pancreatic cancer|stage ib pancreatic cancer
5471047|NCT01416662|stage IIA pancreatic cancer|stage iia pancreatic cancer
5471048|NCT01416623|Advanced solid cancer|advanced solid cancer
5471049|NCT01416623|Henatinib|henatinib
5471051|NCT01416597|Influenza|influenza
5471052|NCT01416597|Systematic review|systematic review
5471053|NCT01416597|Meta-analysis|meta-analysis
5471054|NCT01416597|Mismatched strains|mismatched strains
5471055|NCT01416597|Cross-protection|cross-protection
5471056|NCT01416571|H5N1|h5n1
5471057|NCT01416571|Influenza vaccine|influenza vaccine
5471058|NCT01416571|influenza infection|influenza infection
5471059|NCT01416571|GSK1557484A|gsk1557484a
5471060|NCT01416558|German Breast Group|german breast group
5471061|NCT01416558|GBG Forschungs GmbH|gbg forschungs gmbh
5471063|NCT01416558|GBG 65|gbg 65
5471064|NCT01416558|Tiffany|tiffany
5471065|NCT01416558|Breast Cancer|breast cancer
5453373|NCT01488656|Exhaled nitric oxide|exhaled nitric oxide
5471066|NCT01416558|Metastatic Breast Cancer|metastatic breast cancer
5471067|NCT01416558|Nab-Paclitaxel|nab-paclitaxel
5471068|NCT01416558|Abraxane|abraxane
5471069|NCT01416558|Taxane Failure|taxane failure
5471070|NCT01416545|Primary Prevention|primary prevention
5471071|NCT01416545|Cardiovascular disease|cardiovascular disease
5471073|NCT01416545|Behavior modification|behavior modification
5471074|NCT01416545|Activities, Educational|activities, educational
5471075|NCT01416532|coronary Atheroslcerosis|coronary atheroslcerosis
5471076|NCT01416532|Computed Tomography|computed tomography
5471077|NCT01416519|Continuous Positive Airway Pressure|continuous positive airway pressure
5471078|NCT01416519|Cough|cough
5471079|NCT01416519|Oxygen Inhalation Therapy|oxygen inhalation therapy
5471080|NCT01416506|Pneumonia, surveillance|pneumonia, surveillance
5471081|NCT01416493|acute rheumatoid arthritis|acute rheumatoid arthritis
5471082|NCT01416480|Theobromine|theobromine
5471083|NCT01416480|cough|cough
5471084|NCT01416480|acute bronchitis|acute bronchitis
5471085|NCT01416467|lysosomal storage disease|lysosomal storage disease
5471086|NCT01416467|AAV vector|aav vector
5471087|NCT01416467|gene transfer|gene transfer
5471088|NCT01416467|disease characterization|disease characterization
5471089|NCT01416441|Tourette's Disorder|tourette's disorder
5471090|NCT01416441|tic disorders|tic disorders
5471091|NCT01416428|multiple myeloma|multiple myeloma
5471092|NCT01416428|waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5471093|NCT01416415|Glaucoma, Open-Angle|glaucoma, open-angle
5471094|NCT01416415|Ophthalmic Solutions, Eye drops|ophthalmic solutions, eye drops
5471095|NCT01416415|Instructional Films and Videos|instructional films and videos
5471096|NCT01416402|Hyperuricemia|hyperuricemia
5471097|NCT01416402|gout|gout
5471098|NCT01416402|serum uric acid|serum uric acid
5471099|NCT01416389|Locally|locally
5471100|NCT01416389|Recurrent|recurrent
5471101|NCT01416389|Breast|breast
5471102|NCT01416389|Cancer|cancer
5471103|NCT01416363|firategrast|firategrast
5471104|NCT01416363|pharmacokinetics, modified release, firategrast,|pharmacokinetics, modified release, firategrast,
5471105|NCT01416363|simulated gastro-retentive|simulated gastro-retentive
5471106|NCT01416363|pharmacokinetics|pharmacokinetics
5471107|NCT01416363|healthy volunteers, simulated gastro-retentive|healthy volunteers, simulated gastro-retentive
5471108|NCT01416363|healthy volunteers|healthy volunteers
5471109|NCT01416363|modified release|modified release
5471110|NCT01416324|pharmacodynamics|pharmacodynamics
5471111|NCT01416324|first time in human|first time in human
5471112|NCT01416324|pharmacokinetics|pharmacokinetics
5471113|NCT01416298|Acute Kidney Injury|acute kidney injury
5471114|NCT01416298|Critically ill children|critically ill children
5471115|NCT01416298|Biomarkers|biomarkers
5471116|NCT01416298|NGAL|ngal
5471117|NCT01416298|Fluid Overload|fluid overload
5471118|NCT01416298|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
5471119|NCT01416285|Congestive heart failure (CHF)|congestive heart failure (chf)
5471120|NCT01416285|CHF education|chf education
5471121|NCT01416285|self-care training|self-care training
5471122|NCT01416285|CHF center|chf center
5471123|NCT01416259|QTc Prolongation|qtc prolongation
5471124|NCT01416246|Stem cell Infusions|stem cell infusions
5471125|NCT01416246|Autologous Stem Cell Transplant|autologous stem cell transplant
5471126|NCT01416246|11-105|11-105
5471127|NCT01416233|autologous|autologous
5471129|NCT01416233|orbit|orbit
5471130|NCT01416233|atrophy|atrophy
5471131|NCT01416233|cannula|cannula
5471132|NCT01416220|depression|depression
5471133|NCT01416220|bipolar disorder|bipolar disorder
5471134|NCT01416220|manic depressive illness|manic depressive illness
5471135|NCT01416194|Osteoporosis|osteoporosis
5471136|NCT01416181|Natalizumab|natalizumab
5471137|NCT01416181|secondary|secondary
5471138|NCT01416181|multiple sclerosis|multiple sclerosis
5471139|NCT01416181|MS|ms
5471140|NCT01416181|SPMS|spms
5471141|NCT01416181|Tysabri|tysabri
5471142|NCT01416168|Colon|colon
5471143|NCT01416168|Geriatric|geriatric
5471144|NCT01416168|McCorkle Model|mccorkle model
5471145|NCT01416168|Questionnaire|questionnaire
5471146|NCT01416116|Tramadol|tramadol
5471147|NCT01416116|QUTENZA|qutenza
5471148|NCT01416116|Pre-treatment|pre-treatment
5471149|NCT01416116|Tolerability|tolerability
5471150|NCT01416090|syndactyly|syndactyly
5471151|NCT01416077|fluid|fluid
5471152|NCT01416077|goal-directed|goal-directed
5471153|NCT01416077|FloTrac|flotrac
5471154|NCT01416077|pulse contour analysis|pulse contour analysis
5471155|NCT01416077|postoperative complications|postoperative complications
5471156|NCT01416077|anesthesia|anesthesia
5471157|NCT01416077|esophagus|esophagus
5471158|NCT01416038|vaccine|vaccine
5471159|NCT01416038|immunotherapy|immunotherapy
5471160|NCT01416038|ovarian|ovarian
5471161|NCT01416038|fallopian tube|fallopian tube
5471162|NCT01416038|peritoneal|peritoneal
5471163|NCT01416038|cancer|cancer
5471164|NCT01416038|tumor|tumor
5471165|NCT01416038|Phase 1|phase 1
5471166|NCT01416038|Phase I|phase i
5471167|NCT01416038|combination therapy|combination therapy
5471168|NCT01416025|Voriconazole|voriconazole
5471169|NCT01416025|Therapeutic drug monitoring|therapeutic drug monitoring
5471170|NCT01416025|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5471171|NCT01416025|Hematologic malignancy|hematologic malignancy
5471172|NCT01416025|Invasive mould infection|invasive mould infection
5471173|NCT01415999|anthracycline|anthracycline
5471174|NCT01415999|cardiac function|cardiac function
5471175|NCT01415999|echocardiography|echocardiography
5471176|NCT01415999|biomarkers|biomarkers
5471177|NCT01415986|Advanced head and neck cancer|advanced head and neck cancer
5471178|NCT01415986|Squamous cell carcinoma|squamous cell carcinoma
5471179|NCT01415986|SCC|scc
5471180|NCT01415986|HNSCC|hnscc
5471181|NCT01415973|beef|beef
5471182|NCT01415973|protein|protein
5471183|NCT01415973|synergy|synergy
5471184|NCT01415973|intact beef constituents|intact beef constituents
5471185|NCT01415973|protein constituent|protein constituent
5471186|NCT01415973|Nutrient Synergy|nutrient synergy
5471187|NCT01415960|Prostate Cancer|prostate cancer
5471188|NCT01415960|androgen deprivation therapy.|androgen deprivation therapy.
5471189|NCT01415960|Leuprolide Acetate Depot Formulation|leuprolide acetate depot formulation
5471190|NCT01415960|Pharmacokinetics|pharmacokinetics
5471191|NCT01415960|testosterone|testosterone
5471192|NCT01415960|serum luteinizing hormone|serum luteinizing hormone
5471193|NCT01415960|follicle-stimulating hormone|follicle-stimulating hormone
5471194|NCT01415960|prostate-specific antigen|prostate-specific antigen
5471195|NCT01415947|Heart disease|heart disease
5471196|NCT01415947|Device|device
5471197|NCT01415947|Mitral valve|mitral valve
5471198|NCT01415947|leaflet prolapse|leaflet prolapse
5471199|NCT01415947|Heart valve disease|heart valve disease
5471200|NCT01415947|Cardiovascular disease|cardiovascular disease
5471201|NCT01415947|Neochordae|neochordae
5471202|NCT01415921|heart failure|heart failure
5471203|NCT01415921|autonomic function|autonomic function
5471204|NCT01415921|sympathovagal balance|sympathovagal balance
5471205|NCT01415921|cholinesterase inhibitors|cholinesterase inhibitors
5471206|NCT01415921|pharmacology|pharmacology
5471207|NCT01415908|advanced degenerative disease of the lumbosacral spine|advanced degenerative disease of the lumbosacral spine
5471208|NCT01415908|lumbosacral spine|lumbosacral spine
5471209|NCT01415908|radiculopathy|radiculopathy
5471210|NCT01415908|degenerative instability|degenerative instability
5471211|NCT01415908|spondylolisthesis|spondylolisthesis
5471212|NCT01415908|retrolisthesis|retrolisthesis
5471213|NCT01415908|lateral listhesis|lateral listhesis
5471214|NCT01415908|spinal stenosis|spinal stenosis
5471215|NCT01415908|disc herniation|disc herniation
5471216|NCT01415908|INFUSE Bone Graft|infuse bone graft
5471217|NCT01415908|CD HORIZON Spinal System|cd horizon spinal system
5471218|NCT01415908|CAPSTONE Spinal System|capstone spinal system
5471219|NCT01415895|back pain|back pain
5471220|NCT01415895|cervical pain|cervical pain
5471221|NCT01415895|neuropathic pain|neuropathic pain
5471222|NCT01415895|radicular pain|radicular pain
5471223|NCT01415869|Ventricular Assist Device|ventricular assist device
5471224|NCT01415869|Gastrointestinal Bleeding|gastrointestinal bleeding
5471225|NCT01415869|VAD|vad
5471226|NCT01415856|pulsed electromagnetic fields device|pulsed electromagnetic fields device
5471227|NCT01415856|Torino II|torino ii
5471228|NCT01415856|postoperative knee pain|postoperative knee pain
5471229|NCT01415856|knee replacement|knee replacement
5471230|NCT01415830|Anti-Scorpion venom serum|anti-scorpion venom serum
5471231|NCT01415830|venom|venom
5471232|NCT01415830|efficacy|efficacy
5471233|NCT01415830|safety|safety
5471234|NCT01415830|children|children
5471235|NCT01415817|Quality Improvement|quality improvement
5471236|NCT01415817|Adenoma Detection Rate|adenoma detection rate
5471237|NCT01415817|Polyp detection rate|polyp detection rate
5471238|NCT01415817|Colonoscopy|colonoscopy
5471239|NCT01415817|Training|training
5471240|NCT01415817|Colorectal cancer screening|colorectal cancer screening
5471241|NCT01415804|Dissection|dissection
5471242|NCT01415804|Aorta|aorta
5471243|NCT01415804|Surgery|surgery
5471244|NCT01415791|oral mucosal absorption|oral mucosal absorption
5471245|NCT01415791|pharmacokinetics|pharmacokinetics
5471246|NCT01415791|safety|safety
5471247|NCT01415791|bicalutamide|bicalutamide
5471248|NCT01415791|Japanese|japanese
5471249|NCT01415791|healthy subject|healthy subject
5471250|NCT01415778|Bioequivalence|bioequivalence
5471251|NCT01415778|pharmacokinetics|pharmacokinetics
5471252|NCT01415778|safety|safety
5471253|NCT01415778|bicalutamide|bicalutamide
5471254|NCT01415778|Casodex|casodex
5471255|NCT01415778|Japanese|japanese
5471256|NCT01415778|healthy subject|healthy subject
5471257|NCT01415765|Germinal Center Like B-Cell (GCB) DLBCL|germinal center like b-cell (gcb) dlbcl
5471258|NCT01415765|Activated B-Cell Like (ABC) DLBCL|activated b-cell like (abc) dlbcl
5471259|NCT01415765|NF-KappaB Pathway|nf-kappab pathway
5471260|NCT01415765|Drug Resistance|drug resistance
5471261|NCT01415765|Nedd-8 Activating Enzyme Inhibitor|nedd-8 activating enzyme inhibitor
5471262|NCT01415765|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5471263|NCT01415765|Lymphoma|lymphoma
5471264|NCT01415752|neurotoxicity|neurotoxicity
5471265|NCT01415752|therapy-related toxicity|therapy-related toxicity
5789975|NCT00146302|Low birth weight|low birth weight
5471266|NCT01415752|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5846738|NCT00043628|Hematopoiesis|hematopoiesis
5471270|NCT01415752|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5471271|NCT01415739|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5471272|NCT01415739|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5471273|NCT01415739|adenocarcinoma of the lung|adenocarcinoma of the lung
5471274|NCT01415739|squamous cell lung cancer|squamous cell lung cancer
5471275|NCT01415726|Cord blood stem cells|cord blood stem cells
5471276|NCT01415726|inflammation|inflammation
5471277|NCT01415726|type 2 diabetes|type 2 diabetes
5471278|NCT01415726|stem cell educator|stem cell educator
5471279|NCT01415726|autoimmunity|autoimmunity
5471280|NCT01415726|immune modulation|immune modulation
5471281|NCT01415713|enroll the 80 patients in this trial|enroll the 80 patients in this trial
5471282|NCT01415700|feet STEPPAGE of central neurological origin|feet steppage of central neurological origin
5471283|NCT01415700|implanted functional electrical stimulation|implanted functional electrical stimulation
5471284|NCT01415700|feet orthosis|feet orthosis
5471285|NCT01415687|preoperative care|preoperative care
5471286|NCT01415687|colonoscopy|colonoscopy
5471287|NCT01415687|cathartics|cathartics
5471288|NCT01415674|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5471289|NCT01415674|pre operative treatment|pre operative treatment
5471290|NCT01415674|Afatinib|afatinib
5471291|NCT01415674|BIBW2992|bibw2992
5471292|NCT01415674|Biological markers|biological markers
5471293|NCT01415648|with surgical indication|with surgical indication
5471294|NCT01415648|Cerebral oximetry|cerebral oximetry
5471295|NCT01415648|carotid endarterectomy|carotid endarterectomy
5471296|NCT01415648|MRI|mri
5471297|NCT01415648|ischemic lesion|ischemic lesion
5471298|NCT01415648|cost/effectiveness analysis|cost/effectiveness analysis
5471299|NCT01415648|Neurocognitive Outcome|neurocognitive outcome
5471300|NCT01415648|protein S-100B|protein s-100b
5471301|NCT01415635|Nutritional risk, Hospital food, Nutritional Intervention|nutritional risk, hospital food, nutritional intervention
5471302|NCT01415622|plasma therapy|plasma therapy
5471303|NCT01415622|ulcus cruris|ulcus cruris
5471304|NCT01415609|Gastrointestinal neoplasia|gastrointestinal neoplasia
5456083|NCT01477554|Women|women
5471305|NCT01415609|Submucosal resection|submucosal resection
5471306|NCT01415570|Protein-energy wasting (PEW)|protein-energy wasting (pew)
5471307|NCT01415570|racial disparities|racial disparities
5471308|NCT01415570|hemodialysis|hemodialysis
5471309|NCT01415570|survival paradoxes|survival paradoxes
5471310|NCT01415570|Stage 5|stage 5
5471311|NCT01415557|micronutrient|micronutrient
5471312|NCT01415557|healthy children|healthy children
5471313|NCT01415557|vitamins|vitamins
5471314|NCT01415557|minerals|minerals
5471315|NCT01415557|cognition|cognition
5471316|NCT01415557|physical performance|physical performance
5471317|NCT01415557|iron|iron
5471318|NCT01415557|Micronutrient status|micronutrient status
5471319|NCT01415557|Cognitive Performance|cognitive performance
5471320|NCT01415544|Diabetes|diabetes
5471321|NCT01415531|Stage 1|stage 1
5471322|NCT01415531|Stage 2|stage 2
5471323|NCT01415531|Hypertension|hypertension
5471324|NCT01415518|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
5471325|NCT01415505|Stage 1|stage 1
5471326|NCT01415505|Stage 2|stage 2
5471327|NCT01415505|Hypertension|hypertension
5471328|NCT01415505|1 year open label safety study|1 year open label safety study
5471329|NCT01415492|Exercise|exercise
5472442|NCT01411007|Nicotine|nicotine
5471330|NCT01415492|Physical activity|physical activity
5471331|NCT01415492|Cigarette Smoking|cigarette smoking
5457878|NCT01470131|relapse|relapse
5471332|NCT01415492|Smoking cessation|smoking cessation
5471333|NCT01415492|Multi Vitamin intake|multi vitamin intake
5471334|NCT01415492|Vegetable consumption|vegetable consumption
5471335|NCT01415492|Fruit consumption|fruit consumption
5471346|NCT01415453|retina|retina
5471347|NCT01415453|progressive vision loss|progressive vision loss
5471348|NCT01415453|ultrasound|ultrasound
5471349|NCT01415440|ADHD|adhd
5471350|NCT01415440|Vyvanse|vyvanse
5471351|NCT01415440|stimulant medication|stimulant medication
5471353|NCT01415427|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5471354|NCT01415427|MPS IV Type A|mps iv type a
5471355|NCT01415427|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5471356|NCT01415427|MPS IVA|mps iva
5471357|NCT01415427|Morquio A Syndrome|morquio a syndrome
5471358|NCT01415427|Lysosomal Storage Disorder|lysosomal storage disorder
5471360|NCT01415427|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5471361|NCT01415427|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5471362|NCT01415427|galactose-6-sulfatase|galactose-6-sulfatase
5471363|NCT01415427|GALNS|galns
5471364|NCT01415427|enzyme replacement therapy|enzyme replacement therapy
5471365|NCT01415427|ERT|ert
5471366|NCT01415414|Image quality|image quality
5471367|NCT01415414|CNR|cnr
5471368|NCT01415414|SNR|snr
5471369|NCT01415414|Abdominal|abdominal
5471370|NCT01415414|Pelvic|pelvic
5471371|NCT01415401|Glaucoma|glaucoma
5471372|NCT01415401|Ocular hypertension|ocular hypertension
5471373|NCT01415401|Intraocular pressure (IOP)|intraocular pressure (iop)
5471374|NCT01415401|Open angle glaucoma|open angle glaucoma
5471375|NCT01415401|Pigment dispersion glaucoma|pigment dispersion glaucoma
5471376|NCT01415401|Pigmentary|pigmentary
5471377|NCT01415388|Maintenance of normal blood triglyceride levels|maintenance of normal blood triglyceride levels
5471378|NCT01415375|prostate-specific antigen (146-154)|prostate-specific antigen (146-154)
5471379|NCT01415375|prostate-specific antigen (154-163)|prostate-specific antigen (154-163)
5471380|NCT01415362|transcranial direct current stimulation|transcranial direct current stimulation
5471381|NCT01415362|electroencephalography|electroencephalography
5471382|NCT01415323|Emergency services, psychiatric|emergency services, psychiatric
5471383|NCT01415323|Psychomotor agitation|psychomotor agitation
5471384|NCT01415323|Suicide|suicide
5471385|NCT01415323|Violence|violence
5471386|NCT01415310|Geriatric Psychiatry|geriatric psychiatry
5471387|NCT01415310|Quality register|quality register
5471388|NCT01415310|Quality improvement|quality improvement
5471389|NCT01415310|Quality control|quality control
5471390|NCT01415310|Research elderly patients with psychiatric disorders|research elderly patients with psychiatric disorders
5471391|NCT01415297|Phase 1|phase 1
5471392|NCT01415297|advanced solid tumors|advanced solid tumors
5471393|NCT01415284|Obstetric anesthesia|obstetric anesthesia
5471394|NCT01415284|Spinal anesthesia|spinal anesthesia
5471395|NCT01415284|Hypotension|hypotension
5471396|NCT01415284|Fluid therapy|fluid therapy
5471397|NCT01415284|Cesarean section|cesarean section
5471398|NCT01415284|phenylephrine|phenylephrine
5471399|NCT01415284|cardiac output|cardiac output
5471402|NCT01415271|internet|internet
5471403|NCT01415271|long term care|long term care
5471404|NCT01415258|cancer|cancer
5471405|NCT01415258|vulnerability|vulnerability
5471406|NCT01415258|frail|frail
5471407|NCT01415232|Obesity|obesity
5471408|NCT01415232|Ultrasound|ultrasound
5471409|NCT01415219|rehabilitation|rehabilitation
5471410|NCT01415219|exercise|exercise
5471411|NCT01415219|efficacy|efficacy
5471412|NCT01415219|functional status|functional status
5471413|NCT01415206|Behavioral changes|behavioral changes
5471414|NCT01415206|Multiple risks|multiple risks
5471415|NCT01415180|sepsis|sepsis
5471416|NCT01415180|health related quality of life|health related quality of life
5471417|NCT01415180|functional status|functional status
5471418|NCT01415180|chronic comorbid conditions|chronic comorbid conditions
5471419|NCT01415180|organ dysfunction|organ dysfunction
5471420|NCT01415154|TMS|tms
5471421|NCT01415154|Major Depressive Disorder|major depressive disorder
5471422|NCT01415154|NeuroStar TMS|neurostar tms
5471423|NCT01415141|genotype 1|genotype 1
5471424|NCT01415141|IL28B CC polymorphism|il28b cc polymorphism
5471425|NCT01415141|telaprevir|telaprevir
5471426|NCT01415141|peginterferon|peginterferon
5471427|NCT01415141|ribavirin|ribavirin
5471428|NCT01415115|diabetes|diabetes
5471438|NCT01415063|TACE|tace
5471439|NCT01415050|Osteoporosis|osteoporosis
5471440|NCT01415050|Menopause|menopause
5471441|NCT01415050|Raloxifane|raloxifane
5471442|NCT01415050|Alendronate|alendronate
5471443|NCT01415037|Annular Array Ultrasound|annular array ultrasound
5471444|NCT01415037|Ultrasound Exam|ultrasound exam
5471445|NCT01415037|Posterior Vitreous Detachment|posterior vitreous detachment
5471446|NCT01415037|PVD|pvd
5471447|NCT01415037|Diabetic Retinopathy|diabetic retinopathy
5471448|NCT01415024|CRT|crt
5471449|NCT01415024|Dual LV|dual lv
5471450|NCT01415024|Triple Ventricle stimulation|triple ventricle stimulation
5471451|NCT01415024|two leftventricular leads|two leftventricular leads
5471452|NCT01415024|Av VV optimization|av vv optimization
5471453|NCT01415024|Lv dp/dt measurement|lv dp/dt measurement
5471454|NCT01415011|Afatinib (BIBW2992)|afatinib (bibw2992)
5471455|NCT01415011|EGFR Mutation|egfr mutation
5471456|NCT01415011|Non Small Cell Lung Cancer|non small cell lung cancer
5471457|NCT01415011|Poor performance status|poor performance status
5471462|NCT01414972|Vitamin A|vitamin a
5471463|NCT01414972|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5471464|NCT01414972|gene expression|gene expression
5471465|NCT01414959|intensive care patient|intensive care patient
5471466|NCT01414959|intubation|intubation
5471467|NCT01414959|(please change wording as you like!)|(please change wording as you like!)
5471468|NCT01414920|Drug Therapy|drug therapy
5471469|NCT01414907|Drinking Behavior|drinking behavior
5471470|NCT01414907|Harm Reduction|harm reduction
5471471|NCT01414907|Tobacco Use Cessation|tobacco use cessation
5471472|NCT01414907|Smoking Cessation|smoking cessation
5471473|NCT01414907|Rehabilitation|rehabilitation
5471474|NCT01414907|Health Promotion|health promotion
5471475|NCT01414907|Nutrition Therapy|nutrition therapy
5471476|NCT01414907|Feeding Behavior|feeding behavior
5471477|NCT01414907|Exercise|exercise
5471478|NCT01414881|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5471479|NCT01414881|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5471480|NCT01414881|mipomersen|mipomersen
5471481|NCT01414868|Leukotriene|leukotriene
5471482|NCT01414868|leukotriene receptor antagonist|leukotriene receptor antagonist
5471483|NCT01414868|bronchial provocation test|bronchial provocation test
5471484|NCT01414868|therapeutic outcome|therapeutic outcome
5471485|NCT01414829|Peptic disease|peptic disease
5471486|NCT01414829|Helicobacter pylori|helicobacter pylori
5471487|NCT01414829|Different methods|different methods
5471488|NCT01414816|Multiple Sclerosis|multiple sclerosis
5471489|NCT01414816|Clinical Isolated Syndrome (CIS)|clinical isolated syndrome (cis)
5471490|NCT01414803|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase|rosuvastatin, fenofibrate, creatine kinase, alanine aminotransferase
5471491|NCT01414790|human acellular dermal matrix|human acellular dermal matrix
5471492|NCT01414790|parotid tumor|parotid tumor
5471493|NCT01414790|total parotidectomy|total parotidectomy
5471494|NCT01414777|c-section|c-section
5471495|NCT01414777|Hypotension after spinal anesthesia for C-section|hypotension after spinal anesthesia for c-section
5471496|NCT01414764|rotator cuff tendon repair surgery|rotator cuff tendon repair surgery
5471497|NCT01414764|supraspinatus tendon repair|supraspinatus tendon repair
5471498|NCT01414751|Risk communication|risk communication
5471499|NCT01414751|Shared decision making|shared decision making
5471500|NCT01414751|Cardiovascular diseases|cardiovascular diseases
5471501|NCT01414751|Hypercholesterolemia|hypercholesterolemia
5471502|NCT01414751|Prevention|prevention
5471503|NCT01414725|Multiple Sclerosis|multiple sclerosis
5471504|NCT01414725|Mobility|mobility
5471505|NCT01414725|Balance|balance
5471506|NCT01414725|Core Stability|core stability
5471507|NCT01414725|Physiotherapy|physiotherapy
5471508|NCT01414712|Low- and Intermediate-Risk Prostate Cancer|low- and intermediate-risk prostate cancer
5471509|NCT01414699|dietary variety|dietary variety
5471510|NCT01414699|course sequence|course sequence
5471511|NCT01414699|preschool|preschool
5471512|NCT01414699|child feeding|child feeding
5471513|NCT01414673|IUI|iui
5471514|NCT01414673|HCG|hcg
5471515|NCT01414673|Spontaneous LH|spontaneous lh
5471516|NCT01414673|pregnancy|pregnancy
5471517|NCT01414660|interleukin 7|interleukin 7
5471518|NCT01414660|transplantation|transplantation
5471519|NCT01414660|liver|liver
5471520|NCT01414660|kidney|kidney
5471521|NCT01414660|islet|islet
5471522|NCT01414660|diabetes|diabetes
5471523|NCT01414647|Bilberry|bilberry
5471524|NCT01414647|Vaccinium myrtillus|vaccinium myrtillus
5471525|NCT01414647|Metabolic syndrome|metabolic syndrome
5471526|NCT01414647|Glucose metabolism|glucose metabolism
5471527|NCT01414647|Lipid metabolism|lipid metabolism
5471528|NCT01414647|Inflammation|inflammation
5471529|NCT01414647|Gene expression|gene expression
5471531|NCT01414595|adenocarcinoma of the lung|adenocarcinoma of the lung
5471532|NCT01414595|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5471533|NCT01414595|non-small cell lung cancer|non-small cell lung cancer
5471534|NCT01414595|squamous cell lung cancer|squamous cell lung cancer
5471535|NCT01414582|tDCS|tdcs
5471536|NCT01414582|Stroke|stroke
5471537|NCT01414582|Functional MRI|functional mri
5471538|NCT01414582|Motor Learning|motor learning
5471539|NCT01414543|violence|violence
5471540|NCT01414517|Prebiotics|prebiotics
5471541|NCT01414517|Acute Intestinal Injury|acute intestinal injury
5471542|NCT01414517|Chronic radiation enteritis|chronic radiation enteritis
5471543|NCT01414504|pneumococcal,|pneumococcal,
5471544|NCT01414504|pneumococcal polysaccharide vaccine,|pneumococcal polysaccharide vaccine,
5471545|NCT01414504|challenge dose,|challenge dose,
5471546|NCT01414504|hyporesponsiveness,|hyporesponsiveness,
5471547|NCT01414504|Papua New Guinea|papua new guinea
5471548|NCT01414478|emesis|emesis
5471549|NCT01414478|nausea|nausea
5471550|NCT01414465|Fatty acids|fatty acids
5471551|NCT01414465|orlistat|orlistat
5471552|NCT01414465|lipase|lipase
5471553|NCT01414465|BMC (Body Mass Index) between 30 to 40 kg/m2|bmc (body mass index) between 30 to 40 kg/m2
5471554|NCT01414465|Women|women
5471555|NCT01414465|18 to 45 years|18 to 45 years
5471556|NCT01414465|Premenopausal stage|premenopausal stage
5471557|NCT01414452|Myocardial Infarction|myocardial infarction
5471558|NCT01414452|Reperfusion injury|reperfusion injury
5471559|NCT01414452|Adiponectin|adiponectin
5471560|NCT01414452|endothelial progenitor cells|endothelial progenitor cells
5471561|NCT01414413|HIV|hiv
5471562|NCT01414413|AIDS|aids
5471563|NCT01414413|Antiretroviral therapy|antiretroviral therapy
5471564|NCT01414413|Community-based study|community-based study
5471565|NCT01414413|Cluster-randomised trial|cluster-randomised trial
5471566|NCT01414413|HIV testing|hiv testing
5471567|NCT01414413|Africa|africa
5471568|NCT01414400|Bacteremia|bacteremia
5471569|NCT01414400|Spyglass|spyglass
5471570|NCT01414400|Cholangioscopy|cholangioscopy
5471571|NCT01414387|carotid stenosis|carotid stenosis
5471572|NCT01414387|cerebral embolization|cerebral embolization
5471573|NCT01414387|stents|stents
5471574|NCT01414387|stroke|stroke
5471575|NCT01414374|iron|iron
5471576|NCT01414374|anemia|anemia
5471577|NCT01414374|herbal medicine|herbal medicine
5471578|NCT01414374|phytotherapy|phytotherapy
5471579|NCT01414374|Centella asiatica|centella asiatica
5471580|NCT01414374|Hibiscus sabdariffa|hibiscus sabdariffa
5471581|NCT01414361|Coronary artery stenosis|coronary artery stenosis
5471582|NCT01414361|Fractional flow reserve|fractional flow reserve
5471583|NCT01414361|Intravascular ultrasonography|intravascular ultrasonography
5471584|NCT01414348|participation|participation
5471585|NCT01414348|activities of daily living|activities of daily living
5471586|NCT01414348|brain injuries|brain injuries
5471587|NCT01414348|executive function|executive function
5471588|NCT01414335|amino acids|amino acids
5471589|NCT01414335|immune system|immune system
5471590|NCT01414335|vitamins|vitamins
5471591|NCT01414335|chronic infection|chronic infection
5471592|NCT01414335|common cold|common cold
5471593|NCT01414335|ear|ear
5471594|NCT01414335|nose|nose
5471595|NCT01414335|throat|throat
5471596|NCT01414309|Heart Failure|heart failure
5471597|NCT01414309|Central Sleep Apnea|central sleep apnea
5471598|NCT01414309|Sleep Disordered Breathing|sleep disordered breathing
5471599|NCT01414309|Cardiac Dysfunction|cardiac dysfunction
5471600|NCT01414257|Rheumatrex|rheumatrex
5471601|NCT01414257|High Dose|high dose
5471602|NCT01414244|Irritable Bowel Syndrome|irritable bowel syndrome
5471603|NCT01414244|Glutamine|glutamine
5471604|NCT01414244|Intestinal Permeability|intestinal permeability
5471605|NCT01414231|AML|aml
5471606|NCT01414231|acute myeloid leukaemia|acute myeloid leukaemia
5471607|NCT01414231|low vs intermediate dose AraC|low vs intermediate dose arac
5471608|NCT01414231|CR rate|cr rate
5471609|NCT01414231|patients <60 years|patients <60 years
5471610|NCT01414218|elderly|elderly
5471611|NCT01414218|humor|humor
5471612|NCT01414218|general well being|general well being
5471613|NCT01414218|psychological distress|psychological distress
5471614|NCT01414218|health quality of life|health quality of life
5471615|NCT01414179|nutrition|nutrition
5471616|NCT01414179|environnement|environnement
5471617|NCT01414179|cardiovascular pathology|cardiovascular pathology
5471618|NCT01414153|choroidal neovascularization|choroidal neovascularization
5471619|NCT01414153|age-related macular degeneration|age-related macular degeneration
5471620|NCT01414153|iSONEP|isonep
5471621|NCT01414153|sonepcizumab|sonepcizumab
5471622|NCT01414153|Lucentis|lucentis
5471623|NCT01414153|ranibizumab|ranibizumab
5471624|NCT01414153|Avastin|avastin
5471625|NCT01414153|bevacizumab|bevacizumab
5471626|NCT01414153|Eylea|eylea
5471627|NCT01414153|aflibercept|aflibercept
5471632|NCT01414114|Chronic kidney disease-mineral and bone disorder|chronic kidney disease-mineral and bone disorder
5471633|NCT01414114|Parathyroid hormone|parathyroid hormone
5471634|NCT01414101|Rheumatoid Arthritis|rheumatoid arthritis
5471636|NCT01414088|ENaC|enac
5471637|NCT01414088|NCC|ncc
5471638|NCT01414088|NKCC|nkcc
5471639|NCT01414088|Sodium channels|sodium channels
5471640|NCT01414088|renal biomarkers|renal biomarkers
5471641|NCT01414075|Kidney|kidney
5471642|NCT01414075|ESRD|esrd
5471643|NCT01414075|Renal|renal
5471644|NCT01414075|End-Stage Renal Disease|end-stage renal disease
5471645|NCT01414075|Anemia|anemia
5471646|NCT01414075|Oral anemia treatment|oral anemia treatment
5471647|NCT01414075|Hemoglobin levels|hemoglobin levels
5471648|NCT01414075|Hemodialysis|hemodialysis
5471649|NCT01414075|Peritoneal|peritoneal
5471651|NCT01414075|PD|pd
5471652|NCT01414075|Hb|hb
5471653|NCT01414075|Erythropoietin|erythropoietin
5471654|NCT01414075|Blood count|blood count
5471655|NCT01414062|Breast Cancer|breast cancer
5471656|NCT01414062|Healthy meals|healthy meals
5471657|NCT01414062|Cocinar|cocinar
5471658|NCT01414062|Dietary|dietary
5471659|NCT01414062|Dietary Intervention|dietary intervention
5471660|NCT01414062|fruits and vegetables|fruits and vegetables
5471661|NCT01414062|Cancer survivor|cancer survivor
5471663|NCT01414049|CABG|cabg
5471664|NCT01414049|Off-pump CABG|off-pump cabg
5471665|NCT01414049|Beating heart|beating heart
5471666|NCT01414049|Graft patency|graft patency
5471667|NCT01414049|Computed tomography angiography|computed tomography angiography
5471668|NCT01414049|Angiographic evaluation of coronary graft patency|angiographic evaluation of coronary graft patency
5471669|NCT01414036|cigarette smoking|cigarette smoking
5471670|NCT01414036|patient navigation|patient navigation
5471671|NCT01414036|primary care|primary care
5471672|NCT01414023|High OCI-R scores|high oci-r scores
5471673|NCT01414010|healthy volunteers|healthy volunteers
5471674|NCT01414010|gut microbiota|gut microbiota
5471675|NCT01414010|gut microbiome|gut microbiome
5471676|NCT01414010|prebiotic|prebiotic
5471677|NCT01414010|probiotic|probiotic
5471678|NCT01414010|antibiotic|antibiotic
5471679|NCT01414010|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5471680|NCT01414010|intestinal bacterial overgrowth|intestinal bacterial overgrowth
5471681|NCT01413984|Trauma|trauma
5471682|NCT01413984|incarceration|incarceration
5471683|NCT01413984|treatment|treatment
5471684|NCT01413984|substance abuse|substance abuse
5471685|NCT01413958|Nasal Decongestants|nasal decongestants
5471686|NCT01413958|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5471687|NCT01413958|Rhinitis|rhinitis
5471688|NCT01413958|Nose Conditions|nose conditions
5471689|NCT01413958|Respiratory Tract Diseases|respiratory tract diseases
5471690|NCT01413958|Phenylephrine|phenylephrine
5471691|NCT01413945|Ileocecal valve|ileocecal valve
5471692|NCT01413945|Irritable bowel syndrome|irritable bowel syndrome
5471693|NCT01413945|small bowel bacteria|small bowel bacteria
5471694|NCT01413867|hemorrhoids|hemorrhoids
5471695|NCT01413867|circular staplers|circular staplers
5471696|NCT01413867|mucosal resection|mucosal resection
5471697|NCT01413867|hemostatic suture|hemostatic suture
5471699|NCT01413841|oxygen|oxygen
5471700|NCT01413828|breast cancer|breast cancer
5471701|NCT01413828|adjuvant chemotherapy|adjuvant chemotherapy
5471702|NCT01413828|trastuzumab|trastuzumab
5471703|NCT01413828|anthracycline|anthracycline
5471704|NCT01413815|peri-operative|peri-operative
5471705|NCT01413815|cardiovascular risk|cardiovascular risk
5471706|NCT01413815|oral supplementation|oral supplementation
5471707|NCT01413815|amino acid L-arginine|amino acid l-arginine
5471708|NCT01413802|Thyroid surgery|thyroid surgery
5471709|NCT01413763|Actinic keratosis|actinic keratosis
5471710|NCT01413763|Atrial ectopy|atrial ectopy
5471711|NCT01413724|Administered analgesic therapy|administered analgesic therapy
5471712|NCT01413711|IS|is
5471713|NCT01413711|Pharmacokinetics|pharmacokinetics
5471714|NCT01413711|Area under the curve|area under the curve
5471715|NCT01413711|Maximum plasma concentration|maximum plasma concentration
5471716|NCT01413711|Time to maximum concentration|time to maximum concentration
5471717|NCT01413685|tacrolimus|tacrolimus
5471718|NCT01413685|calcineurin|calcineurin
5471719|NCT01413685|pharmacodynamic|pharmacodynamic
5471720|NCT01413685|TDM|tdm
5471721|NCT01413685|pharmacokinetics|pharmacokinetics
5471722|NCT01413672|ostomy|ostomy
5471723|NCT01413672|colostomy|colostomy
5471724|NCT01413672|ileostomy|ileostomy
5471725|NCT01413672|barrier|barrier
5471726|NCT01413672|irritation|irritation
5471727|NCT01413659|Colorectal surgery|colorectal surgery
5471728|NCT01413659|Surgical site infection|surgical site infection
5471730|NCT01413646|obesity|obesity
5471731|NCT01413646|walnuts|walnuts
5471732|NCT01413646|endothelial function|endothelial function
5471733|NCT01413620|Vitamin E|vitamin e
5471734|NCT01413620|Burn|burn
5471735|NCT01413620|Oxidation|oxidation
5471736|NCT01413620|Lung Dysfunction|lung dysfunction
5471737|NCT01413620|Fatty Liver|fatty liver
5471738|NCT01413620|Lipid Peroxidation|lipid peroxidation
5471739|NCT01413607|nephrectomy|nephrectomy
5471740|NCT01413607|self retaining sutures|self retaining sutures
5471741|NCT01413607|laparoscopy|laparoscopy
5471742|NCT01413594|cerebral palsy|cerebral palsy
5471743|NCT01413594|constraint-induced therapy|constraint-induced therapy
5471744|NCT01413594|constraint-induced movement therapy|constraint-induced movement therapy
5471745|NCT01413594|CP|cp
5471746|NCT01413594|hemiplegia|hemiplegia
5471747|NCT01413594|hand|hand
5471748|NCT01413594|forced use|forced use
5471749|NCT01413594|motor control|motor control
5471750|NCT01413594|children|children
5471751|NCT01413594|HABIT|habit
5471752|NCT01413594|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
5471753|NCT01413594|bilateral training|bilateral training
5471754|NCT01413594|bimanual training|bimanual training
5471755|NCT01413594|functional therapy|functional therapy
5471756|NCT01413594|physical therapy|physical therapy
5471757|NCT01413594|occupational therapy|occupational therapy
5471758|NCT01413594|intensive|intensive
5471759|NCT01413594|pediatric|pediatric
5471760|NCT01413594|development|development
5471761|NCT01413594|upper extremity|upper extremity
5471762|NCT01413594|hemiplegic|hemiplegic
5471763|NCT01413594|childhood stroke|childhood stroke
5471765|NCT01413581|preterm infants|preterm infants
5471766|NCT01413581|Swedish Orphan Biovitrum|swedish orphan biovitrum
5471767|NCT01413581|growth velocity|growth velocity
5471768|NCT01413581|Prevention of growth restriction|prevention of growth restriction
5471769|NCT01413555|blood culture|blood culture
5471770|NCT01413555|emergency department|emergency department
5471771|NCT01413555|quality improvement|quality improvement
5471772|NCT01413542|DPPIV inhibitors|dppiv inhibitors
5471773|NCT01413542|ACE inhibitors|ace inhibitors
5471774|NCT01413542|Bradykinin|bradykinin
5471775|NCT01413542|glucagon-like peptide (GLP-1)|glucagon-like peptide (glp-1)
5471776|NCT01413542|BNP|bnp
5471777|NCT01413542|diabetes|diabetes
5471778|NCT01413542|hypertension|hypertension
5471779|NCT01413529|HIV infected persons with co-occurring drug use|hiv infected persons with co-occurring drug use
5471780|NCT01413516|Varenicline|varenicline
5471781|NCT01413516|Placebo|placebo
5471782|NCT01413516|Inpatient|inpatient
5471783|NCT01413503|Pheochromocytoma|pheochromocytoma
5471784|NCT01413503|Paraganglioma|paraganglioma
5471785|NCT01413503|MIBG|mibg
5471786|NCT01413503|131I-MIBG|131i-mibg
5471787|NCT01413503|Resistant|resistant
5471788|NCT01413503|Relapsed|relapsed
5471789|NCT01413503|Treatment|treatment
5471790|NCT01413503|UCSF|ucsf
5471791|NCT01413503|Pediatric|pediatric
5471792|NCT01413503|Adult|adult
5471793|NCT01413503|Oncology|oncology
5471794|NCT01413490|hepatitis C virus|hepatitis c virus
5471795|NCT01413490|Interferon|interferon
5471796|NCT01413490|rimantadine|rimantadine
5471797|NCT01413490|liver|liver
5471798|NCT01413477|Allergic contact dermatitis|allergic contact dermatitis
5471799|NCT01413477|Nickel allergy|nickel allergy
5471800|NCT01413477|Desensitization therapy|desensitization therapy
5471801|NCT01413464|Renal Transplant|renal transplant
5471802|NCT01413464|Venous Thrombosis|venous thrombosis
5471803|NCT01413464|Deep Vein Thrombosis|deep vein thrombosis
5471804|NCT01413464|Prophylaxis|prophylaxis
5471805|NCT01413464|Bleeding|bleeding
5471806|NCT01413451|Monoclonal IgG Antibody|monoclonal igg antibody
5471807|NCT01413451|Biodistribution|biodistribution
5471808|NCT01413451|Pharmacokinetics|pharmacokinetics
5471809|NCT01413451|HACA|haca
5471810|NCT01413451|Safety|safety
5471811|NCT01413451|Mesothelioma|mesothelioma
5471812|NCT01413451|Ovarian Cancer|ovarian cancer
5471813|NCT01413451|Pancreatic Duct Cancer|pancreatic duct cancer
5471814|NCT01413451|Non-Small Cell Lung Cancer|non-small cell lung cancer
5471815|NCT01413438|Bevacizumab|bevacizumab
5471816|NCT01413438|Quality of Life|quality of life
5471817|NCT01413438|Glioblastoma Multiforme|glioblastoma multiforme
5471818|NCT01413438|Neurosurgery|neurosurgery
5471819|NCT01413438|Glioblastoma|glioblastoma
5471820|NCT01413438|GBM|gbm
5471821|NCT01413438|Brain Tumor|brain tumor
5471822|NCT01413425|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5471823|NCT01413425|Cholesterol|cholesterol
5471824|NCT01413425|SLOS|slos
5471825|NCT01413412|Ventral Hernia|ventral hernia
5471826|NCT01413412|Postoperative Pain|postoperative pain
5471827|NCT01413412|Ventral Hernia Pain Questionnaire|ventral hernia pain questionnaire
5471828|NCT01413412|Postoperative Abdominal wall and muscle function|postoperative abdominal wall and muscle function
5471829|NCT01413412|Biodex|biodex
5471830|NCT01413386|paclitaxel|paclitaxel
5471831|NCT01413386|drug eluting stent|drug eluting stent
5471832|NCT01413373|cephalometry|cephalometry
5471833|NCT01413373|three-dimensional|three-dimensional
5471834|NCT01413373|CT scan|ct scan
5471835|NCT01413373|lateral radiography|lateral radiography
5471836|NCT01413373|facial symmetry|facial symmetry
5471837|NCT01413373|maxillomandibular dysmorphoses|maxillomandibular dysmorphoses
5471838|NCT01413334|Coronary artery disease|coronary artery disease
5471839|NCT01413334|CT|ct
5471840|NCT01413321|Brain Injuries|brain injuries
5471841|NCT01413321|Post Traumatic Encephalopathy|post traumatic encephalopathy
5471842|NCT01413321|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5471843|NCT01413321|Cerebral Stroke|cerebral stroke
5471844|NCT01413321|Vascular Accidents, Brain|vascular accidents, brain
5471845|NCT01413321|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5471846|NCT01413321|Cerebrovascular Accident|cerebrovascular accident
5471847|NCT01413321|hemiparesis|hemiparesis
5471848|NCT01413308|Fontan|fontan
5471849|NCT01413308|lung function test|lung function test
5471850|NCT01413308|nitric oxide production|nitric oxide production
5471851|NCT01413308|NYHA class 1-2 without acute or chronic specified lung disease|nyha class 1-2 without acute or chronic specified lung disease
5471852|NCT01413295|Colorectal Neoplasms|colorectal neoplasms
5471853|NCT01413295|Dendritic Cells|dendritic cells
5471854|NCT01413282|Acute coronary syndrome|acute coronary syndrome
5471855|NCT01413269|breast cancer patients|breast cancer patients
5471856|NCT01413269|breast conservation surgery|breast conservation surgery
5471857|NCT01413269|hypofractionated radiotherapy|hypofractionated radiotherapy
5471858|NCT01413243|Multipe sclerosis, Trichuris suis ova|multipe sclerosis, trichuris suis ova
5471859|NCT01413230|Systemic lupus erythematosus|systemic lupus erythematosus
5471860|NCT01413230|vitamin D supplementation|vitamin d supplementation
5471861|NCT01413230|regulatory T cells|regulatory t cells
5471862|NCT01413230|Th17 cells|th17 cells
5471865|NCT01413204|Canagliflozin|canagliflozin
5471866|NCT01413204|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5471867|NCT01413178|Myeloma|myeloma
5471868|NCT01413178|Multiple Myeloma|multiple myeloma
5471869|NCT01413178|Light chain Multiple Myeloma|light chain multiple myeloma
5471870|NCT01413178|MM|mm
5471871|NCT01413178|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5471872|NCT01413178|Busulfan|busulfan
5471873|NCT01413178|Busulfex|busulfex
5471874|NCT01413178|Myleran|myleran
5471875|NCT01413178|Melphalan|melphalan
5471876|NCT01413178|Alkeran|alkeran
5471877|NCT01413178|G-CSF|g-csf
5471878|NCT01413178|Filgrastim|filgrastim
5471879|NCT01413178|NeupogenTM|neupogentm
5471880|NCT01413178|Questionnaire|questionnaire
5471881|NCT01413178|Survey|survey
5471882|NCT01413178|Quality of Life|quality of life
5471883|NCT01413178|QOL|qol
5471884|NCT01413152|men having sex with men|men having sex with men
5471885|NCT01413139|peripheral Vascular Disease|peripheral vascular disease
5471886|NCT01413139|claudication|claudication
5471887|NCT01413139|rest pain|rest pain
5471888|NCT01413126|Peanut|peanut
5471889|NCT01413126|Blood glucose|blood glucose
5471890|NCT01413126|Insulin|insulin
5471891|NCT01413126|Non-esterified free fatty acids|non-esterified free fatty acids
5471892|NCT01413126|Glucagon-like peptide-1|glucagon-like peptide-1
5471893|NCT01413126|Peptide YY|peptide yy
5471894|NCT01413126|Cholecystokinin|cholecystokinin
5471895|NCT01413126|Appetitive|appetitive
5471896|NCT01413126|Food intake|food intake
5471897|NCT01413087|Pancreatic cancer|pancreatic cancer
5471898|NCT01413087|Gemcitabine|gemcitabine
5471899|NCT01413087|BC-819|bc-819
5471900|NCT01413087|Adenocarcinoma|adenocarcinoma
5471901|NCT01413087|Resectable|resectable
5471902|NCT01413087|H19 gene|h19 gene
5471903|NCT01413087|DTA-H19|dta-h19
5471904|NCT01413087|BioCancell|biocancell
5471905|NCT01413087|inodiftagene vixteplasmid|inodiftagene vixteplasmid
5471906|NCT01413074|End Stage Renal Disease|end stage renal disease
5471907|NCT01413074|ESRD|esrd
5471908|NCT01413074|Peritoneal Dialysis|peritoneal dialysis
5471909|NCT01413074|PD|pd
5471910|NCT01413074|Hemodialysis|hemodialysis
5471911|NCT01413074|HD|hd
5471912|NCT01413061|Other Hindfoot Conditions requiring Subtalar Arthrodesis|other hindfoot conditions requiring subtalar arthrodesis
5471913|NCT01413061|Post-traumatic Arthritis|post-traumatic arthritis
5471914|NCT01413048|Essential Hypertension|essential hypertension
5471915|NCT01413048|Hypertension|hypertension
5471916|NCT01413035|Diabetes|diabetes
5471917|NCT01413035|Diabetes Medicines: Oral Hypoglycemic Drugs and Insulins.|diabetes medicines: oral hypoglycemic drugs and insulins.
5471918|NCT01413035|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5471919|NCT01413035|Transplantation|transplantation
5471920|NCT01413009|delirium|delirium
5471921|NCT01413009|ICU|icu
5471922|NCT01413009|spontaneous awakening trials|spontaneous awakening trials
5471923|NCT01413009|spontaneous breathing trials|spontaneous breathing trials
5471924|NCT01413009|early mobility|early mobility
5471925|NCT01412970|hemodynamic monitoring|hemodynamic monitoring
5471926|NCT01412970|volume responsiveness|volume responsiveness
5471927|NCT01412970|electrical impedance tomography|electrical impedance tomography
5471928|NCT01412957|Best Supportive Care|best supportive care
5471929|NCT01412957|Panitumumab|panitumumab
5471931|NCT01412957|Wild-type KRAS|wild-type kras
5471932|NCT01412957|Overall Survival|overall survival
5471934|NCT01412944|Psoriasis|psoriasis
5471935|NCT01412944|plaque|plaque
5471936|NCT01412944|inflammatory skin disease|inflammatory skin disease
5471937|NCT01412944|scaly patches|scaly patches
5471938|NCT01412944|AIN457|ain457
5471939|NCT01412944|secukinumab|secukinumab
5471940|NCT01412944|Moderate to severe|moderate to severe
5471941|NCT01412918|Tinnitus|tinnitus
5471942|NCT01412918|Inhibitor Device|inhibitor device
5471943|NCT01412918|SCN9 gene|scn9 gene
5471944|NCT01412918|Ringing in the ears|ringing in the ears
5471945|NCT01412918|Milwaukee|milwaukee
5471946|NCT01412918|Medical College of Wisconsin|medical college of wisconsin
5471947|NCT01412905|screening|screening
5471948|NCT01412905|diabetic retinopathy|diabetic retinopathy
5471949|NCT01412892|Neurofibromatosis type 1|neurofibromatosis type 1
5471950|NCT01412892|Everolimus|everolimus
5471951|NCT01412892|Plexiform neurofibromas|plexiform neurofibromas
5471952|NCT01412892|Rapamycin|rapamycin
5471953|NCT01412879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5471954|NCT01412879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5471955|NCT01412879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5471956|NCT01412879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5471957|NCT01412866|schizophrenia|schizophrenia
5471958|NCT01412866|severe mental illness|severe mental illness
5471959|NCT01412866|nicotine|nicotine
5471960|NCT01412866|smoking|smoking
5471961|NCT01412866|motivation|motivation
5471962|NCT01412866|electronic decision support system|electronic decision support system
5471963|NCT01412866|motivational interviewing|motivational interviewing
5471964|NCT01412853|localized|localized
5471965|NCT01412840|Ureterolithiasis|ureterolithiasis
5471967|NCT01412840|Complementary|complementary
5471968|NCT01412840|RCT|rct
5471969|NCT01412827|Single-photon emission computed tomography|single-photon emission computed tomography
5471970|NCT01412827|myocardial perfusion imaging|myocardial perfusion imaging
5471971|NCT01412827|rest/stress|rest/stress
5471972|NCT01412827|treadmill|treadmill
5471973|NCT01412827|persantine|persantine
5471974|NCT01412827|half-dose|half-dose
5471975|NCT01412827|radiotracer|radiotracer
5471976|NCT01412827|tetrofosmin|tetrofosmin
5471977|NCT01412827|Thallium|thallium
5471978|NCT01412827|cadmium zinc telluride|cadmium zinc telluride
5471979|NCT01412827|diagnostic|diagnostic
5471980|NCT01412827|prognostic|prognostic
5471981|NCT01412814|Total knee arthroplasty|total knee arthroplasty
5471982|NCT01412814|Total knee replacement|total knee replacement
5471983|NCT01412814|End-stage knee osteoarthritis|end-stage knee osteoarthritis
5471984|NCT01412814|Gait patterns|gait patterns
5471985|NCT01412814|Neuromuscular education|neuromuscular education
5471986|NCT01412801|Group B streptococcus|group b streptococcus
5471987|NCT01412801|GBS|gbs
5471988|NCT01412801|Vaccine|vaccine
5471989|NCT01412801|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5471990|NCT01412788|breast cancer|breast cancer
5471991|NCT01412788|Breast Conserving Surgery|breast conserving surgery
5471992|NCT01412788|Peri-areolar Incision|peri-areolar incision
5471993|NCT01412775|stress|stress
5471994|NCT01412775|burnout|burnout
5471995|NCT01412775|exhaustion|exhaustion
5471996|NCT01412762|Surgery|surgery
5471997|NCT01412762|interview|interview
5471998|NCT01412762|11-087|11-087
5471999|NCT01412749|registry|registry
5472000|NCT01412749|database|database
5472001|NCT01412749|eHNS|ehns
5472002|NCT01412749|Endoscopic Head and Neck Surgery|endoscopic head and neck surgery
5472003|NCT01412749|Transoral Endoscopic Surgery Trial|transoral endoscopic surgery trial
5472004|NCT01412749|TEST|test
5472005|NCT01412749|melanoma|melanoma
5472006|NCT01412749|head and neck surgery|head and neck surgery
5472007|NCT01412723|Iron Deficiency|iron deficiency
5472008|NCT01412723|Child, Preschool|child, preschool
5472009|NCT01412723|Dietary Iron|dietary iron
5472010|NCT01412723|Ferrous sulfate|ferrous sulfate
5472011|NCT01412723|Bis-glycino iron II|bis-glycino iron ii
5472012|NCT01412710|Type 2 Diabetes|type 2 diabetes
5472013|NCT01412710|Cholecalciferol|cholecalciferol
5472014|NCT01412710|Vitamin D|vitamin d
5472015|NCT01412710|Insulin resistance|insulin resistance
5472016|NCT01412710|Cardiovascular disease risk|cardiovascular disease risk
5472017|NCT01412710|Minorities|minorities
5472018|NCT01412697|Rural youth|rural youth
5472019|NCT01412697|Theory-based intervention|theory-based intervention
5472020|NCT01412697|Randomized by schools|randomized by schools
5472021|NCT01412697|Fruit and vegetable intake|fruit and vegetable intake
5472022|NCT01412697|Health classes|health classes
5472023|NCT01412671|Nexavar|nexavar
5472024|NCT01412671|unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
5472025|NCT01412645|Obesity|obesity
5472026|NCT01412645|Inflammation|inflammation
5472027|NCT01412645|Metabolic Syndrome|metabolic syndrome
5472028|NCT01412645|Insulin sensitivity|insulin sensitivity
5472029|NCT01412645|Osteoporosis|osteoporosis
5472030|NCT01412645|Bone turnover|bone turnover
5472031|NCT01412645|Ectopic fat accumulation|ectopic fat accumulation
5472032|NCT01412645|Resveratrol|resveratrol
5472033|NCT01412619|Neurological Outcome|neurological outcome
5472034|NCT01412619|Intraoperative intracerebral Oxygen level|intraoperative intracerebral oxygen level
5472035|NCT01412619|Mean arterial blood pressure|mean arterial blood pressure
5472036|NCT01412619|Central venous blood pressure|central venous blood pressure
5472037|NCT01412619|Cardiac output|cardiac output
5472038|NCT01412619|Serum Lactate|serum lactate
5472039|NCT01412619|Venous oxygen saturation|venous oxygen saturation
5472040|NCT01412619|Fluid balance|fluid balance
5472041|NCT01412606|Unexplained infertility-endometrial scratching|unexplained infertility-endometrial scratching
5472042|NCT01412606|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility|effect of endometrial biopsy (scratching) on clinical pregnancy rates in women with unexplained infertility
5472043|NCT01412567|Hepatitis B|hepatitis b
5472044|NCT01412567|HBsAg|hbsag
5472045|NCT01412567|Antenatal|antenatal
5472046|NCT01412567|Pregnancy|pregnancy
5472047|NCT01412567|Vertical transmission|vertical transmission
5472048|NCT01412567|Placenta|placenta
5472049|NCT01412567|HBV DNA|hbv dna
5472050|NCT01412554|Insulin resistance|insulin resistance
5472051|NCT01412554|Diabetes mellitus|diabetes mellitus
5472052|NCT01412554|Adipositas|adipositas
5472053|NCT01412541|Arms|arms
5472054|NCT01412541|Experimental|experimental
5472055|NCT01412541|Drug Coated Angioplasty Balloon|drug coated angioplasty balloon
5472056|NCT01412541|Active Comparator|active comparator
5472057|NCT01412541|Standard Angioplasty Balloon|standard angioplasty balloon
5472058|NCT01412515|mTOR inhibitors|mtor inhibitors
5472063|NCT01412489|Uterine synechiae|uterine synechiae
5472064|NCT01412489|HyalobarrierR Gel Endo|hyalobarrierr gel endo
5472065|NCT01412489|Operative hysteroscopy|operative hysteroscopy
5472066|NCT01412489|submucous myoma|submucous myoma
5472067|NCT01412450|symptomatic popliteal artery stenosis or occlusion|symptomatic popliteal artery stenosis or occlusion
5472068|NCT01412437|PKU|pku
5472069|NCT01412437|MRI|mri
5472070|NCT01412437|neurocognition|neurocognition
5472071|NCT01412437|sapropterin dihydrochloride|sapropterin dihydrochloride
5472072|NCT01412424|acromegaly|acromegaly
5472073|NCT01412424|IGF-1|igf-1
5472074|NCT01412424|growth hormone|growth hormone
5472075|NCT01412424|Octreolin|octreolin
5472076|NCT01412424|octreotide|octreotide
5472077|NCT01412424|somatostatin analog|somatostatin analog
5472078|NCT01412411|Anemia|anemia
5472079|NCT01412411|Growth|growth
5472080|NCT01412411|Infants|infants
5472081|NCT01412411|Focus of the study is to assess the level of anemia and growth indicators among the infants|focus of the study is to assess the level of anemia and growth indicators among the infants
5472082|NCT01412398|Fosrenol|fosrenol
5472083|NCT01412398|Hyperphosphatemia|hyperphosphatemia
5472084|NCT01412398|Continuous Cyclic Peritoneal Dialysis|continuous cyclic peritoneal dialysis
5472085|NCT01412372|Irritable Bowel Syndrome|irritable bowel syndrome
5472086|NCT01412372|Diarrhea|diarrhea
5472087|NCT01412372|Mesalamine|mesalamine
5472088|NCT01412372|Gastroenteritis|gastroenteritis
5472089|NCT01412372|abdominal pain|abdominal pain
5472090|NCT01412372|hypersensitivity|hypersensitivity
5472091|NCT01412359|TPN Cholestasis|tpn cholestasis
5472092|NCT01412346|human|human
5472093|NCT01412346|clinical trial|clinical trial
5472094|NCT01412346|dietary intervention study|dietary intervention study
5472095|NCT01412346|blood pressure|blood pressure
5472096|NCT01412346|cardiovascular biomarkers|cardiovascular biomarkers
5472097|NCT01412346|nutritional biomarkers|nutritional biomarkers
5472098|NCT01412346|gene expression|gene expression
5472099|NCT01412307|Hodgkin Lymphoma|hodgkin lymphoma
5472100|NCT01412307|Lenalidomide|lenalidomide
5472101|NCT01412307|Bendamustine|bendamustine
5472102|NCT01412307|Salvage therapy|salvage therapy
5472103|NCT01412307|Palliation|palliation
5472104|NCT01412294|gastric cancer|gastric cancer
5472105|NCT01412294|recurrent gastric cancer|recurrent gastric cancer
5472106|NCT01412294|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5472107|NCT01412294|capecitabine|capecitabine
5472108|NCT01412294|xp|xp
5472109|NCT01412281|Influenza|influenza
5472110|NCT01412281|Virus|virus
5472111|NCT01412281|Vaccination|vaccination
5472112|NCT01412281|Immunisation|immunisation
5472113|NCT01412268|Obesity|obesity
5472114|NCT01412268|Bariatric surgery|bariatric surgery
5472115|NCT01412268|Behavioral changes|behavioral changes
5472116|NCT01412268|Eating habits|eating habits
5472117|NCT01412268|Eating addiction|eating addiction
5472118|NCT01412242|Deep vein thrombosis|deep vein thrombosis
5472119|NCT01412242|Ultrasonography|ultrasonography
5472120|NCT01412242|Pulmonary embolism|pulmonary embolism
5472121|NCT01412242|D-dimer|d-dimer
5472122|NCT01412242|Pre-test probability|pre-test probability
5472123|NCT01412229|Head and neck cancer|head and neck cancer
5472124|NCT01412229|Phase II|phase ii
5472125|NCT01412229|Locally advanced|locally advanced
5472126|NCT01412229|Squamous Cell|squamous cell
5472127|NCT01412229|Carboplatin|carboplatin
5472128|NCT01412229|Nab-paclitaxel|nab-paclitaxel
5472129|NCT01412229|Abraxane|abraxane
5472130|NCT01412229|Cetuximab|cetuximab
5472131|NCT01412229|Induction|induction
5472132|NCT01412229|Chemotherapy|chemotherapy
5472133|NCT01412216|Sedentarism|sedentarism
5472134|NCT01412216|Physical inactivity|physical inactivity
5472135|NCT01412216|Fish oil|fish oil
5472136|NCT01412216|Omega-3 fatty acids|omega-3 fatty acids
5472137|NCT01412216|Endothelial dysfunction|endothelial dysfunction
5472138|NCT01412216|Insulin resistance|insulin resistance
5472139|NCT01412216|Metabolic syndrome|metabolic syndrome
5472140|NCT01412216|peripheral arterial disease|peripheral arterial disease
5472141|NCT01412203|Physical activity|physical activity
5472142|NCT01412203|Healthy weight|healthy weight
5472143|NCT01412203|Healthy eating|healthy eating
5472144|NCT01412203|Physical fitness|physical fitness
5472145|NCT01412203|Children|children
5472146|NCT01412203|School based|school based
5472147|NCT01412203|Community based|community based
5472148|NCT01412203|Obesity|obesity
5472149|NCT01412203|Health promotion|health promotion
5472150|NCT01412203|Socio-ecological|socio-ecological
5472151|NCT01412203|Environment based|environment based
5472152|NCT01412190|Skin rejuvenation|skin rejuvenation
5472153|NCT01412177|Meniere's Disease|meniere's disease
5472154|NCT01412177|Vertigo|vertigo
5475243|NCT01399593|AMR|amr
5472155|NCT01412177|Definitive vertigo|definitive vertigo
5472156|NCT01412177|Vertigo episodes|vertigo episodes
5472157|NCT01412177|Vertigo frequency|vertigo frequency
5472158|NCT01412177|Tinnitus|tinnitus
5472159|NCT01412177|Hearing loss|hearing loss
5472160|NCT01412177|Aural fullness|aural fullness
5458703|NCT01466608|Rosuvastatin|rosuvastatin
5472163|NCT01412164|FIREHAWK|firehawk
5472164|NCT01412164|MicroPort|microport
5472165|NCT01412164|PCI|pci
5472166|NCT01412151|Symptomatic|symptomatic
5472167|NCT01412151|Huntington's Disease|huntington's disease
5472168|NCT01412151|HD|hd
5472169|NCT01412125|Biomarkers|biomarkers
5472170|NCT01412125|Genetic polymorphism|genetic polymorphism
5472171|NCT01412125|Neuroimaging markers|neuroimaging markers
5472172|NCT01412125|Neuropsychology|neuropsychology
5472173|NCT01412099|Exercise|exercise
5472174|NCT01412099|Fast Foods|fast foods
5472175|NCT01412099|Fruits|fruits
5472176|NCT01412099|Vegetables|vegetables
5472177|NCT01412099|Beverages|beverages
5472178|NCT01412099|Non-traditional college students|non-traditional college students
5472179|NCT01412099|Motivational Interviewing|motivational interviewing
5472180|NCT01412099|Peer Counselors|peer counselors
5472181|NCT01412099|Cancer Prevention|cancer prevention
5472182|NCT01412073|caesarean section, intrapartum haemorrhage|caesarean section, intrapartum haemorrhage
5472183|NCT01412060|Schizophrenia|schizophrenia
5472184|NCT01412060|Schizophrenic disorder|schizophrenic disorder
5472185|NCT01412047|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5472186|NCT01412047|PNH|pnh
5472187|NCT01412047|Human Anti-Human Antibody|human anti-human antibody
5472188|NCT01412047|HAHA|haha
5472189|NCT01412047|Soliris|soliris
5472190|NCT01412047|eculizumab|eculizumab
5472191|NCT01412034|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5472192|NCT01412034|Familial Hypercholesterolemia|familial hypercholesterolemia
5621315|NCT00813969|MSC|msc
5472193|NCT01412034|HDL mimetic|hdl mimetic
5472194|NCT01412034|ApoA-1|apoa-1
5472195|NCT01412021|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
5472196|NCT01412008|MRI|mri
5472197|NCT01412008|Magnetic Resonance Imaging|magnetic resonance imaging
5472198|NCT01412008|Botox|botox
5472199|NCT01412008|botulinum toxin|botulinum toxin
5472200|NCT01412008|neurological|neurological
5472201|NCT01412008|stroke|stroke
5472202|NCT01412008|spasticity|spasticity
5472203|NCT01412008|muscle stiffness|muscle stiffness
5472204|NCT01412008|diffusion|diffusion
5472205|NCT01412008|Weill Cornell|weill cornell
5472206|NCT01412008|New York Presbyterian Hospital|new york presbyterian hospital
5472207|NCT01412008|O'Dell|o'dell
5472208|NCT01411995|intrauterine device|intrauterine device
5472209|NCT01411995|pain|pain
5472210|NCT01411995|lidocaine gel|lidocaine gel
5472211|NCT01411982|PACAP (pituitary adenylate cyclase-activating polypeptide)|pacap (pituitary adenylate cyclase-activating polypeptide)
5472212|NCT01411982|Nephrotic syndrome|nephrotic syndrome
5472213|NCT01411982|Thrombosis|thrombosis
5472214|NCT01411982|Platelets|platelets
5472215|NCT01411969|external nasal dilator strip|external nasal dilator strip
5472216|NCT01411969|nasal valve|nasal valve
5472217|NCT01411969|acoustic rhinometry|acoustic rhinometry
5472218|NCT01411956|Health Behavior Theory|health behavior theory
5472219|NCT01411956|Patient Education|patient education
5472220|NCT01411956|Hypertension|hypertension
5472221|NCT01411956|Health beliefs related to hypertension and hypertension treatment|health beliefs related to hypertension and hypertension treatment
5472222|NCT01411943|Epigenetics|epigenetics
5472223|NCT01411943|Inflammatory|inflammatory
5472224|NCT01411943|Psychoneurologic Symptoms|psychoneurologic symptoms
5472225|NCT01411943|Cognitive Dysfunction|cognitive dysfunction
5472227|NCT01411943|Fatigue|fatigue
5472228|NCT01411943|Sleep Disturbance|sleep disturbance
5472229|NCT01411943|Depression|depression
5472230|NCT01411943|Depressive Symptoms|depressive symptoms
5472231|NCT01411943|Anxiety|anxiety
5472232|NCT01411943|Breast Cancer|breast cancer
5472235|NCT01411930|Olanzapine|olanzapine
5472236|NCT01411930|Aripiprazole|aripiprazole
5472237|NCT01411917|surgical stomas|surgical stomas
5472238|NCT01411917|Nerve block|nerve block
5472239|NCT01411904|Leukemia|leukemia
5472240|NCT01411904|magnetic needle|magnetic needle
5472241|NCT01411904|magnetic nanoparticles|magnetic nanoparticles
5472242|NCT01411904|CD34|cd34
5472243|NCT01411891|Arthroplasty|arthroplasty
5472244|NCT01411891|Infection Control|infection control
5472245|NCT01411878|Teen Pregnancy Prevention|teen pregnancy prevention
5472246|NCT01411865|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
5472247|NCT01411865|Cardiovascular risk reduction|cardiovascular risk reduction
5472248|NCT01411865|Knowledge translation|knowledge translation
5472249|NCT01411865|Clinical practice guidelines|clinical practice guidelines
5472250|NCT01411865|Administrative databases|administrative databases
5472251|NCT01411852|fluid volume resuscitation|fluid volume resuscitation
5472252|NCT01411852|trauma|trauma
5472253|NCT01411852|hemorrhagic shock|hemorrhagic shock
5472254|NCT01411839|Depression|depression
5472255|NCT01411839|Latinos|latinos
5472256|NCT01411839|Adherence|adherence
5472257|NCT01411839|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5472258|NCT01411839|HIV/AIDS|hiv/aids
5472259|NCT01411826|Colon cancer screening|colon cancer screening
5472260|NCT01411787|Breast cancer|breast cancer
5472261|NCT01411787|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5472262|NCT01411787|exercise|exercise
5472263|NCT01411787|Ki-67|ki-67
5472264|NCT01411774|Obsessive-compulsive disorder|obsessive-compulsive disorder
5472266|NCT01411761|indirect hyperbilirubinemia|indirect hyperbilirubinemia
5472267|NCT01411761|very low birth weight infants|very low birth weight infants
5472268|NCT01411722|Electrical Activity of Diaphragm|electrical activity of diaphragm
5472269|NCT01411722|Weaning outcome|weaning outcome
5472270|NCT01411722|NAVA|nava
5472271|NCT01411683|Cost estimates|cost estimates
5472272|NCT01411683|Complete Denture|complete denture
5472273|NCT01411683|Dental Economics|dental economics
5472274|NCT01411683|Dental Implants|dental implants
5472275|NCT01411683|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5472276|NCT01411683|Denture Retention|denture retention
5472277|NCT01411683|Edentulous|edentulous
5472278|NCT01411683|Edentulism|edentulism
5472279|NCT01411683|Mini dental implant|mini dental implant
5472280|NCT01411683|Oral Health-Related Quality of Life|oral health-related quality of life
5472281|NCT01411683|Overdenture|overdenture
5472282|NCT01411683|Patient Acceptance of Health Care|patient acceptance of health care
5472283|NCT01411683|Quality of Health Care|quality of health care
5472284|NCT01411683|Quality of Life|quality of life
5472285|NCT01411683|Patient Satisfaction|patient satisfaction
5472286|NCT01411670|Human Protein C|human protein c
5472287|NCT01411670|Activated protein C|activated protein c
5472288|NCT01411670|Microcirculation|microcirculation
5472290|NCT01411670|Sepsis|sepsis
5472291|NCT01411644|POF|pof
5472292|NCT01411644|IOF|iof
5472293|NCT01411644|Poor response|poor response
5472294|NCT01411644|early menopause|early menopause
5472295|NCT01411644|Primary amenorrhea|primary amenorrhea
5472296|NCT01411631|Polyphenols|polyphenols
5472297|NCT01411631|Cognition|cognition
5472298|NCT01411631|Cognitive function|cognitive function
5472299|NCT01411631|Driving performance|driving performance
5472300|NCT01411631|Stress|stress
5472301|NCT01411618|Antiplaque agents|antiplaque agents
5472302|NCT01411618|chemical plaque control|chemical plaque control
5472303|NCT01411618|oral hygiene|oral hygiene
5472304|NCT01411618|essential oils|essential oils
5472305|NCT01411618|alcohol|alcohol
5472306|NCT01411618|mouthwash|mouthwash
5472307|NCT01411605|Obesity|obesity
5472308|NCT01411605|Adolescent|adolescent
5472309|NCT01411605|Exercise training|exercise training
5472310|NCT01411605|Exercise tolerance|exercise tolerance
5472311|NCT01411592|All-Ceramic|all-ceramic
5472312|NCT01411592|Resin-bonded Fixed Dental Protheses|resin-bonded fixed dental protheses
5472313|NCT01411592|Single Retainer|single retainer
5472314|NCT01411592|Randomized Clinical Trial|randomized clinical trial
5472315|NCT01411592|Resin Bond|resin bond
5472316|NCT01411592|Bonding System|bonding system
5472317|NCT01411579|liver|liver
5472318|NCT01411579|metastases|metastases
5472319|NCT01411579|hepatocarcinoma|hepatocarcinoma
5472320|NCT01411579|MR|mr
5472321|NCT01411579|DWI|dwi
5472322|NCT01411579|chemotherapy|chemotherapy
5472323|NCT01411566|KLIPS|klips
5472324|NCT01411553|ICU|icu
5472325|NCT01411553|Telemetry|telemetry
5472326|NCT01411553|ECG lead wire monitoring|ecg lead wire monitoring
5472327|NCT01411553|Infection|infection
5472328|NCT01411553|Nuisance alarms|nuisance alarms
5472329|NCT01411540|Body composition|body composition
5472330|NCT01411540|Health markers|health markers
5472331|NCT01411540|Diet|diet
5472332|NCT01411527|Hormones|hormones
5472333|NCT01411527|Endocrine Disrupters|endocrine disrupters
5472334|NCT01411527|Polymorphism, Genetic|polymorphism, genetic
5472335|NCT01411514|Relapsing remittent multipse sclerosis|relapsing remittent multipse sclerosis
5472336|NCT01411514|Secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5472337|NCT01411514|Clinically isolated syndrome|clinically isolated syndrome
5472338|NCT01411514|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
5472339|NCT01411501|Acupuncture|acupuncture
5472340|NCT01411501|Functional constipation|functional constipation
5472349|NCT01411410|phosphatidylinositol 3΄-kinase (PI3K)|phosphatidylinositol 3΄-kinase (pi3k)
5472350|NCT01411410|paclitaxel|paclitaxel
5472351|NCT01411410|Maximum tolerated Dose|maximum tolerated dose
5472352|NCT01411397|Infection|infection
5472353|NCT01411397|Prosthesis|prosthesis
5472354|NCT01411397|Recurrence|recurrence
5472355|NCT01411397|Strangulation|strangulation
5472356|NCT01411384|Keratoconus (KC)|keratoconus (kc)
5472357|NCT01411384|Corneal collagen cross-linking (CXL)|corneal collagen cross-linking (cxl)
5472358|NCT01411384|Corneal hysteresis (CH)|corneal hysteresis (ch)
5472359|NCT01411384|Corneal resistance factor (CRF)|corneal resistance factor (crf)
5472360|NCT01411384|Ocular Response Analyzer (ORA)|ocular response analyzer (ora)
5472361|NCT01411371|Atrial fibrillation|atrial fibrillation
5472362|NCT01411371|Heart failure|heart failure
5472363|NCT01411371|Catheter ablation|catheter ablation
5472364|NCT01411358|influenza|influenza
5472366|NCT01411358|immunogenicity|immunogenicity
5472367|NCT01411345|Prostate Cancer|prostate cancer
5472368|NCT01411345|Prostate Adenocarcinoma|prostate adenocarcinoma
5472369|NCT01411332|Prostate Cancer|prostate cancer
5472370|NCT01411332|Prostate Adenocarcinoma|prostate adenocarcinoma
5472371|NCT01411319|Prostate Cancer|prostate cancer
5472372|NCT01411319|Prostate Adenocarcinoma|prostate adenocarcinoma
5472373|NCT01411293|cardiovascular disease|cardiovascular disease
5472374|NCT01411293|oxidative stress|oxidative stress
5472375|NCT01411293|dairy consumption|dairy consumption
5472376|NCT01411293|metabolic syndrome|metabolic syndrome
5472377|NCT01411293|obesity|obesity
5472378|NCT01411293|endothelial function|endothelial function
5472390|NCT01411254|DME|dme
5472391|NCT01411241|Dengue|dengue
5472392|NCT01411241|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5472393|NCT01411241|CYD Dengue Vaccines|cyd dengue vaccines
5472394|NCT01411241|Pentaxim™|pentaxim™
5472395|NCT01411228|Gaucher disease|gaucher disease
5472396|NCT01411228|pediatrics|pediatrics
5472397|NCT01411215|Rheumatoid arthritis|rheumatoid arthritis
5472398|NCT01411215|ankylosing spondylitis|ankylosing spondylitis
5472399|NCT01411215|observational study|observational study
5472400|NCT01411202|Malignant Pleural Effusion|malignant pleural effusion
5472401|NCT01411202|Doxycycline|doxycycline
5472402|NCT01411202|Pleurodesis|pleurodesis
5472403|NCT01411202|Pleurx catheter|pleurx catheter
5472404|NCT01411189|therapeutic upper gastrointestinal endoscopy|therapeutic upper gastrointestinal endoscopy
5789976|NCT00146302|Tuberculin|tuberculin
5472405|NCT01411189|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5472406|NCT01411189|endoscopic mucosal resection|endoscopic mucosal resection
5472407|NCT01411189|endoscopic submucosal dissection|endoscopic submucosal dissection
5472408|NCT01411189|PEG|peg
5472409|NCT01411189|EMR|emr
5472410|NCT01411189|ESD|esd
5472411|NCT01411189|endoscopic hemostasis|endoscopic hemostasis
5472412|NCT01411176|upper gastrointestinal endoscopy|upper gastrointestinal endoscopy
5472413|NCT01411176|suspected gastric cancer|suspected gastric cancer
5472414|NCT01411163|Premanifest|premanifest
5472415|NCT01411163|At-Risk|at-risk
5472416|NCT01411163|Huntington's Disease|huntington's disease
5472417|NCT01411163|HD|hd
5472418|NCT01411150|Premanifest|premanifest
5472419|NCT01411150|At-Risk|at-risk
5472420|NCT01411150|Huntington's Disease|huntington's disease
5472421|NCT01411150|HD|hd
5472422|NCT01411124|gabapentin|gabapentin
5472423|NCT01411124|restless leg syndrome|restless leg syndrome
5472424|NCT01411111|Drug-drug interaction|drug-drug interaction
5472425|NCT01411111|rosuvastatin|rosuvastatin
5472426|NCT01411111|asthma|asthma
5472427|NCT01411111|FLAP inhibitor|flap inhibitor
5472428|NCT01411085|Schizophrenia|schizophrenia
5472429|NCT01411085|Alcoholism|alcoholism
5472430|NCT01411085|Dual Diagnosis|dual diagnosis
5472431|NCT01411085|Desipramine|desipramine
5472432|NCT01411085|Risperidone|risperidone
5472433|NCT01411072|Biomarker directed adjuvant chemotherapy|biomarker directed adjuvant chemotherapy
5472434|NCT01411072|resected pancreas cancer|resected pancreas cancer
5472435|NCT01411059|yoga biomechanics seniors|yoga biomechanics seniors
5472436|NCT01411046|Glucocorticoid|glucocorticoid
5472437|NCT01411046|polymorphism|polymorphism
5472438|NCT01411046|Glucocorticoid receptor gene|glucocorticoid receptor gene
5472439|NCT01411046|rheumatoid arthritis|rheumatoid arthritis
5472440|NCT01411046|adrenal insufficiency|adrenal insufficiency
5472441|NCT01411046|prednisolone treatment|prednisolone treatment
5472443|NCT01411007|Cigarettes|cigarettes
5472444|NCT01411007|Smoker|smoker
5472445|NCT01411007|realtime fMRI|realtime fmri
5472446|NCT01411007|brain imaging|brain imaging
5472447|NCT01411007|imaging|imaging
5472448|NCT01410994|glomerular filtration rate|glomerular filtration rate
5472449|NCT01410955|probiotics|probiotics
5472450|NCT01410955|diarrhoea|diarrhoea
5472451|NCT01410955|prevention|prevention
5472452|NCT01410955|colon cancer|colon cancer
5472453|NCT01410955|irinotecan|irinotecan
5472454|NCT01410942|Prostate Cancer|prostate cancer
5472455|NCT01410942|Multimodal Therapy|multimodal therapy
5472456|NCT01410942|MMT|mmt
5472457|NCT01410942|Fatigue|fatigue
5472458|NCT01410942|Cognitive Behavioral Therapy|cognitive behavioral therapy
5472459|NCT01410942|CBT|cbt
5472460|NCT01410942|Radiation therapy|radiation therapy
5472461|NCT01410942|Radiotherapy|radiotherapy
5472462|NCT01410942|RT|rt
5472463|NCT01410942|Functional Assessment of Chronic Illness Therapy - Fatigue|functional assessment of chronic illness therapy - fatigue
5472464|NCT01410942|FACIT-F|facit-f
5472465|NCT01410942|Androgen deprivation therapy|androgen deprivation therapy
5472466|NCT01410942|Methylphenidate|methylphenidate
5472467|NCT01410942|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5472468|NCT01410942|Ritalin|ritalin
5472469|NCT01410942|Concerta|concerta
5472470|NCT01410942|Placebo|placebo
5472471|NCT01410942|Sugar Pill|sugar pill
5472472|NCT01410929|multiple myeloma|multiple myeloma
5472473|NCT01410929|VCF|vcf
5472474|NCT01410929|Vertebral Compression Fracture|vertebral compression fracture
5472475|NCT01410929|Spine|spine
5472476|NCT01410929|Kyphoplasty|kyphoplasty
5472477|NCT01410929|Back pain|back pain
5472478|NCT01410929|Cancer|cancer
5472479|NCT01410916|STEC-HUS|stec-hus
5685315|NCT00556569|Physical activity|physical activity
5685316|NCT00556569|Obesity|obesity
5458953|NCT01465828|ACS|acs
5472480|NCT01410916|Shiga-like toxin-producing Escherichia Coli Hemolytic-Uremic Syndrome|shiga-like toxin-producing escherichia coli hemolytic-uremic syndrome
5472481|NCT01410916|uncontrolled complement activation|uncontrolled complement activation
5472482|NCT01410864|cerebrospinal fluid leaks|cerebrospinal fluid leaks
5472483|NCT01410864|dural opening|dural opening
5472484|NCT01410864|dural sealing|dural sealing
5472485|NCT01410838|Obesity|obesity
5472486|NCT01410838|Food preferences|food preferences
5472487|NCT01410838|Eating Behavior|eating behavior
5472489|NCT01410825|Wiskott|wiskott
5472490|NCT01410825|Gene Transfer|gene transfer
5472491|NCT01410825|Gene Therapy|gene therapy
5472492|NCT01410812|Interest in exercising more|interest in exercising more
5472493|NCT01410799|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5472494|NCT01410799|Growth Hormone Insufficiency|growth hormone insufficiency
5472495|NCT01410799|Aging|aging
5472496|NCT01410799|Growth Hormone|growth hormone
5472497|NCT01410799|Physiologic Effects of Drugs|physiologic effects of drugs
5472498|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5472499|NCT01410799|Hormones|hormones
5472500|NCT01410760|Imaging study|imaging study
5472501|NCT01410760|Perfusion Computerised Tomography|perfusion computerised tomography
5472502|NCT01410747|long-term treatment|long-term treatment
5472503|NCT01410747|tacrolimus|tacrolimus
5472504|NCT01410747|renal failure|renal failure
5472505|NCT01410734|cholecystectomy|cholecystectomy
5472506|NCT01410734|chronic right upper quadrant pain|chronic right upper quadrant pain
5472508|NCT01410721|PTSD|ptsd
5472509|NCT01410721|Veterans|veterans
5472510|NCT01410708|Human Breast Cancer Tissue|human breast cancer tissue
5472511|NCT01410708|Dasatinin|dasatinin
5472512|NCT01410695|Rheumatoid Arthritis|rheumatoid arthritis
5472513|NCT01410695|RA|ra
5472514|NCT01410695|masitinib|masitinib
5472515|NCT01410695|DMARD|dmard
5472516|NCT01410695|methotrexate|methotrexate
5472517|NCT01410682|oral hygiene|oral hygiene
5472518|NCT01410682|ventilator-associated pneumonia|ventilator-associated pneumonia
5472519|NCT01410682|infection control|infection control
5472520|NCT01410682|intensive care|intensive care
5472521|NCT01410682|pediatric nursing|pediatric nursing
5472522|NCT01410682|pediatrics|pediatrics
5472523|NCT01410669|Self-efficacy|self-efficacy
5472524|NCT01410669|Intimate partner violence|intimate partner violence
5472525|NCT01410669|Randomized clinical trial|randomized clinical trial
5472526|NCT01410669|Depression|depression
5472527|NCT01410656|Survivors|survivors
5472528|NCT01410643|puberty|puberty
5472529|NCT01410643|body composition|body composition
5472531|NCT01410643|obesity|obesity
5472532|NCT01410643|optimization of body composition|optimization of body composition
5472533|NCT01410643|pubertal transition|pubertal transition
5472534|NCT01410604|Metformin|metformin
5472535|NCT01410604|Obesity|obesity
5472536|NCT01410604|Insulin resistance|insulin resistance
5472537|NCT01410604|Interleukin six|interleukin six
5472538|NCT01410604|Adiponectin|adiponectin
5472539|NCT01410604|High sensitivity C reactive protein.|high sensitivity c reactive protein.
5472540|NCT01410604|Tumour Necrosis Factor alpha|tumour necrosis factor alpha
5472541|NCT01410591|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5472542|NCT01410591|TIPS|tips
5472543|NCT01410591|liver cirrhosis|liver cirrhosis
5472544|NCT01410591|variceal bleeding|variceal bleeding
5472545|NCT01410591|8- or 10-mm covered stent|8- or 10-mm covered stent
5472546|NCT01410578|sTRE-1|stre-1
5472548|NCT01410578|CRP|crp
5472549|NCT01410578|sepsis|sepsis
5472550|NCT01410578|bacteremia|bacteremia
5472551|NCT01410578|FUO|fuo
5472552|NCT01410578|diagnosis|diagnosis
5472553|NCT01410578|prognosis|prognosis
5472554|NCT01410565|Bladder Cancer|bladder cancer
5472555|NCT01410565|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5472557|NCT01410565|Apaziquone|apaziquone
5472558|NCT01410565|EOquin|eoquin
5472559|NCT01410565|GU Cancer|gu cancer
5472560|NCT01410565|TURBT|turbt
5472561|NCT01410552|Primary prevention|primary prevention
5472562|NCT01410552|Secondary prevention|secondary prevention
5472563|NCT01410539|Stent Thrombosis|stent thrombosis
5472564|NCT01410539|Percutaneous Coronary Intervention|percutaneous coronary intervention
5472565|NCT01410539|Bare Metal Stent|bare metal stent
5472566|NCT01410539|Drug Eluting Stent|drug eluting stent
5472567|NCT01410539|Residual Platelet Reactivity|residual platelet reactivity
5472568|NCT01410539|Optical Coherence Tomography|optical coherence tomography
5472569|NCT01410539|OCT|oct
5472570|NCT01410526|VAC|vac
5472571|NCT01410526|Severe abdominal sepsis|severe abdominal sepsis
5472572|NCT01410526|Peritoneal immune reaction|peritoneal immune reaction
5472573|NCT01410526|Peritonitis|peritonitis
5472574|NCT01410526|Immune peritoneal reaction when abdominal sepsis is treated with VAC|immune peritoneal reaction when abdominal sepsis is treated with vac
5472575|NCT01410500|multiple myeloma|multiple myeloma
5472576|NCT01410487|pulmonary circulation|pulmonary circulation
5472577|NCT01410474|Meningococcal|meningococcal
5472578|NCT01410474|ACWY|acwy
5459052|NCT01465360|Diagnosis|diagnosis
5472579|NCT01410474|bacterial meningitis|bacterial meningitis
5472580|NCT01410474|conjugate vaccine|conjugate vaccine
5472581|NCT01410474|healthy|healthy
5472582|NCT01410474|children|children
5472583|NCT01410474|adolescents|adolescents
5472584|NCT01410474|Taiwan|taiwan
5472585|NCT01410461|painful bladder|painful bladder
5472586|NCT01410461|physical therapy|physical therapy
5472587|NCT01410461|levator ani|levator ani
5472588|NCT01410448|Immunosuppression|immunosuppression
5472589|NCT01410448|Kidney transplantation|kidney transplantation
5472590|NCT01410448|everolimus|everolimus
5472591|NCT01410448|safety|safety
5472592|NCT01410422|COPD|copd
5472593|NCT01410422|Bronchiectasis|bronchiectasis
5472594|NCT01410422|Metabolomics|metabolomics
5472595|NCT01410409|Osteoarthritis, Knee|osteoarthritis, knee
5472596|NCT01410409|Treatment Outcome|treatment outcome
5472597|NCT01410409|Time Factors|time factors
5472598|NCT01410409|Arthroplasty, Replacement|arthroplasty, replacement
5472599|NCT01410409|Rehabilitation|rehabilitation
5472600|NCT01410409|Combined Modality Therapy|combined modality therapy
5472601|NCT01410409|Middle Aged|middle aged
5472602|NCT01410409|Aged|aged
5472603|NCT01410409|Aged, 80 and over|aged, 80 and over
5472604|NCT01410409|Male|male
5472605|NCT01410409|Female|female
5472606|NCT01410409|Humans|humans
5472607|NCT01410409|Analysis of Variance|analysis of variance
5472608|NCT01410396|Atrial Fibrillation|atrial fibrillation
5472609|NCT01410396|Stroke|stroke
5472610|NCT01410383|hypercholesterolemia,|hypercholesterolemia,
5472611|NCT01410383|dyslipidemia,|dyslipidemia,
5472612|NCT01410383|thyroid,|thyroid,
5472613|NCT01410383|safety,|safety,
5472614|NCT01410383|Heterozygous Familial Hypercholesterolaemia|heterozygous familial hypercholesterolaemia
5472615|NCT01410383|coronary artery disease|coronary artery disease
5472616|NCT01410370|Endostar|endostar
5472617|NCT01410370|Radiotherapy|radiotherapy
5472618|NCT01410370|Brain Metastases|brain metastases
5472619|NCT01410357|serious mental illness|serious mental illness
5472620|NCT01410357|diabetes|diabetes
5472621|NCT01410344|HIV|hiv
5472622|NCT01410344|ALL|all
5472623|NCT01410344|AML|aml
5472624|NCT01410344|MDS|mds
5472625|NCT01410344|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5472626|NCT01410331|CLI|cli
5472627|NCT01410331|peripheral vascular disease|peripheral vascular disease
5472628|NCT01410331|PVD|pvd
5472629|NCT01410331|PAD|pad
5472630|NCT01410331|SDF-1|sdf-1
5472631|NCT01410318|Atherosclerosis|atherosclerosis
5472632|NCT01410318|PESA|pesa
5472633|NCT01410318|Subclinical|subclinical
5472634|NCT01410318|Cardiovascular diseases|cardiovascular diseases
5472635|NCT01410318|Coronary disease|coronary disease
5472636|NCT01410318|Heart diseases|heart diseases
5472637|NCT01410318|Heart Failure|heart failure
5472638|NCT01410318|Myocardial Infarction|myocardial infarction
5472640|NCT01410318|Arteriosclerosis|arteriosclerosis
5472641|NCT01410305|Vitamin D Deficiency|vitamin d deficiency
5472642|NCT01410305|HIV+ Children|hiv+ children
5472643|NCT01410305|HIV+ Young Adults|hiv+ young adults
5472644|NCT01410292|fiber|fiber
5472645|NCT01410292|glycemic index|glycemic index
5472646|NCT01410292|glycemic response|glycemic response
5472647|NCT01410292|diabetes|diabetes
5472648|NCT01410292|ghrelin|ghrelin
5472649|NCT01410279|pulmonary hypertension|pulmonary hypertension
5472650|NCT01410279|inspiratory muscle training|inspiratory muscle training
5472651|NCT01410279|inspiratory muscle weakness|inspiratory muscle weakness
5472652|NCT01410279|pulmonary functional|pulmonary functional
5472653|NCT01410279|functional capacity|functional capacity
5472654|NCT01410279|quality of life|quality of life
5472655|NCT01410266|medical abortion|medical abortion
5472656|NCT01410266|first trimester|first trimester
5472657|NCT01410266|follow-up|follow-up
5472658|NCT01410266|pregnancy test|pregnancy test
5472659|NCT01410214|NSCLC|nsclc
5467179|NCT01432106|Hypertension|hypertension
5472660|NCT01410214|EGFR Mutation Positive|egfr mutation positive
5472662|NCT01410214|Erlotinib Versus NVB/Cisplatin as Adjuvant treatment|erlotinib versus nvb/cisplatin as adjuvant treatment
5472663|NCT01410201|Epiretinal Membrane|epiretinal membrane
5472664|NCT01410201|Macular Edema|macular edema
5472665|NCT01410201|Dexamethasone Intravitreal Implant (Ozurdex)|dexamethasone intravitreal implant (ozurdex)
5472666|NCT01410201|Pars Plana Vitrectomy|pars plana vitrectomy
5472667|NCT01410188|open-angle glaucoma|open-angle glaucoma
5472668|NCT01410188|glaucoma|glaucoma
5472669|NCT01410188|ocular hypertension|ocular hypertension
5472670|NCT01410188|intraocular pressure|intraocular pressure
5472671|NCT01410162|Renal|renal
5472672|NCT01410162|Kidney/Pancreas|kidney/pancreas
5472673|NCT01410162|Transplant|transplant
5472674|NCT01410162|conversion|conversion
5472675|NCT01410162|bioequivalence|bioequivalence
5472676|NCT01410162|Mycophenolate Acid|mycophenolate acid
5472677|NCT01410149|PAV (proportional assist ventilation); sleep; polysomnography; mechanical ventilation|pav (proportional assist ventilation); sleep; polysomnography; mechanical ventilation
5472678|NCT01410136|Knee|knee
5472679|NCT01410136|Femur|femur
5472680|NCT01410136|Articular cartilage|articular cartilage
5472681|NCT01410136|Lesions|lesions
5472682|NCT01410136|Defects|defects
5472683|NCT01410136|Osteochondral graft|osteochondral graft
5472684|NCT01410136|Cartilage treatments|cartilage treatments
5472685|NCT01410136|Osteochondritis Dissecans|osteochondritis dissecans
5472687|NCT01410110|Substance Abuse|substance abuse
5472688|NCT01410110|Substance Dependence|substance dependence
5472689|NCT01410110|Cognitive Impairment|cognitive impairment
5472690|NCT01410084|vitamin D|vitamin d
5472691|NCT01410084|falls|falls
5472692|NCT01410084|deficiency|deficiency
5472693|NCT01410084|insufficiency|insufficiency
5472694|NCT01410071|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5472695|NCT01410058|HIV|hiv
5472696|NCT01410058|antiretroviral drug interaction|antiretroviral drug interaction
5472697|NCT01410058|herbal medicine|herbal medicine
5472698|NCT01410058|pharmacokinetics|pharmacokinetics
5472699|NCT01410058|herbal pharmacology|herbal pharmacology
5472700|NCT01410045|Turner syndrome|turner syndrome
5472701|NCT01410045|infertility|infertility
5472702|NCT01410045|ovarian insufficiency|ovarian insufficiency
5472703|NCT01410045|ovarian cryopreservation|ovarian cryopreservation
5472704|NCT01410032|clavicle|clavicle
5472705|NCT01410032|clavicular|clavicular
5472706|NCT01410032|fracture|fracture
5472707|NCT01410032|midshaft|midshaft
5472708|NCT01410032|plate|plate
5472709|NCT01410032|ESIN|esin
5472710|NCT01410032|intramedullary|intramedullary
5472711|NCT01410032|flexible|flexible
5472712|NCT01410032|nailing|nailing
5472713|NCT01410019|X-linked Severe Combined Immunodeficiency (SCID-X1)|x-linked severe combined immunodeficiency (scid-x1)
5472714|NCT01410019|severe infection|severe infection
5472715|NCT01410019|gene therapy|gene therapy
5472716|NCT01410019|HLA identical family donor|hla identical family donor
5472717|NCT01410019|without HLA identical unrelated donor|without hla identical unrelated donor
5472718|NCT01410006|NF1|nf1
5472719|NCT01410006|neurofibromatosis|neurofibromatosis
5472720|NCT01410006|NF|nf
5472721|NCT01409993|BMI greater than 25|bmi greater than 25
5472722|NCT01409993|Elevated fasting blood sugar (100-125mg/dL)|elevated fasting blood sugar (100-125mg/dl)
5472723|NCT01409980|delta phalanx|delta phalanx
5472724|NCT01409980|thumb reconstructed|thumb reconstructed
5472725|NCT01409980|triphalangeal thumbs|triphalangeal thumbs
5472726|NCT01409967|Anemia|anemia
5472727|NCT01409967|Transfusion|transfusion
5472728|NCT01409967|Biological markers|biological markers
5472729|NCT01409954|Fusion|fusion
5472730|NCT01409954|Spine|spine
5472731|NCT01409954|Decompression|decompression
5472732|NCT01409954|Pseudarthrosis|pseudarthrosis
5472733|NCT01409954|bone harvest|bone harvest
5472734|NCT01409954|Instrumented posterolateral fusion|instrumented posterolateral fusion
5472735|NCT01409941|cerebral oxygen saturation,|cerebral oxygen saturation,
5472736|NCT01409941|NTproBNP|ntprobnp
5472737|NCT01409941|hsTNT|hstnt
5472738|NCT01409941|GDF-15|gdf-15
5472739|NCT01409928|obesity|obesity
5472740|NCT01409928|adolescent|adolescent
5472741|NCT01409928|pediatric|pediatric
5472742|NCT01409928|weight loss|weight loss
5472743|NCT01409928|bariatric surgery|bariatric surgery
5472744|NCT01409928|gastric banding|gastric banding
5472745|NCT01409915|Alzheimer's disease|alzheimer's disease
5472746|NCT01409915|neuropsychological assessment|neuropsychological assessment
5472747|NCT01409915|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5472748|NCT01409915|Leukine|leukine
5472749|NCT01409876|histoscanning|histoscanning
5472750|NCT01409876|brachytherapy|brachytherapy
5472751|NCT01409863|post surgical or post traumatic scar on face or scalp|post surgical or post traumatic scar on face or scalp
5472752|NCT01409837|Oligospermia|oligospermia
5472753|NCT01409837|Male infertility|male infertility
5472754|NCT01409837|Lisinopril|lisinopril
5472755|NCT01409824|clinical decision support system|clinical decision support system
5472756|NCT01409824|performance based incentives|performance based incentives
5467281|NCT01431677|Muscle|muscle
5472757|NCT01409824|quality of maternal health care services|quality of maternal health care services
5472758|NCT01409798|Hyperparathyroidism|hyperparathyroidism
5472759|NCT01409798|Hypercalcemia|hypercalcemia
5472760|NCT01409785|supraglottic airway devices in children|supraglottic airway devices in children
5472762|NCT01409759|Interposition plasty|interposition plasty
5472763|NCT01409759|Contracture release|contracture release
5472764|NCT01409746|twin|twin
5472765|NCT01409746|brain development|brain development
5472766|NCT01409746|MRI|mri
5472767|NCT01409720|bony metastases|bony metastases
5472768|NCT01409720|physical exercise|physical exercise
5472769|NCT01409694|Alzheimer Disease|alzheimer disease
5472770|NCT01409694|Vitamin D|vitamin d
5472771|NCT01409694|Cholecalciferol|cholecalciferol
5472772|NCT01409694|Memantine|memantine
5472773|NCT01409694|Cognition Disorders|cognition disorders
5472774|NCT01409655|AIDS, HIV, Adherence, Compliance, Contingency management|aids, hiv, adherence, compliance, contingency management
5472775|NCT01409616|Pharmacodynamics|pharmacodynamics
5472776|NCT01409616|darexaban|darexaban
5472777|NCT01409616|Acetyl Salicylic Acid|acetyl salicylic acid
5472778|NCT01409616|clopidogrel|clopidogrel
5472779|NCT01409616|YM150|ym150
5472780|NCT01409616|Phase 1|phase 1
5472781|NCT01409603|Pharmacodynamics|pharmacodynamics
5472782|NCT01409603|darexaban|darexaban
5472783|NCT01409603|naproxen|naproxen
5472784|NCT01409603|YM150|ym150
5472785|NCT01409603|Phase 1|phase 1
5472786|NCT01409590|Schizophrenia|schizophrenia
5472787|NCT01409590|weight gain|weight gain
5472788|NCT01409590|atypical neuroleptics|atypical neuroleptics
5472789|NCT01409577|Coronary stenosis|coronary stenosis
5472790|NCT01409577|stent|stent
5472791|NCT01409577|fractional flow reserve|fractional flow reserve
5472792|NCT01409564|Alzheimer's dementia|alzheimer's dementia
5472793|NCT01409564|Cilostazol|cilostazol
5472794|NCT01409551|Pleural effusion|pleural effusion
5472795|NCT01409551|VATS|vats
5472796|NCT01409551|hyperthermia|hyperthermia
5472797|NCT01409551|thoracostomy|thoracostomy
5472798|NCT01409551|pleurodesis|pleurodesis
5472799|NCT01409512|Heart rate variability, anti cholinergic medication|heart rate variability, anti cholinergic medication
5472800|NCT01409499|hepatocellular carcinoma, treatments, survival|hepatocellular carcinoma, treatments, survival
5472801|NCT01409486|Pompe disease|pompe disease
5472802|NCT01409486|Alpha glucosidase|alpha glucosidase
5472803|NCT01409486|Newborn screening|newborn screening
5472804|NCT01409486|Tandem Mass Spectrometry (LC-MS-MS)|tandem mass spectrometry (lc-ms-ms)
5472805|NCT01409486|The study aims:|the study aims:
5671456|NCT00615966|phosphatidylserine binding|phosphatidylserine binding
5472806|NCT01409486|To establish the control mean values of alpha glucosidase activity in Dry blood spots of Newborn babies from Israel.|to establish the control mean values of alpha glucosidase activity in dry blood spots of newborn babies from israel.
5472807|NCT01409486|To include the alpha glucosidase assay in the newborn screening program in Israel|to include the alpha glucosidase assay in the newborn screening program in israel
5472808|NCT01409473|Prostate cancer|prostate cancer
5472809|NCT01409473|Stereotactic body radiotherapy|stereotactic body radiotherapy
5472810|NCT01409473|Radiosurgery|radiosurgery
5472811|NCT01409473|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5472812|NCT01409473|SBRT|sbrt
5472813|NCT01409473|IMRT|imrt
5472814|NCT01409473|Early-stage prostate cancer|early-stage prostate cancer
5472815|NCT01409473|Low-risk prostate cancer|low-risk prostate cancer
5472816|NCT01409473|Intermediate-risk prostate cancer|intermediate-risk prostate cancer
5472817|NCT01409473|Intraprostatic lesions|intraprostatic lesions
5472818|NCT01409473|IPL|ipl
5472819|NCT01409421|adherence|adherence
5472820|NCT01409421|glaucoma|glaucoma
5472821|NCT01409421|motivational interviewing|motivational interviewing
5472822|NCT01409408|Hypertension|hypertension
5472823|NCT01409408|Diabetes Mellitus|diabetes mellitus
5472824|NCT01409408|Vascular stiffness|vascular stiffness
5472825|NCT01409408|Endothelial function|endothelial function
5472826|NCT01409395|Drug drug interaction|drug drug interaction
5472827|NCT01409382|neonatal hypoglycemia|neonatal hypoglycemia
5472828|NCT01409382|pregnancy|pregnancy
5472829|NCT01409382|physical activity|physical activity
5472830|NCT01409382|sedentary lifestyle|sedentary lifestyle
5472831|NCT01409382|high-glycemic index diet|high-glycemic index diet
5472832|NCT01409382|take-home baby|take-home baby
5472833|NCT01409382|recurrent miscarriages|recurrent miscarriages
5472834|NCT01409382|preterm delivery|preterm delivery
5472835|NCT01409356|Obesity|obesity
5472836|NCT01409356|Portal hypertension|portal hypertension
5472837|NCT01409356|Cirrhosis|cirrhosis
5472838|NCT01409356|Diet|diet
5472839|NCT01409356|Exercise|exercise
5472840|NCT01409343|advanced solid cancers|advanced solid cancers
5472841|NCT01409343|metastatic solid cancers|metastatic solid cancers
5472842|NCT01409330|insulin sensitivity|insulin sensitivity
5472843|NCT01409330|type 2 diabetes|type 2 diabetes
5472844|NCT01409330|diet intervention|diet intervention
5472845|NCT01409317|Major Depression|major depression
5472846|NCT01409317|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5472847|NCT01409317|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5472855|NCT01409304|Naturalistic Trial|naturalistic trial
5472856|NCT01409304|DTMS|dtms
5472857|NCT01409291|low socioeconomic status|low socioeconomic status
5472858|NCT01409291|stress|stress
5472859|NCT01409291|women|women
5472860|NCT01409291|children|children
5472861|NCT01409291|cortisol|cortisol
5472862|NCT01409265|stroke rehabilitation|stroke rehabilitation
5472863|NCT01409265|perceptual deficits|perceptual deficits
5472864|NCT01409252|Stroke|stroke
5472865|NCT01409252|intracerebral hemorrhage|intracerebral hemorrhage
5472866|NCT01409252|surgery|surgery
5472867|NCT01409239|hospital|hospital
5472868|NCT01409239|diabetes|diabetes
5472869|NCT01409239|glycemic variability|glycemic variability
5472870|NCT01409239|autonomic tone|autonomic tone
5472871|NCT01409226|high-risk of breast cancer|high-risk of breast cancer
5472872|NCT01409226|BRCA1 mutation carrier|brca1 mutation carrier
5472873|NCT01409226|BRCA2 mutation carrier|brca2 mutation carrier
5472874|NCT01409226|diagnostic|diagnostic
5472875|NCT01409226|MRI|mri
5472876|NCT01409226|BI-RADS 4|bi-rads 4
5472877|NCT01409226|mammographically occult|mammographically occult
5472879|NCT01409187|Metastatic Melanoma|metastatic melanoma
5472880|NCT01409187|Cytotoxic Drugs|cytotoxic drugs
5472881|NCT01409187|IPI-Biotherapy|ipi-biotherapy
5472882|NCT01409187|Ipilimumab|ipilimumab
5472883|NCT01409187|Yervoy|yervoy
5472884|NCT01409187|BMS-734016|bms-734016
5472885|NCT01409187|MDX010|mdx010
5472886|NCT01409187|Interferon|interferon
5472887|NCT01409187|IFN Alpha-2b|ifn alpha-2b
5472888|NCT01409187|Intron A|intron a
5472889|NCT01409187|Interferon Apha-2b|interferon apha-2b
5472890|NCT01409187|Interleukin-2|interleukin-2
5472891|NCT01409187|IL-2|il-2
5472892|NCT01409187|Aldesleukin|aldesleukin
5472893|NCT01409187|Proleukin|proleukin
5472894|NCT01409174|Melanoma|melanoma
5472895|NCT01409174|Metastatic|metastatic
5472896|NCT01409174|IPI-Biochemotherapy|ipi-biochemotherapy
5472897|NCT01409174|Chemonaive|chemonaive
5472898|NCT01409174|Advanced stage IV|advanced stage iv
5472899|NCT01409174|Unresectable stage III melanoma|unresectable stage iii melanoma
5472900|NCT01409174|1.0 cm or larger|1.0 cm or larger
5472902|NCT01409174|Yervoy|yervoy
5472903|NCT01409174|BMS-734016|bms-734016
5472904|NCT01409174|MDX010|mdx010
5472905|NCT01409174|Interferon Alpha-2b|interferon alpha-2b
5472906|NCT01409174|Intron A|intron a
5472907|NCT01409174|Temozolomide|temozolomide
5472908|NCT01409174|Temodar|temodar
5472909|NCT01409174|Cisplatin|cisplatin
5472910|NCT01409174|Platinol-AQ|platinol-aq
5472911|NCT01409174|Platinol|platinol
5472912|NCT01409174|CDDP|cddp
5472913|NCT01409174|Interleukin-2|interleukin-2
5472914|NCT01409174|IL-2|il-2
5472915|NCT01409174|Aldesleukin|aldesleukin
5472916|NCT01409174|Proleukin|proleukin
5472917|NCT01409148|Radioimmunoimaging|radioimmunoimaging
5472918|NCT01409148|AL Amyloidosis|al amyloidosis
5472919|NCT01409148|PET/CT|pet/ct
5472920|NCT01409135|Nectin 4 protein, humans|nectin 4 protein, humans
5472921|NCT01409135|Cancer|cancer
5472922|NCT01409135|Pharmacokinetics of AGS-22M6E|pharmacokinetics of ags-22m6e
5472923|NCT01409135|Pharmacokinetics of ASG-22CE|pharmacokinetics of asg-22ce
5472924|NCT01409135|Safety|safety
5472925|NCT01409135|Clinical Trial, Phase 1|clinical trial, phase 1
5472926|NCT01409135|ASG-22ME|asg-22me
5472927|NCT01409135|AGS-22M6E|ags-22m6e
5472928|NCT01409135|ASG-22CE|asg-22ce
5472929|NCT01409135|ASG-22C3|asg-22c3
5472930|NCT01409122|vasodilator|vasodilator
5472931|NCT01409122|nitric oxide|nitric oxide
5472932|NCT01409122|sodium nitrite|sodium nitrite
5472933|NCT01409122|sildenafil|sildenafil
5472934|NCT01409122|PDE-5|pde-5
5472935|NCT01409122|pulmonary hypertension|pulmonary hypertension
5472936|NCT01409122|pulmonary arterial hypertension|pulmonary arterial hypertension
5472937|NCT01409109|Schizophrenia|schizophrenia
5472938|NCT01409109|Schizoaffective|schizoaffective
5472939|NCT01409109|Neuroimaging|neuroimaging
5472940|NCT01409109|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5472941|NCT01409109|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5472942|NCT01409109|Spectroscopy|spectroscopy
5472943|NCT01409083|infiltration|infiltration
5472944|NCT01409083|extravasation|extravasation
5467863|NCT01429545|Tocolysis|tocolysis
5472946|NCT01409083|sodium bicarbonate|sodium bicarbonate
5472947|NCT01409070|MDS|mds
5472948|NCT01409057|Inflammation parameters|inflammation parameters
5472949|NCT01409057|Various blood values|various blood values
5472950|NCT01409057|Clinical Outcome|clinical outcome
5472951|NCT01409057|Residence in ICU/ Hospital|residence in icu/ hospital
5472952|NCT01409057|SAPS-Score|saps-score
5472953|NCT01409057|SOFA-Score|sofa-score
5472954|NCT01409057|Duration of artificial respiration|duration of artificial respiration
5472955|NCT01409044|Patient-Controlled Analgesia (PCA)|patient-controlled analgesia (pca)
5472956|NCT01409044|Music Listening|music listening
5472957|NCT01409044|Opioids|opioids
5472958|NCT01409044|Post Surgical Intensive Care Patient|post surgical intensive care patient
5472959|NCT01409044|Patient-Controlled Analgesia|patient-controlled analgesia
5472960|NCT01409031|newborns|newborns
5472961|NCT01409031|respiratory failure|respiratory failure
5472962|NCT01409031|pulmonary hypertension|pulmonary hypertension
5472963|NCT01409031|treatment|treatment
5472964|NCT01409018|pediatric|pediatric
5472965|NCT01409018|cancer|cancer
5472966|NCT01409018|invasive fungal disease|invasive fungal disease
5472967|NCT01409018|antifungal agent|antifungal agent
5472968|NCT01408992|Hearing screening|hearing screening
5472969|NCT01408992|Questionnaire|questionnaire
5472970|NCT01408992|Hearing disability|hearing disability
5472971|NCT01408979|Severe preeclampsia|severe preeclampsia
5472972|NCT01408979|magnesium sulfate|magnesium sulfate
5472973|NCT01408979|anticonvulsivant|anticonvulsivant
5472974|NCT01408966|Dark chocolate|dark chocolate
5472975|NCT01408966|Catechins|catechins
5472976|NCT01408966|Intrahepatic endothelial dysfunction|intrahepatic endothelial dysfunction
5472978|NCT01408966|Portal Hypertension|portal hypertension
5472979|NCT01408953|Keloid|keloid
5472980|NCT01408927|Thienopyridine resistance|thienopyridine resistance
5459469|NCT01463553|recurrence rate|recurrence rate
5472981|NCT01408927|Aspirin resistance|aspirin resistance
5472982|NCT01408927|Platelet reactivity|platelet reactivity
5472983|NCT01408901|peripheral arterial disease|peripheral arterial disease
5472984|NCT01408901|granulocyte macrophage colony stimulating factor|granulocyte macrophage colony stimulating factor
5472985|NCT01408901|PAD|pad
5472986|NCT01408901|GM-CSF|gm-csf
5472987|NCT01408901|sargramostim|sargramostim
5472988|NCT01408901|leukine|leukine
5472989|NCT01408901|treadmill exercise|treadmill exercise
5472990|NCT01408875|Chronic Heart Failure|chronic heart failure
5472991|NCT01408875|Cardiac rehabilitation|cardiac rehabilitation
5472992|NCT01408875|Exercise training|exercise training
5472993|NCT01408875|Peak VO2|peak vo2
5472994|NCT01408875|Electrical myostimulation|electrical myostimulation
5472995|NCT01408862|GLP1|glp1
5472996|NCT01408862|GIP|gip
5472997|NCT01408862|platelets|platelets
5472998|NCT01408862|human|human
5472999|NCT01408862|aggregation|aggregation
5473000|NCT01408849|Endoscopy|endoscopy
5473001|NCT01408849|Herbal medicine|herbal medicine
5473002|NCT01408849|Phytotherapy|phytotherapy
5473003|NCT01408836|Vasculitis|vasculitis
5473004|NCT01408836|ANCA|anca
5473005|NCT01408836|Therapy|therapy
5473006|NCT01408836|Plasma exchange|plasma exchange
5473007|NCT01408836|Immunosuppression|immunosuppression
5473008|NCT01408823|Pediatrics|pediatrics
5473009|NCT01408823|Scoliosis|scoliosis
5473010|NCT01408823|Pharmacokinetics|pharmacokinetics
5473011|NCT01408823|Hemorrhage|hemorrhage
5473012|NCT01408823|Orthopedic Surgery|orthopedic surgery
5473013|NCT01408810|infliximab|infliximab
5473014|NCT01408810|ulcerative colitis|ulcerative colitis
5473015|NCT01408810|histologic remission|histologic remission
5473016|NCT01408797|clonal deletion|clonal deletion
5473017|NCT01408797|kidney transplantation|kidney transplantation
5473018|NCT01408784|calories|calories
5473019|NCT01408784|counting|counting
5473020|NCT01408784|obesity|obesity
5473021|NCT01408784|overweight|overweight
5473022|NCT01408784|categories|categories
5473023|NCT01408784|calorie|calorie
5473024|NCT01408784|method|method
5473025|NCT01408784|counting calories|counting calories
5473026|NCT01408784|lose weight|lose weight
5473027|NCT01408784|diet|diet
5473028|NCT01408784|energy balance|energy balance
5473029|NCT01408784|energy intake|energy intake
5473030|NCT01408784|24 hours recall|24 hours recall
5473031|NCT01408784|food intake|food intake
5473032|NCT01408771|Urodynamics|urodynamics
5473033|NCT01408771|Overactive Bladder|overactive bladder
5473034|NCT01408745|medical device|medical device
5473035|NCT01408745|sternal closure|sternal closure
5473036|NCT01408745|sternotomy|sternotomy
5473037|NCT01408745|dehiscence|dehiscence
5473038|NCT01408745|sternal wound healing|sternal wound healing
5473039|NCT01408745|randomized trial|randomized trial
5473040|NCT01408745|steel wire|steel wire
5473041|NCT01408732|Epistaxis|epistaxis
5473042|NCT01408732|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5473044|NCT01408732|Sclerotherapy|sclerotherapy
5473045|NCT01408732|Epistaxis (nosebleeds) due to Hereditary Hemorrhagic Telangiectasia|epistaxis (nosebleeds) due to hereditary hemorrhagic telangiectasia
5473046|NCT01408719|Beta-Glucan|beta-glucan
5473047|NCT01408719|Barley|barley
5473048|NCT01408719|Molecular Weight|molecular weight
5473049|NCT01408719|Viscosity|viscosity
5473050|NCT01408719|Cholesterol|cholesterol
5473051|NCT01408719|Stable isotope|stable isotope
5473052|NCT01408719|Gene-nutrient interaction|gene-nutrient interaction
5473053|NCT01408719|Gut microbiota|gut microbiota
5473054|NCT01408693|hip fracture|hip fracture
5473055|NCT01408693|hemiarthroplasty|hemiarthroplasty
5473056|NCT01408693|endoprosthesis|endoprosthesis
5473057|NCT01408693|elderly|elderly
5473058|NCT01408693|minimally invasive surgery|minimally invasive surgery
5473059|NCT01408693|anterior approach|anterior approach
5473060|NCT01408693|geriatric patients|geriatric patients
5473061|NCT01408680|End-stage Renal Disease|end-stage renal disease
5473062|NCT01408680|Hemodialysis|hemodialysis
5473063|NCT01408680|Cardiovascular Disease|cardiovascular disease
5473064|NCT01408680|Antioxidants|antioxidants
5473065|NCT01408680|Atherosclerosis|atherosclerosis
5473066|NCT01408680|Coenzyme Q10|coenzyme q10
5473067|NCT01408667|insulin sensitivity|insulin sensitivity
5473068|NCT01408667|cardiometabolic risk|cardiometabolic risk
5473069|NCT01408667|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5473070|NCT01408654|Suicidal Ideation|suicidal ideation
5473071|NCT01408654|Loneliness|loneliness
5473072|NCT01408654|Social Support|social support
5473073|NCT01408654|Voluntary Workers|voluntary workers
5473074|NCT01408654|Friends/Companions|friends/companions
5473075|NCT01408654|Prevention|prevention
5473076|NCT01408654|Aged|aged
5473077|NCT01408641|topiramate|topiramate
5473078|NCT01408641|PTSD|ptsd
5473079|NCT01408641|drinking|drinking
5473080|NCT01408641|alcohol|alcohol
5473081|NCT01408602|Rheumatoid Arthritis|rheumatoid arthritis
5473083|NCT01408589|craving|craving
5473084|NCT01408589|mood|mood
5473085|NCT01408589|optimum dose of atomoxetine|optimum dose of atomoxetine
5473086|NCT01408576|Lupus|lupus
5473087|NCT01408576|Monoclonal antibody|monoclonal antibody
5473088|NCT01408576|B-Cell immunotherapy|b-cell immunotherapy
5473089|NCT01408576|Epratuzumab|epratuzumab
5473090|NCT01408563|NHL|nhl
5473091|NCT01408563|lymphoma|lymphoma
5473092|NCT01408563|leukemia|leukemia
5473093|NCT01408563|myelodysplastic disorder|myelodysplastic disorder
5473094|NCT01408563|aplastic anemia|aplastic anemia
5473095|NCT01408550|IVIG in pemphigoid|ivig in pemphigoid
5473096|NCT01408550|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
5473097|NCT01408537|inactivated Japanese encephalitis vaccine|inactivated japanese encephalitis vaccine
5473098|NCT01408537|vero cell|vero cell
5473099|NCT01408537|children|children
5473100|NCT01408537|immunogenicity|immunogenicity
5473101|NCT01408537|safety|safety
5473102|NCT01408524|Hypertension|hypertension
5473103|NCT01408524|emergence|emergence
5473104|NCT01408524|craniotomy|craniotomy
5473105|NCT01408524|Hypertension during the emergence after craniotomy|hypertension during the emergence after craniotomy
5473106|NCT01408498|Testosterone|testosterone
5473107|NCT01408498|Social psychology|social psychology
5473108|NCT01408498|Human behavior|human behavior
5473109|NCT01408459|Prostate cancer prevention|prostate cancer prevention
5473110|NCT01408446|Hypertension|hypertension
5473111|NCT01408446|Menthol|menthol
5473112|NCT01408446|Metabolism|metabolism
5473113|NCT01408433|embryo transfer|embryo transfer
5473114|NCT01408433|in-vitro fertilization (IVF)|in-vitro fertilization (ivf)
5473115|NCT01408433|pre-implantation diagnosis (PGD)|pre-implantation diagnosis (pgd)
5473116|NCT01408433|infertility|infertility
5473117|NCT01408433|single embryo transfer|single embryo transfer
5473118|NCT01408433|two embryo transfer|two embryo transfer
5473119|NCT01408433|double embryo transfer|double embryo transfer
5473120|NCT01408420|Renal insufficiency|renal insufficiency
5473121|NCT01408420|Acute Kidney Injury|acute kidney injury
5473122|NCT01408420|Postoperative|postoperative
5473123|NCT01408420|Extracorporeal Circulation|extracorporeal circulation
5473124|NCT01408420|Heart surgery|heart surgery
5473125|NCT01408407|Patients with anal canal, low rectal or gynecological cancer|patients with anal canal, low rectal or gynecological cancer
5473126|NCT01408394|safety|safety
5473127|NCT01408394|pharmacokinetics|pharmacokinetics
5473128|NCT01408394|controlled release|controlled release
5473129|NCT01408394|formulation|formulation
5473130|NCT01408381|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5473131|NCT01408381|Cell Therapy|cell therapy
5473132|NCT01408381|Bone marrow mononuclear cells|bone marrow mononuclear cells
5473133|NCT01408368|Graves' disease|graves' disease
5473134|NCT01408368|total thyroidectomy|total thyroidectomy
5473135|NCT01408368|bilateral subtotal thyroidectomy|bilateral subtotal thyroidectomy
5473136|NCT01408368|Graves' ophthalmopathy|graves' ophthalmopathy
5473137|NCT01408368|morbidity rate|morbidity rate
5473138|NCT01408342|Alemtuzumab|alemtuzumab
5473139|NCT01408342|Rituximab|rituximab
5473140|NCT01408342|Aplastic anemia|aplastic anemia
5473141|NCT01408342|cyclosporine|cyclosporine
5473142|NCT01408316|Healthy Volunteer|healthy volunteer
5473143|NCT01408316|PX-866|px-866
5473144|NCT01408316|PI3K Inhibitor|pi3k inhibitor
5473145|NCT01408303|dyslipidemia|dyslipidemia
5473146|NCT01408303|hyperlipidemia|hyperlipidemia
5473147|NCT01408303|cardiovascular risk|cardiovascular risk
5473148|NCT01408290|seasonal|seasonal
5473149|NCT01408290|prevention|prevention
5473150|NCT01408290|influenza|influenza
5473151|NCT01408290|infection|infection
5473152|NCT01408290|influenza vaccine|influenza vaccine
5473154|NCT01408290|influenza in humans|influenza in humans
5473155|NCT01408277|Diabetic Foot Ulcers|diabetic foot ulcers
5473156|NCT01408277|Diabetic Foot Wounds|diabetic foot wounds
5473157|NCT01408238|Immunotherapy|immunotherapy
5473158|NCT01408238|Skin prick test|skin prick test
5473159|NCT01408238|Standardization|standardization
5473160|NCT01408238|Secale cereale|secale cereale
5473161|NCT01408225|MGUS|mgus
5473162|NCT01408225|Multiple Myeloma|multiple myeloma
5473163|NCT01408225|Tissue Bank|tissue bank
5473164|NCT01408199|Lenalidomide|lenalidomide
5473165|NCT01408199|Refractory Cutaneous Lupus|refractory cutaneous lupus
5473166|NCT01408186|aspirin|aspirin
5473167|NCT01408186|PPI|ppi
5473168|NCT01408186|H2RA|h2ra
5473169|NCT01408173|caffeine|caffeine
5473170|NCT01408173|apnea|apnea
5473171|NCT01408173|prematurity|prematurity
5473172|NCT01408147|Postpartum weight retention|postpartum weight retention
5473173|NCT01408147|Low income women|low income women
5473174|NCT01408147|WIC|wic
5473175|NCT01408147|Online|online
5473176|NCT01408134|Inter-reader variability of myocardial viability imaging|inter-reader variability of myocardial viability imaging
5473177|NCT01408121|Platelet reactivity|platelet reactivity
5473178|NCT01408121|Genotyping|genotyping
5473179|NCT01408108|Hiatal hernia|hiatal hernia
5473180|NCT01408108|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5473181|NCT01408108|Laparoscopic hiatal repair|laparoscopic hiatal repair
5685317|NCT00556543|Rib Fracture|rib fracture
5444630|NCT01525355|EUS|eus
5473182|NCT01408108|Laparoscopic anti-reflux surgery|laparoscopic anti-reflux surgery
5473183|NCT01408108|Partially absorbable lightweight mesh|partially absorbable lightweight mesh
5473185|NCT01408095|glimepiride|glimepiride
5473186|NCT01408095|diabetes type II|diabetes type ii
5473187|NCT01408095|diabetes type 2|diabetes type 2
5473188|NCT01408095|Type 2 diabetes|type 2 diabetes
5473189|NCT01408095|diabetes mellitus|diabetes mellitus
5473190|NCT01408069|headache|headache
5473191|NCT01408069|migraine|migraine
5473192|NCT01408056|Hemangioma|hemangioma
5473193|NCT01408056|Infantile Hemangioma|infantile hemangioma
5473194|NCT01408056|Ulcerated Hemangioma|ulcerated hemangioma
5473195|NCT01408056|Timolol|timolol
5473196|NCT01408056|Beta blocker|beta blocker
5473197|NCT01408056|Vascular anomaly|vascular anomaly
5473198|NCT01408030|epistaxis|epistaxis
5473199|NCT01408030|HHT|hht
5473200|NCT01408030|bevacizumab|bevacizumab
5473201|NCT01408030|tranexamic acid|tranexamic acid
5473202|NCT01408030|nosebleed|nosebleed
5473203|NCT01408030|estrogen|estrogen
5473204|NCT01408004|Renal carcinoma|renal carcinoma
5473205|NCT01408004|Resistance|resistance
5473206|NCT01408004|Reversible|reversible
5473207|NCT01408004|Translational|translational
5473208|NCT01407991|Enteral tube placement|enteral tube placement
5473210|NCT01407978|Pandemic vaccine|pandemic vaccine
5473211|NCT01407978|Seasonal vaccine|seasonal vaccine
5473212|NCT01407978|Prevention|prevention
5473213|NCT01407978|Influenza vaccine|influenza vaccine
5473214|NCT01407978|Influenza in humans|influenza in humans
5473215|NCT01407978|Pandemic influenza in humans|pandemic influenza in humans
5473216|NCT01407978|Influenza vaccine for children|influenza vaccine for children
5473217|NCT01407978|Influenza vaccine for adolescents|influenza vaccine for adolescents
5473218|NCT01407978|Seasonal vaccine for children|seasonal vaccine for children
5473219|NCT01407978|Seasonal vaccine for adolescents|seasonal vaccine for adolescents
5473220|NCT01407965|obesity|obesity
5473221|NCT01407965|pharmacokinetic|pharmacokinetic
5473222|NCT01407965|ertapenem|ertapenem
5473223|NCT01407965|meropenem|meropenem
5473224|NCT01407952|treatment trial|treatment trial
5473225|NCT01407952|cerebral aneurysm|cerebral aneurysm
5473226|NCT01407952|randomized|randomized
5473227|NCT01407952|coils|coils
5473228|NCT01407952|endovascular|endovascular
5473229|NCT01407952|HEAT|heat
5473230|NCT01407952|bare platinum|bare platinum
5473231|NCT01407952|Hydrogel|hydrogel
5473232|NCT01407952|Hydrocoil|hydrocoil
5473233|NCT01407939|Bitter Taste|bitter taste
5473234|NCT01407939|Bitter Blockers|bitter blockers
5473235|NCT01407939|Pediatric Medications|pediatric medications
5473236|NCT01407939|Sensory methodology|sensory methodology
5473237|NCT01407939|Children|children
5473238|NCT01407926|Depression|depression
5473239|NCT01407926|Aging|aging
5473240|NCT01407926|Clinical Effectiveness|clinical effectiveness
5473241|NCT01407926|Home Care|home care
5473242|NCT01407926|Nurse-Led|nurse-led
5473243|NCT01407900|CD NP|cd np
5473244|NCT01407900|dual receptor|dual receptor
5473245|NCT01407900|NPR A|npr a
5473246|NCT01407900|NPR B|npr b
5473247|NCT01407900|Adult, aged over 45|adult, aged over 45
5473248|NCT01407887|children|children
5473249|NCT01407874|Gout|gout
5473250|NCT01407874|Hyperuricemia|hyperuricemia
5473251|NCT01407874|Arthritis|arthritis
5473252|NCT01407874|Joint Disease|joint disease
5473253|NCT01407874|Allopurinol|allopurinol
5473254|NCT01407874|Renal Insufficiency|renal insufficiency
5473255|NCT01407835|Immunotherapy|immunotherapy
5473257|NCT01407835|Standardization|standardization
5473258|NCT01407835|Dactylis glomerata|dactylis glomerata
5473259|NCT01407822|Lung cancer|lung cancer
5473260|NCT01407822|IIIA-N2|iiia-n2
5473261|NCT01407822|Neo-adjuvant treatment|neo-adjuvant treatment
5473262|NCT01407822|EGFR mutations|egfr mutations
5473263|NCT01407822|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5473264|NCT01407796|lung inflammation|lung inflammation
5473265|NCT01407796|positron emission tomography (PET)|positron emission tomography (pet)
5473266|NCT01407796|fluorodeoxyglucose (FDG)|fluorodeoxyglucose (fdg)
5473267|NCT01407796|inducible nitric oxide synthase (iNOS)|inducible nitric oxide synthase (inos)
5473268|NCT01407796|lung anti-inflammatory therapy|lung anti-inflammatory therapy
5473269|NCT01407783|Post-partum depression|post-partum depression
5473270|NCT01407783|Low-income mothers|low-income mothers
5473271|NCT01407783|home nurse visitation|home nurse visitation
5473272|NCT01407770|radiation toxicity|radiation toxicity
5473273|NCT01407770|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5473274|NCT01407770|pain|pain
5473275|NCT01407770|fatigue|fatigue
5473276|NCT01407770|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5473277|NCT01407770|depression|depression
5473278|NCT01407770|cognitive/functional effects|cognitive/functional effects
5473279|NCT01407770|stage IA breast cancer|stage ia breast cancer
5473280|NCT01407770|stage IB breast cancer|stage ib breast cancer
5473281|NCT01407770|stage II breast cancer|stage ii breast cancer
5473282|NCT01407770|stage IIIA breast cancer|stage iiia breast cancer
5473283|NCT01407770|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5473284|NCT01407757|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5473285|NCT01407757|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5473286|NCT01407757|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5473287|NCT01407757|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5473288|NCT01407757|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5473289|NCT01407757|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5473290|NCT01407757|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5473291|NCT01407757|adult acute basophilic leukemia|adult acute basophilic leukemia
5473292|NCT01407757|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5473293|NCT01407757|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5473294|NCT01407757|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5671457|NCT00615940|HER2negative|her2negative
5473295|NCT01407757|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5473296|NCT01407757|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5473297|NCT01407757|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5473298|NCT01407757|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5473299|NCT01407757|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5473300|NCT01407757|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5473301|NCT01407757|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5473302|NCT01407757|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5473303|NCT01407757|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5473304|NCT01407757|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5473305|NCT01407757|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5473306|NCT01407757|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5473307|NCT01407757|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5680284|NCT00578370|Plaque type psoriasis|plaque type psoriasis
5473308|NCT01407757|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5473309|NCT01407757|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5473310|NCT01407757|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5473311|NCT01407757|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5473312|NCT01407757|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5473313|NCT01407757|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5473314|NCT01407731|disseminated neuroblastoma|disseminated neuroblastoma
5473315|NCT01407731|localized resectable neuroblastoma|localized resectable neuroblastoma
5473316|NCT01407731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5473317|NCT01407731|stage 4S neuroblastoma|stage 4s neuroblastoma
5473318|NCT01407718|Knee pain|knee pain
5473319|NCT01407718|tibial nailing|tibial nailing
5473320|NCT01407705|spinal cord injury with traumatic event|spinal cord injury with traumatic event
5473321|NCT01407692|menstrual cycle|menstrual cycle
5473322|NCT01407692|estrogen|estrogen
5473323|NCT01407679|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5473324|NCT01407679|discoid lupus erythematosus|discoid lupus erythematosus
5473325|NCT01407679|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus
5473727|NCT01406171|Midazolam|midazolam
5473326|NCT01407679|lupus erythematosus tumidus|lupus erythematosus tumidus
5473327|NCT01407666|paravertebral block|paravertebral block
5473328|NCT01407666|epidural block|epidural block
5473329|NCT01407666|pain management|pain management
5473330|NCT01407666|liver resection|liver resection
5473331|NCT01407666|comparison|comparison
5473332|NCT01407653|Low back pain|low back pain
5473333|NCT01407653|virtual reality|virtual reality
5473334|NCT01407640|Insulin allergy|insulin allergy
5473335|NCT01407640|adverse drug reaction|adverse drug reaction
5473336|NCT01407640|diabetes|diabetes
5473337|NCT01407640|type 1 hypersensitivity|type 1 hypersensitivity
5473338|NCT01407640|immediate hypersensitivity|immediate hypersensitivity
5473339|NCT01407640|type 4 hypersensitivity|type 4 hypersensitivity
5473340|NCT01407640|insulin analogs|insulin analogs
5473341|NCT01407640|intradermal testing|intradermal testing
5473342|NCT01407640|insulin antibody|insulin antibody
5473343|NCT01407640|mast cell|mast cell
5473344|NCT01407640|CD+ TCELL|cd+ tcell
5473345|NCT01407627|human|human
5473346|NCT01407627|fructose|fructose
5473347|NCT01407627|dextrose|dextrose
5473348|NCT01407627|renin angiotensin system|renin angiotensin system
5473349|NCT01407627|kidney|kidney
5473350|NCT01407627|renal hemodynamics|renal hemodynamics
5473351|NCT01407614|Subarachnoid hemorrhage|subarachnoid hemorrhage
5473352|NCT01407614|delayed cerebral ischemia|delayed cerebral ischemia
5473353|NCT01407614|external lumbar drainage|external lumbar drainage
5473354|NCT01407614|vasospasm|vasospasm
5473355|NCT01407601|vitamin K|vitamin k
5473356|NCT01407601|MK-7|mk-7
5473357|NCT01407601|Hemodialysis|hemodialysis
5473358|NCT01407601|vascular calcification|vascular calcification
5473359|NCT01407601|Matrix Gla protein|matrix gla protein
5473360|NCT01407601|Osteocalcin|osteocalcin
5473361|NCT01407588|Atrial fibrillation|atrial fibrillation
5473362|NCT01407588|Ablation|ablation
5473363|NCT01407575|Buprenorphine|buprenorphine
5473364|NCT01407575|Receptors, opioid|receptors, opioid
5473365|NCT01407575|Receptors, opioid, kappa|receptors, opioid, kappa
5473366|NCT01407536|Stroke|stroke
5473367|NCT01407536|Thermal Stimulation|thermal stimulation
5473368|NCT01407536|Upper Extremity|upper extremity
5473369|NCT01407536|Motor Recovery|motor recovery
5473370|NCT01407536|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5473371|NCT01407523|Levetiracetam|levetiracetam
5473372|NCT01407523|Infusion|infusion
5473373|NCT01407523|Epilepsy|epilepsy
5473374|NCT01407523|Partial Onset Seizures|partial onset seizures
5473375|NCT01407497|HIV|hiv
5473376|NCT01407497|Vaccine|vaccine
5473377|NCT01407497|DNA|dna
5473378|NCT01407497|Prevention|prevention
5473379|NCT01407484|Infertility|infertility
5473380|NCT01407484|Assisted reproductive technology|assisted reproductive technology
5473381|NCT01407484|Double blind therapeutical trial|double blind therapeutical trial
5473382|NCT01407484|Multicentric study|multicentric study
5473383|NCT01407484|Prospective randomized study|prospective randomized study
5473385|NCT01407471|clobetasol|clobetasol
5473386|NCT01407471|atrophy|atrophy
5473387|NCT01407471|skin|skin
5473388|NCT01407471|epidermis|epidermis
5473389|NCT01407471|wound healing|wound healing
5473390|NCT01407471|mineral corticoid receptor|mineral corticoid receptor
5473391|NCT01407471|spironolactone|spironolactone
5473392|NCT01407445|Menopause|menopause
5473393|NCT01407445|Sexual dysfunction|sexual dysfunction
5473394|NCT01407445|Tribulus|tribulus
5473395|NCT01407445|Sexuality|sexuality
5473396|NCT01407445|Phytotherapeutic Drugs|phytotherapeutic drugs
5473397|NCT01407432|Male infertility|male infertility
5473398|NCT01407432|folic acid|folic acid
5473399|NCT01407432|in VITRO fertilization|in vitro fertilization
5473400|NCT01407432|sperm parameters|sperm parameters
5473401|NCT01407432|MTHFR genotype|mthfr genotype
5473402|NCT01407419|Rheumatoid Arthritis|rheumatoid arthritis
5473404|NCT01407393|obesity|obesity
5473405|NCT01407393|weight loss|weight loss
5473406|NCT01407393|body fat|body fat
5473407|NCT01407393|waste cirumference|waste cirumference
5473408|NCT01407393|satiety|satiety
5473409|NCT01407393|appetite|appetite
5473410|NCT01407380|Advanced malignancies|advanced malignancies
5473411|NCT01407380|solid tumors|solid tumors
5473412|NCT01407380|cancer|cancer
5473413|NCT01407367|patient safety|patient safety
5473414|NCT01407367|chronic kidney disease|chronic kidney disease
5473415|NCT01407367|medical errors|medical errors
5473416|NCT01407354|robotic weight support|robotic weight support
5473417|NCT01407354|aquatic exercise|aquatic exercise
5473418|NCT01407354|incomplete motor spinal cord injury|incomplete motor spinal cord injury
5473419|NCT01407354|ASIA C and D|asia c and d
5473420|NCT01407328|shoulder arthroscopic surgery|shoulder arthroscopic surgery
5473421|NCT01407328|respiratory discomfort|respiratory discomfort
5473422|NCT01407328|airway obstruction|airway obstruction
5473423|NCT01407328|restrictive pathology|restrictive pathology
5473424|NCT01407328|diaphragm palsy|diaphragm palsy
5473425|NCT01407315|Continuous subcutaneous glucose monitoring|continuous subcutaneous glucose monitoring
5473426|NCT01407315|Type 1 Diabetes|type 1 diabetes
5473427|NCT01407302|Laryngeal mask airway|laryngeal mask airway
5473436|NCT01407237|visceral fat|visceral fat
5473437|NCT01407224|Exclusive Breastfeeding|exclusive breastfeeding
5473438|NCT01407224|Skin to skin contact|skin to skin contact
5473439|NCT01407224|Cord Clumping|cord clumping
5473440|NCT01407224|Prelactial feeding|prelactial feeding
5473441|NCT01407211|multiple sclerosis|multiple sclerosis
5473442|NCT01407211|Myelin Oligodendrocyte Glycoprotein(MOG)|myelin oligodendrocyte glycoprotein(mog)
5473443|NCT01407211|Vitamin A|vitamin a
5473444|NCT01407211|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5473445|NCT01407211|gene expression|gene expression
5473446|NCT01407211|Th1 Cells|th1 cells
5473447|NCT01407211|Th2 Cells|th2 cells
5473448|NCT01407198|High Risk Chordoma|high risk chordoma
5473449|NCT01407185|heart failure|heart failure
5473450|NCT01407185|quality of life|quality of life
5473451|NCT01407185|fall prevention|fall prevention
5473452|NCT01407185|endurance|endurance
5473453|NCT01407185|resistive training|resistive training
5473455|NCT01407172|Peripheral arterial disease|peripheral arterial disease
5473456|NCT01407172|Hydrogen Sulfide|hydrogen sulfide
5473457|NCT01407172|Gasotransmitter|gasotransmitter
5473458|NCT01407159|type b dissection|type b dissection
5473459|NCT01407159|thoracic stentgraft|thoracic stentgraft
5473460|NCT01407159|aortic stent|aortic stent
5473461|NCT01407159|clinical and technical success|clinical and technical success
5685318|NCT00556543|Rib Fracture Repair|rib fracture repair
5444938|NCT01524016|PET/CT|pet/ct
5473462|NCT01407159|safety and feasibility of E-XL aortic stent|safety and feasibility of e-xl aortic stent
5473463|NCT01407146|acute myocardial infarction|acute myocardial infarction
5473464|NCT01407146|care-seeking behavior|care-seeking behavior
5473465|NCT01407146|acute coronary syndrome|acute coronary syndrome
5473466|NCT01407146|care-seeking delay|care-seeking delay
5473467|NCT01407146|cardiac delay|cardiac delay
5473468|NCT01407146|prehospital delay|prehospital delay
5473469|NCT01407146|acute myocardial infarction & PTSD|acute myocardial infarction & ptsd
5473470|NCT01407146|help seeking behaviors|help seeking behaviors
5473471|NCT01407146|seeking treatment|seeking treatment
5473472|NCT01407146|cardiac patients|cardiac patients
5473473|NCT01407146|decision time|decision time
5473474|NCT01407133|Neuro-otology|neuro-otology
5473475|NCT01407133|Chronic tinnitus|chronic tinnitus
5473476|NCT01407133|Sensory disability|sensory disability
5473477|NCT01407133|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5473478|NCT01407133|Dose escalation|dose escalation
5473479|NCT01407120|Prevention|prevention
5473480|NCT01407120|Divorce|divorce
5473481|NCT01407107|nitroglycerin|nitroglycerin
5473482|NCT01407107|5-flourouracil|5-flourouracil
5473483|NCT01407107|radiation therapy|radiation therapy
5473484|NCT01407107|neo-adjuvant treatment|neo-adjuvant treatment
5473485|NCT01407094|Depression, Major Depressive Disorder, Mood Disorder|depression, major depressive disorder, mood disorder
5473486|NCT01407081|cognitive rehabilitation|cognitive rehabilitation
5473487|NCT01407081|SMART goals|smart goals
5473488|NCT01407081|telehealth|telehealth
5473489|NCT01407055|Coronary Artery Bypass Graft Surgery (CABG)|coronary artery bypass graft surgery (cabg)
5473490|NCT01407055|Patients' Expectations|patients' expectations
5473491|NCT01407055|Coronary Heart Disease|coronary heart disease
5473492|NCT01407055|Illness Perception Intervention|illness perception intervention
5473493|NCT01407055|Randomized Controlled Trial|randomized controlled trial
5473494|NCT01407042|unicondylar knee arthroplasty|unicondylar knee arthroplasty
5473495|NCT01407042|mobile-bearing|mobile-bearing
5473496|NCT01407042|patellofemoral pain|patellofemoral pain
5473497|NCT01407016|metronidazole infusion|metronidazole infusion
5473498|NCT01407003|T2DM, blood glucose, OGTT, LIK066|t2dm, blood glucose, ogtt, lik066
5473499|NCT01406990|aspirin resistance|aspirin resistance
5473500|NCT01406990|hyporesponsive|hyporesponsive
5473501|NCT01406990|CAD|cad
5473502|NCT01406990|women|women
5473503|NCT01406977|Hypophosphatasia|hypophosphatasia
5473504|NCT01406977|HPP|hpp
5473505|NCT01406977|Rathbun's disease|rathbun's disease
5473506|NCT01406964|Chlamidia Antibody test, Hysterosalpyngography, Tubal disease|chlamidia antibody test, hysterosalpyngography, tubal disease
5473507|NCT01406951|sTREM-1|strem-1
5473508|NCT01406951|PCT|pct
5473509|NCT01406951|CPIS|cpis
5473510|NCT01406951|VAP|vap
5473511|NCT01406951|EVC|evc
5473512|NCT01406951|diagnosis|diagnosis
5473513|NCT01406951|prognosis|prognosis
5473514|NCT01406938|Psoriasis|psoriasis
5473515|NCT01406938|plaque|plaque
5473516|NCT01406938|inflammatory skin disease|inflammatory skin disease
5473517|NCT01406938|scaly patches|scaly patches
5473518|NCT01406938|AIN457|ain457
5473519|NCT01406938|secukinumab|secukinumab
5473520|NCT01406938|Moderate to Severe Plaque-type Psoriasis|moderate to severe plaque-type psoriasis
5473521|NCT01406912|Stroke Rehabilitation|stroke rehabilitation
5473522|NCT01406912|Ischemic Stroke|ischemic stroke
5473523|NCT01406912|Virtual Reality|virtual reality
5473524|NCT01406912|Nintendo Wii|nintendo wii
5473525|NCT01406912|Recreational Activity|recreational activity
5473526|NCT01406912|Motor Function|motor function
5473527|NCT01406886|Modifiable environmental|modifiable environmental
5473528|NCT01406886|behavioral factors|behavioral factors
5473529|NCT01406873|Myotonic Dystrophy|myotonic dystrophy
5473530|NCT01406873|Myotonic Dystrophy Type 1 (DM1)|myotonic dystrophy type 1 (dm1)
5473531|NCT01406873|Muscular Dystrophy|muscular dystrophy
5473532|NCT01406873|Mexiletine|mexiletine
5473533|NCT01406860|Headaches|headaches
5473534|NCT01406860|Migraines|migraines
5473535|NCT01406860|Tension headaches|tension headaches
5473536|NCT01406860|Cluster headaches|cluster headaches
5473537|NCT01406847|Spinal Manipulation|spinal manipulation
5473538|NCT01406847|Body-based intervention|body-based intervention
5473539|NCT01406847|Experimental pain|experimental pain
5473541|NCT01406834|Veterans|veterans
5473542|NCT01406834|Killing|killing
5473543|NCT01406834|Military|military
5473545|NCT01406821|platelet-rich-plasma|platelet-rich-plasma
5473546|NCT01406821|platelet|platelet
5473547|NCT01406821|tendinosis|tendinosis
5473548|NCT01406821|tendinitis|tendinitis
5473549|NCT01406821|tendonitis|tendonitis
5473550|NCT01406821|tendinopathy|tendinopathy
5473551|NCT01406821|enthesopathy|enthesopathy
5473552|NCT01406821|muscle|muscle
5473553|NCT01406821|sport|sport
5473554|NCT01406821|tendon|tendon
5473555|NCT01406821|patella|patella
5473556|NCT01406821|patellar tendon|patellar tendon
5473557|NCT01406808|genetic|genetic
5473558|NCT01406808|atherosclerosis|atherosclerosis
5473559|NCT01406808|myocardial infarction|myocardial infarction
5473560|NCT01406808|risk|risk
5473561|NCT01406808|preventive cardiology|preventive cardiology
5473562|NCT01406795|Post Thrombotic Syndrome|post thrombotic syndrome
5473563|NCT01406795|Venous Stasis|venous stasis
5473564|NCT01406795|Venous Occlusions|venous occlusions
5473565|NCT01406795|Venous Stenosis|venous stenosis
5473566|NCT01406782|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5473567|NCT01406782|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5473568|NCT01406782|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5473569|NCT01406782|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5473570|NCT01406743|Spine and pelvis parameters|spine and pelvis parameters
5473571|NCT01406743|Sagittal balance|sagittal balance
5473572|NCT01406743|Database|database
5473573|NCT01406730|running exercise|running exercise
5473574|NCT01406730|cardiac hypertrophy|cardiac hypertrophy
5473576|NCT01406730|maximum oxygen uptake|maximum oxygen uptake
5473577|NCT01406730|intervention|intervention
5473578|NCT01406730|untrained|untrained
5473579|NCT01406730|males|males
5473580|NCT01406717|SPIL1033|spil1033
5473581|NCT01406717|type 2 diabetes mellitus|type 2 diabetes mellitus
5473582|NCT01406691|sleep|sleep
5473583|NCT01406691|delayed sleep phase disorder|delayed sleep phase disorder
5473584|NCT01406691|circadian|circadian
5473586|NCT01406691|adolescent|adolescent
5473587|NCT01406678|remote ischemic preconditioning|remote ischemic preconditioning
5473588|NCT01406678|coronary artery bypass grafting|coronary artery bypass grafting
5473589|NCT01406678|myocardial injury|myocardial injury
5473590|NCT01406665|diabetes|diabetes
5473591|NCT01406665|impaired glucose tolerance|impaired glucose tolerance
5473592|NCT01406652|septic bursitis|septic bursitis
5473593|NCT01406652|bursectomy|bursectomy
5473594|NCT01406652|primary closure|primary closure
5473595|NCT01406639|Hereditary Hemorrhagic Telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5473596|NCT01406639|Nosebleeds|nosebleeds
5473597|NCT01406639|Ranibizumab|ranibizumab
5473598|NCT01406639|Lucentis|lucentis
5473599|NCT01406626|HIV|hiv
5473600|NCT01406626|AIDS|aids
5473601|NCT01406626|Health navigation|health navigation
5473602|NCT01406626|Viral load|viral load
5473603|NCT01406626|Corrections|corrections
5473604|NCT01406613|Observational|observational
5473605|NCT01406613|Bone Density|bone density
5473606|NCT01406613|alendronate|alendronate
5473607|NCT01406613|ibandronate|ibandronate
5473608|NCT01406613|risedronate|risedronate
5473609|NCT01406613|postmenopausal|postmenopausal
5473610|NCT01406613|osteoporosis|osteoporosis
5473611|NCT01406600|recombinant hCG|recombinant hcg
5473612|NCT01406600|poor responder|poor responder
5473613|NCT01406600|oocyte maturity|oocyte maturity
5473615|NCT01406587|Dysuria|dysuria
5473616|NCT01406587|Frequency|frequency
5473617|NCT01406587|Pain|pain
5473618|NCT01406587|Uncomplicated Urinary Tract Infection|uncomplicated urinary tract infection
5473619|NCT01406587|Uncomplicated UTI|uncomplicated uti
5473620|NCT01406587|Urinary Tract Infection|urinary tract infection
5473621|NCT01406587|UTI|uti
5473622|NCT01406587|Burning during urination associated with uncomplicated urinary tract infection|burning during urination associated with uncomplicated urinary tract infection
5473623|NCT01406587|Urination frequency associated with uncomplicated urinary tract infection|urination frequency associated with uncomplicated urinary tract infection
5473724|NCT01406171|Isavuconazole|isavuconazole
5473725|NCT01406171|ASP9766|asp9766
5473624|NCT01406587|Pain associated with uncomplicated urinary tract infection|pain associated with uncomplicated urinary tract infection
5473625|NCT01406574|Hepatocellular carcinoma|hepatocellular carcinoma
5473626|NCT01406561|Meniscectomy|meniscectomy
5473627|NCT01406561|Knee Pain|knee pain
5473628|NCT01406561|Postoperative Pain|postoperative pain
5473629|NCT01406548|Osteopenia|osteopenia
5473630|NCT01406548|osteoporosis|osteoporosis
5473631|NCT01406548|low bone mineral density|low bone mineral density
5473632|NCT01406535|Phosphodiesterase 5 inhibition|phosphodiesterase 5 inhibition
5473633|NCT01406535|myocardial perfusion|myocardial perfusion
5473635|NCT01406535|coronary artery disease|coronary artery disease
5473636|NCT01406535|therapy refractory|therapy refractory
5473637|NCT01406522|Acetylcholine|acetylcholine
5473638|NCT01406522|Cholinesterases|cholinesterases
5473639|NCT01406522|Cocaine|cocaine
5473640|NCT01406522|Self-Administration|self-administration
5473641|NCT01406509|Safety|safety
5473642|NCT01406509|Conjugate vaccine|conjugate vaccine
5473643|NCT01406496|Insulin bolus|insulin bolus
5473644|NCT01406496|glucose excursions|glucose excursions
5473645|NCT01406496|post-prandial|post-prandial
5473646|NCT01406496|timing|timing
5473647|NCT01406496|meal content|meal content
5473648|NCT01406483|Platelet reactivity|platelet reactivity
5473649|NCT01406483|CABG|cabg
5473650|NCT01406483|Perioperative and in hospital bleeding|perioperative and in hospital bleeding
5473651|NCT01406470|IGIV|igiv
5473652|NCT01406470|Primary Immune Deficiency|primary immune deficiency
5473653|NCT01406470|Immunoglobulin G|immunoglobulin g
5473654|NCT01406457|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5460182|NCT01460602|Mantle Cell|mantle cell
5473655|NCT01406444|Anorexia Nervosa|anorexia nervosa
5473656|NCT01406444|Osteopenia|osteopenia
5473657|NCT01406444|Osteoporosis|osteoporosis
5473658|NCT01406444|Bone density|bone density
5473659|NCT01406431|pitavastatin|pitavastatin
5473660|NCT01406431|Livalo|livalo
5476737|NCT01392820|SAD|sad
5473661|NCT01406418|Influenza|influenza
5473662|NCT01406418|Virus|virus
5473663|NCT01406418|Monoclonal|monoclonal
5473664|NCT01406418|Antibody|antibody
5473665|NCT01406418|Immunization|immunization
5473666|NCT01406418|Treatment|treatment
5473667|NCT01406405|Degenerative disc disease|degenerative disc disease
5473668|NCT01406405|spinal stenosis|spinal stenosis
5473669|NCT01406405|herniated disc|herniated disc
5473670|NCT01406392|Misoprostol|misoprostol
5473671|NCT01406392|Sublingual|sublingual
5473672|NCT01406392|Induced|induced
5473673|NCT01406392|Labor|labor
5473674|NCT01406366|Pediatric oral health|pediatric oral health
5473675|NCT01406366|Bright Futures|bright futures
5473676|NCT01406366|Health promotion|health promotion
5473677|NCT01406353|Mitral Stenosis|mitral stenosis
5473678|NCT01406353|Mitral Valvuloplasty|mitral valvuloplasty
5473679|NCT01406314|Phase 1|phase 1
5473680|NCT01406314|Patient|patient
5473681|NCT01406314|Systemic Amyloidosis|systemic amyloidosis
5473683|NCT01406301|prescribing information|prescribing information
5473684|NCT01406288|hemolytic-uremic syndrome|hemolytic-uremic syndrome
5473685|NCT01406288|shiga-toxin-producing E. Coli|shiga-toxin-producing e. coli
5473686|NCT01406262|albiglutide|albiglutide
5473687|NCT01406262|QT interval|qt interval
5473688|NCT01406262|cardiac repolarization|cardiac repolarization
5473689|NCT01406262|ECG study|ecg study
5473690|NCT01406249|unresectable gastric cancer|unresectable gastric cancer
5473691|NCT01406249|recurrent gastric cancer|recurrent gastric cancer
5473692|NCT01406249|StageIV gastric cancer|stageiv gastric cancer
5473693|NCT01406249|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5473694|NCT01406249|XP|xp
5473695|NCT01406249|SP|sp
5473696|NCT01406236|Female|female
5473697|NCT01406236|urgent or elective percutaneous coronary intervention|urgent or elective percutaneous coronary intervention
5473698|NCT01406236|PCI|pci
5473699|NCT01406236|diagnostic angiography|diagnostic angiography
5473700|NCT01406223|Nicotine addiction|nicotine addiction
5473701|NCT01406223|Cigarette smoking|cigarette smoking
5473702|NCT01406223|Smoking cessation|smoking cessation
5473703|NCT01406223|Zyban|zyban
5473704|NCT01406223|Chantix|chantix
5473705|NCT01406223|Nicotine patches|nicotine patches
5473706|NCT01406223|varenicline|varenicline
5473707|NCT01406223|bupropion|bupropion
5473708|NCT01406223|fMRI|fmri
5473709|NCT01406210|Lung Transplant|lung transplant
5473710|NCT01406210|REflux Surgery|reflux surgery
5473711|NCT01406210|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5473712|NCT01406210|Fundoplication|fundoplication
5473713|NCT01406197|Progesterone|progesterone
5473714|NCT01406197|Progestins|progestins
5473715|NCT01406197|Preterm labor|preterm labor
5473716|NCT01406197|Premature birth|premature birth
5473717|NCT01406197|Uterine electromyography|uterine electromyography
5473718|NCT01406197|Uterine contractility|uterine contractility
5473719|NCT01406184|Child Abuse|child abuse
5473720|NCT01406184|Child Neglect|child neglect
5473721|NCT01406184|Child Hospital Emergency Room Presentations|child hospital emergency room presentations
5473722|NCT01406184|Child Well-Care Compliance|child well-care compliance
5473723|NCT01406184|Child Immunization Compliance|child immunization compliance
5473726|NCT01406171|BAL8557|bal8557
5473728|NCT01406171|Healthy volunteers|healthy volunteers
5473729|NCT01406158|Solifenacin succinate|solifenacin succinate
5473730|NCT01406158|VESIcare|vesicare
5473731|NCT01406158|Healthy Volunteers|healthy volunteers
5473732|NCT01406158|YM905|ym905
5473733|NCT01406145|ASP0777|asp0777
5473734|NCT01406145|Alzheimer's Disease|alzheimer's disease
5473735|NCT01406132|ASP015K|asp015k
5473736|NCT01406132|Healthy volunteers|healthy volunteers
5473737|NCT01406106|Hypercholesterolemia|hypercholesterolemia
5473739|NCT01406106|Cardiovascular disease|cardiovascular disease
5473740|NCT01406106|Risks factors|risks factors
5473741|NCT01406106|Primary Care|primary care
5473742|NCT01406093|Candidemia|candidemia
5473743|NCT01406093|Early-onset|early-onset
5473744|NCT01406093|Late-onset|late-onset
5473745|NCT01406093|Health-care associated|health-care associated
5473746|NCT01406093|Nosocomial|nosocomial
5473747|NCT01406080|Photoaging|photoaging
5473748|NCT01406080|Photodamage|photodamage
5473749|NCT01406080|Adapalene|adapalene
5473750|NCT01406080|Differin|differin
5473751|NCT01406067|social skills training,|social skills training,
5473752|NCT01406067|social competence training,|social competence training,
5473753|NCT01406067|Oppositional Defiant Disorder|oppositional defiant disorder
5473754|NCT01406067|peer related aggressive behavior|peer related aggressive behavior
5473755|NCT01406067|randomized controlled trial|randomized controlled trial
5473756|NCT01406054|athletes|athletes
5473757|NCT01406054|injury prevention|injury prevention
5473758|NCT01406054|neuromuscular training|neuromuscular training
5473759|NCT01406054|public school|public school
5473760|NCT01406054|physical education|physical education
5473761|NCT01406054|knee|knee
5473762|NCT01406054|sports|sports
5473763|NCT01406054|ACL|acl
5473764|NCT01406054|KIPP|kipp
5473765|NCT01406041|Fluid and electrolyte imbalance|fluid and electrolyte imbalance
5473766|NCT01406041|Hyponatremia|hyponatremia
5473767|NCT01406041|Hypernatremia|hypernatremia
5473768|NCT01406041|Electrolytes disorder|electrolytes disorder
5473770|NCT01406028|Stress|stress
5473771|NCT01406028|Infertility|infertility
5473772|NCT01406015|Obesity|obesity
5473773|NCT01406015|Insulin resistance|insulin resistance
5473774|NCT01406015|Mineralocorticoid receptor|mineralocorticoid receptor
5473775|NCT01406002|Pharmacokinetics|pharmacokinetics
5473776|NCT01406002|darexaban|darexaban
5473777|NCT01406002|YM150|ym150
5473778|NCT01406002|rifampicin|rifampicin
5473779|NCT01406002|Phase 1|phase 1
5473780|NCT01405989|Pharmacokinetics|pharmacokinetics
5473781|NCT01405989|darexaban|darexaban
5473782|NCT01405989|ketoconazole|ketoconazole
5473783|NCT01405989|Phase 1|phase 1
5473784|NCT01405976|sleep apneas|sleep apneas
5473785|NCT01405976|noninvasive ventilation|noninvasive ventilation
5473787|NCT01405963|Amgen|amgen
5473788|NCT01405963|AMG 157|amg 157
5473789|NCT01405963|Asthma|asthma
5473790|NCT01405898|hypertension|hypertension
5473791|NCT01405898|nitrite|nitrite
5473792|NCT01405898|blood pressure|blood pressure
5473793|NCT01405898|endothelial function|endothelial function
5473794|NCT01405885|Universal Influenza|universal influenza
5473795|NCT01405885|Intradermal DNA vaccine|intradermal dna vaccine
5473796|NCT01405885|Electroporation|electroporation
5473797|NCT01405885|H1 and H5|h1 and h5
5473798|NCT01405885|DNA Vaccination|dna vaccination
5473799|NCT01405885|Influenza|influenza
5473800|NCT01405885|INO-3510|ino-3510
5473801|NCT01405859|Tourette|tourette
5473802|NCT01405859|tic|tic
5473803|NCT01405859|Tourette's|tourette's
5473804|NCT01405859|Tourette syndrome|tourette syndrome
5473805|NCT01405859|Tourette's syndrome|tourette's syndrome
5473806|NCT01405807|Vasculitis|vasculitis
5473807|NCT01405807|ANCA|anca
5473808|NCT01405807|Refractory|refractory
5473809|NCT01405742|Hemophilia|hemophilia
5473810|NCT01405742|Prophylaxis|prophylaxis
5473811|NCT01405742|Recombinant factor VIII|recombinant factor viii
5473812|NCT01405716|Mindfulness|mindfulness
5473813|NCT01405716|Back Pain|back pain
5473814|NCT01405716|Older adults|older adults
5473815|NCT01405703|Clavicle Fractures|clavicle fractures
5473816|NCT01405703|Numbness|numbness
5473817|NCT01405703|Percutaneous plate fixation|percutaneous plate fixation
5473818|NCT01405703|open plate fixation|open plate fixation
5473819|NCT01405703|incision related numbness|incision related numbness
5473820|NCT01405703|union rates|union rates
5473821|NCT01405703|subjective|subjective
5473822|NCT01405703|questionnaire based outcomes|questionnaire based outcomes
5473823|NCT01405703|Diaphyseal|diaphyseal
5473824|NCT01405690|CAD|cad
5473825|NCT01405690|CTCA|ctca
5473826|NCT01405690|multidetector computer tomography (MDCT)|multidetector computer tomography (mdct)
5473827|NCT01405677|Hepatitis A|hepatitis a
5473828|NCT01405677|Vaccination|vaccination
5473829|NCT01405677|Immunisation|immunisation
5473830|NCT01405651|ONO-6950|ono-6950
5473831|NCT01405651|Healthy adult subjects|healthy adult subjects
5473832|NCT01405625|Asthma|asthma
5473833|NCT01405625|Health literacy|health literacy
5473834|NCT01405625|Parent knowledge of appropriate action plan steps|parent knowledge of appropriate action plan steps
5473835|NCT01405599|Ulimorelin|ulimorelin
5473836|NCT01405599|Hepatic Impairment|hepatic impairment
5473837|NCT01405586|elderly|elderly
5473838|NCT01405586|chemotherapy|chemotherapy
5473839|NCT01405573|Child Pugh B|child pugh b
5473840|NCT01405573|first line|first line
5473841|NCT01405547|Gestational Diabetes|gestational diabetes
5473842|NCT01405547|Gestational Hyperglycemia|gestational hyperglycemia
5473843|NCT01405547|Gestational Insulinemia|gestational insulinemia
5473844|NCT01405547|Maternal Obesity|maternal obesity
5473845|NCT01405547|Human Milk|human milk
5473846|NCT01405547|Lactogenesis|lactogenesis
5473847|NCT01405547|Obstetrics|obstetrics
5473848|NCT01405547|Nutrition|nutrition
5473849|NCT01405547|Infant Growth|infant growth
5473850|NCT01405534|Catheterization, Central Venous|catheterization, central venous
5473851|NCT01405521|typhoid vaccine M01ZH09|typhoid vaccine m01zh09
5473852|NCT01405521|Ty21a typhoid vaccine|ty21a typhoid vaccine
5473853|NCT01405508|N01258|n01258
5473854|NCT01405508|Brivaracetam|brivaracetam
5473855|NCT01405508|Epilepsy|epilepsy
5473856|NCT01405508|IV|iv
5473857|NCT01405508|intravenous|intravenous
5473858|NCT01405495|Posttraumatic Stress Disorder|posttraumatic stress disorder
5473859|NCT01405495|Working Memory|working memory
5473860|NCT01405495|Attentional Bias|attentional bias
5473861|NCT01405495|Connectivity|connectivity
5473862|NCT01405495|Structural Neuroimaging|structural neuroimaging
5473863|NCT01405495|Functional Neuroimaging|functional neuroimaging
5473864|NCT01405495|Diffusion Tensor Imaging|diffusion tensor imaging
5473865|NCT01405495|Arterial Spin Labelling|arterial spin labelling
5473866|NCT01405495|Cortisol|cortisol
5473867|NCT01405495|Psychophysiology|psychophysiology
5473868|NCT01405495|Early development of|early development of
5473869|NCT01405482|Botulinum Toxin Type A|botulinum toxin type a
5473870|NCT01405482|Thoracic Outlet Syndrome|thoracic outlet syndrome
5473871|NCT01405469|Achalasia|achalasia
5473872|NCT01405469|Heller myotomy|heller myotomy
5473873|NCT01405469|Dysphagia|dysphagia
5473874|NCT01405469|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5473875|NCT01405456|HIV-infection|hiv-infection
5473876|NCT01405456|eplerenone|eplerenone
5473877|NCT01405456|aldosterone|aldosterone
5473878|NCT01405456|visceral fat|visceral fat
5473879|NCT01405456|lipodystrophy|lipodystrophy
5473880|NCT01405443|Simulator training|simulator training
5473881|NCT01405443|Flexible endoscopy|flexible endoscopy
5473882|NCT01405443|Gastrointestinal endoscopy|gastrointestinal endoscopy
5473883|NCT01405443|Colonoscopy|colonoscopy
5473884|NCT01405443|Training|training
5473885|NCT01405443|Performance|performance
5473886|NCT01405417|Achalasia|achalasia
5473887|NCT01405417|Heller myotomy|heller myotomy
5473888|NCT01405417|Dysphagia|dysphagia
5473889|NCT01405417|Peroral Endoscopic Myotomy|peroral endoscopic myotomy
5473890|NCT01405404|parenting childcare discounts child behavior|parenting childcare discounts child behavior
5473891|NCT01405404|No Intervention Control|no intervention control
5473892|NCT01405404|Intervention no childcare discount|intervention no childcare discount
5473893|NCT01405404|Intervention with childcare discount|intervention with childcare discount
5473894|NCT01405391|Pharma Mar|pharma mar
5473895|NCT01405391|PM01183|pm01183
5473896|NCT01405391|Non-Colorectal Cancer (non-CRC)|non-colorectal cancer (non-crc)
5473897|NCT01405391|Dose finding phase I|dose finding phase i
5473898|NCT01405365|Periodontitis|periodontitis
5473899|NCT01405365|Periodontal diseases|periodontal diseases
5473900|NCT01405365|Obesity|obesity
5473901|NCT01405365|Metronidazole|metronidazole
5473902|NCT01405365|Prognosis|prognosis
5473903|NCT01405365|Probing depth|probing depth
5473904|NCT01405365|Periodontal attachment loss|periodontal attachment loss
5473905|NCT01405352|obesity|obesity
5473906|NCT01405352|vitamin A|vitamin a
5473907|NCT01405352|immune system|immune system
5473908|NCT01405326|rheumatoid arthritis|rheumatoid arthritis
5473909|NCT01405326|biological therapy|biological therapy
5473910|NCT01405326|adalimumab|adalimumab
5473911|NCT01405326|ability to work|ability to work
5473912|NCT01405326|sick leaves|sick leaves
5473913|NCT01405287|stent|stent
5473914|NCT01405287|drug eluting stent|drug eluting stent
5473915|NCT01405287|healing|healing
5473916|NCT01405287|endothelium|endothelium
5473917|NCT01405287|DES|des
5473918|NCT01405287|OCT|oct
5473919|NCT01405287|MI|mi
5473920|NCT01405287|ACS|acs
5473921|NCT01405248|Butylphthalide|butylphthalide
5473922|NCT01405235|Paclitaxel/Topotecan|paclitaxel/topotecan
5473923|NCT01405235|Cisplatin/Topotecan|cisplatin/topotecan
5473924|NCT01405222|exacerbation|exacerbation
5473925|NCT01405222|COPD|copd
5473926|NCT01405222|Cough|cough
5473927|NCT01405209|EKG|ekg
5473928|NCT01405209|AF|af
5473929|NCT01405209|biosignals|biosignals
5473930|NCT01405196|double-blind|double-blind
5473931|NCT01405196|placebo-controlled|placebo-controlled
5473932|NCT01405196|multicenter|multicenter
5473933|NCT01405196|dose-ranging|dose-ranging
5473934|NCT01405196|efficacy|efficacy
5473935|NCT01405196|safety|safety
5473936|NCT01405196|lupus.|lupus.
5473937|NCT01405183|Hepatitis C|hepatitis c
5473938|NCT01405183|Renal Cell Carcinoma|renal cell carcinoma
5473939|NCT01405183|Colorectal Cancer|colorectal cancer
5473945|NCT01405157|bioequivalence study|bioequivalence study
5473946|NCT01405157|methylprednisolone|methylprednisolone
5473948|NCT01405157|tablets|tablets
5473949|NCT01405157|fasting|fasting
5473950|NCT01405144|Photoaging|photoaging
5473951|NCT01405144|Actinic keratosis|actinic keratosis
5473952|NCT01405144|5-fluoruracil|5-fluoruracil
5473953|NCT01405144|Carcinogenesis|carcinogenesis
5473954|NCT01405131|bioequivalence study|bioequivalence study
5473955|NCT01405131|methylprednisolone|methylprednisolone
5473956|NCT01405131|suspension|suspension
5473957|NCT01405131|tablets|tablets
5473958|NCT01405118|Drug-Drug Interaction Healthy Volunteers CP-690|drug-drug interaction healthy volunteers cp-690
5473959|NCT01405118|550 Metformin|550 metformin
5473960|NCT01405092|volume|volume
5473961|NCT01405092|acute kidney injury|acute kidney injury
5473962|NCT01405092|continuous renal replacement|continuous renal replacement
5473968|NCT01405066|Computed Tomography (CT)|computed tomography (ct)
5473969|NCT01405066|Ionizing radiation|ionizing radiation
5473970|NCT01405066|Advanced medical imaging|advanced medical imaging
5473971|NCT01405066|Radiation Dose Audit Reports|radiation dose audit reports
5473972|NCT01405053|Central Nervous System|central nervous system
5473973|NCT01405040|Cardiac|cardiac
5473974|NCT01405040|Output|output
5473975|NCT01405040|Preload|preload
5473976|NCT01405040|Lung|lung
5473977|NCT01405040|Water|water
5473978|NCT01405027|HCV|hcv
5473979|NCT01405027|Genotype1|genotype1
5473980|NCT01405027|Naive|naive
5473981|NCT01405027|Partial responder|partial responder
5473982|NCT01405027|Relapser|relapser
5460472|NCT01459445|hsCRP|hscrp
5473983|NCT01405014|Hold Me Tight|hold me tight
5473984|NCT01405014|Emotionally Focused Therapy|emotionally focused therapy
5473985|NCT01405014|Relationship enhancement|relationship enhancement
5473986|NCT01405014|Couples counseling|couples counseling
5473987|NCT01405014|Marital therapy|marital therapy
5473988|NCT01405014|Acquired brain injury|acquired brain injury
5473989|NCT01405014|Traumatic brain injury|traumatic brain injury
5473990|NCT01405014|Stroke|stroke
5473991|NCT01405001|Emergencies|emergencies
5473992|NCT01405001|War|war
5473993|NCT01405001|Intubation, Intratracheal|intubation, intratracheal
5473994|NCT01404988|Heart Failure|heart failure
5473995|NCT01404988|Telemedicine|telemedicine
5473996|NCT01404988|Medication Adherence|medication adherence
5473997|NCT01404975|Delirium|delirium
5473998|NCT01404975|PVB|pvb
5473999|NCT01404975|PCA|pca
5474000|NCT01404975|Opioid|opioid
5474001|NCT01404975|Aortic Valve replacement|aortic valve replacement
5474002|NCT01404962|Haemophilus influenza type b|haemophilus influenza type b
5474003|NCT01404962|children|children
5474004|NCT01404962|Korea|korea
5474005|NCT01404962|vaccine|vaccine
5474006|NCT01404962|Prevention of haemophilus influenza type b|prevention of haemophilus influenza type b
5474007|NCT01404949|Tretinoin|tretinoin
5474008|NCT01404949|all-trans retinoic acid|all-trans retinoic acid
5474009|NCT01404949|ATRA|atra
5474010|NCT01404949|Vesanoid|vesanoid
5474011|NCT01404949|Arsenic Trioxide|arsenic trioxide
5474012|NCT01404949|ATO|ato
5474013|NCT01404949|Trisenox|trisenox
5474014|NCT01404949|11-040|11-040
5474015|NCT01404936|Lymphoma|lymphoma
5474016|NCT01404936|Hodgkin's Disease|hodgkin's disease
5474017|NCT01404936|Stage III and IV|stage iii and iv
5474018|NCT01404936|Adriamycin|adriamycin
5474019|NCT01404936|Doxorubicin|doxorubicin
5474020|NCT01404936|Rubex|rubex
5474021|NCT01404936|Bleomycin|bleomycin
5474022|NCT01404936|Bleomycin Sulfate|bleomycin sulfate
5474023|NCT01404936|BLM|blm
5474024|NCT01404936|Dacarbazine|dacarbazine
5474025|NCT01404936|DTIC-DOME|dtic-dome
5474026|NCT01404936|Interferon-2A|interferon-2a
5474027|NCT01404936|Interferon-Alfa-2a|interferon-alfa-2a
5474028|NCT01404936|Roferon-A|roferon-a
5474029|NCT01404936|Velban|velban
5474030|NCT01404936|Vinblastine|vinblastine
5474031|NCT01404910|Pregnancy|pregnancy
5474032|NCT01404910|Preeclampsia|preeclampsia
5474033|NCT01404910|Pre-term|pre-term
5474034|NCT01404910|sFlt-1|sflt-1
5474035|NCT01404910|Apheresis|apheresis
5474036|NCT01404910|Hypertension|hypertension
5474037|NCT01404910|Proteinuria|proteinuria
5474038|NCT01404910|VEGF|vegf
5474039|NCT01404897|carbohydrate|carbohydrate
5474040|NCT01404897|DASH diet|dash diet
5474041|NCT01404897|blood pressure|blood pressure
5474042|NCT01404897|cholesterol|cholesterol
5474043|NCT01404884|myopia|myopia
5474044|NCT01404884|astigmatism|astigmatism
5474045|NCT01404884|presbyopia|presbyopia
5474046|NCT01404884|SUPRACOR|supracor
5474047|NCT01404884|multifocal|multifocal
5474048|NCT01404871|OCD|ocd
5474053|NCT01404858|Lifestyle habits|lifestyle habits
5474054|NCT01404845|exudative AMD|exudative amd
5474055|NCT01404845|dietary supplements|dietary supplements
5474056|NCT01404845|macular pigment|macular pigment
5474057|NCT01404845|lutein|lutein
5474058|NCT01404845|zeaxanthin|zeaxanthin
5474059|NCT01404845|Nutrof total|nutrof total
5474060|NCT01404845|in one eye|in one eye
5474061|NCT01404832|Gastroesophageal reflux|gastroesophageal reflux
5474062|NCT01404832|Proton pump inhibitor|proton pump inhibitor
5474063|NCT01404832|Eosinophilic esophagitis|eosinophilic esophagitis
5474064|NCT01404793|Liver Transplantation|liver transplantation
5474065|NCT01404793|Solid Phase Micro Extraction|solid phase micro extraction
5474066|NCT01404793|Rocuronium|rocuronium
5474067|NCT01404793|Metabolomics|metabolomics
5474068|NCT01404793|Pharmacokinetics|pharmacokinetics
5474069|NCT01404793|Clinical Marker|clinical marker
5474070|NCT01404780|Double lumen ET intubation|double lumen et intubation
5474071|NCT01404780|Laryngoscope|laryngoscope
5474072|NCT01404780|Lung Surgery|lung surgery
5474073|NCT01404767|Vascular surgery|vascular surgery
5474075|NCT01404767|hemodynamic control|hemodynamic control
5474080|NCT01404741|MDS|mds
5474081|NCT01404741|CMML|cmml
5474082|NCT01404741|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5474083|NCT01404741|5-azacytidine|5-azacytidine
5474084|NCT01404728|Vaginal length|vaginal length
5474085|NCT01404728|Sexual dysfunction|sexual dysfunction
5474086|NCT01404715|Drug drug interaction|drug drug interaction
5474087|NCT01404702|Neuroblastoma|neuroblastoma
5474088|NCT01404702|Pediatrics|pediatrics
5474089|NCT01404702|Refractory|refractory
5474090|NCT01404702|Immunotherapy|immunotherapy
5474091|NCT01404702|Biological therapy|biological therapy
5474092|NCT01404702|Lymphocytes|lymphocytes
5474093|NCT01404702|Cancer|cancer
5474094|NCT01404702|Bisphosphonate|bisphosphonate
5474095|NCT01404689|dexmedetomidine|dexmedetomidine
5474096|NCT01404689|midazolam|midazolam
5474097|NCT01404689|ERCP|ercp
5474098|NCT01404689|cholangiopancreatography|cholangiopancreatography
5474099|NCT01404689|sedation|sedation
5474100|NCT01404689|propofol|propofol
5474101|NCT01404676|Glucose variability|glucose variability
5474102|NCT01404676|Oxidative stress|oxidative stress
5474103|NCT01404676|Endothelial cell function|endothelial cell function
5474104|NCT01404663|bone marrow CD133 transplantation side effects|bone marrow cd133 transplantation side effects
5474105|NCT01404663|side effects|side effects
5474106|NCT01404650|GIST|gist
5474107|NCT01404650|Refractory|refractory
5474108|NCT01404650|Gastrointestinal|gastrointestinal
5474109|NCT01404650|Stromal|stromal
5474110|NCT01404650|Tumor|tumor
5474111|NCT01404611|with tubes|with tubes
5474112|NCT01404559|Amputee|amputee
5474113|NCT01404559|Transtibial|transtibial
5474114|NCT01404559|Military|military
5474115|NCT01404559|Gait|gait
5474116|NCT01404559|Rehabilitation|rehabilitation
5474117|NCT01404546|stroke smoking cessation cost-free pharmacotherapy|stroke smoking cessation cost-free pharmacotherapy
5474118|NCT01404533|NTBI|ntbi
5474119|NCT01404533|Iron|iron
5474120|NCT01404533|Absorption|absorption
5474121|NCT01404520|#14 Cancer Related fatigue|#14 cancer related fatigue
5474122|NCT01404520|#13 Quality of Life|#13 quality of life
5474123|NCT01404520|"#12 Psychosocial Intervention[ti/ab]"|"#12 psychosocial intervention[ti/ab]"
5474124|NCT01404520|#11 Rehabilitation[tw]|#11 rehabilitation[tw]
5474125|NCT01404520|"#10 Physical Fitness[tw]"|"#10 physical fitness[tw]"
5474126|NCT01404520|"#9 Physical Activity[tw]"|"#9 physical activity[tw]"
5474127|NCT01404520|"#8 Exercise Therapy[tw]"|"#8 exercise therapy[tw]"
5474129|NCT01404520|#6 Hematologic[tw]|#6 hematologic[tw]
5474130|NCT01404520|#5 Hematological[tw]|#5 hematological[tw]
5474131|NCT01404520|#4 Leukemia, Myeloid, Acute[mh]|#4 leukemia, myeloid, acute[mh]
5474132|NCT01404520|"#3 Acute Myeloid Leukemia[tw]"|"#3 acute myeloid leukemia[tw]"
5474133|NCT01404520|"#2 Acute Lymphoblastic Leukemia[tw]"|"#2 acute lymphoblastic leukemia[tw]"
5474134|NCT01404520|"#1 Acute Leukemia[tw]"|"#1 acute leukemia[tw]"
5474135|NCT01404507|Acute Myocardial Infarction|acute myocardial infarction
5474136|NCT01404494|Haptic Skills|haptic skills
5474137|NCT01404494|Computer Assisted Interface|computer assisted interface
5474138|NCT01404494|TBI|tbi
5474139|NCT01404494|Traumatic Brain Injury|traumatic brain injury
5474140|NCT01404481|Urinary retention|urinary retention
5474141|NCT01404481|CISC|cisc
5474142|NCT01404481|Single use|single use
5474143|NCT01404481|Re use|re use
5474144|NCT01404442|midazolam|midazolam
5458880|NCT01466114|MS|ms
5474145|NCT01404442|ketamine|ketamine
5474146|NCT01404442|intrathecal|intrathecal
5474147|NCT01404442|pain|pain
5474148|NCT01404429|Rheumatoid arthritis|rheumatoid arthritis
5474149|NCT01404429|Active|active
5474150|NCT01404390|Phase I|phase i
5474151|NCT01404390|Japanese|japanese
5474152|NCT01404377|breast surgery : postoperative pain; ropivacaine|breast surgery : postoperative pain; ropivacaine
5474153|NCT01404364|Triamcinolone|triamcinolone
5474154|NCT01404364|Chlorpromazine|chlorpromazine
5474155|NCT01404364|Refractory glaucoma|refractory glaucoma
5474156|NCT01404364|Blind painful eye|blind painful eye
5474157|NCT01404351|Reduction mammaplasty|reduction mammaplasty
5474158|NCT01404351|Breast reduction|breast reduction
5474159|NCT01404351|PlasmaBlade|plasmablade
5474160|NCT01404351|PEAK|peak
5474161|NCT01404325|Lung transplantation|lung transplantation
5474162|NCT01404325|everolimus|everolimus
5474163|NCT01404325|kidney function|kidney function
5474164|NCT01404325|renal function|renal function
5474165|NCT01404299|Frailty,|frailty,
5474166|NCT01404299|nutritional supplementation,|nutritional supplementation,
5474167|NCT01404299|functional status|functional status
5474168|NCT01404260|chemotherapy|chemotherapy
5474169|NCT01404260|maintenance therapy|maintenance therapy
5474170|NCT01404260|gefitinib|gefitinib
5474171|NCT01404247|retina|retina
5474172|NCT01404247|optic nerve|optic nerve
5474173|NCT01404247|fovea|fovea
5474174|NCT01404247|Eyes|eyes
5474175|NCT01404247|Neonates|neonates
5474176|NCT01404234|Cystic fibrosis|cystic fibrosis
5474177|NCT01404234|CF|cf
5474178|NCT01404234|PA|pa
5474179|NCT01404234|Pseudomonas aeruginosa|pseudomonas aeruginosa
5474180|NCT01404234|AZLI|azli
5474181|NCT01404234|aztreonam|aztreonam
5474182|NCT01404234|Chronic Pseudomonas aeruginosa|chronic pseudomonas aeruginosa
5474183|NCT01404195|Nutritional supplement|nutritional supplement
5474184|NCT01404195|CaHMB|cahmb
5474185|NCT01404195|Barthel index|barthel index
5474186|NCT01404195|Frailty|frailty
5474187|NCT01404182|seasonal|seasonal
5474188|NCT01404182|prevention|prevention
5474189|NCT01404182|influenza|influenza
5474190|NCT01404182|infection|infection
5474191|NCT01404182|influenza vaccine|influenza vaccine
5474192|NCT01404182|vaccine|vaccine
5474193|NCT01404182|influenza in humans|influenza in humans
5474194|NCT01404169|Alzheimer Disease|alzheimer disease
5474195|NCT01404169|Dementia|dementia
5474196|NCT01404169|Delirium|delirium
5474197|NCT01404169|Amnestic|amnestic
5474198|NCT01404169|Cognitive Disorders|cognitive disorders
5474199|NCT01404169|Donepezil|donepezil
5474200|NCT01404169|Brain Diseases|brain diseases
5474201|NCT01404169|Central Nervous System Diseases|central nervous system diseases
5474202|NCT01404169|Nervous System Diseases|nervous system diseases
5474203|NCT01404169|Tauopathies|tauopathies
5474204|NCT01404169|Neurodegenerative Diseases|neurodegenerative diseases
5474205|NCT01404169|Mental Disorders|mental disorders
5474206|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors
5474207|NCT01404169|Enzy|enzy
5474208|NCT01404156|Esophageal cancer|esophageal cancer
5474209|NCT01404156|Neoadjuvant|neoadjuvant
5474210|NCT01404156|Chemotherapy|chemotherapy
5474211|NCT01404156|Chemoradiation|chemoradiation
5474213|NCT01404156|Esophagectomy|esophagectomy
5474214|NCT01404156|Adenocarcinoma|adenocarcinoma
5474215|NCT01404156|Gastroesophageal|gastroesophageal
5474216|NCT01404130|isotretinoin|isotretinoin
5474217|NCT01404130|hippocampus|hippocampus
5474218|NCT01404130|memory|memory
5474219|NCT01404130|learning|learning
5474220|NCT01404130|CANTAB|cantab
5474221|NCT01404065|transcranial direct current stimulation|transcranial direct current stimulation
5474222|NCT01404052|transcranial direct current stimulation|transcranial direct current stimulation
5474223|NCT01404052|transcranial ultrasound|transcranial ultrasound
5474224|NCT01404039|learning|learning
5474225|NCT01404039|pain perception|pain perception
5474226|NCT01404026|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5474227|NCT01404013|Montelukast|montelukast
5474228|NCT01404013|Cough variant asthma|cough variant asthma
5474229|NCT01404013|Inhaled Corticosteroid|inhaled corticosteroid
5474230|NCT01403987|Education|education
5474231|NCT01403987|Ascites|ascites
5474232|NCT01403987|Liver|liver
5474233|NCT01403987|Guidelines|guidelines
5474234|NCT01403922|Phase I, Randomised, Placebo-Controlled, Double-Blind,Hypertensive Patients, Blood Pressure, Calcium Channel Blockers, Beta Blockers, ACE Inhibitors|phase i, randomised, placebo-controlled, double-blind,hypertensive patients, blood pressure, calcium channel blockers, beta blockers, ace inhibitors
5474235|NCT01403922|Scientific terminology: To determine if treatment with TC5214 alone or in combination with Anti-Hypertensive Medications has an effect on sitting blood pressure|scientific terminology: to determine if treatment with tc5214 alone or in combination with anti-hypertensive medications has an effect on sitting blood pressure
5474236|NCT01403922|Laymen terminology: Hypertension|laymen terminology: hypertension
5474237|NCT01403896|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5474238|NCT01403896|Plerixafor|plerixafor
5474239|NCT01403896|Healthy Donors|healthy donors
5459042|NCT01465360|AD|ad
5474240|NCT01403896|Stem Cell Graft|stem cell graft
5474241|NCT01403883|Rectal cancer|rectal cancer
5474242|NCT01403883|Temporary stoma|temporary stoma
5474243|NCT01403883|Psychological disorders|psychological disorders
5474244|NCT01403870|Low Back Pain|low back pain
5474245|NCT01403857|Acceptability|acceptability
5474246|NCT01403857|liking|liking
5474446|NCT01403090|Pulmonary Embolism|pulmonary embolism
5474247|NCT01403844|resonance Raman spectroscopy|resonance raman spectroscopy
5474248|NCT01403844|Dietary Guidelines|dietary guidelines
5474249|NCT01403844|fruits|fruits
5474250|NCT01403844|biomarkers|biomarkers
5474251|NCT01403844|carotenoids|carotenoids
5474252|NCT01403844|MyPlate|myplate
5474253|NCT01403844|vegetables|vegetables
5474254|NCT01403818|ASP1941|asp1941
5474255|NCT01403818|ipragliflozin|ipragliflozin
5474256|NCT01403818|Mitiglinide calcium hydrate|mitiglinide calcium hydrate
5474257|NCT01403818|Drug-Drug interaction|drug-drug interaction
5474258|NCT01403818|Pharmacokinetics|pharmacokinetics
5474259|NCT01403805|Oral care|oral care
5474260|NCT01403805|Vaccine|vaccine
5474261|NCT01403805|Pneumonia|pneumonia
5474262|NCT01403805|Elderly|elderly
5474263|NCT01403805|Prevention|prevention
5474264|NCT01403805|Primary care|primary care
5474265|NCT01403792|Human Immunodeficiency Virus|human immunodeficiency virus
5474266|NCT01403792|Neutralising monoclonal antibody|neutralising monoclonal antibody
5474267|NCT01403779|Intensity-Modulated Radiation Therapy (IMRT)|intensity-modulated radiation therapy (imrt)
5474268|NCT01403779|Breast cancer|breast cancer
5474269|NCT01403779|Hypofractionation|hypofractionation
5474270|NCT01403766|pediatric|pediatric
5474271|NCT01403766|kidney|kidney
5474272|NCT01403766|transplant|transplant
5474273|NCT01403766|GFR|gfr
5474274|NCT01403766|creatinine|creatinine
5474275|NCT01403766|cystatin C|cystatin c
5474276|NCT01403766|iohexol|iohexol
5474277|NCT01403753|Obesity|obesity
5474278|NCT01403753|Child|child
5474279|NCT01403753|Dietary Habits|dietary habits
5474280|NCT01403740|acquired haemophilia|acquired haemophilia
5474281|NCT01403740|factor VIII|factor viii
5474282|NCT01403727|Biopsy of liver tumors|biopsy of liver tumors
5474283|NCT01403714|acute heart failure|acute heart failure
5474284|NCT01403701|physical therapy|physical therapy
5474285|NCT01403701|pelvic prolapse|pelvic prolapse
5474286|NCT01403701|incontinence|incontinence
5474287|NCT01403701|quality of life|quality of life
5474411|NCT01403246|No previous treatment|no previous treatment
5474288|NCT01403688|fertility high risk, controlled ovarian stimulation, breast cancer|fertility high risk, controlled ovarian stimulation, breast cancer
5685319|NCT00556543|Rib Fracture ORIF|rib fracture orif
5474289|NCT01403675|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),|women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
5474290|NCT01403675|who are in remission (no recurrence of disease for 5 years),|who are in remission (no recurrence of disease for 5 years),
5474291|NCT01403675|who are in normal organ function and have no contraindication for surgery or pregnancy, and|who are in normal organ function and have no contraindication for surgery or pregnancy, and
5474292|NCT01403675|who wish to restore ovarian function using stored ovarian tissue.|who wish to restore ovarian function using stored ovarian tissue.
5474293|NCT01403662|bipolar disorder|bipolar disorder
5474294|NCT01403662|depression|depression
5474295|NCT01403662|major depression|major depression
5474296|NCT01403662|bipolar I depression|bipolar i depression
5474297|NCT01403662|bipolar II depression|bipolar ii depression
5474298|NCT01403662|bipolar I disorder|bipolar i disorder
5474299|NCT01403662|bipolar II disorder|bipolar ii disorder
5474300|NCT01403662|minocycline|minocycline
5474301|NCT01403662|minocin|minocin
5474302|NCT01403623|Hypothermia|hypothermia
5474303|NCT01403623|Newborn|newborn
5474304|NCT01403623|Resuscitation|resuscitation
5474305|NCT01403623|Plastic bag|plastic bag
5474306|NCT01403610|TH-302|th-302
5474307|NCT01403610|Bevacizumab|bevacizumab
5474308|NCT01403610|Phase 2|phase 2
5474309|NCT01403610|Glioma|glioma
5474310|NCT01403610|High Grade Glioma|high grade glioma
5474311|NCT01403610|CNS|cns
5474312|NCT01403597|Skin wrinkling|skin wrinkling
5474313|NCT01403597|Skin aging|skin aging
5474314|NCT01403597|Skin pigmentation|skin pigmentation
5474315|NCT01403545|Safety|safety
5474316|NCT01403545|Tolerability|tolerability
5474317|NCT01403545|Pharmacokinetics|pharmacokinetics
5474318|NCT01403545|Liposomal Curcumin|liposomal curcumin
5456573|NCT01475448|sedentarism|sedentarism
5474319|NCT01403532|Hypogonadotropic Hypogonadism|hypogonadotropic hypogonadism
5474320|NCT01403532|Kallmann Syndrome|kallmann syndrome
5474321|NCT01403532|LH|lh
5474322|NCT01403532|FSH|fsh
5474323|NCT01403506|kidney transplantation|kidney transplantation
5474324|NCT01403506|N-Acetyl Cysteine|n-acetyl cysteine
5474325|NCT01403506|living donor|living donor
5474326|NCT01403506|delayed graft function|delayed graft function
5474327|NCT01403493|Irritable bowel syndrome|irritable bowel syndrome
5474328|NCT01403493|Patient education|patient education
5474329|NCT01403480|Basal Cell Carcinoma|basal cell carcinoma
5474330|NCT01403467|Bronchial disease|bronchial disease
5459086|NCT01465269|TBI|tbi
5474331|NCT01403467|asthma|asthma
5474332|NCT01403467|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5474333|NCT01403467|Bronchoconstriction|bronchoconstriction
5474334|NCT01403454|chronic kidney disease|chronic kidney disease
5474335|NCT01403454|web-based application|web-based application
5474336|NCT01403454|dialysis education|dialysis education
5474337|NCT01403441|Refractory Bipolar Depression|refractory bipolar depression
5474338|NCT01403428|Asthma|asthma
5474339|NCT01403428|non invasive ventilation|non invasive ventilation
5474340|NCT01403428|pediatrics|pediatrics
5474341|NCT01403428|noninvasive positive pressure ventilation (NPPV)|noninvasive positive pressure ventilation (nppv)
5474342|NCT01403402|Congenital Muscular Dystrophy|congenital muscular dystrophy
5474343|NCT01403402|Congenital Myopathy|congenital myopathy
5474344|NCT01403402|Neuromuscular Diseases|neuromuscular diseases
5474345|NCT01403402|Musculoskeletal Diseases|musculoskeletal diseases
5474346|NCT01403389|Kidney Transplant|kidney transplant
5474347|NCT01403389|Delayed Graft Function|delayed graft function
5474348|NCT01403350|Malaria|malaria
5474349|NCT01403350|Fever|fever
5474350|NCT01403350|Acute febrile illness|acute febrile illness
5474351|NCT01403350|Pneumonia|pneumonia
5474352|NCT01403350|Community health worker|community health worker
5474353|NCT01403350|Rapid diagnostic test|rapid diagnostic test
5474354|NCT01403337|peripheral arterial disease|peripheral arterial disease
5474355|NCT01403337|myocardial infarction|myocardial infarction
5474356|NCT01403324|metastatic or locally advanced differentiated thyroid cancer|metastatic or locally advanced differentiated thyroid cancer
5474357|NCT01403324|planned for a therapeutic activity of 131I after thyroid hormone withdrawal|planned for a therapeutic activity of 131i after thyroid hormone withdrawal
5474358|NCT01403311|Anaplastic astrocytoma|anaplastic astrocytoma
5474359|NCT01403311|Astrocytoma|astrocytoma
5474360|NCT01403311|Brain stem glioma|brain stem glioma
5474361|NCT01403311|Ependymoma|ependymoma
5474363|NCT01403311|Glioblastoma multiforme|glioblastoma multiforme
5474364|NCT01403311|Gliosarcoma|gliosarcoma
5474365|NCT01403311|oligodendroglioma|oligodendroglioma
5474366|NCT01403311|Medulloblastoma|medulloblastoma
5474367|NCT01403311|Mixed astrocytoma-ependymoma|mixed astrocytoma-ependymoma
5474368|NCT01403311|ALA|ala
5474369|NCT01403298|Adolescent|adolescent
5474370|NCT01403298|HIV|hiv
5474371|NCT01403298|AIDS|aids
5474372|NCT01403298|Sexual risk|sexual risk
5474373|NCT01403298|Family|family
5474374|NCT01403298|Prevention|prevention
5474375|NCT01403298|Juvenile Drug Court|juvenile drug court
5474376|NCT01403298|Juvenile Justice|juvenile justice
5474377|NCT01403298|Drug Use|drug use
5474378|NCT01403298|Marijuana|marijuana
5474379|NCT01403285|Glioblastoma|glioblastoma
5474380|NCT01403285|stable disease|stable disease
5474381|NCT01403272|pressure ulcers|pressure ulcers
5474382|NCT01403272|stage 1|stage 1
5474383|NCT01403272|stage 2|stage 2
5474384|NCT01403272|stage 3|stage 3
5474385|NCT01403272|stage 4|stage 4
5474386|NCT01403272|wounds|wounds
5474387|NCT01403272|sores|sores
5474388|NCT01403272|infection|infection
5474389|NCT01403272|bioburden|bioburden
5474390|NCT01403272|bacterial contamination|bacterial contamination
5474391|NCT01403272|bed linen|bed linen
5474392|NCT01403272|sheets|sheets
5474393|NCT01403272|underpad|underpad
5474394|NCT01403272|skin assessment|skin assessment
5474395|NCT01403272|microclimate|microclimate
5474396|NCT01403272|shear|shear
5474397|NCT01403272|friction|friction
5474398|NCT01403272|moisture|moisture
5474399|NCT01403272|fabrics|fabrics
5474400|NCT01403272|long term care|long term care
5474401|NCT01403272|nursing home|nursing home
5474402|NCT01403272|decubitus ulcer|decubitus ulcer
5474403|NCT01403272|bed ridden|bed ridden
5474404|NCT01403272|anti-microbial|anti-microbial
5474405|NCT01403259|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5474406|NCT01403259|S-1|s-1
5474407|NCT01403259|Oxaliplatin|oxaliplatin
5474408|NCT01403246|CLL|cll
5474409|NCT01403246|Lenalidomide|lenalidomide
5474410|NCT01403246|Chlorambucil|chlorambucil
5474412|NCT01403233|Pharmacokinetics|pharmacokinetics
5474413|NCT01403233|Safety|safety
5474414|NCT01403207|Sex differences|sex differences
5474415|NCT01403207|knee joint|knee joint
5474416|NCT01403207|inflammatory mediators|inflammatory mediators
5474417|NCT01403207|Vitamin D|vitamin d
5474418|NCT01403207|osteoarthritis|osteoarthritis
5474419|NCT01403194|Sleep Disordered Breathing|sleep disordered breathing
5474420|NCT01403194|CPAP|cpap
5474421|NCT01403194|BiPAP|bipap
5474422|NCT01403194|Cardiovascular risk markers|cardiovascular risk markers
5474423|NCT01403181|HCV|hcv
5474424|NCT01403181|T cells|t cells
5474425|NCT01403181|cytokines|cytokines
5474426|NCT01403181|cytotoxicity|cytotoxicity
5474427|NCT01403181|proliferation|proliferation
5474428|NCT01403168|Osteopathy|osteopathy
5474429|NCT01403168|Breast cancer|breast cancer
5474430|NCT01403168|Pain|pain
5474431|NCT01403155|H5N1|h5n1
5474432|NCT01403155|Avian Influenza|avian influenza
5474433|NCT01403155|DNA Vaccine|dna vaccine
5474434|NCT01403155|Intradermal (ID) Injection|intradermal (id) injection
5474435|NCT01403155|Electroporation|electroporation
5474436|NCT01403155|Healthy Adults|healthy adults
5474437|NCT01403142|heart transplant|heart transplant
5474438|NCT01403142|vasculopathy|vasculopathy
5474439|NCT01403129|keratoconus|keratoconus
5474440|NCT01403129|keratoconus-suspect|keratoconus-suspect
5474441|NCT01403129|ultrasound exam|ultrasound exam
5474442|NCT01403129|acoustic radiation force ultrasound exam|acoustic radiation force ultrasound exam
5474443|NCT01403116|testosterone|testosterone
5474444|NCT01403116|male hypogonadism|male hypogonadism
5474445|NCT01403116|low testosterone|low testosterone
5474744|NCT01401868|solid tumor|solid tumor
5474451|NCT01403077|Superficial femoral artery|superficial femoral artery
5474452|NCT01403077|Peripheral arterial disease|peripheral arterial disease
5474453|NCT01403077|Atherosclerosis|atherosclerosis
5474454|NCT01403077|Intermittent Claudication|intermittent claudication
5474455|NCT01403077|Vascular Diseases|vascular diseases
5474456|NCT01403077|Cardiovascular Diseases|cardiovascular diseases
5474457|NCT01403064|Oral mucositis; head and neck cancer; chemotherapy; radiotherapy|oral mucositis; head and neck cancer; chemotherapy; radiotherapy
5474458|NCT01403038|healthy volunteers|healthy volunteers
5474459|NCT01403038|elagolix|elagolix
5474460|NCT01403038|endometriosis|endometriosis
5474461|NCT01403038|ovarian reserve|ovarian reserve
5474462|NCT01403038|gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
5474463|NCT01403038|ovulation|ovulation
5474464|NCT01403038|ovarian activity|ovarian activity
5474465|NCT01403012|To identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis|to identify clinical and metabolomic markers that underlie variability in response to systemic therapy in psoriasis
5474466|NCT01403012|To identify metabolomic signatures associated with psoriasis|to identify metabolomic signatures associated with psoriasis
5474467|NCT01403012|To identify possible treatment-specific metabolomic signatures|to identify possible treatment-specific metabolomic signatures
5474468|NCT01402999|Growth disorders|growth disorders
5474470|NCT01402999|Easypod|easypod
5474471|NCT01402999|Growth hormone|growth hormone
5474472|NCT01402999|Pediatric subject|pediatric subject
5474473|NCT01402986|Asthma|asthma
5474474|NCT01402986|Tralokinumab|tralokinumab
5474475|NCT01402986|CAT-354|cat-354
5474476|NCT01402960|High-Definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
5474477|NCT01402908|Hepatocellular Carcinoma|hepatocellular carcinoma
5474478|NCT01402908|PI-88|pi-88
5474479|NCT01402908|Phase III|phase iii
5474480|NCT01402908|Adjuvant Therapy|adjuvant therapy
5474481|NCT01402908|Hepatoma|hepatoma
5474482|NCT01402908|Liver Cancer|liver cancer
5474483|NCT01402895|Nerve conduction|nerve conduction
5474484|NCT01402895|H-reflex, mobilizations|h-reflex, mobilizations
5474485|NCT01402895|with neurodynamic component|with neurodynamic component
5474491|NCT01402869|Methemoglobin|methemoglobin
5474492|NCT01402869|Methemoglobinemia|methemoglobinemia
5474493|NCT01402869|Prilocaine|prilocaine
5474494|NCT01402869|Lidocaine|lidocaine
5474495|NCT01402856|Prevention|prevention
5474496|NCT01402856|Adolescent|adolescent
5474497|NCT01402856|Trauma|trauma
5474498|NCT01402856|Driving|driving
5474499|NCT01402843|phase III combination study|phase iii combination study
5474500|NCT01402830|cancer|cancer
5474501|NCT01402830|depression|depression
5474502|NCT01402830|pain|pain
5474503|NCT01402817|NF1|nf1
5474504|NCT01402817|plexiform neurofibromas|plexiform neurofibromas
5474505|NCT01402817|Sunitinib|sunitinib
5474506|NCT01402817|Sutent®|sutent®
5474507|NCT01402739|PoC|poc
5474509|NCT01402739|Multiplate|multiplate
5474510|NCT01402739|transfusion|transfusion
5474511|NCT01402739|cardiac surgery|cardiac surgery
5474512|NCT01402739|drainage blood loss|drainage blood loss
5474513|NCT01402739|chest tube output|chest tube output
5474514|NCT01402726|renal artery|renal artery
5474515|NCT01402726|sympathetic nerves|sympathetic nerves
5474516|NCT01402726|modification|modification
5474517|NCT01402726|heart failure|heart failure
5474518|NCT01402700|Peripheral arterial disease|peripheral arterial disease
5474519|NCT01402700|claudication|claudication
5474520|NCT01402700|stent|stent
5474521|NCT01402700|VISI-Pro|visi-pro
5474522|NCT01402700|Iliac artery|iliac artery
5474523|NCT01402687|Stem Cell Transplant|stem cell transplant
5474524|NCT01402687|Mucositis|mucositis
5474525|NCT01402674|Obesity treatment|obesity treatment
5474526|NCT01402674|Phentermine|phentermine
5474527|NCT01402674|Withholding treatment|withholding treatment
5474528|NCT01402674|Phentermine dependence|phentermine dependence
5789977|NCT00146302|Mortality|mortality
5474529|NCT01402661|rheumatoid arthritis|rheumatoid arthritis
5474530|NCT01402661|psoriatic arthritis|psoriatic arthritis
5474531|NCT01402661|disease registry|disease registry
5474532|NCT01402648|Non adenomatous mucosa|non adenomatous mucosa
5474533|NCT01402648|Estrogen Receptor beta and apoptosis|estrogen receptor beta and apoptosis
5474534|NCT01402648|Adenoma recurrence|adenoma recurrence
5680285|NCT00578370|Psoriasis plaque test|psoriasis plaque test
5474535|NCT01402648|Screening colonoscopy every 3-5 years|screening colonoscopy every 3-5 years
5474536|NCT01402648|patients at intermediate risk for CRC|patients at intermediate risk for crc
5474537|NCT01402635|crowding|crowding
5474538|NCT01402635|Point-of-Care Systems|point-of-care systems
5474539|NCT01402635|emergency medicine|emergency medicine
5474540|NCT01402609|Continuity of care|continuity of care
5474541|NCT01402609|Patient safety|patient safety
5474542|NCT01402609|Communication between acute and community care providers|communication between acute and community care providers
5474543|NCT01402596|Deep Sedation|deep sedation
5474544|NCT01402596|Pediatrics|pediatrics
5474545|NCT01402596|Emergency Hospital Services|emergency hospital services
5474546|NCT01402596|Midazolam|midazolam
5474547|NCT01402596|Chloral hydrate|chloral hydrate
5474548|NCT01402596|Randomized controlled trial|randomized controlled trial
5474549|NCT01402583|Hepatitis C|hepatitis c
5474550|NCT01402583|Gender|gender
5474551|NCT01402583|Menopause|menopause
5474552|NCT01402583|Sustained viral response|sustained viral response
5474553|NCT01402583|Cytokines|cytokines
5474554|NCT01402570|disability|disability
5474555|NCT01402570|polio|polio
5474556|NCT01402570|rehabilitation|rehabilitation
5474557|NCT01402570|wellness|wellness
5474558|NCT01402557|Obesity|obesity
5474559|NCT01402557|Body Weight Changes|body weight changes
5474560|NCT01402557|Internet|internet
5474561|NCT01402544|AMD|amd
5474562|NCT01402544|Choroidal neovascularization|choroidal neovascularization
5474563|NCT01402544|Ranibizumab|ranibizumab
5474564|NCT01402544|Age-related Macular Degeneration|age-related macular degeneration
5474565|NCT01402544|Genome|genome
5474566|NCT01402531|Hereditary hemorrhagic telangiectasia (HHT)|hereditary hemorrhagic telangiectasia (hht)
5474567|NCT01402531|nosebleed|nosebleed
5474568|NCT01402531|Bevacizumab|bevacizumab
5474569|NCT01402531|Avastin|avastin
5474570|NCT01402518|achalasia|achalasia
5474571|NCT01402518|myotomy|myotomy
5474572|NCT01402518|endoscopic myotomy|endoscopic myotomy
5474573|NCT01402518|difficulty swallowing|difficulty swallowing
5474574|NCT01402505|obesity|obesity
5474583|NCT01402492|addiction|addiction
5474584|NCT01402492|treatment|treatment
5474585|NCT01402492|buprenorphine|buprenorphine
5474586|NCT01402492|naltrexone|naltrexone
5474587|NCT01402492|Suboxone|suboxone
5474588|NCT01402492|Vivitrol|vivitrol
5474589|NCT01402479|migraine,|migraine,
5474590|NCT01402479|ramipril,|ramipril,
5474591|NCT01402479|hypertension|hypertension
5474592|NCT01402466|Drug users|drug users
5474593|NCT01402466|criminal justice|criminal justice
5474594|NCT01402466|HIV care|hiv care
5474595|NCT01402466|HAART|haart
5474596|NCT01402466|incarceration|incarceration
5474597|NCT01402453|Incentives|incentives
5474598|NCT01402453|Social psychology|social psychology
5474599|NCT01402453|Randomized trial|randomized trial
5474600|NCT01402453|Hypertension|hypertension
5474601|NCT01402453|Intervention|intervention
5474602|NCT01402453|Pilot Study|pilot study
5474603|NCT01402440|Diffuse Large B-Cell Lymphoma,|diffuse large b-cell lymphoma,
5474604|NCT01402440|Phase 1,|phase 1,
5474605|NCT01402440|CD79 Mutation|cd79 mutation
5474606|NCT01402427|Coronary Artery Disease|coronary artery disease
5474607|NCT01402427|Coronary Angiography|coronary angiography
5474608|NCT01402427|Percutaneous Coronary Intervention|percutaneous coronary intervention
5474609|NCT01402427|Transradial|transradial
5474610|NCT01402427|Radial Artery Spasm|radial artery spasm
5474611|NCT01402427|Verapamil|verapamil
5474612|NCT01402427|Adverse Effects|adverse effects
5474613|NCT01402414|atopic dermatitis|atopic dermatitis
5474614|NCT01402414|NB-UVB|nb-uvb
5474615|NCT01402414|phototherapy|phototherapy
5474617|NCT01402414|Bath-PUVA|bath-puva
5474618|NCT01402414|SCORAD index|scorad index
5474619|NCT01402401|HER2+,|her2+,
5474620|NCT01402401|Gastric Cancer,|gastric cancer,
5474621|NCT01402401|HSP90,|hsp90,
5474622|NCT01402401|2nd-line,|2nd-line,
5474623|NCT01402401|Trastuzumab|trastuzumab
5474624|NCT01402375|Pain Management|pain management
5474625|NCT01402375|Emergency Medicine|emergency medicine
5474626|NCT01402375|Extremity Injuries|extremity injuries
5474627|NCT01402362|Ethiopians|ethiopians
5474628|NCT01402362|Diabetes Mellitus|diabetes mellitus
5474629|NCT01402362|Glucose tolerance|glucose tolerance
5474630|NCT01402362|Israel|israel
5474631|NCT01402362|Included in the year 2000 study|included in the year 2000 study
5474632|NCT01402349|Chronic rhinosinusitis, SNOT 22, Quality of life|chronic rhinosinusitis, snot 22, quality of life
5474633|NCT01402336|Polycystic ovary syndrome|polycystic ovary syndrome
5474634|NCT01402336|ovulation induction|ovulation induction
5474635|NCT01402336|In vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
5474636|NCT01402310|Onset of labor|onset of labor
5474637|NCT01402310|Bishop score|bishop score
5474638|NCT01402310|Cervical length|cervical length
5474639|NCT01402310|Multiple proteins|multiple proteins
5474640|NCT01402310|Cervicovaginal fluid|cervicovaginal fluid
5474641|NCT01402297|apocynin|apocynin
5474642|NCT01402297|COPD|copd
5474643|NCT01402284|Novel Drug Combinations|novel drug combinations
5474644|NCT01402284|Protease Inhibitors|protease inhibitors
5474647|NCT01402284|Multiple Myeloma|multiple myeloma
5474648|NCT01402271|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5474649|NCT01402271|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5474650|NCT01402271|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5474651|NCT01402245|pneumonia|pneumonia
5474652|NCT01402245|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5474653|NCT01402245|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5474654|NCT01402232|contrast-induced nephropathy|contrast-induced nephropathy
5474655|NCT01402232|contrast medium|contrast medium
5474656|NCT01402232|creatinine clearance|creatinine clearance
5474657|NCT01402232|coronary angiography|coronary angiography
5474658|NCT01402232|diabetes|diabetes
5474659|NCT01402232|chronic kidney disease|chronic kidney disease
5474660|NCT01402232|predictive|predictive
5474661|NCT01402219|contrast-induced nephropathy|contrast-induced nephropathy
5474662|NCT01402219|contrast medium|contrast medium
5474663|NCT01402219|creatinine clearance|creatinine clearance
5474664|NCT01402219|coronary angiography|coronary angiography
5474665|NCT01402219|chronic kidney disease|chronic kidney disease
5474666|NCT01402206|Depression|depression
5474667|NCT01402206|Intervention|intervention
5469170|NCT01424059|fear|fear
5474668|NCT01402206|Primary health care|primary health care
5474669|NCT01402193|Breast Cancer|breast cancer
5474670|NCT01402193|Timing of Radiotherapy|timing of radiotherapy
5474671|NCT01402193|TGF-beta1|tgf-beta1
5474672|NCT01402180|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5474673|NCT01402180|lymph nodes recurrence|lymph nodes recurrence
5474674|NCT01402180|chemoradiation|chemoradiation
5474675|NCT01402180|Nimotuzumab|nimotuzumab
5474676|NCT01402141|Chungkookjang|chungkookjang
5474677|NCT01402141|histamine|histamine
5474678|NCT01402141|skin reaction|skin reaction
5474679|NCT01402141|wheal|wheal
5474680|NCT01402128|Soluble fiber|soluble fiber
5474681|NCT01402128|Polycan|polycan
5474682|NCT01402128|Overweight|overweight
5474683|NCT01402128|LDL-C(Low Density Lipoprotein-cholesterol)|ldl-c(low density lipoprotein-cholesterol)
5474684|NCT01402115|Polycan|polycan
5474685|NCT01402115|Bone metabolism|bone metabolism
5474686|NCT01402115|Osteocalcin|osteocalcin
5474687|NCT01402115|Deoxypyridinoline|deoxypyridinoline
5474688|NCT01402102|Aged garlic|aged garlic
5474689|NCT01402102|Hyperlipidemic|hyperlipidemic
5474691|NCT01402102|HDL|hdl
5474692|NCT01402102|Triglyceride|triglyceride
5474693|NCT01402089|phenotyping|phenotyping
5474694|NCT01402089|cytochrome p450|cytochrome p450
5474695|NCT01402089|erlotinib|erlotinib
5474696|NCT01402089|sunitinib|sunitinib
5474697|NCT01402089|lung cancer|lung cancer
5474698|NCT01402089|renal-cell cancer|renal-cell cancer
5474699|NCT01402089|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5461215|NCT01456403|Carotid|carotid
5474700|NCT01402076|Pharmacokinetics|pharmacokinetics
5474701|NCT01402076|Drug Interaction|drug interaction
5474705|NCT01402050|Time from the start of the induction to delivery|time from the start of the induction to delivery
5474706|NCT01402037|type 1 diabetes|type 1 diabetes
5474707|NCT01402037|Prevention|prevention
5474708|NCT01402037|First degree relatives|first degree relatives
5474709|NCT01402037|High risk for type 1 diabetes|high risk for type 1 diabetes
5474710|NCT01402011|Prolotherapy|prolotherapy
5474711|NCT01402011|regenerative injection therapy|regenerative injection therapy
5474712|NCT01402011|dextrose injections|dextrose injections
5474713|NCT01401998|cystic kidney disease|cystic kidney disease
5474714|NCT01401998|polycystic kidney disease|polycystic kidney disease
5474715|NCT01401998|congenital hepatic fibrosis|congenital hepatic fibrosis
5474716|NCT01401998|genetic disease|genetic disease
5474717|NCT01401985|Opioid induced constipation|opioid induced constipation
5474718|NCT01401985|OIC|oic
5474719|NCT01401985|Constipation|constipation
5474720|NCT01401985|Opioid side effects|opioid side effects
5474721|NCT01401985|morphine induced constipation|morphine induced constipation
5474722|NCT01401972|prostate|prostate
5474723|NCT01401972|cancer|cancer
5474724|NCT01401972|ultrasound|ultrasound
5474725|NCT01401972|spectroscopy|spectroscopy
5474726|NCT01401959|Metastatic Breast Cancer|metastatic breast cancer
5474727|NCT01401959|Adjuvant|adjuvant
5474728|NCT01401959|Residual Disease|residual disease
5474729|NCT01401959|eribulin|eribulin
5474730|NCT01401959|Trastuzumab|trastuzumab
5474731|NCT01401920|internal jugular vein cannulation|internal jugular vein cannulation
5474732|NCT01401920|cross-sectional area|cross-sectional area
5474733|NCT01401920|passive leg elevation|passive leg elevation
5474734|NCT01401920|trendelenburg position|trendelenburg position
5474735|NCT01401920|open heart surgery|open heart surgery
5474736|NCT01401907|Palliative care|palliative care
5474737|NCT01401907|Lung|lung
5474738|NCT01401907|Gastric|gastric
5474739|NCT01401907|Liver|liver
5474740|NCT01401907|Pancreatic|pancreatic
5474741|NCT01401907|Esophageal|esophageal
5474742|NCT01401907|Caregiver|caregiver
5474743|NCT01401894|advanced cancer|advanced cancer
5474745|NCT01401868|recurrent|recurrent
5474746|NCT01401868|advanced|advanced
5474747|NCT01401868|metastatic|metastatic
5474748|NCT01401855|Diagnosis|diagnosis
5474749|NCT01401855|Fine Needle Aspiration Biopsy|fine needle aspiration biopsy
5474750|NCT01401842|low back muscular strength and endurance|low back muscular strength and endurance
5474751|NCT01401829|endometrial cancer|endometrial cancer
5474752|NCT01401829|aerobic walking|aerobic walking
5474753|NCT01401829|stretching/flexibility exercises|stretching/flexibility exercises
5474754|NCT01401829|quality of life|quality of life
5474755|NCT01401816|Adolescents|adolescents
5474756|NCT01401816|Sexually Active|sexually active
5474757|NCT01401816|Unprotected Sex|unprotected sex
5474758|NCT01401816|Emergency Contraception|emergency contraception
5474759|NCT01401803|periorbital|periorbital
5474760|NCT01401803|glabella|glabella
5474761|NCT01401803|ptosis|ptosis
5474762|NCT01401803|eyelid|eyelid
5474763|NCT01401803|brow|brow
5474764|NCT01401790|Children|children
5474765|NCT01401790|Adolescents|adolescents
5474766|NCT01401790|Telehomecare|telehomecare
5474767|NCT01401777|Kidney Tumors, Cryoablation, Biopsy|kidney tumors, cryoablation, biopsy
5474768|NCT01401751|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5474769|NCT01401751|Artificial Pancreas|artificial pancreas
5474770|NCT01401738|Shoulder Arthroscopic Surgery|shoulder arthroscopic surgery
5474771|NCT01401725|venous thromboembolism|venous thromboembolism
5474772|NCT01401725|thromboprophylaxis|thromboprophylaxis
5474773|NCT01401725|anticoagulants|anticoagulants
5474774|NCT01401725|hospitalized medical patients|hospitalized medical patients
5474776|NCT01401725|decision support|decision support
5474777|NCT01401725|knowledge translation|knowledge translation
5474778|NCT01401725|patient safety|patient safety
5474779|NCT01401712|ON-Q|on-q
5474780|NCT01401712|epidural|epidural
5474781|NCT01401712|analgesia|analgesia
5474782|NCT01401699|Barrett's|barrett's
5474783|NCT01401699|esophagus|esophagus
5474784|NCT01401699|OCT|oct
5474785|NCT01401699|imaging|imaging
5474786|NCT01401673|Chronic Cough|chronic cough
5474787|NCT01401673|Indantadol|indantadol
5474788|NCT01401660|low back pain|low back pain
5474789|NCT01401647|cardiac arrest|cardiac arrest
5474790|NCT01401647|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5474791|NCT01401647|ventricular fibrillation|ventricular fibrillation
5474792|NCT01401647|pulseless ventricular tachycardia|pulseless ventricular tachycardia
5474793|NCT01401647|Non-traumatic Out of Hospital Cardiac Arrest (OOHCA)|non-traumatic out of hospital cardiac arrest (oohca)
5474794|NCT01401634|Hyperglycemia Hydration|hyperglycemia hydration
5474795|NCT01401621|behavioral economics|behavioral economics
5474796|NCT01401621|nudge|nudge
5474797|NCT01401621|scratch off|scratch off
5474798|NCT01401621|blood pressure check|blood pressure check
5474799|NCT01401621|cholesterol test|cholesterol test
5474800|NCT01401608|VT|vt
5474801|NCT01401608|ventricular tachycardia|ventricular tachycardia
5474802|NCT01401608|ablation|ablation
5474803|NCT01401608|magnetic navigation|magnetic navigation
5474804|NCT01401608|robotic|robotic
5474805|NCT01401582|health care|health care
5474806|NCT01401582|dementia care|dementia care
5474807|NCT01401582|caregiver support|caregiver support
5474808|NCT01401582|epidemiological study|epidemiological study
5474809|NCT01401569|Exercise,|exercise,
5474810|NCT01401569|counseling,|counseling,
5474811|NCT01401569|smoking cessation,|smoking cessation,
5474812|NCT01401569|depressive disorders|depressive disorders
5474813|NCT01401556|osteoporosis|osteoporosis
5474814|NCT01401556|fracture|fracture
5474815|NCT01401556|treatment|treatment
5474816|NCT01401556|guidelines|guidelines
5474817|NCT01401556|quality|quality
5474818|NCT01401543|testosterone|testosterone
5474819|NCT01401543|energy|energy
5474820|NCT01401543|libido|libido
5474821|NCT01401543|erectile function|erectile function
5474822|NCT01401543|weak muscles|weak muscles
5474823|NCT01401530|Neoplasms|neoplasms
5474824|NCT01401530|Neoplasms by Histologic Type|neoplasms by histologic type
5474825|NCT01401530|Lymphoma|lymphoma
5474826|NCT01401530|Non-Hodgkin|non-hodgkin
5474827|NCT01401530|T- Cell|t- cell
5474828|NCT01401530|Lymphatic Diseases|lymphatic diseases
5474829|NCT01401530|Lymphoproliferative Disorders|lymphoproliferative disorders
5474830|NCT01401530|lmmune System Diseases|lmmune system diseases
5474831|NCT01401530|lmmunoproliferative Disorders|lmmunoproliferative disorders
5474832|NCT01401504|Anti-cancer|anti-cancer
5474833|NCT01401504|ASP3026|asp3026
5474834|NCT01401504|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
5474835|NCT01401491|schizophrenia|schizophrenia
5474836|NCT01401491|clozapine|clozapine
5474837|NCT01401491|fluvoxamine|fluvoxamine
5474838|NCT01401491|metabolic syndrome|metabolic syndrome
5474839|NCT01401478|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5474840|NCT01401478|Chronic Renal Insufficiency|chronic renal insufficiency
5680286|NCT00578370|Sonography|sonography
5474841|NCT01401465|perennial allergic rhinitis|perennial allergic rhinitis
5474843|NCT01401452|Monoclonals|monoclonals
5474844|NCT01401452|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5474948|NCT01400945|heartburn|heartburn
5474845|NCT01401452|Psoriasis Area & Severity Index (PASI)|psoriasis area & severity index (pasi)
5474846|NCT01401452|Adalimumab|adalimumab
5474847|NCT01401452|Biological disease modifying anti-rheumatic drugs (BDMARD)|biological disease modifying anti-rheumatic drugs (bdmard)
5474848|NCT01401452|Co-morbidities|co-morbidities
5474849|NCT01401452|Antibodies|antibodies
5474850|NCT01401452|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
5474851|NCT01401439|cystic fibrosis|cystic fibrosis
5474852|NCT01401439|body mass index|body mass index
5474853|NCT01401439|fat free mass|fat free mass
5474854|NCT01401439|Children with cystic fibrosis|children with cystic fibrosis
5474855|NCT01401426|overweight|overweight
5474856|NCT01401426|Obesity, Morbid|obesity, morbid
5474857|NCT01401374|Vitiligo Vulgaris|vitiligo vulgaris
5474858|NCT01401374|Autoimmunity|autoimmunity
5474859|NCT01401374|Thyroid Disease|thyroid disease
5474860|NCT01401296|Depression|depression
5474861|NCT01401296|Online-Therapy|online-therapy
5474862|NCT01401296|Deprexis|deprexis
5474863|NCT01401296|Self-help|self-help
5474864|NCT01401257|PXT3003|pxt3003
5474865|NCT01401257|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
5474866|NCT01401257|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
5474867|NCT01401231|depression|depression
5474868|NCT01401231|pregnancy|pregnancy
5474869|NCT01401218|thoracic aortic surgery|thoracic aortic surgery
5474870|NCT01401218|acute kidney injury|acute kidney injury
5469412|NCT01423201|TIA|tia
5474871|NCT01401205|shoulder arthroscopic surgery|shoulder arthroscopic surgery
5474872|NCT01401205|dyspnea|dyspnea
5474873|NCT01401205|airway diameter|airway diameter
5474874|NCT01401192|thymidylate synthase|thymidylate synthase
5474875|NCT01401179|Preterm Premature Rupture of Fetal Membranes|preterm premature rupture of fetal membranes
5474876|NCT01401179|antibiotic therapy|antibiotic therapy
5474877|NCT01401140|Coronary Artery Bypass|coronary artery bypass
5474878|NCT01401140|Coronary Artery Surgery|coronary artery surgery
5474879|NCT01401140|Coronary Artery Bypass Graft|coronary artery bypass graft
5474880|NCT01401140|Coronary Revascularization|coronary revascularization
5474881|NCT01401140|Cardiac microdialysis|cardiac microdialysis
5474882|NCT01401140|Custodiol|custodiol
5474883|NCT01401140|St Thomas|st thomas
5474884|NCT01401140|Cardioplegic solutions|cardioplegic solutions
5474885|NCT01401127|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5474886|NCT01401127|Exercise|exercise
5474887|NCT01401127|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5474888|NCT01401127|CSII|csii
5474889|NCT01401127|Insulin Pump Therapy|insulin pump therapy
5474890|NCT01401114|Wellnara|wellnara
5474891|NCT01401114|Postmenopausal osteoporosis|postmenopausal osteoporosis
5474892|NCT01401101|mental health|mental health
5474893|NCT01401101|PTSD|ptsd
5474894|NCT01401101|primary care|primary care
5474895|NCT01401101|quality improvement|quality improvement
5474896|NCT01401101|collaborative care|collaborative care
5474897|NCT01401088|patient with refractory glaucoma|patient with refractory glaucoma
5474898|NCT01401075|Quality of Life|quality of life
5474900|NCT01401075|EORTC QLQ-C30|eortc qlq-c30
5474901|NCT01401075|EORTC QLQ-STO22|eortc qlq-sto22
5474902|NCT01401075|5-FU|5-fu
5474903|NCT01401075|Viscum album|viscum album
5474904|NCT01401062|metastatic breast cancer|metastatic breast cancer
5474905|NCT01401062|TGF-beta|tgf-beta
5474906|NCT01401062|fresolimumab|fresolimumab
5474907|NCT01401062|monoclonal antibody|monoclonal antibody
5474908|NCT01401062|radiation therapy|radiation therapy
5474909|NCT01401062|abscopal response|abscopal response
5474910|NCT01401049|Fospropofol|fospropofol
5474911|NCT01401049|Propofol|propofol
5474912|NCT01401049|Colonoscopy|colonoscopy
5474914|NCT01401036|acute myocardial infarction|acute myocardial infarction
5474915|NCT01401036|stents|stents
5474916|NCT01401036|angioplasty|angioplasty
5474917|NCT01401036|thrombosis|thrombosis
5474918|NCT01401010|neutropenia|neutropenia
5474919|NCT01401010|doripenem|doripenem
5474920|NCT01400997|Growth disorders|growth disorders
5474921|NCT01400997|Saizen|saizen
5474922|NCT01400997|Easypod|easypod
5474923|NCT01400997|Growth hormone|growth hormone
5474924|NCT01400997|Pediatric subject|pediatric subject
5474925|NCT01400984|Growth disorders|growth disorders
5474926|NCT01400984|Saizen|saizen
5474927|NCT01400984|Easypod|easypod
5474928|NCT01400984|Growth hormone|growth hormone
5474929|NCT01400984|Pediatric subject|pediatric subject
5474930|NCT01400971|Diabetes|diabetes
5474931|NCT01400971|Insulin|insulin
5474932|NCT01400971|Progression|progression
5474933|NCT01400971|Patient Reported Measures|patient reported measures
5474934|NCT01400971|Adherence|adherence
5474935|NCT01400971|Heterogeneity|heterogeneity
5474936|NCT01400971|Hypoglycemia|hypoglycemia
5474937|NCT01400958|fatigue|fatigue
5474938|NCT01400958|external beam radiation|external beam radiation
5474939|NCT01400958|EBRT|ebrt
5474940|NCT01400958|radiation therapy|radiation therapy
5474941|NCT01400958|placebo|placebo
5474942|NCT01400958|cognitive function|cognitive function
5474943|NCT01400958|TMZ|tmz
5474944|NCT01400958|Temozolomide|temozolomide
5474945|NCT01400945|GERD|gerd
5474946|NCT01400945|endoscopy|endoscopy
5474947|NCT01400945|LA grade|la grade
5474949|NCT01400932|inflammatory lesion|inflammatory lesion
5474950|NCT01400932|Benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
5474951|NCT01400932|once daily|once daily
5474952|NCT01400932|acne vulgaris|acne vulgaris
5474953|NCT01400932|vehicle gel|vehicle gel
5474954|NCT01400932|clindamycin (CLDM) 1%-BPO 3% gel|clindamycin (cldm) 1%-bpo 3% gel
5474955|NCT01400932|non-inflammatory lesion|non-inflammatory lesion
5474956|NCT01400919|Peripheral arterial disease|peripheral arterial disease
5474957|NCT01400919|claudication|claudication
5474958|NCT01400919|stent|stent
5474959|NCT01400919|EverFlex|everflex
5474960|NCT01400919|GPS|gps
5474961|NCT01400919|Iliac Artery|iliac artery
5474962|NCT01400893|Acute Renal Failure|acute renal failure
5474963|NCT01400893|Acute kidney injury|acute kidney injury
5474964|NCT01400893|Acute tubular necrosis|acute tubular necrosis
5474965|NCT01400893|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5474966|NCT01400893|Severe sepsis|severe sepsis
5474967|NCT01400893|Selective cytopheretic device|selective cytopheretic device
5474968|NCT01400880|Maternal Fetal Monitoring|maternal fetal monitoring
5474969|NCT01400867|Infections|infections
5474970|NCT01400867|Pediatrics|pediatrics
5474971|NCT01400867|Teflaro|teflaro
5474972|NCT01400867|cephalosporin|cephalosporin
5474973|NCT01400854|breakthrough cancer pain|breakthrough cancer pain
5789043|NCT00150137|toxic nodular goiter|toxic nodular goiter
5474974|NCT01400841|Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Repair|aortic insufficiency, aortic regurgitation, aortic valve repair
5474976|NCT01400815|smoking cessation|smoking cessation
5474977|NCT01400815|quitting smoking|quitting smoking
5474978|NCT01400776|Postmenopausal Women, Vaginal Dryness|postmenopausal women, vaginal dryness
5474979|NCT01400763|focus of study|focus of study
5474980|NCT01400750|cystic fibrosis- P aeruginosa- eradication-child|cystic fibrosis- p aeruginosa- eradication-child
5474981|NCT01400737|ibuprofen|ibuprofen
5474982|NCT01400737|prophylaxis|prophylaxis
5474983|NCT01400737|VELBW|velbw
5474984|NCT01400724|menopause|menopause
5474985|NCT01400724|metabolic syndrome|metabolic syndrome
5474986|NCT01400724|myo-inositol|myo-inositol
5474987|NCT01400724|insulin resistance|insulin resistance
5474988|NCT01400724|cocoa polyphenols|cocoa polyphenols
5474989|NCT01400724|isoflavones|isoflavones
5474990|NCT01400711|Fast-tract surgery, Enhanced recovery after surgery, multimodal surgery.|fast-tract surgery, enhanced recovery after surgery, multimodal surgery.
5474991|NCT01400698|Intra-uterine growth retardation (IUGR)|intra-uterine growth retardation (iugr)
5474992|NCT01400698|Saizen|saizen
5474993|NCT01400698|Recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5474994|NCT01400698|Final height|final height
5474995|NCT01400698|Bone age|bone age
5474996|NCT01400698|SGA (Small for Gestational Age)|sga (small for gestational age)
5474997|NCT01400685|CLL|cll
5446438|NCT01517789|Surgery|surgery
5461580|NCT01454648|EMS|ems
5474998|NCT01400685|Leukemia|leukemia
5474999|NCT01400685|Untreated|untreated
5475000|NCT01400685|B-CLL|b-cll
5475001|NCT01400685|SLL|sll
5475002|NCT01400672|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5475003|NCT01400659|CSII|csii
5475004|NCT01400659|prandial insulin requirements|prandial insulin requirements
5475005|NCT01400659|bolus calculation|bolus calculation
5475006|NCT01400659|dual-wave bolus|dual-wave bolus
5475007|NCT01400646|Rivaroxaban|rivaroxaban
5475008|NCT01400646|JNJ-39039039|jnj-39039039
5475009|NCT01400646|BAY59-7939|bay59-7939
5475010|NCT01400646|Warfarin|warfarin
5475011|NCT01400646|Transition|transition
5475012|NCT01400633|Myelodysplastic Syndrome|myelodysplastic syndrome
5475013|NCT01400633|Dacogen|dacogen
5475014|NCT01400633|decitabine|decitabine
5475015|NCT01400633|epigenetic therapy|epigenetic therapy
5475016|NCT01400633|hypomethylating agent|hypomethylating agent
5475017|NCT01400620|oral mucositis|oral mucositis
5475019|NCT01400620|head and neck cancer|head and neck cancer
5475021|NCT01400607|knee surgery|knee surgery
5475022|NCT01400607|cartilage injury|cartilage injury
5475023|NCT01400607|knee pain|knee pain
5475024|NCT01400607|cartilage repair|cartilage repair
5475025|NCT01400607|cartilage damage|cartilage damage
5475026|NCT01400607|cartilage lesion|cartilage lesion
5475027|NCT01400607|cartilage defect|cartilage defect
5475028|NCT01400607|articular cartilage lesion|articular cartilage lesion
5475029|NCT01400607|articular cartilage defect|articular cartilage defect
5475030|NCT01400607|juvenile|juvenile
5475031|NCT01400607|cells|cells
5475032|NCT01400607|ISTO Technologies|isto technologies
5475033|NCT01400607|Neocartilage|neocartilage
5475034|NCT01400607|RevaFlex|revaflex
5475035|NCT01400594|Onychomycosis|onychomycosis
5475036|NCT01400555|Prostate Cancer|prostate cancer
5475037|NCT01400555|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5457269|NCT01472627|Velcade|velcade
5475038|NCT01400555|Abiraterone Acetate|abiraterone acetate
5475039|NCT01400555|Docetaxel|docetaxel
5475040|NCT01400555|Prednisone|prednisone
5475041|NCT01400555|Dexamethasone|dexamethasone
5475042|NCT01400542|Early Onset Alzheimer Disease|early onset alzheimer disease
5475043|NCT01400542|Alzheimer Disease|alzheimer disease
5475044|NCT01400542|Sleep Apnea Syndromes|sleep apnea syndromes
5475045|NCT01400542|Obstructive Sleep Apnea Syndromes|obstructive sleep apnea syndromes
5475047|NCT01400542|Continuous Positive Airway Pressure (CPAP) treatment|continuous positive airway pressure (cpap) treatment
5475048|NCT01400529|Osteoarthritis|osteoarthritis
5475049|NCT01400529|knee|knee
5475050|NCT01400529|hip|hip
5475051|NCT01400529|population based|population based
5475052|NCT01400516|Rheumatoid Arthritis|rheumatoid arthritis
5475053|NCT01400516|Bone erosion|bone erosion
5475054|NCT01400516|Osteopenia|osteopenia
5475055|NCT01400503|Multicentric Castleman's Disease|multicentric castleman's disease
5475056|NCT01400503|Multicentric|multicentric
5475057|NCT01400503|Castleman|castleman
5475058|NCT01400503|Siltuximab|siltuximab
5475059|NCT01400503|Long term safety|long term safety
5475060|NCT01400477|Drug Trial|drug trial
5475061|NCT01400477|Smoking|smoking
5475062|NCT01400477|Smoking Cessation|smoking cessation
5475063|NCT01400477|Cognition|cognition
5475064|NCT01400477|Mental Focus|mental focus
5475065|NCT01400464|Giant Cell Arteritis|giant cell arteritis
5475066|NCT01400464|prednisone|prednisone
5475067|NCT01400464|pharmacokinetics|pharmacokinetics
5475068|NCT01400438|Herceptin|herceptin
5475069|NCT01400438|Breast cancer|breast cancer
5475070|NCT01400438|Quality of life|quality of life
5475071|NCT01400438|fatigue|fatigue
5475072|NCT01400399|AJCC DCIS or T1- T2, N0|ajcc dcis or t1- t2, n0
5475073|NCT01400373|Hypothermia, induced|hypothermia, induced
5475074|NCT01400373|Intra-arrest cooling|intra-arrest cooling
5475075|NCT01400373|Cardiac arrest|cardiac arrest
5475076|NCT01400373|Prehospital emergency care|prehospital emergency care
5475077|NCT01400373|Emergency Medical Services|emergency medical services
5475078|NCT01400360|cerebral vasospasm|cerebral vasospasm
5475079|NCT01400360|subarachnoid hemorrhage|subarachnoid hemorrhage
5475080|NCT01400360|transluminal balloon angioplasty|transluminal balloon angioplasty
5475081|NCT01400360|intraarterial treatment|intraarterial treatment
5475082|NCT01400347|Motor activity, lower extremity, physical exercise|motor activity, lower extremity, physical exercise
5475083|NCT01400334|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5475084|NCT01400334|Sudden Cardiac Death|sudden cardiac death
5475085|NCT01400334|Positron Emission Tomography|positron emission tomography
5475086|NCT01400334|Hibernating Myocardium|hibernating myocardium
5475087|NCT01400334|Denervated Myocardium|denervated myocardium
5475088|NCT01400321|dental implant|dental implant
5475089|NCT01400321|soft tissue maintenance|soft tissue maintenance
5475090|NCT01400321|bone remodelling|bone remodelling
5475091|NCT01400321|inclined atrophy|inclined atrophy
5475092|NCT01400308|Methicillin Resistant Staphylococcus Aureus colonization.|methicillin resistant staphylococcus aureus colonization.
5685320|NCT00556543|Flail Chest|flail chest
5475093|NCT01400308|Methicillin Resistant Staphylococcus Aureus infection.|methicillin resistant staphylococcus aureus infection.
5475094|NCT01400295|contrast-induced nephropathy|contrast-induced nephropathy
5475095|NCT01400295|contrast medium|contrast medium
5475096|NCT01400295|creatinine clearance|creatinine clearance
5475097|NCT01400295|coronary angiography|coronary angiography
5475098|NCT01400295|diabetes|diabetes
5475099|NCT01400295|chronic kidney disease|chronic kidney disease
5475101|NCT01400256|diagnostic|diagnostic
5475102|NCT01400243|Marijuana|marijuana
5475103|NCT01400243|Drug withdrawal symptoms|drug withdrawal symptoms
5475104|NCT01400243|Nicotine|nicotine
5475105|NCT01400230|computed tomography|computed tomography
5475106|NCT01400230|intravascular ultrasound|intravascular ultrasound
5475107|NCT01400230|coronary stenosis|coronary stenosis
5475108|NCT01400230|fractional flow reserve|fractional flow reserve
5475109|NCT01400217|Primary Care|primary care
5475110|NCT01400217|Particle size|particle size
5475111|NCT01400217|beclomethasone dipropionate|beclomethasone dipropionate
5475112|NCT01400217|Asthma Management|asthma management
5475113|NCT01400217|Maintenance Therapy|maintenance therapy
5475120|NCT01400191|Hypoglycemic Agents|hypoglycemic agents
5475121|NCT01400191|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5475122|NCT01400191|Gluconeogenesis|gluconeogenesis
5475123|NCT01400191|Pharmacodynamics|pharmacodynamics
5475124|NCT01400191|Pharmacogenetics|pharmacogenetics
5475125|NCT01400178|cochlear implant|cochlear implant
5475126|NCT01400178|children|children
5475127|NCT01400178|follow up|follow up
5475128|NCT01400178|results|results
5475129|NCT01400165|Therapeutic Equivalency|therapeutic equivalency
5475130|NCT01400165|Human Experimentation|human experimentation
5475131|NCT01400165|Bioequivalence|bioequivalence
5475132|NCT01400165|Brand name|brand name
5475133|NCT01400165|Generic|generic
5475134|NCT01400165|Healthy volunteers|healthy volunteers
5475135|NCT01400152|Hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care|hypothermia, body temperature regulation,thermal comfort, active warming, passive warming, prehospital trauma care
5457378|NCT01472133|ECG|ecg
5475136|NCT01400139|Pain|pain
5475137|NCT01400139|Nonmalignant pain|nonmalignant pain
5475138|NCT01400139|Nonneuropathic Pain|nonneuropathic pain
5475139|NCT01400139|Opioid|opioid
5475140|NCT01400126|Ultrapure water,hemodialysis, CRP, blood pressure|ultrapure water,hemodialysis, crp, blood pressure
5475141|NCT01400113|Acute Agitation|acute agitation
5475142|NCT01400113|schizophrenia|schizophrenia
5475143|NCT01400113|bipolar|bipolar
5475144|NCT01400113|psychosis|psychosis
5475145|NCT01400113|panss-ec|panss-ec
5475146|NCT01400100|octreotide|octreotide
5475147|NCT01400100|intraarterial|intraarterial
5475148|NCT01400100|pancreatic hardness|pancreatic hardness
5475149|NCT01400100|pancreatoduodenectomy|pancreatoduodenectomy
5475150|NCT01400100|durometer|durometer
5475151|NCT01400100|dynamometer|dynamometer
5475152|NCT01400087|colonoscopy|colonoscopy
5475153|NCT01400087|Lower Gastrointestinal Tract|lower gastrointestinal tract
5475154|NCT01400087|Cecal intubation|cecal intubation
5475155|NCT01400087|Cap-attached colonoscopy|cap-attached colonoscopy
5475156|NCT01400087|Trainee|trainee
5475157|NCT01400061|obesity, etiology, pathogenesis, treatment|obesity, etiology, pathogenesis, treatment
5475158|NCT01400035|acute cerebral infarction, Vinpocetine|acute cerebral infarction, vinpocetine
5475159|NCT01400022|lichen|lichen
5475160|NCT01400022|sclerosus|sclerosus
5475161|NCT01400022|genital|genital
5475162|NCT01400022|vulvar|vulvar
5475163|NCT01400022|UVA1|uva1
5475164|NCT01400009|Statin|statin
5475165|NCT01400009|HMG COA Reductase Inhibitor|hmg coa reductase inhibitor
5475166|NCT01400009|myalgia|myalgia
5475167|NCT01400009|vitamin D|vitamin d
5475168|NCT01399996|probiotic|probiotic
5475169|NCT01399996|microbiota|microbiota
5475170|NCT01399996|transit time|transit time
5475171|NCT01399996|immunity|immunity
5475172|NCT01399996|immune function|immune function
5475173|NCT01399996|constipation|constipation
5475174|NCT01399996|bowel function|bowel function
5475175|NCT01399983|six minute walk|six minute walk
5475176|NCT01399970|Mobile Teledermatology|mobile teledermatology
5475177|NCT01399970|Telemedicine|telemedicine
5475179|NCT01399957|Multiple Sclerosis|multiple sclerosis
5475180|NCT01399957|Dalfampridine-ER|dalfampridine-er
5475181|NCT01399957|Walking speed|walking speed
5475182|NCT01399944|bitter taste|bitter taste
5475183|NCT01399944|psychophysics|psychophysics
5475184|NCT01399944|genetics|genetics
5475185|NCT01399944|epigenetics|epigenetics
5475186|NCT01399944|bitterness sensitivity|bitterness sensitivity
5475187|NCT01399931|Early stage|early stage
5475188|NCT01399918|Kidney|kidney
5475189|NCT01399918|Everolimus|everolimus
5475190|NCT01399918|Bevacizumab|bevacizumab
5475191|NCT01399918|10-226|10-226
5475192|NCT01399918|non-clear cell histology|non-clear cell histology
5475193|NCT01399918|Advanced|advanced
5475194|NCT01399905|Parkinson's disease|parkinson's disease
5475195|NCT01399905|Levodopa|levodopa
5475196|NCT01399905|Carbidopa|carbidopa
5475197|NCT01399905|Blood brain barrier|blood brain barrier
5475198|NCT01399879|Surface potential|surface potential
5475199|NCT01399879|Electrical|electrical
5475200|NCT01399879|Motion stabilization|motion stabilization
5475201|NCT01399866|D-cycloserine|d-cycloserine
5475202|NCT01399866|Smoking cues|smoking cues
5475203|NCT01399866|Cognitive remediation|cognitive remediation
5475204|NCT01399866|physiologic reactivity|physiologic reactivity
5475205|NCT01399866|craving|craving
5475206|NCT01399853|immunogenicity|immunogenicity
5475207|NCT01399853|safety|safety
5475208|NCT01399853|inactivated EV71 vaccine|inactivated ev71 vaccine
5475209|NCT01399801|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5478245|NCT01386580|Brain Neoplasms|brain neoplasms
5475210|NCT01399801|medically refractory heart failure patients|medically refractory heart failure patients
5475211|NCT01399788|Bioequivalence|bioequivalence
5475212|NCT01399788|Healthy Volunteers|healthy volunteers
5475213|NCT01399775|Atrophy of Edentulous Alveolar Ridge|atrophy of edentulous alveolar ridge
5475214|NCT01399775|Dental Prosthesis, Implant-Supported|dental prosthesis, implant-supported
5475215|NCT01399775|Dental Implants, Single-Tooth|dental implants, single-tooth
5475216|NCT01399762|stroke, acute|stroke, acute
5475217|NCT01399762|mechanical recanalization|mechanical recanalization
5475218|NCT01399762|interventional neuroradiology|interventional neuroradiology
5475219|NCT01399762|clinical registry|clinical registry
5475220|NCT01399749|Cartilage|cartilage
5475221|NCT01399749|Articular|articular
5475222|NCT01399749|Femoral|femoral
5475223|NCT01399749|Knee|knee
5475224|NCT01399749|Chondrocytes|chondrocytes
5475225|NCT01399749|Adipose tissue-derived mesenchymal stem cells|adipose tissue-derived mesenchymal stem cells
5475226|NCT01399736|PCI FFR STEMI MVD|pci ffr stemi mvd
5475227|NCT01399736|FFR guided PCI in acute STEMI patients with MVD|ffr guided pci in acute stemi patients with mvd
5475228|NCT01399723|Severe pneumonia|severe pneumonia
5475229|NCT01399710|colorectal cancer|colorectal cancer
5475230|NCT01399710|CT colonography|ct colonography
5475231|NCT01399710|CAD|cad
5475232|NCT01399671|depression|depression
5475233|NCT01399671|vestibular|vestibular
5475234|NCT01399658|Brachytherapy|brachytherapy
5475235|NCT01399658|Gynecological cancer|gynecological cancer
5475236|NCT01399645|Randomized trial|randomized trial
5475237|NCT01399645|Open label|open label
5475238|NCT01399645|Pilot study|pilot study
5475239|NCT01399645|Single center|single center
5475441|NCT01398761|Handoffs|handoffs
5475244|NCT01399593|Acute Humoral Rejection|acute humoral rejection
5475246|NCT01399593|Living Donor|living donor
5475247|NCT01399593|Kidney Transplant|kidney transplant
5475248|NCT01399580|endothelin receptor antagonists|endothelin receptor antagonists
5475249|NCT01399567|pain|pain
5475250|NCT01399567|depression|depression
5475251|NCT01399567|nursing homes|nursing homes
5475252|NCT01399567|diffusion of innovations|diffusion of innovations
5475253|NCT01399567|clinical trial|clinical trial
5475254|NCT01399541|Symptoms|symptoms
5475255|NCT01399541|Symptoms cluster|symptoms cluster
5475256|NCT01399541|Fatigue|fatigue
5475257|NCT01399541|Depression|depression
5475258|NCT01399541|Sleeplessness|sleeplessness
5475259|NCT01399541|Social support|social support
5475260|NCT01399541|Stigma|stigma
5475261|NCT01399515|Retinitis pigmentosa|retinitis pigmentosa
5475262|NCT01399515|Valproic acid|valproic acid
5475263|NCT01399502|Depression|depression
5475264|NCT01399502|Self Care|self care
5475265|NCT01399489|Aerobic exercise|aerobic exercise
5475266|NCT01399489|Moderate intensity|moderate intensity
5475267|NCT01399489|Ambulatory blood pressure|ambulatory blood pressure
5475268|NCT01399489|Post exercise hypotension|post exercise hypotension
5475269|NCT01399476|Achalasia|achalasia
5475270|NCT01399463|Drug Eluting Stent, Drug Eluting Balloon, Fractional Flow Reserve, DES, DEB, FFR|drug eluting stent, drug eluting balloon, fractional flow reserve, des, deb, ffr
5475271|NCT01399450|Schizophrenia, depressive symptom, paliperidone|schizophrenia, depressive symptom, paliperidone
5475272|NCT01399437|Default Network|default network
5475273|NCT01399437|Schizophrenia|schizophrenia
5475274|NCT01399437|fMRI|fmri
5475275|NCT01399437|Spatial Attention|spatial attention
5475276|NCT01399437|Sentinel Function|sentinel function
5475277|NCT01399424|Shigellosis|shigellosis
5475278|NCT01399424|Safety and Immunogenicity|safety and immunogenicity
5475279|NCT01399424|Conjugate Vaccine|conjugate vaccine
5475280|NCT01399424|Shigella|shigella
5475281|NCT01399424|Vaccine|vaccine
5475287|NCT01399398|Brain Scan|brain scan
5475288|NCT01399398|Kinetic Analysis|kinetic analysis
5475289|NCT01399398|Healthy Subjects|healthy subjects
5475290|NCT01399398|Healthy Volunteer|healthy volunteer
5475292|NCT01399385|Distensibility Imaging|distensibility imaging
5475293|NCT01399385|Arteriosclerosis, Narrowing of Vessels|arteriosclerosis, narrowing of vessels
5475294|NCT01399385|Endothelial Dysfunction|endothelial dysfunction
5475295|NCT01399385|Hardening of the arteries|hardening of the arteries
5475296|NCT01399385|Noninvasive Plaque Imaging|noninvasive plaque imaging
5475297|NCT01399385|Cardiovascular Disease|cardiovascular disease
5475298|NCT01399385|Heart Disease|heart disease
5475299|NCT01399385|Arteriosclerosis|arteriosclerosis
5475300|NCT01399385|Healthy Volunteer|healthy volunteer
5475301|NCT01399385|HV|hv
5461807|NCT01453530|Recovery|recovery
5475302|NCT01399372|neurotoxicity|neurotoxicity
5475303|NCT01399372|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5475304|NCT01399372|radiation toxicity|radiation toxicity
5475305|NCT01399372|cognitive/functional effects|cognitive/functional effects
5475306|NCT01399372|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5475307|NCT01399359|breast cancer|breast cancer
5475308|NCT01399346|Insulin aspart|insulin aspart
5475309|NCT01399346|Type 1 diabetes|type 1 diabetes
5475310|NCT01399346|Glucose clamp|glucose clamp
5475311|NCT01399346|Pharmacodynamics|pharmacodynamics
5475312|NCT01399346|Pharmacokinetics|pharmacokinetics
5475313|NCT01399346|Rapid Acting Insulin Analog|rapid acting insulin analog
5475314|NCT01399333|PDCAAS|pdcaas
5475315|NCT01399333|Bariatric patient|bariatric patient
5475316|NCT01399320|Pilonidal disease|pilonidal disease
5475317|NCT01399320|Excision|excision
5475318|NCT01399320|cyanoacrylate|cyanoacrylate
5475319|NCT01399307|Stem|stem
5475320|NCT01399307|Cell|cell
5475321|NCT01399307|Antria|antria
5475322|NCT01399307|Adipose|adipose
5475323|NCT01399307|Stromal|stromal
5475324|NCT01399307|Vascular|vascular
5475325|NCT01399307|Fraction|fraction
5475326|NCT01399307|Shahram|shahram
5475327|NCT01399307|Shah|shah
5475328|NCT01399307|Rahimian|rahimian
5475329|NCT01399294|Palliative Care|palliative care
5475330|NCT01399294|Advanced Cancer|advanced cancer
5475331|NCT01399294|Constipation|constipation
5475332|NCT01399294|Traditional Chinese Medicine|traditional chinese medicine
5475333|NCT01399294|Syndrome Distribution|syndrome distribution
5475334|NCT01399281|juvenile idiopathic arthritis, biologics, methotrexate|juvenile idiopathic arthritis, biologics, methotrexate
5475335|NCT01399268|Bilateral total knee replacement|bilateral total knee replacement
5475336|NCT01399268|cytokine|cytokine
5475337|NCT01399268|desmosine|desmosine
5475338|NCT01399242|Disorder Related to Renal Transplantation|disorder related to renal transplantation
5475339|NCT01399203|contrast-induced nephropathy|contrast-induced nephropathy
5475340|NCT01399203|contrast medium|contrast medium
5475341|NCT01399203|creatinine clearance|creatinine clearance
5457589|NCT01471184|Eye Drops|eye drops
5475342|NCT01399203|percutaneous coronary intervention|percutaneous coronary intervention
5475343|NCT01399164|Vitamin B-12|vitamin b-12
5475344|NCT01399151|Vitamin D|vitamin d
5475345|NCT01399151|Immune function|immune function
5475346|NCT01399138|Pre-diabetes|pre-diabetes
5475347|NCT01399138|Metabolic syndrome|metabolic syndrome
5475348|NCT01399138|Diabetes|diabetes
5475349|NCT01399138|Hypertension|hypertension
5475350|NCT01399138|Blueberries|blueberries
5475351|NCT01399138|Anthocyanins|anthocyanins
5475352|NCT01399138|Insulin sensitivity|insulin sensitivity
5475353|NCT01399138|Insulin resistance|insulin resistance
5475354|NCT01399125|Alzheimer's|alzheimer's
5475355|NCT01399125|Rivastigmine|rivastigmine
5475356|NCT01399125|Patch|patch
5475357|NCT01399125|Dementia|dementia
5475358|NCT01399112|Smoking Cessation|smoking cessation
5475359|NCT01399112|First episode psychosis|first episode psychosis
5475360|NCT01399112|Electronic Decision Support System|electronic decision support system
5475361|NCT01399099|scar|scar
5475362|NCT01399099|incision|incision
5475363|NCT01399099|wound healing|wound healing
5475364|NCT01399099|scarring|scarring
5475365|NCT01399099|post-surgical|post-surgical
5475366|NCT01399086|Cancer|cancer
5475367|NCT01399086|Breast|breast
5475368|NCT01399086|Metastatic|metastatic
5475369|NCT01399086|Hormonotherapy|hormonotherapy
5475370|NCT01399073|stroke|stroke
5475371|NCT01399073|neglect|neglect
5475372|NCT01399073|hemianopsia|hemianopsia
5475373|NCT01399073|virtual reality|virtual reality
5475374|NCT01399060|Cough|cough
5475375|NCT01399060|tobacco smoke exposure|tobacco smoke exposure
5475376|NCT01399047|Batten Disease|batten disease
5475377|NCT01399034|Epigenomics|epigenomics
5475378|NCT01399034|DNA methylation|dna methylation
5475379|NCT01399034|MicroRNA|microrna
5475380|NCT01399034|Periodontitis|periodontitis
5475381|NCT01399034|Inflammation|inflammation
5475382|NCT01399034|Obesity|obesity
5475383|NCT01399021|Parotidectomy|parotidectomy
5475385|NCT01399021|Timing|timing
5475386|NCT01399021|Hematoma|hematoma
5475387|NCT01399021|Surgical wound infection|surgical wound infection
5475388|NCT01399008|Hyperuricemia|hyperuricemia
5475389|NCT01398995|Type 1 Diabetes|type 1 diabetes
5475390|NCT01398995|Exercise|exercise
5475391|NCT01398995|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5475392|NCT01398969|Randomized|randomized
5475393|NCT01398969|Double Blind|double blind
5475394|NCT01398969|Fecal Transplant|fecal transplant
5475395|NCT01398969|Recurrent|recurrent
5475396|NCT01398969|Clostridium difficile infection|clostridium difficile infection
5475397|NCT01398969|CDI|cdi
5475398|NCT01398969|HBT|hbt
5475399|NCT01398969|Diarrhea|diarrhea
5475400|NCT01398969|Frozen HBT|frozen hbt
5475401|NCT01398969|Thawed HBT|thawed hbt
5475402|NCT01398969|Fecal Enema|fecal enema
5475403|NCT01398956|Levetiracetam|levetiracetam
5590882|NCT00927238|DDD|ddd
5461908|NCT01453244|IL28B|il28b
5475404|NCT01398956|Epilepsy|epilepsy
5475405|NCT01398956|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
5475406|NCT01398943|flow-mediated dilation|flow-mediated dilation
5475407|NCT01398943|arterial stiffness|arterial stiffness
5475408|NCT01398943|intima-media thickness|intima-media thickness
5475409|NCT01398943|pulse wave velocity|pulse wave velocity
5475410|NCT01398943|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5475411|NCT01398943|inflammatory markers|inflammatory markers
5475412|NCT01398943|blood lipids|blood lipids
5475413|NCT01398943|tetrahydrobiopterin|tetrahydrobiopterin
5475414|NCT01398943|body mass index|body mass index
5475415|NCT01398943|hemoglobin A1c|hemoglobin a1c
5475416|NCT01398943|complete blood count|complete blood count
5475417|NCT01398943|oxidative stress biomarkers|oxidative stress biomarkers
5475418|NCT01398943|pulmonary function test|pulmonary function test
5475420|NCT01398943|COPD|copd
5475421|NCT01398930|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.|acupuncture; knee osteoarthritis; adjunctive therapy; chronic pain; algometer; etoricoxib.
5475422|NCT01398917|psc|psc
5475423|NCT01398917|dominant stricture|dominant stricture
5475424|NCT01398904|BDD|bdd
5475425|NCT01398878|Medical education, graduate|medical education, graduate
5475426|NCT01398878|Patient care|patient care
5475427|NCT01398878|Outcome assessment (Health care)|outcome assessment (health care)
5475428|NCT01398878|Work schedule tolerance|work schedule tolerance
5475429|NCT01398865|BDD|bdd
5475430|NCT01398826|Type 1 Diabetes|type 1 diabetes
5475431|NCT01398826|Exercise|exercise
5475432|NCT01398826|Continuous glucose monitoring|continuous glucose monitoring
5475433|NCT01398813|HED|hed
5475434|NCT01398813|XLHED|xlhed
5475435|NCT01398774|Pseudohypoparathyroidism|pseudohypoparathyroidism
5475436|NCT01398774|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5475437|NCT01398761|Continuity of patient care|continuity of patient care
5475438|NCT01398761|Workflow|workflow
5475439|NCT01398761|Quality of signout|quality of signout
5475440|NCT01398761|Web based|web based
5475442|NCT01398761|Multi disciplinary|multi disciplinary
5603437|NCT00884832|FI|fi
5475443|NCT01398761|Written signout|written signout
5475444|NCT01398761|Information science|information science
5475445|NCT01398748|Parkinson's disease|parkinson's disease
5475446|NCT01398748|Neuroprotection|neuroprotection
5475447|NCT01398748|Glutathione|glutathione
5475448|NCT01398748|Intranasal|intranasal
5475449|NCT01398722|cardiac surgery|cardiac surgery
5475450|NCT01398722|prognosis|prognosis
5475451|NCT01398722|intensive insulin therapy|intensive insulin therapy
5475452|NCT01398709|Cardiopulmonary Bypass|cardiopulmonary bypass
5475453|NCT01398709|Prognosis|prognosis
5475454|NCT01398709|Cardiac Surgery|cardiac surgery
5475455|NCT01398709|Rewarming Rate|rewarming rate
5475456|NCT01398696|Patient Information Leaflets|patient information leaflets
5475457|NCT01398696|primary care|primary care
5475458|NCT01398696|patient behaviour|patient behaviour
5475459|NCT01398696|pharyngitis|pharyngitis
5475460|NCT01398696|gastroenteritis|gastroenteritis
5475461|NCT01398670|Type I Diabetes|type i diabetes
5475462|NCT01398670|Wockhardt's Insulin analogue Lispro|wockhardt's insulin analogue lispro
5475463|NCT01398670|Humalog®|humalog®
5475464|NCT01398670|Humalog Mix|humalog mix
5475465|NCT01398670|Wockhardt|wockhardt
5475466|NCT01398670|Biosimilar|biosimilar
5475467|NCT01398670|Phase 3|phase 3
5475468|NCT01398657|localized|localized
5475469|NCT01398657|High risk|high risk
5475470|NCT01398657|Prostate Cancer|prostate cancer
5475471|NCT01398657|Randomized|randomized
5475472|NCT01398657|Cryotherapy|cryotherapy
5475473|NCT01398657|Cryoablation|cryoablation
5475474|NCT01398657|Adjuvant|adjuvant
5475475|NCT01398657|Androgen Deprivation Therapy|androgen deprivation therapy
5475476|NCT01398657|Hormone therapy|hormone therapy
5475477|NCT01398657|ADT|adt
5475478|NCT01398644|Phlebotomy|phlebotomy
5475479|NCT01398644|Therapeutic erythrocytapheresis|therapeutic erythrocytapheresis
5475480|NCT01398644|Hereditary Hemochromatosis|hereditary hemochromatosis
5475481|NCT01398644|maintenance therapy|maintenance therapy
5475482|NCT01398631|Risk scores|risk scores
5475483|NCT01398631|ACS|acs
5475484|NCT01398631|HEART-score|heart-score
5469984|NCT01421173|NeupogenTM|neupogentm
5475485|NCT01398618|latent tuberculosis infection|latent tuberculosis infection
5475487|NCT01398618|interferon-gamma release assay|interferon-gamma release assay
5475488|NCT01398618|preventive therapy|preventive therapy
5475489|NCT01398618|9-month isoniazid|9-month isoniazid
5475490|NCT01398618|4-month rifampin|4-month rifampin
5475491|NCT01398605|Postmenopausal women|postmenopausal women
5475492|NCT01398605|Physical activity|physical activity
5475493|NCT01398605|Cardiovascular risks|cardiovascular risks
5475494|NCT01398605|Cardiac function|cardiac function
5475495|NCT01398605|Dose-response|dose-response
5475496|NCT01398592|Diabetes mellitus Type two|diabetes mellitus type two
5475497|NCT01398592|T2DM|t2dm
5475498|NCT01398592|vildagliptin|vildagliptin
5475499|NCT01398592|sitagliptin|sitagliptin
5475500|NCT01398592|FPG|fpg
5475501|NCT01398592|DPP-4|dpp-4
5475502|NCT01398579|intestinal metaplasia|intestinal metaplasia
5475503|NCT01398579|dysplasia|dysplasia
5475504|NCT01398579|probe-based confocal endomicroscopy|probe-based confocal endomicroscopy
5475505|NCT01398566|TBI|tbi
5475506|NCT01398566|concussion|concussion
5475507|NCT01398566|brain injury|brain injury
5475508|NCT01398553|stroke|stroke
5475509|NCT01398553|tbi|tbi
5475510|NCT01398553|rehabilitation|rehabilitation
5475511|NCT01398553|upper limb|upper limb
5475512|NCT01398527|Long-Term Care|long-term care
5475513|NCT01398527|Vitamin D|vitamin d
5475514|NCT01398501|AML|aml
5475515|NCT01398501|FLT3-ITD|flt3-itd
5475516|NCT01398501|Stem cell transplant|stem cell transplant
5475517|NCT01398488|Trough levels|trough levels
5475518|NCT01398488|Education|education
5475519|NCT01398488|Adherence|adherence
5475520|NCT01398449|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
5475521|NCT01398449|esophagectomy|esophagectomy
5475522|NCT01398449|elective nodal irradiation|elective nodal irradiation
5475523|NCT01398449|adjuvant chemotherapy|adjuvant chemotherapy
5475524|NCT01398436|Central venous saturation|central venous saturation
5475525|NCT01398436|Mixed venous saturation|mixed venous saturation
5475526|NCT01398436|Right atrium|right atrium
5475527|NCT01398436|Central Venous Catheter position|central venous catheter position
5475528|NCT01398423|Hypertension|hypertension
5475529|NCT01398423|Diabetes mellitis|diabetes mellitis
5475530|NCT01398423|Nephropathy|nephropathy
5475531|NCT01398423|Albuminuria|albuminuria
5475532|NCT01398410|Rabeprazole|rabeprazole
5475533|NCT01398410|proton pump inhibitor|proton pump inhibitor
5475534|NCT01398410|Acetylsalicylic Acid|acetylsalicylic acid
5475535|NCT01398410|Aspirin|aspirin
5475536|NCT01398410|Gastric Ulcer|gastric ulcer
5475537|NCT01398410|Duodenal Ulcer|duodenal ulcer
5475539|NCT01398397|XLHED|xlhed
5475540|NCT01398397|X-linked Hypohidrotic Ectodermal Dysplasia (XLHED)|x-linked hypohidrotic ectodermal dysplasia (xlhed)
5475541|NCT01398384|ST Elevation MI|st elevation mi
5475542|NCT01398384|STEMI|stemi
5475543|NCT01398371|Heart failure|heart failure
5475544|NCT01398371|Digoxin withdrawal|digoxin withdrawal
5475545|NCT01398358|obesity|obesity
5475546|NCT01398358|prevention|prevention
5475547|NCT01398358|children|children
5475548|NCT01398319|prevention|prevention
5475549|NCT01398319|alcohol abuse|alcohol abuse
5475550|NCT01398306|Angiogenesis Inhibitors|angiogenesis inhibitors
5475551|NCT01398306|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5475552|NCT01398306|Neoplasms by Histologic Type|neoplasms by histologic type
5475553|NCT01398306|Neoplasms|neoplasms
5475554|NCT01398306|Adenocarcinoma|adenocarcinoma
5475555|NCT01398306|Kidney Neoplasms|kidney neoplasms
5475556|NCT01398306|Urologic Neoplasms|urologic neoplasms
5475557|NCT01398306|Urogenital Neoplasms|urogenital neoplasms
5475558|NCT01398306|Neoplasms by Site|neoplasms by site
5475559|NCT01398306|Kidney Diseases|kidney diseases
5475560|NCT01398306|Angiogenesis Inducing Agents|angiogenesis inducing agents
5475561|NCT01398306|Biological Markers|biological markers
5475562|NCT01398280|Rosacea|rosacea
5475563|NCT01398280|Dermatology|dermatology
5475564|NCT01398280|UCSD|ucsd
5475565|NCT01398280|Skin disease|skin disease
5475566|NCT01398254|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5475567|NCT01398254|Mortality|mortality
5475568|NCT01398228|Quality of care|quality of care
5475569|NCT01398228|Acute Coronary Syndromes (ACS)|acute coronary syndromes (acs)
5475570|NCT01398215|umbilical hernia|umbilical hernia
5475571|NCT01398215|ventral hernia|ventral hernia
5475572|NCT01398202|Vitamin D status|vitamin d status
5475573|NCT01398202|25-hydroxyvitamin D|25-hydroxyvitamin d
5475574|NCT01398202|Vitamin D3|vitamin d3
5475575|NCT01398202|RCT|rct
5475576|NCT01398202|Bio-efficacy|bio-efficacy
5475577|NCT01398189|clozapine|clozapine
5475578|NCT01398189|PET|pet
5475579|NCT01398189|schizophrenia|schizophrenia
5475580|NCT01398189|schizoaffective disorder|schizoaffective disorder
5475581|NCT01398176|gamma delta T cell|gamma delta t cell
5475582|NCT01398176|proliferation|proliferation
5475583|NCT01398163|probiotics|probiotics
5475584|NCT01398163|digestive well-being|digestive well-being
5475585|NCT01398163|fMRI|fmri
5475586|NCT01398163|brain-gut axis|brain-gut axis
5475587|NCT01398150|gamma delta T cell|gamma delta t cell
5475588|NCT01398150|proliferation|proliferation
5475589|NCT01398150|cytokine secretion|cytokine secretion
5475590|NCT01398150|immune function|immune function
5475591|NCT01398150|antioxidant status|antioxidant status
5475592|NCT01398137|Ragweed allergy|ragweed allergy
5475593|NCT01398124|early stage non-small cell lung cancer|early stage non-small cell lung cancer
5475594|NCT01398124|non-small cell lung cancer|non-small cell lung cancer
5475595|NCT01398085|Papillary thyroid carcinoma|papillary thyroid carcinoma
5475596|NCT01398085|Follicular thyroid carcinoma|follicular thyroid carcinoma
5475597|NCT01398085|Hurthle cell carcinoma of the thyroid|hurthle cell carcinoma of the thyroid
5475598|NCT01398085|Iodine Radioisotopes|iodine radioisotopes
5475599|NCT01398059|Sedentary Behavior|sedentary behavior
5475600|NCT01398059|Cardiometabolic Risk|cardiometabolic risk
5475601|NCT01398059|Pediatrics|pediatrics
5475602|NCT01398046|dasatinib|dasatinib
5475603|NCT01398046|betaine|betaine
5475604|NCT01398046|betaine hydrochloride|betaine hydrochloride
5475605|NCT01398046|pharmacokinetics|pharmacokinetics
5475606|NCT01398046|healthy volunteer|healthy volunteer
5475607|NCT01398033|infrapopliteal arteries|infrapopliteal arteries
5475608|NCT01398033|In-stent stenosis|in-stent stenosis
5475609|NCT01398033|long lesions|long lesions
5475610|NCT01398033|drug-coated balloon|drug-coated balloon
5475611|NCT01398020|Bowel Preparation|bowel preparation
5475612|NCT01398020|Patient comfort|patient comfort
5475613|NCT01398020|Bi-Peglyte|bi-peglyte
5475614|NCT01397994|Nicorandil therapy in patients of chronic stable angina|nicorandil therapy in patients of chronic stable angina
5475615|NCT01397968|partial onset seizures|partial onset seizures
5475616|NCT01397968|treatment resistant|treatment resistant
5475617|NCT01397968|partial epilepsy|partial epilepsy
5475618|NCT01397955|Julina|julina
5475619|NCT01397955|Postmenopausal osteoporosis|postmenopausal osteoporosis
5475620|NCT01397942|Diet intervention|diet intervention
5475622|NCT01397942|Vegetables|vegetables
5475623|NCT01397942|Phytochemicals|phytochemicals
5475625|NCT01397916|IDO|ido
5475626|NCT01397903|antidepressant therapy, inadequate control, add-on therapy|antidepressant therapy, inadequate control, add-on therapy
5475627|NCT01397890|Severe chronic obstructive pulmonary disease (COPD) patients|severe chronic obstructive pulmonary disease (copd) patients
5475628|NCT01397877|endometrial cancer|endometrial cancer
5475629|NCT01397877|BKM|bkm
5475630|NCT01397877|monotherapy|monotherapy
5475631|NCT01397877|metastatic|metastatic
5475632|NCT01397877|initial treatment|initial treatment
5475633|NCT01397864|Hereditary Angioedema|hereditary angioedema
5475634|NCT01397864|HAE|hae
5475635|NCT01397864|Angioedema|angioedema
5475636|NCT01397864|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5475637|NCT01397864|rhC1INH|rhc1inh
5475638|NCT01397864|registry|registry
5475639|NCT01397838|Osteopenia|osteopenia
5475640|NCT01397812|Rejection of the Heart Transplant|rejection of the heart transplant
5475641|NCT01397812|Heart Transplant Rejection, an immune-mediated allograft injury|heart transplant rejection, an immune-mediated allograft injury
5475737|NCT01397331|intravenous anesthesia|intravenous anesthesia
5457895|NCT01470040|aspirin|aspirin
5475642|NCT01397812|Non-cellular or humoral rejection in cardiac transplant recipients|non-cellular or humoral rejection in cardiac transplant recipients
5475643|NCT01397812|Right ventricular endomyocardial biopsy to detect Heart transplant rejection|right ventricular endomyocardial biopsy to detect heart transplant rejection
5475644|NCT01397799|Acute Myelogenous Leukemia|acute myelogenous leukemia
5475645|NCT01397799|AML|aml
5475646|NCT01397799|Refractory|refractory
5475647|NCT01397799|Elderly|elderly
5475648|NCT01397773|Hemodialysis|hemodialysis
5475649|NCT01397773|peritoneal dialysis|peritoneal dialysis
5475650|NCT01397773|chronic kidney disease|chronic kidney disease
5475651|NCT01397773|inflammation|inflammation
5475652|NCT01397773|carotis intima media thickness|carotis intima media thickness
5475653|NCT01397760|DIFFICULT TO CONTROL ASTHMA|difficult to control asthma
5475654|NCT01397760|OMALIZUMABE|omalizumabe
5475655|NCT01397747|Cancer|cancer
5475656|NCT01397747|Colorectal Cancer|colorectal cancer
5475657|NCT01397747|Neoplasm|neoplasm
5475658|NCT01397747|Colorectal Neoplasm|colorectal neoplasm
5475659|NCT01397747|Intestinal Neoplasms|intestinal neoplasms
5475660|NCT01397747|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5475661|NCT01397747|Digestive System Neoplasms|digestive system neoplasms
5475662|NCT01397747|Neoplasms by Site|neoplasms by site
5475663|NCT01397747|Neoplasms|neoplasms
5475664|NCT01397747|Digestive System Diseases|digestive system diseases
5475665|NCT01397747|Gastrointestinal Diseases|gastrointestinal diseases
5475666|NCT01397747|Colonic Diseases|colonic diseases
5475667|NCT01397747|Intestinal Diseases|intestinal diseases
5475668|NCT01397747|Rectal Diseases|rectal diseases
5475669|NCT01397734|CML|cml
5475670|NCT01397734|Chronic myelogenous leukemia|chronic myelogenous leukemia
5475671|NCT01397734|Chronic Myeloid leukemia|chronic myeloid leukemia
5475672|NCT01397734|Arsenic|arsenic
5475673|NCT01397734|Arsenic trioxide|arsenic trioxide
5475674|NCT01397734|Imatinib|imatinib
5475675|NCT01397734|Dasatinib|dasatinib
5475676|NCT01397734|Nilotinib|nilotinib
5475677|NCT01397734|TKI|tki
5475678|NCT01397734|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5475679|NCT01397721|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5475685|NCT01397708|Melanoma|melanoma
5475686|NCT01397708|Unresectable|unresectable
5475687|NCT01397682|Comprehensive Geriatric Assessment|comprehensive geriatric assessment
5475688|NCT01397682|Frail elderly|frail elderly
5475689|NCT01397682|Italy/epidemiology|italy/epidemiology
5475690|NCT01397682|Geriatric Health Service|geriatric health service
5475691|NCT01397682|Polypharmacy|polypharmacy
5475692|NCT01397682|Biological Markers|biological markers
5475693|NCT01397682|Epidemiologic Research Design|epidemiologic research design
5475694|NCT01397656|cardiac arrest|cardiac arrest
5475695|NCT01397656|CPR|cpr
5475696|NCT01397656|resuscitation|resuscitation
5475697|NCT01397656|fatigue|fatigue
5475698|NCT01397656|quality|quality
5475699|NCT01397565|Cholecystectomy|cholecystectomy
5475700|NCT01397565|Laparoscopy|laparoscopy
5475701|NCT01397565|Minilaparoscopic surgery|minilaparoscopic surgery
5475702|NCT01397565|Post-operative pain|post-operative pain
5475703|NCT01397565|Recovery time|recovery time
5475704|NCT01397526|Congenital heart disease|congenital heart disease
5475705|NCT01397526|Cardiopulmonary bypass|cardiopulmonary bypass
5475706|NCT01397526|Capillary leak|capillary leak
5475707|NCT01397526|Colloid osmotic pressure|colloid osmotic pressure
5475708|NCT01397526|Children|children
5475709|NCT01397513|Fibrin network structure|fibrin network structure
5475710|NCT01397513|Aspirin treatment|aspirin treatment
5475711|NCT01397513|Platelet microparticles|platelet microparticles
5475712|NCT01397487|morphometric parameters, embryo biopsy|morphometric parameters, embryo biopsy
5475713|NCT01397474|peripheral perfusion|peripheral perfusion
5475717|NCT01397448|proton pump inhibitor|proton pump inhibitor
5475718|NCT01397448|Acetylsalicylic Acid|acetylsalicylic acid
5475720|NCT01397448|Gastric Ulcer|gastric ulcer
5475721|NCT01397448|Duodenal Ulcer|duodenal ulcer
5475722|NCT01397435|Lysosomal diseases|lysosomal diseases
5475723|NCT01397435|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
5475724|NCT01397435|MRI|mri
5475725|NCT01397422|Levodopa-induced dyskinesia|levodopa-induced dyskinesia
5475726|NCT01397422|Parkinsonism|parkinsonism
5475727|NCT01397370|Safety|safety
5475728|NCT01397370|Tolerability|tolerability
5475729|NCT01397370|Pharmacokinetics|pharmacokinetics
5475730|NCT01397370|Pharmacodynamics|pharmacodynamics
5475731|NCT01397357|Cardiac magnetic resonance|cardiac magnetic resonance
5475732|NCT01397357|Myocardial Ischemia|myocardial ischemia
5475733|NCT01397357|Coronary Artery Disease|coronary artery disease
5475734|NCT01397357|suspected Myocardial Ischemia|suspected myocardial ischemia
5475735|NCT01397344|People in the outpatient waiting room|people in the outpatient waiting room
5475736|NCT01397331|inhalational anesthesia|inhalational anesthesia
5475738|NCT01397331|cardiac surgery|cardiac surgery
5475739|NCT01397318|TaiChi Exercise|taichi exercise
5475740|NCT01397318|pregnant women|pregnant women
5475741|NCT01397305|5,10-methylenetetrahydrofolate|5,10-methylenetetrahydrofolate
5475742|NCT01397305|neoadjuvant therapy|neoadjuvant therapy
5475743|NCT01397305|pemetrexed|pemetrexed
5475744|NCT01397305|Neoplasms|neoplasms
5475745|NCT01397305|Rectal Neoplasms|rectal neoplasms
5475746|NCT01397305|Colorectal Neoplasms|colorectal neoplasms
5475747|NCT01397305|Intestinal Neoplasms|intestinal neoplasms
5475748|NCT01397305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5475749|NCT01397305|Digestive System Neoplasms|digestive system neoplasms
5475750|NCT01397305|Neoplasms by Site|neoplasms by site
5475751|NCT01397305|Rectal Diseases|rectal diseases
5475752|NCT01397305|Digestive System Diseases|digestive system diseases
5475753|NCT01397305|Gastrointestinal Diseases|gastrointestinal diseases
5475754|NCT01397305|Intestinal Diseases|intestinal diseases
5475755|NCT01397305|Pharmacologic Actions|pharmacologic actions
5475756|NCT01397305|Therapeutic Uses|therapeutic uses
5475757|NCT01397305|Antineoplastic Agents|antineoplastic agents
5475758|NCT01397305|Enzyme Inhibitors|enzyme inhibitors
5475759|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5475760|NCT01397305|Folic Acid Antagonists|folic acid antagonists
5475761|NCT01397305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5475762|NCT01397305|Antimetabolites|antimetabolites
5475763|NCT01397292|Bronchoscopy|bronchoscopy
5475764|NCT01397292|Interventional Pulmonary|interventional pulmonary
5475765|NCT01397292|Pleuroscopy|pleuroscopy
5475766|NCT01397292|Tracheostomy|tracheostomy
5475767|NCT01397279|type 2 diabetes|type 2 diabetes
5475768|NCT01397279|insulin sensitivity|insulin sensitivity
5475769|NCT01397279|hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5475770|NCT01397266|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5475771|NCT01397266|Cocaine|cocaine
5475772|NCT01397266|impulsivity|impulsivity
5475773|NCT01397266|rating scale|rating scale
5470292|NCT01419873|Insulin|insulin
5475774|NCT01397253|Automated Communication Tools|automated communication tools
5475776|NCT01397253|PCP communication|pcp communication
5475777|NCT01397227|Malaria|malaria
5475778|NCT01397227|Plasmodium falciparum|plasmodium falciparum
5475779|NCT01397227|Vaccination|vaccination
5475780|NCT01397227|Prophylaxis|prophylaxis
5475781|NCT01397227|Adenovirus|adenovirus
5475782|NCT01397188|PiCCO|picco
5475783|NCT01397175|Coronary artery disease|coronary artery disease
5475910|NCT01396629|cartridge IOL|cartridge iol
5475784|NCT01397175|Percutaneous coronary intervention|percutaneous coronary intervention
5475785|NCT01397175|Drug-eluting stent|drug-eluting stent
5475786|NCT01397149|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5475787|NCT01397149|Thrombocytopenia|thrombocytopenia
5475788|NCT01397149|Alkylating agents|alkylating agents
5475789|NCT01397149|Purine derivatives|purine derivatives
5475790|NCT01397149|TPO receptor agonist|tpo receptor agonist
5475791|NCT01397136|Human embryo|human embryo
5475792|NCT01397136|Culture media|culture media
5475793|NCT01397136|Cell-free DNA|cell-free dna
5475794|NCT01397136|In vitro fertilization|in vitro fertilization
5475795|NCT01397136|Infertility|infertility
5475796|NCT01397123|BMI z-score|bmi z-score
5475797|NCT01397123|children|children
5475798|NCT01397123|overweight|overweight
5475799|NCT01397123|school-based intervention|school-based intervention
5475800|NCT01397123|trained teachers|trained teachers
5475801|NCT01397123|fruit|fruit
5475802|NCT01397123|vegetables|vegetables
5475803|NCT01397123|Low nutrition energy dense foods|low nutrition energy dense foods
5475804|NCT01397084|esomeprazole 20mg|esomeprazole 20mg
5475805|NCT01397084|heartburn|heartburn
5475807|NCT01397084|reflux esophagitis|reflux esophagitis
5475808|NCT01397084|Phase IV|phase iv
5475809|NCT01397071|Avocado, antioxidant|avocado, antioxidant
5475810|NCT01397045|Lung|lung
5475811|NCT01397045|Nodule|nodule
5475812|NCT01397045|Rehabilitation|rehabilitation
5475813|NCT01397045|VATS|vats
5475814|NCT01397045|Thoracotomy|thoracotomy
5475815|NCT01397032|attention bias modification treatment|attention bias modification treatment
5475816|NCT01397032|cognitive bias modification|cognitive bias modification
5475817|NCT01397032|attention training|attention training
5475818|NCT01397032|social anxiety|social anxiety
5475819|NCT01397019|Pancreatic cancer|pancreatic cancer
5475820|NCT01397019|Chemotherapy|chemotherapy
5475821|NCT01397019|Chemoradiotherapy|chemoradiotherapy
5475822|NCT01397006|Fibromyalgia|fibromyalgia
5475823|NCT01397006|pregabalin|pregabalin
5475824|NCT01397006|Lyrica|lyrica
5475825|NCT01396980|hemodialysis|hemodialysis
5475826|NCT01396980|intensive care|intensive care
5475827|NCT01396980|microcirculation|microcirculation
5475828|NCT01396967|capsulorhexis|capsulorhexis
5475829|NCT01396954|Liver cirrhosis|liver cirrhosis
5475830|NCT01396954|Diabetes mellitus|diabetes mellitus
5475831|NCT01396954|Hepatogenous diabetes|hepatogenous diabetes
5475832|NCT01396954|Oral glucose tolerance test|oral glucose tolerance test
5475833|NCT01396954|Insulin resistance.|insulin resistance.
5475834|NCT01396941|Diabetes|diabetes
5475835|NCT01396928|Low rectal adenocarcinoma|low rectal adenocarcinoma
5475836|NCT01396915|Skeletal muscle lipid content|skeletal muscle lipid content
5475837|NCT01396915|whole muscle volume|whole muscle volume
5475838|NCT01396915|fasting glucose|fasting glucose
5475839|NCT01396915|insulin|insulin
5475840|NCT01396915|blood urea nitrogen|blood urea nitrogen
5680287|NCT00578370|Cyclosporin|cyclosporin
5475841|NCT01396889|Upper Respiratory Tract Infections|upper respiratory tract infections
5475842|NCT01396889|Echinacea|echinacea
5475843|NCT01396889|viral infections|viral infections
5475844|NCT01396876|Medical clown|medical clown
5475845|NCT01396876|Pediatric emergency medicine|pediatric emergency medicine
5475846|NCT01396876|Emergency procedures|emergency procedures
5475847|NCT01396863|Renal dialysis|renal dialysis
5475848|NCT01396863|Hemodiafiltration|hemodiafiltration
5475849|NCT01396863|Hemodialysis|hemodialysis
5475851|NCT01396850|Psychotic Patients|psychotic patients
5475852|NCT01396837|Diabetic Foot Ulcer|diabetic foot ulcer
5475853|NCT01396837|Diabetic Ulcer|diabetic ulcer
5475854|NCT01396837|Diabetic Wound|diabetic wound
5475855|NCT01396837|Chronic Ulcer|chronic ulcer
5475856|NCT01396837|Chronic Wound|chronic wound
5475857|NCT01396837|Neuropathic Diabetic Foot Ulcer|neuropathic diabetic foot ulcer
5475858|NCT01396837|Neuropathic DFU|neuropathic dfu
5475859|NCT01396837|DFU|dfu
5475860|NCT01396824|Malnutrition|malnutrition
5475861|NCT01396824|Undernutrition|undernutrition
5475862|NCT01396824|Nutrition Assessment|nutrition assessment
5475863|NCT01396824|Nutritional Assessment|nutritional assessment
5475864|NCT01396824|Nutritional Index|nutritional index
5475865|NCT01396824|Prognostic Nutritional Index|prognostic nutritional index
5475866|NCT01396824|Prognostic Nutritional Index (PNI)|prognostic nutritional index (pni)
5475867|NCT01396824|Nutritional Status|nutritional status
5475868|NCT01396824|Prognosis|prognosis
5475869|NCT01396824|Heart Failure|heart failure
5475870|NCT01396824|Cardiovascular Diseases|cardiovascular diseases
5475871|NCT01396824|Body Composition|body composition
5475872|NCT01396824|Body Weights and Measures|body weights and measures
5475873|NCT01396811|Tinea Pedis|tinea pedis
5475874|NCT01396811|Antifungal|antifungal
5475875|NCT01396798|serious infections|serious infections
5475876|NCT01396798|meningitis|meningitis
5475877|NCT01396785|Tinea Pedis|tinea pedis
5475878|NCT01396785|Antifungal|antifungal
5475879|NCT01396772|prediabetes|prediabetes
5475880|NCT01396772|diabetes prevention|diabetes prevention
5475881|NCT01396772|adults|adults
5475882|NCT01396772|lifestyle intervention|lifestyle intervention
5475883|NCT01396772|Social Cognitive Theory|social cognitive theory
5475884|NCT01396772|dietary intake|dietary intake
5475885|NCT01396772|physical activity|physical activity
5475886|NCT01396759|Bubble CPAP|bubble cpap
5475887|NCT01396759|Humidified high flow|humidified high flow
5475888|NCT01396759|Hypoxaemia|hypoxaemia
5475889|NCT01396759|Nasal prong|nasal prong
5475890|NCT01396759|Severe pneumonia|severe pneumonia
5475891|NCT01396733|thyroid|thyroid
5475892|NCT01396733|cancer|cancer
5475893|NCT01396733|redifferentiation|redifferentiation
5475894|NCT01396733|lipoic acid|lipoic acid
5475895|NCT01396707|HER2|her2
5475896|NCT01396707|Trastuzumab|trastuzumab
5475897|NCT01396707|XELOX|xelox
5475898|NCT01396707|PHASE 2|phase 2
5475899|NCT01396681|resected pancreatic cancer|resected pancreatic cancer
5475900|NCT01396668|locally advanced|locally advanced
5475901|NCT01396655|breast cancer|breast cancer
5475902|NCT01396655|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5475903|NCT01396655|molecular marker|molecular marker
5475904|NCT01396655|FDG PET|fdg pet
5475905|NCT01396655|locally advanced breast cancer|locally advanced breast cancer
5475906|NCT01396642|Topical Emollient Therapy|topical emollient therapy
5475907|NCT01396642|Emollient|emollient
5475908|NCT01396642|Preterm|preterm
5475913|NCT01396603|Optical biopsy|optical biopsy
5475914|NCT01396603|Comprehensive Microscopy|comprehensive microscopy
5475915|NCT01396590|Central Nervous System|central nervous system
5475916|NCT01396577|Central Nervous System|central nervous system
5475917|NCT01396564|Type 2 diabetes|type 2 diabetes
5475918|NCT01396564|Resistin|resistin
5475919|NCT01396564|Inflammation|inflammation
5475920|NCT01396564|Insulin Resistance|insulin resistance
5475921|NCT01396551|Anchored Beacon Transponder|anchored beacon transponder
5475922|NCT01396551|Anchored Transponder|anchored transponder
5475923|NCT01396551|Lung cancer|lung cancer
5475924|NCT01396551|Calypso system|calypso system
5475925|NCT01396551|Realtime tracking|realtime tracking
5475926|NCT01396538|anti-HBc alone ；occult HBV infection|anti-hbc alone ；occult hbv infection
5475927|NCT01396525|Atherosclerosis|atherosclerosis
5475928|NCT01396525|Peripheral artery disease|peripheral artery disease
5475929|NCT01396525|Peripheral vascular disease|peripheral vascular disease
5475931|NCT01396525|Claudication|claudication
5475932|NCT01396525|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5475933|NCT01396525|Stent|stent
5475934|NCT01396525|PAOD|paod
5475935|NCT01396525|PVD|pvd
5475936|NCT01396512|Japanese Encephalitis|japanese encephalitis
5475937|NCT01396512|Japanese Encephalitis Virus Disease|japanese encephalitis virus disease
5475938|NCT01396512|IMOJEV™|imojev™
5475939|NCT01396512|CD.JEVAX™|cd.jevax™
5475940|NCT01396499|Leukemia|leukemia
5475941|NCT01396499|Acute leukemias|acute leukemias
5475942|NCT01396499|Relapsed/refractory leukemias|relapsed/refractory leukemias
5475943|NCT01396499|Acute myelogenous leukemia|acute myelogenous leukemia
5475944|NCT01396499|AML|aml
5475945|NCT01396499|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5475946|NCT01396499|ALL|all
5475947|NCT01396499|BKM120|bkm120
5475948|NCT01396486|Omega-3 Fatty Acids|omega-3 fatty acids
5475949|NCT01396486|Fish Oil|fish oil
5475950|NCT01396486|Inositol|inositol
5475951|NCT01396486|Natural supplements|natural supplements
5475952|NCT01396486|Bipolar Spectrum Disorders|bipolar spectrum disorders
5475953|NCT01396486|Mania|mania
5475954|NCT01396486|Depression|depression
5475955|NCT01396486|Children|children
5475956|NCT01396473|afterschool|afterschool
5475957|NCT01396473|accelerometers|accelerometers
5475958|NCT01396473|plate waste|plate waste
5475959|NCT01396473|policy|policy
5475960|NCT01396473|environment|environment
5475961|NCT01396460|respiratory quotient|respiratory quotient
5475962|NCT01396460|fat oxidation|fat oxidation
5475963|NCT01396460|morbid obesity|morbid obesity
5475964|NCT01396460|bariatric|bariatric
5475965|NCT01396460|Bariatric Surgery|bariatric surgery
5475966|NCT01396447|Bipolar I disorder|bipolar i disorder
5475967|NCT01396447|Bipolar depression|bipolar depression
5475968|NCT01396447|Depression|depression
5475969|NCT01396447|Bipolar disorder|bipolar disorder
5475970|NCT01396395|Nicorandil|nicorandil
5475971|NCT01396395|Stable angina|stable angina
5475972|NCT01396382|neuroendocrine|neuroendocrine
5475973|NCT01396382|neuroendocrine carcinoma|neuroendocrine carcinoma
5475974|NCT01396382|neuroendocrine tumor|neuroendocrine tumor
5475975|NCT01396382|carcinoid|carcinoid
5475976|NCT01396382|carcinoid tumor|carcinoid tumor
5475977|NCT01396382|islet cell tumor|islet cell tumor
5475978|NCT01396382|APUDoma|apudoma
5475979|NCT01396382|Gallium|gallium
5475981|NCT01396343|Pediatric Multiple Sclerosis|pediatric multiple sclerosis
5475982|NCT01396343|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5475983|NCT01396343|Clinically Isolated Syndrome|clinically isolated syndrome
5475984|NCT01396343|Demyelinating Disease|demyelinating disease
5475985|NCT01396317|PMR|pmr
5475986|NCT01396317|POLYMYALGIA RHEUMATICA|polymyalgia rheumatica
5475987|NCT01396317|Tocilizumab|tocilizumab
5475988|NCT01396317|Hospital for Special Surgery|hospital for special surgery
5475989|NCT01396317|HSS|hss
5475990|NCT01396317|Robert Spiera|robert spiera
5475991|NCT01396304|leg ulcer|leg ulcer
5475992|NCT01396304|infection|infection
5475993|NCT01396304|closure|closure
5475994|NCT01396304|wound dressings|wound dressings
5475995|NCT01396239|DMD|dmd
5475996|NCT01396226|Atrial refractoriness|atrial refractoriness
5475997|NCT01396226|cardiac electrophysiology|cardiac electrophysiology
5475998|NCT01396226|IKACh|ikach
5475999|NCT01396213|larazotide acetate|larazotide acetate
5476000|NCT01396187|Type 2 diabetes|type 2 diabetes
5476001|NCT01396187|safety|safety
5476002|NCT01396187|multiple dose|multiple dose
5476003|NCT01396187|intravenous|intravenous
5476004|NCT01396174|breast cancer|breast cancer
5476005|NCT01396174|breast tumor|breast tumor
5476006|NCT01396161|Phase 1|phase 1
5476007|NCT01396161|Multiple Doses|multiple doses
5476008|NCT01396161|Safety|safety
5476009|NCT01396161|Pharmacokinetics|pharmacokinetics
5476010|NCT01396161|Pharmacodynamics|pharmacodynamics
5476011|NCT01396161|Healthy Volunteers|healthy volunteers
5476012|NCT01396161|Type 2 Diabetic Patients|type 2 diabetic patients
5476013|NCT01396148|Children and young adults with GIST|children and young adults with gist
5476014|NCT01396148|sunitinib malate|sunitinib malate
5476015|NCT01396148|pharmacokinetics|pharmacokinetics
5476016|NCT01396148|tumor response|tumor response
5476017|NCT01396148|overall survival|overall survival
5476018|NCT01396148|tumor KIT mutation status|tumor kit mutation status
5476019|NCT01396135|Phase 1|phase 1
5476020|NCT01396135|Pharmacokinetics|pharmacokinetics
5476021|NCT01396135|Healthy|healthy
5476022|NCT01396135|Japanese|japanese
5476023|NCT01396135|Non-smokers|non-smokers
5476024|NCT01396135|Major Depressive Disorder|major depressive disorder
5476025|NCT01396135|CP-601|cp-601
5476026|NCT01396135|927|927
5476027|NCT01396096|Bariatric Surgery|bariatric surgery
5476028|NCT01396083|Visual impairment|visual impairment
5476029|NCT01396083|macular edema|macular edema
5476030|NCT01396083|Central retinal vein occlusion|central retinal vein occlusion
5476031|NCT01396083|Dexamethasone implant|dexamethasone implant
5476032|NCT01396083|Ranibizumab|ranibizumab
5476033|NCT01396057|Visual impairment|visual impairment
5476034|NCT01396057|macular edema|macular edema
5476035|NCT01396057|branch retinal vein occlusion|branch retinal vein occlusion
5476036|NCT01396057|Dexamethasone implant|dexamethasone implant
5476037|NCT01396057|Ranibizumab|ranibizumab
5476038|NCT01396044|Quality improvement|quality improvement
5476039|NCT01396044|Checklist|checklist
5476040|NCT01396044|Critical care|critical care
5476041|NCT01396044|Anti-bacterial agents|anti-bacterial agents
5476042|NCT01396044|Mechanical ventilation|mechanical ventilation
5476043|NCT01395966|with tubes|with tubes
5476044|NCT01395953|Buspirone|buspirone
5476045|NCT01395953|Buspar|buspar
5476046|NCT01395953|Autism Spectrum Disorders|autism spectrum disorders
5680288|NCT00578370|Psoriasis|psoriasis
5476047|NCT01395953|Pervasive Developmental Disorders|pervasive developmental disorders
5476048|NCT01395953|Children|children
5476049|NCT01395953|Adolescents|adolescents
5476050|NCT01395953|Anxiety|anxiety
5476051|NCT01395940|Gonadotropin-Releasing Hormone (GnRH) antagonist|gonadotropin-releasing hormone (gnrh) antagonist
5476052|NCT01395927|Canagliflozin|canagliflozin
5476053|NCT01395927|Rifampin|rifampin
5476054|NCT01395927|Pharmacokinetics|pharmacokinetics
5476055|NCT01395901|Prevention of Postoperative Nausea and Vomiting|prevention of postoperative nausea and vomiting
5476056|NCT01395901|Palonosetron|palonosetron
5476057|NCT01395901|Ondansetron|ondansetron
5476058|NCT01395901|Pediatric|pediatric
5476059|NCT01395836|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5476060|NCT01395836|Cardiology|cardiology
5476061|NCT01395836|Cardiac Electrophysiology|cardiac electrophysiology
5476062|NCT01395836|Cardiac Surgery|cardiac surgery
5476063|NCT01395784|Oxycodone|oxycodone
5476064|NCT01395784|Opioid abuse|opioid abuse
5476065|NCT01395771|Effect|effect
5476066|NCT01395771|Phone call|phone call
5476067|NCT01395771|Intervention|intervention
5476068|NCT01395771|Promote|promote
5476069|NCT01395771|HAART adherence|haart adherence
5476070|NCT01395758|KRAS mutation|kras mutation
5476071|NCT01395758|metastatic NSCLC|metastatic nsclc
5476072|NCT01395745|SLE|sle
5476073|NCT01395745|Lupus|lupus
5476074|NCT01395745|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5476075|NCT01395745|Autoimmune Diseases|autoimmune diseases
5476076|NCT01395745|A-623|a-623
5476077|NCT01395745|Blisibimod|blisibimod
5476078|NCT01395719|renal transplantation|renal transplantation
5476079|NCT01395719|glomerular filtration rate|glomerular filtration rate
5476080|NCT01395719|remote ischemic preconditioning|remote ischemic preconditioning
5476081|NCT01395719|remote ischemic conditioning|remote ischemic conditioning
5476082|NCT01395706|Malignant Neoplasm of Breast|malignant neoplasm of breast
5476083|NCT01395706|Sentinel lymph node detection|sentinel lymph node detection
5476084|NCT01395706|ICG fluorescence technique|icg fluorescence technique
5476085|NCT01395706|Population of male and female patients with mamma carcinoma|population of male and female patients with mamma carcinoma
5476086|NCT01395680|cancer adolescent|cancer adolescent
5476087|NCT01395680|resilience|resilience
5476088|NCT01395641|Aromatic Amino Acid Decarboxylase|aromatic amino acid decarboxylase
5476089|NCT01395641|AADC|aadc
5476090|NCT01395641|DDC|ddc
5476091|NCT01395641|Gene Therapy|gene therapy
5476092|NCT01395641|AAV2-AADC|aav2-aadc
5476093|NCT01395641|Viral Vector|viral vector
5476094|NCT01395641|Gene Transfer|gene transfer
5476095|NCT01395641|Aromatic L-Amino Acid Decarboxylase Deficiency|aromatic l-amino acid decarboxylase deficiency
5476096|NCT01395628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5685321|NCT00556543|Implant|implant
5476097|NCT01395628|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5476098|NCT01395628|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5476099|NCT01395628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5476100|NCT01395628|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5846739|NCT00043628|Myocardial Contractility|myocardial contractility
5476101|NCT01395628|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5476103|NCT01395589|clinical trial|clinical trial
5476104|NCT01395589|exacerbation|exacerbation
5476105|NCT01395589|pediatrics|pediatrics
5476106|NCT01395576|Genu recurvatum|genu recurvatum
5476107|NCT01395576|Knee hyper extension|knee hyper extension
5476108|NCT01395576|Orthosis|orthosis
5476109|NCT01395576|Gait analysis|gait analysis
5476110|NCT01395576|Post stroke|post stroke
5476111|NCT01395524|Non-Cancer-Related Pain|non-cancer-related pain
5476112|NCT01395524|Opioid-Induced Constipation.|opioid-induced constipation.
5476113|NCT01395511|whiplash associated disorder,|whiplash associated disorder,
5476114|NCT01395511|Intractable Traumatic Cervical Syndrome,|intractable traumatic cervical syndrome,
5476115|NCT01395511|Acupuncture,|acupuncture,
5476116|NCT01395511|Randomized controlled trial|randomized controlled trial
5476118|NCT01395498|PCP|pcp
5476119|NCT01395498|bronchoalveolar lavage|bronchoalveolar lavage
5476120|NCT01395485|Amgen|amgen
5476121|NCT01395485|Adolescent|adolescent
5476122|NCT01395485|Single Dose|single dose
5476123|NCT01395485|Safety|safety
5476124|NCT01395485|Pharmacokinetics|pharmacokinetics
5476125|NCT01395472|TBI|tbi
5476126|NCT01395472|Acute physical exercise|acute physical exercise
5476127|NCT01395472|Cognitive functions|cognitive functions
5476128|NCT01395472|Mood|mood
5476129|NCT01395459|screening|screening
5476130|NCT01395459|cancer prevention|cancer prevention
5476131|NCT01395459|IVR|ivr
5476132|NCT01395433|Assessing the bioequivalence of escitalopram dosage forms|assessing the bioequivalence of escitalopram dosage forms
5476133|NCT01395420|Phase 1|phase 1
5476134|NCT01395420|open label|open label
5476135|NCT01395420|healthy male and female (post menopausal) volunteers|healthy male and female (post menopausal) volunteers
5476136|NCT01395420|Pharmacokinetics|pharmacokinetics
5476137|NCT01395420|CAZ104|caz104
5476138|NCT01395420|Avibactam|avibactam
5476139|NCT01395420|Ceftazidime|ceftazidime
5607421|NCT00868959|Bipolar|bipolar
5789982|NCT00146276|locally advanced bladder cancer|locally advanced bladder cancer
5789987|NCT00146237|phenytoin|phenytoin
5476140|NCT01395420|open label, at least 2 different regimens, concentration of investigational product (IP), CAZ104, Avibactam, Ceftazidime, Cmax, tmax|open label, at least 2 different regimens, concentration of investigational product (ip), caz104, avibactam, ceftazidime, cmax, tmax
5476141|NCT01395407|Brain|brain
5476142|NCT01395407|Neoplasm|neoplasm
5476143|NCT01395407|Neoplasm Metastasis|neoplasm metastasis
5476144|NCT01395407|Radiosurgery|radiosurgery
5476145|NCT01395394|Phenylketonuria|phenylketonuria
5476146|NCT01395394|PKU|pku
5476147|NCT01395394|tetrahydrobiopterin|tetrahydrobiopterin
5476148|NCT01395394|sapropterin dihydrochloride|sapropterin dihydrochloride
5476149|NCT01395394|BH4|bh4
5476150|NCT01395394|Kuvan|kuvan
5476151|NCT01395394|Oxidative stress|oxidative stress
5476152|NCT01395368|subjective|subjective
5476153|NCT01395368|unilateral|unilateral
5476154|NCT01395368|bilateral|bilateral
5476155|NCT01395368|non-pulsatile|non-pulsatile
5476156|NCT01395368|6 month's duration or longer|6 month's duration or longer
5476157|NCT01395355|binge eating|binge eating
5476158|NCT01395355|loss of control eating|loss of control eating
5476159|NCT01395355|eating in the absence of hunger|eating in the absence of hunger
5476160|NCT01395355|emotional eating|emotional eating
5476161|NCT01395342|Pregnant women|pregnant women
5476162|NCT01395342|Pre-eclampsia|pre-eclampsia
5476163|NCT01395342|Exercise|exercise
5476164|NCT01395342|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
5476165|NCT01395342|Parturition|parturition
5476166|NCT01395303|infarction|infarction
5476167|NCT01395303|stroke|stroke
5476168|NCT01395303|diabetes|diabetes
5476169|NCT01395303|fracture|fracture
5476170|NCT01395303|aortic stenosis|aortic stenosis
5476171|NCT01395303|cancer|cancer
5476177|NCT01395290|vitamin D|vitamin d
5476178|NCT01395277|Nitric Oxide|nitric oxide
5476179|NCT01395277|Vascular Function|vascular function
5476180|NCT01395277|Aging|aging
5476181|NCT01395277|Blood Pressure|blood pressure
5476182|NCT01395277|Arterial Stiffness|arterial stiffness
5476183|NCT01395277|Cardiovascular Disease|cardiovascular disease
5476184|NCT01395277|Cerebral Blood Flow|cerebral blood flow
5476185|NCT01395251|rheumatoid arthritis|rheumatoid arthritis
5476186|NCT01395251|diagnosis|diagnosis
5476187|NCT01395251|sensitivity|sensitivity
5476188|NCT01395251|glucocorticoids|glucocorticoids
5476189|NCT01395238|fathers|fathers
5476190|NCT01395238|parenting|parenting
5476191|NCT01395238|high-risk|high-risk
5476192|NCT01395238|child maltreatment|child maltreatment
5476193|NCT01395238|prevention|prevention
5476194|NCT01395225|Fat Emulsifying|fat emulsifying
5476195|NCT01395225|Radical Cystectomy|radical cystectomy
5476196|NCT01395225|Pelvic Lymph Node Dissection|pelvic lymph node dissection
5685322|NCT00556543|Prosthesis|prosthesis
5462699|NCT01450033|kidney|kidney
5476197|NCT01395225|Pathological Lymph Node Processing|pathological lymph node processing
5476198|NCT01395225|Bladder Cancer|bladder cancer
5476199|NCT01395225|Transitional Cell Carcinoma|transitional cell carcinoma
5476200|NCT01395225|Urothelial Cell Carcinoma|urothelial cell carcinoma
5476201|NCT01395212|Cell-based cardiac regenerative therapy|cell-based cardiac regenerative therapy
5476202|NCT01395212|Intramyocardial injections|intramyocardial injections
5476203|NCT01395212|NOGA procedure|noga procedure
5476204|NCT01395212|Acute myocardial infarction|acute myocardial infarction
5476205|NCT01395199|Magnetic resonance imaging|magnetic resonance imaging
5476206|NCT01395199|Thalassemia|thalassemia
5476207|NCT01395199|Iron overload|iron overload
5476208|NCT01395186|varicocele|varicocele
5476209|NCT01395186|pain|pain
5476210|NCT01395173|detection|detection
5476211|NCT01395160|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5476212|NCT01395160|ADHD|adhd
5476213|NCT01395160|Bipolar Disorder|bipolar disorder
5476214|NCT01395160|Electrophysiological|electrophysiological
5476215|NCT01395160|EEG|eeg
5476216|NCT01395160|ERP|erp
5476217|NCT01395160|Attention|attention
5476218|NCT01395160|Motivation|motivation
5476219|NCT01395160|Mood instability|mood instability
5476220|NCT01395147|Drug Therapy|drug therapy
5476221|NCT01395134|External branch of the superior laryngeal nerve,|external branch of the superior laryngeal nerve,
5476222|NCT01395134|Recurrent laryngeal nerve,|recurrent laryngeal nerve,
5476223|NCT01395134|Intraoperative neuromonitoring,|intraoperative neuromonitoring,
5476224|NCT01395134|Thyroid surgery|thyroid surgery
5476225|NCT01395121|c-KIT mutation|c-kit mutation
5476226|NCT01395121|advanced disease|advanced disease
5476227|NCT01395121|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5476228|NCT01395095|cardiac rehabilitation|cardiac rehabilitation
5476229|NCT01395095|risk factor|risk factor
5476230|NCT01395095|lifestyle|lifestyle
5476231|NCT01395082|Myocarditis|myocarditis
5476232|NCT01395082|Pericarditis|pericarditis
5476233|NCT01395082|Vaccinia virus|vaccinia virus
5476234|NCT01395082|ACAM2000®|acam2000®
5476235|NCT01395082|Smallpox vaccine|smallpox vaccine
5476236|NCT01395069|Post-cataract surgery|post-cataract surgery
5476237|NCT01395069|macular edema|macular edema
5476238|NCT01395056|breast neoplasm|breast neoplasm
5476239|NCT01395056|Neoplasm Metastasis|neoplasm metastasis
5476240|NCT01395056|Drug Therapy|drug therapy
5789988|NCT00146237|SSRI failure|ssri failure
5476241|NCT01395043|Transversus Abdominis Plane catheter|transversus abdominis plane catheter
5476242|NCT01395043|TAP catheter|tap catheter
5476243|NCT01395017|Pancreatic cancer|pancreatic cancer
5476244|NCT01395017|Dasatinib|dasatinib
5476245|NCT01395017|chemotherapy|chemotherapy
5476246|NCT01395017|Locally advanced|locally advanced
5476247|NCT01394991|Epoetin alfa (EPREX, ERYPO)|epoetin alfa (eprex, erypo)
5476248|NCT01394978|Pleural air leak|pleural air leak
5476249|NCT01394978|Pulmonary resection|pulmonary resection
5476250|NCT01394978|Open thoracotomy|open thoracotomy
5476251|NCT01394965|ECG|ecg
5476252|NCT01394965|Mapping|mapping
5476253|NCT01394965|ecg mapping|ecg mapping
5476254|NCT01394965|arrythmias|arrythmias
5476255|NCT01394952|Cardiovascular disease|cardiovascular disease
5476256|NCT01394952|Diabetes Mellitus|diabetes mellitus
5476257|NCT01394952|Dulaglutide|dulaglutide
5476258|NCT01394939|Vaccinia|vaccinia
5476259|NCT01394939|Vaccinia Virus|vaccinia virus
5476260|NCT01394939|JX-594|jx-594
5476261|NCT01394939|Jennerex|jennerex
5476262|NCT01394939|Colorectal Carcinoma|colorectal carcinoma
5476263|NCT01394939|Colorectal cancer|colorectal cancer
5476264|NCT01394939|Colon Cancer|colon cancer
5476265|NCT01394939|Rectal Cancer|rectal cancer
5476266|NCT01394939|oncolytic virus|oncolytic virus
5470793|NCT01417663|Aging|aging
5476270|NCT01394939|Oxaliplatin failure|oxaliplatin failure
5476272|NCT01394939|FOLFIRI failure|folfiri failure
5476273|NCT01394939|Irinotecan failure|irinotecan failure
5476274|NCT01394939|Pexa-Vec|pexa-vec
5476275|NCT01394926|CE-U/S - Contrast-Enhanced U/S|ce-u/s - contrast-enhanced u/s
5476276|NCT01394926|U/S - Ultrasound|u/s - ultrasound
5476277|NCT01394926|Assess effectiveness|assess effectiveness
5476278|NCT01394900|HIV|hiv
5476279|NCT01394900|sexually transmitted infection|sexually transmitted infection
5476280|NCT01394900|STI|sti
5476281|NCT01394900|men who have sex with men|men who have sex with men
5476282|NCT01394900|MSM|msm
5476283|NCT01394900|couples|couples
5476284|NCT01394900|African American|african american
5476285|NCT01394900|Black|black
5476286|NCT01394887|Metformin, inflammation|metformin, inflammation
5476287|NCT01394887|resistin|resistin
5476288|NCT01394887|impaired glucose tolerance|impaired glucose tolerance
5476289|NCT01394887|children|children
5476290|NCT01394874|osteoarthritis|osteoarthritis
5476291|NCT01394874|exercise|exercise
5476292|NCT01394861|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5476293|NCT01394861|ESD|esd
5476294|NCT01394861|EMR|emr
5476295|NCT01394861|Early Gastric Cancer|early gastric cancer
5476296|NCT01394861|Flexible Endoscopic Robotic System|flexible endoscopic robotic system
5476297|NCT01394861|Master Slave Robot|master slave robot
5476298|NCT01394861|Ease & Safety of ESD by Flexible Master Slave Robotic System|ease & safety of esd by flexible master slave robotic system
5476299|NCT01394835|Patient after lung transplantation|patient after lung transplantation
5476300|NCT01394809|osteoporosis|osteoporosis
5476301|NCT01394809|wrist fracture|wrist fracture
5476302|NCT01394809|mental practice|mental practice
5476303|NCT01394809|mirror therapy|mirror therapy
5476304|NCT01394809|immobilization|immobilization
5476305|NCT01394809|elderly|elderly
5476306|NCT01394783|Endotracheal intubation, Teaching, Videolaryngoscope|endotracheal intubation, teaching, videolaryngoscope
5476307|NCT01394770|hypertension|hypertension
5476308|NCT01394770|dialysis|dialysis
5476309|NCT01394770|aliskiren|aliskiren
5476310|NCT01394770|amlodipine|amlodipine
5476311|NCT01394770|outcome|outcome
5476312|NCT01394744|metal|metal
5476313|NCT01394744|ion|ion
5476314|NCT01394744|cytokine|cytokine
5476315|NCT01394744|hip arthroplasty|hip arthroplasty
5476316|NCT01394744|blood|blood
5476317|NCT01394744|Assessment|assessment
5476318|NCT01394744|cytokine profile|cytokine profile
5476319|NCT01394718|analgesic adjunct|analgesic adjunct
5476320|NCT01394718|acetaminophen|acetaminophen
5476321|NCT01394718|spine fusion surgery|spine fusion surgery
5476322|NCT01394718|opiate reduction|opiate reduction
5476323|NCT01394718|pain management after elective surgical operation|pain management after elective surgical operation
5476324|NCT01394705|patients at increased risk for atherosclerosis|patients at increased risk for atherosclerosis
5476325|NCT01394692|intraoperative MRI|intraoperative mri
5476326|NCT01394692|glioma surgery|glioma surgery
5476327|NCT01394692|extent of resection|extent of resection
5476328|NCT01394679|Lung Cancer|lung cancer
5476329|NCT01394679|Recurrent Lung Cancer no treatment within 3 months|recurrent lung cancer no treatment within 3 months
5476330|NCT01394653|YM060|ym060
5476331|NCT01394653|ramosetron|ramosetron
5476332|NCT01394653|orally-disintegrating tablet|orally-disintegrating tablet
5476333|NCT01394653|OD tablet|od tablet
5458636|NCT01466907|stroke|stroke
5476334|NCT01394653|bioequivalence|bioequivalence
5476335|NCT01394614|Cataplexy|cataplexy
5476336|NCT01394614|MSLT|mslt
5476337|NCT01394614|Hypocretin|hypocretin
5476338|NCT01394614|HLA typing|hla typing
5476339|NCT01394614|Polysomnography|polysomnography
5476340|NCT01394614|A/H1N1 vaccine|a/h1n1 vaccine
5476341|NCT01394601|Antipsychotics|antipsychotics
5476342|NCT01394601|schizophrenia|schizophrenia
5476343|NCT01394601|acute inpatient|acute inpatient
5476344|NCT01394588|Cardiac Surgery|cardiac surgery
5476345|NCT01394588|Perioperative Glucose Control|perioperative glucose control
5476346|NCT01394575|breast cancer|breast cancer
5476347|NCT01394575|radiotherapy|radiotherapy
5476348|NCT01394575|simultaneous integrated boost|simultaneous integrated boost
5476349|NCT01394575|tumor bed|tumor bed
5476350|NCT01394575|IMRT|imrt
5476351|NCT01394536|Post-operative|post-operative
5476352|NCT01394536|post-op|post-op
5476353|NCT01394536|nausea|nausea
5476354|NCT01394536|vomiting|vomiting
5476355|NCT01394510|insulin secretion|insulin secretion
5476356|NCT01394510|beta-cell function|beta-cell function
5476357|NCT01394510|oxidative stress|oxidative stress
5476358|NCT01394510|type 2 diabetes|type 2 diabetes
5476359|NCT01394497|Liver Transplantation|liver transplantation
5476360|NCT01394497|Graft Survival|graft survival
5476361|NCT01394497|Graft Rejection|graft rejection
5476362|NCT01394497|Primary Graft Dysfunction|primary graft dysfunction
5470883|NCT01417247|sympathetic nerves|sympathetic nerves
5476363|NCT01394497|Tissue and Organ Harvesting|tissue and organ harvesting
5476364|NCT01394497|Tissue and Organ Procurement|tissue and organ procurement
5476365|NCT01394497|Tissue Donors|tissue donors
5476366|NCT01394497|Cold Ischemia|cold ischemia
5476367|NCT01394471|schizophrenia|schizophrenia
5476368|NCT01394471|schizoaffective disorder|schizoaffective disorder
5476369|NCT01394471|oxytocin|oxytocin
5476370|NCT01394471|OT|ot
5476371|NCT01394471|social cognition|social cognition
5476372|NCT01394471|social functioning|social functioning
5476373|NCT01394471|paranoia|paranoia
5476374|NCT01394471|psychosis|psychosis
5476375|NCT01394471|psychotic symptoms|psychotic symptoms
5476376|NCT01394471|social deficits|social deficits
5476377|NCT01394471|intranasal administration|intranasal administration
5476378|NCT01394458|catheter related infection|catheter related infection
5476379|NCT01394458|bacteremia|bacteremia
5476380|NCT01394458|hemodialysis|hemodialysis
5476381|NCT01394432|Endocardial Stem Cells Injection|endocardial stem cells injection
5476382|NCT01394432|Percutaneous Coronary Intervention|percutaneous coronary intervention
5476383|NCT01394393|obesity treatment|obesity treatment
5476384|NCT01394393|evidence based intervention|evidence based intervention
5476385|NCT01394393|cognitive behavioral treatment|cognitive behavioral treatment
5476386|NCT01394393|virtual reality environments|virtual reality environments
5476387|NCT01394380|sugar|sugar
5476388|NCT01394380|sweetened beverages|sweetened beverages
5462937|NCT01449058|AML|aml
5476389|NCT01394380|hepatic steatosis|hepatic steatosis
5476390|NCT01394380|visceral obesity|visceral obesity
5476391|NCT01394380|metabolic syndrome|metabolic syndrome
5476392|NCT01394367|respiratory therapy|respiratory therapy
5476393|NCT01394367|exercise therapy|exercise therapy
5476394|NCT01394367|oxygen uptake|oxygen uptake
5476395|NCT01394367|quality of life|quality of life
5476396|NCT01394367|right ventricular function|right ventricular function
5476397|NCT01394367|severe pulmonary hypertension|severe pulmonary hypertension
5476398|NCT01394354|Multiple Myeloma relapsed refractory|multiple myeloma relapsed refractory
5476399|NCT01394341|Liraglutide|liraglutide
5476400|NCT01394341|Uremia|uremia
5476401|NCT01394341|Dialysis|dialysis
5476402|NCT01394341|Type 2 diabetes mellitus|type 2 diabetes mellitus
5476403|NCT01394341|Safety|safety
5476404|NCT01394341|Efficacy|efficacy
5476405|NCT01394328|Delirium|delirium
5476406|NCT01394328|Dementia|dementia
5476407|NCT01394328|Confusion Assessment Method|confusion assessment method
5476408|NCT01394328|Elderly|elderly
5476409|NCT01394315|diffuse optical tomography|diffuse optical tomography
5476410|NCT01394315|response|response
5476411|NCT01394315|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5476412|NCT01394315|breast cancer|breast cancer
5476413|NCT01394302|Trigger Finger|trigger finger
5476414|NCT01394289|Standardization|standardization
5476415|NCT01394289|Immunotherapy|immunotherapy
5476416|NCT01394289|Skin prick test|skin prick test
5476417|NCT01394263|prostate cancer|prostate cancer
5476418|NCT01394263|PSA|psa
5476419|NCT01394263|testosterone suppression|testosterone suppression
5476420|NCT01394250|Pain|pain
5476421|NCT01394250|Anxiety|anxiety
5476422|NCT01394250|IV Cannulation|iv cannulation
5476423|NCT01394250|Topical Lidocaine|topical lidocaine
5476424|NCT01394250|Buzzy|buzzy
5476425|NCT01394250|Face, Legs, Activity, Crying, Consolability (FLACC) scale|face, legs, activity, crying, consolability (flacc) scale
5476426|NCT01394250|Faces Pain Scale Revised (FPS-R)|faces pain scale revised (fps-r)
5476427|NCT01394250|Child Rating of Anxiety Scale|child rating of anxiety scale
5476428|NCT01394224|Healthy volunteers|healthy volunteers
5476429|NCT01394224|Japanese|japanese
5458732|NCT01466465|Vitamin D|vitamin d
5476430|NCT01394198|Osteopathic Manipulative Medicine (OMM)|osteopathic manipulative medicine (omm)
5476431|NCT01394198|Neuromuscular Medicine (NMM)|neuromuscular medicine (nmm)
5476432|NCT01394198|Somatic Dysfunction|somatic dysfunction
5476433|NCT01394198|Correlational Study|correlational study
5476434|NCT01394198|Endoscopy|endoscopy
5476435|NCT01394185|marijuana|marijuana
5476436|NCT01394185|dronabinol|dronabinol
5476437|NCT01394185|pharmacotherapy|pharmacotherapy
5476438|NCT01394172|Tidal Volume|tidal volume
5476439|NCT01394172|Pediatric|pediatric
5476440|NCT01394172|Difficult airway|difficult airway
5476441|NCT01394172|Ventilation|ventilation
5476442|NCT01394172|Airway management|airway management
5476443|NCT01394159|passes required to establish diagnosis|passes required to establish diagnosis
5476444|NCT01394146|phosphorus-based food additives|phosphorus-based food additives
5476445|NCT01394146|phosphorus metabolism|phosphorus metabolism
5476446|NCT01394133|HIV Infected Women|hiv infected women
5476447|NCT01394120|Pancreas cancer|pancreas cancer
5476448|NCT01394120|Targeted Therapy|targeted therapy
5476449|NCT01394107|Thromboprophylaxis|thromboprophylaxis
5476450|NCT01394107|Effect of LMWH on coagulation|effect of lmwh on coagulation
5476451|NCT01394107|Pregnancy|pregnancy
5476452|NCT01394107|Neuraxial anesthesia|neuraxial anesthesia
5476453|NCT01394107|Spinal haematoma|spinal haematoma
5476454|NCT01394094|Gum chewing|gum chewing
5476455|NCT01394094|Bowel function|bowel function
5476456|NCT01394094|benign gynecologic surgery|benign gynecologic surgery
5476457|NCT01394081|Veterans|veterans
5476458|NCT01394081|Health Care Utilization|health care utilization
5476459|NCT01394081|Rural Health|rural health
5476461|NCT01394081|Motivational Interviewing|motivational interviewing
5476462|NCT01394068|Selenium level|selenium level
5476463|NCT01394068|Various blood values|various blood values
5476464|NCT01394068|Duration of artificial respiration|duration of artificial respiration
5476465|NCT01394068|Residence in ICU/ Hospital|residence in icu/ hospital
5476466|NCT01394068|SOFA-Score|sofa-score
5476467|NCT01394068|SAPS-Score|saps-score
5476468|NCT01394055|Diabetes Mellitus Type 1 and 2|diabetes mellitus type 1 and 2
5476469|NCT01394055|Delayed Gastric Emptying|delayed gastric emptying
5476470|NCT01394055|Gastroparesis|gastroparesis
5476471|NCT01394055|Gastrointestinal Motility Disorder|gastrointestinal motility disorder
5476472|NCT01394042|Biopsy proven primary prostate cancer|biopsy proven primary prostate cancer
5476473|NCT01394029|iron overload|iron overload
5476474|NCT01394029|iron chelation|iron chelation
5476475|NCT01394029|deferasirox|deferasirox
5476476|NCT01394029|observational|observational
5476477|NCT01394003|Advanced cancer|advanced cancer
5476478|NCT01393977|Spinal Cord Injuries|spinal cord injuries
5476479|NCT01393977|Stem Cell Transplantation|stem cell transplantation
5476480|NCT01393977|Rehabilitation|rehabilitation
5476481|NCT01393951|Recombinant Influenza hemagglutinin vaccine|recombinant influenza hemagglutinin vaccine
5476482|NCT01393938|Mullerian Duct Anomaly|mullerian duct anomaly
5476483|NCT01393938|3-dimensional Ultrasound|3-dimensional ultrasound
5476484|NCT01393938|Magnetic Resonance Imaging|magnetic resonance imaging
5476485|NCT01393912|crenolanib|crenolanib
5476486|NCT01393912|radiation therapy|radiation therapy
5476487|NCT01393912|malignant brain tumors|malignant brain tumors
5476488|NCT01393912|pediatric|pediatric
5476489|NCT01393899|tofacitinib|tofacitinib
5476490|NCT01393899|Xeljanz|xeljanz
5476491|NCT01393899|CP-690,550|cp-690,550
5476492|NCT01393899|maintenance therapy|maintenance therapy
5476493|NCT01393886|Obesity Surgery|obesity surgery
5476494|NCT01393873|Obesity|obesity
5476495|NCT01393873|Type 2 DM|type 2 dm
5476496|NCT01393860|Diabetes|diabetes
5476506|NCT01393834|Delayed cord clamping|delayed cord clamping
5476507|NCT01393834|Umbilical cord|umbilical cord
5476508|NCT01393834|Preterm|preterm
5476509|NCT01393834|Cord milking|cord milking
5476510|NCT01393808|Type 2 diabetes|type 2 diabetes
5476511|NCT01393808|Paricalcitol|paricalcitol
5476512|NCT01393808|Proteinuria|proteinuria
5476513|NCT01393808|Sodium intake|sodium intake
5476514|NCT01393795|Pulmonary Hypertension|pulmonary hypertension
5476515|NCT01393795|Pain|pain
5476516|NCT01393782|high output shock|high output shock
5476517|NCT01393782|distributive shock|distributive shock
5476518|NCT01393782|warm shock|warm shock
5476519|NCT01393782|septic shock|septic shock
5476520|NCT01393782|pressor|pressor
5476521|NCT01393782|angiotensin|angiotensin
5476522|NCT01393782|ATII|atii
5476523|NCT01393782|vasopressor|vasopressor
5476524|NCT01393769|Retinoblastoma|retinoblastoma
5476525|NCT01393769|RTB|rtb
5476526|NCT01393769|Ocular tumour|ocular tumour
5476527|NCT01393769|Melfalan|melfalan
5476528|NCT01393769|Enucleation|enucleation
5476529|NCT01393769|Tumor of the eye|tumor of the eye
5476530|NCT01393769|Eye|eye
5476531|NCT01393769|Ocular cancer|ocular cancer
5476532|NCT01393769|Ocular chemotherapy|ocular chemotherapy
5476533|NCT01393769|Ophthalmic artery|ophthalmic artery
5476534|NCT01393769|Intra-arterial chemotherapy|intra-arterial chemotherapy
5476535|NCT01393743|Central Nervous System|central nervous system
5476536|NCT01393730|prostate|prostate
5476537|NCT01393730|metastatic|metastatic
5476538|NCT01393730|castrate resistant|castrate resistant
5476539|NCT01393704|myomectomy|myomectomy
5476540|NCT01393704|vasopressin|vasopressin
5476541|NCT01393704|blood loss|blood loss
5476542|NCT01393691|nighttime fears|nighttime fears
5476543|NCT01393691|anxiety|anxiety
5476544|NCT01393691|sleep|sleep
5476545|NCT01393691|actigraphy|actigraphy
5476546|NCT01393691|intervention|intervention
5476547|NCT01393652|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
5476548|NCT01393639|treatment of rheumatoid arthritis|treatment of rheumatoid arthritis
5476549|NCT01393639|treatment of RA|treatment of ra
5476550|NCT01393639|patients on methotrexate for rheumatoid arthritis|patients on methotrexate for rheumatoid arthritis
5476551|NCT01393639|prednisone for rheumatoid arthritis|prednisone for rheumatoid arthritis
5476552|NCT01393587|Oxidative Stress|oxidative stress
5476553|NCT01393587|Laproscopy|laproscopy
5476554|NCT01393561|Rhinitis|rhinitis
5476555|NCT01393561|Common cold|common cold
5476556|NCT01393561|Nasal symptoms|nasal symptoms
5476557|NCT01393561|Children|children
5476558|NCT01393548|Rhinitis|rhinitis
5476559|NCT01393548|common cold|common cold
5476560|NCT01393548|nasal symptoms|nasal symptoms
5476561|NCT01393548|children|children
5476562|NCT01393535|Adiponectin|adiponectin
5476563|NCT01393535|Prognosis|prognosis
5476564|NCT01393535|Cardiac Surgery|cardiac surgery
5476565|NCT01393522|headache|headache
5476566|NCT01393522|migraine|migraine
5476567|NCT01393509|PU-H71|pu-h71
5476568|NCT01393509|Solid Tumor|solid tumor
5476569|NCT01393509|Lymphoma|lymphoma
5476571|NCT01393509|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma|incurable, locally advanced or metastatic solid tumor malignancy or lymphoma
5476572|NCT01393496|prematurity|prematurity
5476573|NCT01393496|anemia|anemia
5476574|NCT01393496|transfusion|transfusion
5476575|NCT01393483|esophagectomy|esophagectomy
5476576|NCT01393483|endoscopy|endoscopy
5476577|NCT01393483|biopsy|biopsy
5476578|NCT01393483|Tissue mesothelin|tissue mesothelin
5476579|NCT01393483|Serum mesothelin|serum mesothelin
5476580|NCT01393483|11-037|11-037
5476582|NCT01393470|Vaccine|vaccine
5476583|NCT01393470|long-term efficacy|long-term efficacy
5476584|NCT01393470|registry-based study|registry-based study
5476585|NCT01393470|Evaluation of long-term HPV vaccine efficacy: a population-based, registry-based cohort study in Finland.|evaluation of long-term hpv vaccine efficacy: a population-based, registry-based cohort study in finland.
5476586|NCT01393457|cocaine|cocaine
5476587|NCT01393457|cognition|cognition
5476588|NCT01393457|medication|medication
5476589|NCT01393457|treatment|treatment
5476590|NCT01393444|Electrocorticography|electrocorticography
5476591|NCT01393444|Tetraplegia|tetraplegia
5476592|NCT01393444|Spinal cord injury|spinal cord injury
5476593|NCT01393444|Brainstem stroke|brainstem stroke
5476594|NCT01393444|Neuroprosthetic|neuroprosthetic
5476595|NCT01393444|Brain-computer interface|brain-computer interface
5476596|NCT01393444|Direct brain interface|direct brain interface
5476597|NCT01393444|Neural activity|neural activity
5476598|NCT01393444|Motor cortex|motor cortex
5476599|NCT01393431|Exhaled breath condensate pH|exhaled breath condensate ph
5476600|NCT01393431|Predictive value of pH|predictive value of ph
5476601|NCT01393418|Erythropoietin|erythropoietin
5476602|NCT01393418|Cardiac Surgery|cardiac surgery
5476603|NCT01393418|Renal Biomarker|renal biomarker
5476604|NCT01393418|Acute Kidney Injury|acute kidney injury
5476605|NCT01393418|Hypothermic Circulatory Arrest|hypothermic circulatory arrest
5476606|NCT01393392|smoking cessation|smoking cessation
5476607|NCT01393392|methadone treatment|methadone treatment
5476608|NCT01393392|nicotine addiction|nicotine addiction
5476609|NCT01393392|drug treatment|drug treatment
5476610|NCT01393392|drug addiction|drug addiction
5476611|NCT01393392|tobacco dependence|tobacco dependence
5476612|NCT01393327|physical training|physical training
5476613|NCT01393327|remaining post-operative pulmonary vascular changes|remaining post-operative pulmonary vascular changes
5476614|NCT01393327|right ventricular pump function|right ventricular pump function
5476615|NCT01393327|PEA|pea
5476616|NCT01393301|Nicotine dependence|nicotine dependence
5476617|NCT01393301|Smoking, cessation|smoking, cessation
5476618|NCT01393301|Quitting|quitting
5476619|NCT01393301|Anxiety symptoms|anxiety symptoms
5476620|NCT01393301|Cognitive-behavioral therapy|cognitive-behavioral therapy
5476621|NCT01393275|diabetes|diabetes
5476622|NCT01393275|exercise|exercise
5476623|NCT01393275|intervention|intervention
5476624|NCT01393275|rehabilitation|rehabilitation
5476625|NCT01393275|metabolic rate|metabolic rate
5476626|NCT01393275|sport|sport
5476627|NCT01393249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5476628|NCT01393249|Pediatric|pediatric
5476629|NCT01393249|Asparaginase|asparaginase
5476630|NCT01393249|Pancreatitis|pancreatitis
5476631|NCT01393223|Interstitial Cystitis|interstitial cystitis
5476632|NCT01393223|Painful Bladder Syndrome|painful bladder syndrome
5476633|NCT01393223|Bladder Pain Syndrome|bladder pain syndrome
5476634|NCT01393223|Liposome|liposome
5476635|NCT01393223|LP-08|lp-08
5476636|NCT01393210|insulin sensitivity|insulin sensitivity
5476637|NCT01393210|adipose tissue|adipose tissue
5476638|NCT01393210|inflammation|inflammation
5476639|NCT01393197|HCC|hcc
5476640|NCT01393197|TACE|tace
5476641|NCT01393184|Target therapy|target therapy
5476642|NCT01393171|Anterior Vaginal Prolapse|anterior vaginal prolapse
5476643|NCT01393171|Cystocele|cystocele
5476644|NCT01393171|Pelvic Organ Prolapse|pelvic organ prolapse
5476645|NCT01393145|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5476646|NCT01393145|salmeterol|salmeterol
5476647|NCT01393145|fluticasone|fluticasone
5476648|NCT01393145|formoterol|formoterol
5476649|NCT01393145|FEV1|fev1
5476650|NCT01393145|Moderate-to-severe|moderate-to-severe
5476651|NCT01393132|Dry Eye|dry eye
5476652|NCT01393132|Sjogren's Syndrome|sjogren's syndrome
5476653|NCT01393132|Graft vs. Host Disease|graft vs. host disease
5476654|NCT01393132|Rheumatoid arthritis|rheumatoid arthritis
5476655|NCT01393132|Systemic lupus erythematosus|systemic lupus erythematosus
5476656|NCT01393132|Scleroderma|scleroderma
5476657|NCT01393106|HL|hl
5476658|NCT01393106|idelalisib|idelalisib
5476659|NCT01393106|CAL-101|cal-101
5476660|NCT01393106|GS-1101|gs-1101
5476661|NCT01393106|PI3K|pi3k
5476662|NCT01393093|HCC|hcc
5476663|NCT01393093|TACE|tace
5476664|NCT01393080|nimotuzumab|nimotuzumab
5476665|NCT01393080|non-small cell lung cancer|non-small cell lung cancer
5476666|NCT01393080|chemotherapy|chemotherapy
5476667|NCT01393067|cSEMS|csems
5476668|NCT01393067|NEPS|neps
5476669|NCT01393067|ERCP|ercp
5476670|NCT01393067|biliary stricture|biliary stricture
5476675|NCT01393054|elderly|elderly
5476676|NCT01393028|coronary artery disease|coronary artery disease
5476677|NCT01393028|angina pectoris|angina pectoris
5476678|NCT01393028|Stable chest pain complaints|stable chest pain complaints
5476679|NCT01393015|automatic|automatic
5476680|NCT01393015|automation|automation
5476681|NCT01393015|oxygen|oxygen
5476682|NCT01393015|weaning|weaning
5476683|NCT01393015|COPD|copd
5476684|NCT01393015|exacerbation|exacerbation
5476685|NCT01393002|intensive care|intensive care
5476686|NCT01393002|candidemia|candidemia
5476687|NCT01393002|fungal infection|fungal infection
5476688|NCT01392976|cancer|cancer
5476689|NCT01392976|advanced|advanced
5476690|NCT01392976|solid|solid
5476691|NCT01392976|tumor|tumor
5476692|NCT01392976|gemcitabine|gemcitabine
5476693|NCT01392976|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5476694|NCT01392976|CO-1.01|co-1.01
5476695|NCT01392976|CO-101|co-101
5476696|NCT01392976|CO101|co101
5476697|NCT01392963|botox|botox
5476698|NCT01392963|depression|depression
5476699|NCT01392950|silicone hydrogel contact lenses for daily wear|silicone hydrogel contact lenses for daily wear
5476700|NCT01392937|AIOL|aiol
5476701|NCT01392937|multipurpose solution|multipurpose solution
5476702|NCT01392937|silicone hydrogel lenses|silicone hydrogel lenses
5476703|NCT01392937|The safety and efficacy of the All-in-One Light multipurpose care regimen by comparison with the Aquify care regimen|the safety and efficacy of the all-in-one light multipurpose care regimen by comparison with the aquify care regimen
5476704|NCT01392911|Dose Ranging|dose ranging
5476705|NCT01392911|Extended Early Bactericidal Activity|extended early bactericidal activity
5476706|NCT01392911|Maximum tolerable dose|maximum tolerable dose
5476707|NCT01392911|Pharmacokinetics|pharmacokinetics
5476708|NCT01392911|Pulmonary Tuberculosis|pulmonary tuberculosis
5476709|NCT01392911|Rifampicin|rifampicin
5476710|NCT01392911|Rifafour|rifafour
5476711|NCT01392911|Safety|safety
5476712|NCT01392911|Tolerability|tolerability
5476713|NCT01392911|Max Tolerable Dose|max tolerable dose
5476714|NCT01392898|liraglutide|liraglutide
5476715|NCT01392898|insulin|insulin
5476716|NCT01392898|type 2 diabetes mellitus|type 2 diabetes mellitus
5476717|NCT01392885|Schizophrenia|schizophrenia
5476718|NCT01392885|Schizoaffective Disorder|schizoaffective disorder
5476719|NCT01392885|Brain Health|brain health
5476720|NCT01392885|Exercise|exercise
5476721|NCT01392885|Mental Health|mental health
5476722|NCT01392885|Poor memory|poor memory
5476723|NCT01392872|Immunosuppressant|immunosuppressant
5476724|NCT01392872|Quality of life|quality of life
5476725|NCT01392872|Cognitive function|cognitive function
5476726|NCT01392872|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5476727|NCT01392846|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5476728|NCT01392833|iga nephropathy|iga nephropathy
5476729|NCT01392833|chronic kidney disease|chronic kidney disease
5476730|NCT01392833|proteinuria|proteinuria
5476731|NCT01392833|steroids|steroids
5476732|NCT01392833|azathioprine|azathioprine
5476733|NCT01392820|Phase I|phase i
5476734|NCT01392820|Japan|japan
5476735|NCT01392820|Elderly|elderly
5476739|NCT01392807|Phase 1|phase 1
5476740|NCT01392807|volunteers with hepatic impairment|volunteers with hepatic impairment
5476741|NCT01392807|pharmacokinetics|pharmacokinetics
5476742|NCT01392807|NKTR-118|nktr-118
5476743|NCT01392807|Child-Pugh scale|child-pugh scale
5476744|NCT01392807|AUC|auc
5476745|NCT01392807|Cmax|cmax
5476746|NCT01392807|tmax|tmax
5476747|NCT01392807|t1/2|t1/2
5476748|NCT01392794|YM060|ym060
5476749|NCT01392794|ramosetron|ramosetron
5476750|NCT01392794|orally-disintegrating tablet|orally-disintegrating tablet
5476751|NCT01392794|OD tablet|od tablet
5476752|NCT01392794|bioequivalence|bioequivalence
5476753|NCT01392781|PCOS|pcos
5476754|NCT01392781|hsC-RP|hsc-rp
5476755|NCT01392781|Lp-PLA2|lp-pla2
5476756|NCT01392781|cardiovascular risk|cardiovascular risk
5476757|NCT01392768|Epilepsy|epilepsy
5476758|NCT01392768|Partial|partial
5476759|NCT01392768|Seizures|seizures
5476760|NCT01392768|Adjunctive|adjunctive
5476761|NCT01392690|No condition|no condition
5476762|NCT01392690|Primary prevention|primary prevention
5476763|NCT01392690|Anxiety|anxiety
5476764|NCT01392677|dapagliflozin|dapagliflozin
5476765|NCT01392677|diabetes|diabetes
5476766|NCT01392677|hyperglycaemia|hyperglycaemia
5476767|NCT01392651|Urinary stress incontinence|urinary stress incontinence
5476768|NCT01392651|TVT|tvt
5476769|NCT01392638|Sildenafil|sildenafil
5476770|NCT01392638|Nitric oxide synthase|nitric oxide synthase
5476771|NCT01392638|Polymorphism|polymorphism
5476772|NCT01392638|Hemodynamics|hemodynamics
5476773|NCT01392625|Non ischemic dilated cardiomyopathy|non ischemic dilated cardiomyopathy
5476775|NCT01392625|Heart failure|heart failure
5476776|NCT01392625|Cardiac Stem Cell Transplantation|cardiac stem cell transplantation
5476777|NCT01392625|Stem Cells|stem cells
5476778|NCT01392612|thrombosis|thrombosis
5476779|NCT01392612|hypertension|hypertension
5476780|NCT01392612|gender|gender
5476781|NCT01392612|endothelium|endothelium
5476782|NCT01392599|CRPS Type II|crps type ii
5476783|NCT01392599|Pain|pain
5476784|NCT01392599|Surgery|surgery
5476785|NCT01392599|Regional Subcutaneous Venous Sympathectomy(RSVS)|regional subcutaneous venous sympathectomy(rsvs)
5476786|NCT01392599|Sudeck|sudeck
5476787|NCT01392599|Reflex sympathetic dystrophy (RSD)|reflex sympathetic dystrophy (rsd)
5476788|NCT01392599|Causalgia|causalgia
5476789|NCT01392599|Algodystrophy|algodystrophy
5476790|NCT01392586|survival|survival
5476791|NCT01392586|systemic therapy|systemic therapy
5476792|NCT01392586|upfront surgery|upfront surgery
5476793|NCT01392534|Hypertension|hypertension
5476794|NCT01392534|Telmisartan|telmisartan
5476795|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide
5476796|NCT01392534|Potassium|potassium
5476797|NCT01392534|Glucose metabolism|glucose metabolism
5476798|NCT01392534|Lipid metabolism|lipid metabolism
5476799|NCT01392521|Safety|safety
5476800|NCT01392521|Tolerability|tolerability
5476801|NCT01392521|Pharmacokinetics|pharmacokinetics
5476802|NCT01392495|Pulmonary arterial hypertension|pulmonary arterial hypertension
5476803|NCT01392495|imatinib|imatinib
5476804|NCT01392495|6MWD|6mwd
5476805|NCT01392482|Schizophrenia|schizophrenia
5476806|NCT01392482|Bipolar Disorder|bipolar disorder
5476807|NCT01392469|Pulmonary arterial hypertension|pulmonary arterial hypertension
5476808|NCT01392469|pulmonary vascular resistance|pulmonary vascular resistance
5476809|NCT01392469|imatinib|imatinib
5476810|NCT01392469|bosentan|bosentan
5476811|NCT01392469|sildenafil|sildenafil
5476812|NCT01392456|OHIP-EDENT, VALIDATION, OVERDENTURE, ROMANIAN|ohip-edent, validation, overdenture, romanian
5476813|NCT01392443|Primary Myelofibrosis (MF)|primary myelofibrosis (mf)
5476814|NCT01392443|Post-Polycythemia Vera (PV) MF|post-polycythemia vera (pv) mf
5476815|NCT01392443|Post-Essential Thrombocythemia (ET) MF|post-essential thrombocythemia (et) mf
5476816|NCT01392443|post-PV MF|post-pv mf
5476817|NCT01392443|post-ET MF|post-et mf
5476818|NCT01392443|INC424|inc424
5476819|NCT01392443|Ruxolitinib|ruxolitinib
5476820|NCT01392443|Myelofibrosis|myelofibrosis
5476821|NCT01392443|MF|mf
5476822|NCT01392430|Primary prophylaxis|primary prophylaxis
5476823|NCT01392430|Secondary prophylaxis|secondary prophylaxis
5476824|NCT01392430|Discontinuation|discontinuation
5476825|NCT01392391|Stroke|stroke
5476826|NCT01392391|Exercise|exercise
5476827|NCT01392391|Protein synthesis|protein synthesis
5476828|NCT01392391|Protein breakdown|protein breakdown
5476829|NCT01392391|Muscle atrophy|muscle atrophy
5476830|NCT01392391|Muscle phenotype|muscle phenotype
5476831|NCT01392391|Inflammation|inflammation
5476832|NCT01392391|Insulin resistance|insulin resistance
5476833|NCT01392391|Fitness|fitness
5476834|NCT01392378|Prevenar 13|prevenar 13
5476835|NCT01392378|13vPnC|13vpnc
5476836|NCT01392378|Antipyretic medication|antipyretic medication
5476837|NCT01392378|Healthy subjects|healthy subjects
5476838|NCT01392365|Crohn's disease|crohn's disease
5476839|NCT01392365|Intestinal tuberculosis|intestinal tuberculosis
5476840|NCT01392365|Diagnosis, Differential|diagnosis, differential
5476841|NCT01392352|pazopanib|pazopanib
5476842|NCT01392352|hypertension|hypertension
5476843|NCT01392352|forearm blood flow|forearm blood flow
5476844|NCT01392339|Obstructive Sleep Apnea|obstructive sleep apnea
5476845|NCT01392339|CPAP|cpap
5476846|NCT01392339|hypoxia|hypoxia
5476847|NCT01392339|sleep|sleep
5476848|NCT01392339|translational science|translational science
5476849|NCT01392339|gene expression|gene expression
5476850|NCT01392326|Psoriatic arthritis|psoriatic arthritis
5476851|NCT01392326|PsA|psa
5476852|NCT01392326|ACR|acr
5476853|NCT01392326|CASPAR|caspar
5476854|NCT01392313|carnitine, kidney|carnitine, kidney
5476855|NCT01392287|Geriatric|geriatric
5476856|NCT01392287|Older adults|older adults
5476857|NCT01392287|Major Depressive Disorder|major depressive disorder
5476858|NCT01392287|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5476859|NCT01392287|memantine hydrochloride|memantine hydrochloride
5476860|NCT01392287|N-Acetylaspartylglutamate|n-acetylaspartylglutamate
5476861|NCT01392287|NAAG|naag
5476862|NCT01392287|Cognitive impairment|cognitive impairment
5476863|NCT01392248|EEG|eeg
5476864|NCT01392248|breast cancer surgery|breast cancer surgery
5476865|NCT01392248|prediction|prediction
5476866|NCT01392248|acute postoperative pain|acute postoperative pain
5476867|NCT01392248|chronic pain|chronic pain
5476868|NCT01392235|Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)|recurrent and/or metastatic nasopharyngeal carcinoma (npc)
5476869|NCT01392222|focus group|focus group
5476870|NCT01392222|11-108|11-108
5476871|NCT01392209|BEVACIZUMAB|bevacizumab
5476872|NCT01392209|HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY|hypofractionated stereotactic radiotherapy
5476877|NCT01392196|Renal Impairment|renal impairment
5476878|NCT01392183|Kidney cancer|kidney cancer
5476879|NCT01392183|Renal Cell Carcinoma|renal cell carcinoma
5476880|NCT01392183|Poor-Risk Clear-Cell Renal Cell Carcinoma|poor-risk clear-cell renal cell carcinoma
5476881|NCT01392183|RCC|rcc
5476882|NCT01392183|Metastatic|metastatic
5476883|NCT01392183|Locally advanced|locally advanced
5476884|NCT01392183|Complete response|complete response
5476885|NCT01392183|CR|cr
5476886|NCT01392183|Partial Response|partial response
5476887|NCT01392183|PR|pr
5476888|NCT01392183|Overall survival|overall survival
5476889|NCT01392183|OS|os
5476890|NCT01392183|Time to progression|time to progression
5476891|NCT01392183|TTP|ttp
5476892|NCT01392183|Pazopanib|pazopanib
5476893|NCT01392183|GW786034|gw786034
5476894|NCT01392183|Temsirolimus|temsirolimus
5476895|NCT01392183|CCI-779|cci-779
5476896|NCT01392183|Torisel|torisel
5476897|NCT01392183|Benadryl|benadryl
5476898|NCT01392183|Diphenhydramine|diphenhydramine
5476899|NCT01392183|TemPa|tempa
5476900|NCT01392170|Leukemia|leukemia
5476901|NCT01392170|Chronic Myeloid Leukemia|chronic myeloid leukemia
5476902|NCT01392170|CML|cml
5476903|NCT01392170|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
5476904|NCT01392170|TKI|tki
5476905|NCT01392170|Complete cytogenetic remission|complete cytogenetic remission
5476907|NCT01392170|Minimal residual disease|minimal residual disease
5476908|NCT01392170|MRD|mrd
5476909|NCT01392170|PEG-IFNa-2a|peg-ifna-2a
5476910|NCT01392170|Pegasys|pegasys
5476911|NCT01392170|Peginterferon Alpha-2a|peginterferon alpha-2a
5476912|NCT01392170|Philadelphia chromosome (Ph)-positive|philadelphia chromosome (ph)-positive
5476913|NCT01392170|BCR-ABL1-positive|bcr-abl1-positive
5476914|NCT01392144|Radiation pneumonitis|radiation pneumonitis
5476915|NCT01392144|RP|rp
5476916|NCT01392144|Nitric oxide|nitric oxide
5476917|NCT01392144|NO|no
5476918|NCT01392144|Thoracic|thoracic
5476919|NCT01392144|Esophagus cancer|esophagus cancer
5476920|NCT01392144|Lung cancer|lung cancer
5476921|NCT01392144|Radiation therapy|radiation therapy
5476922|NCT01392144|radiotherapy|radiotherapy
5476923|NCT01392144|RT|rt
5476924|NCT01392144|XRT|xrt
5476925|NCT01392144|Airway|airway
5476926|NCT01392144|Alveolar|alveolar
5476927|NCT01392144|Nitric oxide breath analyzer|nitric oxide breath analyzer
5476928|NCT01392144|Questionnaires|questionnaires
5476929|NCT01392131|Oncoxin|oncoxin
5476930|NCT01392131|Safety of Oncoxin|safety of oncoxin
5476931|NCT01392131|Therapeutic efficacy of Oncoxin|therapeutic efficacy of oncoxin
5476932|NCT01392131|Improvement of quality of life with Oncoxin|improvement of quality of life with oncoxin
5476933|NCT01392131|Survival benefit with Oncoxin|survival benefit with oncoxin
5476934|NCT01392105|Mesenchymal stem cells|mesenchymal stem cells
5476935|NCT01392105|Myocardial infarction|myocardial infarction
5476936|NCT01392105|Left ventricular dysfunction|left ventricular dysfunction
5476937|NCT01392092|Contingency Management|contingency management
5476938|NCT01392092|Drug Self-Administration|drug self-administration
5476939|NCT01392079|CLL|cll
5476940|NCT01392079|17p deletion|17p deletion
5476941|NCT01392079|refractory to fludarabine|refractory to fludarabine
5476942|NCT01392079|subcutaneous alemtuzumab|subcutaneous alemtuzumab
5476943|NCT01392079|CLL with 17p- or refractory to fludarabine|cll with 17p- or refractory to fludarabine
5476944|NCT01392066|breast neoplasms|breast neoplasms
5476945|NCT01392066|spouses/partners|spouses/partners
5476946|NCT01392066|couples|couples
5476947|NCT01392066|interpersonal relations|interpersonal relations
5476948|NCT01392066|psychosocial adjustment|psychosocial adjustment
5476949|NCT01392066|psychological adaptation|psychological adaptation
5476950|NCT01392066|depression|depression
5476951|NCT01392066|quality of life|quality of life
5476952|NCT01392066|dyadic coping|dyadic coping
5476953|NCT01392066|coping behavior|coping behavior
5476954|NCT01392066|cohort|cohort
5476955|NCT01392066|questionnaire|questionnaire
5476956|NCT01392053|labor|labor
5476957|NCT01392053|pain|pain
5476958|NCT01392053|massage|massage
5476959|NCT01392027|Pancreatic Cancer|pancreatic cancer
5476960|NCT01392027|Chronic Pancreatitis|chronic pancreatitis
5459174|NCT01464827|Hepatitis C Genotype 1|hepatitis c genotype 1
5476961|NCT01392027|Diseases of the pancreas|diseases of the pancreas
5476962|NCT01392014|malaria|malaria
5476963|NCT01392014|DHP|dhp
5476964|NCT01392014|PQ|pq
5476965|NCT01392014|gametocytes|gametocytes
5476966|NCT01391975|arteriovenous fistula|arteriovenous fistula
5476967|NCT01391975|surveillance|surveillance
5476968|NCT01391975|arterial stenosis|arterial stenosis
5476969|NCT01391975|venous stenosis|venous stenosis
5476970|NCT01391962|Pharmacodynamics|pharmacodynamics
5476971|NCT01391962|VEGF Inhibitor|vegf inhibitor
5476972|NCT01391962|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5476973|NCT01391962|Anti-Angiogenesis|anti-angiogenesis
5476974|NCT01391962|Gene Expression Profiling|gene expression profiling
5476975|NCT01391949|disability|disability
5476976|NCT01391949|walking|walking
5476977|NCT01391949|feedback|feedback
5476978|NCT01391949|exercise|exercise
5476979|NCT01391923|Lipolysis|lipolysis
5476980|NCT01391923|Cryolipolysis|cryolipolysis
5476981|NCT01391923|Fat Reduction|fat reduction
5476982|NCT01391910|rhinosinusitis|rhinosinusitis
5476983|NCT01391897|somatoform disorders|somatoform disorders
5476984|NCT01391897|PTSD|ptsd
5476985|NCT01391897|epigenetics|epigenetics
5476986|NCT01391897|psychotherapy|psychotherapy
5476987|NCT01391897|psychosomatics|psychosomatics
5476988|NCT01391884|Incretin hormones|incretin hormones
5476989|NCT01391884|GLP-1|glp-1
5476990|NCT01391884|GIP|gip
5476991|NCT01391884|Uremia|uremia
5476992|NCT01391884|Dialysis|dialysis
5476993|NCT01391858|Pregabalin|pregabalin
5476994|NCT01391858|Postoperative pain|postoperative pain
5476995|NCT01391858|Mastectomy|mastectomy
5476996|NCT01391845|progesterone|progesterone
5476997|NCT01391845|glycodelin-A|glycodelin-a
5476998|NCT01391845|ulipristal acetate|ulipristal acetate
5476999|NCT01391832|rTMS|rtms
5477000|NCT01391832|PTSD|ptsd
5477001|NCT01391832|Post Traumatic Stress Disorder|post traumatic stress disorder
5477002|NCT01391832|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5477003|NCT01391832|combat related PTSD|combat related ptsd
5477004|NCT01391832|OEF|oef
5477005|NCT01391832|OIF|oif
5477006|NCT01391832|Veterans|veterans
5477007|NCT01391832|operation enduring freedom|operation enduring freedom
5477008|NCT01391832|operation iraqi freedom|operation iraqi freedom
5477010|NCT01391832|cognitive processing therapy|cognitive processing therapy
5477011|NCT01391819|Brazil|brazil
5477013|NCT01391819|Dengue virus|dengue virus
5477014|NCT01391819|Dengue|dengue
5477015|NCT01391819|Dengue infection|dengue infection
5477016|NCT01391806|Breast cancer|breast cancer
5477017|NCT01391806|Preoperative breast MRI|preoperative breast mri
5477018|NCT01391806|Breast-conserving surgery|breast-conserving surgery
5477019|NCT01391806|Mastectomy|mastectomy
5477020|NCT01391806|Prospective study|prospective study
5477021|NCT01391793|Renal scarring|renal scarring
5477022|NCT01391793|Dexamethasone|dexamethasone
5477023|NCT01391793|Child|child
5477024|NCT01391793|Corticosteroids|corticosteroids
5477025|NCT01391793|Pediatric|pediatric
5477026|NCT01391793|Urinary tract infection|urinary tract infection
5477027|NCT01391793|Escherichia Coli Urinary Tract Infection|escherichia coli urinary tract infection
5477028|NCT01391780|pelvic floor evaluation,|pelvic floor evaluation,
5477029|NCT01391780|women,|women,
5477030|NCT01391780|stress urinary incontinence;|stress urinary incontinence;
5477031|NCT01391780|urgency urinary incontinence.|urgency urinary incontinence.
5477032|NCT01391767|Ridge Preservation|ridge preservation
5477033|NCT01391767|Dental Implant|dental implant
5477034|NCT01391767|Histology|histology
5477035|NCT01391754|child abuse|child abuse
5477036|NCT01391741|Parkinson´s Disease|parkinson´s disease
5477037|NCT01391741|Walking|walking
5477038|NCT01391741|Exercise|exercise
5477039|NCT01391741|Automaticity|automaticity
5477040|NCT01391741|Dual Task|dual task
5477041|NCT01391741|Visual Cues|visual cues
5477042|NCT01391741|Cueing|cueing
5477043|NCT01391741|Neuroplasticity|neuroplasticity
5477044|NCT01391741|Gait analysis|gait analysis
5680289|NCT00578357|problem gambling|problem gambling
5477045|NCT01391715|Gastroesophageal reflux disease|gastroesophageal reflux disease
5477046|NCT01391715|Proton pump inhibitor|proton pump inhibitor
5477047|NCT01391715|standard dose|standard dose
5477048|NCT01391715|Double dose|double dose
5477049|NCT01391676|glaucoma|glaucoma
5477050|NCT01391676|trabeculectomy|trabeculectomy
5477051|NCT01391676|filtering bleb|filtering bleb
5477052|NCT01391676|spectral domain optical coherence tomography|spectral domain optical coherence tomography
5477053|NCT01391663|Drug Therapy|drug therapy
5477055|NCT01391650|double-bundle|double-bundle
5477056|NCT01391650|navigation system|navigation system
5477057|NCT01391637|Long term follow-up|long term follow-up
5477058|NCT01391637|HuCNS-SC cells|hucns-sc cells
5477059|NCT01391637|human central nervous system stem cells|human central nervous system stem cells
5477060|NCT01391624|chocolate|chocolate
5477061|NCT01391624|craving|craving
5477062|NCT01391624|addiction|addiction
5477063|NCT01391624|compulsion|compulsion
5477064|NCT01391598|fibromyalgia|fibromyalgia
5477065|NCT01391598|intravenous lidocaine|intravenous lidocaine
5477066|NCT01391598|substance P|substance p
5477067|NCT01391598|interleukins|interleukins
5477068|NCT01391585|Text|text
5477069|NCT01391585|SMS|sms
5477070|NCT01391585|diabetes|diabetes
5477071|NCT01391585|self-monitoring|self-monitoring
5477072|NCT01391585|self-management|self-management
5477073|NCT01391585|adherence|adherence
5477074|NCT01391572|thoracic esophageal squamous cell carcinoma|thoracic esophageal squamous cell carcinoma
5477075|NCT01391572|esophagectomy|esophagectomy
5477076|NCT01391572|radiation|radiation
5477077|NCT01391572|tumor bed|tumor bed
5477078|NCT01391572|elective nodal irradiation|elective nodal irradiation
5477079|NCT01391559|breathing difficulty|breathing difficulty
5477080|NCT01391520|Acute Kidney Injury|acute kidney injury
5477081|NCT01391520|Contrast-Induced Nephropathy|contrast-induced nephropathy
5477082|NCT01391520|Labile Iron|labile iron
5477083|NCT01391520|Iron Chelation|iron chelation
5477084|NCT01391520|Deferiprone|deferiprone
5477085|NCT01391507|Anti-beta1-receptor autoantibodies|anti-beta1-receptor autoantibodies
5477086|NCT01391507|COR-1|cor-1
5477087|NCT01391507|Heart failure|heart failure
5477088|NCT01391494|Human Enterovirus 71 (EV71)|human enterovirus 71 (ev71)
5477089|NCT01391494|Hand, Foot and Mouth Disease|hand, foot and mouth disease
5477090|NCT01391494|Inactivated Vaccine|inactivated vaccine
5477091|NCT01391494|Human Diploid cell|human diploid cell
5477092|NCT01391494|Safety|safety
5477093|NCT01391494|Immunogenicity|immunogenicity
5477094|NCT01391494|Adverse reactions associated with vaccine|adverse reactions associated with vaccine
5477095|NCT01391481|Perfluorocarbon|perfluorocarbon
5477096|NCT01391481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5477097|NCT01391481|Acute lung injury|acute lung injury
5477098|NCT01391455|Inguinal hernia repair|inguinal hernia repair
5477099|NCT01391455|Mesh|mesh
5477100|NCT01391455|Groin pain|groin pain
5477101|NCT01391455|Testicular pain|testicular pain
5477102|NCT01391442|follow up of troop,|follow up of troop,
5477103|NCT01391442|MRI, Echocardiography, Functional indices|mri, echocardiography, functional indices
5477104|NCT01391416|Hyperhomocysteinemia|hyperhomocysteinemia
5477105|NCT01391416|Chronic kidney disease|chronic kidney disease
5477106|NCT01391403|Schizophrenia|schizophrenia
5477107|NCT01391403|Risperidone|risperidone
5477108|NCT01391403|Artemisinin|artemisinin
5480118|NCT01378585|safety|safety
5477110|NCT01391403|Immune|immune
5477111|NCT01391390|Tardive Dyskinesia|tardive dyskinesia
5477112|NCT01391390|Schizophrenia|schizophrenia
5477113|NCT01391390|Melatonin|melatonin
5477114|NCT01391390|Oxidative Stress|oxidative stress
5477115|NCT01391390|Antioxidant|antioxidant
5477117|NCT01391377|High density Lipoprotein|high density lipoprotein
5477118|NCT01391377|Peripheral arterial disease|peripheral arterial disease
5477119|NCT01391377|Tredaptive|tredaptive
5477120|NCT01391377|Niacin|niacin
5477121|NCT01391377|Laropiprant|laropiprant
5477122|NCT01391377|Plaque|plaque
5477123|NCT01391377|Atherosclerosis|atherosclerosis
5477124|NCT01391377|Lipid content|lipid content
5477125|NCT01391351|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage|carcinoma of the ovary, the fallopian tube or peritoneal serous-type advanced stage
5477126|NCT01391351|chemotherapy with Taxol and Carboplatin|chemotherapy with taxol and carboplatin
5477127|NCT01391351|predictors of therapeutic response|predictors of therapeutic response
5477128|NCT01391351|serum miRNA|serum mirna
5477129|NCT01391351|identification of polymorphisms or SNPs (Single Nucleotide Polymorphism)|identification of polymorphisms or snps (single nucleotide polymorphism)
5477130|NCT01391338|Prostatitis|prostatitis
5477131|NCT01391338|Chronic|chronic
5477132|NCT01391338|Pelvic Pain|pelvic pain
5477133|NCT01391338|NIH-CPSI|nih-cpsi
5477134|NCT01391338|Pain domain score in NIH-CPSI|pain domain score in nih-cpsi
5477135|NCT01391260|Locally Advanced NSCLC|locally advanced nsclc
5477136|NCT01391260|EGFR Mutation Positive|egfr mutation positive
5477137|NCT01391260|Radiotherapy combined Gefitinib|radiotherapy combined gefitinib
5477138|NCT01391247|open angle glaucoma|open angle glaucoma
5477139|NCT01391247|low tension glaucoma|low tension glaucoma
5477140|NCT01391247|oximetry|oximetry
5477141|NCT01391234|Metastatic bone disease|metastatic bone disease
5477142|NCT01391234|Bone metastases|bone metastases
5477143|NCT01391234|Radiation therapy|radiation therapy
5477144|NCT01391234|TomoTherapy|tomotherapy
5477145|NCT01391221|Depression|depression
5477146|NCT01391221|Inflammation|inflammation
5477147|NCT01391221|Cognition|cognition
5477148|NCT01391221|Pain|pain
5477149|NCT01391221|Allostatic load|allostatic load
5477150|NCT01391208|Barrett's Esophagus with High Grade Dysplasia|barrett's esophagus with high grade dysplasia
5477151|NCT01391208|Esophageal adenocarcinoma|esophageal adenocarcinoma
5477152|NCT01391195|low level laser therapy|low level laser therapy
5477153|NCT01391195|muscle performance|muscle performance
5477154|NCT01391195|fatigue index|fatigue index
5477155|NCT01391195|endurance training|endurance training
5477156|NCT01391195|ventilatory threshold|ventilatory threshold
5477157|NCT01391195|VO2Max|vo2max
5477158|NCT01391195|VO2Peak|vo2peak
5477159|NCT01391182|Epsilon Aminocaproic Acid|epsilon aminocaproic acid
5477160|NCT01391182|blood loss|blood loss
5477161|NCT01391182|total hip arthroplasty|total hip arthroplasty
5477162|NCT01391182|reduction in blood transfusions|reduction in blood transfusions
5477163|NCT01391182|Amicar|amicar
5477164|NCT01391156|minoxidil|minoxidil
5477165|NCT01391156|finasteride|finasteride
5477166|NCT01391156|topical|topical
5477167|NCT01391156|lotion|lotion
5477168|NCT01391156|male pattern hair loss|male pattern hair loss
5477169|NCT01391156|androgenetic alopecia|androgenetic alopecia
5477170|NCT01391143|Prostate cancer|prostate cancer
5477171|NCT01391143|Melanoma|melanoma
5477172|NCT01391143|Renal cell carcinoma|renal cell carcinoma
5477173|NCT01391143|Triple-negative breast cancer|triple-negative breast cancer
5477174|NCT01391143|Head and neck cancer|head and neck cancer
5471698|NCT01413841|PCI|pci
5477175|NCT01391143|Bladder cancer|bladder cancer
5477176|NCT01391143|Non-small cell lung cancer|non-small cell lung cancer
5477177|NCT01391143|Squamous cell carcinoma|squamous cell carcinoma
5477178|NCT01391130|Cancer|cancer
5477179|NCT01391130|Tumor|tumor
5477180|NCT01391130|Metastasis|metastasis
5477181|NCT01391117|TMC649128|tmc649128
5477182|NCT01391117|HCV|hcv
5477183|NCT01391117|TMC649128HPC1002|tmc649128hpc1002
5477184|NCT01391117|Hepatitis C|hepatitis c
5477185|NCT01391117|Hep C|hep c
5477186|NCT01391104|Pulmonary Hypertension|pulmonary hypertension
5477187|NCT01391104|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5477188|NCT01391104|Exercise|exercise
5477189|NCT01391104|Six-minute walk test|six-minute walk test
5477190|NCT01391104|sildenafil|sildenafil
5477191|NCT01391078|glaucoma|glaucoma
5477192|NCT01391078|IOP|iop
5477193|NCT01391078|Sensimed Triggerfish|sensimed triggerfish
5477194|NCT01391078|Goldmann Applanation Tonometry|goldmann applanation tonometry
5477195|NCT01391078|fluctuation|fluctuation
5477196|NCT01391078|comparison|comparison
5477197|NCT01391065|Diffusion Weighted MRI|diffusion weighted mri
5477198|NCT01391065|FLT PET|flt pet
5477199|NCT01391065|F-Miso PET|f-miso pet
5477200|NCT01391065|Image Guided Brachytherapy|image guided brachytherapy
5477201|NCT01391065|Cervix|cervix
5671458|NCT00615927|Glioblastoma|glioblastoma
5671459|NCT00615927|Gliosarcoma|gliosarcoma
5477202|NCT01391065|Postoperative Residual Disease/Postoperative recurrences|postoperative residual disease/postoperative recurrences
5477203|NCT01391052|Intrauterine system|intrauterine system
5477204|NCT01391052|reproductive age|reproductive age
5463687|NCT01446016|Chloroquine|chloroquine
5477205|NCT01391052|menstrual bleeding|menstrual bleeding
5477206|NCT01391039|Ductal Carcinoma In-situ|ductal carcinoma in-situ
5477207|NCT01391039|Contrast Ultrasound|contrast ultrasound
5477208|NCT01391039|Microinvasion|microinvasion
5477209|NCT01391039|Elastography|elastography
5477210|NCT01391026|Medical informatics|medical informatics
5477211|NCT01391026|Health services accessibility|health services accessibility
5477212|NCT01391013|Human immunodeficiency virus 1|human immunodeficiency virus 1
5477213|NCT01391013|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5477214|NCT01391013|Immunologic deficiency syndrome|immunologic deficiency syndrome
5477215|NCT01391013|Darunavir/ritonavir|darunavir/ritonavir
5477216|NCT01391013|Darunavir|darunavir
5477217|NCT01391013|Ritonavir|ritonavir
5477218|NCT01391013|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
5477219|NCT01391013|Prezista|prezista
5477220|NCT01391000|rotator cuff surgery|rotator cuff surgery
5477221|NCT01391000|pain|pain
5477222|NCT01391000|exercise therapy|exercise therapy
5477223|NCT01390974|ACS|acs
5477224|NCT01390974|PCI|pci
5477225|NCT01390974|thienopyridines|thienopyridines
5477226|NCT01390974|prasugrel therapy|prasugrel therapy
5477227|NCT01390974|clopidogrel therapy|clopidogrel therapy
5477228|NCT01390961|Allergic conjunctivitis|allergic conjunctivitis
5477229|NCT01390935|guideline adherence|guideline adherence
5477230|NCT01390935|systolic heart failure|systolic heart failure
5477231|NCT01390909|epilepsy|epilepsy
5477232|NCT01390909|anti-epileptic drug|anti-epileptic drug
5477233|NCT01390909|polytherapy|polytherapy
5477234|NCT01390909|adherence|adherence
5477235|NCT01390909|Medicaid|medicaid
5680290|NCT00578357|personalized feedback|personalized feedback
5477236|NCT01390870|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, adherence
5477237|NCT01390818|MEK inhibitor (Pimasertib)|mek inhibitor (pimasertib)
5477238|NCT01390818|PI3K/mTOR Inhibitor|pi3k/mtor inhibitor
5477239|NCT01390818|Solid Tumor|solid tumor
5477241|NCT01390766|Antirejection|antirejection
5477242|NCT01390740|Transthoracic echocardiography|transthoracic echocardiography
5477243|NCT01390727|hypertension|hypertension
5477244|NCT01390727|device-guided breathing|device-guided breathing
5477245|NCT01390727|autonomic function|autonomic function
5477246|NCT01390727|Resperate|resperate
5477247|NCT01390714|Proton Pump Inhibitors|proton pump inhibitors
5477248|NCT01390714|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5477249|NCT01390714|pharmacokinetics|pharmacokinetics
5477250|NCT01390714|pharmacodynamics|pharmacodynamics
5477251|NCT01390701|randomized|randomized
5477252|NCT01390701|cross-over|cross-over
5477253|NCT01390701|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5477254|NCT01390701|felodipin|felodipin
5477255|NCT01390701|hypertension|hypertension
5477256|NCT01390701|blood pressure|blood pressure
5477257|NCT01390701|treatment|treatment
5477258|NCT01390688|Brain-derived Neurotrophic factor|brain-derived neurotrophic factor
5477259|NCT01390688|Low-grade inflammation|low-grade inflammation
5477260|NCT01390688|Cognitive dysfunction|cognitive dysfunction
5477261|NCT01390662|serum 25-hydroxyvitamin d,vitamin D supplement, depression,|serum 25-hydroxyvitamin d,vitamin d supplement, depression,
5477262|NCT01390662|parathyroid hormone|parathyroid hormone
5477263|NCT01390649|ITP|itp
5477264|NCT01390636|Continuous Glucose Monitoring|continuous glucose monitoring
5477265|NCT01390636|Type 1 Diabetes and an Eating Disorder|type 1 diabetes and an eating disorder
5477266|NCT01390636|Eating Disorder Only|eating disorder only
5477267|NCT01390623|Acute Uncomplicated Pyelonephritis|acute uncomplicated pyelonephritis
5477269|NCT01390623|Ceftriaxone|ceftriaxone
5477270|NCT01390623|Cefixime|cefixime
5477271|NCT01390623|Women|women
5477272|NCT01390623|Efficacy|efficacy
5477273|NCT01390610|Continuous Glucose Monitoring|continuous glucose monitoring
5477274|NCT01390610|Self Monitored Blood Glucose|self monitored blood glucose
5477275|NCT01390610|Type 2 Diabetes|type 2 diabetes
5477276|NCT01390597|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5477277|NCT01390597|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5477278|NCT01390597|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5477279|NCT01390597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5477280|NCT01390597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5477281|NCT01390597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5477282|NCT01390584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5477283|NCT01390584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5477284|NCT01390584|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5477285|NCT01390584|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5477286|NCT01390584|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5477287|NCT01390584|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5477288|NCT01390584|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5477289|NCT01390571|adult glioblastoma|adult glioblastoma
5477290|NCT01390571|adult giant cell glioblastoma|adult giant cell glioblastoma
5477291|NCT01390571|adult gliosarcoma|adult gliosarcoma
5477292|NCT01390571|recurrent adult brain tumor|recurrent adult brain tumor
5477293|NCT01390558|Down Syndrome|down syndrome
5477294|NCT01390558|Orthotics|orthotics
5477295|NCT01390558|Gait Analysis|gait analysis
5477296|NCT01390545|Rheumatoid arthritis|rheumatoid arthritis
5477297|NCT01390545|anti-CD20 antibody|anti-cd20 antibody
5477298|NCT01390545|subcutaneous|subcutaneous
5477299|NCT01390532|Left Ventricular Dyssynchrony|left ventricular dyssynchrony
5477300|NCT01390532|Gated blood-pool|gated blood-pool
5477301|NCT01390532|D-SPECT|d-spect
5477302|NCT01390532|Pharmacological stress|pharmacological stress
5477303|NCT01390532|NYHA III/IV|nyha iii/iv
5477304|NCT01390532|LVEF < 35 %|lvef < 35 %
5477305|NCT01390532|QRS > 120 ms|qrs > 120 ms
5477306|NCT01390532|optimal medical treatment|optimal medical treatment
5477307|NCT01390532|cardiac resynchronization therapy|cardiac resynchronization therapy
5477308|NCT01390519|mRCC,|mrcc,
5477309|NCT01390519|observational,|observational,
5477310|NCT01390519|Afinitor,|afinitor,
5477311|NCT01390519|everolimus,|everolimus,
5477312|NCT01390519|2.line|2.line
5477313|NCT01390506|cardiac arrest|cardiac arrest
5477314|NCT01390506|resuscitation|resuscitation
5477315|NCT01390506|neurological outcome|neurological outcome
5477316|NCT01390493|neurofeedback, alpha, anorexia nervosa|neurofeedback, alpha, anorexia nervosa
5477317|NCT01390480|vitamin D|vitamin d
5477318|NCT01390480|Autoimmune disease|autoimmune disease
5477319|NCT01390480|diabetes|diabetes
5477320|NCT01390467|Paracetamol|paracetamol
5477321|NCT01390467|Cognitive impact|cognitive impact
5477322|NCT01390441|Rheumatoid arthritis|rheumatoid arthritis
5477324|NCT01390441|Rituximab|rituximab
5477325|NCT01390441|Rituxan|rituxan
5477326|NCT01390441|MabThera|mabthera
5477327|NCT01390441|Methotrexate|methotrexate
5477328|NCT01390441|Rheumatrex|rheumatrex
5477329|NCT01390441|Trexall|trexall
5477330|NCT01390441|MK-8808|mk-8808
5477331|NCT01390402|Alloreactive haploidentical NK cells|alloreactive haploidentical nk cells
5477332|NCT01390402|Natural killer cells|natural killer cells
5477333|NCT01390402|Stem Cell Transplantation|stem cell transplantation
5477334|NCT01390402|Immune cells|immune cells
5477335|NCT01390402|Chronic myelogenous leukemia|chronic myelogenous leukemia
5477337|NCT01390402|Human leukocyte antigen|human leukocyte antigen
5477338|NCT01390402|HLA|hla
5477339|NCT01390402|Graft-vs-host disease|graft-vs-host disease
5477340|NCT01390402|GVHD|gvhd
5477341|NCT01390402|Antithymocyte globulin|antithymocyte globulin
5477342|NCT01390402|ATG|atg
5477343|NCT01390402|Thymoglobulin|thymoglobulin
5477344|NCT01390402|Interleukin-2|interleukin-2
5477345|NCT01390402|IL-2|il-2
5477346|NCT01390402|Aldesleukin|aldesleukin
5477347|NCT01390402|Proleukin|proleukin
5477348|NCT01390402|Fludarabine|fludarabine
5477349|NCT01390402|Fludarabine phosphate|fludarabine phosphate
5477350|NCT01390402|Fludara|fludara
5477351|NCT01390402|Tacrolimus|tacrolimus
5477352|NCT01390402|Prograf|prograf
5477353|NCT01390402|Busulfan|busulfan
5477354|NCT01390402|Busulfex|busulfex
5477355|NCT01390402|Myleran|myleran
5477356|NCT01390402|Methotrexate|methotrexate
5477357|NCT01390389|Geriatric bipolar depression|geriatric bipolar depression
5477358|NCT01390389|MR Spectroscopy|mr spectroscopy
5477359|NCT01390389|Coenzyme Q10|coenzyme q10
5477360|NCT01390389|Mitochondrial Dysfunction|mitochondrial dysfunction
5477361|NCT01390376|Schizophrenia|schizophrenia
5477362|NCT01390376|NMDA|nmda
5477363|NCT01390376|DAAOI|daaoi
5477364|NCT01390376|Clozapine resistant schizophrenia|clozapine resistant schizophrenia
5477365|NCT01390363|immunization|immunization
5477366|NCT01390363|reminder systems|reminder systems
5477367|NCT01390350|Schnitzler syndrome|schnitzler syndrome
5477368|NCT01390350|autoinflammatory syndrome|autoinflammatory syndrome
5477369|NCT01390337|AC220|ac220
5477370|NCT01390337|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5477371|NCT01390337|De Novo Acute Myeloid Leukemia (AML)|de novo acute myeloid leukemia (aml)
5477372|NCT01390337|Newly diagnosed Acute Myeloid Leukemia (AML)|newly diagnosed acute myeloid leukemia (aml)
5477373|NCT01390337|FMS-like tyrosine kinase (FLT3)|fms-like tyrosine kinase (flt3)
5477374|NCT01390337|FMS-like tyrosine kinase (FLT3) Inhibitor|fms-like tyrosine kinase (flt3) inhibitor
5477375|NCT01390337|Kinase|kinase
5477376|NCT01390337|Kinase Inhibitor|kinase inhibitor
5477377|NCT01390337|Pharmacokinetics|pharmacokinetics
5477378|NCT01390337|ASP2689|asp2689
5477379|NCT01390337|quizartinib|quizartinib
5477380|NCT01390324|Migraine|migraine
5477381|NCT01390324|Naratriptan|naratriptan
5477382|NCT01390324|Naproxen|naproxen
5477383|NCT01390298|chronic pain after knee replacement surgery|chronic pain after knee replacement surgery
5477384|NCT01390272|Hypertension|hypertension
5477385|NCT01390272|Telephone|telephone
5477386|NCT01390272|Disease Management|disease management
5477388|NCT01390272|Pharmacists|pharmacists
5477389|NCT01390272|Nurses|nurses
5477390|NCT01390246|Pregnancy|pregnancy
5477391|NCT01390246|Tobacco use disorder|tobacco use disorder
5477392|NCT01390246|Smoking cessation|smoking cessation
5477394|NCT01390246|Zyban|zyban
5477395|NCT01390233|Labor, obstetric|labor, obstetric
5477396|NCT01390233|Labor, induced|labor, induced
5477397|NCT01390220|Epilepsy|epilepsy
5477398|NCT01390220|seizure clusters|seizure clusters
5477399|NCT01390220|acute repetitive seizures|acute repetitive seizures
5477400|NCT01390220|rescue treatment|rescue treatment
5477401|NCT01390220|ARTEMIS|artemis
5477402|NCT01390207|hCG triggering|hcg triggering
5477403|NCT01390207|pregnancy|pregnancy
5477404|NCT01390207|GnRH antagonist|gnrh antagonist
5477405|NCT01390194|liver disease|liver disease
5477406|NCT01390194|hepatocellular carcinoma|hepatocellular carcinoma
5477407|NCT01390155|Electrocardiography|electrocardiography
5477408|NCT01390155|Coronary Artery Disease|coronary artery disease
5477409|NCT01390155|Atrial Fibrillation|atrial fibrillation
5477410|NCT01390155|Heart Atria|heart atria
5477411|NCT01390155|Coronary Circulation|coronary circulation
5477412|NCT01390155|Ischemia|ischemia
5477413|NCT01390116|gamma delta T cell|gamma delta t cell
5477414|NCT01390116|natural killer cell|natural killer cell
5477415|NCT01390116|proliferation|proliferation
5477416|NCT01390116|cytokine secretion|cytokine secretion
5477417|NCT01390116|Improvement in immune cell function in healthy humans|improvement in immune cell function in healthy humans
5477418|NCT01390103|hip pain|hip pain
5477419|NCT01390090|piriformis muscle|piriformis muscle
5477420|NCT01390077|homogentisic acid|homogentisic acid
5477421|NCT01390051|birth weight|birth weight
5477422|NCT01390051|thrombosis|thrombosis
5477423|NCT01390051|anticoagulant therapy|anticoagulant therapy
5477424|NCT01390025|Influenza|influenza
5477425|NCT01390025|Monoclonal antibody|monoclonal antibody
5477426|NCT01389973|Diseases [C] - Digestive System Diseases [C06]|diseases [c] - digestive system diseases [c06]
5477427|NCT01389973|primary biliary cirrhosis|primary biliary cirrhosis
5477428|NCT01389973|ursodeoxycholic acid (UDCA)|ursodeoxycholic acid (udca)
5477429|NCT01389973|STELARA|stelara
5477430|NCT01389973|ustekinumab|ustekinumab
5477431|NCT01389947|mesenteric ischemia|mesenteric ischemia
5477432|NCT01389947|extracorporeal circulation|extracorporeal circulation
5477433|NCT01389947|microcirculation|microcirculation
5477434|NCT01389947|cardiac surgery|cardiac surgery
5477435|NCT01389947|IFABP|ifabp
5477436|NCT01389947|citrullinemia|citrullinemia
5477437|NCT01389947|glycocalyx|glycocalyx
5477438|NCT01389947|vascular occlusion test|vascular occlusion test
5477439|NCT01389947|NIRS probe on thenar eminence|nirs probe on thenar eminence
5477440|NCT01389934|levo-bupicaine|levo-bupicaine
5477441|NCT01389934|Radical|radical
5477442|NCT01389934|Mastectomy|mastectomy
5477443|NCT01389921|lower urinary tract|lower urinary tract
5477444|NCT01389921|sensory evoked potential|sensory evoked potential
5477445|NCT01389921|contact heat evoked potential stimulation|contact heat evoked potential stimulation
5477446|NCT01389921|electroencephalogram|electroencephalogram
5477447|NCT01389921|cortical processing|cortical processing
5459720|NCT01462578|AML|aml
5477448|NCT01389921|bladder sensations|bladder sensations
5477449|NCT01389921|lower urinary tract dysfunction|lower urinary tract dysfunction
5477450|NCT01389921|overactive bladder|overactive bladder
5477451|NCT01389895|Lupus|lupus
5477452|NCT01389895|Cutaneous lupus|cutaneous lupus
5477453|NCT01389882|mechanical ventilation|mechanical ventilation
5477454|NCT01389882|diaphragm electrical activity|diaphragm electrical activity
5477455|NCT01389882|pressure support|pressure support
5477456|NCT01389869|Emotional tears|emotional tears
5477457|NCT01389869|Postprandial plasma|postprandial plasma
5477458|NCT01389869|Chemosignal|chemosignal
5477459|NCT01389869|Obesity|obesity
5477460|NCT01389869|Appetite|appetite
5477461|NCT01389869|Food intake|food intake
5477466|NCT01389843|Cohort|cohort
5477467|NCT01389843|Heart Disease|heart disease
5477468|NCT01389843|Cardiovascular Diseases|cardiovascular diseases
5477469|NCT01389830|End of Life|end of life
5477470|NCT01389830|EOL|eol
5477471|NCT01389830|Latinos|latinos
5477472|NCT01389830|Hispanic American|hispanic american
5477473|NCT01389830|Medicare beneficiaries|medicare beneficiaries
5477474|NCT01389830|stage III diagnosis|stage iii diagnosis
5477475|NCT01389830|Breast cancer|breast cancer
5477476|NCT01389830|Colorectal cancer|colorectal cancer
5477477|NCT01389830|Prostate cancer|prostate cancer
5477478|NCT01389830|Lung cancer|lung cancer
5477479|NCT01389830|Cancer Prevention and Treatment Demonstration|cancer prevention and treatment demonstration
5477480|NCT01389830|CPTD|cptd
5477481|NCT01389804|transplant, pediatric|transplant, pediatric
5477482|NCT01389791|muscle relaxation|muscle relaxation
5477483|NCT01389791|magnesium sulfate|magnesium sulfate
5477484|NCT01389791|rocuronium|rocuronium
5477485|NCT01389739|continuity of care|continuity of care
5477486|NCT01389739|interprofessional collaboration|interprofessional collaboration
5477487|NCT01389726|custodial grandparents|custodial grandparents
5477488|NCT01389726|kinship caregivers|kinship caregivers
5477489|NCT01389726|grandparents raising grandchildren|grandparents raising grandchildren
5477490|NCT01389726|grandmothers|grandmothers
5477491|NCT01389726|grandchildren|grandchildren
5477492|NCT01389726|psychological well-being|psychological well-being
5477493|NCT01389713|ovarian reserve|ovarian reserve
5477494|NCT01389713|ovarian stimulation|ovarian stimulation
5477495|NCT01389713|clomifene citrate|clomifene citrate
5477496|NCT01389713|high doses Follicle Stimulating Hormone (FSH)|high doses follicle stimulating hormone (fsh)
5477497|NCT01389687|Poliomyelitis|poliomyelitis
5477498|NCT01389687|Inactivated polio vaccine|inactivated polio vaccine
5477499|NCT01389687|Polio|polio
5477500|NCT01389687|Poliovirus|poliovirus
5477501|NCT01389674|coronary stenosis|coronary stenosis
5477502|NCT01389674|Angina pectoris|angina pectoris
5477503|NCT01389674|left ventricular wall motion abnormalities|left ventricular wall motion abnormalities
5477504|NCT01389661|Maxillary bone cysts|maxillary bone cysts
5477505|NCT01389661|Cell therapy|cell therapy
5477506|NCT01389661|Mesenchymal stem cells|mesenchymal stem cells
5477507|NCT01389661|Autologous serum scaffold|autologous serum scaffold
5477508|NCT01389648|adult|adult
5477509|NCT01389635|Abdominoplasty|abdominoplasty
5477510|NCT01389635|Epidural|epidural
5477511|NCT01389622|Acupuncture|acupuncture
5477512|NCT01389622|smoking cessation|smoking cessation
5477513|NCT01389609|Bioequivalence|bioequivalence
5477514|NCT01389609|Orally-disintegrating Tablet|orally-disintegrating tablet
5477515|NCT01389596|safety|safety
5477516|NCT01389596|efficacy|efficacy
5477517|NCT01389596|partial onset seizures|partial onset seizures
5477518|NCT01389596|pediatric|pediatric
5477519|NCT01389596|pregabalin|pregabalin
5477520|NCT01389596|placebo-controlled|placebo-controlled
5477521|NCT01389596|double-blind|double-blind
5477522|NCT01389583|GIST(Gastrointestinal stromal tumor)|gist(gastrointestinal stromal tumor)
5477523|NCT01389583|HSP(Heat Shock Protein)|hsp(heat shock protein)
5477524|NCT01389583|Biomarker|biomarker
5477527|NCT01389557|PQ|pq
5477528|NCT01389557|MST|mst
5477529|NCT01389518|Symptomatic treatment|symptomatic treatment
5477530|NCT01389518|Common Cold|common cold
5477531|NCT01389518|flu syndrome|flu syndrome
5477532|NCT01389505|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5477533|NCT01389505|Bevacizumab|bevacizumab
5477534|NCT01389505|Panretinal Photocoagulation|panretinal photocoagulation
5477535|NCT01389492|meat|meat
5477536|NCT01389492|LDL|ldl
5477537|NCT01389492|MDA|mda
5477538|NCT01389466|Avian influenza|avian influenza
5477539|NCT01389453|umbilical cord mesenchyma stem cell transplantation|umbilical cord mesenchyma stem cell transplantation
5477540|NCT01389440|Resectable pancreatic adenocarcinoma|resectable pancreatic adenocarcinoma
5477541|NCT01389440|Gemcitabine|gemcitabine
5477542|NCT01389440|Erlotinib|erlotinib
5477543|NCT01389440|Radiotherapy|radiotherapy
5477544|NCT01389440|Neoadjuvant treatment|neoadjuvant treatment
5477545|NCT01389414|cholangiocarcinoma|cholangiocarcinoma
5477546|NCT01389414|biliary|biliary
5477547|NCT01389414|gallbladder|gallbladder
5477548|NCT01389414|intrahepatic|intrahepatic
5477549|NCT01389414|extrahepatic|extrahepatic
5477550|NCT01389401|Larynx|larynx
5477551|NCT01389401|GERD|gerd
5477552|NCT01389401|saliva|saliva
5477553|NCT01389401|epidermal growth factor|epidermal growth factor
5477554|NCT01389388|Carotid plaques|carotid plaques
5477555|NCT01389388|inflammatory joint disease|inflammatory joint disease
5477556|NCT01389388|statins|statins
5477557|NCT01389388|inflammation|inflammation
5477558|NCT01389388|lipoprotein components|lipoprotein components
5477559|NCT01389375|Closure Device|closure device
5477560|NCT01389375|Coronary Angiography|coronary angiography
5477561|NCT01389362|Diabetes|diabetes
5477562|NCT01389362|foot ulcer|foot ulcer
5477563|NCT01389362|Chinese herbal medicine|chinese herbal medicine
5477564|NCT01389349|tonsillectomy|tonsillectomy
5477565|NCT01389349|adenotonsillectomy|adenotonsillectomy
5477566|NCT01389349|acupuncture|acupuncture
5477567|NCT01389349|children|children
5477568|NCT01389349|postoperative pain|postoperative pain
5477569|NCT01389349|postoperative nausea|postoperative nausea
5477570|NCT01389336|Fibromyalgia Syndrome|fibromyalgia syndrome
5477571|NCT01389336|Fibromyalgia|fibromyalgia
5477572|NCT01389336|Ayurveda|ayurveda
5477573|NCT01389336|Traditional Indian Medicine|traditional indian medicine
5477575|NCT01389336|Pain|pain
5477576|NCT01389336|Chronic Widespread Pain|chronic widespread pain
5477577|NCT01389297|alcohol dependence intervention|alcohol dependence intervention
5477578|NCT01389297|Internet delivered intervention|internet delivered intervention
5477579|NCT01389297|alcohol dependence treatment|alcohol dependence treatment
5477580|NCT01389297|Internet delivered treatment|internet delivered treatment
5477581|NCT01389284|Naproxen Sodium,|naproxen sodium,
5477582|NCT01389284|dental pain|dental pain
5477583|NCT01389271|Pulmonary hypertension|pulmonary hypertension
5477584|NCT01389271|Inhaled iloprost|inhaled iloprost
5477585|NCT01389271|Efficacy|efficacy
5477586|NCT01389271|Safety|safety
5477587|NCT01389271|Tolerability|tolerability
5477588|NCT01389271|Survival|survival
5477589|NCT01389271|NYHA class III and IV|nyha class iii and iv
5477590|NCT01389219|Post partum|post partum
5477591|NCT01389219|Neonate|neonate
5477592|NCT01389219|community health care workers|community health care workers
5477593|NCT01389193|ibudilast|ibudilast
5477594|NCT01389193|migraine|migraine
5477595|NCT01389193|glial cell|glial cell
5477596|NCT01389154|diagnostic yield|diagnostic yield
5477597|NCT01389154|Electromagnetic Tip Tracked|electromagnetic tip tracked
5477598|NCT01389154|peripheral lung lesion|peripheral lung lesion
5477600|NCT01389141|follicle|follicle
5477601|NCT01389141|hormones|hormones
5477602|NCT01389141|bone|bone
5477603|NCT01389141|muscle|muscle
5477604|NCT01389128|labor|labor
5477605|NCT01389128|pain|pain
5477606|NCT01389128|massage|massage
5477607|NCT01389128|natural birth|natural birth
5477608|NCT01389115|liver cirrhosis|liver cirrhosis
5477609|NCT01389115|oxidative stress|oxidative stress
5477610|NCT01389115|liver transplant|liver transplant
5477611|NCT01389102|Postmenopause|postmenopause
5477612|NCT01389102|Hot Flashes|hot flashes
5477613|NCT01389102|Estradiol|estradiol
5477614|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate
5477615|NCT01389102|Estradiol valerate|estradiol valerate
5477616|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate
5477617|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate
5477618|NCT01389102|Estrogens|estrogens
5477619|NCT01389102|Hormones|hormones
5477620|NCT01389102|Hormones, Hormone Substitutes|hormones, hormone substitutes
5477621|NCT01389102|Hormone Antagonists|hormone antagonists
5477622|NCT01389089|edema reduction|edema reduction
5477623|NCT01389089|ice|ice
5477624|NCT01389089|multi-layer compression bandage|multi-layer compression bandage
5477625|NCT01389089|A-V Impulse compression|a-v impulse compression
5477626|NCT01389089|ankle|ankle
5477627|NCT01389076|Previously Untreated, Advanced-Stage, Follicular Lymphoma|previously untreated, advanced-stage, follicular lymphoma
5477628|NCT01389063|endothelial function|endothelial function
5477629|NCT01389063|CCR5 receptor|ccr5 receptor
5477630|NCT01389063|Maraviroc|maraviroc
5477631|NCT01389063|Abacavir|abacavir
5477632|NCT01389063|Flow Mediated Dilatation|flow mediated dilatation
5477633|NCT01389063|EndoPAT|endopat
5477634|NCT01389037|African American|african american
5477635|NCT01389037|High blood pressure|high blood pressure
5477636|NCT01389024|sickle cell disease|sickle cell disease
5477637|NCT01389024|stroke|stroke
5477638|NCT01389024|silent cerebral infarct|silent cerebral infarct
5477639|NCT01389024|children|children
5477640|NCT01389011|PI|pi
5477642|NCT01389011|Interscalene block|interscalene block
5477643|NCT01388998|fluid management|fluid management
5477644|NCT01388998|fluid therapy|fluid therapy
5477645|NCT01388998|dPP|dpp
5477646|NCT01388998|difference in pulse pressure|difference in pulse pressure
5477647|NCT01388998|PVI|pvi
5477648|NCT01388998|pleth variability index|pleth variability index
5477649|NCT01388998|external pressure applied on the caval vein|external pressure applied on the caval vein
5477650|NCT01388985|Rabies|rabies
5477651|NCT01388985|Vaccination|vaccination
5477652|NCT01388985|Boostability|boostability
5477653|NCT01388972|Community nutritional environment|community nutritional environment
5477654|NCT01388972|Physical activity|physical activity
5477655|NCT01388946|acute postoperative pain|acute postoperative pain
5477656|NCT01388946|late pain|late pain
5477657|NCT01388946|chronic pain|chronic pain
5477658|NCT01388946|wound irrigation with local anesthetic|wound irrigation with local anesthetic
5477659|NCT01388933|Crohn's Disease|crohn's disease
5477660|NCT01388933|natural|natural
5477661|NCT01388933|herbal|herbal
5477663|NCT01388933|inflammatory bowel disease|inflammatory bowel disease
5477664|NCT01388933|Adult ages 18 to 75|adult ages 18 to 75
5477665|NCT01388933|Male and female subjects|male and female subjects
5477666|NCT01388920|COPD|copd
5477667|NCT01388920|Muscle wasting|muscle wasting
5477668|NCT01388907|myomectomy|myomectomy
5477669|NCT01388907|adhesion prevention|adhesion prevention
5477670|NCT01388907|pregnancy rate|pregnancy rate
5477671|NCT01388881|reading difficulties|reading difficulties
5477672|NCT01388868|infusion dose|infusion dose
5477673|NCT01388868|vecuronium|vecuronium
5477674|NCT01388868|motor evoked potential|motor evoked potential
5477675|NCT01388868|neuromuscular blocking agent|neuromuscular blocking agent
5477676|NCT01388855|Heart Failure|heart failure
5477677|NCT01388855|Vitamin D|vitamin d
5477678|NCT01388855|Pain|pain
5477679|NCT01388855|Pilot Study|pilot study
5477680|NCT01388855|RCT|rct
5477681|NCT01388842|severe malaria|severe malaria
5477682|NCT01388842|children|children
5477683|NCT01388842|adjunctive treatment|adjunctive treatment
5477684|NCT01388829|formulation comparison|formulation comparison
5477685|NCT01388816|Randomized|randomized
5477686|NCT01388816|Double-Blind|double-blind
5477687|NCT01388816|Placebo Controlled|placebo controlled
5477688|NCT01388816|Parallel Arm|parallel arm
5477689|NCT01388816|Type II Hyperlipidemia|type ii hyperlipidemia
5477690|NCT01388816|Cholesteryl Ester Transferase Protein Inhibitor|cholesteryl ester transferase protein inhibitor
5477691|NCT01388816|CETP Inhibitor|cetp inhibitor
5477692|NCT01388803|bronchial blocker|bronchial blocker
5477693|NCT01388803|VATS|vats
5477694|NCT01388790|Gastric Cancer|gastric cancer
5477695|NCT01388790|Cetuximab|cetuximab
5477696|NCT01388790|EMD271786|emd271786
5477697|NCT01388790|TS-1|ts-1
5477698|NCT01388790|Cisplatin|cisplatin
5477705|NCT01388764|L-arginine supplement study|l-arginine supplement study
5477706|NCT01388751|Mallet Finger splinting|mallet finger splinting
5477707|NCT01388738|Navigation Brain Stimulation (NEXSTIM)|navigation brain stimulation (nexstim)
5477708|NCT01388738|cerebroprotective drug effectiveness|cerebroprotective drug effectiveness
5477709|NCT01388738|acute ischemic stroke|acute ischemic stroke
5477711|NCT01388725|sCD163|scd163
5477712|NCT01388725|PCT|pct
5477713|NCT01388725|CRP|crp
5477714|NCT01388725|WBC count|wbc count
5477715|NCT01388725|SOFA score|sofa score
5477716|NCT01388725|SIRS|sirs
5477717|NCT01388725|sepsis|sepsis
5477718|NCT01388725|severity|severity
5477719|NCT01388725|prognosis|prognosis
5477720|NCT01388712|Probiotics|probiotics
5477721|NCT01388712|constipation|constipation
5477722|NCT01388712|children|children
5477723|NCT01388699|Migraine with aura|migraine with aura
5477724|NCT01388686|sepsis|sepsis
5477725|NCT01388686|catheter|catheter
5477726|NCT01388686|blood stream infection|blood stream infection
5477727|NCT01388686|blood culture|blood culture
5477728|NCT01388673|prior RYGB procedure|prior rygb procedure
5477729|NCT01388673|regained weight over time|regained weight over time
5477730|NCT01388673|dilated pouch and/or stoma|dilated pouch and/or stoma
5477731|NCT01388660|Healthy|healthy
5477732|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5477733|NCT01388660|Pharmacokinetics|pharmacokinetics
5477734|NCT01388647|Neoadjuvant Treatment|neoadjuvant treatment
5477735|NCT01388647|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5477736|NCT01388634|Length of hospital stay|length of hospital stay
5477737|NCT01388634|readmission|readmission
5477738|NCT01388634|ventral hernia|ventral hernia
5477739|NCT01388621|ovarian cancer|ovarian cancer
5477740|NCT01388621|fallopian cancer|fallopian cancer
5477741|NCT01388621|recurrent|recurrent
5477742|NCT01388621|platinum-sensitive|platinum-sensitive
5477743|NCT01388621|KRAS-Wildtype|kras-wildtype
5477744|NCT01388608|rheumatoid arthritis|rheumatoid arthritis
5477745|NCT01388608|etanercept|etanercept
5477746|NCT01388608|step activity measure|step activity measure
5477747|NCT01388582|contraceptives|contraceptives
5477748|NCT01388582|hormonal|hormonal
5477749|NCT01388582|breastfeeding|breastfeeding
5477750|NCT01388582|infant weight|infant weight
5477751|NCT01388569|stage IV melanoma|stage iv melanoma
5477752|NCT01388556|exercise|exercise
5477753|NCT01388556|Parkinson disease|parkinson disease
5477754|NCT01388556|motor symptoms|motor symptoms
5477755|NCT01388556|gait|gait
5477756|NCT01388556|balance|balance
5477757|NCT01388543|Pharmacokinetics|pharmacokinetics
5477758|NCT01388543|Clinical Pharmacology|clinical pharmacology
5477759|NCT01388543|Pharmacogenomics|pharmacogenomics
5477760|NCT01388543|HIV|hiv
5477761|NCT01388517|Pityriasis alba|pityriasis alba
5477762|NCT01388517|Tacrolimus|tacrolimus
5477763|NCT01388517|Calcitriol|calcitriol
5477764|NCT01388517|Petrolatum|petrolatum
5789989|NCT00146237|depression|depression
5477765|NCT01388491|Contraception|contraception
5477766|NCT01388491|Hemostasis|hemostasis
5477767|NCT01388491|Blood Coagulation|blood coagulation
5477768|NCT01388478|Safety|safety
5477769|NCT01388478|Tolerability|tolerability
5477770|NCT01388478|R(+)Pramipexole|r(+)pramipexole
5477771|NCT01388478|Alzheimer's|alzheimer's
5477772|NCT01388465|Adherence|adherence
5477773|NCT01388465|Intervention|intervention
5477775|NCT01388452|routine HIV testing|routine hiv testing
5477776|NCT01388452|provider-initiated HIV testing and counseling|provider-initiated hiv testing and counseling
5477777|NCT01388452|early infant diagnosis|early infant diagnosis
5477778|NCT01388452|Africa South of the Sahara|africa south of the sahara
5477779|NCT01388439|oseltamivir|oseltamivir
5477780|NCT01388439|influenza|influenza
5477781|NCT01388439|neonate|neonate
5477782|NCT01388439|premature|premature
5477783|NCT01388439|pharmacokinetics|pharmacokinetics
5477784|NCT01388413|neurogenic bladder|neurogenic bladder
5477785|NCT01388413|urinary tract infection|urinary tract infection
5477786|NCT01388400|stroke|stroke
5477787|NCT01388400|rehabilitation|rehabilitation
5477788|NCT01388400|virtual reality|virtual reality
5477789|NCT01388400|upper limb|upper limb
5477790|NCT01388387|pharmacogenetics|pharmacogenetics
5477791|NCT01388387|pharmacokinetics|pharmacokinetics
5477793|NCT01388387|genetic polymorphism|genetic polymorphism
5477794|NCT01388387|CYP3A5|cyp3a5
5477795|NCT01388387|liver transplantation|liver transplantation
5477796|NCT01388374|Delivery of Health Care|delivery of health care
5477797|NCT01388374|Nurse Practitioners|nurse practitioners
5477798|NCT01388374|Out of Hours Medical Care|out of hours medical care
5477799|NCT01388374|Primary Health Care|primary health care
5477800|NCT01388374|Emergency Medical Services|emergency medical services
5477801|NCT01388348|benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5477802|NCT01388348|acoustic vibration|acoustic vibration
5477803|NCT01388322|Pregnancy|pregnancy
5477804|NCT01388322|Preeclampsia|preeclampsia
5477805|NCT01388322|Placental insufficiency|placental insufficiency
5464363|NCT01443351|ITP|itp
5477806|NCT01388283|prognostic marker|prognostic marker
5477807|NCT01388270|Hemodialysis|hemodialysis
5477808|NCT01388270|Anticoagulation|anticoagulation
5477809|NCT01388270|Clotting|clotting
5477810|NCT01388270|Coagulation|coagulation
5477811|NCT01388270|dalteparin|dalteparin
5477812|NCT01388270|Clotting in the extracorporeal system during HD|clotting in the extracorporeal system during hd
5477813|NCT01388270|Antithrombogenic property of Evodial HD filter|antithrombogenic property of evodial hd filter
5477814|NCT01388270|Anticoagulation during HD|anticoagulation during hd
5477815|NCT01388257|Crohn Disease|crohn disease
5477816|NCT01388257|Anoperineal fistula|anoperineal fistula
5477817|NCT01388257|Anal fistula|anal fistula
5477818|NCT01388257|Proctology|proctology
5477819|NCT01388257|Drainage|drainage
5477820|NCT01388257|Colorectal Surgery|colorectal surgery
5477821|NCT01388257|Fistulotomy|fistulotomy
5477822|NCT01388257|Plug|plug
5477823|NCT01388257|Advancement flap|advancement flap
5477824|NCT01388257|Glue|glue
5477825|NCT01388257|Anti Tumor Necrosis Factor-alpha|anti tumor necrosis factor-alpha
5477826|NCT01388257|Adalimumab|adalimumab
5477827|NCT01388244|Screening|screening
5477828|NCT01388244|Risk Assessment|risk assessment
5477829|NCT01388244|Fractures|fractures
5477830|NCT01388244|Absorptiometry, Photon|absorptiometry, photon
5477831|NCT01388244|Fracture prevention|fracture prevention
5477832|NCT01388244|Women|women
5477833|NCT01388244|Patient prespective|patient prespective
5477834|NCT01388231|social phobia, cognitive-behavioral therapy, treatment|social phobia, cognitive-behavioral therapy, treatment
5477835|NCT01388218|Physical Activity|physical activity
5477836|NCT01388218|Patient Reported Outcome (PRO)|patient reported outcome (pro)
5477837|NCT01388218|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5477838|NCT01388218|Innovative Medicines Initiative - Joint Undertaking (IMI-JU)|innovative medicines initiative - joint undertaking (imi-ju)
5477839|NCT01388205|Myopia|myopia
5477840|NCT01388205|Outdoor activity|outdoor activity
5478042|NCT01387399|HIPEC|hipec
5477841|NCT01388205|Physical activity|physical activity
5477842|NCT01388205|Randomized Controlled Trial|randomized controlled trial
5477843|NCT01388205|Pedometer|pedometer
5477844|NCT01388205|Behavior modification|behavior modification
5477845|NCT01388205|Obesity|obesity
5477846|NCT01388192|Pancreaticoduodenectomy|pancreaticoduodenectomy
5477847|NCT01388192|diabetes|diabetes
5477848|NCT01388192|sugar metabolism|sugar metabolism
5477849|NCT01388179|Autism|autism
5477851|NCT01388153|Bioequivalence, acarbose, ODT|bioequivalence, acarbose, odt
5477852|NCT01388140|dissociation|dissociation
5477853|NCT01388140|psychosis|psychosis
5477854|NCT01388140|trauma|trauma
5477855|NCT01388140|parenting|parenting
5477856|NCT01388140|executive functions|executive functions
5477857|NCT01388114|Procalcitonin Measurement|procalcitonin measurement
5477858|NCT01388101|LECT2|lect2
5477859|NCT01388088|Hypertension|hypertension
5477860|NCT01388088|Potassium|potassium
5477861|NCT01388088|Blood-pressure|blood-pressure
5477862|NCT01388075|induction|induction
5477863|NCT01388075|CYP2C9|cyp2c9
5477864|NCT01388075|Genetic variability|genetic variability
5477865|NCT01388075|Expression|expression
5477866|NCT01388062|influenza virus|influenza virus
5477867|NCT01388049|EV71|ev71
5477868|NCT01388036|heart rate|heart rate
5477869|NCT01388023|SmellX|smellx
5477870|NCT01388023|malodor|malodor
5477871|NCT01388023|halitosis|halitosis
5477872|NCT01388023|herbal formulation|herbal formulation
5477873|NCT01388023|natural medicinals|natural medicinals
5477874|NCT01388023|slow release delivery system|slow release delivery system
5477876|NCT01388023|Bad Breath|bad breath
5477877|NCT01388010|probiotics|probiotics
5477878|NCT01388010|gastrointestinal well being|gastrointestinal well being
5477879|NCT01388010|digestive symptoms|digestive symptoms
5477880|NCT01388010|healthy population|healthy population
5477881|NCT01387997|HPV|hpv
5477882|NCT01387984|Type 2 diabetes mellitus|type 2 diabetes mellitus
5477883|NCT01387984|Diabetic complications|diabetic complications
5477884|NCT01387984|YKL-40|ykl-40
5477885|NCT01387971|impression cytology|impression cytology
5477886|NCT01387971|ocular surface disorders|ocular surface disorders
5477887|NCT01387971|ocular surface cells' variation|ocular surface cells' variation
5477889|NCT01387958|Hepatitis C virus|hepatitis c virus
5477890|NCT01387958|Chronically infected|chronically infected
5477891|NCT01387958|treatment naive|treatment naive
5477892|NCT01387958|non responders to prior therapy|non responders to prior therapy
5477893|NCT01387945|Home blood pressure monitoring|home blood pressure monitoring
5477894|NCT01387945|Patient activation|patient activation
5477895|NCT01387945|Patient-centered care|patient-centered care
5477896|NCT01387945|Community Health Aides|community health aides
5477897|NCT01387945|Primary Health Care|primary health care
5477898|NCT01387932|Hepatocellular carcinoma|hepatocellular carcinoma
5477900|NCT01387932|HepaSphere Microspheres|hepasphere microspheres
5477901|NCT01387932|QuadraSphere Microspheres|quadrasphere microspheres
5477902|NCT01387932|Doxorubicin|doxorubicin
5477903|NCT01387919|Set time points during 48 hours of fasting|set time points during 48 hours of fasting
5477904|NCT01387906|mild|mild
5477905|NCT01387906|moderate|moderate
5477906|NCT01387893|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5477907|NCT01387893|BPH|bph
5477908|NCT01387893|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5477909|NCT01387893|LUTS|luts
5477910|NCT01387893|Self-Administered Maneuver|self-administered maneuver
5477911|NCT01387893|Symptomatic Relief|symptomatic relief
5477912|NCT01387893|Digital Repetitive Infrapubic Pressure maneuver|digital repetitive infrapubic pressure maneuver
5477913|NCT01387880|Metastatic colorectal cancer|metastatic colorectal cancer
5477914|NCT01387880|Third line therapy|third line therapy
5477915|NCT01387880|Fourth line therapy|fourth line therapy
5477916|NCT01387880|KRAS mutation status|kras mutation status
5477917|NCT01387880|Cetuximab|cetuximab
5477918|NCT01387880|Everolimus|everolimus
5477919|NCT01387880|Irinotecan|irinotecan
5477920|NCT01387867|Exercise|exercise
5477921|NCT01387867|Hip osteoarthritis|hip osteoarthritis
5477922|NCT01387867|Randomized controlled trial|randomized controlled trial
5477923|NCT01387841|yoga|yoga
5477924|NCT01387841|chemotherapy|chemotherapy
5477925|NCT01387841|nausea|nausea
5477926|NCT01387841|vomiting|vomiting
5477927|NCT01387828|Splenic artery|splenic artery
5477928|NCT01387828|Aneurysm|aneurysm
5477929|NCT01387828|laparoscopic|laparoscopic
5477930|NCT01387828|Vascular reconstruction|vascular reconstruction
5477931|NCT01387828|Splenectomy|splenectomy
5477932|NCT01387815|Effectiveness|effectiveness
5477933|NCT01387815|Psoriasis|psoriasis
5477934|NCT01387815|Observational|observational
5477935|NCT01387815|Prospective|prospective
5477936|NCT01387815|Adalimumab|adalimumab
5477937|NCT01387815|Traditional Systemic Agents|traditional systemic agents
5477938|NCT01387815|Topical Agents|topical agents
5477939|NCT01387815|Comparative|comparative
5477940|NCT01387802|Assessing Effectiveness in Ankylosing Spondylitis|assessing effectiveness in ankylosing spondylitis
5478141|NCT01387022|Tenofovir|tenofovir
5477941|NCT01387789|Product Surveillance|product surveillance
5477942|NCT01387789|Postmarketing|postmarketing
5477943|NCT01387750|Acute Pain|acute pain
5477944|NCT01387750|Musculoskeletal Pain|musculoskeletal pain
5477945|NCT01387750|Topical Analgesic|topical analgesic
5477946|NCT01387737|TA-7284|ta-7284
5477947|NCT01387737|JNJ-28431754|jnj-28431754
5477948|NCT01387737|Canagliflozin|canagliflozin
5477949|NCT01387737|Sodium Glucose Co-Transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5477950|NCT01387724|disseminated neuroblastoma|disseminated neuroblastoma
5477951|NCT01387724|localized resectable neuroblastoma|localized resectable neuroblastoma
5477952|NCT01387724|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5477953|NCT01387724|regional neuroblastoma|regional neuroblastoma
5477954|NCT01387724|stage 4S neuroblastoma|stage 4s neuroblastoma
5477955|NCT01387672|postmenopausal|postmenopausal
5477956|NCT01387672|osteoporosis|osteoporosis
5477957|NCT01387672|bone turnover|bone turnover
5477958|NCT01387672|nitrate|nitrate
5477959|NCT01387672|headache|headache
5477960|NCT01387659|Myfortic|myfortic
5477961|NCT01387659|Simulect|simulect
5477962|NCT01387659|Steroids|steroids
5477963|NCT01387659|Diabetes|diabetes
5477964|NCT01387659|Transplant|transplant
5477965|NCT01387659|Gastric emptying|gastric emptying
5477966|NCT01387659|Gastric motility|gastric motility
5477967|NCT01387646|STI, abuse, substance use, unintended pregnancy|sti, abuse, substance use, unintended pregnancy
5477968|NCT01387633|Nursing care|nursing care
5477969|NCT01387633|Diabetes mellitus|diabetes mellitus
5477971|NCT01387633|Patient compliance|patient compliance
5477972|NCT01387633|Social support|social support
5477973|NCT01387633|Self-efficacy|self-efficacy
5477974|NCT01387633|Adaptation strategy|adaptation strategy
5477975|NCT01387620|Phacoemulsification|phacoemulsification
5477976|NCT01387620|Corneal Edema|corneal edema
5477977|NCT01387620|Corneal Endothelium|corneal endothelium
5477978|NCT01387620|Viscoelastic Substances|viscoelastic substances
5477979|NCT01387607|Pregabalin|pregabalin
5477980|NCT01387607|fibromyalgia|fibromyalgia
5477981|NCT01387594|Crohn's disease lumbar puncture anti-MAdCAM monoclonal antibody PF-00547659 Ulcerative Colitis|crohn's disease lumbar puncture anti-madcam monoclonal antibody pf-00547659 ulcerative colitis
5477982|NCT01387555|liver cancer|liver cancer
5477983|NCT01387555|liver tumor|liver tumor
5477984|NCT01387555|advanced hcc|advanced hcc
5477985|NCT01387555|hepatocellular cancer|hepatocellular cancer
5477986|NCT01387555|Jennerex|jennerex
5477987|NCT01387555|HCC|hcc
5477988|NCT01387555|sorafenib|sorafenib
5477989|NCT01387555|sorafenib failure|sorafenib failure
5477990|NCT01387555|sorafenib intolerant|sorafenib intolerant
5477991|NCT01387555|Nexavar|nexavar
5477992|NCT01387555|Nexavar failure|nexavar failure
5477993|NCT01387555|JX594|jx594
5477994|NCT01387555|oncolytic virus|oncolytic virus
5477995|NCT01387555|vaccinia|vaccinia
5477996|NCT01387555|viral therapy|viral therapy
5477997|NCT01387555|JX|jx
5477998|NCT01387555|Biotherapeutics|biotherapeutics
5477999|NCT01387555|HEP018|hep018
5478000|NCT01387555|traverse|traverse
5478001|NCT01387555|biologic|biologic
5478002|NCT01387555|Pexa-Vec|pexa-vec
5478003|NCT01387542|Schizophrenia|schizophrenia
5478004|NCT01387542|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5478005|NCT01387542|INVEGA|invega
5478006|NCT01387529|Reference Values|reference values
5478007|NCT01387516|nicotine|nicotine
5478008|NCT01387516|juveniles|juveniles
5478009|NCT01387516|detention|detention
5478010|NCT01387503|Hepatocellular Carcinoma|hepatocellular carcinoma
5478011|NCT01387503|Liver Transplantation|liver transplantation
5478012|NCT01387503|Downstaging|downstaging
5478013|NCT01387503|Trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
5478014|NCT01387503|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5478015|NCT01387503|Liver resection|liver resection
5478016|NCT01387503|Sorafenib|sorafenib
5478017|NCT01387490|Mild Traumatic Brain Injury|mild traumatic brain injury
5478018|NCT01387490|Telephone counseling|telephone counseling
5478019|NCT01387477|hypoglycemia|hypoglycemia
5478020|NCT01387477|lactate|lactate
5478021|NCT01387477|glucose|glucose
5478023|NCT01387464|bromfenac concentrations|bromfenac concentrations
5478024|NCT01387464|ISV-303|isv-303
5478026|NCT01387451|Brown adipose tissue|brown adipose tissue
5478027|NCT01387451|Different regions|different regions
5478028|NCT01387451|Chinese adults|chinese adults
5478029|NCT01387438|Brown Adipose Tissue|brown adipose tissue
5478030|NCT01387438|Cross sectional study|cross sectional study
5478031|NCT01387438|Chinese Adults|chinese adults
5478032|NCT01387438|Factor|factor
5478033|NCT01387425|Smoking cessation of diabetic smoker|smoking cessation of diabetic smoker
5478034|NCT01387412|genital warts|genital warts
5478035|NCT01387412|HIV|hiv
5478036|NCT01387412|MSM|msm
5478037|NCT01387412|Peru|peru
5478038|NCT01387412|HPV|hpv
5478039|NCT01387399|ovarian cancer|ovarian cancer
5478040|NCT01387399|recurrence|recurrence
5478041|NCT01387399|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
5478043|NCT01387399|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5478044|NCT01387399|hyperthermic intraperitoneal chemoperfusion|hyperthermic intraperitoneal chemoperfusion
5478045|NCT01387399|cisplatin|cisplatin
5478046|NCT01387373|breast cancer|breast cancer
5478047|NCT01387373|metastatic|metastatic
5478048|NCT01387373|liver metastases|liver metastases
5478049|NCT01387373|intrahepatic|intrahepatic
5478050|NCT01387373|chemotherapy|chemotherapy
5478051|NCT01387360|Myopia|myopia
5478052|NCT01387360|Hyperopia|hyperopia
5478053|NCT01387360|Presbyopia|presbyopia
5478054|NCT01387360|Pseudophakia|pseudophakia
5478055|NCT01387360|LASIK|lasik
5478056|NCT01387347|Thymosin beta 4|thymosin beta 4
5478057|NCT01387347|Dry eye syndrome|dry eye syndrome
5478058|NCT01387347|Dry eye|dry eye
5478059|NCT01387334|resistive exercise|resistive exercise
5478060|NCT01387334|Resistance Exercise Training Program|resistance exercise training program
5478061|NCT01387334|Rubber Bands|rubber bands
5478062|NCT01387334|Glycemic Control|glycemic control
5478063|NCT01387334|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5478064|NCT01387321|Pi3K|pi3k
5478065|NCT01387321|Advanced solid tumor|advanced solid tumor
5478066|NCT01387308|Phase 1|phase 1
5478067|NCT01387308|Healthy male volunteers|healthy male volunteers
5478068|NCT01387308|pharmacokinetics|pharmacokinetics
5478069|NCT01387308|fostamatinib|fostamatinib
5478070|NCT01387308|Scientific Terminology: Bioavailability, R406 plasma AUC and C_maxR406 plasma AUC0-t, t1/2λz and t_max|scientific terminology: bioavailability, r406 plasma auc and c_maxr406 plasma auc0-t, t1/2λz and t_max
5478071|NCT01387308|Laymen Terminology: Amount of R406 in blood|laymen terminology: amount of r406 in blood
5478073|NCT01387295|liver metastases|liver metastases
5478074|NCT01387295|intrahepatic chemotherapy|intrahepatic chemotherapy
5478075|NCT01387256|abortion|abortion
5478076|NCT01387256|mifepristone|mifepristone
5478077|NCT01387256|misoprostol|misoprostol
5478078|NCT01387256|with gestations > 63 days LMP|with gestations > 63 days lmp
5478079|NCT01387243|behavior modification|behavior modification
5478080|NCT01387243|overweight|overweight
5478081|NCT01387243|orlistat|orlistat
5478082|NCT01387230|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5478083|NCT01387230|long acting muscarinic antagonist|long acting muscarinic antagonist
5478084|NCT01387217|GSK2018682|gsk2018682
5478085|NCT01387217|First Time in Human|first time in human
5478086|NCT01387217|Healthy Volunteer|healthy volunteer
5478087|NCT01387204|MEK inhibitor|mek inhibitor
5478088|NCT01387204|elimination|elimination
5478089|NCT01387204|Phase 1|phase 1
5478090|NCT01387204|GSK1120212|gsk1120212
5478091|NCT01387204|cancer|cancer
5478092|NCT01387204|Pharmacokinetics|pharmacokinetics
5478093|NCT01387204|oncology|oncology
5478094|NCT01387204|radiolabeled ADME|radiolabeled adme
5478095|NCT01387178|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5478096|NCT01387178|cost and cost analysis|cost and cost analysis
5478097|NCT01387178|bronchodilators|bronchodilators
5478098|NCT01387178|healthcare utilization|healthcare utilization
5478099|NCT01387178|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5478100|NCT01387178|tiotropium|tiotropium
5478101|NCT01387165|Latin America|latin america
5478102|NCT01387165|diabetes complications|diabetes complications
5478103|NCT01387165|patient compliance|patient compliance
5478104|NCT01387165|Diabetes mellitus, type 2|diabetes mellitus, type 2
5478105|NCT01387165|health services accessibility|health services accessibility
5478106|NCT01387152|chest pain|chest pain
5478107|NCT01387152|myocardial perfusion scintigraphy|myocardial perfusion scintigraphy
5478108|NCT01387152|nuclear stress testing|nuclear stress testing
5478109|NCT01387152|low radiation dose|low radiation dose
5478110|NCT01387139|Ketamine|ketamine
5478111|NCT01387139|Propofol|propofol
5478112|NCT01387139|Procedural Sedation and Analgesia|procedural sedation and analgesia
5478114|NCT01387113|tPA|tpa
5478115|NCT01387113|Thrombolysis|thrombolysis
5478116|NCT01387113|rt-PA|rt-pa
5478117|NCT01387113|Ischemic|ischemic
5478118|NCT01387113|CTP|ctp
5478119|NCT01387113|Imaging|imaging
5478120|NCT01387113|CT Perfusion Imaging|ct perfusion imaging
5478121|NCT01387113|Perfusion|perfusion
5478123|NCT01387113|CT Angiography|ct angiography
5478124|NCT01387113|Acute ischemic stroke|acute ischemic stroke
5478125|NCT01387113|Acute stroke therapy|acute stroke therapy
5478126|NCT01387113|(AIS)|(ais)
5478127|NCT01387100|supportive employment|supportive employment
5478128|NCT01387100|vocational rehabilitation|vocational rehabilitation
5478129|NCT01387087|ASP015K|asp015k
5478130|NCT01387087|Healthy subjects|healthy subjects
5478131|NCT01387087|Pharmacodynamics|pharmacodynamics
5478132|NCT01387087|Maximum tolerated dose|maximum tolerated dose
5478133|NCT01387061|liver resection|liver resection
5478134|NCT01387061|hepatic resection|hepatic resection
5478135|NCT01387061|intraoperative ultrasound|intraoperative ultrasound
5478136|NCT01387048|acne vulgaris|acne vulgaris
5478137|NCT01387048|late-type acne|late-type acne
5478138|NCT01387048|Skinoren|skinoren
5478139|NCT01387048|maintenance|maintenance
5478140|NCT01387022|Antiretroviral treatment|antiretroviral treatment
5478142|NCT01387022|Drug resistance|drug resistance
5478143|NCT01387022|Treatment outcome|treatment outcome
5478144|NCT01386983|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, acute urinary retention, surgery, early, costs
5478145|NCT01386983|benign prostatic hyperplasia|benign prostatic hyperplasia
5478146|NCT01386970|Pharmacokinetics|pharmacokinetics
5478147|NCT01386970|antiretroviral therapy|antiretroviral therapy
5478148|NCT01386970|nucleoside analogs|nucleoside analogs
5478149|NCT01386970|mitochondrial toxicity|mitochondrial toxicity
5478150|NCT01386970|clinical pharmacology|clinical pharmacology
5478151|NCT01386970|cellular pharmacology|cellular pharmacology
5478152|NCT01386970|pharmacogenetics|pharmacogenetics
5478153|NCT01386957|Nephrotic Syndrome|nephrotic syndrome
5478154|NCT01386957|Steroid treatment|steroid treatment
5478155|NCT01386957|Proteinuria|proteinuria
5478156|NCT01386957|Child|child
5478157|NCT01386944|Rotigotine|rotigotine
5478158|NCT01386944|Neupro®|neupro®
5478159|NCT01386944|Augmentation|augmentation
5478160|NCT01386944|Restless Legs Syndrome|restless legs syndrome
5478161|NCT01386944|Moderate to severe|moderate to severe
5478162|NCT01386944|idiopathic|idiopathic
5478163|NCT01386944|adults|adults
5478164|NCT01386931|Biopsy, Fine-Needle|biopsy, fine-needle
5478165|NCT01386931|Endoscopic Ultrasonography|endoscopic ultrasonography
5478166|NCT01386931|cytopathology|cytopathology
5478167|NCT01386918|Hallucinations|hallucinations
5478168|NCT01386918|Schizophrenia|schizophrenia
5478169|NCT01386905|Obesity|obesity
5478170|NCT01386879|suction|suction
5478171|NCT01386879|aspiration|aspiration
5478172|NCT01386879|general anesthesia|general anesthesia
5478173|NCT01386879|intubation|intubation
5478174|NCT01386879|endotracheal tube|endotracheal tube
5478175|NCT01386879|respiratory complications|respiratory complications
5478176|NCT01386866|AMG 706|amg 706
5478177|NCT01386866|Motesanib|motesanib
5478178|NCT01386866|Amgen|amgen
5478179|NCT01386866|Phase 1|phase 1
5478180|NCT01386853|Hyperlipidemia|hyperlipidemia
5478181|NCT01386853|Pitavastatin|pitavastatin
5478182|NCT01386853|Atorvastatin|atorvastatin
5478183|NCT01386840|Efficacy of Treatment|efficacy of treatment
5478184|NCT01386840|Severe|severe
5478185|NCT01386840|home treatment|home treatment
5478186|NCT01386840|treatment at hospital|treatment at hospital
5478187|NCT01386827|Ixiaro|ixiaro
5478188|NCT01386827|japanese encephalitis vaccine|japanese encephalitis vaccine
5478189|NCT01386827|booster|booster
5478190|NCT01386801|Diabetes|diabetes
5478191|NCT01386801|Controls|controls
5478192|NCT01386801|Biospecimen|biospecimen
5478193|NCT01386788|Smoke, cyanide, closed space fires|smoke, cyanide, closed space fires
5478194|NCT01386775|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5478195|NCT01386775|XLHED|xlhed
5478196|NCT01386775|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5478197|NCT01386775|HED|hed
5478198|NCT01386762|paralysis|paralysis
5478199|NCT01386762|paraplegia|paraplegia
5478200|NCT01386762|obesity|obesity
5478201|NCT01386749|Vibration treatment|vibration treatment
5478202|NCT01386749|Fracture healing|fracture healing
5478203|NCT01386749|Muscular function|muscular function
5478204|NCT01386736|insulin resistance|insulin resistance
5478205|NCT01386736|obesity|obesity
5478206|NCT01386736|adolescence|adolescence
5478207|NCT01386736|vitamin D supplementation|vitamin d supplementation
5478208|NCT01386723|eltrombopag|eltrombopag
5478209|NCT01386723|promacta|promacta
5478210|NCT01386723|immune thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5478211|NCT01386710|GBM|gbm
5478212|NCT01386710|AA|aa
5478213|NCT01386710|AO|ao
5478214|NCT01386710|Brain|brain
5478215|NCT01386710|Tumors|tumors
5478216|NCT01386710|Malignant|malignant
5478217|NCT01386710|Glioblastoma|glioblastoma
5478218|NCT01386710|Multiforme|multiforme
5478219|NCT01386710|Anaplastic|anaplastic
5478220|NCT01386710|Astrocytoma|astrocytoma
5478221|NCT01386684|Prostate Cancer|prostate cancer
5478222|NCT01386671|Type 2 Diabetes|type 2 diabetes
5478223|NCT01386671|metformin glycinate|metformin glycinate
5478224|NCT01386671|metabolic control|metabolic control
5478225|NCT01386658|Efficacy|efficacy
5478226|NCT01386658|Hereditary angioedema|hereditary angioedema
5478227|NCT01386658|HAE|hae
5478228|NCT01386658|Pediatric|pediatric
5478229|NCT01386658|Children|children
5478230|NCT01386658|Pharmacokinetics|pharmacokinetics
5478231|NCT01386658|Safety|safety
5478232|NCT01386658|Firazyr|firazyr
5478233|NCT01386658|icatibant|icatibant
5478234|NCT01386645|impaired glucose tolerance|impaired glucose tolerance
5478235|NCT01386645|prediabetes|prediabetes
5478236|NCT01386645|dietary glycemic index|dietary glycemic index
5478237|NCT01386645|beta-cell function|beta-cell function
5478238|NCT01386645|insulin secretion|insulin secretion
5478239|NCT01386645|oxidative stress|oxidative stress
5478240|NCT01386645|glycemic variability|glycemic variability
5478241|NCT01386632|Stage III-IV Squamous Cell Carcinoma|stage iii-iv squamous cell carcinoma
5478242|NCT01386593|Cytochrome|cytochrome
5478243|NCT01386593|Phenotyping|phenotyping
5478244|NCT01386593|Pharmacokinetics|pharmacokinetics
5478249|NCT01386580|Nervous System Neoplasms|nervous system neoplasms
5478250|NCT01386580|Neoplasms by Site|neoplasms by site
5478251|NCT01386580|Brain Diseases|brain diseases
5478252|NCT01386580|Central Nervous System Diseases|central nervous system diseases
5478253|NCT01386580|Nervous System Diseases|nervous system diseases
5478254|NCT01386580|Neoplastic Processes|neoplastic processes
5478255|NCT01386580|Pathologic Processes|pathologic processes
5478256|NCT01386567|hypogonadism|hypogonadism
5478257|NCT01386567|low testosterone|low testosterone
5478259|NCT01386554|H.P. Acthar Gel|h.p. acthar gel
5478260|NCT01386554|Acthar|acthar
5478261|NCT01386554|nephrotic syndrome|nephrotic syndrome
5478262|NCT01386554|idiopathic membranous nephropathy|idiopathic membranous nephropathy
5478263|NCT01386554|proteinuria|proteinuria
5478264|NCT01386515|Adaptation|adaptation
5478265|NCT01386515|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5478266|NCT01386515|Communication about Duchenne Muscular Dystrophy|communication about duchenne muscular dystrophy
5478267|NCT01386515|Sibling|sibling
5478268|NCT01386502|Solid Tumors|solid tumors
5478269|NCT01386502|Monoclonal Antibody|monoclonal antibody
5478270|NCT01386502|Peptide Vaccine|peptide vaccine
5478271|NCT01386502|Toxicity|toxicity
5478272|NCT01386502|PD-1 ligand|pd-1 ligand
5478273|NCT01386502|Solid Tumor|solid tumor
5478274|NCT01386502|Breast Cancer|breast cancer
5478275|NCT01386502|Ovarian Cancer|ovarian cancer
5478276|NCT01386502|Pancreatic Cancer|pancreatic cancer
5478277|NCT01386502|Colon Cancer|colon cancer
5478278|NCT01386502|Sarcoma|sarcoma
5478279|NCT01386489|HIV-uninfected|hiv-uninfected
5478280|NCT01386489|Mucosal Immunity|mucosal immunity
5478281|NCT01386489|Kinetics|kinetics
5478282|NCT01386489|Cytokines|cytokines
5478283|NCT01386489|Chemokines|chemokines
5478284|NCT01386489|Healthy Volunteer|healthy volunteer
5478286|NCT01386476|5-HT1A Receptors|5-ht1a receptors
5478287|NCT01386476|Blood Brain Barrier|blood brain barrier
5478288|NCT01386476|Drug Resistance|drug resistance
5478289|NCT01386476|Healthy Volunteer|healthy volunteer
5478290|NCT01386476|HV|hv
5478291|NCT01386437|Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)|autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced)
5478292|NCT01386437|Fungal Infections|fungal infections
5478293|NCT01386437|Molds|molds
5478294|NCT01386437|Autoimmune Polyendocrinpathy Syndrome (APS) Type 1|autoimmune polyendocrinpathy syndrome (aps) type 1
5478295|NCT01386437|Mucocutaneous Fungal Infection|mucocutaneous fungal infection
5478296|NCT01386437|Invasive Fungal Infection|invasive fungal infection
5478305|NCT01386411|BRCA testing|brca testing
5478306|NCT01386411|Ashkenazi descent|ashkenazi descent
5478307|NCT01386411|11-086|11-086
5478308|NCT01386398|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5478309|NCT01386398|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5478310|NCT01386398|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5478311|NCT01386398|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5478312|NCT01386398|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5478313|NCT01386398|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5478314|NCT01386398|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5478315|NCT01386398|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5478316|NCT01386372|Hyponatremia|hyponatremia
5478317|NCT01386372|Vasopressin|vasopressin
5478318|NCT01386372|Tolvaptan|tolvaptan
5478319|NCT01386372|SIADH|siadh
5478320|NCT01386346|gastroesophageal junction|gastroesophageal junction
5478321|NCT01386346|GEJ|gej
5478322|NCT01386346|esophageal|esophageal
5478323|NCT01386346|esophagus|esophagus
5478324|NCT01386333|Frontotemporal Dementia|frontotemporal dementia
5478325|NCT01386333|oxytocin|oxytocin
5478326|NCT01386333|Pick's disease|pick's disease
5478327|NCT01386320|anaesthetic techniques, regional; surgery orthopaedic|anaesthetic techniques, regional; surgery orthopaedic
5478328|NCT01386307|Pain|pain
5478329|NCT01386307|Hospitalization|hospitalization
5478330|NCT01386281|Julina|julina
5478331|NCT01386281|Postmenopausal osteoporosis|postmenopausal osteoporosis
5478332|NCT01386268|Kogenate FS|kogenate fs
5478333|NCT01386268|Hemophilia A|hemophilia a
5478334|NCT01386255|GERD|gerd
5478335|NCT01386242|Colorectal Cancer|colorectal cancer
5478336|NCT01386242|Novaferon|novaferon
5478337|NCT01386229|hemodynamic stability|hemodynamic stability
5478338|NCT01386229|etomidate|etomidate
5478339|NCT01386229|ketamine|ketamine
5478436|NCT01385787|myeloablative HCT|myeloablative hct
5478437|NCT01385787|PBMTC sites|pbmtc sites
5478340|NCT01386229|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability|coronary artery bypass surgery after induction of anesthesia, hemodynamic stability
5478341|NCT01386216|Critical limb ischemia|critical limb ischemia
5478342|NCT01386216|Peripheral vascular disease|peripheral vascular disease
5478343|NCT01386216|platelet-rich plasma|platelet-rich plasma
5478344|NCT01386203|lung cancer|lung cancer
5478345|NCT01386203|biomarkers|biomarkers
5478346|NCT01386203|breath|breath
5478347|NCT01386203|early detection|early detection
5478348|NCT01386190|preterm infant, body composition, exercise|preterm infant, body composition, exercise
5478349|NCT01386177|MDMA|mdma
5478350|NCT01386177|doxazosin|doxazosin
5478351|NCT01386177|norepinephrine|norepinephrine
5478352|NCT01386177|alpha1- receptor|alpha1- receptor
5478353|NCT01386177|ecstasy|ecstasy
5478354|NCT01386177|stimulants|stimulants
5478355|NCT01386151|Moderate asthmatic, uncontrolled|moderate asthmatic, uncontrolled
5478356|NCT01386138|HIV|hiv
5478357|NCT01386138|HIV Risk|hiv risk
5478358|NCT01386138|Sexually Transmitted Infections|sexually transmitted infections
5478359|NCT01386138|Women|women
5478360|NCT01386138|Pregnancy|pregnancy
5478361|NCT01386138|Neonatal Health|neonatal health
5478362|NCT01386138|Drug Use|drug use
5478363|NCT01386138|Drug Treatment|drug treatment
5478364|NCT01386138|Gender-specific Treatment|gender-specific treatment
5478365|NCT01386138|Methamphetamine|methamphetamine
5478366|NCT01386138|Opioids|opioids
5478367|NCT01386138|Cocaine|cocaine
5478368|NCT01386138|Injection Drugs|injection drugs
5478369|NCT01386138|Stimulants|stimulants
5478370|NCT01386138|Alcohol|alcohol
5478371|NCT01386138|Mandrax|mandrax
5478372|NCT01386138|Marijuana|marijuana
5478373|NCT01386138|Nicotine|nicotine
5478374|NCT01386086|Aripiprazole|aripiprazole
5478375|NCT01386086|adjunctive therapy|adjunctive therapy
5478376|NCT01386086|mood stabilizers|mood stabilizers
5478377|NCT01386086|major depressive disorder|major depressive disorder
5478378|NCT01386086|postpartum|postpartum
5478379|NCT01386086|Augmentation therapy|augmentation therapy
5478381|NCT01386060|Stress|stress
5478382|NCT01386060|Mindfulness|mindfulness
5478383|NCT01386060|Meditation|meditation
5478384|NCT01386047|Clinical Prediction Rules|clinical prediction rules
5478385|NCT01386047|Electronic Health Records|electronic health records
5478386|NCT01386047|Walsh Clinical Prediction Rule|walsh clinical prediction rule
5478387|NCT01386047|Heckerling Clinical Prediction Rule|heckerling clinical prediction rule
5478388|NCT01386034|Nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure|nutrition, protein metabolism, stable isotopes, mass spectrometry, intestinal failure
5478390|NCT01386021|coronary|coronary
5478391|NCT01386021|patency|patency
5478392|NCT01386021|morbidity|morbidity
5478393|NCT01385969|overinflation of LMAs|overinflation of lmas
5478394|NCT01385956|metastatic|metastatic
5478395|NCT01385956|locally advanced|locally advanced
5478396|NCT01385956|combination therapy|combination therapy
5478397|NCT01385956|dose escalation|dose escalation
5478404|NCT01385943|Telemedicine|telemedicine
5478405|NCT01385930|Overweight|overweight
5478406|NCT01385930|Obesity|obesity
5478407|NCT01385930|lifestyle counseling|lifestyle counseling
5478408|NCT01385917|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5478409|NCT01385917|strength and function tests|strength and function tests
5478411|NCT01385878|Microcoaxial phacoemulsification, 1.8mm, 2.2mm|microcoaxial phacoemulsification, 1.8mm, 2.2mm
5478412|NCT01385852|CME|cme
5478413|NCT01385852|OCT|oct
5478414|NCT01385852|Optical coherence tomography|optical coherence tomography
5478415|NCT01385852|macular thickness|macular thickness
5478416|NCT01385839|Alopecia|alopecia
5478417|NCT01385839|Hair transplantation|hair transplantation
5478418|NCT01385839|Needle irritation|needle irritation
5478419|NCT01385839|Medical needling|medical needling
5478420|NCT01385826|Uveitis|uveitis
5478421|NCT01385826|Juvenile arthritis|juvenile arthritis
5478422|NCT01385826|Anti-tumor necrosis factor alpha monoclonal antibody|anti-tumor necrosis factor alpha monoclonal antibody
5478423|NCT01385826|treatment|treatment
5478424|NCT01385813|pre-eclampsia|pre-eclampsia
5478425|NCT01385813|inflammatory markers|inflammatory markers
5478426|NCT01385813|serological biobank|serological biobank
5478427|NCT01385813|To assess whether the inflammatory markers could be useful|to assess whether the inflammatory markers could be useful
5680291|NCT00578357|gambling addiction|gambling addiction
5478428|NCT01385813|in order to identify pregnant women at risk to|in order to identify pregnant women at risk to
5478429|NCT01385813|develop preeclampsia|develop preeclampsia
5478430|NCT01385800|Grass allergy|grass allergy
5478431|NCT01385800|Rhinoconjunctivitis|rhinoconjunctivitis
5478432|NCT01385800|Environmental Exposure Unit|environmental exposure unit
5478433|NCT01385800|Immunotherapy|immunotherapy
5478434|NCT01385800|ToleroMune Grass|toleromune grass
5478435|NCT01385787|Pediatric (ages 0-21 years)|pediatric (ages 0-21 years)
5478438|NCT01385774|Intermittent Claudication|intermittent claudication
5478439|NCT01385774|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5478440|NCT01385774|Supervised Exercise Therapy|supervised exercise therapy
5478441|NCT01385774|Peripheral Arterial Disease|peripheral arterial disease
5478442|NCT01385761|Supraglottic airway devices|supraglottic airway devices
5478443|NCT01385735|Parkinson Disease|parkinson disease
5478444|NCT01385735|Emotion|emotion
5478445|NCT01385735|mood|mood
5478446|NCT01385735|executive function|executive function
5478447|NCT01385709|Lithium|lithium
5478448|NCT01385709|Sertraline|sertraline
5478449|NCT01385683|Healthy volunteer|healthy volunteer
5478450|NCT01385683|Pharmacokinetic|pharmacokinetic
5478451|NCT01385683|pharmacodynamic|pharmacodynamic
5478452|NCT01385683|Polymorphism, Genetic|polymorphism, genetic
5478453|NCT01385670|Patent Foramen Ovale|patent foramen ovale
5478455|NCT01385644|Mesenchymal stem cells|mesenchymal stem cells
5478456|NCT01385644|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5478457|NCT01385631|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5478458|NCT01385631|Intravascular ultrasound|intravascular ultrasound
5478459|NCT01385631|IVUS|ivus
5478460|NCT01385631|Optical coherence tomography|optical coherence tomography
5478461|NCT01385631|OCT|oct
5478462|NCT01385631|Ezetimibe|ezetimibe
5478463|NCT01385631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5478464|NCT01385631|Atorvastatin|atorvastatin
5478465|NCT01385631|Randomized trial|randomized trial
5478466|NCT01385631|Hypolipidemic Agents|hypolipidemic agents
5478467|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5478468|NCT01385631|Pharmacologic Actions|pharmacologic actions
5478469|NCT01385631|Enzyme Inhibitors|enzyme inhibitors
5478470|NCT01385631|Lipid Regulating Agents|lipid regulating agents
5478471|NCT01385631|Therapeutic Uses|therapeutic uses
5478472|NCT01385592|Parkinson Disease|parkinson disease
5478473|NCT01385592|L-dopa|l-dopa
5478474|NCT01385592|Levodopa|levodopa
5478475|NCT01385592|Dyskinesia|dyskinesia
5478476|NCT01385592|Anti-Dyskinesia Agents|anti-dyskinesia agents
5478477|NCT01385579|colorectal cancer screening|colorectal cancer screening
5478478|NCT01385579|fecal occult blood testing (FOBT)|fecal occult blood testing (fobt)
5478480|NCT01385579|community health center|community health center
5478481|NCT01385540|Tinnitus, fMRI, task-based fMRI, attention network|tinnitus, fmri, task-based fmri, attention network
5478482|NCT01385488|lymphedema|lymphedema
5478483|NCT01385488|breast cancer|breast cancer
5478484|NCT01385488|self care|self care
5478485|NCT01385488|bioelectrical impedance|bioelectrical impedance
5478486|NCT01385488|monitoring|monitoring
5478487|NCT01385475|Resistance Training|resistance training
5478488|NCT01385475|Physical Function|physical function
5478489|NCT01385475|Older Adults|older adults
5478490|NCT01385449|nerve block|nerve block
5478491|NCT01385449|shoulder surgery|shoulder surgery
5478492|NCT01385449|physical therapy|physical therapy
5478493|NCT01385436|human papillomavirus (HPV)|human papillomavirus (hpv)
5478494|NCT01385436|cervical cancer|cervical cancer
5478495|NCT01385436|high grade cervical squamous intraepithelial lesion (HSIL)|high grade cervical squamous intraepithelial lesion (hsil)
5478496|NCT01385423|acute myelogenous leukemia|acute myelogenous leukemia
5478497|NCT01385423|natural killer cells|natural killer cells
5478498|NCT01385423|haploidentical donor|haploidentical donor
5478499|NCT01385410|breastfeeding exclusively|breastfeeding exclusively
5478500|NCT01385397|Health system organization|health system organization
5478501|NCT01385345|Vitamin D deficiency|vitamin d deficiency
5478502|NCT01385345|Insulin resistance|insulin resistance
5478503|NCT01385332|Metaphase II|metaphase ii
5478504|NCT01385332|Ovarian stimulation|ovarian stimulation
5478505|NCT01385332|Egg donors|egg donors
5478507|NCT01385319|zotarolimus eluting stent|zotarolimus eluting stent
5478508|NCT01385319|triple anti-thrombotic therapy|triple anti-thrombotic therapy
5478509|NCT01385319|high bleeding riskduration of dual anti-platelet therapy|high bleeding riskduration of dual anti-platelet therapy
5478510|NCT01385293|BKM120|bkm120
5478511|NCT01385293|prostate cancer|prostate cancer
5478512|NCT01385293|metastatic castrate-resistant prostate cancer (mCRPC)|metastatic castrate-resistant prostate cancer (mcrpc)
5478513|NCT01385254|very low birthweight|very low birthweight
5478514|NCT01385254|premature|premature
5478515|NCT01385254|sibling adjustment|sibling adjustment
5478516|NCT01385254|preterm|preterm
5478517|NCT01385241|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5478518|NCT01385241|Stigma|stigma
5680292|NCT00578344|Sickle Cell Disease|sickle cell disease
5478519|NCT01385241|Safe disclosure of seropositive status|safe disclosure of seropositive status
5478520|NCT01385241|HIV positive women|hiv positive women
5478521|NCT01385241|Self-efficacy|self-efficacy
5478522|NCT01385228|prostate cancer|prostate cancer
5478523|NCT01385228|metastatic|metastatic
5478524|NCT01385228|pazopanib|pazopanib
5478525|NCT01385228|docetaxel|docetaxel
5478526|NCT01385228|metastatic prostate cancer|metastatic prostate cancer
5478527|NCT01385215|Vaccination|vaccination
5478528|NCT01385215|Mucosal Immunity|mucosal immunity
5478529|NCT01385215|Nasal Immunization|nasal immunization
5478619|NCT01384968|exercise|exercise
5478530|NCT01385202|Atrial Fibrillation|atrial fibrillation
5478531|NCT01385202|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5478532|NCT01385189|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
5478533|NCT01385189|HHVI|hhvi
5478534|NCT01385189|Human Hookworm|human hookworm
5478535|NCT01385189|Hookworm|hookworm
5478536|NCT01385189|Hookworm Disease|hookworm disease
5478537|NCT01385189|N. americanus|n. americanus
5478538|NCT01385189|Soil-transmitted helminth infection|soil-transmitted helminth infection
5478539|NCT01385189|Intestinal blood loss|intestinal blood loss
5478540|NCT01385189|Iron deficiency anemia|iron deficiency anemia
5478541|NCT01385176|Heart failure|heart failure
5478542|NCT01385176|Congestive heart failure|congestive heart failure
5478543|NCT01385176|New York Heart Association Class II-III|new york heart association class ii-iii
5478544|NCT01385176|Vagal therapy|vagal therapy
5478545|NCT01385176|Vagal nerve stimulation|vagal nerve stimulation
5478546|NCT01385163|mental health|mental health
5478547|NCT01385163|gender-based violence|gender-based violence
5478548|NCT01385163|Africa|africa
5478549|NCT01385150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5478550|NCT01385150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5478551|NCT01385150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5478552|NCT01385150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5478553|NCT01385150|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5478554|NCT01385150|adult acute basophilic leukemia|adult acute basophilic leukemia
5478555|NCT01385150|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5478556|NCT01385150|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5478557|NCT01385150|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5478558|NCT01385150|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5478559|NCT01385150|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5478560|NCT01385150|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5473082|NCT01408589|alcohol|alcohol
5478561|NCT01385150|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5478562|NCT01385150|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5478563|NCT01385150|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5478564|NCT01385137|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5478565|NCT01385137|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5478567|NCT01385137|stage II breast cancer|stage ii breast cancer
5478568|NCT01385137|stage IIIA breast cancer|stage iiia breast cancer
5478569|NCT01385137|pain|pain
5478570|NCT01385137|arthralgia|arthralgia
5478571|NCT01385124|Cannabidiol|cannabidiol
5478572|NCT01385124|GVHD|gvhd
5478573|NCT01385124|Allogeneic transplantation|allogeneic transplantation
5478574|NCT01385124|Prophylaxis|prophylaxis
5478575|NCT01385111|endobronchial ultrasound|endobronchial ultrasound
5478576|NCT01385111|endoscopic ultrasound|endoscopic ultrasound
5478577|NCT01385111|EBUS-TBNA|ebus-tbna
5478578|NCT01385111|EUS-FNA|eus-fna
5478579|NCT01385111|EUS-B-FNA|eus-b-fna
5478580|NCT01385111|lung cancer|lung cancer
5478581|NCT01385111|staging|staging
5478582|NCT01385098|Vitamin D|vitamin d
5478583|NCT01385098|Bariatric surgery|bariatric surgery
5478584|NCT01385098|Roux-en Y surgery|roux-en y surgery
5478585|NCT01385098|Gastric sleeve surgery|gastric sleeve surgery
5478586|NCT01385098|Parathyroid Hormone|parathyroid hormone
5478587|NCT01385085|Vitamin D|vitamin d
5478588|NCT01385085|Sunlight|sunlight
5478589|NCT01385085|Deficiency|deficiency
5478590|NCT01385072|acute leukemia|acute leukemia
5478591|NCT01385072|relapse|relapse
5478592|NCT01385072|induction failure|induction failure
5478593|NCT01385072|allogeneic transplantation|allogeneic transplantation
5478594|NCT01385072|graft versus leukemia effect|graft versus leukemia effect
5478595|NCT01385046|physical inactivity|physical inactivity
5478596|NCT01385046|poor diet|poor diet
5478597|NCT01385020|Red yeast rice|red yeast rice
5478598|NCT01385020|Gemfibrozil|gemfibrozil
5478599|NCT01385020|Drug-drug interaction|drug-drug interaction
5478600|NCT01385020|Pharmacokinetics|pharmacokinetics
5478601|NCT01385007|Rural|rural
5478602|NCT01385007|Veterans|veterans
5478603|NCT01385007|Dementia|dementia
5478604|NCT01385007|Pain|pain
5478605|NCT01385007|Aggression|aggression
5478606|NCT01385007|residence in a VA designated rural area|residence in a va designated rural area
5478607|NCT01385007|presence of a caregiver|presence of a caregiver
5478608|NCT01384994|Colorectal Cancer|colorectal cancer
5478609|NCT01384994|PARLIM|parlim
5478610|NCT01384994|KRAS Wildtype|kras wildtype
5478611|NCT01384994|Liver metastases|liver metastases
5478612|NCT01384981|chronic obstructive pulmonary rehabilitation|chronic obstructive pulmonary rehabilitation
5478613|NCT01384981|COPD|copd
5478614|NCT01384981|non invasive ventilation|non invasive ventilation
5478616|NCT01384981|exercise capacity|exercise capacity
5478617|NCT01384981|pulmonary rehabilitation|pulmonary rehabilitation
5478618|NCT01384968|nitrite|nitrite
5478620|NCT01384968|cycling|cycling
5478621|NCT01384955|scoliosis|scoliosis
5478622|NCT01384955|physical therapy|physical therapy
5478623|NCT01384955|long term outcome|long term outcome
5478624|NCT01384955|pulmonary function|pulmonary function
5478625|NCT01384955|physical fitness|physical fitness
5478626|NCT01384955|health related quality of life|health related quality of life
5478627|NCT01384955|psychopathology|psychopathology
5478628|NCT01384942|Bereavement|bereavement
5478629|NCT01384942|Grief|grief
5478630|NCT01384942|Mourning|mourning
5478631|NCT01384942|Loss|loss
5478632|NCT01384942|Death|death
5478633|NCT01384942|Meaning|meaning
5478634|NCT01384942|Group|group
5478635|NCT01384942|Counseling|counseling
5478636|NCT01384942|Psychotherapy|psychotherapy
5478637|NCT01384942|Uncomplicated|uncomplicated
5478638|NCT01384942|Support|support
5478639|NCT01384916|depression|depression
5478640|NCT01384916|yoga|yoga
5478641|NCT01384916|health education|health education
5478642|NCT01384916|antidepressant|antidepressant
5478643|NCT01384877|Pain|pain
5478644|NCT01384877|Cancer|cancer
5478645|NCT01384877|Lidocaine|lidocaine
5478646|NCT01384877|Sodium Channel Blockers|sodium channel blockers
5478647|NCT01384864|barrett's esophagus|barrett's esophagus
5478648|NCT01384864|intraepithelial neoplasia|intraepithelial neoplasia
5478649|NCT01384864|cross polarized reflectance examination|cross polarized reflectance examination
5478650|NCT01384864|vital-dye enhanced fluorescence examination|vital-dye enhanced fluorescence examination
5478651|NCT01384838|breast cancer|breast cancer
5478652|NCT01384838|physical activity|physical activity
5478653|NCT01384838|sports|sports
5478654|NCT01384838|exercise|exercise
5478655|NCT01384825|Multiple Sclerosis|multiple sclerosis
5478656|NCT01384825|Other Neurodegenerative Diseases|other neurodegenerative diseases
5478657|NCT01384825|Chronic CerebroSpinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
5478658|NCT01384825|Prevalence|prevalence
5478659|NCT01384825|Case-control|case-control
5478660|NCT01384773|Keratoconus|keratoconus
5478661|NCT01384773|Ectasia|ectasia
5478662|NCT01384773|UVA light|uva light
5478663|NCT01384773|riboflavin|riboflavin
5478664|NCT01384773|post-LASIK (laser in situ keratomileusis)|post-lasik (laser in situ keratomileusis)
5478665|NCT01384773|pellucid marginal degeneration|pellucid marginal degeneration
5478666|NCT01384773|irregular astigmatism|irregular astigmatism
5478667|NCT01384721|Computed Tomography Coronary Angiography|computed tomography coronary angiography
5478668|NCT01384721|Coronary Artery Disease|coronary artery disease
5478669|NCT01384721|Prevalence Of Disease|prevalence of disease
5478670|NCT01384721|Prognosis|prognosis
5478671|NCT01384721|Risk Stratification|risk stratification
5478672|NCT01384708|squamous cell cancer|squamous cell cancer
5478673|NCT01384708|squamous cell neoplasia|squamous cell neoplasia
5478674|NCT01384695|Barrett's esophagus|barrett's esophagus
5478675|NCT01384695|confocal microendoscopy|confocal microendoscopy
5478676|NCT01384617|distal pancreatectomy|distal pancreatectomy
5478677|NCT01384617|pancreatic fistula|pancreatic fistula
5478678|NCT01384617|pancreaticojejunostomy|pancreaticojejunostomy
5478679|NCT01384617|Roux-en-Y anastomosis|roux-en-y anastomosis
5478680|NCT01384617|stapling closure|stapling closure
5478681|NCT01384604|Schizophrenia|schizophrenia
5478682|NCT01384604|Schizoaffective disorder|schizoaffective disorder
5478683|NCT01384604|Bipolar disorder|bipolar disorder
5478684|NCT01384604|Psychosis|psychosis
5478685|NCT01384604|Genetics|genetics
5478686|NCT01384604|Phenotype|phenotype
5478687|NCT01384591|oxidative stress|oxidative stress
5478688|NCT01384591|blood flow|blood flow
5478689|NCT01384591|antioxidant|antioxidant
5478690|NCT01384591|muscle|muscle
5478691|NCT01384591|elderly|elderly
5478692|NCT01384552|normal weight|normal weight
5478693|NCT01384552|overweight|overweight
5478694|NCT01384552|dietary restraint|dietary restraint
5478695|NCT01384552|package unit size|package unit size
5478696|NCT01384552|food intake|food intake
5478697|NCT01384539|chronic kidney disease|chronic kidney disease
5478698|NCT01384539|vitamin D deficiency|vitamin d deficiency
5478699|NCT01384526|hormone therapy|hormone therapy
5478700|NCT01384526|ovarian aging|ovarian aging
5478701|NCT01384526|ovarian reserve|ovarian reserve
5478702|NCT01384526|fertility|fertility
5478703|NCT01384526|breast cancer|breast cancer
5478704|NCT01384513|Allogeneic HSCT|allogeneic hsct
5680293|NCT00578344|SCD|scd
5478705|NCT01384513|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5478706|NCT01384487|Viewing and axial cross sectional imaging of ocular|viewing and axial cross sectional imaging of ocular
5478707|NCT01384487|structures, including the anterior chamber|structures, including the anterior chamber
5478708|NCT01384474|Crew Resource Management|crew resource management
5478709|NCT01384474|Surgical safety checklist|surgical safety checklist
5478710|NCT01384474|Postoperative complications|postoperative complications
5478711|NCT01384448|stress echocardiography|stress echocardiography
5478712|NCT01384448|coronary ct angiography|coronary ct angiography
5478713|NCT01384435|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5478714|NCT01384435|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5478715|NCT01384422|methotrexate-refractory|methotrexate-refractory
5478716|NCT01384383|Chronic Hepatitis C|chronic hepatitis c
5478717|NCT01384383|IL28B CC Genotype|il28b cc genotype
5478718|NCT01384383|Treatment naive|treatment naive
5478719|NCT01384383|Peginterferon α-2a (PEG)|peginterferon α-2a (peg)
5478720|NCT01384383|Genotype 1a/b|genotype 1a/b
5478722|NCT01384383|GS 5885|gs 5885
5478723|NCT01384383|Ribavirin (RBV)|ribavirin (rbv)
5478724|NCT01384383|HCV NS5A inhibitor|hcv ns5a inhibitor
5478725|NCT01384383|HCV NS3 protease inhibitor|hcv ns3 protease inhibitor
5478726|NCT01384357|lymphadenopathy|lymphadenopathy
5478727|NCT01384357|needle biopsy|needle biopsy
5478728|NCT01384357|sonography|sonography
5478729|NCT01384331|Implanon users|implanon users
5478730|NCT01384331|Frequent bleeding|frequent bleeding
5478731|NCT01384331|Prolonged bleeding|prolonged bleeding
5478732|NCT01384331|Comparison of treatments|comparison of treatments
5478733|NCT01384331|Placebo controlled|placebo controlled
5478734|NCT01384331|Randomly allocated tretment|randomly allocated tretment
5478735|NCT01384292|Cancer-Related Pain|cancer-related pain
5478736|NCT01384292|Opioid-Induced Constipation|opioid-induced constipation
5478737|NCT01384292|OIC|oic
5478738|NCT01384279|metformin|metformin
5478739|NCT01384279|topiramate|topiramate
5478740|NCT01384279|obesity|obesity
5478741|NCT01384279|metabolic syndrome|metabolic syndrome
5478742|NCT01384266|Intraocular Inflammation following routine Cataract Surgery|intraocular inflammation following routine cataract surgery
5478743|NCT01384253|HER2+|her2+
5478744|NCT01384253|HER-2 positive|her-2 positive
5478745|NCT01384253|intraperitoneal|intraperitoneal
5478746|NCT01384253|intra-abdominal|intra-abdominal
5478747|NCT01384253|Lead 212|lead 212
5478748|NCT01384253|Radio Immunotherapy|radio immunotherapy
5478749|NCT01384253|Alpha particle|alpha particle
5478750|NCT01384253|Antibodies|antibodies
5478751|NCT01384253|Immunoglobulins|immunoglobulins
5478752|NCT01384253|Antibodies, Monoclonal|antibodies, monoclonal
5478753|NCT01384253|Immunologic Factors|immunologic factors
5478754|NCT01384253|Physiological Effects of Drugs|physiological effects of drugs
5478755|NCT01384253|Pharmacologic Actions|pharmacologic actions
5478756|NCT01384253|RIT|rit
5478757|NCT01384240|colon polyps|colon polyps
5478758|NCT01384240|colonic dysplasia|colonic dysplasia
5478759|NCT01384240|anal dysplasia|anal dysplasia
5478760|NCT01384240|microendoscopy|microendoscopy
5478761|NCT01384227|Barrett's esophagus|barrett's esophagus
5478762|NCT01384227|in vivo imaging|in vivo imaging
5478763|NCT01384227|image guide microscope|image guide microscope
5478764|NCT01384201|intestinal metaplasia, gastric cancer|intestinal metaplasia, gastric cancer
5478765|NCT01384175|Epidural Analgesia|epidural analgesia
5478767|NCT01384175|PCEA|pcea
5478768|NCT01384162|ALS|als
5478769|NCT01384162|VEGF165|vegf165
5478770|NCT01384162|Safety|safety
5478771|NCT01384162|Intracerebroventricular|intracerebroventricular
5478772|NCT01384162|Infusion|infusion
5478773|NCT01384162|Implantable|implantable
5478774|NCT01384149|intra ocular pressure|intra ocular pressure
5478775|NCT01384149|open angle glaucoma|open angle glaucoma
5478776|NCT01384149|selective laser trabeculoplasty|selective laser trabeculoplasty
5478777|NCT01384149|external laser treatment|external laser treatment
5478778|NCT01384123|stable pulmonary sarcoidosis with no change in medication during the last 3 months/|stable pulmonary sarcoidosis with no change in medication during the last 3 months/
5478779|NCT01384110|Amylase|amylase
5478780|NCT01384110|Glucosidase|glucosidase
5478781|NCT01384110|Glycemic response|glycemic response
5478782|NCT01384110|Sucrose|sucrose
5478783|NCT01384110|Seaweed|seaweed
5478784|NCT01384097|haemodynamic|haemodynamic
5478785|NCT01384097|goal-directed therapy|goal-directed therapy
5478786|NCT01384097|surgery|surgery
5478787|NCT01384097|anaesthesia|anaesthesia
5478788|NCT01384084|pelvic organ prolapse|pelvic organ prolapse
5478789|NCT01384084|urinary incontinence|urinary incontinence
5478790|NCT01384084|sacropexy|sacropexy
5478791|NCT01384084|sling|sling
5478792|NCT01384071|Low back pain|low back pain
5478793|NCT01384071|Unstable shoes|unstable shoes
5478794|NCT01384071|Gait|gait
5478795|NCT01384071|Balance|balance
5478796|NCT01384058|atherogenic lipoprotein|atherogenic lipoprotein
5478797|NCT01384058|cardiovascular disease|cardiovascular disease
5478798|NCT01384058|coronary artery disease|coronary artery disease
5478799|NCT01384058|type 2 diabetes|type 2 diabetes
5478800|NCT01384058|small, dense LDL|small, dense ldl
5478801|NCT01384045|Type II Diabetes|type ii diabetes
5478802|NCT01384045|Diabetes|diabetes
5478803|NCT01384032|CVD, LDL-C, apoE, SFA, DHA|cvd, ldl-c, apoe, sfa, dha
5478804|NCT01384019|ST-elevation myocardial infarction|st-elevation myocardial infarction
5478805|NCT01384019|percutaneous coronary intervention|percutaneous coronary intervention
5478806|NCT01384019|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5478807|NCT01384019|microvascular occlusion|microvascular occlusion
5478808|NCT01384019|myocardial salvage|myocardial salvage
5478809|NCT01384006|Pancreas transplantation|pancreas transplantation
5478810|NCT01384006|extended donor criteria|extended donor criteria
5478811|NCT01384006|organ survival|organ survival
5478812|NCT01383993|Open-Label|open-label
5478813|NCT01383993|Pharmacokinetics|pharmacokinetics
5478814|NCT01383993|Intravenous to oral switch|intravenous to oral switch
5478815|NCT01383993|Safety|safety
5478819|NCT01383993|High Risk For Systemic Fungal Infection|high risk for systemic fungal infection
5478821|NCT01383980|Enteral Feeding|enteral feeding
5478822|NCT01383980|nasogastric tubes|nasogastric tubes
5478823|NCT01383980|gastrostomy tubes|gastrostomy tubes
5478824|NCT01383980|jejunostomy tubes|jejunostomy tubes
5478825|NCT01383954|Knee osteoarthritis|knee osteoarthritis
5478826|NCT01383941|asthma|asthma
5478827|NCT01383941|rhinitis|rhinitis
5478828|NCT01383941|difficult-to-treat asthmatic|difficult-to-treat asthmatic
5478829|NCT01383941|phenotypes|phenotypes
5478830|NCT01383889|Physical exercise|physical exercise
5478831|NCT01383889|Pregnancy|pregnancy
5478832|NCT01383889|Fetal well being|fetal well being
5478833|NCT01383876|cervical|cervical
5478834|NCT01383876|laminectomy|laminectomy
5478835|NCT01383876|fusion|fusion
5478836|NCT01383876|neurological compression|neurological compression
5478837|NCT01383876|spondylosis|spondylosis
5478838|NCT01383850|preterm infants|preterm infants
5478839|NCT01383850|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5478840|NCT01383850|heliox|heliox
5478841|NCT01383850|bronchopulmonary dysplasia.|bronchopulmonary dysplasia.
5478842|NCT01383837|HIV/STI|hiv/sti
5478843|NCT01383837|Prevention|prevention
5478844|NCT01383837|Adolescents|adolescents
5478845|NCT01383837|Substance Use Disorders|substance use disorders
5478846|NCT01383837|Family-based intervention|family-based intervention
5478847|NCT01383824|Hip Replacement|hip replacement
5478848|NCT01383824|Femoral Component|femoral component
5478849|NCT01383811|Treatment Resistant Depression|treatment resistant depression
5478850|NCT01383811|Exercise|exercise
5478851|NCT01383798|iron deficiency, physical performance, female athletes|iron deficiency, physical performance, female athletes
5478852|NCT01383785|Primary PTCA|primary ptca
5478853|NCT01383785|Thrombus Aspiration Catheter|thrombus aspiration catheter
5478854|NCT01383785|Intracoronary Abciximab|intracoronary abciximab
5478855|NCT01383772|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5478856|NCT01383772|Pan retinal photocoagulation|pan retinal photocoagulation
5478857|NCT01383772|Multi-spot Photocoagulator|multi-spot photocoagulator
5478859|NCT01383759|BORTEZOMIB (VELCADE)|bortezomib (velcade)
5478860|NCT01383759|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5478861|NCT01383759|DEXAMETHASONE|dexamethasone
5478862|NCT01383759|MELPHALAN|melphalan
5478863|NCT01383759|11-061|11-061
5478864|NCT01383746|Cholangiocarcinoma|cholangiocarcinoma
5478865|NCT01383746|RADIOEMBOLIZATION|radioembolization
5478866|NCT01383746|tumor response|tumor response
5478867|NCT01383746|progression-free survival|progression-free survival
5478868|NCT01383746|safety|safety
5478869|NCT01383746|second-line therapy|second-line therapy
5478870|NCT01383720|Aortic Valve Stenosis|aortic valve stenosis
5478871|NCT01383720|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5478872|NCT01383655|wheezy bronchitis|wheezy bronchitis
5478873|NCT01383655|asthma|asthma
5478874|NCT01383655|rhinovirus|rhinovirus
5478875|NCT01383655|magnesium|magnesium
5478876|NCT01383629|Vitrectomy|vitrectomy
5478877|NCT01383629|Local anaesthesia|local anaesthesia
5478878|NCT01383629|Counselling|counselling
5478879|NCT01383629|Fear|fear
5478880|NCT01383629|Visual perception|visual perception
5478881|NCT01383616|osteoporosis|osteoporosis
5478882|NCT01383616|vertebral compression fractures|vertebral compression fractures
5478883|NCT01383603|Cat Allergy|cat allergy
5478884|NCT01383603|Rhinoconjunctivitis|rhinoconjunctivitis
5478885|NCT01383603|Immunotherapy|immunotherapy
5478886|NCT01383603|Cat-PAD|cat-pad
5478887|NCT01383590|Cat allergy|cat allergy
5478888|NCT01383590|Rhinoconjunctivitis|rhinoconjunctivitis
5478889|NCT01383590|Immunotherapy|immunotherapy
5478890|NCT01383590|Cat-PAD|cat-pad
5478891|NCT01383577|Hemorrhoids|hemorrhoids
5478892|NCT01383577|Ligation|ligation
5478893|NCT01383577|Pain|pain
5478894|NCT01383577|Morbidity|morbidity
5478895|NCT01383577|Patient Satisfaction|patient satisfaction
5478896|NCT01383577|Cost-Benefit Analysis|cost-benefit analysis
5478897|NCT01383551|Depression|depression
5478898|NCT01383551|Marital relationship|marital relationship
5478899|NCT01383551|Parental competence|parental competence
5478900|NCT01383538|pancreas|pancreas
5478901|NCT01383538|cancer|cancer
5478902|NCT01383538|adenocarcinoma|adenocarcinoma
5478903|NCT01383538|Oxaliplatin|oxaliplatin
5478904|NCT01383538|Leucovorin|leucovorin
5478905|NCT01383538|Irinotecan|irinotecan
5478906|NCT01383538|5-FU|5-fu
5478907|NCT01383538|IPI-926|ipi-926
5478913|NCT01383512|stroke|stroke
5478914|NCT01383512|rehabilitation|rehabilitation
5478915|NCT01383512|robotics|robotics
5478916|NCT01383512|motor control|motor control
5478917|NCT01383512|upper limb|upper limb
5478918|NCT01383486|Self Selection Tria|self selection tria
5478919|NCT01383473|cancer therapy|cancer therapy
5478920|NCT01383473|school attendance|school attendance
5478921|NCT01383473|cancer diagnosis|cancer diagnosis
5478922|NCT01383473|perception|perception
5478923|NCT01383460|Acute-on-chronic liver failure|acute-on-chronic liver failure
5478924|NCT01383460|ACLF|aclf
5478925|NCT01383460|cirrhosis|cirrhosis
5478926|NCT01383460|acute hepatitis|acute hepatitis
5478927|NCT01383421|Rheumatoid Arthritis|rheumatoid arthritis
5478928|NCT01383421|Patient Support Program|patient support program
5478929|NCT01383421|adalimumab|adalimumab
5478930|NCT01383408|breath sample analysis|breath sample analysis
5478931|NCT01383408|exhalation analysis|exhalation analysis
5478932|NCT01383408|volatile organic compounds|volatile organic compounds
5478933|NCT01383408|screening|screening
5478934|NCT01383408|lung cancer|lung cancer
5478935|NCT01383408|breast cancer|breast cancer
5478936|NCT01383408|ovarian cancer|ovarian cancer
5478937|NCT01383408|canine scent detection|canine scent detection
5478938|NCT01383382|Heart Diseases|heart diseases
5478939|NCT01383382|Cardiovascular Diseases|cardiovascular diseases
5478940|NCT01383382|Acute Myocardial Infarction|acute myocardial infarction
5478941|NCT01383382|Decision Making|decision making
5478942|NCT01383382|Percutaneous Coronary Intervention|percutaneous coronary intervention
5478943|NCT01383382|Informed Consent|informed consent
5478944|NCT01383382|Quality of Care|quality of care
5478945|NCT01383330|megesterol|megesterol
5478946|NCT01383317|Remote Ischemic Preconditioning|remote ischemic preconditioning
5478947|NCT01383317|Acute Pain|acute pain
5478948|NCT01383304|Platelet aggregation|platelet aggregation
5478949|NCT01383304|Aspirin|aspirin
5478950|NCT01383304|Drug resistance|drug resistance
5478951|NCT01383304|Thromboxane B2|thromboxane b2
5478952|NCT01383304|Pharmacologic Actions|pharmacologic actions
5478953|NCT01383304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5478954|NCT01383291|pelvic floor prolapse|pelvic floor prolapse
5478955|NCT01383291|prolift|prolift
5478956|NCT01383291|IVS|ivs
5478957|NCT01383291|Surgery|surgery
5478958|NCT01383278|tobacco|tobacco
5478959|NCT01383278|smoking|smoking
5478960|NCT01383278|smoking cessation|smoking cessation
5478961|NCT01383265|screening colonoscopy|screening colonoscopy
5478962|NCT01383265|adenoma|adenoma
5478963|NCT01383265|water method|water method
5478964|NCT01383252|water method|water method
5478965|NCT01383252|air method|air method
5478966|NCT01383252|unsedated colonoscopy|unsedated colonoscopy
5478967|NCT01383252|adenoma detection|adenoma detection
5478968|NCT01383239|Rotator Cuff Tear Repair|rotator cuff tear repair
5478969|NCT01383239|Rotator Cuff Tear Repair and postoperative treatment|rotator cuff tear repair and postoperative treatment
5478970|NCT01383226|endosonography|endosonography
5478971|NCT01383226|enlarged thoracic lymph adenopathies|enlarged thoracic lymph adenopathies
5478972|NCT01383226|non-cancer patient|non-cancer patient
5478973|NCT01383213|Acute Respiratory Failure|acute respiratory failure
5478975|NCT01383213|Continuous Positive Airway Pressure|continuous positive airway pressure
5478976|NCT01383200|efficacy|efficacy
5478977|NCT01383200|comfort|comfort
5478978|NCT01383187|Deep Burn Trauma|deep burn trauma
5478979|NCT01383187|Dermo-Epidermal Graft|dermo-epidermal graft
5478980|NCT01383187|Platelet Rich Plasma Concentrate (PRP)|platelet rich plasma concentrate (prp)
5478981|NCT01383187|Vancouver Scar Score|vancouver scar score
5478982|NCT01383187|Scarring|scarring
5478983|NCT01383187|Hypertrophic Scarring|hypertrophic scarring
5478984|NCT01383174|Breast cancer|breast cancer
5478985|NCT01383174|Latinas|latinas
5478986|NCT01383174|Peer support counselor|peer support counselor
5478987|NCT01383174|Spanish speaking|spanish speaking
5478988|NCT01383174|Community based|community based
5478989|NCT01383161|Curcumin|curcumin
5478990|NCT01383161|Turmeric|turmeric
5478991|NCT01383161|Memory|memory
5478992|NCT01383161|Cognitive Impairment|cognitive impairment
5478993|NCT01383161|Brain Imaging|brain imaging
5478995|NCT01383148|NSCLC|nsclc
5478996|NCT01383135|Healthy volunteers|healthy volunteers
5478997|NCT01383122|Pulsed electromagnetic field device|pulsed electromagnetic field device
5478998|NCT01383122|Cesarean section|cesarean section
5478999|NCT01383109|Mass Balance|mass balance
5479000|NCT01383109|Accelerated Mass Spectrometry (AMS)|accelerated mass spectrometry (ams)
5479001|NCT01383109|microdose|microdose
5479002|NCT01383109|Focus of the study: ADME|focus of the study: adme
5479003|NCT01383096|OZ439|oz439
5479004|NCT01383096|Bioavailability|bioavailability
5479005|NCT01383096|Food Effect|food effect
5479006|NCT01383083|Pulmonary arterial hypertension|pulmonary arterial hypertension
5479007|NCT01383083|Congenital heart disease|congenital heart disease
5479008|NCT01383083|Eisenmenger physiology|eisenmenger physiology
5479009|NCT01383070|Timely initiation of breast feeding|timely initiation of breast feeding
5479010|NCT01383070|Exclusive breast feeding|exclusive breast feeding
5479011|NCT01383070|Timely introduction of complimentary feeding|timely introduction of complimentary feeding
5479012|NCT01383070|Breast Feeding, Exclusive|breast feeding, exclusive
5479013|NCT01383070|Childbirth and the Puerperium|childbirth and the puerperium
5479014|NCT01383044|Carvedilol|carvedilol
5479309|NCT01381822|Phase 1|phase 1
5479017|NCT01383031|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5479018|NCT01383031|single site|single site
5479019|NCT01383031|randomized controlled trail|randomized controlled trail
5479025|NCT01383005|Treatment satisfaction|treatment satisfaction
5479026|NCT01383005|Adherence to treatment|adherence to treatment
5479027|NCT01382992|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5479028|NCT01382992|erbB-1|erbb-1
5479029|NCT01382979|Alcohol misuse prevention|alcohol misuse prevention
5479030|NCT01382979|College students|college students
5479031|NCT01382979|Intervention and control|intervention and control
5479032|NCT01382966|sclerostin|sclerostin
5479033|NCT01382966|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis
5479034|NCT01382966|carpal tunnel syndrome|carpal tunnel syndrome
5479035|NCT01382966|echocardiography|echocardiography
5479036|NCT01382953|Holter Monitor, Ambulatory Electrocardiography Monitoring|holter monitor, ambulatory electrocardiography monitoring
5479037|NCT01382888|Haemodialysis|haemodialysis
5479038|NCT01382888|Arteriovenous fistula|arteriovenous fistula
5461355|NCT01455636|hand sanitizers|hand sanitizers
5479039|NCT01382888|Severe chronic kidney disease|severe chronic kidney disease
5479040|NCT01382888|Newly constructed primary arteriovenous fistulas in patients planned for haemodialysis|newly constructed primary arteriovenous fistulas in patients planned for haemodialysis
5479041|NCT01382875|Multi-disciplinary management program|multi-disciplinary management program
5479042|NCT01382875|Conventional care program|conventional care program
5479043|NCT01382875|Balance Ability|balance ability
5479044|NCT01382875|Quality of Life|quality of life
5479045|NCT01382862|acute ischemic stroke|acute ischemic stroke
5479046|NCT01382862|thrombolysis|thrombolysis
5479047|NCT01382862|prehospital|prehospital
5479048|NCT01382862|emergency medicine|emergency medicine
5479049|NCT01382862|suspected acute stroke|suspected acute stroke
5479050|NCT01382862|telemedicine|telemedicine
5479051|NCT01382849|amyloid|amyloid
5479052|NCT01382849|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5479053|NCT01382849|hemorrhages|hemorrhages
5479054|NCT01382849|cerebral spot sign|cerebral spot sign
5479055|NCT01382810|dry eye signs and symptoms|dry eye signs and symptoms
5479056|NCT01382771|low back pain|low back pain
5479057|NCT01382771|zygapophysial joint pain|zygapophysial joint pain
5479058|NCT01382771|medial branch block|medial branch block
5479059|NCT01382771|> 6 months duration|> 6 months duration
5479060|NCT01382771|non-radicular|non-radicular
5479061|NCT01382758|Near Infrared Spectroscopy (NIRS)|near infrared spectroscopy (nirs)
5479062|NCT01382758|Acute kidney injury (AKI)|acute kidney injury (aki)
5479064|NCT01382732|Postpartum hemorrhage|postpartum hemorrhage
5479065|NCT01382732|Carbetocin|carbetocin
5479066|NCT01382732|Oxytocin|oxytocin
5479067|NCT01382719|FSAD|fsad
5479068|NCT01382719|HSDD|hsdd
5479069|NCT01382719|female sexual dysfunction|female sexual dysfunction
5479071|NCT01382719|Female Sexual Arousal Disorder|female sexual arousal disorder
5479072|NCT01382719|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5479073|NCT01382693|Behavioral symptoms|behavioral symptoms
5479074|NCT01382693|Long-term care|long-term care
5479075|NCT01382667|mucositis|mucositis
5479076|NCT01382667|dyspepsia|dyspepsia
5479077|NCT01382667|chemotherapy|chemotherapy
5479078|NCT01382667|GLP-2|glp-2
5479079|NCT01382667|questionnaire|questionnaire
5479080|NCT01382641|Cataract surgery|cataract surgery
5479081|NCT01382628|Diabetes|diabetes
5479082|NCT01382628|Ulcers|ulcers
5479083|NCT01382628|Equinus Deformity|equinus deformity
5479084|NCT01382628|Amputation|amputation
5479085|NCT01382628|Achilles Tendon|achilles tendon
5479086|NCT01382628|Limb Loss|limb loss
5479087|NCT01382615|Multiple Myeloma|multiple myeloma
5479088|NCT01382602|Urinary Incontinence, Stress|urinary incontinence, stress
5479089|NCT01382602|Tissue Therapy (Cell Therapy)|tissue therapy (cell therapy)
5479090|NCT01382602|Transplantation, Autologous|transplantation, autologous
5479091|NCT01382589|vitiligo|vitiligo
5479092|NCT01382589|depigmentation|depigmentation
5479093|NCT01382589|phototherapy|phototherapy
5479094|NCT01382589|non-segmental vitiligo|non-segmental vitiligo
5479095|NCT01382576|polycystic ovary syndrome|polycystic ovary syndrome
5479096|NCT01382576|chitotriosidase activity|chitotriosidase activity
5479097|NCT01382563|Eosinophilic Gastrointestinal Disorders|eosinophilic gastrointestinal disorders
5479098|NCT01382563|EGID|egid
5479099|NCT01382563|Eosinophilic Esophagitis|eosinophilic esophagitis
5479100|NCT01382563|Registry|registry
5479101|NCT01382563|Eosinophils|eosinophils
5479102|NCT01382563|Eosinophilia|eosinophilia
5479103|NCT01382563|Eosinophilic enteropathy|eosinophilic enteropathy
5479104|NCT01382563|Eosinophilic enteritis|eosinophilic enteritis
5479105|NCT01382563|Eosinophilic gastritis|eosinophilic gastritis
5479310|NCT01381822|Sunitinib|sunitinib
5479106|NCT01382563|Eosinophilic gastroenteritis|eosinophilic gastroenteritis
5479107|NCT01382563|Eosinophilic gastroenteropathy|eosinophilic gastroenteropathy
5479108|NCT01382550|antithrombin|antithrombin
5479109|NCT01382550|venous thrombosis|venous thrombosis
5479110|NCT01382550|thrombosis risk factors|thrombosis risk factors
5479111|NCT01382550|thrombophilia|thrombophilia
5479112|NCT01382537|Neck|neck
5479113|NCT01382537|Chronic|chronic
5479114|NCT01382537|Musculoskeletal|musculoskeletal
5479115|NCT01382537|Shoulder|shoulder
5479116|NCT01382524|PIV therapy|piv therapy
5479117|NCT01382498|Endothelin-1 high sensitivity CRP|endothelin-1 high sensitivity crp
5479118|NCT01382485|non union|non union
5479119|NCT01382485|bone defect|bone defect
5479120|NCT01382485|tibia non union|tibia non union
5479121|NCT01382485|femur non union|femur non union
5479122|NCT01382485|bone graft|bone graft
5479123|NCT01382472|STEMI|stemi
5479124|NCT01382472|PPCI|ppci
5479125|NCT01382472|Statins|statins
5479126|NCT01382472|Infarct size|infarct size
5479127|NCT01382459|children|children
5479128|NCT01382446|Trauma|trauma
5479129|NCT01382446|Mechanical Ventilation|mechanical ventilation
5479130|NCT01382446|Ventilator Associated Pneumonia|ventilator associated pneumonia
5479131|NCT01382446|Oral Care|oral care
5479132|NCT01382433|Chronic Cannabis Users|chronic cannabis users
5479133|NCT01382433|negative symptoms|negative symptoms
5479134|NCT01382433|cognitive electrophysiology functions|cognitive electrophysiology functions
5461434|NCT01455259|AdCD40L|adcd40l
5479135|NCT01382420|subclinical cushing syndrome|subclinical cushing syndrome
5479136|NCT01382420|hypercortisolism|hypercortisolism
5479137|NCT01382420|adrenal incidentaloma|adrenal incidentaloma
5479138|NCT01382420|adrenalectomy|adrenalectomy
5479139|NCT01382407|skin rash reaction|skin rash reaction
5479140|NCT01382407|ERBITUX® (cetuximab)|erbitux® (cetuximab)
5479141|NCT01382407|acne|acne
5479142|NCT01382394|Sepsis|sepsis
5479143|NCT01382394|heart failure|heart failure
5479144|NCT01382394|BNP|bnp
5479145|NCT01382394|IL-6|il-6
5479146|NCT01382394|Procalcitonin|procalcitonin
5479147|NCT01382394|Prognosis|prognosis
5479148|NCT01382368|Post Pneumonectomy Patients|post pneumonectomy patients
5479149|NCT01382368|IPF|ipf
5479150|NCT01382368|COPD|copd
5479151|NCT01382355|Kidney transplant|kidney transplant
5479152|NCT01382355|Kidney/Pancreas transplant|kidney/pancreas transplant
5479153|NCT01382355|Antibody|antibody
5479154|NCT01382355|Monitoring|monitoring
5479155|NCT01382342|Parkinson's disease|parkinson's disease
5479156|NCT01382342|cognition|cognition
5479157|NCT01382342|executive function|executive function
5479158|NCT01382342|rasagiline|rasagiline
5479159|NCT01382329|Prophylaxis of influenza infection caused by a pandemic influenza virus (H5N1)|prophylaxis of influenza infection caused by a pandemic influenza virus (h5n1)
5479160|NCT01382316|12-step facilitation|12-step facilitation
5479161|NCT01382316|Alcoholics Anonymous|alcoholics anonymous
5479162|NCT01382316|Narcotics Anonymous|narcotics anonymous
5479164|NCT01382316|Self-help|self-help
5479165|NCT01382303|Type 2 Diabetes|type 2 diabetes
5479166|NCT01382303|pentoxifylline|pentoxifylline
5479167|NCT01382303|proteinuria|proteinuria
5479168|NCT01382290|MRI|mri
5479169|NCT01382290|Spine|spine
5479170|NCT01382290|Diffusion|diffusion
5479171|NCT01382264|Poorly controlled diabetes Type 2|poorly controlled diabetes type 2
5479172|NCT01382264|Computer Assisted Decision Support|computer assisted decision support
5479173|NCT01382264|Primary Care Providers|primary care providers
5479174|NCT01382251|Activities of Daily Living|activities of daily living
5479175|NCT01382251|Caregivers|caregivers
5479176|NCT01382251|Ambulatory Surgical Procedures|ambulatory surgical procedures
5479177|NCT01382238|dolutegravir|dolutegravir
5479178|NCT01382238|pediatric|pediatric
5479179|NCT01382238|granule formulation|granule formulation
5479180|NCT01382238|GSK1349572|gsk1349572
5479181|NCT01382238|HIV|hiv
5479182|NCT01382225|Dry eyes|dry eyes
5479183|NCT01382225|Ocular discomfort|ocular discomfort
5479184|NCT01382212|Evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects|evaluate safety through the evaluation of the incidence of hypercalcemia in pediatric subjects
5685323|NCT00556543|Rib fracture non-union|rib fracture non-union
5479185|NCT01382199|Antibiotic Associated Diarrhea in Adult Patients|antibiotic associated diarrhea in adult patients
5479186|NCT01382186|Qualitative|qualitative
5479187|NCT01382186|User, Computer Interface|user, computer interface
5479188|NCT01382186|quantitative|quantitative
5479189|NCT01382186|survey|survey
5479190|NCT01382186|telemedicine|telemedicine
5479191|NCT01382173|Knee injury|knee injury
5479192|NCT01382173|Osteoarthritis|osteoarthritis
5479193|NCT01382173|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
5479194|NCT01382173|Patellar dislocation|patellar dislocation
5479195|NCT01382160|Rheumatoid arthritis|rheumatoid arthritis
5479196|NCT01382160|adalimumab|adalimumab
5479197|NCT01382160|pharmacokinetic-pharmacodynamic relationship|pharmacokinetic-pharmacodynamic relationship
5479198|NCT01382160|immunogenicity|immunogenicity
5479199|NCT01382160|Fc gamma receptors polymorphisms|fc gamma receptors polymorphisms
5479200|NCT01382134|Platelet dysfunction|platelet dysfunction
5479201|NCT01382134|Hemodilution|hemodilution
5479202|NCT01382134|Mild hypothermia|mild hypothermia
5479203|NCT01382134|NSAID|nsaid
5479204|NCT01382134|Desmopressin|desmopressin
5479205|NCT01382121|Peer modeling|peer modeling
5479206|NCT01382121|Observational learning|observational learning
5479207|NCT01382121|Obesity|obesity
5479208|NCT01382121|Adolescents|adolescents
5479209|NCT01382121|Maximum ventilatory oxygen|maximum ventilatory oxygen
5479210|NCT01382121|Aerobic fitness|aerobic fitness
5479211|NCT01382121|Health behaviour|health behaviour
5479212|NCT01382095|ETEC|etec
5479213|NCT01382095|Diarrhea|diarrhea
5479214|NCT01382095|Vaccine|vaccine
5479215|NCT01382082|cognitive function|cognitive function
5479216|NCT01382082|memory|memory
5479217|NCT01382082|attention|attention
5479218|NCT01382082|breast cancer|breast cancer
5479219|NCT01382082|lymphoma|lymphoma
5479220|NCT01382069|androgen|androgen
5479221|NCT01382069|male contraception|male contraception
5479222|NCT01382069|dimethandrolone|dimethandrolone
5479223|NCT01382069|healthy men|healthy men
5479224|NCT01382056|Peripheral Artery Disease|peripheral artery disease
5479225|NCT01382056|Pulses|pulses
5479226|NCT01382056|Beans|beans
5479228|NCT01382043|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5479229|NCT01382043|zotarolimus-eluting stent|zotarolimus-eluting stent
5479230|NCT01382043|sirolimus-eluting stent|sirolimus-eluting stent
5479231|NCT01382043|biodegradable polymer|biodegradable polymer
5479232|NCT01382043|biocompatible polymer|biocompatible polymer
5479233|NCT01382030|Soft tissue sarcoma|soft tissue sarcoma
5479234|NCT01382030|High-risk|high-risk
5479235|NCT01382030|Neoadjuvant|neoadjuvant
5479236|NCT01382030|Adjuvant|adjuvant
5479237|NCT01382030|Chemotherapy|chemotherapy
5479238|NCT01382030|Radiotherapy|radiotherapy
5479239|NCT01382017|lacosamide|lacosamide
5479240|NCT01382017|carbamazepine|carbamazepine
5479241|NCT01382017|placebo|placebo
5479242|NCT01382017|transcranial magnetic stimulation|transcranial magnetic stimulation
5479243|NCT01382017|TMS|tms
5479244|NCT01382017|motor cortex|motor cortex
5479245|NCT01382017|sodium channel|sodium channel
5479246|NCT01382017|inhibition|inhibition
5479247|NCT01382017|threshold|threshold
5479248|NCT01382004|Neglected diseases|neglected diseases
5479249|NCT01382004|Children|children
5479250|NCT01381991|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5479251|NCT01381991|Reflux esophagitis|reflux esophagitis
5479252|NCT01381991|i-scan|i-scan
5479253|NCT01381978|Nutritional status of scholars|nutritional status of scholars
5479254|NCT01381978|Risk factors of obesity|risk factors of obesity
5479255|NCT01381978|Socioeconomical status|socioeconomical status
5479256|NCT01381978|Physical activity habits|physical activity habits
5479257|NCT01381965|spectral-domain optical coherence tomography|spectral-domain optical coherence tomography
5473769|NCT01406028|IVF|ivf
5479258|NCT01381965|idiopathic macular hole|idiopathic macular hole
5479259|NCT01381965|cone outer segment tips line|cone outer segment tips line
5479260|NCT01381965|vitrectomy|vitrectomy
5479261|NCT01381952|X-ray|x-ray
5479262|NCT01381952|Image processing|image processing
5479263|NCT01381952|Neuro angiography|neuro angiography
5479264|NCT01381952|Radiation exposure|radiation exposure
5479265|NCT01381939|Intrahepatic Cholestasis of Pregnancy|intrahepatic cholestasis of pregnancy
5479266|NCT01381939|Induction of labor|induction of labor
5479267|NCT01381939|Pregnancy|pregnancy
5479268|NCT01381939|Caesarian section|caesarian section
5479269|NCT01381939|Pruritus|pruritus
5479270|NCT01381939|IUFD|iufd
5479271|NCT01381926|Type 2 diabetes|type 2 diabetes
5479272|NCT01381926|exenatide|exenatide
5479273|NCT01381926|Byetta|byetta
5479274|NCT01381913|Gastric cancer|gastric cancer
5479275|NCT01381913|Chemoradiotherapy|chemoradiotherapy
5479276|NCT01381913|Adjacent tissue invasion|adjacent tissue invasion
5479277|NCT01381913|Feasibility trial|feasibility trial
5479278|NCT01381900|Canagliflozin|canagliflozin
5479279|NCT01381900|Placebo|placebo
5479280|NCT01381900|Type 2 diabetes mellitus|type 2 diabetes mellitus
5479281|NCT01381887|Canagliflozin|canagliflozin
5479282|NCT01381887|Placebo|placebo
5450648|NCT01500161|ALL|all
5479283|NCT01381887|Type 2 diabetes mellitus|type 2 diabetes mellitus
5479284|NCT01381874|Breast cancer|breast cancer
5479285|NCT01381874|Abiraterone|abiraterone
5479286|NCT01381874|Postmenopausal|postmenopausal
5479287|NCT01381874|Metastatic|metastatic
5479288|NCT01381848|Doripenem|doripenem
5479289|NCT01381848|DORIPED1003|doriped1003
5479290|NCT01381848|Intravenous|intravenous
5479291|NCT01381848|Infection|infection
5479292|NCT01381848|Colonization|colonization
5479293|NCT01381848|Prophylaxis|prophylaxis
5479294|NCT01381848|Pediatric|pediatric
5479295|NCT01381848|Antibiotic|antibiotic
5479296|NCT01381848|Pharmacokinetics|pharmacokinetics
5479297|NCT01381835|TMC435-TiDP16-C126|tmc435-tidp16-c126
5479298|NCT01381835|TMC435-C126|tmc435-c126
5479299|NCT01381835|TMC435|tmc435
5479300|NCT01381835|HCV|hcv
5479301|NCT01381835|Hepatitis C|hepatitis c
5479302|NCT01381835|Hep C|hep c
5479303|NCT01381835|severe renal impairement|severe renal impairement
5479304|NCT01381822|TH-302|th-302
5479305|NCT01381822|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5479306|NCT01381822|RCC|rcc
5479307|NCT01381822|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5479308|NCT01381822|GIST|gist
5479311|NCT01381822|Pancreatic Neuroendocrine Tumors|pancreatic neuroendocrine tumors
5479312|NCT01381822|PNET|pnet
5479313|NCT01381809|Myelodysplastic Syndromes|myelodysplastic syndromes
5479314|NCT01381809|Myeloproliferative Disorders|myeloproliferative disorders
5479315|NCT01381809|Bone Marrow disease|bone marrow disease
5479316|NCT01381809|Anemia|anemia
5479317|NCT01381809|Epoetin Alfa|epoetin alfa
5479318|NCT01381809|Eprex|eprex
5479319|NCT01381809|Erypo|erypo
5479320|NCT01381809|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5479321|NCT01381783|topical anaesthesia|topical anaesthesia
5479322|NCT01381783|Phacoemulsification|phacoemulsification
5479323|NCT01381770|muscular lesions grade 2|muscular lesions grade 2
5479324|NCT01381770|muscular lesions grade 3|muscular lesions grade 3
5479325|NCT01381757|Extensively Drug-Resistant Tuberculosis|extensively drug-resistant tuberculosis
5479326|NCT01381757|First-Line Antituberculous Drugs|first-line antituberculous drugs
5461635|NCT01454440|DES|des
5479327|NCT01381757|Second-Line Antituberculous Drugs|second-line antituberculous drugs
5479328|NCT01381757|Middlebrook Culture|middlebrook culture
5479329|NCT01381757|Agar Proportion Method|agar proportion method
5479330|NCT01381744|Yersinia pestis, vaccine, plague, Flagellin/F1/V, Parent Protocol of 15-0104|yersinia pestis, vaccine, plague, flagellin/f1/v, parent protocol of 15-0104
5479331|NCT01381731|post PRK wound healing|post prk wound healing
5479332|NCT01381718|childhood brain tumor|childhood brain tumor
5479333|NCT01381718|neurotoxicity|neurotoxicity
5479334|NCT01381718|fatigue|fatigue
5479335|NCT01381718|cognitive/functional effects|cognitive/functional effects
5479336|NCT01381718|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5479337|NCT01381705|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5479338|NCT01381705|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5479339|NCT01381653|sexual risk|sexual risk
5479340|NCT01381653|substance use|substance use
5479341|NCT01381653|HIV prevention|hiv prevention
5479342|NCT01381653|intervention acceptability and feasibility|intervention acceptability and feasibility
5479343|NCT01381653|young men who have sex with men|young men who have sex with men
5479344|NCT01381640|paracetamol|paracetamol
5479345|NCT01381640|healthy volunteer|healthy volunteer
5479346|NCT01381640|pharmacoscintography|pharmacoscintography
5479347|NCT01381627|EBUS-TBNA|ebus-tbna
5479348|NCT01381627|Dexmedetomidine|dexmedetomidine
5479349|NCT01381627|Precedex|precedex
5479350|NCT01381627|Remifentanil|remifentanil
5479351|NCT01381627|Ultiva|ultiva
5479352|NCT01381627|Monitored Anesthesia Care|monitored anesthesia care
5479353|NCT01381627|Sedation|sedation
5479354|NCT01381627|Bronchoscopy|bronchoscopy
5479355|NCT01381627|Lung cancer|lung cancer
5479356|NCT01381627|Mediastinal node|mediastinal node
5479357|NCT01381627|Cancer staging|cancer staging
5479358|NCT01381627|Anesthesia|anesthesia
5479359|NCT01381627|Remote location|remote location
5479360|NCT01381614|retrospective database analysis|retrospective database analysis
5479361|NCT01381614|economic burden|economic burden
5479362|NCT01381601|retrospective database analysis|retrospective database analysis
5479363|NCT01381601|economic burden|economic burden
5479364|NCT01381575|HPV infection|hpv infection
5479365|NCT01381575|Human Papillomavirus|human papillomavirus
5479366|NCT01381575|Cervical cancer|cervical cancer
5479367|NCT01381575|HPV-16|hpv-16
5479368|NCT01381575|HPV-18|hpv-18
5479369|NCT01381575|vaccine|vaccine
5479370|NCT01381562|intra-abdominal infection|intra-abdominal infection
5479371|NCT01381562|belly|belly
5479372|NCT01381562|Gram-negative pathogen|gram-negative pathogen
5479374|NCT01381562|peritonitis|peritonitis
5479375|NCT01381549|Gram-negative|gram-negative
5479376|NCT01381549|uropathogens|uropathogens
5479377|NCT01381549|complicated lower urinary tract infection|complicated lower urinary tract infection
5479378|NCT01381549|pyelonephritis|pyelonephritis
5479379|NCT01381536|Anti Blys Antibody|anti blys antibody
5479380|NCT01381523|resource utilization|resource utilization
5479381|NCT01381523|naproxen sodium|naproxen sodium
5479382|NCT01381523|cost and cost analysis|cost and cost analysis
5479383|NCT01381523|triptan|triptan
5479384|NCT01381523|migraine|migraine
5479385|NCT01381510|Benign prostatic hyperplasia|benign prostatic hyperplasia
5479386|NCT01381510|Adherence|adherence
5479387|NCT01381510|Acute urinary retention|acute urinary retention
5479388|NCT01381510|Enlarged prostate|enlarged prostate
5479389|NCT01381510|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5479390|NCT01381510|Surgery|surgery
5479391|NCT01381510|Cost and cost analysis|cost and cost analysis
5479392|NCT01381497|presenteeism|presenteeism
5479393|NCT01381497|migraine disorders|migraine disorders
5479394|NCT01381497|work productivity|work productivity
5479395|NCT01381497|triptan|triptan
5479396|NCT01381497|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
5479397|NCT01381497|absenteeism|absenteeism
5479398|NCT01381484|Periorbital wrinkles|periorbital wrinkles
5479399|NCT01381484|Efficacy and safety|efficacy and safety
5479400|NCT01381432|Antirejection|antirejection
5479401|NCT01381419|pharmacokinetics|pharmacokinetics
5479402|NCT01381419|safety|safety
5479403|NCT01381419|positron emission tomography (PET)|positron emission tomography (pet)
5479404|NCT01381419|single ascending dose|single ascending dose
5479405|NCT01381393|osteoporosis|osteoporosis
5479406|NCT01381393|ibandronate|ibandronate
5479407|NCT01381380|myofascial pain|myofascial pain
5479408|NCT01381380|trigger point injection|trigger point injection
5479409|NCT01381380|manual therapy|manual therapy
5479410|NCT01381367|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5479411|NCT01381367|Inhaled corticosteroid|inhaled corticosteroid
5479412|NCT01381367|Pneumococcal vaccine|pneumococcal vaccine
5479413|NCT01381367|Acute exacerbation|acute exacerbation
5479414|NCT01381367|High-dose daily inhaled corticosteroid usage|high-dose daily inhaled corticosteroid usage
5479415|NCT01381367|Efficacy of the PPSV23 pneumococcal vaccine|efficacy of the ppsv23 pneumococcal vaccine
5479416|NCT01381354|Secondary Progressive Multiple Sclerosis, primary progressive multiple sclerosis|secondary progressive multiple sclerosis, primary progressive multiple sclerosis
5479417|NCT01381328|HIV-1 infected patients|hiv-1 infected patients
5461734|NCT01453842|Glucagon|glucagon
5479418|NCT01381328|RALTEGRAVIR regimen|raltegravir regimen
5479419|NCT01381328|genotypic evaluations|genotypic evaluations
5479420|NCT01381328|phenotypic evaluations|phenotypic evaluations
5479421|NCT01381315|Sentinel lymph node biopsy|sentinel lymph node biopsy
5479422|NCT01381315|Axillary lymph node dissection|axillary lymph node dissection
5479423|NCT01381315|Prevention of lymphedema|prevention of lymphedema
5479424|NCT01381302|Severity of disease|severity of disease
5479425|NCT01381276|Vitamin A|vitamin a
5479426|NCT01381250|Pathological gambling according to DSM and having gambled at least once the past month.|pathological gambling according to dsm and having gambled at least once the past month.
5479427|NCT01381250|Being atleast 18 years old|being atleast 18 years old
5479428|NCT01381237|Balance|balance
5479429|NCT01381237|Postural|postural
5479430|NCT01381237|Rehabilitation|rehabilitation
5479431|NCT01381237|Therapy|therapy
5479432|NCT01381237|computer-assisted|computer-assisted
5479433|NCT01381237|Video Games|video games
5479434|NCT01381237|Center of Pressure|center of pressure
5479435|NCT01381224|low back pain|low back pain
5479436|NCT01381224|lumbar|lumbar
5479437|NCT01381224|injection|injection
5479438|NCT01381224|lumbar pain|lumbar pain
5479439|NCT01381211|Intermediate stage hepatocellular carcinoma|intermediate stage hepatocellular carcinoma
5479440|NCT01381198|cerebral palsy|cerebral palsy
5479441|NCT01381198|distal rectus femoris transfer|distal rectus femoris transfer
5479442|NCT01381198|stiff knee gait pattern|stiff knee gait pattern
5479443|NCT01381198|gait analysis|gait analysis
5479444|NCT01381198|single event multilevel surgery|single event multilevel surgery
5479445|NCT01381198|randomized trial|randomized trial
5479446|NCT01381198|crouch gait|crouch gait
5479447|NCT01381185|myocardial infarction|myocardial infarction
5479448|NCT01381185|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5789044|NCT00150137|antithyroid drugs|antithyroid drugs
5479449|NCT01381185|high platelet reactivity (HPR)|high platelet reactivity (hpr)
5479450|NCT01381172|Heart Failure|heart failure
5479451|NCT01381172|Congestive Heart Failure|congestive heart failure
5479452|NCT01381172|Chronic heart disease|chronic heart disease
5479453|NCT01381172|Cardiac contractility modulation|cardiac contractility modulation
5479454|NCT01381172|CCM|ccm
5479455|NCT01381172|CHF|chf
5479456|NCT01381159|Adherence|adherence
5479457|NCT01381159|Asthma Control|asthma control
5479458|NCT01381159|Asthma Quality Of Life|asthma quality of life
5479459|NCT01381159|Motivational Communication|motivational communication
5479460|NCT01381159|Motivational Interviewing|motivational interviewing
5479461|NCT01381146|criminal behavior|criminal behavior
5482532|NCT01368497|HBV|hbv
5479462|NCT01381146|substance abuse|substance abuse
5479463|NCT01381146|HIV risk behavior|hiv risk behavior
5479464|NCT01381146|criminogenic thinking|criminogenic thinking
5479466|NCT01381146|guilt|guilt
5479467|NCT01381146|empathy|empathy
5479468|NCT01381146|jail inmates|jail inmates
5479469|NCT01381146|restorative justice|restorative justice
5479470|NCT01381146|Crime|crime
5479471|NCT01381133|Substance abuse|substance abuse
5479472|NCT01381133|Adolescent outpatient treatment|adolescent outpatient treatment
5479473|NCT01381133|Continuing care|continuing care
5479474|NCT01381133|Outcomes|outcomes
5479475|NCT01381120|Flank Pain|flank pain
5479476|NCT01381120|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5479477|NCT01381120|LUTS|luts
5479478|NCT01381120|Urgency|urgency
5479479|NCT01381120|Nocturia|nocturia
5479480|NCT01381120|Frequency|frequency
5479481|NCT01381120|Ureteroscopy|ureteroscopy
5479482|NCT01381120|Kidney Stones|kidney stones
5479483|NCT01381120|Stent|stent
5479484|NCT01381120|Incontinence|incontinence
5479485|NCT01381120|VESIcare|vesicare
5479486|NCT01381120|Ureter|ureter
5479487|NCT01381120|Urinary Bladder, Overactive|urinary bladder, overactive
5479488|NCT01381120|OAB|oab
5479489|NCT01381120|Overactive Bladder Syndrome|overactive bladder syndrome
5479490|NCT01381094|anemia|anemia
5479491|NCT01381094|chronic kidney disease|chronic kidney disease
5479493|NCT01381094|chronic renal insufficiency|chronic renal insufficiency
5479494|NCT01381094|renal impairment|renal impairment
5479495|NCT01381094|erythropoietin|erythropoietin
5479496|NCT01381094|safety|safety
5479497|NCT01381094|efficacy|efficacy
5479498|NCT01381094|tolerability|tolerability
5479499|NCT01381094|pharmacokinetics|pharmacokinetics
5479604|NCT01380665|KCI|kci
5479500|NCT01381081|knee osteoarthritis|knee osteoarthritis
5479501|NCT01381081|comparing platelet-rich plasma|comparing platelet-rich plasma
5479502|NCT01381081|intra-articular knee injections|intra-articular knee injections
5479503|NCT01381068|ventilation|ventilation
5479504|NCT01381068|end tidal carbon dioxide|end tidal carbon dioxide
5479505|NCT01381068|hypercapnia|hypercapnia
5479506|NCT01381068|hypocapnia|hypocapnia
5479507|NCT01381068|positive pressure ventilation|positive pressure ventilation
5479508|NCT01381068|neonates|neonates
5479509|NCT01381068|delivery room resuscitation|delivery room resuscitation
5479510|NCT01381055|Cutaneous leishmaniasis|cutaneous leishmaniasis
5479511|NCT01381055|Pentoxifylline|pentoxifylline
5479512|NCT01381055|Meglumine antimoniate|meglumine antimoniate
5479513|NCT01381055|L. braziliensis|l. braziliensis
5479514|NCT01381042|Brown Adipose Tissue|brown adipose tissue
5479515|NCT01381042|Incidence|incidence
5479516|NCT01381042|Factor|factor
5479517|NCT01381042|Human|human
5479518|NCT01381016|LH pulsatility|lh pulsatility
5479519|NCT01381016|Obesity|obesity
5479520|NCT01381016|Reproduction|reproduction
5479521|NCT01381003|Chronic Granulomatous Disease|chronic granulomatous disease
5479522|NCT01381003|Gene therapy|gene therapy
5479523|NCT01381003|X-CGD|x-cgd
5479524|NCT01381003|NADPH-oxidase|nadph-oxidase
5479525|NCT01381003|gp91-phox|gp91-phox
5479526|NCT01380977|crime|crime
5479527|NCT01380977|substance abuse|substance abuse
5479528|NCT01380977|HIV risk|hiv risk
5479529|NCT01380977|criminogenic thinking|criminogenic thinking
5479530|NCT01380977|shame|shame
5479531|NCT01380977|guilt|guilt
5479532|NCT01380977|restorative justice|restorative justice
5479533|NCT01380977|victim impact group|victim impact group
5479534|NCT01380964|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5479535|NCT01380964|biomarkers|biomarkers
5479536|NCT01380964|transcriptomics|transcriptomics
5479537|NCT01380964|mironics|mironics
5479538|NCT01380964|proteomics|proteomics
5479539|NCT01380951|liver cirrhosis|liver cirrhosis
5479540|NCT01380951|chronic hepatitis B|chronic hepatitis b
5479541|NCT01380951|antiviral therapy|antiviral therapy
5479542|NCT01380951|telbivudine|telbivudine
5479543|NCT01380938|genotypes 2 and 3|genotypes 2 and 3
5479544|NCT01380938|combination treatment|combination treatment
5479545|NCT01380938|individualized treatment|individualized treatment
5479546|NCT01380912|breast cancer|breast cancer
5479547|NCT01380912|mastectomy|mastectomy
5479548|NCT01380912|methylprednisoloneacetate|methylprednisoloneacetate
5479549|NCT01380912|seroma|seroma
5479550|NCT01380912|numbers of punctures|numbers of punctures
5479551|NCT01380899|Parkinson Disease|parkinson disease
5479552|NCT01380899|Parkinsonian Disorders|parkinsonian disorders
5479554|NCT01380899|alpha-Synuclein|alpha-synuclein
5479555|NCT01380860|mesh|mesh
5479556|NCT01380860|hernia|hernia
5479557|NCT01380847|Kidney Transplantation|kidney transplantation
5479558|NCT01380847|Allograft|allograft
5479559|NCT01380847|Kidney failure|kidney failure
5479560|NCT01380847|Chronic allograft nephropathy|chronic allograft nephropathy
5479561|NCT01380847|Monitoring|monitoring
5479562|NCT01380847|Urine|urine
5479563|NCT01380834|paravertebral nerve blocks|paravertebral nerve blocks
5479564|NCT01380834|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5482651|NCT01367938|TKA|tka
5479565|NCT01380821|clinical indication for myocardial SPECT|clinical indication for myocardial spect
5479566|NCT01380821|suspected or known coronary artery disease|suspected or known coronary artery disease
5479567|NCT01380795|non-small cell lung cancer carcinoma|non-small cell lung cancer carcinoma
5479568|NCT01380795|circulating tumor cells|circulating tumor cells
5479569|NCT01380795|EGFR|egfr
5479570|NCT01380795|K-ras|k-ras
5479571|NCT01380782|brain tumor|brain tumor
5479572|NCT01380782|recurrent disease|recurrent disease
5479573|NCT01380756|Amgen|amgen
5479574|NCT01380756|Phase 1|phase 1
5479575|NCT01380756|Clinical Trial|clinical trial
5479576|NCT01380756|Aurora kinase inhibitor|aurora kinase inhibitor
5479577|NCT01380756|Open label|open label
5479578|NCT01380756|Oncology|oncology
5479579|NCT01380756|Hematology|hematology
5479580|NCT01380743|Amicus Therapeutics|amicus therapeutics
5479581|NCT01380743|duvoglustat|duvoglustat
5479582|NCT01380743|AT2220|at2220
5479583|NCT01380743|alpha-glucosidase|alpha-glucosidase
5479584|NCT01380743|alglucosidase alfa|alglucosidase alfa
5479585|NCT01380730|Hypercholesterolemia|hypercholesterolemia
5479586|NCT01380730|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5479587|NCT01380704|Depression|depression
5479588|NCT01380678|bevacizumab|bevacizumab
5479589|NCT01380678|pterygium|pterygium
5479590|NCT01380678|treatment|treatment
5479591|NCT01380678|elevation|elevation
5479592|NCT01380665|Prevena|prevena
5479593|NCT01380665|Incision|incision
5479594|NCT01380665|Management|management
5479595|NCT01380665|System|system
5479596|NCT01380665|total|total
5479597|NCT01380665|knee|knee
5479598|NCT01380665|hip|hip
5479599|NCT01380665|replacement|replacement
5479600|NCT01380665|Surgery|surgery
5479601|NCT01380665|Negative|negative
5479602|NCT01380665|Pressure|pressure
5479603|NCT01380665|dressing|dressing
5479612|NCT01380639|6-Minutes-Walking-Distance|6-minutes-walking-distance
5479613|NCT01380639|Vibration training|vibration training
5479614|NCT01380639|Galileo|galileo
5479615|NCT01380639|Pulmonary rehabilitation|pulmonary rehabilitation
5479616|NCT01380626|alpha-1-antitrypsin-deficiency|alpha-1-antitrypsin-deficiency
5479617|NCT01380626|COPD|copd
5479618|NCT01380626|exercise training|exercise training
5479619|NCT01380626|muscle biopsy|muscle biopsy
5479621|NCT01380613|depression|depression
5479622|NCT01380613|drug use,|drug use,
5479623|NCT01380613|risk reduction|risk reduction
5479624|NCT01380600|Vaccinia|vaccinia
5479625|NCT01380600|Vaccinia Virus|vaccinia virus
5479626|NCT01380600|JX-594|jx-594
5479627|NCT01380600|Jennerex|jennerex
5479628|NCT01380600|Colorectal Carcinoma|colorectal carcinoma
5479629|NCT01380600|Colorectal cancer|colorectal cancer
5479630|NCT01380600|Colon Cancer|colon cancer
5479631|NCT01380600|Rectal Cancer|rectal cancer
5479632|NCT01380600|Pexa-Vec|pexa-vec
5479633|NCT01380587|ALL|all
5479634|NCT01380587|XCL1|xcl1
5479635|NCT01380587|Cytokines|cytokines
5479636|NCT01380587|Prognosis|prognosis
5479637|NCT01380574|atrial fibrillation|atrial fibrillation
5479638|NCT01380574|cardioversion|cardioversion
5479639|NCT01380574|stroke|stroke
5479640|NCT01380574|thromboembolism|thromboembolism
5479641|NCT01380561|asimadoline|asimadoline
5479642|NCT01380561|pharmacokinetic|pharmacokinetic
5479643|NCT01380561|excretion of 14C-derived radioactivity|excretion of 14c-derived radioactivity
5479644|NCT01380561|metabolite profile|metabolite profile
5479645|NCT01380561|14C-asimadoline|14c-asimadoline
5479646|NCT01380561|metabolites|metabolites
5479647|NCT01380561|single and multiple oral doses|single and multiple oral doses
5479652|NCT01380522|Bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
5479653|NCT01380509|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
5479654|NCT01380496|bioequivalence|bioequivalence
5479655|NCT01380496|doxycycline monohydrate|doxycycline monohydrate
5479656|NCT01380496|fed|fed
5479658|NCT01380483|doxycycline monohydrate|doxycycline monohydrate
5479659|NCT01380483|fasting|fasting
5479660|NCT01380470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5479661|NCT01380470|Diagnosis differential|diagnosis differential
5479662|NCT01380470|Dyspnea/classification|dyspnea/classification
5479663|NCT01380470|Dyspnea/etiology|dyspnea/etiology
5479664|NCT01380457|bioequivalence|bioequivalence
5479665|NCT01380457|dronabinol|dronabinol
5479666|NCT01380457|fasting|fasting
5479667|NCT01380444|Intertrochanteric fracture|intertrochanteric fracture
5479668|NCT01380444|Gamma3 intramedullary nail|gamma3 intramedullary nail
5479669|NCT01380444|Sliding hip screw|sliding hip screw
5479670|NCT01380431|bioequivalence, lisinopril, fed|bioequivalence, lisinopril, fed
5479671|NCT01380418|Obesity|obesity
5479672|NCT01380405|Inhalators|inhalators
5479673|NCT01380405|Education|education
5479674|NCT01380405|Primary care|primary care
5479675|NCT01380392|Liver cancer|liver cancer
5479676|NCT01380392|Uncertainty|uncertainty
5479677|NCT01380392|Personality|personality
5479678|NCT01380392|coping strategies|coping strategies
5479679|NCT01380379|physical violence|physical violence
5479680|NCT01380379|sexual violence|sexual violence
5479681|NCT01380366|Malabsorption|malabsorption
5479684|NCT01380340|Seniors|seniors
5479685|NCT01380340|Driving|driving
5479686|NCT01380340|Group work|group work
5479687|NCT01380327|cockroach|cockroach
5479688|NCT01380327|immunotherapy|immunotherapy
5479689|NCT01380327|sublingual immunotherapy (SLIT)|sublingual immunotherapy (slit)
5479690|NCT01380327|inner city asthma|inner city asthma
5479691|NCT01380314|leishmaniasis|leishmaniasis
5479692|NCT01380314|cutaneois leishmaniasis|cutaneois leishmaniasis
5479693|NCT01380314|miltefosine|miltefosine
5479694|NCT01380314|oral therapy|oral therapy
5479695|NCT01380314|treatment|treatment
5479696|NCT01380314|imiquimod|imiquimod
5479697|NCT01380301|Leishmaniasis|leishmaniasis
5479698|NCT01380301|Miltefosine|miltefosine
5479699|NCT01380301|Antimony|antimony
5479700|NCT01380301|Therapy|therapy
5479701|NCT01380288|Alzheimer's disease|alzheimer's disease
5479702|NCT01380288|rivastigmine patch|rivastigmine patch
5479703|NCT01380288|white matter change|white matter change
5479704|NCT01380275|recurrent, refractory, bone, soft tissue, sarcomas|recurrent, refractory, bone, soft tissue, sarcomas
5479705|NCT01380262|Colorectal Cancer|colorectal cancer
5479706|NCT01380262|Skin Rash|skin rash
5479707|NCT01380262|Pre-emptive treatment|pre-emptive treatment
5479708|NCT01380262|Doxycycline|doxycycline
5479709|NCT01380262|Anti-EGFR antibody|anti-egfr antibody
5479710|NCT01380262|Cetuximab|cetuximab
5479711|NCT01380262|Panitumumab|panitumumab
5479713|NCT01380249|Phase I multiple doses|phase i multiple doses
5479714|NCT01380249|PDM08|pdm08
5479715|NCT01380249|Cancer Treatment|cancer treatment
5479716|NCT01380249|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
5479717|NCT01380249|Advanced Solid Tumors|advanced solid tumors
5479718|NCT01380249|Prodimed|prodimed
5479719|NCT01380210|Carbon dioxide intoxication|carbon dioxide intoxication
5479720|NCT01380210|Diffusion weighted images(DWI)|diffusion weighted images(dwi)
5479721|NCT01380197|pain|pain
5479722|NCT01380197|sickle cell|sickle cell
5479723|NCT01380197|nubain|nubain
5479724|NCT01380197|morphine|morphine
5479725|NCT01380197|acute chest|acute chest
5479726|NCT01380197|side effects|side effects
5479727|NCT01380184|Relapsed cancer|relapsed cancer
5479728|NCT01380158|pessary|pessary
5479729|NCT01380158|preterm birth|preterm birth
5479730|NCT01380158|short cervix|short cervix
5479731|NCT01380158|cervical incompetence|cervical incompetence
5479732|NCT01380145|multiple myeloma|multiple myeloma
5479733|NCT01380145|MAGE-A3|mage-a3
5479734|NCT01380145|autologous stem cell transplant|autologous stem cell transplant
5479735|NCT01380132|Fecal incontinence|fecal incontinence
5479736|NCT01380132|Treatment|treatment
5479737|NCT01380132|Surgery|surgery
5479738|NCT01380119|sputum conversion|sputum conversion
5479739|NCT01380119|liver biochemistry|liver biochemistry
5479740|NCT01380119|weight loss|weight loss
5479741|NCT01380119|quality of life|quality of life
5479742|NCT01380106|Multiple myeloma|multiple myeloma
5479743|NCT01380106|Relapsed|relapsed
5479744|NCT01380106|Revlimid|revlimid
5479745|NCT01380093|abuse potential|abuse potential
5479746|NCT01380093|abuse liability|abuse liability
5479747|NCT01380093|recreational opioid use|recreational opioid use
5479748|NCT01380093|morphine|morphine
5479749|NCT01380067|Inguinal hernia|inguinal hernia
5479750|NCT01380067|Lateral umbilicus ligament|lateral umbilicus ligament
5479751|NCT01380067|Recurrence|recurrence
5479752|NCT01380054|Pulmonary Hypertension|pulmonary hypertension
5479753|NCT01380054|Quality of life|quality of life
5479754|NCT01380054|Coping|coping
5479755|NCT01380054|Depression|depression
5479756|NCT01380054|Anxiety|anxiety
5479757|NCT01380054|Social support|social support
5479758|NCT01380054|Control beliefs|control beliefs
5479759|NCT01380041|Multiple sclerosisCerebrospinal fluidBiomarkerCytokineArray|multiple sclerosiscerebrospinal fluidbiomarkercytokinearray
5479760|NCT01380028|chronic subdural hematomas|chronic subdural hematomas
5479761|NCT01380028|corticosteroid|corticosteroid
5479762|NCT01380028|treatment|treatment
5479763|NCT01380028|neurosurgery|neurosurgery
5479764|NCT01380028|recurrence, adjuvant|recurrence, adjuvant
5479765|NCT01380015|osteoarthritis|osteoarthritis
5479766|NCT01380015|spearmint|spearmint
5479767|NCT01380015|rosmarinic acid|rosmarinic acid
5479768|NCT01380002|care needs|care needs
5479769|NCT01379976|lung|lung
5479770|NCT01379976|cancer|cancer
5479771|NCT01379976|non small cell lung cancer|non small cell lung cancer
5479772|NCT01379976|Advanced or metastatic non small cell lung cancer|advanced or metastatic non small cell lung cancer
5479773|NCT01379937|influenza|influenza
5479774|NCT01379937|H5N1|h5n1
5479775|NCT01379937|vaccine|vaccine
5479776|NCT01379937|children|children
5479777|NCT01379911|Satiety|satiety
5479778|NCT01379911|Food intake|food intake
5479779|NCT01379911|Yogurt|yogurt
5479780|NCT01379898|Pheochromocytoma|pheochromocytoma
5479781|NCT01379898|Doxazosin|doxazosin
5479782|NCT01379898|Phenoxybenzamine|phenoxybenzamine
5479783|NCT01379885|Pain|pain
5479784|NCT01379885|immunization|immunization
5479785|NCT01379885|distraction|distraction
5479786|NCT01379885|hypnosis|hypnosis
5479787|NCT01379885|injections|injections
5479788|NCT01379885|anxiety|anxiety
5479789|NCT01379872|Prostate|prostate
5479790|NCT01379872|Head and Neck|head and neck
5479791|NCT01379872|Anal|anal
5479792|NCT01379846|Immunostimulation|immunostimulation
5479793|NCT01379846|Haemophilus b conjugate vaccine|haemophilus b conjugate vaccine
5479794|NCT01379846|HIB|hib
5479795|NCT01379833|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5479796|NCT01379833|Neurotrophic corneal ulcer|neurotrophic corneal ulcer
5479797|NCT01379820|NEONATAL RESPIRATORY FAILURE|neonatal respiratory failure
5479798|NCT01379820|OROTRACHEAL cpap|orotracheal cpap
5479799|NCT01379820|NASAL cpap|nasal cpap
5479800|NCT01379820|MECHANICAL VENTILATION|mechanical ventilation
5479801|NCT01379820|PNEUMOTHORAX|pneumothorax
5479802|NCT01379820|COMPENSATION BAG|compensation bag
5479803|NCT01379781|prevention|prevention
5479804|NCT01379781|postpartum depression|postpartum depression
5479805|NCT01379755|stability|stability
5479806|NCT01379755|single-radius|single-radius
5479807|NCT01379755|multi-radius|multi-radius
5479808|NCT01379755|total knee arthroplasty|total knee arthroplasty
5479809|NCT01379742|prostate cancer|prostate cancer
5479810|NCT01379742|prostate brachytherapy|prostate brachytherapy
5612024|NCT00850044|FIH|fih
5479811|NCT01379729|Type 1 Diabetes|type 1 diabetes
5479812|NCT01379729|Transplantation|transplantation
5479813|NCT01379729|Beta Cells|beta cells
5479814|NCT01379729|Encapsulation|encapsulation
5479815|NCT01379703|HIV-1 infected patients|hiv-1 infected patients
5479816|NCT01379703|Protease inhibitor|protease inhibitor
5479817|NCT01379703|Kaletra®|kaletra®
5479818|NCT01379690|HbA1c|hba1c
5479819|NCT01379677|Coronary Artery Disease|coronary artery disease
5479820|NCT01379677|Myocardial perfusion imaging|myocardial perfusion imaging
5479821|NCT01379677|Rubidium|rubidium
5479822|NCT01379677|Technetium|technetium
5479823|NCT01379664|Sevoflurane|sevoflurane
5479824|NCT01379664|Isoflurane|isoflurane
5479825|NCT01379664|volatile anesthetic|volatile anesthetic
5479826|NCT01379664|duration of hospitalization|duration of hospitalization
5479827|NCT01379651|Egg allergy,specific oral tolerance induction|egg allergy,specific oral tolerance induction
5479828|NCT01379638|cardiopulmonary bypass|cardiopulmonary bypass
5479829|NCT01379638|cardiac output|cardiac output
5479830|NCT01379638|flow rate|flow rate
5479831|NCT01379638|lactate|lactate
5479832|NCT01379625|fatty acid oxidation|fatty acid oxidation
5479833|NCT01379625|triheptanoin|triheptanoin
5479834|NCT01379625|long-chain fatty acid oxidation disorders|long-chain fatty acid oxidation disorders
5479835|NCT01379625|LCHADD|lchadd
5479836|NCT01379625|VLCADD|vlcadd
5479837|NCT01379625|CPT2|cpt2
5479838|NCT01379625|TFP|tfp
5479839|NCT01379612|Ultrasound elastography|ultrasound elastography
5479840|NCT01379612|Rectal cancer|rectal cancer
5479841|NCT01379612|Preoperative chemoradiation|preoperative chemoradiation
5479842|NCT01379599|cocaine|cocaine
5479843|NCT01379599|heroin|heroin
5479844|NCT01379599|STIs|stis
5479845|NCT01379599|HIV|hiv
5479846|NCT01379599|brief motivational intervention|brief motivational intervention
5479847|NCT01379599|voluntary testing and counseling|voluntary testing and counseling
5479848|NCT01379586|ONO-4053|ono-4053
5479849|NCT01379586|Healthy adult subjects|healthy adult subjects
5479850|NCT01379586|First time in humans|first time in humans
5479851|NCT01379573|hydroxychloroquine|hydroxychloroquine
5479852|NCT01379573|Plaquenil|plaquenil
5479853|NCT01379573|congenital heart block|congenital heart block
5479854|NCT01379573|neonatal lupus|neonatal lupus
5479855|NCT01379573|systemic lupus erythematosus|systemic lupus erythematosus
5479856|NCT01379573|Sjogren's syndrome|sjogren's syndrome
5479857|NCT01379573|autoantibodies|autoantibodies
5479858|NCT01379573|SSA/Ro|ssa/ro
5479859|NCT01379573|SSB/La|ssb/la
5479860|NCT01379573|autoimmunity|autoimmunity
5479861|NCT01379573|pregnancy|pregnancy
5479862|NCT01379573|immunoglobulin|immunoglobulin
5479863|NCT01379547|Procalcitonin|procalcitonin
5479864|NCT01379547|sepsis|sepsis
5479865|NCT01379547|ICU|icu
5479866|NCT01379547|antibiotic|antibiotic
5479867|NCT01379547|antibiotic duration|antibiotic duration
5479868|NCT01379547|Antibiotic treatment duration|antibiotic treatment duration
5479869|NCT01379534|Solid tumors,|solid tumors,
5479870|NCT01379534|advanced endometrial cancer,|advanced endometrial cancer,
5479871|NCT01379534|Endometrial Cancer,|endometrial cancer,
5479872|NCT01379534|Second-line treatment,|second-line treatment,
5479873|NCT01379534|VEGF,|vegf,
5479874|NCT01379534|Neoplasms,|neoplasms,
5479875|NCT01379534|Endometrial Neoplasms,|endometrial neoplasms,
5479876|NCT01379534|Uterine Neoplasms,|uterine neoplasms,
5479877|NCT01379534|Female Genital Neoplasms,|female genital neoplasms,
5479879|NCT01379534|Carcinoma,|carcinoma,
5479880|NCT01379534|Uterine Diseases,|uterine diseases,
5479881|NCT01379534|Female Genital Diseases,|female genital diseases,
5479882|NCT01379534|Tumors,|tumors,
5479883|NCT01379534|Oral Administration,|oral administration,
5479884|NCT01379534|Capsules,|capsules,
5479885|NCT01379534|Tablets,|tablets,
5479886|NCT01379534|CHIR258,|chir258,
5479887|NCT01379534|CHIR-258,|chir-258,
5479888|NCT01379534|CHIR 258,|chir 258,
5479889|NCT01379534|TKI258,|tki258,
5479890|NCT01379534|TKI-258,|tki-258,
5479895|NCT01379495|burns|burns
5479896|NCT01379495|rehabilitation|rehabilitation
5479897|NCT01379482|Peritoneal carcinomatosis from gastric cancer|peritoneal carcinomatosis from gastric cancer
5479898|NCT01379469|Carbamazepine (Tegretol) use|carbamazepine (tegretol) use
5479899|NCT01379469|severe liver disease|severe liver disease
5479900|NCT01379469|alpha-1-antitrypsin deficiency|alpha-1-antitrypsin deficiency
5479902|NCT01379443|Rehabilitation|rehabilitation
5479903|NCT01379443|Family Functioning|family functioning
5479904|NCT01379443|Mental Health|mental health
5479905|NCT01379443|Costs|costs
5479906|NCT01379443|Integration|integration
5479907|NCT01379430|Vaccine|vaccine
5479908|NCT01379430|Immune response|immune response
5479909|NCT01379417|Prematurity|prematurity
5479910|NCT01379417|Nutrition|nutrition
5479911|NCT01379417|Growth|growth
5479912|NCT01379404|sepsis, fluid status, BIA, CVP|sepsis, fluid status, bia, cvp
5479913|NCT01379391|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5479914|NCT01379391|Platelet Engraftment|platelet engraftment
5479916|NCT01379365|wrinkle rhytid aging|wrinkle rhytid aging
5479917|NCT01379352|liver transplantation|liver transplantation
5479918|NCT01379352|vecuronium|vecuronium
5479919|NCT01379339|Cabazitaxel|cabazitaxel
5479920|NCT01379339|Cabazitaxel and Cisplatin|cabazitaxel and cisplatin
5479921|NCT01379339|Phase I|phase i
5479922|NCT01379339|PF Induction Chemotherapy|pf induction chemotherapy
5479923|NCT01379339|Squamous Cell Carcinoma|squamous cell carcinoma
5479924|NCT01379339|Head and Neck|head and neck
5479925|NCT01379339|Sanofi-Aventis Oncology|sanofi-aventis oncology
5479926|NCT01379339|Locally Advanced|locally advanced
5479927|NCT01379313|laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5479928|NCT01379313|gas exchange|gas exchange
5479929|NCT01379313|inspiratory time|inspiratory time
5479930|NCT01379313|expiratory time|expiratory time
5479931|NCT01379313|I:E ratio|i:e ratio
5479932|NCT01379300|Hemophilia B|hemophilia b
5479933|NCT01379287|Iso-Fludelone|iso-fludelone
5479934|NCT01379287|KOS-1803|kos-1803
5479935|NCT01379287|Dose-Escalation|dose-escalation
5479936|NCT01379287|10-202|10-202
5479937|NCT01379274|MDS|mds
5479938|NCT01379274|Low risk disease|low risk disease
5479939|NCT01379274|IPSS|ipss
5479940|NCT01379261|STEMI|stemi
5479941|NCT01379261|primary PCI|primary pci
5479942|NCT01379261|Hypothermia|hypothermia
5479943|NCT01379261|Endovascular cooling|endovascular cooling
5479944|NCT01379261|Cardiac MRI|cardiac mri
5462227|NCT01451983|Autism|autism
5479945|NCT01379235|independent 65 years old and above|independent 65 years old and above
5479946|NCT01379222|AAA|aaa
5479947|NCT01379222|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5479948|NCT01379222|EVAR|evar
5479949|NCT01379222|Endovascular aneurysm repair|endovascular aneurysm repair
5479950|NCT01379209|AHSCT|ahsct
5479951|NCT01379209|Bone Marrow Transplant|bone marrow transplant
5479952|NCT01379209|Leukemia|leukemia
5479953|NCT01379209|myelodysplastic syndrome|myelodysplastic syndrome
5479954|NCT01379209|hematological malignancies|hematological malignancies
5479955|NCT01379209|Graft-versus-host-disease|graft-versus-host-disease
5479956|NCT01379209|GvHD|gvhd
5479957|NCT01379209|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5479958|NCT01379209|Stem Cell|stem cell
5479959|NCT01379209|Transplantation|transplantation
5479960|NCT01379196|Graves Orbitopathy|graves orbitopathy
5479961|NCT01379196|Macrolide antibiotics|macrolide antibiotics
5479962|NCT01379196|Inflammation|inflammation
5479963|NCT01379196|Clinical Activity Score|clinical activity score
5479965|NCT01379183|Men|men
5479966|NCT01379183|Women|women
5479967|NCT01379183|No known gastrointestinal disease|no known gastrointestinal disease
5479968|NCT01379183|Aged between 18-70 years|aged between 18-70 years
5479969|NCT01379170|brown adipose tissue|brown adipose tissue
5479970|NCT01379170|mitochondrial dysfunction|mitochondrial dysfunction
5479971|NCT01379170|insulin resistance|insulin resistance
5479972|NCT01379157|Patients with ventilator-associated pneumonia|patients with ventilator-associated pneumonia
5479973|NCT01379131|Manifestation|manifestation
5479974|NCT01379131|Coronary Heart Disease|coronary heart disease
5479975|NCT01379131|Myocardial infarction|myocardial infarction
5479976|NCT01379131|Angina pectoris|angina pectoris
5479977|NCT01379131|Unheralded|unheralded
5479978|NCT01379131|General Practice Research Database|general practice research database
5479979|NCT01379131|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5479980|NCT01379131|CALIBER|caliber
5479981|NCT01379118|Total knee replacement|total knee replacement
5479982|NCT01379105|Electromyography|electromyography
5479983|NCT01379105|Muscle Stretching Exercises|muscle stretching exercises
5479984|NCT01379105|Neuromuscular agents|neuromuscular agents
5479985|NCT01379105|Sedentary Lifestyle|sedentary lifestyle
5479986|NCT01379092|Radiography|radiography
5479987|NCT01379092|Breast Specimen Imaging|breast specimen imaging
5479988|NCT01379066|Mycobacterium tuberculosis|mycobacterium tuberculosis
5479989|NCT01379066|Pulmonary tuberculosis|pulmonary tuberculosis
5479990|NCT01379066|Electronic nose|electronic nose
5479991|NCT01379066|Gas chromatography|gas chromatography
5479992|NCT01379053|Staphylococcus aureus|staphylococcus aureus
5479993|NCT01379053|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5479994|NCT01379053|Nosocomial disease|nosocomial disease
5479995|NCT01379053|Electronic nose|electronic nose
5479997|NCT01379040|Cystic Fibrosis|cystic fibrosis
5479998|NCT01379040|Pseudomonas aeruginosa|pseudomonas aeruginosa
5479999|NCT01379040|Volatile Organic Compounds|volatile organic compounds
5480000|NCT01379040|Electronic nose|electronic nose
5480001|NCT01379040|Gas Chromatography|gas chromatography
5480002|NCT01379027|Depression|depression
5480003|NCT01379027|Website intervention|website intervention
5480004|NCT01379027|CBT|cbt
5480005|NCT01379014|Decisional conflict|decisional conflict
5480006|NCT01379014|Disclosure|disclosure
5480007|NCT01379014|Mental Health history|mental health history
5480008|NCT01379014|Mental health service users|mental health service users
5480009|NCT01379014|Decision Aid Tool|decision aid tool
5464811|NCT01441414|CVX-060|cvx-060
5480010|NCT01379014|Vocational Specialists|vocational specialists
5480011|NCT01379001|cholinergic function|cholinergic function
5480012|NCT01379001|aging|aging
5480013|NCT01379001|pharmacologic MRI|pharmacologic mri
5480014|NCT01378949|pain score|pain score
5480015|NCT01378936|criminal behavior|criminal behavior
5480016|NCT01378936|substance abuse|substance abuse
5480017|NCT01378936|HIV risk behavior|hiv risk behavior
5480018|NCT01378936|criminogenic thinking|criminogenic thinking
5480019|NCT01378936|shame|shame
5480020|NCT01378936|guilt|guilt
5480021|NCT01378936|empathy|empathy
5480022|NCT01378936|jail inmates|jail inmates
5480023|NCT01378936|restorative justice|restorative justice
5480024|NCT01378936|crime|crime
5480025|NCT01378923|Mindfulness|mindfulness
5480026|NCT01378923|Values|values
5480027|NCT01378923|Jail Inmates|jail inmates
5480028|NCT01378923|Impulsivity|impulsivity
5480029|NCT01378923|Substance Abuse|substance abuse
5480030|NCT01378923|HIV risk behavior|hiv risk behavior
5480031|NCT01378923|Anxiety|anxiety
5480032|NCT01378923|Depression|depression
5480033|NCT01378923|Criminogenic Thinking|criminogenic thinking
5480034|NCT01378910|HIV|hiv
5480035|NCT01378910|TROPISM|tropism
5480036|NCT01378910|PBMC|pbmc
5480037|NCT01378910|GENOTYPE|genotype
5480038|NCT01378910|454 SEQUENCING|454 sequencing
5480039|NCT01378897|bariatric surgery|bariatric surgery
5480040|NCT01378897|gastric bypass surgery|gastric bypass surgery
5480041|NCT01378884|Gastroparesis|gastroparesis
5480042|NCT01378884|Domperidone|domperidone
5480043|NCT01378884|Motilium|motilium
5480044|NCT01378871|T Cell|t cell
5480045|NCT01378871|T-Cell|t-cell
5480046|NCT01378871|Leukemia|leukemia
5480047|NCT01378871|Lymphoma|lymphoma
5480048|NCT01378871|Leukemia/Lymphoma|leukemia/lymphoma
5480049|NCT01378871|ATL|atl
5480050|NCT01378858|Smoking|smoking
5480051|NCT01378858|Substance-Related Disorders|substance-related disorders
5480052|NCT01378858|medication adherence|medication adherence
5480053|NCT01378858|Methadone|methadone
5480054|NCT01378845|Morbus Raynaud|morbus raynaud
5480055|NCT01378845|Ulcera Hands, Toes|ulcera hands, toes
5480056|NCT01378845|Vasospastic disorder|vasospastic disorder
5480057|NCT01378845|Raynaud's phenomenon|raynaud's phenomenon
5480058|NCT01378832|Intra-abdominal abscess|intra-abdominal abscess
5480059|NCT01378832|wound infection|wound infection
5480060|NCT01378832|colorectal surgery|colorectal surgery
5480061|NCT01378819|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5480062|NCT01378819|Postoperative pain|postoperative pain
5480063|NCT01378806|overweight|overweight
5480064|NCT01378806|obesity|obesity
5480065|NCT01378806|adults|adults
5480066|NCT01378806|children|children
5480067|NCT01378793|Acupressure|acupressure
5480068|NCT01378793|Insomnia|insomnia
5480069|NCT01378793|Sleep Disorders|sleep disorders
5480070|NCT01378780|Stroke|stroke
5480071|NCT01378780|hypertension|hypertension
5480072|NCT01378780|diet|diet
5480073|NCT01378780|sodium|sodium
5480074|NCT01378780|physical activity|physical activity
5480075|NCT01378767|Dietary restriction|dietary restriction
5480076|NCT01378767|oxidative stress|oxidative stress
5480077|NCT01378767|fasting|fasting
5480078|NCT01378754|hydrodilation|hydrodilation
5480079|NCT01378754|general anesthetic|general anesthetic
5480080|NCT01378741|delirium|delirium
5480081|NCT01378741|cardiac surgery|cardiac surgery
5480082|NCT01378741|postoperative sedation|postoperative sedation
5480083|NCT01378728|Optical imaging|optical imaging
5480084|NCT01378728|Fluorescence imaging|fluorescence imaging
5480085|NCT01378728|Chronic and acute wounds|chronic and acute wounds
5480086|NCT01378728|Wound bacteria|wound bacteria
5480087|NCT01378728|Bacterial biofilms|bacterial biofilms
5480088|NCT01378728|Pathogenic bacteria|pathogenic bacteria
5480089|NCT01378728|Microorganisms|microorganisms
5480090|NCT01378728|Wound infection|wound infection
5480091|NCT01378728|Wound healing|wound healing
5480092|NCT01378728|Treatment response assessment|treatment response assessment
5480093|NCT01378715|coronary artery disease|coronary artery disease
5480094|NCT01378715|percutaneous coronary intervention|percutaneous coronary intervention
5480095|NCT01378715|statins|statins
5480096|NCT01378715|periprocedural myocardial infarction|periprocedural myocardial infarction
5480097|NCT01378702|Mistletoe|mistletoe
5480098|NCT01378702|Anthroposophical medicine|anthroposophical medicine
5480099|NCT01378663|Congenital cardiac surgery|congenital cardiac surgery
5480100|NCT01378663|Postoperative pain management|postoperative pain management
5480101|NCT01378650|Tinnitus|tinnitus
5480102|NCT01378650|Medication therapy management|medication therapy management
5480103|NCT01378650|Cilostazol|cilostazol
5480104|NCT01378650|Antiplatelet agents|antiplatelet agents
5480106|NCT01378637|Robotic device|robotic device
5480107|NCT01378637|AMES|ames
5480108|NCT01378637|Stroke|stroke
5480109|NCT01378637|Cerebrovascular Accident|cerebrovascular accident
5480110|NCT01378637|Rehabilitation|rehabilitation
5480111|NCT01378611|intractable childhood epilepsy|intractable childhood epilepsy
5480112|NCT01378611|VNS|vns
5480113|NCT01378611|immune system|immune system
5480114|NCT01378598|erlotinib|erlotinib
5480115|NCT01378598|educational intervention|educational intervention
5480417|NCT01377428|Formoterol|formoterol
5480116|NCT01378598|direct care nurse|direct care nurse
5480117|NCT01378585|DLBS1033|dlbs1033
5480119|NCT01378585|fibrinolytic|fibrinolytic
5480120|NCT01378585|fibrinogenolytic|fibrinogenolytic
5480121|NCT01378585|antiplatelet|antiplatelet
5480122|NCT01378572|ICD|icd
5480123|NCT01378572|sudden cardiac death|sudden cardiac death
5480124|NCT01378572|mapping|mapping
5480125|NCT01378559|Penis prosthesis|penis prosthesis
5480126|NCT01378559|Titan|titan
5480127|NCT01378559|Satisfaction|satisfaction
5480128|NCT01378559|Complications|complications
5480129|NCT01378533|triple-negative breast cancer|triple-negative breast cancer
5480130|NCT01378533|dose-dense|dose-dense
5480131|NCT01378533|epirubicin and cyclophosphamide followed by paclitaxel（AC-T）|epirubicin and cyclophosphamide followed by paclitaxel（ac-t）
5480132|NCT01378533|paclitaxel plus carboplatin（PC）|paclitaxel plus carboplatin（pc）
5480133|NCT01378533|3 years DFS|3 years dfs
5480134|NCT01378533|the tolerance|the tolerance
5480135|NCT01378520|breathlessness|breathlessness
5480136|NCT01378520|resistive load breathing|resistive load breathing
5480137|NCT01378520|beta-endorphins|beta-endorphins
5480138|NCT01378507|endoscopic submucosal dissection|endoscopic submucosal dissection
5480139|NCT01378507|gastrointestinal neoplasm|gastrointestinal neoplasm
5480140|NCT01378494|osteoporosis|osteoporosis
5480141|NCT01378494|bone|bone
5480142|NCT01378494|HIV|hiv
5480143|NCT01378494|antiretrovirals|antiretrovirals
5480144|NCT01378494|inflammation|inflammation
5480145|NCT01378455|handwriting|handwriting
5480146|NCT01378455|cerebral palsy|cerebral palsy
5480147|NCT01378455|visual perception|visual perception
5480148|NCT01378455|sensory function|sensory function
5480149|NCT01378455|motor function|motor function
5480150|NCT01378455|computerized handwriting programs|computerized handwriting programs
5480151|NCT01378442|Cerebral palsy|cerebral palsy
5480152|NCT01378442|bone density|bone density
5480153|NCT01378442|bone strength|bone strength
5480154|NCT01378429|Perennial Allergic Rhinitis|perennial allergic rhinitis
5480155|NCT01378429|PAR|par
5480156|NCT01378416|Acute myelogenous leukemia|acute myelogenous leukemia
5480157|NCT01378416|myelodysplastic Syndrome|myelodysplastic syndrome
5480158|NCT01378416|cancer|cancer
5480159|NCT01378403|Schizophrenia|schizophrenia
5480160|NCT01378403|Cognitive deficites|cognitive deficites
5480161|NCT01378403|Degraded objects|degraded objects
5480162|NCT01378403|Magnocellular pathway|magnocellular pathway
5480163|NCT01378390|Complex perianal fistula|complex perianal fistula
5480164|NCT01378390|Crohn disease|crohn disease
5480165|NCT01378390|Adipose-derived stem cells|adipose-derived stem cells
5480166|NCT01378390|Liposuction|liposuction
5480167|NCT01378377|MEK inhibitor|mek inhibitor
5480168|NCT01378377|Temsirolimus|temsirolimus
5480169|NCT01378377|Neoplasms|neoplasms
5480170|NCT01378377|Phase I|phase i
5480171|NCT01378377|Pimasertib|pimasertib
5480172|NCT01378338|GERD|gerd
5480173|NCT01378338|Comparison between ERD and NERD|comparison between erd and nerd
5480174|NCT01378338|Rate of complete resolution|rate of complete resolution
5480175|NCT01378338|rate of recurrence|rate of recurrence
5480176|NCT01378338|QOL|qol
5480177|NCT01378338|To investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
5480178|NCT01378338|The aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with GERD after treatment with PPI|the aim of this study is to investigate the frequency and related risk factors of recurrence, and quality of life in patients with gerd after treatment with ppi
5480179|NCT01378325|spinal|spinal
5480180|NCT01378325|cesarean delivery|cesarean delivery
5480181|NCT01378325|phenylephrine|phenylephrine
5480182|NCT01378325|hypotension|hypotension
5480183|NCT01378312|vaccine|vaccine
5480184|NCT01378312|TB|tb
5480186|NCT01378299|testosterone|testosterone
5480187|NCT01378273|neuroprotection|neuroprotection
5480188|NCT01378273|erythropoietin|erythropoietin
5480189|NCT01378273|Epo|epo
5480190|NCT01378273|ELGANs|elgans
5480191|NCT01378273|preterm|preterm
5480192|NCT01378273|neonate|neonate
5480193|NCT01378260|Peripheral Arterial Disease|peripheral arterial disease
5480194|NCT01378260|Claudication|claudication
5480195|NCT01378260|Comparative Effectiveness Research|comparative effectiveness research
5480197|NCT01378260|PAD|pad
5480198|NCT01378260|atherosclerosis|atherosclerosis
5480199|NCT01378260|Intermittent claudication|intermittent claudication
5480200|NCT01378260|leg pain|leg pain
5480201|NCT01378247|Heart Failure|heart failure
5480202|NCT01378247|Family Nursing|family nursing
5480203|NCT01378247|Health-Related Quality of Life|health-related quality of life
5480204|NCT01378247|Heart Failure Clinic|heart failure clinic
5480205|NCT01378221|vitamin D|vitamin d
5480206|NCT01378221|cardiac surgery|cardiac surgery
5480207|NCT01378221|inflammation|inflammation
5465015|NCT01440699|Crohn's fistula|crohn's fistula
5480208|NCT01378221|immune system|immune system
5480209|NCT01378221|age|age
5480210|NCT01378208|Intermittent fasting|intermittent fasting
5480211|NCT01378208|Meal frequency|meal frequency
5480212|NCT01378208|body composition|body composition
5480213|NCT01378208|cognitive function|cognitive function
5480214|NCT01378208|glucose metabolism|glucose metabolism
5480215|NCT01378195|Alzheimer's Disease|alzheimer's disease
5480216|NCT01378195|Dementia|dementia
5480217|NCT01378195|caregiving|caregiving
5480218|NCT01378195|caregiver|caregiver
5480219|NCT01378195|coping|coping
5480220|NCT01378195|coping with caregiving|coping with caregiving
5480221|NCT01378195|stress|stress
5480222|NCT01378182|Transplantation,Stem Cell|transplantation,stem cell
5480223|NCT01378182|Wilson's Disease|wilson's disease
5480224|NCT01378169|SIRS|sirs
5480225|NCT01378169|Sepsis|sepsis
5480226|NCT01378169|Severe Sepsis|severe sepsis
5480227|NCT01378169|Septic Shock|septic shock
5480228|NCT01378169|Inflammatory processes|inflammatory processes
5480229|NCT01378169|Cytokines|cytokines
5480230|NCT01378169|HLA-DR|hla-dr
5480231|NCT01378169|HLA type II|hla type ii
5480232|NCT01378169|Chemokines|chemokines
5480233|NCT01378169|TLR expression|tlr expression
5480234|NCT01378169|mRNA expression in whole blood|mrna expression in whole blood
5480235|NCT01378169|Bacterial DNA detection|bacterial dna detection
5480236|NCT01378169|Prognosis factors|prognosis factors
5480237|NCT01378169|Infection|infection
5480238|NCT01378169|Diagnosis|diagnosis
5480239|NCT01378156|Therapy for HIV Infection|therapy for hiv infection
5480240|NCT01378156|Suppressive ART with no failures|suppressive art with no failures
5480241|NCT01378156|Treatment interruption|treatment interruption
5480242|NCT01378143|Colorectal Cancer|colorectal cancer
5480243|NCT01378143|Pentamidine bis(2-hydroxyethanesulfonate)|pentamidine bis(2-hydroxyethanesulfonate)
5480244|NCT01378143|OCZ103-OS|ocz103-os
5480245|NCT01378143|Standard of Care|standard of care
5480246|NCT01378130|CCS|ccs
5480247|NCT01378130|CSC|csc
5480248|NCT01378130|Subretinal Fluid|subretinal fluid
5480249|NCT01378130|multimodal imaging|multimodal imaging
5480250|NCT01378117|diabetes|diabetes
5480251|NCT01378117|non critical care setting|non critical care setting
5480252|NCT01378117|hyperglycemia|hyperglycemia
5480253|NCT01378117|treatment|treatment
5480254|NCT01378117|oral antidiabetic agents|oral antidiabetic agents
5480255|NCT01378117|subcutaneous insulin|subcutaneous insulin
5480256|NCT01378104|reducing dose of peginterferon|reducing dose of peginterferon
5480257|NCT01378104|chronic hepatitis c|chronic hepatitis c
5480258|NCT01378104|Koreans|koreans
5480259|NCT01378104|IL28B polymorphism|il28b polymorphism
5480260|NCT01378091|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5480261|NCT01378078|schizophrenia|schizophrenia
5480262|NCT01378078|negative syndrome|negative syndrome
5480263|NCT01378078|PANSS|panss
5480264|NCT01378065|POP|pop
5480265|NCT01378065|pelvic organ prolapse|pelvic organ prolapse
5480266|NCT01378065|anterior prolapse|anterior prolapse
5480267|NCT01378065|posterior prolapse|posterior prolapse
5480268|NCT01378065|vaginal prolapse|vaginal prolapse
5480269|NCT01378065|vaginal floor reconstruction|vaginal floor reconstruction
5480270|NCT01378039|COPD|copd
5480271|NCT01378039|Asthma|asthma
5480272|NCT01378039|Pathophysiology|pathophysiology
5480273|NCT01378039|Genetics|genetics
5480274|NCT01378039|Phenotype|phenotype
5480275|NCT01378039|Treatment response|treatment response
5480276|NCT01378026|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5480277|NCT01378026|G72|g72
5480278|NCT01378026|SNP|snp
5480279|NCT01378013|Metabonomics|metabonomics
5480280|NCT01378013|Systems biology|systems biology
5480281|NCT01378013|Intelligent knife|intelligent knife
5480282|NCT01378013|Colorectal cancer|colorectal cancer
5480283|NCT01378013|NMR|nmr
5480284|NCT01378013|Mass spectrometry|mass spectrometry
5480285|NCT01377974|Leishmaniasis|leishmaniasis
5480286|NCT01377974|Mucocutaneous Leishmaniasis|mucocutaneous leishmaniasis
5480287|NCT01377974|Therapeutics|therapeutics
5480288|NCT01377974|meglumine antimoniate|meglumine antimoniate
5480290|NCT01377948|Anger|anger
5480291|NCT01377948|Aggression|aggression
5480292|NCT01377948|CBT|cbt
5480293|NCT01377948|Videogame|videogame
5480294|NCT01377948|biofeedback|biofeedback
5480295|NCT01377909|chronic hepatitis C, interferon|chronic hepatitis c, interferon
5480296|NCT01377883|Needle, Anxiety, Pain, Clowns|needle, anxiety, pain, clowns
5480297|NCT01377870|multiple sclerosis mesenchymal stem cell intravenous injection|multiple sclerosis mesenchymal stem cell intravenous injection
5480298|NCT01377844|Diabetes mellitus|diabetes mellitus
5480300|NCT01377818|Exercise trainig|exercise trainig
5480301|NCT01377805|Multiple Sclerosis hydrocephalus|multiple sclerosis hydrocephalus
5480302|NCT01377792|hypertonic saline|hypertonic saline
5480303|NCT01377792|cystic fibrosis|cystic fibrosis
5480304|NCT01377792|pulmonary inflammation|pulmonary inflammation
5480305|NCT01377792|pulmonary exacerbation|pulmonary exacerbation
5480306|NCT01377779|Oxiplex/AP gel|oxiplex/ap gel
5480307|NCT01377779|Prevention of Asherman's syndrome|prevention of asherman's syndrome
5480308|NCT01377779|Intra uterine adhesions|intra uterine adhesions
5480309|NCT01377766|Bell's palsy|bell's palsy
5480310|NCT01377766|psychological stress|psychological stress
5480311|NCT01377766|personality factors|personality factors
5480312|NCT01377766|psychological factors|psychological factors
5480313|NCT01377753|Toxicity|toxicity
5480314|NCT01377753|Thermal Ablation/Damage|thermal ablation/damage
5480315|NCT01377753|Localized Prostate Cancer|localized prostate cancer
5480316|NCT01377753|Laser Ablation|laser ablation
5480317|NCT01377753|PSA Levels|psa levels
5480318|NCT01377753|Prostate Cancer|prostate cancer
5480319|NCT01377740|Lipolysis|lipolysis
5480320|NCT01377740|Cryolipolysis|cryolipolysis
5480321|NCT01377740|Fat Reduction|fat reduction
5480322|NCT01377701|pituitary adenomas|pituitary adenomas
5480323|NCT01377701|recovery of vision|recovery of vision
5480324|NCT01377701|trans-sphenoidal surgery|trans-sphenoidal surgery
5480325|NCT01377688|DKD|dkd
5480326|NCT01377636|Isoproterenol|isoproterenol
5480327|NCT01377636|Bispectral index (BIS)|bispectral index (bis)
5480328|NCT01377636|electrophysiology studies (EPS)|electrophysiology studies (eps)
5480329|NCT01377623|Spinal fusion|spinal fusion
5480330|NCT01377623|Inflammatory response|inflammatory response
5480331|NCT01377623|Inflammatory markers|inflammatory markers
5480332|NCT01377623|Dexmedetomidine|dexmedetomidine
5480333|NCT01377610|Outpatient detoxification|outpatient detoxification
5480334|NCT01377610|Opioid dependence|opioid dependence
5480335|NCT01377610|Naltrexone|naltrexone
5480336|NCT01377610|Vivitrol|vivitrol
5480337|NCT01377610|Buprenorphine|buprenorphine
5480338|NCT01377597|retinal vein occlusion|retinal vein occlusion
5480339|NCT01377597|branch retinal vein occlusion|branch retinal vein occlusion
5480340|NCT01377597|central retinal vein occlusion|central retinal vein occlusion
5480341|NCT01377597|visual impairment|visual impairment
5480342|NCT01377597|macular edema|macular edema
5480343|NCT01377597|ranibizumab|ranibizumab
5480344|NCT01377584|Continuous Positive Airway Pressure|continuous positive airway pressure
5480345|NCT01377584|Patient Compliance|patient compliance
5480346|NCT01377584|Intervention Studies|intervention studies
5480347|NCT01377584|Spouses|spouses
5480348|NCT01377571|diarrhea|diarrhea
5480349|NCT01377571|fever|fever
5480350|NCT01377571|nausea|nausea
5480351|NCT01377571|vomit|vomit
5480352|NCT01377571|irritability|irritability
5480353|NCT01377558|aerobic training|aerobic training
5480354|NCT01377558|resistance training|resistance training
5671460|NCT00615927|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5631221|NCT00774384|Mucosal|mucosal
5480355|NCT01377558|combination of aerobic and resistance training|combination of aerobic and resistance training
5480356|NCT01377558|diabetes|diabetes
5480357|NCT01377558|type 2 diabetes|type 2 diabetes
5480358|NCT01377558|HbA1c|hba1c
5480359|NCT01377558|endothelial dysfunction|endothelial dysfunction
5480360|NCT01377558|inflammation markers|inflammation markers
5480361|NCT01377558|Parodontitis|parodontitis
5480362|NCT01377558|Exercise intervention|exercise intervention
5480363|NCT01377558|training|training
5480364|NCT01377545|Infraclavicular|infraclavicular
5480365|NCT01377545|Nerve Block|nerve block
5480366|NCT01377545|Needle|needle
5480367|NCT01377545|Perineural Catheter|perineural catheter
5480368|NCT01377545|Volunteer|volunteer
5480369|NCT01377545|Upper Extremity Nerve Block|upper extremity nerve block
5480370|NCT01377545|Sensation|sensation
5480371|NCT01377545|Strength|strength
5480372|NCT01377532|Pheochromocytoma|pheochromocytoma
5480373|NCT01377532|Paraganglioma|paraganglioma
5480374|NCT01377532|MIBG|mibg
5480375|NCT01377532|131I-MIBG|131i-mibg
5480376|NCT01377532|Resistant|resistant
5480377|NCT01377532|Relapsed|relapsed
5480378|NCT01377532|Treatment|treatment
5480379|NCT01377532|UCSF|ucsf
5480380|NCT01377532|Pediatric|pediatric
5480381|NCT01377532|Adult|adult
5480382|NCT01377532|Oncology|oncology
5480386|NCT01377519|Magnetic Resonance focused ultrasound|magnetic resonance focused ultrasound
5480387|NCT01377519|HIFU|hifu
5480388|NCT01377519|NOninvasive|noninvasive
5480389|NCT01377519|Treatment|treatment
5480390|NCT01377506|behavioral weight control|behavioral weight control
5480391|NCT01377506|lifestyle intervention|lifestyle intervention
5480392|NCT01377506|memory training|memory training
5480393|NCT01377506|cognitive training|cognitive training
5480394|NCT01377506|community-based|community-based
5480395|NCT01377493|chewing-gum|chewing-gum
5480396|NCT01377493|enamel subsurface lesion|enamel subsurface lesion
5480397|NCT01377493|calcium additives|calcium additives
5480398|NCT01377493|fluoride|fluoride
5480399|NCT01377493|in situ|in situ
5480400|NCT01377467|Osteoporosis|osteoporosis
5480401|NCT01377467|Osteopenia|osteopenia
5480402|NCT01377467|Denosumab|denosumab
5480403|NCT01377467|Transplantation|transplantation
5480404|NCT01377467|Kidney|kidney
5480406|NCT01377454|concussion|concussion
5480407|NCT01377454|mild Traumatic Brain Injury|mild traumatic brain injury
5480408|NCT01377454|balance|balance
5480409|NCT01377454|sensors|sensors
5480410|NCT01377441|Ibuprofen|ibuprofen
5480411|NCT01377441|Cytokines|cytokines
5480412|NCT01377441|Recovery|recovery
5480413|NCT01377441|IV ibuprofen|iv ibuprofen
5480414|NCT01377441|major surgery|major surgery
5480415|NCT01377428|COPD|copd
5480416|NCT01377428|Indacaterol|indacaterol
5480418|NCT01377415|arthroscopy|arthroscopy
5480419|NCT01377415|shoulder surgery|shoulder surgery
5480420|NCT01377415|subacromial|subacromial
5480421|NCT01377415|continuous bupivacaine|continuous bupivacaine
5480422|NCT01377389|Prostate cancer|prostate cancer
5480423|NCT01377389|Castrate sensitive prostate carcinoma|castrate sensitive prostate carcinoma
5480424|NCT01377389|Metastatic prostate carcinoma|metastatic prostate carcinoma
5480425|NCT01377389|Androgen depravation therapy|androgen depravation therapy
5480427|NCT01377389|Prostate-specific antigen|prostate-specific antigen
5480428|NCT01377389|PSA|psa
5480429|NCT01377389|Ipilimumab|ipilimumab
5480430|NCT01377389|Yervoy|yervoy
5480431|NCT01377389|BMS-734016|bms-734016
5480432|NCT01377389|MDX010|mdx010
5480433|NCT01377389|Leuprolide|leuprolide
5480434|NCT01377389|Lupron Depot|lupron depot
5480435|NCT01377389|Leuprolide Acetate|leuprolide acetate
5480436|NCT01377389|Goserelin|goserelin
5480437|NCT01377389|Zoladex|zoladex
5480438|NCT01377389|Degarelix|degarelix
5480439|NCT01377389|Firmagon|firmagon
5480440|NCT01377363|metastatic breast cancer|metastatic breast cancer
5480441|NCT01377363|primary breast cancer|primary breast cancer
5480442|NCT01377350|Heart failure|heart failure
5480443|NCT01377350|monitoring|monitoring
5480444|NCT01377337|cardiac arrest|cardiac arrest
5480445|NCT01377337|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5480446|NCT01377337|(sodium) bicarbonate|(sodium) bicarbonate
5480447|NCT01377337|return of spontaneous circulation|return of spontaneous circulation
5480448|NCT01377337|outcome|outcome
5480449|NCT01377324|Breast cancer|breast cancer
5480450|NCT01377324|Fulvestrant|fulvestrant
5480451|NCT01377324|FES|fes
5480452|NCT01377324|PET|pet
5480453|NCT01377324|Positron|positron
5480454|NCT01377324|Emission|emission
5480455|NCT01377324|Tomography|tomography
5480456|NCT01377324|Fluoroestradiol|fluoroestradiol
5480457|NCT01377324|FES-PET|fes-pet
5480458|NCT01377324|Molecular Imaging|molecular imaging
5480459|NCT01377324|Estrogen Receptor|estrogen receptor
5480460|NCT01377311|limbal stem cell|limbal stem cell
5480461|NCT01377311|amniotic membrane|amniotic membrane
5480462|NCT01377311|ex vivo expansion of autologous limbal stem cell|ex vivo expansion of autologous limbal stem cell
5480463|NCT01377311|unilateral limbal stem cell insufficiency|unilateral limbal stem cell insufficiency
5480464|NCT01377285|chronic kidney disease|chronic kidney disease
5480465|NCT01377285|pentoxifylline|pentoxifylline
5480466|NCT01377285|angiotensin receptor blockers(ARB)|angiotensin receptor blockers(arb)
5480467|NCT01377272|HIV/AIDS|hiv/aids
5480468|NCT01377272|spatial epidemiology|spatial epidemiology
5480469|NCT01377272|geographic information system|geographic information system
5480470|NCT01377272|HIV-infection/Aids|hiv-infection/aids
5480471|NCT01377259|changes|changes
5480472|NCT01377259|tissue|tissue
5480473|NCT01377259|oxygenation|oxygenation
5480474|NCT01377259|saturation|saturation
5480475|NCT01377259|between|between
5480476|NCT01377259|upper|upper
5480477|NCT01377259|lower|lower
5480478|NCT01377259|extremities|extremities
5480479|NCT01377259|patients|patients
5480480|NCT01377259|Adverse Effect|adverse effect
5480481|NCT01377259|Spinal and Epidural|spinal and epidural
5480482|NCT01377246|Somatostatin.|somatostatin.
5480483|NCT01377246|Polycystic kidney disease.|polycystic kidney disease.
5480484|NCT01377246|Renal insufficiency.|renal insufficiency.
5480485|NCT01377233|Schizophrenia|schizophrenia
5480486|NCT01377233|Antipsychotic|antipsychotic
5480487|NCT01377233|Zicronapine|zicronapine
5480491|NCT01377220|11C-Choline|11c-choline
5480492|NCT01377220|alpha fetoprotein|alpha fetoprotein
5480493|NCT01377220|Dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
5480494|NCT01377220|Abdomen computed tomography|abdomen computed tomography
5480495|NCT01377220|Tumoral liver biopsy|tumoral liver biopsy
5480496|NCT01377207|ST segment Elevation Myocardial Infarction|st segment elevation myocardial infarction
5480497|NCT01377207|Optical Coherence Tomography|optical coherence tomography
5480498|NCT01377207|Percutaneous Coronary Intervention|percutaneous coronary intervention
5480499|NCT01377207|Thrombus hystopathology|thrombus hystopathology
5480500|NCT01377207|Gender differences|gender differences
5480501|NCT01377194|Depression|depression
5480502|NCT01377194|Major Depressive Disorder|major depressive disorder
5480503|NCT01377181|Inguinal hernia|inguinal hernia
5480504|NCT01377181|Laparoscope|laparoscope
5480505|NCT01377181|Lateral us ligament|lateral us ligament
5480506|NCT01377181|Recurrence|recurrence
5480507|NCT01377181|Pediatric|pediatric
5480508|NCT01377181|unilateral inguinal hernia|unilateral inguinal hernia
5480509|NCT01377155|basal insulin|basal insulin
5480510|NCT01377155|hypoglycemia|hypoglycemia
5480511|NCT01377155|diabetes mellitus type two|diabetes mellitus type two
5480512|NCT01377142|Uterovaginal prolapse|uterovaginal prolapse
5480513|NCT01377142|hysteropexy|hysteropexy
5480515|NCT01377129|Residual Rotational Laxity|residual rotational laxity
5480516|NCT01377103|heart failure|heart failure
5480517|NCT01377103|hypogonadism|hypogonadism
5480518|NCT01377103|testosterone|testosterone
5480519|NCT01377077|vitiligo|vitiligo
5480520|NCT01377077|piebaldism|piebaldism
5480521|NCT01377077|punchgrafting|punchgrafting
5480522|NCT01377077|minigrafting|minigrafting
5480523|NCT01377077|stable for at least 12 months|stable for at least 12 months
5480525|NCT01377064|physical activity|physical activity
5480526|NCT01377064|cardiovascular disease risk|cardiovascular disease risk
5480527|NCT01377051|COPD|copd
5480528|NCT01377051|Inspiratory capacity|inspiratory capacity
5480529|NCT01377051|Residual volume|residual volume
5480530|NCT01377051|Total lung resistance|total lung resistance
5480531|NCT01377051|Arterial Oxygen|arterial oxygen
5480532|NCT01377038|Osteoarthritis|osteoarthritis
5480533|NCT01377038|Chronic pain|chronic pain
5480534|NCT01377038|Central pain|central pain
5480535|NCT01377012|Rheumatoid Arthritis|rheumatoid arthritis
5480536|NCT01377012|RA|ra
5480537|NCT01377012|ACR|acr
5480538|NCT01377012|inflammatory joints|inflammatory joints
5480539|NCT01376999|Sterility|sterility
5480540|NCT01376999|FSH-r|fsh-r
5480541|NCT01376999|intrauterine insemination|intrauterine insemination
5480542|NCT01376999|unexplained sterility|unexplained sterility
5480543|NCT01376973|stress, temporomandibular disorders.|stress, temporomandibular disorders.
5480544|NCT01376960|forefoot surgery|forefoot surgery
5480545|NCT01376960|Ankle Block|ankle block
5480546|NCT01376960|Popliteal Fossa Block|popliteal fossa block
5480547|NCT01376947|IUD device insertion|iud device insertion
5480548|NCT01376947|Nulliparous|nulliparous
5480549|NCT01376947|Multiparous|multiparous
5480550|NCT01376947|Pain|pain
5480551|NCT01376934|hysteroscopy|hysteroscopy
5480552|NCT01376934|saline solution|saline solution
5480553|NCT01376934|carbon dioxide|carbon dioxide
5480554|NCT01376934|compare two techniques in office hysteroscopy co2 and saline solution|compare two techniques in office hysteroscopy co2 and saline solution
5480555|NCT01376921|Growth disorders|growth disorders
5480556|NCT01376921|Saizen|saizen
5480557|NCT01376921|Easypod|easypod
5480558|NCT01376921|Growth hormone|growth hormone
5480559|NCT01376921|Pediatric subject|pediatric subject
5480560|NCT01376908|Phenylketonuria (PKU)|phenylketonuria (pku)
5480561|NCT01376908|Kuvan® (Sapropterin)|kuvan® (sapropterin)
5480562|NCT01376908|Phe-restricted diet|phe-restricted diet
5480563|NCT01376908|Paediatric <4 years old|paediatric <4 years old
5480564|NCT01376908|responders to BH4|responders to bh4
5480565|NCT01376908|Phe tolerance|phe tolerance
5480566|NCT01376895|Black MSM/W|black msm/w
5480568|NCT01376882|Caffeine|caffeine
5480569|NCT01376882|Withdrawal|withdrawal
5480570|NCT01376882|Cognitive function|cognitive function
5480571|NCT01376882|Mood|mood
5480572|NCT01376882|Cerebral haemodynamics|cerebral haemodynamics
5480573|NCT01376869|Hops|hops
5480574|NCT01376869|Mood|mood
5480575|NCT01376869|Cognitive Function|cognitive function
5480576|NCT01376869|Bioavailability|bioavailability
5480577|NCT01376869|Satiety|satiety
5480578|NCT01376869|Blood Pressure|blood pressure
5480579|NCT01376869|Heart rate|heart rate
5480580|NCT01376856|mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging|mediastinal lymph node with false positive fdg pet/ct results in lung cancer staging
5480581|NCT01376843|latent tuberculosis in health care workers|latent tuberculosis in health care workers
5480583|NCT01376830|Exacerbations|exacerbations
5480584|NCT01376830|Viruses|viruses
5480585|NCT01376817|Severe acute pancreatitis|severe acute pancreatitis
5480586|NCT01376817|total parenteral nutrition|total parenteral nutrition
5480591|NCT01376791|Oral Pathogens|oral pathogens
5480592|NCT01376791|Native Americans|native americans
5480593|NCT01376791|Inflammatory cytokines|inflammatory cytokines
5480594|NCT01376791|Microbial metagenomics|microbial metagenomics
5480599|NCT01376765|SARS, coronavirus, vaccine, adjuvant, Alhydrogel®, severe acute respiratory syndrome|sars, coronavirus, vaccine, adjuvant, alhydrogel®, severe acute respiratory syndrome
5480601|NCT01376739|MR angiography|mr angiography
5480602|NCT01376713|Melanoma|melanoma
5480603|NCT01376687|Osteopathic Medicine|osteopathic medicine
5480604|NCT01376687|Cervical Spine|cervical spine
5480605|NCT01376687|Kinetics|kinetics
5480606|NCT01376674|localised|localised
5480607|NCT01376674|prostate cancer|prostate cancer
5480610|NCT01376661|Prostate Cancer|prostate cancer
5465432|NCT01439165|Tetanus|tetanus
5480611|NCT01376661|Active Surveillance|active surveillance
5480612|NCT01376661|Low risk prostate cancer|low risk prostate cancer
5480613|NCT01376635|Chronic Kidney Disease|chronic kidney disease
5480614|NCT01376635|Autonomic Dysfunction|autonomic dysfunction
5480615|NCT01376609|Stroke|stroke
5480616|NCT01376609|Ischaemic Stroke|ischaemic stroke
5480716|NCT01376323|Efficacy|efficacy
5480617|NCT01376609|Cerebral Infarction|cerebral infarction
5480618|NCT01376609|Cerebrovascular Disorders|cerebrovascular disorders
5480619|NCT01376609|Brain Diseases|brain diseases
5480620|NCT01376609|Nervous System Diseases|nervous system diseases
5480621|NCT01376609|Vascular Diseases|vascular diseases
5480622|NCT01376609|Brain Infarction|brain infarction
5480623|NCT01376609|Brain Ischemia|brain ischemia
5480624|NCT01376609|mismatch|mismatch
5480625|NCT01376609|PWI/DWI mismatch|pwi/dwi mismatch
5480626|NCT01376609|ischaemic penumbra|ischaemic penumbra
5480627|NCT01376609|image analysis|image analysis
5480628|NCT01376596|Remission|remission
5480629|NCT01376596|Psychosocial Functioning|psychosocial functioning
5480630|NCT01376596|Symptoms reduction|symptoms reduction
5480631|NCT01376583|Breast cancer|breast cancer
5480632|NCT01376583|Exercise|exercise
5480633|NCT01376583|Myokines|myokines
5480634|NCT01376583|AMPK|ampk
5480635|NCT01376570|HIV|hiv
5480636|NCT01376570|Opiate dependence|opiate dependence
5480637|NCT01376570|Opiate replacement therapy|opiate replacement therapy
5480638|NCT01376570|Cocaine-related disorders|cocaine-related disorders
5480639|NCT01376570|Risk Reduction Behavior|risk reduction behavior
5480640|NCT01376570|Medication Adherence|medication adherence
5480641|NCT01376570|Motivation|motivation
5480642|NCT01376557|diabetes mellitus|diabetes mellitus
5480643|NCT01376544|Neonate|neonate
5480644|NCT01376544|Weaning|weaning
5480645|NCT01376544|Assist control ventilation|assist control ventilation
5480646|NCT01376544|Pressure support ventilation|pressure support ventilation
5480647|NCT01376531|acute renal failure|acute renal failure
5480648|NCT01376531|cerebrovascular autoregulation|cerebrovascular autoregulation
5480649|NCT01376531|transcranial Doppler|transcranial doppler
5480650|NCT01376531|continuous veno-venous hemodialysis|continuous veno-venous hemodialysis
5480651|NCT01376518|acute respiratory distress syndrome|acute respiratory distress syndrome
5480652|NCT01376518|acute lung injury|acute lung injury
5480653|NCT01376518|cerebrovascular autoregulation|cerebrovascular autoregulation
5480654|NCT01376518|transcranial Doppler|transcranial doppler
5480655|NCT01376518|ventilation|ventilation
5480656|NCT01376505|Vaccine Therapy|vaccine therapy
5480657|NCT01376492|Schizophrenia|schizophrenia
5480658|NCT01376492|Sleep disturbances|sleep disturbances
5480659|NCT01376492|Quality of sleep|quality of sleep
5480660|NCT01376492|Functioning level|functioning level
5480661|NCT01376492|Antipsychotic therapy.|antipsychotic therapy.
5480662|NCT01376479|HFMD|hfmd
5480663|NCT01376479|EV71|ev71
5480664|NCT01376479|Enterovirus|enterovirus
5480665|NCT01376479|INV21|inv21
5480666|NCT01376479|Encephalitis|encephalitis
5480667|NCT01376466|acute appendicitis|acute appendicitis
5480668|NCT01376466|diagnosis|diagnosis
5480669|NCT01376466|computed tomography|computed tomography
5480670|NCT01376453|External Radiation Therapy|external radiation therapy
5480671|NCT01376453|Locally Advanced Rectal|locally advanced rectal
5480672|NCT01376453|Adenocarcinoma|adenocarcinoma
5480673|NCT01376440|three or more loss stools in 24 hours|three or more loss stools in 24 hours
5480674|NCT01376414|dyspepsia|dyspepsia
5480675|NCT01376414|abdominal|abdominal
5480676|NCT01376414|pain|pain
5480677|NCT01376414|helicobacter|helicobacter
5480678|NCT01376414|pylori|pylori
5480679|NCT01376414|[C06.405.748.398]|[c06.405.748.398]
5480680|NCT01376414|[C06.405.748.586]|[c06.405.748.586]
5480681|NCT01376414|[C06.405.748.586.698]|[c06.405.748.586.698]
5480682|NCT01376414|[C06.405.748.586.849]|[c06.405.748.586.849]
5483725|NCT01363401|ALS|als
5480686|NCT01376375|Acupuncture|acupuncture
5480687|NCT01376375|Low Back Pain|low back pain
5480688|NCT01376362|Cystoid Macular Edema|cystoid macular edema
5480689|NCT01376362|Intermediate Uveitis|intermediate uveitis
5480690|NCT01376362|Uveitis|uveitis
5480691|NCT01376362|OCT|oct
5480692|NCT01376362|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5480693|NCT01376349|depression|depression
5480694|NCT01376349|anxiety disorder|anxiety disorder
5480695|NCT01376349|cognitive/functional effects|cognitive/functional effects
5480696|NCT01376349|sexual dysfunction|sexual dysfunction
5480697|NCT01376349|cancer survivor|cancer survivor
5480698|NCT01376349|breast cancer|breast cancer
5480699|NCT01376349|cervical cancer|cervical cancer
5480700|NCT01376349|fallopian tube cancer|fallopian tube cancer
5480701|NCT01376349|uterine sarcoma|uterine sarcoma
5480702|NCT01376349|vaginal cancer|vaginal cancer
5480703|NCT01376349|vulvar cancer|vulvar cancer
5480704|NCT01376349|ovarian epithelial cancer|ovarian epithelial cancer
5480705|NCT01376349|ovarian germ cell tumor|ovarian germ cell tumor
5480706|NCT01376349|ovarian sarcoma|ovarian sarcoma
5480707|NCT01376349|ovarian stromal cancer|ovarian stromal cancer
5465530|NCT01438775|BPH|bph
5480708|NCT01376349|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5480709|NCT01376349|endometrial cancer|endometrial cancer
5480710|NCT01376336|environmental health|environmental health
5480711|NCT01376336|diarrhea|diarrhea
5480712|NCT01376336|water|water
5480713|NCT01376336|HIV|hiv
5480714|NCT01376323|Safety|safety
5480715|NCT01376323|Dose Ranging|dose ranging
5480717|NCT01376258|benign prostatic hyperplasia|benign prostatic hyperplasia
5480718|NCT01376258|acute urinary retention|acute urinary retention
5480719|NCT01376258|adherence|adherence
5480720|NCT01376258|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5480721|NCT01376258|enlarged prostate|enlarged prostate
5480722|NCT01376258|surgery|surgery
5480723|NCT01376232|Anaemia|anaemia
5480724|NCT01376232|Drug- Drug Interaction|drug- drug interaction
5480725|NCT01376219|GINA|gina
5480726|NCT01376219|direct / indirect costs|direct / indirect costs
5480727|NCT01376219|exacerbations|exacerbations
5480728|NCT01376219|European|european
5480729|NCT01376219|asthma control|asthma control
5480730|NCT01376219|Asthma Control Test (TM - QualityMetric Incorporated)|asthma control test (tm - qualitymetric incorporated)
5480731|NCT01376102|osteoporosis|osteoporosis
5480732|NCT01376102|ibandronate|ibandronate
5480733|NCT01376089|Safety|safety
5480734|NCT01376076|schizophrenia|schizophrenia
5480736|NCT01376076|cardiac repolarization|cardiac repolarization
5480737|NCT01376050|venous stasis ulcer|venous stasis ulcer
5480738|NCT01376050|leg ulcer|leg ulcer
5480739|NCT01376037|upper arm|upper arm
5480740|NCT01376037|body contouring|body contouring
5480741|NCT01376037|body shaping|body shaping
5480742|NCT01376024|Carpometacarpal arthritis|carpometacarpal arthritis
5480743|NCT01376024|Basal joint arthritis|basal joint arthritis
5480744|NCT01376024|CMC arthritis|cmc arthritis
5480745|NCT01376024|Osteoarthritis|osteoarthritis
5480746|NCT01376011|quercetin|quercetin
5480747|NCT01376011|brain blood flow|brain blood flow
5480748|NCT01376011|aging|aging
5480749|NCT01376011|memory|memory
5480750|NCT01375998|YAZ|yaz
5480751|NCT01375998|Dysmenorrhea|dysmenorrhea
5480752|NCT01375972|biliary cancer|biliary cancer
5480753|NCT01375972|systemic chemotherapy|systemic chemotherapy
5480754|NCT01375972|S-1|s-1
5480755|NCT01375972|gemcitabine|gemcitabine
5480756|NCT01375972|cisplatin|cisplatin
5480757|NCT01375959|resveratrol|resveratrol
5480758|NCT01375959|glucose intolerance|glucose intolerance
5480759|NCT01375959|insulin resistance|insulin resistance
5480760|NCT01375959|endothelial function|endothelial function
5480761|NCT01375946|Pharmacokinetic Profile (PK) and Safety|pharmacokinetic profile (pk) and safety
5480762|NCT01375946|PK analysis of EE and LNG|pk analysis of ee and lng
5480763|NCT01375933|Smoking|smoking
5480764|NCT01375933|NicVAX|nicvax
5480765|NCT01375933|Smoking vaccine|smoking vaccine
5480766|NCT01375920|Depression|depression
5480767|NCT01375920|Antiglucocorticoid|antiglucocorticoid
5480768|NCT01375920|Anti-depressants|anti-depressants
5480769|NCT01375907|blood cell counts|blood cell counts
5480770|NCT01375907|BUN|bun
5480771|NCT01375907|ALT|alt
5480772|NCT01375907|AST|ast
5480773|NCT01375907|diarrhea|diarrhea
5480774|NCT01375907|fever|fever
5480775|NCT01375907|vomit|vomit
5480776|NCT01375907|nausea|nausea
5480777|NCT01375907|loss of appetite|loss of appetite
5480778|NCT01375907|irritability|irritability
5480779|NCT01375881|HIV|hiv
5480780|NCT01375881|darunavir|darunavir
5480781|NCT01375881|ritonavir|ritonavir
5480782|NCT01375881|Prezista|prezista
5480783|NCT01375881|naive|naive
5480784|NCT01375881|experienced|experienced
5480785|NCT01375868|HPV|hpv
5480786|NCT01375868|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5480787|NCT01375868|antibodies|antibodies
5480788|NCT01375855|Late stent malapposition|late stent malapposition
5480789|NCT01375855|stent thrombosis|stent thrombosis
5480790|NCT01375855|IVUS|ivus
5480791|NCT01375855|non-polimeric stent|non-polimeric stent
5480792|NCT01375816|adenocarcinoma of the colon|adenocarcinoma of the colon
5480793|NCT01375816|recurrent colon cancer|recurrent colon cancer
5480794|NCT01375816|stage IV colon cancer|stage iv colon cancer
5480795|NCT01375816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5480796|NCT01375816|recurrent rectal cancer|recurrent rectal cancer
5480797|NCT01375816|stage IV rectal cancer|stage iv rectal cancer
5480799|NCT01375803|fiber|fiber
5480800|NCT01375803|insulin sensitivity|insulin sensitivity
5480801|NCT01375803|insulin resistance|insulin resistance
5480802|NCT01375803|glucose metabolism|glucose metabolism
5480803|NCT01375790|whole-body vibration|whole-body vibration
5480804|NCT01375790|older people|older people
5480805|NCT01375790|exercise|exercise
5480806|NCT01375790|body balance|body balance
5480807|NCT01375790|muscle performance|muscle performance
5480808|NCT01375790|falls|falls
5480809|NCT01375790|physiotherapy|physiotherapy
5480810|NCT01375777|High cholesterol|high cholesterol
5480811|NCT01375777|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5480812|NCT01375777|Treatment for high cholesterol|treatment for high cholesterol
5480813|NCT01375777|Lowering cholesterol|lowering cholesterol
5480814|NCT01375777|Lowering high cholesterol|lowering high cholesterol
5480815|NCT01375777|Hypercholesterolemia|hypercholesterolemia
5480816|NCT01375764|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5480818|NCT01375764|High Cholesterol|high cholesterol
5480825|NCT01375738|Early gastric cancer|early gastric cancer
5480826|NCT01375712|Hard or lumpy stools|hard or lumpy stools
5480827|NCT01375712|Stool consistency|stool consistency
5480828|NCT01375712|Stool frequency|stool frequency
5480829|NCT01375712|Constipation related symptoms|constipation related symptoms
5480830|NCT01375712|Constipation related quality of life|constipation related quality of life
5480831|NCT01375699|Breast cancer|breast cancer
5480832|NCT01375699|Gastrointestinal cancer|gastrointestinal cancer
5480833|NCT01375699|Genitourinary cancer|genitourinary cancer
5480834|NCT01375699|Sarcoma|sarcoma
5480835|NCT01375699|Gynecologic cancer|gynecologic cancer
5480836|NCT01375686|Diabetes|diabetes
5480837|NCT01375673|Exercise|exercise
5480838|NCT01375673|Heart Failure|heart failure
5480839|NCT01375673|Mixed Effects Modeling|mixed effects modeling
5480840|NCT01375660|Vitamin D|vitamin d
5480841|NCT01375660|Glucose intolerance|glucose intolerance
5480842|NCT01375660|African American men|african american men
5480843|NCT01375647|Oral Vaccines|oral vaccines
5480844|NCT01375647|Vaccine Responsiveness|vaccine responsiveness
5480845|NCT01375647|Tropical Enteropathy|tropical enteropathy
5480846|NCT01375634|Intubation|intubation
5480847|NCT01375634|Gastrointestinal|gastrointestinal
5480851|NCT01375608|Neutropenia|neutropenia
5480852|NCT01375608|Hemaglobin|hemaglobin
5480853|NCT01375608|Coagulation Disorders|coagulation disorders
5480854|NCT01375608|Thrombocytosis|thrombocytosis
5480855|NCT01375608|Red Blood Cells|red blood cells
5480856|NCT01375608|Sickle Cell Disease|sickle cell disease
5480857|NCT01375595|Working Memory|working memory
5480858|NCT01375595|Repetitive TMS (rTMS)|repetitive tms (rtms)
5480859|NCT01375595|Language|language
5480860|NCT01375595|Healthy Volunteer|healthy volunteer
5480861|NCT01375595|HV|hv
5480862|NCT01375582|Dry Eye|dry eye
5480863|NCT01375582|tear film|tear film
5480864|NCT01375582|lipid|lipid
5480865|NCT01375582|tear volume|tear volume
5480866|NCT01375582|environmental chamber|environmental chamber
5480867|NCT01375582|thermal imaging|thermal imaging
5480869|NCT01375569|Monoclonal Antibody|monoclonal antibody
5480870|NCT01375569|Anti-Angiogenic|anti-angiogenic
5480871|NCT01375569|Chimeric|chimeric
5480872|NCT01375569|Apoptosis|apoptosis
5480873|NCT01375569|Liver Cancer|liver cancer
5480874|NCT01375556|Alcohol Clamp|alcohol clamp
5480875|NCT01375556|Pharmacogenetics|pharmacogenetics
5480876|NCT01375556|Family History of Alcoholism|family history of alcoholism
5480877|NCT01375556|Pharmacodynamics|pharmacodynamics
5480878|NCT01375556|Healthy Volunteer|healthy volunteer
5480879|NCT01375556|HV|hv
5480880|NCT01375543|Whole Exome|whole exome
5480881|NCT01375543|Whole Genome|whole genome
5480882|NCT01375543|Rare Disorders|rare disorders
5480883|NCT01375543|Genetic Disorders|genetic disorders
5480891|NCT01375504|Obesity|obesity
5480892|NCT01375504|Body Mass Index|body mass index
5480893|NCT01375504|Mindfulness Training|mindfulness training
5480894|NCT01375504|Attention and Interpretation Therapy|attention and interpretation therapy
5480895|NCT01375491|doxycycline|doxycycline
5480896|NCT01375491|insulin resistance|insulin resistance
5480897|NCT01375491|obesity|obesity
5480898|NCT01375491|inflammation|inflammation
5480899|NCT01375439|Pregnancy|pregnancy
5480900|NCT01375439|vulvovaginitis|vulvovaginitis
5480904|NCT01375426|Treatment failure|treatment failure
5480905|NCT01375426|Double dose amoxicillin|double dose amoxicillin
5480906|NCT01375426|Children|children
5480907|NCT01375413|Parkinson's disease|parkinson's disease
5480908|NCT01375413|Gait|gait
5480909|NCT01375413|Rehabilitation|rehabilitation
5480910|NCT01375413|Cognition|cognition
5480911|NCT01375413|Freezing of gait|freezing of gait
5480912|NCT01375400|aspirin|aspirin
5480913|NCT01375400|platelet|platelet
5480914|NCT01375387|Vimpat|vimpat
5480915|NCT01375387|Pharmacokinetics|pharmacokinetics
5480916|NCT01375387|Healthy Japanese male|healthy japanese male
5480917|NCT01375387|Healthy Chinese male|healthy chinese male
5480918|NCT01375374|Vimpat|vimpat
5480919|NCT01375374|Partial seizures|partial seizures
5480920|NCT01375374|Carbamazepine|carbamazepine
5480921|NCT01375374|Hormone levels|hormone levels
5480922|NCT01375374|Lipid levels|lipid levels
5480923|NCT01375374|Lacosamide|lacosamide
5480924|NCT01375361|albuterol|albuterol
5480925|NCT01375348|Cognitive function|cognitive function
5480926|NCT01375348|Experimental pain|experimental pain
5480927|NCT01375335|Postoperative|postoperative
5480928|NCT01375335|Dobutamine|dobutamine
5480930|NCT01375335|Stunning|stunning
5480931|NCT01375335|Heart failure|heart failure
5480932|NCT01375309|probiotics|probiotics
5480933|NCT01375309|preterm infants|preterm infants
5480934|NCT01375309|enteral feeding|enteral feeding
5480935|NCT01375309|Bifidobacterium on enteral feeding|bifidobacterium on enteral feeding
5480936|NCT01375270|diabetes|diabetes
5480937|NCT01375270|incretin|incretin
5480938|NCT01375270|beta-cell function|beta-cell function
5480939|NCT01375270|glucolipotoxicity|glucolipotoxicity
5480940|NCT01375270|glucagon-like peptide 1|glucagon-like peptide 1
5480941|NCT01375270|glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5480942|NCT01375244|bioequivalence|bioequivalence
5480943|NCT01375244|lisinopril|lisinopril
5480944|NCT01375244|fasting|fasting
5480945|NCT01375205|atopic dermatitis|atopic dermatitis
5480946|NCT01375205|skin care|skin care
5480947|NCT01375179|Inflammatory Bowel disease|inflammatory bowel disease
5480948|NCT01375179|Ulcerative colitis|ulcerative colitis
5480949|NCT01375153|BNP administration|bnp administration
5480950|NCT01375153|appetite|appetite
5480951|NCT01375153|ghrelin|ghrelin
5480952|NCT01375153|PYY|pyy
5480953|NCT01375140|Myeloproliferative Diseases|myeloproliferative diseases
5480954|NCT01375140|Myelofibrosis|myelofibrosis
5480955|NCT01375140|Post essential thrombocythemia/polycythemia vera|post essential thrombocythemia/polycythemia vera
5480956|NCT01375140|Ruxolitinib|ruxolitinib
5480957|NCT01375140|INCB018424|incb018424
5480958|NCT01375140|Lenalidomide|lenalidomide
5480959|NCT01375140|CC-5013|cc-5013
5480960|NCT01375140|Revlimid|revlimid
5480961|NCT01375140|Prednisone|prednisone
5480962|NCT01375140|Interactive Voice Response System|interactive voice response system
5480963|NCT01375140|IVR|ivr
5480964|NCT01375127|Observational|observational
5480965|NCT01375127|clinical follow-up data|clinical follow-up data
5480966|NCT01375114|Advanced Cancers|advanced cancers
5480967|NCT01375114|Solid Tumors|solid tumors
5480968|NCT01375114|Cancer related fatigue|cancer related fatigue
5480969|NCT01375114|CRF|crf
5480970|NCT01375114|Panax ginseng|panax ginseng
5480971|NCT01375114|Placebo|placebo
5480972|NCT01375114|Sugar pill|sugar pill
5480973|NCT01375114|Functional Assessment of Chronic Illness Therapy-Fatigue|functional assessment of chronic illness therapy-fatigue
5480974|NCT01375114|FACIT-F|facit-f
5480975|NCT01375114|Quality of life|quality of life
5480976|NCT01375114|QOL|qol
5480977|NCT01375114|FACT-G|fact-g
5480978|NCT01375114|Hospital Anxiety and Depression Inventory|hospital anxiety and depression inventory
5480979|NCT01375114|Neurocognitive function|neurocognitive function
5480980|NCT01375114|SDMT|sdmt
5480981|NCT01375114|Global Symptom Evaluation|global symptom evaluation
5480982|NCT01375114|GSE|gse
5480983|NCT01375101|lichen planus|lichen planus
5480984|NCT01375101|quercetin|quercetin
5480985|NCT01375088|propolis|propolis
5480986|NCT01375088|mucositis|mucositis
5480987|NCT01375088|radiotherapy|radiotherapy
5480988|NCT01375088|cancer|cancer
5480989|NCT01375049|Cystic fibrosis|cystic fibrosis
5480990|NCT01375049|CF|cf
5480991|NCT01375049|PA|pa
5480992|NCT01375049|Pseudomonas aeruginosa|pseudomonas aeruginosa
5480993|NCT01375049|AZLI|azli
5480994|NCT01375049|aztreonam|aztreonam
5480995|NCT01375036|Cystic fibrosis|cystic fibrosis
5480996|NCT01375036|PA|pa
5480997|NCT01375036|Pseudomonas aeruginosa|pseudomonas aeruginosa
5480998|NCT01375036|CF|cf
5480999|NCT01375036|aztreonam|aztreonam
5481000|NCT01375023|Allogenic Haematopoietic Cell Transplantation|allogenic haematopoietic cell transplantation
5481001|NCT01375023|Total Lymphoid Irradiation|total lymphoid irradiation
5481002|NCT01375023|Anti-Thymocyte Globulin|anti-thymocyte globulin
5481003|NCT01375023|Triple Negative Breast Cancer|triple negative breast cancer
5481005|NCT01375010|Postmenopausal women|postmenopausal women
5481006|NCT01375010|Vitamin D|vitamin d
5481007|NCT01374984|smallpox|smallpox
5481008|NCT01374984|vaccination|vaccination
5481009|NCT01374984|complications|complications
5481010|NCT01374971|Rheumatoid Arthritis|rheumatoid arthritis
5481011|NCT01374971|Cimzia|cimzia
5481012|NCT01374971|Certolizumab Pegol|certolizumab pegol
5481013|NCT01374971|Arthroscopic Synovial biopsy|arthroscopic synovial biopsy
5481014|NCT01374971|Office Based Procedure|office based procedure
5481015|NCT01374971|Biologic|biologic
5475538|NCT01398397|HED|hed
5481016|NCT01374971|Tumor Necrosis Factor (TNF)|tumor necrosis factor (tnf)
5481018|NCT01374932|Asthma|asthma
5481019|NCT01374932|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5481020|NCT01374919|Intravenous iron|intravenous iron
5481021|NCT01374919|ferumoxytol|ferumoxytol
5481022|NCT01374919|iron deficiency anemia|iron deficiency anemia
5481023|NCT01374919|Treatment of iron deficiency|treatment of iron deficiency
5481123|NCT01374490|HIV positive|hiv positive
5481024|NCT01374919|Intolerance of or ineffectiveness of oral iron|intolerance of or ineffectiveness of oral iron
5481026|NCT01374906|Cushing's Disease|cushing's disease
5481027|NCT01374906|Mean Urinary Free Cortisol|mean urinary free cortisol
5481028|NCT01374906|Pasireotide|pasireotide
5481029|NCT01374906|Pasireotide LAR|pasireotide lar
5481030|NCT01374906|Pasireotide long-acting release|pasireotide long-acting release
5481031|NCT01374906|secondary hypercortisolism|secondary hypercortisolism
5481032|NCT01374906|secondary hypercorticism|secondary hypercorticism
5481033|NCT01374906|Itsenko-Cushing disease|itsenko-cushing disease
5481034|NCT01374906|increased secretion of adrenocorticotropic hormone (ACTH)|increased secretion of adrenocorticotropic hormone (acth)
5481035|NCT01374906|hyperpituitarism|hyperpituitarism
5481036|NCT01374893|Function, hospitalization, elderly|function, hospitalization, elderly
5481037|NCT01374880|Heart failure|heart failure
5481038|NCT01374880|Dyspnea|dyspnea
5481039|NCT01374880|Heart disease|heart disease
5481040|NCT01374880|Pulmonary disease|pulmonary disease
5481041|NCT01374880|Natriuretic peptide|natriuretic peptide
5481042|NCT01374880|Rehabilitation|rehabilitation
5481043|NCT01374867|Cardiogenic shock|cardiogenic shock
5481044|NCT01374867|Myocardial infarction|myocardial infarction
5481045|NCT01374867|Low-output syndrome|low-output syndrome
5481046|NCT01374867|Prognosis|prognosis
5481047|NCT01374867|Biomarkers|biomarkers
5481048|NCT01374867|Pathophysiology|pathophysiology
5481049|NCT01374854|type 1 diabetes mellitus|type 1 diabetes mellitus
5481050|NCT01374854|umbilical mesenchymal stem cell|umbilical mesenchymal stem cell
5481051|NCT01374854|mononuclear cell|mononuclear cell
5481052|NCT01374841|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5481053|NCT01374841|High-Risk Hematologic Neoplasms|high-risk hematologic neoplasms
5481054|NCT01374841|Haploidentical Donors|haploidentical donors
5481055|NCT01374841|Cyclophosphamide|cyclophosphamide
5481056|NCT01374828|Toradol|toradol
5481057|NCT01374828|Ketorolac|ketorolac
5481058|NCT01374828|Normal saline|normal saline
5481059|NCT01374828|Laparoscopic|laparoscopic
5481060|NCT01374828|Postoperative pain control|postoperative pain control
5481061|NCT01374828|Incisional analgesia|incisional analgesia
5481062|NCT01374815|Children's diet quality|children's diet quality
5481063|NCT01374815|Health-related social problems|health-related social problems
5481064|NCT01374763|Naloxone|naloxone
5481065|NCT01374763|Oxycodone|oxycodone
5481066|NCT01374763|Constipation|constipation
5481067|NCT01374763|Pain, postoperative|pain, postoperative
5481068|NCT01374763|Physiological effects of drugs|physiological effects of drugs
5481069|NCT01374763|Analgesics, Opioid|analgesics, opioid
5481070|NCT01374724|Tobacco Use|tobacco use
5481071|NCT01374724|Relapse Prevention|relapse prevention
5481072|NCT01374724|Military|military
5481073|NCT01374724|Smokeless Tobacco Use|smokeless tobacco use
5481074|NCT01374724|Dual Use|dual use
5481075|NCT01374711|Endotoxin|endotoxin
5481076|NCT01374711|Inflammation|inflammation
5481078|NCT01374711|GM-CSF|gm-csf
5481079|NCT01374711|IFN-y|ifn-y
5481081|NCT01374698|Aspirin|aspirin
5481082|NCT01374698|Reload|reload
5481083|NCT01374685|BRCA1|brca1
5481084|NCT01374685|BRCA2|brca2
5481085|NCT01374685|Breast Cancer|breast cancer
5481086|NCT01374685|African American|african american
5481087|NCT01374685|Women|women
5481088|NCT01374659|124-I PET|124-i pet
5481089|NCT01374659|FDG-PET|fdg-pet
5481090|NCT01374659|PET/CT|pet/ct
5481091|NCT01374659|recurrence|recurrence
5481092|NCT01374659|differentiated thyroid carcinoma|differentiated thyroid carcinoma
5481093|NCT01374659|diagnostic value|diagnostic value
5481094|NCT01374646|Childhood Obesity|childhood obesity
5481095|NCT01374646|Group Treatment|group treatment
5481096|NCT01374646|Community-based Programs|community-based programs
5481097|NCT01374633|Sevoflurane|sevoflurane
5481098|NCT01374633|Brain injury|brain injury
5481099|NCT01374633|Intra cranial pressure|intra cranial pressure
5481100|NCT01374633|Sedation|sedation
5481101|NCT01374633|Brain injury with initial Glasgow score less than 9|brain injury with initial glasgow score less than 9
5481103|NCT01374607|acute coronary syndrome|acute coronary syndrome
5481104|NCT01374607|myocardial ischemia|myocardial ischemia
5481105|NCT01374607|high-sensitivity cardiac troponin T|high-sensitivity cardiac troponin t
5481106|NCT01374581|retreatment|retreatment
5481107|NCT01374581|artemisinin-based combination|artemisinin-based combination
5481108|NCT01374581|malaria|malaria
5481109|NCT01374581|resistant|resistant
5481110|NCT01374568|Type 2 diabetes|type 2 diabetes
5481111|NCT01374568|sitagliptin|sitagliptin
5481112|NCT01374568|Januvia|januvia
5481113|NCT01374555|Coronary artery disease|coronary artery disease
5481114|NCT01374542|Bronchoscopy|bronchoscopy
5481119|NCT01374516|CYD dengue vaccine|cyd dengue vaccine
5481120|NCT01374516|Flavivirus|flavivirus
5481121|NCT01374516|Dengue Disease|dengue disease
5481122|NCT01374490|HIV +|hiv +
5481124|NCT01374490|HIV associated diarrhea|hiv associated diarrhea
5481125|NCT01374490|AIDS|aids
5481126|NCT01374490|Diarrhea|diarrhea
5481127|NCT01374477|Preeclampsia in Adolescence|preeclampsia in adolescence
5481128|NCT01374477|Adolescent|adolescent
5481129|NCT01374477|Primipaternity|primipaternity
5481130|NCT01374464|Interscalene brachial plexus nerve block|interscalene brachial plexus nerve block
5481131|NCT01374464|Nerve block|nerve block
5481132|NCT01374451|Pancreatic|pancreatic
5465927|NCT01437189|sertraline|sertraline
5481133|NCT01374451|Neuroendocrine tumors|neuroendocrine tumors
5481134|NCT01374451|PNET|pnet
5481137|NCT01374451|Advanced progressive pancreatic neuroendocrine tumor|advanced progressive pancreatic neuroendocrine tumor
5481138|NCT01374438|Alzheimer's disease|alzheimer's disease
5481139|NCT01374438|cognitive function|cognitive function
5481140|NCT01374438|brain glucose utilization|brain glucose utilization
5481141|NCT01374438|FDG-PET|fdg-pet
5481142|NCT01374399|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5481143|NCT01374399|exercise|exercise
5481144|NCT01374399|survival|survival
5481145|NCT01374399|fatigue|fatigue
5481146|NCT01374399|quality of life|quality of life
5481147|NCT01374399|cancer|cancer
5481148|NCT01374399|physical performance|physical performance
5481149|NCT01374386|adolescent obesity|adolescent obesity
5481150|NCT01374373|Chemotherapy|chemotherapy
5481151|NCT01374373|Anemia|anemia
5481152|NCT01374373|Epoetin alfa|epoetin alfa
5481153|NCT01374373|Erythropoiesis stimulating agent (ESA)|erythropoiesis stimulating agent (esa)
5481154|NCT01374360|PNH|pnh
5481155|NCT01374360|Paroxysmal Nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5481156|NCT01374360|Soliris|soliris
5481157|NCT01374360|Eculizumab|eculizumab
5481158|NCT01374308|NASVAC|nasvac
5481159|NCT01374308|Pegylated Interferon-2b|pegylated interferon-2b
5481160|NCT01374308|CHB|chb
5481161|NCT01374269|NSAIDS (Nonsteroidal anti-inflammatory drugs)|nsaids (nonsteroidal anti-inflammatory drugs)
5481162|NCT01374269|Exercise|exercise
5481163|NCT01374269|Physiotherapy|physiotherapy
5481164|NCT01374269|Subacute Low Back Pain|subacute low back pain
5481165|NCT01374269|Pain|pain
5481166|NCT01374269|Visual Analogue Scale|visual analogue scale
5481167|NCT01374269|oswesrty|oswesrty
5481168|NCT01374269|Roland Morris|roland morris
5481169|NCT01374269|SF-36|sf-36
5481170|NCT01374269|Quality of life|quality of life
5481171|NCT01374256|carbapenem|carbapenem
5481172|NCT01374256|sulbactam|sulbactam
5481173|NCT01374256|Acinetobacter baumannii|acinetobacter baumannii
5481174|NCT01374230|clinical outcomes|clinical outcomes
5481175|NCT01374230|radiographic outcomes|radiographic outcomes
5481176|NCT01374230|total knee arthroplasty|total knee arthroplasty
5481177|NCT01374230|survivorship|survivorship
5481178|NCT01374204|Epilepsy|epilepsy
5481179|NCT01374204|Stigma|stigma
5481180|NCT01374191|botox|botox
5481181|NCT01374191|neuroma pain|neuroma pain
5481182|NCT01374191|pain|pain
5481183|NCT01374191|chronic pain|chronic pain
5481184|NCT01374191|botulinum toxin|botulinum toxin
5481185|NCT01374191|botulinum toxin A|botulinum toxin a
5481186|NCT01374191|botox and pain|botox and pain
5481187|NCT01374191|botox and neuroma|botox and neuroma
5481188|NCT01374191|botox treatment|botox treatment
5481189|NCT01374191|onabotulinum|onabotulinum
5481190|NCT01374191|onabotulinum toxin|onabotulinum toxin
5481191|NCT01374191|onabotulinum toxin type A|onabotulinum toxin type a
5481192|NCT01374165|SCD|scd
5481193|NCT01374152|stroke|stroke
5481194|NCT01374152|upper extremity|upper extremity
5481195|NCT01374152|rehabilitation|rehabilitation
5481196|NCT01374152|perfetti|perfetti
5481197|NCT01374139|Bosutinib|bosutinib
5481198|NCT01374139|Bioequivalence and Food Effect Studies|bioequivalence and food effect studies
5481199|NCT01374113|safinamide|safinamide
5481200|NCT01374113|pharmacokinetics|pharmacokinetics
5481201|NCT01374113|renal impairment|renal impairment
5481202|NCT01374113|Moderate and Severe Renal Impairment|moderate and severe renal impairment
5481208|NCT01374100|Standard Exercise|standard exercise
5481209|NCT01374100|Chemotherapy|chemotherapy
5481210|NCT01374100|Advanced cancer|advanced cancer
5481211|NCT01374100|Quality of Life|quality of life
5481212|NCT01374100|Functional Assessment of Cancer Therapy|functional assessment of cancer therapy
5481213|NCT01374100|Hospital Anxiety and Depression Scale|hospital anxiety and depression scale
5481214|NCT01374100|Anxiety|anxiety
5481215|NCT01374100|Depression|depression
5481216|NCT01374100|Cancer Nutrition-Rehabilitation Program|cancer nutrition-rehabilitation program
5481217|NCT01374100|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
5481218|NCT01374100|Simmonds Functional Assessment|simmonds functional assessment
5481219|NCT01374087|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5481220|NCT01374087|Brachytherapy|brachytherapy
5481221|NCT01374087|Triptorelin|triptorelin
5481222|NCT01374087|Hormone Therapy|hormone therapy
5481223|NCT01374074|Barrett's Esophagus (BE)|barrett's esophagus (be)
5481224|NCT01374074|Intestinal metaplasia|intestinal metaplasia
5481225|NCT01374074|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5481226|NCT01374074|Racial Disparity|racial disparity
5481227|NCT01374061|Emergency intubation|emergency intubation
5481228|NCT01374061|Glide scope Ranger|glide scope ranger
5481229|NCT01374061|Pre hospital|pre hospital
5481230|NCT01374035|Health Service|health service
5481231|NCT01374035|Coordination|coordination
5481232|NCT01374035|Referral letters|referral letters
5481233|NCT01374035|Mental Health|mental health
5466022|NCT01436799|sitting|sitting
5481234|NCT01374035|Adults|adults
5481235|NCT01374022|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5481237|NCT01374022|Respiration, Artificial|respiration, artificial
5481238|NCT01373996|Invasive blood pressure monitoring|invasive blood pressure monitoring
5481239|NCT01373996|Intensive care unit|intensive care unit
5481240|NCT01373996|Wireless Technology|wireless technology
5481241|NCT01373983|Neuropathic pain|neuropathic pain
5481242|NCT01373983|Intrathecal analgesia|intrathecal analgesia
5481243|NCT01373983|Ziconotide|ziconotide
5481244|NCT01373983|Bolus|bolus
5481245|NCT01373983|trauma|trauma
5481246|NCT01373983|central|central
5481247|NCT01373983|severe|severe
5481248|NCT01373983|chronic|chronic
5481249|NCT01373970|Functional Dyspepsia|functional dyspepsia
5481250|NCT01373970|Protonpump inhibitor|protonpump inhibitor
5481251|NCT01373970|Rebound Acid HyperSecretion|rebound acid hypersecretion
5481252|NCT01373957|Acute Coronary Syndrome|acute coronary syndrome
5481253|NCT01373957|antithrombotic management|antithrombotic management
5481254|NCT01373957|STEMI|stemi
5481255|NCT01373957|NSTE-ACS|nste-acs
5481257|NCT01373944|SPECT|spect
5481258|NCT01373944|Stress-Only|stress-only
5481259|NCT01373944|Spectrum Dynamics Camera|spectrum dynamics camera
5481260|NCT01373944|Anger|anger
5481261|NCT01373918|cholestasis|cholestasis
5481262|NCT01373918|neonates|neonates
5481263|NCT01373918|parenteral nutrition|parenteral nutrition
5481264|NCT01373918|gastrointestinal disorders|gastrointestinal disorders
5481265|NCT01373905|ARDS|ards
5481266|NCT01373905|PEEP|peep
5481267|NCT01373905|Recruitment maneuver|recruitment maneuver
5481268|NCT01373879|Vaccine|vaccine
5481269|NCT01373879|Immune response|immune response
5481270|NCT01373866|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5481271|NCT01373866|Neuronavigation|neuronavigation
5481272|NCT01373866|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5481273|NCT01373866|Diffusion Tensor Imaging|diffusion tensor imaging
5481274|NCT01373853|Lens Fragmentation|lens fragmentation
5481275|NCT01373853|Cataract|cataract
5481276|NCT01373853|Phacoemulsification|phacoemulsification
5481277|NCT01373853|Femtosecond Laser|femtosecond laser
5481278|NCT01373840|focal|focal
5481279|NCT01373840|dystonia|dystonia
5481280|NCT01373840|dopamine|dopamine
5481281|NCT01373840|receptor|receptor
5481282|NCT01373827|VASER|vaser
5481283|NCT01373827|VASERShape|vasershape
5481285|NCT01373827|ultrasound|ultrasound
5481286|NCT01373801|Postpartum women, after surgical repair of vaginal and cervical lacerations|postpartum women, after surgical repair of vaginal and cervical lacerations
5481287|NCT01373775|Heart failure|heart failure
5481288|NCT01373775|Revisit|revisit
5481289|NCT01373775|Emergency room|emergency room
5481290|NCT01373762|Adherence|adherence
5481291|NCT01373762|Motivation|motivation
5481292|NCT01373762|Health-related fitness|health-related fitness
5481293|NCT01373762|Exercise videogames|exercise videogames
5481294|NCT01373762|Physical Activity|physical activity
5481295|NCT01373749|PPHN|pphn
5481296|NCT01373749|NO inhalation|no inhalation
5481297|NCT01373749|Sildenafil|sildenafil
5481299|NCT01373749|Safety|safety
5481300|NCT01373723|Uterine Cervical Neoplasms|uterine cervical neoplasms
5481301|NCT01373723|cancer screening|cancer screening
5481302|NCT01373723|Costs and Cost Analysis|costs and cost analysis
5481303|NCT01373723|cost-effectiveness analysis|cost-effectiveness analysis
5481304|NCT01373723|Clinical Trial|clinical trial
5481305|NCT01373723|Primary Health Care|primary health care
5481555|NCT01372475|Knee|knee
5481306|NCT01373710|Adverse Reaction to Trastuzumab Administered by intrathecal|adverse reaction to trastuzumab administered by intrathecal
5481307|NCT01373697|Ibuprofen|ibuprofen
5481308|NCT01373697|muscle pain|muscle pain
5481310|NCT01373697|contusions|contusions
5481311|NCT01373697|tendonitis|tendonitis
5481312|NCT01373684|Chronic hepatitis B|chronic hepatitis b
5481313|NCT01373684|HBeAg-negative|hbeag-negative
5481314|NCT01373671|Mammography|mammography
5481315|NCT01373671|Screening|screening
5481316|NCT01373671|Diagnostic|diagnostic
5789045|NCT00150137|radioprotection|radioprotection
5481319|NCT01373632|clinical ischemic|clinical ischemic
5481320|NCT01373619|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5481321|NCT01373619|hemodialysis patients|hemodialysis patients
5481323|NCT01373619|Echocardiography|echocardiography
5481324|NCT01373619|NYHA class|nyha class
5481325|NCT01373619|6-minutes walking test|6-minutes walking test
5481326|NCT01373593|persistent postherniorrhaphy pain|persistent postherniorrhaphy pain
5481327|NCT01373580|presbyopia|presbyopia
5481328|NCT01373580|LASIK|lasik
5481329|NCT01373580|loss of accommodation|loss of accommodation
5481330|NCT01373580|Emmetrope|emmetrope
5481331|NCT01373567|Plaque Psoriasis|plaque psoriasis
5481332|NCT01373528|Sinonasal Budesonide|sinonasal budesonide
5481333|NCT01373528|Endoscopic sinus surgery|endoscopic sinus surgery
5481334|NCT01373528|Hypothalamic-Pituitary-Adrenal Axis Function|hypothalamic-pituitary-adrenal axis function
5481335|NCT01373515|DCOne|dcone
5481336|NCT01373515|DCP-001|dcp-001
5481337|NCT01373515|Second complete remission of AML|second complete remission of aml
5481338|NCT01373515|Relapse AML|relapse aml
5481339|NCT01373489|type 2 diabetes|type 2 diabetes
5481340|NCT01373489|nurse case management|nurse case management
5481341|NCT01373489|telemedicine|telemedicine
5481342|NCT01373476|Diabetic Retinopathy|diabetic retinopathy
5481343|NCT01373476|Traditional Chinese medicine|traditional chinese medicine
5481344|NCT01373476|Diabetic Eye Problems|diabetic eye problems
5481345|NCT01373476|Retinal Disorders|retinal disorders
5481346|NCT01373463|resectable|resectable
5481347|NCT01373437|Ultrasonography|ultrasonography
5481348|NCT01373437|US|us
5481349|NCT01373437|Confirming|confirming
5481350|NCT01373437|Confirmation|confirmation
5481351|NCT01373437|Proper|proper
5481352|NCT01373437|Position|position
5481353|NCT01373437|Endotracheal tube|endotracheal tube
5481354|NCT01373437|ETT|ett
5481355|NCT01373437|Emergency department|emergency department
5481356|NCT01373437|ED|ed
5481357|NCT01373437|Applicability|applicability
5481358|NCT01373437|Accuracy|accuracy
5481359|NCT01373424|Observational study|observational study
5481360|NCT01373424|Cross-sectional and Prospective study|cross-sectional and prospective study
5481361|NCT01373424|Cohort and case-control study|cohort and case-control study
5481362|NCT01373411|CABG|cabg
5481363|NCT01373411|Ticagrelor|ticagrelor
5481364|NCT01373411|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5481365|NCT01373398|bladder cancer|bladder cancer
5481366|NCT01373398|EO9|eo9
5481367|NCT01373398|Apaziquone|apaziquone
5481368|NCT01373385|pediatric urology|pediatric urology
5481369|NCT01373385|vesicoureteral reflux|vesicoureteral reflux
5481370|NCT01373385|ureteral reimplant|ureteral reimplant
5481371|NCT01373385|Deflux|deflux
5481372|NCT01373372|functional dyspepsia|functional dyspepsia
5481373|NCT01373372|GI|gi
5481374|NCT01373359|Misoprostol, oxytocin, postpartum blood loss, hemoglobin|misoprostol, oxytocin, postpartum blood loss, hemoglobin
5481375|NCT01373346|type II diabetes|type ii diabetes
5481376|NCT01373346|Gastric cancer|gastric cancer
5481377|NCT01373346|Long limb Roux-en Y|long limb roux-en y
5481378|NCT01373320|Smoking cessation|smoking cessation
5481379|NCT01373320|Cancer screening|cancer screening
5481380|NCT01373320|Appalachia|appalachia
5481381|NCT01373320|Group-randomized trial|group-randomized trial
5481382|NCT01373320|Faith-placed|faith-placed
5481383|NCT01373307|Overweight|overweight
5481384|NCT01373307|obesity|obesity
5481385|NCT01373307|Appalachian|appalachian
5481386|NCT01373307|intergenerational|intergenerational
5481387|NCT01373307|families|families
5481388|NCT01373307|energy balance|energy balance
5481389|NCT01373307|group-randomized trial|group-randomized trial
5481390|NCT01373294|non-muscle-invasive|non-muscle-invasive
5481391|NCT01373294|transitional cell|transitional cell
5481392|NCT01373294|oral lenalidomide|oral lenalidomide
5481393|NCT01373294|intravesical|intravesical
5481394|NCT01373281|Dengue|dengue
5481395|NCT01373281|Dengue fever|dengue fever
5484463|NCT01360437|CAD|cad
5481396|NCT01373281|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5481397|NCT01373281|CYD dengue vaccine|cyd dengue vaccine
5481398|NCT01373281|Flavivirus|flavivirus
5481399|NCT01373255|Placenta accreta|placenta accreta
5481400|NCT01373255|Internal iliac artery catheterization|internal iliac artery catheterization
5481401|NCT01373255|Post partum bleeding|post partum bleeding
5481402|NCT01373229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5481403|NCT01373229|CLL|cll
5481404|NCT01373203|Acute Lung Injury(ALI)|acute lung injury(ali)
5481405|NCT01373190|epilepsy|epilepsy
5481406|NCT01373190|thermography|thermography
5481407|NCT01373164|Neoplasms|neoplasms
5481408|NCT01373164|Neoplasm Metastasis|neoplasm metastasis
5481409|NCT01373164|Pancreatic Cancer|pancreatic cancer
5481410|NCT01373138|Bioequivalence|bioequivalence
5481411|NCT01373138|Desloratadine and pseudoephedrine|desloratadine and pseudoephedrine
5481413|NCT01373125|Barrett's Esophagus|barrett's esophagus
5481414|NCT01373125|Intestinal metaplasia|intestinal metaplasia
5481415|NCT01373125|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5481416|NCT01373125|Neosquamous epithelium|neosquamous epithelium
5481417|NCT01373125|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5481418|NCT01373112|arthroplasty|arthroplasty
5481419|NCT01373112|knee replacement|knee replacement
5481420|NCT01373112|Osteoarthritis|osteoarthritis
5481421|NCT01373112|knee Infection|knee infection
5481422|NCT01373112|Prosthetic Joint Infection|prosthetic joint infection
5481423|NCT01373112|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
5481424|NCT01373112|Complications; Arthroplasty|complications; arthroplasty
5481425|NCT01373099|arthroplasty|arthroplasty
5481426|NCT01373099|hip replacement|hip replacement
5481427|NCT01373099|Osteoarthritis|osteoarthritis
5481428|NCT01373099|knee Infection|knee infection
5466257|NCT01435785|TCI|tci
5481429|NCT01373099|Prosthetic Joint Infection|prosthetic joint infection
5481430|NCT01373099|Complications; Arthroplasty, Infection or Inflammation|complications; arthroplasty, infection or inflammation
5481431|NCT01373099|Complications; Arthroplasty|complications; arthroplasty
5481432|NCT01373086|Hypertension,|hypertension,
5481433|NCT01373086|mild hypertension,|mild hypertension,
5481434|NCT01373086|moderate hypertension,|moderate hypertension,
5481435|NCT01373086|high blood pressure,|high blood pressure,
5481436|NCT01373086|uncomplicated hypertension.|uncomplicated hypertension.
5481437|NCT01373060|ASP1941|asp1941
5481438|NCT01373060|ipragliflozin|ipragliflozin
5481439|NCT01373060|plasma glucose|plasma glucose
5481440|NCT01373060|urine glucose|urine glucose
5481441|NCT01373047|liver metastases|liver metastases
5481442|NCT01373047|immunotherapy|immunotherapy
5481443|NCT01373047|regional therapy|regional therapy
5481444|NCT01373047|T cells|t cells
5481445|NCT01373008|Inhaled steroids|inhaled steroids
5481446|NCT01373008|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5481447|NCT01373008|Infants with moderate to severe BPD|infants with moderate to severe bpd
5481448|NCT01372995|critical care|critical care
5481449|NCT01372995|nosocomial infection|nosocomial infection
5481450|NCT01372995|antiAntimicrobial peptide expression|antiantimicrobial peptide expression
5481451|NCT01372995|LL-37|ll-37
5481452|NCT01372995|hBD-2|hbd-2
5481453|NCT01372995|cathelicidin|cathelicidin
5481454|NCT01372995|microbial peptide|microbial peptide
5481455|NCT01372956|LDL-C, cholesterol, risk factor|ldl-c, cholesterol, risk factor
5481456|NCT01372943|Clostridium difficile|clostridium difficile
5481457|NCT01372943|recurrent|recurrent
5481458|NCT01372943|infection|infection
5481459|NCT01372930|Etanercept|etanercept
5481460|NCT01372930|acute ST segment elevated myocardial infarction|acute st segment elevated myocardial infarction
5481461|NCT01372930|percutaneous coronary intervention|percutaneous coronary intervention
5481462|NCT01372930|myocardial reperfusion injury|myocardial reperfusion injury
5481463|NCT01372904|Cisplatin|cisplatin
5481464|NCT01372904|Hearing loss|hearing loss
5481465|NCT01372904|Ototoxicity|ototoxicity
5481466|NCT01372904|Intratympanic injection|intratympanic injection
5481467|NCT01372904|Dexamethasone|dexamethasone
5481468|NCT01372904|Steroids|steroids
5481469|NCT01372904|Prevention|prevention
5481470|NCT01372891|Contrast Induced Nephropathy|contrast induced nephropathy
5481471|NCT01372891|percutaneous coronary interventions|percutaneous coronary interventions
5481472|NCT01372878|Polyps|polyps
5481473|NCT01372878|Capsule endoscopy|capsule endoscopy
5481474|NCT01372878|Colonoscopy|colonoscopy
5481475|NCT01372852|Diabetes mellitus|diabetes mellitus
5481476|NCT01372839|Myocardial Infarction|myocardial infarction
5481477|NCT01372839|Unstable Angina|unstable angina
5481478|NCT01372826|Phase 1|phase 1
5481479|NCT01372826|Pharmacokinetics|pharmacokinetics
5481480|NCT01372826|NKTR-118|nktr-118
5481481|NCT01372826|renal impairment|renal impairment
5481482|NCT01372826|parallel study|parallel study
5481483|NCT01372826|QTcF Interval|qtcf interval
5481484|NCT01372826|AUC(0-t)|auc(0-t)
5481485|NCT01372826|Cmax|cmax
5481486|NCT01372826|tmax|tmax
5481487|NCT01372813|Advanced Clear Cell Renal Cell Carcinoma|advanced clear cell renal cell carcinoma
5481488|NCT01372813|Cancer|cancer
5481489|NCT01372813|Renal|renal
5481490|NCT01372813|Renal Cell Carcinoma|renal cell carcinoma
5481494|NCT01372800|cerebrovascular diseases|cerebrovascular diseases
5481495|NCT01372774|neurotoxicity|neurotoxicity
5481496|NCT01372774|radiation toxicity|radiation toxicity
5481497|NCT01372774|cognitive/functional effects|cognitive/functional effects
5481498|NCT01372774|tumors metastatic to brain|tumors metastatic to brain
5481499|NCT01372774|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5481501|NCT01372761|Obesity|obesity
5481502|NCT01372761|Overweight|overweight
5481503|NCT01372748|cardiac arrest|cardiac arrest
5481504|NCT01372748|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5481505|NCT01372735|pancreatic cancer|pancreatic cancer
5481506|NCT01372735|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5481507|NCT01372735|intraoperative radiation therapy|intraoperative radiation therapy
5481509|NCT01372709|abdominal|abdominal
5481510|NCT01372709|aortic|aortic
5481511|NCT01372709|aneurysm|aneurysm
5481512|NCT01372683|Appetite|appetite
5481513|NCT01372683|Satiety|satiety
5481514|NCT01372683|Subjective energy|subjective energy
5481515|NCT01372683|Oats|oats
5481516|NCT01372670|Treating meal related anxiety|treating meal related anxiety
5481517|NCT01372657|cataract|cataract
5481531|NCT01372605|Collaborative care|collaborative care
5481532|NCT01372605|Measurement-Based Care|measurement-based care
5481534|NCT01372553|Family History|family history
5481535|NCT01372553|Risk Stratification|risk stratification
5481536|NCT01372553|Cancer|cancer
5481537|NCT01372553|Thrombosis|thrombosis
5481538|NCT01372527|medical informatics|medical informatics
5481539|NCT01372527|health IT|health it
5481540|NCT01372527|primary care|primary care
5481541|NCT01372527|screening|screening
5481542|NCT01372527|cervical cancer|cervical cancer
5481543|NCT01372527|colorectal cancer|colorectal cancer
5481544|NCT01372527|breast cancer|breast cancer
5481545|NCT01372527|mammography|mammography
5481546|NCT01372527|colonoscopy|colonoscopy
5481547|NCT01372527|pap smear|pap smear
5481548|NCT01372514|Thromboembolism|thromboembolism
5481549|NCT01372514|Venous Thromboembolism|venous thromboembolism
5481550|NCT01372514|Pulmonary Embolism|pulmonary embolism
5481551|NCT01372501|Obesity|obesity
5481552|NCT01372488|Suture self removal|suture self removal
5481553|NCT01372488|non-absorbable sutures|non-absorbable sutures
5481554|NCT01372475|Osteoarthritis|osteoarthritis
5481556|NCT01372475|Hyaluronan|hyaluronan
5481557|NCT01372475|Hyaluronic Acid|hyaluronic acid
5481558|NCT01372475|Viscoelastic|viscoelastic
5481559|NCT01372475|Hydrogel|hydrogel
5481560|NCT01372462|COPD|copd
5481561|NCT01372462|Ventilator|ventilator
5481562|NCT01372462|Constant work rate|constant work rate
5481563|NCT01372449|Autism|autism
5481564|NCT01372449|Psychopharmacology|psychopharmacology
5481565|NCT01372449|Clinical Trial|clinical trial
5481566|NCT01372449|Children|children
5481567|NCT01372436|dental decay|dental decay
5481568|NCT01372436|DMFT|dmft
5481569|NCT01372436|Individual Caries Risk|individual caries risk
5481570|NCT01372436|Risk factors|risk factors
5481571|NCT01372410|Long acting muscarinic antagonist|long acting muscarinic antagonist
5481572|NCT01372410|Tiotropium|tiotropium
5481573|NCT01372410|Chronic Bronchitis|chronic bronchitis
5481574|NCT01372410|Emphysema|emphysema
5481575|NCT01372410|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5481576|NCT01372371|Vancomycin, Gentamycin|vancomycin, gentamycin
5481577|NCT01372371|Local Powder Antibiotic's Efficacy in Controlling Post Surgical Infection|local powder antibiotic's efficacy in controlling post surgical infection
5481578|NCT01372332|homonymous hemianopia|homonymous hemianopia
5481579|NCT01372332|quality of life (QoL)|quality of life (qol)
5481580|NCT01372332|visual exploration|visual exploration
5481581|NCT01372332|on-road car driving|on-road car driving
5481582|NCT01372332|driving simulator|driving simulator
5481583|NCT01372332|useful field of view (UFOV)|useful field of view (ufov)
5481584|NCT01372332|modified field of view (MAFOV)|modified field of view (mafov)
5481585|NCT01372319|glaucoma|glaucoma
5481586|NCT01372319|binocular visual field loss|binocular visual field loss
5481587|NCT01372319|semi-automated kinetic perimetry (SKP)|semi-automated kinetic perimetry (skp)
5481588|NCT01372319|quality of life (QoL)|quality of life (qol)
5481589|NCT01372319|visual exploration|visual exploration
5481590|NCT01372319|on-road car driving|on-road car driving
5481591|NCT01372319|driving simulator|driving simulator
5481592|NCT01372293|PCOS|pcos
5481593|NCT01372293|oral contraceptive pill|oral contraceptive pill
5481594|NCT01372293|polymorphisms|polymorphisms
5481595|NCT01372267|Cognitive Behavioral Therapy|cognitive behavioral therapy
5481596|NCT01372267|Chronic Pain|chronic pain
5481597|NCT01372267|Substance Use Disorders|substance use disorders
5481598|NCT01372267|Psychoeducational control group|psychoeducational control group
5481599|NCT01372254|Cigarette Smoking|cigarette smoking
5481600|NCT01372254|Drug Use|drug use
5481601|NCT01372254|Depressed Mood|depressed mood
5481602|NCT01372241|Papanicolaou test|papanicolaou test
5481603|NCT01372241|Cervical cancer screening|cervical cancer screening
5481604|NCT01372241|Randomized controlled trial|randomized controlled trial
5481605|NCT01372241|Faith-placed|faith-placed
5481606|NCT01372241|Appalachia|appalachia
5481607|NCT01372228|hematopoietic stem cell Tx, chimerism, leukodystrophy|hematopoietic stem cell tx, chimerism, leukodystrophy
5481608|NCT01372215|Breast mass|breast mass
5481609|NCT01372215|Breast lesion|breast lesion
5481610|NCT01372202|Operable|operable
5481611|NCT01372202|Based on CHFR Methylation Status|based on chfr methylation status
5481612|NCT01372202|Diagnostic Biopsies|diagnostic biopsies
5481613|NCT01372189|molecular imaging|molecular imaging
5481614|NCT01372189|epidermal growth factor receptor|epidermal growth factor receptor
5481615|NCT01372189|colorectal neoplasia|colorectal neoplasia
5481616|NCT01372189|confocal laser endomicroscopy|confocal laser endomicroscopy
5481617|NCT01372176|Intensive care unit|intensive care unit
5481618|NCT01372176|Critical illness|critical illness
5481619|NCT01372176|Mortality|mortality
5481620|NCT01372176|Reduced quality of life|reduced quality of life
5481621|NCT01372176|Loss of lean body mass|loss of lean body mass
5481622|NCT01372176|Loss of physical function|loss of physical function
5481623|NCT01372176|Optimised nutritional support|optimised nutritional support
5481624|NCT01372176|Early initiation of nutrition|early initiation of nutrition
5481625|NCT01372176|Indirect calorimetry|indirect calorimetry
5481626|NCT01372163|Phase 1|phase 1
5481627|NCT01372163|Multiple Ascending Doses|multiple ascending doses
5481628|NCT01372163|Safety|safety
5481629|NCT01372163|Pharmacokinetics|pharmacokinetics
5481630|NCT01372163|Healthy Volunteers|healthy volunteers
5481631|NCT01372163|Type 2 Diabetic Patients|type 2 diabetic patients
5481632|NCT01372150|major depressive disorder|major depressive disorder
5481633|NCT01372150|MDD|mdd
5481634|NCT01372150|depression|depression
5481635|NCT01372137|NOX-H94|nox-h94
5481636|NCT01372137|Hepcidin|hepcidin
5481637|NCT01372137|Anemia|anemia
5481638|NCT01372137|Inflammation|inflammation
5481639|NCT01372124|Renal impairment|renal impairment
5481640|NCT01372124|NOX-E36|nox-e36
5481641|NCT01372111|Stg III or IVa Squamous Cell Carcinoma.|stg iii or iva squamous cell carcinoma.
5481642|NCT01372111|Advanced|advanced
5481643|NCT01372098|Domestic Violence|domestic violence
5481644|NCT01372098|Spouse Abuse|spouse abuse
5481645|NCT01372072|chronic respiratory hypercapnic failure|chronic respiratory hypercapnic failure
5481646|NCT01372046|technology transfer|technology transfer
5481647|NCT01372046|skill development|skill development
5481648|NCT01372046|organizational change|organizational change
5481649|NCT01372033|drug treatment|drug treatment
5481650|NCT01372033|substance abuse|substance abuse
5481651|NCT01372033|offenders|offenders
5481652|NCT01372033|high risk|high risk
5481653|NCT01372020|Varicose ulcer|varicose ulcer
5481654|NCT01372020|wound healing|wound healing
5481655|NCT01372020|electrical stimulation|electrical stimulation
5481656|NCT01372007|Rectal carcinoma|rectal carcinoma
5481657|NCT01371994|Radical Robotic Arm|radical robotic arm
5481658|NCT01371994|Vesicare|vesicare
5481659|NCT01371994|Post Prostatectomy Incontinence|post prostatectomy incontinence
5481660|NCT01371994|YM905|ym905
5481661|NCT01371968|Alfentanil|alfentanil
5481662|NCT01371968|optimal dose|optimal dose
5481663|NCT01371968|laryngeal mask airway|laryngeal mask airway
5481664|NCT01371955|diabetic nephropathy|diabetic nephropathy
5481665|NCT01371955|CYBA|cyba
5481666|NCT01371955|p22phox|p22phox
5481667|NCT01371955|RAGE|rage
5481668|NCT01371955|12LOX|12lox
5481669|NCT01371955|genetic|genetic
5481670|NCT01371955|Type 1 Diabetes Mellitus with Diabetic Dermatitis|type 1 diabetes mellitus with diabetic dermatitis
5481671|NCT01371955|caucasian|caucasian
5481672|NCT01371955|more than twenty years of diabetes duration|more than twenty years of diabetes duration
5481673|NCT01371955|older than 18 years|older than 18 years
5481674|NCT01371955|no nephropathy other than diabetic nephropathy|no nephropathy other than diabetic nephropathy
5481675|NCT01371942|Colorectal cancer(CRC)|colorectal cancer(crc)
5481676|NCT01371916|tuberculous meningitis|tuberculous meningitis
5481677|NCT01371916|early secretory antigenic target 6|early secretory antigenic target 6
5481678|NCT01371916|diagnosis|diagnosis
5481679|NCT01371903|morphine|morphine
5481680|NCT01371903|fentanyl|fentanyl
5481681|NCT01371903|dilaudid|dilaudid
5481682|NCT01371903|opioid|opioid
5481683|NCT01371903|capnography|capnography
5481684|NCT01371890|hemodialysis|hemodialysis
5481685|NCT01371890|end-stage renal disease|end-stage renal disease
5481686|NCT01371890|hypertension|hypertension
5481687|NCT01371877|urticaria|urticaria
5481688|NCT01371877|angioedema|angioedema
5481689|NCT01371877|hive|hive
5481690|NCT01371877|swelling|swelling
5481691|NCT01371864|Congenital cardiac disease|congenital cardiac disease
5481692|NCT01371864|Teamwork|teamwork
5481693|NCT01371864|Communication|communication
5481694|NCT01371864|Peri-operative|peri-operative
5481695|NCT01371838|Community-Acquired Bacterial Pneumonia|community-acquired bacterial pneumonia
5481696|NCT01371825|LIPA|lipa
5481697|NCT01371825|Wolman Disease|wolman disease
5481698|NCT01371825|Wolman Phenotype|wolman phenotype
5481699|NCT01371825|Acid Lipase Deficiency|acid lipase deficiency
5481700|NCT01371825|Acid Cholesteryl Hydrolase|acid cholesteryl hydrolase
5481701|NCT01371825|Acid Lipase Disease Deficiency, type 2|acid lipase disease deficiency, type 2
5481702|NCT01371825|Cholesteryl Ester Storage Disease (CESD)|cholesteryl ester storage disease (cesd)
5481703|NCT01371825|Cholesteryl Ester Hydrolase Deficiency|cholesteryl ester hydrolase deficiency
5481704|NCT01371825|Early Onset Lysosomal Acid Lipase Deficiency (Wolman Disease)|early onset lysosomal acid lipase deficiency (wolman disease)
5481705|NCT01371825|LAL Deficiency|lal deficiency
5481706|NCT01371825|Late Onset Lysosomal Acid Lipase Deficiency (CESD)|late onset lysosomal acid lipase deficiency (cesd)
5481707|NCT01371825|Wolman Disease (early onset LAL Deficiency)|wolman disease (early onset lal deficiency)
5481708|NCT01371825|Related Disorders:|related disorders:
5481709|NCT01371825|Non-alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5481710|NCT01371825|Non-alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5481711|NCT01371825|Alcoholic Liver Disease|alcoholic liver disease
5481712|NCT01371825|Cryptogenic Cirrhosis|cryptogenic cirrhosis
5464004|NCT01444781|Diphtheria|diphtheria
5481713|NCT01371825|Niemann-Pick Disease (NPD) Type C|niemann-pick disease (npd) type c
5481714|NCT01371825|Chanarin Dorfman Syndrome|chanarin dorfman syndrome
5481715|NCT01371799|Schizophrenia|schizophrenia
5481716|NCT01371786|Ciclesonide|ciclesonide
5481717|NCT01371786|Allergic Rhinitis|allergic rhinitis
5481718|NCT01371760|Multiple sclerosis|multiple sclerosis
5481719|NCT01371760|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5481720|NCT01371760|Percutaneous Transluminal Angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
5481721|NCT01371760|Internal jugular vein|internal jugular vein
5481722|NCT01371760|Azygous vein|azygous vein
5481723|NCT01371747|Hyperkalemia|hyperkalemia
5481724|NCT01371747|Chronic Kidney Disease|chronic kidney disease
5481725|NCT01371747|Treatment of Hyperkalemia|treatment of hyperkalemia
5481726|NCT01371747|Hypertension|hypertension
5481727|NCT01371747|Diabetic Nephropathy|diabetic nephropathy
5481728|NCT01371734|Major Depressive Disorder|major depressive disorder
5481730|NCT01371734|Depression|depression
5481731|NCT01371721|Major Depressive Disorder|major depressive disorder
5481732|NCT01371721|MDD|mdd
5481733|NCT01371721|Depression|depression
5481734|NCT01371708|Major Depressive Disorder|major depressive disorder
5481735|NCT01371708|MDD|mdd
5481736|NCT01371708|Depression|depression
5481737|NCT01371695|IGF-II levels|igf-ii levels
5481738|NCT01371669|Pulmonary arterial hypertension|pulmonary arterial hypertension
5481739|NCT01371669|Chronic post embolic disease|chronic post embolic disease
5481740|NCT01371669|Sleep hypoxemia|sleep hypoxemia
5481741|NCT01371669|polysomnography|polysomnography
5481742|NCT01371669|sleep apnea|sleep apnea
5481743|NCT01371669|periodic respiration|periodic respiration
5481744|NCT01371617|IPI-926|ipi-926
5481745|NCT01371617|926|926
5481746|NCT01371617|Myelofibrosis|myelofibrosis
5481747|NCT01371617|Hedgehog|hedgehog
5481748|NCT01371617|Infinity Pharmaceuticals|infinity pharmaceuticals
5481749|NCT01371617|Post Essential thrombocythemia|post essential thrombocythemia
5481750|NCT01371617|Post Polycythemia vera|post polycythemia vera
5481751|NCT01371604|Hepatitis C|hepatitis c
5481752|NCT01371604|HCV|hcv
5481753|NCT01371604|treatment-naive|treatment-naive
5481754|NCT01371591|Bleeding|bleeding
5481755|NCT01371591|gastrointestinal|gastrointestinal
5481756|NCT01371591|hemorrhage|hemorrhage
5481757|NCT01371591|ulcer|ulcer
5481758|NCT01371591|varix|varix
5481759|NCT01371591|varices|varices
5481760|NCT01371591|ulcers|ulcers
5481761|NCT01371591|GI|gi
5481762|NCT01371591|stomach|stomach
5481763|NCT01371591|esophagus|esophagus
5481764|NCT01371591|duodenum|duodenum
5481765|NCT01371591|melena|melena
5481766|NCT01371591|hematemesis|hematemesis
5481767|NCT01371591|coffee-ground|coffee-ground
5481768|NCT01371578|Hepatitis C|hepatitis c
5481770|NCT01371578|Rapid Virologic Response|rapid virologic response
5481771|NCT01371578|Sustained Virologic Response|sustained virologic response
5481772|NCT01371578|Direct Acting Antiviral|direct acting antiviral
5481773|NCT01371578|Combination Therapy HCV RNA|combination therapy hcv rna
5481774|NCT01371578|Polymerase inhibitor|polymerase inhibitor
5481775|NCT01371578|Protease inhibitor|protease inhibitor
5481776|NCT01371578|Treatment naïve|treatment naïve
5481777|NCT01371578|GS-5885|gs-5885
5481778|NCT01371578|GS-9190|gs-9190
5481779|NCT01371578|Tegobuvir|tegobuvir
5481780|NCT01371578|GS-9451|gs-9451
5481781|NCT01371565|Cushing's Disease|cushing's disease
5481782|NCT01371565|Cushing's Syndrome|cushing's syndrome
5481783|NCT01371565|Cushings|cushings
5481784|NCT01371565|Pituitary|pituitary
5481785|NCT01371565|Ectopic ACTH secretion|ectopic acth secretion
5481786|NCT01371539|Myopia|myopia
5481787|NCT01371539|Presbyopia|presbyopia
5481788|NCT01371513|Serum prostate specific antigen|serum prostate specific antigen
5481789|NCT01371422|Paravertebral nerve blockade|paravertebral nerve blockade
5481790|NCT01371422|Percutaneous nephrolithotomy/nephrolithotripsy|percutaneous nephrolithotomy/nephrolithotripsy
5481791|NCT01371422|opioids|opioids
5481792|NCT01371422|pain|pain
5481793|NCT01371409|Stroke|stroke
5481795|NCT01371409|Paired Pulse|paired pulse
5481796|NCT01371409|EEG|eeg
5481797|NCT01371409|Motor Learning|motor learning
5481798|NCT01371396|Metabolic syndrome|metabolic syndrome
5481799|NCT01371396|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5481800|NCT01371396|Obesity Metabolism|obesity metabolism
5481801|NCT01371396|Stable isotopes|stable isotopes
5481802|NCT01371396|Dietary weight loss|dietary weight loss
5481803|NCT01371370|low intensity resistance exercise training|low intensity resistance exercise training
5481804|NCT01371370|hypocaloric diet|hypocaloric diet
5481805|NCT01371370|prehypertension|prehypertension
5481806|NCT01371370|hypertension|hypertension
5481807|NCT01371370|obesity|obesity
5481808|NCT01371370|arterial function|arterial function
5481809|NCT01371370|arterial stiffness|arterial stiffness
5481810|NCT01371370|pulse wave velocity|pulse wave velocity
5481811|NCT01371370|autonomic function|autonomic function
5481812|NCT01371370|endothelial function|endothelial function
5481813|NCT01371370|adipocytokines|adipocytokines
5481814|NCT01371357|Remethylation|remethylation
5481815|NCT01371357|Human Subjects|human subjects
5481816|NCT01371357|Clinical Trial|clinical trial
5481817|NCT01371357|B-vitamin|b-vitamin
5481818|NCT01371357|Creatine|creatine
5481819|NCT01371344|Liver Transplantation|liver transplantation
5481820|NCT01371344|Kidney Transplantation|kidney transplantation
5481821|NCT01371344|Heart Transplantation|heart transplantation
5481822|NCT01371344|Pharmacokinetics|pharmacokinetics
5481823|NCT01371331|Kidney Transplantation|kidney transplantation
5481824|NCT01371331|Pharmacokinetics|pharmacokinetics
5481825|NCT01371331|Heart Transplantation|heart transplantation
5481826|NCT01371331|Liver Transplantation|liver transplantation
5481827|NCT01371318|diabetic foot ulcer|diabetic foot ulcer
5481828|NCT01371318|amputation|amputation
5481829|NCT01371318|wounds|wounds
5481830|NCT01371318|diabetic foot|diabetic foot
5481831|NCT01371318|diabetes complications|diabetes complications
5481832|NCT01371292|Physical activity|physical activity
5481833|NCT01371292|Transformational leadership|transformational leadership
5481834|NCT01371292|Physical education|physical education
5481835|NCT01371266|Glucose intolerance|glucose intolerance
5481836|NCT01371266|Insulin resistance|insulin resistance
5481837|NCT01371266|Insulin|insulin
5481838|NCT01371266|metabolic syndrome|metabolic syndrome
5481839|NCT01371266|honey|honey
5481840|NCT01371266|Inflammation|inflammation
5481841|NCT01371266|oxidative stress|oxidative stress
5481842|NCT01371253|Nintendo wii|nintendo wii
5481843|NCT01371253|postural balance|postural balance
5481844|NCT01371253|muscle strength|muscle strength
5481845|NCT01371253|elderly|elderly
5481846|NCT01371240|pancreas cancer|pancreas cancer
5481847|NCT01371240|MRI|mri
5481848|NCT01371240|CT scan|ct scan
5481849|NCT01371227|Multiple myeloma|multiple myeloma
5481850|NCT01371227|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5481851|NCT01371227|JNS002|jns002
5481852|NCT01371227|Bortezomib|bortezomib
5481853|NCT01371214|exercise|exercise
5481854|NCT01371214|exercise movement techniques|exercise movement techniques
5481855|NCT01371214|activities of daily living|activities of daily living
5481856|NCT01371175|HIV|hiv
5481857|NCT01371123|serum aluminum|serum aluminum
5481858|NCT01371123|parenteral nutrition|parenteral nutrition
5481859|NCT01371123|children|children
5481860|NCT01371110|OCD|ocd
5481861|NCT01371110|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5481862|NCT01371110|ketamine|ketamine
5481863|NCT01371110|treatment|treatment
5481864|NCT01371097|Barthel Index|barthel index
5481865|NCT01371097|elderly hospitalised patients|elderly hospitalised patients
5481866|NCT01371097|progressive resistance training|progressive resistance training
5481867|NCT01371071|Clinically isolated syndrome (CIS)|clinically isolated syndrome (cis)
5481868|NCT01371071|Multiple sclerosis (MS)|multiple sclerosis (ms)
5481869|NCT01371071|Immunomodulatory therapy|immunomodulatory therapy
5481870|NCT01371071|Prognostic markers|prognostic markers
5481871|NCT01371071|MRI|mri
5481872|NCT01371071|OCT|oct
5481873|NCT01371058|high on-treatment platelet reactivity|high on-treatment platelet reactivity
5481874|NCT01371058|percutaneous coronary intervention|percutaneous coronary intervention
5481875|NCT01371058|stent thrombosis|stent thrombosis
5481876|NCT01371045|Acromegaly|acromegaly
5481877|NCT01371045|Growth Hormone|growth hormone
5481878|NCT01371045|Carcinoid Syndrome|carcinoid syndrome
5481879|NCT01371045|Somatostatin|somatostatin
5481880|NCT01371019|Preterm Birth, Proteomics|preterm birth, proteomics
5481881|NCT01370993|Hypoxemia|hypoxemia
5481882|NCT01370993|Model|model
5481883|NCT01370993|Bronchoscopes|bronchoscopes
5481884|NCT01370993|Monitored anesthesia care|monitored anesthesia care
5481885|NCT01370980|Medication Adherence|medication adherence
5481886|NCT01370980|Patient Compliance|patient compliance
5481887|NCT01370980|Patient Acceptance of Health Care|patient acceptance of health care
5481888|NCT01370980|Administration, Oral|administration, oral
5481889|NCT01370980|Cancer|cancer
5481890|NCT01370980|Letrozol|letrozol
5481891|NCT01370980|Exemestan|exemestan
5481892|NCT01370980|Imatinib|imatinib
5481893|NCT01370980|Sunitinib|sunitinib
5481894|NCT01370980|Nilotinib|nilotinib
5481895|NCT01370980|Everolimus|everolimus
5481896|NCT01370980|Deferasirox|deferasirox
5481897|NCT01370967|infant|infant
5481898|NCT01370967|term birth|term birth
5481899|NCT01370967|human milk|human milk
5481900|NCT01370967|infant formula|infant formula
5481901|NCT01370967|breast feeding|breast feeding
5481902|NCT01370967|bottle feeding|bottle feeding
5481903|NCT01370967|gastrointestinal tract|gastrointestinal tract
5481904|NCT01370967|quality of life|quality of life
5481905|NCT01370967|infant development|infant development
5481906|NCT01370954|CerefolinNAC|cerefolinnac
5481907|NCT01370954|early memory loss|early memory loss
5481908|NCT01370954|pre-alzheimer's disease|pre-alzheimer's disease
5481909|NCT01370954|cognitive function|cognitive function
5481910|NCT01370954|folic acid|folic acid
5481911|NCT01370954|folate|folate
5481912|NCT01370954|L-methylfolate|l-methylfolate
5481913|NCT01370954|vitamin B12|vitamin b12
5481914|NCT01370954|methylcobalamin|methylcobalamin
5481915|NCT01370954|N-acetylcysteine|n-acetylcysteine
5481923|NCT01370941|Intestinal Absorption of Calcium|intestinal absorption of calcium
5481925|NCT01370928|Pain|pain
5481926|NCT01370928|Discomfort|discomfort
5481927|NCT01370928|Screening|screening
5481928|NCT01370928|Colorectal cancer|colorectal cancer
5482055|NCT01370278|Baking soda|baking soda
5481929|NCT01370928|Colorectal cancer screening, diagnostics of adenomas|colorectal cancer screening, diagnostics of adenomas
5481930|NCT01370915|postoperative pain, nasal septum surgery, pregabalin|postoperative pain, nasal septum surgery, pregabalin
5481931|NCT01370876|Oxaliplatin|oxaliplatin
5481932|NCT01370876|Head and Neck cancer|head and neck cancer
5481934|NCT01370863|Gastroesophageal reflux disease|gastroesophageal reflux disease
5481935|NCT01370863|SPD557|spd557
5481936|NCT01370863|Proton pump inhibitors|proton pump inhibitors
5481937|NCT01370850|Retina pathology|retina pathology
5481938|NCT01370824|Diagnosis|diagnosis
5481939|NCT01370824|Clinical|clinical
5481940|NCT01370824|Punch biopsy|punch biopsy
5481941|NCT01370824|Surgical excision|surgical excision
5481942|NCT01370824|Histology|histology
5481943|NCT01370824|Histopathology|histopathology
5481944|NCT01370824|Observed agreement|observed agreement
5481945|NCT01370824|Diagnostic value|diagnostic value
5481946|NCT01370824|Accuracy|accuracy
5481947|NCT01370824|Interobserver variability|interobserver variability
5481948|NCT01370824|Intraobserver variability|intraobserver variability
5481949|NCT01370811|oxybutynin|oxybutynin
5481950|NCT01370811|clonidine|clonidine
5481951|NCT01370811|OC Oral Solution|oc oral solution
5481952|NCT01370811|sialorrhoea|sialorrhoea
5481953|NCT01370811|Parkinson's disease|parkinson's disease
5481954|NCT01370798|Severe hypospadias|severe hypospadias
5481955|NCT01370798|local oestrogen|local oestrogen
5481956|NCT01370798|promestriene|promestriene
5481957|NCT01370798|Onlay-tube-onlay urethroplasty|onlay-tube-onlay urethroplasty
5481958|NCT01370798|post-operative complications|post-operative complications
5481959|NCT01370798|fistula dehiscence|fistula dehiscence
5481960|NCT01370772|B CLL|b cll
5481961|NCT01370772|Fist line treatment|fist line treatment
5481962|NCT01370759|bowel prep|bowel prep
5481963|NCT01370759|PillCam|pillcam
5481964|NCT01370733|TMS,|tms,
5481965|NCT01370733|MDD,|mdd,
5481966|NCT01370733|Depression,|depression,
5481967|NCT01370733|sTMS,|stms,
5481968|NCT01370733|NEST,|nest,
5481969|NCT01370733|NeoSync,|neosync,
5481970|NCT01370733|EEG,|eeg,
5481971|NCT01370733|synchronous,|synchronous,
5481972|NCT01370733|non-invasive neuromodulation,|non-invasive neuromodulation,
5481973|NCT01370733|transcranial magnetic stimulation,|transcranial magnetic stimulation,
5481974|NCT01370733|antidepressant,|antidepressant,
5481975|NCT01370720|IBS|ibs
5481976|NCT01370720|mast cell activation|mast cell activation
5481977|NCT01370720|low grade inflammation|low grade inflammation
5481978|NCT01370720|visceral hyperalgesia|visceral hyperalgesia
5481979|NCT01370668|functional remediation|functional remediation
5481980|NCT01370668|psychoeducation|psychoeducation
5481981|NCT01370668|neurocognition|neurocognition
5481982|NCT01370629|atrial fibrillation|atrial fibrillation
5481983|NCT01370629|cardioversion|cardioversion
5481984|NCT01370616|Infection|infection
5481985|NCT01370616|Diabetes complications|diabetes complications
5481986|NCT01370616|Diabetes wound infection|diabetes wound infection
5481987|NCT01370616|Soft tissue infection|soft tissue infection
5481988|NCT01370616|Osteomyelitis|osteomyelitis
5481989|NCT01370616|Diabetes mellitus|diabetes mellitus
5481990|NCT01370577|Predictors for asthma control|predictors for asthma control
5481991|NCT01370577|Asthma Exacerbation rate|asthma exacerbation rate
5481992|NCT01370577|Mean frequency of PFT|mean frequency of pft
5481993|NCT01370577|sputum assessments|sputum assessments
5481994|NCT01370577|refill adherence(%)|refill adherence(%)
5481995|NCT01370577|prescription persistence|prescription persistence
5481997|NCT01370564|Cardiac filling pressure|cardiac filling pressure
5481998|NCT01370538|Heartburn|heartburn
5481999|NCT01370525|Heartburn|heartburn
5482000|NCT01370486|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5482001|NCT01370486|Epileptic encephalopathy|epileptic encephalopathy
5482002|NCT01370486|Melatonin|melatonin
5482003|NCT01370486|Tonic seizures|tonic seizures
5482004|NCT01370486|Interictal discharges|interictal discharges
5482005|NCT01370486|Quality of sleep|quality of sleep
5482006|NCT01370473|Hyponatremia|hyponatremia
5482007|NCT01370460|Tranexamic Acid|tranexamic acid
5482008|NCT01370460|Blood transfusion|blood transfusion
5482011|NCT01370447|MELAS|melas
5482012|NCT01370447|Kearns-Sayre|kearns-sayre
5482013|NCT01370447|Alper's|alper's
5482014|NCT01370447|Inherited mitochondrial disease|inherited mitochondrial disease
5482015|NCT01370447|Friedreich's ataxia|friedreich's ataxia
5482016|NCT01370447|POLG1 deficiency|polg1 deficiency
5482017|NCT01370434|MM|mm
5482018|NCT01370408|Autologous stem cell transplant|autologous stem cell transplant
5482019|NCT01370408|BEAM|beam
5482020|NCT01370408|Oral busulfan|oral busulfan
5482021|NCT01370408|Cyclophosphamide|cyclophosphamide
5482022|NCT01370408|Etoposide|etoposide
5482023|NCT01370408|Carboplatin|carboplatin
5482024|NCT01370408|melphalan|melphalan
5482025|NCT01370395|geriatrics|geriatrics
5482026|NCT01370395|troponin|troponin
5482027|NCT01370395|electrocardiography|electrocardiography
5482028|NCT01370395|diagnosis|diagnosis
5482029|NCT01370395|myocardial infarction|myocardial infarction
5482030|NCT01370382|geriatrics|geriatrics
5482031|NCT01370382|troponin|troponin
5482032|NCT01370382|electrocardiography|electrocardiography
5482033|NCT01370382|diagnosis|diagnosis
5482034|NCT01370382|myocardial infarction|myocardial infarction
5482035|NCT01370356|smoking reduction|smoking reduction
5482036|NCT01370356|smoking cessation|smoking cessation
5482037|NCT01370330|Neuroblastoma|neuroblastoma
5482038|NCT01370330|MIBG|mibg
5482039|NCT01370330|131I-MIBG|131i-mibg
5482040|NCT01370330|Resistant|resistant
5482041|NCT01370330|Relapsed|relapsed
5482042|NCT01370330|Treatment|treatment
5482043|NCT01370330|University of California, San Francisco|university of california, san francisco
5482044|NCT01370330|Pediatric|pediatric
5482045|NCT01370330|Oncology|oncology
5482046|NCT01370304|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5482047|NCT01370304|Depression|depression
5482048|NCT01370304|Venlafaxine|venlafaxine
5482049|NCT01370304|fMRI|fmri
5482050|NCT01370291|rTMS|rtms
5482051|NCT01370291|Risperidone|risperidone
5482052|NCT01370278|Central airway obstruction|central airway obstruction
5482053|NCT01370278|lumen obstruction|lumen obstruction
5482054|NCT01370278|Sodium bicarbonate|sodium bicarbonate
5482056|NCT01370278|Normal saline|normal saline
5482057|NCT01370278|Salt water|salt water
5482058|NCT01370278|Airway stents|airway stents
5482059|NCT01370278|Bronchoscopy|bronchoscopy
5482060|NCT01370278|mucus obstruction|mucus obstruction
5482061|NCT01370265|Regadenoson (Lexiscan)|regadenoson (lexiscan)
5482062|NCT01370265|PET N-13 ammonia imaging|pet n-13 ammonia imaging
5482063|NCT01370265|Myocardial Blood Flow (MBF)|myocardial blood flow (mbf)
5482064|NCT01370265|Regadenoson Stress|regadenoson stress
5482065|NCT01370252|ankle arthrodesis|ankle arthrodesis
5482066|NCT01370252|pain|pain
5482067|NCT01370252|arthroscopic technique|arthroscopic technique
5482068|NCT01370252|ankle osteoarthritis|ankle osteoarthritis
5482069|NCT01370239|monoclonal antibody|monoclonal antibody
5482070|NCT01370239|Lewis|lewis
5482071|NCT01370239|breast cancer|breast cancer
5482072|NCT01370213|non-myeloablative haploidentical transplant|non-myeloablative haploidentical transplant
5482073|NCT01370213|hematopoietic cell transplant|hematopoietic cell transplant
5482074|NCT01370213|natural killer cells|natural killer cells
5482075|NCT01370213|adoptive cellular therapy|adoptive cellular therapy
5482076|NCT01370200|citrate|citrate
5482077|NCT01370200|anticoagulation|anticoagulation
5482078|NCT01370200|plasma exchange|plasma exchange
5482079|NCT01370200|efficacy|efficacy
5482080|NCT01370187|Bronchiolitis|bronchiolitis
5482081|NCT01370187|Postbronchiolitis wheezing|postbronchiolitis wheezing
5482082|NCT01370187|Montelukast|montelukast
5482083|NCT01370174|Falls|falls
5482084|NCT01370174|Balance|balance
5482085|NCT01370174|Protective Stepping|protective stepping
5482086|NCT01370174|Lateral Balance|lateral balance
5482087|NCT01370174|Elderly|elderly
5482088|NCT01370161|transjugular intrahepatic portosystemic shunt|transjugular intrahepatic portosystemic shunt
5482089|NCT01370161|TIPS|tips
5482090|NCT01370161|variceal bleeding|variceal bleeding
5482091|NCT01370161|liver cirrhosis|liver cirrhosis
5482092|NCT01370161|hepatitis B|hepatitis b
5482093|NCT01370148|Pharmacokinetics|pharmacokinetics
5482094|NCT01370148|Protein Binding|protein binding
5482095|NCT01370148|Conivaptan|conivaptan
5482096|NCT01370148|Vaprisol|vaprisol
5482097|NCT01370148|Liver Disease|liver disease
5482098|NCT01370148|YM087|ym087
5482099|NCT01370135|neovascular glaucoma|neovascular glaucoma
5482100|NCT01370135|rubeosis|rubeosis
5482101|NCT01370135|anterior chamber|anterior chamber
5482102|NCT01370135|intraocular|intraocular
5482103|NCT01370135|intravitreal injections|intravitreal injections
5482104|NCT01370135|Lucentis|lucentis
5482105|NCT01370135|Ranibizumab|ranibizumab
5482106|NCT01370135|short ans longterm effects|short ans longterm effects
5482107|NCT01370135|best corrected visual acuity|best corrected visual acuity
5482108|NCT01370135|gonioscopy|gonioscopy
5482109|NCT01370135|BCVA|bcva
5482110|NCT01370135|quality of life|quality of life
5482111|NCT01370122|Women over the age of 20|women over the age of 20
5482113|NCT01370083|Viscosity|viscosity
5482114|NCT01370083|Tongue|tongue
5482115|NCT01370083|Pressure|pressure
5482116|NCT01370057|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5482117|NCT01370057|Scoliosis|scoliosis
5482118|NCT01370057|AIS|ais
5482119|NCT01370057|Brace|brace
5482120|NCT01370057|TLSO|tlso
5482121|NCT01370044|Febrile Seizure|febrile seizure
5482122|NCT01370044|Carbon Dioxide|carbon dioxide
5482123|NCT01370044|Carbogen|carbogen
5482124|NCT01370044|Respiratory Alkalosis|respiratory alkalosis
5482125|NCT01370031|Asthma|asthma
5482126|NCT01370031|PK|pk
5482127|NCT01370031|Adults|adults
5482128|NCT01370018|CD4 counts|cd4 counts
5482129|NCT01369992|Metastatic Cancer|metastatic cancer
5482130|NCT01369979|Lumped constant|lumped constant
5482131|NCT01369979|FDG|fdg
5482132|NCT01369979|PET|pet
5482133|NCT01369966|Smoking Cessation|smoking cessation
5482134|NCT01369966|Schizophrenic Smokers|schizophrenic smokers
5482135|NCT01369966|fMRI|fmri
5482136|NCT01369966|Neural Circuits|neural circuits
5482137|NCT01369953|Civic Ideals/Social Norms|civic ideals/social norms
5482138|NCT01369953|Genetic Counseling|genetic counseling
5482139|NCT01369953|Genetic Disorders|genetic disorders
5482140|NCT01369953|Genetic Testing|genetic testing
5482141|NCT01369953|Whole Genome Sequencing|whole genome sequencing
5482142|NCT01369940|Growth Discordancy|growth discordancy
5482143|NCT01369940|Fetal Growth|fetal growth
5482144|NCT01369940|Twin Growth|twin growth
5482145|NCT01369927|Shigellosis|shigellosis
5482146|NCT01369927|Safety and Immunogenicity|safety and immunogenicity
5482147|NCT01369927|Conjugate Vaccine|conjugate vaccine
5482148|NCT01369914|Graft-Versus-Host Disease|graft-versus-host disease
5482149|NCT01369914|Natural History Study|natural history study
5482150|NCT01369914|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5482151|NCT01369914|GVHD|gvhd
5482152|NCT01369901|Exercise|exercise
5482153|NCT01369901|Spinal Bulbar Muscular Atrophy|spinal bulbar muscular atrophy
5482154|NCT01369901|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
5482155|NCT01369901|SBMA|sbma
5482156|NCT01369901|Motor Neuron Disease|motor neuron disease
5482157|NCT01369888|Immunotherapy|immunotherapy
5482158|NCT01369888|Cell Therapy|cell therapy
5482159|NCT01369888|IL-15 Cytokine|il-15 cytokine
5482160|NCT01369888|Melanoma|melanoma
5482161|NCT01369888|Metastatic Melanoma|metastatic melanoma
5482162|NCT01369888|Skin Cancer|skin cancer
5482163|NCT01369875|Immunotherapy|immunotherapy
5482164|NCT01369875|Cell Therapy|cell therapy
5482165|NCT01369875|Metastatic Cancer|metastatic cancer
5482166|NCT01369875|Melanoma|melanoma
5482167|NCT01369875|Metastatic Melanoma|metastatic melanoma
5482168|NCT01369875|Skin Cancer|skin cancer
5482169|NCT01369862|live attenuated flu vaccines|live attenuated flu vaccines
5482170|NCT01369862|influenza A (H1N1)|influenza a (h1n1)
5482171|NCT01369862|intranasal application|intranasal application
5482172|NCT01369862|replication-deficient influenza virus|replication-deficient influenza virus
5482173|NCT01369836|Tafamidis|tafamidis
5482174|NCT01369836|Pharmacokinetics|pharmacokinetics
5482175|NCT01369836|TTR stabilization|ttr stabilization
5482176|NCT01369823|HbA1c|hba1c
5482177|NCT01369823|Paradigm 522/722 Infusion Pump|paradigm 522/722 infusion pump
5482178|NCT01369823|Transmitter (MMT-7703WW)|transmitter (mmt-7703ww)
5482179|NCT01369823|Sensor MMT-7002 (i.e. Glucose Sensor)|sensor mmt-7002 (i.e. glucose sensor)
5482180|NCT01369823|Levels of HbA1c at enrollment higher than 7|levels of hba1c at enrollment higher than 7
5482181|NCT01369810|Epidemiological|epidemiological
5482182|NCT01369810|asthma|asthma
5482183|NCT01369810|COPD|copd
5482184|NCT01369810|reimbursement|reimbursement
5482185|NCT01369810|switch|switch
5482186|NCT01369810|outcomes associated with the change in reimbursement|outcomes associated with the change in reimbursement
5482187|NCT01369797|UPSAV|upsav
5482188|NCT01369797|autonomy|autonomy
5482189|NCT01369797|the elderly of 75 years and older|the elderly of 75 years and older
5482190|NCT01369784|Diffuse large B-cell Lymphoma|diffuse large b-cell lymphoma
5482191|NCT01369784|R-IPI|r-ipi
5482192|NCT01369771|Confocal microscopic findings|confocal microscopic findings
5482193|NCT01369771|Ocular Hypertension|ocular hypertension
5482194|NCT01369771|Open-Angle Glaucoma|open-angle glaucoma
5482195|NCT01369771|Preservative-free eye drops|preservative-free eye drops
5482197|NCT01369758|hysteroscope|hysteroscope
5482198|NCT01369758|myomectomy|myomectomy
5482199|NCT01369758|polypectomy|polypectomy
5482200|NCT01369758|uterine fibroids|uterine fibroids
5482201|NCT01369758|uterine polyps|uterine polyps
5482202|NCT01369745|Rheumatoid Arthritis|rheumatoid arthritis
5482203|NCT01369745|Moderate to severe|moderate to severe
5482204|NCT01369719|Thalassemia|thalassemia
5482205|NCT01369719|Iron overload|iron overload
5482206|NCT01369719|transfusion|transfusion
5482207|NCT01369719|osveral|osveral
5482208|NCT01369719|desferal|desferal
5482209|NCT01369706|electromagnetic interference|electromagnetic interference
5482210|NCT01369706|hand-held metal detector|hand-held metal detector
5482211|NCT01369706|pacemaker|pacemaker
5482212|NCT01369706|cardioverter-defibrillator|cardioverter-defibrillator
5482213|NCT01369693|smokeless tobacco|smokeless tobacco
5482214|NCT01369693|Nicotine|nicotine
5482215|NCT01369693|Cadmium|cadmium
5482216|NCT01369693|lead|lead
5482217|NCT01369693|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
5482218|NCT01369680|Ketamine|ketamine
5482219|NCT01369680|Chronic pain|chronic pain
5482220|NCT01369680|Children|children
5482221|NCT01369680|Oral pain medication|oral pain medication
5482222|NCT01369654|hysterectomy with Bilateral Salpingo Oophorectomy|hysterectomy with bilateral salpingo oophorectomy
5482223|NCT01369654|Oophorectomy|oophorectomy
5482224|NCT01369654|Gynecologic condition|gynecologic condition
5482225|NCT01369641|cisplatin|cisplatin
5482226|NCT01369641|STS|sts
5482227|NCT01369641|sodium thiosulfate|sodium thiosulfate
5482228|NCT01369641|Adults|adults
5482229|NCT01369641|dose range of 80-120mg/m2|dose range of 80-120mg/m2
5482230|NCT01369628|Open label|open label
5482231|NCT01369628|Dose Escalating|dose escalating
5482232|NCT01369628|Phase Ib|phase ib
5482233|NCT01369615|Malignant pain|malignant pain
5482234|NCT01369615|Nonmalignant pain|nonmalignant pain
5482235|NCT01369615|Pain|pain
5482236|NCT01369615|Pediatric|pediatric
5482237|NCT01369615|Opioid|opioid
5482238|NCT01369615|Moderate to severe|moderate to severe
5482239|NCT01369589|Xerostomia|xerostomia
5482240|NCT01369589|dry mouth|dry mouth
5482241|NCT01369589|Sjogren's Syndrome|sjogren's syndrome
5482242|NCT01369563|rhinitis|rhinitis
5482243|NCT01369563|ciclesonide|ciclesonide
5482244|NCT01369563|intermittent rhinitis|intermittent rhinitis
5482245|NCT01369563|persistent rhinitis|persistent rhinitis
5482246|NCT01369524|fluid responsiveness|fluid responsiveness
5482247|NCT01369524|microcirculation|microcirculation
5482248|NCT01369524|Intensive Care|intensive care
5482249|NCT01369511|Disuse Atrophy|disuse atrophy
5482250|NCT01369511|Muscle|muscle
5482251|NCT01369511|Strength|strength
5482252|NCT01369511|Arthroplasty|arthroplasty
5482253|NCT01369511|Hip|hip
5482254|NCT01369511|Joint Replacement|joint replacement
5482255|NCT01369498|Hematology|hematology
5482256|NCT01369498|Myelofibrosis|myelofibrosis
5482257|NCT01369498|Thrombocythemia Myelofibrosis|thrombocythemia myelofibrosis
5482258|NCT01369498|Bone Marrow Diseases|bone marrow diseases
5482259|NCT01369498|Hematologic Diseases|hematologic diseases
5482260|NCT01369498|Blood Diseases|blood diseases
5482261|NCT01369498|Leukemia|leukemia
5482262|NCT01369498|Blood Disorders|blood disorders
5482263|NCT01369485|Urinary Incontinence|urinary incontinence
5482264|NCT01369485|Overactive Bladder|overactive bladder
5482265|NCT01369485|Frequency|frequency
5482266|NCT01369485|Urgency|urgency
5482267|NCT01369459|Comorbid|comorbid
5482268|NCT01369459|ADHD|adhd
5482269|NCT01369459|SUD|sud
5482270|NCT01369459|ASU|asu
5482271|NCT01369446|In vitro fertilization|in vitro fertilization
5482272|NCT01369446|Assisted reproduction|assisted reproduction
5482273|NCT01369446|Noninvasive imaging of embryos|noninvasive imaging of embryos
5482274|NCT01369446|Time lapse imaging of embryos|time lapse imaging of embryos
5482275|NCT01369446|Traditional morphological grading of embryos|traditional morphological grading of embryos
5482276|NCT01369446|Prediction of blastocysts|prediction of blastocysts
5482277|NCT01369433|tivozanib|tivozanib
5482278|NCT01369420|locoregional cancer therapy|locoregional cancer therapy
5482279|NCT01369420|pancreatic cancer|pancreatic cancer
5482280|NCT01369420|unresectable pancreatic cancer|unresectable pancreatic cancer
5482281|NCT01369420|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5482282|NCT01369420|locally advanced, unresectable pancreatic cancer|locally advanced, unresectable pancreatic cancer
5482283|NCT01369420|pancreatic cancer tumor ablation|pancreatic cancer tumor ablation
5482284|NCT01369420|NanoKnife tumor ablation for pancreatic cancer|nanoknife tumor ablation for pancreatic cancer
5482285|NCT01369420|NanoKnife LEDC system tumor ablation|nanoknife ledc system tumor ablation
5482286|NCT01369420|Non thermal ablation|non thermal ablation
5482287|NCT01369420|Irreversible electroporation for pancreatic cancer treatment|irreversible electroporation for pancreatic cancer treatment
5482288|NCT01369420|IRE for unresectable pancreatic cancer|ire for unresectable pancreatic cancer
5482289|NCT01369407|Heart failure|heart failure
5482291|NCT01369407|Heart Diseases|heart diseases
5482292|NCT01369407|Cardiovascular Diseases|cardiovascular diseases
5485318|NCT01356680|PET|pet
5482306|NCT01369381|Laryngoscope|laryngoscope
5482307|NCT01369381|Biomechanics|biomechanics
5482308|NCT01369368|Acute myeloid leukemia|acute myeloid leukemia
5482309|NCT01369368|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5482310|NCT01369368|Relapse|relapse
5482311|NCT01369368|Disease stabilization, survival|disease stabilization, survival
5482312|NCT01369355|Ustekinumab|ustekinumab
5482313|NCT01369355|Stelara, Moderately to severely active Crohn's Disease|stelara, moderately to severely active crohn's disease
5482314|NCT01369355|IBD, Crohn's|ibd, crohn's
5482315|NCT01369355|UNITI|uniti
5482316|NCT01369355|colitis|colitis
5482317|NCT01369355|IL-12|il-12
5482318|NCT01369355|IL-23|il-23
5482319|NCT01369342|ustekinumab|ustekinumab
5482320|NCT01369342|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5482322|NCT01369342|IBD|ibd
5482323|NCT01369342|colitis|colitis
5482324|NCT01369342|crohn|crohn
5482325|NCT01369342|UNITI|uniti
5482326|NCT01369342|Crohn's|crohn's
5482327|NCT01369329|ustekinumab|ustekinumab
5482328|NCT01369329|moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5482329|NCT01369329|tumor necrosis factor, Stelara|tumor necrosis factor, stelara
5482330|NCT01369329|Crohn|crohn
5482331|NCT01369329|Crohn's|crohn's
5482332|NCT01369329|IBD|ibd
5482333|NCT01369329|UNITI|uniti
5482334|NCT01369303|HIV|hiv
5482335|NCT01369290|Depression|depression
5482336|NCT01369290|Antidepressant Medication|antidepressant medication
5482337|NCT01369290|CBT|cbt
5482338|NCT01369277|PF-04991532|pf-04991532
5482339|NCT01369277|safety and tolerability|safety and tolerability
5482340|NCT01369277|PK|pk
5482341|NCT01369277|Japanese and Western population|japanese and western population
5482342|NCT01369264|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5482343|NCT01369264|Electroencephalography (EEG)|electroencephalography (eeg)
5482344|NCT01369264|Magnetic Resonance Imaging|magnetic resonance imaging
5482345|NCT01369264|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5482346|NCT01369238|bee venom acupuncture|bee venom acupuncture
5482347|NCT01369238|east west collaborative medicine|east west collaborative medicine
5482348|NCT01369238|whiplash associated disorder|whiplash associated disorder
5482349|NCT01369225|Randomized|randomized
5482350|NCT01369225|Safety Study|safety study
5482351|NCT01369225|Open Label|open label
5482355|NCT01369173|Healthy|healthy
5482356|NCT01369147|SICU|sicu
5482357|NCT01369147|calories|calories
5482358|NCT01369147|TPN|tpn
5482359|NCT01369147|tube feeding|tube feeding
5482360|NCT01369147|Optimum Energy Dose in SICU|optimum energy dose in sicu
5482361|NCT01369134|self-etch adhesive|self-etch adhesive
5482362|NCT01369134|selective enamel etching|selective enamel etching
5482363|NCT01369134|Adper Easy Bond|adper easy bond
5482364|NCT01369134|Supreme Ultra|supreme ultra
5482365|NCT01369134|Molar and premolar teeth|molar and premolar teeth
5482366|NCT01369134|Adult|adult
5482367|NCT01369134|Class I and II cavities|class i and ii cavities
5482368|NCT01369121|peritumoral brain edema|peritumoral brain edema
5482369|NCT01369121|edema|edema
5482370|NCT01369121|malignant brain tumor|malignant brain tumor
5482371|NCT01369121|brain tumor|brain tumor
5482372|NCT01369121|dexamethasone|dexamethasone
5482373|NCT01369121|Decadron|decadron
5482374|NCT01369108|small Class I|small class i
5482375|NCT01369108|molar and premolar|molar and premolar
5482376|NCT01369108|low stress flowable composite|low stress flowable composite
5482377|NCT01369108|adult|adult
5482378|NCT01369108|Restoration|restoration
5482379|NCT01369108|small caries lesions|small caries lesions
5482380|NCT01369082|islet allograft function|islet allograft function
5482381|NCT01369082|c-peptide production|c-peptide production
5482382|NCT01369082|maintenance immunosuppressive medications|maintenance immunosuppressive medications
5482383|NCT01369069|stroke|stroke
5482385|NCT01369069|hyperglycemia|hyperglycemia
5482386|NCT01369056|antiretroviral therapy, highly active|antiretroviral therapy, highly active
5482387|NCT01369056|treatment adherence|treatment adherence
5482388|NCT01369043|Vitamin E|vitamin e
5482389|NCT01369043|Vitamin C|vitamin c
5482390|NCT01369043|Exercise|exercise
5482391|NCT01369043|Antioxidant|antioxidant
5482392|NCT01369030|L-methylfolate|l-methylfolate
5482393|NCT01369030|Deplin|deplin
5482394|NCT01369030|depression|depression
5482395|NCT01369030|antidepressant|antidepressant
5482396|NCT01369030|combination therapy|combination therapy
5482397|NCT01369030|augmentation|augmentation
5482398|NCT01369030|folate|folate
5482399|NCT01369030|folic acid|folic acid
5482400|NCT01369030|homocysteine|homocysteine
5482401|NCT01369030|methionine|methionine
5482402|NCT01369030|MTHFR genotype|mthfr genotype
5482403|NCT01369030|C677T mutation|c677t mutation
5482404|NCT01369030|vitamin B6|vitamin b6
5482405|NCT01369030|vitamin B12|vitamin b12
5482406|NCT01369017|healthy volunteer|healthy volunteer
5482407|NCT01369017|endotoxin|endotoxin
5482408|NCT01369004|self-weighing|self-weighing
5482409|NCT01369004|self-monitoring|self-monitoring
5482410|NCT01369004|weight loss|weight loss
5482411|NCT01369004|obesity|obesity
5482412|NCT01368991|Coronary Artery Bypass Grafts|coronary artery bypass grafts
5482413|NCT01368991|Sternal Closure|sternal closure
5482414|NCT01368991|Biologic Bone cement|biologic bone cement
5482415|NCT01368978|TIDM|tidm
5482416|NCT01368952|Obstructive Sleep Apnea|obstructive sleep apnea
5482417|NCT01368952|Prone positioning|prone positioning
5482418|NCT01368952|Positional Treatment|positional treatment
5482419|NCT01368952|Hypoxemia|hypoxemia
5482420|NCT01368939|breast imaging|breast imaging
5482422|NCT01368939|dose reduction|dose reduction
5482423|NCT01368939|Tc-99m|tc-99m
5482424|NCT01368939|imaging|imaging
5482425|NCT01368939|cardiac|cardiac
5482426|NCT01368900|Ultherapy™ Treatment|ultherapy™ treatment
5482427|NCT01368900|Ulthera, Inc.|ulthera, inc.
5482428|NCT01368900|Ultrasound treatment for skin tightening|ultrasound treatment for skin tightening
5482430|NCT01368887|scalp psoriasis|scalp psoriasis
5482431|NCT01368861|infant|infant
5482432|NCT01368861|immunizations|immunizations
5482433|NCT01368861|pain|pain
5482434|NCT01368861|pain management|pain management
5482435|NCT01368861|vaccines|vaccines
5482436|NCT01368861|analgesia|analgesia
5482437|NCT01368848|AGMT|agmt
5482439|NCT01368848|non-small cell lung cancer|non-small cell lung cancer
5482440|NCT01368848|bevacizumab|bevacizumab
5482441|NCT01368848|Avastin|avastin
5482442|NCT01368848|Cisplatin|cisplatin
5482443|NCT01368848|Docetaxel|docetaxel
5482444|NCT01368848|Taxotere|taxotere
5482445|NCT01368848|Inoperable|inoperable
5482446|NCT01368848|stages IIIB and IV|stages iiib and iv
5482447|NCT01368809|Ambulatory surgery|ambulatory surgery
5482448|NCT01368809|Pain management|pain management
5482449|NCT01368809|Perioperative outcomes|perioperative outcomes
5482450|NCT01368809|Fentanyl|fentanyl
5482451|NCT01368809|Coughing during insertion of an LMA|coughing during insertion of an lma
5482452|NCT01368809|Ambulatory surgery procedures|ambulatory surgery procedures
5482453|NCT01368796|Vaccine|vaccine
5482454|NCT01368796|Influenza vaccine|influenza vaccine
5482455|NCT01368796|Adjuvanted Influenza vaccine|adjuvanted influenza vaccine
5482456|NCT01368796|Intradermal Influenza vaccine|intradermal influenza vaccine
5482457|NCT01368796|Seniors|seniors
5482458|NCT01368796|Acceptability of vaccines|acceptability of vaccines
5482459|NCT01368796|Influenza|influenza
5482460|NCT01368757|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5482461|NCT01368757|CMML|cmml
5482462|NCT01368757|Lenalidomide|lenalidomide
5482463|NCT01368757|Revlimid|revlimid
5482464|NCT01368744|Breast Neoplasms|breast neoplasms
5482465|NCT01368744|Breast Diseases|breast diseases
5482466|NCT01368705|Infants|infants
5482467|NCT01368705|Nitrogen Balance|nitrogen balance
5482468|NCT01368705|Cardiothoracic surgery|cardiothoracic surgery
5482469|NCT01368705|Congenital heart disease|congenital heart disease
5482470|NCT01368705|Malnutrition|malnutrition
5482471|NCT01368692|subclavian vein catheterization success rate|subclavian vein catheterization success rate
5482472|NCT01368679|Aortic Aneurysm, Abdominal|aortic aneurysm, abdominal
5482473|NCT01368679|Abdominal Aortic|abdominal aortic
5482474|NCT01368666|Aortic valve replacement|aortic valve replacement
5482475|NCT01368666|Aortic stenosis|aortic stenosis
5482477|NCT01368666|Sutureless valve|sutureless valve
5482478|NCT01368666|Stented valve|stented valve
5482479|NCT01368666|Aortic Valve Disease|aortic valve disease
5482480|NCT01368653|Tobacco|tobacco
5482481|NCT01368653|Smoking|smoking
5482482|NCT01368653|Smoking Cessation|smoking cessation
5482483|NCT01368653|Tobacco Dependence|tobacco dependence
5482484|NCT01368653|Tobacco Use|tobacco use
5482485|NCT01368653|Nicotine Dependence|nicotine dependence
5482486|NCT01368627|Coronary Artery Disease|coronary artery disease
5482487|NCT01368627|Restenosis|restenosis
5482488|NCT01368627|Stent thrombosis|stent thrombosis
5482489|NCT01368627|Coronary stents|coronary stents
5482490|NCT01368627|Angioplasty|angioplasty
5482491|NCT01368627|Drug Eluting Stents(DES)|drug eluting stents(des)
5482492|NCT01368614|OHS|ohs
5482493|NCT01368601|Lung Cancer|lung cancer
5482494|NCT01368601|CPAP|cpap
5482495|NCT01368601|PPC|ppc
5482496|NCT01368601|lobectomy|lobectomy
5482497|NCT01368601|One-lung ventilation|one-lung ventilation
5482498|NCT01368588|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5482499|NCT01368588|stage I prostate cancer|stage i prostate cancer
5482500|NCT01368588|stage IIA prostate cancer|stage iia prostate cancer
5482501|NCT01368588|stage IIB prostate cancer|stage iib prostate cancer
5482502|NCT01368588|stage III prostate cancer|stage iii prostate cancer
5482503|NCT01368575|Ischemic|ischemic
5482504|NCT01368575|Mitral|mitral
5482505|NCT01368575|Valve|valve
5482506|NCT01368575|Insufficiency|insufficiency
5482507|NCT01368575|SVR|svr
5482508|NCT01368549|Metanx|metanx
5482509|NCT01368549|diabetes|diabetes
5482510|NCT01368549|neuropathy|neuropathy
5482511|NCT01368549|folic acid|folic acid
5482512|NCT01368549|folate|folate
5482513|NCT01368549|L-methylfolate|l-methylfolate
5482514|NCT01368549|vitamin B6|vitamin b6
5482515|NCT01368549|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5482516|NCT01368549|vitamin B12|vitamin b12
5482517|NCT01368549|methylcobalamin|methylcobalamin
5482518|NCT01368549|DPN|dpn
5482519|NCT01368536|High blood pressure|high blood pressure
5482520|NCT01368536|diabetes|diabetes
5482521|NCT01368523|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5482522|NCT01368523|chronic phase|chronic phase
5482523|NCT01368523|accelerated phase|accelerated phase
5482524|NCT01368523|blastic phase|blastic phase
5482525|NCT01368523|nilotinib|nilotinib
5482526|NCT01368510|obsessive-compulsive disorder (OCD)|obsessive-compulsive disorder (ocd)
5482527|NCT01368510|cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
5482528|NCT01368510|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5482529|NCT01368510|glutamate|glutamate
5482530|NCT01368510|cingulate gyrus|cingulate gyrus
5482531|NCT01368497|Hepatitis B|hepatitis b
5482534|NCT01368471|myocardial infarction|myocardial infarction
5482535|NCT01368471|stent|stent
5482536|NCT01368432|TBI|tbi
5482537|NCT01368432|Depression|depression
5482538|NCT01368432|Mood|mood
5482539|NCT01368432|Behavior|behavior
5482540|NCT01368419|Endostar|endostar
5482541|NCT01368419|Radiotherapy|radiotherapy
5482542|NCT01368419|Esophageal Cancer|esophageal cancer
5482543|NCT01368406|schizophrenia|schizophrenia
5482544|NCT01368406|weight gain|weight gain
5482545|NCT01368406|intervention|intervention
5482546|NCT01368380|Breast cancer|breast cancer
5482547|NCT01368380|Partners|partners
5482548|NCT01368380|Couples|couples
5482549|NCT01368380|Attachment|attachment
5482550|NCT01368380|Intervention|intervention
5482551|NCT01368367|Burns|burns
5482552|NCT01368354|Community Led Total Sanitation|community led total sanitation
5482553|NCT01368354|Open Defecation|open defecation
5482554|NCT01368354|Cysticercosis|cysticercosis
5482555|NCT01368354|Soil transmitted helminths|soil transmitted helminths
5482556|NCT01368354|Zambia|zambia
5482557|NCT01368341|Antibiotics|antibiotics
5482558|NCT01368341|General Practice|general practice
5482559|NCT01368341|Erythema migrans|erythema migrans
5482560|NCT01368341|Borrelia|borrelia
5482561|NCT01368341|Ticks|ticks
5482562|NCT01368328|Type 2 Diabetes|type 2 diabetes
5482563|NCT01368328|Chromium|chromium
5482564|NCT01368328|Insulin resistance|insulin resistance
5482565|NCT01368302|attention bias modification treatment|attention bias modification treatment
5482566|NCT01368302|cognitive bias modification|cognitive bias modification
5482567|NCT01368302|attention training|attention training
5482568|NCT01368302|anxiety|anxiety
5482569|NCT01368276|Melanoma|melanoma
5482570|NCT01368276|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
5482571|NCT01368276|oncolytic|oncolytic
5482572|NCT01368276|OncoVex|oncovex
5482573|NCT01368276|OncoVEX^GM-CSF|oncovex^gm-csf
5482574|NCT01368250|Aortic|aortic
5482575|NCT01368250|Stenosis|stenosis
5482577|NCT01368250|VARC|varc
5482578|NCT01368250|Transcatheter|transcatheter
5482579|NCT01368250|Minimal-invasive|minimal-invasive
5482580|NCT01368237|Computed tomography|computed tomography
5482581|NCT01368237|Myocardial perfusion|myocardial perfusion
5482582|NCT01368237|Coronary heart disease|coronary heart disease
5482583|NCT01368224|Skin sensitivity|skin sensitivity
5482584|NCT01368224|Trans-epidermal water loss|trans-epidermal water loss
5482585|NCT01368224|Clinical score|clinical score
5482586|NCT01368224|skin moisturization factors|skin moisturization factors
5482587|NCT01368224|serum immune-regulatory cytokine|serum immune-regulatory cytokine
5482588|NCT01368224|Evaluation of intestinal flora composition|evaluation of intestinal flora composition
5482589|NCT01368211|Mirasol|mirasol
5482590|NCT01368211|Thrombocytopenic|thrombocytopenic
5482591|NCT01368211|Pathogen reduction|pathogen reduction
5482592|NCT01368211|Platelets|platelets
5482593|NCT01368211|Thromboelastography|thromboelastography
5482594|NCT01368211|CCI|cci
5482595|NCT01368211|Corrected Count Increment|corrected count increment
5482596|NCT01368198|Ocular Emulsion|ocular emulsion
5482597|NCT01368198|OPTIVE™ Lubricant|optive™ lubricant
5482598|NCT01368198|Tear Film Break Up Time|tear film break up time
5482599|NCT01368185|Essential hypertension Uric acid Retrospective Hyzaar|essential hypertension uric acid retrospective hyzaar
5482600|NCT01368172|spinal cord injury|spinal cord injury
5482601|NCT01368172|physical activity|physical activity
5482602|NCT01368172|physical fitness|physical fitness
5482603|NCT01368133|acromegaly|acromegaly
5482604|NCT01368133|pituitary tumor|pituitary tumor
5482605|NCT01368107|IL-7|il-7
5482606|NCT01368107|metastatic breast cancer patients|metastatic breast cancer patients
5482607|NCT01368107|lymphopenia|lymphopenia
5482608|NCT01368094|Pancreaticoduodenectomy|pancreaticoduodenectomy
5482609|NCT01368094|Drainage|drainage
5482610|NCT01368094|Surgical site infection|surgical site infection
5482611|NCT01368068|Perimenopause|perimenopause
5482612|NCT01368068|Depression|depression
5482613|NCT01368055|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
5482614|NCT01368042|Quality of Life changes|quality of life changes
5482615|NCT01368042|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5482616|NCT01368042|Chronic Kidney Disease|chronic kidney disease
5482617|NCT01368042|Hemodialysis|hemodialysis
5482618|NCT01368042|Paricalcitol intravenous treatment|paricalcitol intravenous treatment
5482619|NCT01368029|LGG|lgg
5482620|NCT01368029|Immune response|immune response
5482621|NCT01368029|Influenza vaccine|influenza vaccine
5482622|NCT01368029|Elderly|elderly
5482623|NCT01368029|Healthy|healthy
5482624|NCT01368029|Microbiome|microbiome
5482625|NCT01368016|Smoking Cessation|smoking cessation
5482626|NCT01368016|Nicotine Pharmacodynamics|nicotine pharmacodynamics
5482627|NCT01368003|Castration resistant prostate cancer|castration resistant prostate cancer
5482628|NCT01367990|alopecia|alopecia
5482629|NCT01367990|hair loss|hair loss
5482630|NCT01367990|prevention|prevention
5482631|NCT01367990|radiotherapy|radiotherapy
5482632|NCT01367990|head & neck cancer|head & neck cancer
5482633|NCT01367990|radiodermatitis|radiodermatitis
5477109|NCT01391403|Toxoplasma|toxoplasma
5482634|NCT01367990|radiation dermatitis|radiation dermatitis
5482635|NCT01367990|radiation-induced alopecia|radiation-induced alopecia
5482636|NCT01367977|Ehlers Danlos Syndrome|ehlers danlos syndrome
5482637|NCT01367977|External Communicating Hydrocephalus|external communicating hydrocephalus
5482639|NCT01367977|Postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
5482640|NCT01367977|Chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5482641|NCT01367964|Hypsarrhythmia|hypsarrhythmia
5482642|NCT01367964|Spasms, Infantile|spasms, infantile
5482643|NCT01367964|West Syndrome|west syndrome
5482644|NCT01367951|unstable chest injury|unstable chest injury
5482645|NCT01367951|flail chest|flail chest
5482646|NCT01367951|chest wall injury|chest wall injury
5482647|NCT01367951|rib fracture|rib fracture
5482648|NCT01367938|Osteoarthritis|osteoarthritis
5482649|NCT01367938|Total Knee Replacement|total knee replacement
5482650|NCT01367938|Total Knee Arthroplasty|total knee arthroplasty
5482652|NCT01367938|Knee|knee
5482653|NCT01367925|Osteoarthritis|osteoarthritis
5482654|NCT01367925|Total Knee Replacement|total knee replacement
5482655|NCT01367925|TKA|tka
5482656|NCT01367925|Knee|knee
5482657|NCT01367925|PS|ps
5482658|NCT01367925|CS|cs
5482659|NCT01367912|Luteal phase support|luteal phase support
5482660|NCT01367912|estradiol supplementation|estradiol supplementation
5482661|NCT01367912|IVF/ICSI|ivf/icsi
5482662|NCT01367912|clinical pregnancy rate|clinical pregnancy rate
5482663|NCT01367899|Safety|safety
5482664|NCT01367899|Efficacy|efficacy
5482665|NCT01367886|Urine proteomics|urine proteomics
5482666|NCT01367886|overactive bladder|overactive bladder
5482667|NCT01367860|spine surgery|spine surgery
5482668|NCT01367860|low back pain|low back pain
5482669|NCT01367860|herniated disk|herniated disk
5482670|NCT01367847|Parenting|parenting
5482671|NCT01367847|Parent-Child Relations|parent-child relations
5482672|NCT01367847|Child Behavior|child behavior
5482673|NCT01367834|Turner Syndrome|turner syndrome
5482674|NCT01367834|growth hormone|growth hormone
5482675|NCT01367834|brain development|brain development
5482676|NCT01367821|Obstructive jaundice|obstructive jaundice
5482677|NCT01367821|ERCP|ercp
5482678|NCT01367821|Immune dysfunction|immune dysfunction
5482679|NCT01367821|Endotoxin tolerance|endotoxin tolerance
5482680|NCT01367821|Quorum sensing|quorum sensing
5482681|NCT01367808|Buprenorphine|buprenorphine
5482682|NCT01367808|Vorikonazole|vorikonazole
5482683|NCT01367808|Posakonazole|posakonazole
5482684|NCT01367808|Interactions|interactions
5482685|NCT01367795|palliation|palliation
5482686|NCT01367795|quality of life|quality of life
5482687|NCT01367795|surgery|surgery
5482688|NCT01367795|surgery; palliative|surgery; palliative
5482689|NCT01367795|lifestyle|lifestyle
5482690|NCT01367782|UPDRS|updrs
5482691|NCT01367769|Deep vein thrombosis|deep vein thrombosis
5482692|NCT01367769|superficial thrombophlebitis|superficial thrombophlebitis
5482693|NCT01367769|contrast ultrasound|contrast ultrasound
5846741|NCT00043628|CAD|cad
5482694|NCT01367743|myocardial infarction|myocardial infarction
5482695|NCT01367743|epinephrine|epinephrine
5482696|NCT01367743|norepinephrine|norepinephrine
5482697|NCT01367743|cardiac output|cardiac output
5482698|NCT01367730|osteopenia and osteoporosis|osteopenia and osteoporosis
5482699|NCT01367717|Creatine|creatine
5482700|NCT01367717|Creatinine|creatinine
5482701|NCT01367717|Serum Creatinine|serum creatinine
5482702|NCT01367717|Urine Creatinine|urine creatinine
5482703|NCT01367717|Creatine Monohydrate|creatine monohydrate
5482704|NCT01367717|Creatine Ethyl Ester|creatine ethyl ester
5482705|NCT01367717|Acute Kidney Injury|acute kidney injury
5482706|NCT01367717|Renal|renal
5482707|NCT01367717|Kidney|kidney
5482708|NCT01367704|gender-based violence|gender-based violence
5482709|NCT01367704|intimate partner violence|intimate partner violence
5482710|NCT01367704|relationship abuse|relationship abuse
5482711|NCT01367704|sexual harassment|sexual harassment
5482712|NCT01367704|sexual violence|sexual violence
5482713|NCT01367691|CRT|crt
5482714|NCT01367691|heart failure|heart failure
5482715|NCT01367691|CMR|cmr
5482716|NCT01367691|safety|safety
5482717|NCT01367639|BRCA 1/2 Carriers|brca 1/2 carriers
5482718|NCT01367639|IBSR|ibsr
5482719|NCT01367639|The Work|the work
5482720|NCT01367639|Randomized clinical trial|randomized clinical trial
5482721|NCT01367613|Advanced medical illness|advanced medical illness
5482722|NCT01367600|Advanced medical illness|advanced medical illness
5482723|NCT01367574|Opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
5482724|NCT01367444|Stargardt's Disease|stargardt's disease
5482725|NCT01367431|Xanthohumol|xanthohumol
5482726|NCT01367431|Metabolic syndrome|metabolic syndrome
5482727|NCT01367418|Analgesia: Thoracic epidural, patient controlled|analgesia: thoracic epidural, patient controlled
5482728|NCT01367418|Surgery: Radical retropubic prostatectomy|surgery: radical retropubic prostatectomy
5482729|NCT01367418|Immune system|immune system
5482730|NCT01367418|Inflammation|inflammation
5482731|NCT01367405|Surgical decompression|surgical decompression
5482732|NCT01367405|conservative treatment|conservative treatment
5482733|NCT01367405|incomplete spinal cord lesion|incomplete spinal cord lesion
5482734|NCT01367405|recovery|recovery
5482735|NCT01367379|Physician|physician
5482736|NCT01367379|duty loading|duty loading
5482737|NCT01367379|stress response|stress response
5482738|NCT01367379|Physician with different amount of duty area|physician with different amount of duty area
5482739|NCT01367366|malignant mediastinal lymphadenopathy|malignant mediastinal lymphadenopathy
5482740|NCT01367366|positron emission tomography|positron emission tomography
5482741|NCT01367366|endobronchial ultrasound|endobronchial ultrasound
5482742|NCT01367366|transbronchial needle aspiration|transbronchial needle aspiration
5482743|NCT01367327|Exercise|exercise
5482744|NCT01367288|locally advanced breast cancer|locally advanced breast cancer
5482745|NCT01367288|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5482746|NCT01367288|HER2-negative breast cancer|her2-negative breast cancer
5482747|NCT01367288|stage IIb breast cancer|stage iib breast cancer
5482748|NCT01367288|stage IIIa breast cancer|stage iiia breast cancer
5482749|NCT01367288|Zoledronic acid|zoledronic acid
5482750|NCT01367288|bisphosphonate|bisphosphonate
5482751|NCT01367288|zometa|zometa
5482752|NCT01367288|therapeutic response|therapeutic response
5482753|NCT01367288|VEGF serum|vegf serum
5482754|NCT01367288|tumors markers|tumors markers
5482755|NCT01367288|neoangiogenesis|neoangiogenesis
5482756|NCT01367288|apoptosis|apoptosis
5482757|NCT01367288|proliferation|proliferation
5482758|NCT01367288|disseminated tumors cells|disseminated tumors cells
5482759|NCT01367288|gamma-delta T cells activation|gamma-delta t cells activation
5482760|NCT01367275|colon|colon
5482761|NCT01367275|Colorectum|colorectum
5482762|NCT01367275|Colorectal Cancer|colorectal cancer
5482763|NCT01367275|Plasma FGF|plasma fgf
5482764|NCT01367275|Colorectal adenocarcinoma|colorectal adenocarcinoma
5482765|NCT01367275|Bevacizumab|bevacizumab
5482766|NCT01367275|Brivanib|brivanib
5482767|NCT01367275|BMS-582664|bms-582664
5482768|NCT01367275|Irinotecan|irinotecan
5482769|NCT01367275|CPT-11|cpt-11
5482770|NCT01367275|Camptosar|camptosar
5482771|NCT01367275|Fibroblast Growth Factor|fibroblast growth factor
5482772|NCT01367275|bFGF|bfgf
5482773|NCT01367275|tyrosine kinase receptors|tyrosine kinase receptors
5482774|NCT01367275|vascular endothelial growth factor receptors|vascular endothelial growth factor receptors
5482775|NCT01367275|VEGFR|vegfr
5482776|NCT01367275|fibroblast growth factor receptors|fibroblast growth factor receptors
5482777|NCT01367275|FGFR|fgfr
5482778|NCT01367262|Absorption|absorption
5482779|NCT01367262|Distribution|distribution
5482780|NCT01367262|Metabolism|metabolism
5482781|NCT01367262|Excretion|excretion
5482782|NCT01367249|cataract surgery|cataract surgery
5482783|NCT01367236|HIV|hiv
5482784|NCT01367223|inflammatory response|inflammatory response
5482785|NCT01367223|parenteral nutrition|parenteral nutrition
5482786|NCT01367223|glutamine|glutamine
5482787|NCT01367223|amino acid|amino acid
5482788|NCT01367223|pediatric|pediatric
5482789|NCT01367223|intensive care|intensive care
5482790|NCT01367223|systemic infection|systemic infection
5482791|NCT01367223|abdominal surgery|abdominal surgery
5482793|NCT01367223|mortality|mortality
5482794|NCT01367223|mean stay in the intensive care unit|mean stay in the intensive care unit
5482795|NCT01367223|occurrence of infections|occurrence of infections
5482796|NCT01367210|HIV|hiv
5482797|NCT01367210|AIDS|aids
5482798|NCT01367210|Highly Active AntiRetroviral Therapy|highly active antiretroviral therapy
5482799|NCT01367210|Simplification|simplification
5482800|NCT01367210|Maraviroc|maraviroc
5482801|NCT01367210|Darunavir|darunavir
5482802|NCT01367210|Treatment experienced|treatment experienced
5482803|NCT01367210|Tropism|tropism
5482804|NCT01367197|exercise training|exercise training
5482805|NCT01367197|atrial fibrillation|atrial fibrillation
5482806|NCT01367184|VTE|vte
5482807|NCT01367184|Inferior vena cava|inferior vena cava
5482808|NCT01367184|Venous thrombo-embolism|venous thrombo-embolism
5482809|NCT01367184|Outcome data|outcome data
5482810|NCT01367184|IVC Filters|ivc filters
5482811|NCT01367158|Meningococcal disease|meningococcal disease
5482812|NCT01367158|vaccines|vaccines
5482813|NCT01367158|adolescents|adolescents
5482814|NCT01367158|prevention|prevention
5482815|NCT01367158|Meningitis|meningitis
5482816|NCT01367145|OMEGA-3 polyunsaturated fatty-acids|omega-3 polyunsaturated fatty-acids
5482817|NCT01367145|Peripheral Arterial Disease|peripheral arterial disease
5482818|NCT01367145|Endothelial Function|endothelial function
5482819|NCT01367145|Inflammation|inflammation
5482820|NCT01367145|Platelet Function|platelet function
5482821|NCT01367132|ultrasound|ultrasound
5482822|NCT01367132|first trimester|first trimester
5482823|NCT01367132|umbilical cord|umbilical cord
5482824|NCT01367119|Depression|depression
5482825|NCT01367119|Electroconvulsive therapy|electroconvulsive therapy
5482826|NCT01367119|Ketamine|ketamine
5482827|NCT01367119|Methohexital|methohexital
5482828|NCT01367106|offspring of 21-hydroxylase enzyme block|offspring of 21-hydroxylase enzyme block
5482829|NCT01367093|BIOLOGICAL MARKERS|biological markers
5482830|NCT01367093|INTENSIVE CARE UNIT|intensive care unit
5482831|NCT01367093|MORTALITY|mortality
5482832|NCT01367093|QUALITY OF LIFE|quality of life
5482834|NCT01367080|depression|depression
5482835|NCT01367067|claustrophobia|claustrophobia
5482836|NCT01367067|magnetic resonance imaging|magnetic resonance imaging
5482838|NCT01367067|anxiety|anxiety
5482839|NCT01367067|anxious patients|anxious patients
5482840|NCT01367067|phobic disorders|phobic disorders
5482841|NCT01367067|anxiety disorders|anxiety disorders
5482842|NCT01367067|mental disorders|mental disorders
5482843|NCT01367054|Metformine|metformine
5482844|NCT01367054|adverse events|adverse events
5482845|NCT01367054|bioequivalence|bioequivalence
5482846|NCT01367041|bone|bone
5482847|NCT01367041|muscle electrical activity|muscle electrical activity
5482848|NCT01367041|whole-body vibration|whole-body vibration
5482849|NCT01367028|HER2-positive early breast cancer|her2-positive early breast cancer
5482850|NCT01367015|Preterm|preterm
5482851|NCT01367015|SGA|sga
5482852|NCT01367015|AREDF|aredf
5482853|NCT01367015|Early feeding|early feeding
5482854|NCT01367015|Late feeding|late feeding
5482855|NCT01367015|Feed intolerance|feed intolerance
5482856|NCT01367015|Necrotizing enterocolitis|necrotizing enterocolitis
5482857|NCT01367015|Days to achieve Full Feeds defined as 150 mL/kg|days to achieve full feeds defined as 150 ml/kg
5482858|NCT01367002|Uterine serous papillary carcinoma|uterine serous papillary carcinoma
5482859|NCT01367002|Type II endometrial cancer|type ii endometrial cancer
5482860|NCT01367002|HER2/neu|her2/neu
5482861|NCT01367002|Paclitaxel, Carboplatin, Trastuzumab|paclitaxel, carboplatin, trastuzumab
5482862|NCT01366989|Total Ankle Arthroplasty|total ankle arthroplasty
5482863|NCT01366976|oxidative stress|oxidative stress
5482864|NCT01366976|cardiopulmonary bypass|cardiopulmonary bypass
5482865|NCT01366976|acetaminophen|acetaminophen
5482866|NCT01366976|hemolysis|hemolysis
5482867|NCT01366963|postural tachycardia syndrome|postural tachycardia syndrome
5482868|NCT01366963|brain fog|brain fog
5482869|NCT01366963|cognitive dysfunction|cognitive dysfunction
5482870|NCT01366937|vitamin B12|vitamin b12
5482872|NCT01366937|14C|14c
5482873|NCT01366937|fecal excretion|fecal excretion
5482874|NCT01366924|protein turnover|protein turnover
5482875|NCT01366924|whole body protein turnover|whole body protein turnover
5482876|NCT01366924|essential amino acids|essential amino acids
5482877|NCT01366924|leucine|leucine
5482878|NCT01366911|stem cells|stem cells
5482879|NCT01366911|QCT testing|qct testing
5482880|NCT01366911|Bone density findings|bone density findings
5482881|NCT01366911|mesenchymal stem cells|mesenchymal stem cells
5482882|NCT01366885|Autism|autism
5482883|NCT01366885|Pregnancy|pregnancy
5482884|NCT01366885|Newborn siblings|newborn siblings
5482885|NCT01366872|ankle|ankle
5482886|NCT01366872|arthritis|arthritis
5482887|NCT01366872|total ankle arthroplasty|total ankle arthroplasty
5482888|NCT01366872|Agility LP,|agility lp,
5482889|NCT01366859|Autism|autism
5482890|NCT01366859|Children|children
5482891|NCT01366859|Behavior|behavior
5482892|NCT01366859|Glutathione|glutathione
5482893|NCT01366859|Whey Protein|whey protein
5482914|NCT01366729|Timed up and go|timed up and go
5482915|NCT01366716|Contingency Management|contingency management
5482916|NCT01366716|Cash|cash
5482917|NCT01366716|Substance Abuse|substance abuse
5482918|NCT01366716|Ethics|ethics
5482919|NCT01366703|heart failure|heart failure
5482920|NCT01366703|implantable loop recorder|implantable loop recorder
5482921|NCT01366690|HIV|hiv
5482922|NCT01366690|community health workers|community health workers
5482923|NCT01366690|randomized trial|randomized trial
5482924|NCT01366690|task shifting|task shifting
5482925|NCT01366690|Uganda|uganda
5482926|NCT01366690|retention|retention
5482927|NCT01366690|operations research|operations research
5482928|NCT01366690|implementation research|implementation research
5482929|NCT01366664|Premature Ejaculation|premature ejaculation
5482930|NCT01366664|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5482931|NCT01366664|Dapoxetine|dapoxetine
5482932|NCT01366664|PRILIGY|priligy
5482933|NCT01366664|Terazosin|terazosin
5482934|NCT01366664|Pharmacodynamic|pharmacodynamic
5482935|NCT01366664|Pharmacokinetic|pharmacokinetic
5482936|NCT01366651|Doripenem|doripenem
5482937|NCT01366651|DORIPED1002|doriped1002
5482938|NCT01366651|Intravenous|intravenous
5482939|NCT01366651|Pediatric|pediatric
5482940|NCT01366651|Antibiotic|antibiotic
5482941|NCT01366651|Meningitis|meningitis
5482942|NCT01366638|Hepatitis C, Chronic|hepatitis c, chronic
5482943|NCT01366638|TMC435|tmc435
5482944|NCT01366638|Hepatitis C|hepatitis c
5482945|NCT01366638|Hepatitis C virus|hepatitis c virus
5482946|NCT01366638|Interferon Alfa-2b|interferon alfa-2b
5482947|NCT01366638|Ribavirin|ribavirin
5482948|NCT01366638|Viral ribonucleic acid|viral ribonucleic acid
5482949|NCT01366625|hypertension, resistant|hypertension, resistant
5482950|NCT01366625|obstructive sleep apnea|obstructive sleep apnea
5482951|NCT01366625|renal denervation|renal denervation
5482952|NCT01366625|continuous positive airway pressure therapy|continuous positive airway pressure therapy
5482953|NCT01366612|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5482954|NCT01366612|AML|aml
5482955|NCT01366612|CML|cml
5482956|NCT01366612|MDS|mds
5482957|NCT01366599|highly emetogenic chemotherapy|highly emetogenic chemotherapy
5482958|NCT01366599|HEC|hec
5482959|NCT01366599|moderately emetogenic chemotherapy|moderately emetogenic chemotherapy
5482960|NCT01366599|MEC|mec
5482961|NCT01366573|Pharmacokinetics|pharmacokinetics
5482962|NCT01366573|mu-opioid receptors|mu-opioid receptors
5482963|NCT01366573|Addiction|addiction
5482964|NCT01366573|Pharmacodynamics|pharmacodynamics
5482965|NCT01366573|Alcohol|alcohol
5482966|NCT01366547|Bioavailability|bioavailability
5482967|NCT01366547|Lamivudine|lamivudine
5482968|NCT01366547|Dolutegravir|dolutegravir
5482969|NCT01366547|integrase|integrase
5482970|NCT01366547|Abacavir|abacavir
5482971|NCT01366534|safety|safety
5482972|NCT01366534|Vaccine|vaccine
5482973|NCT01366534|Phase 1/2|phase 1/2
5482974|NCT01366534|immunogenicity|immunogenicity
5482975|NCT01366534|Malaria|malaria
5482976|NCT01366534|efficacy|efficacy
5482977|NCT01366534|sporozoite challenge|sporozoite challenge
5482979|NCT01366495|Test|test
5482980|NCT01366495|Treat|treat
5482981|NCT01366482|Peripheral arterial disease,|peripheral arterial disease,
5482982|NCT01366482|claudication,|claudication,
5482983|NCT01366482|atherectomy,|atherectomy,
5482995|NCT01366443|speculum exam|speculum exam
5482996|NCT01366443|visualization of leakage|visualization of leakage
5482997|NCT01366443|pooling of amniotic fluid in the posterior fornix|pooling of amniotic fluid in the posterior fornix
5482998|NCT01366443|nitrazine testing|nitrazine testing
5482999|NCT01366443|ferning|ferning
5483000|NCT01366430|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
5483001|NCT01366430|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
5483002|NCT01366430|Nystagmus|nystagmus
5483003|NCT01366430|Treatment outcome|treatment outcome
5483004|NCT01366430|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
5483005|NCT01366404|FFR|ffr
5483006|NCT01366391|polycystic ovary syndrome|polycystic ovary syndrome
5483007|NCT01366391|metformin|metformin
5483008|NCT01366391|pharmacokinetic|pharmacokinetic
5483009|NCT01366313|paracetamol|paracetamol
5483010|NCT01366313|morphine|morphine
5483011|NCT01366313|median effective dose|median effective dose
5483012|NCT01366313|pain|pain
5483013|NCT01366287|Relative bioavailability|relative bioavailability
5483014|NCT01366287|food effect|food effect
5483015|NCT01366287|tablet|tablet
5483016|NCT01366287|suspension|suspension
5483017|NCT01366287|single dose|single dose
5483018|NCT01366287|crossover|crossover
5483019|NCT01366287|healthy subjects|healthy subjects
5483020|NCT01366274|Trauma|trauma
5483021|NCT01366261|Flex-rigid pleuroscopy|flex-rigid pleuroscopy
5483022|NCT01366261|pleural biopsy|pleural biopsy
5483023|NCT01366261|pleural effusion|pleural effusion
5483024|NCT01366261|safety|safety
5483025|NCT01366261|thoracoscopy|thoracoscopy
5483026|NCT01366222|asthma|asthma
5483027|NCT01366209|Pirfenidone|pirfenidone
5483028|NCT01366209|ASCEND|ascend
5483029|NCT01366209|IPF|ipf
5483030|NCT01366209|FVC|fvc
5483035|NCT01366196|Analgesics|analgesics
5483036|NCT01366196|Sensory System Agents|sensory system agents
5483037|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents
5483038|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs
5483039|NCT01366196|Pharmacologic Actions|pharmacologic actions
5483040|NCT01366196|Central Nervous System Agents|central nervous system agents
5483041|NCT01366196|Therapeutic Uses|therapeutic uses
5483042|NCT01366196|Anticonvulsants|anticonvulsants
5483043|NCT01366196|GABA Agents|gaba agents
5483044|NCT01366196|Neurotransmitter Agents|neurotransmitter agents
5483045|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5483046|NCT01366170|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
5483047|NCT01366157|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
5483048|NCT01366157|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5483049|NCT01366157|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5483050|NCT01366157|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5483051|NCT01366157|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5483052|NCT01366157|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5483053|NCT01366157|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5483054|NCT01366157|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5483055|NCT01366157|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5483056|NCT01366157|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5483057|NCT01366118|Rectal cancer, Chemoradiotherapy, target therapy|rectal cancer, chemoradiotherapy, target therapy
5483058|NCT01366105|Wound healing|wound healing
5483059|NCT01366105|Negative Pressure Wound Therapy|negative pressure wound therapy
5483060|NCT01366105|V.A.C.|v.a.c.
5483061|NCT01366105|Incision|incision
5486115|NCT01353222|Bladder|bladder
5483063|NCT01366092|GVHD|gvhd
5483064|NCT01366092|bone marrow transplant|bone marrow transplant
5483065|NCT01366092|cord blood transplant|cord blood transplant
5483066|NCT01366092|regulatory T cell|regulatory t cell
5483068|NCT01366066|Stress incontinence|stress incontinence
5483069|NCT01366066|urge incontinence|urge incontinence
5483070|NCT01366066|overactive bladder syndrome|overactive bladder syndrome
5483071|NCT01366066|vibration|vibration
5483072|NCT01366066|nerve stimulation|nerve stimulation
5483073|NCT01366053|Prostate Cancer|prostate cancer
5483074|NCT01366053|Androgen Deprivation Therapy|androgen deprivation therapy
5483075|NCT01366053|Agonist|agonist
5467804|NCT01429844|Acute rejection|acute rejection
5483076|NCT01366053|Antagonist|antagonist
5483077|NCT01366053|PSA Failure|psa failure
5483078|NCT01366053|PSA Rise|psa rise
5483079|NCT01366040|Patient Satisfaction|patient satisfaction
5483080|NCT01366040|Multiple Sclerosis|multiple sclerosis
5483081|NCT01366040|Autoinjector|autoinjector
5483082|NCT01366040|Avonex|avonex
5483083|NCT01366027|pseudobulbar affect|pseudobulbar affect
5483084|NCT01366014|osteoarthritis|osteoarthritis
5483085|NCT01366014|knee|knee
5483086|NCT01366014|pain|pain
5483087|NCT01366014|NSAID|nsaid
5483088|NCT01366001|Opioid|opioid
5483089|NCT01366001|Cocaine|cocaine
5483090|NCT01366001|Dependence|dependence
5483091|NCT01366001|Abuse|abuse
5483092|NCT01366001|Intravenous|intravenous
5483093|NCT01366001|Buprenorphine|buprenorphine
5483094|NCT01365988|fMRI|fmri
5483095|NCT01365988|Risk-Taking|risk-taking
5483096|NCT01365988|Decision-Making|decision-making
5483097|NCT01365988|Memory|memory
5483098|NCT01365988|Resting-State Functional Connectivity|resting-state functional connectivity
5483103|NCT01365962|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5483104|NCT01365962|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5483105|NCT01365962|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5483106|NCT01365962|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5483107|NCT01365962|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5483108|NCT01365949|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5483109|NCT01365936|IVF|ivf
5483110|NCT01365936|ICSI|icsi
5483111|NCT01365936|OHSS|ohss
5483112|NCT01365936|PCOS|pcos
5483113|NCT01365936|recFSH|recfsh
5483114|NCT01365936|HMG|hmg
5483115|NCT01365897|Modafinil|modafinil
5483116|NCT01365897|Memory|memory
5483117|NCT01365897|Executive Functions|executive functions
5483118|NCT01365897|Memory, Short-Term|memory, short-term
5483120|NCT01365897|University Students|university students
5483121|NCT01365897|Stroop Effect|stroop effect
5483122|NCT01365897|Digit Span|digit span
5483123|NCT01365897|Backwards Digit Span|backwards digit span
5483124|NCT01365897|Biber Cognitive Estimation Test|biber cognitive estimation test
5483125|NCT01365871|prostate biopsy|prostate biopsy
5483126|NCT01365871|pain|pain
5483127|NCT01365845|Proton Radiation|proton radiation
5483128|NCT01365845|Breast Cancer|breast cancer
5483129|NCT01365819|Crystal meth dependence|crystal meth dependence
5483130|NCT01365819|crystal meth|crystal meth
5483131|NCT01365819|methamphetamine dependence|methamphetamine dependence
5483132|NCT01365819|substance abuse|substance abuse
5483133|NCT01365806|heart transplantation|heart transplantation
5483134|NCT01365806|allograft rejection|allograft rejection
5483135|NCT01365806|QT interval|qt interval
5483136|NCT01365806|electrocardiogram (ECG)|electrocardiogram (ecg)
5483137|NCT01365793|cerebral edema|cerebral edema
5483138|NCT01365793|diabetic ketoacidosis|diabetic ketoacidosis
5483139|NCT01365793|pediatric diabetes|pediatric diabetes
5483140|NCT01365793|fluid therapy|fluid therapy
5483141|NCT01365780|microcirculation, O2c|microcirculation, o2c
5483142|NCT01365767|Crohn disease|crohn disease
5483143|NCT01365767|Ultrasonography, contrast enhanced|ultrasonography, contrast enhanced
5483144|NCT01365767|Elasticity Imaging Techniques|elasticity imaging techniques
5483145|NCT01365767|Small intestine|small intestine
5483146|NCT01365767|Magnetic Resonance Imaging|magnetic resonance imaging
5483147|NCT01365767|CDAI|cdai
5483148|NCT01365767|Calprotectin|calprotectin
5483149|NCT01365767|IBD|ibd
5483150|NCT01365767|Sonography|sonography
5483151|NCT01365754|Lumbar degenerative disease|lumbar degenerative disease
5483152|NCT01365741|PCI|pci
5483153|NCT01365741|STEMI|stemi
5483154|NCT01365741|Interventions|interventions
5483155|NCT01365741|Heart disease|heart disease
5483156|NCT01365741|Thrombocytic inhibition|thrombocytic inhibition
5483157|NCT01365741|Cross-over study|cross-over study
5483158|NCT01365741|Percutaneous coronary intervention|percutaneous coronary intervention
5483159|NCT01365728|Femtosecond Laser|femtosecond laser
5483160|NCT01365728|FS60|fs60
5483161|NCT01365728|iFS|ifs
5483162|NCT01365728|Intralase|intralase
5483163|NCT01365728|Wavefront-guided LASIK|wavefront-guided lasik
5483164|NCT01365728|IntraLASIK|intralasik
5483165|NCT01365728|LASIK|lasik
5483166|NCT01365728|Myopia|myopia
5483168|NCT01365715|Preoperative embolization|preoperative embolization
5483169|NCT01365715|Transcatheter arterial embolization|transcatheter arterial embolization
5477599|NCT01389141|ovary|ovary
5483178|NCT01365702|COPD|copd
5483179|NCT01365702|tiotropium|tiotropium
5483180|NCT01365702|tuberculous destroyed lung|tuberculous destroyed lung
5483181|NCT01365676|Edema|edema
5483182|NCT01365676|Depression|depression
5483183|NCT01365676|Hot Flashes|hot flashes
5483184|NCT01365676|Anxiety|anxiety
5483185|NCT01365676|Irritability|irritability
5483187|NCT01365663|Hypercholesterolemia|hypercholesterolemia
5483188|NCT01365663|LDL|ldl
5483189|NCT01365663|HDL|hdl
5483190|NCT01365663|apoB|apob
5483191|NCT01365663|hyperlipidemia|hyperlipidemia
5483192|NCT01365663|LNA-oligonucleotide|lna-oligonucleotide
5483193|NCT01365637|safety|safety
5483194|NCT01365637|tolerability|tolerability
5483195|NCT01365637|pharmacokinetics|pharmacokinetics
5483196|NCT01365637|PF-05089771|pf-05089771
5483197|NCT01365598|malaria|malaria
5483198|NCT01365598|uncomplicated malaria|uncomplicated malaria
5483199|NCT01365598|gametocytocidal drug|gametocytocidal drug
5483200|NCT01365598|gametocytocidal|gametocytocidal
5483201|NCT01365598|gametocyte|gametocyte
5483202|NCT01365598|primaquine|primaquine
5483203|NCT01365598|transmission blocking|transmission blocking
5483204|NCT01365598|malaria transmission|malaria transmission
5483205|NCT01365598|sexual parasite|sexual parasite
5483206|NCT01365598|sexual stage|sexual stage
5483207|NCT01365598|Uganda|uganda
5483208|NCT01365598|Africa|africa
5483209|NCT01365585|Pulmonary arterial hypertension|pulmonary arterial hypertension
5483210|NCT01365585|sildenafil citrate|sildenafil citrate
5483211|NCT01365585|Revatio|revatio
5483212|NCT01365572|Drug-eluting stent|drug-eluting stent
5483213|NCT01365559|multiple myeloma|multiple myeloma
5483214|NCT01365559|carfilzomib|carfilzomib
5483215|NCT01365559|relapsed|relapsed
5483216|NCT01365559|refractory|refractory
5483217|NCT01365559|bortezomib|bortezomib
5483218|NCT01365559|Oncotherapeutics|oncotherapeutics
5483219|NCT01365533|Airway Inflammation|airway inflammation
5483220|NCT01365533|Roflumilast|roflumilast
5483221|NCT01365494|Rabies|rabies
5483222|NCT01365494|rabies vaccines|rabies vaccines
5483223|NCT01365494|post-exposure prophylaxis|post-exposure prophylaxis
5483224|NCT01365481|Hypertension, pediatric|hypertension, pediatric
5483322|NCT01365052|Maximum Use Safety Trial|maximum use safety trial
5483225|NCT01365481|Hypertension with or without chronic kidney disease|hypertension with or without chronic kidney disease
5483226|NCT01365468|RAD001,|rad001,
5483227|NCT01365468|Everolimus,|everolimus,
5483228|NCT01365468|Plexiform Neurofibroma,|plexiform neurofibroma,
5483229|NCT01365468|Neurofibromatosis Type 1|neurofibromatosis type 1
5483230|NCT01365455|Psoriasis|psoriasis
5483231|NCT01365455|plaque|plaque
5483232|NCT01365455|plaque-type psoriasis|plaque-type psoriasis
5483233|NCT01365455|IL-17 blocker|il-17 blocker
5483234|NCT01365455|subcutaneous|subcutaneous
5483235|NCT01365455|psoriatic arthritis|psoriatic arthritis
5483236|NCT01365455|injection|injection
5483237|NCT01365455|AIN457|ain457
5483238|NCT01365455|AIN457A|ain457a
5483239|NCT01365455|secukinumab|secukinumab
5483240|NCT01365442|Cholera|cholera
5483241|NCT01365442|Vaccination|vaccination
5483242|NCT01365442|Oral cholera vaccine|oral cholera vaccine
5483243|NCT01365442|Mass vaccination|mass vaccination
5483244|NCT01365442|Oral whole cell cholera vaccine|oral whole cell cholera vaccine
5483245|NCT01365429|Lung Transplant, Transplantation Lung|lung transplant, transplantation lung
5483246|NCT01365416|diabetes|diabetes
5483247|NCT01365416|diabetes remission|diabetes remission
5483248|NCT01365416|obesity|obesity
5483249|NCT01365416|bariatric surgery|bariatric surgery
5483250|NCT01365416|gene expression|gene expression
5483251|NCT01365416|genetic variation|genetic variation
5483252|NCT01365416|metabolomics|metabolomics
5483253|NCT01365416|metabonomics|metabonomics
5483254|NCT01365416|epigenetic variation|epigenetic variation
5483255|NCT01365416|mutations|mutations
5483256|NCT01365390|prospective|prospective
5483257|NCT01365390|Incidence|incidence
5483258|NCT01365390|otitis|otitis
5483259|NCT01365390|observational|observational
5483260|NCT01365390|Epidemiological|epidemiological
5483261|NCT01365390|retrospective|retrospective
5483262|NCT01365377|Anxiety|anxiety
5483263|NCT01365377|Depression|depression
5483264|NCT01365377|Post-traumatic stress disorders|post-traumatic stress disorders
5483265|NCT01365377|Quality of life|quality of life
5483266|NCT01365377|Family|family
5483269|NCT01365364|dopamine|dopamine
5483270|NCT01365364|physical exercise|physical exercise
5483271|NCT01365312|Central line associated infection|central line associated infection
5483272|NCT01365312|PICC associated infection|picc associated infection
5483273|NCT01365312|Neonatal central line associated sepsis|neonatal central line associated sepsis
5483274|NCT01365312|Central line colonization|central line colonization
5483275|NCT01365312|Ethanol Lock|ethanol lock
5483276|NCT01365286|asthma, chronic obstructive pulmonary disease, COPD, ivabradine, heart rate|asthma, chronic obstructive pulmonary disease, copd, ivabradine, heart rate
5483277|NCT01365273|Split thickness skin grafts|split thickness skin grafts
5483278|NCT01365273|Mepitel One|mepitel one
5483279|NCT01365273|Bridal Veil and staples|bridal veil and staples
5483280|NCT01365273|Pain|pain
5680294|NCT00578344|Hemoglobin SS|hemoglobin ss
5468000|NCT01429077|Aphasia|aphasia
5483281|NCT01365247|Co-morbid substance disorders and PTSD|co-morbid substance disorders and ptsd
5483282|NCT01365247|Trauma|trauma
5483283|NCT01365247|Alcohol and other drug use disorders|alcohol and other drug use disorders
5483284|NCT01365247|Treatment outcome|treatment outcome
5483285|NCT01365247|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5483286|NCT01365247|Co-morbid Alcohol and other drug use disorders (AOD)|co-morbid alcohol and other drug use disorders (aod)
5483287|NCT01365247|Behavioral Treatment|behavioral treatment
5483288|NCT01365221|Acute Coronary Syndrome|acute coronary syndrome
5483289|NCT01365221|Clopidogrel|clopidogrel
5483290|NCT01365221|Prasugrel|prasugrel
5483291|NCT01365195|opioid|opioid
5483292|NCT01365195|Fentanyl|fentanyl
5483293|NCT01365195|Anesthetic adjuvant|anesthetic adjuvant
5483294|NCT01365195|Pain management|pain management
5483295|NCT01365195|Perioperative outcomes|perioperative outcomes
5483296|NCT01365195|Constipation|constipation
5483297|NCT01365195|Ileus|ileus
5483298|NCT01365195|Colorectal|colorectal
5483299|NCT01365182|prostate cancer|prostate cancer
5483300|NCT01365182|urinary incontinence|urinary incontinence
5483301|NCT01365182|pelvic floor muscle exercise|pelvic floor muscle exercise
5483302|NCT01365182|self-management|self-management
5483303|NCT01365182|behavioral intervention|behavioral intervention
5483304|NCT01365182|quality of life|quality of life
5483305|NCT01365156|locally advanced cervical cancer|locally advanced cervical cancer
5483306|NCT01365156|pretherapeutic para-aortic surgical staging|pretherapeutic para-aortic surgical staging
5483307|NCT01365156|radiologic staging|radiologic staging
5483308|NCT01365156|pretherapeutic surgical staging|pretherapeutic surgical staging
5483309|NCT01365156|para-aortic metastatic disease|para-aortic metastatic disease
5483310|NCT01365130|esophageal cancer|esophageal cancer
5483311|NCT01365130|gastroesophageal cancer|gastroesophageal cancer
5483312|NCT01365130|gastric cancer|gastric cancer
5483313|NCT01365104|brain blood flow|brain blood flow
5483314|NCT01365104|stroke|stroke
5483315|NCT01365104|cerebrovascular|cerebrovascular
5483316|NCT01365104|aging|aging
5483317|NCT01365104|cerebrovascular hemodynamics|cerebrovascular hemodynamics
5483318|NCT01365078|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5483319|NCT01365078|Stearidonic acid|stearidonic acid
5483320|NCT01365078|Lipid metabolism|lipid metabolism
5483321|NCT01365078|Serum triacylglycerol|serum triacylglycerol
5483323|NCT01365039|contact lens|contact lens
5483324|NCT01365026|Healthy Lifestyle|healthy lifestyle
5483325|NCT01365026|Health promotion|health promotion
5483326|NCT01365026|Counselling|counselling
5483327|NCT01365026|Action Plan|action plan
5483328|NCT01365026|Primary Health Care|primary health care
5483329|NCT01365013|Lifestyle|lifestyle
5483330|NCT01365013|Prediabetic State|prediabetic state
5483331|NCT01365013|Patient Education|patient education
5483332|NCT01365013|Primary Health Care|primary health care
5483333|NCT01365000|Phase 1|phase 1
5483334|NCT01365000|Pharmacokinetics|pharmacokinetics
5483335|NCT01365000|NKTR-118|nktr-118
5483336|NCT01365000|fasting or fed state|fasting or fed state
5483337|NCT01365000|cross-over study|cross-over study
5483338|NCT01365000|AUC(0-t)|auc(0-t)
5483339|NCT01365000|Cmax|cmax
5483340|NCT01365000|tmax|tmax
5483341|NCT01365000|QTcF Interval|qtcf interval
5483342|NCT01364987|transplant|transplant
5483343|NCT01364987|ASP015K|asp015k
5483344|NCT01364987|healthy subjects|healthy subjects
5483345|NCT01364974|ASP015K|asp015k
5483346|NCT01364974|Healthy subjects|healthy subjects
5483347|NCT01364961|Resveratrol|resveratrol
5483349|NCT01364961|PWV|pwv
5483350|NCT01364961|HDL-cholesterol|hdl-cholesterol
5483351|NCT01364961|Macrovasculature|macrovasculature
5483352|NCT01364961|Microvasculature|microvasculature
5483353|NCT01364948|Preterm|preterm
5483354|NCT01364948|VLBW|vlbw
5483355|NCT01364948|Coconut Oil application|coconut oil application
5483356|NCT01364948|Trans epidermal water loss|trans epidermal water loss
5483357|NCT01364948|Weight gain|weight gain
5483358|NCT01364909|Sepsis|sepsis
5483359|NCT01364909|Severe sepsis|severe sepsis
5483360|NCT01364909|Septic shock|septic shock
5483361|NCT01364909|Septicaemia|septicaemia
5483362|NCT01364909|Bacteremia|bacteremia
5483363|NCT01364896|Non-corticosteroid immunosuppressive agent|non-corticosteroid immunosuppressive agent
5477850|NCT01388179|TMS|tms
5483365|NCT01364883|Immune response|immune response
5483366|NCT01364870|Knee OA|knee oa
5483367|NCT01364870|TENS|tens
5483368|NCT01364870|Total knee replacement|total knee replacement
5483369|NCT01364870|Knee arthroplasty|knee arthroplasty
5483370|NCT01364870|total unilateral knee replacement|total unilateral knee replacement
5483382|NCT01364753|Aviation|aviation
5483383|NCT01364714|ICU acquired weakness|icu acquired weakness
5483384|NCT01364701|Erectile dysfunction|erectile dysfunction
5483385|NCT01364701|combination therapy|combination therapy
5483386|NCT01364701|Sildenafil|sildenafil
5483387|NCT01364701|tadalafil|tadalafil
5483388|NCT01364701|PDE5i|pde5i
5483389|NCT01364701|No Conditions|no conditions
5483390|NCT01364688|coronary calcification|coronary calcification
5483391|NCT01364688|vascular calcification|vascular calcification
5483392|NCT01364688|active vitamin D|active vitamin d
5483393|NCT01364688|alfacalcidol|alfacalcidol
5483394|NCT01364675|Impaired fasting glucose|impaired fasting glucose
5483395|NCT01364675|Impaired glucose tolerance|impaired glucose tolerance
5483396|NCT01364675|Pre-diabetes|pre-diabetes
5483397|NCT01364675|Pre-hypertensives|pre-hypertensives
5483398|NCT01364675|Cardiovascular events|cardiovascular events
5483399|NCT01364662|Impulsive Aggression|impulsive aggression
5483400|NCT01364662|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5483401|NCT01364662|ADHD|adhd
5483402|NCT01364649|Sexual Dysfunction, Physiological|sexual dysfunction, physiological
5483403|NCT01364649|Depressive Disorder, Major|depressive disorder, major
5483404|NCT01364649|Depression|depression
5483405|NCT01364649|Antidepressive Agents|antidepressive agents
5483406|NCT01364649|Drug Therapy|drug therapy
5483407|NCT01364636|1-Heart Failure|1-heart failure
5483408|NCT01364636|2-Acute Heart Failure|2-acute heart failure
5483409|NCT01364636|3-Acute Decompensated Heart Failure|3-acute decompensated heart failure
5483410|NCT01364636|4-Worsening Renal Function|4-worsening renal function
5483411|NCT01364636|5-Acute Kidney Injury|5-acute kidney injury
5483412|NCT01364636|6-Cardiorenal Syndrome|6-cardiorenal syndrome
5483413|NCT01364623|testosterone|testosterone
5483414|NCT01364623|pharmacokinetics|pharmacokinetics
5483415|NCT01364610|diagnosis|diagnosis
5483416|NCT01364610|pH measurement|ph measurement
5483417|NCT01364610|catheter|catheter
5483418|NCT01364610|wireless|wireless
5483425|NCT01364571|Staphylococcus aureus|staphylococcus aureus
5483426|NCT01364571|vaccine|vaccine
5483427|NCT01364571|staphylococcal infection|staphylococcal infection
5483428|NCT01364532|transulnar arterial access|transulnar arterial access
5483429|NCT01364532|transradial arterial access|transradial arterial access
5483430|NCT01364532|percutaneous coronary intervention|percutaneous coronary intervention
5483431|NCT01364519|COPD|copd
5483432|NCT01364506|Cardiovascular capacity|cardiovascular capacity
5483433|NCT01364506|Water exercise|water exercise
5483434|NCT01364506|Hydrokinetic Therapy|hydrokinetic therapy
5483435|NCT01364506|Pregnancy|pregnancy
5483436|NCT01364506|Perinatal outcomes|perinatal outcomes
5483437|NCT01364493|HER2-positive|her2-positive
5483438|NCT01364493|adenocarcinoma of the stomach or gastro-esophageal junction|adenocarcinoma of the stomach or gastro-esophageal junction
5483439|NCT01364493|Inoperable|inoperable
5483440|NCT01364493|locally advanced|locally advanced
5483441|NCT01364493|recurrent|recurrent
5483442|NCT01364493|metastatic|metastatic
5483444|NCT01364480|Spinal cord injury|spinal cord injury
5483445|NCT01364480|Brainstem or spinal stroke|brainstem or spinal stroke
5483446|NCT01364480|Neuroprosthetic|neuroprosthetic
5483447|NCT01364480|Brain-machine interface|brain-machine interface
5483448|NCT01364480|Brain-computer interface|brain-computer interface
5483449|NCT01364480|Neural activity|neural activity
5483450|NCT01364454|Colorectal Cancer Screening|colorectal cancer screening
5483451|NCT01364454|Faecal Occult Blood test|faecal occult blood test
5483452|NCT01364454|General Practitioners Involvement|general practitioners involvement
5483453|NCT01364454|Patient's Participation|patient's participation
5483454|NCT01364454|Reminder|reminder
5483455|NCT01364441|ONO-2950|ono-2950
5483456|NCT01364441|healthy adult subjects|healthy adult subjects
5483465|NCT01364415|advanced neuroendocrine tumors|advanced neuroendocrine tumors
5483466|NCT01364402|scheduled for PCI|scheduled for pci
5483467|NCT01364389|Polymyalgia Rheumatica|polymyalgia rheumatica
5483468|NCT01364389|Inflammatory Disease|inflammatory disease
5483469|NCT01364389|Rheumatic Disease|rheumatic disease
5483470|NCT01364376|Gastric Cancer|gastric cancer
5483471|NCT01364363|Transplant|transplant
5483472|NCT01364363|Allogeneic|allogeneic
5483473|NCT01364363|Allogeneic transplant|allogeneic transplant
5483474|NCT01364363|Unrelated donor transplant|unrelated donor transplant
5483475|NCT01364363|MUD|mud
5483476|NCT01364363|HSCT|hsct
5483477|NCT01364363|Stem cell transplant|stem cell transplant
5483478|NCT01364350|type 2 diabetes mellitus|type 2 diabetes mellitus
5483479|NCT01364350|pediatrics|pediatrics
5483480|NCT01364350|post-intervention study|post-intervention study
5483481|NCT01364350|metformin|metformin
5483482|NCT01364350|complications|complications
5483483|NCT01364337|Hypertension|hypertension
5483484|NCT01364324|tuberculosis|tuberculosis
5483485|NCT01364324|pharmacokinetics|pharmacokinetics
5483486|NCT01364324|first-line drugs|first-line drugs
5483487|NCT01364324|gastrectomy|gastrectomy
5483488|NCT01364311|Dry Eye Syndromes|dry eye syndromes
5483489|NCT01364311|Dietary Supplements|dietary supplements
5483490|NCT01364311|Vitamac® Tag and Nacht capsules|vitamac® tag and nacht capsules
5483491|NCT01364311|Lutein|lutein
5483492|NCT01364311|Vitamin C|vitamin c
5483493|NCT01364311|Zinc|zinc
5483494|NCT01364311|ginkgo biloba|ginkgo biloba
5483495|NCT01364311|Flavinoids|flavinoids
5483496|NCT01364311|Fishoil|fishoil
5483497|NCT01364311|Zeaxanthin|zeaxanthin
5483498|NCT01364311|Vitamin E|vitamin e
5468201|NCT01428284|Pharmacokinetic|pharmacokinetic
5483499|NCT01364311|Copper|copper
5483500|NCT01364311|Selen|selen
5483501|NCT01364311|Alpha Lipon acid|alpha lipon acid
5483502|NCT01364311|Break up time (BUT)|break up time (but)
5483503|NCT01364311|Improvement of subjective symptoms of dry eye syndrome|improvement of subjective symptoms of dry eye syndrome
5483504|NCT01364311|Visual Acuity|visual acuity
5483505|NCT01364311|Tear film osmolarity|tear film osmolarity
5483506|NCT01364311|OSI (Objective Scattering Index)|osi (objective scattering index)
5483507|NCT01364311|Schirmer I test|schirmer i test
5483508|NCT01364311|Staining of the cornea with fluorescein|staining of the cornea with fluorescein
5483509|NCT01364311|Impression cytology|impression cytology
5483510|NCT01364311|Tear cytokines/chemokines|tear cytokines/chemokines
5483511|NCT01364311|Data from patient diary how often Hylo-Comod® eye drops were used|data from patient diary how often hylo-comod® eye drops were used
5483512|NCT01364298|Gabapentin/B complex|gabapentin/b complex
5483513|NCT01364298|Pregabalin|pregabalin
5483514|NCT01364298|Pain|pain
5483515|NCT01364298|Neuropathic|neuropathic
5483516|NCT01364298|Gavindo|gavindo
5483517|NCT01364298|Lyrica|lyrica
5483518|NCT01364259|tic douloureux|tic douloureux
5483519|NCT01364246|Progressive Multiple Sclerosis|progressive multiple sclerosis
5483520|NCT01364246|neuromyelitis optica|neuromyelitis optica
5483521|NCT01364246|Umbilical Cord Mesenchymal Stem Cell|umbilical cord mesenchymal stem cell
5483522|NCT01364220|Additional relevant MeSH terms|additional relevant mesh terms
5483523|NCT01364220|Stroke|stroke
5483524|NCT01364220|Cerebral Infarction|cerebral infarction
5483525|NCT01364220|Cerebrovascular Disorders|cerebrovascular disorders
5483526|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5483527|NCT01364220|Magnetic Resonance Imaging|magnetic resonance imaging
5483528|NCT01364220|Recurrence|recurrence
5483529|NCT01364194|Post operative pain|post operative pain
5483530|NCT01364194|Total knee replacement|total knee replacement
5483531|NCT01364194|Total knee arthroplasty|total knee arthroplasty
5483532|NCT01364194|Bupivacaine|bupivacaine
5483533|NCT01364194|Periarticular injection|periarticular injection
5483534|NCT01364194|Placebo|placebo
5483535|NCT01364194|Morphine consumption|morphine consumption
5483536|NCT01364181|Udenafil|udenafil
5483537|NCT01364181|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5483538|NCT01364181|pulmonary hypertension|pulmonary hypertension
5483539|NCT01364181|Phosphodiesterase 5 inhibitors|phosphodiesterase 5 inhibitors
5483540|NCT01364181|Exercise|exercise
5483541|NCT01364181|Dyspnea|dyspnea
5483542|NCT01364129|Diabetes|diabetes
5483543|NCT01364129|Diabetic Retinopathy Screening|diabetic retinopathy screening
5483544|NCT01364129|Ophthalmic Telemedicine|ophthalmic telemedicine
5483545|NCT01364129|Comparative Effectiveness Research|comparative effectiveness research
5483546|NCT01364116|Pulse CO-Oximetry™|pulse co-oximetry™
5483547|NCT01364116|children|children
5483548|NCT01364116|noninvasive|noninvasive
5483549|NCT01364103|pulse pressure variation|pulse pressure variation
5483550|NCT01364103|systolic pressure variation|systolic pressure variation
5483551|NCT01364103|central venous pressure|central venous pressure
5483552|NCT01364103|aortic blood flow velocity variation|aortic blood flow velocity variation
5483553|NCT01364103|pleth variability index|pleth variability index
5483554|NCT01364090|hepatitis C|hepatitis c
5483555|NCT01364090|treatment|treatment
5483556|NCT01364090|injection drug users or receiving opiate substitution therapy|injection drug users or receiving opiate substitution therapy
5483557|NCT01364077|Heart rate|heart rate
5483558|NCT01364077|Dialysis|dialysis
5483559|NCT01364077|ESRD|esrd
5483560|NCT01364077|ivabradine|ivabradine
5483561|NCT01363973|oropharyngeal dysphagia|oropharyngeal dysphagia
5483562|NCT01363973|post-stroke|post-stroke
5483563|NCT01363960|Incidence|incidence
5483564|NCT01363960|neonatal care|neonatal care
5483565|NCT01363960|retinopathy of prematurity|retinopathy of prematurity
5483566|NCT01363960|risk factors|risk factors
5483567|NCT01363934|Erythropoietin|erythropoietin
5483568|NCT01363934|EPO-hFC|epo-hfc
5483569|NCT01363921|CKD5|ckd5
5483570|NCT01363921|dialysis|dialysis
5483571|NCT01363921|high porous membranes|high porous membranes
5483572|NCT01363921|micro-inflammation|micro-inflammation
5483573|NCT01363908|Beta-Thalassemia|beta-thalassemia
5483574|NCT01363908|Sickle Cell Anemia|sickle cell anemia
5483575|NCT01363908|Transfusional iron overload|transfusional iron overload
5483576|NCT01363908|Iron Overload|iron overload
5483577|NCT01363908|Iron Chelation|iron chelation
5483578|NCT01363895|atrial fibrillation|atrial fibrillation
5483579|NCT01363895|catheter ablation|catheter ablation
5483580|NCT01363895|percutaneous closure of LAA|percutaneous closure of laa
5483581|NCT01363895|intervention|intervention
5483582|NCT01363882|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5483583|NCT01363882|Noninvasive Ventilation|noninvasive ventilation
5483584|NCT01363882|Respiratory Dysfunction|respiratory dysfunction
5483585|NCT01363882|Positive Pressure Ventilation|positive pressure ventilation
5483586|NCT01363869|hyperuricemia|hyperuricemia
5483587|NCT01363869|gout|gout
5483588|NCT01363869|uric acid|uric acid
5483589|NCT01363869|xanthine oxidase inhibitor|xanthine oxidase inhibitor
5483590|NCT01363869|green tea|green tea
5483591|NCT01363869|catechins|catechins
5483592|NCT01363869|antioxidant|antioxidant
5483593|NCT01363856|first ever stroke|first ever stroke
5483594|NCT01363843|neoadjuvant|neoadjuvant
5483595|NCT01363843|chemo/radiation|chemo/radiation
5483596|NCT01363843|rectal cancer|rectal cancer
5483597|NCT01363843|rectum cancer|rectum cancer
5483598|NCT01363843|colon cancer|colon cancer
5483599|NCT01363843|colorectal cancer|colorectal cancer
5483600|NCT01363830|Disc|disc
5483601|NCT01363830|lumbar|lumbar
5483602|NCT01363830|herniation|herniation
5483603|NCT01363804|AV-951|av-951
5483604|NCT01363804|Tivozanib|tivozanib
5483605|NCT01363804|Healthy Subjects|healthy subjects
5483606|NCT01363804|rifampin|rifampin
5483607|NCT01363804|Pharmacokinetics|pharmacokinetics
5483608|NCT01363791|Systematic review and meta-analysis|systematic review and meta-analysis
5483609|NCT01363791|Evidence-based medicine (EBM)|evidence-based medicine (ebm)
5483610|NCT01363791|Evidence-based nutrition (EBN)|evidence-based nutrition (ebn)
5483611|NCT01363791|Clinical practice guidelines|clinical practice guidelines
5483612|NCT01363791|Clinical trials|clinical trials
5483613|NCT01363791|Dietary sugars|dietary sugars
5483614|NCT01363791|Fructose|fructose
5465873|NCT01437475|HIV|hiv
5483615|NCT01363791|High fructose corn syrup|high fructose corn syrup
5483616|NCT01363791|Fruit|fruit
5483617|NCT01363791|Isocaloric|isocaloric
5483618|NCT01363791|Hypercaloric|hypercaloric
5483619|NCT01363791|Cardiometabolic risk factors|cardiometabolic risk factors
5483620|NCT01363791|Triglycerides|triglycerides
5483621|NCT01363791|Cholesterol|cholesterol
5483622|NCT01363791|Glycemic control|glycemic control
5483623|NCT01363791|Insulin resistance|insulin resistance
5483624|NCT01363791|Body weight|body weight
5483625|NCT01363791|Uric acid|uric acid
5483626|NCT01363791|Blood pressure|blood pressure
5483627|NCT01363791|Fatty liver|fatty liver
5483628|NCT01363791|Fasting|fasting
5483629|NCT01363791|Postprandial|postprandial
5483630|NCT01363778|AV-951|av-951
5483631|NCT01363778|Tivozanib|tivozanib
5483632|NCT01363778|Healthy Subjects|healthy subjects
5483633|NCT01363778|ketoconazole|ketoconazole
5483634|NCT01363778|Pharmacokinetics|pharmacokinetics
5483635|NCT01363765|diagnosis|diagnosis
5483636|NCT01363765|polymerase chain reaction|polymerase chain reaction
5483637|NCT01363765|sputum smear|sputum smear
5483638|NCT01363765|stepped-wedge design|stepped-wedge design
5483639|NCT01363765|cost-effectiveness|cost-effectiveness
5483640|NCT01363765|Xpert MTB/Rif|xpert mtb/rif
5483641|NCT01363752|Kidney|kidney
5483642|NCT01363752|Kidney Failure, Acute|kidney failure, acute
5483643|NCT01363752|Astagraf XL|astagraf xl
5483644|NCT01363752|Immunosuppression|immunosuppression
5483645|NCT01363752|Advagraf|advagraf
5483646|NCT01363752|Tacrolimus|tacrolimus
5483647|NCT01363752|Transplant|transplant
5483648|NCT01363739|VEGF polymorphism Bevacizumab|vegf polymorphism bevacizumab
5846742|NCT00043628|Heart Disease|heart disease
5483649|NCT01363726|surveillance Rotavirus Gastroenteritis Children|surveillance rotavirus gastroenteritis children
5483650|NCT01363726|< 5 years of age|< 5 years of age
5483652|NCT01363726|Signed informed concent|signed informed concent
5483653|NCT01363674|Growth disorders|growth disorders
5483654|NCT01363674|Saizen|saizen
5483655|NCT01363674|Easypod|easypod
5483656|NCT01363674|Growth hormone|growth hormone
5483657|NCT01363674|Pediatric subject|pediatric subject
5483658|NCT01363661|angina pectoris|angina pectoris
5483659|NCT01363661|atherosclerosis|atherosclerosis
5483660|NCT01363661|endothelial dysfunction|endothelial dysfunction
5483661|NCT01363648|VCI-HS|vci-hs
5483662|NCT01363648|stroke|stroke
5483663|NCT01363648|choline alphoscerate|choline alphoscerate
5483664|NCT01363635|severe sepsis/septic shock|severe sepsis/septic shock
5483665|NCT01363635|organ failure|organ failure
5483667|NCT01363635|PMI|pmi
5483668|NCT01363635|ALI|ali
5483669|NCT01363635|Stroke|stroke
5483670|NCT01363635|ICU death|icu death
5483671|NCT01363622|Vaspin|vaspin
5483672|NCT01363622|LGA|lga
5483673|NCT01363622|SGA|sga
5483674|NCT01363622|Insulin|insulin
5483675|NCT01363622|Blood glucose|blood glucose
5483676|NCT01363596|Infertility|infertility
5483677|NCT01363596|Fertility|fertility
5483678|NCT01363596|Reproductive Medicine|reproductive medicine
5483679|NCT01363596|Pregnancy|pregnancy
5483680|NCT01363596|Conception|conception
5483681|NCT01363596|Miscarriage|miscarriage
5483682|NCT01363596|Ovulation Detection|ovulation detection
5483683|NCT01363596|Cervical Mucus|cervical mucus
5483684|NCT01363596|IVF Alternative|ivf alternative
5483685|NCT01363583|traumatic brain injury|traumatic brain injury
5483686|NCT01363570|Macular Degeneration|macular degeneration
5483687|NCT01363570|Age related macular degeneration|age related macular degeneration
5483688|NCT01363570|Macula Risk|macula risk
5483689|NCT01363570|Genetic test|genetic test
5483690|NCT01363570|Anti-inflammatory|anti-inflammatory
5483691|NCT01363570|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5483692|NCT01363570|Lucentis|lucentis
5483693|NCT01363570|Ranibizumab|ranibizumab
5483694|NCT01363570|Vision loss|vision loss
5483695|NCT01363557|Randomized|randomized
5483696|NCT01363557|Brain Radiation Therapy|brain radiation therapy
5483697|NCT01363557|Lung Cancer|lung cancer
5483698|NCT01363557|Brain Metastasis|brain metastasis
5483699|NCT01363557|Gefitinib|gefitinib
5483700|NCT01363544|ADHD|adhd
5483701|NCT01363544|neurofeedback|neurofeedback
5483702|NCT01363544|exercise|exercise
5483703|NCT01363544|neurophysiology|neurophysiology
5465944|NCT01437085|Needles|needles
5483704|NCT01363531|Prescription|prescription
5483705|NCT01363531|Antibiotic|antibiotic
5483706|NCT01363531|Acute respiratory infections|acute respiratory infections
5483707|NCT01363531|Satisfaction|satisfaction
5483708|NCT01363531|Perception|perception
5483709|NCT01363531|Pharyngitis and/or acute tonsillitis|pharyngitis and/or acute tonsillitis
5483710|NCT01363531|Rhinosinusitis|rhinosinusitis
5483711|NCT01363531|Acute bronchitis|acute bronchitis
5483712|NCT01363531|Acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)|acute exacerbation of chronic obstructive pulmonary disease (mild to moderate)
5483713|NCT01363518|humerus|humerus
5483714|NCT01363518|fracture|fracture
5483715|NCT01363518|operative treatment|operative treatment
5483716|NCT01363518|non-operative treatment|non-operative treatment
5483717|NCT01363492|agalsidase alfa|agalsidase alfa
5483718|NCT01363492|Replagal|replagal
5483719|NCT01363492|Enzyme Replacement Therapy|enzyme replacement therapy
5483720|NCT01363440|Diabetic Macular Edema|diabetic macular edema
5483721|NCT01363440|Diabetic Retinopathy|diabetic retinopathy
5483722|NCT01363414|Dry eye|dry eye
5483723|NCT01363414|Ocular aberration|ocular aberration
5484330|NCT01360996|PCOS|pcos
5483724|NCT01363401|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5483726|NCT01363401|Motor neuron disease|motor neuron disease
5483728|NCT01363401|HYNR-CS inj|hynr-cs inj
5483729|NCT01363401|Autologous bone marrow derived stem cell|autologous bone marrow derived stem cell
5483730|NCT01363401|Intrathecal injection|intrathecal injection
5483731|NCT01363375|Plantar fascia|plantar fascia
5483732|NCT01363375|Plantar fasciitis|plantar fasciitis
5483733|NCT01363375|Foot orthosis|foot orthosis
5483734|NCT01363375|Finite element analysis|finite element analysis
5483735|NCT01363375|Gait analysis|gait analysis
5483736|NCT01363375|Plantar pressure measurement|plantar pressure measurement
5483737|NCT01363362|Selective Laser Trabeculoplasty|selective laser trabeculoplasty
5483738|NCT01363362|pulsatile ocular blood flow|pulsatile ocular blood flow
5483739|NCT01363336|Adalat|adalat
5483740|NCT01363336|Hypertension|hypertension
5483741|NCT01363336|Diabetes|diabetes
5483742|NCT01363336|Chronic kidney disease|chronic kidney disease
5483743|NCT01363297|Relapsed/Refractory Acute Lymphocytic Leukemia (ALL)|relapsed/refractory acute lymphocytic leukemia (all)
5483744|NCT01363258|Elderly|elderly
5483745|NCT01363258|Dementia|dementia
5483746|NCT01363258|Care-resistant behavior|care-resistant behavior
5483747|NCT01363258|Oral health|oral health
5483748|NCT01363258|Long-term care|long-term care
5483749|NCT01363245|cost effectiveness|cost effectiveness
5483750|NCT01363245|behavioral health counseling|behavioral health counseling
5483751|NCT01363232|BKM120|bkm120
5483752|NCT01363232|MEK162|mek162
5483753|NCT01363232|RAS RAF mutations|ras raf mutations
5483754|NCT01363232|triple negative breast cancer|triple negative breast cancer
5483755|NCT01363232|pancreatic cancer, ovarian cancer|pancreatic cancer, ovarian cancer
5483756|NCT01363232|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
5483757|NCT01363232|PI3K inhibitor|pi3k inhibitor
5483758|NCT01363232|MEK inhibitor|mek inhibitor
5483759|NCT01363206|Melanoma|melanoma
5483760|NCT01363206|GM-CSF|gm-csf
5483761|NCT01363206|Ipilimumab|ipilimumab
5483762|NCT01363206|Immunologic Response|immunologic response
5483763|NCT01363193|Weight-based heparin dosing|weight-based heparin dosing
5483764|NCT01363193|Obesity|obesity
5483765|NCT01363193|Body Mass Index|body mass index
5483766|NCT01363193|Venous thromboembolism|venous thromboembolism
5483767|NCT01363193|Atrial fibrillation|atrial fibrillation
5483768|NCT01363193|Lean body weight|lean body weight
5483769|NCT01363193|Unfractionated heparin|unfractionated heparin
5483770|NCT01363193|heparin|heparin
5483771|NCT01363167|vitamin D|vitamin d
5483772|NCT01363167|preterm infants|preterm infants
5483773|NCT01363167|calcium|calcium
5483774|NCT01363167|bone|bone
5483775|NCT01363167|parathyroid hormone|parathyroid hormone
5483776|NCT01363154|Children's Health|children's health
5483777|NCT01363154|Pediatrics|pediatrics
5483778|NCT01363154|Epilepsy|epilepsy
5483779|NCT01363154|Photoparoxysmal|photoparoxysmal
5483780|NCT01363154|Photosensitive|photosensitive
5483781|NCT01363154|Music|music
5483784|NCT01363141|Cardiovascular Diseases|cardiovascular diseases
5483785|NCT01363141|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5483786|NCT01363141|Abdominal Fat|abdominal fat
5483787|NCT01363141|Atherogenic Dyslipidemia|atherogenic dyslipidemia
5483788|NCT01363141|Hypertension|hypertension
5483789|NCT01363141|Hyperglycemia|hyperglycemia
5483790|NCT01363141|Insulin Resistance|insulin resistance
5483791|NCT01363141|Thrombosis state|thrombosis state
5483792|NCT01363115|Body Weight|body weight
5483793|NCT01363115|Dietary Supplement|dietary supplement
5483794|NCT01363115|Calcium|calcium
5483795|NCT01363115|Vitamin D|vitamin d
5483796|NCT01363102|Muscle strength|muscle strength
5483797|NCT01363102|functional mobility|functional mobility
5483798|NCT01363102|outcome|outcome
5483799|NCT01363102|intensive care unit|intensive care unit
5483800|NCT01363102|quality of life|quality of life
5483801|NCT01363037|HIV infections|hiv infections
5483802|NCT01363037|Anti-HIV agents|anti-hiv agents
5483803|NCT01363037|HIV-1|hiv-1
5483804|NCT01363024|Solid Cancers|solid cancers
5483805|NCT01363011|HIV-1|hiv-1
5483806|NCT01363011|Treatment Naive|treatment naive
5483807|NCT01363011|Treatment Experienced|treatment experienced
5483808|NCT01362998|fentanyl, morphine, duramorph, Cesarean section, epidural|fentanyl, morphine, duramorph, cesarean section, epidural
5483809|NCT01362959|Delirium|delirium
5483810|NCT01362959|Psychomotor Agitation|psychomotor agitation
5483811|NCT01362959|Substance Withdrawal Syndrome|substance withdrawal syndrome
5483812|NCT01362959|Nicotine replacement therapy|nicotine replacement therapy
5483813|NCT01362946|Conduct problems|conduct problems
5483814|NCT01362946|callous-unemotional traits|callous-unemotional traits
5483815|NCT01362946|disruptive behavior disorders|disruptive behavior disorders
5483817|NCT01362933|DVT|dvt
5483818|NCT01362933|SVT|svt
5483819|NCT01362933|LMWH|lmwh
5483820|NCT01362933|VKA|vka
5483821|NCT01362933|international Venous Thromboembolism Recommendations|international venous thromboembolism recommendations
5483822|NCT01362920|Sepsis|sepsis
5483823|NCT01362920|Septic shock|septic shock
5483829|NCT01362868|Glaucoma|glaucoma
5483830|NCT01362868|Triggerfish|triggerfish
5483831|NCT01362868|Water drinking test|water drinking test
5483832|NCT01362855|Advance Care Planning|advance care planning
5483833|NCT01362855|End of life|end of life
5483834|NCT01362855|Knowledge translation|knowledge translation
5483835|NCT01362855|Goals of care|goals of care
5483836|NCT01362855|Advance directive|advance directive
5483837|NCT01362855|Lining will|lining will
5483838|NCT01362842|Lung Cancer|lung cancer
5483839|NCT01362842|Symptom distress|symptom distress
5483840|NCT01362842|Post-operation|post-operation
5483841|NCT01362842|Anxiety|anxiety
5483842|NCT01362842|Depression|depression
5483843|NCT01362842|Uncertainty|uncertainty
5483844|NCT01362842|Fear of recurrence|fear of recurrence
5483845|NCT01362842|Self-efficacy|self-efficacy
5483846|NCT01362842|Needs|needs
5483847|NCT01362803|Maximum Tolerated Dose|maximum tolerated dose
5483848|NCT01362803|Pharmacokinetics|pharmacokinetics
5483849|NCT01362803|Pharmacodynamics|pharmacodynamics
5483850|NCT01362803|Response Rate|response rate
5483851|NCT01362803|pain, quality of life and physical functioning|pain, quality of life and physical functioning
5483852|NCT01362803|Neurofibromatosis Type 1|neurofibromatosis type 1
5483853|NCT01362803|NF1|nf1
5483854|NCT01362803|Plexiform Neurofibroma|plexiform neurofibroma
5483855|NCT01362790|Immune Therapy|immune therapy
5483859|NCT01362777|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5483860|NCT01362777|Exercise training program|exercise training program
5483861|NCT01362777|Inflammation|inflammation
5483862|NCT01362777|Oxidative Stress|oxidative stress
5483863|NCT01362777|Resistance to insulin|resistance to insulin
5483864|NCT01362764|Abiraterone Acetate|abiraterone acetate
5483865|NCT01362764|ZYTIGA|zytiga
5483866|NCT01362738|Long-standing persistent atrial fibrillation|long-standing persistent atrial fibrillation
5483867|NCT01362725|spinal cord stimulation|spinal cord stimulation
5483868|NCT01362725|systolic heart failure|systolic heart failure
5483869|NCT01362712|breast cancer|breast cancer
5483870|NCT01362712|radiotherapy|radiotherapy
5483871|NCT01362712|chemoradiotherapy|chemoradiotherapy
5483872|NCT01362712|radiation|radiation
5483873|NCT01362712|chemoradiation|chemoradiation
5483874|NCT01362712|[F-18]|[f-18]
5483875|NCT01362699|Alcoholism|alcoholism
5483876|NCT01362699|Alcohol-Related Disorders|alcohol-related disorders
5483877|NCT01362699|Substance-Related Disorders|substance-related disorders
5483878|NCT01362699|Mental Disorders|mental disorders
5483879|NCT01362699|Alcohol Dependence|alcohol dependence
5483880|NCT01362699|JNJ-31001074|jnj-31001074
5483881|NCT01362699|Bavisant|bavisant
5483882|NCT01362686|diagnosis of Alzheimer's disease|diagnosis of alzheimer's disease
5483883|NCT01362686|medication adherence|medication adherence
5483884|NCT01362673|Phase 1|phase 1
5483885|NCT01362673|Pharmacokinetics|pharmacokinetics
5483886|NCT01362673|food effect|food effect
5483887|NCT01362673|Healthy Japanese|healthy japanese
5483888|NCT01362673|rheumatoid arthritis|rheumatoid arthritis
5483896|NCT01362621|Allergic asthma|allergic asthma
5483897|NCT01362621|Pediatrics|pediatrics
5483898|NCT01362621|Exacerbations|exacerbations
5483899|NCT01362621|Perennial aeroallergens|perennial aeroallergens
5483900|NCT01362621|Inhaled corticosteroids|inhaled corticosteroids
5483901|NCT01362608|Gout|gout
5483902|NCT01362608|Inflammatory gout|inflammatory gout
5483903|NCT01362608|acute gout|acute gout
5483907|NCT01362582|Pancreatic cancer|pancreatic cancer
5483908|NCT01362582|progression under chemotherapy|progression under chemotherapy
5466146|NCT01436292|Burns|burns
5483909|NCT01362582|parenteral nutrition|parenteral nutrition
5483910|NCT01362582|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5483911|NCT01362582|chemotherapy|chemotherapy
5483912|NCT01362569|endotoxin|endotoxin
5483913|NCT01362569|neutrophil function|neutrophil function
5483914|NCT01362569|albumin function|albumin function
5483915|NCT01362543|PTSD|ptsd
5483916|NCT01362543|Depression|depression
5483917|NCT01362543|Refugees|refugees
5483918|NCT01362543|Trauma|trauma
5483919|NCT01362517|Vaccination|vaccination
5483920|NCT01362517|Immunisation|immunisation
5483921|NCT01362517|Virus|virus
5483922|NCT01362517|Diphtheria|diphtheria
5483923|NCT01362517|Pertussis|pertussis
5483924|NCT01362517|Tetanus|tetanus
5483925|NCT01362517|Hepatitis B|hepatitis b
5483926|NCT01362517|Haemophilus Influenzae|haemophilus influenzae
5483927|NCT01362517|Immunity|immunity
5483928|NCT01362504|Pro-adrenomedullin|pro-adrenomedullin
5483929|NCT01362504|Neonatal sepsis|neonatal sepsis
5483930|NCT01362504|Prognosis|prognosis
5483931|NCT01362504|Sepsis marker|sepsis marker
5483932|NCT01362504|Clinical sepsis|clinical sepsis
5483933|NCT01362504|Proven sepsis|proven sepsis
5483934|NCT01362491|Headache|headache
5483935|NCT01362478|schizophrenia|schizophrenia
5483936|NCT01362478|gene promoter|gene promoter
5483937|NCT01362478|methylation|methylation
5483938|NCT01362478|endophenotype|endophenotype
5483939|NCT01362478|epigenetic|epigenetic
5483940|NCT01362452|Leukemia|leukemia
5483941|NCT01362452|Lymphoma|lymphoma
5483942|NCT01362452|CD19-specific T cells|cd19-specific t cells
5483943|NCT01362452|Umbilical cord blood transplantation|umbilical cord blood transplantation
5483944|NCT01362452|B-Lineage Lymphoid Malignancies|b-lineage lymphoid malignancies
5483945|NCT01362452|B-cell leukemia|b-cell leukemia
5483946|NCT01362452|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5483947|NCT01362452|ALL|all
5483948|NCT01362452|Biphenotypic Leukemia|biphenotypic leukemia
5483949|NCT01362452|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5483951|NCT01362452|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5483952|NCT01362452|SLL|sll
5483953|NCT01362452|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5483954|NCT01362452|CLL|cll
5483955|NCT01362452|White blood cells|white blood cells
5483956|NCT01362452|T cells|t cells
5483957|NCT01362452|Melphalan|melphalan
5483958|NCT01362452|Alkeran|alkeran
5483962|NCT01362452|Fludara|fludara
5483963|NCT01362452|ATG|atg
5483964|NCT01362452|Antithymocyte Globulin|antithymocyte globulin
5483965|NCT01362452|Thymoglobulin|thymoglobulin
5483966|NCT01362452|Rituxan|rituxan
5483967|NCT01362452|Rituximab|rituximab
5483968|NCT01362452|Cyclophosphamide|cyclophosphamide
5483969|NCT01362452|Cytoxan|cytoxan
5483970|NCT01362452|Neosar|neosar
5483971|NCT01362439|Schizophrenia|schizophrenia
5483973|NCT01362426|schizophrenia|schizophrenia
5483974|NCT01362426|paliperidone palmitate|paliperidone palmitate
5483975|NCT01362426|INVEGA SUSTENNA|invega sustenna
5483976|NCT01362426|registries|registries
5483977|NCT01362426|quality of healthcare|quality of healthcare
5483978|NCT01362413|pseudarthrosis|pseudarthrosis
5483979|NCT01362413|mineralization|mineralization
5483980|NCT01362413|platelet-rich-plasma|platelet-rich-plasma
5483981|NCT01362413|serum|serum
5483982|NCT01362400|LUNG NEOPLASMS|lung neoplasms
5483983|NCT01362400|LARGE CELL CARCINOMA|large cell carcinoma
5483984|NCT01362400|SQUAMOUS CELL CARCINOMA|squamous cell carcinoma
5483985|NCT01362387|Medical abortion|medical abortion
5483986|NCT01362387|abortion follow-up|abortion follow-up
5483987|NCT01362361|Second line colorectal cancer|second line colorectal cancer
5483988|NCT01362348|Age-related Macular Degeneration|age-related macular degeneration
5483989|NCT01362322|dTpa|dtpa
5483990|NCT01362322|Boostrix|boostrix
5483991|NCT01362309|Alcohol|alcohol
5483992|NCT01362309|Cues|cues
5483993|NCT01362309|Extinction|extinction
5483994|NCT01362309|D-Cycloserine|d-cycloserine
5483995|NCT01362296|NRAS|nras
5483996|NCT01362296|docetaxel|docetaxel
5483997|NCT01362296|NSCLC|nsclc
5483998|NCT01362296|GSK1120212|gsk1120212
5483999|NCT01362296|MEK inhibitor|mek inhibitor
5484000|NCT01362296|targeted therapy|targeted therapy
5484001|NCT01362296|KRAS|kras
5484002|NCT01362296|BRAF|braf
5484003|NCT01362270|Anxiolytics|anxiolytics
5484004|NCT01362270|Sedatives|sedatives
5484005|NCT01362270|Acupuncture Therapy|acupuncture therapy
5484006|NCT01362244|Quality of Life|quality of life
5484007|NCT01362244|Intranasal Steroids|intranasal steroids
5484008|NCT01362244|Severe Nasal Polyposis|severe nasal polyposis
5484009|NCT01362244|Polyp Relapse|polyp relapse
5484011|NCT01362244|Surgery|surgery
5484012|NCT01362231|Fibrosis|fibrosis
5484013|NCT01362231|Pulmonary Fibrosis|pulmonary fibrosis
5484014|NCT01362231|Lung Diseases|lung diseases
5484015|NCT01362231|Interstitial|interstitial
5484016|NCT01362205|Severe Alcohol Withdrawal Delirium Tremens|severe alcohol withdrawal delirium tremens
5484017|NCT01362192|Telangiectasis|telangiectasis
5484018|NCT01362192|Spider Veins|spider veins
5484019|NCT01362192|Excel V|excel v
5484020|NCT01362192|Cutera|cutera
5484021|NCT01362192|Laser|laser
5484022|NCT01362192|Leg Veins|leg veins
5484023|NCT01362192|Venulectasia|venulectasia
5484024|NCT01362192|Lower Extremity veins|lower extremity veins
5484025|NCT01362192|Laser light|laser light
5484026|NCT01362192|KTP|ktp
5484027|NCT01362192|532nm|532nm
5484028|NCT01362179|malignant myeloid hematologic disorders|malignant myeloid hematologic disorders
5484029|NCT01362179|filgrastim|filgrastim
5484030|NCT01362179|long term incidence|long term incidence
5484031|NCT01362179|donors who received and in those who did not receive filgrastim.|donors who received and in those who did not receive filgrastim.
5484036|NCT01362166|XianGu|xiangu
5484037|NCT01362166|frequency response|frequency response
5484038|NCT01362166|resonance|resonance
5484039|NCT01362166|male volunteer|male volunteer
5484040|NCT01362166|aged within 20-35 years old|aged within 20-35 years old
5484041|NCT01362153|Golimumab|golimumab
5484042|NCT01362153|Simponi|simponi
5484043|NCT01362153|Rheumatoid Arthritis|rheumatoid arthritis
5484044|NCT01362153|PK|pk
5484045|NCT01362153|PD|pd
5484046|NCT01362140|Randomized|randomized
5484047|NCT01362140|Darbepoetin alfa|darbepoetin alfa
5484048|NCT01362140|Myelodysplastic Syndromes|myelodysplastic syndromes
5484049|NCT01362140|Placebo-controlled|placebo-controlled
5484050|NCT01362140|low risk MDS|low risk mds
5484051|NCT01362140|intermediate-1 risk MDS|intermediate-1 risk mds
5484052|NCT01362140|International Prognostic Scoring System|international prognostic scoring system
5484054|NCT01362114|Hwa-byung|hwa-byung
5484055|NCT01362114|Sihogayonggolmoryeo-tang|sihogayonggolmoryeo-tang
5484056|NCT01362114|Anxiety|anxiety
5484057|NCT01362101|cue reactivity|cue reactivity
5484058|NCT01362101|physiologic activation|physiologic activation
5484059|NCT01362101|craving|craving
5484060|NCT01362101|smoking cues|smoking cues
5484061|NCT01362101|Behavioral therapy|behavioral therapy
5484062|NCT01362088|microcirculation|microcirculation
5484063|NCT01362088|intensive care|intensive care
5484064|NCT01362088|ultrafiltration|ultrafiltration
5484065|NCT01362088|CVVH|cvvh
5487128|NCT01349049|AML|aml
5484070|NCT01362049|Rehabilitation|rehabilitation
5484071|NCT01362049|Movement System Impairment exercise|movement system impairment exercise
5484072|NCT01362010|Acne|acne
5484073|NCT01362010|Acne Vulgaris|acne vulgaris
5484074|NCT01362010|Topical|topical
5484075|NCT01362010|Minocycline|minocycline
5484076|NCT01362010|Foam|foam
5484077|NCT01362010|Phase II|phase ii
5484078|NCT01361997|Antiseptics|antiseptics
5484079|NCT01361997|Hemoculture contamination|hemoculture contamination
5484080|NCT01361997|Anti-infecting agents, local|anti-infecting agents, local
5484081|NCT01361984|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5484082|NCT01361984|COPD|copd
5484083|NCT01361984|Emphysema|emphysema
5484084|NCT01361984|Chronic Bronchitis|chronic bronchitis
5484086|NCT01361984|Serevent|serevent
5484087|NCT01361971|Insulin resistance|insulin resistance
5484088|NCT01361971|Inflammation|inflammation
5484089|NCT01361971|Hypoxia|hypoxia
5484090|NCT01361945|ER+|er+
5484091|NCT01361945|HER2+|her2+
5484092|NCT01361945|Breast|breast
5484093|NCT01361919|compressions|compressions
5484094|NCT01361919|quality|quality
5484095|NCT01361919|teaching method|teaching method
5484096|NCT01361919|feedback|feedback
5484097|NCT01361919|CPR performance|cpr performance
5484098|NCT01361919|Cardiopulmonary resuscitation (CPR)|cardiopulmonary resuscitation (cpr)
5484099|NCT01361906|Musculoskeletal and Neural Physiological Phenomena|musculoskeletal and neural physiological phenomena
5484100|NCT01361906|Postural Balance|postural balance
5484101|NCT01361906|Eye/hand coordination|eye/hand coordination
5484102|NCT01361893|SIDS|sids
5484103|NCT01361893|African American|african american
5484104|NCT01361893|Infants|infants
5484105|NCT01361893|Disparity|disparity
5484106|NCT01361880|African American|african american
5484107|NCT01361880|Anticipatory Guidance|anticipatory guidance
5484108|NCT01361880|Health Promotion|health promotion
5484109|NCT01361880|Infant Mortality|infant mortality
5484110|NCT01361880|Injury Prevention|injury prevention
5484111|NCT01361880|Nurses|nurses
5484112|NCT01361880|Parent Education|parent education
5484113|NCT01361880|sudden Infant Death Syndrome|sudden infant death syndrome
5484114|NCT01361867|motor adaptation|motor adaptation
5484115|NCT01361867|lower extremity motor learning|lower extremity motor learning
5484116|NCT01361854|polysomnography|polysomnography
5484117|NCT01361854|portable monitoring|portable monitoring
5484118|NCT01361854|sleep|sleep
5484119|NCT01361854|sleep disordered breathing|sleep disordered breathing
5484120|NCT01361854|home based polysomnography|home based polysomnography
5484121|NCT01361841|Latanoprost|latanoprost
5484122|NCT01361841|bimatoprost|bimatoprost
5484123|NCT01361841|travoprost|travoprost
5484124|NCT01361841|non responders|non responders
5484125|NCT01361828|Bevacizumab|bevacizumab
5484126|NCT01361828|VEP|vep
5484127|NCT01361828|ERG|erg
5484128|NCT01361828|Optic nerve and retinal functions following intravitreal bevacizumab|optic nerve and retinal functions following intravitreal bevacizumab
5484129|NCT01361815|Depression|depression
5484130|NCT01361815|MDD|mdd
5484131|NCT01361815|SSRIs|ssris
5484132|NCT01361815|TMS|tms
5484133|NCT01361789|Arthroscopic reconstruction|arthroscopic reconstruction
5484134|NCT01361789|Anterior crucial ligament|anterior crucial ligament
5484136|NCT01361789|Dexamethasone|dexamethasone
5484137|NCT01361776|immune response|immune response
5484138|NCT01361776|TBE-vaccine|tbe-vaccine
5484139|NCT01361776|elderly|elderly
5484140|NCT01361776|additional doses|additional doses
5484141|NCT01361763|Dabigatran|dabigatran
5484142|NCT01361763|Microbleeds|microbleeds
5484143|NCT01361763|Microthrombi|microthrombi
5484144|NCT01361763|CADASIL|cadasil
5484145|NCT01361763|Small Vessel Disease|small vessel disease
5484146|NCT01361737|Preeclampsia|preeclampsia
5484147|NCT01361737|serological bio-bank|serological bio-bank
5484148|NCT01361737|adiponectin|adiponectin
5484149|NCT01361737|suPAR|supar
5484150|NCT01361724|Parkinson's disease|parkinson's disease
5484151|NCT01361724|PD|pd
5484152|NCT01361724|Exercise|exercise
5484153|NCT01361724|Balance|balance
5484154|NCT01361724|Mobility|mobility
5484155|NCT01361698|recovery|recovery
5484156|NCT01361698|illness management|illness management
5484157|NCT01361698|rehabilitation|rehabilitation
5484158|NCT01361698|mental illness|mental illness
5484159|NCT01361698|psychosocial intervention|psychosocial intervention
5484160|NCT01361698|Clinical recovery (increase in functioning, decrease in symptoms)|clinical recovery (increase in functioning, decrease in symptoms)
5484161|NCT01361698|Personal recovery (Hope, optimism, living a fulfilling life)|personal recovery (hope, optimism, living a fulfilling life)
5484162|NCT01361659|anginal complaints|anginal complaints
5484163|NCT01361659|Lithotripsy|lithotripsy
5484164|NCT01361659|no option patients|no option patients
5484165|NCT01361633|d-cycloserine|d-cycloserine
5484166|NCT01361633|geriatric|geriatric
5484167|NCT01361633|neuropsychology|neuropsychology
5484168|NCT01361633|cognition|cognition
5484169|NCT01361633|cognitive-enhancer|cognitive-enhancer
5484170|NCT01361633|aging|aging
5484171|NCT01361633|neuropsychological functioning|neuropsychological functioning
5484172|NCT01361620|genomic markers|genomic markers
5484173|NCT01361620|aspirin resistance|aspirin resistance
5484174|NCT01361607|Cancer pain|cancer pain
5484175|NCT01361607|Opioid therapy|opioid therapy
5484176|NCT01361607|Inadequate analgesia|inadequate analgesia
5484177|NCT01361607|Optimized chronic opioid therapy|optimized chronic opioid therapy
5484178|NCT01361594|Diabetes|diabetes
5484179|NCT01361594|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5484180|NCT01361594|Glycemic control|glycemic control
5484181|NCT01361594|Insulin infusion|insulin infusion
5484182|NCT01361581|Acute renal failure|acute renal failure
5484183|NCT01361581|Anticoagulation|anticoagulation
5484184|NCT01361581|Citrate|citrate
5484185|NCT01361581|Haemodiafiltration|haemodiafiltration
5484186|NCT01361581|Haemofiltration|haemofiltration
5484187|NCT01361581|Renal replacement therapy|renal replacement therapy
5484188|NCT01361568|pain|pain
5484189|NCT01361568|acute pain|acute pain
5484190|NCT01361568|visceral pain|visceral pain
5484191|NCT01361568|kappa agonist|kappa agonist
5484192|NCT01361568|opioid analgesics|opioid analgesics
5484193|NCT01361568|peripheral nervous system agents|peripheral nervous system agents
5484194|NCT01361568|physiological effects of drugs|physiological effects of drugs
5484195|NCT01361568|surgery|surgery
5484196|NCT01361568|hysterectomy|hysterectomy
5484197|NCT01361568|post-operative|post-operative
5484198|NCT01361568|post-operative complications|post-operative complications
5484200|NCT01361542|BMD|bmd
5484201|NCT01361542|Ankylosing spondylitis|ankylosing spondylitis
5484202|NCT01361542|bone health|bone health
5484203|NCT01361542|Anti TNF therapy|anti tnf therapy
5484204|NCT01361542|Disease activity|disease activity
5484205|NCT01361529|dose escalation|dose escalation
5484206|NCT01361516|Urolithiasis|urolithiasis
5484207|NCT01361516|ESWL|eswl
5484208|NCT01361516|Stone Fragmentation efficacy|stone fragmentation efficacy
5484209|NCT01361516|Sedation|sedation
5478615|NCT01384981|NIV|niv
5484210|NCT01361516|General Anaesthesia|general anaesthesia
5484211|NCT01361503|Autism Spectrum Disorders|autism spectrum disorders
5484212|NCT01361503|Pervasive Developmental Disorders|pervasive developmental disorders
5484213|NCT01361503|Asperger's Syndrome|asperger's syndrome
5484214|NCT01361503|Adolescents|adolescents
5484215|NCT01361503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5484216|NCT01361503|Diffusion Tensor Imaging|diffusion tensor imaging
5484217|NCT01361477|General surgical ICU|general surgical icu
5484218|NCT01361477|ICU Siamitra|icu siamitra
5484219|NCT01361477|ICU Salad-Samung|icu salad-samung
5484220|NCT01361477|Data registry|data registry
5484221|NCT01361477|ICU refusal|icu refusal
5484222|NCT01361477|ICU complications|icu complications
5484223|NCT01361477|ICU resource utilization|icu resource utilization
5484224|NCT01361477|Adverse events|adverse events
5484225|NCT01361477|ICU readmission|icu readmission
5484226|NCT01361451|parasternal electromyogram|parasternal electromyogram
5484227|NCT01361451|neural respiratory drive|neural respiratory drive
5484228|NCT01361451|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5484229|NCT01361451|respiratory physiology|respiratory physiology
5484230|NCT01361451|Acute exacerbation|acute exacerbation
5484231|NCT01361425|hypertension|hypertension
5484232|NCT01361425|ultrasonography|ultrasonography
5484233|NCT01361425|preeclampsia|preeclampsia
5484234|NCT01361425|clinical trials|clinical trials
5484235|NCT01361425|treatment|treatment
5484236|NCT01361425|methyldopa|methyldopa
5484237|NCT01361412|ragweed allergy|ragweed allergy
5484238|NCT01361412|immunotherapy|immunotherapy
5484239|NCT01361399|Sore Throat|sore throat
5484240|NCT01361386|Long-term follow up|long-term follow up
5484241|NCT01361386|Antithrombotic management patterns|antithrombotic management patterns
5484242|NCT01361386|Acute Coronary Syndrome|acute coronary syndrome
5484243|NCT01361386|Asia|asia
5484244|NCT01361386|quality of life|quality of life
5484245|NCT01361347|milk allergy|milk allergy
5484246|NCT01361347|desensitization|desensitization
5484247|NCT01361347|anaphylaxis|anaphylaxis
5484248|NCT01361347|school-age|school-age
5484249|NCT01361334|(other than AML M3)|(other than aml m3)
5484250|NCT01361321|follow up|follow up
5484251|NCT01361321|Guided bone regeneration|guided bone regeneration
5484252|NCT01361321|Micro computerized tomography|micro computerized tomography
5484253|NCT01361321|histological examination|histological examination
5484254|NCT01361308|Menopause|menopause
5484255|NCT01361308|Vasomotor Symptoms|vasomotor symptoms
5484256|NCT01361308|Hot Flashes Perimenopause|hot flashes perimenopause
5484257|NCT01361308|Climacteric Symptoms|climacteric symptoms
5484258|NCT01361308|Mesafem|mesafem
5484259|NCT01361308|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5484260|NCT01361295|Atrial fibrillation|atrial fibrillation
5484261|NCT01361295|cerebral embolism|cerebral embolism
5484262|NCT01361295|catheter ablation|catheter ablation
5484263|NCT01361282|Total Corneal Power|total corneal power
5484264|NCT01361282|Optical Coherence Tomography|optical coherence tomography
5484265|NCT01361282|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
5484266|NCT01361256|Macular Degeneration|macular degeneration
5484267|NCT01361256|Visual Impairment|visual impairment
5484268|NCT01361256|Implantable Telescope|implantable telescope
5484269|NCT01361243|Pediatric Overweight|pediatric overweight
5484270|NCT01361243|Pediatric Obesity|pediatric obesity
5484271|NCT01361217|Fluoxetine|fluoxetine
5484272|NCT01361217|CYP3A4|cyp3a4
5484273|NCT01361217|CYP2D6|cyp2d6
5484274|NCT01361217|CYP2C19|cyp2c19
5484275|NCT01361217|Drug-Drug Interaction|drug-drug interaction
5484276|NCT01361217|Multi-CYP Inhibition|multi-cyp inhibition
5484277|NCT01361204|stress|stress
5484278|NCT01361204|students|students
5484279|NCT01361204|pharmacy practice|pharmacy practice
5484280|NCT01361204|theanine|theanine
5484282|NCT01361191|DLBCL|dlbcl
5484284|NCT01361191|IPI|ipi
5484285|NCT01361191|R-MegaCHOP|r-megachop
5484286|NCT01361191|Autologous stem cell transplantation|autologous stem cell transplantation
5484287|NCT01361165|Pediatric|pediatric
5484288|NCT01361165|Data Analysis|data analysis
5484289|NCT01361152|total knee arthroplasty|total knee arthroplasty
5484290|NCT01361152|fixed-bearing|fixed-bearing
5484291|NCT01361152|mobile-bearing|mobile-bearing
5484292|NCT01361152|long-term|long-term
5484293|NCT01361139|Chronic obstructive lung disease|chronic obstructive lung disease
5484294|NCT01361139|Interstitial lung disease|interstitial lung disease
5484295|NCT01361139|Asthma|asthma
5484296|NCT01361139|Sarcoidosis|sarcoidosis
5484297|NCT01361139|Pulmonary hypertension|pulmonary hypertension
5484298|NCT01361139|Ultrasound|ultrasound
5484299|NCT01361139|Doppler|doppler
5484300|NCT01361139|Lung disease diagnosis|lung disease diagnosis
5484301|NCT01361113|Renal Cell Carcinoma|renal cell carcinoma
5484302|NCT01361113|RCC|rcc
5484303|NCT01361113|Votrient|votrient
5484304|NCT01361113|Pazopanib|pazopanib
5484305|NCT01361113|Nephrectomy|nephrectomy
5484306|NCT01361113|Neoadjuvant|neoadjuvant
5484307|NCT01361113|Phase II|phase ii
5484308|NCT01361113|LCCC 1028|lccc 1028
5789046|NCT00150124|Radioiodine therapy|radioiodine therapy
5484309|NCT01361113|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5484310|NCT01361100|Otolaryngology|otolaryngology
5484311|NCT01361087|TGF-B blood levels Atenolol vs, Losartan Study, NIH, NIHLB and NMF|tgf-b blood levels atenolol vs, losartan study, nih, nihlb and nmf
5484312|NCT01361074|Virtual reality|virtual reality
5484313|NCT01361074|Augmented reality|augmented reality
5484314|NCT01361074|In vivo exposure|in vivo exposure
5484315|NCT01361074|One session treatment|one session treatment
5484317|NCT01361074|Efficacy|efficacy
5484318|NCT01361074|Specific phobia|specific phobia
5484319|NCT01361074|Anxiety disorders|anxiety disorders
5484320|NCT01361061|liver cirrhosis|liver cirrhosis
5484321|NCT01361061|screening|screening
5484322|NCT01361061|hepatocellular carcinoma|hepatocellular carcinoma
5484323|NCT01361061|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
5484324|NCT01361048|trichomonas|trichomonas
5484325|NCT01361035|health literacy|health literacy
5484326|NCT01361035|cancer screening|cancer screening
5484327|NCT01361035|doctor-patient communication|doctor-patient communication
5484328|NCT01361035|standardized patient|standardized patient
5484329|NCT01361035|continuing medical education|continuing medical education
5484336|NCT01360944|PPT, topical, psoriasis|ppt, topical, psoriasis
5484337|NCT01360931|Lung cancer|lung cancer
5484338|NCT01360931|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5484340|NCT01360905|Multiples|multiples
5484341|NCT01360892|Hepatitis B virus|hepatitis b virus
5484342|NCT01360892|Hepatitis C virus|hepatitis c virus
5484343|NCT01360892|Chronic hepatitis|chronic hepatitis
5484344|NCT01360892|Liver chlorosis|liver chlorosis
5484345|NCT01360892|Liver stiffness|liver stiffness
5484346|NCT01360892|Liver fibrosis|liver fibrosis
5484347|NCT01360879|Hepatitis B virus|hepatitis b virus
5484348|NCT01360879|Hepatitis C virus|hepatitis c virus
5484349|NCT01360879|Chronic hepatitis|chronic hepatitis
5484350|NCT01360879|Liver cirrhosis|liver cirrhosis
5484351|NCT01360879|Liver stiffness|liver stiffness
5484352|NCT01360879|Liver fibrosis|liver fibrosis
5484353|NCT01360866|OPC-34712|opc-34712
5484354|NCT01360866|brexpiprazole|brexpiprazole
5484355|NCT01360866|Major Depressive Disorder|major depressive disorder
5484356|NCT01360866|Adjunctive Treatment|adjunctive treatment
5484357|NCT01360853|pancreatic cancer|pancreatic cancer
5484358|NCT01360853|gemcitabine|gemcitabine
5484359|NCT01360853|ON 01910.Na|on 01910.na
5484360|NCT01360853|rigosertib sodium|rigosertib sodium
5484361|NCT01360840|Asymptomatic|asymptomatic
5484362|NCT01360840|mildly symptomatic|mildly symptomatic
5484363|NCT01360840|metastatic castrate-resistant prostate cancer|metastatic castrate-resistant prostate cancer
5484364|NCT01360840|mCRPC|mcrpc
5484365|NCT01360827|Safety|safety
5484366|NCT01360827|tolerability|tolerability
5846747|NCT00043615|Survival Factors|survival factors
5484367|NCT01360827|maximum tolerated dose of EMD 1201081|maximum tolerated dose of emd 1201081
5484368|NCT01360827|TLR9 agonists|tlr9 agonists
5484369|NCT01360827|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5484370|NCT01360827|First line subjects|first line subjects
5484371|NCT01360827|recurrent/metastatic|recurrent/metastatic
5484372|NCT01360788|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5484373|NCT01360788|lung function|lung function
5484374|NCT01360788|symptoms|symptoms
5484375|NCT01360788|activity-related dyspnea|activity-related dyspnea
5484376|NCT01360788|quadriceps muscle function|quadriceps muscle function
5484377|NCT01360788|exercise capacity|exercise capacity
5484378|NCT01360788|physical activity in daily life|physical activity in daily life
5484379|NCT01360788|muscle biopsy|muscle biopsy
5484380|NCT01360788|systemic inflammation|systemic inflammation
5484381|NCT01360788|GOLD stage I|gold stage i
5484382|NCT01360788|pulmonary function|pulmonary function
5484383|NCT01360775|Nutritional status|nutritional status
5484384|NCT01360775|Dependent patients|dependent patients
5484385|NCT01360775|Nutritional educational intervention|nutritional educational intervention
5484386|NCT01360775|Caregivers|caregivers
5484387|NCT01360775|Clinical assay|clinical assay
5484388|NCT01360762|Secondary prophylaxis|secondary prophylaxis
5484389|NCT01360762|Visceral leishmaniasis|visceral leishmaniasis
5484390|NCT01360762|Relapses|relapses
5484391|NCT01360762|HIV co-infection|hiv co-infection
5484392|NCT01360762|Pentamidine|pentamidine
5484393|NCT01360762|Ethiopia|ethiopia
5484394|NCT01360749|Pain management|pain management
5484395|NCT01360749|Lidocaine|lidocaine
5484401|NCT01360710|male age 18-30 years old|male age 18-30 years old
5484402|NCT01360710|presence of central obesity|presence of central obesity
5484403|NCT01360710|no history of cardiovascular disease, depression|no history of cardiovascular disease, depression
5484404|NCT01360710|not on any medication|not on any medication
5484405|NCT01360697|Diabetes|diabetes
5484406|NCT01360697|Structured care|structured care
5484408|NCT01360671|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn
5484409|NCT01360671|sildenafil|sildenafil
5484410|NCT01360671|iv|iv
5484411|NCT01360658|Intravenous immunoglobulins|intravenous immunoglobulins
5484412|NCT01360658|Solar urticaria|solar urticaria
5484413|NCT01360658|Minimal urticaria dose|minimal urticaria dose
5484414|NCT01360658|Quality of life|quality of life
5484416|NCT01360645|OPC-34712|opc-34712
5484417|NCT01360645|brexpiprazole|brexpiprazole
5484418|NCT01360645|Major Depressive Disorder|major depressive disorder
5484419|NCT01360645|Adjunctive Treatment|adjunctive treatment
5484420|NCT01360632|OPC-34712|opc-34712
5484421|NCT01360632|brexpiprazole|brexpiprazole
5484422|NCT01360632|Major Depressive Disorder|major depressive disorder
5484423|NCT01360632|Adjunctive Treatment|adjunctive treatment
5484424|NCT01360619|To demonstrate that multifunction Keito is as effective, as safe and accurate as the predicate K014009 on its body fat measurement.|to demonstrate that multifunction keito is as effective, as safe and accurate as the predicate k014009 on its body fat measurement.
5484425|NCT01360606|Liver|liver
5484426|NCT01360606|Mets|mets
5484427|NCT01360593|Pancreas|pancreas
5484428|NCT01360567|green tea|green tea
5484429|NCT01360567|EGCG|egcg
5484430|NCT01360567|type 2 diabetes|type 2 diabetes
5484431|NCT01360567|hyperlipidemia|hyperlipidemia
5484432|NCT01360554|comparative study of PF-00299804 and Erlotinib|comparative study of pf-00299804 and erlotinib
5484433|NCT01360554|Double-Blind Phase 3 trial of TKI|double-blind phase 3 trial of tki
5466652|NCT01434277|Eye Drops|eye drops
5484434|NCT01360541|Barrett oesophagus|barrett oesophagus
5484435|NCT01360541|Low grade dysplasia|low grade dysplasia
5484436|NCT01360541|Radiofrequency ablation|radiofrequency ablation
5484437|NCT01360528|Folic acid replacement|folic acid replacement
5484438|NCT01360528|Folic acid|folic acid
5484439|NCT01360528|Preterm neonate|preterm neonate
5484440|NCT01360515|esophagoscope|esophagoscope
5484441|NCT01360515|esophageal disease|esophageal disease
5484442|NCT01360515|gastroesophageal reflux|gastroesophageal reflux
5484443|NCT01360515|esophageal varices|esophageal varices
5484444|NCT01360502|capsule endoscopy|capsule endoscopy
5484445|NCT01360502|cardiac pacemaker|cardiac pacemaker
5484446|NCT01360502|implantable cardiac defibrillator|implantable cardiac defibrillator
5484447|NCT01360476|hypertension|hypertension
5484448|NCT01360476|left ventricular hypertrophy|left ventricular hypertrophy
5484449|NCT01360476|Vitamin D|vitamin d
5484450|NCT01360476|African-Americans|african-americans
5484451|NCT01360463|drug abuse counseling|drug abuse counseling
5484452|NCT01360463|HIV risk reduction counseling|hiv risk reduction counseling
5484453|NCT01360463|HIV infection|hiv infection
5484454|NCT01360463|injection drug users|injection drug users
5484455|NCT01360463|AIDS|aids
5484456|NCT01360450|opioid withdrawal|opioid withdrawal
5484457|NCT01360450|Neonatal Pain, Agitation, and Sedation Scale (NPASS)|neonatal pain, agitation, and sedation scale (npass)
5484458|NCT01360450|duraclon|duraclon
5484459|NCT01360437|coronary angioplasty|coronary angioplasty
5484460|NCT01360437|clopidogrel hyporesponsiveness|clopidogrel hyporesponsiveness
5484461|NCT01360437|prasugrel|prasugrel
5484462|NCT01360437|ticagrelor|ticagrelor
5484464|NCT01360437|ACS|acs
5484465|NCT01360424|osteoporosis|osteoporosis
5484466|NCT01360424|teriparatide|teriparatide
5484467|NCT01360424|bone turnover|bone turnover
5484468|NCT01360424|New forms of inherited low-turnover osteoporosis|new forms of inherited low-turnover osteoporosis
5484469|NCT01360411|elastography|elastography
5484470|NCT01360411|strain ratio|strain ratio
5484471|NCT01360411|pancreas|pancreas
5484472|NCT01360411|GI wall lesions|gi wall lesions
5484473|NCT01360411|lymph nodes|lymph nodes
5484474|NCT01360398|pathogen|pathogen
5484475|NCT01360398|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5484476|NCT01360398|Acute Exacerbations of Chronic Obstructive Pulmonary Disease|acute exacerbations of chronic obstructive pulmonary disease
5484477|NCT01360398|COPD|copd
5484478|NCT01360398|respiratory|respiratory
5484479|NCT01360398|AECOPD|aecopd
5484480|NCT01360398|exacerbation|exacerbation
5484481|NCT01360385|Central retinal rein occlusion|central retinal rein occlusion
5484482|NCT01360385|Retinal oximetry|retinal oximetry
5484483|NCT01360385|Oxymap Retinal Oximeter|oxymap retinal oximeter
5484484|NCT01360385|Visual acuity|visual acuity
5484485|NCT01360385|Central retinal thickness|central retinal thickness
5484486|NCT01360372|Hydrogen breath test value and gastric residual volume measurements|hydrogen breath test value and gastric residual volume measurements
5484487|NCT01360372|Tube feeding tolerance while taking a stable dose of opiate|tube feeding tolerance while taking a stable dose of opiate
5484488|NCT01360359|low back pain|low back pain
5484489|NCT01360359|core stabilization|core stabilization
5484490|NCT01360359|trunk muscle exercises|trunk muscle exercises
5484491|NCT01360359|physical therapy|physical therapy
5484493|NCT01360346|Enteral Sedation|enteral sedation
5484494|NCT01360346|Intravenous Sedation|intravenous sedation
5484495|NCT01360346|Critically ill ICU patient|critically ill icu patient
5484496|NCT01360346|Conscious Sedation|conscious sedation
5484497|NCT01360346|Deep Sedation|deep sedation
5484498|NCT01360346|RASS|rass
5484499|NCT01360346|CAM-ICU|cam-icu
5484500|NCT01360346|VNR|vnr
5484501|NCT01360346|BPS|bps
5484502|NCT01360346|Propofol|propofol
5484503|NCT01360346|Midazolam|midazolam
5484504|NCT01360346|Hydroxyzine|hydroxyzine
5484505|NCT01360346|Lorazepam|lorazepam
5484506|NCT01360346|Melatonin|melatonin
5484507|NCT01360333|Dehydration|dehydration
5484508|NCT01360333|Hydration|hydration
5484509|NCT01360320|Green tea|green tea
5484510|NCT01360320|polyphenol|polyphenol
5484511|NCT01360320|catechin|catechin
5484512|NCT01360320|EGCG|egcg
5484513|NCT01360320|Epigallocatechin gallate|epigallocatechin gallate
5484514|NCT01360320|colorectal adenoma|colorectal adenoma
5484515|NCT01360320|adenoma prevention|adenoma prevention
5484516|NCT01360320|colon cancer prevention|colon cancer prevention
5484517|NCT01360307|psychometric validation|psychometric validation
5484518|NCT01360307|major depressive disorder|major depressive disorder
5484519|NCT01360307|patient-reported outcome|patient-reported outcome
5484520|NCT01360294|Asthma|asthma
5484521|NCT01360294|Small airways disease|small airways disease
5484522|NCT01360294|Questionnaire|questionnaire
5484523|NCT01360281|Quadriceps strength|quadriceps strength
5484524|NCT01360281|osteoarthritis rehabilitation|osteoarthritis rehabilitation
5484525|NCT01360281|NMES|nmes
5484526|NCT01360255|Hepatocellular Carcinoma|hepatocellular carcinoma
5484527|NCT01360255|transarterial chemoembolisation|transarterial chemoembolisation
5484528|NCT01360255|liver cancer markers: AFP, AFP-L3% and DCP|liver cancer markers: afp, afp-l3% and dcp
5484529|NCT01360242|Acute STEMI|acute stemi
5484530|NCT01360242|Thrombus aspiration|thrombus aspiration
5484531|NCT01360242|Angioplasty|angioplasty
5484532|NCT01360242|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5484533|NCT01360229|Parkinsons Disease|parkinsons disease
5484534|NCT01360229|Fatigue|fatigue
5484535|NCT01360216|Long-acting reversible contraception|long-acting reversible contraception
5484536|NCT01360216|Intrauterine contraception|intrauterine contraception
5484537|NCT01360216|Intrauterine devices|intrauterine devices
5484538|NCT01360216|Single-rod implant|single-rod implant
5484539|NCT01360216|Hormonal contraception|hormonal contraception
5484541|NCT01360190|major depressive disorder|major depressive disorder
5484542|NCT01360190|QEEG|qeeg
5484543|NCT01360190|electroencephalograph|electroencephalograph
5484544|NCT01360190|fluoxtine|fluoxtine
5484545|NCT01360190|placebo|placebo
5484546|NCT01360164|Human Umbilical Cord Mesenchymal Stem Cells|human umbilical cord mesenchymal stem cells
5484547|NCT01360151|VEGF (Vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
5484548|NCT01360125|adult acute basophilic leukemia|adult acute basophilic leukemia
5484549|NCT01360125|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5484550|NCT01360125|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5484551|NCT01360125|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5484552|NCT01360125|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5484553|NCT01360125|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5484554|NCT01360125|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5846748|NCT00043615|Malignancy|malignancy
5484555|NCT01360125|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5484556|NCT01360125|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5484557|NCT01360125|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5484558|NCT01360125|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5484559|NCT01360125|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5484560|NCT01360125|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5484561|NCT01360125|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5484562|NCT01360125|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5484563|NCT01360125|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5484564|NCT01360112|Mosquito|mosquito
5484565|NCT01360112|Membrane|membrane
5484566|NCT01360112|Feeding|feeding
5484567|NCT01360112|Parasites|parasites
5484568|NCT01360112|Infection|infection
5484569|NCT01360112|Malaria|malaria
5484570|NCT01360099|Atypical Hip Fracture|atypical hip fracture
5484571|NCT01360099|Biosphosphonates|biosphosphonates
5484572|NCT01360099|Subtrochanteric Hip Fracture|subtrochanteric hip fracture
5484573|NCT01360099|Osteoporosis|osteoporosis
5484574|NCT01360086|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5484575|NCT01360086|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5484576|NCT01360086|stage IB gastric cancer|stage ib gastric cancer
5484577|NCT01360086|stage IIA gastric cancer|stage iia gastric cancer
5484578|NCT01360086|stage IIB gastric cancer|stage iib gastric cancer
5484579|NCT01360086|stage IIIA gastric cancer|stage iiia gastric cancer
5484580|NCT01360086|stage IIIB gastric cancer|stage iiib gastric cancer
5484581|NCT01360086|stage IIIC gastric cancer|stage iiic gastric cancer
5484583|NCT01360073|low dose aspirin|low dose aspirin
5484584|NCT01360073|PPI|ppi
5484585|NCT01360073|epidemiology|epidemiology
5484586|NCT01360073|Nonfatal MI and coronary death|nonfatal mi and coronary death
5484587|NCT01360047|MI|mi
5484588|NCT01360047|low dose aspirin|low dose aspirin
5484589|NCT01360047|PPI|ppi
5484590|NCT01360047|epidemiology|epidemiology
5484591|NCT01360034|Obstetric labor, premature|obstetric labor, premature
5484592|NCT01360034|Short cervix|short cervix
5484593|NCT01360034|Nifedipine|nifedipine
5484594|NCT01360034|Indomethacin|indomethacin
5484595|NCT01360008|Cardiac arrhythmia|cardiac arrhythmia
5484596|NCT01360008|Catheter ablation|catheter ablation
5484597|NCT01360008|Cohort Study|cohort study
5484598|NCT01360008|cryoballoon|cryoballoon
5484599|NCT01360008|radiofrequency|radiofrequency
5484600|NCT01359995|cytomegalovirus endotheliitis|cytomegalovirus endotheliitis
5484601|NCT01359982|Advanced Solid Tumors|advanced solid tumors
5484602|NCT01359982|Lymphomas|lymphomas
5484603|NCT01359982|Safety|safety
5484604|NCT01359982|Blood flow|blood flow
5484605|NCT01359982|Nitric oxide|nitric oxide
5484606|NCT01359982|Cancer|cancer
5484607|NCT01359982|Dynamic contrast enhanced MRI (DCE-MRI)|dynamic contrast enhanced mri (dce-mri)
5484611|NCT01359969|Angioedema|angioedema
5484612|NCT01359969|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5484613|NCT01359969|rhC1INH|rhc1inh
5484614|NCT01359969|Pediatrics|pediatrics
5484615|NCT01359943|Rheumatoid Arthritis|rheumatoid arthritis
5484616|NCT01359943|RA|ra
5484617|NCT01359943|secukinumab|secukinumab
5484618|NCT01359943|AIN457|ain457
5484619|NCT01359943|inflammatory joints|inflammatory joints
5484620|NCT01359943|American College of Rheumatology|american college of rheumatology
5484621|NCT01359943|ACR|acr
5484622|NCT01359904|dialysate glucose|dialysate glucose
5484623|NCT01359904|glycemic control|glycemic control
5484624|NCT01359904|hypoglycemic episodes|hypoglycemic episodes
5484625|NCT01359878|Postpartum haemorrhage|postpartum haemorrhage
5484626|NCT01359878|Postpartum bleeding|postpartum bleeding
5484627|NCT01359878|Postnatal bleeding|postnatal bleeding
5484628|NCT01359878|Fibrinogen concentrate|fibrinogen concentrate
5484629|NCT01359878|Transfusion|transfusion
5484630|NCT01359878|Haemostatis|haemostatis
5484631|NCT01359878|Thrombelastography|thrombelastography
5484632|NCT01359865|Total hip arthroplasty|total hip arthroplasty
5484633|NCT01359865|lumbar plexus block|lumbar plexus block
5484634|NCT01359865|spinal anesthesia|spinal anesthesia
5484635|NCT01359865|range of motion|range of motion
5484636|NCT01359865|Anesthetic Technique|anesthetic technique
5484637|NCT01359865|Post-operative Pain Scores|post-operative pain scores
5484638|NCT01359852|JNJ-42491293|jnj-42491293
5484639|NCT01359852|JNJ-40411813|jnj-40411813
5484640|NCT01359852|Metabotropic glutamate subtype 2 receptor (mGlu2R)|metabotropic glutamate subtype 2 receptor (mglu2r)
5484641|NCT01359852|Positive allosteric modulator (PAM)|positive allosteric modulator (pam)
5484642|NCT01359852|positron emission tomography (PET)|positron emission tomography (pet)
5484643|NCT01359826|Systemic Lupus Erythematosus|systemic lupus erythematosus
5484644|NCT01359826|Widespread Pain|widespread pain
5484645|NCT01359826|Fibromyalgia|fibromyalgia
5484646|NCT01359826|Fatigue|fatigue
5484647|NCT01359826|Pain|pain
5484648|NCT01359826|Quality of Life|quality of life
5484649|NCT01359800|HIV|hiv
5484650|NCT01359800|HAART|haart
5484652|NCT01359774|Metabolism|metabolism
5484653|NCT01359774|Spectroscopy|spectroscopy
5484658|NCT01359748|Non Invasive Blood Pressure measurement study.|non invasive blood pressure measurement study.
5484659|NCT01359735|Wound|wound
5484660|NCT01359735|non-melanoma skin cancer|non-melanoma skin cancer
5484661|NCT01359735|Mohs micrographic surgery|mohs micrographic surgery
5484662|NCT01359735|Head or neck|head or neck
5484663|NCT01359722|N-acetylcysteine|n-acetylcysteine
5484664|NCT01359722|Myocardial Revascularization|myocardial revascularization
5484665|NCT01359722|Acute Renal Failure|acute renal failure
5484666|NCT01359722|Oxidative Stress|oxidative stress
5484667|NCT01359696|solid cancers|solid cancers
5484668|NCT01359670|Duchenne|duchenne
5484669|NCT01359670|muscular dystrophy|muscular dystrophy
5484671|NCT01359670|sildenafil|sildenafil
5484672|NCT01359670|muscle ischemia|muscle ischemia
5484673|NCT01359670|exercise|exercise
5484674|NCT01359657|Relapsed|relapsed
5484675|NCT01359657|Refractory|refractory
5484676|NCT01359631|Chronic Cluster Headache|chronic cluster headache
5484677|NCT01359618|Phase I|phase i
5484678|NCT01359618|Safety|safety
5484679|NCT01359618|tolerability|tolerability
5484680|NCT01359618|healthy|healthy
5484681|NCT01359618|major depressive disorder|major depressive disorder
5484682|NCT01359618|thorough QT|thorough qt
5484683|NCT01359618|maximum tolerated dose|maximum tolerated dose
5484684|NCT01359618|elimination|elimination
5484685|NCT01359618|heart electrical signal|heart electrical signal
5484686|NCT01359605|ADME|adme
5484687|NCT01359605|Healthy volunteers|healthy volunteers
5484688|NCT01359592|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5484689|NCT01359592|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5484690|NCT01359592|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5484691|NCT01359592|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5484692|NCT01359592|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5484693|NCT01359579|renal impairment|renal impairment
5484694|NCT01359579|phase 1|phase 1
5484695|NCT01359579|healthy volunteers|healthy volunteers
5484696|NCT01359540|Total Hip Arthroplasty|total hip arthroplasty
5484697|NCT01359540|Bone Loss|bone loss
5484698|NCT01359540|Femoral Remodeling|femoral remodeling
5484701|NCT01359540|DXA|dxa
5484702|NCT01359540|DEXA|dexa
5484703|NCT01359540|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
5484704|NCT01359527|Total Hip Replacement|total hip replacement
5484705|NCT01359527|Hip Resurfacing|hip resurfacing
5484706|NCT01359527|Femoral Remodeling|femoral remodeling
5484707|NCT01359527|Bone Loss|bone loss
5484708|NCT01359527|Bone Mineral Density|bone mineral density
5484709|NCT01359527|BMD|bmd
5484710|NCT01359527|DXA|dxa
5484711|NCT01359527|DEXA|dexa
5484712|NCT01359527|THA|tha
5484713|NCT01359501|patients receiving chemotherapy|patients receiving chemotherapy
5484714|NCT01359488|Growth Hormone Deficiency|growth hormone deficiency
5484715|NCT01359488|rhGH|rhgh
5484716|NCT01359488|hGH|hgh
5484717|NCT01359488|Versartis|versartis
5484718|NCT01359488|AGHD|aghd
5484719|NCT01359488|Hormones|hormones
5484720|NCT01359488|Hormone substitute|hormone substitute
5484721|NCT01359488|Endocrin System disease|endocrin system disease
5484722|NCT01359488|Bone disease|bone disease
5484723|NCT01359488|Bone disease, developmental|bone disease, developmental
5484724|NCT01359488|Bone diseases|bone diseases
5484725|NCT01359488|Musculoskeletal diseases|musculoskeletal diseases
5484726|NCT01359488|Bone diseases, endocrine|bone diseases, endocrine
5484727|NCT01359488|Metabolism diseases|metabolism diseases
5484728|NCT01359488|Hypopituitarism|hypopituitarism
5484729|NCT01359488|Pituitary disease|pituitary disease
5484730|NCT01359488|Hypothalmic disease|hypothalmic disease
5484731|NCT01359488|Brain disease|brain disease
5484732|NCT01359488|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5484733|NCT01359488|Hormone replacement therapy|hormone replacement therapy
5484734|NCT01359488|IGF-I|igf-i
5484735|NCT01359488|IGFBP-3|igfbp-3
5484736|NCT01359475|Acetal crowns|acetal crowns
5484737|NCT01359475|Primary molars|primary molars
5484738|NCT01359475|The retention of acetal crowns in primary dentition|the retention of acetal crowns in primary dentition
5484739|NCT01359475|Color changes of acetal crowns|color changes of acetal crowns
5484740|NCT01359462|hepatic cirrhosis patients with ascites|hepatic cirrhosis patients with ascites
5484741|NCT01359449|Meningitis|meningitis
5484742|NCT01359449|Meningococcal Infection|meningococcal infection
5484743|NCT01359449|Menactra®|menactra®
5484744|NCT01359449|MenC|menc
5484745|NCT01359410|Pancreas adenocarcinoma|pancreas adenocarcinoma
5484746|NCT01359410|Precancerous lesions of the pancreas (mucinous cystic neoplasms, IPMN)|precancerous lesions of the pancreas (mucinous cystic neoplasms, ipmn)
5484747|NCT01359410|Pancreas neuroendocrine cancer|pancreas neuroendocrine cancer
5484748|NCT01359397|Adenoca. stomach/gastr. Junct.|adenoca. stomach/gastr. junct.
5487815|NCT01346514|Mental Disorders|mental disorders
5484749|NCT01359384|severe primary immune deficieny|severe primary immune deficieny
5484750|NCT01359371|Smoking Cessation|smoking cessation
5484751|NCT01359371|Telephone|telephone
5484752|NCT01359371|Hospital Volunteers|hospital volunteers
5484753|NCT01359358|MRSA|mrsa
5484754|NCT01359358|MLST|mlst
5484755|NCT01359358|PFGE|pfge
5484756|NCT01359358|Resistance|resistance
5484757|NCT01359358|isolated from colonization|isolated from colonization
5484758|NCT01359345|NSF|nsf
5484759|NCT01359345|ESRD|esrd
5484760|NCT01359345|MRA|mra
5484761|NCT01359345|MRI|mri
5484762|NCT01359345|occurrence of NSF|occurrence of nsf
5484763|NCT01359345|Use of Gadollinum|use of gadollinum
5484764|NCT01359332|Convulsive status EPILEPTICUS|convulsive status epilepticus
5484765|NCT01359332|hypothermia therapy|hypothermia therapy
5484766|NCT01359332|(defined as continuous SEIZURING for longer than 5 min or three seizures|(defined as continuous seizuring for longer than 5 min or three seizures
5484767|NCT01359332|not separated by recovery of normal consciousness|not separated by recovery of normal consciousness
5484768|NCT01359332|or of the level of consciousness present before the|or of the level of consciousness present before the
5484769|NCT01359332|seizures)|seizures)
5484770|NCT01359319|Phase 1 Safety and Pharmacokinetic Study|phase 1 safety and pharmacokinetic study
5484771|NCT01359306|Acute myocardial infarction|acute myocardial infarction
5484772|NCT01359306|Right ventricular infarction|right ventricular infarction
5484773|NCT01359306|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5484774|NCT01359306|Prognosis|prognosis
5484775|NCT01359280|HIV|hiv
5484776|NCT01359280|AIDS|aids
5484777|NCT01359280|Medication|medication
5484778|NCT01359280|Adherence|adherence
5484779|NCT01359241|dysglycemia|dysglycemia
5484780|NCT01359241|diabetes|diabetes
5484781|NCT01359241|closed loop insulin delivery|closed loop insulin delivery
5484782|NCT01359228|Rosacea|rosacea
5484783|NCT01359202|Stroke|stroke
5484784|NCT01359202|ICH|ich
5484785|NCT01359202|Intracerebral hemorrhage|intracerebral hemorrhage
5484786|NCT01359202|acute stroke|acute stroke
5484787|NCT01359202|rfVIIa|rfviia
5484788|NCT01359202|Niastase|niastase
5484789|NCT01359189|Suspected Primary Prostate Cancer|suspected primary prostate cancer
5484790|NCT01359163|bioequivalence study|bioequivalence study
5484791|NCT01359163|marketed vs reformulation tablets|marketed vs reformulation tablets
5484792|NCT01359163|Femulen|femulen
5484793|NCT01359137|Behavior|behavior
5484794|NCT01359137|Drug users|drug users
5484795|NCT01359137|Criminal Justice|criminal justice
5484796|NCT01359137|Probation|probation
5484797|NCT01359124|Osteoarthritis, Knee|osteoarthritis, knee
5484798|NCT01359124|Exercise Therapies|exercise therapies
5484799|NCT01359111|Intradermal injections|intradermal injections
5484800|NCT01359111|Vaccination|vaccination
5484801|NCT01359098|swimmer's ear|swimmer's ear
5484802|NCT01359098|ear drops|ear drops
5484803|NCT01359098|ear foam|ear foam
5484804|NCT01359098|otic foam|otic foam
5484805|NCT01359098|ear infection|ear infection
5484806|NCT01359098|ear pain|ear pain
5484807|NCT01359098|ear inflammation|ear inflammation
5484808|NCT01359085|To compare postoperative pain relief by pregabalin versus ISBPB following arthroscopic rotator cuff repair|to compare postoperative pain relief by pregabalin versus isbpb following arthroscopic rotator cuff repair
5789991|NCT00146224|chronic kidney disease, CKD|chronic kidney disease, ckd
5484809|NCT01359085|To compare postoperative opioid consumption and opioid related AEs|to compare postoperative opioid consumption and opioid related aes
5484810|NCT01359085|To compare patients recovery profile and patients satisfaction|to compare patients recovery profile and patients satisfaction
5484811|NCT01359072|coping|coping
5484812|NCT01359072|psychological distress|psychological distress
5484813|NCT01359072|self-administered intervention|self-administered intervention
5484814|NCT01359059|assess the beneficial effects of PGL administered either pre or post surgery|assess the beneficial effects of pgl administered either pre or post surgery
5484815|NCT01359059|assess the satisfaction rate in the orthopedic oncologic patients|assess the satisfaction rate in the orthopedic oncologic patients
5484816|NCT01359046|CAUTI|cauti
5484817|NCT01359046|UTI|uti
5484818|NCT01359033|Myocardial Infarction|myocardial infarction
5484819|NCT01359033|UK|uk
5484820|NCT01359033|Sweden|sweden
5484821|NCT01359033|National audit registry|national audit registry
5484822|NCT01359033|MINAP|minap
5484823|NCT01359033|RIKS-HIA|riks-hia
5484824|NCT01359020|Fever|fever
5484825|NCT01359020|Ibuprofen|ibuprofen
5484826|NCT01359020|Acetaminophen|acetaminophen
5484827|NCT01359020|Dipyrone|dipyrone
5484828|NCT01359007|Locally advanced unresectable adenocarcinoma of pancreas|locally advanced unresectable adenocarcinoma of pancreas
5484829|NCT01359007|Borderline resectable adenocarcinoma of pancreas|borderline resectable adenocarcinoma of pancreas
5484830|NCT01358994|metformin|metformin
5484831|NCT01358994|type 2 diabetes|type 2 diabetes
5484832|NCT01358994|e-GFR|e-gfr
5484833|NCT01358994|creatinine|creatinine
5484834|NCT01358994|lactic acidosis|lactic acidosis
5484835|NCT01358955|mild cognitive impairment|mild cognitive impairment
5484836|NCT01358955|cognitive therapy|cognitive therapy
5484837|NCT01358955|prevention|prevention
5484838|NCT01358916|antimicrobial resistance|antimicrobial resistance
5484839|NCT01358916|antibiotic prescription|antibiotic prescription
5484841|NCT01358916|cluster-randomized trial|cluster-randomized trial
5484842|NCT01358890|over weight|over weight
5484843|NCT01358890|obesity|obesity
5484844|NCT01358838|Patients with either hypertrophic or atrophic scars|patients with either hypertrophic or atrophic scars
5484845|NCT01358838|Efficacy of ablative 10600nm fractional laser therapy|efficacy of ablative 10600nm fractional laser therapy
5484846|NCT01358838|Laser therapy compared to no treatment of (part of) the scar|laser therapy compared to no treatment of (part of) the scar
5484847|NCT01358825|Infanrix-IPV/Hib|infanrix-ipv/hib
5484848|NCT01358825|Long-term follow up|long-term follow up
5484849|NCT01358825|Persistence|persistence
5484850|NCT01358825|Infanrix hexa|infanrix hexa
5484851|NCT01358812|RAS Wild-Type|ras wild-type
5484852|NCT01358812|BRAF Wild-Type|braf wild-type
5484853|NCT01358799|Chlamydia trachomatis|chlamydia trachomatis
5484854|NCT01358799|APTIMA Assay for Chlamydia trachomatis|aptima assay for chlamydia trachomatis
5484856|NCT01358786|seroma|seroma
5484857|NCT01358786|Procedure|procedure
5484858|NCT01358786|Surgery|surgery
5484859|NCT01358773|Obesity|obesity
5484860|NCT01358773|Therapy|therapy
5484861|NCT01358773|Interdisciplinary|interdisciplinary
5484862|NCT01358760|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
5484863|NCT01358760|Atrophic Vaginitis|atrophic vaginitis
5484864|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone
5484865|NCT01358760|DHEA|dhea
5484866|NCT01358760|Prasterone|prasterone
5484867|NCT01358760|Vaginorm|vaginorm
5484868|NCT01358760|Menopause|menopause
5484869|NCT01358760|Intrarosa|intrarosa
5484870|NCT01358734|AML|aml
5484871|NCT01358734|elderly|elderly
5484872|NCT01358734|acute myelogenous leukemia|acute myelogenous leukemia
5484873|NCT01358734|vidaza|vidaza
5484874|NCT01358734|azacitidine|azacitidine
5484875|NCT01358734|elderly AML|elderly aml
5484876|NCT01358734|revlimid|revlimid
5484877|NCT01358734|lenalidomide|lenalidomide
5484878|NCT01358695|Lateral Canthal Lines|lateral canthal lines
5484879|NCT01358695|Crow's Feet|crow's feet
5484880|NCT01358669|Denosumab|denosumab
5484881|NCT01358669|Total Hip Arthroplasty|total hip arthroplasty
5484882|NCT01358643|OEF/OIF|oef/oif
5484883|NCT01358643|Physical Activity|physical activity
5484884|NCT01358643|Preferences|preferences
5484885|NCT01358630|Periodontitis|periodontitis
5484886|NCT01358630|Vascular disease|vascular disease
5484887|NCT01358630|Proinflammatory cytokines|proinflammatory cytokines
5484888|NCT01358604|localized resectable neuroblastoma|localized resectable neuroblastoma
5484890|NCT01358604|regional neuroblastoma|regional neuroblastoma
5484891|NCT01358604|stage 4S neuroblastoma|stage 4s neuroblastoma
5484892|NCT01358604|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5484893|NCT01358578|Psoriasis,|psoriasis,
5484894|NCT01358578|inflammatory skin disease,|inflammatory skin disease,
5485094|NCT01357824|aspiration|aspiration
5484895|NCT01358578|scaly patches|scaly patches
5484896|NCT01358578|Psoriasis|psoriasis
5484897|NCT01358578|inflammatory skin disease|inflammatory skin disease
5484899|NCT01358552|Neevo DHA|neevo dha
5484900|NCT01358552|L-methylfolate|l-methylfolate
5484901|NCT01358552|anemia during pregnancy|anemia during pregnancy
5484902|NCT01358552|folic acid|folic acid
5484903|NCT01358552|vitamin B12|vitamin b12
5484904|NCT01358552|prenatal vitamins|prenatal vitamins
5484905|NCT01358552|hemoglobin|hemoglobin
5484906|NCT01358552|iron deficiency|iron deficiency
5484907|NCT01358552|Pregnancy|pregnancy
5484908|NCT01358539|palliation|palliation
5484909|NCT01358539|pain education|pain education
5484910|NCT01358526|Low back pain|low back pain
5484911|NCT01358526|Chronic pain|chronic pain
5484912|NCT01358526|Opioid|opioid
5484913|NCT01358526|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5484914|NCT01358513|Positron Emission Tomography|positron emission tomography
5484915|NCT01358513|Inflammation|inflammation
5484916|NCT01358513|Calcification|calcification
5484917|NCT01358500|opioid dependence|opioid dependence
5484918|NCT01358500|tolerant|tolerant
5484919|NCT01358500|dependent|dependent
5484920|NCT01358487|Major depression|major depression
5484921|NCT01358487|Cognitive Behavioral preventive intervention|cognitive behavioral preventive intervention
5484922|NCT01358487|Mood Management|mood management
5484923|NCT01358487|Self-help|self-help
5484924|NCT01358487|Internet|internet
5484925|NCT01358474|Parkinson disease|parkinson disease
5484926|NCT01358474|idiopathic rapid eye movement sleep disorder|idiopathic rapid eye movement sleep disorder
5484927|NCT01358474|Gaucher disease|gaucher disease
5484928|NCT01358474|healthy volunteer|healthy volunteer
5484929|NCT01358448|Treatment of childhood obesity|treatment of childhood obesity
5484930|NCT01358422|Prospective observational study|prospective observational study
5484931|NCT01358422|major adverse cardiac events (MACE)|major adverse cardiac events (mace)
5484932|NCT01358422|clinically significant bleeding events|clinically significant bleeding events
5485059|NCT01357941|deep vein thrombosis|deep vein thrombosis
5484933|NCT01358422|Dual anti-platelet therapy|dual anti-platelet therapy
5484937|NCT01358422|placement of a bare metal or drug eluting stent|placement of a bare metal or drug eluting stent
5484939|NCT01358422|Simon Howell|simon howell
5484941|NCT01358422|European Society of Anaesthesiology|european society of anaesthesiology
5484942|NCT01358409|steatosis|steatosis
5484943|NCT01358409|MR spectroscopy|mr spectroscopy
5484944|NCT01358409|Nebivolol|nebivolol
5484945|NCT01358409|cardiac MRI|cardiac mri
5484946|NCT01358396|Diabetic Macular Edema, Glycemic Control|diabetic macular edema, glycemic control
5484947|NCT01358383|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5484949|NCT01358383|VIMOVO|vimovo
5484950|NCT01358383|fasting state|fasting state
5484951|NCT01358383|Amount of VIMOVO in the blood|amount of vimovo in the blood
5484952|NCT01358383|taken on empty stomach|taken on empty stomach
5484953|NCT01358370|LAL Deficiency|lal deficiency
5484954|NCT01358370|LIPA|lipa
5484955|NCT01358370|Wolman disease|wolman disease
5484957|NCT01358370|Early Onset LAL Deficiency|early onset lal deficiency
5484958|NCT01358370|Acid Lipase Deficiency|acid lipase deficiency
5484959|NCT01358357|Lurasidone|lurasidone
5484960|NCT01358357|Latuda|latuda
5484961|NCT01358357|Bipolar I|bipolar i
5484962|NCT01358318|obesity|obesity
5484963|NCT01358318|satiety|satiety
5484964|NCT01358318|soy protein|soy protein
5484965|NCT01358318|soy fiber|soy fiber
5484966|NCT01358318|control appetite|control appetite
5484967|NCT01358318|reduce food intake|reduce food intake
5484968|NCT01358305|muscle|muscle
5484969|NCT01358305|synthesis|synthesis
5484970|NCT01358305|mTOR|mtor
5484971|NCT01358305|antioxidant|antioxidant
5484972|NCT01358305|inflammatory markers|inflammatory markers
5484973|NCT01358305|soy protein|soy protein
5484974|NCT01358305|whey|whey
5484975|NCT01358305|casein|casein
5484976|NCT01358292|Intramedullary tibia nailing|intramedullary tibia nailing
5484977|NCT01358292|Anterior Knee Pain|anterior knee pain
5484978|NCT01358292|Nail positioning|nail positioning
5484979|NCT01358253|Rituximab|rituximab
5484980|NCT01358253|HyperCVAD|hypercvad
5484981|NCT01358240|Econazole Nitrate|econazole nitrate
5484982|NCT01358240|Foam|foam
5484983|NCT01358240|Quinnova|quinnova
5484984|NCT01358240|Tinea Pedis|tinea pedis
5484985|NCT01358214|Sub-urethral Sling|sub-urethral sling
5484986|NCT01358214|Treatment Outcome|treatment outcome
5484987|NCT01358214|Quality of Life|quality of life
5484988|NCT01358201|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5484989|NCT01358188|Gaucher disease|gaucher disease
5484990|NCT01358188|immunity|immunity
5484991|NCT01358188|inflammation|inflammation
5484992|NCT01358188|macrophage activation|macrophage activation
5485196|NCT01357291|Behavior|behavior
5484993|NCT01358175|Ankylosing spondylitis|ankylosing spondylitis
5484995|NCT01358175|ASAS|asas
5484996|NCT01358175|inflammatory back pain|inflammatory back pain
5484997|NCT01358162|Tuberculosis|tuberculosis
5484998|NCT01358136|Thyroidectomy|thyroidectomy
5484999|NCT01358136|Mitochondria|mitochondria
5485000|NCT01358123|liver cirrhosis|liver cirrhosis
5485001|NCT01358123|portal hypertension|portal hypertension
5485002|NCT01358123|survival|survival
5485003|NCT01358123|von willebrand factor|von willebrand factor
5485004|NCT01358123|hepatic venous pressure gradient|hepatic venous pressure gradient
5485005|NCT01358110|palliative care|palliative care
5485006|NCT01358110|cancer|cancer
5485007|NCT01358110|emergency medicine|emergency medicine
5485008|NCT01358110|end- of- life care|end- of- life care
5485009|NCT01358097|Head and neck cancer|head and neck cancer
5485010|NCT01358097|Oropharyngeal cancer|oropharyngeal cancer
5485011|NCT01358097|Human papillomavirus|human papillomavirus
5485012|NCT01358097|Squamous cell carcinoma|squamous cell carcinoma
5485013|NCT01358097|Radiation treatment|radiation treatment
5485014|NCT01358097|Chemotherapy|chemotherapy
5485015|NCT01358097|Induction chemotherapy|induction chemotherapy
5485016|NCT01358097|Immune status|immune status
5485017|NCT01358097|Immune monitoring|immune monitoring
5485018|NCT01358097|head and neck robotic surgery|head and neck robotic surgery
5485019|NCT01358084|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5485020|NCT01358084|MPM|mpm
5485021|NCT01358084|Maintenance treatment|maintenance treatment
5485022|NCT01358084|NGR-hTNF|ngr-htnf
5485023|NCT01358071|NGR-hTNF|ngr-htnf
5485024|NCT01358071|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5485025|NCT01358071|Doxorubicin|doxorubicin
5485026|NCT01358071|Platinum-resistant|platinum-resistant
5485027|NCT01358071|Progression or recurrence Ovarian Cancer|progression or recurrence ovarian cancer
5485028|NCT01358071|Ovarian Cancer|ovarian cancer
5485029|NCT01358071|Advanced or metastatic|advanced or metastatic
5485030|NCT01358058|Brain tumors|brain tumors
5485031|NCT01358058|Radiation|radiation
5485033|NCT01358058|Gliomas|gliomas
5485034|NCT01358045|Topical|topical
5485035|NCT01358045|Diclofenac|diclofenac
5485036|NCT01358045|Vitamin D3|vitamin d3
5485037|NCT01358032|Fear of falling|fear of falling
5485038|NCT01358032|Cognitive behavioral therapy|cognitive behavioral therapy
5485039|NCT01358032|Randomized controlled trial|randomized controlled trial
5485040|NCT01358032|Frailty|frailty
5485041|NCT01358032|Accidental Falls|accidental falls
5485042|NCT01358006|JNJ-40411813|jnj-40411813
5485043|NCT01358006|Positron Emission Tomography (PET)|positron emission tomography (pet)
5485044|NCT01358006|Serotonin-2A (5-HT2A) receptor antagonist|serotonin-2a (5-ht2a) receptor antagonist
5485045|NCT01358006|Male Volunteers|male volunteers
5485046|NCT01357993|Methylphenidate hydrochloride|methylphenidate hydrochloride
5485047|NCT01357993|Concerta|concerta
5485048|NCT01357993|Adults|adults
5485049|NCT01357993|Attention-Deficit / Hyperactivity Disorder|attention-deficit / hyperactivity disorder
5485050|NCT01357993|ADHD|adhd
5485051|NCT01357993|Long term safety|long term safety
5485052|NCT01357980|Detrusor Muscle Overactivity|detrusor muscle overactivity
5485053|NCT01357954|Postural control|postural control
5485054|NCT01357954|Targeted Training|targeted training
5485056|NCT01357954|Cerebral palsy|cerebral palsy
5485057|NCT01357941|venous thromboembolism|venous thromboembolism
5485058|NCT01357941|thromboembolism|thromboembolism
5485060|NCT01357941|pulmonary embolism|pulmonary embolism
5485061|NCT01357941|thromboprophylaxis|thromboprophylaxis
5485062|NCT01357941|thrombosis|thrombosis
5485063|NCT01357941|embolism and thrombosis|embolism and thrombosis
5485064|NCT01357941|cardiovascular diseases|cardiovascular diseases
5485065|NCT01357941|venous thrombosis|venous thrombosis
5485066|NCT01357941|vascular diseases|vascular diseases
5485067|NCT01357941|anticoagulants|anticoagulants
5485068|NCT01357941|hematologic agents|hematologic agents
5485069|NCT01357941|cardiovascular agents|cardiovascular agents
5485070|NCT01357941|enoxaparin|enoxaparin
5485071|NCT01357941|dalteparin|dalteparin
5485072|NCT01357941|tinzaparin|tinzaparin
5485073|NCT01357941|pregnancy complications|pregnancy complications
5485074|NCT01357928|TEG|teg
5485075|NCT01357928|Thromboelastography|thromboelastography
5485076|NCT01357928|Coagulation|coagulation
5485077|NCT01357915|Cytomegalovirus|cytomegalovirus
5485078|NCT01357915|Vaccine|vaccine
5485079|NCT01357889|pharmacokinetics|pharmacokinetics
5485080|NCT01357889|pharmacodynamics|pharmacodynamics
5485081|NCT01357889|GSK716155|gsk716155
5485082|NCT01357889|albiglutide|albiglutide
5485083|NCT01357863|Lapatinib|lapatinib
5485084|NCT01357863|Observational Study|observational study
5485085|NCT01357863|Trastuzumab|trastuzumab
5485086|NCT01357863|Brazil|brazil
5485087|NCT01357863|Metastatic Breast Cancer|metastatic breast cancer
5485088|NCT01357837|Osteoarthritis, knee|osteoarthritis, knee
5479465|NCT01381146|shame|shame
5485089|NCT01357837|Analgesia|analgesia
5485091|NCT01357837|Painful|painful
5485092|NCT01357824|Intubation|intubation
5485093|NCT01357824|Sellick´s maneuver|sellick´s maneuver
5485095|NCT01357824|[E05.497.578]|[e05.497.578]
5485096|NCT01357811|Genz-112638|genz-112638
5485098|NCT01357798|Headache|headache
5485099|NCT01357798|Allodynia|allodynia
5485100|NCT01357798|Botulinum Toxin Type A|botulinum toxin type a
5485101|NCT01357785|Periodontal ligament stem cells|periodontal ligament stem cells
5485102|NCT01357785|Periodontal regeneration|periodontal regeneration
5485103|NCT01357785|Clinical trial|clinical trial
5485104|NCT01357785|Deep intraosseous defects|deep intraosseous defects
5485105|NCT01357746|Pulmonary arterial blood pressure doppler|pulmonary arterial blood pressure doppler
5485106|NCT01357733|Diffuse, Large B-Cell, Lymphoma|diffuse, large b-cell, lymphoma
5485107|NCT01357733|18F Fluorodeoxyglucose|18f fluorodeoxyglucose
5485108|NCT01357733|Radionuclide-Emission Computed Tomography|radionuclide-emission computed tomography
5485109|NCT01357720|Vaccination|vaccination
5485110|NCT01357720|Immunisation|immunisation
5485111|NCT01357720|Virus|virus
5485112|NCT01357720|Diphtheria|diphtheria
5485113|NCT01357720|Pertussis|pertussis
5485114|NCT01357720|Tetanus|tetanus
5485115|NCT01357720|Hepatitis B|hepatitis b
5485116|NCT01357720|Haemophilus Influenzae|haemophilus influenzae
5485117|NCT01357720|Immunity|immunity
5485118|NCT01357694|psychotherapy|psychotherapy
5485119|NCT01357694|depression|depression
5485120|NCT01357694|anxiety|anxiety
5485121|NCT01357694|surgical patients|surgical patients
5485122|NCT01357681|Huntington Disease|huntington disease
5485123|NCT01357681|Cognition|cognition
5485124|NCT01357681|Motor|motor
5485125|NCT01357681|Behaviour|behaviour
5485126|NCT01357681|Functional Capacity|functional capacity
5485127|NCT01357681|Quality of Life|quality of life
5485128|NCT01357681|Biomarker|biomarker
5485129|NCT01357681|MRI|mri
5485130|NCT01357681|Huntingtin|huntingtin
5485131|NCT01357681|EGCG|egcg
5485132|NCT01357655|Myelogenous|myelogenous
5485133|NCT01357655|Chronic|chronic
5485134|NCT01357655|BCR-ABL Positive|bcr-abl positive
5485135|NCT01357642|asthma|asthma
5485136|NCT01357642|bronchial asthma|bronchial asthma
5485137|NCT01357642|shortness of breath|shortness of breath
5485138|NCT01357629|Vaccination follow-up|vaccination follow-up
5485139|NCT01357616|Glaucoma|glaucoma
5485140|NCT01357616|Open-angle glaucoma|open-angle glaucoma
5485141|NCT01357616|Ocular hypertension|ocular hypertension
5485143|NCT01357616|OH|oh
5485144|NCT01357590|aneurysm, penetrating ulcer, descending thoracic aorta|aneurysm, penetrating ulcer, descending thoracic aorta
5485145|NCT01357577|PTSD|ptsd
5485146|NCT01357577|Substance Use Disorders|substance use disorders
5485147|NCT01357564|dementia|dementia
5485148|NCT01357564|caregivers|caregivers
5485149|NCT01357564|tailored activity|tailored activity
5485150|NCT01357564|neuropsychiatric symptoms|neuropsychiatric symptoms
5485151|NCT01357564|behavioral symptoms|behavioral symptoms
5485152|NCT01357551|obesity|obesity
5485153|NCT01357551|intervention studies|intervention studies
5485154|NCT01357551|patient adherence|patient adherence
5485155|NCT01357538|Bibrocathol|bibrocathol
5485156|NCT01357538|eye ointment|eye ointment
5485157|NCT01357538|blepharitis|blepharitis
5485158|NCT01357538|eye lid|eye lid
5485159|NCT01357525|Pancreas|pancreas
5485160|NCT01357525|Resected|resected
5485161|NCT01357512|prostate cancer diagnosis|prostate cancer diagnosis
5485162|NCT01357512|magnetic resonance imaging|magnetic resonance imaging
5485163|NCT01357512|prostate biopsy|prostate biopsy
5485164|NCT01357486|Hepatocellular Carcinoma|hepatocellular carcinoma
5485165|NCT01357486|CHILD B|child b
5485166|NCT01357486|palliative management|palliative management
5485167|NCT01357486|Sorafenib|sorafenib
5485168|NCT01357486|Pravastatin|pravastatin
5485169|NCT01357473|hormonal values|hormonal values
5485170|NCT01357473|menstruations|menstruations
5485171|NCT01357473|pregnancy|pregnancy
5485172|NCT01357473|antagonist|antagonist
5485173|NCT01357460|Emphysema|emphysema
5485174|NCT01357460|alpha1 antitrypsin deficiency|alpha1 antitrypsin deficiency
5485175|NCT01357460|endoscopic lung volume reduction|endoscopic lung volume reduction
5485176|NCT01357447|Sjogren's syndrome|sjogren's syndrome
5485177|NCT01357447|Cough|cough
5485178|NCT01357408|without an indication for ICD or CRT|without an indication for icd or crt
5485179|NCT01357408|left ventricular function greater than or equal to 40%|left ventricular function greater than or equal to 40%
5485180|NCT01357395|Small Cell Lung Carcinoma|small cell lung carcinoma
5485181|NCT01357382|low fat diet|low fat diet
5485182|NCT01357382|low carbohydrate diet|low carbohydrate diet
5485183|NCT01357369|bacteria infections|bacteria infections
5485184|NCT01357343|Low back pain|low back pain
5485185|NCT01357343|Chiropractic|chiropractic
5485186|NCT01357343|Acupuncture|acupuncture
5485187|NCT01357343|Integrated care|integrated care
5485188|NCT01357330|locally advanced or metastatic|locally advanced or metastatic
5485189|NCT01357317|Kidney disease|kidney disease
5485190|NCT01357317|Hyperphosphatemia|hyperphosphatemia
5485192|NCT01357304|Group treatment|group treatment
5485193|NCT01357304|Physical activity referral|physical activity referral
5485194|NCT01357304|Type 2 diabetes|type 2 diabetes
5485195|NCT01357304|Hypertension|hypertension
5485197|NCT01357291|Drug users|drug users
5485199|NCT01357278|osteoporosis|osteoporosis
5485200|NCT01357278|exercise|exercise
5485201|NCT01357278|intervention|intervention
5485202|NCT01357278|rehabilitation|rehabilitation
5485203|NCT01357278|bone mineral density|bone mineral density
5485204|NCT01357278|muscle strength|muscle strength
5485205|NCT01357265|Seasonal Influenza|seasonal influenza
5485206|NCT01357265|vaccine|vaccine
5485207|NCT01357252|Diabetes mellitus|diabetes mellitus
5485208|NCT01357252|vildagliptin|vildagliptin
5485209|NCT01357239|Fragile X Syndrome|fragile x syndrome
5485210|NCT01357239|Martin-Bell Syndrome|martin-bell syndrome
5485211|NCT01357239|Genetic Diseases|genetic diseases
5485212|NCT01357239|X-Linked|x-linked
5485213|NCT01357239|Escalante's syndrome|escalante's syndrome
5485214|NCT01357226|measurement in two environments|measurement in two environments
5485215|NCT01357213|Botulism, Clostridium|botulism, clostridium
5485216|NCT01357187|Lumbar pathology|lumbar pathology
5467440|NCT01431300|thorax|thorax
5485217|NCT01357187|requiring elective lumbar interbody fusion|requiring elective lumbar interbody fusion
5485218|NCT01357096|intervention|intervention
5485219|NCT01357096|CABG or PTCA|cabg or ptca
5485220|NCT01357083|Melatonin|melatonin
5485221|NCT01357083|Periodicity|periodicity
5485222|NCT01357083|Depressive disorder, major|depressive disorder, major
5485223|NCT01357083|Serum|serum
5485224|NCT01357083|Depression|depression
5485225|NCT01357070|white blood cell|white blood cell
5485226|NCT01357070|broccoli|broccoli
5485227|NCT01357070|P38 Map Kinase|p38 map kinase
5485228|NCT01357057|Medical records|medical records
5485229|NCT01357057|Outcome scale|outcome scale
5485230|NCT01357057|Biological biomarkers|biological biomarkers
5485231|NCT01357044|Semen quality|semen quality
5485232|NCT01357044|Plant extracts|plant extracts
5485233|NCT01357031|Amitriptyline|amitriptyline
5485234|NCT01357031|Placebo|placebo
5485235|NCT01357031|Melatonin|melatonin
5485236|NCT01357031|Migraine|migraine
5485237|NCT01357031|Headache|headache
5485238|NCT01357031|Drug therapy|drug therapy
5485239|NCT01357031|Preventive treatment of migraine|preventive treatment of migraine
5485240|NCT01357018|Ankylosing spondylitis|ankylosing spondylitis
5485241|NCT01357018|Disease activity|disease activity
5485242|NCT01357018|EQ-5D|eq-5d
5485243|NCT01357018|Quality of life|quality of life
5485244|NCT01357018|Rheumatoid arthritis|rheumatoid arthritis
5485245|NCT01356992|non-inferiority phase III study|non-inferiority phase iii study
5485246|NCT01356992|Low-Molecular Weight Heparin|low-molecular weight heparin
5485247|NCT01356992|Versa® (enoxaparin - Eurofarma)|versa® (enoxaparin - eurofarma)
5485248|NCT01356992|Clexane® (enoxaparin - Sanofi-Aventis)|clexane® (enoxaparin - sanofi-aventis)
5485249|NCT01356992|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
5485250|NCT01356979|Medical thoracoscopy|medical thoracoscopy
5485251|NCT01356979|Pleural effusion|pleural effusion
5485252|NCT01356979|Malignant pleural diseases|malignant pleural diseases
5485253|NCT01356979|Tuberculous pleuritis|tuberculous pleuritis
5485254|NCT01356979|Fibrinous pleuritis|fibrinous pleuritis
5485255|NCT01356953|Aerobic Exercise|aerobic exercise
5485256|NCT01356953|Blood Pressure|blood pressure
5485258|NCT01356927|long acting reversible contraception|long acting reversible contraception
5485259|NCT01356927|medical abortion|medical abortion
5485260|NCT01356927|DMPA|dmpa
5485261|NCT01356927|etonogestrel implant|etonogestrel implant
5485262|NCT01356927|Implanon|implanon
5485263|NCT01356927|contraceptive continuation|contraceptive continuation
5485264|NCT01356875|myelodysplastic syndrome|myelodysplastic syndrome
5485265|NCT01356875|Transfusion|transfusion
5485266|NCT01356875|Hydralazine|hydralazine
5485267|NCT01356875|valproic acid|valproic acid
5485268|NCT01356862|mastectomy|mastectomy
5485269|NCT01356862|axillary node dissection|axillary node dissection
5485270|NCT01356862|adjuvant or neoadjuvant|adjuvant or neoadjuvant
5485271|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists
5485272|NCT01356849|Proteinuria|proteinuria
5485273|NCT01356836|Coronary collateral development|coronary collateral development
5485274|NCT01356836|monocyte subsets|monocyte subsets
5485275|NCT01356836|collateralization|collateralization
5485276|NCT01356823|Human Papilloma Virus 16|human papilloma virus 16
5485277|NCT01356823|Human Papilloma Virus 18|human papilloma virus 18
5485278|NCT01356823|vaccine|vaccine
5485279|NCT01356823|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5485280|NCT01356823|cervical Cancer|cervical cancer
5485281|NCT01356810|Delirium|delirium
5485282|NCT01356810|Primary Prevention|primary prevention
5485283|NCT01356810|Elderly|elderly
5485284|NCT01356797|knee arthroscopy|knee arthroscopy
5485285|NCT01356797|hyperbaric bupivacaine|hyperbaric bupivacaine
5485286|NCT01356797|hypobaric levobupivacaine plus fentanyl|hypobaric levobupivacaine plus fentanyl
5485287|NCT01356784|Sick-listed|sick-listed
5485288|NCT01356784|Tailored physical activity|tailored physical activity
5485289|NCT01356784|Patient education|patient education
5485290|NCT01356784|Returning to work|returning to work
5485291|NCT01356784|DK-Sønderborg Municipality|dk-sønderborg municipality
5485292|NCT01356784|columna|columna
5485293|NCT01356784|upper body|upper body
5485294|NCT01356771|Risk Assessment|risk assessment
5485295|NCT01356771|Intervention|intervention
5485296|NCT01356745|premixed nitrous oxide and oxygen|premixed nitrous oxide and oxygen
5485297|NCT01356745|acute pain|acute pain
5485298|NCT01356745|prehospital setting|prehospital setting
5485299|NCT01356732|mechanical ventilation|mechanical ventilation
5485300|NCT01356732|Midazolam|midazolam
5485301|NCT01356732|Ramsay|ramsay
5485302|NCT01356732|Sufentanil|sufentanil
5485303|NCT01356719|Tracheostomy|tracheostomy
5485304|NCT01356719|adverse effects|adverse effects
5485305|NCT01356719|Critical Care|critical care
5485306|NCT01356719|standards|standards
5485307|NCT01356719|safety|safety
5485308|NCT01356706|liver metastases|liver metastases
5485309|NCT01356706|colorectal cancer|colorectal cancer
5485310|NCT01356706|surgery|surgery
5485311|NCT01356706|prognosis|prognosis
5485312|NCT01356693|Cough|cough
5485313|NCT01356693|Common cold|common cold
5485314|NCT01356693|Child|child
5485315|NCT01356693|Adolescent|adolescent
5485316|NCT01356680|Hodgkin Lymphoma|hodgkin lymphoma
5485317|NCT01356680|intermediate stage|intermediate stage
5485319|NCT01356667|American Indians|american indians
5485320|NCT01356667|Native Americans|native americans
5485321|NCT01356667|substance abuse|substance abuse
5485322|NCT01356667|culture|culture
5485323|NCT01356654|Stroke|stroke
5485324|NCT01356654|TDCS|tdcs
5485325|NCT01356654|Gait|gait
5485326|NCT01356654|Balance|balance
5485327|NCT01356654|loss of postural balance|loss of postural balance
5485328|NCT01356641|Antibiotic treatment|antibiotic treatment
5485329|NCT01356641|Non perforated appendicitis|non perforated appendicitis
5485330|NCT01356641|Children|children
5485331|NCT01356628|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5485332|NCT01356628|HCC|hcc
5485333|NCT01356628|Liver Cancer|liver cancer
5485334|NCT01356628|PD-0332991|pd-0332991
5485335|NCT01356615|anticoagulation|anticoagulation
5485336|NCT01356615|hemodialysis|hemodialysis
5485337|NCT01356615|heparin|heparin
5485338|NCT01356615|lipids|lipids
5485339|NCT01356615|low molecular weight heparins|low molecular weight heparins
5485340|NCT01356602|Gout|gout
5485341|NCT01356602|arthritis|arthritis
5485342|NCT01356602|gout flare|gout flare
5485343|NCT01356602|acute gout|acute gout
5485344|NCT01356602|gouty|gouty
5485345|NCT01356602|rheumatic disease|rheumatic disease
5485346|NCT01356602|uric acid|uric acid
5485347|NCT01356563|hemodialysis|hemodialysis
5485348|NCT01356563|pharmacist|pharmacist
5485349|NCT01356563|medication-related problems|medication-related problems
5485350|NCT01356563|compliance|compliance
5485351|NCT01356511|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5485352|NCT01356498|gout|gout
5485353|NCT01356498|chronic gout|chronic gout
5485354|NCT01356485|Sickle cell anemia|sickle cell anemia
5485355|NCT01356485|Sickle cell disease|sickle cell disease
5485356|NCT01356485|Sickling crisis|sickling crisis
5485357|NCT01356485|Vaso-occlusive crisis|vaso-occlusive crisis
5485358|NCT01356485|Carboxyhemoglobin|carboxyhemoglobin
5485359|NCT01356485|Oxygen therapeutic|oxygen therapeutic
5485360|NCT01356485|Hemoglobin solutions|hemoglobin solutions
5485361|NCT01356485|Pegylated hemoglobin|pegylated hemoglobin
5485362|NCT01356472|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5485363|NCT01356472|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5485364|NCT01356472|linezolid|linezolid
5485365|NCT01356472|imipenem/cilastatin|imipenem/cilastatin
5485366|NCT01356459|Pressure ulcers|pressure ulcers
5485367|NCT01356459|ICU|icu
5485368|NCT01356459|Prevention|prevention
5485369|NCT01356446|safety|safety
5485370|NCT01356446|team|team
5485371|NCT01356446|team performance|team performance
5485372|NCT01356446|surgery|surgery
5485373|NCT01356446|outcome|outcome
5485374|NCT01356433|dialysis,inflammation,vitamin C|dialysis,inflammation,vitamin c
5485375|NCT01356420|SLOS|slos
5485376|NCT01356394|Obesity|obesity
5485377|NCT01356394|Metabolic Syndrome|metabolic syndrome
5485378|NCT01356394|Microalbuminuria|microalbuminuria
5485379|NCT01356394|Chronic Kidney Disease|chronic kidney disease
5485380|NCT01356381|Diabetes mellitus|diabetes mellitus
5485381|NCT01356381|vildagliptin|vildagliptin
5485382|NCT01356368|Lung cancer|lung cancer
5485383|NCT01356355|Stent discomfort|stent discomfort
5485384|NCT01356355|Herbmed plus|herbmed plus
5485385|NCT01356355|Tolterodine|tolterodine
5485386|NCT01356342|Influenza|influenza
5485387|NCT01356342|Vaccine|vaccine
5485388|NCT01356342|Immunogenicity|immunogenicity
5485389|NCT01356329|Gynecologic malignancy ,major surgery|gynecologic malignancy ,major surgery
5485390|NCT01356316|Influenza|influenza
5485391|NCT01356316|Vaccine|vaccine
5485392|NCT01356316|Immunogenicity|immunogenicity
5485393|NCT01356303|Lung cancer|lung cancer
5485394|NCT01356290|Medulloblastoma|medulloblastoma
5485396|NCT01356290|Children|children
5485397|NCT01356290|antiangiogenic|antiangiogenic
5485398|NCT01356290|metronomic|metronomic
5485399|NCT01356290|intrathecal|intrathecal
5485410|NCT01356264|surgical recovery|surgical recovery
5485415|NCT01356251|questionnaires|questionnaires
5485416|NCT01356251|Internet-based support group|internet-based support group
5485417|NCT01356251|11-066|11-066
5485418|NCT01356225|pain following dental impaction surgery|pain following dental impaction surgery
5485419|NCT01356199|Gonalgia|gonalgia
5485420|NCT01356199|Quality of Life|quality of life
5485421|NCT01356199|Dietary supplement|dietary supplement
5485422|NCT01356199|Nutrition|nutrition
5485427|NCT01356173|solid cancers|solid cancers
5485428|NCT01356160|Hepatitis C|hepatitis c
5485429|NCT01356160|HCV|hcv
5485430|NCT01356160|Rapid Virologic Response|rapid virologic response
5485431|NCT01356160|Sustained Virologic Response|sustained virologic response
5485432|NCT01356160|Direct Acting Antiviral|direct acting antiviral
5485433|NCT01356160|Combination Therapy HCV RNA|combination therapy hcv rna
5485434|NCT01356160|Protease inhibitor|protease inhibitor
5485435|NCT01356160|Treatment naïve|treatment naïve
5485436|NCT01356160|GS-5885|gs-5885
5485437|NCT01356160|GS-9451|gs-9451
5485438|NCT01356147|ventilator associated pulmonary infections|ventilator associated pulmonary infections
5485439|NCT01356134|multiple sclerosis|multiple sclerosis
5485440|NCT01356134|ehlers danlos syndrome|ehlers danlos syndrome
5485441|NCT01356134|CCSVI|ccsvi
5485442|NCT01356134|chronic cerebrospinal venous insufficiency|chronic cerebrospinal venous insufficiency
5485443|NCT01356134|fundus|fundus
5485444|NCT01356134|retina|retina
5485445|NCT01356108|Conduit|conduit
5485446|NCT01356108|Pulmonic|pulmonic
5485447|NCT01356108|Stenosis|stenosis
5485448|NCT01356108|Regurgitation|regurgitation
5485449|NCT01356108|Dysfunctional|dysfunctional
5485450|NCT01356095|Tuberculosis|tuberculosis
5485451|NCT01356095|Treatment Adherence|treatment adherence
5485452|NCT01356095|knowledge translation|knowledge translation
5485453|NCT01356095|Educational outreach|educational outreach
5485454|NCT01356069|BPD|bpd
5485455|NCT01356069|MHS|mhs
5485456|NCT01356069|heavy users|heavy users
5485457|NCT01356069|sequential psychotherapy|sequential psychotherapy
5485458|NCT01356004|severe resistant|severe resistant
5485459|NCT01355991|Spinal Cord Injury|spinal cord injury
5485460|NCT01355991|Tetraplegia|tetraplegia
5485461|NCT01355991|Pulmonary Function|pulmonary function
5485462|NCT01355991|Bronchodilator|bronchodilator
5485463|NCT01355965|completed standard first line therapy|completed standard first line therapy
5485464|NCT01355965|platinum based double regimen|platinum based double regimen
5485465|NCT01355965|Progressive Disease|progressive disease
5485466|NCT01355965|chosen not to pursue primary standard of care therapy|chosen not to pursue primary standard of care therapy
5485468|NCT01355952|Weight Loss|weight loss
5485469|NCT01355952|Schizophrenia|schizophrenia
5485470|NCT01355952|Alpha Lipoic Acid|alpha lipoic acid
5485472|NCT01355939|Adhesiolysis|adhesiolysis
5485473|NCT01355939|Adhesions|adhesions
5485474|NCT01355939|Intraperitoneal Mesh|intraperitoneal mesh
5485475|NCT01355939|Abdominal Re-exploration|abdominal re-exploration
5485476|NCT01355939|Mesh|mesh
5485477|NCT01355939|Barrier-Coated Mesh|barrier-coated mesh
5485478|NCT01355939|Non-Barrier-Coated Mesh|non-barrier-coated mesh
5485479|NCT01355939|Laparoscopic Approach|laparoscopic approach
5485480|NCT01355939|Open Approach|open approach
5485481|NCT01355939|Abdominal Re-Exploration Surgery|abdominal re-exploration surgery
5485482|NCT01355926|Flexible Fiber-based CO2 Laser|flexible fiber-based co2 laser
5485483|NCT01355926|Monopolar Cautery|monopolar cautery
5485484|NCT01355926|Oral Cavity Lesions|oral cavity lesions
5485485|NCT01355926|Quality of life|quality of life
5485486|NCT01355926|Assessing Pain|assessing pain
5485487|NCT01355926|11-034|11-034
5485494|NCT01355900|Total knee arthroplasty|total knee arthroplasty
5485495|NCT01355900|Tourniquet|tourniquet
5485496|NCT01355900|Blood loss|blood loss
5485497|NCT01355900|Volume loading test|volume loading test
5485498|NCT01355887|blood loss|blood loss
5485499|NCT01355887|hepatectomy|hepatectomy
5485500|NCT01355887|prospective study|prospective study
5485502|NCT01355874|Internal Symptomatic Hemorrhoids|internal symptomatic hemorrhoids
5485503|NCT01355861|sarcopenia|sarcopenia
5485504|NCT01355861|aging|aging
5485505|NCT01355861|rehabilitation|rehabilitation
5485506|NCT01355861|exercise|exercise
5485507|NCT01355848|Suicide|suicide
5485508|NCT01355848|Brief Intervention|brief intervention
5485509|NCT01355848|Youth|youth
5485510|NCT01355848|Acute Medical Setting|acute medical setting
5485511|NCT01355848|Readiness to Change|readiness to change
5485512|NCT01355848|Suicidality|suicidality
5485513|NCT01355835|Parkinson's disease|parkinson's disease
5485514|NCT01355835|gait|gait
5485515|NCT01355835|deep brain stimulation|deep brain stimulation
5485516|NCT01355835|substantia nigra pars reticulata|substantia nigra pars reticulata
5485517|NCT01355835|subthalamic nucleus|subthalamic nucleus
5485518|NCT01355822|abortion|abortion
5485519|NCT01355822|perinatal death|perinatal death
5485520|NCT01355822|IUGR|iugr
5485522|NCT01355822|placental abruption|placental abruption
5485523|NCT01355822|preeclampsia|preeclampsia
5485524|NCT01355809|Six-Minute Walk Test|six-minute walk test
5485525|NCT01355757|shoulder arthroscopy|shoulder arthroscopy
5485526|NCT01355757|24-week follow-up|24-week follow-up
5485527|NCT01355757|quality of life|quality of life
5485528|NCT01355757|rehabilitation achievement|rehabilitation achievement
5485529|NCT01355757|rotator cuff repair|rotator cuff repair
5485530|NCT01355744|humans|humans
5485531|NCT01355744|insect bites|insect bites
5485532|NCT01355731|Registered Nurse|registered nurse
5485533|NCT01355731|Behaviors|behaviors
5485534|NCT01355731|Attitudes|attitudes
5485535|NCT01355692|DME|dme
5485536|NCT01355692|Laser|laser
5485537|NCT01355692|Selective laser therapy|selective laser therapy
5485538|NCT01355692|photocoagulation|photocoagulation
5485539|NCT01355666|pressure ulcers|pressure ulcers
5485540|NCT01355666|stage 1|stage 1
5485541|NCT01355666|stage 2|stage 2
5485542|NCT01355666|stage 3|stage 3
5485543|NCT01355666|stage 4|stage 4
5485544|NCT01355666|wounds|wounds
5485545|NCT01355666|sores|sores
5485546|NCT01355666|infection|infection
5485547|NCT01355666|bioburden|bioburden
5485548|NCT01355666|bacterial contamination|bacterial contamination
5485549|NCT01355666|bed linen|bed linen
5485550|NCT01355666|sheets|sheets
5485551|NCT01355666|underpad|underpad
5485552|NCT01355666|skin assessment|skin assessment
5485553|NCT01355666|microclimate|microclimate
5485554|NCT01355666|shear|shear
5485555|NCT01355666|friction|friction
5485556|NCT01355666|moisture|moisture
5485557|NCT01355666|fabrics|fabrics
5485558|NCT01355666|long term care|long term care
5485559|NCT01355666|nursing home|nursing home
5485560|NCT01355666|decubitus ulcer|decubitus ulcer
5485561|NCT01355666|bed ridden|bed ridden
5485562|NCT01355666|anti-microbial|anti-microbial
5485563|NCT01355653|heat|heat
5485564|NCT01355653|device|device
5485565|NCT01355653|safety|safety
5485566|NCT01355653|performance|performance
5485567|NCT01355653|heatwrap|heatwrap
5485568|NCT01355653|elderly|elderly
5485569|NCT01355653|overweight|overweight
5485570|NCT01355640|heel lance|heel lance
5485571|NCT01355640|pain|pain
5485572|NCT01355640|newborn|newborn
5485573|NCT01355627|CSF leaks|csf leaks
5485574|NCT01355627|Skull base surgery|skull base surgery
5485575|NCT01355627|pseudomeningocele|pseudomeningocele
5485576|NCT01355627|TachoSil®|tachosil®
5485577|NCT01355627|Prevention|prevention
5485578|NCT01355627|post-operative|post-operative
5485579|NCT01355614|Crohn's Disease|crohn's disease
5485581|NCT01355575|Microbiota|microbiota
5485582|NCT01355575|Insulin resistance|insulin resistance
5485583|NCT01355575|Bacterial endotoxin|bacterial endotoxin
5485584|NCT01355575|Hepatic triglyceride|hepatic triglyceride
5485585|NCT01355575|Inflammation|inflammation
5485586|NCT01355549|Shoulder pain|shoulder pain
5485587|NCT01355549|Rotator cuff disease|rotator cuff disease
5485588|NCT01355549|Spinal cord injuries|spinal cord injuries
5485589|NCT01355549|Platelet-rich plasma therapy|platelet-rich plasma therapy
5485590|NCT01355549|Rehabilitation|rehabilitation
5485591|NCT01355536|Preterm birth|preterm birth
5485592|NCT01355536|Preterm labour|preterm labour
5485593|NCT01355536|Polycystic Ovary Syndrome|polycystic ovary syndrome
5485594|NCT01355536|PCOS|pcos
5485595|NCT01355536|Diabetes Mellitus|diabetes mellitus
5485596|NCT01355536|Hyperandrogenism|hyperandrogenism
5485597|NCT01355536|Hirsutism|hirsutism
5485598|NCT01355536|Ovarian cysts|ovarian cysts
5485599|NCT01355536|Anti Muller Hormone|anti muller hormone
5485600|NCT01355536|Hypertension|hypertension
5485601|NCT01355523|Breast cancer surgery|breast cancer surgery
5485602|NCT01355523|Melatonin|melatonin
5485603|NCT01355523|Depression|depression
5485604|NCT01355523|Anxiety|anxiety
5485605|NCT01355523|Sleep disturbances|sleep disturbances
5485606|NCT01355523|Cognitive function|cognitive function
5485607|NCT01355471|rosacea|rosacea
5485608|NCT01355458|rosacea|rosacea
5485609|NCT01355419|Obstructive sleep apnea|obstructive sleep apnea
5485610|NCT01355419|CPAP|cpap
5485611|NCT01355419|actigraphy|actigraphy
5485612|NCT01355419|sleep|sleep
5485613|NCT01355419|physical activity|physical activity
5485614|NCT01355406|FlexStent|flexstent
5485615|NCT01355406|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
5485616|NCT01355406|Self Expanding Stent|self expanding stent
5485617|NCT01355406|Stent|stent
5485618|NCT01355406|Bare Metal Stent|bare metal stent
5485619|NCT01355393|Breast Cancer|breast cancer
5485620|NCT01355393|HER2+|her2+
5485621|NCT01355393|Vaccine|vaccine
5485622|NCT01355393|Stage II|stage ii
5485623|NCT01355393|Stage III|stage iii
5485624|NCT01355393|Stage IV|stage iv
5485625|NCT01355380|Pulmonary arterial hypertension|pulmonary arterial hypertension
5485626|NCT01355380|Inhaled iloprost|inhaled iloprost
5485627|NCT01355380|Quality of life|quality of life
5485628|NCT01355367|BAYA1040 CR|baya1040 cr
5485629|NCT01355367|Nifedipine|nifedipine
5485630|NCT01355367|Essential hypertension|essential hypertension
5485631|NCT01355367|Japanese Patients|japanese patients
5485632|NCT01355367|Phase III|phase iii
5485633|NCT01355367|Extension study|extension study
5485635|NCT01355354|healthy volunteers|healthy volunteers
5485636|NCT01355354|pharmacokinetics|pharmacokinetics
5485637|NCT01355354|Rheumatoid arthritis|rheumatoid arthritis
5485638|NCT01355354|RA, Fostamatinib|ra, fostamatinib
5485639|NCT01355354|Digoxin, drug-drug interaction|digoxin, drug-drug interaction
5485640|NCT01355354|Scientific terminology: Rheumatoid arthritis|scientific terminology: rheumatoid arthritis
5485641|NCT01355354|Fostamatinib|fostamatinib
5485642|NCT01355354|Digoxin|digoxin
5485643|NCT01355354|drug-drug interaction|drug-drug interaction
5485644|NCT01355354|Laymen terminology: Rheumatoid arthritis|laymen terminology: rheumatoid arthritis
5485645|NCT01355354|Amount of Digoxin in blood|amount of digoxin in blood
5485646|NCT01355341|RENAL CALCULI HERBMED PLUS|renal calculi herbmed plus
5485647|NCT01355328|light|light
5485648|NCT01355315|EECP|eecp
5485649|NCT01355315|ischemic cardiomyopathy|ischemic cardiomyopathy
5485650|NCT01355315|endothelin-1|endothelin-1
5485651|NCT01355315|ischemia coronary artery diseases|ischemia coronary artery diseases
5485652|NCT01355315|congestive heart failure not amenable to standard procedures|congestive heart failure not amenable to standard procedures
5485653|NCT01355302|Cancer|cancer
5485654|NCT01355302|Solid Tumors|solid tumors
5485655|NCT01355302|Gastric|gastric
5485656|NCT01355302|Phase I|phase i
5485657|NCT01355302|Phase II|phase ii
5485658|NCT01355289|Chronic Hepatitis C related|chronic hepatitis c related
5485659|NCT01355276|Cinitapride|cinitapride
5485660|NCT01355276|efficacy|efficacy
5485661|NCT01355276|safety|safety
5485662|NCT01355276|mild to moderate functional dyspepsia|mild to moderate functional dyspepsia
5485663|NCT01355263|vitamin a|vitamin a
5485664|NCT01355263|preschool children|preschool children
5485665|NCT01355263|iron metabolic homeostasis|iron metabolic homeostasis
5485666|NCT01355263|supplementation effect|supplementation effect
5485667|NCT01355237|Complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
5485668|NCT01355224|obesity|obesity
5485669|NCT01355224|genetics|genetics
5485670|NCT01355224|risk assessment|risk assessment
5485671|NCT01355224|health behaviors|health behaviors
5485672|NCT01355224|randomized controlled trial|randomized controlled trial
5485673|NCT01355211|Altered Mental Status|altered mental status
5485674|NCT01355211|non-convulsive seizure|non-convulsive seizure
5485675|NCT01355211|status epilepticus|status epilepticus
5485676|NCT01355211|electroencephalography|electroencephalography
5485677|NCT01355185|Seed movement|seed movement
5485679|NCT01355185|prostate brachytherapy|prostate brachytherapy
5485680|NCT01355185|localized|localized
5485681|NCT01355172|Influenza|influenza
5485682|NCT01355172|Vaccine|vaccine
5485683|NCT01355172|Immunogenicity|immunogenicity
5485684|NCT01355159|Pregnancy|pregnancy
5485685|NCT01355159|Folic Acid supplementation|folic acid supplementation
5485686|NCT01355159|Preeclampsia|preeclampsia
5485687|NCT01355146|Patients with proven Fabry's Disease|patients with proven fabry's disease
5485688|NCT01355133|Urinary incontinence|urinary incontinence
5485689|NCT01355133|Myoblasts|myoblasts
5485690|NCT01355133|Muscle derived cells|muscle derived cells
5485691|NCT01355133|Stem cells|stem cells
5485692|NCT01355120|advanced ocular melanoma|advanced ocular melanoma
5485693|NCT01355107|selenium level measurement|selenium level measurement
5485694|NCT01355094|temporary abdomen closure|temporary abdomen closure
5485695|NCT01355094|peritoneal vacuum therapy|peritoneal vacuum therapy
5485696|NCT01355094|open abdomen|open abdomen
5485697|NCT01355094|abdominal compartment syndrome|abdominal compartment syndrome
5485698|NCT01355094|intra-abdominal sepsis|intra-abdominal sepsis
5485699|NCT01355094|intra-abdominal hypertension|intra-abdominal hypertension
5485700|NCT01355094|critical care|critical care
5485701|NCT01355081|Drug Therapy|drug therapy
5485702|NCT01355068|phenytoin|phenytoin
5485703|NCT01355068|chewable tablets|chewable tablets
5485704|NCT01355068|dilantin|dilantin
5485705|NCT01355068|epanutin|epanutin
5485706|NCT01355068|infatabs|infatabs
5485707|NCT01355068|bioequivalence|bioequivalence
5485708|NCT01355068|Partial seizure|partial seizure
5485709|NCT01355068|Tonic-clonic seizure|tonic-clonic seizure
5485710|NCT01355029|Stroke caregivers|stroke caregivers
5485711|NCT01355029|Family Caregivers|family caregivers
5485712|NCT01355029|Stroke|stroke
5485713|NCT01355016|RSV|rsv
5485714|NCT01354977|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5485715|NCT01354977|Glucose Metabolism Disorders|glucose metabolism disorders
5485716|NCT01354977|Metabolic Diseases|metabolic diseases
5485717|NCT01354977|Diabetes Mellitus|diabetes mellitus
5485718|NCT01354977|Endocrin System Diseases|endocrin system diseases
5485719|NCT01354977|Resveratrol|resveratrol
5485720|NCT01354977|Therapeutic Uses|therapeutic uses
5485721|NCT01354964|Glucose Metabolism Disorders|glucose metabolism disorders
5619107|NCT00821847|HIV|hiv
5485722|NCT01354964|Insulin Resistance|insulin resistance
5485723|NCT01354964|Endocrine System|endocrine system
5485724|NCT01354964|Vitamin D|vitamin d
5485725|NCT01354951|Focal Brachytherapy|focal brachytherapy
5485726|NCT01354951|Endorectal coil MRI|endorectal coil mri
5485727|NCT01354951|Quality of Life|quality of life
5485729|NCT01354938|Bronchitis|bronchitis
5485730|NCT01354925|Diabetes type 2|diabetes type 2
5485731|NCT01354925|Fasting|fasting
5485732|NCT01354925|Ramadan|ramadan
5485733|NCT01354925|Insulin analogues|insulin analogues
5485734|NCT01354912|mycobacterial infection|mycobacterial infection
5485735|NCT01354912|culture|culture
5485736|NCT01354912|ct scan|ct scan
5485737|NCT01354886|in-vitro fertilization|in-vitro fertilization
5485738|NCT01354886|reproductive disorder|reproductive disorder
5485739|NCT01354873|Colonoscopy|colonoscopy
5485740|NCT01354873|Colon Polyps|colon polyps
5485741|NCT01354860|knee osteoarthritis|knee osteoarthritis
5485742|NCT01354847|extracorporeal circulation|extracorporeal circulation
5485743|NCT01354847|platelet dysfunction|platelet dysfunction
5485744|NCT01354847|Multiplate electrode aggregometry analyses|multiplate electrode aggregometry analyses
5485745|NCT01354847|Multiplate|multiplate
5485746|NCT01354821|Aorta|aorta
5485747|NCT01354821|Aneurysm|aneurysm
5485748|NCT01354821|endovascular|endovascular
5485749|NCT01354821|stent-graft|stent-graft
5485750|NCT01354808|Cilostazol|cilostazol
5485751|NCT01354808|Platelet|platelet
5485752|NCT01354808|Inflammation|inflammation
5485753|NCT01354808|Myonecrosis|myonecrosis
5485754|NCT01354795|EUS FNA|eus fna
5485755|NCT01354795|stylet|stylet
5485756|NCT01354795|suction|suction
5485757|NCT01354782|Pharmacokinetic|pharmacokinetic
5485758|NCT01354782|Roflumilast|roflumilast
5485759|NCT01354756|sleep apnea|sleep apnea
5485760|NCT01354756|polysomnography|polysomnography
5485761|NCT01354756|obesity|obesity
5485762|NCT01354756|bariatric surgery|bariatric surgery
5485763|NCT01354743|atrophy|atrophy
5485764|NCT01354743|rhytids|rhytids
5485765|NCT01354743|glabellar|glabellar
5485766|NCT01354743|periorbital|periorbital
5485767|NCT01354730|incidence|incidence
5485768|NCT01354730|nature|nature
5485769|NCT01354730|seriousness|seriousness
5485770|NCT01354730|ADRs|adrs
5485771|NCT01354730|vaccination|vaccination
5485772|NCT01354704|deep veinous thrombosis|deep veinous thrombosis
5485773|NCT01354704|enoxaparin|enoxaparin
5485774|NCT01354691|Alzheimer's Disease|alzheimer's disease
5485775|NCT01354691|Dementia|dementia
5485776|NCT01354691|Memory Loss|memory loss
5485777|NCT01354691|Cognitive Impairment|cognitive impairment
5485778|NCT01354691|Brain Diseases|brain diseases
5485779|NCT01354691|Central Nervous System Diseases|central nervous system diseases
5485780|NCT01354691|Nervous System Diseases|nervous system diseases
5485781|NCT01354691|Neurodegenerative Diseases|neurodegenerative diseases
5485782|NCT01354691|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5485783|NCT01354691|Mental Disorders|mental disorders
5485784|NCT01354691|Depression|depression
5485786|NCT01354678|heart failure|heart failure
5485787|NCT01354678|bone marrow mononuclear cells|bone marrow mononuclear cells
5485788|NCT01354665|Multiple sclerosis|multiple sclerosis
5485789|NCT01354665|Interferon beta-1b|interferon beta-1b
5485790|NCT01354665|Fatigue|fatigue
5485791|NCT01354665|Depression|depression
5485792|NCT01354652|lactic acidosis|lactic acidosis
5485793|NCT01354652|entecavir|entecavir
5485794|NCT01354652|lamivudine|lamivudine
5485795|NCT01354626|Hepatic fat accumulation|hepatic fat accumulation
5485796|NCT01354626|Dietary protein|dietary protein
5485797|NCT01354626|NAFLD|nafld
5485798|NCT01354600|Obesity|obesity
5485799|NCT01354600|Appetite|appetite
5485800|NCT01354600|Hormones|hormones
5485801|NCT01354600|Exercise|exercise
5485802|NCT01354600|Body Weight|body weight
5485803|NCT01354587|immunodeficiency|immunodeficiency
5485804|NCT01354574|energy metabolism|energy metabolism
5485805|NCT01354574|lipids|lipids
5485807|NCT01354574|satiety|satiety
5485808|NCT01354574|glycemic load|glycemic load
5485809|NCT01354574|insulin|insulin
5485810|NCT01354561|respiratory physiotherapy|respiratory physiotherapy
5485811|NCT01354561|cardiac autonomic modulation|cardiac autonomic modulation
5485812|NCT01354561|paediatric patients|paediatric patients
5485813|NCT01354548|Trismus|trismus
5485814|NCT01354548|Cancer|cancer
5485815|NCT01354548|Radiotherapy|radiotherapy
5485816|NCT01354548|Quality of life|quality of life
5485817|NCT01354535|periprosthetic|periprosthetic
5485818|NCT01354535|femur fractures|femur fractures
5485819|NCT01354535|Vancouver B1|vancouver b1
5485820|NCT01354509|Normothermia|normothermia
5485821|NCT01354509|fever control|fever control
5485822|NCT01354509|Outcome study|outcome study
5485823|NCT01354496|Healthy Volunteers|healthy volunteers
5485824|NCT01354496|Bioavailability|bioavailability
5485825|NCT01354483|spinal cord injury|spinal cord injury
5485826|NCT01354483|umbilical cord blood mononuclear cell|umbilical cord blood mononuclear cell
5485827|NCT01354483|lithium carbonate|lithium carbonate
5485828|NCT01354470|Meth|meth
5485829|NCT01354470|Methamphetamine Addiction|methamphetamine addiction
5485830|NCT01354470|Methamphetamine Treatment|methamphetamine treatment
5485831|NCT01354470|Modafinil|modafinil
5485832|NCT01354457|Patient with relapsing or refractory CD22+B-acute lymphoblastic leukemia (ALL)|patient with relapsing or refractory cd22+b-acute lymphoblastic leukemia (all)
5485834|NCT01354444|Alzheimer's Disease|alzheimer's disease
5485835|NCT01354431|Advanced/Metastatic|advanced/metastatic
5485836|NCT01354431|clear cell component|clear cell component
5485837|NCT01354392|Relapsed or refractory|relapsed or refractory
5485838|NCT01354392|Large B-Cell|large b-cell
5485839|NCT01354392|Diffuse|diffuse
5485840|NCT01354340|Cholesterol|cholesterol
5485841|NCT01354340|LDL-cholesterol|ldl-cholesterol
5485842|NCT01354340|Coronary artery disease|coronary artery disease
5485843|NCT01354340|Red yeast rice|red yeast rice
5485844|NCT01354340|Plants extract|plants extract
5485845|NCT01354340|Cholesterol excess|cholesterol excess
5485846|NCT01354340|Delivery of Health Care|delivery of health care
5468139|NCT01428661|MDD|mdd
5485847|NCT01354327|Delivery of Health Care|delivery of health care
5485848|NCT01354327|Cholesterol|cholesterol
5485849|NCT01354327|LDL-cholesterol|ldl-cholesterol
5485850|NCT01354327|Coronary artery disease|coronary artery disease
5485851|NCT01354327|Red yeast rice|red yeast rice
5485852|NCT01354327|Plants extract|plants extract
5485853|NCT01354327|Cholesterol excess|cholesterol excess
5485854|NCT01354314|HIV|hiv
5485855|NCT01354314|Neurocognitive impairment|neurocognitive impairment
5485856|NCT01354314|Memory|memory
5485857|NCT01354314|Dementia|dementia
5485858|NCT01354314|CSF marker|csf marker
5485859|NCT01354314|Functional assessment|functional assessment
5485860|NCT01354314|MRS|mrs
5485861|NCT01354314|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5485862|NCT01354314|Arterial spin labeling|arterial spin labeling
5485863|NCT01354314|SSRI|ssri
5485864|NCT01354301|kidney transplantation|kidney transplantation
5485865|NCT01354301|thymoglobulin|thymoglobulin
5485866|NCT01354301|everolimus|everolimus
5485867|NCT01354288|Diabetes|diabetes
5485868|NCT01354288|Children|children
5485869|NCT01354288|Disease management|disease management
5485870|NCT01354288|Ketosis|ketosis
5485871|NCT01354288|Hypoglycemia|hypoglycemia
5485872|NCT01354288|Parents|parents
5485873|NCT01354288|Education|education
5485874|NCT01354275|PCOS|pcos
5485875|NCT01354275|IVF/ICSI|ivf/icsi
5485880|NCT01354262|Vitamin D deficiency|vitamin d deficiency
5485881|NCT01354262|Hemoglobin A1c|hemoglobin a1c
5485882|NCT01354249|preoperative fasting|preoperative fasting
5485883|NCT01354249|insulin resistance|insulin resistance
5485884|NCT01354249|carbohydrates|carbohydrates
5485885|NCT01354249|whey protein|whey protein
5485886|NCT01354249|inflammatory response|inflammatory response
5485887|NCT01354223|silicone hydrogel contact lens|silicone hydrogel contact lens
5485888|NCT01354223|SHCL|shcl
5485889|NCT01354223|stenfilcon A|stenfilcon a
5485890|NCT01354223|ocufilcon B|ocufilcon b
5485891|NCT01354223|daily disposable|daily disposable
5485892|NCT01354223|substantial equivalence|substantial equivalence
5485893|NCT01354223|CooperVision ClearSight™ 1 Day SCL|coopervision clearsight™ 1 day scl
5485894|NCT01354210|Patient Adherence|patient adherence
5485895|NCT01354210|HIV|hiv
5485896|NCT01354197|Adverse events|adverse events
5485897|NCT01354197|Mortality|mortality
5485898|NCT01354197|Readmission|readmission
5485899|NCT01354197|Surgical intensive care unit|surgical intensive care unit
5485900|NCT01354171|active surveillance|active surveillance
5485901|NCT01354171|low risk prostate cancer|low risk prostate cancer
5485902|NCT01354132|schizophrenia|schizophrenia
5485903|NCT01354132|schizoaffective|schizoaffective
5485904|NCT01354132|schizophreniform|schizophreniform
5485905|NCT01354132|early schizophrenia spectrum psychosis|early schizophrenia spectrum psychosis
5485906|NCT01354106|Skin condition after wear|skin condition after wear
5485907|NCT01354093|MacTel|mactel
5485908|NCT01354093|Macular telangiectasia type 2|macular telangiectasia type 2
5485909|NCT01354080|constipation|constipation
5485910|NCT01354080|massage|massage
5485911|NCT01354080|tensegrity|tensegrity
5485912|NCT01354067|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5485913|NCT01354067|Lung Diseases, Obstructive|lung diseases, obstructive
5485915|NCT01354067|Elastic Resistance|elastic resistance
5485916|NCT01354067|Resistance Training|resistance training
5485917|NCT01354067|Minor Muscle Mass|minor muscle mass
5485918|NCT01354067|Local muscle training|local muscle training
5485919|NCT01354054|Knee OA|knee oa
5485920|NCT01354054|TENS|tens
5485921|NCT01354041|fear and health worries about cancer recurrence|fear and health worries about cancer recurrence
5485922|NCT01354028|premature infant|premature infant
5485923|NCT01354028|massage therapy|massage therapy
5485924|NCT01354028|sleep induction|sleep induction
5485925|NCT01354028|relaxation|relaxation
5485926|NCT01354015|Diabetes|diabetes
5485927|NCT01354015|Technology|technology
5485928|NCT01354002|human biological samples|human biological samples
5485929|NCT01354002|tissue banking|tissue banking
5485930|NCT01353989|hepatitis A|hepatitis a
5485931|NCT01353989|vaccination|vaccination
5485932|NCT01353989|elderly|elderly
5485933|NCT01353989|protection to hepatitis A after vaccination|protection to hepatitis a after vaccination
5485934|NCT01353976|Econazole Nitrate|econazole nitrate
5485935|NCT01353976|Foam|foam
5485936|NCT01353976|Quinnova|quinnova
5485937|NCT01353976|Tinea Pedis|tinea pedis
5480289|NCT01377974|miltefosine|miltefosine
5485938|NCT01353950|Costimulatory molecules|costimulatory molecules
5485939|NCT01353950|Cystic Fibrosis|cystic fibrosis
5485940|NCT01353950|Biomarkers|biomarkers
5485941|NCT01353937|wound healing|wound healing
5485942|NCT01353924|Allergy|allergy
5485943|NCT01353924|Vaccine|vaccine
5485944|NCT01353924|rBet v 1|rbet v 1
5485945|NCT01353924|Prevention|prevention
5485946|NCT01353885|Primary Osteoarthritis, Hip|primary osteoarthritis, hip
5485947|NCT01353885|Total Hip Arthroplasty|total hip arthroplasty
5485948|NCT01353885|Anterior Approach|anterior approach
5485949|NCT01353885|Posterior Approach|posterior approach
5485950|NCT01353885|Anterolateral Approach|anterolateral approach
5485951|NCT01353885|Cohort Study|cohort study
5485952|NCT01353885|Outcomes, Complication Rate|outcomes, complication rate
5485953|NCT01353885|Outcomes, Quality of Life|outcomes, quality of life
5485954|NCT01353872|Fatigue|fatigue
5485955|NCT01353872|Tennis|tennis
5485956|NCT01353872|Nutrition|nutrition
5485957|NCT01353872|Tournament simulation|tournament simulation
5485958|NCT01353872|Delivery of Health Care|delivery of health care
5485959|NCT01353846|oocyte donation program|oocyte donation program
5485960|NCT01353846|natural cycle|natural cycle
5485961|NCT01353846|hormone replacement therapy|hormone replacement therapy
5485962|NCT01353820|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
5485963|NCT01353820|Probiotic|probiotic
5485964|NCT01353820|Cholesterol lowering|cholesterol lowering
5485965|NCT01353820|Dairy|dairy
5485966|NCT01353807|Fish oil|fish oil
5485967|NCT01353807|Pregnancy|pregnancy
5485968|NCT01353807|RCT|rct
5485969|NCT01353807|Birth weight|birth weight
5485970|NCT01353807|Gestational age|gestational age
5485971|NCT01353807|Asthma and allergies|asthma and allergies
5485972|NCT01353807|Metabolic syndrome|metabolic syndrome
5485973|NCT01353807|Obesity|obesity
5485974|NCT01353794|SORAFENIB|sorafenib
5485975|NCT01353794|RENAL CELL CARCINOMA|renal cell carcinoma
5485976|NCT01353794|TYROSINE KINASE INHIBITOR|tyrosine kinase inhibitor
5485977|NCT01353794|OBSERVATIONAL STUDY|observational study
5485978|NCT01353781|Phase 1|phase 1
5485979|NCT01353781|advanced solid tumor|advanced solid tumor
5485981|NCT01353781|Ascending|ascending
5485982|NCT01353781|Japanese|japanese
5485983|NCT01353768|Influenza|influenza
5485984|NCT01353755|specific immunotherapy|specific immunotherapy
5485985|NCT01353755|SIT|sit
5485986|NCT01353729|12-lead ECG|12-lead ecg
5485987|NCT01353729|cardiac repolarization|cardiac repolarization
5485988|NCT01353729|QTc|qtc
5485989|NCT01353729|influenza|influenza
5485990|NCT01353729|GR121167|gr121167
5485991|NCT01353729|zanamivir|zanamivir
5485992|NCT01353703|Infanrix hexa™|infanrix hexa™
5485993|NCT01353703|Primary vaccination|primary vaccination
5485994|NCT01353703|India|india
5485995|NCT01353703|combination vaccine|combination vaccine
5485996|NCT01353703|infants|infants
5485997|NCT01353690|Cell Therapy|cell therapy
5485998|NCT01353690|Heart Failure|heart failure
5485999|NCT01353690|Heart Disease|heart disease
5486000|NCT01353690|Myocardial Infarction|myocardial infarction
5486001|NCT01353690|Myocardial Ischemia|myocardial ischemia
5486002|NCT01353690|Autologous|autologous
5486003|NCT01353690|Muscle-derived Cell|muscle-derived cell
5486004|NCT01353677|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5486005|NCT01353677|QOL|qol
5486006|NCT01353664|rollover protocol|rollover protocol
5486007|NCT01353664|romidepsin|romidepsin
5486008|NCT01353664|Gloucester Pharmaceuticals|gloucester pharmaceuticals
5486009|NCT01353664|Celgene Corporation|celgene corporation
5486010|NCT01353664|continuing treatment|continuing treatment
5486011|NCT01353638|Peritoneal dialysis|peritoneal dialysis
5486012|NCT01353638|Alanyl-Glutamine-Dipeptide|alanyl-glutamine-dipeptide
5486013|NCT01353638|Heat shock protein|heat shock protein
5486014|NCT01353638|Peritoneal cells|peritoneal cells
5486015|NCT01353638|functional maintenance of the peritoneal membrane|functional maintenance of the peritoneal membrane
5486043|NCT01353456|Ambulation|ambulation
5486044|NCT01353456|Side effects|side effects
5486045|NCT01353456|Serum sCD40L|serum scd40l
5486046|NCT01353456|Bowel function|bowel function
5486047|NCT01353456|Postoperative pain|postoperative pain
5486048|NCT01353443|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5486049|NCT01353443|AAA|aaa
5486050|NCT01353430|IBMPFD - Inclusion Body Myopathy associated with|ibmpfd - inclusion body myopathy associated with
5486051|NCT01353430|Paget's disease of bone and Frontotemporal Dementia|paget's disease of bone and frontotemporal dementia
5486052|NCT01353430|VCP gene - Valosin-containing protein gene|vcp gene - valosin-containing protein gene
5486053|NCT01353417|Grafting, kidney|grafting, kidney
5486054|NCT01353417|Transplantation, kidney|transplantation, kidney
5486055|NCT01353391|Diabetes|diabetes
5486056|NCT01353391|MiTy|mity
5486058|NCT01353391|Type 2 Diabetes Pregnancy|type 2 diabetes pregnancy
5486059|NCT01353378|dexmedetomidine|dexmedetomidine
5486060|NCT01353378|emergence delirium|emergence delirium
5486061|NCT01353378|sevoflurane anesthesia|sevoflurane anesthesia
5486062|NCT01353378|preschool children|preschool children
5486063|NCT01353378|oral maxillofacial surgery|oral maxillofacial surgery
5486064|NCT01353352|Evaluation|evaluation
5486065|NCT01353352|C-Spine|c-spine
5486066|NCT01353352|Nursing|nursing
5486068|NCT01353339|Kidney Transplant|kidney transplant
5486069|NCT01353339|BK Polyomavirus Infection|bk polyomavirus infection
5486070|NCT01353326|non-inflammatory degenerative joint disease|non-inflammatory degenerative joint disease
5486071|NCT01353326|hip resurfacing|hip resurfacing
5486072|NCT01353326|bone mineral density|bone mineral density
5486073|NCT01353326|cemented|cemented
5486074|NCT01353326|cementless|cementless
5486082|NCT01353300|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5486083|NCT01353300|cystic nephroma|cystic nephroma
5486084|NCT01353300|neuroblastoma|neuroblastoma
5486085|NCT01353300|childhood medulloblastoma|childhood medulloblastoma
5486086|NCT01353300|childhood hepatoblastoma|childhood hepatoblastoma
5486087|NCT01353300|stromal predominant Wilms tumor|stromal predominant wilms tumor
5486088|NCT01353300|hereditary Wilms tumor|hereditary wilms tumor
5486089|NCT01353300|pleuropulmonary blastoma|pleuropulmonary blastoma
5486090|NCT01353287|Transcatheter Aortic Valve Intervention (TAVI)|transcatheter aortic valve intervention (tavi)
5486091|NCT01353287|Live case transmission|live case transmission
5486092|NCT01353261|Platelet reactivity|platelet reactivity
5486093|NCT01353248|Hepatitis C|hepatitis c
5486094|NCT01353248|HCV|hcv
5486095|NCT01353248|Rapid Virologic Response|rapid virologic response
5486096|NCT01353248|Sustained Virologic Response|sustained virologic response
5486097|NCT01353248|Direct Acting Antiviral|direct acting antiviral
5486098|NCT01353248|Combination Therapy|combination therapy
5486099|NCT01353248|HCV RNA|hcv rna
5486100|NCT01353248|Polymerase inhibitor|polymerase inhibitor
5486101|NCT01353248|Protease inhibitor|protease inhibitor
5486102|NCT01353248|Treatment naïve|treatment naïve
5486103|NCT01353248|GS-5885|gs-5885
5486104|NCT01353248|GS-9451|gs-9451
5486105|NCT01353248|Tegobuvir|tegobuvir
5486106|NCT01353235|COPD|copd
5486107|NCT01353235|acute respiratory failure|acute respiratory failure
5486108|NCT01353235|mechanical ventilation|mechanical ventilation
5486109|NCT01353235|non invasive ventilation|non invasive ventilation
5486110|NCT01353235|steroids|steroids
5486125|NCT01353222|Cancer vaccine|cancer vaccine
5486126|NCT01353222|Urothelial carcinoma|urothelial carcinoma
5486127|NCT01353222|Urothelial neoplasms|urothelial neoplasms
5486128|NCT01353222|Neoplasms by site|neoplasms by site
5486129|NCT01353222|Neoplasms|neoplasms
5486130|NCT01353196|carotid|carotid
5486131|NCT01353196|atherosclerosis|atherosclerosis
5486132|NCT01353196|cognitive function|cognitive function
5486133|NCT01353183|biopsies, enteric nervous system, biomarker|biopsies, enteric nervous system, biomarker
5486134|NCT01353170|Serum calcium|serum calcium
5486135|NCT01353170|Dialysate|dialysate
5486136|NCT01353170|Mass balance|mass balance
5486137|NCT01353170|Blood pressure|blood pressure
5486138|NCT01353157|cytokine|cytokine
5486139|NCT01353157|cardiac surgery|cardiac surgery
5486140|NCT01353157|clinical scoring system|clinical scoring system
5486141|NCT01353144|aspirin|aspirin
5486142|NCT01353144|peptic ulcer|peptic ulcer
5486143|NCT01353131|electrocardiogram|electrocardiogram
5486144|NCT01353131|cardiac magnetic resonance|cardiac magnetic resonance
5486145|NCT01353131|heart failure|heart failure
5486146|NCT01353131|sudden cardiac death|sudden cardiac death
5486147|NCT01353131|ECG scoring|ecg scoring
5486148|NCT01353131|Delayed enhancement|delayed enhancement
5486149|NCT01353118|diabetes|diabetes
5486150|NCT01353118|bariatric surgery|bariatric surgery
5486151|NCT01353118|Roux-en-y gastric bypass|roux-en-y gastric bypass
5486152|NCT01353118|retinopathy|retinopathy
5486153|NCT01353118|neuropathy|neuropathy
5486154|NCT01353118|nephropathy|nephropathy
5486155|NCT01353105|cystic fibrosis|cystic fibrosis
5486156|NCT01353105|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5486157|NCT01353105|pulmonary fibrosis|pulmonary fibrosis
5486158|NCT01353092|Randomized Controlled Trial|randomized controlled trial
5486159|NCT01353092|Major depression|major depression
5486160|NCT01353092|Hamilton|hamilton
5486161|NCT01353092|PEMF|pemf
5486162|NCT01353066|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5486163|NCT01353066|BMI 30.0-34.9 kg/m2|bmi 30.0-34.9 kg/m2
5486164|NCT01353053|Immunosuppression|immunosuppression
5486165|NCT01353053|Cytomegalovirus|cytomegalovirus
5486166|NCT01353053|Renal Transplant|renal transplant
5486167|NCT01353053|Atrophy/interstitial|atrophy/interstitial
5486168|NCT01353053|Conversion of tacrolimus everolimus|conversion of tacrolimus everolimus
5486169|NCT01353014|Nutrigenomics|nutrigenomics
5486170|NCT01353014|Diet|diet
5486171|NCT01353014|Nutrition|nutrition
5486172|NCT01353001|Intervention Studies|intervention studies
5486173|NCT01353001|Magnetic Resonance Imaging|magnetic resonance imaging
5486174|NCT01353001|C-Reactive Protein|c-reactive protein
5486175|NCT01352988|C17.300.475|c17.300.475
5486176|NCT01352988|C17.800.480|c17.800.480
5486177|NCT01352975|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5486178|NCT01352975|Dark Adaptation|dark adaptation
5486179|NCT01352975|Age Related Macular Degeneration|age related macular degeneration
5486194|NCT01352936|nephrotoxicity|nephrotoxicity
5486195|NCT01352936|hospital cost|hospital cost
5486196|NCT01352936|Staphylococcus aureus|staphylococcus aureus
5486201|NCT01352923|whether and how PEAR 1 modulate intracellular signaling pathways relevant for platelet function|whether and how pear 1 modulate intracellular signaling pathways relevant for platelet function
5486204|NCT01352897|retrospective|retrospective
5486205|NCT01352884|Cancer|cancer
5486206|NCT01352884|Carcinoma|carcinoma
5486207|NCT01352884|Tumor|tumor
5486208|NCT01352884|Solid tumor|solid tumor
5486209|NCT01352884|Metastatic|metastatic
5486210|NCT01352884|Melanoma|melanoma
5486211|NCT01352871|Immunity, Innate|immunity, innate
5486212|NCT01352871|Attention|attention
5486213|NCT01352871|Concentration|concentration
5486214|NCT01352858|Arthritis|arthritis
5486216|NCT01352858|Auto-immune disorders|auto-immune disorders
5486217|NCT01352832|Chronic NSAID use|chronic nsaid use
5789992|NCT00146224|hemodialysis|hemodialysis
5486218|NCT01352806|accuracy of identifying intralaminar space|accuracy of identifying intralaminar space
5486219|NCT01352793|phase 3 safety study|phase 3 safety study
5486220|NCT01352793|5700 healthy subjects|5700 healthy subjects
5486221|NCT01352793|3 vaccine doses at month 0|3 vaccine doses at month 0
5486222|NCT01352793|2|2
5486223|NCT01352793|and 6|and 6
5486224|NCT01352793|control HAV/saline/HAV|control hav/saline/hav
5486225|NCT01352780|motivational interviewing|motivational interviewing
5486226|NCT01352780|psoriasis|psoriasis
5486227|NCT01352780|self management|self management
5486228|NCT01352767|insulin injection|insulin injection
5486229|NCT01352754|Hip fracture|hip fracture
5486230|NCT01352754|Troponin T|troponin t
5486231|NCT01352754|myocardial infarction|myocardial infarction
5486233|NCT01352741|neuropathic|neuropathic
5486234|NCT01352741|pain assessment|pain assessment
5486235|NCT01352741|centrally acting tapentadol pregabalin|centrally acting tapentadol pregabalin
5486236|NCT01352741|severe chronic|severe chronic
5486237|NCT01352728|Unresectable|unresectable
5486238|NCT01352689|CKD-828|ckd-828
5486239|NCT01352689|Hypertension|hypertension
5486240|NCT01352689|Primary Hypertension|primary hypertension
5486241|NCT01352689|Healthy Volunteer|healthy volunteer
5486242|NCT01352689|S-Amlodipine|s-amlodipine
5486243|NCT01352689|Telmisartan|telmisartan
5486244|NCT01352689|Amlodipine|amlodipine
5486245|NCT01352689|Pharmacokinetic|pharmacokinetic
5486246|NCT01352689|Phase 1|phase 1
5486247|NCT01352676|renal colic|renal colic
5486248|NCT01352676|flank pain|flank pain
5486249|NCT01352676|back pain|back pain
5486250|NCT01352663|Type I Diabetes|type i diabetes
5486251|NCT01352663|Wockhardt|wockhardt
5486252|NCT01352663|Insulin Analogue|insulin analogue
5486253|NCT01352650|leukemia|leukemia
5486254|NCT01352637|Traumatic Event|traumatic event
5486255|NCT01352637|Trauma Survivor|trauma survivor
5486256|NCT01352637|Exposure Therapy|exposure therapy
5486257|NCT01352637|PTSD DCS|ptsd dcs
5486258|NCT01352637|Virtual Reality Exposure|virtual reality exposure
5486259|NCT01352637|Veteran|veteran
5486260|NCT01352637|Combat-related PTSD|combat-related ptsd
5486261|NCT01352611|Tactile Defensiveness|tactile defensiveness
5486262|NCT01352611|Autistic Disorder|autistic disorder
5486263|NCT01352598|prostate cancer|prostate cancer
5486264|NCT01352598|stereotactic radiotherapy|stereotactic radiotherapy
5486265|NCT01352572|Antidepressant Response|antidepressant response
5486266|NCT01352572|Signal Transduction|signal transduction
5486267|NCT01352572|Lymphocyte|lymphocyte
5486268|NCT01352572|Biomarkers|biomarkers
5486269|NCT01352572|Depressed Patients|depressed patients
5486270|NCT01352572|Antidepressant Drug Adverse Reaction|antidepressant drug adverse reaction
5486271|NCT01352559|Pharmacogenomics|pharmacogenomics
5486272|NCT01352559|Prediction of Antidepressant Response|prediction of antidepressant response
5486273|NCT01352559|Depressed Patients|depressed patients
5486274|NCT01352559|biomarkers|biomarkers
5486275|NCT01352559|phenotype|phenotype
5486276|NCT01352559|Antidepressant Response|antidepressant response
5486277|NCT01352559|Adverse Reaction to Drug|adverse reaction to drug
5486278|NCT01352546|vaginismus|vaginismus
5486279|NCT01352546|painful sex|painful sex
5486280|NCT01352546|painful intercourse|painful intercourse
5486281|NCT01352546|dyspareunia|dyspareunia
5486282|NCT01352546|inability to have intercourse|inability to have intercourse
5486283|NCT01352546|inability to consummate marriage|inability to consummate marriage
5486284|NCT01352546|vaginal spasm|vaginal spasm
5486285|NCT01352546|"hitting a wall"|"hitting a wall"
5486286|NCT01352546|pain during sex|pain during sex
5486287|NCT01352546|pain during intercourse|pain during intercourse
5486288|NCT01352546|burning with intercourse|burning with intercourse
5486289|NCT01352520|systemic therapy|systemic therapy
5486290|NCT01352520|cutaneous anaplastic large T cell lymphoma|cutaneous anaplastic large t cell lymphoma
5486292|NCT01352520|lymphomatoid papulosis|lymphomatoid papulosis
5486298|NCT01352520|CD30-positive lymphoproliferative disorders|cd30-positive lymphoproliferative disorders
5486299|NCT01352520|tumor lymphocytes|tumor lymphocytes
5486300|NCT01352520|cutaneous lymphomas|cutaneous lymphomas
5486301|NCT01352520|CD30+ expression|cd30+ expression
5486302|NCT01352520|Hematologic Disorder|hematologic disorder
5486303|NCT01352520|Lymphoma|lymphoma
5486304|NCT01352494|locally advanced breast cancer|locally advanced breast cancer
5486305|NCT01352494|docetaxel|docetaxel
5486306|NCT01352494|gemcitabine|gemcitabine
5486307|NCT01352481|Speech sound development|speech sound development
5486308|NCT01352468|ADHD|adhd
5486309|NCT01352468|cognitive training|cognitive training
5486310|NCT01352455|Hemodialysis|hemodialysis
5486311|NCT01352455|Pediatric|pediatric
5486312|NCT01352455|Outcomes|outcomes
5486313|NCT01352455|Comparative Effectiveness|comparative effectiveness
5486314|NCT01352455|End Stage Renal Disease|end stage renal disease
5486315|NCT01352442|Presbyopia|presbyopia
5486316|NCT01352442|Accommodation|accommodation
5486317|NCT01352442|Near visual acuity|near visual acuity
5486318|NCT01352442|LASIK|lasik
5486319|NCT01352429|adult|adult
5486320|NCT01352429|histologically confirmed|histologically confirmed
5468421|NCT01427270|Opioid|opioid
5486321|NCT01352416|Suppress Atrial Fibrillation|suppress atrial fibrillation
5486322|NCT01352416|heart bypass surgery|heart bypass surgery
5486323|NCT01352416|heart valve surgery|heart valve surgery
5486324|NCT01352403|obesity|obesity
5486325|NCT01352403|bariatric surgery|bariatric surgery
5486326|NCT01352403|gastric bypass|gastric bypass
5486327|NCT01352403|life style intervention|life style intervention
5486328|NCT01352403|cardiac function|cardiac function
5489318|NCT01339949|AMD|amd
5486329|NCT01352390|behavioral economics|behavioral economics
5486330|NCT01352390|nudge|nudge
5486331|NCT01352390|artwork|artwork
5486332|NCT01352390|Pap smear|pap smear
5486333|NCT01352390|Blood pressure check|blood pressure check
5486334|NCT01352390|Cholesterol test|cholesterol test
5486335|NCT01352390|Fasting plasma glucose test|fasting plasma glucose test
5486336|NCT01352364|Physiotherapy.|physiotherapy.
5486337|NCT01352364|Deafness.|deafness.
5486338|NCT01352364|Postural balance.|postural balance.
5486339|NCT01352364|Motor skills.|motor skills.
5486340|NCT01352351|Breast feeding Exclusive|breast feeding exclusive
5486341|NCT01352351|Initiation of breastfeeding|initiation of breastfeeding
5486342|NCT01352338|REPEAT|repeat
5486343|NCT01352338|multiple myeloma|multiple myeloma
5486344|NCT01352338|revlimid|revlimid
5486345|NCT01352338|lenalidomide|lenalidomide
5486346|NCT01352338|cyclophosphamide|cyclophosphamide
5486347|NCT01352338|endoxan|endoxan
5486348|NCT01352338|prednisone|prednisone
5486349|NCT01352338|lenalidomide refractory|lenalidomide refractory
5486350|NCT01352312|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5486351|NCT01352312|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5486352|NCT01352312|B-cell|b-cell
5486353|NCT01352312|leukemia|leukemia
5486354|NCT01352312|lymphoma|lymphoma
5486355|NCT01352312|bendamustine|bendamustine
5486356|NCT01352312|pentostatin|pentostatin
5486357|NCT01352312|ofatumumab|ofatumumab
5486360|NCT01352299|Macintosh laryngoscope blade|macintosh laryngoscope blade
5486361|NCT01352299|MacCoy laryngoscope blade|maccoy laryngoscope blade
5486362|NCT01352299|Miller laryngoscope blade|miller laryngoscope blade
5486363|NCT01352299|TrueView laryngoscope|trueview laryngoscope
5486364|NCT01352286|Multiple myeloma|multiple myeloma
5486365|NCT01352286|Received initial treatment previously|received initial treatment previously
5486366|NCT01352286|Autologous stem cell transplantation|autologous stem cell transplantation
5486367|NCT01352273|advanced Solid tumors|advanced solid tumors
5486368|NCT01352273|harboring RAS|harboring ras
5486369|NCT01352273|harboring BRAFV600E|harboring brafv600e
5486370|NCT01352260|Near Infrared Spectroscopy|near infrared spectroscopy
5486371|NCT01352260|Neuromonitoring|neuromonitoring
5486372|NCT01352260|Aortic Arch Replacement|aortic arch replacement
5486373|NCT01352221|iron deficiency|iron deficiency
5486374|NCT01352221|anaemia|anaemia
5486375|NCT01352221|inflammatory bowel disease|inflammatory bowel disease
5486376|NCT01352221|Crohn's Disease|crohn's disease
5486377|NCT01352208|ASP9521|asp9521
5486378|NCT01352208|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5486379|NCT01352208|Phase 1/2|phase 1/2
5486380|NCT01352195|Forever Free|forever free
5486381|NCT01352143|Neonates|neonates
5486382|NCT01352130|Postoperative nausea and vomiting|postoperative nausea and vomiting
5486383|NCT01352130|Ondansetron|ondansetron
5471050|NCT01416623|phase I|phase i
5486384|NCT01352130|Granisetron|granisetron
5486385|NCT01352130|QTc interval|qtc interval
5486386|NCT01352104|Externalizing Problem Behaviour in Preschoolers|externalizing problem behaviour in preschoolers
5486387|NCT01352091|breast cancer|breast cancer
5486388|NCT01352091|adjuvant endocrine therapy|adjuvant endocrine therapy
5486389|NCT01352091|AI|ai
5486390|NCT01352091|Zoladex|zoladex
5486391|NCT01352078|Non healing ulcer|non healing ulcer
5486392|NCT01352078|Wound|wound
5486393|NCT01352078|Hidradenitis suppurativa|hidradenitis suppurativa
5486394|NCT01352078|Acne Inversa|acne inversa
5486395|NCT01352078|Hidradenitis|hidradenitis
5486396|NCT01352065|Pharmacokinetics|pharmacokinetics
5486397|NCT01352065|Exercise performance|exercise performance
5486398|NCT01352065|Athletes|athletes
5486399|NCT01352052|chronic widespread pain|chronic widespread pain
5486400|NCT01352052|fibromyalgia|fibromyalgia
5486401|NCT01352052|outcome assessment|outcome assessment
5486402|NCT01352052|functional ability|functional ability
5486403|NCT01352052|AMPS|amps
5486404|NCT01352052|rehabilitation|rehabilitation
5486405|NCT01352039|Heparin Sodium|heparin sodium
5486406|NCT01352039|Thromboprophylaxis|thromboprophylaxis
5486407|NCT01352039|Hip Fracture Surgery.|hip fracture surgery.
5486408|NCT01352013|Fibromyalgia|fibromyalgia
5486409|NCT01352013|Omega-3|omega-3
5486410|NCT01352013|Chronic Pain|chronic pain
5486411|NCT01352013|Fatigue|fatigue
5486412|NCT01352013|Mood|mood
5486413|NCT01352013|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5486414|NCT01352013|eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5486415|NCT01352000|self help|self help
5486416|NCT01352000|smoking cessation|smoking cessation
5486417|NCT01352000|cancer prevention|cancer prevention
5486418|NCT01351987|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5486419|NCT01351974|breast cancer|breast cancer
5789993|NCT00146224|epoetin|epoetin
5486420|NCT01351974|sentinel lymph node biopsy|sentinel lymph node biopsy
5486421|NCT01351974|axillary recurrence|axillary recurrence
5486422|NCT01351961|Hypertension|hypertension
5486423|NCT01351961|Cognitive function|cognitive function
5486424|NCT01351948|Immune response|immune response
5486425|NCT01351935|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5486426|NCT01351935|lymphoma|lymphoma
5486427|NCT01351935|leukemia|leukemia
5486428|NCT01351935|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5486429|NCT01351935|b-cell malignancies|b-cell malignancies
5486430|NCT01351935|Btk inhibitor|btk inhibitor
5486431|NCT01351935|Phase 1b|phase 1b
5486432|NCT01351935|Avila Therapeutics|avila therapeutics
5486433|NCT01351935|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5486434|NCT01351883|immunomodulating diet|immunomodulating diet
5486435|NCT01351883|postoperative infection|postoperative infection
5486436|NCT01351857|Type 1 Diabetes|type 1 diabetes
5486437|NCT01351857|17 to 20 years of age|17 to 20 years of age
5486438|NCT01351844|Aromatase inhibitor|aromatase inhibitor
5486439|NCT01351844|Arthralgia Syndrome|arthralgia syndrome
5486440|NCT01351844|Exercise|exercise
5486441|NCT01351831|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5486442|NCT01351831|Resistance training|resistance training
5486443|NCT01351831|Physical Therapy Modalities|physical therapy modalities
5486444|NCT01351831|Randomized Controlled Trial|randomized controlled trial
5486445|NCT01351805|vitamin D|vitamin d
5486446|NCT01351805|omega-3 fatty acid|omega-3 fatty acid
5486447|NCT01351805|fish oil|fish oil
5486448|NCT01351805|prevention|prevention
5486449|NCT01351805|trial|trial
5486450|NCT01351805|autoimmune disease|autoimmune disease
5486451|NCT01351805|rheumatoid arthritis|rheumatoid arthritis
5486452|NCT01351805|psoriasis|psoriasis
5486453|NCT01351805|systemic inflammation|systemic inflammation
5486454|NCT01351805|Interleukin-6|interleukin-6
5486455|NCT01351805|C-reactive peptide|c-reactive peptide
5486456|NCT01351805|tumor necrosis factor|tumor necrosis factor
5486457|NCT01351805|osteoarthritis|osteoarthritis
5486458|NCT01351779|Intraocular pressure|intraocular pressure
5486459|NCT01351779|Contact lens sensor|contact lens sensor
5486460|NCT01351779|Optic disc hemorrhage|optic disc hemorrhage
5486461|NCT01351766|Behavioral Activation|behavioral activation
5486462|NCT01351753|Obesity|obesity
5486463|NCT01351753|Metabolic Syndrome X|metabolic syndrome x
5486464|NCT01351753|Hypertension|hypertension
5486465|NCT01351753|Dyslipidemia|dyslipidemia
5486466|NCT01351753|Impaired glucose tolerance|impaired glucose tolerance
5486468|NCT01351740|Anti-HIV Agents|anti-hiv agents
5486469|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors
5486470|NCT01351727|seniors|seniors
5486471|NCT01351727|seizures|seizures
5486472|NCT01351727|epilepsy|epilepsy
5486473|NCT01351727|quality of life|quality of life
5486474|NCT01351714|D3 resection|d3 resection
5486475|NCT01351714|right colectomy|right colectomy
5486476|NCT01351714|MDCT angiography|mdct angiography
5486477|NCT01351714|lymphadenectomy|lymphadenectomy
5486478|NCT01351714|safe|safe
5486479|NCT01351714|right colon|right colon
5486480|NCT01351714|preoperative|preoperative
5486481|NCT01351701|Diabetic foot|diabetic foot
5486482|NCT01351701|Bacteriological epidemiology|bacteriological epidemiology
5486483|NCT01351701|Wagner's Grading|wagner's grading
5486484|NCT01351701|eastern India|eastern india
5486485|NCT01351688|Phase 1|phase 1
5486486|NCT01351688|Metastatic|metastatic
5486487|NCT01351688|Castration resistant|castration resistant
5486488|NCT01351688|Prostate cancer|prostate cancer
5486489|NCT01351688|Androgen receptor|androgen receptor
5486494|NCT01351675|Diabetic nephropathy|diabetic nephropathy
5486495|NCT01351662|Lupus|lupus
5486496|NCT01351662|stress|stress
5486497|NCT01351649|exercise|exercise
5486498|NCT01351649|adolescent|adolescent
5486499|NCT01351649|intervention|intervention
5486500|NCT01351649|female|female
5486501|NCT01351649|counseling|counseling
5486502|NCT01351636|chronic kidney disease|chronic kidney disease
5486503|NCT01351636|hypertension|hypertension
5486504|NCT01351623|PR-171 (CARFILZOMIB)|pr-171 (carfilzomib)
5486505|NCT01351623|Chemotherapy|chemotherapy
5486506|NCT01351623|10-228|10-228
5486507|NCT01351610|Critical Limb Ischemia|critical limb ischemia
5486508|NCT01351610|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5486509|NCT01351610|Peripheral Artery Disease|peripheral artery disease
5486510|NCT01351610|Peripheral Vascular Disease|peripheral vascular disease
5486511|NCT01351610|Stem Cell Therapy|stem cell therapy
5486533|NCT01351506|Body mass index|body mass index
5486534|NCT01351506|Weight change|weight change
5486535|NCT01351506|ICU outcomes|icu outcomes
5486536|NCT01351493|pressure sore|pressure sore
5486537|NCT01351493|nitric oxide|nitric oxide
5486538|NCT01351480|Auto-immune Disease|auto-immune disease
5486539|NCT01351480|Arthritis|arthritis
5486540|NCT01351480|Rheumatoid Arthritis|rheumatoid arthritis
5486541|NCT01351467|Parkinson's|parkinson's
5486542|NCT01351467|genetic|genetic
5486543|NCT01351467|online|online
5486544|NCT01351467|GWAS|gwas
5486545|NCT01351467|genome wide association|genome wide association
5486546|NCT01351454|Depression|depression
5486547|NCT01351454|Substance Use|substance use
5486548|NCT01351454|HIV Medication Adherence|hiv medication adherence
5486549|NCT01351454|Behavioral Activation|behavioral activation
5486550|NCT01351441|Geriatric|geriatric
5486551|NCT01351441|Pharmacoeconomics|pharmacoeconomics
5486552|NCT01351441|Health Literacy|health literacy
5486553|NCT01351441|Adherence|adherence
5486554|NCT01351428|Non invasive cardiac output monitor|non invasive cardiac output monitor
5486556|NCT01351428|Hypertension|hypertension
5486557|NCT01351428|Pregnancy|pregnancy
5486558|NCT01351428|Pre-Eclampsia|pre-eclampsia
5486559|NCT01351402|Massage|massage
5486560|NCT01351402|Rest|rest
5486561|NCT01351389|Brief|brief
5486562|NCT01351389|Alcohol|alcohol
5486563|NCT01351389|Intervention|intervention
5486564|NCT01351389|Sex|sex
5486565|NCT01351389|Risk|risk
5486566|NCT01351376|Lymphedema, Low Level Laser, Breast Cancer|lymphedema, low level laser, breast cancer
5486567|NCT01351363|Arthroscopic shoulder surgery|arthroscopic shoulder surgery
5486568|NCT01351363|Pain threshold|pain threshold
5486569|NCT01351350|Solid tumor, mTORC1/2 inhibitors, HER2|solid tumor, mtorc1/2 inhibitors, her2
5486570|NCT01351337|Diffusion tensor imaging, Glioma, Intraoperative monitoring, Pyramidal tract, Subcortical|diffusion tensor imaging, glioma, intraoperative monitoring, pyramidal tract, subcortical
5486571|NCT01351337|stimulation, Tractography|stimulation, tractography
5486572|NCT01351324|Endothelial function|endothelial function
5486573|NCT01351324|Non-esterified fatty acids|non-esterified fatty acids
5486574|NCT01351324|Insulin sensitivity|insulin sensitivity
5486575|NCT01351311|treatment|treatment
5486576|NCT01351311|exercise|exercise
5486577|NCT01351311|resistance training|resistance training
5486578|NCT01351311|swiss ball|swiss ball
5486579|NCT01351311|functional capacity|functional capacity
5486580|NCT01351259|Mechanical ventilation|mechanical ventilation
5486581|NCT01351259|Intubation|intubation
5486582|NCT01351259|Cuff pressure|cuff pressure
5486583|NCT01351259|Microaspiration|microaspiration
5486584|NCT01351246|Program Evaluation|program evaluation
5486585|NCT01351246|ADHD|adhd
5486586|NCT01351233|Cataract|cataract
5486587|NCT01351220|CRC screening|crc screening
5486588|NCT01351220|Prevention and early detection of CRC|prevention and early detection of crc
5486589|NCT01351220|Filipino|filipino
5486590|NCT01351220|Dissemination|dissemination
5486591|NCT01351194|Hepatocellular Carcinoma|hepatocellular carcinoma
5486592|NCT01351194|RFA|rfa
5486593|NCT01351194|HR|hr
5486594|NCT01351181|Diabetes|diabetes
5486595|NCT01351168|Parkinson's disease|parkinson's disease
5486596|NCT01351168|zolpidem|zolpidem
5486597|NCT01351155|acute respiratory failure|acute respiratory failure
5486598|NCT01351155|noninvasive ventilation|noninvasive ventilation
5486599|NCT01351129|formulation comparison|formulation comparison
5486600|NCT01351116|brachytherapy|brachytherapy
5486601|NCT01351116|external beam radiation|external beam radiation
5486602|NCT01351116|high dose rate intraluminal brachytherapy|high dose rate intraluminal brachytherapy
5486603|NCT01351116|lung cancer|lung cancer
5486604|NCT01351116|quality of life|quality of life
5486605|NCT01351116|radiation treatment|radiation treatment
5486607|NCT01351103|LGK974|lgk974
5486608|NCT01351103|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5486609|NCT01351103|BRAF mutant colorectal cancer|braf mutant colorectal cancer
5486610|NCT01351103|RNF43 mutation|rnf43 mutation
5486611|NCT01351103|RSPO fusion|rspo fusion
5486617|NCT01351103|cervical scc|cervical scc
5486618|NCT01351103|esophageal scc|esophageal scc
5486620|NCT01351077|Developmental Delay|developmental delay
5486622|NCT01351012|Canola oil|canola oil
5486623|NCT01351012|High oleic canola oil|high oleic canola oil
5486624|NCT01351012|Flax oil|flax oil
5486625|NCT01351012|ALA|ala
5486626|NCT01351012|DHA|dha
5486627|NCT01351012|Metabolic syndrome|metabolic syndrome
5486628|NCT01351012|Cardiovascular disease|cardiovascular disease
5486629|NCT01351012|Endothelial function|endothelial function
5486630|NCT01351012|FADS1|fads1
5486631|NCT01351012|Gut microbiome|gut microbiome
5486632|NCT01351012|Body composition|body composition
5486633|NCT01351012|Psychosocial status|psychosocial status
5486634|NCT01351012|Cholesterol|cholesterol
5486635|NCT01351012|Lipids|lipids
5486636|NCT01351012|Lipoproteins|lipoproteins
5486637|NCT01351012|Inflammation|inflammation
5486638|NCT01351012|Lipid peroxidation|lipid peroxidation
5486639|NCT01350999|Drug Therapy|drug therapy
5486640|NCT01350986|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5486641|NCT01350973|Drug Therapy|drug therapy
5486642|NCT01350960|hypercholesterolemia|hypercholesterolemia
5486643|NCT01350960|hyperlipidemia|hyperlipidemia
5486644|NCT01350960|LDL|ldl
5486645|NCT01350960|HDL|hdl
5486646|NCT01350960|PCSK9|pcsk9
5486647|NCT01350960|LNA-oligonucleotide|lna-oligonucleotide
5486648|NCT01350947|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5486649|NCT01350947|CMML|cmml
5486650|NCT01350921|phase 1|phase 1
5486651|NCT01350921|ticagrelor|ticagrelor
5486652|NCT01350921|venlafaxine|venlafaxine
5486653|NCT01350895|Polycystic ovarian syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5486654|NCT01350882|kidney transplantation|kidney transplantation
5486655|NCT01350882|acute humoral rejection|acute humoral rejection
5486656|NCT01350882|rituximab|rituximab
5486657|NCT01350856|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5486658|NCT01350843|Men|men
5489608|NCT01338805|CNS|cns
5486670|NCT01350778|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5486671|NCT01350765|Birth asphyxia|birth asphyxia
5486672|NCT01350765|Low birth weight|low birth weight
5486673|NCT01350765|neonatal sepsis|neonatal sepsis
5486674|NCT01350765|mortality|mortality
5486675|NCT01350765|community based interventions|community based interventions
5486676|NCT01350752|cost effectiveness|cost effectiveness
5486677|NCT01350752|provider knowledge|provider knowledge
5486678|NCT01350752|schools|schools
5486679|NCT01350726|Cirrhosis|cirrhosis
5486680|NCT01350726|Hepatic Carcinoma|hepatic carcinoma
5486681|NCT01350713|skin|skin
5486682|NCT01350713|burn|burn
5486683|NCT01350713|povidone iodine|povidone iodine
5486684|NCT01350713|cold water|cold water
5486685|NCT01350700|QOL|qol
5486686|NCT01350687|Calcium Phosphore|calcium phosphore
5486687|NCT01350687|Renagel|renagel
5486688|NCT01350674|mediastinal tuberculosis|mediastinal tuberculosis
5486689|NCT01350674|endoscopy|endoscopy
5486690|NCT01350674|EBUS|ebus
5486691|NCT01350674|tuberculous lymphadenopathy|tuberculous lymphadenopathy
5486692|NCT01350674|endobronchial ultrasound|endobronchial ultrasound
5486693|NCT01350661|Asthma|asthma
5486694|NCT01350661|Questionnaires|questionnaires
5486700|NCT01350635|Specific Immunotherapy|specific immunotherapy
5486701|NCT01350635|Grass pollen vaccine|grass pollen vaccine
5486702|NCT01350635|Allergy|allergy
5486703|NCT01350635|Grass Pollen Allergy|grass pollen allergy
5486704|NCT01350622|pain management|pain management
5486705|NCT01350609|essential hypertension, blood pressure, nifedipine, candesartan, FDC|essential hypertension, blood pressure, nifedipine, candesartan, fdc
5486706|NCT01350596|Bioequivalence Study|bioequivalence study
5486707|NCT01350596|Ibuprofen|ibuprofen
5486708|NCT01350596|Alivium|alivium
5486709|NCT01350583|tumor related pain|tumor related pain
5486710|NCT01350570|acupuncture|acupuncture
5486711|NCT01350570|loperamide|loperamide
5486712|NCT01350570|functional diarrhea|functional diarrhea
5486713|NCT01350570|IBS|ibs
5486714|NCT01350557|Elderly|elderly
5486715|NCT01350557|Hip fracture|hip fracture
5486716|NCT01350557|Intervention program|intervention program
5486717|NCT01350544|HIV|hiv
5486718|NCT01350544|Adherence|adherence
5486719|NCT01350544|African American/Black|african american/black
5486720|NCT01350544|Disparities|disparities
5486721|NCT01350531|Obesity|obesity
5486722|NCT01350531|African American adolescents|african american adolescents
5486723|NCT01350531|Motivation|motivation
5486724|NCT01350518|Intra-Abdominal Fat|intra-abdominal fat
5486725|NCT01350518|Metabolic Syndrome|metabolic syndrome
5486726|NCT01350518|Hepatic steatosis|hepatic steatosis
5486727|NCT01350505|Postural Balance|postural balance
5486728|NCT01350505|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5486729|NCT01350492|pain|pain
5486730|NCT01350492|brain imaging|brain imaging
5486731|NCT01350492|exercise|exercise
5486732|NCT01350479|Cross infection|cross infection
5486733|NCT01350479|Long term care|long term care
5486734|NCT01350466|Chronic rhinosinusitis|chronic rhinosinusitis
5486737|NCT01350427|leucine supplementation|leucine supplementation
5486738|NCT01350427|BCCA supplementation|bcca supplementation
5486739|NCT01350427|resistance exercise-induced muscle remodeling|resistance exercise-induced muscle remodeling
5486740|NCT01350401|Melanoma|melanoma
5486741|NCT01350401|Cell Therapy|cell therapy
5486742|NCT01350401|T Cell Therapy|t cell therapy
5486743|NCT01350401|NY-ESO-1|ny-eso-1
5486744|NCT01350401|Immuno-oncology|immuno-oncology
5486745|NCT01350401|Metastatic|metastatic
5486746|NCT01350401|Previously treated|previously treated
5486747|NCT01350401|T Cell Receptor|t cell receptor
5486748|NCT01350388|Chronic Kidney Disease|chronic kidney disease
5486749|NCT01350388|Diabetes|diabetes
5486750|NCT01350388|Febuxostat|febuxostat
5486751|NCT01350388|Inflammation|inflammation
5486752|NCT01350388|Hyperuricemia|hyperuricemia
5486753|NCT01350362|tideglusib|tideglusib
5486754|NCT01350362|Alzheimer|alzheimer
5486755|NCT01350362|NP-12|np-12
5486756|NCT01350362|NP031112|np031112
5486757|NCT01350362|ARGO|argo
5486758|NCT01350362|Noscira|noscira
5486759|NCT01350349|Depression|depression
5486761|NCT01350349|Geriatrics|geriatrics
5486762|NCT01350310|Heart failure|heart failure
5486763|NCT01350310|Dilated cardiomyopathy|dilated cardiomyopathy
5486764|NCT01350310|Stem cells|stem cells
5486765|NCT01350297|tetraplegia|tetraplegia
5486766|NCT01350297|reinnervation|reinnervation
5486767|NCT01350297|phrenic nerve|phrenic nerve
5486768|NCT01350284|Antioxidants|antioxidants
5486769|NCT01350284|Glucose Intolerance prevention and control|glucose intolerance prevention and control
5486770|NCT01350284|Diabetes Mellitus prevention and control|diabetes mellitus prevention and control
5486771|NCT01350271|Hookworm|hookworm
5486772|NCT01350271|Necator americanus|necator americanus
5486773|NCT01350271|Mebendazole|mebendazole
5486774|NCT01350258|allogeneic HSCT|allogeneic hsct
5638790|NCT00744198|TOT|tot
5486775|NCT01350258|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5486776|NCT01350245|Acute Myeloid Leukemia|acute myeloid leukemia
5486777|NCT01350245|Myelodysplastic Syndromes|myelodysplastic syndromes
5486778|NCT01350245|Biphenotypic Leukemia|biphenotypic leukemia
5486779|NCT01350245|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5486780|NCT01350245|Chronic Myeloid Leukemia|chronic myeloid leukemia
5486781|NCT01350245|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5486782|NCT01350245|Plasma Cell Neoplasms|plasma cell neoplasms
5486783|NCT01350245|Lymphoma|lymphoma
5486784|NCT01350245|Hodgkin's Disease|hodgkin's disease
5486785|NCT01350245|Aplastic Anemia|aplastic anemia
5486786|NCT01350245|Hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5486787|NCT01350245|myeloablative haploidentical HSCT|myeloablative haploidentical hsct
5486788|NCT01350245|graft versus host disease (GVHD)|graft versus host disease (gvhd)
5486789|NCT01350232|sickle cell|sickle cell
5486790|NCT01350232|SS disease|ss disease
5486791|NCT01350232|SC disease|sc disease
5486792|NCT01350232|S-thalassemia|s-thalassemia
5486793|NCT01350232|transplant|transplant
5486794|NCT01350232|bone marrow transplant|bone marrow transplant
5486795|NCT01350232|stem cell transplant|stem cell transplant
5486796|NCT01350232|matched sibling|matched sibling
5486797|NCT01350232|haploidentical|haploidentical
5486798|NCT01350232|hemoglobinopathy|hemoglobinopathy
5486799|NCT01350232|anemia|anemia
5486800|NCT01350232|desensitization|desensitization
5486801|NCT01350219|Cord blood stem cells|cord blood stem cells
5486802|NCT01350219|Immune modulation|immune modulation
5486803|NCT01350219|Stem cell educator|stem cell educator
5486804|NCT01350219|Autoimmunity|autoimmunity
5486805|NCT01350219|Islet beta cell regeneration|islet beta cell regeneration
5486806|NCT01350219|Type 1 diabetes|type 1 diabetes
5486807|NCT01350206|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5486808|NCT01350206|Liver Neoplasms|liver neoplasms
5486809|NCT01350206|Therapeutic|therapeutic
5486810|NCT01350206|Chemoembolization,|chemoembolization,
5486811|NCT01350206|TACE|tace
5486812|NCT01350206|hepatic resection|hepatic resection
5486813|NCT01350193|Manuka Honey|manuka honey
5486814|NCT01350193|Irrigation|irrigation
5486815|NCT01350193|Endoscopic Sinus Surgery|endoscopic sinus surgery
5486816|NCT01350180|biochemical failure|biochemical failure
5486817|NCT01350180|hormonal therapy|hormonal therapy
5486818|NCT01350167|Hepatocellular Carcinoma|hepatocellular carcinoma
5486819|NCT01350167|Liver Cancer|liver cancer
5486820|NCT01350167|Ultrasound|ultrasound
5486821|NCT01350167|Computed Tomography|computed tomography
5486822|NCT01350167|Alpha fetoprotein|alpha fetoprotein
5486823|NCT01350167|Cirrhosis|cirrhosis
5486824|NCT01350167|Screening|screening
5486825|NCT01350167|Advanced Liver Disease|advanced liver disease
5486826|NCT01350154|clinical trial|clinical trial
5486827|NCT01350154|sildenafil|sildenafil
5486828|NCT01350154|revatio|revatio
5486829|NCT01350154|muscular dystrophy|muscular dystrophy
5486830|NCT01350154|adult|adult
5486831|NCT01350154|nNOS|nnos
5486832|NCT01350141|Hypercholesterolemia|hypercholesterolemia
5481102|NCT01374620|Cancer|cancer
5486841|NCT01350115|Basal Cell Carcinoma|basal cell carcinoma
5486842|NCT01350115|Gorlin Syndrome,|gorlin syndrome,
5486843|NCT01350115|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
5486844|NCT01350115|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
5486845|NCT01350115|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
5486846|NCT01350115|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
5486847|NCT01350115|Smo inhibitor,|smo inhibitor,
5486848|NCT01350115|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
5486849|NCT01350115|BCCs|bccs
5486850|NCT01350102|Adult|adult
5486851|NCT01350089|energy drinks|energy drinks
5486852|NCT01350089|alcohol intoxication|alcohol intoxication
5486853|NCT01350076|intraoperative fluid|intraoperative fluid
5486854|NCT01350076|pediatric|pediatric
5486855|NCT01350076|goal directed therapy|goal directed therapy
5486856|NCT01350076|pediatric with major abdominal surgery|pediatric with major abdominal surgery
5486857|NCT01350076|ASA less than or equal to 3|asa less than or equal to 3
5486858|NCT01350076|Duration of surgery less than 2 hours|duration of surgery less than 2 hours
5486859|NCT01350076|Body weight more than or equal to 15 kg|body weight more than or equal to 15 kg
5486860|NCT01350063|water|water
5486861|NCT01350063|tubewell|tubewell
5486862|NCT01350063|diarrhea|diarrhea
5486863|NCT01350063|chlorination|chlorination
5486864|NCT01350063|safe storage|safe storage
5486865|NCT01350050|topical pharyngeal anesthesia|topical pharyngeal anesthesia
5486866|NCT01350050|articaine|articaine
5486867|NCT01350037|patient-controlled sedation|patient-controlled sedation
5486868|NCT01350037|propofol|propofol
5486869|NCT01350037|alfentanil|alfentanil
5486870|NCT01350037|remifentanil|remifentanil
5486871|NCT01350037|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5486872|NCT01350024|Conjunctival Mullerectomy|conjunctival mullerectomy
5486873|NCT01350024|Blepharoptosis|blepharoptosis
5486874|NCT01350024|Ptosis surgery|ptosis surgery
5486875|NCT01350024|Pain Control|pain control
5486876|NCT01350011|Nicotine Replacement Therapy|nicotine replacement therapy
5486877|NCT01350011|Buprenorphine|buprenorphine
5486878|NCT01350011|Varenicline|varenicline
5486879|NCT01350011|Smoking Cessation|smoking cessation
5486880|NCT01350011|Addiction|addiction
5486881|NCT01350011|The Innovative System (IS) Treatment|the innovative system (is) treatment
5486882|NCT01350011|The Standard Treatment Control (STC)|the standard treatment control (stc)
5486883|NCT01349985|Naltrexone|naltrexone
5486884|NCT01349985|problem drinking|problem drinking
5486885|NCT01349985|medication adherence|medication adherence
5486886|NCT01349985|adherence|adherence
5486887|NCT01349985|smartphone|smartphone
5486888|NCT01349920|biological markers|biological markers
5486889|NCT01349920|endoscopy|endoscopy
5486890|NCT01349920|gastrointestinal|gastrointestinal
5486891|NCT01349881|Eflornithine/sulindac prevention trial|eflornithine/sulindac prevention trial
5486892|NCT01349868|COPD|copd
5486893|NCT01349829|Hepatitis A|hepatitis a
5486894|NCT01349829|Vaccination|vaccination
5486895|NCT01349829|Immunity|immunity
5486896|NCT01349816|COPD|copd
5486897|NCT01349803|COPD|copd
5486898|NCT01349790|ITP|itp
5486899|NCT01349790|Primary immune thrombocytopenia|primary immune thrombocytopenia
5486900|NCT01349777|antiplatelet therapy post drug eluting stents|antiplatelet therapy post drug eluting stents
5486901|NCT01349764|vitamin D replacement|vitamin d replacement
5486902|NCT01349764|Urolithiasis|urolithiasis
5486903|NCT01349764|deficiency|deficiency
5486904|NCT01349764|insufficiency|insufficiency
5486905|NCT01349751|abdominal incision|abdominal incision
5486906|NCT01349751|hyperbaric|hyperbaric
5486907|NCT01349751|isobaric|isobaric
5486908|NCT01349751|levobupivacaine|levobupivacaine
5486909|NCT01349751|spinal anaesthesia|spinal anaesthesia
5486910|NCT01349725|Safety|safety
5486911|NCT01349699|endotoxemia|endotoxemia
5486912|NCT01349699|inflammation|inflammation
5486913|NCT01349699|iron|iron
5486914|NCT01349699|iron chelation|iron chelation
5486915|NCT01349699|cytokines|cytokines
5486916|NCT01349686|Food|food
5486917|NCT01349686|Fluids|fluids
5486918|NCT01349686|Labor|labor
5486919|NCT01349673|Open-label|open-label
5486920|NCT01349673|Proctitis|proctitis
5486921|NCT01349673|Proctosigmoiditis|proctosigmoiditis
5486922|NCT01349673|Ulcerative|ulcerative
5486923|NCT01349673|Salix|salix
5486924|NCT01349673|Budesonide foam|budesonide foam
5486925|NCT01349673|Budesonide|budesonide
5486926|NCT01349673|Rectal|rectal
5486927|NCT01349673|Gastrointestinal|gastrointestinal
5486928|NCT01349673|Colitis|colitis
5486930|NCT01349673|UP|up
5486931|NCT01349673|UPS|ups
5486932|NCT01349673|Additional relevant MeSH terms:|additional relevant mesh terms:
5486933|NCT01349673|Proctocolitis|proctocolitis
5486934|NCT01349673|Ulcer|ulcer
5486935|NCT01349673|Colitis, Ulcerative|colitis, ulcerative
5486936|NCT01349673|Gastroenteritis|gastroenteritis
5486937|NCT01349673|Gastrointestinal Diseases|gastrointestinal diseases
5486938|NCT01349673|Digestive System Diseases|digestive system diseases
5486939|NCT01349673|Rectal Diseases|rectal diseases
5486940|NCT01349673|Intestinal Diseases|intestinal diseases
5486941|NCT01349673|Colonic Diseases|colonic diseases
5486942|NCT01349673|Sigmoid Diseases|sigmoid diseases
5486943|NCT01349673|Pathologic Processes|pathologic processes
5486944|NCT01349673|Inflammatory Bowel Diseases|inflammatory bowel diseases
5486945|NCT01349673|Bronchodilator Agents|bronchodilator agents
5486946|NCT01349673|Autonomic Agents|autonomic agents
5486947|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents
5486948|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs
5486949|NCT01349673|Pharmacologic Actions|pharmacologic actions
5486950|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents
5486951|NCT01349673|Respiratory System Agents|respiratory system agents
5486952|NCT01349673|Therapeutic Uses|therapeutic uses
5486953|NCT01349673|Glucocorticoids|glucocorticoids
5486954|NCT01349673|Hormones|hormones
5486955|NCT01349673|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
5486956|NCT01349673|Anti-inflammatory Agents|anti-inflammatory agents
5486957|NCT01349660|Glioblastoma multiforme|glioblastoma multiforme
5486959|NCT01349660|Bevacizumab|bevacizumab
5486960|NCT01349660|PI3K Pathway|pi3k pathway
5486961|NCT01349660|BKM120|bkm120
5486962|NCT01349647|FUCOSYL-GM1-KLH|fucosyl-gm1-klh
5486963|NCT01349647|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5486964|NCT01349647|OPT-821|opt-821
5486965|NCT01349647|POLYSIALIC ACID - KLH|polysialic acid - klh
5486966|NCT01349647|Vaccine|vaccine
5486967|NCT01349647|08-095|08-095
5486968|NCT01349634|iodine|iodine
5486969|NCT01349634|goiter|goiter
5486970|NCT01349634|cretinism|cretinism
5486971|NCT01349634|child nutrition|child nutrition
5486972|NCT01349634|cognition|cognition
5486973|NCT01349621|Abnormal Pap results|abnormal pap results
5486974|NCT01349621|Colposcopy|colposcopy
5486975|NCT01349608|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5486976|NCT01349608|Motivational Interviewing|motivational interviewing
5486977|NCT01349608|Health Coaching|health coaching
5486978|NCT01349608|Physical Activity|physical activity
5486979|NCT01349582|flow diversion|flow diversion
5486980|NCT01349582|endovascular treatment|endovascular treatment
5486981|NCT01349582|symptomatic aneurysm|symptomatic aneurysm
5486982|NCT01349582|cavernous carotid aneurysm|cavernous carotid aneurysm
5486983|NCT01349582|ophthalmic aneurysm|ophthalmic aneurysm
5486984|NCT01349582|vertebral aneurysm|vertebral aneurysm
5486985|NCT01349556|cancer|cancer
5486986|NCT01349556|chemotherapy|chemotherapy
5486987|NCT01349556|EGFR inhibitors|egfr inhibitors
5486988|NCT01349556|tretinoin|tretinoin
5486989|NCT01349556|EGFRi drug rash|egfri drug rash
5486990|NCT01349543|Respiratory syncytial virus|respiratory syncytial virus
5486991|NCT01349543|RSV|rsv
5486992|NCT01349543|Immunology|immunology
5486993|NCT01349543|Viral infection|viral infection
5486994|NCT01349543|Bronchiolitis|bronchiolitis
5486995|NCT01349543|Viral challenge|viral challenge
5486996|NCT01349543|Viral lung disease|viral lung disease
5486997|NCT01349530|Usual medical care|usual medical care
5486998|NCT01349530|Anticoagulation by VKAs: COUMADINE® & PREVISCAN®|anticoagulation by vkas: coumadine® & previscan®
5486999|NCT01349530|Anticoagulation clinic care, CREATIF|anticoagulation clinic care, creatif
5487000|NCT01349517|health-related quality of life(HRQL)|health-related quality of life(hrql)
5487001|NCT01349517|Esophageal Cancer|esophageal cancer
5487002|NCT01349491|Atrial Fibrillation|atrial fibrillation
5487003|NCT01349491|Ranolazine|ranolazine
5487004|NCT01349478|paraplegia|paraplegia
5487005|NCT01349478|tetraplegia|tetraplegia
5487006|NCT01349478|passive gait training|passive gait training
5487007|NCT01349478|O2 consumption|o2 consumption
5487008|NCT01349478|exercise capacity|exercise capacity
5487009|NCT01349478|CVD risk factors|cvd risk factors
5487010|NCT01349478|spasticity|spasticity
5487011|NCT01349478|pain|pain
5487012|NCT01349478|bladder, bowel|bladder, bowel
5487013|NCT01349478|well being|well being
5487014|NCT01349465|Hepatitis C|hepatitis c
5487015|NCT01349465|Hepatitis|hepatitis
5487016|NCT01349465|TMC435|tmc435
5487017|NCT01349465|Liver disease|liver disease
5487021|NCT01349452|Ganciclovir|ganciclovir
5487022|NCT01349452|Adenovirus Keratoconjunctivitis|adenovirus keratoconjunctivitis
5487023|NCT01349452|Treatment of viral conjunctivitis|treatment of viral conjunctivitis
5487024|NCT01349426|Lung resection|lung resection
5685324|NCT00556543|Chest wall deformity|chest wall deformity
5487025|NCT01349426|Parenchymal pneumostasis, haemostasis|parenchymal pneumostasis, haemostasis
5487026|NCT01349426|Fissure closure|fissure closure
5487027|NCT01349426|Automatic staplers,LigaSure, Force Triad Generator|automatic staplers,ligasure, force triad generator
5487028|NCT01349426|Bipolar fusion|bipolar fusion
5487029|NCT01349426|Procedure cost|procedure cost
5487030|NCT01349413|Functional dyspepsia|functional dyspepsia
5487031|NCT01349413|symptom response|symptom response
5487032|NCT01349413|postprandial fullness|postprandial fullness
5487033|NCT01349413|gastroesophageal reflux disease|gastroesophageal reflux disease
5487034|NCT01349413|acid suppression|acid suppression
5487035|NCT01349400|asymptomatic|asymptomatic
5487036|NCT01349400|minimally symptomatic|minimally symptomatic
5487037|NCT01349348|Tolvaptan treatment to ascites and hepatic cirrhosis|tolvaptan treatment to ascites and hepatic cirrhosis
5487038|NCT01349322|stage IA breast cancer|stage ia breast cancer
5487039|NCT01349322|stage IB breast cancer|stage ib breast cancer
5487040|NCT01349322|stage II breast cancer|stage ii breast cancer
5487041|NCT01349322|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5487042|NCT01349322|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5487043|NCT01349322|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5487044|NCT01349322|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5487045|NCT01349322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5487046|NCT01349309|Prophylactic Swallowing Exercises|prophylactic swallowing exercises
5487047|NCT01349309|Head and Neck Cancer|head and neck cancer
5487048|NCT01349309|Dysphagia|dysphagia
5487049|NCT01349296|Solid Tumors|solid tumors
5487050|NCT01349283|Hepatitis B Vaccine|hepatitis b vaccine
5487051|NCT01349283|Hepatitis B Virus|hepatitis b virus
5487052|NCT01349283|Antigen|antigen
5487053|NCT01349283|Antibody|antibody
5487054|NCT01349283|Vaccination|vaccination
5487055|NCT01349270|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5487056|NCT01349270|immunoglobulin|immunoglobulin
5487057|NCT01349270|prednisone|prednisone
5487058|NCT01349257|Asthmatic patients|asthmatic patients
5487059|NCT01349244|hydronephrosis|hydronephrosis
5487061|NCT01349244|POC US|poc us
5469111|NCT01424384|healthy volunteers|healthy volunteers
5487062|NCT01349231|obsessive-compulsive disorder|obsessive-compulsive disorder
5487063|NCT01349231|ketamine|ketamine
5487064|NCT01349231|glutamate|glutamate
5487065|NCT01349218|Potassium|potassium
5487066|NCT01349218|Infants|infants
5487067|NCT01349218|Heel Stick|heel stick
5487068|NCT01349218|Less than or equal to 6 months of age|less than or equal to 6 months of age
5487069|NCT01349218|IV catheter blood samples|iv catheter blood samples
5487070|NCT01349218|perioperatively|perioperatively
5487071|NCT01349218|elective surgical procedures|elective surgical procedures
5487072|NCT01349205|OSA|osa
5487073|NCT01349205|Caffeine|caffeine
5487074|NCT01349205|Tonsillectomy|tonsillectomy
5487075|NCT01349205|Adenoidectomy|adenoidectomy
5487076|NCT01349205|Sleep Study|sleep study
5487077|NCT01349192|MRSA|mrsa
5487078|NCT01349192|Cystic Fibrosis|cystic fibrosis
5487079|NCT01349192|Early Infection|early infection
5487080|NCT01349192|Treatment|treatment
5487081|NCT01349179|Hip|hip
5487082|NCT01349179|Arthroplasty|arthroplasty
5487083|NCT01349179|Metal on metal|metal on metal
5487084|NCT01349179|operated on 2002|operated on 2002
5487085|NCT01349166|Obesity|obesity
5487086|NCT01349166|Type 2 diabetes|type 2 diabetes
5487087|NCT01349166|glucose intolerance|glucose intolerance
5487088|NCT01349166|Physical Activity|physical activity
5487089|NCT01349166|Inflammation|inflammation
5487090|NCT01349166|HPA axis|hpa axis
5487091|NCT01349166|Cytokines|cytokines
5487092|NCT01349153|Physical Activity|physical activity
5487093|NCT01349153|Young Adults|young adults
5487094|NCT01349153|Cancer Survivors|cancer survivors
5487095|NCT01349127|Vitamin D|vitamin d
5487096|NCT01349127|Cholecalciferol|cholecalciferol
5487097|NCT01349127|Nutrient requirements|nutrient requirements
5487098|NCT01349127|Randomised Controlled Trial|randomised controlled trial
5487099|NCT01349127|Lactation|lactation
5487100|NCT01349127|pregnancy|pregnancy
5487101|NCT01349127|Cord blood|cord blood
5487102|NCT01349127|Human milk|human milk
5487103|NCT01349127|serum 25-hydroxyvitamin D|serum 25-hydroxyvitamin d
5487104|NCT01349127|deficiency|deficiency
5487105|NCT01349127|insufficiency|insufficiency
5487106|NCT01349127|nutrition|nutrition
5487107|NCT01349114|aliskiren|aliskiren
5487108|NCT01349114|endothelial function|endothelial function
5487109|NCT01349114|hypertension|hypertension
5487509|NCT01347567|Prevention|prevention
5487118|NCT01349088|stage IV breast cancer|stage iv breast cancer
5487119|NCT01349088|motesanib|motesanib
5487120|NCT01349088|ixabepilone|ixabepilone
5487121|NCT01349088|capecitabine|capecitabine
5487122|NCT01349075|Unresectable|unresectable
5487123|NCT01349075|Hepatocellular Carcinoma|hepatocellular carcinoma
5487124|NCT01349075|TheraSphere|therasphere
5487125|NCT01349075|Yttrium-90|yttrium-90
5487126|NCT01349062|Prolonged Viral Suppression|prolonged viral suppression
5487127|NCT01349062|HIV Infections|hiv infections
5487129|NCT01349049|relapsed|relapsed
5487130|NCT01349049|refractory|refractory
5487131|NCT01349036|Glioblastoma|glioblastoma
5487132|NCT01349036|brain cancer|brain cancer
5487133|NCT01349023|energy content|energy content
5487134|NCT01349023|energy density|energy density
5487135|NCT01349023|energy intake|energy intake
5487136|NCT01349023|pre-portioned entrees|pre-portioned entrees
5487137|NCT01349010|hyperlipidemia|hyperlipidemia
5487142|NCT01348997|anxiety|anxiety
5487143|NCT01348984|postoperative|postoperative
5487144|NCT01348984|pain score|pain score
5487145|NCT01348984|morphine consumption|morphine consumption
5487146|NCT01348971|sodium nitrate|sodium nitrate
5487147|NCT01348971|coronary artery bypass surgery|coronary artery bypass surgery
5487148|NCT01348971|ischemia-reperfusion|ischemia-reperfusion
5487149|NCT01348971|myocardial injury|myocardial injury
5487150|NCT01348958|Patello femoral|patello femoral
5487151|NCT01348958|osteoarthritis|osteoarthritis
5487152|NCT01348958|arthroplasty|arthroplasty
5487153|NCT01348945|Partial tear ACL|partial tear acl
5487154|NCT01348945|Stump preserved ACL surgery|stump preserved acl surgery
5487155|NCT01348932|asthma|asthma
5487156|NCT01348932|Chitinase 3-like 1 (CHI3L1)|chitinase 3-like 1 (chi3l1)
5487157|NCT01348932|YKL-40|ykl-40
5487158|NCT01348932|single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
5487159|NCT01348932|Real time PCR|real time pcr
5487160|NCT01348932|gene|gene
5487161|NCT01348919|Cancer|cancer
5487162|NCT01348919|Multiple myeloma|multiple myeloma
5487163|NCT01348919|CEP-18770|cep-18770
5487164|NCT01348919|Lenalidomide|lenalidomide
5487165|NCT01348919|Dexamethasone|dexamethasone
5487166|NCT01348906|cardiopulmonary bypass|cardiopulmonary bypass
5487168|NCT01348893|Education|education
5487169|NCT01348893|Mind Body Therapies|mind body therapies
5487170|NCT01348880|drug-drug interaction|drug-drug interaction
5487171|NCT01348867|Diabetes|diabetes
5487172|NCT01348867|Structured Care|structured care
5487173|NCT01348854|astigmatism|astigmatism
5487174|NCT01348841|community wound care|community wound care
5487175|NCT01348841|systematic wound team referral|systematic wound team referral
5487176|NCT01348841|Advanced in-home nurse wound training|advanced in-home nurse wound training
5487177|NCT01348828|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5487178|NCT01348828|Fenestrated|fenestrated
5487179|NCT01348828|Renal Stent|renal stent
5487180|NCT01348828|Juxtarenal|juxtarenal
5487181|NCT01348828|Pararenal|pararenal
5487182|NCT01348828|Endologix|endologix
5487183|NCT01348828|Renal|renal
5487184|NCT01348802|Knowledge Translation|knowledge translation
5487185|NCT01348802|Push-out Evidence|push-out evidence
5487186|NCT01348802|Technology-Based Knowledge Translation|technology-based knowledge translation
5487187|NCT01348802|Pain|pain
5487188|NCT01348802|Interdisciplinary|interdisciplinary
5487189|NCT01348802|Physician|physician
5487190|NCT01348802|Rehabilitation|rehabilitation
5487191|NCT01348802|Nursing|nursing
5487192|NCT01348802|Knowledge Uptake|knowledge uptake
5487193|NCT01348789|Hair removal|hair removal
5487194|NCT01348789|Hair Clearance|hair clearance
5487195|NCT01348789|Epilation|epilation
5487196|NCT01348776|hair reduction|hair reduction
5487197|NCT01348776|hair removal|hair removal
5487198|NCT01348776|hair clearance|hair clearance
5487200|NCT01348750|PTSD|ptsd
5487201|NCT01348750|Healing Touch|healing touch
5487202|NCT01348750|Guided Imagery|guided imagery
5487203|NCT01348750|Military|military
5487204|NCT01348750|Complementary Medicine|complementary medicine
5487205|NCT01348737|Phase 1|phase 1
5487206|NCT01348737|healthy volunteers|healthy volunteers
5487207|NCT01348737|double-blind|double-blind
5487208|NCT01348737|placebo-controlled|placebo-controlled
5487209|NCT01348737|AZD3839|azd3839
5487210|NCT01348737|pharmacokinetics|pharmacokinetics
5487211|NCT01348737|Alzheimer's Disease|alzheimer's disease
5487212|NCT01348724|Radioactive carbon|radioactive carbon
5487213|NCT01348724|Absorption|absorption
5487214|NCT01348724|Distribution|distribution
5487215|NCT01348724|Metabolism|metabolism
5487216|NCT01348724|Excretion|excretion
5487217|NCT01348724|Healthy Volunteers|healthy volunteers
5487223|NCT01348698|Gene Expression|gene expression
5487224|NCT01348698|Adrenal Tumor|adrenal tumor
5487225|NCT01348672|Age related macular degeneration|age related macular degeneration
5487226|NCT01348672|Glaucoma|glaucoma
5487227|NCT01348672|Diabetic retinopathy|diabetic retinopathy
5487228|NCT01348672|Retinal oxygen saturation|retinal oxygen saturation
5487229|NCT01348672|Blood flow|blood flow
5487230|NCT01348672|Vascular function|vascular function
5487231|NCT01348672|High resolution imaging|high resolution imaging
5487232|NCT01348659|Hypertonic saline|hypertonic saline
5487233|NCT01348659|Extracellular fluid|extracellular fluid
5487234|NCT01348659|cardiopulmonary bypass|cardiopulmonary bypass
5487235|NCT01348646|Smoking|smoking
5487236|NCT01348646|Adolescence|adolescence
5487237|NCT01348646|Brief intervention|brief intervention
5487238|NCT01348633|Doppler SD-OCT Blood Flow Technology|doppler sd-oct blood flow technology
5487239|NCT01348633|Retinal and choroidal blood flow|retinal and choroidal blood flow
5487240|NCT01348633|Canon Laser Blood Flowmeter|canon laser blood flowmeter
5487241|NCT01348620|single port cholecystectomy|single port cholecystectomy
5481491|NCT01372813|Kidney Cancer|kidney cancer
5487242|NCT01348607|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5487243|NCT01348607|sleep disorders|sleep disorders
5487244|NCT01348607|fatigue|fatigue
5487245|NCT01348607|childhood craniopharyngioma|childhood craniopharyngioma
5487246|NCT01348594|Vitamin D|vitamin d
5487247|NCT01348594|In vitro Fertilization|in vitro fertilization
5487248|NCT01348581|Adult|adult
5487249|NCT01348581|Aged|aged
5487250|NCT01348581|Aged, 80 and over|aged, 80 and over
5487251|NCT01348581|Bandages|bandages
5487252|NCT01348581|Biological Dressings|biological dressings
5487253|NCT01348581|Chronic Disease|chronic disease
5487254|NCT01348581|Collagen|collagen
5487255|NCT01348581|Epithelium|epithelium
5487256|NCT01348581|Extracellular Matrix|extracellular matrix
5487257|NCT01348581|Fibroblasts|fibroblasts
5487258|NCT01348581|Granulation Tissue|granulation tissue
5487259|NCT01348581|Humans|humans
5487260|NCT01348581|Leg Ulcer|leg ulcer
5487261|NCT01348581|Middle Aged|middle aged
5487262|NCT01348581|Prospective Studies|prospective studies
5487263|NCT01348581|Soft Tissue Injuries|soft tissue injuries
5487264|NCT01348581|Treatment Outcome|treatment outcome
5487265|NCT01348581|Varicose Ulcer|varicose ulcer
5487266|NCT01348581|Wound Healing|wound healing
5487267|NCT01348581|Wounds and Injuries|wounds and injuries
5487268|NCT01348555|COPD|copd
5487274|NCT01348529|OCD|ocd
5487275|NCT01348529|CBT|cbt
5487276|NCT01348529|Reducing OCD symptoms|reducing ocd symptoms
5487277|NCT01348516|HIV|hiv
5487278|NCT01348490|PMF|pmf
5487279|NCT01348490|PPV-MF|ppv-mf
5487280|NCT01348490|PET-MF|pet-mf
5487281|NCT01348477|inguinal|inguinal
5487282|NCT01348477|hernia|hernia
5487283|NCT01348477|pain|pain
5487284|NCT01348477|inguinodynia|inguinodynia
5487285|NCT01348477|mesh|mesh
5487286|NCT01348464|appendectomy|appendectomy
5487287|NCT01348464|appendicitis|appendicitis
5487288|NCT01348464|laparoscopic surgery|laparoscopic surgery
5487289|NCT01348451|Human spinal cord derived neural stem cell transplantation|human spinal cord derived neural stem cell transplantation
5487290|NCT01348451|ALS|als
5487291|NCT01348438|high risk|high risk
5789994|NCT00146224|Epogen®|epogen®
5487292|NCT01348438|surgical valve replacement|surgical valve replacement
5487293|NCT01348425|PAD|pad
5487294|NCT01348412|non resectable metastases|non resectable metastases
5487295|NCT01348412|liver of colic or rectal origin|liver of colic or rectal origin
5487296|NCT01348412|after failure of the conventional treatments|after failure of the conventional treatments
5487297|NCT01348399|Coronary artery disease requiring drug eluting stents|coronary artery disease requiring drug eluting stents
5487298|NCT01348386|Potassium hydroxide.|potassium hydroxide.
5487299|NCT01348386|Molluscum Contagiosum|molluscum contagiosum
5487300|NCT01348373|drug eluting stents|drug eluting stents
5487301|NCT01348334|Sling surgery|sling surgery
5487302|NCT01348334|synthetic meshes|synthetic meshes
5487303|NCT01348334|ultrapromesh®|ultrapromesh®
5487304|NCT01348334|mix mesh|mix mesh
5487305|NCT01348334|incontinence|incontinence
5487306|NCT01348334|The Ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.|the ultrapromesh® synthetic sling procedures have lower complications incidence and higher success rates than the other synthetic slings in 3-year follow-up.
5487307|NCT01348308|Late diagnosed HIV-1 infected patients|late diagnosed hiv-1 infected patients
5487308|NCT01348308|AIDS-defining events|aids-defining events
5487309|NCT01348308|Immune restoration|immune restoration
5487310|NCT01348295|Mechanical ventilation|mechanical ventilation
5487311|NCT01348295|Children|children
5487312|NCT01348295|Neonates|neonates
5487313|NCT01348295|Pediatric intensive care|pediatric intensive care
5487314|NCT01348282|Neurocognitive Impairment|neurocognitive impairment
5487315|NCT01348282|Controlled Randomized Trial|controlled randomized trial
5487316|NCT01348282|Coadjunctive Treatments|coadjunctive treatments
5487317|NCT01348282|Lithium; Rivastigmine|lithium; rivastigmine
5487318|NCT01348282|Antiretroviral Therapy|antiretroviral therapy
5487319|NCT01348282|HIV Infection|hiv infection
5487320|NCT01348269|bone marrow edema|bone marrow edema
5487321|NCT01348269|Aclasta|aclasta
5487322|NCT01348256|colorectal carcinoma|colorectal carcinoma
5487323|NCT01348256|resectable hepatic metastasis|resectable hepatic metastasis
5487324|NCT01348256|adjuvant treatment|adjuvant treatment
5487325|NCT01348256|dendritic cells|dendritic cells
5487326|NCT01348230|Premature prolonged rupture of membranes|premature prolonged rupture of membranes
5487327|NCT01348230|Premature labor|premature labor
5487328|NCT01348230|Uromodulin|uromodulin
5487329|NCT01348230|Glycosylation|glycosylation
5487330|NCT01348217|unoperated cancers|unoperated cancers
5487331|NCT01348217|oesophagus|oesophagus
5487332|NCT01348217|radiochemotherapy|radiochemotherapy
5487333|NCT01348217|with and without increased doses|with and without increased doses
5487334|NCT01348204|Cystic Fibrosis|cystic fibrosis
5487335|NCT01348191|Thyrotrophin|thyrotrophin
5487336|NCT01348191|Pregnancy|pregnancy
5487337|NCT01348191|Human myometrium|human myometrium
5487338|NCT01348191|Relaxation|relaxation
5487339|NCT01348191|Contractility|contractility
5487340|NCT01348152|Gastric Emptying|gastric emptying
5487342|NCT01348139|patients|patients
5487343|NCT01348139|lung function|lung function
5487344|NCT01348126|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5487345|NCT01348126|NSCLC|nsclc
5487346|NCT01348126|Lung cancer|lung cancer
5487347|NCT01348113|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
5487348|NCT01348113|alcohol dependence|alcohol dependence
5487349|NCT01348113|Alcohol problem|alcohol problem
5487350|NCT01348100|Schizophrenia|schizophrenia
5487351|NCT01348100|Iloperidone|iloperidone
5487352|NCT01348100|Depot|depot
5487353|NCT01348100|Injection|injection
5487354|NCT01348087|Fragile X Syndrome|fragile x syndrome
5487355|NCT01348087|Martin-Bell Syndrome|martin-bell syndrome
5487356|NCT01348087|Genetic Diseases|genetic diseases
5487357|NCT01348087|X-Linked|x-linked
5487358|NCT01348087|Escalante's syndrome|escalante's syndrome
5487359|NCT01348074|warfarin|warfarin
5487360|NCT01348074|surgery|surgery
5487361|NCT01348074|management|management
5487362|NCT01348074|thromboembolism|thromboembolism
5487363|NCT01348074|bleeding|bleeding
5487364|NCT01348061|Alzheimers Disease|alzheimers disease
5487365|NCT01348061|Progressive Supranuclear Palsy|progressive supranuclear palsy
5487366|NCT01348061|CSF|csf
5487367|NCT01348061|Cerebrospinal Fluid|cerebrospinal fluid
5487368|NCT01348061|Biomarker|biomarker
5487369|NCT01348061|Heavy Water|heavy water
5487370|NCT01348061|Cargo proteins|cargo proteins
5487371|NCT01348048|palliative care|palliative care
5487372|NCT01348048|end-of-life care|end-of-life care
5487373|NCT01348048|randomized clinical trial|randomized clinical trial
5487375|NCT01348048|needs assessment|needs assessment
5487376|NCT01348048|patient satisfaction|patient satisfaction
5487377|NCT01348048|cost-effectiveness|cost-effectiveness
5487378|NCT01348048|Screening|screening
5487379|NCT01348035|Autosomal Dominant Polycystic Kidney Disease.|autosomal dominant polycystic kidney disease.
5487380|NCT01348035|Arginine vasopressin|arginine vasopressin
5487381|NCT01348035|Total Kidney Volume|total kidney volume
5487382|NCT01348035|Glomerular Filtration Rate|glomerular filtration rate
5487384|NCT01348009|First-line therapy|first-line therapy
5487385|NCT01348009|Tesetaxel|tesetaxel
5487386|NCT01348009|Taxane|taxane
5487387|NCT01348009|Capecitabine|capecitabine
5487388|NCT01348009|Oral fluoropyrimidine|oral fluoropyrimidine
5487389|NCT01348009|Cisplatin|cisplatin
5487390|NCT01348009|Platinum|platinum
5487391|NCT01347996|AML|aml
5487392|NCT01347996|Leukemia|leukemia
5487393|NCT01347996|Acute Myeloid Leukemia|acute myeloid leukemia
5487394|NCT01347996|Minimal Residual Disease|minimal residual disease
5487395|NCT01347996|Ceplene|ceplene
5487396|NCT01347996|Histamine|histamine
5487397|NCT01347996|interleukin 2|interleukin 2
5487398|NCT01347983|RA|ra
5487399|NCT01347970|childhood cancer survivor|childhood cancer survivor
5487400|NCT01347970|CHF|chf
5487401|NCT01347970|risk of congestive heart failure|risk of congestive heart failure
5487402|NCT01347944|MORE|more
5487403|NCT01347944|Monitoring Revlimid|monitoring revlimid
5487404|NCT01347944|Myelodysplastic Syndrome|myelodysplastic syndrome
5487405|NCT01347944|Transfusion-dependent anemia|transfusion-dependent anemia
5487406|NCT01347944|5q deletion|5q deletion
5487407|NCT01347944|lenalidomide|lenalidomide
5487408|NCT01347918|Fluorine MRI, small intestinal transit and motor activity|fluorine mri, small intestinal transit and motor activity
5487409|NCT01347892|Talar injury|talar injury
5487410|NCT01347892|ankle|ankle
5487411|NCT01347892|lesion|lesion
5487412|NCT01347892|defect|defect
5487413|NCT01347892|cartilage repair|cartilage repair
5487414|NCT01347879|Acne vulgaris|acne vulgaris
5487415|NCT01347879|PDT|pdt
5487416|NCT01347866|Advanced metastatic cancer (solid tumors)|advanced metastatic cancer (solid tumors)
5487417|NCT01347866|PI3K|pi3k
5487418|NCT01347866|mTOR|mtor
5487419|NCT01347866|MEK|mek
5487420|NCT01347840|Obesity Gastric Bypass Roux en Y|obesity gastric bypass roux en y
5487421|NCT01347827|Coronary artery bypass surgery|coronary artery bypass surgery
5487422|NCT01347827|Oximetry|oximetry
5487423|NCT01347827|Brain metabolism|brain metabolism
5487424|NCT01347814|Domperidone|domperidone
5487425|NCT01347814|gastric emptying|gastric emptying
5487426|NCT01347814|obesity|obesity
5487427|NCT01347814|diabetes mellitus|diabetes mellitus
5487428|NCT01347814|Domperidone/pharmacology|domperidone/pharmacology
5487429|NCT01347814|Pharmacologic Actions|pharmacologic actions
5487430|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs
5487431|NCT01347814|Gastrointestinal Agents|gastrointestinal agents
5487432|NCT01347814|Humans|humans
5487433|NCT01347801|GLP-1|glp-1
5487434|NCT01347801|Inflammation|inflammation
5487435|NCT01347801|Glucose|glucose
5487436|NCT01347788|Prostate cancer|prostate cancer
5487437|NCT01347788|Castration Resistant|castration resistant
5487438|NCT01347788|Bone Metastases|bone metastases
5487439|NCT01347775|Renal failure|renal failure
5487440|NCT01347775|Respiratory muscles|respiratory muscles
5487441|NCT01347775|Resistance training|resistance training
5487442|NCT01347762|cannabis dependence|cannabis dependence
5487443|NCT01347762|marijuana dependence|marijuana dependence
5487444|NCT01347762|cannabis use disorders|cannabis use disorders
5487445|NCT01347762|cannabis withdrawal|cannabis withdrawal
5487447|NCT01347749|Meditation|meditation
5487448|NCT01347749|Mindfulness|mindfulness
5487449|NCT01347749|Compassion|compassion
5487450|NCT01347749|Group Psychotherapy|group psychotherapy
5487451|NCT01347749|Emotional Regulation|emotional regulation
5487452|NCT01347749|fMRI|fmri
5487453|NCT01347710|Coronary Artery Disease.|coronary artery disease.
5487454|NCT01347710|Positron Emission Tomography Myocardial Perfusion Imaging.|positron emission tomography myocardial perfusion imaging.
5487455|NCT01347710|Single Positron Emission Computed Tomography.|single positron emission computed tomography.
5487456|NCT01347710|Flurpiridaz F18 Injection.|flurpiridaz f18 injection.
5487457|NCT01347697|rectal neoplasms|rectal neoplasms
5487458|NCT01347697|reconstructive surgical procedure|reconstructive surgical procedure
5487459|NCT01347697|bioprosthesis|bioprosthesis
5487460|NCT01347697|surgical flaps|surgical flaps
5487461|NCT01347697|locomotion|locomotion
5487462|NCT01347697|lesser pelvis|lesser pelvis
5487463|NCT01347684|headache|headache
5487464|NCT01347684|elavil|elavil
5487465|NCT01347684|splints|splints
5487466|NCT01347684|physical therapy|physical therapy
5487467|NCT01347684|behavioral therapy|behavioral therapy
5487468|NCT01347671|analgesia|analgesia
5487469|NCT01347671|analgesics|analgesics
5487470|NCT01347671|pain|pain
5487471|NCT01347671|chronic pain|chronic pain
5487472|NCT01347671|neuropathic pain|neuropathic pain
5487473|NCT01347658|etravirine|etravirine
5487474|NCT01347658|Echinacea purpurea|echinacea purpurea
5487475|NCT01347658|interaction|interaction
5487476|NCT01347645|locally advanced|locally advanced
5487477|NCT01347645|metastatic colon|metastatic colon
5487478|NCT01347645|rectal cancer|rectal cancer
5487479|NCT01347632|Bacterial Vaginosis|bacterial vaginosis
5487480|NCT01347632|Vaginal discharge|vaginal discharge
5487481|NCT01347632|Vaginal infections|vaginal infections
5487482|NCT01347619|Comparative Effectiveness Research Summary Guide (CERSG)|comparative effectiveness research summary guide (cersg)
5487483|NCT01347619|anti-psychotic use|anti-psychotic use
5487484|NCT01347619|Nursing Home|nursing home
5487485|NCT01347619|Long-term care|long-term care
5487486|NCT01347619|Qualitative assessment of influences on CERSG adoption in NH|qualitative assessment of influences on cersg adoption in nh
5487487|NCT01347619|Development of toolkit of CERSG-based products for NHs|development of toolkit of cersg-based products for nhs
5487488|NCT01347619|Evaluation of 3 implementation strategies of the toolkit|evaluation of 3 implementation strategies of the toolkit
5487489|NCT01347606|thyroid|thyroid
5487490|NCT01347606|secure|secure
5487491|NCT01347606|surgery|surgery
5487492|NCT01347606|methylene|methylene
5487493|NCT01347606|blue|blue
5487494|NCT01347593|ceftizoxime|ceftizoxime
5487495|NCT01347593|Cesarean|cesarean
5487496|NCT01347593|post caesarean febrile morbidity|post caesarean febrile morbidity
5487497|NCT01347580|Heart attack|heart attack
5487498|NCT01347580|heart disease|heart disease
5487499|NCT01347580|cardiovascular disease|cardiovascular disease
5487500|NCT01347580|stroke|stroke
5487501|NCT01347580|reperfusion|reperfusion
5487502|NCT01347580|pre hospital settings|pre hospital settings
5487503|NCT01347580|ticagrelor|ticagrelor
5487504|NCT01347580|Percutaneous Coronary Intervention|percutaneous coronary intervention
5487505|NCT01347567|Fingerstick BNP test|fingerstick bnp test
5487506|NCT01347567|Home Health Management System|home health management system
5487507|NCT01347567|Acute Decompensated Heart Failure|acute decompensated heart failure
5487508|NCT01347567|Hospital Readmission|hospital readmission
5487510|NCT01347554|drug-eluting stent|drug-eluting stent
5487511|NCT01347554|everolimus|everolimus
5487512|NCT01347554|zotarolimus|zotarolimus
5487513|NCT01347554|myocardial ischemia|myocardial ischemia
5487514|NCT01347554|cardiovascular diseases|cardiovascular diseases
5487515|NCT01347554|MACE|mace
5487516|NCT01347554|safety|safety
5487517|NCT01347541|PTSD|ptsd
5487518|NCT01347528|Medication adherence|medication adherence
5487519|NCT01347528|Heart failure|heart failure
5487520|NCT01347528|Telemonitoring|telemonitoring
5487521|NCT01347528|Determinants of adherence|determinants of adherence
5487522|NCT01347515|Phenol-enriched olive oil|phenol-enriched olive oil
5487523|NCT01347515|bioavailability|bioavailability
5487524|NCT01347515|bioactivity|bioactivity
5487525|NCT01347489|gender|gender
5487526|NCT01347476|prostate-specific antigen|prostate-specific antigen
5487527|NCT01347476|radical prostatectomy|radical prostatectomy
5487528|NCT01347450|Flavonoids|flavonoids
5487529|NCT01347450|cacao|cacao
5487530|NCT01347450|lipid peroxidation|lipid peroxidation
5487531|NCT01347450|plasma|plasma
5487532|NCT01347437|HIV|hiv
5487533|NCT01347437|antiretroviral medication|antiretroviral medication
5487534|NCT01347437|adherence|adherence
5487535|NCT01347437|adolescent|adolescent
5487536|NCT01347424|NSCLC|nsclc
5487537|NCT01347424|NPC|npc
5487538|NCT01347398|Sleep apnoea|sleep apnoea
5487539|NCT01347398|Diagnosis|diagnosis
5621165|NCT00814554|obesity|obesity
5487540|NCT01347398|Blood pressure|blood pressure
5487541|NCT01347398|Body mass index|body mass index
5487542|NCT01347398|Breath analysis|breath analysis
5487543|NCT01347385|Fibroids|fibroids
5481794|NCT01371409|TMS|tms
5487545|NCT01347385|Barbed suture|barbed suture
5487546|NCT01347372|peer support|peer support
5487547|NCT01347372|peer mentoring|peer mentoring
5487548|NCT01347372|peer counselling|peer counselling
5487549|NCT01347372|arthritis|arthritis
5487550|NCT01347372|chronic disease|chronic disease
5487551|NCT01347372|inflammatory arthritis|inflammatory arthritis
5487552|NCT01347372|early inflammatory arthritis|early inflammatory arthritis
5487553|NCT01347372|rheumatoid arthritis|rheumatoid arthritis
5487554|NCT01347359|Peer support|peer support
5487555|NCT01347359|Peer mentoring|peer mentoring
5487556|NCT01347359|Peer counselling|peer counselling
5487557|NCT01347359|Arthritis|arthritis
5487558|NCT01347359|Inflammatory arthritis|inflammatory arthritis
5487559|NCT01347359|Early inflammatory arthritis|early inflammatory arthritis
5487560|NCT01347359|Rheumatoid arthritis|rheumatoid arthritis
5487561|NCT01347359|Chronic disease|chronic disease
5487562|NCT01347346|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5487563|NCT01347346|Primary immune deficiency|primary immune deficiency
5487564|NCT01347346|ex vivo gene therapy|ex vivo gene therapy
5487565|NCT01347346|hematopoietic stem cells|hematopoietic stem cells
5487566|NCT01347333|liver metastases|liver metastases
5487567|NCT01347333|stereotactic radiotherapy|stereotactic radiotherapy
5487568|NCT01347320|Prostate cancer|prostate cancer
5487569|NCT01347320|preoperative staging|preoperative staging
5487570|NCT01347320|MRI|mri
5487571|NCT01347320|Free surgical margins|free surgical margins
5487573|NCT01347307|spinal metastases|spinal metastases
5487574|NCT01347307|vertebral metastases|vertebral metastases
5487575|NCT01347307|benign spinal tumors|benign spinal tumors
5487576|NCT01347281|Cancer of the Head and Neck|cancer of the head and neck
5487578|NCT01347281|hypoxia|hypoxia
5487579|NCT01347281|PET|pet
5487580|NCT01347281|phase II trial|phase ii trial
5487581|NCT01347268|coasting|coasting
5487582|NCT01347268|withdrawing GnRH agonist|withdrawing gnrh agonist
5487583|NCT01347268|GnRH antagonist|gnrh antagonist
5487584|NCT01347268|IVF|ivf
5487585|NCT01347242|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5487586|NCT01347242|Primary immune deficiency|primary immune deficiency
5487587|NCT01347242|ex vivo gene therapy|ex vivo gene therapy
5487588|NCT01347242|hematopoietic stem cells|hematopoietic stem cells
5487589|NCT01347229|Glaucoma|glaucoma
5487590|NCT01347229|Triggerfish|triggerfish
5487591|NCT01347229|body position|body position
5487592|NCT01347216|Drug treatment|drug treatment
5487593|NCT01347216|Treatment pathways|treatment pathways
5487594|NCT01347216|Clinical routine|clinical routine
5487595|NCT01347216|Registry|registry
5487596|NCT01347216|Treatment outcomes|treatment outcomes
5487597|NCT01347216|Endothelin receptor antagonist|endothelin receptor antagonist
5487598|NCT01347216|Phosphodiesterase-V inhibitor|phosphodiesterase-v inhibitor
5487599|NCT01347216|Prostanoid|prostanoid
5487600|NCT01347216|Sildenafil|sildenafil
5487601|NCT01347216|Bosentan|bosentan
5487602|NCT01347216|Macitentan|macitentan
5487603|NCT01347216|Sitaxentan|sitaxentan
5487604|NCT01347216|Ambrisentan|ambrisentan
5487605|NCT01347216|Imatinib|imatinib
5487606|NCT01347216|Epoprostenol|epoprostenol
5487607|NCT01347216|Treprostinil|treprostinil
5487608|NCT01347216|Iloprost|iloprost
5487609|NCT01347216|Infusion pump|infusion pump
5487610|NCT01347216|Riociguat|riociguat
5487611|NCT01347216|soluble guanylate cyclase stimulator|soluble guanylate cyclase stimulator
5487612|NCT01347216|Quality of life|quality of life
5487613|NCT01347216|Patient-related outcomes|patient-related outcomes
5487614|NCT01347216|Economic model|economic model
5487615|NCT01347216|Adverse event|adverse event
5487616|NCT01347216|Safety|safety
5487617|NCT01347216|Combination therapy|combination therapy
5487618|NCT01347216|Internet|internet
5487619|NCT01347216|Europe|europe
5487620|NCT01347216|Australia|australia
5487621|NCT01347216|Japan|japan
5487622|NCT01347216|Eisenmenger|eisenmenger
5487623|NCT01347216|Adults|adults
5487624|NCT01347216|Children|children
5487625|NCT01347216|Selexipag|selexipag
5487626|NCT01347216|Baltic states|baltic states
5487627|NCT01347203|phase I|phase i
5487628|NCT01347203|healthy volunteers|healthy volunteers
5487629|NCT01347203|crossover study|crossover study
5487630|NCT01347203|pharmacokinetics|pharmacokinetics
5487631|NCT01347203|pharmacodynamics|pharmacodynamics
5487632|NCT01347190|Cystic Fibrosis|cystic fibrosis
5487633|NCT01347164|bisexual|bisexual
5487634|NCT01347164|HIV prevention|hiv prevention
5487635|NCT01347151|Glide scope|glide scope
5487636|NCT01347151|Pentax|pentax
5487637|NCT01347151|C spine movement|c spine movement
5487638|NCT01347138|Screening|screening
5487639|NCT01347138|depression|depression
5487640|NCT01347138|case management|case management
5487641|NCT01347125|DHF (diastolic heart failure)|dhf (diastolic heart failure)
5487642|NCT01347125|HFNEF (heart failure with normal ejection fraction|hfnef (heart failure with normal ejection fraction
5487643|NCT01347112|smoking|smoking
5487644|NCT01347112|tobacco dependence|tobacco dependence
5487645|NCT01347112|alcohol dependence|alcohol dependence
5487646|NCT01347099|CBT|cbt
5487648|NCT01347099|Internet|internet
5487649|NCT01347099|Reduce symptom burden|reduce symptom burden
5487650|NCT01347073|Urea Cycle Disorder|urea cycle disorder
5487651|NCT01347073|UCD|ucd
5487652|NCT01347073|GT4P|gt4p
5487653|NCT01347073|Buphenyl|buphenyl
5487654|NCT01347073|hyperammonemia|hyperammonemia
5487655|NCT01347073|sodium phenylbutyrate|sodium phenylbutyrate
5487656|NCT01347060|Asthma|asthma
5487657|NCT01347060|treatment|treatment
5487658|NCT01347060|Advair and inhaled corticosteroids|advair and inhaled corticosteroids
5487659|NCT01347060|Medicare|medicare
5487660|NCT01347060|Outcomes|outcomes
5487661|NCT01347060|costs|costs
5487662|NCT01347047|Amyloidosis|amyloidosis
5487663|NCT01347047|Known or Suspected|known or suspected
5487664|NCT01347034|radiation|radiation
5487665|NCT01347034|neoadjuvant|neoadjuvant
5487666|NCT01347034|intratumoral|intratumoral
5487667|NCT01347034|autologous|autologous
5487668|NCT01347034|dendritic cells|dendritic cells
5487669|NCT01347021|vaginal colpopexy sacrospinous|vaginal colpopexy sacrospinous
5487670|NCT01347021|vaginal colpopexy uterosacral|vaginal colpopexy uterosacral
5487671|NCT01347008|Sildenafil|sildenafil
5487672|NCT01347008|Endothelial Progenitor Cells|endothelial progenitor cells
5487673|NCT01347008|Laser Doppler Imaging|laser doppler imaging
5487674|NCT01346982|Darunavir|darunavir
5487675|NCT01346982|Silimarine|silimarine
5487676|NCT01346982|interaction|interaction
5487677|NCT01346969|Skin scarring|skin scarring
5487678|NCT01346969|cicatrix|cicatrix
5487679|NCT01346969|breast scar|breast scar
5487680|NCT01346956|Cigarette|cigarette
5487681|NCT01346956|Smoking|smoking
5487682|NCT01346956|Cardiovascular Effects|cardiovascular effects
5487683|NCT01346956|2D Echocardiography|2d echocardiography
5487684|NCT01346956|Doppler|doppler
5487685|NCT01346943|Abdominal Aortic Aneurysms, AAA|abdominal aortic aneurysms, aaa
5487686|NCT01346930|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5487687|NCT01346930|IPF|ipf
5487688|NCT01346930|pulmonary fibrosis|pulmonary fibrosis
5487689|NCT01346917|Colorectal cancer|colorectal cancer
5487690|NCT01346917|Laparoscopic surgery|laparoscopic surgery
5487691|NCT01346917|Postoperative ileus|postoperative ileus
5487692|NCT01346917|Lidocaine|lidocaine
5487693|NCT01346917|Early oral feeding|early oral feeding
5487694|NCT01346878|Ultra deep sequencing|ultra deep sequencing
5487695|NCT01346878|Virological failure|virological failure
5487696|NCT01346878|Salvage antiretroviral therapy|salvage antiretroviral therapy
5487697|NCT01346865|triple anti-platelet therapy|triple anti-platelet therapy
5487698|NCT01346865|dual antiplatelet therapy|dual antiplatelet therapy
5487699|NCT01346865|DES|des
5487700|NCT01346865|Coronary Artery Disease|coronary artery disease
5487701|NCT01346852|pediatrics|pediatrics
5487702|NCT01346852|Medicaid|medicaid
5487703|NCT01346852|asthma|asthma
5487704|NCT01346852|outcomes|outcomes
5487705|NCT01346852|asthma medication ratio|asthma medication ratio
5487706|NCT01346839|Diagnostic delay|diagnostic delay
5487707|NCT01346839|Prevention|prevention
5487708|NCT01346839|Diagnostic errors|diagnostic errors
5487709|NCT01346826|Crohn's disease|crohn's disease
5487710|NCT01346826|Ulcerative colitis|ulcerative colitis
5487711|NCT01346826|Infliximab|infliximab
5487712|NCT01346826|Infusion reaction|infusion reaction
5487713|NCT01346813|Newborns|newborns
5487714|NCT01346813|Premature|premature
5487715|NCT01346813|Pain|pain
5487716|NCT01346813|Pain assessment|pain assessment
5487717|NCT01346813|Painful Procedures|painful procedures
5487718|NCT01346813|Stressful Procedures|stressful procedures
5487719|NCT01346813|Endotracheal Intubation|endotracheal intubation
5487720|NCT01346813|Analgesia|analgesia
5487721|NCT01346813|Sedation|sedation
5487722|NCT01346813|Longterm effects of pain|longterm effects of pain
5487723|NCT01346813|Epidemiology|epidemiology
5487724|NCT01346787|carfilzomib|carfilzomib
5487725|NCT01346787|dexamethasone|dexamethasone
5487726|NCT01346787|cyclophosphamide|cyclophosphamide
5487727|NCT01346787|multiple myeloma|multiple myeloma
5487728|NCT01346787|newly diagnosed|newly diagnosed
5487729|NCT01346774|cystitis|cystitis
5487730|NCT01346774|pyelonephritis|pyelonephritis
5487731|NCT01346774|bladder infection|bladder infection
5487732|NCT01346774|kidney infection|kidney infection
5487733|NCT01346761|Genetic Counseling|genetic counseling
5487734|NCT01346761|Genetic Counseling Interventions|genetic counseling interventions
5487735|NCT01346761|Genetic Testing|genetic testing
5487736|NCT01346761|BRCA1 gene|brca1 gene
5487737|NCT01346761|BRCA2 gene|brca2 gene
5487738|NCT01346761|Risk Communication|risk communication
5487739|NCT01346748|vasospasm prevention|vasospasm prevention
5487740|NCT01346735|Ventilator associated pneumonia|ventilator associated pneumonia
5685325|NCT00556530|Congenital Heart Defects|congenital heart defects
5487741|NCT01346735|Catheter related blood stream infection|catheter related blood stream infection
5680295|NCT00578344|Hemoglobin SC|hemoglobin sc
5472289|NCT01411670|Septic Shock|septic shock
5487742|NCT01346735|Catheter associated urinary tract infection|catheter associated urinary tract infection
5487743|NCT01346735|ICU-related infections (VAP, CAUTI and CRBSI)|icu-related infections (vap, cauti and crbsi)
5487745|NCT01346709|Operative surgical procedures|operative surgical procedures
5487746|NCT01346709|Postoperative pulmonary complications (PPC)|postoperative pulmonary complications (ppc)
5487747|NCT01346709|Epidemiological Study|epidemiological study
5487748|NCT01346709|ARISCAT score|ariscat score
5487749|NCT01346709|Risk Score|risk score
5487750|NCT01346709|Europe|europe
5487751|NCT01346709|PERISCOPE|periscope
5487752|NCT01346709|observational study|observational study
5487753|NCT01346709|Mild respiratory failure|mild respiratory failure
5487754|NCT01346709|Severe respiratory failure|severe respiratory failure
5487755|NCT01346709|acute lung injury (ALI)|acute lung injury (ali)
5487756|NCT01346709|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5487757|NCT01346709|Suspected pulmonary infection|suspected pulmonary infection
5487758|NCT01346709|Pulmonary infiltrate|pulmonary infiltrate
5487759|NCT01346709|Pleural effusion|pleural effusion
5487760|NCT01346709|Atelectasis|atelectasis
5487761|NCT01346709|Pneumothorax|pneumothorax
5487762|NCT01346709|Bronchospasm|bronchospasm
5487763|NCT01346709|Aspiration Pneumonitis|aspiration pneumonitis
5487764|NCT01346709|Cardiopulmonary edema|cardiopulmonary edema
5487765|NCT01346709|Prospective Evaluation|prospective evaluation
5487766|NCT01346709|nonobstetric in-hospital surgical procedure|nonobstetric in-hospital surgical procedure
5487767|NCT01346709|general or regional anaesthesia|general or regional anaesthesia
5487768|NCT01346709|continued 7-day period recruitment|continued 7-day period recruitment
5487769|NCT01346670|Red yeast rice|red yeast rice
5487770|NCT01346670|Lovastatin|lovastatin
5487771|NCT01346670|Bioavailability|bioavailability
5487772|NCT01346657|Nifidipine|nifidipine
5487773|NCT01346657|red yeast rice|red yeast rice
5487774|NCT01346657|drug-drug interaction|drug-drug interaction
5487775|NCT01346644|Probiotic|probiotic
5487776|NCT01346644|infant nutrition|infant nutrition
5487777|NCT01346644|safety|safety
5487778|NCT01346644|infections|infections
5487779|NCT01346618|bone age|bone age
5487780|NCT01346618|children|children
5487781|NCT01346618|x-ray|x-ray
5487782|NCT01346618|ultrasound|ultrasound
5487783|NCT01346618|ultrasound based method|ultrasound based method
5487784|NCT01346618|safe|safe
5487785|NCT01346618|valid|valid
5487786|NCT01346618|reproducable|reproducable
5487787|NCT01346605|Cardiac CT, heart disease|cardiac ct, heart disease
5487788|NCT01346592|Adjuvanted Trivalent Subunit Influenza Vaccine|adjuvanted trivalent subunit influenza vaccine
5487789|NCT01346592|vaccine|vaccine
5487790|NCT01346592|influenza|influenza
5487791|NCT01346592|adjuvant|adjuvant
5487792|NCT01346592|MF-59|mf-59
5487793|NCT01346592|pediatric|pediatric
5487794|NCT01346579|stage IA breast cancer|stage ia breast cancer
5487795|NCT01346579|stage IB breast cancer|stage ib breast cancer
5487796|NCT01346579|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5487797|NCT01346566|Cionni Ring|cionni ring
5487798|NCT01346566|In-the-bag IOL|in-the-bag iol
5487799|NCT01346566|Subluxated lenses|subluxated lenses
5487800|NCT01346566|Intraoperative Performance|intraoperative performance
5487801|NCT01346566|Postoperative Outcome|postoperative outcome
5487802|NCT01346553|Chronic Venous Insufficiency (CVI)|chronic venous insufficiency (cvi)
5487803|NCT01346527|diabetes|diabetes
5487804|NCT01346527|pregnancy|pregnancy
5487805|NCT01346527|left ventricular dysfunction|left ventricular dysfunction
5487806|NCT01346527|neonatal|neonatal
5487807|NCT01346527|lipid|lipid
5487808|NCT01346527|lipotoxicity|lipotoxicity
5487809|NCT01346527|neurodevelopment|neurodevelopment
5487810|NCT01346514|Homeless Persons|homeless persons
5487811|NCT01346514|Housing|housing
5487812|NCT01346514|Case Management|case management
5487813|NCT01346514|Veterans|veterans
5487814|NCT01346514|Substance Related Disorders|substance related disorders
5487816|NCT01346514|Social Adjustment|social adjustment
5487817|NCT01346501|Rheumatoid arthritis|rheumatoid arthritis
5487818|NCT01346488|Rheumatoid arthritis|rheumatoid arthritis
5487819|NCT01346449|Obesity|obesity
5487820|NCT01346423|Sick leave|sick leave
5487821|NCT01346423|musculoskeletal pain|musculoskeletal pain
5487822|NCT01346423|return to work|return to work
5487823|NCT01346423|multidisciplinary intervention|multidisciplinary intervention
5487824|NCT01346423|randomised controlled trial|randomised controlled trial
5487826|NCT01346397|rejection|rejection
5487827|NCT01346397|survival|survival
5487828|NCT01346397|alemtuzumab|alemtuzumab
5487829|NCT01346397|cyclosporine|cyclosporine
5487830|NCT01346397|tacrolimus|tacrolimus
5487831|NCT01346384|intracuff pressure|intracuff pressure
5487832|NCT01346384|laryngeal tube|laryngeal tube
5487833|NCT01346384|nitrous oxide|nitrous oxide
5487834|NCT01346371|Allergic|allergic
5487835|NCT01346371|conjunctivitis|conjunctivitis
5487836|NCT01346371|Allergic conjunctivitis|allergic conjunctivitis
5487837|NCT01346358|Advanced Solid Tumors|advanced solid tumors
5487840|NCT01346293|Tetanus|tetanus
5487841|NCT01346293|Diphtheria|diphtheria
5487842|NCT01346293|Pertussis|pertussis
5487843|NCT01346293|DTap-IPV|dtap-ipv
5487844|NCT01346293|DAPTACEL®|daptacel®
5487845|NCT01346293|VARIVAX®|varivax®
5487846|NCT01346280|Adherence to Evidence-Based Guidelines|adherence to evidence-based guidelines
5487847|NCT01346280|Multidisciplinary Care|multidisciplinary care
5487849|NCT01346280|Quality of Care Outcomes|quality of care outcomes
5487850|NCT01346267|nausea and vomiting|nausea and vomiting
5487851|NCT01346267|unspecified childhood solid tumor|unspecified childhood solid tumor
5487852|NCT01346267|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5487853|NCT01346267|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5487854|NCT01346267|childhood central nervous system germinoma|childhood central nervous system germinoma
5487855|NCT01346267|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5487856|NCT01346267|childhood central nervous system teratoma|childhood central nervous system teratoma
5487857|NCT01346267|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5487858|NCT01346267|childhood mixed glioma|childhood mixed glioma
5487859|NCT01346267|childhood oligodendroglioma|childhood oligodendroglioma
5487860|NCT01346267|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5487861|NCT01346267|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5487862|NCT01346267|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5487863|NCT01346267|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5487864|NCT01346267|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5487865|NCT01346267|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5846749|NCT00043615|Pre-Cancer Condition|pre-cancer condition
5487866|NCT01346267|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5671462|NCT00615927|Imatinib Mesylate|imatinib mesylate
5487867|NCT01346267|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5487868|NCT01346267|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5487869|NCT01346267|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5487870|NCT01346267|childhood ependymoblastoma|childhood ependymoblastoma
5487871|NCT01346267|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5487872|NCT01346267|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5487873|NCT01346267|childhood choroid plexus tumor|childhood choroid plexus tumor
5487874|NCT01346267|childhood craniopharyngioma|childhood craniopharyngioma
5487875|NCT01346267|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5487876|NCT01346267|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5487877|NCT01346267|childhood medulloepithelioma|childhood medulloepithelioma
5487878|NCT01346267|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5487879|NCT01346267|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5487880|NCT01346267|childhood meningioma|childhood meningioma
5487881|NCT01346254|after|after
5487882|NCT01346241|Panic|panic
5487883|NCT01346241|Anxiety|anxiety
5487884|NCT01346228|Panic|panic
5487885|NCT01346228|Panic Disorder|panic disorder
5487886|NCT01346228|Anxiety|anxiety
5487887|NCT01346215|heparin|heparin
5487888|NCT01346215|renal insufficiency, chronic|renal insufficiency, chronic
5487889|NCT01346215|extracorporeal dialysis|extracorporeal dialysis
5487890|NCT01346215|fibrinolytic agents|fibrinolytic agents
5487891|NCT01346215|anticoagulants|anticoagulants
5487892|NCT01346215|aPTT|aptt
5487893|NCT01346202|multi-modal pain therapy, chronic pain|multi-modal pain therapy, chronic pain
5487894|NCT01346189|Cardiovascular Disease|cardiovascular disease
5487895|NCT01346163|Schizophrenia|schizophrenia
5487896|NCT01346163|Cognitive Impairment|cognitive impairment
5487897|NCT01346163|Electrophysiology|electrophysiology
5488002|NCT01345630|Hiv 1|hiv 1
5487898|NCT01346163|H3 receptor antagonist|h3 receptor antagonist
5487899|NCT01346137|ovulation|ovulation
5487900|NCT01346137|unruptured luteinized follicle|unruptured luteinized follicle
5487901|NCT01346137|meloxicam|meloxicam
5487902|NCT01346124|radiation|radiation
5487903|NCT01346124|IMRT|imrt
5487904|NCT01346124|IMPT|impt
5487905|NCT01346098|diabetes|diabetes
5487906|NCT01346098|islet transplantation|islet transplantation
5487907|NCT01346098|pancreas|pancreas
5487908|NCT01346098|pancreatectomy|pancreatectomy
5487909|NCT01346085|islet transplantation|islet transplantation
5487910|NCT01346085|brittle diabetes|brittle diabetes
5487911|NCT01346085|type 1 diabetes|type 1 diabetes
5487912|NCT01346072|tolvaptan|tolvaptan
5487913|NCT01346072|copeptin|copeptin
5487914|NCT01346072|heart failure|heart failure
5487915|NCT01346072|vasopressin antagonist|vasopressin antagonist
5487916|NCT01346059|Clostridium|clostridium
5487917|NCT01346059|Colitis|colitis
5487918|NCT01346059|Intracolonic vancomycin|intracolonic vancomycin
5487919|NCT01346059|psuedomembranous colitis|psuedomembranous colitis
5487921|NCT01346046|Adults 18 years and older|adults 18 years and older
5487922|NCT01346046|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
5487923|NCT01346033|Type 2 Diabetes|type 2 diabetes
5487924|NCT01346033|Adults 18 years and older|adults 18 years and older
5487925|NCT01346033|Taking Control of Your Diabetes Health Fair|taking control of your diabetes health fair
5487940|NCT01345877|pain sensitivity|pain sensitivity
5487941|NCT01345877|pain prediction|pain prediction
5487942|NCT01345877|psychometrics|psychometrics
5487943|NCT01345877|quantitative sensory testing|quantitative sensory testing
5487944|NCT01345864|attention cognition memory problem solving scopolamine challenge|attention cognition memory problem solving scopolamine challenge
5487945|NCT01345825|osteoarthrosis|osteoarthrosis
5487946|NCT01345825|unicompartmental knee replacement|unicompartmental knee replacement
5487947|NCT01345825|knee|knee
5487948|NCT01345825|resistance training|resistance training
5487949|NCT01345825|Muscle power|muscle power
5487950|NCT01345825|gait analysis|gait analysis
5487951|NCT01345825|gait|gait
5487952|NCT01345825|physiotherapy|physiotherapy
5487953|NCT01345825|Gyro sensor|gyro sensor
5487954|NCT01345812|ART|art
5487955|NCT01345812|IVF|ivf
5487956|NCT01345812|Timelapse|timelapse
5487957|NCT01345799|Crohn's Disease Activity Index|crohn's disease activity index
5487959|NCT01345799|Inflammatory Bowel Disease|inflammatory bowel disease
5487960|NCT01345760|Basal Cell Carcinoma|basal cell carcinoma
5487961|NCT01345760|Squamous Cell Carcinoma|squamous cell carcinoma
5487962|NCT01345760|Actinic Keratosis|actinic keratosis
5487963|NCT01345760|microRNA|microrna
5487964|NCT01345760|Dicer|dicer
5487965|NCT01345760|Drosha|drosha
5487966|NCT01345760|RISC|risc
5487967|NCT01345760|microprocessor complex|microprocessor complex
5487968|NCT01345760|Argonaute|argonaute
5487969|NCT01345760|DGCR8|dgcr8
5487970|NCT01345760|TARBP|tarbp
5487971|NCT01345747|laryngeal tube suction|laryngeal tube suction
5487972|NCT01345747|gynecology|gynecology
5487973|NCT01345747|laparoscopic surgery|laparoscopic surgery
5487974|NCT01345721|Meningococcal|meningococcal
5487975|NCT01345721|ACWY|acwy
5487976|NCT01345721|Conjugate Vaccine|conjugate vaccine
5487977|NCT01345721|Meningitis|meningitis
5487978|NCT01345721|Toddlers|toddlers
5487979|NCT01345721|Children|children
5487980|NCT01345721|Persistence|persistence
5487981|NCT01345721|Boost|boost
5487982|NCT01345708|Low dose rituximab|low dose rituximab
5487983|NCT01345708|WAIHA|waiha
5487984|NCT01345708|CHD|chd
5487985|NCT01345695|Childhood diarrhea|childhood diarrhea
5487986|NCT01345695|childhood pneumonia|childhood pneumonia
5487987|NCT01345695|telemedicine|telemedicine
5487988|NCT01345695|cluster|cluster
5487989|NCT01345695|treatment-control trial|treatment-control trial
5487990|NCT01345656|Chronic Heart Failure|chronic heart failure
5487991|NCT01345643|Transfusion|transfusion
5487992|NCT01345643|Hemoglobin level|hemoglobin level
5487993|NCT01345630|Double-blind|double-blind
5487994|NCT01345630|comparative|comparative
5487995|NCT01345630|trial|trial
5487996|NCT01345630|maraviroc|maraviroc
5487997|NCT01345630|versus|versus
5487998|NCT01345630|emtricitabine/tenofovir|emtricitabine/tenofovir
5487999|NCT01345630|both with darunavir/ritonavir|both with darunavir/ritonavir
5488000|NCT01345630|antiretroviral-naive|antiretroviral-naive
5488001|NCT01345630|Ccr5 tropic|ccr5 tropic
5488003|NCT01345630|patients.|patients.
5488005|NCT01345591|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5488006|NCT01345591|Facial Trauma|facial trauma
5488007|NCT01345591|Fat Grafts|fat grafts
5488008|NCT01345591|Autogenous Fat Transfers (AFT)|autogenous fat transfers (aft)
5488009|NCT01345591|Wounded warriors|wounded warriors
5488010|NCT01345578|Urea Cycle Disorders|urea cycle disorders
5488011|NCT01345578|Carbamoyl-Phosphate Synthase I Deficiency Disease|carbamoyl-phosphate synthase i deficiency disease
5488012|NCT01345578|Citrullinemia|citrullinemia
5488013|NCT01345578|Ornithine Carbamoyltransferase Deficiency Disease|ornithine carbamoyltransferase deficiency disease
5488014|NCT01345578|Crigler-Najjar Syndrome|crigler-najjar syndrome
5488015|NCT01345565|fulminant hepatic failure|fulminant hepatic failure
5488016|NCT01345552|Oligo mets|oligo mets
5488017|NCT01345552|Oligometastatic disease|oligometastatic disease
5488019|NCT01345539|Oligometastatic disease|oligometastatic disease
5488020|NCT01345513|Genomic Analysis|genomic analysis
5488021|NCT01345513|Sequencing|sequencing
5488022|NCT01345513|Genetic|genetic
5488023|NCT01345513|Biopsy|biopsy
5488024|NCT01345513|Solid tumors|solid tumors
5488025|NCT01345500|Overweight|overweight
5488026|NCT01345500|Obese|obese
5488027|NCT01345500|Type 2 Diabetic|type 2 diabetic
5488028|NCT01345500|Diabetes|diabetes
5488029|NCT01345500|Weight loss|weight loss
5488030|NCT01345500|Physical activity|physical activity
5488031|NCT01345500|Diet|diet
5488032|NCT01345500|Prepackaged meals|prepackaged meals
5488033|NCT01345487|appetite|appetite
5488034|NCT01345487|protein|protein
5488037|NCT01345448|Glaucoma|glaucoma
5488038|NCT01345448|Brimonidine|brimonidine
5488039|NCT01345448|Transdermal|transdermal
5488040|NCT01345435|telemonitoring|telemonitoring
5488041|NCT01345435|usual care|usual care
5488042|NCT01345435|telemedicine|telemedicine
5488043|NCT01345435|telehealth|telehealth
5488044|NCT01345435|home care|home care
5488045|NCT01345435|Health Care Quality|health care quality
5488046|NCT01345435|Access|access
5488047|NCT01345435|Evaluation|evaluation
5488048|NCT01345409|Musculoskeletal pain|musculoskeletal pain
5488049|NCT01345409|Chronic pain|chronic pain
5488050|NCT01345409|Acupuncture|acupuncture
5488051|NCT01345409|Chiropractic|chiropractic
5488052|NCT01345396|Asthma|asthma
5488053|NCT01345396|Health education|health education
5488054|NCT01345396|Pregnancy|pregnancy
5488055|NCT01345383|smoking|smoking
5488056|NCT01345383|bronchoscopy|bronchoscopy
5488057|NCT01345383|cough|cough
5488058|NCT01345370|Glioblastoma|glioblastoma
5488059|NCT01345357|Solid tumors|solid tumors
5488060|NCT01345357|mantle cell lymphoma|mantle cell lymphoma
5488061|NCT01345357|Gemcitabine|gemcitabine
5488062|NCT01345357|Cisplatin|cisplatin
5488063|NCT01345357|Cancer|cancer
5488064|NCT01345357|Neoplasms|neoplasms
5488065|NCT01345357|Antineoplastic agents|antineoplastic agents
5488069|NCT01345318|pharmacokinetics|pharmacokinetics
5488070|NCT01345318|pharmacodynamics|pharmacodynamics
5488071|NCT01345318|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
5488072|NCT01345305|Sturge-Weber Syndrome|sturge-weber syndrome
5488073|NCT01345305|Biomarkers|biomarkers
5488074|NCT01345305|Quantitative EEG|quantitative eeg
5488075|NCT01345305|Transcranial Doppler Ultrasound|transcranial doppler ultrasound
5488076|NCT01345305|Medical Rehabilitation Scales|medical rehabilitation scales
5488077|NCT01345305|Optical Coherence Tomography|optical coherence tomography
5488078|NCT01345266|Pharyngometry|pharyngometry
5488079|NCT01345266|Novel Dry Powder Inhaler|novel dry powder inhaler
5488081|NCT01345266|Inhalation Profiles|inhalation profiles
5488082|NCT01345253|SLEDAI|sledai
5488083|NCT01345253|Asia|asia
5488084|NCT01345253|placebo|placebo
5488085|NCT01345253|BLys|blys
5488087|NCT01345253|BILAG|bilag
5488088|NCT01345253|systemic lupus erythematosus|systemic lupus erythematosus
5488089|NCT01345253|SELENA|selena
5488090|NCT01345253|Lupus|lupus
5488091|NCT01345253|SRI|sri
5488092|NCT01345253|efficacy|efficacy
5488093|NCT01345253|B cell|b cell
5488094|NCT01345253|SLE Flare Index|sle flare index
5488095|NCT01345253|belimumab|belimumab
5488096|NCT01345253|safety|safety
5488097|NCT01345253|phase III|phase iii
5488098|NCT01345253|B lymphocyte|b lymphocyte
5488099|NCT01345240|Africa|africa
5488100|NCT01345240|Plasmodium falciparum|plasmodium falciparum
5488101|NCT01345240|Malaria vaccine|malaria vaccine
5488102|NCT01345240|hepatitis B|hepatitis b
5488103|NCT01345240|EPI|epi
5488104|NCT01345227|Type 1 diabetes|type 1 diabetes
5488105|NCT01345227|islet transplantation|islet transplantation
5488106|NCT01345227|autotransplantation|autotransplantation
5488107|NCT01345214|ONO-7746|ono-7746
5488108|NCT01345214|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
5488120|NCT01345162|Herniotomy|herniotomy
5488121|NCT01345149|Obesity|obesity
5488122|NCT01345149|Pregnancy|pregnancy
5488123|NCT01345149|Intervention|intervention
5488124|NCT01345149|Diet|diet
5488125|NCT01345149|Physical activity|physical activity
5488129|NCT01345110|dementia|dementia
5488130|NCT01345110|mild cognitive impairment|mild cognitive impairment
5488131|NCT01345110|prevalence|prevalence
5488132|NCT01345110|incidence|incidence
5488133|NCT01345110|elderly|elderly
5488134|NCT01345110|longitudinal study|longitudinal study
5488135|NCT01345110|population study|population study
5488136|NCT01345097|short, metaphyseal-fitting femoral stem|short, metaphyseal-fitting femoral stem
5488137|NCT01345097|cementless anatomical femoral stem|cementless anatomical femoral stem
5488138|NCT01345097|young patient|young patient
5488139|NCT01345097|elderly patient|elderly patient
5488140|NCT01345071|Rheumatoid Arthritis|rheumatoid arthritis
5488141|NCT01345071|Pregnancy|pregnancy
5488142|NCT01345071|Anti-TNF|anti-tnf
5488143|NCT01345071|Preconceptional counselling|preconceptional counselling
5488144|NCT01345071|Disease activity|disease activity
5621986|NCT00811577|VAS|vas
5488145|NCT01345058|Epilepsy|epilepsy
5488146|NCT01345058|antiepileptic drug|antiepileptic drug
5488147|NCT01345058|polytherapy|polytherapy
5488148|NCT01345045|Diabetic Asymmetric Polyneuropathy|diabetic asymmetric polyneuropathy
5488149|NCT01345045|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
5488150|NCT01345045|Diabetic Mononeuropathy Simplex,|diabetic mononeuropathy simplex,
5488151|NCT01345045|Diabetic Autonomic Neuropathy,|diabetic autonomic neuropathy,
5488152|NCT01345045|Diabetic Amyotrophy|diabetic amyotrophy
5488153|NCT01345045|Mononeuropathy|mononeuropathy
5488154|NCT01345045|Diabetic Neuropathy|diabetic neuropathy
5488155|NCT01345045|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5488156|NCT01345045|Diabetic Polyneuropathy|diabetic polyneuropathy
5488157|NCT01345045|Painful|painful
5488158|NCT01345045|Diabetic Mononeuropathy|diabetic mononeuropathy
5488159|NCT01345045|Neuralgia|neuralgia
5488160|NCT01345019|zoledronic acid|zoledronic acid
5488161|NCT01345019|hematologic malignancies|hematologic malignancies
5488162|NCT01345019|SRE|sre
5488163|NCT01345019|skeletal-related event|skeletal-related event
5488164|NCT01345019|blood cancer|blood cancer
5488165|NCT01345019|lytic bone lesions|lytic bone lesions
5488166|NCT01345019|bone metastases|bone metastases
5488167|NCT01345019|myeloma|myeloma
5488168|NCT01345019|fractures|fractures
5488169|NCT01345019|spinal cord compression|spinal cord compression
5488170|NCT01345019|radiation to bone|radiation to bone
5488171|NCT01345019|surgery to bone|surgery to bone
5488172|NCT01345019|bisphosphonates|bisphosphonates
5488173|NCT01345019|Neoplasms, Plasma Cell|neoplasms, plasma cell
5488174|NCT01345019|Paraproteinemias|paraproteinemias
5488175|NCT01345019|Neoplasms|neoplasms
5488176|NCT01345019|Neoplasm Metastasis|neoplasm metastasis
5488177|NCT01345019|Bone Neoplasms|bone neoplasms
5488178|NCT01345019|Bone Marrow Diseases|bone marrow diseases
5488179|NCT01345019|Blood Protein Disorders|blood protein disorders
5488180|NCT01345019|Hematologic Diseases|hematologic diseases
5488181|NCT01345019|multiple myeloma|multiple myeloma
5488182|NCT01345019|denosumab|denosumab
5488183|NCT01345019|Neoplastic Processes|neoplastic processes
5488184|NCT01345019|Bone Diseases|bone diseases
5488185|NCT01345019|Diphosphonates|diphosphonates
5488186|NCT01345019|Bone Density Conservation Agents|bone density conservation agents
5488187|NCT01345006|juvenile macular dystrophy|juvenile macular dystrophy
5488189|NCT01345006|fundus flavimaculatus|fundus flavimaculatus
5488190|NCT01344993|Dry AMD|dry amd
5488191|NCT01344993|Geographic atrophy|geographic atrophy
5488192|NCT01344941|Vaccine response|vaccine response
5488193|NCT01344941|Human Lymphocytes|human lymphocytes
5488194|NCT01344915|Patella|patella
5488195|NCT01344915|Knee|knee
5488196|NCT01344915|Brace|brace
5488197|NCT01344876|multiple myeloma [MM]|multiple myeloma [mm]
5488198|NCT01344876|non-Hodgkin lymphoma [NHL]|non-hodgkin lymphoma [nhl]
5488199|NCT01344876|acute myeloid leukemia [AML]|acute myeloid leukemia [aml]
5488200|NCT01344876|acute lymphoid leukemia [ALL]|acute lymphoid leukemia [all]
5488201|NCT01344876|chronic myeloid leukemia [CML]|chronic myeloid leukemia [cml]
5488202|NCT01344824|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5488203|NCT01344824|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5488204|NCT01344824|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5488205|NCT01344824|adenocarcinoma of the lung|adenocarcinoma of the lung
5488206|NCT01344824|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5470253|NCT01420055|Active|active
5488207|NCT01344824|large cell lung cancer|large cell lung cancer
5488208|NCT01344811|telemonitoring|telemonitoring
5488209|NCT01344811|usual care|usual care
5488210|NCT01344811|telehealth|telehealth
5488211|NCT01344811|home care|home care
5488212|NCT01344811|Health Care Quality|health care quality
5488213|NCT01344811|Access|access
5488214|NCT01344811|Evaluation|evaluation
5488215|NCT01344798|limb girdle muscular dystrophy type 2C|limb girdle muscular dystrophy type 2c
5488216|NCT01344798|gamma-sarcoglycanopathy|gamma-sarcoglycanopathy
5488217|NCT01344798|gene therapy|gene therapy
5488218|NCT01344798|AAV vector|aav vector
5488219|NCT01344798|neuromuscular disease|neuromuscular disease
5488220|NCT01344798|orphan disease|orphan disease
5488221|NCT01344785|Intertrochanteric Fractures|intertrochanteric fractures
5488222|NCT01344785|Intramedullary nailing|intramedullary nailing
5488223|NCT01344785|Hip function|hip function
5488225|NCT01344772|femoral neck fracture|femoral neck fracture
5488226|NCT01344772|total hip arthroplasty|total hip arthroplasty
5488227|NCT01344772|internal fixation|internal fixation
5488228|NCT01344759|Obstructive Sleep Apnea|obstructive sleep apnea
5488230|NCT01344759|Pediatrics|pediatrics
5488231|NCT01344759|Dexmedetomidine|dexmedetomidine
5488232|NCT01344759|Propofol|propofol
5488233|NCT01344759|Anesthesia|anesthesia
5488234|NCT01344746|sleep-disordered breathing|sleep-disordered breathing
5488235|NCT01344733|Major Depressive Disorder|major depressive disorder
5488236|NCT01344733|MDD|mdd
5488237|NCT01344720|Low Back Pain|low back pain
5488238|NCT01344720|Etoricoxib|etoricoxib
5488239|NCT01344720|Oxycodone|oxycodone
5488240|NCT01344707|Hematologic Malignancies|hematologic malignancies
5488241|NCT01344707|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5488242|NCT01344707|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5488243|NCT01344707|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5488244|NCT01344707|Multiple Myeloma (MM)|multiple myeloma (mm)
5488245|NCT01344707|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5488246|NCT01344707|Malignant Lymphomas|malignant lymphomas
5488247|NCT01344707|Histone Deacetylase (HDAC)|histone deacetylase (hdac)
5488248|NCT01344707|4SC-202|4sc-202
5488249|NCT01344707|Phase I|phase i
5488250|NCT01344694|Epicardial fat|epicardial fat
5488251|NCT01344694|Visceral fat|visceral fat
5488252|NCT01344694|atherosclerosis|atherosclerosis
5488253|NCT01344694|coronary computed tomography angiography|coronary computed tomography angiography
5488254|NCT01344694|Carotid Doppler ultrasound|carotid doppler ultrasound
5488255|NCT01344668|Diabetes|diabetes
5488257|NCT01344642|RNA|rna
5488258|NCT01344616|computer-based behavioral support|computer-based behavioral support
5488259|NCT01344603|cardiac surgery|cardiac surgery
5488260|NCT01344603|cardiac anesthesia|cardiac anesthesia
5488261|NCT01344603|epidural|epidural
5488262|NCT01344590|central line associated blood stream infections|central line associated blood stream infections
5488263|NCT01344577|Buccal Plate Augmentation technique|buccal plate augmentation technique
5488264|NCT01344577|socket preservation|socket preservation
5488265|NCT01344577|porcine biomaterial|porcine biomaterial
5488266|NCT01344564|Prostate cancer|prostate cancer
5488267|NCT01344564|Hormone therapy|hormone therapy
5488268|NCT01344564|Testosterone measures|testosterone measures
5488269|NCT01344538|ginger|ginger
5488270|NCT01344538|Zingiber officinale|zingiber officinale
5488271|NCT01344538|Cancer Risk Reductive|cancer risk reductive
5488272|NCT01344538|Eicosanoids|eicosanoids
5488273|NCT01344538|Colorectal Cancer|colorectal cancer
5488274|NCT01344538|Inflammation|inflammation
5488275|NCT01344525|obesity therapy|obesity therapy
5488276|NCT01344525|metabolic syndrome|metabolic syndrome
5488277|NCT01344525|gastrointestinal tract|gastrointestinal tract
5488278|NCT01344525|microbiota|microbiota
5488279|NCT01344525|metabolomics|metabolomics
5488280|NCT01344525|micronutrients|micronutrients
5488281|NCT01344525|outcome|outcome
5488282|NCT01344525|sustainability|sustainability
5488283|NCT01344512|Pharmacokinetic|pharmacokinetic
5488284|NCT01344512|Population|population
5488285|NCT01344512|Children|children
5488286|NCT01344512|Ceftazidime|ceftazidime
5488287|NCT01344512|Ciprofloxacin|ciprofloxacin
5488288|NCT01344512|Voriconazole|voriconazole
5488289|NCT01344512|Pediatric|pediatric
5488290|NCT01344499|women|women
5488291|NCT01344499|laparoscopic subtotal hysterectomy|laparoscopic subtotal hysterectomy
5488292|NCT01344486|women undergoing laparoscopic surgery|women undergoing laparoscopic surgery
5488293|NCT01344473|Remineralisation|remineralisation
5488294|NCT01344473|White Spot Lesions|white spot lesions
5488295|NCT01344473|Orthodontic treatment|orthodontic treatment
5488296|NCT01344473|Tooth Mousse creme|tooth mousse creme
5488297|NCT01344473|Casein Phosphopeptide|casein phosphopeptide
5488298|NCT01344460|magnetic resonance angiography (MRA) of the renal arteries|magnetic resonance angiography (mra) of the renal arteries
5488299|NCT01344447|Supra-aortic vascular disease|supra-aortic vascular disease
5488300|NCT01344447|MRA|mra
5488301|NCT01344447|CTA|cta
5488302|NCT01344447|Males and females aged 18 years or older|males and females aged 18 years or older
5488303|NCT01344447|Stroke|stroke
5470360|NCT01419626|Dental Plaque|dental plaque
5488304|NCT01344447|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
5488305|NCT01344421|Movement capture system|movement capture system
5488306|NCT01344421|Movement analysis|movement analysis
5488307|NCT01344421|Hip dysplasia|hip dysplasia
5488308|NCT01344421|Hip pain|hip pain
5488309|NCT01344421|Quality of life|quality of life
5488310|NCT01344421|Physical function|physical function
5488311|NCT01344408|Dizziness|dizziness
5488312|NCT01344408|rehabilitation|rehabilitation
5488313|NCT01344408|geriatric|geriatric
5488314|NCT01344408|IT-technology|it-technology
5488315|NCT01344382|Adolescent|adolescent
5488317|NCT01344382|Substance Abuse|substance abuse
5488318|NCT01344382|Parent Training|parent training
5488319|NCT01344382|Community Reinforcement and Family Training|community reinforcement and family training
5488320|NCT01344382|CRAFT|craft
5488321|NCT01344382|Community Reinforcement Approach|community reinforcement approach
5488322|NCT01344382|Addiction|addiction
5488323|NCT01344382|Family Intervention|family intervention
5488324|NCT01344369|Healthy Subjects|healthy subjects
5488325|NCT01344369|Bioequivalence|bioequivalence
5488326|NCT01344356|stereotactic radiosurgery|stereotactic radiosurgery
5488327|NCT01344356|head and neck tumors|head and neck tumors
5488328|NCT01344356|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5488329|NCT01344330|Colon cancer|colon cancer
5488330|NCT01344330|Prevention|prevention
5488331|NCT01344330|Cruciferous vegetables|cruciferous vegetables
5488332|NCT01344330|Histone status|histone status
5488333|NCT01344304|aprepitant therapy|aprepitant therapy
5488334|NCT01344304|fosaprepitant therapy|fosaprepitant therapy
5488335|NCT01344304|5HT3-receptor antagonist|5ht3-receptor antagonist
5488336|NCT01344304|dexamethasone|dexamethasone
5488337|NCT01344304|colorectal cancer|colorectal cancer
5488339|NCT01344304|XELOX|xelox
5488340|NCT01344304|SOX|sox
5488341|NCT01344291|hyperprolactinoma|hyperprolactinoma
5488342|NCT01344291|turmeric|turmeric
5488343|NCT01344291|amenorrhea|amenorrhea
5488344|NCT01344265|B-type natriuretic peptide|b-type natriuretic peptide
5488345|NCT01344265|global end diastolic volume|global end diastolic volume
5488346|NCT01344239|aortic aneurysm|aortic aneurysm
5488347|NCT01344239|ischemia/reperfusion|ischemia/reperfusion
5488348|NCT01344239|preconditioning|preconditioning
5488349|NCT01344239|pulmonary injury|pulmonary injury
5488350|NCT01344239|intestinal injury|intestinal injury
5488351|NCT01344226|steroid responder|steroid responder
5488352|NCT01344213|Pregabalin|pregabalin
5488353|NCT01344213|Celecoxib|celecoxib
5488354|NCT01344213|Intrathecal morphine|intrathecal morphine
5488355|NCT01344213|Total knee arthroplasty|total knee arthroplasty
5488356|NCT01344200|Pharmacokinetics|pharmacokinetics
5488357|NCT01344200|Celecoxib|celecoxib
5488358|NCT01344200|Pediatric|pediatric
5488359|NCT01344200|Peds QL|peds ql
5488360|NCT01344200|CYP2C9|cyp2c9
5488361|NCT01344174|Acute-on-chronic liver failure|acute-on-chronic liver failure
5488362|NCT01344174|HBV|hbv
5488363|NCT01344174|Dexamethasone|dexamethasone
5488364|NCT01344174|Prognosis|prognosis
5488365|NCT01344161|Vitamin D|vitamin d
5488366|NCT01344161|Metabolic profile|metabolic profile
5488367|NCT01344161|Overweight|overweight
5488368|NCT01344161|Obesity|obesity
5488369|NCT01344148|Anti- TB|anti- tb
5488370|NCT01344148|HAART|haart
5671463|NCT00615927|Gleevec|gleevec
5488371|NCT01344148|choice of the right moment|choice of the right moment
5488372|NCT01344135|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5488373|NCT01344135|Muscular Atrophy|muscular atrophy
5488374|NCT01344135|Nutritional rehabilitation|nutritional rehabilitation
5488375|NCT01344135|Counselling|counselling
5488376|NCT01344096|Gaucher disease|gaucher disease
5488377|NCT01344096|Thrombocytopathy|thrombocytopathy
5488378|NCT01344096|Imiglucerase|imiglucerase
5488379|NCT01344070|innovator formulations|innovator formulations
5488380|NCT01344070|generic formulations|generic formulations
5488381|NCT01344070|bioequivalence|bioequivalence
5488382|NCT01344070|interchangeability|interchangeability
5488383|NCT01344070|inter-patch variation|inter-patch variation
5488384|NCT01344070|quality of generic drug formulations on the market|quality of generic drug formulations on the market
5488385|NCT01344070|Interchangeability between marketed generic formulations|interchangeability between marketed generic formulations
5488386|NCT01344070|prevalence of large intrasubject variability despite average bioequivalence|prevalence of large intrasubject variability despite average bioequivalence
5488387|NCT01344070|Causes of large intrasubject variability|causes of large intrasubject variability
5488388|NCT01344057|Seasonal Influenza, vaccine|seasonal influenza, vaccine
5488389|NCT01344044|Brain-Computer Interface|brain-computer interface
5488390|NCT01344018|adult angiosarcoma|adult angiosarcoma
5488391|NCT01344018|adult fibrosarcoma|adult fibrosarcoma
5488392|NCT01344018|adult leiomyosarcoma|adult leiomyosarcoma
5488393|NCT01344018|adult liposarcoma|adult liposarcoma
5488394|NCT01344018|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5488395|NCT01344018|adult malignant mesenchymoma|adult malignant mesenchymoma
5488396|NCT01344018|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5470456|NCT01419314|Splint|splint
5488397|NCT01344018|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5488398|NCT01344018|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5488399|NCT01344005|non-small cell lung cancer|non-small cell lung cancer
5488400|NCT01344005|small cell lung cancer|small cell lung cancer
5488401|NCT01344005|tobacco use disorder|tobacco use disorder
5488402|NCT01343992|Embryo transfer|embryo transfer
5488403|NCT01343992|Implantation rate|implantation rate
5488404|NCT01343992|Pregnancy rate|pregnancy rate
5488405|NCT01343992|bedrest|bedrest
5488406|NCT01343992|neutral|neutral
5488407|NCT01343992|benevolent|benevolent
5488408|NCT01343992|deterious|deterious
5488409|NCT01343992|implantation|implantation
5488410|NCT01343992|gestation rates|gestation rates
5488411|NCT01343953|severe aplastic anemia|severe aplastic anemia
5488412|NCT01343953|cord blood transplantation|cord blood transplantation
5488413|NCT01343940|RCT|rct
5488414|NCT01343940|randomized block repeated measures design|randomized block repeated measures design
5488415|NCT01343940|efficacy trial|efficacy trial
5488416|NCT01343940|high risk population|high risk population
5488417|NCT01343927|Chronic low back pain|chronic low back pain
5488418|NCT01343927|Community health center|community health center
5488419|NCT01343927|Yoga|yoga
5488420|NCT01343927|Physical therapy|physical therapy
5488421|NCT01343927|Minority populations|minority populations
5488422|NCT01343927|Health education|health education
5488423|NCT01343862|moderate traumatic brain injury|moderate traumatic brain injury
5488424|NCT01343862|brain contusion|brain contusion
5488425|NCT01343849|breast cancer|breast cancer
5488426|NCT01343849|auto antibodies|auto antibodies
5488427|NCT01343836|autologous tenocytes|autologous tenocytes
5488428|NCT01343836|cell therapy|cell therapy
5488429|NCT01343836|eccentric exercises|eccentric exercises
5488431|NCT01343810|Meditation|meditation
5488432|NCT01343810|Psychological stress|psychological stress
5488433|NCT01343810|Sleep quality|sleep quality
5488434|NCT01343810|Cardiovascular disease|cardiovascular disease
5488435|NCT01343810|Inflammation|inflammation
5488436|NCT01343797|Glycemic index|glycemic index
5488437|NCT01343797|Insulinemic index|insulinemic index
5488438|NCT01343797|Fructo-oligosaccharide syrup|fructo-oligosaccharide syrup
5488439|NCT01343797|Fructose syrup|fructose syrup
5488440|NCT01343797|Aged between eighteen and fifty years old|aged between eighteen and fifty years old
5685530|NCT00555737|Celiac Disease|celiac disease
5488441|NCT01343797|BMI between nineteen and twenty five kg/m²|bmi between nineteen and twenty five kg/m²
5488442|NCT01343797|Non diabetic or pre-diabetic|non diabetic or pre-diabetic
5488443|NCT01343797|Without liver, renal or gastro-intestinal disorder|without liver, renal or gastro-intestinal disorder
5488444|NCT01343797|Non-smoker|non-smoker
5488445|NCT01343784|Voiding trial|voiding trial
5488446|NCT01343784|sling|sling
5488447|NCT01343784|post-operative assessment|post-operative assessment
5488448|NCT01343784|urinary retention|urinary retention
5488449|NCT01343771|Anorexia Nervosa (AN)|anorexia nervosa (an)
5488450|NCT01343771|bone density|bone density
5488451|NCT01343771|DHEA|dhea
5488452|NCT01343771|estrogen therapy|estrogen therapy
5488453|NCT01343771|eating disorder|eating disorder
5488454|NCT01343693|DDD|ddd
5488455|NCT01343693|Deformity|deformity
5488456|NCT01343693|Tumor|tumor
5488457|NCT01343693|Fracture|fracture
5488458|NCT01343693|Cervical|cervical
5488459|NCT01343667|GORE Neuro Protection System|gore neuro protection system
5488460|NCT01343667|GORE Flow Reversal System|gore flow reversal system
5488461|NCT01343667|carotid artery stenosis|carotid artery stenosis
5488462|NCT01343667|embolic protection device|embolic protection device
5488463|NCT01343667|reverse flow|reverse flow
5488464|NCT01343667|proximal occlusion device|proximal occlusion device
5488471|NCT01343667|embolic filter|embolic filter
5488472|NCT01343654|HIV medication adherence|hiv medication adherence
5488473|NCT01343654|drug use|drug use
5488475|NCT01343654|nonadherence to HIV medications|nonadherence to hiv medications
5488476|NCT01343641|Kidney Disease|kidney disease
5488477|NCT01343641|Chronic Kidney Disease|chronic kidney disease
5488478|NCT01343641|Growth Hormone|growth hormone
5488479|NCT01343628|Alcohol, atomoxetine, Strattera, alcohol dependence, alcoholism|alcohol, atomoxetine, strattera, alcohol dependence, alcoholism
5488480|NCT01343602|stroke|stroke
5488481|NCT01343602|Constraint Induced Movement Therapy|constraint induced movement therapy
5488482|NCT01343602|participation|participation
5488483|NCT01343602|Physical Therapy|physical therapy
5488484|NCT01343602|Occupational Therapy|occupational therapy
5488485|NCT01343563|Depression|depression
5488486|NCT01343563|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5488487|NCT01343563|EEG|eeg
5488488|NCT01343563|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5488489|NCT01343550|Borderline Personality Disorder|borderline personality disorder
5488490|NCT01343550|Borderline Personality|borderline personality
5488491|NCT01343550|Borderline|borderline
5488492|NCT01343537|Brain Bleed|brain bleed
5488493|NCT01343537|SAH|sah
5488494|NCT01343537|Vasospasm|vasospasm
5488495|NCT01343524|cystic fibrosis|cystic fibrosis
5488496|NCT01343524|spirometry|spirometry
5488497|NCT01343524|PFT's|pft's
5488498|NCT01343524|pulmonary function test|pulmonary function test
5488499|NCT01343511|Autism|autism
5488500|NCT01343511|human cord blood mononuclear cells|human cord blood mononuclear cells
5488501|NCT01343511|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
5488502|NCT01343498|Solid Tumor Malignancy|solid tumor malignancy
5488503|NCT01343498|Advanced Solid Tumors|advanced solid tumors
5488504|NCT01343498|BEZ235|bez235
5488505|NCT01343498|mTOR Inhibitor|mtor inhibitor
5488506|NCT01343485|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5488507|NCT01343485|Gardasil vaccine|gardasil vaccine
5488508|NCT01343472|Behavior|behavior
5488509|NCT01343472|Drug users|drug users
5488510|NCT01343459|Hypofractionated Whole breast irradiation|hypofractionated whole breast irradiation
5488511|NCT01343459|Hypofractionated Whole breast irradiation long term results|hypofractionated whole breast irradiation long term results
5488512|NCT01343459|Breast conserving therapy|breast conserving therapy
5488513|NCT01343459|IORT with electrons in breast cancer|iort with electrons in breast cancer
5488514|NCT01343459|IOERT as anticipated Boost|ioert as anticipated boost
5488515|NCT01343459|IOERT and hypofractionated whole breast irradiation|ioert and hypofractionated whole breast irradiation
5488516|NCT01343446|Sleep impairment, Coping Style, Diabetes Mellitus|sleep impairment, coping style, diabetes mellitus
5488517|NCT01343433|Delirium|delirium
5488518|NCT01343433|Intensive Care Unit Syndrome|intensive care unit syndrome
5488519|NCT01343433|Bright light therapy|bright light therapy
5488520|NCT01343433|Intensive Care Unit|intensive care unit
5488521|NCT01343420|Skin tests|skin tests
5488522|NCT01343420|Dog Hair|dog hair
5488523|NCT01343420|Allergy Extract|allergy extract
5488524|NCT01343394|Autologous|autologous
5488525|NCT01343394|Stem Cells|stem cells
5488526|NCT01343394|Hearing Loss|hearing loss
5488549|NCT01343303|knee pain|knee pain
5488550|NCT01343303|pain measurement|pain measurement
5488551|NCT01343290|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5488552|NCT01343290|Pharmacokinetic|pharmacokinetic
5488553|NCT01343290|Oral Bioavailability|oral bioavailability
5488554|NCT01343290|Food effect|food effect
5488555|NCT01343277|Advanced Liposarcoma or Leiomyosarcoma|advanced liposarcoma or leiomyosarcoma
5488556|NCT01343277|Trabectedin|trabectedin
5488557|NCT01343277|Yondelis|yondelis
5488558|NCT01343277|Dacarbazine|dacarbazine
5488559|NCT01343277|Anthracycline|anthracycline
5488560|NCT01343277|L-sarcoma|l-sarcoma
5488568|NCT01343251|catheter|catheter
5488569|NCT01343251|chronic renal failure|chronic renal failure
5488570|NCT01343251|end stage renal disease|end stage renal disease
5488571|NCT01343251|renal insufficiency|renal insufficiency
5488573|NCT01343238|diet|diet
5488574|NCT01343238|exercise|exercise
5488575|NCT01343225|African american vitamin d bone density|african american vitamin d bone density
5488576|NCT01343225|African American male or female treatment naive|african american male or female treatment naive
5488577|NCT01343212|hepatocellular carcinoma|hepatocellular carcinoma
5488578|NCT01343212|stiffness|stiffness
5488579|NCT01343186|Peginterferon|peginterferon
5488580|NCT01343186|Healthy subject|healthy subject
5488581|NCT01343186|Pharmacokinetics|pharmacokinetics
5488582|NCT01343186|Pharmacodynamics|pharmacodynamics
5488583|NCT01343186|Safety|safety
5488584|NCT01343173|Leukemia|leukemia
5488585|NCT01343173|Adult Chronic|adult chronic
5488586|NCT01343173|Myeloid|myeloid
5488587|NCT01343147|Hyperthermia|hyperthermia
5488588|NCT01343147|Microwave diathermy|microwave diathermy
5488589|NCT01343147|Hot packs|hot packs
5488590|NCT01343147|Pain|pain
5488793|NCT01342224|pancreatic|pancreatic
5488591|NCT01343147|Physical function|physical function
5488593|NCT01343134|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5488594|NCT01343134|Macular detachment|macular detachment
5488595|NCT01343134|Spectral domain OCT|spectral domain oct
5488596|NCT01343134|Microperimetry|microperimetry
5488597|NCT01343121|Radiotherapy|radiotherapy
5488598|NCT01343121|GemX Chemoradiotherapy|gemx chemoradiotherapy
5488599|NCT01343121|Bladder Cancer|bladder cancer
5488600|NCT01343108|Emotional Labor|emotional labor
5488601|NCT01343108|Burnout|burnout
5488602|NCT01343108|Job Satisfaction|job satisfaction
5488603|NCT01343108|Emotional Intelligence|emotional intelligence
5488604|NCT01343108|Job stress|job stress
5488605|NCT01343108|Job involvement|job involvement
5488606|NCT01343095|ICU Delirium|icu delirium
5488607|NCT01343095|Delirium|delirium
5488608|NCT01343095|Sleep Quality|sleep quality
5488609|NCT01343095|Sleep Efficiency|sleep efficiency
5488610|NCT01343095|ICU Noise|icu noise
5488611|NCT01343095|Noise Reduction|noise reduction
5488612|NCT01343095|Earplugs|earplugs
5488613|NCT01343095|Noise Canceling Headphones|noise canceling headphones
5488614|NCT01343069|safety|safety
5488615|NCT01343069|team|team
5488616|NCT01343069|team performance|team performance
5488617|NCT01343069|surgery|surgery
5488618|NCT01343069|outcome|outcome
5488619|NCT01343056|Diabetes Self Management Education (DSME)|diabetes self management education (dsme)
5488620|NCT01343056|Diabetes|diabetes
5488621|NCT01343056|Self Management Support (SMS)|self management support (sms)
5488630|NCT01343017|Anaesthesia|anaesthesia
5488644|NCT01342991|Haemorrhoidectomy|haemorrhoidectomy
5488645|NCT01342991|Laser Haemorrhoidectomy|laser haemorrhoidectomy
5488646|NCT01342991|Milligan-Morgan Haemorrhoidectomy|milligan-morgan haemorrhoidectomy
5488647|NCT01342991|Open Haemorrhoidectomy|open haemorrhoidectomy
5488650|NCT01342952|pulmonary arterial hypertension|pulmonary arterial hypertension
5488651|NCT01342952|pediatrics|pediatrics
5488652|NCT01342939|Monogenetic diabetes|monogenetic diabetes
5488653|NCT01342939|Diabetes mellitus|diabetes mellitus
5488654|NCT01342926|age-related macular degeneration|age-related macular degeneration
5488655|NCT01342926|geographic atrophy|geographic atrophy
5488656|NCT01342926|dry AMD|dry amd
5488657|NCT01342900|tissue oxygenation|tissue oxygenation
5488658|NCT01342900|higk risk surgery|higk risk surgery
5488659|NCT01342900|high risk patient|high risk patient
5488660|NCT01342900|postoperative complications|postoperative complications
5488661|NCT01342874|inositol|inositol
5488662|NCT01342874|gestational diabetes mellitus|gestational diabetes mellitus
5488663|NCT01342874|obstetric adverse outcomes|obstetric adverse outcomes
5488665|NCT01342861|caloric intake|caloric intake
5488666|NCT01342861|breakfast|breakfast
5488667|NCT01342861|transthyretin (prealbumin)|transthyretin (prealbumin)
5488668|NCT01342861|albumin|albumin
5488669|NCT01342861|Length of stay|length of stay
5488670|NCT01342848|NSTE-ACS|nste-acs
5488671|NCT01342848|PCI|pci
5488672|NCT01342848|Thrombus Aspiration|thrombus aspiration
5488673|NCT01342848|IVUS|ivus
5488674|NCT01342848|Periprocedural Myocardial Infarction|periprocedural myocardial infarction
5488675|NCT01342835|propofol|propofol
5488676|NCT01342835|sevoflurane|sevoflurane
5488677|NCT01342835|postoperative pain|postoperative pain
5488678|NCT01342835|children|children
5488679|NCT01342822|Heart disease|heart disease
5488680|NCT01342822|Coronary Revascularization|coronary revascularization
5488681|NCT01342809|Depression|depression
5488682|NCT01342809|Hopelessness|hopelessness
5488683|NCT01342809|Suicidal ideation|suicidal ideation
5488684|NCT01342796|Cell mediated immunity|cell mediated immunity
5488685|NCT01342796|cell mediated immune response|cell mediated immune response
5488686|NCT01342796|Children|children
5488687|NCT01342796|adjuvanted|adjuvanted
5488688|NCT01342783|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5488689|NCT01342783|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5488690|NCT01342783|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5488691|NCT01342783|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5488692|NCT01342783|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5488693|NCT01342783|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5488694|NCT01342744|Cardiovascular risk factors|cardiovascular risk factors
5488695|NCT01342731|Tigecycline|tigecycline
5488696|NCT01342731|A.baumannii|a.baumannii
5488697|NCT01342731|Drug safety|drug safety
5488698|NCT01342718|Irritable bowel syndrome|irritable bowel syndrome
5488699|NCT01342718|Herbal medicine|herbal medicine
5488700|NCT01342718|Probiotics|probiotics
5488701|NCT01342679|chronic myeloid leukemia|chronic myeloid leukemia
5488702|NCT01342679|dasatinib|dasatinib
5488703|NCT01342679|complete molecular response|complete molecular response
5488704|NCT01342666|High density lipoprotein cholesterol|high density lipoprotein cholesterol
5488705|NCT01342666|Tomato|tomato
5488706|NCT01342666|Lycopene|lycopene
5488707|NCT01342666|Hypoalphalipoproteinemia|hypoalphalipoproteinemia
5488708|NCT01342666|Dyslipidemia|dyslipidemia
5488709|NCT01342653|Peritoneal|peritoneal
5488710|NCT01342653|Carcinomatosis|carcinomatosis
5488711|NCT01342653|Gastric|gastric
5488712|NCT01342653|Cancer|cancer
5488713|NCT01342653|NIPS|nips
5488714|NCT01342653|HIPEC|hipec
5488715|NCT01342627|Renal Carcinoma|renal carcinoma
5488716|NCT01342627|Metastatic|metastatic
5488718|NCT01342627|Elderly|elderly
5488719|NCT01342614|Hypertension|hypertension
5488720|NCT01342614|Insulin Resistance|insulin resistance
5488721|NCT01342614|Hyperinsulinemia|hyperinsulinemia
5488722|NCT01342614|Metformin|metformin
5488723|NCT01342614|Fosinopril|fosinopril
5488724|NCT01342588|Pedicle screws|pedicle screws
5488725|NCT01342588|safety|safety
5488726|NCT01342575|ACDF|acdf
5488727|NCT01342549|Alcohol Use Disorders|alcohol use disorders
5488728|NCT01342549|Traumatic Brain Injury|traumatic brain injury
5488729|NCT01342549|Mood and Anxiety Disorders|mood and anxiety disorders
5488730|NCT01342536|Depression|depression
5488731|NCT01342523|Smoking Cessation|smoking cessation
5488732|NCT01342523|Smoking|smoking
5488733|NCT01342523|Nicotine|nicotine
5488734|NCT01342510|Intravenous Anesthesia|intravenous anesthesia
5488735|NCT01342510|General Anesthesia|general anesthesia
5488736|NCT01342497|diabetic foot ulcer|diabetic foot ulcer
5488737|NCT01342471|Physical activity intervention|physical activity intervention
5488738|NCT01342471|walking|walking
5488739|NCT01342471|TV|tv
5488740|NCT01342471|sedentary|sedentary
5789995|NCT00146211|Trial|trial
5488741|NCT01342458|Knee osteoarthritis|knee osteoarthritis
5488742|NCT01342458|Shoes|shoes
5488744|NCT01342458|Biomechanics|biomechanics
5488745|NCT01342432|low back pain|low back pain
5488746|NCT01342432|balance reeducation|balance reeducation
5488747|NCT01342432|pain|pain
5488748|NCT01342432|function|function
5488749|NCT01342367|Prostate cancer|prostate cancer
5488750|NCT01342367|Quality of Life|quality of life
5488751|NCT01342354|Pancreatic Cancer|pancreatic cancer
5488752|NCT01342354|Stereotactic Radiation|stereotactic radiation
5488753|NCT01342328|Sleep disruption|sleep disruption
5488754|NCT01342328|Sleep hygiene|sleep hygiene
5488755|NCT01342328|Sedative agents and sleep|sedative agents and sleep
5488756|NCT01342328|Electroencephalography|electroencephalography
5488757|NCT01342328|REM sleep|rem sleep
5488758|NCT01342328|Magnetoencephalography|magnetoencephalography
5488759|NCT01342315|Tinea Cruris, antifungal|tinea cruris, antifungal
5488760|NCT01342302|Breast Cancer|breast cancer
5488761|NCT01342302|Couples|couples
5488762|NCT01342302|Distress|distress
5488763|NCT01342302|Online Support|online support
5488764|NCT01342302|e-health|e-health
5488765|NCT01342302|Intervention|intervention
5488766|NCT01342302|Relationships|relationships
5488767|NCT01342289|Nonmyeloablative|nonmyeloablative
5488768|NCT01342289|Allogeneic|allogeneic
5488769|NCT01342289|Bone Marrow Transplant (BMT)|bone marrow transplant (bmt)
5488770|NCT01342289|Tacrolimus|tacrolimus
5488771|NCT01342289|Cyclophosphamide|cyclophosphamide
5488772|NCT01342276|Heart failure|heart failure
5488773|NCT01342276|Self-management|self-management
5488774|NCT01342276|Telehealth|telehealth
5488775|NCT01342276|Internet|internet
5488776|NCT01342263|Chronic disease management|chronic disease management
5488777|NCT01342263|Ischemic heart disease|ischemic heart disease
5488778|NCT01342263|Heart failure|heart failure
5488779|NCT01342263|Chronic kidney disease|chronic kidney disease
5488780|NCT01342263|Diabetes|diabetes
5488781|NCT01342263|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5488782|NCT01342263|Telehealth|telehealth
5488783|NCT01342263|Internet|internet
5488784|NCT01342250|Decompensated Liver Cirrhosis|decompensated liver cirrhosis
5488785|NCT01342250|Umbilical Cord Mesenchymal Stem Cells|umbilical cord mesenchymal stem cells
5488786|NCT01342237|Brain tumors|brain tumors
5488787|NCT01342237|Stem cell transplantation|stem cell transplantation
5488788|NCT01342237|topotecan|topotecan
5488789|NCT01342237|thiotepa|thiotepa
5488790|NCT01342237|carboplatin|carboplatin
5488791|NCT01342237|melphalan|melphalan
5488795|NCT01342224|adenocarcinoma|adenocarcinoma
5488796|NCT01342224|vaccine|vaccine
5488797|NCT01342211|PF-04950615|pf-04950615
5488798|NCT01342211|RN316|rn316
5488799|NCT01342198|pregabalin|pregabalin
5488800|NCT01342198|pharmacokinetics|pharmacokinetics
5488801|NCT01342198|bioavailability|bioavailability
5488802|NCT01342198|bioequivalence|bioequivalence
5488803|NCT01342185|Medical ozone therapy|medical ozone therapy
5488804|NCT01342185|chronic hepatitis B|chronic hepatitis b
5488805|NCT01342172|Bladder Cancer|bladder cancer
5488806|NCT01342172|Urothelial Cancer|urothelial cancer
5488807|NCT01342172|Chemotherapy|chemotherapy
5488808|NCT01342172|First-line|first-line
5488809|NCT01342172|Metastatic|metastatic
5488810|NCT01342159|bevacizumab, diabetic macular edema, triamcinolone|bevacizumab, diabetic macular edema, triamcinolone
5488811|NCT01342146|pegylated Somatropin|pegylated somatropin
5488812|NCT01342146|PEG-GH|peg-gh
5488813|NCT01342146|Growth hormone|growth hormone
5488814|NCT01342146|PEG-rhGH|peg-rhgh
5488815|NCT01342146|Growth hormone deficiency (GHD)|growth hormone deficiency (ghd)
5488816|NCT01342146|Phase 2 study|phase 2 study
5488817|NCT01342120|atypical antipsychotics|atypical antipsychotics
5488818|NCT01342120|quetiapine|quetiapine
5488819|NCT01342107|Contact Lenses|contact lenses
5488820|NCT01342107|Contact Lens Care|contact lens care
5483062|NCT01366092|stem cell transplant|stem cell transplant
5488822|NCT01342107|Myopia|myopia
5488823|NCT01342094|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
5488824|NCT01342081|Primary open angle glaucoma or ocular hypertension|primary open angle glaucoma or ocular hypertension
5488825|NCT01342068|Thoracic outlet syndrome|thoracic outlet syndrome
5488826|NCT01342068|Osteopathic medicine|osteopathic medicine
5488827|NCT01342068|Osteopathic Manual Manipulations|osteopathic manual manipulations
5488828|NCT01342068|OMT|omt
5488829|NCT01342068|Wright's Test|wright's test
5488830|NCT01342068|Adson's Test|adson's test
5488831|NCT01342068|Halstead's Maneuver|halstead's maneuver
5488832|NCT01342068|TOS|tos
5488833|NCT01342068|Vascular Sonography|vascular sonography
5488834|NCT01342042|diabetes|diabetes
5488835|NCT01342042|rRE-4|rre-4
5488836|NCT01342042|exenatide|exenatide
5488837|NCT01342042|metformin|metformin
5488838|NCT01342042|CSPC ZhongQi|cspc zhongqi
5488839|NCT01342029|Microvascular Coronary Dysfunction (MCD)|microvascular coronary dysfunction (mcd)
5488840|NCT01342016|prograf|prograf
5488841|NCT01342016|nephritis|nephritis
5488842|NCT01342016|leflunomide|leflunomide
5488843|NCT01342016|immunosuppressant|immunosuppressant
5488844|NCT01342003|HCV infection|hcv infection
5473384|NCT01407471|aldosterone|aldosterone
5488845|NCT01342003|genotype 1a|genotype 1a
5488846|NCT01342003|genotype 1 b|genotype 1 b
5488847|NCT01341990|Contact Lenses|contact lenses
5488848|NCT01341990|Contact Lens Care|contact lens care
5488849|NCT01341990|Multi-Purpose Solution|multi-purpose solution
5488850|NCT01341977|Contact Lenses|contact lenses
5671464|NCT00615927|Hydroxyurea|hydroxyurea
5488851|NCT01341977|Contact Lens Care|contact lens care
5488852|NCT01341977|Multi-Purpose Solution|multi-purpose solution
5488853|NCT01341964|Clopidogrel|clopidogrel
5488854|NCT01341964|Aspirin|aspirin
5488855|NCT01341964|Interaction|interaction
5488856|NCT01341951|liver failure, Acute|liver failure, acute
5488857|NCT01341938|Smokeless Tobacco Use|smokeless tobacco use
5488858|NCT01341925|childhood depression|childhood depression
5488859|NCT01341899|Type 1 diabetes|type 1 diabetes
5488860|NCT01341899|stem cell|stem cell
5488861|NCT01341899|C-peptide|c-peptide
5488862|NCT01341899|Immune function|immune function
5488863|NCT01341886|differentiated thyroid cancer|differentiated thyroid cancer
5488864|NCT01341886|THS suppression|ths suppression
5488865|NCT01341886|metformin|metformin
5488866|NCT01341834|Nasopharyngeal carcinoma, antiangiogenesis, HDACi, mTOR, Phase Ib|nasopharyngeal carcinoma, antiangiogenesis, hdaci, mtor, phase ib
5488867|NCT01341821|Leadership Style|leadership style
5488868|NCT01341821|Team Climate|team climate
5488869|NCT01341808|Crohn's disease|crohn's disease
5488870|NCT01341808|Ulcerative colitis|ulcerative colitis
5488871|NCT01341808|Hepatitis A|hepatitis a
5488872|NCT01341808|vaccine|vaccine
5488873|NCT01341795|Newly diagnosed type 2 diabetes patients|newly diagnosed type 2 diabetes patients
5488874|NCT01341782|Secondary hyperparathyroidism|secondary hyperparathyroidism
5488875|NCT01341782|Paricalcitol|paricalcitol
5488876|NCT01341782|Hemodialysis|hemodialysis
5488877|NCT01341782|Maxacalcitol|maxacalcitol
5488878|NCT01341756|Gastric Cancer|gastric cancer
5488879|NCT01341756|Radiotherapy|radiotherapy
5488880|NCT01341756|palliation|palliation
5488881|NCT01341756|bleeding|bleeding
5488882|NCT01341756|pain|pain
5488883|NCT01341756|obstruction|obstruction
5488884|NCT01341743|chronic hepatitis B|chronic hepatitis b
5488885|NCT01341743|inadequate response|inadequate response
5488886|NCT01341743|NUC therapy|nuc therapy
5488887|NCT01341730|Atherosclerosis|atherosclerosis
5488888|NCT01341730|Pioglitazone|pioglitazone
5488889|NCT01341730|Atorvastatin|atorvastatin
5488890|NCT01341730|PET CT|pet ct
5488891|NCT01341717|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5488893|NCT01341717|Insulin|insulin
5488894|NCT01341704|malaria|malaria
5488895|NCT01341704|vaccine|vaccine
5488896|NCT01341704|clinical trials|clinical trials
5488897|NCT01341704|proof of concept|proof of concept
5488898|NCT01341704|efficacy|efficacy
5488899|NCT01341691|chronic kidney disease|chronic kidney disease
5488900|NCT01341691|K2CG chewing gum|k2cg chewing gum
5488901|NCT01341691|phosphorus|phosphorus
5488902|NCT01341691|saliva|saliva
5488903|NCT01341678|chronic kidney disease|chronic kidney disease
5488904|NCT01341678|phosphorus|phosphorus
5488905|NCT01341678|circadian rhythm|circadian rhythm
5488906|NCT01341678|saliva|saliva
5488907|NCT01341665|hyponatremia|hyponatremia
5488908|NCT01341665|SIADH|siadh
5488909|NCT01341665|copeptin|copeptin
5488910|NCT01341639|combination vaccine|combination vaccine
5488911|NCT01341639|diphtheria|diphtheria
5488912|NCT01341639|pertussis|pertussis
5488913|NCT01341639|tetanus|tetanus
5488914|NCT01341639|hepatitis B|hepatitis b
5488915|NCT01341639|Hep B|hep b
5488916|NCT01341639|Haemophilus influenzae b|haemophilus influenzae b
5488918|NCT01341639|polio|polio
5488919|NCT01341639|poliovirus|poliovirus
5488920|NCT01341626|delinquency|delinquency
5488921|NCT01341626|drug use|drug use
5488922|NCT01341626|HIV risk behavior|hiv risk behavior
5488924|NCT01341600|Clopidogrel|clopidogrel
5488925|NCT01341600|Pharmacogenetics|pharmacogenetics
5488926|NCT01341600|Platelets|platelets
5488927|NCT01341600|Healthy Subjects|healthy subjects
5488928|NCT01341587|SMBG (self monitoring of blood glucose)|smbg (self monitoring of blood glucose)
5488929|NCT01341587|diabetes|diabetes
5488930|NCT01341587|mobile technology|mobile technology
5488931|NCT01341574|spatial neglect|spatial neglect
5488932|NCT01341574|stroke|stroke
5488933|NCT01341548|Nasal|nasal
5488934|NCT01341548|Cluster Headache|cluster headache
5488935|NCT01341548|Episodic Cluster|episodic cluster
5488936|NCT01341548|Headache|headache
5488937|NCT01341548|Phase 3|phase 3
5488938|NCT01341548|Civamide|civamide
5488939|NCT01341548|TRPV-1 Receptor|trpv-1 receptor
5488940|NCT01341509|Surgical Treatment of Insertional Achilles Tendinopathy|surgical treatment of insertional achilles tendinopathy
5488941|NCT01341496|Metastatic Cancer|metastatic cancer
5488942|NCT01341496|Cancer Vaccine|cancer vaccine
5488943|NCT01341496|Immunotherapy|immunotherapy
5488944|NCT01341496|Chest Metastases|chest metastases
5488945|NCT01341496|Sarcoma|sarcoma
5488946|NCT01341496|Melanoma|melanoma
5488947|NCT01341483|erectile dysfunction|erectile dysfunction
5488948|NCT01341483|internal pudendal artery|internal pudendal artery
5488950|NCT01341483|coronary artery disease|coronary artery disease
5488951|NCT01341483|peripheral atherosclerotic disease|peripheral atherosclerotic disease
5488952|NCT01341431|Parkinson disease|parkinson disease
5488953|NCT01341431|Bee venom|bee venom
5488954|NCT01341431|Motor fluctuations|motor fluctuations
5488955|NCT01341431|Disease progression|disease progression
5488956|NCT01341418|tibia|tibia
5488957|NCT01341418|suprapatellar|suprapatellar
5488958|NCT01341392|Drug-Drug interaction between the CKD-501 and Amlodipine|drug-drug interaction between the ckd-501 and amlodipine
5488959|NCT01341379|Ureagenesis|ureagenesis
5488960|NCT01341379|Urea cycle|urea cycle
5488961|NCT01341379|Inborn errors of metabolism|inborn errors of metabolism
5488962|NCT01341366|Laparoscopic surgery|laparoscopic surgery
5488963|NCT01341340|Stent|stent
5488964|NCT01341340|Infrapopliteal|infrapopliteal
5488965|NCT01341340|Tibial|tibial
5488966|NCT01341340|Limb Salvage|limb salvage
5488967|NCT01341327|Left Main|left main
5488968|NCT01341314|joint pain|joint pain
5488969|NCT01341314|stiffness|stiffness
5488970|NCT01341301|allogeneic stem cell transplant|allogeneic stem cell transplant
5488971|NCT01341301|TJU 2 Step|tju 2 step
5488972|NCT01341301|HSCT|hsct
5488973|NCT01341301|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5488974|NCT01341288|prostate cancer|prostate cancer
5488975|NCT01341288|EUCLIDIAN|euclidian
5488976|NCT01341288|Endo-Uro Computed Lattice for Intratumoral Delivery, Implantation, Ablation with Nanosensing|endo-uro computed lattice for intratumoral delivery, implantation, ablation with nanosensing
5488977|NCT01341288|robot|robot
5488978|NCT01341288|brachytherapy|brachytherapy
5488979|NCT01341288|seed implantation|seed implantation
5488980|NCT01341275|hepatitis B vaccine|hepatitis b vaccine
5488981|NCT01341275|duration of protection|duration of protection
5488982|NCT01341275|adolescent immunization|adolescent immunization
5488983|NCT01341275|anamnestic response|anamnestic response
5488984|NCT01341275|booster dose|booster dose
5488985|NCT01341275|Immunity to hepatitis B as measured by anti-HBSAg titers|immunity to hepatitis b as measured by anti-hbsag titers
5488986|NCT01341262|autologous stem cell transplantation|autologous stem cell transplantation
5488987|NCT01341262|thalidomide|thalidomide
5488988|NCT01341262|induction therapy|induction therapy
5488989|NCT01341236|VLBW|vlbw
5488990|NCT01341236|IUGR|iugr
5488991|NCT01341236|NIRS|nirs
5488992|NCT01341236|enteral nutrition|enteral nutrition
5488993|NCT01341236|superior mesenteric artery doppler|superior mesenteric artery doppler
5488994|NCT01341210|Patients Satisfaction|patients satisfaction
5488995|NCT01341210|Decision Making|decision making
5488999|NCT01341197|Helicobacter pylori stool antigen test|helicobacter pylori stool antigen test
5489000|NCT01341197|Mass screening|mass screening
5489001|NCT01341197|Bidirectional endoscopy|bidirectional endoscopy
5489003|NCT01341184|rifampin|rifampin
5489004|NCT01341184|TMC207|tmc207
5489005|NCT01341184|tuberculosis|tuberculosis
5489006|NCT01341171|tamoxifen|tamoxifen
5489007|NCT01341171|aromatase inhibitors|aromatase inhibitors
5489008|NCT01341171|breast cancer|breast cancer
5489009|NCT01341171|platelets|platelets
5489010|NCT01341158|Malignatn Melanoma|malignatn melanoma
5489011|NCT01341145|hypertension|hypertension
5489012|NCT01341145|aerobic exercise|aerobic exercise
5489013|NCT01341145|relaxation|relaxation
5489014|NCT01341145|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5489015|NCT01341145|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5489016|NCT01341145|brain health|brain health
5489018|NCT01341132|Hepatocellular Carcinoma|hepatocellular carcinoma
5489019|NCT01341132|MRI|mri
5489020|NCT01341132|Liver|liver
5489021|NCT01341106|chronic hepatitis B|chronic hepatitis b
5489022|NCT01341106|liver fibrosis|liver fibrosis
5489035|NCT01341028|GLP-1|glp-1
5489036|NCT01341028|insulin|insulin
5489037|NCT01341028|laparoscopic|laparoscopic
5489038|NCT01341028|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5489039|NCT01341028|gastric fundus resection|gastric fundus resection
5489040|NCT01341002|Postoperative Care|postoperative care
5489041|NCT01341002|red blood cell transfusion|red blood cell transfusion
5489042|NCT01341002|venous oxygen saturation|venous oxygen saturation
5489043|NCT01340989|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas|women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
5489044|NCT01340976|Cancer Related Anemia|cancer related anemia
5489045|NCT01340963|Chagas heart disease|chagas heart disease
5489046|NCT01340963|ventricular tachycardia|ventricular tachycardia
5489047|NCT01340963|atrial fibrillation|atrial fibrillation
5489048|NCT01340963|stroke|stroke
5489049|NCT01340963|cardiac death|cardiac death
5489050|NCT01340963|signal averaged electrocardiogram|signal averaged electrocardiogram
5489051|NCT01340950|Prevention|prevention
5489052|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents
5489053|NCT01340950|Neuropsychological Tests|neuropsychological tests
5489054|NCT01340937|Diphtheria|diphtheria
5489055|NCT01340937|Tetanus|tetanus
5489056|NCT01340937|Whooping Cough (pertussis)|whooping cough (pertussis)
5489057|NCT01340937|Poliomyelitis|poliomyelitis
5489058|NCT01340937|Hepatitis B infection|hepatitis b infection
5489059|NCT01340937|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
5489060|NCT01340924|Gestational diabetes|gestational diabetes
5489061|NCT01340924|Type 2 diabetes|type 2 diabetes
5489062|NCT01340898|meningococcal conjugate vaccine|meningococcal conjugate vaccine
5489063|NCT01340898|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
5489064|NCT01340898|meningococcal diseases|meningococcal diseases
5489065|NCT01340898|Immunogenicity|immunogenicity
5489066|NCT01340898|Neisseria meningitidis|neisseria meningitidis
5489067|NCT01340898|co-administration|co-administration
5489068|NCT01340898|routine vaccines|routine vaccines
5489069|NCT01340885|attention|attention
5489070|NCT01340885|mild cognitive impairment|mild cognitive impairment
5489071|NCT01340885|dementia|dementia
5489072|NCT01340872|iron deficiency|iron deficiency
5489073|NCT01340872|anaemia|anaemia
5489074|NCT01340872|inflammatory bowel disease|inflammatory bowel disease
5489075|NCT01340872|ulcerative colitis|ulcerative colitis
5489080|NCT01340846|gemfibrozil|gemfibrozil
5489081|NCT01340846|BRAF|braf
5489082|NCT01340846|Drug Interactions|drug interactions
5489083|NCT01340846|GSK2118436|gsk2118436
5489084|NCT01340846|warfarin|warfarin
5489085|NCT01340846|ketoconazole|ketoconazole
5489086|NCT01340846|BRAF inhibitor|braf inhibitor
5489087|NCT01340846|oncology|oncology
5489088|NCT01340846|BRAF positive tumor|braf positive tumor
5489089|NCT01340833|GSK2118436|gsk2118436
5489090|NCT01340833|BRAF inhibitor|braf inhibitor
5489091|NCT01340833|BRAF-mutation positive tumor|braf-mutation positive tumor
5489092|NCT01340833|Oncology|oncology
5489093|NCT01340833|absolute bioavailability|absolute bioavailability
5489094|NCT01340833|microtracer|microtracer
5489095|NCT01340781|inpatients|inpatients
5489096|NCT01340781|medical|medical
5489097|NCT01340781|polysomnogram|polysomnogram
5489098|NCT01340781|questionnaires|questionnaires
5489099|NCT01340768|Glucose metabolism disorders Metabolic diseases Peptidase inhibitors|glucose metabolism disorders metabolic diseases peptidase inhibitors
5489100|NCT01340755|Rectal cancer|rectal cancer
5489101|NCT01340742|Remote ischemic preconditioning|remote ischemic preconditioning
5489102|NCT01340742|Abdominal surgery|abdominal surgery
5489103|NCT01340742|Perioperative complications|perioperative complications
5489104|NCT01340729|melanoma|melanoma
5489105|NCT01340729|TPI 287|tpi 287
5489106|NCT01340729|tumor recurrence|tumor recurrence
5489107|NCT01340729|tumor progression|tumor progression
5489108|NCT01340729|novel taxane analog|novel taxane analog
5489109|NCT01340703|optic disc pit|optic disc pit
5489110|NCT01340703|retinal detachment|retinal detachment
5489111|NCT01340703|retinoschisis|retinoschisis
5489112|NCT01340703|vitrectomy|vitrectomy
5483372|NCT01364831|sleep time|sleep time
5489119|NCT01340677|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5489120|NCT01340677|Pharmacokinetic|pharmacokinetic
5489121|NCT01340677|Dose proportionality|dose proportionality
5489122|NCT01340664|Canagliflozin|canagliflozin
5489123|NCT01340664|Placebo|placebo
5489124|NCT01340664|Metformin|metformin
5489125|NCT01340664|Hemoglobin A1c|hemoglobin a1c
5489126|NCT01340664|Type 2 diabetes mellitus|type 2 diabetes mellitus
5489127|NCT01340651|myelofibrosis|myelofibrosis
5489128|NCT01340651|myeloproliferative neoplasms|myeloproliferative neoplasms
5489129|NCT01340651|PMF|pmf
5489130|NCT01340651|PET-MF|pet-mf
5489131|NCT01340651|PPV-MF|ppv-mf
5489132|NCT01340638|Seal pressure|seal pressure
5489133|NCT01340638|Cookgas|cookgas
5489134|NCT01340638|AirQ|airq
5489135|NCT01340638|LMA|lma
5489136|NCT01340638|supraglottic device|supraglottic device
5489137|NCT01340625|Healthy Subjects|healthy subjects
5489138|NCT01340612|large aneurysm|large aneurysm
5489139|NCT01340612|wide-necked aneurysm|wide-necked aneurysm
5489140|NCT01340612|recurring aneurysm|recurring aneurysm
5489141|NCT01340586|PHARMACOKINETIC|pharmacokinetic
5489142|NCT01340586|NOS|nos
5489143|NCT01340573|Chronic Hepatitis C|chronic hepatitis c
5489144|NCT01340573|pegylated interferon|pegylated interferon
5489145|NCT01340573|PegIntron Pen|pegintron pen
5473682|NCT01406314|Amyloidosis|amyloidosis
5489146|NCT01340573|Ribavirin|ribavirin
5489147|NCT01340560|Endometrium, local injury, implantation, pregnancy, in vitro fertilization|endometrium, local injury, implantation, pregnancy, in vitro fertilization
5489148|NCT01340547|Phase I|phase i
5489149|NCT01340547|Safety|safety
5489150|NCT01340547|PK|pk
5489151|NCT01340547|ECG QTc|ecg qtc
5489152|NCT01340547|Efficacy|efficacy
5489153|NCT01340547|Palifosfamide-tris|palifosfamide-tris
5489154|NCT01340547|non-randomized|non-randomized
5489155|NCT01340534|Surgical wound infection|surgical wound infection
5489156|NCT01340534|Oxygen|oxygen
5489157|NCT01340534|Cesarean|cesarean
5489158|NCT01340521|Pituitary Hormone Response|pituitary hormone response
5489159|NCT01340521|Clomiphene Citrate|clomiphene citrate
5489160|NCT01340521|Follicle Stimulating Hormone|follicle stimulating hormone
5489161|NCT01340521|Luteinizing Hormone|luteinizing hormone
5789996|NCT00146211|ethyl-EPA|ethyl-epa
5489162|NCT01340508|Pathological complete response|pathological complete response
5489163|NCT01340508|Intensity modulated radiotherapy|intensity modulated radiotherapy
5489164|NCT01340508|Rectal cancer|rectal cancer
5489165|NCT01340495|Breast Cancer|breast cancer
5489166|NCT01340495|Mastectomy|mastectomy
5489167|NCT01340482|XLH|xlh
5489168|NCT01340469|nosocomial infections|nosocomial infections
5489169|NCT01340469|necrotizing enterocolitis|necrotizing enterocolitis
5489170|NCT01340469|preterm infants|preterm infants
5489171|NCT01340469|ver low birth weight|ver low birth weight
5489172|NCT01340469|probiotics|probiotics
5489173|NCT01340456|4beta-OHcholesterol|4beta-ohcholesterol
5489174|NCT01340456|Midazolam|midazolam
5489176|NCT01340456|Enzyme induction|enzyme induction
5489177|NCT01340456|Drug metabolism|drug metabolism
5489178|NCT01340430|her2 positive breast cancer|her2 positive breast cancer
5489179|NCT01340430|her2 positive non operable breast cancer|her2 positive non operable breast cancer
5489180|NCT01340430|her2 positive locally advanced breast cancer|her2 positive locally advanced breast cancer
5489181|NCT01340430|neoadjuvant trastuzumab|neoadjuvant trastuzumab
5489182|NCT01340430|pathologic complete response|pathologic complete response
5489183|NCT01340417|melatonin|melatonin
5489184|NCT01340417|preterm|preterm
5489185|NCT01340417|deficiency|deficiency
5489186|NCT01340417|neuroprotection|neuroprotection
5489187|NCT01340391|cast, radius fracture|cast, radius fracture
5489188|NCT01340378|neonatal surgery|neonatal surgery
5489189|NCT01340378|Blalock-Taussig shunt|blalock-taussig shunt
5489190|NCT01340339|Jaundice|jaundice
5489191|NCT01340339|Hyperbilirubinemia|hyperbilirubinemia
5489192|NCT01340339|Phototherapy and Super-LED Fluorescent lamps|phototherapy and super-led fluorescent lamps
5489387|NCT01339689|ganaxolone|ganaxolone
5489193|NCT01340326|Post myocardial infarction ventricular remodeling|post myocardial infarction ventricular remodeling
5489194|NCT01340326|valsartan|valsartan
5489195|NCT01340313|caudal block, children, ultrasound, urological surgery|caudal block, children, ultrasound, urological surgery
5489196|NCT01340300|Colorectal|colorectal
5489197|NCT01340300|Breast|breast
5489198|NCT01340300|Insulin|insulin
5489199|NCT01340300|Exercise|exercise
5489200|NCT01340287|Plant sterol|plant sterol
5489201|NCT01340287|Hypercholesterolemia|hypercholesterolemia
5489202|NCT01340287|diet|diet
5489203|NCT01340287|dairy|dairy
5489204|NCT01340287|isoprostanes|isoprostanes
5489205|NCT01340287|Midly hypercholesterolemic subjects|midly hypercholesterolemic subjects
5489206|NCT01340274|Community Reinforcement and Family Training|community reinforcement and family training
5489207|NCT01340274|Concerned Significant Others|concerned significant others
5489208|NCT01340274|Identified Problem Gambler|identified problem gambler
5489209|NCT01340274|Therapeutics|therapeutics
5489210|NCT01340261|Pediatric|pediatric
5489211|NCT01340261|Chronic Pain|chronic pain
5489212|NCT01340248|food effect|food effect
5489213|NCT01340248|pharmacokinetics|pharmacokinetics
5489214|NCT01340248|healthy male volunteers|healthy male volunteers
5489215|NCT01340222|Preterm labour|preterm labour
5489216|NCT01340222|monocyte|monocyte
5489217|NCT01340222|lymphocyte|lymphocyte
5489218|NCT01340222|MCP-1|mcp-1
5489219|NCT01340222|Treg Lymphocytes|treg lymphocytes
5489220|NCT01340222|biologic markers|biologic markers
5489221|NCT01340222|immunology|immunology
5489222|NCT01340222|HLA-DR|hla-dr
5489223|NCT01340222|Th17|th17
5489224|NCT01340183|Phase I|phase i
5489225|NCT01340183|safety|safety
5489226|NCT01340183|tolerability|tolerability
5489227|NCT01340183|pharmacokinetics|pharmacokinetics
5489228|NCT01340183|AZD5099|azd5099
5489229|NCT01340183|volunteers|volunteers
5489230|NCT01340183|safety of the drug AZD5099|safety of the drug azd5099
5489231|NCT01340183|blood and urine levels of AZD5099|blood and urine levels of azd5099
5489232|NCT01340183|single intravenous doses|single intravenous doses
5489233|NCT01340183|healthy volunteers|healthy volunteers
5489234|NCT01340157|Fexinidazole|fexinidazole
5489235|NCT01340157|Phase I|phase i
5489236|NCT01340157|Bioavailability study|bioavailability study
5489237|NCT01340157|Food effect|food effect
5489238|NCT01340157|Human African Trypanosomiasis|human african trypanosomiasis
5489239|NCT01340144|total knee replacement|total knee replacement
5489240|NCT01340144|patellar crepitus|patellar crepitus
5489241|NCT01340144|Replacement of knee joint|replacement of knee joint
5489242|NCT01340131|CKD-828|ckd-828
5489243|NCT01340131|Hypertension|hypertension
5489244|NCT01340131|Primary Hypertension|primary hypertension
5489245|NCT01340131|Healthy Volunteer|healthy volunteer
5489246|NCT01340131|S-Amlodipine|s-amlodipine
5489247|NCT01340131|Telmisartan|telmisartan
5489248|NCT01340131|Amlodipine|amlodipine
5489249|NCT01340131|Pharmacokinetic|pharmacokinetic
5489250|NCT01340131|Phase 1|phase 1
5489251|NCT01340118|Asthma|asthma
5489252|NCT01340118|FEF25-75|fef25-75
5671465|NCT00615927|Droxia|droxia
5489253|NCT01340118|exhaled nitric oxide|exhaled nitric oxide
5489254|NCT01340118|inhaled corticosteroid|inhaled corticosteroid
5489255|NCT01340118|children|children
5489256|NCT01340105|Microwave ablation|microwave ablation
5489257|NCT01340105|Radiofrequency ablation|radiofrequency ablation
5489258|NCT01340105|Randomised controlled trial|randomised controlled trial
5489259|NCT01340092|Family Navigator|family navigator
5489260|NCT01340092|Autistic Disorder|autistic disorder
5489261|NCT01340092|Early Intervention|early intervention
5489262|NCT01340092|Developmental Disabilities|developmental disabilities
5489263|NCT01340092|Child Development Disorders|child development disorders
5489264|NCT01340079|diabetes mellitus, non-insulin dependent|diabetes mellitus, non-insulin dependent
5489265|NCT01340066|urinary incontinence|urinary incontinence
5489266|NCT01340066|stress incontinence|stress incontinence
5489267|NCT01340066|urge incontinence|urge incontinence
5489272|NCT01340040|advanced solid malignancies|advanced solid malignancies
5489274|NCT01340040|Insulin like growth factor|insulin like growth factor
5489275|NCT01340040|Japanese|japanese
5489276|NCT01340027|Urinary incontinence|urinary incontinence
5489277|NCT01340027|Overactive bladder (OAB)|overactive bladder (oab)
5489278|NCT01340027|Micturition|micturition
5489279|NCT01340027|Frequency|frequency
5489280|NCT01340027|YM178|ym178
5489281|NCT01340027|Urgency incontinence|urgency incontinence
5489282|NCT01340027|Urgency|urgency
5489283|NCT01340014|Glaucoma|glaucoma
5489284|NCT01340014|Intraocular pressure|intraocular pressure
5489285|NCT01340014|Tonometry, ocular|tonometry, ocular
5489286|NCT01340001|Dementia with Lewy bodies|dementia with lewy bodies
5489287|NCT01340001|Nucleus basalis of Meynert|nucleus basalis of meynert
5489288|NCT01340001|Deep brain stimulation|deep brain stimulation
5489289|NCT01339988|Stem-cells|stem-cells
5489290|NCT01339988|Transplantation|transplantation
5489291|NCT01339988|Busulfex|busulfex
5489388|NCT01339676|Vitamin D|vitamin d
5489292|NCT01339988|Cyclophosphamide|cyclophosphamide
5489293|NCT01339988|Total-Body-Ittadiation|total-body-ittadiation
5489294|NCT01339975|Renal Cell Carcinoma|renal cell carcinoma
5489295|NCT01339975|Nephrectomy|nephrectomy
5489296|NCT01339975|Antiangiogenics|antiangiogenics
5489297|NCT01339975|Chemokines|chemokines
5489298|NCT01339975|Prognostic value|prognostic value
5489299|NCT01339975|Carcinoma|carcinoma
5489300|NCT01339975|Carcinoma, Renal Cell|carcinoma, renal cell
5489301|NCT01339975|Kidney Neoplasms|kidney neoplasms
5489302|NCT01339975|Kidney Diseases|kidney diseases
5489303|NCT01339975|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5489304|NCT01339975|Neoplasms by Histologic Type|neoplasms by histologic type
5489305|NCT01339975|Neoplasms|neoplasms
5489306|NCT01339975|Adenocarcinoma|adenocarcinoma
5489308|NCT01339975|Urogenital Neoplasms|urogenital neoplasms
5489309|NCT01339975|Neoplasms by Site|neoplasms by site
5489310|NCT01339975|Urologic Diseases|urologic diseases
5489311|NCT01339975|Adjuvants, Immunologic|adjuvants, immunologic
5489312|NCT01339975|Physiological Effects of Drugs|physiological effects of drugs
5489313|NCT01339975|Pharmacologic Actions|pharmacologic actions
5489314|NCT01339975|Biomarkers|biomarkers
5489315|NCT01339975|Targeted therapies|targeted therapies
5489316|NCT01339975|Surgery|surgery
5489317|NCT01339962|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5489319|NCT01339949|wet AMD|wet amd
5489320|NCT01339949|Macular Degeneration|macular degeneration
5489321|NCT01339949|wet Age-related Macular Degeneration|wet age-related macular degeneration
5489322|NCT01339949|Age-Related Macular Degeneration|age-related macular degeneration
5489323|NCT01339949|IRay|iray
5489324|NCT01339949|radiation|radiation
5489325|NCT01339949|Oraya|oraya
5489326|NCT01339949|Oraya Therapeutics, Inc|oraya therapeutics, inc
5489327|NCT01339949|Low-voltage stereotactic radiosurgery|low-voltage stereotactic radiosurgery
5489328|NCT01339949|radiosurgery|radiosurgery
5489329|NCT01339949|x-ray|x-ray
5489330|NCT01339949|Lucentis|lucentis
5489331|NCT01339949|external beam radiation|external beam radiation
5489332|NCT01339923|Meningococcal disease|meningococcal disease
5489333|NCT01339923|Vaccines|vaccines
5489334|NCT01339923|intercalated administration|intercalated administration
5489335|NCT01339910|Acute Myelogenous Leukemia|acute myelogenous leukemia
5489336|NCT01339910|Myelodysplastic Syndrome|myelodysplastic syndrome
5489337|NCT01339897|N6022, GSNORi|n6022, gsnori
5489338|NCT01339884|Friedreich ataxia|friedreich ataxia
5489339|NCT01339884|Resveratrol|resveratrol
5489340|NCT01339884|Frataxin|frataxin
5489341|NCT01339884|Cardiomyopathy|cardiomyopathy
5489342|NCT01339884|Oxidative stress|oxidative stress
5489343|NCT01339871|Pazopanib|pazopanib
5489344|NCT01339871|Vorinostat|vorinostat
5489345|NCT01339871|Advanced Malignancies|advanced malignancies
5489346|NCT01339845|Cholera vaccine|cholera vaccine
5489347|NCT01339845|Behaviour change intervention|behaviour change intervention
5489348|NCT01339845|Cost effectiveness and cost-benefit|cost effectiveness and cost-benefit
5489349|NCT01339845|Prevention of cholera|prevention of cholera
5489350|NCT01339845|Control of Cholera|control of cholera
5489351|NCT01339845|Vaccination|vaccination
5489352|NCT01339806|mTBI|mtbi
5489353|NCT01339806|Concussion|concussion
5489354|NCT01339793|corporate social responsibility|corporate social responsibility
5489355|NCT01339793|social identity theory|social identity theory
5489356|NCT01339793|stakeholder theory|stakeholder theory
5489357|NCT01339793|organizational commitment|organizational commitment
5489358|NCT01339793|organizational performance|organizational performance
5489359|NCT01339767|Autism|autism
5489360|NCT01339767|Language Acquisition|language acquisition
5489361|NCT01339767|Language Development|language development
5489362|NCT01339767|Toddlers|toddlers
5489363|NCT01339754|recurrent pancreatic cancer|recurrent pancreatic cancer
5489364|NCT01339754|stage IV pancreatic cancer|stage iv pancreatic cancer
5489365|NCT01339754|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5489366|NCT01339741|Psoriasis Vulgaris|psoriasis vulgaris
5489367|NCT01339741|Vitamin D Deficiency|vitamin d deficiency
5489368|NCT01339741|Vitamin D Insufficiency|vitamin d insufficiency
5489369|NCT01339741|Vitamin D Supplement|vitamin d supplement
5489370|NCT01339741|Psoriasis Area and Severity Index (PASI Score)|psoriasis area and severity index (pasi score)
5489371|NCT01339741|Dermatologic Life Qualify Index (DLQI)|dermatologic life qualify index (dlqi)
5489372|NCT01339715|Ryodoraku|ryodoraku
5489373|NCT01339715|Heart Rate Variability|heart rate variability
5489374|NCT01339715|Traditional medicine|traditional medicine
5489375|NCT01339715|Autonomic Nervous System|autonomic nervous system
5489376|NCT01339715|Acupuncture|acupuncture
5489377|NCT01339715|Far Infrared Ray|far infrared ray
5489378|NCT01339715|CV12 Acupoint|cv12 acupoint
5489379|NCT01339702|Traumatic Brain Injury|traumatic brain injury
5489381|NCT01339702|Head Trauma|head trauma
5489382|NCT01339702|Acute Traumatic Brain Injury|acute traumatic brain injury
5489383|NCT01339702|Trauma, Brain|trauma, brain
5489384|NCT01339689|PTSD|ptsd
5489385|NCT01339689|Posttraumatic Stress Disorder|posttraumatic stress disorder
5489386|NCT01339689|pharmacotherapy|pharmacotherapy
5489389|NCT01339676|Multiple Sclerosis|multiple sclerosis
5489390|NCT01339676|MRI|mri
5489391|NCT01339676|Randomised Trial|randomised trial
5489392|NCT01339676|Finland|finland
5489393|NCT01339650|Solid Tumor|solid tumor
5489394|NCT01339650|BRCA 1 and BRCA 2 Mutations|brca 1 and brca 2 mutations
5489395|NCT01339650|Breast Cancer 1|breast cancer 1
5489396|NCT01339650|Breast Cancer 2|breast cancer 2
5489397|NCT01339650|High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancers|high grade serous ovarian, fallopian tube, or primary peritoneal cancers
5489398|NCT01339650|Solid Tumors|solid tumors
5489399|NCT01339637|Impaired Glucose Tolerance|impaired glucose tolerance
5489400|NCT01339637|Diabetes Risk Factors|diabetes risk factors
5489401|NCT01339637|Dark Skin|dark skin
5489402|NCT01339624|analgesia|analgesia
5489403|NCT01339624|renal colic|renal colic
5489405|NCT01339624|nasal fentanyl|nasal fentanyl
5489406|NCT01339624|morphine.|morphine.
5489407|NCT01339624|treatment of acute renal colic|treatment of acute renal colic
5489408|NCT01339611|quality of life|quality of life
5489409|NCT01339611|medical adherence|medical adherence
5489410|NCT01339611|warfarin|warfarin
5489411|NCT01339611|Health education|health education
5489412|NCT01339572|autologous transplantation|autologous transplantation
5489413|NCT01339572|peripheral stem cell mobilization|peripheral stem cell mobilization
5489414|NCT01339559|Epilepsy|epilepsy
5489415|NCT01339559|Brivaracetam|brivaracetam
5489416|NCT01339559|Partial Onset Seizures|partial onset seizures
5489417|NCT01339559|Adjunctive treatment|adjunctive treatment
5489418|NCT01339546|ecologic|ecologic
5489419|NCT01339546|cross sectional|cross sectional
5489420|NCT01339546|trend analysis|trend analysis
5489421|NCT01339533|ALI|ali
5489422|NCT01339533|ARDS|ards
5489423|NCT01339481|Orencia|orencia
5489424|NCT01339481|Abatacept|abatacept
5489425|NCT01339481|Rheumatoid Arthritis|rheumatoid arthritis
5489426|NCT01339481|Infusion|infusion
5489427|NCT01339468|advagraf|advagraf
5489428|NCT01339468|prograf|prograf
5489429|NCT01339468|living donor liver transplantation|living donor liver transplantation
5489430|NCT01339468|FK506|fk506
5489431|NCT01339468|Immunosuppressant|immunosuppressant
5489432|NCT01339455|Neuromyelitis Optica|neuromyelitis optica
5489433|NCT01339455|NMO|nmo
5489434|NCT01339455|Devic's Disease|devic's disease
5489435|NCT01339455|Stem Cell Transplant|stem cell transplant
5489436|NCT01339429|wound|wound
5489437|NCT01339429|negative pressure wound therapy|negative pressure wound therapy
5489438|NCT01339429|non-powered negative pressure wound therapy|non-powered negative pressure wound therapy
5489439|NCT01339390|Obesity|obesity
5489440|NCT01339390|Veteran|veteran
5489441|NCT01339390|Self Care|self care
5489442|NCT01339390|Patient Education|patient education
5489443|NCT01339390|Peer Group|peer group
5471437|NCT01415063|RFA|rfa
5489444|NCT01339377|Ozone|ozone
5489445|NCT01339377|Oxygen|oxygen
5489446|NCT01339377|Oxygen-Ozone|oxygen-ozone
5489447|NCT01339377|AO-1000|ao-1000
5489448|NCT01339377|ActiveO|activeo
5489449|NCT01339377|Herniated Disc|herniated disc
5489450|NCT01339377|Disc|disc
5489451|NCT01339377|Lumbar|lumbar
5489452|NCT01339351|breast cancer|breast cancer
5489453|NCT01339351|social connection|social connection
5489454|NCT01339325|Laparo-endoscopic single site cholecystectomy|laparo-endoscopic single site cholecystectomy
5489455|NCT01339325|Quality of Life|quality of life
5489456|NCT01339325|Postoperative Pain|postoperative pain
5489457|NCT01339325|Cosmetics|cosmetics
5489458|NCT01339325|Complication|complication
5489459|NCT01339312|Rabies|rabies
5489460|NCT01339312|Rabies virus|rabies virus
5489461|NCT01339312|Purified Vero Rabies Vaccine - Serum Free|purified vero rabies vaccine - serum free
5489462|NCT01339299|COS|cos
5489463|NCT01339299|ART|art
5489464|NCT01339299|Infertility|infertility
5489466|NCT01339273|Laparoscopic hemicolectomy|laparoscopic hemicolectomy
5489467|NCT01339273|Laparoscopic anterior resection|laparoscopic anterior resection
5489468|NCT01339273|laparoscopic colonic resection|laparoscopic colonic resection
5489469|NCT01339247|Bioequivalence|bioequivalence
5489470|NCT01339247|Paroxetine reference/test|paroxetine reference/test
5489471|NCT01339247|healthy volunteers|healthy volunteers
5489472|NCT01339247|Fed condition|fed condition
5489473|NCT01339234|treadmill exercise|treadmill exercise
5489474|NCT01339234|rehabilitation|rehabilitation
5489475|NCT01339234|progressive multiple sclerosis|progressive multiple sclerosis
5489476|NCT01339234|functional ability|functional ability
5489477|NCT01339234|quality of life|quality of life
5489478|NCT01339234|fatigue|fatigue
5489479|NCT01339221|Observational|observational
5489480|NCT01339221|Rotarix™|rotarix™
5489481|NCT01339221|post-marketing|post-marketing
5489482|NCT01339208|Type 2 Diabetes|type 2 diabetes
5489483|NCT01339195|Dementia|dementia
5489484|NCT01339195|Alzheimer disease|alzheimer disease
5489485|NCT01339195|stroke|stroke
5489486|NCT01339195|cognitive impairment|cognitive impairment
5489487|NCT01339182|somatropin|somatropin
5489488|NCT01339182|PK|pk
5489489|NCT01339182|PD|pd
5489490|NCT01339182|male|male
5489491|NCT01339182|pharmacokinetics|pharmacokinetics
5489492|NCT01339182|pharmacodynamics|pharmacodynamics
5489493|NCT01339182|safety|safety
5489494|NCT01339169|YF476|yf476
5489495|NCT01339169|Hypergastrinaemia|hypergastrinaemia
5489496|NCT01339169|netazepide|netazepide
5489497|NCT01339169|gastric carcinoids|gastric carcinoids
5489498|NCT01339156|Safety|safety
5489499|NCT01339156|Tolerability|tolerability
5489500|NCT01339156|Food Effect|food effect
5489501|NCT01339156|Pharmacokinetics|pharmacokinetics
5489502|NCT01339143|Vildagliptin|vildagliptin
5489503|NCT01339130|Alzheimer disease|alzheimer disease
5489504|NCT01339130|Stroke|stroke
5489505|NCT01339130|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5489506|NCT01339130|Lewy Body Dementia|lewy body dementia
5489507|NCT01339130|Huntington Disease|huntington disease
5489508|NCT01339130|mild cognitive impairment|mild cognitive impairment
5489511|NCT01339117|irritable bowel syndrome|irritable bowel syndrome
5489513|NCT01339117|chronic abdominal pain|chronic abdominal pain
5489514|NCT01339117|recurrent abdominal pain|recurrent abdominal pain
5489515|NCT01339104|Cardiovascular safety|cardiovascular safety
5489516|NCT01339078|Biliary strictures|biliary strictures
5489517|NCT01339078|liver transplantation|liver transplantation
5489518|NCT01339065|ketamine|ketamine
5489519|NCT01339065|inflammatory|inflammatory
5489520|NCT01339065|pro inflammatory|pro inflammatory
5489521|NCT01339065|pro inflammatory markers IL-6 and IL-1beta|pro inflammatory markers il-6 and il-1beta
5489522|NCT01339052|BKM120|bkm120
5489523|NCT01339052|Brain tumor|brain tumor
5489524|NCT01339039|AMD3100|amd3100
5489525|NCT01339039|plerixafor|plerixafor
5489526|NCT01339039|Mozobil|mozobil
5489527|NCT01339039|bevacizumab|bevacizumab
5489528|NCT01339026|Acute coronary syndrome|acute coronary syndrome
5489529|NCT01339026|Platelet reactivity|platelet reactivity
5489530|NCT01339026|Clopidogrel|clopidogrel
5489531|NCT01339026|Percutaneous coronary intervention|percutaneous coronary intervention
5489532|NCT01339013|Quantification|quantification
5489533|NCT01339013|ventilatory requirements|ventilatory requirements
5489534|NCT01339013|charcoal filter|charcoal filter
5489535|NCT01339000|Colorectal Cancer|colorectal cancer
5489536|NCT01339000|Breast Cancer|breast cancer
5489537|NCT01339000|Immunization|immunization
5489538|NCT01339000|Immunocompromised Host|immunocompromised host
5489539|NCT01339000|Bladder Cancer|bladder cancer
5489540|NCT01339000|Colon Cancer|colon cancer
5474128|NCT01404520|#7 Exercise[tw]|#7 exercise[tw]
5489542|NCT01338987|Leuprolide|leuprolide
5489543|NCT01338987|Thymic Renewal|thymic renewal
5489544|NCT01338987|Stem Cell Transplant|stem cell transplant
5489545|NCT01338987|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5489546|NCT01338987|Acute Myelogenous Leukemia|acute myelogenous leukemia
5489547|NCT01338987|Myelodysplastic Syndrome|myelodysplastic syndrome
5671466|NCT00615927|Hydrea|hydrea
5789997|NCT00146211|Miraxion™|miraxion™
5789998|NCT00146211|treating|treating
5489548|NCT01338974|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5489549|NCT01338974|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5489550|NCT01338974|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5489551|NCT01338974|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5489552|NCT01338974|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5489553|NCT01338974|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5489554|NCT01338974|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5489555|NCT01338974|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5489556|NCT01338974|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5489559|NCT01338974|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5489560|NCT01338974|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5489561|NCT01338974|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5489562|NCT01338974|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5489563|NCT01338974|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5489564|NCT01338961|Cardiopulmonary Bypass|cardiopulmonary bypass
5489565|NCT01338961|Hypothermia|hypothermia
5489566|NCT01338961|Normothermia|normothermia
5489567|NCT01338961|Troponin I|troponin i
5489568|NCT01338961|Bleeding|bleeding
5489570|NCT01338935|Phase I trial|phase i trial
5489571|NCT01338935|safety|safety
5489572|NCT01338935|efficacy|efficacy
5489573|NCT01338935|pharmacokinetics|pharmacokinetics
5489574|NCT01338935|estimated dose|estimated dose
5489575|NCT01338935|Neuromuscular Blocking Agents|neuromuscular blocking agents
5489576|NCT01338935|Treatment Effectiveness|treatment effectiveness
5489577|NCT01338935|Drug Antagonism|drug antagonism
5489578|NCT01338909|prasugrel|prasugrel
5489579|NCT01338909|clopidogrel|clopidogrel
5489580|NCT01338909|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5489581|NCT01338909|high platelet reactivity|high platelet reactivity
5489582|NCT01338896|Rotigotine|rotigotine
5489584|NCT01338883|HIV-1 Infection|hiv-1 infection
5489585|NCT01338883|CCR5-tropic|ccr5-tropic
5489586|NCT01338883|Anti-retroviral naive|anti-retroviral naive
5489587|NCT01338870|Phase 2|phase 2
5489588|NCT01338870|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
5489589|NCT01338870|Type 2 diabetes|type 2 diabetes
5489590|NCT01338857|neurofibromatosis1 (NF1)|neurofibromatosis1 (nf1)
5489591|NCT01338857|Recurrent or progressive optic pathway gliomas (OPG)|recurrent or progressive optic pathway gliomas (opg)
5489592|NCT01338857|Recurrent or progressive low-grade glioma|recurrent or progressive low-grade glioma
5489593|NCT01338857|sorafenib|sorafenib
5489594|NCT01338857|low-grade astrocytoma|low-grade astrocytoma
5489595|NCT01338844|Poor oocyte quality|poor oocyte quality
5489599|NCT01338831|prolactin,|prolactin,
5489600|NCT01338831|prolactin receptor|prolactin receptor
5489601|NCT01338831|uterine leiomyoma|uterine leiomyoma
5489602|NCT01338818|Attention Deficit /Hyperactivity Disorder,|attention deficit /hyperactivity disorder,
5489603|NCT01338818|hyperactivity|hyperactivity
5489604|NCT01338805|Partial onset seizure|partial onset seizure
5489605|NCT01338805|seizure frequency|seizure frequency
5489606|NCT01338805|nervous system diseases|nervous system diseases
5489607|NCT01338805|central nervous system diseases|central nervous system diseases
5489609|NCT01338805|brain diseases|brain diseases
5489610|NCT01338805|neurologic manifestations|neurologic manifestations
5489611|NCT01338805|adjunctive treatment|adjunctive treatment
5489612|NCT01338805|AEDs|aeds
5489613|NCT01338805|antiepileptic drug|antiepileptic drug
5489614|NCT01338779|Tolerance|tolerance
5489615|NCT01338779|Renal|renal
5489616|NCT01338779|Allograft|allograft
5489617|NCT01338779|B Cell Signature|b cell signature
5489618|NCT01338766|spondylolisthesis|spondylolisthesis
5489619|NCT01338766|lumbar spinal stenosis|lumbar spinal stenosis
5489620|NCT01338753|breast|breast
5489621|NCT01338753|cancer|cancer
5489622|NCT01338753|Pharmacogenomics|pharmacogenomics
5489623|NCT01338753|bevacizumab|bevacizumab
5489624|NCT01338740|Chrohn's disease|chrohn's disease
5489625|NCT01338740|Moderate to severely active Crohn's disease patients|moderate to severely active crohn's disease patients
5489626|NCT01338714|HBV carrier|hbv carrier
5489627|NCT01338714|HBV DNA title|hbv dna title
5489628|NCT01338714|Chinese Medicine|chinese medicine
5489629|NCT01338714|Liver function|liver function
5489630|NCT01338714|RHD-1|rhd-1
5489631|NCT01338701|TBI|tbi
5489632|NCT01338701|Headaches|headaches
5489633|NCT01338701|Military|military
5489634|NCT01338701|Acupuncture|acupuncture
5671467|NCT00615927|Hydroxycarbamide|hydroxycarbamide
5489635|NCT01338701|Walter Reed Army Medical Center|walter reed army medical center
5489636|NCT01338701|Fort Belvoir Community Hospital|fort belvoir community hospital
5489637|NCT01338675|Chronic granulomatous disease|chronic granulomatous disease
5489638|NCT01338675|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5489639|NCT01338662|Parkinson`s disease|parkinson`s disease
5489640|NCT01338649|Parkinson's disease|parkinson's disease
5489641|NCT01338649|Daytime somnolence|daytime somnolence
5489642|NCT01338649|Sleepiness|sleepiness
5489643|NCT01338649|Light therapy|light therapy
5489644|NCT01338636|Exercise-induced pulmonary arterial hypertension (EIPAH)|exercise-induced pulmonary arterial hypertension (eipah)
5492599|NCT01326273|adoptive therapy|adoptive therapy
5489645|NCT01338636|Pulmonary arterial hypertension (PAH)|pulmonary arterial hypertension (pah)
5489646|NCT01338636|ambrisentan|ambrisentan
5489647|NCT01338636|Advanced cardiopulmonary exercise test (CPET)|advanced cardiopulmonary exercise test (cpet)
5489648|NCT01338623|bioequivalence|bioequivalence
5489649|NCT01338623|tansulosine|tansulosine
5489650|NCT01338610|Ocular discomfort|ocular discomfort
5489651|NCT01338597|thyroidectomy|thyroidectomy
5489652|NCT01338597|invasiveness|invasiveness
5489653|NCT01338584|Pelvic floor muscle training|pelvic floor muscle training
5489654|NCT01338584|Post prostatectomy|post prostatectomy
5489655|NCT01338584|Early regaining of urinary continence|early regaining of urinary continence
5489656|NCT01338584|Positive improvement in quality of life|positive improvement in quality of life
5489657|NCT01338571|stool fatty acid|stool fatty acid
5489658|NCT01338532|Hip osteoarthritis|hip osteoarthritis
5489659|NCT01338532|Exercise|exercise
5489660|NCT01338532|Patient Education|patient education
5489661|NCT01338532|Total Hip Replacement|total hip replacement
5489662|NCT01338506|Military|military
5489663|NCT01338506|Posttraumatic Stress Disorder|posttraumatic stress disorder
5489664|NCT01338506|PTSD|ptsd
5489665|NCT01338506|PostTraumatic Stress Disorders|posttraumatic stress disorders
5489666|NCT01338506|Combat|combat
5489667|NCT01338506|Psychological Treatment|psychological treatment
5489668|NCT01338506|Psychotherapy|psychotherapy
5489669|NCT01338506|Trauma|trauma
5489670|NCT01338506|Posttraumatic Stress|posttraumatic stress
5489671|NCT01338506|Prolonged Exposure|prolonged exposure
5489672|NCT01338506|Exposure therapy|exposure therapy
5489673|NCT01338506|Behavior Therapy|behavior therapy
5489674|NCT01338506|Cognitive Behavior Therapy|cognitive behavior therapy
5489675|NCT01338506|Stress Disorders|stress disorders
5489676|NCT01338506|Drug Abuse|drug abuse
5489677|NCT01338506|Drug Dependence|drug dependence
5489687|NCT01338467|Cyclocoagulation|cyclocoagulation
5489688|NCT01338467|High Intensity Focused Ultrasound|high intensity focused ultrasound
5489689|NCT01338441|Drug induced QT prolongation|drug induced qt prolongation
5489690|NCT01338428|rape|rape
5489691|NCT01338428|sexual assault|sexual assault
5489692|NCT01338428|intervention|intervention
5489693|NCT01338428|female university students|female university students
5489698|NCT01338363|acid suppressing drugs|acid suppressing drugs
5483959|NCT01362452|Thiotepa|thiotepa
5489704|NCT01338350|pharmacodynamics|pharmacodynamics
5489705|NCT01338350|AZD5423|azd5423
5489706|NCT01338350|Japanese|japanese
5489707|NCT01338337|Low risk International Prognostic Scoring System (IPSS) (0 or Int-1)|low risk international prognostic scoring system (ipss) (0 or int-1)
5489708|NCT01338337|Patients who have not responded to previous treatment with erythropoietin (EPO)|patients who have not responded to previous treatment with erythropoietin (epo)
5489709|NCT01338337|Eastern Cooperative Oncology Group (ECOG) score ≤ 3|eastern cooperative oncology group (ecog) score ≤ 3
5489710|NCT01338324|Biomarker|biomarker
5489711|NCT01338324|Pharmacokinetics|pharmacokinetics
5489712|NCT01338324|Villous|villous
5489714|NCT01338324|Celiac disease|celiac disease
5489715|NCT01338298|Schizophrenia|schizophrenia
5489716|NCT01338298|Symptomatic Hyperprolactinemia|symptomatic hyperprolactinemia
5489717|NCT01338298|Hormone|hormone
5489718|NCT01338298|Menstrual|menstrual
5489724|NCT01338142|postmenopausal|postmenopausal
5489725|NCT01338142|women|women
5489726|NCT01338142|absorption|absorption
5489727|NCT01338142|calcium|calcium
5489728|NCT01338142|amorphous calcium|amorphous calcium
5489729|NCT01338129|vitamin c|vitamin c
5489730|NCT01338129|ascorbic acid|ascorbic acid
5489731|NCT01338129|ankle fracture|ankle fracture
5489732|NCT01338129|crps|crps
5489734|NCT01338129|crps prevention|crps prevention
5489735|NCT01338116|computerized decision support system|computerized decision support system
5489736|NCT01338116|PCR|pcr
5489737|NCT01338116|antibiotic treatment|antibiotic treatment
5489738|NCT01338103|Pemphigus|pemphigus
5489739|NCT01338103|Rituximab|rituximab
5489740|NCT01338103|Cylex|cylex
5489741|NCT01338090|VEGF imaging|vegf imaging
5489742|NCT01338090|neuroendocrine tumors|neuroendocrine tumors
5489743|NCT01338090|biomarker|biomarker
5489744|NCT01338090|mTOR inhibition|mtor inhibition
5489745|NCT01338077|Alginate|alginate
5671468|NCT00615927|Imatinib|imatinib
5489746|NCT01338077|Gastroesophageal reflux disease|gastroesophageal reflux disease
5489747|NCT01338064|Silicosis|silicosis
5489748|NCT01338051|Community based participatory research|community based participatory research
5489750|NCT01338025|Bridging|bridging
5489751|NCT01338025|Strategy|strategy
5471729|NCT01413659|Symbiotic|symbiotic
5489752|NCT01338012|metastatic castrate resistant prostate cancer|metastatic castrate resistant prostate cancer
5489753|NCT01338012|prostate cancer|prostate cancer
5489754|NCT01338012|prostate|prostate
5489755|NCT01338012|immune therapy|immune therapy
5489756|NCT01338012|immunotherapy|immunotherapy
5489757|NCT01338012|vaccine|vaccine
5489758|NCT01338012|dendritic cells|dendritic cells
5489759|NCT01338012|antigen-presenting cells|antigen-presenting cells
5489765|NCT01338012|booster|booster
5489766|NCT01338012|retreatment|retreatment
5489767|NCT01338012|immune memory|immune memory
5489768|NCT01338012|immune response|immune response
5489769|NCT01337986|Multiple Sclerosis|multiple sclerosis
5489770|NCT01337986|Optic Neuritis|optic neuritis
5489771|NCT01337986|Ampyra|ampyra
5489772|NCT01337986|Dalfampridine|dalfampridine
5489773|NCT01337986|Fampridine|fampridine
5489774|NCT01337986|Remote Optic Neuritis|remote optic neuritis
5489775|NCT01337986|Contrast Sensitivity|contrast sensitivity
5489776|NCT01337986|Treatment|treatment
5489777|NCT01337973|violence|violence
5489778|NCT01337973|aggression|aggression
5489779|NCT01337973|Substance-Related Disorders|substance-related disorders
5489780|NCT01337973|Alcohol-Related Disorders|alcohol-related disorders
5489781|NCT01337973|Drug-Related Disorders|drug-related disorders
5489783|NCT01337960|Robotics|robotics
5489784|NCT01337960|Neurorehabilitation|neurorehabilitation
5489785|NCT01337947|Type 1 diabetes|type 1 diabetes
5489786|NCT01337947|adolescents|adolescents
5489787|NCT01337947|exercise|exercise
5489788|NCT01337947|vascular function|vascular function
5489789|NCT01337934|Septic shock|septic shock
5489790|NCT01337934|Sepsis|sepsis
5489791|NCT01337934|Albumin|albumin
5489792|NCT01337934|Lactated Ringer|lactated ringer
5489793|NCT01337908|depression|depression
5489794|NCT01337908|quality of life|quality of life
5489795|NCT01337908|disability|disability
5489796|NCT01337895|Dairy|dairy
5489797|NCT01337895|obesity|obesity
5489798|NCT01337895|overweight|overweight
5489799|NCT01337895|weight loss|weight loss
5489800|NCT01337895|adults|adults
5489801|NCT01337882|Air Pollution|air pollution
5489802|NCT01337882|Diesel exhaust|diesel exhaust
5489803|NCT01337882|Biodiesel exhaust|biodiesel exhaust
5489804|NCT01337882|Vascular function|vascular function
5489805|NCT01337882|Fibrinolysis|fibrinolysis
5489806|NCT01337882|Acute vascular and endothelial responses|acute vascular and endothelial responses
5484066|NCT01362075|Shoulder Arthroplasty|shoulder arthroplasty
5489807|NCT01337869|Bascom Procedure, Limberg, Pilonidal Disease|bascom procedure, limberg, pilonidal disease
5489808|NCT01337856|time-effectiveness|time-effectiveness
5489809|NCT01337856|hand hygiene protocols|hand hygiene protocols
5489810|NCT01337843|Chronic low back pain|chronic low back pain
5489811|NCT01337843|cognitive behavioral pain management|cognitive behavioral pain management
5489812|NCT01337843|coping|coping
5489813|NCT01337843|mindfulness|mindfulness
5489814|NCT01337843|physical activity|physical activity
5489815|NCT01337843|Back Pain Lower Back Chronic|back pain lower back chronic
5489816|NCT01337830|smoking|smoking
5489817|NCT01337830|smokeless|smokeless
5489818|NCT01337830|aversion|aversion
5489819|NCT01337830|nicotine|nicotine
5489820|NCT01337830|nicotine replacement|nicotine replacement
5489821|NCT01337817|smoking|smoking
5489822|NCT01337817|smokeless|smokeless
5489823|NCT01337817|aversion|aversion
5489824|NCT01337817|nicotine|nicotine
5489825|NCT01337817|nicotine replacement|nicotine replacement
5489826|NCT01337791|chronic hepatitis B|chronic hepatitis b
5489827|NCT01337791|hepatitis B virus|hepatitis b virus
5489828|NCT01337791|perinatal transmission|perinatal transmission
5489829|NCT01337791|Telbivudine|telbivudine
5489830|NCT01337778|gender based violence|gender based violence
5489831|NCT01337778|maternal and child health|maternal and child health
5489832|NCT01337778|women|women
5489833|NCT01337778|India|india
5489834|NCT01337765|BEZ235,|bez235,
5489835|NCT01337765|MEK162|mek162
5489836|NCT01337765|RAS RAF mutations,|ras raf mutations,
5489837|NCT01337765|triple negative breast cancer|triple negative breast cancer
5489838|NCT01337765|pancreatic cancer,|pancreatic cancer,
5489839|NCT01337765|NSCLC progressed on EGFR TKI|nsclc progressed on egfr tki
5489840|NCT01337765|PI3K/mTOR inhibitor,|pi3k/mtor inhibitor,
5489841|NCT01337765|MEK inhibitor|mek inhibitor
5489842|NCT01337765|Advanced and selected solid tumors|advanced and selected solid tumors
5489843|NCT01337752|multiple myeloma|multiple myeloma
5489844|NCT01337752|renal insufficiency|renal insufficiency
5671469|NCT00615927|Brain tumor|brain tumor
5489845|NCT01337752|untreated multiple myeloma|untreated multiple myeloma
5489846|NCT01337739|Hysteroscopic Surgery|hysteroscopic surgery
5489847|NCT01337739|Dexmedetomidine|dexmedetomidine
5489849|NCT01337739|Opioids|opioids
5489850|NCT01337726|Depression|depression
5489851|NCT01337726|Heart Failure|heart failure
5489852|NCT01337726|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5489853|NCT01337726|Quality of Life|quality of life
5489854|NCT01337726|Functional Impairment|functional impairment
5489879|NCT01337648|Fecal metabolites|fecal metabolites
5489880|NCT01337609|Depression|depression
5489881|NCT01337609|Irritable Bowel Syndrome|irritable bowel syndrome
5489882|NCT01337609|Probiotic|probiotic
5489883|NCT01337609|Bacillus Coagulans|bacillus coagulans
5489884|NCT01337596|pain|pain
5489885|NCT01337596|neuropathic pain|neuropathic pain
5489886|NCT01337596|headaches|headaches
5489887|NCT01337583|HIV Infections|hiv infections
5489888|NCT01337583|Anti-HIV agents|anti-hiv agents
5489889|NCT01337583|HIV-1|hiv-1
5489890|NCT01337570|HIV Infections|hiv infections
5489891|NCT01337570|Anti-HIV agents|anti-hiv agents
5489892|NCT01337570|HIV-1|hiv-1
5489893|NCT01337557|Allergic conjunctivitis|allergic conjunctivitis
5489894|NCT01337544|HAPLOIDENTICAL STEM CELL TRANSPLANTATION|haploidentical stem cell transplantation
5489895|NCT01337544|NK CELL|nk cell
5489896|NCT01337544|IL-15|il-15
5489897|NCT01337531|Ovarian Response in PCOS|ovarian response in pcos
5489898|NCT01337531|pregnancy rate in PCOS|pregnancy rate in pcos
5489899|NCT01337531|miscarriage rate in PCOS|miscarriage rate in pcos
5489900|NCT01337518|Prostate Specific Antigen|prostate specific antigen
5489901|NCT01337518|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5489902|NCT01337518|Adenocarcinoma|adenocarcinoma
5489903|NCT01337518|Androgen Receptor|androgen receptor
5489904|NCT01337518|Metastases|metastases
5489905|NCT01337505|INNO-206|inno-206
5489906|NCT01337505|Phase 1|phase 1
5489907|NCT01337505|DOXO-EMCH|doxo-emch
5489908|NCT01337505|Advanced solid tumors|advanced solid tumors
5489909|NCT01337492|Hepatocellular Carcinoma|hepatocellular carcinoma
5489910|NCT01337492|Orthotopic Liver Transplant|orthotopic liver transplant
5489911|NCT01337466|Phase I|phase i
5489912|NCT01337466|FIAU|fiau
5489913|NCT01337466|Fialuridine|fialuridine
5489914|NCT01337466|Biodistribution|biodistribution
5489915|NCT01337466|Dosimetry|dosimetry
5489916|NCT01337466|Prosthetic|prosthetic
5489917|NCT01337466|Joint|joint
5489918|NCT01337466|Infection|infection
5489919|NCT01337466|PET-CT|pet-ct
5489920|NCT01337453|botulinum toxin|botulinum toxin
5489921|NCT01337453|flu like symptoms|flu like symptoms
5489922|NCT01337453|frequency of FLS|frequency of fls
5489923|NCT01337453|Botox|botox
5489924|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid
5489925|NCT01337440|sitagliptin|sitagliptin
5489926|NCT01337440|bile acids|bile acids
5489927|NCT01337440|GLP-1|glp-1
5489928|NCT01337427|multiple sclerosis|multiple sclerosis
5489929|NCT01337427|relapsing|relapsing
5489930|NCT01337427|MS|ms
5489931|NCT01337427|injectable|injectable
5484199|NCT01361542|TNF|tnf
5489932|NCT01337427|subcutaneous|subcutaneous
5489933|NCT01337427|SC|sc
5489934|NCT01337427|PEGylated|pegylated
5489935|NCT01337427|interferon|interferon
5489936|NCT01337427|PEG|peg
5489937|NCT01337427|OCT|oct
5489938|NCT01337427|Optical Coherence Tomography|optical coherence tomography
5489939|NCT01337414|age-related macular degeneration|age-related macular degeneration
5489940|NCT01337414|screening|screening
5489941|NCT01337414|monitoring|monitoring
5489942|NCT01337414|diagnosis|diagnosis
5489943|NCT01337414|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or AREDS grade 3/4 AMD)|dry or non-neovascular age-related macular degeneration (high risk, intermediate, geographic atrophy or areds grade 3/4 amd)
5489944|NCT01337401|Cediranib|cediranib
5489945|NCT01337401|ASPS|asps
5489946|NCT01337401|Sarcoma|sarcoma
5489947|NCT01337362|Diabetes|diabetes
5489948|NCT01337362|Hypoglycaemia|hypoglycaemia
5489949|NCT01337362|EEG|eeg
5489950|NCT01337362|Thermography|thermography
5489952|NCT01337362|QTc interval|qtc interval
5489953|NCT01337362|Hypoglycemic alarm device|hypoglycemic alarm device
5489954|NCT01337362|Hormone response|hormone response
5489955|NCT01337349|Pentoxifylline|pentoxifylline
5490083|NCT01336829|HIV|hiv
5846750|NCT00043615|Cancer Risk|cancer risk
5489956|NCT01337349|Chronic Congestive Heart Failure|chronic congestive heart failure
5489957|NCT01337349|Left Systolic Function|left systolic function
5489959|NCT01337323|allergic rhinitis, allergies, concomitant medications, allergy symptoms|allergic rhinitis, allergies, concomitant medications, allergy symptoms
5489960|NCT01337310|Advanced solid tumors|advanced solid tumors
5489961|NCT01337297|crack cocaine|crack cocaine
5489962|NCT01337297|addiction|addiction
5489963|NCT01337297|tDCS|tdcs
5489964|NCT01337297|ERP|erp
5489965|NCT01337297|P300|p300
5489966|NCT01337297|attention|attention
5489967|NCT01337297|inhibitory control|inhibitory control
5489968|NCT01337297|working memory|working memory
5489969|NCT01337271|artificial, ventilation|artificial, ventilation
5489970|NCT01337271|mechanical ventilation|mechanical ventilation
5489972|NCT01337258|cost effectiveness|cost effectiveness
5489973|NCT01337258|dutasteride|dutasteride
5489974|NCT01337258|elevated risk population|elevated risk population
5489975|NCT01337258|Prostate cancer|prostate cancer
5489976|NCT01337258|prevention|prevention
5489977|NCT01337245|Envenomation|envenomation
5489978|NCT01337245|Coral Snake|coral snake
5489979|NCT01337245|Antivenom|antivenom
5490082|NCT01336829|Hepatitis C|hepatitis c
5489980|NCT01337245|Micrurus fulvius|micrurus fulvius
5489981|NCT01337232|language development disorders|language development disorders
5471933|NCT01412957|Phase 3|phase 3
5489982|NCT01337232|learning disorders|learning disorders
5489983|NCT01337232|sentences|sentences
5489984|NCT01337232|syntax|syntax
5489985|NCT01337232|school-age|school-age
5489986|NCT01337232|language|language
5489987|NCT01337219|cystic fibrosis|cystic fibrosis
5489988|NCT01337219|bioequivalence|bioequivalence
5489989|NCT01337219|pharmacokinetic|pharmacokinetic
5489990|NCT01337219|sputum|sputum
5489991|NCT01337219|plasma|plasma
5489992|NCT01337206|Esophageal Stenosis|esophageal stenosis
5489993|NCT01337206|Esopageal Strictures|esopageal strictures
5489994|NCT01337206|Esophageal Dysphagia|esophageal dysphagia
5489995|NCT01337193|stress urinary incontinence|stress urinary incontinence
5489996|NCT01337193|exercise|exercise
5489997|NCT01337193|pelvic floor muscles|pelvic floor muscles
5489998|NCT01337193|biofeedback|biofeedback
5489999|NCT01337193|rehabilitative ultrasound imaging|rehabilitative ultrasound imaging
5490000|NCT01337180|lung function|lung function
5490001|NCT01337180|respiratory symptoms|respiratory symptoms
5490002|NCT01337180|dust|dust
5490003|NCT01337180|inflammation|inflammation
5490004|NCT01337180|prospective|prospective
5490005|NCT01337167|Diphtheria|diphtheria
5490006|NCT01337167|Tetanus|tetanus
5490007|NCT01337167|Whooping Cough (pertussis)|whooping cough (pertussis)
5490008|NCT01337167|Poliomyelitis|poliomyelitis
5490009|NCT01337167|Hepatitis B infection|hepatitis b infection
5490010|NCT01337167|Haemophilus influenzae type b infection|haemophilus influenzae type b infection
5490011|NCT01337154|NSCLC|nsclc
5490012|NCT01337154|non-small cell lung cancer|non-small cell lung cancer
5490013|NCT01337154|tamibarotene|tamibarotene
5490014|NCT01337141|Telemedicine|telemedicine
5490015|NCT01337141|Type 1 diabetes|type 1 diabetes
5490016|NCT01337141|Metabolic control optimisation|metabolic control optimisation
5490017|NCT01337141|Health care costs|health care costs
5490018|NCT01337141|Intervention study|intervention study
5490019|NCT01337141|Access to internet|access to internet
5490020|NCT01337115|Postoperative pain|postoperative pain
5490021|NCT01337115|Knee arthroplasty|knee arthroplasty
5490022|NCT01337115|Peripheral nerve blocks|peripheral nerve blocks
5490023|NCT01337115|Sciatic nerve block|sciatic nerve block
5490024|NCT01337115|Femoral nerve block|femoral nerve block
5490025|NCT01337102|Lung Cancer|lung cancer
5490026|NCT01337102|Stage 3b|stage 3b
5490027|NCT01337102|Stage 4|stage 4
5490028|NCT01337102|First Line Chemotherapy Treatment|first line chemotherapy treatment
5490029|NCT01337102|Quality Of Life|quality of life
5490030|NCT01337102|Palliative Care|palliative care
5490031|NCT01337102|Randomized|randomized
5490032|NCT01337102|Lung Cancer Scale|lung cancer scale
5490033|NCT01337089|Cancer pain|cancer pain
5490034|NCT01337089|Opioid therapy|opioid therapy
5490035|NCT01337089|Inadequate analgesia|inadequate analgesia
5490036|NCT01337089|Optimized chronic opioid therapy|optimized chronic opioid therapy
5490037|NCT01337063|Adverse drug events|adverse drug events
5490038|NCT01337050|Hepatocellular Carcinoma|hepatocellular carcinoma
5490039|NCT01337050|Advanced/Metastatic solid tumors|advanced/metastatic solid tumors
5490040|NCT01337037|video-assisted thoracic surgery|video-assisted thoracic surgery
5490041|NCT01337037|Lung cancer|lung cancer
5490042|NCT01337037|lobectomy|lobectomy
5490045|NCT01337024|BoNT/A,|bont/a,
5490046|NCT01337024|adverse effects|adverse effects
5490047|NCT01337011|Chronic Ischemic Cardiomyopathy|chronic ischemic cardiomyopathy
5490048|NCT01336998|necrotizing enterocolitis|necrotizing enterocolitis
5490049|NCT01336998|arginine supplementation|arginine supplementation
5490050|NCT01336998|calprotectin|calprotectin
5490051|NCT01336985|Chemoembolization|chemoembolization
5490052|NCT01336985|Hepatic Metastases|hepatic metastases
5490053|NCT01336985|Irinotecan|irinotecan
5490054|NCT01336985|Drug Eluding Beads|drug eluding beads
5490055|NCT01336985|Colorectal Cancer|colorectal cancer
5490056|NCT01336985|Liver Cancer|liver cancer
5490057|NCT01336985|Hepatic Cancer|hepatic cancer
5490058|NCT01336985|Melanoma|melanoma
5490059|NCT01336959|Acute Kidney Injury|acute kidney injury
5490060|NCT01336959|Cardiopulmonary Bypass|cardiopulmonary bypass
5490061|NCT01336959|CABG|cabg
5490062|NCT01336959|Cardiac Surgery|cardiac surgery
5490063|NCT01336946|lifestyle|lifestyle
5490064|NCT01336946|mental disorder|mental disorder
5490065|NCT01336907|CNV|cnv
5490066|NCT01336907|AMD|amd
5490067|NCT01336907|Wet-treated CNV|wet-treated cnv
5474616|NCT01402414|balneophototherapy|balneophototherapy
5490068|NCT01336894|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5490069|NCT01336894|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5490070|NCT01336855|HIV|hiv
5490071|NCT01336855|Observational|observational
5490072|NCT01336855|Pathogenesis|pathogenesis
5490073|NCT01336855|Immunology|immunology
5490074|NCT01336855|Virology|virology
5490075|NCT01336855|Control|control
5490076|NCT01336855|Healthy control|healthy control
5490077|NCT01336855|Men who have sex with men|men who have sex with men
5490078|NCT01336842|panobinostat|panobinostat
5490079|NCT01336842|cisplatin|cisplatin
5490080|NCT01336842|pemetrexed|pemetrexed
5490081|NCT01336842|dose escalation|dose escalation
5490084|NCT01336829|TMC125IFD1001|tmc125ifd1001
5490085|NCT01336829|TMC125|tmc125
5490086|NCT01336829|Intelence|intelence
5490087|NCT01336829|etravirine|etravirine
5490088|NCT01336829|ETR|etr
5490089|NCT01336829|TMC278|tmc278
5490090|NCT01336829|telaprevir|telaprevir
5490091|NCT01336829|TVR|tvr
5490092|NCT01336829|VX-950|vx-950
5490093|NCT01336829|healthy volunteers|healthy volunteers
5490094|NCT01336829|crossover|crossover
5490095|NCT01336816|smoking|smoking
5490096|NCT01336816|smokeless|smokeless
5490097|NCT01336816|aversion|aversion
5490098|NCT01336816|nicotine|nicotine
5490099|NCT01336816|nicotine replacement|nicotine replacement
5490100|NCT01336790|Lymphatic disease|lymphatic disease
5490101|NCT01336790|Lymphedema|lymphedema
5490102|NCT01336790|Lymphangiomatosis|lymphangiomatosis
5490103|NCT01336790|Lymphangiectasia|lymphangiectasia
5490104|NCT01336790|Protein-losing enteropathy|protein-losing enteropathy
5490105|NCT01336790|Vascular Anomalies|vascular anomalies
5490106|NCT01336777|obesity|obesity
5490107|NCT01336777|adipocyte differentiation|adipocyte differentiation
5490108|NCT01336777|inflammation|inflammation
5490109|NCT01336777|insulin resistance|insulin resistance
5490110|NCT01336777|visceral fat|visceral fat
5490111|NCT01336777|regional fat depots|regional fat depots
5490112|NCT01336764|driving distress|driving distress
5490113|NCT01336764|veterans|veterans
5490114|NCT01336764|OEF/OIF|oef/oif
5490115|NCT01336738|Phase 2|phase 2
5490116|NCT01336738|safety and efficacy study with PF-04991532|safety and efficacy study with pf-04991532
5490117|NCT01336738|Type 2 diabetes|type 2 diabetes
5490118|NCT01336725|Morbid obesity|morbid obesity
5490119|NCT01336725|Patient education|patient education
5490120|NCT01336712|CML|cml
5490121|NCT01336712|CLL|cll
5490122|NCT01336712|AML|aml
5490123|NCT01336712|ALL|all
5490124|NCT01336712|MDS|mds
5490125|NCT01336712|HD|hd
5490126|NCT01336712|NHL|nhl
5490127|NCT01336712|MFB|mfb
5490128|NCT01336712|P.vera|p.vera
5490129|NCT01336712|Essential Thrombocytosis|essential thrombocytosis
5490130|NCT01336699|Shigella sonnei|shigella sonnei
5490131|NCT01336699|shigellosis|shigellosis
5490132|NCT01336699|vaccine|vaccine
5490133|NCT01336699|WRSs2|wrss2
5490134|NCT01336699|WRSs3|wrss3
5490135|NCT01336673|Glucophage XR|glucophage xr
5490136|NCT01336673|Tolerability|tolerability
5490137|NCT01336660|Effectiveness|effectiveness
5490138|NCT01336660|New Antivenom|new antivenom
5490139|NCT01336660|North Africa and Middle East Scorpio Envenomation|north africa and middle east scorpio envenomation
5490140|NCT01336634|BRAF V600E|braf v600e
5490141|NCT01336634|trametinib|trametinib
5490142|NCT01336634|dabrafenib|dabrafenib
5490143|NCT01336634|GSK2118436|gsk2118436
5490144|NCT01336634|GSK1120212|gsk1120212
5490145|NCT01336634|Oncology|oncology
5490146|NCT01336634|Non-Small Cell Lung Cancer|non-small cell lung cancer
5490147|NCT01336621|Partial-onset seizures|partial-onset seizures
5490148|NCT01336621|retigabine IR|retigabine ir
5490149|NCT01336621|Open Label Extension|open label extension
5490150|NCT01336621|GW582892|gw582892
5490151|NCT01336621|Epilepsy|epilepsy
5490152|NCT01336595|total knee arthroplasty|total knee arthroplasty
5490153|NCT01336595|oxidized zirconium|oxidized zirconium
5490154|NCT01336595|genesis II|genesis ii
5490155|NCT01336595|femoral component|femoral component
5490156|NCT01336595|cobalt chrome|cobalt chrome
5490157|NCT01336582|suitable candidate|suitable candidate
5490158|NCT01336582|single agent docetaxel therapy|single agent docetaxel therapy
5490159|NCT01336582|Advanced Solid Tumor|advanced solid tumor
5490160|NCT01336569|Primary Open-Angle Glaucoma|primary open-angle glaucoma
5490161|NCT01336569|Ocular Hypertension|ocular hypertension
5490162|NCT01336569|Pigment Dispersion Glaucoma|pigment dispersion glaucoma
5490164|NCT01336556|Oral appliance|oral appliance
5490165|NCT01336556|Continuous positive airway pressure|continuous positive airway pressure
5490168|NCT01336543|Non small cell lung cancer|non small cell lung cancer
5490169|NCT01336543|Inoperable Stage III|inoperable stage iii
5490170|NCT01336543|Inoperable|inoperable
5490171|NCT01336543|Stage III|stage iii
5490172|NCT01336530|Oesophageal pain|oesophageal pain
5490173|NCT01336530|Radiotherapy|radiotherapy
5490174|NCT01336530|Combined radio-chemotherapy|combined radio-chemotherapy
5490175|NCT01336530|Oesophageal symptoms|oesophageal symptoms
5490177|NCT01336517|Hemiplegia|hemiplegia
5490178|NCT01336517|AFO|afo
5490179|NCT01336517|Gait|gait
5490180|NCT01336478|NK|nk
5490181|NCT01336478|natural killer|natural killer
5490182|NCT01336478|immunotherapy|immunotherapy
5490183|NCT01336478|leukemia|leukemia
5490184|NCT01336478|hematological malignancies|hematological malignancies
5490185|NCT01336478|stem cell transplantation|stem cell transplantation
5490186|NCT01336478|adoptive therapy|adoptive therapy
5490187|NCT01336439|Bruxism|bruxism
5490188|NCT01336439|Polysomnography|polysomnography
5490189|NCT01336439|Botulinum toxin type A|botulinum toxin type a
5490190|NCT01336439|Masseter muscle|masseter muscle
5490191|NCT01336439|Temporal muscle|temporal muscle
5490192|NCT01336426|Peripheral Artery Disease|peripheral artery disease
5490194|NCT01336413|brain injuries, traumatic|brain injuries, traumatic
5490195|NCT01336413|pregnenolone|pregnenolone
5490196|NCT01336413|Veteran|veteran
5490197|NCT01336413|OEF/OIF|oef/oif
5490198|NCT01336413|neurosteroid|neurosteroid
5490199|NCT01336413|allopregnanolone|allopregnanolone
5490200|NCT01336400|Single cell haplotyping|single cell haplotyping
5490201|NCT01336400|Preimplantation genetic diagnosis|preimplantation genetic diagnosis
5490202|NCT01336361|Palliative Care|palliative care
5490203|NCT01336361|Physical Therapy|physical therapy
5490204|NCT01336361|Functionally Dependent Elderly|functionally dependent elderly
5490205|NCT01336348|Prasugrel|prasugrel
5490206|NCT01336348|Tirofiban|tirofiban
5490207|NCT01336348|Clopidogrel|clopidogrel
5490208|NCT01336348|glycoprotein IIa/IIIa inhibitors|glycoprotein iia/iiia inhibitors
5490209|NCT01336348|P2Y12 blockers|p2y12 blockers
5490210|NCT01336335|sleep apnea, obstructive|sleep apnea, obstructive
5490211|NCT01336335|sympathetic nerve activity|sympathetic nerve activity
5490212|NCT01336335|treatment|treatment
5490213|NCT01336322|beta-cell function|beta-cell function
5490214|NCT01336322|insulin resistance|insulin resistance
5490215|NCT01336309|Yoga|yoga
5490216|NCT01336283|COPD|copd
5490217|NCT01336283|Exercise Training|exercise training
5490218|NCT01336270|Melanoma|melanoma
5490219|NCT01336270|NK cells|nk cells
5490220|NCT01336270|T lymphocytes|t lymphocytes
5490221|NCT01336270|macrophages|macrophages
5490222|NCT01336257|Decision Support Techniques|decision support techniques
5490223|NCT01336257|Electronic Health Records|electronic health records
5490224|NCT01336257|Reminder Systems|reminder systems
5490225|NCT01336257|Early Detection of Cancer|early detection of cancer
5490226|NCT01336257|Mammography|mammography
5490227|NCT01336257|Women|women
5490228|NCT01336244|Safety|safety
5490229|NCT01336244|Tolerability|tolerability
5490230|NCT01336244|Pharmacokinetics|pharmacokinetics
5490231|NCT01336231|quality of life|quality of life
5490232|NCT01336231|cognitive functions|cognitive functions
5490233|NCT01336231|antiangiogenic agents|antiangiogenic agents
5490234|NCT01336231|kidney cancer|kidney cancer
5490235|NCT01336231|metastatic|metastatic
5490236|NCT01336218|Phase 1|phase 1
5490237|NCT01336218|healthy volunteers|healthy volunteers
5490238|NCT01336218|Rheumatoid arthritis|rheumatoid arthritis
5490240|NCT01336218|Fostamatinib|fostamatinib
5490241|NCT01336218|Rifampicin|rifampicin
5490242|NCT01336218|drug-drug interaction|drug-drug interaction
5490243|NCT01336218|Pharmacokinetics|pharmacokinetics
5490244|NCT01336218|Amount of Rifampicin in blood|amount of rifampicin in blood
5490245|NCT01336205|Non-Cancer-Related Pain|non-cancer-related pain
5490246|NCT01336205|Opioid-Induced Constipation|opioid-induced constipation
5490248|NCT01336192|Maintenance therapy|maintenance therapy
5490249|NCT01336192|Gemcitabine|gemcitabine
5490250|NCT01336179|gingivitis|gingivitis
5490251|NCT01336179|dental plaque|dental plaque
5490252|NCT01336179|oral hygiene|oral hygiene
5490253|NCT01336179|toothbrush|toothbrush
5490254|NCT01336179|chewing sticks|chewing sticks
5490255|NCT01336166|H1N1|h1n1
5490256|NCT01336166|Vaccine|vaccine
5490257|NCT01336166|Immunogenicity|immunogenicity
5490258|NCT01336166|Safety|safety
5490259|NCT01336153|Safety|safety
5490260|NCT01336153|Efficacy|efficacy
5490261|NCT01336153|MLC601|mlc601
5490262|NCT01336153|motor recovery|motor recovery
5490263|NCT01336140|regadenoson|regadenoson
5490264|NCT01336140|chronic kidney disease|chronic kidney disease
5490265|NCT01336140|renal failure|renal failure
5490266|NCT01336140|lexiscan|lexiscan
5490267|NCT01336140|aminophylline|aminophylline
5490268|NCT01336140|SPECT|spect
5490269|NCT01336140|Myocardial Perfusion Imaging|myocardial perfusion imaging
5490270|NCT01336140|pharmacologic stress test|pharmacologic stress test
5490271|NCT01336140|Patients with stage IV or V chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (Lexiscan ®)|patients with stage iv or v chronic kidney disease being assessed with nuclear stress testing of the heart using the stress agent regadenoson (lexiscan ®)
5490272|NCT01336127|Occupational Therapy|occupational therapy
5490273|NCT01336127|Parkinson's Disease|parkinson's disease
5490275|NCT01336127|RCT|rct
5490276|NCT01336127|Activities of daily living|activities of daily living
5490277|NCT01336127|Participation|participation
5490278|NCT01336127|Caregiver's Burden|caregiver's burden
5490279|NCT01336127|Economic evaluation|economic evaluation
5490280|NCT01336101|PAD|pad
5490281|NCT01336101|SFA|sfa
5490282|NCT01336088|dyskinesia|dyskinesia
5490283|NCT01336088|Parkinson's disease|parkinson's disease
5490284|NCT01336075|Percutaneous radiofrequency catheter ablation|percutaneous radiofrequency catheter ablation
5490285|NCT01336075|Mini invasive thoracoscopic radiofrequency ablation|mini invasive thoracoscopic radiofrequency ablation
5490286|NCT01336062|advanced|advanced
5490287|NCT01336062|resistant to prior chemotherapy|resistant to prior chemotherapy
5490288|NCT01336010|Hepatitis C|hepatitis c
5490289|NCT01336010|Acute Hepatitis C|acute hepatitis c
5490290|NCT01336010|Early chronic Hepatitis C|early chronic hepatitis c
5490291|NCT01335997|Low-density lipoprotein|low-density lipoprotein
5490292|NCT01335997|LDL|ldl
5490293|NCT01335997|High-density lipoprotein|high-density lipoprotein
5490294|NCT01335997|HDL|hdl
5490295|NCT01335997|Niacin|niacin
5490296|NCT01335997|Lipid modifying therapy|lipid modifying therapy
5490297|NCT01335997|Cholesterol|cholesterol
5490298|NCT01335997|High cholesterol|high cholesterol
5490299|NCT01335997|Triglycerides|triglycerides
5490300|NCT01335984|telemonitoring|telemonitoring
5490301|NCT01335984|usual care|usual care
5490302|NCT01335984|telemedicine|telemedicine
5490303|NCT01335984|telehealth|telehealth
5490304|NCT01335984|home care|home care
5490305|NCT01335984|Health Care Quality|health care quality
5490306|NCT01335984|Access|access
5490307|NCT01335984|Evaluation|evaluation
5490308|NCT01335971|COPD|copd
5490309|NCT01335971|Nrf2|nrf2
5490310|NCT01335971|Sulforaphane|sulforaphane
5490311|NCT01335945|Cryoablation|cryoablation
5490312|NCT01335945|Cryotherapy|cryotherapy
5490313|NCT01335945|Cryosurgery|cryosurgery
5490314|NCT01335945|Pancreas|pancreas
5490315|NCT01335945|Pancreatic Cancer|pancreatic cancer
5490316|NCT01335945|Celiac Plexus|celiac plexus
5490317|NCT01335945|Pain|pain
5490318|NCT01335945|Abdominal pain|abdominal pain
5490319|NCT01335932|Acute Lung Injury|acute lung injury
5490320|NCT01335932|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5490321|NCT01335932|Respiratory Failure|respiratory failure
5490322|NCT01335932|Cytomegalovirus seropositive|cytomegalovirus seropositive
5490323|NCT01335932|Infection|infection
5490324|NCT01335932|Intravenous Ganciclovir|intravenous ganciclovir
5490325|NCT01335932|Non-immunocompromised|non-immunocompromised
5490326|NCT01335932|Valganciclovir|valganciclovir
5490327|NCT01335919|Hemoglobin|hemoglobin
5490328|NCT01335919|Monitoring, Physiologic|monitoring, physiologic
5490329|NCT01335919|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
5490330|NCT01335906|Cancer Screening Tests|cancer screening tests
5490331|NCT01335906|Early Diagnosis of Cancer|early diagnosis of cancer
5490332|NCT01335906|Mammography|mammography
5490333|NCT01335906|Informed Consent|informed consent
5490334|NCT01335906|Consent Forms|consent forms
5490335|NCT01335893|Imaging|imaging
5490336|NCT01335893|Indocyanine Green|indocyanine green
5490337|NCT01335893|Lung Cancer|lung cancer
5490338|NCT01335893|Lung Neoplasms|lung neoplasms
5490339|NCT01335893|Preliminary Study|preliminary study
5490340|NCT01335880|Obesity|obesity
5490341|NCT01335880|Heart Disease|heart disease
5490342|NCT01335880|Seniors|seniors
5490343|NCT01335880|Elderly|elderly
5490344|NCT01335880|Chronic Disease|chronic disease
5490345|NCT01335880|Prevention|prevention
5490346|NCT01335854|Apnea-hypopnea index|apnea-hypopnea index
5490347|NCT01335854|Continuous positive airway pressure|continuous positive airway pressure
5490348|NCT01335854|CPAP adherence|cpap adherence
5490350|NCT01335828|Elastography|elastography
5490351|NCT01335828|Thyroid nodules|thyroid nodules
5490352|NCT01335828|Needles punction|needles punction
5490353|NCT01335828|Thyroid surgery|thyroid surgery
5490354|NCT01335828|Patients with thyroids nodules|patients with thyroids nodules
5490355|NCT01335802|Abortion, Spontaneous|abortion, spontaneous
5490356|NCT01335802|Pre-eclampsia|pre-eclampsia
5490357|NCT01335802|Gestational hypertension|gestational hypertension
5490358|NCT01335802|Pregnancy Complications|pregnancy complications
5490359|NCT01335802|Subclinical hypothyroidism|subclinical hypothyroidism
5490360|NCT01335802|Thyroperoxidase antibodies (TPOab)|thyroperoxidase antibodies (tpoab)
5490361|NCT01335802|Mitochondrial dysfunction|mitochondrial dysfunction
5490362|NCT01335789|marijuana|marijuana
5490363|NCT01335789|substance abuse|substance abuse
5490364|NCT01335789|drug abuse|drug abuse
5490366|NCT01335789|drug addiction|drug addiction
5490367|NCT01335776|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5490368|NCT01335776|Cognitive Behavior Therapy|cognitive behavior therapy
5490369|NCT01335776|Actigraphy|actigraphy
5490370|NCT01335776|Noninferiority|noninferiority
5490371|NCT01335776|MBSR|mbsr
5490372|NCT01335776|CBT-I|cbt-i
5490373|NCT01335763|HbA1c|hba1c
5490374|NCT01335763|Multicentre before-after design|multicentre before-after design
5490375|NCT01335763|Glycemic control|glycemic control
5490376|NCT01335763|Community pharmacists|community pharmacists
5490377|NCT01335750|corneal staining|corneal staining
5490378|NCT01335698|Pediatric|pediatric
5490379|NCT01335685|Drug Therapy|drug therapy
5490380|NCT01335672|Myocardial infarction|myocardial infarction
5490381|NCT01335672|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5490382|NCT01335672|General Practice Research Database|general practice research database
5490383|NCT01335672|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5490385|NCT01335659|FFR|ffr
5490386|NCT01335659|IVUS|ivus
5490387|NCT01335659|QCA|qca
5490388|NCT01335633|MS|ms
5490389|NCT01335633|Neuropsychological tests|neuropsychological tests
5490390|NCT01335620|HIV|hiv
5490391|NCT01335620|Pharmatokinetic|pharmatokinetic
5490392|NCT01335620|60 years old|60 years old
5490393|NCT01335620|Raltegravir|raltegravir
5490395|NCT01335607|Hepatitis C Virus|hepatitis c virus
5490396|NCT01335594|Sleep apnea, obstructive|sleep apnea, obstructive
5490397|NCT01335594|Deglutition Disorders|deglutition disorders
5490398|NCT01335594|Manometry|manometry
5490399|NCT01335594|Endoscopy|endoscopy
5490400|NCT01335568|Hepatocyte|hepatocyte
5490401|NCT01335568|Scaffold|scaffold
5490402|NCT01335568|Matrix|matrix
5490403|NCT01335568|Liver cirrhosis|liver cirrhosis
5490404|NCT01335568|Liver insufficiency|liver insufficiency
5490405|NCT01335529|HCV infection|hcv infection
5490406|NCT01335529|HIV-1 infection|hiv-1 infection
5490407|NCT01335503|gluten|gluten
5490408|NCT01335451|AZD5213|azd5213
5490409|NCT01335451|safety|safety
5490410|NCT01335451|pharmacokinetics|pharmacokinetics
5490411|NCT01335451|single dose|single dose
5490412|NCT01335451|repeated dose|repeated dose
5490413|NCT01335451|young|young
5490414|NCT01335451|elderly|elderly
5490415|NCT01335451|Japanese|japanese
5490416|NCT01335451|healthy subject|healthy subject
5490417|NCT01335438|total knee arthroplasty|total knee arthroplasty
5490418|NCT01335438|cemented|cemented
5490419|NCT01335438|cementless|cementless
5490420|NCT01335438|fixation|fixation
5490421|NCT01335438|posterior stabilized|posterior stabilized
5490422|NCT01335438|cruciate retaining|cruciate retaining
5490423|NCT01335425|Language problems|language problems
5490424|NCT01335425|childhood epilepsy|childhood epilepsy
5490425|NCT01335425|bening (rolandic) epilepsy (of childhood) with centro temporal spikes|bening (rolandic) epilepsy (of childhood) with centro temporal spikes
5490426|NCT01335425|brain maturation|brain maturation
5490427|NCT01335425|structral connectivity|structral connectivity
5490428|NCT01335425|functional connectivity|functional connectivity
5490429|NCT01335399|Newly Diagnosed|newly diagnosed
5490430|NCT01335399|Previously Untreated|previously untreated
5490431|NCT01335373|Vaginal candidiasis|vaginal candidiasis
5490432|NCT01335373|Bacterial vaginosis (also known as non-specific, or Gardnerellosis, or anaerobic vaginosis)|bacterial vaginosis (also known as non-specific, or gardnerellosis, or anaerobic vaginosis)
5490433|NCT01335373|Trichomonal vaginitis|trichomonal vaginitis
5490434|NCT01335373|Vaginitis due to mixed infection|vaginitis due to mixed infection
5490435|NCT01335360|nevirapine|nevirapine
5490436|NCT01335360|pharmacokinetics|pharmacokinetics
5490437|NCT01335347|Influenza|influenza
5490438|NCT01335347|pandemic|pandemic
5490439|NCT01335347|avian influenza|avian influenza
5490440|NCT01335347|H5N1|h5n1
5490441|NCT01335347|flu|flu
5490442|NCT01335334|Effectiveness|effectiveness
5490443|NCT01335334|eradication|eradication
5490444|NCT01335334|Asymptomatic|asymptomatic
5490445|NCT01335321|viscosupplementation|viscosupplementation
5490446|NCT01335321|intra-articular injection|intra-articular injection
5490447|NCT01335321|hyaluronic acid|hyaluronic acid
5490448|NCT01335321|osteoarthritis|osteoarthritis
5490449|NCT01335321|knee|knee
5490450|NCT01335308|Pediatric Obesity|pediatric obesity
5490451|NCT01335308|Motivational Interviewing|motivational interviewing
5490452|NCT01335308|Overweight|overweight
5490453|NCT01335308|Behavior Change|behavior change
5490454|NCT01335295|Flavocoxid|flavocoxid
5490455|NCT01335295|Duchenne muscular dystrophy|duchenne muscular dystrophy
5490456|NCT01335295|pilot study|pilot study
5490457|NCT01335256|Phase I, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule|phase i, dose escalation, kinase inhibitor, cyclin-dependent kinase inhibitor, target therapy, small molecule
5490458|NCT01335243|Orthopedic Procedures|orthopedic procedures
5490459|NCT01335243|Spine|spine
5490460|NCT01335243|Interbody fusion|interbody fusion
5490461|NCT01335243|Arthrodesis|arthrodesis
5490462|NCT01335243|Lumbar Vertebrae|lumbar vertebrae
5490463|NCT01335243|CT Scan|ct scan
5490464|NCT01335243|Spine balance|spine balance
5490465|NCT01335243|Instrumented fusion|instrumented fusion
5490466|NCT01335243|Posterior fusion|posterior fusion
5490467|NCT01335243|Degenerative spine|degenerative spine
5490468|NCT01335243|painful|painful
5490471|NCT01335230|Hepatitis C|hepatitis c
5490472|NCT01335230|HIV and Hepatitis C coinfection|hiv and hepatitis c coinfection
5490473|NCT01335230|HIV/HCV|hiv/hcv
5490474|NCT01335217|Depression|depression
5490475|NCT01335217|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5490476|NCT01335217|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5490477|NCT01335217|Post Traumatic Stress Disorder|post traumatic stress disorder
5490478|NCT01335204|Castration-resistant prostate cancer|castration-resistant prostate cancer
5475018|NCT01400620|chemoradiation|chemoradiation
5490479|NCT01335204|Prostate Cancer|prostate cancer
5490480|NCT01335204|JEVTANA|jevtana
5490481|NCT01335204|Cabazitaxel|cabazitaxel
5490482|NCT01335204|Bavituximab|bavituximab
5490484|NCT01335191|vaccine|vaccine
5490485|NCT01335191|lipopeptide|lipopeptide
5490487|NCT01335191|TUTI-16|tuti-16
5490488|NCT01335191|THYMON|thymon
5490489|NCT01335178|Tobacco smoke exposure|tobacco smoke exposure
5490490|NCT01335178|Secondhand smoke exposure|secondhand smoke exposure
5490491|NCT01335178|Passive smoking|passive smoking
5490492|NCT01335178|Child health|child health
5490493|NCT01335178|Prevention|prevention
5490494|NCT01335178|Tobacco control|tobacco control
5490495|NCT01335178|Motivational Interviewing|motivational interviewing
5490496|NCT01335178|Air quality|air quality
5490497|NCT01335178|Pilot Study|pilot study
5490498|NCT01335165|PNH|pnh
5490499|NCT01335152|stress|stress
5490500|NCT01335152|depression|depression
5490501|NCT01335152|anxiety|anxiety
5490502|NCT01335152|web|web
5490503|NCT01335152|internet|internet
5490504|NCT01335152|coping|coping
5490505|NCT01335139|sublingual immunotherapy|sublingual immunotherapy
5490506|NCT01335139|subcutaneous immunotherapy|subcutaneous immunotherapy
5490507|NCT01335126|Artificial tears|artificial tears
5490508|NCT01335100|Functional outcome|functional outcome
5490509|NCT01335100|Quality of life|quality of life
5490510|NCT01335100|Global Positioning System (GPS)|global positioning system (gps)
5490511|NCT01335100|Advanced tracking technologies|advanced tracking technologies
5490512|NCT01335100|Time-space activity.|time-space activity.
5490513|NCT01335100|walking speed|walking speed
5490514|NCT01335100|distances|distances
5490515|NCT01335100|number of walking events and destinations|number of walking events and destinations
5490516|NCT01335087|sleep apnea|sleep apnea
5490517|NCT01335087|secondary prevention|secondary prevention
5490518|NCT01335087|cardiovascular endpoint|cardiovascular endpoint
5490519|NCT01335061|Hemophilia B|hemophilia b
5490520|NCT01335061|on-demand|on-demand
5490521|NCT01335061|prophylaxis|prophylaxis
5490522|NCT01335061|nonacog alfa|nonacog alfa
5490523|NCT01335061|BeneFIX|benefix
5490524|NCT01335061|FIX|fix
5490525|NCT01335048|Clopidogrel|clopidogrel
5490526|NCT01335048|Statins|statins
5490527|NCT01335048|Platelet reactivity|platelet reactivity
5490528|NCT01335048|Point-of-care platelet function test|point-of-care platelet function test
5490529|NCT01335035|Iron metabolism,|iron metabolism,
5490530|NCT01335035|Allogenetic Hematopoietic Stem Cell Transplant,|allogenetic hematopoietic stem cell transplant,
5490531|NCT01335035|haematological diseases|haematological diseases
5490532|NCT01335009|melanoma|melanoma
5490533|NCT01335009|malignant|malignant
5490534|NCT01335009|metastatic|metastatic
5490535|NCT01334983|cancer|cancer
5490536|NCT01334983|function|function
5490537|NCT01334983|fatigue|fatigue
5490538|NCT01334983|late stage|late stage
5490539|NCT01334983|metastases|metastases
5490540|NCT01334983|quality of life|quality of life
5490541|NCT01334983|functional decline in cancer|functional decline in cancer
5490542|NCT01334944|Pain|pain
5490543|NCT01334944|Fever|fever
5490544|NCT01334931|Exposure to Ionizing Radiation|exposure to ionizing radiation
5490545|NCT01334931|Occupational Exposure to Radiation|occupational exposure to radiation
5490546|NCT01334918|pharmacologic stress|pharmacologic stress
5490547|NCT01334918|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5490548|NCT01334918|regadenoson|regadenoson
5490549|NCT01334918|ischemia|ischemia
5490550|NCT01334905|Overactive Bladder|overactive bladder
5490553|NCT01334905|mirabegron|mirabegron
5490554|NCT01334905|Food effect|food effect
5490555|NCT01334879|radiation|radiation
5490556|NCT01334879|retinopathy|retinopathy
5490557|NCT01334879|anti-VEGF|anti-vegf
5490558|NCT01334879|eye|eye
5490559|NCT01334866|Minimally invasive coronary surgery|minimally invasive coronary surgery
5490560|NCT01334866|Coronary artery bypass grafting|coronary artery bypass grafting
5490561|NCT01334866|MICS CABG|mics cabg
5490562|NCT01334840|Cardiovascular risk|cardiovascular risk
5490563|NCT01334840|Cholecystokinin|cholecystokinin
5490564|NCT01334840|Gallbladder emptying|gallbladder emptying
5490565|NCT01334840|Lipid absorption|lipid absorption
5490566|NCT01334840|Postprandial triacylglycerols|postprandial triacylglycerols
5493514|NCT01322386|PSC|psc
5490567|NCT01334840|Sodium-bicarbonated mineral water|sodium-bicarbonated mineral water
5490568|NCT01334827|topical microbicide|topical microbicide
5490569|NCT01334827|primary prevention|primary prevention
5490571|NCT01334827|AIDS|aids
5490572|NCT01334827|drug delivery systems|drug delivery systems
5490573|NCT01334801|aortic stenosis|aortic stenosis
5490574|NCT01334801|von Willebrand factor|von willebrand factor
5490575|NCT01334801|mitral valve replacement|mitral valve replacement
5490576|NCT01334801|aortic valve replacement|aortic valve replacement
5490577|NCT01334801|prosthetic valve dysfunction|prosthetic valve dysfunction
5490578|NCT01334801|brain natriuretic peptide|brain natriuretic peptide
5490579|NCT01334801|mitral valve regurgitation|mitral valve regurgitation
5490580|NCT01334801|aortic valve regurgitation|aortic valve regurgitation
5490581|NCT01334801|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5490582|NCT01334801|tricuspid insufficiency|tricuspid insufficiency
5490583|NCT01334788|sleep deprivation|sleep deprivation
5490584|NCT01334788|sleep restriction|sleep restriction
5490585|NCT01334775|Inguinal hernia|inguinal hernia
5490586|NCT01334775|Postoperative pain|postoperative pain
5490587|NCT01334775|Surgical mesh|surgical mesh
5490588|NCT01334762|minimal to mild endometriosis|minimal to mild endometriosis
5490589|NCT01334762|letrozole|letrozole
5490590|NCT01334762|clomiphene citrate|clomiphene citrate
5490591|NCT01334762|IUI|iui
5490592|NCT01334749|Stroke|stroke
5490593|NCT01334749|Dementia|dementia
5490594|NCT01334749|Dementia, Vascular|dementia, vascular
5490595|NCT01334749|Alzheimer's Disease|alzheimer's disease
5490596|NCT01334749|Intracranial Hemorrhage|intracranial hemorrhage
5490597|NCT01334749|Brain Ischemia|brain ischemia
5490598|NCT01334736|smoking cessation|smoking cessation
5490599|NCT01334736|contingency management|contingency management
5490600|NCT01334736|spirometry|spirometry
5490601|NCT01334736|lung age|lung age
5472556|NCT01410565|NMIBC|nmibc
5789999|NCT00146211|mild|mild
5790000|NCT00146211|moderate|moderate
5490602|NCT01334723|Benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention|benign prostatic hyperplasia, enlarged prostate, 5-alpha-reductase inhibitor, adherence, surgery, acute urinary retention
5490603|NCT01334710|Liver cancer|liver cancer
5490604|NCT01334697|Cardiotrophin-1|cardiotrophin-1
5490606|NCT01334684|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5490607|NCT01334684|Metformin Efficacy|metformin efficacy
5490608|NCT01334684|Gene Expression Profiles|gene expression profiles
5490609|NCT01334684|Personalized Medicine|personalized medicine
5490610|NCT01334671|ST-elevation myocardial infarction(STEMI)|st-elevation myocardial infarction(stemi)
5490611|NCT01334671|emergency percutaneous coronary intervention(PCI)|emergency percutaneous coronary intervention(pci)
5490612|NCT01334671|lipitor or Atorvastatin|lipitor or atorvastatin
5490613|NCT01334658|Corneal endothelium|corneal endothelium
5490614|NCT01334658|Cataract surgery|cataract surgery
5490615|NCT01334658|Irrigation solutions intraocular|irrigation solutions intraocular
5490616|NCT01334658|Phacoemulsification|phacoemulsification
5490617|NCT01334645|Copeptin|copeptin
5490618|NCT01334645|Troponin|troponin
5490619|NCT01334645|Diagnosis|diagnosis
5490620|NCT01334645|Chest pain|chest pain
5490621|NCT01334645|Acute Coronary Syndrome|acute coronary syndrome
5490622|NCT01334645|Acute Myocardial Infarction|acute myocardial infarction
5490623|NCT01334645|Unstable Angina|unstable angina
5490624|NCT01334632|Electrophysiological study|electrophysiological study
5490625|NCT01334632|Nerve block|nerve block
5490626|NCT01334632|Analgesia, patient-controlled|analgesia, patient-controlled
5490627|NCT01334632|Shoulder surgery|shoulder surgery
5490628|NCT01334619|Anesthetic techniques,regional|anesthetic techniques,regional
5490629|NCT01334619|Drug delivery,volume|drug delivery,volume
5490630|NCT01334619|Anesthetic, local: ropivacaine|anesthetic, local: ropivacaine
5490631|NCT01334606|diabetes|diabetes
5490632|NCT01334606|pen needle|pen needle
5490633|NCT01334606|basal insulin|basal insulin
5490634|NCT01334606|long-acting insulin|long-acting insulin
5490635|NCT01334554|African American|african american
5490636|NCT01334554|Women|women
5490637|NCT01334554|Metabolic Syndrome|metabolic syndrome
5490638|NCT01334554|Endothelial function|endothelial function
5490639|NCT01334554|Sildenafil citrate|sildenafil citrate
5490640|NCT01334528|Deployment Acquired Mild Traumatic Brain Injury|deployment acquired mild traumatic brain injury
5490641|NCT01334528|Persistent Post-Concussive Symptoms|persistent post-concussive symptoms
5490645|NCT01334502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5490646|NCT01334502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5490647|NCT01334489|Monochorionic pregnancy|monochorionic pregnancy
5490648|NCT01334489|Twin to twin transfusion syndrome|twin to twin transfusion syndrome
5490649|NCT01334489|Cervical pessary|cervical pessary
5490650|NCT01334489|Cervical lenght|cervical lenght
5490651|NCT01334476|Data Repository|data repository
5490652|NCT01334476|Facilitate Recruitment of Participants for Ongoing and Future Research|facilitate recruitment of participants for ongoing and future research
5490653|NCT01334450|Improvement of ADAS-COG|improvement of adas-cog
5490655|NCT01334437|ovarian cancer|ovarian cancer
5490656|NCT01334437|Associated Auto Antibodies|associated auto antibodies
5490657|NCT01334424|Robot assisted laparoscopic radical prostatectomy|robot assisted laparoscopic radical prostatectomy
5490658|NCT01334424|Hypoperfusion reperfusion injury,|hypoperfusion reperfusion injury,
5490659|NCT01334424|Propofol|propofol
5490660|NCT01334424|oxidative stress|oxidative stress
5490661|NCT01334398|Traumatic Brain Injury|traumatic brain injury
5490662|NCT01334372|suicide|suicide
5490663|NCT01334372|veterans|veterans
5490664|NCT01334372|assessment|assessment
5490665|NCT01334372|CAMS|cams
5490666|NCT01334359|physical activity|physical activity
5490667|NCT01334359|fitness|fitness
5490668|NCT01334359|brain health|brain health
5490669|NCT01334359|cognition|cognition
5490670|NCT01334359|scholastic achievement|scholastic achievement
5490671|NCT01334359|preadolescent children|preadolescent children
5490672|NCT01334346|Running|running
5490673|NCT01334346|Footwear|footwear
5490674|NCT01334346|Injury incidence|injury incidence
5490675|NCT01334346|injury risk|injury risk
5490676|NCT01334346|pain|pain
5490677|NCT01334333|kidney transplant|kidney transplant
5490678|NCT01334333|tacrolimus|tacrolimus
5490679|NCT01334333|medication adherence|medication adherence
5490680|NCT01334333|depression|depression
5490681|NCT01334333|neuropsychological|neuropsychological
5490682|NCT01334333|cognition|cognition
5490683|NCT01334333|Self-efficacy|self-efficacy
5490684|NCT01334333|everyday problem solving|everyday problem solving
5490685|NCT01334320|oral squamous cell carcinoma|oral squamous cell carcinoma
5490686|NCT01334320|elective neck dissection|elective neck dissection
5490687|NCT01334320|"watchful waiting"|"watchful waiting"
5490688|NCT01334320|survival benefit|survival benefit
5490689|NCT01334320|recurrence rate|recurrence rate
5490690|NCT01334307|Emphysema|emphysema
5490691|NCT01334307|RePneu|repneu
5490692|NCT01334294|CNV|cnv
5490693|NCT01334294|AMD|amd
5490694|NCT01334281|Panel Reactive Antibody (PRA)|panel reactive antibody (pra)
5490695|NCT01334281|Sensitization|sensitization
5490696|NCT01334281|Organ Transplant|organ transplant
5490697|NCT01334268|In-stent Late Lumen Loss (LLL)|in-stent late lumen loss (lll)
5490698|NCT01334268|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5490699|NCT01334268|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5490700|NCT01334268|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5490701|NCT01334268|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5490702|NCT01334268|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5490703|NCT01334268|STENT THROMBOSIS|stent thrombosis
5490704|NCT01334268|RESTENOTIC LESION|restenotic lesion
5490705|NCT01334268|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5490706|NCT01334268|REAL-WORLD|real-world
5490707|NCT01334268|THE RANDOMIZED CONTROLLED TRIAL|the randomized controlled trial
5490708|NCT01334255|Pigment epithelial detachment|pigment epithelial detachment
5490709|NCT01334255|Exudative age-related macular degeneration|exudative age-related macular degeneration
5490710|NCT01334255|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5490711|NCT01334242|Pharmacodynamics|pharmacodynamics
5490712|NCT01334229|sitagliptin|sitagliptin
5490713|NCT01334229|diabetes|diabetes
5490714|NCT01334229|apolipoprotein B48 and B100|apolipoprotein b48 and b100
5490715|NCT01334216|smoking|smoking
5490716|NCT01334216|quitting|quitting
5490717|NCT01334216|tobacco|tobacco
5490718|NCT01334216|Parental|parental
5490719|NCT01334203|Chronic angina|chronic angina
5490720|NCT01334203|Angina pectoris|angina pectoris
5490721|NCT01334203|Coronary artery disease|coronary artery disease
5490722|NCT01334203|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5490724|NCT01334190|AE adverse event|ae adverse event
5490725|NCT01334190|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5490726|NCT01334190|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5490727|NCT01334190|ART antiretroviral therapy|art antiretroviral therapy
5484934|NCT01358422|aspirin alone therapy|aspirin alone therapy
5490728|NCT01334190|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5490729|NCT01334190|DCF data collection forms|dcf data collection forms
5490730|NCT01334190|DMC Data Monitoring Committee|dmc data monitoring committee
5490731|NCT01334190|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5490732|NCT01334190|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5490733|NCT01334190|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5490734|NCT01334190|ICH International Conference of Harmonisation|ich international conference of harmonisation
5490735|NCT01334190|IND Investigational New Drug Application|ind investigational new drug application
5490736|NCT01334190|IRB Institutional Review Board|irb institutional review board
5490737|NCT01334190|IU international units|iu international units
5490738|NCT01334190|mg milligram(s)|mg milligram(s)
5490739|NCT01334190|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5490740|NCT01334190|PCR polymerase chain reaction|pcr polymerase chain reaction
5490741|NCT01334190|SAE serious adverse event|sae serious adverse event
5490742|NCT01334190|µg microgram|µg microgram
5490743|NCT01334190|ULN upper limit of the normal range|uln upper limit of the normal range
5490744|NCT01334190|WB Western Blot|wb western blot
5490745|NCT01334190|post-marketing monitoring|post-marketing monitoring
5490747|NCT01334190|efficacy|efficacy
5490748|NCT01334190|acceptability|acceptability
5490749|NCT01334164|substance use disorder|substance use disorder
5490750|NCT01334164|offenders|offenders
5490751|NCT01334164|reentry|reentry
5490752|NCT01334164|HIV risk behavior|hiv risk behavior
5490753|NCT01334164|recidivism|recidivism
5490754|NCT01334138|hypertension|hypertension
5490755|NCT01334138|sodium|sodium
5490756|NCT01334138|diet|diet
5490757|NCT01334125|Double Diabetes|double diabetes
5490758|NCT01334125|Type 1 diabetes|type 1 diabetes
5490759|NCT01334125|Type 2 diabetes|type 2 diabetes
5490760|NCT01334125|Obesity|obesity
5490761|NCT01334125|Acanthosis nigricans|acanthosis nigricans
5490762|NCT01334125|Diabetes associated autoantibodies|diabetes associated autoantibodies
5490763|NCT01334112|Hepatocellular Carcinoma|hepatocellular carcinoma
5490764|NCT01334112|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5490765|NCT01334112|Liver Cancer|liver cancer
5490766|NCT01334112|Axitinib|axitinib
5490767|NCT01334112|AG-013736|ag-013736
5490768|NCT01334086|AML|aml
5490769|NCT01334073|Phase I|phase i
5490770|NCT01334073|Axitinib|axitinib
5490771|NCT01334073|Everolimus|everolimus
5490772|NCT01334073|Maximum tolerated dose (MTD)|maximum tolerated dose (mtd)
5490773|NCT01334073|solid tumor|solid tumor
5490774|NCT01334073|Renal cell cancer (RCC)|renal cell cancer (rcc)
5490775|NCT01334073|Pharmacokinetics (PK/PD)|pharmacokinetics (pk/pd)
5490776|NCT01334008|Circulating tumor DNA|circulating tumor dna
5490777|NCT01334008|Choroidal Melanoma|choroidal melanoma
5490778|NCT01333995|Peer counselling|peer counselling
5490779|NCT01333995|Infant|infant
5490780|NCT01333995|Intervention|intervention
5490781|NCT01333995|breastfeeding|breastfeeding
5490782|NCT01333995|complementary feeding|complementary feeding
5490783|NCT01333995|stunting|stunting
5490784|NCT01333982|Neonatal Sepsis|neonatal sepsis
5490785|NCT01333982|Evaluation|evaluation
5490786|NCT01333982|Bangladesh|bangladesh
5490787|NCT01333982|Drying|drying
5490788|NCT01333982|Wrapping|wrapping
5490789|NCT01333982|Bathing|bathing
5490790|NCT01333943|Total Knee Replacement|total knee replacement
5490791|NCT01333943|Regional Anesthesia|regional anesthesia
5490792|NCT01333943|Quadriceps|quadriceps
5490793|NCT01333943|Muscle Strength|muscle strength
5490794|NCT01333943|Muscle Strength Dynamometer|muscle strength dynamometer
5490795|NCT01333943|Quadriceps muscle strength after regional anesthesia for TKA|quadriceps muscle strength after regional anesthesia for tka
5490796|NCT01333930|immunological effects|immunological effects
5490797|NCT01333930|Active O2|active o2
5490798|NCT01333930|strenuous exercise|strenuous exercise
5490799|NCT01333930|procedures|procedures
5490800|NCT01333930|pharmacodynamic parameters|pharmacodynamic parameters
5490801|NCT01333930|blood sampling scheme|blood sampling scheme
5490802|NCT01333917|Curcumin|curcumin
5490803|NCT01333917|Colorectal Cancer|colorectal cancer
5490804|NCT01333917|GWAS|gwas
5490805|NCT01333865|Memantine|memantine
5490806|NCT01333865|Namenda|namenda
5490807|NCT01333865|Autism Spectrum Disorders|autism spectrum disorders
5490808|NCT01333865|Pervasive Developmental Disorders|pervasive developmental disorders
5490809|NCT01333865|Adults|adults
5490810|NCT01333852|head and neck cancer|head and neck cancer
5490811|NCT01333852|paclitaxel|paclitaxel
5490812|NCT01333852|metformin|metformin
5490813|NCT01333852|squamous cell carcinoma|squamous cell carcinoma
5490814|NCT01333839|CABG surgery|cabg surgery
5490815|NCT01333839|exercise intervention|exercise intervention
5490816|NCT01333839|insulin sensitivity|insulin sensitivity
5490817|NCT01333839|muscle mass|muscle mass
5490818|NCT01333813|immune response|immune response
5490819|NCT01333813|Engerix-B™Kinder|engerix-b™kinder
5490820|NCT01333813|Persistence|persistence
5490821|NCT01333813|challenge dose|challenge dose
5490822|NCT01333787|dietary fiber|dietary fiber
5490823|NCT01333787|clinical trial|clinical trial
5490825|NCT01333787|children|children
5490826|NCT01333774|Diabetes|diabetes
5490827|NCT01333774|Acarbose|acarbose
5490828|NCT01333774|Diet|diet
5490829|NCT01333774|Compliance|compliance
5490830|NCT01333774|Advising|advising
5490831|NCT01333761|right to left cardiac shunt finding|right to left cardiac shunt finding
5490832|NCT01333748|breast cancer|breast cancer
5490833|NCT01333748|ovarian cancer|ovarian cancer
5490834|NCT01333748|BRCA 1 and BRCA 2|brca 1 and brca 2
5490835|NCT01333735|cognitive functions|cognitive functions
5490836|NCT01333735|quality of life|quality of life
5490837|NCT01333735|breast cancer|breast cancer
5490838|NCT01333735|chemotherapy|chemotherapy
5490839|NCT01333735|ages patients|ages patients
5490840|NCT01333709|locally advanced rectal carcinoma|locally advanced rectal carcinoma
5490841|NCT01333709|Tailored treatment strategy|tailored treatment strategy
5490842|NCT01333709|MRI volumetry|mri volumetry
5490843|NCT01333709|Early tumor response|early tumor response
5490844|NCT01333696|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5490846|NCT01333683|tinnitus|tinnitus
5490847|NCT01333683|hearing loss|hearing loss
5490848|NCT01333683|arterial hypertension|arterial hypertension
5490850|NCT01333657|sTREM-1|strem-1
5490851|NCT01333657|sepsis|sepsis
5490852|NCT01333657|SIRS|sirs
5490853|NCT01333657|blood|blood
5490854|NCT01333657|urine|urine
5490855|NCT01333657|diagnosis|diagnosis
5490856|NCT01333657|prognosis|prognosis
5490857|NCT01333644|HIV Infection|hiv infection
5490858|NCT01333644|Endothelial function|endothelial function
5490859|NCT01333644|Cardiovascular Disease|cardiovascular disease
5490860|NCT01333644|Inflammation|inflammation
5490861|NCT01333644|Antiretroviral medication|antiretroviral medication
5490862|NCT01333644|Treatment naive|treatment naive
5490863|NCT01333644|Treatment experienced|treatment experienced
5490864|NCT01333631|Locally advanced unresectable pancreatic cancer|locally advanced unresectable pancreatic cancer
5490865|NCT01333618|Filter Tilt|filter tilt
5490866|NCT01333618|Preventional efficiency|preventional efficiency
5490867|NCT01333618|Günther Tulip filter|günther tulip filter
5490868|NCT01333618|Transfemoral Approach|transfemoral approach
5490869|NCT01333605|Hodgkin lymphoma|hodgkin lymphoma
5490870|NCT01333605|Chemotherapy|chemotherapy
5490871|NCT01333605|IGEV|igev
5490872|NCT01333605|Autologous stem cell transplantation|autologous stem cell transplantation
5490873|NCT01333592|Type 2 diabetes|type 2 diabetes
5490874|NCT01333592|HbA1c|hba1c
5490875|NCT01333592|Long-term study|long-term study
5490876|NCT01333553|birthmark|birthmark
5490877|NCT01333540|constipation|constipation
5490878|NCT01333540|opioid induced|opioid induced
5490879|NCT01333514|diabetes|diabetes
5490880|NCT01333514|prandial|prandial
5490881|NCT01333514|insulin|insulin
5490882|NCT01333514|aspart|aspart
5490883|NCT01333514|carbohydrate|carbohydrate
5490884|NCT01333514|inpatient|inpatient
5490885|NCT01333514|novolog|novolog
5490886|NCT01333501|Multiple sclerosis|multiple sclerosis
5490887|NCT01333501|cognitive symptoms|cognitive symptoms
5490888|NCT01333501|relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5490889|NCT01333501|fingolimod|fingolimod
5490890|NCT01333501|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5490891|NCT01333488|Traumatic|traumatic
5490892|NCT01333488|Brain|brain
5490893|NCT01333488|Injury|injury
5490894|NCT01333475|Targeted Therapy|targeted therapy
5490895|NCT01333475|KRAS Mutation|kras mutation
5490896|NCT01333475|Metastatic Colorectal Cancer|metastatic colorectal cancer
5490897|NCT01333475|Colorectal Cancer|colorectal cancer
5490898|NCT01333449|Decitabine|decitabine
5490899|NCT01333449|MDS, myelodysplastic syndrome|mds, myelodysplastic syndrome
5490900|NCT01333449|prospective open label, phaseII|prospective open label, phaseii
5490901|NCT01333449|Allogeneic Hematopoietic cell transplant|allogeneic hematopoietic cell transplant
5490902|NCT01333423|Breast Cancer|breast cancer
5490903|NCT01333423|Metastatic Triple Negative|metastatic triple negative
5490904|NCT01333423|ER/PR/HER2 negative|er/pr/her2 negative
5490905|NCT01333423|Locally advanced|locally advanced
5490906|NCT01333423|Stage IV|stage iv
5490907|NCT01333423|Metastatic|metastatic
5490908|NCT01333423|Seliciclib|seliciclib
5490909|NCT01333423|Liposomal Doxorubicin|liposomal doxorubicin
5490910|NCT01333423|Doxil|doxil
5490911|NCT01333423|Doxorubicin Hydrochloride (Liposomal)|doxorubicin hydrochloride (liposomal)
5490912|NCT01333410|vitiligo|vitiligo
5490913|NCT01333410|tacrolimus|tacrolimus
5490914|NCT01333410|mometasone furoate|mometasone furoate
5490915|NCT01333371|Distal Radius|distal radius
5490916|NCT01333371|Volar locked plating|volar locked plating
5490917|NCT01333371|Cost Effectiveness|cost effectiveness
5490918|NCT01333371|Randomization|randomization
5490919|NCT01333371|Outcomes|outcomes
5490920|NCT01333358|Relapsing|relapsing
5490921|NCT01333358|remitting|remitting
5490922|NCT01333345|Cataract replacement surgery|cataract replacement surgery
5490923|NCT01333345|implantation|implantation
5490924|NCT01333345|EC-3 IOL|ec-3 iol
5490925|NCT01333332|Pancreas|pancreas
5490926|NCT01333332|Radiation|radiation
5490927|NCT01333319|liver transplantation|liver transplantation
5490928|NCT01333319|acute kidney injury|acute kidney injury
5490929|NCT01333306|tDCS|tdcs
5490930|NCT01333306|cognitive training|cognitive training
5490931|NCT01333293|mastocytosis|mastocytosis
5490932|NCT01333293|omalizumab|omalizumab
5490933|NCT01333267|Endocrine System Diseases|endocrine system diseases
5490934|NCT01333267|MusculoSkeletal System Disease|musculoskeletal system disease
5490935|NCT01333267|Hormones|hormones
5490936|NCT01333267|Postmenopausal Women|postmenopausal women
5490937|NCT01333267|Bone metabolism|bone metabolism
5490938|NCT01333267|Physiologic Properties|physiologic properties
5490939|NCT01333267|African-Americans|african-americans
5490940|NCT01333254|urinary tract infections|urinary tract infections
5490941|NCT01333254|urinary catheterisation|urinary catheterisation
5490942|NCT01333241|Hispanic/Latina Americans|hispanic/latina americans
5490943|NCT01333241|Cardiovascular diseases|cardiovascular diseases
5490945|NCT01333241|Intervention|intervention
5490946|NCT01333215|Suicide, Attempted|suicide, attempted
5490947|NCT01333215|Cognitive Symptoms|cognitive symptoms
5490948|NCT01333202|Fresh lime|fresh lime
5490949|NCT01333202|nicotine gum|nicotine gum
5490950|NCT01333202|smoking cessation|smoking cessation
5490951|NCT01333202|craving|craving
5490952|NCT01333189|total knee arthroplasty|total knee arthroplasty
5490953|NCT01333189|osteoarthritis|osteoarthritis
5490954|NCT01333189|biomechanics|biomechanics
5490955|NCT01333189|gait|gait
5490956|NCT01333176|Type 2 Diabetes|type 2 diabetes
5490957|NCT01333176|Hb A1c screening for diabetes in aboriginals|hb a1c screening for diabetes in aboriginals
5490958|NCT01333150|Temporomandibular disorders|temporomandibular disorders
5490959|NCT01333150|Orofacial pain|orofacial pain
5490960|NCT01333137|Triple negative breast cancer|triple negative breast cancer
5490961|NCT01333124|Preoperative chemoradiotherapy with Gemcitabine|preoperative chemoradiotherapy with gemcitabine
5490962|NCT01333098|anxiety|anxiety
5490963|NCT01333098|older adult|older adult
5490964|NCT01333098|memory|memory
5490965|NCT01333098|cognitive|cognitive
5490966|NCT01333098|Saint Louis|saint louis
5490967|NCT01333098|treatment|treatment
5490968|NCT01333098|cognitive impariment|cognitive impariment
5490969|NCT01333085|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5490970|NCT01333085|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5490971|NCT01333085|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5490972|NCT01333085|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5490973|NCT01333085|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5490974|NCT01333085|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5490975|NCT01333085|tongue cancer|tongue cancer
5490976|NCT01333072|Autistic Disorder|autistic disorder
5490977|NCT01333059|Sedation|sedation
5490979|NCT01333059|Pediatric|pediatric
5490980|NCT01333046|Hodgkin Lymphoma|hodgkin lymphoma
5490981|NCT01333046|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5490983|NCT01333033|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5490984|NCT01333033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5490985|NCT01333033|stage IB esophageal cancer|stage ib esophageal cancer
5490986|NCT01333033|stage IIA esophageal cancer|stage iia esophageal cancer
5490987|NCT01333033|stage IIB esophageal cancer|stage iib esophageal cancer
5490988|NCT01333033|stage IIIA esophageal cancer|stage iiia esophageal cancer
5490989|NCT01333033|stage IIIB esophageal cancer|stage iiib esophageal cancer
5490990|NCT01333033|stage IIIC esophageal cancer|stage iiic esophageal cancer
5490991|NCT01333020|emulsion|emulsion
5490992|NCT01333020|protein|protein
5490993|NCT01333020|cross-linking|cross-linking
5490994|NCT01333020|gastric emptying|gastric emptying
5490995|NCT01332955|Hepatitis C, Chronic|hepatitis c, chronic
5490996|NCT01332955|HIV Infection|hiv infection
5490997|NCT01332955|Telaprevir|telaprevir
5490998|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a
5490999|NCT01332955|Ribavirin|ribavirin
5491000|NCT01332955|Pharmacokinetic|pharmacokinetic
5491001|NCT01332955|Pharmacogenetic|pharmacogenetic
5491002|NCT01332955|Previous peginterferon-ribavirin regimen failure|previous peginterferon-ribavirin regimen failure
5491003|NCT01332942|Anemia|anemia
5491004|NCT01332929|brain radiation therapy|brain radiation therapy
5491005|NCT01332929|Bevacizumab|bevacizumab
5491006|NCT01332929|brain metastasis|brain metastasis
5491007|NCT01332929|solid tumor|solid tumor
5491008|NCT01332916|No metastatic breast cancer|no metastatic breast cancer
5491009|NCT01332916|cognitive troubles|cognitive troubles
5491010|NCT01332916|adjuvant chemotherapy|adjuvant chemotherapy
5491011|NCT01332890|Drug interaction|drug interaction
5491012|NCT01332890|revaprazan|revaprazan
5491013|NCT01332890|Itopride HCI|itopride hci
5491014|NCT01332877|Obesity|obesity
5491015|NCT01332877|Weight loss|weight loss
5491016|NCT01332877|Ghrelin|ghrelin
5491017|NCT01332877|Satiety|satiety
5491018|NCT01332877|Hunger|hunger
5491019|NCT01332864|headache|headache
5491020|NCT01332864|migraine|migraine
5491021|NCT01332864|cephalgia|cephalgia
5491022|NCT01332864|osteopathic manipulative treatment|osteopathic manipulative treatment
5491023|NCT01332851|child welfare|child welfare
5491024|NCT01332851|child protective services|child protective services
5491025|NCT01332851|child abuse|child abuse
5491026|NCT01332851|child neglect|child neglect
5491027|NCT01332851|infant|infant
5491028|NCT01332851|parenting|parenting
5491029|NCT01332825|olfaction|olfaction
5491030|NCT01332825|smell dysfunction|smell dysfunction
5491031|NCT01332812|Dexamethasone|dexamethasone
5491032|NCT01332812|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5491033|NCT01332812|General Anesthesia|general anesthesia
5491034|NCT01332812|neuropsychological tests|neuropsychological tests
5491035|NCT01332799|cardiovascular disease|cardiovascular disease
5477240|NCT01390818|Phase I|phase i
5491036|NCT01332799|kidney transplantation|kidney transplantation
5491037|NCT01332786|AML|aml
5491038|NCT01332760|ergonomics|ergonomics
5491039|NCT01332760|workplace|workplace
5491040|NCT01332760|occupational|occupational
5491041|NCT01332760|tool|tool
5491042|NCT01332760|dental|dental
5491043|NCT01332760|dentist|dentist
5491045|NCT01332747|TG|tg
5491046|NCT01332747|HDL|hdl
5491047|NCT01332747|LDL|ldl
5491048|NCT01332747|VLDL|vldl
5491049|NCT01332734|microcirculation|microcirculation
5491050|NCT01332734|SDF|sdf
5491051|NCT01332734|magnesium sulfate|magnesium sulfate
5491052|NCT01332721|TRC105|trc105
5491053|NCT01332721|CD105|cd105
5491054|NCT01332721|Endoglin|endoglin
5491055|NCT01332721|Solid Tumors|solid tumors
5491056|NCT01332721|Avastin|avastin
5491057|NCT01332721|Bevacizumab|bevacizumab
5491058|NCT01332708|high complex carbohydrates|high complex carbohydrates
5491059|NCT01332708|hypocaloric diet|hypocaloric diet
5475621|NCT01397942|Type 2 diabetes|type 2 diabetes
5491060|NCT01332708|cholinergic status|cholinergic status
5491061|NCT01332708|overweight|overweight
5491062|NCT01332708|obese|obese
5491063|NCT01332695|tremor|tremor
5491064|NCT01332695|WHIGET|whiget
5491065|NCT01332695|Fahn Tolosa Marin Scale|fahn tolosa marin scale
5491066|NCT01332682|head and neck cancer|head and neck cancer
5491067|NCT01332682|resistance training|resistance training
5491068|NCT01332682|nutrition counseling|nutrition counseling
5491069|NCT01332682|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
5491070|NCT01332669|hepatocellular carcinoma|hepatocellular carcinoma
5491071|NCT01332669|chemoembolization|chemoembolization
5491072|NCT01332669|drug eluting beads|drug eluting beads
5491073|NCT01332669|HCC|hcc
5491074|NCT01332669|Liver cancer|liver cancer
5491075|NCT01332669|Korea|korea
5491076|NCT01332643|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5491077|NCT01332643|recurrent pregnancy loss|recurrent pregnancy loss
5491078|NCT01332643|infertility|infertility
5491079|NCT01332643|genetic screening|genetic screening
5491080|NCT01332643|trisomy 21|trisomy 21
5491081|NCT01332643|Down syndrome|down syndrome
5491082|NCT01332630|Breast cancer|breast cancer
5491083|NCT01332630|Brain metastases|brain metastases
5491084|NCT01332630|TPI 287|tpi 287
5491085|NCT01332630|Computed Tomography|computed tomography
5491086|NCT01332630|CT|ct
5491087|NCT01332630|Magnetic Resonance Imaging|magnetic resonance imaging
5491088|NCT01332630|MRI|mri
5491089|NCT01332617|Multiple Myeloma|multiple myeloma
5491090|NCT01332617|Simvastatin|simvastatin
5491091|NCT01332617|Zoledronic|zoledronic
5491092|NCT01332617|Bortezomib|bortezomib
5491093|NCT01332617|Bendamustine|bendamustine
5491094|NCT01332617|Methylprednisolone|methylprednisolone
5491095|NCT01332591|STEMI, primary PCI, non-infarct, non-culprit lesion, CABG|stemi, primary pci, non-infarct, non-culprit lesion, cabg
5491096|NCT01332565|GSK1349572|gsk1349572
5491097|NCT01332565|pharmacokinetics|pharmacokinetics
5491098|NCT01332565|Japanese|japanese
5491099|NCT01332565|HIV|hiv
5491100|NCT01332552|pharmacokinetics|pharmacokinetics
5491101|NCT01332552|First administration to human|first administration to human
5491102|NCT01332552|antiviral activity|antiviral activity
5491103|NCT01332552|safety|safety
5491104|NCT01332552|hepatitis C|hepatitis c
5491105|NCT01332526|FFT|fft
5491106|NCT01332526|inflammation|inflammation
5491107|NCT01332526|lipid metabolism|lipid metabolism
5491108|NCT01332526|hyperuricemia|hyperuricemia
5491109|NCT01332526|Agents Affecting Uric Acid Metabolism|agents affecting uric acid metabolism
5491110|NCT01332513|Healthy Volunteers|healthy volunteers
5491111|NCT01332500|Triptans|triptans
5491112|NCT01332500|Migraine|migraine
5491113|NCT01332487|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5491114|NCT01332487|prostate surgery|prostate surgery
5491115|NCT01332487|alpha-blocker|alpha-blocker
5491116|NCT01332487|enlarged prostate|enlarged prostate
5491117|NCT01332487|acute urinary retention|acute urinary retention
5491118|NCT01332487|Benign prostatic hyperplasia|benign prostatic hyperplasia
5491119|NCT01332474|Botox|botox
5491120|NCT01332474|JCP|jcp
5491121|NCT01332448|Xenical|xenical
5491122|NCT01332448|Alli|alli
5491123|NCT01332448|safety|safety
5491124|NCT01332448|meta-analysis|meta-analysis
5491125|NCT01332448|liver-function test|liver-function test
5491126|NCT01332448|Roche|roche
5491128|NCT01332435|Enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs|enlarged prostate, 5-alpha-reductase inhibitor, alpha-blocker, early, costs
5491129|NCT01332370|Retrospective|retrospective
5491130|NCT01332370|Type 2 Diabetes|type 2 diabetes
5491131|NCT01332370|Cost Analysis|cost analysis
5491132|NCT01332370|Rosiglitazone|rosiglitazone
5491134|NCT01332357|fluticasone/propionate salmeterol combination|fluticasone/propionate salmeterol combination
5491135|NCT01332357|hospitalization|hospitalization
5491136|NCT01332357|emergency department|emergency department
5491137|NCT01332357|asthma|asthma
5491138|NCT01332344|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
5491139|NCT01332344|Asthma|asthma
5491140|NCT01332344|inhaled corticosteroids|inhaled corticosteroids
5491141|NCT01332344|outcomes|outcomes
5491142|NCT01332331|pulmonary arterial hypertension|pulmonary arterial hypertension
5491143|NCT01332331|pediatric|pediatric
5491144|NCT01332292|inhalation profiles|inhalation profiles
5491145|NCT01332292|pharmacokinetics|pharmacokinetics
5491146|NCT01332292|pharyngometry|pharyngometry
5491147|NCT01332292|asthma|asthma
5491148|NCT01332292|pediatric subjects|pediatric subjects
5491150|NCT01332292|Fluticasone furoate|fluticasone furoate
5491151|NCT01332292|safety|safety
5491152|NCT01332266|Cancer|cancer
5491153|NCT01332266|head and neck|head and neck
5491154|NCT01332266|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5491155|NCT01332266|phase I|phase i
5491156|NCT01332266|phase II|phase ii
5491157|NCT01332253|Tonsillectomy, Pediatric|tonsillectomy, pediatric
5491158|NCT01332240|staging|staging
5491159|NCT01332240|endosonography|endosonography
5491160|NCT01332240|lung cancer|lung cancer
5491161|NCT01332240|stage III|stage iii
5491162|NCT01332214|Phase 1|phase 1
5491163|NCT01332214|healthy male volunteers|healthy male volunteers
5491164|NCT01332214|dose escalation|dose escalation
5491165|NCT01332214|pharmacokinetics|pharmacokinetics
5491166|NCT01332214|Single Ascending Dose|single ascending dose
5491167|NCT01332214|AZD2820 Cmax|azd2820 cmax
5491168|NCT01332214|tmax|tmax
5491169|NCT01332214|t1/2λz|t1/2λz
5491170|NCT01332201|Advagraf|advagraf
5491171|NCT01332201|Heart|heart
5491172|NCT01332201|Lung|lung
5491173|NCT01332201|Pancreas|pancreas
5491174|NCT01332201|Transplant|transplant
5491175|NCT01332201|Immunosuppression|immunosuppression
5491176|NCT01332201|Pharmacokinetics|pharmacokinetics
5491177|NCT01332162|Hypertrophic Obstructive Cardiomyopathy (HOCM)|hypertrophic obstructive cardiomyopathy (hocm)
5491178|NCT01332162|Pacing|pacing
5491179|NCT01332149|Diabetic Neuropathies|diabetic neuropathies
5491180|NCT01332149|Pain|pain
5491181|NCT01332149|Efficacy of pregabalin|efficacy of pregabalin
5491182|NCT01332149|Placebo controlled|placebo controlled
5491183|NCT01332110|Footwear|footwear
5491184|NCT01332110|Motion Analysis|motion analysis
5491185|NCT01332110|Running Injury|running injury
5491186|NCT01332097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5491187|NCT01332097|Exacerbation|exacerbation
5491188|NCT01332097|Pulmonary Inflammation|pulmonary inflammation
5491189|NCT01332084|SOTI|soti
5491190|NCT01332084|tolerance|tolerance
5491191|NCT01332084|desensitization|desensitization
5491192|NCT01332084|challenge test|challenge test
5491193|NCT01332084|HA wheat cereals|ha wheat cereals
5491194|NCT01332071|Metformin|metformin
5491195|NCT01332071|Rosiglitazone|rosiglitazone
5491196|NCT01332071|Healthy volunteers|healthy volunteers
5491197|NCT01332071|Avandamet|avandamet
5491198|NCT01332071|Fed conditions|fed conditions
5491199|NCT01332071|Bioequivalence|bioequivalence
5491200|NCT01332058|Peripheral arterial disease|peripheral arterial disease
5491201|NCT01332058|Walking|walking
5491202|NCT01332058|Motivational Interviewing|motivational interviewing
5491203|NCT01332032|cost effectiveness|cost effectiveness
5491204|NCT01332032|screening mammography|screening mammography
5491205|NCT01332032|repeat mammography|repeat mammography
5491206|NCT01332032|telephone counseling|telephone counseling
5491207|NCT01332032|computerized reminders|computerized reminders
5491208|NCT01332032|compliance|compliance
5491209|NCT01332019|Subcutaneous|subcutaneous
5491210|NCT01332019|Extension|extension
5491211|NCT01332019|Interferon|interferon
5491212|NCT01332019|MS|ms
5491213|NCT01332019|PEGylated|pegylated
5491214|NCT01332019|Injectable|injectable
5491215|NCT01332019|SC|sc
5491216|NCT01332019|PEG|peg
5491217|NCT01332019|peginterferon beta-1a|peginterferon beta-1a
5491218|NCT01332019|Relapsing|relapsing
5491219|NCT01331993|Phase 1|phase 1
5491220|NCT01331993|crossover|crossover
5491221|NCT01331993|bioequivalence|bioequivalence
5491222|NCT01331993|naproxen|naproxen
5491223|NCT01331993|esomeprazole|esomeprazole
5491224|NCT01331993|vimovo|vimovo
5491225|NCT01331993|healthy volunteers|healthy volunteers
5491226|NCT01331980|cystic fibrosis|cystic fibrosis
5491227|NCT01331980|bone|bone
5491228|NCT01331967|pioglitazone|pioglitazone
5491229|NCT01331967|optical coherence tomography|optical coherence tomography
5491230|NCT01331967|microRNA|microrna
5491231|NCT01331967|neointima|neointima
5491232|NCT01331967|major adverse cardiovascular event|major adverse cardiovascular event
5491233|NCT01331941|AMG 386|amg 386
5491234|NCT01331941|Pharmacokinetic|pharmacokinetic
5491235|NCT01331941|Renal Impairment|renal impairment
5491236|NCT01331928|Sequential chemotherapy, gastric cancer|sequential chemotherapy, gastric cancer
5491237|NCT01331915|Metastatic Melanoma|metastatic melanoma
5491238|NCT01331915|Safety|safety
5491239|NCT01331915|Theravac vaccine|theravac vaccine
5491240|NCT01331915|HLA-A2 typing|hla-a2 typing
5491241|NCT01331915|Tyrosinase.A2 gene expression|tyrosinase.a2 gene expression
5491242|NCT01331902|Adenosine|adenosine
5491243|NCT01331902|Nicorandil|nicorandil
5491244|NCT01331902|Fractional Flow Reserve|fractional flow reserve
5491245|NCT01331902|Maximal Hyperemia|maximal hyperemia
5491246|NCT01331889|transfusion|transfusion
5491247|NCT01331889|liver transplantation|liver transplantation
5491248|NCT01331889|potassium|potassium
5491249|NCT01331876|Cognitive and Behavioral Therapy|cognitive and behavioral therapy
5491250|NCT01331863|Bronchial disease|bronchial disease
5491251|NCT01331863|Lung cancer surgery|lung cancer surgery
5491252|NCT01331863|Aorta/aortic Allograft|aorta/aortic allograft
5491253|NCT01331863|homograft|homograft
5491254|NCT01331863|Tracheal disease|tracheal disease
5491255|NCT01331863|Benign|benign
5491256|NCT01331863|Malignant|malignant
5491257|NCT01331824|Bladder Cancer|bladder cancer
5491258|NCT01331824|Urothelial Cancer|urothelial cancer
5491259|NCT01331824|Chemotherapy|chemotherapy
5491260|NCT01331824|Second-line|second-line
5491261|NCT01331824|Metastatic|metastatic
5491263|NCT01331811|Tuberculosis|tuberculosis
5491264|NCT01331811|Diagnosis|diagnosis
5475806|NCT01397084|rabeprazole 10mg|rabeprazole 10mg
5491265|NCT01331811|Pediatrics|pediatrics
5491266|NCT01331811|Asia|asia
5491267|NCT01331811|Africa|africa
5491268|NCT01331798|Abdominoplasty|abdominoplasty
5491269|NCT01331785|paracentesis|paracentesis
5491270|NCT01331785|ascites|ascites
5491271|NCT01331785|hypotension|hypotension
5491272|NCT01331772|Breast cancer|breast cancer
5491273|NCT01331772|Adapted Physical activity|adapted physical activity
5491274|NCT01331772|Nutrition|nutrition
5491275|NCT01331772|Assessment|assessment
5491276|NCT01331772|Patient education|patient education
5491277|NCT01331759|Burnout|burnout
5491278|NCT01331759|Subthreshold Disorder|subthreshold disorder
5491279|NCT01331707|drug-eluting stent|drug-eluting stent
5491280|NCT01331707|Zotarolimus|zotarolimus
5491281|NCT01331707|Everolimus|everolimus
5491282|NCT01331707|all comers population|all comers population
5491283|NCT01331707|target vessel failure|target vessel failure
5491284|NCT01331707|coronary artery disease|coronary artery disease
5491285|NCT01331681|Diabetic Macular Edema (DME)|diabetic macular edema (dme)
5491286|NCT01331681|VEGF Trap-Eye|vegf trap-eye
5491287|NCT01331681|Best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
5491288|NCT01331642|Gaucher Disease|gaucher disease
5491289|NCT01331642|Biomarker|biomarker
5491290|NCT01331629|breast cancer|breast cancer
5491291|NCT01331629|fatigue|fatigue
5491292|NCT01331629|quality of life|quality of life
5491293|NCT01331629|art-therapie|art-therapie
5491294|NCT01331629|adjuvant radiotherapy|adjuvant radiotherapy
5491295|NCT01331616|Prospective study|prospective study
5491296|NCT01331616|Glioblastoma|glioblastoma
5491297|NCT01331616|Avastin|avastin
5491298|NCT01331616|Visual Evoked Potential|visual evoked potential
5491299|NCT01331616|Optic neuropathy|optic neuropathy
5491300|NCT01331616|Chemo-radiotherapy|chemo-radiotherapy
5491302|NCT01331603|primary myelofibrosis|primary myelofibrosis
5491303|NCT01331603|low+high risk MDS patients|low+high risk mds patients
5491304|NCT01331603|patients|patients
5491305|NCT01331577|Healthy|healthy
5491306|NCT01331577|Primary Prevention|primary prevention
5491307|NCT01331577|Stress|stress
5491308|NCT01331577|Kinesiology|kinesiology
5491309|NCT01331577|cognitive behavioural therapy|cognitive behavioural therapy
5491310|NCT01331577|Prevention|prevention
5491311|NCT01331564|Pregnancy|pregnancy
5491312|NCT01331564|Postpartum|postpartum
5491313|NCT01331564|Weight gain|weight gain
5491314|NCT01331564|Weight retention|weight retention
5491315|NCT01331564|Behavior|behavior
5491316|NCT01331564|Electronic Media|electronic media
5491317|NCT01331564|Randomized Clinical Trial|randomized clinical trial
5491318|NCT01331551|Inflammatory Bowel disease|inflammatory bowel disease
5491319|NCT01331538|temporomandibular dysfunction|temporomandibular dysfunction
5491320|NCT01331538|posture|posture
5491321|NCT01331525|Small cell lung cancer|small cell lung cancer
5491322|NCT01331525|Chemotherapy|chemotherapy
5491323|NCT01331525|Immunotherapy|immunotherapy
5491324|NCT01331525|CTLA-4|ctla-4
5491325|NCT01331525|Ipilimumab|ipilimumab
5491326|NCT01331512|Clinical Geriatrics|clinical geriatrics
5491327|NCT01331512|Biomechanics|biomechanics
5491328|NCT01331512|Epidemiology|epidemiology
5491329|NCT01331512|Decline in Ambulation|decline in ambulation
5491330|NCT01331499|Blood loss|blood loss
5491331|NCT01331499|transfusions|transfusions
5491332|NCT01331499|instrumented spinal fusion|instrumented spinal fusion
5491333|NCT01331486|Prehypertension|prehypertension
5491335|NCT01331486|Flow mediated dilation|flow mediated dilation
5491336|NCT01331486|Hawthorn|hawthorn
5491337|NCT01331473|Carotid Artery|carotid artery
5491338|NCT01331473|Stenting|stenting
5491339|NCT01331473|CAS|cas
5491340|NCT01331473|proximal protection|proximal protection
5491341|NCT01331460|HIV|hiv
5491342|NCT01331460|HIV risk|hiv risk
5491343|NCT01331460|Sexually Transmitted Diseases|sexually transmitted diseases
5491344|NCT01331460|Drug Use|drug use
5491345|NCT01331460|Women|women
5491346|NCT01331460|Drug Treatment|drug treatment
5491347|NCT01331460|opioids|opioids
5491348|NCT01331460|injection drug use|injection drug use
5491349|NCT01331460|stimulants|stimulants
5491350|NCT01331460|gender-specific treatment|gender-specific treatment
5491351|NCT01331395|Infertility|infertility
5491352|NCT01331395|IVF|ivf
5491353|NCT01331395|Acupuncture|acupuncture
5491354|NCT01331382|Resveratrol|resveratrol
5491355|NCT01331382|Piperine|piperine
5491356|NCT01331382|Cerebral blood flow|cerebral blood flow
5491357|NCT01331382|Near- infrared spectroscopy|near- infrared spectroscopy
5491358|NCT01331382|Bioavailability|bioavailability
5491360|NCT01331369|compliance|compliance
5491361|NCT01331369|persistence|persistence
5491362|NCT01331369|drop out|drop out
5491363|NCT01331369|abandon|abandon
5491364|NCT01331356|Chronic proctalgia|chronic proctalgia
5491365|NCT01331356|Botulinum toxin type A|botulinum toxin type a
5491366|NCT01331356|Ganglion Impar|ganglion impar
5491367|NCT01331356|Perineal pain|perineal pain
5491368|NCT01331356|Pudendal neuralgia|pudendal neuralgia
5491369|NCT01331356|Refractory chronic proctalgia|refractory chronic proctalgia
5491370|NCT01331343|Diabetes|diabetes
5491371|NCT01331343|Glycemic Control|glycemic control
5491372|NCT01331343|Continuous Glucose Monitoring|continuous glucose monitoring
5491373|NCT01331330|Depressive Disorder|depressive disorder
5491374|NCT01331330|Unipolar|unipolar
5491375|NCT01331330|Implantable Stimulation Electrodes|implantable stimulation electrodes
5491376|NCT01331317|Cardiovascular disease and mortality|cardiovascular disease and mortality
5491377|NCT01331317|Plasma NTproBNP|plasma ntprobnp
5491378|NCT01331317|UAER|uaer
5491379|NCT01331304|Bipolar disorder|bipolar disorder
5491380|NCT01331304|Comparative effectiveness trial|comparative effectiveness trial
5491381|NCT01331304|Lithium|lithium
5491382|NCT01331304|Quetiapine|quetiapine
5491383|NCT01331291|bosutinib|bosutinib
5491384|NCT01331291|SKI-606|ski-606
5491385|NCT01331278|total joint replacement|total joint replacement
5491386|NCT01331278|knee|knee
5491582|NCT01330485|skills|skills
5491387|NCT01331265|perceived lactose intolerance|perceived lactose intolerance
5491388|NCT01331265|calcium/dairy consumption|calcium/dairy consumption
5491389|NCT01331265|specific health outcomes|specific health outcomes
5491390|NCT01331239|Cushing Disease|cushing disease
5491391|NCT01331239|LCI699|lci699
5491392|NCT01331239|Pituitary Gland|pituitary gland
5491393|NCT01331239|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5491394|NCT01331213|Pregabalin|pregabalin
5491395|NCT01331213|Irritable Bowel Syndrome|irritable bowel syndrome
5491396|NCT01331213|motor|motor
5491397|NCT01331213|sensation|sensation
5491398|NCT01331213|colon|colon
5491399|NCT01331213|human|human
5491400|NCT01331200|ischemic stroke|ischemic stroke
5491401|NCT01331200|tissue plasminogen activator|tissue plasminogen activator
5491402|NCT01331200|early mobilization|early mobilization
5491403|NCT01331200|patient safety|patient safety
5491404|NCT01331200|length of stay|length of stay
5491405|NCT01331187|Echocardiography|echocardiography
5491406|NCT01331187|Heart failure|heart failure
5491407|NCT01331187|Ultrasonography|ultrasonography
5491408|NCT01331187|pocket-size device|pocket-size device
5491409|NCT01331187|Aorta|aorta
5491410|NCT01331187|Education|education
5491411|NCT01331174|knee|knee
5491412|NCT01331174|osteoarthritis|osteoarthritis
5491413|NCT01331174|physical therapy|physical therapy
5491414|NCT01331174|pulsed short wave|pulsed short wave
5491415|NCT01331161|shingles vaccine|shingles vaccine
5491416|NCT01331161|immune responses|immune responses
5491417|NCT01331148|sickle cell disease|sickle cell disease
5491418|NCT01331148|vitamin D|vitamin d
5491419|NCT01331148|pediatrics|pediatrics
5491420|NCT01331148|pain|pain
5491421|NCT01331135|pediatrics|pediatrics
5491422|NCT01331135|sirolimus|sirolimus
5491423|NCT01331135|relapse|relapse
5491424|NCT01331109|Fibromyalgia|fibromyalgia
5491425|NCT01331109|Pediatric Fibromyalgia|pediatric fibromyalgia
5491426|NCT01331109|Adolescent Fibromyalgia|adolescent fibromyalgia
5491427|NCT01331109|milnacipran|milnacipran
5491428|NCT01331109|Savella|savella
5491429|NCT01331109|loss of therapeutic response|loss of therapeutic response
5491430|NCT01331109|Forest Research Institute|forest research institute
5491431|NCT01331109|Pain|pain
5491432|NCT01331109|Fatigue|fatigue
5491433|NCT01331109|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
5491434|NCT01331096|thyroid gland resection surgery|thyroid gland resection surgery
5491435|NCT01331096|total intravenous anesthesia|total intravenous anesthesia
5485678|NCT01355185|implants|implants
5491436|NCT01331070|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5491438|NCT01331057|Language|language
5491439|NCT01331057|Evaluation transcultural|evaluation transcultural
5491440|NCT01331057|Intra Familial Relationship|intra familial relationship
5491441|NCT01331057|Transmissions mother|transmissions mother
5491442|NCT01331057|Tongue french|tongue french
5491443|NCT01331057|Language tamil|language tamil
5491444|NCT01331057|Language arabic|language arabic
5491445|NCT01331057|Language soninke|language soninke
5491446|NCT01331057|Language cultural|language cultural
5491447|NCT01331057|Affiliations crossbreeding|affiliations crossbreeding
5491449|NCT01331044|Severe Acute Malnutrition|severe acute malnutrition
5491450|NCT01331044|Children|children
5491451|NCT01331044|Body composition|body composition
5491452|NCT01331044|Microbiota|microbiota
5491453|NCT01331044|Short Chain Fatty Acid|short chain fatty acid
5491454|NCT01331044|Acceptability of RUTF|acceptability of rutf
5491455|NCT01331044|Edema free 15 percent weight gain|edema free 15 percent weight gain
5491456|NCT01331044|Changes in body composition|changes in body composition
5491457|NCT01331044|Gut microbiota|gut microbiota
5491458|NCT01331044|Genome wide association|genome wide association
5491459|NCT01331031|temporomandibular disorder|temporomandibular disorder
5491460|NCT01331031|adolescents|adolescents
5491461|NCT01331005|Macular Edema|macular edema
5491462|NCT01331005|Non steroidal anti-inflammatories|non steroidal anti-inflammatories
5491463|NCT01330992|Circadian rhythms|circadian rhythms
5491464|NCT01330992|Melatonin|melatonin
5491465|NCT01330992|Ocular light exposure|ocular light exposure
5491466|NCT01330992|Darkness Exposure|darkness exposure
5491467|NCT01330992|Performance|performance
5491468|NCT01330992|Alertness|alertness
5491469|NCT01330979|Intraocular pressure|intraocular pressure
5491470|NCT01330966|surgically unresectable chondrosarcoma|surgically unresectable chondrosarcoma
5491471|NCT01330953|Anemia|anemia
5491472|NCT01330940|Kidney stones|kidney stones
5491473|NCT01330940|Calcium|calcium
5491474|NCT01330940|citrate|citrate
5491475|NCT01330927|VA106483|va106483
5491476|NCT01330927|Nocturia|nocturia
5491477|NCT01330927|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5491479|NCT01330927|Elderly|elderly
5491480|NCT01330927|Males|males
5491481|NCT01330927|Nocturnal voids|nocturnal voids
5491482|NCT01330927|Anti-diuretic|anti-diuretic
5491483|NCT01330914|Obesity, Morbid|obesity, morbid
5491484|NCT01330914|Bariatric Surgery|bariatric surgery
5491485|NCT01330914|Gastric Bypass|gastric bypass
5491486|NCT01330914|Calcium Metabolism Disorders|calcium metabolism disorders
5491487|NCT01330914|Vitamin D|vitamin d
5491488|NCT01330914|Bone Density|bone density
5491489|NCT01330914|Body Composition|body composition
5491490|NCT01330914|Weight Loss|weight loss
5491492|NCT01330888|religion|religion
5491493|NCT01330888|caregiver|caregiver
5491494|NCT01330888|combat stress disorder|combat stress disorder
5491495|NCT01330862|patient outcomes|patient outcomes
5790001|NCT00146211|Huntington's|huntington's
5491496|NCT01330849|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5491497|NCT01330849|School|school
5491498|NCT01330849|Behavioral Intervention|behavioral intervention
5491499|NCT01330849|RCT|rct
5491500|NCT01330823|pancreatic carcinoma|pancreatic carcinoma
5491501|NCT01330823|L-Carnitine|l-carnitine
5491502|NCT01330823|quality of life|quality of life
5491503|NCT01330823|survival|survival
5491504|NCT01330823|malnutrition|malnutrition
5491505|NCT01330823|cancer cachexia|cancer cachexia
5491506|NCT01330823|fatigue|fatigue
5491507|NCT01330810|Pharmacokinetics|pharmacokinetics
5491508|NCT01330810|Dietary Supplements|dietary supplements
5491509|NCT01330810|Curcumin|curcumin
5491510|NCT01330797|Cataract|cataract
5491511|NCT01330797|Intravitreal|intravitreal
5491512|NCT01330797|Ranibizumab|ranibizumab
5491513|NCT01330797|LOCS III|locs iii
5491514|NCT01330758|Phase I|phase i
5491515|NCT01330758|Healthy male and non-fertile female volunteers|healthy male and non-fertile female volunteers
5491516|NCT01330758|Bioavailability|bioavailability
5491517|NCT01330758|AZD8931|azd8931
5491518|NCT01330745|cardiopulmonary bypass|cardiopulmonary bypass
5491519|NCT01330745|mesenteric|mesenteric
5491520|NCT01330745|microcirculatory function|microcirculatory function
5491521|NCT01330732|SPINESCAN®|spinescan®
5491522|NCT01330732|kyphosis|kyphosis
5491523|NCT01330719|Periodontitis|periodontitis
5491524|NCT01330706|Skin Diseases [C17.800]|skin diseases [c17.800]
5491525|NCT01330706|Nail Diseases [C17.800.529]|nail diseases [c17.800.529]
5491526|NCT01330706|Nails, Ingrown [C17.800.529.406]|nails, ingrown [c17.800.529.406]
5491527|NCT01330693|ADHD|adhd
5491528|NCT01330693|Atomoxetine|atomoxetine
5491529|NCT01330693|Biomarker|biomarker
5491530|NCT01330680|coffee|coffee
5491531|NCT01330680|caffeine|caffeine
5491532|NCT01330680|blood pressure|blood pressure
5491533|NCT01330680|nutrigenetics|nutrigenetics
5491534|NCT01330680|gene polymorphisms|gene polymorphisms
5491535|NCT01330680|Acute Cardiovascular and Neuropsychologic Effects|acute cardiovascular and neuropsychologic effects
5491536|NCT01330667|Hyperbilirubinemia|hyperbilirubinemia
5491537|NCT01330667|Breastfeeding|breastfeeding
5491540|NCT01330654|Undergoing laparoscopic surgical procedure|undergoing laparoscopic surgical procedure
5491542|NCT01330641|Tendonitis|tendonitis
5491543|NCT01330641|Rotator Cuff|rotator cuff
5491544|NCT01330641|Shoulder|shoulder
5491545|NCT01330641|Injection|injection
5491546|NCT01330628|peripheral arterial disease|peripheral arterial disease
5491547|NCT01330628|in stent restenosis|in stent restenosis
5491548|NCT01330628|peripheral vascular disease|peripheral vascular disease
5491550|NCT01330615|plantar warts|plantar warts
5491551|NCT01330615|cryotherapy|cryotherapy
5491552|NCT01330589|Percutaneous coronary intervention|percutaneous coronary intervention
5491553|NCT01330589|Clopidogrel|clopidogrel
5491554|NCT01330589|St. John's Wort|st. john's wort
5491555|NCT01330589|CYP 2C19 loss-of-function allele|cyp 2c19 loss-of-function allele
5491556|NCT01330576|Hypothermia|hypothermia
5491557|NCT01330576|cooling|cooling
5491558|NCT01330576|necrotizing enterocolitis|necrotizing enterocolitis
5491559|NCT01330576|NEC|nec
5491560|NCT01330576|neonates|neonates
5491561|NCT01330576|preterm|preterm
5491562|NCT01330563|Drug-Drug interaction between the CKD-501 and ketoconazole|drug-drug interaction between the ckd-501 and ketoconazole
5491563|NCT01330550|High fiber sugar free biscuit|high fiber sugar free biscuit
5491564|NCT01330550|pre-diabetics|pre-diabetics
5491565|NCT01330537|perceptual development|perceptual development
5491566|NCT01330537|topological perception theory|topological perception theory
5491567|NCT01330537|familiarization/novelty preference method|familiarization/novelty preference method
5491568|NCT01330537|Discriminate a disk and a ring (topologically different),|discriminate a disk and a ring (topologically different),
5491569|NCT01330537|Discriminate a disk and a triangle (geometrically different)|discriminate a disk and a triangle (geometrically different)
5491570|NCT01330537|Detect a change in the number of holes|detect a change in the number of holes
5491571|NCT01330537|Detect the size of the hole|detect the size of the hole
5491572|NCT01330511|Newborn infant|newborn infant
5491573|NCT01330511|Congenital hydronephrosis|congenital hydronephrosis
5491574|NCT01330511|Postnatal imaging evaluation|postnatal imaging evaluation
5491575|NCT01330511|Diagnostic algorithm|diagnostic algorithm
5491576|NCT01330498|Longitudinal assessment of biomarkers|longitudinal assessment of biomarkers
5491577|NCT01330498|duration of natalizumab|duration of natalizumab
5491578|NCT01330498|stratification of risk for PML|stratification of risk for pml
5491579|NCT01330485|depression|depression
5491580|NCT01330485|emotion regulation|emotion regulation
5491581|NCT01330485|affect regulation|affect regulation
5491583|NCT01330485|randomized controlled trial|randomized controlled trial
5491584|NCT01330485|mediation|mediation
5491585|NCT01330472|Alprazolam|alprazolam
5491587|NCT01330472|Bioequivalence|bioequivalence
5491588|NCT01330472|Panic disorder with or without agoraphobia.|panic disorder with or without agoraphobia.
5491589|NCT01330459|Pain during first trimester surgical abortion|pain during first trimester surgical abortion
5491590|NCT01330446|Head and Neck Cancer|head and neck cancer
5491591|NCT01330446|HNC|hnc
5491592|NCT01330446|Fatigue|fatigue
5491593|NCT01330446|Patient-Reported Fatigue|patient-reported fatigue
5491594|NCT01330446|Fatigue-Symptom Intervention|fatigue-symptom intervention
5491595|NCT01330446|Postoperative Radiation Therapy|postoperative radiation therapy
5491596|NCT01330446|Postoperative Chemoradiation Therapy|postoperative chemoradiation therapy
5491597|NCT01330446|Armodafinil|armodafinil
5491598|NCT01330446|Nuvigil|nuvigil
5491599|NCT01330446|Placebo|placebo
5491600|NCT01330446|Sugar Pill|sugar pill
5491601|NCT01330446|Questionnaires|questionnaires
5491602|NCT01330446|Surveys|surveys
5491603|NCT01330394|Alcoholism|alcoholism
5491604|NCT01330394|Lesch's typology|lesch's typology
5491605|NCT01330394|tDCS|tdcs
5491606|NCT01330394|ERP|erp
5491607|NCT01330394|P300|p300
5491608|NCT01330394|FAB|fab
5491609|NCT01330394|MMSE|mmse
5491610|NCT01330394|Cognitive tasks|cognitive tasks
5491611|NCT01330368|Systemic Lupus Erythematosus|systemic lupus erythematosus
5491612|NCT01330368|SLE|sle
5491613|NCT01330368|Lupus|lupus
5491614|NCT01330368|children with SLE|children with sle
5491615|NCT01330355|Ocular infections, bacterial|ocular infections, bacterial
5491616|NCT01330329|Obesity|obesity
5491617|NCT01330329|Weight loss|weight loss
5491618|NCT01330329|Exercise|exercise
5491619|NCT01330329|Intervention studies|intervention studies
5491620|NCT01330303|Bioequivalence|bioequivalence
5491621|NCT01330303|Healthy volunteers|healthy volunteers
5491622|NCT01330303|tamsulosin hydrochloride|tamsulosin hydrochloride
5491623|NCT01330303|Fed administration|fed administration
5491624|NCT01330290|Rotigotine|rotigotine
5491625|NCT01330290|Neupro®|neupro®
5491626|NCT01330290|Parkinson|parkinson
5491627|NCT01330290|Treatment preference|treatment preference
5491628|NCT01330290|Care-giving|care-giving
5491629|NCT01330277|Hunter Disease|hunter disease
5491630|NCT01330277|Biomarker|biomarker
5491631|NCT01330264|Intracranial Pressure (ICP) Monitoring|intracranial pressure (icp) monitoring
5491632|NCT01330264|Admission to Intensive Care Unit (ICU)|admission to intensive care unit (icu)
5491633|NCT01330238|Low back pain|low back pain
5491634|NCT01330238|Modic changes|modic changes
5491635|NCT01330238|Vertebral endplate signal changes|vertebral endplate signal changes
5491637|NCT01330238|Zoledronic acid|zoledronic acid
5491638|NCT01330238|Bisphosphonates|bisphosphonates
5491639|NCT01330238|RCT|rct
5491640|NCT01330199|Healthy|healthy
5491641|NCT01330199|Female|female
5491642|NCT01330199|Volunteer|volunteer
5491643|NCT01330160|stroke|stroke
5491644|NCT01330160|Brain ischemia|brain ischemia
5491645|NCT01330160|Intracranial hemorrhage|intracranial hemorrhage
5491646|NCT01330160|Dementia, Vascular|dementia, vascular
5491647|NCT01330160|Alzheimer's disease|alzheimer's disease
5491648|NCT01330147|HPV|hpv
5491649|NCT01330147|oral cancer|oral cancer
5491650|NCT01330147|oropharyngeal cancer|oropharyngeal cancer
5491651|NCT01330147|tonsillectomy|tonsillectomy
5491652|NCT01330134|procedural|procedural
5491653|NCT01330121|Adherence with discharge diabetes medications|adherence with discharge diabetes medications
5491654|NCT01330121|Diabeted mellitus type 2 greater than one year|diabeted mellitus type 2 greater than one year
5491655|NCT01330121|Patient with provider and prescriptions filled within CCHS|patient with provider and prescriptions filled within cchs
5491661|NCT01330095|Enteral feeding|enteral feeding
5491662|NCT01330095|Growth|growth
5491663|NCT01330095|amount of enteral feeding|amount of enteral feeding
5491664|NCT01330082|Photodynamic therapy|photodynamic therapy
5491665|NCT01330082|Light-emitting diode|light-emitting diode
5491666|NCT01330082|toluidine blue|toluidine blue
5491667|NCT01330082|scaling and root planing|scaling and root planing
5491668|NCT01330056|Laryngeal and pharyngeal preservation, survivals|laryngeal and pharyngeal preservation, survivals
5491669|NCT01330043|smoking cessation intervention|smoking cessation intervention
5491670|NCT01330017|Seasonal allergies|seasonal allergies
5491672|NCT01329991|Methotrexate|methotrexate
5491673|NCT01329978|Hepatitis C|hepatitis c
5491674|NCT01329978|HCV|hcv
5491675|NCT01329978|Chronic Hepatitis C|chronic hepatitis c
5491676|NCT01329965|Cardiovascular disease|cardiovascular disease
5491677|NCT01329965|Inflammation|inflammation
5491678|NCT01329965|LPS|lps
5491679|NCT01329965|Endotoxin|endotoxin
5491680|NCT01329939|Asthma|asthma
5491681|NCT01329939|Obesity|obesity
5491682|NCT01329939|Pediatric|pediatric
5491683|NCT01329939|Inflammation|inflammation
5491684|NCT01329939|Leukotriene|leukotriene
5491685|NCT01329939|Montelukast|montelukast
5491686|NCT01329926|Parkinson's disease|parkinson's disease
5491687|NCT01329926|Neural stem cells|neural stem cells
5491688|NCT01329900|Chemotherapy|chemotherapy
5491689|NCT01329900|Stem Cell Collection|stem cell collection
5491690|NCT01329900|Ofatumumab|ofatumumab
5491691|NCT01329900|Arzerra|arzerra
5491692|NCT01329900|Ifosfamide|ifosfamide
5491693|NCT01329900|Ifex|ifex
5491694|NCT01329900|Etoposide|etoposide
5491695|NCT01329900|VePesid|vepesid
5491696|NCT01329900|Mesna|mesna
5491697|NCT01329900|Mesnex|mesnex
5491698|NCT01329900|G-CSF|g-csf
5491699|NCT01329900|Filgrastim|filgrastim
5491700|NCT01329900|Neupogen|neupogen
5491701|NCT01329900|Apheresis|apheresis
5491702|NCT01329887|microcirculation|microcirculation
5491704|NCT01329887|ketanserin|ketanserin
5491705|NCT01329887|severe sepsis|severe sepsis
5491706|NCT01329861|chronic back pain|chronic back pain
5491707|NCT01329861|internet based treatment|internet based treatment
5491708|NCT01329861|pain management programme|pain management programme
5491709|NCT01329861|cognitive behavioural therapy|cognitive behavioural therapy
5491710|NCT01329861|minimal therapist contact|minimal therapist contact
5491711|NCT01329848|Accommodation|accommodation
5491712|NCT01329848|Reading|reading
5491713|NCT01329848|Autorefraction|autorefraction
5491714|NCT01329822|type 2 diabetes|type 2 diabetes
5491715|NCT01329822|overweight|overweight
5491716|NCT01329809|metastatic colorectal cancer|metastatic colorectal cancer
5491717|NCT01329809|colon cancer|colon cancer
5491718|NCT01329809|liver metastasis|liver metastasis
5491719|NCT01329809|Pexa-vec|pexa-vec
5491720|NCT01329809|JX-594|jx-594
5491721|NCT01329796|dysmenorrhea,|dysmenorrhea,
5491722|NCT01329796|pelvic pain|pelvic pain
5491723|NCT01329796|dyspareunia|dyspareunia
5491724|NCT01329796|endometriosis|endometriosis
5491725|NCT01329770|Neurodevelopmental disability|neurodevelopmental disability
5491726|NCT01329770|Hyperactivity|hyperactivity
5491727|NCT01329770|Anxiety|anxiety
5491728|NCT01329770|Cognitive problems|cognitive problems
5491729|NCT01329770|Behavioural symptoms|behavioural symptoms
5491730|NCT01329770|Fragile X syndrome|fragile x syndrome
5491731|NCT01329770|Autism|autism
5491732|NCT01329770|inherited Genetic condition|inherited genetic condition
5491733|NCT01329757|Spinal Cord Injury|spinal cord injury
5491734|NCT01329757|Growth Hormone|growth hormone
5491735|NCT01329757|Trauma|trauma
5491736|NCT01329757|Incomplete|incomplete
5491737|NCT01329757|ASIA|asia
5491738|NCT01329744|HIV lipodystrophy|hiv lipodystrophy
5485980|NCT01353781|AKT|akt
5491739|NCT01329731|white spot lesion|white spot lesion
5491741|NCT01329731|fluoride|fluoride
5491742|NCT01329731|amine fluoride|amine fluoride
5491743|NCT01329731|orthodontics|orthodontics
5491744|NCT01329731|remineralization|remineralization
5491745|NCT01329731|brackets|brackets
5491746|NCT01329718|Stability of the Septin 9 biomarker|stability of the septin 9 biomarker
5491747|NCT01329718|Epi Pro Colon Test|epi pro colon test
5491748|NCT01329718|CRC|crc
5491749|NCT01329692|RYGB|rygb
5491750|NCT01329692|Intervention|intervention
5491751|NCT01329692|follow-up|follow-up
5491752|NCT01329692|standard-of-care|standard-of-care
5491753|NCT01329692|Back on Track program|back on track program
5491754|NCT01329692|poor weight loss|poor weight loss
5491755|NCT01329692|morbidly obese|morbidly obese
5491760|NCT01329666|Parathyroid Hormone|parathyroid hormone
5491761|NCT01329666|Osteoporosis|osteoporosis
5491762|NCT01329666|Bone Density|bone density
5491763|NCT01329666|Vitamin D repletion|vitamin d repletion
5491764|NCT01329666|Vitamin D Supplements|vitamin d supplements
5491765|NCT01329653|cerebral blood volume|cerebral blood volume
5491766|NCT01329653|aging|aging
5491767|NCT01329653|exercise|exercise
5491768|NCT01329640|Metronimic chemotherapy|metronimic chemotherapy
5491769|NCT01329640|Locally Advanced HER2-positive Breast Cancer|locally advanced her2-positive breast cancer
5491770|NCT01329601|cognitive training|cognitive training
5491771|NCT01329601|Alzheimer disease|alzheimer disease
5491772|NCT01329601|tertiary prevention|tertiary prevention
5491773|NCT01329588|Female sex workers|female sex workers
5491774|NCT01329588|West Africa|west africa
5491775|NCT01329588|Presumptive treatment|presumptive treatment
5491776|NCT01329588|Sexually transmitted infections|sexually transmitted infections
5491777|NCT01329575|endoluminal ultrasound|endoluminal ultrasound
5491778|NCT01329575|Mediastinal LN invasion|mediastinal ln invasion
5491779|NCT01329562|Menstrual migraine|menstrual migraine
5491780|NCT01329562|Menstrually-related migraine|menstrually-related migraine
5491781|NCT01329562|Treximet|treximet
5491782|NCT01329562|CGRP|cgrp
5491783|NCT01329562|calcitonin gene-related peptide|calcitonin gene-related peptide
5491784|NCT01329536|Alzheimer's Disease|alzheimer's disease
5491785|NCT01329536|Agitation|agitation
5491786|NCT01329536|Genetics|genetics
5491787|NCT01329536|Apolipoprotein|apolipoprotein
5491788|NCT01329536|ApoE4|apoe4
5491789|NCT01329523|Dementia|dementia
5491790|NCT01329523|Insulin-like growth factor|insulin-like growth factor
5491792|NCT01329523|APO E4|apo e4
5491793|NCT01329523|Genetics|genetics
5491794|NCT01329510|ADHD|adhd
5491795|NCT01329510|Adult|adult
5491796|NCT01329484|Alzheimer|alzheimer
5491797|NCT01329484|Dementia|dementia
5491798|NCT01329484|Computer|computer
5491799|NCT01329484|Cognitive training|cognitive training
5491800|NCT01329484|Reminiscence therapy|reminiscence therapy
5491801|NCT01329458|FLL|fll
5491802|NCT01329458|CEUS|ceus
5491803|NCT01329458|SonoVue|sonovue
5491804|NCT01329458|HCC|hcc
5491805|NCT01329458|Liver metastases|liver metastases
5491806|NCT01329458|Hemangiomas|hemangiomas
5491807|NCT01329458|FNH|fnh
5491808|NCT01329445|Cartilage repair|cartilage repair
5491809|NCT01329445|Articular cartilage defects|articular cartilage defects
5491810|NCT01329432|surfactant|surfactant
5491811|NCT01329432|intubation|intubation
5491812|NCT01329432|spontaneous breathing|spontaneous breathing
5491813|NCT01329432|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5491814|NCT01329406|Osteoarthritis (OA)|osteoarthritis (oa)
5491815|NCT01329406|Milnacipran|milnacipran
5491816|NCT01329406|Serotonin-norepinephrine reuptake inhibitor (SNRI)|serotonin-norepinephrine reuptake inhibitor (snri)
5491817|NCT01329406|Knee pain|knee pain
5491818|NCT01329393|Disability|disability
5491819|NCT01329393|Social Security|social security
5491820|NCT01329393|Representative Payee|representative payee
5491821|NCT01329380|Ankylosing Spondylitis|ankylosing spondylitis
5491822|NCT01329367|EVASYON|evasyon
5491823|NCT01329367|GENOI|genoi
5491824|NCT01329367|antioxidants|antioxidants
5491825|NCT01329367|legume|legume
5491826|NCT01329367|fish|fish
5491827|NCT01329354|Follicular lymphoma|follicular lymphoma
5491828|NCT01329354|Follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
5491829|NCT01329354|Autologous effector lymphocytes|autologous effector lymphocytes
5491830|NCT01329354|Cell Therapy|cell therapy
5491831|NCT01329354|Maintenance therapy|maintenance therapy
5491832|NCT01329354|Rituximab|rituximab
5491833|NCT01329341|PTSD|ptsd
5491834|NCT01329341|Service Dogs|service dogs
5491835|NCT01329328|whole-body vibration|whole-body vibration
5491836|NCT01329328|radiofrequency|radiofrequency
5491837|NCT01329328|hormonal status|hormonal status
5491838|NCT01329328|muscular strength|muscular strength
5491839|NCT01329328|balance|balance
5491840|NCT01329276|COPD|copd
5491841|NCT01329276|Symbicort|symbicort
5491842|NCT01329276|Turbohaler|turbohaler
5491843|NCT01329276|Computational Fluid Dynamics|computational fluid dynamics
5491844|NCT01329276|Functional Imaging|functional imaging
5491845|NCT01329276|Budesonide|budesonide
5491846|NCT01329276|Formoterol|formoterol
5491848|NCT01329250|Tuberculosis|tuberculosis
5491849|NCT01329250|Moxifloxacin|moxifloxacin
5491850|NCT01329250|Pharmacokinetics|pharmacokinetics
5491851|NCT01329250|Safety|safety
5491852|NCT01329237|drug-eluting stent|drug-eluting stent
5491853|NCT01329237|coronary endothelial function|coronary endothelial function
5494785|NCT01316913|COPD|copd
5491854|NCT01329237|coronary imaging|coronary imaging
5491855|NCT01329224|acetylsalicylic acid resistance|acetylsalicylic acid resistance
5491856|NCT01329211|Gastroparesis|gastroparesis
5491857|NCT01329211|Quality of Life|quality of life
5491858|NCT01329198|tourette|tourette
5491859|NCT01329198|tourette's|tourette's
5491861|NCT01329198|tourette syndrome|tourette syndrome
5491862|NCT01329198|tourette's syndrome|tourette's syndrome
5491863|NCT01329185|EBV Viremia in posttransplant kidney recipients|ebv viremia in posttransplant kidney recipients
5491864|NCT01329185|CMV viremia in posttransplant kidney recipients|cmv viremia in posttransplant kidney recipients
5491865|NCT01329172|PUFA|pufa
5491866|NCT01329172|Cystic Fibrosis|cystic fibrosis
5491867|NCT01329172|Nasal brushing|nasal brushing
5491868|NCT01329172|Mucins|mucins
5491869|NCT01329172|Mucin production|mucin production
5491870|NCT01329159|High altitude|high altitude
5491871|NCT01329159|respiratory function|respiratory function
5491872|NCT01329159|cardiorespiratory health|cardiorespiratory health
5491873|NCT01329159|indoor pollution|indoor pollution
5491874|NCT01329146|pulse pressure variation|pulse pressure variation
5491875|NCT01329146|preload dependency|preload dependency
5491876|NCT01329146|one-lung ventilation|one-lung ventilation
5491877|NCT01329146|thoracic surgery|thoracic surgery
5491878|NCT01329133|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5491879|NCT01329133|Obsessive compulsive disorder|obsessive compulsive disorder
5491880|NCT01329133|ventral striatum|ventral striatum
5491881|NCT01329133|subthalamic nucleus|subthalamic nucleus
5491882|NCT01329107|Rehabilitation|rehabilitation
5491883|NCT01329107|Enhanced Recovery|enhanced recovery
5491884|NCT01329107|Health related Qouality of Life|health related qouality of life
5491885|NCT01329107|Patient outcomes|patient outcomes
5491886|NCT01329094|Severe mental illness|severe mental illness
5491887|NCT01329094|physical activity|physical activity
5491889|NCT01329081|Rehabilitation|rehabilitation
5491890|NCT01329081|Strength training|strength training
5491891|NCT01329081|Long-term effect|long-term effect
5491892|NCT01329081|Activity and participation after fast-track knee arthroplasty|activity and participation after fast-track knee arthroplasty
5491893|NCT01329068|breast cancer|breast cancer
5491894|NCT01329042|Potassium sodium citrate|potassium sodium citrate
5491895|NCT01329042|stone recurrence|stone recurrence
5491896|NCT01329042|ESWL|eswl
5491897|NCT01329042|PCNL|pcnl
5491898|NCT01329042|Hypocitraturia|hypocitraturia
5491899|NCT01329042|intervention|intervention
5491900|NCT01329029|COPD|copd
5491901|NCT01329029|Roflumilast|roflumilast
5491902|NCT01329029|Daxas|daxas
5491903|NCT01329016|Pregnancy|pregnancy
5491904|NCT01329016|Glyburide|glyburide
5491905|NCT01329016|Metformin|metformin
5491906|NCT01329016|Pharmacokinetics|pharmacokinetics
5491907|NCT01329016|Pharmacodynamics|pharmacodynamics
5491908|NCT01329003|Silicosis|silicosis
5491909|NCT01328990|IPTc|iptc
5491910|NCT01328990|malaria|malaria
5491911|NCT01328990|children|children
5491912|NCT01328990|pharmacokinetics|pharmacokinetics
5491913|NCT01328990|amodiaquiane|amodiaquiane
5491914|NCT01328990|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5491915|NCT01328964|pediatric|pediatric
5491916|NCT01328964|asthma|asthma
5491917|NCT01328964|outcomes|outcomes
5491918|NCT01328964|inhaled cortcosteroids|inhaled cortcosteroids
5491919|NCT01328938|Pegfilgrastim|pegfilgrastim
5491920|NCT01328938|neutropenia|neutropenia
5491921|NCT01328925|Rotavirus|rotavirus
5491922|NCT01328925|Viral gastroenteritis|viral gastroenteritis
5491923|NCT01328925|Gastroenteritis|gastroenteritis
5491924|NCT01328912|ischemic preconditioning|ischemic preconditioning
5491925|NCT01328912|cardiac surgery|cardiac surgery
5491926|NCT01328912|vascular surgery|vascular surgery
5491927|NCT01328899|Emphysema|emphysema
5491928|NCT01328899|COPD|copd
5491929|NCT01328899|RePneu|repneu
5491930|NCT01328886|omalizumab|omalizumab
5491931|NCT01328886|allergic asthma|allergic asthma
5491932|NCT01328886|pediatric patients|pediatric patients
5491933|NCT01328873|Pulmonary infiltrates|pulmonary infiltrates
5491934|NCT01328873|stem cell transplant|stem cell transplant
5491935|NCT01328873|leukemia|leukemia
5491936|NCT01328860|Autologous|autologous
5491937|NCT01328860|Stem Cells|stem cells
5491939|NCT01328860|Children|children
5491940|NCT01328834|Nephritis, Lupus|nephritis, lupus
5491941|NCT01328834|Tacrolimus|tacrolimus
5491942|NCT01328821|Safety|safety
5491943|NCT01328821|Tolerability|tolerability
5491944|NCT01328821|Pharmacokinetics|pharmacokinetics
5491945|NCT01328821|Healthy volunteers|healthy volunteers
5491946|NCT01328808|Acetaminophen|acetaminophen
5491947|NCT01328808|Preterm Infants|preterm infants
5491948|NCT01328795|Cardiogoniometry|cardiogoniometry
5491949|NCT01328795|Chest Pain Unit|chest pain unit
5491950|NCT01328795|ST-elevation|st-elevation
5491951|NCT01328795|Troponin|troponin
5491952|NCT01328795|Catheter intervention|catheter intervention
5491953|NCT01328795|Fast Track|fast track
5491954|NCT01328782|elbow fracture|elbow fracture
5491955|NCT01328782|supracondylar elbow fracture|supracondylar elbow fracture
5491956|NCT01328782|elbow|elbow
5491957|NCT01328782|fracture|fracture
5491958|NCT01328782|pain management|pain management
5491959|NCT01328782|pediatric|pediatric
5491960|NCT01328769|uric acid|uric acid
5491961|NCT01328769|febuxostat|febuxostat
5491962|NCT01328769|hypertension|hypertension
5491963|NCT01328769|intra-renal renin-angiotensin system|intra-renal renin-angiotensin system
5491964|NCT01328769|renal plasma flow|renal plasma flow
5491965|NCT01328769|angiotensin II|angiotensin ii
5491966|NCT01328756|ADHD|adhd
5491967|NCT01328730|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
5491968|NCT01328730|epicardial coronary arteries.|epicardial coronary arteries.
5491969|NCT01328704|Iron deficiency|iron deficiency
5491970|NCT01328704|Vitamin D deficiency|vitamin d deficiency
5491971|NCT01328704|Anemia|anemia
5491972|NCT01328704|Athletes|athletes
5491973|NCT01328704|Triathletes|triathletes
5491974|NCT01328704|Triathlon|triathlon
5491975|NCT01328691|Carcinoma, Renal Cell|carcinoma, renal cell
5491976|NCT01328691|thrombus|thrombus
5491977|NCT01328691|body mass index|body mass index
5491978|NCT01328691|grade|grade
5491979|NCT01328678|Alopecia Areata|alopecia areata
5491980|NCT01328678|Vitamin D|vitamin d
5491981|NCT01328678|Parathyroid|parathyroid
5491982|NCT01328678|Calcium|calcium
5491983|NCT01328652|LPR|lpr
5491984|NCT01328652|LTH|lth
5491985|NCT01328639|Collaborative care|collaborative care
5491986|NCT01328639|Diabetes management|diabetes management
5491987|NCT01328639|Depression management|depression management
5491988|NCT01328639|Primary care|primary care
5491989|NCT01328626|Safety|safety
5491990|NCT01328626|Maximum Tolerated Dose|maximum tolerated dose
5491991|NCT01328626|Pharmacokinetics|pharmacokinetics
5491992|NCT01328626|ABT-199|abt-199
5491993|NCT01328626|Preliminary Efficacy|preliminary efficacy
5491994|NCT01328626|Cancer|cancer
5491995|NCT01328626|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5491996|NCT01328626|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5491997|NCT01328613|BDNF|bdnf
5491998|NCT01328613|Homeosis|homeosis
5491999|NCT01328613|Women|women
5492000|NCT01328613|Childbirth|childbirth
5492001|NCT01328613|Major Depressive Disorder|major depressive disorder
5492002|NCT01328600|Placenta|placenta
5492003|NCT01328600|Pregnancy|pregnancy
5492004|NCT01328600|Hypertension|hypertension
5492005|NCT01328600|Supplementation|supplementation
5492006|NCT01328600|Antibody|antibody
5492007|NCT01328587|Autoimmunity|autoimmunity
5492008|NCT01328587|Neutropenia|neutropenia
5492009|NCT01328587|Cytokine|cytokine
5492010|NCT01328587|Hematopoiesis|hematopoiesis
5492011|NCT01328587|Thrombocytopenia|thrombocytopenia
5492012|NCT01328587|Aplastic Anemia|aplastic anemia
5492013|NCT01328574|Progression-Free Survival|progression-free survival
5492014|NCT01328574|Carcinoma of the Bladder|carcinoma of the bladder
5492015|NCT01328574|Cancer of the Renal Pelvis|cancer of the renal pelvis
5492016|NCT01328574|Ureter Cancer|ureter cancer
5492017|NCT01328574|Survival|survival
5492018|NCT01328574|Bladder Cancer|bladder cancer
5492019|NCT01328574|Renal Pelvis Cancer|renal pelvis cancer
5492020|NCT01328574|Urothelial Cancer|urothelial cancer
5492021|NCT01328561|Arginine|arginine
5492022|NCT01328561|Oxytocin|oxytocin
5492023|NCT01328561|Vasopressin|vasopressin
5492024|NCT01328561|Placebo|placebo
5492025|NCT01328561|Analgesia|analgesia
5492026|NCT01328561|Healthy Volunteer|healthy volunteer
5492027|NCT01328561|HV|hv
5492028|NCT01328548|varicella-zoster virus|varicella-zoster virus
5492029|NCT01328548|vaccine|vaccine
5492030|NCT01328548|T-cell|t-cell
5492031|NCT01328548|genes|genes
5492032|NCT01328548|frail elderly|frail elderly
5492033|NCT01328548|immunosenescence|immunosenescence
5492034|NCT01328548|immune and genetic correlates of response to zoster vaccine in the elderly|immune and genetic correlates of response to zoster vaccine in the elderly
5492035|NCT01328509|Zinc|zinc
5492036|NCT01328496|Hematologic Malignancies|hematologic malignancies
5492037|NCT01328496|Umbilical Cord Blood transplantation|umbilical cord blood transplantation
5492038|NCT01328496|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5492039|NCT01328483|Neonates|neonates
5492040|NCT01328483|Intrapartum Oropharyngeal Suctioning|intrapartum oropharyngeal suctioning
5492041|NCT01328483|Meconium Aspiration Syndrome|meconium aspiration syndrome
5492042|NCT01328470|platelet|platelet
5492043|NCT01328470|cilostazol|cilostazol
5492044|NCT01328470|clopidogrel|clopidogrel
5492045|NCT01328470|chronic kidney disease|chronic kidney disease
5492046|NCT01328457|Leishmaniasis, Visceral|leishmaniasis, visceral
5492047|NCT01328457|kala-azar|kala-azar
5492048|NCT01328457|Paromomycin|paromomycin
5492049|NCT01328457|Bangladesh|bangladesh
5492050|NCT01328457|Injections, Intramuscular|injections, intramuscular
5492051|NCT01328457|Treatment Outcome|treatment outcome
5492052|NCT01328457|Patient compliance|patient compliance
5492053|NCT01328457|Medication adherence|medication adherence
5492054|NCT01328457|Drug toxicity|drug toxicity
5492055|NCT01328431|Tobacco Use Cessation|tobacco use cessation
5492056|NCT01328431|Smoking Cessation|smoking cessation
5492057|NCT01328431|Nicotine Replacement Therapy|nicotine replacement therapy
5492058|NCT01328431|Brief Intervention|brief intervention
5492061|NCT01328392|GERD|gerd
5492062|NCT01328366|Quality of Life|quality of life
5492063|NCT01328366|Psychosocial factors|psychosocial factors
5492064|NCT01328353|triage|triage
5492065|NCT01328353|aprn|aprn
5492066|NCT01328353|telehealth|telehealth
5492067|NCT01328353|CCHCN|cchcn
5492068|NCT01328353|advanced practice nurse|advanced practice nurse
5492069|NCT01328353|improve family quality of life|improve family quality of life
5492070|NCT01328353|reduce unplanned use of health care services|reduce unplanned use of health care services
5492071|NCT01328353|telehealth triage intervention|telehealth triage intervention
5492072|NCT01328340|muscle power, exercise, aging|muscle power, exercise, aging
5492073|NCT01328301|gait|gait
5492074|NCT01328301|hemiplegia|hemiplegia
5492075|NCT01328301|treadmill|treadmill
5492076|NCT01328301|physiotherapy|physiotherapy
5492077|NCT01328301|rehabilitation|rehabilitation
5492078|NCT01328288|HIV related adverse events|hiv related adverse events
5492079|NCT01328288|Immunological failure|immunological failure
5492080|NCT01328288|virological failure|virological failure
5492081|NCT01328288|quality of life|quality of life
5492083|NCT01328288|genotypic resistance|genotypic resistance
5492084|NCT01328275|HIV related adverse events|hiv related adverse events
5492085|NCT01328275|immunological failure|immunological failure
5492086|NCT01328275|virological failure|virological failure
5492087|NCT01328275|quality of life|quality of life
5492088|NCT01328275|depression|depression
5492089|NCT01328275|genotypic resistance|genotypic resistance
5492090|NCT01328262|Hemoglobins|hemoglobins
5492091|NCT01328249|Breast Cancer|breast cancer
5492092|NCT01328249|HER2-normal Stage I to III invasive breast cancer|her2-normal stage i to iii invasive breast cancer
5492093|NCT01328236|Bortezomib|bortezomib
5492094|NCT01328236|PCL|pcl
5492095|NCT01328223|Hepatocellular carcinoma|hepatocellular carcinoma
5492096|NCT01328223|radiotherapy|radiotherapy
5492097|NCT01328223|sorafenib|sorafenib
5492098|NCT01328210|metabolic syndrome|metabolic syndrome
5492099|NCT01328210|Phlebotomy|phlebotomy
5492100|NCT01328210|blood letting|blood letting
5492101|NCT01328210|hypertension|hypertension
5492102|NCT01328210|insulin sensitivity|insulin sensitivity
5492103|NCT01328197|Treovance|treovance
5492104|NCT01328197|aneurysm|aneurysm
5492105|NCT01328197|AAA|aaa
5492106|NCT01328158|Kaletra, Lopinavir (LPV)/Ritonavir (RTV), Human Immunodeficiency Virus (HIV) infection|kaletra, lopinavir (lpv)/ritonavir (rtv), human immunodeficiency virus (hiv) infection
5492107|NCT01328132|Liver|liver
5492108|NCT01328132|transplant|transplant
5492109|NCT01328132|albumin|albumin
5492110|NCT01328067|MRgFus|mrgfus
5492111|NCT01328067|Uterine Fibroids|uterine fibroids
5492112|NCT01328067|Pelvic Pain|pelvic pain
5492113|NCT01328067|Quality of Life|quality of life
5492114|NCT01328067|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5492115|NCT01328054|cancer|cancer
5492116|NCT01328054|cardiac repolarization|cardiac repolarization
5492117|NCT01328054|Holter monitor|holter monitor
5492118|NCT01328054|pharmacokinetics|pharmacokinetics
5492119|NCT01328054|GW572016|gw572016
5492120|NCT01328054|lapatinib|lapatinib
5492121|NCT01328054|QTc interval|qtc interval
5492122|NCT01328054|safety|safety
5492123|NCT01328054|ECG|ecg
5492124|NCT01328041|GSK1349572|gsk1349572
5492125|NCT01328041|resistance to raltegravir or elvitegravir|resistance to raltegravir or elvitegravir
5492126|NCT01328041|Integrase inhibitor|integrase inhibitor
5492127|NCT01328041|ART-experienced|art-experienced
5492128|NCT01328041|dolutegravir|dolutegravir
5492129|NCT01328028|Invasive cervical cancer|invasive cervical cancer
5492130|NCT01328028|Human papillomavirus|human papillomavirus
5492131|NCT01328015|hyperhidrosis|hyperhidrosis
5492132|NCT01328015|oxybutynin|oxybutynin
5492133|NCT01328015|plantar sweating|plantar sweating
5492134|NCT01328015|compensatory sweating|compensatory sweating
5492135|NCT01328002|Fibromyalgia|fibromyalgia
5492136|NCT01328002|Pediatric Fibromyalgia|pediatric fibromyalgia
5492137|NCT01328002|Adolescent Fibromyalgia|adolescent fibromyalgia
5492138|NCT01328002|milnacipran|milnacipran
5492139|NCT01328002|Savella|savella
5492140|NCT01328002|loss of therapeutic response|loss of therapeutic response
5492141|NCT01328002|Forest Research Institute|forest research institute
5492142|NCT01328002|Pain|pain
5492143|NCT01328002|Fatigue|fatigue
5492144|NCT01328002|Serotonin Norepinephrine Reuptake Inhibitors|serotonin norepinephrine reuptake inhibitors
5492145|NCT01328002|Randomized Withdrawal|randomized withdrawal
5492146|NCT01327989|Solitaire FR Device|solitaire fr device
5492147|NCT01327989|Mechanical Thrombectomy|mechanical thrombectomy
5492148|NCT01327989|Recanalization|recanalization
5492149|NCT01327989|Brain artery recanalization|brain artery recanalization
5486467|NCT01351740|HIV|hiv
5492151|NCT01327989|Interventional Neuroradiology|interventional neuroradiology
5492152|NCT01327989|STAR|star
5492153|NCT01327989|Acute Ischemic Stroke|acute ischemic stroke
5492154|NCT01327976|Obesity|obesity
5492155|NCT01327976|Bariatric surgery|bariatric surgery
5492156|NCT01327976|Excess weight loss|excess weight loss
5492157|NCT01327976|Vagus nerve|vagus nerve
5492158|NCT01327976|Vagal blocking|vagal blocking
5492159|NCT01327976|vBloc Therapy|vbloc therapy
5685531|NCT00555737|Capsule Endoscopy|capsule endoscopy
5492160|NCT01327963|Gastroesophageal reflux disease|gastroesophageal reflux disease
5492162|NCT01327963|Heartburn|heartburn
5492163|NCT01327963|Reflux|reflux
5492164|NCT01327963|Regurgitation|regurgitation
5492165|NCT01327963|Hoarseness|hoarseness
5492166|NCT01327963|Cough|cough
5492167|NCT01327950|Percutaneous treatment|percutaneous treatment
5492168|NCT01327950|Superficial Femoral Artery lesions|superficial femoral artery lesions
5492169|NCT01327950|EPIC Nitinol Vascular Stent System|epic nitinol vascular stent system
5492170|NCT01327911|Mactel|mactel
5492171|NCT01327911|Macular Telangiectasia Type 2|macular telangiectasia type 2
5492173|NCT01327898|HIV/AIDS|hiv/aids
5492174|NCT01327898|sexual risk|sexual risk
5492175|NCT01327898|substance use|substance use
5492176|NCT01327872|Idiopathic Thrombocytopenia Purpura(ITP)|idiopathic thrombocytopenia purpura(itp)
5492177|NCT01327872|Acute and Chronic Thrombocytopenia Associated with Chronic Liver Disease|acute and chronic thrombocytopenia associated with chronic liver disease
5492179|NCT01327846|Cardiovascular Death|cardiovascular death
5492180|NCT01327846|Myocardial Infarction|myocardial infarction
5492181|NCT01327846|Stroke|stroke
5492182|NCT01327846|Canakinumab|canakinumab
5492183|NCT01327846|IL-1B|il-1b
5492184|NCT01327846|hsCRP|hscrp
5492185|NCT01327820|Oxygen consumption|oxygen consumption
5492186|NCT01327820|Aortic Aneurysm|aortic aneurysm
5492187|NCT01327820|Peripheral Arterial Disease|peripheral arterial disease
5492188|NCT01327807|Registries|registries
5492189|NCT01327807|Cystinosis|cystinosis
5492190|NCT01327807|Nephropathic Cystinosis|nephropathic cystinosis
5492191|NCT01327807|Renal Fanconi Syndrome|renal fanconi syndrome
5492192|NCT01327807|Cystine|cystine
5492193|NCT01327807|Kidney|kidney
5492194|NCT01327807|Rare Diseases|rare diseases
5492195|NCT01327794|recurrent pancreatic cancer|recurrent pancreatic cancer
5492196|NCT01327794|stage III pancreatic cancer|stage iii pancreatic cancer
5492197|NCT01327794|stage IV pancreatic cancer|stage iv pancreatic cancer
5492198|NCT01327768|Stroke,|stroke,
5492199|NCT01327768|Stem Cell,|stem cell,
5492200|NCT01327768|Olfactory Ensheathing Cells,|olfactory ensheathing cells,
5492201|NCT01327768|Intracerebral Implantation of Olfactory Ensheathing Cells.|intracerebral implantation of olfactory ensheathing cells.
5492202|NCT01327755|Selenium|selenium
5492203|NCT01327755|HIV/ AIDS|hiv/ aids
5492204|NCT01327755|CD4 counts|cd4 counts
5492205|NCT01327755|Antiretroviral therapy|antiretroviral therapy
5492206|NCT01327742|Relay|relay
5492207|NCT01327742|Thoracic|thoracic
5492208|NCT01327742|Aneurysm|aneurysm
5492209|NCT01327729|pegylated interferon|pegylated interferon
5492210|NCT01327729|interferon|interferon
5492211|NCT01327729|HCV|hcv
5492212|NCT01327729|genotype 4|genotype 4
5492213|NCT01327703|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5492214|NCT01327703|Cystic Fibrosis|cystic fibrosis
5492215|NCT01327703|Steatorrhea|steatorrhea
5492216|NCT01327703|Malabsorption|malabsorption
5492217|NCT01327703|Malnutrition|malnutrition
5492218|NCT01327677|pain management|pain management
5492219|NCT01327677|opioid analgesic therapy|opioid analgesic therapy
5492220|NCT01327677|safety|safety
5492221|NCT01327677|craniotomy|craniotomy
5492222|NCT01327664|Quiescent uveitis|quiescent uveitis
5492223|NCT01327664|intermediate uveitis|intermediate uveitis
5492224|NCT01327664|panuveitis|panuveitis
5492225|NCT01327664|posterior uveitis|posterior uveitis
5492226|NCT01327664|uveitis|uveitis
5492227|NCT01327651|Drug Administration Schedule|drug administration schedule
5492228|NCT01327651|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
5492229|NCT01327651|Pharmacokinetics|pharmacokinetics
5492230|NCT01327625|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5492231|NCT01327625|Graft versus host disease|graft versus host disease
5492232|NCT01327625|Bronchiolitis obliterans|bronchiolitis obliterans
5492233|NCT01327625|Azithromycin|azithromycin
5492234|NCT01327625|N-acetylcystein|n-acetylcystein
5492235|NCT01327625|Fluticasone|fluticasone
5492236|NCT01327625|Inhaled steroid|inhaled steroid
5492237|NCT01327612|AMG 655|amg 655
5492238|NCT01327612|AMG 479|amg 479
5492239|NCT01327612|Apoptosis|apoptosis
5492240|NCT01327612|Monoclonal Antibody|monoclonal antibody
5492241|NCT01327612|Tumor Necrosis Factor|tumor necrosis factor
5492242|NCT01327612|Insulin-like Growth Factor|insulin-like growth factor
5492243|NCT01327612|Bevacizumab|bevacizumab
5492244|NCT01327612|Modified FOLFOX6|modified folfox6
5492245|NCT01327612|mFOLFOX6|mfolfox6
5492246|NCT01327612|FOLFOX|folfox
5492247|NCT01327612|Lymphoma|lymphoma
5492248|NCT01327612|Trail Receptor|trail receptor
5492249|NCT01327612|ganitumab|ganitumab
5492250|NCT01327612|conatumumab|conatumumab
5492260|NCT01327586|HIV risk reduction|hiv risk reduction
5492261|NCT01327573|chronic kidney allograft injury|chronic kidney allograft injury
5492262|NCT01327573|complement protein|complement protein
5492263|NCT01327573|eculizumab|eculizumab
5492264|NCT01327573|Kidney transplantation|kidney transplantation
5492265|NCT01327560|hemodialysis patients|hemodialysis patients
5492266|NCT01327560|sleep quality|sleep quality
5492267|NCT01327560|restless legs syndrome|restless legs syndrome
5492268|NCT01327560|excessive daytime sleepiness|excessive daytime sleepiness
5492269|NCT01327560|sleep apnea syndrome|sleep apnea syndrome
5492270|NCT01327547|HIV coinfection|hiv coinfection
5492271|NCT01327547|maraviroc|maraviroc
5492272|NCT01327547|CCR5 blocker|ccr5 blocker
5492273|NCT01327547|entry inhibitor|entry inhibitor
5492274|NCT01327547|liver disease|liver disease
5492275|NCT01327547|viral hepatitis|viral hepatitis
5492276|NCT01327534|STEMI|stemi
5492277|NCT01327534|clopidogrel|clopidogrel
5492278|NCT01327534|prasugrel|prasugrel
5492279|NCT01327534|platelet reactivity index|platelet reactivity index
5492280|NCT01327534|ST resolution|st resolution
5492281|NCT01327495|Androgen replacement in men|androgen replacement in men
5492282|NCT01327482|Raltegravir|raltegravir
5492283|NCT01327482|Pharmacokinetics|pharmacokinetics
5492284|NCT01327456|health literacy|health literacy
5492285|NCT01327456|self-management|self-management
5492286|NCT01327456|inhaler technique|inhaler technique
5492287|NCT01327443|NAFLD|nafld
5492288|NCT01327443|NASH|nash
5492289|NCT01327443|Weight loss|weight loss
5492290|NCT01327443|Exercise|exercise
5492291|NCT01327443|NAS scores|nas scores
5492292|NCT01327443|Mitochondrial dysfunction|mitochondrial dysfunction
5492293|NCT01327430|glycerophosphates|glycerophosphates
5492499|NCT01326663|Mood|mood
5492298|NCT01327391|on line hemodiafiltration|on line hemodiafiltration
5492299|NCT01327391|tolerance|tolerance
5492300|NCT01327391|quality of life|quality of life
5492301|NCT01327391|cardiovascular risk|cardiovascular risk
5492302|NCT01327391|Hemodialysis patients|hemodialysis patients
5492303|NCT01327365|significant coronary artery disease|significant coronary artery disease
5492304|NCT01327365|PCI|pci
5492305|NCT01327365|radial approach|radial approach
5492306|NCT01327365|women|women
5492307|NCT01327365|bifurcation lesion|bifurcation lesion
5492308|NCT01327365|ostial lesion|ostial lesion
5492309|NCT01327365|7 Fr guiding catheter|7 fr guiding catheter
5492310|NCT01327365|percutaneous coronary intervention|percutaneous coronary intervention
5492311|NCT01327352|lupus|lupus
5492312|NCT01327326|Pain modulation|pain modulation
5492313|NCT01327326|Experimental pain|experimental pain
5492314|NCT01327313|alpha v integrin|alpha v integrin
5492315|NCT01327313|antibody|antibody
5492316|NCT01327313|solid tumor|solid tumor
5492317|NCT01327313|Japanese|japanese
5492318|NCT01327313|EMD525797|emd525797
5492319|NCT01327300|Irritable Bowel Syndrome|irritable bowel syndrome
5492320|NCT01327300|Irritable Bowel Syndrome Treatment|irritable bowel syndrome treatment
5492321|NCT01327300|Mesalamine|mesalamine
5492322|NCT01327300|Anti-inflammatory drugs|anti-inflammatory drugs
5492323|NCT01327300|5-ASA drugs|5-asa drugs
5492324|NCT01327300|Apriso ™|apriso ™
5492325|NCT01327287|thoracic epidural|thoracic epidural
5492326|NCT01327287|blunt|blunt
5492327|NCT01327287|blunt thoracic injury|blunt thoracic injury
5492328|NCT01327274|Pectus excavatum|pectus excavatum
5492329|NCT01327274|Chest wall deformity|chest wall deformity
5492330|NCT01327274|Magnetic Mini-Mover Procedure|magnetic mini-mover procedure
5492331|NCT01327274|Pectus Severity Index|pectus severity index
5492332|NCT01327274|pediatric medical device|pediatric medical device
5492333|NCT01327274|magnetic alteration|magnetic alteration
5492334|NCT01327274|sunken chest|sunken chest
5492335|NCT01327261|levodopa|levodopa
5492336|NCT01327261|benserazide|benserazide
5492337|NCT01327261|bioequivalence|bioequivalence
5492338|NCT01327261|pharmacokinetics|pharmacokinetics
5492339|NCT01327261|A Single - Dose|a single - dose
5492340|NCT01327261|Randomized- Sequence|randomized- sequence
5492341|NCT01327261|Open -Label Crossover Study|open -label crossover study
5492342|NCT01327248|Bronchiolitis obliterans|bronchiolitis obliterans
5492343|NCT01327248|HRCT|hrct
5492344|NCT01327248|Sputum|sputum
5492346|NCT01327248|Inflammation|inflammation
5492347|NCT01327248|adaptive immune system|adaptive immune system
5492348|NCT01327248|innate immune system|innate immune system
5492349|NCT01327222|age-related macular degeneration|age-related macular degeneration
5492350|NCT01327222|bevacizumab|bevacizumab
5492356|NCT01327157|Facial Paralysis / rehabilitation.|facial paralysis / rehabilitation.
5492357|NCT01327157|Dental Occlusion.|dental occlusion.
5492358|NCT01327157|Occlusal Adjustment.|occlusal adjustment.
5492359|NCT01327157|Malocclusion / therapy.|malocclusion / therapy.
5492360|NCT01327092|Injury|injury
5492361|NCT01327092|Injury Prevention|injury prevention
5492362|NCT01327092|Cincinnati Home Injury Prevention|cincinnati home injury prevention
5492363|NCT01327092|Injury Hazards|injury hazards
5492364|NCT01327092|Modifiable Injury Hazards|modifiable injury hazards
5492365|NCT01327092|CHIP|chip
5492366|NCT01327092|Literacy Promotion|literacy promotion
5492367|NCT01327092|Reduce exposure to injury hazards|reduce exposure to injury hazards
5492368|NCT01327092|preventable and medically attended injury|preventable and medically attended injury
5492369|NCT01327092|young children|young children
5492370|NCT01327079|NICU|nicu
5492371|NCT01327079|Methadone|methadone
5492372|NCT01327079|neonates|neonates
5492373|NCT01327066|QTc|qtc
5492374|NCT01327066|ECG Effects|ecg effects
5492375|NCT01327053|locally advanced basal cell carcinoma|locally advanced basal cell carcinoma
5492376|NCT01327053|metastatic basal cell carcinoma|metastatic basal cell carcinoma
5492377|NCT01327053|LDE225|lde225
5492378|NCT01327053|sonidegib|sonidegib
5492379|NCT01327053|Basel Cell Carcinoma (BCC)|basel cell carcinoma (bcc)
5492381|NCT01327053|Basel Cell Carcinoma|basel cell carcinoma
5492382|NCT01327053|BCC|bcc
5492383|NCT01327040|light|light
5492384|NCT01327040|melatonin|melatonin
5492385|NCT01327040|circadian|circadian
5492386|NCT01327040|delayed sleep phase disorder|delayed sleep phase disorder
5492387|NCT01327040|circadian light sensitivity|circadian light sensitivity
5492388|NCT01327040|circadian timing system|circadian timing system
5492389|NCT01327027|vasopressin|vasopressin
5492390|NCT01327027|antisocial|antisocial
5492391|NCT01327027|affiliation|affiliation
5492392|NCT01327014|Hyperlipidemia|hyperlipidemia
5492393|NCT01327014|Cholesterol|cholesterol
5492394|NCT01327014|Lipids|lipids
5492395|NCT01327014|Lipoproteins|lipoproteins
5492396|NCT01327014|XueZhiKang|xuezhikang
5492397|NCT01327014|Botanical|botanical
5492398|NCT01327001|Asthma bronchiale, fixed combination|asthma bronchiale, fixed combination
5492399|NCT01326988|Spinal anesthesia|spinal anesthesia
5492400|NCT01326988|ultrasound|ultrasound
5492401|NCT01326988|real-time|real-time
5492402|NCT01326975|infant, premature|infant, premature
5492403|NCT01326975|infant, very low birth weight|infant, very low birth weight
5492404|NCT01326975|diaphragm|diaphragm
5492405|NCT01326975|apnea|apnea
5492406|NCT01326975|continuous positive airway pressure|continuous positive airway pressure
5492407|NCT01326936|Online education|online education
5492408|NCT01326936|Medical education|medical education
5492409|NCT01326936|Substance abuse training|substance abuse training
5492410|NCT01326936|Drug abuse training|drug abuse training
5492411|NCT01326923|Head|head
5492412|NCT01326923|Neck|neck
5492413|NCT01326923|Locally advanced|locally advanced
5492414|NCT01326923|Squamous Cell|squamous cell
5492415|NCT01326923|Hypopharynx|hypopharynx
5492416|NCT01326923|Larynx|larynx
5492417|NCT01326923|Oral Cavity|oral cavity
5492418|NCT01326923|Base of Tongue|base of tongue
5492419|NCT01326923|Tonsil|tonsil
5492420|NCT01326923|Neck lymph node|neck lymph node
5492421|NCT01326923|Resection|resection
5492422|NCT01326910|Eczema|eczema
5492423|NCT01326884|aortic aneurysm|aortic aneurysm
5492424|NCT01326884|iliac aneurysm|iliac aneurysm
5492425|NCT01326884|endovascular procedures|endovascular procedures
5492426|NCT01326871|cancer|cancer
5492427|NCT01326871|immunotherapy|immunotherapy
5492428|NCT01326871|immunochemotherapy|immunochemotherapy
5492429|NCT01326871|combinational therapy|combinational therapy
5492430|NCT01326871|targeted|targeted
5492431|NCT01326871|metastatic|metastatic
5492432|NCT01326871|muscle invasive|muscle invasive
5492433|NCT01326871|interleukin-2|interleukin-2
5492434|NCT01326871|cisplatin|cisplatin
5492435|NCT01326871|gemcitabine|gemcitabine
5492436|NCT01326871|antitumor|antitumor
5492437|NCT01326871|TCR|tcr
5492438|NCT01326871|T-cell receptor|t-cell receptor
5492439|NCT01326871|p53|p53
5492440|NCT01326871|p53 gene|p53 gene
5492441|NCT01326871|p53 tumor supressor protein|p53 tumor supressor protein
5492442|NCT01326871|urothelial cancer|urothelial cancer
5492443|NCT01326871|bladder cancer|bladder cancer
5492444|NCT01326871|renal pelvis cancer|renal pelvis cancer
5492445|NCT01326871|ureters cancer|ureters cancer
5492446|NCT01326871|urethra cancer|urethra cancer
5492447|NCT01326871|HLA-A2 positive|hla-a2 positive
5492448|NCT01326871|HLA-A*0201/p53 aa264-272|hla-a*0201/p53 aa264-272
5492449|NCT01326871|HLA complex|hla complex
5492450|NCT01326871|Muscle Invasive or Metastatic|muscle invasive or metastatic
5492451|NCT01326858|Ocular discomfort|ocular discomfort
5486760|NCT01350349|Dementia|dementia
5492452|NCT01326858|AL-4943A Ophthalmic Solution|al-4943a ophthalmic solution
5492453|NCT01326845|Gastrointestinal adverse events,|gastrointestinal adverse events,
5492454|NCT01326845|myelodysplastic syndrome,|myelodysplastic syndrome,
5492455|NCT01326845|transfusional iron overload diarrhea,|transfusional iron overload diarrhea,
5492456|NCT01326845|constipation abdominal pain,|constipation abdominal pain,
5492457|NCT01326845|vomiting|vomiting
5492458|NCT01326832|THA|tha
5492459|NCT01326819|Near infrared spectroscopy|near infrared spectroscopy
5492460|NCT01326819|Skin pigmentation|skin pigmentation
5492461|NCT01326819|Regional oxygen saturation|regional oxygen saturation
5492462|NCT01326806|Parent-based intervention|parent-based intervention
5492463|NCT01326806|Sexual risk behavior|sexual risk behavior
5492464|NCT01326806|Adolescents|adolescents
5492465|NCT01326793|telepsychiatry|telepsychiatry
5492466|NCT01326793|MDD|mdd
5492467|NCT01326793|Depression|depression
5492468|NCT01326793|Major Depressive Disorder|major depressive disorder
5492474|NCT01326780|Safety|safety
5492475|NCT01326780|Sebum|sebum
5492476|NCT01326741|clonal mast cell disorder|clonal mast cell disorder
5492477|NCT01326741|exercise-induced anaphylaxis|exercise-induced anaphylaxis
5492478|NCT01326741|hypotension|hypotension
5492479|NCT01326728|Relapse|relapse
5492480|NCT01326728|Hematologic Malignancy|hematologic malignancy
5492481|NCT01326728|Allogeneic|allogeneic
5685532|NCT00555737|small Bowel Disease|small bowel disease
5492482|NCT01326728|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5492483|NCT01326728|Leukemia|leukemia
5492484|NCT01326728|Lymphoma|lymphoma
5492485|NCT01326728|Hodgkin Lymphoma|hodgkin lymphoma
5492491|NCT01326676|Polypill|polypill
5492492|NCT01326676|Red Heart Pill|red heart pill
5492493|NCT01326676|Cardiovascular disease|cardiovascular disease
5492494|NCT01326676|Secondary prevention|secondary prevention
5492495|NCT01326676|carotid intima media thickness|carotid intima media thickness
5492496|NCT01326663|Veterans|veterans
5492498|NCT01326663|Alcoholism|alcoholism
5492500|NCT01326650|vitamin D, mortality, event-free survival, heart failure|vitamin d, mortality, event-free survival, heart failure
5492501|NCT01326637|primary health care|primary health care
5492502|NCT01326637|aged|aged
5492503|NCT01326624|heart failure|heart failure
5492504|NCT01326624|ventricular dysfunction|ventricular dysfunction
5492505|NCT01326624|sudden death|sudden death
5492506|NCT01326624|sudden cardiac arrest|sudden cardiac arrest
5492507|NCT01326624|ventricular tachycardia|ventricular tachycardia
5492508|NCT01326624|ventricular fibrillation|ventricular fibrillation
5492509|NCT01326624|wearable defibrillator|wearable defibrillator
5492510|NCT01326611|Chronic lung disease|chronic lung disease
5492511|NCT01326611|Clarithromycin|clarithromycin
5492512|NCT01326611|Ureaplasma urealyticum|ureaplasma urealyticum
5492513|NCT01326598|V Go™|v go™
5492514|NCT01326598|Type 2 Diabetes|type 2 diabetes
5492515|NCT01326598|Insulin|insulin
5492516|NCT01326598|Oral Anti Hypoglycemic Drugs|oral anti hypoglycemic drugs
5492517|NCT01326585|Scleral Buckling|scleral buckling
5492518|NCT01326585|Dexamethasone|dexamethasone
5492519|NCT01326585|Post-operative Nausea and Vomiting|post-operative nausea and vomiting
5492521|NCT01326572|Pulmonary disease|pulmonary disease
5492522|NCT01326572|emphysema|emphysema
5492523|NCT01326572|COPD|copd
5492524|NCT01326559|induction chemotherapy|induction chemotherapy
5492525|NCT01326559|docetaxel|docetaxel
5492526|NCT01326559|cisplatin|cisplatin
5492527|NCT01326559|fluorouracil|fluorouracil
5492528|NCT01326559|cetuximab|cetuximab
5492529|NCT01326559|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5492530|NCT01326546|Therapeutic HBV Vaccine|therapeutic hbv vaccine
5492531|NCT01326546|Chronic Hepatitis B|chronic hepatitis b
5492532|NCT01326546|HBeAg positive|hbeag positive
5492533|NCT01326546|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
5492534|NCT01326533|pre-diabetes|pre-diabetes
5492535|NCT01326533|hydroxychloroquine|hydroxychloroquine
5492536|NCT01326533|frequently sampled intravenous glucose tolerance testing|frequently sampled intravenous glucose tolerance testing
5492537|NCT01326533|insulin resistance|insulin resistance
5492538|NCT01326533|insulin secretion|insulin secretion
5492539|NCT01326533|glucose tolerance|glucose tolerance
5492540|NCT01326507|pulmonary embolism|pulmonary embolism
5492541|NCT01326507|Heart-type fatty acid-binding protein|heart-type fatty acid-binding protein
5492542|NCT01326507|cardiac biomarkers|cardiac biomarkers
5492543|NCT01326507|risk stratification|risk stratification
5492544|NCT01326494|Upper Respiratory Tract Infection|upper respiratory tract infection
5492545|NCT01326494|Asthma|asthma
5474469|NCT01402999|Saizen|saizen
5492546|NCT01326494|URTI induced exacerbation of Asthma|urti induced exacerbation of asthma
5492547|NCT01326481|TRC105|trc105
5492548|NCT01326481|Breast Cancer|breast cancer
5492549|NCT01326481|CD105|cd105
5492550|NCT01326481|Endoglin|endoglin
5492551|NCT01326481|TRACON Pharma|tracon pharma
5492552|NCT01326481|Roswell Park Cancer Institute|roswell park cancer institute
5492553|NCT01326481|Department of Defense|department of defense
5492554|NCT01326468|head and neck cancer|head and neck cancer
5492555|NCT01326468|temsirolimus|temsirolimus
5492556|NCT01326468|cetuximab|cetuximab
5492557|NCT01326468|cisplatin|cisplatin
5492558|NCT01326468|radiation therapy|radiation therapy
5492559|NCT01326455|transradial|transradial
5492561|NCT01326455|device|device
5492562|NCT01326455|Care of the radial artery post transradial angiogram|care of the radial artery post transradial angiogram
5492563|NCT01326442|weight loss|weight loss
5492564|NCT01326442|overweight|overweight
5492565|NCT01326442|body composition|body composition
5492566|NCT01326442|visceral obesity|visceral obesity
5492567|NCT01326442|insulin|insulin
5492568|NCT01326442|glucose tolerance|glucose tolerance
5492569|NCT01326442|cholesterol|cholesterol
5492575|NCT01326416|obesity|obesity
5492576|NCT01326416|metabolic syndrome|metabolic syndrome
5492577|NCT01326416|leucine|leucine
5492578|NCT01326416|arginine|arginine
5492579|NCT01326416|physical activity|physical activity
5492580|NCT01326403|proximal|proximal
5492582|NCT01326403|fractures|fractures
5492583|NCT01326338|Diarrhea|diarrhea
5492584|NCT01326325|Cancer|cancer
5492585|NCT01326325|Refractory pain|refractory pain
5492586|NCT01326325|Uncontrolled pain|uncontrolled pain
5492587|NCT01326325|Ketamine|ketamine
5492588|NCT01326286|Comparative Effectiveness Research|comparative effectiveness research
5492589|NCT01326286|Prostatectomy|prostatectomy
5492590|NCT01326286|radiotherapy|radiotherapy
5492591|NCT01326286|quality of life|quality of life
5492592|NCT01326273|CMV|cmv
5492593|NCT01326273|cytomegalovirus|cytomegalovirus
5492594|NCT01326273|autologous|autologous
5492595|NCT01326273|leukemia|leukemia
5492596|NCT01326273|hematological malignancies|hematological malignancies
5492597|NCT01326273|stem cell transplantation|stem cell transplantation
5492598|NCT01326273|CMV reactivation|cmv reactivation
5492609|NCT01326221|tenofovir|tenofovir
5492610|NCT01326221|emtricitabine|emtricitabine
5492611|NCT01326221|Pharmacokinetics|pharmacokinetics
5492612|NCT01326221|Healthy Volunteers|healthy volunteers
5492613|NCT01326208|electrical impedance tomography|electrical impedance tomography
5492614|NCT01326208|positive end-expiratory pressure|positive end-expiratory pressure
5492615|NCT01326208|regional ventilation delay index|regional ventilation delay index
5492616|NCT01326195|HIV Prevention|hiv prevention
5492617|NCT01326195|Dating Violence|dating violence
5492619|NCT01326195|Romantic relationships|romantic relationships
5492620|NCT01326195|Adolescents|adolescents
5492621|NCT01326195|Sexuality|sexuality
5492622|NCT01326195|Underserved youth|underserved youth
5492623|NCT01326182|asthma|asthma
5492624|NCT01326182|depression|depression
5492625|NCT01326182|Latino|latino
5492626|NCT01326169|Alcohol|alcohol
5492627|NCT01326169|brief intervention|brief intervention
5492628|NCT01326169|injuries|injuries
5492629|NCT01326156|Osteoarthritis|osteoarthritis
5492630|NCT01326156|Knee|knee
5492631|NCT01326156|Knee cap|knee cap
5492632|NCT01326156|Patella|patella
5492633|NCT01326156|Patellofemoral|patellofemoral
5492640|NCT01326130|Integrated care network|integrated care network
5492641|NCT01326130|Chronic care model|chronic care model
5492642|NCT01326130|Health services research|health services research
5492643|NCT01326117|gastroparesis|gastroparesis
5492644|NCT01326117|gastric emptying|gastric emptying
5492645|NCT01326117|diabetes|diabetes
5492646|NCT01326117|Stomach Diseases|stomach diseases
5492647|NCT01326117|Gastrointestinal Diseases|gastrointestinal diseases
5492648|NCT01326117|Digestive System Diseases|digestive system diseases
5492649|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5492650|NCT01326117|Neurologic Manifestations|neurologic manifestations
5492651|NCT01326117|Paralysis|paralysis
5492652|NCT01326117|Signs and Symptoms|signs and symptoms
5492653|NCT01326117|Pharmacologic Actions|pharmacologic actions
5492654|NCT01326104|Medulloblastoma|medulloblastoma
5492655|NCT01326104|Primitive Neuroectodermal Tumor|primitive neuroectodermal tumor
5492656|NCT01326091|Lumbar fusion surgery|lumbar fusion surgery
5492657|NCT01326078|sedation|sedation
5492658|NCT01326078|children|children
5492659|NCT01326078|leukemia|leukemia
5492660|NCT01326078|bone marrow biopsy|bone marrow biopsy
5492661|NCT01326013|Stool|stool
5492662|NCT01326013|Feces|feces
5492663|NCT01326013|Gastrointestinal|gastrointestinal
5492664|NCT01326013|Pathogen|pathogen
5492665|NCT01326013|Panel|panel
5492666|NCT01326013|xTAG GPP|xtag gpp
5492667|NCT01326013|Infectious colitis|infectious colitis
5492668|NCT01326013|Gastroenteritis|gastroenteritis
5492669|NCT01326013|Detection|detection
5492670|NCT01325987|Type 2 diabetes|type 2 diabetes
5492671|NCT01325987|Vitamin D deficiency|vitamin d deficiency
5492672|NCT01325987|Glycemic control|glycemic control
5492673|NCT01325974|Malaria|malaria
5492674|NCT01325974|Plasmodium falciparum|plasmodium falciparum
5492675|NCT01325974|Diagnosis|diagnosis
5492676|NCT01325974|Rapid diagnostic test|rapid diagnostic test
5492677|NCT01325974|malaria transmission|malaria transmission
5492678|NCT01325961|prostate, cervical and anal canal cancers with pelvic lymph node irradiation|prostate, cervical and anal canal cancers with pelvic lymph node irradiation
5492679|NCT01325948|COPD|copd
5492680|NCT01325935|Coronary Artery Disease|coronary artery disease
5492681|NCT01325935|Coronary Disease|coronary disease
5492682|NCT01325935|Myocardial Ischemia|myocardial ischemia
5492683|NCT01325935|Heart Disease|heart disease
5492684|NCT01325935|Cardiovascular Disease|cardiovascular disease
5492685|NCT01325935|Arteriosclerosis|arteriosclerosis
5492686|NCT01325935|Arterial Occlusive Disease|arterial occlusive disease
5492687|NCT01325935|Vascular Disease|vascular disease
5492689|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5492690|NCT01325896|Multiple Mieloma, PEG-Intron|multiple mieloma, peg-intron
5492691|NCT01325870|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5492692|NCT01325818|Coronary Artery Disease|coronary artery disease
5492693|NCT01325818|Coronary Disease|coronary disease
5492694|NCT01325818|Dyslipidemia|dyslipidemia
5492695|NCT01325818|Stable Angina Pectoris|stable angina pectoris
5492696|NCT01325818|Heart Diseases|heart diseases
5492697|NCT01325818|Cardiovascular Diseases|cardiovascular diseases
5492698|NCT01325818|Arteriosclerosis|arteriosclerosis
5492699|NCT01325818|Arterial Occlusive Diseases|arterial occlusive diseases
5492700|NCT01325818|Vascular Diseases Pravastatin|vascular diseases pravastatin
5492701|NCT01325818|Rosuvastatin|rosuvastatin
5492702|NCT01325818|Anticholesteremic Agents|anticholesteremic agents
5492703|NCT01325818|Antilipemic Agents|antilipemic agents
5492704|NCT01325818|Antimetabolites|antimetabolites
5492705|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5492706|NCT01325818|Pharmacologic Actions|pharmacologic actions
5492707|NCT01325818|Therapeutic Uses|therapeutic uses
5492708|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5492709|NCT01325805|Miscarriage|miscarriage
5492710|NCT01325805|Recurrent Pregnancy Loss|recurrent pregnancy loss
5492711|NCT01325805|Obesity|obesity
5492712|NCT01325805|Overweight|overweight
5492713|NCT01325805|Diet|diet
5492714|NCT01325792|Complex ventral incisional hernia repair|complex ventral incisional hernia repair
5492715|NCT01325792|reapproximation of the rectus abdominis muscle|reapproximation of the rectus abdominis muscle
5492716|NCT01325792|retrorectus or intraperitoneal placement technique|retrorectus or intraperitoneal placement technique
5492717|NCT01325792|mobility for midline fascial closure|mobility for midline fascial closure
5492718|NCT01325779|deep venous thrombosis|deep venous thrombosis
5492720|NCT01325779|enoxaparin|enoxaparin
5492721|NCT01325779|heparin|heparin
5492722|NCT01325779|surgical intensive care|surgical intensive care
5492723|NCT01325766|Cystic Fibrosis|cystic fibrosis
5492724|NCT01325766|Yoga|yoga
5492725|NCT01325701|PCI-32765|pci-32765
5492726|NCT01325701|Lymphoma, B-Cell|lymphoma, b-cell
5492727|NCT01325701|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5492728|NCT01325701|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5492729|NCT01325701|Germinal Center B-Cell|germinal center b-cell
5492730|NCT01325701|Activated B-Cell|activated b-cell
5492731|NCT01325688|PEP005|pep005
5492732|NCT01325688|Peplin|peplin
5492733|NCT01325688|sBCC|sbcc
5492734|NCT01325675|Atrial fibrillation|atrial fibrillation
5492735|NCT01325675|Motor activity|motor activity
5492736|NCT01325649|rectal cancer|rectal cancer
5492737|NCT01325649|MRI|mri
5492738|NCT01325649|selective preoperative radiochemotherapy|selective preoperative radiochemotherapy
5492739|NCT01325649|involvement of circumferential resection margin|involvement of circumferential resection margin
5492740|NCT01325649|locoregional recurrence rate|locoregional recurrence rate
5492741|NCT01325636|Allogenic haematopoietic stem cell transplant|allogenic haematopoietic stem cell transplant
5492742|NCT01325636|Cytomegalovirus or Adenovirus infection|cytomegalovirus or adenovirus infection
5492743|NCT01325636|Graft versus Host|graft versus host
5492744|NCT01325623|Automatic Magnet Mode (AMM)|automatic magnet mode (amm)
5492745|NCT01325623|Vagal Nerve Stimulation|vagal nerve stimulation
5492746|NCT01325610|vitamin D|vitamin d
5492747|NCT01325610|kidney|kidney
5492748|NCT01325610|renal|renal
5492749|NCT01325597|Heart failure|heart failure
5492750|NCT01325597|Electric stimulation|electric stimulation
5492751|NCT01325597|Breathing exercises|breathing exercises
5492752|NCT01325571|prograf|prograf
5492753|NCT01325571|immunosuppressant|immunosuppressant
5492754|NCT01325558|cancer|cancer
5492755|NCT01325558|tissue factor|tissue factor
5492756|NCT01325558|solid tumor|solid tumor
5492757|NCT01325558|ovarian cancer|ovarian cancer
5492758|NCT01325558|breast cancer|breast cancer
5492759|NCT01325558|non-small cell lung cancer|non-small cell lung cancer
5492760|NCT01325558|colon cancer|colon cancer
5492761|NCT01325558|pancreatic cancer|pancreatic cancer
5492762|NCT01325558|head and neck cancer|head and neck cancer
5492763|NCT01325558|prostate cancer|prostate cancer
5492764|NCT01325558|soft-tissue sarcoma|soft-tissue sarcoma
5492765|NCT01325558|metastatic|metastatic
5492766|NCT01325558|gemcitabine|gemcitabine
5492767|NCT01325558|anti-tumor|anti-tumor
5492768|NCT01325558|venous thromboembolism|venous thromboembolism
5492769|NCT01325545|Stroke|stroke
5492770|NCT01325545|Atrial Fibrillation|atrial fibrillation
5492771|NCT01325532|depression|depression
5492772|NCT01325532|Major Depressive Disorder|major depressive disorder
5492773|NCT01325532|MDD|mdd
5492774|NCT01325532|Cranial Electrical Stimulation|cranial electrical stimulation
5492775|NCT01325532|CES|ces
5492776|NCT01325506|Prostatectomy|prostatectomy
5492777|NCT01325493|opioid tolerance|opioid tolerance
5492779|NCT01325493|scoliosis|scoliosis
5492780|NCT01325493|pupillometry|pupillometry
5492781|NCT01325480|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5492782|NCT01325480|Pacing|pacing
5492783|NCT01325480|His Bundle|his bundle
5492784|NCT01325467|coronary artery disease|coronary artery disease
5492785|NCT01325467|high frequency QRS analysis|high frequency qrs analysis
5492786|NCT01325467|ischemia|ischemia
5492787|NCT01325467|exercise testing|exercise testing
5492788|NCT01325467|diagnosis of coronary artery disease|diagnosis of coronary artery disease
5492789|NCT01325454|Pleural effusion|pleural effusion
5492790|NCT01325454|angiogenic cytokine|angiogenic cytokine
5492791|NCT01325454|fibrinolytic activity|fibrinolytic activity
5492792|NCT01325441|BBI608, thymic cancer|bbi608, thymic cancer
5492793|NCT01325415|Phase 1|phase 1
5492794|NCT01325415|healthy male volunteers|healthy male volunteers
5492795|NCT01325415|cross-over study|cross-over study
5492802|NCT01325376|obesity|obesity
5492803|NCT01325363|Schizophrenia|schizophrenia
5492804|NCT01325363|Novel metaphor|novel metaphor
5492805|NCT01325298|Keratoconus|keratoconus
5492806|NCT01325298|Ectasia|ectasia
5492807|NCT01325298|cross linking|cross linking
5685533|NCT00555724|Relapsed|relapsed
5492808|NCT01325298|collagen cross linking|collagen cross linking
5492809|NCT01325298|corneal crosslinking|corneal crosslinking
5492810|NCT01325298|corneal diseases|corneal diseases
5492811|NCT01325298|eye diseases|eye diseases
5492812|NCT01325285|Intraocular pressure|intraocular pressure
5492813|NCT01325285|Hypercapnia|hypercapnia
5492814|NCT01325285|Hyperoxia|hyperoxia
5492815|NCT01325285|Rebreathing circuit|rebreathing circuit
5492816|NCT01325272|otoacoustic emissions in newborns|otoacoustic emissions in newborns
5492817|NCT01325246|ventral hernia|ventral hernia
5492819|NCT01325246|clinical|clinical
5492820|NCT01325246|reoperation|reoperation
5492821|NCT01325233|Astragulus polysaccharides|astragulus polysaccharides
5492822|NCT01325233|Hemorrhagic stroke|hemorrhagic stroke
5492823|NCT01325207|Breast Cancer|breast cancer
5492824|NCT01325194|DLBCL|dlbcl
5492825|NCT01325194|FL grade 3B|fl grade 3b
5492826|NCT01325194|high risk|high risk
5492827|NCT01325194|CNS prophylaxis|cns prophylaxis
5492828|NCT01325194|chemoimmunotherapy|chemoimmunotherapy
5492829|NCT01325181|Chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5492830|NCT01325181|Ranibizumab|ranibizumab
5492831|NCT01325181|Photodynamic therapy|photodynamic therapy
5492832|NCT01325168|PTSD|ptsd
5492833|NCT01325168|empathy|empathy
5492834|NCT01325168|oxytocin|oxytocin
5492835|NCT01325155|Air Pollution|air pollution
5492836|NCT01325155|particulate matter|particulate matter
5492837|NCT01325155|cardiovascular Disease|cardiovascular disease
5492838|NCT01325142|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
5492839|NCT01325129|ESIN|esin
5492840|NCT01325129|Clavicular Fracture|clavicular fracture
5492841|NCT01325129|Dislocation|dislocation
5492842|NCT01325129|Children|children
5492843|NCT01325129|Adolescents|adolescents
5492844|NCT01325116|STEMI|stemi
5492845|NCT01325116|Medication Adherence|medication adherence
5492846|NCT01325116|Quality Improvement|quality improvement
5492847|NCT01325103|Spinal cord injury|spinal cord injury
5492848|NCT01325103|Mesenchymal stem cells|mesenchymal stem cells
5492849|NCT01325103|Bone marrow|bone marrow
5492850|NCT01325090|neuropathic pain due to thoracotomy|neuropathic pain due to thoracotomy
5492851|NCT01325090|Neuropathic Pain Due to Thoracoscopy|neuropathic pain due to thoracoscopy
5492975|NCT01324622|Myeloradiculopathy|myeloradiculopathy
5492852|NCT01325077|Nurse-based, acute pain service, pediatric, postoperative,|nurse-based, acute pain service, pediatric, postoperative,
5492853|NCT01325077|pain|pain
5492859|NCT01325051|raltegravir|raltegravir
5492860|NCT01325051|pharmacokinetics|pharmacokinetics
5492861|NCT01325051|healthy|healthy
5492862|NCT01325051|male|male
5492863|NCT01325051|volunteers|volunteers
5492864|NCT01325051|gastrointestinal|gastrointestinal
5492865|NCT01325051|tract|tract
5492866|NCT01325038|resting metabolic rate|resting metabolic rate
5492867|NCT01325025|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5492868|NCT01325025|Demyelinating Diseases|demyelinating diseases
5492869|NCT01325025|Magnetic Resonance Imaging|magnetic resonance imaging
5492870|NCT01325025|Diffusion Tensor Imaging|diffusion tensor imaging
5492871|NCT01325025|Relaxometry|relaxometry
5492872|NCT01325025|Spectroscopy|spectroscopy
5492873|NCT01325025|Longitudinal Studies|longitudinal studies
5492874|NCT01325012|Pain|pain
5492875|NCT01325012|Surgery|surgery
5492876|NCT01325012|Catheter|catheter
5492877|NCT01325012|Nerve Block|nerve block
5492878|NCT01325012|Popliteal|popliteal
5492879|NCT01325012|Subgluteal|subgluteal
5492880|NCT01325012|Sciatic|sciatic
5492881|NCT01325012|UCSD|ucsd
5492882|NCT01325012|Moderate-to-severe pain|moderate-to-severe pain
5492883|NCT01325012|Perineural Catheter|perineural catheter
5492884|NCT01325012|Orthopedic Surgery|orthopedic surgery
5492885|NCT01325012|foot surgery surgery|foot surgery surgery
5492886|NCT01325012|sciatic perineural catheter|sciatic perineural catheter
5492887|NCT01325012|age =>18|age =>18
5846751|NCT00043563|Cognitive-behavior Therapy|cognitive-behavior therapy
5492895|NCT01324960|IPSS|ipss
5492896|NCT01324960|High risk|high risk
5492897|NCT01324960|Azacitidine|azacitidine
5492898|NCT01324960|Ceplene|ceplene
5492899|NCT01324947|Myeloma|myeloma
5492900|NCT01324947|Multiple Myeloma|multiple myeloma
5492901|NCT01324947|Relapsed Multiple Myeloma|relapsed multiple myeloma
5492902|NCT01324947|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5492903|NCT01324947|Refractory Myeloma|refractory myeloma
5492904|NCT01324947|Resistant Multiple Myeloma|resistant multiple myeloma
5492905|NCT01324947|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5492906|NCT01324947|Pomalidomide|pomalidomide
5492907|NCT01324947|Lenalidomide-resistant|lenalidomide-resistant
5492908|NCT01324947|Bortezomib-resistant|bortezomib-resistant
5492909|NCT01324947|Companion|companion
5492910|NCT01324934|acute rejection|acute rejection
5492911|NCT01324934|chronic rejection|chronic rejection
5492912|NCT01324934|subclinical rejection|subclinical rejection
5492913|NCT01324934|renal transplantation|renal transplantation
5492914|NCT01324934|steroid-free|steroid-free
5492915|NCT01324934|kidney transplantation|kidney transplantation
5492916|NCT01324895|Small intestinal bacterial overgrowth syndrome (SIBO)|small intestinal bacterial overgrowth syndrome (sibo)
5492917|NCT01324895|bacterial overgrowth syndrome|bacterial overgrowth syndrome
5492918|NCT01324895|Small Bowel Bacterial Overgrowth Syndrome (SBBOS)|small bowel bacterial overgrowth syndrome (sbbos)
5492919|NCT01324895|14-Co2 D-Xylose Breath Testing|14-co2 d-xylose breath testing
5492920|NCT01324895|Antibiotics|antibiotics
5492921|NCT01324895|Prokinteics|prokinteics
5492922|NCT01324895|Prokinetic Agents|prokinetic agents
5492923|NCT01324882|colonoscopy|colonoscopy
5492924|NCT01324869|KH902|kh902
5492925|NCT01324869|Diabetic macular Edema|diabetic macular edema
5492926|NCT01324869|Intravitreal injection|intravitreal injection
5492927|NCT01324869|Multiple injections|multiple injections
5492928|NCT01324869|20 patients|20 patients
5492929|NCT01324869|0.5mg/eye/time|0.5mg/eye/time
5492930|NCT01324856|pancreatic cancer|pancreatic cancer
5492931|NCT01324856|periampulary cancer|periampulary cancer
5492932|NCT01324856|pancreaticogastro vs pancreaticojejuno anastomosis|pancreaticogastro vs pancreaticojejuno anastomosis
5492933|NCT01324843|Safety and Tolerability|safety and tolerability
5492934|NCT01324843|Intradermal Electroporation|intradermal electroporation
5492935|NCT01324817|Non-Contact|non-contact
5492936|NCT01324817|Radar|radar
5492937|NCT01324817|Doppler|doppler
5492938|NCT01324817|Respiratory|respiratory
5492939|NCT01324817|Respiration|respiration
5492940|NCT01324817|Breathing|breathing
5492941|NCT01324817|Rate|rate
5492942|NCT01324817|Frequency|frequency
5492943|NCT01324817|Respiratory Mechanics|respiratory mechanics
5492944|NCT01324817|Respiratory Rate Measurement|respiratory rate measurement
5492945|NCT01324817|Apnea|apnea
5492946|NCT01324817|Sleep Apnea|sleep apnea
5492947|NCT01324804|postoperative wound healing|postoperative wound healing
5492948|NCT01324778|Edentulism in the Upper Jaw|edentulism in the upper jaw
5492949|NCT01324765|Women|women
5492950|NCT01324765|PTSD|ptsd
5492951|NCT01324765|Group Therapy|group therapy
5492952|NCT01324765|Incarceration|incarceration
5492953|NCT01324752|Drug-drug interaction|drug-drug interaction
5492954|NCT01324752|Pharmacokinetics|pharmacokinetics
5492955|NCT01324752|PA21|pa21
5492957|NCT01324726|Extended spectrum beta lactamase producing organisms|extended spectrum beta lactamase producing organisms
5492958|NCT01324687|Telemedicine|telemedicine
5492959|NCT01324687|Geriatrics|geriatrics
5492960|NCT01324674|Common Mental Disorder|common mental disorder
5492961|NCT01324674|Efficacy of Bach´s flower remedy|efficacy of bach´s flower remedy
5492962|NCT01324674|Spiritual well-being|spiritual well-being
5492963|NCT01324648|Guided self-help|guided self-help
5492964|NCT01324648|Telephone delivery|telephone delivery
5492965|NCT01324648|Cognitive behavior therapy|cognitive behavior therapy
5492966|NCT01324648|Bibliotherapy|bibliotherapy
5492967|NCT01324635|glioma|glioma
5492968|NCT01324635|meningioma|meningioma
5492969|NCT01324635|brain metastasis|brain metastasis
5492970|NCT01324635|stereotactic|stereotactic
5474899|NCT01401075|QoL|qol
5492971|NCT01324635|radiotherapy|radiotherapy
5492972|NCT01324635|radiosurgery|radiosurgery
5492973|NCT01324622|Spinal Cord Diseases|spinal cord diseases
5492974|NCT01324622|Myelopathy|myelopathy
5492976|NCT01324622|Laminectomy|laminectomy
5492977|NCT01324622|Laminoplasty|laminoplasty
5492978|NCT01324609|choroidal nevus|choroidal nevus
5492979|NCT01324609|vitrectomy|vitrectomy
5492980|NCT01324596|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5492981|NCT01324596|Bortezomib|bortezomib
5492982|NCT01324596|R-CHOP|r-chop
5492983|NCT01324596|Molecular profiling|molecular profiling
5492984|NCT01324596|Chemotherapy|chemotherapy
5492985|NCT01324570|Pain|pain
5492986|NCT01324570|Opioid|opioid
5492987|NCT01324570|Analgesia|analgesia
5492988|NCT01324570|Moderate to severe pain|moderate to severe pain
5492989|NCT01324557|Continuous glucose monitoring|continuous glucose monitoring
5492990|NCT01324557|CAPD patients|capd patients
5492991|NCT01324557|Insulin pump|insulin pump
5492992|NCT01324544|Acute Pain|acute pain
5492993|NCT01324544|Opioid|opioid
5492995|NCT01324531|Bankart repair|bankart repair
5492996|NCT01324531|remplissage|remplissage
5492997|NCT01324531|Hill-Sachs defect|hill-sachs defect
5492998|NCT01324531|shoulder instability|shoulder instability
5492999|NCT01324531|anterior shoulder instability|anterior shoulder instability
5493000|NCT01324492|phase Ib,|phase ib,
5493001|NCT01324492|RAD001,|rad001,
5493002|NCT01324492|advanced pulmonary neuroendocrine tumor|advanced pulmonary neuroendocrine tumor
5493003|NCT01324479|Non-small cell lung cancer,|non-small cell lung cancer,
5493004|NCT01324479|hepatocellular,|hepatocellular,
5493005|NCT01324479|gastric,|gastric,
5493006|NCT01324479|renal cell,|renal cell,
5493007|NCT01324479|c-MET,|c-met,
5493008|NCT01324479|refractory,|refractory,
5493009|NCT01324479|glioblastoma,|glioblastoma,
5493010|NCT01324479|breast,|breast,
5493011|NCT01324479|nasopharyngeal,|nasopharyngeal,
5493012|NCT01324479|confirmed evidence of c-MET dysregulation|confirmed evidence of c-met dysregulation
5493013|NCT01324453|Acute Myocardial Infarction|acute myocardial infarction
5493014|NCT01324453|STEMI|stemi
5493015|NCT01324453|Post Conditioning|post conditioning
5493016|NCT01324453|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5493017|NCT01324440|Bacterial Vaccines|bacterial vaccines
5493018|NCT01324440|Staphylococcus Aureus|staphylococcus aureus
5493019|NCT01324440|Adjuvanted Vaccine|adjuvanted vaccine
5493020|NCT01324427|Telemedicine|telemedicine
5493021|NCT01324427|Virtual Medical Visit|virtual medical visit
5493022|NCT01324427|Quality of Life|quality of life
5493023|NCT01324427|11-022|11-022
5493024|NCT01324401|Peanut Allergy|peanut allergy
5493025|NCT01324401|Peanut Hypersensitivity|peanut hypersensitivity
5493027|NCT01324362|Asthma|asthma
5493028|NCT01324362|Sont|sont
5493029|NCT01324362|FSC|fsc
5493030|NCT01324362|BHR|bhr
5493031|NCT01324349|Hepatic|hepatic
5493032|NCT01324349|Topical Hemostat|topical hemostat
5493033|NCT01324336|ALL|all
5493034|NCT01324336|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5493035|NCT01324336|6-Mercaptopurine|6-mercaptopurine
5493036|NCT01324336|Pediatric|pediatric
5493037|NCT01324323|ROMI-001|romi-001
5493038|NCT01324323|romi|romi
5493039|NCT01324323|Romidepsin|romidepsin
5493040|NCT01324323|Istodax|istodax
5493041|NCT01324323|advanced malignancy|advanced malignancy
5493042|NCT01324323|PK|pk
5493043|NCT01324323|pharmacokinetics|pharmacokinetics
5493044|NCT01324310|ROMI-001|romi-001
5493045|NCT01324310|romi|romi
5493046|NCT01324310|Romidepsin|romidepsin
5493047|NCT01324310|Istodax|istodax
5493048|NCT01324310|advanced malignancy|advanced malignancy
5493049|NCT01324310|PK|pk
5493050|NCT01324310|pharmacokinetics|pharmacokinetics
5493051|NCT01324297|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5493052|NCT01324297|Sensitivity and Specificity|sensitivity and specificity
5493053|NCT01324297|Skin Tests|skin tests
5493054|NCT01324297|Biological Markers|biological markers
5493055|NCT01324284|Lubiprostone|lubiprostone
5493056|NCT01324284|Bowel preparation regime|bowel preparation regime
5493057|NCT01324271|Tympanostomy tube placement|tympanostomy tube placement
5493058|NCT01324258|pancreatic cancer (combination with gemcitabine)|pancreatic cancer (combination with gemcitabine)
5493059|NCT01324258|Non-small cell lung cancer (combination with gemcitabine)|non-small cell lung cancer (combination with gemcitabine)
5493060|NCT01324258|solid tumors (single agent)|solid tumors (single agent)
5493061|NCT01324258|MEK inhibitor|mek inhibitor
5493062|NCT01324258|GSK1120212|gsk1120212
5493063|NCT01324258|biliary cancer (combination with gemcitabine)|biliary cancer (combination with gemcitabine)
5493064|NCT01324258|urothelial cancer (combination with gemcitabine)|urothelial cancer (combination with gemcitabine)
5493065|NCT01324245|Salt|salt
5493066|NCT01324245|Balance|balance
5493067|NCT01324245|Renin Angiotensin System|renin angiotensin system
5493068|NCT01324245|Fenoldopam\blood Pressure|fenoldopam\blood pressure
5493069|NCT01324245|Sodium|sodium
5493070|NCT01324219|nursing staff|nursing staff
5493071|NCT01324219|residents|residents
5493072|NCT01324206|Magnetic Resonance Imaging|magnetic resonance imaging
5493073|NCT01324206|Healthy Volunteers|healthy volunteers
5493074|NCT01324180|ALL|all
5493075|NCT01324180|Relapsed|relapsed
5493076|NCT01324180|Refractory|refractory
5493077|NCT01324167|schizophrenia|schizophrenia
5493078|NCT01324167|schizoaffective disorder|schizoaffective disorder
5493084|NCT01324128|PA21|pa21
5493085|NCT01324128|Phosphate Binder|phosphate binder
5493086|NCT01324115|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5493087|NCT01324102|Neoplasms|neoplasms
5493088|NCT01324089|Resveratrol|resveratrol
5493089|NCT01324089|Piperine|piperine
5493090|NCT01324076|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5493091|NCT01324076|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5493092|NCT01324076|advanced adult primary liver cancer|advanced adult primary liver cancer
5493093|NCT01324063|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5493094|NCT01324037|suspected upper extremity deep vein thrombosis|suspected upper extremity deep vein thrombosis
5487374|NCT01348048|quality of life|quality of life
5493095|NCT01324037|diagnostic algorithm|diagnostic algorithm
5493096|NCT01324024|Menopause|menopause
5493097|NCT01324024|Aging|aging
5493098|NCT01324024|Memory|memory
5493099|NCT01324024|Women|women
5493100|NCT01323998|enlarged prostate|enlarged prostate
5493226|NCT01323517|Isolated Limb Infusion|isolated limb infusion
5493101|NCT01323998|Benign prostatic hyperplasia|benign prostatic hyperplasia
5493102|NCT01323998|alpha-blocker|alpha-blocker
5493103|NCT01323998|5-alpha-reductase inhibitor|5-alpha-reductase inhibitor
5493104|NCT01323972|Malaria|malaria
5493105|NCT01323972|Plasmodium falciparum|plasmodium falciparum
5493106|NCT01323959|BoostrixTM Polio|boostrixtm polio
5493107|NCT01323959|dTpa-IPV|dtpa-ipv
5493108|NCT01323959|booster|booster
5493109|NCT01323946|H5N1|h5n1
5493110|NCT01323946|influenza infection|influenza infection
5493111|NCT01323946|Influenza vaccine GSK1562902A|influenza vaccine gsk1562902a
5493112|NCT01323933|Solid tumors|solid tumors
5493113|NCT01323933|Oncology|oncology
5493114|NCT01323933|Cancer|cancer
5493115|NCT01323920|Stem Cell Transplant|stem cell transplant
5627876|NCT00788099|Aplidin|aplidin
5493116|NCT01323920|Allogeneic Transplant|allogeneic transplant
5493117|NCT01323920|Donors|donors
5493118|NCT01323907|Total Parenteral Nutrition-induced Cholestasis|total parenteral nutrition-induced cholestasis
5493119|NCT01323907|Omegaven|omegaven
5493120|NCT01323907|liver disease|liver disease
5493121|NCT01323907|Cholestasis|cholestasis
5493122|NCT01323907|Fat emulsions|fat emulsions
5493123|NCT01323881|theta burst stimulation, stroke, motor, plasticity|theta burst stimulation, stroke, motor, plasticity
5493124|NCT01323842|renal colic|renal colic
5493125|NCT01323842|hydronephrosis|hydronephrosis
5493126|NCT01323842|abdominal aortic aneurysm|abdominal aortic aneurysm
5493127|NCT01323842|ultrasound|ultrasound
5493128|NCT01323842|emergency medicine|emergency medicine
5493129|NCT01323842|urolithiasis|urolithiasis
5493130|NCT01323829|High Tone Pelvic Floor Dysfunction|high tone pelvic floor dysfunction
5493131|NCT01323829|Botulinum toxin type A|botulinum toxin type a
5493132|NCT01323829|EMG|emg
5493133|NCT01323803|Eosinophilic Esophagitis|eosinophilic esophagitis
5493134|NCT01323790|Non-Cancer-Related Pain|non-cancer-related pain
5493135|NCT01323790|Opioid-Induced Constipation|opioid-induced constipation
5493136|NCT01323777|Cataracts|cataracts
5493137|NCT01323777|Intraocular lens|intraocular lens
5493138|NCT01323777|Multifocal|multifocal
5493139|NCT01323777|Toric|toric
5493140|NCT01323777|Astigmatism|astigmatism
5493141|NCT01323777|Presbyopia|presbyopia
5493142|NCT01323764|Hydrocephalus|hydrocephalus
5493143|NCT01323764|CSF shunts|csf shunts
5493144|NCT01323764|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5493145|NCT01323764|NPH|nph
5493146|NCT01323764|ShuntCheck|shuntcheck
5493147|NCT01323764|Shunt Malfunction|shunt malfunction
5493148|NCT01323764|Suspected shunt malfunction in adult hydrocephalus patients|suspected shunt malfunction in adult hydrocephalus patients
5493149|NCT01323738|Psychoeducation|psychoeducation
5493150|NCT01323738|Group Control|group control
5493151|NCT01323725|Team-based financial incentives|team-based financial incentives
5493152|NCT01323725|Smoking cessation|smoking cessation
5493153|NCT01323712|CKD|ckd
5493154|NCT01323712|LV mass|lv mass
5493155|NCT01323712|Vitamin D|vitamin d
5493156|NCT01323712|LV function|lv function
5493157|NCT01323699|Parkinson Disease|parkinson disease
5493158|NCT01323699|Anxiety|anxiety
5493159|NCT01323699|Depression|depression
5493160|NCT01323647|IPV|ipv
5493161|NCT01323647|PoliorixTM|poliorixtm
5493162|NCT01323647|China|china
5493163|NCT01323608|Thalassemia|thalassemia
5493164|NCT01323608|hypercalciuria|hypercalciuria
5493165|NCT01323608|vitamin D|vitamin d
5493166|NCT01323608|To conduct a pilot study to determine the effect of various doses of|to conduct a pilot study to determine the effect of various doses of
5493167|NCT01323608|vitamin D supplementation on vitamin D stores and their association with calcium excretion|vitamin d supplementation on vitamin d stores and their association with calcium excretion
5493168|NCT01323595|Pain control|pain control
5493169|NCT01323595|testicular sperm extraction|testicular sperm extraction
5493171|NCT01323582|Gastroparesis|gastroparesis
5493172|NCT01323582|Gastroparesis Treatment|gastroparesis treatment
5493173|NCT01323582|Gastric Emptying|gastric emptying
5493174|NCT01323582|Prokinetic Agents|prokinetic agents
5493175|NCT01323582|Macrolides|macrolides
5493176|NCT01323582|Erythromycin|erythromycin
5493177|NCT01323582|Azithromycin|azithromycin
5493178|NCT01323582|Erythromycin Cardiac Side-effects|erythromycin cardiac side-effects
5493179|NCT01323582|Erythromycin drug interactions|erythromycin drug interactions
5493180|NCT01323582|AZI|azi
5493181|NCT01323569|Sativex|sativex
5493182|NCT01323569|Cannabinoids|cannabinoids
5493183|NCT01323569|Abuse potential|abuse potential
5493184|NCT01323569|Addiction|addiction
5493185|NCT01323556|Panic disorder|panic disorder
5493186|NCT01323556|agoraphobia|agoraphobia
5493187|NCT01323556|panic attacks|panic attacks
5493188|NCT01323556|exposure based learning|exposure based learning
5493189|NCT01323556|interoceptive exposure exercises|interoceptive exposure exercises
5493193|NCT01323543|Back Pains, Low|back pains, low
5493194|NCT01323543|Low Back Pains|low back pains
5493195|NCT01323543|Pain, Low Back|pain, low back
5493198|NCT01323543|Lower Back Pain|lower back pain
5493199|NCT01323543|Back Pain, Lower|back pain, lower
5493200|NCT01323543|Back Pains, Lower|back pains, lower
5493201|NCT01323543|Lower Back Pains|lower back pains
5493202|NCT01323543|Pain, Lower Back|pain, lower back
5493203|NCT01323543|Pains, Lower Back|pains, lower back
5493204|NCT01323543|Low Back Ache|low back ache
5493205|NCT01323543|Ache, Low Back|ache, low back
5493206|NCT01323543|Aches, Low Back|aches, low back
5493207|NCT01323543|Back Ache, Low|back ache, low
5493208|NCT01323543|Back Aches, Low|back aches, low
5493209|NCT01323543|Low Back Aches|low back aches
5493210|NCT01323543|Low Backache|low backache
5493211|NCT01323543|Backache, Low|backache, low
5493212|NCT01323543|Backaches, Low|backaches, low
5493213|NCT01323543|Low Backaches|low backaches
5493214|NCT01323543|Low Back Pain, Recurrent|low back pain, recurrent
5493215|NCT01323543|Recurrent Low Back Pain|recurrent low back pain
5493216|NCT01323543|Low Back Pain, Postural|low back pain, postural
5493217|NCT01323543|Postural Low Back Pain|postural low back pain
5493218|NCT01323543|Low Back Pain, Mechanical|low back pain, mechanical
5493219|NCT01323543|Mechanical Low Back Pain|mechanical low back pain
5493220|NCT01323543|Low Back Pain, Posterior Compartment|low back pain, posterior compartment
5493221|NCT01323530|metastatic breast cancer|metastatic breast cancer
5493222|NCT01323517|skin|skin
5493223|NCT01323517|DACTINOMYCIN|dactinomycin
5493224|NCT01323517|MDX-010 (Ipilimumab)|mdx-010 (ipilimumab)
5493225|NCT01323517|MELPHALAN|melphalan
5493227|NCT01323517|10-101|10-101
5493228|NCT01323504|Stage 5 arteritis|stage 5 arteritis
5493229|NCT01323504|Stage 6 arteritis|stage 6 arteritis
5493230|NCT01323504|rutherford classification|rutherford classification
5493231|NCT01323491|smoking cessation|smoking cessation
5493232|NCT01323491|nicotine replacement therapy|nicotine replacement therapy
5493233|NCT01323491|routine smokers|routine smokers
5493234|NCT01323478|Depressive Disorder|depressive disorder
5493235|NCT01323478|Depression|depression
5493236|NCT01323478|Depressive Disorder, Major|depressive disorder, major
5493237|NCT01323478|Mood Disorders|mood disorders
5493238|NCT01323478|Mental Disorders|mental disorders
5493239|NCT01323478|Behavioural Symptoms|behavioural symptoms
5493240|NCT01323465|Sativex|sativex
5493241|NCT01323465|Cytochrome P450|cytochrome p450
5493242|NCT01323465|Pharmacokinetics|pharmacokinetics
5493243|NCT01323465|Cannabinoids|cannabinoids
5493244|NCT01323465|ketoconazole|ketoconazole
5493245|NCT01323465|omeprazole|omeprazole
5493246|NCT01323465|rifampicin|rifampicin
5493247|NCT01323452|entecavir|entecavir
5493248|NCT01323452|hepatitis B|hepatitis b
5493249|NCT01323439|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
5493250|NCT01323426|urinary incontinence, stress|urinary incontinence, stress
5493251|NCT01323426|autologous|autologous
5493252|NCT01323413|stroke|stroke
5493253|NCT01323413|penumbra|penumbra
5493254|NCT01323413|determinants|determinants
5493255|NCT01323413|CT perfusion|ct perfusion
5493256|NCT01323400|GIST|gist
5493257|NCT01323400|Resistant|resistant
5493258|NCT01323400|Pazopanib|pazopanib
5493259|NCT01323400|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5493260|NCT01323400|Best supportive care|best supportive care
5493261|NCT01323400|Progression-free survival|progression-free survival
5493262|NCT01323400|Overall survival|overall survival
5493263|NCT01323400|Objective response rate|objective response rate
5493264|NCT01323400|Best response|best response
5493265|NCT01323400|Tolerance profile|tolerance profile
5493266|NCT01323374|Fibromyalgia|fibromyalgia
5493268|NCT01323374|droxidopa|droxidopa
5493269|NCT01323374|pain|pain
5493270|NCT01323361|inflammation|inflammation
5493271|NCT01323361|laparoscopy|laparoscopy
5493272|NCT01323361|hernia|hernia
5493273|NCT01323361|incisional|incisional
5493274|NCT01323361|trauma|trauma
5493275|NCT01323348|Diabetes|diabetes
5493277|NCT01323348|Diabetic Retinopathy|diabetic retinopathy
5493279|NCT01323335|Uric Acid|uric acid
5493280|NCT01323335|Rasburicase|rasburicase
5493281|NCT01323335|Inflammatory Markers|inflammatory markers
5493282|NCT01323322|Socioeconomic Status|socioeconomic status
5493283|NCT01323322|Longitudinal Study|longitudinal study
5493284|NCT01323322|Health Disparities|health disparities
5493285|NCT01323322|Epidemiology|epidemiology
5493286|NCT01323322|Diversity|diversity
5493290|NCT01323296|Myocardial infarction|myocardial infarction
5493291|NCT01323296|Magnetic resonance|magnetic resonance
5493292|NCT01323296|Nanoparticle|nanoparticle
5493293|NCT01323296|Iron|iron
5493294|NCT01323296|Inflammation|inflammation
5493295|NCT01323283|Omega-3|omega-3
5493296|NCT01323283|physical activity|physical activity
5493297|NCT01323283|children|children
5493298|NCT01323283|obesity|obesity
5493299|NCT01323283|sedentary|sedentary
5493300|NCT01323283|accelerometry|accelerometry
5493301|NCT01323283|BMI|bmi
5493302|NCT01323283|fatty acids|fatty acids
5493303|NCT01323283|inflammatory markers|inflammatory markers
5493304|NCT01323283|intervention|intervention
5493305|NCT01323283|randomized|randomized
5493306|NCT01323283|double blind|double blind
5493307|NCT01323270|Healthy adolescents|healthy adolescents
5493308|NCT01323257|TMC435-TiDP16-C115|tmc435-tidp16-c115
5493309|NCT01323257|TMC435-C115|tmc435-c115
5493310|NCT01323257|TMC435|tmc435
5493311|NCT01323257|HCV|hcv
5493312|NCT01323257|Hepatitis C|hepatitis c
5493313|NCT01323257|Hep C|hep c
5493314|NCT01323257|healthy volunteers|healthy volunteers
5493315|NCT01323244|TMC435-TiDP16-C213|tmc435-tidp16-c213
5493316|NCT01323244|TMC435-C213|tmc435-c213
5493317|NCT01323244|TMC435|tmc435
5493318|NCT01323244|HCV|hcv
5493319|NCT01323244|Hepatitis C|hepatitis c
5493320|NCT01323231|XY-Zone|xy-zone
5493321|NCT01323231|school drop-out risk|school drop-out risk
5493322|NCT01323231|protective factors|protective factors
5493323|NCT01323231|truancy|truancy
5493324|NCT01323218|Obstructive sleep apnea-hypopnea syndrome|obstructive sleep apnea-hypopnea syndrome
5493325|NCT01323218|OSAHS|osahs
5493326|NCT01323218|Vitamin D|vitamin d
5493327|NCT01323205|JNJ-40411813|jnj-40411813
5493328|NCT01323192|Concerta|concerta
5493329|NCT01323192|Adults|adults
5493330|NCT01323192|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5493331|NCT01323192|ADHD|adhd
5493332|NCT01323192|Methylphenidate hydrochloride|methylphenidate hydrochloride
5493333|NCT01323179|Postoperative pain|postoperative pain
5493334|NCT01323179|Postoperative opioid requirements|postoperative opioid requirements
5493335|NCT01323166|rectal cancer|rectal cancer
5493336|NCT01323140|hypogonadism, testosterone, transdermal system|hypogonadism, testosterone, transdermal system
5493337|NCT01323114|type 2 diabetes mellitus|type 2 diabetes mellitus
5493338|NCT01323114|non-morbidly obese|non-morbidly obese
5493339|NCT01323114|laparoscopic duodenal exclusion|laparoscopic duodenal exclusion
5493340|NCT01323088|Childhood obesity|childhood obesity
5493341|NCT01323088|Visceral fat|visceral fat
5493342|NCT01323088|Insulin resistance|insulin resistance
5493343|NCT01323088|Liver fat|liver fat
5493344|NCT01323088|Skeletal muscle lipid|skeletal muscle lipid
5493345|NCT01323088|Regular exercise|regular exercise
5493346|NCT01323062|chemotherapy naive|chemotherapy naive
5493347|NCT01323062|stage IV non squamous non small cell lung cancer|stage iv non squamous non small cell lung cancer
5493348|NCT01323062|Phase 1b|phase 1b
5493349|NCT01323062|Bavituximab|bavituximab
5493350|NCT01323062|Chimeric 3G4|chimeric 3g4
5493351|NCT01323062|U of North Carolina at Chapel Hill|u of north carolina at chapel hill
5493352|NCT01323049|extubation strategy|extubation strategy
5493353|NCT01323010|asthma|asthma
5493354|NCT01323010|albuterol|albuterol
5493355|NCT01323010|metered dose inhalers|metered dose inhalers
5493356|NCT01322984|ASD|asd
5493357|NCT01322984|Startle|startle
5493358|NCT01322971|Bacterial Vaginosis|bacterial vaginosis
5493359|NCT01322971|Infertility|infertility
5493360|NCT01322971|Miscarriage|miscarriage
5493361|NCT01322971|Metronidazole|metronidazole
5493362|NCT01322958|bedside ultrasound|bedside ultrasound
5493363|NCT01322932|Medication Adherence|medication adherence
5493364|NCT01322932|HIV Infection|hiv infection
5493365|NCT01322932|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [Substance Name]|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination [substance name]
5493366|NCT01322932|efavirenz|efavirenz
5493367|NCT01322932|emtricitabine|emtricitabine
5493368|NCT01322932|Patient Satisfaction|patient satisfaction
5493369|NCT01322932|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5493370|NCT01322919|PresbyLASIK|presbylasik
5493371|NCT01322919|Presbyopia|presbyopia
5493372|NCT01322919|LASIK|lasik
5493373|NCT01322919|Supracor|supracor
5493374|NCT01322919|refractive|refractive
5493375|NCT01322919|Myopia|myopia
5493376|NCT01322919|Hyperopia|hyperopia
5493377|NCT01322906|ABMLF|abmlf
5493378|NCT01322906|Allogenic Bone marrow Mesenchymal Stem Cells|allogenic bone marrow mesenchymal stem cells
5493379|NCT01322906|Liver Failure|liver failure
5493380|NCT01322906|Transplantation|transplantation
5493381|NCT01322893|Metastatic breast cancer|metastatic breast cancer
5493382|NCT01322893|Circulating tumour cells|circulating tumour cells
5493383|NCT01322893|CTC|ctc
5493384|NCT01322893|Prognostic factors|prognostic factors
5493385|NCT01322893|Treatment response|treatment response
5493386|NCT01322880|domestic violence|domestic violence
5493387|NCT01322867|bioequivalence study|bioequivalence study
5493388|NCT01322867|alprazolam|alprazolam
5493389|NCT01322867|frontal|frontal
5493390|NCT01322854|IMRT|imrt
5493391|NCT01322854|Integrated boost|integrated boost
5493392|NCT01322854|adjuvant radiotherapy|adjuvant radiotherapy
5493393|NCT01322854|breast cancer|breast cancer
5493795|NCT01321216|vaccine|vaccine
5493394|NCT01322854|breast conserving surgery|breast conserving surgery
5493395|NCT01322841|CHICA|chica
5493396|NCT01322841|clinical decision support|clinical decision support
5493397|NCT01322828|Bicep|bicep
5493398|NCT01322828|Tendon|tendon
5493399|NCT01322828|Distal|distal
5493400|NCT01322828|Ruptures|ruptures
5493401|NCT01322828|Randomized|randomized
5493402|NCT01322828|Surgery|surgery
5493403|NCT01322815|colon cancer|colon cancer
5493404|NCT01322815|metastatic|metastatic
5493405|NCT01322815|vaccine|vaccine
5493406|NCT01322802|Ovarian Cancer|ovarian cancer
5493407|NCT01322802|Vaccine|vaccine
5493408|NCT01322802|Stage III|stage iii
5493409|NCT01322802|Stage IV|stage iv
5493410|NCT01322802|Remission|remission
5493411|NCT01322789|Diabetes mellitus|diabetes mellitus
5493412|NCT01322789|Stem cells|stem cells
5493413|NCT01322789|Autologous stem cell transplantation|autologous stem cell transplantation
5493414|NCT01322789|Autoimmune diseases|autoimmune diseases
5493415|NCT01322776|Mantle Cell Lymphoma|mantle cell lymphoma
5493416|NCT01322776|Recurrent|recurrent
5493417|NCT01322776|Bortezomib|bortezomib
5493418|NCT01322776|Combination Treatment|combination treatment
5493419|NCT01322737|resection|resection
5493420|NCT01322737|open|open
5493421|NCT01322737|laparoscopic|laparoscopic
5493422|NCT01322737|benign|benign
5493423|NCT01322737|malignant|malignant
5493424|NCT01322737|disease|disease
5493425|NCT01322737|colon|colon
5477888|NCT01387971|Limbal insufficiency|limbal insufficiency
5493426|NCT01322737|gastric|gastric
5479492|NCT01381094|CKD|ckd
5493427|NCT01322724|colonoscopy|colonoscopy
5493428|NCT01322724|colon cancer screening|colon cancer screening
5493429|NCT01322724|patient discomfort scores|patient discomfort scores
5493430|NCT01322724|sedation medication requirements|sedation medication requirements
5493431|NCT01322724|water insertion method|water insertion method
5493432|NCT01322711|Thromboxane|thromboxane
5493433|NCT01322711|Aspirin|aspirin
5493434|NCT01322711|Atorvastatin|atorvastatin
5493435|NCT01322711|Platelet activation|platelet activation
5493436|NCT01322711|Thrombin Activation|thrombin activation
5493437|NCT01322711|Oxidative stress|oxidative stress
5493439|NCT01322685|Tuberculosis|tuberculosis
5493440|NCT01322685|Lung cancer|lung cancer
5493441|NCT01322672|Anesthetic Agents|anesthetic agents
5493442|NCT01322672|POCD|pocd
5493443|NCT01322672|Delirium|delirium
5493444|NCT01322672|Cognitive Testing|cognitive testing
5493445|NCT01322672|Aging|aging
5493446|NCT01322672|Surgery|surgery
5493447|NCT01322672|fMRI|fmri
5493448|NCT01322672|Diffusion Tensor Imaging|diffusion tensor imaging
5493449|NCT01322672|White Matter|white matter
5493450|NCT01322659|Mechanical ventilation|mechanical ventilation
5493451|NCT01322659|Weaning|weaning
5493452|NCT01322659|Noninvasive ventilation|noninvasive ventilation
5493453|NCT01322659|Acute respiratory failure|acute respiratory failure
5493454|NCT01322659|Helmet|helmet
5493455|NCT01322646|ADHD|adhd
5493456|NCT01322646|Driving|driving
5493457|NCT01322646|Behavior modification|behavior modification
5493458|NCT01322633|Pantoprazole|pantoprazole
5493459|NCT01322633|proton pump inhibitor|proton pump inhibitor
5493460|NCT01322633|gastric cancer|gastric cancer
5493461|NCT01322633|digestive system cancer|digestive system cancer
5493462|NCT01322633|cancer|cancer
5493463|NCT01322607|Exercise|exercise
5493464|NCT01322607|Rehabilitation|rehabilitation
5493465|NCT01322607|Stroke|stroke
5493466|NCT01322594|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5493467|NCT01322594|COPD|copd
5493468|NCT01322581|Plasmodium|plasmodium
5493469|NCT01322581|PBMC|pbmc
5493470|NCT01322581|Malaria|malaria
5493471|NCT01322568|Aging|aging
5493472|NCT01322568|Gene|gene
5493473|NCT01322568|Environment|environment
5493474|NCT01322568|Inflammation|inflammation
5493475|NCT01322568|Iceland|iceland
5493476|NCT01322555|PBR28|pbr28
5493477|NCT01322555|Positron Emission Tomography (PET)|positron emission tomography (pet)
5493478|NCT01322555|Propofol|propofol
5493479|NCT01322555|Autism|autism
5493480|NCT01322555|Immune Response|immune response
5493481|NCT01322555|Autism Spectrum Disorders|autism spectrum disorders
5493483|NCT01322555|Healthy Volunteer|healthy volunteer
5493484|NCT01322555|HV|hv
5493485|NCT01322529|nulliparity|nulliparity
5493486|NCT01322529|pregnant women|pregnant women
5493487|NCT01322529|pregnancy outcomes|pregnancy outcomes
5493488|NCT01322529|pregnancy complications|pregnancy complications
5493490|NCT01322490|metastatic|metastatic
5493491|NCT01322490|prostate cancer|prostate cancer
5493492|NCT01322490|castrate-resistant|castrate-resistant
5493493|NCT01322490|vaccine|vaccine
5493494|NCT01322490|immunotherapy|immunotherapy
5493495|NCT01322490|Phase 3|phase 3
5493496|NCT01322477|Identification of treatment efficacy in patients with advanced HCC by PET/CT F18-FDG|identification of treatment efficacy in patients with advanced hcc by pet/ct f18-fdg
5493497|NCT01322464|Sativex|sativex
5493498|NCT01322464|bio-availability|bio-availability
5493499|NCT01322464|cannabinoid|cannabinoid
5493500|NCT01322464|pharmacokinetics|pharmacokinetics
5493501|NCT01322451|Safety|safety
5493502|NCT01322451|Tolerability|tolerability
5493503|NCT01322451|Pharmacokinetics|pharmacokinetics
5493504|NCT01322438|healthy volunteers|healthy volunteers
5493505|NCT01322438|rifampin|rifampin
5493506|NCT01322438|pharmacokinetics|pharmacokinetics
5493507|NCT01322438|single dose|single dose
5493508|NCT01322412|Adapted physical activity|adapted physical activity
5493509|NCT01322412|breast cancer|breast cancer
5493510|NCT01322399|low back pain|low back pain
5493511|NCT01322399|chronic pain|chronic pain
5493512|NCT01322399|manual therapy|manual therapy
5493513|NCT01322399|Structural Integration|structural integration
5493515|NCT01322386|BA|ba
5493516|NCT01322373|Alzheimer's disease|alzheimer's disease
5493517|NCT01322373|magnetoencephalography|magnetoencephalography
5493518|NCT01322373|MEG|meg
5493519|NCT01322373|SNI|sni
5493520|NCT01322347|End Stage Renal Disease|end stage renal disease
5493521|NCT01322347|Hemodialysis|hemodialysis
5493522|NCT01322347|SFP|sfp
5493523|NCT01322347|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
5493524|NCT01322334|Snoring|snoring
5493525|NCT01322334|Sleep apnea|sleep apnea
5493526|NCT01322334|Pharyngeal muscle tone|pharyngeal muscle tone
5493527|NCT01322321|ACZ885|acz885
5493528|NCT01322321|diabetes|diabetes
5493529|NCT01322321|type 1|type 1
5493530|NCT01322321|C-peptide|c-peptide
5493531|NCT01322308|lupus|lupus
5493532|NCT01322308|HDL particles|hdl particles
5493533|NCT01322308|endothelial function|endothelial function
5493534|NCT01322308|pioglitazone|pioglitazone
5493535|NCT01322243|Anxiety|anxiety
5493536|NCT01322243|Metabolic state|metabolic state
5493537|NCT01322243|Stress|stress
5493538|NCT01322230|Instructional Design|instructional design
5493539|NCT01322230|Online learning module|online learning module
5493540|NCT01322230|Surgical education|surgical education
5493541|NCT01322217|Medication adherence|medication adherence
5493542|NCT01322217|Substance use|substance use
5493543|NCT01322217|Sexual risk behaviors|sexual risk behaviors
5493544|NCT01322204|codeine, neonates, pediatric pharmacology|codeine, neonates, pediatric pharmacology
5493545|NCT01322191|pain, pain management, pediatrics, morphine pharmacokinetics|pain, pain management, pediatrics, morphine pharmacokinetics
5493546|NCT01322178|cetuximab|cetuximab
5493547|NCT01322178|colorectal carcinoma|colorectal carcinoma
5493548|NCT01322165|Marfan syndrome|marfan syndrome
5493549|NCT01322165|Turner syndrome|turner syndrome
5493550|NCT01322165|Bicuspid aortic valve|bicuspid aortic valve
5493551|NCT01322165|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5493552|NCT01322165|Loeys-Dietz syndrome|loeys-dietz syndrome
5493553|NCT01322165|Aneurysm|aneurysm
5493554|NCT01322165|Genetic|genetic
5493555|NCT01322165|aortic|aortic
5493556|NCT01322165|thoracic|thoracic
5493557|NCT01322165|mutation|mutation
5493558|NCT01322165|dissection|dissection
5493559|NCT01322152|metastases|metastases
5493560|NCT01322152|neoplasm|neoplasm
5493561|NCT01322139|Sativex|sativex
5493562|NCT01322139|Cannabinoid|cannabinoid
5493563|NCT01322139|Electrocardiogram|electrocardiogram
5493564|NCT01322139|QT interval|qt interval
5493565|NCT01322113|BIPOLAR|bipolar
5493566|NCT01322113|MANIA|mania
5493567|NCT01322113|DEPRESSION|depression
5493568|NCT01322100|Brain Metastases, CNS Metastases|brain metastases, cns metastases
5493569|NCT01322087|Nutrition|nutrition
5493570|NCT01322087|new energy dense food concept|new energy dense food concept
5493571|NCT01322074|Acute postoperative pain|acute postoperative pain
5493572|NCT01322074|systemic inflammation|systemic inflammation
5493574|NCT01322074|IL6|il6
5493575|NCT01322061|Gallbladder removal|gallbladder removal
5493576|NCT01322061|acute cholecystitis|acute cholecystitis
5493577|NCT01322061|Laparoscopic cholecestectomy|laparoscopic cholecestectomy
5493578|NCT01322048|Sympathetic Hyperactivity|sympathetic hyperactivity
5493579|NCT01322048|Traumatic Brain Injury|traumatic brain injury
5493580|NCT01322048|Agitation|agitation
5493581|NCT01322048|Severe TBI|severe tbi
5493582|NCT01322048|TBI|tbi
5493583|NCT01322048|Catecholamines|catecholamines
5493584|NCT01322048|Heart rate variability|heart rate variability
5493585|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists
5493586|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5493587|NCT01322048|Cognitive Impairment|cognitive impairment
5493588|NCT01322022|Autism|autism
5493589|NCT01322022|Autism Spectrum Disorders|autism spectrum disorders
5493590|NCT01322022|Sleep Problems|sleep problems
5493591|NCT01322022|Sleep Disturbances|sleep disturbances
5493592|NCT01322022|Interventions|interventions
5493593|NCT01322009|Children|children
5493594|NCT01322009|Brain injury|brain injury
5493596|NCT01321996|PET/CT|pet/ct
5493597|NCT01321996|68Ga-DOTANOC|68ga-dotanoc
5493598|NCT01321996|IPF|ipf
5493599|NCT01321996|NSIP|nsip
5493600|NCT01321996|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5493601|NCT01321931|Smoking Cessation|smoking cessation
5493602|NCT01321931|Nicotine pharmacokinetics|nicotine pharmacokinetics
5493603|NCT01321892|HRME|hrme
5493604|NCT01321892|High-resolution microendoscope|high-resolution microendoscope
5493605|NCT01321892|Optical imaging technology|optical imaging technology
5493606|NCT01321892|Non-invasive fluorescence and reflectance imaging|non-invasive fluorescence and reflectance imaging
5493607|NCT01321892|Upper aerodigestive tract|upper aerodigestive tract
5493608|NCT01321892|Cancer surgery|cancer surgery
5493609|NCT01321892|Squamous cell carcinoma|squamous cell carcinoma
5493610|NCT01321892|Oral cavity|oral cavity
5493611|NCT01321892|Oropharynx|oropharynx
5493612|NCT01321892|Larynx|larynx
5493613|NCT01321892|Hypopharynx|hypopharynx
5493862|NCT01320956|children|children
5493614|NCT01321892|Squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx|squamous cell carcinoma of the oral cavity, oropharynx, larynx, and/or hypopharynx
5493615|NCT01321879|Gram Positive Bloodstream Infections|gram positive bloodstream infections
5493617|NCT01321879|Staphylococcus aureus|staphylococcus aureus
5493618|NCT01321879|Enterococci|enterococci
5493619|NCT01321879|Streptococci|streptococci
5493620|NCT01321879|Pneumococci|pneumococci
5493621|NCT01321879|Corynebacterium|corynebacterium
5493622|NCT01321879|Propionibacterium or Bacillus species|propionibacterium or bacillus species
5493623|NCT01321879|Telavancin|telavancin
5493624|NCT01321879|Vibativ|vibativ
5493625|NCT01321866|Angioplasty|angioplasty
5493626|NCT01321866|cutting balloon|cutting balloon
5493627|NCT01321853|Home health care|home health care
5493628|NCT01321853|Medication Management|medication management
5493629|NCT01321853|Cognitive impairment|cognitive impairment
5493630|NCT01321853|Medication adherence|medication adherence
5493631|NCT01321853|Older adults|older adults
5685534|NCT00555724|refractory|refractory
5493632|NCT01321853|Care Coordination management|care coordination management
5493633|NCT01321840|Endometriosis|endometriosis
5493634|NCT01321840|pain|pain
5493635|NCT01321840|sart|sart
5493636|NCT01321840|autonomic nervous system|autonomic nervous system
5493637|NCT01321840|fMRI|fmri
5493638|NCT01321840|perfusion|perfusion
5493639|NCT01321840|connectivity|connectivity
5493640|NCT01321840|hypnotherapy|hypnotherapy
5493641|NCT01321840|traditional Chinese medicine|traditional chinese medicine
5493642|NCT01321827|ABPA|abpa
5493643|NCT01321814|Hyperacusis|hyperacusis
5493644|NCT01321814|Personality|personality
5493645|NCT01321814|Comorbidity|comorbidity
5493646|NCT01321814|Treatment|treatment
5493647|NCT01321814|Cognitive behavioral therapy|cognitive behavioral therapy
5493648|NCT01321801|Pregabalin|pregabalin
5493649|NCT01321801|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5493650|NCT01321801|Postoperative pain|postoperative pain
5493651|NCT01321801|Opioid consumption|opioid consumption
5493652|NCT01321788|thromboprophylaxis|thromboprophylaxis
5493653|NCT01321788|pregnancy|pregnancy
5493654|NCT01321788|post-cesarian section|post-cesarian section
5493655|NCT01321762|Prolapse|prolapse
5493656|NCT01321762|Childbirth|childbirth
5493657|NCT01321762|Pregnancy|pregnancy
5493658|NCT01321749|ischemic cerebral vascular disease|ischemic cerebral vascular disease
5493659|NCT01321749|stroke secondary prevention|stroke secondary prevention
5493660|NCT01321749|remote ischemic preconditioning|remote ischemic preconditioning
5493661|NCT01321736|dietary fiber|dietary fiber
5493662|NCT01321736|enteral nutrition|enteral nutrition
5493663|NCT01321736|laxation|laxation
5493664|NCT01321723|Osteoporosis|osteoporosis
5493665|NCT01321723|Bone Diseases, Metabolic|bone diseases, metabolic
5493666|NCT01321723|Bone Diseases|bone diseases
5493667|NCT01321723|Bone Density Conservation Agents|bone density conservation agents
5493668|NCT01321710|sleep hygiene|sleep hygiene
5493669|NCT01321710|actigraphy|actigraphy
5493670|NCT01321710|maternal|maternal
5493671|NCT01321710|infant|infant
5493672|NCT01321710|postpartum period|postpartum period
5493673|NCT01321710|immunization|immunization
5493674|NCT01321710|acetaminophen|acetaminophen
5493675|NCT01321697|Being seen in the Winthrop P. Rockefeller Cancer Institute for vulvar|being seen in the winthrop p. rockefeller cancer institute for vulvar
5493676|NCT01321697|cancer requiring lymph node evaluation for the ipsilateral or contralateral|cancer requiring lymph node evaluation for the ipsilateral or contralateral
5493677|NCT01321697|groin|groin
5493678|NCT01321671|pregabalin|pregabalin
5493679|NCT01321671|pharmacokinetics|pharmacokinetics
5493680|NCT01321671|bioavailability|bioavailability
5493681|NCT01321671|bioequivalence|bioequivalence
5493682|NCT01321658|Geriatric Assessment|geriatric assessment
5493683|NCT01321658|Perioperative Care|perioperative care
5493684|NCT01321658|Colorectal Neoplasms|colorectal neoplasms
5493685|NCT01321658|Frail Elderly|frail elderly
5493686|NCT01321645|Acne Vulgaris|acne vulgaris
5493687|NCT01321645|Homoeopathy|homoeopathy
5493688|NCT01321645|Homeopathy|homeopathy
5493689|NCT01321645|Azadirachta Indica|azadirachta indica
5493690|NCT01321632|Acne Vulgaris|acne vulgaris
5493691|NCT01321632|Homoeopathy|homoeopathy
5493692|NCT01321632|Zingiber officinalis|zingiber officinalis
5493693|NCT01321619|Chronic venous insufficiency|chronic venous insufficiency
5493694|NCT01321619|Hemorrhoidal syndrome|hemorrhoidal syndrome
5493695|NCT01321619|Varicell|varicell
5493696|NCT01321606|infection|infection
5493697|NCT01321606|probiotics|probiotics
5493698|NCT01321567|rabeprazole sodium|rabeprazole sodium
5493699|NCT01321567|refractory reflux esophagitis|refractory reflux esophagitis
5493700|NCT01321541|non-hodgkin lymphoma|non-hodgkin lymphoma
5493701|NCT01321541|DLBCL|dlbcl
5493702|NCT01321541|relapsed|relapsed
5493703|NCT01321541|aggressive NHL|aggressive nhl
5493704|NCT01321541|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5493705|NCT01321541|Rituximab|rituximab
5493706|NCT01321541|Rituxan|rituxan
5493707|NCT01321541|Pixantrone|pixantrone
5493709|NCT01321541|non hodgkin's lymphoma|non hodgkin's lymphoma
5493710|NCT01321541|de novo DLBCL|de novo dlbcl
5493711|NCT01321541|DLBCL transformed from Indolent Lymphoma|dlbcl transformed from indolent lymphoma
5487958|NCT01345799|Crohn's Disease|crohn's disease
5493715|NCT01321489|Sildenafil Citrate Tablet Sublingual|sildenafil citrate tablet sublingual
5493716|NCT01321489|Erectile dysfunction|erectile dysfunction
5493717|NCT01321437|Melanoma|melanoma
5493718|NCT01321437|Axitinib|axitinib
5493719|NCT01321437|Anti-angiogenesis|anti-angiogenesis
5493720|NCT01321437|Neoadjuvant Melanoma|neoadjuvant melanoma
5493721|NCT01321424|Dry Eye|dry eye
5493722|NCT01321424|Tear Osmolarity|tear osmolarity
5493723|NCT01321424|Meibomain Gland Disease|meibomain gland disease
5493724|NCT01321424|Aqueous Dificiency|aqueous dificiency
5493725|NCT01321424|Tear film abnormality|tear film abnormality
5628530|NCT00786019|Women|women
5493726|NCT01321411|Respiratory Muscle Blood Flow|respiratory muscle blood flow
5493727|NCT01321411|Work of Breathing|work of breathing
5685535|NCT00555724|solid tumor|solid tumor
5493729|NCT01321398|High Frequency Oscillation|high frequency oscillation
5493730|NCT01321398|Oscillation|oscillation
5493732|NCT01321398|Transpulmonary pressure|transpulmonary pressure
5493733|NCT01321385|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5493734|NCT01321385|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5493735|NCT01321385|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5493736|NCT01321385|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5493737|NCT01321385|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5493738|NCT01321385|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5493739|NCT01321385|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5493740|NCT01321385|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5493741|NCT01321385|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5493742|NCT01321385|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5493743|NCT01321385|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5493744|NCT01321346|Relapse|relapse
5493745|NCT01321346|Lymphoblastic|lymphoblastic
5493746|NCT01321346|Leukemia|leukemia
5493747|NCT01321346|Panobinostat|panobinostat
5493748|NCT01321346|LBH589|lbh589
5493749|NCT01321346|Refractory|refractory
5493750|NCT01321346|Hodgkin's|hodgkin's
5493751|NCT01321346|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5493753|NCT01321346|Myelogenous|myelogenous
5493754|NCT01321346|Acute|acute
5493755|NCT01321346|Childhood|childhood
5493756|NCT01321346|Pediatric|pediatric
5493757|NCT01321346|ALL|all
5493758|NCT01321346|AML|aml
5493759|NCT01321346|NHL|nhl
5493760|NCT01321346|HD|hd
5493761|NCT01321333|thoracic spinal cord injury|thoracic spinal cord injury
5493762|NCT01321333|spinal cord injury thoracic|spinal cord injury thoracic
5493763|NCT01321333|sub-acute spinal cord injury|sub-acute spinal cord injury
5493764|NCT01321333|human neural stem cells|human neural stem cells
5493765|NCT01321333|stem cells|stem cells
5493766|NCT01321333|stem cells transplant|stem cells transplant
5493767|NCT01321333|stem cells transplant spinal cord injury|stem cells transplant spinal cord injury
5493768|NCT01321320|ICUAP|icuap
5493769|NCT01321320|Critical illness|critical illness
5493770|NCT01321320|Muscle wasting|muscle wasting
5493771|NCT01321320|ICU|icu
5493772|NCT01321307|Aphtostomatitis|aphtostomatitis
5493773|NCT01321307|Mucositis|mucositis
5493774|NCT01321307|Mouth sores|mouth sores
5493775|NCT01321307|Natural|natural
5493776|NCT01321307|Herbal|herbal
5493777|NCT01321281|Osteoarthritis|osteoarthritis
5493778|NCT01321268|orange peel skin|orange peel skin
5493779|NCT01321268|cellulite|cellulite
5493780|NCT01321255|Myocardial Infarction|myocardial infarction
5493781|NCT01321255|Treatment Adherence|treatment adherence
5493782|NCT01321242|Resting heart rate|resting heart rate
5475683|NCT01397721|smokers|smokers
5493783|NCT01321242|Stable Angina|stable angina
5493784|NCT01321242|Hypertension|hypertension
5493785|NCT01321242|beta-blockers|beta-blockers
5493786|NCT01321229|Sleep apnea|sleep apnea
5493787|NCT01321229|NIHSS scale|nihss scale
5493788|NCT01321229|FIM scale|fim scale
5493789|NCT01321229|FUGL-MEYER scale|fugl-meyer scale
5493790|NCT01321216|rotavirus|rotavirus
5493791|NCT01321216|gastroenteritis|gastroenteritis
5493792|NCT01321216|children|children
5493793|NCT01321216|Pediatric|pediatric
5493794|NCT01321216|dehydration|dehydration
5493796|NCT01321203|carbon dioxide insufflation|carbon dioxide insufflation
5493797|NCT01321177|Schizophrenia|schizophrenia
5493798|NCT01321177|Schizoaffective Disorder|schizoaffective disorder
5493799|NCT01321177|Schizophreniform Disorder|schizophreniform disorder
5493800|NCT01321177|Brief Psychotic Disorder|brief psychotic disorder
5493801|NCT01321177|Psychotic Disorder NOS|psychotic disorder nos
5493802|NCT01321177|First Episode|first episode
5493804|NCT01321151|Concussions|concussions
5493805|NCT01321151|Resveratrol|resveratrol
5493806|NCT01321151|Boxers|boxers
5493807|NCT01321151|ImPACT|impact
5493809|NCT01321138|Electrophysiological study|electrophysiological study
5493810|NCT01321138|Nerve block|nerve block
5493811|NCT01321138|Analgesia, Patient-Controlled|analgesia, patient-controlled
5493812|NCT01321138|Anterior cruciate ligament|anterior cruciate ligament
5493813|NCT01321125|Antiseptics|antiseptics
5493814|NCT01321125|Administration cutaneously|administration cutaneously
5493815|NCT01321125|Chlorine compounds|chlorine compounds
5493816|NCT01321125|Anti-infecting agents, local|anti-infecting agents, local
5493817|NCT01321112|Conversion|conversion
5493818|NCT01321112|Mycophenolate mofetil|mycophenolate mofetil
5493819|NCT01321112|Calcineurin inhibitors|calcineurin inhibitors
5493820|NCT01321112|Liver transplantation|liver transplantation
5493821|NCT01321112|Gene expression|gene expression
5493822|NCT01321099|Iron absorption|iron absorption
5493823|NCT01321099|Complementary food fortificant|complementary food fortificant
5493824|NCT01321099|Young children|young children
5493826|NCT01321060|severe acute pancreatitis|severe acute pancreatitis
5493827|NCT01321060|acute fluid collection|acute fluid collection
5493828|NCT01321060|catheter drainage|catheter drainage
5493829|NCT01321060|repeated aspiration|repeated aspiration
5493830|NCT01321047|sedation|sedation
5493831|NCT01321047|benzodiazepine|benzodiazepine
5493833|NCT01321047|propofol|propofol
5493834|NCT01321034|Lipoprotein (a)|lipoprotein (a)
5493835|NCT01321034|LPA|lpa
5493836|NCT01321034|Niacin|niacin
5493837|NCT01321034|Kringle IV-2 repeats|kringle iv-2 repeats
5493838|NCT01321008|NK cell lymphoma-nasal type|nk cell lymphoma-nasal type
5493839|NCT01321008|Stage I/II|stage i/ii
5493840|NCT01321008|Radiation therapy|radiation therapy
5493841|NCT01321008|XRT|xrt
5493842|NCT01321008|chemotherapy|chemotherapy
5493843|NCT01321008|CHOP|chop
5493844|NCT01321008|Cyclophosphamide|cyclophosphamide
5493845|NCT01321008|Cytoxan|cytoxan
5493846|NCT01321008|Neosar|neosar
5493847|NCT01321008|Adriamycin|adriamycin
5493848|NCT01321008|Doxorubicin|doxorubicin
5493849|NCT01321008|Rubex|rubex
5493850|NCT01321008|Vincristine|vincristine
5493851|NCT01321008|Oncovin|oncovin
5493852|NCT01321008|Prednisone|prednisone
5493853|NCT01320995|Second degree vaginal tear|second degree vaginal tear
5493854|NCT01320995|Perineal ultrasound|perineal ultrasound
5493855|NCT01320995|Anal incontinence|anal incontinence
5493856|NCT01320982|Schizophrenia|schizophrenia
5493857|NCT01320982|schizoaffective disorder|schizoaffective disorder
5493858|NCT01320969|mindfulness, fear conditioning|mindfulness, fear conditioning
5493859|NCT01320956|hypnosis|hypnosis
5493860|NCT01320956|HYPNOANALGESIA|hypnoanalgesia
5493861|NCT01320956|surgery|surgery
5493863|NCT01320956|anxiety|anxiety
5493864|NCT01320956|morphine|morphine
5493865|NCT01320956|pain|pain
5493866|NCT01320956|A-VAS|a-vas
5493867|NCT01320956|orthopaedics|orthopaedics
5493868|NCT01320956|osteotomy|osteotomy
5493869|NCT01320956|tenotomy|tenotomy
5493870|NCT01320956|arthrodesis|arthrodesis
5493871|NCT01320956|spinal column surgery|spinal column surgery
5493872|NCT01320943|stopping oral antiviral therapy|stopping oral antiviral therapy
5493873|NCT01320943|HBsAg loss|hbsag loss
5493874|NCT01320943|seroconversion|seroconversion
5493875|NCT01320943|restarting oral antiviral therapy|restarting oral antiviral therapy
5493876|NCT01320930|Effect of Pulmonary rehabilitation.|effect of pulmonary rehabilitation.
5493877|NCT01320930|Exercise capacity|exercise capacity
5493878|NCT01320930|Quality of life|quality of life
5493879|NCT01320917|obesity|obesity
5493880|NCT01320917|contraceptives hormonal|contraceptives hormonal
5493881|NCT01320917|levonorgestrel-releasing intrauterine device|levonorgestrel-releasing intrauterine device
5493882|NCT01320917|cardiovascular risk|cardiovascular risk
5493883|NCT01320904|Closed Kinetic Chain|closed kinetic chain
5493884|NCT01320904|NMES|nmes
5493885|NCT01320904|Knee Osteoarthritis|knee osteoarthritis
5493886|NCT01320891|general anaesthesia for major abdominal surgery|general anaesthesia for major abdominal surgery
5493887|NCT01320878|pulmonary hypertension|pulmonary hypertension
5493888|NCT01320852|Transplant|transplant
5493889|NCT01320826|colonoscopy|colonoscopy
5493890|NCT01320826|primary care physicians|primary care physicians
5493891|NCT01320826|quality assurance|quality assurance
5493892|NCT01320813|da vinci robot|da vinci robot
5493893|NCT01320813|Thyroidectomy|thyroidectomy
5493894|NCT01320787|Brain|brain
5493895|NCT01320787|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5493896|NCT01320787|Locally advanced breast cancer|locally advanced breast cancer
5493897|NCT01320787|Estrogen receptor|estrogen receptor
5493898|NCT01320787|ER|er
5493899|NCT01320787|Progesterone receptor|progesterone receptor
5493900|NCT01320787|PR|pr
5493901|NCT01320787|Negative for ErbB2|negative for erbb2
5493902|NCT01320787|Malignant tumor of the central nervous system|malignant tumor of the central nervous system
5493903|NCT01320787|CNS|cns
5493904|NCT01320761|Formulation Comparison|formulation comparison
5493905|NCT01320748|Abstinence from alcohol|abstinence from alcohol
5493906|NCT01320748|Substance Abuse and Mental Health Services|substance abuse and mental health services
5493907|NCT01320748|Social Support|social support
5493908|NCT01320748|Psychosocial Support Systems|psychosocial support systems
5493909|NCT01320748|Psychological support|psychological support
5493910|NCT01320748|Cognitive Support|cognitive support
5493911|NCT01320748|Emotional Support|emotional support
5493912|NCT01320748|Mental Support|mental support
5493913|NCT01320748|Psychosocial Support|psychosocial support
5493914|NCT01320748|Intervention Studies|intervention studies
5493915|NCT01320748|Prevention & control|prevention & control
5493916|NCT01320748|Preventive therapy|preventive therapy
5493917|NCT01320748|Treatment|treatment
5493918|NCT01320748|Therapy|therapy
5478389|NCT01386021|allograft|allograft
5493919|NCT01320748|Magnetic Resonance Imaging|magnetic resonance imaging
5493920|NCT01320748|fMRI|fmri
5493921|NCT01320748|Imaging|imaging
5493922|NCT01320748|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5493924|NCT01320748|MRI, Functional|mri, functional
5493925|NCT01320748|Clinical Protocols|clinical protocols
5493926|NCT01320748|Protocols, Treatment|protocols, treatment
5493927|NCT01320748|Drug Abuse Treatment Center|drug abuse treatment center
5493928|NCT01320748|Substance Abuse Treatment Center|substance abuse treatment center
5493929|NCT01320735|Lucrin Depot|lucrin depot
5493930|NCT01320735|intermittent adjuvant regimen|intermittent adjuvant regimen
5493931|NCT01320735|advanced prostate cancer|advanced prostate cancer
5493932|NCT01320735|Leuprorelin|leuprorelin
5493933|NCT01320722|renin angiotensin system|renin angiotensin system
5493934|NCT01320722|vitamin D|vitamin d
5493935|NCT01320722|uric acid|uric acid
5493936|NCT01320722|allopurinol|allopurinol
5493937|NCT01320722|probenecid|probenecid
5493938|NCT01320722|endothelial function|endothelial function
5493939|NCT01320709|Emergency contraception|emergency contraception
5493940|NCT01320709|Contraception|contraception
5493941|NCT01320670|pharmacoresistance|pharmacoresistance
5493942|NCT01320657|Self-ligating|self-ligating
5493943|NCT01320657|orthodontic|orthodontic
5493944|NCT01320657|appliance|appliance
5493945|NCT01320657|expansion|expansion
5493946|NCT01320657|dental inclination|dental inclination
5493947|NCT01320657|Expansion and inclination changes arising with orthodontic treatment|expansion and inclination changes arising with orthodontic treatment
5493948|NCT01320644|Uterine prolapse|uterine prolapse
5493949|NCT01320644|vaginal prolapse|vaginal prolapse
5493950|NCT01320644|mesh erosion|mesh erosion
5493951|NCT01320644|urinary incontinence|urinary incontinence
5493952|NCT01320644|bowel symptoms|bowel symptoms
5493953|NCT01320631|uterine prolapse|uterine prolapse
5493954|NCT01320631|vaginal prolapse|vaginal prolapse
5493955|NCT01320618|uterine prolapse|uterine prolapse
5493956|NCT01320618|vaginal prolapse|vaginal prolapse
5493957|NCT01320618|mesh erosion|mesh erosion
5493958|NCT01320618|urinary incontinence|urinary incontinence
5493959|NCT01320618|bowel symptoms|bowel symptoms
5493960|NCT01320592|Patient must have histologically or cytologically-confirmed metastatic|patient must have histologically or cytologically-confirmed metastatic
5493961|NCT01320592|breast cancer|breast cancer
5493962|NCT01320592|Any ER, PR or Her2 status is allowed.|any er, pr or her2 status is allowed.
5493963|NCT01320592|Tumor must express Retinoblastoma (Rb) protein, defined as|tumor must express retinoblastoma (rb) protein, defined as
5493964|NCT01320592|any measurable staining by immunohistochemistry on the invasive tumor component|any measurable staining by immunohistochemistry on the invasive tumor component
5493965|NCT01320592|<3 prior cyttoxic chemotherapy regimens for metastatic disease.|<3 prior cyttoxic chemotherapy regimens for metastatic disease.
5493966|NCT01320592|Performance status of 0-1 on the ECOG Performance Scale and life expectancy > 3 months.|performance status of 0-1 on the ecog performance scale and life expectancy > 3 months.
5493967|NCT01320592|Patient must have evaluable disease. Measureable disease is not required.|patient must have evaluable disease. measureable disease is not required.
5493968|NCT01320592|The subject has adequate organ function|the subject has adequate organ function
5493969|NCT01320579|atopic dermatitis|atopic dermatitis
5493970|NCT01320579|cis-urocanic acid|cis-urocanic acid
5846752|NCT00043563|Minimal Attention Control|minimal attention control
5493971|NCT01320566|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
5493972|NCT01320566|Bolilogic Lung Volume Reduction (BLVR)|bolilogic lung volume reduction (blvr)
5493973|NCT01320566|AeriSeal|aeriseal
5493974|NCT01320566|treatment|treatment
5493975|NCT01320566|device|device
5493976|NCT01320566|breathing|breathing
5493977|NCT01320566|COPD|copd
5493978|NCT01320566|emphysema|emphysema
5493979|NCT01320566|heterogeneous|heterogeneous
5493980|NCT01320566|homogeneous|homogeneous
5493981|NCT01320566|Pathologic Processes|pathologic processes
5493982|NCT01320566|Respiratory Tract Diseases|respiratory tract diseases
5493983|NCT01320566|Lung Diseases|lung diseases
5493984|NCT01320566|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5494192|NCT01319682|Lidocaine|lidocaine
5493985|NCT01320527|dietary supplement|dietary supplement
5493986|NCT01320527|cognition|cognition
5493987|NCT01320527|mood|mood
5493988|NCT01320527|Alzheimer's disease|alzheimer's disease
5493989|NCT01320527|memory loss|memory loss
5493990|NCT01320501|Lung Cancer|lung cancer
5493991|NCT01320488|Breast Cancer|breast cancer
5493992|NCT01320475|thoracic epidural analgesia|thoracic epidural analgesia
5493993|NCT01320475|epidural opioid|epidural opioid
5493994|NCT01320475|ketamine|ketamine
5493995|NCT01320475|adverse effect|adverse effect
5493996|NCT01320462|Smoking|smoking
5493997|NCT01320462|quit|quit
5493998|NCT01320462|surgery|surgery
5493999|NCT01320462|anesthesia|anesthesia
5494000|NCT01320462|champix|champix
5494001|NCT01320449|EPO|epo
5494002|NCT01320449|Proteomics|proteomics
5494003|NCT01320449|Carbohydrate metabolism|carbohydrate metabolism
5494004|NCT01320449|Fat metabolism|fat metabolism
5494005|NCT01320449|Protein metabolism|protein metabolism
5494006|NCT01320436|Ulcerative colitis|ulcerative colitis
5494007|NCT01320436|Curcumin|curcumin
5494008|NCT01320423|Intracerebral Haemorrhage|intracerebral haemorrhage
5494009|NCT01320384|ALI|ali
5494010|NCT01320371|barbed sutures|barbed sutures
5494011|NCT01320371|knotted sutures|knotted sutures
5494012|NCT01320371|total knee arthroplasty|total knee arthroplasty
5494013|NCT01320371|knee surgery|knee surgery
5494014|NCT01320358|Patient compliance|patient compliance
5494015|NCT01320358|ECMPS-IEM|ecmps-iem
5494016|NCT01320358|transplantation|transplantation
5494017|NCT01320358|renal maintenance|renal maintenance
5494018|NCT01320358|Proteus|proteus
5494019|NCT01320345|Diabetes Mellitus|diabetes mellitus
5494020|NCT01320345|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5494021|NCT01320345|Retinopathy|retinopathy
5494022|NCT01320345|Diabetic Nephropathy|diabetic nephropathy
5494023|NCT01320345|Fenofibrate|fenofibrate
5494024|NCT01320332|Ulcerative colitis|ulcerative colitis
5494025|NCT01320332|ASP3291|asp3291
5494026|NCT01320293|Moderate to Severe Chronic plaque type psoriasis|moderate to severe chronic plaque type psoriasis
5494027|NCT01320280|Prostate cancer, BIBW 2992 (Afatinib) , HER inhibitor|prostate cancer, bibw 2992 (afatinib) , her inhibitor
5494028|NCT01320267|Resectable right colon cancer|resectable right colon cancer
5494029|NCT01320254|Palliative treatment|palliative treatment
5494030|NCT01320254|Panitumumab|panitumumab
5494031|NCT01320254|Cisplatin|cisplatin
5494032|NCT01320254|Cisplatinum|cisplatinum
5494033|NCT01320254|Gemcitabine|gemcitabine
5494034|NCT01320254|Vectibix|vectibix
5494035|NCT01320228|Obesity|obesity
5494036|NCT01320228|orlistat|orlistat
5494037|NCT01320228|fat excretion|fat excretion
5494038|NCT01320228|fiber|fiber
5494039|NCT01320228|dairy calcium|dairy calcium
5494040|NCT01320215|da Vinci Robot|da vinci robot
5494041|NCT01320215|uterine prolapse|uterine prolapse
5494042|NCT01320215|vaginal prolapse|vaginal prolapse
5494043|NCT01320215|sacrohysteropexy|sacrohysteropexy
5494044|NCT01320202|End Stage Renal Disease|end stage renal disease
5494045|NCT01320202|Hemodialysis|hemodialysis
5494046|NCT01320202|SFP|sfp
5494047|NCT01320202|Hemodialysis-dependent chronic renal failure|hemodialysis-dependent chronic renal failure
5494048|NCT01320189|Energy intake|energy intake
5494049|NCT01320189|Protein requirement|protein requirement
5494050|NCT01320189|Satiety|satiety
5494051|NCT01320189|Protein leverage hypothesis|protein leverage hypothesis
5494052|NCT01320150|persistent postsurgical pain (PPP)|persistent postsurgical pain (ppp)
5494053|NCT01320137|Immunological assay|immunological assay
5494054|NCT01320137|Birch allergy|birch allergy
5494055|NCT01320124|Contractures|contractures
5494056|NCT01320124|Total knee arthroplasty|total knee arthroplasty
5494057|NCT01320124|Tissue bank|tissue bank
5494058|NCT01320124|Osteoarthritis|osteoarthritis
5494059|NCT01320124|Gene expressions|gene expressions
5494060|NCT01320111|progression free survival|progression free survival
5494061|NCT01320111|paclitaxel|paclitaxel
5494062|NCT01320111|sorafenib|sorafenib
5494063|NCT01320111|metastatic breast cancer|metastatic breast cancer
5494064|NCT01320098|Attention|attention
5494065|NCT01320098|Behavior Problems|behavior problems
5494066|NCT01320098|Compliance|compliance
5494067|NCT01320098|Evaluation|evaluation
5494068|NCT01320098|Preschool|preschool
5494069|NCT01320098|ADHD|adhd
5494070|NCT01320098|Overactive|overactive
5494071|NCT01320098|Inattentive|inattentive
5846753|NCT00043550|Major Depressive Disorder|major depressive disorder
5494072|NCT01320098|Attention Deficit Hyperactivity Disorder in Preschoolers|attention deficit hyperactivity disorder in preschoolers
5475980|NCT01396382|PET Scan|pet scan
5494073|NCT01320085|Metastatic melanoma,|metastatic melanoma,
5494074|NCT01320085|BRAF-mutant,|braf-mutant,
5494075|NCT01320085|NRAS-mutant|nras-mutant
5494076|NCT01320072|aspirin|aspirin
5494077|NCT01320072|asthma|asthma
5494078|NCT01320072|diagnosis|diagnosis
5494079|NCT01320072|prostaglandins|prostaglandins
5494080|NCT01320072|leukotrienes|leukotrienes
5494081|NCT01320059|18F-Fluoro-PEG6-IPQA|18f-fluoro-peg6-ipqa
5494082|NCT01320059|Radioactive Imaging Solution|radioactive imaging solution
5494083|NCT01320059|Non-Small Cell Lung Cancer|non-small cell lung cancer
5494084|NCT01320059|Positron Emission Tomography|positron emission tomography
5494085|NCT01320059|PET Scan|pet scan
5494086|NCT01320059|CT|ct
5494087|NCT01320059|Computed Tomography|computed tomography
5494088|NCT01320046|Urinary Incontinence|urinary incontinence
5494089|NCT01320046|Vulvar pruritus|vulvar pruritus
5494090|NCT01320046|Vulvar contact dermatitis|vulvar contact dermatitis
5494097|NCT01320020|Monoclonal Antibody|monoclonal antibody
5494098|NCT01320020|Removab|removab
5494099|NCT01319994|glucocorticoid|glucocorticoid
5494100|NCT01319981|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5494101|NCT01319981|ALL|all
5494102|NCT01319981|Lymphoblastic lymphoma|lymphoblastic lymphoma
5494103|NCT01319981|Cytoxan|cytoxan
5494104|NCT01319981|Neosar|neosar
5494105|NCT01319981|Mesnex|mesnex
5494106|NCT01319981|Liposomal Vincristine|liposomal vincristine
5494107|NCT01319981|Vincristine Sulfate Liposomes Injection|vincristine sulfate liposomes injection
5494108|NCT01319981|Marqibo|marqibo
5494109|NCT01319981|Dexamethasone|dexamethasone
5494110|NCT01319981|Adriamycin|adriamycin
5494111|NCT01319981|Rubex|rubex
5494113|NCT01319981|Cytosar|cytosar
5494114|NCT01319981|DepoCyt|depocyt
5494115|NCT01319981|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5494116|NCT01319981|Imatinib Mesylate|imatinib mesylate
5494117|NCT01319981|Gleevec|gleevec
5494118|NCT01319981|ST1571|st1571
5494119|NCT01319981|NSC-716051|nsc-716051
5494120|NCT01319981|Filgrastim|filgrastim
5494121|NCT01319981|Neupogen|neupogen
5494122|NCT01319968|Postpartum dyspareunia|postpartum dyspareunia
5494123|NCT01319968|Vaginal atrophy|vaginal atrophy
5494124|NCT01319955|Pneumonia|pneumonia
5494125|NCT01319955|Influenza|influenza
5494126|NCT01319955|Child|child
5494127|NCT01319955|Respiratory|respiratory
5494128|NCT01319955|Pathogen|pathogen
5494129|NCT01319942|Radiotherapy|radiotherapy
5494130|NCT01319942|Sorafenib|sorafenib
5494131|NCT01319942|Treatment outcome|treatment outcome
5494132|NCT01319929|Osteoarthritis, knee pain, osteoarthritic knee pain|osteoarthritis, knee pain, osteoarthritic knee pain
5494133|NCT01319903|sepsis|sepsis
5494134|NCT01319903|inflammation|inflammation
5494135|NCT01319903|complement|complement
5494136|NCT01319903|immune system|immune system
5494137|NCT01319890|all histologic subtypes|all histologic subtypes
5494138|NCT01319890|benign|benign
5494139|NCT01319890|malignant|malignant
5494140|NCT01319864|leukemia|leukemia
5494141|NCT01319851|bone marrow transplant|bone marrow transplant
5494142|NCT01319851|sickle cell disease|sickle cell disease
5494143|NCT01319851|thalassemia|thalassemia
5494144|NCT01319851|Glanzmann thrombasthenia|glanzmann thrombasthenia
5494145|NCT01319851|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5494146|NCT01319851|chronic-granulomatous disease|chronic-granulomatous disease
5494147|NCT01319851|severe congenital neutropenia|severe congenital neutropenia
5494148|NCT01319851|leukocyte adhesion deficiency|leukocyte adhesion deficiency
5494149|NCT01319851|Schwachman-Diamond syndrome|schwachman-diamond syndrome
5494150|NCT01319851|Diamond-Blackfan anemia|diamond-blackfan anemia
5494151|NCT01319851|Fanconi anemia|fanconi anemia
5494152|NCT01319851|dyskeratosis-congenita|dyskeratosis-congenita
5494153|NCT01319851|Chediak-Higashi syndrome|chediak-higashi syndrome
5494154|NCT01319851|severe aplastic anemia|severe aplastic anemia
5494155|NCT01319838|neuroblastoma|neuroblastoma
5494156|NCT01319838|isotretinoin|isotretinoin
5494157|NCT01319812|Vascular intervention|vascular intervention
5494158|NCT01319812|Endovascular|endovascular
5494159|NCT01319812|Peripheral stent|peripheral stent
5494160|NCT01319799|Embolism|embolism
5494161|NCT01319799|Nervous system|nervous system
5494162|NCT01319799|Aorta|aorta
5494163|NCT01319799|Valves|valves
5494164|NCT01319799|Ultrasonics|ultrasonics
5494165|NCT01319786|Hypertension|hypertension
5494166|NCT01319786|Microvascular function|microvascular function
5494167|NCT01319760|STEMI|stemi
5494168|NCT01319747|atrial|atrial
5494169|NCT01319747|fibrillation|fibrillation
5494170|NCT01319747|pvi|pvi
5494171|NCT01319747|vats|vats
5494172|NCT01319747|ablation|ablation
5494173|NCT01319734|Vitamin C|vitamin c
5494174|NCT01319734|Oxidative stress|oxidative stress
5494175|NCT01319734|Type 2DM|type 2dm
5494176|NCT01319721|Amniotic membrane|amniotic membrane
5494177|NCT01319721|Limbal conjunctival autograft|limbal conjunctival autograft
5494178|NCT01319721|Limbal|limbal
5494179|NCT01319721|Conjunctival|conjunctival
5494180|NCT01319721|Mitomycin C|mitomycin c
5494181|NCT01319721|Recurrent pterygium|recurrent pterygium
5494182|NCT01319721|Pterygium|pterygium
5494183|NCT01319708|ovarian stimulation|ovarian stimulation
5494184|NCT01319708|climiphene citrate|climiphene citrate
5494185|NCT01319708|Gonadotropin-Releasing Hormone agonists/antagonists|gonadotropin-releasing hormone agonists/antagonists
5494186|NCT01319708|Follicle Stimulating Hormone|follicle stimulating hormone
5494187|NCT01319695|corifollitropin alfa|corifollitropin alfa
5494188|NCT01319695|FSH ovarian stimulation|fsh ovarian stimulation
5494198|NCT01319656|Chronic Care Model|chronic care model
5494199|NCT01319656|Patient centered medical home|patient centered medical home
5494200|NCT01319643|Oxygen|oxygen
5494201|NCT01319643|Hyperoxia|hyperoxia
5494202|NCT01319643|Intensive care unit|intensive care unit
5494203|NCT01319643|Mortality|mortality
5494204|NCT01319643|Organ dysfunction|organ dysfunction
5494205|NCT01319643|Postoperative care|postoperative care
5494206|NCT01319630|sepsis|sepsis
5494207|NCT01319630|microcirculation|microcirculation
5494208|NCT01319630|saline|saline
5494209|NCT01319630|crystalloid|crystalloid
5494210|NCT01319630|colloid|colloid
5494211|NCT01319630|albumin|albumin
5494212|NCT01319630|hydroxyethyl starch|hydroxyethyl starch
5494213|NCT01319578|chronic kidney disease|chronic kidney disease
5494214|NCT01319578|phosphorus|phosphorus
5494215|NCT01319578|phosphate|phosphate
5494216|NCT01319578|saliva|saliva
5494217|NCT01319578|K2CG|k2cg
5494218|NCT01319578|medical food|medical food
5494219|NCT01319578|chitosan|chitosan
5494220|NCT01319565|Young TIL|young til
5494221|NCT01319565|Metastatic Melanoma|metastatic melanoma
5494222|NCT01319565|Immunotherapy|immunotherapy
5494223|NCT01319565|Adoptive Cell Therapy|adoptive cell therapy
5494224|NCT01319565|Skin Cancer|skin cancer
5494225|NCT01319552|red blood cells|red blood cells
5494226|NCT01319552|transfusion|transfusion
5494227|NCT01319552|storage|storage
5494228|NCT01319552|sickle cell disease|sickle cell disease
5494229|NCT01319552|β-thalassemia|β-thalassemia
5494230|NCT01319552|hemoglobin-associated iron|hemoglobin-associated iron
5494231|NCT01319526|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5494232|NCT01319526|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5494233|NCT01319526|HIV infection|hiv infection
5494234|NCT01319500|Drug Utilization|drug utilization
5494235|NCT01319500|Oral Contraceptives|oral contraceptives
5494236|NCT01319474|Deep vein thrombosis|deep vein thrombosis
5494237|NCT01319474|Pulmonary embolism|pulmonary embolism
5494238|NCT01319474|Ultrasound|ultrasound
5494239|NCT01319474|Pregnancy|pregnancy
5494240|NCT01319461|Osteoarthritis|osteoarthritis
5494241|NCT01319461|Hyalgan|hyalgan
5494242|NCT01319448|Sickle cell disease|sickle cell disease
5494243|NCT01319448|Malaria|malaria
5494244|NCT01319448|Intermittent Preventive Treatment (IPT)|intermittent preventive treatment (ipt)
5494245|NCT01319448|prophylaxis|prophylaxis
5494246|NCT01319435|Ciprofloxacin|ciprofloxacin
5494247|NCT01319435|Neonates|neonates
5494248|NCT01319435|Gram negative infection|gram negative infection
5494249|NCT01319422|myeloma|myeloma
5494250|NCT01319422|multiple myeloma|multiple myeloma
5494251|NCT01319422|pomalidomide|pomalidomide
5494252|NCT01319422|immunomodulatory|immunomodulatory
5494253|NCT01319409|Anterior cruciate ligament surgery|anterior cruciate ligament surgery
5494254|NCT01319409|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5494255|NCT01319409|Single bundle anterior cruciate ligament reconstruction|single bundle anterior cruciate ligament reconstruction
5494256|NCT01319409|Double bundle anterior cruciate ligament reconstruction|double bundle anterior cruciate ligament reconstruction
5494257|NCT01319409|Randomized clinical trial|randomized clinical trial
5494258|NCT01319396|breathing rate|breathing rate
5494259|NCT01319383|HIV-1 Infection|hiv-1 infection
5494260|NCT01319383|HIV RNA <50 copies/mL|hiv rna <50 copies/ml
5494261|NCT01319383|Stable ART|stable art
5494262|NCT01319383|Resting CD4+ T cells|resting cd4+ t cells
5494263|NCT01319383|Leukapheresis|leukapheresis
5494264|NCT01319383|Vorinostat|vorinostat
5494265|NCT01319383|HIV RNA expression|hiv rna expression
5494266|NCT01319383|PK visits|pk visits
5494267|NCT01319331|diabetes|diabetes
5494268|NCT01319331|type 1 diabetes|type 1 diabetes
5494269|NCT01319331|AAT|aat
5494270|NCT01319331|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5494271|NCT01319279|Pharmacokinetics|pharmacokinetics
5494272|NCT01319279|Hydrocodone|hydrocodone
5494273|NCT01319279|Extended Release|extended release
5494274|NCT01319279|Hepatic impairment|hepatic impairment
5494275|NCT01319266|hydrocodone|hydrocodone
5494276|NCT01319266|extended release|extended release
5494277|NCT01319266|pharmacokinetics|pharmacokinetics
5494278|NCT01319266|renal impairment|renal impairment
5494279|NCT01319253|Cystic Fibrosis|cystic fibrosis
5494280|NCT01319253|Pseudomonas aeruginosa|pseudomonas aeruginosa
5494281|NCT01319227|Periprosthetic bone remodeling|periprosthetic bone remodeling
5494282|NCT01319227|Stress shielding|stress shielding
5494283|NCT01319227|Short femoral stem|short femoral stem
5494285|NCT01319227|Polyethylene wear|polyethylene wear
5494286|NCT01319214|cocaine addiction treatment craving|cocaine addiction treatment craving
5494287|NCT01319188|Age-related macular degeneration|age-related macular degeneration
5494288|NCT01319188|ranibizumab|ranibizumab
5494289|NCT01319188|acute thromboembolic events|acute thromboembolic events
5494290|NCT01319188|coronary artery disease|coronary artery disease
5494291|NCT01319188|cerebrovascular disease|cerebrovascular disease
5494292|NCT01319175|hip flexion strength training|hip flexion strength training
5494293|NCT01319175|elastic bands|elastic bands
5494294|NCT01319175|external resistance|external resistance
5494296|NCT01319149|molecular methods|molecular methods
5494297|NCT01319136|new infusion test method|new infusion test method
5494298|NCT01319136|reference method|reference method
5494299|NCT01319136|cerebrospinal fluid dynamics|cerebrospinal fluid dynamics
5494300|NCT01319123|dressing for venous leg ulcers|dressing for venous leg ulcers
5494301|NCT01319110|Cardiac Arrest|cardiac arrest
5494302|NCT01319110|Post Cardiac Arrest|post cardiac arrest
5494303|NCT01319110|CoQ10|coq10
5494304|NCT01319110|Ubiquinone|ubiquinone
5494305|NCT01319110|Post Arrest|post arrest
5494306|NCT01319097|Reduction on local soft tissue edema|reduction on local soft tissue edema
5494307|NCT01319058|obstructive sleep apnea|obstructive sleep apnea
5494308|NCT01319058|Tonsillectomy|tonsillectomy
5494309|NCT01319058|Tonsillotomy|tonsillotomy
5494310|NCT01319058|Inflammation|inflammation
5494311|NCT01319058|Pain|pain
5494312|NCT01319058|Post tonsillectomy bleeding|post tonsillectomy bleeding
5494313|NCT01319045|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5494314|NCT01319045|Congenital Heart Disease|congenital heart disease
5494315|NCT01319045|Eisenmenger's Syndrome|eisenmenger's syndrome
5494316|NCT01319045|Prostacyclin|prostacyclin
5494317|NCT01319045|Iloprost|iloprost
5494318|NCT01319019|lung function|lung function
5494319|NCT01319019|bronchodilator|bronchodilator
5494320|NCT01319019|COPD, dose response, dosing interval, efficacy, safety, PD, PK|copd, dose response, dosing interval, efficacy, safety, pd, pk
5494321|NCT01319006|relative bioavailability|relative bioavailability
5494322|NCT01318993|GSK1605786A; Inflammatory Bowel Disease; Crohn's disease; long-term treatment; quality of life; CCR9 antagonist|gsk1605786a; inflammatory bowel disease; crohn's disease; long-term treatment; quality of life; ccr9 antagonist
5494323|NCT01318980|ADME|adme
5494324|NCT01318980|IV radiolabelled|iv radiolabelled
5494325|NCT01318980|pharmacokinetics|pharmacokinetics
5494326|NCT01318967|Renal blood flow|renal blood flow
5494327|NCT01318967|Regional renal blood flow|regional renal blood flow
5494328|NCT01318967|MRI|mri
5494329|NCT01318941|Ophthalmology, age-related macular degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, ranibizumab|ophthalmology, age-related macular degeneration, diabetic macular edema, retinal vein occlusion, ranibizumab
5494330|NCT01318941|Ophthalmology|ophthalmology
5494331|NCT01318941|Age-related macular degeneration|age-related macular degeneration
5494332|NCT01318941|Diabetic Macular Edema|diabetic macular edema
5494333|NCT01318941|Retinal Vein Occlusion|retinal vein occlusion
5494334|NCT01318941|LUMINOUS|luminous
5494335|NCT01318941|Ranibizumab|ranibizumab
5494336|NCT01318928|Periodontitis|periodontitis
5494337|NCT01318928|antibiotics|antibiotics
5494338|NCT01318928|treatment period|treatment period
5494339|NCT01318928|microbiology|microbiology
5494340|NCT01318915|Kidney transplantation|kidney transplantation
5494341|NCT01318915|Living donor transplant|living donor transplant
5494342|NCT01318915|Graft rejection|graft rejection
5494343|NCT01318915|Graft loss|graft loss
5494344|NCT01318915|Induction with rituximab and ATG|induction with rituximab and atg
5494345|NCT01318915|Immunosuppression (IS)|immunosuppression (is)
5494346|NCT01318889|Dexpanthenol|dexpanthenol
5494347|NCT01318889|Radiotherapy|radiotherapy
5494348|NCT01318889|chemotherapy|chemotherapy
5494349|NCT01318889|Mucositis|mucositis
5494350|NCT01318876|influenza|influenza
5494351|NCT01318876|vaccine safety|vaccine safety
5494352|NCT01318876|adverse events|adverse events
5494353|NCT01318876|health care workers|health care workers
5494354|NCT01318863|aged matched normal control samples|aged matched normal control samples
5494355|NCT01318850|schizophrenia|schizophrenia
5494356|NCT01318850|cognitive remediation|cognitive remediation
5494357|NCT01318850|fMRI|fmri
5494358|NCT01318837|OABSS|oabss
5494359|NCT01318837|IPSS|ipss
5494360|NCT01318837|PPBC|ppbc
5494361|NCT01318837|Solifenacin|solifenacin
5494362|NCT01318824|Neonatal Respiratory Failure|neonatal respiratory failure
5494363|NCT01318824|Newborn Infant|newborn infant
5494364|NCT01318824|BiPAP|bipap
5494365|NCT01318824|NIPPV|nippv
5494366|NCT01318811|Heparin|heparin
5494367|NCT01318811|CRRT|crrt
5494368|NCT01318811|Continuous renal replacement therapy|continuous renal replacement therapy
5494369|NCT01318811|CVVHD|cvvhd
5494371|NCT01318798|Development|development
5494372|NCT01318798|Pre- and intra-operative predictors|pre- and intra-operative predictors
5494373|NCT01318798|Acute renal failure|acute renal failure
5494374|NCT01318798|Liver Surgery|liver surgery
5494375|NCT01318798|Prediction score|prediction score
5494376|NCT01318798|Validation|validation
5494378|NCT01318798|Decision curve analysis|decision curve analysis
5494379|NCT01318798|predictors of acute renal failure after liver resection|predictors of acute renal failure after liver resection
5494380|NCT01318785|secondary arm-lymphedema|secondary arm-lymphedema
5494381|NCT01318785|breast cancer related arm-lymphedema|breast cancer related arm-lymphedema
5494382|NCT01318746|change of potassium amount, circadian and day-to-day variability|change of potassium amount, circadian and day-to-day variability
5494383|NCT01318733|Rosacea|rosacea
5494384|NCT01318720|Neck Pain|neck pain
5494385|NCT01318720|Thrust Manipulation|thrust manipulation
5494386|NCT01318720|Non-Thrust Manipulation|non-thrust manipulation
5494387|NCT01318707|Severe Hemophilia A|severe hemophilia a
5494388|NCT01318707|Hemophilia A Patients|hemophilia a patients
5494389|NCT01318707|Serum collection vs a method of added FVIII to blood samples|serum collection vs a method of added fviii to blood samples
5494390|NCT01318694|Chronic hepatitis C|chronic hepatitis c
5494391|NCT01318694|Cyclophilin inhibitor|cyclophilin inhibitor
5494392|NCT01318681|driving, memory, cognition|driving, memory, cognition
5494393|NCT01318668|fmri smoking vaccination mood|fmri smoking vaccination mood
5629431|NCT00782353|HCV|hcv
5494394|NCT01318655|Phase I|phase i
5494395|NCT01318655|Japan|japan
5494396|NCT01318655|SAD|sad
5494397|NCT01318655|MAD|mad
5494398|NCT01318642|Adenocarcinoma|adenocarcinoma
5494399|NCT01318642|pancreas|pancreas
5494400|NCT01318642|pancreatic cancer|pancreatic cancer
5494401|NCT01318642|local|local
5494402|NCT01318642|unresectable|unresectable
5494403|NCT01318642|stage II|stage ii
5494404|NCT01318642|stage III|stage iii
5494405|NCT01318616|hip adduction strength training|hip adduction strength training
5494406|NCT01318616|Improvement in adductor strength|improvement in adductor strength
5685536|NCT00555711|Brain tumor|brain tumor
5494407|NCT01318590|Pancreatitis, Chronic|pancreatitis, chronic
5494408|NCT01318590|Abdominal Pain|abdominal pain
5494409|NCT01318590|Celiac bloc|celiac bloc
5494410|NCT01318590|Endosonography|endosonography
5494411|NCT01318564|Type II Diabetes|type ii diabetes
5494412|NCT01318564|Unit dose packaging devices|unit dose packaging devices
5494413|NCT01318564|Metformin|metformin
5494414|NCT01318564|Lisinopril|lisinopril
5494415|NCT01318564|Enalapril|enalapril
5494416|NCT01318564|Atorvastatin|atorvastatin
5494417|NCT01318564|Lipitor|lipitor
5494418|NCT01318564|Simvastatin|simvastatin
5494419|NCT01318564|Aspirin|aspirin
5494420|NCT01318564|Questionnaires|questionnaires
5494421|NCT01318551|Anemia|anemia
5494422|NCT01318538|Substance use disorders, Gender differences, women, treatment outcomes, group therapy|substance use disorders, gender differences, women, treatment outcomes, group therapy
5494423|NCT01318499|cataract|cataract
5494424|NCT01318499|inflammation|inflammation
5494425|NCT01318499|pain|pain
5494426|NCT01318499|inflammatory cells|inflammatory cells
5494427|NCT01318499|aqueous flare|aqueous flare
5494428|NCT01318473|cancer|cancer
5494429|NCT01318460|coronary artery disease|coronary artery disease
5494430|NCT01318460|levosimendan|levosimendan
5494431|NCT01318460|coronary artery bypass grafting|coronary artery bypass grafting
5494432|NCT01318460|cardiac surgery|cardiac surgery
5494433|NCT01318447|Hepatic metastases|hepatic metastases
5494434|NCT01318447|Liver metastases|liver metastases
5494435|NCT01318447|Colorectal cancer|colorectal cancer
5494436|NCT01318447|Colorectal adenocarcinoma|colorectal adenocarcinoma
5494437|NCT01318447|Accuray|accuray
5494438|NCT01318447|CyberKnife|cyberknife
5494439|NCT01318434|Outpatient|outpatient
5494440|NCT01318421|Relapsing forms of secondary progressive multiple sclerosis (SPMS)or relapsing-remitting multiple sclerosis (RRMS)|relapsing forms of secondary progressive multiple sclerosis (spms)or relapsing-remitting multiple sclerosis (rrms)
5494441|NCT01318356|Q fever|q fever
5494442|NCT01318356|Cognitive behavioral therapy|cognitive behavioral therapy
5494443|NCT01318356|Doxycycline|doxycycline
5494444|NCT01318356|Fatigue|fatigue
5494445|NCT01318356|Coxiella|coxiella
5494446|NCT01318343|Cryolipolysis|cryolipolysis
5494447|NCT01318343|Abdominal Fat|abdominal fat
5494448|NCT01318343|Adipose Tissue|adipose tissue
5494449|NCT01318343|Fat Reduction|fat reduction
5494450|NCT01318343|Non Invasive|non invasive
5494451|NCT01318304|innate immunity|innate immunity
5494452|NCT01318304|HIV|hiv
5494453|NCT01318304|pregnancy|pregnancy
5494454|NCT01318304|vaginal immunity|vaginal immunity
5494455|NCT01318291|IVF|ivf
5494456|NCT01318291|Drop out|drop out
5494457|NCT01318278|Hypotension|hypotension
5494458|NCT01318278|Low blood pressure|low blood pressure
5494459|NCT01318278|Neonate|neonate
5494460|NCT01318278|Dopamine|dopamine
5494461|NCT01318278|Vasopressin|vasopressin
5494462|NCT01318278|Extremely Low Birth Weight Infant|extremely low birth weight infant
5494463|NCT01318265|drug interactions|drug interactions
5494464|NCT01318265|ketoconazole|ketoconazole
5494465|NCT01318265|pharmacokinetics|pharmacokinetics
5494467|NCT01318252|Elevated IOP|elevated iop
5494468|NCT01318226|postherpetic neuralgia|postherpetic neuralgia
5494469|NCT01318226|shingles|shingles
5494470|NCT01318226|analgesia|analgesia
5494471|NCT01318226|neuropathic pain|neuropathic pain
5494472|NCT01318213|VRE|vre
5494473|NCT01318213|MRSA|mrsa
5494474|NCT01318200|Primary liver cancer|primary liver cancer
5494475|NCT01318200|Hepatocellular carcinoma|hepatocellular carcinoma
5494476|NCT01318200|CyberKnife|cyberknife
5494477|NCT01318200|Accuray|accuray
5494478|NCT01318200|TACE|tace
5494479|NCT01318200|Transarterial chemoembolization|transarterial chemoembolization
5494480|NCT01318187|renal colic|renal colic
5494481|NCT01318187|paracetamol|paracetamol
5494482|NCT01318187|morphine|morphine
5494483|NCT01318187|emergency department|emergency department
5494484|NCT01318174|Pulmonary embolism|pulmonary embolism
5494485|NCT01318174|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5494486|NCT01318161|Epidural analgesia|epidural analgesia
5494487|NCT01318161|Patient controlled analgesia|patient controlled analgesia
5494488|NCT01318161|Colorectal cancer|colorectal cancer
5494489|NCT01318161|Morbidity|morbidity
5494490|NCT01318161|Mortality|mortality
5494491|NCT01318148|Echinocandins|echinocandins
5494492|NCT01318148|Caspofungin|caspofungin
5494493|NCT01318148|Pharmacokinetics|pharmacokinetics
5494494|NCT01318148|Prophylaxis|prophylaxis
5494495|NCT01318148|Antifungal|antifungal
5494497|NCT01318148|Acute Leucemia|acute leucemia
5494498|NCT01318135|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5494499|NCT01318135|Diabetes Mellitus|diabetes mellitus
5494500|NCT01318135|Drug Therapy|drug therapy
5494501|NCT01318122|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5494502|NCT01318122|Diabetes Mellitus|diabetes mellitus
5494503|NCT01318122|Drug Therapy|drug therapy
5494504|NCT01318109|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5494505|NCT01318109|Diabetes Mellitus|diabetes mellitus
5494506|NCT01318109|Drug Therapy|drug therapy
5494507|NCT01318096|safety|safety
5494509|NCT01318096|raltegravir|raltegravir
5494510|NCT01318096|HBV/HIV co-infection|hbv/hiv co-infection
5494511|NCT01318083|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5494512|NCT01318083|Diabetes Mellitus|diabetes mellitus
5494513|NCT01318083|Drug Therapy|drug therapy
5494514|NCT01318070|Diabetes Mellitus - Type2|diabetes mellitus - type2
5494515|NCT01318070|Diabetes Mellitus|diabetes mellitus
5494516|NCT01318070|Drug Therapy|drug therapy
5494517|NCT01318057|Pharmacogenetics|pharmacogenetics
5494518|NCT01318057|Warfarin|warfarin
5494519|NCT01318057|Personalized Medicine|personalized medicine
5494520|NCT01318057|Puerto Ricans|puerto ricans
5494521|NCT01318057|Physiogenomics|physiogenomics
5494522|NCT01318057|Hispanics|hispanics
5494523|NCT01318057|Anticoagulants|anticoagulants
5494524|NCT01318057|Cardiovascular|cardiovascular
5494525|NCT01318057|Deep Vein Thrombosis with or without Pulmonary Embolism|deep vein thrombosis with or without pulmonary embolism
5494526|NCT01318057|Cardiac Valvular Replacement|cardiac valvular replacement
5494527|NCT01318044|thiopental|thiopental
5494528|NCT01318044|propofol|propofol
5494529|NCT01318044|sedation|sedation
5494531|NCT01318031|DDI|ddi
5494532|NCT01318031|Healthy Volunteers|healthy volunteers
5494533|NCT01318018|depression|depression
5494534|NCT01318018|bispectral index|bispectral index
5494535|NCT01318018|electroconvulsive therapy|electroconvulsive therapy
5494536|NCT01318018|magnetic seizure therapy|magnetic seizure therapy
5494537|NCT01317992|Medication overuse headache|medication overuse headache
5494538|NCT01317992|ibudilast|ibudilast
5494539|NCT01317992|glia|glia
5494540|NCT01317940|Leukemia|leukemia
5494541|NCT01317940|ALL|all
5494542|NCT01317940|Vitamin D|vitamin d
5494543|NCT01317940|Bone Density|bone density
5494544|NCT01317940|Body Fat|body fat
5494545|NCT01317940|Obesity|obesity
5494546|NCT01317940|Adipose|adipose
5494547|NCT01317927|belionstat|belionstat
5494548|NCT01317927|warfarin|warfarin
5494549|NCT01317927|hematological malignancy|hematological malignancy
5494550|NCT01317927|solid tumors|solid tumors
5494551|NCT01317927|PK/PD study|pk/pd study
5494552|NCT01317901|follicular lymphoma|follicular lymphoma
5494553|NCT01317901|small lymphocytic lymphoma|small lymphocytic lymphoma
5494554|NCT01317901|marginal zone lymphoma|marginal zone lymphoma
5494555|NCT01317901|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5494556|NCT01317901|indolent lymphoma|indolent lymphoma
5494557|NCT01317888|high grade gliomas of the brain|high grade gliomas of the brain
5494558|NCT01317888|anti-body treatment|anti-body treatment
5494559|NCT01317888|survival|survival
5494560|NCT01317862|labor induction, transcervical foley catheter, prostaglandin|labor induction, transcervical foley catheter, prostaglandin
5494561|NCT01317849|folic acid|folic acid
5494562|NCT01317849|B vitamins|b vitamins
5494563|NCT01317849|secondary prevention|secondary prevention
5494564|NCT01317849|stroke|stroke
5494565|NCT01317849|randomized controlled trial|randomized controlled trial
5494566|NCT01317849|homocysteine|homocysteine
5494567|NCT01317836|pancreatic cystic lesion|pancreatic cystic lesion
5494569|NCT01317836|PET-CT|pet-ct
5494570|NCT01317836|diagnosis|diagnosis
5494571|NCT01317823|Multiparas, Bishop score, Cervical length, Cervical ripening|multiparas, bishop score, cervical length, cervical ripening
5494572|NCT01317810|Overactive Bladder (OAB)|overactive bladder (oab)
5494573|NCT01317810|Observational|observational
5494574|NCT01317810|Registry|registry
5494575|NCT01317797|Rheumatoid Arthritis|rheumatoid arthritis
5494577|NCT01317797|Human IgG1 monoclonal antibody|human igg1 monoclonal antibody
5494578|NCT01317797|GM-CSF monoclonal antibody|gm-csf monoclonal antibody
5494579|NCT01317784|diagnosis screening|diagnosis screening
5494580|NCT01317784|HIV serodiagnosis|hiv serodiagnosis
5494581|NCT01317784|HCV antibodies|hcv antibodies
5494582|NCT01317784|serologic tests|serologic tests
5494583|NCT01317784|Bedside testing|bedside testing
5494584|NCT01317784|diagnostic test kits|diagnostic test kits
5494585|NCT01317784|syphilis serodiagnosis|syphilis serodiagnosis
5494586|NCT01317771|Proximal Biceps Pathology|proximal biceps pathology
5494587|NCT01317758|influenza, vaccine, H5N1|influenza, vaccine, h5n1
5494588|NCT01317745|H5N1, vaccine, influenza|h5n1, vaccine, influenza
5494589|NCT01317732|Energy expenditure, physical activity, accelerometer, magnetometer, monitoring|energy expenditure, physical activity, accelerometer, magnetometer, monitoring
5494590|NCT01317719|Rupture of Distal Bicep Tendon|rupture of distal bicep tendon
5494591|NCT01317706|Bishop score, Cervical length, Cervical ripening, Labor induction|bishop score, cervical length, cervical ripening, labor induction
5494593|NCT01317693|Erectile Dysfunction|erectile dysfunction
5494594|NCT01317693|ED|ed
5494595|NCT01317693|Shock waves|shock waves
5494596|NCT01317693|Therapy|therapy
5494597|NCT01317680|Erectile Dysfunction|erectile dysfunction
5494598|NCT01317680|ED|ed
5494599|NCT01317680|PDE5 inhibitors|pde5 inhibitors
5494600|NCT01317680|LI-ESWT|li-eswt
5494601|NCT01317667|Ricin|ricin
5494602|NCT01317667|RVEc|rvec
5494603|NCT01317654|Tuberculosis meningitis|tuberculosis meningitis
5685537|NCT00555698|DBS|dbs
5494604|NCT01317628|tobacco smoke, intervention program|tobacco smoke, intervention program
5494606|NCT01317615|Lung cancer,|lung cancer,
5494607|NCT01317615|Neuroendocrine Tumors,|neuroendocrine tumors,
5494608|NCT01317615|RAD001|rad001
5494609|NCT01317602|Atrial Fibrillation|atrial fibrillation
5494611|NCT01317589|Pain|pain
5494612|NCT01317589|Cancer of Head and Neck|cancer of head and neck
5494613|NCT01317589|methadone|methadone
5494614|NCT01317589|Fentanyl|fentanyl
5494615|NCT01317576|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5494616|NCT01317576|Exercise|exercise
5494617|NCT01317563|asthma|asthma
5494618|NCT01317563|obesity|obesity
5494619|NCT01317563|nutrition|nutrition
5494620|NCT01317563|antioxidant|antioxidant
5494621|NCT01317550|Non-Small Cell Lung Cancer|non-small cell lung cancer
5494622|NCT01317550|NSCLC|nsclc
5494623|NCT01317550|Symptoms|symptoms
5494624|NCT01317550|Concurrent Chemoradiation|concurrent chemoradiation
5494625|NCT01317550|CXRT|cxrt
5494626|NCT01317550|Fatigue|fatigue
5494627|NCT01317550|Pain|pain
5494628|NCT01317550|Disturbed Sleep|disturbed sleep
5494629|NCT01317550|Lack of Appetite|lack of appetite
5494630|NCT01317550|Drowsiness|drowsiness
5494631|NCT01317550|Armodafinil|armodafinil
5494632|NCT01317550|Nuvigil|nuvigil
5494633|NCT01317550|Minocycline|minocycline
5494634|NCT01317550|Dynacin|dynacin
5494635|NCT01317550|Minocin|minocin
5494636|NCT01317550|Minocin PAC|minocin pac
5494637|NCT01317550|Myrac|myrac
5494638|NCT01317550|Solodyn|solodyn
5494639|NCT01317550|Placebo|placebo
5494640|NCT01317537|personal health records|personal health records
5494641|NCT01317524|Milk|milk
5494642|NCT01317524|Homogenization|homogenization
5494643|NCT01317524|Postprandial hyperlipidemia|postprandial hyperlipidemia
5494644|NCT01317524|Postprandial inflammation|postprandial inflammation
5494645|NCT01317524|Overweight|overweight
5494646|NCT01317498|ART|art
5494647|NCT01317498|antiretroviral|antiretroviral
5494648|NCT01317498|treatment|treatment
5494649|NCT01317498|Vietnam|vietnam
5494650|NCT01317498|Asia|asia
5494651|NCT01317498|viral load|viral load
5494652|NCT01317485|diverticulitis|diverticulitis
5494653|NCT01317485|perforation|perforation
5494654|NCT01317485|sigmoidectomy|sigmoidectomy
5494655|NCT01317485|sigmoid resection|sigmoid resection
5494656|NCT01317485|lavage|lavage
5494657|NCT01317485|laparoscopic|laparoscopic
5494658|NCT01317485|wash-out|wash-out
5494659|NCT01317485|rinsing|rinsing
5494660|NCT01317485|hartmann|hartmann
5494661|NCT01317485|end-colostomy|end-colostomy
5494662|NCT01317485|primary anastomosis|primary anastomosis
5494663|NCT01317472|laryngopharyngeal reflux, acid reflux, throat reflux|laryngopharyngeal reflux, acid reflux, throat reflux
5494664|NCT01317459|Self management|self management
5494665|NCT01317459|Diabetes type one|diabetes type one
5494666|NCT01317459|Empowerment|empowerment
5494667|NCT01317459|Intrinsic motivation|intrinsic motivation
5494668|NCT01317446|gingivitis index|gingivitis index
5494673|NCT01317446|clinical trial|clinical trial
5494674|NCT01317433|Metastatic Colorectal Cancer|metastatic colorectal cancer
5494675|NCT01317433|K-RAS wild-type|k-ras wild-type
5494676|NCT01317433|FOLFIRI|folfiri
5494677|NCT01317433|Cetuximab|cetuximab
5494678|NCT01317407|postoperative delirium|postoperative delirium
5494679|NCT01317394|non-albicans candidemia|non-albicans candidemia
5494680|NCT01317368|Postoperative analgesic treatment|postoperative analgesic treatment
5494681|NCT01317368|TAP block|tap block
5494682|NCT01317368|Prostatectomy|prostatectomy
5494683|NCT01317368|Double blinded randomized clinical trial|double blinded randomized clinical trial
5494684|NCT01317355|Cancer|cancer
5494685|NCT01317355|Symptom burden|symptom burden
5494686|NCT01317355|Symptom cluster|symptom cluster
5494687|NCT01317355|Distress|distress
5494694|NCT01317342|extended criteria liver grafts|extended criteria liver grafts
5494695|NCT01317342|donation after cardiac death|donation after cardiac death
5494696|NCT01317342|hypothermic machine liver perfusion|hypothermic machine liver perfusion
5494697|NCT01317342|liver reperfusion injury|liver reperfusion injury
5494698|NCT01317303|paired associative stimulation|paired associative stimulation
5494699|NCT01317303|theta burst stimulation|theta burst stimulation
5494700|NCT01317303|transcranial magnetic stimulation|transcranial magnetic stimulation
5494701|NCT01317303|neuroplasticity|neuroplasticity
5494702|NCT01317303|healthy controls|healthy controls
5494703|NCT01317290|Conversion of ALA|conversion of ala
5494704|NCT01317277|interventions|interventions
5494705|NCT01317277|technology|technology
5494706|NCT01317277|drug abuse|drug abuse
5494707|NCT01317277|methamphetamine|methamphetamine
5494708|NCT01317264|β-glucan|β-glucan
5494709|NCT01317264|cholesterol|cholesterol
5494710|NCT01317264|bile acids|bile acids
5494711|NCT01317264|blood glucose|blood glucose
5494712|NCT01317264|appetite|appetite
5494713|NCT01317251|Obesity prevention|obesity prevention
5494714|NCT01317251|appetite regulation|appetite regulation
5494715|NCT01317251|hyperlipidemia|hyperlipidemia
5494716|NCT01317238|Smallpox vaccine efficacy|smallpox vaccine efficacy
5494718|NCT01317225|Obstetric labor, premature|obstetric labor, premature
5494719|NCT01317225|Short cervix|short cervix
5494720|NCT01317212|Glioblastoma multiforme|glioblastoma multiforme
5494721|NCT01317212|Carboplatin|carboplatin
5494722|NCT01317212|Convection-enhanced delivery|convection-enhanced delivery
5494723|NCT01317199|Rising psa|rising psa
5494724|NCT01317186|FGF 23|fgf 23
5494725|NCT01317186|ADMA|adma
5494726|NCT01317186|chronic kidney disease|chronic kidney disease
5494727|NCT01317186|Ca-P metabolism disorder|ca-p metabolism disorder
5494728|NCT01317173|Chronic kidney disease progression|chronic kidney disease progression
5494729|NCT01317173|FGF 23|fgf 23
5494730|NCT01317173|Klotho|klotho
5494737|NCT01317147|pharmacokinetics|pharmacokinetics
5494738|NCT01317147|serotonin reuptake inhibitors|serotonin reuptake inhibitors
5494739|NCT01317147|gastric bypass|gastric bypass
5494740|NCT01317147|depression|depression
5494741|NCT01317147|bioavailability|bioavailability
5494742|NCT01317147|drug absorption|drug absorption
5494743|NCT01317147|area under curve|area under curve
5494744|NCT01317134|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5494745|NCT01317134|Prognostic factors|prognostic factors
5494746|NCT01317134|Signal transduction|signal transduction
5494747|NCT01317134|Genetics|genetics
5494748|NCT01317121|Patients with a first episode of schizophrenia|patients with a first episode of schizophrenia
5494749|NCT01317121|Subjects at risk for psychosis|subjects at risk for psychosis
5494750|NCT01317108|node-negative|node-negative
5494751|NCT01317095|Rigid fixation|rigid fixation
5494752|NCT01317095|Sternal closure|sternal closure
5494753|NCT01317095|Open heart surgery|open heart surgery
5494754|NCT01317082|Postoperative Nausea & Vomiting.|postoperative nausea & vomiting.
5494755|NCT01317017|Psoriasis|psoriasis
5494756|NCT01317004|Multiple sclerosis|multiple sclerosis
5494757|NCT01317004|Fingolimod|fingolimod
5494758|NCT01317004|Disease Modifying Therapy|disease modifying therapy
5494759|NCT01317004|TSQM-9|tsqm-9
5494760|NCT01316991|chewing gum|chewing gum
5494761|NCT01316991|appetite|appetite
5494762|NCT01316991|hunger|hunger
5494763|NCT01316991|satiety|satiety
5494764|NCT01316991|metabolic|metabolic
5494765|NCT01316991|nutrition|nutrition
5494766|NCT01316991|gut peptide hormones|gut peptide hormones
5494767|NCT01316991|psychological phenomena and processes|psychological phenomena and processes
5494768|NCT01316965|Postoperative delirium|postoperative delirium
5494769|NCT01316965|elderly|elderly
5494770|NCT01316965|prevention|prevention
5494771|NCT01316965|stepped wedge design|stepped wedge design
5494772|NCT01316965|healthcare workers|healthcare workers
5494773|NCT01316952|carvedilol|carvedilol
5494774|NCT01316952|propranolol|propranolol
5494775|NCT01316952|hypersensitivity reactions|hypersensitivity reactions
5494776|NCT01316952|beta- blockers|beta- blockers
5494777|NCT01316952|Coreg|coreg
5494778|NCT01316939|Crohn's disease, oral CCR9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life|crohn's disease, oral ccr9 antagonist, placebo-controlled, maintenance of remission, 52-week treatment, quality of life
5494779|NCT01316926|fast condition|fast condition
5494780|NCT01316926|Paroxetine reference/test|paroxetine reference/test
5494781|NCT01316926|healthy volunteers|healthy volunteers
5494782|NCT01316926|Bioequivalence|bioequivalence
5494783|NCT01316913|tiotropium|tiotropium
5495087|NCT01316354|Whole grain|whole grain
5494787|NCT01316900|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5494789|NCT01316900|COPD|copd
5494790|NCT01316900|long-acting beta agonist|long-acting beta agonist
5494791|NCT01316887|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5494792|NCT01316887|COPD|copd
5494794|NCT01316887|long-acting beta agonist|long-acting beta agonist
5494795|NCT01316887|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5494796|NCT01316887|tolerability|tolerability
5494797|NCT01316887|safety|safety
5494798|NCT01316874|Valrubicin|valrubicin
5494800|NCT01316874|AD 32, BCG-refractory CIS|ad 32, bcg-refractory cis
5494801|NCT01316874|Carcinoma in situ (CIS) previously treated with BCG|carcinoma in situ (cis) previously treated with bcg
5494802|NCT01316848|AV-951|av-951
5494803|NCT01316848|tivozanib|tivozanib
5494804|NCT01316848|healthy Subjects|healthy subjects
5494805|NCT01316848|food Effect|food effect
5494806|NCT01316848|pharmacokinetics|pharmacokinetics
5494807|NCT01316835|retrospective,sitagliptin, glycemia control,real world|retrospective,sitagliptin, glycemia control,real world
5494808|NCT01316822|CSF1R|csf1r
5494810|NCT01316822|CSF-1|csf-1
5494811|NCT01316822|c-FMS|c-fms
5494812|NCT01316822|Tumor-associated macrophage|tumor-associated macrophage
5494813|NCT01316822|Macrophage-Colony Stimulating Factor-1|macrophage-colony stimulating factor-1
5494814|NCT01316822|Receptor tyrosine kinase inhibitor|receptor tyrosine kinase inhibitor
5494815|NCT01316822|Tumor cell-induced osteolysis|tumor cell-induced osteolysis
5494816|NCT01316809|Brain|brain
5494817|NCT01316809|Tumor|tumor
5494818|NCT01316809|Recurrent|recurrent
5494819|NCT01316809|Surgery|surgery
5494820|NCT01316809|Radiation|radiation
5494821|NCT01316809|Glioma|glioma
5494822|NCT01316809|Brain Tumor|brain tumor
5494824|NCT01316809|Astrocytoma|astrocytoma
5494825|NCT01316809|Brainstem Glioma|brainstem glioma
5494826|NCT01316796|Sickle Cell Disease|sickle cell disease
5494827|NCT01316796|Hemolysis|hemolysis
5494828|NCT01316796|Anemia|anemia
5494829|NCT01316796|Nitric Oxide|nitric oxide
5494830|NCT01316796|Blood Flow|blood flow
5494831|NCT01316796|Leg Ulcer|leg ulcer
5494832|NCT01316796|Sickle Cell Anemia|sickle cell anemia
5494833|NCT01316796|Thalassemia|thalassemia
5494834|NCT01316796|Hemolytic Blood Disorder|hemolytic blood disorder
5494839|NCT01316770|Xerostomia|xerostomia
5494840|NCT01316770|Sjögren's Syndrome|sjögren's syndrome
5494841|NCT01316770|Interventional Study|interventional study
5494842|NCT01316770|Sjogren's Syndrome|sjogren's syndrome
5494843|NCT01316770|Dry Mouth|dry mouth
5494844|NCT01316744|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5494845|NCT01316744|anxiety disorder|anxiety disorder
5494846|NCT01316744|depression|depression
5494847|NCT01316744|pain|pain
5494848|NCT01316744|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5494849|NCT01316744|neuropathy|neuropathy
5494850|NCT01316744|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5494851|NCT01316744|acute undifferentiated leukemia|acute undifferentiated leukemia
5494852|NCT01316744|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5494853|NCT01316744|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5494854|NCT01316744|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5494855|NCT01316744|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5494856|NCT01316744|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5494857|NCT01316744|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5494858|NCT01316744|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5494859|NCT01316744|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5494860|NCT01316744|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5494861|NCT01316744|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5494862|NCT01316744|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5494863|NCT01316744|mast cell leukemia|mast cell leukemia
5494864|NCT01316744|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5494865|NCT01316744|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5494866|NCT01316744|prolymphocytic leukemia|prolymphocytic leukemia
5494867|NCT01316744|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5494868|NCT01316744|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5494869|NCT01316744|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5494870|NCT01316744|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5494871|NCT01316744|refractory hairy cell leukemia|refractory hairy cell leukemia
5494872|NCT01316744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5494873|NCT01316744|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5494874|NCT01316744|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5494875|NCT01316744|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5494876|NCT01316744|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5494877|NCT01316744|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5494878|NCT01316744|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5489175|NCT01340456|CYP3A4|cyp3a4
5476774|NCT01392625|Dilated cardiomyopathy|dilated cardiomyopathy
5494881|NCT01316744|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5494882|NCT01316744|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5494883|NCT01316744|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5494884|NCT01316744|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5494885|NCT01316744|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5494886|NCT01316744|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5494887|NCT01316744|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5494888|NCT01316744|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5494889|NCT01316744|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5494890|NCT01316744|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5494891|NCT01316744|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5494892|NCT01316744|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5494893|NCT01316744|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5494894|NCT01316744|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5494895|NCT01316744|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5494896|NCT01316744|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5494897|NCT01316744|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5494898|NCT01316744|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5494899|NCT01316744|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5494900|NCT01316744|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5494901|NCT01316744|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5494902|NCT01316744|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5494903|NCT01316744|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5494904|NCT01316744|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5494905|NCT01316744|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5494906|NCT01316744|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5494907|NCT01316744|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5494908|NCT01316744|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5494909|NCT01316744|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5494910|NCT01316744|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5494911|NCT01316744|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5494912|NCT01316744|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5494913|NCT01316744|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5494914|NCT01316744|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5494915|NCT01316744|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5494916|NCT01316744|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5494917|NCT01316744|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5494918|NCT01316744|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5494919|NCT01316744|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5494920|NCT01316744|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5494921|NCT01316744|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5494922|NCT01316744|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5494923|NCT01316744|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5494924|NCT01316744|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5494925|NCT01316744|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5494926|NCT01316744|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5494927|NCT01316744|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5494928|NCT01316744|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5494929|NCT01316744|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5494930|NCT01316744|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5494931|NCT01316744|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5494932|NCT01316744|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5494933|NCT01316744|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5494934|NCT01316744|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5494935|NCT01316744|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5494936|NCT01316744|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5489268|NCT01340066|mixed incontinence|mixed incontinence
5494937|NCT01316744|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5494938|NCT01316744|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5476873|NCT01392209|Brain|brain
5494939|NCT01316744|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5494940|NCT01316744|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5494941|NCT01316744|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5494942|NCT01316744|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5494943|NCT01316744|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5494944|NCT01316744|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5494945|NCT01316744|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5495176|NCT01316094|Pharmacokinetics|pharmacokinetics
5494946|NCT01316744|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5494947|NCT01316744|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5494948|NCT01316744|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5494949|NCT01316744|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5494950|NCT01316744|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5494951|NCT01316744|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5494952|NCT01316744|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5494953|NCT01316744|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5685538|NCT00555698|Depression|depression
5494954|NCT01316744|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5494955|NCT01316744|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5494956|NCT01316744|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5494957|NCT01316744|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5494958|NCT01316744|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5494959|NCT01316744|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5494960|NCT01316744|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5494961|NCT01316744|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5494962|NCT01316744|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5494963|NCT01316744|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5494964|NCT01316744|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5494965|NCT01316744|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5494966|NCT01316744|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5494967|NCT01316744|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5494968|NCT01316744|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5494969|NCT01316744|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5494970|NCT01316744|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5494971|NCT01316744|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5494972|NCT01316744|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5494973|NCT01316744|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5494974|NCT01316744|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5494975|NCT01316744|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5494976|NCT01316744|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5494977|NCT01316744|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5494978|NCT01316744|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5494979|NCT01316744|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5494980|NCT01316744|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5494981|NCT01316744|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5494982|NCT01316744|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5494983|NCT01316744|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5494984|NCT01316744|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5494985|NCT01316744|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5494986|NCT01316744|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5494990|NCT01316744|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5494991|NCT01316744|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5494992|NCT01316744|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5494993|NCT01316744|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5494994|NCT01316744|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5494995|NCT01316744|primary myelofibrosis|primary myelofibrosis
5494996|NCT01316744|essential thrombocythemia|essential thrombocythemia
5494997|NCT01316744|polycythemia vera|polycythemia vera
5494998|NCT01316744|extramedullary plasmacytoma|extramedullary plasmacytoma
5494999|NCT01316744|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5495000|NCT01316744|stage I multiple myeloma|stage i multiple myeloma
5495001|NCT01316744|stage II multiple myeloma|stage ii multiple myeloma
5495002|NCT01316744|stage III multiple myeloma|stage iii multiple myeloma
5495003|NCT01316744|primary systemic amyloidosis|primary systemic amyloidosis
5495004|NCT01316744|refractory multiple myeloma|refractory multiple myeloma
5495005|NCT01316744|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5495006|NCT01316744|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5495007|NCT01316744|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5495008|NCT01316744|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5495012|NCT01316679|Liver Disease without HCC|liver disease without hcc
5495013|NCT01316666|orthostatic hypotension|orthostatic hypotension
5495014|NCT01316666|Multiple System Atrophy|multiple system atrophy
5495015|NCT01316666|Pure Autonomic Failure|pure autonomic failure
5495016|NCT01316666|Parkinson's Disease|parkinson's disease
5495017|NCT01316627|Body Dysmorphic Disorder (BDD)|body dysmorphic disorder (bdd)
5495018|NCT01316627|Cognitive Behavior Therapy (CBT)|cognitive behavior therapy (cbt)
5495019|NCT01316627|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5495020|NCT01316627|Mirror Retraining|mirror retraining
5495021|NCT01316627|Crooked Mirror Externalization Therapy|crooked mirror externalization therapy
5495022|NCT01316614|Fine-Needle Aspiration|fine-needle aspiration
5495024|NCT01316614|Solid Mass|solid mass
5495025|NCT01316614|Endoscopic Ultrasound (EUS)|endoscopic ultrasound (eus)
5495026|NCT01316588|recolonization|recolonization
5495027|NCT01316588|Plastic adhesive drape|plastic adhesive drape
5495029|NCT01316588|SSI|ssi
5495030|NCT01316588|bacterial growth|bacterial growth
5495031|NCT01316575|Continuous Positive Airway Pressure|continuous positive airway pressure
5495032|NCT01316575|Postoperative Complications|postoperative complications
5495033|NCT01316575|Respiratory Insufficiency|respiratory insufficiency
5495034|NCT01316575|Colorectal Surgery|colorectal surgery
5495040|NCT01316536|pain, agitation, music|pain, agitation, music
5495041|NCT01316523|Lenalidomide|lenalidomide
5495042|NCT01316523|Rituximab|rituximab
5495043|NCT01316523|untreated indolent Non-Hodgkin's Lymphoma|untreated indolent non-hodgkin's lymphoma
5495044|NCT01316510|Probiotic|probiotic
5495045|NCT01316510|bifidobacteria|bifidobacteria
5495046|NCT01316510|intestinal motility|intestinal motility
5495047|NCT01316497|Acute kidney injury|acute kidney injury
5495048|NCT01316497|Ischemic preconditioning|ischemic preconditioning
5495049|NCT01316497|Congenital heart defects|congenital heart defects
5495050|NCT01316497|Cardiac surgical procedures|cardiac surgical procedures
5495051|NCT01316497|Infant|infant
5495052|NCT01316497|Child|child
5495053|NCT01316484|Cognitive Debriefing|cognitive debriefing
5495054|NCT01316471|Chronic Pain|chronic pain
5495055|NCT01316471|Abdominal Pain|abdominal pain
5495056|NCT01316471|Headache|headache
5495057|NCT01316471|Adolescents|adolescents
5495058|NCT01316471|Internet Interventions|internet interventions
5495059|NCT01316471|Behavioral Interventions|behavioral interventions
5495060|NCT01316458|Prostate cancer,|prostate cancer,
5495061|NCT01316458|radical prostatectomy,|radical prostatectomy,
5495062|NCT01316458|PSA rise|psa rise
5495063|NCT01316445|Electroencephalography|electroencephalography
5495064|NCT01316445|Benzodiazepines|benzodiazepines
5495065|NCT01316445|Midazolam|midazolam
5495066|NCT01316432|Cenderitide|cenderitide
5495067|NCT01316432|CD-NP|cd-np
5495068|NCT01316432|Natriuretic peptide|natriuretic peptide
5495069|NCT01316432|Heart failure|heart failure
5495070|NCT01316432|Chronic heart failure|chronic heart failure
5495071|NCT01316432|HF|hf
5495072|NCT01316432|CHF|chf
5495073|NCT01316406|safety|safety
5495074|NCT01316406|efficacy|efficacy
5495075|NCT01316406|treatment|treatment
5495076|NCT01316406|PPES|ppes
5495077|NCT01316406|Palmar-Plantar Erythrodysesthesia Syndrome|palmar-plantar erythrodysesthesia syndrome
5495078|NCT01316406|Hand-foot syndrome|hand-foot syndrome
5495079|NCT01316406|capecitabine|capecitabine
5495080|NCT01316393|xerostomia, saliva, mucoprotection, oral health|xerostomia, saliva, mucoprotection, oral health
5495081|NCT01316367|Health Promotion Education|health promotion education
5495082|NCT01316367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5495083|NCT01316367|Cardiovascular Risk Factors|cardiovascular risk factors
5495084|NCT01316367|Spain|spain
5495088|NCT01316354|Dietary fibre|dietary fibre
5495089|NCT01316354|Metabolic syndrome|metabolic syndrome
5495090|NCT01316354|Glycemic index|glycemic index
5495091|NCT01316354|Satiety|satiety
5495092|NCT01316328|toxicity after single shot partial breast irradiation (SSPBI)|toxicity after single shot partial breast irradiation (sspbi)
5495093|NCT01316302|Social Anxiety Disorder|social anxiety disorder
5495094|NCT01316302|Social Phobia|social phobia
5495095|NCT01316302|SAD|sad
5495096|NCT01316289|tibial fractures|tibial fractures
5495097|NCT01316289|pilon|pilon
5495098|NCT01316289|pilon fractures|pilon fractures
5495099|NCT01316289|tibial plafond|tibial plafond
5495100|NCT01316289|reduction quality|reduction quality
5495101|NCT01316289|anatomical reduction|anatomical reduction
5495102|NCT01316289|functional outcome|functional outcome
5495107|NCT01316276|cystic fibrosis transmembrane conductance regulator (CFTR)|cystic fibrosis transmembrane conductance regulator (cftr)
5495108|NCT01316276|Anti-bacterial Agent|anti-bacterial agent
5495109|NCT01316276|Arikayce|arikayce
5495110|NCT01316276|ALIS|alis
5495111|NCT01316276|LAI|lai
5495112|NCT01316250|chronic myelogenous leukemia|chronic myelogenous leukemia
5495113|NCT01316250|nilotinib|nilotinib
5495114|NCT01316250|complete cytogenetic response|complete cytogenetic response
5495115|NCT01316250|imatinib mesylate|imatinib mesylate
5495116|NCT01316237|Hepatitis C|hepatitis c
5495117|NCT01316237|HCV|hcv
5495118|NCT01316237|HCV RNA|hcv rna
5495119|NCT01316237|Polymerase inhibitor|polymerase inhibitor
5495120|NCT01316237|Treatment naïve|treatment naïve
5495121|NCT01316237|GS-6620|gs-6620
5495122|NCT01316224|Psoriasis|psoriasis
5495123|NCT01316224|Incidence|incidence
5495124|NCT01316224|Quality of Life|quality of life
5495125|NCT01316224|Psoriatic Arthritis|psoriatic arthritis
5495126|NCT01316224|Prevalence|prevalence
5495127|NCT01316211|Back Pains|back pains
5495128|NCT01316211|Pain, Back|pain, back
5495129|NCT01316211|Pains, Back|pains, back
5495130|NCT01316211|Backache|backache
5495131|NCT01316211|Backaches|backaches
5495132|NCT01316211|Back Ache|back ache
5495133|NCT01316211|Ache, Back|ache, back
5495134|NCT01316211|Aches, Back|aches, back
5495135|NCT01316211|Back Aches|back aches
5495136|NCT01316211|Back Pain without Radiation|back pain without radiation
5495137|NCT01316211|Vertebrogenic Pain Syndrome|vertebrogenic pain syndrome
5495138|NCT01316211|Pain Syndrome, Vertebrogenic|pain syndrome, vertebrogenic
5495139|NCT01316211|Pain Syndromes, Vertebrogenic|pain syndromes, vertebrogenic
5495140|NCT01316211|Syndrome, Vertebrogenic Pain|syndrome, vertebrogenic pain
5495141|NCT01316211|Syndromes, Vertebrogenic Pain|syndromes, vertebrogenic pain
5495142|NCT01316211|Vertebrogenic Pain Syndromes|vertebrogenic pain syndromes
5495143|NCT01316211|Back Pain with Radiation|back pain with radiation
5495144|NCT01316211|Stenosis, spinal|stenosis, spinal
5495145|NCT01316211|Caudal stenosis|caudal stenosis
5495146|NCT01316211|Spondylopathy|spondylopathy
5495147|NCT01316211|Spondylopathies|spondylopathies
5495148|NCT01316211|Low back pain|low back pain
5495149|NCT01316211|Lower back pain|lower back pain
5495150|NCT01316198|human study|human study
5495151|NCT01316198|AMD|amd
5495152|NCT01316198|lutein|lutein
5495153|NCT01316198|zeaxanthin|zeaxanthin
5495154|NCT01316198|optical density|optical density
5495155|NCT01316185|Hepatitis D|hepatitis d
5495156|NCT01316185|HDV|hdv
5495157|NCT01316185|Hepatitis|hepatitis
5495158|NCT01316172|consultation|consultation
5495159|NCT01316146|Hodgkin's Lymphoma|hodgkin's lymphoma
5495160|NCT01316146|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5495161|NCT01316146|Lymphoma|lymphoma
5495162|NCT01316146|T lymphocytes|t lymphocytes
5495163|NCT01316133|Tacrolimus|tacrolimus
5495164|NCT01316133|Prograf|prograf
5495165|NCT01316133|FK506|fk506
5495166|NCT01316133|Proteinuria|proteinuria
5495167|NCT01316133|Calcineurin inhibitor|calcineurin inhibitor
5495168|NCT01316120|Self-collected vaginal samples|self-collected vaginal samples
5495169|NCT01316120|HPV|hpv
5495170|NCT01316120|HPV self-obtained sample|hpv self-obtained sample
5495171|NCT01316120|HPV specimen transport medium|hpv specimen transport medium
5495172|NCT01316107|ASP1941|asp1941
5495173|NCT01316107|long-term safety|long-term safety
5495174|NCT01316107|nateglinide|nateglinide
5495175|NCT01316107|Diabetes mellitus|diabetes mellitus
5495177|NCT01316094|ASP1941|asp1941
5495178|NCT01316094|Renal impairment|renal impairment
5495179|NCT01316081|antioxidant supplementation|antioxidant supplementation
5495180|NCT01316081|childhood obesity|childhood obesity
5495181|NCT01316081|hepcidin|hepcidin
5495182|NCT01316081|iron status|iron status
5495183|NCT01316081|oxidative stress|oxidative stress
5495184|NCT01316081|inflammation|inflammation
5495185|NCT01316068|diabetic nephropathy|diabetic nephropathy
5495186|NCT01316068|albuminuria|albuminuria
5495187|NCT01316068|type 2 diabetes|type 2 diabetes
5495188|NCT01316068|sulodexide|sulodexide
5495189|NCT01316042|Puberty|puberty
5495190|NCT01316042|Hormones|hormones
5495191|NCT01316029|Laying-on-of-hands|laying-on-of-hands
5495192|NCT01316029|Therapeutic touch|therapeutic touch
5495193|NCT01316029|cross-sectional study|cross-sectional study
5495194|NCT01316029|healing environment|healing environment
5495195|NCT01316029|safety and effectiveness|safety and effectiveness
5495196|NCT01316029|optimal condition for the intervention|optimal condition for the intervention
5495197|NCT01316016|obesity|obesity
5495198|NCT01316016|glucose intolerance|glucose intolerance
5495199|NCT01316016|cholesterol|cholesterol
5495200|NCT01316016|blood pressure|blood pressure
5495201|NCT01316003|cone outer segment tips line|cone outer segment tips line
5495202|NCT01316003|Optical coherence tomography|optical coherence tomography
5495203|NCT01315990|Phase IV Study|phase iv study
5495204|NCT01315990|Metastatic Colorectal Cancer (mCRC|metastatic colorectal cancer (mcrc
5495205|NCT01315990|Cetuximab (Erbitux)|cetuximab (erbitux)
5495206|NCT01315990|first-line treatment|first-line treatment
5495207|NCT01315990|acneiform follicular exanthema|acneiform follicular exanthema
5495209|NCT01315990|vitamin K1|vitamin k1
5495210|NCT01315977|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5495211|NCT01315977|Antioxidant oxidant balance|antioxidant oxidant balance
5495212|NCT01315977|Activation of Antioxidant Response Element|activation of antioxidant response element
5495213|NCT01315964|cholesterol|cholesterol
5495214|NCT01315964|plant sterols|plant sterols
5495215|NCT01315964|atherosclerosis|atherosclerosis
5495216|NCT01315964|arterial stiffness|arterial stiffness
5495217|NCT01315951|Non scalp Seborrheic Dermatitis|non scalp seborrheic dermatitis
5495218|NCT01315925|Acute myeloid leukemia|acute myeloid leukemia
5495219|NCT01315925|invasive fungal infection|invasive fungal infection
5495220|NCT01315925|Aspergillosis|aspergillosis
5495221|NCT01315925|candidiasis|candidiasis
5495222|NCT01315912|clomiphene citrate|clomiphene citrate
5495223|NCT01315912|infertility|infertility
5495224|NCT01315912|letrozole|letrozole
5495225|NCT01315899|Raynaud's phenomenon|raynaud's phenomenon
5495226|NCT01315899|Systemic sclerosis|systemic sclerosis
5495227|NCT01315886|sublingual|sublingual
5495228|NCT01315886|fentanyl|fentanyl
5495229|NCT01315886|titration|titration
5495230|NCT01315886|conversion|conversion
5495231|NCT01315886|breakthrough cancer pain|breakthrough cancer pain
5495232|NCT01315886|pain intensity difference|pain intensity difference
5495234|NCT01315886|Edmonton Symptom Assessment System|edmonton symptom assessment system
5495235|NCT01315886|ESAS|esas
5495236|NCT01315873|myeloma|myeloma
5495237|NCT01315873|multiple myeloma|multiple myeloma
5495238|NCT01315873|relapsed myeloma|relapsed myeloma
5495239|NCT01315873|refractory myeloma|refractory myeloma
5495241|NCT01315860|Pregnancy|pregnancy
5495242|NCT01315860|Biomechanics|biomechanics
5495243|NCT01315821|Saccharomyces boulardii|saccharomyces boulardii
5495244|NCT01315821|necrotizing enterocolitis|necrotizing enterocolitis
5495245|NCT01315795|polycystic liver disease|polycystic liver disease
5495246|NCT01315782|Sepsis|sepsis
5495247|NCT01315782|Severe sepsis|severe sepsis
5495248|NCT01315782|Septic shock|septic shock
5495249|NCT01315782|Alveolar dead space|alveolar dead space
5495250|NCT01315782|Multi-organ failure|multi-organ failure
5495251|NCT01315730|stuttering|stuttering
5495252|NCT01315730|haptic|haptic
5495253|NCT01315730|feedback|feedback
5495254|NCT01315730|fluency|fluency
5495255|NCT01315691|Cystic Fibrosis|cystic fibrosis
5495256|NCT01315691|Respiratory Infections|respiratory infections
5495257|NCT01315691|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5495258|NCT01315691|Amikacin|amikacin
5495259|NCT01315691|Anti-bacterial agents|anti-bacterial agents
5495260|NCT01315678|Cystic Fibrosis|cystic fibrosis
5495261|NCT01315678|Respiratory Infections|respiratory infections
5495262|NCT01315678|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5495263|NCT01315678|CFTR|cftr
5495264|NCT01315678|Amikacin|amikacin
5495265|NCT01315678|Anti-bacterial Agents|anti-bacterial agents
5495266|NCT01315678|Amikacin liposome inhalation suspension (ALIS)|amikacin liposome inhalation suspension (alis)
5495267|NCT01315665|broccoli sprouts|broccoli sprouts
5495268|NCT01315665|sulforaphane|sulforaphane
5495269|NCT01315665|triterpenoid|triterpenoid
5495270|NCT01315665|Nrf2 activation|nrf2 activation
5495271|NCT01315665|cystic fibrosis|cystic fibrosis
5495272|NCT01315665|healthy volunteers|healthy volunteers
5495273|NCT01315665|anti-inflammatory|anti-inflammatory
5495274|NCT01315652|1 Rheumatoid arthritis|1 rheumatoid arthritis
5495275|NCT01315652|2 Education|2 education
5495276|NCT01315652|3 Co-morbidities|3 co-morbidities
5495277|NCT01315652|4 Nurse|4 nurse
5495278|NCT01315639|Dementia|dementia
5495279|NCT01315639|Cognitive impairment|cognitive impairment
5495280|NCT01315639|Memory impairment|memory impairment
5495281|NCT01315639|Mild Cognitive Impairment|mild cognitive impairment
5495282|NCT01315639|Cerebrospinal fluid|cerebrospinal fluid
5495283|NCT01315639|Plasma|plasma
5495284|NCT01315639|Biomarker|biomarker
5495285|NCT01315639|Longitudinal|longitudinal
5495286|NCT01315639|Abeta peptide amyloid, saPP alpha|abeta peptide amyloid, sapp alpha
5495287|NCT01315639|Oculomotor impairment|oculomotor impairment
5495288|NCT01315626|Bronchiectasis|bronchiectasis
5495289|NCT01315626|pulmonary exacerbations|pulmonary exacerbations
5495290|NCT01315626|pulmonary infections|pulmonary infections
5495291|NCT01315574|Glaucoma|glaucoma
5495292|NCT01315574|Xalatan|xalatan
5495293|NCT01315574|Travatan Z|travatan z
5495294|NCT01315574|Latanoprost|latanoprost
5495295|NCT01315574|Travoprost|travoprost
5495296|NCT01315574|Dry Eye|dry eye
5495297|NCT01315561|acute low back pain|acute low back pain
5495298|NCT01315561|motion stlye acupuncture treatment|motion stlye acupuncture treatment
5495299|NCT01315561|disability|disability
5495300|NCT01315561|MSAT|msat
5789047|NCT00150124|Graves' disease|graves' disease
5495308|NCT01315522|Endoscopy|endoscopy
5495309|NCT01315522|Cholangiopancreatography|cholangiopancreatography
5495310|NCT01315522|Endoscopic Retrograde|endoscopic retrograde
5495311|NCT01315509|Severe mental illness|severe mental illness
5495312|NCT01315509|Dental measures|dental measures
5495313|NCT01315509|Resistant depression|resistant depression
5495314|NCT01315496|Human Immunoglobulin G|human immunoglobulin g
5495315|NCT01315496|Sepsis|sepsis
5495316|NCT01315496|Septic shock|septic shock
5495317|NCT01315483|Breast cancer|breast cancer
5495318|NCT01315483|survivors|survivors
5495319|NCT01315483|weight lose|weight lose
5495320|NCT01315483|dietary pattern|dietary pattern
5477336|NCT01390402|CML|cml
5495321|NCT01315470|improving pregnancy rate and endometrial thickness|improving pregnancy rate and endometrial thickness
5495322|NCT01315457|alemtuzumab, infection, prophylaxis, treatment|alemtuzumab, infection, prophylaxis, treatment
5495323|NCT01315431|Solid tumor malignancy, excluding lymphoma|solid tumor malignancy, excluding lymphoma
5495324|NCT01315418|Probiotic - Lactobacillus casei DN-114 001 - dairy product -|probiotic - lactobacillus casei dn-114 001 - dairy product -
5495325|NCT01315418|infections - firemen|infections - firemen
5495326|NCT01315418|Common infectious diseases, occuring in healthy subjects,|common infectious diseases, occuring in healthy subjects,
5495327|NCT01315418|including upper respiratory tract infections (defined as|including upper respiratory tract infections (defined as
5495328|NCT01315418|rhinopharyngitis, sore throat, sinusitis and otitis)|rhinopharyngitis, sore throat, sinusitis and otitis)
5495329|NCT01315418|lower respiratory tract infections (defined as bronchitis|lower respiratory tract infections (defined as bronchitis
5495330|NCT01315418|pneumopathy and flu and flu-like syndromes)|pneumopathy and flu and flu-like syndromes)
5495331|NCT01315418|gastrointestinal tract infection defined as gastroenteritis|gastrointestinal tract infection defined as gastroenteritis
5495332|NCT01315405|Emotional facial expression|emotional facial expression
5495333|NCT01315405|Apathy|apathy
5495334|NCT01315405|Mirror neurons|mirror neurons
5495335|NCT01315379|Prolonged Exposure|prolonged exposure
5495337|NCT01315379|PTSD|ptsd
5495338|NCT01315379|Mild Traumatic Brain Injury|mild traumatic brain injury
5495339|NCT01315379|Post Concussive Syndrome|post concussive syndrome
5495340|NCT01315366|Vitamin D|vitamin d
5495341|NCT01315366|Elderly|elderly
5495342|NCT01315366|Cardiovascular profile|cardiovascular profile
5495343|NCT01315366|Insulin resistance|insulin resistance
5495344|NCT01315366|Gene polymorphisms|gene polymorphisms
5495345|NCT01315327|Tourette's Disorder, Obsessive-Compulsive Disorder, tics|tourette's disorder, obsessive-compulsive disorder, tics
5495346|NCT01315314|Glucose degradation products|glucose degradation products
5495347|NCT01315314|Inflammation|inflammation
5495348|NCT01315314|Endothelial dysfunction|endothelial dysfunction
5495349|NCT01315314|Soluble adhesion molecules|soluble adhesion molecules
5495350|NCT01315314|Peritoneal dialysis|peritoneal dialysis
5495351|NCT01315301|Efavirenz|efavirenz
5495352|NCT01315301|Rifampicin|rifampicin
5495353|NCT01315301|HAART|haart
5495354|NCT01315301|Anti Tuberculosis|anti tuberculosis
5495355|NCT01315288|Medical decision making|medical decision making
5495356|NCT01315288|Asymptomatic Carotid Stenosis|asymptomatic carotid stenosis
5495357|NCT01315275|visual impairment|visual impairment
5495358|NCT01315275|macular edema|macular edema
5495359|NCT01315275|ranibizumab|ranibizumab
5495360|NCT01315275|visual impairment due to macular edema|visual impairment due to macular edema
5495361|NCT01315262|Sildenafil 100|sildenafil 100
5495362|NCT01315262|restoring erectile function after radical prostatectomy|restoring erectile function after radical prostatectomy
5495363|NCT01315249|QVA149|qva149
5495364|NCT01315249|indacaterol|indacaterol
5495365|NCT01315249|NVA237|nva237
5495366|NCT01315249|COPD|copd
5495367|NCT01315249|fluticasone/salmeterol|fluticasone/salmeterol
5495368|NCT01315236|Amikacin Liposome Inhalation Suspension (ALIS)|amikacin liposome inhalation suspension (alis)
5495369|NCT01315236|Arikayce|arikayce
5495370|NCT01315210|Fibromyalgia|fibromyalgia
5495371|NCT01315210|Fatigue|fatigue
5495372|NCT01315210|D-Ribose|d-ribose
5495373|NCT01315197|Low back Pain|low back pain
5495374|NCT01315184|Interactive Voice Response|interactive voice response
5495375|NCT01315184|Computer-based Treatment|computer-based treatment
5495376|NCT01315184|Opioid Agonist|opioid agonist
5495377|NCT01315184|Buprenorphine|buprenorphine
5495378|NCT01315184|Methadone|methadone
5495379|NCT01315171|medium chain triglycerides|medium chain triglycerides
5495380|NCT01315171|hypoglycemia|hypoglycemia
5495381|NCT01315171|cognitive function|cognitive function
5495392|NCT01315132|Hodgkin's Disease|hodgkin's disease
5495393|NCT01315093|In Vitro Fertilisation|in vitro fertilisation
5495395|NCT01315080|mammillary fistula|mammillary fistula
5495396|NCT01315080|triamcinolone|triamcinolone
5495397|NCT01315080|ultrasound management|ultrasound management
5495398|NCT01315080|percutaneous treatment|percutaneous treatment
5495399|NCT01315067|kidney transplantation|kidney transplantation
5495400|NCT01315067|acute rejection|acute rejection
5495401|NCT01315067|diagnosis|diagnosis
5495402|NCT01315067|urine analysis|urine analysis
5495403|NCT01315067|urinary peptides|urinary peptides
5495404|NCT01315067|mass spectrometry|mass spectrometry
5495405|NCT01315067|allograft biopsy|allograft biopsy
5495406|NCT01315067|pathology|pathology
5495407|NCT01315067|diagnostic study|diagnostic study
5495408|NCT01315054|IDUs|idus
5495409|NCT01315054|high risk behaviors|high risk behaviors
5495410|NCT01315054|HIV|hiv
5495411|NCT01315054|MMT dosage and retention|mmt dosage and retention
5495412|NCT01315054|psychosocial services|psychosocial services
5495413|NCT01315028|mania|mania
5495414|NCT01315028|hypomania|hypomania
5495415|NCT01315028|bipolar affective disorder|bipolar affective disorder
5495416|NCT01315028|psychological intervention|psychological intervention
5495417|NCT01315028|cognitive therapy|cognitive therapy
5495418|NCT01315015|Breast cancer|breast cancer
5495419|NCT01315015|Breast neoplasm|breast neoplasm
5495420|NCT01315015|Magnetic Resonance Imaging|magnetic resonance imaging
5495421|NCT01315015|Breast density|breast density
5495422|NCT01315015|Early detection of cancer|early detection of cancer
5495423|NCT01315015|Cancer screening test|cancer screening test
5495424|NCT01315015|Secondary prevention|secondary prevention
5495425|NCT01315002|nicotine|nicotine
5495426|NCT01315002|schizophrenia|schizophrenia
5495427|NCT01315002|endophenotype|endophenotype
5495428|NCT01314976|Children|children
5495429|NCT01314976|parasite|parasite
5495430|NCT01314976|intestinal|intestinal
5495431|NCT01314976|treatment|treatment
5495432|NCT01314976|RCT|rct
5495433|NCT01314937|preschool-age children|preschool-age children
5495434|NCT01314937|soil-transmitted helminths|soil-transmitted helminths
5495435|NCT01314937|growth|growth
5495436|NCT01314937|development|development
5495437|NCT01314937|deworming|deworming
5495438|NCT01314924|Hypertension|hypertension
5495439|NCT01314924|Endothelial dysfunction|endothelial dysfunction
5495440|NCT01314924|Vascular stiffness|vascular stiffness
5495441|NCT01314924|Use of one or two antihypertensive drugs|use of one or two antihypertensive drugs
5495442|NCT01314911|H1N1|h1n1
5495443|NCT01314911|Complications|complications
5495444|NCT01314911|PCR|pcr
5495445|NCT01314911|Seasonal Influenza|seasonal influenza
5495446|NCT01314911|Viral Shedding|viral shedding
5495447|NCT01314898|Single dose|single dose
5495448|NCT01314898|cross-over|cross-over
5495449|NCT01314898|active-control|active-control
5495450|NCT01314898|placebo control|placebo control
5495451|NCT01314898|antimineralocorticoid activity|antimineralocorticoid activity
5495452|NCT01314885|Healthy|healthy
5495453|NCT01314872|Overactive bladder|overactive bladder
5495454|NCT01314872|MK-4618|mk-4618
5495455|NCT01314872|tolterodine|tolterodine
5495456|NCT01314859|Nifedipine|nifedipine
5495457|NCT01314859|Obstetric Labor|obstetric labor
5495458|NCT01314859|Premature|premature
5495459|NCT01314859|Tocolysis|tocolysis
5495460|NCT01314833|Luminal A|luminal a
5495461|NCT01314833|Luminal B|luminal b
5495462|NCT01314833|Her-2 overexpression|her-2 overexpression
5495463|NCT01314833|DFS|dfs
5495464|NCT01314833|DDFS|ddfs
5495465|NCT01314833|OS|os
5495466|NCT01314820|Knee|knee
5495467|NCT01314820|Osteoarthritis|osteoarthritis
5495468|NCT01314820|Effusion.|effusion.
5495469|NCT01314807|COPD|copd
5495470|NCT01314781|Overactive Bladder|overactive bladder
5495471|NCT01314781|urinary frequency|urinary frequency
5495472|NCT01314755|Head and Neck neoplasm|head and neck neoplasm
5495474|NCT01314755|Carcinoma|carcinoma
5495475|NCT01314755|Infection|infection
5495476|NCT01314755|Post-operative|post-operative
5495477|NCT01314755|Surgery|surgery
5495478|NCT01314755|Immune-enhancing|immune-enhancing
5495479|NCT01314742|neonates|neonates
5495480|NCT01314742|mechanical ventilation|mechanical ventilation
5495481|NCT01314742|oral care|oral care
5495482|NCT01314742|duration of mechanical ventilation|duration of mechanical ventilation
5495483|NCT01314742|feasibility|feasibility
5495484|NCT01314742|ventilator-associated pneumonia|ventilator-associated pneumonia
5495485|NCT01314729|Orthodontic fixed retainer|orthodontic fixed retainer
5495486|NCT01314729|fiber-reinforced-composite retainer|fiber-reinforced-composite retainer
5495487|NCT01314729|composite-wire retainer|composite-wire retainer
5495488|NCT01314690|obesity|obesity
5495489|NCT01314690|low calorie diet|low calorie diet
5495490|NCT01314690|intestinal microbiota|intestinal microbiota
5495491|NCT01314690|inflammation (systemic and in adipose tissue)|inflammation (systemic and in adipose tissue)
5495492|NCT01314690|fat mass|fat mass
5495493|NCT01314690|Impact of nutritional transition on intestinal microbiota|impact of nutritional transition on intestinal microbiota
5495494|NCT01314690|relation between food intake, clinical parameters and intestinal microbiota|relation between food intake, clinical parameters and intestinal microbiota
5495495|NCT01314664|Non-Muscle Invasive Bladder Cancer|non-muscle invasive bladder cancer
5495496|NCT01314664|CIS|cis
5495497|NCT01314664|BCG Refractory|bcg refractory
5495498|NCT01314651|Migraine Disorders|migraine disorders
5495499|NCT01314651|Chronic migraine|chronic migraine
5495500|NCT01314651|Insomnia|insomnia
5495501|NCT01314651|Behavioral sleep management|behavioral sleep management
5495502|NCT01314612|Insomnia|insomnia
5495503|NCT01314612|group psychotherapy|group psychotherapy
5495504|NCT01314612|nightmares|nightmares
5495505|NCT01314612|PTSD|ptsd
5495506|NCT01314612|posttraumatic stress disorder|posttraumatic stress disorder
5495507|NCT01314612|Veterans|veterans
5495508|NCT01314612|cognitive-behavioral intervention|cognitive-behavioral intervention
5495509|NCT01314599|Leukemia|leukemia
5495510|NCT01314599|lurbinectedin|lurbinectedin
5495511|NCT01314599|PM01183|pm01183
5495512|NCT01314599|Pharma Mar|pharma mar
5495513|NCT01314599|Acute Leukemia in Relapse and Primary Refractory|acute leukemia in relapse and primary refractory
5495514|NCT01314586|hypercholesterolemia|hypercholesterolemia
5495515|NCT01314586|postmenopause|postmenopause
5495516|NCT01314586|secoisolariciresinol diglucoside|secoisolariciresinol diglucoside
5495517|NCT01314586|flaxseed|flaxseed
5495518|NCT01314586|lignans|lignans
5495519|NCT01314586|enterolactone|enterolactone
5495520|NCT01314586|enterodiol|enterodiol
5495521|NCT01314586|serum cholesterol|serum cholesterol
5495522|NCT01314586|LDL cholesterol|ldl cholesterol
5495523|NCT01314573|High intensity exercise training|high intensity exercise training
5495524|NCT01314573|Vascular health|vascular health
5495525|NCT01314573|Endothelial function|endothelial function
5495526|NCT01314573|Circulating angiogenic cells|circulating angiogenic cells
5495527|NCT01314573|endothelial progenitor cells|endothelial progenitor cells
5495528|NCT01314573|Aerobic capacity|aerobic capacity
5495529|NCT01314573|Arterial stiffness|arterial stiffness
5495530|NCT01314573|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
5495531|NCT01314560|Lowe syndrome|lowe syndrome
5495532|NCT01314560|OCRL|ocrl
5495533|NCT01314560|Haemostasis|haemostasis
5495534|NCT01314560|Bleeding Disorders|bleeding disorders
5495535|NCT01314560|Platelet Function Tests|platelet function tests
5495536|NCT01314547|Environment|environment
5495537|NCT01314547|spondylarthritis|spondylarthritis
5495538|NCT01314547|vasculitis|vasculitis
5495539|NCT01314547|stress|stress
5495541|NCT01314547|vaccine|vaccine
5495542|NCT01314534|Kabuki syndrome|kabuki syndrome
5495543|NCT01314534|Genetic|genetic
5495544|NCT01314534|CGH-array|cgh-array
5495545|NCT01314521|Suicide|suicide
5495546|NCT01314521|Depression|depression
5495547|NCT01314521|Adolescents|adolescents
5495548|NCT01314508|pre-pubertal children|pre-pubertal children
5495549|NCT01314508|pre-transplant|pre-transplant
5495550|NCT01314508|not treated with growth hormone for at least 3 months|not treated with growth hormone for at least 3 months
5495551|NCT01314495|Alopecia Areata|alopecia areata
5495552|NCT01314482|Neuropathic pain|neuropathic pain
5495553|NCT01314482|Minocycline|minocycline
5495554|NCT01314469|Quality of life in patients with macular edema compared to patients without macular edema.|quality of life in patients with macular edema compared to patients without macular edema.
5495555|NCT01314456|Prostate biopsy|prostate biopsy
5495556|NCT01314456|Trans-rectal ultrasound|trans-rectal ultrasound
5495557|NCT01314456|Prostate cancer|prostate cancer
5495558|NCT01314443|smoking cessation|smoking cessation
5495559|NCT01314443|gamma-tocopherol|gamma-tocopherol
5495560|NCT01314443|nicotine-replacement therapy|nicotine-replacement therapy
5495561|NCT01314443|oxidative stress|oxidative stress
5495562|NCT01314417|Uveitis|uveitis
5495563|NCT01314417|Macular Edema|macular edema
5495564|NCT01314417|Methotrexate|methotrexate
5495565|NCT01314404|Human papillomavirus|human papillomavirus
5495566|NCT01314404|Prevalence|prevalence
5495567|NCT01314404|Knowledge Attitude and Practice|knowledge attitude and practice
5495568|NCT01314404|Willingness to Participate|willingness to participate
5495570|NCT01314404|HPV|hpv
5495571|NCT01314391|stage I Wilms tumor|stage i wilms tumor
5495572|NCT01314391|stage II Wilms tumor|stage ii wilms tumor
5495573|NCT01314391|stage III Wilms tumor|stage iii wilms tumor
5495574|NCT01314391|stage IV Wilms tumor|stage iv wilms tumor
5495575|NCT01314391|stage V Wilms tumor|stage v wilms tumor
5495576|NCT01314391|renal failure|renal failure
5495577|NCT01314378|Mindfulness|mindfulness
5495578|NCT01314378|Cognitive behavioral therapy|cognitive behavioral therapy
5495579|NCT01314378|Smoking|smoking
5495580|NCT01314378|Impulsivity|impulsivity
5495581|NCT01314378|Inhibitory Control|inhibitory control
5495582|NCT01314326|Optical Coherence Tomography|optical coherence tomography
5495583|NCT01314326|Glaucoma|glaucoma
5495584|NCT01314326|Advanced Imaging|advanced imaging
5495585|NCT01314313|SAPIEN XT|sapien xt
5495586|NCT01314313|Transfemoral|transfemoral
5495587|NCT01314313|Transapical|transapical
5495588|NCT01314313|Transaortic|transaortic
5495589|NCT01314313|NovaFlex|novaflex
5495590|NCT01314313|TAVI|tavi
5495591|NCT01314313|Aortic Stenosis|aortic stenosis
5495592|NCT01314313|THV|thv
5495593|NCT01314313|Aortic Valve|aortic valve
5495594|NCT01314313|Transcatheter Heart Valve|transcatheter heart valve
5495595|NCT01314313|TAVR|tavr
5495596|NCT01314300|Child, adolescent, young adult|child, adolescent, young adult
5495598|NCT01314300|Lidocaine|lidocaine
5495599|NCT01314287|Anaesthesia|anaesthesia
5495600|NCT01314287|pulmonary complications|pulmonary complications
5495601|NCT01314287|Atelectasis|atelectasis
5495602|NCT01314274|Epistaxis|epistaxis
5495603|NCT01314274|Osler|osler
5495604|NCT01314274|Weber|weber
5495605|NCT01314274|Rendu|rendu
5495606|NCT01314274|HHT|hht
5495607|NCT01314274|Hereditary haemorrhagic telangiectasia|hereditary haemorrhagic telangiectasia
5495608|NCT01314248|airway sealing pressure|airway sealing pressure
5495609|NCT01314248|fiberoptic assessment|fiberoptic assessment
5495610|NCT01314248|ease and time for successful insertion|ease and time for successful insertion
5495611|NCT01314248|incidence of gastric insufflation|incidence of gastric insufflation
5495612|NCT01314248|complications were also evaluated|complications were also evaluated
5495613|NCT01314235|anticoagulation with ASS|anticoagulation with ass
5495614|NCT01314235|anticoagulation with clopidogrel|anticoagulation with clopidogrel
5495615|NCT01314209|dexmedetomidine|dexmedetomidine
5495616|NCT01314209|pharmacokinetics|pharmacokinetics
5477574|NCT01389336|CAM|cam
5495617|NCT01314209|critical illness|critical illness
5495618|NCT01314209|continuous renal replacement therapy|continuous renal replacement therapy
5495619|NCT01314196|biceps|biceps
5495620|NCT01314196|resistance training|resistance training
5495621|NCT01314196|rehabilitation|rehabilitation
5495622|NCT01314196|impact syndrome|impact syndrome
5495623|NCT01314183|Knee|knee
5495624|NCT01314183|Physical Therapy|physical therapy
5495625|NCT01314183|Exercise|exercise
5495626|NCT01314170|Implant, glaucoma, refractory glaucoma.|implant, glaucoma, refractory glaucoma.
5495627|NCT01314157|low back pain|low back pain
5495628|NCT01314157|pain|pain
5495629|NCT01314157|incapacity|incapacity
5495630|NCT01314157|life quality|life quality
5495631|NCT01314157|rehabilitation|rehabilitation
5495632|NCT01314144|axillary clearance|axillary clearance
5495633|NCT01314144|wound infiltration|wound infiltration
5495634|NCT01314144|wound infusion|wound infusion
5495635|NCT01314144|local anaesthetic wound infusion|local anaesthetic wound infusion
5495636|NCT01314118|abiraterone acetate|abiraterone acetate
5495637|NCT01314118|prednisone|prednisone
5495638|NCT01314118|zytiga|zytiga
5495639|NCT01314092|crohn's disease|crohn's disease
5495640|NCT01314092|fistula|fistula
5495641|NCT01314092|complex|complex
5495642|NCT01314079|Crohn's fistula|crohn's fistula
5495643|NCT01314079|Autologous adipose derived stem cell|autologous adipose derived stem cell
5495644|NCT01314053|Daptomycin|daptomycin
5495645|NCT01314053|Serious Gram-positive Infections|serious gram-positive infections
5495646|NCT01314040|Dietary protein|dietary protein
5495647|NCT01314040|Biomarkers|biomarkers
5495648|NCT01314040|filtration rate|filtration rate
5495649|NCT01314040|urinary acid excretion|urinary acid excretion
5495650|NCT01314014|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5495651|NCT01314014|Lymphoma, Low Grade|lymphoma, low grade
5495652|NCT01314014|Lymphoma, Intermediate Grade|lymphoma, intermediate grade
5495653|NCT01314014|Lymphoma, High Grade|lymphoma, high grade
5495654|NCT01314014|Lymphoma, B Cell|lymphoma, b cell
5495655|NCT01314001|Tobacco, Smoking, Varenicline, Nicotine Patch|tobacco, smoking, varenicline, nicotine patch
5495656|NCT01313988|dose-response study|dose-response study
5495657|NCT01313988|blood lipid profile|blood lipid profile
5495658|NCT01313988|plant sterols|plant sterols
5495659|NCT01313988|fish oil|fish oil
5495660|NCT01313975|Electrolyte disturbances|electrolyte disturbances
5495661|NCT01313975|Fluid balance|fluid balance
5495662|NCT01313975|subarachnoid hemorrhage|subarachnoid hemorrhage
5495663|NCT01313975|traumatic brain injury|traumatic brain injury
5495665|NCT01313975|SIADH|siadh
5495669|NCT01313962|influenza|influenza
5495670|NCT01313949|Diabetes|diabetes
5495671|NCT01313949|Peer Support|peer support
5495672|NCT01313949|Structured Care|structured care
5495673|NCT01313936|Neuroblastoma|neuroblastoma
5495674|NCT01313936|MIBG|mibg
5495675|NCT01313936|131I-MIBG|131i-mibg
5495676|NCT01313936|Irinotecan|irinotecan
5495677|NCT01313936|Vincristine|vincristine
5495678|NCT01313936|Resistant|resistant
5495679|NCT01313936|Relapsed|relapsed
5495680|NCT01313936|Treatment|treatment
5495681|NCT01313936|UCSF|ucsf
5495682|NCT01313936|Pediatric|pediatric
5495683|NCT01313936|Oncology|oncology
5495684|NCT01313923|Pemphigus|pemphigus
5495685|NCT01313910|HIV|hiv
5495686|NCT01313910|diarrhea|diarrhea
5495687|NCT01313897|Multiple Myeloma|multiple myeloma
5495688|NCT01313832|ventricular septal defect|ventricular septal defect
5495689|NCT01313832|remote ischemic preconditioning|remote ischemic preconditioning
5495690|NCT01313832|pulmonary hypertension|pulmonary hypertension
5495691|NCT01313832|infant with ventricular septal defect and pulmonary hypertension|infant with ventricular septal defect and pulmonary hypertension
5495692|NCT01313819|Freezing|freezing
5495693|NCT01313806|dementia|dementia
5495694|NCT01313806|memory loss|memory loss
5495695|NCT01313806|cognitive decline|cognitive decline
5495696|NCT01313793|Bioequivalence (BE) Study|bioequivalence (be) study
5495697|NCT01313793|Healthy Volunteers|healthy volunteers
5495698|NCT01313780|cancer related pain|cancer related pain
5495700|NCT01313767|upperlimb|upperlimb
5495701|NCT01313767|Botulinum toxin|botulinum toxin
5495702|NCT01313754|Skin closure|skin closure
5495703|NCT01313754|dermabond|dermabond
5495704|NCT01313754|vicryl|vicryl
5495705|NCT01313754|monocryl|monocryl
5495706|NCT01313754|Suburethral sling|suburethral sling
5495707|NCT01313754|Transobturator Sling|transobturator sling
5495708|NCT01313754|Pain|pain
5495709|NCT01313754|Discomfort|discomfort
5495710|NCT01313754|Skin irritation|skin irritation
5495711|NCT01313728|Acne|acne
5495712|NCT01313728|Irritation|irritation
5495713|NCT01313715|Safety|safety
5495714|NCT01313715|Immunogenicity|immunogenicity
5495715|NCT01313715|inactivated EV71 vaccine|inactivated ev71 vaccine
5671470|NCT00615927|Malignant brain tumor|malignant brain tumor
5495716|NCT01313702|polypill, compliance, cardiovascular disease|polypill, compliance, cardiovascular disease
5495717|NCT01313689|OMB157|omb157
5495718|NCT01313689|Lymphocytic|lymphocytic
5495719|NCT01313689|Chronic|chronic
5495720|NCT01313689|Safety|safety
5495721|NCT01313689|Refractory|refractory
5495722|NCT01313689|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5495723|NCT01313689|Oncology|oncology
5495724|NCT01313689|Ofatumumab|ofatumumab
5495725|NCT01313689|Efficacy|efficacy
5495726|NCT01313689|Physicians' Choice|physicians' choice
5495727|NCT01313689|Bulky Fludarabine Refractory Chronic Lymphocytic Leukemia|bulky fludarabine refractory chronic lymphocytic leukemia
5495728|NCT01313689|CLL|cll
5495729|NCT01313676|COPD|copd
5495730|NCT01313676|Cardiovascular disease|cardiovascular disease
5495731|NCT01313676|Novel Dry Powder Inhaler|novel dry powder inhaler
5495732|NCT01313676|Survival|survival
5495733|NCT01313663|GW786034|gw786034
5495734|NCT01313663|non-small cell lung cancer|non-small cell lung cancer
5495735|NCT01313663|NSCLC|nsclc
5495736|NCT01313663|pemetrexed|pemetrexed
5495737|NCT01313663|pazopanib|pazopanib
5495738|NCT01313650|long-acting beta agonist|long-acting beta agonist
5495739|NCT01313650|anticholinergic|anticholinergic
5495740|NCT01313637|anticholinergic|anticholinergic
5495741|NCT01313637|long-acting beta agonist|long-acting beta agonist
5481933|NCT01370863|GERD|gerd
5495742|NCT01313598|Patients with solid tumors|patients with solid tumors
5495743|NCT01313598|Treatment-refractory|treatment-refractory
5495744|NCT01313585|Primary care|primary care
5495745|NCT01313585|asthma management|asthma management
5495746|NCT01313585|inhaler device|inhaler device
5495747|NCT01313585|maintenance therapy|maintenance therapy
5495748|NCT01313585|reliever therapy|reliever therapy
5495749|NCT01313585|Easibreathe salbutamol|easibreathe salbutamol
5495750|NCT01313572|Coronary Artery Disease|coronary artery disease
5495751|NCT01313572|Myocardial Perfusion Imaging|myocardial perfusion imaging
5495752|NCT01313559|Castrate Resistant|castrate resistant
5495753|NCT01313559|Chemotherapy Naive|chemotherapy naive
5495754|NCT01313559|Prostate Cancer|prostate cancer
5495755|NCT01313559|SOM230|som230
5495756|NCT01313559|Everolimus|everolimus
5495757|NCT01313546|Femoral nerve block|femoral nerve block
5495758|NCT01313546|total knee arthroplasty|total knee arthroplasty
5495759|NCT01313533|Atherosclerosis of Autologous Vein Bypass Graft|atherosclerosis of autologous vein bypass graft
5495760|NCT01313507|Primary Immunodeficiency Disease|primary immunodeficiency disease
5495761|NCT01313507|PID|pid
5495762|NCT01313494|COPD|copd
5495763|NCT01313494|Roflumilast|roflumilast
5495764|NCT01313494|FEV1|fev1
5495769|NCT01313468|NEAT|neat
5495771|NCT01313468|stroke volume|stroke volume
5495772|NCT01313455|Oligomenorrhea|oligomenorrhea
5495773|NCT01313455|Adrenal Hyperplasia|adrenal hyperplasia
5495774|NCT01313455|Obesity|obesity
5495775|NCT01313455|Hyperandrogenism|hyperandrogenism
5495776|NCT01313455|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5495777|NCT01313455|PCOS|pcos
5495778|NCT01313455|Polycystic Ovary|polycystic ovary
5495779|NCT01313455|Healthy Volunteer|healthy volunteer
5495796|NCT01313416|Recombinant Monoclonal Antibody|recombinant monoclonal antibody
5495797|NCT01313416|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5495799|NCT01313416|PD-1 Receptor|pd-1 receptor
5495800|NCT01313416|Pancreas Cancer|pancreas cancer
5495801|NCT01313416|Pancreatic Cancer|pancreatic cancer
5495802|NCT01313403|5-HT1A Receptors|5-ht1a receptors
5495803|NCT01313403|Major Depression|major depression
5495804|NCT01313403|PET Imaging|pet imaging
5495805|NCT01313403|Depression|depression
5495806|NCT01313403|Healthy Volunteer|healthy volunteer
5495807|NCT01313403|HV|hv
5495808|NCT01313390|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5495809|NCT01313390|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5495810|NCT01313390|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5495811|NCT01313390|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5495812|NCT01313390|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5495813|NCT01313390|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5495814|NCT01313390|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5495815|NCT01313390|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5495816|NCT01313390|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5495817|NCT01313390|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5495818|NCT01313390|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5495819|NCT01313390|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5495820|NCT01313390|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5495821|NCT01313390|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5495822|NCT01313390|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5495823|NCT01313390|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5495824|NCT01313390|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5477774|NCT01388452|HIV|hiv
5790002|NCT00146198|Postoperative pain|postoperative pain
5495825|NCT01313390|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5495826|NCT01313390|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5495827|NCT01313390|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5495828|NCT01313390|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5495829|NCT01313390|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5495830|NCT01313390|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5495831|NCT01313390|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5495832|NCT01313390|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5495833|NCT01313390|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5495834|NCT01313390|recurrent salivary gland cancer|recurrent salivary gland cancer
5495835|NCT01313390|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5495836|NCT01313390|stage III salivary gland cancer|stage iii salivary gland cancer
5495837|NCT01313390|stage IV salivary gland cancer|stage iv salivary gland cancer
5495838|NCT01313390|tongue cancer|tongue cancer
5495839|NCT01313377|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5495840|NCT01313377|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5495841|NCT01313377|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5495842|NCT01313377|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5495843|NCT01313377|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5495844|NCT01313377|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5495845|NCT01313377|localized gallbladder cancer|localized gallbladder cancer
5495846|NCT01313325|hippotherapy|hippotherapy
5495847|NCT01313325|neuromuscular disorders|neuromuscular disorders
5495848|NCT01313325|balance deficits|balance deficits
5495849|NCT01313325|participation|participation
5495850|NCT01313286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5495851|NCT01313260|Refractory partial epilepsies|refractory partial epilepsies
5495852|NCT01313247|Paracetamol|paracetamol
5495853|NCT01313247|opioids|opioids
5495854|NCT01313247|cancer pain|cancer pain
5495857|NCT01313221|severe|severe
5495858|NCT01313221|etanercept|etanercept
5495859|NCT01313221|Enbrel|enbrel
5495860|NCT01313221|topical|topical
5495861|NCT01313208|RA|ra
5495862|NCT01313208|Enbrel|enbrel
5495863|NCT01313208|DMARD|dmard
5495864|NCT01313208|Joint Count|joint count
5495865|NCT01313208|Rheumatoid Arthritis|rheumatoid arthritis
5495866|NCT01313208|Etanercept|etanercept
5495867|NCT01313208|disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
5495868|NCT01313169|Electronic medical record reminders, Panel management|electronic medical record reminders, panel management
5495869|NCT01313156|Metabolic Syndrome, Syndrome X, MetS,|metabolic syndrome, syndrome x, mets,
5495870|NCT01313156|Type 2 Diabetes|type 2 diabetes
5495871|NCT01313143|AOP200704, Esmolol, Pharmacokinetics, Pharmacodynamics|aop200704, esmolol, pharmacokinetics, pharmacodynamics
5495872|NCT01313130|traumatic brain injury|traumatic brain injury
5495873|NCT01313130|post traumatic stress disorder|post traumatic stress disorder
5495874|NCT01313130|Diffusion tensor imaging|diffusion tensor imaging
5495875|NCT01313130|resting state functional connectivity|resting state functional connectivity
5495876|NCT01313130|genetic factors|genetic factors
5495877|NCT01313117|chemotherapy|chemotherapy
5495878|NCT01313117|peripheral neuropathy|peripheral neuropathy
5495879|NCT01313117|paclitaxel|paclitaxel
5495880|NCT01313117|breast cancer|breast cancer
5495881|NCT01313078|Ovarian Cancer|ovarian cancer
5495882|NCT01313078|Fallopian Tube Cancer|fallopian tube cancer
5495883|NCT01313078|Primary Peritoneal Cancer|primary peritoneal cancer
5495884|NCT01313078|Relapsed or Refractory|relapsed or refractory
5495885|NCT01313078|Pegaspargase|pegaspargase
5495886|NCT01313078|Pegylated L-Asparaginase|pegylated l-asparaginase
5495887|NCT01313065|VX15/2503|vx15/2503
5495888|NCT01313065|Semaphorin 4D|semaphorin 4d
5495889|NCT01313065|SEMA4D|sema4d
5495890|NCT01313065|CD100|cd100
5495891|NCT01313065|safety|safety
5495892|NCT01313065|tolerability|tolerability
5495893|NCT01313065|pharmacokinetics|pharmacokinetics
5495894|NCT01313065|pharmacodynamics|pharmacodynamics
5495895|NCT01313065|advanced solid tumors|advanced solid tumors
5495896|NCT01313052|Psychotic|psychotic
5495897|NCT01313052|Criminal|criminal
5495898|NCT01313039|Breast Cancer|breast cancer
5495899|NCT01313039|ER-negative|er-negative
5495900|NCT01313039|Allred Score|allred score
5495901|NCT01313026|Percutaneous nerve evaluation|percutaneous nerve evaluation
5495902|NCT01313026|Transanal irrigation|transanal irrigation
5495903|NCT01313026|Low anterior resection syndrome|low anterior resection syndrome
5495904|NCT01313000|fat, transfer, autologous fat transfer, bicep|fat, transfer, autologous fat transfer, bicep
5495905|NCT01312948|Obstructive sleep apnea|obstructive sleep apnea
5495906|NCT01312948|OSA|osa
5495907|NCT01312948|CPAP|cpap
5495908|NCT01312948|CPAP mask|cpap mask
5495909|NCT01312948|Non-invasive ventilation|non-invasive ventilation
5495910|NCT01312948|NIV|niv
5495911|NCT01312935|Percutaneous Coronary Intervention|percutaneous coronary intervention
5495912|NCT01312935|Heparin|heparin
5495913|NCT01312935|Angioplasty|angioplasty
5495914|NCT01312935|LMWH|lmwh
5495915|NCT01312909|smoking cessation in adolescents|smoking cessation in adolescents
5495916|NCT01312857|colon|colon
5495917|NCT01312857|rectal|rectal
5495918|NCT01312857|liver|liver
5495919|NCT01312857|AMG 954 (Panitumumab)|amg 954 (panitumumab)
5495920|NCT01312857|DEXAMETHASONE|dexamethasone
5495921|NCT01312857|FLOXURIDINE|floxuridine
5495922|NCT01312857|FLUOROURACIL|fluorouracil
5495923|NCT01312857|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5495924|NCT01312857|LEUCOVORIN|leucovorin
5495925|NCT01312857|10-137|10-137
5495926|NCT01312831|cobalamin|cobalamin
5495927|NCT01312831|B12|b12
5495928|NCT01312831|homocysteine|homocysteine
5495929|NCT01312831|MMA|mma
5495930|NCT01312831|holotranscobalamin|holotranscobalamin
5495931|NCT01312831|Eligen|eligen
5495932|NCT01312805|asthma|asthma
5495933|NCT01312805|clinical decision support|clinical decision support
5495934|NCT01312805|CHICA|chica
5495935|NCT01312792|Severe Pneumonia|severe pneumonia
5495936|NCT01312792|Pneumonia|pneumonia
5495937|NCT01312792|ARI|ari
5495938|NCT01312792|IMCI|imci
5495939|NCT01312792|Modified IMCI|modified imci
5495940|NCT01312792|1st level Health facilities|1st level health facilities
5495941|NCT01312792|Children|children
5495942|NCT01312792|Operational Research|operational research
5495943|NCT01312792|Bangladesh|bangladesh
5495944|NCT01312792|Treatment of Severe Pneumonia|treatment of severe pneumonia
5495945|NCT01312779|Mitral Valve Replacement|mitral valve replacement
5495946|NCT01312779|23mm CEP|23mm cep
5495947|NCT01312779|Magna|magna
5495948|NCT01312740|obesity|obesity
5495949|NCT01312740|dietary treatment|dietary treatment
5495950|NCT01312740|high protein diet|high protein diet
5495951|NCT01312740|Low glycaemic index|low glycaemic index
5495956|NCT01312740|effect on weight loss|effect on weight loss
5495957|NCT01312727|Tubulointerstitial renal diseases|tubulointerstitial renal diseases
5495958|NCT01312727|Hereditary renal diseases|hereditary renal diseases
5495960|NCT01312727|Renin gene|renin gene
5495961|NCT01312714|Hemodialysis|hemodialysis
5495962|NCT01312714|Peritoneal dialysis|peritoneal dialysis
5495963|NCT01312714|Vitamin D Deficiency|vitamin d deficiency
5495964|NCT01312714|blood pressure|blood pressure
5495965|NCT01312714|arterial stiffness|arterial stiffness
5495966|NCT01312714|Heart function|heart function
5495967|NCT01312714|Renin-angiotensin system|renin-angiotensin system
5495969|NCT01312714|FGF-23|fgf-23
5495970|NCT01312714|Brain natriuretic peptide|brain natriuretic peptide
5495971|NCT01312701|cancer|cancer
5495972|NCT01312701|immunomonitoring|immunomonitoring
5495973|NCT01312701|CD247 -zeta chain|cd247 -zeta chain
5495974|NCT01312701|chronic inflamation|chronic inflamation
5495975|NCT01312701|anticancertherapy|anticancertherapy
5495976|NCT01312688|Early Goal Directed Hemodunamic Therapy in Sepsis|early goal directed hemodunamic therapy in sepsis
5495977|NCT01312675|severe sepsis|severe sepsis
5495978|NCT01312675|mechanical ventilation|mechanical ventilation
5495979|NCT01312610|orange juice|orange juice
5495980|NCT01312610|cognitive function|cognitive function
5495981|NCT01312610|flavonoids|flavonoids
5495982|NCT01312610|flavanones|flavanones
5495983|NCT01312597|Flavonoid|flavonoid
5495984|NCT01312597|Cognitive performance|cognitive performance
5495985|NCT01312597|Cognitive function|cognitive function
5495986|NCT01312597|Executive function|executive function
5495987|NCT01312597|fMRI|fmri
5495988|NCT01312597|Cerebral blood flow|cerebral blood flow
5495989|NCT01312597|Acute|acute
5495990|NCT01312584|Flavanol|flavanol
5495991|NCT01312584|Cocoa|cocoa
5495992|NCT01312584|Vascular function|vascular function
5495993|NCT01312584|Absorption|absorption
5495994|NCT01312584|Metabolism|metabolism
5495995|NCT01312584|Alkalisation|alkalisation
5495996|NCT01312558|obstructive sleep apnoea/hypopnoea syndrome|obstructive sleep apnoea/hypopnoea syndrome
5495997|NCT01312558|Mediterranean diet|mediterranean diet
5495998|NCT01312558|exercise|exercise
5495999|NCT01312558|weight loss|weight loss
5496000|NCT01312558|continuous positive airway pressure|continuous positive airway pressure
5496001|NCT01312558|lipid peroxidation|lipid peroxidation
5496007|NCT01312532|Total knee arthroplasty|total knee arthroplasty
5496008|NCT01312532|Fixed-bearing|fixed-bearing
5650252|NCT00701038|CHF|chf
5496009|NCT01312532|Mobile-bearing|mobile-bearing
5496010|NCT01312519|Bone marrow biopsy of iliac crest|bone marrow biopsy of iliac crest
5496011|NCT01312506|metastatic|metastatic
5496012|NCT01312506|melanoma|melanoma
5496013|NCT01312506|CNS|cns
5496014|NCT01312493|Head and neck cancer|head and neck cancer
5496015|NCT01312493|Phase II|phase ii
5496016|NCT01312493|Locally advanced|locally advanced
5496017|NCT01312493|Panitumumab|panitumumab
5496018|NCT01312493|Vectibix|vectibix
5496019|NCT01312493|Lineberger|lineberger
5496020|NCT01312493|Radiation Therapy|radiation therapy
5496021|NCT01312493|Intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5496022|NCT01312493|Stage III to IVB|stage iii to ivb
5496023|NCT01312480|Tobacco|tobacco
5496024|NCT01312480|Tobacco Prevention|tobacco prevention
5496025|NCT01312480|Tobacco Cessation|tobacco cessation
5496026|NCT01312480|5A's Model|5a's model
5496027|NCT01312480|Adolescence|adolescence
5496028|NCT01312480|Media Use|media use
5496029|NCT01312454|intravitreal injection|intravitreal injection
5496030|NCT01312454|intraocular pressure|intraocular pressure
5496031|NCT01312454|open-angle glaucoma|open-angle glaucoma
5496032|NCT01312454|ocular hypertension|ocular hypertension
5496033|NCT01312441|Vitamin D|vitamin d
5496034|NCT01312441|Ergocalciferol|ergocalciferol
5496035|NCT01312415|total knee arthroplasty|total knee arthroplasty
5496036|NCT01312415|total knee replacement|total knee replacement
5496037|NCT01312415|local infiltration analgesia|local infiltration analgesia
5496038|NCT01312415|intra-articular local anaesthesia|intra-articular local anaesthesia
5685326|NCT00556530|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5496039|NCT01312415|patients undergoing total knee arthroplasty (total knee replacement)|patients undergoing total knee arthroplasty (total knee replacement)
5496040|NCT01312363|Alzheimer's disease|alzheimer's disease
5496041|NCT01312363|Rivastigmine|rivastigmine
5496043|NCT01312363|Tolerability|tolerability
5496044|NCT01312350|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5496045|NCT01312350|definitive chemoradiation therapy|definitive chemoradiation therapy
5496046|NCT01312350|head and neck cancer|head and neck cancer
5496047|NCT01312350|base of tongue|base of tongue
5496048|NCT01312350|Locally advanced|locally advanced
5496049|NCT01312337|gefitinib|gefitinib
5496050|NCT01312337|EGFR mutation negative|egfr mutation negative
5496051|NCT01312337|NSCLC|nsclc
5496052|NCT01312324|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5496053|NCT01312324|thymic cancer|thymic cancer
5496054|NCT01312311|nasopharyngeal cancer|nasopharyngeal cancer
5496062|NCT01312272|Schizophrenia|schizophrenia
5496063|NCT01312272|Social Intelligence|social intelligence
5496064|NCT01312272|Perception, Social|perception, social
5496065|NCT01312272|Oxytocin|oxytocin
5496066|NCT01312259|Painful Bladder Syndrome|painful bladder syndrome
5496069|NCT01312259|Fecal incontinence|fecal incontinence
5496070|NCT01312259|Constipation|constipation
5496071|NCT01312259|Sexual dysfunction|sexual dysfunction
5496072|NCT01312259|Dyspareunia|dyspareunia
5496073|NCT01312259|Vulvodynia|vulvodynia
5496074|NCT01312246|vessel ligation|vessel ligation
5496075|NCT01312246|colon resection|colon resection
5496076|NCT01312207|tractional retinoschisis|tractional retinoschisis
5496077|NCT01312207|traction retinal detachment|traction retinal detachment
5496078|NCT01312194|Periapical Periodontitis|periapical periodontitis
5496079|NCT01312194|Dental Pulp Necrosis|dental pulp necrosis
5496080|NCT01312194|Root canal Therapy|root canal therapy
5496081|NCT01312194|Adolescent|adolescent
5496082|NCT01312181|Technology based intervention|technology based intervention
5496083|NCT01312181|HIV primary care clinic|hiv primary care clinic
5496084|NCT01312181|Brief behavioral intervention|brief behavioral intervention
5496085|NCT01312181|Drug abuse|drug abuse
5496086|NCT01312168|Cardiovascular disease|cardiovascular disease
5496087|NCT01312168|Continuous positive airway pressure|continuous positive airway pressure
5496088|NCT01312168|Endothelium|endothelium
5496089|NCT01312168|Vascular function|vascular function
5496090|NCT01312168|Inflammation|inflammation
5496091|NCT01312168|Sleep Apnea|sleep apnea
5496092|NCT01312168|Obstructive|obstructive
5496093|NCT01312155|endotracheal|endotracheal
5496094|NCT01312155|intubation|intubation
5496095|NCT01312155|video|video
5496096|NCT01312155|time|time
5496097|NCT01312129|Alcohol|alcohol
5496098|NCT01312129|Sulfasalazine|sulfasalazine
5496099|NCT01312116|Internet treatment|internet treatment
5496101|NCT01312116|guided self-help|guided self-help
5496102|NCT01312103|Safety Planning|safety planning
5496103|NCT01312090|Weight loss|weight loss
5496104|NCT01312090|brown adipose tissue|brown adipose tissue
5496105|NCT01312090|white adipose tissue|white adipose tissue
5496106|NCT01312090|muscle, metabolism|muscle, metabolism
5496107|NCT01312090|cold exposure|cold exposure
5496108|NCT01312077|total hip arthroplasty|total hip arthroplasty
5496109|NCT01312077|total hip replacement|total hip replacement
5496110|NCT01312077|local infiltration analgesia|local infiltration analgesia
5496111|NCT01312077|wound infusion|wound infusion
5496112|NCT01312077|patients undergoing total hip replacement (total hip arthroplasty)|patients undergoing total hip replacement (total hip arthroplasty)
5496113|NCT01312064|rituximab|rituximab
5496114|NCT01312064|everolimus|everolimus
5496115|NCT01312038|Eustachian tube|eustachian tube
5496116|NCT01312038|otitis|otitis
5496117|NCT01312038|middle-ear pressure|middle-ear pressure
5496118|NCT01312038|simethicone|simethicone
5496119|NCT01312012|hepatitis B virus,mother-infant transmission, nucleoside analog,pregnant women|hepatitis b virus,mother-infant transmission, nucleoside analog,pregnant women
5496120|NCT01311999|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay|latent tuberculosis, renal failure, dialysis, interferon-gamma release assay
5496121|NCT01311986|atopic dermatitis|atopic dermatitis
5496122|NCT01311986|nummular eczema|nummular eczema
5496123|NCT01311986|chemokines|chemokines
5496124|NCT01311973|Chronic kidney disease, phosphorus, salivary phosphorus|chronic kidney disease, phosphorus, salivary phosphorus
5496125|NCT01311960|pterygium|pterygium
5496126|NCT01311960|recurrent pterygium|recurrent pterygium
5496127|NCT01311960|bevacizumab|bevacizumab
5496128|NCT01311960|VEGF|vegf
5496129|NCT01311960|anti-VEGF|anti-vegf
5496130|NCT01311947|Chronic hepatitis B|chronic hepatitis b
5496131|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a
5496132|NCT01311921|enterovirus 71, host genetics, social, behavior, environmental factors|enterovirus 71, host genetics, social, behavior, environmental factors
5496133|NCT01311908|Pancreaticoduodenectomy|pancreaticoduodenectomy
5496134|NCT01311908|Roux-en-Y reconstruction|roux-en-y reconstruction
5496135|NCT01311908|Reflux esophagitis|reflux esophagitis
5496136|NCT01311895|acute|acute
5496137|NCT01311895|pain|pain
5496138|NCT01311895|emergency department|emergency department
5496139|NCT01311895|hydromorphone|hydromorphone
5496140|NCT01311856|Behavioral intervention|behavioral intervention
5496142|NCT01311856|Physical Assessment|physical assessment
5496143|NCT01311856|Questionnaire|questionnaire
5496145|NCT01311856|Telephone counseling|telephone counseling
5496147|NCT01311856|Overweight cancer survivors|overweight cancer survivors
5496148|NCT01311856|Exercise and weight management program|exercise and weight management program
5496149|NCT01311791|Left ventricular augmentation|left ventricular augmentation
5496150|NCT01311791|Left ventricular restoration|left ventricular restoration
5496151|NCT01311765|Postoperative peritonitis|postoperative peritonitis
5496152|NCT01311765|Intra-abdominal infection|intra-abdominal infection
5496154|NCT01311765|Laparotomy|laparotomy
5496155|NCT01311765|Nosocomial infection|nosocomial infection
5496156|NCT01311765|Antibiotic therapy|antibiotic therapy
5496157|NCT01311765|Duration of treatment|duration of treatment
5496158|NCT01311765|Multidrug resistant bacteria|multidrug resistant bacteria
5496159|NCT01311752|human papillomavirus|human papillomavirus
5496161|NCT01311739|Pharmacokinetics|pharmacokinetics
5496162|NCT01311713|cancer|cancer
5496163|NCT01311713|tumors|tumors
5496164|NCT01311713|PARP|parp
5496165|NCT01311700|Ischemia|ischemia
5496166|NCT01311700|Reperfusion|reperfusion
5496167|NCT01311700|Myocardial infarction|myocardial infarction
5496168|NCT01311700|Beta blockers|beta blockers
5496169|NCT01311700|Metoprolol|metoprolol
5496170|NCT01311700|Acute myocardial infarction|acute myocardial infarction
5496171|NCT01311700|Necrosis|necrosis
5496172|NCT01311700|Salvaged Myocardium|salvaged myocardium
5496173|NCT01311687|Myeloma|myeloma
5496174|NCT01311687|Multiple Myeloma|multiple myeloma
5496175|NCT01311687|Relapsed Multiple Myeloma|relapsed multiple myeloma
5496176|NCT01311687|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5496177|NCT01311687|Refractory Myeloma|refractory myeloma
5496178|NCT01311687|Resistant Multiple Myeloma|resistant multiple myeloma
5496179|NCT01311687|Treatment-resistant Multiple Myeloma|treatment-resistant multiple myeloma
5496180|NCT01311687|Pomalidomide|pomalidomide
5496181|NCT01311687|Lenalidomide-resistant|lenalidomide-resistant
5496182|NCT01311687|Bortezomib-resistant|bortezomib-resistant
5496185|NCT01311635|Phase 1|phase 1
5496186|NCT01311635|bioavailability study|bioavailability study
5496187|NCT01311635|AZD1981|azd1981
5496188|NCT01311635|tablets|tablets
5496189|NCT01311635|To study the relative bioavailability of single dose AZD1981 via three different tablets|to study the relative bioavailability of single dose azd1981 via three different tablets
5496190|NCT01311635|To compare the bioavailability between three different AZD1981 tablets|to compare the bioavailability between three different azd1981 tablets
5496191|NCT01311622|drug-drug interaction|drug-drug interaction
5496192|NCT01311622|Phase 1|phase 1
5496193|NCT01311622|healthy subjects|healthy subjects
5496194|NCT01311622|warfarin|warfarin
5496195|NCT01311622|Rheumatoid arthritis|rheumatoid arthritis
5496196|NCT01311622|RA|ra
5496197|NCT01311622|fostamatinib open-label|fostamatinib open-label
5496198|NCT01311622|pharmacokinetics|pharmacokinetics
5496199|NCT01311622|pharmacodynamics|pharmacodynamics
5496200|NCT01311622|level of Warfarin in the blood|level of warfarin in the blood
5496201|NCT01311609|Systane, Dry Eye|systane, dry eye
5496202|NCT01311596|icons in clinic or office for patients with Autism|icons in clinic or office for patients with autism
5496203|NCT01311583|Self-care|self-care
5496204|NCT01311583|Teach Back|teach back
5496205|NCT01311557|Tetanus|tetanus
5496206|NCT01311557|Diphtheria|diphtheria
5496207|NCT01311557|Pertussis|pertussis
5496208|NCT01311557|Tdap vaccine|tdap vaccine
5496209|NCT01311557|Adacel®|adacel®
5496210|NCT01311531|Fracture|fracture
5496211|NCT01311531|Radius|radius
5496212|NCT01311531|Surgery|surgery
5496213|NCT01311531|Osteosynthesis|osteosynthesis
5496214|NCT01311518|Thymosin Beta 4|thymosin beta 4
5496215|NCT01311518|Thymosin β4 (Tβ4) Injectable Solution|thymosin β4 (tβ4) injectable solution
5496216|NCT01311518|RGN-352|rgn-352
5496217|NCT01311505|bioequivalence; rifampicin|bioequivalence; rifampicin
5496218|NCT01311492|Alzheimer's Disease|alzheimer's disease
5496219|NCT01311492|exercise|exercise
5496220|NCT01311492|physical activity|physical activity
5496221|NCT01311492|intervention|intervention
5496222|NCT01311479|Osteopathic Manipulation|osteopathic manipulation
5496223|NCT01311479|Interstitial Cystitis|interstitial cystitis
5496224|NCT01311479|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
5496225|NCT01311466|Liver transplantation|liver transplantation
5496226|NCT01311466|Overall survival|overall survival
5496227|NCT01311440|RCT|rct
5496228|NCT01311440|modified Atkins diet|modified atkins diet
5496229|NCT01311440|epilepsy|epilepsy
5496230|NCT01311440|adults|adults
5496231|NCT01311440|ketogenic diet|ketogenic diet
5496232|NCT01311401|2 diabetes mellitus,Circassians, High fasting glucose|2 diabetes mellitus,circassians, high fasting glucose
5496233|NCT01311388|cancer|cancer
5496234|NCT01311375|spinal,, bone, cord injury, lipid,antioxidant|spinal,, bone, cord injury, lipid,antioxidant
5496235|NCT01311362|Steady-state|steady-state
5496236|NCT01311362|Ambrisentan|ambrisentan
5496237|NCT01311362|St. Johns Wort|st. johns wort
5485501|NCT01355887|PTC|ptc
5496238|NCT01311349|Susceptibility of tigecycline|susceptibility of tigecycline
5496239|NCT01311349|Drug Resistance, Bacterial|drug resistance, bacterial
5496240|NCT01311336|Pegfilgrastim|pegfilgrastim
5496241|NCT01311336|Loratadine|loratadine
5496242|NCT01311336|Myalgia/arthralgia|myalgia/arthralgia
5496243|NCT01311323|Multivessel Coronary Artery Disease|multivessel coronary artery disease
5496244|NCT01311323|Left Main Narrowing|left main narrowing
5496245|NCT01311323|Percutaneous Coronary Intervention|percutaneous coronary intervention
5496246|NCT01311323|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5496247|NCT01311323|Drug-Eluting Stent|drug-eluting stent
5496248|NCT01311310|troponin, open heart surgery, children|troponin, open heart surgery, children
5496249|NCT01311284|Nasotracheal intubation|nasotracheal intubation
5496250|NCT01311284|Macintosh laryngoscope|macintosh laryngoscope
5496251|NCT01311284|Airtraq|airtraq
5496252|NCT01311284|McGrath|mcgrath
5496253|NCT01311284|Manikin|manikin
5496254|NCT01311284|airway management|airway management
5496255|NCT01311271|Stroke|stroke
5490654|NCT01334437|blood test|blood test
5496256|NCT01311271|Cerebrovascular disease|cerebrovascular disease
5496257|NCT01311271|hemiplegia|hemiplegia
5496258|NCT01311271|Transcranial magnetic stimulation|transcranial magnetic stimulation
5496259|NCT01311271|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5496260|NCT01311271|rTMS|rtms
5496261|NCT01311271|rehabilitation|rehabilitation
5496262|NCT01311271|Upper Extremity|upper extremity
5496263|NCT01311258|AML|aml
5496264|NCT01311258|MDS|mds
5496265|NCT01311245|Risky drinking|risky drinking
5496266|NCT01311245|Brief intervention|brief intervention
5496267|NCT01311245|Computer-generated feedback|computer-generated feedback
5496268|NCT01311245|Stage-tailored|stage-tailored
5496269|NCT01311245|Non-stage-tailored|non-stage-tailored
5496270|NCT01311232|rituximab, lymphoma, hepatitis B virus|rituximab, lymphoma, hepatitis b virus
5496271|NCT01311206|knee osteoarthritis|knee osteoarthritis
5496272|NCT01311206|isokinetic knee extensor strength|isokinetic knee extensor strength
5496273|NCT01311206|quadriceps volume|quadriceps volume
5496274|NCT01311206|symptomatic knee osteoarthritis|symptomatic knee osteoarthritis
5496275|NCT01311193|Circadian rhythms|circadian rhythms
5496276|NCT01311193|Sleep-wake cycles|sleep-wake cycles
5496277|NCT01311193|Melatonin|melatonin
5496278|NCT01311193|Borderline Personality Disorder|borderline personality disorder
5496279|NCT01311193|Light therapy|light therapy
5496280|NCT01311167|Dexamethasone|dexamethasone
5496281|NCT01311167|Sodium|sodium
5496282|NCT01311154|carriers|carriers
5496283|NCT01311154|resistant Enterobacteriaceae|resistant enterobacteriaceae
5496285|NCT01311154|antibiotic|antibiotic
5496286|NCT01311128|Blood pressure|blood pressure
5496287|NCT01311128|Heart rate|heart rate
5496288|NCT01311128|Cardiac output|cardiac output
5496289|NCT01311128|Critical care|critical care
5496290|NCT01311128|Perioperative care|perioperative care
5496291|NCT01311102|Pain score|pain score
5496292|NCT01311102|IUD placement|iud placement
5496293|NCT01311076|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5496295|NCT01311076|Glucose|glucose
5496296|NCT01311076|Drug Therapy|drug therapy
5496297|NCT01311050|Metastatic Colorectal Cancer|metastatic colorectal cancer
5496298|NCT01311037|Premenopausal Women with Advanced Breast Cancer|premenopausal women with advanced breast cancer
5496299|NCT01311024|Children|children
5496300|NCT01311024|Pneumococcal Vaccines|pneumococcal vaccines
5496301|NCT01311011|Critical Limb Ischemia|critical limb ischemia
5496302|NCT01310998|Schizophrenia|schizophrenia
5496303|NCT01310998|high intensity exercise|high intensity exercise
5496304|NCT01310998|interval training exercise|interval training exercise
5496305|NCT01310985|Rectal Cancer|rectal cancer
5496306|NCT01310972|Adjuvant Colon Cancer|adjuvant colon cancer
5496307|NCT01310959|Aplastic Anemia Marrow Failure Syndrome|aplastic anemia marrow failure syndrome
5496308|NCT01310946|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5496309|NCT01310894|Prostatic Disease|prostatic disease
5496310|NCT01310894|Genital Neoplasm,male|genital neoplasm,male
5496311|NCT01310894|Urogenital neoplasm|urogenital neoplasm
5496312|NCT01310894|Genital disease,male|genital disease,male
5496313|NCT01310894|Male urogenital disease|male urogenital disease
5496314|NCT01310894|Neoplasms|neoplasms
5478285|NCT01386489|HV|hv
5496315|NCT01310894|Neoplasms by site|neoplasms by site
5496316|NCT01310894|Prostatic neoplasm|prostatic neoplasm
5496317|NCT01310894|Carcinoma|carcinoma
5496318|NCT01310881|Neurogenesis|neurogenesis
5496319|NCT01310881|hippocampal stem cells|hippocampal stem cells
5496320|NCT01310881|depression|depression
5496321|NCT01310881|stroke|stroke
5496322|NCT01310868|adult giant cell glioblastoma|adult giant cell glioblastoma
5496323|NCT01310868|adult gliosarcoma|adult gliosarcoma
5496324|NCT01310868|adult glioblastoma|adult glioblastoma
5496325|NCT01310855|adult giant cell glioblastoma|adult giant cell glioblastoma
5496326|NCT01310855|adult glioblastoma|adult glioblastoma
5496327|NCT01310855|adult gliosarcoma|adult gliosarcoma
5496328|NCT01310855|recurrent adult brain tumor|recurrent adult brain tumor
5496329|NCT01310842|Smoker|smoker
5496330|NCT01310842|Smoking Cessation|smoking cessation
5496331|NCT01310842|Social Determinants|social determinants
5496332|NCT01310842|Environmental Effects|environmental effects
5496333|NCT01310842|Individual-level effects|individual-level effects
5496334|NCT01310842|Nicotine patch|nicotine patch
5496335|NCT01310842|Smart Phone|smart phone
5496337|NCT01310842|Global Positioning System|global positioning system
5496338|NCT01310842|GPS|gps
5496339|NCT01310842|Questionnaires|questionnaires
5496340|NCT01310842|Saliva samples|saliva samples
5496341|NCT01310829|Genetic counselor|genetic counselor
5496342|NCT01310829|Genetic counseling degree program|genetic counseling degree program
5496343|NCT01310829|Genetic counseling students|genetic counseling students
5496344|NCT01310829|Virtual reality-based intervention|virtual reality-based intervention
5496345|NCT01310829|VR|vr
5496346|NCT01310829|Genetic counseling|genetic counseling
5496347|NCT01310829|hereditary cancers|hereditary cancers
5496348|NCT01310829|Questionnaires|questionnaires
5496349|NCT01310829|Physiological measurements|physiological measurements
5496350|NCT01310829|Skin sensors|skin sensors
5496351|NCT01310816|malignant neoplasms of the bone|malignant neoplasms of the bone
5496352|NCT01310816|bone sarcoma|bone sarcoma
5496353|NCT01310803|Urinary Bladder Neoplasms|urinary bladder neoplasms
5496354|NCT01310803|Neoplasms|neoplasms
5496355|NCT01310803|Urologic Neoplasms|urologic neoplasms
5496356|NCT01310803|Urogenital Neoplasms|urogenital neoplasms
5496357|NCT01310803|Neoplasms by Site|neoplasms by site
5496358|NCT01310803|Urinary Bladder Diseases|urinary bladder diseases
5496359|NCT01310803|Urologic Diseases|urologic diseases
5496361|NCT01310803|Valstar|valstar
5496362|NCT01310790|septic shock|septic shock
5496363|NCT01310790|lactic acid clearance|lactic acid clearance
5496364|NCT01310790|ScVO2|scvo2
5496365|NCT01310777|Open-Angle glaucoma|open-angle glaucoma
5496366|NCT01310777|Ocular Hypertension|ocular hypertension
5496367|NCT01310777|OAG|oag
5496368|NCT01310777|OHT|oht
5496369|NCT01310764|Intraocular pressure|intraocular pressure
5496370|NCT01310764|Trabeculectomy|trabeculectomy
5496371|NCT01310764|Mitomycin C|mitomycin c
5496372|NCT01310764|Bevacizumab|bevacizumab
5496373|NCT01310738|Visceral leishmaniasis|visceral leishmaniasis
5496374|NCT01310738|Leishmania infantum|leishmania infantum
5496375|NCT01310738|Leishmania chagasi|leishmania chagasi
5496376|NCT01310725|CABG|cabg
5496377|NCT01310725|LIMA|lima
5496378|NCT01310725|saphenous vein|saphenous vein
5496379|NCT01310725|radial artery|radial artery
5496380|NCT01310712|hyperhidrosis|hyperhidrosis
5496381|NCT01310712|oxybutynin|oxybutynin
5496382|NCT01310699|Colonoscopy|colonoscopy
5496383|NCT01310699|Diagnostic imaging|diagnostic imaging
5496384|NCT01310699|Colorectal Neoplasm|colorectal neoplasm
5496385|NCT01310699|Tandem Colonoscopy|tandem colonoscopy
5496386|NCT01310699|Flat Polyp|flat polyp
5496387|NCT01310699|Nonpolypoid|nonpolypoid
5496388|NCT01310699|Flat and Depressed Lesions|flat and depressed lesions
5496389|NCT01310699|Primary Prevention|primary prevention
5496391|NCT01310686|wet AMD anti-VEGF|wet amd anti-vegf
5496392|NCT01310686|Genetic analysis of patients with Wet AMD who have not responded fully to anti-VEGF treatments|genetic analysis of patients with wet amd who have not responded fully to anti-vegf treatments
5496393|NCT01310673|Gout|gout
5496394|NCT01310673|Allopurinol|allopurinol
5496395|NCT01310673|Acute gout|acute gout
5496396|NCT01310647|estradiol|estradiol
5496397|NCT01310647|testosterone|testosterone
5496398|NCT01310647|combined oral contraceptive|combined oral contraceptive
5496399|NCT01310647|low responders|low responders
5496400|NCT01310647|ICSI|icsi
5496401|NCT01310634|Neonates|neonates
5496402|NCT01310634|Parenting|parenting
5496403|NCT01310634|Anxiety|anxiety
5496404|NCT01310634|Depression|depression
5496405|NCT01310621|Neonate|neonate
5496406|NCT01310621|Meconium aspiration syndrome|meconium aspiration syndrome
5496407|NCT01310621|surfactant lung lavage|surfactant lung lavage
5496408|NCT01310608|Atherosclerosis aorta|atherosclerosis aorta
5496409|NCT01310608|A-View|a-view
5496410|NCT01310608|Distal ascending aorta|distal ascending aorta
5496411|NCT01310608|Transoesophageal echocardiography|transoesophageal echocardiography
5496412|NCT01310608|CABG|cabg
5496413|NCT01310608|Cerebral embolisation|cerebral embolisation
5496414|NCT01310595|Musculoskeletal manipulations|musculoskeletal manipulations
5478380|NCT01386086|resistant|resistant
5496415|NCT01310595|Proprioception|proprioception
5496416|NCT01310595|Postural balance|postural balance
5496417|NCT01310582|Sevoflurane|sevoflurane
5496418|NCT01310582|Desflurane|desflurane
5496419|NCT01310569|PCOS, Skinfold thickness, HOMA-IR|pcos, skinfold thickness, homa-ir
5496420|NCT01310556|OGTT|ogtt
5496421|NCT01310556|coronary artery disease|coronary artery disease
5496422|NCT01310543|Teenage pregnancy|teenage pregnancy
5496423|NCT01310543|Adolescent|adolescent
5496424|NCT01310543|Sexual health|sexual health
5496425|NCT01310543|Youth development|youth development
5496426|NCT01310530|Breast Cancer|breast cancer
5496427|NCT01310530|Partial Breast|partial breast
5496428|NCT01310530|Proton Beam|proton beam
5496429|NCT01310517|Angiogram|angiogram
5496430|NCT01310517|Injected Contrast|injected contrast
5496431|NCT01310517|Heart Function|heart function
5496432|NCT01310517|contrast dye|contrast dye
5496433|NCT01310478|Recombinant human endostatin|recombinant human endostatin
5496434|NCT01310478|Metastatic colorectal cancer|metastatic colorectal cancer
5496436|NCT01310478|MTD|mtd
5496437|NCT01310478|Pharmacokinetics|pharmacokinetics
5496438|NCT01310452|diabetes, basal insulin, metformin, liver fat, visceral fat|diabetes, basal insulin, metformin, liver fat, visceral fat
5496439|NCT01310426|Anal Sphincter injury|anal sphincter injury
5496440|NCT01310426|Fecal Incontinence|fecal incontinence
5496441|NCT01310413|Influenza|influenza
5496442|NCT01310413|H5N1|h5n1
5496443|NCT01310413|Pandemic|pandemic
5496444|NCT01310400|Influenza|influenza
5496445|NCT01310400|Virus|virus
5496446|NCT01310400|Vaccination|vaccination
5496447|NCT01310400|Immunisation|immunisation
5496448|NCT01310387|Lung cancer|lung cancer
5496449|NCT01310387|Cancer pain|cancer pain
5496450|NCT01310387|Opioid|opioid
5496451|NCT01310374|influenza vaccine|influenza vaccine
5496452|NCT01310374|immune response|immune response
5496453|NCT01310374|dynamic changes|dynamic changes
5496454|NCT01310361|Pharyngitis|pharyngitis
5496455|NCT01310361|Group A β-hemolytic Streptococci|group a β-hemolytic streptococci
5496456|NCT01310361|Exudate|exudate
5490849|NCT01333683|ototoxicity|ototoxicity
5496457|NCT01310361|Erythema Penicillin|erythema penicillin
5496458|NCT01310361|Amoxicillin|amoxicillin
5496459|NCT01310348|Bone|bone
5496460|NCT01310348|Muscle strength|muscle strength
5496461|NCT01310348|whole-body vibration|whole-body vibration
5496462|NCT01310335|sclerostin|sclerostin
5496463|NCT01310335|whole-body vibration|whole-body vibration
5496464|NCT01310322|Phase I|phase i
5496465|NCT01310322|Healthy male volunteers|healthy male volunteers
5496466|NCT01310322|mild asthmatics|mild asthmatics
5496467|NCT01310322|pharmacokinetics|pharmacokinetics
5496468|NCT01310322|Bioavailability and AUC|bioavailability and auc
5496469|NCT01310322|Level of AZD5423 in your blood|level of azd5423 in your blood
5496470|NCT01310309|Stents|stents
5496471|NCT01310309|Drug-eluting Stent|drug-eluting stent
5496472|NCT01310309|Angioplasty|angioplasty
5496473|NCT01310309|Coronary Artery stenosis|coronary artery stenosis
5496474|NCT01310309|Coronary Artery Stent Restenosis|coronary artery stent restenosis
5496475|NCT01310309|Stent Thrombosis|stent thrombosis
5496476|NCT01310296|Phase 1|phase 1
5496477|NCT01310296|Normal Healthy Volunteers|normal healthy volunteers
5496478|NCT01310296|Mass Balance|mass balance
5496479|NCT01310296|ADME|adme
5496480|NCT01310296|Absolute Bioavailability|absolute bioavailability
5496481|NCT01310283|dental caries|dental caries
5496482|NCT01310283|children|children
5496483|NCT01310283|mutans streptococci|mutans streptococci
5496484|NCT01310283|lactobacilli|lactobacilli
5496485|NCT01310283|cariogenic bacteria|cariogenic bacteria
5496486|NCT01310244|Phase 1/2|phase 1/2
5496487|NCT01310244|MTD|mtd
5496488|NCT01310244|stage IV|stage iv
5496489|NCT01310244|NSCLC|nsclc
5496490|NCT01310244|chemo-naive|chemo-naive
5496491|NCT01310244|Mixed-cell dose escalation|mixed-cell dose escalation
5496492|NCT01310244|lung cancer|lung cancer
5496493|NCT01310244|non-small-cell|non-small-cell
5496494|NCT01310244|phase I|phase i
5496495|NCT01310244|Belinostat|belinostat
5496496|NCT01310244|Carboplatin|carboplatin
5496497|NCT01310244|Paclitaxel|paclitaxel
5496498|NCT01310244|adenocarcinoma|adenocarcinoma
5496499|NCT01310244|PXD-101|pxd-101
5496500|NCT01310231|Metastatic Breast Cancer|metastatic breast cancer
5496501|NCT01310231|Metformin|metformin
5496502|NCT01310218|orthopedics, carpal tunnel syndrome, postoperative care|orthopedics, carpal tunnel syndrome, postoperative care
5496503|NCT01310205|HCV|hcv
5496504|NCT01310205|Genotype 1|genotype 1
5496505|NCT01310205|relapsers|relapsers
5496506|NCT01310205|non cirrhotic|non cirrhotic
5496507|NCT01310205|Chronic Hepatitis C|chronic hepatitis c
5496508|NCT01310179|gene therapy|gene therapy
5496509|NCT01310179|advanced solid tumors|advanced solid tumors
5496510|NCT01310179|Head and Neck cancer|head and neck cancer
5496511|NCT01310179|intratumoral therapy|intratumoral therapy
5496512|NCT01310166|Multiple sclerosis|multiple sclerosis
5496513|NCT01310166|RRMS|rrms
5496514|NCT01310166|relapsing-remitting|relapsing-remitting
5496515|NCT01310166|fingolimod|fingolimod
5496516|NCT01310166|biomarkers|biomarkers
5496517|NCT01310140|Metabolic Syndrome|metabolic syndrome
5496518|NCT01310140|Insulin Resistance|insulin resistance
5496519|NCT01310140|Massachusetts General Hospital|massachusetts general hospital
5496520|NCT01310140|Major Depressive Disorder|major depressive disorder
5496521|NCT01310140|Major Depressive Disorder with Psychotic Features|major depressive disorder with psychotic features
5496522|NCT01310140|Cortisol|cortisol
5496523|NCT01310140|Dexamethasone Suppression Test|dexamethasone suppression test
5496524|NCT01310127|NSAID|nsaid
5496525|NCT01310127|Ocular Inflammation|ocular inflammation
5496526|NCT01310127|bromfenac|bromfenac
5496527|NCT01310114|Human Placenta-Derived Cells|human placenta-derived cells
5496528|NCT01310114|Stem cells|stem cells
5496529|NCT01310114|Stroke|stroke
5496530|NCT01310114|PDA001|pda001
5496531|NCT01310114|Celgene|celgene
5496532|NCT01310114|cenplacel-L|cenplacel-l
5496533|NCT01310101|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5496534|NCT01310101|Refractory|refractory
5496535|NCT01310101|Relapse|relapse
5496536|NCT01310101|Ofatumumab|ofatumumab
5496537|NCT01310101|Dexamethasone|dexamethasone
5496538|NCT01310088|Childhood|childhood
5496539|NCT01310088|Child|child
5496540|NCT01310088|adolescent|adolescent
5496641|NCT01309711|MRI|mri
5496541|NCT01310088|central blood pressure|central blood pressure
5496542|NCT01310088|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5496543|NCT01310088|ABPM|abpm
5496544|NCT01310088|clinic blood pressure|clinic blood pressure
5496545|NCT01310088|pulse wave velocity|pulse wave velocity
5496546|NCT01310088|PWV|pwv
5496547|NCT01310088|Pulse cave analysis|pulse cave analysis
5496548|NCT01310088|PWA|pwa
5496549|NCT01310088|heart rate variability|heart rate variability
5496550|NCT01310088|HRV|hrv
5496551|NCT01310088|Echocardiography|echocardiography
5496552|NCT01310088|Urine microalbuminuria|urine microalbuminuria
5496553|NCT01310088|blood samples|blood samples
5496554|NCT01310075|Mastectomy|mastectomy
5496555|NCT01310075|Bioprosthetic Mesh|bioprosthetic mesh
5496556|NCT01310075|Breast Reconstruction|breast reconstruction
5496557|NCT01310075|Tissue Expander|tissue expander
5496558|NCT01310075|Alloderm|alloderm
5496559|NCT01310075|Surgimend|surgimend
5496560|NCT01310062|hepatocellular carcinoma|hepatocellular carcinoma
5496561|NCT01310062|microarray|microarray
5496562|NCT01310062|gene expression profiling|gene expression profiling
5496563|NCT01310062|biomarkers|biomarkers
5496564|NCT01310049|Exploratory study in healthy subjects|exploratory study in healthy subjects
5496565|NCT01310023|Conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications|conditions and diagnoses potentially related to perinatal exposure to antiretroviral medications
5496566|NCT01309997|Imatinib|imatinib
5496567|NCT01309997|Rituximab|rituximab
5496568|NCT01309997|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
5496569|NCT01309984|Monitored anesthesia care|monitored anesthesia care
5496570|NCT01309971|Assessment|assessment
5496571|NCT01309971|Questionable Caries|questionable caries
5496572|NCT01309958|Dental Caries|dental caries
5496573|NCT01309958|Intervention|intervention
5496574|NCT01309958|Non-invasive treatment for early caries|non-invasive treatment for early caries
5496575|NCT01309919|intrauterine device|intrauterine device
5496576|NCT01309919|Mirena|mirena
5496577|NCT01309919|levonorgestrel intrauterine system|levonorgestrel intrauterine system
5496578|NCT01309919|postpartum contraception|postpartum contraception
5496579|NCT01309893|Contact lens|contact lens
5496580|NCT01309880|Contact lens|contact lens
5496581|NCT01309854|Phase 1|phase 1
5496582|NCT01309854|healthy volunteers|healthy volunteers
5496583|NCT01309854|pharmacokinetics|pharmacokinetics
5496584|NCT01309854|Rheumatoid arthritis|rheumatoid arthritis
5496586|NCT01309854|fostamatinib|fostamatinib
5496587|NCT01309854|pioglitazone|pioglitazone
5496588|NCT01309854|drug-drug interaction|drug-drug interaction
5496589|NCT01309841|Non-Cancer-Related Pain, Opioid-Induced Constipation|non-cancer-related pain, opioid-induced constipation
5496590|NCT01309828|Renal Insufficiency|renal insufficiency
5496591|NCT01309828|Kidney Diseases|kidney diseases
5496592|NCT01309828|Hypertension|hypertension
5496593|NCT01309828|Drug Therapy|drug therapy
5496594|NCT01309815|neoplasms|neoplasms
5496595|NCT01309815|existentialism|existentialism
5496596|NCT01309815|existential concerns|existential concerns
5496597|NCT01309815|Meaning making|meaning making
5496598|NCT01309815|early palliative phase|early palliative phase
5496599|NCT01309815|elderly|elderly
5496600|NCT01309802|botox|botox
5496601|NCT01309802|raynaud's|raynaud's
5496602|NCT01309802|botulinum toxin|botulinum toxin
5496603|NCT01309802|botulinum toxin A|botulinum toxin a
5496604|NCT01309802|raynaud's disease|raynaud's disease
5496605|NCT01309802|raynaud's syndrome|raynaud's syndrome
5496606|NCT01309802|raynaud's phenomenon|raynaud's phenomenon
5496607|NCT01309802|ischemic digits|ischemic digits
5496608|NCT01309802|ischemia|ischemia
5496609|NCT01309802|botox treatment|botox treatment
5496610|NCT01309802|onabotulinum|onabotulinum
5496611|NCT01309802|onabotulinum toxin|onabotulinum toxin
5496612|NCT01309802|onabotulinum toxin type A|onabotulinum toxin type a
5496613|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal
5496614|NCT01309789|Antibody-Drug Conjugate|antibody-drug conjugate
5496615|NCT01309789|Antigens, CD30|antigens, cd30
5496616|NCT01309789|Drug Therapy|drug therapy
5496617|NCT01309789|Hematologic Diseases|hematologic diseases
5496618|NCT01309789|Lymphoma|lymphoma
5496619|NCT01309789|monomethyl auristatin E|monomethyl auristatin e
5496620|NCT01309789|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5496621|NCT01309789|Lymphoma, T-cell|lymphoma, t-cell
5496622|NCT01309789|Lymphoma, NK-cell|lymphoma, nk-cell
5496623|NCT01309737|Xeljanz|xeljanz
5496624|NCT01309737|tofacitinib|tofacitinib
5496625|NCT01309737|Jak-inhibitor|jak-inhibitor
5496626|NCT01309737|oral treatment|oral treatment
5496627|NCT01309737|chronic|chronic
5496628|NCT01309737|severe|severe
5496629|NCT01309737|moderate|moderate
5496630|NCT01309737|Pruritus|pruritus
5496631|NCT01309737|Itch|itch
5496632|NCT01309737|DLQI|dlqi
5496633|NCT01309737|treatment|treatment
5496634|NCT01309737|safety|safety
5496635|NCT01309737|efficacy|efficacy
5496636|NCT01309737|CP-690,550|cp-690,550
5496637|NCT01309737|Plaque Psoriasis|plaque psoriasis
5496638|NCT01309737|Psoriasis Vulgaris|psoriasis vulgaris
5496639|NCT01309724|Hypotension|hypotension
5496640|NCT01309724|Fluid|fluid
5496642|NCT01309711|Biomarkers|biomarkers
5496643|NCT01309711|Neonatal encephalopathy|neonatal encephalopathy
5496644|NCT01309711|Therapeutic hypothermia|therapeutic hypothermia
5496645|NCT01309698|Drug interaction|drug interaction
5496646|NCT01309685|Cognition|cognition
5496647|NCT01309685|Smoking|smoking
5496648|NCT01309685|Nicotine|nicotine
5496649|NCT01309685|Varenicline|varenicline
5496650|NCT01309685|Withdrawal|withdrawal
5496651|NCT01309672|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5496652|NCT01309672|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5496653|NCT01309672|stage IV prostate cancer|stage iv prostate cancer
5496654|NCT01309672|recurrent prostate cancer|recurrent prostate cancer
5496655|NCT01309659|Anemia|anemia
5496656|NCT01309659|Unexplained anemia|unexplained anemia
5496657|NCT01309659|elderly|elderly
5496658|NCT01309659|geriatric|geriatric
5496659|NCT01309659|older adults|older adults
5496662|NCT01309659|iron|iron
5496663|NCT01309659|pactte|pactte
5496664|NCT01309659|pactee|pactee
5496665|NCT01309659|aging|aging
5496666|NCT01309659|aged|aged
5496668|NCT01309659|older|older
5496669|NCT01309646|Primary vaccination|primary vaccination
5496670|NCT01309646|combination vaccine|combination vaccine
5496671|NCT01309646|South Korea|south korea
5496672|NCT01309633|locally advanced|locally advanced
5496673|NCT01309633|metastatic|metastatic
5496674|NCT01309620|zinc, oxidative stress, vascular indices, type 2 diabetes|zinc, oxidative stress, vascular indices, type 2 diabetes
5496675|NCT01309581|depression|depression
5496676|NCT01309581|electroconvulsive therapy|electroconvulsive therapy
5496677|NCT01309581|ketamine|ketamine
5496678|NCT01309581|antidepressant|antidepressant
5496679|NCT01309555|Growth disorders|growth disorders
5496680|NCT01309555|Saizen|saizen
5496681|NCT01309555|easypod™|easypod™
5496682|NCT01309555|Growth hormone|growth hormone
5496683|NCT01309555|Pediatric subject|pediatric subject
5496684|NCT01309542|major depressive disorder|major depressive disorder
5496685|NCT01309542|desvenlafaxine|desvenlafaxine
5496686|NCT01309542|antidepressant|antidepressant
5496687|NCT01309529|general thoracic surgery|general thoracic surgery
5496688|NCT01309529|epidural analgesia|epidural analgesia
5496689|NCT01309529|postoperative retention of urine|postoperative retention of urine
5496690|NCT01309529|postoperative urinary tract infection|postoperative urinary tract infection
5496691|NCT01309529|catheter associated urinary tract infection|catheter associated urinary tract infection
5496692|NCT01309516|Postnatal depression|postnatal depression
5496693|NCT01309516|Maternal depression|maternal depression
5496694|NCT01309516|Psychosocial intervention|psychosocial intervention
5496695|NCT01309490|high eIF4E expression|high eif4e expression
5496696|NCT01309490|solid tumor cancer|solid tumor cancer
5496697|NCT01309477|Refractory Nephrotic Syndrome|refractory nephrotic syndrome
5496698|NCT01309477|Tacrolimus|tacrolimus
5496699|NCT01309451|diabetic macular edema|diabetic macular edema
5496701|NCT01309438|Healthy|healthy
5496702|NCT01309438|Renal Insufficiency|renal insufficiency
5496703|NCT01309438|Rivaroxaban (BAY 59-7939, JNJ-39039039)|rivaroxaban (bay 59-7939, jnj-39039039)
5496704|NCT01309438|Erythromycin|erythromycin
5496705|NCT01309438|Pharmacokinetic|pharmacokinetic
5496706|NCT01309438|Pharmacodynamic|pharmacodynamic
5496707|NCT01309425|tapentadol|tapentadol
5496708|NCT01309425|NUCYNTA|nucynta
5496709|NCT01309425|CG5503|cg5503
5496710|NCT01309425|R331333|r331333
5496711|NCT01309425|pharmacokinetics|pharmacokinetics
5496712|NCT01309425|healthy volunteer|healthy volunteer
5496713|NCT01309412|Relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5496714|NCT01309412|CNTO 328|cnto 328
5496715|NCT01309412|siltuximab|siltuximab
5496716|NCT01309412|bortezomib|bortezomib
5496717|NCT01309412|dexamethasone|dexamethasone
5496718|NCT01309399|bone formation rate|bone formation rate
5496719|NCT01309399|total hip arthroplasty|total hip arthroplasty
5496720|NCT01309386|Tapentadol|tapentadol
5496721|NCT01309386|Tumor related pain|tumor related pain
5496722|NCT01309386|Opioid|opioid
5496723|NCT01309386|Cancer related pain|cancer related pain
5496724|NCT01309386|Morphine|morphine
5496725|NCT01309373|Schizophrenia|schizophrenia
5496726|NCT01309373|Schizoaffective Disorder|schizoaffective disorder
5496727|NCT01309373|Remission|remission
5496728|NCT01309373|Psychosocial|psychosocial
5496729|NCT01309373|Symtomatic|symtomatic
5496730|NCT01309373|Integration|integration
5496731|NCT01309373|Schizoaffective|schizoaffective
5496732|NCT01309373|Adherence|adherence
5496733|NCT01309360|ultrasound|ultrasound
5496734|NCT01309360|methaemoglobin|methaemoglobin
5496735|NCT01309360|prilocaine|prilocaine
5496736|NCT01309360|regional anesthesia|regional anesthesia
5496737|NCT01309360|ASA risk groups I-II|asa risk groups i-ii
5496738|NCT01309360|adult outpatients|adult outpatients
5496739|NCT01309360|surgical spectrum covered procedures|surgical spectrum covered procedures
5496740|NCT01309360|distal forearm|distal forearm
5496741|NCT01309360|hand|hand
5496742|NCT01309347|prosthetic socket, residual limb volume fluctuation|prosthetic socket, residual limb volume fluctuation
5496744|NCT01309334|PET-scan|pet-scan
5496745|NCT01309334|multiple myeloma|multiple myeloma
5496746|NCT01309334|prognosis|prognosis
5496747|NCT01309334|pharmacoeconomic analysis|pharmacoeconomic analysis
5496748|NCT01309321|Perinatal|perinatal
5496749|NCT01309321|Handwashing|handwashing
5496750|NCT01309321|Neonatal|neonatal
5496751|NCT01309321|Morbidity|morbidity
5496752|NCT01309321|Mortality|mortality
5496753|NCT01309321|Primiparous|primiparous
5496754|NCT01309321|Health behavior|health behavior
5496755|NCT01309321|Developing countries|developing countries
5496757|NCT01309321|Omphalitis|omphalitis
5496758|NCT01309321|Infectious disease|infectious disease
5496759|NCT01309321|Bangladesh|bangladesh
5496760|NCT01309308|cervical length|cervical length
5496761|NCT01309308|sweeping the membranes|sweeping the membranes
5496762|NCT01309256|distal gastrectomy|distal gastrectomy
5496763|NCT01309256|Robotic gastrectomy|robotic gastrectomy
5496765|NCT01309256|learning curve|learning curve
5496766|NCT01309256|cost-effectiveness|cost-effectiveness
5496767|NCT01309256|quality of life|quality of life
5496768|NCT01309256|acute inflammatory reaction|acute inflammatory reaction
5496769|NCT01309256|Robotic and laparoscopic surgery|robotic and laparoscopic surgery
5496770|NCT01309243|HIV|hiv
5496771|NCT01309243|HIV-1|hiv-1
5496772|NCT01309243|Antiretroviral Treatment-Naïve|antiretroviral treatment-naïve
5496773|NCT01309230|Stage III|stage iii
5496774|NCT01309230|Stage IV|stage iv
5496775|NCT01309230|epithelial ovarian cancer|epithelial ovarian cancer
5496776|NCT01309230|ovarian cancer|ovarian cancer
5496777|NCT01309230|Adjuvant|adjuvant
5496778|NCT01309230|immunotherapy|immunotherapy
5496779|NCT01309204|open-angle glaucoma|open-angle glaucoma
5496780|NCT01309204|ocular hypertension|ocular hypertension
5496781|NCT01309204|OAG|oag
5496782|NCT01309204|OHT|oht
5496783|NCT01309191|Androgenetic Alopecia|androgenetic alopecia
5496784|NCT01309191|Minoxidil|minoxidil
5496785|NCT01309191|Microarray|microarray
5496786|NCT01309165|stroke|stroke
5496787|NCT01309165|cognition|cognition
5496788|NCT01309165|cognitive strategies|cognitive strategies
5496789|NCT01309165|motor skill acquisition|motor skill acquisition
5496790|NCT01309165|participation|participation
5496791|NCT01309152|cefazolin|cefazolin
5496792|NCT01309152|microdialysis|microdialysis
5496793|NCT01309152|morbid obesity|morbid obesity
5496794|NCT01309152|pharmacokinetics|pharmacokinetics
5496795|NCT01309126|Colorectal Cancer|colorectal cancer
5496796|NCT01309126|KRAS Wild Type|kras wild type
5496797|NCT01309126|Imprime PGG|imprime pgg
5496798|NCT01309126|Cetuximab|cetuximab
5496799|NCT01309126|Phase 3|phase 3
5496800|NCT01309126|Efficacy|efficacy
5496801|NCT01309126|Safety|safety
5496802|NCT01309126|Recurrent or Progressive KRAS Wild Type Colorectal Cancer|recurrent or progressive kras wild type colorectal cancer
5496803|NCT01309087|Gene Expression|gene expression
5496804|NCT01309087|Lung Cancer|lung cancer
5496805|NCT01309087|Smoking|smoking
5496806|NCT01309074|Anxiety|anxiety
5496807|NCT01309074|Epilepsy|epilepsy
5496808|NCT01309048|bone metastasis|bone metastasis
5496809|NCT01309048|Patients with bone metastasis|patients with bone metastasis
5496810|NCT01309035|Prothesis fixation|prothesis fixation
5496811|NCT01309035|Bloodlessness|bloodlessness
5496812|NCT01309022|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5496813|NCT01309022|T1D|t1d
5496814|NCT01309022|T1DM|t1dm
5496815|NCT01309022|Islets of Langerhans Transplantation|islets of langerhans transplantation
5496816|NCT01309022|Pancreatic Islets Transplantation|pancreatic islets transplantation
5496817|NCT01309022|Islet Transplant|islet transplant
5496818|NCT01309022|Tacrolimus|tacrolimus
5496819|NCT01309022|Sirolimus|sirolimus
5496820|NCT01309022|Mycophenolate mofetil|mycophenolate mofetil
5496821|NCT01309022|Mycophenolic acid|mycophenolic acid
5496822|NCT01309009|Infantile Colic|infantile colic
5496823|NCT01309009|Tachykinin antagonist|tachykinin antagonist
5496824|NCT01309009|Nepadutant|nepadutant
5496825|NCT01308996|alveolar ridge augmentation|alveolar ridge augmentation
5496826|NCT01308996|edentulous ridge|edentulous ridge
5496827|NCT01308996|alveolar ridge defect|alveolar ridge defect
5496828|NCT01308996|posterior mandible defect|posterior mandible defect
5496829|NCT01308996|bone morphogenic protein|bone morphogenic protein
5496830|NCT01308996|osseointegration|osseointegration
5496831|NCT01308983|Prehypertension|prehypertension
5496832|NCT01308983|Flow mediated dilation|flow mediated dilation
5496833|NCT01308983|Pulse wave velocity|pulse wave velocity
5496834|NCT01308983|carotid compliance|carotid compliance
5496835|NCT01308983|Prehypertension and amiloride|prehypertension and amiloride
5496836|NCT01308944|invasive epithelial ovarian cancer,|invasive epithelial ovarian cancer,
5496837|NCT01308944|primary peritoneal carcinoma,|primary peritoneal carcinoma,
5496838|NCT01308944|fallopian tube cancer|fallopian tube cancer
5496839|NCT01308931|Contraception|contraception
5496840|NCT01308931|IUD|iud
5496841|NCT01308931|Essure|essure
5496842|NCT01308931|Tubal ligation|tubal ligation
5496843|NCT01308931|Anti-Mullerian hormone|anti-mullerian hormone
5496844|NCT01308918|Thoracic surgery|thoracic surgery
5496947|NCT01308346|total coronary occlusion|total coronary occlusion
5496845|NCT01308918|Double lumen tube intubation|double lumen tube intubation
5496846|NCT01308918|GlideScope|glidescope
5496847|NCT01308918|Stylet|stylet
5496848|NCT01308905|Neuroblastoma|neuroblastoma
5496849|NCT01308879|Contextualized Feedback System (CFS)|contextualized feedback system (cfs)
5496850|NCT01308879|Mental health outcomes|mental health outcomes
5496851|NCT01308879|Quality improvement|quality improvement
5496852|NCT01308879|Feedback|feedback
5496853|NCT01308879|Clinical trial|clinical trial
5496854|NCT01308866|cardiovascular diseases|cardiovascular diseases
5496855|NCT01308866|patient education|patient education
5496856|NCT01308866|primary health care|primary health care
5496857|NCT01308866|consumer participation|consumer participation
5496858|NCT01308866|decision aids|decision aids
5496859|NCT01308840|Unresectable|unresectable
5496860|NCT01308840|metastatic|metastatic
5496861|NCT01308840|biliary tract|biliary tract
5496862|NCT01308840|gallbladder cancer|gallbladder cancer
5496863|NCT01308827|Children 28 days to 36 months of age with suspected pneumococcal disease|children 28 days to 36 months of age with suspected pneumococcal disease
5496864|NCT01308814|Perimenopause|perimenopause
5496866|NCT01308814|Depression|depression
5496867|NCT01308814|Cardiovascular health|cardiovascular health
5496868|NCT01308801|fibromyalgia|fibromyalgia
5496869|NCT01308801|pain|pain
5496870|NCT01308801|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5496871|NCT01308801|rehabilitation exercise|rehabilitation exercise
5496872|NCT01308801|quality of life|quality of life
5496873|NCT01308788|glaucoma blood flow|glaucoma blood flow
5496874|NCT01308775|SIS.NET|sis.net
5496875|NCT01308736|tobacco|tobacco
5496876|NCT01308736|nicotine|nicotine
5496877|NCT01308736|cigarette smoking|cigarette smoking
5496878|NCT01308710|endothelial function|endothelial function
5496879|NCT01308710|lipids|lipids
5496880|NCT01308710|pediatrics|pediatrics
5496881|NCT01308697|Flail|flail
5496882|NCT01308697|Chest|chest
5496883|NCT01308671|coronary artery disease|coronary artery disease
5496884|NCT01308671|varenicline|varenicline
5496885|NCT01308671|clopidogrel|clopidogrel
5496886|NCT01308658|TMC114-C176|tmc114-c176
5496887|NCT01308658|TMC114|tmc114
5496888|NCT01308658|DRV|drv
5496889|NCT01308658|HIV|hiv
5496890|NCT01308658|Healthy volunteers|healthy volunteers
5496891|NCT01308645|SBP Injection|sbp injection
5496892|NCT01308645|HCC|hcc
5496893|NCT01308632|glioblastoma|glioblastoma
5496894|NCT01308632|temozolamide|temozolamide
5496895|NCT01308632|radiotherapy|radiotherapy
5496896|NCT01308632|TMZ|tmz
5496897|NCT01308632|irinotecan|irinotecan
5496898|NCT01308606|TMC435-TiDP16-C116|tmc435-tidp16-c116
5496899|NCT01308606|TMC435-C116|tmc435-c116
5496900|NCT01308606|TMC435|tmc435
5496901|NCT01308606|HCV|hcv
5496902|NCT01308606|Hepatitis C|hepatitis c
5496903|NCT01308606|Hep C|hep c
5496904|NCT01308606|healthy volunteers|healthy volunteers
5496905|NCT01308554|TAP block|tap block
5496906|NCT01308554|Pain|pain
5496907|NCT01308554|Obesity|obesity
5496908|NCT01308554|Surgery|surgery
5497034|NCT01307943|mental health|mental health
5496909|NCT01308554|Laparoscopic gastric bypass|laparoscopic gastric bypass
5496910|NCT01308528|Venous Thromboembolism|venous thromboembolism
5496911|NCT01308515|knee|knee
5496912|NCT01308515|osteoarthritis|osteoarthritis
5496913|NCT01308515|joint|joint
5496914|NCT01308515|replacement|replacement
5496915|NCT01308515|knee surgery|knee surgery
5496916|NCT01308502|laryngopharyngeal reflux|laryngopharyngeal reflux
5496918|NCT01308502|GERD|gerd
5496919|NCT01308502|gastroesophageal reflux|gastroesophageal reflux
5496920|NCT01308502|nasopharyngeal probe|nasopharyngeal probe
5496921|NCT01308463|elbow long-term Survivorship|elbow long-term survivorship
5496922|NCT01308463|Study participant Discovery Elbow Multi-center Study who|study participant discovery elbow multi-center study who
5496923|NCT01308463|consent for the Discovery Elbow Long-term SurvivorshipStudy|consent for the discovery elbow long-term survivorshipstudy
5496924|NCT01308450|ADHD Normative Control Group|adhd normative control group
5496925|NCT01308424|Herpes Labialis|herpes labialis
5496926|NCT01308424|Herpes Simplex|herpes simplex
5496927|NCT01308424|Herpes|herpes
5496928|NCT01308411|Asthma|asthma
5496929|NCT01308411|Inhaled Corticosteroids|inhaled corticosteroids
5496930|NCT01308411|Exhaled Nitric oxide|exhaled nitric oxide
5496931|NCT01308411|Airways inflammation|airways inflammation
5496932|NCT01308411|Step down|step down
5496933|NCT01308411|Predicting response|predicting response
5496934|NCT01308372|cardiovascular risk|cardiovascular risk
5496935|NCT01308372|France|france
5496936|NCT01308372|General practice|general practice
5496937|NCT01308372|Primary prevention|primary prevention
5496938|NCT01308372|Non treated patients|non treated patients
5496939|NCT01308359|fetal movement|fetal movement
5496940|NCT01308346|Bioabsorbable|bioabsorbable
5496941|NCT01308346|Coronary Stent|coronary stent
5496942|NCT01308346|Everolimus|everolimus
5496943|NCT01308346|drug eluting stents|drug eluting stents
5496944|NCT01308346|stents|stents
5496945|NCT01308346|angioplasty|angioplasty
5496946|NCT01308346|coronary artery disease|coronary artery disease
5497138|NCT01307514|DIABETES|diabetes
5496948|NCT01308346|coronary artery restenosis|coronary artery restenosis
5496949|NCT01308346|stent thrombosis|stent thrombosis
5496950|NCT01308346|myocardial ischemia|myocardial ischemia
5496951|NCT01308346|coronary artery stenosis|coronary artery stenosis
5496952|NCT01308307|Non-cycloplegic photorefraction|non-cycloplegic photorefraction
5496953|NCT01308307|cycloplegic refraction,|cycloplegic refraction,
5496954|NCT01308307|Amblyopia|amblyopia
5496955|NCT01308294|Melanoma|melanoma
5496956|NCT01308294|Stage II-IV|stage ii-iv
5496957|NCT01308294|Immunotherapy|immunotherapy
5496958|NCT01308294|Vaccination|vaccination
5496959|NCT01308294|HLA class I and II tumor-specific peptides|hla class i and ii tumor-specific peptides
5496960|NCT01308294|IMP321|imp321
5496961|NCT01308294|Montanide ISA-51 VG|montanide isa-51 vg
5496962|NCT01308268|STH|sth
5496963|NCT01308268|Soil-transmitted Helminthiasis|soil-transmitted helminthiasis
5496964|NCT01308268|mass drug administration|mass drug administration
5496965|NCT01308229|Bifurcation|bifurcation
5496966|NCT01308229|Dedicated|dedicated
5496967|NCT01308229|Drug-eluting stent|drug-eluting stent
5496968|NCT01308229|Angioplasty|angioplasty
5496969|NCT01308229|Coronary artery disease|coronary artery disease
5496970|NCT01308229|Coronary artery stenosis|coronary artery stenosis
5496971|NCT01308216|Transcranial Laser Therapy|transcranial laser therapy
5496972|NCT01308216|Hemiplegia|hemiplegia
5496973|NCT01308216|Rehabilitation|rehabilitation
5496974|NCT01308216|Physiotherapy|physiotherapy
5496975|NCT01308216|Ischemic stroke|ischemic stroke
5496976|NCT01308190|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5496977|NCT01308190|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5496978|NCT01308190|Rectal Cancer|rectal cancer
5496979|NCT01308190|T2-T3s-N0|t2-t3s-n0
5496980|NCT01308164|Type 1 diabetes|type 1 diabetes
5496981|NCT01308164|Insulin Pump Therapy|insulin pump therapy
5496982|NCT01308151|CBT, self harm, depression, cultural adaptation, Pakistan|cbt, self harm, depression, cultural adaptation, pakistan
5496983|NCT01308138|Physical Activity|physical activity
5496985|NCT01308138|Physical Deconditioning|physical deconditioning
5496986|NCT01308125|Stable Angina|stable angina
5496987|NCT01308125|Coronary artery disease|coronary artery disease
5496988|NCT01308125|PCI|pci
5496989|NCT01308125|Reperfusion|reperfusion
5496990|NCT01308125|Myocardial Infarction|myocardial infarction
5496991|NCT01308125|collateral flow pressure index|collateral flow pressure index
5496992|NCT01308125|CFpI|cfpi
5496993|NCT01308125|pressure controlled intermittent coronary sinus occlusion|pressure controlled intermittent coronary sinus occlusion
5496994|NCT01308125|PICSO|picso
5496995|NCT01308112|Iron|iron
5496996|NCT01308112|Plasmodium|plasmodium
5496997|NCT01308112|Malaria|malaria
5496998|NCT01308112|Pregnancy|pregnancy
5496999|NCT01308112|Kenya|kenya
5497000|NCT01308099|POTS|pots
5497001|NCT01308099|Vascular Endothelial Function|vascular endothelial function
5497002|NCT01308086|Cancer|cancer
5497003|NCT01308086|colorectal cancer|colorectal cancer
5497004|NCT01308086|adjuvant chemotherapy|adjuvant chemotherapy
5497005|NCT01308086|capecitabine|capecitabine
5497006|NCT01308086|oxaliplatin|oxaliplatin
5497007|NCT01308086|5 fluorouracil|5 fluorouracil
5497008|NCT01308060|Canthal lines|canthal lines
5497009|NCT01308034|non GIST sarcomas|non gist sarcomas
5497010|NCT01308034|sunitinib|sunitinib
5497011|NCT01308034|radiotherapy|radiotherapy
5497012|NCT01308034|dose escalation|dose escalation
5497013|NCT01308021|Rhinoconjunctivitis|rhinoconjunctivitis
5497014|NCT01308021|Allergy|allergy
5497015|NCT01308021|Grass pollen|grass pollen
5497016|NCT01308021|Hypersensitivity|hypersensitivity
5497017|NCT01308021|Immune system disorder|immune system disorder
5497018|NCT01308008|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5497019|NCT01308008|Mobility Limitation|mobility limitation
5497020|NCT01307995|GDM|gdm
5497021|NCT01307995|incretin effect|incretin effect
5497022|NCT01307995|gestation|gestation
5497023|NCT01307995|reversibility|reversibility
5497024|NCT01307982|Gastroesophageal Reflux|gastroesophageal reflux
5497025|NCT01307982|Nervous System Diseases|nervous system diseases
5497026|NCT01307982|Fundoplication|fundoplication
5497027|NCT01307982|Enteral Nutrition|enteral nutrition
5497028|NCT01307969|liposomes|liposomes
5497029|NCT01307969|ropivacaine|ropivacaine
5497030|NCT01307969|dental anesthesia|dental anesthesia
5497031|NCT01307969|dentistry|dentistry
5497032|NCT01307943|MBSR|mbsr
5497033|NCT01307943|adolescent|adolescent
5497035|NCT01307930|Echinocandin|echinocandin
5497036|NCT01307930|Obesity|obesity
5497037|NCT01307930|Pharmacokinetics|pharmacokinetics
5497038|NCT01307930|Pharmacodynamics|pharmacodynamics
5497039|NCT01307930|Fungal infection|fungal infection
5497040|NCT01307917|diabetes mellitus|diabetes mellitus
5497041|NCT01307917|diabetic nephropathy|diabetic nephropathy
5497042|NCT01307917|vascular endothelial dysfunction|vascular endothelial dysfunction
5497043|NCT01307917|flavonoids|flavonoids
5497044|NCT01307917|flow-mediated dilation|flow-mediated dilation
5497045|NCT01307904|Glycemic index|glycemic index
5497046|NCT01307904|Dates|dates
5497047|NCT01307904|Blood glucose|blood glucose
5497048|NCT01307891|Triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5497057|NCT01307865|sculptra aesthetic|sculptra aesthetic
5497058|NCT01307865|poly-L-lactic acid|poly-l-lactic acid
5497059|NCT01307852|Fiber optic radiation detectors|fiber optic radiation detectors
5497060|NCT01307852|Enhanced endorectal balloon|enhanced endorectal balloon
5497061|NCT01307852|Radiation treatment|radiation treatment
5497062|NCT01307852|Radiotherapy|radiotherapy
5497063|NCT01307852|External beam radiation|external beam radiation
5497064|NCT01307852|Dosimetry|dosimetry
5497065|NCT01307839|labor|labor
5497066|NCT01307839|epidural|epidural
5497067|NCT01307826|massage|massage
5497068|NCT01307826|shoulder|shoulder
5497069|NCT01307826|pain|pain
5497070|NCT01307826|range of motion|range of motion
5497071|NCT01307826|restricted range of motion|restricted range of motion
5497072|NCT01307813|colon distal|colon distal
5497073|NCT01307813|surgical resection|surgical resection
5497074|NCT01307787|exercise|exercise
5497075|NCT01307787|education|education
5497076|NCT01307787|self-management|self-management
5497077|NCT01307787|rehabilitation|rehabilitation
5497078|NCT01307774|parental acceptability of HPV vaccine|parental acceptability of hpv vaccine
5497079|NCT01307761|fine needle aspiration; predictor; ultrasonography; thyroid cancer|fine needle aspiration; predictor; ultrasonography; thyroid cancer
5497080|NCT01307748|aromatherapy|aromatherapy
5497081|NCT01307748|stress|stress
5497082|NCT01307748|older adults|older adults
5497083|NCT01307748|stress-related change|stress-related change
5497084|NCT01307735|myocarditis|myocarditis
5497085|NCT01307735|edema|edema
5497086|NCT01307735|hyperemia|hyperemia
5497087|NCT01307735|fibrosis|fibrosis
5497088|NCT01307735|necrosis|necrosis
5497089|NCT01307735|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
5497090|NCT01307722|left atrial distensibility|left atrial distensibility
5497091|NCT01307722|advanced chronic heart failure|advanced chronic heart failure
5497092|NCT01307722|decompensation|decompensation
5497093|NCT01307722|rehospitalization|rehospitalization
5497094|NCT01307722|prognosis|prognosis
5497095|NCT01307722|all-cause mortality|all-cause mortality
5497096|NCT01307722|heart failure with hospitalization|heart failure with hospitalization
5497097|NCT01307722|the duration of hospitalization|the duration of hospitalization
5497098|NCT01307696|Umbilical Hernia Repair|umbilical hernia repair
5497099|NCT01307696|PVP Mesh|pvp mesh
5497100|NCT01307683|Pregnancy|pregnancy
5497101|NCT01307683|Overweight|overweight
5497102|NCT01307683|Obese|obese
5497103|NCT01307683|Stress|stress
5497104|NCT01307683|Mindfulness|mindfulness
5497105|NCT01307657|clopidogrel|clopidogrel
5497106|NCT01307657|platelet|platelet
5497107|NCT01307657|platelet function test|platelet function test
5497108|NCT01307657|healthy|healthy
5497109|NCT01307657|Platelet function tests|platelet function tests
5497110|NCT01307644|Overweight|overweight
5497111|NCT01307644|Obesity|obesity
5497112|NCT01307644|Rural Health|rural health
5497113|NCT01307644|Weight Loss|weight loss
5497114|NCT01307644|Weight Maintenance|weight maintenance
5497115|NCT01307644|Rural Middle Aged and Older Women|rural middle aged and older women
5497116|NCT01307644|Web Intervention Weight Loss|web intervention weight loss
5497117|NCT01307644|Class I, II, & III obese (BMI 28 to 45)|class i, ii, & iii obese (bmi 28 to 45)
5497118|NCT01307605|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5497119|NCT01307605|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5497120|NCT01307605|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5497121|NCT01307605|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5497122|NCT01307605|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5497123|NCT01307605|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5497124|NCT01307605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5497125|NCT01307605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5479063|NCT01382732|Pre-eclampsia|pre-eclampsia
5497126|NCT01307605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5497127|NCT01307605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5497128|NCT01307605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5497129|NCT01307605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5500024|NCT01295684|cranberry|cranberry
5497130|NCT01307592|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5497131|NCT01307592|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5497132|NCT01307592|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5497133|NCT01307592|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5497134|NCT01307592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5497136|NCT01307579|leukemia|leukemia
5497137|NCT01307579|invasive fungal infection|invasive fungal infection
5497139|NCT01307514|PHARMACOKINETICS|pharmacokinetics
5497140|NCT01307514|PHARMACODYNAMICS|pharmacodynamics
5497141|NCT01307514|INSULIN|insulin
5497142|NCT01307501|Cryoablation|cryoablation
5497143|NCT01307501|Cryotherapy|cryotherapy
5497144|NCT01307501|Cryosurgery|cryosurgery
5497145|NCT01307501|Metastatic|metastatic
5497146|NCT01307501|Lung|lung
5497147|NCT01307501|Pleura|pleura
5497148|NCT01307501|Tumors|tumors
5497149|NCT01307488|HIV|hiv
5497150|NCT01307488|AIDS|aids
5497151|NCT01307488|Atazanavir|atazanavir
5497152|NCT01307488|Simplification|simplification
5497153|NCT01307475|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
5497398|NCT01306656|Vitamin D Deficiency|vitamin d deficiency
5497154|NCT01307475|Delayed Onset Post-Traumatic Stress Disorder|delayed onset post-traumatic stress disorder
5497155|NCT01307475|Post-Traumatic Neuroses|post-traumatic neuroses
5497156|NCT01307475|Posttraumatic Neuroses|posttraumatic neuroses
5497157|NCT01307475|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5497158|NCT01307475|Posttraumatic Stress Disorders|posttraumatic stress disorders
5497159|NCT01307475|PTSD|ptsd
5497160|NCT01307475|Post TraumaticStress Disorder|post traumaticstress disorder
5497161|NCT01307475|Endogenous Depression|endogenous depression
5497162|NCT01307475|Neurotic Depression|neurotic depression
5497168|NCT01307475|Emotional Depression|emotional depression
5497169|NCT01307475|Quality of Life|quality of life
5497170|NCT01307449|pneumococcal vaccine|pneumococcal vaccine
5497171|NCT01307449|immune responses|immune responses
5497172|NCT01307436|Hepatitis A Vaccine|hepatitis a vaccine
5497173|NCT01307436|Combined Vaccines|combined vaccines
5497174|NCT01307436|DTP Vaccine|dtp vaccine
5497175|NCT01307436|MMR Vaccine|mmr vaccine
5497176|NCT01307423|psoriasis|psoriasis
5497177|NCT01307423|Arthritis|arthritis
5497178|NCT01307423|Psoriatic Arthritis|psoriatic arthritis
5497179|NCT01307423|inflammation|inflammation
5497180|NCT01307423|skin condition|skin condition
5497181|NCT01307423|inflammatory cells|inflammatory cells
5497182|NCT01307423|apremilast|apremilast
5497183|NCT01307423|CC-10004|cc-10004
5497184|NCT01307423|phosphodiesterase type 4|phosphodiesterase type 4
5497185|NCT01307410|Patients with type 2 diabetes and participated in 3B Study|patients with type 2 diabetes and participated in 3b study
5497186|NCT01307384|Total Hip Arthroplasty|total hip arthroplasty
5497187|NCT01307384|Total Hip Replacement (THR)|total hip replacement (thr)
5497188|NCT01307384|Primary Hip Arthroplasty|primary hip arthroplasty
5497190|NCT01307384|THR|thr
5497191|NCT01307371|Bone Marrow Mononuclear cells;|bone marrow mononuclear cells;
5497192|NCT01307371|Diabetes;|diabetes;
5497193|NCT01307371|ST-segment Elevation Myocardial Infarction;|st-segment elevation myocardial infarction;
5497194|NCT01307371|Percutaneous Coronary Intervention;|percutaneous coronary intervention;
5497195|NCT01307371|Left Ventricular Function|left ventricular function
5497196|NCT01307332|Multiple Sclerosis|multiple sclerosis
5497197|NCT01307332|MS|ms
5497198|NCT01307332|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5497199|NCT01307332|RRMS|rrms
5497200|NCT01307332|Alemtuzumab|alemtuzumab
5497201|NCT01307332|Demyelination|demyelination
5497202|NCT01307332|Remyelination|remyelination
5497203|NCT01307332|Tolerogenic|tolerogenic
5497204|NCT01307332|T cells|t cells
5497205|NCT01307332|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5497206|NCT01307332|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5497207|NCT01307332|Nervous System Diseases|nervous system diseases
5497208|NCT01307332|Demyelinating Diseases|demyelinating diseases
5497209|NCT01307332|Autoimmune Diseases|autoimmune diseases
5497210|NCT01307332|Immune System Diseases|immune system diseases
5497211|NCT01307319|Allergies|allergies
5497212|NCT01307319|Hayfever|hayfever
5497213|NCT01307306|Thermal injury|thermal injury
5497214|NCT01307306|Chemical Burn|chemical burn
5497215|NCT01307306|Flame Burn|flame burn
5497216|NCT01307280|Behavioral Weight Management Intervention|behavioral weight management intervention
5497217|NCT01307280|weight loss|weight loss
5497218|NCT01307280|cost-effective analysis|cost-effective analysis
5497219|NCT01307280|high blood pressure|high blood pressure
5497220|NCT01307280|randomized clinical trial|randomized clinical trial
5497221|NCT01307280|behavioral interventions|behavioral interventions
5497222|NCT01307280|physical activity|physical activity
5497223|NCT01307280|dietary change|dietary change
5497224|NCT01307280|obesity|obesity
5497225|NCT01307267|Phase 1|phase 1
5497226|NCT01307267|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5497227|NCT01307267|Advanced malignancies|advanced malignancies
5497228|NCT01307241|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5497229|NCT01307241|prognostic factor|prognostic factor
5497230|NCT01307241|pharmacogenetics.|pharmacogenetics.
5497231|NCT01307228|Knowledge translation|knowledge translation
5497233|NCT01307228|Health systems|health systems
5497234|NCT01307215|TAP block|tap block
5497235|NCT01307215|incision pain|incision pain
5497236|NCT01307215|total hysterectomy|total hysterectomy
5497238|NCT01307202|arthroplasty|arthroplasty
5497239|NCT01307202|postoperative pain|postoperative pain
5497240|NCT01307202|gabapentin|gabapentin
5497241|NCT01307189|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5497242|NCT01307189|Exercise|exercise
5497243|NCT01307189|Endurance shuttle walking test|endurance shuttle walking test
5497244|NCT01307189|Bronchodilation|bronchodilation
5497245|NCT01307189|Tiotropium|tiotropium
5497246|NCT01307176|ataxia|ataxia
5497247|NCT01307176|exercise|exercise
5497248|NCT01307176|training|training
5497249|NCT01307176|cerebellar|cerebellar
5497250|NCT01307176|rehabilitation|rehabilitation
5497251|NCT01307163|saliva|saliva
5497252|NCT01307163|liver transplantation|liver transplantation
5497253|NCT01307163|children|children
5497254|NCT01307163|In this prospective study 60 subjects will be examined|in this prospective study 60 subjects will be examined
5491657|NCT01330108|PAH|pah
5497257|NCT01307163|informed consent forms signed be the examinees parents|informed consent forms signed be the examinees parents
5497259|NCT01307150|Dead Sea|dead sea
5497260|NCT01307150|Climatotherapy|climatotherapy
5497261|NCT01307150|SCORAD|scorad
5497262|NCT01307124|safety and efficacy|safety and efficacy
5497263|NCT01307124|low dose LPV/r|low dose lpv/r
5497264|NCT01307124|standard dose LPV/r|standard dose lpv/r
5497265|NCT01307124|HIV infected children|hiv infected children
5497266|NCT01307111|Misoprostol|misoprostol
5497267|NCT01307111|IUD insertion|iud insertion
5497268|NCT01307111|Nulliparous Women|nulliparous women
5497269|NCT01307111|Contraception|contraception
5497270|NCT01307111|Family Planning|family planning
5497271|NCT01307111|IUD insertion in nulliparous women|iud insertion in nulliparous women
5497272|NCT01307098|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
5497273|NCT01307098|Lysosomal Storage Disease|lysosomal storage disease
5680296|NCT00578344|Hemoglobin Sb0/+|hemoglobin sb0/+
5497274|NCT01307098|Late Onset Lysosomal Acid Lipase (LAL) Deficiency|late onset lysosomal acid lipase (lal) deficiency
5497275|NCT01307098|Acid cholesteryl ester hydrolase deficiency, type 2|acid cholesteryl ester hydrolase deficiency, type 2
5497276|NCT01307098|Acid lipase disease|acid lipase disease
5497277|NCT01307098|Cholesterol ester hydrolase deficiency|cholesterol ester hydrolase deficiency
5497278|NCT01307098|LAL Deficiency|lal deficiency
5497279|NCT01307098|LIPA Deficiency|lipa deficiency
5497280|NCT01307098|Wolman disease|wolman disease
5497281|NCT01307085|remote ischemic preconditioning|remote ischemic preconditioning
5497282|NCT01307085|lung injury|lung injury
5497283|NCT01307085|pulmonary resection|pulmonary resection
5497284|NCT01307072|periodic examinations, compliance|periodic examinations, compliance
5497285|NCT01307059|Growth disorders|growth disorders
5497286|NCT01307059|Saizen|saizen
5497287|NCT01307059|Easypod|easypod
5497288|NCT01307059|Growth hormone|growth hormone
5497289|NCT01307059|Pediatric subject|pediatric subject
5497290|NCT01307046|Essential hypertension|essential hypertension
5497291|NCT01307046|Uncontrolled hypertension|uncontrolled hypertension
5497292|NCT01307046|Antihypertensive agents|antihypertensive agents
5497293|NCT01307046|Blood pressure|blood pressure
5497294|NCT01307033|Essential hypertension|essential hypertension
5497295|NCT01307033|Uncontrolled hypertension|uncontrolled hypertension
5497296|NCT01307033|Antihypertensive agents|antihypertensive agents
5497297|NCT01307033|Blood pressure|blood pressure
5497298|NCT01307020|Moderate to severe pain|moderate to severe pain
5497299|NCT01307020|Postoperative pain|postoperative pain
5497300|NCT01307020|Analgesics|analgesics
5497301|NCT01307020|Dexketoprofen|dexketoprofen
5497302|NCT01307020|Tramadol|tramadol
5497303|NCT01306994|Exercise Test|exercise test
5497304|NCT01306994|Bicycle Ergometry Test|bicycle ergometry test
5497305|NCT01306994|Stress Test|stress test
5497306|NCT01306981|Diabetes Mellitus|diabetes mellitus
5497307|NCT01306981|Diabetes Complications|diabetes complications
5497308|NCT01306981|Retinal Diseases|retinal diseases
5497309|NCT01306981|Endothelial Growth Factors|endothelial growth factors
5497310|NCT01306981|Monoclonal Antibodies|monoclonal antibodies
5497311|NCT01306981|Ranibizumab|ranibizumab
5497312|NCT01306981|Vitrectomy|vitrectomy
5497313|NCT01306981|Vitreoretinal Surgery|vitreoretinal surgery
5497314|NCT01306968|mild tramatic brain injury|mild tramatic brain injury
5497315|NCT01306968|mTBI|mtbi
5497316|NCT01306968|hyperbaric oxygen|hyperbaric oxygen
5497317|NCT01306968|post concussive symptoms|post concussive symptoms
5497318|NCT01306968|active duty military|active duty military
5497319|NCT01306968|veterans|veterans
5497328|NCT01306929|Huntington Disease.|huntington disease.
5497329|NCT01306916|thyroid disease, hyperthyroidism|thyroid disease, hyperthyroidism
5497330|NCT01306903|Minimizing Cardiopulmonary Bypass MECC damage organ failure|minimizing cardiopulmonary bypass mecc damage organ failure
5497331|NCT01306877|hemorrhoid|hemorrhoid
5497332|NCT01306877|hemorrhoid stapler|hemorrhoid stapler
5497333|NCT01306864|Endoscopic Hemostasis|endoscopic hemostasis
5497334|NCT01306864|Peptic Ulcer|peptic ulcer
5497335|NCT01306864|Recurrent Bleeding|recurrent bleeding
5497336|NCT01306864|Injection Therapy|injection therapy
5497337|NCT01306864|Thermal Probe|thermal probe
5497338|NCT01306851|fibrin glue|fibrin glue
5497339|NCT01306851|anastomotic leak|anastomotic leak
5497340|NCT01306851|gastrointestinal high risk anastomosis|gastrointestinal high risk anastomosis
5497341|NCT01306838|Short bowel syndrome|short bowel syndrome
5497342|NCT01306838|Necrotizing enterocolitis|necrotizing enterocolitis
5497343|NCT01306838|Small intestine perforation|small intestine perforation
5497344|NCT01306838|Enterostomy|enterostomy
5497345|NCT01306838|Intralipid|intralipid
5497346|NCT01306838|Microlipid|microlipid
5497347|NCT01306838|Fish oil|fish oil
5497348|NCT01306825|Daptomycin|daptomycin
5497349|NCT01306825|Bone disease,infectious|bone disease,infectious
5497350|NCT01306825|Osteomyelitis|osteomyelitis
5497351|NCT01306825|Diabetic foot|diabetic foot
5497352|NCT01306825|Staphylococcus aureus|staphylococcus aureus
5497353|NCT01306812|Adolescent|adolescent
5497355|NCT01306812|Criminology|criminology
5497357|NCT01306812|Environment|environment
5497358|NCT01306812|Mono amine Oxidase|mono amine oxidase
5497359|NCT01306812|Serotonin|serotonin
5497360|NCT01306812|Social Support|social support
5497361|NCT01306799|Barrett's Esophagus|barrett's esophagus
5497362|NCT01306799|Erosive Esophagitis|erosive esophagitis
5497363|NCT01306799|Proton Pump Inhibitor (PPI)|proton pump inhibitor (ppi)
5497365|NCT01306799|Bone Density|bone density
5497366|NCT01306799|GERD|gerd
5497367|NCT01306799|ulcer prophylaxis|ulcer prophylaxis
5497368|NCT01306773|Influenza A|influenza a
5497369|NCT01306773|convalescent plasma|convalescent plasma
5497370|NCT01306773|death|death
5497371|NCT01306760|depression|depression
5497372|NCT01306760|electroconvulsive therapy|electroconvulsive therapy
5497373|NCT01306760|ketamine|ketamine
5497374|NCT01306747|Chronic pain|chronic pain
5497375|NCT01306747|Stanford chronic pain self-management programme|stanford chronic pain self-management programme
5497376|NCT01306747|Patient education|patient education
5497377|NCT01306734|Extracorporeal circulation|extracorporeal circulation
5497378|NCT01306734|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5497379|NCT01306734|aortic aneurism|aortic aneurism
5497380|NCT01306734|neurological injury|neurological injury
5497381|NCT01306734|inflammation|inflammation
5497382|NCT01306734|coagulation|coagulation
5497383|NCT01306708|Adhesive Capsulitis|adhesive capsulitis
5497384|NCT01306708|Shoulder|shoulder
5497386|NCT01306695|Dementia|dementia
5497387|NCT01306695|Depressive symptoms|depressive symptoms
5497388|NCT01306695|Caregiver Burden|caregiver burden
5497389|NCT01306695|Hispanic|hispanic
5497390|NCT01306695|Latino|latino
5497391|NCT01306695|Intervention|intervention
5497392|NCT01306695|Geriatric Depression Scale|geriatric depression scale
5497393|NCT01306695|Zarit Caregiver Burden Scale|zarit caregiver burden scale
5497394|NCT01306656|Endocrinology|endocrinology
5497395|NCT01306656|Metabolic Bone Disease|metabolic bone disease
5497396|NCT01306656|Primary Hyperparathyroidism|primary hyperparathyroidism
5497397|NCT01306656|PHPT|phpt
5497399|NCT01306656|Bone Mineral Density|bone mineral density
5497400|NCT01306656|Hyper-calcemia|hyper-calcemia
5497401|NCT01306643|Indolent Non-Hodgkin's Lymphoma|indolent non-hodgkin's lymphoma
5497402|NCT01306643|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5497403|NCT01306643|iNHL|inhl
5497405|NCT01306643|CAL-101|cal-101
5497406|NCT01306643|PI3K|pi3k
5497407|NCT01306643|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5497408|NCT01306643|Follicular Lymphoma (FL)|follicular lymphoma (fl)
5497409|NCT01306643|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5497410|NCT01306643|Marginal Zone Lymphoma (MZL)|marginal zone lymphoma (mzl)
5497411|NCT01306630|AV-951|av-951
5497412|NCT01306630|tivozanib|tivozanib
5497416|NCT01306604|Lipid Metabolism|lipid metabolism
5497417|NCT01306604|Lysosomal Storage Diseases|lysosomal storage diseases
5497418|NCT01306604|Metabolic Diseases|metabolic diseases
5497419|NCT01306604|Lipid Metabolism Disorders|lipid metabolism disorders
5497420|NCT01306591|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5497422|NCT01306591|Multicenter Randomized Study|multicenter randomized study
5497423|NCT01306578|Guillain Barre syndrome|guillain barre syndrome
5497424|NCT01306578|IVIG|ivig
5497425|NCT01306578|Plasma exchange|plasma exchange
5497426|NCT01306565|Unstable angina|unstable angina
5497427|NCT01306565|NSTMI|nstmi
5497428|NCT01306565|Statin|statin
5497429|NCT01306565|Atorvastatin|atorvastatin
5497430|NCT01306552|Tobacco use|tobacco use
5497431|NCT01306552|Adolescents|adolescents
5497432|NCT01306552|Primary prevention|primary prevention
5497433|NCT01306552|Program effectiveness|program effectiveness
5497434|NCT01306552|Parental component|parental component
5497435|NCT01306539|deep brain stimulation|deep brain stimulation
5497436|NCT01306539|subthalamic nucleus|subthalamic nucleus
5497437|NCT01306526|Thin-cap fibroatheroma|thin-cap fibroatheroma
5497438|NCT01306526|Vulnerable plaque|vulnerable plaque
5497439|NCT01306526|Coronary artery disease|coronary artery disease
5497440|NCT01306526|Obstructive sleep apnea|obstructive sleep apnea
5497441|NCT01306526|Intravascular Ultrasound|intravascular ultrasound
5497442|NCT01306513|emphysema|emphysema
5497443|NCT01306513|lung volume reduction surgery|lung volume reduction surgery
5497444|NCT01306513|mesenchymal stromal cells|mesenchymal stromal cells
5497445|NCT01306500|Gastric lavage|gastric lavage
5497446|NCT01306500|Neonate|neonate
5497447|NCT01306500|Meconium stained amniotic fluid|meconium stained amniotic fluid
5497448|NCT01306500|Feeding problems|feeding problems
5497449|NCT01306487|macular hole|macular hole
5497450|NCT01306474|CD4/CD25 Tr cell,TNF,IFN-γ,IL-2|cd4/cd25 tr cell,tnf,ifn-γ,il-2
5497451|NCT01306448|constipation|constipation
5497452|NCT01306448|gastro|gastro
5497453|NCT01306448|vibrating capsule|vibrating capsule
5497454|NCT01306448|safety|safety
5497455|NCT01306435|Osteoarthritis|osteoarthritis
5497456|NCT01306435|Low Power Laser Therapy|low power laser therapy
5497457|NCT01306435|Exercise|exercise
5497459|NCT01306422|hoodia gordonii|hoodia gordonii
5497460|NCT01306422|energy intake|energy intake
5497461|NCT01306422|food intake|food intake
5497462|NCT01306422|efficacy|efficacy
5497463|NCT01306422|body weight|body weight
5497464|NCT01306422|functional food|functional food
5497465|NCT01306422|plant extract|plant extract
5497466|NCT01306422|safety|safety
5497467|NCT01306422|steroid glycosides|steroid glycosides
5497468|NCT01306422|tolerability|tolerability
5497469|NCT01306409|anemia|anemia
5497470|NCT01306409|kidney disease|kidney disease
5497471|NCT01306396|NAFLD|nafld
5497472|NCT01306396|metabolic syndrome|metabolic syndrome
5497473|NCT01306396|children|children
5497474|NCT01306396|fructose|fructose
5497475|NCT01306383|SODIS|sodis
5497476|NCT01306383|waterborne|waterborne
5497477|NCT01306383|Disease|disease
5497478|NCT01306383|Diarrhoea|diarrhoea
5497479|NCT01306383|dysentery|dysentery
5497480|NCT01306370|primary knee arthroplasty|primary knee arthroplasty
5497481|NCT01306370|fibrin glue|fibrin glue
5497482|NCT01306370|tranexamic acid|tranexamic acid
5497483|NCT01306370|topic|topic
5497484|NCT01306357|Turner's syndrome|turner's syndrome
5497485|NCT01306357|somatropin|somatropin
5497486|NCT01306357|human growth hormone deficiency|human growth hormone deficiency
5497487|NCT01306344|Qualitative Research|qualitative research
5497488|NCT01306344|Interview, Psychological|interview, psychological
5497489|NCT01306344|Patients|patients
5497490|NCT01306344|Nurses|nurses
5497491|NCT01306344|Physicians|physicians
5497492|NCT01306305|Influenza|influenza
5497493|NCT01306305|Virus|virus
5497494|NCT01306305|Vaccination|vaccination
5497495|NCT01306305|Immunisation|immunisation
5497496|NCT01306292|Pulmonary hypertension|pulmonary hypertension
5497497|NCT01306292|Right heart Catheterization|right heart catheterization
5497498|NCT01306279|Cystic Fibrosis|cystic fibrosis
5497499|NCT01306279|Infection|infection
5497500|NCT01306279|Pulmonary exacerbation|pulmonary exacerbation
5497501|NCT01306279|Hypermutators|hypermutators
5497502|NCT01306279|Bacterial diversity|bacterial diversity
5497503|NCT01306279|Quorum sensing|quorum sensing
5497504|NCT01306266|active duty|active duty
5497505|NCT01306266|blast induced|blast induced
5497506|NCT01306266|headache|headache
5497507|NCT01306253|Influenza|influenza
5497508|NCT01306253|Virus|virus
5497509|NCT01306253|Vaccination|vaccination
5497510|NCT01306253|Immunisation|immunisation
5497511|NCT01306240|Infant newborn|infant newborn
5497512|NCT01306240|Infant preterm|infant preterm
5497513|NCT01306240|Acute respiratory distress syndrome|acute respiratory distress syndrome
5497515|NCT01306240|Hyaline Membrane disease|hyaline membrane disease
5497516|NCT01306240|Newborn acute respiratory distress syndrome (ARDS)|newborn acute respiratory distress syndrome (ards)
5497517|NCT01306227|Infant, newborn|infant, newborn
5497518|NCT01306227|Infant, preterm|infant, preterm
5497519|NCT01306227|Thyroid|thyroid
5497520|NCT01306227|Outcome|outcome
5497521|NCT01306227|Newborns less than 32 weeks of gestation|newborns less than 32 weeks of gestation
5497522|NCT01306227|TSH < 20 mIU/L and a FT4 < 0.80 ng/dL|tsh < 20 miu/l and a ft4 < 0.80 ng/dl
5497523|NCT01306201|Hospital Setting|hospital setting
5497524|NCT01306188|metastatic cancer|metastatic cancer
5497525|NCT01306188|lymphopenia|lymphopenia
5497526|NCT01306188|T cell receptor diversity|t cell receptor diversity
5497527|NCT01306149|biochemical parameters|biochemical parameters
5497528|NCT01306149|mineral metabolism|mineral metabolism
5497529|NCT01306149|protein-bound uremic retention solutes|protein-bound uremic retention solutes
5497530|NCT01306149|incident PD patients|incident pd patients
5497534|NCT01306123|bioavailability|bioavailability
5497535|NCT01306123|pharmacokinetics|pharmacokinetics
5497536|NCT01306123|cyanocobalamin|cyanocobalamin
5497537|NCT01306123|intranasal|intranasal
5497538|NCT01306123|intramuscular|intramuscular
5497539|NCT01306110|Liver fibrosis|liver fibrosis
5497540|NCT01306110|diabetes|diabetes
5497541|NCT01306110|Fibroscan|fibroscan
5497542|NCT01306110|Fibrotest|fibrotest
5497543|NCT01306110|noninvasive fibrosis biomarkers|noninvasive fibrosis biomarkers
5497544|NCT01306097|Zinc Supplement|zinc supplement
5497545|NCT01306097|Diarrhea|diarrhea
5497546|NCT01306097|Sever Diarrhea|sever diarrhea
5497547|NCT01306084|Respiratory Infections|respiratory infections
5497548|NCT01306084|Norovirus|norovirus
5497549|NCT01306084|Adenovirus|adenovirus
5497550|NCT01306084|Viral Infection|viral infection
5497551|NCT01306084|Respiratory Viruses|respiratory viruses
5497552|NCT01306058|Hepatocellular Carcinoma|hepatocellular carcinoma
5497554|NCT01306058|Sorafenib|sorafenib
5497555|NCT01306058|Liver Cancer|liver cancer
5497556|NCT01306058|Monoclonal Antibody|monoclonal antibody
5497562|NCT01306032|PARP Inhibitor|parp inhibitor
5497563|NCT01306032|BRCA Mutations|brca mutations
5497564|NCT01306032|DNA Damage Repair|dna damage repair
5497565|NCT01306032|Pharmacodynamics|pharmacodynamics
5497566|NCT01306032|Metronomic Cyclophosphamide|metronomic cyclophosphamide
5497567|NCT01306032|Ovarian Cancer|ovarian cancer
5497568|NCT01306032|Breast Cancer|breast cancer
5497569|NCT01306032|Fallopian Tube Cancer|fallopian tube cancer
5497570|NCT01306032|Peritoneal Cancer|peritoneal cancer
5497571|NCT01306019|T cell, B cell, NK cell|t cell, b cell, nk cell
5497572|NCT01306019|Gene Transfer|gene transfer
5497573|NCT01306019|Peripheral Blood Stem Cells|peripheral blood stem cells
5497574|NCT01306019|Common Gamma Chain (gamma c),|common gamma chain (gamma c),
5497575|NCT01306019|Immune Reconstitution|immune reconstitution
5497577|NCT01306006|Vaccines|vaccines
5497578|NCT01305954|Breast|breast
5497579|NCT01305954|Cancer|cancer
5497580|NCT01305954|Breast Cancer|breast cancer
5497581|NCT01305954|New Diagnosis|new diagnosis
5497582|NCT01305954|Treatment|treatment
5497583|NCT01305954|Chemotherapy|chemotherapy
5497584|NCT01305954|Blood|blood
5497585|NCT01305954|Blood Draw|blood draw
5497586|NCT01305954|Lab Draw|lab draw
5497587|NCT01305954|Gene|gene
5497588|NCT01305954|Gene Therapy|gene therapy
5497589|NCT01305954|Geriatric|geriatric
5497590|NCT01305954|Oncology|oncology
5497591|NCT01305954|Muss|muss
5497592|NCT01305954|UNC|unc
5497593|NCT01305954|North Carolina Cancer Hospital|north carolina cancer hospital
5497594|NCT01305954|Initial Treatment|initial treatment
5497595|NCT01305954|CBC|cbc
5497596|NCT01305941|everolimus|everolimus
5497597|NCT01305941|trastuzumab|trastuzumab
5497598|NCT01305941|vinorelbine|vinorelbine
5497599|NCT01305941|RAD001|rad001
5497600|NCT01305941|Breast Cancer|breast cancer
5497601|NCT01305941|Herceptin|herceptin
5497602|NCT01305941|Navelbine|navelbine
5497603|NCT01305941|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5497604|NCT01305941|Brain Metastases|brain metastases
5497605|NCT01305915|single-session group|single-session group
5497606|NCT01305915|psychoeducational intervention|psychoeducational intervention
5497607|NCT01305889|Depression|depression
5497608|NCT01305889|Cerebral perfusion|cerebral perfusion
5497609|NCT01305889|Brain derived neurotropic factor|brain derived neurotropic factor
5497610|NCT01305889|Problem Solving Therapy|problem solving therapy
5497611|NCT01305889|Sertraline|sertraline
5497612|NCT01305876|yoga|yoga
5497613|NCT01305876|emotional behavioral disorder|emotional behavioral disorder
5497614|NCT01305876|intervention|intervention
5497615|NCT01305876|school|school
5497616|NCT01305876|meditation|meditation
5497617|NCT01305876|focus: yoga intervention in students with emotional behavioral disorders in an urban school|focus: yoga intervention in students with emotional behavioral disorders in an urban school
5497618|NCT01305863|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5497619|NCT01305850|Aliskiren|aliskiren
5497620|NCT01305850|Losartan|losartan
5497621|NCT01305850|Peritoneal membrane dysfunction|peritoneal membrane dysfunction
5497623|NCT01305837|methylprednisolone|methylprednisolone
5497624|NCT01305837|osteopontin|osteopontin
5497625|NCT01305837|inflammation|inflammation
5497626|NCT01305837|demyelinating|demyelinating
5497627|NCT01305824|arteriovenous fistula|arteriovenous fistula
5497628|NCT01305824|AVF|avf
5497629|NCT01305824|hemodialysis|hemodialysis
5497630|NCT01305824|vascular access|vascular access
5497631|NCT01305824|dialysis|dialysis
5497632|NCT01305824|fistula|fistula
5497633|NCT01305824|PRT-201|prt-201
5497634|NCT01305824|vonapanitase|vonapanitase
5497635|NCT01305824|kidney|kidney
5497636|NCT01305824|renal|renal
5497637|NCT01305811|Complex Medical Illness|complex medical illness
5497638|NCT01305811|Gulf War Illness|gulf war illness
5497639|NCT01305811|Veteran|veteran
5497640|NCT01305798|Biometric Screenings|biometric screenings
5497641|NCT01305798|Active Choice|active choice
5497642|NCT01305798|Behavioral Economics|behavioral economics
5497643|NCT01305798|Default|default
5497644|NCT01305772|SCCHN|scchn
5497645|NCT01305772|untreated|untreated
5497646|NCT01305772|Stage III or IVa-b (M0)|stage iii or iva-b (m0)
5497647|NCT01305759|Total knee arthroplasty|total knee arthroplasty
5497648|NCT01305759|Total hip arthroplasty|total hip arthroplasty
5497649|NCT01305759|Peri acetabular osteotomy|peri acetabular osteotomy
5497650|NCT01305759|Social class|social class
5497651|NCT01305759|Health related quality of life|health related quality of life
5497652|NCT01305746|SLE|sle
5497653|NCT01305746|Lupus|lupus
5497654|NCT01305746|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5497655|NCT01305746|A-623|a-623
5497656|NCT01305746|Autoimmune Diseases|autoimmune diseases
5497657|NCT01305746|Blisibimod|blisibimod
5497658|NCT01305733|Pain relief|pain relief
5497659|NCT01305720|mydriatic|mydriatic
5497660|NCT01305720|NIRS|nirs
5497661|NCT01305720|preterm|preterm
5497662|NCT01305720|eye drops|eye drops
5497663|NCT01305720|cerebral|cerebral
5497664|NCT01305720|mesenteric oxygenation|mesenteric oxygenation
5497665|NCT01305707|Consolidation ECT|consolidation ect
5497666|NCT01305707|Pharmacotherapy|pharmacotherapy
5497667|NCT01305707|Efficacy|efficacy
5497668|NCT01305707|Depression|depression
5497669|NCT01305707|Prevention|prevention
5497670|NCT01305707|Electroconvulsive therapy|electroconvulsive therapy
5497671|NCT01305707|Drug therapy|drug therapy
5497672|NCT01305668|COPD|copd
5497673|NCT01305668|Emphysema phenotype|emphysema phenotype
5497674|NCT01305655|Drug: Glucarpidase|drug: glucarpidase
5497675|NCT01305642|Postnatal development|postnatal development
5497676|NCT01305642|Breast milk fortification|breast milk fortification
5497677|NCT01305642|Composition of breast milk|composition of breast milk
5497679|NCT01305629|Medication Adherence|medication adherence
5497680|NCT01305629|Substance Use|substance use
5497681|NCT01305629|Older adults|older adults
5497682|NCT01305629|Treatment|treatment
5497683|NCT01305616|Open angle Glaucoma|open angle glaucoma
5497684|NCT01305616|Yellow-tinted intraocular lens|yellow-tinted intraocular lens
5497685|NCT01305616|Short-wavelength Automated Perimetry (SWAP)|short-wavelength automated perimetry (swap)
5497686|NCT01305616|Standard Automated Perimetry (SAP)|standard automated perimetry (sap)
5497687|NCT01305616|cataract|cataract
5497688|NCT01305590|HIV|hiv
5497689|NCT01305590|AIDS|aids
5497690|NCT01305590|Medication Adherence|medication adherence
5497691|NCT01305590|Commitment Devices|commitment devices
5497692|NCT01305590|Behavioral Economics|behavioral economics
5497693|NCT01305564|Pulmonary embolism (PE)|pulmonary embolism (pe)
5497694|NCT01305564|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5497695|NCT01305564|Vena cava|vena cava
5497696|NCT01305564|Vena cava filter|vena cava filter
5497697|NCT01305564|Inferior vena cava|inferior vena cava
5497698|NCT01305564|Venous thromboembolic disease (VTED)|venous thromboembolic disease (vted)
5497699|NCT01305525|SCS|scs
5497700|NCT01305525|St. Jude Medical|st. jude medical
5497701|NCT01305525|Neuromodulation|neuromodulation
5497702|NCT01305512|Solid|solid
5497703|NCT01305512|Tumor|tumor
5497704|NCT01305512|Taxane|taxane
5497705|NCT01305499|AML|aml
5497706|NCT01305447|smoking cessation|smoking cessation
5497707|NCT01305447|exercise maintenance|exercise maintenance
5497708|NCT01305447|preventing relapse|preventing relapse
5497709|NCT01305447|weight gain|weight gain
5497710|NCT01305447|group-mediated cognitive behavioural therapy|group-mediated cognitive behavioural therapy
5497711|NCT01305434|diabetes mellitus type 2|diabetes mellitus type 2
5497712|NCT01305434|mulberry leaf extract|mulberry leaf extract
5497713|NCT01305434|post prandial blood glucose|post prandial blood glucose
5497714|NCT01305421|ICU|icu
5497715|NCT01305421|muscle strength|muscle strength
5497716|NCT01305421|mechanical ventilation|mechanical ventilation
5497717|NCT01305421|weaning|weaning
5497718|NCT01305408|Bipolar I Disorder|bipolar i disorder
5497719|NCT01305395|Cardiac Allograft Vasculopathy in Heart Transplant|cardiac allograft vasculopathy in heart transplant
5497720|NCT01305382|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5497721|NCT01305369|ASTHMA|asthma
5497722|NCT01305369|PLATELET RECEPTOR P2Y12|platelet receptor p2y12
5497723|NCT01305369|PRASUGREL|prasugrel
5497724|NCT01305369|INFLAMMATION|inflammation
5497725|NCT01305356|degenerative joint disease|degenerative joint disease
5497726|NCT01305356|DJD|djd
5497727|NCT01305356|joint fusion|joint fusion
5497728|NCT01305356|hindfoot|hindfoot
5497729|NCT01305356|congenital deformity|congenital deformity
5497730|NCT01305356|osteoarthritis|osteoarthritis
5497731|NCT01305356|rheumatoid arthritis|rheumatoid arthritis
5497732|NCT01305356|post-traumatic arthritis|post-traumatic arthritis
5497733|NCT01305356|ankylosing spondylitis|ankylosing spondylitis
5498248|NCT01303380|HIDS|hids
5497734|NCT01305356|Augment(tm) Injectable Bone Graft|augment(tm) injectable bone graft
5497735|NCT01305356|autologous bone graft|autologous bone graft
5497736|NCT01305356|autogenous bone graft|autogenous bone graft
5497737|NCT01305356|beta-TCP|beta-tcp
5497738|NCT01305356|bovine collagen|bovine collagen
5497739|NCT01305356|rhPDGF(bb)|rhpdgf(bb)
5497740|NCT01305343|Spinal Deformity|spinal deformity
5497741|NCT01305343|Scoliosis|scoliosis
5497742|NCT01305343|Neurologic complications|neurologic complications
5497743|NCT01305330|small renal mass|small renal mass
5497744|NCT01305330|active surveillance|active surveillance
5497745|NCT01305330|kidney mass|kidney mass
5497746|NCT01305330|kidney tumour|kidney tumour
5497748|NCT01305291|dietary fiber|dietary fiber
5497749|NCT01305291|satiety response|satiety response
5497750|NCT01305291|hunger|hunger
5497751|NCT01305291|CCK|cck
5497752|NCT01305291|PYY|pyy
5484010|NCT01362244|Endoscopic Polyp Score|endoscopic polyp score
5497753|NCT01305291|ghrelin|ghrelin
5497754|NCT01305291|GIP|gip
5497755|NCT01305291|GLP-1|glp-1
5497756|NCT01305278|Balance|balance
5497757|NCT01305278|Rehabilitation|rehabilitation
5497758|NCT01305278|Vestibular|vestibular
5497759|NCT01305265|sore throat|sore throat
5497760|NCT01305265|dysphagia|dysphagia
5497761|NCT01305265|hoarseness|hoarseness
5497762|NCT01305265|post operative|post operative
5497763|NCT01305265|endotracheal intubation|endotracheal intubation
5497764|NCT01305239|Observational|observational
5497765|NCT01305239|epidemiological|epidemiological
5497766|NCT01305239|cohort|cohort
5497767|NCT01305239|cross-sectional|cross-sectional
5497768|NCT01305239|prospective|prospective
5497769|NCT01305239|multicenter|multicenter
5497770|NCT01305239|survey|survey
5497771|NCT01305239|France.|france.
5497772|NCT01305226|THR 100|thr 100
5497773|NCT01305174|Common Iliac Artery and External Iliac Artery|common iliac artery and external iliac artery
5497774|NCT01305161|1Allergy|1allergy
5497775|NCT01305161|2 Neuromuscular blockers|2 neuromuscular blockers
5497776|NCT01305148|warfarin|warfarin
5497777|NCT01305148|genetic testing|genetic testing
5497778|NCT01305148|personalized medicine|personalized medicine
5497779|NCT01305148|anti-coagulants|anti-coagulants
5497780|NCT01305148|coumadin|coumadin
5497910|NCT01304693|CNV|cnv
5497781|NCT01305135|myelodysplastic syndrome, azacitidine, idarubicin|myelodysplastic syndrome, azacitidine, idarubicin
5497782|NCT01305122|Glioma|glioma
5497783|NCT01305122|Neurocognitive functions|neurocognitive functions
5497784|NCT01305096|heart rate variability|heart rate variability
5497785|NCT01305096|oxygen uptake|oxygen uptake
5497786|NCT01305096|heart rate recovery|heart rate recovery
5497787|NCT01305096|perceived stress|perceived stress
5497788|NCT01305096|sleep|sleep
5497789|NCT01305096|blood pressure|blood pressure
5497790|NCT01305096|body mass index|body mass index
5497791|NCT01305096|body weight|body weight
5497792|NCT01305096|hand grip strength|hand grip strength
5497793|NCT01305096|sleep quality|sleep quality
5497794|NCT01305096|subjective health complaints|subjective health complaints
5497795|NCT01305096|blood lipids|blood lipids
5497796|NCT01305096|salivary cortisol|salivary cortisol
5497797|NCT01305096|blood sugar|blood sugar
5497798|NCT01305096|HbA1C|hba1c
5497799|NCT01305096|Adiponectin|adiponectin
5497800|NCT01305096|Leptin|leptin
5497801|NCT01305096|Adipolipoproteins|adipolipoproteins
5497802|NCT01305096|blood proteins|blood proteins
5497803|NCT01305096|cytokines|cytokines
5497804|NCT01305096|insomnia|insomnia
5497805|NCT01305096|sleeplessness|sleeplessness
5497806|NCT01305096|yoga|yoga
5497807|NCT01305070|Standard balloon angioplasty|standard balloon angioplasty
5497808|NCT01305070|POBA|poba
5497809|NCT01305070|Angioplasty with paclitaxel-eluting balloon|angioplasty with paclitaxel-eluting balloon
5497810|NCT01305070|Superficial femoral artery|superficial femoral artery
5497811|NCT01305057|dry skin condition|dry skin condition
5497812|NCT01305044|tai chi|tai chi
5497813|NCT01305044|elderly cancer survivor|elderly cancer survivor
5497814|NCT01305044|mind body intervention|mind body intervention
5497815|NCT01305031|Asphyxia|asphyxia
5497816|NCT01305031|Resuscitation|resuscitation
5497817|NCT01305031|Room Air|room air
5497818|NCT01305018|Branched-chain amino acids|branched-chain amino acids
5497819|NCT01305018|Leucine|leucine
5497820|NCT01305018|Muscle damage|muscle damage
5497821|NCT01305018|Inflammation|inflammation
5497822|NCT01305018|supplementation|supplementation
5497823|NCT01305018|resistance exercise-induced|resistance exercise-induced
5497824|NCT01305005|blood flow|blood flow
5497825|NCT01304992|Dietary protein|dietary protein
5497826|NCT01304992|Lupin protein|lupin protein
5497827|NCT01304992|Cholesterol metabolism|cholesterol metabolism
5497828|NCT01304992|Protein metabolism|protein metabolism
5497829|NCT01304992|Hypercholesterolemia|hypercholesterolemia
5497830|NCT01304992|Protein-enriched drinks|protein-enriched drinks
5497831|NCT01304979|acupuncture|acupuncture
5497832|NCT01304979|auricular acu-therapy|auricular acu-therapy
5497833|NCT01304979|gua sha therapy|gua sha therapy
5497834|NCT01304979|low back 'spine fusion'|low back 'spine fusion'
5497835|NCT01304979|post surgical pain|post surgical pain
5497836|NCT01304979|post surgical recovery|post surgical recovery
5497837|NCT01304979|Pain and recovery from 'spine fusion' surgery|pain and recovery from 'spine fusion' surgery
5497838|NCT01304966|RRP|rrp
5497839|NCT01304966|HPV|hpv
5497840|NCT01304953|General anaesthetics|general anaesthetics
5497841|NCT01304953|gynaecological laparoscopy|gynaecological laparoscopy
5497842|NCT01304953|anaesthetic i.v.|anaesthetic i.v.
5497843|NCT01304953|propofol|propofol
5497844|NCT01304953|anaesthetic volatile|anaesthetic volatile
5497845|NCT01304953|evoflurane|evoflurane
5497846|NCT01304953|antiemetics|antiemetics
5497847|NCT01304953|reopisetron|reopisetron
5497848|NCT01304953|postoperative pain|postoperative pain
5497849|NCT01304940|Stress|stress
5497850|NCT01304940|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5497851|NCT01304940|Stress Disorders, Traumatic|stress disorders, traumatic
5497852|NCT01304927|Reproduction|reproduction
5497853|NCT01304927|Sex hormones|sex hormones
5497854|NCT01304927|Glucose metabolism|glucose metabolism
5497855|NCT01304927|Bone metabolism|bone metabolism
5497856|NCT01304927|Calcium|calcium
5497857|NCT01304927|Sperm|sperm
5497858|NCT01304927|testis|testis
5497859|NCT01304927|bone|bone
5497860|NCT01304927|endocrinology|endocrinology
5497861|NCT01304914|Respiratory tract infections|respiratory tract infections
5497862|NCT01304914|Gastrointestinal tract infections|gastrointestinal tract infections
5497863|NCT01304914|Pediatrics|pediatrics
5497864|NCT01304914|Specimen collection|specimen collection
5497865|NCT01304901|Acute asthma|acute asthma
5497866|NCT01304901|Children|children
5497867|NCT01304901|Montelukast|montelukast
5497868|NCT01304901|Emergency room|emergency room
5497869|NCT01304888|Food consumption|food consumption
5497870|NCT01304875|Fabry disease|fabry disease
5497871|NCT01304875|alpha-galactosidase deficiency|alpha-galactosidase deficiency
5497872|NCT01304875|exercise|exercise
5497873|NCT01304875|pulmonary|pulmonary
5497874|NCT01304849|Hodgkin's Lymphoma|hodgkin's lymphoma
5497875|NCT01304849|PET CT scan|pet ct scan
5497876|NCT01304849|Escalated BEACOPP|escalated beacopp
5497877|NCT01304849|ABVD|abvd
5497878|NCT01304849|Response adapted therapy|response adapted therapy
5497879|NCT01304836|Kidney|kidney
5497880|NCT01304836|Diabetes Mellitus|diabetes mellitus
5497881|NCT01304836|Transplant|transplant
5497882|NCT01304836|Immunosuppression|immunosuppression
5497883|NCT01304823|T1R2/T1R3|t1r2/t1r3
5497884|NCT01304823|gastric emptying|gastric emptying
5497886|NCT01304823|lactisole|lactisole
5497887|NCT01304823|nutrient sensing|nutrient sensing
5497888|NCT01304810|NicVAX|nicvax
5497889|NCT01304810|Smoking cessation|smoking cessation
5497890|NCT01304797|MM302|mm302
5497891|NCT01304797|Breast Cancer|breast cancer
5497892|NCT01304797|Locally advanced/unresectable|locally advanced/unresectable
5497893|NCT01304797|metastatic|metastatic
5497894|NCT01304784|Solid tumors|solid tumors
5497895|NCT01304784|Failed at least one line of standard therapy|failed at least one line of standard therapy
5497896|NCT01304771|Safety|safety
5497897|NCT01304771|AKSB|aksb
5497898|NCT01304771|probiotic|probiotic
5497899|NCT01304771|synbiotic|synbiotic
5497900|NCT01304771|enterococcus|enterococcus
5497901|NCT01304771|Saccharomyces|saccharomyces
5497902|NCT01304771|elderly|elderly
5497903|NCT01304771|influenza|influenza
5497904|NCT01304771|vaccine|vaccine
5497905|NCT01304771|immune|immune
5497906|NCT01304771|response|response
5497908|NCT01304693|Wet AMD|wet amd
5497909|NCT01304693|Exudative|exudative
5497911|NCT01304667|Vulvar cancer|vulvar cancer
5497912|NCT01304667|Radiotherapy|radiotherapy
5497913|NCT01304667|Chemotherapy|chemotherapy
5497914|NCT01304654|acute lung injury|acute lung injury
5497915|NCT01304654|respiratory distress syndrome|respiratory distress syndrome
5497916|NCT01304654|neoplasms|neoplasms
5497917|NCT01304654|child|child
5497918|NCT01304641|Dyslipidemia|dyslipidemia
5497919|NCT01304641|Cardiovascular|cardiovascular
5497920|NCT01304641|Statin|statin
5497921|NCT01304628|asthma|asthma
5497922|NCT01304615|Overweight|overweight
5497923|NCT01304615|Obesity|obesity
5497924|NCT01304615|Young Adults|young adults
5497925|NCT01304615|Energy Density|energy density
5497926|NCT01304615|Culinary Skills|culinary skills
5497927|NCT01304615|Physical Activity|physical activity
5497928|NCT01304615|Consumption of Self-made Meals|consumption of self-made meals
5497929|NCT01304615|Family History of diabetes|family history of diabetes
5497930|NCT01304602|colorectal cancer|colorectal cancer
5497931|NCT01304602|BKM120|bkm120
5497932|NCT01304602|irinotecan|irinotecan
5497934|NCT01304589|vulvodynia|vulvodynia
5497936|NCT01304576|stroke|stroke
5497937|NCT01304576|parietal lesions|parietal lesions
5497938|NCT01304550|non-invasive|non-invasive
5497939|NCT01304550|hemoglobin|hemoglobin
5497940|NCT01304524|CIN 2/3 or CIN 3|cin 2/3 or cin 3
5497941|NCT01304524|Cervical cancer|cervical cancer
5497942|NCT01304524|Papillomavirus|papillomavirus
5497943|NCT01304485|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5498635|NCT01301898|MPS II|mps ii
5497944|NCT01304485|sodium acetate c11|sodium acetate c11
5497945|NCT01304485|PET|pet
5497946|NCT01304485|prostate cancer|prostate cancer
5497947|NCT01304485|rising PSA|rising psa
5497948|NCT01304485|PSA recurrence|psa recurrence
5497949|NCT01304485|biochemical recurrence|biochemical recurrence
5497950|NCT01304472|coronary angioplasty|coronary angioplasty
5497951|NCT01304472|clopidogrel resistance|clopidogrel resistance
5497952|NCT01304472|prasugrel|prasugrel
5497953|NCT01304446|Nutritional support|nutritional support
5497954|NCT01304446|Cancer|cancer
5497955|NCT01304446|Malnutrition|malnutrition
5497956|NCT01304446|Child|child
5497957|NCT01304446|Adolescent|adolescent
5497958|NCT01304446|pediatric|pediatric
5497959|NCT01304420|Juvenile idiopathic arthritis|juvenile idiopathic arthritis
5497960|NCT01304420|Ultrasonography|ultrasonography
5497961|NCT01304420|Cartilage|cartilage
5497962|NCT01304420|Cartilage biomarkers|cartilage biomarkers
5497963|NCT01304420|Bone biomarkers|bone biomarkers
5497964|NCT01304407|Rothmund-Thomson Syndrome|rothmund-thomson syndrome
5497965|NCT01304407|Calcium absorption|calcium absorption
5497966|NCT01304407|Bone density|bone density
5497967|NCT01304394|Parenteral Nutrition|parenteral nutrition
5497968|NCT01304394|Multi Chamber Bag|multi chamber bag
5497969|NCT01304381|Heart failure|heart failure
5497970|NCT01304381|Palliative care|palliative care
5497971|NCT01304381|Integrated care|integrated care
5497972|NCT01304368|Hyperthermia, Induced|hyperthermia, induced
5497973|NCT01304368|Randomized Controlled Trial|randomized controlled trial
5497974|NCT01304368|Neck Pain|neck pain
5497975|NCT01304368|Sensory Thresholds|sensory thresholds
5497976|NCT01304368|Pain Measurements|pain measurements
5497977|NCT01304355|IBS|ibs
5497978|NCT01304355|Cognition|cognition
5497979|NCT01304355|Kynurenine Pathway|kynurenine pathway
5497980|NCT01304355|Gastrointestinal|gastrointestinal
5497981|NCT01304342|Propofol|propofol
5497982|NCT01304342|remifentanil|remifentanil
5497983|NCT01304342|fentanyl|fentanyl
5497984|NCT01304342|ERCP|ercp
5497985|NCT01304342|Quality of sedation|quality of sedation
5497986|NCT01304342|recovery|recovery
5497992|NCT01304303|platinum|platinum
5497993|NCT01304290|inflammatory process|inflammatory process
5497994|NCT01304290|hyperglycaemia|hyperglycaemia
5497995|NCT01304290|inflammatory cytokine response|inflammatory cytokine response
5497996|NCT01304290|organ survival|organ survival
5497997|NCT01304290|hyperinsulinemic clamp|hyperinsulinemic clamp
5497998|NCT01304277|Replagal|replagal
5497999|NCT01304264|glaucoma, ocular, blood flow, fluctuations|glaucoma, ocular, blood flow, fluctuations
5498000|NCT01304251|short-term fasting|short-term fasting
5498001|NCT01304251|adjuvant chemotherapy|adjuvant chemotherapy
5498002|NCT01304251|toxicity|toxicity
5498003|NCT01304251|side-effects|side-effects
5680297|NCT00578344|HLA genotype|hla genotype
5498004|NCT01304238|Retrospective evaluation of patients with acute Heparin-induced Thrombocytopenia type II treated with Fondaparinux|retrospective evaluation of patients with acute heparin-induced thrombocytopenia type ii treated with fondaparinux
5498005|NCT01304225|diabetic retinopathy|diabetic retinopathy
5498006|NCT01304225|photocoagulation|photocoagulation
5498007|NCT01304225|PASCAL laser|pascal laser
5498008|NCT01304212|total knee arthroplasty|total knee arthroplasty
5498009|NCT01304212|intraarticular infiltration|intraarticular infiltration
5498010|NCT01304212|femoral block|femoral block
5498011|NCT01304199|Cancer survivor|cancer survivor
5498012|NCT01304199|Neoplasms|neoplasms
5498013|NCT01304199|Treatments|treatments
5498014|NCT01304199|Physical status|physical status
5498015|NCT01304199|Psychosocial status|psychosocial status
5498016|NCT01304199|Survivorship survey|survivorship survey
5498017|NCT01304199|Survivorship care|survivorship care
5498018|NCT01304199|Research|research
5498019|NCT01304199|Cancer patient|cancer patient
5498020|NCT01304186|Health literacy|health literacy
5498022|NCT01304186|Medication Adherence|medication adherence
5498023|NCT01304186|IMB Model|imb model
5498024|NCT01304173|BCG|bcg
5498025|NCT01304173|refractory|refractory
5498026|NCT01304173|NMIBC|nmibc
5498027|NCT01304173|CIS|cis
5498028|NCT01304173|non-muscle invasive|non-muscle invasive
5498029|NCT01304160|pancreatic cancer|pancreatic cancer
5498030|NCT01304160|stereotactic body radiotherapy|stereotactic body radiotherapy
5498031|NCT01304160|radiation|radiation
5498032|NCT01304160|gemcitabine|gemcitabine
5498033|NCT01304160|locally advanced|locally advanced
5498034|NCT01304147|ketamine|ketamine
5498035|NCT01304147|depression|depression
5498036|NCT01304147|treatment resistance|treatment resistance
5498037|NCT01304147|intranasal, antidepressant|intranasal, antidepressant
5498038|NCT01304147|glutamate|glutamate
5498039|NCT01304147|NMDA receptor|nmda receptor
5498040|NCT01304121|Bone tumors|bone tumors
5498041|NCT01304121|Bioactive glass|bioactive glass
5498042|NCT01304121|Autogenous bone grafting|autogenous bone grafting
5498043|NCT01304121|Allogeneic bone grafting|allogeneic bone grafting
5498044|NCT01304121|PET imaging|pet imaging
5498636|NCT01301898|Idursulfase|idursulfase
5498045|NCT01304108|Venous Thromboembolism|venous thromboembolism
5498046|NCT01304108|Delivery of Health Care|delivery of health care
5498047|NCT01304108|Quality Improvement|quality improvement
5498048|NCT01304108|Evidence-Based Practice|evidence-based practice
5498049|NCT01304095|Coronary Artery Disease, Angina, Metabolic Syndrome|coronary artery disease, angina, metabolic syndrome
5498050|NCT01304082|pain pH local anesthetics|pain ph local anesthetics
5498051|NCT01304069|Pharmacokinetics|pharmacokinetics
5498052|NCT01304069|Pharmacodynamics|pharmacodynamics
5498053|NCT01304056|Ventilatory physiology|ventilatory physiology
5498054|NCT01304043|ovarian tumors|ovarian tumors
5498055|NCT01304043|rare ovarian tumors|rare ovarian tumors
5498056|NCT01304043|germinal tumors|germinal tumors
5498057|NCT01304043|sexual cords tumors|sexual cords tumors
5498058|NCT01304043|observatory|observatory
5498060|NCT01304030|Empathy|empathy
5498061|NCT01304017|rehabilitation|rehabilitation
5484316|NCT01361074|ICT|ict
5498062|NCT01304017|stroke|stroke
5498063|NCT01304017|intervention|intervention
5498064|NCT01304017|physical activity|physical activity
5498065|NCT01304017|participation|participation
5498066|NCT01304004|Obesity|obesity
5498067|NCT01304004|Yogurt|yogurt
5498068|NCT01304004|Proteins|proteins
5498069|NCT01304004|Fibres|fibres
5498070|NCT01304004|Women|women
5498071|NCT01304004|Satiety|satiety
5498072|NCT01303952|cold agglutinin disease|cold agglutinin disease
5498073|NCT01303952|hemolysis|hemolysis
5498074|NCT01303952|eculizumab|eculizumab
5498075|NCT01303952|terminal complement inhibition|terminal complement inhibition
5498076|NCT01303939|Glaucoma|glaucoma
5498077|NCT01303939|MRI Brain Scan|mri brain scan
5498078|NCT01303939|Voxel-Based Morphometry|voxel-based morphometry
5498079|NCT01303926|QoL|qol
5498080|NCT01303926|EQ5D score|eq5d score
5498081|NCT01303926|cisplatin pemetrexed|cisplatin pemetrexed
5492469|NCT01326793|Skype|skype
5498087|NCT01303900|Haemophilia|haemophilia
5498088|NCT01303900|Cardiovascular disease|cardiovascular disease
5498089|NCT01303900|Cardiovascular disease risk factors|cardiovascular disease risk factors
5498090|NCT01303900|Prospective|prospective
5498091|NCT01303900|QRISK2|qrisk2
5498092|NCT01303900|Hypertension|hypertension
5498093|NCT01303900|Hypercholesterolaemia|hypercholesterolaemia
5498094|NCT01303900|Diabetes|diabetes
5498095|NCT01303900|Obesity|obesity
5498096|NCT01303887|PACIFICO|pacifico
5498097|NCT01303887|Follicular Lymphoma|follicular lymphoma
5498098|NCT01303887|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5498099|NCT01303887|Rituximab|rituximab
5498100|NCT01303887|R-CVP|r-cvp
5498101|NCT01303887|R-FC|r-fc
5498102|NCT01303887|Older|older
5498103|NCT01303874|Rheumatoid arthritis|rheumatoid arthritis
5498104|NCT01303874|Inflammatory arthritis|inflammatory arthritis
5498105|NCT01303874|Undifferentiated arthritis|undifferentiated arthritis
5498106|NCT01303874|Etanercept|etanercept
5498107|NCT01303874|Combination Therapy|combination therapy
5498108|NCT01303861|Nicotine addiction|nicotine addiction
5498109|NCT01303861|Cigarette smoking|cigarette smoking
5498110|NCT01303861|Smoking cessation|smoking cessation
5498111|NCT01303861|Zyban|zyban
5498112|NCT01303861|Chantix|chantix
5498113|NCT01303861|Nicotine patches|nicotine patches
5498114|NCT01303861|Nicotrol Inhaler|nicotrol inhaler
5498115|NCT01303861|varenicline|varenicline
5498116|NCT01303861|bupropion|bupropion
5498117|NCT01303848|Blood lactate|blood lactate
5498118|NCT01303848|Lipid transfer proteins|lipid transfer proteins
5498119|NCT01303848|Lactate|lactate
5498120|NCT01303848|PLTP|pltp
5498121|NCT01303848|CETP|cetp
5498122|NCT01303848|PPARs|ppars
5498123|NCT01303848|CLOCk|clock
5498124|NCT01303848|Bal1|bal1
5498125|NCT01303835|malignant glioma|malignant glioma
5498126|NCT01303835|glioblastoma multiforme|glioblastoma multiforme
5498127|NCT01303835|quality of life|quality of life
5498128|NCT01303835|naltrexone|naltrexone
5498129|NCT01303809|Perioperative care|perioperative care
5498130|NCT01303809|Fast-track|fast-track
5498131|NCT01303809|Enhanced Recovery After Surgery|enhanced recovery after surgery
5498132|NCT01303809|ERAS|eras
5498133|NCT01303809|Obesity|obesity
5498134|NCT01303809|Bariatric surgery|bariatric surgery
5498135|NCT01303809|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5498137|NCT01303783|Nifedipine GITS|nifedipine gits
5498138|NCT01303783|Candesartan|candesartan
5498139|NCT01303783|mild to moderate Hypertension|mild to moderate hypertension
5498140|NCT01303783|Combination therapy|combination therapy
5498141|NCT01303770|Multiple Sclerosis|multiple sclerosis
5498142|NCT01303770|Cognitive impairment|cognitive impairment
5498143|NCT01303770|Self-management programs|self-management programs
5498144|NCT01303770|Occupational Therapy|occupational therapy
5498145|NCT01303770|Rehabilitation|rehabilitation
5498146|NCT01303757|obesity|obesity
5498147|NCT01303731|Spinal anesthesia|spinal anesthesia
5498148|NCT01303731|Cesarean section|cesarean section
5498640|NCT01301885|biomarker|biomarker
5498149|NCT01303731|Marcaine Spinal 0.5% Heavy minidose|marcaine spinal 0.5% heavy minidose
5498150|NCT01303731|Fentanyl|fentanyl
5498151|NCT01303731|Local Anesthetics|local anesthetics
5498152|NCT01303718|LV Dysfunction|lv dysfunction
5498153|NCT01303718|Heart Failure|heart failure
5498154|NCT01303705|progressive metastatic prostate cancer|progressive metastatic prostate cancer
5498155|NCT01303705|cancer of the prostate|cancer of the prostate
5498156|NCT01303705|prostate cancer|prostate cancer
5498157|NCT01303692|bone mineral loss|bone mineral loss
5498158|NCT01303692|prostate cancer|prostate cancer
5498159|NCT01303692|GnRH agonist alone vs. GnRH agonist plus anti-androgen combination|gnrh agonist alone vs. gnrh agonist plus anti-androgen combination
5498160|NCT01303679|First line metastatic breast cancer|first line metastatic breast cancer
5498161|NCT01303679|Positive estrogen receptors|positive estrogen receptors
5498162|NCT01303679|Negative HER2 receptors|negative her2 receptors
5498163|NCT01303679|At least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray|at least stable disease after 4 months of paclitaxel-bevcizumab induction chemotheray
5498164|NCT01303653|endoscopic tissue closure,|endoscopic tissue closure,
5498165|NCT01303653|gastro-gastric fistulas,|gastro-gastric fistulas,
5498166|NCT01303653|gastrointestinal perforations|gastrointestinal perforations
5498168|NCT01303627|Remifentanil|remifentanil
5498169|NCT01303627|Laryngeal mask airway removal|laryngeal mask airway removal
5498170|NCT01303627|Hemodynamic changing|hemodynamic changing
5498171|NCT01303627|Infusion|infusion
5498172|NCT01303627|Ureterorenoscopy|ureterorenoscopy
5498173|NCT01303614|hysterosalpingography|hysterosalpingography
5498174|NCT01303614|prilocaine|prilocaine
5498175|NCT01303614|local anaesthetic|local anaesthetic
5498176|NCT01303614|pain relief|pain relief
5498177|NCT01303614|gynecological pathology|gynecological pathology
5498178|NCT01303601|Olanzapine|olanzapine
5498179|NCT01303601|Monotherapy|monotherapy
5498180|NCT01303601|bipolar Ⅰ depression|bipolar ⅰ depression
5498181|NCT01303588|elderly patients|elderly patients
5498182|NCT01303575|Adolescents|adolescents
5498184|NCT01303575|Sexual Health|sexual health
5498185|NCT01303575|Sex Education|sex education
5498186|NCT01303575|Pregnancy Prevention|pregnancy prevention
5498187|NCT01303575|Abstinence Education|abstinence education
5498188|NCT01303575|HIV|hiv
5498189|NCT01303575|Human Immunodeficiency Virus|human immunodeficiency virus
5498190|NCT01303575|STI|sti
5498191|NCT01303575|Chlamydia|chlamydia
5498192|NCT01303575|Gonorrhea|gonorrhea
5498193|NCT01303575|Sexually Transmitted Infections|sexually transmitted infections
5498194|NCT01303575|American Indian|american indian
5498195|NCT01303575|Alaska Native|alaska native
5498196|NCT01303575|Native American|native american
5498197|NCT01303575|Internet-Based|internet-based
5498198|NCT01303575|Computer-based Education|computer-based education
5498199|NCT01303575|Computer-based learning|computer-based learning
5498200|NCT01303562|oat|oat
5498201|NCT01303562|barley|barley
5498202|NCT01303562|whole grain|whole grain
5498203|NCT01303562|bioavailability|bioavailability
5498204|NCT01303562|phytochemical|phytochemical
5498205|NCT01303549|Liver transplantation|liver transplantation
5498206|NCT01303549|Hepatic transplant|hepatic transplant
5498207|NCT01303549|Antifungal prophylaxis|antifungal prophylaxis
5498208|NCT01303549|Anidulafungin|anidulafungin
5498209|NCT01303549|Liposomal Amphotericin B|liposomal amphotericin b
5498210|NCT01303523|LMWH|lmwh
5498211|NCT01303523|heparin|heparin
5498212|NCT01303523|immobilization|immobilization
5498213|NCT01303523|anticoagulant prophylaxis|anticoagulant prophylaxis
5498214|NCT01303523|leg injuries|leg injuries
5498215|NCT01303523|thromboembolism|thromboembolism
5498216|NCT01303510|Influenza|influenza
5498217|NCT01303510|Virus|virus
5498218|NCT01303510|Vaccination|vaccination
5498219|NCT01303510|Immunisation|immunisation
5498220|NCT01303497|Angiosarcoma|angiosarcoma
5498221|NCT01303497|Paclitaxel|paclitaxel
5498222|NCT01303497|bevacizumab|bevacizumab
5498223|NCT01303471|pain assessment|pain assessment
5498224|NCT01303471|anesthesia|anesthesia
5498225|NCT01303471|analgesia|analgesia
5498226|NCT01303471|opioid|opioid
5498227|NCT01303471|HRV|hrv
5498228|NCT01303471|APV|apv
5498229|NCT01303471|autonomic nervous system (ANS)|autonomic nervous system (ans)
5498230|NCT01303471|pupil size|pupil size
5498231|NCT01303458|community resource|community resource
5498232|NCT01303458|well-child care visit|well-child care visit
5498233|NCT01303458|low-income|low-income
5498234|NCT01303432|Joint discomfort|joint discomfort
5498235|NCT01303432|Functional Food|functional food
5498236|NCT01303432|Joint function|joint function
5498238|NCT01303419|mammography|mammography
5498239|NCT01303406|randomized withdrawal|randomized withdrawal
5498240|NCT01303406|idebenone|idebenone
5498241|NCT01303406|friedreich's ataxia|friedreich's ataxia
5498242|NCT01303406|Miconos|miconos
5498243|NCT01303406|Patient reported outcome|patient reported outcome
5498244|NCT01303406|ICARS|icars
5498245|NCT01303393|Patient education. Patient discharge. Needs assessment.|patient education. patient discharge. needs assessment.
5498246|NCT01303380|Hyper IgD syndrome|hyper igd syndrome
5498247|NCT01303380|canakinumab|canakinumab
5498249|NCT01303380|mevalonate kinase deficiency|mevalonate kinase deficiency
5498250|NCT01303380|MKD|mkd
5498251|NCT01303367|Dementia|dementia
5498252|NCT01303367|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
5498253|NCT01303354|Epidural, Transforaminal, Steroid Injection, Dexamethasone|epidural, transforaminal, steroid injection, dexamethasone
5498254|NCT01303315|C19 246 300|c19 246 300
5498255|NCT01303302|C19 246 300|c19 246 300
5498256|NCT01303289|Total Enteral Nutrition|total enteral nutrition
5498257|NCT01303289|Severe insufficient nutrition|severe insufficient nutrition
5498258|NCT01303289|T-Diet plus Standard|t-diet plus standard
5498259|NCT01303289|Lipidic profile|lipidic profile
5498260|NCT01303289|Quality of life|quality of life
5498261|NCT01303276|retinal vein occlusion|retinal vein occlusion
5498262|NCT01303276|anti-VEGF|anti-vegf
5498263|NCT01303276|blood flow|blood flow
5498264|NCT01303263|efficiency|efficiency
5498265|NCT01303263|cost-awareness|cost-awareness
5498266|NCT01303263|hospitals|hospitals
5498267|NCT01303263|graduate medical education|graduate medical education
5498268|NCT01303250|goal-directed fluid optimization|goal-directed fluid optimization
5498269|NCT01303250|hemodynamic optimization|hemodynamic optimization
5498270|NCT01303250|crystalloid|crystalloid
5498271|NCT01303250|colloid|colloid
5498272|NCT01303237|LA SCCHN|la scchn
5498273|NCT01303237|Cetuximab|cetuximab
5498274|NCT01303237|RT|rt
5498275|NCT01303237|PMS|pms
5498276|NCT01303224|Irritable Bowel Syndrome|irritable bowel syndrome
5498277|NCT01303224|Colon, irritable|colon, irritable
5492719|NCT01325779|DVT|dvt
5498278|NCT01303224|Bowel disease|bowel disease
5498279|NCT01303211|Meningococcal serogroup A conjugate vaccine|meningococcal serogroup a conjugate vaccine
5498280|NCT01303211|Vaccine efficacy|vaccine efficacy
5498281|NCT01303211|Serogroup A meningococcal diseases|serogroup a meningococcal diseases
5498283|NCT01303198|APAP|apap
5498284|NCT01303198|sleep apnea|sleep apnea
5498285|NCT01303185|Psoriatic Nail|psoriatic nail
5498286|NCT01303185|Pulsed dye laser|pulsed dye laser
5498287|NCT01303159|Cholangiocarcinoma|cholangiocarcinoma
5498288|NCT01303159|Pancreatic Cancer|pancreatic cancer
5498289|NCT01303159|Radiofrequency|radiofrequency
5498290|NCT01303159|Ablation|ablation
5498291|NCT01303146|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5498292|NCT01303146|Enzyme replacement therapy|enzyme replacement therapy
5498293|NCT01303146|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5498294|NCT01303133|beta amyloid, Down Syndrome, Alzheimer's Disease|beta amyloid, down syndrome, alzheimer's disease
5498295|NCT01303081|Smoking Cessation|smoking cessation
5498296|NCT01303081|Work-site|work-site
5498297|NCT01303081|Incentives|incentives
5498298|NCT01303081|Health Behavior|health behavior
5498299|NCT01303081|Smoking|smoking
5498300|NCT01303068|CF|cf
5498301|NCT01303055|Pancreatic beta Cell|pancreatic beta cell
5498302|NCT01303055|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5498303|NCT01303055|Glucose Metabolism Disorders|glucose metabolism disorders
5498304|NCT01303055|Metabolic Diseases|metabolic diseases
5498305|NCT01303055|Endocrine System Diseases|endocrine system diseases
5498306|NCT01303055|Metformin|metformin
5498307|NCT01303055|Hypoglycemic Agents|hypoglycemic agents
5498308|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs
5498309|NCT01303055|Pharmacologic Actions|pharmacologic actions
5498310|NCT01303055|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5498311|NCT01303055|Oral Glucose Tolerance Test|oral glucose tolerance test
5498312|NCT01303042|insulin LISPRO|insulin lispro
5498313|NCT01303042|Insulin therapy|insulin therapy
5498314|NCT01303042|hemoglobin A1c protein, human|hemoglobin a1c protein, human
5498315|NCT01303042|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5498316|NCT01303042|Quality of Life|quality of life
5498317|NCT01303042|Hypoglycemia|hypoglycemia
5498318|NCT01303042|Diabetes Mellitus|diabetes mellitus
5498319|NCT01303042|1,5-Anhydroglucitol|1,5-anhydroglucitol
5498320|NCT01303029|Pancreatic cancer|pancreatic cancer
5498321|NCT01303029|gemcitabine|gemcitabine
5498322|NCT01303029|erlotinib|erlotinib
5498323|NCT01303029|capecitabine|capecitabine
5498324|NCT01302990|Influenza|influenza
5498325|NCT01302990|Respiratory disease|respiratory disease
5498326|NCT01302990|Prevention|prevention
5498327|NCT01302977|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5498328|NCT01302977|Fetal anomalies|fetal anomalies
5498329|NCT01302964|Autistic Disorder|autistic disorder
5498330|NCT01302964|Asperger's Disorder|asperger's disorder
5498331|NCT01302964|Pervasive Developmental Disorder|pervasive developmental disorder
5498332|NCT01302951|pharmacokinetics|pharmacokinetics
5498333|NCT01302951|liver resection|liver resection
5498334|NCT01302938|Double-blind|double-blind
5498335|NCT01302938|Placebo-controlled|placebo-controlled
5498336|NCT01302938|frequency|frequency
5498337|NCT01302938|urgency|urgency
5498338|NCT01302938|web-based|web-based
5498339|NCT01302938|incontinence|incontinence
5498340|NCT01302938|methodology|methodology
5498341|NCT01302938|ediary|ediary
5498342|NCT01302938|safety|safety
5498343|NCT01302938|efficacy|efficacy
5498344|NCT01302938|tolerability ER|tolerability er
5498345|NCT01302938|overactive bladder|overactive bladder
5498346|NCT01302912|ocular adnexal lymphomas|ocular adnexal lymphomas
5498347|NCT01302886|High risk Smoldering multiple myeloma,|high risk smoldering multiple myeloma,
5498348|NCT01302886|BHQ880,|bhq880,
5498349|NCT01302886|MM|mm
5498350|NCT01302873|Tinnitus|tinnitus
5498351|NCT01302873|AMPA Receptor antagonist|ampa receptor antagonist
5498352|NCT01302860|Cryopyrin-associated periodic syndromes (CAPS)|cryopyrin-associated periodic syndromes (caps)
5498353|NCT01302860|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5498354|NCT01302860|Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID)|muckle-wells syndrome (mws) or neonatal onset multisystem inflammatory disease (nomid)
5498355|NCT01302860|children|children
5498356|NCT01302860|systemic autoinflammatory disease|systemic autoinflammatory disease
5498357|NCT01302860|CIAS-1 gene|cias-1 gene
5498358|NCT01302860|NALP-3|nalp-3
5498359|NCT01302860|NLRP3|nlrp3
5498360|NCT01302860|ACZ885|acz885
5498361|NCT01302860|Ilaris|ilaris
5498362|NCT01302860|human monoclonal anti-human interleukin-1 beta (IL-beta)|human monoclonal anti-human interleukin-1 beta (il-beta)
5498363|NCT01302860|antibody|antibody
5498364|NCT01302860|autosomal dominant|autosomal dominant
5498365|NCT01302860|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5498366|NCT01302847|Integrase Inhibitors|integrase inhibitors
5498367|NCT01302847|Infant|infant
5498368|NCT01302847|Child|child
5498369|NCT01302847|Adolescent|adolescent
5498370|NCT01302834|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5498378|NCT01302808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5498379|NCT01302808|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5498380|NCT01302808|malignant pleural effusion|malignant pleural effusion
5498381|NCT01302808|adenocarcinoma of the lung|adenocarcinoma of the lung
5498382|NCT01302808|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5498383|NCT01302808|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5498384|NCT01302808|large cell lung cancer|large cell lung cancer
5498385|NCT01302808|squamous cell lung cancer|squamous cell lung cancer
5498386|NCT01302795|Interleukin 1 beta|interleukin 1 beta
5498387|NCT01302795|Canakinumab|canakinumab
5498388|NCT01302795|autoinflammatory syndrome|autoinflammatory syndrome
5482978|NCT01366495|Seek|seek
5498389|NCT01302782|Altitude|altitude
5498390|NCT01302782|Glucose|glucose
5498391|NCT01302769|Acute Sore Throat|acute sore throat
5498392|NCT01302769|Ear Acupuncture|ear acupuncture
5498393|NCT01302756|gestational diabetes|gestational diabetes
5498394|NCT01302756|gestational hypertension|gestational hypertension
5498395|NCT01302756|folic acid|folic acid
5498396|NCT01302743|Diabetes|diabetes
5498397|NCT01302743|Metformin|metformin
5498398|NCT01302743|Cinnamon|cinnamon
5498399|NCT01302730|ankylosing spondylitis|ankylosing spondylitis
5498400|NCT01302730|spondylarthritis|spondylarthritis
5498401|NCT01302730|inflammatory back pain|inflammatory back pain
5498402|NCT01302730|seronegative|seronegative
5498403|NCT01302717|Left ventricular pacing|left ventricular pacing
5498404|NCT01302704|Vitamin D|vitamin d
5498405|NCT01302704|Proton Pump Inhibitors|proton pump inhibitors
5498406|NCT01302691|Essential hypertension|essential hypertension
5498407|NCT01302691|Uncontrolled hypertension|uncontrolled hypertension
5498408|NCT01302691|Antihypertensive agents|antihypertensive agents
5498409|NCT01302691|Blood pressure|blood pressure
5498410|NCT01302652|acromegaly|acromegaly
5498411|NCT01302652|growth hormone|growth hormone
5498412|NCT01302652|growth hormone deficiency|growth hormone deficiency
5498413|NCT01302626|NSCLC|nsclc
5498414|NCT01302626|SCLC|sclc
5498415|NCT01302626|lung cancer|lung cancer
5498416|NCT01302626|RNA|rna
5498417|NCT01302626|DNA|dna
5498418|NCT01302626|imaging|imaging
5498419|NCT01302626|genomics|genomics
5498420|NCT01302626|proteomics|proteomics
5498421|NCT01302626|predictive model|predictive model
5498422|NCT01302626|prospective study|prospective study
5498423|NCT01302613|rectal cancer|rectal cancer
5498424|NCT01302574|T1R2/T1R3|t1r2/t1r3
5498425|NCT01302574|gastric emptying|gastric emptying
5498427|NCT01302574|lactisole|lactisole
5498428|NCT01302574|nutrient sensing|nutrient sensing
5498429|NCT01302561|adults|adults
5498430|NCT01302561|fiber|fiber
5498431|NCT01302561|cold|cold
5498432|NCT01302561|flu|flu
5498433|NCT01302561|immune function|immune function
5498434|NCT01302561|microbiota|microbiota
5498435|NCT01302548|Abscess|abscess
5498436|NCT01302548|Wound Irrigation|wound irrigation
5498437|NCT01302548|Wound Debridement|wound debridement
5498438|NCT01302548|Wound Healing|wound healing
5498439|NCT01302548|Incision and drainage|incision and drainage
5498440|NCT01302548|Chlorhexidine|chlorhexidine
5498441|NCT01302535|Yoga|yoga
5498442|NCT01302535|Hypertension|hypertension
5498443|NCT01302535|Quality of Life|quality of life
5498444|NCT01302535|Primary Health Care|primary health care
5498445|NCT01302509|Nutritional support.|nutritional support.
5498446|NCT01302509|Cancer.|cancer.
5498447|NCT01302509|Malnutrition.|malnutrition.
5498448|NCT01302509|Child.|child.
5498449|NCT01302509|Adolescent|adolescent
5498450|NCT01302496|Previously Treated|previously treated
5498451|NCT01302496|Unresectable|unresectable
5498452|NCT01302496|Stage III or IV Melanoma|stage iii or iv melanoma
5498453|NCT01302470|biventricular pacing|biventricular pacing
5498454|NCT01302457|Thermal Burn Trauma|thermal burn trauma
5498455|NCT01302444|treprostinil|treprostinil
5498456|NCT01302444|pulmonary hypertension, tadalafil|pulmonary hypertension, tadalafil
5498457|NCT01302431|experimental|experimental
5498458|NCT01302431|intervention|intervention
5498459|NCT01302431|nurse-led|nurse-led
5498460|NCT01302431|nurse specialist|nurse specialist
5498461|NCT01302431|multiple sclerosis|multiple sclerosis
5498462|NCT01302431|support of caregivers|support of caregivers
5498463|NCT01302418|Respiratory Virus|respiratory virus
5498464|NCT01302418|Influenza|influenza
5498465|NCT01302418|RSV|rsv
5498466|NCT01302418|Parainfluenza|parainfluenza
5498467|NCT01302418|Metapneumovirus|metapneumovirus
5498468|NCT01302418|Rhinovirus|rhinovirus
5498469|NCT01302418|Coxsackie virus|coxsackie virus
5498470|NCT01302418|Echo virus|echo virus
5498471|NCT01302418|Adenovirus|adenovirus
5498472|NCT01302418|Coronavirus|coronavirus
5498473|NCT01302418|Bocavirus|bocavirus
5498474|NCT01302405|Advanced solid tumor|advanced solid tumor
5498475|NCT01302405|cancer|cancer
5498476|NCT01302405|phase 1|phase 1
5498477|NCT01302405|pancreatic cancer|pancreatic cancer
5498478|NCT01302405|colon cancer|colon cancer
5498479|NCT01302405|unresectable neoplastic disease|unresectable neoplastic disease
5498480|NCT01302405|Progressive cancer|progressive cancer
5498481|NCT01302405|metastatic solid tumor|metastatic solid tumor
5498482|NCT01302379|Obesity|obesity
5498483|NCT01302379|Survival|survival
5498484|NCT01302379|Weight loss|weight loss
5498485|NCT01302379|Metformin|metformin
5498486|NCT01302379|Biological markers|biological markers
5498487|NCT01302366|multiple myeloma|multiple myeloma
5498488|NCT01302366|myeloma|myeloma
5498489|NCT01302366|asymptomatic myeloma|asymptomatic myeloma
5498490|NCT01302366|smoldering myeloma|smoldering myeloma
5498491|NCT01302366|Asymptomatic (smoldering) myeloma|asymptomatic (smoldering) myeloma
5498492|NCT01302353|Phase I trial|phase i trial
5498493|NCT01302353|Emulsified Isoflurane|emulsified isoflurane
5498494|NCT01302353|Health volunteer|health volunteer
5498495|NCT01302340|Dementia|dementia
5498496|NCT01302340|Alzheimer|alzheimer
5498497|NCT01302340|Cannabis|cannabis
5498498|NCT01302340|THC|thc
5498499|NCT01302340|Behavioral Disturbances|behavioral disturbances
5498500|NCT01302340|Neuropsychiatric Inventory|neuropsychiatric inventory
5498501|NCT01302327|Wolfram syndrome|wolfram syndrome
5498502|NCT01302327|Diabetes mellitus|diabetes mellitus
5498503|NCT01302327|Exenatide|exenatide
5498504|NCT01302327|GLP-1 analog|glp-1 analog
5498505|NCT01302327|beta cell function|beta cell function
5498506|NCT01302301|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
5498507|NCT01302288|endolumenal myotomy, per oral endoscopic myotomy|endolumenal myotomy, per oral endoscopic myotomy
5498508|NCT01302275|neuropathic pain|neuropathic pain
5498509|NCT01302275|oxcarbazepine|oxcarbazepine
5498510|NCT01302275|pain mechanism|pain mechanism
5498511|NCT01302262|Smoking-induced dopamine release|smoking-induced dopamine release
5498512|NCT01302262|[11C]-(+)-PHNO PET Study|[11c]-(+)-phno pet study
5498513|NCT01302249|Glaucoma|glaucoma
5498514|NCT01302249|Intraocular pressure|intraocular pressure
5498515|NCT01302249|Ocular hypertension|ocular hypertension
5498516|NCT01302236|Elderly|elderly
5498517|NCT01302236|Early stage chronic kidney disease|early stage chronic kidney disease
5498518|NCT01302236|Hypertension|hypertension
5498519|NCT01302236|Eplerenone|eplerenone
5498520|NCT01302223|burns|burns
5498521|NCT01302223|Growth Factors, Combined Defect of|growth factors, combined defect of
5498522|NCT01302223|inflammation|inflammation
5498523|NCT01302223|Cytokine Storm|cytokine storm
5498524|NCT01302210|MRSA|mrsa
5498525|NCT01302210|Cluster Randomized Trial|cluster randomized trial
5498526|NCT01302210|Infection Control Intervention|infection control intervention
5498527|NCT01302197|Stroke|stroke
5498528|NCT01302197|Body Composition|body composition
5498529|NCT01302197|Glucose Tolerance|glucose tolerance
5498530|NCT01302171|dilated cardiomyopathy|dilated cardiomyopathy
5498531|NCT01302171|adult stem cells|adult stem cells
5498532|NCT01302171|bone marrow progenitor cells|bone marrow progenitor cells
5498533|NCT01302171|bone marrow stem cells|bone marrow stem cells
5498534|NCT01302171|autologous|autologous
5498535|NCT01302171|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5498536|NCT01302171|intracoronary injection|intracoronary injection
5498537|NCT01302171|left ventricular function|left ventricular function
5498662|NCT01301703|rheumatoid pertussis tetanus|rheumatoid pertussis tetanus
5498637|NCT01301885|endometriosis|endometriosis
5498638|NCT01301885|dysmenorrhea|dysmenorrhea
5498639|NCT01301885|infertility|infertility
5498538|NCT01302171|To determine if patient's own bone marrow derived stem cells can be used to improve cardiac function|to determine if patient's own bone marrow derived stem cells can be used to improve cardiac function
5498539|NCT01302158|Drug-Drug interaction|drug-drug interaction
5498540|NCT01302158|ASP1941|asp1941
5498541|NCT01302158|Glimepiride|glimepiride
5498542|NCT01302158|Healthy subjects|healthy subjects
5498543|NCT01302145|pharmacokinetics|pharmacokinetics
5498544|NCT01302145|metformin|metformin
5498545|NCT01302145|Drug to drug interaction|drug to drug interaction
5498546|NCT01302145|ASP1941|asp1941
5498547|NCT01302132|Mass Balance|mass balance
5498548|NCT01302132|ASP1941|asp1941
5498549|NCT01302132|Pharmacokinetics|pharmacokinetics
5498550|NCT01302119|Onychomycosis|onychomycosis
5498551|NCT01302119|nail fungus|nail fungus
5498552|NCT01302119|toenail fungus|toenail fungus
5498553|NCT01302119|fungal nail|fungal nail
5498554|NCT01302119|hyperkeratosis|hyperkeratosis
5498555|NCT01302119|nail infection|nail infection
5498556|NCT01302119|nail treatment|nail treatment
5498561|NCT01302119|onycholysis|onycholysis
5498562|NCT01302119|podiatrist|podiatrist
5498563|NCT01302119|podiatry|podiatry
5498564|NCT01302119|subungual|subungual
5498565|NCT01302119|tinea unguium|tinea unguium
5498566|NCT01302119|antifungal|antifungal
5498567|NCT01302119|anti-fungal|anti-fungal
5498568|NCT01302119|dermatologist|dermatologist
5498569|NCT01302119|dermatology|dermatology
5498570|NCT01302119|dermatophyte|dermatophyte
5498571|NCT01302119|distal subungual onychomycosis|distal subungual onychomycosis
5498572|NCT01302119|yellow nail|yellow nail
5498573|NCT01302119|thick nail|thick nail
5498574|NCT01302119|brittle nail|brittle nail
5498575|NCT01302119|crumbling nail|crumbling nail
5498576|NCT01302119|discolored nail|discolored nail
5498577|NCT01302119|weak nail|weak nail
5498578|NCT01302106|Myelodysplastic Syndromes|myelodysplastic syndromes
5498579|NCT01302106|Clofarabine|clofarabine
5498580|NCT01302106|Low Dose Cytarabine|low dose cytarabine
5498581|NCT01302106|Poor risk MDS|poor risk mds
5498582|NCT01302080|prospective|prospective
5498584|NCT01302080|sertraline|sertraline
5498585|NCT01302080|long-term impact|long-term impact
5483171|NCT01365715|Embolization|embolization
5498586|NCT01302080|cognition|cognition
5498587|NCT01302080|emotional and physical development|emotional and physical development
5498588|NCT01302080|pubertal maturation|pubertal maturation
5498589|NCT01302054|Bladder Overactive|bladder overactive
5498590|NCT01302054|Overactive urinary bladder|overactive urinary bladder
5498591|NCT01302054|Overactive Bladder|overactive bladder
5498592|NCT01302041|bone turnover|bone turnover
5498593|NCT01302041|hormone-naïve|hormone-naïve
5498594|NCT01302041|prostate specific antigen|prostate specific antigen
5498595|NCT01302041|Prostate Cancer|prostate cancer
5498596|NCT01302028|Renal Impairment|renal impairment
5498597|NCT01302028|ASP1941|asp1941
5498598|NCT01302028|Pharmacokinetics|pharmacokinetics
5498599|NCT01302002|Breast Cancer|breast cancer
5498600|NCT01302002|Metformin|metformin
5498601|NCT01302002|Pre-Surgery|pre-surgery
5498602|NCT01301989|Sleep|sleep
5498603|NCT01301989|Children|children
5498604|NCT01301989|Disparities|disparities
5498605|NCT01301989|Minority|minority
5498606|NCT01301989|Urban|urban
5498607|NCT01301976|nutritional state|nutritional state
5498608|NCT01301976|nutrients intake|nutrients intake
5498609|NCT01301976|ulcerative colitis|ulcerative colitis
5498610|NCT01301950|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
5498611|NCT01301950|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
5498612|NCT01301950|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
5498613|NCT01301950|Knee Replacement Arthroplasties|knee replacement arthroplasties
5498614|NCT01301950|Knee Replacement Arthroplasty|knee replacement arthroplasty
5498615|NCT01301950|Knee Replacement, Total|knee replacement, total
5498616|NCT01301950|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
5498617|NCT01301950|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
5498618|NCT01301950|Replacement, Total Knee|replacement, total knee
5498619|NCT01301950|Total Knee Replacement|total knee replacement
5498620|NCT01301937|Mucosal Leishmaniasis|mucosal leishmaniasis
5501527|NCT01289834|RSA|rsa
5498632|NCT01301911|phase I|phase i
5498633|NCT01301911|HER2 positive or uncertain advanced breast cancer|her2 positive or uncertain advanced breast cancer
5498634|NCT01301898|Hunter syndrome|hunter syndrome
5498641|NCT01301885|drug target|drug target
5498642|NCT01301859|older adults|older adults
5498643|NCT01301859|adherence|adherence
5498644|NCT01301859|antidepressant|antidepressant
5498645|NCT01301859|depression|depression
5498646|NCT01301833|insulin resistance|insulin resistance
5498647|NCT01301820|maintenance treatment|maintenance treatment
5498648|NCT01301820|Disease free survival|disease free survival
5498649|NCT01301794|Hypertriglyceridemia|hypertriglyceridemia
5498650|NCT01301794|Fish oil|fish oil
5498651|NCT01301794|Omega 3 fatty acids|omega 3 fatty acids
5498652|NCT01301768|Dietary Intervention|dietary intervention
5498653|NCT01301768|Pregnancy Jail|pregnancy jail
5498654|NCT01301768|Iodine Deficiency|iodine deficiency
5498655|NCT01301768|Iodine Nutrition|iodine nutrition
5498656|NCT01301768|Dietary Habits|dietary habits
5498657|NCT01301768|Urinary Iodine|urinary iodine
5498658|NCT01301768|Pregnancy|pregnancy
5498659|NCT01301768|Group Education|group education
5498660|NCT01301768|Cluster Randomized Trial|cluster randomized trial
5498661|NCT01301768|Primary Health Care|primary health care
5498663|NCT01301690|neck mass|neck mass
5498664|NCT01301690|ultrasound|ultrasound
5498666|NCT01301690|BMVC|bmvc
5493079|NCT01324141|Anal Cancer|anal cancer
5493080|NCT01324141|Radioprotector|radioprotector
5493081|NCT01324141|Topical|topical
5493082|NCT01324141|Radiation|radiation
5498667|NCT01301664|The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.|the bone marrow-derived mesenchymal stem cells (bmmscs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
5671228|NCT00616590|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5671471|NCT00615927|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5685327|NCT00556530|Copy Number Variations|copy number variations
5685328|NCT00556530|Whole Genome Association Study|whole genome association study
5484898|NCT01358552|Neevo|neevo
5498668|NCT01301664|The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.|the synovial-derived mesenchymal stem cells (smscs) were isolated from synovial membranes in the joint replacement surgery.
5498669|NCT01301664|Cartilage slices were obtained from discard cartilage in the joint replacement surgery.|cartilage slices were obtained from discard cartilage in the joint replacement surgery.
5498671|NCT01301651|Balance|balance
5498672|NCT01301651|Parkinson's disease|parkinson's disease
5498673|NCT01301651|Dual Task|dual task
5498674|NCT01301625|MitraClip|mitraclip
5498675|NCT01301625|mitral regurgitation (MR)|mitral regurgitation (mr)
5498676|NCT01301625|mitral valve insufficiency|mitral valve insufficiency
5498677|NCT01301625|percutaneous mitral valve repair|percutaneous mitral valve repair
5498678|NCT01301625|congestive heart failure|congestive heart failure
5498679|NCT01301612|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma|carcinoma or adenocarcinoma or uterine cervix adenosquamous carcinoma
5498680|NCT01301599|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5498681|NCT01301599|alpha blocker|alpha blocker
5498682|NCT01301599|5-alpha reductase inhibitor|5-alpha reductase inhibitor
5498683|NCT01301599|combination therapy|combination therapy
5498684|NCT01301560|Asymptomatic brain metastasis|asymptomatic brain metastasis
5498685|NCT01301560|NSCLC|nsclc
5498686|NCT01301560|GKS|gks
5498687|NCT01301534|abdominal aortic aneurysm|abdominal aortic aneurysm
5498688|NCT01301521|Pre-Diabetes|pre-diabetes
5498689|NCT01301521|cinnamon|cinnamon
5498690|NCT01301508|atopic dermatitis|atopic dermatitis
5498691|NCT01301495|Esophageal Cancer, Malignant, Dysphagia, Esophagus, Cancer|esophageal cancer, malignant, dysphagia, esophagus, cancer
5498692|NCT01301482|Acute Sore Throat|acute sore throat
5498693|NCT01301482|Ear Acupuncture|ear acupuncture
5498694|NCT01301456|Phase 1|phase 1
5498695|NCT01301456|Type 2 Diabetes|type 2 diabetes
5498696|NCT01301456|CVX-096|cvx-096
5498697|NCT01301443|Age Related Macular Degeneration|age related macular degeneration
5498698|NCT01301430|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
5498699|NCT01301430|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5498700|NCT01301430|Oncolytic virus|oncolytic virus
5498701|NCT01301417|Compression Anastomosis|compression anastomosis
5498702|NCT01301404|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
5498703|NCT01301404|Spinal morphine|spinal morphine
5498704|NCT01301404|Total knee replacement (TKR)|total knee replacement (tkr)
5498705|NCT01301404|blood sugar|blood sugar
5498706|NCT01301404|carbohydrate drink|carbohydrate drink
5498707|NCT01301391|B3 and C malignant thymoma|b3 and c malignant thymoma
5498708|NCT01301365|autonomic response|autonomic response
5498709|NCT01301352|Critical Care|critical care
5498710|NCT01301352|Intubation, gastrointestinal|intubation, gastrointestinal
5498712|NCT01301352|Infant|infant
5498713|NCT01301352|Adolescent|adolescent
5498714|NCT01301352|Continuous positive airway pressure|continuous positive airway pressure
5498715|NCT01301352|Enteral Nutrition|enteral nutrition
5498716|NCT01301339|Pre-Diabetes|pre-diabetes
5498717|NCT01301339|Diabetes|diabetes
5498718|NCT01301339|cardiovascular risks|cardiovascular risks
5498719|NCT01301326|retinal arterial macroaneurysm|retinal arterial macroaneurysm
5498720|NCT01301326|laser treatment|laser treatment
5498721|NCT01301313|Acute heart failure|acute heart failure
5498722|NCT01301313|Children|children
5498723|NCT01301313|Levosimendan|levosimendan
5498724|NCT01301313|Inotropic treatment|inotropic treatment
5498725|NCT01301274|hyponatremia|hyponatremia
5498726|NCT01301274|maintenance solutions|maintenance solutions
5498727|NCT01301274|pediatrics|pediatrics
5498728|NCT01301261|Sugammadex|sugammadex
5498729|NCT01301261|entropy|entropy
5498730|NCT01301261|bispectral index|bispectral index
5498734|NCT01301261|end-tidal CO2|end-tidal co2
5498735|NCT01301261|hemodynamics|hemodynamics
5498736|NCT01301261|general anesthesia|general anesthesia
5498737|NCT01301248|locally advanced,|locally advanced,
5498738|NCT01301248|unresectable,|unresectable,
5498739|NCT01301248|head and neck squamous cell carcinoma,|head and neck squamous cell carcinoma,
5498740|NCT01301248|stage III/IV|stage iii/iv
5498741|NCT01301235|Mitochondria|mitochondria
5498742|NCT01301222|octreotide|octreotide
5498743|NCT01301222|pancreatic fistula|pancreatic fistula
5498744|NCT01301222|soft pancreas|soft pancreas
5498745|NCT01301222|pancreatoduodenectomy|pancreatoduodenectomy
5498746|NCT01301196|sedentary behaviour|sedentary behaviour
5498747|NCT01301196|diabetes|diabetes
5498748|NCT01301196|structured education|structured education
5498749|NCT01301196|18-30 years olds|18-30 years olds
5498750|NCT01301196|family history of T2DM or CVD|family history of t2dm or cvd
5498751|NCT01301196|BMI ≥ 25 (≥23 for south Asians)|bmi ≥ 25 (≥23 for south asians)
5498756|NCT01301170|Neck pain|neck pain
5498759|NCT01301170|Manipulation|manipulation
5498760|NCT01301144|Tuberculosis|tuberculosis
5498761|NCT01301144|Urea Breath Test|urea breath test
5498762|NCT01301118|Transplantation Infection|transplantation infection
5498763|NCT01301118|Wound of skin|wound of skin
5498766|NCT01301118|Infection|infection
5498767|NCT01301105|pain regulation|pain regulation
5498769|NCT01301105|affect|affect
5498770|NCT01301105|attention|attention
5498771|NCT01301105|brain|brain
5498772|NCT01301105|immune|immune
5498773|NCT01301105|endocrine|endocrine
5498774|NCT01301079|Remifentanil|remifentanil
5498775|NCT01301079|Hyperalgesia|hyperalgesia
5498776|NCT01301079|Ketamine|ketamine
5498777|NCT01301079|Von Frey's filament|von frey's filament
5498778|NCT01301079|Algometer|algometer
5498779|NCT01301079|Interleukines|interleukines
5498780|NCT01301079|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
5498781|NCT01301053|hyperglycemia and increased mortality in the ICU|hyperglycemia and increased mortality in the icu
5498782|NCT01301053|hypoglycemia and increased mortality in the ICU|hypoglycemia and increased mortality in the icu
5498783|NCT01301053|glucose variability and increased mortality in the ICU|glucose variability and increased mortality in the icu
5498784|NCT01301053|Continuous Glucose Monitoring (CGM) and hypoglycemia|continuous glucose monitoring (cgm) and hypoglycemia
5498785|NCT01301053|hypoglycemia|hypoglycemia
5498786|NCT01301053|reducing ICU mortality|reducing icu mortality
5498787|NCT01301040|breast cancer, elderly, early cardiac toxicity|breast cancer, elderly, early cardiac toxicity
5498788|NCT01301027|End stage renal disease|end stage renal disease
5498789|NCT01301027|Hemodialysis|hemodialysis
5498790|NCT01301027|Pioglitazone|pioglitazone
5498791|NCT01301027|Adipokines|adipokines
5498792|NCT01301014|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, Lachman test, sensitivity, specificity|accuracy, anterior cruciate ligament, diagnostic value, examination, knee, lachman test, sensitivity, specificity
5498793|NCT01301001|Vulvodynia|vulvodynia
5498794|NCT01300988|HIV infection|hiv infection
5498795|NCT01300988|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
5498796|NCT01300988|CCR5 expression|ccr5 expression
5498797|NCT01300988|Treatment Naive|treatment naive
5498798|NCT01300975|Leishmaniasis|leishmaniasis
5498799|NCT01300975|intralesional antimony|intralesional antimony
5501744|NCT01289054|CML|cml
5498800|NCT01300975|cryotherapy|cryotherapy
5498801|NCT01300962|Xeloda|xeloda
5498802|NCT01300962|Capecitabine|capecitabine
5498803|NCT01300962|BKM120|bkm120
5498804|NCT01300962|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5498805|NCT01300962|Metastatic|metastatic
5498806|NCT01300962|BYL719 Breast Cancer|byl719 breast cancer
5498807|NCT01300949|Contrast Sensitivity|contrast sensitivity
5498808|NCT01300949|Pelli-Robson Test|pelli-robson test
5498809|NCT01300923|Fragile X Syndrome|fragile x syndrome
5498810|NCT01300923|Acamprosate|acamprosate
5498811|NCT01300910|Adult Males|adult males
5498812|NCT01300910|Circumcision|circumcision
5498813|NCT01300910|HIV prevention|hiv prevention
5498814|NCT01300910|Device|device
5498815|NCT01300910|Shang Ring|shang ring
5498816|NCT01300897|cortical evoked potentials, motor evoked potential responses|cortical evoked potentials, motor evoked potential responses
5498817|NCT01300845|Oxygen mask|oxygen mask
5498818|NCT01300845|Oxygen cannula|oxygen cannula
5498819|NCT01300845|Humidification|humidification
5498820|NCT01300845|Oxygen therapy|oxygen therapy
5498821|NCT01300845|Intensive Care Unit|intensive care unit
5498822|NCT01300832|Surgery|surgery
5498823|NCT01300832|Deep Vein Thrombosis|deep vein thrombosis
5498824|NCT01300832|Preoperative|preoperative
5498825|NCT01300819|Rotigotine|rotigotine
5498826|NCT01300819|Neupro®|neupro®
5498931|NCT01300416|PGWB|pgwb
5498827|NCT01300819|Non-motor symptoms|non-motor symptoms
5498828|NCT01300806|HIV|hiv
5498829|NCT01300806|harmful substance use|harmful substance use
5498830|NCT01300793|V-RICE|v-rice
5498831|NCT01300793|Relapsed NHL|relapsed nhl
5498832|NCT01300793|Primary Refractory NHL|primary refractory nhl
5498833|NCT01300780|bleaching agent|bleaching agent
5498834|NCT01300780|tooth bleaching|tooth bleaching
5498835|NCT01300780|sensibility|sensibility
5498836|NCT01300754|Osgood-Schlatter|osgood-schlatter
5498837|NCT01300754|Tendinosis|tendinosis
5498838|NCT01300754|Apophysitis|apophysitis
5498839|NCT01300754|Enthesopathy|enthesopathy
5498840|NCT01300754|Dextrose.|dextrose.
5498841|NCT01300728|Intravenous immunotherapy|intravenous immunotherapy
5498842|NCT01300728|Conversion to Alzheimer Disease|conversion to alzheimer disease
5498843|NCT01300715|zygapophysial joint|zygapophysial joint
5498844|NCT01300715|facet joint|facet joint
5498845|NCT01300715|low back pain|low back pain
5498846|NCT01300715|radiofrequency|radiofrequency
5498847|NCT01300715|neurotomy|neurotomy
5498848|NCT01300689|HPV|hpv
5498849|NCT01300689|MSM|msm
5498850|NCT01300689|Vaccine|vaccine
5498851|NCT01300689|China|china
5498852|NCT01300676|Tualang honey|tualang honey
5498853|NCT01300676|HRT|hrt
5498854|NCT01300676|safety profiles|safety profiles
5498855|NCT01300676|cardiovascular parameters|cardiovascular parameters
5498856|NCT01300676|hormonal levels|hormonal levels
5498857|NCT01300676|bone changes|bone changes
5498858|NCT01300676|postmenopausal women|postmenopausal women
5498859|NCT01300650|Heart failure|heart failure
5498860|NCT01300650|Inflammation|inflammation
5498861|NCT01300650|Interleukin-1|interleukin-1
5685329|NCT00556517|Hamstring|hamstring
5498862|NCT01300650|Cardiopulmonary exercise|cardiopulmonary exercise
5498863|NCT01300637|schizophrenia|schizophrenia
5498864|NCT01300637|clozapine|clozapine
5498865|NCT01300637|metabolic dysregulation|metabolic dysregulation
5498866|NCT01300637|metformin|metformin
5498868|NCT01300624|therapy|therapy
5498869|NCT01300624|treatment|treatment
5498870|NCT01300624|verbs|verbs
5498871|NCT01300624|sentences|sentences
5498872|NCT01300611|Double Cord Blood Transplantation|double cord blood transplantation
5498873|NCT01300611|Neutrophil Engraftment|neutrophil engraftment
5480798|NCT01375803|dietary fiber|dietary fiber
5498874|NCT01300611|Platelet Engraftment|platelet engraftment
5498875|NCT01300611|Immune Reconstitution|immune reconstitution
5498876|NCT01300611|Mucositis|mucositis
5498877|NCT01300585|Breast|breast
5498878|NCT01300585|Cancer|cancer
5498879|NCT01300559|efficacy|efficacy
5498880|NCT01300559|hemoglobin|hemoglobin
5498881|NCT01300559|spine|spine
5498882|NCT01300546|Frequent migraine|frequent migraine
5498883|NCT01300546|Migraine transformation|migraine transformation
5498884|NCT01300546|Migraine|migraine
5498885|NCT01300546|Treximet|treximet
5498886|NCT01300546|Naproxen|naproxen
5498887|NCT01300546|Sumatriptan|sumatriptan
5498888|NCT01300533|Cancer|cancer
5498889|NCT01300533|Neoplasms|neoplasms
5498890|NCT01300533|Solid Tumor|solid tumor
5498891|NCT01300533|Ovarian Cancer|ovarian cancer
5498892|NCT01300533|Lung Cancer|lung cancer
5498893|NCT01300533|Non-Small Cell Lung Cancer|non-small cell lung cancer
5498894|NCT01300533|Pancreatic Cancer|pancreatic cancer
5498895|NCT01300533|Breast Cancer|breast cancer
5498896|NCT01300533|Endometrial Cancer|endometrial cancer
5498897|NCT01300533|Melanoma|melanoma
5498898|NCT01300533|Prostate Cancer|prostate cancer
5498899|NCT01300533|Skin Cancer|skin cancer
5498900|NCT01300533|Head and Neck Cancer|head and neck cancer
5498901|NCT01300533|Solid Malignancies|solid malignancies
5498902|NCT01300520|Fluoroscopy|fluoroscopy
5498903|NCT01300520|Femoral fracture|femoral fracture
5498904|NCT01300520|Tibial fracture|tibial fracture
5498905|NCT01300520|Spinal Fusion|spinal fusion
5498906|NCT01300507|stent thrombosis|stent thrombosis
5498907|NCT01300507|intra coronary imaging|intra coronary imaging
5498908|NCT01300507|blood platelet function testing|blood platelet function testing
5498909|NCT01300494|bifurcation lesion|bifurcation lesion
5498910|NCT01300494|optimal viewing angle|optimal viewing angle
5498911|NCT01300494|automated software|automated software
5498912|NCT01300468|advanced/metastatic solid tumors|advanced/metastatic solid tumors
5498913|NCT01300455|Insomnia|insomnia
5498914|NCT01300455|obstructive sleep apnea|obstructive sleep apnea
5498915|NCT01300455|orexin receptor antagonist|orexin receptor antagonist
5498916|NCT01300442|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5498917|NCT01300442|diaphragm|diaphragm
5498918|NCT01300442|electrical stimulation|electrical stimulation
5498919|NCT01300442|pulmonary rehabilitation|pulmonary rehabilitation
5498920|NCT01300429|core biopsy|core biopsy
5498921|NCT01300429|Resistance to Crizotinib|resistance to crizotinib
5498922|NCT01300429|Non-small Cell Lung Cancer|non-small cell lung cancer
5498923|NCT01300429|11-014|11-014
5498924|NCT01300416|Kidney transplantation|kidney transplantation
5498925|NCT01300416|mycophenolate sodium|mycophenolate sodium
5498926|NCT01300416|EC-MPS|ec-mps
5498927|NCT01300416|Health Related Quality of Life|health related quality of life
5498928|NCT01300416|GI symptoms|gi symptoms
5498929|NCT01300416|Immunosuppressants|immunosuppressants
5498930|NCT01300416|HRQL|hrql
5498932|NCT01300416|GIQLI|giqli
5498933|NCT01300390|liver transplant|liver transplant
5498934|NCT01300390|end-stage liver disease|end-stage liver disease
5498935|NCT01300390|cirrhosis|cirrhosis
5498936|NCT01300377|Post-operative pain|post-operative pain
5498937|NCT01300377|pain|pain
5498938|NCT01300377|pacemaker|pacemaker
5498939|NCT01300377|defibrillator|defibrillator
5498940|NCT01300377|post-operative narcotic use|post-operative narcotic use
5498941|NCT01300377|local anesthesia|local anesthesia
5498942|NCT01300351|Advanced breast cancer|advanced breast cancer
5498943|NCT01300351|metastatic breast cancer|metastatic breast cancer
5498944|NCT01300338|Diabetes|diabetes
5498945|NCT01300325|Bronchiolitis, 3% Hypertonic Saline Solution|bronchiolitis, 3% hypertonic saline solution
5498946|NCT01300312|eperisone|eperisone
5498947|NCT01300312|diclofenac|diclofenac
5498948|NCT01300312|low back pain|low back pain
5498949|NCT01300299|lung cancer|lung cancer
5498950|NCT01300299|radiation|radiation
5498951|NCT01300299|stereotactic|stereotactic
5498952|NCT01300273|Diabetic nephropathy|diabetic nephropathy
5498953|NCT01300273|Podocyte|podocyte
5498954|NCT01300273|Low Protein Diet|low protein diet
5498955|NCT01300273|Ketoanalogs|ketoanalogs
5498956|NCT01300234|tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5498958|NCT01300234|adefovir dipivoxil|adefovir dipivoxil
5498959|NCT01300221|Three dimension echocardiography|three dimension echocardiography
5498960|NCT01300221|Congenital heart disease|congenital heart disease
5498961|NCT01300221|Z-score|z-score
5498962|NCT01300208|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5485191|NCT01357317|Parathyroid hormone|parathyroid hormone
5498963|NCT01300208|subacute lupus erythematosus|subacute lupus erythematosus
5498964|NCT01300208|discoid lupus erythematosus|discoid lupus erythematosus
5498965|NCT01300208|lupus|lupus
5498966|NCT01300195|VATS|vats
5498967|NCT01300195|standardized surgery|standardized surgery
5498968|NCT01300195|persistent pain|persistent pain
5498969|NCT01300182|ACLR|aclr
5498970|NCT01300169|Suicide|suicide
5498971|NCT01300169|Assessment|assessment
5498972|NCT01300169|Intervention|intervention
5498973|NCT01300169|CAMS|cams
5498974|NCT01300156|Hodgkin's disease|hodgkin's disease
5498975|NCT01300156|lymphoma|lymphoma
5498976|NCT01300156|Relapsed|relapsed
5498977|NCT01300156|refractory|refractory
5498978|NCT01300130|neurological development|neurological development
5498979|NCT01300130|preterm infants|preterm infants
5498980|NCT01300130|fatty acid status|fatty acid status
5498981|NCT01300117|cardiac surgery|cardiac surgery
5498982|NCT01300117|adamts13|adamts13
5498983|NCT01300117|TTP|ttp
5498984|NCT01300117|extracorporeal circulation|extracorporeal circulation
5498985|NCT01300117|Heart-Lung Machine|heart-lung machine
5498986|NCT01300104|prostate cancer progression|prostate cancer progression
5498987|NCT01300104|active surveillance|active surveillance
5498988|NCT01300104|whole grain rye|whole grain rye
5498989|NCT01300104|exercise|exercise
5498990|NCT01300104|insulin sensitivity|insulin sensitivity
5498991|NCT01300104|quality of life|quality of life
5498992|NCT01300091|Shoulder|shoulder
5498993|NCT01300091|Pain|pain
5498994|NCT01300091|Range of Motion|range of motion
5498995|NCT01300091|Disability Evaluation|disability evaluation
5498996|NCT01300091|Function|function
5498997|NCT01300091|Sick Leave|sick leave
5498998|NCT01300091|Primary Health Care|primary health care
5498999|NCT01300091|Visual Analog Scale|visual analog scale
5499000|NCT01300091|Visual Analog Pain Scale|visual analog pain scale
5499001|NCT01300091|The American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form|the american shoulder and elbow surgeons standardized shoulder assessment form
5499002|NCT01300078|Hot Flashes|hot flashes
5499003|NCT01300078|Hot Flushes|hot flushes
5499004|NCT01300078|Vasomotor Symptoms|vasomotor symptoms
5499005|NCT01300078|Menopausal Symptoms|menopausal symptoms
5499006|NCT01300052|psoriasis|psoriasis
5499007|NCT01300039|nephrolithiasis|nephrolithiasis
5499008|NCT01300039|urolithiasis|urolithiasis
5499009|NCT01300039|hyperoxaluria|hyperoxaluria
5499010|NCT01300039|Helicobacter pylori|helicobacter pylori
5499011|NCT01300026|Low intermediate grade B cell Lymphoma|low intermediate grade b cell lymphoma
5499012|NCT01300026|Non-cutaneous T-cell NHL|non-cutaneous t-cell nhl
5499013|NCT01300026|Mantle Cell Lymphoma|mantle cell lymphoma
5499014|NCT01300026|PI3K delta|pi3k delta
5499015|NCT01300026|Lymphoid|lymphoid
5499017|NCT01300026|MCL|mcl
5499018|NCT01300026|Hematologic|hematologic
5499019|NCT01300026|CLL|cll
5499020|NCT01300026|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5499021|NCT01300013|Intravenous|intravenous
5499022|NCT01300013|IV|iv
5499023|NCT01300013|Left Ventricular Systolic Dysfunction|left ventricular systolic dysfunction
5499024|NCT01300013|Hospitalized|hospitalized
5499025|NCT01300013|Acute heart failure|acute heart failure
5499026|NCT01300013|Heart failure|heart failure
5499027|NCT01300013|Left ventricular ejection fraction|left ventricular ejection fraction
5499028|NCT01300013|pharmacokinetics|pharmacokinetics
5499029|NCT01300013|Pharmacodynamics|pharmacodynamics
5499030|NCT01300013|Dyspnea|dyspnea
5499031|NCT01300013|hospitalization|hospitalization
5499032|NCT01300013|In-patient|in-patient
5499038|NCT01299987|Intraoperative Radiotherapy|intraoperative radiotherapy
5499039|NCT01299987|Early Breast Cancer|early breast cancer
5499040|NCT01299987|Elderly Patients|elderly patients
5499041|NCT01299974|Family-centered|family-centered
5499042|NCT01299974|teaching|teaching
5499043|NCT01299974|residents|residents
5499044|NCT01299974|family faculty|family faculty
5499045|NCT01299961|Rheumatoid Arthritis|rheumatoid arthritis
5499046|NCT01299961|Subcutaneous Abatacept|subcutaneous abatacept
5499047|NCT01299961|Ultrasound|ultrasound
5499049|NCT01299948|AIDS|aids
5499050|NCT01299948|CD4|cd4
5499051|NCT01299948|progression|progression
5499052|NCT01299948|immune activation|immune activation
5499053|NCT01299935|stress reduction|stress reduction
5499054|NCT01299935|Transcendental Meditation technique|transcendental meditation technique
5499055|NCT01299935|secondary prevention of coronary heart disease|secondary prevention of coronary heart disease
5499056|NCT01299922|Lupus nephritis|lupus nephritis
5499057|NCT01299922|Therapy|therapy
5499058|NCT01299922|Cyclosporin|cyclosporin
5499059|NCT01299922|Mycophenolic acid|mycophenolic acid
5499060|NCT01299909|Mindfulness Training for Smokers|mindfulness training for smokers
5499061|NCT01299909|Smoking|smoking
5499063|NCT01299909|Addiction|addiction
5499064|NCT01299909|behavioral intervention|behavioral intervention
5499065|NCT01299909|Nicotine|nicotine
5499066|NCT01299909|Tobacco|tobacco
5499067|NCT01299909|Mindfulness|mindfulness
5499068|NCT01299909|Meditation|meditation
5499069|NCT01299909|MBSR|mbsr
5685330|NCT00556517|Strain|strain
5499070|NCT01299909|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5499071|NCT01299909|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5499072|NCT01299909|MBCT|mbct
5499073|NCT01299909|Mindfulness Based Relapse Prevention|mindfulness based relapse prevention
5499074|NCT01299909|MBRP|mbrp
5499075|NCT01299909|Mindfulness Training|mindfulness training
5499076|NCT01299909|Nicotine Patch|nicotine patch
5499077|NCT01299909|Quit Line|quit line
5499078|NCT01299909|Phone counseling|phone counseling
5499079|NCT01299909|Freedom from Smoking|freedom from smoking
5499080|NCT01299896|Cigarette Smoking|cigarette smoking
5499081|NCT01299896|Smoking, Tobacco|smoking, tobacco
5481017|NCT01374971|Anti-TNF|anti-tnf
5499082|NCT01299896|Tobacco Smoking|tobacco smoking
5499083|NCT01299896|Smoking Cessation|smoking cessation
5499084|NCT01299896|Tobacco Dependence|tobacco dependence
5499085|NCT01299883|Cancer|cancer
5499086|NCT01299883|CVD|cvd
5499087|NCT01299883|African American|african american
5499088|NCT01299883|Health Education Intervention|health education intervention
5499089|NCT01299883|Intervention RCT|intervention rct
5499090|NCT01299883|Study focus is to examine the influence of health education regarding either CVD or CVD and cancer on health behaviors.|study focus is to examine the influence of health education regarding either cvd or cvd and cancer on health behaviors.
5499091|NCT01299857|pemphigus|pemphigus
5499092|NCT01299857|Mabthéra (R)|mabthéra (r)
5499093|NCT01299857|B lymphocytes|b lymphocytes
5499094|NCT01299857|desmogleines|desmogleines
5499095|NCT01299844|Type 2 Diabetes|type 2 diabetes
5499096|NCT01299818|central pain|central pain
5499097|NCT01299818|spine surgey|spine surgey
5499098|NCT01299818|outcome|outcome
5499099|NCT01299818|patients undergo spinal surgery|patients undergo spinal surgery
5499100|NCT01299805|Drug Therapy|drug therapy
5499101|NCT01299805|pharmacodynamic|pharmacodynamic
5499102|NCT01299792|spinal cord injury|spinal cord injury
5499103|NCT01299792|urodynamics|urodynamics
5499104|NCT01299792|ultrasound|ultrasound
5499105|NCT01299792|neurogenic bladder dysfunction|neurogenic bladder dysfunction
5499106|NCT01299779|hyponatremia|hyponatremia
5499107|NCT01299779|PEG-SD|peg-sd
5499108|NCT01299779|PEG-ELS|peg-els
5499109|NCT01299766|Mild Cognitive Impairment|mild cognitive impairment
5499110|NCT01299766|Memory|memory
5499115|NCT01299714|Human Papilloma Virus|human papilloma virus
5499116|NCT01299714|vaccine|vaccine
5499117|NCT01299714|stress|stress
5499118|NCT01299714|cervical cancer|cervical cancer
5499119|NCT01299714|GARDASIL|gardasil
5499120|NCT01299701|Advanced or metastatic cancer|advanced or metastatic cancer
5499121|NCT01299701|refractory|refractory
5499122|NCT01299701|core phase|core phase
5499123|NCT01299701|extension phase|extension phase
5499124|NCT01299701|dose escalation|dose escalation
5499125|NCT01299701|standard chemotherapy|standard chemotherapy
5499126|NCT01299701|docetaxel|docetaxel
5499127|NCT01299701|paclitaxel|paclitaxel
5499128|NCT01299701|carboplatin|carboplatin
5499129|NCT01299701|safety|safety
5499130|NCT01299701|tolerability|tolerability
5499131|NCT01299675|MR conditional|mr conditional
5499133|NCT01299636|PM060184|pm060184
5499134|NCT01299636|Phase I|phase i
5499135|NCT01299636|Pharma Mar|pharma mar
5499136|NCT01299623|breast cancer|breast cancer
5499137|NCT01299623|breast cancer prevention|breast cancer prevention
5499138|NCT01299623|African American women|african american women
5499139|NCT01299610|Atopic Dermatitis|atopic dermatitis
5499140|NCT01299610|GW870086X|gw870086x
5499141|NCT01299610|TIS|tis
5499142|NCT01299610|IGA|iga
5499143|NCT01299597|repeat dose|repeat dose
5499144|NCT01299597|statins|statins
5499145|NCT01299597|safety and tolerability|safety and tolerability
5499146|NCT01299597|drug interaction|drug interaction
5499147|NCT01299597|sb649868|sb649868
5499148|NCT01299597|healthy male subjects|healthy male subjects
5499149|NCT01299597|pharmacokinetics|pharmacokinetics
5499150|NCT01299558|pharmacokinetics|pharmacokinetics
5499151|NCT01299558|GW642444|gw642444
5499152|NCT01299558|absolute bioavailability|absolute bioavailability
5499153|NCT01299558|healthy subjects|healthy subjects
5499154|NCT01299558|fluticasone furoate|fluticasone furoate
5499155|NCT01299558|GW685698|gw685698
5499156|NCT01299545|Rheumatoid Arthritis|rheumatoid arthritis
5499157|NCT01299545|Anti TNF|anti tnf
5499158|NCT01299545|Infliximab|infliximab
5499159|NCT01299545|Methotrexate|methotrexate
5499160|NCT01299545|DMARDs|dmards
5499161|NCT01299545|Gene expression biomarkers|gene expression biomarkers
5499162|NCT01299519|obesity|obesity
5499163|NCT01299519|weight loss|weight loss
5499164|NCT01299519|insulin resistance|insulin resistance
5499165|NCT01299506|soft tissue sarcoma|soft tissue sarcoma
5499166|NCT01299506|trabectedin|trabectedin
5499167|NCT01299506|Netherlands|netherlands
5499168|NCT01299493|carcinoma|carcinoma
5499169|NCT01299493|colorectal cancer|colorectal cancer
5499170|NCT01299493|community health centers|community health centers
5499171|NCT01299493|cluster-randomized|cluster-randomized
5499172|NCT01299493|health behavior|health behavior
5499173|NCT01299480|Healthy adolescents|healthy adolescents
5499174|NCT01299467|Asthma|asthma
5499175|NCT01299467|duration of action|duration of action
5499176|NCT01299467|allergen challenge|allergen challenge
5499177|NCT01299428|CEREBRAL OXYGENATION|cerebral oxygenation
5499178|NCT01299428|HYPERNATREMİA|hypernatremia
5499179|NCT01299428|NEWBORN|newborn
5499180|NCT01299428|NA VALUES|na values
5499181|NCT01299415|ASA404,|asa404,
5499182|NCT01299415|Phase I,|phase i,
5499183|NCT01299415|Oncology,|oncology,
5499184|NCT01299415|CYP1A2,|cyp1a2,
5499185|NCT01299415|fluvoxamine,|fluvoxamine,
5499186|NCT01299415|drug drug interaction,|drug drug interaction,
5499187|NCT01299415|Novartis,|novartis,
5499188|NCT01299415|Antisoma|antisoma
5499189|NCT01299389|Paliperidone palmitate|paliperidone palmitate
5499190|NCT01299389|Schizophrenia|schizophrenia
5499191|NCT01299376|Essential hypertension|essential hypertension
5499192|NCT01299376|Antihypertensive agents|antihypertensive agents
5499193|NCT01299376|Blood pressure|blood pressure
5499194|NCT01299376|Uncontrolled hypertension|uncontrolled hypertension
5499195|NCT01299363|Prolapse|prolapse
5499196|NCT01299363|Pain with intercourse|pain with intercourse
5499197|NCT01299363|Dyspareunia|dyspareunia
5499198|NCT01299363|Post operative pain|post operative pain
5499199|NCT01299350|Heart failure|heart failure
5499200|NCT01299350|Nt-proBNP|nt-probnp
5499201|NCT01299324|CHF|chf
5499202|NCT01299311|insulin sensitivity|insulin sensitivity
5499203|NCT01299285|Absorption|absorption
5499204|NCT01299285|Distribution|distribution
5499205|NCT01299285|Metabolism|metabolism
5499206|NCT01299285|Excretion|excretion
5499207|NCT01299285|Mass balance|mass balance
5499208|NCT01299285|Metabolic profile|metabolic profile
5499209|NCT01299285|Radiolabeled study|radiolabeled study
5499210|NCT01299285|14C|14c
5499211|NCT01299259|Text message reminders|text message reminders
5499212|NCT01299259|Pelvic inflammatory disease|pelvic inflammatory disease
5499213|NCT01299259|PID|pid
5499214|NCT01299259|Primary care follow-up|primary care follow-up
5499215|NCT01299259|Emergency department care|emergency department care
5499216|NCT01299259|Discharge instructions|discharge instructions
5499217|NCT01299246|Diabetic Foot|diabetic foot
5499218|NCT01299246|non-invasive DFP assessment tools|non-invasive dfp assessment tools
5499219|NCT01299246|early detection of DFP|early detection of dfp
5499220|NCT01299220|Erlotinib|erlotinib
5499221|NCT01299220|Acitretin|acitretin
5499222|NCT01299220|Rash|rash
5499223|NCT01299220|Dermatology|dermatology
5499224|NCT01299220|Oncology|oncology
5499225|NCT01299207|Stents|stents
5499226|NCT01299207|Drug-Eluting Stents|drug-eluting stents
5499227|NCT01299207|Stent Thrombosis|stent thrombosis
5499228|NCT01299207|Bleeding|bleeding
5499229|NCT01299207|Dual-Antiplatelet Therapy|dual-antiplatelet therapy
5499230|NCT01299194|BRONCHIECTASIS|bronchiectasis
5499231|NCT01299194|PSEUDOMONAS AERUGINOSA|pseudomonas aeruginosa
5499232|NCT01299194|STATIN|statin
5499233|NCT01299194|OUTCOME|outcome
5499234|NCT01299181|Bronchiectasis|bronchiectasis
5499235|NCT01299181|Outcome|outcome
5499236|NCT01299181|Statin therapy|statin therapy
5499713|NCT01297049|Diabetes|diabetes
5499237|NCT01299168|global gene expression|global gene expression
5499238|NCT01299168|molecular diagnostic classifiers|molecular diagnostic classifiers
5499239|NCT01299155|Intraocular Lens|intraocular lens
5499240|NCT01299155|Presbyopia Correcting IOL|presbyopia correcting iol
5499241|NCT01299142|Influenza|influenza
5499242|NCT01299142|antibodies|antibodies
5499243|NCT01299142|monoclonal|monoclonal
5499244|NCT01299142|virus|virus
5499245|NCT01299129|Uveitis|uveitis
5499246|NCT01299129|Cystoid macular edema|cystoid macular edema
5499247|NCT01299129|microperimetry|microperimetry
5499248|NCT01299129|functional visual acuity|functional visual acuity
5499249|NCT01299129|intravitreal triamcinolone|intravitreal triamcinolone
5499250|NCT01299116|AE-adverse event|ae-adverse event
5499251|NCT01299116|FDA-(U.S.) Food and Drug Administration|fda-(u.s.) food and drug administration
5499252|NCT01299116|GCP-Good Clinical Practice guidelines|gcp-good clinical practice guidelines
5499253|NCT01299116|ICH-International Committee on Harmonisation|ich-international committee on harmonisation
5499254|NCT01299116|IRB-Institutional Review Board|irb-institutional review board
5499255|NCT01299116|IU-International units|iu-international units
5499256|NCT01299116|mg-milligram(s)|mg-milligram(s)
5499257|NCT01299116|mm3-cubic millimeter(s)|mm3-cubic millimeter(s)
5499258|NCT01299116|LARC-Long-Acting reversible contraception|larc-long-acting reversible contraception
5499259|NCT01299116|PPCNC-Planned Parenthood of North Carolina|ppcnc-planned parenthood of north carolina
5499260|NCT01299116|SAE-serious adverse event|sae-serious adverse event
5499261|NCT01299116|SARC-Short-Acting reversible contraception|sarc-short-acting reversible contraception
5499262|NCT01299116|µg-microgram|µg-microgram
5499263|NCT01299116|ULN-upper limit of the normal range|uln-upper limit of the normal range
5499264|NCT01299116|SubQ-subcutaneous|subq-subcutaneous
5499265|NCT01299103|wrinkle|wrinkle
5499266|NCT01299103|rhytide|rhytide
5499268|NCT01299090|rhytides|rhytides
5499269|NCT01299077|Lumbar disc degenerative disease|lumbar disc degenerative disease
5499270|NCT01299077|Methycobal|methycobal
5499271|NCT01299064|mindfulness-based intervention|mindfulness-based intervention
5499272|NCT01299064|symptoms reduction|symptoms reduction
5499273|NCT01299064|mental health|mental health
5499274|NCT01299051|Weight Management|weight management
5499275|NCT01299051|Employee Health|employee health
5499276|NCT01299038|Crestor|crestor
5499277|NCT01299038|TFBP|tfbp
5499278|NCT01299038|rosuvastatin|rosuvastatin
5499279|NCT01299025|balance|balance
5499280|NCT01299025|walking|walking
5499281|NCT01298999|Barrett's Esophagus|barrett's esophagus
5499282|NCT01298999|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5499283|NCT01298999|GERD|gerd
5499284|NCT01298999|Acid Reflux|acid reflux
5499285|NCT01298986|atrial fibrillation ablation procedures|atrial fibrillation ablation procedures
5499404|NCT01298323|Patient Outreach|patient outreach
5499286|NCT01298960|Poor Ovarian response in IVF|poor ovarian response in ivf
5499287|NCT01298960|Metaphase II oocytes|metaphase ii oocytes
5499288|NCT01298960|Pregnancy Rate|pregnancy rate
5499289|NCT01298960|Growth Hormone|growth hormone
5499290|NCT01298947|Photoablative Atherectomy|photoablative atherectomy
5499291|NCT01298947|Paclitaxel-Coated Balloon|paclitaxel-coated balloon
5499292|NCT01298947|Instent Femoro-popliteal Obstructions|instent femoro-popliteal obstructions
5499293|NCT01298921|Headache|headache
5499294|NCT01298921|Cluster Headache|cluster headache
5499295|NCT01298921|Oxygen Therapy|oxygen therapy
5499296|NCT01298908|varicose veins, oedema|varicose veins, oedema
5499297|NCT01298895|optical components|optical components
5499298|NCT01298895|pseudoexfoliation|pseudoexfoliation
5499299|NCT01298895|cataract|cataract
5499300|NCT01298895|LENSTAR® LS 900®|lenstar® ls 900®
5499301|NCT01298882|Type 2 diabetes mellitus|type 2 diabetes mellitus
5499302|NCT01298882|Overweight|overweight
5499303|NCT01298882|Obesity|obesity
5499304|NCT01298869|CKD|ckd
5499305|NCT01298869|HPV infection|hpv infection
5499306|NCT01298869|HPV vaccine|hpv vaccine
5499307|NCT01298869|antibodies titer|antibodies titer
5499308|NCT01298856|hydrotherapy|hydrotherapy
5499309|NCT01298856|chronic ankle instability|chronic ankle instability
5499310|NCT01298856|ankle taping|ankle taping
5499311|NCT01298843|Confirmed or Suspected Infections|confirmed or suspected infections
5499312|NCT01298817|Obesity|obesity
5499313|NCT01298817|Aging|aging
5499314|NCT01298817|Soy|soy
5499315|NCT01298817|Weight Loss|weight loss
5499316|NCT01298817|Ectopic Fat|ectopic fat
5499317|NCT01298778|chronic pain post delivery|chronic pain post delivery
5499318|NCT01298778|postpartum depression|postpartum depression
5499319|NCT01298778|tailored pain management|tailored pain management
5499320|NCT01298765|buccal soluble film|buccal soluble film
5499321|NCT01298739|asthma control level , ACQ|asthma control level , acq
5499322|NCT01298726|PHARMACEUTICAL SERVICES|pharmaceutical services
5499323|NCT01298726|DIABETES MELLITUS|diabetes mellitus
5499324|NCT01298713|Hormonoresistance|hormonoresistance
5499325|NCT01298713|tamoxifen|tamoxifen
5499326|NCT01298713|Previously received anti-aromatase treatment|previously received anti-aromatase treatment
5499327|NCT01298713|mTor inhibitor|mtor inhibitor
5499328|NCT01298687|open-angle glaucoma|open-angle glaucoma
5499329|NCT01298687|ocular hypertension|ocular hypertension
5499330|NCT01298687|divided dose|divided dose
5499331|NCT01298661|Exercise Test|exercise test
5499332|NCT01298661|Reproducibility of Results|reproducibility of results
5499333|NCT01298661|Mortality|mortality
5499334|NCT01298648|Crohn's Disease|crohn's disease
5499335|NCT01298635|Primary angle-closure glaucoma|primary angle-closure glaucoma
5499336|NCT01298635|cataract|cataract
5499337|NCT01298635|trabeculectomy|trabeculectomy
5499338|NCT01298635|phacotrabeculectomy|phacotrabeculectomy
5499339|NCT01298609|Fibromyalgia|fibromyalgia
5499340|NCT01298609|Occipital Nerve Stimulation|occipital nerve stimulation
5499341|NCT01298570|Metastatic Colorectal Cancer|metastatic colorectal cancer
5499342|NCT01298570|K-RAS mutation|k-ras mutation
5499343|NCT01298570|BRAF mutation|braf mutation
5499344|NCT01298570|Regorafenib|regorafenib
5499345|NCT01298570|BAY 73-4506|bay 73-4506
5499346|NCT01298570|FOLFIRI|folfiri
5499347|NCT01298570|Irinotecan|irinotecan
5499348|NCT01298570|5-FU|5-fu
5499349|NCT01298570|Leucovorin|leucovorin
5499350|NCT01298570|Placebo|placebo
5499351|NCT01298570|Phase II|phase ii
5499352|NCT01298570|Multi-Center|multi-center
5499353|NCT01298570|Randomized|randomized
5499354|NCT01298570|Lineberger|lineberger
5499355|NCT01298570|North Carolina Cancer Hospital|north carolina cancer hospital
5499356|NCT01298570|UNC|unc
5499357|NCT01298557|Traumatic brain injury|traumatic brain injury
5499358|NCT01298557|Post-concussive symptoms|post-concussive symptoms
5499359|NCT01298557|Brain imaging|brain imaging
5499360|NCT01298557|Neurocognitive testing|neurocognitive testing
5499361|NCT01298544|Vaccine|vaccine
5499362|NCT01298544|Prevenar|prevenar
5499363|NCT01298544|Pneumococcal disease|pneumococcal disease
5499364|NCT01298531|Etanercept|etanercept
5499365|NCT01298531|Axial Spondyloarthritis|axial spondyloarthritis
5499366|NCT01298531|NSAIDs sparing effect|nsaids sparing effect
5499367|NCT01298518|multiple dose study in type 2 diabetes patients|multiple dose study in type 2 diabetes patients
5499368|NCT01298505|Phase 1 multiple dose safety toleration fexofenadine|phase 1 multiple dose safety toleration fexofenadine
5499369|NCT01298492|Active Crohn's disease|active crohn's disease
5499370|NCT01298492|Anti-TNF Refractory|anti-tnf refractory
5499371|NCT01298492|Immunosuppressant Refractory|immunosuppressant refractory
5499372|NCT01298479|volume delivery|volume delivery
5499373|NCT01298466|identification|identification
5499375|NCT01298466|neuropathic|neuropathic
5499376|NCT01298466|low back pain|low back pain
5499377|NCT01298466|primary care|primary care
5499378|NCT01298466|pregabalin|pregabalin
5499379|NCT01298414|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5499380|NCT01298401|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5499381|NCT01298401|stage IIB pancreatic cancer|stage iib pancreatic cancer
5499382|NCT01298401|stage III pancreatic cancer|stage iii pancreatic cancer
5499383|NCT01298388|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5499384|NCT01298388|cancer survivor|cancer survivor
5499385|NCT01298388|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5499386|NCT01298388|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5499387|NCT01298388|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5499388|NCT01298388|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
5499389|NCT01298388|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5499390|NCT01298388|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5499391|NCT01298388|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5499392|NCT01298388|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5499393|NCT01298375|Metabolic flexibility|metabolic flexibility
5499394|NCT01298375|Mitochondrial function|mitochondrial function
5499395|NCT01298375|Human primary myoblasts|human primary myoblasts
5499396|NCT01298375|Lipid metabolism|lipid metabolism
5499397|NCT01298336|Mycobacterium Xenopi Pulmonary Infection|mycobacterium xenopi pulmonary infection
5499398|NCT01298336|Clarithromycin|clarithromycin
5499399|NCT01298336|Moxifloxacin|moxifloxacin
5499400|NCT01298323|Medullary Thyroid Cancer|medullary thyroid cancer
5499401|NCT01298323|Locally advanced|locally advanced
5499403|NCT01298323|Vandetanib|vandetanib
5499405|NCT01298310|Morton's neuroma, QST measurements|morton's neuroma, qst measurements
5499406|NCT01298297|Buprenorphine, acute pain, analgesia|buprenorphine, acute pain, analgesia
5499407|NCT01298284|Variceal bleeding|variceal bleeding
5499408|NCT01298284|portal hypertension|portal hypertension
5499409|NCT01298284|hepatocelluar carcinoma|hepatocelluar carcinoma
5499410|NCT01298284|endoscopic variceal ligation|endoscopic variceal ligation
5499411|NCT01298284|non-selective beta-blocker|non-selective beta-blocker
5499412|NCT01298284|rebleeding|rebleeding
5499413|NCT01298271|gastric variceal bleeding|gastric variceal bleeding
5499414|NCT01298271|primaryprevention|primaryprevention
5499415|NCT01298271|cyanoacrylate injection|cyanoacrylate injection
5499416|NCT01298271|non-selective beta-blocker|non-selective beta-blocker
5499417|NCT01298245|diabetes|diabetes
5499714|NCT01297049|obesity|obesity
5499418|NCT01298245|diabetic retinopathy|diabetic retinopathy
5499419|NCT01298245|Chinese|chinese
5499420|NCT01298245|gene|gene
5499421|NCT01298245|associations|associations
5499422|NCT01298206|A/H1N1 Influenza|a/h1n1 influenza
5499423|NCT01298206|swine flu|swine flu
5499424|NCT01298206|virus disease|virus disease
5499425|NCT01298206|Avian flu|avian flu
5499426|NCT01298193|Early-stage breast cancer patients|early-stage breast cancer patients
5499427|NCT01298180|Prader-Willi Syndrome|prader-willi syndrome
5499428|NCT01298180|Growth Hormone Deficiency|growth hormone deficiency
5499429|NCT01298167|Cyanoacrylate|cyanoacrylate
5499430|NCT01298167|Fast Absorbing Gut|fast absorbing gut
5499431|NCT01298167|Mohs Surgery|mohs surgery
5499432|NCT01298167|Epidermal closure method|epidermal closure method
5499433|NCT01298154|Food intake|food intake
5499434|NCT01298154|Blood glucose|blood glucose
5499435|NCT01298154|Pulses|pulses
5499436|NCT01298154|Protein|protein
5499437|NCT01298141|Replagal|replagal
5499438|NCT01298141|Enzyme Replacement Therapy|enzyme replacement therapy
5499439|NCT01298141|agalsidase alfa|agalsidase alfa
5499440|NCT01298115|chronic kidney disease|chronic kidney disease
5499441|NCT01298115|dialysis|dialysis
5499442|NCT01298115|pre dialysis education|pre dialysis education
5499443|NCT01298115|transplantation|transplantation
5499444|NCT01298115|conservative care|conservative care
5499445|NCT01298102|kidney|kidney
5499446|NCT01298102|transplantation|transplantation
5499447|NCT01298102|haemodialysis|haemodialysis
5499448|NCT01298102|vaccination|vaccination
5499449|NCT01298102|influenza H1N1 2009|influenza h1n1 2009
5499450|NCT01298089|Flap|flap
5499451|NCT01298089|LASIK|lasik
5499452|NCT01298089|Corneal|corneal
5499453|NCT01298076|Diabetes|diabetes
5499454|NCT01298076|Retinopathy|retinopathy
5499455|NCT01298076|Macular oedema|macular oedema
5499456|NCT01298076|Laser|laser
5499457|NCT01298076|Photocoagulation|photocoagulation
5499458|NCT01298076|Fovea|fovea
5499459|NCT01298076|Steroid|steroid
5499460|NCT01298076|Bevacizumab|bevacizumab
5499461|NCT01298076|Intravitreal|intravitreal
5499462|NCT01298037|Immunology, Hepatitis B, HBV|immunology, hepatitis b, hbv
5499463|NCT01298024|Achilles tendon rupture|achilles tendon rupture
5499464|NCT01298024|Non-surgical treatment|non-surgical treatment
5499465|NCT01298024|Exercise|exercise
5499466|NCT01298024|Neuromuscular training|neuromuscular training
5499467|NCT01298011|operable|operable
5499468|NCT01298011|pancreas|pancreas
5499469|NCT01298011|Abraxane|abraxane
5499470|NCT01298011|Gemcitabine|gemcitabine
5499471|NCT01298011|Preoperative|preoperative
5499472|NCT01298011|potentially|potentially
5499473|NCT01298011|Pancreatic Cancer|pancreatic cancer
5499474|NCT01297985|Serious mental illness|serious mental illness
5499475|NCT01297985|Psychiatric disability|psychiatric disability
5499476|NCT01297985|Mental health peer-led|mental health peer-led
5499477|NCT01297985|Mental illness education|mental illness education
5499478|NCT01297985|Illness self-management|illness self-management
5499479|NCT01297972|Aplastic Anemia|aplastic anemia
5499480|NCT01297972|Mesenchymal Stem Cells|mesenchymal stem cells
5499481|NCT01297959|Surgical Wound Infection|surgical wound infection
5499482|NCT01297959|Therapeutic Enzyme System|therapeutic enzyme system
5499483|NCT01297959|Singlet Oxygen|singlet oxygen
5499484|NCT01297959|Peroxidase|peroxidase
5499485|NCT01297959|Glucose Oxidase|glucose oxidase
5499486|NCT01297959|Colorectal surgery|colorectal surgery
5499487|NCT01297959|Incisional Surgical Site Infections (SSI)|incisional surgical site infections (ssi)
5499488|NCT01297959|Anti-infective Agents, Local|anti-infective agents, local
5499489|NCT01297959|Clinical Trial, Phase III|clinical trial, phase iii
5499490|NCT01297933|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5499491|NCT01297933|cholestasis|cholestasis
5499492|NCT01297933|short bowel syndrome|short bowel syndrome
5499493|NCT01297933|Omegaven|omegaven
5499494|NCT01297920|Open-Angle Glaucoma|open-angle glaucoma
5499495|NCT01297920|Ocular Hypertension|ocular hypertension
5499496|NCT01297920|Brinzolamide|brinzolamide
5499497|NCT01297920|Brimonidine|brimonidine
5499498|NCT01297920|Intraocular pressure|intraocular pressure
5499499|NCT01297907|Crohn's Disease|crohn's disease
5502401|NCT01286259|Cure|cure
5499500|NCT01297907|Bronchial hyper reactivity|bronchial hyper reactivity
5499501|NCT01297907|Fractional exhaled NO|fractional exhaled no
5499502|NCT01297907|Methacholine Challenge Test|methacholine challenge test
5499503|NCT01297907|Pediatric Crohn's Disease Activity Index|pediatric crohn's disease activity index
5499504|NCT01297907|To determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for Crohn disease|to determine the frequency of bronchial hyperreactivity in pediatric patients followed and treated for crohn disease
5499505|NCT01297894|A. baumannii|a. baumannii
5499506|NCT01297894|colistin|colistin
5499507|NCT01297894|fosfomycin|fosfomycin
5499508|NCT01297881|Caucasian outpatients|caucasian outpatients
5499509|NCT01297881|undiagnosed respiratory symptoms|undiagnosed respiratory symptoms
5499510|NCT01297881|dyspnea|dyspnea
5499511|NCT01297881|cough|cough
5499512|NCT01297881|sputum|sputum
5499513|NCT01297829|ibuprofen|ibuprofen
5499514|NCT01297829|postoperative narcotics|postoperative narcotics
5499515|NCT01297829|visual analog pain scale|visual analog pain scale
5499516|NCT01297829|inguinal hernia repair|inguinal hernia repair
5499517|NCT01297829|umbilical hernia repair|umbilical hernia repair
5499518|NCT01297790|Cough|cough
5499519|NCT01297790|Inhalational cough challenges|inhalational cough challenges
5499520|NCT01297790|Cough reflex sensitivity|cough reflex sensitivity
5499521|NCT01297790|Chronic cough.|chronic cough.
5499522|NCT01297777|Mast cell|mast cell
5499523|NCT01297777|Mastocytosis|mastocytosis
5499524|NCT01297777|Mast cell disease|mast cell disease
5499525|NCT01297738|diet manipulation|diet manipulation
5499526|NCT01297738|serotonin|serotonin
5499527|NCT01297738|dopamine|dopamine
5499528|NCT01297738|insulin sensitivity|insulin sensitivity
5499529|NCT01297725|Cesarean section|cesarean section
5499530|NCT01297725|Cesarean section[*methods]|cesarean section[*methods]
5499531|NCT01297725|Fascia [*surgery]|fascia [*surgery]
5499532|NCT01297725|Randomized Controlled Trial|randomized controlled trial
5499533|NCT01297725|Abdominal Wall [*surgery]|abdominal wall [*surgery]
5499534|NCT01297725|Pain, postoperative|pain, postoperative
5499535|NCT01297725|Surgical wound infection|surgical wound infection
5499536|NCT01297712|screening colonoscopy|screening colonoscopy
5499537|NCT01297712|adenoma|adenoma
5499538|NCT01297712|hyperplastic polyp|hyperplastic polyp
5499539|NCT01297712|differential diagnosis|differential diagnosis
5499540|NCT01297699|Graves´ orbitopathy|graves´ orbitopathy
5499541|NCT01297699|Graves´ ophthalmopathy|graves´ ophthalmopathy
5499542|NCT01297699|Thyroid eye disease|thyroid eye disease
5499543|NCT01297699|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5499544|NCT01297699|Tocilizumab|tocilizumab
5499545|NCT01297699|EUGOGO|eugogo
5499546|NCT01297699|CAS|cas
5499547|NCT01297686|Chronic plantar fasciitis|chronic plantar fasciitis
5499548|NCT01297686|Workplace injury|workplace injury
5499549|NCT01297686|Foot and Ankle Disability Index|foot and ankle disability index
5499550|NCT01297686|Ultrasound measure of disease severity|ultrasound measure of disease severity
5499551|NCT01297673|vesico-ureteral reflux|vesico-ureteral reflux
5499552|NCT01297673|neurogenic bladder dysfunction|neurogenic bladder dysfunction
5499553|NCT01297673|spinal cord injury|spinal cord injury
5499554|NCT01297660|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5499555|NCT01297660|detrusor sphincter dyssynergia|detrusor sphincter dyssynergia
5499557|NCT01297660|video urodynamic|video urodynamic
5499558|NCT01297660|spinal cord injury|spinal cord injury
5499559|NCT01297647|urinary tract infection|urinary tract infection
5499560|NCT01297647|urodynamics|urodynamics
5499561|NCT01297647|spinal cord injury|spinal cord injury
5499562|NCT01297634|Botulinum toxin type A|botulinum toxin type a
5499563|NCT01297634|Hyperfunctional forehead lines|hyperfunctional forehead lines
5499564|NCT01297634|Randomized controlled trial|randomized controlled trial
5499565|NCT01297634|Double-blinded trial|double-blinded trial
5499566|NCT01297634|Electromyogram (EMG)|electromyogram (emg)
5499567|NCT01297634|Electromyographic activity|electromyographic activity
5499568|NCT01297634|Frontal Area|frontal area
5499569|NCT01297621|breast hypertrophy|breast hypertrophy
5499570|NCT01297621|physical activity|physical activity
5499571|NCT01297621|sexuality|sexuality
5499572|NCT01297621|patient satisfaction|patient satisfaction
5499573|NCT01297595|relative bioavailability|relative bioavailability
5499574|NCT01297595|pharmacokinetics|pharmacokinetics
5499575|NCT01297595|crizotinib|crizotinib
5499576|NCT01297595|oral liquid formulation|oral liquid formulation
5499577|NCT01297595|formulated capsule|formulated capsule
5499578|NCT01297582|ONO-6950|ono-6950
5499579|NCT01297582|Healthy Adult Subjects|healthy adult subjects
5499580|NCT01297569|Diabetic macular edema|diabetic macular edema
5499581|NCT01297569|Macular edema|macular edema
5499583|NCT01297569|Diabetic retinopathy|diabetic retinopathy
5499584|NCT01297569|Diabetic eye disease|diabetic eye disease
5499585|NCT01297569|anti-VEGF|anti-vegf
5499586|NCT01297569|ranibizumab|ranibizumab
5499587|NCT01297569|Lucentis|lucentis
5499588|NCT01297556|Irritable Bowel Syndrome|irritable bowel syndrome
5499589|NCT01297543|Induction chemotherapy|induction chemotherapy
5499590|NCT01297543|Re-induction chemotherapy|re-induction chemotherapy
5499591|NCT01297543|Consolidation chemotherapy|consolidation chemotherapy
5499592|NCT01297543|Leukemia|leukemia
5499593|NCT01297543|Myelodysplasia|myelodysplasia
5499595|NCT01297530|Dose Escalation|dose escalation
5499596|NCT01297530|Hypoxia inducible factor 1 alpha|hypoxia inducible factor 1 alpha
5499597|NCT01297530|Neoplasms|neoplasms
5499598|NCT01297517|AOG|aog
5499599|NCT01297517|OHT|oht
5499600|NCT01297517|Open-Angle Glaucoma|open-angle glaucoma
5499601|NCT01297517|Ocular Hypertension|ocular hypertension
5499602|NCT01297504|palivizumab|palivizumab
5499603|NCT01297504|lower respiratory tract infection|lower respiratory tract infection
5499604|NCT01297504|Respiratory syncytial virus|respiratory syncytial virus
5499605|NCT01297504|usage patterns|usage patterns
5499606|NCT01297491|NSCLC|nsclc
5499607|NCT01297491|PI3K|pi3k
5499608|NCT01297465|Ovulation Induction|ovulation induction
5499609|NCT01297465|Ovarian Stimulation|ovarian stimulation
5499610|NCT01297465|Reproductive Technique, Assisted|reproductive technique, assisted
5499818|NCT01296581|Tumors|tumors
5499611|NCT01297465|Assisted Reproductive Technics|assisted reproductive technics
5499612|NCT01297465|Assisted Reproductive Technique|assisted reproductive technique
5499613|NCT01297465|Reproductive Technology, Assisted|reproductive technology, assisted
5499614|NCT01297452|BKM120|bkm120
5499615|NCT01297452|CARBOPLATIN|carboplatin
5499616|NCT01297452|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5499617|NCT01297452|Chemotherapy|chemotherapy
5499618|NCT01297452|10-192|10-192
5499619|NCT01297439|shoulder dystocia,|shoulder dystocia,
5499620|NCT01297439|Mac Roberts' maneuver,|mac roberts' maneuver,
5499621|NCT01297439|pushing maneuver|pushing maneuver
5499622|NCT01297413|allogeneic|allogeneic
5499623|NCT01297413|adult|adult
5499624|NCT01297413|stem|stem
5499625|NCT01297413|cells|cells
5499626|NCT01297413|stroke|stroke
5499627|NCT01297413|ischemic|ischemic
5499628|NCT01297400|Burns, Partial Thickness Burns|burns, partial thickness burns
5499629|NCT01297387|Diabetic Patients|diabetic patients
5499630|NCT01297387|Critical Limb Ischemia|critical limb ischemia
5499631|NCT01297387|Revascularization|revascularization
5499632|NCT01297374|Obesity|obesity
5499633|NCT01297348|Lybrel|lybrel
5499634|NCT01297348|levonorgestrel|levonorgestrel
5499635|NCT01297348|ethinyl estradiol|ethinyl estradiol
5499636|NCT01297348|venus thromboembolism (VTE)|venus thromboembolism (vte)
5499637|NCT01297348|oral contraceptives (OC)|oral contraceptives (oc)
5499638|NCT01297348|safety|safety
5499639|NCT01297348|database study|database study
5499640|NCT01297348|case-control study|case-control study
5499641|NCT01297335|intrathecal|intrathecal
5499642|NCT01297335|clonidine|clonidine
5499643|NCT01297335|poorly|poorly
5499646|NCT01297322|vascular closure system|vascular closure system
5499647|NCT01297322|manual compression|manual compression
5499648|NCT01297322|femoral arteriotomy|femoral arteriotomy
5499649|NCT01297322|percutaneous endovascular procedures|percutaneous endovascular procedures
5499650|NCT01297309|PTH 1-84|pth 1-84
5499651|NCT01297309|Hypoparathyroidism|hypoparathyroidism
5499652|NCT01297309|Parathyroid Hormone 1-84|parathyroid hormone 1-84
5499653|NCT01297309|NPSP558|npsp558
5499654|NCT01297296|heart failure|heart failure
5499655|NCT01297296|percutaneous|percutaneous
5499656|NCT01297296|interventional cardiology|interventional cardiology
5499657|NCT01297296|apical remodeling|apical remodeling
5499658|NCT01297296|LV dilatation|lv dilatation
5499659|NCT01297296|akinesis|akinesis
5499660|NCT01297296|dyskinesis|dyskinesis
5499661|NCT01297296|myocardial infarction|myocardial infarction
5499662|NCT01297283|Heart failure|heart failure
5499663|NCT01297283|Cardiac resynchronization|cardiac resynchronization
5499664|NCT01297283|Leadless ECG|leadless ecg
5499665|NCT01297283|Follow-up|follow-up
5499666|NCT01297244|AV-951|av-951
5499667|NCT01297244|Tivozanib|tivozanib
5499668|NCT01297244|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5499669|NCT01297244|RCC|rcc
5499670|NCT01297244|Biomarkers|biomarkers
5499671|NCT01297231|fibroglandular tissue|fibroglandular tissue
5499672|NCT01297231|tamoxifen|tamoxifen
5499673|NCT01297231|MRI|mri
5499674|NCT01297231|Background Parenchymal Enhancement|background parenchymal enhancement
5499675|NCT01297231|10-217|10-217
5499676|NCT01297218|Alzheimer, Mesenchymal Stem Cells, Umbilical Cord Blood|alzheimer, mesenchymal stem cells, umbilical cord blood
5499677|NCT01297205|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
5499678|NCT01297205|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5499679|NCT01297205|Premature infants|premature infants
5499680|NCT01297192|YM178|ym178
5499681|NCT01297192|Mirabegron|mirabegron
5499682|NCT01297192|DDI|ddi
5499683|NCT01297192|Phase I|phase i
5499684|NCT01297192|Solifenacin|solifenacin
5499685|NCT01297192|Pharmacokinetics|pharmacokinetics
5499686|NCT01297192|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
5499687|NCT01297179|Pharmacokinetics|pharmacokinetics
5499688|NCT01297179|Oral contraceptives|oral contraceptives
5499689|NCT01297179|Drug interactions|drug interactions
5499690|NCT01297179|Pharmacokinetics of mirabegron|pharmacokinetics of mirabegron
5499691|NCT01297153|Congenital Cataract|congenital cataract
5846754|NCT00043537|Phobic Disorders|phobic disorders
5499692|NCT01297153|Children younger than 2 years|children younger than 2 years
5499693|NCT01297153|Aphakia|aphakia
5499694|NCT01297153|Primary IOL Implantation|primary iol implantation
5499695|NCT01297140|Psychiatry|psychiatry
5499696|NCT01297140|Behaviour|behaviour
5499697|NCT01297140|Alzheimer's|alzheimer's
5499698|NCT01297140|Personality|personality
5499699|NCT01297088|Proof of Mechanism|proof of mechanism
5499700|NCT01297088|Phase I|phase i
5499701|NCT01297088|Neoplasm|neoplasm
5499702|NCT01297088|Inflammation|inflammation
5499703|NCT01297075|Health Services Research|health services research
5499704|NCT01297075|Chronic Care|chronic care
5499705|NCT01297075|Outreach Visits|outreach visits
5499706|NCT01297075|Primary care|primary care
5499707|NCT01297075|chronic disease management|chronic disease management
5499708|NCT01297062|Diabetes|diabetes
5499709|NCT01297062|exenatide|exenatide
5499710|NCT01297062|Amylin|amylin
5499711|NCT01297062|Lilly|lilly
5499712|NCT01297062|QT interval|qt interval
5499715|NCT01297049|behavior therapy|behavior therapy
5499716|NCT01297049|self management|self management
5499717|NCT01297036|Pharmacokinetics|pharmacokinetics
5499718|NCT01297036|Bioequivalence|bioequivalence
5499719|NCT01297036|Donepezil|donepezil
5499720|NCT01297023|calcium phosphate|calcium phosphate
5499721|NCT01297023|vitamin d3|vitamin d3
5499722|NCT01297023|bone metabolism|bone metabolism
5499723|NCT01297023|human study|human study
5499724|NCT01297010|Nausea and Vomiting|nausea and vomiting
5499725|NCT01297010|Vomiting|vomiting
5499726|NCT01297010|Postoperative|postoperative
5499727|NCT01297010|Anesthesia|anesthesia
5499728|NCT01296997|calcium phosphate|calcium phosphate
5499729|NCT01296997|incretins|incretins
5499730|NCT01296997|human study|human study
5499731|NCT01296984|Rectal cancer|rectal cancer
5499732|NCT01296984|APR|apr
5499733|NCT01296958|Taenia solium|taenia solium
5499734|NCT01296958|cysticercosis|cysticercosis
5499735|NCT01296958|neurocysticercosis|neurocysticercosis
5499736|NCT01296919|Chronic rhinosinusitis|chronic rhinosinusitis
5499737|NCT01296919|Histopathology|histopathology
5499738|NCT01296919|Infundibulum|infundibulum
5499739|NCT01296919|Lamina propria|lamina propria
5499740|NCT01296919|Uncinate process|uncinate process
5499741|NCT01296906|Reminder/recall messages|reminder/recall messages
5499742|NCT01296906|reminders|reminders
5499743|NCT01296906|recall|recall
5499744|NCT01296906|immunizations|immunizations
5499745|NCT01296906|immunization information systems|immunization information systems
5499746|NCT01296906|effectiveness of reminder/recall|effectiveness of reminder/recall
5499747|NCT01296906|population-based reminder/recall|population-based reminder/recall
5499748|NCT01296867|Laser ablation algorithms|laser ablation algorithms
5499749|NCT01296867|Excimer laser|excimer laser
5499750|NCT01296867|Refractive correction|refractive correction
5499751|NCT01296867|Corneal Asphericity Adjustment|corneal asphericity adjustment
5499753|NCT01296841|telemedicine|telemedicine
5499754|NCT01296841|remote consultation|remote consultation
5499755|NCT01296841|telehealth|telehealth
5499756|NCT01296841|ehealth|ehealth
5499757|NCT01296841|image archiving|image archiving
5499758|NCT01296841|inflammatory bowel disease|inflammatory bowel disease
5499759|NCT01296815|Kaposi sarcoma|kaposi sarcoma
5499760|NCT01296815|HIV|hiv
5499761|NCT01296815|Bevacizumab|bevacizumab
5499762|NCT01296802|Ecstasy|ecstasy
5499763|NCT01296802|MDMA|mdma
5499764|NCT01296802|Serotonin|serotonin
5499765|NCT01296802|Neurotoxicity|neurotoxicity
5499766|NCT01296802|dexfenfluramine|dexfenfluramine
5499767|NCT01296802|Positron emission tomography|positron emission tomography
5499768|NCT01296802|altanserin|altanserin
5499769|NCT01296802|5-HT2A receptor|5-ht2a receptor
5499770|NCT01296776|exercise|exercise
5499771|NCT01296776|whole-body electromyostimulation|whole-body electromyostimulation
5499772|NCT01296776|bone mineral density|bone mineral density
5499773|NCT01296776|falls|falls
5499774|NCT01296776|physical fitness|physical fitness
5499775|NCT01296776|pain|pain
5499777|NCT01296763|Cisplatin|cisplatin
5499778|NCT01296763|Carboplatin|carboplatin
5499779|NCT01296763|Mitomycin-C|mitomycin-c
5499780|NCT01296763|Olaparib|olaparib
5499781|NCT01296763|AZD2281|azd2281
5499782|NCT01296711|Rheumatoid arthritis|rheumatoid arthritis
5499783|NCT01296711|CDP6038|cdp6038
5499784|NCT01296711|Interleukin-6|interleukin-6
5499785|NCT01296698|Smoking Cessation|smoking cessation
5499786|NCT01296698|Tobacco Use Disorder|tobacco use disorder
5499787|NCT01296685|cardiovascular surgical procedure|cardiovascular surgical procedure
5499788|NCT01296672|Finasteride|finasteride
5499789|NCT01296672|Placebo|placebo
5499790|NCT01296672|Prostate cancer|prostate cancer
5499791|NCT01296672|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5499792|NCT01296672|Men at intermediate risk of prostate cancer|men at intermediate risk of prostate cancer
5499793|NCT01296672|Men scheduled for prostate biopsy|men scheduled for prostate biopsy
5499794|NCT01296659|sarcoma|sarcoma
5499795|NCT01296659|Ridaforolimus|ridaforolimus
5499796|NCT01296659|soft tissue sarcoma|soft tissue sarcoma
5499797|NCT01296659|unresectable sarcoma|unresectable sarcoma
5499800|NCT01296646|Substance Abuse|substance abuse
5499801|NCT01296646|Alcohol Abuse|alcohol abuse
5499802|NCT01296646|Alcohol Addiction|alcohol addiction
5499803|NCT01296633|health literacy|health literacy
5499804|NCT01296633|patient education|patient education
5499805|NCT01296633|medication adherence|medication adherence
5499806|NCT01296633|patient/provider communication|patient/provider communication
5499807|NCT01296633|Diabetes Mellitus|diabetes mellitus
5499808|NCT01296607|Pharmacodynamics|pharmacodynamics
5499809|NCT01296607|Pharmacokinetics|pharmacokinetics
5499810|NCT01296607|Urocortin 2|urocortin 2
5499811|NCT01296607|Urocortin 3|urocortin 3
5499812|NCT01296607|Reproducibility|reproducibility
5499813|NCT01296607|Onset/ Offset|onset/ offset
5499814|NCT01296607|Forearm blood flow|forearm blood flow
5499815|NCT01296607|Plethysmography|plethysmography
5499816|NCT01296607|Heart Failure|heart failure
5499817|NCT01296581|Cancer|cancer
5499819|NCT01296581|VEGFR|vegfr
5499820|NCT01296581|PDGFR|pdgfr
5499821|NCT01296568|metastatic solid tumors|metastatic solid tumors
5499822|NCT01296568|Malignant/M-Neoplasm|malignant/m-neoplasm
5499823|NCT01296568|Pancreas NOS|pancreas nos
5499824|NCT01296568|Absorption|absorption
5499825|NCT01296568|Distribution|distribution
5499826|NCT01296568|Metabolism|metabolism
5499827|NCT01296568|Excretion|excretion
5499828|NCT01296568|Mass balance|mass balance
5499829|NCT01296568|Metabolic profile|metabolic profile
5499830|NCT01296568|Radiolabeled study|radiolabeled study
5499831|NCT01296516|Women|women
5499832|NCT01296516|Postpartum|postpartum
5499833|NCT01296516|GDM|gdm
5499834|NCT01296503|Multiple Myeloma|multiple myeloma
5499835|NCT01296503|Treatment|treatment
5499836|NCT01296503|Maintenance|maintenance
5499837|NCT01296503|Thalidomide|thalidomide
5499838|NCT01296490|oxidative stress, physical exercise, fitness level|oxidative stress, physical exercise, fitness level
5499839|NCT01296477|Asthma|asthma
5499840|NCT01296477|ASTHMA IQ tool|asthma iq tool
5499841|NCT01296477|Asthma Control Test (ACT)|asthma control test (act)
5499842|NCT01296477|EPR-3 Guidelines, Exacerbations|epr-3 guidelines, exacerbations
5499843|NCT01296464|Parkinson's Disease|parkinson's disease
5499844|NCT01296464|Motor response|motor response
5499845|NCT01296464|Wearing-off|wearing-off
5499846|NCT01296451|Hepatitis C|hepatitis c
5499847|NCT01296451|vaccine|vaccine
5499848|NCT01296451|Adenovirus|adenovirus
5499849|NCT01296451|MVA|mva
5499850|NCT01296451|chronic infection|chronic infection
5499851|NCT01296451|interferon|interferon
5499852|NCT01296451|ribavirin|ribavirin
5499853|NCT01296425|Growth disorders|growth disorders
5486180|NCT01352975|AMD|amd
5499855|NCT01296425|Easypod|easypod
5499856|NCT01296425|Growth hormone|growth hormone
5499857|NCT01296425|Pediatric subject|pediatric subject
5499858|NCT01296399|in stent restenosis|in stent restenosis
5499859|NCT01296399|bare metal stent|bare metal stent
5499860|NCT01296399|drug eluting stent|drug eluting stent
5499861|NCT01296399|de novo lesion|de novo lesion
5499862|NCT01296373|HIV-1|hiv-1
5499863|NCT01296373|immune|immune
5499864|NCT01296373|restoration|restoration
5499865|NCT01296373|observational|observational
5499866|NCT01296360|immune response|immune response
5499867|NCT01296360|IC51-325|ic51-325
5499868|NCT01296360|Japanese Encephalitis|japanese encephalitis
5499869|NCT01296360|Intercell AG|intercell ag
5499870|NCT01296347|Ketamine|ketamine
5499871|NCT01296347|Thoracotomy|thoracotomy
5499872|NCT01296347|VATS|vats
5499873|NCT01296347|Pain|pain
5499874|NCT01296334|opioids|opioids
5499875|NCT01296334|analgesia|analgesia
5499876|NCT01296334|secondary hyperalgesia|secondary hyperalgesia
5499877|NCT01296334|quantitative sensory testing|quantitative sensory testing
5499878|NCT01296334|inflammatory injury|inflammatory injury
5499879|NCT01296308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5499880|NCT01296308|Diabetic Neuropathy|diabetic neuropathy
5499881|NCT01296308|Complementary Medicine|complementary medicine
5499882|NCT01296308|Alternative Medicine|alternative medicine
5499883|NCT01296308|Integrative Medicine|integrative medicine
5499884|NCT01296308|Quality of Life|quality of life
5499885|NCT01296308|Quantitative Sensory Testing|quantitative sensory testing
5499886|NCT01296295|smoking cessation advice|smoking cessation advice
5499887|NCT01296295|spirometry|spirometry
5499888|NCT01296295|primary health care|primary health care
5499889|NCT01296269|social cognition|social cognition
5499890|NCT01296269|oxytocin|oxytocin
5499891|NCT01296269|vasopressin|vasopressin
5499892|NCT01296269|decision making|decision making
5499893|NCT01296269|social decision making|social decision making
5499894|NCT01296256|Bendamustine|bendamustine
5499895|NCT01296256|Conditioning Therapy|conditioning therapy
5499896|NCT01296256|Autologous Stem Cell Transplant|autologous stem cell transplant
5499897|NCT01296256|Aggressive Non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
5499898|NCT01296243|Castration-resistant prostate cancer|castration-resistant prostate cancer
5499899|NCT01296243|Tesetaxel|tesetaxel
5499900|NCT01296243|Taxanes|taxanes
5499901|NCT01296243|Chemotherapy-naive|chemotherapy-naive
5499902|NCT01296243|Chemotherapy-exposed|chemotherapy-exposed
5499903|NCT01296243|Progressive, metastatic castration-resistant prostate cancer|progressive, metastatic castration-resistant prostate cancer
5499904|NCT01296217|Patients with infiltrant prostatic carcinoma|patients with infiltrant prostatic carcinoma
5499905|NCT01296165|Travel|travel
5499906|NCT01296165|Spread|spread
5499907|NCT01296165|Antibiotic resistance|antibiotic resistance
5499908|NCT01296139|Non-Cutaneous Malignancy|non-cutaneous malignancy
5499909|NCT01296139|Prostatectomy|prostatectomy
5499910|NCT01296139|Metastatic Prostate Cancer|metastatic prostate cancer
5499911|NCT01296139|Imaging Study|imaging study
5499912|NCT01296139|Magnetic Resonance Imaging|magnetic resonance imaging
5499913|NCT01296139|Prostate Cancer|prostate cancer
5499914|NCT01296126|Post Traumatic Stress Disorder (PTSD)|post traumatic stress disorder (ptsd)
5499916|NCT01296126|TBI|tbi
5499917|NCT01296126|Traumatic Brain Injury|traumatic brain injury
5499918|NCT01296126|Post Traumatic Stress Disorder|post traumatic stress disorder
5499919|NCT01296126|PTSD|ptsd
5499920|NCT01296100|impaired glucose tolerance|impaired glucose tolerance
5499921|NCT01296100|nutrition|nutrition
5499922|NCT01296100|physical activity|physical activity
5499923|NCT01296087|Asthma|asthma
5499924|NCT01296087|Mild to Moderate Asthma|mild to moderate asthma
5499925|NCT01296074|monocyte|monocyte
5499926|NCT01296074|cardiopulmonary bypass|cardiopulmonary bypass
5499927|NCT01296074|cardiac surgery|cardiac surgery
5499928|NCT01296061|Dialysis|dialysis
5499929|NCT01296061|Renal Transplantation|renal transplantation
5499930|NCT01296061|Failure of allograft|failure of allograft
5499931|NCT01296048|weight|weight
5499932|NCT01296048|body fat|body fat
5499933|NCT01296048|total body water|total body water
5499934|NCT01296048|bone mass|bone mass
5499935|NCT01296048|muscle mass|muscle mass
5499936|NCT01296035|recurrent ovarian cancer|recurrent ovarian cancer
5499937|NCT01296035|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
5499938|NCT01296022|Heart rhythm disturbances|heart rhythm disturbances
5499939|NCT01296022|Implantable cardiac defibrillator|implantable cardiac defibrillator
5499940|NCT01296009|embryonic implantation|embryonic implantation
5499941|NCT01296009|endometrial receptivity|endometrial receptivity
5499942|NCT01296009|traditional Chinese medicines|traditional chinese medicines
5499943|NCT01296009|in vitro fertilization-embryo transfer|in vitro fertilization-embryo transfer
5499944|NCT01296009|pregnant rate|pregnant rate
5499945|NCT01295970|Surgery of the brain|surgery of the brain
5499947|NCT01295970|Brain Metastasis|brain metastasis
5499948|NCT01295944|Chemotherapy|chemotherapy
5499949|NCT01295944|Brain Tumor|brain tumor
5499950|NCT01295944|Spinal Cord Tumor|spinal cord tumor
5499953|NCT01295931|Near-infrared|near-infrared
5499955|NCT01295931|Indocyanine green|indocyanine green
5499956|NCT01295931|ICG|icg
5499957|NCT01295931|Melanoma|melanoma
5499958|NCT01295931|Fluorescent dyes|fluorescent dyes
5499959|NCT01295931|Lymph nodes|lymph nodes
5499960|NCT01295931|Experimental camera|experimental camera
5499961|NCT01295918|probiotic|probiotic
5499962|NCT01295918|AAD|aad
5499963|NCT01295918|Lactobacillus reuteri|lactobacillus reuteri
5499964|NCT01295918|diarrhea|diarrhea
5499965|NCT01295892|menopause|menopause
5499966|NCT01295892|obesity|obesity
5499967|NCT01295892|capillary|capillary
5499968|NCT01295892|microcirculation|microcirculation
5499969|NCT01295892|estrogen|estrogen
5499970|NCT01295892|Microvascular Function|microvascular function
5499971|NCT01295879|Vitamin D insufficiency|vitamin d insufficiency
5499972|NCT01295866|chronic nasal inflammation|chronic nasal inflammation
5499973|NCT01295866|nasal nitric oxide|nasal nitric oxide
5499974|NCT01295866|atopy|atopy
5499975|NCT01295827|Melanoma|melanoma
5499976|NCT01295827|Carcinoma|carcinoma
5499977|NCT01295827|Cancer|cancer
5499978|NCT01295827|Advanced cancer|advanced cancer
5499979|NCT01295827|Metastatic cancer|metastatic cancer
5499980|NCT01295827|Metastatic melanoma|metastatic melanoma
5499981|NCT01295827|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5499982|NCT01295827|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5499983|NCT01295814|Interstitial cystitis|interstitial cystitis
5499984|NCT01295814|Humira|humira
5499985|NCT01295814|Adalimumab|adalimumab
5499986|NCT01295801|Linezolid|linezolid
5499987|NCT01295801|Vitamin B6|vitamin b6
5499988|NCT01295801|Linezolid-associated cytopenias|linezolid-associated cytopenias
5499989|NCT01295775|diabetic retinopathy|diabetic retinopathy
5499990|NCT01295775|sulodexide|sulodexide
5499991|NCT01295775|hard exudates|hard exudates
5499992|NCT01295775|microaneurysms|microaneurysms
5499993|NCT01295775|hemorrhages|hemorrhages
5499994|NCT01295775|intraretinal microvascular abnormalities|intraretinal microvascular abnormalities
5499995|NCT01295762|Children|children
5499996|NCT01295762|Cancer|cancer
5499997|NCT01295762|Immunomonitoring|immunomonitoring
5499998|NCT01295762|Prognostic/Predictive Factors|prognostic/predictive factors
5499999|NCT01295762|Immunotherapy|immunotherapy
5500000|NCT01295749|cardiac arrest|cardiac arrest
5500002|NCT01295749|Emergency|emergency
5500003|NCT01295749|Nurse|nurse
5500004|NCT01295749|laryngeal Tube|laryngeal tube
5500005|NCT01295736|scleroderma|scleroderma
5500006|NCT01295736|digital|digital
5500007|NCT01295736|ulcer|ulcer
5500008|NCT01295723|Breast cancer|breast cancer
5500009|NCT01295723|Radiation therapy|radiation therapy
5500010|NCT01295723|Mobetron|mobetron
5500011|NCT01295723|IOERT|ioert
5500012|NCT01295723|IORT|iort
5500013|NCT01295723|Hypofractionated radiation therapy|hypofractionated radiation therapy
5500014|NCT01295723|Partial breast radiation|partial breast radiation
5500015|NCT01295710|adult acute myeloid leukemia|adult acute myeloid leukemia
5500016|NCT01295710|adult acute lymphoid leukemia|adult acute lymphoid leukemia
5500017|NCT01295710|adult myelodysplastic syndrome|adult myelodysplastic syndrome
5500018|NCT01295710|allogenic stem cell transplantation|allogenic stem cell transplantation
5500019|NCT01295710|unrelated donor|unrelated donor
5500020|NCT01295710|GVHD|gvhd
5500028|NCT01295658|cancer|cancer
5500029|NCT01295658|cancer survivorship|cancer survivorship
5500030|NCT01295658|psychosocial needs|psychosocial needs
5500031|NCT01295658|cancer experience|cancer experience
5500032|NCT01295658|metastatic breast cancer|metastatic breast cancer
5500033|NCT01295658|breast cancer|breast cancer
5500034|NCT01295658|caregiver|caregiver
5500045|NCT01295632|Recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5500046|NCT01295632|Hormone resistant prostate cancer|hormone resistant prostate cancer
5500047|NCT01295632|Relapsed ovarian carcinoma|relapsed ovarian carcinoma
5500048|NCT01295632|Refractory ovarian carcinoma|refractory ovarian carcinoma
5500049|NCT01295632|Refractory breast cancer|refractory breast cancer
5500050|NCT01295632|Relapsed breast cancer|relapsed breast cancer
5500051|NCT01295619|Dura|dura
5500052|NCT01295619|Sealant|sealant
5500053|NCT01295619|Cranial|cranial
5500054|NCT01295619|Craniotomy|craniotomy
5500055|NCT01295619|CSF leakage|csf leakage
5500056|NCT01295619|CSF leakage following cranial surgery|csf leakage following cranial surgery
5500057|NCT01295606|cefazolin|cefazolin
5500058|NCT01295606|prophylaxis|prophylaxis
5500059|NCT01295606|pharmacokinetics|pharmacokinetics
5500060|NCT01295606|newborn|newborn
5500061|NCT01295593|CLL previously treated|cll previously treated
5500062|NCT01295567|ischemia reperfusion injury|ischemia reperfusion injury
5500064|NCT01295567|dipyridamole|dipyridamole
5500065|NCT01295567|HS-troponin-I|hs-troponin-i
5500066|NCT01295554|Peripheral arterial disease, MRA|peripheral arterial disease, mra
5500067|NCT01295541|ICU LOS|icu los
5500068|NCT01295541|Progressive Mobility|progressive mobility
5500070|NCT01295528|blood pressure|blood pressure
5500072|NCT01295515|HIV|hiv
5500073|NCT01295515|Replication|replication
5500074|NCT01295515|Antiretroviral|antiretroviral
5500075|NCT01295515|Interferon|interferon
5500076|NCT01295515|Reservoirs|reservoirs
5500077|NCT01295476|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5500078|NCT01295476|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5500079|NCT01295476|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5500080|NCT01295476|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5500081|NCT01295476|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5500082|NCT01295476|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5500083|NCT01295463|sexual dysfunction|sexual dysfunction
5500084|NCT01295463|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5500085|NCT01295463|infertility|infertility
5500086|NCT01295463|colon cancer|colon cancer
5500087|NCT01295463|male breast cancer|male breast cancer
5500088|NCT01295463|breast cancer|breast cancer
5500089|NCT01295463|germ cell tumor|germ cell tumor
5500090|NCT01295463|ovarian sarcoma|ovarian sarcoma
5500091|NCT01295463|uterine sarcoma|uterine sarcoma
5500092|NCT01295463|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5500093|NCT01295463|osteosarcoma|osteosarcoma
5500094|NCT01295463|chronic myelogenous leukemia|chronic myelogenous leukemia
5500095|NCT01295463|non-Hodgkin lymphoma|non-hodgkin lymphoma
5500096|NCT01295463|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5500097|NCT01295463|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5500098|NCT01295463|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5500099|NCT01295463|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5500100|NCT01295463|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5500101|NCT01295463|mast cell leukemia|mast cell leukemia
5500102|NCT01295463|hairy cell leukemia|hairy cell leukemia
5500103|NCT01295463|prolymphocytic leukemia|prolymphocytic leukemia
5500104|NCT01295463|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5500105|NCT01295463|adult acute myeloid leukemia|adult acute myeloid leukemia
5500106|NCT01295463|adult Hodgkin lymphoma|adult hodgkin lymphoma
5500107|NCT01295463|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5500108|NCT01295463|small intestine lymphoma|small intestine lymphoma
5500109|NCT01295463|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5500110|NCT01295463|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5500111|NCT01295463|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5500112|NCT01295463|intraocular lymphoma|intraocular lymphoma
5500113|NCT01295463|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5500114|NCT01295463|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5500115|NCT01295463|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5500116|NCT01295463|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5500117|NCT01295463|acute undifferentiated leukemia|acute undifferentiated leukemia
5500118|NCT01295463|central nervous system leukemia|central nervous system leukemia
5500119|NCT01295463|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5500120|NCT01295463|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5500121|NCT01295463|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5500123|NCT01295463|adult soft tissue sarcoma|adult soft tissue sarcoma
5500124|NCT01295463|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5500125|NCT01295463|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
5500126|NCT01295463|cutaneous lymphoma|cutaneous lymphoma
5500127|NCT01295463|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5500128|NCT01295450|Phase III|phase iii
5500129|NCT01295450|Apevinat BC|apevinat bc
5500130|NCT01295450|Lack of appetite|lack of appetite
5500131|NCT01295437|inguinal hernia, Lichtenstein hernioplasty, chronic pain|inguinal hernia, lichtenstein hernioplasty, chronic pain
5500132|NCT01295424|Cardiac Arrest|cardiac arrest
5500133|NCT01295424|Intensive Care Unit|intensive care unit
5500134|NCT01295424|Emergency Medical Service|emergency medical service
5500135|NCT01295385|type 2 diabetes|type 2 diabetes
5500136|NCT01295385|Cardiovascular diseases|cardiovascular diseases
5500137|NCT01295385|coronary syndrome have abnormalities of glucidic metabolism|coronary syndrome have abnormalities of glucidic metabolism
5500138|NCT01295372|Schizophrenia|schizophrenia
5500139|NCT01295372|Antipsychotic|antipsychotic
5500140|NCT01295372|Risperidone|risperidone
5500141|NCT01295372|Lu 31-130|lu 31-130
5500142|NCT01295359|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5500144|NCT01295359|Hospital|hospital
5500145|NCT01295359|Exercise Tolerance|exercise tolerance
5500146|NCT01295359|Physical Therapy|physical therapy
5500147|NCT01295320|Herpes Zoster|herpes zoster
5500148|NCT01295320|vaccine|vaccine
5500149|NCT01295320|safety|safety
5500150|NCT01295320|immunogenicity|immunogenicity
5494568|NCT01317836|PET|pet
5500155|NCT01295294|Uterine Hemorrhage|uterine hemorrhage
5500156|NCT01295294|Contraception|contraception
5500157|NCT01295294|Contraceptive Methods|contraceptive methods
5500158|NCT01295294|Intrauterine devices|intrauterine devices
5500159|NCT01295294|Mirena|mirena
5500160|NCT01295268|Vulvar pain|vulvar pain
5500161|NCT01295268|Vulvodynia|vulvodynia
5500162|NCT01295268|Vestibulodynia|vestibulodynia
5500163|NCT01295268|Vulvar vestibulitis|vulvar vestibulitis
5500164|NCT01295255|Allergic rhinitis|allergic rhinitis
5500165|NCT01295255|Psychological status|psychological status
5500166|NCT01295255|Asthma|asthma
5500167|NCT01295255|Aeroallergen|aeroallergen
5500168|NCT01295242|HPV|hpv
5500169|NCT01295242|Cervical Cancer|cervical cancer
5500170|NCT01295216|prehypertension|prehypertension
5500171|NCT01295216|blood pressure|blood pressure
5500172|NCT01295216|mobile technology|mobile technology
5500173|NCT01295216|Latin America|latin america
5500174|NCT01295216|behavioral change|behavioral change
5500175|NCT01295216|healthy lifestyles|healthy lifestyles
5500177|NCT01295177|wound healing|wound healing
5500178|NCT01295177|diabetes mellitus|diabetes mellitus
5500179|NCT01295164|keratoconus, wave-front sensing technology, aberrometer|keratoconus, wave-front sensing technology, aberrometer
5500180|NCT01295138|Constipation|constipation
5500181|NCT01295138|Caesarean section|caesarean section
5500182|NCT01295138|Abdominal Pain|abdominal pain
5500183|NCT01295138|Nausea|nausea
5500184|NCT01295138|Vomiting|vomiting
5500185|NCT01295125|Infected ventral hernia|infected ventral hernia
5500186|NCT01295125|Contaminated incisional hernia|contaminated incisional hernia
5500187|NCT01295099|scar formation|scar formation
5500188|NCT01295099|5-FU|5-fu
5500189|NCT01295099|genetic link|genetic link
5500190|NCT01295099|psychological impact|psychological impact
5500191|NCT01295099|social impact|social impact
5500192|NCT01295086|Adenocarcinoma of the gastro-esophageal|adenocarcinoma of the gastro-esophageal
5500193|NCT01295086|Her2|her2
5500194|NCT01295086|Dose finding|dose finding
5500195|NCT01295086|Taxotere (Docetaxel)|taxotere (docetaxel)
5500196|NCT01295086|Eloxatin (Oxaliplatin)|eloxatin (oxaliplatin)
5503095|NCT01282918|ICD|icd
5500197|NCT01295086|Xeloda (Capecitabine)|xeloda (capecitabine)
5500198|NCT01295086|Herceptin (Trastuzumab)|herceptin (trastuzumab)
5500199|NCT01295073|Trientine|trientine
5500200|NCT01295073|Cataract surgery|cataract surgery
5500201|NCT01295073|Macular Edema|macular edema
5500202|NCT01295060|Acromegaly|acromegaly
5500203|NCT01295060|Octreotide|octreotide
5500204|NCT01295060|IGF-1|igf-1
5500205|NCT01295060|Growth Hormone|growth hormone
5500206|NCT01295060|Implant|implant
5500207|NCT01295060|Hydrogel|hydrogel
5500208|NCT01295047|Marfan Syndrome|marfan syndrome
5500209|NCT01295047|Large arterial function|large arterial function
5500210|NCT01295047|LV function|lv function
5500211|NCT01295047|atenolol|atenolol
5500212|NCT01295047|perindopril|perindopril
5500213|NCT01295047|verapamil|verapamil
5500214|NCT01295047|central arterial pressure|central arterial pressure
5500215|NCT01295034|HIV|hiv
5500216|NCT01295034|combination antiretroviral therapy|combination antiretroviral therapy
5500217|NCT01295034|vitamin D|vitamin d
5500218|NCT01295034|low bone density|low bone density
5500219|NCT01295021|The prevalence of sympathetic overactivity in hypertensive patients.|the prevalence of sympathetic overactivity in hypertensive patients.
5500220|NCT01295008|Fabry disease|fabry disease
5500221|NCT01295008|Male pattern baldness|male pattern baldness
5500222|NCT01295008|Alopecia|alopecia
5500223|NCT01295008|GLA gene mutation|gla gene mutation
5500224|NCT01295008|Alpha-galactosidase A|alpha-galactosidase a
5500225|NCT01294995|short term consumption|short term consumption
5500226|NCT01294995|Chinese liquor|chinese liquor
5500227|NCT01294995|serum lipids|serum lipids
5500228|NCT01294995|uric acid|uric acid
5500229|NCT01294995|inflammation biomarkers|inflammation biomarkers
5500230|NCT01294982|OAB|oab
5500231|NCT01294982|Over Active Bladder|over active bladder
5500232|NCT01294982|overactive bladder|overactive bladder
5500233|NCT01294982|Urinary Urge Incontinence|urinary urge incontinence
5500234|NCT01294982|Urinary Incontinence|urinary incontinence
5500235|NCT01294969|Allergic conjunctivitis|allergic conjunctivitis
5500236|NCT01294956|Dry eye|dry eye
5500237|NCT01294956|artificial tears|artificial tears
5500238|NCT01294956|corneal staining|corneal staining
5500239|NCT01294943|Intensive Care Units|intensive care units
5500240|NCT01294943|Biofilms|biofilms
5500241|NCT01294943|Tongue|tongue
5500242|NCT01294943|Infection|infection
5500243|NCT01294943|Pneumonia/Aspiration|pneumonia/aspiration
5500244|NCT01294930|hip fracture|hip fracture
5500245|NCT01294930|mortality|mortality
5500246|NCT01294930|complications|complications
5500247|NCT01294904|Hormone|hormone
5500248|NCT01294904|Sperm|sperm
5500249|NCT01294904|Chronic kidney disease|chronic kidney disease
5500250|NCT01294891|Rheology|rheology
5500251|NCT01294891|Sickle cell|sickle cell
5500252|NCT01294891|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5500253|NCT01294891|contrast ultrasound|contrast ultrasound
5486606|NCT01351116|bronchus|bronchus
5500254|NCT01294878|anti-IgE treatment|anti-ige treatment
5500255|NCT01294878|interstitial cystitis/bladder pain syndrome|interstitial cystitis/bladder pain syndrome
5500256|NCT01294878|omalizumab|omalizumab
5500257|NCT01294865|Sepsis|sepsis
5500258|NCT01294865|late-onset|late-onset
5500259|NCT01294865|suPAR|supar
5500260|NCT01294852|prophylactic|prophylactic
5500261|NCT01294852|surfactant|surfactant
5500262|NCT01294852|premature|premature
5500263|NCT01294852|mechanical ventilation|mechanical ventilation
5500264|NCT01294852|mortality|mortality
5500265|NCT01294852|morbidities|morbidities
5500266|NCT01294839|sinus-node dysfunction|sinus-node dysfunction
5500267|NCT01294839|RVOTs pacing|rvots pacing
5500268|NCT01294839|RVA pacing|rva pacing
5500269|NCT01294826|Colorectal Neoplasms|colorectal neoplasms
5500270|NCT01294826|Intestinal Neoplasms|intestinal neoplasms
5500271|NCT01294826|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5500272|NCT01294826|Digestive System Neoplasms|digestive system neoplasms
5500273|NCT01294826|Neoplasms by Site|neoplasms by site
5500274|NCT01294826|Neoplasms|neoplasms
5500275|NCT01294826|Digestive System Diseases|digestive system diseases
5500276|NCT01294826|Gastrointestinal Diseases|gastrointestinal diseases
5500277|NCT01294826|Colonic Diseases|colonic diseases
5500278|NCT01294826|Intestinal Diseases|intestinal diseases
5500279|NCT01294826|Rectal Diseases|rectal diseases
5500280|NCT01294826|Cetuximab|cetuximab
5500281|NCT01294826|HSP90 Heat-Shock Proteins|hsp90 heat-shock proteins
5500282|NCT01294826|EGFR protein, human|egfr protein, human
5500283|NCT01294813|Electric Impedance Tomography (EIT)|electric impedance tomography (eit)
5500284|NCT01294813|Ventilation|ventilation
5500285|NCT01294813|Bronchoscopy|bronchoscopy
5500286|NCT01294813|Lung Impedance|lung impedance
5500287|NCT01294813|Recruitment|recruitment
5500288|NCT01294800|Parkinson's disease|parkinson's disease
5500289|NCT01294787|COPD|copd
5500290|NCT01294787|QVA149|qva149
5500291|NCT01294787|tiotropium|tiotropium
5500292|NCT01294787|exercise|exercise
5500293|NCT01294787|exercise tolerance|exercise tolerance
5500294|NCT01294787|combination bronchodilator|combination bronchodilator
5500295|NCT01294787|moderate to severe COPD|moderate to severe copd
5500296|NCT01294774|Lupus erythematosus|lupus erythematosus
5500297|NCT01294774|skin lupus|skin lupus
5500298|NCT01294761|HIV-1|hiv-1
5500310|NCT01294709|angina pectoris|angina pectoris
5500311|NCT01294709|coronary artery disease|coronary artery disease
5500312|NCT01294709|calcitonin gene-related peptide|calcitonin gene-related peptide
5500313|NCT01294709|exercise tolerance,|exercise tolerance,
5500314|NCT01294696|Osteoarthritis|osteoarthritis
5500315|NCT01294696|Standard of care|standard of care
5500316|NCT01294683|Low-density lipoprotein|low-density lipoprotein
5500318|NCT01294683|High-density lipoprotein|high-density lipoprotein
5500319|NCT01294683|HDL|hdl
5500320|NCT01294683|Niacin|niacin
5500321|NCT01294683|Lipid modifying therapy|lipid modifying therapy
5500322|NCT01294683|Cholesterol|cholesterol
5500323|NCT01294683|High cholesterol|high cholesterol
5500324|NCT01294683|Triglycerides|triglycerides
5500325|NCT01294683|Mixed Dyslipidemia|mixed dyslipidemia
5500332|NCT01294657|Obesity|obesity
5500333|NCT01294657|Cancer Risk|cancer risk
5500334|NCT01294657|African Americans|african americans
5500335|NCT01294657|Diet|diet
5500336|NCT01294657|Physical Activity|physical activity
5500337|NCT01294631|Canagliflozin|canagliflozin
5500338|NCT01294631|JNJ-28431754|jnj-28431754
5500339|NCT01294631|Hydrochlorothiazide|hydrochlorothiazide
5500340|NCT01294631|Pharmacokinetic|pharmacokinetic
5500341|NCT01294631|Pharmacodynamic|pharmacodynamic
5500342|NCT01294618|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5500343|NCT01294618|nilotinib|nilotinib
5500344|NCT01294618|pegylated interferon|pegylated interferon
5500345|NCT01294618|BCR-ABL Philadelphia chromosome|bcr-abl philadelphia chromosome
5500346|NCT01294618|Hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination|hematologic, cytogenetic and molecular response rates and kinetics will be studied in addition to the safety of the combination
5500347|NCT01294605|DTPa|dtpa
5500348|NCT01294605|Td|td
5500349|NCT01294605|IPV|ipv
5500350|NCT01294579|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5500351|NCT01294579|Ofatumumab|ofatumumab
5500352|NCT01294579|Relapsed|relapsed
5500353|NCT01294579|Rituximab|rituximab
5500354|NCT01294579|Bendamustine|bendamustine
5500355|NCT01294566|safety|safety
5500356|NCT01294566|motilin agonist|motilin agonist
5500357|NCT01294566|single dose|single dose
5500358|NCT01294566|ascending dose|ascending dose
5500359|NCT01294566|GSK1322888|gsk1322888
5500360|NCT01294566|migrating motor complex|migrating motor complex
5500361|NCT01294566|tolerability|tolerability
5500362|NCT01294566|FTIH|ftih
5500363|NCT01294566|gastric emptying|gastric emptying
5500364|NCT01294527|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5500365|NCT01294527|cardiac pacing|cardiac pacing
5500366|NCT01294527|electrical stimulation|electrical stimulation
5500367|NCT01294527|bi-ventricular pacing|bi-ventricular pacing
5486735|NCT01350453|CIT|cit
5500368|NCT01294514|Respiratory Rate|respiratory rate
5500369|NCT01294501|Medication administration|medication administration
5500370|NCT01294501|Medication errors|medication errors
5500372|NCT01294501|Pediatric Emergency Department|pediatric emergency department
5500373|NCT01294501|Web-based education|web-based education
5500374|NCT01294488|PCIT|pcit
5500375|NCT01294488|Child Maltreatment Prevention|child maltreatment prevention
5500376|NCT01294488|Practitioner Fidelity|practitioner fidelity
5500377|NCT01294462|acute coronary syndrome|acute coronary syndrome
5500378|NCT01294462|coronary disease|coronary disease
5500379|NCT01294462|coronary artery disease|coronary artery disease
5500380|NCT01294436|Phase3|phase3
5500381|NCT01294436|Clinical trial|clinical trial
5500382|NCT01294436|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5500383|NCT01294423|Phase3|phase3
5500384|NCT01294423|Clinical trial|clinical trial
5500385|NCT01294423|Type2 Diabetes Mellitus|type2 diabetes mellitus
5500386|NCT01294397|Amgen|amgen
5500387|NCT01294397|Phase 1|phase 1
5500388|NCT01294397|Postmenopausal|postmenopausal
5500389|NCT01294397|Osteopenia|osteopenia
5500390|NCT01294397|Rheumatoid|rheumatoid
5500391|NCT01294397|Bone Mineral Density|bone mineral density
5500392|NCT01294397|Arthritis|arthritis
5500393|NCT01294397|Pharmacokinetics|pharmacokinetics
5500394|NCT01294397|Osteoporosis|osteoporosis
5500395|NCT01294371|Lucrin Depot|lucrin depot
5500396|NCT01294371|genital endometriosis|genital endometriosis
5500397|NCT01294371|6 months therapy|6 months therapy
5500398|NCT01294358|Pancreatic Cancer|pancreatic cancer
5500399|NCT01294358|Regional Therapy|regional therapy
5500408|NCT01294332|Mood|mood
5500409|NCT01294332|Aerobic Exercise Training|aerobic exercise training
5500410|NCT01294332|Cardiorespiratory Fitness|cardiorespiratory fitness
5500411|NCT01294319|Cortical Resistance|cortical resistance
5500412|NCT01294319|ACTH|acth
5500413|NCT01294319|Glucocorticoid|glucocorticoid
5500414|NCT01294319|Mifepristone|mifepristone
5500415|NCT01294319|SPIRONOLACTONE|spironolactone
5500416|NCT01294319|Exercise|exercise
5500417|NCT01294319|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
5500418|NCT01294319|Healthy Volunteer|healthy volunteer
5500419|NCT01294319|HV|hv
5500420|NCT01294280|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
5500421|NCT01294280|Stage II Non-Small Cell Lung Cancer|stage ii non-small cell lung cancer
5500422|NCT01294267|Ventricular Tachycardia|ventricular tachycardia
5500423|NCT01294267|Radio Frequency Ablation|radio frequency ablation
5500424|NCT01294267|Percutaneous Left Ventricular Assist Device|percutaneous left ventricular assist device
5500425|NCT01294267|Hemodynamic Management|hemodynamic management
5500426|NCT01294267|Interventional Cardiac Procedure|interventional cardiac procedure
5500427|NCT01294267|Mechanical Cardiac Assistance|mechanical cardiac assistance
5500428|NCT01294267|Intra-Aortic Balloon Pump|intra-aortic balloon pump
5500429|NCT01294267|Coronary Intervention|coronary intervention
5500430|NCT01294267|Impella 2.5|impella 2.5
5500431|NCT01294267|Circulation Support system|circulation support system
5500432|NCT01294254|wound reepithelialization|wound reepithelialization
5500433|NCT01294241|Epidermolysis bullosa|epidermolysis bullosa
5500434|NCT01294241|Wound healing|wound healing
5500435|NCT01294241|Epithelialization|epithelialization
5500436|NCT01294215|BAYA1040|baya1040
5500437|NCT01294215|Nifedipine|nifedipine
5500438|NCT01294215|Essential hypertension|essential hypertension
5500439|NCT01294215|Japanese Patients|japanese patients
5500440|NCT01294215|Phase III|phase iii
5500441|NCT01294215|combination study|combination study
5500442|NCT01294215|14024|14024
5500443|NCT01294202|GIST|gist
5500444|NCT01294202|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5500445|NCT01294202|unresectable|unresectable
5500446|NCT01294202|metastatic|metastatic
5500447|NCT01294202|AT13387|at13387
5500448|NCT01294202|Astex|astex
5500449|NCT01294202|Gleevec|gleevec
5500450|NCT01294202|Imatinib|imatinib
5500451|NCT01294189|end-of-life decisions, critical care, advance directive|end-of-life decisions, critical care, advance directive
5500452|NCT01294176|Optic Neuritis|optic neuritis
5500453|NCT01294176|Lipoic Acid|lipoic acid
5500454|NCT01294176|Multiple Sclerosis|multiple sclerosis
5500455|NCT01294176|Antioxidant|antioxidant
5500456|NCT01294176|OCT|oct
5500457|NCT01294176|Acute|acute
5500458|NCT01294163|Xenon|xenon
5500459|NCT01294163|Sevoflurane|sevoflurane
5500460|NCT01294163|Propofol|propofol
5500461|NCT01294163|Total intravenous anaesthesia|total intravenous anaesthesia
5500462|NCT01294163|Anaesthesia|anaesthesia
5500463|NCT01294163|Coronary artery disease|coronary artery disease
5500464|NCT01294163|Coronary artery bypass graft|coronary artery bypass graft
5500465|NCT01294137|frail|frail
5500466|NCT01294137|elderly|elderly
5500467|NCT01294137|hospitalized|hospitalized
5500468|NCT01294137|sleep apnea|sleep apnea
5500469|NCT01294137|oximetry|oximetry
5500470|NCT01294111|Fatigue|fatigue
5500471|NCT01294111|Quality of life|quality of life
5500472|NCT01294111|Elderly|elderly
5500473|NCT01294098|Femoral Fractures|femoral fractures
5500474|NCT01294098|Pediatrics|pediatrics
5500475|NCT01294098|Pain, Postoperative|pain, postoperative
5500476|NCT01294072|curcumin|curcumin
5500477|NCT01294072|plant exosomes|plant exosomes
5500478|NCT01294072|malignant colon tissue|malignant colon tissue
5500479|NCT01294059|Fibromyalgia|fibromyalgia
5500480|NCT01294059|Hyperalgesia|hyperalgesia
5500481|NCT01294059|Pain|pain
5500482|NCT01294059|Central Sensitization|central sensitization
5500483|NCT01294046|Episodic migraine headache|episodic migraine headache
5500484|NCT01294020|Transplant|transplant
5500485|NCT01294020|Liver|liver
5500486|NCT01294020|Tacrolimus|tacrolimus
5500487|NCT01294020|Kidney|kidney
5500488|NCT01294020|Heart|heart
5500489|NCT01294020|Lung|lung
5500490|NCT01294020|Immunosuppression|immunosuppression
5500491|NCT01294020|Advagraf|advagraf
5500492|NCT01294020|Pharmacokinetics|pharmacokinetics
5500493|NCT01293994|Chronic Pain, Genetic Variation, Opioid Medications, Pain|chronic pain, genetic variation, opioid medications, pain
5500494|NCT01293968|Aphthous Stomatitis|aphthous stomatitis
5500495|NCT01293968|Ibuprofen|ibuprofen
5500496|NCT01293968|treatment efficacy|treatment efficacy
5500497|NCT01293955|cartilage|cartilage
5500498|NCT01293955|knee osteoarthritis|knee osteoarthritis
5500499|NCT01293955|protective effect|protective effect
5500698|NCT01293084|hypertonic saline|hypertonic saline
5500500|NCT01293942|unresectable liver-only metastases in colorectal cancer|unresectable liver-only metastases in colorectal cancer
5500501|NCT01293916|pediatric|pediatric
5500502|NCT01293916|femur|femur
5500503|NCT01293916|femoral|femoral
5500504|NCT01293916|fracture|fracture
5500505|NCT01293916|spica|spica
5500506|NCT01293916|cast|cast
5500507|NCT01293916|diaphyseal|diaphyseal
5500508|NCT01293916|single|single
5500509|NCT01293916|double|double
5500510|NCT01293916|patient age 2 to 6 years old|patient age 2 to 6 years old
5500511|NCT01293903|Immunomodulation|immunomodulation
5500512|NCT01293890|adherence|adherence
5500513|NCT01293890|medication|medication
5500514|NCT01293890|exacerbations|exacerbations
5500515|NCT01293890|hospital admission|hospital admission
5500516|NCT01293877|Laparoscopy|laparoscopy
5500517|NCT01293877|obesity|obesity
5500518|NCT01293877|gastric|gastric
5500519|NCT01293877|restrictive|restrictive
5500520|NCT01293864|structural analysis, diffusible proteins, glycosaminoglycans|structural analysis, diffusible proteins, glycosaminoglycans
5500521|NCT01293851|Biomarkers|biomarkers
5500522|NCT01293851|Gene Expression|gene expression
5500523|NCT01293851|Neuropathic Pain|neuropathic pain
5500524|NCT01293851|Neurotoxicity|neurotoxicity
5500525|NCT01293851|Chemotherapy|chemotherapy
5500526|NCT01293851|Peripheral Neuropathic Pain|peripheral neuropathic pain
5500527|NCT01293851|Cancer|cancer
5500528|NCT01293838|Adolescents|adolescents
5500529|NCT01293838|Anxiety Disorder|anxiety disorder
5500530|NCT01293838|Cipralex|cipralex
5500531|NCT01293838|Social Phobia|social phobia
5500532|NCT01293838|Separation Anxiety Disorder|separation anxiety disorder
5500533|NCT01293838|Panic Disorder|panic disorder
5500534|NCT01293838|Generalized Anxiety Disorder|generalized anxiety disorder
5500535|NCT01293838|physiological arousal|physiological arousal
5500536|NCT01293838|stress response|stress response
5500537|NCT01293838|salivary cortisol|salivary cortisol
5500538|NCT01293838|salivary alpha-amylase|salivary alpha-amylase
5500539|NCT01293838|heart rate variability|heart rate variability
5500540|NCT01293799|Randomized|randomized
5500541|NCT01293799|Peritoneal dialysis|peritoneal dialysis
5500542|NCT01293799|Peritonitis|peritonitis
5500543|NCT01293799|Primary prevention|primary prevention
5500544|NCT01293799|Quality control|quality control
5500545|NCT01293799|Self care|self care
5500546|NCT01293799|Kidney failure, chronic|kidney failure, chronic
5500547|NCT01293786|magnesium|magnesium
5500548|NCT01293786|kidney transplantation|kidney transplantation
5500549|NCT01293786|hypomagnesemia|hypomagnesemia
5500550|NCT01293773|Randomized controlled trial|randomized controlled trial
5500551|NCT01293773|Drug-eluting Stent|drug-eluting stent
5500552|NCT01293773|Multicenter study|multicenter study
5500553|NCT01293760|intrauterine device|intrauterine device
5500554|NCT01293760|contraception|contraception
5500555|NCT01293747|Estrogen|estrogen
5500556|NCT01293747|Progesterone|progesterone
5500557|NCT01293747|Microspheres|microspheres
5500558|NCT01293747|Menopause|menopause
5500559|NCT01293747|Pharmacokinetics|pharmacokinetics
5500560|NCT01293734|bronchial asthma|bronchial asthma
5500561|NCT01293734|cold type|cold type
5500562|NCT01293734|heat type|heat type
5500563|NCT01293734|Asthenia type|asthenia type
5500564|NCT01293734|TCM syndrome|tcm syndrome
5500565|NCT01293734|symptoms|symptoms
5500566|NCT01293734|physical signs|physical signs
5500567|NCT01293721|Bone Mineral Density|bone mineral density
5500568|NCT01293721|Vibration|vibration
5500569|NCT01293721|Rehabilitation|rehabilitation
5500570|NCT01293721|Fracture healing rate|fracture healing rate
5500571|NCT01293708|Octogenarians|octogenarians
5500572|NCT01293708|HRQOL|hrqol
5500573|NCT01293708|mortality|mortality
5500574|NCT01293708|prospective observational|prospective observational
5500580|NCT01293695|hypnotizability|hypnotizability
5500581|NCT01293669|Type 2 Diabetes|type 2 diabetes
5500582|NCT01293669|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5500583|NCT01293604|Barley|barley
5500584|NCT01293604|Oats|oats
5500585|NCT01293604|Whole grains|whole grains
5500586|NCT01293604|Cardiovascular disease|cardiovascular disease
5500587|NCT01293604|adults not taking lipid-lowering or glucoregulatory medications.|adults not taking lipid-lowering or glucoregulatory medications.
5500588|NCT01293591|Garlic|garlic
5500589|NCT01293591|Cancer biomarkers|cancer biomarkers
5500590|NCT01293591|Gene expression|gene expression
5500591|NCT01293591|Oxidative stress|oxidative stress
5500592|NCT01293591|DNA damage|dna damage
5500593|NCT01293578|Decision Aids|decision aids
5680298|NCT00578344|Severe anemia|severe anemia
5500594|NCT01293578|Shared Medical Decision Making|shared medical decision making
5500595|NCT01293578|Patient Education|patient education
5500596|NCT01293578|Endocrine System Diseases|endocrine system diseases
5500597|NCT01293578|Glucose Metabolism Disorders|glucose metabolism disorders
5500598|NCT01293578|Metabolic Diseases|metabolic diseases
5500599|NCT01293565|X-Linked Hypohidrotic Ectodermal Dysplasia|x-linked hypohidrotic ectodermal dysplasia
5500995|NCT01291914|knee|knee
5500600|NCT01293565|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5500601|NCT01293565|XLHED|xlhed
5500602|NCT01293565|HED|hed
5500603|NCT01293539|Retinoblastoma|retinoblastoma
5500604|NCT01293539|intra-arterial chemotherapy|intra-arterial chemotherapy
5500605|NCT01293539|angiography|angiography
5500606|NCT01293526|Heart failure|heart failure
5500607|NCT01293526|echocardiography|echocardiography
5500608|NCT01293513|Only patients with Acute or Primary HIV infection will be studied|only patients with acute or primary hiv infection will be studied
5500609|NCT01293500|SIRS|sirs
5500610|NCT01293500|shock|shock
5500611|NCT01293500|sepsis|sepsis
5500612|NCT01293500|pediatric|pediatric
5500613|NCT01293500|inter-facility transport|inter-facility transport
5500614|NCT01293500|specialized transport|specialized transport
5500615|NCT01293500|NIRS monitoring|nirs monitoring
5500616|NCT01293487|Phase 1|phase 1
5500617|NCT01293487|Osteopenia|osteopenia
5500618|NCT01293487|RN564|rn564
5500619|NCT01293448|Esophagectomy|esophagectomy
5500620|NCT01293448|Barrett's Esophagus|barrett's esophagus
5500621|NCT01293435|Community Acquired Pneumonia (CAP)|community acquired pneumonia (cap)
5500622|NCT01293435|Complicated Skin and Skin Structures Infections (cSSSI)|complicated skin and skin structures infections (csssi)
5500623|NCT01293435|Complicated Skin and Soft Tissues Infections (cSSTI)|complicated skin and soft tissues infections (cssti)
5500624|NCT01293435|Antibiotics|antibiotics
5500625|NCT01293435|Infection management|infection management
5500626|NCT01293435|Use of Resources|use of resources
5500627|NCT01293435|MRSA|mrsa
5500628|NCT01293435|PRSP|prsp
5500629|NCT01293422|PXR, glucose, cholesterol|pxr, glucose, cholesterol
5500630|NCT01293396|insulin aspart 30|insulin aspart 30
5500631|NCT01293396|insulin aspart 70|insulin aspart 70
5500632|NCT01293396|insulin aspart|insulin aspart
5500633|NCT01293396|postprandial glucose and lipid metabolism|postprandial glucose and lipid metabolism
5500634|NCT01293396|consecutive mixed meals|consecutive mixed meals
5500635|NCT01293344|Cardiovascular diseases|cardiovascular diseases
5500636|NCT01293344|Controlled nutritional intervention|controlled nutritional intervention
5500637|NCT01293344|Sex differences|sex differences
5500638|NCT01293344|Women|women
5500639|NCT01293344|Men|men
5500640|NCT01293344|Cardiovascular risk|cardiovascular risk
5500641|NCT01293344|Lipid profile|lipid profile
5500642|NCT01293344|Blood pressure|blood pressure
5500643|NCT01293344|Insulin sensitivity|insulin sensitivity
5500644|NCT01293344|Inflammatory markers|inflammatory markers
5500645|NCT01293344|Endothelial function|endothelial function
5500646|NCT01293344|Oxidative stress|oxidative stress
5500647|NCT01293331|Dengue Fever Fever Seroprevalence|dengue fever fever seroprevalence
5500648|NCT01293318|Copeptin|copeptin
5500649|NCT01293318|Vasopressin|vasopressin
5500650|NCT01293318|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
5500651|NCT01293305|osteoarthritis|osteoarthritis
5500652|NCT01293292|Osteoporosis|osteoporosis
5500653|NCT01293292|Forsteo|forsteo
5500655|NCT01293279|HCV viral genotypes|hcv viral genotypes
5500656|NCT01293279|host genotypes|host genotypes
5500657|NCT01293279|IL28B|il28b
5500658|NCT01293279|ITPA|itpa
5500659|NCT01293279|RNA|rna
5500660|NCT01293279|China|china
5500661|NCT01293266|Propofol|propofol
5500662|NCT01293266|Metabolic Acidosis|metabolic acidosis
5500663|NCT01293266|Pediatric Cardiology|pediatric cardiology
5500664|NCT01293266|Anesthesia|anesthesia
5500665|NCT01293227|Wrist Fracture|wrist fracture
5495086|NCT01316354|Beta glucan|beta glucan
5500666|NCT01293214|limb transplantation|limb transplantation
5500667|NCT01293214|limb allotransplantation|limb allotransplantation
5500668|NCT01293214|hand transplantation|hand transplantation
5500669|NCT01293214|hand allotransplantation|hand allotransplantation
5500670|NCT01293214|hand amputation|hand amputation
5500671|NCT01293214|leg transplantation|leg transplantation
5500672|NCT01293201|SAR|sar
5500673|NCT01293201|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5500674|NCT01293188|Aortic Valve Replacement|aortic valve replacement
5500675|NCT01293188|Bioprosthetic|bioprosthetic
5500676|NCT01293175|whole grains|whole grains
5500678|NCT01293175|overweight|overweight
5500679|NCT01293175|bioavailability|bioavailability
5500680|NCT01293175|antioxidant status|antioxidant status
5500681|NCT01293175|inflammation|inflammation
5500682|NCT01293162|Metabolic syndrome|metabolic syndrome
5500683|NCT01293162|Cardiovascular risk|cardiovascular risk
5500684|NCT01293149|knee, reconstructive surgery|knee, reconstructive surgery
5500685|NCT01293149|femoral nerve block|femoral nerve block
5500686|NCT01293136|knee|knee
5500687|NCT01293136|reconstructive surgery|reconstructive surgery
5500688|NCT01293136|femoral nerve block|femoral nerve block
5500689|NCT01293123|HIV|hiv
5485257|NCT01356940|Ambulation|ambulation
5500690|NCT01293123|raltegravir|raltegravir
5500691|NCT01293123|cerebrospinal fluid|cerebrospinal fluid
5500692|NCT01293110|urodynamics|urodynamics
5500693|NCT01293110|neurogenic lower urinary tract dysfunction|neurogenic lower urinary tract dysfunction
5500694|NCT01293110|neurological disease/injury|neurological disease/injury
5500695|NCT01293084|mucociliary clearance|mucociliary clearance
5500696|NCT01293084|children|children
5500697|NCT01293084|cystic fibrosis|cystic fibrosis
5500699|NCT01293071|Antibiotic rotation|antibiotic rotation
5500700|NCT01293071|Cycling|cycling
5500701|NCT01293071|Mixing|mixing
5500702|NCT01293071|Gram-negative|gram-negative
5500703|NCT01293071|EU|eu
5500704|NCT01293071|Multi center|multi center
5500705|NCT01293071|Multi Centre|multi centre
5500706|NCT01293071|Cluster randomized trial|cluster randomized trial
5500707|NCT01293071|Cross over|cross over
5500708|NCT01293058|opioid|opioid
5500709|NCT01293058|overdose|overdose
5500710|NCT01293058|naloxone|naloxone
5500711|NCT01293058|intranasal|intranasal
5500712|NCT01293045|Osteoporosis|osteoporosis
5500713|NCT01293045|Postmenopausal women|postmenopausal women
5500714|NCT01293045|Functional food|functional food
5500715|NCT01293045|Hydrolysed collagen|hydrolysed collagen
5500716|NCT01293045|Bone metabolism|bone metabolism
5500717|NCT01293045|Bone marker of resorption|bone marker of resorption
5500718|NCT01293045|Bone marker of formation|bone marker of formation
5500719|NCT01293032|Estrogen Receptor Positive|estrogen receptor positive
5500720|NCT01293032|Progesterone Receptor Positive|progesterone receptor positive
5500721|NCT01293032|HER2/Neu Negative|her2/neu negative
5500722|NCT01293032|Breast Cancer|breast cancer
5500723|NCT01293019|Complementary and alternative medicine|complementary and alternative medicine
5500724|NCT01293019|Osteopathic treatment|osteopathic treatment
5500725|NCT01293006|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5500727|NCT01292980|Pressure ulcers|pressure ulcers
5500728|NCT01292980|Therapy surfaces|therapy surfaces
5500729|NCT01292980|Mattresses|mattresses
5500730|NCT01292980|Deep Tissue Injury|deep tissue injury
5500731|NCT01292980|pressure ulcer treatment|pressure ulcer treatment
5500732|NCT01292967|Flavanol|flavanol
5500733|NCT01292967|cocoa|cocoa
5500734|NCT01292967|maltitol|maltitol
5500735|NCT01292967|absorption|absorption
5500736|NCT01292967|metabolism|metabolism
5500737|NCT01292967|chocolate|chocolate
5500738|NCT01292967|food matrix|food matrix
5500739|NCT01292967|bioavailability|bioavailability
5500740|NCT01292954|blueberries|blueberries
5500741|NCT01292954|vascular function|vascular function
5500742|NCT01292954|FMD|fmd
5500743|NCT01292954|Blood pressure|blood pressure
5500744|NCT01292954|Laser Doppler|laser doppler
5500745|NCT01292954|pharmacokinetics|pharmacokinetics
5500746|NCT01292954|absorption|absorption
5500747|NCT01292954|metabolism|metabolism
5500748|NCT01292954|polyphenols|polyphenols
5500749|NCT01292954|flavonoids|flavonoids
5500750|NCT01292928|Atherosclerosis, Superficial Femoral Artery (SFA), Proximal Popliteal Artery (PPA), lower extremities, Stenting|atherosclerosis, superficial femoral artery (sfa), proximal popliteal artery (ppa), lower extremities, stenting
5500751|NCT01292915|Re-bleeding, NVUGIB|re-bleeding, nvugib
5500752|NCT01292889|Seasonal Affective Disorder|seasonal affective disorder
5500753|NCT01292889|Major Depressive Disorder|major depressive disorder
5500754|NCT01292889|Depression|depression
5500755|NCT01292889|Winter Blues|winter blues
5500756|NCT01292876|MTURR|mturr
5500757|NCT01292876|ECM|ecm
5500758|NCT01292876|Muscle Loss|muscle loss
5500759|NCT01292876|Tendon|tendon
5500760|NCT01292876|Tendon Repair|tendon repair
5500761|NCT01292876|Muscle Repair|muscle repair
5500762|NCT01292876|Soft Tissue Repair|soft tissue repair
5500763|NCT01292876|Scaffold|scaffold
5500764|NCT01292876|Extracellular Matrix|extracellular matrix
5500765|NCT01292863|Peritoneal dialysis|peritoneal dialysis
5500766|NCT01292863|Biocompatible dialysis fluid|biocompatible dialysis fluid
5500768|NCT01292850|Skin|skin
5500769|NCT01292850|sterility|sterility
5500770|NCT01292850|ethylchloride|ethylchloride
5500771|NCT01292850|ethyl|ethyl
5500772|NCT01292850|chloride|chloride
5500773|NCT01292850|spray|spray
5500774|NCT01292837|Levetiracetam|levetiracetam
5500775|NCT01292837|Epilepsy|epilepsy
5500776|NCT01292837|Generalized tonic-clonic seizures|generalized tonic-clonic seizures
5500777|NCT01292824|Hepatitis C virus|hepatitis c virus
5500779|NCT01292824|Scavenger receptor-BI|scavenger receptor-bi
5500780|NCT01292824|High density lipoprotein|high density lipoprotein
5500781|NCT01292824|Liver transplantation|liver transplantation
5500782|NCT01292811|Spinal Cord Injury|spinal cord injury
5500783|NCT01292811|Functional Electrical Stimulation|functional electrical stimulation
5500784|NCT01292811|Hand function|hand function
5500785|NCT01292811|Tetraplegia|tetraplegia
5500786|NCT01292798|Diabetes|diabetes
5500787|NCT01292798|Macula|macula
5500788|NCT01292798|Edema|edema
5500789|NCT01292798|Retina|retina
5500790|NCT01292772|breast cancer|breast cancer
5500791|NCT01292772|bilateral mastectomy|bilateral mastectomy
5500792|NCT01292772|immediate breast reconstruction|immediate breast reconstruction
5500793|NCT01292772|locally advanced unilateral breast cancer|locally advanced unilateral breast cancer
5500794|NCT01292772|bilateral mastectomy for prophylaxis|bilateral mastectomy for prophylaxis
5500795|NCT01292759|stroke volume|stroke volume
5500796|NCT01292759|cardiac output|cardiac output
5500797|NCT01292759|validation|validation
5500798|NCT01292733|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
5500799|NCT01292733|Women diagnosed with reproductive cancer|women diagnosed with reproductive cancer
5500800|NCT01292733|Women with relatives who have had ovarian or breast cancer|women with relatives who have had ovarian or breast cancer
5500801|NCT01292720|vitamin D deficiency, vitamin D insufficiency, heart failure|vitamin d deficiency, vitamin d insufficiency, heart failure
5500802|NCT01292707|malaria|malaria
5500803|NCT01292707|rdt|rdt
5500804|NCT01292707|fever|fever
5500805|NCT01292707|treatment|treatment
5500806|NCT01292694|supine hypertension|supine hypertension
5500807|NCT01292694|autonomic failure|autonomic failure
5500808|NCT01292694|angiotensin|angiotensin
5500809|NCT01292694|losartan|losartan
5500810|NCT01292694|captopril|captopril
5500811|NCT01292681|colorectal cancer|colorectal cancer
5500812|NCT01292681|FDG-PET-CT|fdg-pet-ct
5500813|NCT01292681|MRS,|mrs,
5500814|NCT01292681|DCE-MRI|dce-mri
5500815|NCT01292681|DWI|dwi
5500816|NCT01292681|colorectal cancer with histologically proven distant metastases|colorectal cancer with histologically proven distant metastases
5500817|NCT01292642|cognitive behavioral therapy|cognitive behavioral therapy
5500818|NCT01292642|nicotine dependence|nicotine dependence
5500819|NCT01292642|cannabis dependence|cannabis dependence
5500820|NCT01292642|smoking cessation|smoking cessation
5500821|NCT01292642|nicotine replacement therapy|nicotine replacement therapy
5500822|NCT01292629|intraocular lens|intraocular lens
5500823|NCT01292629|IOL|iol
5500824|NCT01292629|cataract|cataract
5500825|NCT01292629|Hoya|hoya
5500826|NCT01292629|surgical|surgical
5500827|NCT01292629|optics|optics
5500828|NCT01292629|ocular|ocular
5500829|NCT01292629|visual acuity|visual acuity
5500830|NCT01292577|Schizophrenia|schizophrenia
5500831|NCT01292577|Schizoaffective Disorder|schizoaffective disorder
5500832|NCT01292577|Cannabis|cannabis
5500833|NCT01292577|Alcohol|alcohol
5500834|NCT01292577|Substance Misuse|substance misuse
5500835|NCT01292577|Cognition|cognition
5500836|NCT01292577|Psychosocial Treatment|psychosocial treatment
5500837|NCT01292577|Cognitive Enhancement Therapy|cognitive enhancement therapy
5500838|NCT01292577|Personal Therapy|personal therapy
5500839|NCT01292577|Treatment as Usual|treatment as usual
5500840|NCT01292551|single ventricle physiology|single ventricle physiology
5500841|NCT01292551|Fontan procedure|fontan procedure
5500842|NCT01292525|Withdrawal of Tacrolimus and renal graft|withdrawal of tacrolimus and renal graft
5500843|NCT01292525|renal allograft|renal allograft
5500844|NCT01292525|stable renal function|stable renal function
5500845|NCT01292512|Bereavement management|bereavement management
5500846|NCT01292512|Complicated grief|complicated grief
5500847|NCT01292499|psychotherapy|psychotherapy
5500848|NCT01292499|psychoeducation|psychoeducation
5500849|NCT01292499|depression|depression
5500850|NCT01292447|Pain measurement|pain measurement
5500851|NCT01292447|Intrauterine devices|intrauterine devices
5500852|NCT01292447|Lidocaine|lidocaine
5500853|NCT01292434|Diet|diet
5500854|NCT01292434|Obesity|obesity
5500855|NCT01292434|Child Preschool|child preschool
5500856|NCT01292434|Treatment Outcome|treatment outcome
5500857|NCT01292434|Body Mass Index|body mass index
5500858|NCT01292434|Intervention Studies|intervention studies
5500859|NCT01292434|Randomized Controlled Trial|randomized controlled trial
5500860|NCT01292434|Child Day Care Centers|child day care centers
5500861|NCT01292434|Schools Nursery|schools nursery
5500862|NCT01292434|Child Care|child care
5500863|NCT01292408|autophagy|autophagy
5500864|NCT01292408|hydroxychloroquine|hydroxychloroquine
5500865|NCT01292408|hypoxia|hypoxia
5500866|NCT01292408|proven invasive adenocarcinoma of the breast: tumors are found to be ER negative (<10% ER pos cells)|proven invasive adenocarcinoma of the breast: tumors are found to be er negative (<10% er pos cells)
5500867|NCT01292395|dietary supplement|dietary supplement
5500868|NCT01292395|protein metabolism|protein metabolism
5500869|NCT01292395|bone turnover|bone turnover
5500870|NCT01292382|Elderly|elderly
5500871|NCT01292382|Memory|memory
5500872|NCT01292382|Cognition|cognition
5500873|NCT01292382|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5500874|NCT01292369|breath test|breath test
5500875|NCT01292369|colon cancer|colon cancer
5500876|NCT01292369|breast cancer|breast cancer
5500877|NCT01292343|third molars|third molars
5500878|NCT01292343|triclosan|triclosan
5500879|NCT01292343|toothpaste|toothpaste
5500880|NCT01292343|dry socket|dry socket
5500881|NCT01292343|wound infection|wound infection
5500882|NCT01292330|liver Tumor|liver tumor
5500883|NCT01292317|NGAL|ngal
5500884|NCT01292317|neutrophil gelatinase-associated Lipocalin|neutrophil gelatinase-associated lipocalin
5500885|NCT01292317|contrast media nephropathy|contrast media nephropathy
5485471|NCT01355939|Hernia|hernia
5500887|NCT01292317|volume expansion|volume expansion
5500888|NCT01292317|acute kidney injury|acute kidney injury
5500889|NCT01292317|contrast media|contrast media
5500890|NCT01292304|Cirrhotic|cirrhotic
5500891|NCT01292304|Tolvaptan|tolvaptan
5500892|NCT01292304|v2 receptor antagonist|v2 receptor antagonist
5500893|NCT01292291|stage I prostate cancer|stage i prostate cancer
5500894|NCT01292291|stage IIA prostate cancer|stage iia prostate cancer
5500895|NCT01292291|stage IIB prostate cancer|stage iib prostate cancer
5501197|NCT01291225|rural|rural
5500896|NCT01292278|subarachnoid hemorrhage|subarachnoid hemorrhage
5500897|NCT01292278|cerebral vasospasm|cerebral vasospasm
5500898|NCT01292278|neuropeptide Y|neuropeptide y
5500899|NCT01292278|spontaneous|spontaneous
5500900|NCT01292278|aneurysmal|aneurysmal
5500901|NCT01292265|Arthritis|arthritis
5500902|NCT01292265|Joint pain|joint pain
5500903|NCT01292265|Inflammation|inflammation
5500904|NCT01292265|Rheumatoid Arthritis|rheumatoid arthritis
5500905|NCT01292239|Hepatitis C, Chronic|hepatitis c, chronic
5500906|NCT01292239|Hepatitis C|hepatitis c
5500907|NCT01292239|Hepatitis C virus|hepatitis c virus
5500908|NCT01292239|Interferon Alfa-2a|interferon alfa-2a
5500909|NCT01292239|Ribavirin|ribavirin
5500910|NCT01292239|Viral RNA|viral rna
5500911|NCT01292213|Chronic cough|chronic cough
5500912|NCT01292213|Haemophilus influenzae|haemophilus influenzae
5500913|NCT01292200|Chinese women|chinese women
5500914|NCT01292200|Mammography|mammography
5500915|NCT01292200|Breast Cancer|breast cancer
5500916|NCT01292187|Osteoporosis|osteoporosis
5500917|NCT01292187|Osteopenia|osteopenia
5500918|NCT01292187|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5500919|NCT01292187|Bone Diseases, Metabolic|bone diseases, metabolic
5500920|NCT01292187|Bone Diseases|bone diseases
5500921|NCT01292187|Musculoskeletal Diseases|musculoskeletal diseases
5500922|NCT01292187|Salmon calcitonin|salmon calcitonin
5500923|NCT01292187|Calcitonin|calcitonin
5500924|NCT01292174|HIV prevention|hiv prevention
5500925|NCT01292161|Hepatitis C|hepatitis c
5500926|NCT01292161|Silymarin|silymarin
5500927|NCT01292161|Quality of life|quality of life
5500928|NCT01292148|resuscitation, hypothermia|resuscitation, hypothermia
5500929|NCT01292135|Lymphoma, B-Cell|lymphoma, b-cell
5500930|NCT01292135|Leukemia, Lymphoid|leukemia, lymphoid
5500931|NCT01292135|Leukemia, B-Cell|leukemia, b-cell
5500932|NCT01292135|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5500933|NCT01292122|Wounds|wounds
5500934|NCT01292122|Grafts|grafts
5500935|NCT01292122|Wound Healing|wound healing
5500936|NCT01292122|Cell Therapy|cell therapy
5500937|NCT01292122|Split-thickness skin graft donor site wound|split-thickness skin graft donor site wound
5500938|NCT01292109|endoscopy|endoscopy
5500939|NCT01292109|colonoscopy|colonoscopy
5500940|NCT01292109|preparation for surgery|preparation for surgery
5500941|NCT01292096|homelessness|homelessness
5500942|NCT01292096|substance use|substance use
5500943|NCT01292096|frequent hospitalization|frequent hospitalization
5500944|NCT01292096|frequent users of health services|frequent users of health services
5500945|NCT01292096|enhanced care management|enhanced care management
5656449|NCT00676624|severe|severe
5500946|NCT01292096|coordination services p|coordination services p
5500947|NCT01292096|high risk for frequent hospitalization|high risk for frequent hospitalization
5500948|NCT01292070|Fel d 1 protein, Felis domesticus|fel d 1 protein, felis domesticus
5500949|NCT01292070|Injections, Intradermal|injections, intradermal
5500950|NCT01292057|Alcohol|alcohol
5500951|NCT01292057|Aripiprazole|aripiprazole
5500952|NCT01292057|Impulsivity|impulsivity
5500953|NCT01292057|Alcoholism|alcoholism
5500954|NCT01292057|drinking|drinking
5500955|NCT01292057|treatment|treatment
5500956|NCT01292057|craving|craving
5500957|NCT01292057|brain imaging|brain imaging
5500958|NCT01292057|genetics|genetics
5500959|NCT01292044|elastography|elastography
5500960|NCT01292044|cytology|cytology
5500962|NCT01292031|MDR-GNB|mdr-gnb
5500963|NCT01292031|colistin|colistin
5500965|NCT01292018|Management of dyslipidemia in Type 2 Diabetes Mellitus adult patients in India|management of dyslipidemia in type 2 diabetes mellitus adult patients in india
5500966|NCT01292018|Dyslipidemia control rates in Type 2 diabetic Mellitus patients|dyslipidemia control rates in type 2 diabetic mellitus patients
5500967|NCT01292005|pancreatitis|pancreatitis
5500968|NCT01292005|pancreatic necrosis|pancreatic necrosis
5500969|NCT01292005|severe acute pancreatitis (SAP)|severe acute pancreatitis (sap)
5500970|NCT01292005|Alcoholic pancreatitis|alcoholic pancreatitis
5500971|NCT01292005|gallstone pancreatitis|gallstone pancreatitis
5500972|NCT01291992|Non-convulsive seizures|non-convulsive seizures
5500973|NCT01291992|Cardiac Surgery|cardiac surgery
5500975|NCT01291992|24 hour EEG Monitoring|24 hour eeg monitoring
5500976|NCT01291979|Pain|pain
5500977|NCT01291979|Preemptive|preemptive
5500978|NCT01291979|Lidocaine|lidocaine
5500979|NCT01291979|Intravenous|intravenous
5500980|NCT01291979|Tonsillectomy|tonsillectomy
5500981|NCT01291966|medication errors|medication errors
5500982|NCT01291966|Patient Compliance|patient compliance
5500983|NCT01291966|patient safety|patient safety
5500984|NCT01291966|polypharmacy|polypharmacy
5500985|NCT01291953|atrial fibrillation|atrial fibrillation
5500986|NCT01291953|screening|screening
5500987|NCT01291953|prevention|prevention
5500988|NCT01291953|case finding|case finding
5500989|NCT01291953|primary care|primary care
5500990|NCT01291927|Periampullary carcinoma|periampullary carcinoma
5500991|NCT01291927|Pancreas-sparing Duodenectomy|pancreas-sparing duodenectomy
5500992|NCT01291927|pancreaticoduodenectomy|pancreaticoduodenectomy
5500993|NCT01291927|lymphadenectomy|lymphadenectomy
5500994|NCT01291914|Osteoarthritis|osteoarthritis
5500996|NCT01291914|intra-articular|intra-articular
5500997|NCT01291914|safety|safety
5500998|NCT01291914|efficacy|efficacy
5500999|NCT01291914|pharmacokinetics|pharmacokinetics
5501000|NCT01291914|pain|pain
5501001|NCT01291901|pain|pain
5501002|NCT01291901|cancer|cancer
5501003|NCT01291901|malignancy|malignancy
5501004|NCT01291901|intractable|intractable
5501005|NCT01291901|gene therapy|gene therapy
5501006|NCT01291901|enkephalin|enkephalin
5501007|NCT01291901|opioid|opioid
5501008|NCT01291875|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5501009|NCT01291875|Periodontal Disease|periodontal disease
5501010|NCT01291875|metabolic control|metabolic control
5501011|NCT01291875|periodontal treatment|periodontal treatment
5501012|NCT01291875|inflammatory markers|inflammatory markers
5501013|NCT01291849|nasal surgery|nasal surgery
5501014|NCT01291849|endoscopic sinus surgery|endoscopic sinus surgery
5501015|NCT01291849|septoplasty|septoplasty
5501016|NCT01291849|Cough|cough
5501017|NCT01291836|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5501018|NCT01291836|Acute Decompensated Heart Failure (ADHF)|acute decompensated heart failure (adhf)
5501019|NCT01291836|Neutrophil Gelatinase Associated Lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
5501020|NCT01291836|biomarker|biomarker
5501021|NCT01291823|gefitinib|gefitinib
5501022|NCT01291823|radiation|radiation
5501023|NCT01291823|esophageal cancer|esophageal cancer
5501024|NCT01291797|congenital heart disease|congenital heart disease
5501025|NCT01291797|neurodevelopmental outcome|neurodevelopmental outcome
5501026|NCT01291797|AEEG|aeeg
5501027|NCT01291797|sleep wake cycles|sleep wake cycles
5501028|NCT01291784|monoclonal antibody|monoclonal antibody
5501029|NCT01291771|End stage renal disease|end stage renal disease
5501030|NCT01291771|myocardial microvascular disease|myocardial microvascular disease
5501031|NCT01291771|cardiorenal syndrome|cardiorenal syndrome
5501032|NCT01291771|coronary flow reserve|coronary flow reserve
5501033|NCT01291771|index of microvascular resistance|index of microvascular resistance
5501034|NCT01291771|Patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation|patients with end stage renal disease scheduled or not for kidney or kidney + pancreatic transplantation
5501035|NCT01291758|Persian Gulf War|persian gulf war
5501036|NCT01291758|Gulf War Syndrome|gulf war syndrome
5501037|NCT01291758|GWI|gwi
5501038|NCT01291758|Gulf War Illness|gulf war illness
5501039|NCT01291758|Exercise|exercise
5501040|NCT01291758|Chronic Fatigue|chronic fatigue
5501041|NCT01291758|Fibromyalgia|fibromyalgia
5501042|NCT01291758|Veterans|veterans
5501043|NCT01291758|Irritable Bowel Syndrome|irritable bowel syndrome
5501044|NCT01291758|Migraine headaches|migraine headaches
5501045|NCT01291758|Neuropathy|neuropathy
5501046|NCT01291719|closed loop glucose control|closed loop glucose control
5501047|NCT01291719|intensive care glucose control|intensive care glucose control
5501048|NCT01291706|Transcranial Doppler|transcranial doppler
5501049|NCT01291706|Mild and moderate Traumatic Brain Injury|mild and moderate traumatic brain injury
5501050|NCT01291706|Neurological deterioration|neurological deterioration
5501051|NCT01291706|Brain CT scan|brain ct scan
5501052|NCT01291693|Hazardous drinking|hazardous drinking
5501053|NCT01291693|general hospital|general hospital
5501054|NCT01291693|brief intervention|brief intervention
5501055|NCT01291693|Motivational Interviewing|motivational interviewing
5501056|NCT01291693|computer-generated feedback|computer-generated feedback
5501057|NCT01291693|stage-tailored|stage-tailored
5501058|NCT01291693|delivery channel|delivery channel
5501059|NCT01291680|Pregnancy|pregnancy
5501060|NCT01291680|Chronic pain|chronic pain
5501061|NCT01291680|Fibromyalgia|fibromyalgia
5501063|NCT01291654|Paracetamol|paracetamol
5501064|NCT01291654|Indomethacin|indomethacin
5501065|NCT01291654|Ibuprofen|ibuprofen
5501066|NCT01291641|Hyperlipidemias|hyperlipidemias
5501067|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5501068|NCT01291641|Probucol|probucol
5501069|NCT01291641|Cilostazol|cilostazol
5501070|NCT01291628|Capecitabine|capecitabine
5501071|NCT01291628|Hand and foot syndrome|hand and foot syndrome
5501072|NCT01291628|Socks|socks
5501073|NCT01291628|Copper|copper
5501074|NCT01291628|Toxicity|toxicity
5501075|NCT01291602|NXL104|nxl104
5501076|NCT01291602|ceftazidime|ceftazidime
5501077|NCT01291602|CAZ104|caz104
5501078|NCT01291602|Healthy Japanese volunteers|healthy japanese volunteers
5501079|NCT01291602|Phase 1|phase 1
5501080|NCT01291602|Single and Multiple Dose Study|single and multiple dose study
5501081|NCT01291589|HIV-infected|hiv-infected
5501083|NCT01291589|HIV prevention|hiv prevention
5501084|NCT01291576|Deep infiltrating endometriosis|deep infiltrating endometriosis
5501085|NCT01291576|Rectal endometriosis|rectal endometriosis
5501086|NCT01291576|Colorectal resection|colorectal resection
5501087|NCT01291576|Nodule excision|nodule excision
5501088|NCT01291576|Rectal shaving|rectal shaving
5501089|NCT01291576|Functional outcomes|functional outcomes
5501090|NCT01291576|Constipation|constipation
5501091|NCT01291563|TMC207TBC1003|tmc207tbc1003
5501092|NCT01291563|TMC207|tmc207
5501093|NCT01291563|M.Tuberculosis|m.tuberculosis
5501095|NCT01291563|Moxifloxacin|moxifloxacin
5501096|NCT01291563|ECG|ecg
5501097|NCT01291563|QT/QTc|qt/qtc
5501098|NCT01291563|Healthy volunteers|healthy volunteers
5501099|NCT01291550|Detecting volatile biomarkers using breath sample|detecting volatile biomarkers using breath sample
5501100|NCT01291537|Advanced|advanced
5501101|NCT01291537|Severe form|severe form
5501102|NCT01291524|pregabalin|pregabalin
5501103|NCT01291524|pharmacokinetics|pharmacokinetics
5501104|NCT01291524|bioavailability|bioavailability
5501105|NCT01291524|bioequivalence|bioequivalence
5501106|NCT01291511|Schizophrenia|schizophrenia
5501107|NCT01291511|Mental Disorders|mental disorders
5501108|NCT01291511|Antipsychotic Agents|antipsychotic agents
5501109|NCT01291511|Iloperdione|iloperdione
5501110|NCT01291511|Relapse Prevention|relapse prevention
5501111|NCT01291498|Primary Parathyroid Adenomas|primary parathyroid adenomas
5501112|NCT01291485|HIV|hiv
5501113|NCT01291485|Medication adherence|medication adherence
5501114|NCT01291485|computer-based intervention|computer-based intervention
5501115|NCT01291472|ketorolac|ketorolac
5501116|NCT01291472|pain|pain
5501117|NCT01291472|pregnancy|pregnancy
5501118|NCT01291472|non-pregnant state|non-pregnant state
5501119|NCT01291459|HIV|hiv
5501120|NCT01291459|naive patients|naive patients
5501121|NCT01291459|maraviroc|maraviroc
5501122|NCT01291459|raltegravir|raltegravir
5501123|NCT01291446|Intestinal gas production|intestinal gas production
5501124|NCT01291446|Intestinal microbiota|intestinal microbiota
5501125|NCT01291407|Combined Modality|combined modality
5501126|NCT01291407|Gastric Cancer|gastric cancer
5501127|NCT01291407|Radiation Therapy|radiation therapy
5501128|NCT01291407|S-1|s-1
5501129|NCT01291394|Growth disorders|growth disorders
5501130|NCT01291394|Saizen|saizen
5501131|NCT01291394|Easypod|easypod
5501132|NCT01291394|Growth hormone|growth hormone
5501133|NCT01291394|Pediatric subject|pediatric subject
5501134|NCT01291381|allergic rhinitis|allergic rhinitis
5501135|NCT01291381|peripheral tolerance|peripheral tolerance
5501136|NCT01291381|regulatory T cells|regulatory t cells
5501137|NCT01291381|specific immunotherapy|specific immunotherapy
5501138|NCT01291381|Tr1 cells|tr1 cells
5501139|NCT01291368|Sedation|sedation
5501140|NCT01291368|Delirium|delirium
5501141|NCT01291368|PTSD|ptsd
5501142|NCT01291368|Depression|depression
5501143|NCT01291368|Anxiety|anxiety
5501144|NCT01291368|HRQoL|hrqol
5501145|NCT01291368|CAM-ICU|cam-icu
5501146|NCT01291368|RASS|rass
5501147|NCT01291368|SF-36|sf-36
5501148|NCT01291368|ICU-memory tool|icu-memory tool
5501149|NCT01291368|Antipsychotic Agents|antipsychotic agents
5501150|NCT01291368|Mobilization|mobilization
5501151|NCT01291368|ICU-nursing|icu-nursing
5501152|NCT01291368|ICU|icu
5501153|NCT01291368|intensive care|intensive care
5501154|NCT01291368|critical care|critical care
5501155|NCT01291368|critical care nursing|critical care nursing
5501156|NCT01291355|Maternal position|maternal position
5501157|NCT01291355|Occipitoposterior position|occipitoposterior position
5501158|NCT01291355|Labor|labor
5501159|NCT01291355|Dystocia|dystocia
5501160|NCT01291355|Fetal presentation Abnormalities|fetal presentation abnormalities
5501161|NCT01291342|Pregnancy|pregnancy
5501162|NCT01291342|Preeclampsia|preeclampsia
5501163|NCT01291342|Volatile biomarkers|volatile biomarkers
5501164|NCT01291342|Chemical sensors|chemical sensors
5501166|NCT01291342|Nanosensors|nanosensors
5501167|NCT01291342|NA-NOSE|na-nose
5501169|NCT01291329|acute ST-Elevation Myocardial Infarction|acute st-elevation myocardial infarction
5501170|NCT01291303|Non invasive ventilation|non invasive ventilation
5501171|NCT01291303|acute exacerbation of COPD|acute exacerbation of copd
5501172|NCT01291303|optimized ventilation|optimized ventilation
5501173|NCT01291290|rAAA|raaa
5501174|NCT01291290|Platelets|platelets
5501176|NCT01291290|Massive bleeding|massive bleeding
5501177|NCT01291290|Coagulopathy|coagulopathy
5501178|NCT01291277|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5501179|NCT01291277|esophageal varices|esophageal varices
5501180|NCT01291277|gastrointestinal endoscopy|gastrointestinal endoscopy
5501181|NCT01291277|ligation|ligation
5501182|NCT01291264|Chlamydia trachomatis|chlamydia trachomatis
5501183|NCT01291264|Neisseria gonorrhoeae|neisseria gonorrhoeae
5501184|NCT01291264|Sexually Transmitted Diseases|sexually transmitted diseases
5501185|NCT01291238|learning disability|learning disability
5501186|NCT01291238|blood lipids|blood lipids
5501187|NCT01291238|cardio metabolic risk factors|cardio metabolic risk factors
5501188|NCT01291238|upper secondary school for learning disability students|upper secondary school for learning disability students
5501189|NCT01291238|adolescents|adolescents
5501190|NCT01291238|cardio respiratory fitness|cardio respiratory fitness
5501191|NCT01291238|absorptiometry photos|absorptiometry photos
5501192|NCT01291225|playgrounds|playgrounds
5501193|NCT01291225|farms|farms
5501194|NCT01291225|injury prevention|injury prevention
5501195|NCT01291225|safety knowledge, attitudes and practices|safety knowledge, attitudes and practices
5501196|NCT01291225|safe play|safe play
5501198|NCT01291212|In Vitro Fertilization|in vitro fertilization
5501199|NCT01291212|Testosterone|testosterone
5501200|NCT01291212|Ovarian Stimulation|ovarian stimulation
5501201|NCT01291212|Luteinizing Hormone|luteinizing hormone
5501202|NCT01291199|double-blind placebo controlled cross-over study|double-blind placebo controlled cross-over study
5501203|NCT01291186|spinal anesthesia|spinal anesthesia
5501204|NCT01291186|intrathecal bupivacaine|intrathecal bupivacaine
5501205|NCT01291186|median effective dose|median effective dose
5501206|NCT01291186|height|height
5501207|NCT01291147|pain|pain
5501208|NCT01291147|anaesthetic|anaesthetic
5501209|NCT01291121|Age related macular degeneration|age related macular degeneration
5501210|NCT01291121|Intravitreal ranibizumab|intravitreal ranibizumab
5501211|NCT01291121|Intravitreal expansile gas injection|intravitreal expansile gas injection
5501212|NCT01291082|Breast cancer|breast cancer
5501213|NCT01291082|metastasis|metastasis
5501214|NCT01291082|bone|bone
5501215|NCT01291082|diffusion MRI|diffusion mri
5501216|NCT01291069|Fontan|fontan
5501217|NCT01291069|Tadalafil|tadalafil
5501218|NCT01291069|Exercise performance|exercise performance
5501219|NCT01291056|Clomiphene citrate|clomiphene citrate
5501220|NCT01291056|Mood symptoms|mood symptoms
5501221|NCT01291056|Infertility|infertility
5501222|NCT01291056|Superovulation|superovulation
5501223|NCT01291056|Effects of clomiphene on mood|effects of clomiphene on mood
5501224|NCT01291043|Shiatsu|shiatsu
5501225|NCT01291043|Fibromyalgia|fibromyalgia
5501226|NCT01291043|Pain|pain
5501227|NCT01291043|Quality of sleep|quality of sleep
5501228|NCT01291043|Balance|balance
5501229|NCT01291043|Quality of life|quality of life
5501230|NCT01291017|Advanced stage|advanced stage
5501231|NCT01290952|off-pump|off-pump
5501232|NCT01290952|bypass|bypass
5501233|NCT01290952|coronary artery surgery|coronary artery surgery
5501234|NCT01290939|adult glioblastoma|adult glioblastoma
5501235|NCT01290939|recurrent adult brain tumor|recurrent adult brain tumor
5501236|NCT01290939|Cognition Disorders|cognition disorders
5501237|NCT01290939|functional defects|functional defects
5501238|NCT01290926|advanced chemorefractory colorectal cancer|advanced chemorefractory colorectal cancer
5501239|NCT01290926|sorafenib|sorafenib
5501240|NCT01290926|capecitabine|capecitabine
5501241|NCT01290926|FDG-PET|fdg-pet
5501242|NCT01290926|early metabolic response|early metabolic response
5501243|NCT01290913|peanut allergy|peanut allergy
5501244|NCT01290913|Xolair|xolair
5501245|NCT01290900|NXL104|nxl104
5501246|NCT01290900|CAZ104|caz104
5501247|NCT01290900|Ceftazidime|ceftazidime
5501248|NCT01290900|CXL104|cxl104
5501249|NCT01290900|Ceftaroline|ceftaroline
5501250|NCT01290900|Healthy Male Volunteers|healthy male volunteers
5501251|NCT01290900|Phase 1|phase 1
5501253|NCT01290900|Single Dose Study|single dose study
5501254|NCT01290874|Asthma|asthma
5501255|NCT01290874|Blacks|blacks
5501256|NCT01290874|LABA|laba
5501257|NCT01290874|Tiotropium|tiotropium
5501258|NCT01290874|Spiriva|spiriva
5501259|NCT01290874|African American|african american
5501260|NCT01290874|Serevent|serevent
5501261|NCT01290874|salmeterol|salmeterol
5501262|NCT01290874|Foradil|foradil
5501263|NCT01290874|formoterol|formoterol
5501264|NCT01290874|Advair|advair
5501265|NCT01290874|Symbicort|symbicort
5501266|NCT01290874|Dulera|dulera
5501267|NCT01290861|Huntington's Disease|huntington's disease
5501269|NCT01290861|Cognitive Testing|cognitive testing
5501270|NCT01290861|Cognition|cognition
5501271|NCT01290861|pre-manifest Huntington's Disease|pre-manifest huntington's disease
5501272|NCT01290848|pediatrics|pediatrics
5501273|NCT01290848|Health Promotion Campaign|health promotion campaign
5501274|NCT01290848|Community events|community events
5501275|NCT01290835|Stereotactic radiotherapy|stereotactic radiotherapy
5501276|NCT01290835|CyberKnife following lumpectomy|cyberknife following lumpectomy
5501277|NCT01290835|Breast cancer|breast cancer
5501278|NCT01290822|Biventricular pacing|biventricular pacing
5501279|NCT01290822|Dilated Cardiomyopathy|dilated cardiomyopathy
5501280|NCT01290822|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5501281|NCT01290822|Congestive heart failure|congestive heart failure
5501282|NCT01290822|Cardiac allograft|cardiac allograft
5637772|NCT00748150|flu|flu
5501283|NCT01290822|Cardiac surgery|cardiac surgery
5501284|NCT01290822|AVD|avd
5501285|NCT01290822|VVD|vvd
5501286|NCT01290822|LV pacing site|lv pacing site
5501287|NCT01290822|pacing optimization|pacing optimization
5501288|NCT01290809|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5501289|NCT01290809|lung cancer|lung cancer
5501290|NCT01290783|mCRC|mcrc
5501291|NCT01290783|CRC|crc
5501292|NCT01290783|colorectal|colorectal
5501293|NCT01290783|irinotecan|irinotecan
5501294|NCT01290783|Hyaluronic acid|hyaluronic acid
5501295|NCT01290783|Hyaluronan|hyaluronan
5501296|NCT01290770|obesity|obesity
5501297|NCT01290770|men|men
5501298|NCT01290770|TFPI|tfpi
5501299|NCT01290770|Lipoprotein(a)|lipoprotein(a)
5501300|NCT01290770|Lp(a)|lp(a)
5501301|NCT01290770|Tissue Factor pathway inhibitor|tissue factor pathway inhibitor
5501302|NCT01290770|aspirin|aspirin
5501303|NCT01290744|leprosy|leprosy
5501304|NCT01290744|ENL|enl
5501305|NCT01290744|clofazimine|clofazimine
5501306|NCT01290731|Hepatitis C, Chronic|hepatitis c, chronic
5501307|NCT01290731|Hepatitis C virus|hepatitis c virus
5501308|NCT01290731|Interferon Alfa-2a|interferon alfa-2a
5501309|NCT01290731|Ribavirin|ribavirin
5501310|NCT01290731|Viral RNA|viral rna
5501311|NCT01290705|Knee|knee
5501312|NCT01290705|Anterior Cruciate Ligament|anterior cruciate ligament
5501313|NCT01290705|Pain|pain
5501314|NCT01290705|Patella|patella
5501315|NCT01290705|Exercise Therapy|exercise therapy
5501316|NCT01290692|Brain Neoplasms|brain neoplasms
5501317|NCT01290692|Central Nervous System Neoplasms|central nervous system neoplasms
5501318|NCT01290692|Brain Diseases|brain diseases
5501319|NCT01290692|Neoplasms|neoplasms
5501321|NCT01290692|Glioblastoma|glioblastoma
5501322|NCT01290692|Astrocytoma|astrocytoma
5501323|NCT01290692|Nervous System Diseases|nervous system diseases
5501324|NCT01290692|Central Nervous System Diseases|central nervous system diseases
5501325|NCT01290692|Glioma|glioma
5501326|NCT01290692|Recurrent astrocytoma|recurrent astrocytoma
5501327|NCT01290692|Recurrent glioma|recurrent glioma
5501328|NCT01290692|Cancer vaccine|cancer vaccine
5501329|NCT01290692|Immunotherapy|immunotherapy
5501330|NCT01290692|Killer T cells|killer t cells
5501331|NCT01290692|Activated T cells|activated t cells
5501332|NCT01290692|GM-CSF|gm-csf
5501333|NCT01290692|Activated lymphocytes|activated lymphocytes
5501334|NCT01290679|Hepatitis C|hepatitis c
5501335|NCT01290679|TMC435|tmc435
5501336|NCT01290679|HCV|hcv
5501337|NCT01290679|Hep C|hep c
5501338|NCT01290679|genotype 1|genotype 1
5501339|NCT01290601|malaria|malaria
5501340|NCT01290601|Plasmodium vivax|plasmodium vivax
5501341|NCT01290601|adults|adults
5501342|NCT01290601|treatment|treatment
5501343|NCT01290601|tafenoquine|tafenoquine
5501344|NCT01290562|SBRT|sbrt
5501345|NCT01290562|spinal Metastases|spinal metastases
5501346|NCT01290562|Paraspinal Metastases|paraspinal metastases
5501347|NCT01290562|spinal Metastases and SBRT|spinal metastases and sbrt
5501348|NCT01290562|Paraspinal Metastases and SBRT|paraspinal metastases and sbrt
5501349|NCT01290536|Liver metastases|liver metastases
5501350|NCT01290510|tendinopathy|tendinopathy
5501351|NCT01290510|hyaluronan|hyaluronan
5501353|NCT01290510|hyaluronic acid|hyaluronic acid
5501354|NCT01290484|Lymphatic malformation, vascular malformation|lymphatic malformation, vascular malformation
5501355|NCT01290458|Eccentric training|eccentric training
5501356|NCT01290458|Free radicals|free radicals
5501357|NCT01290458|Antioxidant supplements|antioxidant supplements
5501358|NCT01290458|Training adaptations|training adaptations
5501359|NCT01290458|Lipid profile|lipid profile
5501360|NCT01290445|varenicline|varenicline
5501361|NCT01290445|smoking|smoking
5501362|NCT01290445|smoking cessation|smoking cessation
5501363|NCT01290445|cohort study|cohort study
5501364|NCT01290445|drug safety|drug safety
5501365|NCT01290445|prospective study|prospective study
5501366|NCT01290432|female fertility|female fertility
5501367|NCT01290432|ovarian reserve|ovarian reserve
5501368|NCT01290432|oocyte quality|oocyte quality
5501369|NCT01290432|oocyte quantity|oocyte quantity
5501370|NCT01290432|antimullerian hormone|antimullerian hormone
5501371|NCT01290432|AMH|amh
5501372|NCT01290432|dietary supplements|dietary supplements
5501377|NCT01290406|Endometrial cancer,|endometrial cancer,
5501378|NCT01290406|uterine cancer,|uterine cancer,
5487744|NCT01346735|India|india
5501379|NCT01290406|PI3K,|pi3k,
5501380|NCT01290406|mTOR,|mtor,
5501381|NCT01290406|targeted therapy|targeted therapy
5501382|NCT01290393|vaccine|vaccine
5501383|NCT01290393|Spontaneous abortions|spontaneous abortions
5501384|NCT01290393|Human papillomavirus|human papillomavirus
5501386|NCT01290393|Cervarix|cervarix
5501387|NCT01290393|pregnancy|pregnancy
5501388|NCT01290380|Solid tumor malignancies,|solid tumor malignancies,
5501389|NCT01290380|simvastatin,|simvastatin,
5501390|NCT01290380|caffeine,|caffeine,
5501391|NCT01290380|omeprazole and diclofenac,|omeprazole and diclofenac,
5501392|NCT01290380|ASA404,|asa404,
5501393|NCT01290380|PK data|pk data
5501394|NCT01290367|Chronic Lumbar Back Pain|chronic lumbar back pain
5501395|NCT01290367|Low back pain|low back pain
5501396|NCT01290367|Back pain|back pain
5501397|NCT01290367|Degenerative Disc Disease|degenerative disc disease
5501398|NCT01290367|Injection of Degenerated Lumbar Disc|injection of degenerated lumbar disc
5501399|NCT01290367|Stem Cells|stem cells
5501400|NCT01290367|Adult Stem Cells|adult stem cells
5483364|NCT01364883|Vaccine|vaccine
5501401|NCT01290367|Allogeneic Mesenchymal Precursor cells (MPCs)|allogeneic mesenchymal precursor cells (mpcs)
5501402|NCT01290367|Mesoblast|mesoblast
5501403|NCT01290354|Brain penetration|brain penetration
5501404|NCT01290354|positron emission tomography|positron emission tomography
5501405|NCT01290354|Lapatinib|lapatinib
5501406|NCT01290341|fungal infection|fungal infection
5501407|NCT01290341|athlete foot|athlete foot
5501408|NCT01290328|anemia|anemia
5501409|NCT01290328|kidney transplant|kidney transplant
5501410|NCT01290328|alloimmunity|alloimmunity
5501411|NCT01290289|Labor|labor
5501412|NCT01290289|Epidural|epidural
5501413|NCT01290289|Combined spinal epidural|combined spinal epidural
5501414|NCT01290289|pethidine|pethidine
5501415|NCT01290276|Ondansetron|ondansetron
5501416|NCT01290276|Methylphenidate|methylphenidate
5501417|NCT01290263|Glioblastoma|glioblastoma
5501419|NCT01290263|Brain Tumor|brain tumor
5501420|NCT01290263|Glioma|glioma
5501421|NCT01290237|vancomycin|vancomycin
5501422|NCT01290237|loading dose|loading dose
5501423|NCT01290237|pharmacokinetic|pharmacokinetic
5501424|NCT01290237|pediatric|pediatric
5504258|NCT01277679|MRI|mri
5501425|NCT01290237|Methicillin-Resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5501426|NCT01290237|Serious infection with Gram positive bacteria|serious infection with gram positive bacteria
5501427|NCT01290211|maraviroc|maraviroc
5501428|NCT01290211|fosamprenavir|fosamprenavir
5501429|NCT01290211|drug interaction|drug interaction
5501430|NCT01290211|pharmacokinetics|pharmacokinetics
5501431|NCT01290211|HIV|hiv
5501432|NCT01290211|AIDS|aids
5501433|NCT01290211|CCR5|ccr5
5501434|NCT01290211|protease inhibitor|protease inhibitor
5501435|NCT01290198|epoxy-eicosatrienoic acid|epoxy-eicosatrienoic acid
5501436|NCT01290198|Laser Doppler|laser doppler
5501437|NCT01290198|Endothelium derived hyperpolarizing factor|endothelium derived hyperpolarizing factor
5501438|NCT01290198|cutaneous microcirculation|cutaneous microcirculation
5501439|NCT01290198|post-occlusive hyperaemia|post-occlusive hyperaemia
5501440|NCT01290198|thermal hyperemia|thermal hyperemia
5501441|NCT01290198|intradermal microdialysis|intradermal microdialysis
5501442|NCT01290198|fluconazole|fluconazole
5501443|NCT01290185|Arthroplasty|arthroplasty
5501444|NCT01290185|Pharmacol Nerve Block|pharmacol nerve block
5501445|NCT01290172|Liver transplant|liver transplant
5501446|NCT01290172|portal hypertension|portal hypertension
5501447|NCT01290159|tolerance to heat|tolerance to heat
5501448|NCT01290146|Heart Failure|heart failure
5501449|NCT01290146|Levosimendan|levosimendan
5501450|NCT01290146|Inotropic agents|inotropic agents
5501451|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5501452|NCT01290146|Vasodilators|vasodilators
5501453|NCT01290146|Diuretics|diuretics
5501454|NCT01290120|Burkitt Lymphoma|burkitt lymphoma
5501455|NCT01290120|B-ALL|b-all
5501456|NCT01290120|Adult patients|adult patients
5501457|NCT01290107|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5501458|NCT01290107|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5501459|NCT01290081|Tuberculosis|tuberculosis
5501460|NCT01290081|Injecting drug users|injecting drug users
5501461|NCT01290081|Case management|case management
5501462|NCT01290068|Intraocular Lens|intraocular lens
5501463|NCT01290055|Yellow Fever|yellow fever
5501464|NCT01290055|Vaccine|vaccine
5501465|NCT01290055|Memory T Cells|memory t cells
5501466|NCT01290029|pediatric|pediatric
5501467|NCT01290029|CKD|ckd
5501468|NCT01290029|dialysis|dialysis
5495780|NCT01313455|HV|hv
5501469|NCT01290029|paediatric|paediatric
5501470|NCT01290016|randomized controlled trial|randomized controlled trial
5501471|NCT01290016|children|children
5501472|NCT01290016|obesity|obesity
5501473|NCT01290016|nutrition|nutrition
5501474|NCT01290016|exercise|exercise
5501475|NCT01290003|Antibacterial agents|antibacterial agents
5501476|NCT01290003|Neonate|neonate
5501477|NCT01290003|Meconium stained amniotic fluid|meconium stained amniotic fluid
5501478|NCT01290003|Neonatal sepsis|neonatal sepsis
5501479|NCT01289977|Sandfly|sandfly
5501480|NCT01289977|leishmaniasis|leishmaniasis
5501481|NCT01289977|immune response|immune response
5501482|NCT01289977|individuals age 18-50|individuals age 18-50
5501483|NCT01289951|HIV|hiv
5501484|NCT01289951|VHC|vhc
5501485|NCT01289951|Advanced hepatic cirrhosis|advanced hepatic cirrhosis
5501486|NCT01289951|Pharmacokinetic|pharmacokinetic
5501487|NCT01289951|Raltegravir|raltegravir
5501488|NCT01289938|pharmacokinetic|pharmacokinetic
5501489|NCT01289938|pharmacogenetic|pharmacogenetic
5501490|NCT01289938|Metoclopramide|metoclopramide
5501491|NCT01289938|Diphenhydramine|diphenhydramine
5501492|NCT01289938|CYP2D6 polymorphisms|cyp2d6 polymorphisms
5501493|NCT01289925|dietary supplement|dietary supplement
5501494|NCT01289925|selenium|selenium
5501495|NCT01289925|healthy volunteer|healthy volunteer
5501496|NCT01289925|Johns Hopkins|johns hopkins
5501497|NCT01289925|older|older
5501498|NCT01289925|aging|aging
5501499|NCT01289925|geriatrics|geriatrics
5501500|NCT01289925|baltimore|baltimore
5501501|NCT01289925|mineral|mineral
5501502|NCT01289925|over 70|over 70
5501503|NCT01289912|Tuberous Sclerosis Complex|tuberous sclerosis complex
5501504|NCT01289912|Autism|autism
5501505|NCT01289912|Neurocognition|neurocognition
5501506|NCT01289912|RAD001|rad001
5501507|NCT01289912|Everolimus|everolimus
5501508|NCT01289912|Afinitor|afinitor
5501510|NCT01289899|BR-A-657|br-a-657
5501511|NCT01289899|Fimasartan|fimasartan
5501512|NCT01289899|multiple-dose|multiple-dose
5501513|NCT01289899|pharmacokinetic|pharmacokinetic
5501514|NCT01289899|pharmacodynamic|pharmacodynamic
5501515|NCT01289899|safety|safety
5501516|NCT01289886|single-dose|single-dose
5501517|NCT01289886|pharmacokinetic|pharmacokinetic
5501518|NCT01289886|pharmacodynamic|pharmacodynamic
5501519|NCT01289886|safety|safety
5501520|NCT01289847|Primary Immune Deficiency Disorders|primary immune deficiency disorders
5501521|NCT01289847|Common Variable Immunodeficiency|common variable immunodeficiency
5501522|NCT01289847|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5501523|NCT01289847|Hyper-IgM syndrome|hyper-igm syndrome
5501524|NCT01289847|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5501525|NCT01289847|Immunoglobulins|immunoglobulins
5846755|NCT00043537|Mutism|mutism
5501526|NCT01289847|Bacterial Infections|bacterial infections
5501528|NCT01289834|Bone Cement|bone cement
5501529|NCT01289808|Glucose|glucose
5501530|NCT01289808|analgesic|analgesic
5501531|NCT01289808|newborns|newborns
5501532|NCT01289795|Stroke|stroke
5501533|NCT01289795|Cerebral Infarction|cerebral infarction
5501534|NCT01289795|Cerebrovascular Disorders|cerebrovascular disorders
5501535|NCT01289795|Brain Diseases|brain diseases
5501536|NCT01289795|Central Nervous System Diseases|central nervous system diseases
5501537|NCT01289782|Hepatitis C|hepatitis c
5501538|NCT01289782|TMC435|tmc435
5501539|NCT01289782|HCV|hcv
5501540|NCT01289782|Hep C|hep c
5501541|NCT01289782|Genotype 1|genotype 1
5501542|NCT01289756|pharmacokinetic|pharmacokinetic
5501543|NCT01289756|clomiphene|clomiphene
5501544|NCT01289756|CYP2D6 polymorphisms|cyp2d6 polymorphisms
5501545|NCT01289756|inhibition of CYP2D6 and CYP3A4|inhibition of cyp2d6 and cyp3a4
5501546|NCT01289743|ankylosing spondylitis|ankylosing spondylitis
5501547|NCT01289743|atanercept|atanercept
5501548|NCT01289743|therapy|therapy
5501549|NCT01289743|magnetic resonance imaging|magnetic resonance imaging
5501550|NCT01289730|undifferentiated spondyloarthritis|undifferentiated spondyloarthritis
5501551|NCT01289730|etanercept|etanercept
5501552|NCT01289730|therapy|therapy
5501553|NCT01289730|magnetic resonance imaging|magnetic resonance imaging
5501554|NCT01289717|biomarkers|biomarkers
5501555|NCT01289717|proteogenomic profiling|proteogenomic profiling
5501556|NCT01289717|acute rejection|acute rejection
5501557|NCT01289717|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy|chronic allograft nephropathy/interstitial fibrosis and tubular atrophy
5501558|NCT01289704|Charcot−Marie−Tooth disease,|charcot−marie−tooth disease,
5501559|NCT01289704|CMT1A,|cmt1a,
5501560|NCT01289704|rehabilitation,|rehabilitation,
5501561|NCT01289704|treadmill,|treadmill,
5501562|NCT01289704|stretching,|stretching,
5501563|NCT01289704|proprioception,|proprioception,
5501564|NCT01289704|Randomised Controlled Trial.|randomised controlled trial.
5501565|NCT01289691|One Lung Ventilation|one lung ventilation
5501566|NCT01289691|Atelectasis|atelectasis
5501567|NCT01289691|Oxygenation|oxygenation
5501568|NCT01289678|acute myelogenous leukemia|acute myelogenous leukemia
5501569|NCT01289678|interleukin-2|interleukin-2
5501570|NCT01289665|lubricating|lubricating
5501571|NCT01289665|gel|gel
5501572|NCT01289665|speculum|speculum
5501573|NCT01289665|Pain, Pelvic|pain, pelvic
5501574|NCT01289665|Examination, Gynecological|examination, gynecological
5501575|NCT01289652|Acute hepatitis C (HCV)|acute hepatitis c (hcv)
5501576|NCT01289652|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5501577|NCT01289639|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5501578|NCT01289639|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5501579|NCT01289639|insulin resistance|insulin resistance
5501580|NCT01289639|pioglitazone|pioglitazone
5501582|NCT01289626|Calciphylaxis, dialysis|calciphylaxis, dialysis
5501583|NCT01289613|Bispectral Index|bispectral index
5501584|NCT01289613|Anesthesia|anesthesia
5501585|NCT01289613|Asymmetry|asymmetry
5501586|NCT01289587|Diabetes|diabetes
5501587|NCT01289587|Physical activity|physical activity
5501588|NCT01289587|Body composition|body composition
5501589|NCT01289587|Aerobic fitness|aerobic fitness
5501590|NCT01289587|Metabolic control|metabolic control
5501591|NCT01289574|androgen receptor degradation enhancer|androgen receptor degradation enhancer
5501592|NCT01289548|remote ischaemic preconditioning|remote ischaemic preconditioning
5501593|NCT01289548|kidney transplantation|kidney transplantation
5501594|NCT01289535|Influenza vaccine|influenza vaccine
5501595|NCT01289535|immune response|immune response
5501596|NCT01289535|elderly|elderly
5501597|NCT01289522|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5501598|NCT01289522|recurrent or metastatic|recurrent or metastatic
5501599|NCT01289522|first line chemotherapy|first line chemotherapy
5501600|NCT01289522|cetuximab|cetuximab
5501601|NCT01289522|docetaxel|docetaxel
5483666|NCT01363635|AKI|aki
5501602|NCT01289522|cisplatin|cisplatin
5501603|NCT01289522|antineoplastic agents|antineoplastic agents
5501604|NCT01289522|First Line Palliative Treatment|first line palliative treatment
5501605|NCT01289496|Ribavirin|ribavirin
5501606|NCT01289496|Pegasys|pegasys
5501607|NCT01289496|Hepatitis|hepatitis
5501608|NCT01289483|awake fiberoptic intubation (AFI)|awake fiberoptic intubation (afi)
5501609|NCT01289483|difficult airway|difficult airway
5501610|NCT01289483|fospropofol|fospropofol
5501640|NCT01289444|hospitalization|hospitalization
5501641|NCT01289444|communication|communication
5501642|NCT01289444|family intervention|family intervention
5501643|NCT01289444|Family Centered Advance Care Planning|family centered advance care planning
5501644|NCT01289444|decision making|decision making
5501645|NCT01289444|advance care planning|advance care planning
5501646|NCT01289444|end of life|end of life
5501647|NCT01289418|H1N1|h1n1
5501648|NCT01289418|vaccine safety|vaccine safety
5501649|NCT01289418|adverse events|adverse events
5501650|NCT01289418|health care workers|health care workers
5501651|NCT01289405|obstructive sleep apnea|obstructive sleep apnea
5501652|NCT01289405|oropharyngeal exercises|oropharyngeal exercises
5501653|NCT01289405|speech therapy|speech therapy
5501654|NCT01289392|Obstructive Sleep Apnea|obstructive sleep apnea
5501656|NCT01289392|Oral appliance|oral appliance
5501657|NCT01289392|Aerobic exercise|aerobic exercise
5501658|NCT01289392|Resistance training|resistance training
5501659|NCT01289379|pneumoperitoneum|pneumoperitoneum
5501660|NCT01289379|laparoscopy|laparoscopy
5501661|NCT01289379|HFJV|hfjv
5501662|NCT01289379|cardiovascular|cardiovascular
5501663|NCT01289379|Symptomatic|symptomatic
5501664|NCT01289353|triple negative|triple negative
5501665|NCT01289353|breast cancer|breast cancer
5501666|NCT01289353|adjuvant therapy|adjuvant therapy
5501667|NCT01289353|Carboplatin|carboplatin
5501668|NCT01289353|chemotherapy|chemotherapy
5501669|NCT01289353|radiation therapy|radiation therapy
5501670|NCT01289353|chemo-radiotherapy|chemo-radiotherapy
5501671|NCT01289353|accelerated radiotherapy|accelerated radiotherapy
5501672|NCT01289340|wound healing|wound healing
5501674|NCT01289340|burn|burn
5501675|NCT01289314|total laparoscopic hysterectomy|total laparoscopic hysterectomy
5501676|NCT01289314|laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
5501677|NCT01289301|renal transplantation|renal transplantation
5501678|NCT01289301|polyoma BK virus infection|polyoma bk virus infection
5501679|NCT01289301|everolimus|everolimus
5501680|NCT01289301|calcineurin inhibitor|calcineurin inhibitor
5501681|NCT01289301|mTOR inhibitor|mtor inhibitor
5501682|NCT01289288|colorectal cancer screening|colorectal cancer screening
5501683|NCT01289288|Chinese Americans|chinese americans
5501684|NCT01289288|patients nonadherent with CRC Screening|patients nonadherent with crc screening
5501685|NCT01289275|tobacco cessation|tobacco cessation
5501686|NCT01289275|smoking cessation|smoking cessation
5501687|NCT01289275|telephone|telephone
5501688|NCT01289275|self-help|self-help
5501689|NCT01289275|smoking abstinence|smoking abstinence
5501690|NCT01289275|tobacco use disorder|tobacco use disorder
5501691|NCT01289275|hospital|hospital
5501692|NCT01289275|cardiopulmonary diseases|cardiopulmonary diseases
5501693|NCT01289275|disparity|disparity
5501694|NCT01289262|Cesarean section|cesarean section
5501695|NCT01289262|Kerr incision|kerr incision
5501696|NCT01289262|Purse string suturing in CS|purse string suturing in cs
5501697|NCT01289262|Continuous locked suturing in CS|continuous locked suturing in cs
5501698|NCT01289249|meropenem|meropenem
5501699|NCT01289249|child|child
5501700|NCT01289249|bacterial infection|bacterial infection
5495952|NCT01312740|adipocytes|adipocytes
5501707|NCT01289184|Air Pollution|air pollution
5501708|NCT01289184|Photocopiers|photocopiers
5501709|NCT01289184|Other Specified Personal Exposures|other specified personal exposures
5501710|NCT01289184|History Presenting Hazards to Health|history presenting hazards to health
5501711|NCT01289171|The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated|the efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among hiv+ children were investigated
5486359|NCT01352312|CLL|cll
5501712|NCT01289158|malonic and methylmalonic aciduria|malonic and methylmalonic aciduria
5501713|NCT01289158|malonyl-coenzyme A decarboxylase|malonyl-coenzyme a decarboxylase
5501714|NCT01289158|MLYCD|mlycd
5501715|NCT01289145|Action Planning|action planning
5501716|NCT01289145|Positive Outcome Expectancies|positive outcome expectancies
5501717|NCT01289145|Randomized Controlled Trial|randomized controlled trial
5501718|NCT01289145|Stages of change|stages of change
5501719|NCT01289145|Health behavior|health behavior
5501720|NCT01289145|Motivation|motivation
5501721|NCT01289132|Drug Therapy|drug therapy
5501722|NCT01289119|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5501723|NCT01289119|Drug Therapy|drug therapy
5501724|NCT01289106|Hepatitis B vaccine|hepatitis b vaccine
5501725|NCT01289106|HIV infection|hiv infection
5501726|NCT01289106|Modified HBV vaccine dose|modified hbv vaccine dose
5501727|NCT01289106|Modified HBV vaccine schedule|modified hbv vaccine schedule
5501728|NCT01289093|inguinal hernia|inguinal hernia
5501729|NCT01289093|incisional hernia|incisional hernia
5501730|NCT01289093|quality of life|quality of life
5501731|NCT01289093|disease-specific|disease-specific
5501732|NCT01289080|Schizophrenia|schizophrenia
5501733|NCT01289080|psychiatric disorders|psychiatric disorders
5501734|NCT01289080|renal failure|renal failure
5501735|NCT01289067|Metastatic|metastatic
5501736|NCT01289067|Castration Resistant|castration resistant
5501737|NCT01289067|Prostate Cancer|prostate cancer
5501738|NCT01289054|Female|female
5501739|NCT01289054|Pregnancy|pregnancy
5501740|NCT01289054|Hematologic Pregnancy|hematologic pregnancy
5501741|NCT01289054|Complications|complications
5501742|NCT01289054|Registry|registry
5501743|NCT01289054|Pregnant Registry|pregnant registry
5501745|NCT01289054|GIST|gist
5501746|NCT01289054|Gleevec|gleevec
5501747|NCT01289054|Tasigna|tasigna
5501748|NCT01289054|Glivec|glivec
5504607|NCT01276236|HIV|hiv
5501749|NCT01289054|Pregnancy Exposure|pregnancy exposure
5501750|NCT01289041|Advanced endometrial cancer|advanced endometrial cancer
5501751|NCT01289041|PI3K pathway|pi3k pathway
5501752|NCT01289041|second-line treatment|second-line treatment
5501753|NCT01289028|GIST|gist
5501754|NCT01289028|Imatinib|imatinib
5501755|NCT01289028|Sunitinib|sunitinib
5501756|NCT01289028|Gastrointestinal|gastrointestinal
5501757|NCT01289028|Stromal|stromal
5501758|NCT01289028|Tumors|tumors
5501759|NCT01289015|fungal infection|fungal infection
5501760|NCT01289015|athlete foot|athlete foot
5501761|NCT01288989|Advanced Solid Tumors|advanced solid tumors
5501762|NCT01288976|Mitral Valve|mitral valve
5501763|NCT01288976|Mitral Regurgitation|mitral regurgitation
5501764|NCT01288976|MitraClip|mitraclip
5501765|NCT01288976|Mitral Valve Surgery|mitral valve surgery
5501766|NCT01288976|Mitral Valve Insufficiency or Mitral Regurgitation|mitral valve insufficiency or mitral regurgitation
5501767|NCT01288963|melanoma|melanoma
5501768|NCT01288963|IL-2|il-2
5501769|NCT01288963|Aldesleukin|aldesleukin
5501770|NCT01288950|BCG vaccine|bcg vaccine
5501771|NCT01288950|Vitamin D|vitamin d
5501772|NCT01288950|Cholecalciferol|cholecalciferol
5501773|NCT01288950|Tuberculosis|tuberculosis
5501774|NCT01288937|Milnacipran|milnacipran
5501775|NCT01288937|Idiopathic Peripheral Neuropathy|idiopathic peripheral neuropathy
5501776|NCT01288937|Diabetic neuropathy|diabetic neuropathy
5501777|NCT01288937|Neuropathic pain|neuropathic pain
5501778|NCT01288911|Metastatic|metastatic
5501779|NCT01288911|MDV3100|mdv3100
5501780|NCT01288911|Prostate|prostate
5501781|NCT01288911|progressive|progressive
5501782|NCT01288911|Cancer|cancer
5501783|NCT01288911|enzalutamide|enzalutamide
5501784|NCT01288898|ASP1941|asp1941
5501785|NCT01288898|Diabetes Mellitus|diabetes mellitus
5501786|NCT01288898|Multiple ascending doses|multiple ascending doses
5501787|NCT01288898|Healthy subjects|healthy subjects
5501788|NCT01288885|ASP1941|asp1941
5501789|NCT01288885|Diabetes Mellitus|diabetes mellitus
5501791|NCT01288872|Praziquantal, Schistosomiasis, pregnant women, Philippines|praziquantal, schistosomiasis, pregnant women, philippines
5501792|NCT01288859|polyphenols|polyphenols
5501793|NCT01288859|curcumin|curcumin
5501794|NCT01288859|bioavailability|bioavailability
5501795|NCT01288859|cocoa|cocoa
5501796|NCT01288846|medication list|medication list
5501797|NCT01288846|changes in medication|changes in medication
5501798|NCT01288846|prescription medication|prescription medication
5501799|NCT01288833|Colonoscopy|colonoscopy
5501800|NCT01288833|Diagnostic Imaging|diagnostic imaging
5501801|NCT01288833|Colorectal Neoplasm|colorectal neoplasm
5501802|NCT01288833|Primary Prevention|primary prevention
5501803|NCT01288833|Cost and Cost Analysis|cost and cost analysis
5501804|NCT01288833|Endoscopy|endoscopy
5501805|NCT01288807|Fibromyalgia|fibromyalgia
5501806|NCT01288807|pain|pain
5501807|NCT01288794|Cirrhosis|cirrhosis
5501808|NCT01288794|Uncomplicated ascites|uncomplicated ascites
5501809|NCT01288794|Refractory ascites|refractory ascites
5501810|NCT01288794|Chronic albumin treatment|chronic albumin treatment
5501811|NCT01288781|High Altitude Headache; intra-cranial pressure; hypoxia|high altitude headache; intra-cranial pressure; hypoxia
5501812|NCT01288768|Meniscal injury|meniscal injury
5501813|NCT01288768|Knee arthroscopy|knee arthroscopy
5501814|NCT01288768|Middleaged|middleaged
5501815|NCT01288768|Functional outcome|functional outcome
5501816|NCT01288755|TMC278-TiDP6-C153|tmc278-tidp6-c153
5501817|NCT01288755|TMC278-C153|tmc278-c153
5501818|NCT01288755|TMC278|tmc278
5501820|NCT01288742|TMC435-TiDP16-C108|tmc435-tidp16-c108
5501821|NCT01288742|TMC435-C108|tmc435-c108
5501822|NCT01288742|TMC435|tmc435
5501823|NCT01288742|HPC|hpc
5501824|NCT01288742|HCV|hcv
5501825|NCT01288742|Hepatitis C|hepatitis c
5501826|NCT01288716|ASD|asd
5501827|NCT01288716|Autism|autism
5501828|NCT01288716|Asperger Syndrome|asperger syndrome
5501829|NCT01288703|urinary incontinence|urinary incontinence
5501830|NCT01288690|Refugees|refugees
5501831|NCT01288690|Trauma|trauma
5501832|NCT01288690|Narrative|narrative
5501833|NCT01288690|Exposure|exposure
5501834|NCT01288690|Middle East|middle east
5501835|NCT01288690|Therapy|therapy
5483782|NCT01363154|Mozart|mozart
5501836|NCT01288677|Healthy volunteer|healthy volunteer
5501837|NCT01288677|TMC649128HPC1001|tmc649128hpc1001
5501838|NCT01288677|TMC649128|tmc649128
5501839|NCT01288677|HCV|hcv
5501840|NCT01288677|Hepatitis C|hepatitis c
5501841|NCT01288677|healthy volunteers|healthy volunteers
5501842|NCT01288677|Phase I trial|phase i trial
5501843|NCT01288664|Lupus Nephritis|lupus nephritis
5501844|NCT01288664|Tacrolimus|tacrolimus
5501845|NCT01288664|Induction Phase|induction phase
5501846|NCT01288651|Pulmonary arterial hypertension|pulmonary arterial hypertension
5501847|NCT01288651|Iron deficiency|iron deficiency
5501848|NCT01288651|Exercise|exercise
5501849|NCT01288638|Polycystic Ovary Syndrome|polycystic ovary syndrome
5501850|NCT01288638|Metabolic Syndrome|metabolic syndrome
5501851|NCT01288638|Pulse|pulse
5501852|NCT01288638|Lifestyle Intervention|lifestyle intervention
5501853|NCT01288638|Aerobic Exercise|aerobic exercise
5501855|NCT01288625|Identify whether Cytofos can reduce the incidence and duration of HNC patients' oral mucositis caused by radiotherapy.|identify whether cytofos can reduce the incidence and duration of hnc patients' oral mucositis caused by radiotherapy.
5501856|NCT01288612|Barrett's Esophagus|barrett's esophagus
5501857|NCT01288599|Laparoscopy|laparoscopy
5501858|NCT01288599|Randomized|randomized
5501859|NCT01288599|Single port access|single port access
5501860|NCT01288599|Adnexal disease|adnexal disease
5501861|NCT01288599|LESS|less
5501862|NCT01288586|Post Traumatic Arthritis|post traumatic arthritis
5501863|NCT01288586|Rheumatoid Arthritis|rheumatoid arthritis
5501864|NCT01288586|Osteoarthritis|osteoarthritis
5501865|NCT01288560|medical imaging|medical imaging
5501866|NCT01288560|heart failure|heart failure
5501867|NCT01288560|morbidity and mortality|morbidity and mortality
5501868|NCT01288560|PET/CT,CMR,SPECT, echo, coronary angiography|pet/ct,cmr,spect, echo, coronary angiography
5501869|NCT01288560|knowledge translation|knowledge translation
5501870|NCT01288560|cost effectiveness|cost effectiveness
5501871|NCT01288560|quality of life|quality of life
5501872|NCT01288560|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5501873|NCT01288547|cognition|cognition
5501874|NCT01288547|attention|attention
5501875|NCT01288547|methylxanthine|methylxanthine
5501876|NCT01288521|kidney transplantation|kidney transplantation
5501877|NCT01288521|tacrolimus|tacrolimus
5501878|NCT01288521|P-glycoprotein|p-glycoprotein
5501879|NCT01288521|ABCB1|abcb1
5501880|NCT01288521|genotyping|genotyping
5501881|NCT01288482|Methacholine challenge|methacholine challenge
5501882|NCT01288482|nebulizer|nebulizer
5501883|NCT01288482|English-Wright|english-wright
5501884|NCT01288482|AeroEclipse II|aeroeclipse ii
5501885|NCT01288469|10020603|10020603
5501886|NCT01288456|medical device, space-occupying device|medical device, space-occupying device
5501887|NCT01288430|Heat shock protein 90|heat shock protein 90
5501888|NCT01288430|Advanced solid tumors|advanced solid tumors
5501889|NCT01288430|Non-small cell lung carcinoma|non-small cell lung carcinoma
5501890|NCT01288430|Epidermal growth factor receptor|epidermal growth factor receptor
5501891|NCT01288430|Tyrosine kinase inhibitor acquired resistance|tyrosine kinase inhibitor acquired resistance
5501892|NCT01288430|Non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.|non-small cell lung carcinoma with acquired resistance to erlotinib, gefitinib, afatinib or others.
5501893|NCT01288417|HIV infections|hiv infections
5501894|NCT01288417|HCV infections|hcv infections
5501895|NCT01288417|interaction|interaction
5501896|NCT01288417|pharmacokinetics|pharmacokinetics
5501897|NCT01288417|raltegravir|raltegravir
5501898|NCT01288417|boceprevir|boceprevir
5501899|NCT01288404|Bevacizumab, impending recurrent pterygium|bevacizumab, impending recurrent pterygium
5501900|NCT01288378|fungal infection|fungal infection
5501901|NCT01288378|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5501902|NCT01288378|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5501903|NCT01288378|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5501998|NCT01287975|Stroke Rehabilitation|stroke rehabilitation
5501904|NCT01288378|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5501905|NCT01288378|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5501906|NCT01288378|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5501907|NCT01288378|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5501908|NCT01288378|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5501909|NCT01288378|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5501910|NCT01288378|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5501911|NCT01288378|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5501912|NCT01288378|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5483892|NCT01362634|HIV/AIDS|hiv/aids
5501913|NCT01288365|heart failure|heart failure
5501914|NCT01288365|preserved ejection fraction|preserved ejection fraction
5501915|NCT01288352|early treatment|early treatment
5501916|NCT01288352|rhythm control|rhythm control
5501917|NCT01288352|atrial fibrillation|atrial fibrillation
5501918|NCT01288352|cardiovascular complications|cardiovascular complications
5501919|NCT01288313|human milk|human milk
5501920|NCT01288313|polyunsaturated fatty acids|polyunsaturated fatty acids
5501921|NCT01288313|linolenic acid|linolenic acid
5501922|NCT01288313|rapeseed oil|rapeseed oil
5501923|NCT01288287|Certolizumab pegol|certolizumab pegol
5501924|NCT01288287|Cimzia®|cimzia®
5501925|NCT01288274|Contraception|contraception
5501926|NCT01288274|Family planning|family planning
5501927|NCT01288274|Task Shifting|task shifting
5501928|NCT01288274|Community based distribution|community based distribution
5501929|NCT01288274|Ethiopia|ethiopia
5501931|NCT01288248|Airway|airway
5501932|NCT01288248|Airway laryngeal mask|airway laryngeal mask
5501933|NCT01288248|Endotracheal tube|endotracheal tube
5501934|NCT01288248|Respiration artificial|respiration artificial
5501935|NCT01288248|Laryngospasm|laryngospasm
5501936|NCT01288248|Safety of airway laryngeal mask|safety of airway laryngeal mask
5501937|NCT01288235|proton radiotherapy|proton radiotherapy
5501938|NCT01288222|acute myelogenous leukemia|acute myelogenous leukemia
5501939|NCT01288222|hematopoietic cell transplantation|hematopoietic cell transplantation
5501940|NCT01288222|unrelated donor|unrelated donor
5501941|NCT01288209|Hepatitis C, Chronic|hepatitis c, chronic
5501943|NCT01288209|Hepatitis C virus|hepatitis c virus
5501944|NCT01288209|Interferon Alfa-2a|interferon alfa-2a
5501945|NCT01288209|Ribavirin|ribavirin
5501946|NCT01288209|Viral RNA|viral rna
5501947|NCT01288196|CNTO 6785|cnto 6785
5501948|NCT01288196|Intravenous|intravenous
5501949|NCT01288196|Subcutaneous|subcutaneous
5501950|NCT01288196|Pharmacokinetics|pharmacokinetics
5501951|NCT01288196|Immunogenicity|immunogenicity
5501952|NCT01288196|Safety|safety
5501953|NCT01288196|Tolerability|tolerability
5501954|NCT01288183|tobacco|tobacco
5501955|NCT01288183|smoking|smoking
5501956|NCT01288183|tDCS|tdcs
5501957|NCT01288183|DLPFC|dlpfc
5501958|NCT01288170|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma|cystic fibrosis, bioequivalence, pharmacokinetic, sputum, plasma
5501959|NCT01288157|healthy|healthy
5501960|NCT01288157|adult|adult
5501961|NCT01288157|Chinese|chinese
5501962|NCT01288157|male|male
5501963|NCT01288157|Simponi|simponi
5501964|NCT01288157|CNTO 148|cnto 148
5501965|NCT01288144|Screening|screening
5501966|NCT01288144|Gestational diabetes mellitus|gestational diabetes mellitus
5501967|NCT01288131|Anti-r-HuEpo antibody|anti-r-huepo antibody
5501968|NCT01288131|Anti-r-HuEpo associated PRCA|anti-r-huepo associated prca
5501969|NCT01288131|Treatment|treatment
5501970|NCT01288131|Absolute reticulocyte count|absolute reticulocyte count
5501971|NCT01288105|drug-eluting stents|drug-eluting stents
5501972|NCT01288105|noncardiac surgery|noncardiac surgery
5501973|NCT01288092|Metastatic breast cancer|metastatic breast cancer
5501974|NCT01288092|HER2 negative|her2 negative
5501975|NCT01288092|HR positive|hr positive
5501976|NCT01288092|PI3K pathway|pi3k pathway
5501977|NCT01288092|no more than 2 prior lines of chemotherapy|no more than 2 prior lines of chemotherapy
5501978|NCT01288092|Metastatic Breast Cancer(MBC)|metastatic breast cancer(mbc)
5501979|NCT01288079|Major Depressive Disorder|major depressive disorder
5501981|NCT01288079|Monotherapy|monotherapy
5501982|NCT01288079|Inadequate Response to Antidepressant Therapy|inadequate response to antidepressant therapy
5501983|NCT01288066|Shoulder|shoulder
5501984|NCT01288066|Total arthroplasty|total arthroplasty
5501985|NCT01288066|Hemiarthroplasty|hemiarthroplasty
5501986|NCT01288066|Resurfacing|resurfacing
5501987|NCT01288066|Glenoid|glenoid
5501988|NCT01288066|Constant score|constant score
5501989|NCT01288040|stroke|stroke
5501990|NCT01288040|treadmill|treadmill
5501991|NCT01288040|walking|walking
5501992|NCT01288040|hemiparesis|hemiparesis
5501993|NCT01288040|training|training
5501994|NCT01288014|immune response|immune response
5501995|NCT01288014|varicella zoster virus (VZV)|varicella zoster virus (vzv)
5501996|NCT01288014|cytokine levels|cytokine levels
5501997|NCT01288014|immunization|immunization
5502395|NCT01286259|HIV|hiv
5501999|NCT01287975|Brain Computer Interface|brain computer interface
5502000|NCT01287975|Upper Limb Rehabilitation|upper limb rehabilitation
5502001|NCT01287975|EEG-based Motor Imagery|eeg-based motor imagery
5502002|NCT01287975|Robotic Rehabilitation|robotic rehabilitation
5502003|NCT01287975|Haptic Knob|haptic knob
5502004|NCT01287962|Apatinib|apatinib
5502005|NCT01287962|Non-small Cell Lung Cancer|non-small cell lung cancer
5502006|NCT01287962|VEGFR TKIs|vegfr tkis
5502007|NCT01287949|Diphtheria|diphtheria
5502008|NCT01287949|Tetanus|tetanus
5502009|NCT01287949|Poliomyelitis|poliomyelitis
5502010|NCT01287949|Pertussis (acellular)|pertussis (acellular)
5502011|NCT01287949|Biological/vaccine|biological/vaccine
5502012|NCT01287936|Chronic Stroke|chronic stroke
5502013|NCT01287936|Stable Stroke|stable stroke
5502014|NCT01287923|Hematology|hematology
5502015|NCT01287923|Secondary lymphoid organs|secondary lymphoid organs
5502016|NCT01287910|Cardiac|cardiac
5502017|NCT01287910|Angina|angina
5502018|NCT01287910|Chest pain|chest pain
5502019|NCT01287897|Crohn's Disease|crohn's disease
5502020|NCT01287897|safety|safety
5502021|NCT01287897|efficacy|efficacy
5502022|NCT01287897|pharmacokinetics|pharmacokinetics
5502023|NCT01287897|pharmacodynamics|pharmacodynamics
5502024|NCT01287897|Crohn's Disease Activity Index (CDAI)|crohn's disease activity index (cdai)
5502026|NCT01287884|VBG|vbg
5502027|NCT01287884|pH|ph
5502028|NCT01287884|pCO2|pco2
5502029|NCT01287871|Cervical Cancer Screening|cervical cancer screening
5502030|NCT01287845|Prostate cancer|prostate cancer
5502031|NCT01287845|Neoplasm|neoplasm
5502032|NCT01287845|Diagnostic Imaging|diagnostic imaging
5502033|NCT01287845|PET (Positron Emission Tomography) -tracer|pet (positron emission tomography) -tracer
5502034|NCT01287845|PET-diagnosis|pet-diagnosis
5502035|NCT01287832|Methicillin-resistant|methicillin-resistant
5502036|NCT01287832|Staphylococcus aureus|staphylococcus aureus
5502037|NCT01287806|ulinastatin|ulinastatin
5502038|NCT01287806|inhalation injury|inhalation injury
5502039|NCT01287780|Humans|humans
5502041|NCT01287780|Gentamicin administration and dosage|gentamicin administration and dosage
5502042|NCT01287780|Surgical sponges|surgical sponges
5502043|NCT01287780|Treatment outcomes|treatment outcomes
5502044|NCT01287767|Dementia|dementia
5502045|NCT01287767|Depression|depression
5502046|NCT01287767|Burden of care|burden of care
5502047|NCT01287767|Psychosocial intervention|psychosocial intervention
5502048|NCT01287767|Family home care|family home care
5502049|NCT01287702|early feeding|early feeding
5502050|NCT01287702|varices bleeding|varices bleeding
5502051|NCT01287702|to evaluate impact of early feeding on early rebleeding after ligation of varices|to evaluate impact of early feeding on early rebleeding after ligation of varices
5502052|NCT01287689|Non-interventional trial|non-interventional trial
5502053|NCT01287689|immunodeficiency|immunodeficiency
5502054|NCT01287689|outcome study, registry|outcome study, registry
5502055|NCT01287689|long-term outcomes, drug utilization|long-term outcomes, drug utilization
5502056|NCT01287689|effectiveness, treatment patterns|effectiveness, treatment patterns
5671970|NCT00613379|treatment naïve|treatment naïve
5502057|NCT01287689|patient characteristics under real life conditions|patient characteristics under real life conditions
5502058|NCT01287689|factors for treatment success|factors for treatment success
5502059|NCT01287689|long-term tolerability|long-term tolerability
5502060|NCT01287689|quality of life|quality of life
5502061|NCT01287637|Rectal cancer|rectal cancer
5502062|NCT01287637|Temporary ileostomy|temporary ileostomy
5502063|NCT01287637|Ealy reversal|ealy reversal
5502064|NCT01287637|Morbidity|morbidity
5502065|NCT01287637|Mortality|mortality
5502066|NCT01287637|Quality of life|quality of life
5502067|NCT01287637|Economic effect|economic effect
5502068|NCT01287624|triple negative breast cancer|triple negative breast cancer
5502069|NCT01287624|fine line chemotherapy|fine line chemotherapy
5502070|NCT01287611|Cesarean section|cesarean section
5502071|NCT01287611|Kerr incision|kerr incision
5502072|NCT01287611|Purse string suturing in C/S|purse string suturing in c/s
5502073|NCT01287611|Continuous locked suturing in C/S|continuous locked suturing in c/s
5502075|NCT01287598|Probe substrate|probe substrate
5502077|NCT01287598|small molecule|small molecule
5502078|NCT01287598|pharmacokinetics|pharmacokinetics
5502079|NCT01287585|Hepatocellular carcinoma|hepatocellular carcinoma
5502080|NCT01287585|Arginine|arginine
5502081|NCT01287585|Arginine deiminase|arginine deiminase
5502082|NCT01287585|ADI-PEG 20|adi-peg 20
5502083|NCT01287572|TcCO2|tcco2
5502084|NCT01287572|sedation|sedation
5502085|NCT01287572|procedure|procedure
5502086|NCT01287572|PICU|picu
5502087|NCT01287559|NEC|nec
5502088|NCT01287559|Premature Infant|premature infant
5502089|NCT01287533|Rheumatoid arthritis|rheumatoid arthritis
5502090|NCT01287533|Glucocorticoid induced osteoporosis|glucocorticoid induced osteoporosis
5502091|NCT01287533|Vertebral fracture|vertebral fracture
5502092|NCT01287507|VLBW, NEC, Late onset sepsis|vlbw, nec, late onset sepsis
5502093|NCT01287494|elderly|elderly
5502094|NCT01287494|care management|care management
5502095|NCT01287494|primary care|primary care
5502096|NCT01287481|Fibromyalgia|fibromyalgia
5502097|NCT01287481|Behavioral interventions|behavioral interventions
5502098|NCT01287481|Psychological interventions|psychological interventions
5502099|NCT01287468|phytomedicines|phytomedicines
5502100|NCT01287468|breast cancer|breast cancer
5502101|NCT01287468|stromal fibroblasts|stromal fibroblasts
5502102|NCT01287468|MDSCs|mdscs
5502103|NCT01287468|functional mechanism|functional mechanism
5502104|NCT01287455|Asthma|asthma
5502105|NCT01287455|Vitamin D|vitamin d
5502106|NCT01287455|airway reactivity|airway reactivity
5502107|NCT01287455|metacholine challenge test|metacholine challenge test
5502108|NCT01287429|Ultrasonography|ultrasonography
5502109|NCT01287416|Suicide Intervention|suicide intervention
5502110|NCT01287416|Applied Suicide Intervention Skills Training (ASIST)|applied suicide intervention skills training (asist)
5502111|NCT01287416|Resilience Retreat|resilience retreat
5502112|NCT01287416|First Nations|first nations
5468804|NCT01425684|MRI|mri
5502113|NCT01287416|Suicide Intervention and Response Inventory (SIRI)|suicide intervention and response inventory (siri)
5502114|NCT01287403|Cereals|cereals
5502115|NCT01287403|Alkylresorcinols|alkylresorcinols
5502116|NCT01287403|Betaine|betaine
5502117|NCT01287403|Phenolics|phenolics
5502118|NCT01287403|Plasma and urine cereal phytochemicals|plasma and urine cereal phytochemicals
5502119|NCT01287390|squamous cell carcinoma|squamous cell carcinoma
5502120|NCT01287390|oral cavity|oral cavity
5502121|NCT01287390|oropharynx|oropharynx
5502122|NCT01287390|hypopharynx|hypopharynx
5502123|NCT01287390|larynx|larynx
5502124|NCT01287377|tobacco cessation|tobacco cessation
5502125|NCT01287377|smoking cessation|smoking cessation
5502126|NCT01287377|nicotine|nicotine
5502127|NCT01287377|counseling|counseling
5502128|NCT01287377|telephone|telephone
5502129|NCT01287377|self-help|self-help
5502130|NCT01287377|smoking abstinence|smoking abstinence
5502131|NCT01287377|tobacco use disorder|tobacco use disorder
5502132|NCT01287377|nicotine replacement therapy|nicotine replacement therapy
5502136|NCT01287351|observational|observational
5502137|NCT01287351|Fluticasone propionate|fluticasone propionate
5502138|NCT01287351|Metred dose inhaler|metred dose inhaler
5502139|NCT01287351|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
5502140|NCT01287351|Asthma management|asthma management
5502141|NCT01287351|Inhaled corticosteroids|inhaled corticosteroids
5502142|NCT01287351|Beclomethasone dipropionate|beclomethasone dipropionate
5502144|NCT01287325|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5502145|NCT01287325|Cough|cough
5502146|NCT01287325|DNK333|dnk333
5502147|NCT01287312|We will treat children age 1 month to 20 years with recurrent TEF after surgical failure|we will treat children age 1 month to 20 years with recurrent tef after surgical failure
5502148|NCT01287299|pregnancy|pregnancy
5502149|NCT01287299|obesity|obesity
5502150|NCT01287299|diet glycemic load|diet glycemic load
5502151|NCT01287299|body composition|body composition
5502152|NCT01287299|body fat|body fat
5502153|NCT01287299|gestational weight gain|gestational weight gain
5502154|NCT01287299|insulin resistance|insulin resistance
5502155|NCT01287286|Cancers|cancers
5502156|NCT01287286|Antrodia cinnamomea|antrodia cinnamomea
5502157|NCT01287286|Chemotherapy|chemotherapy
5502158|NCT01287286|Gastrointestinal Disorder|gastrointestinal disorder
5502159|NCT01287273|frozen-thawed|frozen-thawed
5502160|NCT01287273|IVF|ivf
5502161|NCT01287273|incubation|incubation
5502162|NCT01287273|pregnancy rate|pregnancy rate
5502163|NCT01287273|Pregnancy rate of frozen-thawed embryos of IVF treatments|pregnancy rate of frozen-thawed embryos of ivf treatments
5502164|NCT01287260|BAYA1040_Nifedipine|baya1040_nifedipine
5502165|NCT01287260|Nifedipine|nifedipine
5502166|NCT01287260|Essential hypertension|essential hypertension
5502167|NCT01287260|Japanese Patients|japanese patients
5502168|NCT01287260|Phase III|phase iii
5502169|NCT01287260|13176|13176
5502170|NCT01287247|Cervical dystonia|cervical dystonia
5502171|NCT01287247|Blepharospasm|blepharospasm
5502172|NCT01287208|Physical activity|physical activity
5502173|NCT01287208|Accelerometer|accelerometer
5502174|NCT01287208|Steps|steps
5502175|NCT01287208|Medical residents|medical residents
5502176|NCT01287195|Ulcerative Colitis|ulcerative colitis
5502177|NCT01287195|Inflammatory Bowel Disease|inflammatory bowel disease
5502178|NCT01287182|Asymptomatic Myocardial Ischemic patients|asymptomatic myocardial ischemic patients
5502184|NCT01287143|Fever|fever
5502185|NCT01287143|Signs and Symptoms|signs and symptoms
5502186|NCT01287143|Febrile Assessment Tool (FAST)|febrile assessment tool (fast)
5502187|NCT01287130|Antibodies|antibodies
5502188|NCT01287130|Pharmacokinetics|pharmacokinetics
5502189|NCT01287130|Kinase Inhibitors|kinase inhibitors
5502190|NCT01287130|Colon Cancer|colon cancer
5502191|NCT01287130|K-Ras|k-ras
5502192|NCT01287130|Colorectal Cancer|colorectal cancer
5502193|NCT01287130|Solid Tumor|solid tumor
5502194|NCT01287104|Leukemia/Lymphoma|leukemia/lymphoma
5502195|NCT01287104|Hematologic Malignancies|hematologic malignancies
5502196|NCT01287104|Leukemia|leukemia
5502197|NCT01287104|Lymphoma|lymphoma
5502198|NCT01287104|Ewing Sarcoma|ewing sarcoma
5502199|NCT01287104|Rhabdomyosarcoma|rhabdomyosarcoma
5502200|NCT01287104|Neuroblastoma|neuroblastoma
5502201|NCT01287104|Healthy Donor|healthy donor
5502202|NCT01287078|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5502203|NCT01287078|Inhaled Cyclosporine|inhaled cyclosporine
5502204|NCT01287078|Graft-Versus-Host Disease|graft-versus-host disease
5502205|NCT01287078|GVHD|gvhd
5502206|NCT01287078|Bronchiolitis Obliterans|bronchiolitis obliterans
5502207|NCT01287078|Lung|lung
5502208|NCT01287065|Fluticasone furoate|fluticasone furoate
5502209|NCT01287065|Vilanterol|vilanterol
5502210|NCT01287065|Efficacy|efficacy
5502211|NCT01287065|FEV1|fev1
5502212|NCT01287065|FF/VI Inhalation powder|ff/vi inhalation powder
5502213|NCT01287052|Migraine|migraine
5502214|NCT01287052|Pediatric|pediatric
5502215|NCT01287052|Adolescent|adolescent
5502216|NCT01287052|Nitrous Oxide|nitrous oxide
5502217|NCT01287026|MRI Catheterization|mri catheterization
5502218|NCT01287026|Right Heart Catheterization|right heart catheterization
5790003|NCT00146198|Inguinal Hernia Repair|inguinal hernia repair
5502219|NCT01287026|Pulmonary Artery Catheterization|pulmonary artery catheterization
5502220|NCT01287026|MRI Safety|mri safety
5502221|NCT01287026|Jugular Vein Catheterization|jugular vein catheterization
5502222|NCT01287026|Heart Catheterization|heart catheterization
5502223|NCT01287026|Heart Disease|heart disease
5502224|NCT01287026|Cardiovascular Disease|cardiovascular disease
5502225|NCT01287013|Image Guided Procedures|image guided procedures
5502226|NCT01287013|Xperguide CT|xperguide ct
5502227|NCT01287013|Electromagnetic Tracking|electromagnetic tracking
5502228|NCT01287013|Navigation|navigation
5502229|NCT01287013|Image Guided Procedure|image guided procedure
5502230|NCT01287013|Cancer|cancer
5502231|NCT01287013|Granuloma|granuloma
5502233|NCT01287000|Mental Health|mental health
5502234|NCT01287000|Dispersant(s)|dispersant(s)
5502235|NCT01287000|Oil Spill|oil spill
5502236|NCT01287000|Cancer|cancer
5502237|NCT01286987|BRCA1 Protein|brca1 protein
5502238|NCT01286987|BRCA2 Protein|brca2 protein
5502239|NCT01286961|Bowel preparation|bowel preparation
5502240|NCT01286961|Polyethylene glycols|polyethylene glycols
5502241|NCT01286961|Colonoscopy|colonoscopy
5502242|NCT01286961|Outpatient|outpatient
5502243|NCT01286948|LNG gel|lng gel
5502244|NCT01286948|oral LNG|oral lng
5502245|NCT01286948|follicle rupture|follicle rupture
5502246|NCT01286948|intra-vaginal administration|intra-vaginal administration
5502247|NCT01286948|growth of the leading follicle|growth of the leading follicle
5502248|NCT01286948|preovulatory peak of serum luteinizing hormone|preovulatory peak of serum luteinizing hormone
5502249|NCT01286948|characteristics of the cervical mucus|characteristics of the cervical mucus
5502250|NCT01286948|serum levels of estradiol (E2) and progesterone (P)|serum levels of estradiol (e2) and progesterone (p)
5502251|NCT01286935|Parkinson's Disease|parkinson's disease
5502253|NCT01286935|Levodopa|levodopa
5502254|NCT01286935|Patients with idiopathic Parkinson's Disease with motor fluctuations,|patients with idiopathic parkinson's disease with motor fluctuations,
5502255|NCT01286922|diabetes|diabetes
5502256|NCT01286922|exercise|exercise
5502257|NCT01286922|insulin resistance|insulin resistance
5502258|NCT01286922|interval training|interval training
5502259|NCT01286922|physical activity|physical activity
5502260|NCT01286909|Metabolic|metabolic
5502261|NCT01286896|advanced solid tumors|advanced solid tumors
5502262|NCT01286883|stem cell markers|stem cell markers
5502263|NCT01286883|prognostic markers|prognostic markers
5502264|NCT01286883|metastatic colorectal cancer|metastatic colorectal cancer
5502265|NCT01286883|circulating tumor cells|circulating tumor cells
5502266|NCT01286883|tumor microenvironment|tumor microenvironment
5502267|NCT01286883|colorectal cancer|colorectal cancer
5502268|NCT01286883|advanced colorectal cancer|advanced colorectal cancer
5502269|NCT01286870|Primary Breast Reconstruction|primary breast reconstruction
5502270|NCT01286831|Accelerator Mass Spectrometry (AMS)|accelerator mass spectrometry (ams)
5502271|NCT01286831|Beta-2 agonist|beta-2 agonist
5502272|NCT01286831|Absorption, Distribution, Metabolism and Excretion (ADME)|absorption, distribution, metabolism and excretion (adme)
5502273|NCT01286831|Radiolabel|radiolabel
5502274|NCT01286818|Colon Cancer|colon cancer
5502275|NCT01286818|Rectal Cancer|rectal cancer
5502276|NCT01286766|unresectable|unresectable
5502277|NCT01286766|locally advanced|locally advanced
5502279|NCT01286740|HIV|hiv
5502280|NCT01286740|Treatment Experienced|treatment experienced
5502281|NCT01286701|Bioequivalence|bioequivalence
5502282|NCT01286701|crossover|crossover
5502283|NCT01286701|Terbinafine hydrochloride|terbinafine hydrochloride
5502284|NCT01286701|fed|fed
5502285|NCT01286688|Bioequivalence|bioequivalence
5502286|NCT01286688|crossover|crossover
5502287|NCT01286688|Terbinafine hydrochloride|terbinafine hydrochloride
5502288|NCT01286688|Fasting|fasting
5502289|NCT01286675|ASCT|asct
5502290|NCT01286675|G-CSF|g-csf
5502291|NCT01286662|gardner syndrome|gardner syndrome
5473209|NCT01407978|Influenza|influenza
5502292|NCT01286662|colorectal carcinoma|colorectal carcinoma
5502293|NCT01286662|desmoid tumor|desmoid tumor
5502294|NCT01286662|resection|resection
5502295|NCT01286662|colon|colon
5502296|NCT01286649|Alopecia|alopecia
5502297|NCT01286649|Alopecia, Androgenetic|alopecia, androgenetic
5502298|NCT01286649|Androgenetic Alopecia|androgenetic alopecia
5502299|NCT01286636|artificial neural network|artificial neural network
5502300|NCT01286610|vibration|vibration
5502301|NCT01286610|ICU|icu
5502302|NCT01286610|blood pressure|blood pressure
5502303|NCT01286610|intracranial pressure|intracranial pressure
5502304|NCT01286610|infection|infection
5502305|NCT01286610|indirect calorimetry|indirect calorimetry
5502306|NCT01286597|lactose intolerance|lactose intolerance
5502307|NCT01286597|DNA sequencing|dna sequencing
5502308|NCT01286597|psychosocial factors|psychosocial factors
5502309|NCT01286597|irritable bowel syndrome|irritable bowel syndrome
5502310|NCT01286597|visceral hypersensitivity|visceral hypersensitivity
5502311|NCT01286584|varenicline|varenicline
5502312|NCT01286584|alcohol|alcohol
5502313|NCT01286584|placebo|placebo
5502314|NCT01286584|smoking cessation|smoking cessation
5502315|NCT01286545|Ankylosing spondylitis|ankylosing spondylitis
5502316|NCT01286545|Infliximab|infliximab
5790004|NCT00146198|Capsaicin|capsaicin
5502317|NCT01286545|Radiographic progression|radiographic progression
5502318|NCT01286532|Asthma, Asthma in Children|asthma, asthma in children
5502319|NCT01286519|pharmacokinetics|pharmacokinetics
5502320|NCT01286506|Pulse pressure variation|pulse pressure variation
5502321|NCT01286506|Continuous venovenous hemodialysis|continuous venovenous hemodialysis
5502322|NCT01286506|Volume status|volume status
5502323|NCT01286506|Critical care|critical care
5502324|NCT01286493|HIV|hiv
5502325|NCT01286493|booster|booster
5502326|NCT01286493|rabies|rabies
5502327|NCT01286493|immune response|immune response
5502328|NCT01286480|Health Care Transition|health care transition
5502338|NCT01286441|Verruca vulgaris|verruca vulgaris
5502340|NCT01286428|cancer|cancer
5502341|NCT01286428|tumor|tumor
5502342|NCT01286428|ablation|ablation
5502343|NCT01286428|Pathfinder|pathfinder
5502344|NCT01286415|Posttraumatic Stress Disorder|posttraumatic stress disorder
5502345|NCT01286415|Cognitive Processing Therapy|cognitive processing therapy
5502346|NCT01286415|combat|combat
5502347|NCT01286415|military|military
5502348|NCT01286415|CPT|cpt
5502349|NCT01286415|group therapy|group therapy
5502350|NCT01286402|Smoking cessation during pregnancy|smoking cessation during pregnancy
5502351|NCT01286402|bupropion|bupropion
5502352|NCT01286389|Mild cognitive impairment|mild cognitive impairment
5502353|NCT01286389|Dementia|dementia
5502354|NCT01286389|Obesity|obesity
5502355|NCT01286389|Overweight|overweight
5502356|NCT01286389|diet|diet
5502357|NCT01286389|caloric restriction|caloric restriction
5502358|NCT01286389|body composition|body composition
5502359|NCT01286389|weight loss|weight loss
5502360|NCT01286376|Symbiotics|symbiotics
5502361|NCT01286376|Fiber|fiber
5502362|NCT01286376|Constipation|constipation
5502363|NCT01286363|Bite force|bite force
5502364|NCT01286363|Dental occlusion|dental occlusion
5502365|NCT01286363|Face|face
5502366|NCT01286363|Mastication|mastication
5502367|NCT01286363|Morphology|morphology
5502368|NCT01286350|motivational interviewing|motivational interviewing
5502369|NCT01286350|problem solving skills training|problem solving skills training
5502370|NCT01286350|family communication|family communication
5502371|NCT01286350|social support|social support
5502372|NCT01286350|adolescents|adolescents
5502373|NCT01286337|axilla|axilla
5502374|NCT01286337|surgery|surgery
5502375|NCT01286337|technique|technique
5502376|NCT01286337|bipolar vessel sealing|bipolar vessel sealing
5502377|NCT01286324|Matricaria|matricaria
5502378|NCT01286324|Chamomile|chamomile
5502379|NCT01286324|Herb|herb
5502380|NCT01286324|Insomnia|insomnia
5502381|NCT01286311|Health Education|health education
5502382|NCT01286311|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5502383|NCT01286311|Hypolipidemic Agents/therapeutic use|hypolipidemic agents/therapeutic use
5502384|NCT01286311|Patient Education as Topic|patient education as topic
5502385|NCT01286298|diode laser|diode laser
5502386|NCT01286298|gingival enlargement|gingival enlargement
5502387|NCT01286298|gingival overgrowth|gingival overgrowth
5502388|NCT01286298|gingival hyperplasia|gingival hyperplasia
5502389|NCT01286298|orthodontics|orthodontics
5502390|NCT01286285|influenza|influenza
5502391|NCT01286285|acute respiratory infections|acute respiratory infections
5502393|NCT01286285|intensive care units|intensive care units
5502394|NCT01286285|epidemiology|epidemiology
5502396|NCT01286259|HAART suppressed|haart suppressed
5502397|NCT01286259|Disulfiram|disulfiram
5502398|NCT01286259|Antabuse|antabuse
5502399|NCT01286259|Latent reservoir|latent reservoir
5502400|NCT01286259|Eradication|eradication
5502402|NCT01286246|Progesterone|progesterone
5502403|NCT01286246|Randomized controlled trial|randomized controlled trial
5502404|NCT01286233|fatigue|fatigue
5488743|NCT01342458|Gait|gait
5502405|NCT01286233|sleep disorders|sleep disorders
5502406|NCT01286233|depression|depression
5502407|NCT01286233|stage IA breast cancer|stage ia breast cancer
5502408|NCT01286233|stage IB breast cancer|stage ib breast cancer
5502409|NCT01286233|stage II breast cancer|stage ii breast cancer
5502410|NCT01286233|stage IIIA breast cancer|stage iiia breast cancer
5502411|NCT01286207|Migraine headache|migraine headache
5502412|NCT01286181|COPD|copd
5502413|NCT01286181|Biofeedback|biofeedback
5502414|NCT01286181|Dyspnea|dyspnea
5502415|NCT01286181|Quality of life|quality of life
5502416|NCT01286181|Stress|stress
5502417|NCT01286168|Bilateral breast mastectomy|bilateral breast mastectomy
5502418|NCT01286168|Immediate tissue expanders reconstruction|immediate tissue expanders reconstruction
5502419|NCT01286155|Barrett's esophagus|barrett's esophagus
5502420|NCT01286155|gastroesophageal reflux disease|gastroesophageal reflux disease
5502421|NCT01286155|GERD|gerd
5502422|NCT01286142|Prospective, Observational Safety Study|prospective, observational safety study
5502423|NCT01286116|heart failure|heart failure
5502424|NCT01286116|percutaneous|percutaneous
5502441|NCT01286077|bone marrow cancer|bone marrow cancer
5502442|NCT01286077|Myeloma-related bone disease|myeloma-related bone disease
5502443|NCT01286077|bone mineral density|bone mineral density
5502444|NCT01286077|bone markers|bone markers
5502445|NCT01286064|adenocarcinoma,|adenocarcinoma,
5502446|NCT01286064|colorectal tumors,|colorectal tumors,
5502447|NCT01286064|endogenous porphyrins,|endogenous porphyrins,
5502448|NCT01286064|fluorescence,|fluorescence,
5502449|NCT01286064|tumor markers.|tumor markers.
5502450|NCT01286051|ovulation induction, GnRH|ovulation induction, gnrh
5502451|NCT01286038|platelets|platelets
5502452|NCT01286025|medical education|medical education
5502453|NCT01286025|problem-based learning|problem-based learning
5502454|NCT01286025|interactive tutorial|interactive tutorial
5502455|NCT01286012|End Stage Renal Disease, Hemodialysis, SFP|end stage renal disease, hemodialysis, sfp
5502456|NCT01285986|Graft patency|graft patency
5502457|NCT01285986|Limb salvage|limb salvage
5502458|NCT01285960|Uterine fibroids|uterine fibroids
5502459|NCT01285960|MRgFUS|mrgfus
5502460|NCT01285960|ExAblate|exablate
5502461|NCT01285960|Focused Ultrasound|focused ultrasound
5502462|NCT01285960|Symptomatic uterine fibroids|symptomatic uterine fibroids
5502463|NCT01285947|pain experience|pain experience
5502464|NCT01285947|energy devices|energy devices
5502465|NCT01285947|Ulthera|ulthera
5502466|NCT01285947|Thermage|thermage
5502467|NCT01285947|VBeam|vbeam
5502468|NCT01285921|hippocampal|hippocampal
5502469|NCT01285921|vestibular test|vestibular test
5502470|NCT01285908|Baroreceptor|baroreceptor
5502471|NCT01285908|Norepinephrine|norepinephrine
5502472|NCT01285908|Orthostatic Hypotension|orthostatic hypotension
5502473|NCT01285908|Sympathetic Nervous System|sympathetic nervous system
5502474|NCT01285908|Blood Pressure|blood pressure
5502475|NCT01285895|Lung and heart transplantations|lung and heart transplantations
5502476|NCT01285895|Mucoviscidosis|mucoviscidosis
5502477|NCT01285895|Educational needs|educational needs
5502478|NCT01285882|Lung transplantations|lung transplantations
5502479|NCT01285882|Representations|representations
5502480|NCT01285882|Mucoviscidosis|mucoviscidosis
5502481|NCT01285869|Pneumonia|pneumonia
5502482|NCT01285869|Intervention Studies|intervention studies
5502483|NCT01285869|Aged|aged
5502484|NCT01285869|Aged, 80 and over|aged, 80 and over
5502485|NCT01285869|Geriatric Assessment|geriatric assessment
5502486|NCT01285856|patients|patients
5502487|NCT01285856|illicit consumption of psychotropic agents and alcohol|illicit consumption of psychotropic agents and alcohol
5502488|NCT01285856|buprenorphine|buprenorphine
5502489|NCT01285856|methadone|methadone
5502490|NCT01285830|Infants|infants
5502491|NCT01285830|Probiotics|probiotics
5502492|NCT01285830|Prevention|prevention
5502493|NCT01285830|Lactobacillus reuteri|lactobacillus reuteri
5502494|NCT01285830|Eczema|eczema
5502495|NCT01285830|IgE|ige
5502496|NCT01285830|Sensitization|sensitization
5502497|NCT01285830|Microbiota|microbiota
5502498|NCT01285830|Chemokines|chemokines
5502499|NCT01285791|morbid obesity|morbid obesity
5502500|NCT01285791|intra-abdominal visceral fat|intra-abdominal visceral fat
5502501|NCT01285791|gastric bypass|gastric bypass
5502502|NCT01285791|sleeve gastrectomy|sleeve gastrectomy
5502503|NCT01285791|gastric banding|gastric banding
5502504|NCT01285791|visceral fat|visceral fat
5502505|NCT01285778|Anal squamous cell carcinoma|anal squamous cell carcinoma
5502506|NCT01285778|panitumumab|panitumumab
5502507|NCT01285778|chemoradiation|chemoradiation
5502508|NCT01285778|anal cancer|anal cancer
5502509|NCT01285778|GEMCAD-09-02|gemcad-09-02
5502510|NCT01285739|Pulmonary Disease, Chronic Obstructive.|pulmonary disease, chronic obstructive.
5502511|NCT01285739|Tracheostomy.|tracheostomy.
5502512|NCT01285739|Invasive Mechanical Ventilation.|invasive mechanical ventilation.
5502513|NCT01285739|Non-Invasive Mechanical Ventilation.|non-invasive mechanical ventilation.
5502514|NCT01285726|Peritoneal dialysis|peritoneal dialysis
5502515|NCT01285726|Hydration status|hydration status
5502516|NCT01285726|Residual renal function|residual renal function
5502517|NCT01285726|Bioimpedance spectroscopy|bioimpedance spectroscopy
5502518|NCT01285726|Body composition monitor|body composition monitor
5502520|NCT01285713|Gastroenteritis|gastroenteritis
5502521|NCT01285713|Dehydration in Gastroenteritis|dehydration in gastroenteritis
5502522|NCT01285687|Tonsillectomy|tonsillectomy
5502523|NCT01285687|Post-Operative Pain|post-operative pain
5502524|NCT01285687|Acupuncture|acupuncture
5502525|NCT01285674|cisplatin|cisplatin
5502526|NCT01285674|ototoxicity|ototoxicity
5502527|NCT01285674|intratympanic steroids|intratympanic steroids
5502528|NCT01285661|Deep venous thrombosis|deep venous thrombosis
5502529|NCT01285661|Pulmonary embolism|pulmonary embolism
5502530|NCT01285661|Ultrasonography|ultrasonography
5502531|NCT01285661|D-dimer|d-dimer
5502532|NCT01285661|Venous thromboembolism|venous thromboembolism
5502533|NCT01285661|Bleeding|bleeding
5502534|NCT01285648|chest tubes,|chest tubes,
5502535|NCT01285648|Continuous Positive Airway Pressure,|continuous positive airway pressure,
5502536|NCT01285648|lung resection, thoracic surgery,|lung resection, thoracic surgery,
5502537|NCT01285648|noninvasive ventilation,|noninvasive ventilation,
5502538|NCT01285648|postoperative|postoperative
5502539|NCT01285622|Surgery; gynecological|surgery; gynecological
5502540|NCT01285622|Stroke volume|stroke volume
5502541|NCT01285596|Pharmacokinetics|pharmacokinetics
5502542|NCT01285596|Cardiography|cardiography
5502543|NCT01285596|Impedance|impedance
5502544|NCT01285596|Age groups|age groups
5502545|NCT01285596|Gender Identity|gender identity
5502546|NCT01285583|Amyotrophoc Lateral Sclerosis|amyotrophoc lateral sclerosis
5502547|NCT01285583|TRO19622|tro19622
5502548|NCT01285583|Olesoxime|olesoxime
5502549|NCT01285583|Trophos|trophos
5502550|NCT01285557|Gastric Cancer , S-1, Phase 3|gastric cancer , s-1, phase 3
5502551|NCT01285544|statins|statins
5502552|NCT01285544|cholesterol|cholesterol
5502553|NCT01285544|hypercholesterolemia|hypercholesterolemia
5502554|NCT01285544|atorvastatin|atorvastatin
5502555|NCT01285544|Dyslipidemia in cardiovascular disease (KoLipinon)|dyslipidemia in cardiovascular disease (kolipinon)
5502556|NCT01285531|lumbar puncture|lumbar puncture
5502557|NCT01285531|Compass|compass
5502558|NCT01285531|pressure transducer|pressure transducer
5502559|NCT01285531|manometry|manometry
5502560|NCT01285531|The focus of the study is to improve lumbar puncture(LP)success, reduce the number of LP attempts, reduce the number of traumatic attempts.|the focus of the study is to improve lumbar puncture(lp)success, reduce the number of lp attempts, reduce the number of traumatic attempts.
5502561|NCT01285518|Type 2 diabetes|type 2 diabetes
5502562|NCT01285518|intravenous|intravenous
5502563|NCT01285518|single dose|single dose
5502564|NCT01285505|alprazolam|alprazolam
5502565|NCT01285505|sublingual|sublingual
5502566|NCT01285505|bioequivalence|bioequivalence
5502567|NCT01285492|COPD|copd
5502568|NCT01285492|QVA149|qva149
5502569|NCT01285492|NVA237|nva237
5502570|NCT01285492|indacaterol|indacaterol
5502571|NCT01285492|combination bronchodilator|combination bronchodilator
5502572|NCT01285479|Fingolimod|fingolimod
5502573|NCT01285479|FTY720|fty720
5502574|NCT01285479|Gilenya|gilenya
5502575|NCT01285479|Multiple sclerosis|multiple sclerosis
5502577|NCT01285479|Safety|safety
5502578|NCT01285479|Pregnancy|pregnancy
5502579|NCT01285479|Pregnancy outcomes|pregnancy outcomes
5502580|NCT01285466|Cancer|cancer
5502581|NCT01285466|BEZ235|bez235
5502582|NCT01285466|BKM120|bkm120
5502583|NCT01285466|paclitaxel|paclitaxel
5502584|NCT01285466|trastuzumab|trastuzumab
5502585|NCT01285453|ASA404,|asa404,
5502586|NCT01285453|vadimezan,|vadimezan,
5502587|NCT01285453|docetaxel|docetaxel
5502588|NCT01285440|breast|breast
5502589|NCT01285440|biopsy|biopsy
5502590|NCT01285440|suspicious lesion|suspicious lesion
5502591|NCT01285440|molecular breast imaging|molecular breast imaging
5502592|NCT01285427|DNA, sequencing|dna, sequencing
5502593|NCT01285427|Identification and definition of Class I and II Human Leukocyte Antigens (HLA)|identification and definition of class i and ii human leukocyte antigens (hla)
5502693|NCT01285024|hemostat|hemostat
5502594|NCT01285414|Glioblastoma|glioblastoma
5502595|NCT01285414|Brain Neoplasms|brain neoplasms
5502596|NCT01285414|Brain Cancer|brain cancer
5502597|NCT01285414|Verubulin|verubulin
5502598|NCT01285401|Multiple Sclerosis|multiple sclerosis
5502599|NCT01285401|Rebif|rebif
5502600|NCT01285401|VigantOL® oil|vigantol® oil
5502601|NCT01285401|Vitamin D|vitamin d
5502602|NCT01285401|Add-on treatment|add-on treatment
5502603|NCT01285388|Safety|safety
5502604|NCT01285388|Tolerability|tolerability
5502605|NCT01285388|Pharmacokinetic|pharmacokinetic
5502606|NCT01285362|Fatty Liver Disease|fatty liver disease
5502608|NCT01285362|Docosahexaenoic Acid|docosahexaenoic acid
5502609|NCT01285362|Eicosapentanoic Acid|eicosapentanoic acid
5502610|NCT01285362|Omega-3 Fatty Acids|omega-3 fatty acids
5502611|NCT01285362|Elevated Transaminases|elevated transaminases
5502612|NCT01285362|Fish oil supplements|fish oil supplements
5502613|NCT01285349|HIV, STI, condom use, drug use,|hiv, sti, condom use, drug use,
5502614|NCT01285336|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5502615|NCT01285336|DNA repair system|dna repair system
5502616|NCT01285336|polymorphism|polymorphism
5502617|NCT01285336|susceptibility|susceptibility
5502618|NCT01285336|copy number variation (CNV)|copy number variation (cnv)
5502619|NCT01285310|Rheumatoid, Arthritis|rheumatoid, arthritis
5502620|NCT01285297|Transmyocardial revascularization (TMR)|transmyocardial revascularization (tmr)
5502621|NCT01285297|Bone marrow aspirate concentrate (BMAC)|bone marrow aspirate concentrate (bmac)
5502622|NCT01285297|Angina|angina
5502623|NCT01285284|Colonoscopy|colonoscopy
5502624|NCT01285284|Music|music
5502625|NCT01285284|Tolerance|tolerance
5502626|NCT01285284|Pain|pain
5502627|NCT01285284|Anxiety|anxiety
5502628|NCT01285284|Dose of sedative drugs administered during the procedure|dose of sedative drugs administered during the procedure
5502629|NCT01285271|xenon|xenon
5502630|NCT01285271|sevoflurane|sevoflurane
5502631|NCT01285271|cardiac anesthesia|cardiac anesthesia
5502632|NCT01285271|CABG|cabg
5502633|NCT01285271|Bypass surgery|bypass surgery
5502634|NCT01285258|Peripartum|peripartum
5502635|NCT01285258|hysterectomy|hysterectomy
5502636|NCT01285258|placenta accreta|placenta accreta
5502637|NCT01285258|mortality|mortality
5502638|NCT01285245|insulin sensitivity|insulin sensitivity
5502639|NCT01285245|interleukin-1 receptor antagonist|interleukin-1 receptor antagonist
5502640|NCT01285245|inflammation|inflammation
5502641|NCT01285245|hyperglycemia-induced insulin resistance|hyperglycemia-induced insulin resistance
5502642|NCT01285219|Granulocyte colony-stimulating factor , recombinant|granulocyte colony-stimulating factor , recombinant
5502643|NCT01285219|Polyethylene glycols|polyethylene glycols
5502644|NCT01285219|Neutropenia|neutropenia
5502645|NCT01285219|Drug therapy, combination|drug therapy, combination
5502646|NCT01285193|hypertension|hypertension
5502647|NCT01285193|high blood pressure|high blood pressure
5502648|NCT01285193|treatment|treatment
5502649|NCT01285193|breath control|breath control
5502650|NCT01285193|breathing exercise|breathing exercise
5502651|NCT01285193|audio CD|audio cd
5502652|NCT01285180|COPD|copd
5502653|NCT01285180|Quality of life|quality of life
5502654|NCT01285180|sociodemographic data|sociodemographic data
5502655|NCT01285180|cost-of-illness data|cost-of-illness data
5502656|NCT01285180|roflumilast|roflumilast
5502657|NCT01285180|Daxas|daxas
5502658|NCT01285167|COPD|copd
5502659|NCT01285167|Quality of life|quality of life
5502660|NCT01285167|lung function|lung function
5502661|NCT01285167|spirometry|spirometry
5502662|NCT01285167|roflumilast|roflumilast
5502663|NCT01285167|Daxas|daxas
5502664|NCT01285167|severe COPD|severe copd
5502665|NCT01285154|Hip dysplasia|hip dysplasia
5502666|NCT01285154|Triple Osteotomy|triple osteotomy
5502667|NCT01285154|Femoral Head Coverage|femoral head coverage
5502668|NCT01285154|Femoral Head Medialization|femoral head medialization
5502669|NCT01285141|HIV Infections|hiv infections
5502670|NCT01285141|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5502671|NCT01285115|Generalized anxiety disorder|generalized anxiety disorder
5502672|NCT01285115|Jingji-zhengchong|jingji-zhengchong
5502673|NCT01285115|Gamisoyosan|gamisoyosan
5502674|NCT01285115|anxiety|anxiety
5502675|NCT01285063|overweight|overweight
5502676|NCT01285063|obesity|obesity
5502677|NCT01285063|physical fitness|physical fitness
5502678|NCT01285063|kinder garden|kinder garden
5502679|NCT01285063|preschool|preschool
5502680|NCT01285050|HIV|hiv
5502681|NCT01285050|Human immunodeficiency virus|human immunodeficiency virus
5502682|NCT01285050|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5502683|NCT01285050|AIDS Virus|aids virus
5502684|NCT01285050|Immunodeficiency Virus, Human|immunodeficiency virus, human
5502685|NCT01285050|Virus, Human Immunodeficiency|virus, human immunodeficiency
5502686|NCT01285050|Hepatitis C|hepatitis c
5502687|NCT01285050|Hepatitis C, chronic|hepatitis c, chronic
5502688|NCT01285050|Hepatitis C virus|hepatitis c virus
5502689|NCT01285050|Hepatitis C antibodies|hepatitis c antibodies
5502690|NCT01285050|Hepatitis C antigens|hepatitis c antigens
5502691|NCT01285024|total hip arthroplasty|total hip arthroplasty
5502692|NCT01285024|transfusion|transfusion
5502694|NCT01285011|arthrodesis|arthrodesis
5502695|NCT01285011|PIP joint|pip joint
5502696|NCT01284998|forefoot deformities|forefoot deformities
5502697|NCT01284998|basal osteotomy|basal osteotomy
5502698|NCT01284959|cognitive function|cognitive function
5502699|NCT01284959|subjective experiences|subjective experiences
5502700|NCT01284959|neuroleptic-induced deficit syndrome|neuroleptic-induced deficit syndrome
5502701|NCT01284959|paliperidone extended-release|paliperidone extended-release
5502702|NCT01284959|risperidone|risperidone
5502703|NCT01284946|PCT sporadic or familial|pct sporadic or familial
5502710|NCT01284933|Carotid Artery Plaque|carotid artery plaque
5502711|NCT01284933|Atherosclerosis|atherosclerosis
5502712|NCT01284920|docetaxel|docetaxel
5502713|NCT01284920|Response Evaluation Criteria in Solid Tumor (RECIST)|response evaluation criteria in solid tumor (recist)
5502714|NCT01284920|PSA level|psa level
5487383|NCT01348009|Gastric cancer|gastric cancer
5502715|NCT01284920|MDV3100|mdv3100
5502716|NCT01284907|Asthma|asthma
5473585|NCT01406691|teen|teen
5502717|NCT01284907|Asthma therapy|asthma therapy
5502718|NCT01284907|Randomized controlled trial|randomized controlled trial
5502719|NCT01284907|children|children
5502720|NCT01284894|Dysphagia|dysphagia
5502721|NCT01284894|Conventional manometry|conventional manometry
5502722|NCT01284894|High resolution manometry|high resolution manometry
5502723|NCT01284881|MRA|mra
5502724|NCT01284881|compliance|compliance
5502725|NCT01284881|OSAHS|osahs
5502726|NCT01284868|Mechanisms of Pharmacological Action|mechanisms of pharmacological action
5502727|NCT01284868|Pharmacodynamics|pharmacodynamics
5502728|NCT01284868|Pharmacokinetics|pharmacokinetics
5502729|NCT01284855|neurotoxic envenoming (WHO ICD-10 T63.0)|neurotoxic envenoming (who icd-10 t63.0)
5502730|NCT01284842|sleep-deprivation|sleep-deprivation
5502731|NCT01284842|virtual reality|virtual reality
5502732|NCT01284842|residency|residency
5502733|NCT01284842|performance|performance
5502734|NCT01284816|severely obese patients|severely obese patients
5502735|NCT01284803|patients|patients
5502736|NCT01284803|moderate depression|moderate depression
5502737|NCT01284777|cancerology|cancerology
5502738|NCT01284777|genetic|genetic
5502739|NCT01284764|Endoscopy|endoscopy
5502740|NCT01284764|Gastrectomy|gastrectomy
5502741|NCT01284764|Stomach neoplasms|stomach neoplasms
5502742|NCT01284738|TM|tm
5502743|NCT01284738|TI|ti
5502744|NCT01284738|MP|mp
5502745|NCT01284712|treatment by bleedings|treatment by bleedings
5502746|NCT01284699|Parkinson|parkinson
5502747|NCT01284699|contraindication to Intracerebral electrode implantation|contraindication to intracerebral electrode implantation
5502748|NCT01284699|Gamma Knife radiosurgery|gamma knife radiosurgery
5502749|NCT01284686|Pathophysiology|pathophysiology
5502750|NCT01284686|Parkinson|parkinson
5502751|NCT01284686|neuronal oscillations|neuronal oscillations
5502752|NCT01284673|Cord blood stem|cord blood stem
5502753|NCT01284673|neonatal asphyxia|neonatal asphyxia
5502754|NCT01284647|Chronic Erosive Gastritis|chronic erosive gastritis
5502755|NCT01284647|Teprenone|teprenone
5502756|NCT01284647|Sucralfate|sucralfate
5502757|NCT01284634|Cannabidiol|cannabidiol
5502758|NCT01284634|Fatty liver|fatty liver
5502759|NCT01284634|Diabetes|diabetes
5502760|NCT01284634|Body fat|body fat
5502761|NCT01284608|Observational|observational
5502762|NCT01284608|prospective|prospective
5502763|NCT01284608|metabolic changes|metabolic changes
5502764|NCT01284608|metabolic syndrome|metabolic syndrome
5502765|NCT01284608|diabetes|diabetes
5502766|NCT01284608|prostatic cancer|prostatic cancer
5502767|NCT01284608|risk fracture|risk fracture
5502768|NCT01284595|Radioactive carbon|radioactive carbon
5502769|NCT01284595|Absorption|absorption
5502770|NCT01284595|Distribution|distribution
5502771|NCT01284595|Metabolism|metabolism
5502772|NCT01284595|Excretion|excretion
5502773|NCT01284595|Healthy Volunteers|healthy volunteers
5502774|NCT01284582|CETP|cetp
5502775|NCT01284582|Vaccine|vaccine
5502776|NCT01284582|Cholesterol|cholesterol
5502777|NCT01284582|Inhibition|inhibition
5502778|NCT01284556|partial onset seizures|partial onset seizures
5502779|NCT01284530|Epilepsy|epilepsy
5502780|NCT01284530|Pediatrics|pediatrics
5502781|NCT01284530|Young Adults|young adults
5502782|NCT01284517|Bipolar I Depression|bipolar i depression
5502783|NCT01284517|Lurasidone|lurasidone
5502784|NCT01284517|Latuda|latuda
5502785|NCT01284491|Breast reduction|breast reduction
5502786|NCT01284491|PlasmaBlade|plasmablade
5502787|NCT01284491|Electrosurgery|electrosurgery
5502788|NCT01284491|PEAK Surgical|peak surgical
5502789|NCT01284491|Medtronic Advanced Energy|medtronic advanced energy
5502790|NCT01284491|Medtronic|medtronic
5502791|NCT01284478|pseudophakic cystoid macular edema, diabetic macular edema, Irvine Gass Syndrome, cataract surgery, ozurdex, dexamethasone|pseudophakic cystoid macular edema, diabetic macular edema, irvine gass syndrome, cataract surgery, ozurdex, dexamethasone
5497049|NCT01307891|Metastatic breast cancer|metastatic breast cancer
5502794|NCT01284465|Barriers to diabetes self-management|barriers to diabetes self-management
5502795|NCT01284452|Septic shock|septic shock
5502796|NCT01284452|Severe sepsis|severe sepsis
5502797|NCT01284452|Acute lung injury|acute lung injury
5502798|NCT01284452|Acute respiratory distress syndrome|acute respiratory distress syndrome
5502800|NCT01284426|Chronic urticaria|chronic urticaria
5502801|NCT01284426|Natural course|natural course
5502802|NCT01284426|Remission|remission
5502803|NCT01284400|heart failure|heart failure
5502804|NCT01284400|disease management|disease management
5502811|NCT01284374|Attitude to Health|attitude to health
5502812|NCT01284374|Decision Making|decision making
5502813|NCT01284374|Qualitative Research|qualitative research
5502814|NCT01284361|intermittent catheter|intermittent catheter
5502815|NCT01284361|preference|preference
5502816|NCT01284348|Chemotherapy induced anemia|chemotherapy induced anemia
5502817|NCT01284348|Non-small cell lung cancer|non-small cell lung cancer
5502818|NCT01284335|Advanced solid tumors|advanced solid tumors
5502819|NCT01284335|Unresectable|unresectable
5502820|NCT01284335|Metastatic|metastatic
5502821|NCT01284335|Limited treatment options|limited treatment options
5502822|NCT01284335|Measurable or nonmeasurable disease|measurable or nonmeasurable disease
5502823|NCT01284309|Intraocular Pressure (IOP)|intraocular pressure (iop)
5502824|NCT01284309|YM178|ym178
5502825|NCT01284283|Arthrosis|arthrosis
5502826|NCT01284283|Rheumatoid Arthrosis|rheumatoid arthrosis
5502827|NCT01284283|Arthritic Joint|arthritic joint
5502828|NCT01284283|Rheumatoid Arthritis|rheumatoid arthritis
5502829|NCT01284283|Osteoarthritis|osteoarthritis
5502830|NCT01284283|Total Ankle Replacement|total ankle replacement
5502831|NCT01284270|Cardiac MRI|cardiac mri
5502832|NCT01284270|Plaque|plaque
5502833|NCT01284257|EC-MPS|ec-mps
5502835|NCT01284257|kidney transplant|kidney transplant
5502836|NCT01284257|outcomes|outcomes
5502837|NCT01284257|mycophenolate sodium|mycophenolate sodium
5502838|NCT01284257|mycophenolic acid (MPA)|mycophenolic acid (mpa)
5502839|NCT01284244|Urinary Incontinence, Stress|urinary incontinence, stress
5502840|NCT01284244|pessary|pessary
5502841|NCT01284244|conservative management|conservative management
5502842|NCT01284231|MEDI-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific T-cell engager|medi-565, gastrointestinal adenocarcinomas, carcinoembryonic antigen, bispecific t-cell engager
5502843|NCT01284205|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer
5502844|NCT01284205|superficial bladder cancer|superficial bladder cancer
5502845|NCT01284192|B-cell Lymphoma|b-cell lymphoma
5502846|NCT01284192|Advanced Malignancies|advanced malignancies
5502847|NCT01284192|Anaplastic Lymphoma Kinase (ALK)|anaplastic lymphoma kinase (alk)
5502849|NCT01284192|Solid Tumor|solid tumor
5502850|NCT01284179|Functional Chest Pain|functional chest pain
5502851|NCT01284179|Functional GI Disorders|functional gi disorders
5502852|NCT01284179|Home Hypnotherapy|home hypnotherapy
5502853|NCT01284153|respiratory gating|respiratory gating
5502854|NCT01284153|prone radiotherapy|prone radiotherapy
5502855|NCT01284153|breast cancer|breast cancer
5502856|NCT01284140|Critical illness|critical illness
5502857|NCT01284140|Sleep|sleep
5502858|NCT01284140|Polysomnography|polysomnography
5502859|NCT01284140|Respiratory failure|respiratory failure
5502860|NCT01284140|Circadian rhythm|circadian rhythm
5502861|NCT01284140|Sedation|sedation
5502862|NCT01284127|superficial siderosis|superficial siderosis
5502863|NCT01284114|Elderly chronic kidney disease|elderly chronic kidney disease
5502864|NCT01284114|Hypertension|hypertension
5502865|NCT01284114|Aliskiren|aliskiren
5502866|NCT01284088|Male Circumcision|male circumcision
5502867|NCT01284088|HIV Prevention|hiv prevention
5502868|NCT01284088|Medical Device|medical device
5502869|NCT01284062|Active Ulcerative Colitis|active ulcerative colitis
5502870|NCT01284062|Phase 2A|phase 2a
5502871|NCT01284062|Double-blind|double-blind
5502872|NCT01284062|Randomized|randomized
5502873|NCT01284062|PK/PD Biomarker Study|pk/pd biomarker study
5502874|NCT01284049|Home Parenteral Nutrition|home parenteral nutrition
5502875|NCT01284049|Intralipid 20%®|intralipid 20%®
5502876|NCT01284049|OMEGAVEN 10%®|omegaven 10%®
5502877|NCT01284049|Liver diseases|liver diseases
5502878|NCT01284036|Healthy subject|healthy subject
5502879|NCT01284036|safety|safety
5502880|NCT01284036|PK study|pk study
5502881|NCT01284036|healthy volunteers|healthy volunteers
5502882|NCT01284023|near infrared spectroscopy|near infrared spectroscopy
5502883|NCT01284023|acute compartment syndrome|acute compartment syndrome
5502885|NCT01283997|Multiple Myeloma|multiple myeloma
5502886|NCT01283997|Neuropathy|neuropathy
5502887|NCT01283997|Peripheral Nerve Function|peripheral nerve function
5502888|NCT01283997|Touch Detection Threshold|touch detection threshold
5502889|NCT01283997|Nerve Damage|nerve damage
5502890|NCT01283997|Thalidomide|thalidomide
5502891|NCT01283997|Bortezomib|bortezomib
5502892|NCT01283997|Velcade|velcade
5502893|NCT01283997|Minocycline|minocycline
5502894|NCT01283997|Dynacin|dynacin
5502895|NCT01283997|Minocin|minocin
5502896|NCT01283997|Minocin PAC|minocin pac
5502897|NCT01283997|Myrac|myrac
5502900|NCT01283984|tolerability|tolerability
5502901|NCT01283984|healthy|healthy
5502902|NCT01283984|inhaled|inhaled
5502903|NCT01283984|respiratory disease|respiratory disease
5502904|NCT01283958|Iloprost, Eisenmenger's syndrome|iloprost, eisenmenger's syndrome
5502905|NCT01283945|VEGFRs|vegfrs
5502906|NCT01283945|FGFR1|fgfr1
5502907|NCT01283945|angiogenesis|angiogenesis
5502908|NCT01283906|Mucositis|mucositis
5502909|NCT01283906|Head and Neck Cancer|head and neck cancer
5502910|NCT01283906|Squamous Cell Cancer|squamous cell cancer
5502911|NCT01283906|Chemotherapy|chemotherapy
5502912|NCT01283906|Radiation Therapy|radiation therapy
5502913|NCT01283906|Oral Rinse|oral rinse
5502914|NCT01283880|kidney|kidney
5502915|NCT01283880|transplantation|transplantation
5502916|NCT01283880|metabolic acidosis|metabolic acidosis
5502917|NCT01283880|renal tubular acidosis|renal tubular acidosis
5502918|NCT01283880|nephrocalcinosis|nephrocalcinosis
5502919|NCT01283815|Laparoscopy|laparoscopy
5502920|NCT01283815|Drainage|drainage
5502921|NCT01283815|Appendectomy|appendectomy
5487577|NCT01347281|[18F]HX4|[18f]hx4
5502922|NCT01283789|breast|breast
5502923|NCT01283789|cancer|cancer
5502924|NCT01283789|metastatic|metastatic
5502925|NCT01283789|metastasis|metastasis
5502926|NCT01283763|Cervical Intraepithelial Neoplasia, Imiquimod, conization|cervical intraepithelial neoplasia, imiquimod, conization
5502927|NCT01283750|care coordination|care coordination
5502928|NCT01283750|dementia care|dementia care
5502929|NCT01283750|intervention|intervention
5502930|NCT01283750|unmet needs|unmet needs
5502931|NCT01283750|community|community
5502932|NCT01283750|older adults|older adults
5502933|NCT01283750|caregiver|caregiver
5502934|NCT01283737|Osteochondritis Dissecans|osteochondritis dissecans
5502935|NCT01283737|OCD|ocd
5502936|NCT01283737|Mosaicplasty|mosaicplasty
5502937|NCT01283737|Demineralised Bone Matrix|demineralised bone matrix
5502938|NCT01283737|DBX|dbx
5502939|NCT01283737|DBX Putty|dbx putty
5502940|NCT01283724|Endometriosis|endometriosis
5502941|NCT01283724|DEXA|dexa
5658958|NCT00666965|RLS|rls
5502942|NCT01283724|Adolescent|adolescent
5502943|NCT01283724|Safety|safety
5502944|NCT01283724|Efficacy|efficacy
5502945|NCT01283724|Post-menarche|post-menarche
5502946|NCT01283711|wrinkles reduction|wrinkles reduction
5502947|NCT01283711|rhytides reduction|rhytides reduction
5502948|NCT01283711|RF treatment|rf treatment
5502949|NCT01283698|psoriasis|psoriasis
5502950|NCT01283698|topical|topical
5502951|NCT01283698|PPT|ppt
5502952|NCT01283685|Exercise, Physical|exercise, physical
5502953|NCT01283672|Whole grains|whole grains
5502954|NCT01283672|Barley|barley
5502955|NCT01283672|Oats|oats
5502956|NCT01283672|Cardiovascular disease|cardiovascular disease
5502957|NCT01283672|Postprandial lipid metabolism|postprandial lipid metabolism
5502958|NCT01283672|Endothelial function|endothelial function
5502959|NCT01283672|Risk of cardiovascular disease in healthy men and women|risk of cardiovascular disease in healthy men and women
5502960|NCT01283659|computed tomographic angiography|computed tomographic angiography
5502961|NCT01283659|coronary angiogram|coronary angiogram
5502962|NCT01283659|cost effectiveness|cost effectiveness
5502963|NCT01283659|QoL|qol
5502964|NCT01283659|Heart failure|heart failure
5502965|NCT01283659|diagnostic accuracy|diagnostic accuracy
5502966|NCT01283659|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5502967|NCT01283633|neuromodulation|neuromodulation
5502968|NCT01283633|remote presence robotics|remote presence robotics
5502969|NCT01283620|stroke|stroke
5502970|NCT01283620|extremity, upper|extremity, upper
5502971|NCT01283607|in vitro fertilization|in vitro fertilization
5502972|NCT01283607|e-health|e-health
5502973|NCT01283607|cognitive behavioral therapy|cognitive behavioral therapy
5502974|NCT01283607|psychosocial risk profile|psychosocial risk profile
5502975|NCT01283607|emotional maladjustment|emotional maladjustment
5502976|NCT01283568|PMS, climacteric, depression|pms, climacteric, depression
5502977|NCT01283555|Microbicide, Applicator, Safety|microbicide, applicator, safety
5502978|NCT01283542|Non-functioning pituitary adenoma,|non-functioning pituitary adenoma,
5502979|NCT01283542|pasireotide LAR,|pasireotide lar,
5502980|NCT01283542|tumor volume|tumor volume
5502981|NCT01283529|Intrathoracal blood volume|intrathoracal blood volume
5502982|NCT01283529|Cardiac output|cardiac output
5502983|NCT01283529|Children|children
5502984|NCT01283516|ALK inhibitor,|alk inhibitor,
5502985|NCT01283516|NSCLC,|nsclc,
5502986|NCT01283516|LDK378,|ldk378,
5502987|NCT01283516|ceritinib,|ceritinib,
5502988|NCT01283516|genetic abnormalities|genetic abnormalities
5502989|NCT01283503|PI3K,|pi3k,
5502990|NCT01283503|Advanced solid tumor|advanced solid tumor
5502991|NCT01283490|topical anesthetic, sonophoresis|topical anesthetic, sonophoresis
5502992|NCT01283477|Caesarean Delivery|caesarean delivery
5502993|NCT01283477|Pruritis|pruritis
5502994|NCT01283477|Intrathecal Morphine|intrathecal morphine
5502995|NCT01283477|Acupuncture At LI11|acupuncture at li11
5502996|NCT01283464|Retinol|retinol
5502997|NCT01283464|Tretinoin|tretinoin
5503009|NCT01283360|HIV negative|hiv negative
5503010|NCT01283360|microbicide|microbicide
5503011|NCT01283360|prevention|prevention
5503012|NCT01283347|Parkinson's disease|parkinson's disease
5503013|NCT01283334|Head and Neck Cancer|head and neck cancer
5503014|NCT01283334|Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)|recurrent metastatic squamous cell carcinoma of the head and neck (scchn)
5503015|NCT01283321|Hemostasis|hemostasis
5503016|NCT01283321|Cardiopulmonary bypass (heart-lung machine)|cardiopulmonary bypass (heart-lung machine)
5503017|NCT01283321|Fibrinogen|fibrinogen
5503018|NCT01283321|platelet|platelet
5503019|NCT01283308|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5503020|NCT01283308|India|india
5503021|NCT01283308|Prevention & Control|prevention & control
5503022|NCT01283308|Lifestyle Intervention|lifestyle intervention
5503023|NCT01283308|Translational Research|translational research
5503024|NCT01283269|Rehabilitation|rehabilitation
5503025|NCT01283269|Cognitive Intervention|cognitive intervention
5503026|NCT01283269|Prevention|prevention
5503027|NCT01283243|ARFI Imaging|arfi imaging
5503028|NCT01283243|Normal values|normal values
5503029|NCT01283243|HIV infection|hiv infection
5503030|NCT01283230|ARFI imaging|arfi imaging
5503031|NCT01283230|normal values|normal values
5503032|NCT01283230|chronic liver disease|chronic liver disease
5503033|NCT01283230|liver donors|liver donors
5503034|NCT01283230|kidney donors|kidney donors
5503035|NCT01283191|substance use|substance use
5503037|NCT01283191|drug abuse|drug abuse
5503038|NCT01283191|exercise|exercise
5503039|NCT01283191|physical activity|physical activity
5503040|NCT01283178|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
5503041|NCT01283165|health education|health education
5503042|NCT01283165|Polyparasitism|polyparasitism
5503043|NCT01283165|school based deworming program|school based deworming program
5503044|NCT01283165|integrated control of parasites|integrated control of parasites
5503045|NCT01283152|Hepatic Encephalopathy|hepatic encephalopathy
5503046|NCT01283152|HE|he
5503047|NCT01283152|Cirrhosis|cirrhosis
5503048|NCT01283152|PSE|pse
5503049|NCT01283152|Portosystemic Encephalopathy|portosystemic encephalopathy
5503050|NCT01283152|Hepatic coma|hepatic coma
5503051|NCT01283152|AMS|ams
5503052|NCT01283152|Altered mental status|altered mental status
5503053|NCT01283152|Complications of cirrhosis|complications of cirrhosis
5503054|NCT01283152|Chronic liver disease|chronic liver disease
5503055|NCT01283139|SLE|sle
5503056|NCT01283139|Systemic Lupus Erythematosus|systemic lupus erythematosus
5503057|NCT01283139|Sifalimumab|sifalimumab
5503058|NCT01283139|MEDI-545|medi-545
5503059|NCT01283126|Hypoglycemia, cognitive function|hypoglycemia, cognitive function
5503060|NCT01283113|Visceral Fat|visceral fat
5503061|NCT01283113|Waist Circumference|waist circumference
5503062|NCT01283113|Bioelectrical Impedance|bioelectrical impedance
5503063|NCT01283113|Metabolic Syndrome|metabolic syndrome
5503064|NCT01283113|Obesity|obesity
5503065|NCT01283113|Type 2 Diabetes|type 2 diabetes
5503066|NCT01283100|HIV, GSK2248761, GSK1349572, drug interaction, pharmacokinetics|hiv, gsk2248761, gsk1349572, drug interaction, pharmacokinetics
5503067|NCT01283087|TNS|tns
5503068|NCT01283087|Spinal anesthesia|spinal anesthesia
5503069|NCT01283087|Lidocaine|lidocaine
5503070|NCT01283048|Kidney Cancer|kidney cancer
5503071|NCT01283048|Avastin|avastin
5503072|NCT01283022|Pharmacokinetics|pharmacokinetics
5503073|NCT01283022|Misoprostol Vaginal Insert|misoprostol vaginal insert
5503074|NCT01283022|Induction of labor|induction of labor
5503075|NCT01283022|Cervical Ripening|cervical ripening
5503076|NCT01283022|Rate of Cesarean section|rate of cesarean section
5503077|NCT01283009|pneumoniae|pneumoniae
5503078|NCT01282996|Mechanical ventilation|mechanical ventilation
5503079|NCT01282996|Postoperative pulmonary complications|postoperative pulmonary complications
5503080|NCT01282996|Positive end-expiratory pressure|positive end-expiratory pressure
5503081|NCT01282996|Protective lung ventilation|protective lung ventilation
5503082|NCT01282996|Alveolar recruitment maneuver|alveolar recruitment maneuver
5503083|NCT01282996|General anesthesia|general anesthesia
5503084|NCT01282996|Abdominal surgery|abdominal surgery
5503089|NCT01282931|Women|women
5503090|NCT01282931|Stage IV|stage iv
5503091|NCT01282931|Metastatic|metastatic
5503092|NCT01282931|Breast Cancer|breast cancer
5503093|NCT01282931|Progressed|progressed
5503097|NCT01282918|intra-operative DF testing|intra-operative df testing
5503098|NCT01282918|VT|vt
5503099|NCT01282892|Visceral fat|visceral fat
5503100|NCT01282892|fatty liver|fatty liver
5503101|NCT01282892|atherosclerosis|atherosclerosis
5503102|NCT01282892|coronary computed tomography angiography|coronary computed tomography angiography
5503103|NCT01282879|Itraconazole oral solution|itraconazole oral solution
5503104|NCT01282879|invasive fungal infections|invasive fungal infections
5503105|NCT01282879|prophylaxis|prophylaxis
5503106|NCT01282879|Graft vs Host Disease|graft vs host disease
5503107|NCT01282879|transplantation|transplantation
5503108|NCT01282853|peptic ulcer|peptic ulcer
5503109|NCT01282853|hemorrhage|hemorrhage
5503110|NCT01282853|rapid urease test|rapid urease test
5503111|NCT01282853|urea breath test|urea breath test
5503112|NCT01282840|LUTS|luts
5503113|NCT01282814|Bioequivalence|bioequivalence
5503114|NCT01282814|Healthy Subjects|healthy subjects
5503115|NCT01282801|Bioequivalence|bioequivalence
5503116|NCT01282801|Healthy Subjects|healthy subjects
5503117|NCT01282788|infant nutrition|infant nutrition
5503118|NCT01282788|complementary feeding|complementary feeding
5503119|NCT01282788|malnutrition|malnutrition
5503120|NCT01282788|stunting of growth|stunting of growth
5503121|NCT01282775|overweight|overweight
5503122|NCT01282775|obesity|obesity
5503123|NCT01282775|worksite|worksite
5503124|NCT01282762|Prevention of Hepatitis B infection.|prevention of hepatitis b infection.
5503125|NCT01282762|End Stage Renal Disease|end stage renal disease
5503126|NCT01282762|Hepatitis B vaccination|hepatitis b vaccination
5503127|NCT01282762|Hepatitis B virus (HBV)|hepatitis b virus (hbv)
5503128|NCT01282749|Overweight|overweight
5503129|NCT01282749|Obesity|obesity
5503130|NCT01282749|African American|african american
5503131|NCT01282749|Women|women
5503132|NCT01282749|Translational|translational
5503134|NCT01282749|Community based participatory research|community based participatory research
5503135|NCT01282736|eating disorder|eating disorder
5503136|NCT01282736|binge eating|binge eating
5503137|NCT01282684|Safety|safety
5503138|NCT01282684|Tolerability|tolerability
5503139|NCT01282684|Pharmacokinetics|pharmacokinetics
5503140|NCT01282684|PLX5622|plx5622
5503141|NCT01282671|breathing exercises|breathing exercises
5503142|NCT01282671|cardiac surgery|cardiac surgery
5503143|NCT01282671|lung function|lung function
5503144|NCT01282671|postoperative complication|postoperative complication
5503145|NCT01282671|positive expiratory pressure|positive expiratory pressure
5503146|NCT01282658|CPT-11,pharmacogenomics,colorectal cancer|cpt-11,pharmacogenomics,colorectal cancer
5503147|NCT01282645|Cranial defect|cranial defect
5503149|NCT01282645|patient specific implant|patient specific implant
5503150|NCT01282645|PEEK|peek
5503151|NCT01282645|polyether ether ketone|polyether ether ketone
5503152|NCT01282645|craniectomy|craniectomy
5503153|NCT01282645|craniotomy|craniotomy
5503154|NCT01282632|depression|depression
5503155|NCT01282632|treatment resistant depression|treatment resistant depression
5503156|NCT01282632|unipolar|unipolar
5503157|NCT01282632|non- psychotic major depression|non- psychotic major depression
5503158|NCT01282632|add-on to a serotonin type antidepressants|add-on to a serotonin type antidepressants
5503159|NCT01282632|risperidone|risperidone
5503160|NCT01282632|olanzapine|olanzapine
5503161|NCT01282632|double blind comparison|double blind comparison
5503162|NCT01282632|randomized|randomized
5503163|NCT01282606|Chemonucleolysis|chemonucleolysis
5503164|NCT01282606|Lumbar Vertebrae|lumbar vertebrae
5503165|NCT01282606|Hernia|hernia
5503166|NCT01282593|TEL/ALM1_positive ALL relapses|tel/alm1_positive all relapses
5503167|NCT01282580|Women at high risk of developing breast cancer|women at high risk of developing breast cancer
5503168|NCT01282541|Tearing, Epiphora, Botulinum Toxin A|tearing, epiphora, botulinum toxin a
5503169|NCT01282502|rectal cancer|rectal cancer
5503170|NCT01282502|chemotherapy|chemotherapy
5503171|NCT01282502|chemoradiation|chemoradiation
5503172|NCT01282476|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
5503173|NCT01282476|Panobinostat|panobinostat
5503174|NCT01282476|LBH589 (Panobinostat)|lbh589 (panobinostat)
5503175|NCT01282476|LBH-589 (Panobinostat)|lbh-589 (panobinostat)
5503176|NCT01282476|HDAC inhibitor (Histone deacetylase inhibitor)|hdac inhibitor (histone deacetylase inhibitor)
5503177|NCT01282476|DAC inhibitor (deacetylase inhibitor)|dac inhibitor (deacetylase inhibitor)
5503178|NCT01282476|deacetylase inhibitor|deacetylase inhibitor
5503179|NCT01282476|lymphoma|lymphoma
5503180|NCT01282463|Carcinoma, Renal Cell|carcinoma, renal cell
5503182|NCT01282450|NSCLC|nsclc
5503183|NCT01282424|indolent Non-Hodgkin Lymphoma|indolent non-hodgkin lymphoma
5503184|NCT01282424|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5503185|NCT01282424|iNHL|inhl
5503186|NCT01282424|NHL|nhl
5503187|NCT01282424|GS-1101|gs-1101
5503188|NCT01282424|CAL-101|cal-101
5503189|NCT01282424|PI3K|pi3k
5503190|NCT01282424|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5503191|NCT01282424|Follicular Lymphoma (FL)|follicular lymphoma (fl)
5503192|NCT01282424|Small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
5503193|NCT01282424|Lymphoplasmacytoid lymphoma (LPL)|lymphoplasmacytoid lymphoma (lpl)
5503194|NCT01282424|Marginal zone lymphoma (MZL)|marginal zone lymphoma (mzl)
5503195|NCT01282372|Ankylosing spondylitis|ankylosing spondylitis
5503196|NCT01282372|Sleep|sleep
5503197|NCT01282372|Psoriatic arthritis|psoriatic arthritis
5503198|NCT01282372|Work Productivity|work productivity
5503199|NCT01282372|Rheumatoid Arthritis|rheumatoid arthritis
5503200|NCT01282359|Educational asthma program|educational asthma program
5503201|NCT01282359|Clusters analysis study|clusters analysis study
5503202|NCT01282359|Asthma Control Test|asthma control test
5503203|NCT01282346|Glaucoma shunt|glaucoma shunt
5503204|NCT01282346|Ocular implant|ocular implant
5503205|NCT01282346|Gold|gold
5503206|NCT01282346|Trabeculectomy|trabeculectomy
5503207|NCT01282320|Randomized Controlled Trial|randomized controlled trial
5503208|NCT01282320|Clinical Tria|clinical tria
5503209|NCT01282320|Postmenopause|postmenopause
5503210|NCT01282320|Hot-flashes|hot-flashes
5503211|NCT01282320|Quality of life|quality of life
5503212|NCT01282320|Physical Fitness|physical fitness
5503213|NCT01282307|Guided Self-Determination|guided self-determination
5503214|NCT01282307|Improving insight|improving insight
5503215|NCT01282307|Autonomy-supportive problem solving intervention|autonomy-supportive problem solving intervention
5503216|NCT01282307|Evaluate the effects of the method Guided Self-Determination|evaluate the effects of the method guided self-determination
5503217|NCT01282307|Improving insight in patients diagnosed with schizophrenia|improving insight in patients diagnosed with schizophrenia
5503218|NCT01282281|Bipolar Disorder|bipolar disorder
5503219|NCT01282281|Youth|youth
5503220|NCT01282281|Adults|adults
5503221|NCT01282281|Endocrine-metabolic changes|endocrine-metabolic changes
5503222|NCT01282268|fragile X syndrome|fragile x syndrome
5503223|NCT01282268|autism spectrum disorder|autism spectrum disorder
5503224|NCT01282242|acute stroke, IV rt-PA, Activase, Alteplase|acute stroke, iv rt-pa, activase, alteplase
5503225|NCT01282229|LANAP, Laser dentistry|lanap, laser dentistry
5503226|NCT01282203|General surgery|general surgery
5503227|NCT01282203|General anesthesia|general anesthesia
5503228|NCT01282203|Inhalation anesthesia|inhalation anesthesia
5503229|NCT01282203|Sevorane|sevorane
5503230|NCT01282203|Sevoflurane|sevoflurane
5503231|NCT01282190|dyslipidemia, motivational interview, prevention|dyslipidemia, motivational interview, prevention
5503232|NCT01282177|surveillance, safety , tolerability , vaccine|surveillance, safety , tolerability , vaccine
5503233|NCT01282164|glucagon stimulation test|glucagon stimulation test
5503234|NCT01282164|insulin tolerance test|insulin tolerance test
5503235|NCT01282164|growth hormone deficiency|growth hormone deficiency
5503236|NCT01282164|hypothalamic-pituitary disorders|hypothalamic-pituitary disorders
5503237|NCT01282151|NSCLC|nsclc
5503238|NCT01282151|Non Squamous cell|non squamous cell
5503239|NCT01282151|Docetaxel|docetaxel
5503240|NCT01282151|Pemetrexed|pemetrexed
5503241|NCT01282138|Allergic conjunctivitis|allergic conjunctivitis
5503242|NCT01282125|general population|general population
5503243|NCT01282125|prevalence|prevalence
5503244|NCT01282125|Norway|norway
5503245|NCT01282099|all children entering the PICU eligible for enrollment|all children entering the picu eligible for enrollment
5503246|NCT01282099|age range: neonate to 16 years|age range: neonate to 16 years
5503247|NCT01282086|Sevorane|sevorane
5503248|NCT01282086|Sevoflurane|sevoflurane
5503249|NCT01282086|General anesthesia|general anesthesia
5503250|NCT01282086|Inhalation anesthesia|inhalation anesthesia
5503251|NCT01282086|General surgery|general surgery
5503252|NCT01282073|Idiopathic membranous nephropathy|idiopathic membranous nephropathy
5503253|NCT01282073|Mycophenolate mofetil|mycophenolate mofetil
5503254|NCT01282073|Proteinuria|proteinuria
5503255|NCT01282073|Renal function|renal function
5503256|NCT01282060|HBA1C|hba1c
5503257|NCT01282060|DIABETES-RELATED COMPLICATIONS|diabetes-related complications
5503258|NCT01282060|GLYCAEMIC BALANCE|glycaemic balance
5503259|NCT01282047|Lenalidomide|lenalidomide
5503260|NCT01282047|Kaposi|kaposi
5503262|NCT01282047|efficacy|efficacy
5503263|NCT01282047|safety|safety
5503264|NCT01282034|CHONDRAL|chondral
5503265|NCT01282034|OSTEOCHONDRAL|osteochondral
5503266|NCT01282021|Serologic RBC Antigens|serologic rbc antigens
5503267|NCT01282021|RBC Antigen Molecular Studies|rbc antigen molecular studies
5503268|NCT01282021|Blood Transfusion|blood transfusion
5503269|NCT01282021|RBC Antigen Profiles|rbc antigen profiles
5503270|NCT01282021|Alloimmunization|alloimmunization
5503271|NCT01282008|Online Surveys|online surveys
5503272|NCT01282008|Tobacco Corrective Statements|tobacco corrective statements
5503274|NCT01282008|Focus Groups|focus groups
5503275|NCT01281995|Biologic Samples|biologic samples
5503276|NCT01281995|Hydrocortisone|hydrocortisone
5503277|NCT01281995|Laboratory Research Specimens|laboratory research specimens
5503283|NCT01281982|Gliomas|gliomas
5503284|NCT01281982|Pet Scan|pet scan
5503285|NCT01281982|Blood Brain Barrier|blood brain barrier
5503286|NCT01281982|P-Glycoprotein|p-glycoprotein
5503287|NCT01281982|Brain Tumor|brain tumor
5503288|NCT01281982|Glioma|glioma
5503289|NCT01281982|Glioblastoma Multiforme|glioblastoma multiforme
5503291|NCT01281969|Placebo Controlled|placebo controlled
5503292|NCT01281969|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5503293|NCT01281969|Children and Adolescents|children and adolescents
5503294|NCT01281969|Intravenous Immunoglobulin|intravenous immunoglobulin
5503295|NCT01281969|PANDAS|pandas
5503296|NCT01281956|Epilepsy|epilepsy
5503297|NCT01281956|Drug Trial|drug trial
5503298|NCT01281956|Serotonin|serotonin
5503299|NCT01281956|Serotonin 1A Receptor|serotonin 1a receptor
5503300|NCT01281956|Temporal Lobe Epilepsy|temporal lobe epilepsy
5503301|NCT01281956|Partial Epilepsy|partial epilepsy
5503302|NCT01281930|Superficial abscess|superficial abscess
5503303|NCT01281930|packing material|packing material
5503304|NCT01281930|wick|wick
5503305|NCT01281930|incision and drainage|incision and drainage
5503306|NCT01281917|velcade|velcade
5503307|NCT01281917|temsirolimus|temsirolimus
5503308|NCT01281917|non-hodgkins lymphoma|non-hodgkins lymphoma
5503309|NCT01281891|Drug: Morphine intrathecal|drug: morphine intrathecal
5503310|NCT01281891|Pain: Postoperative|pain: postoperative
5503311|NCT01281891|Surgery: Total hip arthroplasty|surgery: total hip arthroplasty
5503312|NCT01281878|primary hyperoxaluria|primary hyperoxaluria
5503313|NCT01281878|Pyridoxal-phosphate|pyridoxal-phosphate
5503314|NCT01281839|Hepatitis C|hepatitis c
5503315|NCT01281839|TMC435|tmc435
5503316|NCT01281839|HCV|hcv
5503317|NCT01281839|Hep C|hep c
5503318|NCT01281839|Genotype 1|genotype 1
5503324|NCT01281787|FAP= post-surgery atrial fibrillation|fap= post-surgery atrial fibrillation
5503325|NCT01281787|ACEI= angiotensin converting enzyme-inhibitors|acei= angiotensin converting enzyme-inhibitors
5503326|NCT01281787|ARBs= angiotensin II receptor blockers|arbs= angiotensin ii receptor blockers
5503327|NCT01281787|NT-proBNP= brain natriuretic peptide|nt-probnp= brain natriuretic peptide
5503328|NCT01281748|acute exacerbation of COPD|acute exacerbation of copd
5503329|NCT01281735|treatment outcome|treatment outcome
5503330|NCT01281735|side effects|side effects
5503331|NCT01281735|Protein Kinase Inhibitors|protein kinase inhibitors
5503332|NCT01281735|pediatrics|pediatrics
5503333|NCT01281722|healthy adults|healthy adults
5503334|NCT01281722|melanoma|melanoma
5503335|NCT01281696|Breast cancer|breast cancer
5503336|NCT01281696|CNS metastasis|cns metastasis
5503337|NCT01281696|Brain metastasis|brain metastasis
5503338|NCT01281696|Leptomeningeal metastasis|leptomeningeal metastasis
5503339|NCT01281696|Bevacizumab|bevacizumab
5503340|NCT01281696|Etoposide|etoposide
5503341|NCT01281696|Cisplatin|cisplatin
5503342|NCT01281670|H reflex; muscle activation; rate of force development; whole body vibration|h reflex; muscle activation; rate of force development; whole body vibration
5503343|NCT01281657|Fingolimod|fingolimod
5503344|NCT01281657|FTY720|fty720
5503345|NCT01281657|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5503346|NCT01281657|Multiple sclerosis|multiple sclerosis
5503348|NCT01281657|Safety|safety
5503349|NCT01281657|Efficacy|efficacy
5503350|NCT01281644|Keratosis pilaris (KP)|keratosis pilaris (kp)
5503351|NCT01281631|ALS|als
5503352|NCT01281618|Barrett's esophagus|barrett's esophagus
5503353|NCT01281605|Type 2 diabetes|type 2 diabetes
5503354|NCT01281605|Basal insulin|basal insulin
5503355|NCT01281605|Insulin detemir|insulin detemir
5503356|NCT01281605|Insulin titration algorithm|insulin titration algorithm
5503357|NCT01281579|Pharmacokinetics|pharmacokinetics
5503358|NCT01281579|Pharmacodynamics|pharmacodynamics
5503359|NCT01281579|Canagliflozin|canagliflozin
5503360|NCT01281566|Cisapride (Prepulsid)|cisapride (prepulsid)
5503361|NCT01281566|Feeding intolerance|feeding intolerance
5503362|NCT01281566|Enteral feeding|enteral feeding
5503363|NCT01281566|Nasogastric tube|nasogastric tube
5503364|NCT01281566|Neonate|neonate
5503365|NCT01281553|Cisapride (PREPULSID)|cisapride (prepulsid)
5503366|NCT01281553|Placebo|placebo
5503367|NCT01281553|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5503368|NCT01281553|Gastro-oesophageal Reflux Disease (GORD)|gastro-oesophageal reflux disease (gord)
5503369|NCT01281540|Cisapride ( PREPULSID )|cisapride ( prepulsid )
5503370|NCT01281540|Placebo|placebo
5503371|NCT01281540|Idiopathic|idiopathic
5503372|NCT01281540|Stomach Diseases|stomach diseases
5503373|NCT01281540|Stomach|stomach
5503374|NCT01281527|Paliperidone palmitate|paliperidone palmitate
5503375|NCT01281527|Schizophrenia|schizophrenia
5503376|NCT01281527|Intramuscular injection|intramuscular injection
5503377|NCT01281501|Dyspepsia|dyspepsia
5503669|NCT01280097|REM sleep|rem sleep
5503378|NCT01281501|Emergency treatment|emergency treatment
5503379|NCT01281501|Pantoprazole|pantoprazole
5503380|NCT01281501|Antacid|antacid
5503381|NCT01281501|Pain measurement|pain measurement
5503382|NCT01281475|Angelman syndrome|angelman syndrome
5503383|NCT01281475|Levodopa|levodopa
5503384|NCT01281475|Carbidopa|carbidopa
5503385|NCT01281475|L-dopa|l-dopa
5503386|NCT01281462|complicated Urinary Tract Infection|complicated urinary tract infection
5503387|NCT01281462|Acute Pyelonephritis|acute pyelonephritis
5503388|NCT01281436|childhood|childhood
5503389|NCT01281436|overweight|overweight
5503390|NCT01281436|obesity|obesity
5503391|NCT01281436|Health information technology|health information technology
5503393|NCT01281436|Motivational Interviewing|motivational interviewing
5503394|NCT01281410|respiratory muscles|respiratory muscles
5503395|NCT01281410|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
5503396|NCT01281410|inspiratory muscle training|inspiratory muscle training
5503397|NCT01281397|cardiac surgery|cardiac surgery
5503398|NCT01281397|aggregometry|aggregometry
5503399|NCT01281397|thromboelastometry|thromboelastometry
5503400|NCT01281397|platelet function|platelet function
5503401|NCT01281397|bleeding|bleeding
5503402|NCT01281397|antiplatelet therapy|antiplatelet therapy
5503403|NCT01281384|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5503404|NCT01281384|echocardiography|echocardiography
5503405|NCT01281384|heart failure|heart failure
5503406|NCT01281384|imaging|imaging
5503407|NCT01281384|cost effectiveness|cost effectiveness
5503408|NCT01281384|quality of life|quality of life
5503409|NCT01281384|definitive diagnosis|definitive diagnosis
5503410|NCT01281384|prospective comparative effectiveness randomized clinical trial|prospective comparative effectiveness randomized clinical trial
5503411|NCT01281358|Premature infants|premature infants
5503412|NCT01281358|Motor Development|motor development
5503413|NCT01281345|icu|icu
5503414|NCT01281345|candida|candida
5503415|NCT01281345|epidemiology|epidemiology
5503416|NCT01281345|blood stream infection|blood stream infection
5503417|NCT01281345|candidemia|candidemia
5503418|NCT01281332|menopause|menopause
5503419|NCT01281332|hot flash|hot flash
5503420|NCT01281332|quality of life|quality of life
5503421|NCT01281319|preterm labor|preterm labor
5503422|NCT01281319|PROM|prom
5503423|NCT01281319|mycoplasma|mycoplasma
5503424|NCT01281319|ureaplasma|ureaplasma
5503425|NCT01281319|high risk pregnancy|high risk pregnancy
5503426|NCT01281306|hypertension|hypertension
5489749|NCT01338025|HIV|hiv
5503427|NCT01281306|blood pressure|blood pressure
5503428|NCT01281306|LCZ696|lcz696
5503429|NCT01281306|dual-acting|dual-acting
5503430|NCT01281306|neprilysin|neprilysin
5503431|NCT01281306|nep inhibitor|nep inhibitor
5503432|NCT01281306|vasopeptidase|vasopeptidase
5503433|NCT01281306|angiotensin receptor|angiotensin receptor
5503434|NCT01281306|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
5503435|NCT01281293|V-COMPAS; Vagus Nerve Stimulation Clinical Outcomes;|v-compas; vagus nerve stimulation clinical outcomes;
5503436|NCT01281280|PuLsE 2, Drug-resistant Epilepsy Partial-onset Seizures|pulse 2, drug-resistant epilepsy partial-onset seizures
5503437|NCT01281267|facial transplantation|facial transplantation
5503438|NCT01281267|face transplantation|face transplantation
5503439|NCT01281267|composite tissue allotransplantation|composite tissue allotransplantation
5503441|NCT01281267|composite tissue allograft|composite tissue allograft
5503442|NCT01281267|facial allograft|facial allograft
5503443|NCT01281254|Fallopian tube cancer|fallopian tube cancer
5503444|NCT01281254|Primary peritoneal cancer|primary peritoneal cancer
5503445|NCT01281254|AMG386|amg386
5503446|NCT01281254|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5503447|NCT01281254|Recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5503448|NCT01281241|MTWA|mtwa
5503449|NCT01281241|mechanical alternans|mechanical alternans
5503450|NCT01281228|Exenatide|exenatide
5503451|NCT01281228|Type 2 diabetes mellitus|type 2 diabetes mellitus
5503452|NCT01281228|Incretin hormones|incretin hormones
5503453|NCT01281228|GLP-1 agonist|glp-1 agonist
5503454|NCT01281228|Satiety|satiety
5503455|NCT01281228|Reward|reward
5503456|NCT01281215|Pharmaceutical Education|pharmaceutical education
5503457|NCT01281215|Rational Drug Use|rational drug use
5503458|NCT01281215|Asthma|asthma
5503459|NCT01281202|Cocaine|cocaine
5503460|NCT01281202|Cocaine Addiction Treatment|cocaine addiction treatment
5503461|NCT01281202|Cocaine Treatment|cocaine treatment
5503462|NCT01281202|Vigabatrin|vigabatrin
5503463|NCT01281202|CPP-109|cpp-109
5503464|NCT01281202|Catalyst|catalyst
5503465|NCT01281202|National Institute on Drug Abuse|national institute on drug abuse
5503466|NCT01281189|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5503467|NCT01281189|ALS|als
5503468|NCT01281189|Motor Neurone Disease|motor neurone disease
5503469|NCT01281137|stage IA breast cancer|stage ia breast cancer
5503470|NCT01281137|stage IB breast cancer|stage ib breast cancer
5503471|NCT01281137|stage II breast cancer|stage ii breast cancer
5503472|NCT01281137|stage IIIA breast cancer|stage iiia breast cancer
5503473|NCT01281098|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
5503474|NCT01281098|Diabetes Mellitus Type I, Type II|diabetes mellitus type i, type ii
5503475|NCT01281098|Pegaptanib|pegaptanib
5503476|NCT01281098|Panretinal Photocoagulation|panretinal photocoagulation
5503477|NCT01281085|Shoulder|shoulder
5503478|NCT01281085|Outcome treatment|outcome treatment
5503479|NCT01281085|Validation Studies|validation studies
5503480|NCT01281085|Biomechanics|biomechanics
5503481|NCT01281033|primary PCI|primary pci
5503482|NCT01281033|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5503483|NCT01281033|thrombus aspiration|thrombus aspiration
5503484|NCT01281020|Glaucoma|glaucoma
5503485|NCT01281020|Adherence|adherence
5503486|NCT01281020|Fixed combination therapy|fixed combination therapy
5503487|NCT01281007|Herpes Simplex Virus|herpes simplex virus
5503488|NCT01280994|Lung Disease|lung disease
5503489|NCT01280994|Pulmonary Disease|pulmonary disease
5503490|NCT01280994|Diagnostic Imaging|diagnostic imaging
5503492|NCT01280981|Menorrhagia|menorrhagia
5503493|NCT01280981|Heavy Menstrual Bleeding|heavy menstrual bleeding
5503494|NCT01280981|Lysteda|lysteda
5503495|NCT01280955|Plerixafor and Allogeneic Myeloablative Stem Cell Transplant|plerixafor and allogeneic myeloablative stem cell transplant
5503496|NCT01280942|clinical deterioration|clinical deterioration
5503497|NCT01280942|detection algorithms|detection algorithms
5503498|NCT01280942|automated warning systems|automated warning systems
5503499|NCT01280929|High Risk Proliferative Diabetic Retinopathy|high risk proliferative diabetic retinopathy
5503500|NCT01280929|Ranibizumab|ranibizumab
5503501|NCT01280929|Panretinal Photocoagulation|panretinal photocoagulation
5503502|NCT01280903|Osteoarthritis, Knee|osteoarthritis, knee
5503503|NCT01280903|Hypertension|hypertension
5503504|NCT01280903|Exercise|exercise
5503505|NCT01280903|Physical activity|physical activity
5503506|NCT01280903|Self Efficacy|self efficacy
5503507|NCT01280903|Patient Compliance|patient compliance
5503508|NCT01280903|Aged|aged
5503509|NCT01280890|Dementia|dementia
5503510|NCT01280890|Nursing home|nursing home
5503511|NCT01280890|Person-centred Care|person-centred care
5503512|NCT01280890|Staff training|staff training
5503513|NCT01280877|optic neuropathy|optic neuropathy
5503514|NCT01280877|visual field|visual field
5503515|NCT01280877|electric stimulation|electric stimulation
5503516|NCT01280877|alternating current|alternating current
5503517|NCT01280877|perimetry|perimetry
5503518|NCT01280851|Living renal donor|living renal donor
5489848|NCT01337739|Sedation|sedation
5503519|NCT01280851|Magnetic Resonance Imaging|magnetic resonance imaging
5503520|NCT01280851|Renal vascular anatomy|renal vascular anatomy
5503521|NCT01280851|Renal function|renal function
5503522|NCT01280812|mobile phone|mobile phone
5503523|NCT01280812|physical activity|physical activity
5503524|NCT01280812|women|women
5503525|NCT01280812|maintenance|maintenance
5503526|NCT01280812|health promotion|health promotion
5503527|NCT01280812|prevention|prevention
5503528|NCT01280799|Anorexia Nervosa|anorexia nervosa
5503529|NCT01280799|Adolescents|adolescents
5503530|NCT01280799|Family Treatment|family treatment
5503531|NCT01280799|Eating Disorder|eating disorder
5503532|NCT01280799|Acceptance and Commitment Therapy|acceptance and commitment therapy
5503533|NCT01280786|AML|aml
5503534|NCT01280786|leukemia|leukemia
5503535|NCT01280786|relapsed or refractory AML|relapsed or refractory aml
5503536|NCT01280773|weaning, mechanical ventilation|weaning, mechanical ventilation
5503537|NCT01280747|Prior authorization|prior authorization
5503538|NCT01280747|Fibromyalgia|fibromyalgia
5503539|NCT01280747|Painful Diabetic Peripheral Neuropathy|painful diabetic peripheral neuropathy
5503540|NCT01280747|Policy|policy
5503541|NCT01280747|Real World Data|real world data
5503542|NCT01280734|melatonin|melatonin
5503543|NCT01280734|circadin|circadin
5503544|NCT01280734|zolpidem|zolpidem
5503545|NCT01280734|body sway|body sway
5503546|NCT01280734|postural instability|postural instability
5503547|NCT01280708|Urology|urology
5503548|NCT01280708|Nephrology|nephrology
5503549|NCT01280708|Renal and pancreas transplantation|renal and pancreas transplantation
5503550|NCT01280708|Data base|data base
5503551|NCT01280708|Epidemiology|epidemiology
5503552|NCT01280695|Type 2|type 2
5503553|NCT01280695|Diabetes Mellitus|diabetes mellitus
5503554|NCT01280695|Diabetes|diabetes
5503555|NCT01280695|High blood sugar|high blood sugar
5503556|NCT01280695|Blood sugar|blood sugar
5503557|NCT01280695|Blood glucose|blood glucose
5503558|NCT01280695|Glucose|glucose
5503559|NCT01280682|type 1 diabetes|type 1 diabetes
5503560|NCT01280682|age|age
5503561|NCT01280682|course of disease|course of disease
5503562|NCT01280682|autoantibodies|autoantibodies
5503563|NCT01280682|C-peptide levels|c-peptide levels
5503564|NCT01280669|Non-infectious|non-infectious
5503565|NCT01280669|Uveitis|uveitis
5503566|NCT01280669|Panuveitis|panuveitis
5503567|NCT01280643|stage IVA colon cancer|stage iva colon cancer
5503568|NCT01280643|stage IVA rectal cancer|stage iva rectal cancer
5503569|NCT01280643|stage IVB colon cancer|stage ivb colon cancer
5503570|NCT01280643|stage IVB rectal cancer|stage ivb rectal cancer
5503571|NCT01280630|ACS: Acute coronary syndrome Retrospective Registry|acs: acute coronary syndrome retrospective registry
5503572|NCT01280617|Renal Transplant|renal transplant
5503573|NCT01280617|Thymoglubulin|thymoglubulin
5503574|NCT01280591|Naproxen sodium|naproxen sodium
5503575|NCT01280591|Diphenhydramine|diphenhydramine
5503578|NCT01280565|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5503579|NCT01280565|c-Kit juxta membrane mutation|c-kit juxta membrane mutation
5503580|NCT01280552|Glioblastoma Multiforme|glioblastoma multiforme
5503581|NCT01280539|Multiple Sclerosis|multiple sclerosis
5503582|NCT01280539|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5503583|NCT01280539|Cortical Excitability|cortical excitability
5503585|NCT01280487|PI3K inhibitor|pi3k inhibitor
5503586|NCT01280474|depression during pregnancy|depression during pregnancy
5503587|NCT01280474|postpartum depression|postpartum depression
5503588|NCT01280474|pregnancy outcomes|pregnancy outcomes
5503589|NCT01280474|newborn development|newborn development
5503590|NCT01280474|paternal psychopathology|paternal psychopathology
5503591|NCT01280461|Pneumonia|pneumonia
5503592|NCT01280448|Lung Cancer|lung cancer
5503593|NCT01280448|Tobacco Smoking|tobacco smoking
5503594|NCT01280448|gene polymorphism|gene polymorphism
5503595|NCT01280435|Online Discourse|online discourse
5503596|NCT01280435|e-Learning|e-learning
5503597|NCT01280435|Biopsy|biopsy
5503598|NCT01280435|Virtual Pathologic Section|virtual pathologic section
5503599|NCT01280422|ROCDR|rocdr
5503600|NCT01280396|metabolic|metabolic
5503601|NCT01280396|SGAs|sgas
5503602|NCT01280396|clozapine|clozapine
5503603|NCT01280383|non-invasive ventilation|non-invasive ventilation
5503604|NCT01280383|diaphragm|diaphragm
5503605|NCT01280383|electrical activity|electrical activity
5503606|NCT01280383|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5503607|NCT01280383|critically ill patients|critically ill patients
5503608|NCT01280370|Incisional hernia repair|incisional hernia repair
5503609|NCT01280357|Fetal Heart Rate (FHR)|fetal heart rate (fhr)
5503610|NCT01280357|Uterine Activity (UA)|uterine activity (ua)
5503611|NCT01280357|Labor & Delivery|labor & delivery
5503612|NCT01280331|Bunionectomy|bunionectomy
5503613|NCT01280305|schizophrenia|schizophrenia
5503614|NCT01280305|schizoaffective disorder|schizoaffective disorder
5503615|NCT01280292|central hypothyroidism, hypopituitarism, eltroxin|central hypothyroidism, hypopituitarism, eltroxin
5685331|NCT00556517|Rehabilitation|rehabilitation
5685332|NCT00556517|muscles|muscles
5503616|NCT01280279|Behavior modification, Behavior therapy, Nocturia, Polyuria, Quality of life|behavior modification, behavior therapy, nocturia, polyuria, quality of life
5503617|NCT01280266|Pathological Conditions|pathological conditions
5503618|NCT01280266|Signs and Symptoms|signs and symptoms
5503619|NCT01280266|Blood circulation|blood circulation
5503620|NCT01280253|Predictor|predictor
5503621|NCT01280253|outcome|outcome
5503622|NCT01280253|biochemical|biochemical
5503623|NCT01280240|anemia|anemia
5503624|NCT01280240|cancer|cancer
5503626|NCT01280227|Symptom management|symptom management
5503627|NCT01280227|Symptom assessment|symptom assessment
5503628|NCT01280227|Patient satisfaction|patient satisfaction
5503629|NCT01280227|Patient-provider communication|patient-provider communication
5503630|NCT01280201|Neuroendocrine Tumors|neuroendocrine tumors
5503631|NCT01280201|Pazopanib|pazopanib
5503632|NCT01280201|GETNE|getne
5503633|NCT01280201|Biomarkers|biomarkers
5503634|NCT01280188|Diabetes|diabetes
5503635|NCT01280175|BDP|bdp
5503636|NCT01280175|Formoterol|formoterol
5503637|NCT01280175|pMDI|pmdi
5503638|NCT01280175|Aerochamber Plus|aerochamber plus
5503639|NCT01280175|Charcoal|charcoal
5503640|NCT01280162|Plasmodium falciparum, Plasmodium vivax|plasmodium falciparum, plasmodium vivax
5503641|NCT01280149|substance P|substance p
5503642|NCT01280149|allergic rhinitis|allergic rhinitis
5503643|NCT01280149|allergen immunotherapy|allergen immunotherapy
5503644|NCT01280136|HIV|hiv
5503645|NCT01280136|Sexually Transmitted Diseases|sexually transmitted diseases
5503646|NCT01280136|Pregnancy Prevention|pregnancy prevention
5503647|NCT01280136|Abstinence Education|abstinence education
5503648|NCT01280136|Adolescents|adolescents
5503649|NCT01280136|Sexual Health|sexual health
5503650|NCT01280123|Parkinson's Disease|parkinson's disease
5503651|NCT01280123|Biomarkers|biomarkers
5503652|NCT01280110|dry eye|dry eye
5503653|NCT01280110|pseudophakia|pseudophakia
5503654|NCT01280110|cornea|cornea
5503655|NCT01280110|lubricating drop|lubricating drop
5503656|NCT01280110|BAK|bak
5503657|NCT01280110|blood aqueous barrier|blood aqueous barrier
5503658|NCT01280110|blood-retina barrier|blood-retina barrier
5503659|NCT01280097|Intensive care unit delirium|intensive care unit delirium
5503660|NCT01280097|Sleep disruption|sleep disruption
5503661|NCT01280097|Sleep hygiene|sleep hygiene
5503662|NCT01280097|Early mobilization in the Intensive care unit|early mobilization in the intensive care unit
5503663|NCT01280097|Sedative agents and sleep|sedative agents and sleep
5503664|NCT01280097|Circadian rhythm|circadian rhythm
5503665|NCT01280097|Cognitive disorder|cognitive disorder
5503666|NCT01280097|Electroencephalography (EEG) to measure sleep|electroencephalography (eeg) to measure sleep
5503667|NCT01280097|Confusion Assessment Method in the Intensive Care Unit|confusion assessment method in the intensive care unit
5503668|NCT01280097|Immune function|immune function
5503670|NCT01280084|neonate activity|neonate activity
5503672|NCT01280032|intraoperative radiotherapy|intraoperative radiotherapy
5503673|NCT01280032|kyphoplasty|kyphoplasty
5503674|NCT01280032|spinal metastases|spinal metastases
5503675|NCT01280019|functional residual capacity|functional residual capacity
5503676|NCT01280019|electrical impedance tomography|electrical impedance tomography
5503677|NCT01280019|inflammatory parameters|inflammatory parameters
5503678|NCT01280006|Obstructive Sleep Apnea|obstructive sleep apnea
5503679|NCT01280006|Hypoxia|hypoxia
5503680|NCT01280006|Sleep|sleep
5503681|NCT01280006|Blood Pressure|blood pressure
5503682|NCT01280006|Hypertension|hypertension
5503683|NCT01280006|Myocardial Infarction|myocardial infarction
5503685|NCT01280006|Ventilation|ventilation
5503686|NCT01280006|Brain|brain
5503687|NCT01280006|Cerebral Blood Flow|cerebral blood flow
5503688|NCT01280006|Renal Blood Flow|renal blood flow
5503689|NCT01279980|ERAS|eras
5503690|NCT01279980|Local anaesthetic wound catheter|local anaesthetic wound catheter
5503691|NCT01279980|Painbuster|painbuster
5503692|NCT01279980|Epidural|epidural
5503693|NCT01279980|colorectal surgery|colorectal surgery
5503694|NCT01279980|enhanced recovery program|enhanced recovery program
5503695|NCT01279967|Pleural Mesothelioma|pleural mesothelioma
5503696|NCT01279967|ADI-PEG 20|adi-peg 20
5503697|NCT01279928|paediatric and adolescent population|paediatric and adolescent population
5503698|NCT01279928|nailfold capillaroscopy|nailfold capillaroscopy
5503699|NCT01279928|laser Doppler flowmetry|laser doppler flowmetry
5503700|NCT01279928|retinal vessel calibre|retinal vessel calibre
5503701|NCT01279928|retinal vessel fractal analysis|retinal vessel fractal analysis
5503702|NCT01279928|24 hour Ambulatory Blood Pressure Monitoring|24 hour ambulatory blood pressure monitoring
5503703|NCT01279915|ASP0456|asp0456
5503704|NCT01279915|Pharmacokinetics|pharmacokinetics
5503705|NCT01279915|safety|safety
5503706|NCT01279915|tolerability|tolerability
5503707|NCT01279902|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5503708|NCT01279902|rituximab|rituximab
5503709|NCT01279902|CHOP|chop
5503710|NCT01279902|abbreviated therapy|abbreviated therapy
5503711|NCT01279889|hypotension|hypotension
5503712|NCT01279889|cesarean delivery|cesarean delivery
5503713|NCT01279889|cardiac output|cardiac output
5503715|NCT01279889|plethysmography variability index|plethysmography variability index
5503716|NCT01279863|Pneumonia|pneumonia
5503717|NCT01279863|Cough|cough
5503718|NCT01279863|Shortness of breath|shortness of breath
5503719|NCT01279863|VRI|vri
5503720|NCT01279850|Lyrica|lyrica
5503721|NCT01279850|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5503722|NCT01279850|Safety|safety
5503723|NCT01279850|Neuropathic Pain|neuropathic pain
5503724|NCT01279850|Post Marketing Surveillance|post marketing surveillance
5503725|NCT01279837|swallowing disorders|swallowing disorders
5503726|NCT01279837|swallowing therapy|swallowing therapy
5503727|NCT01279837|head neck cancer|head neck cancer
5503728|NCT01279837|oropharyngeal dysphagia|oropharyngeal dysphagia
5503729|NCT01279824|swallowing, treatment, stroke,rehabilitation|swallowing, treatment, stroke,rehabilitation
5503730|NCT01279811|spinal cord injury, CSF, biomarkers, CSF pressure|spinal cord injury, csf, biomarkers, csf pressure
5503731|NCT01279798|Lung Cancer|lung cancer
5503732|NCT01279798|NSCLC|nsclc
5503733|NCT01279798|stage III or IV NSCLC|stage iii or iv nsclc
5503734|NCT01279785|Molecular Imaging|molecular imaging
5503735|NCT01279785|PSMA|psma
5503736|NCT01279785|adenocarcinoma|adenocarcinoma
5503737|NCT01279785|prostatectomy|prostatectomy
5503738|NCT01279759|Anterior Cruciate Ligament Reconstruction Predictive Factors|anterior cruciate ligament reconstruction predictive factors
5503739|NCT01279759|Function Downstairs walking Step time Symmetry|function downstairs walking step time symmetry
5503740|NCT01279746|DVT Ultrasound compression Hypoxia Pulmonary Emboli|dvt ultrasound compression hypoxia pulmonary emboli
5503741|NCT01279746|Occult DVT in hypoxic patients|occult dvt in hypoxic patients
5503742|NCT01279733|microarray|microarray
5503743|NCT01279720|Adenosine deaminase deficiency|adenosine deaminase deficiency
5503744|NCT01279720|Gene therapy|gene therapy
5503745|NCT01279694|newly-diagnosed multiple myeloma.|newly-diagnosed multiple myeloma.
5503746|NCT01279681|neurotoxicity|neurotoxicity
5503747|NCT01279681|cognitive/functional effects|cognitive/functional effects
5503748|NCT01279681|stage IVA colon cancer|stage iva colon cancer
5503749|NCT01279681|stage IVA rectal cancer|stage iva rectal cancer
5503750|NCT01279681|stage IVB colon cancer|stage ivb colon cancer
5503751|NCT01279681|stage IVB rectal cancer|stage ivb rectal cancer
5503752|NCT01279681|recurrent colon cancer|recurrent colon cancer
5503753|NCT01279681|recurrent rectal cancer|recurrent rectal cancer
5503754|NCT01279668|Montelukast|montelukast
5503755|NCT01279668|Persistent cough|persistent cough
5503756|NCT01279668|Adults|adults
5503757|NCT01279668|Double-blind randomised placebo controlled trial|double-blind randomised placebo controlled trial
5503758|NCT01279642|Catheterization, Peripheral|catheterization, peripheral
5503759|NCT01279642|Ultrasonography, Interventional|ultrasonography, interventional
5503760|NCT01279642|Nursing|nursing
5503761|NCT01279642|Pediatric|pediatric
5504057|NCT01278407|Aricept|aricept
5503762|NCT01279629|chronic plaque psoriasis|chronic plaque psoriasis
5503763|NCT01279629|To evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis|to evaluate the efficacy of the drugs under study for treating chronic plaque psoriasis
5503764|NCT01279616|sickle cell|sickle cell
5503765|NCT01279616|stem cell transplant|stem cell transplant
5503766|NCT01279603|Cancer|cancer
5503767|NCT01279590|Hyperlipidemia|hyperlipidemia
5503768|NCT01279590|Dyslipidemia|dyslipidemia
5503769|NCT01279590|Metabolic diseases|metabolic diseases
5503770|NCT01279590|Lipid metabolism disorders|lipid metabolism disorders
5503771|NCT01279590|Hyperlipoproteinemia Type IIa|hyperlipoproteinemia type iia
5503772|NCT01279590|Hyperlipoproteinemia Type IIb|hyperlipoproteinemia type iib
5503773|NCT01279590|Hypercholesterolemia, Autosomal Dominant|hypercholesterolemia, autosomal dominant
5503774|NCT01279590|Hypercholesterolemia, Autosomal Dominant, Type B|hypercholesterolemia, autosomal dominant, type b
5503775|NCT01279590|Frederickson Type IIa|frederickson type iia
5503776|NCT01279590|Frederickson Type IIb Hyperlipidemia|frederickson type iib hyperlipidemia
5503777|NCT01279577|Crohn´s disease|crohn´s disease
5488465|NCT01343667|GNPS|gnps
5503778|NCT01279577|Trichuris suis|trichuris suis
5503779|NCT01279577|randomized|randomized
5503780|NCT01279577|placebo|placebo
5503781|NCT01279577|induction of remission|induction of remission
5503782|NCT01279577|porcine whipworm|porcine whipworm
5503783|NCT01279564|Endotracheal intubation and its outcomes|endotracheal intubation and its outcomes
5503784|NCT01279538|Pharmacology|pharmacology
5503785|NCT01279538|Pharmacokinetics|pharmacokinetics
5503786|NCT01279538|ASKP1240|askp1240
5503787|NCT01279538|Kidney Transplantation|kidney transplantation
5503788|NCT01279525|Falls|falls
5503789|NCT01279525|Prevention|prevention
5503790|NCT01279525|Elderly|elderly
5503791|NCT01279512|Metformin Acarbose pco infertility overweight|metformin acarbose pco infertility overweight
5503792|NCT01279499|Morbid obesity|morbid obesity
5503793|NCT01279499|Sevoflurane|sevoflurane
5503794|NCT01279499|Propofol|propofol
5503795|NCT01279499|Remifentanyl|remifentanyl
5503796|NCT01279499|BIS|bis
5503797|NCT01279499|Cardiovascular stability|cardiovascular stability
5503798|NCT01279499|Recovery scores|recovery scores
5503799|NCT01279499|Drug consumption|drug consumption
5503800|NCT01279486|Pregnancy,|pregnancy,
5671971|NCT00613366|intrauterine device|intrauterine device
5503801|NCT01279473|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5503803|NCT01279473|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5503804|NCT01279473|Philadelphia Chromosome Positive, ph+ ALL|philadelphia chromosome positive, ph+ all
5503805|NCT01279473|Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|acute lymphoblastic leukemia (philadelphia chromosome positive)
5503806|NCT01279460|chronic kidney disease|chronic kidney disease
5503807|NCT01279460|CKD|ckd
5503808|NCT01279460|pulse wave velocity|pulse wave velocity
5503809|NCT01279460|PWV|pwv
5503810|NCT01279447|infrapatellar nerve|infrapatellar nerve
5503811|NCT01279447|saphenous nerve|saphenous nerve
5503812|NCT01279447|knee arthroscopy|knee arthroscopy
5503813|NCT01279447|nerve block|nerve block
5503814|NCT01279408|Palliative treatment|palliative treatment
5503815|NCT01279408|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5503816|NCT01279408|Patients with Asymptomatic Centrally Located Advance NSCLC who are palliative|patients with asymptomatic centrally located advance nsclc who are palliative
5503817|NCT01279395|atherosclerosis|atherosclerosis
5503818|NCT01279395|cholesterol|cholesterol
5503819|NCT01279395|cyclooxygenase|cyclooxygenase
5503820|NCT01279395|gene expression|gene expression
5503821|NCT01279395|lipid metabolism|lipid metabolism
5503822|NCT01279382|Symptoms|symptoms
5503823|NCT01279382|Psychological status|psychological status
5503824|NCT01279382|Hypnotherapy|hypnotherapy
5503825|NCT01279382|Relaxation training|relaxation training
5503826|NCT01279369|Pregnancy|pregnancy
5503827|NCT01279369|Trauma|trauma
5503828|NCT01279369|Placental Abruption|placental abruption
5503829|NCT01279369|Fetal fibronectin|fetal fibronectin
5503830|NCT01279356|Liver diseases|liver diseases
5503831|NCT01279356|Volatile organic compounds|volatile organic compounds
5503832|NCT01279356|Inflammation|inflammation
5503833|NCT01279356|Oxidative stress|oxidative stress
5503834|NCT01279356|non-invasive tests|non-invasive tests
5503835|NCT01279343|labor induction|labor induction
5503836|NCT01279343|foley bulb|foley bulb
5503837|NCT01279343|misoprostol|misoprostol
5503838|NCT01279330|Colorectal Cancer|colorectal cancer
5503839|NCT01279330|Screening|screening
5503840|NCT01279330|General Practitioner|general practitioner
5503841|NCT01279330|Fecal Occult Blood Tests|fecal occult blood tests
5503842|NCT01279304|breast cancer|breast cancer
5503843|NCT01279304|locoregional recurrence rate|locoregional recurrence rate
5503844|NCT01279304|neoadjuvant chemotherapy and surgery|neoadjuvant chemotherapy and surgery
5503845|NCT01279304|radiotherapy|radiotherapy
5503846|NCT01279304|risk model|risk model
5503847|NCT01279304|overall survival|overall survival
5503848|NCT01279304|relapse free survival|relapse free survival
5503849|NCT01279304|cT1-2cN0-1 breast cancer|ct1-2cn0-1 breast cancer
5503850|NCT01279291|advanced solid tumor|advanced solid tumor
5503851|NCT01279291|Ovarian cancer|ovarian cancer
5503853|NCT01279291|Fallopian tube cancer|fallopian tube cancer
5503854|NCT01279278|Colorectal Cancer|colorectal cancer
5503855|NCT01279278|Screening|screening
5503856|NCT01279278|General Practitioner|general practitioner
5503857|NCT01279278|Fecal Occult Blood Tests|fecal occult blood tests
5503858|NCT01279265|Lactobacillus|lactobacillus
5503859|NCT01279265|Probiotic|probiotic
5503860|NCT01279265|Crying time|crying time
5503861|NCT01279265|Fecal microbiota|fecal microbiota
5503862|NCT01279265|Calprotectin|calprotectin
5503864|NCT01279265|Infant Crying|infant crying
5503865|NCT01279265|Barr Diary|barr diary
5503866|NCT01279265|Breath Hydrogen|breath hydrogen
5503867|NCT01279265|Clinical Design|clinical design
5503868|NCT01279239|Poly Trauma|poly trauma
5503869|NCT01279239|Metabonomics|metabonomics
5503870|NCT01279239|NMR|nmr
5503871|NCT01279239|MOF|mof
5503872|NCT01279200|letrozole|letrozole
5503873|NCT01279200|ovulation monitoring|ovulation monitoring
5503874|NCT01279200|pregnancy rate|pregnancy rate
5503875|NCT01279187|dental|dental
5503876|NCT01279187|implant|implant
5503877|NCT01279174|Hip, arthrosis|hip, arthrosis
5503878|NCT01279161|overweight, obesity, children, insulin, pump therapy, FTO|overweight, obesity, children, insulin, pump therapy, fto
5503879|NCT01279148|biopsy guidance|biopsy guidance
5503880|NCT01279148|tracking device|tracking device
5503881|NCT01279135|IGRT,Postoperative, Cervix, Late toxicity, Bowel|igrt,postoperative, cervix, late toxicity, bowel
5503882|NCT01279109|gestational weight gain|gestational weight gain
5503883|NCT01279096|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5503884|NCT01279096|relapse|relapse
5503885|NCT01279096|childhood|childhood
5503886|NCT01279096|clofarabine|clofarabine
5503887|NCT01279070|Schizophrenia|schizophrenia
5503888|NCT01279070|Cognitive remediation|cognitive remediation
5503889|NCT01279070|Group training|group training
5503890|NCT01279070|Executive function|executive function
5503891|NCT01279070|Social functioning|social functioning
5503892|NCT01279057|Rhinitis, allergic, seasonal, fluticasone furoate, equivalence|rhinitis, allergic, seasonal, fluticasone furoate, equivalence
5503895|NCT01279044|SUMSM|sumsm
5660114|NCT00662545|HIV|hiv
5503896|NCT01279018|Persistent postsurgical pain|persistent postsurgical pain
5503897|NCT01279018|breast cancer|breast cancer
5503898|NCT01279018|postmastectomy pain syndrome|postmastectomy pain syndrome
5503899|NCT01279018|neuropathic pain|neuropathic pain
5503900|NCT01279005|MSM|msm
5503901|NCT01279005|focus group|focus group
5503902|NCT01279005|HIV|hiv
5503903|NCT01279005|risk-taking|risk-taking
5503904|NCT01279005|risk-denial|risk-denial
5503905|NCT01279005|signature on inform consent, willing to participate, MSM either HIV positive or negative, age 20-50 years old|signature on inform consent, willing to participate, msm either hiv positive or negative, age 20-50 years old
5503906|NCT01278992|fatigue|fatigue
5503907|NCT01278992|adaptogen|adaptogen
5503908|NCT01278992|Rhodiola rosea|rhodiola rosea
5503909|NCT01278979|obstetric|obstetric
5503910|NCT01278979|perineal tear|perineal tear
5503911|NCT01278979|perineal injury|perineal injury
5503912|NCT01278979|diagnosis|diagnosis
5503913|NCT01278966|Epilepsy|epilepsy
5503914|NCT01278966|Diet|diet
5503915|NCT01278966|the Modified Atkins Diet|the modified atkins diet
5503916|NCT01278966|Ketogenic diet|ketogenic diet
5503917|NCT01278953|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5503918|NCT01278953|atrial fibrillation|atrial fibrillation
5503919|NCT01278953|radiofrequency ablation|radiofrequency ablation
5503920|NCT01278953|pulmonary vein isolation|pulmonary vein isolation
5503921|NCT01278953|ablation catheter|ablation catheter
5503922|NCT01278953|RF|rf
5503923|NCT01278953|contact force sensing|contact force sensing
5503924|NCT01278953|contact force|contact force
5503925|NCT01278953|contact force assisted ablation|contact force assisted ablation
5503926|NCT01278927|exercise|exercise
5503927|NCT01278927|stress management|stress management
5503928|NCT01278927|post transplant|post transplant
5503929|NCT01278927|physical and emotional relaxation|physical and emotional relaxation
5503930|NCT01278901|helicobacter pylori|helicobacter pylori
5503931|NCT01278901|urease test|urease test
5503932|NCT01278901|13C-UBT|13c-ubt
5503933|NCT01278901|the focus of the study is to evaluate a possible effect of PPI therapy on Helicobacter pylori diagnostic tests|the focus of the study is to evaluate a possible effect of ppi therapy on helicobacter pylori diagnostic tests
5503934|NCT01278888|Lung cancer|lung cancer
5503935|NCT01278888|Pain|pain
5503936|NCT01278888|Quality of life|quality of life
5503937|NCT01278888|Economy|economy
5503938|NCT01278875|High density lipoproteins|high density lipoproteins
5503939|NCT01278875|Acute coronary syndromes|acute coronary syndromes
5503940|NCT01278875|Cellular cholesterol efflux|cellular cholesterol efflux
5503941|NCT01278875|HDL: proteomics|hdl: proteomics
5503942|NCT01278875|Nitric Acid production|nitric acid production
5503943|NCT01278862|Crowns|crowns
5503944|NCT01278862|posterior teeth|posterior teeth
5503945|NCT01278862|CAD CAM crowns|cad cam crowns
5503946|NCT01278862|digital veneer system|digital veneer system
5503947|NCT01278862|Lava|lava
5503949|NCT01278849|Advanced or metastatic cancer,|advanced or metastatic cancer,
5503950|NCT01278849|refractory,|refractory,
5503951|NCT01278849|core phase,|core phase,
5503952|NCT01278849|extension phase,|extension phase,
5503953|NCT01278849|dose escalation,|dose escalation,
5503954|NCT01278849|standard chemotherapy,|standard chemotherapy,
5503955|NCT01278849|pharmacokinetics,|pharmacokinetics,
5503956|NCT01278849|doctaxel,|doctaxel,
5503957|NCT01278849|paclitaxel,|paclitaxel,
5503958|NCT01278849|carboplatin,|carboplatin,
5503960|NCT01278849|tolerability,|tolerability,
5503985|NCT01278745|prevention|prevention
5503986|NCT01278745|cardiac transplantation|cardiac transplantation
5503987|NCT01278745|rituximab|rituximab
5503988|NCT01278732|arterial hypertension|arterial hypertension
5503989|NCT01278719|Antrochoanal polyp|antrochoanal polyp
5503990|NCT01278719|Ethmoidal polyp|ethmoidal polyp
5503991|NCT01278719|Recurrence|recurrence
5503992|NCT01278719|Risk factors|risk factors
5503993|NCT01278719|Environmental factors|environmental factors
5503994|NCT01278719|Gene expression|gene expression
5503995|NCT01278719|Micro array|micro array
5503996|NCT01278719|Mutation|mutation
5503997|NCT01278693|Renal failure, hemodialysis, dyslipidemia, L-carnitine.|renal failure, hemodialysis, dyslipidemia, l-carnitine.
5503998|NCT01278680|Behavioral economics|behavioral economics
5503999|NCT01278680|Incentives|incentives
5504001|NCT01278667|ADHD|adhd
5504002|NCT01278667|Memory|memory
5504003|NCT01278667|Social|social
5504004|NCT01278667|Emotion|emotion
5504005|NCT01278667|Methylphenidate|methylphenidate
5504006|NCT01278641|Fibromyalgia|fibromyalgia
5504007|NCT01278641|Widespread pain|widespread pain
5504008|NCT01278641|Fatigue|fatigue
5504009|NCT01278641|Physical exercise|physical exercise
5504010|NCT01278602|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5504011|NCT01278602|Chemotherapy|chemotherapy
5504012|NCT01278602|R-ESHAP|r-eshap
5504013|NCT01278602|Autologous stem cell transplantation|autologous stem cell transplantation
5504014|NCT01278576|Muscle spasticity|muscle spasticity
5504015|NCT01278576|Stroke|stroke
5504016|NCT01278576|Botulinum Toxins|botulinum toxins
5504017|NCT01278576|Lower extremity|lower extremity
5504018|NCT01278576|Ankle|ankle
5504019|NCT01278563|Low Glycemic Index Diet|low glycemic index diet
5504020|NCT01278537|elderly|elderly
5504021|NCT01278537|cancer surgery|cancer surgery
5504022|NCT01278537|quality of life|quality of life
5504023|NCT01278537|empowerment|empowerment
5504024|NCT01278537|shared-decision|shared-decision
5504025|NCT01278524|Delirium|delirium
5504026|NCT01278524|Analgosedation|analgosedation
5504028|NCT01278524|Pain|pain
5504029|NCT01278524|Implementation|implementation
5504030|NCT01278511|Canadian C-Spine Rule|canadian c-spine rule
5504031|NCT01278511|Prehospital Emergency Care|prehospital emergency care
5504032|NCT01278511|Cervical Spine Injuries|cervical spine injuries
5504033|NCT01278511|Cervical Spine Fractures|cervical spine fractures
5504034|NCT01278511|Emergency Medicine Undergraduates|emergency medicine undergraduates
5504035|NCT01278498|Escitalopram|escitalopram
5504036|NCT01278498|Depression|depression
5504037|NCT01278498|Stroke|stroke
5504038|NCT01278485|Diabetes complications|diabetes complications
5506893|NCT01266863|E test|e test
5504039|NCT01278472|cholecystectomy|cholecystectomy
5504040|NCT01278472|laparoscopic|laparoscopic
5504041|NCT01278472|single-port|single-port
5504042|NCT01278472|gallstones|gallstones
5504043|NCT01278459|endothelial function|endothelial function
5504044|NCT01278459|cardiovascular|cardiovascular
5504045|NCT01278446|Cow's Milk Allergy|cow's milk allergy
5504046|NCT01278446|CMA|cma
5504047|NCT01278433|Polio|polio
5504048|NCT01278433|Poliovirus|poliovirus
5504049|NCT01278433|IMOVAX Polio™|imovax polio™
5504050|NCT01278420|Visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery|visual outcomes with bilateral implantation of tecnis mf and restor iols six months post cataract surgery
5504051|NCT01278407|DLB|dlb
5504052|NCT01278407|Dementia with Lewy bodies|dementia with lewy bodies
5504053|NCT01278407|Lewy Body Disease|lewy body disease
5504054|NCT01278407|Dementia|dementia
5504055|NCT01278407|E2020|e2020
5504056|NCT01278407|Donepezil|donepezil
5504058|NCT01278394|Onychomycosis|onychomycosis
5504059|NCT01278394|Fungal Nail|fungal nail
5504060|NCT01278381|pancreas, pancreaticoduodenectomy, major complications|pancreas, pancreaticoduodenectomy, major complications
5504061|NCT01278368|pancreatic cancer, neoadjuvant chemotherapy|pancreatic cancer, neoadjuvant chemotherapy
5504062|NCT01278355|pain|pain
5504063|NCT01278355|acupuncture|acupuncture
5504064|NCT01278342|Sandostatin LAR|sandostatin lar
5504065|NCT01278342|High Dose|high dose
5504066|NCT01278342|GH-receptor antagonist|gh-receptor antagonist
5504067|NCT01278342|combination with dopamine-agonist|combination with dopamine-agonist
5504068|NCT01278342|acromegalic patients|acromegalic patients
5504069|NCT01278342|octreotide acetate|octreotide acetate
5504070|NCT01278342|Somavert|somavert
5504071|NCT01278342|Dostinex|dostinex
5504072|NCT01278342|pegvisomant|pegvisomant
5504073|NCT01278342|cabergoline|cabergoline
5504074|NCT01278342|not adequately controlled|not adequately controlled
5504076|NCT01278329|Music|music
5504077|NCT01278329|Foetal learning|foetal learning
5504078|NCT01278329|Brazelton Neonatal Behavioral Assessment Scale|brazelton neonatal behavioral assessment scale
5504079|NCT01278316|PTSD|ptsd
5504080|NCT01278316|TBI|tbi
5504081|NCT01278316|Cognition|cognition
5504082|NCT01278316|Cognitive Training|cognitive training
5504083|NCT01278303|Coarctation|coarctation
5504084|NCT01278303|Aorta|aorta
5504085|NCT01278290|Triptorelin acetate|triptorelin acetate
5504086|NCT01278290|precocious puberty|precocious puberty
5504087|NCT01278290|premature thelarche|premature thelarche
5504088|NCT01278290|GnRH analog|gnrh analog
5504089|NCT01278290|Diagnostic validation study|diagnostic validation study
5504090|NCT01278277|Stargardt disease|stargardt disease
5504091|NCT01278277|macula|macula
5504092|NCT01278277|electroretinogram|electroretinogram
5504093|NCT01278277|saffron|saffron
5504094|NCT01278264|Transversus abdominis plane block|transversus abdominis plane block
5504095|NCT01278264|Ultrasound guided|ultrasound guided
5504096|NCT01278264|Abdominoplasty|abdominoplasty
5504097|NCT01278238|Hypotension|hypotension
5504098|NCT01278238|Caesarean section|caesarean section
5504099|NCT01278238|Spinal anaesthesia|spinal anaesthesia
5504100|NCT01278238|Lower limb compression / wrapping|lower limb compression / wrapping
5504101|NCT01278238|Phenylephrine|phenylephrine
5504102|NCT01278225|Neurofeedback|neurofeedback
5504103|NCT01278225|Neural Function|neural function
5504104|NCT01278225|Neuromodulation|neuromodulation
5504105|NCT01278225|Chemotherapy-Induced Neuropathic Pain|chemotherapy-induced neuropathic pain
5504106|NCT01278225|Electroencephalogram|electroencephalogram
5504108|NCT01278225|Biofeedback|biofeedback
5504109|NCT01278225|BF|bf
5504110|NCT01278225|Quality of Life|quality of life
5504111|NCT01278225|QOL|qol
5504112|NCT01278225|Pain Quality Assessment Scale|pain quality assessment scale
5504113|NCT01278225|PQAS|pqas
5504114|NCT01278225|Brief Symptom Inventory|brief symptom inventory
5504115|NCT01278225|BSI|bsi
5504116|NCT01278225|Sleep Disturbances|sleep disturbances
5504117|NCT01278225|Fatigue|fatigue
5504118|NCT01278225|Questionnaires|questionnaires
5504119|NCT01278212|breast cancer|breast cancer
5504120|NCT01278212|breast neoplasm|breast neoplasm
5504121|NCT01278212|breast tumor|breast tumor
5490486|NCT01335191|Tat|tat
5504122|NCT01278212|radiotherapy|radiotherapy
5504123|NCT01278212|radiation|radiation
5504124|NCT01278212|accelerated|accelerated
5504125|NCT01278212|lumpectomy|lumpectomy
5504126|NCT01278199|Bronchial Artery Embolization|bronchial artery embolization
5504127|NCT01278199|Non-severe Hemoptysis|non-severe hemoptysis
5504128|NCT01278199|Bleeding mild-to-moderate abundance|bleeding mild-to-moderate abundance
5504129|NCT01278199|Volume ranging from 100 ml to 200 ml|volume ranging from 100 ml to 200 ml
5504130|NCT01278186|Coronary stenosis|coronary stenosis
5504131|NCT01278186|Bifurcation|bifurcation
5504132|NCT01278186|Drug-eluting balloon|drug-eluting balloon
5504133|NCT01278186|Drug-eluting stent|drug-eluting stent
5504134|NCT01278186|Angiographic follow-up|angiographic follow-up
5504135|NCT01278186|Late Lumen Loss|late lumen loss
5504136|NCT01278186|Restenosis|restenosis
5504137|NCT01278173|Vigabatrin-associated vision change|vigabatrin-associated vision change
5846757|NCT00043511|HIV Seronegativity|hiv seronegativity
5504138|NCT01278173|Adult refractory complex partial seizures|adult refractory complex partial seizures
5504139|NCT01278173|CPS|cps
5504140|NCT01278173|Epilepsy|epilepsy
5504141|NCT01278173|Seizures|seizures
5504142|NCT01278173|Brain diseases|brain diseases
5504143|NCT01278173|Central Nervous System Diseases|central nervous system diseases
5504144|NCT01278173|Nervous System Diseases|nervous system diseases
5504145|NCT01278173|Neurologic Manifestations|neurologic manifestations
5504146|NCT01278173|Enzyme Inhibitors|enzyme inhibitors
5504147|NCT01278173|GABA Agents|gaba agents
5504148|NCT01278147|cancer|cancer
5504149|NCT01278147|fatigue program education|fatigue program education
5504150|NCT01278121|Obesity|obesity
5504151|NCT01278121|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5504152|NCT01278121|Cardiovascular diseases|cardiovascular diseases
5504153|NCT01278108|Safety|safety
5504154|NCT01278108|Tolerability|tolerability
5504155|NCT01278108|Pharmacokinetics|pharmacokinetics
5504156|NCT01278095|Safety|safety
5504157|NCT01278095|Tolerability|tolerability
5504158|NCT01278095|Pharmacokinetics|pharmacokinetics
5504159|NCT01278082|Randomized|randomized
5504160|NCT01278082|double-blind|double-blind
5504161|NCT01278082|Placebo-controlled|placebo-controlled
5504162|NCT01278082|budesonide|budesonide
5504163|NCT01278082|collagenous colitis|collagenous colitis
5504164|NCT01278082|acute treatment|acute treatment
5504165|NCT01278082|maintaining remission|maintaining remission
5504166|NCT01278069|Acute myeloid Leukemia|acute myeloid leukemia
5504167|NCT01278069|Myeloid Sarcoma|myeloid sarcoma
5504168|NCT01278069|Extramedullary Acute myeloid Leukemia|extramedullary acute myeloid leukemia
5504169|NCT01278069|18FDG-PET-CT|18fdg-pet-ct
5504170|NCT01278056|Non-alcoholic steatohepatitis (NASH) and increased iron storage / disturbed distribution|non-alcoholic steatohepatitis (nash) and increased iron storage / disturbed distribution
5504172|NCT01278043|Percutaneous Coronary Intervention|percutaneous coronary intervention
5504173|NCT01278043|Coronary artery disease|coronary artery disease
5504174|NCT01278043|Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention|antiplatelet response, interval variability & events in percutaneous coronary intervention
5504175|NCT01278017|nontyphoidal salmonellae|nontyphoidal salmonellae
5504176|NCT01278017|enterocolitis|enterocolitis
5504177|NCT01278017|ceftriaxone|ceftriaxone
5504178|NCT01278004|Adult cancer patients with chemotherapy-induced painful peripheral neuropathy|adult cancer patients with chemotherapy-induced painful peripheral neuropathy
5504179|NCT01277991|Bioequivalence|bioequivalence
5504180|NCT01277991|healthy volunteer study|healthy volunteer study
5504181|NCT01277991|Rheumatoid Arthritis|rheumatoid arthritis
5504182|NCT01277978|Caesarean section|caesarean section
5504183|NCT01277978|Cardiovascular effects|cardiovascular effects
5504184|NCT01277978|Postpartum hemorrhage|postpartum hemorrhage
5504185|NCT01277978|Carbetocin|carbetocin
5504186|NCT01277978|Oxytocin|oxytocin
5504187|NCT01277965|Algorithm basal insulin|algorithm basal insulin
5660425|NCT00661830|tract|tract
5504188|NCT01277965|physical activity|physical activity
5504189|NCT01277965|Type 1 diabetes|type 1 diabetes
5504190|NCT01277965|Insulin pump treatment|insulin pump treatment
5504191|NCT01277952|Traumatic Brain Injury|traumatic brain injury
5504193|NCT01277926|Breast Cancer|breast cancer
5504194|NCT01277926|Hormone Receptor Positive, Advanced Breast Cancer|hormone receptor positive, advanced breast cancer
5504195|NCT01277913|diabetes|diabetes
5504196|NCT01277913|vitamin D|vitamin d
5504197|NCT01277913|bone density|bone density
5504198|NCT01277913|children|children
5504199|NCT01277887|Smoking|smoking
5504200|NCT01277887|Nicotine|nicotine
5504201|NCT01277887|Nicotine polacrilex|nicotine polacrilex
5504202|NCT01277887|Nicotine replacement|nicotine replacement
5504203|NCT01277861|Desflurane, Fentanyl, Airway responses|desflurane, fentanyl, airway responses
5504204|NCT01277848|PLAC1|plac1
5504205|NCT01277848|pregnant|pregnant
5504206|NCT01277848|first prenatal visit|first prenatal visit
5504207|NCT01277848|pre-eclampsia|pre-eclampsia
5504208|NCT01277835|video-assisted|video-assisted
5504209|NCT01277835|thoracic surgery|thoracic surgery
5504210|NCT01277835|VATS|vats
5504211|NCT01277835|lidocaine infusion|lidocaine infusion
5504212|NCT01277835|VATS procedures|vats procedures
5504213|NCT01277822|Hypertension|hypertension
5504214|NCT01277822|Uncontrolled hypertension|uncontrolled hypertension
5504215|NCT01277822|High blood pressure|high blood pressure
5504216|NCT01277822|Uncontrolled high blood pressure|uncontrolled high blood pressure
5504217|NCT01277822|Untreated high blood pressure|untreated high blood pressure
5504218|NCT01277822|Untreated hypertension|untreated hypertension
5504219|NCT01277822|Essential hypertension|essential hypertension
5504220|NCT01277809|Long term care|long term care
5504221|NCT01277809|Aging|aging
5504222|NCT01277809|Accidental Falls|accidental falls
5504223|NCT01277809|Muscle Weakness|muscle weakness
5504224|NCT01277809|Gait|gait
5504225|NCT01277809|Physical Fitness|physical fitness
5504226|NCT01277809|Muscle Strength|muscle strength
5504227|NCT01277809|Postural Balance|postural balance
5504228|NCT01277809|Activities of Daily Living|activities of daily living
5504229|NCT01277809|Body Weight|body weight
5504234|NCT01277770|Thymoglobulin|thymoglobulin
5504235|NCT01277770|Kidney Transplant Recipients|kidney transplant recipients
5504236|NCT01277770|Steroid-Free|steroid-free
5504237|NCT01277770|Immunosuppression|immunosuppression
5504238|NCT01277744|Desmoplastic small round cell tumor|desmoplastic small round cell tumor
5504240|NCT01277744|Hyperthermic peritoneal perfusion|hyperthermic peritoneal perfusion
5504241|NCT01277744|HIPEC|hipec
5504242|NCT01277744|Complete abdominal tumor excision|complete abdominal tumor excision
5504243|NCT01277744|Extensive abdominal disease|extensive abdominal disease
5504244|NCT01277744|Non-carcinoma tumors|non-carcinoma tumors
5504245|NCT01277744|Abdominal cavity|abdominal cavity
5504246|NCT01277744|Cisplatin|cisplatin
5504247|NCT01277744|Platinol-AQ|platinol-aq
5504248|NCT01277744|Platinol|platinol
5504249|NCT01277744|CDDP|cddp
5504250|NCT01277744|Diffuse peritoneal tumor|diffuse peritoneal tumor
5504251|NCT01277744|Retroperitoneal tumor|retroperitoneal tumor
5504252|NCT01277744|Ovarian germ cell|ovarian germ cell
5504253|NCT01277744|Wilms' tumor|wilms' tumor
5504254|NCT01277705|Booster vaccination|booster vaccination
5504255|NCT01277692|First administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis C patients|first administration to human, safety, pharmacokinetics, healthy subjects, antiviral activity, hepatitis c patients
5504256|NCT01277679|lung water measures|lung water measures
5504257|NCT01277679|pulmonary edema|pulmonary edema
5504259|NCT01277679|heart failure|heart failure
5504260|NCT01277666|Crohn's disease|crohn's disease
5504261|NCT01277666|capsule|capsule
5504262|NCT01277666|GSK1605786A|gsk1605786a
5504263|NCT01277666|quality of life|quality of life
5504264|NCT01277666|inflammatory bowel disease|inflammatory bowel disease
5504265|NCT01277666|oral therapy|oral therapy
5504266|NCT01277653|Hepatocellular carcinoma|hepatocellular carcinoma
5504267|NCT01277640|male tolerance|male tolerance
5504283|NCT01277601|Tenofovir disoproxil fumarate (TDF)|tenofovir disoproxil fumarate (tdf)
5504284|NCT01277601|Peginterferon α-2a (Peg-IFN)|peginterferon α-2a (peg-ifn)
5504285|NCT01277588|fetal scalp sampling|fetal scalp sampling
5504286|NCT01277588|experience questionnaire|experience questionnaire
5504288|NCT01277575|aphasia|aphasia
5504289|NCT01277575|language|language
5504290|NCT01277562|Breast Cancer|breast cancer
5504291|NCT01277562|Prostate Cancer|prostate cancer
5504292|NCT01277562|Osteopenia|osteopenia
5504293|NCT01277562|Osteoporosis|osteoporosis
5504294|NCT01277562|Secondary causes of bone loss|secondary causes of bone loss
5504295|NCT01277549|Leukapheresis|leukapheresis
5504296|NCT01277549|Hematopoetic Stem Cell Mobilization|hematopoetic stem cell mobilization
5504297|NCT01277510|dialysis|dialysis
5504298|NCT01277510|sensipar|sensipar
5504299|NCT01277510|mimpara|mimpara
5504300|NCT01277510|hemodialysis|hemodialysis
5504301|NCT01277510|peritoneal dialysis|peritoneal dialysis
5504302|NCT01277510|renal|renal
5504303|NCT01277510|parathyroid hormone|parathyroid hormone
5504304|NCT01277510|pediatric|pediatric
5504305|NCT01277497|Chronic kidney disease|chronic kidney disease
5504306|NCT01277497|Phosphate binder|phosphate binder
5504307|NCT01277497|Sevelamer carbonate|sevelamer carbonate
5504308|NCT01277497|Calcium acetate|calcium acetate
5504309|NCT01277497|Vascular calcification|vascular calcification
5504310|NCT01277497|Endothelial Dysfunction|endothelial dysfunction
5504311|NCT01277484|decitabine|decitabine
5504312|NCT01277484|dose|dose
5504313|NCT01277484|schedule|schedule
5504314|NCT01277484|safety|safety
5504315|NCT01277484|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5504316|NCT01277471|meal frequency|meal frequency
5504317|NCT01277471|type two diabetes|type two diabetes
5504318|NCT01277458|HIV|hiv
5504319|NCT01277458|MSM|msm
5504320|NCT01277458|Ethnicity|ethnicity
5504321|NCT01277445|gut microbiome|gut microbiome
5504322|NCT01277445|prebiotics|prebiotics
5504323|NCT01277445|immunological status|immunological status
5504324|NCT01277445|fructans|fructans
5504325|NCT01277432|Diabetes|diabetes
5504326|NCT01277432|Depression|depression
5504327|NCT01277406|Colorectal Carcinoma|colorectal carcinoma
5504328|NCT01277406|Resminostat|resminostat
5504329|NCT01277406|HDAC|hdac
5504330|NCT01277406|4SC-201|4sc-201
5504331|NCT01277406|Phase I|phase i
5504332|NCT01277406|Phase II|phase ii
5504333|NCT01277393|Enteral nutrition feeding|enteral nutrition feeding
5504334|NCT01277380|H1N1 Influenza virus|h1n1 influenza virus
5504335|NCT01277380|swine flu|swine flu
5504336|NCT01277380|Real Time RT-PCR|real time rt-pcr
5504337|NCT01277367|Obesity|obesity
5504338|NCT01277367|Sedentary|sedentary
5504339|NCT01277367|Physical activity|physical activity
5504340|NCT01277367|exercise|exercise
5504341|NCT01277367|incentives|incentives
5504342|NCT01277354|Cognitive Processing Therapy (CPT)|cognitive processing therapy (cpt)
5504343|NCT01277315|ALS|als
5504344|NCT01277315|Anakinra|anakinra
5504345|NCT01277315|Kineret|kineret
5504346|NCT01277315|Progressive Muscular Atrophy|progressive muscular atrophy
5504347|NCT01277315|PMA|pma
5504348|NCT01277315|Safety Trial|safety trial
5504349|NCT01277315|Tolerability Trial|tolerability trial
5504350|NCT01277289|dexamethasone|dexamethasone
5504351|NCT01277289|ery-dex|ery-dex
5504352|NCT01277289|Chron's disease|chron's disease
5504353|NCT01277289|CD|cd
5504354|NCT01277276|Medical tool|medical tool
5504355|NCT01277263|Breast Cancer|breast cancer
5504356|NCT01277250|Hospitalized adults|hospitalized adults
5504357|NCT01277250|Tobacco users|tobacco users
5504358|NCT01277250|Smokers|smokers
5504359|NCT01277250|Smoking cessation|smoking cessation
5504360|NCT01277250|Web-based|web-based
5504363|NCT01277224|physical activity|physical activity
5504364|NCT01277224|obesity|obesity
5504365|NCT01277224|adiposity|adiposity
5504366|NCT01277224|children|children
5504367|NCT01277224|blood lipids|blood lipids
5504368|NCT01277224|blood pressure|blood pressure
5504369|NCT01277224|randomized controlled trials|randomized controlled trials
5504370|NCT01277211|Contraception|contraception
5504371|NCT01277211|NuvaRing|nuvaring
5504372|NCT01277198|kidney calculi|kidney calculi
5504373|NCT01277198|ureteral calculi|ureteral calculi
5504374|NCT01277198|cystoscopes|cystoscopes
5504375|NCT01277198|laparoscopes|laparoscopes
5504376|NCT01277185|calcium|calcium
5504377|NCT01277185|healthy|healthy
5504378|NCT01277185|Mexican-American adolescents|mexican-american adolescents
5504379|NCT01277185|camp|camp
5504380|NCT01277185|girls|girls
5504381|NCT01277185|boys|boys
5504382|NCT01277185|bone|bone
5504383|NCT01277172|DLBCL|dlbcl
5504384|NCT01277172|pharmacokinetics|pharmacokinetics
5504385|NCT01277172|pharmacodynamics|pharmacodynamics
5504386|NCT01277172|Rituximab|rituximab
5504387|NCT01277172|LymphomaLymphoma|lymphomalymphoma
5504388|NCT01277172|Non-HodgkinLymphoma|non-hodgkinlymphoma
5504389|NCT01277172|B-CellLymphoma|b-celllymphoma
5504390|NCT01277172|Large B-Cell|large b-cell
5504391|NCT01277172|Disorders Lymphatic Diseases|disorders lymphatic diseases
5504392|NCT01277172|Immunoproliferative Disorders|immunoproliferative disorders
5504393|NCT01277172|Antineoplastic Agents|antineoplastic agents
5504394|NCT01277172|Adverse Effects|adverse effects
5504395|NCT01277159|Analgesia|analgesia
5504396|NCT01277159|Duration|duration
5504397|NCT01277159|Popliteal Fossa Nerve Block|popliteal fossa nerve block
5504398|NCT01277159|Dexamethasone|dexamethasone
5504399|NCT01277159|Buprenorphine|buprenorphine
5504400|NCT01277159|Additives|additives
5504401|NCT01277159|Ankle surgery|ankle surgery
5504402|NCT01277146|Phase 1|phase 1
5504403|NCT01277146|dose escalation|dose escalation
5504404|NCT01277146|histologically confirmed|histologically confirmed
5504405|NCT01277146|malignancy metastatic|malignancy metastatic
5504407|NCT01277107|LPS|lps
5504408|NCT01277107|TST|tst
5504409|NCT01277107|WASO|waso
5504410|NCT01277107|Subjects With Insomnia characterized by both Difficulty in Falling Asleep and Staying Asleep|subjects with insomnia characterized by both difficulty in falling asleep and staying asleep
5504411|NCT01277081|Paracetamol|paracetamol
5504412|NCT01277081|Common cold|common cold
5504413|NCT01277068|obese patients|obese patients
5504414|NCT01277068|TRL|trl
5504415|NCT01277068|the bariatric surgery|the bariatric surgery
5504416|NCT01277042|Safety|safety
5504417|NCT01277042|HPV vaccine|hpv vaccine
5504418|NCT01277042|Immune response|immune response
5504419|NCT01277042|Human papillomavirus|human papillomavirus
5504420|NCT01277042|China|china
5504421|NCT01277016|Amyloidosis|amyloidosis
5504422|NCT01277016|Bortezomib|bortezomib
5504423|NCT01276977|Migraine|migraine
5504424|NCT01276977|Acute Migraine|acute migraine
5504425|NCT01276977|Headache|headache
5504426|NCT01276964|menses|menses
5504427|NCT01276964|quantitative determination of menstrual losses|quantitative determination of menstrual losses
5504428|NCT01276964|kinetic definition of menses|kinetic definition of menses
5504429|NCT01276951|Cocoa|cocoa
5504430|NCT01276951|Chocolate|chocolate
5504431|NCT01276951|Endothelial disfunction|endothelial disfunction
5504432|NCT01276951|Cardiovascular disease|cardiovascular disease
5504433|NCT01276951|Blood Pressure|blood pressure
5504434|NCT01276951|Hypertension|hypertension
5504435|NCT01276938|Breast cancer|breast cancer
5504436|NCT01276938|Intra Operative Radiation Therapy|intra operative radiation therapy
5504437|NCT01276938|Toxicity|toxicity
5504438|NCT01276925|Hip arthroplasty|hip arthroplasty
5504439|NCT01276925|Peripheral nervous blockade|peripheral nervous blockade
5504440|NCT01276925|Postoperative|postoperative
5504441|NCT01276925|Pain|pain
5504442|NCT01276925|Ropivacaine|ropivacaine
5504443|NCT01276899|Breast Cancer|breast cancer
5504444|NCT01276899|Triple negative breast cancer|triple negative breast cancer
5504445|NCT01276899|ERnegative, PRnegative and Her2negative|ernegative, prnegative and her2negative
5504446|NCT01276899|Taxanes|taxanes
5504447|NCT01276899|Metastases|metastases
5504448|NCT01276899|Biomarkers|biomarkers
5504449|NCT01276899|Resistance|resistance
5504450|NCT01276899|Biobanking|biobanking
5504451|NCT01276899|Breast cancer with unresectable metastases to the liver|breast cancer with unresectable metastases to the liver
5504452|NCT01276899|Breast cancer with unresectable metastases to the skin|breast cancer with unresectable metastases to the skin
5504453|NCT01276899|Breast cancer with unresectable metastases to the lymph node|breast cancer with unresectable metastases to the lymph node
5504454|NCT01276899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5504544|NCT01276470|Antibody|antibody
5504545|NCT01276470|Autoimmune Diseases|autoimmune diseases
5498711|NCT01301352|Child|child
5789048|NCT00150124|toxic nodular goiter|toxic nodular goiter
5504455|NCT01276886|Left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°C, confirmed by imaging.|left sided acute diverticulitis diagnosed clinically by the presence of abdominal pain, leukocytosis (>11x109) and/or fever >38°c, confirmed by imaging.
5504456|NCT01276886|CT criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.|ct criteria: localized thickening (≥4 mm) of the colonic wall and signs of inflammation of the pericolic fat, abscess and/or extraluminal air and/or contrast.
5486490|NCT01351688|Down regulation|down regulation
5486491|NCT01351688|Japanese|japanese
5486492|NCT01351675|Chronic kidney disease|chronic kidney disease
5486493|NCT01351675|Type 2 diabetes|type 2 diabetes
5504457|NCT01276886|US criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.|us criteria: bowel wall thickening (>4 mm), diverticular inflammation, pericolic fat edema, intramural or pericolic inflammatory mass, intramural fistula.
5504458|NCT01276886|WSCE criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.|wsce criteria: segmental luminal narrowing and a tethered mucosa with or without a mass effect or extravasation of contrast and/or extraluminal air.
5504459|NCT01276873|Artificial Respiration|artificial respiration
5504460|NCT01276873|Suction|suction
5504461|NCT01276873|Pain|pain
5504462|NCT01276873|Nursing|nursing
5504463|NCT01276873|Neonatology|neonatology
5504464|NCT01276860|Obstructive Sleep Apnea|obstructive sleep apnea
5504465|NCT01276860|Pediatric Obstructive Sleep Apnea|pediatric obstructive sleep apnea
5504467|NCT01276860|PVT|pvt
5504468|NCT01276860|Psychomotor Vigilance Testing|psychomotor vigilance testing
5504469|NCT01276860|Psychomotor Vigilance Task|psychomotor vigilance task
5504470|NCT01276847|psoriasis|psoriasis
5504471|NCT01276847|Ustekinumab|ustekinumab
5504472|NCT01276847|Stelara|stelara
5504473|NCT01276847|Etanercept|etanercept
5504474|NCT01276847|Enbrel|enbrel
5504475|NCT01276821|Bronchiolitis|bronchiolitis
5504476|NCT01276821|L-Epinephrine|l-epinephrine
5504477|NCT01276821|3% Hypertonic Saline|3% hypertonic saline
5504478|NCT01276821|Clinical Severity Score|clinical severity score
5504479|NCT01276808|Magnetic navigation, percutaneous coronary intervention|magnetic navigation, percutaneous coronary intervention
5504480|NCT01276769|Triple Negative Breast Cancer|triple negative breast cancer
5504481|NCT01276769|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5504482|NCT01276769|Platinum|platinum
5504483|NCT01276730|Advanced cervical cancer|advanced cervical cancer
5504484|NCT01276730|India|india
5504485|NCT01276691|Vascular function|vascular function
5504486|NCT01276691|Inflammation|inflammation
5504487|NCT01276691|Oxidative stress|oxidative stress
5504488|NCT01276691|Hemostatic balance|hemostatic balance
5504489|NCT01276691|Aspirin|aspirin
5504490|NCT01276691|Firefighting|firefighting
5504491|NCT01276678|CAD|cad
5504492|NCT01276665|Bladder cancer|bladder cancer
5504493|NCT01276665|urinary diversion|urinary diversion
5504494|NCT01276665|Postoperative Complications|postoperative complications
5504495|NCT01276665|Fluid Therapy|fluid therapy
5504496|NCT01276665|Norepinephrine|norepinephrine
5504497|NCT01276652|Polysomnography|polysomnography
5504498|NCT01276652|Circadian rhythmicity|circadian rhythmicity
5504499|NCT01276639|Xeljanz|xeljanz
5504500|NCT01276639|tofacitinib|tofacitinib
5504501|NCT01276639|chronic|chronic
5504502|NCT01276639|Pruritus|pruritus
5504503|NCT01276639|Itch|itch
5504504|NCT01276639|DLQI|dlqi
5504505|NCT01276639|severe|severe
5504506|NCT01276639|moderate|moderate
5504507|NCT01276639|treatment|treatment
5504508|NCT01276639|safety|safety
5504509|NCT01276639|efficacy|efficacy
5504510|NCT01276639|CP-690,550|cp-690,550
5504511|NCT01276639|Plaque Psoriasis|plaque psoriasis
5504512|NCT01276639|Psoriasis Vulgaris|psoriasis vulgaris
5504513|NCT01276639|Jax-inhibitor|jax-inhibitor
5504514|NCT01276639|Oral Treatment|oral treatment
5846758|NCT00043511|Plasmids|plasmids
5504520|NCT01276587|children|children
5504521|NCT01276587|vitamin D|vitamin d
5504522|NCT01276587|safety|safety
5504523|NCT01276574|PET/CT|pet/ct
5504524|NCT01276574|Ovarian cancer|ovarian cancer
5504525|NCT01276574|HE4|he4
5504526|NCT01276561|laparoscopy|laparoscopy
5504527|NCT01276561|splenectomy|splenectomy
5504528|NCT01276561|single site|single site
5504529|NCT01276561|trial|trial
5504530|NCT01276522|Schnitzler syndrome|schnitzler syndrome
5504531|NCT01276522|IL-1 beta|il-1 beta
5504532|NCT01276522|Canakinumab|canakinumab
5504533|NCT01276522|Ilaris|ilaris
5504534|NCT01276522|Treatment|treatment
5504535|NCT01276522|Efficacy|efficacy
5504536|NCT01276522|Safety|safety
5504537|NCT01276509|Crohn's disease Safety Efficacy Pharmacokinetics Pharmacodynamics Crohn's Disease Activity Index (CDAI)|crohn's disease safety efficacy pharmacokinetics pharmacodynamics crohn's disease activity index (cdai)
5504538|NCT01276483|GIST|gist
5504539|NCT01276483|Response Monitoring|response monitoring
5504540|NCT01276483|Functional Magnetic Imaging|functional magnetic imaging
5504541|NCT01276483|Positron Emission Tomography|positron emission tomography
5504542|NCT01276483|Computer Tomography|computer tomography
5504543|NCT01276470|Adult and Pediatric Autoimmune Disease|adult and pediatric autoimmune disease
5504546|NCT01276470|Autoimmunity Pathogenesis|autoimmunity pathogenesis
5504547|NCT01276470|Environmental Risk Factors|environmental risk factors
5504548|NCT01276470|Myositis|myositis
5504549|NCT01276457|immunosuppression|immunosuppression
5504550|NCT01276457|kidney transplantation|kidney transplantation
5504551|NCT01276457|everolimus|everolimus
5504552|NCT01276457|safety|safety
5504553|NCT01276444|valve repair|valve repair
5504554|NCT01276444|postoperative period|postoperative period
5504555|NCT01276444|goal-directed therapy|goal-directed therapy
5504556|NCT01276444|pulmonary artery catheter|pulmonary artery catheter
5504557|NCT01276444|transpulmonary thermodilution|transpulmonary thermodilution
5486621|NCT01351064|ADHD|adhd
5504558|NCT01276444|central venous oxygen saturation|central venous oxygen saturation
5504559|NCT01276392|regional and systemical anticoagulation|regional and systemical anticoagulation
5504560|NCT01276392|continuous renal replacement therapy|continuous renal replacement therapy
5504561|NCT01276392|multiplate|multiplate
5504562|NCT01276392|rotational thrombelastometry|rotational thrombelastometry
5504563|NCT01276379|colorectal cancer|colorectal cancer
5504564|NCT01276379|advanced|advanced
5504565|NCT01276379|metastatic|metastatic
5504566|NCT01276379|KRAS|kras
5504567|NCT01276379|biomarkers (BRAF, IGF1P/MMp7,PI3K-PTEN)|biomarkers (braf, igf1p/mmp7,pi3k-pten)
5504568|NCT01276379|cetuximab|cetuximab
5504569|NCT01276366|Heel lance|heel lance
5504570|NCT01276366|Premature|premature
5504571|NCT01276366|Breast milk|breast milk
5504572|NCT01276353|Alzheimer Disease|alzheimer disease
5504573|NCT01276353|Dementia|dementia
5504574|NCT01276353|Delirium|delirium
5504575|NCT01276353|Amnestic|amnestic
5504576|NCT01276353|Cognitive Disorders|cognitive disorders
5504577|NCT01276353|Donepezil|donepezil
5504578|NCT01276353|Brain Diseases|brain diseases
5504579|NCT01276353|Central Nervous System Diseases|central nervous system diseases
5504580|NCT01276353|Nervous System Diseases|nervous system diseases
5504581|NCT01276353|Tauopathies|tauopathies
5504582|NCT01276353|Neurodegenerative Diseases|neurodegenerative diseases
5504583|NCT01276353|Mental Disorders|mental disorders
5504584|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors
5504585|NCT01276353|Enzy|enzy
5504586|NCT01276340|Urinary Incontinence|urinary incontinence
5504587|NCT01276340|Urinary stress incontinence|urinary stress incontinence
5504588|NCT01276340|Urinary urge incontinence|urinary urge incontinence
5504589|NCT01276340|Women|women
5504590|NCT01276340|electrical stimulation|electrical stimulation
5504591|NCT01276340|KEAT stimulator|keat stimulator
5504592|NCT01276340|quality of life|quality of life
5504593|NCT01276314|SCAR|scar
5504594|NCT01276314|anti-TNF-a|anti-tnf-a
5504595|NCT01276275|Acute coronary syndrome, thienopyridine, epidemiology|acute coronary syndrome, thienopyridine, epidemiology
5504596|NCT01276262|Phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, Rheumatoid arthritis, RA, fostamatinib|phase 1, healthy female volunteers, oral contraceptive, pharmacokinetics, rheumatoid arthritis, ra, fostamatinib
5504597|NCT01276249|Aptus Endosystem|aptus endosystem
5504598|NCT01276249|EndoStaple|endostaple
5504599|NCT01276249|Endograft|endograft
5504600|NCT01276249|Stent Graft|stent graft
5504601|NCT01276249|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5504602|NCT01276249|Heli-FX|heli-fx
5504603|NCT01276249|EndoAnchor|endoanchor
5504604|NCT01276236|Kaposi's Sarcoma|kaposi's sarcoma
5504605|NCT01276236|Maraviroc|maraviroc
5504606|NCT01276236|CCR5|ccr5
5504608|NCT01276223|Dry eye|dry eye
5504609|NCT01276223|ocular discomfort|ocular discomfort
5504610|NCT01276197|hypertension|hypertension
5504611|NCT01276197|healthcare disparities|healthcare disparities
5504612|NCT01276197|minority health|minority health
5504613|NCT01276197|health behavior|health behavior
5504614|NCT01276184|HPV Vaccine|hpv vaccine
5504615|NCT01276184|HPV vaccination|hpv vaccination
5504617|NCT01276184|Text Message|text message
5504618|NCT01276184|Gardasil|gardasil
5504619|NCT01276145|pudendal artery disease|pudendal artery disease
5504620|NCT01276145|erectile dysfunction|erectile dysfunction
5504621|NCT01276145|coronary angiography|coronary angiography
5504622|NCT01276145|coronary disease|coronary disease
5504623|NCT01276145|cardiac|cardiac
5504624|NCT01276132|percutaneous coronary artery intervention|percutaneous coronary artery intervention
5504625|NCT01276132|coronary disease|coronary disease
5504627|NCT01276119|single-dose|single-dose
5504628|NCT01276119|pharmacokinetics|pharmacokinetics
5504629|NCT01276119|healthy subjects|healthy subjects
5504630|NCT01276106|AC-201|ac-201
5504631|NCT01276106|Interleukin 1 inhibitor|interleukin 1 inhibitor
5504632|NCT01276093|Atrial fibrillation|atrial fibrillation
5504633|NCT01276093|PVI ablation|pvi ablation
5504634|NCT01276093|Elderly patients|elderly patients
5504635|NCT01276093|Efficacy|efficacy
5504636|NCT01276041|MAB 2C4 (PERTUZUMAB)|mab 2c4 (pertuzumab)
5504637|NCT01276041|MAB HER 2 (HERCEPTIN) (TRASTUZUMAB)|mab her 2 (herceptin) (trastuzumab)
5504638|NCT01276041|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5504639|NCT01276041|10-142|10-142
5504640|NCT01276041|Stage IV HER2 (+) breast cancer|stage iv her2 (+) breast cancer
5504641|NCT01276028|Acupuncture|acupuncture
5504642|NCT01276028|Hot Flashes|hot flashes
5504643|NCT01276028|Menopause|menopause
5504644|NCT01276028|Vasomotor Symptoms|vasomotor symptoms
5504645|NCT01276015|BoNT-A-botulinum neurotoxin type A|bont-a-botulinum neurotoxin type a
5504646|NCT01276015|CMAP-compound muscle action potential|cmap-compound muscle action potential
5504647|NCT01276015|CP-cerebral palsy|cp-cerebral palsy
5504648|NCT01276015|LG-lateral gastrocnemius|lg-lateral gastrocnemius
5504649|NCT01276015|MG-medial gastrocnemius|mg-medial gastrocnemius
5504650|NCT01276015|TA-tibialis anterior|ta-tibialis anterior
5504651|NCT01276015|PROMS-passive range of movement|proms-passive range of movement
5504652|NCT01276015|MAS-modified Ashworth scale|mas-modified ashworth scale
5504653|NCT01276015|EVGS-Edinburgh visual gait scale|evgs-edinburgh visual gait scale
5486736|NCT01350453|Stroke|stroke
5504654|NCT01276015|GMF-CS-gross motor function classification system|gmf-cs-gross motor function classification system
5504656|NCT01276002|pancreatic pseudocysts|pancreatic pseudocysts
5504657|NCT01275976|C1-esterase inhibitor|c1-esterase inhibitor
5504658|NCT01275976|Systemic inflammation|systemic inflammation
5504659|NCT01275976|Sepsis|sepsis
5504660|NCT01275976|Trauma|trauma
5504661|NCT01275976|Multiple Organ Dysfunction Syndrome|multiple organ dysfunction syndrome
5504662|NCT01275976|Cytokines|cytokines
5504663|NCT01275963|Echocardiography|echocardiography
5504664|NCT01275963|Strain imaging|strain imaging
5504665|NCT01275963|Ventricular Dysfunction|ventricular dysfunction
5504666|NCT01275963|Cardiomyopathy|cardiomyopathy
5504667|NCT01275963|Longitudinal left ventricular function|longitudinal left ventricular function
5504668|NCT01275950|Tobacco vendor|tobacco vendor
5504670|NCT01275950|knowledge|knowledge
5504671|NCT01275950|attitude|attitude
5504672|NCT01275950|practice|practice
5504673|NCT01275950|direct advertisements|direct advertisements
5504674|NCT01275950|surrogate advertisements|surrogate advertisements
5504675|NCT01275924|Syndesmosis|syndesmosis
5504676|NCT01275924|Injury|injury
5504677|NCT01275924|Ankle|ankle
5504678|NCT01275924|Fracture|fracture
5504679|NCT01275898|NIRS|nirs
5504680|NCT01275898|cerebral oxygenation|cerebral oxygenation
5504681|NCT01275885|cholecalciferol|cholecalciferol
5504682|NCT01275885|infant|infant
5504683|NCT01275885|bone mineral density|bone mineral density
5504684|NCT01275872|guided imagery|guided imagery
5504685|NCT01275872|progressive muscle relaxation|progressive muscle relaxation
5504686|NCT01275872|complimentary and alternative medicine|complimentary and alternative medicine
5504687|NCT01275872|quality of life|quality of life
5504688|NCT01275872|stress|stress
5504689|NCT01275872|pain|pain
5504690|NCT01275872|anxiety|anxiety
5504691|NCT01275859|Neoadjuvant|neoadjuvant
5504692|NCT01275859|Letrozole|letrozole
5504693|NCT01275859|Lapatinib|lapatinib
5504694|NCT01275859|Postmenopausal|postmenopausal
5504695|NCT01275846|heart failure|heart failure
5504696|NCT01275846|congestive heart failure|congestive heart failure
5504697|NCT01275846|telemedicine|telemedicine
5504698|NCT01275833|Implantable ICD|implantable icd
5504699|NCT01275833|First Degree AV block|first degree av block
5504700|NCT01275820|diabetes, insulin, blood sugar|diabetes, insulin, blood sugar
5504701|NCT01275807|climacteric, climacteric syndrome|climacteric, climacteric syndrome
5504702|NCT01275794|Type 2 Diabetes|type 2 diabetes
5504703|NCT01275781|Phase 1|phase 1
5504704|NCT01275781|healthy male volunteers|healthy male volunteers
5504705|NCT01275781|radioactivity|radioactivity
5504706|NCT01275781|excretion|excretion
5504707|NCT01275781|metabolism|metabolism
5504708|NCT01275781|AZD9742|azd9742
5504709|NCT01275781|amount of radioactive AZD9742 in urine, feces, and vomitus (if appropriate)|amount of radioactive azd9742 in urine, feces, and vomitus (if appropriate)
5504710|NCT01275768|radio-frequency ablation|radio-frequency ablation
5504711|NCT01275768|Malignant jaundice|malignant jaundice
5504712|NCT01275755|opioid therapy|opioid therapy
5504713|NCT01275755|constipation|constipation
5504714|NCT01275755|chronic noncancer pain|chronic noncancer pain
5504715|NCT01275755|mu opioid receptor antagonist|mu opioid receptor antagonist
5504716|NCT01275755|ADL5945|adl5945
5504717|NCT01275755|Opioid Induced Constipation|opioid induced constipation
5504718|NCT01275742|Heart failure|heart failure
5504719|NCT01275742|Depression|depression
5504720|NCT01275742|Depressive symptoms|depressive symptoms
5504721|NCT01275742|Cognitive therapy|cognitive therapy
5504722|NCT01275742|Hospitalization|hospitalization
5504723|NCT01275742|Quality of life|quality of life
5504724|NCT01275729|Renal Replacement Therapy|renal replacement therapy
5504725|NCT01275729|Diuretics|diuretics
5504726|NCT01275729|Biomarkers|biomarkers
5504727|NCT01275729|Renal Insufficiency|renal insufficiency
5504728|NCT01275729|Furosemide|furosemide
5504729|NCT01275729|Therapeutic Uses|therapeutic uses
5504730|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs
5504731|NCT01275729|Biological Markers|biological markers
5504732|NCT01275716|Patient Education|patient education
5504733|NCT01275716|coronary artery disease|coronary artery disease
5504734|NCT01275716|Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications.|impact of coronary images used during patient education on coronary artery disease and subsequent lifestyle modifications.
5504827|NCT01275326|Infectious Aerosols|infectious aerosols
5504828|NCT01275313|Pressure ulcers|pressure ulcers
5504735|NCT01275703|To determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with PH|to determine the utility of a noninvasive method of measuring cardiac output during exercise testing in patients with ph
5504736|NCT01275690|cardiac|cardiac
5504737|NCT01275690|pulmonary hypertension|pulmonary hypertension
5486833|NCT01350141|dyslipidemia|dyslipidemia
5486834|NCT01350141|high cholesterol|high cholesterol
5486836|NCT01350141|antibody|antibody
5504738|NCT01275690|To determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with PH|to determine the accuracy of a noninvasive method of measuring cardiac output as compared to the standard invasive approach in patients with ph
5504739|NCT01275651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5504740|NCT01275651|recurrent prostate cancer|recurrent prostate cancer
5504741|NCT01275638|cortisol, prednisolone, adrenal insufficiency, sepsis|cortisol, prednisolone, adrenal insufficiency, sepsis
5504743|NCT01275625|naive|naive
5504745|NCT01275625|zidovudine|zidovudine
5504746|NCT01275625|lamivudine|lamivudine
5504747|NCT01275625|combivir|combivir
5504748|NCT01275625|Clade A|clade a
5504749|NCT01275612|Mesenchymal Stromal Cells|mesenchymal stromal cells
5504750|NCT01275612|Solid tumors|solid tumors
5504751|NCT01275612|Cisplatin therapy|cisplatin therapy
5504752|NCT01275612|Acute kidney injury|acute kidney injury
5504753|NCT01275586|NF1|nf1
5504754|NCT01275586|plexiform neurofibromas|plexiform neurofibromas
5504755|NCT01275586|nilotinib|nilotinib
5504756|NCT01275586|Tasigna|tasigna
5671972|NCT00613366|cervical dilation|cervical dilation
5504757|NCT01275573|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5504758|NCT01275573|pain threshold|pain threshold
5504759|NCT01275573|Parkinson's disease|parkinson's disease
5504760|NCT01275573|Pain threshold in Parkinson's disease|pain threshold in parkinson's disease
5504761|NCT01275547|Patient controlled analgesia|patient controlled analgesia
5504762|NCT01275547|Morphine|morphine
5504763|NCT01275547|S-Ketamine intranasal|s-ketamine intranasal
5504764|NCT01275547|Midazolam intranasal|midazolam intranasal
5504765|NCT01275534|Stem cell transplantation|stem cell transplantation
5504766|NCT01275534|Symptom experience|symptom experience
5504767|NCT01275534|Late effects|late effects
5504768|NCT01275534|Self-management|self-management
5504769|NCT01275508|Subjects with active Crohn's disease|subjects with active crohn's disease
5504770|NCT01275508|Safety and tolerability of FITC-Adalimumab|safety and tolerability of fitc-adalimumab
5504771|NCT01275508|Intestinal topical application|intestinal topical application
5504772|NCT01275495|Stroke|stroke
5504773|NCT01275495|Family Caregivers|family caregivers
5504774|NCT01275495|Cerebrovascular Accident|cerebrovascular accident
5504775|NCT01275495|Carers|carers
5504776|NCT01275495|Care Givers|care givers
5504777|NCT01275495|Depression|depression
5504778|NCT01275495|Life change events|life change events
5504779|NCT01275495|Family health|family health
5504780|NCT01275495|Quality of life|quality of life
5504781|NCT01275495|Cost|cost
5504782|NCT01275495|Intervention studies|intervention studies
5504783|NCT01275495|Clinical trial|clinical trial
5504784|NCT01275482|Latent Myofascial trigger point.|latent myofascial trigger point.
5504785|NCT01275482|Transverse friction massage|transverse friction massage
5504786|NCT01275482|Local twitch response|local twitch response
5504787|NCT01275482|Effectiveness|effectiveness
5504788|NCT01275469|Impaired Glucose tolerance|impaired glucose tolerance
5504789|NCT01275469|OGTT|ogtt
5504790|NCT01275469|PPARs|ppars
5504791|NCT01275456|allergen provocation|allergen provocation
5504792|NCT01275456|environmental challenge|environmental challenge
5504793|NCT01275456|allergen chamber|allergen chamber
5504794|NCT01275456|house dust mite|house dust mite
5504795|NCT01275456|immunotherapy|immunotherapy
5504797|NCT01275430|central venous catheters|central venous catheters
5504798|NCT01275430|peripherally inserted central catheters (PICC_|peripherally inserted central catheters (picc_
5504799|NCT01275430|Electrocardiography (ECG)|electrocardiography (ecg)
5504800|NCT01275430|intravascular ECG|intravascular ecg
5504801|NCT01275430|Tip Positioning System|tip positioning system
5504802|NCT01275417|Acupuncture|acupuncture
5504803|NCT01275404|Erectile Dysfunction|erectile dysfunction
5504804|NCT01275404|focus group|focus group
5504805|NCT01275404|Quality of Life|quality of life
5504806|NCT01275404|10-204|10-204
5504807|NCT01275391|Tobacco use|tobacco use
5504808|NCT01275391|Alcohol abuse|alcohol abuse
5504809|NCT01275391|Drug abuse|drug abuse
5504810|NCT01275391|Substance use|substance use
5504811|NCT01275391|Prevention|prevention
5504812|NCT01275391|Brief intervention|brief intervention
5504813|NCT01275391|Screening|screening
5504814|NCT01275391|Adolescents|adolescents
5504815|NCT01275365|Mobility Limitation|mobility limitation
5504816|NCT01275365|Low Protein Intake|low protein intake
5504817|NCT01275365|Older Men|older men
5504818|NCT01275365|Testosterone|testosterone
5504819|NCT01275352|left ventricular hypertrophy|left ventricular hypertrophy
5504820|NCT01275352|heart failure|heart failure
5504821|NCT01275339|Aortic valve stenosis|aortic valve stenosis
5504822|NCT01275339|Tadalafil|tadalafil
5504823|NCT01275339|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5504824|NCT01275339|Hypertension, pulmonary|hypertension, pulmonary
5504825|NCT01275339|Hypertrophy, left ventricular|hypertrophy, left ventricular
5504826|NCT01275326|Indoor Air Quality|indoor air quality
5504829|NCT01275313|wheelchairs|wheelchairs
5504830|NCT01275313|wheelchair functional capacity|wheelchair functional capacity
5504831|NCT01275313|custom-fitted wheelchair|custom-fitted wheelchair
5499132|NCT01299649|CAD|cad
5486929|NCT01349673|UC|uc
5504832|NCT01275287|Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis|anti-neutrophil cytoplasmic antibody-associated vasculitis
5504833|NCT01275287|Complement Activation|complement activation
5504834|NCT01275274|ANCA|anca
5504835|NCT01275274|Vasculitis|vasculitis
5504836|NCT01275274|Pauci-immune vasculitis|pauci-immune vasculitis
5504837|NCT01275261|Stroke|stroke
5504838|NCT01275261|Urinary Tract Infection|urinary tract infection
5504839|NCT01275248|OCD|ocd
5504840|NCT01275248|Obsessive Compulsive Disorder|obsessive compulsive disorder
5504841|NCT01275222|GIST|gist
5504842|NCT01275222|everolimus|everolimus
5504843|NCT01275222|mTOR|mtor
5504844|NCT01275222|Imatinib resistant|imatinib resistant
5504845|NCT01275222|Imatinib-refractory/resistant gastrointestinal stromal tumors|imatinib-refractory/resistant gastrointestinal stromal tumors
5504846|NCT01275209|HCD122|hcd122
5504847|NCT01275209|Lucatumumab|lucatumumab
5504848|NCT01275209|CD40|cd40
5504849|NCT01275209|Follicular Lymphoma|follicular lymphoma
5504850|NCT01275209|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5504851|NCT01275209|Antibody|antibody
5504852|NCT01275196|Newly diagnosed,|newly diagnosed,
5504853|NCT01275196|Ph+ chronic myeloid leukemia,|ph+ chronic myeloid leukemia,
5504855|NCT01275183|HNSCC|hnscc
5504856|NCT01275183|SCC|scc
5504857|NCT01275183|head and neck|head and neck
5504858|NCT01275183|squamous cell|squamous cell
5504859|NCT01275183|nasopharyngeal|nasopharyngeal
5504860|NCT01275157|Absorption|absorption
5504861|NCT01275157|Distribution|distribution
5504862|NCT01275157|Metabolism|metabolism
5504863|NCT01275157|Excretion|excretion
5504864|NCT01275157|Mass balance|mass balance
5504865|NCT01275157|Metabolic profile|metabolic profile
5504866|NCT01275157|Radiolabeled study|radiolabeled study
5504867|NCT01275157|14C|14c
5504868|NCT01275131|Insulin analog|insulin analog
5504869|NCT01275131|Type 1 diabetes mellitus|type 1 diabetes mellitus
5504870|NCT01275131|Pharmacokinetic|pharmacokinetic
5504871|NCT01275131|Glucodynamic|glucodynamic
5504872|NCT01275131|Phase 1|phase 1
5504873|NCT01275092|robotic-assisted PCI|robotic-assisted pci
5504874|NCT01275092|coronary intervention|coronary intervention
5504875|NCT01275092|CorPath PRECISE|corpath precise
5504876|NCT01275092|PCI|pci
5504877|NCT01275079|tonsillectomy|tonsillectomy
5504878|NCT01275079|nasalance|nasalance
5504879|NCT01275079|tonsil volume|tonsil volume
5504880|NCT01275079|Thai|thai
5504881|NCT01275079|adult|adult
5504882|NCT01275066|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5504883|NCT01275066|MPS IV Type A|mps iv type a
5504884|NCT01275066|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5504885|NCT01275066|MPS IVA|mps iva
5504886|NCT01275066|Morquio A Syndrome|morquio a syndrome
5504887|NCT01275066|Lysosomal Storage Disorder|lysosomal storage disorder
5504888|NCT01275066|LSD|lsd
5504889|NCT01275066|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5504890|NCT01275066|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5504891|NCT01275066|galactose-6-sulfatase|galactose-6-sulfatase
5504892|NCT01275066|GALNS|galns
5504893|NCT01275066|enzyme replacement therapy|enzyme replacement therapy
5504894|NCT01275066|ERT|ert
5504895|NCT01275053|Leptin|leptin
5504896|NCT01275053|In Vivo|in vivo
5504897|NCT01275053|Diabetic|diabetic
5504898|NCT01275053|Obese|obese
5504899|NCT01275053|Lean|lean
5504900|NCT01275040|diabetes|diabetes
5504901|NCT01275040|mobile screening|mobile screening
5504902|NCT01275040|complications|complications
5504903|NCT01275040|primary care|primary care
5504904|NCT01275040|specialised care|specialised care
5504905|NCT01275040|quality of care|quality of care
5504906|NCT01275027|diabetes|diabetes
5504907|NCT01275027|blood sugar|blood sugar
5504908|NCT01275027|insulin|insulin
5504909|NCT01275027|nutritional supplement|nutritional supplement
5504910|NCT01275027|nutraceutical|nutraceutical
5504911|NCT01275014|TMJ|tmj
5504912|NCT01275014|corticosteroids|corticosteroids
5504913|NCT01275014|osteoarthritis|osteoarthritis
5504914|NCT01275014|arthrocentesis|arthrocentesis
5504915|NCT01275014|pain|pain
5504916|NCT01275001|brain|brain
5504917|NCT01275001|brain development|brain development
5504918|NCT01275001|MRI|mri
5504919|NCT01275001|preschool children|preschool children
5504920|NCT01275001|cortical mantle thickness|cortical mantle thickness
5504921|NCT01275001|hippocampal volume|hippocampal volume
5504922|NCT01274988|Opiate dependence|opiate dependence
5504923|NCT01274988|Deep brain stimulation|deep brain stimulation
5504924|NCT01274988|Nucleus accumbens|nucleus accumbens
5504925|NCT01274949|LI-ESWT|li-eswt
5504926|NCT01274949|Erectile Dysfunction|erectile dysfunction
5504927|NCT01274949|Radical Prostatectomy|radical prostatectomy
5504928|NCT01274949|Non PDE5 inhibitor responders|non pde5 inhibitor responders
5504929|NCT01274949|Shock wave|shock wave
5504930|NCT01274923|Erectile dysfunction|erectile dysfunction
5504931|NCT01274923|Low Intensity Shock Wave|low intensity shock wave
5504932|NCT01274910|Fish Oil|fish oil
5504934|NCT01274910|Analgetics|analgetics
5504935|NCT01274897|Meningococcal|meningococcal
5504936|NCT01274897|ACWY-CRM|acwy-crm
5504937|NCT01274897|Conjugate Vaccine|conjugate vaccine
5504938|NCT01274897|Meningitis|meningitis
5504939|NCT01274897|Adolescents|adolescents
5504940|NCT01274897|Persistence|persistence
5504941|NCT01274897|Adults|adults
5504942|NCT01274884|Acromioclavicular|acromioclavicular
5504943|NCT01274884|Injury|injury
5504944|NCT01274884|Dislocation|dislocation
5504945|NCT01274884|Surgery|surgery
5504946|NCT01274871|Thoracotomy|thoracotomy
5504947|NCT01274871|Chronic Pain|chronic pain
5504948|NCT01274871|persistent post-surgical pain|persistent post-surgical pain
5504949|NCT01274858|persistent pain|persistent pain
5504950|NCT01274858|neuropathic pain|neuropathic pain
5504951|NCT01274858|Thoracotomy|thoracotomy
5504952|NCT01274858|Chronic Pain|chronic pain
5504953|NCT01274845|Meconium aspiration syndrome|meconium aspiration syndrome
5504954|NCT01274845|Heliox|heliox
5504955|NCT01274845|Mechanical ventilation|mechanical ventilation
5504956|NCT01274845|Newborn|newborn
5504957|NCT01274832|Parkinson|parkinson
5504958|NCT01274832|DBS of STN|dbs of stn
5504959|NCT01274832|PD|pd
5504960|NCT01274832|Deep Brain stimulation of STN|deep brain stimulation of stn
5504961|NCT01274832|Early treatment|early treatment
5504962|NCT01274819|delirium|delirium
5504963|NCT01274819|confusion|confusion
5504964|NCT01274806|breast cancer|breast cancer
5504965|NCT01274806|physical therapy|physical therapy
5504966|NCT01274806|massage|massage
5504967|NCT01274806|core stability|core stability
5504968|NCT01274793|functional constipation|functional constipation
5504969|NCT01274793|functional diarrhea|functional diarrhea
5504970|NCT01274793|acupuncture|acupuncture
5504971|NCT01274754|neuroprotection|neuroprotection
5504972|NCT01274754|erythromycin|erythromycin
5504973|NCT01274754|neurocognitive assessment|neurocognitive assessment
5504974|NCT01274741|Posttraumatic stress disorder|posttraumatic stress disorder
5504975|NCT01274741|Substance use disorder|substance use disorder
5504976|NCT01274741|Treatment efficacy|treatment efficacy
5504977|NCT01274741|Randomized trial|randomized trial
5504978|NCT01274741|Trauma|trauma
5504979|NCT01274741|Substance abuse|substance abuse
5504980|NCT01274741|Addiction|addiction
5504981|NCT01274728|Acute myocardial infarction|acute myocardial infarction
5504982|NCT01274728|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5504983|NCT01274728|Drug-eluting balloon|drug-eluting balloon
5504984|NCT01274728|Bivalirudin|bivalirudin
5504985|NCT01274715|Behavioral health coaching|behavioral health coaching
5504986|NCT01274715|Diabetes|diabetes
5504987|NCT01274715|Emotional health|emotional health
5504988|NCT01274702|History of|history of
5504989|NCT01274702|Patients|patients
5504990|NCT01274702|acute|acute
5504991|NCT01274689|lagophthalmos|lagophthalmos
5504992|NCT01274689|parotis tumor|parotis tumor
5504993|NCT01274689|m. orbicularis oculi paresis|m. orbicularis oculi paresis
5504994|NCT01274676|stenting|stenting
5504995|NCT01274676|carotid plaque|carotid plaque
5504996|NCT01274676|stenosis|stenosis
5504997|NCT01274676|angioplasty|angioplasty
5504998|NCT01274663|Single Ascending Dose|single ascending dose
5504999|NCT01274663|Phase 1|phase 1
5505000|NCT01274663|Safety and Tolerability|safety and tolerability
5505001|NCT01274663|PK|pk
5505004|NCT01274637|low molecular weight heparin|low molecular weight heparin
5505006|NCT01274637|prophylaxis|prophylaxis
5505007|NCT01274637|Dalteparin Sodium|dalteparin sodium
5505008|NCT01274624|Colorectal|colorectal
5505009|NCT01274624|Cancer|cancer
5505010|NCT01274624|REOLYSIN®|reolysin®
5505011|NCT01274624|Chemotherapy|chemotherapy
5505012|NCT01274624|FOLFIRI|folfiri
5505013|NCT01274624|Reovirus|reovirus
5505014|NCT01274624|Oncolytic virus|oncolytic virus
5505015|NCT01274624|Fluorouracil|fluorouracil
5505016|NCT01274624|Irinotecan|irinotecan
5505017|NCT01274624|Leucovorin|leucovorin
5505018|NCT01274624|Bevacizumab|bevacizumab
5505019|NCT01274611|sweating|sweating
5505020|NCT01274611|sweat|sweat
5505021|NCT01274611|underarm|underarm
5505022|NCT01274611|axillary|axillary
5505023|NCT01274611|hyperhidrosis|hyperhidrosis
5505024|NCT01274611|botox|botox
5505025|NCT01274611|liposuction|liposuction
5505026|NCT01274611|suction-curettage|suction-curettage
5505027|NCT01274611|suction|suction
5505028|NCT01274611|curettage|curettage
5505029|NCT01274598|Probiotics|probiotics
5505030|NCT01274598|Safety|safety
5505031|NCT01274598|Elderly|elderly
5505032|NCT01274598|Lactobacillus|lactobacillus
5505033|NCT01274598|LGG|lgg
5505034|NCT01274559|MK-0524A/ER|mk-0524a/er
5505035|NCT01274559|Hypercholesterolemia|hypercholesterolemia
5505036|NCT01274559|Dyslipidemia|dyslipidemia
5505037|NCT01274559|Niacin|niacin
5505038|NCT01274559|Laropiprant|laropiprant
5505039|NCT01274533|ATLL|atll
5505040|NCT01274520|ECD liver transplant allografts|ecd liver transplant allografts
5505041|NCT01274520|Hypothermic machine perfusion|hypothermic machine perfusion
5505042|NCT01274520|Cold storage preservation|cold storage preservation
5505043|NCT01274520|liver transplant|liver transplant
5487138|NCT01348997|cancer|cancer
5505044|NCT01274520|portable bypass system|portable bypass system
5505045|NCT01274520|machine perfusion preservation|machine perfusion preservation
5505046|NCT01274520|extended criteria liver|extended criteria liver
5505047|NCT01274507|Asthma|asthma
5505049|NCT01274507|Healthy|healthy
5505050|NCT01274507|Longitudinal Study|longitudinal study
5505051|NCT01274507|Bronchoscopy|bronchoscopy
5505052|NCT01274494|Hypertension|hypertension
5505053|NCT01274481|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5505054|NCT01274481|Acute Lung Injury|acute lung injury
5505055|NCT01274481|pulmonary hypertension|pulmonary hypertension
5505056|NCT01274481|oxygenation|oxygenation
5505057|NCT01274481|lung mechanics|lung mechanics
5505058|NCT01274481|gas exchange|gas exchange
5505059|NCT01274455|Gene therapy|gene therapy
5505060|NCT01274455|pancreatic carcinoma|pancreatic carcinoma
5505061|NCT01274455|gemcitabine|gemcitabine
5505062|NCT01274455|endoscopic ultrasound|endoscopic ultrasound
5505063|NCT01274442|dental implant|dental implant
5505064|NCT01274429|Peanut allergy|peanut allergy
5505065|NCT01274429|Immunotherapy|immunotherapy
5505067|NCT01274416|Anorexia Nervosa|anorexia nervosa
5505068|NCT01274416|Eating Disorder|eating disorder
5505069|NCT01274416|Treatment|treatment
5505070|NCT01274416|Acceptance and Commitment Therapy|acceptance and commitment therapy
5505071|NCT01274416|Separated Family Treatment|separated family treatment
5505072|NCT01274403|Multiple Myeloma|multiple myeloma
5505073|NCT01274403|Elderly patients|elderly patients
5505074|NCT01274390|Cardiac Surgery|cardiac surgery
5505075|NCT01274390|Red Blood Cell|red blood cell
5505076|NCT01274390|Transfusion|transfusion
5505077|NCT01274390|Oxygen Saturation|oxygen saturation
5505078|NCT01274390|Microvascular Flow|microvascular flow
5505079|NCT01274377|nonmyeloablative allogeneic stem cell transplantation|nonmyeloablative allogeneic stem cell transplantation
5505080|NCT01274377|cytomegalovirus|cytomegalovirus
5505081|NCT01274377|donor lymphocyte infusions|donor lymphocyte infusions
5505082|NCT01274377|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5505083|NCT01274364|Diabetes|diabetes
5505084|NCT01274364|Structured Care|structured care
5505085|NCT01274351|First line treatment|first line treatment
5505086|NCT01274351|newly diagnosed|newly diagnosed
5505087|NCT01274351|Philadelphia chromosome positive|philadelphia chromosome positive
5505088|NCT01274351|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5505090|NCT01274351|CML-CP|cml-cp
5505091|NCT01274351|major molecular response|major molecular response
5505092|NCT01274351|Social risk|social risk
5505093|NCT01274325|asthma|asthma
5505094|NCT01274312|Somato-sensory reflex arch|somato-sensory reflex arch
5505095|NCT01274312|Spinal cord injury|spinal cord injury
5505096|NCT01274312|Xiao Procedure|xiao procedure
5505097|NCT01274299|Infants|infants
5505098|NCT01274299|morphometry|morphometry
5505099|NCT01274299|face|face
5505100|NCT01274299|3D|3d
5505101|NCT01274286|hospital accreditation|hospital accreditation
5505102|NCT01274286|patient-centered|patient-centered
5505103|NCT01274286|healthcare quality index|healthcare quality index
5505104|NCT01274286|documentary analysis|documentary analysis
5505105|NCT01274286|meta analysis|meta analysis
5505106|NCT01274273|Bevacizumab|bevacizumab
5505107|NCT01274273|interleukin-2|interleukin-2
5505108|NCT01274273|interferon-alpha|interferon-alpha
5505109|NCT01274260|child|child
5505110|NCT01274260|infant|infant
5505111|NCT01274260|lung injury|lung injury
5505112|NCT01274260|inflammation|inflammation
5505113|NCT01274260|pneumonia|pneumonia
5505114|NCT01274260|ventilator|ventilator
5505115|NCT01274247|Tongue-tie|tongue-tie
5505116|NCT01274247|Ankyloglossia|ankyloglossia
5505117|NCT01274234|EPC capturing sirolimus eluting COMBO stent|epc capturing sirolimus eluting combo stent
5505118|NCT01274234|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5505119|NCT01274234|Early neointimal healing and stent coverage|early neointimal healing and stent coverage
5505120|NCT01274234|Late neointimal thickness, neointimal area, and lumen loss|late neointimal thickness, neointimal area, and lumen loss
5505121|NCT01274208|Gaucher disease, Hepatitis C , Glucocerebroside immunity|gaucher disease, hepatitis c , glucocerebroside immunity
5505122|NCT01274195|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5505123|NCT01274156|Erectile dysfunction|erectile dysfunction
5505124|NCT01274156|Low Intensity Shock Wave|low intensity shock wave
5505125|NCT01274143|Colorectal|colorectal
5505126|NCT01274143|Cancer|cancer
5505127|NCT01274143|Colon|colon
5505128|NCT01274143|Rectal|rectal
5505129|NCT01274143|Behavioral Intervention|behavioral intervention
5505130|NCT01274143|Screening|screening
5505131|NCT01274143|Motivational Interviewing|motivational interviewing
5505132|NCT01274143|Extended Parallel Process Model|extended parallel process model
5505133|NCT01274143|Implementation Intentions|implementation intentions
5505134|NCT01274143|Family CARE|family care
5505135|NCT01274117|Chronic renal failure|chronic renal failure
5505593|NCT01272531|valproate|valproate
5505136|NCT01274117|Basilic vein transposition fistula|basilic vein transposition fistula
5505137|NCT01274104|statin-related myalgia|statin-related myalgia
5505138|NCT01274104|high cholesterol|high cholesterol
5505139|NCT01274091|Gene-diet interaction|gene-diet interaction
5505140|NCT01274091|PPARgamma gene|ppargamma gene
5505141|NCT01274091|Pro12Ala|pro12ala
5505142|NCT01274091|Fatty acids|fatty acids
5505143|NCT01274091|Dietary modification|dietary modification
5505144|NCT01274091|Insulin sensitivity|insulin sensitivity
5505145|NCT01274091|Glucose metabolism|glucose metabolism
5505146|NCT01274078|inflammation|inflammation
5505149|NCT01274065|psychiatry|psychiatry
5505150|NCT01274065|psychiatric illness|psychiatric illness
5505151|NCT01274065|developmental disability|developmental disability
5505152|NCT01274065|mental health|mental health
5505153|NCT01274065|medication burden|medication burden
5505154|NCT01274052|Gestational diabetes mellitus|gestational diabetes mellitus
5505155|NCT01274052|Meal test|meal test
5505156|NCT01274052|Incretin hormones|incretin hormones
5505157|NCT01274052|Glucagon-like peptide-1 (GLP-1)|glucagon-like peptide-1 (glp-1)
5505158|NCT01274052|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5505159|NCT01274052|Insulin|insulin
5505160|NCT01274052|C-peptide|c-peptide
5505161|NCT01274052|Glucagon|glucagon
5505162|NCT01274026|phenylketonuria|phenylketonuria
5505163|NCT01274026|PKU|pku
5505164|NCT01274026|phenylalanine|phenylalanine
5505165|NCT01274026|neurotransmitters|neurotransmitters
5505166|NCT01274026|gene|gene
5505167|NCT01274026|Kuvan|kuvan
5505168|NCT01274026|sapropterin|sapropterin
5505169|NCT01274013|Hepatitis C|hepatitis c
5505170|NCT01274013|Chronic Hepatitis C|chronic hepatitis c
5505171|NCT01274013|Vitamin D|vitamin d
5505172|NCT01274013|Vitamin D deficiency|vitamin d deficiency
5505173|NCT01274000|diarrhea|diarrhea
5505174|NCT01274000|IBS|ibs
5505175|NCT01274000|Colonic disease|colonic disease
5505176|NCT01274000|YM060|ym060
5505177|NCT01274000|Ramosetron|ramosetron
5505178|NCT01273974|intradermal influenza vaccine|intradermal influenza vaccine
5505179|NCT01273974|hemodialysis patients|hemodialysis patients
5505180|NCT01273935|Aspirin, Acute Cerebrovascular Ischemia, Platelet Function|aspirin, acute cerebrovascular ischemia, platelet function
5505181|NCT01273922|NDV-3|ndv-3
5505182|NCT01273922|vaccine|vaccine
5505183|NCT01273922|Staphylococcus aureus|staphylococcus aureus
5505184|NCT01273922|MRSA|mrsa
5505185|NCT01273922|Candida|candida
5505186|NCT01273909|Breast Cancer|breast cancer
5505187|NCT01273909|BRACA1/2 Genotype|braca1/2 genotype
5505188|NCT01273909|Acquired Lymphedema|acquired lymphedema
5505189|NCT01273909|Congenital Lymphedema|congenital lymphedema
5505190|NCT01273896|STA-9090|sta-9090
5505191|NCT01273896|advanced breast cancer|advanced breast cancer
5505192|NCT01273896|10-145|10-145
5505193|NCT01273883|hearing|hearing
5505194|NCT01273883|magnesium|magnesium
5505195|NCT01273870|hemodialysis|hemodialysis
5505196|NCT01273870|high-flux-dialyzer|high-flux-dialyzer
5505197|NCT01273870|performance|performance
5505198|NCT01273870|blood compatibility|blood compatibility
5505199|NCT01273857|Cardiac progenitor cells|cardiac progenitor cells
5505200|NCT01273857|Cell therapy|cell therapy
5505201|NCT01273857|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5505202|NCT01273857|Single Ventricle|single ventricle
5505203|NCT01273857|Norwood|norwood
5505204|NCT01273857|Sano modification|sano modification
5505205|NCT01273857|Glenn|glenn
5505206|NCT01273857|Fontan|fontan
5505207|NCT01273844|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5505208|NCT01273844|amyloidosis|amyloidosis
5505209|NCT01273844|Bortezomib|bortezomib
5505210|NCT01273831|intraocular pressure, anesthesia,cisatracurium,atracurium.|intraocular pressure, anesthesia,cisatracurium,atracurium.
5505211|NCT01273818|inguinal hernia|inguinal hernia
5505212|NCT01273818|infection prophylaxis|infection prophylaxis
5505213|NCT01273818|topical gentamicin|topical gentamicin
5505214|NCT01273805|metastatic pancreatic cancer|metastatic pancreatic cancer
5476117|NCT01395498|CMV|cmv
5491586|NCT01330472|Xanax|xanax
5505215|NCT01273805|hydroxychloroquine|hydroxychloroquine
5505216|NCT01273779|sepsis|sepsis
5505217|NCT01273779|talactoferrin|talactoferrin
5505218|NCT01273779|lactoferrin|lactoferrin
5505219|NCT01273779|recombinant human lactoferrin|recombinant human lactoferrin
5505220|NCT01273753|End-stage renal disease|end-stage renal disease
5505221|NCT01273753|Hemodialysis|hemodialysis
5505222|NCT01273753|Bioimpedance analysis|bioimpedance analysis
5505223|NCT01273753|Blood volume monitoring|blood volume monitoring
5505224|NCT01273740|PTFE bypass|ptfe bypass
5505225|NCT01273740|femoro-popliteal|femoro-popliteal
5505226|NCT01273740|femoro-crural|femoro-crural
5505227|NCT01273740|popliteal arteries|popliteal arteries
5505228|NCT01273740|crural arteries|crural arteries
5505229|NCT01273740|external support|external support
5505230|NCT01273740|crtical limb ischemia|crtical limb ischemia
5505231|NCT01273727|epiretinal membrane|epiretinal membrane
5505232|NCT01273727|macular pucker|macular pucker
5505233|NCT01273727|cellophane maculopathy|cellophane maculopathy
5505234|NCT01273727|macular edema|macular edema
5505235|NCT01273727|retinal edema|retinal edema
5505236|NCT01273727|ozurdex|ozurdex
5505245|NCT01273701|psychosocial intervention|psychosocial intervention
5505246|NCT01273701|contingency management|contingency management
5505247|NCT01273701|slow prosecution|slow prosecution
5505248|NCT01273701|substance use disorder|substance use disorder
5505249|NCT01273688|pain|pain
5505250|NCT01273688|elbow|elbow
5505251|NCT01273688|tendinopathy|tendinopathy
5505252|NCT01273675|Hypertension|hypertension
5505253|NCT01273675|Primary disease|primary disease
5505254|NCT01273662|HCC|hcc
5505255|NCT01273649|muscle activation|muscle activation
5505256|NCT01273649|ACL reconstruction|acl reconstruction
5505257|NCT01273649|cryotherapy|cryotherapy
5505258|NCT01273649|TENS|tens
5505259|NCT01273636|Endometrial hyperplasia|endometrial hyperplasia
5505260|NCT01273636|Hysterectomy|hysterectomy
5505261|NCT01273636|Endometrial carcinoma|endometrial carcinoma
5505262|NCT01273623|PAD, Peripheral Arterial Disease, Calcium, Atherectomy, Jetstream|pad, peripheral arterial disease, calcium, atherectomy, jetstream
5505271|NCT01273597|Parathyroid hormone,Kidney failure, chronic,Hyperparathyroidism, secondary|parathyroid hormone,kidney failure, chronic,hyperparathyroidism, secondary
5505272|NCT01273584|Metformin, obese, pregnancy, gestational diabetes|metformin, obese, pregnancy, gestational diabetes
5505273|NCT01273571|Canagliflozin|canagliflozin
5505274|NCT01273571|Metformin (GLUCOPHAGE IR)|metformin (glucophage ir)
5505275|NCT01273571|Pharmacokinetics|pharmacokinetics
5505276|NCT01273571|Pharmacodynamics|pharmacodynamics
5505277|NCT01273558|Canagliflozin|canagliflozin
5505278|NCT01273558|Renal threshold for glucose|renal threshold for glucose
5505279|NCT01273558|Pharmacodynamics|pharmacodynamics
5505280|NCT01273545|Dapoxetine hydrochloride (PRILIGY)|dapoxetine hydrochloride (priligy)
5505281|NCT01273545|Premature ejaculation|premature ejaculation
5505282|NCT01273532|tapentadol|tapentadol
5505283|NCT01273532|NUCYNTA|nucynta
5505284|NCT01273532|CG5503|cg5503
5505285|NCT01273532|R331333|r331333
5505286|NCT01273532|pharmacokinetics|pharmacokinetics
5505287|NCT01273532|healthy volunteer|healthy volunteer
5505288|NCT01273519|Ankylosing|ankylosing
5505289|NCT01273519|Rheumatoid|rheumatoid
5505290|NCT01273519|Antibodies|antibodies
5505291|NCT01273519|Arthritis|arthritis
5505292|NCT01273519|Pain|pain
5505293|NCT01273519|Antirheumatic Agents|antirheumatic agents
5505294|NCT01273519|Psoriatic|psoriatic
5505295|NCT01273519|Spondylitis|spondylitis
5505296|NCT01273519|Monoclonals|monoclonals
5505297|NCT01273506|tapentadol|tapentadol
5505298|NCT01273506|NUCYNTA|nucynta
5505299|NCT01273506|CG5503|cg5503
5505300|NCT01273506|R331333|r331333
5505301|NCT01273506|pharmacokinetics|pharmacokinetics
5505302|NCT01273506|healthy volunteer|healthy volunteer
5505303|NCT01273493|Trabectedin, YONDELIS|trabectedin, yondelis
5505304|NCT01273493|Antineoplastic Agents|antineoplastic agents
5505305|NCT01273493|Solid tumors|solid tumors
5505306|NCT01273493|Locally advanced or metastatic disease|locally advanced or metastatic disease
5505307|NCT01273493|Chemotherapy|chemotherapy
5505308|NCT01273493|Pharmacokinetics|pharmacokinetics
5505309|NCT01273493|Hepatic Dysfunction|hepatic dysfunction
5505310|NCT01273480|Trabectedin, YONDELIS|trabectedin, yondelis
5505311|NCT01273480|Rifampin (RIFADIN)|rifampin (rifadin)
5505312|NCT01273480|Antineoplastic Agents|antineoplastic agents
5505313|NCT01273480|Solid tumors|solid tumors
5505314|NCT01273480|Locally advanced or metastatic disease|locally advanced or metastatic disease
5505315|NCT01273480|Chemotherapy|chemotherapy
5505316|NCT01273480|Pharmacokinetics|pharmacokinetics
5505317|NCT01273467|Ischemic Cerebral Infarction|ischemic cerebral infarction
5505318|NCT01273467|Stroke|stroke
5505319|NCT01273467|CNTO0007|cnto0007
5505320|NCT01273467|42037788|42037788
5505321|NCT01273454|Open-label|open-label
5505322|NCT01273454|Non-interventional|non-interventional
5505323|NCT01273454|OROS hydromorphone|oros hydromorphone
5505324|NCT01273454|Korean cancer patients|korean cancer patients
5491671|NCT01329991|RA|ra
5505325|NCT01273415|hormone receptor-positive breast cancer|hormone receptor-positive breast cancer
5505326|NCT01273415|nomogram|nomogram
5505327|NCT01273415|Ki67|ki67
5505328|NCT01273415|Effects of Chemotherapy|effects of chemotherapy
5505329|NCT01273402|colorectal cancer|colorectal cancer
5505330|NCT01273402|TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 anti-HSG Fab)|tf2 (recombinant, humanized tri-fab bsmab composed of 2 humanized mn-14 anti-cea fab x and one 679 anti-hsg fab)
5505348|NCT01273337|Ischemia|ischemia
5505349|NCT01273337|Ischemic Stroke|ischemic stroke
5505350|NCT01273337|Middle Cerebral Artery|middle cerebral artery
5505351|NCT01273337|MCA|mca
5505352|NCT01273337|Stem Cells|stem cells
5505353|NCT01273337|Stem Cell|stem cell
5505354|NCT01273337|Autologous Bone Marrow|autologous bone marrow
5505355|NCT01273337|Ipsilateral MCA|ipsilateral mca
5505356|NCT01273324|Osteoarthritis|osteoarthritis
5505357|NCT01273311|Brain Aging|brain aging
5505358|NCT01273311|Diabetes|diabetes
5505359|NCT01273311|Aging|aging
5505360|NCT01273311|Obesity|obesity
5505361|NCT01273311|CARDIA|cardia
5505362|NCT01273298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5505363|NCT01273298|exercise|exercise
5505364|NCT01273298|dynamic hyperinflation|dynamic hyperinflation
5505365|NCT01273298|cardioselective beta blockers|cardioselective beta blockers
5505366|NCT01273272|Cognitive Behavior Therapy|cognitive behavior therapy
5505367|NCT01273272|Early dementia, Alzheimer type|early dementia, alzheimer type
5505368|NCT01273259|Hypertension, pulmonary|hypertension, pulmonary
5505369|NCT01273259|DHEA|dhea
5505370|NCT01273259|six-minute walk test|six-minute walk test
5505371|NCT01273259|pulmonary arterial pressure|pulmonary arterial pressure
5505375|NCT01273207|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5505376|NCT01273207|Inhaled Cyclosporine|inhaled cyclosporine
5505377|NCT01273207|Graft-Versus-Host Disease|graft-versus-host disease
5505378|NCT01273194|Palliative Care|palliative care
5505379|NCT01273194|Survey|survey
5505380|NCT01273194|Quality of Life|quality of life
5505381|NCT01273194|Attitudes|attitudes
5505382|NCT01273194|Pediatric Cancer|pediatric cancer
5505383|NCT01273181|Immunotherapy|immunotherapy
5505384|NCT01273181|Gene Therapy|gene therapy
5505385|NCT01273181|Metastatic Cancer|metastatic cancer
5505386|NCT01273181|Clinical Response|clinical response
5505387|NCT01273181|Metastatic Melanoma|metastatic melanoma
5505388|NCT01273181|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5505402|NCT01273155|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5505403|NCT01273155|Liver Dysfunction|liver dysfunction
5505404|NCT01273155|Pharmacokinetics|pharmacokinetics
5505405|NCT01273155|UGT1A1 Polymorphisms|ugt1a1 polymorphisms
5505407|NCT01273155|Cancer|cancer
5505408|NCT01273155|Lymphoma|lymphoma
5505409|NCT01273142|Human Immunodeficiency Virus, liver toxicity, hapatitis co-infection|human immunodeficiency virus, liver toxicity, hapatitis co-infection
5505410|NCT01273129|Neurosurgery|neurosurgery
5505411|NCT01273129|Childhood Epilepsy|childhood epilepsy
5505412|NCT01273129|Epilepsy|epilepsy
5505413|NCT01273129|Frontal Lobe Epilepsy|frontal lobe epilepsy
5505414|NCT01273129|Temporal Lobe Epilepsy|temporal lobe epilepsy
5505415|NCT01273116|frailty|frailty
5505416|NCT01273116|integrated care|integrated care
5505417|NCT01273116|hospital|hospital
5505418|NCT01273116|geriatrics|geriatrics
5505419|NCT01273116|hospital-wide intervention|hospital-wide intervention
5505420|NCT01273090|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5505421|NCT01273090|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5505422|NCT01273090|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5505423|NCT01273090|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5505424|NCT01273090|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5505591|NCT01272531|divalproex sodium|divalproex sodium
5505425|NCT01273090|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5505426|NCT01273090|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5505427|NCT01273090|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5505428|NCT01273090|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5505429|NCT01273090|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5505430|NCT01273090|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5505431|NCT01273090|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5505432|NCT01273090|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5505433|NCT01273090|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5505434|NCT01273090|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5505435|NCT01273090|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5505436|NCT01273090|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5505437|NCT01273090|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5491791|NCT01329523|IGF|igf
5505438|NCT01273090|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5505439|NCT01273090|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5505440|NCT01273090|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
5505441|NCT01273090|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5505442|NCT01273090|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5505443|NCT01273090|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5505444|NCT01273090|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5505445|NCT01273090|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5505446|NCT01273090|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5505447|NCT01273090|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5505448|NCT01273090|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5505449|NCT01273090|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5505450|NCT01273090|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5505451|NCT01273090|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5505452|NCT01273090|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5505453|NCT01273090|childhood central nervous system germinoma|childhood central nervous system germinoma
5505454|NCT01273090|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5505455|NCT01273090|childhood central nervous system teratoma|childhood central nervous system teratoma
5505456|NCT01273090|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5505457|NCT01273090|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5505458|NCT01273090|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5505459|NCT01273090|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5505461|NCT01273090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5505462|NCT01273090|childhood Burkitt lymphoma|childhood burkitt lymphoma
5505463|NCT01273090|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5505464|NCT01273090|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5505465|NCT01273090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5505466|NCT01273090|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5505467|NCT01273090|intraocular lymphoma|intraocular lymphoma
5505468|NCT01273090|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5505469|NCT01273090|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5505470|NCT01273090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5505471|NCT01273090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5505472|NCT01273090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5505473|NCT01273090|small intestine lymphoma|small intestine lymphoma
5505475|NCT01273077|Rotarix|rotarix
5505476|NCT01273064|HCV|hcv
5505477|NCT01273064|Null Responders|null responders
5505478|NCT01273051|Rectal Cancer|rectal cancer
5505479|NCT01273051|Radiochemotherapy|radiochemotherapy
5505480|NCT01273051|TEM|tem
5505481|NCT01273051|Organ preservation|organ preservation
5505482|NCT01273025|pharmacokinetic|pharmacokinetic
5505483|NCT01273025|lime powder regimen|lime powder regimen
5505484|NCT01273025|kidney stone|kidney stone
5505485|NCT01273025|Oxidative stress|oxidative stress
5505486|NCT01273012|probiotic|probiotic
5505487|NCT01273012|cost-effectiveness|cost-effectiveness
5505488|NCT01273012|diarrhea|diarrhea
5505489|NCT01273012|children|children
5505613|NCT01272440|antibodies|antibodies
5505490|NCT01273012|Sum of the monetary cost of the hospitalization|sum of the monetary cost of the hospitalization
5505491|NCT01272999|Acute otitis media|acute otitis media
5505492|NCT01272999|Prevnar 13|prevnar 13
5505493|NCT01272999|Streptococcus pneumoniae|streptococcus pneumoniae
5505592|NCT01272531|Depakote|depakote
5505494|NCT01272986|Determination of the level of oxidised LDL by measuring the level of IgG in Blood|determination of the level of oxidised ldl by measuring the level of igg in blood
5505495|NCT01272960|Contraception|contraception
5505496|NCT01272960|Postnatal care|postnatal care
5505497|NCT01272947|Blunt soft tissue injury/contusion|blunt soft tissue injury/contusion
5505498|NCT01272934|Ankle Sprain, soft tissue injury|ankle sprain, soft tissue injury
5505499|NCT01272895|OCT images|oct images
5505500|NCT01272895|Stent strut coverage|stent strut coverage
5505501|NCT01272895|Endothelialization|endothelialization
5505502|NCT01272895|Neointimal thickness, area and hyperplasia|neointimal thickness, area and hyperplasia
5505503|NCT01272895|Stent malapposition|stent malapposition
5505504|NCT01272830|total joint arthroplasty|total joint arthroplasty
5505506|NCT01272830|ALVAL (Aseptic Lymphocyte-Dominant Vasculitis-Associated Lesion)|alval (aseptic lymphocyte-dominant vasculitis-associated lesion)
5505507|NCT01272830|osteolysis|osteolysis
5505508|NCT01272830|periprosthetic metallosis|periprosthetic metallosis
5505509|NCT01272817|Nonmyeloablative transplant|nonmyeloablative transplant
5505510|NCT01272817|Allogeneic transplant|allogeneic transplant
5505511|NCT01272817|Transplant|transplant
5505512|NCT01272804|Pharmacokinetics PK Pharmacodynamics PD T2DM Phase 1 Type 2 diabetes mellitus safety and tolerability|pharmacokinetics pk pharmacodynamics pd t2dm phase 1 type 2 diabetes mellitus safety and tolerability
5505513|NCT01272791|metastatic stage IV pancreatic cancer|metastatic stage iv pancreatic cancer
5505514|NCT01272765|obesity|obesity
5505515|NCT01272765|weight loss|weight loss
5505516|NCT01272765|weight management|weight management
5505517|NCT01272765|anti-psychotic medication|anti-psychotic medication
5505518|NCT01272765|Zyprexa|zyprexa
5505519|NCT01272765|Seroquel|seroquel
5505520|NCT01272765|Risperdal|risperdal
5505521|NCT01272752|obesity|obesity
5505522|NCT01272752|weight loss|weight loss
5505523|NCT01272752|weight management|weight management
5505524|NCT01272752|anti-psychotic medication|anti-psychotic medication
5505525|NCT01272752|nutriceutical|nutriceutical
5505526|NCT01272739|obesity|obesity
5505527|NCT01272739|weight loss|weight loss
5505528|NCT01272739|weight management|weight management
5505529|NCT01272739|overweight|overweight
5505530|NCT01272739|nutriceutical|nutriceutical
5505531|NCT01272687|Parkinson Disease|parkinson disease
5505532|NCT01272687|Parkinsonian Disorders|parkinsonian disorders
5505533|NCT01272687|Brain Diseases|brain diseases
5505534|NCT01272687|Central Nervous System Diseases|central nervous system diseases
5505535|NCT01272687|Nervous System Diseases|nervous system diseases
5505536|NCT01272687|Neurodegenerative Diseases|neurodegenerative diseases
5505537|NCT01272661|breastfeeding|breastfeeding
5505538|NCT01272661|low-income|low-income
5505539|NCT01272661|high-risk|high-risk
5505540|NCT01272661|African-American|african-american
5505541|NCT01272661|health disparity|health disparity
5505542|NCT01272648|Rehabilitation|rehabilitation
5505543|NCT01272648|Coping|coping
5505544|NCT01272648|Prostate cancer|prostate cancer
5505545|NCT01272648|Nursing|nursing
5505547|NCT01272648|Pelvic floor exercises|pelvic floor exercises
5505548|NCT01272648|Motivational Interviewing|motivational interviewing
5505549|NCT01272635|Asthma|asthma
5505550|NCT01272635|Wheezing|wheezing
5505551|NCT01272635|Respiratory Tract Illness|respiratory tract illness
5505552|NCT01272635|Azythromycin|azythromycin
5505553|NCT01272635|Prednisolone|prednisolone
5505554|NCT01272635|Preschool-age|preschool-age
5505555|NCT01272622|Quality of life|quality of life
5505556|NCT01272622|Endocrinology|endocrinology
5505557|NCT01272622|Oncology|oncology
5505558|NCT01272622|Hypothalamus|hypothalamus
5505559|NCT01272622|Irradiation|irradiation
5505560|NCT01272622|Neurosurgery|neurosurgery
5505561|NCT01272622|Pediatric Brain tumors|pediatric brain tumors
5505562|NCT01272622|Randomized trial|randomized trial
5505563|NCT01272596|Multiple Sclerosis|multiple sclerosis
5505564|NCT01272596|Visual Contrast Acuity|visual contrast acuity
5505565|NCT01272596|Visual Contrast Sensitivity|visual contrast sensitivity
5505566|NCT01272596|Sloan Charts|sloan charts
5505567|NCT01272583|Type 1 diabetes|type 1 diabetes
5505568|NCT01272583|DPP-4 inhibitor|dpp-4 inhibitor
5505569|NCT01272583|Glucagon|glucagon
5505570|NCT01272570|breast|breast
5505571|NCT01272570|oral|oral
5505572|NCT01272570|cancer|cancer
5505573|NCT01272557|HCC|hcc
5505574|NCT01272544|Dental caries|dental caries
5505575|NCT01272544|Epidemiology|epidemiology
5505576|NCT01272544|Gingivitis|gingivitis
5505577|NCT01272544|Oral health|oral health
5505578|NCT01272531|pharmacogenetics|pharmacogenetics
5505579|NCT01272531|bipolar disorders|bipolar disorders
5505580|NCT01272531|affective disorders|affective disorders
5505581|NCT01272531|mood disorders|mood disorders
5505582|NCT01272531|pharmacologic actions|pharmacologic actions
5505583|NCT01272531|psychotropic drugs|psychotropic drugs
5505584|NCT01272531|antimanic agents|antimanic agents
5505585|NCT01272531|antidepressant agents|antidepressant agents
5505586|NCT01272531|lithium|lithium
5505587|NCT01272531|lithium carbonate|lithium carbonate
5505588|NCT01272531|Lithobid|lithobid
5505589|NCT01272531|Eskalith|eskalith
5505590|NCT01272531|divalproex|divalproex
5505594|NCT01272518|chaos theory heart rate variability mania bipolar disorder|chaos theory heart rate variability mania bipolar disorder
5505595|NCT01272479|hemodialysis|hemodialysis
5505596|NCT01272479|hepatitis C|hepatitis c
5505597|NCT01272479|inflammation|inflammation
5505598|NCT01272479|iron stores|iron stores
5505599|NCT01272479|prohepcidin|prohepcidin
5505600|NCT01272466|multiple myeloma|multiple myeloma
5505601|NCT01272466|vaccination|vaccination
5505602|NCT01272466|antiapoptotic proteins|antiapoptotic proteins
5505603|NCT01272466|proteasome inhibition|proteasome inhibition
5505604|NCT01272453|coronary artery disease|coronary artery disease
5505605|NCT01272453|CT scan|ct scan
5505606|NCT01272453|coronary angiography|coronary angiography
5505607|NCT01272453|chest pain|chest pain
5505608|NCT01272453|aortic aneurysm|aortic aneurysm
5505609|NCT01272453|pulmonary embolism|pulmonary embolism
5505610|NCT01272440|PEG-asparaginase|peg-asparaginase
5505611|NCT01272440|children|children
5505612|NCT01272440|pharmacokinetics|pharmacokinetics
5505614|NCT01272440|acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5505615|NCT01272440|adverse effects|adverse effects
5505616|NCT01272414|Eyelid retraction|eyelid retraction
5505617|NCT01272414|Botulinum Toxins|botulinum toxins
5505618|NCT01272388|Aortic valve stenosis|aortic valve stenosis
5505619|NCT01272388|Tadalafil|tadalafil
5505620|NCT01272388|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5505621|NCT01272388|Hypertension, pulmonary|hypertension, pulmonary
5505622|NCT01272388|Hypertrophy, left ventricular|hypertrophy, left ventricular
5505623|NCT01272362|Indacaterol|indacaterol
5505624|NCT01272362|COPD|copd
5505625|NCT01272362|LABA|laba
5505626|NCT01272362|Reversibility|reversibility
5505627|NCT01272349|spinal cord injury|spinal cord injury
5505628|NCT01272349|walking|walking
5505629|NCT01272349|low oxygen|low oxygen
5505631|NCT01272349|strength|strength
5505632|NCT01272336|spinal cord injury, low oxygen, strength, motor control|spinal cord injury, low oxygen, strength, motor control
5505633|NCT01272323|Cat allergy|cat allergy
5505634|NCT01272323|Rhinoconjunctivitis|rhinoconjunctivitis
5505635|NCT01272310|Chronic Hepatitis C|chronic hepatitis c
5505636|NCT01272310|Combination Therapy|combination therapy
5505637|NCT01272310|Hydroxychloroquine|hydroxychloroquine
5505638|NCT01272310|Pegylated Interferon Alpha-2a|pegylated interferon alpha-2a
5505639|NCT01272310|Ribavirin|ribavirin
5505640|NCT01272310|Chronic Hepatitis C Genotype 1 infected adult subjects|chronic hepatitis c genotype 1 infected adult subjects
5505641|NCT01272297|LI-ESWT|li-eswt
5505642|NCT01272297|Erectile Dysfunction|erectile dysfunction
5505643|NCT01272297|Non PDE5 inhibitor responders|non pde5 inhibitor responders
5505644|NCT01272297|Shock wave|shock wave
5505645|NCT01272284|Female|female
5505646|NCT01272284|Stress urinary incontinence|stress urinary incontinence
5505647|NCT01272284|Mini sling|mini sling
5505648|NCT01272284|Single incision sling|single incision sling
5505649|NCT01272284|Urinary incontinence|urinary incontinence
5499915|NCT01296126|MRI|mri
5505650|NCT01272284|Mixed urinary incontinence|mixed urinary incontinence
5505651|NCT01272284|Additional relevant MeSH terms:|additional relevant mesh terms:
5505653|NCT01272284|Urinary Incontinence, Stress|urinary incontinence, stress
5505654|NCT01272284|Pathological Processes|pathological processes
5505655|NCT01272284|Urination Disorders|urination disorders
5505656|NCT01272284|Urological Disorders|urological disorders
5505657|NCT01272284|Urological Manifestations|urological manifestations
5505658|NCT01272284|Signs and Symptoms|signs and symptoms
5505659|NCT01272271|Contact lens|contact lens
5505660|NCT01272271|Infection|infection
5505662|NCT01272245|Acute Myelogenous Leukemia|acute myelogenous leukemia
5505663|NCT01272245|AML|aml
5505664|NCT01272245|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5505665|NCT01272245|MDS|mds
5505666|NCT01272245|Omacetaxine|omacetaxine
5505667|NCT01272245|Cytarabine|cytarabine
5505668|NCT01272245|ARA-C|ara-c
5505669|NCT01272245|Cytosar|cytosar
5505670|NCT01272245|DepoCyt|depocyt
5505671|NCT01272245|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5505672|NCT01272180|Safety|safety
5505673|NCT01272180|Immunogenicity|immunogenicity
5505674|NCT01272180|Vaccine|vaccine
5505675|NCT01272180|Meningococcal|meningococcal
5505676|NCT01272180|Seroresponse|seroresponse
5505677|NCT01272167|Post-menopausal women|post-menopausal women
5505678|NCT01272167|Grapefruit juice|grapefruit juice
5505679|NCT01272167|Naringin|naringin
5505680|NCT01272167|Vascular protection|vascular protection
5505681|NCT01272167|Bone metabolism|bone metabolism
5505682|NCT01272154|Cerebellum|cerebellum
5505683|NCT01272154|Cortical plasticity|cortical plasticity
5505684|NCT01272154|Sensorimotor adaptation|sensorimotor adaptation
5505685|NCT01272154|Dystonia|dystonia
5505686|NCT01272154|Cerebral Palsy|cerebral palsy
5505687|NCT01272154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5505688|NCT01272154|and|and
5505689|NCT01272141|Metastatic breast cancer|metastatic breast cancer
5505690|NCT01272141|Triple negative breast cancer|triple negative breast cancer
5505792|NCT01271777|PPARs|ppars
5505793|NCT01271777|Insulin resistance|insulin resistance
5505794|NCT01271751|Atherogenic-dyslipidaemia|atherogenic-dyslipidaemia
5505694|NCT01272115|Empowerment approach|empowerment approach
5505695|NCT01272115|Primary care services|primary care services
5505696|NCT01272076|Age Related Macular Degeneration|age related macular degeneration
5505697|NCT01272076|Geographic Atrophy|geographic atrophy
5505698|NCT01272076|Imaging|imaging
5505699|NCT01272076|OCT|oct
5505700|NCT01272063|Drusen|drusen
5505701|NCT01272063|Dry AMD|dry amd
5505702|NCT01272063|OCT|oct
5505703|NCT01272063|Imaging|imaging
5505709|NCT01272024|clinical trial|clinical trial
5505710|NCT01272024|symptom education|symptom education
5505711|NCT01272024|advanced cancer|advanced cancer
5505713|NCT01272011|Spinal cord injuries|spinal cord injuries
5505714|NCT01272011|Walking recovery|walking recovery
5505715|NCT01271998|antibiotic|antibiotic
5505716|NCT01271998|healthy subjects|healthy subjects
5505717|NCT01271998|pharmacokinetics|pharmacokinetics
5505718|NCT01271985|Cardiovascular Diseases|cardiovascular diseases
5505719|NCT01271985|Drug Combinations|drug combinations
5505720|NCT01271985|prevention and control|prevention and control
5505721|NCT01271985|Aspirin|aspirin
5505722|NCT01271985|Antihypertensive Agents|antihypertensive agents
5505723|NCT01271985|Antilipemic Agents|antilipemic agents
5505724|NCT01271959|Ovarian|ovarian
5505725|NCT01271959|Fallopian Tube|fallopian tube
5505726|NCT01271959|Peritoneal|peritoneal
5505727|NCT01271959|Uterine Neoplasms|uterine neoplasms
5505728|NCT01271959|Vulva|vulva
5505729|NCT01271959|Endometrial|endometrial
5505730|NCT01271959|Cervical|cervical
5505731|NCT01271959|Lung|lung
5505732|NCT01271959|Carcinoid|carcinoid
5505733|NCT01271959|Sarcoma|sarcoma
5505734|NCT01271959|Mesothelioma|mesothelioma
5505735|NCT01271959|Adenocarcinoma|adenocarcinoma
5505736|NCT01271959|Colorectal|colorectal
5505737|NCT01271959|Breast|breast
5505738|NCT01271959|Assay|assay
5505739|NCT01271959|Chemotherapy|chemotherapy
5505740|NCT01271959|Recurrent|recurrent
5505741|NCT01271959|Refractory|refractory
5505742|NCT01271959|Persistent|persistent
5505743|NCT01271959|Chemoresponse|chemoresponse
5505744|NCT01271933|fibromyalgia|fibromyalgia
5505745|NCT01271933|pain|pain
5505746|NCT01271933|pregabalin|pregabalin
5505747|NCT01271933|Lyrica|lyrica
5505748|NCT01271920|Trastuzumab-refractory|trastuzumab-refractory
5505749|NCT01271920|advanced HER2-positive breast cancer,|advanced her2-positive breast cancer,
5505750|NCT01271920|Hsp90,|hsp90,
5505751|NCT01271920|2nd or 3rd line treatment|2nd or 3rd line treatment
5505752|NCT01271907|Skin Cancer|skin cancer
5505753|NCT01271907|Malignancy|malignancy
5505754|NCT01271907|Immunotherapy|immunotherapy
5505755|NCT01271907|Melanoma Peptides|melanoma peptides
5505756|NCT01271907|Melanoma|melanoma
5505757|NCT01271907|Metastatic Melanoma|metastatic melanoma
5505758|NCT01271894|HIV|hiv
5505759|NCT01271894|efavirenz|efavirenz
5505760|NCT01271894|pharmacokinetic|pharmacokinetic
5505761|NCT01271881|Hemodialysis|hemodialysis
5505763|NCT01271881|Angiograph|angiograph
5505764|NCT01271881|Angiogram|angiogram
5671472|NCT00615927|Progressive glioblastoma multiforme|progressive glioblastoma multiforme
5505765|NCT01271881|Adult patients who are currently receiving hemodialysis treatment via an AV vascular graft or fistula located in the upper extremity|adult patients who are currently receiving hemodialysis treatment via an av vascular graft or fistula located in the upper extremity
5505766|NCT01271868|Recombinant Factor IX|recombinant factor ix
5505768|NCT01271855|Opium|opium
5505769|NCT01271855|Suppository|suppository
5505770|NCT01271829|Avocados|avocados
5505771|NCT01271829|Satiety|satiety
5505772|NCT01271829|Feeding study|feeding study
5505773|NCT01271816|genetics|genetics
5505774|NCT01271816|sudden death|sudden death
5505775|NCT01271816|monitoring|monitoring
5505776|NCT01271816|loop recorder|loop recorder
5505777|NCT01271816|cardiomyopathy|cardiomyopathy
5505778|NCT01271790|Hepatitis C|hepatitis c
5505779|NCT01271790|HCV|hcv
5505780|NCT01271790|Rapid Virologic Response|rapid virologic response
5505781|NCT01271790|Sustained Virologic Response|sustained virologic response
5505782|NCT01271790|Direct Acting Antiviral|direct acting antiviral
5505783|NCT01271790|Combination Therapy|combination therapy
5505784|NCT01271790|HCV RNA|hcv rna
5505785|NCT01271790|Polymerase inhibitor|polymerase inhibitor
5505786|NCT01271790|Protease inhibitor|protease inhibitor
5505787|NCT01271790|Treatment naïve|treatment naïve
5505788|NCT01271790|GS-9190|gs-9190
5505789|NCT01271790|GS-9451|gs-9451
5505790|NCT01271777|Pre-diabetes|pre-diabetes
5505791|NCT01271777|Clamp technique|clamp technique
5505795|NCT01271751|PPARs|ppars
5505796|NCT01271738|Breast Cancer|breast cancer
5505797|NCT01271738|Tumors or cancer of the human breast|tumors or cancer of the human breast
5505798|NCT01271738|Breast Tumors|breast tumors
5505799|NCT01271738|Cancer of Breast|cancer of breast
5505800|NCT01271738|Cancer of the Breast|cancer of the breast
5505801|NCT01271738|Human Mammary Carcinoma|human mammary carcinoma
5505802|NCT01271738|Neoplasms, Breast|neoplasms, breast
5505803|NCT01271712|Gastrointestinal stromal cancer|gastrointestinal stromal cancer
5505804|NCT01271712|GIST|gist
5505805|NCT01271712|multikinase inhibitor|multikinase inhibitor
5505806|NCT01271699|Fabry Disease|fabry disease
5505807|NCT01271699|Fabry´s Disease|fabry´s disease
5505808|NCT01271699|Anderson-Fabry Disease|anderson-fabry disease
5505809|NCT01271699|Multiple Sclerosis|multiple sclerosis
5505810|NCT01271660|muscle cramp|muscle cramp
5505811|NCT01271660|liver cirrhosis|liver cirrhosis
5505812|NCT01271660|pregabalin|pregabalin
5505813|NCT01271647|osteopenia,chinese herb|osteopenia,chinese herb
5505814|NCT01271634|cross-transmission|cross-transmission
5505815|NCT01271634|offending vessel|offending vessel
5505816|NCT01271621|Airtraq, Intraocular pressure|airtraq, intraocular pressure
5505817|NCT01271608|Accident prevention|accident prevention
5505818|NCT01271608|Blood-borne pathogens|blood-borne pathogens
5505819|NCT01271608|Protective devices.|protective devices.
5505820|NCT01271608|Needlestick injuries|needlestick injuries
5505821|NCT01271608|Injections subcutaneous|injections subcutaneous
5505822|NCT01271608|Injections intradermal|injections intradermal
5505824|NCT01271595|autonomic nervous system|autonomic nervous system
5505825|NCT01271595|seasonal allergic rhinitis|seasonal allergic rhinitis
5505826|NCT01271582|Colorecatal cancer|colorecatal cancer
5505827|NCT01271582|Gastric cancer|gastric cancer
5505829|NCT01271582|UGT1A1|ugt1a1
5505830|NCT01271582|Neutropenia|neutropenia
5505831|NCT01271556|COPD|copd
5505832|NCT01271556|LABA|laba
5505833|NCT01271556|salmeterol|salmeterol
5505834|NCT01271543|Comparison of hemodynamic|comparison of hemodynamic
5505835|NCT01271543|endotracheal intubation|endotracheal intubation
5505836|NCT01271543|changes induced by|changes induced by
5505837|NCT01271543|performed|performed
5505838|NCT01271543|the aid of the SOS|the aid of the sos
5505839|NCT01271543|as compared to the Macintosh Laryngoscope|as compared to the macintosh laryngoscope
5505840|NCT01271530|Late Effects of Polio|late effects of polio
5505841|NCT01271530|Cardiovascular Fitness|cardiovascular fitness
5505842|NCT01271530|Fatigue|fatigue
5505843|NCT01271530|Energy cost of Walking|energy cost of walking
5505844|NCT01271530|Pain|pain
5505845|NCT01271517|Basal insulin|basal insulin
5505846|NCT01271517|long acting insulin analogs|long acting insulin analogs
5505847|NCT01271517|metabolic control|metabolic control
5505848|NCT01271517|HbA1c|hba1c
5505849|NCT01271517|C-peptide|c-peptide
5505850|NCT01271517|IGF-I|igf-i
5505851|NCT01271517|GH|gh
5505852|NCT01271517|IGFBP|igfbp
5505853|NCT01271504|Cancer|cancer
5505854|NCT01271504|liver|liver
5505855|NCT01271504|hepatocellular carcinoma|hepatocellular carcinoma
5505856|NCT01271504|phase I|phase i
5505857|NCT01271504|phase II|phase ii
5505858|NCT01271491|Pediatric|pediatric
5505859|NCT01271478|inflammation|inflammation
5505860|NCT01271478|telmisartan|telmisartan
5505861|NCT01271478|captopril|captopril
5505862|NCT01271478|hemodialysis|hemodialysis
5505863|NCT01271426|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5505864|NCT01271426|Ranibizumab|ranibizumab
5505865|NCT01271400|Infertility treatments|infertility treatments
5505992|NCT01270854|Normal saline|normal saline
5505866|NCT01271400|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
5505867|NCT01271400|IVF.|ivf.
5505868|NCT01271400|ART.|art.
5505869|NCT01271400|Cryopreservation|cryopreservation
5505870|NCT01271400|Slow-Freeze|slow-freeze
5505871|NCT01271400|Freeze / thaw survival rates|freeze / thaw survival rates
5505872|NCT01271400|Blastocyst formation|blastocyst formation
5505873|NCT01271400|Pregnancy|pregnancy
5505874|NCT01271387|Liver disease|liver disease
5505875|NCT01271387|pharmacokinetics|pharmacokinetics
5505876|NCT01271374|African American|african american
5505877|NCT01271374|Hypertension|hypertension
5505878|NCT01271374|Cardiometabolic Syndrome|cardiometabolic syndrome
5505879|NCT01271361|thrombus aspiration|thrombus aspiration
5505880|NCT01271361|Drug-Eluting Stent|drug-eluting stent
5505881|NCT01271361|optical frequency domain imaging (OFDI)|optical frequency domain imaging (ofdi)
5505882|NCT01271335|CTO|cto
5505883|NCT01271335|Angioplasty|angioplasty
5505884|NCT01271335|PCI|pci
5505885|NCT01271322|PET|pet
5505886|NCT01271322|response evaluation|response evaluation
5505887|NCT01271322|neoadjuvant|neoadjuvant
5505888|NCT01271322|radiochemotherapy|radiochemotherapy
5505889|NCT01271322|adenocarcinoma of the esophagogastric junction|adenocarcinoma of the esophagogastric junction
5505890|NCT01271322|esophageal carcinoma|esophageal carcinoma
5505891|NCT01271322|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction|evaluation of preoperative (radio)-chemotherapy in patients with adenocarcinomas of the oesophagogastric junction
5505892|NCT01271296|Addison Disease|addison disease
5505893|NCT01271296|Pharmacokinetics|pharmacokinetics
5505894|NCT01271296|Hormone Replacement Therapy|hormone replacement therapy
5505895|NCT01271296|cortisone acetate|cortisone acetate
5505896|NCT01271296|Quality of Life|quality of life
5505897|NCT01271270|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5505898|NCT01271270|Palomid 529|palomid 529
5505899|NCT01271270|Age Related Macular Degeneration|age related macular degeneration
5505901|NCT01271257|misoprostol, pharmacokinetics|misoprostol, pharmacokinetics
5505902|NCT01271231|periodontal treatment, diabetes, glycemia, glycated hemoglobin|periodontal treatment, diabetes, glycemia, glycated hemoglobin
5505903|NCT01271205|pneumonia|pneumonia
5505904|NCT01271205|RDW|rdw
5505905|NCT01271205|mortality|mortality
5505906|NCT01271205|prognostic factor|prognostic factor
5505907|NCT01271192|local recurrent rectal cancer|local recurrent rectal cancer
5505908|NCT01271192|surgical resection|surgical resection
5505909|NCT01271192|adjuvant therapy|adjuvant therapy
5505910|NCT01271179|orthotopic liver transplantation|orthotopic liver transplantation
5505911|NCT01271179|preservation solution|preservation solution
5505912|NCT01271179|peribiliary plexus|peribiliary plexus
5505913|NCT01271179|nonanastomotic biliary strictures|nonanastomotic biliary strictures
5505915|NCT01271166|Colorectal,|colorectal,
5505916|NCT01271166|Cancer|cancer
5505917|NCT01271153|Septic shock|septic shock
5505918|NCT01271127|radiation therapy|radiation therapy
5505919|NCT01271127|coronary artery disease|coronary artery disease
5505920|NCT01271127|Hodgkin Lymphoma|hodgkin lymphoma
5505921|NCT01271101|Non-ST-elevated acute coronary syndromes (NSTE-ACS)|non-st-elevated acute coronary syndromes (nste-acs)
5505922|NCT01271101|anticoagulation|anticoagulation
5505923|NCT01271088|ototoxicity|ototoxicity
5505924|NCT01271088|aminoglycoside|aminoglycoside
5505925|NCT01271088|vancomycine|vancomycine
5505926|NCT01271088|peritoneal dialysis|peritoneal dialysis
5505927|NCT01271088|peritonitis|peritonitis
5505928|NCT01271075|urticaria|urticaria
5505929|NCT01271075|bilastine|bilastine
5505930|NCT01271062|Resolvment of Diabetes Mellitus, Type 2|resolvment of diabetes mellitus, type 2
5505931|NCT01271062|gastric bypass|gastric bypass
5505932|NCT01271036|Lubricating Agents|lubricating agents
5505933|NCT01271036|Personal Lubricant|personal lubricant
5505934|NCT01270984|Imatinib mesylate|imatinib mesylate
5505935|NCT01270984|Pharmacokinetics|pharmacokinetics
5505936|NCT01270984|Healthy volunteers|healthy volunteers
5505937|NCT01270971|Onychomycosis|onychomycosis
5505938|NCT01270971|nail fungus|nail fungus
5505939|NCT01270971|toenail fungus|toenail fungus
5505940|NCT01270971|fungal nail|fungal nail
5505941|NCT01270971|hyperkeratosis|hyperkeratosis
5505942|NCT01270971|nail infection|nail infection
5505943|NCT01270971|nail treatment|nail treatment
5505944|NCT01270971|toenail infection|toenail infection
5505945|NCT01270971|toenail treatment|toenail treatment
5505946|NCT01270971|foot dermatoses|foot dermatoses
5505947|NCT01270971|fungal culture|fungal culture
5505948|NCT01270971|onycholysis|onycholysis
5505949|NCT01270971|podiatrist|podiatrist
5505950|NCT01270971|podiatry|podiatry
5505951|NCT01270971|subungual|subungual
5505952|NCT01270971|tinea unguium|tinea unguium
5505953|NCT01270971|antifungal|antifungal
5505954|NCT01270971|anti-fungal|anti-fungal
5505955|NCT01270971|dermatologist|dermatologist
5505956|NCT01270971|dermatology|dermatology
5505957|NCT01270971|dermatophyte|dermatophyte
5505958|NCT01270971|distal subungual onychomycosis|distal subungual onychomycosis
5505959|NCT01270971|yellow nail|yellow nail
5505960|NCT01270971|thick nail|thick nail
5505961|NCT01270971|brittle nail|brittle nail
5505966|NCT01270906|Neoplasms|neoplasms
5505967|NCT01270906|Cancer|cancer
5505968|NCT01270906|Tumors|tumors
5505969|NCT01270906|Administration|administration
5505970|NCT01270906|oral|oral
5505972|NCT01270906|CHIR-258|chir-258
5505973|NCT01270906|CHIR 258|chir 258
5505974|NCT01270906|TKI258|tki258
5505975|NCT01270906|TKI-258|tki-258
5505976|NCT01270906|TKI 258|tki 258
5505977|NCT01270906|dose finding|dose finding
5505978|NCT01270893|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5505979|NCT01270893|GIST|gist
5505980|NCT01270893|Nilotinib|nilotinib
5505981|NCT01270893|AMN107|amn107
5505982|NCT01270893|Tasigna|tasigna
5505983|NCT01270867|Ischemia|ischemia
5505984|NCT01270867|Stroke|stroke
5505985|NCT01270867|Ischemic Stroke|ischemic stroke
5505986|NCT01270867|Mechanical Thrombectomy|mechanical thrombectomy
5505987|NCT01270867|Brain|brain
5505988|NCT01270867|Brain clot|brain clot
5505989|NCT01270867|Cerebrovascular disease|cerebrovascular disease
5505990|NCT01270867|Recanalization|recanalization
5505991|NCT01270867|Revascularization|revascularization
5505993|NCT01270854|Plasmalyte|plasmalyte
5505994|NCT01270854|Intravenous fluid|intravenous fluid
5505995|NCT01270854|Traumatic injury|traumatic injury
5505997|NCT01270828|Control Release Pregabalin in Post Herpetic Neuralgia|control release pregabalin in post herpetic neuralgia
5505999|NCT01270815|pharmacokinetics|pharmacokinetics
5506000|NCT01270815|bioavailability|bioavailability
5506001|NCT01270815|bioequivalence|bioequivalence
5506002|NCT01270802|Endothelial function|endothelial function
5506003|NCT01270802|Vitamin D|vitamin d
5506004|NCT01270802|Efavirenz|efavirenz
5506005|NCT01270802|Raltegravir|raltegravir
5506006|NCT01270789|beta-cell function|beta-cell function
5506007|NCT01270789|GLP-1 analogue|glp-1 analogue
5506008|NCT01270789|diabetes|diabetes
5506009|NCT01270776|Randomized Controlled Trial|randomized controlled trial
5506010|NCT01270776|Chlorhexidine|chlorhexidine
5506011|NCT01270776|Infant, Premature|infant, premature
5506012|NCT01270763|Obesity|obesity
5506013|NCT01270763|physical fitness|physical fitness
5506014|NCT01270763|cholesterol levels|cholesterol levels
5506015|NCT01270763|genetics|genetics
5506016|NCT01270763|weight loss|weight loss
5506017|NCT01270750|ENDOTHELIN RECEPTOR ANTAGONIST|endothelin receptor antagonist
5506018|NCT01270750|BOSENTAN|bosentan
5506019|NCT01270750|SECONDARY PULMONARY HYPERTENSION|secondary pulmonary hypertension
5506020|NCT01270750|RHEUMATOID FEVER|rheumatoid fever
5506021|NCT01270750|CONGESTIVE HEART FAILURE|congestive heart failure
5506022|NCT01270750|SECONDARY PULMONARY HYPERTENSION DUE TO MITRAL STENOSIS|secondary pulmonary hypertension due to mitral stenosis
5506023|NCT01270711|compliance study|compliance study
5506024|NCT01270711|effectiveness study|effectiveness study
5506025|NCT01270711|hyperprolactinemia|hyperprolactinemia
5506026|NCT01270711|Parkinson's disease|parkinson's disease
5506027|NCT01270711|retrospective cohort study|retrospective cohort study
5506028|NCT01270698|colorectal cancer|colorectal cancer
5506029|NCT01270672|MDMA|mdma
5506030|NCT01270672|carvedilol|carvedilol
5506031|NCT01270672|norepinephrine|norepinephrine
5506032|NCT01270672|alpha - beta receptor|alpha - beta receptor
5506033|NCT01270672|Ecstasy|ecstasy
5506034|NCT01270672|stimulant|stimulant
5506035|NCT01270659|Fentanyl buccal tablet|fentanyl buccal tablet
5506036|NCT01270646|Cardiac insufficiency|cardiac insufficiency
5506037|NCT01270646|Invasive procedure|invasive procedure
5506038|NCT01270646|Heart Failure|heart failure
5506039|NCT01270646|Noninvasive procedure|noninvasive procedure
5506040|NCT01270646|Congestive Heart Failure|congestive heart failure
5506041|NCT01270646|Mapping|mapping
5506042|NCT01270646|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5506043|NCT01270646|Open study|open study
5506044|NCT01270646|Cardiac Pacings, Artificial|cardiac pacings, artificial
5506045|NCT01270646|Hemodynamics|hemodynamics
5506046|NCT01270620|elderly obese|elderly obese
5506047|NCT01270581|transient tachypnea of the newborn|transient tachypnea of the newborn
5506048|NCT01270581|high flow nasal cannula|high flow nasal cannula
5506049|NCT01270581|bubble nasal|bubble nasal
5506050|NCT01270581|continuous positive airway pressure|continuous positive airway pressure
5506051|NCT01270568|positive psychology|positive psychology
5506052|NCT01270568|cardiovascular disease|cardiovascular disease
5506053|NCT01270542|Traction Retinal Detachment (PDR)|traction retinal detachment (pdr)
5506054|NCT01270542|Proliferative Diabetic Retinopathy (PDR)|proliferative diabetic retinopathy (pdr)
5506055|NCT01270529|Physical Activity|physical activity
5506056|NCT01270529|Physical Performance|physical performance
5506057|NCT01270529|Physical Functioning|physical functioning
5506059|NCT01270529|ESRD|esrd
5506060|NCT01270529|Transplant Recipients|transplant recipients
5506061|NCT01270516|diaphragm|diaphragm
5500317|NCT01294683|LDL|ldl
5506062|NCT01270516|limb muscle|limb muscle
5506063|NCT01270516|EPA|epa
5506064|NCT01270516|HMB|hmb
5506065|NCT01270516|ICU patients|icu patients
5506066|NCT01270503|Meningitis|meningitis
5506067|NCT01270503|Meningococcal disease|meningococcal disease
5506068|NCT01270503|Menactra®|menactra®
5506069|NCT01270490|candidemia|candidemia
5506070|NCT01270490|candida sepsis|candida sepsis
5506071|NCT01270490|invasive fungal disease|invasive fungal disease
5506072|NCT01270477|Frost injury|frost injury
5506073|NCT01270451|Weight maintenance|weight maintenance
5506074|NCT01270451|Group counseling|group counseling
5506075|NCT01270451|Prevention of diseases|prevention of diseases
5506076|NCT01270425|systemic sclerosis|systemic sclerosis
5506077|NCT01270425|hashimoto thyroiditis|hashimoto thyroiditis
5506078|NCT01270425|thyroid nodules|thyroid nodules
5506079|NCT01270412|Osteoarthritis|osteoarthritis
5506080|NCT01270412|PRP|prp
5506081|NCT01270412|PRGF|prgf
5506082|NCT01270412|Hyaluronic acid|hyaluronic acid
5506083|NCT01270386|NSCLC|nsclc
5506084|NCT01270386|apatinib|apatinib
5506085|NCT01270386|phase II|phase ii
5506086|NCT01270386|lung|lung
5506087|NCT01270386|cancer|cancer
5506090|NCT01270321|Thyroid Cancer|thyroid cancer
5506091|NCT01270308|Bioequivalence|bioequivalence
5506092|NCT01270308|two way crossover|two way crossover
5506093|NCT01270295|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5506493|NCT01268657|PTSD|ptsd
5506094|NCT01270295|Soluble RAGE (sRAGE)|soluble rage (srage)
5506095|NCT01270295|Endogenous secretory RAGE (esRAGE)|endogenous secretory rage (esrage)
5506096|NCT01270295|High-mobility group box-1 protein (HMGB-1)|high-mobility group box-1 protein (hmgb-1)
5506097|NCT01270295|Extracellular newly-identified RAGE-binding protein (EN-RAGE or S100A12)|extracellular newly-identified rage-binding protein (en-rage or s100a12)
5506098|NCT01270295|Advanced glycation endproducts (AGEs)|advanced glycation endproducts (ages)
5506099|NCT01270295|Pentosidine|pentosidine
5506100|NCT01270295|N--carboxymethyllysine|n--carboxymethyllysine
5506101|NCT01270295|Acute lung injury (ALI)|acute lung injury (ali)
5506102|NCT01270295|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5506103|NCT01270295|Alveolar epithelium|alveolar epithelium
5506104|NCT01270295|Mechanical ventilation|mechanical ventilation
5506105|NCT01270295|Intensive Care Unit (ICU)|intensive care unit (icu)
5506106|NCT01270269|Asthenia|asthenia
5506107|NCT01270269|Muscle Weakness|muscle weakness
5506108|NCT01270269|Brain Injuries|brain injuries
5506109|NCT01270269|Critical Illness|critical illness
5506110|NCT01270269|Critical Illness Myoneuropathy|critical illness myoneuropathy
5506111|NCT01270269|Rehabilitation|rehabilitation
5506112|NCT01270269|Sepsis|sepsis
5506113|NCT01270269|Respiratory Failure|respiratory failure
5506114|NCT01270269|Delirium|delirium
5506115|NCT01270269|Over-sedation|over-sedation
5506119|NCT01270269|Muscular Diseases|muscular diseases
5506120|NCT01270269|Musculoskeletal Diseases|musculoskeletal diseases
5506121|NCT01270269|Neuromuscular Manifestations|neuromuscular manifestations
5506122|NCT01270269|Neurologic Manifestations|neurologic manifestations
5506123|NCT01270269|Pathologic Processes|pathologic processes
5506124|NCT01270269|Brain Diseases|brain diseases
5506125|NCT01270269|Central Nervous System Diseases|central nervous system diseases
5506126|NCT01270269|Craniocerebral Trauma|craniocerebral trauma
5506127|NCT01270269|Trauma, Nervous System|trauma, nervous system
5506128|NCT01270269|Wounds and Injuries|wounds and injuries
5506129|NCT01270269|Disorders of Environmental Origin|disorders of environmental origin
5506131|NCT01270230|HIV Prevention Intervention|hiv prevention intervention
5506132|NCT01270230|African American Men who have Sex with Men|african american men who have sex with men
5506133|NCT01270217|Automobile driving|automobile driving
5506134|NCT01270217|Driving under the influence|driving under the influence
5506135|NCT01270217|Interview, psychological|interview, psychological
5506136|NCT01270217|Brief intervention|brief intervention
5506137|NCT01270217|Brief motivational interview|brief motivational interview
5506138|NCT01270204|Dysphagia|dysphagia
5506139|NCT01270204|Swallowing Problems|swallowing problems
5506140|NCT01270204|Dynamic Fluoroscopic Swallow Study|dynamic fluoroscopic swallow study
5506141|NCT01270204|Aspiration|aspiration
5506142|NCT01270204|Regurgitation|regurgitation
5506143|NCT01270204|Acid Reflux|acid reflux
5506144|NCT01270191|Exenatide, Beta-Cell Function, Glycemic Control|exenatide, beta-cell function, glycemic control
5506145|NCT01270191|in Newly Diagnosed Type 2 Diabetic Patients|in newly diagnosed type 2 diabetic patients
5506146|NCT01270165|lamivudine|lamivudine
5506147|NCT01270165|telbivudine|telbivudine
5506148|NCT01270165|adefovir|adefovir
5506149|NCT01270165|lamivudine resistance|lamivudine resistance
5506150|NCT01270152|ascorbic acid|ascorbic acid
5506151|NCT01270152|catheterization central venous|catheterization central venous
5506152|NCT01270152|nursing care|nursing care
5506153|NCT01270139|nanoparticles|nanoparticles
5506154|NCT01270139|mesenchymal stem cell|mesenchymal stem cell
5506155|NCT01270139|plasmonics|plasmonics
5506156|NCT01270139|atherosclerosis|atherosclerosis
5506157|NCT01270139|IVUS|ivus
5506158|NCT01270139|stenting|stenting
5506159|NCT01270126|optic neuropathy|optic neuropathy
5506160|NCT01270126|alternating current stimulation|alternating current stimulation
5506162|NCT01270126|restoration|restoration
5506163|NCT01270126|plasticity|plasticity
5506164|NCT01270087|Rheumatoid arthritis, cardiovascular disease, adalimumab|rheumatoid arthritis, cardiovascular disease, adalimumab
5506165|NCT01270074|double blind placebo controlled randomised clinical trial|double blind placebo controlled randomised clinical trial
5506166|NCT01270074|azithromycin|azithromycin
5506167|NCT01270074|infant|infant
5506168|NCT01270074|pediatric|pediatric
5506169|NCT01270074|cystic fibrosis|cystic fibrosis
5506170|NCT01270074|bronchiectasis|bronchiectasis
5506171|NCT01270061|HIV testing|hiv testing
5506172|NCT01270061|black Africans|black africans
5506173|NCT01270061|immigrants|immigrants
5506174|NCT01270061|health screening|health screening
5506175|NCT01270048|Hwa-byung, Bunsimgi-eum(Fenxinqiyin)|hwa-byung, bunsimgi-eum(fenxinqiyin)
5506176|NCT01269996|type 2 diabetes mellitus|type 2 diabetes mellitus
5506177|NCT01269996|JUBILEE Study|jubilee study
5506178|NCT01269996|Janumet|janumet
5506179|NCT01269996|Lantus|lantus
5506180|NCT01269983|low back pain|low back pain
5506181|NCT01269983|fascial manipulation|fascial manipulation
5506182|NCT01269983|physioterapy|physioterapy
5506183|NCT01269983|physical activity|physical activity
5506184|NCT01269957|halitosis|halitosis
5506185|NCT01269957|pediatric dentistry|pediatric dentistry
5506186|NCT01269957|mouth breathing|mouth breathing
5506187|NCT01269944|osteoarthritis|osteoarthritis
5506189|NCT01269944|high wedge tibial osteotomy|high wedge tibial osteotomy
5506190|NCT01269944|dGEMRIC|dgemric
5506191|NCT01269931|endobronchial ultrasound|endobronchial ultrasound
5506192|NCT01269931|bronchoscopy|bronchoscopy
5506193|NCT01269931|education|education
5506194|NCT01269931|interventional bronchoscopy|interventional bronchoscopy
5506195|NCT01269931|simulation|simulation
5506196|NCT01269918|Craniotomy, pain relief|craniotomy, pain relief
5506197|NCT01269918|Adult solid neoplasm|adult solid neoplasm
5506198|NCT01269892|diarrhea, lactose, milk, weight, acute.|diarrhea, lactose, milk, weight, acute.
5506199|NCT01269879|epicondylitis|epicondylitis
5506200|NCT01269879|pain|pain
5506201|NCT01269879|tendon|tendon
5506202|NCT01269866|Lupus Pain|lupus pain
5506203|NCT01269866|Lupus|lupus
5506204|NCT01269866|Pain|pain
5506205|NCT01269866|Systemic Lupus Erythematosus|systemic lupus erythematosus
5506206|NCT01269866|Duloxetine|duloxetine
5506207|NCT01269866|Cymbalta|cymbalta
5506208|NCT01269853|GBM|gbm
5506209|NCT01269853|AA|aa
5506210|NCT01269853|AO|ao
5506211|NCT01269853|Brain|brain
5506212|NCT01269853|Tumors|tumors
5506213|NCT01269853|Malignant|malignant
5506214|NCT01269853|Glioblastoma|glioblastoma
5506215|NCT01269853|Multiforme|multiforme
5506216|NCT01269853|Anaplastic|anaplastic
5506217|NCT01269853|Astrocytoma|astrocytoma
5506218|NCT01269827|inflammation|inflammation
5506219|NCT01269827|pentoxifylline|pentoxifylline
5506220|NCT01269827|hemodialysis|hemodialysis
5506221|NCT01269814|Gastrointestinal bleeding|gastrointestinal bleeding
5506222|NCT01269814|Emergency endoscopy|emergency endoscopy
5506223|NCT01269814|Rockall Risk Scoring System|rockall risk scoring system
5506224|NCT01269801|BOTOX|botox
5506225|NCT01269801|JUVEDERM|juvederm
5506226|NCT01269801|Prospective|prospective
5506227|NCT01269801|Open Label|open label
5506228|NCT01269801|Randomized|randomized
5506229|NCT01269801|Crossover Study|crossover study
5506230|NCT01269788|non-erosive reflux disease|non-erosive reflux disease
5506231|NCT01269788|heartburn|heartburn
5506232|NCT01269788|functional|functional
5506233|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
5506234|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors
5506235|NCT01269762|Red yeast rice|red yeast rice
5506236|NCT01269762|Lovastatin|lovastatin
5506237|NCT01269762|Drug-drug interaction|drug-drug interaction
5506238|NCT01269762|Pharmacokinetics|pharmacokinetics
5506239|NCT01269749|Hyperthyroidism|hyperthyroidism
5506240|NCT01269749|Antithyroid drugs|antithyroid drugs
5506241|NCT01269749|Cancer|cancer
5506242|NCT01269749|Dosimetry|dosimetry
5506243|NCT01269749|Children|children
5506244|NCT01269736|electrocardiographic monitoring|electrocardiographic monitoring
5506245|NCT01269736|arrhythmia|arrhythmia
5506246|NCT01269736|myocardial ischemia|myocardial ischemia
5506247|NCT01269723|Smoking|smoking
5506248|NCT01269723|influenza|influenza
5506249|NCT01269723|influenza vaccine|influenza vaccine
5506250|NCT01269710|Second Generation Antipsychotics|second generation antipsychotics
5506251|NCT01269710|Schizophrenia|schizophrenia
5506252|NCT01269710|Schizoaffective|schizoaffective
5506253|NCT01269710|Schizophreniform|schizophreniform
5506254|NCT01269710|Psychosis NOS|psychosis nos
5506255|NCT01269710|Mood Disorders|mood disorders
5506256|NCT01269710|Weight|weight
5506257|NCT01269710|Autism|autism
5506258|NCT01269697|AMD|amd
5506259|NCT01269697|food supplementation|food supplementation
5506260|NCT01269697|macular pigments|macular pigments
5506261|NCT01269697|luthéine|luthéine
5506262|NCT01269697|zéaxanthine|zéaxanthine
5506263|NCT01269697|visual acuity|visual acuity
5506264|NCT01269697|prevention|prevention
5506265|NCT01269697|genetique risk|genetique risk
5506266|NCT01269684|Kidney|kidney
5506267|NCT01269684|renal|renal
5506268|NCT01269684|transplantation|transplantation
5506269|NCT01269684|tacrolimus|tacrolimus
5506270|NCT01269684|everolimus|everolimus
5506271|NCT01269684|stable allograft recipients|stable allograft recipients
5506272|NCT01269671|Functional Abdominal Pain|functional abdominal pain
5506273|NCT01269671|Irritable Bowel Syndrome|irritable bowel syndrome
5506274|NCT01269671|IBS|ibs
5506275|NCT01269671|Functional Dyspepsia|functional dyspepsia
5506276|NCT01269671|Melatonin|melatonin
5506277|NCT01269671|Simethicone|simethicone
5506278|NCT01269671|Peppermint Oil|peppermint oil
5506279|NCT01269671|mentharil|mentharil
5506280|NCT01269671|functional bowel disorders|functional bowel disorders
5506281|NCT01269671|quality of life|quality of life
5506282|NCT01269645|Cancer|cancer
5506283|NCT01269645|Clinical trials|clinical trials
5506284|NCT01269632|teenagers to adult transition|teenagers to adult transition
5506285|NCT01269632|comparison|comparison
5506286|NCT01269619|back pain|back pain
5506287|NCT01269619|posture|posture
5506288|NCT01269619|lumbar support|lumbar support
5506289|NCT01269619|dynamic support|dynamic support
5506290|NCT01269593|PET Scan|pet scan
5506291|NCT01269593|124I-PUH71|124i-puh71
5506292|NCT01269593|10-139|10-139
5506293|NCT01269567|RectalNeoplasms|rectalneoplasms
5506294|NCT01269567|Colorectal Neoplasms|colorectal neoplasms
5506295|NCT01269567|Intestinal Neoplasms|intestinal neoplasms
5506296|NCT01269567|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5506297|NCT01269567|Digestive System Neoplasms|digestive system neoplasms
5506298|NCT01269567|Neoplasms by Site|neoplasms by site
5506299|NCT01269567|Digestive System Diseases|digestive system diseases
5506300|NCT01269567|Gastrointestinal Diseases|gastrointestinal diseases
5506301|NCT01269567|Intestinal Diseases|intestinal diseases
5506302|NCT01269567|Rectal Diseases|rectal diseases
5506303|NCT01269554|diarrhea|diarrhea
5506304|NCT01269554|Guinea-Bissau|guinea-bissau
5506305|NCT01269554|Finland|finland
5506306|NCT01269554|Children|children
5506307|NCT01269554|Adults|adults
5506308|NCT01269554|Intestinal pathogens|intestinal pathogens
5506309|NCT01269554|Bacteria|bacteria
5506310|NCT01269554|Virus|virus
5506311|NCT01269554|Parasites|parasites
5506312|NCT01269528|Palivizumab|palivizumab
5506313|NCT01269528|Airway Hyperreactivity|airway hyperreactivity
5506315|NCT01269528|MCT|mct
5506316|NCT01269515|Cox-2 inhibitor|cox-2 inhibitor
5506320|NCT01269515|progression markers|progression markers
5506321|NCT01269515|vaccine|vaccine
5506322|NCT01269489|quality of life|quality of life
5506323|NCT01269489|general Slovenian population|general slovenian population
5506324|NCT01269489|EORTC QLQ C30|eortc qlq c30
5506325|NCT01269463|Attention deficit|attention deficit
5506326|NCT01269463|Hyperactivity|hyperactivity
5506327|NCT01269463|Impulsivity|impulsivity
5506328|NCT01269463|Inattention|inattention
5685333|NCT00556504|add-on treatment|add-on treatment
5506329|NCT01269450|second trimester vaginal bleeding|second trimester vaginal bleeding
5506331|NCT01269450|preterm birth|preterm birth
5506332|NCT01269450|progesterone|progesterone
5506333|NCT01269437|mild to moderate asthma|mild to moderate asthma
5506334|NCT01269424|adult giant cell glioblastoma|adult giant cell glioblastoma
5506335|NCT01269424|adult glioblastoma|adult glioblastoma
5506336|NCT01269424|adult gliosarcoma|adult gliosarcoma
5506337|NCT01269385|Imprime PGG|imprime pgg
5506338|NCT01269372|polyps|polyps
5506339|NCT01269372|capsule endoscopy|capsule endoscopy
5506340|NCT01269372|colonoscopy|colonoscopy
5506341|NCT01269346|Locally recurrent|locally recurrent
5506342|NCT01269346|metastatic HER2Positive breast cancer|metastatic her2positive breast cancer
5506343|NCT01269307|Anesthesia|anesthesia
5506344|NCT01269307|Pain|pain
5506345|NCT01269307|Procedural sedation|procedural sedation
5506346|NCT01269307|Airway/Anesthesia/Analgesia|airway/anesthesia/analgesia
5506347|NCT01269294|Hepatitis C|hepatitis c
5506348|NCT01269294|TMC435-TiDP16-C117|tmc435-tidp16-c117
5506349|NCT01269294|TMC435-C117|tmc435-c117
5506350|NCT01269294|TMC435|tmc435
5506351|NCT01269294|HCV|hcv
5506352|NCT01269294|Moxifloxacin|moxifloxacin
5506353|NCT01269294|ECG|ecg
5506354|NCT01269294|QT|qt
5506355|NCT01269294|QTc|qtc
5506356|NCT01269281|Bioequivalence|bioequivalence
5506357|NCT01269281|two way crossover|two way crossover
5506358|NCT01269242|coronary restenosis|coronary restenosis
5506359|NCT01269242|angioplasty|angioplasty
5506360|NCT01269242|stent|stent
5506361|NCT01269242|MCP-1/CCL2|mcp-1/ccl2
5506362|NCT01269242|MCP-3/CCL7|mcp-3/ccl7
5506363|NCT01269203|multiple myeloma|multiple myeloma
5506364|NCT01269203|MM|mm
5506365|NCT01269203|maintenance therapy|maintenance therapy
5506366|NCT01269203|lenalidomide|lenalidomide
5506367|NCT01269203|bone marrow transplantation|bone marrow transplantation
5506368|NCT01269203|auto-HSCT|auto-hsct
5506369|NCT01269203|Autologous Hematopoietic Stem Cell Transplantation|autologous hematopoietic stem cell transplantation
5506370|NCT01269203|NF-kB inhibition|nf-kb inhibition
5506371|NCT01269203|reducing symptoms|reducing symptoms
5506372|NCT01269203|maintenance chemotherapy|maintenance chemotherapy
5506373|NCT01269203|inflammatory cytokines|inflammatory cytokines
5506374|NCT01269203|nuclear factor kappa B|nuclear factor kappa b
5506376|NCT01269203|interleukin|interleukin
5506377|NCT01269203|IL-6|il-6
5506378|NCT01269203|tumor necrosis factor|tumor necrosis factor
5506379|NCT01269203|TNF-a|tnf-a
5506380|NCT01269203|NF-kB activation levels|nf-kb activation levels
5506381|NCT01269177|ACPE|acpe
5506382|NCT01269177|Acute respiratory failure|acute respiratory failure
5506383|NCT01269177|Non invasive ventilation|non invasive ventilation
5506384|NCT01269177|acute cardiogenic pulmonary edema|acute cardiogenic pulmonary edema
5506385|NCT01269164|Face Transplant|face transplant
5506386|NCT01269164|Facial Transplantation|facial transplantation
5506387|NCT01269164|Composite Facial Allograft Transplantation|composite facial allograft transplantation
5506388|NCT01269151|Age-Related Macular Degeneration|age-related macular degeneration
5506389|NCT01269151|Retinal Function|retinal function
5506390|NCT01269151|multifocal-ERG|multifocal-erg
5506391|NCT01269151|Electroretinography|electroretinography
5506392|NCT01269151|microperimetry|microperimetry
5506393|NCT01269151|Lucentis|lucentis
5506394|NCT01269151|Ranibizumab|ranibizumab
5506395|NCT01269151|longterm effects|longterm effects
5506396|NCT01269151|best corrected visual acuity|best corrected visual acuity
5506397|NCT01269151|BCVA|bcva
5506398|NCT01269138|Inherited Factor VII deficiency|inherited factor vii deficiency
5506399|NCT01269138|Inhibitor development in Factor VII deficiency|inhibitor development in factor vii deficiency
5506400|NCT01269138|Bleeding in Factor VII Deficiency|bleeding in factor vii deficiency
5506401|NCT01269138|Surgery in Factor VII deficiency|surgery in factor vii deficiency
5506402|NCT01269138|Prophylaxis in Factor VII Deficiency|prophylaxis in factor vii deficiency
5506403|NCT01269125|cytokines|cytokines
5506404|NCT01269125|endometriosis|endometriosis
5506405|NCT01269125|fertilization rate|fertilization rate
5506406|NCT01269125|follicular fluid|follicular fluid
5506407|NCT01269125|pregnancy rate|pregnancy rate
5506408|NCT01269099|hypokalemia|hypokalemia
5506409|NCT01269099|intravenous patient controlled analgesia|intravenous patient controlled analgesia
5506410|NCT01269086|Primary Heath Care|primary heath care
5506411|NCT01269086|Preventive Medicine|preventive medicine
5506412|NCT01269086|Adolescent Health Services|adolescent health services
5506414|NCT01269086|Family|family
5506415|NCT01269086|Family Practice|family practice
5506416|NCT01269073|Obstructive Sleep Apnea|obstructive sleep apnea
5506417|NCT01269060|Colorectal Cancer, laparoscopic surgery|colorectal cancer, laparoscopic surgery
5506418|NCT01269047|type 1 diabetes|type 1 diabetes
5506419|NCT01269047|Symlin|symlin
5506420|NCT01269047|Byetta|byetta
5506421|NCT01269047|CGMS iPro|cgms ipro
5506422|NCT01269034|Type 1 diabetes Milletus|type 1 diabetes milletus
5506423|NCT01269034|diabetes|diabetes
5506424|NCT01269034|healthy controls|healthy controls
5506425|NCT01269034|exenatide|exenatide
5506426|NCT01269034|byetta|byetta
5506427|NCT01269021|MMF treatment IgA Nephropathy (IgAN)|mmf treatment iga nephropathy (igan)
5506428|NCT01269008|Closed loop|closed loop
5506429|NCT01269008|type 1 diabetes|type 1 diabetes
5506430|NCT01269008|Symlin|symlin
5506431|NCT01269008|Byetta|byetta
5506432|NCT01269008|diabetes|diabetes
5506433|NCT01269008|insulin|insulin
5506434|NCT01269008|insulin pump|insulin pump
5506435|NCT01268995|NODAT|nodat
5506436|NCT01268995|kidney transplantation|kidney transplantation
5506437|NCT01268995|beta cell function|beta cell function
5506438|NCT01268995|insulin|insulin
5506439|NCT01268995|Tacrolimus|tacrolimus
5506440|NCT01268995|Cyclosporine A|cyclosporine a
5506441|NCT01268982|socket preservation|socket preservation
5506442|NCT01268982|alveolar ridge augmentation|alveolar ridge augmentation
5506443|NCT01268969|pilonidal disease PND|pilonidal disease pnd
5506444|NCT01268943|rectal neoplasms|rectal neoplasms
5506445|NCT01268943|aged|aged
5506446|NCT01268943|radiotherapy|radiotherapy
5506447|NCT01268943|drug therapy|drug therapy
5506448|NCT01268943|dose-escalation|dose-escalation
5506449|NCT01268943|capecitabine|capecitabine
5506450|NCT01268930|ovarian reserve|ovarian reserve
5506451|NCT01268930|endometrioma excision|endometrioma excision
5506452|NCT01268930|hemostatic matrix|hemostatic matrix
5506453|NCT01268930|bipolar electrocoagulation|bipolar electrocoagulation
5506454|NCT01268930|thermal injury|thermal injury
5506455|NCT01268917|coronary artery disease|coronary artery disease
5506456|NCT01268917|off-pump coronary artery bypass|off-pump coronary artery bypass
5506457|NCT01268917|aspirin|aspirin
5506458|NCT01268891|Azilect|azilect
5506459|NCT01268891|Motor fluctuations|motor fluctuations
5506460|NCT01268891|Parkinson´s Disease|parkinson´s disease
5506461|NCT01268891|Rasagiline|rasagiline
5506462|NCT01268878|effect of febrile neutropenia resulting chemotherapy by TPF|effect of febrile neutropenia resulting chemotherapy by tpf
5506463|NCT01268865|Acoustic Radiation Force Impulse (ARFI)|acoustic radiation force impulse (arfi)
5506464|NCT01268865|Virtual Touch Quantification (VTQ)|virtual touch quantification (vtq)
5506465|NCT01268865|liver stiffness measurement (LSM)|liver stiffness measurement (lsm)
5506466|NCT01268865|liver fibrosis|liver fibrosis
5506467|NCT01268865|cirrhosis|cirrhosis
5506468|NCT01268865|hepatitis B|hepatitis b
5506469|NCT01268865|hepatitis C|hepatitis c
5500726|NCT01292980|sDTI|sdti
5506470|NCT01268839|TMC278, rilpivirine, efavirenz, healthy volunteer|tmc278, rilpivirine, efavirenz, healthy volunteer
5506473|NCT01268761|Ovarian hyperstimulation syndrome (OHSS)|ovarian hyperstimulation syndrome (ohss)
5506474|NCT01268761|GnRH antagonist|gnrh antagonist
5506475|NCT01268761|Ascitis.|ascitis.
5506476|NCT01268748|single site surgery|single site surgery
5506477|NCT01268748|laparoscopic surgery|laparoscopic surgery
5506478|NCT01268748|pain|pain
5506479|NCT01268748|nausea|nausea
5506480|NCT01268735|Dysfunctional Tear Syndrome|dysfunctional tear syndrome
5506481|NCT01268735|Dry Eye|dry eye
5506482|NCT01268735|LIPCOF|lipcof
5506483|NCT01268735|Hydroxypropyl-guar|hydroxypropyl-guar
5506484|NCT01268722|Nitinol Stent|nitinol stent
5506485|NCT01268722|Balloon angioplasty|balloon angioplasty
5506486|NCT01268722|Chronic total occlusions|chronic total occlusions
5506487|NCT01268722|Femoropopliteal|femoropopliteal
5506488|NCT01268696|diabetes|diabetes
5506489|NCT01268696|obesity|obesity
5506490|NCT01268696|hypertension|hypertension
5506491|NCT01268696|dyslipidemia|dyslipidemia
5506492|NCT01268683|Ischemic stroke|ischemic stroke
5506494|NCT01268657|Fear of Falling|fear of falling
5506495|NCT01268657|Older Adults|older adults
5506496|NCT01268657|Injurious Falls|injurious falls
5506497|NCT01268657|Exposure Therapy|exposure therapy
5506498|NCT01268644|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5506499|NCT01268631|Fibromyalgia|fibromyalgia
5506500|NCT01268631|Pain modulation|pain modulation
5506501|NCT01268618|IBS|ibs
5506502|NCT01268618|Diarrhea|diarrhea
5506503|NCT01268618|Dyspepsia|dyspepsia
5506504|NCT01268605|Dental caries|dental caries
5506505|NCT01268605|Resin based composite|resin based composite
5506506|NCT01268605|Hypersensitivity|hypersensitivity
5506507|NCT01268605|Teeth|teeth
5506508|NCT01268605|Dentistry|dentistry
5506509|NCT01268605|Practice-based research network|practice-based research network
5506510|NCT01268592|fertility preservation|fertility preservation
5506511|NCT01268592|oocyte cryopreservation|oocyte cryopreservation
5506512|NCT01268592|vitrification|vitrification
5506513|NCT01268592|egg freezing|egg freezing
5506514|NCT01268592|fertility preservation in female cancer patients|fertility preservation in female cancer patients
5506515|NCT01268579|ribavirin|ribavirin
5506516|NCT01268579|VIRAZOLE|virazole
5506517|NCT01268579|tonsil|tonsil
5506518|NCT01268579|base of tongue|base of tongue
5506519|NCT01268579|squamous cell carcinoma|squamous cell carcinoma
5506520|NCT01268579|10-218|10-218
5506521|NCT01268566|Glioblastoma|glioblastoma
5506522|NCT01268553|pulmonary arterial hypertension|pulmonary arterial hypertension
5506523|NCT01268553|inhaled prostacyclin|inhaled prostacyclin
5506524|NCT01268540|intraocular lens|intraocular lens
5506525|NCT01268540|IOL|iol
5506526|NCT01268540|cataract|cataract
5506527|NCT01268540|refractive astigmatism|refractive astigmatism
5506528|NCT01268540|Aspheric|aspheric
5506529|NCT01268540|Toric|toric
5506530|NCT01268540|Hoya|hoya
5506531|NCT01268540|Surgical|surgical
5506532|NCT01268540|Optics|optics
5506533|NCT01268540|visual acuity|visual acuity
5506534|NCT01268527|Psoriasis vulgaris|psoriasis vulgaris
5506535|NCT01268514|Complex|complex
5506536|NCT01268514|Abdominal Wall Reconstruction|abdominal wall reconstruction
5506537|NCT01268514|AWR|awr
5506538|NCT01268514|Hernia|hernia
5506539|NCT01268475|Bronchiectasis|bronchiectasis
5506540|NCT01268475|Quality of Life|quality of life
5506541|NCT01268475|Respiratory Function Tests|respiratory function tests
5506542|NCT01268475|Exercise Test|exercise test
5506543|NCT01268449|Tinnitus|tinnitus
5506544|NCT01268449|Low power laser|low power laser
5506545|NCT01268423|Percutaneous tracheostomy|percutaneous tracheostomy
5506546|NCT01268423|Swallowing dysfunction|swallowing dysfunction
5506547|NCT01268423|Mechanical ventilation|mechanical ventilation
5506548|NCT01268423|Intensive Care|intensive care
5506549|NCT01268410|Acute respiratory failure|acute respiratory failure
5506550|NCT01268410|Acute lung injury|acute lung injury
5506551|NCT01268410|Acute respiratory distress syndrome|acute respiratory distress syndrome
5506552|NCT01268410|Mechanical Ventilation|mechanical ventilation
5506553|NCT01268410|Non-Invasive Ventilation|non-invasive ventilation
5506554|NCT01268397|elderly|elderly
5506555|NCT01268397|wrist fracture|wrist fracture
5506556|NCT01268397|fracture of the distal radius|fracture of the distal radius
5506557|NCT01268397|volar plate|volar plate
5506558|NCT01268397|plaster cast|plaster cast
5506559|NCT01268384|pancreatic cancer|pancreatic cancer
5506560|NCT01268384|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5506561|NCT01268384|gemcitabine|gemcitabine
5506562|NCT01268384|capecitabine|capecitabine
5506563|NCT01268371|Coronary artery disease|coronary artery disease
5506564|NCT01268371|Stent|stent
5506565|NCT01268345|blood glucose|blood glucose
5506566|NCT01268332|Placebo IVR as a delivery method|placebo ivr as a delivery method
5506567|NCT01268319|Myocardial Infarction|myocardial infarction
5506568|NCT01268319|percutaneous coronary intervention|percutaneous coronary intervention
5506569|NCT01268319|embolization|embolization
5506570|NCT01268319|necrotic core|necrotic core
5506571|NCT01268319|vulnerable plaque|vulnerable plaque
5506572|NCT01268319|coronary plaque rupture|coronary plaque rupture
5506573|NCT01268306|contact lens|contact lens
5506574|NCT01268306|corneal staining|corneal staining
5506575|NCT01268306|fluorescein staining|fluorescein staining
5506576|NCT01268306|preservatives|preservatives
5506577|NCT01268306|keratitis|keratitis
5506578|NCT01268306|punctate keratopathy|punctate keratopathy
5506579|NCT01268306|superficial punctate keratopathy|superficial punctate keratopathy
5506581|NCT01268293|Cancer|cancer
5506582|NCT01268254|wine|wine
5506583|NCT01268254|aging|aging
5506584|NCT01268254|atherosclerosis|atherosclerosis
5506585|NCT01268254|telomere|telomere
5506586|NCT01268254|tomography|tomography
5506587|NCT01268254|coronary vessels|coronary vessels
5506588|NCT01268241|Fabry Disease|fabry disease
5506589|NCT01268241|Fabry´s Disease|fabry´s disease
5506590|NCT01268241|Anderson-Fabry Disease|anderson-fabry disease
5506591|NCT01268228|intracoronary ECG|intracoronary ecg
5506592|NCT01268228|coronary bifurcation stenosis|coronary bifurcation stenosis
5506593|NCT01268228|side branch compromise|side branch compromise
5506691|NCT01267734|Zotarolimus|zotarolimus
5506594|NCT01268228|Periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ECG|periprocedural myonecrosis during coronary bifurcation lesion stenting assessed with ic ecg
5506595|NCT01268215|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5506596|NCT01268215|Budesonide|budesonide
5506597|NCT01268215|Infasurf|infasurf
5506598|NCT01268202|cutaneous radioinduced fibrosis|cutaneous radioinduced fibrosis
5506599|NCT01268189|burn wound|burn wound
5506600|NCT01268189|management with oxygen|management with oxygen
5506601|NCT01268176|Vitamin D|vitamin d
5506602|NCT01268176|vitamin D deficiency|vitamin d deficiency
5506603|NCT01268176|vitamin D absorption|vitamin d absorption
5506604|NCT01268163|Docetaxel|docetaxel
5506606|NCT01268163|Pharmacokinetic|pharmacokinetic
5506607|NCT01268163|Bioequivalence|bioequivalence
5506608|NCT01268137|MDD|mdd
5506609|NCT01268137|DBS|dbs
5506610|NCT01268124|Japanese|japanese
5506611|NCT01268111|vitamin D deficiency, insulin sensitivity|vitamin d deficiency, insulin sensitivity
5846759|NCT00043511|Vaccines, DNA|vaccines, dna
5506612|NCT01268098|Hypoparathyroidism, rhPTH[1-84], NPSP558|hypoparathyroidism, rhpth[1-84], npsp558
5506613|NCT01268085|Radiation Safety|radiation safety
5506614|NCT01268085|Computerized Physician Order Entry|computerized physician order entry
5506615|NCT01268085|Decision Support|decision support
5506616|NCT01268085|Cat Scans|cat scans
5506617|NCT01268072|COPD|copd
5506618|NCT01268059|Non-small cell lung cancer|non-small cell lung cancer
5506619|NCT01268059|NSCLC|nsclc
5506621|NCT01268046|postmenopausal women|postmenopausal women
5506622|NCT01268046|estrogen|estrogen
5506623|NCT01268046|memory|memory
5506624|NCT01268033|rituximab|rituximab
5506625|NCT01268033|idiopathic nephrotic syndrome|idiopathic nephrotic syndrome
5506626|NCT01268033|minimal change disease|minimal change disease
5506627|NCT01268033|focal and segmental glomerulosclerosis|focal and segmental glomerulosclerosis
5506628|NCT01268020|Alzheimer|alzheimer
5506629|NCT01268020|AD|ad
5506630|NCT01267994|Steroid|steroid
5506631|NCT01267994|Steroid-Resistant|steroid-resistant
5488717|NCT01342627|Sorafenib|sorafenib
5506632|NCT01267994|Autoimmune Inner Ear Disease|autoimmune inner ear disease
5506633|NCT01267994|Immune Mediated Hearing Loss|immune mediated hearing loss
5506634|NCT01267994|Sudden Sensorineural Hearing Loss|sudden sensorineural hearing loss
5506635|NCT01267994|Meniere's Disease|meniere's disease
5506636|NCT01267994|Autoimmune|autoimmune
5506637|NCT01267994|Hearing|hearing
5506638|NCT01267981|Small bowel|small bowel
5506639|NCT01267981|video-capsule endoscopy|video-capsule endoscopy
5506640|NCT01267981|gastrointestinal bleeding|gastrointestinal bleeding
5506641|NCT01267981|polyethylene glycol|polyethylene glycol
5506642|NCT01267968|pharmacokinetics|pharmacokinetics
5506643|NCT01267968|bronchoalveolar lavage|bronchoalveolar lavage
5506644|NCT01267968|GSK2251052|gsk2251052
5506645|NCT01267968|pulmonary|pulmonary
5506646|NCT01267968|healthy volunteer|healthy volunteer
5506647|NCT01267968|antimicrobial|antimicrobial
5506648|NCT01267942|Adenotonsillectomy.|adenotonsillectomy.
5506649|NCT01267929|Children with cerebral palsy|children with cerebral palsy
5506650|NCT01267929|Gross Motor Function Measure|gross motor function measure
5506651|NCT01267929|Imitative learning|imitative learning
5506652|NCT01267929|Mirror neuron|mirror neuron
5506653|NCT01267929|Action observation|action observation
5506654|NCT01267929|Conventional physical therapy|conventional physical therapy
5506655|NCT01267916|intrinsic positive end-expiratory pressure|intrinsic positive end-expiratory pressure
5506656|NCT01267916|obesity|obesity
5506657|NCT01267916|ventilator setting|ventilator setting
5506658|NCT01267916|respiratory rate|respiratory rate
5506659|NCT01267903|Vaccines Adverse Reaction|vaccines adverse reaction
5506660|NCT01267890|ethics|ethics
5506661|NCT01267890|law|law
5506662|NCT01267890|surrogate|surrogate
5506663|NCT01267890|conflict|conflict
5506664|NCT01267877|U.S. Preventive Services Task Force|u.s. preventive services task force
5506665|NCT01267877|Patient attitude|patient attitude
5506666|NCT01267877|Mammogram|mammogram
5506667|NCT01267877|Guideline|guideline
5506668|NCT01267864|migraine|migraine
5506669|NCT01267864|emergency|emergency
5506671|NCT01267864|ketorolac|ketorolac
5506672|NCT01267864|valproate|valproate
5506673|NCT01267851|gynecologic disease|gynecologic disease
5506674|NCT01267838|Coronary artery disease|coronary artery disease
5506675|NCT01267838|Restenosis|restenosis
5506676|NCT01267838|Stent thrombosis|stent thrombosis
5506677|NCT01267825|Disc herniation|disc herniation
5506678|NCT01267825|Lumbosacral radiculopathy|lumbosacral radiculopathy
5506679|NCT01267825|Corticosteroids|corticosteroids
5506680|NCT01267786|Oxidotic stress|oxidotic stress
5506681|NCT01267773|depression|depression
5506682|NCT01267773|conduct problems|conduct problems
5506683|NCT01267760|dialysis|dialysis
5506684|NCT01267760|hemodialysis|hemodialysis
5506685|NCT01267760|Effect of recycled low-volume dialysate on dialysis efficacy|effect of recycled low-volume dialysate on dialysis efficacy
5506686|NCT01267747|Atrial fibrillation|atrial fibrillation
5506687|NCT01267747|Atrial Flutter|atrial flutter
5506688|NCT01267747|Primary Aldosteronism|primary aldosteronism
5506689|NCT01267747|Aldosterone Producing Adenoma|aldosterone producing adenoma
5506690|NCT01267734|Everolimus|everolimus
5506692|NCT01267734|Cilostazol|cilostazol
5506693|NCT01267734|Clopidogrel|clopidogrel
5506694|NCT01267721|heart surgery|heart surgery
5506695|NCT01267695|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5506696|NCT01267695|Imatinib mesylate|imatinib mesylate
5506697|NCT01267695|Perioperative therapy|perioperative therapy
5506698|NCT01267682|Delirium|delirium
5506699|NCT01267682|Dementia|dementia
5506700|NCT01267682|Non-pharmacological Intervention|non-pharmacological intervention
5506701|NCT01267682|Post-acute care|post-acute care
5506702|NCT01267669|Variceal bleeding|variceal bleeding
5506703|NCT01267669|Endoscopic therapy|endoscopic therapy
5506704|NCT01267669|Band ligation|band ligation
5506705|NCT01267669|Somatostatin|somatostatin
5506706|NCT01267669|Vasoactive drugs|vasoactive drugs
5506707|NCT01267669|Octreotide|octreotide
5506708|NCT01267643|Alefacept|alefacept
5506709|NCT01267643|Amevive|amevive
5506710|NCT01267643|Aplastic Anemia|aplastic anemia
5506711|NCT01267643|Moderate to Severe Aplastic Anemia|moderate to severe aplastic anemia
5506712|NCT01267630|Delirium of Mixed Origin|delirium of mixed origin
5506713|NCT01267630|Subacute Delirium|subacute delirium
5506714|NCT01267630|Mental Disorders, Organic|mental disorders, organic
5506715|NCT01267630|Organic Brain Syndrome, Nonpsychotic|organic brain syndrome, nonpsychotic
5506716|NCT01267630|Organic Mental Disorders|organic mental disorders
5506717|NCT01267630|Organic Mental Disorders, Psychotic|organic mental disorders, psychotic
5506718|NCT01267630|Psychoses, Traumatic|psychoses, traumatic
5506719|NCT01267630|Cognition Disorder|cognition disorder
5506720|NCT01267630|Confusion state|confusion state
5506723|NCT01267617|hypotension|hypotension
5506724|NCT01267617|circulatory stress|circulatory stress
5506725|NCT01267617|photo-plethysmography|photo-plethysmography
5506726|NCT01267578|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
5506727|NCT01267565|ventilator-acquired pneumonia|ventilator-acquired pneumonia
5506728|NCT01267565|prevention|prevention
5506730|NCT01267565|tracheal aspiration|tracheal aspiration
5506731|NCT01267565|microaspiration|microaspiration
5506732|NCT01267552|Breast cancer|breast cancer
5506733|NCT01267552|Surgery|surgery
5506734|NCT01267552|Complications|complications
5506735|NCT01267552|Drainage|drainage
5506736|NCT01267552|Seroma|seroma
5506737|NCT01267539|Suan Zao Ren Tang, climacteric, PSQI, WHOQOL-BREF|suan zao ren tang, climacteric, psqi, whoqol-bref
5506738|NCT01267526|Growth disorders|growth disorders
5506739|NCT01267526|Saizen|saizen
5506740|NCT01267526|Easypod|easypod
5506741|NCT01267526|Growth hormone|growth hormone
5506742|NCT01267526|Pediatric subject|pediatric subject
5506743|NCT01267513|oxygen saturation|oxygen saturation
5506744|NCT01267513|pulse rate|pulse rate
5506745|NCT01267513|tachycardia|tachycardia
5506746|NCT01267513|bradycardia|bradycardia
5506747|NCT01267513|hypoxia|hypoxia
5506748|NCT01267487|Heparin|heparin
5506749|NCT01267487|Protamine|protamine
5506750|NCT01267487|Cardiopulmonary Bypass|cardiopulmonary bypass
5506751|NCT01267487|Titration|titration
5506752|NCT01267474|School children|school children
5506753|NCT01267474|Sugar intake|sugar intake
5506754|NCT01267474|Nutritional education program|nutritional education program
5506755|NCT01267461|To asses the biological actions of insulin analogs in primary tumor cells|to asses the biological actions of insulin analogs in primary tumor cells
5506756|NCT01267448|Diabetes Mellitus Type2.|diabetes mellitus type2.
5506757|NCT01267448|Severe Hyperglycemia - blood glucose levels >300mg/dl.|severe hyperglycemia - blood glucose levels >300mg/dl.
5506758|NCT01267435|Arthroscopy, Anterior Cruciate Ligament, Tibial Tunnel.|arthroscopy, anterior cruciate ligament, tibial tunnel.
5506759|NCT01267422|Leber's Hereditary Optic Neuropathy,11778 LHON mutation,|leber's hereditary optic neuropathy,11778 lhon mutation,
5506760|NCT01267422|rAAV2-ND4,triamcinolone acetonide|raav2-nd4,triamcinolone acetonide
5506761|NCT01267409|Mapping the emotional territories of the STN|mapping the emotional territories of the stn
5789049|NCT00150124|antithyroid drugs|antithyroid drugs
5506762|NCT01267409|Identifying the emotional spectral signature of the STN single unit activity|identifying the emotional spectral signature of the stn single unit activity
5506763|NCT01267409|Manipulating emotional processing of PD patients by high and low frequency stimulation|manipulating emotional processing of pd patients by high and low frequency stimulation
5506764|NCT01267409|Affecting long-term emotional states of the PD patients|affecting long-term emotional states of the pd patients
5506765|NCT01267396|Bioequivalence|bioequivalence
5506766|NCT01267396|Sertraline|sertraline
5506767|NCT01267396|crossover|crossover
5506768|NCT01267383|Bioequivalence|bioequivalence
5506769|NCT01267383|Sertraline|sertraline
5506770|NCT01267383|crossover|crossover
5506771|NCT01267370|clinical trial|clinical trial
5506772|NCT01267370|dietary fiber|dietary fiber
5506773|NCT01267370|constipation|constipation
5506774|NCT01267370|children|children
5506775|NCT01267357|Serous Papillary Endometrial Cancer|serous papillary endometrial cancer
5506776|NCT01267357|Endometrioid endometrial cancer|endometrioid endometrial cancer
5506777|NCT01267357|biomarkers|biomarkers
5506778|NCT01267357|P16|p16
5506779|NCT01267357|P53|p53
5506780|NCT01267357|Prognosis|prognosis
5506781|NCT01267344|biliary tract cancer|biliary tract cancer
5506782|NCT01267344|BTC|btc
5506783|NCT01267344|cetuximaba|cetuximaba
5506784|NCT01267331|Old Myocardial Infarction|old myocardial infarction
5506785|NCT01267331|Stem Cell Therapy|stem cell therapy
5506786|NCT01267331|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5506787|NCT01267331|Coronary Artery Disease|coronary artery disease
5506788|NCT01267318|Gastric juice|gastric juice
5506789|NCT01267318|Stomach|stomach
5506790|NCT01267318|GI|gi
5506791|NCT01267318|Gastric juice samples with presence of blood.|gastric juice samples with presence of blood.
5506792|NCT01267305|esophagectomy|esophagectomy
5506793|NCT01267305|lung resection|lung resection
5506794|NCT01267305|venous thromboembolism|venous thromboembolism
5506795|NCT01267305|low molecular weight heparin|low molecular weight heparin
5506796|NCT01267305|chest drainage|chest drainage
5506797|NCT01267305|TEG|teg
5506798|NCT01267292|cocaine dependence|cocaine dependence
5506799|NCT01267292|psychopharmacology|psychopharmacology
5506800|NCT01267292|attentional bias|attentional bias
5506801|NCT01267292|risky decision making|risky decision making
5506802|NCT01267292|buspirone|buspirone
5506803|NCT01267292|methylphenidate|methylphenidate
5506804|NCT01267227|Hyperlipidemia|hyperlipidemia
5506805|NCT01267227|Cholesterol|cholesterol
5506806|NCT01267227|Blood Pressure|blood pressure
5506807|NCT01267227|Oxidative Stress|oxidative stress
5506808|NCT01267227|Pterostilbene|pterostilbene
5506809|NCT01267227|Blueberry|blueberry
5506810|NCT01267227|Grape Extract|grape extract
5506811|NCT01267201|Single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/mL) versus methylprednisolone tablet (32 mg)|single dose bioavailability study of methylprednisolone powder for oral suspension (4mg/ml) versus methylprednisolone tablet (32 mg)
5506812|NCT01267162|CHB|chb
5506813|NCT01267149|superficial vertical perioral lines|superficial vertical perioral lines
5506814|NCT01267149|superficial horizontal and lateral canthal lines|superficial horizontal and lateral canthal lines
5506815|NCT01267149|correct moderate to severe facial wrinkles and folds|correct moderate to severe facial wrinkles and folds
5506816|NCT01267136|Tonsillectomy|tonsillectomy
5506817|NCT01267136|Pain|pain
5506818|NCT01267136|Pediatric|pediatric
5506819|NCT01267136|Opioids|opioids
5506820|NCT01267136|Tramadol|tramadol
5506821|NCT01267136|Codeine|codeine
5506822|NCT01267097|Pediatric Obesity|pediatric obesity
5506823|NCT01267097|Treatment|treatment
5506824|NCT01267097|Cognitive Behavioural Therapy|cognitive behavioural therapy
5506825|NCT01267097|Psychoeducation|psychoeducation
5506826|NCT01267097|Canada|canada
5506827|NCT01267084|Trabectedin (YONDELIS)|trabectedin (yondelis)
5506828|NCT01267084|Ketoconazole|ketoconazole
5506829|NCT01267084|Antineoplastic Agents|antineoplastic agents
5506830|NCT01267084|Solid tumors|solid tumors
5506831|NCT01267084|Locally advanced or metastatic disease|locally advanced or metastatic disease
5506832|NCT01267084|Chemotherapy|chemotherapy
5506833|NCT01267084|Pharmacokinetics|pharmacokinetics
5506834|NCT01267071|Entero-test|entero-test
5506835|NCT01267071|Phase I|phase i
5506836|NCT01267071|GSK962040|gsk962040
5506837|NCT01267071|i.v. microtracer|i.v. microtracer
5506838|NCT01267071|radioactivity|radioactivity
5506839|NCT01267071|pharmacokinetics|pharmacokinetics
5506840|NCT01267071|healthy volunteer|healthy volunteer
5506841|NCT01267058|Booster vaccination|booster vaccination
5506842|NCT01267045|Persian Gulf Syndrome|persian gulf syndrome
5506843|NCT01267045|Pain|pain
5506844|NCT01267045|Fatigue|fatigue
5506845|NCT01267045|Attention|attention
5506846|NCT01267045|Meditation|meditation
5506847|NCT01267019|social cognition|social cognition
5506848|NCT01267019|training intervention|training intervention
5506849|NCT01266993|Immunogenicity|immunogenicity
5506850|NCT01266993|Persistence|persistence
5506851|NCT01266993|Safety|safety
5506852|NCT01266993|Conjugate vaccine|conjugate vaccine
5506853|NCT01266993|Meningococcal vaccine|meningococcal vaccine
5506854|NCT01266980|cortisol|cortisol
5506855|NCT01266980|renal impairment|renal impairment
5506856|NCT01266980|serum potassium|serum potassium
5506857|NCT01266980|pharmacokinetics|pharmacokinetics
5506858|NCT01266980|Fluticasone furoate|fluticasone furoate
5506859|NCT01266980|heart rate|heart rate
5506860|NCT01266967|GSK2118436|gsk2118436
5506861|NCT01266967|Metastatic melanoma to the brain|metastatic melanoma to the brain
5506862|NCT01266967|Brain metastases|brain metastases
5506863|NCT01266967|Braf mutation|braf mutation
5506864|NCT01266967|Brain neoplasm|brain neoplasm
5506865|NCT01266967|BRAF inhibitor|braf inhibitor
5506866|NCT01266954|Cancer|cancer
5506867|NCT01266954|18F FDG|18f fdg
5506870|NCT01266954|Positron Emission Tomography|positron emission tomography
5506872|NCT01266954|AKT Inhibitor|akt inhibitor
5506873|NCT01266954|GSK2141795|gsk2141795
5506874|NCT01266941|pharmacokinetics|pharmacokinetics
5506875|NCT01266941|hepatic impairment|hepatic impairment
5506876|NCT01266941|heart rate|heart rate
5506877|NCT01266941|serum potassium|serum potassium
5506878|NCT01266941|serum cortisol|serum cortisol
5506879|NCT01266941|GW642444M|gw642444m
5506880|NCT01266941|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
5506881|NCT01266915|SCLE|scle
5506882|NCT01266915|CLE|cle
5506883|NCT01266915|DLE|dle
5506913|NCT01266785|crohn's|crohn's
5506914|NCT01266785|Infliximab|infliximab
5506915|NCT01266785|Inflammatory bowel disease|inflammatory bowel disease
5506916|NCT01266785|digestive tract|digestive tract
5506917|NCT01266785|Interleukin|interleukin
5506918|NCT01266772|asthma; children; montelukast; treatment; exacerbation|asthma; children; montelukast; treatment; exacerbation
5506919|NCT01266759|Menorrhagia|menorrhagia
5506920|NCT01266759|Vaginal ring|vaginal ring
5506921|NCT01266759|Norethisterone Acetate|norethisterone acetate
5506922|NCT01266746|gas tamponade,|gas tamponade,
5506923|NCT01266746|macular hole,|macular hole,
5506924|NCT01266746|macular hole retinal detachment,|macular hole retinal detachment,
5506925|NCT01266746|optical coherence tomography|optical coherence tomography
5506926|NCT01266733|fibromyalgia, non pharmacological intervention|fibromyalgia, non pharmacological intervention
5506927|NCT01266720|pancreatic cancer|pancreatic cancer
5506928|NCT01266720|peptide vaccine|peptide vaccine
5506929|NCT01266720|VEGFR|vegfr
5506930|NCT01266720|gemcitabine|gemcitabine
5506931|NCT01266707|Hepatocellular carcinoma|hepatocellular carcinoma
5506932|NCT01266707|peptide vaccine|peptide vaccine
5506933|NCT01266707|VEGFR|vegfr
5506934|NCT01266694|Pericardial effusion|pericardial effusion
5506935|NCT01266694|Cardiac surgery|cardiac surgery
5506936|NCT01266694|Tamponade|tamponade
5506937|NCT01266694|colchicine|colchicine
5506938|NCT01266668|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5506939|NCT01266668|Breast|breast
5506940|NCT01266668|Rituximab|rituximab
5506941|NCT01266642|Breast cancer|breast cancer
5506942|NCT01266642|Early invasive breast cancer|early invasive breast cancer
5506943|NCT01266642|Ductal carcinoma in situ of the breast|ductal carcinoma in situ of the breast
5506944|NCT01266642|Tis|tis
5506945|NCT01266642|T1|t1
5506946|NCT01266642|T2|t2
5506947|NCT01266642|N0|n0
5506948|NCT01266642|N1mic|n1mic
5506949|NCT01266642|N1a|n1a
5506950|NCT01266642|Lumpectomy|lumpectomy
5506951|NCT01266642|Hypofractionated whole breast irradiation|hypofractionated whole breast irradiation
5506952|NCT01266642|HF-WBI|hf-wbi
5506953|NCT01266642|Conventionally fractionated whole breast irradiation|conventionally fractionated whole breast irradiation
5506954|NCT01266642|CF-WBI|cf-wbi
5506955|NCT01266642|Radiation therapy|radiation therapy
5506956|NCT01266642|Radiotherapy|radiotherapy
5506957|NCT01266629|small bowel|small bowel
5506958|NCT01266616|Interleukin-12|interleukin-12
5506959|NCT01266616|Electroporation|electroporation
5506960|NCT01266616|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5506980|NCT01266551|Antireflux procedure|antireflux procedure
5506981|NCT01266551|Gastroesophageal reflux|gastroesophageal reflux
5506982|NCT01266551|Infant sleep position|infant sleep position
5506983|NCT01266551|pH monitoring|ph monitoring
5506984|NCT01266499|Klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant Klebsiella (KPC), eradication,|klebsiella , pneumonia, carbapenem-hydrolyzing lactamase, carbapenem-resistant klebsiella (kpc), eradication,
5506985|NCT01266486|Breast cancer|breast cancer
5506986|NCT01266486|Pharmacodynamics|pharmacodynamics
5506987|NCT01266486|AMPK|ampk
5506988|NCT01266486|PET Scan|pet scan
5506989|NCT01266473|Adults|adults
5506990|NCT01266434|moderate persistent asthma|moderate persistent asthma
5663901|NCT00646048|AAA|aaa
5506991|NCT01266434|Inhaled corticosteroids|inhaled corticosteroids
5506992|NCT01266421|DNG|dng
5506993|NCT01266421|Anemia|anemia
5506994|NCT01266421|Depression|depression
5506995|NCT01266408|Drospirenone|drospirenone
5506996|NCT01266408|Dienogest|dienogest
5506997|NCT01266408|Metafolin|metafolin
5506998|NCT01266408|Folic acid|folic acid
5506999|NCT01266408|Safety|safety
5507000|NCT01266395|morning symptoms COPD|morning symptoms copd
5507001|NCT01266369|mastocytosis|mastocytosis
5507002|NCT01266369|D816V|d816v
5507003|NCT01266369|handicaps|handicaps
5507004|NCT01266356|Minor Traumatic Brain Injury|minor traumatic brain injury
5507005|NCT01266356|Translation|translation
5507006|NCT01266343|Glaucoma|glaucoma
5507009|NCT01266330|dairy|dairy
5507010|NCT01266330|inflammation|inflammation
5507011|NCT01266330|reactive oxygen species|reactive oxygen species
5507012|NCT01266330|oxidative stress|oxidative stress
5507013|NCT01266330|body composition|body composition
5507014|NCT01266291|Tuberous sclerosis|tuberous sclerosis
5507015|NCT01266291|TS|ts
5507016|NCT01266291|Seizures|seizures
5507017|NCT01266278|shoulder injuries|shoulder injuries
5507018|NCT01266265|pulmonary arterial hypertension|pulmonary arterial hypertension
5507019|NCT01266265|PAH|pah
5507020|NCT01266265|treprostinil sodium|treprostinil sodium
5507021|NCT01266265|Tyvaso|tyvaso
5507022|NCT01266265|inhalation|inhalation
5507023|NCT01266265|Ventavis|ventavis
5507024|NCT01266265|iloprost|iloprost
5507025|NCT01266265|prostacyclin|prostacyclin
5507026|NCT01266265|epoprostenol sodium|epoprostenol sodium
5507027|NCT01266265|Flolan|flolan
5507028|NCT01266265|Veletri|veletri
5507029|NCT01266265|subcutaneous and intravenous prostacyclin analogue|subcutaneous and intravenous prostacyclin analogue
5507030|NCT01266265|Remodulin|remodulin
5507031|NCT01266265|oral ERA|oral era
5507032|NCT01266265|bosentan|bosentan
5507033|NCT01266265|Tracleer|tracleer
5507034|NCT01266265|ambrisentan|ambrisentan
5507035|NCT01266265|Letairis|letairis
5507036|NCT01266265|oral PDE5 inhibitors|oral pde5 inhibitors
5507037|NCT01266265|sildenafil|sildenafil
5507038|NCT01266265|Revatio|revatio
5507039|NCT01266265|tadalafil|tadalafil
5507040|NCT01266265|Adcirca|adcirca
5507041|NCT01266265|Opsumit|opsumit
5507042|NCT01266265|macitentan|macitentan
5507043|NCT01266265|Adempas|adempas
5507044|NCT01266265|riociguat|riociguat
5507045|NCT01266265|Orenitram|orenitram
5507046|NCT01266265|oral treprostinil|oral treprostinil
5507047|NCT01266252|neonates|neonates
5507048|NCT01266252|single organ respiratory failure|single organ respiratory failure
5507049|NCT01266239|Bifurcation lesion, drug-eluting stent, symmetric expansion|bifurcation lesion, drug-eluting stent, symmetric expansion
5507050|NCT01266226|Rotator cuff tears|rotator cuff tears
5507051|NCT01266226|ACP|acp
5507052|NCT01266213|fulvestrant|fulvestrant
5507053|NCT01266213|anastrozole|anastrozole
5507054|NCT01266213|goserelin|goserelin
5507055|NCT01266213|tamoxifen|tamoxifen
5507056|NCT01266213|premenopausal|premenopausal
5507057|NCT01266213|hormone receptor positive|hormone receptor positive
5507058|NCT01266200|microcirculation|microcirculation
5507059|NCT01266200|vertebral fracture|vertebral fracture
5507060|NCT01266200|inflammation|inflammation
5507061|NCT01266200|minimal-invasive surgery|minimal-invasive surgery
5507062|NCT01266187|FOLFOX|folfox
5507064|NCT01266187|cetuximab|cetuximab
5507065|NCT01266174|CIAS|cias
5507066|NCT01266174|Cognition|cognition
5507067|NCT01266174|Schizophrenia|schizophrenia
5507068|NCT01266174|Eltoprazine|eltoprazine
5507069|NCT01266161|dental pain|dental pain
5507070|NCT01266161|multiple dose|multiple dose
5507071|NCT01266161|ibuprofen|ibuprofen
5507072|NCT01266161|third molar extraction|third molar extraction
5507073|NCT01266135|Interstitial Lung Disease|interstitial lung disease
5507074|NCT01266135|Usual Interstitial Pneumonia|usual interstitial pneumonia
5507075|NCT01266135|Fibrosis,|fibrosis,
5507076|NCT01266135|Pulmonary Fibrosis,|pulmonary fibrosis,
5507077|NCT01266135|Respiratory Disease,|respiratory disease,
5507078|NCT01266135|Interstitial Lung Disease,|interstitial lung disease,
5507079|NCT01266135|Biological Therapy,|biological therapy,
5507080|NCT01266135|Therapeutic Uses,|therapeutic uses,
5507081|NCT01266122|HIV|hiv
5507082|NCT01266122|Psychosocial problems|psychosocial problems
5507083|NCT01266122|MSM|msm
5507084|NCT01266122|India|india
5507085|NCT01266109|Substance Use|substance use
5507086|NCT01266109|Delinquency|delinquency
5507087|NCT01266109|Juvenile Drug Court|juvenile drug court
5507088|NCT01266109|Contingency Management|contingency management
5507089|NCT01266109|Family Engagement|family engagement
5507090|NCT01266096|124I-cRGDY-PEG-dots|124i-crgdy-peg-dots
5507091|NCT01266096|Pet scan|pet scan
5507092|NCT01266096|10-155|10-155
5507093|NCT01266096|melanoma|melanoma
5507094|NCT01266096|brain|brain
5507095|NCT01266083|MONTANIDE ISA 51|montanide isa 51
5507096|NCT01266083|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
5507097|NCT01266083|vaccine|vaccine
5507098|NCT01266083|10-143|10-143
5507099|NCT01266070|VHL|vhl
5507100|NCT01266070|Hemangioblastoma|hemangioblastoma
5507101|NCT01266070|Tumor of the central nervous system|tumor of the central nervous system
5507102|NCT01266070|TKI258|tki258
5507103|NCT01266057|Advanced Malignancies|advanced malignancies
5507104|NCT01266057|Metastatic cancers|metastatic cancers
5507105|NCT01266057|Sirolimus|sirolimus
5507106|NCT01266057|Hydroxychloroquine|hydroxychloroquine
5507108|NCT01266057|Plaquenil|plaquenil
5507109|NCT01266057|Rapamune|rapamune
5507110|NCT01266057|Saha|saha
5507111|NCT01266057|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5507112|NCT01266057|MSK-390|msk-390
5507113|NCT01266057|Zolinza|zolinza
5507114|NCT01266044|Radiation-induced xerostomia|radiation-induced xerostomia
5507115|NCT01266044|Acupuncture|acupuncture
5507116|NCT01266044|Oropharyngeal cancer|oropharyngeal cancer
5507117|NCT01266044|Radiation Therapy|radiation therapy
5507118|NCT01266044|IMRT|imrt
5507119|NCT01266044|Dry mouth|dry mouth
5507120|NCT01266031|Glioblastoma Multiforme|glioblastoma multiforme
5507121|NCT01266018|small cell lung cancer|small cell lung cancer
5507122|NCT01266018|SCLC|sclc
5507123|NCT01266018|ADI-PEG 20|adi-peg 20
5507124|NCT01266018|arginine deiminase pegylated|arginine deiminase pegylated
5507125|NCT01266005|HBe Ag(-) Chronic Hepatitis B|hbe ag(-) chronic hepatitis b
5507126|NCT01265992|Secondary hyperparathyroidism|secondary hyperparathyroidism
5507127|NCT01265992|Mineral and Bone Disorder (CKD-MBD)|mineral and bone disorder (ckd-mbd)
5507128|NCT01265992|Chronic Kidney Disease|chronic kidney disease
5507129|NCT01265979|advanced|advanced
5507130|NCT01265979|metastatic|metastatic
5507131|NCT01265979|gastro-intestinal|gastro-intestinal
5507132|NCT01265979|stromal|stromal
5507133|NCT01265979|GIST|gist
5507134|NCT01265979|regorafenib|regorafenib
5507135|NCT01265966|Moderate Sedation|moderate sedation
5507136|NCT01265966|Sedation, Deep|sedation, deep
5507137|NCT01265953|cancer prevention|cancer prevention
5507138|NCT01265953|isothiocyanate|isothiocyanate
5507139|NCT01265953|sulforaphane|sulforaphane
5507140|NCT01265940|bladder cancer|bladder cancer
5507141|NCT01265940|urothelial cancer|urothelial cancer
5507142|NCT01265940|metastatic urothelial cancer|metastatic urothelial cancer
5507143|NCT01265940|advanced urothelial cancer|advanced urothelial cancer
5507144|NCT01265927|Breast Cancer|breast cancer
5507145|NCT01265927|Breast Tumors|breast tumors
5507146|NCT01265927|Cancer of Breast|cancer of breast
5507147|NCT01265927|Cancer of the Breast|cancer of the breast
5507148|NCT01265927|Genes, HER-2|genes, her-2
5507149|NCT01265927|Genes, HER2|genes, her2
5507150|NCT01265901|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5507151|NCT01265901|First line|first line
5507152|NCT01265901|Eligible for sunitinib|eligible for sunitinib
5507157|NCT01265862|Supraglottic airway devices|supraglottic airway devices
5507158|NCT01265862|Patients undergoing general anesthesia|patients undergoing general anesthesia
5507159|NCT01265836|Dyslipidemia Treatment and Cardiovascular Outcomes|dyslipidemia treatment and cardiovascular outcomes
5507160|NCT01265823|Humira|humira
5507161|NCT01265823|Adalimumab|adalimumab
5507162|NCT01265823|Plaque Psoriasis|plaque psoriasis
5507163|NCT01265810|stomatitis|stomatitis
5507164|NCT01265810|targeted therapy|targeted therapy
5507165|NCT01265810|Caphosol|caphosol
5507166|NCT01265810|mouthrinses|mouthrinses
5507167|NCT01265771|Arrhythmia|arrhythmia
5507168|NCT01265771|Children|children
5507169|NCT01265758|Atrial fibrillation|atrial fibrillation
5507170|NCT01265758|Cardiac arrhythmia|cardiac arrhythmia
5507171|NCT01265758|ECG|ecg
5507172|NCT01265758|Telemonitoring|telemonitoring
5507173|NCT01265758|Telemetry|telemetry
5507174|NCT01265758|Holter|holter
5507175|NCT01265745|Phase I|phase i
5507176|NCT01265732|Phase 1|phase 1
5507177|NCT01265732|relative bioavailability|relative bioavailability
5507178|NCT01265732|healthy volunteers|healthy volunteers
5507179|NCT01265732|pharmacokinetics|pharmacokinetics
5507180|NCT01265732|suspension|suspension
5507181|NCT01265732|dispersion|dispersion
5507182|NCT01265719|Prospective|prospective
5507183|NCT01265719|non-interventional|non-interventional
5507184|NCT01265719|longitudinal|longitudinal
5507185|NCT01265719|cohort study|cohort study
5507186|NCT01265706|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5507187|NCT01265680|Blood Transfusion|blood transfusion
5507188|NCT01265680|Heart surgery|heart surgery
5507189|NCT01265680|Erythropoietin|erythropoietin
5507194|NCT01265654|Hormonal Treatment|hormonal treatment
5507195|NCT01265615|chronic allograft nephropathy|chronic allograft nephropathy
5507196|NCT01265615|stem-progenitor cells|stem-progenitor cells
5507197|NCT01265615|cardiorenal syndrome|cardiorenal syndrome
5507198|NCT01265615|calcitriol|calcitriol
5507199|NCT01265615|paricalcitol|paricalcitol
5507200|NCT01265615|cholecalciferol|cholecalciferol
5507201|NCT01265615|cardiac repair|cardiac repair
5507202|NCT01265615|renal repair|renal repair
5507203|NCT01265602|Actinic Keratosis|actinic keratosis
5507204|NCT01265602|AK|ak
5507205|NCT01265602|NMSC|nmsc
5507206|NCT01265589|RDS|rds
5507207|NCT01265589|Infant, newborn|infant, newborn
5507208|NCT01265589|Vitamin A|vitamin a
5507209|NCT01265589|Surfactant|surfactant
5507210|NCT01265563|silymarin|silymarin
5507211|NCT01265563|glutathione|glutathione
5507212|NCT01265563|diabetic nephropathies|diabetic nephropathies
5507213|NCT01265563|oxidative stress|oxidative stress
5507214|NCT01265563|N-acetylcysteine|n-acetylcysteine
5507215|NCT01265563|protein tholation|protein tholation
5507217|NCT01265537|Tacrolimus|tacrolimus
5507218|NCT01265537|Diabetes after transplant|diabetes after transplant
5507219|NCT01265537|Acute rejection prevention|acute rejection prevention
5507220|NCT01265537|New onset diabetes after transplant|new onset diabetes after transplant
5507221|NCT01265511|Hepatitis C|hepatitis c
5507222|NCT01265511|SCY-635|scy-635
5507223|NCT01265511|Ribavirin|ribavirin
5507224|NCT01265511|Interferon|interferon
5507225|NCT01265498|Farnesoid X Receptor|farnesoid x receptor
5507226|NCT01265498|FXR|fxr
5507227|NCT01265498|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5507228|NCT01265498|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5507229|NCT01265498|NAFLD|nafld
5507230|NCT01265498|NASH|nash
5507231|NCT01265498|obeticholic acid|obeticholic acid
5507232|NCT01265472|Translocator Protein|translocator protein
5507233|NCT01265472|Basal Cell Carcinoma|basal cell carcinoma
5507234|NCT01265472|Squamous Cell Carcinoma|squamous cell carcinoma
5507235|NCT01265472|Malignancy|malignancy
5507236|NCT01265446|Sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.|sore throat, upper respiratory tract infection, lozenge with lidocaine and cetylpyridinium chloride.
5507237|NCT01265433|GM-CSF|gm-csf
5507238|NCT01265433|MONTANIDE ISA 51|montanide isa 51
5507239|NCT01265433|WT1 PEPTIDE SPECIFIC T CELLS|wt1 peptide specific t cells
5507240|NCT01265433|Vaccine|vaccine
5507241|NCT01265433|10-134|10-134
5507242|NCT01265420|Dupuytren|dupuytren
5507243|NCT01265420|Dupuytren's Disease|dupuytren's disease
5507248|NCT01265394|Amyloid|amyloid
5507249|NCT01265394|Magnetic resonance imaging|magnetic resonance imaging
5507250|NCT01265394|Positron Emission Tomography|positron emission tomography
5507251|NCT01265394|Standard uptake value ratios|standard uptake value ratios
5507252|NCT01265394|Healthy Subjects|healthy subjects
5507256|NCT01265368|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5507257|NCT01265368|Tumor Vaccine|tumor vaccine
5507258|NCT01265368|Cell-based Therapy|cell-based therapy
5507259|NCT01265342|Bronchial Spasm|bronchial spasm
5507260|NCT01265342|Respiratory Tract Infections|respiratory tract infections
5507261|NCT01265342|Viral wheezing|viral wheezing
5507262|NCT01265342|Child, Preschool|child, preschool
5507263|NCT01265342|Beclomethasone|beclomethasone
5507264|NCT01265342|Italy|italy
5507265|NCT01265342|Physicians, Primary Care|physicians, primary care
5507266|NCT01265342|Pediatrics|pediatrics
5507267|NCT01265316|Cardiac arrest, CPR, pediatric|cardiac arrest, cpr, pediatric
5507268|NCT01265303|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry|ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry
5507269|NCT01265290|Cardiac arrhythmia|cardiac arrhythmia
5507270|NCT01265290|Cardiogenic syncope|cardiogenic syncope
5507271|NCT01265290|Pediatrics|pediatrics
5507272|NCT01265290|Children|children
5685334|NCT00556504|botanical drug|botanical drug
5507273|NCT01265277|sudden infant death syndrome|sudden infant death syndrome
5507274|NCT01265277|SIDS|sids
5507275|NCT01265277|infant|infant
5507276|NCT01265277|licensed day care|licensed day care
5507277|NCT01265277|sleep patterns|sleep patterns
5507278|NCT01265277|stress levels|stress levels
5507279|NCT01265264|Gout|gout
5507280|NCT01265264|hyperuricemia|hyperuricemia
5507281|NCT01265264|arthritis|arthritis
5507282|NCT01265264|joint diseases|joint diseases
5507283|NCT01265264|allopurinol|allopurinol
5507284|NCT01265251|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5507285|NCT01265251|Neuropsychological Test|neuropsychological test
5507286|NCT01265251|Assessment of cognitive disorders/dementia|assessment of cognitive disorders/dementia
5507287|NCT01265251|Neuropsychological assessment|neuropsychological assessment
5507288|NCT01265238|Spastic equinovarus foot|spastic equinovarus foot
5507289|NCT01265238|Stroke|stroke
5507290|NCT01265238|Neurotomy|neurotomy
5507291|NCT01265238|Tendon surgery|tendon surgery
5507292|NCT01265225|breast cancer stages 0-II|breast cancer stages 0-ii
5507293|NCT01265199|AML|aml
5507294|NCT01265186|Sedation|sedation
5507295|NCT01265186|BIS|bis
5507296|NCT01265186|aEEG|aeeg
5507297|NCT01265186|Neonatal Pain and Sedation Scale|neonatal pain and sedation scale
5507298|NCT01265186|neonate|neonate
5507299|NCT01265186|newborn|newborn
5507300|NCT01265173|SBP|sbp
5507301|NCT01265173|liver cirrhosis|liver cirrhosis
5507302|NCT01265173|antibiotics|antibiotics
5507303|NCT01265134|the elders|the elders
5507304|NCT01265134|falling|falling
5507305|NCT01265134|loss balance|loss balance
5507306|NCT01265121|Acromegaly|acromegaly
5507307|NCT01265121|Insulin resistance|insulin resistance
5507308|NCT01265121|Euglycemic Clamp|euglycemic clamp
5507309|NCT01265121|Somatostatin analogues|somatostatin analogues
5507310|NCT01265095|VRE|vre
5507311|NCT01265069|Helicobacter pylori|helicobacter pylori
5507312|NCT01265069|concomitant therapy|concomitant therapy
5507313|NCT01265069|high dose dual therapy|high dose dual therapy
5507314|NCT01265069|antibiotic resistance|antibiotic resistance
5507315|NCT01265043|oral health|oral health
5507316|NCT01265043|oral hygiene|oral hygiene
5507317|NCT01265043|bacteria|bacteria
5507318|NCT01265043|quality of life|quality of life
5507319|NCT01265043|Clinical oral health in patients following acute stroke|clinical oral health in patients following acute stroke
5507320|NCT01265043|Oral opportunistic pathogens in patients following acute stroke|oral opportunistic pathogens in patients following acute stroke
5507321|NCT01265043|Oral health-related quality of life in patients following acute stroke|oral health-related quality of life in patients following acute stroke
5507323|NCT01265030|Sirolimus|sirolimus
5507324|NCT01265030|Surgically-Resectable Desmoid Tumor|surgically-resectable desmoid tumor
5507325|NCT01265017|type 1 diabetes|type 1 diabetes
5507326|NCT01265017|pregnancy|pregnancy
5507327|NCT01265017|insulin requirement|insulin requirement
5507328|NCT01265004|Functional outcome|functional outcome
5507329|NCT01264991|Sham|sham
5507330|NCT01264991|Meniscus tear|meniscus tear
5507331|NCT01264991|Meniscectomy|meniscectomy
5507332|NCT01264978|COPD|copd
5507333|NCT01264978|Rehabilitation|rehabilitation
5507334|NCT01264978|Neuromuscular stimulation|neuromuscular stimulation
5507335|NCT01264978|Quadriceps muscle|quadriceps muscle
5507336|NCT01264978|Magnetic stimulation|magnetic stimulation
5507337|NCT01264965|Pain|pain
5507338|NCT01264965|Analgesia|analgesia
5507339|NCT01264965|Cognitive impairment|cognitive impairment
5507340|NCT01264965|Randomized controlled trial|randomized controlled trial
5507341|NCT01264965|Physical function|physical function
5507342|NCT01264952|Liver metastases of colorectal cancer|liver metastases of colorectal cancer
5507343|NCT01264952|Bleomycin|bleomycin
5507344|NCT01264952|Electrochemotherapy|electrochemotherapy
5507345|NCT01264900|Psychotherapy|psychotherapy
5507346|NCT01264900|Cognitive Behavioral Therapy|cognitive behavioral therapy
5507347|NCT01264900|Aggression|aggression
5507348|NCT01264900|fMRI|fmri
5507349|NCT01264900|Behavioral Intervention|behavioral intervention
5507350|NCT01264887|analgesia|analgesia
5507351|NCT01264887|analgesics|analgesics
5507352|NCT01264887|chronic pain|chronic pain
5507353|NCT01264887|tumour related pain|tumour related pain
5507354|NCT01264887|chronic malignant tumor-related pain|chronic malignant tumor-related pain
5507355|NCT01264861|Evaluate dopamine and serotonin activity in the brain at 3 doses of Safinamide|evaluate dopamine and serotonin activity in the brain at 3 doses of safinamide
5507356|NCT01264848|multiple sclerosis|multiple sclerosis
5507361|NCT01264809|diabetes|diabetes
5507362|NCT01264796|Korean American, type 2 diabetes, culturally tailored|korean american, type 2 diabetes, culturally tailored
5507363|NCT01264770|Rheumatoid Arthritis|rheumatoid arthritis
5507364|NCT01264770|OSKIRA|oskira
5507365|NCT01264770|fostamatinib|fostamatinib
5507366|NCT01264757|pedometer|pedometer
5507367|NCT01264757|accelerometer|accelerometer
5507368|NCT01264757|moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
5507370|NCT01264757|randomized trial|randomized trial
5507371|NCT01264744|Bladder cancer|bladder cancer
5507372|NCT01264744|Chromosomal aberrations|chromosomal aberrations
5507373|NCT01264744|FISH|fish
5507376|NCT01264731|peptide vaccine|peptide vaccine
5507377|NCT01264731|aldara|aldara
5507378|NCT01264731|imiquimod|imiquimod
5507379|NCT01264731|immunotherapy|immunotherapy
5507380|NCT01264718|minority health|minority health
5507381|NCT01264718|child|child
5507382|NCT01264718|Medicaid|medicaid
5507383|NCT01264705|Cirrhosis|cirrhosis
5507384|NCT01264705|GI Cancer|gi cancer
5507385|NCT01264705|Hepatitis|hepatitis
5507386|NCT01264705|Oncology|oncology
5507387|NCT01264679|Iron deficiency anemia|iron deficiency anemia
5507388|NCT01264679|Feraheme|feraheme
5507389|NCT01264679|ferumoxytol|ferumoxytol
5507390|NCT01264679|chronic kidney disease|chronic kidney disease
5507391|NCT01264679|CKD|ckd
5507392|NCT01264679|pediatric|pediatric
5507393|NCT01264679|dialysis-dependent|dialysis-dependent
5507394|NCT01264679|nondialysis-dependent|nondialysis-dependent
5507395|NCT01264666|Chinese tea flavor liquor|chinese tea flavor liquor
5507396|NCT01264666|postprandial|postprandial
5507397|NCT01264666|uric acid|uric acid
5671473|NCT00615901|cyclophosphamide|cyclophosphamide
5507398|NCT01264666|high-sensitive C-reactive protein|high-sensitive c-reactive protein
5507399|NCT01264653|cataract|cataract
5507400|NCT01264640|Brain-derived neurotrophic factor (BDNF)|brain-derived neurotrophic factor (bdnf)
5507401|NCT01264640|Platelets|platelets
5507403|NCT01264640|Clopidogrel|clopidogrel
5507404|NCT01264627|Hypertension|hypertension
5507405|NCT01264627|Blood pressure|blood pressure
5507406|NCT01264627|Breathing|breathing
5507407|NCT01264627|PetCO2|petco2
5507408|NCT01264627|Stress|stress
5507409|NCT01264614|exercise|exercise
5507410|NCT01264614|neuropsychological|neuropsychological
5507411|NCT01264614|dementia|dementia
5507412|NCT01264614|Alzheimer's Disease|alzheimer's disease
5507413|NCT01264614|mild cognitive impairment|mild cognitive impairment
5507414|NCT01264614|strength|strength
5507415|NCT01264614|MCI|mci
5507416|NCT01264614|AD|ad
5507417|NCT01264614|EEG|eeg
5507418|NCT01264614|neurophysiological|neurophysiological
5507419|NCT01264614|growth factor|growth factor
5507420|NCT01264614|cognitive decline|cognitive decline
5507421|NCT01264614|executive function|executive function
5507422|NCT01264601|Anaphylaxis to Egg|anaphylaxis to egg
5507423|NCT01264601|Severe Egg Allergy|severe egg allergy
5507424|NCT01264575|spinal anesthesia|spinal anesthesia
5507425|NCT01264575|intrathecal bupivacaine|intrathecal bupivacaine
5507427|NCT01264575|ED50|ed50
5507428|NCT01264575|ED95|ed95
5507429|NCT01264562|chemotherapy, adjuvant|chemotherapy, adjuvant
5507430|NCT01264562|adverse effects|adverse effects
5507431|NCT01264562|breast neoplasms|breast neoplasms
5507432|NCT01264562|cognition disorders|cognition disorders
5507433|NCT01264562|Stress Disorders, post-traumatic|stress disorders, post-traumatic
5507434|NCT01264562|cortisol|cortisol
5507435|NCT01264549|ischemic stroke|ischemic stroke
5507436|NCT01264549|stroke-associated infections|stroke-associated infections
5507437|NCT01264549|biomarkers|biomarkers
5507439|NCT01264549|immune and infection parameters|immune and infection parameters
5507440|NCT01264536|lactoferrin|lactoferrin
5507441|NCT01264536|sepsis|sepsis
5507442|NCT01264536|neonates|neonates
5507443|NCT01264536|prevention|prevention
5507444|NCT01264536|infections|infections
5507445|NCT01264523|chrononutrition|chrononutrition
5507446|NCT01264523|moderately high protein|moderately high protein
5507447|NCT01264523|glycemic index|glycemic index
5507448|NCT01264523|type-2 diabetes|type-2 diabetes
5507449|NCT01264523|overweight|overweight
5507450|NCT01264523|obesity|obesity
5507451|NCT01264523|weight management|weight management
5507452|NCT01264510|conductive hearing loss|conductive hearing loss
5507453|NCT01264510|mixed hearing loss|mixed hearing loss
5507454|NCT01264510|unilateral deafness|unilateral deafness
5507455|NCT01264510|implanted with Baha|implanted with baha
5510244|NCT01251965|Acute lymphocytic leukemia|acute lymphocytic leukemia
5510245|NCT01251965|ALL|all
5507456|NCT01264510|conductive or mixed hearing loss implanted with a Baha or|conductive or mixed hearing loss implanted with a baha or
5507457|NCT01264510|unilateral deafness implanted with a Baha|unilateral deafness implanted with a baha
5507459|NCT01264484|Non-interventional|non-interventional
5507460|NCT01264484|Post market release study|post market release study
5507461|NCT01264484|Germany|germany
5507462|NCT01264484|Treated with Advantage prosthetic heart valve|treated with advantage prosthetic heart valve
5507463|NCT01264471|Gulf War Syndrome|gulf war syndrome
5507464|NCT01264471|Gulf War Illness|gulf war illness
5507465|NCT01264471|Mitochondrial defects|mitochondrial defects
5507466|NCT01264471|Mitochondrial disorders|mitochondrial disorders
5507467|NCT01264471|Persian Gulf Syndrome|persian gulf syndrome
5507468|NCT01264445|HIV|hiv
5507469|NCT01264328|Head and neck cancer, panitumumab, TTCC-2009-03|head and neck cancer, panitumumab, ttcc-2009-03
5507470|NCT01264315|Lenalidomide|lenalidomide
5507471|NCT01264315|Tandem Autologous-Allogeneic Transplant|tandem autologous-allogeneic transplant
5507472|NCT01264302|Bioequivalence|bioequivalence
5507473|NCT01264302|Finasteride|finasteride
5507474|NCT01264302|crossover|crossover
5507475|NCT01264289|Bioequivalence|bioequivalence
5507476|NCT01264289|Finasteride|finasteride
5507477|NCT01264289|crossover|crossover
5507478|NCT01264276|ROP|rop
5507479|NCT01264276|Retinopathy of Prematurity|retinopathy of prematurity
5507480|NCT01264276|Telemedicine|telemedicine
5507481|NCT01264263|cIMT|cimt
5507482|NCT01264263|hs CRP (C-reactive protein)|hs crp (c-reactive protein)
5507483|NCT01264263|DM (Diabetic Mellitus)|dm (diabetic mellitus)
5507484|NCT01264263|Korea|korea
5507485|NCT01264263|Corelation between cIMT (carotid intima media thickness)|corelation between cimt (carotid intima media thickness)
5507486|NCT01264263|Cardio Vascular risk in Diabetic Mellitus|cardio vascular risk in diabetic mellitus
5507487|NCT01264250|Safety|safety
5507493|NCT01264237|Etoricoxib|etoricoxib
5507494|NCT01264211|Efficacy of Diacerein|efficacy of diacerein
5507495|NCT01264211|Safety of Diacerein|safety of diacerein
5507496|NCT01264211|Carry-over effect of Diacerein|carry-over effect of diacerein
5507497|NCT01264172|Functional outcome|functional outcome
5507498|NCT01264172|Microcirculation|microcirculation
5507499|NCT01264172|Inflammatory response|inflammatory response
5664444|NCT00643305|HIV|hiv
5507500|NCT01264159|Developing acute heart failure|developing acute heart failure
5507501|NCT01264146|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5507502|NCT01264146|calcaneal fracture|calcaneal fracture
5507503|NCT01264146|calcaneal plating|calcaneal plating
5507504|NCT01264146|wound infection|wound infection
5507505|NCT01264146|microcirculation|microcirculation
5507506|NCT01264120|Obesity|obesity
5507507|NCT01264120|Bariatric surgery|bariatric surgery
5507508|NCT01264120|Health Psychology|health psychology
5507509|NCT01264081|Lapatinib|lapatinib
5507510|NCT01264081|Melanoma|melanoma
5507511|NCT01264081|ERBB4 Mutation|erbb4 mutation
5507512|NCT01264081|Malignant Melanoma|malignant melanoma
5507513|NCT01264081|Skin Cancer|skin cancer
5507514|NCT01264068|Suan-Tsao-Jen-Tang ,Jia-Wey-Shiau-Yau-San,metabolomics,menopause|suan-tsao-jen-tang ,jia-wey-shiau-yau-san,metabolomics,menopause
5507520|NCT01264042|Iron Supplementation,|iron supplementation,
5507521|NCT01264042|week 24 to 28 at study day|week 24 to 28 at study day
5507522|NCT01264029|Well-Being|well-being
5507523|NCT01264029|Tai Chi|tai chi
5507524|NCT01264029|Obesity|obesity
5507525|NCT01264029|Mindfulness|mindfulness
5507526|NCT01264029|Meditation|meditation
5507527|NCT01264029|Overweight|overweight
5507528|NCT01264003|inguinal hernia, antibiotic, prophylaxis|inguinal hernia, antibiotic, prophylaxis
5507529|NCT01263990|hemodynamic monitoring systems|hemodynamic monitoring systems
5507530|NCT01263990|stroke volume|stroke volume
5507531|NCT01263977|septic shock|septic shock
5507533|NCT01263977|outcome|outcome
5507534|NCT01263964|ischemic stroke|ischemic stroke
5507535|NCT01263964|troponin elevation|troponin elevation
5507536|NCT01263964|transient apical ballooning|transient apical ballooning
5507537|NCT01263964|acute coronary syndrome|acute coronary syndrome
5507538|NCT01263964|troponin elevation,|troponin elevation,
5507539|NCT01263964|culprit lesion on coronary angiogram,|culprit lesion on coronary angiogram,
5507540|NCT01263964|troponin elevation and stroke localisation (temporal lobe?)|troponin elevation and stroke localisation (temporal lobe?)
5507541|NCT01263951|Differentiated metastatic thyroid cancer|differentiated metastatic thyroid cancer
5507543|NCT01263938|monocytes|monocytes
5507544|NCT01263938|CD16+|cd16+
5507545|NCT01263938|statins|statins
5507546|NCT01263938|mcp1|mcp1
5507547|NCT01263938|inflammation|inflammation
5507548|NCT01263925|Alprostadil|alprostadil
5507549|NCT01263925|Prostaglandin E1|prostaglandin e1
5507550|NCT01263925|Prostavasin®|prostavasin®
5507551|NCT01263925|PAOD|paod
5507552|NCT01263912|Polyunsaturated fatty acids|polyunsaturated fatty acids
5507553|NCT01263912|Cognitive development|cognitive development
5507554|NCT01263912|Growth|growth
5507555|NCT01263912|Infection|infection
5507556|NCT01263899|Lymphoid malignancies|lymphoid malignancies
5507557|NCT01263899|Hodgkin lymphoma|hodgkin lymphoma
5507558|NCT01263899|Mantle Cell Lymphoma|mantle cell lymphoma
5507559|NCT01263899|Indolent Lymphoma|indolent lymphoma
5507561|NCT01263847|Dietary Supplement: Galactooligosaccharide|dietary supplement: galactooligosaccharide
5507562|NCT01263834|Trabeculectomy|trabeculectomy
5507563|NCT01263834|bevacizumab|bevacizumab
5507564|NCT01263834|intraocular pressure|intraocular pressure
5507565|NCT01263821|glioma|glioma
5507566|NCT01263821|biologic imaging|biologic imaging
5507567|NCT01263821|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5507568|NCT01263821|magnetic resonance imaging|magnetic resonance imaging
5507569|NCT01263821|perfusion imaging|perfusion imaging
5507570|NCT01263821|diffusion imaging|diffusion imaging
5507571|NCT01263821|functional magnetic resonance imaging|functional magnetic resonance imaging
5507572|NCT01263821|radiation therapy|radiation therapy
5507573|NCT01263821|intensity modulated radiation therapy|intensity modulated radiation therapy
5507574|NCT01263808|Indacaterol|indacaterol
5507575|NCT01263808|Moxifloxacin|moxifloxacin
5507576|NCT01263782|Non-Small Cell Lung Cancer|non-small cell lung cancer
5507577|NCT01263782|NSCLL|nscll
5507579|NCT01263782|Metastatic disease|metastatic disease
5507580|NCT01263782|Cixutumumab|cixutumumab
5507581|NCT01263782|IMC-A12|imc-a12
5507582|NCT01263782|Carboplatin|carboplatin
5507583|NCT01263782|Paraplatin|paraplatin
5507584|NCT01263782|Pemetrexed|pemetrexed
5507585|NCT01263782|LY231514|ly231514
5507586|NCT01263782|Alimta|alimta
5507587|NCT01263782|MTA|mta
5507588|NCT01263782|Multitargeted Antifolate|multitargeted antifolate
5507589|NCT01263782|NSC-698037|nsc-698037
5507590|NCT01263782|Bevacizumab|bevacizumab
5507591|NCT01263782|Avastin|avastin
5507592|NCT01263782|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5507593|NCT01263782|rhuMAb-VEGF|rhumab-vegf
5507594|NCT01263769|Locally advanced clear cell renal cell carcinoma|locally advanced clear cell renal cell carcinoma
5507595|NCT01263769|AG-013736|ag-013736
5507596|NCT01263769|Axitinib|axitinib
5507597|NCT01263769|Radical nephrectomy|radical nephrectomy
5507598|NCT01263756|Driving|driving
5507599|NCT01263756|Autism Spectrum Disorders|autism spectrum disorders
5507600|NCT01263756|ASD|asd
5507601|NCT01263756|Attention Deficits|attention deficits
5507603|NCT01263756|Adolescents|adolescents
5507604|NCT01263756|Pervasive Developmental Disorders|pervasive developmental disorders
5507605|NCT01263743|Stage 1 hypertension|stage 1 hypertension
5507606|NCT01263717|HIV|hiv
5507607|NCT01263717|lipodystrophy|lipodystrophy
5507608|NCT01263717|tesamorelin|tesamorelin
5507609|NCT01263717|Egrifta|egrifta
5507610|NCT01263717|growth hormone releasing hormone|growth hormone releasing hormone
5507611|NCT01263691|AVA|ava
5507612|NCT01263691|AV7909|av7909
5507613|NCT01263691|Anthrax vaccine|anthrax vaccine
5507614|NCT01263678|Decisional Conflict|decisional conflict
5507615|NCT01263678|Coaching|coaching
5507616|NCT01263678|Decisional Regret|decisional regret
5507617|NCT01263665|stent-graft|stent-graft
5507618|NCT01263665|superficial femoral artery|superficial femoral artery
5507619|NCT01263665|SFA|sfa
5507620|NCT01263665|peripheral artery disease|peripheral artery disease
5507621|NCT01263665|PAD|pad
5507622|NCT01263652|Pain|pain
5507623|NCT01263652|intramuscular|intramuscular
5507624|NCT01263652|oral|oral
5507625|NCT01263652|spine|spine
5507626|NCT01263652|preference|preference
5507627|NCT01263639|patient satisfaction|patient satisfaction
5507628|NCT01263639|patient-physician relationship|patient-physician relationship
5507629|NCT01263639|orthopaedic trauma|orthopaedic trauma
5507630|NCT01263626|Cough|cough
5507631|NCT01263626|Chronic Cough|chronic cough
5507632|NCT01263626|Reflux|reflux
5507633|NCT01263600|Hepatitis B|hepatitis b
5507634|NCT01263600|HBV|hbv
5507636|NCT01263587|Hepatitis B|hepatitis b
5507637|NCT01263587|HBV|hbv
5507638|NCT01263587|Cohort Study|cohort study
5507639|NCT01263574|Catheter related infections prevention/control|catheter related infections prevention/control
5507640|NCT01263574|Anti infective agents|anti infective agents
5507641|NCT01263574|Catheter related infections prevention|catheter related infections prevention
5507642|NCT01263561|glaucoma|glaucoma
5507643|NCT01263561|filtration surgery|filtration surgery
5507644|NCT01263561|trabeculectomy|trabeculectomy
5507645|NCT01263561|ExPRESS shunt|express shunt
5507646|NCT01263522|primary prevention|primary prevention
5507647|NCT01263522|endurance|endurance
5507648|NCT01263522|cardiovascular risk factors|cardiovascular risk factors
5507649|NCT01263522|training|training
5507650|NCT01263522|exercise|exercise
5507651|NCT01263522|non-responder|non-responder
5507652|NCT01263509|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5507653|NCT01263509|Diabetes Mellitus|diabetes mellitus
5507654|NCT01263509|Drug Therapy|drug therapy
5507655|NCT01263496|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5507656|NCT01263496|Diabetes Mellitus|diabetes mellitus
5507657|NCT01263496|Drug Therapy|drug therapy
5507658|NCT01263483|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5507659|NCT01263483|Diabetes Mellitus|diabetes mellitus
5507660|NCT01263483|Drug Therapy|drug therapy
5507661|NCT01263470|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5507662|NCT01263470|Diabetes Mellitus|diabetes mellitus
5507663|NCT01263470|Drug Therapy|drug therapy
5507664|NCT01263457|Growth disorders|growth disorders
5507665|NCT01263457|Saizen|saizen
5507666|NCT01263457|EasypodTM|easypodtm
5507667|NCT01263457|Growth hormone|growth hormone
5507668|NCT01263457|Pediatric subject|pediatric subject
5507669|NCT01263444|AZARGA®|azarga®
5507670|NCT01263444|Open angle glaucoma|open angle glaucoma
5507671|NCT01263444|Prostaglandin Therapy|prostaglandin therapy
5507672|NCT01263431|Hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy|hemorrhoidectomy, haemorrhoidal dearterialisation, anopexy
5507673|NCT01263418|Follicular Lymphoma|follicular lymphoma
5507674|NCT01263418|Marginal Zone Lymphoma|marginal zone lymphoma
5507675|NCT01263418|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5507676|NCT01263418|Elderly|elderly
5507677|NCT01263418|Newly Diagnosed|newly diagnosed
5507678|NCT01263418|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5489700|NCT01338363|children|children
5507679|NCT01263418|University of North Carolina|university of north carolina
5507680|NCT01263418|Ofatumumab|ofatumumab
5507682|NCT01263418|Phase 2|phase 2
5507683|NCT01263418|Geriatric|geriatric
5507684|NCT01263418|Lymphoma|lymphoma
5507685|NCT01263405|Sarcoma|sarcoma
5507686|NCT01263392|Neurogenic bladder|neurogenic bladder
5507687|NCT01263392|Spina bifida|spina bifida
5507688|NCT01263392|Intermittent catheterization|intermittent catheterization
5507689|NCT01263392|Urinary tract infections|urinary tract infections
5507690|NCT01263379|gene transfer|gene transfer
5507691|NCT01263366|Radiodermatitis|radiodermatitis
5507692|NCT01263366|Prevention|prevention
5507693|NCT01263366|Radiotherapy|radiotherapy
5507694|NCT01263366|Breast|breast
5507695|NCT01263366|Radiation Dermatitis|radiation dermatitis
5507696|NCT01263353|Carcinoid tumor,|carcinoid tumor,
5507697|NCT01263353|Gastroenteropancreatic Neuroendocrine Tumors,|gastroenteropancreatic neuroendocrine tumors,
5507698|NCT01263353|Pulmonary Neuroendocrine Tumors,|pulmonary neuroendocrine tumors,
5507699|NCT01263353|pasireotide LAR,|pasireotide lar,
5664766|NCT00641849|BMI|bmi
5507700|NCT01263353|SOM230 LAR,|som230 lar,
5507701|NCT01263353|everolimus,|everolimus,
5507702|NCT01263353|RAD001,|rad001,
5507703|NCT01263353|Advanced Neuroendocrine Tumor,|advanced neuroendocrine tumor,
5507704|NCT01263353|Gastroenteropancreatic System|gastroenteropancreatic system
5507705|NCT01263340|COPD|copd
5507706|NCT01263340|observational study|observational study
5507707|NCT01263340|prevalence|prevalence
5507708|NCT01263340|characterisation|characterisation
5507709|NCT01263327|human papillomavirus vaccine|human papillomavirus vaccine
5507710|NCT01263314|Hypertension|hypertension
5507711|NCT01263301|subclavian steal|subclavian steal
5507712|NCT01263301|carotid duplex|carotid duplex
5507713|NCT01263301|subclavian stenosis|subclavian stenosis
5507714|NCT01263301|hemodialysis with vascular access in the upper limbs|hemodialysis with vascular access in the upper limbs
5507715|NCT01263301|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes|the focus of this study is to see if duplex can be used as an tool to differentiate the different causes of subclavian steal syndromes
5507716|NCT01263275|depression|depression
5507717|NCT01263275|direct current stimulation|direct current stimulation
5507718|NCT01263275|alternative electrode montage|alternative electrode montage
5507719|NCT01263262|Surgical site infection|surgical site infection
5507720|NCT01263262|Corneal toxicity|corneal toxicity
5507721|NCT01263262|Ototoxicity|ototoxicity
5507722|NCT01263262|Povidone-iodine|povidone-iodine
5507723|NCT01263262|Chlorhexidine-alcohol|chlorhexidine-alcohol
5507725|NCT01263249|Nerve Block|nerve block
5507726|NCT01263249|Anterior|anterior
5507727|NCT01263249|Posterior|posterior
5507731|NCT01263249|Lower Extremity Nerve Blocks|lower extremity nerve blocks
5507733|NCT01263210|Recurrent acute otitis media|recurrent acute otitis media
5507734|NCT01263210|Conjugate pneumococcal vaccine|conjugate pneumococcal vaccine
5507735|NCT01263210|Ventilation tube treatment|ventilation tube treatment
5507736|NCT01263210|Nasopharyngeal flora|nasopharyngeal flora
5507737|NCT01263184|shoulder|shoulder
5507738|NCT01263184|strength|strength
5507739|NCT01263184|quality of life|quality of life
5507740|NCT01263171|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5507741|NCT01263171|stage IIIB rectal cancer|stage iiib rectal cancer
5507742|NCT01263171|stage IIIC rectal cancer|stage iiic rectal cancer
5507743|NCT01263158|randomised controlled trial|randomised controlled trial
5507744|NCT01263158|nulliparous women|nulliparous women
5507745|NCT01263158|slow labour progress|slow labour progress
5507746|NCT01263158|prolonged labour|prolonged labour
5507747|NCT01263158|oxytocin augmentation|oxytocin augmentation
5507748|NCT01263158|operative delivery|operative delivery
5507749|NCT01263158|childbirth experience|childbirth experience
5507750|NCT01263132|Polyneuropathy|polyneuropathy
5507751|NCT01263132|Diabetes Mellitus|diabetes mellitus
5507752|NCT01263132|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5507753|NCT01263080|mirtazapine|mirtazapine
5507754|NCT01263080|folic acid|folic acid
5507755|NCT01263080|schizophrenia|schizophrenia
5507756|NCT01263067|Posttraumatic Stress Disorder|posttraumatic stress disorder
5507757|NCT01263067|PTSD|ptsd
5507758|NCT01263067|Car Accident|car accident
5507759|NCT01263067|Auto Accident|auto accident
5507760|NCT01263067|Lifespan Integration|lifespan integration
5507761|NCT01263054|Back Pain|back pain
5507762|NCT01263054|Low Back Pain|low back pain
5507763|NCT01263054|Discogenic Back Pain|discogenic back pain
5507764|NCT01263041|Glutamine, NEC, L-arginine,Preterm,Sepsis|glutamine, nec, l-arginine,preterm,sepsis
5507765|NCT01263015|GSK1349572|gsk1349572
5507766|NCT01263015|Abacavir/Lamivudine|abacavir/lamivudine
5507767|NCT01263015|Treatment-naive|treatment-naive
5507768|NCT01263015|HIV Infection|hiv infection
5507769|NCT01263015|Dolutegravir|dolutegravir
5507770|NCT01263015|integrase inhibitor|integrase inhibitor
5507771|NCT01263015|Atripla|atripla
5507772|NCT01262989|Bioequivalence|bioequivalence
5507773|NCT01262989|Tamsulosin|tamsulosin
5507774|NCT01262989|Healthy volunteers|healthy volunteers
5507775|NCT01262989|Fast conditions|fast conditions
5507776|NCT01262976|Tuberculosis vaccine|tuberculosis vaccine
5507777|NCT01262963|GSK2118436|gsk2118436
5507778|NCT01262963|BRAF inhibitor|braf inhibitor
5507779|NCT01262963|BRAF positive tumor|braf positive tumor
5507780|NCT01262963|ADME|adme
5507781|NCT01262963|Oncology|oncology
5507782|NCT01262937|confocal, biliary, esophagus|confocal, biliary, esophagus
5507783|NCT01262924|Booster vaccination|booster vaccination
5507784|NCT01262898|tolerability|tolerability
5507785|NCT01262898|pharmacokinetics|pharmacokinetics
5507786|NCT01262898|13 C oral breath test|13 c oral breath test
5507787|NCT01262898|Type I and II Diabetes mellitus|type i and ii diabetes mellitus
5507788|NCT01262898|gastroparesis|gastroparesis
5507789|NCT01262898|gut motility|gut motility
5507790|NCT01262898|phase II|phase ii
5507791|NCT01262898|pharmacodynamics|pharmacodynamics
5507792|NCT01262898|repeat dose|repeat dose
5507793|NCT01262898|gastric emptying|gastric emptying
5507794|NCT01262898|symptoms|symptoms
5507795|NCT01262898|GSK962040|gsk962040
5507796|NCT01262885|pharmacokinetics|pharmacokinetics
5507797|NCT01262885|tolerability|tolerability
5507798|NCT01262885|single dose|single dose
5507799|NCT01262885|antibiotics|antibiotics
5507800|NCT01262885|repeat dose|repeat dose
5507801|NCT01262885|GSK2251052|gsk2251052
5507802|NCT01262885|safety|safety
5507803|NCT01262872|Haemophilus influenzae|haemophilus influenzae
5507804|NCT01262872|Streptococcus pneumoniae|streptococcus pneumoniae
5507805|NCT01262872|The Gambia|the gambia
5507806|NCT01262872|immunogenicity|immunogenicity
5507807|NCT01262872|nasopharyngeal carriage|nasopharyngeal carriage
5507808|NCT01262872|infants|infants
5507809|NCT01262872|safety|safety
5507810|NCT01262872|Pneumococcal vaccine|pneumococcal vaccine
5507811|NCT01262872|children|children
5507812|NCT01262846|HIV|hiv
5507813|NCT01262846|Flu vaccination|flu vaccination
5507814|NCT01262846|HIV infected individuals|hiv infected individuals
5507815|NCT01262846|Fluzone SD|fluzone sd
5507816|NCT01262846|Fluzone HD|fluzone hd
5507817|NCT01262820|Pazopanib|pazopanib
5507818|NCT01262820|Non Squamous Non Small Cell Lung Cancer|non squamous non small cell lung cancer
5507819|NCT01262820|After Progress on first line therapy|after progress on first line therapy
5507820|NCT01262820|Using Bevacizumab|using bevacizumab
5507821|NCT01262807|fracture|fracture
5507823|NCT01262807|adult|adult
5507824|NCT01262807|range of motion|range of motion
5507829|NCT01262781|fructose|fructose
5507830|NCT01262781|maternal diet|maternal diet
5507831|NCT01262768|Nutrition|nutrition
5507832|NCT01262768|Obesity|obesity
5507833|NCT01262768|Parent|parent
5507834|NCT01262768|Portion Size Estimation|portion size estimation
5507835|NCT01262768|Accuracy|accuracy
5507836|NCT01262755|GERD|gerd
5507837|NCT01262755|IBS|ibs
5507838|NCT01262755|Minority|minority
5507839|NCT01262742|pregnancy|pregnancy
5507840|NCT01262742|postpartum hemorrhage|postpartum hemorrhage
5507841|NCT01262742|Cesarean delivery|cesarean delivery
5507842|NCT01262742|carbetocin|carbetocin
5507843|NCT01262729|xenon inhalation|xenon inhalation
5507844|NCT01262729|therapeutical hypothermia|therapeutical hypothermia
5507845|NCT01262729|patients after cardiopulmonary resuscitation|patients after cardiopulmonary resuscitation
5507846|NCT01262729|efficacy|efficacy
5507847|NCT01262729|safety|safety
5507848|NCT01262716|Chest wall progression breast cancer|chest wall progression breast cancer
5507849|NCT01262716|PDT|pdt
5507850|NCT01262716|Photofrin|photofrin
5507851|NCT01262716|Photosensitizer|photosensitizer
5507852|NCT01262690|First-in-human (FIH)|first-in-human (fih)
5507853|NCT01262690|Single Ascending Dose (SAD) Study|single ascending dose (sad) study
5507854|NCT01262690|TAM-163|tam-163
5507855|NCT01262690|PF-05230901|pf-05230901
5507856|NCT01262690|Cachexia|cachexia
5507857|NCT01262677|Partial epilepsy|partial epilepsy
5507858|NCT01262677|partial seizures|partial seizures
5507859|NCT01262677|epilepsy|epilepsy
5507860|NCT01262677|seizures|seizures
5507861|NCT01262677|adjunctive therapy|adjunctive therapy
5507862|NCT01262677|intervention|intervention
5507863|NCT01262677|controlled-release|controlled-release
5507864|NCT01262677|placebo-controlled|placebo-controlled
5507865|NCT01262677|seizure|seizure
5507866|NCT01262664|Advanced prostate cancer|advanced prostate cancer
5507867|NCT01262664|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5507868|NCT01262664|Prohibitin-TP01|prohibitin-tp01
5507869|NCT01262651|Cancer pain|cancer pain
5507870|NCT01262651|Opioid therapy|opioid therapy
5507871|NCT01262651|Inadequate analgesia|inadequate analgesia
5507872|NCT01262651|Optimized chronic opioid therapy|optimized chronic opioid therapy
5507873|NCT01262625|stable angina|stable angina
5507874|NCT01262625|recurrent chest pain|recurrent chest pain
5507875|NCT01262625|chest pain|chest pain
5507876|NCT01262625|angina equivalent|angina equivalent
5507877|NCT01262625|diagnosis|diagnosis
5507878|NCT01262625|coronary artery disease|coronary artery disease
5507879|NCT01262612|cediranib|cediranib
5507880|NCT01262612|malignant ascites|malignant ascites
5507881|NCT01262612|malignant pleural effusion|malignant pleural effusion
5507882|NCT01262599|Breast and abdomen morbidities after TRAM flap surgery|breast and abdomen morbidities after tram flap surgery
5507883|NCT01262599|TRAM flap surgery|tram flap surgery
5507884|NCT01262599|Post-mastectomy breast reconstructive surgery|post-mastectomy breast reconstructive surgery
5507885|NCT01262586|Type II Diabetes Mellitus|type ii diabetes mellitus
5507886|NCT01262586|Vildagliptin|vildagliptin
5507887|NCT01262586|Glimepiride|glimepiride
5507888|NCT01262586|Continuous glucose monitoring|continuous glucose monitoring
5507889|NCT01262560|pain|pain
5507890|NCT01262560|dysphagia|dysphagia
5507891|NCT01262560|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5507892|NCT01262560|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5507893|NCT01262560|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5507894|NCT01262560|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5507895|NCT01262560|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5507896|NCT01262560|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5507897|NCT01262560|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5507898|NCT01262560|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5507899|NCT01262560|limited stage small cell lung cancer|limited stage small cell lung cancer
5507900|NCT01262560|recurrent small cell lung cancer|recurrent small cell lung cancer
5507901|NCT01262560|esophagitis|esophagitis
5507902|NCT01262534|Psoriasis|psoriasis
5507903|NCT01262534|comorbidities, associated treatment, quality of life|comorbidities, associated treatment, quality of life
5507904|NCT01262521|Dietary nitrate|dietary nitrate
5507905|NCT01262508|autonomic nervous system|autonomic nervous system
5507906|NCT01262482|adenocarcinoma|adenocarcinoma
5507907|NCT01262482|gastric|gastric
5507908|NCT01262482|gastroesophageal junction|gastroesophageal junction
5507909|NCT01262482|Relapsed|relapsed
5507910|NCT01262482|sorafenib|sorafenib
5507911|NCT01262482|oxaliplatin|oxaliplatin
5507912|NCT01262443|Atrial flutter|atrial flutter
5507913|NCT01262430|Osteoarthritis|osteoarthritis
5507914|NCT01262417|colorectal cancer|colorectal cancer
5507915|NCT01262417|two stage surgery for the resection of hepatic metastases|two stage surgery for the resection of hepatic metastases
5507917|NCT01262417|abdominal and peri-hepatic adhesion|abdominal and peri-hepatic adhesion
5507918|NCT01262391|Overactive bladder|overactive bladder
5507919|NCT01262391|Solifenacin suspension|solifenacin suspension
5507920|NCT01262391|Pharmacokinetics|pharmacokinetics
5507921|NCT01262391|Single-dose|single-dose
5507922|NCT01262391|Pediatric|pediatric
5507923|NCT01262365|Lupus|lupus
5507924|NCT01262365|Monoclonal antibody|monoclonal antibody
5507925|NCT01262365|B-Cell immunotherapy|b-cell immunotherapy
5507926|NCT01262365|Epratuzumab|epratuzumab
5507927|NCT01262339|Primary focal hyperhidrosis|primary focal hyperhidrosis
5507928|NCT01262339|interdermal injections|interdermal injections
5507929|NCT01262339|iontophoresis|iontophoresis
5507930|NCT01262339|BTX-A|btx-a
5507931|NCT01262300|Immunosenescence|immunosenescence
5507932|NCT01262300|Shingles|shingles
5507933|NCT01262300|Vitamin D|vitamin d
5507934|NCT01262300|Varicella Zoster Virus|varicella zoster virus
5507935|NCT01262300|Vaccine|vaccine
5507936|NCT01262300|Immune Response|immune response
5507937|NCT01262300|Geriatrics|geriatrics
5507938|NCT01262287|Randomized Trial|randomized trial
5507939|NCT01262287|Medication for Heavy Drinking|medication for heavy drinking
5507940|NCT01262287|Dutasteride Treatment|dutasteride treatment
5507941|NCT01262261|opioid dependence|opioid dependence
5507942|NCT01262261|opioid addiction|opioid addiction
5507943|NCT01262261|buprenorphine|buprenorphine
5507944|NCT01262261|implant|implant
5507945|NCT01262261|methadone|methadone
5507946|NCT01262261|heroin|heroin
5507954|NCT01262235|Solid tumor|solid tumor
5507955|NCT01262235|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5507956|NCT01262235|Hodgkin's Disease|hodgkin's disease
5507957|NCT01262235|Neuroendocrine tumors (NET)|neuroendocrine tumors (net)
5507958|NCT01262235|Adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
5507959|NCT01262235|Carcinoid|carcinoid
5507960|NCT01262222|Predictive Value For Postoperative Cardiac Events|predictive value for postoperative cardiac events
5507961|NCT01262222|Endothelial Dysfunction|endothelial dysfunction
5507962|NCT01262222|10-206|10-206
5507963|NCT01262209|Vision loss|vision loss
5507964|NCT01262209|Chronic glaucoma|chronic glaucoma
5507965|NCT01262209|Low vision rehabilitation|low vision rehabilitation
5507966|NCT01262196|Trauma|trauma
5507967|NCT01262196|Hemorrhage|hemorrhage
5507968|NCT01262196|Hemorrhagic shock|hemorrhagic shock
5507969|NCT01262196|Lactic acidosis|lactic acidosis
5507970|NCT01262196|Oxygen carriers|oxygen carriers
5507971|NCT01262196|Oxygen therapeutics|oxygen therapeutics
5507972|NCT01262196|Hemoglobin solutions|hemoglobin solutions
5507973|NCT01262196|Red cell substitutes|red cell substitutes
5507974|NCT01262196|PEG-hemoglobin|peg-hemoglobin
5508359|NCT01260376|VLDL-TG|vldl-tg
5507978|NCT01262183|irresectable|irresectable
5507979|NCT01262170|dietary supplement|dietary supplement
5507980|NCT01262170|nutraceutical|nutraceutical
5507981|NCT01262157|Erectile dysfunction|erectile dysfunction
5507982|NCT01262157|PDE5 Inhibitor|pde5 inhibitor
5507983|NCT01262157|Low intensity shock wave therapy.|low intensity shock wave therapy.
5507984|NCT01262144|Cervical Cancer|cervical cancer
5507986|NCT01262144|SUV Max|suv max
5507987|NCT01262131|Fibromyalgia|fibromyalgia
5507988|NCT01262131|Pain associated with Fibromyalgia|pain associated with fibromyalgia
5507989|NCT01262118|Cholesterol metabolism|cholesterol metabolism
5507990|NCT01262118|Cholesterol flux|cholesterol flux
5507991|NCT01262118|Rheumatoid Arthritis|rheumatoid arthritis
5507992|NCT01262118|Tasocitinib|tasocitinib
5507993|NCT01262118|CP-690|cp-690
5507994|NCT01262118|550|550
5507995|NCT01262105|CFU|cfu
5507996|NCT01262105|surgery site|surgery site
5507997|NCT01262092|opioid dependent|opioid dependent
5507998|NCT01262092|detoxification|detoxification
5507999|NCT01262092|buprenorphine|buprenorphine
5508000|NCT01262092|suboxone|suboxone
5508001|NCT01262092|opiate|opiate
5508002|NCT01262079|influenza|influenza
5508003|NCT01262079|healthy volunteer|healthy volunteer
5508004|NCT01262079|immunity|immunity
5508005|NCT01262079|antibody|antibody
5508006|NCT01262079|blood sample|blood sample
5508007|NCT01262066|hypertension|hypertension
5508008|NCT01262066|stress reduction|stress reduction
5508009|NCT01262053|Computerized Physician Order Entry|computerized physician order entry
5508010|NCT01262053|CPOE|cpoe
5508011|NCT01262053|Wrong Patient|wrong patient
5508012|NCT01262053|Juxtaposition|juxtaposition
5508014|NCT01262053|Medical Errors|medical errors
5508015|NCT01262040|NBI|nbi
5508016|NCT01262040|ENDOMETRIUM|endometrium
5508017|NCT01262040|FALLOPIAN TUBE|fallopian tube
5508018|NCT01262040|OVARY|ovary
5508019|NCT01262040|PERITONEUM|peritoneum
5508020|NCT01262040|Surgery|surgery
5508021|NCT01262040|Lung|lung
5508022|NCT01262040|Pancreatic|pancreatic
5508023|NCT01262040|Esophageal|esophageal
5508024|NCT01262040|thorascopic|thorascopic
5508025|NCT01262040|laparoscopic|laparoscopic
5508026|NCT01262040|robotic|robotic
5508038|NCT01261975|Ocular Surgery|ocular surgery
5508039|NCT01261975|Intraocular Lens|intraocular lens
5508040|NCT01261962|Humoral immunity|humoral immunity
5508041|NCT01261962|Neutrophil function|neutrophil function
5508042|NCT01261962|Gene expression|gene expression
5508043|NCT01261949|Tinnitus|tinnitus
5508044|NCT01261949|chronic subjective tinnitus|chronic subjective tinnitus
5510831|NCT01249209|lifestyle intervention|lifestyle intervention
5508049|NCT01261936|Congenital Bleeding Disorders(CBDs)|congenital bleeding disorders(cbds)
5508050|NCT01261936|Diagnosis and treatment of menorrhagia in CBDs|diagnosis and treatment of menorrhagia in cbds
5508051|NCT01261897|Adductor-Canal-Blockade|adductor-canal-blockade
5508052|NCT01261897|postoperative pain|postoperative pain
5508053|NCT01261897|US-guided nerve block|us-guided nerve block
5508054|NCT01261897|total knee arthroplasty|total knee arthroplasty
5508055|NCT01261884|Pregnancy|pregnancy
5508056|NCT01261884|Exercise|exercise
5508057|NCT01261884|Hypertension|hypertension
5508058|NCT01261884|Preeclampsia|preeclampsia
5508059|NCT01261884|Resistance exercise|resistance exercise
5508060|NCT01261858|Sternal closure|sternal closure
5508061|NCT01261858|Coronary artery bypass grafting|coronary artery bypass grafting
5508062|NCT01261858|Biologic bone cement|biologic bone cement
5508063|NCT01261845|Delivery of Health Care|delivery of health care
5508064|NCT01261845|Equity in Health Services|equity in health services
5508065|NCT01261845|Ethnic Groups|ethnic groups
5508066|NCT01261845|Health Services Research|health services research
5508067|NCT01261845|Health Surveys|health surveys
5508068|NCT01261845|Immigration|immigration
5508069|NCT01261845|Referral and Consultation|referral and consultation
5508070|NCT01261845|Resource Allocation|resource allocation
5508071|NCT01261845|Social Justice|social justice
5508072|NCT01261845|Vulnerable Populations|vulnerable populations
5508075|NCT01261819|cystoscopy, minimally invasive hysterectomy|cystoscopy, minimally invasive hysterectomy
5508077|NCT01261793|Monoclonal antibody|monoclonal antibody
5508078|NCT01261793|B-Cell immunotherapy|b-cell immunotherapy
5508079|NCT01261793|Epratuzumab|epratuzumab
5508080|NCT01261780|neuropathy,paraneoplastic|neuropathy,paraneoplastic
5508081|NCT01261780|paraneoplastic peripheral neuropathy|paraneoplastic peripheral neuropathy
5508082|NCT01261780|pain|pain
5508083|NCT01261780|hyperalgesia|hyperalgesia
5508084|NCT01261754|Metastatic Prostate Adenocarcinoma|metastatic prostate adenocarcinoma
5508085|NCT01261728|Gemcitabine|gemcitabine
5508086|NCT01261728|Cisplatin|cisplatin
5508087|NCT01261728|Bladder|bladder
5508088|NCT01261728|radical nephroureterectomy|radical nephroureterectomy
5508089|NCT01261728|ureterectomy|ureterectomy
5508090|NCT01261728|10-208|10-208
5508091|NCT01261702|Magnesium sulphate|magnesium sulphate
5508092|NCT01261702|Post Pulmonary Resection|post pulmonary resection
5508093|NCT01261702|Pain|pain
5508094|NCT01261689|Epidural analgesia|epidural analgesia
5508095|NCT01261689|Instrumental delivery|instrumental delivery
5508096|NCT01261689|Maternal outcome|maternal outcome
5508097|NCT01261689|Neonatal outcome|neonatal outcome
5508098|NCT01261676|caesarean section|caesarean section
5508099|NCT01261676|labour, obstetric|labour, obstetric
5508100|NCT01261676|implementation guidelines|implementation guidelines
5508101|NCT01261676|quality indicators|quality indicators
5685335|NCT00556504|HCV genotype 1|hcv genotype 1
5790005|NCT00146185|Needlestick pain|needlestick pain
5790006|NCT00146185|Venipuncture pain|venipuncture pain
5508102|NCT01261650|widespread chronic pain, transcranial direct current stimulation, fibromyalgia|widespread chronic pain, transcranial direct current stimulation, fibromyalgia
5508103|NCT01261637|cesarean, pain, transversus abdominus plane block|cesarean, pain, transversus abdominus plane block
5508105|NCT01261598|Positron-Emission Tomography|positron-emission tomography
5508106|NCT01261598|PET Scan|pet scan
5508107|NCT01261598|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5508108|NCT01261598|Radiation Oncology|radiation oncology
5508110|NCT01261585|Positron-Emission Tomography|positron-emission tomography
5508111|NCT01261585|PET Scan|pet scan
5508112|NCT01261585|FDG|fdg
5508113|NCT01261585|FLT|flt
5508114|NCT01261585|FMISO|fmiso
5508115|NCT01261585|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5508116|NCT01261585|chemo-Radiation Oncology|chemo-radiation oncology
5508118|NCT01261572|Prostatic neoplasms|prostatic neoplasms
5502334|NCT01286467|Safety|safety
5508132|NCT01261494|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5508133|NCT01261494|Glucose Metabolism Disorders|glucose metabolism disorders
5508134|NCT01261494|Metabolic Diseases|metabolic diseases
5508135|NCT01261494|Cardiovascular Diseases|cardiovascular diseases
5508137|NCT01261494|OGTT|ogtt
5508138|NCT01261481|Bioavailability|bioavailability
5508139|NCT01261468|Chronic pain|chronic pain
5508140|NCT01261468|Electric Stimulation Therapy|electric stimulation therapy
5508141|NCT01261468|Neurologic Examination|neurologic examination
5508142|NCT01261442|distal symmetric polyneuropathy|distal symmetric polyneuropathy
5508143|NCT01261442|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5508144|NCT01261442|posterior tibial nerve|posterior tibial nerve
5508145|NCT01261442|regional anesthesia|regional anesthesia
5508146|NCT01261442|nerve conduction study|nerve conduction study
5508147|NCT01261429|Pigmented villonodular synovitis|pigmented villonodular synovitis
5508148|NCT01261429|tenosynovial giant cell tumour|tenosynovial giant cell tumour
5508149|NCT01261429|nilotinib|nilotinib
5508150|NCT01261416|seizures|seizures
5508151|NCT01261416|epilepsy|epilepsy
5508152|NCT01261416|neonatal|neonatal
5508153|NCT01261416|levetiracetam|levetiracetam
5508154|NCT01261403|Human Placenta-Derived Cells|human placenta-derived cells
5508155|NCT01261390|Sleep Apnea|sleep apnea
5508156|NCT01261390|Heart Disease|heart disease
5508157|NCT01261390|Risk factors for heart disease|risk factors for heart disease
5508158|NCT01261377|COPD, obstructive sleep apnea, OSA, BPAP, CPAP|copd, obstructive sleep apnea, osa, bpap, cpap
5508159|NCT01261364|GeneSight|genesight
5508160|NCT01261364|Assurex|assurex
5508161|NCT01261364|AssureRx|assurerx
5508162|NCT01261351|Pre eclampsia|pre eclampsia
5508163|NCT01261351|Endogenous thrombin potential|endogenous thrombin potential
5508164|NCT01261338|PCBs|pcbs
5508165|NCT01261338|Olestra|olestra
5508166|NCT01261325|Epilepsy|epilepsy
5508167|NCT01261325|Brivaracetam|brivaracetam
5508168|NCT01261325|Partial Onset Seizures|partial onset seizures
5508169|NCT01261325|Adjunctive treatment|adjunctive treatment
5508170|NCT01261312|SGI-110|sgi-110
5508171|NCT01261312|DNA Hypomethylating Agent|dna hypomethylating agent
5508172|NCT01261312|Intermediate 1, Intermediate 2, CMML or High Risk MDS|intermediate 1, intermediate 2, cmml or high risk mds
5508173|NCT01261312|AML|aml
5508174|NCT01261299|Phase 0 Clinical trial|phase 0 clinical trial
5508175|NCT01261299|Human microdosing trial|human microdosing trial
5508176|NCT01261299|Drug resistance, neoplasm|drug resistance, neoplasm
5508177|NCT01261299|Carcinoma, Non-small cell lung|carcinoma, non-small cell lung
5508178|NCT01261299|Urinary Bladder Neoplasm|urinary bladder neoplasm
5508179|NCT01261299|Individualized Medicine|individualized medicine
5508181|NCT01261299|Carboplatin-DNA adducts|carboplatin-dna adducts
5508182|NCT01261286|inflammation|inflammation
5508183|NCT01261286|receptor downregulation|receptor downregulation
5508184|NCT01261286|reduced response|reduced response
5508185|NCT01261286|calcium channels|calcium channels
5508186|NCT01261286|PK-PD relationship|pk-pd relationship
5508187|NCT01261273|PCI|pci
5508188|NCT01261273|observational registry|observational registry
5508189|NCT01261260|uridine|uridine
5508190|NCT01261260|gamma-amino butyric acid|gamma-amino butyric acid
5508191|NCT01261260|Magnetic Resonance Imaging|magnetic resonance imaging
5508192|NCT01261260|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5508193|NCT01261260|Proton Echo-Planar Spectroscopic Imaging|proton echo-planar spectroscopic imaging
5508194|NCT01261234|Carotid Artery Disease|carotid artery disease
5508195|NCT01261234|Carotid Artery Stenting|carotid artery stenting
5508196|NCT01261234|In stent restenosis|in stent restenosis
5508197|NCT01261234|Cardiovascular event|cardiovascular event
5508198|NCT01261234|Intima Media Thickness|intima media thickness
5508199|NCT01261208|HIV, AIDS, Helicobacter pylori|hiv, aids, helicobacter pylori
5508201|NCT01261182|School feeding|school feeding
5508202|NCT01261182|Infant nutrition|infant nutrition
5508203|NCT01261182|Mother's nutrition|mother's nutrition
5508204|NCT01261182|Fortified food|fortified food
5508205|NCT01261182|Anemia|anemia
5508206|NCT01261182|Cluster randomized controlled trials|cluster randomized controlled trials
5508207|NCT01261182|Effectiveness|effectiveness
5508208|NCT01261182|Impact evaluation studies|impact evaluation studies
5508209|NCT01261182|Uganda|uganda
5508210|NCT01261169|Mycophenolate sodium (Myfortic®)|mycophenolate sodium (myfortic®)
5508211|NCT01261169|Corticosteroid-refractory autoimmune Uveitis|corticosteroid-refractory autoimmune uveitis
5508212|NCT01261130|Human Hookworm Vaccine Initiative|human hookworm vaccine initiative
5508213|NCT01261130|HHVI|hhvi
5508214|NCT01261130|Human Hookworm|human hookworm
5508215|NCT01261130|Hookworm|hookworm
5508216|NCT01261130|Hookworm Disease|hookworm disease
5508217|NCT01261130|N. americanus|n. americanus
5508218|NCT01261130|Soil-transmitted helminth infection|soil-transmitted helminth infection
5508219|NCT01261130|Intestinal blood loss|intestinal blood loss
5508220|NCT01261130|Iron deficiency anemia|iron deficiency anemia
5508221|NCT01261117|Patent ductus arteriosis|patent ductus arteriosis
5508222|NCT01261117|İbuprofen|ibuprofen
5508223|NCT01261117|Extremely Low Birth Weigh infant|extremely low birth weigh infant
5508224|NCT01261104|hearing loss|hearing loss
5508225|NCT01261104|handicap|handicap
5508231|NCT01261091|Tracheostomy|tracheostomy
5508232|NCT01261091|Tracheotomy|tracheotomy
5508233|NCT01261091|Percutaneous Dilatative Tracheostomy|percutaneous dilatative tracheostomy
5508234|NCT01261091|Weaning|weaning
5508235|NCT01261091|Ventilation|ventilation
5508236|NCT01261078|intrathecal epinephrine|intrathecal epinephrine
5508237|NCT01261078|duration of anesthesia|duration of anesthesia
5508238|NCT01261078|quality of anesthesia|quality of anesthesia
5508239|NCT01261078|intrathecal fentanyl|intrathecal fentanyl
5508240|NCT01261065|beta blockers|beta blockers
5508241|NCT01261065|heart failure|heart failure
5508242|NCT01261065|contractility|contractility
5508243|NCT01261065|remodeling|remodeling
5508244|NCT01261052|glucose sensors|glucose sensors
5508245|NCT01261052|artificial pancreas|artificial pancreas
5508246|NCT01261052|Diabetes Mellitus|diabetes mellitus
5508247|NCT01261013|Keratoconus|keratoconus
5508248|NCT01261013|intrastromal corneal ring segment|intrastromal corneal ring segment
5508249|NCT01261013|To evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages|to evaluate the visual and refractive outcomes of intrastromal corneal ring segment in keratoconic eyes at different stages
5508250|NCT01261000|Acromegaly|acromegaly
5508251|NCT01260987|Moderate to severe actinic keratoses|moderate to severe actinic keratoses
5508252|NCT01260987|Difficult to treat nodular basal cell carcinomas|difficult to treat nodular basal cell carcinomas
5508253|NCT01260974|Invasive fungal infections|invasive fungal infections
5508254|NCT01260974|Liver Transplantation|liver transplantation
5508255|NCT01260974|Organ Transplantation|organ transplantation
5508256|NCT01260974|Mycoses|mycoses
5508257|NCT01260974|Fungus Diseases|fungus diseases
5508258|NCT01260974|Antifungal Agents|antifungal agents
5508259|NCT01260974|Invasive Mycosis|invasive mycosis
5508260|NCT01260948|Bioequivalence|bioequivalence
5508261|NCT01260948|Healthy Subjects|healthy subjects
5508262|NCT01260935|GERD|gerd
5508263|NCT01260935|laparoscopic surgery|laparoscopic surgery
5508264|NCT01260935|gastroesophageal|gastroesophageal
5508265|NCT01260935|reflux|reflux
5508266|NCT01260922|Bioequivalence|bioequivalence
5508267|NCT01260922|Healthy Subjects|healthy subjects
5508268|NCT01260896|Bioequivalence|bioequivalence
5508269|NCT01260896|Healthy Subjects|healthy subjects
5508270|NCT01260883|ketorolac pharmacokinetics|ketorolac pharmacokinetics
5508271|NCT01260883|ketorolac stereo-isomers|ketorolac stereo-isomers
5508272|NCT01260883|infants|infants
5508273|NCT01260883|postoperative analgesia|postoperative analgesia
5508274|NCT01260883|safety|safety
5508275|NCT01260857|Spirinolactone|spirinolactone
5508276|NCT01260857|Hydroflumethiazide|hydroflumethiazide
5508277|NCT01260857|Hypertension|hypertension
5508278|NCT01260857|Filipinos|filipinos
5508279|NCT01260857|Diabetes mellitus|diabetes mellitus
5508280|NCT01260857|Proteinuria|proteinuria
5508281|NCT01260831|BedsidePEWS|bedsidepews
5508282|NCT01260831|Intensive Care|intensive care
5508283|NCT01260818|Tranexamic Acid|tranexamic acid
5508284|NCT01260805|bioequivalence|bioequivalence
5508285|NCT01260805|study|study
5508286|NCT01260805|ethinylestradiol|ethinylestradiol
5508287|NCT01260805|gestodene|gestodene
5508288|NCT01260740|Traumatic Brain Injury|traumatic brain injury
5508289|NCT01260740|Explicit Learning|explicit learning
5508290|NCT01260740|Primary Motor Cortex|primary motor cortex
5508291|NCT01260740|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5508292|NCT01260740|Implicit Learning|implicit learning
5508293|NCT01260740|Healthy Volunteer|healthy volunteer
5508294|NCT01260740|HV|hv
5508295|NCT01260727|HIV Preventive Vaccine|hiv preventive vaccine
5508296|NCT01260675|phase 1 study|phase 1 study
5508297|NCT01260675|volunteers|volunteers
5508298|NCT01260662|Deep Procedural Sedation|deep procedural sedation
5508299|NCT01260662|Propofol|propofol
5508300|NCT01260662|Ketamine|ketamine
5508301|NCT01260662|Emergency Department|emergency department
5508302|NCT01260662|Monitoring|monitoring
5508303|NCT01260662|Capnography|capnography
5508304|NCT01260662|Procedural Sedation in the Emergency Department|procedural sedation in the emergency department
5685336|NCT00556504|TCM-700C|tcm-700c
5508305|NCT01260649|Electroconvulsive treatment|electroconvulsive treatment
5508306|NCT01260649|ketamine|ketamine
5490349|NCT01335828|Echography|echography
5508307|NCT01260649|Major Depression|major depression
5508308|NCT01260649|Treatment-resistant Major Depressive Disorder|treatment-resistant major depressive disorder
5508309|NCT01260623|asthma|asthma
5508310|NCT01260623|pharmacokinetics|pharmacokinetics
5508311|NCT01260623|prednisone|prednisone
5508312|NCT01260623|prednisolone|prednisolone
5508313|NCT01260623|asthma exacerbation|asthma exacerbation
5508314|NCT01260623|pharmacokinetic profile|pharmacokinetic profile
5508315|NCT01260610|Hepatitis B, Tenofovir, Telbivudine|hepatitis b, tenofovir, telbivudine
5508316|NCT01260597|smoking|smoking
5508317|NCT01260597|quit line re-enrollment and IVR systems|quit line re-enrollment and ivr systems
5508318|NCT01260584|thienopyridine|thienopyridine
5508319|NCT01260584|antiplatelet|antiplatelet
5508320|NCT01260584|prasugrel|prasugrel
5508321|NCT01260584|clopidogrel|clopidogrel
5508322|NCT01260571|blackheads and pimples|blackheads and pimples
5508323|NCT01260571|Acne vulgaris grade II|acne vulgaris grade ii
5508324|NCT01260532|Autoimmune thyroid disease|autoimmune thyroid disease
5508325|NCT01260506|Relapsed Glioblastoma Multiforme, GBM|relapsed glioblastoma multiforme, gbm
5508326|NCT01260493|very frail|very frail
5508327|NCT01260493|case manager|case manager
5508328|NCT01260493|integrated care|integrated care
5508329|NCT01260493|multiprofessional|multiprofessional
5508330|NCT01260493|intervention|intervention
5508331|NCT01260480|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
5508332|NCT01260480|Head and neck neoplasms|head and neck neoplasms
5508333|NCT01260480|Diagnostic imaging|diagnostic imaging
5508334|NCT01260467|recurrent|recurrent
5508335|NCT01260454|Qutenza|qutenza
5508336|NCT01260454|Capsaicin|capsaicin
5508337|NCT01260454|Remodulin|remodulin
5508338|NCT01260454|Treprostinil|treprostinil
5508339|NCT01260428|hypoxia|hypoxia
5508340|NCT01260428|O2 diffusion and convection|o2 diffusion and convection
5508341|NCT01260428|cardiac output|cardiac output
5508342|NCT01260428|PEEP|peep
5508343|NCT01260428|Effects of hypoxia|effects of hypoxia
5508344|NCT01260415|colorectal cancer|colorectal cancer
5508345|NCT01260415|liver metastases|liver metastases
5508346|NCT01260415|panitumumab|panitumumab
5508347|NCT01260415|FOLFOX|folfox
5508348|NCT01260415|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
5508349|NCT01260402|heart failure|heart failure
5508350|NCT01260402|Cardiomyopathy, dilated|cardiomyopathy, dilated
5508351|NCT01260402|Coronary disease|coronary disease
5508352|NCT01260402|Cardiac Pacing, Artificial|cardiac pacing, artificial
5508353|NCT01260402|cardiac resynchronization therapy|cardiac resynchronization therapy
5508354|NCT01260402|Hemodynamics|hemodynamics
5508355|NCT01260402|Randomized Controlled Trials|randomized controlled trials
5508356|NCT01260402|Open Study|open study
5508485|NCT01259947|medicinal plant|medicinal plant
5508357|NCT01260389|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5508358|NCT01260389|COPD|copd
5508360|NCT01260376|Metabolism|metabolism
5508361|NCT01260376|Exercise|exercise
5508362|NCT01260376|Free Fatty Acids|free fatty acids
5508363|NCT01260350|PSI-7977|psi-7977
5508364|NCT01260350|Sofosbuvir|sofosbuvir
5508365|NCT01260350|GS-7977|gs-7977
5508366|NCT01260350|GS-5885|gs-5885
5508367|NCT01260350|GS-9669|gs-9669
5508368|NCT01260350|FDC|fdc
5508369|NCT01260350|ribavirin|ribavirin
5508370|NCT01260350|RBV|rbv
5508371|NCT01260350|Pegylated Interferon|pegylated interferon
5508372|NCT01260350|PEG-IFN|peg-ifn
5508373|NCT01260350|Chronic Hepatitis C Infection|chronic hepatitis c infection
5508374|NCT01260350|HCV|hcv
5508375|NCT01260350|Hepatitis|hepatitis
5508376|NCT01260350|Genotype 1|genotype 1
5508377|NCT01260350|Genotype 2|genotype 2
5508378|NCT01260350|Genotype 3|genotype 3
5508379|NCT01260350|GT 1|gt 1
5508380|NCT01260350|GT 2|gt 2
5508381|NCT01260350|GT 3|gt 3
5508382|NCT01260350|Hemophilia|hemophilia
5508383|NCT01260337|Weight loss|weight loss
5508384|NCT01260337|Type 2 Diabetes|type 2 diabetes
5508385|NCT01260337|Behavior Modification|behavior modification
5508386|NCT01260337|portion control|portion control
5508387|NCT01260324|Phosphodiesterase type 5 inhibitors|phosphodiesterase type 5 inhibitors
5508388|NCT01260324|non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
5508389|NCT01260324|descriptive epidemiology study|descriptive epidemiology study
5508390|NCT01260311|Observational|observational
5508391|NCT01260298|MC1 VASER VASERShape|mc1 vaser vasershape
5508392|NCT01260272|Cardiovascular|cardiovascular
5508393|NCT01260272|Risk Factors|risk factors
5508394|NCT01260272|Cardiovascular Disease|cardiovascular disease
5508395|NCT01260272|Glucose|glucose
5508396|NCT01260272|Blood Pressure|blood pressure
5508398|NCT01260272|Weight|weight
5508399|NCT01260272|Waist Circumference|waist circumference
5508400|NCT01260259|Pediatric|pediatric
5508401|NCT01260259|Cardiac|cardiac
5508402|NCT01260259|Surgery|surgery
5508403|NCT01260259|Cardiopulmonary|cardiopulmonary
5508404|NCT01260259|Bypass|bypass
5508405|NCT01260259|Myocardial|myocardial
5508406|NCT01260259|Kidney|kidney
5508407|NCT01260259|Lung|lung
5508408|NCT01260259|Injury|injury
5508409|NCT01260233|smoking cessation|smoking cessation
5508410|NCT01260233|complications|complications
5508411|NCT01260233|cigarettes|cigarettes
5508412|NCT01260233|preoperative|preoperative
5508413|NCT01260233|perioperative|perioperative
5508414|NCT01260233|surgery|surgery
5508415|NCT01260233|education|education
5508416|NCT01260233|nicotine replacement therapy|nicotine replacement therapy
5508417|NCT01260207|Acute Coronary Syndrome|acute coronary syndrome
5508418|NCT01260207|Interactive Voice Response Technology|interactive voice response technology
5508419|NCT01260207|Best Practice Guidelines|best practice guidelines
5508420|NCT01260207|Compliance|compliance
5508421|NCT01260207|Health Care Utilization|health care utilization
5508422|NCT01260168|Cancer|cancer
5508423|NCT01260168|Colorectal Cancer|colorectal cancer
5508424|NCT01260168|Neoplasm|neoplasm
5508425|NCT01260168|Colorectal Neoplasm|colorectal neoplasm
5508426|NCT01260168|Intestinal Neoplasms|intestinal neoplasms
5508427|NCT01260168|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5508428|NCT01260168|Digestive System Neoplasms|digestive system neoplasms
5508429|NCT01260168|Neoplasms by Site|neoplasms by site
5508430|NCT01260168|Neoplasms|neoplasms
5508431|NCT01260168|Digestive System Diseases|digestive system diseases
5508432|NCT01260168|Gastrointestinal Diseases|gastrointestinal diseases
5508433|NCT01260168|Colonic Diseases|colonic diseases
5508434|NCT01260168|Intestinal Diseases|intestinal diseases
5508435|NCT01260168|Rectal Diseases|rectal diseases
5508437|NCT01260129|silodosin|silodosin
5508438|NCT01260116|Efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia|efficacy,safety,ziprasidone,depressive symptoms ,schizophrenia
5508439|NCT01260103|Optic pathway glioma, recurrent|optic pathway glioma, recurrent
5508440|NCT01260103|Optic pathway glioma, progressive|optic pathway glioma, progressive
5508441|NCT01260103|Temozolomide|temozolomide
5508442|NCT01260103|Temodar|temodar
5508443|NCT01260103|TMZ|tmz
5508444|NCT01260103|Antineoplastons|antineoplastons
5508445|NCT01260103|ANP therapy|anp therapy
5508446|NCT01260103|Atengenal (A10)|atengenal (a10)
5508447|NCT01260103|Astugenal (AS2-1)|astugenal (as2-1)
5508448|NCT01260090|Minimally conscious states|minimally conscious states
5508449|NCT01260090|Persistently vegetative states|persistently vegetative states
5508450|NCT01260090|Traumatic brain injury|traumatic brain injury
5508451|NCT01260064|Appendicitis|appendicitis
5508452|NCT01260064|Open appendectomy|open appendectomy
5508453|NCT01260064|Laparoscopic appendectomy|laparoscopic appendectomy
5508454|NCT01260064|Endoclip|endoclip
5508455|NCT01260064|Intracorporeal suture|intracorporeal suture
5508456|NCT01260064|Quality-of-life|quality-of-life
5508457|NCT01260038|Non Small Cell Lung Cancer|non small cell lung cancer
5508458|NCT01260038|observational study|observational study
5508459|NCT01260038|EGFR mutation analysis|egfr mutation analysis
5508460|NCT01260038|EGFR mutation status|egfr mutation status
5508461|NCT01260038|testing turn around time|testing turn around time
5508462|NCT01260025|Tolerability|tolerability
5508463|NCT01260025|Pharmacokinetics|pharmacokinetics
5508464|NCT01260025|Endostatin|endostatin
5508465|NCT01260025|antiangiogenesis|antiangiogenesis
5508466|NCT01260025|cancer|cancer
5508467|NCT01260012|Schistosoma mansoni|schistosoma mansoni
5508468|NCT01260012|Schistosomiasis|schistosomiasis
5508469|NCT01260012|periportal fibrosis|periportal fibrosis
5508470|NCT01260012|antioxidant|antioxidant
5508471|NCT01260012|fibrosis reversal|fibrosis reversal
5508472|NCT01259999|malnutrition|malnutrition
5508473|NCT01259999|oleic-acid|oleic-acid
5508474|NCT01259999|micronutrient supplement|micronutrient supplement
5508475|NCT01259999|old peoples home|old peoples home
5508476|NCT01259986|Vitiligo|vitiligo
5508477|NCT01259986|Laser|laser
5508478|NCT01259986|Segmental vitiligo|segmental vitiligo
5508479|NCT01259986|Acral vitiligo|acral vitiligo
5508480|NCT01259973|Pharmacogenetics|pharmacogenetics
5508481|NCT01259973|Antipsychotics|antipsychotics
5508482|NCT01259973|Extrapyramidal Symptoms|extrapyramidal symptoms
5508483|NCT01259947|headache|headache
5508484|NCT01259947|migraine|migraine
5508486|NCT01259947|essential oil|essential oil
5508487|NCT01259947|phytotherapy|phytotherapy
5508488|NCT01259934|Randomized Phase III trial|randomized phase iii trial
5508489|NCT01259934|Adjuvant therapy|adjuvant therapy
5508490|NCT01259934|Interferon|interferon
5508491|NCT01259934|Melanoma|melanoma
5508492|NCT01259921|EEG biofeedback|eeg biofeedback
5508493|NCT01259921|neurofeedback|neurofeedback
5508494|NCT01259921|PTSD|ptsd
5508495|NCT01259921|Affect Regulation|affect regulation
5508496|NCT01259921|Chronic Trauma|chronic trauma
5508497|NCT01259908|laparoscopic aortic surgery|laparoscopic aortic surgery
5508503|NCT01259856|PEGASYS|pegasys
5508504|NCT01259856|Pegylated Interferon Alfa-2a|pegylated interferon alfa-2a
5508505|NCT01259843|Acute aortic syndrome|acute aortic syndrome
5508506|NCT01259830|fast-track|fast-track
5508507|NCT01259830|colon or rectal surgery|colon or rectal surgery
5508508|NCT01259830|pain relief|pain relief
5508509|NCT01259817|Polycythemia Vera|polycythemia vera
5685337|NCT00556504|genotype I|genotype i
5508510|NCT01259817|Essential Thrombocythemia|essential thrombocythemia
5508511|NCT01259817|Hydroxyurea Resistant|hydroxyurea resistant
5490551|NCT01334905|Urinary incontinence|urinary incontinence
5508512|NCT01259817|Abdominal Vein Thrombosis|abdominal vein thrombosis
5508513|NCT01259817|PEGASYS|pegasys
5508514|NCT01259804|peanut|peanut
5508515|NCT01259804|food allergy|food allergy
5508516|NCT01259804|anaphylaxis|anaphylaxis
5508517|NCT01259804|immunotherapy|immunotherapy
5508518|NCT01259778|Growth disorders|growth disorders
5508519|NCT01259778|Saizen|saizen
5508520|NCT01259778|easypod™|easypod™
5508521|NCT01259778|Growth hormone|growth hormone
5508522|NCT01259778|Pediatric subject|pediatric subject
5508523|NCT01259765|llama antibody|llama antibody
5508524|NCT01259765|rotavirus diarrhoea|rotavirus diarrhoea
5508525|NCT01259765|children|children
5508526|NCT01259752|Trauma|trauma
5508527|NCT01259752|ankle sprain|ankle sprain
5508528|NCT01259752|emergency|emergency
5508529|NCT01259752|compression stocking|compression stocking
5508530|NCT01259739|trained cyclists|trained cyclists
5508531|NCT01259739|no medications|no medications
5508532|NCT01259739|no diseases|no diseases
5508533|NCT01259739|non-smokers|non-smokers
5508534|NCT01259726|Diarrhea|diarrhea
5508535|NCT01259726|Clostridium difficile|clostridium difficile
5508536|NCT01259726|Clostridium infections|clostridium infections
5508537|NCT01259726|Signs and Symptoms Digestive|signs and symptoms digestive
5508538|NCT01259726|Bacterial Infections|bacterial infections
5508539|NCT01259726|Pharmacologic Actions|pharmacologic actions
5508540|NCT01259713|Ambisome|ambisome
5508542|NCT01259713|invasive fungal infection|invasive fungal infection
5508543|NCT01259713|prophylaxis|prophylaxis
5508544|NCT01259713|liposomal amphotericin B|liposomal amphotericin b
5508545|NCT01259713|Invasive fungal infection prophylaxis|invasive fungal infection prophylaxis
5508546|NCT01259700|High blood pressure|high blood pressure
5508547|NCT01259700|Primary care|primary care
5508548|NCT01259700|Cardiovascular disease prevention|cardiovascular disease prevention
5508549|NCT01259700|Salt reduction|salt reduction
5508550|NCT01259687|Electrocardiogram|electrocardiogram
5508551|NCT01259687|Arterial line waveform|arterial line waveform
5508552|NCT01259687|Cardiac output|cardiac output
5508553|NCT01259674|Pediatric|pediatric
5508554|NCT01259674|children|children
5508555|NCT01259674|acute cough|acute cough
5508556|NCT01259674|treatment|treatment
5508557|NCT01259674|syrup|syrup
5508558|NCT01259674|protective natural extracts|protective natural extracts
5508559|NCT01259661|physical activity|physical activity
5508560|NCT01259661|metabolic syndrome|metabolic syndrome
5508561|NCT01259661|postmenopausal women|postmenopausal women
5508562|NCT01259661|exercise training|exercise training
5508563|NCT01259648|remifentanil|remifentanil
5508564|NCT01259648|anesthesia induction|anesthesia induction
5508565|NCT01259648|reactional tachycardia|reactional tachycardia
5508566|NCT01259635|Parkinson's disease|parkinson's disease
5508567|NCT01259635|freezing of gait|freezing of gait
5508568|NCT01259609|Diabetic Macular Edema|diabetic macular edema
5508569|NCT01259609|Ciliary Body|ciliary body
5508570|NCT01259609|Ultrasound Biomicroscopy|ultrasound biomicroscopy
5508571|NCT01259609|Vitrectomy|vitrectomy
5508572|NCT01259596|anxiety|anxiety
5508573|NCT01259596|rural|rural
5508574|NCT01259596|elderly|elderly
5508575|NCT01259544|CP-Chronic Pancreatitis|cp-chronic pancreatitis
5508576|NCT01259544|DPT-Di peptide breath test|dpt-di peptide breath test
5508577|NCT01259544|ePFT- Endoscopic pancreatic function test|epft- endoscopic pancreatic function test
5508578|NCT01259531|strong|strong
5508579|NCT01259531|silodosin|silodosin
5508580|NCT01259531|benign prostatic hyperplasia|benign prostatic hyperplasia
5508582|NCT01259531|lower urinary tract symptoms associated with severe BPH|lower urinary tract symptoms associated with severe bph
5508583|NCT01259505|no number|no number
5508584|NCT01259492|Attention Deficit /Hyperactivity Disorder, hyperactivity|attention deficit /hyperactivity disorder, hyperactivity
5508585|NCT01259479|Solid Tumors|solid tumors
5508586|NCT01259479|Maximum Tolerated Dose|maximum tolerated dose
5508587|NCT01259479|Parmacokinetics|parmacokinetics
5508588|NCT01259479|Pharmacogenomics|pharmacogenomics
5508589|NCT01259479|Satraplatin|satraplatin
5508590|NCT01259479|Cancer|cancer
5508592|NCT01259479|Brain Tumor|brain tumor
5508593|NCT01259466|Smoking cessation|smoking cessation
5508594|NCT01259466|Overweight|overweight
5508595|NCT01259466|Obesity|obesity
5508596|NCT01259466|Internet treatment|internet treatment
5508597|NCT01259453|Hepatitis B vaccination|hepatitis b vaccination
5508598|NCT01259453|Syringe exchange programs|syringe exchange programs
5508599|NCT01259453|Injection drug users|injection drug users
5508600|NCT01259453|Hepatitis B prevention through vaccination|hepatitis b prevention through vaccination
5508601|NCT01259440|Telemedicine|telemedicine
5508602|NCT01259440|continuous positive airway pressure|continuous positive airway pressure
5508603|NCT01259440|treatment adherence|treatment adherence
5508604|NCT01259427|Mental Disorders|mental disorders
5508605|NCT01259427|Psychotic Disorders|psychotic disorders
5508606|NCT01259427|Schizophrenia|schizophrenia
5508607|NCT01259427|Stigmatization|stigmatization
5508608|NCT01259427|Mood Disorders|mood disorders
5508609|NCT01259427|Schizophrenia and Disorders with Psychotic Feature|schizophrenia and disorders with psychotic feature
5508610|NCT01259414|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5508611|NCT01259414|Liver Neoplasms|liver neoplasms
5508612|NCT01259414|Survival analysis|survival analysis
5508613|NCT01259414|treatment outcome|treatment outcome
5508614|NCT01259414|administration drugs|administration drugs
5508615|NCT01259414|Chemoembolization,|chemoembolization,
5508616|NCT01259414|TACE|tace
5508617|NCT01259414|polyvinyl alcohol|polyvinyl alcohol
5508618|NCT01259414|water-soluble contrast mesium|water-soluble contrast mesium
5508619|NCT01259414|iopamidol|iopamidol
5508620|NCT01259414|lipiodol|lipiodol
5508621|NCT01259414|distilled water|distilled water
5508623|NCT01259401|Rehabilitation|rehabilitation
5508624|NCT01259401|Behavior therapy|behavior therapy
5508625|NCT01259401|Insomnia|insomnia
5508626|NCT01259388|Multiple sclerosis|multiple sclerosis
5508627|NCT01259388|Lithium|lithium
5508628|NCT01259349|cataract,|cataract,
5508629|NCT01259349|phacoemulsification,|phacoemulsification,
5508630|NCT01259349|one percent ultrasound|one percent ultrasound
5508631|NCT01259349|endothelial cell density|endothelial cell density
5508632|NCT01259336|Itraconazole|itraconazole
5508633|NCT01259336|chronic cavitary pulmonary aspergillosis|chronic cavitary pulmonary aspergillosis
5508634|NCT01259336|Aspergillosis|aspergillosis
5508635|NCT01259336|fungal ball|fungal ball
5508636|NCT01259336|mycetoma|mycetoma
5508637|NCT01259336|efficacy|efficacy
5508638|NCT01259336|safety|safety
5508639|NCT01259310|fertility|fertility
5508640|NCT01259310|women|women
5508641|NCT01259310|epilepsy|epilepsy
5508642|NCT01259310|pregnancy|pregnancy
5508643|NCT01259310|seizures|seizures
5508644|NCT01259310|seizure frequency|seizure frequency
5508645|NCT01259310|ovulation|ovulation
5508646|NCT01259310|menstruation|menstruation
5508647|NCT01259310|hormones|hormones
5508648|NCT01259310|progesterone|progesterone
5508649|NCT01259297|Aliskiren|aliskiren
5508650|NCT01259297|Elderly|elderly
5508651|NCT01259297|Major Cardiovascular Events|major cardiovascular events
5508652|NCT01259297|Effect of aliskiren-based regimen on major CV events (composite of CV death, non-fatal MI, non-fatal stroke and significant heart failure) in the elderly|effect of aliskiren-based regimen on major cv events (composite of cv death, non-fatal mi, non-fatal stroke and significant heart failure) in the elderly
5508653|NCT01259284|Breast cancer|breast cancer
5508654|NCT01259284|Colorectal cancer|colorectal cancer
5508655|NCT01259284|Genitourinary cancer|genitourinary cancer
5508656|NCT01259284|Head and neck cancers|head and neck cancers
5508657|NCT01259284|Lung cancer|lung cancer
5508658|NCT01259284|Melanoma|melanoma
5508659|NCT01259284|Sarcoma|sarcoma
5508660|NCT01259284|Atorvastatin|atorvastatin
5508661|NCT01259284|Lipitor|lipitor
5508662|NCT01259284|Fish Oil supplement|fish oil supplement
5508663|NCT01259284|Placebo|placebo
5508664|NCT01259271|human|human
5508666|NCT01259271|modulation|modulation
5508667|NCT01259271|Healthy human|healthy human
5508668|NCT01259271|sNCT|snct
5508669|NCT01259271|stimulation|stimulation
5508670|NCT01259258|varicocele, methylene blue, varicocelectomy, hydrocele,|varicocele, methylene blue, varicocelectomy, hydrocele,
5508671|NCT01259245|Chronic obstructive pulmonary disease COPD|chronic obstructive pulmonary disease copd
5508672|NCT01259245|pulmonary rehabilitation program PRP|pulmonary rehabilitation program prp
5508673|NCT01259245|Tai chi|tai chi
5508674|NCT01259219|HIV|hiv
5508675|NCT01259219|Completion of TB treamtment|completion of tb treamtment
5508676|NCT01259206|Calcaneal Spur, Diabetic Obese Patients|calcaneal spur, diabetic obese patients
5508677|NCT01259193|Hepatocellular Carcinoma|hepatocellular carcinoma
5508678|NCT01259193|Sorafenib|sorafenib
5508679|NCT01259193|Zoledronic Acid|zoledronic acid
5508680|NCT01259193|toxic reaction|toxic reaction
5508681|NCT01259180|acupuncture|acupuncture
5508682|NCT01259167|JOBA, Low Back Pain, Physical Exercise|joba, low back pain, physical exercise
5508683|NCT01259141|macrolide- resistant Mycoplasma pneumoniae,|macrolide- resistant mycoplasma pneumoniae,
5508684|NCT01259141|Mycoplasm pneumonia antibiotic therapy|mycoplasm pneumonia antibiotic therapy
5508685|NCT01259115|Healthy subjects|healthy subjects
5508686|NCT01259115|Opioid|opioid
5508688|NCT01259102|Healthy subjects|healthy subjects
5508689|NCT01259102|Opioid|opioid
5508690|NCT01259102|Transdermal|transdermal
5508691|NCT01259089|Adenocarcinoma of the Lung|adenocarcinoma of the lung
5508692|NCT01259089|Non-small Cell Lung Cancer|non-small cell lung cancer
5508693|NCT01259063|GEMCITABINE|gemcitabine
5508694|NCT01259063|RAD001(EVEROLIMUS)|rad001(everolimus)
5508695|NCT01259063|urinary|urinary
5508696|NCT01259063|BCG-Refractory|bcg-refractory
5508697|NCT01259063|Intravesical|intravesical
5508698|NCT01259063|10-165|10-165
5508699|NCT01259050|ALS treatment|als treatment
5508700|NCT01259050|Zinc|zinc
5508701|NCT01259050|Copper|copper
5508702|NCT01259050|BMAA|bmaa
5508703|NCT01259050|ALS|als
5508704|NCT01259037|Elastography|elastography
5508705|NCT01259037|Cutaneous|cutaneous
5508706|NCT01259037|Imaging|imaging
5490746|NCT01334190|safety|safety
5508707|NCT01259024|hepatocellular carcinoma|hepatocellular carcinoma
5508708|NCT01259024|chemoembolization|chemoembolization
5508709|NCT01259024|transarterial chemoembolization|transarterial chemoembolization
5508710|NCT01259024|liver cancer|liver cancer
5508711|NCT01259024|doxorubicin|doxorubicin
5508712|NCT01259024|drug-eluting beads|drug-eluting beads
5508713|NCT01259024|LC Bead|lc bead
5508714|NCT01259011|end stage renal disease|end stage renal disease
5508715|NCT01259011|dialysis|dialysis
5508716|NCT01259011|end of life decision making|end of life decision making
5508717|NCT01259011|surrogate psychological morbidities|surrogate psychological morbidities
5508718|NCT01258985|Knee|knee
5508719|NCT01258985|Knee osteoarthritis|knee osteoarthritis
5508720|NCT01258985|osteoarthritis|osteoarthritis
5508721|NCT01258985|Knee pain|knee pain
5508722|NCT01258985|Tai Chi|tai chi
5508723|NCT01258985|Physical Therapy|physical therapy
5508724|NCT01258985|mind-body exercise|mind-body exercise
5508725|NCT01258972|Bifurcation lesions|bifurcation lesions
5508726|NCT01258959|Ultrasound, retrobulbar, parabulbar, ophthalmic surgery.|ultrasound, retrobulbar, parabulbar, ophthalmic surgery.
5508727|NCT01258946|epicardial adipose pcos|epicardial adipose pcos
5508728|NCT01258933|Leukemia|leukemia
5508729|NCT01258933|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5508731|NCT01258933|Lymphoma|lymphoma
5508732|NCT01258933|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5508733|NCT01258933|SLL|sll
5508734|NCT01258933|Ofatumumab|ofatumumab
5508735|NCT01258920|Schizophrenia|schizophrenia
5508736|NCT01258920|Paliperidone palmitate|paliperidone palmitate
5508737|NCT01258920|Intramascular Injection|intramascular injection
5508738|NCT01258907|BI-204|bi-204
5508739|NCT01258868|Mesothelioma|mesothelioma
5508740|NCT01258868|Esophageal Cancer|esophageal cancer
5508741|NCT01258868|Lung Cancer|lung cancer
5508742|NCT01258868|Thoracic Malignancies|thoracic malignancies
5508743|NCT01258868|Tumor Cell Vaccine|tumor cell vaccine
5508744|NCT01258842|Influenza|influenza
5508745|NCT01258842|Prevention|prevention
5508746|NCT01258842|Probiotic|probiotic
5508747|NCT01258829|Heart Failure Cardiac Resynchronisation Therapy|heart failure cardiac resynchronisation therapy
5508748|NCT01258816|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5508749|NCT01258816|Pharmacokinetics|pharmacokinetics
5508750|NCT01258816|Elacytarabine|elacytarabine
5508751|NCT01258816|CP-4055|cp-4055
5508752|NCT01258803|asthma|asthma
5508753|NCT01258803|children|children
5508754|NCT01258803|persistent|persistent
5508756|NCT01258790|tics|tics
5508757|NCT01258790|tourette|tourette
5508758|NCT01258777|Healthy volunteers|healthy volunteers
5508759|NCT01258777|Japanese male|japanese male
5508760|NCT01258777|Caucasian male|caucasian male
5508761|NCT01258777|Simponi|simponi
5508762|NCT01258764|hypertension|hypertension
5508851|NCT01258153|Nepadutant|nepadutant
5508763|NCT01258764|Blood Pressure control|blood pressure control
5508764|NCT01258764|hypertension treatment|hypertension treatment
5508765|NCT01258764|antihypertensive|antihypertensive
5508766|NCT01258764|N of 1 study|n of 1 study
5508767|NCT01258751|Healthy Volunteers|healthy volunteers
5508768|NCT01258738|Early ankylosing spondylitis (SpA) study; efficacy and safety and health out comes|early ankylosing spondylitis (spa) study; efficacy and safety and health out comes
5508769|NCT01258725|amnioinfusion, severe idiopahic oligohydramnios|amnioinfusion, severe idiopahic oligohydramnios
5508770|NCT01258673|Fimasartan|fimasartan
5508771|NCT01258673|Fimasartan/Hydrochlorothiazide combination|fimasartan/hydrochlorothiazide combination
5508772|NCT01258647|infant nutrition|infant nutrition
5508773|NCT01258647|complementary feeding|complementary feeding
5508774|NCT01258647|malnutrition|malnutrition
5508775|NCT01258647|stunting of growth|stunting of growth
5508776|NCT01258634|Osteosarcoma|osteosarcoma
5508777|NCT01258634|Surgically Resectable High Grade Osteosarcoma|surgically resectable high grade osteosarcoma
5508778|NCT01258634|Lung Metastases Only|lung metastases only
5508779|NCT01258621|distal pancreatectomy, laparoscopy, learning curve|distal pancreatectomy, laparoscopy, learning curve
5508780|NCT01258608|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5508781|NCT01258608|Mapatumumab|mapatumumab
5508782|NCT01258608|HGS1012|hgs1012
5508783|NCT01258608|sorafenib|sorafenib
5508784|NCT01258595|Influenza|influenza
5503003|NCT01283412|Delirium|delirium
5508786|NCT01258595|High-Dose Trivalent Inactivated Influenza Vaccine|high-dose trivalent inactivated influenza vaccine
5508787|NCT01258595|Influenza vaccines|influenza vaccines
5508789|NCT01258582|Testing|testing
5508790|NCT01258582|HIV Seronegativity|hiv seronegativity
5508791|NCT01258569|laparoscopic|laparoscopic
5508793|NCT01258569|resection|resection
5508794|NCT01258569|Entereg|entereg
5508795|NCT01258543|Global osteopathic evaluation|global osteopathic evaluation
5508796|NCT01258543|Non-specific back pain|non-specific back pain
5508797|NCT01258543|Inter-examiner reliability|inter-examiner reliability
5508798|NCT01258530|influenza, bioequivalence, oseltamivir, Tamiflu, over-encapsulation|influenza, bioequivalence, oseltamivir, tamiflu, over-encapsulation
5508799|NCT01258517|RDS|rds
5508800|NCT01258517|surfactant|surfactant
5508801|NCT01258517|cerebral oxygenation|cerebral oxygenation
5508802|NCT01258517|near infrared spectroscopy|near infrared spectroscopy
5508803|NCT01258504|Steady-state|steady-state
5508804|NCT01258504|Bosentan|bosentan
5508805|NCT01258504|St. Johns Wort|st. johns wort
5508806|NCT01258478|NSCLC, rehabilitation, CPET, lung resection|nsclc, rehabilitation, cpet, lung resection
5508807|NCT01258465|Communication|communication
5508808|NCT01258465|Pivotal Response Training|pivotal response training
5508809|NCT01258465|Picture Exchange Communication System|picture exchange communication system
5508810|NCT01258439|HIV|hiv
5508811|NCT01258439|cardiovascular disease|cardiovascular disease
5508812|NCT01258439|post prandial lipids|post prandial lipids
5508813|NCT01258439|ritonavir|ritonavir
5508814|NCT01258439|darunavir|darunavir
5508815|NCT01258439|raltegravir|raltegravir
5508816|NCT01258439|arterial stiffness|arterial stiffness
5508817|NCT01258439|tonometry|tonometry
5508818|NCT01258413|Cervical Cancer|cervical cancer
5508819|NCT01258413|Radical hysterectomy, Laparoscopic|radical hysterectomy, laparoscopic
5508820|NCT01258413|Overall survival|overall survival
5508821|NCT01258413|Disease-free five-years survival|disease-free five-years survival
5508822|NCT01258374|Pharmacokinetics, raltegravir, darunavir, NRTI sparing regimen|pharmacokinetics, raltegravir, darunavir, nrti sparing regimen
5508823|NCT01258361|preoperative fasting|preoperative fasting
5508824|NCT01258296|Postoperative pain|postoperative pain
5508825|NCT01258296|Breast reconstruction|breast reconstruction
5508826|NCT01258296|Abdominal flap breast reconstruction|abdominal flap breast reconstruction
5508827|NCT01258257|Aneurysm|aneurysm
5508828|NCT01258257|Subarachnoid hemorrhage|subarachnoid hemorrhage
5508829|NCT01258257|Lumbar drain|lumbar drain
5508830|NCT01258257|Cerebral vasospasm|cerebral vasospasm
5508831|NCT01258257|Cerebral Ventricles|cerebral ventricles
5508832|NCT01258257|Cerebrospinal Fluid|cerebrospinal fluid
5508833|NCT01258257|Prospective Studies|prospective studies
5508834|NCT01258257|Drainage/methods*|drainage/methods*
5508835|NCT01258257|Humans|humans
5508836|NCT01258257|Subarachnoid Hemorrhage/cerebrospinal fluid*|subarachnoid hemorrhage/cerebrospinal fluid*
5508837|NCT01258257|Subarachnoid Hemorrhage/complications*|subarachnoid hemorrhage/complications*
5508838|NCT01258257|Subarachnoid Space/surgery*|subarachnoid space/surgery*
5508839|NCT01258257|Vasospasm, Intracranial/etiology|vasospasm, intracranial/etiology
5508840|NCT01258257|Vasospasm, Intracranial/surgery*|vasospasm, intracranial/surgery*
5508841|NCT01258244|Out-of-Hospital Cardiac Arrest, OHCA|out-of-hospital cardiac arrest, ohca
5508842|NCT01258205|Amgen|amgen
5508843|NCT01258205|AMG 139|amg 139
5508844|NCT01258205|Crohn's Disease|crohn's disease
5508845|NCT01258192|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5508846|NCT01258192|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5508847|NCT01258192|albumin-bound paclitaxel|albumin-bound paclitaxel
5508848|NCT01258192|cisplatin|cisplatin
5508849|NCT01258153|Infantile Colic|infantile colic
5508850|NCT01258153|tachykinin antagonist|tachykinin antagonist
5508852|NCT01258140|CT angiography|ct angiography
5508853|NCT01258140|radiation dose|radiation dose
5508854|NCT01258140|contrast medium|contrast medium
5508856|NCT01258127|Vinorelbine|vinorelbine
5508857|NCT01258127|Carboplatin|carboplatin
5508858|NCT01258114|Overweight|overweight
5508860|NCT01258114|Balneotherapy|balneotherapy
5508861|NCT01258114|Spa Therapy|spa therapy
5508862|NCT01258114|balneology|balneology
5508863|NCT01258114|hydrotherapy|hydrotherapy
5508864|NCT01258114|SF 12|sf 12
5508865|NCT01258114|Nutritional counselling|nutritional counselling
5508866|NCT01258114|Zelen double consent|zelen double consent
5508867|NCT01258114|Lifestyle modification program|lifestyle modification program
5508868|NCT01258114|IMC|imc
5508869|NCT01258088|psoriasis|psoriasis
5508870|NCT01258075|Type 2 diabetes mellitus|type 2 diabetes mellitus
5508871|NCT01258075|Blood glucose|blood glucose
5508872|NCT01258075|Anti-diabetic|anti-diabetic
5508873|NCT01258075|Bile acid sequestrant|bile acid sequestrant
5508874|NCT01258075|Colesevelam HCl|colesevelam hcl
5508875|NCT01258075|Oral suspension|oral suspension
5508876|NCT01258075|Pediatric|pediatric
5508877|NCT01258075|Add-on therapy|add-on therapy
5508878|NCT01258075|Add-on to metformin|add-on to metformin
5508879|NCT01258075|Metformin|metformin
5508880|NCT01258075|Adolescent|adolescent
5508881|NCT01258075|Lipid|lipid
5508882|NCT01258049|Plasmodium infections|plasmodium infections
5508883|NCT01258049|Remittent fever|remittent fever
5508884|NCT01258049|Artemether|artemether
5508885|NCT01258049|Artemesinins|artemesinins
5508886|NCT01258049|Quinine|quinine
5508887|NCT01258049|Malaria|malaria
5493573|NCT01322074|CRP|crp
5508888|NCT01258049|Protozoan infections|protozoan infections
5508889|NCT01258049|sublingual drug delivery|sublingual drug delivery
5508890|NCT01258049|Parasitic disease|parasitic disease
5508891|NCT01258049|Antiprotozoan agents|antiprotozoan agents
5508892|NCT01258036|Bone microarchitecture|bone microarchitecture
5508893|NCT01258036|Bone mineral density|bone mineral density
5508894|NCT01258036|Bone markers|bone markers
5508895|NCT01258036|hereditary determinism|hereditary determinism
5508896|NCT01258010|Red blood cell transfusion|red blood cell transfusion
5508897|NCT01258010|Neurosurgery|neurosurgery
5508898|NCT01258010|Orthopedic surgery|orthopedic surgery
5508899|NCT01258010|Tranexamic acid|tranexamic acid
5508900|NCT01258010|Surgical blood loss|surgical blood loss
5508901|NCT01257997|No specific experimental conditions|no specific experimental conditions
5508902|NCT01257971|Cholesterol|cholesterol
5508903|NCT01257971|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5508904|NCT01257971|cardiovascular risk|cardiovascular risk
5508905|NCT01257971|LDLl|ldll
5508906|NCT01257958|Vitamin D, 19 nor Vitamin D, Multiple Sclerosis|vitamin d, 19 nor vitamin d, multiple sclerosis
5508907|NCT01257932|Breast Cancer|breast cancer
5508908|NCT01257906|acne|acne
5508909|NCT01257906|Ziana|ziana
5508910|NCT01257906|clindamycin|clindamycin
5508911|NCT01257906|tretinoin|tretinoin
5508912|NCT01257893|migraine|migraine
5508913|NCT01257893|chronic migraine|chronic migraine
5508914|NCT01257893|migraine with aura|migraine with aura
5508915|NCT01257893|migraine without aura|migraine without aura
5508917|NCT01257893|platelets|platelets
5508918|NCT01257880|Migraine|migraine
5508919|NCT01257880|Migraine with Aura|migraine with aura
5508920|NCT01257880|Aura|aura
5508921|NCT01257880|Patent Foramen Ovale|patent foramen ovale
5508922|NCT01257880|Platelets|platelets
5508923|NCT01257880|Sleep Apnea|sleep apnea
5508924|NCT01257880|Cognitive Function|cognitive function
5508925|NCT01257867|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5508926|NCT01257867|Oxidative stress|oxidative stress
5508927|NCT01257867|Neurogenesis|neurogenesis
5508928|NCT01257867|Lithium|lithium
5508929|NCT01257867|Lithia water|lithia water
5508930|NCT01257854|busulfan|busulfan
5508931|NCT01257854|pharmacogenetic|pharmacogenetic
5508932|NCT01257854|pharmacokinetic|pharmacokinetic
5508933|NCT01257854|toxicity|toxicity
5508934|NCT01257854|survival|survival
5508935|NCT01257841|Fasting|fasting
5508936|NCT01257841|Gut hormones|gut hormones
5508937|NCT01257841|Inflammatory Cytokines|inflammatory cytokines
5508938|NCT01257815|Diabetes mellitus|diabetes mellitus
5508939|NCT01257815|Diabetic retinopathy|diabetic retinopathy
5508940|NCT01257815|Macular oedema|macular oedema
5508941|NCT01257815|Visual acuity|visual acuity
5508942|NCT01257789|laparoscopic gastric bypass|laparoscopic gastric bypass
5508943|NCT01257789|learning curve|learning curve
5508944|NCT01257789|complications|complications
5508945|NCT01257789|operative time|operative time
5508946|NCT01257776|Critical Limb Ischemia (CLI)|critical limb ischemia (cli)
5508947|NCT01257776|Diabetes|diabetes
5508948|NCT01257776|Mesenchymal Stem Cells|mesenchymal stem cells
5508949|NCT01257776|Regenerative Therapy|regenerative therapy
5508950|NCT01257763|needles/adverse effects|needles/adverse effects
5508951|NCT01257763|administration, cutaneous|administration, cutaneous
5508952|NCT01257763|erythema|erythema
5508953|NCT01257763|pain measurement|pain measurement
5508954|NCT01257763|Safety|safety
5508955|NCT01257763|Microstructure Transdermal System|microstructure transdermal system
5508956|NCT01257750|corneal neovascularization|corneal neovascularization
5508957|NCT01257750|pazopanib|pazopanib
5508958|NCT01257750|votrient|votrient
5508959|NCT01257750|rosacea|rosacea
5508960|NCT01257737|Urea Cycle Disorders|urea cycle disorders
5508961|NCT01257737|GT4P|gt4p
5508962|NCT01257737|HPN-100|hpn-100
5508963|NCT01257737|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
5508964|NCT01257737|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5508965|NCT01257737|Phenylbutyrate|phenylbutyrate
5508966|NCT01257737|Hyperion|hyperion
5508967|NCT01257737|BUPHENYL|buphenyl
5508968|NCT01257737|hyperammonemia|hyperammonemia
5508969|NCT01257724|Knowledge translation|knowledge translation
5508970|NCT01257724|Community based organizations|community based organizations
5508971|NCT01257724|HIV/AIDS|hiv/aids
5508972|NCT01257711|Gastric Cancer|gastric cancer
5508973|NCT01257711|Gastrectomy|gastrectomy
5508974|NCT01257711|Billroth 2|billroth 2
5508975|NCT01257711|Roux-en-Y|roux-en-y
5508976|NCT01257698|Vitrectomy|vitrectomy
5508977|NCT01257698|Gas bubble|gas bubble
5508978|NCT01257698|Retinal detachment|retinal detachment
5508979|NCT01257698|Macular hole|macular hole
5508980|NCT01257698|Aqueous suppressant|aqueous suppressant
5508981|NCT01257672|acute gastroenteritis|acute gastroenteritis
5508982|NCT01257672|vomiting|vomiting
5508983|NCT01257672|ondansetron|ondansetron
5508985|NCT01257672|symptomatic treatment|symptomatic treatment
5508986|NCT01257659|Rectocele|rectocele
5508987|NCT01257659|Trans anal STARR resection|trans anal starr resection
5508988|NCT01257659|Transvaginal repair|transvaginal repair
5508989|NCT01257633|da Vinci surgical robot|da vinci surgical robot
5508990|NCT01257633|laryngeal cancer|laryngeal cancer
5508991|NCT01257620|Inflammatory Bowel Disease|inflammatory bowel disease
5508992|NCT01257620|Coeliac Disease|coeliac disease
5508993|NCT01257594|Gliomas|gliomas
5508994|NCT01257594|Erlotinib|erlotinib
5508995|NCT01257594|Glioblastoma|glioblastoma
5508997|NCT01257594|Gliosarcoma|gliosarcoma
5508998|NCT01257594|Glioma|glioma
5508999|NCT01257581|ALS|als
5509000|NCT01257581|Lou Gehrig's Disease|lou gehrig's disease
5685338|NCT00556491|renal|renal
5509001|NCT01257581|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5509002|NCT01257581|Creatine|creatine
5509003|NCT01257581|Tamoxifen|tamoxifen
5509004|NCT01257581|Selection Design|selection design
5509005|NCT01257542|randomized|randomized
5509006|NCT01257542|parallel|parallel
5509007|NCT01257542|double-blind|double-blind
5509008|NCT01257542|placebo-controlled|placebo-controlled
5509009|NCT01257542|cough|cough
5509010|NCT01257542|efficacy|efficacy
5509011|NCT01257542|safety|safety
5509012|NCT01257542|dextromethorphan|dextromethorphan
5509013|NCT01257529|pregabalin|pregabalin
5509014|NCT01257529|pharmacokinetics|pharmacokinetics
5509019|NCT01257516|bioavailability|bioavailability
5509020|NCT01257516|bioequivalence|bioequivalence
5509021|NCT01257503|children|children
5509022|NCT01257503|upper respiratory tract infections|upper respiratory tract infections
5509023|NCT01257503|homeopathy|homeopathy
5509024|NCT01257477|Diarrhea|diarrhea
5509025|NCT01257477|IBS|ibs
5509026|NCT01257477|Irritable Bowel Syndrome|irritable bowel syndrome
5509027|NCT01257464|CFRD|cfrd
5509028|NCT01257464|sitagliptin|sitagliptin
5509029|NCT01257464|cystic fibrosis-related diabetes|cystic fibrosis-related diabetes
5509030|NCT01257464|incretins|incretins
5509031|NCT01257464|hyperglycemia|hyperglycemia
5509032|NCT01257464|GIP|gip
5509033|NCT01257464|GLP-1|glp-1
5509034|NCT01257451|Type 2 Diabetes Mellitus, Vildagliptin, Elderly Patients|type 2 diabetes mellitus, vildagliptin, elderly patients
5509035|NCT01257412|Phase III|phase iii
5509036|NCT01257412|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5509037|NCT01257412|inadequate glycaemic control|inadequate glycaemic control
5509038|NCT01257360|RAS-Wildtype|ras-wildtype
5509039|NCT01257360|Radiotherapy|radiotherapy
5509040|NCT01257360|Neoadjuvant treatment|neoadjuvant treatment
5509041|NCT01257347|Medication adherence|medication adherence
5509042|NCT01257347|clinical inertia|clinical inertia
5509043|NCT01257347|treatment intensification|treatment intensification
5509044|NCT01257347|quality of care|quality of care
5509045|NCT01257334|type 2 diabetes|type 2 diabetes
5509046|NCT01257308|lung cancer|lung cancer
5509047|NCT01257295|dietary fiber|dietary fiber
5509048|NCT01257295|energy intake|energy intake
5509049|NCT01257295|appetite|appetite
5509050|NCT01257295|satiety hormones|satiety hormones
5509051|NCT01257295|glucose|glucose
5509052|NCT01257295|gastric emptying|gastric emptying
5509053|NCT01257269|Thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5509054|NCT01257269|ADAMTS13|adamts13
5509055|NCT01257269|Von Willebrand factor|von willebrand factor
5509056|NCT01257269|Von Willebrand factor cleaving protease|von willebrand factor cleaving protease
5509061|NCT01257243|symptoms|symptoms
5509062|NCT01257243|cold|cold
5509063|NCT01257243|flu|flu
5509064|NCT01257217|Intraocular Lens|intraocular lens
5509065|NCT01257217|Presbyopia|presbyopia
5509066|NCT01257217|multifocal|multifocal
5509067|NCT01257191|Vehicle Emissions|vehicle emissions
5509068|NCT01257191|Diesel Exhaust|diesel exhaust
5509069|NCT01257165|Automobile driving|automobile driving
5509070|NCT01257165|Zopiclone|zopiclone
5509071|NCT01257165|Drug safety|drug safety
5509072|NCT01257165|Traffic accidents|traffic accidents
5509073|NCT01257139|To evaluate a geriatric scale designed to help with treatment|to evaluate a geriatric scale designed to help with treatment
5509074|NCT01257139|allocation to dual-agent therapy based on platinum or to|allocation to dual-agent therapy based on platinum or to
5509075|NCT01257139|single-agent chemotherapy in elderly subjects with advancedstage|single-agent chemotherapy in elderly subjects with advancedstage
5509076|NCT01257139|NSCLC, based on the time to failure in the two arms|nsclc, based on the time to failure in the two arms
5509077|NCT01257126|Upper respiratory tract infections|upper respiratory tract infections
5509078|NCT01257126|diclofenac potassium|diclofenac potassium
5509079|NCT01257126|nimesulide|nimesulide
5509080|NCT01257126|fever|fever
5509081|NCT01257126|pain|pain
5509082|NCT01257113|shoulder pain|shoulder pain
5509083|NCT01257113|shoulder impingement|shoulder impingement
5509084|NCT01257113|rotatorcuff pathology|rotatorcuff pathology
5509085|NCT01257113|supervised exercise|supervised exercise
5509086|NCT01257113|homebased exercise|homebased exercise
5509090|NCT01257087|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5509091|NCT01257087|Obesity|obesity
5509092|NCT01257087|Bariatric Surgery|bariatric surgery
5493752|NCT01321346|Lymphoma|lymphoma
5509094|NCT01257087|Microvascular complications|microvascular complications
5509095|NCT01257087|Intensive|intensive
5509096|NCT01257087|Conservative|conservative
5509097|NCT01257074|Herpes Simplex|herpes simplex
5509098|NCT01257061|Dermatitis|dermatitis
5509099|NCT01257061|Dermatitis, Atopic|dermatitis, atopic
5509100|NCT01257048|Oxygen enhanced magnetic resonance imaging|oxygen enhanced magnetic resonance imaging
5509101|NCT01257048|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5509102|NCT01257048|method evaluation|method evaluation
5509103|NCT01257035|Rectum cancer|rectum cancer
5509104|NCT01257035|FAZA|faza
5509105|NCT01257035|18F-FAZA-PET/CT|18f-faza-pet/ct
5509106|NCT01257035|Radiotherapy|radiotherapy
5509107|NCT01257035|Chemoradiotherapy|chemoradiotherapy
5509108|NCT01257022|Prevention|prevention
5509110|NCT01257022|Substance use|substance use
5509111|NCT01257022|Hispanic|hispanic
5509112|NCT01257022|Adolescents|adolescents
5509113|NCT01257022|Unsafe sexual behavior|unsafe sexual behavior
5509114|NCT01257022|Behavioral intervention|behavioral intervention
5509120|NCT01256983|Daytime Sleepiness|daytime sleepiness
5509121|NCT01256944|PCOS|pcos
5509122|NCT01256944|DM|dm
5509123|NCT01256944|Hypertension|hypertension
5509124|NCT01256944|CVD|cvd
5509125|NCT01256931|2009 H1N1 influenza vaccine, organ transplant patients,|2009 h1n1 influenza vaccine, organ transplant patients,
5509126|NCT01256931|booster with Fluarix|booster with fluarix
5509127|NCT01256918|cataract|cataract
5509128|NCT01256918|phacoemulsification|phacoemulsification
5509129|NCT01256918|phacochop|phacochop
5509130|NCT01256918|phacotip|phacotip
5509131|NCT01256879|cimetidine|cimetidine
5509132|NCT01256879|pharmacokinetics|pharmacokinetics
5509133|NCT01256879|formulation|formulation
5509134|NCT01256866|Dexmedetomidine|dexmedetomidine
5509135|NCT01256866|Midazolam|midazolam
5509136|NCT01256866|Sedation|sedation
5509137|NCT01256866|Mechanical ventilation|mechanical ventilation
5509138|NCT01256866|Critically ill patients|critically ill patients
5509139|NCT01256853|histologically confirmed EBV+ NPC patients|histologically confirmed ebv+ npc patients
5509140|NCT01256827|age-related macular degeneration|age-related macular degeneration
5509141|NCT01256827|ranibizumab|ranibizumab
5509142|NCT01256827|geographic atrophy|geographic atrophy
5509143|NCT01256827|ANCHOR Study|anchor study
5509144|NCT01256827|MARINA Study|marina study
5509145|NCT01256814|HIV/AIDS|hiv/aids
5509146|NCT01256814|Adult|adult
5509147|NCT01256814|Behavioral Intervention|behavioral intervention
5509148|NCT01256814|Sleep|sleep
5509149|NCT01256814|Physical Activity|physical activity
5509150|NCT01256801|Metastatic Breast Neoplasms|metastatic breast neoplasms
5509151|NCT01256801|Gene Expression Profiling|gene expression profiling
5509152|NCT01256801|immunotherapy|immunotherapy
5509153|NCT01256788|viscosupplementation|viscosupplementation
5509154|NCT01256788|meniscus tear|meniscus tear
5509253|NCT01256346|baby|baby
5509155|NCT01256788|degenerative joint disease|degenerative joint disease
5509156|NCT01256775|atherosclerosis|atherosclerosis
5509157|NCT01256775|carotid intima-media thickness|carotid intima-media thickness
5509158|NCT01256775|intermittent claudication|intermittent claudication
5509159|NCT01256775|Nitric Oxide / NO|nitric oxide / no
5509160|NCT01256762|imetelstat|imetelstat
5509161|NCT01256762|imetelstat sodium|imetelstat sodium
5509162|NCT01256762|GRN163L|grn163l
5509163|NCT01256762|telomerase inhibitor|telomerase inhibitor
5509164|NCT01256762|telomerase inhibition|telomerase inhibition
5509165|NCT01256762|metastatic breast cancer|metastatic breast cancer
5509166|NCT01256762|locally recurrent breast cancer|locally recurrent breast cancer
5509167|NCT01256762|Bevacizumab|bevacizumab
5509168|NCT01256762|Paclitaxel|paclitaxel
5509169|NCT01256762|Avastin|avastin
5509170|NCT01256762|Taxol|taxol
5509171|NCT01256762|HER-2-negative|her-2-negative
5509172|NCT01256762|First-Line Chemotherapy|first-line chemotherapy
5509173|NCT01256762|Second-Line Chemotherapy|second-line chemotherapy
5509174|NCT01256723|drug eluting stent (DES)|drug eluting stent (des)
5509175|NCT01256723|unprotected left main coronary artery (ULMCA)|unprotected left main coronary artery (ulmca)
5509176|NCT01256684|Vulvar/vaginal atrophy|vulvar/vaginal atrophy
5509177|NCT01256684|Atrophic Vaginitis|atrophic vaginitis
5509178|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone
5509179|NCT01256684|DHEA|dhea
5509180|NCT01256684|Prasterone|prasterone
5509181|NCT01256684|Vaginorm|vaginorm
5509182|NCT01256684|Menopause|menopause
5509183|NCT01256684|Intrarosa|intrarosa
5509184|NCT01256671|Vulvar/Vaginal Atrophy|vulvar/vaginal atrophy
5509185|NCT01256671|Atrophic Vaginitis|atrophic vaginitis
5509186|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone
5509187|NCT01256671|DHEA|dhea
5509188|NCT01256671|Prasterone|prasterone
5509189|NCT01256671|Vaginorm|vaginorm
5509190|NCT01256671|Menopause|menopause
5509191|NCT01256671|Intrarosa|intrarosa
5509192|NCT01256658|P. falciparum|p. falciparum
5509193|NCT01256658|malaria|malaria
5509194|NCT01256658|asymptomatic carriers|asymptomatic carriers
5509195|NCT01256658|bed-nets|bed-nets
5509196|NCT01256658|ITN-insecticide-treated net|itn-insecticide-treated net
5509197|NCT01256658|idiopathic trigeminal neuralgia|idiopathic trigeminal neuralgia
5509198|NCT01256658|RDT-Rapid diagnostic test|rdt-rapid diagnostic test
5509200|NCT01256645|mechanical ventilation|mechanical ventilation
5509201|NCT01256645|blood transfusion|blood transfusion
5509202|NCT01256645|spontaneous breathing trials|spontaneous breathing trials
5509203|NCT01256619|Marvelon|marvelon
5509204|NCT01256619|PMS|pms
5509205|NCT01256619|serum Lipids|serum lipids
5509206|NCT01256593|Lyrica|lyrica
5509207|NCT01256593|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5509208|NCT01256593|Safety|safety
5509209|NCT01256593|Neuropathic Pain|neuropathic pain
5509210|NCT01256593|Post Marketing Surveillance|post marketing surveillance
5509211|NCT01256554|Stereotactic Radiosurgery|stereotactic radiosurgery
5509213|NCT01256554|Radiation|radiation
5509214|NCT01256554|Radiotherapy|radiotherapy
5509215|NCT01256554|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
5509216|NCT01256554|MESCC|mescc
5509217|NCT01256528|Invasive breast carcinoma|invasive breast carcinoma
5509218|NCT01256528|Breast reconstruction|breast reconstruction
5509219|NCT01256528|Mastectomy|mastectomy
5509220|NCT01256528|Breast cancer|breast cancer
5509221|NCT01256528|Delayed-delayed breast reconstruction|delayed-delayed breast reconstruction
5509222|NCT01256528|Post-mastectomy radiation therapy|post-mastectomy radiation therapy
5509223|NCT01256515|Healthy adults aged 50 or older|healthy adults aged 50 or older
5509224|NCT01256489|KPro|kpro
5509225|NCT01256489|Keratoprosthesis|keratoprosthesis
5509226|NCT01256489|Stevens-Johnson Syndrome|stevens-johnson syndrome
5509227|NCT01256489|Infliximab|infliximab
5509228|NCT01256489|Corneal Blindness|corneal blindness
5509229|NCT01256450|buccal soluble film|buccal soluble film
5509230|NCT01256450|enriched enrollment|enriched enrollment
5509231|NCT01256450|randomized withdrawal|randomized withdrawal
5509232|NCT01256437|Acneiform eruption|acneiform eruption
5509233|NCT01256437|papulopustular|papulopustular
5509234|NCT01256437|EGFR|egfr
5509235|NCT01256437|cetuximab|cetuximab
5509236|NCT01256437|erlotinib|erlotinib
5509237|NCT01256437|gefitinib|gefitinib
5509238|NCT01256437|panitumumab|panitumumab
5509239|NCT01256437|eruption secondary to treatment with either cetuximab|eruption secondary to treatment with either cetuximab
5509240|NCT01256424|CIN|cin
5509241|NCT01256411|hypertension|hypertension
5509242|NCT01256411|blood pressure|blood pressure
5509243|NCT01256411|LCZ696|lcz696
5509244|NCT01256411|dual-acting|dual-acting
5509245|NCT01256411|neprilysin|neprilysin
5509246|NCT01256411|nep inhibitor|nep inhibitor
5509247|NCT01256411|vasopeptidase|vasopeptidase
5509248|NCT01256411|angiotensin receptor|angiotensin receptor
5509249|NCT01256411|angiotensin receptor neprilysin inhibitor (ARNi)|angiotensin receptor neprilysin inhibitor (arni)
5509250|NCT01256372|Cardiac surgery|cardiac surgery
5509251|NCT01256372|Acute kidney injury|acute kidney injury
5509252|NCT01256346|Premature|premature
5509256|NCT01256307|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5509258|NCT01256307|Inflammation|inflammation
5509259|NCT01256307|Oxidative Stress|oxidative stress
5509260|NCT01256307|Insulin resistance|insulin resistance
5509261|NCT01256294|Renal transplant|renal transplant
5509262|NCT01256294|kidney transplant|kidney transplant
5509263|NCT01256294|immunosuppressive therapy|immunosuppressive therapy
5509264|NCT01256294|anti-rejection medication|anti-rejection medication
5509265|NCT01256294|pharmacokinetics|pharmacokinetics
5509266|NCT01256294|tacrolimus|tacrolimus
5509267|NCT01256281|Sickle Cell Disease|sickle cell disease
5509268|NCT01256281|Pain|pain
5509269|NCT01256281|Vasoocclusion|vasoocclusion
5509270|NCT01256281|Nerve Block|nerve block
5509271|NCT01256281|Regional Anesthesia|regional anesthesia
5509272|NCT01256268|metastatic|metastatic
5509273|NCT01256268|recurrent|recurrent
5509274|NCT01256268|Solid Cancer|solid cancer
5509275|NCT01256255|transplant|transplant
5509276|NCT01256255|influenza infection|influenza infection
5509277|NCT01256242|tendon|tendon
5509278|NCT01256242|shoulder|shoulder
5509279|NCT01256242|rotator cuff|rotator cuff
5509280|NCT01256242|Glenohumeral|glenohumeral
5509281|NCT01256229|deafness|deafness
5509282|NCT01256229|hearing loss|hearing loss
5509283|NCT01256229|developmental delay|developmental delay
5509284|NCT01256229|mental retardation|mental retardation
5509285|NCT01256216|Arthritis|arthritis
5509286|NCT01256216|Osteoarthritis|osteoarthritis
5509287|NCT01256216|Arthroplasty|arthroplasty
5509288|NCT01256203|PDT|pdt
5509289|NCT01256203|Porfimer sodium|porfimer sodium
5509290|NCT01256203|Phototoxicity|phototoxicity
5509291|NCT01256203|Sunscreen|sunscreen
5509292|NCT01256177|Bipolar Depression|bipolar depression
5509293|NCT01256177|Mental disease,|mental disease,
5509294|NCT01256164|fibrin sealants|fibrin sealants
5509295|NCT01256164|hemostatics|hemostatics
5509296|NCT01256164|time to hemostasis|time to hemostasis
5509297|NCT01256151|Bioequivalence|bioequivalence
5509298|NCT01256151|sublingual|sublingual
5509299|NCT01256151|alprazolam|alprazolam
5509300|NCT01256151|pharmacokinetics|pharmacokinetics
5509301|NCT01256138|Allogene MSCs|allogene mscs
5509302|NCT01256138|transplantation|transplantation
5509303|NCT01256138|chronic liver diseases|chronic liver diseases
5509304|NCT01256138|portal vein|portal vein
5509305|NCT01256125|allogene MSCs|allogene mscs
5509306|NCT01256125|transplantation|transplantation
5509307|NCT01256125|chronic liver diseases|chronic liver diseases
5509308|NCT01256125|peripheral vein|peripheral vein
5509309|NCT01256112|obesity|obesity
5509310|NCT01256112|behavioral intervention|behavioral intervention
5509311|NCT01256112|family based|family based
5509312|NCT01256112|weight loss|weight loss
5509313|NCT01256099|Self-help treatment|self-help treatment
5509314|NCT01256099|Internet treatment|internet treatment
5509316|NCT01256099|Prevention|prevention
5509317|NCT01256099|Comorbidity|comorbidity
5509318|NCT01256060|Autism Spectrum disorder|autism spectrum disorder
5509319|NCT01256060|Oxytocin|oxytocin
5509320|NCT01256060|Clinical Trial|clinical trial
5509321|NCT01256060|Children|children
5509322|NCT01256060|Pharmacology|pharmacology
5509327|NCT01256034|immunonutrition|immunonutrition
5509328|NCT01256034|pancreaticoduodenectomy|pancreaticoduodenectomy
5509329|NCT01256034|Th1|th1
5509330|NCT01256034|Th2|th2
5509331|NCT01256008|Breast Cancer|breast cancer
5509332|NCT01256008|Depression|depression
5509333|NCT01256008|Anxiety|anxiety
5509334|NCT01256008|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5509335|NCT01255995|PXF|pxf
5509336|NCT01255982|Bipolar depression|bipolar depression
5509337|NCT01255982|subsyndromal symptoms|subsyndromal symptoms
5509338|NCT01255982|functioning|functioning
5509339|NCT01255982|cognitive function|cognitive function
5509340|NCT01255969|Dialysis|dialysis
5509341|NCT01255969|Physical exercise|physical exercise
5509342|NCT01255969|Clinical Trial|clinical trial
5509343|NCT01255969|Quality of Life|quality of life
5509344|NCT01255969|Performance|performance
5509345|NCT01255969|Fitness|fitness
5509346|NCT01255969|Cardiovascular Mortality|cardiovascular mortality
5509347|NCT01255969|Vascular access|vascular access
5509348|NCT01255956|restenosis|restenosis
5509349|NCT01255956|ISR|isr
5509350|NCT01255956|in-stent restenosis|in-stent restenosis
5509351|NCT01255956|drug eluting stent|drug eluting stent
5509352|NCT01255956|rapamycin eluting stent|rapamycin eluting stent
5509353|NCT01255956|paclitaxel eluting balloon catheter|paclitaxel eluting balloon catheter
5509354|NCT01255943|MRSA|mrsa
5509355|NCT01255943|bloodstream infections|bloodstream infections
5509356|NCT01255943|hemodialysis|hemodialysis
5509357|NCT01255930|Pregnant Women|pregnant women
5509358|NCT01255930|Sonographic Textures|sonographic textures
5509359|NCT01255917|Tio identify role of NGF in pain in CP|tio identify role of ngf in pain in cp
5509360|NCT01255917|Identify biomarkers related to progression of CP|identify biomarkers related to progression of cp
5509361|NCT01255891|high risk localized adenocarcinoma of the prostate|high risk localized adenocarcinoma of the prostate
5509362|NCT01255878|Sleep bruxism|sleep bruxism
5509363|NCT01255878|Gabapentine|gabapentine
5509364|NCT01255878|Occlusal splint|occlusal splint
5509365|NCT01255878|Polysomnography|polysomnography
5509366|NCT01255865|Thermometry|thermometry
5509367|NCT01255865|Deep Tissue Temperature|deep tissue temperature
5509368|NCT01255865|Core Temperature|core temperature
5509369|NCT01255865|Body Temperature|body temperature
5509370|NCT01255865|Rectal Temperature|rectal temperature
5509371|NCT01255865|Oral Temperature|oral temperature
5509372|NCT01255852|atorvastatin|atorvastatin
5509373|NCT01255852|intracranial artery stenting|intracranial artery stenting
5509374|NCT01255852|restenosis|restenosis
5509375|NCT01255839|double-balloon|double-balloon
5509376|NCT01255839|balloon catheter|balloon catheter
5509377|NCT01255839|prostaglandin|prostaglandin
5509378|NCT01255839|minprostin|minprostin
5509379|NCT01255839|induction of labour|induction of labour
5509380|NCT01255839|fetal outcome|fetal outcome
5509381|NCT01255826|Preterm|preterm
5509382|NCT01255826|Neonates|neonates
5509383|NCT01255826|Delivery room|delivery room
5509384|NCT01255826|Resuscitation|resuscitation
5509385|NCT01255826|Ventilation|ventilation
5509386|NCT01255826|Neopuff|neopuff
5509387|NCT01255826|CPAP|cpap
5509388|NCT01255813|Chronic Cluster Headache|chronic cluster headache
5509389|NCT01255787|Major Depressive Disorder|major depressive disorder
5509390|NCT01255787|Depression|depression
5509391|NCT01255787|Melancholia|melancholia
5509392|NCT01255787|Drug Therapy|drug therapy
5509393|NCT01255774|subfoveal CNV|subfoveal cnv
5509394|NCT01255774|Wet (Exudative) AMD|wet (exudative) amd
5509395|NCT01255774|macular degeneration|macular degeneration
5509396|NCT01255761|Certolizumab Pegol|certolizumab pegol
5509397|NCT01255761|Cimzia|cimzia
5509398|NCT01255761|Rheumatoid Arthritis|rheumatoid arthritis
5509399|NCT01255761|CDAI|cdai
5509400|NCT01255761|RAPID3|rapid3
5509401|NCT01255748|cancer, proton, radiation|cancer, proton, radiation
5509402|NCT01255735|pediatrics|pediatrics
5509403|NCT01255735|voice|voice
5509404|NCT01255735|voice therapy|voice therapy
5509405|NCT01255735|vocal therapy|vocal therapy
5509406|NCT01255735|hoarseness|hoarseness
5509407|NCT01255722|iodinated contrast media, coronary artery disease|iodinated contrast media, coronary artery disease
5509408|NCT01255709|Asthma|asthma
5509410|NCT01255709|wheezing|wheezing
5509411|NCT01255696|Celiac Disease|celiac disease
5509412|NCT01255696|Coeliac Disease|coeliac disease
5509413|NCT01255696|Celiac Sprue|celiac sprue
5509414|NCT01255696|Keliakia Disease|keliakia disease
5509415|NCT01255683|Chronic|chronic
5509416|NCT01255683|Sinusitis|sinusitis
5509417|NCT01255683|Steroid|steroid
5509418|NCT01255683|treatment|treatment
5509419|NCT01255670|Peritonsillar Abscess|peritonsillar abscess
5509420|NCT01255670|Quinsy|quinsy
5509421|NCT01255670|Penicillin|penicillin
5509423|NCT01255670|Recurrence|recurrence
5509424|NCT01255605|Intermittent preventive treatment with sulfadoxin-pyrimethamine|intermittent preventive treatment with sulfadoxin-pyrimethamine
5509425|NCT01255605|in Bobo-Dioulasso peri-urban areas, 5 years after its implementation|in bobo-dioulasso peri-urban areas, 5 years after its implementation
5509426|NCT01255605|Burkina Faso.|burkina faso.
5509427|NCT01255592|Bronchiectasis|bronchiectasis
5509428|NCT01255592|Neutrophil|neutrophil
5509429|NCT01255592|Respiratory disease|respiratory disease
5509430|NCT01255592|Sputum|sputum
5509431|NCT01255579|asthma|asthma
5509432|NCT01255579|small airways|small airways
5509433|NCT01255579|inhaled corticosteroids|inhaled corticosteroids
5509434|NCT01255540|Coronary heart disease in patients over|coronary heart disease in patients over
5509435|NCT01255540|80 years of age.|80 years of age.
5509436|NCT01255488|Search engine|search engine
5509437|NCT01255488|Clinical decision-making|clinical decision-making
5509438|NCT01255488|Research abstracts|research abstracts
5509439|NCT01255488|Full-text manuscripts|full-text manuscripts
5509440|NCT01255488|Family Nurse Practitioners|family nurse practitioners
5509441|NCT01255462|AMD,|amd,
5509442|NCT01255462|ARMD,|armd,
5509443|NCT01255462|Age-related Macular Degeneration,|age-related macular degeneration,
5509444|NCT01255462|Eye Disease,|eye disease,
5509445|NCT01255462|Wet AMD,|wet amd,
5509446|NCT01255462|Neovascular AMD,|neovascular amd,
5509447|NCT01255462|Choroidal Neovascular Membrane,|choroidal neovascular membrane,
5509448|NCT01255462|Choroidal Neovascularization,|choroidal neovascularization,
5509449|NCT01255462|Drusen,|drusen,
5509450|NCT01255462|Geographic Atrophy,|geographic atrophy,
5509451|NCT01255462|Complement,|complement,
5509453|NCT01255462|Antibody|antibody
5509454|NCT01255449|Forced oscillation technique|forced oscillation technique
5509455|NCT01255449|Respiratory input impedance|respiratory input impedance
5509456|NCT01255449|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5509457|NCT01255449|Obliterative bronchiolitis|obliterative bronchiolitis
5509458|NCT01255423|Ankle sprain, soft tissue injury|ankle sprain, soft tissue injury
5509459|NCT01255397|male infertility|male infertility
5509460|NCT01255397|natural cycle IVF|natural cycle ivf
5509461|NCT01255397|in-vitro fertilization|in-vitro fertilization
5509462|NCT01255397|intrauterine inseminatio|intrauterine inseminatio
5509464|NCT01255371|Second line antiretroviral treatment|second line antiretroviral treatment
5509465|NCT01255371|Sub saharian Africa|sub saharian africa
5509466|NCT01255371|Generic|generic
5509467|NCT01255358|Ataxia Teleangiectasia|ataxia teleangiectasia
5509468|NCT01255358|AT|at
5509469|NCT01255358|Ery-Dex|ery-dex
5509470|NCT01255358|Dexamethasone|dexamethasone
5509471|NCT01255358|Dexamethasone sodium phosphate|dexamethasone sodium phosphate
5509472|NCT01255345|Physiotherapy|physiotherapy
5509473|NCT01255345|Multidisciplinary Pain Centers|multidisciplinary pain centers
5509474|NCT01255345|Pain measurements|pain measurements
5509475|NCT01255345|Physical activity|physical activity
5509476|NCT01255345|Quality of life|quality of life
5509477|NCT01255332|ITP|itp
5509478|NCT01255319|MDS|mds
5509479|NCT01255306|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5509480|NCT01255306|Pars plana vitrectomy|pars plana vitrectomy
5509481|NCT01255306|Silicone oil|silicone oil
5509482|NCT01255306|Retinal nerve fibre layer|retinal nerve fibre layer
5509483|NCT01255293|Retinal detachment|retinal detachment
5509484|NCT01255293|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
5509485|NCT01255293|Diabetic retinopathy|diabetic retinopathy
5509486|NCT01255293|Vitrectomy|vitrectomy
5509487|NCT01255293|Silicone oil|silicone oil
5509488|NCT01255280|Crystal methamphetamine abuse|crystal methamphetamine abuse
5509489|NCT01255280|Crystal methamphetamine dependence|crystal methamphetamine dependence
5509490|NCT01255280|Sexual risk behavior|sexual risk behavior
5509491|NCT01255280|Men who have sex with men (MSM)|men who have sex with men (msm)
5509492|NCT01255280|Behavioral activation|behavioral activation
5509493|NCT01255267|Acute coronary syndrome and chronic coronary artery disease patients|acute coronary syndrome and chronic coronary artery disease patients
5509494|NCT01255254|he effect of gingival scaling on Metabolic control|he effect of gingival scaling on metabolic control
5509495|NCT01255241|Lower Limbs Deformities|lower limbs deformities
5509496|NCT01255241|kinetics|kinetics
5509497|NCT01255241|kinematics|kinematics
5509498|NCT01255241|gait|gait
5509499|NCT01255241|energy expenditure|energy expenditure
5509500|NCT01255228|obesity|obesity
5509501|NCT01255228|body composition|body composition
5509502|NCT01255228|adipocyte-derived cytokine|adipocyte-derived cytokine
5509503|NCT01255228|low glycemic index|low glycemic index
5509504|NCT01255215|malaria|malaria
5509505|NCT01255215|children|children
5509506|NCT01255202|preeclampsia|preeclampsia
5509507|NCT01255202|toxemia|toxemia
5509508|NCT01255202|twin|twin
5509509|NCT01255202|pregnancy|pregnancy
5509510|NCT01255202|pp13|pp13
5509511|NCT01255202|prediction|prediction
5509512|NCT01255202|kongo red|kongo red
5509513|NCT01255189|NIRS|nirs
5509514|NCT01255176|Infant|infant
5509515|NCT01255176|Physical Therapy|physical therapy
5509516|NCT01255163|Alzheimer's|alzheimer's
5509517|NCT01255163|Brain insulin resistance|brain insulin resistance
5509518|NCT01255163|Diabetes|diabetes
5509519|NCT01255150|Genetic Ancestry Analysis|genetic ancestry analysis
5509520|NCT01255150|Molecular Profiling|molecular profiling
5509521|NCT01255150|Smoking Status|smoking status
5509522|NCT01255150|Wood Smoke Exposure|wood smoke exposure
5509523|NCT01255150|EGFR Mutation Analysis|egfr mutation analysis
5509524|NCT01255150|Non Small Cell Lung Cancer|non small cell lung cancer
5509525|NCT01255137|Selective VEGF Inhibitor|selective vegf inhibitor
5509526|NCT01255137|Clinical Activity|clinical activity
5509527|NCT01255137|Response Rate|response rate
5509528|NCT01255137|Measurable Disease|measurable disease
5509529|NCT01255137|Biological Markers|biological markers
5509530|NCT01255137|Adrenocortical Cancer|adrenocortical cancer
5509531|NCT01255111|Chronic respiratory failure|chronic respiratory failure
5509532|NCT01255111|Noninvasive ventilation|noninvasive ventilation
5509533|NCT01255111|Patient-ventilator interactions|patient-ventilator interactions
5509534|NCT01255111|Sleep|sleep
5509535|NCT01255111|Sleep fragmentation|sleep fragmentation
5509536|NCT01255085|Obesity|obesity
5509537|NCT01255085|Food intake regulation|food intake regulation
5509538|NCT01255085|blood glucose regulation|blood glucose regulation
5509539|NCT01255085|protein|protein
5509540|NCT01255085|fiber|fiber
5509541|NCT01255085|pulses|pulses
5509542|NCT01255085|yellow peas|yellow peas
5509544|NCT01255072|elderly|elderly
5509545|NCT01255072|depression|depression
5509546|NCT01255072|neuronavegation|neuronavegation
5509547|NCT01255072|neurocognition|neurocognition
5509548|NCT01255059|Genome-wide association studies(GWAS)|genome-wide association studies(gwas)
5509549|NCT01255059|Single nucleotide polymorphism(SNP)|single nucleotide polymorphism(snp)
5509550|NCT01255059|Lung cancer|lung cancer
5509551|NCT01255033|perioperative surgery|perioperative surgery
5509552|NCT01255033|regional oxygenation|regional oxygenation
5509553|NCT01255033|hypoxemia|hypoxemia
5509554|NCT01255033|brain hypoxemia|brain hypoxemia
5509555|NCT01255033|spectroscopy, near-infrared|spectroscopy, near-infrared
5509556|NCT01255020|α-Keto Acid|α-keto acid
5509557|NCT01255020|Restricted Protein Diet|restricted protein diet
5509558|NCT01255020|Residual Renal Function|residual renal function
5509559|NCT01255007|Colorectal|colorectal
5509561|NCT01255007|metastases|metastases
5509562|NCT01255007|Primovist|primovist
5509563|NCT01255007|MRI|mri
5509564|NCT01255007|CT|ct
5509565|NCT01255007|cancer|cancer
5509566|NCT01255007|resection|resection
5509567|NCT01255007|MDCT|mdct
5509568|NCT01255007|Diffusion|diffusion
5509569|NCT01255007|Weighted|weighted
5509570|NCT01255007|3T|3t
5509571|NCT01254994|hepatitis B|hepatitis b
5509572|NCT01254994|acute on chronic liver failure (ACHBLF)|acute on chronic liver failure (achblf)
5509573|NCT01254994|entecavir|entecavir
5509574|NCT01254994|treatment|treatment
5509575|NCT01254994|predicting|predicting
5509576|NCT01254981|Percutaneous coronary intervention|percutaneous coronary intervention
5509577|NCT01254981|DES|des
5509578|NCT01254981|Angina pectoris|angina pectoris
5509579|NCT01254981|Stent|stent
5509580|NCT01254968|blood flow in the middle cerebral artery of brain|blood flow in the middle cerebral artery of brain
5509581|NCT01254955|2009 H1N1 influenza vaccine, organ transplant patients|2009 h1n1 influenza vaccine, organ transplant patients
5509582|NCT01254942|exercise|exercise
5509583|NCT01254942|hip fractures|hip fractures
5509584|NCT01254942|rehabilitation|rehabilitation
5509585|NCT01254942|aged|aged
5509586|NCT01254942|aged 80 and over|aged 80 and over
5509587|NCT01254929|Cancer|cancer
5509588|NCT01254929|Bone metastases|bone metastases
5509589|NCT01254916|Chronic Rhinosinusitis|chronic rhinosinusitis
5509590|NCT01254916|Sinonasal Outcome test 22|sinonasal outcome test 22
5509591|NCT01254903|Stereotactic Radiosurgery|stereotactic radiosurgery
5509592|NCT01254903|Radiation|radiation
5509593|NCT01254903|Radiotherapy|radiotherapy
5509594|NCT01254903|Metastatic Epidural Spinal Cord Compression|metastatic epidural spinal cord compression
5509595|NCT01254903|MESCC|mescc
5509596|NCT01254890|Relapsed Acute Leukemia|relapsed acute leukemia
5509597|NCT01254890|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5509598|NCT01254890|CMML|cmml
5509599|NCT01254890|Myelodysplastic Syndrome|myelodysplastic syndrome
5509600|NCT01254890|MDS|mds
5509601|NCT01254890|Acute myeloid leukemia|acute myeloid leukemia
5509602|NCT01254890|AML|aml
5509604|NCT01254890|Azacitidine|azacitidine
5509605|NCT01254890|5-aza|5-aza
5509606|NCT01254890|Vidaza|vidaza
5509607|NCT01254890|5-AZC|5-azc
5509608|NCT01254890|AZA-CR|aza-cr
5509609|NCT01254890|Ladakamycin|ladakamycin
5509610|NCT01254890|NSC-102816|nsc-102816
5509611|NCT01254890|Sorafenib|sorafenib
5509612|NCT01254890|Nexavar|nexavar
5509613|NCT01254890|BAY43-9006|bay43-9006
5509614|NCT01254877|HIV|hiv
5509615|NCT01254864|Castrate resistant prostate cancer|castrate resistant prostate cancer
5509616|NCT01254864|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5509617|NCT01254864|Sunitinib Malate|sunitinib malate
5509618|NCT01254864|SUO11248|suo11248
5509619|NCT01254864|Sutent|sutent
5509620|NCT01254864|BMS-354825|bms-354825
5509621|NCT01254864|Sprycel|sprycel
5509622|NCT01254851|discharge criteria, gynecologic surgery, post-op ambulation|discharge criteria, gynecologic surgery, post-op ambulation
5509623|NCT01254825|Adductor Canal Block (ACB)|adductor canal block (acb)
5509624|NCT01254825|Diagnostic Knee Arthroscopy|diagnostic knee arthroscopy
5509626|NCT01254825|Pain|pain
5509627|NCT01254825|Ultrasound block|ultrasound block
5509628|NCT01254812|pulmonary function|pulmonary function
5509629|NCT01254812|BD-TAP-block|bd-tap-block
5509630|NCT01254786|VATS|vats
5509631|NCT01254786|one lung ventilation|one lung ventilation
5509632|NCT01254786|continuous positive pressure ventilation|continuous positive pressure ventilation
5509633|NCT01254786|high frequency positive pressure ventilation|high frequency positive pressure ventilation
5509634|NCT01254721|Acute bipolar mania|acute bipolar mania
5509635|NCT01254721|Seroquel XR|seroquel xr
5509636|NCT01254721|Seroquel XR plus lithium|seroquel xr plus lithium
5509637|NCT01254721|Quetiapine fumarate|quetiapine fumarate
5509638|NCT01254695|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
5509639|NCT01254695|Fecal Incontinence|fecal incontinence
5509640|NCT01254695|Sacral Nerve Stimulation|sacral nerve stimulation
5509641|NCT01254695|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
5509642|NCT01254682|wrist|wrist
5509643|NCT01254682|joint|joint
5509644|NCT01254682|arthroscopy|arthroscopy
5509645|NCT01254682|hyaluronan|hyaluronan
5509646|NCT01254682|hyaluronic acid|hyaluronic acid
5509647|NCT01254682|Necessity of Arthroscopic surgery|necessity of arthroscopic surgery
5509648|NCT01254669|Haitian girls, African American girls|haitian girls, african american girls
5509649|NCT01254669|Brief Negotiated Interview|brief negotiated interview
5509650|NCT01254669|cognitive behavioral intervention|cognitive behavioral intervention
5509651|NCT01254669|HPV vaccine|hpv vaccine
5509652|NCT01254669|cervical cancer|cervical cancer
5509653|NCT01254643|Papillomavirus vaccines|papillomavirus vaccines
5509654|NCT01254643|Uterine cervical cancer|uterine cervical cancer
5509655|NCT01254643|Human Papilloma Virus infections|human papilloma virus infections
5509656|NCT01254630|Herpes zoster|herpes zoster
5509657|NCT01254630|vaccine|vaccine
5509658|NCT01254630|herpes-zoster-related complications|herpes-zoster-related complications
5509659|NCT01254630|immunocompromised|immunocompromised
5509660|NCT01254630|herpes zoster-associated pain|herpes zoster-associated pain
5509661|NCT01254630|solid tumor malignancy|solid tumor malignancy
5509662|NCT01254630|hematologic malignancy|hematologic malignancy
5509663|NCT01254604|Tafluprost|tafluprost
5509664|NCT01254604|Glaucoma|glaucoma
5509665|NCT01254604|Ocular Hypertension|ocular hypertension
5509666|NCT01254604|Timolol|timolol
5509667|NCT01254604|Eye Disorder|eye disorder
5509668|NCT01254604|Preservative-Free|preservative-free
5509669|NCT01254604|Prostaglandin Analogue|prostaglandin analogue
5509670|NCT01254591|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5509671|NCT01254591|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5509672|NCT01254591|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5509673|NCT01254591|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5509674|NCT01254591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5509675|NCT01254591|stage I colon cancer|stage i colon cancer
5509676|NCT01254591|stage IIA colon cancer|stage iia colon cancer
5509677|NCT01254591|stage IIB colon cancer|stage iib colon cancer
5509678|NCT01254591|stage IIC colon cancer|stage iic colon cancer
5509679|NCT01254591|stage IIIA colon cancer|stage iiia colon cancer
5509680|NCT01254591|stage I rectal cancer|stage i rectal cancer
5509681|NCT01254591|stage IIA rectal cancer|stage iia rectal cancer
5509682|NCT01254591|stage IIB rectal cancer|stage iib rectal cancer
5509683|NCT01254591|stage IIC rectal cancer|stage iic rectal cancer
5509684|NCT01254591|stage IIIA rectal cancer|stage iiia rectal cancer
5509685|NCT01254591|stage IA breast cancer|stage ia breast cancer
5509686|NCT01254591|stage IB breast cancer|stage ib breast cancer
5509687|NCT01254591|stage II breast cancer|stage ii breast cancer
5509688|NCT01254591|stage IIIA breast cancer|stage iiia breast cancer
5509689|NCT01254591|stage IIIB breast cancer|stage iiib breast cancer
5509690|NCT01254591|stage I esophageal cancer|stage i esophageal cancer
5509691|NCT01254591|stage II esophageal cancer|stage ii esophageal cancer
5509692|NCT01254591|stage III esophageal cancer|stage iii esophageal cancer
5509693|NCT01254591|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5509694|NCT01254591|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5509695|NCT01254591|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5509696|NCT01254591|stage I laryngeal cancer|stage i laryngeal cancer
5509697|NCT01254591|stage II laryngeal cancer|stage ii laryngeal cancer
5509698|NCT01254591|stage III laryngeal cancer|stage iii laryngeal cancer
5509699|NCT01254591|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5509716|NCT01254565|Renal Dialysis|renal dialysis
5509717|NCT01254565|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5509718|NCT01254565|Parathyroid hormone|parathyroid hormone
5509719|NCT01254539|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5509720|NCT01254539|Bone marrow|bone marrow
5509721|NCT01254539|Stem cells|stem cells
5509722|NCT01254539|Autologous|autologous
5509724|NCT01254513|Metastatic Prostate cancer|metastatic prostate cancer
5509725|NCT01254513|Elderly patients|elderly patients
5509726|NCT01254513|Vulnerable and Frail (SIOG classification)|vulnerable and frail (siog classification)
5509727|NCT01254513|castration-resistant|castration-resistant
5509728|NCT01254500|patients with brain lesions|patients with brain lesions
5509729|NCT01254474|Depolarization, tissue|depolarization, tissue
5491740|NCT01329731|initial caries|initial caries
5509730|NCT01254474|Repolarization, tissue|repolarization, tissue
5509731|NCT01254474|Cardiac Arrhythmias|cardiac arrhythmias
5509732|NCT01254474|Action potentials, monophasic|action potentials, monophasic
5509733|NCT01254474|Mapping, Catheter|mapping, catheter
5509734|NCT01254474|Cardiac activation|cardiac activation
5509735|NCT01254461|Phase 1|phase 1
5509736|NCT01254461|Drug-Drug interaction|drug-drug interaction
5509737|NCT01254461|pravastatin|pravastatin
5509738|NCT01254461|AZD1981|azd1981
5509937|NCT01253252|Spiral computed tomography|spiral computed tomography
5511126|NCT01247844|adult Males|adult males
5509739|NCT01254461|The pharmacokinetics resulting from AZD1981 and pravastatin interaction|the pharmacokinetics resulting from azd1981 and pravastatin interaction
5509740|NCT01254461|The effects of taking a combination of AZD1981 and pravastatin|the effects of taking a combination of azd1981 and pravastatin
5509741|NCT01254448|Alzheimer's Disease|alzheimer's disease
5509742|NCT01254435|Colonoscopy|colonoscopy
5509743|NCT01254435|Positioning in colonoscopy|positioning in colonoscopy
5509744|NCT01254435|Quality control|quality control
5509745|NCT01254422|Dengue fever|dengue fever
5509746|NCT01254422|Dengue hemorrhagic fever|dengue hemorrhagic fever
5509747|NCT01254422|CYD dengue vaccine|cyd dengue vaccine
5509748|NCT01254409|pulmonary, fibrosis|pulmonary, fibrosis
5509749|NCT01254396|Bioavailability Food Effect Oral Dissolving Tablet (ODT)|bioavailability food effect oral dissolving tablet (odt)
5509750|NCT01254383|Bioequivalence Oral Dissolving Tablet|bioequivalence oral dissolving tablet
5509751|NCT01254357|Burns|burns
5509752|NCT01254357|Trauma|trauma
5509753|NCT01254357|Outcomes|outcomes
5509754|NCT01254357|Quality of Life|quality of life
5509755|NCT01254344|Colorectal surgery|colorectal surgery
5509756|NCT01254318|hematological malignancy|hematological malignancy
5509757|NCT01254318|fungal infection|fungal infection
5509758|NCT01254318|leukemia|leukemia
5509759|NCT01254305|Depression|depression
5509760|NCT01254305|Fatigue|fatigue
5509761|NCT01254305|Major Depressive Disorder|major depressive disorder
5509762|NCT01254266|morbid obesity|morbid obesity
5509763|NCT01254266|adolescents|adolescents
5509764|NCT01254266|inpatient treatment|inpatient treatment
5509765|NCT01254253|percutaneous coronary intervention|percutaneous coronary intervention
5509766|NCT01254253|chronic total occlusion|chronic total occlusion
5509767|NCT01254253|coronary angiography|coronary angiography
5509768|NCT01254253|single photon emission CT|single photon emission ct
5509769|NCT01254253|Multislice coronary CT angiography|multislice coronary ct angiography
5509770|NCT01254227|Cardiac iron overload,|cardiac iron overload,
5509771|NCT01254227|deferasirox,|deferasirox,
5509772|NCT01254227|deferoxamine|deferoxamine
5509773|NCT01254214|Mindfulness|mindfulness
5509774|NCT01254214|Quality of life|quality of life
5509775|NCT01254214|Transplantation|transplantation
5509776|NCT01254214|Renal disease|renal disease
5509777|NCT01254188|Chronic myeloid leukemia,|chronic myeloid leukemia,
5509778|NCT01254188|CML,|cml,
5509779|NCT01254188|nilotinib,|nilotinib,
5509780|NCT01254188|myelogenous,|myelogenous,
5509781|NCT01254188|Philadelphia chromosome|philadelphia chromosome
5509782|NCT01254162|Oily Skin|oily skin
5509783|NCT01254162|Sebum|sebum
5509784|NCT01254123|Glucagon Like Peptide-1|glucagon like peptide-1
5509785|NCT01254123|Exenatide|exenatide
5509786|NCT01254123|myocardial infarction|myocardial infarction
5509788|NCT01254123|PCI|pci
5509789|NCT01254084|Herbal medicine; Type 2 diabetes; Gynostemma pentaphyllum Tea; Insulin sensitivity;|herbal medicine; type 2 diabetes; gynostemma pentaphyllum tea; insulin sensitivity;
5509790|NCT01254071|GI198745|gi198745
5509791|NCT01254071|Tamsulosin hydrochloride|tamsulosin hydrochloride
5509792|NCT01254071|Dutasteride|dutasteride
5509793|NCT01254071|food effect|food effect
5509794|NCT01254071|healthy male subjects|healthy male subjects
5509795|NCT01254071|north-east Asian ancestry|north-east asian ancestry
5509796|NCT01254071|Bioequivalence|bioequivalence
5509797|NCT01254071|cross-over design|cross-over design
5509798|NCT01254071|Pilot bioequivalence|pilot bioequivalence
5509799|NCT01254032|CAT|cat
5509800|NCT01254032|COPD|copd
5509801|NCT01254019|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5509802|NCT01254019|DMD|dmd
5509803|NCT01254019|968|968
5509804|NCT01254019|GSK|gsk
5509805|NCT01254019|Duchenne|duchenne
5509806|NCT01253993|Disruptive Behavior Disorders, Substance abuse,|disruptive behavior disorders, substance abuse,
5509807|NCT01253993|Iowa Gambling Task, Decision Making.|iowa gambling task, decision making.
5509808|NCT01253980|pneumonitis|pneumonitis
5509809|NCT01253980|paraffin|paraffin
5509810|NCT01253980|kerosene|kerosene
5509811|NCT01253967|Gastroenteritis|gastroenteritis
5509812|NCT01253967|Hospital surveillance|hospital surveillance
5509813|NCT01253967|Rotavirus gastroenteritis|rotavirus gastroenteritis
5509814|NCT01253954|invasive candida infection|invasive candida infection
5509815|NCT01253941|COPD, Intensive Resistive Breathing, Cytokine IL6,|copd, intensive resistive breathing, cytokine il6,
5509816|NCT01253928|body composition|body composition
5509817|NCT01253928|insulin sensitivity|insulin sensitivity
5509818|NCT01253928|protein metabolism|protein metabolism
5509819|NCT01253928|pioglitazone|pioglitazone
5509820|NCT01253889|Functional echocardiography|functional echocardiography
5509821|NCT01253889|oral glucose|oral glucose
5509822|NCT01253889|neonatal stress|neonatal stress
5509823|NCT01253863|Clinical Examination, Accuracy, Hand, Tendon, Injury.|clinical examination, accuracy, hand, tendon, injury.
5509824|NCT01253850|hiv|hiv
5509825|NCT01253850|antiretroviral|antiretroviral
5509826|NCT01253850|adherence|adherence
5509827|NCT01253850|adolescent|adolescent
5509828|NCT01253837|L19|l19
5509829|NCT01253837|antibody|antibody
5509830|NCT01253837|monoclonal|monoclonal
5509831|NCT01253837|tumor targeting|tumor targeting
5509832|NCT01253837|TNFa|tnfa
5509833|NCT01253837|colorectal cancer|colorectal cancer
5510243|NCT01251965|AML|aml
5509834|NCT01253837|Phase I: Patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.|phase i: patients with relapsed or refractory locally advanced or metastatic solid tumors not amenable to standard systemic therapy.
5509835|NCT01253837|Phase II: Patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.|phase ii: patients with relapsed or refractory locally advanced or metastatic colorectal cancer not amenable to standard systemic therapy.
5509836|NCT01253824|NPC-01|npc-01
5509837|NCT01253824|IKH-01|ikh-01
5509838|NCT01253824|Pharmacodynamics|pharmacodynamics
5509839|NCT01253824|Norethisterone|norethisterone
5509840|NCT01253824|Ethinyl Estradiol|ethinyl estradiol
5509841|NCT01253824|Estradiol|estradiol
5509842|NCT01253824|Progesterone|progesterone
5509843|NCT01253824|FSH|fsh
5509844|NCT01253824|LH|lh
5509845|NCT01253798|exercise|exercise
5509846|NCT01253798|hydrotherapy|hydrotherapy
5509847|NCT01253759|Transpupillary thermotherapy|transpupillary thermotherapy
5509848|NCT01253759|Choroidal melanoma|choroidal melanoma
5509849|NCT01253759|ICG-Photodynamic therapy|icg-photodynamic therapy
5509851|NCT01253746|open NTD|open ntd
5509852|NCT01253746|spina bifida|spina bifida
5509853|NCT01253746|anencephaly|anencephaly
5509854|NCT01253746|closed NTD|closed ntd
5509855|NCT01253746|lipomeningocele|lipomeningocele
5509856|NCT01253746|tethered cord.|tethered cord.
5509857|NCT01253733|Cystic Fibrosis|cystic fibrosis
5509858|NCT01253733|Inflammatory Bowel Disease|inflammatory bowel disease
5509859|NCT01253733|Type 1 Diabetes|type 1 diabetes
5509860|NCT01253733|Chronic Disease Management|chronic disease management
5509861|NCT01253733|SMS|sms
5509862|NCT01253733|Text messages|text messages
5509863|NCT01253733|Internet|internet
5509864|NCT01253733|Healthcare Interactions|healthcare interactions
5509865|NCT01253720|obesity|obesity
5509866|NCT01253720|text messages|text messages
5509867|NCT01253720|internet|internet
5509868|NCT01253720|cancer|cancer
5509869|NCT01253720|overweight|overweight
5509870|NCT01253707|Solid Tumors|solid tumors
5509871|NCT01253707|C-met inhibitor|c-met inhibitor
5509872|NCT01253694|Diabetes|diabetes
5509873|NCT01253694|edema|edema
5509874|NCT01253694|ranibizumab|ranibizumab
5509875|NCT01253694|bevacizumab|bevacizumab
5509876|NCT01253694|refractory|refractory
5509877|NCT01253681|AMG 386|amg 386
5509878|NCT01253681|Ovarian Cancer|ovarian cancer
5509879|NCT01253655|Healthy Volunteers|healthy volunteers
5509880|NCT01253629|Fragile X Syndrome|fragile x syndrome
5509881|NCT01253629|Martin-Bell Syndrome|martin-bell syndrome
5509882|NCT01253629|Genetic Diseases|genetic diseases
5509883|NCT01253629|X-Linked|x-linked
5509884|NCT01253603|Asthma|asthma
5509885|NCT01253590|atrial fibrillation|atrial fibrillation
5509886|NCT01253590|ECG monitor|ecg monitor
5509887|NCT01253590|Blood pressure device|blood pressure device
5509888|NCT01253590|Remote Cardiac Monitoring|remote cardiac monitoring
5509889|NCT01253551|VX-950HEP1001|vx-950hep1001
5509890|NCT01253551|hepatitis|hepatitis
5509891|NCT01253551|telaprevir|telaprevir
5509892|NCT01253551|raltegravir|raltegravir
5509893|NCT01253551|crossover|crossover
5509894|NCT01253551|healthy volunteers|healthy volunteers
5509895|NCT01253551|VX-950.|vx-950.
5509896|NCT01253525|Adenocarcinoma|adenocarcinoma
5509897|NCT01253525|Gastroesophageal Junction|gastroesophageal junction
5509898|NCT01253512|Ischemic Stroke|ischemic stroke
5509899|NCT01253512|Thrombolysis|thrombolysis
5509900|NCT01253486|expressive writing|expressive writing
5509901|NCT01253486|cardiac rehabilitation|cardiac rehabilitation
5509902|NCT01253473|COPD|copd
5509903|NCT01253460|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5509904|NCT01253460|CLL|cll
5509905|NCT01253460|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5509906|NCT01253460|SLL|sll
5509907|NCT01253460|Cyclophosphamide|cyclophosphamide
5509908|NCT01253460|Rituximab|rituximab
5509909|NCT01253460|Sapacitabine|sapacitabine
5509910|NCT01253460|Cytoxan|cytoxan
5509911|NCT01253460|Neosar|neosar
5509912|NCT01253460|Rituxan|rituxan
5509913|NCT01253434|Transdermal Administration|transdermal administration
5509914|NCT01253421|MDD|mdd
5509915|NCT01253421|Major Depressive Disorder|major depressive disorder
5509916|NCT01253421|Amisulpride|amisulpride
5509917|NCT01253408|anandamide|anandamide
5509918|NCT01253408|cannabinoid|cannabinoid
5509919|NCT01253408|fatty acid amide hydrolase|fatty acid amide hydrolase
5509920|NCT01253408|gastric|gastric
5509921|NCT01253408|motility|motility
5509922|NCT01253408|small bowel|small bowel
5509923|NCT01253395|Exercise|exercise
5509924|NCT01253395|Pain|pain
5509925|NCT01253369|pazopanib|pazopanib
5509926|NCT01253317|Rett Syndrome|rett syndrome
5509927|NCT01253317|IGF-1|igf-1
5509928|NCT01253317|Increlex|increlex
5509929|NCT01253317|Mecasermin|mecasermin
5509930|NCT01253317|IGF1|igf1
5509931|NCT01253317|MECP2|mecp2
5509932|NCT01253317|RTT|rtt
5509933|NCT01253252|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5509934|NCT01253252|Prosthesis|prosthesis
5509935|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5509936|NCT01253252|Positron-emission Tomography|positron-emission tomography
5510440|NCT01251094|impairment|impairment
5509938|NCT01253252|Biological markers|biological markers
5509939|NCT01253239|Visual outcomes|visual outcomes
5509940|NCT01253239|Patient satisfaction|patient satisfaction
5509941|NCT01253213|Prostate cancer|prostate cancer
5509942|NCT01253213|Ultrasound molecular imaging|ultrasound molecular imaging
5509943|NCT01253213|Contrast agent|contrast agent
5509944|NCT01253213|BR55|br55
5509945|NCT01253213|VEGFR2|vegfr2
5509946|NCT01253200|Type 1 Atrial Flutter|type 1 atrial flutter
5509947|NCT01253200|Typical Atrial Flutter|typical atrial flutter
5509948|NCT01253200|Arrhythmias, Cardiac|arrhythmias, cardiac
5509949|NCT01253200|Heart Diseases|heart diseases
5509950|NCT01253200|Cardiovascular Diseases|cardiovascular diseases
5509951|NCT01253161|advanced|advanced
5509952|NCT01253161|metastatic|metastatic
5509953|NCT01253161|unresectable|unresectable
5509954|NCT01253161|carcinoma|carcinoma
5509955|NCT01253161|gastrointestinal tract|gastrointestinal tract
5509956|NCT01253161|lungs|lungs
5509957|NCT01253161|colon|colon
5509958|NCT01253161|liver|liver
5509959|NCT01253161|rectum|rectum
5509960|NCT01253161|small intestine|small intestine
5509961|NCT01253161|stomach|stomach
5509962|NCT01253161|pancreatic|pancreatic
5509963|NCT01253148|Liver|liver
5509964|NCT01253148|Bile Duct|bile duct
5509965|NCT01253135|Fibrin, white petrolatum, wound healing|fibrin, white petrolatum, wound healing
5509966|NCT01253096|Interleukin|interleukin
5509972|NCT01253096|melanoma|melanoma
5509973|NCT01253096|tumor targeting|tumor targeting
5509974|NCT01253096|intratumoral|intratumoral
5680299|NCT00578344|Transfusion therapy|transfusion therapy
5680300|NCT00578331|rhinitis|rhinitis
5509975|NCT01253096|Malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage III or stage IV without visceral metastases.|malignant melanoma with presence of injectable soft-tissue metastases either in clinical stage iii or stage iv without visceral metastases.
5509976|NCT01253083|Mobility|mobility
5509977|NCT01253083|Developmental Delay|developmental delay
5509978|NCT01253083|Cerebral Palsy|cerebral palsy
5509979|NCT01253083|Early Walking|early walking
5509980|NCT01253083|Postural Control|postural control
5509981|NCT01253057|cleaning staff|cleaning staff
5509982|NCT01253057|antineoplastic agents|antineoplastic agents
5509983|NCT01253044|OEF/OIF|oef/oif
5509984|NCT01253044|Veterans|veterans
5509985|NCT01253044|Psychotherapy|psychotherapy
5509986|NCT01253031|hearing loss|hearing loss
5509987|NCT01253031|aging|aging
5509988|NCT01253031|short term memory|short term memory
5509989|NCT01253031|attentional blink|attentional blink
5509990|NCT01253018|stroke|stroke
5509991|NCT01253018|robotics|robotics
5509992|NCT01253018|upper extremity rehabilitation|upper extremity rehabilitation
5509993|NCT01252992|Extrapulmonary|extrapulmonary
5509994|NCT01252992|Tuberculosis|tuberculosis
5509995|NCT01252992|Paradoxical reaction|paradoxical reaction
5509996|NCT01252992|Risk factors|risk factors
5509997|NCT01252992|Incidence|incidence
5509998|NCT01252992|CT scan|ct scan
5509999|NCT01252992|Natural history|natural history
5510000|NCT01252992|Immune system phenomena|immune system phenomena
5510001|NCT01252992|Immune markers|immune markers
5510002|NCT01252992|Gene Expression Profiling|gene expression profiling
5510003|NCT01252979|MELAS|melas
5510004|NCT01252979|Ketones|ketones
5510005|NCT01252979|Medium Chain Triglycerides|medium chain triglycerides
5510006|NCT01252979|MCT oil|mct oil
5510007|NCT01252979|Mitochondrial Disorder|mitochondrial disorder
5510008|NCT01252979|Heteroplasmy|heteroplasmy
5510009|NCT01252979|3243AG|3243ag
5510010|NCT01252979|Subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.|subject is informed and given ample opportunity to consider his/her participation and has given his/her written consent.
5510011|NCT01252979|Subject is willing and able to comply with all trial requirements.|subject is willing and able to comply with all trial requirements.
5510012|NCT01252979|Subject harbors the 3243 A>G mtDNA mutation at a level detectable in blood.|subject harbors the 3243 a>g mtdna mutation at a level detectable in blood.
5510013|NCT01252979|Female subjects of child-bearing potential must not be pregnant.|female subjects of child-bearing potential must not be pregnant.
5510014|NCT01252979|Subjects must not have Diabetes Mellitus.|subjects must not have diabetes mellitus.
5510015|NCT01252966|Tobacco|tobacco
5510016|NCT01252966|Smoking|smoking
5510017|NCT01252966|Cognition|cognition
5510018|NCT01252966|Behavioral Training|behavioral training
5510019|NCT01252966|Relapse|relapse
5510020|NCT01252953|vascular disease|vascular disease
5510021|NCT01252953|lipids|lipids
5510022|NCT01252953|cholesteryl ester transfer protein (CETP) inhibition|cholesteryl ester transfer protein (cetp) inhibition
5510023|NCT01252953|anacetrapib|anacetrapib
5510024|NCT01252940|HIV-1|hiv-1
5510026|NCT01252940|Treatment Experienced|treatment experienced
5510027|NCT01252914|Open angle|open angle
5510028|NCT01252914|Glaucoma|glaucoma
5510029|NCT01252914|Surgery|surgery
5510030|NCT01252914|Ocular Hypertension|ocular hypertension
5510031|NCT01252914|Eye Diseases|eye diseases
5510032|NCT01252901|WT1|wt1
5510033|NCT01252901|Wilms Tumor|wilms tumor
5510034|NCT01252901|Denys-Drash Syndrome|denys-drash syndrome
5510035|NCT01252901|Nephrotic Syndrome|nephrotic syndrome
5510036|NCT01252901|Proteinuria|proteinuria
5510037|NCT01252888|Open angle|open angle
5510038|NCT01252888|Glaucoma|glaucoma
5510039|NCT01252888|Surgery|surgery
5510040|NCT01252888|Glaucoma Open-Angle|glaucoma open-angle
5510041|NCT01252888|Ocular Hypertension|ocular hypertension
5510042|NCT01252888|Eye Diseases|eye diseases
5510043|NCT01252875|LDL-C|ldl-c
5510044|NCT01252875|Cholesterol|cholesterol
5510045|NCT01252875|Stroke|stroke
5510046|NCT01252875|Transient ischemic attack|transient ischemic attack
5510047|NCT01252875|Statin|statin
5510048|NCT01252875|Lipid lowering therapy|lipid lowering therapy
5510049|NCT01252862|Open angle|open angle
5510050|NCT01252862|Glaucoma|glaucoma
5510051|NCT01252862|Surgery|surgery
5510052|NCT01252862|Ocular Hypertension|ocular hypertension
5510053|NCT01252862|eye diseases|eye diseases
5510054|NCT01252849|Open angle|open angle
5510055|NCT01252849|Glaucoma|glaucoma
5510056|NCT01252849|surgery|surgery
5510057|NCT01252849|Glaucoma, Open-Angle|glaucoma, open-angle
5510058|NCT01252849|Ocular Hypertension|ocular hypertension
5510059|NCT01252849|Eye Diseases|eye diseases
5510060|NCT01252823|Hemodialysis|hemodialysis
5510061|NCT01252823|Cardiac Arrhythmia|cardiac arrhythmia
5510062|NCT01252823|Cardiac Death|cardiac death
5510063|NCT01252823|Implantable Loop Recorder|implantable loop recorder
5510064|NCT01252810|CATH Catheterization|cath catheterization
5510065|NCT01252810|CI-AKI Contrast-induced acute kidney injury|ci-aki contrast-induced acute kidney injury
5510066|NCT01252810|DM Diabetes mellitus|dm diabetes mellitus
5510067|NCT01252810|eGFR Estimated glomerular filtration rate|egfr estimated glomerular filtration rate
5510068|NCT01252810|MDRD Modification of Diet in Renal Disease|mdrd modification of diet in renal disease
5510069|NCT01252810|NYHA New York Heart Association|nyha new york heart association
5510070|NCT01252810|PCI Percutaneous coronary intervention|pci percutaneous coronary intervention
5510071|NCT01252810|SCr Serum creatinine|scr serum creatinine
5510072|NCT01252797|brain metastases|brain metastases
5510074|NCT01252771|phosphorus|phosphorus
5510075|NCT01252771|dialysis|dialysis
5510076|NCT01252771|PhosLo|phoslo
5510077|NCT01252732|ABSSSI|absssi
5510078|NCT01252732|Skin Infection|skin infection
5510079|NCT01252732|Abscess|abscess
5510080|NCT01252719|ABSSSI|absssi
5510081|NCT01252719|Skin Infection|skin infection
5510082|NCT01252719|Abscess|abscess
5510083|NCT01252706|brief intervention|brief intervention
5510084|NCT01252706|alcohol|alcohol
5510085|NCT01252706|nicotine|nicotine
5510086|NCT01252706|drug abuse|drug abuse
5510087|NCT01252654|Lasik|lasik
5510088|NCT01252654|Femtosecond Laser|femtosecond laser
5510089|NCT01252654|Visumax|visumax
5510090|NCT01252654|IntraLase|intralase
5510091|NCT01252654|Myopia|myopia
5510092|NCT01252654|Myopic Patients undergoing LASIK|myopic patients undergoing lasik
5510093|NCT01252641|HIV|hiv
5510094|NCT01252628|CRC|crc
5510095|NCT01252628|SCCHN|scchn
5510096|NCT01252628|PX-866|px-866
5510097|NCT01252628|Cetuximab|cetuximab
5510099|NCT01252628|Colon|colon
5510100|NCT01252628|Head and Neck|head and neck
5510101|NCT01252628|Colorectal cancer|colorectal cancer
5510102|NCT01252628|Squamous cell carcinoma|squamous cell carcinoma
5510103|NCT01252628|PI-3K|pi-3k
5510104|NCT01252628|PI3 kinase|pi3 kinase
5510105|NCT01252628|PI3K|pi3k
5510106|NCT01252615|ICD|icd
5510107|NCT01252615|HF|hf
5510108|NCT01252615|cardiac arrest|cardiac arrest
5510109|NCT01252615|VF|vf
5510110|NCT01252615|cardiac arrhythmias|cardiac arrhythmias
5510111|NCT01252602|breastfeeding, EPDS, prenatal depression|breastfeeding, epds, prenatal depression
5510112|NCT01252589|Chronic Myeloid Leukemia|chronic myeloid leukemia
5510113|NCT01252589|Quality of Life|quality of life
5510114|NCT01252589|Symptoms|symptoms
5510115|NCT01252589|Patient-Reported outcomes|patient-reported outcomes
5510116|NCT01252589|Questionnaire|questionnaire
5510117|NCT01252576|FSFI|fsfi
5510118|NCT01252576|female sexual function|female sexual function
5510119|NCT01252576|italian validation|italian validation
5510120|NCT01252563|ENTER10|enter10
5510121|NCT01252563|Hypertension|hypertension
5510122|NCT01252563|Japanese|japanese
5510123|NCT01252563|Norvasc 10mg|norvasc 10mg
5510124|NCT01252563|Post Marketing surveillance|post marketing surveillance
5510126|NCT01252550|GI|gi
5510127|NCT01252550|QOL|qol
5510128|NCT01252550|Pathophysiology|pathophysiology
5510129|NCT01252550|Gut microbiota|gut microbiota
5510130|NCT01252550|Danone|danone
5510131|NCT01252550|Activia|activia
5510132|NCT01252550|Probiotics|probiotics
5510133|NCT01252537|HIV|hiv
5510135|NCT01252537|Immunosuppression|immunosuppression
5510136|NCT01252537|ART|art
5510137|NCT01252537|Ethiopia|ethiopia
5510138|NCT01252537|Primary health care|primary health care
5510139|NCT01252524|diabetes mellitus|diabetes mellitus
5510140|NCT01252524|fiber|fiber
5510141|NCT01252524|glycemic control|glycemic control
5510142|NCT01252524|calcium polycarbophil|calcium polycarbophil
5510143|NCT01252511|Malabsorption after RYGB|malabsorption after rygb
5510144|NCT01252511|Fat Malabsorption and maldigestion|fat malabsorption and maldigestion
5510145|NCT01252511|Obesity surgery|obesity surgery
5510146|NCT01252511|Bariatric surgery|bariatric surgery
5510147|NCT01252498|Cancer of the head and neck|cancer of the head and neck
5510148|NCT01252498|Radiotherapy|radiotherapy
5510149|NCT01252498|Prostaglandins|prostaglandins
5510150|NCT01252485|AML|aml
5510151|NCT01252485|Registry study|registry study
5510152|NCT01252485|Biology and Outcome|biology and outcome
5510153|NCT01252485|Higher Risk MDS|higher risk mds
5510154|NCT01252472|Flomax|flomax
5510155|NCT01252472|Floppy iris Syndrome|floppy iris syndrome
5510156|NCT01252472|Tamsulosin|tamsulosin
5510157|NCT01252459|AA-PET|aa-pet
5510158|NCT01252459|T1-Gd-MRI|t1-gd-mri
5510159|NCT01252459|re-irradiation|re-irradiation
5510160|NCT01252459|recurrent glioma|recurrent glioma
5510161|NCT01252446|ICD 10|icd 10
5510162|NCT01252446|Attention-Deficit-Hyperactivity-Disorder (ADHD)|attention-deficit-hyperactivity-disorder (adhd)
5510163|NCT01252446|Comorbidity|comorbidity
5510164|NCT01252446|Social-demographic profile|social-demographic profile
5510165|NCT01252420|Distal Vein Thrombosis|distal vein thrombosis
5510166|NCT01252420|Proximal Vein Thrombosis|proximal vein thrombosis
5510167|NCT01252420|Pulmonary Embolism|pulmonary embolism
5510168|NCT01252420|Post-thrombotic syndrome|post-thrombotic syndrome
5510169|NCT01252420|Limited duration treatment|limited duration treatment
5510170|NCT01252407|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5510171|NCT01252407|Sympathetic nervous system|sympathetic nervous system
5510172|NCT01252407|Parasympathetic nervous system|parasympathetic nervous system
5510174|NCT01252342|Oxytocin|oxytocin
5510175|NCT01252342|Intramyometrial|intramyometrial
5510176|NCT01252329|high risk cutaneous squamous cell carcinoma|high risk cutaneous squamous cell carcinoma
5510177|NCT01252329|selective neck dissection|selective neck dissection
5510178|NCT01252329|elective lymph node management|elective lymph node management
5510179|NCT01252329|clinical nodal observation|clinical nodal observation
5510180|NCT01252303|Obesity, weight loss, meal replacements|obesity, weight loss, meal replacements
5510181|NCT01252264|biorepository|biorepository
5510182|NCT01252264|genetics|genetics
5510183|NCT01252264|craniofacial|craniofacial
5510184|NCT01252264|cleft lip|cleft lip
5510185|NCT01252264|cleft palate|cleft palate
5510186|NCT01252251|PASIREOTIDE (SOM230)|pasireotide (som230)
5510187|NCT01252251|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5510189|NCT01252251|10-123|10-123
5510190|NCT01252225|Chronic Cough|chronic cough
5510191|NCT01252225|Lidocaine|lidocaine
5510192|NCT01252212|HIV, antiretroviral, adherence, SMS, cell phone|hiv, antiretroviral, adherence, sms, cell phone
5510193|NCT01252199|Shigamabs|shigamabs
5510194|NCT01252199|Monoclonal|monoclonal
5510195|NCT01252199|Antibodies|antibodies
5510196|NCT01252199|Shiga|shiga
5510197|NCT01252199|Toxin|toxin
5510198|NCT01252199|E.coli|e.coli
5510199|NCT01252199|HUS|hus
5510200|NCT01252199|Bloody|bloody
5510201|NCT01252199|Diarrhea|diarrhea
5510202|NCT01252186|Contraception|contraception
5510203|NCT01252186|Hemostasis|hemostasis
5510204|NCT01252186|Blood Coagulation|blood coagulation
5510205|NCT01252173|endotracheal|endotracheal
5510206|NCT01252173|intubation|intubation
5510207|NCT01252173|tracheal|tracheal
5510208|NCT01252173|pressure|pressure
5510209|NCT01252173|cufflator|cufflator
5510210|NCT01252160|Neuralgia, Postherpetic|neuralgia, postherpetic
5510211|NCT01252160|QUTENZA|qutenza
5510212|NCT01252134|Soft Contact lens|soft contact lens
5510213|NCT01252134|Multi-purpose solution|multi-purpose solution
5510214|NCT01252134|Wettability|wettability
5510215|NCT01252121|Dry Eye|dry eye
5510216|NCT01252121|Ocular Retention Time|ocular retention time
5510217|NCT01252108|Helicobacter pylori|helicobacter pylori
5510218|NCT01252108|peptic ulcer disease|peptic ulcer disease
5510219|NCT01252108|stomach ulcers|stomach ulcers
5510220|NCT01252108|gastric cancer|gastric cancer
5510221|NCT01252095|PG545|pg545
5510222|NCT01252095|Phase I|phase i
5510223|NCT01252095|Progen|progen
5510224|NCT01252095|antimetastatic|antimetastatic
5510225|NCT01252095|antiangiogenic|antiangiogenic
5510226|NCT01252095|advanced cancer patients|advanced cancer patients
5510227|NCT01252095|solid tumors|solid tumors
5510228|NCT01252095|solid tumours|solid tumours
5510229|NCT01252082|metabolic control|metabolic control
5510230|NCT01252082|fasting plasma glucose|fasting plasma glucose
5510231|NCT01252082|glycated hemoglobin|glycated hemoglobin
5510232|NCT01252043|cholestasis|cholestasis
5510233|NCT01252043|children|children
5510234|NCT01252030|CAD, physical activity, rehabilitation, prevention|cad, physical activity, rehabilitation, prevention
5510235|NCT01252004|Left ventricular ballooning|left ventricular ballooning
5510236|NCT01251978|Choroidal melanoma|choroidal melanoma
5510237|NCT01251978|Ranibizumab|ranibizumab
5510238|NCT01251978|Transpupillary Thermotherapy|transpupillary thermotherapy
5510239|NCT01251978|CSTIP|cstip
5510240|NCT01251978|Indocyanine Green|indocyanine green
5510241|NCT01251965|Relapsed Acute Leukemia|relapsed acute leukemia
5510242|NCT01251965|Acute myeloid leukemia|acute myeloid leukemia
5510249|NCT01251965|INCB018424|incb018424
5510250|NCT01251926|Bevacizumab|bevacizumab
5510251|NCT01251926|Camptothecin|camptothecin
5510252|NCT01251926|EZN-2208|ezn-2208
5510253|NCT01251926|Anti-Angiogenesis|anti-angiogenesis
5510254|NCT01251926|Advanced Cancer|advanced cancer
5510255|NCT01251926|Cancer|cancer
5510256|NCT01251926|Solid Tumor|solid tumor
5510257|NCT01251913|Tissue Harvest|tissue harvest
5510258|NCT01251913|Hospice|hospice
5510259|NCT01251913|Autopsy|autopsy
5510260|NCT01251913|Crainiotomy|crainiotomy
5510261|NCT01251913|Brain Tumor|brain tumor
5510262|NCT01251913|Glioma|glioma
5510263|NCT01251913|Astrocytoma|astrocytoma
5510269|NCT01251887|Lipids|lipids
5510270|NCT01251887|Obesity|obesity
5510271|NCT01251887|Omega-3 Fatty Acids|omega-3 fatty acids
5510272|NCT01251887|Overweight|overweight
5510273|NCT01251848|Sitaxentan|sitaxentan
5510274|NCT01251848|ritonavir|ritonavir
5510275|NCT01251848|drug interaction|drug interaction
5510276|NCT01251848|pharmacokinetics|pharmacokinetics
5510277|NCT01251835|Sitaxsentan|sitaxsentan
5510278|NCT01251835|Rifampin|rifampin
5510279|NCT01251835|Drug Interaction|drug interaction
5510280|NCT01251835|Pharmacokinetics|pharmacokinetics
5510287|NCT01251757|cardiovascular disease|cardiovascular disease
5510288|NCT01251757|randomized clinical trial|randomized clinical trial
5510289|NCT01251757|medication adherence|medication adherence
5510290|NCT01251757|health information technology|health information technology
5510291|NCT01251757|adult|adult
5510292|NCT01251757|telephone calls|telephone calls
5510293|NCT01251757|IVR|ivr
5510294|NCT01251744|Pregnancy|pregnancy
5510295|NCT01251744|Congenital|congenital
5510296|NCT01251744|Cytomegalovirus infection|cytomegalovirus infection
5510297|NCT01251718|Donepezil hydrochloride|donepezil hydrochloride
5510298|NCT01251718|Alzheimer's Disease|alzheimer's disease
5510299|NCT01251705|Cornea|cornea
5510300|NCT01251705|SL OCT|sl oct
5510301|NCT01251705|Spectral OCT Cornea modul|spectral oct cornea modul
5510302|NCT01251705|ultrasound pachymetry|ultrasound pachymetry
5510303|NCT01251705|Pentacam|pentacam
5510304|NCT01251692|Corneal erosions|corneal erosions
5510305|NCT01251692|PTK|ptk
5510306|NCT01251679|handwashing|handwashing
5510307|NCT01251679|masks|masks
5510308|NCT01251679|infectious disease transmission|infectious disease transmission
5510309|NCT01251666|Colorectal cancer|colorectal cancer
5510310|NCT01251666|Screening|screening
5510311|NCT01251666|Average-risk population|average-risk population
5510312|NCT01251666|faecal occult blood tests|faecal occult blood tests
5510313|NCT01251640|pancreatic cancer,|pancreatic cancer,
5510314|NCT01251640|MEK-inhibitor|mek-inhibitor
5510315|NCT01251627|Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Decitabine|myelodysplastic syndromes, chronic myelomonocytic leukemia, decitabine
5510316|NCT01251614|Randomized|randomized
5510321|NCT01251588|Symptomatic focal cartilage defects|symptomatic focal cartilage defects
5510322|NCT01251588|Microfracture|microfracture
5510323|NCT01251588|MACI|maci
5510324|NCT01251588|Autologous chondrocyte|autologous chondrocyte
5510325|NCT01251549|ReWalk|rewalk
5510326|NCT01251549|Paraplegia|paraplegia
5510327|NCT01251549|Spinal Cord Injuries (SCI)|spinal cord injuries (sci)
5510328|NCT01251536|colorectal cancer|colorectal cancer
5510329|NCT01251536|K-Ras wildtype|k-ras wildtype
5510330|NCT01251536|first line metastatic|first line metastatic
5510331|NCT01251536|standard cetuximab + FOLFIRI|standard cetuximab + folfiri
5510332|NCT01251536|dose escalation cetuximab|dose escalation cetuximab
5510333|NCT01251523|Asthma|asthma
5510334|NCT01251471|major depressive disorder|major depressive disorder
5510335|NCT01251471|MDD|mdd
5510336|NCT01251471|imaging genetics|imaging genetics
5510337|NCT01251471|pharmacoMRI|pharmacomri
5510338|NCT01251432|otitis media|otitis media
5510339|NCT01251432|Eustachian tube|eustachian tube
5510340|NCT01251432|allergy|allergy
5510341|NCT01251432|gastroesophageal reflux|gastroesophageal reflux
5510342|NCT01251432|tympanostomy tube|tympanostomy tube
5510343|NCT01251419|Generic Medication|generic medication
5510344|NCT01251419|Brand Name Medication|brand name medication
5510345|NCT01251419|Conversion Rates|conversion rates
5510346|NCT01251419|Social Proximity|social proximity
5492345|NCT01327248|Blood|blood
5510347|NCT01251419|Behavioral Economics|behavioral economics
5510348|NCT01251406|Stable|stable
5510349|NCT01251406|Chronic Heart Failure|chronic heart failure
5510350|NCT01251406|Systolic|systolic
5510356|NCT01251341|inflammation|inflammation
5510357|NCT01251341|immune system|immune system
5510358|NCT01251341|cytokines|cytokines
5510359|NCT01251341|meditation|meditation
5510360|NCT01251341|compassion|compassion
5510361|NCT01251341|attention|attention
5510362|NCT01251315|Glutathione|glutathione
5510363|NCT01251315|Antioxidant|antioxidant
5510364|NCT01251315|Free radical|free radical
5510365|NCT01251315|Oxidative stress|oxidative stress
5510366|NCT01251315|N-Acetyl Cysteine|n-acetyl cysteine
5510367|NCT01251315|Glutathione precursor|glutathione precursor
5510368|NCT01251302|Corus CAD|corus cad
5510369|NCT01251302|Age/Sex/Gene Expression Score|age/sex/gene expression score
5510370|NCT01251302|Molecular Genetics|molecular genetics
5510371|NCT01251302|Atherosclerosis|atherosclerosis
5510372|NCT01251302|ASGES|asges
5510373|NCT01251302|Gene Expression|gene expression
5510374|NCT01251302|GES|ges
5510375|NCT01251302|CAD|cad
5510376|NCT01251302|CVD|cvd
5510377|NCT01251302|CHD|chd
5510378|NCT01251302|Clinical Utility|clinical utility
5510379|NCT01251302|Precision Medicine|precision medicine
5510380|NCT01251302|Coronary Artery Disease|coronary artery disease
5510381|NCT01251302|Angina Pectoris|angina pectoris
5510382|NCT01251302|Chest Pain|chest pain
5510383|NCT01251302|Cardiovascular Disease|cardiovascular disease
5510384|NCT01251302|Coronary Heart Disease|coronary heart disease
5510385|NCT01251302|IMPACT|impact
5510386|NCT01251302|IMPACT-CARD|impact-card
5510387|NCT01251263|headaches|headaches
5510388|NCT01251263|migraines|migraines
5510389|NCT01251263|breakthrough bleeding|breakthrough bleeding
5510390|NCT01251263|breakthrough spotting|breakthrough spotting
5510391|NCT01251263|menstrually associated migraines|menstrually associated migraines
5510392|NCT01251263|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
5510393|NCT01251224|asthma|asthma
5510394|NCT01251224|mouse allergen|mouse allergen
5510395|NCT01251224|environmental intervention|environmental intervention
5510396|NCT01251211|BOTULINUM TOXIN|botulinum toxin
5510397|NCT01251211|NEUROPATHIC PAIN|neuropathic pain
5510398|NCT01251211|RANDOMIZED CONTROLLED TRIAL|randomized controlled trial
5510399|NCT01251185|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5510400|NCT01251185|Heart Failure|heart failure
5510401|NCT01251185|Congestive Heart Failure|congestive heart failure
5510402|NCT01251185|Non-invasive|non-invasive
5510403|NCT01251185|Device Trial|device trial
5510404|NCT01251185|NYHA (New York Heart Association)|nyha (new york heart association)
5510405|NCT01251185|Ischemic cardiomyopathy|ischemic cardiomyopathy
5510406|NCT01251185|Ischemia|ischemia
5510407|NCT01251185|Myocardial contractility|myocardial contractility
5510408|NCT01251159|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5510409|NCT01251159|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5510410|NCT01251159|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5510411|NCT01251159|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5510412|NCT01251159|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5513165|NCT01238718|BIS|bis
5510443|NCT01251081|sepsis|sepsis
5510444|NCT01251081|acute kidney injury|acute kidney injury
5510445|NCT01251081|survival|survival
5510446|NCT01251068|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion|anemic preterms, cerebral oxygenation,somatic oxygenation, blood transfusion
5510447|NCT01251055|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5510448|NCT01251055|glycine transporter|glycine transporter
5510449|NCT01251055|schizophrenia|schizophrenia
5510450|NCT01251016|Type 2 diabetes mellitus|type 2 diabetes mellitus
5510451|NCT01251016|Y-Roux gastric bypass|y-roux gastric bypass
5510452|NCT01251016|Gut hormones|gut hormones
5510453|NCT01251016|Gene expression|gene expression
5510454|NCT01251016|Surgery|surgery
5510455|NCT01251003|Traumatic Brain Injury|traumatic brain injury
5510456|NCT01251003|TBI|tbi
5510457|NCT01251003|Pediatric|pediatric
5510458|NCT01251003|Chronic|chronic
5510459|NCT01250990|Niacin|niacin
5510460|NCT01250990|HDL|hdl
5510461|NCT01250990|Reverse cholesterol transport|reverse cholesterol transport
5510462|NCT01250977|Non-treatment seeking smokers, reporting consumption of at least|non-treatment seeking smokers, reporting consumption of at least
5510463|NCT01250977|10 cigarettes per day for at least the past 6 months|10 cigarettes per day for at least the past 6 months
5510464|NCT01250951|Iron Overload|iron overload
5510465|NCT01250951|hemotranfusion|hemotranfusion
5510466|NCT01250951|deferasirox|deferasirox
5510467|NCT01250951|ferritin|ferritin
5510468|NCT01250951|Rare anemia|rare anemia
5510469|NCT01250951|Transfusional Iron Overload|transfusional iron overload
5510470|NCT01250938|autism|autism
5510471|NCT01250938|autism spectrum disorders|autism spectrum disorders
5510472|NCT01250938|pervasive developmental disorders|pervasive developmental disorders
5510473|NCT01250938|intervention|intervention
5510474|NCT01250938|low-income|low-income
5510475|NCT01250938|underserved populations|underserved populations
5510476|NCT01250938|underrepresented populations|underrepresented populations
5510477|NCT01250925|Contact lens|contact lens
5510478|NCT01250925|Lens care|lens care
5510479|NCT01250912|Ablation|ablation
5510480|NCT01250912|Arrythmia|arrythmia
5510482|NCT01250899|HIV|hiv
5510483|NCT01250899|Vitamin D|vitamin d
5510484|NCT01250899|HAART|haart
5510485|NCT01250860|Manual therapy|manual therapy
5510486|NCT01250860|DoboMed exercise|dobomed exercise
5510487|NCT01250860|Spirometric test|spirometric test
5510488|NCT01250847|ARMS|arms
5510489|NCT01250847|Ultra High Risk|ultra high risk
5510490|NCT01250847|Quetiapine|quetiapine
5510491|NCT01250847|Verbal memory|verbal memory
5510492|NCT01250821|Infertility|infertility
5510493|NCT01250821|Anovulation|anovulation
5510494|NCT01250821|Ovulation induction|ovulation induction
5510495|NCT01250795|Prevention|prevention
5510496|NCT01250782|Glutamine, trauma patients, infections, mortality|glutamine, trauma patients, infections, mortality
5510497|NCT01250769|dental|dental
5510498|NCT01250769|dentist|dentist
5510499|NCT01250769|plaque|plaque
5510500|NCT01250769|IP Cleaning|ip cleaning
5510501|NCT01250756|vaccine|vaccine
5510502|NCT01250756|pneumococcal conjugate|pneumococcal conjugate
5510503|NCT01250743|genotype 1|genotype 1
5510504|NCT01250730|PK profile in Japanese healthy male volunteers|pk profile in japanese healthy male volunteers
5510505|NCT01250717|prostatectomy|prostatectomy
5510506|NCT01250717|docetaxel|docetaxel
5510507|NCT01250704|Neuromyotonia, Isaac's syndrome; Peripheral nerve hyperexcitability; Myokymia; Potassium channelopathy|neuromyotonia, isaac's syndrome; peripheral nerve hyperexcitability; myokymia; potassium channelopathy
5510508|NCT01250691|pneumonia|pneumonia
5510509|NCT01250691|ICU|icu
5510510|NCT01250691|isolation room|isolation room
5510511|NCT01250691|clinical epidemiology|clinical epidemiology
5510512|NCT01250691|infection control|infection control
5510513|NCT01250678|multiple sclerosis|multiple sclerosis
5510514|NCT01250678|cognitive impairment|cognitive impairment
5510515|NCT01250678|natalizumab|natalizumab
5510516|NCT01250678|SDMT|sdmt
5510517|NCT01250665|multiple sclerosis|multiple sclerosis
5510518|NCT01250665|cognitive impairment|cognitive impairment
5510519|NCT01250665|interferon-beta 1b|interferon-beta 1b
5510520|NCT01250665|corpus callosum index|corpus callosum index
5510521|NCT01250652|Chronic urticaria|chronic urticaria
5510522|NCT01250652|Urticaria|urticaria
5510523|NCT01250652|Antihistamine|antihistamine
5510524|NCT01250639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5510525|NCT01250639|non-aboriginal Taiwanese|non-aboriginal taiwanese
5510526|NCT01250639|Genome-wide association study|genome-wide association study
5510527|NCT01250626|Inulin|inulin
5510528|NCT01250626|childhood GFR formula|childhood gfr formula
5510529|NCT01250587|Open label|open label
5510530|NCT01250587|dose-finding Phase 1 study|dose-finding phase 1 study
5510531|NCT01250574|CD64|cd64
5510532|NCT01250574|Procalcitonin|procalcitonin
5510533|NCT01250561|gabapentin|gabapentin
5510534|NCT01250561|valacyclovir|valacyclovir
5510536|NCT01250561|shingles|shingles
5510537|NCT01250548|Rheumatoid arthritis|rheumatoid arthritis
5510538|NCT01250548|RA|ra
5511125|NCT01247857|Ropivacaine|ropivacaine
5510539|NCT01250548|Active rheumatoid arthritis|active rheumatoid arthritis
5510540|NCT01250535|Drug drug interactions|drug drug interactions
5510541|NCT01250535|Warfarin|warfarin
5510542|NCT01250535|Anticoagulants|anticoagulants
5510543|NCT01250535|Lovastatin|lovastatin
5510544|NCT01250535|Statins|statins
5510545|NCT01250535|CYP4F2|cyp4f2
5510546|NCT01250535|Vitamin K|vitamin k
5510547|NCT01250509|Obesity|obesity
5510548|NCT01250509|Mindfulness based stress reduction|mindfulness based stress reduction
5510549|NCT01250509|Mindful eating|mindful eating
5510550|NCT01250509|Stress|stress
5510551|NCT01250509|Overnutrition|overnutrition
5510552|NCT01250509|Nutrition Disorders|nutrition disorders
5510553|NCT01250509|Overweight|overweight
5510554|NCT01250509|Body Weight|body weight
5510555|NCT01250509|Signs and Symptoms|signs and symptoms
5510556|NCT01250496|regadenoson|regadenoson
5510557|NCT01250496|lexiscan|lexiscan
5510558|NCT01250496|aminophylline|aminophylline
5510559|NCT01250496|SPECT|spect
5510560|NCT01250496|Myocardial Perfusion Imaging|myocardial perfusion imaging
5510561|NCT01250496|pharmacologic stress test|pharmacologic stress test
5510562|NCT01250483|prostate|prostate
5510563|NCT01250483|prostate-specific antigen|prostate-specific antigen
5510564|NCT01250483|benign prostatic hyperplasia|benign prostatic hyperplasia
5510565|NCT01250483|adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5510566|NCT01250444|Inspiratory Muscle Training|inspiratory muscle training
5510567|NCT01250444|Hypertension|hypertension
5510568|NCT01250444|Breathing Exercises|breathing exercises
5510569|NCT01250444|Cardiac Rehabilitation|cardiac rehabilitation
5510570|NCT01250418|Bispectral Index|bispectral index
5510571|NCT01250418|Ketamine|ketamine
5510572|NCT01250392|Active choice|active choice
5510573|NCT01250392|Nurse visits|nurse visits
5510574|NCT01250392|Behavioral economics|behavioral economics
5510575|NCT01250366|Safety and Pharmacokinetics|safety and pharmacokinetics
5510576|NCT01250353|ocular surface reconstruction|ocular surface reconstruction
5510577|NCT01250353|conjunctival healing|conjunctival healing
5510578|NCT01250353|pterygium|pterygium
5510579|NCT01250353|latex biomembrane|latex biomembrane
5510580|NCT01250353|pterygium surgery|pterygium surgery
5510581|NCT01250340|Diabetes|diabetes
5510582|NCT01250340|Isoprostanes|isoprostanes
5510583|NCT01250340|Thromboxane|thromboxane
5510584|NCT01250340|Aspirin|aspirin
5510585|NCT01250327|right ventricular outflow tract|right ventricular outflow tract
5510586|NCT01250327|endovascular valve insertion|endovascular valve insertion
5510587|NCT01250327|economic evaluation|economic evaluation
5510588|NCT01250327|valved stent|valved stent
5510589|NCT01250314|osteoporosis|osteoporosis
5510591|NCT01250314|bone micro-architecture|bone micro-architecture
5510592|NCT01250314|bone markers|bone markers
5510593|NCT01250301|Smoking Cessation|smoking cessation
5510594|NCT01250301|Tobacco Dependence|tobacco dependence
5510595|NCT01250301|De-nicotinised cigarettes|de-nicotinised cigarettes
5510596|NCT01250288|Health Information Technology|health information technology
5510597|NCT01250288|Health Records, Personal|health records, personal
5510598|NCT01250288|Hospital Information Systems|hospital information systems
5510599|NCT01250288|Patient Access to Records|patient access to records
5510600|NCT01250288|Medical Records|medical records
5510601|NCT01250288|Medical Record Systems, Computerized|medical record systems, computerized
5510602|NCT01250275|Canola Oil|canola oil
5510603|NCT01250275|Peripheral Arterial Disease|peripheral arterial disease
5510604|NCT01250275|Peripheral Vascular Disease|peripheral vascular disease
5510605|NCT01250275|PAD|pad
5510606|NCT01250262|low back pain|low back pain
5510607|NCT01250262|obese|obese
5510608|NCT01250262|fear avoidance|fear avoidance
5510609|NCT01250262|disability and low back pain|disability and low back pain
5510610|NCT01250262|chronic low back pain in obese older adults|chronic low back pain in obese older adults
5680301|NCT00578331|perennial allergic rhinitis|perennial allergic rhinitis
5680302|NCT00578331|allergic rhinitis|allergic rhinitis
5510611|NCT01250249|To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited with BCG vaccine of serum institute of India limited|to compare safety and reactogenecity of bcg vaccine of green signal biopharma private limited with bcg vaccine of serum institute of india limited
5510612|NCT01250236|brimonidine|brimonidine
5510613|NCT01250236|alpha-2 adrenoceptor|alpha-2 adrenoceptor
5510614|NCT01250236|cornea|cornea
5510615|NCT01250236|corneal thickness|corneal thickness
5510616|NCT01250223|Lymphoma, Follicular|lymphoma, follicular
5510617|NCT01250223|Prognosis|prognosis
5510618|NCT01250223|Progression-Free Survival|progression-free survival
5510619|NCT01250223|Outcome|outcome
5510620|NCT01250223|International Cooperation|international cooperation
5510621|NCT01250223|Data Collection|data collection
5510622|NCT01250223|Prospective studies|prospective studies
5510623|NCT01250223|Rare Diseases|rare diseases
5510624|NCT01250210|contraception|contraception
5510625|NCT01250210|pregnancy prevention|pregnancy prevention
5510626|NCT01250197|Normal Volunteers|normal volunteers
5510627|NCT01250184|Myofascial pain|myofascial pain
5510628|NCT01250184|Trigger points.|trigger points.
5510629|NCT01250184|Lidocaine injection.|lidocaine injection.
5510630|NCT01250184|Physical therapy|physical therapy
5510631|NCT01250171|Dry eye|dry eye
5510632|NCT01250171|IL17/ IL-1β|il17/ il-1β
5510633|NCT01250171|Biologic|biologic
5510634|NCT01250158|Liver Percutaneous Isolated Localized Perfusion|liver percutaneous isolated localized perfusion
5510635|NCT01250158|PILP|pilp
5510636|NCT01250158|Isolated Hepatic Perfusion|isolated hepatic perfusion
5510637|NCT01250158|IHP|ihp
5510638|NCT01250158|Liver metastases|liver metastases
5510639|NCT01250158|Unresectable liver metastases of different etiologies|unresectable liver metastases of different etiologies
5510640|NCT01250132|Traumatic brain injury|traumatic brain injury
5510641|NCT01250132|Paediatrics|paediatrics
5510642|NCT01250132|Hypopituitarism|hypopituitarism
5510643|NCT01250106|probiotics|probiotics
5510644|NCT01250106|prevention|prevention
5510645|NCT01250106|dietary intervention|dietary intervention
5510646|NCT01250106|insulin resistance|insulin resistance
5510647|NCT01250106|obesity|obesity
5510648|NCT01250106|type 2 diabetes|type 2 diabetes
5510649|NCT01250015|colorectal cancer|colorectal cancer
5510650|NCT01250015|consent|consent
5510651|NCT01250015|screening|screening
5510652|NCT01250002|Pain|pain
5510653|NCT01250002|MQOR 40|mqor 40
5510654|NCT01250002|Lidocaine|lidocaine
5510655|NCT01250002|Gynecologic|gynecologic
5510656|NCT01250002|Surgery|surgery
5510657|NCT01250002|Laparoscopic|laparoscopic
5510658|NCT01249989|Physical Activity|physical activity
5510659|NCT01249989|Sedentary Lifestyle|sedentary lifestyle
5510660|NCT01249989|Diet|diet
5510661|NCT01249989|Health Behavior|health behavior
5510662|NCT01249976|blood culture|blood culture
5510663|NCT01249976|central venous catheter|central venous catheter
5510664|NCT01249976|acridine orange leucocyte cytospin test|acridine orange leucocyte cytospin test
5510665|NCT01249976|semi-quantitative skin culture|semi-quantitative skin culture
5510666|NCT01249963|acute pancreatitis|acute pancreatitis
5510667|NCT01249963|enteral nutrition|enteral nutrition
5510668|NCT01249963|nutritional status|nutritional status
5510669|NCT01249963|pancreas|pancreas
5510670|NCT01249963|T-Diet plus Atémpero|t-diet plus atémpero
5510671|NCT01249950|Morbid obesity|morbid obesity
5510672|NCT01249950|teenagers|teenagers
5510673|NCT01249950|co-morbidities|co-morbidities
5510674|NCT01249950|bariatric surgery|bariatric surgery
5510675|NCT01249950|epidemiology|epidemiology
5510676|NCT01249937|Macular Degeneration|macular degeneration
5510677|NCT01249937|Age-related macular degeneration|age-related macular degeneration
5510678|NCT01249937|Anti-inflammatory|anti-inflammatory
5510679|NCT01249937|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5510680|NCT01249937|Lucentis|lucentis
5510681|NCT01249937|Ranibizumab|ranibizumab
5510682|NCT01249937|Kenalog|kenalog
5510683|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide
5510684|NCT01249937|Vision loss|vision loss
5510685|NCT01249924|Obstructive sleep apnea (OSA), continuous positive airway pressure(CPAP), surgery, anesthesia|obstructive sleep apnea (osa), continuous positive airway pressure(cpap), surgery, anesthesia
5510686|NCT01249911|Infants|infants
5510687|NCT01249898|Fracture in the Scaphoid fractures|fracture in the scaphoid fractures
5510688|NCT01249885|pacifier sucking|pacifier sucking
5510689|NCT01249885|children|children
5510690|NCT01249885|occlusion|occlusion
5510691|NCT01249885|drooling|drooling
5510692|NCT01249872|open gastric by-pass|open gastric by-pass
5510693|NCT01249872|super morbidly obese patients|super morbidly obese patients
5510694|NCT01249872|postoperative thoracic epidural analgesia|postoperative thoracic epidural analgesia
5510695|NCT01249872|different drug regimens (morphine and levobupivacaine)|different drug regimens (morphine and levobupivacaine)
5504796|NCT01275443|HIV|hiv
5510696|NCT01249872|Lung function tests|lung function tests
5510697|NCT01249872|Postoperative Bowel recovery|postoperative bowel recovery
5510698|NCT01249872|Postoperative Ambulation|postoperative ambulation
5510699|NCT01249859|stomach disease|stomach disease
5510700|NCT01249859|signet ring cell carcinoma|signet ring cell carcinoma
5510701|NCT01249859|chemotherapy|chemotherapy
5510702|NCT01249859|Prognostic|prognostic
5510703|NCT01249833|Influenza|influenza
5510704|NCT01249833|Cognition|cognition
5510705|NCT01249833|Attention|attention
5510706|NCT01249833|Simple Reaction Time|simple reaction time
5510707|NCT01249833|Alertness|alertness
5510708|NCT01249833|Calmness|calmness
5510709|NCT01249833|Contentment|contentment
5510711|NCT01249820|anidulafungin|anidulafungin
5510712|NCT01249820|antifungal prophylaxis|antifungal prophylaxis
5510713|NCT01249820|allogeneic haematopoietic stem cell transplant|allogeneic haematopoietic stem cell transplant
5510714|NCT01249820|myeloablative chemotherapy|myeloablative chemotherapy
5510715|NCT01249820|AML-MDS|aml-mds
5510716|NCT01249820|pharmacokinetics|pharmacokinetics
5510717|NCT01249807|Cancer Screening|cancer screening
5510718|NCT01249807|health service utilization model|health service utilization model
5510719|NCT01249807|quality of health life|quality of health life
5510721|NCT01249794|non invasive ventilation|non invasive ventilation
5510722|NCT01249794|cardiac surgery|cardiac surgery
5510723|NCT01249794|continuous positive airway pressure|continuous positive airway pressure
5510724|NCT01249768|Prospective study|prospective study
5510725|NCT01249768|diagnostic accuracy|diagnostic accuracy
5510726|NCT01249768|CSF|csf
5510727|NCT01249768|MRI|mri
5510728|NCT01249742|diabetes mellitus|diabetes mellitus
5510729|NCT01249742|adolescent|adolescent
5510730|NCT01249742|online intervention|online intervention
5510731|NCT01249742|psychosocial|psychosocial
5510732|NCT01249742|quality of life|quality of life
5510733|NCT01249729|Magnetic Resonance Imaging, 3D reconstructed image|magnetic resonance imaging, 3d reconstructed image
5510734|NCT01249716|follow-up home visit|follow-up home visit
5510735|NCT01249716|Geriatric Disorder|geriatric disorder
5510736|NCT01249716|rehabilitation|rehabilitation
5510737|NCT01249690|Bortezomib,Thalidomide,bone metabolites|bortezomib,thalidomide,bone metabolites
5510738|NCT01249677|type 2 diabetes|type 2 diabetes
5510739|NCT01249677|first phase insulin secretion|first phase insulin secretion
5510740|NCT01249677|beta-cell rest|beta-cell rest
5510741|NCT01249677|basal insulin|basal insulin
5510742|NCT01249664|sham-controlled|sham-controlled
5510743|NCT01249664|pathologic myopia|pathologic myopia
5510744|NCT01249664|mCNV|mcnv
5510745|NCT01249664|choroidal neovascularization|choroidal neovascularization
5510746|NCT01249664|intravitreal injection|intravitreal injection
5510747|NCT01249664|vision loss|vision loss
5510748|NCT01249664|macular damage|macular damage
5510749|NCT01249651|Patients, Single|patients, single
5510750|NCT01249638|Bevacizumab|bevacizumab
5510751|NCT01249638|Capecitabine|capecitabine
5510752|NCT01249638|Irinotecan|irinotecan
5510753|NCT01249638|mCRC|mcrc
5510754|NCT01249625|Influenza|influenza
5510755|NCT01249625|H1N1|h1n1
5513610|NCT01237210|PD|pd
5510756|NCT01249625|Respiratory protection|respiratory protection
5632542|NCT00769561|Pain|pain
5510757|NCT01249625|N95 respirator|n95 respirator
5510758|NCT01249625|Medical mask|medical mask
5510759|NCT01249625|Personal protective equipment|personal protective equipment
5510760|NCT01249625|Facial protective equipment|facial protective equipment
5510761|NCT01249625|Pandemic planning|pandemic planning
5510762|NCT01249612|Knee joint icing|knee joint icing
5510763|NCT01249612|knee-extension strength|knee-extension strength
5510764|NCT01249599|Takotsubo Syndrome|takotsubo syndrome
5510765|NCT01249599|apical balooning syndrome|apical balooning syndrome
5510766|NCT01249599|stress-cardiomyopathy|stress-cardiomyopathy
5510767|NCT01249599|endothelial function|endothelial function
5510768|NCT01249599|sympathetic nervous activity|sympathetic nervous activity
5510769|NCT01249599|platelet adhesion|platelet adhesion
5510770|NCT01249599|arterial compliance|arterial compliance
5510771|NCT01249573|fascia therapy|fascia therapy
5510772|NCT01249573|transcutaneous fibrolysis|transcutaneous fibrolysis
5510773|NCT01249573|acute ankle distortion|acute ankle distortion
5510774|NCT01249495|leg ulcer|leg ulcer
5510775|NCT01249495|wound therapy|wound therapy
5510776|NCT01249495|Pro-inflammatory interleukins|pro-inflammatory interleukins
5510777|NCT01249482|Helicobacter pylori|helicobacter pylori
5510778|NCT01249482|reflux|reflux
5510779|NCT01249482|acid rebound|acid rebound
5510780|NCT01249391|Hand|hand
5510781|NCT01249391|osteoarthritis|osteoarthritis
5510782|NCT01249391|splint|splint
5510783|NCT01249391|pain|pain
5510784|NCT01249391|deformity|deformity
5510785|NCT01249391|function|function
5510786|NCT01249378|Nutrition|nutrition
5510787|NCT01249378|Lipid|lipid
5510788|NCT01249378|Digestion|digestion
5510789|NCT01249378|Endotoxemia|endotoxemia
5510790|NCT01249378|Inflammation|inflammation
5510791|NCT01249378|Metabolism|metabolism
5510792|NCT01249378|Stable Isotope|stable isotope
5510793|NCT01249378|Obesity|obesity
5510794|NCT01249365|medically significant conditions|medically significant conditions
5510798|NCT01249352|Esophageal Cancer|esophageal cancer
5510799|NCT01249352|Nimotuzumab|nimotuzumab
5510800|NCT01249352|EF024|ef024
5510801|NCT01249352|EF024-201|ef024-201
5510802|NCT01249339|smokeless tobacco|smokeless tobacco
5510803|NCT01249339|Nicotine|nicotine
5510804|NCT01249339|Cadmium|cadmium
5510805|NCT01249339|lead|lead
5510806|NCT01249339|Tobacco Specific Nitrosamines|tobacco specific nitrosamines
5510807|NCT01249326|Morbid obesity,|morbid obesity,
5510808|NCT01249326|Bariatric surgery, by-pass, sleeve gastrectomy,|bariatric surgery, by-pass, sleeve gastrectomy,
5510809|NCT01249326|Nitrogen balance,|nitrogen balance,
5510810|NCT01249326|Protein requirement,|protein requirement,
5510811|NCT01249326|Weight loss|weight loss
5510812|NCT01249326|Muscle wasting, muscle disability|muscle wasting, muscle disability
5510813|NCT01249313|Risk|risk
5510814|NCT01249313|outcome|outcome
5510815|NCT01249300|Dysphagia caused by cerebral vascular accidents|dysphagia caused by cerebral vascular accidents
5510816|NCT01249287|stroke|stroke
5510817|NCT01249287|stem cell|stem cell
5510818|NCT01249274|cocaine abuse|cocaine abuse
5510819|NCT01249274|cocaine dependence|cocaine dependence
5510820|NCT01249274|postpartum period|postpartum period
5510821|NCT01249261|Postmenopausal Women|postmenopausal women
5510822|NCT01249261|Osteoporosis|osteoporosis
5510823|NCT01249248|Heart rate variability|heart rate variability
5510824|NCT01249248|Autonomic dysfunction|autonomic dysfunction
5510825|NCT01249248|Exercise|exercise
5510826|NCT01249248|Sports|sports
5510827|NCT01249248|Competition|competition
5510828|NCT01249248|Athletes|athletes
5510829|NCT01249209|obesity|obesity
5510830|NCT01249209|adults|adults
5510836|NCT01249183|Diphteria|diphteria
5510837|NCT01249183|Biological / vaccine|biological / vaccine
5510838|NCT01249170|Communication skills|communication skills
5510841|NCT01249157|10-189|10-189
5510842|NCT01249144|Intraocular Lens (IOL)|intraocular lens (iol)
5510843|NCT01249144|Quarter Diopter|quarter diopter
5510844|NCT01249144|Biaspheric|biaspheric
5510845|NCT01249105|MK-2206|mk-2206
5510847|NCT01249092|biliary cirrhosis|biliary cirrhosis
5510848|NCT01249066|AMP-activated protein kinase|amp-activated protein kinase
5510849|NCT01249066|lung adenocarcinomas|lung adenocarcinomas
5510850|NCT01249066|Prognosis|prognosis
5510851|NCT01249066|Observation study|observation study
5510852|NCT01249053|OPA1|opa1
5510853|NCT01249053|lung adenocarcinomas|lung adenocarcinomas
5510854|NCT01249053|Prognosis|prognosis
5510855|NCT01249053|Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma|expression of optic atrophy type 1 (opa1) protein in lung adenocarcinoma
5510856|NCT01249040|Frozen shoulder|frozen shoulder
5510857|NCT01249040|pain scale|pain scale
5510858|NCT01249040|range of motion(ROM)|range of motion(rom)
5510859|NCT01249040|muscle strength|muscle strength
5510860|NCT01249040|shoulder arthrography|shoulder arthrography
5510861|NCT01249027|Drug eluting stents|drug eluting stents
5510862|NCT01249027|Stents|stents
5510864|NCT01249027|DES|des
5510865|NCT01249027|XIENCE V EECSS|xience v eecss
5510866|NCT01249001|pediatrics|pediatrics
5510867|NCT01249001|nausea|nausea
5510868|NCT01249001|vomiting|vomiting
5510869|NCT01249001|chemotherapy|chemotherapy
5510870|NCT01249001|antiemetic|antiemetic
5510871|NCT01248988|Pneumococcal vaccine|pneumococcal vaccine
5510872|NCT01248988|Safety|safety
5510873|NCT01248988|Synflorix|synflorix
5510874|NCT01248988|Pneumococcal diseases|pneumococcal diseases
5510875|NCT01248975|asthma|asthma
5510876|NCT01248975|GSK2190915|gsk2190915
5510877|NCT01248962|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5510878|NCT01248962|CARBOPLATIN|carboplatin
5510879|NCT01248962|DEXAMETHASONE|dexamethasone
5510880|NCT01248962|GEMCITABINE|gemcitabine
5510881|NCT01248962|LIPODOX(LIPOSOMAL DOXORUBICIN)|lipodox(liposomal doxorubicin)
5510882|NCT01248962|MONTELUKAST (SINGULAR)|montelukast (singular)
5510883|NCT01248962|TAXOL (PACLITAXEL|taxol (paclitaxel
5510884|NCT01248962|Fallopian Tubes|fallopian tubes
5510885|NCT01248962|10-184|10-184
5510886|NCT01248949|Advanced solid tumors|advanced solid tumors
5510887|NCT01248949|Advanced recurrent ovarian tumors|advanced recurrent ovarian tumors
5510888|NCT01248949|MEDI3617|medi3617
5510889|NCT01248949|Ang2|ang2
5510890|NCT01248949|Ovarian cancer|ovarian cancer
5510891|NCT01248949|Malignant glioma|malignant glioma
5510892|NCT01248923|relapsed multiple myeloma|relapsed multiple myeloma
5510893|NCT01248923|plasma cell dyscrasia|plasma cell dyscrasia
5510894|NCT01248923|plasmacytoma|plasmacytoma
5510895|NCT01248923|kinesin spindle protein|kinesin spindle protein
5510896|NCT01248923|anti-mitotic|anti-mitotic
5510897|NCT01248884|combination vaccine|combination vaccine
5510898|NCT01248884|Primary vaccination|primary vaccination
5510899|NCT01248871|renal|renal
5510900|NCT01248871|transplantation|transplantation
5510901|NCT01248871|Volatile|volatile
5510902|NCT01248871|anesthetic|anesthetic
5510903|NCT01248845|Mechanical ventilation|mechanical ventilation
5510904|NCT01248845|Electrical diaphragmatic activity|electrical diaphragmatic activity
5510905|NCT01248832|tobacco cessation|tobacco cessation
5510906|NCT01248832|smoking cessation|smoking cessation
5510907|NCT01248832|telephone|telephone
5510908|NCT01248832|self-help|self-help
5510909|NCT01248832|smoking abstinence|smoking abstinence
5510910|NCT01248832|tobacco use disorder|tobacco use disorder
5510911|NCT01248832|disparity|disparity
5510912|NCT01248819|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5510913|NCT01248819|Nebulization|nebulization
5510914|NCT01248819|Ropivacaine|ropivacaine
5510915|NCT01248806|Lung nodule|lung nodule
5510916|NCT01248806|Screening|screening
5510917|NCT01248806|Spiral low - dose computed tomography|spiral low - dose computed tomography
5510918|NCT01248806|Lung cancer|lung cancer
5510919|NCT01248793|Ankylosing Sponylitis, injection, golimumab, simponi|ankylosing sponylitis, injection, golimumab, simponi
5510920|NCT01248780|Rheumatoid Arthritis|rheumatoid arthritis
5510921|NCT01248780|injection|injection
5510922|NCT01248780|golimumab|golimumab
5510923|NCT01248780|simponi|simponi
5510941|NCT01248741|interstitial radiation,|interstitial radiation,
5510942|NCT01248741|brachytherapy|brachytherapy
5510943|NCT01248728|Autism Spectrum Disorder|autism spectrum disorder
5510944|NCT01248728|Clinical Trial|clinical trial
5510945|NCT01248728|Omega-3 Fatty Acids|omega-3 fatty acids
5510946|NCT01248728|Toddlers|toddlers
5510947|NCT01248715|pneumonia, bacterial|pneumonia, bacterial
5510948|NCT01248715|pneumonia, viral|pneumonia, viral
5510949|NCT01248715|respiratory tract infections|respiratory tract infections
5510950|NCT01248715|oseltamivir, therapeutic use|oseltamivir, therapeutic use
5510951|NCT01248702|Myocardial Infarction|myocardial infarction
5510952|NCT01248702|Heart Failure|heart failure
5510953|NCT01248702|Sudden Cardiac Death|sudden cardiac death
5510954|NCT01248702|Critical Pathways|critical pathways
5510955|NCT01248676|cancer radiation patient education|cancer radiation patient education
5510956|NCT01248663|pancreatic cancer|pancreatic cancer
5510957|NCT01248663|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
5510958|NCT01248663|delayed gastric emptying|delayed gastric emptying
5510959|NCT01248663|reconstruction|reconstruction
5510960|NCT01248650|Safety evaluation|safety evaluation
5510961|NCT01248650|Pharmacokinetic analysis|pharmacokinetic analysis
5510962|NCT01248637|pancreas|pancreas
5510963|NCT01248637|pancreatic cancer|pancreatic cancer
5510964|NCT01248637|pancreatic tumor|pancreatic tumor
5510965|NCT01248637|pimonidazole|pimonidazole
5510966|NCT01248637|hypoxia|hypoxia
5510967|NCT01248637|whipple's resection|whipple's resection
5510968|NCT01248624|Palliative Care|palliative care
5510969|NCT01248624|Quality of Life|quality of life
5510970|NCT01248624|Satisfaction with Care|satisfaction with care
5510971|NCT01248611|pain|pain
5510972|NCT01248611|adverse effects|adverse effects
5510973|NCT01248611|safety|safety
5510974|NCT01248611|feasibility|feasibility
5510975|NCT01248585|Symptom Control|symptom control
5510976|NCT01248572|Cataract|cataract
5510977|NCT01248572|Biaspheric intraocular lens|biaspheric intraocular lens
5510978|NCT01248572|Uniplanar intraocular lens|uniplanar intraocular lens
5510979|NCT01248572|Effective lens position|effective lens position
5510980|NCT01248546|Breast cancer|breast cancer
5510981|NCT01248546|Computer-aided detection|computer-aided detection
5510982|NCT01248546|Mammography screening|mammography screening
5510983|NCT01248546|Digital breast tomosynthesis|digital breast tomosynthesis
5510984|NCT01248533|Abdominal aortic aneurysm, atherosclerosis|abdominal aortic aneurysm, atherosclerosis
5510985|NCT01248520|Pregnancy|pregnancy
5510986|NCT01248520|Influenza Vaccination|influenza vaccination
5510987|NCT01248507|COPD|copd
5510988|NCT01248481|Acarbose/Glucobay®|acarbose/glucobay®
5510989|NCT01248481|Basal insulin|basal insulin
5510990|NCT01248481|PPG (Postprandial Glycaemia)|ppg (postprandial glycaemia)
5510991|NCT01248468|Pain, Migraine|pain, migraine
5510992|NCT01248455|Monoclonal Antibody|monoclonal antibody
5510993|NCT01248455|NK Cell Mediated Killing|nk cell mediated killing
5510994|NCT01248455|Response Rate|response rate
5510995|NCT01248455|Pharmacokinetics|pharmacokinetics
5510996|NCT01248455|Biological Activity|biological activity
5510997|NCT01248455|Smoldering Multiple Myeloma|smoldering multiple myeloma
5510999|NCT01248442|Vitamin D Deficiency|vitamin d deficiency
5511000|NCT01248442|Autoimmune disease|autoimmune disease
5511001|NCT01248442|Diabetes|diabetes
5511002|NCT01248429|thyrosine kinase inhibitor|thyrosine kinase inhibitor
5511003|NCT01248429|phosphokinase creatinin|phosphokinase creatinin
5511004|NCT01248429|myalgia|myalgia
5511005|NCT01248416|Aromatase|aromatase
5511006|NCT01248416|Growth|growth
5511007|NCT01248416|Letrozole|letrozole
5511008|NCT01248416|Anastrozole|anastrozole
5511010|NCT01248416|Children|children
5511011|NCT01248416|Puberty|puberty
5511012|NCT01248403|RAD001|rad001
5511013|NCT01248403|Paclitaxel|paclitaxel
5511014|NCT01248403|gastric cancer|gastric cancer
5511015|NCT01248403|advanced gastric or esophagogastric junction cancer|advanced gastric or esophagogastric junction cancer
5511016|NCT01248390|traumatic brain injury|traumatic brain injury
5511017|NCT01248390|post-concussion|post-concussion
5511018|NCT01248377|Cephalosporins|cephalosporins
5511019|NCT01248377|Drug hypersensitivity|drug hypersensitivity
5511020|NCT01248351|aspirin, clopidogrel, pharmacodynamics, platelet transfusion|aspirin, clopidogrel, pharmacodynamics, platelet transfusion
5511021|NCT01248299|Chemotherapy|chemotherapy
5511022|NCT01248299|Best Supportive Care|best supportive care
5511023|NCT01248286|Diabetes|diabetes
5511024|NCT01248286|Prediabetes|prediabetes
5511025|NCT01248286|Prevention|prevention
5511026|NCT01248286|Whole grain|whole grain
5511027|NCT01248286|Advanced glycation end products|advanced glycation end products
5511028|NCT01248286|Insulin sensitivity|insulin sensitivity
5511029|NCT01248273|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5511030|NCT01248273|MUC-1 KLH|muc-1 klh
5511032|NCT01248273|TF(C)-KLH|tf(c)-klh
5511033|NCT01248273|TN(C)-KLH|tn(c)-klh
5511034|NCT01248273|Immunization|immunization
5511035|NCT01248273|Vaccine|vaccine
5511036|NCT01248273|09-184|09-184
5511037|NCT01248260|Fetal body size|fetal body size
5511038|NCT01248260|Fetal brain size|fetal brain size
5511039|NCT01248260|Folic acid|folic acid
5511040|NCT01248247|Non small cell lung cancer|non small cell lung cancer
5511041|NCT01248247|Biopsy accessible tumor|biopsy accessible tumor
5511042|NCT01248247|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
5511043|NCT01248247|Stage IV non small cell lung cancer|stage iv non small cell lung cancer
5511044|NCT01248234|elderly|elderly
5511045|NCT01248234|hypertensive|hypertensive
5511046|NCT01248234|anesthesia|anesthesia
5511047|NCT01248221|Breath test|breath test
5511048|NCT01248221|Dyspepsia|dyspepsia
5511049|NCT01248221|Gastric Emptying|gastric emptying
5511050|NCT01248221|Gastroparesis|gastroparesis
5511051|NCT01248208|egg allergy|egg allergy
5511052|NCT01248208|influenza vaccine|influenza vaccine
5511053|NCT01248195|Schizophrenia|schizophrenia
5511054|NCT01248195|Schizophreniform disorder|schizophreniform disorder
5511055|NCT01248195|Schizoaffective disorder|schizoaffective disorder
5511056|NCT01248195|Imaging|imaging
5511057|NCT01248195|Prognosis|prognosis
5511058|NCT01248195|Treatment guidelines|treatment guidelines
5511059|NCT01248195|Pharmacogenetics|pharmacogenetics
5511060|NCT01248182|acetabular fracture|acetabular fracture
5511061|NCT01248182|pelvic ring injury|pelvic ring injury
5511062|NCT01248143|Green Tea|green tea
5511063|NCT01248143|Fermented papaya preparation|fermented papaya preparation
5511064|NCT01248143|Diabetes|diabetes
5511065|NCT01248143|Cardiovascular diseases|cardiovascular diseases
5511066|NCT01248143|Atherosclerotic plaques|atherosclerotic plaques
5511067|NCT01248143|Glucose|glucose
5511068|NCT01248143|Dietary supplements and functional foods|dietary supplements and functional foods
5511069|NCT01248130|Omega-3 Fatty Acid|omega-3 fatty acid
5511070|NCT01248130|Autism Spectrum Disorders|autism spectrum disorders
5511071|NCT01248130|Pervasive Developmental Disorders|pervasive developmental disorders
5511072|NCT01248130|Children|children
5511073|NCT01248130|Cognitive Functioning|cognitive functioning
5511074|NCT01248117|PCV|pcv
5511075|NCT01248117|polypoidal|polypoidal
5511076|NCT01248117|choroidal|choroidal
5511077|NCT01248117|vasculopathy|vasculopathy
5511078|NCT01248104|Cardiac Surgery|cardiac surgery
5511079|NCT01248104|Antifibrinolytic agents|antifibrinolytic agents
5511080|NCT01248104|Blood transfusion|blood transfusion
5511081|NCT01248104|epsilon aminocaproic acid|epsilon aminocaproic acid
5511082|NCT01248104|tranexamic acid|tranexamic acid
5511083|NCT01248091|IUD, Insertion, Decrease, Pain|iud, insertion, decrease, pain
5511084|NCT01248078|elective cesarean section|elective cesarean section
5511085|NCT01248078|antibiotic prophylaxis|antibiotic prophylaxis
5511086|NCT01248078|cefazoline|cefazoline
5511087|NCT01248078|wound infection|wound infection
5511088|NCT01248065|Asthma|asthma
5511089|NCT01248065|Vitamin D|vitamin d
5511090|NCT01248065|Corticosteroids|corticosteroids
5511091|NCT01248065|Treatment failure|treatment failure
5511092|NCT01248039|Muscle strength, functional performance, joint replacement|muscle strength, functional performance, joint replacement
5511093|NCT01248026|Cardiovascular disease|cardiovascular disease
5511094|NCT01248026|Buttermilk|buttermilk
5511095|NCT01248026|Blood lipids|blood lipids
5511096|NCT01248026|Cholesterol absorption|cholesterol absorption
5511097|NCT01248026|Cholesterol synthesis|cholesterol synthesis
5511098|NCT01248000|Hodgkin lymphoma|hodgkin lymphoma
5511099|NCT01248000|FDG-PET|fdg-pet
5511100|NCT01248000|prognostic factor|prognostic factor
5511101|NCT01248000|clinical trial|clinical trial
5511102|NCT01247987|IVF, assisted reproduction, embryo transfer|ivf, assisted reproduction, embryo transfer
5511103|NCT01247974|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5511104|NCT01247974|New Onset Postoperative Atrial Fibrillation|new onset postoperative atrial fibrillation
5511105|NCT01247948|pedicle screw of fixation operation|pedicle screw of fixation operation
5511106|NCT01247948|spine surgery|spine surgery
5511107|NCT01247948|navigation assisted|navigation assisted
5511108|NCT01247935|Pain|pain
5511109|NCT01247935|Acupuncture|acupuncture
5511110|NCT01247935|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5511111|NCT01247935|Colonoscopy|colonoscopy
5511112|NCT01247922|Pediatric Ependymoma|pediatric ependymoma
5511113|NCT01247922|Ependymoma|ependymoma
5511114|NCT01247922|Tarceva|tarceva
5511115|NCT01247922|Erlotinib|erlotinib
5511116|NCT01247883|Phase 1|phase 1
5511117|NCT01247883|relative bioavailability|relative bioavailability
5511118|NCT01247883|healthy volunteers|healthy volunteers
5511119|NCT01247883|pharmacokinetics|pharmacokinetics
5511120|NCT01247883|solution|solution
5511121|NCT01247883|tablet|tablet
5511122|NCT01247870|Chronic obstructive pulmonary disease, COPD, metformin|chronic obstructive pulmonary disease, copd, metformin
5511123|NCT01247857|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5511124|NCT01247857|Nebulization|nebulization
5511132|NCT01247805|Powder for oral suspention|powder for oral suspention
5511133|NCT01247792|sepsis|sepsis
5511134|NCT01247792|organ failure|organ failure
5511135|NCT01247792|end-of-life decisions|end-of-life decisions
5511136|NCT01247792|patient-centered communication|patient-centered communication
5511137|NCT01247779|gynecology|gynecology
5511138|NCT01247779|oncology|oncology
5511139|NCT01247779|coelioscopy|coelioscopy
5511140|NCT01247779|robot|robot
5511141|NCT01247779|morbidity|morbidity
5511142|NCT01247727|Heart rate variability|heart rate variability
5511143|NCT01247727|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5511144|NCT01247714|T-Diet plus Diabet NP|t-diet plus diabet np
5511145|NCT01247714|Diabetic|diabetic
5511146|NCT01247714|Enteral Nutrition|enteral nutrition
5511147|NCT01247714|Glycaemic response|glycaemic response
5511148|NCT01247714|Metabolic Syndrome|metabolic syndrome
5511149|NCT01247714|Insulin resistance|insulin resistance
5511150|NCT01247714|Lipidic profile|lipidic profile
5511152|NCT01247701|Umbilical Cord Blood|umbilical cord blood
5511153|NCT01247701|Transplant|transplant
5511154|NCT01247701|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5511155|NCT01247701|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5511156|NCT01247701|Pediatric|pediatric
5511157|NCT01247701|Myeloid Hematological Malignancies|myeloid hematological malignancies
5511158|NCT01247701|Busulfan|busulfan
5511159|NCT01247701|Cytoxan|cytoxan
5511160|NCT01247701|Cyclophosphamide|cyclophosphamide
5511161|NCT01247701|Fludarabine|fludarabine
5511162|NCT01247688|Lymphoid|lymphoid
5511163|NCT01247688|hematologic malignancy|hematologic malignancy
5511164|NCT01247688|UCB|ucb
5511165|NCT01247688|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5511166|NCT01247688|Total Body Irradiation|total body irradiation
5511167|NCT01247688|Cytoxan|cytoxan
5511168|NCT01247688|Cyclophosphamide|cyclophosphamide
5511169|NCT01247688|Fludarabine|fludarabine
5511170|NCT01247662|Autism spectrum disorder|autism spectrum disorder
5511171|NCT01247662|Social Responsiveness Scale|social responsiveness scale
5511172|NCT01247662|Childhood Asperger's Syndrome Test|childhood asperger's syndrome test
5511173|NCT01247662|Adult Autism Spectrum Quotient|adult autism spectrum quotient
5511174|NCT01247662|psychometric|psychometric
5511175|NCT01247649|Continuous glucose monitoring system|continuous glucose monitoring system
5511176|NCT01247649|Non invasive|non invasive
5511177|NCT01247649|Type 1 diabetes|type 1 diabetes
5511178|NCT01247649|Dielectric spectroscopy|dielectric spectroscopy
5511179|NCT01247636|HLRQ|hlrq
5511180|NCT01247636|Elderly|elderly
5511182|NCT01247636|Mobility|mobility
5511183|NCT01247636|Fear of falling|fear of falling
5511184|NCT01247623|Non-resectable, advanced malignant melanoma.|non-resectable, advanced malignant melanoma.
5511190|NCT01247584|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5511191|NCT01247584|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5511192|NCT01247584|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5511193|NCT01247584|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5493196|NCT01323543|Pains, Low Back|pains, low back
5511194|NCT01247584|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5511195|NCT01247584|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5511196|NCT01247584|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5511197|NCT01247584|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5511198|NCT01247558|Metanx®|metanx®
5511199|NCT01247558|diabetes|diabetes
5511200|NCT01247558|neuropathy|neuropathy
5511201|NCT01247558|peripheral neurological disorder|peripheral neurological disorder
5511202|NCT01247558|peripheral circulation disorder|peripheral circulation disorder
5511203|NCT01247558|folic acid|folic acid
5511204|NCT01247558|folate|folate
5511205|NCT01247558|L-methylfolate|l-methylfolate
5511206|NCT01247558|vitamin B6|vitamin b6
5511207|NCT01247558|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5511208|NCT01247558|vitamin B12|vitamin b12
5511209|NCT01247558|methylcobalamin|methylcobalamin
5511210|NCT01247545|Remote ischemic preconditioning|remote ischemic preconditioning
5511211|NCT01247545|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5511212|NCT01247545|Cardioprotection|cardioprotection
5511213|NCT01247545|Clinical Outcomes|clinical outcomes
5511214|NCT01247532|Cancer|cancer
5511215|NCT01247532|Fatigue|fatigue
5511216|NCT01247532|Mindfulness|mindfulness
5511217|NCT01247532|Meditation|meditation
5511218|NCT01247532|Neoplasms|neoplasms
5511219|NCT01247506|microRNA|microrna
5511221|NCT01247493|AML|aml
5511222|NCT01247493|Efficacy|efficacy
5511223|NCT01247493|tolerability|tolerability
5511225|NCT01247454|primary prevention|primary prevention
5511226|NCT01247454|ASA|asa
5511227|NCT01247454|physician behavioral change|physician behavioral change
5511228|NCT01247454|Patient behavioral change|patient behavioral change
5511229|NCT01247441|All breast cancer patients who were diagnosed or managed in NUH will be included into this registry|all breast cancer patients who were diagnosed or managed in nuh will be included into this registry
5511230|NCT01247428|Coronary Artery Disease|coronary artery disease
5511231|NCT01247428|Drug-eluting Stent|drug-eluting stent
5511232|NCT01247428|Sirolimus|sirolimus
5511233|NCT01247415|anaphylaxis|anaphylaxis
5511234|NCT01247415|allergy|allergy
5511235|NCT01247415|IgE mediated|ige mediated
5511236|NCT01247415|ORS|ors
5511237|NCT01247415|oculorespiratory syndrome|oculorespiratory syndrome
5511238|NCT01247415|Allergic-like reactions|allergic-like reactions
5511239|NCT01247415|H1N1|h1n1
5511240|NCT01247415|Arepanrix|arepanrix
5511241|NCT01247402|peripheral arterial disease|peripheral arterial disease
5511242|NCT01247402|in-stent restenosis|in-stent restenosis
5511243|NCT01247402|drug eluting balloon|drug eluting balloon
5511244|NCT01247389|laparoscopy|laparoscopy
5511245|NCT01247389|colon resection|colon resection
5511246|NCT01247389|incisional hernia|incisional hernia
5511247|NCT01247376|inflammation|inflammation
5511248|NCT01247376|arthroscopy|arthroscopy
5511249|NCT01247376|knee|knee
5511250|NCT01247376|microdialysis|microdialysis
5511251|NCT01247363|Diabetes glucokinase safety|diabetes glucokinase safety
5511252|NCT01247311|Vitamin D|vitamin d
5511253|NCT01247311|pulse wave velocity|pulse wave velocity
5511254|NCT01247298|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5511255|NCT01247298|Trans-Arterial Chemobolizaion (TACE)|trans-arterial chemobolizaion (tace)
5511256|NCT01247298|Radiation Induced Liver Disease (RILD)|radiation induced liver disease (rild)
5511257|NCT01247298|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5511258|NCT01247285|Bioequivalence|bioequivalence
5511259|NCT01247285|Healthy Subjects|healthy subjects
5511260|NCT01247272|Bioequivalence|bioequivalence
5511261|NCT01247272|Healthy Subjects|healthy subjects
5511262|NCT01247259|allergic rhinitis|allergic rhinitis
5511263|NCT01247259|immunotherapy|immunotherapy
5511264|NCT01247259|sublingual|sublingual
5511265|NCT01247246|Oral Mucositis|oral mucositis
5511266|NCT01247246|Head and Neck|head and neck
5511267|NCT01247246|Head and Neck Neoplasms|head and neck neoplasms
5511268|NCT01247246|Mucositis|mucositis
5511269|NCT01247246|Stomatitis|stomatitis
5511270|NCT01247246|Neoplasms by Site|neoplasms by site
5511271|NCT01247246|Neoplasms|neoplasms
5511272|NCT01247246|Gastroenteritis|gastroenteritis
5511273|NCT01247246|Gastrointestinal Diseases|gastrointestinal diseases
5511274|NCT01247246|Digestive System Diseases|digestive system diseases
5511275|NCT01247246|Mouth Diseases|mouth diseases
5511276|NCT01247246|Stomatognathic Diseases|stomatognathic diseases
5511277|NCT01247246|SCV-07|scv-07
5511278|NCT01247233|breast cancer|breast cancer
5511279|NCT01247233|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
5511280|NCT01247233|invasive cancer|invasive cancer
5511281|NCT01247233|Hypofractionated Irradiation|hypofractionated irradiation
5511282|NCT01247233|Lumpectomy|lumpectomy
5511283|NCT01247220|Macular Edema|macular edema
5511284|NCT01247220|Branch retinal vein occlusion|branch retinal vein occlusion
5511285|NCT01247220|Ranibizumab|ranibizumab
5511286|NCT01247207|Duchenne muscular dystrophy|duchenne muscular dystrophy
5511287|NCT01247207|Becker muscular dystrophy|becker muscular dystrophy
5511288|NCT01247207|Nonsense mutation|nonsense mutation
5511289|NCT01247207|Premature stop codon|premature stop codon
5511290|NCT01247207|DMD|dmd
5511291|NCT01247207|BMD|bmd
5511292|NCT01247207|nmDBMD|nmdbmd
5511293|NCT01247207|DBMD|dbmd
5511294|NCT01247207|Ataluren|ataluren
5511295|NCT01247207|PTC124|ptc124
5511296|NCT01247194|hepatitis C|hepatitis c
5511297|NCT01247194|NS5A|ns5a
5511298|NCT01247194|HCV RNA|hcv rna
5511299|NCT01247181|compliance|compliance
5511300|NCT01247181|observance|observance
5511301|NCT01247181|mobile phone|mobile phone
5511302|NCT01247181|SMS|sms
5511303|NCT01247181|text message|text message
5511304|NCT01247181|ARV|arv
5511305|NCT01247181|HAART|haart
5511306|NCT01247181|AIDS|aids
5511307|NCT01247168|Refractory|refractory
5511308|NCT01247168|Solid tumors|solid tumors
5511309|NCT01247168|Cancer|cancer
5511310|NCT01247142|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5511311|NCT01247142|exhaled breath condensate|exhaled breath condensate
5511312|NCT01247129|Superficial inferior epigastric artery flap, delay phenomenon|superficial inferior epigastric artery flap, delay phenomenon
5511313|NCT01247103|healthy volunteers|healthy volunteers
5511314|NCT01247103|safety|safety
5511315|NCT01247103|tolerability|tolerability
5511316|NCT01247090|hypertension|hypertension
5511317|NCT01247090|end stage renal disease|end stage renal disease
5511318|NCT01247090|vasopressin|vasopressin
5511319|NCT01247090|Arginine Vasopressin|arginine vasopressin
5511321|NCT01247090|Pitressin®|pitressin®
5511322|NCT01247077|selenium|selenium
5511323|NCT01247077|neuropsychological testing|neuropsychological testing
5511324|NCT01247077|autoantibodies|autoantibodies
5511325|NCT01247064|Bronchiolitis|bronchiolitis
5511326|NCT01247064|Hypertonic Saline|hypertonic saline
5511327|NCT01247051|priming|priming
5511328|NCT01247051|cardiac surgery|cardiac surgery
5511329|NCT01247051|cardio pulmonary bypass|cardio pulmonary bypass
5511330|NCT01247051|precoating|precoating
5511331|NCT01246999|Influenza|influenza
5511332|NCT01246999|A/California/7/2009-like (2009 H1N1)|a/california/7/2009-like (2009 h1n1)
5511333|NCT01246999|A/Perth/16/2009-like (H3N2)|a/perth/16/2009-like (h3n2)
5511334|NCT01246999|B/Brisbane/60/2008-like (B/Victoria lineage)|b/brisbane/60/2008-like (b/victoria lineage)
5511335|NCT01246973|Oral Curcumin|oral curcumin
5511336|NCT01246973|Radiation Dermatitis|radiation dermatitis
5511337|NCT01246973|Breast Cancer Patients|breast cancer patients
5511338|NCT01246960|cancer|cancer
5511340|NCT01246960|esophagus|esophagus
5511341|NCT01246960|gastroesophageal|gastroesophageal
5511342|NCT01246947|Moderate Tricuspid Valve Regurgitation|moderate tricuspid valve regurgitation
5511343|NCT01246947|Tricuspid Valve Repair|tricuspid valve repair
5511344|NCT01246947|Mitral Value Surgery|mitral value surgery
5511345|NCT01246921|Vitiligo, repigmentation, satisfaction|vitiligo, repigmentation, satisfaction
5511346|NCT01246908|TRD|trd
5511347|NCT01246895|Cartilage repair|cartilage repair
5511348|NCT01246895|Cartilage|cartilage
5511349|NCT01246895|Knee|knee
5511350|NCT01246895|Knee Pain|knee pain
5511351|NCT01246895|Microfracture|microfracture
5511352|NCT01246895|Arthroscopy|arthroscopy
5511353|NCT01246895|Bone Marrow Stimulation|bone marrow stimulation
5511354|NCT01246895|Chondrogenesis|chondrogenesis
5511355|NCT01246895|Scaffold|scaffold
5511356|NCT01246895|Chitosan|chitosan
5511357|NCT01246895|Articular Cartilage Repair|articular cartilage repair
5511358|NCT01246882|Stroke, gait, walking, disability|stroke, gait, walking, disability
5511359|NCT01246882|wireless inertial sensing|wireless inertial sensing
5511360|NCT01246882|mobile health|mobile health
5511361|NCT01246869|brain, cancer,glioblastoma multiforme, meningioma, glioma|brain, cancer,glioblastoma multiforme, meningioma, glioma
5511362|NCT01246856|Cardiotoxicity|cardiotoxicity
5511363|NCT01246856|Breast cancer treatment|breast cancer treatment
5511364|NCT01246856|MIBG scintigraphy|mibg scintigraphy
5511365|NCT01246856|Strain Echocardiography|strain echocardiography
5511366|NCT01246856|patients who have been treated with TAC one year previously|patients who have been treated with tac one year previously
5511367|NCT01246843|sunitinib|sunitinib
5511368|NCT01246843|sorafenib|sorafenib
5511369|NCT01246843|cognitive functioning|cognitive functioning
5511370|NCT01246817|Carcinoma, Renal Cell|carcinoma, renal cell
5511371|NCT01246817|temsirolimus|temsirolimus
5511372|NCT01246817|FLT-PET|flt-pet
5511373|NCT01246817|FDG-PET|fdg-pet
5511374|NCT01246817|Adult patients with metastatic RCC (any histology and any MSKCC prognostic score), with documented|adult patients with metastatic rcc (any histology and any mskcc prognostic score), with documented
5798693|NCT00111358|HIV, AIDS, metabolic syndrome|hiv, aids, metabolic syndrome
5798694|NCT00111345|Acute|acute
5511375|NCT01246817|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±|progressive disease after more than two prior systemic treatments with any of the following: cytokines (±
5511376|NCT01246817|chemotherapy), sunitinib, sorafenib, or bevacizumab (± IFN).|chemotherapy), sunitinib, sorafenib, or bevacizumab (± ifn).
5511377|NCT01246804|HIV infections|hiv infections
5511378|NCT01246804|interaction|interaction
5511379|NCT01246804|pharmacokinetics|pharmacokinetics
5511380|NCT01246791|NPC-01|npc-01
5511381|NCT01246791|Pharmacokinetics|pharmacokinetics
5511382|NCT01246791|Healthy female volunteer|healthy female volunteer
5511383|NCT01246791|Norethisterone|norethisterone
5511384|NCT01246791|Ethinyl Estradiol|ethinyl estradiol
5511385|NCT01246765|Atypical Antipsychotics and pregnancy|atypical antipsychotics and pregnancy
5511386|NCT01246765|Pregnancy|pregnancy
5511387|NCT01246765|Medication use during pregnancy|medication use during pregnancy
5511388|NCT01246752|AML, Leukemia|aml, leukemia
5511389|NCT01246752|Acute Myeloid Leukemia|acute myeloid leukemia
5511390|NCT01246752|HSCT|hsct
5511391|NCT01246752|Stem Cell Transplantation|stem cell transplantation
5511393|NCT01246752|Chemotherapy|chemotherapy
5511394|NCT01246739|mild hypercortisolism|mild hypercortisolism
5511395|NCT01246739|adrenal tumour|adrenal tumour
5511396|NCT01246739|surgical procedures, elective|surgical procedures, elective
5511397|NCT01246739|indication|indication
5511398|NCT01246726|cancer, breast, radiotherapy, boost|cancer, breast, radiotherapy, boost
5511399|NCT01246713|acetaminophen|acetaminophen
5511400|NCT01246713|excipients|excipients
5511401|NCT01246700|Parkinson's disease|parkinson's disease
5511402|NCT01246700|Randomized single-blind crossover trial|randomized single-blind crossover trial
5511403|NCT01246700|Sensory Attention Focused Exercise|sensory attention focused exercise
5511404|NCT01246674|function, hip muscle strength, hip replacement, hip pain,|function, hip muscle strength, hip replacement, hip pain,
5511405|NCT01246609|acid base balance|acid base balance
5511406|NCT01246609|Percutaneous Lithotripsy|percutaneous lithotripsy
5511408|NCT01246583|Randomized|randomized
5511409|NCT01246583|Placebo Controlled|placebo controlled
5511410|NCT01246583|Double Blind|double blind
5511411|NCT01246583|Parallel Group|parallel group
5511412|NCT01246583|chronic plaque psoriasis|chronic plaque psoriasis
5511413|NCT01246583|topical treatment|topical treatment
5511414|NCT01246583|skin diseases|skin diseases
5511415|NCT01246583|papulosquamous|papulosquamous
5511416|NCT01246570|exercise|exercise
5511417|NCT01246570|heart|heart
5511418|NCT01246570|coronary disease|coronary disease
5511419|NCT01246570|rehabilitation|rehabilitation
5511420|NCT01246557|Patients with Chronic Lymphatic Leukemia relapsing or resistant to treatment|patients with chronic lymphatic leukemia relapsing or resistant to treatment
5511421|NCT01246544|Patient Safety|patient safety
5511422|NCT01246544|The Helsinki Declaration on Patient Safety in Anaesthesiology|the helsinki declaration on patient safety in anaesthesiology
5511423|NCT01246544|Helsinki Declaration on Patient Safety|helsinki declaration on patient safety
5669329|NCT00623935|AML|aml
5511424|NCT01246544|European Board of Anaesthesiology (EBA)|european board of anaesthesiology (eba)
5511425|NCT01246544|European Society of Anaesthesiology (ESA)|european society of anaesthesiology (esa)
5511426|NCT01246531|Urolithiasis|urolithiasis
5511427|NCT01246531|Renal calculi|renal calculi
5511428|NCT01246531|Aging|aging
5511429|NCT01246531|Osteoporosis|osteoporosis
5511430|NCT01246518|distal subungual onychomycosis|distal subungual onychomycosis
5511431|NCT01246466|Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation, Ablation, catheter ablation|persistent atrial fibrillation, longstanding persistent atrial fibrillation, ablation, catheter ablation
5511432|NCT01246427|Adjuvant hormonal therapy|adjuvant hormonal therapy
5511433|NCT01246427|Homeopathic treatment|homeopathic treatment
5511434|NCT01246427|Hot flashes|hot flashes
5511435|NCT01246427|Quality of life|quality of life
5511436|NCT01246427|Hot flash score|hot flash score
5511437|NCT01246414|Asthma|asthma
5511438|NCT01246414|Exhaled breath condensates|exhaled breath condensates
5511439|NCT01246414|Cytokines|cytokines
5511440|NCT01246388|Fibrosis|fibrosis
5511441|NCT01246388|Steatosis|steatosis
5511442|NCT01246388|Liver biopsy|liver biopsy
5511443|NCT01246388|Elastography|elastography
5511444|NCT01246388|MRI|mri
5511445|NCT01246349|Motivational Interviewing|motivational interviewing
5511446|NCT01246349|Child and Adolescent Self-Efficacy|child and adolescent self-efficacy
5511447|NCT01246349|Health Behaviours|health behaviours
5511448|NCT01246336|Parkinson's disease, Parkinsonism|parkinson's disease, parkinsonism
5511449|NCT01246336|Biomarkers|biomarkers
5511450|NCT01246336|Exhaled breath|exhaled breath
5511451|NCT01246336|Nanothechnology|nanothechnology
5511452|NCT01246323|Visual analogue scale|visual analogue scale
5511453|NCT01246323|pain level|pain level
5511454|NCT01246323|analgesia|analgesia
5511455|NCT01246323|combined anesthesia|combined anesthesia
5511456|NCT01246284|Alopecia areata|alopecia areata
5511457|NCT01246284|Intralesional|intralesional
5511458|NCT01246284|Triamcinolone acetonide|triamcinolone acetonide
5511459|NCT01246284|Concentration|concentration
5511460|NCT01246258|primary ciliary dyskinesia|primary ciliary dyskinesia
5511461|NCT01246258|otolith|otolith
5511462|NCT01246258|vestibular tests|vestibular tests
5511586|NCT01245790|Patients|patients
5511463|NCT01246245|PIN SITE INFECTION AFTER EXTERNAL FIXATION|pin site infection after external fixation
5511464|NCT01246219|Idiopathic Short stature|idiopathic short stature
5511465|NCT01246219|Self Image|self image
5511466|NCT01246219|GH therapy|gh therapy
5511467|NCT01246219|Psychological distress|psychological distress
5511468|NCT01246206|● Non-Hodgkin lymphoma,|● non-hodgkin lymphoma,
5511469|NCT01246206|● Hodgkin disease,|● hodgkin disease,
5511470|NCT01246206|● Acute Myelogenous or Acute Lymphocytic Leukemia|● acute myelogenous or acute lymphocytic leukemia
5511471|NCT01246206|● Myelodysplastic Syndromes,|● myelodysplastic syndromes,
5511472|NCT01246206|● Chronic Myelogenous Leukemia|● chronic myelogenous leukemia
5511473|NCT01246206|● Multiple Myeloma|● multiple myeloma
5511474|NCT01246206|● Chronic Lymphocytic Leukemia|● chronic lymphocytic leukemia
5511475|NCT01246206|● Myelofibrosis and other myeloproliferative disorders;|● myelofibrosis and other myeloproliferative disorders;
5511476|NCT01246193|CKD-828|ckd-828
5511477|NCT01246193|Hypertension|hypertension
5511478|NCT01246193|Primary Hypertension|primary hypertension
5511479|NCT01246193|Healthy Volunteer|healthy volunteer
5511480|NCT01246193|S-Amlodipine|s-amlodipine
5511481|NCT01246193|Telmisartan|telmisartan
5511482|NCT01246193|Amlodipine|amlodipine
5511483|NCT01246193|Pharmacokinetic|pharmacokinetic
5511484|NCT01246193|Phase 1|phase 1
5511485|NCT01246180|Skin, microcirculation; ASIC, pressure ulcer|skin, microcirculation; asic, pressure ulcer
5511486|NCT01246167|Proximal humerus fracture|proximal humerus fracture
5511487|NCT01246167|conservative|conservative
5511488|NCT01246167|locking plate|locking plate
5511489|NCT01246167|Philos|philos
5511490|NCT01246167|Hemiprosthesis|hemiprosthesis
5511491|NCT01246154|ASTHMA|asthma
5511492|NCT01246141|tricuspid valve regurgitation|tricuspid valve regurgitation
5511493|NCT01246141|replacement|replacement
5511494|NCT01246141|repair|repair
5511495|NCT01246141|outcomes|outcomes
5511496|NCT01246128|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5511498|NCT01246128|PET Imaging|pet imaging
5511499|NCT01246102|Targeted Therapy|targeted therapy
5511500|NCT01246102|HER2 Positive Cancer|her2 positive cancer
5511501|NCT01246102|Cancer|cancer
5511502|NCT01246102|Solid Tumor|solid tumor
5511503|NCT01246102|Breast Cancer|breast cancer
5511504|NCT01246089|Ranibizumab|ranibizumab
5511505|NCT01246089|Myopia|myopia
5511506|NCT01246089|Complications|complications
5511507|NCT01246089|Neovascularization|neovascularization
5511508|NCT01246089|OCT|oct
5511509|NCT01246050|Heart Failure|heart failure
5511510|NCT01246050|Outcome Assessment|outcome assessment
5511511|NCT01246050|Congestive Heart Failure|congestive heart failure
5511512|NCT01246037|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5511513|NCT01246037|Beta-blocker|beta-blocker
5904026|NCT00007813|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5511514|NCT01246037|Adrenergic Receptor Antagonist|adrenergic receptor antagonist
5511515|NCT01245998|Thrombophlebitis|thrombophlebitis
5511516|NCT01245998|Venous thrombosis|venous thrombosis
5511517|NCT01245998|Pulmonary embolism|pulmonary embolism
5511518|NCT01245998|Anticoagulants|anticoagulants
5511519|NCT01245998|Low-Molecular-Weight Heparin|low-molecular-weight heparin
5511520|NCT01245985|SCCHN|scchn
5511521|NCT01245985|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5511522|NCT01245985|oropharyngeal carcinoma|oropharyngeal carcinoma
5511523|NCT01245985|hypopharyngeal carcinoma|hypopharyngeal carcinoma
5511524|NCT01245985|laryngeal carcinoma|laryngeal carcinoma
5511525|NCT01245972|pulsed dye laser|pulsed dye laser
5511526|NCT01245972|PDL|pdl
5511527|NCT01245972|basal cell carcinoma|basal cell carcinoma
5511528|NCT01245972|squamous cell carcinoma|squamous cell carcinoma
5511529|NCT01245972|BCC|bcc
5511530|NCT01245972|SCC|scc
5511531|NCT01245972|594nM laser|594nm laser
5511532|NCT01245959|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5511533|NCT01245959|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5511534|NCT01245959|Induction chemotherapy|induction chemotherapy
5511535|NCT01245959|Clinical trial|clinical trial
5511536|NCT01245946|Acne moderate|acne moderate
5511537|NCT01245946|Photodynamic Therapy|photodynamic therapy
5511538|NCT01245946|Topical retinoids|topical retinoids
5511539|NCT01245946|Antimicrobial agents|antimicrobial agents
5511540|NCT01245933|COPD|copd
5511541|NCT01245933|register|register
5511542|NCT01245933|comorbidities|comorbidities
5511543|NCT01245933|systemic inflammation|systemic inflammation
5511544|NCT01245920|Dental implant|dental implant
5511545|NCT01245920|Alveolar bone|alveolar bone
5511546|NCT01245920|Clinical attachment Level|clinical attachment level
5511547|NCT01245907|Hot flashes|hot flashes
5511548|NCT01245907|Menopause|menopause
5511549|NCT01245907|HRQoL|hrqol
5511550|NCT01245907|Applied relaxation|applied relaxation
5511551|NCT01245907|Insomnia|insomnia
5511552|NCT01245907|Women's knowledge|women's knowledge
5511553|NCT01245894|Index of microcirculatory resistance|index of microcirculatory resistance
5511554|NCT01245894|Fractional Flow Reserve|fractional flow reserve
5511555|NCT01245881|controlled trial|controlled trial
5798695|NCT00111345|myeloid|myeloid
5511556|NCT01245881|fractional photothermolysis|fractional photothermolysis
5511557|NCT01245881|laser surgery|laser surgery
5511558|NCT01245881|melasma|melasma
5511559|NCT01245881|pigment disorder|pigment disorder
5511560|NCT01245868|Spinal anaesthesia|spinal anaesthesia
5511561|NCT01245868|Bupivacaine|bupivacaine
5511562|NCT01245868|Lidocaine|lidocaine
5511563|NCT01245868|Duration of blockade|duration of blockade
5511564|NCT01245855|Prostaglandin E1|prostaglandin e1
5511565|NCT01245855|percutaneous coronary intervention|percutaneous coronary intervention
5511566|NCT01245855|Cardiac troponin T|cardiac troponin t
5511567|NCT01245855|Creatine kinase-MB|creatine kinase-mb
5511568|NCT01245829|Cross Infection|cross infection
5511569|NCT01245829|Nosocomial Infection|nosocomial infection
5511570|NCT01245829|Healthcare Acquired Infection|healthcare acquired infection
5511571|NCT01245829|Hospital Paperwork|hospital paperwork
5511572|NCT01245829|Observation Charts|observation charts
5511573|NCT01245829|Critical Care|critical care
5511574|NCT01245829|Contamination|contamination
5511575|NCT01245816|colon polyps|colon polyps
5511576|NCT01245803|rosuvastatin|rosuvastatin
5511577|NCT01245803|angioplasty|angioplasty
5511578|NCT01245803|acute coronary syndrome|acute coronary syndrome
5511579|NCT01245790|Phase 1|phase 1
5511580|NCT01245790|healthy volunteers|healthy volunteers
5511581|NCT01245790|volunteers with renal impairment|volunteers with renal impairment
5511582|NCT01245790|pharmacokinetics|pharmacokinetics
5511583|NCT01245790|Rheumatoid arthritis|rheumatoid arthritis
5511585|NCT01245790|fostamatinib|fostamatinib
5511587|NCT01245777|RLS|rls
5511588|NCT01245777|Pregnancy|pregnancy
5511589|NCT01245777|Iron Deficiency|iron deficiency
5511590|NCT01245777|Anaemia|anaemia
5511591|NCT01245764|Cervical cancer|cervical cancer
5511592|NCT01245764|vulvar cancer|vulvar cancer
5511593|NCT01245764|vaginal cancer|vaginal cancer
5511595|NCT01245764|human papillomavirus|human papillomavirus
5511596|NCT01245751|Shingles|shingles
5511597|NCT01245751|Vaccine|vaccine
5511598|NCT01245699|Cardiac arrest, CPR, quality improvement|cardiac arrest, cpr, quality improvement
5511599|NCT01245686|Diet interventions|diet interventions
5511600|NCT01245686|Physical activity interventions|physical activity interventions
5511601|NCT01245686|Medication adherence|medication adherence
5511602|NCT01245686|Tailored interventions|tailored interventions
5511603|NCT01245673|Advanced Disease|advanced disease
5511604|NCT01245673|MAGE-A3 Immunizations with Hiltonol|mage-a3 immunizations with hiltonol
5511605|NCT01245673|Vaccine-Primed Autologous T-Cells|vaccine-primed autologous t-cells
5511606|NCT01245673|Lenalidomide Maintenance|lenalidomide maintenance
5511607|NCT01245660|Phase 0|phase 0
5511608|NCT01245660|Bladder carcinoma|bladder carcinoma
5511609|NCT01245660|egf pathway|egf pathway
5511610|NCT01245660|infiltrative bladder carcinoma|infiltrative bladder carcinoma
5511611|NCT01245660|cystectomy|cystectomy
5511612|NCT01245660|LAPATINIB|lapatinib
5511613|NCT01245647|women|women
5511615|NCT01245647|alcohol|alcohol
5511616|NCT01245647|medication|medication
5511617|NCT01245647|adherence|adherence
5511618|NCT01245647|acceptability|acceptability
5511619|NCT01245621|palliative care|palliative care
5511620|NCT01245621|end of life care|end of life care
5511621|NCT01245621|quality of life|quality of life
5511622|NCT01245621|caregivers|caregivers
5511623|NCT01245608|Atorvastatin|atorvastatin
5511624|NCT01245608|Aspirin|aspirin
5511625|NCT01245608|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5511626|NCT01245608|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5511627|NCT01245608|antihypertensive agents|antihypertensive agents
5511628|NCT01245595|Acute Kidney Injury (AKI)|acute kidney injury (aki)
5511629|NCT01245595|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
5511630|NCT01245530|Alzheimer disease|alzheimer disease
5511631|NCT01245517|hyperphosphatemia or malnutrition|hyperphosphatemia or malnutrition
5511632|NCT01245478|Surgical Procedures, Elective|surgical procedures, elective
5511633|NCT01245452|Rheumatoid arthritis|rheumatoid arthritis
5511634|NCT01245452|Tocilizumab|tocilizumab
5511635|NCT01245452|Cardiorespiratory endurance|cardiorespiratory endurance
5511636|NCT01245426|Asthma|asthma
5511637|NCT01245426|GW870086|gw870086
5511638|NCT01245426|Efficacy|efficacy
5511639|NCT01245426|FEV1|fev1
5511640|NCT01245413|Stoma|stoma
5511641|NCT01245413|adhesive|adhesive
5511642|NCT01245413|warm|warm
5511643|NCT01245413|moist|moist
5511644|NCT01245413|cycling|cycling
5511645|NCT01245413|men|men
5511646|NCT01245413|peel-value|peel-value
5511647|NCT01245413|healthy men 50-70 years old|healthy men 50-70 years old
5511648|NCT01245413|men with colostoma, above 18 years|men with colostoma, above 18 years
5511649|NCT01245400|Z-Lig|z-lig
5511650|NCT01245400|allograft|allograft
5511651|NCT01245400|ACL|acl
5511652|NCT01245400|Anterior Cruciate Ligament|anterior cruciate ligament
5511653|NCT01245400|ACLR|aclr
5511654|NCT01245400|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5511655|NCT01245400|EU|eu
5511656|NCT01245400|European Union|european union
5511657|NCT01245400|S. Africa|s. africa
5511658|NCT01245400|Reconstruction of ruptured anterior cruciate ligaments|reconstruction of ruptured anterior cruciate ligaments
5511660|NCT01245387|observational|observational
5511661|NCT01245387|Phase 4|phase 4
5511662|NCT01245387|non-interventional|non-interventional
5511663|NCT01245387|open-label|open-label
5511664|NCT01245361|Undifferentiated Arthritis|undifferentiated arthritis
5511665|NCT01245361|Rheumatoid Arthritis|rheumatoid arthritis
5511666|NCT01245361|Infliximab|infliximab
5511667|NCT01245348|Schizophrenia|schizophrenia
5511668|NCT01245348|Bipolar Disorder|bipolar disorder
5511669|NCT01245348|atypical antipsychotic|atypical antipsychotic
5511670|NCT01245348|adherence|adherence
5511671|NCT01245348|cost effectiveness|cost effectiveness
5511672|NCT01245348|pharmacogenetics|pharmacogenetics
5511673|NCT01245348|mental illness|mental illness
5511674|NCT01245348|SULT4A1|sult4a1
5511676|NCT01245335|Critical Limb Ischemia|critical limb ischemia
5511677|NCT01245335|PAOD|paod
5511678|NCT01245335|Peripheral Arterial Disease|peripheral arterial disease
5511679|NCT01245335|Stem Cells|stem cells
5511680|NCT01245335|Limb amputation|limb amputation
5511681|NCT01245335|Leg ulcers|leg ulcers
5511682|NCT01245322|treatment, lactobacilli|treatment, lactobacilli
5511683|NCT01245296|Umbilical cord|umbilical cord
5511684|NCT01245296|cord clamping|cord clamping
5511685|NCT01245296|iron|iron
5511686|NCT01245296|Ferritin|ferritin
5511687|NCT01245296|newborn|newborn
5511688|NCT01245296|jaundice|jaundice
5511689|NCT01245296|infant|infant
5511690|NCT01245296|development|development
5511691|NCT01245296|infections|infections
5511692|NCT01245283|knee|knee
5511693|NCT01245283|osteoarthritis|osteoarthritis
5511694|NCT01245283|pain|pain
5511695|NCT01245283|function|function
5511696|NCT01245283|impairment|impairment
5511698|NCT01245270|blaeberries|blaeberries
5511699|NCT01245270|bilberries|bilberries
5511700|NCT01245270|blueberries|blueberries
5511701|NCT01245270|mirtoselect|mirtoselect
5511702|NCT01245270|glucose AUC|glucose auc
5511703|NCT01245257|Inflammation|inflammation
5511704|NCT01245257|Urea Synthesis|urea synthesis
5511705|NCT01245257|Catabolism|catabolism
5511706|NCT01245257|Nitrogen balance|nitrogen balance
5511806|NCT01244737|Children|children
5511707|NCT01245231|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5511708|NCT01245179|sickle cell anemia|sickle cell anemia
5511709|NCT01245179|sickle cell thalassemia|sickle cell thalassemia
5511710|NCT01245179|HDAC inhibitor|hdac inhibitor
5511711|NCT01245179|hemoglobin F|hemoglobin f
5511712|NCT01245179|sickle beta thalassemia|sickle beta thalassemia
5511713|NCT01245179|Fetal Hemoglobin|fetal hemoglobin
5511714|NCT01245153|Urinary incontinence, Pelvic floor muscle training|urinary incontinence, pelvic floor muscle training
5511715|NCT01245140|Palmo-Plantar Pustolosis|palmo-plantar pustolosis
5511716|NCT01245127|Schnitzler syndrome|schnitzler syndrome
5511717|NCT01245101|HIV raltegravir intensification replication activation|hiv raltegravir intensification replication activation
5511718|NCT01245088|Crohn's disease|crohn's disease
5511719|NCT01245088|chondroitin sulfate|chondroitin sulfate
5511720|NCT01245062|MEK inhibitor|mek inhibitor
5511722|NCT01245062|Metastatic Melanoma|metastatic melanoma
5511723|NCT01245062|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
5511724|NCT01245062|GSK1120212|gsk1120212
5511726|NCT01245049|dTpa-IPV|dtpa-ipv
5511727|NCT01245049|Boostrix Polio|boostrix polio
5511728|NCT01245049|Repevax|repevax
5511729|NCT01245049|Priorix|priorix
5511730|NCT01245036|Sarcoidosis|sarcoidosis
5511731|NCT01245036|Tuberculosis|tuberculosis
5511732|NCT01245010|Metabolic Syndrome|metabolic syndrome
5511733|NCT01245010|Water|water
5511734|NCT01245010|Obesity|obesity
5511735|NCT01245010|Clinical trial|clinical trial
5511736|NCT01245010|Prevention|prevention
5511737|NCT01244997|Partial edentulism|partial edentulism
5511738|NCT01244997|Bone atrophy|bone atrophy
5511739|NCT01244997|Bone healing|bone healing
5511740|NCT01244984|asthma|asthma
5511741|NCT01244984|Fluticasone furoate|fluticasone furoate
5511742|NCT01244984|GW642444|gw642444
5511743|NCT01244958|Active rheumatoid arthritis|active rheumatoid arthritis
5511744|NCT01244958|leflunomide|leflunomide
5511745|NCT01244958|rituximab|rituximab
5511746|NCT01244958|inadequate clinical response to leflunomide|inadequate clinical response to leflunomide
5511747|NCT01244945|Functional Constipation|functional constipation
5511748|NCT01244945|Functional Foods|functional foods
5511749|NCT01244945|Probiotics|probiotics
5511750|NCT01244945|Lactobacillus reuteri|lactobacillus reuteri
5511751|NCT01244906|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5511752|NCT01244906|Acute Myelogenous Leukemia|acute myelogenous leukemia
5511753|NCT01244906|Myelodysplastic Syndrome|myelodysplastic syndrome
5511754|NCT01244906|Myelofibrosis|myelofibrosis
5511755|NCT01244906|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5511756|NCT01244906|Acute Lymphoblastic Lymphoma|acute lymphoblastic lymphoma
5511757|NCT01244906|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5511758|NCT01244906|Prolymphocytic Leukemia|prolymphocytic leukemia
5511759|NCT01244906|Low-grade non-Hodgkin's Lymphoma|low-grade non-hodgkin's lymphoma
5511760|NCT01244906|Mantle Cell Lymphoma|mantle cell lymphoma
5511761|NCT01244906|Hodgkin Lymphoma|hodgkin lymphoma
5511762|NCT01244906|Myeloma|myeloma
5511763|NCT01244880|PF-02545920|pf-02545920
5511764|NCT01244880|ketamine|ketamine
5511765|NCT01244880|fMRI|fmri
5511766|NCT01244880|associative Learning|associative learning
5511767|NCT01244854|chronic mental disorders|chronic mental disorders
5511768|NCT01244854|cardiovascular disease|cardiovascular disease
5511769|NCT01244854|behavior change|behavior change
5511770|NCT01244841|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5511771|NCT01244841|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5511772|NCT01244841|Discharge|discharge
5511773|NCT01244841|Health status|health status
5511774|NCT01244841|Quality of care|quality of care
5511775|NCT01244815|Bi-polar I disorder|bi-polar i disorder
5511776|NCT01244815|antipsychotic|antipsychotic
5511777|NCT01244815|serotonin|serotonin
5511778|NCT01244815|dopamine|dopamine
5511779|NCT01244815|noradrenalin|noradrenalin
5511780|NCT01244815|histamine|histamine
5511781|NCT01244815|pediatric|pediatric
5511782|NCT01244802|yellow fever vaccine|yellow fever vaccine
5511783|NCT01244789|endometrial cancer|endometrial cancer
5511784|NCT01244789|chemotherapy|chemotherapy
5511785|NCT01244789|carboplatin|carboplatin
5511786|NCT01244789|paclitaxel|paclitaxel
5511787|NCT01244789|Stage 1 & 2|stage 1 & 2
5511788|NCT01244789|node-negative|node-negative
5511789|NCT01244789|intermediate risk|intermediate risk
5511790|NCT01244789|high risk|high risk
5511791|NCT01244763|Kidney|kidney
5511792|NCT01244763|Chronic Kidney Disease|chronic kidney disease
5511793|NCT01244763|CKD|ckd
5511794|NCT01244763|Renal|renal
5511795|NCT01244763|Anemia|anemia
5511796|NCT01244763|Oral anemia treatment|oral anemia treatment
5511797|NCT01244763|Hemoglobin levels|hemoglobin levels
5511798|NCT01244763|Erythropoietin|erythropoietin
5511799|NCT01244763|Blood count|blood count
5511800|NCT01244763|Predialysis|predialysis
5511801|NCT01244763|Pre-dialysis|pre-dialysis
5511802|NCT01244763|Hb|hb
5511803|NCT01244763|Non-dialysis|non-dialysis
5511804|NCT01244750|Chronic Phase - Chronic Myeloid Leukemia|chronic phase - chronic myeloid leukemia
5511805|NCT01244737|Brain neoplasms|brain neoplasms
5511807|NCT01244737|Positron-Emission Tomography|positron-emission tomography
5511808|NCT01244737|18F-FLT|18f-flt
5511809|NCT01244711|Major Depression|major depression
5511810|NCT01244711|Generalized Anxiety Disorder|generalized anxiety disorder
5511811|NCT01244711|Benzodiazepine|benzodiazepine
5511812|NCT01244711|Quetiapine|quetiapine
5511813|NCT01244698|Surgical Site Infection, Breast Reconstruction, Antibiotics|surgical site infection, breast reconstruction, antibiotics
5511814|NCT01244685|bowel resection|bowel resection
5511815|NCT01244685|Deltex CardioQ Probe|deltex cardioq probe
5511816|NCT01244685|fluid management|fluid management
5511817|NCT01244672|Hemorrhoids|hemorrhoids
5511818|NCT01244672|THD|thd
5511819|NCT01244672|Ferguson|ferguson
5511820|NCT01244659|Tacrolimus|tacrolimus
5511821|NCT01244659|Immunosuppressive Agents|immunosuppressive agents
5511822|NCT01244659|Kidney transplantation|kidney transplantation
5511823|NCT01244646|Diabetes Mellitus|diabetes mellitus
5511824|NCT01244646|Type 2|type 2
5511825|NCT01244646|DMT2|dmt2
5511826|NCT01244646|T2DM|t2dm
5511827|NCT01244646|metformin|metformin
5511828|NCT01244646|sulfonylurea|sulfonylurea
5511829|NCT01244646|hypoglycemia|hypoglycemia
5511830|NCT01244646|weight|weight
5511831|NCT01244646|quality of life|quality of life
5511832|NCT01244646|compliance|compliance
5511833|NCT01244633|Tourette's|tourette's
5511834|NCT01244633|Ecopipam|ecopipam
5511835|NCT01244633|Dopamine receptors|dopamine receptors
5511836|NCT01244633|Efficacy|efficacy
5511837|NCT01244633|Safety|safety
5511838|NCT01244633|Adults|adults
5511839|NCT01244620|A pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state|a pharmacokinetic drug-drug interaction study between sitaxsentan and tadalafil and between sitaxsentan and sildenafil at the steady-state
5511840|NCT01244594|Spinal Cord Injury|spinal cord injury
5511841|NCT01244594|Cycling|cycling
5511842|NCT01244594|Functional Electrical Stimulation|functional electrical stimulation
5511843|NCT01244581|middle ear effusion|middle ear effusion
5511844|NCT01244581|amoxicillin-clavulanate|amoxicillin-clavulanate
5511845|NCT01244581|tympanometry|tympanometry
5511846|NCT01244568|Prostate Cancer|prostate cancer
5511847|NCT01244568|Decision support interventions (DESI)|decision support interventions (desi)
5511848|NCT01244568|Comparative Effectiveness Research (CER)|comparative effectiveness research (cer)
5511849|NCT01244542|Schizophrenia|schizophrenia
5511850|NCT01244542|DSM IV criteria|dsm iv criteria
5511851|NCT01244542|Pain insensitivity|pain insensitivity
5511852|NCT01244542|Painful perception|painful perception
5511853|NCT01244542|Opioid receptors|opioid receptors
5511854|NCT01244490|ADHD|adhd
5685339|NCT00556491|kidney|kidney
5511855|NCT01244477|Stress Disorders, Post Traumatic|stress disorders, post traumatic
5511856|NCT01244477|Trust|trust
5511857|NCT01244477|functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5511864|NCT01244451|Bendamustine|bendamustine
5511865|NCT01244451|Ofatumumab|ofatumumab
5511866|NCT01244438|endometrial cancer|endometrial cancer
5511867|NCT01244438|FGFR2 mutations|fgfr2 mutations
5511868|NCT01244412|Fundus photography|fundus photography
5511869|NCT01244399|inositol|inositol
5511870|NCT01244399|caffeine|caffeine
5511871|NCT01244399|NTDs|ntds
5511872|NCT01244386|Computed tomography|computed tomography
5511873|NCT01244386|Iterative reconstruction|iterative reconstruction
5511874|NCT01244386|Automatic tube current modulation|automatic tube current modulation
5511875|NCT01244386|Crohn's disease|crohn's disease
5511876|NCT01244386|Inflammatory bowel disease|inflammatory bowel disease
5511877|NCT01244386|Radiation dose optimization|radiation dose optimization
5511878|NCT01244386|C reactive protein|c reactive protein
5511879|NCT01244373|Best-corrected visual acuity|best-corrected visual acuity
5511880|NCT01244373|posterior capsule opacification|posterior capsule opacification
5511881|NCT01244373|QUATRIX® Aspheric Evolutive pre-loaded|quatrix® aspheric evolutive pre-loaded
5511882|NCT01244360|resveratrol|resveratrol
5511883|NCT01244360|insulin|insulin
5511884|NCT01244360|inflammation|inflammation
5511885|NCT01244360|cognition|cognition
5511886|NCT01244360|metabolism|metabolism
5511887|NCT01244347|folic acid|folic acid
5511888|NCT01244347|malformations|malformations
5511889|NCT01244347|prevention|prevention
5511890|NCT01244334|cataract surgery, vision, corneal edema, retinal thickness|cataract surgery, vision, corneal edema, retinal thickness
5511891|NCT01244321|End stage heart failure|end stage heart failure
5511892|NCT01244321|heart transplantation|heart transplantation
5511893|NCT01244321|Ventricular assist device|ventricular assist device
5496390|NCT01310699|Endoscopy|endoscopy
5511894|NCT01244321|Patients with end stage heart failure|patients with end stage heart failure
5511895|NCT01244321|awaiting heart transplantation|awaiting heart transplantation
5511899|NCT01244308|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5511900|NCT01244308|Heart failure|heart failure
5511901|NCT01244295|Grief|grief
5511905|NCT01244295|Treatment study|treatment study
5511906|NCT01244282|brain imaging|brain imaging
5511907|NCT01244269|Parkinson's disease|parkinson's disease
5511908|NCT01244269|Methylphenidate|methylphenidate
5511909|NCT01244269|Non motor symptoms|non motor symptoms
5511910|NCT01244269|Postural control|postural control
5511912|NCT01244243|rehabilitation|rehabilitation
5511913|NCT01244204|vitamin D deficiency|vitamin d deficiency
5511914|NCT01244204|tuberculin sin test|tuberculin sin test
5511916|NCT01244204|tuberculosis|tuberculosis
5511917|NCT01244191|Non squamous, non-small-cell lung cancer|non squamous, non-small-cell lung cancer
5511918|NCT01244191|Epidermal growth factor receptor, wild type|epidermal growth factor receptor, wild type
5511919|NCT01244191|c-Met inhibitor|c-met inhibitor
5511920|NCT01244178|Sepsis|sepsis
5511921|NCT01244178|Insulin|insulin
5511922|NCT01244139|BIIB033|biib033
5511923|NCT01244139|Multiple Sclerosis|multiple sclerosis
5511924|NCT01244139|anti-LINGO-1 antibody|anti-lingo-1 antibody
5511925|NCT01244139|Relapsing Remitting MS|relapsing remitting ms
5511926|NCT01244139|remyelination|remyelination
5511927|NCT01244139|myelin repair|myelin repair
5511928|NCT01244139|Multiple ascending dose|multiple ascending dose
5511929|NCT01244139|Secondary progessive MS|secondary progessive ms
5511930|NCT01244126|otitis media|otitis media
5511931|NCT01244126|recurrent ear infections (otitis media)|recurrent ear infections (otitis media)
5511932|NCT01244100|Food-effects PK study in healthy subjects.|food-effects pk study in healthy subjects.
5511933|NCT01244087|Inquiry-based stress reduction|inquiry-based stress reduction
5511934|NCT01244087|Quality of life|quality of life
5511935|NCT01244087|breast cancer|breast cancer
5511936|NCT01244048|n3 LC-PUFA, yoghurt, inflammatory markers|n3 lc-pufa, yoghurt, inflammatory markers
5511937|NCT01244035|High blood pressure|high blood pressure
5511938|NCT01244022|Colorectal cancer|colorectal cancer
5511939|NCT01244022|Surgical stress response|surgical stress response
5511940|NCT01244022|interleukins|interleukins
5511941|NCT01244009|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
5511942|NCT01243996|Patent ductus arteriosus, ibuprofen, preterm infants|patent ductus arteriosus, ibuprofen, preterm infants
5511943|NCT01243970|Spinal anaesthesia|spinal anaesthesia
5511944|NCT01243970|phenylephrine|phenylephrine
5511945|NCT01243970|ephedrine|ephedrine
5511946|NCT01243970|ECG changes|ecg changes
5511947|NCT01243970|Caesarean delivery|caesarean delivery
5511948|NCT01243970|Myocardial ischaemia|myocardial ischaemia
5511949|NCT01243970|Cardiac output|cardiac output
5511950|NCT01243970|hypotension|hypotension
5511951|NCT01243944|INCB018424|incb018424
5511952|NCT01243931|Phototherapeutic keratectomy|phototherapeutic keratectomy
5511953|NCT01243931|Optical coherence tomography|optical coherence tomography
5511954|NCT01243931|Corneal opacity|corneal opacity
5511955|NCT01243931|Corneal dystrophy|corneal dystrophy
5511956|NCT01243918|Acute respiratory failure|acute respiratory failure
5511957|NCT01243918|Oxygen therapy delivery systems|oxygen therapy delivery systems
5511958|NCT01243918|Non invasive ventilation|non invasive ventilation
5511959|NCT01243918|High concentration mask|high concentration mask
5511960|NCT01243918|Hypoxemic pneumonia|hypoxemic pneumonia
5511965|NCT01243840|Central aortic pressure|central aortic pressure
5511966|NCT01243840|Aortic pulse wave velocity|aortic pulse wave velocity
5511967|NCT01243840|Aortic PWV using a single pressure recording|aortic pwv using a single pressure recording
5511968|NCT01243840|Vascular aging|vascular aging
5511969|NCT01243840|Left ventricular hypertrophy|left ventricular hypertrophy
5511970|NCT01243840|Left ventricular diastolic function|left ventricular diastolic function
5511971|NCT01243827|Hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, LV mass index, LV diastolic function|hypertension, carvedilol, bisoprolol, central pulse pressure, pulse pressure amplification, reflection magnitude, lv mass index, lv diastolic function
5511972|NCT01243814|hyaluronate|hyaluronate
5511973|NCT01243814|hyaluronic acid|hyaluronic acid
5511974|NCT01243814|viscosupplementation|viscosupplementation
5511975|NCT01243801|chronic pain|chronic pain
5511976|NCT01243801|persistent postsurgical pain|persistent postsurgical pain
5511977|NCT01243801|hyperalgesia|hyperalgesia
5511978|NCT01243801|ketamine|ketamine
5511979|NCT01243801|quantitative sensory testing|quantitative sensory testing
5511980|NCT01243788|COPD|copd
5511981|NCT01243788|Seretide|seretide
5511982|NCT01243788|Combivent|combivent
5511983|NCT01243788|effect and safety|effect and safety
5511984|NCT01243788|Twelve weeks|twelve weeks
5511985|NCT01243775|NSCLC|nsclc
5511986|NCT01243762|Colorectal cancer|colorectal cancer
5511987|NCT01243762|Solid tumors|solid tumors
5511988|NCT01243762|Ovarian cancer|ovarian cancer
5511989|NCT01243762|Fallopian tube cancer|fallopian tube cancer
5506117|NCT01270269|Aging|aging
5511990|NCT01243762|Primary peritoneal cancer|primary peritoneal cancer
5511991|NCT01243749|Target Vessel Revascularization (TVR)|target vessel revascularization (tvr)
5511995|NCT01243749|Target Lesion Failure (TLF)|target lesion failure (tlf)
5511996|NCT01243749|Stent Thrombosis|stent thrombosis
5511997|NCT01243749|Restenotic Lesion|restenotic lesion
5511998|NCT01243749|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5512001|NCT01243736|bleeding|bleeding
5512002|NCT01243736|blood in stool|blood in stool
5512003|NCT01243736|abdomen pain|abdomen pain
5512004|NCT01243736|Gastrointestinal bleeding|gastrointestinal bleeding
5512005|NCT01243736|capsule endoscopy (CE)|capsule endoscopy (ce)
5512006|NCT01243723|Dyschesia treatment|dyschesia treatment
5512007|NCT01243723|Inconfort related to dyschesia|inconfort related to dyschesia
5512008|NCT01243723|Quality of life|quality of life
5512009|NCT01243723|Bowel function index|bowel function index
5512010|NCT01243697|Desogestrel|desogestrel
5512011|NCT01243697|Chemosensitivity|chemosensitivity
5512012|NCT01243684|Spinal cord|spinal cord
5512013|NCT01243684|cervical spondylosis|cervical spondylosis
5512014|NCT01243684|myelopathy|myelopathy
5512015|NCT01243671|Behçet's, intestinal|behçet's, intestinal
5512016|NCT01243658|Oxytocin|oxytocin
5512018|NCT01243658|Borderline|borderline
5512019|NCT01243632|malignant pleural mesothelioma|malignant pleural mesothelioma
5512020|NCT01243632|chemotherapy|chemotherapy
5512021|NCT01243632|gemcitabine|gemcitabine
5512022|NCT01243632|cisplatin|cisplatin
5512023|NCT01243632|long infusion|long infusion
5512024|NCT01243619|PET|pet
5512025|NCT01243619|CT|ct
5512026|NCT01243619|radiotherapy|radiotherapy
5512027|NCT01243606|Anxiety|anxiety
5512028|NCT01243606|Depression|depression
5512029|NCT01243606|Obsessive Compulsive Disorder|obsessive compulsive disorder
5512030|NCT01243606|Panic Disorder|panic disorder
5512031|NCT01243606|Generalized Anxiety Disorder|generalized anxiety disorder
5512032|NCT01243606|Social Anxiety Disorder|social anxiety disorder
5512033|NCT01243606|Transdiagnostic Treatment|transdiagnostic treatment
5512034|NCT01243606|CBT|cbt
5512035|NCT01243593|pediatrics|pediatrics
5512036|NCT01243593|anesthesia|anesthesia
5512037|NCT01243593|pyeloplasty|pyeloplasty
5512038|NCT01243593|Transversus Abdominis Plane Block|transversus abdominis plane block
5512039|NCT01243593|Regional Anesthesia|regional anesthesia
5512040|NCT01243580|PK and safety|pk and safety
5512041|NCT01243580|Pharmacokinetic profile (PK) and safety|pharmacokinetic profile (pk) and safety
5512042|NCT01243554|Exercise training|exercise training
5512043|NCT01243554|Pregnancy|pregnancy
5512044|NCT01243554|Obesity|obesity
5512045|NCT01243528|Malnutrition|malnutrition
5512046|NCT01243528|Infection|infection
5512047|NCT01243528|Neurological|neurological
5512048|NCT01243515|Central Venous Pressure|central venous pressure
5512049|NCT01243515|Kidney Diseases|kidney diseases
5512050|NCT01243515|Chronic Kidney Disease|chronic kidney disease
5512051|NCT01243515|Healthy Subjects|healthy subjects
5512052|NCT01243515|Non-Invasive Monitor|non-invasive monitor
5512053|NCT01243489|CML|cml
5512054|NCT01243489|compliance|compliance
5512055|NCT01243489|compliance supporting measures|compliance supporting measures
5512056|NCT01243489|complete cytogenetic response|complete cytogenetic response
5512057|NCT01243489|mayor molecular remission|mayor molecular remission
5512058|NCT01243489|Philadelphia chromosome|philadelphia chromosome
5512059|NCT01243489|BCR-ABL|bcr-abl
5512060|NCT01243489|Imatinib|imatinib
5512061|NCT01243489|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5512062|NCT01243489|smart blister|smart blister
5512068|NCT01243437|plague, ciprofloxacin|plague, ciprofloxacin
5512069|NCT01243411|Peyronie's Disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
5512070|NCT01243398|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5512071|NCT01243398|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5512072|NCT01243398|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5512073|NCT01243398|recurrent esophageal cancer|recurrent esophageal cancer
5494091|NCT01320033|acne vulgaris|acne vulgaris
5512074|NCT01243398|stage IA esophageal cancer|stage ia esophageal cancer
5512075|NCT01243398|stage IB esophageal cancer|stage ib esophageal cancer
5512076|NCT01243398|stage IIA esophageal cancer|stage iia esophageal cancer
5512077|NCT01243398|stage IIB esophageal cancer|stage iib esophageal cancer
5512078|NCT01243398|stage IIIA esophageal cancer|stage iiia esophageal cancer
5512079|NCT01243398|stage IIIB esophageal cancer|stage iiib esophageal cancer
5512080|NCT01243398|stage IIIC esophageal cancer|stage iiic esophageal cancer
5512081|NCT01243398|stage IV esophageal cancer|stage iv esophageal cancer
5512082|NCT01243385|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5512083|NCT01243385|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5512084|NCT01243385|stage III prostate cancer|stage iii prostate cancer
5512185|NCT01242930|imetelstat|imetelstat
5512085|NCT01243385|stage IV prostate cancer|stage iv prostate cancer
5512086|NCT01243385|recurrent prostate cancer|recurrent prostate cancer
5512087|NCT01243372|recurrent colon cancer|recurrent colon cancer
5512088|NCT01243372|stage IIIA colon cancer|stage iiia colon cancer
5512089|NCT01243372|stage IIIB colon cancer|stage iiib colon cancer
5512092|NCT01243372|stage IVB colon cancer|stage ivb colon cancer
5512093|NCT01243372|recurrent rectal cancer|recurrent rectal cancer
5512094|NCT01243372|stage III rectal cancer|stage iii rectal cancer
5512095|NCT01243372|stage IV rectal cancer|stage iv rectal cancer
5512096|NCT01243346|Gastrointestinal Stromal Tumor|gastrointestinal stromal tumor
5512097|NCT01243346|PDGFR Inhibitor|pdgfr inhibitor
5512098|NCT01243346|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
5512099|NCT01243281|hepatitis B|hepatitis b
5512101|NCT01243281|pegylated interferon|pegylated interferon
5512102|NCT01243281|entecavir|entecavir
5512103|NCT01243255|hypercholesterolemia|hypercholesterolemia
5512104|NCT01243255|low density lipoprotein|low density lipoprotein
5512105|NCT01243255|undertreatment of hypercholesterolemia|undertreatment of hypercholesterolemia
5512106|NCT01243242|ADHD,Adults,MG01CI,METADOXINE|adhd,adults,mg01ci,metadoxine
5512108|NCT01243216|Labor|labor
5512109|NCT01243216|Epidural Analgesia|epidural analgesia
5512110|NCT01243216|Epidural Anesthesia|epidural anesthesia
5512111|NCT01243216|Spinal Anesthesia|spinal anesthesia
5512112|NCT01243216|Ultrasound|ultrasound
5512113|NCT01243216|Neuraxial Analgesia|neuraxial analgesia
5512114|NCT01243216|Neuraxial Anesthesia|neuraxial anesthesia
5512115|NCT01243216|Cesarean delivery|cesarean delivery
5512116|NCT01243203|Smoking, surgery, Anesthesia, quit|smoking, surgery, anesthesia, quit
5512117|NCT01243190|leukemia|leukemia
5512118|NCT01243190|small lymphocytic leukemia|small lymphocytic leukemia
5512119|NCT01243190|SLL|sll
5512120|NCT01243190|CLL|cll
5512121|NCT01243190|ofatumumab|ofatumumab
5512122|NCT01243190|untreated|untreated
5512123|NCT01243190|early stage|early stage
5512124|NCT01243190|high-risk|high-risk
5512125|NCT01243177|Lacosamide|lacosamide
5512126|NCT01243177|Vimpat®|vimpat®
5512127|NCT01243177|Epilepsy|epilepsy
5512128|NCT01243177|Monotherapy|monotherapy
5512129|NCT01243177|Velocity|velocity
5512130|NCT01243164|confidence|confidence
5512131|NCT01243164|wheelchair performance|wheelchair performance
5512132|NCT01243151|Hypercholesterolemia|hypercholesterolemia
5512133|NCT01243151|Dyslipidemia|dyslipidemia
5512134|NCT01243151|LDL|ldl
5512135|NCT01243151|High Cholesterol|high cholesterol
5512136|NCT01243151|Japanese Volunteers|japanese volunteers
5512137|NCT01243151|PF-04950615|pf-04950615
5512138|NCT01243151|RN316|rn316
5512139|NCT01243138|Cross-sectional|cross-sectional
5512140|NCT01243138|epidemiological study|epidemiological study
5512141|NCT01243138|to evaluate the prevalence of CV risk factors in patients attending general practice in AfME region|to evaluate the prevalence of cv risk factors in patients attending general practice in afme region
5512142|NCT01243125|Blockage|blockage
5512143|NCT01243125|Encrustation|encrustation
5512144|NCT01243125|Catheter|catheter
5512145|NCT01243125|Spinal Cord Injury|spinal cord injury
5512146|NCT01243125|SCI|sci
5512147|NCT01243086|Macular Degeneration|macular degeneration
5512148|NCT01243086|Age-related macular degeneration|age-related macular degeneration
5512149|NCT01243086|Anti-inflammatory|anti-inflammatory
5512150|NCT01243086|Anti-vascular endothelial growth factor (Anti-VEGF)|anti-vascular endothelial growth factor (anti-vegf)
5512151|NCT01243086|Lucentis|lucentis
5512152|NCT01243086|Ranibizumab|ranibizumab
5512153|NCT01243086|OZURDEX|ozurdex
5512154|NCT01243086|Dexamethasone|dexamethasone
5512155|NCT01243086|Vision loss|vision loss
5512156|NCT01243073|imetelstat|imetelstat
5512157|NCT01243073|imetelstat sodium|imetelstat sodium
5512158|NCT01243073|GRN163L|grn163l
5512159|NCT01243073|telomerase inhibitor|telomerase inhibitor
5512160|NCT01243073|telomerase|telomerase
5512161|NCT01243073|essential thrombocytosis|essential thrombocytosis
5512162|NCT01243073|essential thrombocythemia|essential thrombocythemia
5512163|NCT01243073|ET|et
5512164|NCT01243073|polycythemia vera|polycythemia vera
5512165|NCT01243073|PV|pv
5512166|NCT01243060|Sleep Aid|sleep aid
5512167|NCT01243047|Second line treatment for metastatic colorectal cancer|second line treatment for metastatic colorectal cancer
5512168|NCT01243008|Lyme disease|lyme disease
5512169|NCT01243008|Borreliosis|borreliosis
5512170|NCT01243008|Azithromycin|azithromycin
5512171|NCT01242982|5. metacarpal fracture/fractures|5. metacarpal fracture/fractures
5512172|NCT01242982|subcapital|subcapital
5512173|NCT01242982|shaft|shaft
5512174|NCT01242982|closed|closed
5512175|NCT01242956|stroke|stroke
5512176|NCT01242956|video-based training|video-based training
5512177|NCT01242956|rehabilitation|rehabilitation
5512178|NCT01242943|I131|i131
5512179|NCT01242943|L19|l19
5512180|NCT01242943|antibody|antibody
5512181|NCT01242943|monoclonal|monoclonal
5512182|NCT01242943|tumour targeting|tumour targeting
5512183|NCT01242943|radioimmunotherapy|radioimmunotherapy
5512184|NCT01242943|cancer|cancer
5512186|NCT01242930|imetelstat sodium|imetelstat sodium
5512187|NCT01242930|GRN163L|grn163l
5512188|NCT01242930|telomerase inhibitor|telomerase inhibitor
5506317|NCT01269515|HIV|hiv
5512189|NCT01242930|telomerase inhibition|telomerase inhibition
5512190|NCT01242930|multiple myeloma|multiple myeloma
5512192|NCT01242930|myeloma progenitor cells|myeloma progenitor cells
5512193|NCT01242904|dialysis solutions|dialysis solutions
5512194|NCT01242904|renal replacement therapy|renal replacement therapy
5512195|NCT01242904|peritoneal dialysis|peritoneal dialysis
5512196|NCT01242904|bimodal solution|bimodal solution
5512197|NCT01242904|glucose sparing therapy|glucose sparing therapy
5512198|NCT01242891|Ventricular Assist Device|ventricular assist device
5512199|NCT01242891|Pediatric Ventricular Assist Device|pediatric ventricular assist device
5512200|NCT01242878|HbSS|hbss
5512201|NCT01242878|Sickle cell anemia|sickle cell anemia
5512202|NCT01242878|HbSC|hbsc
5512203|NCT01242878|HbSbetathalassemia|hbsbetathalassemia
5512204|NCT01242878|Hemoglobinopathy|hemoglobinopathy
5512205|NCT01242878|Hemoglobinopathies|hemoglobinopathies
5512206|NCT01242865|Stress|stress
5512207|NCT01242865|Anxiety|anxiety
5512208|NCT01242865|Resilience|resilience
5512209|NCT01242865|Mindfulness|mindfulness
5512210|NCT01242865|Quality of Life|quality of life
5512211|NCT01242865|Stress Management|stress management
5512212|NCT01242852|Hysteroscopy|hysteroscopy
5512213|NCT01242852|infertility|infertility
5512214|NCT01242852|subfertility|subfertility
5512215|NCT01242852|intrauterine abnormalities|intrauterine abnormalities
5512216|NCT01242852|intracavitary pathology|intracavitary pathology
5512218|NCT01242852|ICSI|icsi
5512219|NCT01242852|in vitro fertilization|in vitro fertilization
5512220|NCT01242852|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5512221|NCT01242839|CACICOL20|cacicol20
5512222|NCT01242813|TNF-receptor associated periodic syndrome|tnf-receptor associated periodic syndrome
5512223|NCT01242813|fevers|fevers
5512224|NCT01242813|rashes|rashes
5512225|NCT01242813|musculoskeletal and abdominal pain|musculoskeletal and abdominal pain
5512226|NCT01242813|periorbital edema|periorbital edema
5512227|NCT01242813|TNFR1|tnfr1
5512228|NCT01242800|male breast cancer|male breast cancer
5512229|NCT01242800|stage IV breast cancer|stage iv breast cancer
5512230|NCT01242787|Chronic hepatitis B|chronic hepatitis b
5512231|NCT01242787|LB80380|lb80380
5512232|NCT01242787|treatment-naive|treatment-naive
5512233|NCT01242787|entecavir|entecavir
5512234|NCT01242787|Extension|extension
5512235|NCT01242774|AML|aml
5512236|NCT01242774|bone marrow|bone marrow
5512237|NCT01242774|abnormal blast cells of myeloid|abnormal blast cells of myeloid
5512238|NCT01242774|acute leukemia|acute leukemia
5512239|NCT01242774|cytogenetic abnormalities|cytogenetic abnormalities
5512240|NCT01242774|HDACi|hdaci
5512241|NCT01242761|Accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service|accuracy of diagnostic ultrasound based in community or as part of a specialist hospital-based service
5512242|NCT01242735|Obsessive Compulsive Disorder|obsessive compulsive disorder
5512243|NCT01242735|OCD|ocd
5512244|NCT01242735|Exercise|exercise
5512245|NCT01242735|Aerobic Exercise|aerobic exercise
5512246|NCT01242722|Heart failure|heart failure
5512247|NCT01242722|auto threshold|auto threshold
5512248|NCT01242722|pacing|pacing
5512249|NCT01242722|CRT-D recipients|crt-d recipients
5512250|NCT01242722|Left Ventricular (LV) evoked response signals|left ventricular (lv) evoked response signals
5512251|NCT01242696|Drug Eluting Stents|drug eluting stents
5512252|NCT01242696|Observational|observational
5512253|NCT01242696|All-Comers|all-comers
5512255|NCT01242657|Youth Tobacco Use|youth tobacco use
5512256|NCT01242657|Physical Activity|physical activity
5512257|NCT01242657|Smoking Cessation Intervention|smoking cessation intervention
5512258|NCT01242618|nasal cartilage diseases|nasal cartilage diseases
5512259|NCT01242605|unresectable|unresectable
5512260|NCT01242605|advanced|advanced
5512261|NCT01242566|Temozolomide|temozolomide
5512262|NCT01242566|Elderly|elderly
5512263|NCT01242566|Glioblastoma|glioblastoma
5512264|NCT01242566|Karnofsky performance score (KPS)|karnofsky performance score (kps)
5512265|NCT01242540|Pain|pain
5512266|NCT01242540|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5512267|NCT01242527|dyslipidemia|dyslipidemia
5512268|NCT01242527|hyperlipidemia|hyperlipidemia
5512269|NCT01242527|omega-3 carboxylic acid|omega-3 carboxylic acid
5512270|NCT01242514|Rheumatoid Arthritis|rheumatoid arthritis
5512271|NCT01242514|OSKIRA|oskira
5512272|NCT01242514|Fostamatinib|fostamatinib
5512273|NCT01242501|Prevention|prevention
5512274|NCT01242501|Counseling|counseling
5512275|NCT01242501|Behavioral interventions|behavioral interventions
5512276|NCT01242501|HIV risk reduction|hiv risk reduction
5512277|NCT01242488|Rheumatoid Arthritis|rheumatoid arthritis
5512278|NCT01242488|CDP6038|cdp6038
5512279|NCT01242488|Interleukin-6|interleukin-6
5512280|NCT01242488|Tocilizumab|tocilizumab
5512281|NCT01242475|tuberculosis|tuberculosis
5512282|NCT01242475|rdESAT-6|rdesat-6
5512283|NCT01242475|CFP-10|cfp-10
5512284|NCT01242475|skin test|skin test
5512285|NCT01242475|diagnostic test|diagnostic test
5512286|NCT01242462|Conventional mechanical ventilation|conventional mechanical ventilation
5506413|NCT01269086|Spouses|spouses
5512287|NCT01242462|Mid-frequency ventilation|mid-frequency ventilation
5512288|NCT01242462|Respiratory Distress Syndrome|respiratory distress syndrome
5512289|NCT01242462|Preterm Newborn Infant|preterm newborn infant
5512290|NCT01242462|Mean Airway Pressure|mean airway pressure
5512291|NCT01242462|Mean Arterial Pressure|mean arterial pressure
5512292|NCT01242462|Mean Peak Inspiratory Pressure|mean peak inspiratory pressure
5512293|NCT01242449|Breast cancer|breast cancer
5512294|NCT01242449|Metastatic|metastatic
5512295|NCT01242449|HER2 positive|her2 positive
5512296|NCT01242449|vinorelbine|vinorelbine
5512297|NCT01242436|Ovarian Cancer|ovarian cancer
5512298|NCT01242436|Peritoneal Metastasis|peritoneal metastasis
5512299|NCT01242436|Whole body diffusion MRI|whole body diffusion mri
5512301|NCT01242423|musculoskeletal shockwave therapy|musculoskeletal shockwave therapy
5512302|NCT01242410|Short cervix|short cervix
5512303|NCT01242410|Preterm birth|preterm birth
5512304|NCT01242410|Cervical pessary|cervical pessary
5512305|NCT01242410|Twins|twins
5512306|NCT01242371|Schizophrenia|schizophrenia
5512307|NCT01242371|Schizoaffective|schizoaffective
5512308|NCT01242371|Probiotic supplements|probiotic supplements
5512309|NCT01242371|Gliadin|gliadin
5512310|NCT01242371|Casein|casein
5512311|NCT01242358|hypoxaemia - capnography - integrated pulmonary index - PEG|hypoxaemia - capnography - integrated pulmonary index - peg
5512312|NCT01242345|Hypoxemia|hypoxemia
5512313|NCT01242345|Capnography|capnography
5512314|NCT01242345|Integrated pulmonary index|integrated pulmonary index
5512315|NCT01242345|Sedation|sedation
5512316|NCT01242345|Propofol|propofol
5512317|NCT01242345|Safety|safety
5512318|NCT01242332|perioperative|perioperative
5512319|NCT01242332|pregabalin|pregabalin
5512320|NCT01242332|arthroscopic anterior cruciate ligament reconstruction|arthroscopic anterior cruciate ligament reconstruction
5512321|NCT01242332|postoperative pain management|postoperative pain management
5512322|NCT01242319|quality improvement|quality improvement
5512323|NCT01242319|implementation trials|implementation trials
5512324|NCT01242319|cholesterol guidelines|cholesterol guidelines
5512325|NCT01242319|patient activation|patient activation
5512326|NCT01242306|endothelial dysfunction acetylcholine bms ses|endothelial dysfunction acetylcholine bms ses
5512327|NCT01242280|Acute variceal bleeding|acute variceal bleeding
5512328|NCT01242280|Massive bleeding|massive bleeding
5512329|NCT01242280|Liver Cirrhosis|liver cirrhosis
5512330|NCT01242280|Esophageal tamponade|esophageal tamponade
5512331|NCT01242280|Esophageal stent|esophageal stent
5512332|NCT01242267|multiple myeloma|multiple myeloma
5512333|NCT01242267|transplant|transplant
5512334|NCT01242267|Multiple myeloma patients undergoing transplant|multiple myeloma patients undergoing transplant
5512335|NCT01242254|KH902|kh902
5512336|NCT01242254|age-related macular degeneration|age-related macular degeneration
5512337|NCT01242254|choroidal neovascularization|choroidal neovascularization
5512338|NCT01242254|intravitreal injection|intravitreal injection
5512339|NCT01242254|multiple injections|multiple injections
5512340|NCT01242241|Propofol|propofol
5512341|NCT01242241|Childhood obesity|childhood obesity
5512342|NCT01242241|Pharmacodynamics|pharmacodynamics
5512343|NCT01242228|Dipeptidyl peptidase-4 inhibitor|dipeptidyl peptidase-4 inhibitor
5512344|NCT01242228|ASP1941|asp1941
5512345|NCT01242228|DPP-4 inhibitor|dpp-4 inhibitor
5512346|NCT01242228|long-term safety|long-term safety
5512347|NCT01242228|Diabetes mellitus|diabetes mellitus
5512348|NCT01242215|Diabetes mellitus|diabetes mellitus
5512349|NCT01242215|sulfonylurea|sulfonylurea
5512350|NCT01242215|ASP1941|asp1941
5512351|NCT01242202|Diabetes mellitus|diabetes mellitus
5512352|NCT01242202|alpha glucosidase inhibitor|alpha glucosidase inhibitor
5512353|NCT01242202|ASP1941|asp1941
5512354|NCT01242202|long-term safety|long-term safety
5512355|NCT01242150|Acute Respiratory Failure|acute respiratory failure
5512356|NCT01242150|Continuous Positive Airway Pressure|continuous positive airway pressure
5512357|NCT01242150|Infants|infants
5512358|NCT01242150|Helmet|helmet
5512359|NCT01242111|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5512360|NCT01242111|MPS IV Type A|mps iv type a
5512361|NCT01242111|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5512362|NCT01242111|MPS IVA|mps iva
5512363|NCT01242111|Morquio A Syndrome|morquio a syndrome
5512364|NCT01242111|Lysosomal Storage Disorder|lysosomal storage disorder
5512366|NCT01242111|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5512367|NCT01242111|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5512368|NCT01242111|galactose-6-sulfatase|galactose-6-sulfatase
5512369|NCT01242111|GALNS|galns
5512370|NCT01242111|enzyme replacement therapy|enzyme replacement therapy
5512371|NCT01242111|ERT|ert
5512372|NCT01242098|Asthma|asthma
5512373|NCT01242098|Combination therapy|combination therapy
5512374|NCT01242098|Primary care management|primary care management
5512375|NCT01242098|Switch|switch
5512376|NCT01242098|ICS/LABA|ics/laba
5512377|NCT01242098|Fostair|fostair
5512378|NCT01242098|Seretide|seretide
5512379|NCT01242085|alignment|alignment
5512380|NCT01242072|malignancy|malignancy
5512381|NCT01242072|etoposide and carboplatin|etoposide and carboplatin
5512382|NCT01242072|non small cell lung cancer|non small cell lung cancer
5512383|NCT01242072|small cell lung cancer|small cell lung cancer
5512384|NCT01242072|testicular cancer|testicular cancer
5512385|NCT01242072|thymoma|thymoma
5512386|NCT01242072|ovarian cancer|ovarian cancer
5512387|NCT01242072|osteosarcoma|osteosarcoma
5512388|NCT01242059|Obesity|obesity
5512389|NCT01242059|Food intake regulation|food intake regulation
5512390|NCT01242059|blood glucose regulation|blood glucose regulation
5512391|NCT01242059|protein|protein
5512392|NCT01242059|fiber|fiber
5512393|NCT01242059|pulses|pulses
5512394|NCT01242059|yellow peas|yellow peas
5512395|NCT01242046|female sexual arousal|female sexual arousal
5512396|NCT01242033|red raspberries|red raspberries
5512397|NCT01242033|post-prandial|post-prandial
5512398|NCT01242033|oxidative stress|oxidative stress
5512399|NCT01242033|antioxidants|antioxidants
5512400|NCT01242033|polyphenols|polyphenols
5512401|NCT01242033|vitamin C|vitamin c
5512402|NCT01242033|acute dietary intervention|acute dietary intervention
5512403|NCT01242007|Myotonic dystrophy|myotonic dystrophy
5512404|NCT01242007|Steinert's disease|steinert's disease
5512405|NCT01241981|Breast|breast
5512406|NCT01241981|Cancer|cancer
5512407|NCT01241981|Digital|digital
5512408|NCT01241981|Mammography|mammography
5512409|NCT01241981|Tomosynthesis|tomosynthesis
5512410|NCT01241968|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5512411|NCT01241968|Myocardial Ischemia|myocardial ischemia
5512412|NCT01241968|Refractory Angina|refractory angina
5512414|NCT01241942|Lung Transplant|lung transplant
5512415|NCT01241942|Emphysema|emphysema
5512416|NCT01241942|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5512417|NCT01241942|Cystic Fibrosis|cystic fibrosis
5512418|NCT01241942|Pulmonary Fibrosis|pulmonary fibrosis
5512419|NCT01241942|Bronchiectasis|bronchiectasis
5512420|NCT01241942|Sarcoidosis|sarcoidosis
5512421|NCT01241942|Pulmonary Hypertension|pulmonary hypertension
5512422|NCT01241942|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5512423|NCT01241929|advanced cancer|advanced cancer
5512424|NCT01241916|elbow, splint|elbow, splint
5512425|NCT01241903|Platelet activation|platelet activation
5512426|NCT01241903|platelet leukocyte aggregates|platelet leukocyte aggregates
5512427|NCT01241890|Cystic Fibrosis|cystic fibrosis
5512428|NCT01241890|Children|children
5512429|NCT01241890|Exhaled Breath Condensate|exhaled breath condensate
5512430|NCT01241890|Non-invasive Inflammatory Markers|non-invasive inflammatory markers
5512431|NCT01241890|Volatile Organic Compounds|volatile organic compounds
5512432|NCT01241890|Home monitoring|home monitoring
5512433|NCT01241890|Quality of life|quality of life
5512434|NCT01241838|Heart failure|heart failure
5512435|NCT01241838|Left ventricular hypertrophy|left ventricular hypertrophy
5512436|NCT01241838|Diastolic dysfunction|diastolic dysfunction
5512437|NCT01241825|capsule endoscopy|capsule endoscopy
5512438|NCT01241825|chewing gum|chewing gum
5512439|NCT01241825|small bowel transit time|small bowel transit time
5512440|NCT01241812|knee|knee
5512441|NCT01241812|osteoarthritis|osteoarthritis
5512442|NCT01241799|endoscopic ultrasound guided fine needle aspiration (EUS-FNA)|endoscopic ultrasound guided fine needle aspiration (eus-fna)
5512443|NCT01241799|pancreatic biopsy|pancreatic biopsy
5512444|NCT01241799|randomized|randomized
5512445|NCT01241799|single blind|single blind
5685340|NCT00556491|injury|injury
5512446|NCT01241799|fine needle aspiration (FNA) adequacy|fine needle aspiration (fna) adequacy
5512447|NCT01241799|fine needle aspiration (FNA) accuracy|fine needle aspiration (fna) accuracy
5512448|NCT01241786|chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5512449|NCT01241786|small lymphocytic lymphoma (SLL)|small lymphocytic lymphoma (sll)
5512451|NCT01241773|TMC435-C123|tmc435-c123
5512452|NCT01241773|TMC435|tmc435
5512453|NCT01241773|HCV|hcv
5512454|NCT01241773|Hepatitis C|hepatitis c
5512455|NCT01241760|Genotype 1 chronic hepatitis C|genotype 1 chronic hepatitis c
5512456|NCT01241760|VX-950-C211|vx-950-c211
5512457|NCT01241760|VX-950|vx-950
5512458|NCT01241760|IL28B|il28b
5512459|NCT01241760|Telaprevir|telaprevir
5512460|NCT01241760|Hepatitis C|hepatitis c
5512461|NCT01241760|BID|bid
5512462|NCT01241760|Q8h|q8h
5512463|NCT01241760|SOC|soc
5512464|NCT01241734|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
5512465|NCT01241721|Breast Diseases|breast diseases
5512466|NCT01241721|Breast Neoplasms|breast neoplasms
5512467|NCT01241721|Neoplasms|neoplasms
5512468|NCT01241695|Oral nutritional supplement, diabetes mellitus type 2, glycaemic control|oral nutritional supplement, diabetes mellitus type 2, glycaemic control
5512469|NCT01241695|Oral nutritional supplement (Food for special medical purposes)|oral nutritional supplement (food for special medical purposes)
5512470|NCT01241682|Mesothelioma|mesothelioma
5512471|NCT01241682|Dendritic cells|dendritic cells
5512472|NCT01241682|Cyclophosphamide|cyclophosphamide
5512473|NCT01241682|Tumor lysate-loaded|tumor lysate-loaded
5512474|NCT01241682|Immunotherapy|immunotherapy
5512475|NCT01241656|Prostate cancer|prostate cancer
5512476|NCT01241656|Decision support intervention (DESI)|decision support intervention (desi)
5512579|NCT01241318|neonate|neonate
5512477|NCT01241656|Shared medical appointments (SMA)|shared medical appointments (sma)
5512478|NCT01241656|Comparative effectiveness research (CER)|comparative effectiveness research (cer)
5512480|NCT01241643|immune-based therapies|immune-based therapies
5512481|NCT01241643|HIV|hiv
5512482|NCT01241643|infectious disease|infectious disease
5512483|NCT01241643|immune non-responders|immune non-responders
5512484|NCT01241630|Somato-sensory reflex arch|somato-sensory reflex arch
5512485|NCT01241630|Spinal cord injury|spinal cord injury
5512486|NCT01241630|Xiao Procedure|xiao procedure
5512487|NCT01241617|Lung disease|lung disease
5512488|NCT01241617|Lobectomy|lobectomy
5512489|NCT01241617|Pulmonary resection|pulmonary resection
5512490|NCT01241591|CP-690,550|cp-690,550
5512491|NCT01241591|Etanercept|etanercept
5512492|NCT01241591|Moderate|moderate
5512493|NCT01241591|Severe|severe
5512494|NCT01241591|Chronic|chronic
5512495|NCT01241591|Plaque|plaque
5512496|NCT01241591|Psoriasis|psoriasis
5512497|NCT01241591|Efficacy|efficacy
5512498|NCT01241591|Safety|safety
5512499|NCT01241591|Tofacitinib|tofacitinib
5512500|NCT01241591|Xeljanz|xeljanz
5512501|NCT01241591|OPT Compare|opt compare
5512502|NCT01241591|OPT|opt
5512503|NCT01241591|head-to-head|head-to-head
5512504|NCT01241591|non-inferiority|non-inferiority
5512505|NCT01241591|Psoriasis vulgaris|psoriasis vulgaris
5512506|NCT01241591|short-term|short-term
5512507|NCT01241591|Itch|itch
5512508|NCT01241591|Pruritus|pruritus
5512509|NCT01241591|Plaque psoriasis|plaque psoriasis
5512510|NCT01241591|DLQI|dlqi
5512511|NCT01241578|Obesity|obesity
5512512|NCT01241578|Behavior Therapy|behavior therapy
5512513|NCT01241578|Lifestyle|lifestyle
5512514|NCT01241578|Technology|technology
5512515|NCT01241578|Cellular Phone|cellular phone
5512516|NCT01241565|lung cancer|lung cancer
5512517|NCT01241565|lobectomy|lobectomy
5512518|NCT01241565|wedge resection|wedge resection
5512519|NCT01241552|Clostridium difficile|clostridium difficile
5512520|NCT01241552|recurrent Clostridium difficile|recurrent clostridium difficile
5512521|NCT01241552|vancomycin|vancomycin
5512522|NCT01241552|metronidazole|metronidazole
5512523|NCT01241552|monoclonal antibody|monoclonal antibody
5512524|NCT01241552|Clostridium difficile infection (CDI)|clostridium difficile infection (cdi)
5512525|NCT01241526|COPD|copd
5512526|NCT01241526|COMET|comet
5512527|NCT01241526|Disease management|disease management
5512528|NCT01241513|glutathione|glutathione
5512529|NCT01241513|redox status|redox status
5512530|NCT01241513|carotid body chemosensitivity|carotid body chemosensitivity
5512531|NCT01241513|ventilation|ventilation
5512532|NCT01241500|Myelodysplastic syndromes|myelodysplastic syndromes
5512533|NCT01241500|MDS|mds
5512534|NCT01241487|Hypertension, Valsartan/Amlodipine,|hypertension, valsartan/amlodipine,
5512535|NCT01241461|Advanced Cancer|advanced cancer
5512536|NCT01241461|Metastatic Cancer|metastatic cancer
5512537|NCT01241461|p70s6 inhibitor|p70s6 inhibitor
5512538|NCT01241448|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5512539|NCT01241422|Asthma|asthma
5512540|NCT01241422|Mild asthma|mild asthma
5512541|NCT01241422|Singulair|singulair
5512542|NCT01241422|JNJ 40929837|jnj 40929837
5512543|NCT01241422|Montelukast|montelukast
5512544|NCT01241409|Healthy|healthy
5512545|NCT01241409|Sprinkle Capsule Formulation|sprinkle capsule formulation
5512546|NCT01241409|Rabeprazole sodium|rabeprazole sodium
5512547|NCT01241409|Pharmacokinetics|pharmacokinetics
5798696|NCT00111345|leukemia|leukemia
5512548|NCT01241409|Bioequivalence|bioequivalence
5512550|NCT01241396|Multiple Myeloma|multiple myeloma
5512551|NCT01241396|observational|observational
5512553|NCT01241396|non-interventional|non-interventional
5512554|NCT01241396|international|international
5512555|NCT01241396|epidemiology|epidemiology
5512556|NCT01241396|treatment|treatment
5512557|NCT01241396|routine clinical practice|routine clinical practice
5512558|NCT01241396|retrospective|retrospective
5512559|NCT01241396|prospective|prospective
5512560|NCT01241383|Scleroderma renal crisis|scleroderma renal crisis
5512561|NCT01241383|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5512562|NCT01241383|bosentan|bosentan
5512563|NCT01241383|endothelin receptor antagonist|endothelin receptor antagonist
5512564|NCT01241370|Retinal endothelia dysfunction|retinal endothelia dysfunction
5512565|NCT01241370|Type 2 diabetes mellitus|type 2 diabetes mellitus
5512566|NCT01241370|Insulin-resistance|insulin-resistance
5512567|NCT01241370|micro-lightguide spectrophotometry|micro-lightguide spectrophotometry
5512568|NCT01241370|laserdopplerfluxmetry|laserdopplerfluxmetry
5512569|NCT01241357|Iron|iron
5512570|NCT01241357|Iron overload|iron overload
5512571|NCT01241357|Hepatic iron concentration|hepatic iron concentration
5512572|NCT01241357|High-temperature superconductivity|high-temperature superconductivity
5512573|NCT01241357|Magnetic susceptibility|magnetic susceptibility
5512574|NCT01241357|Susceptometer|susceptometer
5512575|NCT01241344|Adv|adv
5512576|NCT01241344|Hematopoeitic Stem cell Transplant|hematopoeitic stem cell transplant
5512577|NCT01241344|HSCT|hsct
5512578|NCT01241331|moderate to severe facial acne vulgaris|moderate to severe facial acne vulgaris
5512580|NCT01241318|omphalitis|omphalitis
5512581|NCT01241318|neonatal mortality|neonatal mortality
5512583|NCT01241318|umbilical cord infection|umbilical cord infection
5512584|NCT01241305|Vasculitis|vasculitis
5512585|NCT01241305|CSS|css
5512586|NCT01241305|EGPA|egpa
5512587|NCT01241305|GCA|gca
5512588|NCT01241305|GPA|gpa
5512589|NCT01241305|WG|wg
5512590|NCT01241305|MPA|mpa
5512591|NCT01241305|PAN|pan
5512592|NCT01241305|TAK|tak
5512593|NCT01241279|cataract surgery|cataract surgery
5512594|NCT01241279|intraocular lens|intraocular lens
5512595|NCT01241266|Peptic Ulcer Bleeding|peptic ulcer bleeding
5512596|NCT01241266|high risk|high risk
5512597|NCT01241266|None-Interventional Study|none-interventional study
5512598|NCT01241266|he proportion of peptic ulcer bleeding patients who are at high risk (Forrest Ia-IIb)|he proportion of peptic ulcer bleeding patients who are at high risk (forrest ia-iib)
5512599|NCT01241253|legumes|legumes
5512600|NCT01241253|glycemic response|glycemic response
5512601|NCT01241253|glucose|glucose
5512602|NCT01241253|type 2 diabetes mellitus|type 2 diabetes mellitus
5512603|NCT01241227|liver fibrosis|liver fibrosis
5512604|NCT01241227|survival|survival
5512605|NCT01241227|transient elastography|transient elastography
5512606|NCT01241214|Seasonal allergic rhinitis|seasonal allergic rhinitis
5512607|NCT01241214|SAR|sar
5512608|NCT01241214|Allergic rhinitis|allergic rhinitis
5512609|NCT01241214|Allergies|allergies
5512610|NCT01241201|intestinal health|intestinal health
5512611|NCT01241201|probiotics|probiotics
5512612|NCT01241201|inflammation|inflammation
5512613|NCT01241201|biomarkers|biomarkers
5512614|NCT01241188|tuberculosis|tuberculosis
5512615|NCT01241188|rdESAT-6|rdesat-6
5512616|NCT01241188|CFP-10|cfp-10
5512617|NCT01241188|skin test|skin test
5512618|NCT01241188|diagnostic test|diagnostic test
5512619|NCT01241175|IOP|iop
5512620|NCT01241175|ophthalmic anesthesia|ophthalmic anesthesia
5512621|NCT01241175|magnesium sulfate|magnesium sulfate
5512622|NCT01241162|Neuroblastoma|neuroblastoma
5512623|NCT01241162|Ewings sarcoma|ewings sarcoma
5512624|NCT01241162|osteogenic sarcoma|osteogenic sarcoma
5512625|NCT01241162|rhabdomyosarcoma|rhabdomyosarcoma
5512626|NCT01241162|synovial sarcoma|synovial sarcoma
5512627|NCT01241162|high-risk|high-risk
5512628|NCT01241162|relapsed|relapsed
5512629|NCT01241162|children|children
5512630|NCT01241149|Nissen fundoplication|nissen fundoplication
5512631|NCT01241149|non-acid reflux disease|non-acid reflux disease
5512632|NCT01241149|anti-reflux surgery|anti-reflux surgery
5512633|NCT01241136|pilonidal disease, cystectomy, recurrence|pilonidal disease, cystectomy, recurrence
5512634|NCT01241123|return of bowel function, post-operative, colon surgery|return of bowel function, post-operative, colon surgery
5512635|NCT01241110|PID, Ofloxacin, Azitromicine, Metronidazole|pid, ofloxacin, azitromicine, metronidazole
5512636|NCT01241097|endothelial function|endothelial function
5512637|NCT01241097|statins|statins
5512638|NCT01241097|ezetimibe|ezetimibe
5512639|NCT01241097|pleiotropism|pleiotropism
5512640|NCT01241084|asthmatic children|asthmatic children
5512641|NCT01241071|Lumbar region|lumbar region
5512642|NCT01241071|Pain|pain
5512643|NCT01241071|Fascia|fascia
5512644|NCT01241071|Electromyography|electromyography
5512645|NCT01241071|Goniometry|goniometry
5512646|NCT01241058|pediatrics, crohn's disease, disease course, therapy|pediatrics, crohn's disease, disease course, therapy
5512647|NCT01241032|DA-8159|da-8159
5512648|NCT01241032|Udenafil|udenafil
5512649|NCT01241032|Alcohol|alcohol
5512650|NCT01241019|asphyxia neonatorum, hypothermia, neuroprotection|asphyxia neonatorum, hypothermia, neuroprotection
5512651|NCT01241006|Relapse|relapse
5512652|NCT01241006|Corticosteroids|corticosteroids
5512653|NCT01240993|parenting intervention|parenting intervention
5512654|NCT01240993|mother-child relations|mother-child relations
5512655|NCT01240993|substance abuse|substance abuse
5512656|NCT01240993|attachment|attachment
5512657|NCT01240993|child development|child development
5512658|NCT01240967|Phase 1|phase 1
5512659|NCT01240967|healthy volunteers|healthy volunteers
5512660|NCT01240967|volunteers with renal impairment|volunteers with renal impairment
5512661|NCT01240967|pharmacokinetics|pharmacokinetics
5512662|NCT01240967|TC-5214|tc-5214
5512663|NCT01240954|Rhinitis|rhinitis
5512664|NCT01240954|Allergic|allergic
5512665|NCT01240954|Immunotherapy|immunotherapy
5512666|NCT01240915|safety efficacy MultiStem(r) moderate to severe Ulcerative Colitis|safety efficacy multistem(r) moderate to severe ulcerative colitis
5512667|NCT01240902|Valvular Heart Disease|valvular heart disease
5512668|NCT01240902|Critical Aortic Stenosis|critical aortic stenosis
5512669|NCT01240902|Severe Aortic Stenosis|severe aortic stenosis
5512670|NCT01240902|High Risk|high risk
5512671|NCT01240902|Aortic Valve Replacement|aortic valve replacement
5512672|NCT01240889|Ragweed allergies|ragweed allergies
5512673|NCT01240889|acoustic rhinometry|acoustic rhinometry
5512674|NCT01240889|nasal allergen challenge|nasal allergen challenge
5512675|NCT01240876|Sciatica|sciatica
5512676|NCT01240876|Pain|pain
5512677|NCT01240863|osteoarthritis|osteoarthritis
5512678|NCT01240863|low back pain|low back pain
5512679|NCT01240863|Moderate to Severe Pain|moderate to severe pain
5512680|NCT01240850|Retroperitoneal fibrosis|retroperitoneal fibrosis
5512681|NCT01240850|Inflammatory aneurysms|inflammatory aneurysms
5512682|NCT01240850|Methotrexate|methotrexate
5512683|NCT01240850|Prednisone|prednisone
5512684|NCT01240850|Aorta|aorta
5512685|NCT01240837|glycaemic index|glycaemic index
5512686|NCT01240837|arenga pinnata sugar|arenga pinnata sugar
5512687|NCT01240837|palm sugar|palm sugar
5512688|NCT01240837|diabetes|diabetes
5512689|NCT01240824|bladder cancer|bladder cancer
5512690|NCT01240824|urothelial carcinoma|urothelial carcinoma
5512691|NCT01240824|transitional cell carcinoma bladder|transitional cell carcinoma bladder
5512692|NCT01240824|ureter|ureter
5512693|NCT01240811|intrauterine device|intrauterine device
5512694|NCT01240811|IUD|iud
5512695|NCT01240811|levonorgestrel|levonorgestrel
5512696|NCT01240811|copper|copper
5512697|NCT01240811|CD4|cd4
5512698|NCT01240811|CCR5|ccr5
5512699|NCT01240811|microflora|microflora
5512700|NCT01240798|Depression|depression
5512701|NCT01240798|Anxiety|anxiety
5512702|NCT01240798|Coronary disease|coronary disease
5512703|NCT01240785|gestational diabetes|gestational diabetes
5512704|NCT01240785|metformin|metformin
5512705|NCT01240785|insulin|insulin
5512706|NCT01240772|Haemorrhoids, Surgery, Cost-effectiveness, Morbidity, Risk assessment,RCT, Stapled haemorrhoidopexy, Doppler-guided, Haemorrhoidal artery ligation, Outcome|haemorrhoids, surgery, cost-effectiveness, morbidity, risk assessment,rct, stapled haemorrhoidopexy, doppler-guided, haemorrhoidal artery ligation, outcome
5512707|NCT01240759|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5512708|NCT01240759|Metformin|metformin
5512709|NCT01240746|Influenza|influenza
5512710|NCT01240746|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
5512711|NCT01240746|Trivalent Influenza Vaccine|trivalent influenza vaccine
5512712|NCT01240746|Influenza viruses|influenza viruses
5512713|NCT01240746|Fluzone®|fluzone®
5512714|NCT01240720|I131|i131
5512715|NCT01240720|F16|f16
5512716|NCT01240720|antibody|antibody
5512717|NCT01240720|monoclonal|monoclonal
5512718|NCT01240720|tumor targeting|tumor targeting
5512719|NCT01240720|radioimmunotherapy|radioimmunotherapy
5512720|NCT01240720|lymphoma, breast and lung cancer|lymphoma, breast and lung cancer
5512721|NCT01240720|Patients with different cancer types|patients with different cancer types
5512722|NCT01240694|Lupus|lupus
5512723|NCT01240694|SLE|sle
5512724|NCT01240681|Locally Advanced Breast Cancer (LABC)|locally advanced breast cancer (labc)
5512725|NCT01240681|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5512726|NCT01240681|Fluorothymidine Positron Emission Tomography (FLT PET)|fluorothymidine positron emission tomography (flt pet)
5512727|NCT01240681|Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood oxygen level dependent magnetic resonance imaging (bold mri)
5512728|NCT01240681|tumor response|tumor response
5512729|NCT01240681|mastectomy|mastectomy
5512730|NCT01240668|Hyponatremia|hyponatremia
5512731|NCT01240668|Euvolemia|euvolemia
5512732|NCT01240668|Hypervolemia|hypervolemia
5512733|NCT01240668|Euvolemic|euvolemic
5512734|NCT01240668|Hypervolemic|hypervolemic
5512735|NCT01240655|LCL161|lcl161
5512736|NCT01240655|solid tumors|solid tumors
5512737|NCT01240655|paclitaxel|paclitaxel
5512738|NCT01240642|Advanced or metastatic cancer|advanced or metastatic cancer
5512739|NCT01240642|refractory|refractory
5512740|NCT01240642|core phase|core phase
5512741|NCT01240642|extension phase|extension phase
5512742|NCT01240642|dose escalation|dose escalation
5512743|NCT01240642|standard chemotherapy|standard chemotherapy
5512744|NCT01240642|doctaxel|doctaxel
5512745|NCT01240642|paclitaxel|paclitaxel
5512746|NCT01240642|carboplatin|carboplatin
5512747|NCT01240642|safety|safety
5512748|NCT01240642|tolerability|tolerability
5512749|NCT01240616|Nicotine|nicotine
5512750|NCT01240616|Mecamylamine|mecamylamine
5512751|NCT01240616|Attention|attention
5512752|NCT01240616|fMRI|fmri
5512753|NCT01240616|Default Network|default network
5512754|NCT01240616|Healthy Volunteer|healthy volunteer
5512755|NCT01240616|HV|hv
5512756|NCT01240603|Artemisinin|artemisinin
5512757|NCT01240603|Malaria|malaria
5512758|NCT01240603|Drug Resistance|drug resistance
5512759|NCT01240603|Hemoglobin E|hemoglobin e
5512760|NCT01240590|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5512761|NCT01240590|Crolibulin|crolibulin
5512762|NCT01240590|Solid Tumors|solid tumors
5512763|NCT01240590|ATC|atc
5512764|NCT01240577|IPdR|ipdr
5512765|NCT01240577|Pharmacokinetics|pharmacokinetics
5512766|NCT01240577|Early Phase I|early phase i
5512767|NCT01240577|Cancer|cancer
5512768|NCT01240577|Solid Tumor|solid tumor
5512769|NCT01240577|Lymphoma|lymphoma
5512770|NCT01240551|Imaging|imaging
5512771|NCT01240551|Bone Metastasis|bone metastasis
5512772|NCT01240551|Bone Scan|bone scan
5512773|NCT01240551|Radiopharmaceutical|radiopharmaceutical
5512774|NCT01240551|Pet Scan|pet scan
5512775|NCT01240551|Prostate Cancer|prostate cancer
5512776|NCT01240525|graft versus host disease|graft versus host disease
5512777|NCT01240525|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5512778|NCT01240525|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5512779|NCT01240525|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5512780|NCT01240525|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5512781|NCT01240525|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5512782|NCT01240525|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5512783|NCT01240525|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5512784|NCT01240525|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5512785|NCT01240525|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5512786|NCT01240525|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5512787|NCT01240525|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5512788|NCT01240525|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5512789|NCT01240525|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5512790|NCT01240525|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5512791|NCT01240525|Hodgkin's lymphoma|hodgkin's lymphoma
5512792|NCT01240525|Chronic (Pro-)lymphocytic leukaemia|chronic (pro-)lymphocytic leukaemia
5512793|NCT01240525|Plasma cell myeloma|plasma cell myeloma
5512794|NCT01240525|Acute myeloid leukaemia|acute myeloid leukaemia
5512795|NCT01240525|Acute lymphoblastic leukaemia|acute lymphoblastic leukaemia
5512796|NCT01240525|Myelodysplastic syndrome|myelodysplastic syndrome
5512797|NCT01240525|Chronic myelomonocytic leukaemia|chronic myelomonocytic leukaemia
5512798|NCT01240499|Weight management|weight management
5512799|NCT01240499|New weight paradigm|new weight paradigm
5512800|NCT01240499|Overweight women|overweight women
5512801|NCT01240499|Eating behaviors|eating behaviors
5512802|NCT01240499|Appetite ratings|appetite ratings
5512803|NCT01240499|Blood lipids|blood lipids
5512804|NCT01240486|IRIS|iris
5512806|NCT01240486|Immune|immune
5512807|NCT01240486|Reconstitution|reconstitution
5512808|NCT01240486|Inflammatory|inflammatory
5512809|NCT01240486|Syndrome|syndrome
5512810|NCT01240473|kala azar|kala azar
5512811|NCT01240473|visceral leishmaniasis|visceral leishmaniasis
5512812|NCT01240473|diagnosis|diagnosis
5512813|NCT01240473|drug resistance|drug resistance
5512814|NCT01240473|Therapeutics|therapeutics
5512815|NCT01240473|Capacity Building|capacity building
5512816|NCT01240447|NSCLC|nsclc
5512817|NCT01240447|lung cancer, small-cell|lung cancer, small-cell
5512818|NCT01240447|advanced lung cancer|advanced lung cancer
5512819|NCT01240434|trocar hernia closure laparoscopy|trocar hernia closure laparoscopy
5512820|NCT01240421|Metastatic breast cancer with no other treatment options|metastatic breast cancer with no other treatment options
5512821|NCT01240395|Multiple chemical sensitivities|multiple chemical sensitivities
5512822|NCT01240395|MCS|mcs
5512823|NCT01240395|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5512824|NCT01240395|MBCT|mbct
5512825|NCT01240369|VEGFC|vegfc
5512826|NCT01240369|CTTN|cttn
5512827|NCT01240369|miR326|mir326
5512828|NCT01240369|ESCC|escc
5512829|NCT01240369|NSCLC|nsclc
5512830|NCT01240356|transcranial doppler|transcranial doppler
5512831|NCT01240356|sonothrombolysis|sonothrombolysis
5512832|NCT01240356|ultrasound|ultrasound
5512833|NCT01240356|stroke|stroke
5512834|NCT01240343|Biobank|biobank
5512835|NCT01240343|Genetics|genetics
5512836|NCT01240330|Deep Vein Thrombosis|deep vein thrombosis
5512837|NCT01240330|Effects of compression therapy|effects of compression therapy
5512838|NCT01240330|Peak Flow Velocity|peak flow velocity
5512839|NCT01240317|expert system|expert system
5512840|NCT01240317|decision support system|decision support system
5512841|NCT01240317|human patient simulator|human patient simulator
5512843|NCT01240291|glutamine|glutamine
5512845|NCT01240291|alanyl-glutamine|alanyl-glutamine
5512846|NCT01240265|Vitamin D deficiency|vitamin d deficiency
5512847|NCT01240265|Rickets|rickets
5512848|NCT01240265|Infant|infant
5512849|NCT01240265|Nutrition|nutrition
5512850|NCT01240252|diabetes|diabetes
5512851|NCT01240252|insulin resistance|insulin resistance
5512852|NCT01240239|Pre anesthesia consultation|pre anesthesia consultation
5512853|NCT01240239|telemedicine|telemedicine
5512854|NCT01240213|Vitamin D|vitamin d
5512855|NCT01240213|lifestyle intervention|lifestyle intervention
5512856|NCT01240213|postmenopausal women|postmenopausal women
5512857|NCT01240200|diabetes|diabetes
5512858|NCT01240200|elderly|elderly
5512859|NCT01240200|insulin injections|insulin injections
5512860|NCT01240187|epilepsy|epilepsy
5512861|NCT01240174|Antibiotic|antibiotic
5512862|NCT01240174|Antimicrobial|antimicrobial
5512863|NCT01240174|Prescribing|prescribing
5512864|NCT01240174|Cough|cough
5512865|NCT01240174|Acute Bronchitis|acute bronchitis
5512866|NCT01240161|Glioblastoma multiforme|glioblastoma multiforme
5512867|NCT01240161|FLT|flt
5512868|NCT01240161|PET|pet
5512869|NCT01240148|Allodynia|allodynia
5512870|NCT01240148|hyperalgesia|hyperalgesia
5512872|NCT01240135|Contact Lens Wear|contact lens wear
5512873|NCT01240135|Contact Lens Solution|contact lens solution
5512874|NCT01240135|Multi-purpose disinfecting solution|multi-purpose disinfecting solution
5512875|NCT01240135|Myopia|myopia
5513060|NCT01239199|Exhaled Nitric Oxide|exhaled nitric oxide
5512876|NCT01240122|Corneal staining and comfort evaluation in normal, habitual contact lens wearers.|corneal staining and comfort evaluation in normal, habitual contact lens wearers.
5512880|NCT01240083|Depression|depression
5512881|NCT01240083|Transcranial magnetic stimulation|transcranial magnetic stimulation
5512882|NCT01240083|Thetaburst Stimulation|thetaburst stimulation
5512883|NCT01240083|Alternative treatment methods|alternative treatment methods
5512884|NCT01240070|diabetes,|diabetes,
5512885|NCT01240070|cardiovascular|cardiovascular
5512886|NCT01240070|risk factor|risk factor
5512887|NCT01240070|cardiovascular event|cardiovascular event
5512888|NCT01240070|intervention|intervention
5512889|NCT01240057|Isolated Congenital Diaphragmatic Hernia|isolated congenital diaphragmatic hernia
5512890|NCT01240057|Fetal Surgery|fetal surgery
5512891|NCT01240057|Pulmonary Hypoplasia|pulmonary hypoplasia
5512892|NCT01240044|Newborn Pain|newborn pain
5512893|NCT01240044|Respiratory Physiotherapy|respiratory physiotherapy
5512894|NCT01240044|Neonatal intensive care unit|neonatal intensive care unit
5512895|NCT01240031|Malnutrition|malnutrition
5512896|NCT01240031|Nutritional Risk|nutritional risk
5512897|NCT01240031|Intake|intake
5512898|NCT01240031|Food sensory|food sensory
5512899|NCT01240031|Nutritional therapy|nutritional therapy
5512900|NCT01240031|Energy|energy
5512901|NCT01240031|Protein|protein
5512902|NCT01240031|Handgrip strength|handgrip strength
5512903|NCT01240031|Reaction time|reaction time
5512904|NCT01240031|Quality of Life|quality of life
5512905|NCT01239979|coronary artery disease|coronary artery disease
5512906|NCT01239966|Acute Respiratory Distress syndrome|acute respiratory distress syndrome
5512907|NCT01239966|Acute renal Failure|acute renal failure
5512908|NCT01239953|In-stent restenosis|in-stent restenosis
5512909|NCT01239953|Drug-eluting balloon|drug-eluting balloon
5512910|NCT01239953|Drug-eluting stent|drug-eluting stent
5512911|NCT01239953|Angiography|angiography
5512912|NCT01239953|Minimal lumen diameter|minimal lumen diameter
5512913|NCT01239940|In-stent restenosis|in-stent restenosis
5512914|NCT01239940|Drug-eluting balloon|drug-eluting balloon
5512915|NCT01239940|Drug-eluting stent|drug-eluting stent
5512916|NCT01239940|Angiography|angiography
5512917|NCT01239940|Minimal lumen diameter|minimal lumen diameter
5512918|NCT01239927|diverticulitis|diverticulitis
5512919|NCT01239927|hartmann|hartmann
5512920|NCT01239927|anastomosis|anastomosis
5512921|NCT01239914|drug eluting stent|drug eluting stent
5512922|NCT01239914|coronary artery disease|coronary artery disease
5512923|NCT01239914|Korean registry|korean registry
5512924|NCT01239901|sickle cell disease|sickle cell disease
5512925|NCT01239901|sickle cell anemia|sickle cell anemia
5512926|NCT01239901|sickled cells|sickled cells
5512927|NCT01239901|blood vessel|blood vessel
5512928|NCT01239901|iron overload|iron overload
5512929|NCT01239888|Depression|depression
5512930|NCT01239888|Treatment resistant depression|treatment resistant depression
5512931|NCT01239888|Oxytocin|oxytocin
5512932|NCT01239888|Estrogen Modulators|estrogen modulators
5512933|NCT01239888|HPA axis|hpa axis
5512934|NCT01239888|Mental Disorders|mental disorders
5512935|NCT01239888|Estrogens|estrogens
5512936|NCT01239888|Tibolone|tibolone
5512937|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators
5512938|NCT01239888|Androgens|androgens
5512939|NCT01239888|Hormones|hormones
5512940|NCT01239888|Hormone Substitutes|hormone substitutes
5512941|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs
5512942|NCT01239888|Pharmacologic Actions|pharmacologic actions
5512943|NCT01239888|Hormone Antagonists|hormone antagonists
5512944|NCT01239888|Bone Density Conservation Agents|bone density conservation agents
5512945|NCT01239888|Estrogen Antagonists|estrogen antagonists
5512946|NCT01239862|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation|pulmonary, silicosis, chronic and accelerated silicosis, autologous transplantation
5512947|NCT01239862|bone marrow cells, stem cells, cell therapy|bone marrow cells, stem cells, cell therapy
5512948|NCT01239849|Diabetes Mellitus, Hypercholesterolemia|diabetes mellitus, hypercholesterolemia
5512949|NCT01239836|urinary incontinence, self-management, cost, self-efficacy, continence promotion|urinary incontinence, self-management, cost, self-efficacy, continence promotion
5512950|NCT01239823|osteoarthritis|osteoarthritis
5512951|NCT01239823|whole body vibration|whole body vibration
5512952|NCT01239823|mobility|mobility
5512953|NCT01239823|rehabilitation|rehabilitation
5512954|NCT01239810|hyaluronic acid|hyaluronic acid
5512955|NCT01239810|cartilage|cartilage
5512956|NCT01239810|T2 mapping|t2 mapping
5512957|NCT01239810|quantitative|quantitative
5512958|NCT01239810|MRI|mri
5512959|NCT01239810|volume|volume
5512960|NCT01239784|pediatrics|pediatrics
5512962|NCT01239784|Neurodevelopmental deficit|neurodevelopmental deficit
5512963|NCT01239784|Neurodevelopmental Rehabilitation|neurodevelopmental rehabilitation
5512964|NCT01239771|Safety|safety
5512965|NCT01239771|tolerability|tolerability
5512966|NCT01239771|healthy|healthy
5512967|NCT01239771|stable disease|stable disease
5512968|NCT01239771|oral|oral
5512969|NCT01239771|tablet|tablet
5513061|NCT01239199|Asthma|asthma
5512970|NCT01239745|Hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen|hormone adjuvant treatment of early breast cancer with aromatase inhibitors following 2-3 years of tamoxifen
5512971|NCT01239719|Allergic dermatitis|allergic dermatitis
5512972|NCT01239693|Stunting|stunting
5512973|NCT01239693|Growth failure|growth failure
5512974|NCT01239693|Malnutrition|malnutrition
5512975|NCT01239693|Lipid based nutrient supplement|lipid based nutrient supplement
5512977|NCT01239693|Prevention|prevention
5512978|NCT01239693|Malawi|malawi
5512979|NCT01239693|Sub-Saharan Africa|sub-saharan africa
5512980|NCT01239693|Dietary supplementation|dietary supplementation
5512981|NCT01239693|Efficacy|efficacy
5512982|NCT01239693|Pregnancy|pregnancy
5512983|NCT01239693|Infancy|infancy
5512984|NCT01239693|Newborn|newborn
5512985|NCT01239680|hemorrhagic shock|hemorrhagic shock
5512986|NCT01239680|glutamine|glutamine
5512987|NCT01239680|trauma resuscitation|trauma resuscitation
5512988|NCT01239680|department of defense|department of defense
5512989|NCT01239680|trauma|trauma
5512990|NCT01239667|Health related quality of Life, Self Care behavior, activities of daily living|health related quality of life, self care behavior, activities of daily living
5512991|NCT01239654|acute|acute
5512992|NCT01239654|coronary|coronary
5512993|NCT01239654|syndrome|syndrome
5512994|NCT01239654|everolimus|everolimus
5512995|NCT01239654|zotarolimus|zotarolimus
5512996|NCT01239654|optical|optical
5512997|NCT01239654|coherence|coherence
5512998|NCT01239654|tomography|tomography
5512999|NCT01239641|Uterine Fibroids|uterine fibroids
5513000|NCT01239641|Myoectomy|myoectomy
5513001|NCT01239641|High Intensity Focused Ultrasound|high intensity focused ultrasound
5513002|NCT01239641|ablation|ablation
5513003|NCT01239602|changes in cortical excitability in subjects with chronic stroke after stem cell therapy|changes in cortical excitability in subjects with chronic stroke after stem cell therapy
5513004|NCT01239589|Patients admitted as for an acute bipolar manic episode|patients admitted as for an acute bipolar manic episode
5513005|NCT01239589|Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR|description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine ir or quetiapine xr
5513006|NCT01239563|kidney transplantation|kidney transplantation
5513007|NCT01239563|donation after cardiac death|donation after cardiac death
5513008|NCT01239563|ischemia-reperfusion injury|ischemia-reperfusion injury
5513009|NCT01239563|thymoglobulin|thymoglobulin
5513010|NCT01239563|steroid avoidance|steroid avoidance
5513011|NCT01239563|lymphocyte|lymphocyte
5513012|NCT01239550|Insulin|insulin
5513013|NCT01239550|Detemir|detemir
5513014|NCT01239550|Dopamine, brain,neurotransmitter|dopamine, brain,neurotransmitter
5513015|NCT01239550|Diabetes|diabetes
5513016|NCT01239550|Obesity|obesity
5513017|NCT01239550|Neurotransmitters|neurotransmitters
5513018|NCT01239524|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast MRI|breast reconstruction, latissimus dorsi flap, thoracodorsal nerve, skeletal muscle disuse, breast mri
5513019|NCT01239485|Pediatric refractory or relapsed acute leukemia|pediatric refractory or relapsed acute leukemia
5513020|NCT01239472|chronic allograft nephropathy|chronic allograft nephropathy
5513021|NCT01239472|cytokines|cytokines
5513022|NCT01239472|kidney transplant|kidney transplant
5513023|NCT01239472|calcineurin inhibitors withdrawn|calcineurin inhibitors withdrawn
5513024|NCT01239446|Hodgkin lymphoma|hodgkin lymphoma
5513025|NCT01239446|mediastinal irradiation|mediastinal irradiation
5513026|NCT01239446|Coronary Artery Disease|coronary artery disease
5513027|NCT01239394|NHL|nhl
5513028|NCT01239394|ofatumumab|ofatumumab
5513029|NCT01239381|proton radiation|proton radiation
5513030|NCT01239381|stereotactic body radiotherapy|stereotactic body radiotherapy
5513031|NCT01239381|SBRT|sbrt
5513032|NCT01239368|Multiple Myeloma|multiple myeloma
5513033|NCT01239368|High Risk|high risk
5513034|NCT01239368|Newly Diagnosed|newly diagnosed
5513035|NCT01239368|Adoptive Immunotherapy|adoptive immunotherapy
5513036|NCT01239368|Autologous|autologous
5513037|NCT01239329|Complex multiple disabilities|complex multiple disabilities
5513038|NCT01239329|Malnutrition|malnutrition
5513039|NCT01239277|muscle|muscle
5513040|NCT01239277|FSR|fsr
5513041|NCT01239277|protein|protein
5513042|NCT01239277|carbohydrate|carbohydrate
5513043|NCT01239277|leucine|leucine
5513044|NCT01239251|GlowCap|glowcap
5513045|NCT01239251|adjuvant endocrine therapy|adjuvant endocrine therapy
5513046|NCT01239238|asthma|asthma
5513047|NCT01239238|children|children
5513048|NCT01239238|home monitoring|home monitoring
5513049|NCT01239238|exhaled breath condensate|exhaled breath condensate
5513050|NCT01239238|non-invasive inflammatory markers|non-invasive inflammatory markers
5513051|NCT01239238|volatile organic compounds|volatile organic compounds
5513052|NCT01239225|Patients undergoing coronary angiography|patients undergoing coronary angiography
5513053|NCT01239212|seizures|seizures
5513055|NCT01239212|levetiracetam|levetiracetam
5513056|NCT01239212|Epilepsy|epilepsy
5513057|NCT01239212|central nervous system diseases|central nervous system diseases
5513058|NCT01239212|anticonvulsants|anticonvulsants
5513059|NCT01239199|Infants|infants
5513062|NCT01239199|Tobacco smoke exposure|tobacco smoke exposure
5513068|NCT01239173|Posttraumatic stress disorder|posttraumatic stress disorder
5513069|NCT01239173|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5513070|NCT01239173|Amygdala|amygdala
5513071|NCT01239173|emotion regulation|emotion regulation
5513072|NCT01239173|memory|memory
5513073|NCT01239160|lymphedema|lymphedema
5513074|NCT01239160|pneumatic compression device|pneumatic compression device
5513075|NCT01239160|randomised clinical trial|randomised clinical trial
5513076|NCT01239160|volume reduction|volume reduction
5513077|NCT01239147|weight maintenance|weight maintenance
5513078|NCT01239134|Malignant melanoma|malignant melanoma
5513079|NCT01239134|Metastatic|metastatic
5513080|NCT01239134|Unresectable|unresectable
5513081|NCT01239134|Stage III or Stage IV|stage iii or stage iv
5513082|NCT01239134|Solid tumor|solid tumor
5513083|NCT01239121|drug toxicity|drug toxicity
5513084|NCT01239121|drug interactions|drug interactions
5513085|NCT01239121|electronic health records|electronic health records
5513086|NCT01239121|medical errors|medical errors
5513087|NCT01239043|Meningitis|meningitis
5513088|NCT01239043|Meningococcal Meningitis|meningococcal meningitis
5513089|NCT01239043|Meningococcal Infections|meningococcal infections
5513090|NCT01239043|Menactra®|menactra®
5513091|NCT01239043|Menomune®|menomune®
5513092|NCT01239043|Meningococcal vaccine|meningococcal vaccine
5513093|NCT01239030|inattention|inattention
5513094|NCT01239030|impulsivity|impulsivity
5513095|NCT01239030|hyperactivity|hyperactivity
5513096|NCT01239030|ADHD|adhd
5513097|NCT01239004|dyslipidemia|dyslipidemia
5513098|NCT01239004|hyperlipidemia|hyperlipidemia
5513099|NCT01239004|hyperglycemia|hyperglycemia
5513100|NCT01239004|impaired fasting glucose|impaired fasting glucose
5513101|NCT01238978|Diabetes mellitus, vildagliptin, hypoglycemia, elderly|diabetes mellitus, vildagliptin, hypoglycemia, elderly
5513102|NCT01238952|solid tumors|solid tumors
5513103|NCT01238952|breast cancer|breast cancer
5513104|NCT01238952|triple negative breast cancer|triple negative breast cancer
5513105|NCT01238952|HER2 negative|her2 negative
5513106|NCT01238952|ER negative|er negative
5513107|NCT01238952|PR negative|pr negative
5513108|NCT01238939|solid tumors|solid tumors
5513109|NCT01238939|colorectal cancer|colorectal cancer
5513110|NCT01238926|Oxidative stress|oxidative stress
5513111|NCT01238926|Parkinson's disease|parkinson's disease
5513112|NCT01238926|Homocysteine|homocysteine
5513113|NCT01238926|Glutathione|glutathione
5513114|NCT01238926|B vitamins|b vitamins
5513115|NCT01238887|Satiety|satiety
5513116|NCT01238887|Food Intake|food intake
5513117|NCT01238887|Weight Loss|weight loss
5513118|NCT01238887|Oxidative Stress|oxidative stress
5513119|NCT01238887|botanicals|botanicals
5513120|NCT01238887|Garcinia Cambogia-derived hydroxycitric acid|garcinia cambogia-derived hydroxycitric acid
5513121|NCT01238861|Asthma|asthma
5513122|NCT01238861|Benralizumab|benralizumab
5513123|NCT01238861|MEDI-563|medi-563
5513124|NCT01238848|Hypertonic|hypertonic
5513125|NCT01238848|Saline|saline
5513126|NCT01238848|Bronchiolitis|bronchiolitis
5513127|NCT01238848|Efficacy|efficacy
5513128|NCT01238835|Sapien XT Valve|sapien xt valve
5513129|NCT01238835|Valvular Heart Disease|valvular heart disease
5513131|NCT01238835|Heart Valve Therapy|heart valve therapy
5513132|NCT01238835|Transapical|transapical
5513133|NCT01238835|Transcatheter|transcatheter
5513134|NCT01238809|Compliance|compliance
5513135|NCT01238809|France|france
5513136|NCT01238796|telavancin|telavancin
5513137|NCT01238796|Pharmacokinetics|pharmacokinetics
5513138|NCT01238796|Severe renal disease|severe renal disease
5513139|NCT01238796|VIBATIV®|vibativ®
5513140|NCT01238796|ASP9809|asp9809
5513141|NCT01238770|Ovarian cancer|ovarian cancer
5513142|NCT01238757|Prospective Studies|prospective studies
5513143|NCT01238757|Humans, pediatric|humans, pediatric
5513144|NCT01238757|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
5513145|NCT01238757|Respiration, Artificial/methods*|respiration, artificial/methods*
5513146|NCT01238757|Intensive Care|intensive care
5513147|NCT01238757|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
5680303|NCT00578292|transfusion-dependent|transfusion-dependent
5513148|NCT01238757|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
5513149|NCT01238757|Patients/statistics & numerical data*|patients/statistics & numerical data*
5513151|NCT01238757|Respiratory Muscles/innervation|respiratory muscles/innervation
5513152|NCT01238757|Child|child
5513153|NCT01238757|Child, Preschool|child, preschool
5513154|NCT01238757|Infant|infant
5513155|NCT01238757|Infant, Newborn|infant, newborn
5513156|NCT01238757|Intensive Care Units, Pediatric|intensive care units, pediatric
5513157|NCT01238757|Respiratory Rate*|respiratory rate*
5513158|NCT01238731|Valve replacement|valve replacement
5513159|NCT01238731|pulmonary hypertension|pulmonary hypertension
5513160|NCT01238731|long term follow up|long term follow up
5513162|NCT01238718|anesthetic depth|anesthetic depth
5513163|NCT01238718|hemodynamics|hemodynamics
5513164|NCT01238718|rapid sequence induction|rapid sequence induction
5513166|NCT01238705|Hypertension|hypertension
5513167|NCT01238705|Antihypertensive Agents|antihypertensive agents
5513168|NCT01238705|Combination|combination
5513169|NCT01238705|Sexual Dysfunction|sexual dysfunction
5513170|NCT01238705|Oxidative Stress|oxidative stress
5513171|NCT01238692|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5513172|NCT01238692|DLBCL|dlbcl
5513173|NCT01238692|Relapsed B-cell lymphoma|relapsed b-cell lymphoma
5513174|NCT01238692|Refractory B-cell lymphoma|refractory b-cell lymphoma
5513175|NCT01238692|B-cell Lymphoma|b-cell lymphoma
5513176|NCT01238692|Panobinostat|panobinostat
5513177|NCT01238692|LBH589|lbh589
5513178|NCT01238692|Rituximab|rituximab
5513179|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5513180|NCT01238666|liver|liver
5513181|NCT01238666|cancer|cancer
5513182|NCT01238666|tumor|tumor
5513183|NCT01238666|ablation|ablation
5513184|NCT01238666|Pathfinder|pathfinder
5513185|NCT01238653|liver|liver
5513186|NCT01238653|cancer|cancer
5513187|NCT01238653|tumor|tumor
5513188|NCT01238653|Pathfinder|pathfinder
5513189|NCT01238640|Smoking Cessation|smoking cessation
5513190|NCT01238640|Nicotine|nicotine
5513191|NCT01238627|Smoking Cessation|smoking cessation
5513192|NCT01238627|Nicotine pharmacokinetics|nicotine pharmacokinetics
5513193|NCT01238614|maternal depression|maternal depression
5513194|NCT01238614|clinical decision support|clinical decision support
5513195|NCT01238601|Breast augmentation|breast augmentation
5513196|NCT01238575|Pervasive Developmental Disorders|pervasive developmental disorders
5513198|NCT01238575|PDD-NOS|pdd-nos
5513199|NCT01238575|Autistic Disorder|autistic disorder
5513200|NCT01238575|Autism|autism
5513201|NCT01238575|Asperger's Disorder|asperger's disorder
5513202|NCT01238575|Hyperactivity|hyperactivity
5513203|NCT01238575|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5513204|NCT01238575|ADHD|adhd
5513205|NCT01238575|Medication|medication
5513206|NCT01238575|Drug|drug
5513207|NCT01238575|Guanfacine|guanfacine
5513208|NCT01238575|Intuniv|intuniv
5513209|NCT01238575|Placebo|placebo
5513210|NCT01238575|Methylphenidate|methylphenidate
5513211|NCT01238562|cancer patient|cancer patient
5513212|NCT01238562|chemotherapy|chemotherapy
5513213|NCT01238562|carboplatin|carboplatin
5513214|NCT01238562|taxol|taxol
5513215|NCT01238562|cyclophosphamide|cyclophosphamide
5513216|NCT01238562|pharmorubicin|pharmorubicin
5513217|NCT01238549|Spinal Cord Injuries|spinal cord injuries
5513218|NCT01238549|Quality of Life|quality of life
5513219|NCT01238536|Epidural Steroid Injection|epidural steroid injection
5513220|NCT01238536|Low Back Pain|low back pain
5513221|NCT01238536|Spinal Stenosis|spinal stenosis
5513222|NCT01238536|Elderly|elderly
5513223|NCT01238523|tibia|tibia
5513224|NCT01238523|shaft|shaft
5513225|NCT01238523|fracture|fracture
5513226|NCT01238523|children|children
5513227|NCT01238497|SAPIEN XT™|sapien xt™
5513228|NCT01238497|Transfemoral|transfemoral
5513229|NCT01238497|NovaFlex|novaflex
5513230|NCT01238497|NovaFlex+|novaflex+
5513231|NCT01238497|NF|nf
5513232|NCT01238497|NF+|nf+
5513233|NCT01238497|Transapical|transapical
5513234|NCT01238497|Transaortic|transaortic
5513235|NCT01238497|Ascendra2|ascendra2
5513236|NCT01238497|Ascendra+|ascendra+
5513237|NCT01238497|Asc+|asc+
5513238|NCT01238497|aortic stenosis|aortic stenosis
5513239|NCT01238497|aortic valve|aortic valve
5513240|NCT01238497|Transcatheter Heart Valve|transcatheter heart valve
5513241|NCT01238497|THV|thv
5513242|NCT01238484|Ankle Equinus|ankle equinus
5513243|NCT01238484|Ankle contracture|ankle contracture
5513244|NCT01238484|Diabetes Mellitus|diabetes mellitus
5513245|NCT01238484|Dynasplint|dynasplint
5513246|NCT01238484|AFD|afd
5513247|NCT01238471|retinopathy of prematurity|retinopathy of prematurity
5513248|NCT01238471|Propranolol|propranolol
5513249|NCT01238471|Vascular endothelial growth factor|vascular endothelial growth factor
5513250|NCT01238471|premature infant|premature infant
5513251|NCT01238458|[18F]AV-45 PET amyloid binding imaging|[18f]av-45 pet amyloid binding imaging
5513252|NCT01238458|Alzheimer's disease|alzheimer's disease
5495208|NCT01315990|rash|rash
5513253|NCT01238458|mild cognitive impartment,|mild cognitive impartment,
5513254|NCT01238445|Pediatric|pediatric
5513255|NCT01238432|Pediatric|pediatric
5513256|NCT01238432|Polymorphism, Genetic|polymorphism, genetic
5513257|NCT01238432|Adrenergic beta-Agonists|adrenergic beta-agonists
5513258|NCT01238406|Type 1 diabetes|type 1 diabetes
5513259|NCT01238406|Closed loop|closed loop
5513260|NCT01238406|Artificial Pancreas|artificial pancreas
5513261|NCT01238380|Monogenic diabetes|monogenic diabetes
5513262|NCT01238380|HNF1A|hnf1a
5513263|NCT01238380|HNF4A|hnf4a
5513264|NCT01238380|GCK|gck
5513266|NCT01238380|health economic model|health economic model
5513267|NCT01238354|Weight Loss|weight loss
5513384|NCT01238224|Insulin resistance|insulin resistance
5513385|NCT01238224|Phosphodiesterase-5 inhibition|phosphodiesterase-5 inhibition
5513386|NCT01238224|Microdialysis|microdialysis
5513387|NCT01238224|Type 2 diabetes|type 2 diabetes
5513388|NCT01238224|Endothelial dysfunction|endothelial dysfunction
5513389|NCT01238224|Oral hypoglycaemic agents|oral hypoglycaemic agents
5513390|NCT01238185|oral leukoplakia|oral leukoplakia
5513391|NCT01238172|stage I prostate cancer|stage i prostate cancer
5671579|NCT00615433|Latuda|latuda
5513392|NCT01238172|stage IIB prostate cancer|stage iib prostate cancer
5513393|NCT01238172|stage IIA prostate cancer|stage iia prostate cancer
5513394|NCT01238172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5513395|NCT01238159|Natural killer cell|natural killer cell
5513396|NCT01238159|T cell|t cell
5513397|NCT01238159|Lymphoma|lymphoma
5513398|NCT01238159|Radiation|radiation
5513399|NCT01238159|Chemotherapy|chemotherapy
5513400|NCT01238120|Cancer|cancer
5513401|NCT01238120|Cognitive difficulties|cognitive difficulties
5513402|NCT01238107|Cachexia|cachexia
5513403|NCT01238107|Cancer|cancer
5513404|NCT01238094|colorectal cancer|colorectal cancer
5513405|NCT01238094|simvastatin|simvastatin
5513406|NCT01238094|second-line chemotherapy|second-line chemotherapy
5513407|NCT01238081|Cystic fibrosis|cystic fibrosis
5513408|NCT01238055|advanced gastric cancer|advanced gastric cancer
5513409|NCT01238055|sunitinib|sunitinib
5513410|NCT01238055|docetaxel|docetaxel
5513411|NCT01238055|fluoropyrimidine platinum based chemotherapy|fluoropyrimidine platinum based chemotherapy
5513412|NCT01238029|Dose finding study|dose finding study
5513413|NCT01238029|Combination|combination
5513414|NCT01237990|liver|liver
5513415|NCT01237990|cancer|cancer
5513416|NCT01237990|tumor|tumor
5513417|NCT01237951|Autologous Hematopoietic-Cell Support|autologous hematopoietic-cell support
5513418|NCT01237951|Stem Cell Transplant|stem cell transplant
5513419|NCT01237951|Busulfan|busulfan
5513420|NCT01237951|Myleran|myleran
5513421|NCT01237951|Busulfex|busulfex
5513422|NCT01237951|Gemcitabine|gemcitabine
5513423|NCT01237951|Gemzar|gemzar
5513424|NCT01237951|Melphalan|melphalan
5513425|NCT01237951|Alkeran|alkeran
5513426|NCT01237951|Decadron|decadron
5513427|NCT01237951|Dexamethasone|dexamethasone
5513428|NCT01237951|G-CSF|g-csf
5513429|NCT01237951|Filgrastim|filgrastim
5513430|NCT01237951|Neupogen|neupogen
5513431|NCT01237925|Sunburn|sunburn
5513432|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine
5513434|NCT01237925|Cream|cream
5513435|NCT01237899|Kidney|kidney
5513436|NCT01237899|Renal|renal
5513437|NCT01237886|spontaneous breathing trial|spontaneous breathing trial
5513438|NCT01237886|heart rate variability|heart rate variability
5513439|NCT01237886|respiratory rate variability|respiratory rate variability
5513440|NCT01237873|Aliskiren|aliskiren
5513441|NCT01237873|Amlodipine|amlodipine
5513442|NCT01237873|Essential hypertension|essential hypertension
5513443|NCT01237873|Long term|long term
5513444|NCT01237860|Foot drop|foot drop
5513445|NCT01237860|Thigh muscle weakness|thigh muscle weakness
5513446|NCT01237860|Upper Motor Neuron injury or disease|upper motor neuron injury or disease
5513447|NCT01237847|inflammatory bowel disease|inflammatory bowel disease
5513448|NCT01237847|IBD|ibd
5513449|NCT01237847|Crohn's disease|crohn's disease
5513450|NCT01237847|ulcerative colitis|ulcerative colitis
5513451|NCT01237847|adolescent|adolescent
5513452|NCT01237808|AML|aml
5513453|NCT01237808|NPM1 Mutation|npm1 mutation
5685341|NCT00556491|acute|acute
5513454|NCT01237808|elderly patients (>60 years)|elderly patients (>60 years)
5513455|NCT01237808|unfit for intensive chemotherapy|unfit for intensive chemotherapy
5513456|NCT01237795|Chloramine T|chloramine t
5513457|NCT01237795|Complete Denture|complete denture
5513458|NCT01237795|Dental Plaque Index|dental plaque index
5513459|NCT01237795|Dentifrice|dentifrice
5513460|NCT01237795|Denture Bases|denture bases
5513461|NCT01237795|Denture Cleansers|denture cleansers
5513462|NCT01237795|Edentulous Mouth|edentulous mouth
5513463|NCT01237795|Fluorosurfactant|fluorosurfactant
5495306|NCT01315535|TMD|tmd
5513464|NCT01237795|Oral Health|oral health
5513465|NCT01237795|Toothpaste|toothpaste
5513466|NCT01237782|Candida|candida
5513467|NCT01237782|Complete Denture|complete denture
5513468|NCT01237782|Dental Plaque Index|dental plaque index
5513469|NCT01237782|Denture Bases|denture bases
5513470|NCT01237782|Denture Cleansers|denture cleansers
5513471|NCT01237782|Edentulous Mouth|edentulous mouth
5513472|NCT01237782|Mutans Streptococci|mutans streptococci
5513473|NCT01237782|Oral Health|oral health
5513474|NCT01237782|Propolis|propolis
5513475|NCT01237782|Streptococcus mutans|streptococcus mutans
5513476|NCT01237769|vitamin D|vitamin d
5513477|NCT01237769|Metabolic syndrome|metabolic syndrome
5513478|NCT01237769|Hypertension|hypertension
5513479|NCT01237769|Dyslipidemia|dyslipidemia
5513480|NCT01237769|Dysglycemia|dysglycemia
5513481|NCT01237769|Inflammation|inflammation
5513482|NCT01237756|pediatric anesthesia|pediatric anesthesia
5507560|NCT01263899|SB1518|sb1518
5513483|NCT01237756|endotracheal tube|endotracheal tube
5513484|NCT01237756|electrical impedance tomography|electrical impedance tomography
5513485|NCT01237756|misplacement|misplacement
5513486|NCT01237756|endobronchial|endobronchial
5513488|NCT01237743|Nervous system|nervous system
5513490|NCT01237743|Valves|valves
5513491|NCT01237743|Ultrasonics|ultrasonics
5513492|NCT01237730|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5513493|NCT01237730|peristomal wound infection|peristomal wound infection
5904027|NCT00007813|childhood craniopharyngioma|childhood craniopharyngioma
5513494|NCT01237730|prophylactic antibiotics|prophylactic antibiotics
5513495|NCT01237717|hypertension|hypertension
5513496|NCT01237691|drug use|drug use
5513497|NCT01237691|drug arrests|drug arrests
5513498|NCT01237691|incarceration|incarceration
5513499|NCT01237678|Immunogen|immunogen
5513500|NCT01237678|Lung|lung
5513501|NCT01237678|Small Cell Lung Cancer|small cell lung cancer
5513502|NCT01237678|Carboplatin|carboplatin
5513503|NCT01237678|ADC|adc
5513504|NCT01237665|locally resectable advanced adenocarcinoma of the rectum|locally resectable advanced adenocarcinoma of the rectum
5513505|NCT01237652|Isolated Systolic Hypertension|isolated systolic hypertension
5513506|NCT01237652|Perioperative Myocardial Ischemia|perioperative myocardial ischemia
5513507|NCT01237652|Perioperative Cardiovascular adverse events|perioperative cardiovascular adverse events
5513508|NCT01237639|Red Cells|red cells
5513509|NCT01237639|Transfusion|transfusion
5513510|NCT01237639|Trigger|trigger
5513511|NCT01237639|Threshold|threshold
5513512|NCT01237639|Hematopoietic Stem cell Transplantation|hematopoietic stem cell transplantation
5513513|NCT01237626|Driving|driving
5513514|NCT01237626|Aging|aging
5513515|NCT01237626|Older drivers|older drivers
5513516|NCT01237626|Medical Fitness to drive|medical fitness to drive
5513517|NCT01237626|Health Status|health status
5513518|NCT01237626|At-fault collisions|at-fault collisions
5513519|NCT01237613|Achilles|achilles
5513520|NCT01237613|Rupture|rupture
5513521|NCT01237613|Tendon|tendon
5513522|NCT01237613|Artelon|artelon
5513523|NCT01237600|Ocular surface damage|ocular surface damage
5513524|NCT01237600|Limbal deficiency|limbal deficiency
5513525|NCT01237600|Cultivated corneal epithelial stem cell transplantation|cultivated corneal epithelial stem cell transplantation
5513526|NCT01237587|Adolescents|adolescents
5513527|NCT01237587|Juvenile Primary Fibromyalgia Syndrome|juvenile primary fibromyalgia syndrome
5513528|NCT01237574|Liver Diseases|liver diseases
5513529|NCT01237574|Alcoholic|alcoholic
5513530|NCT01237574|Metabolic Diseases|metabolic diseases
5513531|NCT01237574|cohort|cohort
5513532|NCT01237574|liver disease|liver disease
5513533|NCT01237561|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5513534|NCT01237561|COPD Guidelines|copd guidelines
5513535|NCT01237561|Patient Activation|patient activation
5513536|NCT01237561|Lung Age|lung age
5513537|NCT01237548|water pipe smoking|water pipe smoking
5513538|NCT01237548|acute effect|acute effect
5513539|NCT01237548|Endothelial|endothelial
5513540|NCT01237548|healthy adults who smoke narghile|healthy adults who smoke narghile
5513541|NCT01237535|Unexplained infertility|unexplained infertility
5513542|NCT01237535|Insemination|insemination
5513543|NCT01237535|Luteal phase support|luteal phase support
5513544|NCT01237535|Ovarian stimulation|ovarian stimulation
5513545|NCT01237522|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5513546|NCT01237522|Metabolic Clearance Rate|metabolic clearance rate
5513547|NCT01237522|Pharmacokinetics|pharmacokinetics
5513548|NCT01237522|Pharmacogenetics|pharmacogenetics
5513549|NCT01237509|EEG|eeg
5513550|NCT01237509|Sleep|sleep
5513551|NCT01237509|device|device
5513552|NCT01237509|diabetes|diabetes
5513553|NCT01237509|hypoglycemia|hypoglycemia
5513554|NCT01237483|reirradiation with Erbitux|reirradiation with erbitux
5513555|NCT01237483|HNSCC|hnscc
5513556|NCT01237483|local recurrent inoperable Squamous Cell Cancer of the Head and Neck|local recurrent inoperable squamous cell cancer of the head and neck
5513557|NCT01237470|inguinal hernia|inguinal hernia
5513558|NCT01237470|hernia recurrence|hernia recurrence
5513559|NCT01237470|no mesh techniques|no mesh techniques
5513560|NCT01237470|Desarda technique|desarda technique
5513561|NCT01237444|Lopinavir/ritonavir plus 3TC as a dual therapy regimen.|lopinavir/ritonavir plus 3tc as a dual therapy regimen.
5513562|NCT01237431|Water drinking|water drinking
5513563|NCT01237431|osmoreceptors|osmoreceptors
5513564|NCT01237431|autonomic failure|autonomic failure
5513565|NCT01237431|syncope|syncope
5513566|NCT01237431|blood pressure|blood pressure
5513567|NCT01237431|liver transplant|liver transplant
5513568|NCT01237405|osteoarthritis|osteoarthritis
5513569|NCT01237405|nuclear medicine|nuclear medicine
5513570|NCT01237405|macrophages|macrophages
5513571|NCT01237392|wound debridement|wound debridement
5513572|NCT01237392|requiring debridement|requiring debridement
5513573|NCT01237366|HIV/AIDS|hiv/aids
5513574|NCT01237366|Methamphetamine|methamphetamine
5513576|NCT01237340|Adult Growth Hormone Deficiency (AGHD)|adult growth hormone deficiency (aghd)
5513577|NCT01237340|immunogenicity|immunogenicity
5513578|NCT01237340|growth hormone|growth hormone
5513579|NCT01237340|antibodies|antibodies
5513580|NCT01237340|GH biomarkers|gh biomarkers
5513581|NCT01237340|IGF-I|igf-i
5513582|NCT01237327|Metastatic Breast Cancer|metastatic breast cancer
5513583|NCT01237327|Advanced|advanced
5513584|NCT01237327|Postmenopausal|postmenopausal
5513585|NCT01237327|Exemestane vs Megestrol|exemestane vs megestrol
5513586|NCT01237314|type 2 diabetes|type 2 diabetes
5513587|NCT01237314|metformin|metformin
5513588|NCT01237314|glargine|glargine
5513589|NCT01237314|exenatide|exenatide
5513590|NCT01237314|glycemic impact of food|glycemic impact of food
5513591|NCT01237314|continuous glucose monitoring|continuous glucose monitoring
5513592|NCT01237301|Type 2 Diabetes|type 2 diabetes
5513593|NCT01237301|Continuous Glucose Monitoring|continuous glucose monitoring
5513594|NCT01237275|Pharmacogenomics|pharmacogenomics
5513595|NCT01237275|Prediction of Antidepressant Response|prediction of antidepressant response
5513596|NCT01237275|Depressed Patients|depressed patients
5513597|NCT01237262|psoriasis|psoriasis
5513598|NCT01237262|immune infiltrate|immune infiltrate
5513599|NCT01237262|dendritic cells|dendritic cells
5513600|NCT01237262|cytokine expression|cytokine expression
5513601|NCT01237249|Multiple Myeloma|multiple myeloma
5513603|NCT01237249|Revlimid|revlimid
5513604|NCT01237236|Advanced solid tumor|advanced solid tumor
5513605|NCT01237236|lymphoma|lymphoma
5513606|NCT01237223|Aliskiren|aliskiren
5513607|NCT01237223|Amlodipine|amlodipine
5513608|NCT01237223|Essential hypertension|essential hypertension
5513609|NCT01237210|Parkinson's Disease|parkinson's disease
5513611|NCT01237210|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5513612|NCT01237184|initial dental implant stability|initial dental implant stability
5513613|NCT01237184|maxillary sinus proximity|maxillary sinus proximity
5513614|NCT01237184|bicortical fixation|bicortical fixation
5513615|NCT01237171|Brachytherapy|brachytherapy
5513616|NCT01237171|Lung Brachytherapy|lung brachytherapy
5513617|NCT01237171|NSCLC|nsclc
5513618|NCT01237171|Sub-lobar resection|sub-lobar resection
5513619|NCT01237158|GAD1,|gad1,
5513620|NCT01237158|GAD67,|gad67,
5513621|NCT01237158|bipolar,|bipolar,
5513622|NCT01237158|GABA,|gaba,
5513623|NCT01237158|Glutamate,|glutamate,
5513624|NCT01237158|Reelin,|reelin,
5513625|NCT01237158|Rln,|rln,
5513626|NCT01237158|Spectroscopy|spectroscopy
5513627|NCT01237158|euthymic bipolar I patients|euthymic bipolar i patients
5513628|NCT01237145|pigeon|pigeon
5513629|NCT01237145|bird fancier|bird fancier
5513630|NCT01237145|extrinsic allergic alveolitis|extrinsic allergic alveolitis
5513631|NCT01237145|BAL|bal
5513632|NCT01237145|broncho-alveolar lavage|broncho-alveolar lavage
5513633|NCT01237145|elispot|elispot
5513634|NCT01237145|antigen|antigen
5513635|NCT01237106|PCOS|pcos
5513636|NCT01237106|IVM|ivm
5513637|NCT01237106|Polycystic ovarian syndrome|polycystic ovarian syndrome
5513638|NCT01237106|In Vitro Maturation|in vitro maturation
5513639|NCT01237106|IVF|ivf
5513640|NCT01237093|Fish Diet|fish diet
5513641|NCT01237093|Meat Diet|meat diet
5513642|NCT01237093|Biomarkers|biomarkers
5513643|NCT01237093|Stable Isotopes|stable isotopes
5513644|NCT01237093|Dietary Intake|dietary intake
5513645|NCT01237067|PARP inhibitor, womens's cancers, relapsed, recurrent|parp inhibitor, womens's cancers, relapsed, recurrent
5513646|NCT01237067|Ovarian, breast, endometrial, cervical|ovarian, breast, endometrial, cervical
5513647|NCT01237067|Carboplatin|carboplatin
5513648|NCT01237067|BRCA 1 and BRCA 2|brca 1 and brca 2
5513649|NCT01237054|18-FDG PET/CT|18-fdg pet/ct
5513650|NCT01237054|Abnormal Plasma Cells|abnormal plasma cells
5513651|NCT01237054|Serum Free Light-Chain Abnormality|serum free light-chain abnormality
5513652|NCT01237054|Serum M-Protein|serum m-protein
5513653|NCT01237054|DCE-MRI|dce-mri
5685342|NCT00556491|bypass|bypass
5513654|NCT01237054|Multiple Myeloma|multiple myeloma
5513655|NCT01237054|Smoldering Multiple Myeloma|smoldering multiple myeloma
5513656|NCT01237054|SMM|smm
5513657|NCT01237054|MM|mm
5513658|NCT01237041|Child|child
5513659|NCT01237041|Body Fat|body fat
5513660|NCT01237041|Niacin|niacin
5513661|NCT01237041|Growth Hormone|growth hormone
5513662|NCT01237041|Obesity|obesity
5513663|NCT01237041|Overweight|overweight
5513664|NCT01237041|Growth Hormones|growth hormones
5513665|NCT01237041|Short Stature|short stature
5513666|NCT01237041|Children|children
5513667|NCT01237015|Neonate|neonate
5513668|NCT01237015|Oral feeding|oral feeding
5513669|NCT01237015|Nasal CPAP|nasal cpap
5513670|NCT01237015|Sucking|sucking
5513671|NCT01237015|Swallowing|swallowing
5513672|NCT01237015|Breathing|breathing
5513673|NCT01237002|Liver ischemia; Pringle time|liver ischemia; pringle time
5513674|NCT01236989|anatomical resection|anatomical resection
5513675|NCT01236989|non-anatomical resection|non-anatomical resection
5513676|NCT01236989|IOUS-guided finger compression|ious-guided finger compression
5513677|NCT01236963|Clinical trial|clinical trial
5513678|NCT01236963|Prevention mouthrinse|prevention mouthrinse
5513679|NCT01236963|Dental Floss|dental floss
5513680|NCT01236950|Clinical Trial|clinical trial
5513681|NCT01236950|Prevention Mouthrinse|prevention mouthrinse
5513682|NCT01236937|CT, lung nodule biopsy, Respiration Gated, Lung Cancer|ct, lung nodule biopsy, respiration gated, lung cancer
5513683|NCT01236911|Calcium , TBI,complications, days in hospital|calcium , tbi,complications, days in hospital
5513684|NCT01236898|N-acetylneuraminic acid,|n-acetylneuraminic acid,
5513685|NCT01236898|pharmacokinetics|pharmacokinetics
5513686|NCT01236898|hIBM|hibm
5513687|NCT01236872|Nitrate|nitrate
5513688|NCT01236872|Nitrite|nitrite
5513689|NCT01236872|Vegetable|vegetable
5513690|NCT01236872|Aortic stiffness|aortic stiffness
5513691|NCT01236859|Gabapentin|gabapentin
5513692|NCT01236859|prophylaxis|prophylaxis
5513693|NCT01236859|incidence of pruritus|incidence of pruritus
5513694|NCT01236859|intrathecal morphine|intrathecal morphine
5513695|NCT01236846|Vitamin D fortification|vitamin d fortification
5513696|NCT01236846|Yogurt Drink|yogurt drink
5513697|NCT01236846|Efficacy|efficacy
5513698|NCT01236833|Lactated Ringer's Solution|lactated ringer's solution
5513699|NCT01236833|Isotonic Solution|isotonic solution
5513700|NCT01236833|Intestinal Disease|intestinal disease
5513701|NCT01236833|Feeding Intolerance|feeding intolerance
5513702|NCT01236833|Necrotizing Enterocolitis|necrotizing enterocolitis
5513703|NCT01236833|Newborn|newborn
5513704|NCT01236833|Premature Infant|premature infant
5513705|NCT01236820|L5|l5
5513706|NCT01236820|LDL|ldl
5513707|NCT01236820|Cardiovascular disease|cardiovascular disease
5513708|NCT01236820|Chronic kidney disease|chronic kidney disease
5513709|NCT01236820|Hemodialysis|hemodialysis
5513710|NCT01236807|Adenosine|adenosine
5513711|NCT01236807|Magnetic Resonance Imaging|magnetic resonance imaging
5513712|NCT01236807|MR perfusion|mr perfusion
5513713|NCT01236807|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5513714|NCT01236807|FFR|ffr
5513715|NCT01236807|Pressure wire|pressure wire
5513716|NCT01236807|Coronary Disease|coronary disease
5513717|NCT01236807|Heart Diseases|heart diseases
5513718|NCT01236807|Cardiovascular Diseases|cardiovascular diseases
5513719|NCT01236807|Arteriosclerosis|arteriosclerosis
5513720|NCT01236781|breast cancer|breast cancer
5513721|NCT01236781|screening|screening
5513722|NCT01236781|diagnostics|diagnostics
5513723|NCT01236781|diagnosis|diagnosis
5513724|NCT01236781|high-risk|high-risk
5513725|NCT01236781|breast neoplasms|breast neoplasms
5513726|NCT01236781|digital mammography|digital mammography
5513727|NCT01236781|mammography|mammography
5513728|NCT01236781|tomosynthesis|tomosynthesis
5513729|NCT01236781|dense breasts|dense breasts
5513730|NCT01236781|radiation dose|radiation dose
5513731|NCT01236781|comparison|comparison
5513732|NCT01236781|Hologic|hologic
5513733|NCT01236781|Pennsylvania|pennsylvania
5513734|NCT01236781|Philadelphia|philadelphia
5513735|NCT01236781|breast study|breast study
5513736|NCT01236781|mammo|mammo
5513737|NCT01236781|tomo|tomo
5513738|NCT01236781|mammary|mammary
5513739|NCT01236768|Contraceptive|contraceptive
5513740|NCT01236755|children|children
5513741|NCT01236755|corneal reshaping|corneal reshaping
5513742|NCT01236755|myopia|myopia
5513743|NCT01236755|myopia progression|myopia progression
5513744|NCT01236755|orthokeratology|orthokeratology
5513745|NCT01236742|children|children
5513746|NCT01236742|corneal reshaping|corneal reshaping
5513747|NCT01236742|myopia|myopia
5513748|NCT01236742|myopia progression|myopia progression
5513749|NCT01236742|orthokeratology|orthokeratology
5513750|NCT01236729|knee replacement|knee replacement
5513751|NCT01236729|disability|disability
5513752|NCT01236729|older people|older people
5513753|NCT01236716|squamous cell carcinoma of lung|squamous cell carcinoma of lung
5513754|NCT01236716|Albumin bound paclitaxel|albumin bound paclitaxel
5513755|NCT01236716|chemotherapy|chemotherapy
5513756|NCT01236703|SIRS|sirs
5513757|NCT01236703|Sepsis|sepsis
5513758|NCT01236703|hematological infection score|hematological infection score
5513759|NCT01236690|Transcatheter arterial embolization|transcatheter arterial embolization
5513760|NCT01236690|Cinobufacin injection|cinobufacin injection
5513761|NCT01236690|hepatoma|hepatoma
5513762|NCT01236677|Pathogen|pathogen
5513763|NCT01236664|memory training|memory training
5513764|NCT01236664|mnemonics|mnemonics
5513765|NCT01236664|cognition|cognition
5513766|NCT01236664|work|work
5513767|NCT01236638|Primary Myelofibrosis|primary myelofibrosis
5513768|NCT01236638|Post-Polycythemia Vera|post-polycythemia vera
5513769|NCT01236638|Post-Essential Thrombocythemia|post-essential thrombocythemia
5513770|NCT01236638|CYT387 (momelotinib)|cyt387 (momelotinib)
5513771|NCT01236599|preterm infant, thermoregulation, polyethylene bag|preterm infant, thermoregulation, polyethylene bag
5513772|NCT01236534|Multiple Sclerosis|multiple sclerosis
5513773|NCT01236534|Constipation|constipation
5513774|NCT01236534|Multiple Sclerosis Associated Constipation|multiple sclerosis associated constipation
5513775|NCT01236495|thoracotomy|thoracotomy
5513776|NCT01236495|postoperative pain|postoperative pain
5513777|NCT01236495|spinal morphine|spinal morphine
5513778|NCT01236482|Pregnancy|pregnancy
5513779|NCT01236482|Postpartum hemorrhage|postpartum hemorrhage
5513780|NCT01236482|Uterine tone|uterine tone
5513781|NCT01236482|Oxytocin|oxytocin
5513782|NCT01236482|Ergometrine|ergometrine
5513783|NCT01236482|Pharmacokinetic-pharmacodynamic analysis|pharmacokinetic-pharmacodynamic analysis
5513784|NCT01236456|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5513785|NCT01236456|cyclophosphamide|cyclophosphamide
5513796|NCT01236365|Type 1 diabetes|type 1 diabetes
5513797|NCT01236365|Children|children
5513798|NCT01236365|Statins|statins
5513799|NCT01236365|Hypercholesterolemia|hypercholesterolemia
5513800|NCT01236365|Lipoproteins|lipoproteins
5513801|NCT01236365|C reactive protein|c reactive protein
5513802|NCT01236365|Continuous glucose monitors|continuous glucose monitors
5513803|NCT01236365|Adolescence|adolescence
5513804|NCT01236365|Abdominal magnetic resonance imaging|abdominal magnetic resonance imaging
5513805|NCT01236365|Toll like receptors|toll like receptors
5513806|NCT01236365|Receptors of advanced glycation end products|receptors of advanced glycation end products
5513807|NCT01236365|Nutrition|nutrition
5513808|NCT01236144|Myeloid|myeloid
5513809|NCT01236144|Leukaemia|leukaemia
5513810|NCT01236144|Acute|acute
5513811|NCT01236144|Myelodysplastic|myelodysplastic
5513812|NCT01236144|Pilot|pilot
5513813|NCT01236144|Cardiff|cardiff
5513814|NCT01236144|Haematology|haematology
5513815|NCT01236144|Burnett|burnett
5513816|NCT01236144|AC220|ac220
5513817|NCT01236144|Plerixafor|plerixafor
5513818|NCT01236144|Ganetespib|ganetespib
5513819|NCT01235936|anemia|anemia
5513820|NCT01235936|chronic kidney disease|chronic kidney disease
5513822|NCT01235936|chronic renal insufficiency|chronic renal insufficiency
5513823|NCT01235936|renal impairment|renal impairment
5513824|NCT01235936|erythropoietin|erythropoietin
5513825|NCT01235936|safety|safety
5513826|NCT01235936|efficacy|efficacy
5513827|NCT01235936|tolerability|tolerability
5513828|NCT01235936|pharmacokinetics|pharmacokinetics
5513829|NCT01235923|anemia|anemia
5513830|NCT01235923|transfusions|transfusions
5513831|NCT01235923|erythropoiesis|erythropoiesis
5513832|NCT01235923|neonate|neonate
5513833|NCT01235923|preterm|preterm
5513834|NCT01235832|cholesterol|cholesterol
5513835|NCT01235832|triglycerides|triglycerides
5513836|NCT01235832|low-density lipoprotein|low-density lipoprotein
5513837|NCT01235832|high-density lipoprotein|high-density lipoprotein
5513838|NCT01235832|reverse cholesterol transport|reverse cholesterol transport
5513839|NCT01235819|type 1 diabetes|type 1 diabetes
5513840|NCT01235819|exenatide|exenatide
5513841|NCT01235819|sitagliptin|sitagliptin
5513842|NCT01235793|Relapsed|relapsed
5513843|NCT01235793|Refractory|refractory
5513844|NCT01235793|Primary Central Nervous System B-cell Lymphoma|primary central nervous system b-cell lymphoma
5513845|NCT01235793|Autologous Stem Cell Transplant|autologous stem cell transplant
5513846|NCT01235793|Temozolomide|temozolomide
5513847|NCT01235793|B-Cell Lymphoma|b-cell lymphoma
5513848|NCT01235793|RBEAM|rbeam
5513849|NCT01235793|Conditioning Regimen|conditioning regimen
5513850|NCT01235780|corneal hysteresis, ocular response analyzer|corneal hysteresis, ocular response analyzer
5513851|NCT01236625|Tissue Adhesions|tissue adhesions
5513852|NCT01236625|Adhesiolysis|adhesiolysis
5513853|NCT01236625|Inadvertent enterotomy|inadvertent enterotomy
5513854|NCT01236625|Prospective cohort study|prospective cohort study
5513855|NCT01236625|Quality of life|quality of life
5513856|NCT01236612|Plasmodium|plasmodium
5513857|NCT01236612|falciparum|falciparum
5513858|NCT01236612|malaria|malaria
5513859|NCT01236612|chloroquine|chloroquine
5513860|NCT01236612|immunity|immunity
5513861|NCT01236586|Maximum Tolerated Dose|maximum tolerated dose
5513862|NCT01236586|Toxicity|toxicity
5513863|NCT01236586|Pharmacokinetics|pharmacokinetics
5513864|NCT01236586|NOTCH Signaling Pathway|notch signaling pathway
5513865|NCT01236586|Expression of JAGGED 1 and 2|expression of jagged 1 and 2
5513866|NCT01236586|Cancer|cancer
5513867|NCT01236586|Solid Tumor|solid tumor
5513868|NCT01236586|Brain Tumor|brain tumor
5513869|NCT01236586|Wilms Tumor|wilms tumor
5513870|NCT01236586|Osteosarcoma|osteosarcoma
5513871|NCT01236586|Lymphoma|lymphoma
5513872|NCT01236573|Gene Therapy|gene therapy
5513873|NCT01236573|Immunotherapy|immunotherapy
5513874|NCT01236573|Adoptive Cell Therapy|adoptive cell therapy
5513875|NCT01236573|Metastatic Melanoma|metastatic melanoma
5513876|NCT01236521|Back pain|back pain
5513877|NCT01236521|Care Management|care management
5513878|NCT01236521|Pain|pain
5513879|NCT01236521|Patient outcomes|patient outcomes
5513880|NCT01236521|Patient-center Care|patient-center care
5513881|NCT01236521|Primary care|primary care
5513882|NCT01236508|White Matter Hyperintensity|white matter hyperintensity
5513883|NCT01236508|Stroke|stroke
5513889|NCT01236430|Hyperlipidemia|hyperlipidemia
5513890|NCT01236430|statin|statin
5513891|NCT01236430|Ezetimibe|ezetimibe
5513892|NCT01236430|Zetia|zetia
5513893|NCT01236430|Atorvastatin|atorvastatin
5513894|NCT01236430|Lipitor|lipitor
5513895|NCT01236378|Organ Transplants|organ transplants
5513996|NCT01235806|scaphoid|scaphoid
5513896|NCT01236378|Anti-Rejection Therapy|anti-rejection therapy
5513897|NCT01236378|Pharmacokinetics|pharmacokinetics
5513898|NCT01236352|Advanced Cancer, Various, NOS|advanced cancer, various, nos
5513900|NCT01236313|Cardiac Surgery|cardiac surgery
5513901|NCT01236313|Pulse Pressure|pulse pressure
5513902|NCT01236300|Pancreatic cysts|pancreatic cysts
5513903|NCT01236274|Myocardial Infarction|myocardial infarction
5513904|NCT01236274|Antipsychotic agents|antipsychotic agents
5513905|NCT01236274|Self-controlled case series method|self-controlled case series method
5513906|NCT01236274|General Practice Research Database|general practice research database
5513907|NCT01236274|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5513908|NCT01236274|CALIBER|caliber
5513909|NCT01236261|Fungemia, fungal infection, susceptibility, antifungal|fungemia, fungal infection, susceptibility, antifungal
5513910|NCT01236248|drugs|drugs
5513911|NCT01236248|youth|youth
5513912|NCT01236248|parent|parent
5513913|NCT01236248|computer|computer
5513914|NCT01236248|prevention|prevention
5513915|NCT01236222|commuter cycling|commuter cycling
5513916|NCT01236222|fitness|fitness
5513917|NCT01236222|metabolic syndrome|metabolic syndrome
5513918|NCT01236222|children|children
5513919|NCT01236196|pain|pain
5513920|NCT01236196|chronic pain|chronic pain
5513921|NCT01236196|cognitive therapy|cognitive therapy
5513922|NCT01236196|telehealth|telehealth
5513923|NCT01236183|manual skill|manual skill
5513924|NCT01236183|anesthesia residents|anesthesia residents
5513925|NCT01236170|Amputees|amputees
5513926|NCT01236170|spinal cord injuries|spinal cord injuries
5513927|NCT01236170|quality of life|quality of life
5513928|NCT01236170|satisfaction|satisfaction
5513929|NCT01236170|healthcare disparities|healthcare disparities
5513930|NCT01236170|wheelchairs|wheelchairs
5513931|NCT01236157|Cardiology|cardiology
5513932|NCT01236092|resolution of low back pain|resolution of low back pain
5513933|NCT01236092|show measurable improvement in disc measurement|show measurable improvement in disc measurement
5513934|NCT01236092|conservative therapy vs. surgery in resolving low back pain|conservative therapy vs. surgery in resolving low back pain
5513935|NCT01236066|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5513936|NCT01236066|Rotarix|rotarix
5513937|NCT01236066|RotaTeq|rotateq
5513938|NCT01236066|Gastroenteritis|gastroenteritis
5513939|NCT01236053|renal cancer|renal cancer
5513940|NCT01236053|pancreatic cancer|pancreatic cancer
5513941|NCT01236053|epidemiology|epidemiology
5513942|NCT01236053|renal cell carcinoma|renal cell carcinoma
5513943|NCT01236053|nervous system cancer|nervous system cancer
5513944|NCT01236053|lung cancer|lung cancer
5513945|NCT01236053|breast cancer|breast cancer
5513946|NCT01236053|case-control|case-control
5513947|NCT01236053|GPRD|gprd
5513948|NCT01236053|Gapabentin|gapabentin
5513949|NCT01236053|cancer|cancer
5513950|NCT01236053|anal cancer|anal cancer
5513951|NCT01236053|bone and joint cancer|bone and joint cancer
5513952|NCT01236053|renal pelvis cancer|renal pelvis cancer
5513953|NCT01236053|penis cancer|penis cancer
5513954|NCT01236053|stomach cancer|stomach cancer
5513955|NCT01236053|bladder cancer|bladder cancer
5513956|NCT01236040|H5N1|h5n1
5513957|NCT01236040|Influenza|influenza
5513958|NCT01236040|Pandemic|pandemic
5513959|NCT01236001|Lacosamide|lacosamide
5513960|NCT01236001|Vimpat®|vimpat®
5513961|NCT01235975|Neisseria meningitidis|neisseria meningitidis
5513962|NCT01235975|Meningococcal Vaccines|meningococcal vaccines
5513963|NCT01235975|serogroups A,C, W-135 or Y|serogroups a,c, w-135 or y
5513964|NCT01235975|meningococcal diseases|meningococcal diseases
5513965|NCT01235975|meningococcal conjugate vaccine|meningococcal conjugate vaccine
5513966|NCT01235975|Immunogenicity|immunogenicity
5513967|NCT01235962|anti-angiogenic agent|anti-angiogenic agent
5685343|NCT00556491|cardiac|cardiac
5513968|NCT01235962|renal cell carcinoma|renal cell carcinoma
5513970|NCT01235962|adjuvant therapy|adjuvant therapy
5513971|NCT01235962|VEGFR inhibitor|vegfr inhibitor
5513972|NCT01235949|Pneumococcal vaccine|pneumococcal vaccine
5513973|NCT01235949|Immunogenicity|immunogenicity
5513974|NCT01235949|Safety|safety
5513975|NCT01235949|Fever|fever
5513976|NCT01235949|Primary vaccination|primary vaccination
5513977|NCT01235949|Booster vaccination|booster vaccination
5513978|NCT01235949|Pneumococcal disease|pneumococcal disease
5513979|NCT01235949|Prophylactic antipyretic|prophylactic antipyretic
5513981|NCT01235910|Cardiac transplantation|cardiac transplantation
5513982|NCT01235910|Aliskiren|aliskiren
5513983|NCT01235910|Cyclosporine|cyclosporine
5513984|NCT01235897|Neoplasms|neoplasms
5513985|NCT01235897|Paclitaxel|paclitaxel
5513986|NCT01235897|Trastuzumab|trastuzumab
5513987|NCT01235884|gaseous colic, regurgitation and of constipation|gaseous colic, regurgitation and of constipation
5513988|NCT01235871|Safety|safety
5513989|NCT01235871|Tolerability|tolerability
5513990|NCT01235871|SB1578|sb1578
5513991|NCT01235858|Epidural analgesia|epidural analgesia
5513992|NCT01235858|Epidural anesthesia labor|epidural anesthesia labor
5513993|NCT01235858|Aseptic technique|aseptic technique
5513994|NCT01235858|gown|gown
5513995|NCT01235858|no gown|no gown
5513998|NCT01235806|ESAOTE|esaote
5513999|NCT01235767|birth weight|birth weight
5514000|NCT01235767|prematurity|prematurity
5514001|NCT01235767|gestational age|gestational age
5514002|NCT01235767|low birth weight|low birth weight
5514003|NCT01235767|pregnancy|pregnancy
5514004|NCT01235767|nutrition|nutrition
5514005|NCT01235767|Vietnam|vietnam
5514006|NCT01235754|testosterone|testosterone
5514007|NCT01235754|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5514008|NCT01235754|menopause|menopause
5514009|NCT01235741|Pramlintide|pramlintide
5514010|NCT01235741|Metreleptin|metreleptin
5514011|NCT01235741|Obesity|obesity
5514012|NCT01235741|Amylin|amylin
5514013|NCT01235741|Takeda|takeda
5514014|NCT01235715|osteoarthritis|osteoarthritis
5514015|NCT01235715|total knee replacement|total knee replacement
5514016|NCT01235702|high blood pressure, hypertension, African Americans, perceived stress|high blood pressure, hypertension, african americans, perceived stress
5514017|NCT01235676|obesity|obesity
5514018|NCT01235676|lifestyle|lifestyle
5514019|NCT01235676|pregnancy|pregnancy
5514020|NCT01235676|newborn infant|newborn infant
5514021|NCT01235663|obesity, insulin resistance|obesity, insulin resistance
5514022|NCT01235637|COMFORT B score|comfort b score
5514023|NCT01235637|Bis score|bis score
5514024|NCT01235624|Autosomal dominant retinitis pigmentosa|autosomal dominant retinitis pigmentosa
5514025|NCT01235624|Rare disease|rare disease
5514026|NCT01235624|Genetics|genetics
5514027|NCT01235598|Cimzia®|cimzia®
5514028|NCT01235598|CDP870|cdp870
5514029|NCT01235598|CZP|czp
5514030|NCT01235598|Certolizumab Pegol|certolizumab pegol
5514031|NCT01235598|Rheumatoid Arthritis|rheumatoid arthritis
5514032|NCT01235598|MRI|mri
5514033|NCT01235572|Acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5514034|NCT01235572|Adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5514035|NCT01235572|Adult acute basophilic leukemia|adult acute basophilic leukemia
5514036|NCT01235572|De|de
5514037|NCT01235572|novo myelodysplastic syndromes|novo myelodysplastic syndromes
5514038|NCT01235572|Secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5514039|NCT01235572|Untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5514040|NCT01235546|Pregnancy|pregnancy
5514041|NCT01235546|Cesarean section|cesarean section
5514042|NCT01235546|Antibiotic|antibiotic
5514043|NCT01235546|Infections|infections
5514044|NCT01235533|late-life depression|late-life depression
5514045|NCT01235533|recurrence of depression|recurrence of depression
5514046|NCT01235533|cognition|cognition
5514047|NCT01235533|N-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5514048|NCT01235481|pulmonary rehabilitation|pulmonary rehabilitation
5514049|NCT01235481|exercise therapy|exercise therapy
5514050|NCT01235481|chronic lung disease|chronic lung disease
5514051|NCT01235481|self-efficacy|self-efficacy
5514052|NCT01235468|umbilical cord blood|umbilical cord blood
5514053|NCT01235468|ex vivo expansion|ex vivo expansion
5514054|NCT01235468|engraftment|engraftment
5514055|NCT01235468|GVHD|gvhd
5514056|NCT01235455|Multiple Sclerosis|multiple sclerosis
5514057|NCT01235455|Adherence|adherence
5514058|NCT01235455|Interferon beta-1b|interferon beta-1b
5514059|NCT01235455|Coping styles|coping styles
5514060|NCT01235442|Psoriasis|psoriasis
5514062|NCT01235442|etanercept|etanercept
5514063|NCT01235442|clobetasol propionate|clobetasol propionate
5514064|NCT01235429|Diabetes|diabetes
5514065|NCT01235429|Behavioral intervention|behavioral intervention
5514066|NCT01235429|diabetes self-management|diabetes self-management
5514067|NCT01235429|Native Hawaiians|native hawaiians
5514068|NCT01235429|health disparities|health disparities
5514069|NCT01235403|Epilepsy treatment.|epilepsy treatment.
5514070|NCT01235403|Anti-epileptic drugs|anti-epileptic drugs
5514071|NCT01235403|Seizures|seizures
5514072|NCT01235390|Postmenopausal women|postmenopausal women
5514073|NCT01235390|walnuts|walnuts
5514074|NCT01235377|prescribing patterns|prescribing patterns
5514075|NCT01235377|thiazide|thiazide
5514076|NCT01235377|chlorthalidone|chlorthalidone
5514077|NCT01235377|hydrochlorothiazide|hydrochlorothiazide
5514078|NCT01235377|target dose|target dose
5514079|NCT01235377|cluster randomized trial|cluster randomized trial
5514080|NCT01235364|Foley catheter|foley catheter
5514081|NCT01235364|induction|induction
5514087|NCT01235351|Percutaneous coronary intervention|percutaneous coronary intervention
5514088|NCT01235351|Clopidogrel|clopidogrel
5514089|NCT01235351|Genetics|genetics
5514090|NCT01235351|Platelet Function|platelet function
5514091|NCT01235325|vitamin K|vitamin k
5514092|NCT01235325|supplementation|supplementation
5514093|NCT01235325|bone health indices|bone health indices
5514095|NCT01235325|Crohn's disease|crohn's disease
5514191|NCT01234753|Adults with CHD|adults with chd
5514096|NCT01235286|remote ischemic preconditioning, free flap, microcirculation|remote ischemic preconditioning, free flap, microcirculation
5514097|NCT01235260|REGRANEX (becaplermin)|regranex (becaplermin)
5514098|NCT01235260|Platelet-derived growth factor BB|platelet-derived growth factor bb
5514100|NCT01235260|Cancer incidence|cancer incidence
5514101|NCT01235260|Cancer mortality|cancer mortality
5514102|NCT01235260|Lower Extremity Diabetic Neuropathic Ulcer|lower extremity diabetic neuropathic ulcer
5514103|NCT01235234|Dry eye disease|dry eye disease
5514104|NCT01235234|KCS|kcs
5514105|NCT01235234|Aqueous Deficient Dry Eye|aqueous deficient dry eye
5514106|NCT01235208|Overweight|overweight
5514107|NCT01235208|Obesity|obesity
5514108|NCT01235208|Metabolic syndrome|metabolic syndrome
5514109|NCT01235208|Diet|diet
5514110|NCT01235208|Carbohydrate|carbohydrate
5514111|NCT01235208|Low glycemic index|low glycemic index
5514112|NCT01235208|Eurodiet|eurodiet
5514113|NCT01235195|bioequivalence study|bioequivalence study
5514114|NCT01235195|sertraline 50 mg|sertraline 50 mg
5514115|NCT01235195|capsules vs tablets|capsules vs tablets
5514116|NCT01235182|acute dyspnea|acute dyspnea
5514117|NCT01235182|prehospital emergency setting|prehospital emergency setting
5514118|NCT01235182|differential diagnosis|differential diagnosis
5514119|NCT01235182|ultrasound|ultrasound
5514120|NCT01235182|NT-proBNP|nt-probnp
5514121|NCT01235156|Premature ventricular contraction|premature ventricular contraction
5514122|NCT01235156|Frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia|frequent premature ventricular contraction, with or without a short array of non-sustained ventricular tachycardia
5514123|NCT01235143|incidence|incidence
5514124|NCT01235143|emergence agitation|emergence agitation
5514125|NCT01235143|sevoflurane|sevoflurane
5514126|NCT01235143|desflurane|desflurane
5514127|NCT01235143|ambulatory pediatric surgery|ambulatory pediatric surgery
5514128|NCT01235117|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5514129|NCT01235091|HIV prevention|hiv prevention
5514130|NCT01235091|substance abuse|substance abuse
5514131|NCT01235091|high risk behaviors|high risk behaviors
5514132|NCT01235091|peer intervention|peer intervention
5514133|NCT01235065|airway management|airway management
5514134|NCT01235065|trauma|trauma
5514135|NCT01235065|intubation|intubation
5514136|NCT01235052|Head and neck neoplasms|head and neck neoplasms
5514137|NCT01235052|Positron Emission Tomography|positron emission tomography
5514138|NCT01235052|F18 fluoromisonidazole|f18 fluoromisonidazole
5514139|NCT01235026|Obesity|obesity
5514140|NCT01235026|Type-2 Diabetes|type-2 diabetes
5514141|NCT01235026|Metabolic syndrome|metabolic syndrome
5514142|NCT01235026|Low grade inflammation|low grade inflammation
5514143|NCT01235026|Metabolic endotoxinemia|metabolic endotoxinemia
5514144|NCT01235026|Insulin resistance|insulin resistance
5514145|NCT01235026|Lipopolysaccharide|lipopolysaccharide
5514146|NCT01235026|LPS-binding protein|lps-binding protein
5514147|NCT01235026|sCD14|scd14
5514148|NCT01235026|Synbiotic|synbiotic
5514149|NCT01235026|Oligofructose|oligofructose
5514150|NCT01235026|Bifidobacterium animalis subsp. lactis Bb12|bifidobacterium animalis subsp. lactis bb12
5514151|NCT01235026|probiotic|probiotic
5514152|NCT01235026|Prebiotic|prebiotic
5514153|NCT01235013|HIV-1 infection|hiv-1 infection
5514154|NCT01235013|Maraviroc|maraviroc
5514155|NCT01235013|CD4 lymphocyte count|cd4 lymphocyte count
5514157|NCT01235000|Infant|infant
5514158|NCT01235000|Dose-Response relationship, immunologic|dose-response relationship, immunologic
5514159|NCT01235000|Prime-boost response|prime-boost response
5514160|NCT01234987|Cancer|cancer
5514161|NCT01234987|Breast Cancer|breast cancer
5514162|NCT01234987|Colon cancer|colon cancer
5514163|NCT01234987|Lung Cancer|lung cancer
5514164|NCT01234974|multiple myeloma|multiple myeloma
5514165|NCT01234948|Halitosis|halitosis
5514166|NCT01234948|VSC|vsc
5514167|NCT01234948|Periodontitis|periodontitis
5514168|NCT01234948|Gingivitis|gingivitis
5514169|NCT01234948|Putative periodontal pathogens|putative periodontal pathogens
5514170|NCT01234948|Real-time PCR|real-time pcr
5495959|NCT01312727|Uromodulin|uromodulin
5514171|NCT01234909|Missed immunizations|missed immunizations
5514172|NCT01234896|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5514173|NCT01234883|dehydration|dehydration
5514174|NCT01234883|gastroenteritis|gastroenteritis
5514175|NCT01234870|Myocardial Perfusion Imaging|myocardial perfusion imaging
5514176|NCT01234870|Magnetic Resonance Imaging|magnetic resonance imaging
5514177|NCT01234857|mTOR|mtor
5514178|NCT01234857|breast cancer|breast cancer
5514179|NCT01234857|estrogen receptor positive|estrogen receptor positive
5514180|NCT01234844|pet-therapy|pet-therapy
5514181|NCT01234844|guinea-pigs|guinea-pigs
5514182|NCT01234844|rehabilitation|rehabilitation
5514183|NCT01234844|elderly|elderly
5514184|NCT01234831|MRSA|mrsa
5514185|NCT01234831|colonization|colonization
5514186|NCT01234831|nucleic acid amplification|nucleic acid amplification
5514187|NCT01234831|chromogenic agar|chromogenic agar
5514188|NCT01234818|Endometrial hyperplasia|endometrial hyperplasia
5514189|NCT01234818|LNG-IUS|lng-ius
5514190|NCT01234792|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5514192|NCT01234753|GUCH|guch
5514193|NCT01234753|Congenital heart disease|congenital heart disease
5514194|NCT01234753|Computer-based education|computer-based education
5514195|NCT01234753|Nursing|nursing
5514196|NCT01234740|Los Angeles|los angeles
5514197|NCT01234727|diabetes, SMBG, glucose testing systems, accuracy|diabetes, smbg, glucose testing systems, accuracy
5514198|NCT01234714|Fatty Liver|fatty liver
5514199|NCT01234714|Liver|liver
5514200|NCT01234714|Magnetic Resonance Imaging|magnetic resonance imaging
5514201|NCT01234714|Surgery|surgery
5514202|NCT01234701|Liver|liver
5514203|NCT01234701|Neoplasms|neoplasms
5514204|NCT01234701|Magnetic Resonance Imaging|magnetic resonance imaging
5514205|NCT01234701|Surgery|surgery
5514206|NCT01234701|Pathology|pathology
5514207|NCT01234688|Exercise Tolerance|exercise tolerance
5514208|NCT01234688|Physical Endurance|physical endurance
5514209|NCT01234675|Fibromyalgia|fibromyalgia
5514210|NCT01234675|Sleep disorders|sleep disorders
5514211|NCT01234675|Forest Laboratories|forest laboratories
5514212|NCT01234675|Milnacipran|milnacipran
5514213|NCT01234662|Elective cesarean sections|elective cesarean sections
5514214|NCT01234662|Postoperative pain level|postoperative pain level
5514215|NCT01234662|Spinal anesthesia|spinal anesthesia
5514216|NCT01234662|Combined spinal epidural anesthesia|combined spinal epidural anesthesia
5514217|NCT01234662|Epidural catheter|epidural catheter
5514218|NCT01234649|gestational diabetes mellitus|gestational diabetes mellitus
5514219|NCT01234649|type 2 diabetes mellitus|type 2 diabetes mellitus
5514220|NCT01234649|metabolic dysfunction|metabolic dysfunction
5514221|NCT01234649|impaired fasting glucose|impaired fasting glucose
5514222|NCT01234649|impaired glucose tolerance|impaired glucose tolerance
5514223|NCT01234649|incretin mimetic|incretin mimetic
5514224|NCT01234636|Platelets|platelets
5514225|NCT01234636|Platelet aggregation|platelet aggregation
5514226|NCT01234636|Platelet activation|platelet activation
5514227|NCT01234636|Platelet function|platelet function
5514228|NCT01234636|Light transmission aggregometry|light transmission aggregometry
5514229|NCT01234636|Flow cytometry|flow cytometry
5514230|NCT01234636|Platelet function analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
5514231|NCT01234636|Linoleic acid, conjugated|linoleic acid, conjugated
5514232|NCT01234636|cis9, trans11 conjugated linoleic acid|cis9, trans11 conjugated linoleic acid
5514233|NCT01234636|dietary supplement|dietary supplement
5514234|NCT01234636|short-term intervention|short-term intervention
5514235|NCT01234623|Umbilical cord serum, eyedrops, GVHD, SS-I, corneal healing|umbilical cord serum, eyedrops, gvhd, ss-i, corneal healing
5514236|NCT01234610|Exercise|exercise
5514237|NCT01234610|Aortic aneurysm|aortic aneurysm
5514238|NCT01234610|Feasibility|feasibility
5514239|NCT01234610|Vascular disease|vascular disease
5514240|NCT01234571|Pulmonary hypertension|pulmonary hypertension
5514241|NCT01234571|Remodulin (Treprostenil sodium)|remodulin (treprostenil sodium)
5514242|NCT01234571|End-stage renal disease|end-stage renal disease
5514243|NCT01234571|Hemo-dialysis|hemo-dialysis
5514244|NCT01234558|depression|depression
5514245|NCT01234558|NMDA antagonist|nmda antagonist
5514246|NCT01234558|treatment resistant|treatment resistant
5514247|NCT01234519|ureter cancer|ureter cancer
5514248|NCT01234519|renal pelvis cancer|renal pelvis cancer
5514249|NCT01234519|bladder cancer|bladder cancer
5514251|NCT01234506|long term care|long term care
5514252|NCT01234506|lignans|lignans
5514253|NCT01234506|oxidative stress|oxidative stress
5514254|NCT01234506|inflammation|inflammation
5514256|NCT01234506|dementia|dementia
5514257|NCT01234506|postural balance|postural balance
5514258|NCT01234506|depression|depression
5514259|NCT01234506|muscle weakness|muscle weakness
5514260|NCT01234506|quality of life|quality of life
5514261|NCT01234506|pain|pain
5514262|NCT01234493|ankle; fracture; syndesmosis;|ankle; fracture; syndesmosis;
5514263|NCT01234467|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5514264|NCT01234467|Elderly|elderly
5514265|NCT01234467|Newly Diagnosed|newly diagnosed
5685344|NCT00556491|minocycline|minocycline
5514266|NCT01234467|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5514267|NCT01234467|University of North Carolina|university of north carolina
5514268|NCT01234467|Bendamustine|bendamustine
5514269|NCT01234467|Rituximab|rituximab
5514270|NCT01234467|Rituxan|rituxan
5514271|NCT01234467|Treanda|treanda
5514272|NCT01234467|Phase 2|phase 2
5514273|NCT01234467|Geriatric|geriatric
5514274|NCT01234467|Lymphoma|lymphoma
5514275|NCT01234428|laparoscopy|laparoscopy
5514276|NCT01234428|adjustable gastric banding|adjustable gastric banding
5514277|NCT01234428|morbid obesity|morbid obesity
5514278|NCT01234428|esophageal motility|esophageal motility
5514279|NCT01234428|esophageal dilatation|esophageal dilatation
5514280|NCT01234415|nasal|nasal
5514281|NCT01234415|septum|septum
5514282|NCT01234415|reconstruction|reconstruction
5514283|NCT01234402|Breast Cancer|breast cancer
5514284|NCT01234363|Renal allograft|renal allograft
5514285|NCT01234363|kidney|kidney
5514286|NCT01234363|fibrosis|fibrosis
5514287|NCT01234363|elastography|elastography
5514288|NCT01234363|elasticity|elasticity
5514289|NCT01234337|Breast Cancer|breast cancer
5514290|NCT01234337|HER2-neu|her2-neu
5514291|NCT01234324|Stomach Neoplasms|stomach neoplasms
5514576|NCT01233063|email|email
5514292|NCT01234324|Gastroesophageal Junction Neoplasms|gastroesophageal junction neoplasms
5514293|NCT01234324|gastric cancer|gastric cancer
5514294|NCT01234324|cancer of the gastroesophageal junction|cancer of the gastroesophageal junction
5514295|NCT01234285|sepsis|sepsis
5514296|NCT01234285|septic shock|septic shock
5514297|NCT01234285|anticoagulation|anticoagulation
5514298|NCT01234285|intensive care unit|intensive care unit
5514299|NCT01234272|patients with|patients with
5514300|NCT01234272|undergoing|undergoing
5514301|NCT01234272|gastrectomy|gastrectomy
5514302|NCT01234259|Wrinkles|wrinkles
5514303|NCT01234259|rhytides|rhytides
5514304|NCT01234259|Cellulite|cellulite
5514305|NCT01234259|circumference reduction|circumference reduction
5514306|NCT01234246|Colorectal cancer|colorectal cancer
5514307|NCT01234246|Sexual function|sexual function
5514308|NCT01234246|Sexual dysfunction|sexual dysfunction
5514309|NCT01234246|Quality of (sexual) life|quality of (sexual) life
5514310|NCT01234246|Partners|partners
5514311|NCT01234246|Body image|body image
5514312|NCT01234246|Anxiety (state and trait)|anxiety (state and trait)
5514313|NCT01234246|Depressive symptoms|depressive symptoms
5514314|NCT01234246|Personality|personality
5514315|NCT01234233|hypothermia, accidental|hypothermia, accidental
5514316|NCT01234233|prewarming|prewarming
5514317|NCT01234233|body temperature monitoring|body temperature monitoring
5514318|NCT01234233|preoperative warming|preoperative warming
5514319|NCT01234233|sublingual temperature assessment|sublingual temperature assessment
5514320|NCT01234233|tympanic temperature assessment|tympanic temperature assessment
5514321|NCT01234220|Aldosterone|aldosterone
5514322|NCT01234220|Primary Aldosteronism|primary aldosteronism
5514323|NCT01234220|Aldosterone Producing Adenoma (APA)|aldosterone producing adenoma (apa)
5514324|NCT01234220|Idiopathic Adrenal Hyperplasia (IHA)|idiopathic adrenal hyperplasia (iha)
5514325|NCT01234220|Adrenal Venous Sampling|adrenal venous sampling
5514326|NCT01234207|Progressive addition lenses|progressive addition lenses
5514327|NCT01234207|Customized free-form|customized free-form
5514328|NCT01234207|Presbyopia|presbyopia
5514329|NCT01234207|Bifocals|bifocals
5514330|NCT01234207|Subjective assessment|subjective assessment
5514331|NCT01234207|Visual performance|visual performance
5514332|NCT01234207|Visual acuity|visual acuity
5514333|NCT01234207|Amsler grid|amsler grid
5514334|NCT01234194|Composite Variability Index|composite variability index
5514335|NCT01234194|Bispectral Index|bispectral index
5514336|NCT01234194|Electromyography|electromyography
5514337|NCT01234194|Nociception|nociception
5514338|NCT01234194|Pain|pain
5514339|NCT01234155|Exercise|exercise
5514340|NCT01234155|Diabetes|diabetes
5514341|NCT01234155|Obesity|obesity
5514342|NCT01234155|Insulin Sensitivity|insulin sensitivity
5514343|NCT01234155|Insulin Secretion|insulin secretion
5514344|NCT01234155|Beta-cell Function|beta-cell function
5514345|NCT01234155|Glycemic Control|glycemic control
5514347|NCT01234155|GLP-1|glp-1
5514348|NCT01234142|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch|varenicline transdermal percutaneous transcutaneous transdermal delivery system patch
5514349|NCT01234129|multiple myeloma|multiple myeloma
5514350|NCT01234129|stem cell transplant|stem cell transplant
5514351|NCT01234129|zoledronic acid|zoledronic acid
5514352|NCT01234116|Post exposure prophylaxis|post exposure prophylaxis
5514354|NCT01234103|sexually transmitted infection|sexually transmitted infection
5514355|NCT01234103|sexual risk|sexual risk
5514356|NCT01234103|HIV|hiv
5514357|NCT01234103|young adults|young adults
5514358|NCT01234103|cognitive-behavioral intervention|cognitive-behavioral intervention
5514359|NCT01234090|Aphasia|aphasia
5514360|NCT01234090|Quality of Life|quality of life
5514361|NCT01234077|scheduled for a polysomnogram (overnight sleep study)|scheduled for a polysomnogram (overnight sleep study)
5514362|NCT01234064|Symptomatic Venous Thromboembolism|symptomatic venous thromboembolism
5498765|NCT01301118|Graft Loss|graft loss
5514363|NCT01234064|Graduated Compression Stockings|graduated compression stockings
5514364|NCT01234064|Randomized Controlled Trial|randomized controlled trial
5514365|NCT01234064|Noncardiac Surgery|noncardiac surgery
5514366|NCT01234038|Non-small cell lung cancer|non-small cell lung cancer
5514367|NCT01234025|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5514368|NCT01234012|melanoma|melanoma
5514369|NCT01234012|breast cancer|breast cancer
5514370|NCT01234012|ovarian cancer|ovarian cancer
5514371|NCT01234012|prostate cancer|prostate cancer
5514372|NCT01234012|esophageal cancer|esophageal cancer
5514373|NCT01234012|uterine cancer|uterine cancer
5514374|NCT01234012|sarcoma|sarcoma
5514375|NCT01234012|NY-ESO-1|ny-eso-1
5514376|NCT01233999|Scleroderma|scleroderma
5514377|NCT01233999|Raynaud's Syndrome|raynaud's syndrome
5514378|NCT01233986|Acute Ischemic Stroke|acute ischemic stroke
5514379|NCT01233986|Atherosclerosis|atherosclerosis
5514380|NCT01233986|Apolipoprotein B48|apolipoprotein b48
5514381|NCT01233973|nursing home|nursing home
5514382|NCT01233973|advance care planning|advance care planning
5514383|NCT01233960|Crohn's Disease|crohn's disease
5514384|NCT01233960|Adult Stem Cell Therapy|adult stem cell therapy
5514385|NCT01233960|inflammation of the gastrointestinal tract|inflammation of the gastrointestinal tract
5514386|NCT01233934|Insect bites|insect bites
5514387|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine
5514389|NCT01233934|Cream|cream
5514390|NCT01233882|Renal impairment|renal impairment
5514391|NCT01233882|healthy volunteers|healthy volunteers
5514392|NCT01233869|Bosutinib|bosutinib
5514393|NCT01233869|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5514394|NCT01233843|induction chemotherapy|induction chemotherapy
5514395|NCT01233843|followed by irradiation and concurrent Erbitux, or radiochemotherapy|followed by irradiation and concurrent erbitux, or radiochemotherapy
5514396|NCT01233830|safety, tolerability, pharmacokinetics, AZD2423, Japanese|safety, tolerability, pharmacokinetics, azd2423, japanese
5514397|NCT01233817|Spinal muscular atrophy|spinal muscular atrophy
5514398|NCT01233817|Neuromuscular disorder|neuromuscular disorder
5514399|NCT01233817|Progressive strength training|progressive strength training
5514400|NCT01233817|Children|children
5514401|NCT01233804|influenza vaccination rates|influenza vaccination rates
5514402|NCT01233791|high tone pelvic floor dysfunction|high tone pelvic floor dysfunction
5514403|NCT01233791|levator pain|levator pain
5514404|NCT01233791|dyspareunia|dyspareunia
5514405|NCT01233778|Cardiovascular disease|cardiovascular disease
5514406|NCT01233778|Omega-3 fatty acids|omega-3 fatty acids
5514407|NCT01233778|Inflammation|inflammation
5514408|NCT01233778|Endothelial function|endothelial function
5514409|NCT01233778|Canola oil|canola oil
5514410|NCT01233765|Periodontitis|periodontitis
5514411|NCT01233765|Neutrophil|neutrophil
5514412|NCT01233765|Inflammation|inflammation
5514413|NCT01233752|systemic morphine analgesia|systemic morphine analgesia
5514414|NCT01233752|pharmacogenetics|pharmacogenetics
5514415|NCT01233752|pharmacokinetics|pharmacokinetics
5514416|NCT01233739|rhizarthrosis|rhizarthrosis
5514417|NCT01233739|Chondroitin sulfate|chondroitin sulfate
5514418|NCT01233739|Placebo|placebo
5514419|NCT01233726|Critical illness|critical illness
5514420|NCT01233726|Hyperglycemia|hyperglycemia
5514421|NCT01233726|Mechanical Ventilation|mechanical ventilation
5514422|NCT01233726|Enteral nutrition|enteral nutrition
5514423|NCT01233726|T-Diet plus Diabet IR|t-diet plus diabet ir
5514424|NCT01233726|Malnutrition|malnutrition
5514425|NCT01233726|Insulin resistance|insulin resistance
5514426|NCT01233726|Metabolic stress|metabolic stress
5514427|NCT01233713|Emergency Surgery|emergency surgery
5514428|NCT01233713|Bowel perforation|bowel perforation
5514429|NCT01233713|Diverticulitis|diverticulitis
5514430|NCT01233713|Neoplasms|neoplasms
5514431|NCT01233713|Postoperative Complications|postoperative complications
5514432|NCT01233713|Randomized Controlled Trial|randomized controlled trial
5514433|NCT01233700|living donation|living donation
5514434|NCT01233700|organ donation|organ donation
5514435|NCT01233700|psychological adaptation|psychological adaptation
5514436|NCT01233700|mental health|mental health
5514437|NCT01233700|physical well-being|physical well-being
5514438|NCT01233700|interpersonal relations|interpersonal relations
5514439|NCT01233700|quality of life|quality of life
5514440|NCT01233700|psychosocial factors|psychosocial factors
5514441|NCT01233687|Recurrent|recurrent
5514442|NCT01233687|progressive|progressive
5514443|NCT01233687|advanced|advanced
5514444|NCT01233648|heart failure|heart failure
5514446|NCT01233609|retinitis pigmentosa|retinitis pigmentosa
5514447|NCT01233609|valproic acid|valproic acid
5514448|NCT01233609|visual field|visual field
5514449|NCT01233596|congenital nasolacrimal duct obstruction|congenital nasolacrimal duct obstruction
5514450|NCT01233596|monocanalicular intubation|monocanalicular intubation
5514451|NCT01233596|bicanalicular intubation|bicanalicular intubation
5514452|NCT01233596|complications|complications
5514453|NCT01233583|Regulatory T-cells, psoriasis, IL-10.|regulatory t-cells, psoriasis, il-10.
5514454|NCT01233570|Cutaneous Crohns Disease|cutaneous crohns disease
5514455|NCT01233570|Topical Tacrolimus|topical tacrolimus
5514456|NCT01233570|Protopic|protopic
5514457|NCT01233570|Metastatic Crohns Disease|metastatic crohns disease
5514458|NCT01233570|Pyoderma Gangrenosum|pyoderma gangrenosum
5514459|NCT01233570|Granulomatous chelitis|granulomatous chelitis
5514460|NCT01233570|Oral crohns disease|oral crohns disease
5514461|NCT01233570|Perianal crohns disease|perianal crohns disease
5514462|NCT01233544|Colorectal carcinoma|colorectal carcinoma
5514464|NCT01233544|Stereotactic body radiation therapy|stereotactic body radiation therapy
5514465|NCT01233544|Radiofrequency ablation|radiofrequency ablation
5514466|NCT01233518|CCTA Coronary Artery Disease CAD|ccta coronary artery disease cad
5514467|NCT01233492|adult glioblastoma|adult glioblastoma
5514468|NCT01233492|adult giant cell glioblastoma|adult giant cell glioblastoma
5514469|NCT01233492|adult gliosarcoma|adult gliosarcoma
5514470|NCT01233479|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5514471|NCT01233479|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5514472|NCT01233479|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5514473|NCT01233479|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5514474|NCT01233479|childhood medulloepithelioma|childhood medulloepithelioma
5514475|NCT01233479|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5514476|NCT01233479|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5514477|NCT01233479|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5514478|NCT01233414|Pervasive Developmental Disorder|pervasive developmental disorder
5514479|NCT01233414|Autism|autism
5514480|NCT01233414|Children|children
5514481|NCT01233414|Behavior Therapy|behavior therapy
5514482|NCT01233414|Aggression|aggression
5514483|NCT01233414|Tantrums|tantrums
5514484|NCT01233414|Noncompliance|noncompliance
5514485|NCT01233401|Pertussis, Vaccination, Adult|pertussis, vaccination, adult
5514486|NCT01233375|cancer|cancer
5514487|NCT01233375|metastatic|metastatic
5514488|NCT01233375|pancreatic|pancreatic
5514489|NCT01233375|pancreas|pancreas
5514490|NCT01233375|adenocarcinoma|adenocarcinoma
5514491|NCT01233375|gemcitabine|gemcitabine
5514492|NCT01233375|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5514493|NCT01233375|CO-1.01|co-1.01
5514494|NCT01233375|CO-101|co-101
5514495|NCT01233375|CO101|co101
5514496|NCT01233375|Stage 4|stage 4
5514497|NCT01233375|Stage IV|stage iv
5514498|NCT01233375|Gemcitabine-Refractory|gemcitabine-refractory
5514499|NCT01233375|Second-Line Therapy|second-line therapy
5514500|NCT01233362|Cholera|cholera
5514501|NCT01233362|Vaccine|vaccine
5514502|NCT01233362|Kolkata|kolkata
5514503|NCT01233362|West Bengal|west bengal
5514504|NCT01233362|India|india
5514505|NCT01233362|Immunogenicity|immunogenicity
5514506|NCT01233362|Vaccination Schedules|vaccination schedules
5514507|NCT01233349|overweight|overweight
5514508|NCT01233349|obesity|obesity
5514509|NCT01233349|weight loss|weight loss
5514510|NCT01233349|body fat|body fat
5514511|NCT01233349|waist circumference|waist circumference
5514512|NCT01233349|satiety|satiety
5514513|NCT01233336|ACS,|acs,
5514514|NCT01233336|HGF,|hgf,
5514515|NCT01233336|myocardial infarction|myocardial infarction
5514516|NCT01233336|markers of myocardial injury|markers of myocardial injury
5514517|NCT01233336|acute coronary syndrome (ACS)|acute coronary syndrome (acs)
5514518|NCT01233336|prognostic factors in patients with ACS|prognostic factors in patients with acs
5514519|NCT01233323|Phrenic nerve stimulation|phrenic nerve stimulation
5514520|NCT01233323|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5514521|NCT01233323|Heart Failure|heart failure
5514522|NCT01233323|Heart Diseases|heart diseases
5514523|NCT01233310|Crohn's Disease|crohn's disease
5514524|NCT01233297|wheeze|wheeze
5514525|NCT01233297|infections|infections
5514526|NCT01233271|algorithm|algorithm
5514527|NCT01233271|tight glycemic control|tight glycemic control
5514528|NCT01233271|glucose control|glucose control
5514529|NCT01233271|intensive care|intensive care
5514530|NCT01233271|insulin|insulin
5514531|NCT01233271|ICU|icu
5514532|NCT01233258|Haemophilia treatment|haemophilia treatment
5514533|NCT01233258|rFVIII|rfviii
5514534|NCT01233245|Multiple Sclerosis|multiple sclerosis
5514535|NCT01233245|Adherence|adherence
5514536|NCT01233245|Interferon beta-1b|interferon beta-1b
5514537|NCT01233245|Coping Styles|coping styles
5514538|NCT01233232|Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease|chronic obstructive pulmonary disease, neutrophil, respiratory disease
5514539|NCT01233219|systemic morphine analgesia|systemic morphine analgesia
5514540|NCT01233219|pharmacogenetics|pharmacogenetics
5514541|NCT01233219|pharmacokinetics|pharmacokinetics
5514543|NCT01233206|Polycystic ovary syndrome|polycystic ovary syndrome
5514544|NCT01233206|Cancelled cycles|cancelled cycles
5514545|NCT01233206|OHSS|ohss
5514546|NCT01233206|Infertility|infertility
5514547|NCT01233193|Home blood pressure measurement|home blood pressure measurement
5514548|NCT01233193|Pharmaceutical Services|pharmaceutical services
5514549|NCT01233193|Medication adherence|medication adherence
5514550|NCT01233193|hypertension management|hypertension management
5685345|NCT00556491|prevention|prevention
5514551|NCT01233193|Blood Pressure|blood pressure
5514554|NCT01233180|hyperthermia, induced|hyperthermia, induced
5514555|NCT01233180|touch perception|touch perception
5514556|NCT01233180|randomized controlled trial|randomized controlled trial
5514557|NCT01233167|dual antiplatelet therapy|dual antiplatelet therapy
5514558|NCT01233167|sirolimus drug-eluting stent|sirolimus drug-eluting stent
5514559|NCT01233167|major adverse cardiac events|major adverse cardiac events
5514560|NCT01233167|bleeding|bleeding
5514561|NCT01233141|peripheral artery disease stage IV (Fontaine's classification) or stage 5 and 6 (Rutherford's classification|peripheral artery disease stage iv (fontaine's classification) or stage 5 and 6 (rutherford's classification
5514562|NCT01233102|liver Cirrhosis|liver cirrhosis
5514563|NCT01233102|Mesenchymal stem cells|mesenchymal stem cells
5514564|NCT01233102|Hepatic artery infusion|hepatic artery infusion
5514565|NCT01233102|Intravenous infusion|intravenous infusion
5514566|NCT01233089|Myopia|myopia
5514567|NCT01233089|contact lenses|contact lenses
5514568|NCT01233089|children|children
5514569|NCT01233063|behavior change|behavior change
5514570|NCT01233063|physical activity|physical activity
5514571|NCT01233063|nutrition|nutrition
5514572|NCT01233063|fruits and vegetables|fruits and vegetables
5514573|NCT01233063|saturated fat|saturated fat
5514574|NCT01233063|trans fat|trans fat
5514575|NCT01233063|added sugars|added sugars
5514578|NCT01233063|obesity|obesity
5514579|NCT01233063|aging|aging
5514580|NCT01233050|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision|undergoing elective colon and /or rectal surgical procedures involving an abdominal incision
5514581|NCT01233024|Adult|adult
5514582|NCT01233024|Women|women
5514583|NCT01233024|Dietary Fiber|dietary fiber
5514584|NCT01233024|Satiety Response|satiety response
5514585|NCT01233024|Food Intake|food intake
5514586|NCT01233011|Intubating laryngeal airway|intubating laryngeal airway
5514587|NCT01233011|Pediatric|pediatric
5514588|NCT01233011|Observational study|observational study
5514589|NCT01232998|Patient Satisfaction|patient satisfaction
5514590|NCT01232985|Atopic Dermatitis|atopic dermatitis
5514591|NCT01232985|Pruritus|pruritus
5514592|NCT01232972|vitrification|vitrification
5514593|NCT01232972|egg freezing|egg freezing
5514594|NCT01232972|oocyte cryopreservation|oocyte cryopreservation
5514595|NCT01232972|female fertility potential|female fertility potential
5514596|NCT01232972|fertility preservation|fertility preservation
5514597|NCT01232972|Fertility preservation, female|fertility preservation, female
5514598|NCT01232959|Gallbladder removal|gallbladder removal
5514599|NCT01232946|Diabetes|diabetes
5514600|NCT01232946|Myocardial metabolism|myocardial metabolism
5514601|NCT01232933|PICC|picc
5514602|NCT01232920|uveitis|uveitis
5514603|NCT01232920|antimetabolite|antimetabolite
5514604|NCT01232920|immunosuppressive|immunosuppressive
5514605|NCT01232920|clinical trial|clinical trial
5514606|NCT01232907|Spinal Cord Injury (SCI)|spinal cord injury (sci)
5514607|NCT01232894|indacaterol|indacaterol
5514608|NCT01232894|COPD|copd
5514609|NCT01232894|Long-acting beta2-agonist (LABA)|long-acting beta2-agonist (laba)
5514610|NCT01232868|Innate immunity|innate immunity
5514611|NCT01232868|Adaptive immunity|adaptive immunity
5514612|NCT01232868|Slu shot|slu shot
5514613|NCT01232868|Elderly|elderly
5514614|NCT01232855|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5514615|NCT01232855|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5514616|NCT01232855|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5514617|NCT01232855|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5514618|NCT01232855|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5514619|NCT01232855|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5514620|NCT01232855|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5514621|NCT01232842|adult acute myeloid leukemia|adult acute myeloid leukemia
5514622|NCT01232842|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5514623|NCT01232803|Rectal Microbicides|rectal microbicides
5514624|NCT01232803|Tenofovir|tenofovir
5514625|NCT01232803|Rectal use|rectal use
5514626|NCT01232803|Rectal mucosal damage|rectal mucosal damage
5514627|NCT01232790|Schizophrenia|schizophrenia
5514628|NCT01232790|working memory|working memory
5514629|NCT01232790|N-Acetylcysteine|n-acetylcysteine
5514630|NCT01232777|Retinopathy of Prematurity|retinopathy of prematurity
5514631|NCT01232777|Bevacizumab|bevacizumab
5514632|NCT01232777|Avastin|avastin
5514633|NCT01232777|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5514634|NCT01232751|health|health
5514635|NCT01232751|women|women
5514636|NCT01232725|BSID III|bsid iii
5514637|NCT01232725|Human Milk|human milk
5514638|NCT01232725|Donor Human Milk|donor human milk
5514639|NCT01232725|Preterm infant|preterm infant
5514640|NCT01232725|Breastfeeding|breastfeeding
5514641|NCT01232712|MUC1|muc1
5514642|NCT01232712|ImMucin|immucin
5514643|NCT01232712|Vaccine|vaccine
5514646|NCT01232699|weight loss|weight loss
5514647|NCT01232699|internet treatment|internet treatment
5514648|NCT01232699|motivational interviewing|motivational interviewing
5514649|NCT01232686|Communicable Diseases|communicable diseases
5514650|NCT01232686|Epidemiology|epidemiology
5514651|NCT01232686|Population surveillance|population surveillance
5514652|NCT01232686|Computerized Medical Record|computerized medical record
5514653|NCT01232686|Data collection|data collection
5514654|NCT01232673|Critical Limb Ischemia|critical limb ischemia
5514655|NCT01232673|Bone-Marrow Aspiration Concentrate|bone-marrow aspiration concentrate
5514656|NCT01232673|Diabetes Mellitus|diabetes mellitus
5514657|NCT01232673|Major Amputation|major amputation
5514658|NCT01232647|osteoporosis|osteoporosis
5514660|NCT01232647|BONE MINERAL DENSITY|bone mineral density
5514661|NCT01232647|BIOCHEMICAL MARKERS OF BONE TURNOVER|biochemical markers of bone turnover
5514662|NCT01232634|pediatrics|pediatrics
5514663|NCT01232634|haemophilia|haemophilia
5514664|NCT01232634|ultrasound|ultrasound
5514666|NCT01232634|arthropathy|arthropathy
5514667|NCT01232608|Coronary Artery Disease|coronary artery disease
5514668|NCT01232608|Atherosclerosis.|atherosclerosis.
5514669|NCT01232608|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5514670|NCT01232608|Exercise|exercise
5514671|NCT01232608|HbA1c|hba1c
5514672|NCT01232608|Carotid Atherosclerotic Disease|carotid atherosclerotic disease
5514673|NCT01232608|Inflammation|inflammation
5514674|NCT01232595|Clostridium difficile,|clostridium difficile,
5514675|NCT01232595|C. difficile,|c. difficile,
5514676|NCT01232595|CDI,|cdi,
5514677|NCT01232595|Clostridium difficile-associated disease,|clostridium difficile-associated disease,
5514678|NCT01232595|CDAD,|cdad,
5514679|NCT01232595|pseudomembranous colitis,|pseudomembranous colitis,
5514680|NCT01232595|PMC,|pmc,
5514681|NCT01232595|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5514682|NCT01232582|Lower back pain, Facets joints Osteoarthritis|lower back pain, facets joints osteoarthritis
5514683|NCT01232556|inotuzumab ozogamicin|inotuzumab ozogamicin
5514684|NCT01232556|aggressive Non-Hodgkin lymphoma|aggressive non-hodgkin lymphoma
5514685|NCT01232556|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5514686|NCT01232556|relapsed/refractory lymphoma|relapsed/refractory lymphoma
5514687|NCT01232543|Atopic Dermatitis|atopic dermatitis
5514688|NCT01232530|Malria, ACT, Safety, Efficacy, pregarnancy|malria, act, safety, efficacy, pregarnancy
5514689|NCT01232504|Allo-HSCT|allo-hsct
5514690|NCT01232504|rhGM-CSF|rhgm-csf
5514691|NCT01232504|Systemic fungal infection (SFI)|systemic fungal infection (sfi)
5514692|NCT01232478|Cystic Fibrosis|cystic fibrosis
5514693|NCT01232478|Adherence|adherence
5514694|NCT01232478|Problem-Solving|problem-solving
5514695|NCT01232478|Adolescents|adolescents
5514696|NCT01232478|Education|education
5514697|NCT01232478|Skills Remediation|skills remediation
5514698|NCT01232465|sperm DNA integrity|sperm dna integrity
5514699|NCT01232465|Toluidine blue assay (TBA)|toluidine blue assay (tba)
5514700|NCT01232465|IVF outcome|ivf outcome
5514701|NCT01232452|lung cancer|lung cancer
5514702|NCT01232452|advanced|advanced
5514703|NCT01232452|non-small cell|non-small cell
5514704|NCT01232413|Thorough QT (TQT)|thorough qt (tqt)
5514705|NCT01232413|ASP1941|asp1941
5514706|NCT01232400|subarachnoid hemorrhage|subarachnoid hemorrhage
5514707|NCT01232400|esmolol|esmolol
5514708|NCT01232400|cardiac function|cardiac function
5514709|NCT01232400|cardiac electrophysiology|cardiac electrophysiology
5514710|NCT01232387|Fetomaternal hemorrhage|fetomaternal hemorrhage
5514711|NCT01232387|neonatal anemia|neonatal anemia
5514712|NCT01232387|perinatal epidemiology|perinatal epidemiology
5514713|NCT01232387|Kleihauer-Betke|kleihauer-betke
5514714|NCT01232387|flow cytometry|flow cytometry
5514715|NCT01232374|Nimotuzumab|nimotuzumab
5514716|NCT01232374|local advanced esophageal squamous cell carcinoma|local advanced esophageal squamous cell carcinoma
5514717|NCT01232374|chemo-irradiation|chemo-irradiation
5514718|NCT01232361|ADHD|adhd
5514719|NCT01232361|HIV|hiv
5514720|NCT01232361|Pharmacokinetics|pharmacokinetics
5514721|NCT01232348|bronchial asthma|bronchial asthma
5514722|NCT01232348|Symbicort|symbicort
5514723|NCT01232335|bronchial asthma|bronchial asthma
5514724|NCT01232335|Symbicort|symbicort
5514725|NCT01232335|long term use,|long term use,
5514726|NCT01232322|bronchial asthma|bronchial asthma
5514727|NCT01232322|Pulmicort Respules|pulmicort respules
5514728|NCT01232322|long term use|long term use
5514729|NCT01232322|pediatrics|pediatrics
5514730|NCT01232309|Arterial Health|arterial health
5514731|NCT01232309|Fiber|fiber
5514732|NCT01232309|Chitin-glucan|chitin-glucan
5514733|NCT01232309|oxidized LDL|oxidized ldl
5514734|NCT01232296|Hepatocellular Carcinoma|hepatocellular carcinoma
5514735|NCT01232296|HCC|hcc
5514736|NCT01232296|Liver cancer|liver cancer
5514737|NCT01232296|Child Pugh A|child pugh a
5514738|NCT01232296|HCC Stage C|hcc stage c
5514739|NCT01232257|Chronic kidney disease|chronic kidney disease
5514740|NCT01232257|Chronic kidney failure|chronic kidney failure
5514741|NCT01232257|End stage kidney disease|end stage kidney disease
5514742|NCT01232257|End stage renal disease|end stage renal disease
5514743|NCT01232257|Hydrogen sulfide|hydrogen sulfide
5514744|NCT01232257|N-acetylcysteine|n-acetylcysteine
5514745|NCT01232257|Acetylcysteine|acetylcysteine
5514746|NCT01232244|Incretin hormones|incretin hormones
5514748|NCT01232244|Satiety|satiety
5514749|NCT01232244|Hunger|hunger
5514750|NCT01232244|Energy expenditure|energy expenditure
5514751|NCT01232231|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5514752|NCT01232231|decolonization|decolonization
5514753|NCT01232231|random allocation|random allocation
5514755|NCT01232218|Cerebral Vascular Accident|cerebral vascular accident
5514756|NCT01232218|Stroke|stroke
5514757|NCT01232218|Hemiplegic|hemiplegic
5514759|NCT01232218|range of motion|range of motion
5514760|NCT01232218|scapula|scapula
5514761|NCT01232218|mobilization|mobilization
5514762|NCT01232205|antioxidant supplementation|antioxidant supplementation
5514763|NCT01232205|preeclampsia|preeclampsia
5514764|NCT01232153|chest tube|chest tube
5514765|NCT01232153|preoxygenation|preoxygenation
5514766|NCT01232153|NIV|niv
5514767|NCT01232153|out-of-hospital|out-of-hospital
5514768|NCT01232153|patients needing tracheal chest tube managed by Medical Mobile Emergency rescue services|patients needing tracheal chest tube managed by medical mobile emergency rescue services
5514769|NCT01232140|COPD|copd
5514775|NCT01232101|covered, uncovered, palliative treatment, stent|covered, uncovered, palliative treatment, stent
5514777|NCT01232088|standardized drug syringe labelling|standardized drug syringe labelling
5514778|NCT01232088|European ICU|european icu
5514779|NCT01232075|Letrozole ,Clomiphene citrate , IUI,unexplained infertility|letrozole ,clomiphene citrate , iui,unexplained infertility
5514780|NCT01232062|breast neoplasm|breast neoplasm
5514781|NCT01232062|Neoplasm Metastasis|neoplasm metastasis
5514782|NCT01232062|Drug Therapy|drug therapy
5514783|NCT01232049|healthy volunteers|healthy volunteers
5514784|NCT01232036|healthy volunteers|healthy volunteers
5514785|NCT01232023|Indobufen|indobufen
5514786|NCT01232023|healthy volunteers|healthy volunteers
5514787|NCT01232010|SK-3530|sk-3530
5514788|NCT01232010|renal impairment|renal impairment
5514789|NCT01232010|healthy volunteers|healthy volunteers
5514790|NCT01231997|Udenafil|udenafil
5514791|NCT01231997|DA-8159|da-8159
5514792|NCT01231997|renal impairment|renal impairment
5514793|NCT01231997|healthy volunteers|healthy volunteers
5514794|NCT01231984|diabetes|diabetes
5514795|NCT01231984|obesity|obesity
5514796|NCT01231984|hypoglycemia|hypoglycemia
5514797|NCT01231984|hyperglycemia|hyperglycemia
5514798|NCT01231984|pen needle|pen needle
5514799|NCT01231971|amyloid|amyloid
5514800|NCT01231971|plaques|plaques
5514801|NCT01231971|neuroimaging|neuroimaging
5514802|NCT01231971|biomarkers|biomarkers
5514803|NCT01231971|cognition disorder|cognition disorder
5514804|NCT01231971|early detection|early detection
5514805|NCT01231971|Amnestic MCI|amnestic mci
5514806|NCT01231971|pre-dementia|pre-dementia
5514807|NCT01231971|dementia|dementia
5514808|NCT01231971|Alzheimer's disease|alzheimer's disease
5514809|NCT01231971|tau|tau
5514810|NCT01231958|Puerto Rican; CVD; Hispanic; health disparities; allostatic load; diet|puerto rican; cvd; hispanic; health disparities; allostatic load; diet
5514811|NCT01231945|Cervical Cancer|cervical cancer
5514812|NCT01231945|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5514813|NCT01231945|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5514820|NCT01231893|human, spinal cord injury, olfactory ensheathing cells, transplantation|human, spinal cord injury, olfactory ensheathing cells, transplantation
5514821|NCT01231880|Malaria|malaria
5514822|NCT01231867|Coronary Heart Disease|coronary heart disease
5514823|NCT01231867|Acute Coronary Syndrome|acute coronary syndrome
5514824|NCT01231867|Drug interactions|drug interactions
5514825|NCT01231867|Clopidogrel|clopidogrel
5514826|NCT01231867|Proton Pump Inhibitors|proton pump inhibitors
5514827|NCT01231867|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5514828|NCT01231854|atopic hand dermatitis|atopic hand dermatitis
5514829|NCT01231854|Chronic hand dermatitis|chronic hand dermatitis
5514830|NCT01231828|sleep|sleep
5514831|NCT01231828|cirrhosis|cirrhosis
5514832|NCT01231828|encephalopathy|encephalopathy
5514833|NCT01231828|simulated driving|simulated driving
5514834|NCT01231828|sleep disorders|sleep disorders
5514835|NCT01231815|Heart transplantation|heart transplantation
5514836|NCT01231789|cardiac surgery|cardiac surgery
5514837|NCT01231789|RIPC|ripc
5514838|NCT01231789|brain injury|brain injury
5514839|NCT01231776|cardiopulmonary bypass|cardiopulmonary bypass
5514840|NCT01231776|sleep|sleep
5514842|NCT01231763|HIV prevention|hiv prevention
5514843|NCT01231763|Vaginal film|vaginal film
5514844|NCT01231763|Microbicide|microbicide
5514845|NCT01231763|Administration, intravaginal|administration, intravaginal
5514846|NCT01231737|Prophylasy|prophylasy
5514847|NCT01231737|recurrent urinary tract infection|recurrent urinary tract infection
5514848|NCT01231737|prulifloxacin|prulifloxacin
5514849|NCT01231737|phosphomycin|phosphomycin
5514850|NCT01231711|depression|depression
5514851|NCT01231711|post traumatic stress syndrome|post traumatic stress syndrome
5514853|NCT01231711|veteran|veteran
5514854|NCT01231711|military|military
5514855|NCT01231711|stigma|stigma
5514856|NCT01231711|mental health self-efficacy|mental health self-efficacy
5514857|NCT01231698|septic shock|septic shock
5514858|NCT01231698|esmolol|esmolol
5514859|NCT01231698|tachycardia|tachycardia
5514860|NCT01231698|betablockers|betablockers
5508916|NCT01257893|aspirin|aspirin
5496661|NCT01309659|over 65|over 65
5514865|NCT01231659|RAD001 (Everolimus)|rad001 (everolimus)
5514866|NCT01231659|Letrozole|letrozole
5514867|NCT01231659|Breast cancer|breast cancer
5514868|NCT01231659|Metastatic Breast cancer|metastatic breast cancer
5514869|NCT01231659|Estrogen receptor positive|estrogen receptor positive
5514870|NCT01231659|Failure of Tamoxifen|failure of tamoxifen
5514871|NCT01231659|Anastrozole or Examestane|anastrozole or examestane
5514872|NCT01231646|Folate Receptor Autoantibodies|folate receptor autoantibodies
5514873|NCT01231646|Epilepsy|epilepsy
5514874|NCT01231646|Psychiatric conditions|psychiatric conditions
5514875|NCT01231633|Macular Edema|macular edema
5514876|NCT01231633|Central Retinal Vein Occlusion|central retinal vein occlusion
5514877|NCT01231620|Seasonal Influenza|seasonal influenza
5514878|NCT01231620|Pandemic|pandemic
5514879|NCT01231620|Orthomyxoviridae Infections|orthomyxoviridae infections
5514880|NCT01231620|Influenza|influenza
5514881|NCT01231620|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5514882|NCT01231620|Enzyme Inhibitors|enzyme inhibitors
5514883|NCT01231620|Influenza, seasonal|influenza, seasonal
5514884|NCT01231620|Respiratory Tract Diseases|respiratory tract diseases
5514885|NCT01231620|Zanamivir|zanamivir
5514886|NCT01231620|Pharmacologic Actions|pharmacologic actions
5514887|NCT01231620|Antiviral Agents|antiviral agents
5514888|NCT01231620|Anti-Infective Agents|anti-infective agents
5514890|NCT01231620|Neuraminidase inhibitor|neuraminidase inhibitor
5514891|NCT01231620|Influenza B virus|influenza b virus
5514892|NCT01231594|BRAF Inhibitor|braf inhibitor
5514893|NCT01231594|Cancer|cancer
5514894|NCT01231594|Safety|safety
5514895|NCT01231594|GSK2118436|gsk2118436
5514896|NCT01231594|BRAF mutation positive tumors|braf mutation positive tumors
5514897|NCT01231568|food effect; high fat meal|food effect; high fat meal
5514898|NCT01231568|GSK2118436|gsk2118436
5514899|NCT01231568|pharmacokinetic|pharmacokinetic
5514900|NCT01231568|particle size|particle size
5514901|NCT01231568|BRAF inhibitor|braf inhibitor
5514902|NCT01231568|BRAF positive tumor|braf positive tumor
5514903|NCT01231555|antiretroviral|antiretroviral
5514904|NCT01231555|HAART|haart
5514905|NCT01231555|NNRTI|nnrti
5514906|NCT01231555|emtricitabine|emtricitabine
5514907|NCT01231555|Sexually Transmitted Disease|sexually transmitted disease
5514908|NCT01231555|antiretroviral therapy (ART)-naive adults|antiretroviral therapy (art)-naive adults
5514909|NCT01231555|Immunologic Deficiency Syndrome|immunologic deficiency syndrome
5514910|NCT01231555|tenofovir|tenofovir
5514911|NCT01231555|abacavir|abacavir
5514912|NCT01231555|Retroviridae Infections|retroviridae infections
5514913|NCT01231555|GSK2248761|gsk2248761
5514914|NCT01231555|lamivudine|lamivudine
5514915|NCT01231555|Acquired ImmunoDeficiency Syndrome (AIDS)|acquired immunodeficiency syndrome (aids)
5514916|NCT01231555|HIV infection|hiv infection
5514917|NCT01231555|efavirenz|efavirenz
5514918|NCT01231542|GSK1349572|gsk1349572
5514919|NCT01231542|pharmacokinetics|pharmacokinetics
5514920|NCT01231542|dolutegravir|dolutegravir
5514921|NCT01231542|integrase|integrase
5514922|NCT01231542|rifabutin|rifabutin
5514923|NCT01231542|rifampin|rifampin
5514924|NCT01231516|ART-experienced|art-experienced
5514925|NCT01231516|Integrase inhibitor|integrase inhibitor
5514926|NCT01231516|Raltegravir|raltegravir
5514927|NCT01231516|GSK1349572|gsk1349572
5514928|NCT01231516|Integrase inhibitor naive|integrase inhibitor naive
5514929|NCT01231503|Africa|africa
5514930|NCT01231503|malaria vaccine|malaria vaccine
5514931|NCT01231503|schedule|schedule
5514933|NCT01231503|Plasmodium falciparum|plasmodium falciparum
5514934|NCT01231477|anaesthetic techniques, inhalation|anaesthetic techniques, inhalation
5514935|NCT01231477|sevoflurane|sevoflurane
5514936|NCT01231477|Cytokines|cytokines
5514937|NCT01231477|Immune response|immune response
5514938|NCT01231464|safety|safety
5514939|NCT01231464|efficacy|efficacy
5514940|NCT01231464|placebo|placebo
5514941|NCT01231464|allergic rhinitis|allergic rhinitis
5514942|NCT01231464|fluticasone furoate|fluticasone furoate
5514948|NCT01231425|lumbalgia|lumbalgia
5514949|NCT01231425|acupuncture|acupuncture
5514950|NCT01231386|Female Breast Cancer|female breast cancer
5514951|NCT01231386|miRNA expression|mirna expression
5514952|NCT01231386|Neoadjuvant/Adjuvant Treatment|neoadjuvant/adjuvant treatment
5514953|NCT01231386|Locally and Inflammatory Breast Cancer|locally and inflammatory breast cancer
5514954|NCT01231373|varicose veins|varicose veins
5514955|NCT01231360|claudication|claudication
5514956|NCT01231360|peripheral artery disease|peripheral artery disease
5514958|NCT01231347|pancreas|pancreas
5514959|NCT01231347|gemcitabine|gemcitabine
5514960|NCT01231347|metastatic|metastatic
5509015|NCT01257529|bioavailability|bioavailability
5509016|NCT01257529|bioequivalence|bioequivalence
5509017|NCT01257516|pregabalin|pregabalin
5514964|NCT01231256|preventive health consultation|preventive health consultation
5514965|NCT01231256|General practice|general practice
5514967|NCT01231256|life style|life style
5515063|NCT01230840|calcium|calcium
5515064|NCT01230840|magnesium|magnesium
5514968|NCT01231243|tooth bleaching, bleaching agent, hydrogen peroxide|tooth bleaching, bleaching agent, hydrogen peroxide
5496764|NCT01309256|registry|registry
5514969|NCT01231230|asthma, corticosteroids, bronchodilator, airway blood flow|asthma, corticosteroids, bronchodilator, airway blood flow
5514970|NCT01231204|Breast Cancer|breast cancer
5514971|NCT01231204|Mastectomy|mastectomy
5514972|NCT01231204|UCSD|ucsd
5514973|NCT01231204|Surgery|surgery
5514974|NCT01231204|PVB Catheter|pvb catheter
5514975|NCT01231204|Paravertebral Catheter|paravertebral catheter
5514976|NCT01231204|Breast Pain|breast pain
5514977|NCT01231204|Mastectomy Pain|mastectomy pain
5514978|NCT01231204|Postoperative Pain|postoperative pain
5514979|NCT01231139|Brain Injury|brain injury
5514980|NCT01231139|Temperature|temperature
5514981|NCT01231139|Paracetamol|paracetamol
5514982|NCT01231139|Phase 2|phase 2
5514983|NCT01231139|TBI|tbi
5514984|NCT01231126|Induced labor|induced labor
5514985|NCT01231126|Misoprostol|misoprostol
5514986|NCT01231126|Postpartum blood|postpartum blood
5514987|NCT01231126|Erythrocyte indices|erythrocyte indices
5514988|NCT01231126|Vaginal delivery|vaginal delivery
5514989|NCT01231113|malaria,|malaria,
5514990|NCT01231113|pregnancy,|pregnancy,
5514991|NCT01231113|dihydroartemisinin-piperaquine,|dihydroartemisinin-piperaquine,
5514992|NCT01231113|efficacy,|efficacy,
5514993|NCT01231113|safety,|safety,
5514994|NCT01231113|Ghana|ghana
5514995|NCT01231087|energy expenditure|energy expenditure
5514996|NCT01231087|morbid obesity|morbid obesity
5514997|NCT01231087|bariatric surgery|bariatric surgery
5514998|NCT01231087|nutritional follow-up|nutritional follow-up
5514999|NCT01231074|obesity|obesity
5515000|NCT01231074|weight gain|weight gain
5515001|NCT01231074|metformin|metformin
5515002|NCT01231074|psychotropic drugs|psychotropic drugs
5515003|NCT01231061|spine metastasis|spine metastasis
5515004|NCT01231061|SBRT|sbrt
5515005|NCT01231061|Radiosurgery|radiosurgery
5515006|NCT01231035|acute cardiac syndrome|acute cardiac syndrome
5515007|NCT01231035|stent thrombosis|stent thrombosis
5515008|NCT01231035|platelet function|platelet function
5515009|NCT01231035|antiplatelet therapy|antiplatelet therapy
5515010|NCT01231022|breast neoplasm|breast neoplasm
5515011|NCT01231022|Neoplasm Metastasis|neoplasm metastasis
5515012|NCT01231022|Stem Cells|stem cells
5515013|NCT01231022|Drug-Induced Liver Injury|drug-induced liver injury
5515014|NCT01230996|cervical adenocarcinoma|cervical adenocarcinoma
5515015|NCT01230996|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5515016|NCT01230996|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5515017|NCT01230996|stage IB cervical cancer|stage ib cervical cancer
5515018|NCT01230996|stage IIA cervical cancer|stage iia cervical cancer
5515019|NCT01230996|stage IIB cervical cancer|stage iib cervical cancer
5515020|NCT01230996|stage III cervical cancer|stage iii cervical cancer
5515021|NCT01230996|stage IVA cervical cancer|stage iva cervical cancer
5515022|NCT01230983|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5515023|NCT01230983|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5515024|NCT01230983|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5515025|NCT01230983|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5515026|NCT01230983|cardiac toxicity|cardiac toxicity
5515027|NCT01230957|Clostridium difficile infection|clostridium difficile infection
5515028|NCT01230957|Diarrhea|diarrhea
5515029|NCT01230957|Pseudomembranous colitis|pseudomembranous colitis
5517679|NCT01218971|Alcohol Dependence|alcohol dependence
5515030|NCT01230957|Clostridium Difficile Toxoid Vaccine|clostridium difficile toxoid vaccine
5515031|NCT01230957|ACAM-CDIFF™ vaccine|acam-cdiff™ vaccine
5515032|NCT01230944|GERD|gerd
5515033|NCT01230944|LNF|lnf
5515034|NCT01230944|CNF|cnf
5515035|NCT01230944|Laparoscopic Nissen fundoplication|laparoscopic nissen fundoplication
5515036|NCT01230944|Open Nissen fundoplication|open nissen fundoplication
5515037|NCT01230944|Antireflux surgery|antireflux surgery
5515038|NCT01230931|Acetabulum|acetabulum
5515039|NCT01230931|Fracture|fracture
5515040|NCT01230931|Hemostatis|hemostatis
5515041|NCT01230931|Vitagel|vitagel
5515042|NCT01230931|Fibrin sealant|fibrin sealant
5515043|NCT01230918|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5515044|NCT01230918|Acute Coronary Syndrome|acute coronary syndrome
5515045|NCT01230918|Myocardial Fibrosis|myocardial fibrosis
5515046|NCT01230918|Fibrogenesis|fibrogenesis
5515047|NCT01230918|Intimal Hyperplasia|intimal hyperplasia
5515049|NCT01230918|avB3 Integrin Expression|avb3 integrin expression
5515050|NCT01230905|Androgen Suppression Therapy|androgen suppression therapy
5515051|NCT01230905|Hormonal Toxicity|hormonal toxicity
5515052|NCT01230905|Quantitative PET|quantitative pet
5515053|NCT01230905|Myocardial blood flow|myocardial blood flow
5515054|NCT01230905|Coronary blood flow reserve|coronary blood flow reserve
5515055|NCT01230905|Endothelial dysfunction|endothelial dysfunction
5515056|NCT01230905|Coronary Artery Disease|coronary artery disease
5515058|NCT01230879|Airway remodeling|airway remodeling
5515059|NCT01230879|Airway segmentation|airway segmentation
5515060|NCT01230879|Chest CT|chest ct
5515061|NCT01230866|Proton Radiation Prostate Cancer|proton radiation prostate cancer
5515065|NCT01230827|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5515066|NCT01230827|golimumab|golimumab
5515067|NCT01230827|juvenile arthritis|juvenile arthritis
5515069|NCT01230827|anti TNF alpha medications|anti tnf alpha medications
5515070|NCT01230827|juvenile psoriatic arthritis|juvenile psoriatic arthritis
5515071|NCT01230814|Bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, Kenya|bacterial vaginosis, metronidazole, miconazole, vulvovaginal candidiasis, trichomonas vaginalis, women, kenya
5515073|NCT01230788|Leukemia|leukemia
5515074|NCT01230788|Rituximab|rituximab
5515075|NCT01230788|Pediatrics|pediatrics
5515076|NCT01230762|Dapoxetine, Orgasmic disorder|dapoxetine, orgasmic disorder
5515077|NCT01230762|Premature ejaculation|premature ejaculation
5515078|NCT01230762|Sexual dysfunction|sexual dysfunction
5515079|NCT01230762|Sexual intercourse|sexual intercourse
5515080|NCT01230762|Ejaculation|ejaculation
5515081|NCT01230762|Erectile Dysfunction|erectile dysfunction
5515082|NCT01230749|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5515083|NCT01230749|Diabetes Mellitus|diabetes mellitus
5515084|NCT01230749|Hyperglycemia|hyperglycemia
5515085|NCT01230749|JNJ-41443532|jnj-41443532
5515086|NCT01230749|Pioglitazone|pioglitazone
5515087|NCT01230749|Placebo|placebo
5515088|NCT01230697|Advanced|advanced
5515089|NCT01230697|hepatocarcinoma|hepatocarcinoma
5515090|NCT01230684|CEUS|ceus
5515091|NCT01230684|Endoleaks|endoleaks
5515092|NCT01230684|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5515093|NCT01230658|prophylactic enoxaparin|prophylactic enoxaparin
5515094|NCT01230658|Roux en Y gastric bypass surgery|roux en y gastric bypass surgery
5515095|NCT01230632|assisted reproduction technology|assisted reproduction technology
5515096|NCT01230632|Metabolic risk factors|metabolic risk factors
5515097|NCT01230632|In Vitro Fertilisation|in vitro fertilisation
5515098|NCT01230606|Percutaneous Intervention|percutaneous intervention
5515099|NCT01230606|Percutaneous Coronary Intervention|percutaneous coronary intervention
5515100|NCT01230606|Catheterization|catheterization
5515101|NCT01230606|Coronary Catheterization|coronary catheterization
5515102|NCT01230606|Same day Discharge|same day discharge
5515103|NCT01230606|Next Day Discharge|next day discharge
5515104|NCT01230606|Patient Satisfaction|patient satisfaction
5515105|NCT01230606|Multi-Center|multi-center
5515106|NCT01230606|Randomized|randomized
5515107|NCT01230606|Low-risk PCI|low-risk pci
5515108|NCT01230606|BlindedClosure device|blindedclosure device
5515109|NCT01230606|Vascular closure device|vascular closure device
5515110|NCT01230580|Protease Inhibitors|protease inhibitors
5515111|NCT01230580|RNA virus infections|rna virus infections
5515112|NCT01230580|Virus diseases|virus diseases
5515113|NCT01230580|Sexually Transmitted Diseases viral|sexually transmitted diseases viral
5515114|NCT01230580|Immune system diseases|immune system diseases
5515115|NCT01230580|Anti-infective Agents|anti-infective agents
5515116|NCT01230580|Drug resistance|drug resistance
5515117|NCT01230567|Problem wounds|problem wounds
5515118|NCT01230567|Non healing wounds|non healing wounds
5515119|NCT01230567|BCC|bcc
5515120|NCT01230567|SCC|scc
5515121|NCT01230567|Vasculitis|vasculitis
5515122|NCT01230554|contact lens|contact lens
5515123|NCT01230541|Semen characteristics|semen characteristics
5515124|NCT01230541|Erectile Dysfunction|erectile dysfunction
5515125|NCT01230515|Oncology Pain Management in outpatient hospice setting|oncology pain management in outpatient hospice setting
5515126|NCT01230502|immunosuppression|immunosuppression
5515127|NCT01230502|anti-rejection|anti-rejection
5515128|NCT01230502|immune tolerance|immune tolerance
5515129|NCT01230476|Locally advanced nasopharyngeal carcinoma|locally advanced nasopharyngeal carcinoma
5515130|NCT01230476|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5515131|NCT01230476|Chemoradiation|chemoradiation
5515132|NCT01230476|Cetuximab|cetuximab
5515133|NCT01230463|Pain, Postoperative|pain, postoperative
5515134|NCT01230463|Ketorolac|ketorolac
5515135|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5515136|NCT01230463|Intraoperative Care|intraoperative care
5499582|NCT01297569|DME|dme
5515137|NCT01230450|urodynamic urinary incontinence, sub-urethral tape|urodynamic urinary incontinence, sub-urethral tape
5515138|NCT01230437|montelukast|montelukast
5515139|NCT01230437|asthma|asthma
5515140|NCT01230437|allergic rhinitis|allergic rhinitis
5515141|NCT01230437|nasal epithelial cells|nasal epithelial cells
5509212|NCT01256554|SSRS|ssrs
5515142|NCT01230437|inflammatory mediators|inflammatory mediators
5515144|NCT01230424|Knee arthritis|knee arthritis
5515145|NCT01230424|MRI|mri
5515146|NCT01230424|Steroid|steroid
5515147|NCT01230411|Episodic migraine|episodic migraine
5515148|NCT01230385|lersivirine|lersivirine
5515149|NCT01230385|UK-453|uk-453
5515150|NCT01230385|061|061
5515151|NCT01230385|safety|safety
5515152|NCT01230385|tolerability|tolerability
5515153|NCT01230385|pharmacokinetics|pharmacokinetics
5515154|NCT01230385|HIV|hiv
5515155|NCT01230385|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5515156|NCT01230385|NNRTI|nnrti
5515157|NCT01230359|Autism|autism
5515158|NCT01230359|Children|children
5515159|NCT01230359|ASD|asd
5515160|NCT01230359|Vitamin B6|vitamin b6
5515161|NCT01230359|Magnesium|magnesium
5515162|NCT01230320|Cost estimates|cost estimates
5515163|NCT01230320|Complete Denture|complete denture
5515164|NCT01230320|Dental Economics|dental economics
5515165|NCT01230320|Dental Impression Technique|dental impression technique
5515166|NCT01230320|Denture Retention|denture retention
5515167|NCT01230320|Edentulous|edentulous
5515168|NCT01230320|Edentulism|edentulism
5515169|NCT01230320|Oral Health-Related Quality of Life|oral health-related quality of life
5515170|NCT01230320|Patient Acceptance of Health Care|patient acceptance of health care
5515171|NCT01230320|Patient Satisfaction|patient satisfaction
5515172|NCT01230320|Quality of Health Care|quality of health care
5515173|NCT01230320|Quality of Life|quality of life
5515174|NCT01230307|Vitamin D|vitamin d
5515175|NCT01230307|Systolic failure|systolic failure
5515176|NCT01230307|Genomics|genomics
5515177|NCT01230307|Biomarkers|biomarkers
5515178|NCT01230307|Exercise|exercise
5515179|NCT01230307|Quality of Life|quality of life
5515180|NCT01230294|echocardiography of the right heart|echocardiography of the right heart
5515181|NCT01230294|3D 4D echocardiography|3d 4d echocardiography
5515182|NCT01230294|strain measurement|strain measurement
5515183|NCT01230294|chronic heart failure|chronic heart failure
5515184|NCT01230294|pulmonary hypertension|pulmonary hypertension
5515185|NCT01230281|C3G|c3g
5515186|NCT01230281|Oxidative stress|oxidative stress
5515187|NCT01230281|Antioxidant|antioxidant
5515188|NCT01230281|Black bean|black bean
5515189|NCT01230268|C3G|c3g
5515190|NCT01230268|Oxidative stress|oxidative stress
5515191|NCT01230268|Antioxidant|antioxidant
5515192|NCT01230268|Mulberry|mulberry
5515193|NCT01230255|intra-abdominal pressure|intra-abdominal pressure
5515194|NCT01230255|intra-abdominal hypertension|intra-abdominal hypertension
5515195|NCT01230255|abdominal compartment syndrome|abdominal compartment syndrome
5515196|NCT01230255|open abdomen|open abdomen
5515197|NCT01230255|percutaneous|percutaneous
5515198|NCT01230242|Mirena|mirena
5515199|NCT01230242|postplacental intrauterine device|postplacental intrauterine device
5515200|NCT01230242|postpartum insertion|postpartum insertion
5515201|NCT01230229|Intermittent claudication|intermittent claudication
5515202|NCT01230229|Superficial femoral artery|superficial femoral artery
5515203|NCT01230229|Stenting|stenting
5515204|NCT01230229|Medical treatment|medical treatment
5515205|NCT01230229|Quality of life|quality of life
5515206|NCT01230216|coronary artery disease|coronary artery disease
5515207|NCT01230216|hypertension|hypertension
5515208|NCT01230190|infants|infants
5515209|NCT01230190|adaptive immunology|adaptive immunology
5515210|NCT01230190|atopic dermatitis|atopic dermatitis
5515211|NCT01230190|probiotics|probiotics
5515212|NCT01230151|Deep Brain Stimulation|deep brain stimulation
5515213|NCT01230151|DBS|dbs
5515214|NCT01230151|Parkinson's disease|parkinson's disease
5515215|NCT01230151|PD|pd
5515216|NCT01230151|Patients who have a preexisting Deep Brain Stimulation (DBS) system for the treatment of Parkinson's disease (PD)|patients who have a preexisting deep brain stimulation (dbs) system for the treatment of parkinson's disease (pd)
5515217|NCT01230125|Inflammation|inflammation
5515218|NCT01230125|Pain|pain
5515219|NCT01230125|Ocular surgery|ocular surgery
5515220|NCT01230099|Critical Illness|critical illness
5515221|NCT01230099|Mechanical Ventilation|mechanical ventilation
5515222|NCT01230099|Palliative Care|palliative care
5515223|NCT01230099|Caregivers|caregivers
5515224|NCT01230086|ICD|icd
5515225|NCT01230086|DFT-testing|dft-testing
5515226|NCT01230073|ICD|icd
5515228|NCT01230073|Quality of life|quality of life
5515229|NCT01230060|ocular surgery|ocular surgery
5515230|NCT01230060|phacoemulsification|phacoemulsification
5515231|NCT01230047|depression|depression
5515232|NCT01230047|anxiety|anxiety
5515233|NCT01230047|psychoeducation|psychoeducation
5515234|NCT01230047|self-help|self-help
5515235|NCT01230047|psychosocial|psychosocial
5680304|NCT00578292|homozygous b0/+-thalassemia|homozygous b0/+-thalassemia
5499644|NCT01297335|controlled|controlled
5515236|NCT01230034|Imidapril, Ramipril, Hypertension, Type 2 diabetes mellitus, Microalbuminuria|imidapril, ramipril, hypertension, type 2 diabetes mellitus, microalbuminuria
5515237|NCT01230008|primary mediastinal lymphoma|primary mediastinal lymphoma
5515238|NCT01230008|radiotherapy|radiotherapy
5515239|NCT01230008|chemotherapy|chemotherapy
5515240|NCT01230008|rituximab|rituximab
5515241|NCT01229969|falls, balance problems, gaming systems, balance assessments|falls, balance problems, gaming systems, balance assessments
5515242|NCT01229956|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5515244|NCT01229956|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5515245|NCT01229930|cervical adenocarcinoma|cervical adenocarcinoma
5515246|NCT01229930|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5515247|NCT01229930|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5515248|NCT01229930|recurrent cervical cancer|recurrent cervical cancer
5515249|NCT01229930|stage IVB cervical cancer|stage ivb cervical cancer
5515250|NCT01229930|stage IVA cervical cancer|stage iva cervical cancer
5515251|NCT01229891|vitamin D fortification|vitamin d fortification
5515454|NCT01228994|baclofen|baclofen
5515253|NCT01229891|type 2 diabetes|type 2 diabetes
5515254|NCT01229891|efficacy|efficacy
5515255|NCT01229852|Fibromyalgia|fibromyalgia
5515256|NCT01229852|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5515257|NCT01229852|Pain|pain
5515258|NCT01229839|Carcinoma,Hepatocellular|carcinoma,hepatocellular
5515259|NCT01229839|Liver Neoplasms|liver neoplasms
5515260|NCT01229839|Therapeutic|therapeutic
5515261|NCT01229839|Chemoembolization,|chemoembolization,
5515262|NCT01229839|TACE|tace
5515263|NCT01229839|pharmacokinetics|pharmacokinetics
5515264|NCT01229839|Iodized Oil/administration & dosage|iodized oil/administration & dosage
5515265|NCT01229839|polyvinyl alcohol|polyvinyl alcohol
5515266|NCT01229839|Humans|humans
5515267|NCT01229826|Uterine fibroids|uterine fibroids
5515268|NCT01229826|Uterine leiomyomas|uterine leiomyomas
5515269|NCT01229826|MR Elastography|mr elastography
5515270|NCT01229826|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5515271|NCT01229826|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5515272|NCT01229813|Untreated|untreated
5515273|NCT01229813|First line|first line
5515274|NCT01229813|Chemotherapy|chemotherapy
5515275|NCT01229813|Maintenance treatment|maintenance treatment
5515276|NCT01229813|KRAS wt|kras wt
5515277|NCT01229813|KRAS mutated|kras mutated
5515278|NCT01229813|Anti-angiogenetic treatment|anti-angiogenetic treatment
5515279|NCT01229813|Metronomic capecitabine|metronomic capecitabine
5515280|NCT01229813|bevacizumab|bevacizumab
5515281|NCT01229813|erlotinib|erlotinib
5515282|NCT01229813|Translational research|translational research
5515283|NCT01229800|Polyethylene Glycol, Sodium Phosphate, Bowel preparation, Efficacy|polyethylene glycol, sodium phosphate, bowel preparation, efficacy
5515284|NCT01229787|asthma|asthma
5515285|NCT01229787|allergies|allergies
5515286|NCT01229787|obesity|obesity
5515287|NCT01229761|HIV|hiv
5515288|NCT01229761|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5515289|NCT01229761|Breast Feeding|breast feeding
5515290|NCT01229761|Infant Mortality|infant mortality
5515291|NCT01229761|Morbidity|morbidity
5515292|NCT01229761|Botswana|botswana
5515293|NCT01229761|Africa|africa
5515294|NCT01229761|Infectious disease transmission, vertical|infectious disease transmission, vertical
5515295|NCT01229761|adverse drug event|adverse drug event
5515296|NCT01229735|levetiracetam|levetiracetam
5515297|NCT01229735|topiramate|topiramate
5515298|NCT01229735|epilepsy|epilepsy
5515299|NCT01229735|partial seizures|partial seizures
5515300|NCT01229722|adherence|adherence
5515301|NCT01229722|reminders|reminders
5515302|NCT01229722|text messages|text messages
5515303|NCT01229722|SMS|sms
5515304|NCT01229722|mHealth|mhealth
5515305|NCT01229709|Tinnitus|tinnitus
5515306|NCT01229709|Mindfulness|mindfulness
5515307|NCT01229709|MBSR|mbsr
5515308|NCT01229709|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5515309|NCT01229709|MBTR|mbtr
5515310|NCT01229696|Popliteal|popliteal
5515311|NCT01229696|UCSD|ucsd
5515312|NCT01229696|Postoperative pain|postoperative pain
5515313|NCT01229696|Foot surgery|foot surgery
5515314|NCT01229696|Ankle surgery|ankle surgery
5515315|NCT01229696|Popliteal Catheter|popliteal catheter
5515316|NCT01229696|Popliteal Nerve Block|popliteal nerve block
5515317|NCT01229696|Lower extremity surgery|lower extremity surgery
5515318|NCT01229696|Bifurcation|bifurcation
5515319|NCT01229696|Catheter Insertion Site|catheter insertion site
5515320|NCT01229683|UCSD|ucsd
5515321|NCT01229683|Perineural Nerve Block|perineural nerve block
5515322|NCT01229683|Shoulder Surgery|shoulder surgery
5515323|NCT01229683|Pain|pain
5515324|NCT01229683|Grip Strength|grip strength
5515325|NCT01229683|Sensation|sensation
5515326|NCT01229683|Interscalene Nerve Block|interscalene nerve block
5515327|NCT01229670|Heart failure|heart failure
5515328|NCT01229670|Hemorheology|hemorheology
5515329|NCT01229670|Atherothrombosis|atherothrombosis
5515330|NCT01229670|Angiogenesis|angiogenesis
5515331|NCT01229657|Reopening of macular hole;|reopening of macular hole;
5515332|NCT01229657|Visual acuity;|visual acuity;
5515333|NCT01229657|Phacoemulsification cataract surgery;|phacoemulsification cataract surgery;
5515334|NCT01229657|Vitrectomy|vitrectomy
5515335|NCT01229644|Glioma|glioma
5515336|NCT01229644|Brain Cancer|brain cancer
5515337|NCT01229644|Recurrent glioma|recurrent glioma
5515338|NCT01229644|Low grade glioma|low grade glioma
5515339|NCT01229644|PDGFR Inhibitor|pdgfr inhibitor
5515340|NCT01229644|Crenolanib (CP-868,596)|crenolanib (cp-868,596)
5515341|NCT01229644|Neo-adjuvant Therapy|neo-adjuvant therapy
5515342|NCT01229631|Periodontitis|periodontitis
5515343|NCT01229631|Dietary supplementation|dietary supplementation
5515344|NCT01229618|Prostate Cancer|prostate cancer
5515345|NCT01229592|infection|infection
5515346|NCT01229592|catheter|catheter
5515347|NCT01229592|bacteriaemia|bacteriaemia
5515349|NCT01229579|poliomyelitis|poliomyelitis
5515351|NCT01229579|zinc supplement|zinc supplement
5515352|NCT01229579|diarrhea|diarrhea
5515353|NCT01229579|placebo|placebo
5515354|NCT01229579|double blind randomized control trial|double blind randomized control trial
5515355|NCT01229579|elemental zinc|elemental zinc
5515356|NCT01229579|seroconversion|seroconversion
5515357|NCT01229579|bOPV|bopv
5515358|NCT01229579|infants|infants
5515359|NCT01229579|immunity|immunity
5515360|NCT01229527|Colonoscopy|colonoscopy
5515361|NCT01229527|Remifentanil|remifentanil
5515362|NCT01229527|Sedation|sedation
5515363|NCT01229514|Children|children
5515364|NCT01229514|before|before
5515365|NCT01229514|the age of 2 years|the age of 2 years
5515366|NCT01229475|Atrial fibrillation|atrial fibrillation
5515367|NCT01229475|recurrence|recurrence
5515368|NCT01229475|repeat procedure|repeat procedure
5515369|NCT01229475|linear ablation|linear ablation
5515370|NCT01229475|stepwise approach|stepwise approach
5515371|NCT01229449|Dental pain|dental pain
5515372|NCT01229449|Ibuprofen|ibuprofen
5515373|NCT01229449|Acetaminophen|acetaminophen
5515374|NCT01229449|Nurofen Plus®|nurofen plus®
5515375|NCT01229449|Panadeine® Extra|panadeine® extra
5515376|NCT01229449|Paracetamol|paracetamol
5515377|NCT01229436|Dupuytren's|dupuytren's
5515378|NCT01229436|treatment|treatment
5515379|NCT01229436|injection|injection
5515380|NCT01229436|recovery|recovery
5515381|NCT01229436|health care resources|health care resources
5515382|NCT01229397|Influenza|influenza
5515383|NCT01229397|Virus|virus
5515384|NCT01229397|Vaccination|vaccination
5515385|NCT01229397|Immunisation|immunisation
5515386|NCT01229371|Influenza|influenza
5515387|NCT01229371|Virus|virus
5515388|NCT01229371|Vaccination|vaccination
5515389|NCT01229371|Immunisation|immunisation
5515390|NCT01229358|vascular surgery|vascular surgery
5515391|NCT01229358|wound infection|wound infection
5515392|NCT01229358|wound complication|wound complication
5515393|NCT01229332|Motor fluctuations levodopa pharmacokinetics carbidopa solution continuous|motor fluctuations levodopa pharmacokinetics carbidopa solution continuous
5515394|NCT01229319|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod|actinic keratosis, keratocytic lesion, keratoses, cryotherapy, imiquimod
5515395|NCT01229293|Mechanical muscle function|mechanical muscle function
5515396|NCT01229293|Muscle strength|muscle strength
5515397|NCT01229293|Hip replacement|hip replacement
5515398|NCT01229293|Osteoarthritis|osteoarthritis
5515399|NCT01229293|Hip arthroplasty|hip arthroplasty
5515400|NCT01229280|Bioequivalence|bioequivalence
5515401|NCT01229280|Darifenacin|darifenacin
5515402|NCT01229280|Healthy volunteers|healthy volunteers
5515403|NCT01229280|Postprandial|postprandial
5515404|NCT01229267|Herpes zoster|herpes zoster
5515405|NCT01229267|vaccine|vaccine
5515406|NCT01229267|herpes zoster-related complications|herpes zoster-related complications
5515407|NCT01229267|immunocompromised|immunocompromised
5515408|NCT01229267|autologous hematopoietic cell transplants|autologous hematopoietic cell transplants
5515409|NCT01229254|Betrixaban|betrixaban
5515410|NCT01229254|MK-4448|mk-4448
5515411|NCT01229254|nonvalvular atrial fibrillation|nonvalvular atrial fibrillation
5515412|NCT01229241|local anesthetic|local anesthetic
5515413|NCT01229241|epidural|epidural
5515414|NCT01229241|pharmacokinetics|pharmacokinetics
5515415|NCT01229241|plasmatic concentration|plasmatic concentration
5515416|NCT01229241|epidural continuous infusion|epidural continuous infusion
5515417|NCT01229202|trabeculectomy|trabeculectomy
5515418|NCT01229202|glaucoma surgery|glaucoma surgery
5515419|NCT01229202|bevacizumab|bevacizumab
5515420|NCT01229202|Vascular Endothelial Growth Inhibitor|vascular endothelial growth inhibitor
5515421|NCT01229202|glaucoma|glaucoma
5515422|NCT01229189|Vitamin D|vitamin d
5515423|NCT01229189|Effectiveness|effectiveness
5515424|NCT01229189|Pregnant women and their neonates|pregnant women and their neonates
5515425|NCT01229163|Motivational Incentive|motivational incentive
5515426|NCT01229163|Automation|automation
5515427|NCT01229163|Contingency Management|contingency management
5515428|NCT01229163|Counseling Adherance|counseling adherance
5515429|NCT01229150|Kinase Signal Transduction Pathway|kinase signal transduction pathway
5515430|NCT01229150|Tumor Mutational Analysis|tumor mutational analysis
5515431|NCT01229150|Tissue Immunohistochemistry|tissue immunohistochemistry
5515432|NCT01229150|MIB-1 (Ki-67) Rate|mib-1 (ki-67) rate
5515433|NCT01229150|PERK Level|perk level
5515434|NCT01229150|Lung Cancer|lung cancer
5515435|NCT01229150|Non-Small Cell Lung Cancer|non-small cell lung cancer
5515436|NCT01229124|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5685346|NCT00556491|Acute Kidney Failure|acute kidney failure
5515437|NCT01229085|Psoriasis, mometasone, salicylic acid.|psoriasis, mometasone, salicylic acid.
5515439|NCT01229072|Non-inferiority|non-inferiority
5515441|NCT01229059|insulin resistance|insulin resistance
5515442|NCT01229059|mitochondria|mitochondria
5515443|NCT01229046|presumed sepsis|presumed sepsis
5515444|NCT01229033|Atrial fibrillation|atrial fibrillation
5515445|NCT01229033|ablation|ablation
5515446|NCT01229033|atrial flutter|atrial flutter
5515447|NCT01229020|Emphysema|emphysema
5515448|NCT01229020|COPD|copd
5515449|NCT01229020|lung sounds|lung sounds
5515450|NCT01229020|vibration response imaging|vibration response imaging
5515451|NCT01229007|Hemophilia A|hemophilia a
5515452|NCT01229007|Children|children
5515453|NCT01228994|smoking cessation treatment|smoking cessation treatment
5515455|NCT01228994|Smoking cessation counselling|smoking cessation counselling
5515456|NCT01228968|obesity|obesity
5515457|NCT01228942|ovarian cancer|ovarian cancer
5515458|NCT01228942|fallopian tube cancer|fallopian tube cancer
5515459|NCT01228942|primary peritoneal cancer|primary peritoneal cancer
5515460|NCT01228929|Dry Eye|dry eye
5515461|NCT01228929|Non-invasive instruments|non-invasive instruments
5515462|NCT01228929|MGD|mgd
5515463|NCT01228929|Environment|environment
5515464|NCT01228929|Thermal Imaging|thermal imaging
5515465|NCT01228916|tobacco|tobacco
5515466|NCT01228916|smoking|smoking
5515467|NCT01228916|secondhand smoke|secondhand smoke
5515468|NCT01228903|uric acid kidney disease endothelial dysfunction|uric acid kidney disease endothelial dysfunction
5515469|NCT01228851|Parkinson's Disease|parkinson's disease
5515470|NCT01228851|Rehabilitation|rehabilitation
5515471|NCT01228851|Balance|balance
5515472|NCT01228851|Exercise|exercise
5515473|NCT01228851|Parkinson's disease with balance deficits|parkinson's disease with balance deficits
5515474|NCT01228851|H&Y 2.5-3|h&y 2.5-3
5515475|NCT01228838|postherpetic neuralgia|postherpetic neuralgia
5515476|NCT01228838|PHN|phn
5515477|NCT01228838|capsaicin|capsaicin
5515478|NCT01228838|herpes zoster|herpes zoster
5515479|NCT01228838|shingles|shingles
5515480|NCT01228838|analgesics|analgesics
5515481|NCT01228838|neuropathy|neuropathy
5515482|NCT01228825|Cardiac surgery|cardiac surgery
5515483|NCT01228825|Cardiopulmonary bypass|cardiopulmonary bypass
5515484|NCT01228825|Antibiotic prophylaxis|antibiotic prophylaxis
5515485|NCT01228825|Cefuroxime|cefuroxime
5515486|NCT01228812|Rheumatoid arthritis, physical activity|rheumatoid arthritis, physical activity
5515487|NCT01228799|trabeculectomy,|trabeculectomy,
5515488|NCT01228799|canaloplasty,|canaloplasty,
5515489|NCT01228799|glaucoma surgery|glaucoma surgery
5515490|NCT01228799|non-penetrating surgery|non-penetrating surgery
5515491|NCT01228786|VDR, CaSR, PTH, Cyclin D1, Ki67, PCNA|vdr, casr, pth, cyclin d1, ki67, pcna
5515492|NCT01228773|Cancer Survivors, Fatigue, web-based, tailored program|cancer survivors, fatigue, web-based, tailored program
5515493|NCT01228760|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5515494|NCT01228760|ASG-5ME|asg-5me
5515495|NCT01228760|Pharmacokinetics of ASG-5ME|pharmacokinetics of asg-5me
5515496|NCT01228747|Levetiracetam|levetiracetam
5515497|NCT01228747|epilepsy|epilepsy
5515498|NCT01228747|generalized tonic-clonic|generalized tonic-clonic
5515499|NCT01228734|Metastatic colorectal cancer|metastatic colorectal cancer
5515500|NCT01228734|RAS wild type|ras wild type
5515501|NCT01228734|Cetuximab|cetuximab
5515502|NCT01228734|First line treatment|first line treatment
5515503|NCT01228734|First occurrence of metastatic colorectal cancer in Chinese subjects with RAS wildtype|first occurrence of metastatic colorectal cancer in chinese subjects with ras wildtype
5515504|NCT01228734|status|status
5515505|NCT01228708|Implementation strategy|implementation strategy
5515506|NCT01228708|Chronic disease management programme|chronic disease management programme
5515507|NCT01228708|COPD|copd
5515508|NCT01228695|steroids|steroids
5515509|NCT01228695|patients treated with systemic steroids|patients treated with systemic steroids
5515510|NCT01228682|Sodium|sodium
5515511|NCT01228682|SIADH|siadh
5515512|NCT01228682|Hyponatremia|hyponatremia
5515513|NCT01228682|Vasopressin|vasopressin
5515514|NCT01228682|Salt|salt
5515515|NCT01228682|Water|water
5515516|NCT01228656|Psoriasis|psoriasis
5515517|NCT01228643|Pancreatic enzymes.|pancreatic enzymes.
5798697|NCT00111345|Acute myeloid leukemia|acute myeloid leukemia
5515518|NCT01228643|To evaluate the efficacy of drugs in chronic renal failure|to evaluate the efficacy of drugs in chronic renal failure
5515519|NCT01228630|rhinitis, loratadine, coated pill|rhinitis, loratadine, coated pill
5499946|NCT01295970|Radiosurgery|radiosurgery
5515520|NCT01228617|Smoking Cessation|smoking cessation
5515521|NCT01228617|Nicotine pharmacokinetics|nicotine pharmacokinetics
5515522|NCT01228604|open label|open label
5515523|NCT01228604|Ritalin®|ritalin®
5515524|NCT01228604|ADHD|adhd
5515525|NCT01228578|Multivitamins|multivitamins
5515526|NCT01228578|HIV/AIDS|hiv/aids
5515527|NCT01228578|Immune reconstitution|immune reconstitution
5515528|NCT01228578|Weight Gain|weight gain
5515529|NCT01228578|Quality of Life|quality of life
5515530|NCT01228565|Head and neck carcinoma treated by radiotherapy plus erbitux|head and neck carcinoma treated by radiotherapy plus erbitux
5515531|NCT01228552|Acute Migraine Treatment|acute migraine treatment
5515532|NCT01228552|Migraine Treatment|migraine treatment
5515534|NCT01228552|Headache|headache
5515535|NCT01228552|Treatment|treatment
5515536|NCT01228539|PTSD|ptsd
5515537|NCT01228539|Anger|anger
5515538|NCT01228539|Aggression|aggression
5515539|NCT01228539|Military|military
5515540|NCT01228487|Oxidative Dysbalance|oxidative dysbalance
5515541|NCT01228487|Oxidative Stress|oxidative stress
5515542|NCT01228487|Biomarker|biomarker
5497356|NCT01306812|Genes|genes
5515543|NCT01228461|Hodgkin Lymphoma Survivors|hodgkin lymphoma survivors
5515544|NCT01228461|Adolescent and Young Adults|adolescent and young adults
5515545|NCT01228448|external beam proton radiotherapy|external beam proton radiotherapy
5515546|NCT01228448|PET|pet
5515547|NCT01228435|NSCLC|nsclc
5515548|NCT01228435|IPI-504|ipi-504
5515549|NCT01228435|ALK translocation|alk translocation
5515550|NCT01228435|Hsp90 inhibitor|hsp90 inhibitor
5515639|NCT01227980|Alcoholics|alcoholics
5515551|NCT01228422|Will be studied 24 subjects divided Research and 2 parallel groups|will be studied 24 subjects divided research and 2 parallel groups
5515552|NCT01228422|The treatment is a dose of 3MUI of alpha interferon 2nd|the treatment is a dose of 3mui of alpha interferon 2nd
5515553|NCT01228422|There will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.|there will be collection of blood at times: 0, 2, 4, 6, 8, 10, 12, 16, 24, 36, 48, 72 and 96 hours.
5515554|NCT01228422|The volunteers will be hospitalized 24 hours.|the volunteers will be hospitalized 24 hours.
5515555|NCT01228422|Will be measured labels the AUC, Tmax, Cmax, neopterin and beta2-microglobulin|will be measured labels the auc, tmax, cmax, neopterin and beta2-microglobulin
5515556|NCT01228409|Psoriasis|psoriasis
5515557|NCT01228409|phototherapy|phototherapy
5515558|NCT01228409|soriatane|soriatane
5515559|NCT01228409|acitretin|acitretin
5515560|NCT01228409|retinoid-related adverse events|retinoid-related adverse events
5515561|NCT01228396|bladder|bladder
5515562|NCT01228396|optic neuritis|optic neuritis
5515563|NCT01228396|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis
5515564|NCT01228396|AIMSPRO|aimspro
5515565|NCT01228396|hyperimmune caprine serum|hyperimmune caprine serum
5515566|NCT01228396|hyperimmune goat serum|hyperimmune goat serum
5515567|NCT01228383|Monoclonal antibody|monoclonal antibody
5515568|NCT01228383|Rabies|rabies
5515569|NCT01228383|Post-exposure prophylaxis|post-exposure prophylaxis
5515570|NCT01228370|sildosin|sildosin
5515571|NCT01228370|neurogenic bladder|neurogenic bladder
5515572|NCT01228370|voiding dysfunction|voiding dysfunction
5515573|NCT01228357|Pharmacogenomics|pharmacogenomics
5515574|NCT01228357|Depressed Patients|depressed patients
5515575|NCT01228344|Artemether-lumefantrine|artemether-lumefantrine
5515576|NCT01228344|demographics|demographics
5515577|NCT01228344|malaria|malaria
5515578|NCT01228331|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5515579|NCT01228331|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5515580|NCT01228318|HAART|haart
5515581|NCT01228318|Antiresorptive drugs|antiresorptive drugs
5515582|NCT01228318|HIV/AIDS|hiv/aids
5515583|NCT01228318|Bone loss|bone loss
5515584|NCT01228305|ventricular septal defect|ventricular septal defect
5515585|NCT01228305|atrioventricular septal defect|atrioventricular septal defect
5515586|NCT01228305|oxidative stress|oxidative stress
5515587|NCT01228305|cardiopulmonary bypass|cardiopulmonary bypass
5515588|NCT01228305|acetaminophen|acetaminophen
5515589|NCT01228305|hemolysis|hemolysis
5515590|NCT01228305|acute kidney injury|acute kidney injury
5515591|NCT01228305|Congenital heart disease undergoing cardiopulmonary bypass|congenital heart disease undergoing cardiopulmonary bypass
5515592|NCT01228292|Anticoagulation|anticoagulation
5515593|NCT01228292|Intensive Care Medicine|intensive care medicine
5515594|NCT01228292|Hemodialysis|hemodialysis
5515595|NCT01228292|Critical Ill Patients|critical ill patients
5515596|NCT01228279|Peritoneal Dialysis|peritoneal dialysis
5515597|NCT01228279|Dialysis Solutions|dialysis solutions
5515598|NCT01228279|Artificial Kidney|artificial kidney
5515599|NCT01228279|Renal Replacement Therapy|renal replacement therapy
5515600|NCT01228279|Renal Dialysis|renal dialysis
5515601|NCT01228279|Sympathetic Nervous System|sympathetic nervous system
5515602|NCT01228279|Leptin|leptin
5515603|NCT01228279|Icodextrin|icodextrin
5515604|NCT01228266|Multiple Sclerosis|multiple sclerosis
5515605|NCT01228240|Diabetes mellitus, type 2, Metformin, Generic, Efficacy|diabetes mellitus, type 2, metformin, generic, efficacy
5515606|NCT01228227|Myonecrosis|myonecrosis
5515607|NCT01228227|Percutaneous Angioplasty|percutaneous angioplasty
5515608|NCT01228227|Myocardial Infarction|myocardial infarction
5515609|NCT01228188|FTMH|ftmh
5515610|NCT01228188|PPV|ppv
5515611|NCT01228188|inverted ILM repositioning|inverted ilm repositioning
5515612|NCT01228149|glaucoma|glaucoma
5515613|NCT01228149|trabeculectomy|trabeculectomy
5515614|NCT01228149|intraocular pressure|intraocular pressure
5515615|NCT01228136|Adenotonsillectomy|adenotonsillectomy
5515616|NCT01228136|Tranexamic acid|tranexamic acid
5515617|NCT01228136|Blood loss|blood loss
5509723|NCT01254539|Safety|safety
5515618|NCT01228136|Postoperative hemorrhage|postoperative hemorrhage
5515619|NCT01228084|sulforaphane|sulforaphane
5515620|NCT01228084|broccoli sprout extract (BSE)|broccoli sprout extract (bse)
5515622|NCT01228084|recurrent prostate cancer|recurrent prostate cancer
5515623|NCT01228084|phase II|phase ii
5515624|NCT01228071|testosterone deficiency|testosterone deficiency
5515625|NCT01228071|hypogonadism|hypogonadism
5515626|NCT01228058|Trauma|trauma
5515627|NCT01228058|Coagulopathy|coagulopathy
5515628|NCT01228058|Coagulopathy in adult trauma patients|coagulopathy in adult trauma patients
5497458|NCT01306435|Knee|knee
5790007|NCT00146185|Procedural pain|procedural pain
5515629|NCT01228045|Patients with histologically proved adenocarcinoma of advanced gastric cancer|patients with histologically proved adenocarcinoma of advanced gastric cancer
5515630|NCT01228019|Usual practice re-examination|usual practice re-examination
5515631|NCT01228006|Reduction of stress and fatigue|reduction of stress and fatigue
5515632|NCT01227993|Central Serous Chorioretinopathy|central serous chorioretinopathy
5515633|NCT01227993|Finasteride|finasteride
5515634|NCT01227993|Proscar|proscar
5515635|NCT01227993|Retinal Eye Disease|retinal eye disease
5515636|NCT01227980|Addiction|addiction
5515637|NCT01227980|Alcohol|alcohol
5515638|NCT01227980|Alcohol Treatment|alcohol treatment
5515640|NCT01227980|Alcohol Dependence|alcohol dependence
5515641|NCT01227980|Anxiety Disorder|anxiety disorder
5515642|NCT01227980|Alcoholism|alcoholism
5515643|NCT01227967|Adaptive Design|adaptive design
5515644|NCT01227967|At Risk|at risk
5515645|NCT01227967|H1N1|h1n1
5515646|NCT01227967|Synergy|synergy
5515647|NCT01227967|TCAD|tcad
5515648|NCT01227954|cognitive/functional effects|cognitive/functional effects
5515649|NCT01227954|tumors metastatic to brain|tumors metastatic to brain
5515650|NCT01227954|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5515651|NCT01227941|advanced solid tumors|advanced solid tumors
5515652|NCT01227941|ovarian cancer|ovarian cancer
5515653|NCT01227941|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5515654|NCT01227941|Doxil|doxil
5515655|NCT01227941|Caelyx|caelyx
5515656|NCT01227928|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5515657|NCT01227928|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5515658|NCT01227928|primary peritoneal cancer|primary peritoneal cancer
5515659|NCT01227928|ovarian cancer|ovarian cancer
5515660|NCT01227928|Fallopian Tube Cancer|fallopian tube cancer
5515661|NCT01227928|gynecologic cancer|gynecologic cancer
5515662|NCT01227928|anti-angiogenesis|anti-angiogenesis
5515663|NCT01227928|pazopanib|pazopanib
5515664|NCT01227915|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
5515665|NCT01227902|Seizures|seizures
5515666|NCT01227902|retigabine IR|retigabine ir
5515667|NCT01227902|GW582892|gw582892
5515668|NCT01227902|Epilepsy|epilepsy
5515669|NCT01227902|Open label, flexible dose|open label, flexible dose
5515670|NCT01227902|Partial-onset seizures|partial-onset seizures
5515671|NCT01227889|Metastatic melanoma|metastatic melanoma
5515672|NCT01227889|melanoma|melanoma
5515673|NCT01227889|BRAF mutant|braf mutant
5515674|NCT01227889|Advanced melanoma|advanced melanoma
5515675|NCT01227876|Control of postoperative inflammation in cataract surgery by phacoemulsification|control of postoperative inflammation in cataract surgery by phacoemulsification
5515676|NCT01227863|SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS|signs and symptoms of acute bacterial conjunctivitis
5515677|NCT01227850|Leptin|leptin
5515678|NCT01227850|IGF1|igf1
5515679|NCT01227850|Refeeding Index|refeeding index
5515680|NCT01227850|Hypophosphataemia|hypophosphataemia
5515681|NCT01227850|Primary focus of the study was to detemine whether the 'Refeeding Index', could reliably predict,that the refeeding syndrome would occur|primary focus of the study was to detemine whether the 'refeeding index', could reliably predict,that the refeeding syndrome would occur
5515682|NCT01227837|omega 3|omega 3
5515683|NCT01227837|CRT_AICD|crt_aicd
5515684|NCT01227837|congestive heart failure|congestive heart failure
5515685|NCT01227837|CHF|chf
5515686|NCT01227824|integrase inhibitor|integrase inhibitor
5515687|NCT01227824|HIV Infection|hiv infection
5515688|NCT01227824|raltegravir|raltegravir
5515689|NCT01227824|GSK1349572|gsk1349572
5515690|NCT01227811|Darifenacin|darifenacin
5515691|NCT01227811|Bioequivalence|bioequivalence
5515692|NCT01227811|Healthy volunteers|healthy volunteers
5515693|NCT01227811|Postprandial|postprandial
5515694|NCT01227798|influenza A, H1N1|influenza a, h1n1
5515695|NCT01227772|gastric cancer vaccine|gastric cancer vaccine
5515696|NCT01227772|OTSGC-A24|otsgc-a24
5515697|NCT01227772|A Phase I/IIa study|a phase i/iia study
5515698|NCT01227772|HLA-A24-positive|hla-a24-positive
5798698|NCT00111319|Front Line|front line
5515699|NCT01227746|Advanced gastro-intestinal stromal tumors|advanced gastro-intestinal stromal tumors
5515700|NCT01227720|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5515701|NCT01227694|Cell therapy|cell therapy
5515702|NCT01227694|Regenerative therapy|regenerative therapy
5515703|NCT01227694|Advance therapy|advance therapy
5515704|NCT01227694|Bone marrow|bone marrow
5515705|NCT01227694|Mesenchymal stem cell|mesenchymal stem cell
5515706|NCT01227694|Autologous|autologous
5515707|NCT01227694|Interventional clinical trial|interventional clinical trial
5515708|NCT01227694|Osteoarthrosis|osteoarthrosis
5515710|NCT01227694|Knee|knee
5515711|NCT01227655|Parkinson|parkinson
5515713|NCT01227655|Wearing-off|wearing-off
5515714|NCT01227655|Levodopa/DDCI|levodopa/ddci
5515715|NCT01227642|Prostate Cancer|prostate cancer
5515716|NCT01227642|Prostate brachytherapy|prostate brachytherapy
5515717|NCT01227642|Ultrasound treatment planning|ultrasound treatment planning
5515718|NCT01227616|Iron deficiency anemia (IDA), Feraheme, ferumoxytol, chronic kidney disease (CKD), hemodialysis, magnetic resonance imaging (MRI)|iron deficiency anemia (ida), feraheme, ferumoxytol, chronic kidney disease (ckd), hemodialysis, magnetic resonance imaging (mri)
5790008|NCT00146172|Tumors|tumors
5515719|NCT01227603|Bioequivalence|bioequivalence
5515720|NCT01227603|Nifedipine|nifedipine
5515721|NCT01227603|Candesartan|candesartan
5515722|NCT01227603|FDC|fdc
5515723|NCT01227590|Herbal medicine|herbal medicine
5515724|NCT01227590|African Potato|african potato
5515725|NCT01227590|Hypoxis obtusa|hypoxis obtusa
5515726|NCT01227590|Drug interaction|drug interaction
5515727|NCT01227590|HIV Infections|hiv infections
5515728|NCT01227590|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5515729|NCT01227590|Healthy Subjects|healthy subjects
5515730|NCT01227590|Anti-retroviral Agents|anti-retroviral agents
5515731|NCT01227590|Lopinavir|lopinavir
5515732|NCT01227590|Ritonavir|ritonavir
5515733|NCT01227577|CML|cml
5515734|NCT01227577|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5515735|NCT01227577|Leukemia|leukemia
5515736|NCT01227577|CML-CP|cml-cp
5515737|NCT01227577|Nilotinib|nilotinib
5515738|NCT01227564|Early Alzheimer's disease|early alzheimer's disease
5515739|NCT01227564|active immunization|active immunization
5515740|NCT01227564|amyloid imaging|amyloid imaging
5515741|NCT01227551|Melanoma|melanoma
5515742|NCT01227551|CALM|calm
5515743|NCT01227538|Beta cell reserve, urinary C peptide|beta cell reserve, urinary c peptide
5515744|NCT01227512|Hyponatremia|hyponatremia
5515745|NCT01227512|Dilutional Hyponatremia|dilutional hyponatremia
5515746|NCT01227512|Euvolemic Hyponatremia|euvolemic hyponatremia
5515747|NCT01227512|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5515748|NCT01227512|Fluid Restriction|fluid restriction
5515749|NCT01227512|Tolvaptan|tolvaptan
5515750|NCT01227486|Intubation, intratracheal|intubation, intratracheal
5515751|NCT01227486|Ultrasonography|ultrasonography
5515752|NCT01227486|Auscultation|auscultation
5515753|NCT01227486|Capnography|capnography
5515754|NCT01227486|Obesity|obesity
5515755|NCT01227473|prediabetes|prediabetes
5515756|NCT01227473|African Americans|african americans
5515757|NCT01227473|mindfulness|mindfulness
5515758|NCT01227473|behavioral|behavioral
5515759|NCT01227473|diabetes|diabetes
5515760|NCT01227460|Type 1 diabetes, Sitagliptin|type 1 diabetes, sitagliptin
5515761|NCT01227434|Glioblastoma|glioblastoma
5515762|NCT01227434|Gliosarcoma|gliosarcoma
5515763|NCT01227434|Anaplastic astrocytoma|anaplastic astrocytoma
5515764|NCT01227434|Malignant astrocytoma NOS|malignant astrocytoma nos
5515765|NCT01227434|Malignant glioma|malignant glioma
5515766|NCT01227434|GBM|gbm
5515767|NCT01227421|influenza|influenza
5515768|NCT01227408|Patients with confirmed breast cancer for neoadjuvant chemotherapy|patients with confirmed breast cancer for neoadjuvant chemotherapy
5515769|NCT01227395|HIV|hiv
5515770|NCT01227395|Post Marketing Surveillance|post marketing surveillance
5515771|NCT01227369|Bisphosphonates|bisphosphonates
5515772|NCT01227369|OPSAT-Q|opsat-q
5515773|NCT01227356|Chronic myeloid leukemia, imatinib, interferon|chronic myeloid leukemia, imatinib, interferon
5515774|NCT01227343|Gender differences|gender differences
5515775|NCT01227343|nicotine|nicotine
5515776|NCT01227343|cigarette smoking habits|cigarette smoking habits
5515777|NCT01227343|behavior changes|behavior changes
5515778|NCT01227317|Dyspnea|dyspnea
5515779|NCT01227317|Mortality|mortality
5515780|NCT01227291|Glaucoma|glaucoma
5515781|NCT01227291|IOP|iop
5515782|NCT01227291|siRNAs|sirnas
5515783|NCT01227291|RNAi|rnai
5515784|NCT01227291|beta inhibitor|beta inhibitor
5515785|NCT01227278|Benralizumab|benralizumab
5515786|NCT01227278|MEDI-563|medi-563
5515787|NCT01227278|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5515788|NCT01227226|Dry eye|dry eye
5515789|NCT01227187|Hemodialysis|hemodialysis
5515790|NCT01227187|Anticoagulation|anticoagulation
5515791|NCT01227187|Xigris|xigris
5515792|NCT01227187|PTT|ptt
5515793|NCT01227174|propofol only|propofol only
5515794|NCT01227174|safety and efficacy|safety and efficacy
5515795|NCT01227161|ASA I-II children between the age 0-7|asa i-ii children between the age 0-7
5515796|NCT01227161|general anesthesia|general anesthesia
5798699|NCT00111319|Multiple Myeloma|multiple myeloma
5515797|NCT01227148|critical care, glycemic control, insulin, nitrogen balance|critical care, glycemic control, insulin, nitrogen balance
5515798|NCT01227135|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5515799|NCT01227135|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5515800|NCT01227122|NGAL plasmatic level|ngal plasmatic level
5515801|NCT01227122|Preoperative KIDNEY FAILURE, CHRONIC|preoperative kidney failure, chronic
5685347|NCT00556478|Premature Ejaculation|premature ejaculation
5515802|NCT01227122|Postoperative KIDNEY FAILURE, ACUTE|postoperative kidney failure, acute
5515803|NCT01227122|Cardiac Surgery Procedures|cardiac surgery procedures
5515804|NCT01227109|Infections|infections
5515805|NCT01227109|Cancer|cancer
5515806|NCT01227109|Procalcitonin|procalcitonin
5515807|NCT01227109|C reactive protein|c reactive protein
5515808|NCT01227096|electroacupuncture pediatric cardioprotection|electroacupuncture pediatric cardioprotection
5515809|NCT01227083|AQLQ and cAQOL|aqlq and caqol
5515810|NCT01227070|Asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes|asthma, hospitalization, children, exhaled nitric oxide, lung function, breath condensate, cysteinyl leukotrienes
5497678|NCT01305629|HIV|hiv
5515811|NCT01227057|exposure therapy|exposure therapy
5515812|NCT01227057|case management|case management
5515813|NCT01227057|older adults|older adults
5515814|NCT01227057|cognitive rehabilitation|cognitive rehabilitation
5515815|NCT01227044|Substance Abuse Counseling|substance abuse counseling
5515816|NCT01227044|Adherence (medication)|adherence (medication)
5515817|NCT01227044|Alcohol Abuse|alcohol abuse
5515818|NCT01227044|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
5515819|NCT01227044|Naltrexone|naltrexone
5515820|NCT01227044|Vivitrol|vivitrol
5515821|NCT01227044|HIV|hiv
5515822|NCT01227031|Genetic susceptibility of androgenetic alopecia|genetic susceptibility of androgenetic alopecia
5515823|NCT01227031|Genetic difference in Finasteride response|genetic difference in finasteride response
5515824|NCT01227005|Transfusion|transfusion
5515825|NCT01227005|Whole Blood|whole blood
5515826|NCT01227005|Trauma|trauma
5515827|NCT01227005|Coagulopathy|coagulopathy
5515828|NCT01227005|Component Therapy|component therapy
5515829|NCT01227005|Civilian|civilian
5515830|NCT01227005|Military|military
5515831|NCT01226992|Clostridium difficile|clostridium difficile
5515832|NCT01226992|Fecal Transplant|fecal transplant
5515833|NCT01226992|Recurrent Diarrhea|recurrent diarrhea
5515834|NCT01226992|Abdominal distension/bloating|abdominal distension/bloating
5515835|NCT01226992|Fever|fever
5515836|NCT01226979|rectal cancer|rectal cancer
5515837|NCT01226979|high dose endorectal brachytherapy|high dose endorectal brachytherapy
5515838|NCT01226953|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5515839|NCT01226953|Vaccine|vaccine
5515840|NCT01226953|Anti-PRP antibody|anti-prp antibody
5515841|NCT01226914|EVICEL, Fibrin Sealant, Thyroidectomy|evicel, fibrin sealant, thyroidectomy
5515842|NCT01226901|Poly (ADP-ribose) polymerase (PARP) inhibitor|poly (adp-ribose) polymerase (parp) inhibitor
5515843|NCT01226901|tumor|tumor
5515844|NCT01226901|cancer|cancer
5515845|NCT01226888|brown adipose tissue|brown adipose tissue
5515846|NCT01226888|androgen deprivation therapy|androgen deprivation therapy
5515847|NCT01226875|SWL|swl
5515848|NCT01226875|kidney stones|kidney stones
5515849|NCT01226875|renal calculi|renal calculi
5515850|NCT01226862|Stroke|stroke
5515851|NCT01226862|Telemedicine|telemedicine
5515852|NCT01226862|Telestroke|telestroke
5515853|NCT01226849|diffuse large B-cell lymphoma relapse refractory|diffuse large b-cell lymphoma relapse refractory
5515854|NCT01226836|Pulmonary Rehabilitation|pulmonary rehabilitation
5515855|NCT01226823|cholestasis|cholestasis
5515856|NCT01226823|pregnancy|pregnancy
5515857|NCT01226823|ursodeoxycholic acid|ursodeoxycholic acid
5515858|NCT01226823|ICP|icp
5515859|NCT01226797|Chronic HCV infection|chronic hcv infection
5515860|NCT01226797|raised ALT|raised alt
5515861|NCT01226797|transaminitis|transaminitis
5515862|NCT01226797|HCV infection|hcv infection
5515863|NCT01226771|hepatitis V virus|hepatitis v virus
5515864|NCT01226771|genotype 1|genotype 1
5515865|NCT01226771|ribavirin|ribavirin
5515866|NCT01226771|interferon|interferon
5515867|NCT01226771|Alternative ribavirin dosing|alternative ribavirin dosing
5515868|NCT01226758|Safety|safety
5515869|NCT01226758|Tolerability|tolerability
5515870|NCT01226758|Efficacy|efficacy
5515871|NCT01226758|Influenza|influenza
5515872|NCT01226758|Flu|flu
5515873|NCT01226758|Virus|virus
5515874|NCT01226758|Vaccine|vaccine
5515875|NCT01226745|Multiple sclerosis|multiple sclerosis
5515876|NCT01226745|ONO-4641|ono-4641
5515877|NCT01226745|MSC2430913A|msc2430913a
5515878|NCT01226745|Efficacy|efficacy
5515879|NCT01226732|Solid tumor|solid tumor
5515880|NCT01226732|Capecitabine|capecitabine
5515881|NCT01226732|Hsp90 inhibitor AUY922|hsp90 inhibitor auy922
5515882|NCT01226719|liver-only metastatic KRAS wild-type colorectal cancer|liver-only metastatic kras wild-type colorectal cancer
5655691|NCT00679549|OSA|osa
5515883|NCT01226719|Panitumumab|panitumumab
5515884|NCT01226719|Oxaliplatin|oxaliplatin
5515885|NCT01226719|Irinotecan|irinotecan
5515886|NCT01226719|Leucovorin|leucovorin
5515887|NCT01226719|5-Fluorouracil|5-fluorouracil
5515888|NCT01226706|Urinary incontinence, urge|urinary incontinence, urge
5798700|NCT00111319|Untreated|untreated
5515889|NCT01226706|detrusor hyperreflexia|detrusor hyperreflexia
5515890|NCT01226706|detrusor instability|detrusor instability
5515891|NCT01226706|non-neurogenic|non-neurogenic
5515892|NCT01226706|Female Urogenital Diseases and Pregnancy Complications|female urogenital diseases and pregnancy complications
5515893|NCT01226706|Female Urogenital Diseases|female urogenital diseases
5515894|NCT01226706|Urologic Diseases|urologic diseases
5515895|NCT01226706|Urination Disorders|urination disorders
5515896|NCT01226706|Urinary Incontinence|urinary incontinence
5515898|NCT01226693|single dose bioequivalence study|single dose bioequivalence study
5904028|NCT00007813|recurrent childhood brain tumor|recurrent childhood brain tumor
5515899|NCT01226693|balanced incomplete block design|balanced incomplete block design
5515901|NCT01226693|P38 kinase inhibitor|p38 kinase inhibitor
5515903|NCT01226680|Schirmer test|schirmer test
5515904|NCT01226680|corneal staining|corneal staining
5515905|NCT01226680|OSDI|osdi
5515907|NCT01226667|fibromyalgia|fibromyalgia
5515908|NCT01226667|lyrica|lyrica
5515909|NCT01226667|pregabalin|pregabalin
5515910|NCT01226654|Quantitative Imaging of Multiple Sclerosis|quantitative imaging of multiple sclerosis
5515911|NCT01226641|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5515912|NCT01226641|SCORE|score
5515913|NCT01226641|Telemedicine|telemedicine
5515914|NCT01226641|Arterial blood pressure|arterial blood pressure
5515915|NCT01226641|Daily physical activity|daily physical activity
5515916|NCT01226628|Macular degeneration|macular degeneration
5515917|NCT01226628|Age-related macular degeneration|age-related macular degeneration
5515918|NCT01226628|Cell therapy|cell therapy
5515919|NCT01226628|CNTO 2476|cnto 2476
5515920|NCT01226628|Human umbilical tissue-derived cells|human umbilical tissue-derived cells
5515921|NCT01226628|hUTC|hutc
5515922|NCT01226628|Geographic Atrophy|geographic atrophy
5515923|NCT01226628|Subretinal|subretinal
5515924|NCT01226628|Visual Acuity|visual acuity
5516206|NCT01225198|Minerals|minerals
5515925|NCT01226615|Chondroitin sulphate|chondroitin sulphate
5515926|NCT01226615|Knee osteoarthritis|knee osteoarthritis
5515927|NCT01226615|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5515928|NCT01226602|Ticagrelor|ticagrelor
5515929|NCT01226602|Healthy|healthy
5515930|NCT01226602|Coronary flow velocity|coronary flow velocity
5515931|NCT01226602|Adenosine|adenosine
5515932|NCT01226589|Cancer cancer|cancer cancer
5515933|NCT01226589|MRS|mrs
5515934|NCT01226589|Treatment response|treatment response
5515935|NCT01226589|Histologically confirmed diagnosed Breast cancer.|histologically confirmed diagnosed breast cancer.
5515936|NCT01226589|Patient is 18 years or older.|patient is 18 years or older.
5515937|NCT01226589|Karnofsky performance score is equal to or greater than 70.|karnofsky performance score is equal to or greater than 70.
5515938|NCT01226589|No previously irradiated or recurrent breast.|no previously irradiated or recurrent breast.
5515939|NCT01226589|No contraindication to MRS/MRI.|no contraindication to mrs/mri.
5515940|NCT01226576|MRgFUS|mrgfus
5515941|NCT01226576|Prostate Cancer|prostate cancer
5515942|NCT01226576|Low-Intermediate Risk Prostate Cancer|low-intermediate risk prostate cancer
5515943|NCT01226576|Localized Prostate Cancer|localized prostate cancer
5515944|NCT01226576|InSightec|insightec
5515945|NCT01226576|ExAblate|exablate
5515946|NCT01226563|STEMI|stemi
5515947|NCT01226563|Acute Myocardial Infarction|acute myocardial infarction
5515948|NCT01226563|Congestive Heart Failure|congestive heart failure
5515949|NCT01226563|Left Ventricular Remodeling|left ventricular remodeling
5515950|NCT01226563|Devices, Medical|devices, medical
5515951|NCT01226550|hyperthermic intraoperative peritoneal chemotherapy (HIPEC)|hyperthermic intraoperative peritoneal chemotherapy (hipec)
5515952|NCT01226550|Irinotecan|irinotecan
5515953|NCT01226550|Pharmacokinetics|pharmacokinetics
5515954|NCT01226550|peritoneal carcinomatosis (PC)|peritoneal carcinomatosis (pc)
5515955|NCT01226537|Taurine,Diabetes mellitus,oxidative stress,glycemic control|taurine,diabetes mellitus,oxidative stress,glycemic control
5515956|NCT01226498|Blood Transfusion, Autologous|blood transfusion, autologous
5515957|NCT01226498|Blood Preservation/adverse effects|blood preservation/adverse effects
5515958|NCT01226498|Blood Transfusion/adverse effects|blood transfusion/adverse effects
5515959|NCT01226498|Endothelium, Vascular/physiopathology|endothelium, vascular/physiopathology
5515960|NCT01226498|Inflammation Mediators|inflammation mediators
5515961|NCT01226485|Cancer|cancer
5515962|NCT01226485|Terminal|terminal
5515963|NCT01226485|Solid Tumor|solid tumor
5515964|NCT01226485|End Stage|end stage
5515965|NCT01226485|Metastatic|metastatic
5515966|NCT01226472|PTCL|ptcl
5515967|NCT01226472|CTCL|ctcl
5515968|NCT01226472|MF|mf
5515969|NCT01226472|SS|ss
5515970|NCT01226459|Female Pattern Baldness|female pattern baldness
5515971|NCT01226433|AE adverse event|ae adverse event
5515972|NCT01226433|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5515973|NCT01226433|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5515974|NCT01226433|ART antiretroviral therapy|art antiretroviral therapy
5515975|NCT01226433|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5515976|NCT01226433|DCF data collection forms|dcf data collection forms
5515977|NCT01226433|DMC Data Monitoring Committee|dmc data monitoring committee
5515978|NCT01226433|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5515979|NCT01226433|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5685348|NCT00556478|Lidocaine|lidocaine
5515980|NCT01226433|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5515981|NCT01226433|ICH International Conference of Harmonisation|ich international conference of harmonisation
5510098|NCT01252628|ERBITUX|erbitux
5515982|NCT01226433|IND Investigational New Drug Application|ind investigational new drug application
5515983|NCT01226433|IRB Institutional Review Board|irb institutional review board
5515984|NCT01226433|IU International units|iu international units
5515985|NCT01226433|mg milligram(s)|mg milligram(s)
5515986|NCT01226433|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5515987|NCT01226433|PCR polymerase chain reaction|pcr polymerase chain reaction
5515988|NCT01226433|SAE serious adverse event|sae serious adverse event
5515989|NCT01226433|µg microgram|µg microgram
5515990|NCT01226433|ULN upper limit of the normal range|uln upper limit of the normal range
5515991|NCT01226433|WB Western Blot|wb western blot
5497935|NCT01304589|PVD|pvd
5515993|NCT01226420|Alefacept|alefacept
5515994|NCT01226420|Amevive|amevive
5515995|NCT01226407|Solid Tumour|solid tumour
5515996|NCT01226394|peritoneal carcinomatosis|peritoneal carcinomatosis
5515997|NCT01226394|HIPEC|hipec
5515998|NCT01226394|controlled clinical trial|controlled clinical trial
5515999|NCT01226381|Paracetamol and setrons|paracetamol and setrons
5516000|NCT01226381|No disease, healthy volunteers|no disease, healthy volunteers
5516001|NCT01226368|HIV, HPV, cervical-vaginal smear|hiv, hpv, cervical-vaginal smear
5516002|NCT01226342|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5516003|NCT01226329|Minority Groups|minority groups
5516004|NCT01226329|Decision Making|decision making
5516005|NCT01226329|Patient Participation|patient participation
5516006|NCT01226329|Mental Health Services|mental health services
5516007|NCT01226329|retention|retention
5516008|NCT01226329|attendance|attendance
5516009|NCT01226329|patient activation|patient activation
5516010|NCT01226329|Hispanic Americans|hispanic americans
5516011|NCT01226329|patient-provider communication|patient-provider communication
5516012|NCT01226316|Advanced solid malignancy,PIK3CA mutated,AKT1 mutated, PTEN mutation, PTEN alteration, metastatic,ER+,breast,ovarian,endometrial,AZD5363,AKT inhibitor,|advanced solid malignancy,pik3ca mutated,akt1 mutated, pten mutation, pten alteration, metastatic,er+,breast,ovarian,endometrial,azd5363,akt inhibitor,
5516013|NCT01226290|uterine fibroid RF ablation|uterine fibroid rf ablation
5516014|NCT01226290|intrauterine ultrasound|intrauterine ultrasound
5516015|NCT01226290|VizAblate|vizablate
5516016|NCT01226264|Uterine cervical cancer|uterine cervical cancer
5516017|NCT01226264|diffusion-weighted MRI|diffusion-weighted mri
5516018|NCT01226264|recurrence|recurrence
5516019|NCT01226251|oral malodour|oral malodour
5516020|NCT01226251|halitosis|halitosis
5516021|NCT01226251|Subjects consulting a bad breath clinic|subjects consulting a bad breath clinic
5516022|NCT01226225|Patients with recent coronary event|patients with recent coronary event
5516023|NCT01226212|Older people|older people
5516024|NCT01226212|Synbiotic|synbiotic
5516025|NCT01226212|Prebiotic|prebiotic
5516026|NCT01226212|Probiotic|probiotic
5516027|NCT01226212|Bacteria|bacteria
5516029|NCT01226186|Knee replacement|knee replacement
5516030|NCT01226186|Pain control|pain control
5516031|NCT01226186|Self medication|self medication
5516032|NCT01226173|Prospective screening of blood donors.|prospective screening of blood donors.
5516033|NCT01226147|Lupus Nephritis|lupus nephritis
5516034|NCT01226147|SLE|sle
5516035|NCT01226147|retinoid|retinoid
5516036|NCT01226147|tamibarotene|tamibarotene
5516037|NCT01226134|Functional Dyspepsia|functional dyspepsia
5516038|NCT01226134|Itopride|itopride
5516039|NCT01226134|Gastric Emptying|gastric emptying
5516040|NCT01226134|Gastric Accommodation|gastric accommodation
5516041|NCT01226134|Dyspeptic Symptoms|dyspeptic symptoms
5516042|NCT01226121|dupuytren|dupuytren
5516043|NCT01226121|dupuytren's|dupuytren's
5516044|NCT01226095|Osteoarthritis|osteoarthritis
5516045|NCT01226095|Pain|pain
5516046|NCT01226095|Morning stiffness|morning stiffness
5516047|NCT01226069|superficial phlebitis|superficial phlebitis
5516048|NCT01226069|cannula-related vein inflammation|cannula-related vein inflammation
5516049|NCT01226069|Glycerine magnesium sulphate|glycerine magnesium sulphate
5516050|NCT01226069|Hirudoid cream|hirudoid cream
5516051|NCT01226069|Nursing|nursing
5516052|NCT01226056|advanced solid tumors|advanced solid tumors
5516053|NCT01226056|Sorafenib (Nexavar®)|sorafenib (nexavar®)
5516054|NCT01226056|RAD001 (everolimus)|rad001 (everolimus)
5516055|NCT01226056|tumor molecular targets|tumor molecular targets
5516056|NCT01226030|Advanced Solid Tumors|advanced solid tumors
5516057|NCT01226017|Oxytocin|oxytocin
5516058|NCT01226017|Animal Assisted therapy|animal assisted therapy
5516059|NCT01226017|Farm animals|farm animals
5516060|NCT01226017|Healthy nursing students|healthy nursing students
5516061|NCT01226004|radiosurgery|radiosurgery
5516062|NCT01226004|prostate|prostate
5516064|NCT01226004|early|early
5516065|NCT01226004|intermediate|intermediate
5516066|NCT01226004|CyberKnife|cyberknife
5516067|NCT01225991|Pain, Fatigue, Geriatric, Rheumatoid Arthritis, Milnacipran|pain, fatigue, geriatric, rheumatoid arthritis, milnacipran
5798701|NCT00111306|Lupus|lupus
5516068|NCT01225978|Genetic Information|genetic information
5516069|NCT01225978|Variant Updates|variant updates
5516070|NCT01225978|Information Technology|information technology
5516071|NCT01225978|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5516072|NCT01225978|Hearing Loss|hearing loss
5516073|NCT01225978|Oncology|oncology
5516074|NCT01225965|Particulate Matter induced inflammation of the lung|particulate matter induced inflammation of the lung
5516079|NCT01225926|Intraocular Lens|intraocular lens
5516081|NCT01225913|asthma|asthma
5516082|NCT01225913|lung function|lung function
5516083|NCT01225913|inflammation|inflammation
5516084|NCT01225874|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5516085|NCT01225874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5516086|NCT01225874|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5516087|NCT01225809|AD01 follow-up extension|ad01 follow-up extension
5516088|NCT01225796|Bicarbonate|bicarbonate
5516089|NCT01225796|Chronic allograft nephropathy|chronic allograft nephropathy
5516090|NCT01225796|Urinary TGF-beta|urinary tgf-beta
5516091|NCT01225796|Urinary acid excretion|urinary acid excretion
5516092|NCT01225770|green tea|green tea
5516093|NCT01225770|gargling|gargling
5516094|NCT01225770|prophylaxis|prophylaxis
5516095|NCT01225770|influenza|influenza
5516096|NCT01225770|Respiratory Tract Infections|respiratory tract infections
5516097|NCT01225770|high school students|high school students
5516098|NCT01225757|Echocardiography|echocardiography
5516099|NCT01225757|HIPEC|hipec
5516100|NCT01225692|Brain Injury|brain injury
5516101|NCT01225692|Head Trauma|head trauma
5516102|NCT01225692|Trauma Systems|trauma systems
5516103|NCT01225692|Head Injury Guideline|head injury guideline
5516104|NCT01225692|Time to Tertiary Care|time to tertiary care
5516105|NCT01225679|Congenital Central Hypoventilation Syndrome|congenital central hypoventilation syndrome
5516106|NCT01225679|Phox2B gene|phox2b gene
5516107|NCT01225679|invasive ventilation|invasive ventilation
5516108|NCT01225679|genetics|genetics
5516109|NCT01225679|late-onset|late-onset
5516110|NCT01225679|sleep|sleep
5516111|NCT01225679|central sleep apnea|central sleep apnea
5516112|NCT01225666|MOD-4023|mod-4023
5516113|NCT01225666|Growth Hormone Deficient Adults|growth hormone deficient adults
5516114|NCT01225666|Phase II|phase ii
5516115|NCT01225653|Latanoprost|latanoprost
5516116|NCT01225653|vasodilation|vasodilation
5516117|NCT01225653|diabetic retinopathy|diabetic retinopathy
5516118|NCT01225640|Tuberculosis|tuberculosis
5516120|NCT01225640|WBA|wba
5516121|NCT01225627|Chronic disease management|chronic disease management
5516122|NCT01225627|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5516123|NCT01225627|Discharge planning|discharge planning
5516124|NCT01225627|Discharge coordinator|discharge coordinator
5516125|NCT01225614|Home ventilation|home ventilation
5516126|NCT01225614|Myotonic dystrophy type 1 (DM1)|myotonic dystrophy type 1 (dm1)
5516127|NCT01225575|large cartilage defects|large cartilage defects
5516128|NCT01225575|knee joint|knee joint
5516129|NCT01225575|femoral condyle, tibia, trochlear, retropatellar|femoral condyle, tibia, trochlear, retropatellar
5516130|NCT01225562|Heart attack|heart attack
5516131|NCT01225562|Heart Disease|heart disease
5516132|NCT01225562|Acute coronary syndrome|acute coronary syndrome
5516133|NCT01225562|ACS|acs
5516134|NCT01225562|Cardiovascular Disease|cardiovascular disease
5516135|NCT01225549|Allergen Challenge|allergen challenge
5516136|NCT01225549|Asthma|asthma
5516137|NCT01225549|Inhaled selective glucocorticoid receptor agonist (iSEGRA)|inhaled selective glucocorticoid receptor agonist (isegra)
5516138|NCT01225536|BRAF mutations|braf mutations
5516139|NCT01225510|recurrent glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
5516140|NCT01225510|CVX-060|cvx-060
5516141|NCT01225510|PF-04856884|pf-04856884
5516142|NCT01225510|phase 2|phase 2
5516143|NCT01225510|open-label|open-label
5516144|NCT01225510|bevacizumab|bevacizumab
5516145|NCT01225510|anti-angiogenic|anti-angiogenic
5516146|NCT01225497|Randomized|randomized
5516147|NCT01225497|Pilot study|pilot study
5516148|NCT01225497|VISA-A|visa-a
5516149|NCT01225497|VAS|vas
5516150|NCT01225484|Knee arthroplasty, perioperative analgesia|knee arthroplasty, perioperative analgesia
5516151|NCT01225471|novel epitope peptide|novel epitope peptide
5500654|NCT01293292|Teriparatide|teriparatide
5516152|NCT01225471|CTL|ctl
5516153|NCT01225471|advanced prostate cancer|advanced prostate cancer
5516154|NCT01225458|Elderly patients|elderly patients
5516155|NCT01225458|renal insufficiency|renal insufficiency
5516156|NCT01225458|systematized gerontologic evaluation|systematized gerontologic evaluation
5516157|NCT01225419|Plerixafor|plerixafor
5516158|NCT01225419|Hematopoietic Stem Cell Transplant mobilization|hematopoietic stem cell transplant mobilization
5516159|NCT01225419|children|children
5516160|NCT01225406|Third line ARV therapy|third line arv therapy
5516161|NCT01225406|HIV RNA|hiv rna
5516162|NCT01225406|Absolute CD4+ T cell count|absolute cd4+ t cell count
5516163|NCT01225406|serious adverse events (SAEs)|serious adverse events (saes)
5516164|NCT01225406|Drug resistance|drug resistance
5516205|NCT01225198|Vitamins|vitamins
5516207|NCT01225185|neurological complications|neurological complications
5516208|NCT01225185|brain blood flow autoregulation|brain blood flow autoregulation
5516209|NCT01225159|tight glycemic control|tight glycemic control
5516210|NCT01225159|cardiac surgery|cardiac surgery
5516211|NCT01225146|Ischemic|ischemic
5516212|NCT01225146|Central|central
5516213|NCT01225146|Retinal|retinal
5516214|NCT01225146|Vein|vein
5516215|NCT01225146|Occlusion|occlusion
5516216|NCT01225146|Ranibizumab|ranibizumab
5516217|NCT01225146|Lucentis|lucentis
5516218|NCT01225146|CRVO|crvo
5516219|NCT01225146|ISCRVO|iscrvo
5516220|NCT01225133|Osteoarthritis, Osteoarthrosis, Arthritis, Arthrosis|osteoarthritis, osteoarthrosis, arthritis, arthrosis
5516221|NCT01225107|Burns|burns
5516222|NCT01225107|Infections|infections
5516223|NCT01225107|Cranberry|cranberry
5516224|NCT01225094|AAA|aaa
5516225|NCT01225094|abdominal aortic aneurysm|abdominal aortic aneurysm
5516226|NCT01225094|acute kidney injury|acute kidney injury
5516227|NCT01225094|ischemia-reperfusion|ischemia-reperfusion
5516228|NCT01225081|ASP1941|asp1941
5516229|NCT01225081|Diabetes mellitus|diabetes mellitus
5516230|NCT01225081|pioglitazone|pioglitazone
5516231|NCT01225042|infectious diarrhea|infectious diarrhea
5510435|NCT01251107|ABVD|abvd
5516232|NCT01225042|probiotics|probiotics
5516233|NCT01225042|prevention|prevention
5516234|NCT01225042|dietary intervention|dietary intervention
5516235|NCT01225042|E. coli infection|e. coli infection
5516236|NCT01225042|intestinal infection|intestinal infection
5516237|NCT01225042|intestinal resistance|intestinal resistance
5516238|NCT01225029|premature birth|premature birth
5516239|NCT01225029|late preterm birth|late preterm birth
5516240|NCT01225029|respiratory distress of the newborn|respiratory distress of the newborn
5516241|NCT01225029|Transient tachypnea of the newborn|transient tachypnea of the newborn
5516242|NCT01225003|gliomas|gliomas
5516243|NCT01225003|magnetic resonance|magnetic resonance
5516244|NCT01225003|diffusion kurtosis imaging|diffusion kurtosis imaging
5516245|NCT01225003|MR spectroscopy|mr spectroscopy
5516246|NCT01225003|grading|grading
5516247|NCT01224990|gastro-intestinal tumor|gastro-intestinal tumor
5516248|NCT01224990|accurate staging|accurate staging
5516249|NCT01224990|whole-body diffusion weighted MRI|whole-body diffusion weighted mri
5516250|NCT01224990|non-invasive|non-invasive
5516251|NCT01224925|carious exposure|carious exposure
5516252|NCT01224925|pulp capping|pulp capping
5516254|NCT01224925|Dycal|dycal
5516255|NCT01224912|Insomnia|insomnia
5516256|NCT01224912|Intervention|intervention
5516257|NCT01224912|Self-help|self-help
5516258|NCT01224912|Internet|internet
5516259|NCT01224899|Heart Failure|heart failure
5516260|NCT01224899|Sympathetic Nervous System|sympathetic nervous system
5516261|NCT01224899|Sympathectomy|sympathectomy
5516262|NCT01224899|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5516263|NCT01224899|Ventricular Dysfunction, Left|ventricular dysfunction, left
5516264|NCT01224886|Aging|aging
5516265|NCT01224886|Insulin resistance|insulin resistance
5516266|NCT01224886|Ectopic lipids|ectopic lipids
5516267|NCT01224886|Obesity|obesity
5516279|NCT01224860|Telmisartan|telmisartan
5516280|NCT01224860|Losartan|losartan
5516281|NCT01224860|Renal transplant|renal transplant
5516283|NCT01224847|Intravitreal Injection|intravitreal injection
5516284|NCT01224847|Anesthesia|anesthesia
5516285|NCT01224834|Ragweed, allergy, sublingual immunotherapy|ragweed, allergy, sublingual immunotherapy
5516286|NCT01224821|iodine I 131 tositumomab|iodine i 131 tositumomab
5516287|NCT01224821|anti-B1 Antibody|anti-b1 antibody
5516288|NCT01224821|Bexxar|bexxar
5516289|NCT01224821|radioimmunotherapy|radioimmunotherapy
5516290|NCT01224821|tositumomab|tositumomab
5516291|NCT01224808|von Willebrand Disease|von willebrand disease
5516292|NCT01224795|uncomplicated influenza|uncomplicated influenza
5516293|NCT01224782|Zemplar capsules|zemplar capsules
5516294|NCT01224782|Chronic kidney disease (CKD) stage 3 or 4|chronic kidney disease (ckd) stage 3 or 4
5516295|NCT01224782|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5516296|NCT01224782|Postmarketing observational study (PMOS)|postmarketing observational study (pmos)
5516297|NCT01224756|Tonsillitis|tonsillitis
5516298|NCT01224756|Pharyngitis|pharyngitis
5516299|NCT01224756|Sore Throat|sore throat
5516300|NCT01224756|Drug Therapy|drug therapy
5516301|NCT01224717|Osteoporosis|osteoporosis
5516302|NCT01224704|Hypertonic Saline Infusion|hypertonic saline infusion
5516303|NCT01224704|Water Deprivation|water deprivation
5516304|NCT01224704|Thirst|thirst
5516305|NCT01224704|Water/Electrolytes Homeostasis|water/electrolytes homeostasis
5516306|NCT01224704|Obesity|obesity
5516312|NCT01224678|breast cancer|breast cancer
5516313|NCT01224665|stage II bladder cancer|stage ii bladder cancer
5516314|NCT01224665|stage III bladder cancer|stage iii bladder cancer
5516315|NCT01224665|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5516316|NCT01224652|gastric cancer|gastric cancer
5516317|NCT01224652|paclitaxel|paclitaxel
5516318|NCT01224652|irinotecan|irinotecan
5516319|NCT01224639|dengue fever|dengue fever
5516320|NCT01224639|live attenuated tetravalent dengue vaccine|live attenuated tetravalent dengue vaccine
5516321|NCT01224639|TDV|tdv
5516322|NCT01224639|Drug therapy|drug therapy
5516323|NCT01224626|VRE|vre
5516324|NCT01224626|Japanese|japanese
5516325|NCT01224626|Post Marketing Surveillance|post marketing surveillance
5516326|NCT01224600|lower limbs|lower limbs
5516327|NCT01224600|Arterial Diseases|arterial diseases
5516328|NCT01224587|Imaging technique|imaging technique
5516329|NCT01224587|gastric transport through the gut|gastric transport through the gut
5516330|NCT01224574|atrial fribrillation, cardiovascular events, aging, D-dimer|atrial fribrillation, cardiovascular events, aging, d-dimer
5516331|NCT01224561|Thinness|thinness
5516332|NCT01224561|Leanness|leanness
5516333|NCT01224561|healthy volunteers|healthy volunteers
5516334|NCT01224561|Lipid metabolism disorder|lipid metabolism disorder
5516335|NCT01224548|vegan|vegan
5516336|NCT01224548|diet|diet
5516337|NCT01224548|diabetes|diabetes
5516338|NCT01224548|overweight|overweight
5516339|NCT01224548|workplace|workplace
5516340|NCT01224548|nutrition|nutrition
5516341|NCT01224548|diabetes and/or overweight|diabetes and/or overweight
5516342|NCT01224535|Complementary foods|complementary foods
5516343|NCT01224535|Amaranth|amaranth
5516344|NCT01224535|Food Based approaches|food based approaches
5516345|NCT01224535|Iron Deficiency anemia|iron deficiency anemia
5516346|NCT01224535|Arid Areas|arid areas
5516347|NCT01224535|Africa|africa
5516348|NCT01224522|Randomized Controlled Trial|randomized controlled trial
5516349|NCT01224522|Total Knee Arthroplasty|total knee arthroplasty
5516350|NCT01224522|Patient Matched Cutting Blocks|patient matched cutting blocks
5516351|NCT01224509|Cervix|cervix
5516352|NCT01224509|EP3 receptors|ep3 receptors
5516353|NCT01224509|Mifepristone|mifepristone
5516354|NCT01224509|Prostaglandin|prostaglandin
5516355|NCT01224509|Receptors|receptors
5516356|NCT01224509|Steroids|steroids
5516357|NCT01224496|Chronic cytopenic haematological diseases|chronic cytopenic haematological diseases
5516358|NCT01224496|Chinese herbal concoction|chinese herbal concoction
5516359|NCT01224496|Supportive management|supportive management
5516360|NCT01224444|colon polyps|colon polyps
5516361|NCT01224444|adenoma resection|adenoma resection
5516362|NCT01224444|colon cancer screening|colon cancer screening
5516363|NCT01224444|colonoscopy|colonoscopy
5516364|NCT01224431|pain|pain
5516365|NCT01224431|lidocaine|lidocaine
5516366|NCT01224431|lumbar puncture|lumbar puncture
5516367|NCT01224431|j-tip|j-tip
5516368|NCT01224418|Tacrolimus|tacrolimus
5516369|NCT01224418|Prograf|prograf
5516370|NCT01224418|Calcinurin inhibitor|calcinurin inhibitor
5516371|NCT01224418|Rheumatoid arthritis(RA)|rheumatoid arthritis(ra)
5516372|NCT01224392|colorectal cancer|colorectal cancer
5516373|NCT01224392|colorectal neoplasms|colorectal neoplasms
5516374|NCT01224392|radiotherapy|radiotherapy
5675376|NCT00599573|HIV|hiv
5516375|NCT01224392|chemoradiotherapy|chemoradiotherapy
5516376|NCT01224392|T3-4 rectal cancer|t3-4 rectal cancer
5516377|NCT01224379|Lumbar spine|lumbar spine
5516378|NCT01224379|fusion|fusion
5516379|NCT01224379|adjacent instability|adjacent instability
5516380|NCT01224379|topping-off.|topping-off.
5516381|NCT01224366|Add-on to insulin|add-on to insulin
5516382|NCT01224327|Liver cirrhosis|liver cirrhosis
5516383|NCT01224327|Radiology|radiology
5516384|NCT01224327|Mesenchymal Stem Cells|mesenchymal stem cells
5516385|NCT01224327|Umbilical Cord|umbilical cord
5516386|NCT01224314|Haemodynamics|haemodynamics
5516387|NCT01224314|Hypotension|hypotension
5516388|NCT01224314|Potassium|potassium
5516389|NCT01224314|Haemodialysis|haemodialysis
5516390|NCT01224314|Dialysis fluids|dialysis fluids
5516391|NCT01224301|seasonal influenza vaccine|seasonal influenza vaccine
5516392|NCT01224301|school-based clinics|school-based clinics
5516393|NCT01224301|economic analysis of school based influenza vaccine delivery|economic analysis of school based influenza vaccine delivery
5516394|NCT01224301|pediatric influenza vaccine rates|pediatric influenza vaccine rates
5516395|NCT01224301|Influenza vaccine information for parents|influenza vaccine information for parents
5516396|NCT01224288|RCC|rcc
5516397|NCT01224288|Kidney cancer|kidney cancer
5516398|NCT01224288|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5516399|NCT01224288|mRCC|mrcc
5516400|NCT01224288|Dynamic contrast enhanced CT|dynamic contrast enhanced ct
5516401|NCT01224288|DCE-CT|dce-ct
5516402|NCT01224288|Tumor perfusion|tumor perfusion
5516403|NCT01224275|group based care|group based care
5516404|NCT01224275|antenatal care|antenatal care
5516405|NCT01224275|parents satisfaction|parents satisfaction
5516406|NCT01224275|Antenatal care´s organization and patient satisfaction|antenatal care´s organization and patient satisfaction
5516407|NCT01224262|influenza vaccine|influenza vaccine
5516408|NCT01224262|seasonal influenza|seasonal influenza
5516409|NCT01224262|novel vaccine|novel vaccine
5516410|NCT01224262|flu|flu
5516411|NCT01224249|Selenium|selenium
5516412|NCT01224249|Selenoprotein P|selenoprotein p
5516413|NCT01224249|Fish|fish
5516414|NCT01224249|Shellfish|shellfish
5516415|NCT01224249|Bioavailability|bioavailability
5516416|NCT01224223|asthma|asthma
5516417|NCT01224210|portopulmonary hypertension|portopulmonary hypertension
5516418|NCT01224210|portal hypertension|portal hypertension
5516419|NCT01224210|esophageal or gastric varices|esophageal or gastric varices
5516420|NCT01224210|right heart catheterization|right heart catheterization
5516421|NCT01224210|transpulmonary gradient|transpulmonary gradient
5516422|NCT01224210|Endothelin Receptor Antagonist|endothelin receptor antagonist
5516423|NCT01224210|Ambrisentan|ambrisentan
5516424|NCT01224210|Letairis|letairis
5516425|NCT01224210|pulmonary hemodynamics|pulmonary hemodynamics
5516426|NCT01224197|TMC435HPC1004|tmc435hpc1004
5516427|NCT01224197|TMC435|tmc435
5516428|NCT01224197|HCV|hcv
5516429|NCT01224197|Hepatitis C|hepatitis c
5498282|NCT01303198|CPAP|cpap
5516430|NCT01224197|Healthy Chinese volunteer|healthy chinese volunteer
5516431|NCT01224184|HIV|hiv
5516432|NCT01224184|Sexually Transmitted Diseases|sexually transmitted diseases
5516433|NCT01224184|Substance Abuse Detection|substance abuse detection
5516434|NCT01224184|Randomized Controlled Trial|randomized controlled trial
5516435|NCT01224132|Atopic dermatitis, probiotic, SCORAD index, prick tests, cytokines|atopic dermatitis, probiotic, scorad index, prick tests, cytokines
5516436|NCT01224119|foot ankle arthritis bone graft|foot ankle arthritis bone graft
5516437|NCT01224054|Tolerance alimentary|tolerance alimentary
5516438|NCT01224054|Morbid obesity|morbid obesity
5516439|NCT01224054|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5516440|NCT01224041|Tacrolimus|tacrolimus
5516441|NCT01224041|Prograf|prograf
5516442|NCT01224041|Calcinurin inhibitor|calcinurin inhibitor
5516443|NCT01224041|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5516444|NCT01224028|Tacrolimus|tacrolimus
5516446|NCT01224028|Calcinurin inhibitor|calcinurin inhibitor
5516447|NCT01224028|Albuminurea|albuminurea
5516448|NCT01224028|Proteinurea|proteinurea
5516449|NCT01224028|FK506|fk506
5516450|NCT01224002|Cross-Sectional|cross-sectional
5516451|NCT01224002|Observational|observational
5516452|NCT01224002|Comparative|comparative
5516453|NCT01224002|Retrospective|retrospective
5516454|NCT01224002|Feasibility|feasibility
5516455|NCT01224002|Dental Decay|dental decay
5516456|NCT01224002|Drug Abuse|drug abuse
5516457|NCT01224002|Survey|survey
5516465|NCT01223963|Retrospective|retrospective
5516466|NCT01223924|cancer|cancer
5516467|NCT01223898|CML,|cml,
5516468|NCT01223898|nilotinib,|nilotinib,
5516469|NCT01223898|midazolam|midazolam
5671474|NCT00615901|methotrexate|methotrexate
5904029|NCT00007813|disseminated neuroblastoma|disseminated neuroblastoma
5516470|NCT01223859|Radiofrequency, ablation, RFA, RFTA, RFITT, soft palate.|radiofrequency, ablation, rfa, rfta, rfitt, soft palate.
5516471|NCT01223833|breast cancer|breast cancer
5516472|NCT01223833|postmenopausal|postmenopausal
5516473|NCT01223833|aromatase inhibitors|aromatase inhibitors
5516474|NCT01223833|tamoxifen|tamoxifen
5516475|NCT01223833|arthralgia|arthralgia
5516476|NCT01223833|IGF-I|igf-i
5516478|NCT01223833|grip strength|grip strength
5516479|NCT01223807|COPD, diaphragm, rehabilitation|copd, diaphragm, rehabilitation
5516480|NCT01223794|Fall|fall
5516481|NCT01223794|all in surgical & Medical in-patient|all in surgical & medical in-patient
5516482|NCT01223781|Freezing|freezing
5516483|NCT01223781|biofeedback|biofeedback
5516484|NCT01223781|motor learning|motor learning
5516485|NCT01223781|freezing of gait in PD|freezing of gait in pd
5516486|NCT01223755|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5516487|NCT01223755|Sirolimus|sirolimus
5516488|NCT01223755|Renal insufficiency|renal insufficiency
5516489|NCT01223729|Acetyl-L-carnitine;|acetyl-l-carnitine;
5516490|NCT01223729|Minimal hepatic encephalopathy;|minimal hepatic encephalopathy;
5516491|NCT01223729|Quality of life;|quality of life;
5516492|NCT01223729|Depression.|depression.
5516493|NCT01223716|amblyopia treatment|amblyopia treatment
5516494|NCT01223716|neural plasticity|neural plasticity
5516495|NCT01223716|perceptual learning|perceptual learning
5516496|NCT01223716|vision therapy|vision therapy
5516497|NCT01223716|spatial vision|spatial vision
5516498|NCT01223716|video games|video games
5516499|NCT01223716|occlusion therapy|occlusion therapy
5516500|NCT01223703|n-3 PUFAs|n-3 pufas
5516501|NCT01223703|Heart Failure|heart failure
5516502|NCT01223703|Dilated cardiomyopathy|dilated cardiomyopathy
5516503|NCT01223703|Ejection Fraction|ejection fraction
5516504|NCT01223703|Exercise Capacity|exercise capacity
5516505|NCT01223690|sepsis|sepsis
5516506|NCT01223690|infection|infection
5516507|NCT01223690|bacteremia|bacteremia
5516508|NCT01223690|clarithromycin|clarithromycin
5516509|NCT01223664|ABMSC|abmsc
5516510|NCT01223664|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
5516511|NCT01223664|Liver cirrhosis|liver cirrhosis
5516512|NCT01223664|Transplantation|transplantation
5516513|NCT01223651|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5516514|NCT01223651|Continuous Glucose Monitoring System|continuous glucose monitoring system
5516515|NCT01223651|Accuracy|accuracy
5516516|NCT01223651|Altitude|altitude
5516517|NCT01223638|Congenital hypothyroidism(CH)|congenital hypothyroidism(ch)
5516518|NCT01223638|Hearing loss among children with CH|hearing loss among children with ch
5516519|NCT01223612|Diabetes Mellitus|diabetes mellitus
5516520|NCT01223612|Diabetes Complications|diabetes complications
5516521|NCT01223612|Retinal Diseases|retinal diseases
5516522|NCT01223612|Edema|edema
5516523|NCT01223612|Endothelial Growth Factors|endothelial growth factors
5516524|NCT01223612|Monoclonal Antibodies|monoclonal antibodies
5516525|NCT01223612|Ranibizumab|ranibizumab
5516526|NCT01223612|Laser therapy|laser therapy
5516527|NCT01223599|pilonidal disease|pilonidal disease
5516528|NCT01223599|natal cleft|natal cleft
5516529|NCT01223599|limberg flap|limberg flap
5516530|NCT01223560|Artificial pancreas|artificial pancreas
5516531|NCT01223560|Model predictive control|model predictive control
5516532|NCT01223560|Virtual patient|virtual patient
5516533|NCT01223547|Carbohydrate counting|carbohydrate counting
5516534|NCT01223547|Insulin bolus calculation|insulin bolus calculation
5516535|NCT01223534|Tuberculosis|tuberculosis
5516536|NCT01223534|Latent tuberculosis infection|latent tuberculosis infection
5516537|NCT01223534|Tuberculin skin test|tuberculin skin test
5516538|NCT01223534|Interferon-gamma release assays|interferon-gamma release assays
5516539|NCT01223534|Contact-tracing study|contact-tracing study
5516540|NCT01223521|Contraception|contraception
5516541|NCT01223521|Abortion|abortion
5516542|NCT01223521|First trimester|first trimester
5516543|NCT01223521|Intrauterine device|intrauterine device
5516544|NCT01223482|Miscarriage|miscarriage
5516545|NCT01223482|Karyotyping|karyotyping
5516546|NCT01223482|Genetic testing|genetic testing
5516547|NCT01223469|Atrial Fibrillation|atrial fibrillation
5516548|NCT01223469|Supraventricular Tachycardia|supraventricular tachycardia
5516549|NCT01223469|Contact Force|contact force
5516550|NCT01223469|RF Ablation|rf ablation
5516551|NCT01223469|Radiofrequency|radiofrequency
5516552|NCT01223469|Pulmonary Vein Isolation|pulmonary vein isolation
5516553|NCT01223469|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5516554|NCT01223456|Saxagliptin|saxagliptin
5516555|NCT01223456|type 2 diabetes|type 2 diabetes
5516556|NCT01223456|clinical practice|clinical practice
5516557|NCT01223443|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5516558|NCT01223443|Drug Eluting Stent|drug eluting stent
5516559|NCT01223443|Saphenous Vein Graft|saphenous vein graft
5516560|NCT01223430|septic shock|septic shock
5516561|NCT01223430|shock reversal|shock reversal
5516563|NCT01223430|traditional Chinese medicine|traditional chinese medicine
5516564|NCT01223404|nicotine|nicotine
5516565|NCT01223404|mecamylamine|mecamylamine
5516566|NCT01223404|attention|attention
5516567|NCT01223404|default network|default network
5516568|NCT01223404|fMRI|fmri
5516569|NCT01223391|orthostatic|orthostatic
5516570|NCT01223391|abdominal compression|abdominal compression
5516571|NCT01223365|moderate to severe pain|moderate to severe pain
5516572|NCT01223365|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5516573|NCT01223365|postherpetic neuralgia|postherpetic neuralgia
5516574|NCT01223365|traumatic injury|traumatic injury
5516575|NCT01223365|complex regional pain syndrome|complex regional pain syndrome
5516576|NCT01223365|back pain|back pain
5516577|NCT01223365|neck pain|neck pain
5516578|NCT01223365|osteoarthritis|osteoarthritis
5516579|NCT01223365|rheumatoid arthritis|rheumatoid arthritis
5516580|NCT01223352|pulmonary arterial hypertension|pulmonary arterial hypertension
5516581|NCT01223352|children|children
5516582|NCT01223352|pediatric|pediatric
5516583|NCT01223352|bosentan|bosentan
5516584|NCT01223339|Ertugliflozin|ertugliflozin
5516585|NCT01223339|Japanese and Western population|japanese and western population
5516586|NCT01223339|pharmacokinetics|pharmacokinetics
5516587|NCT01223339|pharmacodynamics|pharmacodynamics
5516588|NCT01223326|Acetylcysteine|acetylcysteine
5516589|NCT01223313|Contraception|contraception
5516590|NCT01223313|Woman's Condom|woman's condom
5516591|NCT01223313|Female Condom|female condom
5516592|NCT01223313|Condom|condom
5516593|NCT01223287|NICHD Neonatal Research Network|nichd neonatal research network
5516594|NCT01223287|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5516595|NCT01223287|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5516596|NCT01223287|Prematurity|prematurity
5516597|NCT01223287|Mechanical ventilation|mechanical ventilation
5516598|NCT01223287|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5516599|NCT01223274|NICHD Neonatal Research Network|nichd neonatal research network
5516600|NCT01223274|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5516802|NCT01222481|Function|function
5516601|NCT01223274|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5516602|NCT01223274|Prematurity|prematurity
5516603|NCT01223274|Mechanical ventilation|mechanical ventilation
5516604|NCT01223274|Positive-Pressure Ventilation|positive-pressure ventilation
5516605|NCT01223274|Surfactant|surfactant
5516606|NCT01223274|Intubation|intubation
5516607|NCT01223274|Pulse oximetry|pulse oximetry
5516608|NCT01223274|Oxygen saturation|oxygen saturation
5516609|NCT01223261|NICHD Neonatal Research Network|nichd neonatal research network
5516610|NCT01223261|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5516611|NCT01223261|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5516612|NCT01223261|Prematurity|prematurity
5516613|NCT01223261|Laparotomy|laparotomy
5516614|NCT01223261|Drainage|drainage
5516615|NCT01223261|Isolated intestinal perforation|isolated intestinal perforation
5516616|NCT01223261|Focal intestinal performation|focal intestinal performation
5516617|NCT01223248|radiation|radiation
5516618|NCT01223248|Hypofractionated Image- Guided|hypofractionated image- guided
5516621|NCT01223248|10-154|10-154
5516622|NCT01223235|FALLOPIAN TUBE|fallopian tube
5516623|NCT01223235|OVARY|ovary
5516624|NCT01223235|PERITONEUM|peritoneum
5516625|NCT01223235|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5516626|NCT01223235|GLOBO H-KLH CONJUGATE|globo h-klh conjugate
5516627|NCT01223235|MUC-1 KLH|muc-1 klh
5516628|NCT01223235|OPT-821|opt-821
5516629|NCT01223235|TF (C) - KLH|tf (c) - klh
5516630|NCT01223235|TN(C)-KLH|tn(c)-klh
5516631|NCT01223235|10-099|10-099
5516632|NCT01223222|Uncomplicated skin infections|uncomplicated skin infections
5516633|NCT01223222|Impetigo|impetigo
5516634|NCT01223222|Gram-negative|gram-negative
5516635|NCT01223222|Diagnosis of uncomplicated, Gram-positive, skin infection. This may include patients with mild eczema/dermatoses such as atopic dermatitis.|diagnosis of uncomplicated, gram-positive, skin infection. this may include patients with mild eczema/dermatoses such as atopic dermatitis.
5516636|NCT01223222|Gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),|gram-positive organisms which in the opinion of the investigator are causative for infection of the lesion(s),
5516637|NCT01223209|Cancer|cancer
5516638|NCT01223209|Carcinoma|carcinoma
5516640|NCT01223209|Curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start|curative surgery for carcinoma at least three months and not more than 5 years prior to treatment start
5516641|NCT01223196|Type 2 Diabetes, Thiazolidinediones, TIMP-3, TACE, TNF-a,|type 2 diabetes, thiazolidinediones, timp-3, tace, tnf-a,
5516642|NCT01223196|insulin resistance|insulin resistance
5516643|NCT01223183|cystic fibrosis|cystic fibrosis
5516644|NCT01223183|nuclear medicine|nuclear medicine
5516645|NCT01223183|aerosol|aerosol
5516646|NCT01223183|nebulizer|nebulizer
5516647|NCT01223170|Tailoring|tailoring
5516648|NCT01223170|Cardiac rehabilitation|cardiac rehabilitation
5516649|NCT01223170|Internet based intervention|internet based intervention
5516650|NCT01223170|Exercise|exercise
5516651|NCT01223170|Cardiovascular Disease rehabilitation|cardiovascular disease rehabilitation
5516652|NCT01223157|obesity|obesity
5656709|NCT00675597|07-178|07-178
5516653|NCT01223157|endocannabinoids|endocannabinoids
5516654|NCT01223144|Cognition|cognition
5516655|NCT01223144|orbitofrontal cortex|orbitofrontal cortex
5516656|NCT01223144|Iowa Gambling Task|iowa gambling task
5516657|NCT01223144|facial emotion recognition|facial emotion recognition
5516658|NCT01223118|Oocyte|oocyte
5516659|NCT01223118|vitrification|vitrification
5516660|NCT01223118|IVF|ivf
5516661|NCT01223118|PGD|pgd
5516662|NCT01223118|embryo biopsy|embryo biopsy
5516663|NCT01223105|slow freeze|slow freeze
5516664|NCT01223105|cryopreservation|cryopreservation
5516665|NCT01223105|vitrification|vitrification
5516666|NCT01223105|oocyte preservation|oocyte preservation
5516667|NCT01223092|IVF|ivf
5516668|NCT01223092|infertility|infertility
5516669|NCT01223092|DNA|dna
5516670|NCT01223079|r-hFSH|r-hfsh
5516671|NCT01223079|r-hLH|r-hlh
5516672|NCT01223066|Macrolane|macrolane
5516673|NCT01223053|Sprain|sprain
5516674|NCT01223053|Strain|strain
5516675|NCT01223053|Pain|pain
5516676|NCT01223053|Ankle Pain|ankle pain
5516677|NCT01223053|Knee Pain|knee pain
5516678|NCT01223053|Wrist Pain|wrist pain
5516679|NCT01223053|Hand Pain|hand pain
5516680|NCT01223027|Dovitinib|dovitinib
5516681|NCT01223027|TKI|tki
5516682|NCT01223027|Renal cell cancer|renal cell cancer
5516683|NCT01223027|RCC|rcc
5516684|NCT01223027|mRCC|mrcc
5516685|NCT01223014|Radioactive|radioactive
5516686|NCT01223014|ADME|adme
5516687|NCT01223014|Neuropathic pain|neuropathic pain
5516688|NCT01223001|Depression|depression
5516689|NCT01223001|Traumatic brain injury|traumatic brain injury
5516690|NCT01223001|Duloxetine|duloxetine
5516691|NCT01223001|Cymbalta|cymbalta
5516692|NCT01223001|impaired cognitive function|impaired cognitive function
5516693|NCT01222975|risperidone fasting study|risperidone fasting study
5516694|NCT01222936|LBH581|lbh581
5516695|NCT01222936|Panobinostat|panobinostat
5516696|NCT01222936|Small Cell Lung Carcinoma|small cell lung carcinoma
5516697|NCT01222923|Risperidone fed study|risperidone fed study
5516803|NCT01222481|Cognition|cognition
5516698|NCT01222910|Valacyclovir hydrochloride fasting study|valacyclovir hydrochloride fasting study
5516699|NCT01222897|Valacyclovir hydrochloride fed study|valacyclovir hydrochloride fed study
5516700|NCT01222871|Treatment|treatment
5516701|NCT01222858|Obesity|obesity
5516702|NCT01222858|Primary Care|primary care
5516703|NCT01222858|Internet|internet
5516704|NCT01222858|Technology|technology
5516705|NCT01222858|Behavior Modification|behavior modification
5516706|NCT01222819|Febrile neutropenia|febrile neutropenia
5516707|NCT01222819|growth factors|growth factors
5516708|NCT01222819|leukemia|leukemia
5516709|NCT01222806|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5516710|NCT01222806|Cocaine|cocaine
5516711|NCT01222806|Cue-Induced Craving|cue-induced craving
5516712|NCT01222806|Repetitive TMS (rTMS)|repetitive tms (rtms)
5516713|NCT01222806|Cocaine Craving|cocaine craving
5498557|NCT01302119|toenail infection|toenail infection
5516714|NCT01222793|High Weight Gain Liability (HWLA)|high weight gain liability (hwla)
5516715|NCT01222793|Antipsychotic|antipsychotic
5516716|NCT01222793|Obesity|obesity
5516717|NCT01222793|Low Weight Gain|low weight gain
5516718|NCT01222793|Schizophrenia|schizophrenia
5516719|NCT01222793|Food Craving|food craving
5516720|NCT01222780|Hematologic Malignancies|hematologic malignancies
5516721|NCT01222780|Vincristine Sulfate|vincristine sulfate
5516722|NCT01222780|Maximum Tolerated Dose|maximum tolerated dose
5516723|NCT01222780|Pharmacokinetics|pharmacokinetics
5516724|NCT01222780|Solid Tumors|solid tumors
5516725|NCT01222780|Cancer|cancer
5516726|NCT01222780|Pediatrics|pediatrics
5516727|NCT01222780|Sarcoma|sarcoma
5516728|NCT01222780|Wilms Tumor|wilms tumor
5516729|NCT01222780|Leukemia|leukemia
5516730|NCT01222780|Lymphoma|lymphoma
5516731|NCT01222780|Brain Tumor|brain tumor
5516733|NCT01222767|PNET|pnet
5516734|NCT01222767|EOE|eoe
5516735|NCT01222754|Newly Diagnosed|newly diagnosed
5516736|NCT01222754|DIPG|dipg
5516737|NCT01222754|Radiation Therapy|radiation therapy
5516738|NCT01222754|CC-5013|cc-5013
5516739|NCT01222754|XRT|xrt
5516740|NCT01222754|Brain Tumor|brain tumor
5516741|NCT01222754|Glioma|glioma
5516742|NCT01222754|Pediatrics|pediatrics
5516743|NCT01222741|PID|pid
5516744|NCT01222741|Primary Immune Deficiencies|primary immune deficiencies
5516745|NCT01222741|Candida|candida
5516746|NCT01222741|Immune Abnormalities|immune abnormalities
5516747|NCT01222741|Diabetic|diabetic
5516748|NCT01222728|PET Imaging|pet imaging
5516749|NCT01222728|Vestibular Schwannoma|vestibular schwannoma
5516750|NCT01222728|Neurofibromatosis|neurofibromatosis
5516751|NCT01222728|Neurofibromatosis Type 2|neurofibromatosis type 2
5516752|NCT01222728|NF2|nf2
5516753|NCT01222702|CDIFF|cdiff
5516754|NCT01222702|CDAD|cdad
5516755|NCT01222702|CDI|cdi
5516756|NCT01222702|Clostridium difficile infection|clostridium difficile infection
5516757|NCT01222676|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5516758|NCT01222676|stage II bladder cancer|stage ii bladder cancer
5516759|NCT01222676|stage III bladder cancer|stage iii bladder cancer
5516760|NCT01222676|stage IV bladder cancer|stage iv bladder cancer
5516761|NCT01222663|peritonitis|peritonitis
5516762|NCT01222663|septic shock|septic shock
5516763|NCT01222663|hemoperfusion|hemoperfusion
5516764|NCT01222663|Polymyxin B|polymyxin b
5516765|NCT01222663|endotoxin|endotoxin
5516766|NCT01222650|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5516768|NCT01222650|α1A-AR antagonist|α1a-ar antagonist
5516769|NCT01222637|advanced solid cancers|advanced solid cancers
5516770|NCT01222637|metastatic solid cancers|metastatic solid cancers
5516771|NCT01222624|advanced solid malignancies|advanced solid malignancies
5516772|NCT01222611|HIV|hiv
5516773|NCT01222611|HCV|hcv
5516774|NCT01222611|HIV/HCV|hiv/hcv
5516775|NCT01222611|Coinfection|coinfection
5516776|NCT01222611|Fosamprenavir|fosamprenavir
5516777|NCT01222585|Metronidazole|metronidazole
5516778|NCT01222585|Neonate|neonate
5516779|NCT01222585|Premature|premature
5516780|NCT01222585|Sepsis|sepsis
5516781|NCT01222585|Necrotizing enterocolitis|necrotizing enterocolitis
5516782|NCT01222572|radiation therapy|radiation therapy
5516783|NCT01222572|stereotactic radiotherapy|stereotactic radiotherapy
5516784|NCT01222572|stereotactic boost|stereotactic boost
5516785|NCT01222559|Cartilage defects|cartilage defects
5516786|NCT01222559|Knee joint|knee joint
5516787|NCT01222559|Femoral Condyle|femoral condyle
5516788|NCT01222507|tinnitus|tinnitus
5516789|NCT01222507|cognition|cognition
5516790|NCT01222507|brain processing speed|brain processing speed
5516791|NCT01222507|Brain Fitness Program|brain fitness program
5516792|NCT01222507|Posit Science|posit science
5516793|NCT01222494|Child Psychiatry|child psychiatry
5516794|NCT01222494|Obesity|obesity
5516795|NCT01222494|Antipsychotic|antipsychotic
5516796|NCT01222481|Head and Neck Cancer|head and neck cancer
5516797|NCT01222481|Functional Status|functional status
5516798|NCT01222481|Cognitive Status|cognitive status
5516799|NCT01222481|Neurocognitive Assessments|neurocognitive assessments
5516800|NCT01222481|Performance-based Assessments|performance-based assessments
5516801|NCT01222481|Cancer|cancer
5516804|NCT01222481|Quality of Life|quality of life
5516805|NCT01222468|Spasticity, Spinal Cord Injury|spasticity, spinal cord injury
5516806|NCT01222455|Phase 1|phase 1
5516807|NCT01222455|Healthy volunteers|healthy volunteers
5516808|NCT01222455|Volunteers with hepatic impairment|volunteers with hepatic impairment
5516809|NCT01222455|Pharmacokinetics|pharmacokinetics
5516810|NCT01222455|Fostamatinib|fostamatinib
5516811|NCT01222442|Respiratory disease|respiratory disease
5516812|NCT01222442|Bronchiolitis|bronchiolitis
5516813|NCT01222442|Emphysema|emphysema
5516814|NCT01222442|Lung disease causing persistent narrowing of the airways|lung disease causing persistent narrowing of the airways
5516815|NCT01222390|Breast Cancer Reconstruction|breast cancer reconstruction
5516816|NCT01222390|Tissue Expander|tissue expander
5516817|NCT01222390|3-D Camera|3-d camera
5516818|NCT01222390|Breast Reconstruction|breast reconstruction
5516819|NCT01222390|Crescentric|crescentric
5516821|NCT01222390|Fill-Volume|fill-volume
5516822|NCT01222390|Lower Pole|lower pole
5516823|NCT01222390|Upper Pole|upper pole
5516824|NCT01222390|Acellular Dermis|acellular dermis
5516825|NCT01222390|3-D Imaging|3-d imaging
5516826|NCT01222364|NICHD Neonatal Research Network|nichd neonatal research network
5516827|NCT01222364|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5516828|NCT01222364|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5516829|NCT01222364|Prematurity|prematurity
5516830|NCT01222351|Alzheimer's disease|alzheimer's disease
5516831|NCT01222351|Positron emission tomography|positron emission tomography
5516832|NCT01222351|Biomarker|biomarker
5516833|NCT01222351|Plasma Aβ|plasma aβ
5516834|NCT01222351|Brain amyloid plaque load|brain amyloid plaque load
5516835|NCT01222338|Mycobacterium|mycobacterium
5516836|NCT01222338|MDR-TB|mdr-tb
5516837|NCT01222338|XDR-TB|xdr-tb
5516839|NCT01222338|HCV|hcv
5516840|NCT01222325|kidney calculi|kidney calculi
5516841|NCT01222325|urolithiasis|urolithiasis
5516842|NCT01222325|urologic surgical procedures|urologic surgical procedures
5516843|NCT01222325|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
5516844|NCT01222312|advanced NSCLC|advanced nsclc
5516845|NCT01222312|oxaliplatin|oxaliplatin
5516846|NCT01222312|cisplatin|cisplatin
5516847|NCT01222312|docetaxel|docetaxel
5516848|NCT01222312|locally advanced or metastatic non small cell lung cancer (stage IIIB-IV)|locally advanced or metastatic non small cell lung cancer (stage iiib-iv)
5516849|NCT01222286|Smoldering Multiple Myeloma|smoldering multiple myeloma
5516850|NCT01222273|cystic fibrosis|cystic fibrosis
5516851|NCT01222273|Allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
5516852|NCT01222273|A. fumigatus|a. fumigatus
5516853|NCT01222273|Immune response|immune response
5516854|NCT01222260|Amyloidosis|amyloidosis
5516855|NCT01222260|Dexamethasone|dexamethasone
5516856|NCT01222260|Bendamustine|bendamustine
5516857|NCT01222260|Relapsed AL Amyloidosis|relapsed al amyloidosis
5516858|NCT01222247|Betamethasone|betamethasone
5516859|NCT01222247|Steroids|steroids
5516860|NCT01222247|Perinatology|perinatology
5516861|NCT01222247|Late Preterm|late preterm
5516862|NCT01222221|adult gliosarcoma|adult gliosarcoma
5516863|NCT01222221|adult giant cell glioblastoma|adult giant cell glioblastoma
5516864|NCT01222221|adult glioblastoma|adult glioblastoma
5516865|NCT01222208|Bowel resection|bowel resection
5516866|NCT01222195|Myelodysplastic Syndrome|myelodysplastic syndrome
5516867|NCT01222195|Red cell transfusion independence|red cell transfusion independence
5516868|NCT01222195|Darbepoetin alfa|darbepoetin alfa
5516869|NCT01222195|Lenalidomide|lenalidomide
5516871|NCT01222195|Revlimid|revlimid
5516872|NCT01222195|Aranesp|aranesp
5516873|NCT01222195|Erythropoietin|erythropoietin
5516874|NCT01222195|Erythropoiesis Stimulating Protein|erythropoiesis stimulating protein
5516875|NCT01222182|low density lipoprotein (LDL) cholesterol|low density lipoprotein (ldl) cholesterol
5516876|NCT01222182|statin|statin
5516877|NCT01222182|dose equivalent|dose equivalent
5516878|NCT01222182|Hypercholesterolemia (defined by LDL guidelines)|hypercholesterolemia (defined by ldl guidelines)
5516879|NCT01222169|Anesthesia|anesthesia
5516880|NCT01222169|Children|children
5516881|NCT01222169|Larynx|larynx
5516882|NCT01222156|Cardiac arrhythmias|cardiac arrhythmias
5516883|NCT01222156|Catheter ablation|catheter ablation
5516884|NCT01222156|Electrophysiology|electrophysiology
5516885|NCT01222156|Magnetic|magnetic
5516886|NCT01222156|Mapping|mapping
5516887|NCT01222156|Remote navigation|remote navigation
5516888|NCT01222143|AML|aml
5516889|NCT01222143|NOVE-HiDAC|nove-hidac
5516890|NCT01222143|Nilotinib|nilotinib
5516891|NCT01222130|HIV|hiv
5516892|NCT01222130|Infant infection|infant infection
5516893|NCT01222130|Diagnosis|diagnosis
5516894|NCT01222130|Non-virological algorithm|non-virological algorithm
5516895|NCT01222117|Acute Limb Ischemia|acute limb ischemia
5516896|NCT01222104|vascular closure|vascular closure
5516897|NCT01222104|Angio-Seal|angio-seal
5516898|NCT01222104|Interventional radiology|interventional radiology
5516899|NCT01222104|femoral artery|femoral artery
5516900|NCT01222078|newly diagnosed type 1 diabetes mellitus|newly diagnosed type 1 diabetes mellitus
5516901|NCT01222078|re-treatment|re-treatment
5516902|NCT01222078|intravenous otelixizumab|intravenous otelixizumab
5516903|NCT01222078|beta-cell preservation|beta-cell preservation
5516904|NCT01222065|Glaucoma|glaucoma
5516905|NCT01222065|Neurotubules|neurotubules
5516906|NCT01222065|Birefringence|birefringence
5516907|NCT01222065|Retinal Nerve Fiber Layer (RNFL)|retinal nerve fiber layer (rnfl)
5516908|NCT01222052|high risk breast cancer|high risk breast cancer
5516909|NCT01222052|low risk breast cancer|low risk breast cancer
5516911|NCT01222052|urokinase-type plasminogen activator|urokinase-type plasminogen activator
5516912|NCT01222052|PAI|pai
5516913|NCT01222052|plasminogen activator inhibitor-type|plasminogen activator inhibitor-type
5516914|NCT01222039|Graft versus host disease|graft versus host disease
5516915|NCT01222039|Mesenchymal stem cell|mesenchymal stem cell
5516916|NCT01222039|Allogeneic mesenchymal stem cell|allogeneic mesenchymal stem cell
5790009|NCT00146172|Neratinib|neratinib
5516918|NCT01222039|Allotransplant|allotransplant
5516919|NCT01222039|Allogenic|allogenic
5516920|NCT01222039|Mesenchymal Stem Cells|mesenchymal stem cells
5516921|NCT01222039|Immune System Diseases|immune system diseases
5516922|NCT01222039|Chronic|chronic
5516923|NCT01222039|Expanded|expanded
5516924|NCT01222026|Primary Hyperparathyroidism|primary hyperparathyroidism
5516925|NCT01222026|Osteopenia|osteopenia
5516926|NCT01222026|Osteoporosis|osteoporosis
5516927|NCT01221987|Human papillomavirus|human papillomavirus
5516928|NCT01221987|neoplasia|neoplasia
5516929|NCT01221974|Hydrosalpinx or infertility|hydrosalpinx or infertility
5516930|NCT01221961|Major spine surgery|major spine surgery
5516931|NCT01221961|Hemoglobin|hemoglobin
5516932|NCT01221961|Blood transfusion|blood transfusion
5516933|NCT01221948|Deep Brain Stimulation|deep brain stimulation
5516934|NCT01221948|Parkinson's Disease|parkinson's disease
5516935|NCT01221935|retrospective chart review study|retrospective chart review study
5516936|NCT01221935|desvenlafaxine utilization|desvenlafaxine utilization
5516937|NCT01221935|psychiatrists and primary care physicians|psychiatrists and primary care physicians
5516938|NCT01221935|treatment of major depressive disorder|treatment of major depressive disorder
5516939|NCT01221909|bleeding|bleeding
5516940|NCT01221909|dacryocystorhinostomy|dacryocystorhinostomy
5516941|NCT01221909|operative duration|operative duration
5516942|NCT01221896|Localization of a parathyroid adenoma in patients with primary hyperparathyroidism.|localization of a parathyroid adenoma in patients with primary hyperparathyroidism.
5516943|NCT01221883|Posttraumatic Stress|posttraumatic stress
5516945|NCT01221883|Diazepam|diazepam
5516946|NCT01221870|Metastatic breast cancer|metastatic breast cancer
5516947|NCT01221870|First-line therapy|first-line therapy
5516948|NCT01221870|Tesetaxel|tesetaxel
5516949|NCT01221870|Oral taxane|oral taxane
5516950|NCT01221857|Double Umbilical Cord Blood Stem Cell Transplantation|double umbilical cord blood stem cell transplantation
5516951|NCT01221857|Hematological Malignancies|hematological malignancies
5516952|NCT01221857|HLA Mismatched Donors|hla mismatched donors
5904030|NCT00007813|stage 4S neuroblastoma|stage 4s neuroblastoma
5516953|NCT01221857|Cord Blood Transplantation|cord blood transplantation
5516954|NCT01221844|Lactoferrin|lactoferrin
5516955|NCT01221844|Pregnancy|pregnancy
5516956|NCT01221844|Hereditary Thrombophilia|hereditary thrombophilia
5516957|NCT01221844|Iron deficiency|iron deficiency
5516958|NCT01221844|Iron deficiency anemia|iron deficiency anemia
5516959|NCT01221818|Inflammatory Bowel Disease|inflammatory bowel disease
5516960|NCT01221805|deep venous thrombosis|deep venous thrombosis
5516961|NCT01221805|pulmonary embolism|pulmonary embolism
5516962|NCT01221805|venous thromboembolism|venous thromboembolism
5516963|NCT01221805|D-dimer|d-dimer
5516964|NCT01221805|Wells score|wells score
5516965|NCT01221805|Wells clinical pretest probability|wells clinical pretest probability
5516966|NCT01221792|PTSD|ptsd
5516967|NCT01221792|Anxiety|anxiety
5516968|NCT01221792|Trauma|trauma
5516969|NCT01221792|Assault|assault
5516970|NCT01221792|Victim|victim
5516971|NCT01221792|Witness|witness
5516972|NCT01221792|Post Traumatic Stress Disorder|post traumatic stress disorder
5516973|NCT01221792|Combat veteran|combat veteran
5516974|NCT01221792|Flashbacks|flashbacks
5516975|NCT01221792|Nightmares|nightmares
5516976|NCT01221792|Sleep Disturbance|sleep disturbance
5516977|NCT01221792|Hyperarousal|hyperarousal
5516978|NCT01221792|Numbness|numbness
5516979|NCT01221792|Avoidance|avoidance
5516980|NCT01221779|Intensive language therapy|intensive language therapy
5516981|NCT01221779|Anomia|anomia
5516982|NCT01221779|Magnetic Resonance Imaging|magnetic resonance imaging
5516983|NCT01221766|adnexal|adnexal
5516984|NCT01221766|hair and nail|hair and nail
5516985|NCT01221766|chronic graft vs host disease|chronic graft vs host disease
5516986|NCT01221766|children|children
5516987|NCT01221753|SSCHN|sschn
5516988|NCT01221753|HPV|hpv
5516989|NCT01221753|IMRT|imrt
5516990|NCT01221740|To show that patients with greater pain sensitivity|to show that patients with greater pain sensitivity
5516991|NCT01221740|will show greater improvement in their symptoms|will show greater improvement in their symptoms
5516992|NCT01221740|(self-reported pain intensity, mood, sleep, and|(self-reported pain intensity, mood, sleep, and
5516993|NCT01221740|quality of life) than those with lower pain|quality of life) than those with lower pain
5516994|NCT01221740|sensitivity, based on QST, after taking milnacipran.|sensitivity, based on qst, after taking milnacipran.
5516995|NCT01221740|To compare outcome differences|to compare outcome differences
5516996|NCT01221740|(pain intensity, mood, activity interference,|(pain intensity, mood, activity interference,
5516997|NCT01221740|sleep, and side effects) with those patients|sleep, and side effects) with those patients
5516998|NCT01221740|who are either taking or not taking opioids for|who are either taking or not taking opioids for
5516999|NCT01221740|their pain 10 weeks after being prescribed milnacipran.|their pain 10 weeks after being prescribed milnacipran.
5517000|NCT01221740|To show that patients who are older, male,|to show that patients who are older, male,
5517001|NCT01221740|with more medical comorbidities, greater disability,|with more medical comorbidities, greater disability,
5517002|NCT01221740|and longer pain duration will report less improvement|and longer pain duration will report less improvement
5498867|NCT01300624|Aphasia|aphasia
5790010|NCT00146172|HKI-272|hki-272
5517003|NCT01221740|(pain, mood, sleep, health-related quality of life)|(pain, mood, sleep, health-related quality of life)
5517004|NCT01221740|and treatment satisfaction while taking milnacipran|and treatment satisfaction while taking milnacipran
5517005|NCT01221740|compared with others without such characteristics.|compared with others without such characteristics.
5517006|NCT01221740|identify patients back or neck pain|identify patients back or neck pain
5517007|NCT01221740|greater 6 months|greater 6 months
5517008|NCT01221740|QST|qst
5517009|NCT01221740|10 weeks|10 weeks
5517010|NCT01221740|milnacipran|milnacipran
5517011|NCT01221740|pain intensity|pain intensity
5517012|NCT01221740|mood|mood
5517013|NCT01221740|activity|activity
5517014|NCT01221740|interference|interference
5517015|NCT01221740|sleep|sleep
5517016|NCT01221740|side effects|side effects
5517017|NCT01221740|age|age
5517018|NCT01221740|gender|gender
5517019|NCT01221740|medical comorbidities|medical comorbidities
5517020|NCT01221740|pain diagnosis|pain diagnosis
5517021|NCT01221740|pain duration|pain duration
5517022|NCT01221740|disability status|disability status
5517023|NCT01221727|Amgen|amgen
5517024|NCT01221727|Phase 1|phase 1
5517025|NCT01221727|Postmenopausal|postmenopausal
5517026|NCT01221727|Osteoporosis|osteoporosis
5517027|NCT01221714|nutritional supplements|nutritional supplements
5517028|NCT01221714|supplements|supplements
5517029|NCT01221714|vitamins|vitamins
5517030|NCT01221714|omega-3|omega-3
5517031|NCT01221714|Amerisciences|amerisciences
5517032|NCT01221714|Carlos Montesinos|carlos montesinos
5517033|NCT01221701|depression|depression
5517034|NCT01221701|psychological treatments|psychological treatments
5517035|NCT01221701|Cognitive Behavioral Therapy|cognitive behavioral therapy
5517036|NCT01221701|child social/emotional functioning|child social/emotional functioning
5517037|NCT01221701|parenting|parenting
5517038|NCT01221701|home visitation|home visitation
5517039|NCT01221688|Sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5517040|NCT01221688|large operable breast cancer|large operable breast cancer
5904031|NCT00007813|recurrent neuroblastoma|recurrent neuroblastoma
5517041|NCT01221688|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5517042|NCT01221688|patients with large operable breast cancer after neoadjuvant chemotherapy (NAC)|patients with large operable breast cancer after neoadjuvant chemotherapy (nac)
5517043|NCT01221675|Small Cell Lung Cancer or CEA-expressing Non Small Cell Lung Carcinoma (NSCLC)|small cell lung cancer or cea-expressing non small cell lung carcinoma (nsclc)
5517044|NCT01221675|Radio Immunotherapy|radio immunotherapy
5517045|NCT01221675|Lutetium|lutetium
5517046|NCT01221675|patient ≥ 18 years of age with CEA-positive SCLC in partial response|patient ≥ 18 years of age with cea-positive sclc in partial response
5517047|NCT01221675|or who failed at least two lines of standard radiation and/or chemotherapy|or who failed at least two lines of standard radiation and/or chemotherapy
5517048|NCT01221675|or Patients with histologic diagnosis of NSCLC|or patients with histologic diagnosis of nsclc
5517049|NCT01221662|Siwu tang|siwu tang
5517050|NCT01221662|brain hypoperfusion|brain hypoperfusion
5517051|NCT01221662|cognition function|cognition function
5517052|NCT01221623|Peyronie's Disease|peyronie's disease
5517053|NCT01221623|penile plaque|penile plaque
5517054|NCT01221623|penile curvature|penile curvature
5517055|NCT01221610|Stenosis|stenosis
5517056|NCT01221610|Occlusions|occlusions
5517058|NCT01221610|PTA|pta
5517059|NCT01221610|POBA|poba
5517060|NCT01221610|DRB|drb
5517061|NCT01221597|Peyronie's Disease|peyronie's disease
5517062|NCT01221597|penile plaque|penile plaque
5517063|NCT01221597|penile curvature|penile curvature
5517064|NCT01221584|Dyslipidaemia|dyslipidaemia
5517065|NCT01221584|LDL-C goals|ldl-c goals
5517066|NCT01221584|guidelines|guidelines
5517067|NCT01221571|Phase I|phase i
5517068|NCT01221571|Dose escalation|dose escalation
5517069|NCT01221571|AFM 13|afm 13
5517070|NCT01221571|Natural killer cell|natural killer cell
5517071|NCT01221545|Diabetes Mellitus|diabetes mellitus
5517072|NCT01221519|Phase I|phase i
5517073|NCT01221519|Bioavailability|bioavailability
5517074|NCT01221519|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5517075|NCT01221519|Diabetic treatment|diabetic treatment
5517076|NCT01221519|Metformin|metformin
5517077|NCT01221519|High blood sugar|high blood sugar
5517078|NCT01221506|unresectable|unresectable
5517079|NCT01221506|metastatic|metastatic
5517080|NCT01221506|clear cell renal carcinoma|clear cell renal carcinoma
5517081|NCT01221493|solitary pulmonary nodules|solitary pulmonary nodules
5517082|NCT01221493|transbronchial lung biopsy|transbronchial lung biopsy
5517083|NCT01221493|endobronchial ultrasound|endobronchial ultrasound
5517084|NCT01221454|ABMSC|abmsc
5517085|NCT01221454|Allogenic bone marrow mesenchymal stem cells|allogenic bone marrow mesenchymal stem cells
5517086|NCT01221454|Liver Failure|liver failure
5517087|NCT01221454|Transplantation|transplantation
5517088|NCT01221441|Cartilage|cartilage
5517089|NCT01221441|Knee|knee
5517090|NCT01221441|Osteoarthritis|osteoarthritis
5517091|NCT01221428|Ulcerative colitis|ulcerative colitis
5685349|NCT00556478|Prilocaine|prilocaine
5517092|NCT01221428|Mesenchymal Stem Cells|mesenchymal stem cells
5517093|NCT01221428|Umbilical Cord|umbilical cord
5517094|NCT01221389|hemorrhage|hemorrhage
5517095|NCT01221389|plasma|plasma
5517096|NCT01221389|coagulopathy|coagulopathy
5517097|NCT01221389|trauma|trauma
5517098|NCT01221363|Life style disease|life style disease
5517099|NCT01221363|Obesity|obesity
5517100|NCT01221363|Sedentary behaviour|sedentary behaviour
5517101|NCT01221363|Cardiovascular biomarkers|cardiovascular biomarkers
5517102|NCT01221350|Asthma|asthma
5517103|NCT01221350|Allergic rhinitis|allergic rhinitis
5517104|NCT01221350|Respiratory disease|respiratory disease
5517105|NCT01221350|Allergy|allergy
5517106|NCT01221350|Lipoic acid|lipoic acid
5517107|NCT01221350|Thioctic acid|thioctic acid
5517108|NCT01221350|Antioxidant|antioxidant
5517109|NCT01221350|Oxidative stress|oxidative stress
5517110|NCT01221311|stenosis|stenosis
5517111|NCT01221311|bile duct|bile duct
5517112|NCT01221311|chronic pancreatitis|chronic pancreatitis
5517113|NCT01221311|postoperative|postoperative
5517114|NCT01221311|post-liver transplant|post-liver transplant
5517115|NCT01221285|Cockroach|cockroach
5517116|NCT01221285|Immunotherapy|immunotherapy
5517117|NCT01221285|Subcutaneous immunotherapy|subcutaneous immunotherapy
5517118|NCT01221285|Inner city asthma|inner city asthma
5517119|NCT01221272|SPECT MPI|spect mpi
5517120|NCT01221246|Acute Middle Cerebral Artery Ischemic Stroke within 18 hours|acute middle cerebral artery ischemic stroke within 18 hours
5517121|NCT01221207|diabetic foot ulcers|diabetic foot ulcers
5517122|NCT01221207|casting|casting
5517123|NCT01221207|wound care|wound care
5517124|NCT01221194|diabetes|diabetes
5517125|NCT01221194|foot ulcer prevention|foot ulcer prevention
5517126|NCT01221194|therapeutic stockings|therapeutic stockings
5517127|NCT01221181|Dense deposit disease|dense deposit disease
5517128|NCT01221181|C3 nephropathy|c3 nephropathy
5517130|NCT01221168|prostate|prostate
5517131|NCT01221168|cancer|cancer
5517132|NCT01221168|genetic|genetic
5517133|NCT01221168|epidemiology|epidemiology
5517134|NCT01221168|susceptibility|susceptibility
5517135|NCT01221155|Musculoskeletal|musculoskeletal
5517136|NCT01221142|Hypothermia, ICH|hypothermia, ich
5517137|NCT01221129|zinc|zinc
5517138|NCT01221129|reticulocyte|reticulocyte
5517139|NCT01221129|PBMC|pbmc
5517140|NCT01221129|whole blood|whole blood
5517141|NCT01221129|transcriptome|transcriptome
5517142|NCT01221129|microarray|microarray
5517143|NCT01221116|coronary artery disease,|coronary artery disease,
5517144|NCT01221116|aortic stenosis,|aortic stenosis,
5517145|NCT01221116|heart failure|heart failure
5517146|NCT01221103|Dexamethasone|dexamethasone
5517147|NCT01221103|Ofatumumab|ofatumumab
5517148|NCT01221103|Bendamustine|bendamustine
5517149|NCT01221103|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5517150|NCT01221103|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5517151|NCT01221090|Type 2 diabetes|type 2 diabetes
5517152|NCT01221090|Health disparities|health disparities
5517153|NCT01221090|Central Texas|central texas
5517155|NCT01221090|CDSMP|cdsmp
5517156|NCT01221077|NSCLC|nsclc
5517157|NCT01221077|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5517158|NCT01221077|EGFR|egfr
5517159|NCT01221077|Non-small cell lung cancer|non-small cell lung cancer
5517160|NCT01221077|Tarceva|tarceva
5517161|NCT01221077|Activating mutations|activating mutations
5517162|NCT01221077|OSI-906|osi-906
5517163|NCT01221077|Chemonaive|chemonaive
5517164|NCT01221077|IGF-IR|igf-ir
5517165|NCT01221077|Erlotinib|erlotinib
5517166|NCT01221064|Breast cancer|breast cancer
5517167|NCT01221064|Axillary clearance|axillary clearance
5517168|NCT01221064|lymphorrhoea|lymphorrhoea
5517169|NCT01221051|third stage of labor,oxytocics, postpartum hemorrhage,|third stage of labor,oxytocics, postpartum hemorrhage,
5517170|NCT01221025|Parecoxib;|parecoxib;
5517171|NCT01221025|emergence delirium;|emergence delirium;
5517172|NCT01221025|postoperative pain;|postoperative pain;
5517173|NCT01221025|elderly patients;|elderly patients;
5517174|NCT01221025|abdominal surgery|abdominal surgery
5517175|NCT01221025|Parecoxib on emergence agitation and postoperative pain|parecoxib on emergence agitation and postoperative pain
5517176|NCT01220999|Clinical trial|clinical trial
5517177|NCT01220999|CS-1008 mAb|cs-1008 mab
5517178|NCT01220999|monoclonal antibody CS-1008|monoclonal antibody cs-1008
5517179|NCT01220999|Positron-Emission Tomography|positron-emission tomography
5517180|NCT01220999|Pharmacokinetics|pharmacokinetics
5517181|NCT01220999|Pharmacodynamics|pharmacodynamics
5517182|NCT01220999|apoptosis|apoptosis
5517183|NCT01220999|caspases|caspases
5517184|NCT01220986|Liver regeneration|liver regeneration
5517185|NCT01220986|Innate immune response|innate immune response
5517186|NCT01220973|stage IV prostate cancer|stage iv prostate cancer
5517187|NCT01220973|stage III prostate cancer|stage iii prostate cancer
5517188|NCT01220973|recurrent prostate cancer|recurrent prostate cancer
5517189|NCT01220973|stage IIB prostate cancer|stage iib prostate cancer
5517190|NCT01220973|stage IIA prostate cancer|stage iia prostate cancer
5517191|NCT01220960|art therapy|art therapy
5517192|NCT01220960|breast cancer|breast cancer
5517194|NCT01220960|young women|young women
5517195|NCT01220960|older women|older women
5517196|NCT01220960|quality of life|quality of life
5517197|NCT01220960|meaning making|meaning making
5517198|NCT01220960|support group|support group
5517199|NCT01220960|art making|art making
5517200|NCT01220960|art symbols|art symbols
5517201|NCT01220908|LVRS (Lung Volume Reduction Surgery)|lvrs (lung volume reduction surgery)
5517202|NCT01220908|LVRC (Lung Volume Reduction Coil)|lvrc (lung volume reduction coil)
5517203|NCT01220908|Emphysema|emphysema
5517204|NCT01220908|coil|coil
5517205|NCT01220908|RePneu|repneu
5517206|NCT01220895|Adoptive cellular therapy|adoptive cellular therapy
5517207|NCT01220895|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5517208|NCT01220882|Slipped capital femoral epiphysis|slipped capital femoral epiphysis
5517209|NCT01220856|Islet transplantation|islet transplantation
5517210|NCT01220856|Type 1 diabetes mellitus|type 1 diabetes mellitus
5517211|NCT01220843|chronic renal failure|chronic renal failure
5517212|NCT01220843|FGF23|fgf23
5517213|NCT01220843|Sevelamer carbonate|sevelamer carbonate
5517214|NCT01220830|Multiple sclerosis|multiple sclerosis
5517215|NCT01220830|RFQMR|rfqmr
5517216|NCT01220830|Cytotron|cytotron
5517217|NCT01220830|EDSS|edss
5517218|NCT01220830|QOL assessment with FAMS|qol assessment with fams
5517219|NCT01220817|prostate|prostate
5517220|NCT01220817|cancer|cancer
5517221|NCT01220817|psa|psa
5517222|NCT01220817|psadt|psadt
5517223|NCT01220817|pomegranate|pomegranate
5517224|NCT01220817|POMx|pomx
5517225|NCT01220791|methylprednisolone|methylprednisolone
5517226|NCT01220791|IVF|ivf
5798702|NCT00111306|Antibody|antibody
5517228|NCT01220791|corticosteroid|corticosteroid
5517229|NCT01220791|late follicular phase|late follicular phase
5517230|NCT01220791|pregnancy rates|pregnancy rates
5517231|NCT01220765|hypoxemia|hypoxemia
5517232|NCT01220765|capnography|capnography
5517233|NCT01220765|sedation|sedation
5517234|NCT01220752|IMRT|imrt
5517235|NCT01220752|carbon ion therapy|carbon ion therapy
5517236|NCT01220752|paranasal sinus|paranasal sinus
5517237|NCT01220752|nasal cavity|nasal cavity
5517238|NCT01220752|adenocarcinoma|adenocarcinoma
5517239|NCT01220752|squamous cell carcinoma|squamous cell carcinoma
5517240|NCT01220739|ischemic stroke|ischemic stroke
5517241|NCT01220739|transcranial laser|transcranial laser
5517242|NCT01220739|tissue plasminogen activator|tissue plasminogen activator
5517243|NCT01220739|therapy|therapy
5517245|NCT01220713|Traumatic Brain Injury|traumatic brain injury
5517246|NCT01220713|Veterans|veterans
5517247|NCT01220713|Hyperbaric Oxygen Treatment|hyperbaric oxygen treatment
5517248|NCT01220713|OEF/OIF|oef/oif
5517249|NCT01220713|Post-Concussive Symptoms|post-concussive symptoms
5517250|NCT01220713|Blast Exposure|blast exposure
5517251|NCT01220687|Prematurity|prematurity
5517252|NCT01220687|Oxygen exposure|oxygen exposure
5517253|NCT01220687|Nitric Oxide|nitric oxide
5517254|NCT01220674|neuropsychological assessment|neuropsychological assessment
5517255|NCT01220674|cognitive impairment|cognitive impairment
5517256|NCT01220674|computer-aided diagnostic tool|computer-aided diagnostic tool
5517257|NCT01220661|Colorectal Surgery|colorectal surgery
5517258|NCT01220661|Surgical Wound Infection|surgical wound infection
5517259|NCT01220661|Laparoscopy|laparoscopy
5517260|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents
5517261|NCT01220648|Chronic myeloid leukemia|chronic myeloid leukemia
5517262|NCT01220648|interferon alfa|interferon alfa
5517263|NCT01220648|nilotinib|nilotinib
5517264|NCT01220648|combination|combination
5517265|NCT01220648|CML|cml
5517266|NCT01220648|Philadelphia chromosome positive (Ph+) chronic myeloid leukemia patients in chronic phase (CML-CP) after switch from previous CML treatment|philadelphia chromosome positive (ph+) chronic myeloid leukemia patients in chronic phase (cml-cp) after switch from previous cml treatment
5517267|NCT01220635|Depressive Symptoms|depressive symptoms
5517268|NCT01220635|Depression prevention|depression prevention
5517269|NCT01220635|Adolescents|adolescents
5517270|NCT01220635|School-Based Services|school-based services
5517271|NCT01220635|Health Behavior|health behavior
5517272|NCT01220622|Stroke|stroke
5517273|NCT01220622|Mild cognitive impairment|mild cognitive impairment
5517274|NCT01220622|Nimodipine|nimodipine
5517275|NCT01220583|stage I salivary gland cancer|stage i salivary gland cancer
5517276|NCT01220583|stage II salivary gland cancer|stage ii salivary gland cancer
5517277|NCT01220583|stage III salivary gland cancer|stage iii salivary gland cancer
5517278|NCT01220583|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5517279|NCT01220583|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5517280|NCT01220583|stage IVA salivary gland cancer|stage iva salivary gland cancer
5517382|NCT01220154|peritoneal|peritoneal
5517281|NCT01220583|stage IVB salivary gland cancer|stage ivb salivary gland cancer
5517282|NCT01220583|stage IVC salivary gland cancer|stage ivc salivary gland cancer
5517283|NCT01220570|breast cancer|breast cancer
5517284|NCT01220570|ridaforolimus|ridaforolimus
5517285|NCT01220570|ridaforolimus/dalotuzumab combination therapy|ridaforolimus/dalotuzumab combination therapy
5517286|NCT01220557|Diabetes mellitus, education, self management|diabetes mellitus, education, self management
5517287|NCT01220531|DiGeorge Anomaly|digeorge anomaly
5517288|NCT01220531|Thymus Transplantation|thymus transplantation
5517289|NCT01220531|DiGeorge Syndrome|digeorge syndrome
5517291|NCT01220531|Low T cell numbers|low t cell numbers
5517292|NCT01220531|Immunoreconstitution|immunoreconstitution
5517293|NCT01220531|Immunodeficiency|immunodeficiency
5517294|NCT01220531|Complete DiGeorge|complete digeorge
5517295|NCT01220531|Typical DiGeorge|typical digeorge
5517296|NCT01220531|Atypical DiGeorge|atypical digeorge
5517297|NCT01220531|Complete DiGeorge Anomaly|complete digeorge anomaly
5517298|NCT01220505|scoliosis|scoliosis
5517299|NCT01220505|kyphosis|kyphosis
5517300|NCT01220505|spinal deformity|spinal deformity
5517301|NCT01220505|curvature|curvature
5517302|NCT01220505|lordosis|lordosis
5517303|NCT01220492|liver cirrhosis|liver cirrhosis
5517304|NCT01220492|mesenchymal stem cells|mesenchymal stem cells
5517305|NCT01220492|longer term survival|longer term survival
5517306|NCT01220492|safety|safety
5517307|NCT01220479|Type 1 Diabetes, Bone mineral density, Growth|type 1 diabetes, bone mineral density, growth
5517308|NCT01220479|Cardiovascular diseases, Exercise, Training,|cardiovascular diseases, exercise, training,
5517309|NCT01220479|Child, Adolescent|child, adolescent
5517310|NCT01220440|ADHD|adhd
5517311|NCT01220440|Children|children
5517312|NCT01220440|Methylphenidate|methylphenidate
5517313|NCT01220440|Dextroamphetamine|dextroamphetamine
5517314|NCT01220440|Placebo|placebo
5517315|NCT01220440|Crossover|crossover
5517316|NCT01220440|Double Blind|double blind
5517317|NCT01220440|Neuropsychological tests|neuropsychological tests
5517318|NCT01220440|Behavioural Questionnaires|behavioural questionnaires
5517319|NCT01220427|high-risk prostate cancer|high-risk prostate cancer
5517320|NCT01220427|radical prostatectomy|radical prostatectomy
5517321|NCT01220427|micro-RNA|micro-rna
5517322|NCT01220401|Nightmare|nightmare
5517323|NCT01220401|PTSD|ptsd
5517324|NCT01220401|Posttraumatic stress disorder|posttraumatic stress disorder
5517326|NCT01220401|Exposure Relaxation Rescription Therapy|exposure relaxation rescription therapy
5517327|NCT01220401|Sleep|sleep
5517328|NCT01220388|Aldosterone|aldosterone
5517329|NCT01220388|L-lysine|l-lysine
5517330|NCT01220388|Cortisol|cortisol
5517331|NCT01220388|Adrenal glands|adrenal glands
5517332|NCT01220375|Mobilization of autologous peripheral blood progenitor cells PBPC|mobilization of autologous peripheral blood progenitor cells pbpc
5517333|NCT01220375|Autologous stem cell mobilization|autologous stem cell mobilization
5517334|NCT01220375|Multiple Myeloma|multiple myeloma
5517335|NCT01220375|Plerixafor|plerixafor
5517336|NCT01220362|Analgesia, Epidural|analgesia, epidural
5517337|NCT01220362|Urodynamics|urodynamics
5517338|NCT01220362|Urinary Retention|urinary retention
5517339|NCT01220284|solid tumors|solid tumors
5517340|NCT01220284|oral treatment|oral treatment
5517341|NCT01220284|platinum compound|platinum compound
5517342|NCT01220284|vinca alkaloid|vinca alkaloid
5517343|NCT01220284|drug combination|drug combination
5517344|NCT01220271|Glioma|glioma
5517345|NCT01220271|Glioblastoma|glioblastoma
5517346|NCT01220245|endoluminal|endoluminal
5517347|NCT01220245|surgical|surgical
5517348|NCT01220245|bypass|bypass
5517349|NCT01220245|patency|patency
5517350|NCT01220245|quality of life|quality of life
5517351|NCT01220245|multicentre|multicentre
5517352|NCT01220245|RCT|rct
5517353|NCT01220245|superficial femoral artery|superficial femoral artery
5517354|NCT01220245|vascular patency|vascular patency
5517355|NCT01220232|Lersivirine|lersivirine
5517356|NCT01220232|UK-453|uk-453
5517357|NCT01220232|061|061
5517358|NCT01220232|NNRTI|nnrti
5517359|NCT01220232|Abacavir|abacavir
5517360|NCT01220232|Lamivudine|lamivudine
5517361|NCT01220232|Combivir|combivir
5517362|NCT01220232|Pharmacokinetics|pharmacokinetics
5517363|NCT01220232|Drug Interaction|drug interaction
5517364|NCT01220232|HIV|hiv
5517365|NCT01220232|AIDS|aids
5517366|NCT01220219|pregabalin|pregabalin
5517367|NCT01220219|pharmacokinetics|pharmacokinetics
5517368|NCT01220219|bioavailability|bioavailability
5517369|NCT01220219|bioequivalence|bioequivalence
5517370|NCT01220206|ED|ed
5517371|NCT01220206|POMx|pomx
5517372|NCT01220206|Pomegranate|pomegranate
5517373|NCT01220206|Erectile dysfunction|erectile dysfunction
5517374|NCT01220180|epilepsy|epilepsy
5517375|NCT01220180|neuropathic pain|neuropathic pain
5517376|NCT01220180|fibromyalgia|fibromyalgia
5517377|NCT01220180|post-market surveillance|post-market surveillance
5517378|NCT01220180|prospective observational|prospective observational
5517379|NCT01220154|ovarian|ovarian
5517380|NCT01220154|cancer|cancer
5517381|NCT01220154|fallopian tube|fallopian tube
5517383|NCT01220154|intraperitoneal|intraperitoneal
5517384|NCT01220154|bevacizumab|bevacizumab
5517385|NCT01220154|carboplatin|carboplatin
5517386|NCT01220154|paclitaxel|paclitaxel
5517387|NCT01220154|chemo-naive|chemo-naive
5517388|NCT01220128|WT1|wt1
5517389|NCT01220128|neoadjuvant|neoadjuvant
5517390|NCT01220128|tumor antigen|tumor antigen
5517391|NCT01220128|immunotherapy|immunotherapy
5517393|NCT01220128|adult|adult
5517394|NCT01220115|sickle cell disease|sickle cell disease
5517395|NCT01220115|iron over load|iron over load
5517396|NCT01220102|acne|acne
5517397|NCT01220102|Epiduo|epiduo
5517398|NCT01220102|adapalene/ benzoyl peroxide|adapalene/ benzoyl peroxide
5517399|NCT01220089|obesity|obesity
5517400|NCT01220089|weight loss|weight loss
5517401|NCT01220076|Tamoxifen,|tamoxifen,
5517402|NCT01220076|Breat Cancer|breat cancer
5517403|NCT01220076|Pharmacogenetic|pharmacogenetic
5517404|NCT01220076|non metastatic breast cancer, HR +|non metastatic breast cancer, hr +
5517405|NCT01220063|RSHF|rshf
5517406|NCT01220063|Irinotecan|irinotecan
5517407|NCT01220063|Colorectal Cancer|colorectal cancer
5517408|NCT01220063|metastases|metastases
5517409|NCT01220050|Paricalcitol|paricalcitol
5517410|NCT01220050|Renal transplant|renal transplant
5517411|NCT01220050|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5517412|NCT01220011|Fetoscopic Laser surgery|fetoscopic laser surgery
5517413|NCT01220011|Stage 1 Twin - twin transfusion syndrome|stage 1 twin - twin transfusion syndrome
5517414|NCT01219998|Postoperative Complications|postoperative complications
5517415|NCT01219998|Acute Kidney Failure|acute kidney failure
5517416|NCT01219998|Peritoneal Dialysis|peritoneal dialysis
5517417|NCT01219998|NGAL|ngal
5517418|NCT01219985|positron emission tomography / computed tomography|positron emission tomography / computed tomography
5517419|NCT01219985|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
5517420|NCT01219985|liver neoplasm|liver neoplasm
5517421|NCT01219985|respiratory motion|respiratory motion
5517422|NCT01219972|Bone marrow transplant|bone marrow transplant
5517423|NCT01219972|Pulmonary complications|pulmonary complications
5517424|NCT01219959|ESRD|esrd
5517426|NCT01219959|CAPD|capd
5517427|NCT01219946|Chronic Obstructive Pulmonary Disease, symptoms|chronic obstructive pulmonary disease, symptoms
5517429|NCT01219920|Phase III|phase iii
5517430|NCT01219920|FOLFOXIRI|folfoxiri
5517431|NCT01219920|FOLFIRI|folfiri
5517432|NCT01219894|Coronary Disease|coronary disease
5517433|NCT01219894|Stent|stent
5517434|NCT01219894|Healing|healing
5517435|NCT01219894|Anti-platelet therapy|anti-platelet therapy
5517436|NCT01219881|desflurane|desflurane
5517437|NCT01219881|sevoflurane|sevoflurane
5517438|NCT01219855|Parathyroid Diseases|parathyroid diseases
5517439|NCT01219855|Renal Insufficiency|renal insufficiency
5517440|NCT01219855|Kidney Failure, Chronic|kidney failure, chronic
5517441|NCT01219855|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5517442|NCT01219855|Vitamin D|vitamin d
5517443|NCT01219855|Hyperparathyroidism|hyperparathyroidism
5517444|NCT01219855|Kidney Diseases|kidney diseases
5517445|NCT01219855|Kidney Failure|kidney failure
5517446|NCT01219855|Renal Insufficiency, Chronic|renal insufficiency, chronic
5517447|NCT01219842|Intermittent claudication|intermittent claudication
5517448|NCT01219842|Health Related Quality of Life|health related quality of life
5517449|NCT01219842|Walking performance|walking performance
5517450|NCT01219842|Daily walking capacity|daily walking capacity
5517451|NCT01219829|Pancreatic intraepithelial neoplasia (PanIN)|pancreatic intraepithelial neoplasia (panin)
5517452|NCT01219829|Pancreatic Cancer|pancreatic cancer
5517453|NCT01219829|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
5517454|NCT01219829|Field Effect|field effect
5517455|NCT01219829|Genetic mutations in pancreatic cancer|genetic mutations in pancreatic cancer
5517456|NCT01219816|efficacy of Chemo-immunotherapy|efficacy of chemo-immunotherapy
5517457|NCT01219803|Dose-Response Relationship, type 2 diabetes,TCM|dose-response relationship, type 2 diabetes,tcm
5517458|NCT01219790|Patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.|patients with painful vertebral metastases with a prostate cancer with an indication of analgesic treatment.
5517459|NCT01219777|bevacizumab|bevacizumab
5517460|NCT01219777|paclitaxel|paclitaxel
5517461|NCT01219777|carboplatin|carboplatin
5517462|NCT01219777|ovarian|ovarian
5517463|NCT01219777|cancer|cancer
5517464|NCT01219777|fallopian tube|fallopian tube
5517465|NCT01219777|primary peritoneal|primary peritoneal
5517466|NCT01219764|Helicobacter pylori infection|helicobacter pylori infection
5517467|NCT01219764|quadruple therapy|quadruple therapy
5517468|NCT01219764|Amoxicillin|amoxicillin
5517469|NCT01219764|Metronidazole|metronidazole
5517470|NCT01219764|Clarithromycin|clarithromycin
5517471|NCT01219764|Rabeprazole|rabeprazole
5517472|NCT01219738|Asthma, airway blood flow, budesonide, glucocorticosteroid.|asthma, airway blood flow, budesonide, glucocorticosteroid.
5517473|NCT01219725|Body composition|body composition
5517474|NCT01219725|Endothelial function|endothelial function
5517475|NCT01219725|Lipoprotein profile|lipoprotein profile
5517476|NCT01219725|Inflammatory markers|inflammatory markers
5517477|NCT01219725|Aerobic capacity|aerobic capacity
5517478|NCT01219725|Thrombotic markers|thrombotic markers
5517479|NCT01219725|Arterial stiffness|arterial stiffness
5517480|NCT01219725|Cardiac function|cardiac function
5517481|NCT01219725|Traditional and emerging cardiovascular disease risk factors|traditional and emerging cardiovascular disease risk factors
5517482|NCT01219712|NT-proBNP|nt-probnp
5517484|NCT01219712|left ventricular dysfunction|left ventricular dysfunction
5517485|NCT01219712|cardiac complications|cardiac complications
5517486|NCT01219699|advanced solid tumors|advanced solid tumors
5517487|NCT01219699|mutation|mutation
5517488|NCT01219699|amplification|amplification
5517489|NCT01219699|wild type|wild type
5517490|NCT01219699|PIK3CA gene|pik3ca gene
5517491|NCT01219699|dose-escalation|dose-escalation
5517492|NCT01219699|estrogen receptor positive breast cancer|estrogen receptor positive breast cancer
5499374|NCT01298466|chronic|chronic
5517493|NCT01219686|unipolar depression, escitalopram, pindolol|unipolar depression, escitalopram, pindolol
5517494|NCT01219673|Epithelial carcinoma|epithelial carcinoma
5517495|NCT01219673|Oropharynx|oropharynx
5517496|NCT01219673|Larynx|larynx
5517497|NCT01219673|Symptom-management|symptom-management
5517498|NCT01219673|Chemoradiation|chemoradiation
5517499|NCT01219673|Placebo|placebo
5517500|NCT01219673|Armodafinil|armodafinil
5517501|NCT01219673|Nuvigil|nuvigil
5517502|NCT01219673|Bupropion|bupropion
5517503|NCT01219673|Wellbutrin|wellbutrin
5517504|NCT01219673|Wellbutrin SR|wellbutrin sr
5517505|NCT01219673|Zyban|zyban
5517506|NCT01219673|Minocycline|minocycline
5517507|NCT01219673|Dynacin|dynacin
5517508|NCT01219673|Minocin|minocin
5517509|NCT01219673|Minocin PAC|minocin pac
5517510|NCT01219673|Myrac|myrac
5517511|NCT01219673|Solodyn|solodyn
5517512|NCT01219660|sleep|sleep
5517513|NCT01219660|apnea|apnea
5517514|NCT01219647|Multiple Sclerosis|multiple sclerosis
5517515|NCT01219647|Exercise|exercise
5517516|NCT01219647|Cognition|cognition
5517517|NCT01219621|Symphony DR 2550,|symphony dr 2550,
5517518|NCT01219621|Dual Chamber Pacemaker,|dual chamber pacemaker,
5517519|NCT01219621|Sorin,|sorin,
5517520|NCT01219621|Ela Medical,|ela medical,
5517521|NCT01219621|DDD Mode,|ddd mode,
5517522|NCT01219621|AAIsafeR2 mode,|aaisafer2 mode,
5517523|NCT01219621|AV-Conduction,|av-conduction,
5517524|NCT01219621|Reducing Ventricular Pacing,|reducing ventricular pacing,
5517525|NCT01219621|Congestive Heart Failure,|congestive heart failure,
5517526|NCT01219621|Cardiac Function,|cardiac function,
5517527|NCT01219621|Atrial Arrhythmia,|atrial arrhythmia,
5517528|NCT01219621|Atrial Fibrillation,|atrial fibrillation,
5517529|NCT01219621|Atrial and Ventricular Hemodynamics,|atrial and ventricular hemodynamics,
5517530|NCT01219621|Long AV-delays.|long av-delays.
5517531|NCT01219621|Ventricular Function,|ventricular function,
5517532|NCT01219621|Implantation,|implantation,
5517533|NCT01219595|Urinary Tract Infection|urinary tract infection
5517535|NCT01219582|Diabetes Mellitus Type-2|diabetes mellitus type-2
5517536|NCT01219582|Acarbose|acarbose
5517537|NCT01219582|Metformin|metformin
5517538|NCT01219582|Drug Therapy, Combination|drug therapy, combination
5517539|NCT01219569|blindness|blindness
5517540|NCT01219569|ischemic optic neuropathy|ischemic optic neuropathy
5517541|NCT01219556|Hypertension|hypertension
5517542|NCT01219556|Antihypertensive Agents|antihypertensive agents
5517543|NCT01219556|Drug Therapy, Combination|drug therapy, combination
5517544|NCT01219556|Olmesartan Medoxomil|olmesartan medoxomil
5517545|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide
5517546|NCT01219543|Advanced solid malignancies|advanced solid malignancies
5517547|NCT01219543|Child-Pugh A to B7 advanced hepatocellular carcinoma|child-pugh a to b7 advanced hepatocellular carcinoma
5517548|NCT01219543|EGFR and/or ROS mutant NSCLC|egfr and/or ros mutant nsclc
5517549|NCT01219543|Non-smokers with lung metastasis|non-smokers with lung metastasis
5517550|NCT01219543|Gastric cancer|gastric cancer
5517551|NCT01219543|Solid tumour|solid tumour
5517552|NCT01219543|AZD1480|azd1480
5517553|NCT01219543|JAK1/JAK2 kinase inhibitor|jak1/jak2 kinase inhibitor
5517554|NCT01219530|gestational carrier|gestational carrier
5517555|NCT01219530|intended parent|intended parent
5517557|NCT01219517|embryo biopsy|embryo biopsy
5517558|NCT01219517|DNA fingerprinting|dna fingerprinting
5517559|NCT01219517|SNP|snp
5517560|NCT01219504|PGD|pgd
5517561|NCT01219504|IVF|ivf
5517562|NCT01219491|egg donor|egg donor
5517563|NCT01219491|recipients|recipients
5517564|NCT01219491|donor characteristics|donor characteristics
5517565|NCT01219478|To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion|to investigate the relationship between retinal thickness (rt) and metabolic risks (mrs) in patients without retinal lesion
5517566|NCT01219465|Diabetes Mellitus|diabetes mellitus
5517567|NCT01219465|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5517568|NCT01219465|mesenchymal stem cells|mesenchymal stem cells
5517569|NCT01219465|Umbilical cord|umbilical cord
5517570|NCT01219452|Dilated Cardiomyopathy|dilated cardiomyopathy
5517571|NCT01219452|Umbilical cord|umbilical cord
5517572|NCT01219452|Mesenchymal stem cells|mesenchymal stem cells
5517573|NCT01219452|Children|children
5517574|NCT01219439|discarded pathological specimens|discarded pathological specimens
5517575|NCT01219439|discarded media|discarded media
5517576|NCT01219439|IVF|ivf
5517577|NCT01219426|Gambling|gambling
5517578|NCT01219426|cognitive distortions|cognitive distortions
5517579|NCT01219426|assessment tool|assessment tool
5517580|NCT01219426|validation|validation
5517582|NCT01219413|aliskiren|aliskiren
5517583|NCT01219413|renin inhibitor|renin inhibitor
5517584|NCT01219413|proteinuria|proteinuria
5517585|NCT01219413|chronic kidney diseases|chronic kidney diseases
5517586|NCT01219413|ACE inhibitor|ace inhibitor
5517587|NCT01219400|DPP-4|dpp-4
5517588|NCT01219400|GLP-1|glp-1
5517589|NCT01219400|Glucagon|glucagon
5517590|NCT01219400|Catecholamines|catecholamines
5517591|NCT01219400|Counterregulation|counterregulation
5517592|NCT01219400|Insulin-treatment|insulin-treatment
5517593|NCT01219400|Type 2 diabetes|type 2 diabetes
5517594|NCT01219387|AMH|amh
5517595|NCT01219387|inhibin B|inhibin b
5517596|NCT01219387|infertility|infertility
5517597|NCT01219374|egg donor|egg donor
5517598|NCT01219361|Donated embryos|donated embryos
5517599|NCT01219348|IDO enzyme|ido enzyme
5517600|NCT01219348|Vaccination trial|vaccination trial
5517601|NCT01219348|Immunotherapy|immunotherapy
5517602|NCT01219348|NSCLC, stage III_IV|nsclc, stage iii_iv
5517603|NCT01219348|Indeolamine 2,3 dioxygenase = IDO|indeolamine 2,3 dioxygenase = ido
5517604|NCT01219335|IVF|ivf
5517605|NCT01219322|general endotracheal anesthesia|general endotracheal anesthesia
5517606|NCT01219322|ASA I or II|asa i or ii
5517607|NCT01219309|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5517608|NCT01219309|Omega 3/6 fatty acids|omega 3/6 fatty acids
5517609|NCT01219309|Developmental coordination disorder|developmental coordination disorder
5517610|NCT01219309|Reading/writing difficulties.|reading/writing difficulties.
5517611|NCT01219296|infertility|infertility
5517612|NCT01219296|IVF|ivf
5517613|NCT01219283|PGD|pgd
5517614|NCT01219283|IVF|ivf
5517615|NCT01219270|Radiocontrast media,|radiocontrast media,
5517616|NCT01219270|hyponatremia|hyponatremia
5517617|NCT01219257|SpA|spa
5517618|NCT01219257|Anti-TNF alpha treatment|anti-tnf alpha treatment
5517619|NCT01219257|Ultrasonography|ultrasonography
5517621|NCT01219257|Enthesitis|enthesitis
5517622|NCT01219244|memory|memory
5517623|NCT01219244|diet|diet
5517630|NCT01219231|cognition|cognition
5517631|NCT01219231|prevention|prevention
5517632|NCT01219231|cognitive decline|cognitive decline
5517633|NCT01219231|Lifestyle|lifestyle
5517634|NCT01219218|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5517635|NCT01219218|Myocardial Ischemia|myocardial ischemia
5517636|NCT01219218|Refractory Angina|refractory angina
5517637|NCT01219205|macular edema secondary to retinal benous occlusion|macular edema secondary to retinal benous occlusion
5517638|NCT01219179|Extremely Low Birth Weight Infants|extremely low birth weight infants
5517639|NCT01219179|Hypernatremia|hypernatremia
5517640|NCT01219179|Enteral Sterile Water Feeds|enteral sterile water feeds
5517641|NCT01219153|Letrozole ,IVF, poor responders , GnRH antagonist|letrozole ,ivf, poor responders , gnrh antagonist
5517642|NCT01219140|POMx|pomx
5517643|NCT01219140|Osteopenia|osteopenia
5517644|NCT01219140|postmenopausal women|postmenopausal women
5517645|NCT01219140|Pomegranate|pomegranate
5517646|NCT01219127|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5517647|NCT01219114|Daptomycin|daptomycin
5517648|NCT01219114|endocarditis|endocarditis
5517649|NCT01219114|complicated skin and skin structure infection|complicated skin and skin structure infection
5517650|NCT01219101|Ethinyl estradiol|ethinyl estradiol
5517651|NCT01219101|Polycystic ovary syndrome|polycystic ovary syndrome
5517652|NCT01219101|Intrauterine insemination|intrauterine insemination
5517653|NCT01219049|Diet|diet
5517654|NCT01219049|Fibromyalgia|fibromyalgia
5517655|NCT01219049|Pain|pain
5517656|NCT01219049|Drug|drug
5517657|NCT01219049|Amino-acid|amino-acid
5517658|NCT01219049|Fatigue|fatigue
5517659|NCT01219036|Asthma|asthma
5517660|NCT01219036|Non-adherence|non-adherence
5517661|NCT01219036|Fractional exhaled nitric oxide|fractional exhaled nitric oxide
5517662|NCT01219023|Hand foot syndrome|hand foot syndrome
5517663|NCT01219023|Palmar Plantar Erythrodysesthesia|palmar plantar erythrodysesthesia
5517664|NCT01219023|chemotherapy|chemotherapy
5517665|NCT01219023|Sunitinib|sunitinib
5517666|NCT01219023|Capecitebine|capecitebine
5517667|NCT01219023|Sildenafil|sildenafil
5517668|NCT01219010|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
5517669|NCT01219010|Smoldering Multiple Myeloma|smoldering multiple myeloma
5517670|NCT01219010|Indolent Multiple Myeloma|indolent multiple myeloma
5517672|NCT01219010|Siltuximab|siltuximab
5517673|NCT01219010|CNTO 328|cnto 328
5517674|NCT01219010|IL-6|il-6
5517675|NCT01219010|Monoclonal Antibody|monoclonal antibody
5517676|NCT01218997|Alcoholism|alcoholism
5517677|NCT01218997|Alcohol dependence|alcohol dependence
5517678|NCT01218984|Opiate Dependence|opiate dependence
5517684|NCT01218932|interactions|interactions
5517685|NCT01218906|Dengue Fever Fever Dengue Infection|dengue fever fever dengue infection
5517686|NCT01218867|Clinical Response|clinical response
5517687|NCT01218867|Metastatic Cancer|metastatic cancer
5517688|NCT01218867|Immunotherapy|immunotherapy
5517689|NCT01218867|Adoptive Cell Therapy|adoptive cell therapy
5517696|NCT01218841|Fish oil|fish oil
5517697|NCT01218841|Omega-3 fatty acids|omega-3 fatty acids
5517698|NCT01218841|Parenteral lipid emulsions|parenteral lipid emulsions
5517699|NCT01218841|Immune response|immune response
5517700|NCT01218841|Surgery|surgery
5517701|NCT01218828|Contrast|contrast
5517702|NCT01218828|nephropathy|nephropathy
5517703|NCT01218828|cardiac catheterization|cardiac catheterization
5517704|NCT01218828|angiography|angiography
5517705|NCT01218828|percutaneous coronary intervention is|percutaneous coronary intervention is
5517706|NCT01218802|HIV|hiv
5517707|NCT01218802|Heart Disease|heart disease
5517708|NCT01218802|Bone Density|bone density
5517709|NCT01218789|Blindness|blindness
5517710|NCT01218789|Eye Diseases|eye diseases
5517711|NCT01218789|Nap Disorders|nap disorders
5499556|NCT01297660|compliance|compliance
5517712|NCT01218789|Circadian Rhythm Disorders|circadian rhythm disorders
5517713|NCT01218789|Sleep disorders|sleep disorders
5517714|NCT01218789|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5517715|NCT01218789|Dyssomnias|dyssomnias
5517716|NCT01218789|Nervous System Diseases|nervous system diseases
5517717|NCT01218776|Acute Coronary Syndrome, Eastern Europe, Therapies|acute coronary syndrome, eastern europe, therapies
5517718|NCT01218763|Cardiac Event recorder|cardiac event recorder
5517719|NCT01218763|Sensitivity|sensitivity
5517720|NCT01218763|Efficacy|efficacy
5517721|NCT01218750|DDME, ppV, ILM peeling, bevacizumab injection|ddme, ppv, ilm peeling, bevacizumab injection
5517722|NCT01218685|Immunocompromised patients|immunocompromised patients
5517723|NCT01218685|Safety of pandemic influenza A (H1N1)vaccine|safety of pandemic influenza a (h1n1)vaccine
5517724|NCT01218685|Immunogenicity of pandemic influenza A (H1N1)vaccine|immunogenicity of pandemic influenza a (h1n1)vaccine
5517725|NCT01218672|BPH|bph
5517726|NCT01218672|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5517727|NCT01218659|Amicus Therapeutics|amicus therapeutics
5517728|NCT01218659|Galafold|galafold
5517729|NCT01218659|AT1001|at1001
5517730|NCT01218659|Migalastat|migalastat
5517731|NCT01218646|Influenza|influenza
5517732|NCT01218646|Quadrivalent Inactivated Influenza Vaccine|quadrivalent inactivated influenza vaccine
5517733|NCT01218646|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5517734|NCT01218646|Influenza viruses|influenza viruses
5517735|NCT01218607|Heart Septal Defects, Atrial|heart septal defects, atrial
5517736|NCT01218607|Pulmonary Circulation|pulmonary circulation
5517737|NCT01218607|Ventricular Function, Right|ventricular function, right
5517738|NCT01218607|Echocardiography, Stress|echocardiography, stress
5517739|NCT01218607|Ergometry|ergometry
5517740|NCT01218607|Tissue Doppler Imaging|tissue doppler imaging
5517741|NCT01218594|Stage III|stage iii
5517742|NCT01218594|Unresectable|unresectable
5517743|NCT01218594|Non-small cell lung cancer|non-small cell lung cancer
5517744|NCT01218581|Adenomyosis, letrozole, GnRH-a|adenomyosis, letrozole, gnrh-a
5517745|NCT01218555|kidney cancer|kidney cancer
5517746|NCT01218555|adenoidcystic cancer|adenoidcystic cancer
5517747|NCT01218542|Secondary brain malignancies|secondary brain malignancies
5517748|NCT01218542|RapidArc|rapidarc
5517749|NCT01218542|Volumetric modulated arc therapy|volumetric modulated arc therapy
5517750|NCT01218529|Brain metastases from lung and breast tumors|brain metastases from lung and breast tumors
5517751|NCT01218490|surgery|surgery
5517752|NCT01218490|ovarian cancer|ovarian cancer
5517753|NCT01218490|lymphadectomy|lymphadectomy
5517754|NCT01218477|Leukemia|leukemia
5517755|NCT01218477|(Chronic Myeloid Leukemia-Chronic Phase and Advanced)|(chronic myeloid leukemia-chronic phase and advanced)
5517756|NCT01218464|Liver Failure|liver failure
5517757|NCT01218464|Mesenchymal Stem Cells|mesenchymal stem cells
5517758|NCT01218464|Model for End-Stage Liver Disease|model for end-stage liver disease
5517759|NCT01218464|Ascite|ascite
5517760|NCT01218464|Serum Albumin|serum albumin
5517761|NCT01218425|dopamine|dopamine
5517762|NCT01218425|EEG|eeg
5517763|NCT01218425|episodic memory|episodic memory
5517764|NCT01218425|contingent negative variation|contingent negative variation
5517765|NCT01218425|response preparation|response preparation
5517766|NCT01218425|levodopa|levodopa
5517767|NCT01218425|methylphenidate|methylphenidate
5517768|NCT01218412|Physical Activity|physical activity
5517769|NCT01218412|Motivational Interviewing|motivational interviewing
5517770|NCT01218412|Web-based|web-based
5517771|NCT01218412|Physician Referral|physician referral
5517772|NCT01218399|Asthma|asthma
5517773|NCT01218386|ICSI|icsi
5517774|NCT01218386|GnRH antagonists|gnrh antagonists
5517775|NCT01218386|planning|planning
5517776|NCT01218373|older people|older people
5517777|NCT01218373|living independently at home|living independently at home
5517778|NCT01218360|Crohn's disease|crohn's disease
5517779|NCT01218360|standard-of-care|standard-of-care
5517780|NCT01218360|Crohn Disease|crohn disease
5517781|NCT01218360|Active Crohn's Disease|active crohn's disease
5517782|NCT01218347|OATP1B1|oatp1b1
5517783|NCT01218347|rosuvastatin|rosuvastatin
5517784|NCT01218321|antiepileptic drugs|antiepileptic drugs
5517785|NCT01218321|mitochondria|mitochondria
5517786|NCT01218308|Influenza|influenza
5517787|NCT01218295|COPD|copd
5517788|NCT01218295|inspiratory muscles training|inspiratory muscles training
5517789|NCT01218282|COPD|copd
5517790|NCT01218282|home exercise training|home exercise training
5517791|NCT01218269|anastomoses|anastomoses
5517792|NCT01218256|diabetes mellitus|diabetes mellitus
5517793|NCT01218256|type 2 diabetes|type 2 diabetes
5517795|NCT01218256|resistance training|resistance training
5517796|NCT01218256|hypertrophy training|hypertrophy training
5517797|NCT01218256|endurance training|endurance training
5517798|NCT01218243|Acupuncture|acupuncture
5517799|NCT01218243|Mild and moderate BPH|mild and moderate bph
5517800|NCT01218230|Pegaptanib, myopic CNVM, intravitreal anti-VEGF|pegaptanib, myopic cnvm, intravitreal anti-vegf
5517801|NCT01218217|TB|tb
5517802|NCT01218217|Tuberculosis|tuberculosis
5517803|NCT01218217|EBA|eba
5517804|NCT01218217|Pulmonary|pulmonary
5499645|NCT01297335|hypertension|hypertension
5517805|NCT01218217|Early Bactericidal Activity|early bactericidal activity
5517806|NCT01218204|Pharmacodynamics|pharmacodynamics
5517807|NCT01218204|Lipids|lipids
5517808|NCT01218204|Dyslipidemia|dyslipidemia
5517809|NCT01218204|Safety|safety
5517810|NCT01218204|GSK1292263|gsk1292263
5517811|NCT01218204|Ezetimibe|ezetimibe
5517812|NCT01218204|Statin|statin
5517813|NCT01218204|Pharmacokinetics|pharmacokinetics
5517814|NCT01218204|Tolerability|tolerability
5517815|NCT01218204|Atorvastatin|atorvastatin
5517816|NCT01218191|subarachnoid hemorrhage|subarachnoid hemorrhage
5517817|NCT01218191|scintigraphy|scintigraphy
5517818|NCT01218191|neurocardiogenic injury|neurocardiogenic injury
5517819|NCT01218178|acute myocardial infarction|acute myocardial infarction
5517820|NCT01218178|acute kidney injury|acute kidney injury
5517821|NCT01218178|contrast induced nephropathy|contrast induced nephropathy
5517822|NCT01218178|primary PCI|primary pci
5517823|NCT01218178|sodium-bicarbonate|sodium-bicarbonate
5517824|NCT01218178|N-acetylcysteine|n-acetylcysteine
5517826|NCT01218152|NF1|nf1
5517827|NCT01218152|MPNST|mpnst
5517828|NCT01218152|plasma|plasma
5517829|NCT01218152|microarray CGH|microarray cgh
5677187|NCT00591526|APL|apl
5517830|NCT01218139|neurofibroma|neurofibroma
5517831|NCT01218139|MPNST|mpnst
5517832|NCT01218139|array CGH|array cgh
5517833|NCT01218139|sequencing|sequencing
5517834|NCT01218113|Human Immunodeficiency Virus (HIV)-1|human immunodeficiency virus (hiv)-1
5517835|NCT01218113|safety|safety
5517836|NCT01218113|vaccine|vaccine
5517837|NCT01218113|immunogenicity|immunogenicity
5517838|NCT01218113|reactogenicity|reactogenicity
5517839|NCT01218113|HIV infection|hiv infection
5517840|NCT01218087|Positional Head Shape Deformity|positional head shape deformity
5517841|NCT01218074|bleeding|bleeding
5517842|NCT01218074|blood sparing procedure|blood sparing procedure
5517843|NCT01218074|desmopressin|desmopressin
5517844|NCT01218074|aggregometry|aggregometry
5517845|NCT01218074|thromboelastography|thromboelastography
5517846|NCT01218061|Pre-diabetes|pre-diabetes
5517847|NCT01218061|Type 2 diabetes|type 2 diabetes
5517848|NCT01218061|Biomarkers|biomarkers
5517849|NCT01218061|Cohort|cohort
5517850|NCT01218061|Diabetes Risk Score|diabetes risk score
5517851|NCT01218048|Carcinoma|carcinoma
5517852|NCT01218048|Head and Neck|head and neck
5517853|NCT01218048|Cetuximab|cetuximab
5517854|NCT01218048|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
5517855|NCT01218035|Hip osteoarthritis|hip osteoarthritis
5517856|NCT01218035|Bisphophonate therapy|bisphophonate therapy
5517857|NCT01218035|Zoledronic acid|zoledronic acid
5517858|NCT01218035|Radiostereometric analysis|radiostereometric analysis
5517859|NCT01218035|Osteoporosis|osteoporosis
5517860|NCT01218009|asthma|asthma
5517861|NCT01218009|dry powder inhaler|dry powder inhaler
5517862|NCT01218009|short-acting beta2-agonist|short-acting beta2-agonist
5517863|NCT01218009|SABA|saba
5517864|NCT01218009|bronchoconstriction|bronchoconstriction
5517865|NCT01218009|bronchodilation|bronchodilation
5517866|NCT01218009|bronchodilator|bronchodilator
5517867|NCT01218009|metered dose inhaler|metered dose inhaler
5517868|NCT01217996|working memory intervention|working memory intervention
5517869|NCT01217996|memory impairment|memory impairment
5517870|NCT01217996|cognitive late effects|cognitive late effects
5517871|NCT01217996|Childhood Cancer Survivors|childhood cancer survivors
5517872|NCT01217970|methamphetamine|methamphetamine
5517873|NCT01217970|dependence|dependence
5517874|NCT01217970|stimulant|stimulant
5517875|NCT01217970|amphetamine|amphetamine
5517876|NCT01217970|los angeles|los angeles
5517877|NCT01217970|meth|meth
5517878|NCT01217970|speed|speed
5517879|NCT01217970|crank|crank
5517880|NCT01217970|abuse|abuse
5517881|NCT01217957|Drug therapy|drug therapy
5517882|NCT01217944|Pathologic myopia|pathologic myopia
5517883|NCT01217944|PM|pm
5517884|NCT01217944|choroidal neovascularization|choroidal neovascularization
5517885|NCT01217944|CNV|cnv
5517886|NCT01217944|ranibizumab|ranibizumab
5517887|NCT01217944|verteporfin PDT|verteporfin pdt
5517888|NCT01217931|Renal Cell Carcinoma|renal cell carcinoma
5517889|NCT01217931|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5517890|NCT01217931|Clear cell component|clear cell component
5517892|NCT01217931|Bevacizumab|bevacizumab
5517893|NCT01217931|Everolimus|everolimus
5517894|NCT01217931|Pazopanib|pazopanib
5517895|NCT01217931|GW786034|gw786034
5517896|NCT01217931|Avastin|avastin
5517897|NCT01217931|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5517898|NCT01217931|rhuMAb-VEGF|rhumab-vegf
5517899|NCT01217931|Afinitor|afinitor
5517900|NCT01217931|RAD001|rad001
5517901|NCT01217918|PH-797804|ph-797804
5517902|NCT01217918|Japanese|japanese
5517903|NCT01217918|Phase 1|phase 1
5517904|NCT01217918|multiple dose study|multiple dose study
5517905|NCT01217905|Phase 1|phase 1
5517906|NCT01217905|Type 2 diabetes|type 2 diabetes
5517907|NCT01217905|obesity|obesity
5517908|NCT01217905|Japanese healthy volunteer|japanese healthy volunteer
5517909|NCT01217905|AZD7687|azd7687
5517910|NCT01217892|Type 2 diabetes|type 2 diabetes
5517911|NCT01217892|metformin treated|metformin treated
5517912|NCT01217892|inadequate control|inadequate control
5517913|NCT01217892|metformin treatment alone|metformin treatment alone
5517914|NCT01217879|Cough|cough
5517915|NCT01217879|Telmisartan|telmisartan
5517916|NCT01217879|Bradykinin|bradykinin
5517917|NCT01217879|Tolerability|tolerability
5517918|NCT01217866|laparoscopic|laparoscopic
5517919|NCT01217866|vaginal|vaginal
5517920|NCT01217866|hysterectomy|hysterectomy
5517921|NCT01217840|Adolescents, Vitamin D|adolescents, vitamin d
5517922|NCT01217788|Generalized Social Phobia|generalized social phobia
5517923|NCT01217788|Social Anxiety Disorder|social anxiety disorder
5517924|NCT01217788|Social Phobia|social phobia
5517925|NCT01217788|Phobic Disorders|phobic disorders
5517926|NCT01217788|Phobias|phobias
5658307|NCT00669526|CBT|cbt
5517927|NCT01217775|PMDD, Premenstrual, Dysphoria, Mood Swings, Bloating.|pmdd, premenstrual, dysphoria, mood swings, bloating.
5517928|NCT01217762|Oraya|oraya
5517929|NCT01217762|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
5517930|NCT01217762|low voltage stereotactic radiosurgery|low voltage stereotactic radiosurgery
5904032|NCT00007813|stage IV childhood liver cancer|stage iv childhood liver cancer
5517931|NCT01217762|radiosurgery|radiosurgery
5517932|NCT01217762|radiotherapy|radiotherapy
5517933|NCT01217762|IRay|iray
5517934|NCT01217762|AMD|amd
5517935|NCT01217762|Macular Degeneration|macular degeneration
5517936|NCT01217762|Wet AMD|wet amd
5517937|NCT01217762|xray|xray
5517938|NCT01217762|radiation|radiation
5517939|NCT01217762|x ray|x ray
5517940|NCT01217762|external beam radiation|external beam radiation
5517941|NCT01217762|Ranibizumab|ranibizumab
5517942|NCT01217762|Lucentis|lucentis
5517943|NCT01217723|Acute leukemia (myeloid,lymphoid,or biphenotypic)|acute leukemia (myeloid,lymphoid,or biphenotypic)
5517944|NCT01217723|Chronic myeloid leukemia|chronic myeloid leukemia
5517945|NCT01217723|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5517946|NCT01217723|Lymphoma|lymphoma
5517947|NCT01217723|Myelodysplastic syndrome|myelodysplastic syndrome
5517948|NCT01217723|Myeloproliferative disorder|myeloproliferative disorder
5517949|NCT01217710|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5517950|NCT01217710|Physical Activity|physical activity
5517951|NCT01217710|Self Management|self management
5517952|NCT01217710|Exercise|exercise
5517953|NCT01217710|Technology|technology
5517954|NCT01217710|Motivational Interviewing|motivational interviewing
5517955|NCT01217697|Metastatic Castration-Resistant Prostate Cancer (CRPC)|metastatic castration-resistant prostate cancer (crpc)
5517956|NCT01217697|Abiraterone Acetate|abiraterone acetate
5517957|NCT01217671|Pulmonary, Emphysema|pulmonary, emphysema
5517958|NCT01217671|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5517959|NCT01217658|Randomized Trial|randomized trial
5517960|NCT01217658|Infant Colic|infant colic
5517961|NCT01217658|Abusive Head Trauma|abusive head trauma
5517962|NCT01217658|Shaken Baby Syndrome|shaken baby syndrome
5517963|NCT01217645|Major depression disorder|major depression disorder
5517964|NCT01217632|Connective tissue growth factor (CTGF)|connective tissue growth factor (ctgf)
5517965|NCT01217632|human IgG1 monoclonal antibody|human igg1 monoclonal antibody
5517966|NCT01217619|neoadjuvant treatment|neoadjuvant treatment
5517967|NCT01217593|mastectomy|mastectomy
5517968|NCT01217593|breast cancer|breast cancer
5517969|NCT01217593|breast surgery|breast surgery
5517970|NCT01217580|c-section|c-section
5517971|NCT01217580|cesarean section|cesarean section
5517972|NCT01217580|TAP block|tap block
5517973|NCT01217580|pain|pain
5517974|NCT01217580|pain after delivery|pain after delivery
5517975|NCT01217580|pain after C-section|pain after c-section
5517976|NCT01217580|pain after C-section delivery|pain after c-section delivery
5517977|NCT01217580|pain after cesarean delivery|pain after cesarean delivery
5517978|NCT01217580|pain after cesarean|pain after cesarean
5517979|NCT01217567|cicatrix|cicatrix
5517980|NCT01217567|cesarean section|cesarean section
5517981|NCT01217567|sutures|sutures
5517982|NCT01217567|surgical staples|surgical staples
5517983|NCT01217567|postoperative pain|postoperative pain
5517984|NCT01217567|Infection|infection
5517985|NCT01217554|Low Back Pain|low back pain
5517986|NCT01217554|Disability|disability
5517987|NCT01217554|Kinematic measures|kinematic measures
5517988|NCT01217541|Dementia|dementia
5517989|NCT01217541|BPSD|bpsd
5517990|NCT01217541|Quality of Life|quality of life
5517991|NCT01217541|Person-centred care|person-centred care
5517992|NCT01217541|Job satisfaction|job satisfaction
5517993|NCT01217541|Nursing home|nursing home
5517994|NCT01217541|Primary care|primary care
5517996|NCT01217528|CRTD|crtd
5517997|NCT01217528|Sudden cardiac death|sudden cardiac death
5517998|NCT01217528|Device settings|device settings
5517999|NCT01217528|Patients who received ICD/CRTD for primary prevention of sudden cardiac death|patients who received icd/crtd for primary prevention of sudden cardiac death
5518000|NCT01217502|Aged|aged
5518001|NCT01217502|Homes for the aged|homes for the aged
5518002|NCT01217502|Self management|self management
5518003|NCT01217502|Personal autonomy|personal autonomy
5518004|NCT01217502|Disease management|disease management
5499854|NCT01296425|Saizen|saizen
5518005|NCT01217502|Self efficacy|self efficacy
5518006|NCT01217502|Participation|participation
5518007|NCT01217489|breast|breast
5518008|NCT01217489|cancer|cancer
5518009|NCT01217489|diagnosis|diagnosis
5518010|NCT01217489|electrical|electrical
5518011|NCT01217489|non-invasive|non-invasive
5518012|NCT01217489|mammography|mammography
5518013|NCT01217476|Diabetic foot|diabetic foot
5518014|NCT01217476|Neuropathic|neuropathic
5518015|NCT01217476|Wound|wound
5518016|NCT01217476|Growth factor|growth factor
5518017|NCT01217463|Diabetic foot|diabetic foot
5518018|NCT01217463|Neuropathic|neuropathic
5518019|NCT01217463|Wound|wound
5518020|NCT01217463|Growth factor|growth factor
5658430|NCT00668902|CYP2C19|cyp2c19
5518021|NCT01217424|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5518022|NCT01217424|pain|pain
5518023|NCT01217424|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5789050|NCT00150124|levothyroxine|levothyroxine
5518024|NCT01217398|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5518025|NCT01217398|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5518026|NCT01217398|iris melanoma|iris melanoma
5518027|NCT01217398|metastatic intraocular melanoma|metastatic intraocular melanoma
5518028|NCT01217398|stage IV intraocular melanoma|stage iv intraocular melanoma
5518029|NCT01217385|stage IIIA breast cancer|stage iiia breast cancer
5518030|NCT01217385|stage IIIB breast cancer|stage iiib breast cancer
5518031|NCT01217385|stage IIIC breast cancer|stage iiic breast cancer
5518032|NCT01217372|Recurrent idiopathic calcium oxalate nephrolithiasis.|recurrent idiopathic calcium oxalate nephrolithiasis.
5518033|NCT01217333|Telephones|telephones
5518034|NCT01217333|Community-Based Participatory Research|community-based participatory research
5518035|NCT01217333|Participation, Patient|participation, patient
5518036|NCT01217333|Rural health services|rural health services
5518037|NCT01217320|rheumatology|rheumatology
5518038|NCT01217320|creatine supplementation|creatine supplementation
5518039|NCT01217320|quality of life|quality of life
5518040|NCT01217320|strength|strength
5518041|NCT01217320|juvenile systemic lupus erythematosus|juvenile systemic lupus erythematosus
5518042|NCT01217320|juvenile dermatomyositis|juvenile dermatomyositis
5518043|NCT01217307|Metformin|metformin
5518044|NCT01217307|ST elevation myocardial infarction (STEMI)|st elevation myocardial infarction (stemi)
5518045|NCT01217307|Coronary artery disease|coronary artery disease
5518046|NCT01217307|Heart failure|heart failure
5518047|NCT01217307|Diabetes|diabetes
5518048|NCT01217294|anaesthetic techniques, regional|anaesthetic techniques, regional
5518049|NCT01217294|analgesia, post-operative|analgesia, post-operative
5518050|NCT01217294|fascia iliaca compartment block|fascia iliaca compartment block
5518051|NCT01217294|ultrasound guided|ultrasound guided
5518052|NCT01217294|surgery, orthopaedic|surgery, orthopaedic
5518053|NCT01217281|CKD, Renal, Chronic Kidney Disease, Periodontitis, Perio|ckd, renal, chronic kidney disease, periodontitis, perio
5518054|NCT01217255|Hemophilia|hemophilia
5518055|NCT01217255|Burden of Illness|burden of illness
5518056|NCT01217255|Pediatric|pediatric
5518057|NCT01217255|Quality of Life|quality of life
5518058|NCT01217255|Disability|disability
5518059|NCT01217255|Participation|participation
5518060|NCT01217242|cerebral palsy|cerebral palsy
5518061|NCT01217242|walking activity|walking activity
5518062|NCT01217242|physical activity|physical activity
5518063|NCT01217242|participation|participation
5518064|NCT01217242|activity performance|activity performance
5518065|NCT01217242|activity capacity|activity capacity
5518066|NCT01217229|Hodgkin Lymphoma|hodgkin lymphoma
5518067|NCT01217216|Breast Cancer|breast cancer
5518068|NCT01217216|Weight loss|weight loss
5518069|NCT01217216|Group Intervention|group intervention
5518070|NCT01217216|Telephone Intervention|telephone intervention
5518071|NCT01217177|Cervical cancer,|cervical cancer,
5518072|NCT01217177|radiotherapy,|radiotherapy,
5518073|NCT01217177|chemotherapy,|chemotherapy,
5518075|NCT01217177|everolimus|everolimus
5518076|NCT01217164|nutrition|nutrition
5518077|NCT01217164|very low birth weight|very low birth weight
5518078|NCT01217164|premature|premature
5518079|NCT01217151|Hemodynamic Monitoring|hemodynamic monitoring
5518080|NCT01217151|Goal-Directed Therapy|goal-directed therapy
5518081|NCT01217138|Anaphylaxis, autoinjector, design, epinephrine|anaphylaxis, autoinjector, design, epinephrine
5518082|NCT01217125|tuberousclerosis, angiomyolipoma, rapamycin|tuberousclerosis, angiomyolipoma, rapamycin
5518083|NCT01217112|Dyslipidemias|dyslipidemias
5518084|NCT01217112|Diabetes|diabetes
5518085|NCT01217112|Liver Fat|liver fat
5518086|NCT01217112|Body Fat|body fat
5518087|NCT01217099|refractory mycoplasma pneumoniae pneumonia|refractory mycoplasma pneumoniae pneumonia
5518088|NCT01217060|Adenocarcinoma|adenocarcinoma
5518089|NCT01217060|Squamous cell carcinoma|squamous cell carcinoma
5518090|NCT01217060|Thoracic esophagus|thoracic esophagus
5518091|NCT01217060|Gastroesophageal junction|gastroesophageal junction
5518092|NCT01217060|Chemoradiotherapy|chemoradiotherapy
5518093|NCT01217060|Esophagectomy|esophagectomy
5518094|NCT01217060|5-Fluorouracil|5-fluorouracil
5518095|NCT01217060|Docetaxel|docetaxel
5518096|NCT01217060|Radiation|radiation
5518097|NCT01217060|Radiotherapy|radiotherapy
5518098|NCT01217060|XRT|xrt
5518099|NCT01217060|IMRT|imrt
5518100|NCT01217060|Taxotere|taxotere
5518101|NCT01217060|Adrucil|adrucil
5518102|NCT01217060|Efudex|efudex
5518103|NCT01217060|Dexamethasone|dexamethasone
5518104|NCT01217060|Decadron|decadron
5518105|NCT01217047|Spinal cord injury|spinal cord injury
5518106|NCT01217047|Functional electrical stimulation|functional electrical stimulation
5518107|NCT01217047|Rehabilitation|rehabilitation
5518108|NCT01217047|Growth factors|growth factors
5518109|NCT01217047|Cytokines|cytokines
5518110|NCT01217034|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5518112|NCT01217034|sorafenib|sorafenib
5518113|NCT01217034|Time to untreatable progression|time to untreatable progression
5518114|NCT01217034|TTUP|ttup
5518115|NCT01217008|Spinal Cord Injury|spinal cord injury
5518116|NCT01217008|GRNOPC1|grnopc1
5518117|NCT01216995|Heart Attack|heart attack
5518118|NCT01216995|Regenerative Cells|regenerative cells
5518119|NCT01216995|Stem Cells|stem cells
5518120|NCT01216982|Mood Disorders|mood disorders
5518121|NCT01216982|Depression|depression
5518122|NCT01216982|Combat Disorders|combat disorders
5518123|NCT01216982|Stress Disorders|stress disorders
5518124|NCT01216982|Fatty Acids, Omega-3|fatty acids, omega-3
5518125|NCT01216982|Military Personnel|military personnel
5518126|NCT01216982|Docosahexaenoic Acids/*therapeutic use|docosahexaenoic acids/*therapeutic use
5518127|NCT01216982|Eicosapentaenoic Acid/*therapeutic use|eicosapentaenoic acid/*therapeutic use
5518128|NCT01216956|extended release nicotinic acid|extended release nicotinic acid
5518129|NCT01216956|non esterified fatty acid (NEFA)|non esterified fatty acid (nefa)
5518130|NCT01216956|insulin resistance|insulin resistance
5518131|NCT01216956|Cholesteryl ester transfer protein (CETP)|cholesteryl ester transfer protein (cetp)
5518132|NCT01216956|High density lipoprotein cholesterol|high density lipoprotein cholesterol
5518133|NCT01216891|Schizophrenia|schizophrenia
5518134|NCT01216891|Schizoaffective Disorder|schizoaffective disorder
5518135|NCT01216891|Schizophreniform Disorder|schizophreniform disorder
5518136|NCT01216891|Delusional Disorder|delusional disorder
5518137|NCT01216891|Psychosis|psychosis
5518138|NCT01216891|First episode|first episode
5518139|NCT01216865|Diabetic foot|diabetic foot
5518140|NCT01216865|critical limb ischemia|critical limb ischemia
5518141|NCT01216865|mesenchymal stem cells|mesenchymal stem cells
5518142|NCT01216865|umbilical cord|umbilical cord
5518143|NCT01216813|esophageal cancer|esophageal cancer
5518144|NCT01216813|gastric cancer|gastric cancer
5518145|NCT01216813|cervical cancer|cervical cancer
5518146|NCT01216813|fallopian tube cancer|fallopian tube cancer
5518147|NCT01216813|ovarian epithelial cancer|ovarian epithelial cancer
5518148|NCT01216813|ovarian germ cell tumor|ovarian germ cell tumor
5518149|NCT01216813|ovarian sarcoma|ovarian sarcoma
5518150|NCT01216813|ovarian stromal cancer|ovarian stromal cancer
5518151|NCT01216813|endometrial cancer|endometrial cancer
5518152|NCT01216813|uterine sarcoma|uterine sarcoma
5518153|NCT01216813|vaginal cancer|vaginal cancer
5518154|NCT01216813|vulvar cancer|vulvar cancer
5518155|NCT01216813|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5518156|NCT01216800|ototoxicity|ototoxicity
5518157|NCT01216800|radiation toxicity|radiation toxicity
5518158|NCT01216800|stage I salivary gland cancer|stage i salivary gland cancer
5518159|NCT01216800|stage II salivary gland cancer|stage ii salivary gland cancer
5518160|NCT01216800|stage III salivary gland cancer|stage iii salivary gland cancer
5518161|NCT01216761|Bacteremia|bacteremia
5518162|NCT01216761|Blood culture|blood culture
5518163|NCT01216761|Contamination|contamination
5518164|NCT01216761|Antiseptic agents|antiseptic agents
5518165|NCT01216748|airway blood flow|airway blood flow
5518166|NCT01216748|albuterol|albuterol
5518167|NCT01216748|acidosis|acidosis
5518168|NCT01216748|alkalosis|alkalosis
5518170|NCT01216735|inhaled corticosteroids|inhaled corticosteroids
5518171|NCT01216735|brachial flow|brachial flow
5518172|NCT01216735|airway blood flow|airway blood flow
5518173|NCT01216735|albuterol|albuterol
5518174|NCT01216735|spirometry|spirometry
5518175|NCT01216735|endothelial dysfunction|endothelial dysfunction
5518176|NCT01216722|Muscle Wasting|muscle wasting
5518177|NCT01216722|Strengthening|strengthening
5518178|NCT01216722|Liver Disease|liver disease
5518179|NCT01216722|Transplant|transplant
5518180|NCT01216709|Infant|infant
5518181|NCT01216709|Dietary Supplements|dietary supplements
5518182|NCT01216709|Food, Fortified|food, fortified
5518183|NCT01216709|Iron Absorption|iron absorption
5518184|NCT01216696|ipilimumab|ipilimumab
5518185|NCT01216696|melanoma|melanoma
5518186|NCT01216696|NY-ESO-1|ny-eso-1
5518187|NCT01216683|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5518188|NCT01216683|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5518189|NCT01216683|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5518190|NCT01216683|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5518191|NCT01216683|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5518192|NCT01216683|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5518193|NCT01216683|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5518194|NCT01216683|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5518195|NCT01216683|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5518196|NCT01216683|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5518197|NCT01216683|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5658662|NCT00667888|IMRT|imrt
5518198|NCT01216683|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5518199|NCT01216670|Reveal® XT|reveal® xt
5518200|NCT01216670|Acute Heart Failure|acute heart failure
5518201|NCT01216670|Low Ejection Fraction|low ejection fraction
5518202|NCT01216670|Reveal® XT implanted|reveal® xt implanted
5518203|NCT01216657|melanoma|melanoma
5518204|NCT01216657|sunitinib|sunitinib
5518205|NCT01216644|gastric cancer|gastric cancer
5518206|NCT01216644|perioperative|perioperative
5518207|NCT01216644|FLOT|flot
5518209|NCT01216644|pathological complete remission|pathological complete remission
5518210|NCT01216644|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach|locally advanced resectable adenocarcinoma of the esophagogastric juction or the stomach
5518212|NCT01216631|oligoarthritis|oligoarthritis
5518214|NCT01216631|intraarticular|intraarticular
5518215|NCT01216618|MiniMed paradigm insulin pumps|minimed paradigm insulin pumps
5518216|NCT01216618|insulin Lispro|insulin lispro
5518217|NCT01216618|Insulin Asprt.|insulin asprt.
5518218|NCT01216592|COPD|copd
5518219|NCT01216592|Airway inflammation|airway inflammation
5518220|NCT01216592|Symptoms|symptoms
5518221|NCT01216592|Lung function|lung function
5518222|NCT01216592|Correlation|correlation
5518223|NCT01216553|Bronchiolitis|bronchiolitis
5518224|NCT01216553|Infants|infants
5518225|NCT01216553|Nebulized Inhalation|nebulized inhalation
5518226|NCT01216553|RSV|rsv
5518227|NCT01216553|Oxygen|oxygen
5518228|NCT01216540|vancomycin|vancomycin
5518229|NCT01216540|nephrotoxicity|nephrotoxicity
5518230|NCT01216540|length of stay|length of stay
5518231|NCT01216540|costs|costs
5518232|NCT01216527|Stage IIB or III squamous cell esophageal carcinoma.|stage iib or iii squamous cell esophageal carcinoma.
5518233|NCT01216514|chronic inflammatory bowel diseases|chronic inflammatory bowel diseases
5518234|NCT01216514|crohn disease|crohn disease
5518235|NCT01216514|hemorrhagic rectocolitis|hemorrhagic rectocolitis
5518236|NCT01216514|immunological markers|immunological markers
5518237|NCT01216514|serological markers|serological markers
5518238|NCT01216514|ANCA|anca
5518239|NCT01216514|ASCA|asca
5518240|NCT01216488|Forearm surgery|forearm surgery
5518241|NCT01216488|Hand surgery|hand surgery
5518242|NCT01216488|Anesthesia|anesthesia
5518243|NCT01216462|Acute Coronary Syndrome|acute coronary syndrome
5518244|NCT01216449|Citalopram|citalopram
5518245|NCT01216449|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5518246|NCT01216449|fMRI|fmri
5518247|NCT01216449|Pharmacokinetics|pharmacokinetics
5518248|NCT01216449|Pharmacodynamics|pharmacodynamics
5518249|NCT01216449|Amygdala|amygdala
5518250|NCT01216449|Elderly|elderly
5518251|NCT01216436|melanoma|melanoma
5518252|NCT01216436|immunotherapy|immunotherapy
5518253|NCT01216436|dendritic cell|dendritic cell
5518254|NCT01216436|GITR-ligand|gitr-ligand
5518255|NCT01216436|CTLA-4|ctla-4
5518256|NCT01216423|Patent Foramen Ovale|patent foramen ovale
5518257|NCT01216423|Pulmonary embolism|pulmonary embolism
5518258|NCT01216423|Stroke|stroke
5518259|NCT01216410|Nausea|nausea
5518260|NCT01216410|Vomiting|vomiting
5518261|NCT01216371|carcinoma|carcinoma
5518262|NCT01216371|metastases|metastases
5518263|NCT01216371|renal|renal
5518264|NCT01216371|lung|lung
5518265|NCT01216358|Headache|headache
5518266|NCT01216358|Contraception|contraception
5518267|NCT01216319|Biodesign|biodesign
5518268|NCT01216319|Nipple Reconstruction|nipple reconstruction
5518269|NCT01216319|Breast Cancer|breast cancer
5518270|NCT01216319|Mastectomy|mastectomy
5518272|NCT01216306|Physical Activity|physical activity
5518273|NCT01216306|Sedentary Activity|sedentary activity
5518274|NCT01216306|Television viewing|television viewing
5518275|NCT01216306|Latino|latino
5518276|NCT01216306|Hispanic|hispanic
5518277|NCT01216306|Preschool|preschool
5518278|NCT01216306|School|school
5518279|NCT01216306|Head Start|head start
5518280|NCT01216293|Drug Therapy|drug therapy
5518281|NCT01216280|Natura-alpha|natura-alpha
5518282|NCT01216280|ulcerative colitis|ulcerative colitis
5518283|NCT01216280|cytokines|cytokines
5518284|NCT01216280|Th1|th1
5518285|NCT01216280|Th17|th17
5518286|NCT01216267|chromogranin A|chromogranin a
5518287|NCT01216267|neuroendocrine|neuroendocrine
5518288|NCT01216267|carcinoid|carcinoid
5500152|NCT01295307|relapsed|relapsed
5518289|NCT01216267|Proton Pump Inhibitor|proton pump inhibitor
5518290|NCT01216254|breast cancer|breast cancer
5518291|NCT01216254|stage 2|stage 2
5518292|NCT01216254|breast conserving therapy|breast conserving therapy
5518293|NCT01216254|sentinel lymph node dissection|sentinel lymph node dissection
5518294|NCT01216254|high frequency electrocoagulation|high frequency electrocoagulation
5518295|NCT01216202|Rectal cancer|rectal cancer
5518296|NCT01216202|Preoperative radiotherapy|preoperative radiotherapy
5518297|NCT01216202|Pelvic surgery|pelvic surgery
5518298|NCT01216202|Sexual function|sexual function
5518299|NCT01216202|Wellbeing|wellbeing
5518300|NCT01216202|Hormone levels|hormone levels
5518301|NCT01216202|Spermatogenesis|spermatogenesis
5518302|NCT01216189|Rectal cancer|rectal cancer
5518303|NCT01216189|Preoperative radiotherapy|preoperative radiotherapy
5518304|NCT01216189|Pelvic surgery|pelvic surgery
5518305|NCT01216189|Sexual function|sexual function
5518306|NCT01216189|Wellbeing|wellbeing
5518307|NCT01216189|Hormone levels|hormone levels
5518308|NCT01216176|Breast Cancer|breast cancer
5518309|NCT01216176|Postmenopausal|postmenopausal
5518310|NCT01216176|Metastatic Phase I ONLY|metastatic phase i only
5518311|NCT01216176|AZD0530 (saracatinib)|azd0530 (saracatinib)
5518313|NCT01216176|Phase I for metastatic disease|phase i for metastatic disease
5518314|NCT01216176|Phase II for newly diagnosed breast cancer|phase ii for newly diagnosed breast cancer
5518315|NCT01216176|Pharmacokinetic|pharmacokinetic
5518317|NCT01216176|Hormone Receptor|hormone receptor
5518318|NCT01216176|Estrogen Receptor|estrogen receptor
5518319|NCT01216176|Progesterone Receptor|progesterone receptor
5518322|NCT01216176|HER negative|her negative
5518323|NCT01216176|Aromatase Inhibitors|aromatase inhibitors
5518324|NCT01216163|Pain following third molar extraction (wisdom tooth)|pain following third molar extraction (wisdom tooth)
5518325|NCT01216150|antifibrinolytic drug|antifibrinolytic drug
5518326|NCT01216150|coronary surgery|coronary surgery
5518327|NCT01216150|hemorrhage|hemorrhage
5518328|NCT01216150|aspirin|aspirin
5518329|NCT01216150|clopidogrel|clopidogrel
5518330|NCT01216137|Multiple Sclerosis|multiple sclerosis
5518331|NCT01216137|Fatigue|fatigue
5518332|NCT01216137|Balance|balance
5518333|NCT01216137|Upright Postural Control|upright postural control
5518334|NCT01216137|Dizziness|dizziness
5518335|NCT01216124|triple negative local advanced breast cancer(TNLABC),neoadjuvant chemotherapy|triple negative local advanced breast cancer(tnlabc),neoadjuvant chemotherapy
5518336|NCT01216111|triple negative breast cancer，local recurrence,distant metastasis|triple negative breast cancer，local recurrence,distant metastasis
5518337|NCT01216098|Intrapartum|intrapartum
5518338|NCT01216098|Clinical trial|clinical trial
5518339|NCT01216098|Perinatal|perinatal
5518340|NCT01216098|Doula|doula
5518341|NCT01216098|VBAC|vbac
5518342|NCT01216098|Perinatal Outcomes|perinatal outcomes
5518343|NCT01216072|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5518344|NCT01216072|Disease Modifying Therapy|disease modifying therapy
5518345|NCT01216072|fingolimod|fingolimod
5518346|NCT01216072|Patient Reported Outcomes|patient reported outcomes
5518347|NCT01216059|adherence|adherence
5518348|NCT01216059|text message|text message
5518349|NCT01216059|reminder|reminder
5518350|NCT01216059|adolescents|adolescents
5518351|NCT01216033|Breast cancer|breast cancer
5518352|NCT01216033|Diagnostics|diagnostics
5518353|NCT01216033|HER2|her2
5518354|NCT01216033|Imaging|imaging
5518355|NCT01216033|Metastases|metastases
5518356|NCT01216033|SPECT|spect
5518357|NCT01216033|Imaging of metastases|imaging of metastases
5518358|NCT01216020|Head and Neck Cancer|head and neck cancer
5518359|NCT01216020|Radiotherapy|radiotherapy
5518360|NCT01216020|Cetuximab|cetuximab
5518361|NCT01216020|Cisplatin|cisplatin
5518362|NCT01216007|Plasma|plasma
5518363|NCT01216007|bupivacaine|bupivacaine
5518364|NCT01216007|concentration|concentration
5518365|NCT01216007|caudal|caudal
5518366|NCT01216007|epidural|epidural
5518367|NCT01216007|TIVA|tiva
5518368|NCT01216007|Inhalational|inhalational
5518369|NCT01216007|anesthesia|anesthesia
5518370|NCT01216007|Caudal epidural|caudal epidural
5518371|NCT01215981|influenza vaccine|influenza vaccine
5518372|NCT01215955|Type 2 Diabetes|type 2 diabetes
5518373|NCT01215955|Insulin|insulin
5518374|NCT01215955|Algorithms|algorithms
5518375|NCT01215955|Blood glucose levels|blood glucose levels
5518376|NCT01215942|Rheumatoid Arthritis|rheumatoid arthritis
5518377|NCT01215929|methamphetamine withdrawal|methamphetamine withdrawal
5518378|NCT01215929|mood|mood
5518379|NCT01215929|retention|retention
5518380|NCT01215929|sleep|sleep
5518381|NCT01215916|Solid tumors|solid tumors
5518382|NCT01215890|Crohn's disease|crohn's disease
5518383|NCT01215890|Low bone mineral density|low bone mineral density
5518384|NCT01215890|inflammatory bowel disease|inflammatory bowel disease
5518385|NCT01215890|bisphosphonate|bisphosphonate
5518386|NCT01215877|Bladder cancer|bladder cancer
5518387|NCT01215877|Previously treated patients|previously treated patients
5518388|NCT01215877|Tesetaxel|tesetaxel
5518389|NCT01215877|Oral taxane|oral taxane
5518390|NCT01215864|metastatic tumors|metastatic tumors
5518391|NCT01215864|refractory tumors|refractory tumors
5790011|NCT00146172|Nerlynx|nerlynx
5518392|NCT01215864|recurrent tumors|recurrent tumors
5518393|NCT01215851|Tuberculosis|tuberculosis
5518394|NCT01215851|EBA|eba
5518395|NCT01215851|TMC207|tmc207
5518396|NCT01215851|pretomanid|pretomanid
5518397|NCT01215851|Early Bactericidal Activity|early bactericidal activity
5518398|NCT01215851|Pulmonary Tuberculosis|pulmonary tuberculosis
5518399|NCT01215851|PA-824|pa-824
5518400|NCT01215851|bedaquiline|bedaquiline
5518401|NCT01215851|pyrazinamide|pyrazinamide
5518402|NCT01215851|moxifloxacin|moxifloxacin
5518403|NCT01215851|ethambutol|ethambutol
5518404|NCT01215851|rifafour|rifafour
5518405|NCT01215838|HCC|hcc
5518406|NCT01215838|hepatocellular carcinoma|hepatocellular carcinoma
5518407|NCT01215838|Eovist|eovist
5518408|NCT01215838|MR|mr
5518409|NCT01215838|MRI|mri
5518410|NCT01215838|magnetic resonance|magnetic resonance
5518411|NCT01215825|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5518412|NCT01215825|systemic steroid|systemic steroid
5518413|NCT01215799|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5518414|NCT01215799|HRPC|hrpc
5518415|NCT01215760|peripheral nerve injury|peripheral nerve injury
5518416|NCT01215760|sensory reeducation|sensory reeducation
5512549|NCT01241409|Safety|safety
5518417|NCT01215760|brain plasticity|brain plasticity
5518418|NCT01215760|training with a mirror|training with a mirror
5518419|NCT01215760|rehabilitation|rehabilitation
5518420|NCT01215747|Kiacta for AA amyloidosis|kiacta for aa amyloidosis
5518421|NCT01215721|Incontinence|incontinence
5518422|NCT01215721|Robotic Prostatectomy|robotic prostatectomy
5518423|NCT01215721|Prostate Cancer|prostate cancer
5518424|NCT01215708|Kidney calculi|kidney calculi
5518425|NCT01215708|Lithotripsy|lithotripsy
5518426|NCT01215708|Calcium channel blockers|calcium channel blockers
5518427|NCT01215708|Adrenergic alpha-antagonists.|adrenergic alpha-antagonists.
5518428|NCT01215695|Intubation, Endotracheal|intubation, endotracheal
5518429|NCT01215695|Endotracheal Intubation, adverse events|endotracheal intubation, adverse events
5518430|NCT01215682|infections|infections
5518431|NCT01215682|immune system|immune system
5518432|NCT01215682|vitamin D|vitamin d
5518433|NCT01215682|sport|sport
5518434|NCT01215682|children|children
5518435|NCT01215669|Influenza|influenza
5518436|NCT01215669|Influenza Virus Vaccines|influenza virus vaccines
5518437|NCT01215669|Intradermal Injections|intradermal injections
5518438|NCT01215643|Chronic hepatitis C genotype 2|chronic hepatitis c genotype 2
5518439|NCT01215643|Chronic hepatitis C genotype 3|chronic hepatitis c genotype 3
5518440|NCT01215643|Cyclophilin inhibitor|cyclophilin inhibitor
5518441|NCT01215630|Veins|veins
5518442|NCT01215630|Exercise tests|exercise tests
5518443|NCT01215630|maximal oxygen uptake|maximal oxygen uptake
5518444|NCT01215630|VO2max|vo2max
5518445|NCT01215617|Randomized controlled study|randomized controlled study
5518446|NCT01215617|Exercise training|exercise training
5518447|NCT01215617|Lung function|lung function
5518448|NCT01215617|Heart function|heart function
5518449|NCT01215604|elderly patients|elderly patients
5518450|NCT01215604|acute infection|acute infection
5518451|NCT01215604|translation initiation factors|translation initiation factors
5518452|NCT01215604|eIF4E|eif4e
5518453|NCT01215604|eIF4G|eif4g
5518454|NCT01215591|Neonatal|neonatal
5518455|NCT01215591|Nasal CPAP|nasal cpap
5518456|NCT01215591|Randomized controlled trial|randomized controlled trial
5518457|NCT01215591|Weaning|weaning
5518458|NCT01215578|Neuroendocrine Tumors|neuroendocrine tumors
5518459|NCT01215578|Neuroectodermal Tumors|neuroectodermal tumors
5518460|NCT01215578|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5518461|NCT01215578|Neoplasms by Histologic Type|neoplasms by histologic type
5518462|NCT01215578|Neoplasms|neoplasms
5518463|NCT01215578|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5518464|NCT01215578|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5518465|NCT01215578|Pancreatic Neoplasms|pancreatic neoplasms
5518466|NCT01215578|Digestive System Neoplasms|digestive system neoplasms
5518467|NCT01215578|Neoplasms by Site|neoplasms by site
5518468|NCT01215578|Endocrine Gland Neoplasms|endocrine gland neoplasms
5518469|NCT01215578|Adenoma, Islet Cell|adenoma, islet cell
5518470|NCT01215578|Adenocarcinoma|adenocarcinoma
5518471|NCT01215578|Carcinoma|carcinoma
5518472|NCT01215578|Adenoma|adenoma
5518473|NCT01215578|Digestive System Diseases|digestive system diseases
5518474|NCT01215578|Pancreatic Diseases|pancreatic diseases
5518475|NCT01215578|Endocrine System Diseases|endocrine system diseases
5518476|NCT01215578|Sunitinib|sunitinib
5518477|NCT01215578|Antineoplastic Agents|antineoplastic agents
5518478|NCT01215578|Therapeutic Uses|therapeutic uses
5518479|NCT01215578|Pharmacologic Actions|pharmacologic actions
5518480|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors
5518481|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents
5518482|NCT01215578|Growth Substances|growth substances
5518483|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs
5518484|NCT01215578|Growth Inhibitors|growth inhibitors
5518485|NCT01215565|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5518486|NCT01215565|Carcinoma|carcinoma
5518487|NCT01215565|Fibrosis|fibrosis
5518488|NCT01215565|Liver Neoplasms|liver neoplasms
5518489|NCT01215565|Pathologic Processes|pathologic processes
5518490|NCT01215565|Digestive System Neoplasms|digestive system neoplasms
5518491|NCT01215565|Neoplasms by Site|neoplasms by site
5518492|NCT01215565|Neoplasms|neoplasms
5518493|NCT01215565|Liver Diseases|liver diseases
5518494|NCT01215565|Adenocarcinoma|adenocarcinoma
5518495|NCT01215565|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5518496|NCT01215565|Neoplasms by Histologic Type|neoplasms by histologic type
5518497|NCT01215565|Sunitinib|sunitinib
5518498|NCT01215565|Antineoplastic Agents|antineoplastic agents
5518499|NCT01215565|Therapeutic Uses|therapeutic uses
5518500|NCT01215565|Pharmacologic Actions|pharmacologic actions
5518501|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors
5518502|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents
5518503|NCT01215565|Growth Substances|growth substances
5518504|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs
5518505|NCT01215565|Growth Inhibitors|growth inhibitors
5518506|NCT01215500|solid tumor cancer|solid tumor cancer
5518507|NCT01215500|epithelial carcinoma|epithelial carcinoma
5518508|NCT01215487|CML Predictive Study|cml predictive study
5518509|NCT01215461|Neonatal mortality|neonatal mortality
5518510|NCT01215461|Preterm birth|preterm birth
5518511|NCT01215461|Low gestational age|low gestational age
5518514|NCT01215448|Quality of life|quality of life
5518515|NCT01215448|Lifestyle|lifestyle
5518516|NCT01215448|Complementary medicine|complementary medicine
5518517|NCT01215422|Surgical procedures|surgical procedures
5518518|NCT01215422|Intubation|intubation
5518519|NCT01215422|Anesthesiologist|anesthesiologist
5518520|NCT01215422|Laryngoscope|laryngoscope
5518521|NCT01215422|Videolaryngoscope|videolaryngoscope
5518522|NCT01215409|Levitra|levitra
5518523|NCT01215409|Erectile dysfunction|erectile dysfunction
5518524|NCT01215409|Taiwan|taiwan
5518525|NCT01215396|Branched Chain Amino Acids|branched chain amino acids
5518526|NCT01215396|Mental Performance|mental performance
5518527|NCT01215396|Muscular Performance|muscular performance
5518528|NCT01215396|Central Fatigue Theory|central fatigue theory
5518529|NCT01215383|HDL|hdl
5518530|NCT01215383|psychiatric patients|psychiatric patients
5518531|NCT01215383|psychiatric patients before and during antipsychotic therapy|psychiatric patients before and during antipsychotic therapy
5518532|NCT01215357|Pathological Gambling|pathological gambling
5518533|NCT01215357|ecopipam|ecopipam
5518534|NCT01215357|Dopamine|dopamine
5518535|NCT01215331|Gestational Diabetes Mellitus|gestational diabetes mellitus
5518536|NCT01215331|Treatment|treatment
5518537|NCT01215331|Insulin|insulin
5518538|NCT01215331|Metformin|metformin
5518539|NCT01215331|Glyburide|glyburide
5518662|NCT01214681|Biomarkers|biomarkers
5518540|NCT01215318|FDG PET/CT, vaginal tampon, urinary contamination, pitfall|fdg pet/ct, vaginal tampon, urinary contamination, pitfall
5518541|NCT01215305|Gastroesophageal Reflux Disease, extraesophageal symptoms|gastroesophageal reflux disease, extraesophageal symptoms
5518542|NCT01215292|testosterone|testosterone
5518543|NCT01215292|acyline|acyline
5518544|NCT01215292|ketoconazole|ketoconazole
5518545|NCT01215292|dutasteride|dutasteride
5518546|NCT01215292|anastrazole|anastrazole
5518547|NCT01215292|Intratesticular hormone concentration|intratesticular hormone concentration
5518548|NCT01215279|Respiratory disease|respiratory disease
5518549|NCT01215279|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5518550|NCT01215266|Bladder cancer|bladder cancer
5518551|NCT01215266|Chemotherapy|chemotherapy
5518552|NCT01215266|Urothelium cancer|urothelium cancer
5518553|NCT01215253|Sudden Death|sudden death
5518554|NCT01215253|Ranolazine|ranolazine
5518555|NCT01215253|Heart failure|heart failure
5518556|NCT01215253|Ventricular tachycardia|ventricular tachycardia
5518557|NCT01215253|Ventricular fibrillation|ventricular fibrillation
5518558|NCT01215253|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5518559|NCT01215214|metabolite profiles|metabolite profiles
5518560|NCT01215214|pharmacokinetics|pharmacokinetics
5518561|NCT01215214|CYP3A|cyp3a
5518562|NCT01215214|metabolomics|metabolomics
5518563|NCT01215201|Periodontal maintenance|periodontal maintenance
5518564|NCT01215201|≥5mm probing depth|≥5mm probing depth
5518565|NCT01215201|bleeding on probing and/or suppuration|bleeding on probing and/or suppuration
5518566|NCT01215188|Invasive pneumococcal disease|invasive pneumococcal disease
5518567|NCT01215188|Pneumonia|pneumonia
5518568|NCT01215188|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5518569|NCT01215175|Pneumococcal vaccines|pneumococcal vaccines
5518570|NCT01215149|HIV|hiv
5518571|NCT01215110|Bedaquiline|bedaquiline
5518572|NCT01215110|Sirturo|sirturo
5518573|NCT01215110|Early Bactericidal Activity|early bactericidal activity
5518574|NCT01215110|EBA|eba
5518575|NCT01215110|Pulmonary Tuberculosis|pulmonary tuberculosis
5518576|NCT01215110|TMC207|tmc207
5518577|NCT01215084|Human Volunteers|human volunteers
5518578|NCT01215071|Lymphadenectomy|lymphadenectomy
5518579|NCT01215071|Extension|extension
5518580|NCT01215071|Bladder cancer|bladder cancer
5518581|NCT01215058|Compliance, France|compliance, france
5790012|NCT00146159|Multiple Sclerosis|multiple sclerosis
5790013|NCT00146146|transsexualism|transsexualism
5518582|NCT01215058|Gastrointestinal bleeding ulcer or symptomatic ulcer with NSAID|gastrointestinal bleeding ulcer or symptomatic ulcer with nsaid
5518583|NCT01215045|AcrySof ReSTOR Aspheric +4|acrysof restor aspheric +4
5518584|NCT01215032|castration-resistant prostate cancer|castration-resistant prostate cancer
5518585|NCT01215032|insulin levels|insulin levels
5518586|NCT01215032|metformin|metformin
5518587|NCT01215019|traumatic brain injury|traumatic brain injury
5518588|NCT01214993|GSK1349572|gsk1349572
5518589|NCT01214993|para-aminohippurate|para-aminohippurate
5518590|NCT01214993|iohexol|iohexol
5518591|NCT01214980|Low-frequency ultrasound|low-frequency ultrasound
5518592|NCT01214980|Wound healing|wound healing
5518593|NCT01214980|Split thickness wound healing|split thickness wound healing
5518594|NCT01214980|Skin graft donor site healing|skin graft donor site healing
5518595|NCT01214967|risk factors for maternal depression|risk factors for maternal depression
5518596|NCT01214954|Total Hip Replacement|total hip replacement
5518597|NCT01214954|Rehabilitation|rehabilitation
5518598|NCT01214954|Resistance training|resistance training
5518600|NCT01214928|cholecalciferol|cholecalciferol
5518601|NCT01214928|hemodialysis|hemodialysis
5518602|NCT01214928|randomized controlled trial|randomized controlled trial
5518603|NCT01214928|pilot|pilot
5518604|NCT01214889|Diphtheria|diphtheria
5518605|NCT01214889|Tetanus|tetanus
5518606|NCT01214889|Pertussis|pertussis
5518607|NCT01214889|Haemophilus influenzae type B|haemophilus influenzae type b
5518609|NCT01214889|PENTAXIM™|pentaxim™
5518610|NCT01214889|TETRAXIM™|tetraxim™
5518611|NCT01214863|Toric Intraocular Lens (IOL)|toric intraocular lens (iol)
5518612|NCT01214850|Meningococcal vaccines|meningococcal vaccines
5518613|NCT01214850|Meningococcal B|meningococcal b
5518614|NCT01214850|Meningococcal ACWY serogroups|meningococcal acwy serogroups
5518615|NCT01214837|Meningococcal|meningococcal
5518616|NCT01214837|ACWY|acwy
5518617|NCT01214837|Conjugate Vaccine|conjugate vaccine
5518618|NCT01214837|Meningitis|meningitis
5518619|NCT01214837|Infants|infants
5518620|NCT01214837|Persistence|persistence
5518621|NCT01214824|Diabetes|diabetes
5518622|NCT01214824|Continuous Glucose Monitoring|continuous glucose monitoring
5518623|NCT01214811|The change in signs of inflammation/local infection|the change in signs of inflammation/local infection
5518624|NCT01214811|To evaluate the comfort, conformability,|to evaluate the comfort, conformability,
5518625|NCT01214811|Pain during wear|pain during wear
5518626|NCT01214798|sesamoid displacement,|sesamoid displacement,
5518627|NCT01214798|metacarpophalangeal joint,|metacarpophalangeal joint,
5518628|NCT01214798|radial condylar ridge of the metacarpal head.|radial condylar ridge of the metacarpal head.
5518629|NCT01214772|pregnancy|pregnancy
5518630|NCT01214772|heparin|heparin
5518631|NCT01214772|fertilization|fertilization
5518632|NCT01214759|HIV|hiv
5518633|NCT01214759|prevention|prevention
5518634|NCT01214759|prophylaxis|prophylaxis
5518635|NCT01214759|Raltegravir|raltegravir
5518636|NCT01214759|Truvada|truvada
5518637|NCT01214746|Statin|statin
5518638|NCT01214746|L-NMMA|l-nmma
5518639|NCT01214746|Healthy subjects|healthy subjects
5518640|NCT01214746|Nephrology|nephrology
5518641|NCT01214707|Exercise/No active Treatment|exercise/no active treatment
5518642|NCT01214694|TBI|tbi
5518643|NCT01214694|intracranial edema|intracranial edema
5518644|NCT01214694|brain edema|brain edema
5518645|NCT01214694|craniocerebral trauma|craniocerebral trauma
5518646|NCT01214694|head injury|head injury
5518647|NCT01214694|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5518648|NCT01214694|subdural hematoma|subdural hematoma
5518649|NCT01214694|brain concussion|brain concussion
5518650|NCT01214694|head injuries, closed|head injuries, closed
5518651|NCT01214694|epidural hematoma|epidural hematoma
5518652|NCT01214694|extra-axial hemorrhage|extra-axial hemorrhage
5518653|NCT01214694|cortical contusion|cortical contusion
5518654|NCT01214694|Additional relevant MeSH terms:|additional relevant mesh terms:
5518655|NCT01214694|Nervous System Diseases|nervous system diseases
5518656|NCT01214694|Wounds and Injuries|wounds and injuries
5518657|NCT01214694|Disorders of Environmental Origin|disorders of environmental origin
5519142|NCT01212653|Golimumab|golimumab
5518658|NCT01214694|Central Nervous System Diseases|central nervous system diseases
5518659|NCT01214694|Trauma, Nervous System|trauma, nervous system
5518660|NCT01214694|Brain Diseases|brain diseases
5518661|NCT01214694|Brain Injuries|brain injuries
5518663|NCT01214681|Colorectal cancer|colorectal cancer
5518664|NCT01214681|Resistant starch|resistant starch
5518665|NCT01214681|Polydextrose|polydextrose
5518666|NCT01214681|Non-digestible carbohydrate|non-digestible carbohydrate
5518667|NCT01214655|Acute Myelogenous Leukemia|acute myelogenous leukemia
5518668|NCT01214655|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5518669|NCT01214655|Chronic Myelogenous Leukemia,Blast Crisis|chronic myelogenous leukemia,blast crisis
5518670|NCT01214642|Advanced Cancer|advanced cancer
5518671|NCT01214642|Cancer|cancer
5518672|NCT01214629|Advanced Cancer|advanced cancer
5518673|NCT01214629|Metastatic Cancer|metastatic cancer
5518674|NCT01214629|Cancer|cancer
5518675|NCT01214603|Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute|acute myelogenous leukemia, acute myeloid leukemia, acute
5518676|NCT01214603|Leukemia, Leukemia|leukemia, leukemia
5518677|NCT01214577|PEP005|pep005
5518678|NCT01214577|Peplin|peplin
5518679|NCT01214577|Photo-damage|photo-damage
5518680|NCT01214564|PEP005|pep005
5518681|NCT01214564|Peplin|peplin
5518682|NCT01214564|Seborrhoeic Keratosis|seborrhoeic keratosis
5518683|NCT01214538|Vaccine pneumococcal natural history Acute otitis media|vaccine pneumococcal natural history acute otitis media
5518684|NCT01214525|Meatal stenosis|meatal stenosis
5518685|NCT01214525|Meatotomy|meatotomy
5518686|NCT01214525|Uroflow|uroflow
5518687|NCT01214525|Postvoid residual|postvoid residual
5518688|NCT01214499|Refractory angina|refractory angina
5518689|NCT01214499|Transmyocardial revascularization|transmyocardial revascularization
5518690|NCT01214499|Stem cells|stem cells
5518691|NCT01214499|Diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment|diffuse coronary disease not amenable to percutaneous coronary intervention, and angina, despite proper medical treatment
5518692|NCT01214486|HIV|hiv
5518693|NCT01214486|RAL|ral
5518694|NCT01214486|Raltegravir|raltegravir
5518695|NCT01214486|Isentress|isentress
5518696|NCT01214486|Pharmacokinetics|pharmacokinetics
5518697|NCT01214473|Clinical sepsis|clinical sepsis
5518698|NCT01214473|Pneumonia|pneumonia
5518699|NCT01214473|Diarrhea|diarrhea
5518710|NCT01214421|ADPKD|adpkd
5512842|NCT01240317|anesthesia|anesthesia
5518711|NCT01214421|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5518712|NCT01214421|Adult Polycystic Kidney Disease|adult polycystic kidney disease
5518714|NCT01214395|peritoneal dialysis|peritoneal dialysis
5518715|NCT01214382|Gastric Bypass|gastric bypass
5518716|NCT01214382|Bariatric Surgery|bariatric surgery
5518717|NCT01214382|Sertraline|sertraline
5518718|NCT01214382|Zoloft|zoloft
5518719|NCT01214382|Pharmacokinetic|pharmacokinetic
5518720|NCT01214369|intraosseous injection|intraosseous injection
5518721|NCT01214369|X-tip|x-tip
5518722|NCT01214369|PDL injection|pdl injection
5518723|NCT01214369|Supplementary Injection|supplementary injection
5518724|NCT01214356|diabetes|diabetes
5518725|NCT01214356|kidney disease|kidney disease
5518726|NCT01214356|vitamin D|vitamin d
5518727|NCT01214343|sorafenib|sorafenib
5518728|NCT01214343|Hepatic intraarterial infusion chemotherapy|hepatic intraarterial infusion chemotherapy
5518729|NCT01214343|HAIC|haic
5518730|NCT01214343|Low dose FP|low dose fp
5518731|NCT01214343|cisplatin|cisplatin
5518732|NCT01214343|fluorouracil|fluorouracil
5518733|NCT01214330|cervical cancer|cervical cancer
5518734|NCT01214317|multiple sclerosis|multiple sclerosis
5518735|NCT01214317|mitoxantrone|mitoxantrone
5518736|NCT01214317|plasmapheresis|plasmapheresis
5518737|NCT01214317|induction therapy|induction therapy
5518738|NCT01214304|Colposcopy|colposcopy
5518739|NCT01214291|fractures|fractures
5518740|NCT01214291|prostate cancer|prostate cancer
5518741|NCT01214291|androgen deprivation therapy|androgen deprivation therapy
5518742|NCT01214278|bioavailability|bioavailability
5518743|NCT01214278|marine n-3 fatty acids|marine n-3 fatty acids
5518744|NCT01214278|EPA|epa
5518745|NCT01214278|DHA|dha
5518746|NCT01214252|Repair of patients' abdominal wall defects|repair of patients' abdominal wall defects
5518747|NCT01214187|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5518748|NCT01214187|IPF|ipf
5518749|NCT01214187|pulmonary fibrosis|pulmonary fibrosis
5518750|NCT01214187|carbon monoxide|carbon monoxide
5518751|NCT01214174|cataract|cataract
5518752|NCT01214174|inflammation|inflammation
5518753|NCT01214161|IUD|iud
5518754|NCT01214161|Lidocaine gel|lidocaine gel
5518755|NCT01214135|Mental disorder|mental disorder
5518756|NCT01214135|antipsychotic treatment|antipsychotic treatment
5518757|NCT01214122|Phase 1|phase 1
5519143|NCT01212653|Simponi|simponi
5518758|NCT01214122|Drug-Drug interaction|drug-drug interaction
5518759|NCT01214122|warfarin|warfarin
5518760|NCT01214122|AZD9668|azd9668
5518761|NCT01214122|resulting from AZD9668 and Warfarin interaction|resulting from azd9668 and warfarin interaction
5518762|NCT01214122|pharmacokinetics|pharmacokinetics
5518763|NCT01214122|pharmacodynamics|pharmacodynamics
5518764|NCT01214096|Chronic Heart failure|chronic heart failure
5518766|NCT01214096|MRI|mri
5518767|NCT01214083|N-acetylcysteine|n-acetylcysteine
5518768|NCT01214083|naltrexone|naltrexone
5518769|NCT01214070|Visual Perception|visual perception
5518770|NCT01214070|Vision, Ocular|vision, ocular
5518771|NCT01214070|Neuronal Plasticity|neuronal plasticity
5518772|NCT01214057|chronic rhinosinusitis|chronic rhinosinusitis
5518773|NCT01214057|endoscopic sinus surgery|endoscopic sinus surgery
5518774|NCT01214057|TIVA|tiva
5518775|NCT01214057|surgical field visualization|surgical field visualization
5518776|NCT01214031|Confocal laser endomicroscope|confocal laser endomicroscope
5518777|NCT01214031|Adenomatous polyps|adenomatous polyps
5518778|NCT01214031|Colonoscopy|colonoscopy
5518779|NCT01214005|nicotine|nicotine
5518780|NCT01214005|reinforcement|reinforcement
5518781|NCT01214005|craving|craving
5518782|NCT01214005|relapse|relapse
5790014|NCT00146146|testosterone|testosterone
5518783|NCT01213966|Acute uncomplicated Plasmodium Falciparum malaria|acute uncomplicated plasmodium falciparum malaria
5518784|NCT01213966|Blood stage Plasmodium Vivax malaria|blood stage plasmodium vivax malaria
5518785|NCT01213953|Vertebral disc, mesenchymal stem cell.|vertebral disc, mesenchymal stem cell.
5518786|NCT01213914|Burns|burns
5518787|NCT01213914|Hemofiltration|hemofiltration
5518788|NCT01213914|Vasopressins|vasopressins
5518789|NCT01213914|Kidney Failure Acute|kidney failure acute
5518790|NCT01213914|Shock, Septic|shock, septic
5518792|NCT01213901|Insulin injection technique|insulin injection technique
5518793|NCT01213888|Diabetic retinopathy|diabetic retinopathy
5518794|NCT01213888|pan-retinal photocoagulation|pan-retinal photocoagulation
5518796|NCT01213875|heart failure|heart failure
5518797|NCT01213875|nursing|nursing
5518798|NCT01213875|home based intervention|home based intervention
5518799|NCT01213875|cost|cost
5518800|NCT01213875|efficacy|efficacy
5518801|NCT01213862|Home Based education|home based education
5518802|NCT01213862|Knowledge of Disease|knowledge of disease
5518803|NCT01213862|Self-Care Skills|self-care skills
5518804|NCT01213862|Quality of Life|quality of life
5518805|NCT01213862|Heart Failure|heart failure
5518806|NCT01213862|Randomized Clinical Trial|randomized clinical trial
5518807|NCT01213836|Stable schizophrenia|stable schizophrenia
5518808|NCT01213836|cognitive functioning|cognitive functioning
5518809|NCT01213823|invasive candidiasis|invasive candidiasis
5518810|NCT01213823|candidemia|candidemia
5518811|NCT01213823|severe hepatic injury|severe hepatic injury
5518812|NCT01213823|echinocandins|echinocandins
5518813|NCT01213823|anidulafungin|anidulafungin
5518814|NCT01213823|caspofungin|caspofungin
5518815|NCT01213823|micafungin|micafungin
5518816|NCT01213810|HIV|hiv
5518817|NCT01213810|VZV (Varicella zoster Virus)|vzv (varicella zoster virus)
5518818|NCT01213810|vaccine|vaccine
5518819|NCT01213810|T cell|t cell
5518820|NCT01213810|immunogenicity|immunogenicity
5518821|NCT01213810|safety|safety
5518822|NCT01213797|Suicide|suicide
5518823|NCT01213771|Preoperative|preoperative
5518824|NCT01213771|Intervention|intervention
5518825|NCT01213771|Support|support
5518826|NCT01213771|Care|care
5518827|NCT01213758|liver function|liver function
5518828|NCT01213758|galactose|galactose
5518829|NCT01213758|18-F-deoxy-galactose|18-f-deoxy-galactose
5518830|NCT01213758|PET/CT|pet/ct
5518831|NCT01213758|stereotactic body radiation therapy|stereotactic body radiation therapy
5518832|NCT01213758|SBRT|sbrt
5518833|NCT01213745|lung|lung
5518834|NCT01213745|cancer|cancer
5518835|NCT01213745|quality of life|quality of life
5518836|NCT01213732|L19, antibody, monoclonal, tumor targeting, TNFa, ILP, melanoma|l19, antibody, monoclonal, tumor targeting, tnfa, ilp, melanoma
5518837|NCT01213719|betaine, creatine, strength|betaine, creatine, strength
5518838|NCT01213706|airway blood flow|airway blood flow
5518839|NCT01213706|albuterol|albuterol
5518840|NCT01213706|Whole Body Periodic Acceleration (WBPA)|whole body periodic acceleration (wbpa)
5518841|NCT01213706|Nitric Oxide|nitric oxide
5518842|NCT01213706|Endothelial Dysfunction|endothelial dysfunction
5518843|NCT01213693|COPD|copd
5518844|NCT01213693|Bacteria|bacteria
5518845|NCT01213693|Virus|virus
5518846|NCT01213693|Inhaled Corticosteroids|inhaled corticosteroids
5518847|NCT01213680|Inflammatory Bowel Disease, IBD|inflammatory bowel disease, ibd
5518848|NCT01213654|Lung cancer|lung cancer
5518849|NCT01213654|VATS Lobectomy|vats lobectomy
5518850|NCT01213641|Cryopyrin-associated periodic syndromes(CAPS)|cryopyrin-associated periodic syndromes(caps)
5518851|NCT01213641|CIAS1 protein|cias1 protein
5518852|NCT01213641|NLRP3 protein|nlrp3 protein
5518853|NCT01213641|human cryopyrin protein|human cryopyrin protein
5518854|NCT01213641|Familial Cold Autoinflammatory Syndrome(FCAS)|familial cold autoinflammatory syndrome(fcas)
5518855|NCT01213641|Muckle-Wells Syndrome(MWS)|muckle-wells syndrome(mws)
5518856|NCT01213641|Neonatal Onset Multisystem Inflammatory disease(NOMID)|neonatal onset multisystem inflammatory disease(nomid)
5518857|NCT01213641|NALP3|nalp3
5518858|NCT01213641|canakinumab|canakinumab
5518859|NCT01213641|Interleukin-1(IL-1)|interleukin-1(il-1)
5518860|NCT01213628|abdominal surgery|abdominal surgery
5518861|NCT01213628|hypothermia|hypothermia
5518862|NCT01213628|wound desiccation|wound desiccation
5518864|NCT01213602|Trauma patients|trauma patients
5518865|NCT01213589|descending|descending
5518866|NCT01213589|thoracic|thoracic
5518867|NCT01213589|aortic|aortic
5518868|NCT01213589|dissection|dissection
5518869|NCT01213589|Valiant|valiant
5518870|NCT01213589|Medtronic|medtronic
5518871|NCT01213589|Type B|type b
5518872|NCT01213589|VIRTUE|virtue
5518873|NCT01213589|stent|stent
5518874|NCT01213576|Lymphatic filariasis|lymphatic filariasis
5518875|NCT01213576|microfilaria|microfilaria
5518876|NCT01213576|Albendazole|albendazole
5518877|NCT01213576|ivermectin|ivermectin
5518878|NCT01213576|human immunodeficiency|human immunodeficiency
5518879|NCT01213563|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5518880|NCT01213537|Heart failure|heart failure
5518881|NCT01213524|nicotine|nicotine
5518882|NCT01213524|craving|craving
5518883|NCT01213524|dual-diagnosis|dual-diagnosis
5518884|NCT01213524|comorbidity|comorbidity
5518885|NCT01213511|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation|coronary artery disease; coronary artery bypass grafting; cardiopulmonary bypass; minimal extracorporeal circulation
5518886|NCT01213498|Nephrology|nephrology
5518887|NCT01213498|Atorvastatin|atorvastatin
5518888|NCT01213498|L-NMMA|l-nmma
5518889|NCT01213498|NO|no
5518890|NCT01213472|ASCI|asci
5518891|NCT01213472|melanoma|melanoma
5518892|NCT01213472|tumor antigen|tumor antigen
5518893|NCT01213472|unresectable|unresectable
5518894|NCT01213472|progressive|progressive
5518895|NCT01213472|NY-ESO-1|ny-eso-1
5518896|NCT01213472|adult|adult
5518897|NCT01213472|cancer-testis antigen|cancer-testis antigen
5518898|NCT01213472|Immunotherapy|immunotherapy
5518899|NCT01213459|Human papillomavirus|human papillomavirus
5518900|NCT01213446|Von Willebrand Disease|von willebrand disease
5518901|NCT01213420|Donor sites after wound closure|donor sites after wound closure
5518902|NCT01213407|Dendritic cell|dendritic cell
5518903|NCT01213407|Cancer vaccine|cancer vaccine
5518904|NCT01213407|Anti-tumor immune therapy|anti-tumor immune therapy
5518905|NCT01213407|Interleukine-12|interleukine-12
5518906|NCT01213407|Individualised autologous therapy|individualised autologous therapy
5518907|NCT01213407|Brain cancer|brain cancer
5518908|NCT01213407|Temozolomide|temozolomide
5518909|NCT01213407|Radiotherapy|radiotherapy
5518910|NCT01213407|Irradiation|irradiation
5518911|NCT01213407|High-grade glioma|high-grade glioma
5518912|NCT01213407|Advanced therapy medicinal product ATMP|advanced therapy medicinal product atmp
5518914|NCT01213407|Leukocyte apheresis|leukocyte apheresis
5518915|NCT01213407|Neurosurgery|neurosurgery
5518916|NCT01213407|Neurooncology|neurooncology
5518917|NCT01213407|Neurology|neurology
5518918|NCT01213407|Immunology|immunology
5518919|NCT01213407|Tumor immunology|tumor immunology
5518920|NCT01213407|Transfusion medicine|transfusion medicine
5518921|NCT01213407|Monocyte|monocyte
5518922|NCT01213407|Killer cell|killer cell
5518923|NCT01213407|Cytotoxic T-cell|cytotoxic t-cell
5518924|NCT01213407|Cytotoxic T-lymphocyte|cytotoxic t-lymphocyte
5518925|NCT01213394|Framingham score|framingham score
5518926|NCT01213394|kidney transplant|kidney transplant
5518927|NCT01213394|immunosuppression|immunosuppression
5518928|NCT01213394|cardiovascular disease|cardiovascular disease
5518929|NCT01213394|CellCept|cellcept
5518930|NCT01213394|mycophenolate mofetil|mycophenolate mofetil
5518931|NCT01213355|Randomized|randomized
5518932|NCT01213355|double-blind|double-blind
5518933|NCT01213355|placebo-controlled|placebo-controlled
5518934|NCT01213355|5-way crossover|5-way crossover
5518935|NCT01213355|single oral administrations of PF 05212377|single oral administrations of pf 05212377
5518936|NCT01213355|scopolamine induced deficits in healthy subjects|scopolamine induced deficits in healthy subjects
5518937|NCT01213342|dry eye disease|dry eye disease
5518938|NCT01213316|HIV|hiv
5518939|NCT01213316|antiretroviral|antiretroviral
5518940|NCT01213316|human immunodeficiency virus|human immunodeficiency virus
5518941|NCT01213316|Raltegravir|raltegravir
5518942|NCT01213316|Adults with HIV-1 infection|adults with hiv-1 infection
5518943|NCT01213303|cardiovascular risk|cardiovascular risk
5518944|NCT01213303|metabolic syndrome|metabolic syndrome
5518945|NCT01213303|fatty acids|fatty acids
5518946|NCT01213303|oxysterols|oxysterols
5518947|NCT01213303|antioxidants|antioxidants
5518948|NCT01213303|oxidative stress|oxidative stress
5518949|NCT01213290|Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)|endoscopic ultrasound-guided fine-needle aspiration (eus-fna)
5518950|NCT01213290|Stylet|stylet
5518951|NCT01213277|Diabetes Mellitus|diabetes mellitus
5518952|NCT01213277|HbA1c|hba1c
5518953|NCT01213277|Glycation Rate|glycation rate
5518954|NCT01213277|Fructosamine|fructosamine
5519248|NCT01212146|Prebiotics|prebiotics
5518955|NCT01213264|neuromuscular blockade, NMBA, sugammadex, Bridion, TOF,|neuromuscular blockade, nmba, sugammadex, bridion, tof,
5518956|NCT01213238|Liver metastasis|liver metastasis
5518957|NCT01213238|hepatic arterial infusion|hepatic arterial infusion
5518959|NCT01213238|Eloxatin|eloxatin
5518960|NCT01213238|Xeloda|xeloda
5518961|NCT01213238|Avastin|avastin
5518962|NCT01213238|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5518963|NCT01213238|rhuMAb-VEGF|rhumab-vegf
5518964|NCT01213238|Oxaliplatin|oxaliplatin
5518965|NCT01213238|Capecitabine|capecitabine
5518966|NCT01213238|Bevacizumab|bevacizumab
5518967|NCT01213225|Elderly|elderly
5518968|NCT01213225|Hospitalization|hospitalization
5518969|NCT01213225|Geriatrics|geriatrics
5518970|NCT01213225|Mortality|mortality
5518971|NCT01213225|Readmission|readmission
5518972|NCT01213225|Length of Stay|length of stay
5518973|NCT01213212|Caloric restriction|caloric restriction
5518974|NCT01213212|type 2 diabetes|type 2 diabetes
5518975|NCT01213212|abdominal obesity|abdominal obesity
5518976|NCT01213212|renal disease|renal disease
5518977|NCT01213186|stem cell|stem cell
5518978|NCT01213186|hiv|hiv
5518979|NCT01213186|CD4|cd4
5518980|NCT01213186|immune activation|immune activation
5518981|NCT01213173|angina pectoris|angina pectoris
5518982|NCT01213173|chest pain|chest pain
5518983|NCT01213173|heart rate|heart rate
5518984|NCT01213160|Phase I|phase i
5518985|NCT01213160|cancer|cancer
5518986|NCT01213160|solid tumours|solid tumours
5518987|NCT01213160|advanced solid malignancies|advanced solid malignancies
5518988|NCT01213160|dose escalation|dose escalation
5518989|NCT01213160|FGFR TKI|fgfr tki
5518991|NCT01213147|Pregnancy|pregnancy
5518992|NCT01213147|Clomiphene Citrate|clomiphene citrate
5518995|NCT01213134|Medical Education|medical education
5518996|NCT01213134|Resident Training|resident training
5518997|NCT01213134|Portfolio|portfolio
5518998|NCT01213121|bipolar depression|bipolar depression
5518999|NCT01213121|heart rate variability|heart rate variability
5519000|NCT01213121|cardio-respiratory coupling|cardio-respiratory coupling
5519001|NCT01213121|electroencephalography|electroencephalography
5519002|NCT01213108|Örebro prevention program|örebro prevention program
5519003|NCT01213108|Youth drinking|youth drinking
5519004|NCT01213095|Lymphoma|lymphoma
5519005|NCT01213095|B-Cell|b-cell
5519006|NCT01213095|Marginal Zone|marginal zone
5519007|NCT01213095|Rituximab|rituximab
5519008|NCT01213082|Exudative Age-related Macular Degeneration|exudative age-related macular degeneration
5519009|NCT01213082|Proton beam irradiation|proton beam irradiation
5519010|NCT01213082|ranibizumab|ranibizumab
5519011|NCT01213082|bevacizumab|bevacizumab
5519012|NCT01213082|anti-VEGF therapy|anti-vegf therapy
5513130|NCT01238835|Aortic Stenosis|aortic stenosis
5519013|NCT01213056|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5519014|NCT01213056|Chronic Headache Pain|chronic headache pain
5519015|NCT01213056|Randomized Controlled Trial.|randomized controlled trial.
5519016|NCT01213043|emphysema|emphysema
5519017|NCT01213043|alpha 1-antitrypsin|alpha 1-antitrypsin
5519018|NCT01213043|alpha 1-antitrypsin deficiency (AATD)|alpha 1-antitrypsin deficiency (aatd)
5519019|NCT01213043|alpha 1-proteinase inhibitor (Alpha-1 PI)|alpha 1-proteinase inhibitor (alpha-1 pi)
5519021|NCT01213030|[F-18]HX4|[f-18]hx4
5519022|NCT01213030|FMISO|fmiso
5519023|NCT01213030|[F-18]FMISO|[f-18]fmiso
5519024|NCT01213030|Solitary Tumor|solitary tumor
5519025|NCT01213030|Hypoxia|hypoxia
5519026|NCT01213017|Certolizumab pegol|certolizumab pegol
5519027|NCT01213017|Magnetic Resonance Imaging|magnetic resonance imaging
5519028|NCT01213017|Rheumatoid Arthritis|rheumatoid arthritis
5519029|NCT01213017|RAPID 3|rapid 3
5519030|NCT01213004|gastro-esophageal junction|gastro-esophageal junction
5519031|NCT01213004|lung|lung
5519032|NCT01213004|abdominal|abdominal
5519033|NCT01213004|cone-beam CT (CBCT)|cone-beam ct (cbct)
5519034|NCT01213004|10-146|10-146
5519035|NCT01212991|Progressive Metastatic Prostate Cancer|progressive metastatic prostate cancer
5519036|NCT01212978|Aging|aging
5519037|NCT01212978|Endothelium,Vascular|endothelium,vascular
5519038|NCT01212978|Arterial Remodeling|arterial remodeling
5519039|NCT01212978|Ventricular Vascular Coupling|ventricular vascular coupling
5519040|NCT01212978|Nitric Oxide|nitric oxide
5519041|NCT01212978|Walking|walking
5519042|NCT01212978|Software|software
5519043|NCT01212965|Selenium|selenium
5519044|NCT01212965|Lymphatic Malformations|lymphatic malformations
5519045|NCT01212965|Adolescents|adolescents
5519046|NCT01212939|Dead pulps and open root ends|dead pulps and open root ends
5519047|NCT01212939|Patients who have teeth with dead pulp and open root ends|patients who have teeth with dead pulp and open root ends
5519048|NCT01212900|Atherosclerosis|atherosclerosis
5519049|NCT01212900|Cardiovascular Disease|cardiovascular disease
5519050|NCT01212900|Cardiac MRI|cardiac mri
5519051|NCT01212900|Cardiac CT|cardiac ct
5519052|NCT01212900|Cholesterol|cholesterol
5519053|NCT01212887|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5519054|NCT01212887|recurrent colon cancer|recurrent colon cancer
5519055|NCT01212887|stage IIIA colon cancer|stage iiia colon cancer
5519061|NCT01212887|stage IIIA rectal cancer|stage iiia rectal cancer
5519062|NCT01212887|stage IIIB rectal cancer|stage iiib rectal cancer
5519063|NCT01212887|stage IIIC rectal cancer|stage iiic rectal cancer
5519064|NCT01212887|stage IVA rectal cancer|stage iva rectal cancer
5519065|NCT01212887|stage IVB rectal cancer|stage ivb rectal cancer
5519066|NCT01212887|recurrent gastric cancer|recurrent gastric cancer
5519067|NCT01212887|stage IV gastric cancer|stage iv gastric cancer
5519068|NCT01212887|recurrent pancreatic cancer|recurrent pancreatic cancer
5519069|NCT01212887|stage III pancreatic cancer|stage iii pancreatic cancer
5519070|NCT01212887|stage IV pancreatic cancer|stage iv pancreatic cancer
5519071|NCT01212887|recurrent breast cancer|recurrent breast cancer
5519072|NCT01212887|stage IIIC breast cancer|stage iiic breast cancer
5519073|NCT01212887|stage IV breast cancer|stage iv breast cancer
5519074|NCT01212887|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5519075|NCT01212887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5519076|NCT01212887|recurrent small cell lung cancer|recurrent small cell lung cancer
5519077|NCT01212887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5519078|NCT01212887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5519079|NCT01212887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5519080|NCT01212887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5519081|NCT01212887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5519082|NCT01212887|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5519083|NCT01212887|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5519084|NCT01212887|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5519085|NCT01212887|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5519086|NCT01212887|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5519087|NCT01212887|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5519088|NCT01212887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5519089|NCT01212887|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5519090|NCT01212848|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5519093|NCT01212835|gastroesophageal reflux disease|gastroesophageal reflux disease
5519094|NCT01212835|Morbid obesity|morbid obesity
5519095|NCT01212835|esophagitis|esophagitis
5519097|NCT01212835|silastic ring|silastic ring
5519098|NCT01212835|Gastric bypass|gastric bypass
5519099|NCT01212796|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5519106|NCT01212770|Psoriatic Arthritis|psoriatic arthritis
5519107|NCT01212770|Psoriasis|psoriasis
5519108|NCT01212770|Arthritis|arthritis
5519109|NCT01212770|inflammation|inflammation
5519110|NCT01212770|skin condition|skin condition
5519111|NCT01212770|inflammatory cells|inflammatory cells
5519112|NCT01212770|apremilast|apremilast
5519113|NCT01212770|CC-10004|cc-10004
5519114|NCT01212770|phosphodiesterase type 4|phosphodiesterase type 4
5519115|NCT01212757|Psoriasis|psoriasis
5519116|NCT01212757|Arthritis|arthritis
5519117|NCT01212757|Psoriatic Arthritis|psoriatic arthritis
5519118|NCT01212757|inflammation|inflammation
5519119|NCT01212757|skin condition|skin condition
5519120|NCT01212757|inflammatory cells|inflammatory cells
5519121|NCT01212757|apremilast|apremilast
5519122|NCT01212757|CC-10004|cc-10004
5519123|NCT01212757|phosphodiesterase type 4|phosphodiesterase type 4
5519124|NCT01212744|PEG PAL; PKU; injection;|peg pal; pku; injection;
5519125|NCT01212731|Patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.|patients with malignancies of the skull base or patients with low grade glioma who require radiotherapy.
5519126|NCT01212718|Colorectal Cancer|colorectal cancer
5519127|NCT01212718|non resectable metastasis|non resectable metastasis
5519128|NCT01212718|reference lesion|reference lesion
5519130|NCT01212718|thymidylate synthase quantitation|thymidylate synthase quantitation
5519131|NCT01212679|nerve growth factor|nerve growth factor
5519132|NCT01212679|traumatic brain injury|traumatic brain injury
5519133|NCT01212679|intranasal|intranasal
5519134|NCT01212679|prognosis|prognosis
5519135|NCT01212679|neurological function|neurological function
5519136|NCT01212666|Adductor Canal Block (ACB)|adductor canal block (acb)
5519137|NCT01212666|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
5519138|NCT01212666|Saphenous nerve|saphenous nerve
5519139|NCT01212666|Pain|pain
5519140|NCT01212666|Ultrasound block|ultrasound block
5519141|NCT01212653|Ankylosing Spondylitis|ankylosing spondylitis
5519144|NCT01212653|Anti-TNF alpha|anti-tnf alpha
5519145|NCT01212653|EPCs|epcs
5519146|NCT01212653|Vascular stiffness|vascular stiffness
5519147|NCT01212640|Transfusion, distress|transfusion, distress
5519148|NCT01212627|Non-Small Cell Lung Cancer|non-small cell lung cancer
5519149|NCT01212601|safety|safety
5519150|NCT01212601|efficacy|efficacy
5519151|NCT01212601|Chinese patients|chinese patients
5519152|NCT01212601|practice|practice
5519154|NCT01212588|Borderline|borderline
5519155|NCT01212588|personality disorder|personality disorder
5519156|NCT01212588|mifepristone|mifepristone
5519157|NCT01212575|Mental disorder|mental disorder
5519158|NCT01212575|Antipsychotic treatment|antipsychotic treatment
5519159|NCT01212562|basal cell carcinoma|basal cell carcinoma
5519161|NCT01212562|imiquimod|imiquimod
5519162|NCT01212562|immunocryosurgery|immunocryosurgery
5519163|NCT01212549|basal cell carcinoma|basal cell carcinoma
5519164|NCT01212549|cryosurgery|cryosurgery
5519165|NCT01212549|imiquimod|imiquimod
5519166|NCT01212549|immunocryosurgery|immunocryosurgery
5519167|NCT01212536|children|children
5519168|NCT01212536|intubation|intubation
5519169|NCT01212536|laryngoscope|laryngoscope
5519170|NCT01212523|propofol|propofol
5519171|NCT01212523|isoflurane|isoflurane
5519172|NCT01212523|pulmonary hypertension|pulmonary hypertension
5519173|NCT01212523|congenital heart disease|congenital heart disease
5519174|NCT01212510|metastatic colorectal cancer|metastatic colorectal cancer
5519175|NCT01212510|circulating tumor markers|circulating tumor markers
5519176|NCT01212510|circulating tumor cell|circulating tumor cell
5519177|NCT01212510|circulating tumor DNA|circulating tumor dna
5519178|NCT01212510|marker's kinetic|marker's kinetic
5519179|NCT01212497|mindfulness|mindfulness
5519180|NCT01212497|meditation|meditation
5519181|NCT01212497|training|training
5519182|NCT01212497|coaching|coaching
5519183|NCT01212497|virtual coach|virtual coach
5519184|NCT01212471|Sign and symptoms of dry eye disease|sign and symptoms of dry eye disease
5519185|NCT01212458|gesunde Probanden|gesunde probanden
5519186|NCT01212432|Gram positive infection and CRRT|gram positive infection and crrt
5678887|NCT00584467|GEM|gem
5519187|NCT01212406|Organ rejection|organ rejection
5519188|NCT01212406|Lung transplantation|lung transplantation
5519189|NCT01212406|Bronchiolitis Obliterans|bronchiolitis obliterans
5519190|NCT01212406|Vitamin D|vitamin d
5519191|NCT01212406|Prevention|prevention
5519192|NCT01212393|venous thromboembolism disease|venous thromboembolism disease
5519193|NCT01212393|emergency|emergency
5519194|NCT01212393|prevention|prevention
5519195|NCT01212393|thromboprophylaxis|thromboprophylaxis
5519196|NCT01212393|medical|medical
5519197|NCT01212393|hosptitalization|hosptitalization
5519198|NCT01212393|health care risks|health care risks
5519199|NCT01212380|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5519200|NCT01212380|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5519201|NCT01212380|Prolymphocytic Leukemia|prolymphocytic leukemia
5519202|NCT01212367|Gene transfer|gene transfer
5519203|NCT01212367|Immunology|immunology
5519204|NCT01212367|Cancer|cancer
5519205|NCT01212354|intensity modulated radiotherapy|intensity modulated radiotherapy
5519206|NCT01212354|selective dose escalation|selective dose escalation
5519207|NCT01212354|hypoxia|hypoxia
5519208|NCT01212354|head cancer|head cancer
5519209|NCT01212354|neck cancer|neck cancer
5519210|NCT01212341|Allogenetic NK cells|allogenetic nk cells
5519211|NCT01212341|Lymphomas|lymphomas
5519212|NCT01212341|Solid tumors|solid tumors
5519213|NCT01212328|T2DM|t2dm
5519214|NCT01212328|Decision support software|decision support software
5519215|NCT01212328|care coordinator|care coordinator
5519216|NCT01212315|Wound infection|wound infection
5519217|NCT01212315|SSI|ssi
5519218|NCT01212315|Suture|suture
5519219|NCT01212302|Clopidogrel|clopidogrel
5519220|NCT01212302|ASA|asa
5519221|NCT01212302|Low Response|low response
5519222|NCT01212302|Resistance|resistance
5519223|NCT01212263|PCOS|pcos
5519224|NCT01212263|Clomiphene resistance|clomiphene resistance
5519225|NCT01212263|ovulation induction|ovulation induction
5519226|NCT01212263|low dose uFSH|low dose ufsh
5519227|NCT01212263|uFSH step-up protocol|ufsh step-up protocol
5519228|NCT01212237|glioma|glioma
5519229|NCT01212237|meningioma|meningioma
5519230|NCT01212237|anaplastic astrocytoma|anaplastic astrocytoma
5519231|NCT01212211|Hyponatremia; Sodium level|hyponatremia; sodium level
5519232|NCT01212211|Falls|falls
5519233|NCT01212211|Gait|gait
5519234|NCT01212211|elderly|elderly
5519235|NCT01212185|oxytocin|oxytocin
5519236|NCT01212185|alcohol withdrawal|alcohol withdrawal
5519237|NCT01212185|lorazepam|lorazepam
5519238|NCT01212185|alcoholism|alcoholism
5519239|NCT01212185|intranasal administration|intranasal administration
5519240|NCT01212185|CIWA-Ar|ciwa-ar
5519241|NCT01212172|Hair removal|hair removal
5519242|NCT01212172|Laser|laser
5519243|NCT01212172|Diode laser|diode laser
5519244|NCT01212159|Internet based monitoring system|internet based monitoring system
5519245|NCT01212146|Artichokes|artichokes
5519246|NCT01212146|Constipation|constipation
5519247|NCT01212146|Functional Foods|functional foods
5519257|NCT01212094|MS|ms
5519258|NCT01212094|Secondary-Progressive Multiple Sclerosis|secondary-progressive multiple sclerosis
5519259|NCT01212094|SP-MS|sp-ms
5519260|NCT01212081|Virtual Reality|virtual reality
5519261|NCT01212081|Schizophrenia|schizophrenia
5519262|NCT01212081|Cannabis|cannabis
5519263|NCT01212081|Assessment|assessment
5519264|NCT01212081|Craving|craving
5519265|NCT01212068|MEG|meg
5519266|NCT01212068|Epilepsy|epilepsy
5519267|NCT01212068|Brain Imaging|brain imaging
5519268|NCT01212068|Brain Scan|brain scan
5519269|NCT01212068|Auditory Processing|auditory processing
5519270|NCT01212068|Auditory Perceptual Disorder|auditory perceptual disorder
5519271|NCT01212055|PBSC Collection|pbsc collection
5519272|NCT01212055|Immunodeficiency|immunodeficiency
5519273|NCT01212055|Spectra Apheresis System|spectra apheresis system
5519274|NCT01212055|Stem Cell Mobilization|stem cell mobilization
5519275|NCT01212055|Leukapheresis|leukapheresis
5519276|NCT01212042|Pneumonia|pneumonia
5519277|NCT01212042|Pulmonary Pathogens|pulmonary pathogens
5519278|NCT01212042|HIV|hiv
5519279|NCT01212042|Immunocompromised Host|immunocompromised host
5519280|NCT01212042|Respiratory Infection|respiratory infection
5519281|NCT01212042|Mycobacteria|mycobacteria
5519285|NCT01212016|Eosinophilic Esophagitis|eosinophilic esophagitis
5519286|NCT01212016|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5519287|NCT01212016|Peanut Allergy|peanut allergy
5519288|NCT01212016|T Cell|t cell
5519289|NCT01212016|IgE|ige
5519290|NCT01212016|Food Allergy|food allergy
5519297|NCT01211990|Pediatric|pediatric
5519298|NCT01211990|Children|children
5519299|NCT01211990|Cancer|cancer
5519300|NCT01211990|Bone Marrow Transplant|bone marrow transplant
5519301|NCT01211977|Muckle Wells Syndrome|muckle wells syndrome
5519302|NCT01211977|Autoinflammatory|autoinflammatory
5519303|NCT01211977|Interleukin-1|interleukin-1
5519304|NCT01211951|Dry eye syndromes|dry eye syndromes
5519305|NCT01211951|Corneal diseases|corneal diseases
5519306|NCT01211951|Conjunctival diseases|conjunctival diseases
5904033|NCT00007813|recurrent childhood liver cancer|recurrent childhood liver cancer
5519307|NCT01211938|phase II/III|phase ii/iii
5519308|NCT01211938|upper aerodigestive tract carcinoma|upper aerodigestive tract carcinoma
5519309|NCT01211938|re irradiation|re irradiation
5519310|NCT01211938|Recurrent or second upper aerodigestive tract carcinoma|recurrent or second upper aerodigestive tract carcinoma
5519311|NCT01211925|unreconstructable peripheral arterial disease|unreconstructable peripheral arterial disease
5519312|NCT01211912|Fetal movement|fetal movement
5519313|NCT01211912|Fetal breathing|fetal breathing
5519314|NCT01211912|Acetaminophen|acetaminophen
5519315|NCT01211899|polymorphism,|polymorphism,
5519316|NCT01211899|plasminogen activator inhibitor,|plasminogen activator inhibitor,
5519317|NCT01211899|disseminated intravascular coagulation,|disseminated intravascular coagulation,
5519318|NCT01211886|Brain natriuretic peptide|brain natriuretic peptide
5519319|NCT01211886|Cardio-renal syndrome|cardio-renal syndrome
5519321|NCT01211873|Contrast Agent|contrast agent
5519322|NCT01211873|MRI|mri
5519323|NCT01211873|Dotarem|dotarem
5519324|NCT01211873|Magnevist|magnevist
5519325|NCT01211860|DCCR|dccr
5519326|NCT01211860|Diazoxide Chonline Controlled-Release Tablet = DCCR|diazoxide chonline controlled-release tablet = dccr
5519327|NCT01211860|Hypertriglyceridemia|hypertriglyceridemia
5519328|NCT01211860|Triglycerides|triglycerides
5519329|NCT01211860|Pharmacokinetics|pharmacokinetics
5519330|NCT01211847|triglycerides|triglycerides
5519331|NCT01211847|Apo B|apo b
5519332|NCT01211847|non-HDL|non-hdl
5519333|NCT01211847|statin|statin
5519334|NCT01211847|fenofibrate|fenofibrate
5519335|NCT01211795|Migraine|migraine
5519336|NCT01211795|Prevention|prevention
5519337|NCT01211795|Treatment|treatment
5519338|NCT01211795|Ketoprofen|ketoprofen
5519339|NCT01211795|Trigeminal nerve|trigeminal nerve
5519340|NCT01211782|Alzheimer's disease|alzheimer's disease
5519341|NCT01211782|AD|ad
5519342|NCT01211782|AC-1204|ac-1204
5519343|NCT01211782|ketogenic|ketogenic
5519344|NCT01211782|ketosis|ketosis
5519345|NCT01211769|PUFAs|pufas
5519346|NCT01211769|Alcoholism|alcoholism
5519347|NCT01211769|Treatment|treatment
5519348|NCT01211769|Effectiveness|effectiveness
5519349|NCT01211743|SILS|sils
5519350|NCT01211743|Oxidative Stress|oxidative stress
5519351|NCT01211743|8-epiPGF2a|8-epipgf2a
5519352|NCT01211743|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
5519353|NCT01211730|Liver|liver
5519354|NCT01211730|transplantation|transplantation
5519355|NCT01211730|Glucose|glucose
5519356|NCT01211730|Hyperglycemia|hyperglycemia
5519357|NCT01211730|Insulin|insulin
5519358|NCT01211730|Rejection|rejection
5519359|NCT01211730|Hypoglycemia|hypoglycemia
5519360|NCT01211717|Branched Chained Amino Acids|branched chained amino acids
5519361|NCT01211717|Delayed Onset Muscle Soreness|delayed onset muscle soreness
5519362|NCT01211717|Diabetes|diabetes
5519363|NCT01211717|Muscle Damage|muscle damage
5519364|NCT01211704|Bipolar, Alcoholism|bipolar, alcoholism
5519365|NCT01211691|Hematologic|hematologic
5519366|NCT01211691|Leukemia|leukemia
5519367|NCT01211691|Malignancies|malignancies
5519368|NCT01211691|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5519369|NCT01211665|IVMP|ivmp
5519370|NCT01211665|corticosteroids|corticosteroids
5519371|NCT01211665|IRIS|iris
5519372|NCT01211665|Progressive Multifocal Leukoencephalopathy|progressive multifocal leukoencephalopathy
5519373|NCT01211665|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5519374|NCT01211665|PML|pml
5519375|NCT01211652|Compliance|compliance
5519377|NCT01211652|Self-administered questionnaire to patients|self-administered questionnaire to patients
5519378|NCT01211613|Manipulation|manipulation
5519379|NCT01211613|Chiropractic|chiropractic
5519380|NCT01211613|Low Back Pain|low back pain
5519381|NCT01211600|Staples|staples
5519382|NCT01211600|Sutures|sutures
5519383|NCT01211600|Wound infections|wound infections
5519384|NCT01211600|Cosmesis|cosmesis
5519385|NCT01211600|Aesthetic appearance of skin incision|aesthetic appearance of skin incision
5519386|NCT01211587|Parkinson's Disease|parkinson's disease
5519387|NCT01211587|Cognition|cognition
5519388|NCT01211587|Safinamide|safinamide
5519389|NCT01211587|Phase 2|phase 2
5519390|NCT01211587|Non-demented patients|non-demented patients
5519391|NCT01211587|Levodopa|levodopa
5519392|NCT01211587|Dopamine agonist|dopamine agonist
5519393|NCT01211535|Soft contact lenses|soft contact lenses
5519394|NCT01211535|Multi-purpose Solution|multi-purpose solution
5519395|NCT01211522|Delirium|delirium
5519396|NCT01211522|Intensive care|intensive care
5519397|NCT01211522|Mechanical ventilation|mechanical ventilation
5519398|NCT01211522|Antipsychotic|antipsychotic
5519399|NCT01211522|Haloperidol|haloperidol
5519400|NCT01211522|Ziprasidone|ziprasidone
5519401|NCT01211522|Randomized|randomized
5519402|NCT01211522|Placebo|placebo
5519403|NCT01211522|Sepsis|sepsis
5519404|NCT01211522|Sedation|sedation
5519405|NCT01211522|Long-term cognitive impairment|long-term cognitive impairment
5519406|NCT01211509|montelukast|montelukast
5519407|NCT01211509|cysteinyl leukotriene|cysteinyl leukotriene
5519408|NCT01211509|lung transplantation|lung transplantation
5519409|NCT01211509|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5519410|NCT01211496|functional testing|functional testing
5519411|NCT01211496|resistance training|resistance training
5519412|NCT01211496|velocity training|velocity training
5519414|NCT01211496|geriatric|geriatric
5519417|NCT01211496|leg strength|leg strength
5519418|NCT01211483|Lung cancer|lung cancer
5519419|NCT01211470|MRSA|mrsa
5519420|NCT01211470|ABSSSI|absssi
5519421|NCT01211470|Staphylococcus aureus|staphylococcus aureus
5519422|NCT01211457|Sapacitabine|sapacitabine
5519423|NCT01211457|decitabine|decitabine
5519424|NCT01211457|venetoclax|venetoclax
5519425|NCT01211457|elderly|elderly
5519426|NCT01211457|AML|aml
5519427|NCT01211457|MDS|mds
5519428|NCT01211457|Refractory|refractory
5519429|NCT01211457|relapsed|relapsed
5519430|NCT01211457|untreated|untreated
5519431|NCT01211444|Obstructive Sleep Apnea|obstructive sleep apnea
5519432|NCT01211444|OSA|osa
5519433|NCT01211444|Hypoglossal nerve stimulation|hypoglossal nerve stimulation
5519434|NCT01211444|Sleep apnea|sleep apnea
5519435|NCT01211431|cesarean section|cesarean section
5519436|NCT01211431|pain|pain
5519437|NCT01211431|ropivacain|ropivacain
5519438|NCT01211431|diclofena|diclofena
5519439|NCT01211431|morphine|morphine
5519440|NCT01211405|MDMA|mdma
5519441|NCT01211405|Psychotherapy|psychotherapy
5519443|NCT01211405|Posttraumatic Stress Disorder|posttraumatic stress disorder
5519444|NCT01211379|colorectal cancer screening|colorectal cancer screening
5519445|NCT01211379|primary care|primary care
5519446|NCT01211379|health disparities|health disparities
5519447|NCT01211366|cell saver|cell saver
5519448|NCT01211366|allogeneic RBCs|allogeneic rbcs
5519449|NCT01211366|washed cells|washed cells
5519450|NCT01211366|PRBC transfusion|prbc transfusion
5519451|NCT01211353|Alcohol|alcohol
5519452|NCT01211353|Brief Intervention|brief intervention
5519453|NCT01211353|Personalized Feedback|personalized feedback
5519454|NCT01211353|Veterans|veterans
5519455|NCT01211340|Hospice|hospice
5519456|NCT01211340|Caregivers|caregivers
5519457|NCT01211340|Interdisciplinary Team|interdisciplinary team
5519458|NCT01211340|Pain management|pain management
5519459|NCT01211314|hypertension|hypertension
5519460|NCT01211314|Fixed combination|fixed combination
5519461|NCT01211314|lercanidipine|lercanidipine
5519462|NCT01211314|enalapril|enalapril
5519463|NCT01211314|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5519464|NCT01211301|obesity|obesity
5519465|NCT01211301|overweight|overweight
5519466|NCT01211301|weight loss|weight loss
5519467|NCT01211301|randomized controlled trial|randomized controlled trial
5519468|NCT01211301|Medifast|medifast
5519469|NCT01211288|HIV|hiv
5519470|NCT01211288|Implant|implant
5519471|NCT01211288|Crown|crown
5519472|NCT01211275|mesothelioma|mesothelioma
5519473|NCT01211275|chemotherapy|chemotherapy
5519474|NCT01211275|translational research|translational research
5519475|NCT01211275|axitinib|axitinib
5519476|NCT01211262|Melanoma|melanoma
5519477|NCT01211262|Phase I|phase i
5519478|NCT01211262|Biologic|biologic
5519479|NCT01211249|Methotrexate-refractory|methotrexate-refractory
5519480|NCT01211223|Chronic periodontitis|chronic periodontitis
5519481|NCT01211223|Metronidazole plus Amoxicillin|metronidazole plus amoxicillin
5519482|NCT01211223|Mechanical periodontal therapy|mechanical periodontal therapy
5519483|NCT01211223|Scaling and Root Planning|scaling and root planning
5519484|NCT01211223|Periodontal treatment|periodontal treatment
5519485|NCT01211210|rectal cancer|rectal cancer
5519486|NCT01211210|neoadjuvant therapy|neoadjuvant therapy
5519487|NCT01211210|oxaliplatin|oxaliplatin
5519488|NCT01211210|radiation|radiation
5519489|NCT01211184|Hip surgery|hip surgery
5519490|NCT01211184|Metabolism|metabolism
5519492|NCT01211184|Body fluids|body fluids
5519493|NCT01211184|Complications|complications
5519494|NCT01211171|Cough|cough
5519495|NCT01211171|Telmisartan|telmisartan
5519496|NCT01211171|Bradykinin|bradykinin
5519497|NCT01211171|Tolerability|tolerability
5519498|NCT01211158|emergency department|emergency department
5519499|NCT01211158|procedural sedation|procedural sedation
5519500|NCT01211158|ketofol|ketofol
5519501|NCT01211158|ketamine|ketamine
5519502|NCT01211158|propofol|propofol
5519503|NCT01211158|conscious sedation|conscious sedation
5519504|NCT01211145|Migraine|migraine
5519505|NCT01211145|Headache|headache
5519506|NCT01211145|Pain|pain
5519507|NCT01211145|Efficacy|efficacy
5519508|NCT01211145|Adolescents|adolescents
5519509|NCT01211132|Colon polyps|colon polyps
5519510|NCT01211132|Adenoma detection|adenoma detection
5519511|NCT01211132|Cap|cap
5519512|NCT01211132|Standard|standard
5519513|NCT01211132|Colon Cancer|colon cancer
5519514|NCT01211106|Treatment|treatment
5519515|NCT01211106|PTSD|ptsd
5519516|NCT01211106|Addiction|addiction
5519517|NCT01211093|vibration|vibration
5519518|NCT01211093|muscle|muscle
5519519|NCT01211093|cerebrovascular accident|cerebrovascular accident
5519520|NCT01211093|exercise|exercise
5519521|NCT01211093|rehabilitation|rehabilitation
5519522|NCT01211080|infancy hemangioma|infancy hemangioma
5519523|NCT01211080|propranolol|propranolol
5519524|NCT01211080|study design|study design
5519525|NCT01211080|side effects|side effects
5519526|NCT01211080|safety|safety
5519527|NCT01211067|Inguinal hernia|inguinal hernia
5519528|NCT01211067|Inguinal ring|inguinal ring
5519529|NCT01211067|Histology|histology
5519530|NCT01211067|Hernioplasty|hernioplasty
5519531|NCT01211067|Lichtenstein|lichtenstein
5519532|NCT01211041|Candida albicans, fungemia , prognostic factor|candida albicans, fungemia , prognostic factor
5519533|NCT01211028|Critical leg ischemia|critical leg ischemia
5519534|NCT01211028|Adipose derived Stroma/Stem Cells|adipose derived stroma/stem cells
5519535|NCT01211028|Autologous|autologous
5519536|NCT01211028|Angiogenesis|angiogenesis
5519537|NCT01211002|Radiotherapy|radiotherapy
5519538|NCT01211002|rh-endostatin|rh-endostatin
5519539|NCT01211002|chemotherapy|chemotherapy
5519540|NCT01211002|NSCLC|nsclc
5519541|NCT01210976|levosimendan|levosimendan
5519542|NCT01210976|CABG|cabg
5519543|NCT01210976|AVR|avr
5519544|NCT01210950|distraction|distraction
5519545|NCT01210950|osteogenesis|osteogenesis
5519546|NCT01210950|limb length discrepancy|limb length discrepancy
5519547|NCT01210950|callus|callus
5513821|NCT01235936|CKD|ckd
5519548|NCT01210937|Internal Carotid Artery Stenosis|internal carotid artery stenosis
5519549|NCT01210937|Carotid Endarterectomy|carotid endarterectomy
5519551|NCT01210937|Cerebrovascular|cerebrovascular
5519552|NCT01210937|Atherosclerosis|atherosclerosis
5519553|NCT01210924|children|children
5519554|NCT01210924|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5519555|NCT01210924|antiretroviral therapy|antiretroviral therapy
5519556|NCT01210924|China|china
5519557|NCT01210924|Mortality|mortality
5519558|NCT01210911|pancreatic cancer|pancreatic cancer
5519559|NCT01210911|metformin|metformin
5519560|NCT01210911|MAPK pathway|mapk pathway
5519561|NCT01210911|PI3K/Akt pathway|pi3k/akt pathway
5519562|NCT01210911|gemcitabine|gemcitabine
5519563|NCT01210898|Influenza|influenza
5519564|NCT01210898|Trivalent|trivalent
5519565|NCT01210898|Adjuvanted|adjuvanted
5519566|NCT01210898|Vaccine|vaccine
5519567|NCT01210898|Children|children
5519568|NCT01210885|Meningococcal Disease|meningococcal disease
5519569|NCT01210885|Vaccines|vaccines
5519570|NCT01210885|Adolescents|adolescents
5519571|NCT01210872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5519572|NCT01210872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5519573|NCT01210872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5519574|NCT01210872|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5519575|NCT01210872|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5519576|NCT01210872|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5519577|NCT01210872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5519578|NCT01210872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5519579|NCT01210872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5685350|NCT00556478|EMLA® cream|emla® cream
5519580|NCT01210872|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5519581|NCT01210872|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5519582|NCT01210872|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5519583|NCT01210872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5519584|NCT01210872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5519585|NCT01210872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5519586|NCT01210872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5519587|NCT01210872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5519588|NCT01210872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5519589|NCT01210872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5519590|NCT01210872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5519591|NCT01210872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5519592|NCT01210872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5519593|NCT01210872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5519594|NCT01210872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5519595|NCT01210872|tongue cancer|tongue cancer
5519596|NCT01210859|detrusitol|detrusitol
5519597|NCT01210859|overactive|overactive
5519598|NCT01210859|bladder|bladder
5519599|NCT01210859|ureteral|ureteral
5519600|NCT01210859|stents|stents
5519601|NCT01210846|AV-951|av-951
5519602|NCT01210846|tivozanib|tivozanib
5519603|NCT01210846|QTc|qtc
5519604|NCT01210846|advanced solid tumors|advanced solid tumors
5519605|NCT01210846|pharmacokinetics|pharmacokinetics
5519606|NCT01210833|Finger Fractures|finger fractures
5519607|NCT01210833|Tendon Injuries|tendon injuries
5519608|NCT01210833|Soft Tissue Injuries|soft tissue injuries
5519609|NCT01210781|All indication for deep brain stimulation (DBS)|all indication for deep brain stimulation (dbs)
5519610|NCT01210768|Phase II|phase ii
5519611|NCT01210768|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5519612|NCT01210768|Adjuvant Chemotherapy|adjuvant chemotherapy
5519613|NCT01210768|Breast Cancer|breast cancer
5519614|NCT01210755|Antithrombotics|antithrombotics
5519615|NCT01210755|Haemostatics|haemostatics
5519616|NCT01210755|Antidote|antidote
5519617|NCT01210729|stroke|stroke
5519618|NCT01210729|mechanical recanalization|mechanical recanalization
5519619|NCT01210729|self-expanding stent|self-expanding stent
5519620|NCT01210729|Solitaire|solitaire
5519621|NCT01210716|Therapeutic plasma exchange|therapeutic plasma exchange
5519622|NCT01210716|Autoimmune diseases|autoimmune diseases
5519623|NCT01210716|Kidney transplant|kidney transplant
5519624|NCT01210716|Hematologic disorders|hematologic disorders
5519625|NCT01210716|Monoclonal gammopathy|monoclonal gammopathy
5519626|NCT01210716|Neurologic disorders|neurologic disorders
5519627|NCT01210703|Acoustic Pharyngometry|acoustic pharyngometry
5519628|NCT01210703|CPAP|cpap
5519630|NCT01210690|Levetiracetam|levetiracetam
5519631|NCT01210690|Keppra® Oral Solution|keppra® oral solution
5519632|NCT01210690|Keppra® in Children|keppra® in children
5519633|NCT01210677|Cardiac Sarcoidosis|cardiac sarcoidosis
5519634|NCT01210677|Sarcoidosis|sarcoidosis
5519635|NCT01210664|Diabetes|diabetes
5519636|NCT01210664|Treg|treg
5519637|NCT01210651|Yoga|yoga
5519638|NCT01210651|Major Depression|major depression
5519639|NCT01210651|Self-Efficacy|self-efficacy
5519640|NCT01210651|Self-Esteem|self-esteem
5519641|NCT01210651|Hatha yoga|hatha yoga
5519642|NCT01210651|mind-body therapies|mind-body therapies
5519643|NCT01210651|depression|depression
5519644|NCT01210625|Constipation|constipation
5519645|NCT01210599|Back Pain|back pain
5519646|NCT01210599|Bisphosphonate|bisphosphonate
5519647|NCT01210599|Pamidronate|pamidronate
5519648|NCT01210599|Bone Pain|bone pain
5519649|NCT01210573|Heart Failure|heart failure
5519650|NCT01210573|Heart-Assist Devices|heart-assist devices
5519651|NCT01210573|Left Ventricular Assist Device|left ventricular assist device
5519652|NCT01210560|Kidney Disease|kidney disease
5519653|NCT01210560|Polycystic Kidney Disease|polycystic kidney disease
5519654|NCT01210521|Asthmatic Patients|asthmatic patients
5519655|NCT01210521|Vitamin D|vitamin d
5519656|NCT01210521|Steroid Resistant Asthmatic Patients|steroid resistant asthmatic patients
5519657|NCT01210521|cholecalciferol|cholecalciferol
5519658|NCT01210508|Cancer patients with metastases to the spinal column|cancer patients with metastases to the spinal column
5519659|NCT01210495|Hepatocellular Carcinoma|hepatocellular carcinoma
5519660|NCT01210482|Torisel|torisel
5519787|NCT01209897|Smoking|smoking
5519661|NCT01210482|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5519662|NCT01210469|elderly|elderly
5519663|NCT01210469|postural balance|postural balance
5519664|NCT01210469|musculoskeletal equilibrium|musculoskeletal equilibrium
5519665|NCT01210469|posture|posture
5519666|NCT01210469|muscle strength|muscle strength
5519667|NCT01210469|muscle stretching exercises|muscle stretching exercises
5519668|NCT01210456|Chronic Kidney Disease|chronic kidney disease
5519669|NCT01210456|Contrast Media|contrast media
5519670|NCT01210456|Acute Kidney Injury|acute kidney injury
5519671|NCT01210456|N-Acetylcysteine|n-acetylcysteine
5519672|NCT01210456|Bicarbonate|bicarbonate
5519673|NCT01210443|sitaxentan sodium pulmonary hypertension|sitaxentan sodium pulmonary hypertension
5519674|NCT01210430|Postural Tachycardia Syndrome|postural tachycardia syndrome
5519675|NCT01210430|Orthostatic Intolerance|orthostatic intolerance
5519676|NCT01210430|Reactive Oxygen Species|reactive oxygen species
5519677|NCT01210430|Oxidative Stress|oxidative stress
5519678|NCT01210430|Angiotensin II|angiotensin ii
5519679|NCT01210430|Nitric Oxide|nitric oxide
5519680|NCT01210430|Blood Flow|blood flow
5519682|NCT01210430|Ascorbic Acid|ascorbic acid
5519683|NCT01210430|Vitamin C|vitamin c
5519684|NCT01210430|Losartan|losartan
5519685|NCT01210417|Trauma|trauma
5519686|NCT01210417|Hypovolemia|hypovolemia
5519687|NCT01210417|Hemorrhage|hemorrhage
5519688|NCT01210417|Out of hospital trauma|out of hospital trauma
5519689|NCT01210404|Drug interaction with methadone.|drug interaction with methadone.
5519690|NCT01210378|NSCLC|nsclc
5519691|NCT01210378|Nitroglycerin|nitroglycerin
5519692|NCT01210378|Tumour perfusion|tumour perfusion
5519694|NCT01210378|Toxicity|toxicity
5519695|NCT01210378|Phase II|phase ii
5519696|NCT01210378|HX4|hx4
5519697|NCT01210365|CHF functional class II|chf functional class ii
5519698|NCT01210365|Patients with CHF|patients with chf
5519699|NCT01210365|Patients with CHF functional class II (NYHA) of any etiology|patients with chf functional class ii (nyha) of any etiology
5519700|NCT01210352|surgical pain|surgical pain
5519701|NCT01210352|acute pain|acute pain
5501581|NCT01289639|fenofibrate|fenofibrate
5519702|NCT01210352|Acute Post Surgical Pain|acute post surgical pain
5519703|NCT01210339|phase 1|phase 1
5519704|NCT01210339|cross-over|cross-over
5519705|NCT01210339|drug-drug Interaction|drug-drug interaction
5519706|NCT01210339|esomeprazole|esomeprazole
5519707|NCT01210339|acetylsalicylic acid|acetylsalicylic acid
5519708|NCT01210339|clopidogrel|clopidogrel
5519709|NCT01210339|healthy volunteers|healthy volunteers
5519710|NCT01210339|cardiovascular disease|cardiovascular disease
5519711|NCT01210339|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
5519712|NCT01210326|TESE|tese
5519713|NCT01210326|TESA|tesa
5519714|NCT01210326|non obstructive|non obstructive
5519715|NCT01210326|azoospermi|azoospermi
5519716|NCT01210313|physical activity|physical activity
5519717|NCT01210300|caesarean section|caesarean section
5519718|NCT01210300|vaginal birth after caesarean section|vaginal birth after caesarean section
5519719|NCT01210300|repeat caesarean section|repeat caesarean section
5519720|NCT01210300|childbirth expectation|childbirth expectation
5519721|NCT01210300|childbirth experience|childbirth experience
5519722|NCT01210287|hepatitis B virus reactivation|hepatitis b virus reactivation
5519723|NCT01210287|HBsAg negative|hbsag negative
5519724|NCT01210287|HBcAb positive|hbcab positive
5519725|NCT01210287|lymphoma|lymphoma
5519726|NCT01210287|rituximab|rituximab
5519728|NCT01210261|CPAP|cpap
5519729|NCT01210261|APAP|apap
5519730|NCT01210261|SPAP|spap
5519731|NCT01210261|Obstructive Sleep Apnea|obstructive sleep apnea
5519732|NCT01210261|Sleep Apnea|sleep apnea
5519733|NCT01210235|colorectal cancer screening|colorectal cancer screening
5519734|NCT01210235|preventive health|preventive health
5519735|NCT01210235|primary care|primary care
5519736|NCT01210209|Ewing sarcoma|ewing sarcoma
5519737|NCT01210209|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5519738|NCT01210196|Fabry|fabry
5519739|NCT01210183|Dextrose|dextrose
5519740|NCT01210183|Cartilage|cartilage
5519741|NCT01210183|Regeneration|regeneration
5519742|NCT01210170|asthma,|asthma,
5519743|NCT01210170|inhaled corticosteroids,|inhaled corticosteroids,
5519744|NCT01210170|airway blood flow,|airway blood flow,
5519745|NCT01210170|mometasone,|mometasone,
5519746|NCT01210170|albuterol|albuterol
5519747|NCT01210170|spirometry|spirometry
5519748|NCT01210144|Infertility|infertility
5519749|NCT01210144|Gonal-f|gonal-f
5519750|NCT01210144|gene expression|gene expression
5519751|NCT01210144|Assisted Reproductive Technologies|assisted reproductive technologies
5519752|NCT01210144|Follitropin alfa|follitropin alfa
5519753|NCT01210144|endometrium|endometrium
5519754|NCT01210131|Toxicity|toxicity
5519755|NCT01210131|Progression|progression
5519756|NCT01210131|Survival|survival
5519757|NCT01210131|SCLC|sclc
5519758|NCT01210118|Pregnancy|pregnancy
5519759|NCT01210118|Smoking cessation|smoking cessation
5519760|NCT01210118|Cognitive-Behavioural interventions|cognitive-behavioural interventions
5519761|NCT01210105|intubation|intubation
5519762|NCT01210105|video laryngoscopes|video laryngoscopes
5519763|NCT01210079|opioid-induced hyperalgesia|opioid-induced hyperalgesia
5519764|NCT01210079|methadone|methadone
5519765|NCT01210079|gabapentin|gabapentin
5519766|NCT01210079|opioid addiction|opioid addiction
5519767|NCT01210066|inflammation|inflammation
5519768|NCT01210066|opioid-induced hyperalgesia|opioid-induced hyperalgesia
5519769|NCT01210066|bupenorphine|bupenorphine
5519770|NCT01210066|prescription opioid abuse|prescription opioid abuse
5519771|NCT01210053|Non-Small Cell Lung Cancer|non-small cell lung cancer
5519772|NCT01210040|Pregnancy|pregnancy
5519773|NCT01210040|Iron deficiency|iron deficiency
5519774|NCT01210040|Iron supplementation|iron supplementation
5519775|NCT01210040|Burkina Faso|burkina faso
5519776|NCT01210014|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
5519777|NCT01210014|treatment|treatment
5519778|NCT01210014|zinc sulphate|zinc sulphate
5519779|NCT01209975|blood flow|blood flow
5519780|NCT01209975|glaucoma|glaucoma
5519781|NCT01209975|SLT|slt
5519782|NCT01209936|Body Fat|body fat
5519783|NCT01209936|Total body water|total body water
5519784|NCT01209923|Percent body fat|percent body fat
5519785|NCT01209923|Body Composition|body composition
5519786|NCT01209923|Stayhealthy|stayhealthy
5519788|NCT01209858|epilepsy|epilepsy
5519789|NCT01209845|depression|depression
5519790|NCT01209845|suicide ideation|suicide ideation
5519791|NCT01209845|emergency department|emergency department
5519792|NCT01209845|ketamine|ketamine
5519793|NCT01209832|Metastatic Tumors|metastatic tumors
5519794|NCT01209832|Lymphoma|lymphoma
5519795|NCT01209819|Bone Mineral Density|bone mineral density
5519796|NCT01209819|Adults|adults
5519797|NCT01209780|seasonal influenza, vaccine|seasonal influenza, vaccine
5519798|NCT01209767|Cellulite|cellulite
5519799|NCT01209767|Cryolipolysis|cryolipolysis
5519800|NCT01209767|Zeltiq|zeltiq
5519801|NCT01209767|Subcision|subcision
5519802|NCT01209754|Pregnancy|pregnancy
5519803|NCT01209754|Chemoprophylactic Exposure|chemoprophylactic exposure
5519804|NCT01209754|Mother|mother
5519805|NCT01209754|Infant|infant
5519806|NCT01209754|malformations|malformations
5519807|NCT01209754|HIV|hiv
5519808|NCT01209728|insomnia|insomnia
5519809|NCT01209728|insomniacs|insomniacs
5519810|NCT01209728|simulated driving|simulated driving
5519811|NCT01209728|alcohol|alcohol
5519812|NCT01209728|ethanol|ethanol
5519813|NCT01209715|airway blood flow,|airway blood flow,
5519814|NCT01209715|COPD,|copd,
5519815|NCT01209715|endothelial dysfunction|endothelial dysfunction
5519816|NCT01209715|inhaled corticosteroids|inhaled corticosteroids
5519817|NCT01209676|melanoma, with advanced unresectable|melanoma, with advanced unresectable
5519818|NCT01209663|General Surgery|general surgery
5519819|NCT01209663|Emergency treatment|emergency treatment
5519820|NCT01209663|Postoperative care|postoperative care
5519821|NCT01209663|Intermediate care unit|intermediate care unit
5519822|NCT01209663|High dependency unit|high dependency unit
5519823|NCT01209663|Mortality|mortality
5519824|NCT01209637|stable coronary artery disease|stable coronary artery disease
5519825|NCT01209637|significant coronary stenosis|significant coronary stenosis
5519826|NCT01209624|prospective|prospective
5519827|NCT01209624|non-interventional|non-interventional
5519828|NCT01209624|observational|observational
5519829|NCT01209624|multi-center|multi-center
5519831|NCT01209598|soft tissue|soft tissue
5519832|NCT01209598|Palbociclib (PD0332991)|palbociclib (pd0332991)
5519834|NCT01209572|energy expenditure|energy expenditure
5519835|NCT01209572|heart rate|heart rate
5519836|NCT01209572|accelerometry|accelerometry
5519837|NCT01209572|body temperature|body temperature
5519838|NCT01209572|heat flow galvanic response of skin|heat flow galvanic response of skin
5519839|NCT01209546|Bronchiectasis|bronchiectasis
5519840|NCT01209546|Pulmonary function|pulmonary function
5519841|NCT01209546|Respiratory muscle strength|respiratory muscle strength
5519842|NCT01209546|Respiratory secretions|respiratory secretions
5519843|NCT01209533|Asthma|asthma
5519844|NCT01209520|Lung Cancer|lung cancer
5519845|NCT01209520|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5519846|NCT01209520|NSCLC|nsclc
5519847|NCT01209520|Methylation Analysis|methylation analysis
5519848|NCT01209520|Hypermethylation|hypermethylation
5519849|NCT01209520|Targeted Genes|targeted genes
5519850|NCT01209520|Tumorigenesis|tumorigenesis
5519851|NCT01209520|Tumor Supressor Genes|tumor supressor genes
5519852|NCT01209507|Adrenal suppression|adrenal suppression
5519853|NCT01209507|Chemotherapy fatigue|chemotherapy fatigue
5519854|NCT01209507|Quality of life|quality of life
5519855|NCT01209494|sudden cardiac death|sudden cardiac death
5519856|NCT01209494|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5519857|NCT01209494|ventricular arrhythmias|ventricular arrhythmias
5519858|NCT01209494|genetic syndromes|genetic syndromes
5519859|NCT01209494|calcium metabolism|calcium metabolism
5519860|NCT01209494|ventricular repolarization|ventricular repolarization
5519861|NCT01209494|ECG|ecg
5519862|NCT01209494|T wave|t wave
5519863|NCT01209494|programmed electrical stimulation|programmed electrical stimulation
5519864|NCT01209494|alternans|alternans
5519865|NCT01209494|late potentials|late potentials
5519866|NCT01209494|risk stratification|risk stratification
5519867|NCT01209481|fruits|fruits
5519868|NCT01209481|vegetables|vegetables
5519869|NCT01209481|primary health care|primary health care
5519870|NCT01209481|nutritional education|nutritional education
5519871|NCT01209455|Acetylcysteine|acetylcysteine
5519872|NCT01209455|Adverse effects|adverse effects
5519873|NCT01209455|Acetaminophen|acetaminophen
5519874|NCT01209455|Anaphylactoid reactions|anaphylactoid reactions
5519875|NCT01209442|Glioblastoma|glioblastoma
5519876|NCT01209442|Multiforme|multiforme
5519877|NCT01209429|Calorie restriction|calorie restriction
5519878|NCT01209429|GH/IGF-I axis|gh/igf-i axis
5519880|NCT01209429|SIRT1|sirt1
5519881|NCT01209429|Intracellular signaling peptides and proteins|intracellular signaling peptides and proteins
5519882|NCT01209429|Fasting|fasting
5519883|NCT01209429|Growth hormone|growth hormone
5519884|NCT01209429|IGF-1|igf-1
5519885|NCT01209416|ghrelin|ghrelin
5519886|NCT01209416|metabolism|metabolism
5519887|NCT01209416|type 2 diabetes|type 2 diabetes
5519888|NCT01209416|insulin resistance|insulin resistance
5519889|NCT01209403|Dialysis|dialysis
5519890|NCT01209403|Malnutrition|malnutrition
5519891|NCT01209403|Insulin-Like Growth Factor I|insulin-like growth factor i
5519892|NCT01209403|Insulin-Like Growth Factor Binding Protein 1|insulin-like growth factor binding protein 1
5519893|NCT01209403|Inflammation|inflammation
5519895|NCT01209390|regenerative|regenerative
5519896|NCT01209390|repair|repair
5519897|NCT01209390|cartilage lesion|cartilage lesion
5519898|NCT01209377|standard|standard
5519899|NCT01209377|fixed|fixed
5519900|NCT01209377|no focus|no focus
5501790|NCT01288885|First in Men|first in men
5519901|NCT01209377|EMDR treatment with bilateral stimulation via eye movement|emdr treatment with bilateral stimulation via eye movement
5519902|NCT01209377|EMDR treatment with fixed eyes|emdr treatment with fixed eyes
5519903|NCT01209377|Trauma exposition without external stimulus|trauma exposition without external stimulus
5519904|NCT01209364|comparative|comparative
5519905|NCT01209364|randomized|randomized
5519906|NCT01209364|double-blind|double-blind
5519908|NCT01209364|knee OA|knee oa
5519909|NCT01209351|Pharmacokinetics|pharmacokinetics
5519910|NCT01209351|Pharmacodynamics|pharmacodynamics
5519911|NCT01209351|teduglutide|teduglutide
5519912|NCT01209325|human papilloma virus infection|human papilloma virus infection
5519913|NCT01209325|anal cancer|anal cancer
5519914|NCT01209325|penile cancer|penile cancer
5519915|NCT01209325|HIV infection|hiv infection
5519916|NCT01209299|recurrent melanoma|recurrent melanoma
5519917|NCT01209299|stage IIIC melanoma|stage iiic melanoma
5519918|NCT01209299|stage IV melanoma|stage iv melanoma
5519919|NCT01209286|Blinatumomab|blinatumomab
5519920|NCT01209286|B-ALL|b-all
5519921|NCT01209286|adult ALL|adult all
5519922|NCT01209286|relapsed ALL|relapsed all
5519923|NCT01209286|refractory ALL|refractory all
5519924|NCT01209286|Leukemia|leukemia
5519925|NCT01209286|ALL|all
5519926|NCT01209286|Lymphatic diseases|lymphatic diseases
5519927|NCT01209286|Lymphoproliferative disorders|lymphoproliferative disorders
5519928|NCT01209286|bispecific antibody|bispecific antibody
5519929|NCT01209286|anti-CD19|anti-cd19
5519930|NCT01209286|Immunotherapeutic treatment|immunotherapeutic treatment
5519932|NCT01209273|Automated Peritoneal Dialysis|automated peritoneal dialysis
5519933|NCT01209273|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5519934|NCT01209273|End Stage Renal Disease|end stage renal disease
5519935|NCT01209260|Transseptal Puncture|transseptal puncture
5519936|NCT01209260|Radiofrequency Energy|radiofrequency energy
5519937|NCT01209260|Left Atrium Access|left atrium access
5519938|NCT01209260|Left Atrial Catheterization|left atrial catheterization
5519939|NCT01209260|Ablation|ablation
5519940|NCT01209260|Transseptal Catheterization|transseptal catheterization
5519941|NCT01209260|Electrocautery|electrocautery
5519942|NCT01209260|Catheter Ablation|catheter ablation
5519943|NCT01209260|Atrial Fibrillation|atrial fibrillation
5519944|NCT01209247|Fluoroquinolone -resistance|fluoroquinolone -resistance
5519945|NCT01209247|Commensal flora|commensal flora
5519946|NCT01209247|Emergence of resistance|emergence of resistance
5519947|NCT01209234|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5519948|NCT01209234|MRSA|mrsa
5519949|NCT01209195|Ovarian cancer|ovarian cancer
5519950|NCT01209195|HER-2 negative breast cancer|her-2 negative breast cancer
5519951|NCT01209195|Breast cancer|breast cancer
5519952|NCT01209195|Fallopian tube cancer|fallopian tube cancer
5519953|NCT01209169|Kidney Renal|kidney renal
5519954|NCT01209117|formulation|formulation
5519955|NCT01209117|bioavailability|bioavailability
5519956|NCT01209117|pharmacokinetics|pharmacokinetics
5519957|NCT01209117|GSK2248761|gsk2248761
5519958|NCT01209104|omeprazole|omeprazole
5519959|NCT01209104|proton pump inhibitor|proton pump inhibitor
5519960|NCT01209104|COPD|copd
5519961|NCT01209104|CXCR2 inhibitor|cxcr2 inhibitor
5519962|NCT01209104|bioavailability|bioavailability
5519963|NCT01209104|food-effect|food-effect
5519964|NCT01209078|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5519965|NCT01209078|linezolid|linezolid
5519966|NCT01209078|repeat dose|repeat dose
5519967|NCT01209078|GSK1322322|gsk1322322
5519968|NCT01209065|integrase|integrase
5519969|NCT01209065|fosamprenavir|fosamprenavir
5519970|NCT01209065|ritonavir|ritonavir
5519971|NCT01209065|GSK1349572|gsk1349572
5519972|NCT01209052|COPD|copd
5519973|NCT01209052|CXCR2 inhibitor|cxcr2 inhibitor
5519974|NCT01209039|Schizophrenia|schizophrenia
5519975|NCT01209039|PET|pet
5519976|NCT01209026|Fluticasone furoate (GW685698)|fluticasone furoate (gw685698)
5519977|NCT01209026|moxifloxacin|moxifloxacin
5519978|NCT01209026|QTc|qtc
5519979|NCT01209026|GW642444|gw642444
5519980|NCT01209026|pharmacokinetics|pharmacokinetics
5519981|NCT01209013|PDT|pdt
5519982|NCT01209013|porfimer sodium|porfimer sodium
5519983|NCT01209013|BE|be
5519984|NCT01209000|Focal and Segmental Glomerulosclerosis|focal and segmental glomerulosclerosis
5519985|NCT01209000|Focal & Segmental Glomerulosclerosis|focal & segmental glomerulosclerosis
5519986|NCT01209000|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5519987|NCT01209000|FSGS|fsgs
5519988|NCT01209000|Minimal change disease|minimal change disease
5519989|NCT01209000|MCD|mcd
5519990|NCT01209000|Membranous Nephropathy|membranous nephropathy
5519991|NCT01209000|MN|mn
5519992|NCT01209000|Nephrotic Syndrome|nephrotic syndrome
5519993|NCT01209000|Neph Syndrome|neph syndrome
5519995|NCT01209000|NephCure|nephcure
5519996|NCT01209000|Halpin|halpin
5519997|NCT01208974|Breast Cancer|breast cancer
5519998|NCT01208974|Nipple Area Complex|nipple area complex
5519999|NCT01208974|Mastectomy|mastectomy
5520000|NCT01208974|Radiation Therapy|radiation therapy
5520001|NCT01208974|Nipple-Sparing|nipple-sparing
5520002|NCT01208974|Breast Reconstruction|breast reconstruction
5520003|NCT01208961|Eicosapentaenoic Acid|eicosapentaenoic acid
5520004|NCT01208961|Docosahexaenoic Acid|docosahexaenoic acid
5520005|NCT01208961|Hypertriglyceridemia|hypertriglyceridemia
5520006|NCT01208961|Omega-3 acid ethyl esters|omega-3 acid ethyl esters
5520007|NCT01208961|Omega-3 carboxylic acids|omega-3 carboxylic acids
5520008|NCT01208961|Epanova|epanova
5520009|NCT01208961|Lovaza|lovaza
5520010|NCT01208961|bioavailability|bioavailability
5520011|NCT01208961|pharmacokinetics|pharmacokinetics
5520012|NCT01208961|low-fat meal|low-fat meal
5520013|NCT01208961|high-fat meal|high-fat meal
5520014|NCT01208948|macular edema|macular edema
5520015|NCT01208948|diabetes mellitus|diabetes mellitus
5520016|NCT01208948|prevention alpha lipoic acid|prevention alpha lipoic acid
5520017|NCT01208935|Randomized|randomized
5520018|NCT01208935|Double blind|double blind
5520019|NCT01208935|double-dummy|double-dummy
5520020|NCT01208935|placebo-controlled|placebo-controlled
5520021|NCT01208896|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5520022|NCT01208896|Reduced-intensity conditioning|reduced-intensity conditioning
5520023|NCT01208896|Chemosensitive relapsed follicular lymphoma|chemosensitive relapsed follicular lymphoma
5520024|NCT01208883|Primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.|primary non-operated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
5520025|NCT01208831|Advanced tumors|advanced tumors
5520026|NCT01208831|hedgehog|hedgehog
5514255|NCT01234506|aging|aging
5520028|NCT01208792|Auto antibodies|auto antibodies
5520029|NCT01208792|Target antigens|target antigens
5520030|NCT01208792|2D-immunoblot|2d-immunoblot
5520031|NCT01208792|Reactive oxygen species|reactive oxygen species
5520032|NCT01208792|Pulmonary arterial hypertension|pulmonary arterial hypertension
5520033|NCT01208792|Systemic sclerosis|systemic sclerosis
5520034|NCT01208792|Human immunodeficiency virus infection|human immunodeficiency virus infection
5520035|NCT01208792|Porto pulmonary hypertension|porto pulmonary hypertension
5520036|NCT01208792|Congenital heart defect|congenital heart defect
5520037|NCT01208792|Systemic lupus erythematosus|systemic lupus erythematosus
5520166|NCT01208220|Enzymatic debridement|enzymatic debridement
5520038|NCT01208792|Mixed connective tissue disease|mixed connective tissue disease
5520039|NCT01208792|Sjögren's syndrome|sjögren's syndrome
5520041|NCT01208779|HR+ breast cancer|hr+ breast cancer
5520042|NCT01208779|epidemiology|epidemiology
5520043|NCT01208766|Multiple Myeloma (Kahler's disease)|multiple myeloma (kahler's disease)
5520044|NCT01208753|Safety|safety
5520045|NCT01208753|Tolerability|tolerability
5520046|NCT01208753|Pharmacokinetics|pharmacokinetics
5520047|NCT01208740|Gonadotropins|gonadotropins
5520048|NCT01208740|infertility|infertility
5520049|NCT01208740|IVF|ivf
5520050|NCT01208740|metformin|metformin
5520051|NCT01208740|PCOS|pcos
5520052|NCT01208740|poor prognosis|poor prognosis
5520053|NCT01208740|poor responder|poor responder
5520054|NCT01208727|Myocardial infarction|myocardial infarction
5520055|NCT01208727|Postconditioning|postconditioning
5520056|NCT01208727|Microvascular obstruction|microvascular obstruction
5520057|NCT01208727|No reflow|no reflow
5520058|NCT01208727|MRI|mri
5520059|NCT01208714|Renal artery stenosis|renal artery stenosis
5520060|NCT01208714|Atherosclerosis|atherosclerosis
5520061|NCT01208714|Arterial hypertension|arterial hypertension
5520062|NCT01208714|Percutaneous renal angioplasty|percutaneous renal angioplasty
5520063|NCT01208714|Stenting|stenting
5520064|NCT01208701|Atorvastatin|atorvastatin
5520065|NCT01208701|L-NMMA|l-nmma
5520066|NCT01208701|NO|no
5520068|NCT01208701|Diabetes Mellitus|diabetes mellitus
5520069|NCT01208688|Spinal Cord Injuries|spinal cord injuries
5520070|NCT01208662|Lenalidomide|lenalidomide
5520071|NCT01208662|Bortezomib|bortezomib
5520072|NCT01208662|Dexamethasone|dexamethasone
5520073|NCT01208662|Stem Cell Transplant|stem cell transplant
5520074|NCT01208662|Myeloma|myeloma
5520075|NCT01208662|Multiple Myeloma|multiple myeloma
5520076|NCT01208649|exenatide|exenatide
5520077|NCT01208649|hepatic steatosis|hepatic steatosis
5520078|NCT01208649|insulin resistance|insulin resistance
5520079|NCT01208649|insulin sensitizers|insulin sensitizers
5520080|NCT01208649|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5520081|NCT01208649|- GLP1-Analog|- glp1-analog
5520082|NCT01208636|Vitamin D deficiency|vitamin d deficiency
5520083|NCT01208636|Sun|sun
5520084|NCT01208636|Genetics|genetics
5671475|NCT00615901|fluorouracil|fluorouracil
5680025|NCT00579501|Myxoid|myxoid
5520085|NCT01208584|functional MRI,primary motor cortex,spinal cord injury|functional mri,primary motor cortex,spinal cord injury
5520086|NCT01208571|Harmful use|harmful use
5520087|NCT01208571|Hazardous use|hazardous use
5520088|NCT01208571|Dependence|dependence
5520089|NCT01208558|Blood pressure|blood pressure
5520090|NCT01208558|Cereals|cereals
5520091|NCT01208558|Diet Therapy|diet therapy
5520092|NCT01208558|Dietary carbohydrates|dietary carbohydrates
5520093|NCT01208558|Dietary fiber|dietary fiber
5520094|NCT01208558|Exercise Therapy|exercise therapy
5520095|NCT01208558|Food|food
5520096|NCT01208558|Glucose intolerance|glucose intolerance
5520097|NCT01208558|Lifestyle|lifestyle
5520098|NCT01208558|Physiotherapy|physiotherapy
5520099|NCT01208558|Stroke|stroke
5520100|NCT01208558|TIA|tia
5520101|NCT01208558|Waist circumference|waist circumference
5520102|NCT01208558|Weight loss|weight loss
5520103|NCT01208545|taxol|taxol
5520104|NCT01208545|vincristine|vincristine
5520105|NCT01208545|oxaliplatin|oxaliplatin
5520106|NCT01208545|chemotherapy|chemotherapy
5520107|NCT01208545|nerve degeneration|nerve degeneration
5520108|NCT01208545|nerve conduction|nerve conduction
5520109|NCT01208545|cancer|cancer
5520110|NCT01208545|nerve conduction studies|nerve conduction studies
5520111|NCT01208519|Drug resistance, Microbial|drug resistance, microbial
5520112|NCT01208519|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5520113|NCT01208519|ESBL|esbl
5520114|NCT01208519|Colonisation|colonisation
5520115|NCT01208519|Screening|screening
5520116|NCT01208519|Gram-negative|gram-negative
5520117|NCT01208493|prematurity|prematurity
5520118|NCT01208493|enteral feeding|enteral feeding
5520119|NCT01208493|proteins|proteins
5520120|NCT01208493|formula|formula
5520121|NCT01208480|stage II breast cancer|stage ii breast cancer
5520122|NCT01208480|stage IIIA breast cancer|stage iiia breast cancer
5520123|NCT01208480|stage IIIB breast cancer|stage iiib breast cancer
5520124|NCT01208480|stage IIIC breast cancer|stage iiic breast cancer
5520125|NCT01208480|triple-negative breast cancer|triple-negative breast cancer
5520126|NCT01208428|Depression|depression
5520127|NCT01208415|Zenith aortoiliac aneurysm|zenith aortoiliac aneurysm
5520128|NCT01208415|iliac aneurysm|iliac aneurysm
5520130|NCT01208415|connections|connections
5520131|NCT01208415|endovascular graft|endovascular graft
5520132|NCT01208415|graft-iliac bifurcation|graft-iliac bifurcation
5520133|NCT01208415|Aneurysm|aneurysm
5520134|NCT01208415|Vascular Diseases|vascular diseases
5520135|NCT01208415|Cardiovascular Diseases|cardiovascular diseases
5520136|NCT01208363|Iron fortification|iron fortification
5520137|NCT01208363|polyphenols|polyphenols
5520138|NCT01208363|NaFeEDTA|nafeedta
5520139|NCT01208363|cowpea|cowpea
5520140|NCT01208363|school feeding program|school feeding program
5520141|NCT01208350|Weight Loss|weight loss
5520142|NCT01208350|Motivation|motivation
5520143|NCT01208350|Workplace|workplace
5520144|NCT01208350|Web platform|web platform
5520145|NCT01208337|Rejection|rejection
5520146|NCT01208324|Cognitive difficulties|cognitive difficulties
5520147|NCT01208324|memory impairment|memory impairment
5520148|NCT01208324|mood changes|mood changes
5520149|NCT01208324|brain activation|brain activation
5520150|NCT01208311|Alcoholic cirrhosis|alcoholic cirrhosis
5520151|NCT01208311|hepatitis c cirrhosis|hepatitis c cirrhosis
5520152|NCT01208311|cirrhosis|cirrhosis
5520153|NCT01208298|Cold Sore Patch|cold sore patch
5520154|NCT01208272|Body Mass Index|body mass index
5520155|NCT01208272|Bulimia/therapy|bulimia/therapy
5520156|NCT01208272|Comorbidity|comorbidity
5520157|NCT01208272|Interpersonal Relations|interpersonal relations
5520158|NCT01208272|Psychotherapy/methods|psychotherapy/methods
5520159|NCT01208259|Body Mass Index|body mass index
5520160|NCT01208259|Bulimia/therapy|bulimia/therapy
5520161|NCT01208259|Comorbidity|comorbidity
5520162|NCT01208259|Interpersonal Relations|interpersonal relations
5520163|NCT01208259|Psychotherapy/methods|psychotherapy/methods
5520164|NCT01208233|Phase 2 Ischemic stroke Safety and efficacy|phase 2 ischemic stroke safety and efficacy
5520165|NCT01208220|Collagenase Santyl|collagenase santyl
5520167|NCT01208220|maintenance debridement|maintenance debridement
5520168|NCT01208220|VAC|vac
5520169|NCT01208220|NPWT|npwt
5520170|NCT01208194|Advanced colorectal carcinoma|advanced colorectal carcinoma
5520171|NCT01208194|Maintenance therapy|maintenance therapy
5520172|NCT01208194|Immunomodulator|immunomodulator
5520173|NCT01208168|toenail fungus|toenail fungus
5520174|NCT01208168|onychomycosis|onychomycosis
5520175|NCT01208168|nail infection|nail infection
5520176|NCT01208155|Phase 1|phase 1
5520177|NCT01208155|Healthy|healthy
5520178|NCT01208155|pharmacokinetics|pharmacokinetics
5520179|NCT01208155|Fostamatinib|fostamatinib
5520180|NCT01208142|toe walker|toe walker
5520181|NCT01208142|Pediatric toe walking|pediatric toe walking
5520182|NCT01208142|ankle flexion|ankle flexion
5520183|NCT01208129|toenail fungus|toenail fungus
5520184|NCT01208129|onychomycosis|onychomycosis
5520185|NCT01208129|nail infection|nail infection
5904034|NCT00007813|childhood hepatoblastoma|childhood hepatoblastoma
5680145|NCT00579020|cornea|cornea
5520186|NCT01208116|Atherosclerosis|atherosclerosis
5520187|NCT01208116|Prognosis|prognosis
5520188|NCT01208116|Flow-mediated dilatation|flow-mediated dilatation
5520189|NCT01208116|Brachial-ankle pulse wave velocity|brachial-ankle pulse wave velocity
5520190|NCT01208116|Carotid Intimal-Medial Thickness|carotid intimal-medial thickness
5520191|NCT01208116|coronary artery calcification score|coronary artery calcification score
5520192|NCT01208116|Ankle-brachial index|ankle-brachial index
5520193|NCT01208090|psoriasis|psoriasis
5520194|NCT01208090|chronic plaque psoriasis|chronic plaque psoriasis
5520195|NCT01208090|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5520196|NCT01208077|ED hemodynamic profiles|ed hemodynamic profiles
5520197|NCT01208077|patients treated under current clinical standards|patients treated under current clinical standards
5520198|NCT01208077|Acute CHF|acute chf
5520199|NCT01208077|Stroke syndromes|stroke syndromes
5520200|NCT01208077|Systemic infection|systemic infection
5520201|NCT01208064|adenocarcinoma of the lung|adenocarcinoma of the lung
5520202|NCT01208064|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5520203|NCT01208064|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5520204|NCT01208064|large cell lung cancer|large cell lung cancer
5520205|NCT01208064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5520206|NCT01208064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5520207|NCT01208064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5520208|NCT01208038|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
5520210|NCT01208025|Imaging|imaging
5520211|NCT01208012|Diabetes Mellitus treatment Metformin|diabetes mellitus treatment metformin
5520212|NCT01207999|Human papillomavirus|human papillomavirus
5520213|NCT01207960|dental phobia|dental phobia
5520214|NCT01207960|psychotherapy|psychotherapy
5520215|NCT01207960|eye movement desensitization and reprocessing - EMDR|eye movement desensitization and reprocessing - emdr
5520216|NCT01207960|efficacy|efficacy
5520217|NCT01207960|wait-list control|wait-list control
5520219|NCT01207947|Erectile dysfunction|erectile dysfunction
5520220|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5520221|NCT01207947|Combination use with alpha-blockers|combination use with alpha-blockers
5520222|NCT01207934|diabetes|diabetes
5520223|NCT01207934|obesity|obesity
5520225|NCT01207908|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5520226|NCT01207908|Insulin like growth factor|insulin like growth factor
5520227|NCT01207908|6 minute walk test|6 minute walk test
5520228|NCT01207869|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5520229|NCT01207869|Extremely premature infant|extremely premature infant
5520230|NCT01207869|Mesenchymal stem cells (MSCs)|mesenchymal stem cells (mscs)
5520231|NCT01207869|umbilical cord|umbilical cord
5520232|NCT01207856|Multiple sclerosis|multiple sclerosis
5520233|NCT01207856|functional MRI|functional mri
5520234|NCT01207856|cognitive rehabilitation|cognitive rehabilitation
5520235|NCT01207856|ecological evaluation|ecological evaluation
5520236|NCT01207856|neuroplasticity|neuroplasticity
5520237|NCT01207843|Computed tomography|computed tomography
5520238|NCT01207830|Obesity|obesity
5520239|NCT01207817|a light flash in each eye for a total of 48 measurements|a light flash in each eye for a total of 48 measurements
5520240|NCT01207804|Obesity|obesity
5520241|NCT01207791|drug abuse|drug abuse
5520242|NCT01207791|emergency department|emergency department
5520243|NCT01207791|brief intervention|brief intervention
5520244|NCT01207791|motivational interviewing|motivational interviewing
5520246|NCT01207778|brain|brain
5520247|NCT01207778|development|development
5520248|NCT01207778|erythropoietin|erythropoietin
5520249|NCT01207778|neuroprotection|neuroprotection
5520250|NCT01207778|MRI|mri
5520251|NCT01207765|Multiple Myeloma|multiple myeloma
5520252|NCT01207765|Zevalin|zevalin
5520253|NCT01207752|dry eye, meibomian gland dysfunction, tear film break up time|dry eye, meibomian gland dysfunction, tear film break up time
5520254|NCT01207739|Prolonged antibiotic treatment in Lyme disease|prolonged antibiotic treatment in lyme disease
5520255|NCT01207739|Doxycycline|doxycycline
5520256|NCT01207739|Clarithromycin|clarithromycin
5520257|NCT01207739|Hydroxychloroquine|hydroxychloroquine
5520258|NCT01207700|post discharge intervention|post discharge intervention
5520259|NCT01207700|adherence|adherence
5520260|NCT01207700|compliance|compliance
5520261|NCT01207700|community health worker|community health worker
5520262|NCT01207674|Pathological gambling|pathological gambling
5520263|NCT01207674|"at risk gambling"|"at risk gambling"
5520264|NCT01207674|gambling practice evolution|gambling practice evolution
5520265|NCT01207674|psychiatric comorbidities|psychiatric comorbidities
5520266|NCT01207674|gambling trajectory|gambling trajectory
5520267|NCT01207674|cognitive distortions|cognitive distortions
5520268|NCT01207674|ADHD|adhd
5520269|NCT01207674|addiction|addiction
5520270|NCT01207674|recourse to care|recourse to care
5520271|NCT01207661|Mesenchymal cells|mesenchymal cells
5520272|NCT01207661|osteoarthritis|osteoarthritis
5904035|NCT00007813|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5520273|NCT01207661|intra articular injection|intra articular injection
5520274|NCT01207648|Interferon beta 1a|interferon beta 1a
5520275|NCT01207648|Autoimmune Diseases|autoimmune diseases
5520276|NCT01207648|Demyelinating Diseases|demyelinating diseases
5520277|NCT01207648|Immune System Diseases|immune system diseases
5520278|NCT01207648|Immunologic Factors|immunologic factors
5520279|NCT01207648|Nervous System Diseases|nervous system diseases
5520280|NCT01207648|Physiological Effects of Drugs|physiological effects of drugs
5520281|NCT01207648|Demyelinating Autoimmune Diseases, CNS|demyelinating autoimmune diseases, cns
5520282|NCT01207648|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
5520283|NCT01207648|Retrospective Cohort Study|retrospective cohort study
5520284|NCT01207635|Cancer|cancer
5520285|NCT01207635|Arimidex|arimidex
5520286|NCT01207609|Obesity|obesity
5502179|NCT01287169|Bisphenol A|bisphenol a
5520287|NCT01207609|Morbid Obesity|morbid obesity
5520288|NCT01207609|Bariatric Surgery|bariatric surgery
5520289|NCT01207609|Laparoscopic Gastric Plication|laparoscopic gastric plication
5520290|NCT01207596|Pain|pain
5520291|NCT01207596|Neuropathy|neuropathy
5520292|NCT01207596|Neuropathic Pain|neuropathic pain
5523006|NCT01196520|Malaria|malaria
5520293|NCT01207596|Hydromorphone|hydromorphone
5520294|NCT01207583|vaccine|vaccine
5520295|NCT01207583|infant|infant
5520296|NCT01207583|healthy subjects|healthy subjects
5520297|NCT01207570|flexibility|flexibility
5520298|NCT01207570|muscle|muscle
5520299|NCT01207570|stretching|stretching
5520300|NCT01207570|cerebral palsy|cerebral palsy
5520301|NCT01207570|developmental|developmental
5520302|NCT01207557|Healthcare personnel|healthcare personnel
5520303|NCT01207557|influenza|influenza
5520304|NCT01207557|immunization|immunization
5520306|NCT01207557|vaccine|vaccine
5520307|NCT01207544|motor|motor
5520308|NCT01207544|balance|balance
5520309|NCT01207544|developmental|developmental
5520310|NCT01207544|physiotherapy|physiotherapy
5520311|NCT01207531|sepsis|sepsis
5520312|NCT01207531|miRNA|mirna
5520313|NCT01207518|influenza|influenza
5520314|NCT01207518|immunization|immunization
5520315|NCT01207518|healthcare personnel|healthcare personnel
5520316|NCT01207505|bipolar disorder|bipolar disorder
5520317|NCT01207505|depression|depression
5520318|NCT01207505|mania|mania
5520319|NCT01207505|emotion regulation|emotion regulation
5520320|NCT01207505|dialectical behavior therapy|dialectical behavior therapy
5520321|NCT01207505|group therapy|group therapy
5520322|NCT01207505|mindfulness|mindfulness
5520323|NCT01207492|nilotinib|nilotinib
5520324|NCT01207453|Arthritis, Rheumatoid|arthritis, rheumatoid
5520325|NCT01207453|Milnacipran|milnacipran
5520326|NCT01207453|Pain|pain
5520327|NCT01207440|CML|cml
5520328|NCT01207440|ALL|all
5520329|NCT01207440|PH|ph
5520330|NCT01207440|ponatinib|ponatinib
5520331|NCT01207440|Ph+ALL|ph+all
5520332|NCT01207440|T315I mutation|t315i mutation
5520333|NCT01207440|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5520334|NCT01207427|opioid therapy|opioid therapy
5520335|NCT01207427|constipation|constipation
5520336|NCT01207427|chronic noncancer pain|chronic noncancer pain
5520337|NCT01207427|mu opioid receptor antagonist|mu opioid receptor antagonist
5520338|NCT01207427|ADL5945|adl5945
5520339|NCT01207414|Schizophrenia|schizophrenia
5520340|NCT01207414|iloperidone|iloperidone
5520341|NCT01207414|switch|switch
5520342|NCT01207414|gradual switch|gradual switch
5520343|NCT01207414|immediate switch|immediate switch
5520344|NCT01207401|intrauterine device|intrauterine device
5520345|NCT01207401|local anesthetic|local anesthetic
5520346|NCT01207388|Blinatumomab|blinatumomab
5520347|NCT01207388|MRD|mrd
5520348|NCT01207388|B-ALL|b-all
5520349|NCT01207388|Minimal residual disease|minimal residual disease
5520350|NCT01207388|adult ALL|adult all
5520351|NCT01207388|Leukemia|leukemia
5520352|NCT01207388|ALL|all
5520353|NCT01207388|Lymphatic diseases|lymphatic diseases
5520354|NCT01207388|Lymphoproliferative disorders|lymphoproliferative disorders
5520355|NCT01207388|bispecific antibody|bispecific antibody
5520356|NCT01207388|anti-CD19|anti-cd19
5520357|NCT01207388|Immunotherapeutic treatment|immunotherapeutic treatment
5520358|NCT01207375|memory|memory
5520359|NCT01207375|learning|learning
5520360|NCT01207375|Traumatic Brain Injury|traumatic brain injury
5520362|NCT01207375|treatment|treatment
5520363|NCT01207375|therapy|therapy
5520364|NCT01207349|Type 2 diabetes|type 2 diabetes
5520365|NCT01207349|Secondary prevention|secondary prevention
5520366|NCT01207349|Physical activity|physical activity
5520367|NCT01207349|Nutritional education|nutritional education
5520368|NCT01207349|HbA1c|hba1c
5520369|NCT01207349|Reunion island|reunion island
5520370|NCT01207349|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in Saint Pierre (GHSR) and Saint Denis (CHD)|diabetic patients, both female and male, age >=18 years, able to practise a physical activity, in saint pierre (ghsr) and saint denis (chd)
5520371|NCT01207336|stroke|stroke
5520372|NCT01207336|rehabilitation|rehabilitation
5671476|NCT00615901|PEG-filgrastim|peg-filgrastim
5520373|NCT01207336|transcranial direct current stimulation|transcranial direct current stimulation
5520374|NCT01207336|nerve stimulation|nerve stimulation
5520376|NCT01207310|smoking of 10 cigarettes per day|smoking of 10 cigarettes per day
5520377|NCT01207297|Lupus nephritis|lupus nephritis
5520378|NCT01207297|tacrolimus|tacrolimus
5520379|NCT01207297|cyclophosphamide|cyclophosphamide
5520380|NCT01207271|depression|depression
5520381|NCT01207271|community mental health|community mental health
5520382|NCT01207271|treatment|treatment
5520383|NCT01207271|psychotherapy|psychotherapy
5520384|NCT01207271|mediators|mediators
5520385|NCT01207258|Motivational Interviewing|motivational interviewing
5520386|NCT01207258|Brief Intervention|brief intervention
5520387|NCT01207258|Intimate Partner Violence|intimate partner violence
5520388|NCT01207258|Domestic Violence|domestic violence
5520389|NCT01207258|Alcohol Abuse|alcohol abuse
5520390|NCT01207245|Cystic fibrosis|cystic fibrosis
5520391|NCT01207245|Tobramycin|tobramycin
5520392|NCT01207245|Pharmacokinetics|pharmacokinetics
5520393|NCT01207245|Toxicity|toxicity
5520394|NCT01207232|seasonal influenza|seasonal influenza
5520395|NCT01207232|behavioral economics|behavioral economics
5520396|NCT01207232|implementation intentions|implementation intentions
5520398|NCT01207232|nudge|nudge
5520399|NCT01207219|psychosis|psychosis
5520400|NCT01207219|yoga|yoga
5520401|NCT01207219|aerobic exercise|aerobic exercise
5520402|NCT01207219|memory|memory
5520403|NCT01207219|attention|attention
5520404|NCT01207219|neuro cognition|neuro cognition
5520405|NCT01207206|Patient suffering from severe cancer pain despite the opioid treatment|patient suffering from severe cancer pain despite the opioid treatment
5520406|NCT01207206|Opiate tolerance suspected on the basis of rapid escalation in opiate dose|opiate tolerance suspected on the basis of rapid escalation in opiate dose
5520407|NCT01207206|Severe opiate side effects|severe opiate side effects
5520408|NCT01207193|bone cyst bone defect mesenchymal cell|bone cyst bone defect mesenchymal cell
5520409|NCT01207180|emergency medicine|emergency medicine
5520410|NCT01207180|primary care physicians|primary care physicians
5520411|NCT01207141|Liver Transplantation|liver transplantation
5520412|NCT01207141|Thymoglobulin|thymoglobulin
5520413|NCT01207141|Rejection|rejection
5520414|NCT01207102|Breast cancer|breast cancer
5520415|NCT01207102|Triple negative|triple negative
5520417|NCT01207089|tolerability|tolerability
5520418|NCT01207089|PK|pk
5520419|NCT01207089|healthy|healthy
5520420|NCT01207089|overweight|overweight
5520421|NCT01207089|obese|obese
5520422|NCT01207076|CD45+ disease|cd45+ disease
5520423|NCT01207063|Radiotherapy|radiotherapy
5520424|NCT01207063|NSCLC|nsclc
5520425|NCT01207063|Stage II-III non-small cell lung cancer|stage ii-iii non-small cell lung cancer
5520426|NCT01207050|sleep disorders|sleep disorders
5520427|NCT01207050|traumatic brain injury|traumatic brain injury
5520428|NCT01207024|knee arthrosis|knee arthrosis
5520429|NCT01207024|obesity|obesity
5520430|NCT01207024|MRI|mri
5520431|NCT01207024|bariatric surgery|bariatric surgery
5520432|NCT01206998|preterm labor|preterm labor
5520433|NCT01206998|progesterone|progesterone
5520434|NCT01206998|tocolysis|tocolysis
5520435|NCT01206998|cervical length|cervical length
5520436|NCT01206985|Paracetamol|paracetamol
5520437|NCT01206985|per-oral mucosa PMB|per-oral mucosa pmb
5520438|NCT01206985|No disease, healthy volunteers|no disease, healthy volunteers
5520439|NCT01206972|venous thromboembolism|venous thromboembolism
5520440|NCT01206972|prevention|prevention
5520441|NCT01206972|orthopaedic surgery|orthopaedic surgery
5520442|NCT01206959|BP|bp
5521218|NCT01203826|Soft Bones|soft bones
5520443|NCT01206946|Respiratory distress|respiratory distress
5520444|NCT01206946|Antenatal steroids|antenatal steroids
5520445|NCT01206946|late preterm|late preterm
5520446|NCT01206933|HIV/HCV Coinfection|hiv/hcv coinfection
5520447|NCT01206933|Tat Protein|tat protein
5520449|NCT01206920|HIV|hiv
5520450|NCT01206920|AIDS|aids
5520451|NCT01206920|Co-morbidities|co-morbidities
5520452|NCT01206907|sickle cell anemia|sickle cell anemia
5520453|NCT01206907|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5520454|NCT01206907|burn victim|burn victim
5520455|NCT01206907|cancer|cancer
5520456|NCT01206907|Chronic pain of malignant or non-malignant etiology|chronic pain of malignant or non-malignant etiology
5520458|NCT01206894|chest wall invasion|chest wall invasion
5520459|NCT01206894|transthoracic ultrasound|transthoracic ultrasound
5520460|NCT01206881|breast cancer|breast cancer
5520461|NCT01206881|neoadjuvant|neoadjuvant
5520462|NCT01206881|liposomal doxorubicin|liposomal doxorubicin
5520463|NCT01206881|PET scan|pet scan
5520464|NCT01206868|kidney, transplantation, surgery, complications, lymphocele, fluid collections.|kidney, transplantation, surgery, complications, lymphocele, fluid collections.
5520465|NCT01206855|MIST Therapy|mist therapy
5520466|NCT01206842|functional capacity|functional capacity
5520467|NCT01206842|training|training
5520468|NCT01206842|neurocognition|neurocognition
5520469|NCT01206829|Hearing Impaired Persons|hearing impaired persons
5520470|NCT01206829|Tinnitus|tinnitus
5520471|NCT01206829|Life Change Events|life change events
5520472|NCT01206829|Adaptation, Psychological|adaptation, psychological
5520473|NCT01206829|Rehabilitation, Vocational|rehabilitation, vocational
5520474|NCT01206829|Cognitive Therapy|cognitive therapy
5520475|NCT01206829|Avoidance Learning|avoidance learning
5520476|NCT01206829|Escape Reaction|escape reaction
5520477|NCT01206803|ovarian stimulation|ovarian stimulation
5520478|NCT01206803|recombinant FSH|recombinant fsh
5520479|NCT01206803|GnRH-antagonist|gnrh-antagonist
5520480|NCT01206803|corifollitropin alfa|corifollitropin alfa
5520481|NCT01206790|PTSD|ptsd
5520482|NCT01206790|Narrative Exposure Therapy|narrative exposure therapy
5520483|NCT01206790|torture victims|torture victims
5520484|NCT01206790|immune system|immune system
5520485|NCT01206777|Hypersensitivity Reactions|hypersensitivity reactions
5520486|NCT01206777|B-cell malignancies|b-cell malignancies
5520487|NCT01206764|RCC,|rcc,
5520488|NCT01206764|mTOR pathway,|mtor pathway,
5520489|NCT01206764|angiogenesis,|angiogenesis,
5520490|NCT01206764|PFS,|pfs,
5520491|NCT01206764|partial response [PR] + complete response [CR])|partial response [pr] + complete response [cr])
5520492|NCT01206764|metastatic recurrent renal cell carcinoma|metastatic recurrent renal cell carcinoma
5520493|NCT01206764|metastatic unresectable renal cell carcinoma|metastatic unresectable renal cell carcinoma
5520495|NCT01206725|exercise|exercise
5520496|NCT01206725|tissue Doppler velocity|tissue doppler velocity
5520497|NCT01206712|Diabetes Mellitus Type 2|diabetes mellitus type 2
5520498|NCT01206712|insulin glargine|insulin glargine
5520499|NCT01206712|Metformin|metformin
5520500|NCT01206686|seasonal influenza|seasonal influenza
5520501|NCT01206686|behavioral economics|behavioral economics
5520502|NCT01206686|nudge|nudge
5520503|NCT01206686|implementations intentions|implementations intentions
5520504|NCT01206686|vaccination|vaccination
5520505|NCT01206621|dyspnea|dyspnea
5520506|NCT01206621|COPD|copd
5520507|NCT01206621|CHF|chf
5520508|NCT01206621|asthma|asthma
5520509|NCT01206608|Breast augmentation|breast augmentation
5520510|NCT01206608|Pain|pain
5520511|NCT01206608|Analgesia|analgesia
5520512|NCT01206595|Postoperative Pain|postoperative pain
5520513|NCT01206595|Bunionectomy|bunionectomy
5520514|NCT01206595|Analgesia|analgesia
5520516|NCT01206569|systemic lupus erythematosus|systemic lupus erythematosus
5520517|NCT01206556|HUMAN PAPILLOMA VIRUS|human papilloma virus
5520518|NCT01206556|HPV|hpv
5520519|NCT01206543|Craniopharyngioma|craniopharyngioma
5520520|NCT01206543|Surgery|surgery
5520521|NCT01206543|Intraoperative imaging|intraoperative imaging
5520522|NCT01206543|Rate of total removal|rate of total removal
5520523|NCT01206530|histologically documented|histologically documented
5520524|NCT01206530|advanced|advanced
5520525|NCT01206530|metastatic|metastatic
5520526|NCT01206530|adenocarcinoma|adenocarcinoma
5520527|NCT01206530|colon|colon
5520528|NCT01206530|rectum|rectum
5520529|NCT01206517|asenapine|asenapine
5520530|NCT01206517|pediatric schizophrenia|pediatric schizophrenia
5520531|NCT01206517|bipolar I disorder|bipolar i disorder
5520532|NCT01206504|West Nile virus|west nile virus
5520533|NCT01206504|WNV|wnv
5520534|NCT01206504|Encephalitis|encephalitis
5520535|NCT01206504|Meningitis|meningitis
5520536|NCT01206504|Acute Flaccid Paralysis|acute flaccid paralysis
5520537|NCT01206504|Monoclonal Antibody|monoclonal antibody
5520538|NCT01206504|WNND|wnnd
5520539|NCT01206504|West Nile Neuroinvasive Disease|west nile neuroinvasive disease
5520786|NCT01205347|Myocardial infarction|myocardial infarction
5520540|NCT01206504|Accidental Exposure to West Nile Virus|accidental exposure to west nile virus
5520541|NCT01206452|Atrial Fibrillation; Ablation|atrial fibrillation; ablation
5520542|NCT01206426|Urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline|urothelial, cancer, cisplatin, neoadjuvant, chemotherapy, germline
5520543|NCT01206413|overweight; treatment; women|overweight; treatment; women
5520544|NCT01206400|eugonadal, testosterone|eugonadal, testosterone
5520545|NCT01206374|Vitiligo Vulgaris|vitiligo vulgaris
5520546|NCT01206361|Real world|real world
5520547|NCT01206361|observational|observational
5520548|NCT01206361|retrospective|retrospective
5520549|NCT01206361|database analysis|database analysis
5520550|NCT01206348|Acne|acne
5520551|NCT01206335|Cancer Cachexia|cancer cachexia
5520552|NCT01206335|Anorexia|anorexia
5520553|NCT01206335|Advanced Malignancies|advanced malignancies
5520554|NCT01206335|Weight Loss|weight loss
5520555|NCT01206335|Fatigue|fatigue
5520556|NCT01206335|Karnofsky|karnofsky
5520557|NCT01206335|C-Reactive Protein|c-reactive protein
5520558|NCT01206335|Simmonds Functional Assessment|simmonds functional assessment
5520559|NCT01206322|diabetes, blood flow, brain perfusion, cognitive function|diabetes, blood flow, brain perfusion, cognitive function
5520560|NCT01206309|Graft vs Host Disease|graft vs host disease
5520561|NCT01206309|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5520562|NCT01206309|Bone Marrow Transplantation|bone marrow transplantation
5520563|NCT01206309|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5520564|NCT01206309|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5680648|NCT00577174|Obesity|obesity
5520565|NCT01206296|Adjuvant|adjuvant
5520566|NCT01206296|Intraperitoneal|intraperitoneal
5520567|NCT01206296|Gemcitabine|gemcitabine
5520568|NCT01206296|Pancreas|pancreas
5520569|NCT01206296|Adenocarcinoma|adenocarcinoma
5520570|NCT01206283|traumatic brain injury|traumatic brain injury
5520571|NCT01206283|subarachnoid hemorrhage|subarachnoid hemorrhage
5520572|NCT01206283|secondary brain ischemia|secondary brain ischemia
5520573|NCT01206283|microdialysis|microdialysis
5520574|NCT01206283|modified Lund concept|modified lund concept
5520575|NCT01206283|cerebral perfusion pressure|cerebral perfusion pressure
5520576|NCT01206283|intracranial pressure|intracranial pressure
5520577|NCT01206270|Klinefelter|klinefelter
5520578|NCT01206270|Leydig|leydig
5520579|NCT01206270|Testicular Tumor|testicular tumor
5520581|NCT01206270|Infertility|infertility
5520582|NCT01206257|Survey|survey
5520583|NCT01206257|Angiography|angiography
5520584|NCT01206257|ADR|adr
5520585|NCT01206257|Image quality|image quality
5520586|NCT01206244|dry eye|dry eye
5520587|NCT01206244|tear meniscus|tear meniscus
5520588|NCT01206244|tear osmolarity|tear osmolarity
5520589|NCT01206231|Standard daily practice in managing patients with hypercholesterolemia|standard daily practice in managing patients with hypercholesterolemia
5520590|NCT01206218|Gastric Cancer, BRCA1|gastric cancer, brca1
5520591|NCT01206205|De novo Multiple Myeloma|de novo multiple myeloma
5520593|NCT01206205|Lenalidomide|lenalidomide
5520594|NCT01206205|induction therapy|induction therapy
5520595|NCT01206205|consolidation therapy|consolidation therapy
5520596|NCT01206205|maintenance therapy|maintenance therapy
5520597|NCT01206205|High dose therapy|high dose therapy
5520598|NCT01206205|frontline therapy including new drugs and high dose therapy|frontline therapy including new drugs and high dose therapy
5520599|NCT01206192|Intimate Terrorism|intimate terrorism
5520600|NCT01206192|Situational couple violence|situational couple violence
5520601|NCT01206192|Mental health|mental health
5520602|NCT01206192|Chinese|chinese
5520603|NCT01206192|Women|women
5520604|NCT01206179|nonunion fracture bone formation pain relief|nonunion fracture bone formation pain relief
5520605|NCT01206166|Randomized trial|randomized trial
5520606|NCT01206166|Parental nutrition|parental nutrition
5520607|NCT01206166|Enteral nutrition|enteral nutrition
5520613|NCT01206114|effectiveness|effectiveness
5520614|NCT01206075|Beta Thalassemia Major|beta thalassemia major
5520615|NCT01206075|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5520616|NCT01206075|Gene Transfer Techniques|gene transfer techniques
5520617|NCT01206062|blood pressure|blood pressure
5520618|NCT01206062|antihypertensive|antihypertensive
5520619|NCT01206062|systolic|systolic
5520620|NCT01206062|diastolic|diastolic
5520621|NCT01206062|heart failure|heart failure
5520622|NCT01206062|myocardial infarction|myocardial infarction
5520623|NCT01206062|stroke|stroke
5520624|NCT01206062|chronic kidney disease|chronic kidney disease
5520625|NCT01206062|dementia|dementia
5520626|NCT01206062|cognitive decline|cognitive decline
5520627|NCT01206049|Cholangiocarcinoma|cholangiocarcinoma
5520628|NCT01206049|Inoperable|inoperable
5520629|NCT01206049|KRAS mutation|kras mutation
5520630|NCT01206049|Biological treatment|biological treatment
5520631|NCT01206049|Combination chemotherapy|combination chemotherapy
5520632|NCT01206049|Monoclonal antibody|monoclonal antibody
5520633|NCT01206036|castration|castration
5520634|NCT01206036|prostate cancer|prostate cancer
5520635|NCT01206036|castration resistant prostate cancer|castration resistant prostate cancer
5520636|NCT01206036|PSA|psa
5520637|NCT01206036|Docetaxel|docetaxel
5520638|NCT01206036|Temsirolimus|temsirolimus
5520639|NCT01206036|disease progression free survival|disease progression free survival
5520640|NCT01206036|DPFS|dpfs
5520641|NCT01206036|dose escalation|dose escalation
5520642|NCT01206023|Multiple Sclerosis|multiple sclerosis
5520643|NCT01206023|Breath|breath
5520644|NCT01206023|Diagnosis|diagnosis
5520645|NCT01206023|Discrimination MS/healthy subj. via exhaled breath samples|discrimination ms/healthy subj. via exhaled breath samples
5520646|NCT01206010|Tobacco Dependence|tobacco dependence
5520647|NCT01206010|Smoking cessation|smoking cessation
5520648|NCT01206010|Varenicline|varenicline
5520649|NCT01206010|Tailored dosing|tailored dosing
5520650|NCT01205997|magnesium|magnesium
5520651|NCT01205997|fentanyl|fentanyl
5520652|NCT01205997|intrathecal|intrathecal
5520653|NCT01205997|pain|pain
5520654|NCT01205984|Chronic rhinosinusitis|chronic rhinosinusitis
5520655|NCT01205984|Computed tomography scan|computed tomography scan
5520656|NCT01205984|Methylprednisolone|methylprednisolone
5520657|NCT01205971|Motivational interviewing|motivational interviewing
5520658|NCT01205971|Community-based multimodal intervention|community-based multimodal intervention
5520659|NCT01205971|Dental Health Advocates|dental health advocates
5904036|NCT00007813|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5520660|NCT01205971|Prevention of ECC|prevention of ecc
5520661|NCT01205971|Randomized clinical trial|randomized clinical trial
5520663|NCT01205958|Neck pain|neck pain
5520664|NCT01205958|western medicine|western medicine
5520665|NCT01205958|oriental medicine|oriental medicine
5520666|NCT01205958|acupuncture|acupuncture
5520667|NCT01205958|needle|needle
5520668|NCT01205945|Aortic aneurysm, abdominal|aortic aneurysm, abdominal
5520669|NCT01205945|Screening|screening
5520670|NCT01205945|Mortality|mortality
5520671|NCT01205932|venous thromboembolism|venous thromboembolism
5520672|NCT01205932|prevention|prevention
5520673|NCT01205932|othopaedic surgery|othopaedic surgery
5520675|NCT01205919|Internet Training|internet training
5520676|NCT01205919|Cognitive-Behavior Therapy|cognitive-behavior therapy
5520677|NCT01205919|CBT|cbt
5520678|NCT01205906|Tinnitus|tinnitus
5520679|NCT01205906|Internet Training|internet training
5520680|NCT01205906|Cognitive-Behavior Therapy|cognitive-behavior therapy
5520681|NCT01205906|CBT|cbt
5520682|NCT01205880|combination treatment|combination treatment
5520683|NCT01205880|topical corticosteroid|topical corticosteroid
5520684|NCT01205880|vitamin D analogue|vitamin d analogue
5520685|NCT01205880|clobex|clobex
5520686|NCT01205880|vectical|vectical
5520687|NCT01205880|clobetasol|clobetasol
5520688|NCT01205880|calcitriol|calcitriol
5502607|NCT01285362|Hepatic Steatosis|hepatic steatosis
5520689|NCT01205867|Butyrylcholinesterase deficiency|butyrylcholinesterase deficiency
5520690|NCT01205867|tolerability|tolerability
5520691|NCT01205867|safety|safety
5520692|NCT01205867|AZD8848|azd8848
5520693|NCT01205867|pharmacokinetics|pharmacokinetics
5520694|NCT01205867|pharmacodynamics|pharmacodynamics
5520695|NCT01205867|BChE deficient subjects and matched control subject|bche deficient subjects and matched control subject
5520696|NCT01205854|rheumatoid arthritis|rheumatoid arthritis
5520697|NCT01205854|ultrasonography|ultrasonography
5520698|NCT01205854|remission|remission
5520699|NCT01205854|imaging remission|imaging remission
5520700|NCT01205854|tight control|tight control
5520701|NCT01205854|treat to target|treat to target
5520702|NCT01205841|Ottawa Ankle and Foot Rules|ottawa ankle and foot rules
5520703|NCT01205841|Buffalo Rule|buffalo rule
5520704|NCT01205841|Bernese Ankle Rules|bernese ankle rules
5520705|NCT01205841|Low Risk Exam|low risk exam
5520706|NCT01205841|Malleolar Zone Algorithm|malleolar zone algorithm
5520707|NCT01205841|Clinical decision rule|clinical decision rule
5520708|NCT01205841|Ankle injury|ankle injury
5520709|NCT01205841|Ankle sprain|ankle sprain
5520710|NCT01205841|Inversion trauma|inversion trauma
5520711|NCT01205828|liver cancer|liver cancer
5520712|NCT01205828|hepatocellular|hepatocellular
5520713|NCT01205828|temozolomide|temozolomide
5520714|NCT01205828|veliparib|veliparib
5520715|NCT01205802|patency, hepatic venous congestion, liver transplantation|patency, hepatic venous congestion, liver transplantation
5520716|NCT01205789|Drug eluting stents|drug eluting stents
5520717|NCT01205789|Stents|stents
5520718|NCT01205789|Angioplasty|angioplasty
5520719|NCT01205789|Left Main Coronary Artery Disease|left main coronary artery disease
5520720|NCT01205776|Drug eluting stents|drug eluting stents
5520721|NCT01205776|Stents|stents
5520722|NCT01205776|Unprotected Left Main Coronary Artery Disease|unprotected left main coronary artery disease
5520723|NCT01205776|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5520724|NCT01205737|DLBCL|dlbcl
5520725|NCT01205737|pharmacokinetics|pharmacokinetics
5520726|NCT01205737|pharmacodynamics|pharmacodynamics
5520727|NCT01205711|recurrent colon cancer|recurrent colon cancer
5520728|NCT01205711|stage IV colon cancer|stage iv colon cancer
5520729|NCT01205711|recurrent rectal cancer|recurrent rectal cancer
5520730|NCT01205711|stage IV rectal cancer|stage iv rectal cancer
5520731|NCT01205672|Endometrium|endometrium
5521510|NCT01202812|Coagulation|coagulation
5520732|NCT01205672|Gynecologic malignancy|gynecologic malignancy
5520733|NCT01205672|Endometrial adenocarcinoma|endometrial adenocarcinoma
5520734|NCT01205672|Insulin/glucose metabolism|insulin/glucose metabolism
5520735|NCT01205672|Metformin|metformin
5520736|NCT01205646|prostate cancer|prostate cancer
5520737|NCT01205646|metastatic|metastatic
5520738|NCT01205646|zoledronate|zoledronate
5520739|NCT01205646|zometa|zometa
5520740|NCT01205633|neurodegenerative disease|neurodegenerative disease
5520741|NCT01205633|neurovascular disease|neurovascular disease
5520742|NCT01205633|fatigue|fatigue
5520743|NCT01205633|Hubbard Foundation|hubbard foundation
5520744|NCT01205633|angioplasty|angioplasty
5520745|NCT01205620|CABG|cabg
5520746|NCT01205607|traumatic brain injury|traumatic brain injury
5520747|NCT01205594|CABG surgery|cabg surgery
5520748|NCT01205581|Fluzone|fluzone
5520749|NCT01205581|Trivalent Influenza Vaccine|trivalent influenza vaccine
5520750|NCT01205555|intra uterine insemination|intra uterine insemination
5520751|NCT01205529|Atrial Fibrillation|atrial fibrillation
5520752|NCT01205529|ST elevation|st elevation
5520753|NCT01205529|Genotype|genotype
5520754|NCT01205503|chemobrain|chemobrain
5520755|NCT01205503|Oxidative Stress|oxidative stress
5520756|NCT01205503|Mesna|mesna
5520757|NCT01205477|Anserine bursitis|anserine bursitis
5520758|NCT01205464|Persistent symptoms|persistent symptoms
5520759|NCT01205464|Doxycycline|doxycycline
5520760|NCT01205464|Placebo|placebo
5520761|NCT01205464|Neuroborreliosis|neuroborreliosis
5520762|NCT01205451|GSK1358820|gsk1358820
5520763|NCT01205451|upper limb|upper limb
5520764|NCT01205451|spasticity|spasticity
5520765|NCT01205451|post-stroke|post-stroke
5520766|NCT01205438|SLE|sle
5520767|NCT01205438|Systemic Lupus Erythematosis|systemic lupus erythematosis
5520768|NCT01205438|Lupus|lupus
5520769|NCT01205438|autoimmune disease|autoimmune disease
5520770|NCT01205438|LY2127399|ly2127399
5520771|NCT01205438|Immune System Disease|immune system disease
5520772|NCT01205425|Computed coronary angiography|computed coronary angiography
5520773|NCT01205425|Stent implantation|stent implantation
5520775|NCT01205386|CTO|cto
5520776|NCT01205386|peripheral artery occlusive disease|peripheral artery occlusive disease
5520777|NCT01205386|PAOD|paod
5520778|NCT01205386|SFA|sfa
5520779|NCT01205386|superficial femoral artery|superficial femoral artery
5520780|NCT01205360|Analgesia, labour;|analgesia, labour;
5520781|NCT01205360|Analgesic techniques, epidural;|analgesic techniques, epidural;
5520782|NCT01205360|Drug delivery, intermittent bolus;|drug delivery, intermittent bolus;
5520783|NCT01205360|Anesthetics local, Bupivacaine;|anesthetics local, bupivacaine;
5520784|NCT01205360|Analgesics opioid, Fentanyl;|analgesics opioid, fentanyl;
5520787|NCT01205347|Insulin sensitivity|insulin sensitivity
5520788|NCT01205334|Glioblastoma multiforme|glioblastoma multiforme
5520789|NCT01205334|GBM|gbm
5520790|NCT01205334|Brain Cancer|brain cancer
5520791|NCT01205334|CTL|ctl
5520792|NCT01205321|Neoplasm|neoplasm
5520793|NCT01205321|PET/CT diagnosis|pet/ct diagnosis
5520794|NCT01205321|PET tracer|pet tracer
5520795|NCT01205308|Plant stanols|plant stanols
5520796|NCT01205308|type 1 diabetes|type 1 diabetes
5520797|NCT01205308|sterol metabolism|sterol metabolism
5520798|NCT01205308|cholesterol|cholesterol
5520799|NCT01205295|hip|hip
5520800|NCT01205295|shoulder|shoulder
5520801|NCT01205295|mental disorders|mental disorders
5520802|NCT01205295|anxiety|anxiety
5520803|NCT01205295|concern|concern
5520804|NCT01205295|efficacy of treatment|efficacy of treatment
5520805|NCT01205282|ASD|asd
5520806|NCT01205269|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5520807|NCT01205269|safety|safety
5520808|NCT01205269|inhalation|inhalation
5520809|NCT01205269|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
5520810|NCT01205256|Methadone pharmacokinetics in adolescents|methadone pharmacokinetics in adolescents
5520811|NCT01205243|Abacavir|abacavir
5520812|NCT01205243|post-marketing surveillance|post-marketing surveillance
5520813|NCT01205230|Esomeprazole|esomeprazole
5520814|NCT01205230|Pharmacogenetics|pharmacogenetics
5520815|NCT01205230|Pharmacokinetics|pharmacokinetics
5520816|NCT01205230|Ketoconazole|ketoconazole
5520817|NCT01205230|Pazopanib|pazopanib
5520818|NCT01205230|Drug Interaction|drug interaction
5520819|NCT01205230|Safety|safety
5520820|NCT01205230|Solid Tumors|solid tumors
5520821|NCT01205217|lapatinib|lapatinib
5520822|NCT01205217|epirubicin|epirubicin
5520823|NCT01205217|cyclophosphamide|cyclophosphamide
5520824|NCT01205217|trastuzumab|trastuzumab
5520825|NCT01205217|paclitaxel|paclitaxel
5520826|NCT01205217|neoadjuvant therapy|neoadjuvant therapy
5520827|NCT01205217|Breast Cancer|breast cancer
5520828|NCT01205204|Clonidine|clonidine
5520829|NCT01205204|Fentanyl|fentanyl
5520830|NCT01205204|Bupivacaine|bupivacaine
5520831|NCT01205204|Spinal Anesthesia|spinal anesthesia
5520832|NCT01205204|Lower Segment Caesarian Section|lower segment caesarian section
5520833|NCT01205191|Cognitive behavioural therapy|cognitive behavioural therapy
5520834|NCT01205191|Anxiety|anxiety
5520835|NCT01205191|Primary care|primary care
5520836|NCT01205191|Effectiveness trial|effectiveness trial
5520837|NCT01205191|Cell-phone supported therapy|cell-phone supported therapy
5520838|NCT01205152|Hypophosphatasia|hypophosphatasia
5520839|NCT01205152|HPP|hpp
5520840|NCT01205152|Bone disease|bone disease
5520841|NCT01205152|Soft bones|soft bones
5520842|NCT01205152|Low alkaline phosphatase|low alkaline phosphatase
5520843|NCT01205152|Genetic metabolic disorder|genetic metabolic disorder
5520844|NCT01205152|Alkaline phosphatase|alkaline phosphatase
5520845|NCT01205152|Tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5520846|NCT01205152|Rickets|rickets
5520847|NCT01205152|Osteomalacia|osteomalacia
5520848|NCT01205139|TMC435-TiDP16-C114|tmc435-tidp16-c114
5520849|NCT01205139|TMC435-C114|tmc435-c114
5520850|NCT01205139|TMC435|tmc435
5520851|NCT01205139|HCV|hcv
5520852|NCT01205139|Hepatitis C|hepatitis c
5520853|NCT01205126|Pain|pain
5520854|NCT01205126|Hydromorphone hydrochloride|hydromorphone hydrochloride
5520855|NCT01205126|Oxycodone hydrochloride|oxycodone hydrochloride
5520856|NCT01205100|Gastrointestinal Diseases|gastrointestinal diseases
5520857|NCT01205100|Irritable Bowel Syndrome|irritable bowel syndrome
5520858|NCT01205100|Behavioral Research|behavioral research
5520859|NCT01205100|Biofeedback|biofeedback
5520860|NCT01205074|Patients with chronic liver disease and cirrhosis|patients with chronic liver disease and cirrhosis
5520861|NCT01205035|Idiopathic Parafoveal Telangiectasia|idiopathic parafoveal telangiectasia
5520862|NCT01205035|Macular Telangiectasia|macular telangiectasia
5520863|NCT01205035|Macula Lutea/pathology|macula lutea/pathology
5520864|NCT01205035|Retinal Diseases/pathology|retinal diseases/pathology
5520865|NCT01205035|Retinal Pigments/metabolism|retinal pigments/metabolism
5520866|NCT01205035|Telangiectasis/metabolism|telangiectasis/metabolism
5520867|NCT01205035|Telangiectasis/pathology|telangiectasis/pathology
5520868|NCT01205009|in-vitro fertilization|in-vitro fertilization
5520869|NCT01205009|poor responders|poor responders
5520870|NCT01205009|human chorionic gonadotropin|human chorionic gonadotropin
5520871|NCT01205009|Fertility Agents, Female|fertility agents, female
5520872|NCT01204996|monoclonal antibody|monoclonal antibody
5520873|NCT01204996|solid tumor|solid tumor
5520874|NCT01204996|chemotherapy|chemotherapy
5520875|NCT01204996|standard of care|standard of care
5520876|NCT01204983|very low birth weight infant|very low birth weight infant
5520877|NCT01204983|donor human milk|donor human milk
5520878|NCT01204970|Confocal Laser Scanning Microendoscopy|confocal laser scanning microendoscopy
5520879|NCT01204970|Small airways|small airways
5520880|NCT01204970|COPD|copd
5520881|NCT01204970|Lung transplantation|lung transplantation
5520882|NCT01204957|Homocysteine|homocysteine
5520883|NCT01204957|Insulin-like growth factor|insulin-like growth factor
5520884|NCT01204957|Insulin-like growth factor binding protein|insulin-like growth factor binding protein
5520885|NCT01204957|Serum estrogen|serum estrogen
5520886|NCT01204957|Urinary phytoestrogens|urinary phytoestrogens
5520887|NCT01204957|Thyroid hormones|thyroid hormones
5520888|NCT01204931|reflux|reflux
5520889|NCT01204931|gastroesophageal reflux disease|gastroesophageal reflux disease
5520890|NCT01204931|GERD|gerd
5520892|NCT01204918|Depression|depression
5520893|NCT01204918|Treatment refractory|treatment refractory
5520894|NCT01204918|Glutamate|glutamate
5520895|NCT01204918|Riluzole|riluzole
5520896|NCT01204918|Major depressive disorder|major depressive disorder
5520897|NCT01204918|psychopharmacology|psychopharmacology
5520898|NCT01204918|rilutek|rilutek
5520899|NCT01204905|HIV-1|hiv-1
5520901|NCT01204905|Viral Load|viral load
5520902|NCT01204905|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5520903|NCT01204866|Allergic-Like Reaction|allergic-like reaction
5520904|NCT01204866|Selected Formulation Components|selected formulation components
5520905|NCT01204853|sitaxentan sodium hypertension|sitaxentan sodium hypertension
5520906|NCT01204840|in vitro fertilization|in vitro fertilization
5520908|NCT01204840|poor responder|poor responder
5520909|NCT01204840|growth hormone|growth hormone
5520910|NCT01204840|Poor responders to in vitro fertilization treatments|poor responders to in vitro fertilization treatments
5520911|NCT01204827|Patients with chronic HBeAg negative hepatitis B virus infection treated with Sebivo (Telbivudine)|patients with chronic hbeag negative hepatitis b virus infection treated with sebivo (telbivudine)
5520912|NCT01204814|HIV|hiv
5520913|NCT01204814|Drug resistance|drug resistance
5520914|NCT01204814|mutations|mutations
5520915|NCT01204814|ARV's|arv's
5520916|NCT01204801|Cancer|cancer
5520917|NCT01204801|Breast Cancer|breast cancer
5520918|NCT01204801|Breast Tumor|breast tumor
5520919|NCT01204801|Breast Neoplasm|breast neoplasm
5520920|NCT01204801|Neoplasms by Site|neoplasms by site
5520921|NCT01204801|Neoplasms|neoplasms
5520922|NCT01204801|Breast Diseases|breast diseases
5520923|NCT01204801|Breast Conserving Surgery|breast conserving surgery
5520924|NCT01204801|Breast Conservation|breast conservation
5520925|NCT01204801|Partial Mastectomy|partial mastectomy
5520926|NCT01204801|Lumpectomy|lumpectomy
5520927|NCT01204801|Mastectomy|mastectomy
5520928|NCT01204801|Surgery|surgery
5520929|NCT01204801|Neoadjuvant Therapy|neoadjuvant therapy
5520930|NCT01204801|Primary Therapy|primary therapy
5520931|NCT01204801|Neoadjuvant Systemic Therapy|neoadjuvant systemic therapy
5520932|NCT01204801|Thermotherapy|thermotherapy
5520933|NCT01204801|Fever Therapy|fever therapy
5520934|NCT01204801|Hot Temperature|hot temperature
5520935|NCT01204801|Hyperthermia|hyperthermia
5520936|NCT01204801|Hyperthermia, Therapeutic|hyperthermia, therapeutic
5520937|NCT01204801|Hyperthermia, Local|hyperthermia, local
5520938|NCT01204801|Hyperthermia, Induced|hyperthermia, induced
5520939|NCT01204801|Therapeutic Hyperthermia|therapeutic hyperthermia
5520940|NCT01204801|Microwave|microwave
5520941|NCT01204801|Focused Microwave|focused microwave
5520942|NCT01204801|Focused Microwave Thermotherapy|focused microwave thermotherapy
5520943|NCT01204801|Minimally Invasive|minimally invasive
5520944|NCT01204801|Doxorubicin|doxorubicin
5520945|NCT01204801|Epirubicin|epirubicin
5520946|NCT01204801|Epidoxirubicin|epidoxirubicin
5520947|NCT01204801|Immunosuppresive Agent|immunosuppresive agent
5520948|NCT01204801|Immunologic Factors|immunologic factors
5520949|NCT01204801|Physiological Effects of Drugs|physiological effects of drugs
5520950|NCT01204801|Chemotherapy|chemotherapy
5520951|NCT01204801|Drug Therapy|drug therapy
5520952|NCT01204801|Pharmalogic Actions|pharmalogic actions
5520953|NCT01204801|Antirheumatic Agents|antirheumatic agents
5520954|NCT01204801|Therapeutic Uses|therapeutic uses
5520955|NCT01204801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5520956|NCT01204801|Alkylating Agents|alkylating agents
5520957|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5520958|NCT01204801|Antineoplastic Agents|antineoplastic agents
5520959|NCT01204801|Myeloblative Agonists|myeloblative agonists
5520960|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic
5520961|NCT01204801|Anthracycline Agents|anthracycline agents
5520962|NCT01204788|Acute myelogenous leukemia|acute myelogenous leukemia
5520964|NCT01204788|Undifferentiated and bi-phenotypic leukemia|undifferentiated and bi-phenotypic leukemia
5520965|NCT01204788|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
5520966|NCT01204788|Chronic myelogenous leukemia|chronic myelogenous leukemia
5520968|NCT01204788|Radiated Prophylactic White Cell Transfusions|radiated prophylactic white cell transfusions
5520969|NCT01204788|Therapeutic Radiated White Cell Transfusion|therapeutic radiated white cell transfusion
5520970|NCT01204788|prophylactic antibiotics|prophylactic antibiotics
5520971|NCT01204749|AMGEN|amgen
5520972|NCT01204749|AMG 386|amg 386
5520973|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors
5520974|NCT01204749|Fallopian Tube Cancer|fallopian tube cancer
5520979|NCT01204736|tendon transfer|tendon transfer
5520980|NCT01204736|elbow|elbow
5520981|NCT01204723|Marijuana Abuse|marijuana abuse
5520982|NCT01204723|Nicotine Dependence|nicotine dependence
5520983|NCT01204723|Nicotine Withdrawal|nicotine withdrawal
5520984|NCT01204723|neurokinin Receptor|neurokinin receptor
5520985|NCT01204723|NK1 Receptor antagonist|nk1 receptor antagonist
5520986|NCT01204723|Substance P|substance p
5520987|NCT01204723|Recurrence|recurrence
5520988|NCT01204723|Substance Withdrawal Syndrome|substance withdrawal syndrome
5520989|NCT01204723|Substance-Related Disorders|substance-related disorders
5520990|NCT01204723|Disorders of Environmental Origin|disorders of environmental origin
5520991|NCT01204723|Mental Disorders|mental disorders
5520992|NCT01204723|Disease Attributes|disease attributes
5520993|NCT01204723|Pathologic Processes|pathologic processes
5520994|NCT01204723|Tetrahydrocannabinol|tetrahydrocannabinol
5520995|NCT01204723|Therapeutic Uses|therapeutic uses
5520996|NCT01204723|Psychotropic Drugs|psychotropic drugs
5520997|NCT01204723|Analgesics, Non-Narcotic|analgesics, non-narcotic
5520998|NCT01204723|Analgesics|analgesics
5515227|NCT01230073|Home-Monitoring|home-monitoring
5520999|NCT01204723|Sensory System Agents|sensory system agents
5521000|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents
5521001|NCT01204723|Neurotransmitter Agents|neurotransmitter agents
5521002|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5521003|NCT01204723|Narcotic Antagonists|narcotic antagonists
5521004|NCT01204723|cannabis|cannabis
5521005|NCT01204710|Prostate Cancer|prostate cancer
5521010|NCT01204671|influenza infection|influenza infection
5521011|NCT01204671|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
5521012|NCT01204658|Haemophilus influenzae|haemophilus influenzae
5521013|NCT01204658|Streptococcus pneumoniae|streptococcus pneumoniae
5521014|NCT01204658|immunogenicity|immunogenicity
5521015|NCT01204658|Pneumococcal vaccine|pneumococcal vaccine
5521017|NCT01204658|safety|safety
5521018|NCT01204619|peritoneal dialysis|peritoneal dialysis
5521019|NCT01204567|HLRQ|hlrq
5521020|NCT01204567|elderly|elderly
5521021|NCT01204567|aerobic fitness|aerobic fitness
5521022|NCT01204567|cognitive capacity|cognitive capacity
5521023|NCT01204554|perforator flaps|perforator flaps
5521024|NCT01204541|Non-exudative age-related macular degeneration|non-exudative age-related macular degeneration
5521025|NCT01204528|Dysfunction in CKD|dysfunction in ckd
5521027|NCT01204515|irritable bowel syndrome|irritable bowel syndrome
5521028|NCT01204515|abdominal pain|abdominal pain
5521029|NCT01204515|urgency|urgency
5521030|NCT01204515|bloating|bloating
5521031|NCT01204515|diarrhea|diarrhea
5521032|NCT01204515|constipation|constipation
5521033|NCT01204502|Gene therapy|gene therapy
5521034|NCT01204502|Haploidentical|haploidentical
5521035|NCT01204502|Bone marrow transplant|bone marrow transplant
5521036|NCT01204502|Graft versus host disease|graft versus host disease
5521037|NCT01204502|haploidentical stem cell transplantation|haploidentical stem cell transplantation
5521038|NCT01204502|T-cell suicide gene therapy|t-cell suicide gene therapy
5521039|NCT01204450|recurrent childhood brain tumor|recurrent childhood brain tumor
5521040|NCT01204450|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5521041|NCT01204450|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5521042|NCT01204450|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5521043|NCT01204450|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5521044|NCT01204450|recurrent neuroblastoma|recurrent neuroblastoma
5521045|NCT01204450|recurrent osteosarcoma|recurrent osteosarcoma
5521046|NCT01204450|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5521047|NCT01204437|adjuvant chemotherapy|adjuvant chemotherapy
5521048|NCT01204437|primary carcinoma|primary carcinoma
5521049|NCT01204437|elderly non frail patients|elderly non frail patients
5521050|NCT01204437|EC|ec
5521051|NCT01204437|CMF|cmf
5521052|NCT01204437|Capecitabine|capecitabine
5521053|NCT01204437|Nab-Paclitaxel|nab-paclitaxel
5521054|NCT01204424|minimal invasive|minimal invasive
5521055|NCT01204424|sinus floor augmentation|sinus floor augmentation
5521056|NCT01204424|sinuslift|sinuslift
5521057|NCT01204424|dental implants|dental implants
5521058|NCT01204411|Efficacy|efficacy
5521059|NCT01204411|Safety|safety
5521060|NCT01204411|Artesunate-amodiaquine|artesunate-amodiaquine
5521061|NCT01204411|Malaria|malaria
5521062|NCT01204411|Plasmodium falciparum|plasmodium falciparum
5521063|NCT01204411|Malnutrition|malnutrition
5521064|NCT01204385|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
5521065|NCT01204385|Acute Otitis Media|acute otitis media
5521066|NCT01204385|Streptococcus Pneumoniae|streptococcus pneumoniae
5521067|NCT01204385|etiology|etiology
5521070|NCT01204372|Combination chemotherapy|combination chemotherapy
5521071|NCT01204372|Targeted agents|targeted agents
5521072|NCT01204346|adolescents|adolescents
5521073|NCT01204346|MBT|mbt
5521074|NCT01204346|depression|depression
5521075|NCT01204346|emerging personality disorder|emerging personality disorder
5521076|NCT01204333|Cerebral venous and sinus thrombosis|cerebral venous and sinus thrombosis
5521077|NCT01204333|Cerebral venous thrombosis|cerebral venous thrombosis
5521078|NCT01204333|Sinus Thrombosis, Intracranial|sinus thrombosis, intracranial
5521079|NCT01204333|Endovascular thrombolysis|endovascular thrombolysis
5521080|NCT01204333|Thrombolysis|thrombolysis
5521081|NCT01204333|Thrombectomy|thrombectomy
5521082|NCT01204320|Restenosis|restenosis
5521083|NCT01204320|POBA|poba
5521084|NCT01204320|Stenting|stenting
5521085|NCT01204320|Paclitaxel|paclitaxel
5521086|NCT01204281|Proportional Assist Ventilation plus|proportional assist ventilation plus
5521087|NCT01204281|Acute respiratory failure|acute respiratory failure
5521088|NCT01204281|Mechanical ventilation|mechanical ventilation
5521089|NCT01204268|cerebral ischemia|cerebral ischemia
5521090|NCT01204268|sevoflurane preconditioning|sevoflurane preconditioning
5521091|NCT01204268|intracranial aneurysm surgery|intracranial aneurysm surgery
5521092|NCT01204255|healthy, no evidence of disease|healthy, no evidence of disease
5521093|NCT01204242|Breast Cancer|breast cancer
5521094|NCT01204229|Alcohol Consumption|alcohol consumption
5515350|NCT01229579|OPV|opv
5521095|NCT01204229|Social Anxiety|social anxiety
5521096|NCT01204229|Depression|depression
5521097|NCT01204229|Brief Intervention|brief intervention
5521098|NCT01204229|Motivational Interviewing|motivational interviewing
5521099|NCT01204229|Cognitive Behavioral Therapy|cognitive behavioral therapy
5521100|NCT01204229|Sub-Clinical Social Anxiety|sub-clinical social anxiety
5521101|NCT01204229|Sub-Clinical Depression|sub-clinical depression
5521102|NCT01204216|Hemoglobin A1c|hemoglobin a1c
5521103|NCT01204216|HbA1c|hba1c
5521104|NCT01204216|glycated serum proteins|glycated serum proteins
5521105|NCT01204216|fructosamine|fructosamine
5521106|NCT01204216|glycated albumin|glycated albumin
5521107|NCT01204216|glycation gap|glycation gap
5521108|NCT01204203|mesothelioma|mesothelioma
5521109|NCT01204203|zoledronic acid|zoledronic acid
5521110|NCT01204203|zometa|zometa
5521111|NCT01204203|bisphosphonate therapy|bisphosphonate therapy
5521112|NCT01204203|CT scan|ct scan
5521113|NCT01204203|PET scan|pet scan
5521114|NCT01204190|Administration|administration
5521115|NCT01204190|Cutaneous|cutaneous
5521116|NCT01204177|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5521117|NCT01204177|MEK inhibitor|mek inhibitor
5521118|NCT01204177|Sorafenib|sorafenib
5521119|NCT01204177|Disease control rate (DCR)|disease control rate (dcr)
5521120|NCT01204177|Safety|safety
5521121|NCT01204164|AML|aml
5521122|NCT01204164|ALL|all
5521123|NCT01204164|MDS|mds
5521124|NCT01204164|CML in blast crisis|cml in blast crisis
5521125|NCT01204164|Multiple Myeloma|multiple myeloma
5521126|NCT01204164|Carfilzomib refractory|carfilzomib refractory
5521127|NCT01204138|RA, treatment, TNF, cytokines|ra, treatment, tnf, cytokines
5521128|NCT01204112|Drug-Drug Interaction|drug-drug interaction
5521129|NCT01204112|Tasocitinib (CP-690|tasocitinib (cp-690
5521130|NCT01204112|550)|550)
5521131|NCT01204112|Rifampin|rifampin
5521132|NCT01204112|Healthy Volunteers|healthy volunteers
5521133|NCT01204099|PX-866|px-866
5521134|NCT01204099|Non small cell lung cancer|non small cell lung cancer
5521135|NCT01204099|solid tumors|solid tumors
5521136|NCT01204099|Squamous cell cancer of the head and neck|squamous cell cancer of the head and neck
5521137|NCT01204099|docetaxel|docetaxel
5521138|NCT01204099|NSCLC|nsclc
5521139|NCT01204099|taxotere|taxotere
5521140|NCT01204099|SCCHN|scchn
5521141|NCT01204099|PI-3K|pi-3k
5521142|NCT01204099|PI3 kinase|pi3 kinase
5521143|NCT01204099|PI3K|pi3k
5521144|NCT01204086|Major Depressive Disorder|major depressive disorder
5521145|NCT01204086|Antidepressants|antidepressants
5521146|NCT01204086|Pharmacogenetics|pharmacogenetics
5521147|NCT01204086|venlafaxine|venlafaxine
5521148|NCT01204086|fluoxetine|fluoxetine
5521149|NCT01204060|Nasal Allergen Lipopolysaccharide Inflammation Asthma|nasal allergen lipopolysaccharide inflammation asthma
5521150|NCT01204034|COPD|copd
5521151|NCT01204034|Formoterol|formoterol
5521152|NCT01204034|Beclomethasone Dipropionate|beclomethasone dipropionate
5521153|NCT01204034|Computational Fluid Dynamics|computational fluid dynamics
5521154|NCT01204034|Functional Imaging|functional imaging
5521155|NCT01204034|Central and Peripheral Airways|central and peripheral airways
5521156|NCT01204034|BODE index|bode index
5521157|NCT01204034|COPD Assessment Test (CAT)|copd assessment test (cat)
5521158|NCT01204034|Borg CR10 scale|borg cr10 scale
5521159|NCT01204021|Stress|stress
5521160|NCT01204021|loneliness|loneliness
5521161|NCT01204021|social isolation|social isolation
5521162|NCT01204021|autonomic activity|autonomic activity
5521163|NCT01204021|inflammation|inflammation
5521164|NCT01204021|Perceived social isolation|perceived social isolation
5521165|NCT01204021|Chronic stress|chronic stress
5521166|NCT01203982|CIMT|cimt
5521167|NCT01203982|IVUS-VH|ivus-vh
5521168|NCT01203982|Coronary artery disease|coronary artery disease
5521169|NCT01203956|AutoAdjust|autoadjust
5521170|NCT01203956|SmartFlex|smartflex
5521171|NCT01203956|Apnea Hypopnea Index|apnea hypopnea index
5521172|NCT01203956|Patient reported outcomes|patient reported outcomes
5521173|NCT01203943|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5521174|NCT01203943|Pulmonary Fibrosis|pulmonary fibrosis
5521175|NCT01203943|Fibrosis|fibrosis
5521176|NCT01203943|Interstitial Lung Disease|interstitial lung disease
5521177|NCT01203943|Lung Diseases, Interstitial|lung diseases, interstitial
5521178|NCT01203943|CC-930|cc-930
5521179|NCT01203930|CLL|cll
5521180|NCT01203930|SLL|sll
5521181|NCT01203930|GS-1101|gs-1101
5521182|NCT01203930|CAL-101|cal-101
5521183|NCT01203930|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5521184|NCT01203930|Rituximab|rituximab
5521185|NCT01203930|Rituxan|rituxan
5521186|NCT01203917|Gefitinib|gefitinib
5521187|NCT01203917|EGFR TKI|egfr tki
5521188|NCT01203917|efficacy|efficacy
5521189|NCT01203917|Caucasian patients|caucasian patients
5521190|NCT01203917|EGFR mutation positive advanced NSCLC|egfr mutation positive advanced nsclc
5521191|NCT01203917|safety|safety
5521192|NCT01203904|bronchial asthma, Pulmicort, long term use, pediatrics|bronchial asthma, pulmicort, long term use, pediatrics
5521193|NCT01203891|SPECT|spect
5521194|NCT01203891|Imaging|imaging
5521195|NCT01203891|Healthy brain|healthy brain
5521196|NCT01203891|regional cerebral blood flow|regional cerebral blood flow
5521197|NCT01203878|Imiquimod|imiquimod
5521198|NCT01203878|Photodynamic therapy|photodynamic therapy
5521199|NCT01203878|Actinic keratoses|actinic keratoses
5521200|NCT01203878|Sequential therapy|sequential therapy
5521201|NCT01203878|Therapeutic uses|therapeutic uses
5521202|NCT01203865|Fibromyalgia|fibromyalgia
5521203|NCT01203865|Fatigue|fatigue
5521204|NCT01203852|hypertension|hypertension
5521205|NCT01203852|antihypertensive drug|antihypertensive drug
5521206|NCT01203852|pharmacogenetics|pharmacogenetics
5521207|NCT01203852|genetics|genetics
5521208|NCT01203852|blood pressure|blood pressure
5521209|NCT01203852|glucose|glucose
5521210|NCT01203839|stage 1 breast cancer|stage 1 breast cancer
5521211|NCT01203839|invasive ductal breast|invasive ductal breast
5521212|NCT01203839|Partial Breast Irradiation (PBI)|partial breast irradiation (pbi)
5521213|NCT01203839|radiation|radiation
5521214|NCT01203839|10-114|10-114
5521215|NCT01203826|Hypophosphatasia|hypophosphatasia
5521216|NCT01203826|HPP|hpp
5521217|NCT01203826|Bone Disease|bone disease
5521219|NCT01203826|Low Alkaline Phosphatase|low alkaline phosphatase
5521220|NCT01203826|genetic metabolic disorder|genetic metabolic disorder
5521221|NCT01203826|alkaline phosphatase|alkaline phosphatase
5521222|NCT01203826|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5521223|NCT01203826|rickets|rickets
5521224|NCT01203826|osteomalacia|osteomalacia
5521225|NCT01203813|Chronic kidney disease|chronic kidney disease
5521226|NCT01203813|Quality improvement|quality improvement
5521227|NCT01203813|Self management support|self management support
5521228|NCT01203813|Electronic health records|electronic health records
5521229|NCT01203813|Clinical decision support|clinical decision support
5521230|NCT01203813|Electronic reminders|electronic reminders
5521231|NCT01203813|Patient outreach|patient outreach
5521232|NCT01203787|Hepatocellular Carcinoma|hepatocellular carcinoma
5521234|NCT01203787|Liver Cancer|liver cancer
5521235|NCT01203774|Diabetes|diabetes
5521236|NCT01203761|loneliness|loneliness
5521237|NCT01203735|Non-small-cell lung cancer|non-small-cell lung cancer
5521238|NCT01203735|Valproic acid|valproic acid
5521239|NCT01203735|Chemotherapy|chemotherapy
5521240|NCT01203735|Radiotherapy|radiotherapy
5521241|NCT01203722|Reduced intensity|reduced intensity
5521242|NCT01203722|partially HLA mismatched allogeneic BMT|partially hla mismatched allogeneic bmt
5521243|NCT01203722|Acute leukemias|acute leukemias
5521244|NCT01203722|Chronic leukemias|chronic leukemias
5521245|NCT01203722|Myelodysplasia|myelodysplasia
5521246|NCT01203722|Lymphomas|lymphomas
5521247|NCT01203722|Unrelated or non-first-degree related donors|unrelated or non-first-degree related donors
5521248|NCT01203722|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
5521249|NCT01203709|lupus|lupus
5521250|NCT01203709|nephritis|nephritis
5521251|NCT01203709|glomerulonephritis|glomerulonephritis
5521252|NCT01203709|nephropathy|nephropathy
5521253|NCT01203709|refractory|refractory
5521254|NCT01203696|Clopidogrel|clopidogrel
5521255|NCT01203696|Platelet reactivity|platelet reactivity
5521256|NCT01203696|Amlodipine|amlodipine
5521257|NCT01203683|depression|depression
5503181|NCT01282450|Radiotherapy|radiotherapy
5521258|NCT01203670|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
5521259|NCT01203670|Aspartate Amino Transferase (ASAT)|aspartate amino transferase (asat)
5521260|NCT01203670|Alanine Amino transferase (ALAT)|alanine amino transferase (alat)
5521261|NCT01203670|gamma Glutamyl transpeptidase (gamma GT)|gamma glutamyl transpeptidase (gamma gt)
5521269|NCT01203618|Resectable, non-functioning pituitary adenoma|resectable, non-functioning pituitary adenoma
5521270|NCT01203618|Pituitary tumor|pituitary tumor
5521271|NCT01203618|Pituitary adenoma|pituitary adenoma
5521272|NCT01203618|Pituitary macroadenoma|pituitary macroadenoma
5521273|NCT01203605|Operative surgical procedures|operative surgical procedures
5521274|NCT01203605|mortality|mortality
5521275|NCT01203605|adverse effects|adverse effects
5521276|NCT01203605|Postoperative complications|postoperative complications
5521277|NCT01203605|Epidemiological Study|epidemiological study
5521278|NCT01203592|Congenital myasthenic syndrome|congenital myasthenic syndrome
5521279|NCT01203592|Albuterol|albuterol
5521280|NCT01203592|Neuromuscular transmission|neuromuscular transmission
5521281|NCT01203579|CDT-Lung,CT scan,lung cancer detection|cdt-lung,ct scan,lung cancer detection
5521282|NCT01203566|Single incision laparoscopic surgery|single incision laparoscopic surgery
5521283|NCT01203566|Single site access laparoscopic surgery|single site access laparoscopic surgery
5521284|NCT01203566|SILS|sils
5521285|NCT01203566|Single-port access|single-port access
5521286|NCT01203566|Laparoendoscopic single site surgery|laparoendoscopic single site surgery
5521287|NCT01203566|Appendectomy|appendectomy
5521288|NCT01203553|Incisional hernias|incisional hernias
5521289|NCT01203553|Prophylaxis|prophylaxis
5521290|NCT01203553|Preperitoneal mesh|preperitoneal mesh
5521291|NCT01203527|H1N1 influenza|h1n1 influenza
5521292|NCT01203527|Swine flu|swine flu
5521293|NCT01203527|Oseltamivir|oseltamivir
5521294|NCT01203527|Tamiflu|tamiflu
5521295|NCT01203527|Pregnancy|pregnancy
5521296|NCT01203514|NICHD Neonatal Research Network|nichd neonatal research network
5521297|NCT01203514|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521298|NCT01203514|Prematurity|prematurity
5521299|NCT01203514|Erythrocyte transfusions|erythrocyte transfusions
5521300|NCT01203514|Erythropoietin (Epo)|erythropoietin (epo)
5521301|NCT01203514|Blood loss|blood loss
5521302|NCT01203514|Phlebotomy|phlebotomy
5521303|NCT01203501|NICHD Neonatal Research Network|nichd neonatal research network
5521304|NCT01203501|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521305|NCT01203501|Prematurity|prematurity
5521306|NCT01203501|Antenatal Magnesium sulfate|antenatal magnesium sulfate
5521307|NCT01203488|NICHD Neonatal Research Network|nichd neonatal research network
5521308|NCT01203488|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521309|NCT01203488|Prematurity|prematurity
5521310|NCT01203488|Vitamin A|vitamin a
5521311|NCT01203488|Chronic Lung Disease|chronic lung disease
5521312|NCT01203475|NICHD Neonatal Research Network|nichd neonatal research network
5521313|NCT01203475|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521314|NCT01203475|Prematurity|prematurity
5521315|NCT01203475|Growth Curve|growth curve
5521316|NCT01203475|Head Circumference|head circumference
5521317|NCT01203475|Length|length
5521318|NCT01203449|NICHD Neonatal Research Network|nichd neonatal research network
5521319|NCT01203449|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521320|NCT01203449|Prematurity|prematurity
5521321|NCT01203449|Gestational Age|gestational age
5521322|NCT01203436|NICHD Neonatal Research Network|nichd neonatal research network
5521323|NCT01203436|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5671477|NCT00615888|elective open repair|elective open repair
5521324|NCT01203436|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521325|NCT01203436|Prematurity|prematurity
5521326|NCT01203423|NICHD Neonatal Research Network|nichd neonatal research network
5521327|NCT01203423|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521328|NCT01203423|Prematurity|prematurity
5521329|NCT01203423|Persistent Pulmonary Hypertension of Newborn (PPHN)|persistent pulmonary hypertension of newborn (pphn)
5521330|NCT01203410|NICHD Neonatal Research Network|nichd neonatal research network
5521331|NCT01203410|Term infant|term infant
5521332|NCT01203410|Hyperbilirubinemia|hyperbilirubinemia
5521333|NCT01203397|SUPERFICIAL VARICOSE VEINS|superficial varicose veins
5521334|NCT01203371|naftopidil|naftopidil
5521335|NCT01203371|symptoms of lower urinary tract|symptoms of lower urinary tract
5521336|NCT01203371|benign prostate hyperplasia|benign prostate hyperplasia
5521337|NCT01203371|LUTS|luts
5521338|NCT01203358|NICHD Neonatal Research Network|nichd neonatal research network
5521339|NCT01203358|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521340|NCT01203358|Prematurity|prematurity
5521341|NCT01203358|Respiratory distress syndrome|respiratory distress syndrome
5521342|NCT01203358|Surfactant|surfactant
5521343|NCT01203345|NICHD Neonatal Research Network|nichd neonatal research network
5521344|NCT01203345|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5521345|NCT01203345|Prematurity|prematurity
5521346|NCT01203345|Septicemia|septicemia
5521347|NCT01203345|Meningitis|meningitis
5521348|NCT01203345|Urinary tract infection|urinary tract infection
5521349|NCT01203345|Immune globulin|immune globulin
5521350|NCT01203332|HIV testing|hiv testing
5521351|NCT01203332|Latino|latino
5521352|NCT01203332|Latina|latina
5521353|NCT01203332|Men who have sex with men|men who have sex with men
5521354|NCT01203319|immunogenicity|immunogenicity
5521355|NCT01203319|safety|safety
5521356|NCT01203319|recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5521357|NCT01203319|nonresponders|nonresponders
5521358|NCT01203306|bevacizumab|bevacizumab
5521359|NCT01203306|somatostatin analogue|somatostatin analogue
5521360|NCT01203306|metronomic capecitabine|metronomic capecitabine
5521361|NCT01203306|neuroendocrine tumors|neuroendocrine tumors
5521362|NCT01203280|icing|icing
5521363|NCT01203280|boxer|boxer
5521364|NCT01203280|balance|balance
5521365|NCT01203280|neck range of motion|neck range of motion
5521366|NCT01203280|neck isometric strength|neck isometric strength
5521367|NCT01203280|balance performance|balance performance
5521368|NCT01203267|Breast Neoplasms|breast neoplasms
5521369|NCT01203267|Neoadjuvant|neoadjuvant
5521370|NCT01203267|Chemotherapy|chemotherapy
5521371|NCT01203267|Paclitaxel|paclitaxel
5521372|NCT01203267|Carboplatin|carboplatin
5521373|NCT01203267|Pathological Complete Remission|pathological complete remission
5521374|NCT01203254|Colesevelam|colesevelam
5521375|NCT01203254|IBD|ibd
5521376|NCT01203254|Bile Acid Malabsorption|bile acid malabsorption
5521377|NCT01203254|Crohns disease|crohns disease
5521378|NCT01203228|Reduced Intensity conditioning|reduced intensity conditioning
5521379|NCT01203228|Myeloablative conditionig|myeloablative conditionig
5521380|NCT01203228|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5521381|NCT01203228|MUD|mud
5521382|NCT01203215|exercise|exercise
5521383|NCT01203215|physical activity|physical activity
5521384|NCT01203215|women|women
5521385|NCT01203215|community|community
5521386|NCT01203202|PE|pe
5521387|NCT01203202|IELT|ielt
5521388|NCT01203202|DCIT|dcit
5521389|NCT01203189|dandruff, flaky scalp|dandruff, flaky scalp
5521390|NCT01203176|Endometrial polyp|endometrial polyp
5521391|NCT01203176|Endometrial carcinoma|endometrial carcinoma
5521392|NCT01203176|Endometrial hyperplasia|endometrial hyperplasia
5521393|NCT01203176|Postmenopausal symptomatic women|postmenopausal symptomatic women
5521394|NCT01203176|Postmenopausal asymptomatic women|postmenopausal asymptomatic women
5521396|NCT01203163|porfimer sodium|porfimer sodium
5521397|NCT01203163|esophageal cancer|esophageal cancer
5521398|NCT01203163|NSCLC|nsclc
5521399|NCT01203163|HGD in BE|hgd in be
5521400|NCT01203137|tricuspid regurgitation, severe|tricuspid regurgitation, severe
5521401|NCT01203124|Intranasal|intranasal
5521402|NCT01203124|Biomarker|biomarker
5521403|NCT01203124|Healthy|healthy
5521404|NCT01203124|Effect of different doses and dosing regimens of AZD8848 on biomarkers|effect of different doses and dosing regimens of azd8848 on biomarkers
5521405|NCT01203124|Effect different doses and dosing frequency of AZD8848 on biomarkers|effect different doses and dosing frequency of azd8848 on biomarkers
5521406|NCT01203098|prevention|prevention
5521407|NCT01203098|venous thromboembolism|venous thromboembolism
5521408|NCT01203098|edoxaban|edoxaban
5521409|NCT01203098|anticoagulants|anticoagulants
5521410|NCT01203072|prevention|prevention
5521411|NCT01203072|venous thromboembolism|venous thromboembolism
5521412|NCT01203072|edoxaban|edoxaban
5521413|NCT01203072|factor Xa|factor xa
5521414|NCT01203046|DURATION OF THERAPY|duration of therapy
5521415|NCT01203046|PENETRATING ABDOMINAL TRAUMA|penetrating abdominal trauma
5521416|NCT01203033|acute myeloid leukemia|acute myeloid leukemia
5521417|NCT01203033|single cell network profiling|single cell network profiling
5521418|NCT01203033|AML|aml
5521419|NCT01203033|SCNP|scnp
5521420|NCT01203020|Hodgkin's|hodgkin's
5521421|NCT01203020|non-Hodgkin's|non-hodgkin's
5521422|NCT01203020|lymphomas|lymphomas
5521423|NCT01203020|allogeneic hematopoietic progenitor cell transplant|allogeneic hematopoietic progenitor cell transplant
5521424|NCT01203020|HPCT|hpct
5521425|NCT01203020|busulfex|busulfex
5521426|NCT01203020|fludarabine|fludarabine
5521427|NCT01203020|reduced-toxicity conditioning|reduced-toxicity conditioning
5521428|NCT01203020|reduced-intensity conditioning|reduced-intensity conditioning
5521429|NCT01202994|Alzheimer's disease|alzheimer's disease
5521430|NCT01202994|Mild cognitive impairment|mild cognitive impairment
5521431|NCT01202994|PET|pet
5521432|NCT01202994|Practice effects|practice effects
5521433|NCT01202981|glistenings|glistenings
5521434|NCT01202981|contrast sensitivity|contrast sensitivity
5521435|NCT01202981|visual quality|visual quality
5521436|NCT01202981|straylight|straylight
5521437|NCT01202981|AcrySof IOL|acrysof iol
5521438|NCT01202968|intubation electric stimulation deglutition disorder|intubation electric stimulation deglutition disorder
5521439|NCT01202955|Smoking, Abstinence|smoking, abstinence
5521440|NCT01202929|High Resolution Manometry|high resolution manometry
5521441|NCT01202929|achalasia|achalasia
5521442|NCT01202929|dysphagia|dysphagia
5521443|NCT01202929|GERD|gerd
5521444|NCT01202929|chest pain|chest pain
5521445|NCT01202929|Post fundoplication|post fundoplication
5798703|NCT00111306|B-cell immunotherapy|b-cell immunotherapy
5521446|NCT01202916|children with congenital heart disease|children with congenital heart disease
5521447|NCT01202903|omalizumab|omalizumab
5521448|NCT01202903|asthma|asthma
5521449|NCT01202903|immunoglobulin E|immunoglobulin e
5521450|NCT01202903|IgE|ige
5521451|NCT01202890|lenalidomide|lenalidomide
5521452|NCT01202890|revlimid|revlimid
5521453|NCT01202890|liposomal doxorubicin|liposomal doxorubicin
5521454|NCT01202890|doxil|doxil
5521455|NCT01202890|bevacizumab|bevacizumab
5521456|NCT01202890|avastin|avastin
5521457|NCT01202890|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5521458|NCT01202890|ovarian cancer|ovarian cancer
5521459|NCT01202877|Myelodysplastic Syndrome|myelodysplastic syndrome
5521460|NCT01202877|MDS|mds
5521461|NCT01202877|Refractory acute leukemias|refractory acute leukemias
5521462|NCT01202877|Relapsed acute leukemia|relapsed acute leukemia
5521463|NCT01202877|Acute myeloid leukemia|acute myeloid leukemia
5521464|NCT01202877|AML|aml
5521465|NCT01202877|5-Azacytidine|5-azacytidine
5521466|NCT01202877|Azacitidine|azacitidine
5521467|NCT01202877|5-aza|5-aza
5521468|NCT01202877|Vidaza|vidaza
5521469|NCT01202877|5-AZC|5-azc
5521470|NCT01202877|AZA-CR|aza-cr
5521471|NCT01202877|Ladakamycin|ladakamycin
5521472|NCT01202877|NSC-102816|nsc-102816
5521473|NCT01202877|PKC412|pkc412
5521474|NCT01202864|Intracerebral Hemorrhage|intracerebral hemorrhage
5521475|NCT01202864|ICH|ich
5521476|NCT01202864|Stroke|stroke
5521477|NCT01202864|Cerebrovascular accident|cerebrovascular accident
5521478|NCT01202851|radiotherapy|radiotherapy
5521479|NCT01202851|radiation therapy|radiation therapy
5521480|NCT01202851|stretching|stretching
5521481|NCT01202851|relaxation|relaxation
5521482|NCT01202851|quality of life|quality of life
5521483|NCT01202851|QOL|qol
5521484|NCT01202851|fatigue|fatigue
5521485|NCT01202851|sleep disturbances|sleep disturbances
5521486|NCT01202851|mental health|mental health
5521487|NCT01202851|cost-effectiveness analysis|cost-effectiveness analysis
5521488|NCT01202851|work productivity|work productivity
5521489|NCT01202851|home productivity|home productivity
5521490|NCT01202851|cortisol rhythmicity|cortisol rhythmicity
5521491|NCT01202838|Cranial bone reconstruction, composite|cranial bone reconstruction, composite
5521492|NCT01202825|HCV genotype 1 infected patients|hcv genotype 1 infected patients
5521493|NCT01202825|TMC647055HPC1001|tmc647055hpc1001
5521494|NCT01202825|TMC647055|tmc647055
5521496|NCT01202825|Hepatitis C|hepatitis c
5521497|NCT01202825|Healthy volunteers|healthy volunteers
5521498|NCT01202825|TMC435|tmc435
5521499|NCT01202812|Sickle Cell Anemia|sickle cell anemia
5521500|NCT01202812|Sickle Cell Disease|sickle cell disease
5521501|NCT01202812|Hemoglobin SS Disease|hemoglobin ss disease
5521502|NCT01202812|Hemoglobin S beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
5521503|NCT01202812|Inflammation|inflammation
5521504|NCT01202812|Quality of Life|quality of life
5521505|NCT01202812|Sickle Thalassemia|sickle thalassemia
5521506|NCT01202812|C-Reative Protein|c-reative protein
5521507|NCT01202812|Hemolytic Anemia|hemolytic anemia
5521508|NCT01202812|Hemostasis|hemostasis
5521509|NCT01202812|Biomarkers|biomarkers
5521520|NCT01202799|Topical NSAID|topical nsaid
5521521|NCT01202799|Diclofenac|diclofenac
5521522|NCT01202786|Cancer of Unknown Primary Site (CUP)|cancer of unknown primary site (cup)
5521523|NCT01202773|Rheumatoid Arthritis|rheumatoid arthritis
5521524|NCT01202760|Rheumatoid Arthritis|rheumatoid arthritis
5521525|NCT01202734|CONCERTA|concerta
5521526|NCT01202734|Methylphenidate HCl|methylphenidate hcl
5521527|NCT01202734|Pharmacokinetic|pharmacokinetic
5521528|NCT01202734|Safety|safety
5521529|NCT01202734|Adult|adult
5521530|NCT01202734|Men|men
5521532|NCT01202721|Congenital|congenital
5521533|NCT01202721|Aortic Valve|aortic valve
5521534|NCT01202721|Bicuspid|bicuspid
5521535|NCT01202721|Aortopathy|aortopathy
5521536|NCT01202721|bicuspid aortic valve aortopathy|bicuspid aortic valve aortopathy
5521537|NCT01202708|chronic renal failure|chronic renal failure
5521538|NCT01202708|hemodiafiltration|hemodiafiltration
5521539|NCT01202682|Healthy subject exercise study|healthy subject exercise study
5521540|NCT01202656|Fertility Agents, Female|fertility agents, female
5521541|NCT01202656|In vitro fertilization|in vitro fertilization
5521542|NCT01202643|Thin Endometrium|thin endometrium
5521543|NCT01202643|Asherman's Syndrome|asherman's syndrome
5521544|NCT01202643|Endometrial Scarring|endometrial scarring
5521545|NCT01202630|Clostridium difficile|clostridium difficile
5521546|NCT01202630|diarrhea|diarrhea
5521547|NCT01202617|Seroquel XR|seroquel xr
5521548|NCT01202617|schizophrenia|schizophrenia
5521549|NCT01202617|relapse prevention|relapse prevention
5521550|NCT01202604|Bipolar disorder I and II|bipolar disorder i and ii
5521551|NCT01202604|mood event|mood event
5521552|NCT01202604|manic or depressive|manic or depressive
5521553|NCT01202604|Greece|greece
5521554|NCT01202591|Breast Cancer|breast cancer
5521555|NCT01202591|ER+|er+
5521556|NCT01202591|FGFR1|fgfr1
5521558|NCT01202591|AZD4547|azd4547
5521559|NCT01202591|Fulvestrant|fulvestrant
5798704|NCT00111293|Attention|attention
5521560|NCT01202565|Post-marketing observational study (PMOS) Protocol|post-marketing observational study (pmos) protocol
5521561|NCT01202565|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5521562|NCT01202565|Treatment of Scalp and Nail Affection|treatment of scalp and nail affection
5521563|NCT01202565|Effectiveness of Adalimumab (HUMIRA®)|effectiveness of adalimumab (humira®)
5521564|NCT01202552|influenza|influenza
5521566|NCT01202552|intradermal injection|intradermal injection
5521567|NCT01202526|Insulin resistance|insulin resistance
5521568|NCT01202526|Gastric bypass|gastric bypass
5521569|NCT01202513|Vitiligo|vitiligo
5521570|NCT01202513|Repigmentation|repigmentation
5521571|NCT01202487|Laceration|laceration
5521572|NCT01202487|Lacerations|lacerations
5521573|NCT01202487|LET|let
5521574|NCT01202487|Lidocaine Epinephrine Tetracaine|lidocaine epinephrine tetracaine
5521575|NCT01202487|LAT|lat
5521576|NCT01202487|Lidocaine Adrenaline Tetracaine|lidocaine adrenaline tetracaine
5521577|NCT01202487|Tissue Adhesive|tissue adhesive
5521578|NCT01202487|Skin Glue|skin glue
5521579|NCT01202487|Pre-Treatment with LET|pre-treatment with let
5521580|NCT01202487|Pre-Treatment with LAT|pre-treatment with lat
5521581|NCT01202487|Pre-Treatment with Lidocaine Epinephrine Tetracaine|pre-treatment with lidocaine epinephrine tetracaine
5521582|NCT01202487|Pre-Treatment with Lidocaine Adrenaline Tetracaine|pre-treatment with lidocaine adrenaline tetracaine
5521583|NCT01202487|Use of LET with Skin Glue|use of let with skin glue
5521584|NCT01202487|Use of LET with Tissue Adhesive|use of let with tissue adhesive
5521585|NCT01202487|Histoacryl|histoacryl
5521586|NCT01202461|Diabetic macular edema|diabetic macular edema
5521587|NCT01202461|Combination therapy for DME|combination therapy for dme
5521588|NCT01202461|DME|dme
5521589|NCT01202448|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5521590|NCT01202448|central nervous system|central nervous system
5521591|NCT01202448|prognosis|prognosis
5521592|NCT01202435|pregabalin|pregabalin
5521593|NCT01202435|pharmacokinetics|pharmacokinetics
5521594|NCT01202435|bioavailability|bioavailability
5521595|NCT01202435|bioequivalence|bioequivalence
5521596|NCT01202422|pregabalin|pregabalin
5521597|NCT01202422|pharmacokinetics|pharmacokinetics
5521598|NCT01202422|bioavailability|bioavailability
5521599|NCT01202422|bioequivalence|bioequivalence
5521614|NCT01202396|ulcerative colitis|ulcerative colitis
5521615|NCT01202396|microbiota|microbiota
5521616|NCT01202396|defensins|defensins
5521617|NCT01202396|epithelial integrity|epithelial integrity
5521618|NCT01202370|Cancer|cancer
5521619|NCT01202370|Tumors|tumors
5521620|NCT01202357|Psychotic Disorders|psychotic disorders
5521621|NCT01202357|Psychosis|psychosis
5521622|NCT01202344|Angioplasty|angioplasty
5521623|NCT01202344|Stenosis|stenosis
5521624|NCT01202344|Restenosis|restenosis
5521625|NCT01202344|Elastic Recoil|elastic recoil
5521626|NCT01202344|cheduled for percutaneous dilation of a peripheral artery|cheduled for percutaneous dilation of a peripheral artery
5521627|NCT01202344|Target lesion in native artery|target lesion in native artery
5521628|NCT01202344|Baseline lumen diameter greater than 4 mm|baseline lumen diameter greater than 4 mm
5521629|NCT01202331|Bacterial Infections|bacterial infections
5521630|NCT01202331|Chlamydia Infections|chlamydia infections
5521631|NCT01202331|Eye Diseases|eye diseases
5521632|NCT01202318|Cerebrovascular Accident|cerebrovascular accident
5521633|NCT01202318|Stroke,Acute|stroke,acute
5521634|NCT01202305|HIV|hiv
5521635|NCT01202305|HIV persistence|hiv persistence
5521636|NCT01202305|Lymph node fibrosis|lymph node fibrosis
5521637|NCT01202292|overweight|overweight
5521638|NCT01202292|obesity|obesity
5521639|NCT01202292|motivational intervention|motivational intervention
5685351|NCT00556478|topical anesthetics|topical anesthetics
5521640|NCT01202279|Acute Upper Respiratory Track Infection Who Seek Treatment|acute upper respiratory track infection who seek treatment
5521641|NCT01202266|Multiple Ascending Dose|multiple ascending dose
5521643|NCT01202266|Safety and Tolerability|safety and tolerability
5521644|NCT01202266|PK|pk
5521645|NCT01202266|Healthy Subjects|healthy subjects
5521646|NCT01202253|Ecalta|ecalta
5521647|NCT01202253|Eraxis|eraxis
5521648|NCT01202253|Candida|candida
5521649|NCT01202253|Candidemia|candidemia
5521650|NCT01202253|Systemic Candidiasis|systemic candidiasis
5521651|NCT01202253|ICU|icu
5521652|NCT01202253|Intensive Care Unit|intensive care unit
5521653|NCT01202253|Critical Care Unit|critical care unit
5521654|NCT01202240|Drug-Drug Interaction|drug-drug interaction
5521655|NCT01202240|Healthy Volunteers|healthy volunteers
5521656|NCT01202240|Tasocitinib (CP-690|tasocitinib (cp-690
5521657|NCT01202240|550)|550)
5521658|NCT01202240|Ketoconazole|ketoconazole
5521659|NCT01202227|Central Nervous System Diseases|central nervous system diseases
5521660|NCT01202227|Therapeutic Uses|therapeutic uses
5521661|NCT01202227|Wounds and Injuries|wounds and injuries
5521662|NCT01202227|Trauma|trauma
5521663|NCT01202227|Nervous System|nervous system
5521664|NCT01202227|pregabalin|pregabalin
5680305|NCT00578292|severe variants of b0/+-thalassemia|severe variants of b0/+-thalassemia
5521665|NCT01202188|QVA149, COPD, combination bronchodilator, indacaterol, glycopyrronium bromide|qva149, copd, combination bronchodilator, indacaterol, glycopyrronium bromide
5521666|NCT01202175|Genetic risk of hypertension|genetic risk of hypertension
5521667|NCT01202162|Induction|induction
5521668|NCT01202162|Coughing|coughing
5521669|NCT01202162|Anesthesia|anesthesia
5521671|NCT01202149|elidel|elidel
5521672|NCT01202149|non-medicated device|non-medicated device
5521673|NCT01202149|hylatopic plus|hylatopic plus
5521674|NCT01202149|pimecrolimus|pimecrolimus
5521675|NCT01202149|bilateral comparison study|bilateral comparison study
5521676|NCT01202149|topical therapy|topical therapy
5521677|NCT01202136|pancreatic cyst|pancreatic cyst
5521678|NCT01202136|IPMN|ipmn
5521679|NCT01202136|PAN INs|pan ins
5521680|NCT01202136|Pancreatic cancer|pancreatic cancer
5521681|NCT01202136|pancreatic neoplasia|pancreatic neoplasia
5521682|NCT01202071|Rabeprazole|rabeprazole
5521683|NCT01202071|proton pump inhibitor|proton pump inhibitor
5521684|NCT01202071|pharmacokinetics|pharmacokinetics
5521685|NCT01202071|pharmacodynamics|pharmacodynamics
5521686|NCT01202071|healthy adult male Japanese subjects|healthy adult male japanese subjects
5521687|NCT01202058|Coronary artery disease|coronary artery disease
5521688|NCT01202058|Drug-eluting stents|drug-eluting stents
5521689|NCT01202058|Reservoir technology|reservoir technology
5521690|NCT01202045|Echocardiography, Stress|echocardiography, stress
5521691|NCT01202045|right heart catheterization|right heart catheterization
5521692|NCT01202032|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5521693|NCT01202032|Advanced solid tumors|advanced solid tumors
5521694|NCT01202032|Dose escalation|dose escalation
5521695|NCT01202032|Association Pazopanib-Bevacizumab|association pazopanib-bevacizumab
5521696|NCT01202019|cardiovascular risk|cardiovascular risk
5521697|NCT01202019|exercise|exercise
5521698|NCT01202019|post-exercise diet supplementation|post-exercise diet supplementation
5521699|NCT01202006|Heart failure|heart failure
5521700|NCT01202006|Diagnosis|diagnosis
5521701|NCT01202006|Treatment|treatment
5521702|NCT01202006|Primary care|primary care
5521703|NCT01201993|syncope|syncope
5521704|NCT01201993|evaluation|evaluation
5521705|NCT01201993|recurrence|recurrence
5521706|NCT01201993|morbidity|morbidity
5521707|NCT01201980|essential arterial hypertension|essential arterial hypertension
5521708|NCT01201980|calcium antagonist|calcium antagonist
5521709|NCT01201967|Collaborative care|collaborative care
5521710|NCT01201967|Cardiovascular disease|cardiovascular disease
5521711|NCT01201967|Depression|depression
5521712|NCT01201967|Anxiety|anxiety
5521714|NCT01201954|sucrose|sucrose
5521715|NCT01201954|newborn|newborn
5521716|NCT01201954|mechanical ventilation|mechanical ventilation
5521717|NCT01201876|Dental Caries|dental caries
5521718|NCT01201876|Assessments|assessments
5521719|NCT01201876|dental materials|dental materials
5521720|NCT01201863|Testosterone|testosterone
5521721|NCT01201863|Traumatic Brain Injury|traumatic brain injury
5521722|NCT01201863|Hypogonadism|hypogonadism
5521723|NCT01201863|Endocrine Dysfunction|endocrine dysfunction
5521724|NCT01201863|Low Testosterone in men with new Traumatic Brain Injury|low testosterone in men with new traumatic brain injury
5521725|NCT01201850|radiation necrosis|radiation necrosis
5521726|NCT01201850|Bevacizumab (Avastin®)|bevacizumab (avastin®)
5521727|NCT01201850|Central Nervous System Tumors|central nervous system tumors
5521728|NCT01201837|Acute coronary syndrome|acute coronary syndrome
5521729|NCT01201837|HDL mimetic|hdl mimetic
5521730|NCT01201837|ApoA-I|apoa-i
5521731|NCT01201824|lung cancer|lung cancer
5521732|NCT01201824|intracavitary ultrasound|intracavitary ultrasound
5521733|NCT01201824|pulmonary nodules|pulmonary nodules
5521734|NCT01201824|VATS procedures|vats procedures
5521735|NCT01201811|Myelodysplastic Syndromes|myelodysplastic syndromes
5521736|NCT01201811|Taiwan|taiwan
5521737|NCT01201811|Azacitidine|azacitidine
5521738|NCT01201811|Vidaza|vidaza
5521739|NCT01201811|Celgene|celgene
5521740|NCT01201811|Pathologic Processes|pathologic processes
5521742|NCT01201811|Bone Marrow Diseases|bone marrow diseases
5521743|NCT01201811|Hematologic Diseases|hematologic diseases
5521744|NCT01201811|Antineoplastic Agents|antineoplastic agents
5521745|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5521746|NCT01201811|Antimetabolites|antimetabolites
5521747|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5521748|NCT01201811|Pharmacologic Actions|pharmacologic actions
5521749|NCT01201811|Therapeutic Uses|therapeutic uses
5521750|NCT01201811|Enzyme inhibitors|enzyme inhibitors
5521751|NCT01201785|diabetes mellitus, coronary artery disease, aspirin therapy|diabetes mellitus, coronary artery disease, aspirin therapy
5521752|NCT01201772|coronary artery disease|coronary artery disease
5521753|NCT01201772|percutaneous coronary revascularization|percutaneous coronary revascularization
5521754|NCT01201772|prasugrel therapy|prasugrel therapy
5521755|NCT01201759|cardiovascular risk|cardiovascular risk
5521756|NCT01201746|Non-surgical periodontal therapy|non-surgical periodontal therapy
5521757|NCT01201746|Coronary heart disease (CHD)|coronary heart disease (chd)
5521758|NCT01201746|periodontal Disease|periodontal disease
5521759|NCT01201746|hsCRP|hscrp
5521760|NCT01201746|Fibrinogen|fibrinogen
5521761|NCT01201746|WBCs|wbcs
5521762|NCT01201720|cirrhosis|cirrhosis
5521763|NCT01201720|cirrhotic patients with acute on chronic liver failure|cirrhotic patients with acute on chronic liver failure
5521764|NCT01201707|Multiple Sclerosis|multiple sclerosis
5521765|NCT01201707|Angioplasty|angioplasty
5503671|NCT01280084|labour analgesia|labour analgesia
5521768|NCT01201694|Surface-controlled water soluble curcumin|surface-controlled water soluble curcumin
5521770|NCT01201694|Dietary supplements|dietary supplements
5521771|NCT01201681|Post-operative pain|post-operative pain
5521772|NCT01201681|intra-operative pain|intra-operative pain
5521773|NCT01201681|root canal therapy|root canal therapy
5521774|NCT01201681|feasibility|feasibility
5521775|NCT01201681|post-surgical persistent pain|post-surgical persistent pain
5521776|NCT01201668|post-operative pain|post-operative pain
5521777|NCT01201668|root canal therapy|root canal therapy
5521778|NCT01201668|feasibility|feasibility
5521779|NCT01201668|post-surgical persistent pain|post-surgical persistent pain
5521780|NCT01201655|Posthepatitic cirrhosis;|posthepatitic cirrhosis;
5521781|NCT01201655|Hepatocarcinogenesis;|hepatocarcinogenesis;
5521782|NCT01201655|Splenectomy;|splenectomy;
5521783|NCT01201642|Bell's palsy|bell's palsy
5521784|NCT01201642|Prednisolone|prednisolone
5521785|NCT01201642|acupuncture|acupuncture
5521786|NCT01201629|Ischemic Strokes|ischemic strokes
5521787|NCT01201629|t DC stimulation|t dc stimulation
5521788|NCT01201629|Functional recovery|functional recovery
5521789|NCT01201616|Cognitive function|cognitive function
5521790|NCT01201616|mood|mood
5521791|NCT01201616|women|women
5521792|NCT01201616|high fat diet|high fat diet
5521793|NCT01201616|high carbohydrate diet|high carbohydrate diet
5521794|NCT01201603|Women|women
5521795|NCT01201603|Orange Juice|orange juice
5521796|NCT01201603|Insulin Resistance|insulin resistance
5521797|NCT01201603|Obesity|obesity
5521798|NCT01201590|Insulin resistance|insulin resistance
5521799|NCT01201590|obesity|obesity
5521800|NCT01201590|cocoa|cocoa
5521801|NCT01201590|women|women
5521802|NCT01201577|Quorum sensing|quorum sensing
5521803|NCT01201577|Prebiotics|prebiotics
5521804|NCT01201577|Probiotics|probiotics
5521805|NCT01201577|Sepsis|sepsis
5521806|NCT01201564|umbilical hernia,|umbilical hernia,
5521807|NCT01201564|wound complications,|wound complications,
5521808|NCT01201564|mesh repair, IPOM,|mesh repair, ipom,
5521809|NCT01201564|quality of life,|quality of life,
5521810|NCT01201564|sublay mesh repair,|sublay mesh repair,
5521811|NCT01201564|recurrence rate|recurrence rate
5521812|NCT01201551|Alphagan|alphagan
5521813|NCT01201551|Xalatan|xalatan
5521814|NCT01201551|corneal temperature|corneal temperature
5521815|NCT01201551|primary vascular dysregulation|primary vascular dysregulation
5521816|NCT01201512|TMJD pain|tmjd pain
5521817|NCT01201512|feasibility|feasibility
5521818|NCT01201486|Ultrasound|ultrasound
5521819|NCT01201486|Pregnancy|pregnancy
5521820|NCT01201486|Fetal heart defects|fetal heart defects
5521821|NCT01201486|Color doppler|color doppler
5521822|NCT01201473|effect of participation|effect of participation
5521823|NCT01201473|effect of association|effect of association
5521824|NCT01201460|glucose testing|glucose testing
5521825|NCT01201447|Assessment|assessment
5521826|NCT01201447|Questionable Caries|questionable caries
5521827|NCT01201434|cystic fibrosis|cystic fibrosis
5521828|NCT01201434|probiotics|probiotics
5521829|NCT01201434|pulmonary|pulmonary
5521830|NCT01201434|infections|infections
5521831|NCT01201421|patient satisfaction|patient satisfaction
5521832|NCT01201421|assessments|assessments
5521833|NCT01201421|dental caries|dental caries
5521834|NCT01201421|dental materials|dental materials
5521835|NCT01201408|Dental Caries|dental caries
5521836|NCT01201408|Assessments|assessments
5521837|NCT01201408|dental materials|dental materials
5521838|NCT01201395|Dental Caries|dental caries
5521839|NCT01201395|Assessment|assessment
5521840|NCT01201395|dental materials|dental materials
5521841|NCT01201382|Depression|depression
5521842|NCT01201382|Prevention|prevention
5521843|NCT01201382|Adolescents|adolescents
5521844|NCT01201369|Percutaneous Coronary Intervention|percutaneous coronary intervention
5521845|NCT01201369|Coronary Artery Stenosis|coronary artery stenosis
5521846|NCT01201369|Acute Myocardial Infarction|acute myocardial infarction
5521847|NCT01201369|Coronary Artery Stent|coronary artery stent
5521848|NCT01201369|Optical Coherence Tomography|optical coherence tomography
5521849|NCT01201356|Fingolimod|fingolimod
5521851|NCT01201356|Relapsing forms of MS|relapsing forms of ms
5521852|NCT01201356|Multiple Sclerosis|multiple sclerosis
5521853|NCT01201356|Efficacy|efficacy
5521854|NCT01201343|Multiple sclerosis, relapsing, remitting|multiple sclerosis, relapsing, remitting
5521855|NCT01201343|Interferon-beta|interferon-beta
5521857|NCT01201317|Analgesic effect|analgesic effect
5521858|NCT01201304|Anxiety sensitivity|anxiety sensitivity
5521859|NCT01201304|Panic|panic
5521860|NCT01201291|TBI|tbi
5521861|NCT01201291|Normobaric hyperoxia|normobaric hyperoxia
5521862|NCT01201291|Outcome|outcome
5521863|NCT01201291|GOS|gos
5521864|NCT01201291|GOSE|gose
5521865|NCT01201278|intranasal insulin|intranasal insulin
5524568|NCT01190176|HPV|hpv
5521869|NCT01201239|raltegravir|raltegravir
5521870|NCT01201239|HIV-1|hiv-1
5521871|NCT01201239|drug resistance|drug resistance
5521872|NCT01201226|Primordial ovarian follicles|primordial ovarian follicles
5521873|NCT01201226|PTEN|pten
5521874|NCT01201226|PI3K activating peptide|pi3k activating peptide
5521875|NCT01201226|Low ovarian reserve|low ovarian reserve
5521876|NCT01201226|Gonadotrophins|gonadotrophins
5521877|NCT01201213|Bupivacaine|bupivacaine
5521878|NCT01201213|levobupivacaine|levobupivacaine
5521879|NCT01201213|ropivacaine|ropivacaine
5521880|NCT01201200|Obstructive Sleep Apnea|obstructive sleep apnea
5521881|NCT01201200|Right Ventricular Function|right ventricular function
5521882|NCT01201200|Pulmonary Hypertension|pulmonary hypertension
5521883|NCT01201187|ADHD(Attention Deficit Hyperactivity Disorder)|adhd(attention deficit hyperactivity disorder)
5521884|NCT01201174|Hemolysis in Patients with Hereditary Spherocytosis|hemolysis in patients with hereditary spherocytosis
5521885|NCT01201174|with documented family history of HS.|with documented family history of hs.
5521886|NCT01201174|spherocyte morphology,|spherocyte morphology,
5521887|NCT01201174|splenomegaly and non-immune mediated hemolysis.|splenomegaly and non-immune mediated hemolysis.
5521888|NCT01201161|Diabetic Retinopathy|diabetic retinopathy
5521889|NCT01201161|Retinal detachment|retinal detachment
5521890|NCT01201161|Vitreous Hemorrhage|vitreous hemorrhage
5521891|NCT01201161|Preoperative Ranibizumab|preoperative ranibizumab
5521892|NCT01201161|pars plana vitrectomy|pars plana vitrectomy
5521893|NCT01201148|depression|depression
5521894|NCT01201148|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5521895|NCT01201148|random noise stimulation|random noise stimulation
5521896|NCT01201148|oscillatory tDCS|oscillatory tdcs
5521897|NCT01201148|intermittent tDCS|intermittent tdcs
5521898|NCT01201122|Pediatric|pediatric
5521899|NCT01201122|Ulcerative colitis|ulcerative colitis
5521901|NCT01201122|Mesalamine|mesalamine
5521902|NCT01201122|Dosing|dosing
5521903|NCT01201109|Carpal tunnel syndrome|carpal tunnel syndrome
5521904|NCT01201109|Entrapment neuropathies|entrapment neuropathies
5521905|NCT01201109|Diabetes|diabetes
5521906|NCT01201096|neuroendocrine tumor|neuroendocrine tumor
5521907|NCT01201096|liver metastasis|liver metastasis
5521908|NCT01201096|peptide receptor therapy|peptide receptor therapy
5521909|NCT01201096|gastro-entero-pancreatic system|gastro-entero-pancreatic system
5521910|NCT01201057|SPL7013|spl7013
5521911|NCT01201057|VivaGel|vivagel
5521912|NCT01201057|bacterial vaginosis|bacterial vaginosis
5521913|NCT01201057|BV|bv
5521914|NCT01201044|BAI|bai
5521915|NCT01201044|3DCRT|3dcrt
5521916|NCT01201031|for the active surveillance of VRE colinization and infection|for the active surveillance of vre colinization and infection
5521917|NCT01201018|Tumor|tumor
5521918|NCT01201018|cancer|cancer
5521919|NCT01201018|metastasis|metastasis
5521920|NCT01200992|Urinary Bladder Neoplasms|urinary bladder neoplasms
5521921|NCT01200992|Neoplasms|neoplasms
5521922|NCT01200992|Urologic Neoplasms|urologic neoplasms
5521923|NCT01200992|Urogenital Neoplasms|urogenital neoplasms
5521924|NCT01200992|Neoplasms by Site|neoplasms by site
5521925|NCT01200992|Urinary Bladder Diseases|urinary bladder diseases
5521926|NCT01200992|Urologic Diseases|urologic diseases
5521927|NCT01200992|Mycobacterial cell wall DNA complex|mycobacterial cell wall dna complex
5521928|NCT01200992|Intravesical drug administration|intravesical drug administration
5521929|NCT01200979|Gene Expression|gene expression
5521930|NCT01200979|IN VITRO|in vitro
5521931|NCT01200979|Immunosuppression|immunosuppression
5521933|NCT01200979|Neutrophils|neutrophils
5521934|NCT01200979|Pregnancy|pregnancy
5521935|NCT01200979|Immune Function|immune function
5521936|NCT01200966|Essential Tremor|essential tremor
5521937|NCT01200966|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5521938|NCT01200966|Ethanol|ethanol
5521939|NCT01200966|Alcohol|alcohol
5521940|NCT01200966|Alcohol Clamp|alcohol clamp
5521942|NCT01200953|Select Agents|select agents
5521943|NCT01200953|Biosafety|biosafety
5521944|NCT01200953|Bioterrorism|bioterrorism
5521945|NCT01200953|SCSU (Special Clinical Studies Unit)|scsu (special clinical studies unit)
5521946|NCT01200953|Infectious Disease|infectious disease
5521947|NCT01200953|Bioterrorism-Related Illness|bioterrorism-related illness
5521951|NCT01200927|infant|infant
5521952|NCT01200927|sitting|sitting
5521953|NCT01200927|postural control|postural control
5521954|NCT01200914|Hemodialysis|hemodialysis
5521955|NCT01200914|Fistula|fistula
5521956|NCT01200914|Angiograph|angiograph
5521957|NCT01200914|Angiogram|angiogram
5521958|NCT01200901|depression|depression
5521959|NCT01200901|healthy|healthy
5521960|NCT01200875|PRP|prp
5521961|NCT01200875|platelet rich plasma|platelet rich plasma
5521962|NCT01200875|platelet|platelet
5521963|NCT01200875|growth hormone|growth hormone
5521964|NCT01200875|tendonitis|tendonitis
5521965|NCT01200875|tendinosis|tendinosis
5521966|NCT01200875|tendinopathy|tendinopathy
5521967|NCT01200875|enthesopathy|enthesopathy
5521968|NCT01200875|muscle|muscle
5521969|NCT01200875|sport|sport
5521970|NCT01200875|tendon|tendon
5521971|NCT01200862|Obese|obese
5521972|NCT01200862|obesity|obesity
5521973|NCT01200862|hypogonadism|hypogonadism
5521974|NCT01200862|hypogonadotropic|hypogonadotropic
5521975|NCT01200862|hyperestrogenemic|hyperestrogenemic
5521976|NCT01200862|testosterone|testosterone
5521977|NCT01200862|hypogonadal|hypogonadal
5521978|NCT01200836|Statins|statins
5521979|NCT01200836|Immune Modulation|immune modulation
5521980|NCT01200836|Healthy Volunteer|healthy volunteer
5521981|NCT01200823|Laboratory Research|laboratory research
5521982|NCT01200823|Biologic Samples|biologic samples
5521983|NCT01200823|Tissue Collection|tissue collection
5521984|NCT01200823|Tissue Procurement|tissue procurement
5521985|NCT01200771|FDG-PET/CT|fdg-pet/ct
5521987|NCT01200771|Chronic Inflammatory syndrome|chronic inflammatory syndrome
5521988|NCT01200771|Fever of unknown origin|fever of unknown origin
5521989|NCT01200745|neck pain|neck pain
5521990|NCT01200745|capsaicin|capsaicin
5521991|NCT01200745|dermal patch|dermal patch
5521992|NCT01200732|Tadalafil|tadalafil
5521993|NCT01200732|phosphodiesterase-5 inhibitor|phosphodiesterase-5 inhibitor
5521994|NCT01200732|Eisenmenger syndrome|eisenmenger syndrome
5521995|NCT01200719|brain electrical stimulation|brain electrical stimulation
5521996|NCT01200719|sub-acute post-stroke|sub-acute post-stroke
5521997|NCT01200719|rehabilitation|rehabilitation
5521998|NCT01200706|children aged under 5 years|children aged under 5 years
5521999|NCT01200706|Non-severe|non-severe
5522000|NCT01200693|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5522001|NCT01200693|Drug-Eluting Stents|drug-eluting stents
5522002|NCT01200680|Pediatric and Adult|pediatric and adult
5522003|NCT01200680|Gene Identification|gene identification
5522004|NCT01200680|Rare Bone Cancer|rare bone cancer
5522005|NCT01200680|All Chordoma Sites|all chordoma sites
5522006|NCT01200680|Sporadic Chordoma|sporadic chordoma
5522007|NCT01200680|Bone Cancer|bone cancer
5522008|NCT01200654|Population pharmacokinetics|population pharmacokinetics
5522009|NCT01200654|Linezolid|linezolid
5522010|NCT01200654|Monolix|monolix
5522011|NCT01200654|nonlinear mixed effects models|nonlinear mixed effects models
5522012|NCT01200641|melatonin|melatonin
5522013|NCT01200641|gabapentin|gabapentin
5522014|NCT01200641|anxiety|anxiety
5522015|NCT01200641|pain|pain
5522016|NCT01200641|retrobulbar block|retrobulbar block
5522017|NCT01200628|posttraumatic stress disorder|posttraumatic stress disorder
5522018|NCT01200628|acute PTSD|acute ptsd
5522019|NCT01200628|PTSD|ptsd
5522020|NCT01200628|motor vehicle accident|motor vehicle accident
5516166|NCT01225380|HCV|hcv
5522029|NCT01200576|IRB: Institutional Review Board|irb: institutional review board
5522030|NCT01200576|IUD: Intra-uterine Device|iud: intra-uterine device
5522031|NCT01200576|LTPM: Long-term and Permanent Contraceptive Methods|ltpm: long-term and permanent contraceptive methods
5522032|NCT01200576|MSI: Marie Stopes International|msi: marie stopes international
5522033|NCT01200576|MSM: Marie Stopes Madagascar|msm: marie stopes madagascar
5522034|NCT01200576|PHSC: Protection of Human Subjects Committee|phsc: protection of human subjects committee
5522035|NCT01200576|PI: Principal Investigator|pi: principal investigator
5522036|NCT01200576|SAE: Serious Adverse Event|sae: serious adverse event
5522037|NCT01200576|Sino-Implant (II)|sino-implant (ii)
5522038|NCT01200576|SOP: Standard Operating Procedure|sop: standard operating procedure
5522039|NCT01200576|Zarin|zarin
5522040|NCT01200563|MIST Therapy|mist therapy
5522041|NCT01200563|Negative Pressure Wound Therapy|negative pressure wound therapy
5522042|NCT01200563|Wound care in long-term acute care hospital|wound care in long-term acute care hospital
5522043|NCT01200563|Wound care in skilled nursing facility setting|wound care in skilled nursing facility setting
5522044|NCT01200550|Gastroesophageal reflux disease|gastroesophageal reflux disease
5522045|NCT01200550|GERD Impact Scale|gerd impact scale
5522046|NCT01200537|IVF|ivf
5522047|NCT01200537|poor responders|poor responders
5522048|NCT01200537|follicle synchrony|follicle synchrony
5522049|NCT01200537|IVF response|ivf response
5522050|NCT01200537|estrogen|estrogen
5522051|NCT01200537|estradiol (E2)|estradiol (e2)
5522052|NCT01200537|oral contraceptive pill (OCP)|oral contraceptive pill (ocp)
5522053|NCT01200537|birth control pill (BCP)|birth control pill (bcp)
5522054|NCT01200524|Analgesic effect|analgesic effect
5522055|NCT01200511|intraocular lens|intraocular lens
5522056|NCT01200511|multifocal|multifocal
5522058|NCT01200498|Primary Polycythemia Vera|primary polycythemia vera
5522059|NCT01200498|Post Polycythemia Vera|post polycythemia vera
5522060|NCT01200498|Post Essential Thrombocythemia Myelofibrosis|post essential thrombocythemia myelofibrosis
5522061|NCT01200498|SB939|sb939
5522062|NCT01200498|PMF|pmf
5522063|NCT01200498|post-PV MF|post-pv mf
5522064|NCT01200498|post-ET MF|post-et mf
5522065|NCT01200485|Supportive Care|supportive care
5522066|NCT01200485|Recombinant urate oxidase|recombinant urate oxidase
5522067|NCT01200485|Chemotherapy|chemotherapy
5522068|NCT01200485|Tumor Lysis Syndrome (TLS)|tumor lysis syndrome (tls)
5522069|NCT01200485|Hematologic malignancies|hematologic malignancies
5522070|NCT01200485|Acute myeloid leukemia|acute myeloid leukemia
5522071|NCT01200472|EHOA|ehoa
5522072|NCT01200459|Obesity|obesity
5522073|NCT01200459|Weight Loss|weight loss
5522074|NCT01200459|Healthy Lifestyle|healthy lifestyle
5522075|NCT01200459|Social|social
5522076|NCT01200459|Mobile|mobile
5522077|NCT01200459|Facebook|facebook
5522078|NCT01200459|Text Messages|text messages
5522079|NCT01200446|Asthma|asthma
5503948|NCT01278862|clinical|clinical
5522080|NCT01200446|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5522081|NCT01200446|Inflammation|inflammation
5522082|NCT01200446|Airway|airway
5522083|NCT01200446|Fish Oil|fish oil
5522084|NCT01200446|Docosahexaenoic Acid|docosahexaenoic acid
5522085|NCT01200446|DHA|dha
5522086|NCT01200433|dexmedetomidine|dexmedetomidine
5522087|NCT01200433|propofol|propofol
5522088|NCT01200433|cerebral blood flow|cerebral blood flow
5522089|NCT01200433|brain oxygenation|brain oxygenation
5522090|NCT01200420|Antisense|antisense
5522091|NCT01200420|miR-122 antagonist|mir-122 antagonist
5522092|NCT01200420|host factor|host factor
5522093|NCT01200420|CHC|chc
5522094|NCT01200407|Hypertension|hypertension
5522095|NCT01200407|fixed drug combination|fixed drug combination
5522096|NCT01200407|Filipinos|filipinos
5522097|NCT01200407|Amlodipine|amlodipine
5522098|NCT01200407|Olmesartan medoxomil|olmesartan medoxomil
5522099|NCT01200407|uncontrolled hypertension|uncontrolled hypertension
5522100|NCT01200407|difficult to treat hypertension|difficult to treat hypertension
5522101|NCT01200394|Diabetic nephropathy|diabetic nephropathy
5522102|NCT01200394|chronic kidney disease|chronic kidney disease
5522103|NCT01200394|PF-00489791|pf-00489791
5522104|NCT01200394|phosphodiesterase|phosphodiesterase
5522105|NCT01200394|PDE5|pde5
5522106|NCT01200381|ICD|icd
5522107|NCT01200381|CRTD|crtd
5522108|NCT01200381|Remote care|remote care
5522109|NCT01200381|Remote monitoring|remote monitoring
5522110|NCT01200381|Heart failure|heart failure
5522111|NCT01200368|vaccine|vaccine
5522112|NCT01200368|pneumococcal conjugate|pneumococcal conjugate
5522113|NCT01200355|MICAFUNGIN|micafungin
5522114|NCT01200355|POSACONAZOLE|posaconazole
5522115|NCT01200355|antifungal|antifungal
5522116|NCT01200355|prolonged neutropenia|prolonged neutropenia
5522117|NCT01200355|10-038|10-038
5522118|NCT01200342|Uveal melanoma|uveal melanoma
5522119|NCT01200342|Carboplatin|carboplatin
5522120|NCT01200342|Genasense|genasense
5522121|NCT01200342|Paclitaxel|paclitaxel
5522122|NCT01200342|oblimersen|oblimersen
5522123|NCT01200342|GCP|gcp
5522124|NCT01200329|Hodgkin's disease|hodgkin's disease
5522125|NCT01200329|Relapsed|relapsed
5522126|NCT01200329|Refractory|refractory
5522127|NCT01200329|High-dose chemotherapy|high-dose chemotherapy
5522128|NCT01200329|Busulfan|busulfan
5522129|NCT01200329|Gemcitabine|gemcitabine
5522130|NCT01200329|Melphalan|melphalan
5522131|NCT01200316|Colon Cancer|colon cancer
5522132|NCT01200316|Abdominal Surgery|abdominal surgery
5522133|NCT01200316|Stress|stress
5522134|NCT01200316|Rocking Motion|rocking motion
5522135|NCT01200316|Salivary Cortisol|salivary cortisol
5522136|NCT01200316|Postoperative Ileus|postoperative ileus
5522137|NCT01200303|colon cancer|colon cancer
5522138|NCT01200303|adenomatous colonic polyps|adenomatous colonic polyps
5522139|NCT01200303|colon screening|colon screening
5522140|NCT01200303|CT Colonography (Virtual Colonoscopy)|ct colonography (virtual colonoscopy)
5522141|NCT01200303|Computer Aided Detection|computer aided detection
5522142|NCT01200303|Electronic Cleansing|electronic cleansing
5522143|NCT01200290|end stage renal disease|end stage renal disease
5522144|NCT01200290|end stage kidney disease|end stage kidney disease
5522145|NCT01200290|ESRD|esrd
5522146|NCT01200290|Uremia|uremia
5522147|NCT01200290|Renal Dialysis|renal dialysis
5522148|NCT01200277|osteoporosis|osteoporosis
5522149|NCT01200277|vertebral fracture|vertebral fracture
5522150|NCT01200277|vertebroplasty|vertebroplasty
5522151|NCT01200277|percutaneous|percutaneous
5522152|NCT01200238|STA9090|sta9090
5522153|NCT01200238|STA-9090|sta-9090
5522154|NCT01200238|HSP90|hsp90
5522155|NCT01200212|Palliative Therapy|palliative therapy
5522156|NCT01200212|bevacizimab|bevacizimab
5522157|NCT01200212|Avastin|avastin
5522158|NCT01200212|Xeloda|xeloda
5522159|NCT01200212|metastatic breast cancer|metastatic breast cancer
5522160|NCT01200212|Progression Free Survival|progression free survival
5522161|NCT01200212|Time to Progression|time to progression
5522162|NCT01200212|Overall survival|overall survival
5522163|NCT01200173|Probiotic - Lactobacillus casei DN-114 001 - dairy|probiotic - lactobacillus casei dn-114 001 - dairy
5522164|NCT01200173|product - infections - children|product - infections - children
5522165|NCT01200160|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5522166|NCT01200160|Hypertriglyceridemia|hypertriglyceridemia
5522167|NCT01200160|Latin America|latin america
5522168|NCT01200160|Cardiovascular Diseases|cardiovascular diseases
5522169|NCT01200160|Cholesterol|cholesterol
5522170|NCT01200160|Sedentary Lifestyle|sedentary lifestyle
5522171|NCT01200160|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5522172|NCT01200134|glioma patients : anaplasic glioma (grade III) and GBM (grade IV)|glioma patients : anaplasic glioma (grade iii) and gbm (grade iv)
5522173|NCT01200121|Symptomatic malignant ascites due to advanced-stage gastrointestinal cancers|symptomatic malignant ascites due to advanced-stage gastrointestinal cancers
5522174|NCT01200108|Severe Asthma, requiring chronic oral steroid use|severe asthma, requiring chronic oral steroid use
5522175|NCT01200082|chronic hepatitis C/B|chronic hepatitis c/b
5522176|NCT01200082|alcoholic liver disease|alcoholic liver disease
5522177|NCT01200082|primary biliary cirrhosis|primary biliary cirrhosis
5522178|NCT01200082|primary sclerosing cholangitis|primary sclerosing cholangitis
5522179|NCT01200082|progressive familial intrahepatic cholestasis|progressive familial intrahepatic cholestasis
5522180|NCT01200069|depression,myalgia|depression,myalgia
5522181|NCT01200056|Volumetric virtual histology intravascular ultrasound.|volumetric virtual histology intravascular ultrasound.
5522182|NCT01200056|Statin-naive patient.|statin-naive patient.
5522183|NCT01200056|Varying doses atorvastatin.|varying doses atorvastatin.
5522184|NCT01200056|Clinical outcomes.|clinical outcomes.
5522185|NCT01200043|Childhood obesity|childhood obesity
5522186|NCT01200043|metabolic syndrome|metabolic syndrome
5522187|NCT01200043|insulin resistance|insulin resistance
5522188|NCT01200043|intrahepatic fat|intrahepatic fat
5522189|NCT01200043|hypertension|hypertension
5522190|NCT01200030|Sitting balance|sitting balance
5522191|NCT01200030|Stroke|stroke
5522192|NCT01200017|T cell depleted|t cell depleted
5522193|NCT01200017|Matched unrelated donors|matched unrelated donors
5522194|NCT01200017|Haplocompatible donors|haplocompatible donors
5522195|NCT01200017|Graft vs Host Disease|graft vs host disease
5522196|NCT01200017|Hemoglobinopathies|hemoglobinopathies
5522197|NCT01200017|Leukemia|leukemia
5522198|NCT01200017|Leukemia, Lymphoid|leukemia, lymphoid
5522204|NCT01200017|Myelodysplastic Syndromes|myelodysplastic syndromes
5522206|NCT01200017|Osteopetrosis|osteopetrosis
5522207|NCT01200017|Pancytopenia|pancytopenia
5522208|NCT01200017|Immune System Diseases|immune system diseases
5522209|NCT01200017|Hematologic Diseases|hematologic diseases
5522210|NCT01200017|Genetic Diseases, Inborn|genetic diseases, inborn
5522211|NCT01200017|Neoplasms by Histologic Type|neoplasms by histologic type
5522212|NCT01200017|Neoplasms|neoplasms
5522213|NCT01200017|Lymphoproliferative Disorders|lymphoproliferative disorders
5522214|NCT01200017|Lymphatic Diseases|lymphatic diseases
5522215|NCT01200017|Immunoproliferative Disorders|immunoproliferative disorders
5522216|NCT01200017|Myeloproliferative Disorders|myeloproliferative disorders
5522217|NCT01200017|Bone Marrow Diseases|bone marrow diseases
5522218|NCT01200017|Precancerous Conditions|precancerous conditions
5522219|NCT01200017|Osteosclerosis|osteosclerosis
5522220|NCT01200017|Osteochondrodysplasias|osteochondrodysplasias
5522221|NCT01200017|Bone Diseases, Developmental|bone diseases, developmental
5522222|NCT01200017|Bone Diseases|bone diseases
5522223|NCT01200017|Musculoskeletal Diseases|musculoskeletal diseases
5522224|NCT01200017|Severe acquired and congenital cytopenias|severe acquired and congenital cytopenias
5522225|NCT01200017|White and red blood cell abnormalities|white and red blood cell abnormalities
5522226|NCT01200004|Advanced solid tumor|advanced solid tumor
5522228|NCT01200004|Grifola frondosa|grifola frondosa
5522229|NCT01200004|Basidiomycete fungus|basidiomycete fungus
5522230|NCT01200004|Lenalidomide|lenalidomide
5522231|NCT01199978|radiation|radiation
5522232|NCT01199978|fractionated proton radiation|fractionated proton radiation
5522233|NCT01199952|contraception|contraception
5522234|NCT01199939|Human Immunodeficiency Virus|human immunodeficiency virus
5522236|NCT01199939|Etravirine|etravirine
5522237|NCT01199939|Darunavir|darunavir
5522238|NCT01199939|Prezista|prezista
5522239|NCT01199939|Intelence|intelence
5522240|NCT01199939|Ritonavir|ritonavir
5522241|NCT01199939|INROADS|inroads
5522242|NCT01199926|25-hydroxyvitamin D|25-hydroxyvitamin d
5522243|NCT01199926|Parathyroid hormone|parathyroid hormone
5522244|NCT01199926|Lean mass|lean mass
5522245|NCT01199926|Muscular strength|muscular strength
5522246|NCT01199926|Glucose tolerance|glucose tolerance
5522247|NCT01199913|problems with thinking after surgery;|problems with thinking after surgery;
5522248|NCT01199900|Healthy People|healthy people
5522249|NCT01199900|Glucocorticoids|glucocorticoids
5522250|NCT01199900|Prednisone|prednisone
5798705|NCT00111293|Executive Function|executive function
5522251|NCT01199887|safety, biologic effects, IPF, autoimmune|safety, biologic effects, ipf, autoimmune
5522252|NCT01199874|Rotavirus|rotavirus
5522253|NCT01199874|Rotavirus vaccine|rotavirus vaccine
5522254|NCT01199874|Dosing schedule|dosing schedule
5522255|NCT01199874|Immunogenicity|immunogenicity
5522256|NCT01199874|Breast feeding|breast feeding
5522257|NCT01199874|Pakistan|pakistan
5522258|NCT01199861|Relapsing multiple sclerosis|relapsing multiple sclerosis
5522260|NCT01199861|Immune response|immune response
5522261|NCT01199848|nutrition|nutrition
5522262|NCT01199848|polyphenolic|polyphenolic
5522263|NCT01199848|strawberry|strawberry
5522264|NCT01199848|insulin resistance|insulin resistance
5522265|NCT01199848|metabolic syndrome|metabolic syndrome
5522266|NCT01199835|obesity|obesity
5522267|NCT01199835|metabolic syndrome|metabolic syndrome
5522268|NCT01199835|fecal fat excretion|fecal fat excretion
5522269|NCT01199835|fecal calcium|fecal calcium
5522270|NCT01199835|weight loss|weight loss
5522271|NCT01199835|appetite regulation|appetite regulation
5522272|NCT01199835|intestinal micro flora|intestinal micro flora
5522273|NCT01199835|lipid profile|lipid profile
5522274|NCT01199835|energy balance|energy balance
5522275|NCT01199783|Diabetic Foot,MRSA,|diabetic foot,mrsa,
5522276|NCT01199783|Complicated skin and skin structure infections|complicated skin and skin structure infections
5522277|NCT01199783|Antimicrobial therapy|antimicrobial therapy
5522278|NCT01199783|Daptomycin|daptomycin
5522279|NCT01199770|pasta|pasta
5522280|NCT01199770|appetite|appetite
5522281|NCT01199770|hunger|hunger
5522282|NCT01199770|satiety|satiety
5522283|NCT01199770|nutrition|nutrition
5522284|NCT01199770|metabolic|metabolic
5522285|NCT01199770|gut peptide hormones|gut peptide hormones
5522286|NCT01199770|psychological phenomena and processes|psychological phenomena and processes
5522287|NCT01199757|ocular symptoms|ocular symptoms
5522288|NCT01199757|nasal symptoms|nasal symptoms
5522289|NCT01199757|Allergic Rhinitis|allergic rhinitis
5522290|NCT01199757|Symptom Free Days|symptom free days
5522291|NCT01199757|Quality of Life|quality of life
5522292|NCT01199744|Influenza|influenza
5522293|NCT01199744|Relenza®|relenza®
5522294|NCT01199744|SSMP|ssmp
5522295|NCT01199731|raltegravir|raltegravir
5522296|NCT01199731|NNRTI|nnrti
5522297|NCT01199731|ritonavir|ritonavir
5522298|NCT01199731|darunavir|darunavir
5522299|NCT01199731|HIV|hiv
5522300|NCT01199731|GSK2248761|gsk2248761
5522301|NCT01199731|antiretroviral|antiretroviral
5522302|NCT01199731|HIV Infection|hiv infection
5522303|NCT01199731|HAART|haart
5522304|NCT01199718|Multiple myeloma|multiple myeloma
5522305|NCT01199718|Plasmacytoma|plasmacytoma
5522306|NCT01199705|Immune globulin subcutaneous|immune globulin subcutaneous
5522307|NCT01199705|SCIG|scig
5522308|NCT01199705|Primary immunodeficiency|primary immunodeficiency
5522309|NCT01199705|PID|pid
5522310|NCT01199679|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5522311|NCT01199679|Heartburn|heartburn
5522312|NCT01199679|Regurgitation|regurgitation
5522313|NCT01199679|Dyspepsia|dyspepsia
5522314|NCT01199666|Underimmunization, text message, vaccination|underimmunization, text message, vaccination
5522315|NCT01199666|Underimmunization|underimmunization
5522316|NCT01199653|clavicle fractures|clavicle fractures
5522317|NCT01199653|midshaft|midshaft
5522318|NCT01199653|dislocated|dislocated
5522319|NCT01199653|operative treatment|operative treatment
5522320|NCT01199653|conservative treatment|conservative treatment
5522321|NCT01199653|non-operative treatment|non-operative treatment
5522322|NCT01199653|randomized controlled trial|randomized controlled trial
5522324|NCT01199627|total hip replacement|total hip replacement
5522325|NCT01199627|tranexamic acid|tranexamic acid
5522326|NCT01199614|Hypoparathyroidism|hypoparathyroidism
5522327|NCT01199614|Hypopara|hypopara
5522328|NCT01199614|HPTH|hpth
5522329|NCT01199614|Hypocalcemia|hypocalcemia
5522330|NCT01199614|Hypercalciuria|hypercalciuria
5522331|NCT01199614|PTH|pth
5522332|NCT01199614|PTH(1-84)|pth(1-84)
5522333|NCT01199588|VLU|vlu
5522334|NCT01199588|Venous Leg Ulcers|venous leg ulcers
5522335|NCT01199588|Ulcers|ulcers
5522336|NCT01199588|chronic wounds|chronic wounds
5522337|NCT01199588|wounds|wounds
5522338|NCT01199588|Nexagon|nexagon
5522339|NCT01199588|CoDa|coda
5522340|NCT01199575|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5522342|NCT01199575|Relapsed or Refractory|relapsed or refractory
5522343|NCT01199575|previously treated|previously treated
5522344|NCT01199536|Helicobacter-positive duodenal ulcer|helicobacter-positive duodenal ulcer
5522345|NCT01199523|YM178|ym178
5522346|NCT01199523|Mirabegron|mirabegron
5522347|NCT01199523|QT|qt
5522348|NCT01199497|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.|cough, acute rhinitis, nasal congestion, common cold, nasal symptoms, children.
5522349|NCT01199497|Nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.|nasal congestion and non-productive cough, with or without associate other nasal and extranasal symptoms.
5522350|NCT01199484|Cow's milk allergy|cow's milk allergy
5522351|NCT01199484|food allergy|food allergy
5522352|NCT01199484|oral desensitization|oral desensitization
5522353|NCT01199484|randomized trial|randomized trial
5522354|NCT01199484|specific oral tolerance induction.|specific oral tolerance induction.
5522355|NCT01199471|Sevoflurane|sevoflurane
5522356|NCT01199471|Physician's Practice Patterns|physician's practice patterns
5522357|NCT01199471|Economics, Pharmaceutical|economics, pharmaceutical
5522359|NCT01199458|Lower Esophageal Sphincter|lower esophageal sphincter
5522360|NCT01199458|Barrier pressure|barrier pressure
5522361|NCT01199445|vitamin A deficiency|vitamin a deficiency
5522362|NCT01199432|Primary Breast Cancer|primary breast cancer
5522363|NCT01199419|multivessel coronary artery disease|multivessel coronary artery disease
5522364|NCT01199419|drug-eluting stent|drug-eluting stent
5522365|NCT01199419|CABG|cabg
5522366|NCT01199419|cost-effectiveness|cost-effectiveness
5522367|NCT01199406|gallstone|gallstone
5522368|NCT01199406|gallbladder|gallbladder
5522369|NCT01199406|cholecystectomy|cholecystectomy
5522370|NCT01199406|laparoscopic|laparoscopic
5522371|NCT01199406|pain|pain
5522372|NCT01199393|breast neoplasm|breast neoplasm
5522373|NCT01199393|drug therapy|drug therapy
5522374|NCT01199393|polymorphism|polymorphism
5522375|NCT01199393|gene|gene
5522376|NCT01199380|Smoking, Smoking Cessation|smoking, smoking cessation
5522377|NCT01199367|advanced or metastatic breast cancer|advanced or metastatic breast cancer
5522378|NCT01199354|Invasive breast carcinoma|invasive breast carcinoma
5522379|NCT01199341|Phase 1|phase 1
5522380|NCT01199341|Drug-Drug interaction|drug-drug interaction
5522381|NCT01199341|warfarin|warfarin
5522382|NCT01199341|AZD1981|azd1981
5522383|NCT01199328|Nexium|nexium
5522384|NCT01199328|aspirin|aspirin
5522385|NCT01199328|peptic ulcers|peptic ulcers
5522386|NCT01199328|pharmacodynamic (PD)|pharmacodynamic (pd)
5522387|NCT01199328|Esomoeprazole|esomoeprazole
5522388|NCT01199315|safety|safety
5522389|NCT01199315|tolerability|tolerability
5522390|NCT01199315|AZD1446|azd1446
5522392|NCT01199315|ADHD|adhd
5522393|NCT01199315|Japanese|japanese
5522394|NCT01199302|Amgen|amgen
5522395|NCT01199302|Crohn's|crohn's
5522396|NCT01199302|Inflammatory Bowel Disease|inflammatory bowel disease
5522397|NCT01199302|IBD|ibd
5522398|NCT01199302|Irritable Bowel Syndrome|irritable bowel syndrome
5522399|NCT01199302|IBS|ibs
5522400|NCT01199302|Inflammation|inflammation
5522401|NCT01199302|bowel|bowel
5522402|NCT01199302|colon|colon
5522403|NCT01199302|gastrointestinal|gastrointestinal
5522404|NCT01199289|Amgen|amgen
5522405|NCT01199289|chronic inflammatory disease|chronic inflammatory disease
5522406|NCT01199289|wheezing|wheezing
5522407|NCT01199276|Delirium|delirium
5522408|NCT01199276|Hip Fracture|hip fracture
5522409|NCT01199276|Elderly|elderly
5522410|NCT01199237|Reflex, Pharyngeal|reflex, pharyngeal
5522411|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation
5522412|NCT01199224|Solid Tumors|solid tumors
5522413|NCT01199224|veliparib|veliparib
5522414|NCT01199224|refractory|refractory
5522415|NCT01199224|relapsed|relapsed
5522416|NCT01199211|hypertrophy, exercise, HDL, lipids, cholesterol|hypertrophy, exercise, hdl, lipids, cholesterol
5522417|NCT01199198|Hyponatremia|hyponatremia
5522418|NCT01199198|Serum sodium|serum sodium
5522419|NCT01199198|Tolvaptan|tolvaptan
5522420|NCT01199198|Placebo|placebo
5522421|NCT01199172|Student teachers with normal or mildly disordered voices|student teachers with normal or mildly disordered voices
5522422|NCT01199159|misoprostol|misoprostol
5522423|NCT01199159|hysterectomy|hysterectomy
5522424|NCT01199159|operative blood loss|operative blood loss
5522425|NCT01199159|total abdominal hysterectomy|total abdominal hysterectomy
5522426|NCT01199146|Abiraterone acetate|abiraterone acetate
5522427|NCT01199120|Omega-3|omega-3
5522428|NCT01199120|Cognition|cognition
5522429|NCT01199120|Malnourishment|malnourishment
5522430|NCT01199107|PTSD|ptsd
5522431|NCT01199107|Anxiety|anxiety
5522432|NCT01199107|Behavior Therapy|behavior therapy
5522433|NCT01199107|Prolonged Exposure|prolonged exposure
5522434|NCT01199107|Exercise|exercise
5522435|NCT01199107|Wellness|wellness
5522436|NCT01199107|Posttraumatic|posttraumatic
5522437|NCT01199107|Stress|stress
5522438|NCT01199094|low density lipoprotein receptor 5|low density lipoprotein receptor 5
5522439|NCT01199094|high bone mass|high bone mass
5522440|NCT01199094|autosomal dominant osteopetrosis type I|autosomal dominant osteopetrosis type i
5522441|NCT01199094|bone turnover markers|bone turnover markers
5522442|NCT01199068|PPAR gamma agonist|ppar gamma agonist
5522443|NCT01199068|Tumor|tumor
5522444|NCT01199068|Cancer|cancer
5522445|NCT01199068|Antineoplastic Agent|antineoplastic agent
5522446|NCT01199068|Respiratory Tract Neoplasms|respiratory tract neoplasms
5522447|NCT01199068|Erlotinib|erlotinib
5522448|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors
5522449|NCT01199068|Neoplasms|neoplasms
5522450|NCT01199055|PPAR gamma agonist|ppar gamma agonist
5522451|NCT01199055|Tumor|tumor
5522452|NCT01199055|Cancer|cancer
5522453|NCT01199055|Antineoplastic Agent|antineoplastic agent
5522454|NCT01199055|Respiratory Tract Neoplasms|respiratory tract neoplasms
5522455|NCT01199055|Carboplatin|carboplatin
5522456|NCT01199055|Paclitaxel|paclitaxel
5522457|NCT01199055|Neoplasms|neoplasms
5522458|NCT01199029|Healthy People|healthy people
5522459|NCT01199029|Glucocorticoids|glucocorticoids
5522460|NCT01199029|Prednisone|prednisone
5522461|NCT01199016|Acute otitis media|acute otitis media
5522462|NCT01199016|Prevnar 13|prevnar 13
5522463|NCT01199016|Streptococcus pneumoniae|streptococcus pneumoniae
5522464|NCT01199016|nasopharyngeal colonization.|nasopharyngeal colonization.
5522465|NCT01198977|multiple sclerosis|multiple sclerosis
5522466|NCT01198977|Fatigue|fatigue
5522467|NCT01198977|exercise|exercise
5522468|NCT01198977|telemedicine|telemedicine
5522469|NCT01198977|motivational interviewing|motivational interviewing
5522470|NCT01198977|counseling|counseling
5522471|NCT01198977|depression|depression
5522472|NCT01198977|physical activity|physical activity
5522473|NCT01198964|ECoG|ecog
5522474|NCT01198964|Epilepsy|epilepsy
5522475|NCT01198964|cortical|cortical
5522476|NCT01198964|stimulation|stimulation
5522477|NCT01198964|Electrocorticography|electrocorticography
5522478|NCT01198964|electrodes|electrodes
5522479|NCT01198964|mapping|mapping
5522480|NCT01198938|Cardiac surgery, delirium, melatonin|cardiac surgery, delirium, melatonin
5522481|NCT01198925|Infectious disease|infectious disease
5522482|NCT01198925|piperacillin|piperacillin
5522483|NCT01198925|continuous infusion|continuous infusion
5522484|NCT01198925|extended infusion|extended infusion
5522485|NCT01198912|rhinosinusitis|rhinosinusitis
5522486|NCT01198912|doxycycline|doxycycline
5522487|NCT01198912|Chronic rhinosinusitis with or without nasal polyps|chronic rhinosinusitis with or without nasal polyps
5522488|NCT01198899|Fabry-Anderson disease|fabry-anderson disease
5522489|NCT01198899|gen mutation|gen mutation
5522490|NCT01198899|left ventricular hypertrophy|left ventricular hypertrophy
5522491|NCT01198886|Mobility disability|mobility disability
5522492|NCT01198886|Older adults|older adults
5522493|NCT01198886|Physical activity|physical activity
5522494|NCT01198886|Nutritional status|nutritional status
5522495|NCT01198860|HBsAg|hbsag
5522496|NCT01198847|child overweight|child overweight
5522497|NCT01198847|child obesity|child obesity
5522498|NCT01198847|prevention|prevention
5522499|NCT01198847|targeted intervention|targeted intervention
5522500|NCT01198847|development of overweight|development of overweight
5522501|NCT01198834|ankle sprains|ankle sprains
5522502|NCT01198821|pancreas|pancreas
5522503|NCT01198821|adenocarcinoma|adenocarcinoma
5522504|NCT01198821|metastatic|metastatic
5522505|NCT01198821|unresectable|unresectable
5522506|NCT01198808|Bladder cancer|bladder cancer
5522507|NCT01198808|chemotherapy|chemotherapy
5522508|NCT01198808|T cells|t cells
5522509|NCT01198808|Immunotherapy|immunotherapy
5522510|NCT01198808|Tumor-specific immunity in bladder cancer|tumor-specific immunity in bladder cancer
5522511|NCT01198795|depression|depression
5522512|NCT01198795|major depressive disorder|major depressive disorder
5522513|NCT01198795|escitalopram|escitalopram
5522514|NCT01198795|Lexapro|lexapro
5522515|NCT01198795|pediatric|pediatric
5522516|NCT01198769|Human rotavirus vaccine|human rotavirus vaccine
5522517|NCT01198756|Influenza|influenza
5522518|NCT01198743|Genetics modifications|genetics modifications
5522519|NCT01198743|colorectal cancer|colorectal cancer
5522520|NCT01198743|prognosis aim|prognosis aim
5522522|NCT01198743|Plasma|plasma
5522524|NCT01198730|CAD|cad
5522525|NCT01198730|Meal tolerance test|meal tolerance test
5522526|NCT01198704|Hepatocellular carcinoma|hepatocellular carcinoma
5522527|NCT01198704|Cirrhosis|cirrhosis
5522528|NCT01198704|Transplantation|transplantation
5522529|NCT01198691|metallic staples|metallic staples
5522530|NCT01198691|absorbable staples|absorbable staples
5522531|NCT01198691|Cesarean Delivery|cesarean delivery
5522533|NCT01198665|chemotherpy|chemotherpy
5522534|NCT01198665|T cell lymphoma|t cell lymphoma
5522535|NCT01198626|community-acquired bacterial pneumonia|community-acquired bacterial pneumonia
5522536|NCT01198626|CABP|cabp
5522537|NCT01198626|CAP|cap
5522538|NCT01198626|pneumonia|pneumonia
5522539|NCT01198626|pneumonia, bacterial|pneumonia, bacterial
5522540|NCT01198626|bacterial infections|bacterial infections
5522541|NCT01198626|anti-bacterial agents|anti-bacterial agents
5522542|NCT01198626|anti-infective agents|anti-infective agents
5522543|NCT01198626|lung disease, interstitial|lung disease, interstitial
5522544|NCT01198626|respiratory tract diseases|respiratory tract diseases
5522545|NCT01198626|respiratory tract infections|respiratory tract infections
5522546|NCT01198626|community-acquired infections|community-acquired infections
5522547|NCT01198613|Ragweed allergy|ragweed allergy
5522548|NCT01198613|Rhinoconjunctivitis|rhinoconjunctivitis
5522549|NCT01198613|Exposure chamber|exposure chamber
5522550|NCT01198613|Immunotherapy|immunotherapy
5522551|NCT01198613|ToleroMune Ragweed|toleromune ragweed
5522552|NCT01198587|Diarrhea|diarrhea
5522553|NCT01198587|Gastroenteritis|gastroenteritis
5522554|NCT01198587|Zinc Supplementation|zinc supplementation
5522555|NCT01198574|anemia|anemia
5522556|NCT01198574|iron supplementation|iron supplementation
5522557|NCT01198574|sub-clinical inflammation|sub-clinical inflammation
5522558|NCT01198574|adolescents|adolescents
5522559|NCT01198561|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5522560|NCT01198561|Major Depressive Disorder|major depressive disorder
5522561|NCT01198522|Interleukin, IL2, Gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, Pancreatic cancer,|interleukin, il2, gemcitabine, monoclonal, antibody, cytokine, tumour targeting, dose finding, fusion protein, pancreatic cancer,
5522563|NCT01198509|rheumatoid arthritis|rheumatoid arthritis
5522564|NCT01198509|psoriatic arthritis|psoriatic arthritis
5522565|NCT01198509|periodontitis|periodontitis
5522566|NCT01198509|microbiota|microbiota
5522567|NCT01198509|microbiome|microbiome
5522568|NCT01198509|vancomycin|vancomycin
5522569|NCT01198509|doxycycline|doxycycline
5522570|NCT01198509|T cell|t cell
5522571|NCT01198509|Th17|th17
5522572|NCT01198496|hypertension|hypertension
5522573|NCT01198496|stroke|stroke
5522574|NCT01198496|blood pressure|blood pressure
5522575|NCT01198483|refraction|refraction
5522576|NCT01198483|refractive error|refractive error
5522577|NCT01198483|combined surgery|combined surgery
5522578|NCT01198483|microincision|microincision
5522579|NCT01198483|smallincision|smallincision
5522580|NCT01198483|cataract surgery|cataract surgery
5522581|NCT01198483|vitrectomy|vitrectomy
5522582|NCT01198470|Low back pain|low back pain
5522583|NCT01198470|Leg pain|leg pain
5522584|NCT01198470|Discogenic pain|discogenic pain
5522585|NCT01198470|Degenerative Disc Disease (DDD)|degenerative disc disease (ddd)
5522586|NCT01198470|Herniated disc|herniated disc
5522587|NCT01198470|Radiculopathy|radiculopathy
5522588|NCT01198457|Clodronate|clodronate
5522589|NCT01198457|Compliance|compliance
5522590|NCT01198444|Contraception|contraception
5522591|NCT01198444|Compliance|compliance
5522592|NCT01198431|Appetite regulation|appetite regulation
5522593|NCT01198431|Physical activity|physical activity
5522594|NCT01198431|Energy balance|energy balance
5522595|NCT01198418|STI|sti
5522596|NCT01198418|MSM|msm
5522598|NCT01198418|Prevention|prevention
5522599|NCT01198418|Men having sex with men|men having sex with men
5522600|NCT01198405|coronary artery disease|coronary artery disease
5522601|NCT01198405|enhanced external counterpulsation|enhanced external counterpulsation
5522602|NCT01198392|gastric cancer|gastric cancer
5522603|NCT01198379|aspirin|aspirin
5522604|NCT01198379|aspirin resistance|aspirin resistance
5522605|NCT01198379|hemodialysis|hemodialysis
5522606|NCT01198379|cardiovascular|cardiovascular
5522607|NCT01198379|Prevalence of aspirin resistance, cardiovascular events, and safety profile|prevalence of aspirin resistance, cardiovascular events, and safety profile
5522608|NCT01198366|Tuberculosis|tuberculosis
5522609|NCT01198366|Vaccine|vaccine
5522610|NCT01198366|Immunogenicity|immunogenicity
5522611|NCT01198366|Prevention of Tuberculosis|prevention of tuberculosis
5522612|NCT01198353|Schizophrenia|schizophrenia
5522613|NCT01198353|Schizoaffective Disorder|schizoaffective disorder
5522614|NCT01198353|Ziprasidone|ziprasidone
5522615|NCT01198353|Switch|switch
5522616|NCT01198353|Metabolic syndrome|metabolic syndrome
5522618|NCT01198327|CRVO|crvo
5522619|NCT01198327|BRVO|brvo
5522620|NCT01198327|Horizon|horizon
5522621|NCT01198327|Bravo|bravo
5522622|NCT01198327|Cruise|cruise
5522623|NCT01198314|long term|long term
5522624|NCT01198314|stable|stable
5522625|NCT01198314|recipients|recipients
5522626|NCT01198301|Metastatic Breast Neoplasms|metastatic breast neoplasms
5522627|NCT01198301|Gene Expression Profiling|gene expression profiling
5522628|NCT01198301|Drug Therapy|drug therapy
5522629|NCT01198288|COPD|copd
5522630|NCT01198288|Respiratory Physiotherapy|respiratory physiotherapy
5522631|NCT01198275|PUFA atrial fibrillation|pufa atrial fibrillation
5522632|NCT01198262|polymerase chain reaction|polymerase chain reaction
5522633|NCT01198236|hematological malignancy|hematological malignancy
5522634|NCT01198236|previous proven or probable invasive fungal infection|previous proven or probable invasive fungal infection
5522635|NCT01198223|denture stomatitis|denture stomatitis
5522636|NCT01198223|nystatin|nystatin
5522637|NCT01198223|garlic|garlic
5522638|NCT01198210|pain|pain
5522639|NCT01198210|tonsillectomy|tonsillectomy
5522640|NCT01198210|peritonsillar infiltration|peritonsillar infiltration
5522641|NCT01198210|postoperative pain|postoperative pain
5522642|NCT01198197|Nociceptin/Orphanin FQ Peptide (NOP)|nociceptin/orphanin fq peptide (nop)
5522643|NCT01198197|PET Imaging|pet imaging
5522644|NCT01198197|Brain Imaging|brain imaging
5522645|NCT01198197|Healthy Volunteer|healthy volunteer
5522646|NCT01198197|HV|hv
5522647|NCT01198145|diarrhea|diarrhea
5522648|NCT01198145|gastrointestinal complications|gastrointestinal complications
5680306|NCT00578292|chronic transfusion therapy|chronic transfusion therapy
5522649|NCT01198145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5522650|NCT01198132|Multiple Sclerosis Relapsing-Remitting|multiple sclerosis relapsing-remitting
5522651|NCT01198132|Relapsing Multiple Sclerosis (RMS)|relapsing multiple sclerosis (rms)
5522653|NCT01198132|Vitamin D3|vitamin d3
5522654|NCT01198132|Cholecalciferol|cholecalciferol
5522655|NCT01198119|oral cavity tumor|oral cavity tumor
5522656|NCT01198119|narrow band imaging|narrow band imaging
5522657|NCT01198119|subclinical cancer lesion|subclinical cancer lesion
5522658|NCT01198106|simulator sickness|simulator sickness
5522659|NCT01198106|scopolamine|scopolamine
5522660|NCT01198106|cinnarizine|cinnarizine
5522661|NCT01198093|Alzheimer's disease|alzheimer's disease
5522662|NCT01198093|Mild Cognitive Impairment|mild cognitive impairment
5522663|NCT01198093|cohort study|cohort study
5522664|NCT01198080|Avascular osteonecrosis,CD133+,core decompression|avascular osteonecrosis,cd133+,core decompression
5522666|NCT01198054|Lenalidomide|lenalidomide
5522667|NCT01198015|Rett syndrome|rett syndrome
5522668|NCT01198015|Nutritional status|nutritional status
5522669|NCT01198015|Creatine metabolism|creatine metabolism
5522670|NCT01198002|Rheumatoid Arthritis|rheumatoid arthritis
5522671|NCT01197989|pustulosis|pustulosis
5522672|NCT01197989|soles|soles
5522673|NCT01197989|teflon|teflon
5522674|NCT01197976|psoriasis|psoriasis
5522675|NCT01197976|soles|soles
5522676|NCT01197976|teflon|teflon
5522677|NCT01197963|Type 2 diabetes mellitus|type 2 diabetes mellitus
5522678|NCT01197950|acupuncture|acupuncture
5522679|NCT01197950|labour|labour
5522680|NCT01197950|pain|pain
5522681|NCT01197950|pain relief|pain relief
5522682|NCT01197950|complementary|complementary
5522683|NCT01197924|child cancer brain|child cancer brain
5522684|NCT01197898|Diabetic|diabetic
5522685|NCT01197898|Foot|foot
5522686|NCT01197898|Ulcers|ulcers
5522687|NCT01197898|Wounds|wounds
5522688|NCT01197833|varicose veins|varicose veins
5522689|NCT01197833|Great saphenous vein|great saphenous vein
5522690|NCT01197833|varicosities|varicosities
5522691|NCT01197820|HIFU|hifu
5522692|NCT01197820|mobile organs|mobile organs
5522693|NCT01197820|thermometry|thermometry
5522694|NCT01197820|MR|mr
5522695|NCT01197820|liver|liver
5522696|NCT01197820|kidney|kidney
5522697|NCT01197820|cancer|cancer
5516870|NCT01222195|CC-5013|cc-5013
5522698|NCT01197820|Liver tumors, kidney carcinoma|liver tumors, kidney carcinoma
5522699|NCT01197807|Suctioning|suctioning
5522700|NCT01197807|Wiping|wiping
5522701|NCT01197807|Neonate|neonate
5522702|NCT01197807|Resuscitation|resuscitation
5522703|NCT01197794|Efficacy|efficacy
5522704|NCT01197794|safety|safety
5522705|NCT01197794|tolerability|tolerability
5522706|NCT01197794|dose finding|dose finding
5522707|NCT01197794|asthma patients|asthma patients
5522708|NCT01197781|Phase I|phase i
5522709|NCT01197781|FosD|fosd
5522710|NCT01197781|fostamatinib disodium|fostamatinib disodium
5522711|NCT01197781|verapamil|verapamil
5522712|NCT01197781|healthy volunteers|healthy volunteers
5522713|NCT01197755|Rheumatoid Arthritis|rheumatoid arthritis
5522714|NCT01197742|Diabetes|diabetes
5522715|NCT01197742|STEMI|stemi
5522716|NCT01197742|NSTEMI|nstemi
5522717|NCT01197742|Myocardial infarction|myocardial infarction
5522718|NCT01197729|Myocardial infarction|myocardial infarction
5522719|NCT01197729|ST-Elevation myocardial infarction|st-elevation myocardial infarction
5522720|NCT01197729|Non-ST-Elevation myocardial infarction|non-st-elevation myocardial infarction
5522721|NCT01197729|Register|register
5522722|NCT01197729|CARDS|cards
5522723|NCT01197716|Chest Pain Unit|chest pain unit
5522724|NCT01197716|Myocardial infarction|myocardial infarction
5522725|NCT01197716|Register|register
5522726|NCT01197716|Admission to a Chest Pain Unit for any reason|admission to a chest pain unit for any reason
5522727|NCT01197703|Clinical Practice Cardiac CT|clinical practice cardiac ct
5522728|NCT01197703|Clinical Implications Coronary CT Angiography|clinical implications coronary ct angiography
5522729|NCT01197703|Radiation Exposure of Coronary CT Angiography|radiation exposure of coronary ct angiography
5522730|NCT01197703|Registry|registry
5522731|NCT01197690|Bronchial asthma|bronchial asthma
5522732|NCT01197690|level of control of asthma|level of control of asthma
5522733|NCT01197690|fractional exhaled nitric oxide (FeNO)|fractional exhaled nitric oxide (feno)
5522734|NCT01197690|asthma control test (ACT)|asthma control test (act)
5522735|NCT01197677|CMR|cmr
5522738|NCT01197677|myocard scarring|myocard scarring
5522739|NCT01197651|Aorta|aorta
5522740|NCT01197651|Aorta-Stent-Graft|aorta-stent-graft
5522741|NCT01197651|Surgical operation|surgical operation
5522742|NCT01197651|Aortic dissection|aortic dissection
5522743|NCT01197638|Cardiac arrhythmia|cardiac arrhythmia
5522744|NCT01197638|Catheter ablation|catheter ablation
5522745|NCT01197638|Register|register
5522746|NCT01197625|Vaccination treatment, dendritic cells|vaccination treatment, dendritic cells
5522747|NCT01197599|Healthy Control|healthy control
5522748|NCT01197586|surfactant protein B|surfactant protein b
5522749|NCT01197586|differential diagnostics|differential diagnostics
5522750|NCT01197560|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5522751|NCT01197560|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5522752|NCT01197560|relapsed|relapsed
5522753|NCT01197560|refractory|refractory
5522754|NCT01197560|relapsed/refractory|relapsed/refractory
5522755|NCT01197560|DLBCL|dlbcl
5522756|NCT01197560|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5522757|NCT01197547|Menorrhagia|menorrhagia
5522758|NCT01197534|Rheumatoid Arthritis|rheumatoid arthritis
5522759|NCT01197521|Rheumatoid Arthritis|rheumatoid arthritis
5522760|NCT01197508|Major Depressive Disorder, MDD, Depression|major depressive disorder, mdd, depression
5522761|NCT01197482|asthma|asthma
5522762|NCT01197482|inhalation|inhalation
5522763|NCT01197469|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5522764|NCT01197456|Breast cancer|breast cancer
5522765|NCT01197456|Ovarian insufficiency|ovarian insufficiency
5522766|NCT01197456|Ovarian failure|ovarian failure
5522767|NCT01197456|Reproduction|reproduction
5522768|NCT01197443|obesity|obesity
5522769|NCT01197443|overweight|overweight
5522770|NCT01197443|overweight children|overweight children
5522771|NCT01197443|overweight parents|overweight parents
5522772|NCT01197443|families with overweight child|families with overweight child
5522773|NCT01197443|body mass index|body mass index
5522775|NCT01197443|weight|weight
5522776|NCT01197443|childhood obesity|childhood obesity
5522777|NCT01197443|diet|diet
5522778|NCT01197443|treatment|treatment
5522779|NCT01197443|parent modeling|parent modeling
5522780|NCT01197443|traffic light diet|traffic light diet
5522781|NCT01197443|stop light diet|stop light diet
5522782|NCT01197430|volleyball|volleyball
5522783|NCT01197430|neck vertical stability training|neck vertical stability training
5522784|NCT01197430|eye-hand coordination|eye-hand coordination
5522785|NCT01197417|Sickle Cell Disease|sickle cell disease
5522786|NCT01197417|Magnesium Sulfate|magnesium sulfate
5522787|NCT01197417|Pediatric|pediatric
5522788|NCT01197404|HIV Prevention|hiv prevention
5522789|NCT01197378|cystinosis|cystinosis
5522790|NCT01197378|cysteamine|cysteamine
5522791|NCT01197378|inheritable disease|inheritable disease
5522792|NCT01197378|orphan disease|orphan disease
5522793|NCT01197378|CTNS protein, human|ctns protein, human
5522794|NCT01197378|metabolic disease|metabolic disease
5522795|NCT01197378|nephropathic cystinosis|nephropathic cystinosis
5522796|NCT01197365|Acidified milk|acidified milk
5522798|NCT01197365|Bifidobacteria|bifidobacteria
5522799|NCT01197365|Infant formula|infant formula
5522800|NCT01197365|Galacto-oligosaccharides|galacto-oligosaccharides
5522801|NCT01197365|Growth|growth
5522802|NCT01197365|Infants|infants
5522803|NCT01197365|Prebiotics|prebiotics
5522804|NCT01197352|Alcohol|alcohol
5522805|NCT01197352|Abuse|abuse
5522806|NCT01197352|Drinking|drinking
5522807|NCT01197352|Behavior|behavior
5522808|NCT01197352|Text|text
5522809|NCT01197352|Computer|computer
5522810|NCT01197339|acute phonotrauma|acute phonotrauma
5522811|NCT01197339|computer modeling|computer modeling
5522812|NCT01197339|resonant voice|resonant voice
5522813|NCT01197339|breathy voice|breathy voice
5522814|NCT01197339|voice rest|voice rest
5522815|NCT01197339|relaxation|relaxation
5522816|NCT01197326|patient deterioration|patient deterioration
5522817|NCT01197326|unplanned ICU admissions|unplanned icu admissions
5522818|NCT01197326|rapid response teams|rapid response teams
5522819|NCT01197313|chronic heart failure (CHF); anxiety and depression; quality of life (QOL); exercise|chronic heart failure (chf); anxiety and depression; quality of life (qol); exercise
5522820|NCT01197300|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions
5522821|NCT01197287|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5522823|NCT01197274|skin prick test|skin prick test
5522824|NCT01197274|mite sensitivity|mite sensitivity
5522825|NCT01197261|Severe pain|severe pain
5522826|NCT01197261|Bladder Pain Syndrome|bladder pain syndrome
5522827|NCT01197261|Interstitial Cystitis|interstitial cystitis
5522828|NCT01197261|Painful Bladder Syndrome|painful bladder syndrome
5522829|NCT01197261|Severe pain due to Bladder Pain Syndrome/Interstitial Cystitis/Painful Bladder Syndrome|severe pain due to bladder pain syndrome/interstitial cystitis/painful bladder syndrome
5522831|NCT01197248|voiding|voiding
5522832|NCT01197248|dysfunction|dysfunction
5522833|NCT01197235|darbepoetin, chronic kidney disease, coronary angiography|darbepoetin, chronic kidney disease, coronary angiography
5522834|NCT01197222|Laparoscopic|laparoscopic
5522835|NCT01197222|EndoClear|endoclear
5522836|NCT01197222|Lens Cleaning Device|lens cleaning device
5522837|NCT01197209|Prostate Cancer|prostate cancer
5522838|NCT01197209|Prostatectomy|prostatectomy
5522839|NCT01197209|Postectomy|postectomy
5522840|NCT01197209|Oncology|oncology
5522841|NCT01197209|REIC|reic
5522842|NCT01197209|Dikkoff|dikkoff
5522843|NCT01197209|Apoptosis|apoptosis
5522844|NCT01197196|Migraine|migraine
5522845|NCT01197196|Obesity|obesity
5522846|NCT01197196|Weight loss|weight loss
5522847|NCT01197196|Lifestyle|lifestyle
5522848|NCT01197196|Behavior|behavior
5522849|NCT01197183|Hypothyroidism|hypothyroidism
5522850|NCT01197183|Thyroid hormones|thyroid hormones
5522851|NCT01197170|Hormonal therapies|hormonal therapies
5522852|NCT01197170|Estrogen receptor|estrogen receptor
5522853|NCT01197170|Progesterone receptor|progesterone receptor
5522854|NCT01197170|Hormone blockade|hormone blockade
5522855|NCT01197170|Hormone-positive tumors|hormone-positive tumors
5522856|NCT01197170|Advanced cancer|advanced cancer
5522857|NCT01197170|Metastatic cancer|metastatic cancer
5522858|NCT01197170|Avastin|avastin
5522859|NCT01197170|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5522860|NCT01197170|rhuMAB-VEGF|rhumab-vegf
5522861|NCT01197170|Afinitor|afinitor
5522862|NCT01197170|RAD001|rad001
5522863|NCT01197170|Nexavar|nexavar
5522864|NCT01197170|BAY43-9006|bay43-9006
5522865|NCT01197170|OSI-774|osi-774
5522866|NCT01197170|Tarceva|tarceva
5522867|NCT01197157|chronic hepatitis C|chronic hepatitis c
5522868|NCT01197157|genotype 4|genotype 4
5522869|NCT01197157|treatment naive patients|treatment naive patients
5522870|NCT01197157|Egypt|egypt
5522872|NCT01197144|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5522873|NCT01197144|Autonomic|autonomic
5522874|NCT01197144|Vagus|vagus
5522875|NCT01197144|adalimumab|adalimumab
5522876|NCT01197131|autism|autism
5522877|NCT01197131|autism spectrum disorder|autism spectrum disorder
5522878|NCT01197131|steroids|steroids
5522879|NCT01197131|steroid metabolites|steroid metabolites
5522880|NCT01197131|urinary steroid metabolites|urinary steroid metabolites
5522881|NCT01197131|hormone formation|hormone formation
5522882|NCT01197131|androgen precursor|androgen precursor
5522883|NCT01197118|gastric cancer|gastric cancer
5522884|NCT01197118|sequence chemoradiotherapy|sequence chemoradiotherapy
5522885|NCT01197118|OLF regimen|olf regimen
5522886|NCT01197118|survival rate|survival rate
5522887|NCT01197105|gingivitis|gingivitis
5522888|NCT01197105|schinus terebinthifolius|schinus terebinthifolius
5522889|NCT01197105|natural products|natural products
5522890|NCT01197092|Diabetes|diabetes
5522892|NCT01197079|Vaccine|vaccine
5522893|NCT01197079|Vaccine utilization|vaccine utilization
5522894|NCT01197079|Disease awareness|disease awareness
5522895|NCT01197053|Peanut Allergy|peanut allergy
5522896|NCT01197053|Food Allergy|food allergy
5522897|NCT01197053|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5522899|NCT01197040|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
5522900|NCT01197040|Complete remission|complete remission
5522901|NCT01197040|Myfortic|myfortic
5522902|NCT01197040|Minimal Change Disease|minimal change disease
5522903|NCT01197014|Amlodipine, Losartan|amlodipine, losartan
5522904|NCT01197001|Amlodipine, Losartan|amlodipine, losartan
5522905|NCT01196988|GSK Biologicals influenza vaccine GSK2321138A|gsk biologicals influenza vaccine gsk2321138a
5522906|NCT01196988|influenza infection|influenza infection
5522907|NCT01196975|Influenza|influenza
5522908|NCT01196962|central venous catheter|central venous catheter
5522909|NCT01196962|complications|complications
5522910|NCT01196962|internal jugular vein|internal jugular vein
5522911|NCT01196962|randomized trial|randomized trial
5522912|NCT01196962|subclavian vein|subclavian vein
5522913|NCT01196949|Ankle|ankle
5522914|NCT01196949|Chronic|chronic
5522915|NCT01196949|Instability|instability
5522916|NCT01196949|Manipulative|manipulative
5522917|NCT01196949|Rehabilitative|rehabilitative
5522918|NCT01196949|Manipulation|manipulation
5522919|NCT01196949|Rehabilitation|rehabilitation
5522920|NCT01196936|Cancer survivors|cancer survivors
5522921|NCT01196936|Low Dose Tamoxifen|low dose tamoxifen
5522922|NCT01196936|Breast Cancer Risk Reduction|breast cancer risk reduction
5522923|NCT01196897|Atrial fibrillation|atrial fibrillation
5522924|NCT01196897|Stroke|stroke
5522925|NCT01196897|Warfarin|warfarin
5522926|NCT01196897|Coumadin|coumadin
5522928|NCT01196897|Trans Ischemic Attack|trans ischemic attack
5522929|NCT01196884|Patients with primary Immune Thrombocytopenia (ITP)|patients with primary immune thrombocytopenia (itp)
5522930|NCT01196871|Amicus Therapeutics|amicus therapeutics
5522931|NCT01196871|AT1001|at1001
5509109|NCT01257022|HIV|hiv
5522932|NCT01196871|Galafold|galafold
5522933|NCT01196871|Migalastat|migalastat
5522934|NCT01196871|Pharmacokinetics|pharmacokinetics
5522935|NCT01196845|adipose tissue|adipose tissue
5522936|NCT01196845|obese patients|obese patients
5522937|NCT01196845|inflammation|inflammation
5522938|NCT01196845|oxidative stress|oxidative stress
5522939|NCT01196845|sleep apnea syndrome|sleep apnea syndrome
5522940|NCT01196806|Non-Invasive Blood Pressure(NIBP)|non-invasive blood pressure(nibp)
5522941|NCT01196793|Feverish illness in children|feverish illness in children
5522942|NCT01196767|Sternotomy|sternotomy
5522943|NCT01196767|Pain|pain
5522944|NCT01196767|Respiratory function|respiratory function
5522945|NCT01196767|Opiates|opiates
5522946|NCT01196767|Patient-controlled|patient-controlled
5522947|NCT01196767|Scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied|scheduled cardiac surgery under general anaesthesia without any locoregional anaesthesia protocol other than this presently studied
5522948|NCT01196754|Pharmacokinetics|pharmacokinetics
5522949|NCT01196754|Sevoflurane|sevoflurane
5522950|NCT01196754|Fluorides|fluorides
5522951|NCT01196754|Sedation|sedation
5522952|NCT01196754|Adult patients with a predicted sedation more than 48 h|adult patients with a predicted sedation more than 48 h
5798706|NCT00111293|Vision|vision
5798707|NCT00111293|fMRI|fmri
5522953|NCT01196754|Stable respiratory and hemodynamic conditions for SBT|stable respiratory and hemodynamic conditions for sbt
5522954|NCT01196754|Consent of patients|consent of patients
5522955|NCT01196754|Arterial line|arterial line
5522956|NCT01196715|Quality of Life|quality of life
5522957|NCT01196715|Erythroid response|erythroid response
5522958|NCT01196715|disease progression|disease progression
5522959|NCT01196715|survival|survival
5522960|NCT01196715|Overall erythroid response at 24 weeks|overall erythroid response at 24 weeks
5522961|NCT01196715|Quality of life at 24 weeks|quality of life at 24 weeks
5522962|NCT01196715|Quality of life at 12, 36 and 52 weeks|quality of life at 12, 36 and 52 weeks
5522963|NCT01196715|Overall erythroid response at 12 and 52 weeks|overall erythroid response at 12 and 52 weeks
5522964|NCT01196715|Incidence of disease progression|incidence of disease progression
5522965|NCT01196715|Overall Survival|overall survival
5522966|NCT01196702|common variable immunodeficiency|common variable immunodeficiency
5522967|NCT01196702|granulomatous disease|granulomatous disease
5522968|NCT01196702|crohns disease|crohns disease
5522969|NCT01196702|bronchiectasis|bronchiectasis
5522970|NCT01196702|immunoglobulin replacement or treatment|immunoglobulin replacement or treatment
5522971|NCT01196702|B-cell immunophenotyping|b-cell immunophenotyping
5522972|NCT01196689|Pharmacokinetics AZD1981|pharmacokinetics azd1981
5522973|NCT01196689|Asthma|asthma
5522974|NCT01196676|AZD4451|azd4451
5522975|NCT01196676|Bipolar|bipolar
5522976|NCT01196676|depression|depression
5522977|NCT01196663|TMS|tms
5522978|NCT01196637|thoracic outlet syndrome|thoracic outlet syndrome
5522979|NCT01196637|brachial plexopathy|brachial plexopathy
5522980|NCT01196637|ultrasonography|ultrasonography
5522981|NCT01196624|PTSD|ptsd
5522982|NCT01196624|FLASHBACKS|flashbacks
5522983|NCT01196624|TMS|tms
5522984|NCT01196624|EXPOSURE|exposure
5522985|NCT01196611|Voice disorders|voice disorders
5522986|NCT01196611|Voice|voice
5522987|NCT01196598|pelvic floor|pelvic floor
5522989|NCT01196585|Pleura|pleura
5522990|NCT01196585|biopsy|biopsy
5522991|NCT01196585|diagnosis|diagnosis
5522993|NCT01196585|ultrasonography|ultrasonography
5522994|NCT01196572|stricture|stricture
5522995|NCT01196572|urethra|urethra
5522996|NCT01196572|laser|laser
5522997|NCT01196572|urethrotomy|urethrotomy
5522998|NCT01196572|holmium|holmium
5523293|NCT01195220|Chlamydia|chlamydia
5522999|NCT01196572|bladder outlet obstruction|bladder outlet obstruction
5523000|NCT01196559|ovarian cancer|ovarian cancer
5523001|NCT01196546|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5523002|NCT01196546|vildagliptin|vildagliptin
5523003|NCT01196546|metformin|metformin
5523004|NCT01196520|Burkitt Lymphoma|burkitt lymphoma
5523005|NCT01196520|Epstein-Barr Virus|epstein-barr virus
5523007|NCT01196494|Obstructive left-sided colonic cancer|obstructive left-sided colonic cancer
5523008|NCT01196494|Colorectal stent|colorectal stent
5523009|NCT01196494|Intraoperative colon lavage|intraoperative colon lavage
5523010|NCT01196494|Lavage|lavage
5523011|NCT01196494|Stent|stent
5523012|NCT01196468|HIV|hiv
5523013|NCT01196468|Testing|testing
5523014|NCT01196468|Targeted|targeted
5523015|NCT01196468|Indicator|indicator
5523016|NCT01196468|Diseases|diseases
5523017|NCT01196468|Anal dysplasia|anal dysplasia
5523018|NCT01196468|Cervical dysplasia|cervical dysplasia
5523019|NCT01196468|STI|sti
5523020|NCT01196468|Lymphoma|lymphoma
5523021|NCT01196468|Seborrhoeic dermatitis|seborrhoeic dermatitis
5523022|NCT01196468|Exanthema|exanthema
5523023|NCT01196468|Thrombocytpaenia|thrombocytpaenia
5523024|NCT01196468|Lymphopaenia|lymphopaenia
5523025|NCT01196468|Hypergammaglobulinaemia|hypergammaglobulinaemia
5523026|NCT01196455|Metastatic breast cancer patients|metastatic breast cancer patients
5523027|NCT01196403|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5523028|NCT01196403|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5523029|NCT01196403|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5523030|NCT01196403|stage I bladder cancer|stage i bladder cancer
5523031|NCT01196403|stage II bladder cancer|stage ii bladder cancer
5523032|NCT01196403|stage III bladder cancer|stage iii bladder cancer
5523033|NCT01196377|Asthma|asthma
5523034|NCT01196377|Acute asthma|acute asthma
5523035|NCT01196377|Pediatrics|pediatrics
5523036|NCT01196364|Girls|girls
5523037|NCT01196351|boys|boys
5523038|NCT01196351|obesity|obesity
5523039|NCT01196351|physical activity|physical activity
5523040|NCT01196351|exercise|exercise
5523041|NCT01196338|Ankle fracture|ankle fracture
5523042|NCT01196338|Return to work|return to work
5523043|NCT01196338|Return to function|return to function
5523044|NCT01196338|Rehabilitation|rehabilitation
5523045|NCT01196338|Weight-bearing|weight-bearing
5523046|NCT01196325|Diabetes|diabetes
5523047|NCT01196325|Diabetic Macular Edema|diabetic macular edema
5523048|NCT01196325|Laser|laser
5523049|NCT01196325|Anti-VEGF|anti-vegf
5523050|NCT01196325|Morphology|morphology
5523051|NCT01196325|Blood Flow|blood flow
5523052|NCT01196325|Vision|vision
5523053|NCT01196312|anxiety sensitivity|anxiety sensitivity
5523054|NCT01196312|heroin|heroin
5523055|NCT01196299|diffusion tensor imaging|diffusion tensor imaging
5523056|NCT01196299|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5523057|NCT01196299|traumatic brain injury|traumatic brain injury
5523058|NCT01196299|Metabolite changes|metabolite changes
5523059|NCT01196299|Cerebral perfusion|cerebral perfusion
5523060|NCT01196299|Hemorrhagic burden|hemorrhagic burden
5523061|NCT01196286|First-episode psychosis|first-episode psychosis
5523062|NCT01196286|cognitive remediation|cognitive remediation
5523063|NCT01196286|family psychoeducation|family psychoeducation
5523064|NCT01196273|Cardiac Diseases,|cardiac diseases,
5523065|NCT01196273|HIV-Infection,|hiv-infection,
5523066|NCT01196273|AIDS,|aids,
5523067|NCT01196273|Antiretroviral Therapy,|antiretroviral therapy,
5523068|NCT01196273|Cardiovascular Medication,|cardiovascular medication,
5523069|NCT01196273|Risk Factors,|risk factors,
5523070|NCT01196273|coronary heart disease,|coronary heart disease,
5523071|NCT01196273|heart failure,|heart failure,
5523072|NCT01196273|metabolic syndrome|metabolic syndrome
5523073|NCT01196260|efficiency|efficiency
5523074|NCT01196260|capecitabine|capecitabine
5523075|NCT01196260|oxaliplatin|oxaliplatin
5523076|NCT01196260|colorectal cancer|colorectal cancer
5523077|NCT01196247|pancreatic cancer|pancreatic cancer
5523078|NCT01196247|molecular profiling|molecular profiling
5523079|NCT01196247|SU2C|su2c
5523080|NCT01196247|Second line therapy|second line therapy
5523081|NCT01196247|Stage 4|stage 4
5523082|NCT01196208|Disease, Hodgkin|disease, hodgkin
5523083|NCT01196208|Lymphoma|lymphoma
5523084|NCT01196208|Monomethylauristatin E|monomethylauristatin e
5523085|NCT01196208|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5523086|NCT01196208|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5523087|NCT01196208|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5523088|NCT01196208|Antibodies, Monoclonal|antibodies, monoclonal
5523089|NCT01196208|Antibody-Drug Conjugate|antibody-drug conjugate
5523090|NCT01196208|Antigens, CD30|antigens, cd30
5523091|NCT01196208|Hematologic Diseases|hematologic diseases
5523092|NCT01196208|Immunotherapy|immunotherapy
5523093|NCT01196195|antiretroviral therapy|antiretroviral therapy
5523094|NCT01196195|child|child
5523095|NCT01196195|HIV-1|hiv-1
5523096|NCT01196169|daptomycin|daptomycin
5523097|NCT01196169|vancomycin|vancomycin
5523098|NCT01196169|perioperative|perioperative
5523099|NCT01196169|prophylaxis|prophylaxis
5523100|NCT01196169|arthroplasty|arthroplasty
5523101|NCT01196169|prosthesis|prosthesis
5523102|NCT01196169|preoperative|preoperative
5523103|NCT01196156|Infant, Small for Gestational Age|infant, small for gestational age
5523104|NCT01196156|Dwarfism Pituitary|dwarfism pituitary
5523105|NCT01196156|Saizen|saizen
5523106|NCT01196156|Somatropin; Growth Hormone|somatropin; growth hormone
5523107|NCT01196156|Insulin resistance|insulin resistance
5523108|NCT01196143|Ovulation induction|ovulation induction
5523109|NCT01196143|Intrauterine insemination|intrauterine insemination
5523110|NCT01196143|Gonal-f|gonal-f
5523111|NCT01196143|Controlled ovarian stimulation|controlled ovarian stimulation
5683725|NCT00563433|Floxin|floxin
5523112|NCT01196143|Female infertility|female infertility
5523113|NCT01196130|Metastatic colorectal cancer|metastatic colorectal cancer
5523114|NCT01196130|CRC|crc
5523115|NCT01196130|Colorectal adenocarcinoma|colorectal adenocarcinoma
5523116|NCT01196130|Biomarker determination|biomarker determination
5523117|NCT01196130|Tumor tissue|tumor tissue
5523118|NCT01196130|Treatment protocols|treatment protocols
5523119|NCT01196117|automatic positive airway pressure (APAP)|automatic positive airway pressure (apap)
5523120|NCT01196117|continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5523121|NCT01196117|Salivary Cortisol|salivary cortisol
5523123|NCT01196117|Sleep Apnea and/or any Sleep Disordered Breathing|sleep apnea and/or any sleep disordered breathing
5523124|NCT01196091|Lupus|lupus
5523125|NCT01196091|SLE|sle
5523126|NCT01196091|Systemic Lupus Erythematosis|systemic lupus erythematosis
5523127|NCT01196091|autoimmune disease|autoimmune disease
5523128|NCT01196091|LY2127399|ly2127399
5523129|NCT01196091|Immune system disease|immune system disease
5523130|NCT01196026|Influenza|influenza
5523131|NCT01196026|H1N1|h1n1
5523132|NCT01196026|Fluarix|fluarix
5523133|NCT01196026|Pandemrix|pandemrix
5523134|NCT01195987|Hepatitis C|hepatitis c
5523135|NCT01195987|Arthritis|arthritis
5523136|NCT01195974|oral contraceptive, drug interaction, pharmacokinetics|oral contraceptive, drug interaction, pharmacokinetics
5523137|NCT01195961|Direct Current Stimulation|direct current stimulation
5523138|NCT01195961|Learning|learning
5523139|NCT01195961|Cognitive Enhancement|cognitive enhancement
5523140|NCT01195961|Cognitive Tasks|cognitive tasks
5523141|NCT01195961|Cognitive Training|cognitive training
5523142|NCT01195961|Developmental Dyscalculia|developmental dyscalculia
5523143|NCT01195961|Learning Disability|learning disability
5523144|NCT01195961|Cognition Disorder|cognition disorder
5523145|NCT01195948|Uveitis|uveitis
5523146|NCT01195948|Oral Tolerance|oral tolerance
5523147|NCT01195922|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5523148|NCT01195922|Oral Cancer|oral cancer
5523149|NCT01195922|mTOR Inhibitors|mtor inhibitors
5523150|NCT01195922|Targeted Therapies|targeted therapies
5523152|NCT01195922|Head and Neck Cancer|head and neck cancer
5523153|NCT01195922|Squamous Cell Carcinoma|squamous cell carcinoma
5523154|NCT01195922|Tongue Cancer|tongue cancer
5523155|NCT01195883|IV fluid|iv fluid
5523156|NCT01195883|recovery|recovery
5523157|NCT01195883|goal directed fluid replacement|goal directed fluid replacement
5523158|NCT01195883|improved patient recovery|improved patient recovery
5523159|NCT01195870|Multiple sclerosis|multiple sclerosis
5523160|NCT01195870|Rebif|rebif
5523161|NCT01195870|Interferon beta-1a|interferon beta-1a
5523162|NCT01195857|Multiple sclerosis|multiple sclerosis
5523163|NCT01195857|Rebif|rebif
5523164|NCT01195857|Interferon beta-1a|interferon beta-1a
5523165|NCT01195844|Pediatric gastroenteritis, rotavirus infection|pediatric gastroenteritis, rotavirus infection
5523166|NCT01195818|Albuminuria, hyperfiltration, RAS inhibitors, ADMA|albuminuria, hyperfiltration, ras inhibitors, adma
5523167|NCT01195805|Blood pressure, PWV, HRV, PWV, potassium|blood pressure, pwv, hrv, pwv, potassium
5523168|NCT01195792|Opioid receptors|opioid receptors
5523169|NCT01195792|Body weight|body weight
5523170|NCT01195792|Over-eating behaviour|over-eating behaviour
5523171|NCT01195792|Obesity|obesity
5523172|NCT01195792|Fat mass|fat mass
5523173|NCT01195779|immunogenicity|immunogenicity
5523174|NCT01195779|safety|safety
5523175|NCT01195779|Influenza|influenza
5523176|NCT01195779|children|children
5523177|NCT01195779|vaccine|vaccine
5523178|NCT01195766|Hodgkin|hodgkin
5523179|NCT01195766|Ofatumumab|ofatumumab
5523180|NCT01195766|Lymphoma|lymphoma
5523181|NCT01195753|Urea cycle Disorders|urea cycle disorders
5523182|NCT01195740|Suicide Ideation|suicide ideation
5523183|NCT01195740|Depression|depression
5523184|NCT01195740|Family Conflict|family conflict
5523185|NCT01195701|female sexual dysfunction|female sexual dysfunction
5523186|NCT01195701|anorgasmia|anorgasmia
5523187|NCT01195701|clitoral complex|clitoral complex
5523189|NCT01195701|testosterone|testosterone
5523190|NCT01195662|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5523191|NCT01195662|Diabetes Mellitus|diabetes mellitus
5523192|NCT01195662|Endocrine System Diseases|endocrine system diseases
5523193|NCT01195662|Glucose Metabolism Disorders|glucose metabolism disorders
5523194|NCT01195662|Metabolic Diseases|metabolic diseases
5523195|NCT01195662|Angiotensin Receptor Inhibitors|angiotensin receptor inhibitors
5523196|NCT01195662|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5523197|NCT01195662|Antihypertensive Agents|antihypertensive agents
5523198|NCT01195662|Cardiovascular Agents|cardiovascular agents
5523199|NCT01195662|Pharmacological Actions|pharmacological actions
5523200|NCT01195636|Pain from Shingles, PHN, Postherpetic Neuralgia|pain from shingles, phn, postherpetic neuralgia
5523201|NCT01195623|varicose veins|varicose veins
5523202|NCT01195623|venous insufficiency|venous insufficiency
5523203|NCT01195623|surgery|surgery
5904037|NCT00007813|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5523204|NCT01195623|duplex|duplex
5523205|NCT01195623|recurrence|recurrence
5523206|NCT01195597|electronic cigarette|electronic cigarette
5523207|NCT01195597|ENDD|endd
5523208|NCT01195597|nicotine|nicotine
5523209|NCT01195597|smoking cessation|smoking cessation
5523210|NCT01195597|smoking reduction|smoking reduction
5523211|NCT01195584|complication rate in 3 cohorts (BMI < 25, > 25 and > 30)|complication rate in 3 cohorts (bmi < 25, > 25 and > 30)
5523212|NCT01195558|Non-24|non-24
5523213|NCT01195558|N24HSWD|n24hswd
5523214|NCT01195558|Blindness|blindness
5523215|NCT01195558|Sleep|sleep
5523216|NCT01195558|Wake|wake
5523217|NCT01195558|Circadian Rhythm|circadian rhythm
5523219|NCT01195545|Veritas® Collagen Matrix, Hiatal hernia|veritas® collagen matrix, hiatal hernia
5523220|NCT01195532|hypoglycemic drug|hypoglycemic drug
5523221|NCT01195519|peritoneal dialysis|peritoneal dialysis
5523222|NCT01195519|hemodialysis patients|hemodialysis patients
5523223|NCT01195506|We Will Collect the Bone Marrow Specimens From AML Patients|we will collect the bone marrow specimens from aml patients
5523224|NCT01195493|Chronic periodontitis|chronic periodontitis
5523225|NCT01195480|Immunotherapy|immunotherapy
5523226|NCT01195480|Gene Therapy|gene therapy
5523227|NCT01195480|Paediatric|paediatric
5523228|NCT01195480|B cell Acute Lymphoblastic Leukaemia|b cell acute lymphoblastic leukaemia
5523229|NCT01195441|Preeclampsia|preeclampsia
5523230|NCT01195441|Doppler ultrasound|doppler ultrasound
5523231|NCT01195441|First trimester|first trimester
5523232|NCT01195441|Acetylsalicylic acid|acetylsalicylic acid
5523233|NCT01195402|COPD|copd
5523234|NCT01195402|pulmonary rehabilitation|pulmonary rehabilitation
5523235|NCT01195389|dementia|dementia
5523236|NCT01195389|memory loss|memory loss
5523237|NCT01195389|cognitive decline|cognitive decline
5523238|NCT01195376|PI3K|pi3k
5523239|NCT01195376|mTOR|mtor
5523240|NCT01195376|Advanced solid tumor|advanced solid tumor
5523241|NCT01195363|bipolar disorder, mania, depression|bipolar disorder, mania, depression
5523242|NCT01195350|Ischemic Stroke|ischemic stroke
5523243|NCT01195350|Hemorrhagic Stroke|hemorrhagic stroke
5523244|NCT01195350|Blood pressure|blood pressure
5523245|NCT01195350|Intensive care|intensive care
5523246|NCT01195337|Sedentary minority adult|sedentary minority adult
5523247|NCT01195337|Psychosocial factors|psychosocial factors
5523248|NCT01195337|Environmental factors|environmental factors
5523249|NCT01195337|Obesity|obesity
5523250|NCT01195337|Physical Activity|physical activity
5523251|NCT01195337|PA|pa
5523252|NCT01195337|Cancer Risk|cancer risk
5523253|NCT01195337|African Americans|african americans
5523254|NCT01195337|Latino|latino
5523255|NCT01195324|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5523256|NCT01195324|Warfarin|warfarin
5523257|NCT01195324|Pharmacokinetic|pharmacokinetic
5523258|NCT01195324|Pharmacodynamic|pharmacodynamic
5523259|NCT01195324|Prothrombin time (PT)|prothrombin time (pt)
5523260|NCT01195324|International normalized ratio (INR)|international normalized ratio (inr)
5523261|NCT01195311|Refractory, Advanced malignancies|refractory, advanced malignancies
5523262|NCT01195298|metastatic breast cancer|metastatic breast cancer
5523263|NCT01195298|elderly patients|elderly patients
5523264|NCT01195298|chemoimmunotherapy|chemoimmunotherapy
5523265|NCT01195298|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
5523266|NCT01195285|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5523267|NCT01195285|Quality of life|quality of life
5523268|NCT01195285|Biliary Cholic|biliary cholic
5523269|NCT01195285|Chronic Cholecystitis|chronic cholecystitis
5523270|NCT01195285|Symptomatic Cholelithiasis|symptomatic cholelithiasis
5523271|NCT01195259|rosiglitazone|rosiglitazone
5523272|NCT01195259|ADOPT|adopt
5523273|NCT01195259|metformin|metformin
5523274|NCT01195259|malignancy|malignancy
5523275|NCT01195259|RECORD|record
5523276|NCT01195246|end stage renal failure|end stage renal failure
5523277|NCT01195246|renal failure|renal failure
5523278|NCT01195246|kidney failure|kidney failure
5523279|NCT01195246|kidney failure, chronic|kidney failure, chronic
5523280|NCT01195246|chronic kidney failure|chronic kidney failure
5523281|NCT01195246|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
5523282|NCT01195246|hepatitis B vaccine|hepatitis b vaccine
5523283|NCT01195246|hepatitis B|hepatitis b
5523284|NCT01195246|hepatitis|hepatitis
5523285|NCT01195246|HBV|hbv
5523286|NCT01195246|prevention and control|prevention and control
5523287|NCT01195246|dialysis|dialysis
5523288|NCT01195233|Xerostomia|xerostomia
5523289|NCT01195233|Radiotherapy of head and neck|radiotherapy of head and neck
5523290|NCT01195233|BioXtra|bioxtra
5523291|NCT01195220|STI screening|sti screening
5523292|NCT01195220|Emergency Department|emergency department
5523294|NCT01195220|Gonorrhea|gonorrhea
5523295|NCT01195220|HIV|hiv
5523296|NCT01195220|behavior|behavior
5523297|NCT01195220|teenagers|teenagers
5523298|NCT01195220|intervention|intervention
5523299|NCT01195207|CNTO 3157|cnto 3157
5523300|NCT01195207|healthy volunteers|healthy volunteers
5523301|NCT01195207|asthma|asthma
5523302|NCT01195194|T-cell lymphocyte allo-recognition|t-cell lymphocyte allo-recognition
5523303|NCT01195194|CNI-free immunosuppressive regimen|cni-free immunosuppressive regimen
5523304|NCT01195194|Enzyme-linked immunospot (ELISPOT)|enzyme-linked immunospot (elispot)
5523305|NCT01195181|peginterferon alfa 2a and 2b type|peginterferon alfa 2a and 2b type
5523306|NCT01195181|ribavirin|ribavirin
5523307|NCT01195181|chronic hepatitis C|chronic hepatitis c
5523308|NCT01195181|antiviral therapy cost/efficacy|antiviral therapy cost/efficacy
5523309|NCT01195181|viral kinetics|viral kinetics
5523310|NCT01195168|PCOS|pcos
5523311|NCT01195155|PCOS|pcos
5523312|NCT01195142|PCOS|pcos
5523313|NCT01195129|Stent|stent
5523314|NCT01195129|cerebral aneursym|cerebral aneursym
5523315|NCT01195129|neurology|neurology
5523316|NCT01195129|radiology|radiology
5523317|NCT01195116|Post-operative pain management|post-operative pain management
5523318|NCT01195116|Pain Management|pain management
5523319|NCT01195116|Painful bladder syndrome|painful bladder syndrome
5523320|NCT01195116|frequency and urgency|frequency and urgency
5523321|NCT01195116|Dexmedetomidine|dexmedetomidine
5523322|NCT01195116|hydrodistension|hydrodistension
5523323|NCT01195103|Procedural sedation|procedural sedation
5523324|NCT01195103|Regional Anesthesia block|regional anesthesia block
5523325|NCT01195103|Orthopedic surgery|orthopedic surgery
5523326|NCT01195103|Lusedra|lusedra
5523327|NCT01195103|Fospropofol disodium|fospropofol disodium
5523328|NCT01195103|Midazolam|midazolam
5523329|NCT01195090|sitagliptin|sitagliptin
5523330|NCT01195090|pioglitazone|pioglitazone
5523331|NCT01195090|type 2 diabetes|type 2 diabetes
5523333|NCT01195077|Dietary intervention|dietary intervention
5523334|NCT01195077|Algae|algae
5523335|NCT01195077|HIV progression|hiv progression
5523336|NCT01195077|Algae specific kind|algae specific kind
5523337|NCT01195064|COPD patients|copd patients
5523338|NCT01195064|OSAS patients|osas patients
5523339|NCT01195064|cardiovascular surgery|cardiovascular surgery
5523340|NCT01195064|Endothelial function|endothelial function
5523341|NCT01195051|Medication Reconciliation|medication reconciliation
5523342|NCT01195051|Inpatient|inpatient
5523343|NCT01195051|Electronic Medical Records|electronic medical records
5798708|NCT00111293|Top-Down|top-down
5523344|NCT01195038|Avian influenza, H5N1, pandemic, recombinant HA vaccine|avian influenza, h5n1, pandemic, recombinant ha vaccine
5523345|NCT01195025|Blood volume|blood volume
5523346|NCT01195025|blood coagulation|blood coagulation
5523347|NCT01195025|volume kinetics|volume kinetics
5523348|NCT01195012|child|child
5523349|NCT01195012|primary care|primary care
5523350|NCT01195012|treatment|treatment
5523351|NCT01195012|parenting|parenting
5523352|NCT01195012|lifestyle behaviors|lifestyle behaviors
5523353|NCT01194999|OAB|oab
5523354|NCT01194999|Urinary Bladder, Overactive|urinary bladder, overactive
5523355|NCT01194999|Overactive Bladder Syndrome|overactive bladder syndrome
5523356|NCT01194999|VESIcare|vesicare
5523357|NCT01194999|Urgency|urgency
5523358|NCT01194999|Nocturia|nocturia
5523359|NCT01194999|Frequency|frequency
5523360|NCT01194999|Urge Urinary Incontinence|urge urinary incontinence
5523361|NCT01194999|UUI|uui
5523362|NCT01194999|Pubovaginal Sling|pubovaginal sling
5523363|NCT01194999|PVS|pvs
5523364|NCT01194999|Incontinence|incontinence
5523365|NCT01194986|Receptor binding|receptor binding
5523366|NCT01194986|Histamine H3 receptor|histamine h3 receptor
5523367|NCT01194986|binding|binding
5523368|NCT01194986|radioligand|radioligand
5523369|NCT01194973|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5523370|NCT01194960|cancer of prostate|cancer of prostate
5523371|NCT01194960|cancer of the prostate|cancer of the prostate
5523372|NCT01194960|neoplasms prostate|neoplasms prostate
5523373|NCT01194960|neoplasms prostatic|neoplasms prostatic
5523374|NCT01194960|prostate cancer|prostate cancer
5523375|NCT01194960|prostate neoplasms|prostate neoplasms
5523376|NCT01194960|prostatic cancer|prostatic cancer
5523377|NCT01194960|prostate specific antigen|prostate specific antigen
5523378|NCT01194960|prostatic hyperplasia|prostatic hyperplasia
5523379|NCT01194947|banal-appearing nevi|banal-appearing nevi
5523380|NCT01194947|NEVUS|nevus
5523381|NCT01194934|Stem Cell Transplantation|stem cell transplantation
5523383|NCT01194934|L-oligonucleotide Aptamer|l-oligonucleotide aptamer
5523384|NCT01194934|Spiegelmer|spiegelmer
5523385|NCT01194934|Hematopoietic Stem Cells|hematopoietic stem cells
5523386|NCT01194908|Breast Cancer|breast cancer
5523387|NCT01194908|Breast Tumors|breast tumors
5523388|NCT01194908|Breast Neoplasms|breast neoplasms
5523389|NCT01194895|esophagectomy|esophagectomy
5523390|NCT01194895|acute lung injury|acute lung injury
5523391|NCT01194895|protective ventilation|protective ventilation
5523392|NCT01194869|Breast Cancer|breast cancer
5523393|NCT01194856|HIV|hiv
5523394|NCT01194856|Lipoatrophy|lipoatrophy
5523689|NCT01193491|Hsp90|hsp90
5523395|NCT01194856|mitochondrial dysfunction|mitochondrial dysfunction
5523396|NCT01194817|total knee arthroplasty|total knee arthroplasty
5523397|NCT01194817|total knee replacement|total knee replacement
5523398|NCT01194817|cementless TKA|cementless tka
5523399|NCT01194817|high flexion|high flexion
5523400|NCT01194817|trabecular metal|trabecular metal
5671479|NCT00615888|morbidity and mortality|morbidity and mortality
5523401|NCT01194804|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
5523402|NCT01194804|Eculizumab|eculizumab
5523404|NCT01194791|Amyloidosis|amyloidosis
5523405|NCT01194791|Lenalidomide|lenalidomide
5523406|NCT01194713|Alzheimer Disease|alzheimer disease
5523407|NCT01194713|Cerebrospinal fluid|cerebrospinal fluid
5523410|NCT01194700|lung bioavailability|lung bioavailability
5523411|NCT01194700|asthma|asthma
5523412|NCT01194700|seretide|seretide
5523413|NCT01194700|Spacer|spacer
5509603|NCT01254890|5-azacitidine|5-azacitidine
5523414|NCT01194687|Estrogens|estrogens
5523415|NCT01194687|Fecal Microbiome|fecal microbiome
5523416|NCT01194687|Fecal Occult Blood|fecal occult blood
5523417|NCT01194674|Microplasmin|microplasmin
5523418|NCT01194674|Macular Edema|macular edema
5523419|NCT01194674|Uveitis|uveitis
5523420|NCT01194661|Inhibitory Control|inhibitory control
5523421|NCT01194661|Executive Function|executive function
5523422|NCT01194661|fMRI|fmri
5523424|NCT01194661|TBI|tbi
5523425|NCT01194661|Traumatic Brain Injury|traumatic brain injury
5523426|NCT01194661|Healthy Volunteer|healthy volunteer
5523427|NCT01194661|HV|hv
5523428|NCT01194648|urinary incontinence|urinary incontinence
5523429|NCT01194648|male erectile disorder|male erectile disorder
5523430|NCT01194648|therapy-related toxicity|therapy-related toxicity
5523431|NCT01194648|stage I prostate cancer|stage i prostate cancer
5523432|NCT01194648|stage IIB prostate cancer|stage iib prostate cancer
5523433|NCT01194648|stage IIA prostate cancer|stage iia prostate cancer
5523434|NCT01194635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5523435|NCT01194635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5523436|NCT01194635|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5523437|NCT01194635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5523438|NCT01194635|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5523439|NCT01194635|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5798709|NCT00111293|Visual Processing|visual processing
5523440|NCT01194635|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5523441|NCT01194609|Low dose radiation|low dose radiation
5523442|NCT01194609|Adoptive immune cell therapy|adoptive immune cell therapy
5523443|NCT01194609|Cervical cancer|cervical cancer
5523445|NCT01194596|smoking cessation advice|smoking cessation advice
5523446|NCT01194596|spirometry|spirometry
5523447|NCT01194596|primary health care|primary health care
5523448|NCT01194583|electronic cigarette|electronic cigarette
5523449|NCT01194583|nicotine|nicotine
5523450|NCT01194583|smoking cessation|smoking cessation
5523451|NCT01194583|smoking reduction|smoking reduction
5523452|NCT01194557|history of fever|history of fever
5523453|NCT01194557|measured fever|measured fever
5523454|NCT01194557|appropriate treatment|appropriate treatment
5523455|NCT01194557|appropriate referral|appropriate referral
5523456|NCT01194531|Preimplantation Gentic Screening|preimplantation gentic screening
5523457|NCT01194531|PGS|pgs
5523458|NCT01194531|In Vitro Fertilization|in vitro fertilization
5523459|NCT01194531|IVF|ivf
5523460|NCT01194531|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5523461|NCT01194531|PGD|pgd
5523462|NCT01194518|Life experience|life experience
5523463|NCT01194518|Life style|life style
5523464|NCT01194518|Health behavior|health behavior
5523465|NCT01194518|Mixed method|mixed method
5523466|NCT01194505|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5523467|NCT01194505|obturator nerve block|obturator nerve block
5523468|NCT01194505|sciatic nerve block|sciatic nerve block
5523469|NCT01194505|femoral nerve block|femoral nerve block
5523470|NCT01194505|posterior lumbar plexus block|posterior lumbar plexus block
5523471|NCT01194505|ultrasound guided nerve block|ultrasound guided nerve block
5523472|NCT01194492|plasma albumin|plasma albumin
5523473|NCT01194492|inflammatory reaction|inflammatory reaction
5523474|NCT01194492|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5523475|NCT01194479|type 1 diabetes|type 1 diabetes
5523476|NCT01194479|hypoglycemia|hypoglycemia
5523477|NCT01194479|formoterol|formoterol
5523478|NCT01194466|Head and Neck Cancer|head and neck cancer
5523479|NCT01194466|Oral Cancer|oral cancer
5523480|NCT01194466|Laryngeal Cancer|laryngeal cancer
5523481|NCT01194466|Oropharyngeal Cancer|oropharyngeal cancer
5523482|NCT01194466|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5523483|NCT01194466|Oral Mucositis|oral mucositis
5523484|NCT01194466|Pain|pain
5523485|NCT01194466|Function|function
5523486|NCT01194466|TENS|tens
5523487|NCT01194466|Functional Pain|functional pain
5523488|NCT01194466|Non-pharamcologic|non-pharamcologic
5523489|NCT01194466|Quality of Life|quality of life
5523490|NCT01194427|Preoperative|preoperative
5523491|NCT01194427|Neoadjuvant|neoadjuvant
5523492|NCT01194388|Patients presenting with an intracranial aneurysm|patients presenting with an intracranial aneurysm
5523493|NCT01194362|aortic valve disease|aortic valve disease
5523494|NCT01194362|gene expression|gene expression
5523495|NCT01194349|S. pneumoniae|s. pneumoniae
5523496|NCT01194349|thrombocytosis|thrombocytosis
5523497|NCT01194349|pediatric patients|pediatric patients
5523498|NCT01194349|The study aimed to understand the diagnostic value of thrombocytosis in children with S. pneumoniae infection|the study aimed to understand the diagnostic value of thrombocytosis in children with s. pneumoniae infection
5523499|NCT01194336|Central nervous system|central nervous system
5648016|NCT00710788|death|death
5523500|NCT01194336|Cholinesterase|cholinesterase
5523501|NCT01194336|Neurocognitive performance testing|neurocognitive performance testing
5523502|NCT01194323|esophageal erosion|esophageal erosion
5523503|NCT01194323|abnormal pH monitoring|abnormal ph monitoring
5523505|NCT01194310|cataract|cataract
5523506|NCT01194297|influenza|influenza
5523507|NCT01194297|premature infant|premature infant
5523508|NCT01194297|very low birth weight infant|very low birth weight infant
5523509|NCT01194297|immunization|immunization
5523510|NCT01194297|vaccine|vaccine
5523511|NCT01194271|Hormone Ablation|hormone ablation
5523512|NCT01194271|Prostate adenocarcinoma|prostate adenocarcinoma
5523513|NCT01194271|Radical prostatectomy|radical prostatectomy
5523514|NCT01194271|Leuprolide Acetate|leuprolide acetate
5523515|NCT01194271|Lupron Depot|lupron depot
5523516|NCT01194271|Ipilimumab|ipilimumab
5523517|NCT01194271|BMS-734016|bms-734016
5523518|NCT01194271|MDX010|mdx010
5523519|NCT01194258|Type 2 diabetes|type 2 diabetes
5523520|NCT01194245|Type 1 diabetes|type 1 diabetes
5523521|NCT01194232|Cystic Fibrosis|cystic fibrosis
5523523|NCT01194232|CMRI|cmri
5523524|NCT01194232|vascularization|vascularization
5523525|NCT01194232|perfusion|perfusion
5523526|NCT01194219|Plaque Psoriasis|plaque psoriasis
5523527|NCT01194193|Cancer|cancer
5523528|NCT01194193|Advanced solid tumours|advanced solid tumours
5523529|NCT01194193|lymphomas|lymphomas
5523530|NCT01194193|dose escalation|dose escalation
5523531|NCT01194193|preliminary anti-tumour activity|preliminary anti-tumour activity
5523532|NCT01194193|Tor kinase inhibitor|tor kinase inhibitor
5523533|NCT01194193|oral administration|oral administration
5523534|NCT01194193|intermittent dosing|intermittent dosing
5526319|NCT01182909|NPC|npc
5523539|NCT01194141|Barth syndrome|barth syndrome
5523540|NCT01194141|cardiomyopathy|cardiomyopathy
5523541|NCT01194141|mitochondria|mitochondria
5523542|NCT01194141|cardiolipin|cardiolipin
5523543|NCT01194128|caregivers,|caregivers,
5523544|NCT01194128|institutionalization,|institutionalization,
5523545|NCT01194128|dementia patients,|dementia patients,
5523546|NCT01194128|bereavement,|bereavement,
5523547|NCT01194128|grief|grief
5523548|NCT01194128|complicated grief|complicated grief
5523549|NCT01194115|surgical site infection|surgical site infection
5523550|NCT01194115|obesity|obesity
5523551|NCT01194115|pregnancy|pregnancy
5523552|NCT01194115|cesarean section|cesarean section
5523553|NCT01194115|cesarean delivery|cesarean delivery
5523554|NCT01194102|Stroke|stroke
5523555|NCT01194102|Exercise|exercise
5523556|NCT01194102|Physical function|physical function
5523557|NCT01194102|Community program|community program
5523558|NCT01194102|Patient education|patient education
5523559|NCT01194102|Self-management|self-management
5523560|NCT01194089|Nicotine|nicotine
5523561|NCT01194089|Postoperative pain|postoperative pain
5523562|NCT01194089|Bariatric surgery|bariatric surgery
5523563|NCT01194076|cognitive behavior therapy|cognitive behavior therapy
5523564|NCT01194076|exposure and response prevention|exposure and response prevention
5523565|NCT01194076|pediatric|pediatric
5523566|NCT01194076|obsessive compulsive disorder|obsessive compulsive disorder
5523567|NCT01194076|child|child
5523568|NCT01194076|anxiety|anxiety
5523569|NCT01194076|intensive|intensive
5523571|NCT01194076|CBT|cbt
5523572|NCT01194063|short bowel syndrome|short bowel syndrome
5523573|NCT01194063|parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5523574|NCT01194063|pediatric|pediatric
5523575|NCT01194037|Hepatitis C|hepatitis c
5523576|NCT01194037|HCV|hcv
5523577|NCT01194037|Interferon|interferon
5523578|NCT01194037|Hanferon|hanferon
5523579|NCT01194024|Inhalation Injury, Smoke|inhalation injury, smoke
5523581|NCT01194011|Health care quality, information openness, health care information website|health care quality, information openness, health care information website
5523582|NCT01193972|Smoking cessation|smoking cessation
5523583|NCT01193972|Smoking|smoking
5523584|NCT01193972|Tobacco|tobacco
5523585|NCT01193946|Protein requirement|protein requirement
5523586|NCT01193946|Elderly women|elderly women
5523690|NCT01193478|Hepatitis C|hepatitis c
5523587|NCT01193946|Indicator amino acid oxidation|indicator amino acid oxidation
5523588|NCT01193933|adult ALL|adult all
5523589|NCT01193933|Ph-negative|ph-negative
5523590|NCT01193933|dexamethasone|dexamethasone
5523591|NCT01193933|L-asparaginase|l-asparaginase
5523592|NCT01193920|Group B streptococcus|group b streptococcus
5523593|NCT01193920|GBS|gbs
5523594|NCT01193920|Vaccine|vaccine
5523595|NCT01193920|Prevention of group B streptococcus infection|prevention of group b streptococcus infection
5523596|NCT01193907|Typhoid fever|typhoid fever
5523597|NCT01193907|Glycoconjugate vaccine|glycoconjugate vaccine
5523598|NCT01193907|Vi polysaccharide|vi polysaccharide
5523599|NCT01193907|Immunogenicity|immunogenicity
5523600|NCT01193894|IBD|ibd
5523601|NCT01193894|UC|uc
5523602|NCT01193894|Profermin|profermin
5523603|NCT01193894|Fresubin|fresubin
5523604|NCT01193894|Probiotics|probiotics
5523605|NCT01193894|Dietetic|dietetic
5523606|NCT01193855|stage IIB prostate cancer|stage iib prostate cancer
5523607|NCT01193855|stage IIA prostate cancer|stage iia prostate cancer
5523608|NCT01193816|restlessness during mechanical ventilation weaning|restlessness during mechanical ventilation weaning
5523609|NCT01193803|Prosthetic Joint Infections|prosthetic joint infections
5523610|NCT01193803|Vertebral Osteomyelitis|vertebral osteomyelitis
5523611|NCT01193803|Septic arthritis|septic arthritis
5523612|NCT01193803|Molecular methods|molecular methods
5523613|NCT01193790|chronic tonsillitis|chronic tonsillitis
5523614|NCT01193790|radio-frequency coblation|radio-frequency coblation
5523615|NCT01193790|radio-frequency coblation in chronic tonsillitis treatment|radio-frequency coblation in chronic tonsillitis treatment
5523616|NCT01193777|Carnitine|carnitine
5523618|NCT01193777|Sepsis|sepsis
5523619|NCT01193764|acne|acne
5523620|NCT01193764|cocoa|cocoa
5523621|NCT01193764|chocolate|chocolate
5523622|NCT01193764|gelatin|gelatin
5523623|NCT01193764|pustule|pustule
5523624|NCT01193764|comedones|comedones
5523625|NCT01193764|papules|papules
5523626|NCT01193764|pustules|pustules
5523627|NCT01193751|Birth Asphyxia|birth asphyxia
5523628|NCT01193751|Newborn's Resuscitation|newborn's resuscitation
5523629|NCT01193751|Death|death
5523630|NCT01193751|Neurodevelopmental Impairment|neurodevelopmental impairment
5523637|NCT01193660|stem cell|stem cell
5523638|NCT01193660|cerebral palsy|cerebral palsy
5523639|NCT01193634|ICD VR 9250, DR 9550 and CRT 9750 - PARADYM RF ICD|icd vr 9250, dr 9550 and crt 9750 - paradym rf icd
5523640|NCT01193621|early evaluation|early evaluation
5523641|NCT01193621|pharmacokinetics|pharmacokinetics
5523642|NCT01193621|pharmacodynamics|pharmacodynamics
5523643|NCT01193621|Biodistribution|biodistribution
5523644|NCT01193621|D2-receptor occupancy|d2-receptor occupancy
5523645|NCT01193608|Randomized|randomized
5523646|NCT01193608|Safety Study|safety study
5523647|NCT01193608|Adaptive|adaptive
5523648|NCT01193608|Double Blind|double blind
5523649|NCT01193582|Prevenar|prevenar
5523650|NCT01193582|catch-up|catch-up
5523651|NCT01193582|pneumococcal|pneumococcal
5523652|NCT01193582|pneumonia|pneumonia
5523653|NCT01193556|Tonsillectomy|tonsillectomy
5523654|NCT01193556|PlasmaBlade|plasmablade
5523655|NCT01193556|Electrosurgery|electrosurgery
5523656|NCT01193556|PEAK Surgical|peak surgical
5523657|NCT01193556|Medtronic Advanced Energy|medtronic advanced energy
5523658|NCT01193556|Medtronic|medtronic
5523659|NCT01193530|Sleep Disturbances|sleep disturbances
5523660|NCT01193530|Depression|depression
5523661|NCT01193530|Anxiety|anxiety
5523662|NCT01193530|Fatigue|fatigue
5523663|NCT01193530|Quality of life|quality of life
5523664|NCT01193517|Refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
5523665|NCT01193517|CRC|crc
5523666|NCT01193517|colorectal adenocarcinoma with metastatic disease|colorectal adenocarcinoma with metastatic disease
5523667|NCT01193517|Azacitidine|azacitidine
5523668|NCT01193517|5-Azacytidine|5-azacytidine
5523669|NCT01193517|5-aza|5-aza
5523670|NCT01193517|Vidaza|vidaza
5523671|NCT01193517|5-AZC|5-azc
5523672|NCT01193517|AZA-CR|aza-cr
5523673|NCT01193517|Ladakamycin|ladakamycin
5523674|NCT01193517|NSC-102816|nsc-102816
5523675|NCT01193517|Capecitabine|capecitabine
5523676|NCT01193517|Oxaliplatin|oxaliplatin
5523677|NCT01193517|CAPOX|capox
5523678|NCT01193517|Xeloda|xeloda
5523679|NCT01193517|Eloxatin|eloxatin
5523680|NCT01193517|Hypermethylation|hypermethylation
5523681|NCT01193517|CpG island methylator phenotype|cpg island methylator phenotype
5523682|NCT01193504|Prevention of Retinal Thickening and CME Following Phacoemulsification|prevention of retinal thickening and cme following phacoemulsification
5523683|NCT01193504|Pseudophakia following cataract surgery|pseudophakia following cataract surgery
5523684|NCT01193491|Phase 1|phase 1
5523685|NCT01193491|AML|aml
5523686|NCT01193491|CML|cml
5523687|NCT01193491|MPD|mpd
5523688|NCT01193491|Client Proteins|client proteins
5523691|NCT01193478|HCV RNA|hcv rna
5523692|NCT01193478|multiple ascending dose|multiple ascending dose
5523693|NCT01193478|NS5A|ns5a
5523694|NCT01193478|GS-5885|gs-5885
5523695|NCT01193478|chronic genotype 1 HCV infection|chronic genotype 1 hcv infection
5523696|NCT01193465|Humidity|humidity
5523697|NCT01193465|Temperature|temperature
5523698|NCT01193465|Low Flow Anesthesia|low flow anesthesia
5523699|NCT01193452|elderly patients|elderly patients
5523700|NCT01193452|advanced colorectal cancer|advanced colorectal cancer
5523701|NCT01193452|chemotherapy|chemotherapy
5523702|NCT01193452|S-1|s-1
5523703|NCT01193452|5-fluorouracil|5-fluorouracil
5523704|NCT01193452|leucovorin|leucovorin
5523705|NCT01193439|thoracoscopy|thoracoscopy
5523706|NCT01193439|pleural diseases|pleural diseases
5523707|NCT01193439|complications|complications
5523708|NCT01193439|safety|safety
5523709|NCT01193426|Hepatic|hepatic
5523710|NCT01193426|cirrhosis|cirrhosis
5523711|NCT01193426|IL-6|il-6
5523712|NCT01193426|IL-8|il-8
5523713|NCT01193426|Leptine|leptine
5523714|NCT01193413|acute pancreatitis|acute pancreatitis
5648292|NCT00709761|MBC|mbc
5523715|NCT01193413|Drainage|drainage
5523716|NCT01193413|Pancreatic surgery|pancreatic surgery
5523717|NCT01193413|Biological Markers/analysis|biological markers/analysis
5523718|NCT01193413|Infection diagnosis|infection diagnosis
5523719|NCT01193413|ROC Curve|roc curve
5523720|NCT01193413|Sensitivity and Specificity|sensitivity and specificity
5523721|NCT01193413|Endoscopic ultrasonography|endoscopic ultrasonography
5523722|NCT01193400|Acute myelogenous leukemia|acute myelogenous leukemia
5523723|NCT01193400|Clofarabine|clofarabine
5523724|NCT01193400|Cytarabine|cytarabine
5523725|NCT01193374|Childhood Obesity|childhood obesity
5523726|NCT01193374|Primary Care|primary care
5523727|NCT01193374|Counseling|counseling
5523728|NCT01193374|Screening|screening
5526441|NCT01182389|Catheter Ablation|catheter ablation
5523729|NCT01193348|Atypical Hemolytic-Uremic Syndrome|atypical hemolytic-uremic syndrome
5523730|NCT01193335|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5523731|NCT01193335|premature|premature
5523732|NCT01193335|immunization|immunization
5523733|NCT01193335|safety.|safety.
5523734|NCT01193296|Diabetes mellitus, vildagliptin, continuous glucose monitoring|diabetes mellitus, vildagliptin, continuous glucose monitoring
5523735|NCT01193283|Aplastic Anemia|aplastic anemia
5523736|NCT01193283|Immunosuppression|immunosuppression
5523737|NCT01193283|T-Cells|t-cells
5523738|NCT01193283|Hematopoiesis|hematopoiesis
5523739|NCT01193283|Autoimmunity|autoimmunity
5523740|NCT01193283|Severe Aplastic Anemia|severe aplastic anemia
5523741|NCT01193270|NICHD Neonatal Research Network|nichd neonatal research network
5523742|NCT01193270|Intraventricular Hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5523743|NCT01193270|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5523744|NCT01193270|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5523745|NCT01193270|Prematurity|prematurity
5523746|NCT01193257|Drug therapy|drug therapy
5523747|NCT01193231|Laser Vision Correction|laser vision correction
5523748|NCT01193231|Photorefractive Keratectomy|photorefractive keratectomy
5523749|NCT01193231|PRK|prk
5523750|NCT01193231|Nearsighted|nearsighted
5523751|NCT01193231|Myopia|myopia
5523752|NCT01193205|Borderline Personality Disorder|borderline personality disorder
5523753|NCT01193205|Skills Training|skills training
5523754|NCT01193205|Dialectical Behavior Therapy|dialectical behavior therapy
5523755|NCT01193205|Suicidal and parasuicidal behavior|suicidal and parasuicidal behavior
5523756|NCT01193192|Neevo|neevo
5523757|NCT01193192|Neevo DHA|neevo dha
5523758|NCT01193192|L-methylfolate|l-methylfolate
5523759|NCT01193192|anemia during pregnancy|anemia during pregnancy
5523760|NCT01193192|folic acid|folic acid
5523761|NCT01193192|vitamin B12|vitamin b12
5523762|NCT01193192|prenatal vitamins|prenatal vitamins
5523763|NCT01193192|hemoglobin|hemoglobin
5523764|NCT01193192|iron deficiency|iron deficiency
5523765|NCT01193192|Pregnancy|pregnancy
5523766|NCT01193166|Schizophrenia|schizophrenia
5523767|NCT01193166|Risperidone|risperidone
5523768|NCT01193166|Risperdal|risperdal
5505652|NCT01272284|Stress|stress
5523769|NCT01193166|Paliperidone palmitate|paliperidone palmitate
5523770|NCT01193166|Aripiprazole|aripiprazole
5523771|NCT01193166|Haloperidol|haloperidol
5523772|NCT01193166|Olanzapine|olanzapine
5523773|NCT01193166|Paliperidone|paliperidone
5523774|NCT01193166|Perphenazine|perphenazine
5523775|NCT01193166|Quetiapine|quetiapine
5523776|NCT01193153|schizoaffective disorder|schizoaffective disorder
5523777|NCT01193153|paliperidone palmitate|paliperidone palmitate
5523778|NCT01193153|INVEGA SUSTENNA|invega sustenna
5523779|NCT01193153|schizoaffective disorder relapse prevention|schizoaffective disorder relapse prevention
5523780|NCT01193140|veliparib|veliparib
5523781|NCT01193140|relapsed and refractory tumors|relapsed and refractory tumors
5523782|NCT01193140|Temodar|temodar
5523783|NCT01193140|temozolomide|temozolomide
5523784|NCT01193140|ABT-888|abt-888
5523785|NCT01193140|Solid Tumors|solid tumors
5523786|NCT01193114|substance abuse|substance abuse
5523787|NCT01193114|homeless mothers|homeless mothers
5523789|NCT01193101|blood pressure|blood pressure
5523790|NCT01193101|LCZ696|lcz696
5523791|NCT01193101|dual-acting|dual-acting
5523792|NCT01193101|neprilysin|neprilysin
5523793|NCT01193101|nep inhibitor|nep inhibitor
5523794|NCT01193101|vasopeptidase|vasopeptidase
5523795|NCT01193101|angiotensin receptor|angiotensin receptor
5523796|NCT01193101|ARNi|arni
5523797|NCT01193101|Essential hypertension|essential hypertension
5523798|NCT01193088|CMT|cmt
5523799|NCT01193088|CMT1A|cmt1a
5523800|NCT01193075|Charcot Marie Tooth disease|charcot marie tooth disease
5523801|NCT01193075|CMT|cmt
5523802|NCT01193075|HMSN|hmsn
5523803|NCT01193075|HMN|hmn
5523804|NCT01193075|HSN|hsn
5523805|NCT01193075|CMT1|cmt1
5523806|NCT01193075|CMT2|cmt2
5523807|NCT01193062|healthy volunteers|healthy volunteers
5523808|NCT01193062|pharmacokinetics-pharmacodynamics|pharmacokinetics-pharmacodynamics
5523809|NCT01193062|cerebrospinal fluid|cerebrospinal fluid
5523810|NCT01193062|serial sampling|serial sampling
5523811|NCT01193049|Nasal Allergen Challenge, Inhaled Allergen Challenge, Asthma|nasal allergen challenge, inhaled allergen challenge, asthma
5648395|NCT00709462|Vaccine|vaccine
5523812|NCT01193036|Psychosocial|psychosocial
5523813|NCT01193036|Skin Problems|skin problems
5523814|NCT01193036|Supportive Care|supportive care
5523815|NCT01193036|Melanoma|melanoma
5523816|NCT01193036|Questionnaire|questionnaire
5523817|NCT01193023|Prospective Studies|prospective studies
5523818|NCT01193023|Humans, pediatric|humans, pediatric
5523819|NCT01193023|Positive-Pressure Respiration/methods*|positive-pressure respiration/methods*
5523820|NCT01193023|Respiration, Artificial/methods*|respiration, artificial/methods*
5523821|NCT01193023|Intensive Care|intensive care
5523822|NCT01193023|Intensive Care Units/statistics & numerical data*|intensive care units/statistics & numerical data*
5523823|NCT01193023|Respiration, Artificial/statistics & numerical data*|respiration, artificial/statistics & numerical data*
5523824|NCT01193023|Patients/statistics & numerical data*|patients/statistics & numerical data*
5523825|NCT01193023|Prevalence|prevalence
5523826|NCT01193023|Respiratory Muscles/innervation|respiratory muscles/innervation
5523827|NCT01192997|Meningitis|meningitis
5523828|NCT01192997|Meningococci|meningococci
5523829|NCT01192997|Meningitis C|meningitis c
5523830|NCT01192997|Meningitis A|meningitis a
5523831|NCT01192997|Meningitis W135|meningitis w135
5523832|NCT01192997|Meningitis Y|meningitis y
5523833|NCT01192997|Antibody|antibody
5523834|NCT01192971|hcc, apatinib, phase II, cancer|hcc, apatinib, phase ii, cancer
5523835|NCT01192958|swine flu|swine flu
5523836|NCT01192958|novel h1n1v|novel h1n1v
5523837|NCT01192958|novel h1n1|novel h1n1
5523838|NCT01192958|h1n1|h1n1
5523839|NCT01192945|Azacitidin|azacitidin
5523840|NCT01192945|Vidaza|vidaza
5523841|NCT01192945|Piaza|piaza
5523842|NCT01192945|myelodysplastic syndrome|myelodysplastic syndrome
5523843|NCT01192945|MDS|mds
5523844|NCT01192945|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5523845|NCT01192945|CMML|cmml
5523846|NCT01192945|acute myeloid leukemia|acute myeloid leukemia
5523847|NCT01192945|AML|aml
5523848|NCT01192945|daily routine|daily routine
5523849|NCT01192945|concomitant antiemetic therapy|concomitant antiemetic therapy
5523850|NCT01192945|germany|germany
5523851|NCT01192945|non-interventional study|non-interventional study
5523852|NCT01192919|bronchial carcinoma|bronchial carcinoma
5523853|NCT01192919|registry|registry
5523854|NCT01192919|real life treatment|real life treatment
5523855|NCT01192919|cohort study|cohort study
5523856|NCT01192919|NSCLC|nsclc
5523857|NCT01192919|SCLC|sclc
5523858|NCT01192919|Germany|germany
5523859|NCT01192854|Clevudine|clevudine
5523860|NCT01192854|efficacy|efficacy
5523861|NCT01192854|safety|safety
5523862|NCT01192854|chronic hepatitis B|chronic hepatitis b
5523863|NCT01192841|physician uniform|physician uniform
5523864|NCT01192841|MRSA|mrsa
5523865|NCT01192841|bacterial contamination|bacterial contamination
5523866|NCT01192828|cystathionine beta-synthase (CBS)|cystathionine beta-synthase (cbs)
5523867|NCT01192802|albendazole|albendazole
5523868|NCT01192802|ascaris|ascaris
5523869|NCT01192802|trichiurus|trichiurus
5523870|NCT01192802|hookworms|hookworms
5523871|NCT01192789|Severe pneumonia|severe pneumonia
5523872|NCT01192789|Pneumonia|pneumonia
5523873|NCT01192789|Lady health workers|lady health workers
5523874|NCT01192789|Amoxicillin|amoxicillin
5523875|NCT01192789|Treatment failure|treatment failure
5523876|NCT01192789|Injectable Antibiotics|injectable antibiotics
5523877|NCT01192789|Referral treatment|referral treatment
5523878|NCT01192789|Health Facility|health facility
5523879|NCT01192789|Under five children|under five children
5523880|NCT01192789|home based management|home based management
5523881|NCT01192789|community case management|community case management
5523882|NCT01192776|NICHD Neonatal Research Network|nichd neonatal research network
5523883|NCT01192776|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5523884|NCT01192776|Hypothermia|hypothermia
5523885|NCT01192776|Neonatal depression|neonatal depression
5523886|NCT01192776|Perinatal asphyxia|perinatal asphyxia
5523887|NCT01192776|Fetal acidosis|fetal acidosis
5518074|NCT01217177|rad001,|rad001,
5523888|NCT01192750|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5523889|NCT01192750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5523890|NCT01192750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5523892|NCT01192750|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5523893|NCT01192750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5523894|NCT01192750|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5524016|NCT01192295|Nonmalignant pain|nonmalignant pain
5523895|NCT01192750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5523896|NCT01192750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5523897|NCT01192750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5685352|NCT00556465|diabetic nephropathy|diabetic nephropathy
5510073|NCT01252784|higher risk MDS|higher risk mds
5523898|NCT01192750|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5523899|NCT01192750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5523900|NCT01192750|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5523901|NCT01192750|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5523902|NCT01192750|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5523903|NCT01192750|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5523904|NCT01192750|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5523905|NCT01192750|recurrent salivary gland cancer|recurrent salivary gland cancer
5523906|NCT01192750|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5523907|NCT01192737|pandemic|pandemic
5523909|NCT01192737|pregnancy|pregnancy
5523910|NCT01192737|cohort|cohort
5523911|NCT01192737|vaccine|vaccine
5523912|NCT01192737|Influenza and Pregnancy|influenza and pregnancy
5523915|NCT01192724|Percutaneous coronary intervention|percutaneous coronary intervention
5523917|NCT01192711|telemedicine|telemedicine
5523918|NCT01192711|self monitoring blood glucose|self monitoring blood glucose
5523919|NCT01192698|cirrhosis|cirrhosis
5523920|NCT01192698|hepatitis C|hepatitis c
5523921|NCT01192685|Depression|depression
5523922|NCT01192685|Depressed|depressed
5523924|NCT01192685|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5523925|NCT01192646|maternal health|maternal health
5523926|NCT01192646|birth preparedness|birth preparedness
5523927|NCT01192646|cost effectiveness|cost effectiveness
5523928|NCT01192646|male involvement|male involvement
5523929|NCT01192646|delivery at hospital|delivery at hospital
5523930|NCT01192646|complication readiness|complication readiness
5523931|NCT01192646|Health seeking behavior in pregnancy, labour and pregnancy complication|health seeking behavior in pregnancy, labour and pregnancy complication
5523932|NCT01192633|Sarcoma|sarcoma
5523933|NCT01192633|gemcitabine|gemcitabine
5523934|NCT01192633|vincristine|vincristine
5523935|NCT01192633|cisplatin|cisplatin
5523936|NCT01192633|chemotherapy|chemotherapy
5523937|NCT01192620|Pediatric Appendicitis|pediatric appendicitis
5523938|NCT01192620|Pathway|pathway
5523939|NCT01192594|symptom management|symptom management
5523940|NCT01192594|empowerment|empowerment
5523941|NCT01192594|medication adherence|medication adherence
5523942|NCT01192594|recovery|recovery
5523943|NCT01192594|schizophrenia|schizophrenia
5523944|NCT01192594|post-psychotic adjustment process|post-psychotic adjustment process
5523945|NCT01192594|psychological adjustment|psychological adjustment
5523946|NCT01192594|psychiatric case managers|psychiatric case managers
5523947|NCT01192594|psychosis|psychosis
5523948|NCT01192594|insight|insight
5523949|NCT01192594|cognitive function|cognitive function
5523950|NCT01192581|brain hypoperfusion|brain hypoperfusion
5523951|NCT01192581|Vuloven|vuloven
5523952|NCT01192581|computed tomography perfusion|computed tomography perfusion
5523953|NCT01192555|Neuroblastoma|neuroblastoma
5523954|NCT01192555|Chemotherapy|chemotherapy
5523955|NCT01192555|Pediatrics|pediatrics
5523956|NCT01192555|Cytoxan|cytoxan
5523957|NCT01192555|immunotherapy|immunotherapy
5523958|NCT01192555|vaccine|vaccine
5523959|NCT01192529|Senile|senile
5523960|NCT01192529|Dementia|dementia
5523961|NCT01192529|Neurodegenerative|neurodegenerative
5523962|NCT01192529|Supressi|supressi
5523963|NCT01192529|Specific diet|specific diet
5523964|NCT01192529|Cognitive Status|cognitive status
5523965|NCT01192529|Memory|memory
5523966|NCT01192529|Malnutrition|malnutrition
5523967|NCT01192529|Parkinson|parkinson
5523968|NCT01192529|Alzheimer|alzheimer
5523969|NCT01192516|Osteoarthritis|osteoarthritis
5523970|NCT01192516|Activity Pacing|activity pacing
5523971|NCT01192503|Restless Legs Syndrome|restless legs syndrome
5523972|NCT01192503|rasagiline|rasagiline
5523973|NCT01192503|futility|futility
5523974|NCT01192477|Air pollution|air pollution
5523975|NCT01192477|Ozone|ozone
5523976|NCT01192477|Health effects of ozone exposure|health effects of ozone exposure
5523980|NCT01192438|cancer|cancer
5523981|NCT01192438|ablation|ablation
5523982|NCT01192438|laser-induced|laser-induced
5523983|NCT01192438|focal therapy|focal therapy
5523984|NCT01192425|PNH clone cells|pnh clone cells
5523985|NCT01192425|Aplastic Anemia|aplastic anemia
5523987|NCT01192425|Myelodysplastic Syndromes|myelodysplastic syndromes
5523988|NCT01192425|MDS|mds
5523989|NCT01192425|bone marrow failure syndromes|bone marrow failure syndromes
5523990|NCT01192425|FLAER|flaer
5523991|NCT01192425|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5523992|NCT01192412|hypertension|hypertension
5523993|NCT01192412|pregnancy|pregnancy
5523994|NCT01192412|antihypertensive therapy|antihypertensive therapy
5523995|NCT01192412|perinatal outcome|perinatal outcome
5523996|NCT01192412|maternal outcome|maternal outcome
5685353|NCT00556465|proteinuria|proteinuria
5523997|NCT01192412|Non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy|non-severe, non-proteinuric pre-existing or gestational hypertension in pregnancy
5523998|NCT01192399|Hemolytic Paroxysmal Nocturnal Hemoglobinuria|hemolytic paroxysmal nocturnal hemoglobinuria
5523999|NCT01192399|Eculizumab|eculizumab
5524000|NCT01192399|PNH|pnh
5524001|NCT01192399|Japan|japan
5524002|NCT01192360|pediatrics|pediatrics
5524003|NCT01192360|Heart Disease|heart disease
5524004|NCT01192360|Cystic Fibrosis|cystic fibrosis
5524005|NCT01192360|Severe Asthma|severe asthma
5524006|NCT01192360|Magnetic Resonance Imaging|magnetic resonance imaging
5524007|NCT01192334|knee osteoarthritis arthroplasty postural balance|knee osteoarthritis arthroplasty postural balance
5524008|NCT01192321|intraocular lens|intraocular lens
5524009|NCT01192321|Toric|toric
5524010|NCT01192308|Breast cancer|breast cancer
5524011|NCT01192308|Tamoxifen|tamoxifen
5524012|NCT01192308|Pharmacokinetics|pharmacokinetics
5524014|NCT01192308|CYP2D6|cyp2d6
5524015|NCT01192295|Malignant pain|malignant pain
5524017|NCT01192295|Pediatric|pediatric
5524018|NCT01192295|Opioid|opioid
5524019|NCT01192295|Moderate to severe malignant or nonmalignant pain|moderate to severe malignant or nonmalignant pain
5524020|NCT01192282|Female Genital Warts|female genital warts
5524021|NCT01192282|HPV Typing|hpv typing
5524022|NCT01192282|HIV Status|hiv status
5524023|NCT01192282|Treatment Modalities and Recurrence|treatment modalities and recurrence
5524024|NCT01192282|Socio-economic Burdens|socio-economic burdens
5524025|NCT01192269|cheek cells|cheek cells
5524026|NCT01192269|phospholipids|phospholipids
5524027|NCT01192269|fatty acids|fatty acids
5524028|NCT01192269|docosahexaenoic acid|docosahexaenoic acid
5524029|NCT01192269|Buccal Cheek cells|buccal cheek cells
5524030|NCT01192269|non invasive fatty acid status marker|non invasive fatty acid status marker
5524031|NCT01192256|smoking|smoking
5524032|NCT01192256|cessation|cessation
5524033|NCT01192256|mortality|mortality
5524034|NCT01192256|quality of life|quality of life
5524035|NCT01192243|Objective response rate|objective response rate
5524036|NCT01192243|Time to Progression|time to progression
5524037|NCT01192243|Quality of Live|quality of live
5524038|NCT01192230|Objective response rate|objective response rate
5524039|NCT01192230|Disease control rate|disease control rate
5524040|NCT01192230|Disease free survival|disease free survival
5524041|NCT01192230|Overall survival|overall survival
5524042|NCT01192230|Quality of Live|quality of live
5524043|NCT01192230|Nonsmall cell lung cancer|nonsmall cell lung cancer
5524044|NCT01192230|toxicity|toxicity
5524045|NCT01192217|video-assisted thoracic surgery|video-assisted thoracic surgery
5524046|NCT01192217|axillary mini-thoracotomy|axillary mini-thoracotomy
5524047|NCT01192217|bullectomy|bullectomy
5524048|NCT01192204|FBR, OSCC, chemoprevention|fbr, oscc, chemoprevention
5524049|NCT01192191|GW642444|gw642444
5524050|NCT01192191|COPD|copd
5524051|NCT01192191|Fluticasone Furoate|fluticasone furoate
5524052|NCT01192178|pediatric|pediatric
5524053|NCT01192178|exacerbation|exacerbation
5524054|NCT01192178|viral induced exacerbation|viral induced exacerbation
5524055|NCT01192178|asthma|asthma
5524056|NCT01192165|Taxotere|taxotere
5524057|NCT01192165|Cisplatin|cisplatin
5524058|NCT01192165|Carboplatin|carboplatin
5524059|NCT01192165|Trametinib|trametinib
5524060|NCT01192165|GSK1120212|gsk1120212
5524061|NCT01192165|Tarceva|tarceva
5524062|NCT01192165|KRAS|kras
5524063|NCT01192165|Pemetrexed|pemetrexed
5524064|NCT01192165|MEK inhibitor|mek inhibitor
5524065|NCT01192165|nab-Paclitaxel|nab-paclitaxel
5524066|NCT01192165|Docetaxel|docetaxel
5524067|NCT01192165|Alimta|alimta
5524068|NCT01192165|Abraxane|abraxane
5524069|NCT01192165|Erlotinib|erlotinib
5524070|NCT01192113|Mecobalamin|mecobalamin
5524071|NCT01192113|peripheral neuropathy|peripheral neuropathy
5524072|NCT01192113|diabetic neuropathy|diabetic neuropathy
5524073|NCT01192100|Protein-rich breakfast|protein-rich breakfast
5524074|NCT01192100|Breakfast Skipping|breakfast skipping
5524075|NCT01192100|Adolescents|adolescents
5524076|NCT01192100|Obesity|obesity
5524077|NCT01192100|Increased dietary protein|increased dietary protein
5524078|NCT01192100|Breakfast|breakfast
5524079|NCT01192100|fMRI|fmri
5524080|NCT01192100|Ghrelin|ghrelin
5524086|NCT01192087|Cetuximab|cetuximab
5524087|NCT01192074|Obstetric|obstetric
5524088|NCT01192074|Analgesia|analgesia
5524089|NCT01192074|Anesthesia|anesthesia
5524090|NCT01192074|Obstetric Anesthesia|obstetric anesthesia
5524091|NCT01192074|Obstetric Analgesia|obstetric analgesia
5524092|NCT01192074|ultrasound|ultrasound
5524093|NCT01192074|ultrasonography|ultrasonography
5524094|NCT01192074|epidural analgesia|epidural analgesia
5524095|NCT01192074|epidural anesthesia|epidural anesthesia
5524096|NCT01192074|spinal anesthesia|spinal anesthesia
5524097|NCT01192074|neuraxial anesthesia|neuraxial anesthesia
5524098|NCT01192074|neuraxial analgesia|neuraxial analgesia
5524099|NCT01192074|pregnancy|pregnancy
5524100|NCT01192074|labor|labor
5524101|NCT01192074|cesarean delivery|cesarean delivery
5685354|NCT00556465|antioxidant|antioxidant
5524102|NCT01192074|cesarean section|cesarean section
5524103|NCT01192061|autonomic nervous system|autonomic nervous system
5524104|NCT01192061|heart rate variability|heart rate variability
5524105|NCT01192061|blood pressure variability|blood pressure variability
5524106|NCT01192061|retrobulbar hemodynamics|retrobulbar hemodynamics
5524107|NCT01192061|vascular dysregulation|vascular dysregulation
5524108|NCT01192048|Congenital Heart Disease|congenital heart disease
5524109|NCT01192048|birth defect|birth defect
5524110|NCT01192048|genetics|genetics
5524111|NCT01192048|gene|gene
5524113|NCT01192048|direct sequencing|direct sequencing
5524114|NCT01192048|microarray|microarray
5524115|NCT01192048|single nucleotide polymorphism|single nucleotide polymorphism
5524116|NCT01192048|whole genome array comparative genomic hybridization|whole genome array comparative genomic hybridization
5524117|NCT01192048|chromosomal copy number change|chromosomal copy number change
5524118|NCT01192048|nucleotide sequence variation|nucleotide sequence variation
5524119|NCT01192048|exome sequencing|exome sequencing
5524120|NCT01192048|whole exome sequencing|whole exome sequencing
5524121|NCT01192035|Africa, Western|africa, western
5524122|NCT01192035|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5524123|NCT01192022|Liver resection|liver resection
5524124|NCT01192022|Liver transplantation|liver transplantation
5524125|NCT01192022|Liver surgery|liver surgery
5524126|NCT01192022|Secondary hemostasis|secondary hemostasis
5524127|NCT01192009|Leucine|leucine
5524128|NCT01192009|Skeletal Muscle Disuse|skeletal muscle disuse
5524129|NCT01192009|Atrophy|atrophy
5524130|NCT01192009|Proteolysis|proteolysis
5524131|NCT01191996|SPMS|spms
5524132|NCT01191996|PPMS|ppms
5524134|NCT01191996|Multiple Sclerosis|multiple sclerosis
5524135|NCT01191970|epidural|epidural
5524136|NCT01191970|beta-endorphins|beta-endorphins
5524137|NCT01191970|breast-feeding|breast-feeding
5524138|NCT01191970|colostrum|colostrum
5524139|NCT01191970|feeding|feeding
5524140|NCT01191957|Acute Myeloid Leukemia|acute myeloid leukemia
5524141|NCT01191957|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5524142|NCT01191918|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5524143|NCT01191918|donepezil|donepezil
5524144|NCT01191918|bipolar disorder|bipolar disorder
5524145|NCT01191918|mania|mania
5524146|NCT01191918|lithium|lithium
5524147|NCT01191892|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5524148|NCT01191892|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5524149|NCT01191892|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5524150|NCT01191892|stage III bladder cancer|stage iii bladder cancer
5524151|NCT01191892|stage IV bladder cancer|stage iv bladder cancer
5524152|NCT01191892|anterior urethral cancer|anterior urethral cancer
5524153|NCT01191892|posterior urethral cancer|posterior urethral cancer
5524154|NCT01191892|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5524155|NCT01191892|ureter cancer|ureter cancer
5524156|NCT01191866|diabetes mellitus|diabetes mellitus
5524157|NCT01191866|psychosocial|psychosocial
5524158|NCT01191866|metabolic control|metabolic control
5524159|NCT01191866|quality of life questionnaires|quality of life questionnaires
5524160|NCT01191866|children|children
5524161|NCT01191866|adolescents|adolescents
5524167|NCT01191840|staphylococci|staphylococci
5524168|NCT01191814|pancreatic cancer|pancreatic cancer
5524169|NCT01191814|obstructive jaundice|obstructive jaundice
5524170|NCT01191814|Obstructive jaundice secondary to pancreatic cancer|obstructive jaundice secondary to pancreatic cancer
5524171|NCT01191801|Leukemia|leukemia
5524172|NCT01191801|Acute Myeloid Leukemia|acute myeloid leukemia
5524173|NCT01191801|Hematologic|hematologic
5524174|NCT01191801|Hematologic diseases|hematologic diseases
5524175|NCT01191801|Blood|blood
5524176|NCT01191801|Cancer|cancer
5524177|NCT01191801|Malignancy|malignancy
5524178|NCT01191801|Vosaroxin|vosaroxin
5524179|NCT01191801|Cytarabine|cytarabine
5524180|NCT01191801|First Relapsed AML|first relapsed aml
5524181|NCT01191801|Refractory AML|refractory aml
5524182|NCT01191801|VALOR|valor
5524183|NCT01191801|Sunesis|sunesis
5524184|NCT01191801|Voreloxin|voreloxin
5524185|NCT01191801|SNS-595|sns-595
5524186|NCT01191788|Depression|depression
5524187|NCT01191788|Substance Use|substance use
5524188|NCT01191788|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
5524190|NCT01191775|DNAi|dnai
5524191|NCT01191775|Oncology|oncology
5524192|NCT01191775|Antineoplastic agent|antineoplastic agent
5524193|NCT01191775|Lymphoma|lymphoma
5524194|NCT01191775|PNT2258|pnt2258
5524195|NCT01191762|secondary hyperparathyroidism|secondary hyperparathyroidism
5524196|NCT01191762|phosphate|phosphate
5524197|NCT01191762|calcium|calcium
5524198|NCT01191762|chronic kidney disease|chronic kidney disease
5524199|NCT01191749|Hematologic Disorder|hematologic disorder
5524200|NCT01191749|Aplastic Anemia|aplastic anemia
5524201|NCT01191749|T - Cell Large Granular Lymphocytic Leukemia|t - cell large granular lymphocytic leukemia
5524202|NCT01191749|T-LGL|t-lgl
5524203|NCT01191749|Myelodysplastic Syndrome|myelodysplastic syndrome
5524204|NCT01191749|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5524205|NCT01191749|CLL|cll
5524206|NCT01191749|Chemotherapy|chemotherapy
5524207|NCT01191749|Alemtuzumab|alemtuzumab
5524208|NCT01191736|hands only|hands only
5524209|NCT01191736|CPR|cpr
5524210|NCT01191736|resuscitation|resuscitation
5524211|NCT01191736|cardiac arrest|cardiac arrest
5524212|NCT01191736|Education of general public regarding resuscitation methods|education of general public regarding resuscitation methods
5524213|NCT01191723|Healthy Volunteers|healthy volunteers
5524214|NCT01191710|progesterone|progesterone
5524215|NCT01191697|HER2 positive|her2 positive
5524216|NCT01191671|Child Development|child development
5524217|NCT01191671|Child|child
5524218|NCT01191671|Daycare centers|daycare centers
5524219|NCT01191671|Language|language
5524220|NCT01191645|Lower esophageal sphincter pressure|lower esophageal sphincter pressure
5524222|NCT01191645|Remifentanil|remifentanil
5524223|NCT01191645|Metoclopramide|metoclopramide
5524224|NCT01191645|Naloxone|naloxone
5524225|NCT01191645|High resolution solid state manometry|high resolution solid state manometry
5524226|NCT01191632|T cell|t cell
5524227|NCT01191632|surgery|surgery
5524228|NCT01191632|radiation|radiation
5524229|NCT01191619|McIvor retractor|mcivor retractor
5524230|NCT01191619|Proseal laryngeal mask airway|proseal laryngeal mask airway
5524231|NCT01191606|pressure controlled|pressure controlled
5524232|NCT01191606|volume controlled|volume controlled
5524233|NCT01191606|arterial oxygenation|arterial oxygenation
5524234|NCT01191606|one lung ventilation|one lung ventilation
5524235|NCT01191593|Adductor-Canal-Blockade|adductor-canal-blockade
5524236|NCT01191593|postoperative pain|postoperative pain
5524237|NCT01191593|US-guided nerve block|us-guided nerve block
5524238|NCT01191593|revision knee arthroplasty|revision knee arthroplasty
5524239|NCT01191567|acute wounds|acute wounds
5524240|NCT01191567|postoperative wounds|postoperative wounds
5524241|NCT01191541|ara-c|ara-c
5524242|NCT01191541|As2O3|as2o3
5524243|NCT01191541|pediatric|pediatric
5524244|NCT01191541|acute|acute
5524245|NCT01191528|Adult|adult
5524246|NCT01191528|Post|post
5524247|NCT01191528|operative|operative
5524248|NCT01191528|oximetry|oximetry
5524249|NCT01191528|capnometry|capnometry
5524250|NCT01191528|Integrated|integrated
5524251|NCT01191528|Pulmonary|pulmonary
5524252|NCT01191528|Index|index
5524253|NCT01191528|End-tidal|end-tidal
5524254|NCT01191528|Monitoring Respiratory status|monitoring respiratory status
5524255|NCT01191528|post-operative|post-operative
5524256|NCT01191515|Previous Cataract patients|previous cataract patients
5524257|NCT01191515|Monofocal IOL implant|monofocal iol implant
5524258|NCT01191515|Evaluation|evaluation
5524259|NCT01191502|Patients who have had binocular implantation of the Tecnis Multifocal IOL or the Crystalens™ HD Accommodating IOL.|patients who have had binocular implantation of the tecnis multifocal iol or the crystalens™ hd accommodating iol.
5524260|NCT01191476|Sevoflurane|sevoflurane
5524261|NCT01191476|Propofol|propofol
5524262|NCT01191476|Economics|economics
5524263|NCT01191476|Pharmaceutical|pharmaceutical
5524264|NCT01191476|Chinese|chinese
5524265|NCT01191450|chlortalidone|chlortalidone
5524266|NCT01191450|amiloride|amiloride
5524267|NCT01191450|arterial hypertension|arterial hypertension
5524268|NCT01191424|Asthma|asthma
5524269|NCT01191424|PK|pk
5524270|NCT01191424|Adolescents|adolescents
5524271|NCT01191424|Adults|adults
5524272|NCT01191411|colorectal neoplasms|colorectal neoplasms
5524273|NCT01191411|screening|screening
5524274|NCT01191398|Hypersalivation|hypersalivation
5524275|NCT01191398|Conscious Sedation|conscious sedation
5524276|NCT01191398|Procedural Sedation|procedural sedation
5524277|NCT01191398|Ketamine|ketamine
5524278|NCT01191398|Atropine|atropine
5524279|NCT01191398|Glycopyrrolate|glycopyrrolate
5524280|NCT01191385|HCC|hcc
5524281|NCT01191385|Liver cancer|liver cancer
5524282|NCT01191385|Cancer of liver|cancer of liver
5524283|NCT01191385|Cancer, liver|cancer, liver
5524284|NCT01191385|Hepatic cancer|hepatic cancer
5524285|NCT01191385|Cancer, hepatic|cancer, hepatic
5524286|NCT01191385|Carcinoma, hepatocellular|carcinoma, hepatocellular
5524287|NCT01191372|Hemophilia A|hemophilia a
5524288|NCT01191372|Hemophilia B|hemophilia b
5524289|NCT01191372|pharmacokinetics|pharmacokinetics
5524291|NCT01191372|Tissue Factor Pathway Inhibitor|tissue factor pathway inhibitor
5524292|NCT01191333|Mood Disorder|mood disorder
5524293|NCT01191333|Depression|depression
5524294|NCT01191333|stress disorder, post-traumatic|stress disorder, post-traumatic
5524295|NCT01191333|Depressive Disorder|depressive disorder
5524296|NCT01191333|Stress Disorders, Traumatic|stress disorders, traumatic
5524297|NCT01191333|substance related disorders|substance related disorders
5524298|NCT01191333|Transcranial Magnetic Stimulation, repetitive|transcranial magnetic stimulation, repetitive
5524299|NCT01191333|transcranial magnetic stimulation|transcranial magnetic stimulation
5524300|NCT01191333|Veterans|veterans
5524301|NCT01191333|mental health|mental health
5685356|NCT00556439|Arteritis|arteritis
5524302|NCT01191320|Adult onset hypogonadotropic hypogonadism|adult onset hypogonadotropic hypogonadism
5524303|NCT01191307|Primary dystonia|primary dystonia
5524304|NCT01191307|Epilepsy|epilepsy
5524305|NCT01191307|Hydrocephalus|hydrocephalus
5524306|NCT01191307|Bladder Control|bladder control
5524307|NCT01191307|Deaf or Hearing Impaired|deaf or hearing impaired
5524308|NCT01191294|Melanoma|melanoma
5524309|NCT01191294|Simulation Training|simulation training
5524310|NCT01191294|Medical Students|medical students
5524311|NCT01191281|food habits|food habits
5524312|NCT01191281|nutrition requirements|nutrition requirements
5524313|NCT01191281|antiretroviral therapy|antiretroviral therapy
5524314|NCT01191255|ESRD|esrd
5524315|NCT01191255|end-stage renal disease|end-stage renal disease
5524316|NCT01191255|dialysis|dialysis
5524317|NCT01191255|hemodialysis|hemodialysis
5508855|NCT01258127|Pemetrexed|pemetrexed
5524318|NCT01191255|peritoneal dialysis|peritoneal dialysis
5524319|NCT01191255|hemodialysis (HD)|hemodialysis (hd)
5524320|NCT01191255|peritoneal dialysis (PD)|peritoneal dialysis (pd)
5524321|NCT01191255|chronic renal insufficiency|chronic renal insufficiency
5524322|NCT01191255|phosphate binder|phosphate binder
5524323|NCT01191255|kidney failure|kidney failure
5524324|NCT01191255|renal failure|renal failure
5524325|NCT01191242|methadone|methadone
5524327|NCT01191203|Acceptability and Adherence to methods|acceptability and adherence to methods
5524328|NCT01191190|Leukemia|leukemia
5524329|NCT01191190|Chronic leukemia|chronic leukemia
5524330|NCT01191190|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5524331|NCT01191190|Relapsed|relapsed
5524332|NCT01191190|Refractory|refractory
5524333|NCT01191177|oral fish oil|oral fish oil
5524334|NCT01191177|Lovaza|lovaza
5524335|NCT01191177|Omega-3-acid supplementation|omega-3-acid supplementation
5524336|NCT01191164|Brachytherapy, Partial Breast Irradiation, Breast Seed Implant, Palladium Seeds|brachytherapy, partial breast irradiation, breast seed implant, palladium seeds
5524337|NCT01191151|Orthopedic surgery|orthopedic surgery
5524338|NCT01191151|sports medicine|sports medicine
5524339|NCT01191138|Delayed Gastric emptying|delayed gastric emptying
5524340|NCT01191138|Gastric emptying scintigraphy|gastric emptying scintigraphy
5524341|NCT01191138|Pancreatic fistula|pancreatic fistula
5524342|NCT01191138|Pancreatic Neoplasms|pancreatic neoplasms
5524343|NCT01191138|Whipple Operation|whipple operation
5524344|NCT01191086|Epilepsy|epilepsy
5524345|NCT01191086|partial onset seizure|partial onset seizure
5524346|NCT01191086|adjunctive therapy|adjunctive therapy
5524347|NCT01191073|edentulous|edentulous
5524348|NCT01191060|Progression free survival prolongation|progression free survival prolongation
5524349|NCT01191060|Disease Progression|disease progression
5524350|NCT01191060|Overall survival|overall survival
5524351|NCT01191021|breath|breath
5524352|NCT01191021|propofol|propofol
5524353|NCT01191021|general anesthesia|general anesthesia
5524354|NCT01191008|Xalacom Regulatory post marketing commitment plan safety|xalacom regulatory post marketing commitment plan safety
5524355|NCT01190995|Pain|pain
5524356|NCT01190995|Neonate|neonate
5524357|NCT01190995|Procedure|procedure
5524358|NCT01190995|Neurobehavioural outcome|neurobehavioural outcome
5524359|NCT01190969|Elderly|elderly
5524360|NCT01190969|malnutrition|malnutrition
5524361|NCT01190969|nutritional supplement|nutritional supplement
5524362|NCT01190917|Autism|autism
5524363|NCT01190917|Autism Spectrum Disorder|autism spectrum disorder
5524364|NCT01190917|Disorder|disorder
5524365|NCT01190917|Autistic|autistic
5524366|NCT01190917|Asperger Syndrome|asperger syndrome
5524367|NCT01190917|social skills group|social skills group
5524368|NCT01190917|behavioral intervention|behavioral intervention
5524369|NCT01190917|Imaging, Magnetic Resonance|imaging, magnetic resonance
5524370|NCT01190917|fMRI|fmri
5524371|NCT01190917|Functional MRI|functional mri
5524372|NCT01190917|MRI, Functional|mri, functional
5524373|NCT01190917|Magnetic Resonance Imaging|magnetic resonance imaging
5524374|NCT01190917|Functional|functional
5524375|NCT01190904|Androgen deficiency|androgen deficiency
5524376|NCT01190904|Erectile dysfunction|erectile dysfunction
5524377|NCT01190904|Coronary Artery Disease|coronary artery disease
5524378|NCT01190904|Coronary Revascularization|coronary revascularization
5524379|NCT01190904|Diabetes mellitus|diabetes mellitus
5524381|NCT01190904|Stroke|stroke
5524382|NCT01190904|MACCE|macce
5524384|NCT01190904|ED|ed
5524385|NCT01190904|CAD|cad
5518512|NCT01215461|VLBW|vlbw
5524386|NCT01190904|Development of predictive cardiovascular/cerebrovascular AE|development of predictive cardiovascular/cerebrovascular ae
5524387|NCT01190891|Rotator cuff tendonitis|rotator cuff tendonitis
5524388|NCT01190891|Shoulder pain|shoulder pain
5524389|NCT01190891|Shoulder impingement|shoulder impingement
5524390|NCT01190839|Crohn's Disease|crohn's disease
5524391|NCT01190839|Inflammatory Bowel Disease|inflammatory bowel disease
5524392|NCT01190839|infliximab|infliximab
5524393|NCT01190839|TNF-alpha|tnf-alpha
5524394|NCT01190826|Stable moderate asthma|stable moderate asthma
5524395|NCT01190813|amblyopia, levodopa|amblyopia, levodopa
5524396|NCT01190800|Alzheimer's Disease|alzheimer's disease
5524397|NCT01190800|Capacity assessment|capacity assessment
5524399|NCT01190800|Capacity to consent to treatment|capacity to consent to treatment
5524400|NCT01190800|Capacity to vote|capacity to vote
5524401|NCT01190800|Capacity to appoint a proxy|capacity to appoint a proxy
5524402|NCT01190787|Multiple Myeloma|multiple myeloma
5524403|NCT01190787|Elderly Patients|elderly patients
5524404|NCT01190787|Diagnosis|diagnosis
5524405|NCT01190787|Velcade subcutaneous|velcade subcutaneous
5524406|NCT01190787|Prednisone|prednisone
5524407|NCT01190787|Melphalan|melphalan
5524408|NCT01190787|Cyclophosphamide|cyclophosphamide
5524409|NCT01190774|dental anxiety|dental anxiety
5524410|NCT01190774|state anxiety|state anxiety
5524411|NCT01190774|randomised control trial|randomised control trial
5524412|NCT01190774|psychological intervention|psychological intervention
5524413|NCT01190761|Bioequivalence|bioequivalence
5524415|NCT01190761|Reminyl|reminyl
5524416|NCT01190761|Galantamine hydrobromide|galantamine hydrobromide
5524417|NCT01190761|Healthy subjects|healthy subjects
5524418|NCT01190748|Bioequivalence|bioequivalence
5524419|NCT01190748|Galantamine|galantamine
5524420|NCT01190748|Reminyl|reminyl
5524421|NCT01190748|Galantamine hydrobromide|galantamine hydrobromide
5524422|NCT01190748|Healthy subjects|healthy subjects
5524423|NCT01190735|Caffeine|caffeine
5524424|NCT01190735|Parkinson's Disease|parkinson's disease
5524425|NCT01190735|Parkinson Disease|parkinson disease
5524426|NCT01190735|Parkinsonian Disorders|parkinsonian disorders
5524427|NCT01190735|Basal Ganglia Diseases|basal ganglia diseases
5524428|NCT01190735|Brain Diseases|brain diseases
5524429|NCT01190735|Central Nervous System Diseases|central nervous system diseases
5524430|NCT01190735|Nervous System Diseases|nervous system diseases
5524431|NCT01190735|Movement Disorders|movement disorders
5524432|NCT01190735|Neurodegenerative Diseases|neurodegenerative diseases
5524433|NCT01190735|Caffeine citrate|caffeine citrate
5524434|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5524435|NCT01190735|Pharmacologic Actions|pharmacologic actions
5524436|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants
5524437|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs
5524438|NCT01190735|Central Nervous System Agents|central nervous system agents
5524439|NCT01190735|Therapeutic Uses|therapeutic uses
5524440|NCT01190722|Day case surgery|day case surgery
5524441|NCT01190722|postoperative pain|postoperative pain
5524442|NCT01190722|NSAIDs|nsaids
5524443|NCT01190722|Coxibs|coxibs
5524444|NCT01190709|Close Fracture|close fracture
5524445|NCT01190709|Tibia|tibia
5524446|NCT01190709|Unreamed Intramedullary Nailing|unreamed intramedullary nailing
5524447|NCT01190709|Dynamic Compression Plate|dynamic compression plate
5524448|NCT01190696|Spica Cast|spica cast
5524450|NCT01190696|Femoral Shaft Fracture|femoral shaft fracture
5524451|NCT01190696|Children|children
5524452|NCT01190670|ASP015K|asp015k
5524453|NCT01190670|tacrolimus|tacrolimus
5524454|NCT01190670|healthy volunteers|healthy volunteers
5524455|NCT01190657|Teprenone|teprenone
5524456|NCT01190657|safety|safety
5524457|NCT01190657|efficacy|efficacy
5524458|NCT01190657|acute gastric lesion|acute gastric lesion
5524459|NCT01190657|chronic gastritis|chronic gastritis
5524460|NCT01190644|Red Blood Cell Mass|red blood cell mass
5524461|NCT01190644|Plasma Volume|plasma volume
5524462|NCT01190644|Solid Tumors|solid tumors
5524463|NCT01190631|intraocular lens|intraocular lens
5524464|NCT01190631|cataracts|cataracts
5524465|NCT01190631|total residual spherical aberration|total residual spherical aberration
5524466|NCT01190631|high order aberrations|high order aberrations
5524467|NCT01190605|HIV|hiv
5524468|NCT01190605|postpartum|postpartum
5524469|NCT01190605|postpartum entry into HIV care|postpartum entry into hiv care
5524470|NCT01190592|Resistance training|resistance training
5524471|NCT01190592|Body Composition|body composition
5524472|NCT01190592|Cardiovascular Risk factors|cardiovascular risk factors
5524473|NCT01190592|Dairy|dairy
5524474|NCT01190579|Coronary Artery Disease|coronary artery disease
5524475|NCT01190579|Chest Pain|chest pain
5524476|NCT01190579|Computed Tomography|computed tomography
5524477|NCT01190566|Magnetic Resonance Imaging, Functional|magnetic resonance imaging, functional
5524478|NCT01190566|Tomography, Positron-Emission|tomography, positron-emission
5524480|NCT01190553|amantadine|amantadine
5524481|NCT01190553|parkinson disease|parkinson disease
5524482|NCT01190553|dyskinesia|dyskinesia
5524483|NCT01190540|On site support services.|on site support services.
5524492|NCT01190501|antihypertensive treatments|antihypertensive treatments
5524493|NCT01190488|End of life decision making|end of life decision making
5524494|NCT01190488|End of life decision aid|end of life decision aid
5524495|NCT01190488|Palliative care decision making|palliative care decision making
5524496|NCT01190488|Palliative care decision aid|palliative care decision aid
5524497|NCT01190488|Advanced care planning|advanced care planning
5524499|NCT01190475|Endometriosis|endometriosis
5524500|NCT01190475|Infertility|infertility
5524501|NCT01190475|Pain|pain
5524502|NCT01190475|Vaginal Diseases|vaginal diseases
5524503|NCT01190475|Uterine Diseases|uterine diseases
5524504|NCT01190462|recurrent colon cancer|recurrent colon cancer
5524505|NCT01190462|stage III colon cancer|stage iii colon cancer
5524506|NCT01190462|stage IV colon cancer|stage iv colon cancer
5524507|NCT01190462|recurrent rectal cancer|recurrent rectal cancer
5524508|NCT01190462|stage III rectal cancer|stage iii rectal cancer
5524509|NCT01190462|stage IV rectal cancer|stage iv rectal cancer
5524510|NCT01190449|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5524511|NCT01190449|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5798710|NCT00111293|Lesion|lesion
5524512|NCT01190449|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5524513|NCT01190449|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5524514|NCT01190449|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5524515|NCT01190449|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5524516|NCT01190449|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5524517|NCT01190449|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5524518|NCT01190449|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5524519|NCT01190449|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5524520|NCT01190449|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5524521|NCT01190449|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5524522|NCT01190436|Hypertension|hypertension
5524523|NCT01190436|Diabetes Mellitus|diabetes mellitus
5524524|NCT01190436|Bisoprolol|bisoprolol
5524526|NCT01190410|Certolizumab Pegol|certolizumab pegol
5524527|NCT01190410|Cimzia®|cimzia®
5524528|NCT01190410|Crohn's Disease|crohn's disease
5524529|NCT01190410|Children and Adolescents with Crohn's Disease|children and adolescents with crohn's disease
5524530|NCT01190397|Warming goggles|warming goggles
5524531|NCT01190384|Metabolic Syndrome|metabolic syndrome
5524532|NCT01190384|Inflammation|inflammation
5524533|NCT01190384|Antioxidants|antioxidants
5524534|NCT01190384|Satiety|satiety
5524535|NCT01190384|Fiber|fiber
5524536|NCT01190371|Artemisinin tolerance|artemisinin tolerance
5524537|NCT01190345|breast cancer|breast cancer
5524538|NCT01190332|common bile duct stones|common bile duct stones
5524539|NCT01190319|blood pressure|blood pressure
5524540|NCT01190319|strawberry|strawberry
5524541|NCT01190319|fruit phenolics|fruit phenolics
5524542|NCT01190319|LDL oxidation|ldl oxidation
5524543|NCT01190319|Flow mediated dilation (FMD)|flow mediated dilation (fmd)
5524544|NCT01190254|Asenapine|asenapine
5524545|NCT01190254|adolescents|adolescents
5524546|NCT01190254|schizophrenia|schizophrenia
5524547|NCT01190254|phase IIIb|phase iiib
5524548|NCT01190254|placebo-controlled|placebo-controlled
5524549|NCT01190241|targeted therapy|targeted therapy
5524550|NCT01190241|individualized medicine|individualized medicine
5524551|NCT01190241|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5524552|NCT01190241|kinome profiling|kinome profiling
5524553|NCT01190241|Metastasized|metastasized
5524554|NCT01190228|Japanese Encephalitis|japanese encephalitis
5524555|NCT01190228|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5524556|NCT01190228|Varicella|varicella
5524557|NCT01190228|Varicella vaccine|varicella vaccine
5524558|NCT01190215|Influenza|influenza
5524559|NCT01190215|Pandemrix|pandemrix
5524560|NCT01190215|H1N1|h1n1
5524561|NCT01190215|Fluarix|fluarix
5524562|NCT01190202|Malaria|malaria
5524565|NCT01190189|HPV vaccine|hpv vaccine
5524566|NCT01190189|Medically significant conditions|medically significant conditions
5524570|NCT01190176|Cervical neoplasia|cervical neoplasia
5524571|NCT01190176|Human papillomavirus|human papillomavirus
5524572|NCT01190176|Papillomavirus|papillomavirus
5524573|NCT01190176|Cervical cancer|cervical cancer
5524574|NCT01190176|Human papillomavirus (HPV) type 16/18 infections|human papillomavirus (hpv) type 16/18 infections
5524575|NCT01190163|Vaginal Birth delivery within 24 hours and C-section rate|vaginal birth delivery within 24 hours and c-section rate
5524576|NCT01190150|Cyclic Heavy Menstrual Bleed|cyclic heavy menstrual bleed
5524577|NCT01190150|Menorraghia|menorraghia
5524578|NCT01190137|Optimal vitamin D status|optimal vitamin d status
5524579|NCT01190137|25-hydroxy vitamin D|25-hydroxy vitamin d
5524580|NCT01190137|Rickets and bone mineralization|rickets and bone mineralization
5524581|NCT01190137|Breast fed infants|breast fed infants
5524582|NCT01190137|Cholecalciferol and ergocalciferol|cholecalciferol and ergocalciferol
5524583|NCT01190124|HIV infections|hiv infections
5524584|NCT01190124|HIV-1|hiv-1
5524585|NCT01190124|HIV-2|hiv-2
5524586|NCT01190124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5524587|NCT01190124|AIDS|aids
5524588|NCT01190124|Anti-Retroviral Agents|anti-retroviral agents
5524589|NCT01190124|Raltegravir|raltegravir
5524590|NCT01190124|Integrase Inhibitors|integrase inhibitors
5524591|NCT01190124|multiple-experienced HIV infected patients|multiple-experienced hiv infected patients
5524592|NCT01190111|interleukin-7|interleukin-7
5524593|NCT01190111|immune-based therapy|immune-based therapy
5524595|NCT01190111|viral disease|viral disease
5524596|NCT01190098|Partial epilepsy|partial epilepsy
5524597|NCT01190098|Excessive daytime sleepiness|excessive daytime sleepiness
5524598|NCT01190098|Epworth Sleepiness Scale|epworth sleepiness scale
5524599|NCT01190098|Maintenance of Wakefulness Test|maintenance of wakefulness test
5524600|NCT01190085|alcoholism|alcoholism
5524601|NCT01190085|ghrelin|ghrelin
5524602|NCT01190085|craving|craving
5524603|NCT01190072|Blood lipids|blood lipids
5524604|NCT01190072|percutaneous coronary intervention|percutaneous coronary intervention
5524605|NCT01190072|lipid lowering treatment|lipid lowering treatment
5524607|NCT01190059|Transplantation|transplantation
5524608|NCT01190059|Lung Transplantation|lung transplantation
5524609|NCT01190059|Transplantation Lung|transplantation lung
5524610|NCT01190046|elderly|elderly
5524611|NCT01190046|muscle|muscle
5524612|NCT01190046|disuse|disuse
5524613|NCT01190046|osteoarthritis|osteoarthritis
5524614|NCT01190046|exercise|exercise
5524615|NCT01189994|Fibromyalgia|fibromyalgia
5524616|NCT01189994|Acupuncture|acupuncture
5524617|NCT01189994|Randomized Controlled Trial|randomized controlled trial
5524618|NCT01189994|Pain|pain
5524619|NCT01189994|Quality of Life|quality of life
5524620|NCT01189968|Phase 1,|phase 1,
5524621|NCT01189968|dose escalation,|dose escalation,
5524622|NCT01189968|histologically|histologically
5524623|NCT01189968|confirmed|confirmed
5524624|NCT01189968|malignancy|malignancy
5524625|NCT01189968|metastatic|metastatic
5524626|NCT01189955|thyroidectomy|thyroidectomy
5524627|NCT01189955|harmonic|harmonic
5524629|NCT01189942|Phase 1|phase 1
5524630|NCT01189942|dose escalation|dose escalation
5524631|NCT01189942|histologically|histologically
5524632|NCT01189942|confirmed|confirmed
5524633|NCT01189942|malignancy|malignancy
5524634|NCT01189942|metastatic|metastatic
5524635|NCT01189929|Phase 1,|phase 1,
5524636|NCT01189929|dose escalation,|dose escalation,
5524637|NCT01189929|histologically|histologically
5524638|NCT01189929|cytologically|cytologically
5524639|NCT01189929|confirmed|confirmed
5524640|NCT01189929|malignancy|malignancy
5524641|NCT01189929|metastatic|metastatic
5524642|NCT01189890|Type 2 Diabetes Mellitus, Hemoglobin A1C, glucagon-like peptide 1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 inhibitor (DPP-4)|type 2 diabetes mellitus, hemoglobin a1c, glucagon-like peptide 1 (glp-1), gastric inhibitory polypeptide (gip), dipeptidyl peptidase 4 inhibitor (dpp-4)
5524643|NCT01189877|Direct pO2 Measurements|direct po2 measurements
5524644|NCT01189877|10-121|10-121
5524648|NCT01189838|Cancer|cancer
5524649|NCT01189838|cysteine-rich 61|cysteine-rich 61
5524650|NCT01189838|prognosis|prognosis
5524651|NCT01189838|transitional cell carcinoma|transitional cell carcinoma
5524652|NCT01189825|Physiological|physiological
5524653|NCT01189825|Antidepressive Agents|antidepressive agents
5524654|NCT01189812|hopelessness|hopelessness
5524655|NCT01189812|alone|alone
5524656|NCT01189812|sad|sad
5524657|NCT01189812|troubled|troubled
5524658|NCT01189812|depression|depression
5524659|NCT01189799|Co-occurring Disorders|co-occurring disorders
5524660|NCT01189799|Depression|depression
5524661|NCT01189799|Substance Dependence|substance dependence
5524662|NCT01189799|Motivational Therapy|motivational therapy
5524663|NCT01189799|Aftercare|aftercare
5524664|NCT01189799|Cognitive Behavioral Therapy|cognitive behavioral therapy
5524665|NCT01189786|Haploidentical Stem Cell Transplant|haploidentical stem cell transplant
5524666|NCT01189786|CD34+ Selection|cd34+ selection
5518791|NCT01213901|Insulin absorption|insulin absorption
5524667|NCT01189786|CliniMACS CD34 Reagent system|clinimacs cd34 reagent system
5524669|NCT01189773|limb trauma|limb trauma
5524670|NCT01189734|common bile duct stones|common bile duct stones
5524671|NCT01189734|laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
5524672|NCT01189734|intraoperative ercp|intraoperative ercp
5524673|NCT01189734|Preoperatively diagnosed common bile duct stones|preoperatively diagnosed common bile duct stones
5524674|NCT01189721|remifentanil|remifentanil
5524675|NCT01189721|hyperalgesia|hyperalgesia
5524676|NCT01189708|Abdominal aortic aneurysm|abdominal aortic aneurysm
5524677|NCT01189708|Abdominal hernia|abdominal hernia
5524678|NCT01189695|HIV or AIDS|hiv or aids
5524679|NCT01189695|Lopinavir|lopinavir
5524680|NCT01189695|Ritonavir|ritonavir
5524681|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents
5524682|NCT01189695|treatment failure|treatment failure
5524683|NCT01189695|treatment experienced|treatment experienced
5524684|NCT01189695|NNRTI failure|nnrti failure
5524685|NCT01189695|monotherapy|monotherapy
5524686|NCT01189682|catheter|catheter
5524687|NCT01189682|dressing|dressing
5524688|NCT01189682|chlorhexidine|chlorhexidine
5524689|NCT01189682|Patient admitted in ICU with a CVC or art. catheter|patient admitted in icu with a cvc or art. catheter
5524690|NCT01189669|PCOS|pcos
5524691|NCT01189656|Chronic hepatitis B patients|chronic hepatitis b patients
5524692|NCT01189643|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5524693|NCT01189643|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5524694|NCT01189643|TEMOZOLOMIDE|temozolomide
5524695|NCT01189643|DSRCT|dsrct
5524696|NCT01189643|10-091|10-091
5524697|NCT01189630|"Real World Electronic Database with clinical information"|"real world electronic database with clinical information"
5524698|NCT01189630|related to Implantable Cardiac devices.|related to implantable cardiac devices.
5524699|NCT01189617|Personal Lubricant|personal lubricant
5524700|NCT01189604|propofol endoscopy sedation|propofol endoscopy sedation
5524701|NCT01189578|Recreational|recreational
5524702|NCT01189578|cocaine|cocaine
5524703|NCT01189578|fMRI|fmri
5524704|NCT01189578|neuroimaging|neuroimaging
5524705|NCT01189578|craving|craving
5524706|NCT01189578|impulsivity|impulsivity
5524707|NCT01189565|Total Hip Replacement/Revision|total hip replacement/revision
5524708|NCT01189526|Branch retinal vein occlusion|branch retinal vein occlusion
5524709|NCT01189526|macular edema|macular edema
5524710|NCT01189526|intravitreal injection|intravitreal injection
5524711|NCT01189526|ranibizumab|ranibizumab
5524712|NCT01189513|Recurrent Glioblastoma|recurrent glioblastoma
5524713|NCT01189513|Gliosarcoma|gliosarcoma
5524714|NCT01189513|SCH 900105|sch 900105
5524715|NCT01189500|Pharmacokinetic|pharmacokinetic
5524716|NCT01189500|safety and tolerability|safety and tolerability
5524717|NCT01189500|genetic testing|genetic testing
5524718|NCT01189500|CYP 2D6|cyp 2d6
5524719|NCT01189487|ampicillin sodium/sulbactam sodium|ampicillin sodium/sulbactam sodium
5524720|NCT01189487|Unasyn-S|unasyn-s
5524721|NCT01189487|community acquired pneumonia|community acquired pneumonia
5524722|NCT01189487|bacterial pneumonia|bacterial pneumonia
5524723|NCT01189474|Meibomian Gland Dysfunction|meibomian gland dysfunction
5524724|NCT01189461|pegaptanib sodium|pegaptanib sodium
5524725|NCT01189461|diabetic macular edema|diabetic macular edema
5524726|NCT01189448|Congenital Toxoplasmosis,|congenital toxoplasmosis,
5524727|NCT01189448|Pregnancy,|pregnancy,
5524728|NCT01189448|prenatal diagnosis,|prenatal diagnosis,
5524729|NCT01189448|mother-to-child transmission,|mother-to-child transmission,
5524730|NCT01189448|prevention,|prevention,
5524731|NCT01189448|spiramycine,|spiramycine,
5524732|NCT01189448|pyrimethamine-sulfadiazine|pyrimethamine-sulfadiazine
5524733|NCT01189435|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
5524734|NCT01189435|Lung|lung
5524735|NCT01189435|recurrent|recurrent
5524736|NCT01189435|10-097|10-097
5524737|NCT01189435|Gefitinib|gefitinib
5524738|NCT01189422|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5524739|NCT01189422|T1DM|t1dm
5524740|NCT01189409|Constipation|constipation
5524741|NCT01189409|Opioids|opioids
5524742|NCT01189409|Cancer|cancer
5524743|NCT01189409|Polyethylene glycol|polyethylene glycol
5524744|NCT01189409|Sennosides|sennosides
5524745|NCT01189409|Opioid Therapy|opioid therapy
5524746|NCT01189396|asthma|asthma
5524747|NCT01189396|bronchospasm|bronchospasm
5524748|NCT01189396|COPD|copd
5524749|NCT01189396|reversibility|reversibility
5524750|NCT01189396|efficacy|efficacy
5524751|NCT01189383|Melanoma|melanoma
5524752|NCT01189383|Vaccine|vaccine
5524753|NCT01189383|Dendritic Cell|dendritic cell
5524754|NCT01189383|Immune response|immune response
5524755|NCT01189383|Safety|safety
5524756|NCT01189383|Efficacy|efficacy
5524757|NCT01189370|carcinoma, renal cell|carcinoma, renal cell
5524758|NCT01189370|kidney|kidney
5524759|NCT01189370|cancer|cancer
5524760|NCT01189357|meniscal transplant|meniscal transplant
5524761|NCT01189344|Obesity|obesity
5524763|NCT01189344|Absorption|absorption
5524764|NCT01189344|Thyroid function|thyroid function
5524765|NCT01189331|Coronary artery disease|coronary artery disease
5524766|NCT01189331|CT|ct
5524767|NCT01189331|Computational flow dynamics|computational flow dynamics
5524768|NCT01189305|Drug Abuse|drug abuse
5506670|NCT01267864|metoclopramide|metoclopramide
5524770|NCT01189292|postoperative nausea and vomitus|postoperative nausea and vomitus
5524771|NCT01189292|PONV|ponv
5524772|NCT01189292|thyroid surgery|thyroid surgery
5524773|NCT01189253|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5524774|NCT01189253|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5524775|NCT01189253|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5524776|NCT01189253|adult angiosarcoma|adult angiosarcoma
5524777|NCT01189253|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5524778|NCT01189253|adult epithelioid sarcoma|adult epithelioid sarcoma
5524779|NCT01189253|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5524780|NCT01189253|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5524781|NCT01189253|adult fibrosarcoma|adult fibrosarcoma
5524782|NCT01189253|adult leiomyosarcoma|adult leiomyosarcoma
5524783|NCT01189253|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5524784|NCT01189253|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5524785|NCT01189253|adult malignant mesenchymoma|adult malignant mesenchymoma
5524786|NCT01189253|adult neurofibrosarcoma|adult neurofibrosarcoma
5524787|NCT01189253|adult synovial sarcoma|adult synovial sarcoma
5524788|NCT01189227|stage IV colon cancer|stage iv colon cancer
5524789|NCT01189227|adenocarcinoma of the colon|adenocarcinoma of the colon
5685357|NCT00556439|Takayasu's|takayasu's
5524790|NCT01189227|stage IV rectal cancer|stage iv rectal cancer
5524791|NCT01189227|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5524792|NCT01189227|liver metastases|liver metastases
5524793|NCT01189162|Primary treatment of RDS and treatment of RDS post extubation|primary treatment of rds and treatment of rds post extubation
5524794|NCT01189136|Voiding dysfunction|voiding dysfunction
5524795|NCT01189123|influenza|influenza
5524796|NCT01189123|vaccine|vaccine
5524797|NCT01189123|cell mediated immunity|cell mediated immunity
5524798|NCT01189123|elderly|elderly
5524799|NCT01189123|high dose influenza vaccine|high dose influenza vaccine
5524800|NCT01189110|smoking cessation|smoking cessation
5524801|NCT01189110|veterans|veterans
5524802|NCT01189110|auriculotherapy|auriculotherapy
5524803|NCT01189084|Alzheimer's disease|alzheimer's disease
5524804|NCT01189084|amyloid beta|amyloid beta
5524805|NCT01189084|vaccine|vaccine
5524806|NCT01189071|Stents [E07.695.750]|stents [e07.695.750]
5524807|NCT01189071|Darifenacin (C101207)|darifenacin (c101207)
5524808|NCT01189071|Kidney calculi|kidney calculi
5524809|NCT01189058|Perinatal stroke|perinatal stroke
5524810|NCT01189058|Periventricular venous infarction|periventricular venous infarction
5524811|NCT01189058|Presumed perinatal stroke|presumed perinatal stroke
5524812|NCT01189058|Neonatal stroke|neonatal stroke
5524813|NCT01189058|Arterial ischemic stroke|arterial ischemic stroke
5524814|NCT01189058|Fetal stroke|fetal stroke
5524815|NCT01189058|Transcranial magnetic stimulation|transcranial magnetic stimulation
5524816|NCT01189058|Constraint-induced movement therapy|constraint-induced movement therapy
5524817|NCT01189058|CIMT|cimt
5524818|NCT01189058|Cerebral palsy|cerebral palsy
5524819|NCT01189058|Congenital hemiplegia|congenital hemiplegia
5524820|NCT01189058|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
5524821|NCT01189058|Neuroplasticity|neuroplasticity
5524822|NCT01189058|Developmental plasticity|developmental plasticity
5524823|NCT01189045|Stroke|stroke
5524824|NCT01189045|Exercise|exercise
5524825|NCT01189045|Rehabilitation|rehabilitation
5524826|NCT01189045|Risk factors|risk factors
5524827|NCT01189019|ranibizumab|ranibizumab
5524828|NCT01189019|Wet macular degeneration|wet macular degeneration
5524829|NCT01189019|macular degeneration|macular degeneration
5524830|NCT01189019|PED|ped
5524831|NCT01189019|Retinal Pigment Epithelial Detachment|retinal pigment epithelial detachment
5524832|NCT01188967|Drugs, Investigational|drugs, investigational
5524833|NCT01188967|Nicotine Dependence|nicotine dependence
5524834|NCT01188967|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
5524835|NCT01188967|Relapse Prevention|relapse prevention
5524836|NCT01188967|Smoking Cessation|smoking cessation
5524837|NCT01188967|Nicotine Cessation Therapies|nicotine cessation therapies
5524838|NCT01188954|Seroma|seroma
5524839|NCT01188954|Doxycycline|doxycycline
5524840|NCT01188954|Cardiopulmonary By-Pass|cardiopulmonary by-pass
5524841|NCT01188954|Femoral Artery/Vein Cannulation|femoral artery/vein cannulation
5524842|NCT01188954|Prevent Seroma Formation|prevent seroma formation
5524843|NCT01188915|Hodgkin disease|hodgkin disease
5524844|NCT01188915|Breast cancer|breast cancer
5524845|NCT01188889|Chronic Myeloid Leukemia|chronic myeloid leukemia
5524846|NCT01188876|carboplatin|carboplatin
5524847|NCT01188876|recurrent|recurrent
5524848|NCT01188876|platinum sensitive|platinum sensitive
5524849|NCT01188876|pralatrexate|pralatrexate
5524850|NCT01188850|CIN 2 or 3|cin 2 or 3
5524851|NCT01188850|cervical cancer|cervical cancer
5524852|NCT01188850|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5524853|NCT01188837|Osteoarthritis, Knee|osteoarthritis, knee
5524854|NCT01188837|Manipulation Therapy|manipulation therapy
5524855|NCT01188811|Multiple Sclerosis|multiple sclerosis
5524856|NCT01188811|Multiple sclerosis, chronic progressive|multiple sclerosis, chronic progressive
5524857|NCT01188811|Neuroprotective agents|neuroprotective agents
5790015|NCT00146146|dihydrotestosterone|dihydrotestosterone
5524859|NCT01188811|Optical coherence tomography|optical coherence tomography
5524860|NCT01188811|Gait|gait
5524861|NCT01188811|Thioctic acid|thioctic acid
5524862|NCT01188811|Alpha-lipoic acid|alpha-lipoic acid
5524863|NCT01188798|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5524864|NCT01188798|Graft versus host disease|graft versus host disease
5524865|NCT01188798|Tacrolimus|tacrolimus
5524866|NCT01188798|Sirolimus|sirolimus
5524867|NCT01188798|Methotrexate|methotrexate
5524868|NCT01188798|Pentostatin|pentostatin
5524869|NCT01188785|siRNA|sirna
5524870|NCT01188785|RNA interference (RNAi)|rna interference (rnai)
5524871|NCT01188785|Cancer|cancer
5524872|NCT01188785|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5524873|NCT01188785|Pancreatic cancer|pancreatic cancer
5524874|NCT01188785|Solid tumor|solid tumor
5524875|NCT01188785|Operable pancreatic ductal adenocarcinoma|operable pancreatic ductal adenocarcinoma
5524876|NCT01188785|Non operable pancreatic ductal adenocarcinoma|non operable pancreatic ductal adenocarcinoma
5524877|NCT01188772|Hepatitis C Virus|hepatitis c virus
5524878|NCT01188772|HCV|hcv
5524879|NCT01188772|hepatitis|hepatitis
5524880|NCT01188772|Genotype 1|genotype 1
5524881|NCT01188772|Genotype 2|genotype 2
5524882|NCT01188772|Genotype 3|genotype 3
5524883|NCT01188759|Aspergillosis|aspergillosis
5524884|NCT01188759|Combination Therapy|combination therapy
5524885|NCT01188759|Voriconazole|voriconazole
5524886|NCT01188759|Anidulafungin|anidulafungin
5524887|NCT01188746|catheter|catheter
5524888|NCT01188746|palliative|palliative
5524889|NCT01188746|quality of life|quality of life
5524890|NCT01188746|10-059|10-059
5524891|NCT01188733|portal hypertension|portal hypertension
5524892|NCT01188733|varices|varices
5524893|NCT01188733|cirrhosis|cirrhosis
5524894|NCT01188733|octreotide|octreotide
5524895|NCT01188733|somatostatin analog|somatostatin analog
5524896|NCT01188733|Child Pugh Class A,B|child pugh class a,b
5524897|NCT01188707|Non small cell lung cancer|non small cell lung cancer
5524898|NCT01188707|Belinostat|belinostat
5524899|NCT01188707|Erlotinib|erlotinib
5524900|NCT01188707|HDAC inhibitor|hdac inhibitor
5524901|NCT01188707|Phase I/II|phase i/ii
5524903|NCT01188681|TRU-016|tru-016
5524904|NCT01188681|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5524905|NCT01188681|relapsed CLL|relapsed cll
5524906|NCT01188681|bendamustine|bendamustine
5524907|NCT01188668|Pharmacokinetic|pharmacokinetic
5524908|NCT01188668|safety and tolerability|safety and tolerability
5524909|NCT01188668|genetic testing|genetic testing
5524910|NCT01188668|CYP 2D6 and CYP 3A4|cyp 2d6 and cyp 3a4
5524911|NCT01188655|Ankylosing Spondylitis|ankylosing spondylitis
5524912|NCT01188642|childhood obesity|childhood obesity
5524913|NCT01188642|adipocytokines|adipocytokines
5524914|NCT01188642|physical exercise|physical exercise
5524915|NCT01188642|nutrition education|nutrition education
5524916|NCT01188629|Preventive Care|preventive care
5524917|NCT01188629|Medication Management|medication management
5524918|NCT01188629|Electronic Medical Records|electronic medical records
5524919|NCT01188629|Automated Telephone System|automated telephone system
5524920|NCT01188616|Childhood Obesity|childhood obesity
5524921|NCT01188616|Obesity Intervention|obesity intervention
5524922|NCT01188590|Post operative Respiratory insufficiency|post operative respiratory insufficiency
5524923|NCT01188577|asthma|asthma
5524924|NCT01188577|bronchospasm|bronchospasm
5524925|NCT01188577|wheezing|wheezing
5524926|NCT01188577|shortness of breath|shortness of breath
5524927|NCT01188564|Hereditary Angioedema|hereditary angioedema
5524929|NCT01188564|Angioedema|angioedema
5524930|NCT01188564|Recombinant C1 Inhibitor|recombinant c1 inhibitor
5524931|NCT01188564|rhC1INH|rhc1inh
5524932|NCT01188551|myringotomy|myringotomy
5524933|NCT01188551|pressure equalization tubes|pressure equalization tubes
5524934|NCT01188538|P. acnes, Acne vulgaris|p. acnes, acne vulgaris
5524935|NCT01188525|pharmacokinetics|pharmacokinetics
5524936|NCT01188525|enzymes|enzymes
5524937|NCT01188525|metabolism prediction|metabolism prediction
5524938|NCT01188512|Live nasal vaccine for prevention of pertussis|live nasal vaccine for prevention of pertussis
5524939|NCT01188473|Status Asthmaticus|status asthmaticus
5524940|NCT01188473|Noninvasive Positive Pressure Ventilation|noninvasive positive pressure ventilation
5524941|NCT01188473|Asthma in Children|asthma in children
5524942|NCT01188460|Insomnia|insomnia
5524943|NCT01188460|Chronic pain|chronic pain
5524944|NCT01188447|cervical-spine injuries|cervical-spine injuries
5524945|NCT01188447|cervical-spine fractures|cervical-spine fractures
5524946|NCT01188447|spinal cord injury|spinal cord injury
5524947|NCT01188447|neck injury|neck injury
5524948|NCT01188447|Canadian C-Spine Rule|canadian c-spine rule
5524949|NCT01188447|paramedics|paramedics
5524950|NCT01188447|emergency medical services|emergency medical services
5524951|NCT01188434|Methamphetamine|methamphetamine
5524952|NCT01188434|Substance Abuse|substance abuse
5524953|NCT01188434|Child Neglect|child neglect
5686128|NCT00553436|EMR|emr
5524954|NCT01188434|Child Welfare|child welfare
5524955|NCT01188434|Evidence Based Practice|evidence based practice
5524956|NCT01188382|Intracranial pressure|intracranial pressure
5524957|NCT01188382|resistance|resistance
5524958|NCT01188382|CSF outflow|csf outflow
5524959|NCT01188382|elderly|elderly
5524960|NCT01188382|reference value|reference value
5524961|NCT01188369|levosimendan|levosimendan
5524962|NCT01188369|heart failure|heart failure
5524963|NCT01188369|inotropics|inotropics
5524964|NCT01188369|diastolic dysfunction|diastolic dysfunction
5524965|NCT01188369|left ventricular hypertrophy|left ventricular hypertrophy
5524966|NCT01188369|aortic valve stenosis|aortic valve stenosis
5524967|NCT01188356|Reply|reply
5524968|NCT01188356|Symphony|symphony
5524969|NCT01188356|Atrial arrhythmias|atrial arrhythmias
5524970|NCT01188356|V pacing|v pacing
5524971|NCT01188356|Evaluate the incidence and evolution over-time of co-morbidities|evaluate the incidence and evolution over-time of co-morbidities
5524972|NCT01188343|Japanese Encephalitis|japanese encephalitis
5524973|NCT01188343|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5524974|NCT01188343|Measles|measles
5524975|NCT01188343|Mumps|mumps
5524976|NCT01188343|Rubella|rubella
5524977|NCT01188330|acute myeloid leukemia|acute myeloid leukemia
5524978|NCT01188291|Optical Coherence Tomography|optical coherence tomography
5524979|NCT01188291|Retinal Nerve Fiber Layer Thickness|retinal nerve fiber layer thickness
5524980|NCT01188291|Obstructive Sleep Apnea|obstructive sleep apnea
5524981|NCT01188291|Hypopnea syndrome|hypopnea syndrome
5524982|NCT01188291|Glaucoma|glaucoma
5524983|NCT01188252|Phase I|phase i
5524984|NCT01188252|Dose escalation|dose escalation
5524985|NCT01188252|Kinase inhibitor|kinase inhibitor
5524986|NCT01188252|Cyclin-dependent kinases|cyclin-dependent kinases
5524987|NCT01188239|electronic cigarette|electronic cigarette
5524988|NCT01188239|nicotine|nicotine
5524989|NCT01188239|smoking cessation|smoking cessation
5524990|NCT01188239|smoking reduction|smoking reduction
5524991|NCT01188187|custirsen sodium|custirsen sodium
5524992|NCT01188187|prostate cancer|prostate cancer
5524993|NCT01188187|overall survival|overall survival
5524994|NCT01188187|Metastatic Castrate Resistant Prostate Cancer|metastatic castrate resistant prostate cancer
5524995|NCT01188174|AML|aml
5524996|NCT01188174|primary induction failure|primary induction failure
5798711|NCT00111293|Prefrontal|prefrontal
5524997|NCT01188161|Posturography|posturography
5524998|NCT01188161|Balance|balance
5524999|NCT01188161|Falls|falls
5525000|NCT01188161|Gyroscope|gyroscope
5525001|NCT01188161|Rotational Chair|rotational chair
5525002|NCT01188161|Vestibular|vestibular
5525003|NCT01188161|Movement Disorders|movement disorders
5525004|NCT01188135|depression|depression
5525005|NCT01188135|interactive voice messaging|interactive voice messaging
5525006|NCT01188135|patient persistence with antidepressant medication treatment|patient persistence with antidepressant medication treatment
5525007|NCT01188122|VAP|vap
5525008|NCT01188109|Pancreatic Neoplasms|pancreatic neoplasms
5525009|NCT01188109|Pancreatic cancer|pancreatic cancer
5525010|NCT01188096|glioma|glioma
5525011|NCT01188096|pediatrics|pediatrics
5525012|NCT01188096|cancer|cancer
5525013|NCT01188096|brain tumor|brain tumor
5525014|NCT01188096|low grade glioma|low grade glioma
5525015|NCT01188083|NASH|nash
5525016|NCT01188083|non-alcoholic fatty-liver disease|non-alcoholic fatty-liver disease
5525017|NCT01188083|Hispanic|hispanic
5525018|NCT01188083|overweight|overweight
5525019|NCT01188070|Behavioral/Social|behavioral/social
5525020|NCT01188070|Cardiology|cardiology
5525021|NCT01188070|Clinical Laboratory Methods|clinical laboratory methods
5525022|NCT01188070|Congestive Heart Failure|congestive heart failure
5525023|NCT01188070|Heart Disease|heart disease
5525024|NCT01188070|Knowledge Dissemination|knowledge dissemination
5525025|NCT01188070|Lipids|lipids
5525026|NCT01188070|Nursing|nursing
5525027|NCT01188070|Health Promotion|health promotion
5525028|NCT01188070|Alzheimer's Disease/Dementia|alzheimer's disease/dementia
5525029|NCT01188057|Bioequivalence|bioequivalence
5525030|NCT01188057|ALPRAZOLAM|alprazolam
5525031|NCT01188057|Healthy subjects|healthy subjects
5525032|NCT01188044|Motor activity|motor activity
5525033|NCT01188044|Infant|infant
5525034|NCT01188044|Validation studies|validation studies
5525035|NCT01188044|Malawi|malawi
5525036|NCT01188044|Sub-Saharan Africa|sub-saharan africa
5525037|NCT01188031|Bioequivalence|bioequivalence
5525038|NCT01188031|ALPRAZOLAM|alprazolam
5525039|NCT01188031|Healthy subjects|healthy subjects
5525040|NCT01188018|Smoking|smoking
5525041|NCT01188018|Smoking Cessation|smoking cessation
5525042|NCT01188018|Nicotine Dependence|nicotine dependence
5525043|NCT01188018|Tobacco Use Cessation|tobacco use cessation
5525044|NCT01188018|Health Education|health education
5525045|NCT01188018|Patient Education|patient education
5525046|NCT01188005|OSAS|osas
5525047|NCT01188005|Sleep Apnoea|sleep apnoea
5525048|NCT01188005|IL6|il6
5525049|NCT01188005|TNFα|tnfα
5525050|NCT01188005|Oxidative Stress|oxidative stress
5525051|NCT01188005|Antioxidants|antioxidants
5904039|NCT00007813|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5525053|NCT01187992|Acute coronary syndrome|acute coronary syndrome
5789051|NCT00150124|radioprotection|radioprotection
5525054|NCT01187992|Advanced coronary artery disease|advanced coronary artery disease
5525056|NCT01187979|HIV prevention|hiv prevention
5525057|NCT01187979|Adolescents|adolescents
5525058|NCT01187979|South Africa|south africa
5525059|NCT01187979|HIV|hiv
5525060|NCT01187966|Parkinson's Disease|parkinson's disease
5525061|NCT01187966|PD|pd
5525062|NCT01187966|Levodopa|levodopa
5525063|NCT01187966|Patients with idiopathic Parkinson's disease with motor fluctuations|patients with idiopathic parkinson's disease with motor fluctuations
5525064|NCT01187953|Tacrolimus|tacrolimus
5525065|NCT01187953|Acute Rejection|acute rejection
5525066|NCT01187953|Kidney|kidney
5525067|NCT01187940|Autism Spectrum Disorder;|autism spectrum disorder;
5525068|NCT01187940|Psychoeducation|psychoeducation
5525069|NCT01187914|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5525070|NCT01187914|Radio-frequency Ablation|radio-frequency ablation
5525071|NCT01187914|Ablation|ablation
5525072|NCT01187914|Open irrigation cooled-tip|open irrigation cooled-tip
5525073|NCT01187901|Familial Adenomatous Polyposis|familial adenomatous polyposis
5525074|NCT01187901|Attenuated Familial Polyposis|attenuated familial polyposis
5525075|NCT01187888|PSP|psp
5525076|NCT01187888|Progressive Supranuclear Palsy|progressive supranuclear palsy
5525077|NCT01187888|Rasagiline|rasagiline
5525078|NCT01187888|Azilect|azilect
5525079|NCT01187888|PROSPERA|prospera
5525080|NCT01187875|satiety, dietary fiber|satiety, dietary fiber
5525081|NCT01187823|Chronic heart failure|chronic heart failure
5525082|NCT01187823|Central sleep apnea|central sleep apnea
5525083|NCT01187823|Obstructive sleep apnea|obstructive sleep apnea
5525084|NCT01187823|Adaptive servo ventilation|adaptive servo ventilation
5525085|NCT01187810|leukemia,lymphoma|leukemia,lymphoma
5525086|NCT01187758|antibiotic use|antibiotic use
5525087|NCT01187758|antibiotic prescription|antibiotic prescription
5525088|NCT01187758|antibiotic resistant S. pneumoniae|antibiotic resistant s. pneumoniae
5525089|NCT01187758|MRSA|mrsa
5525090|NCT01187745|renal calculi|renal calculi
5525091|NCT01187732|skin damage|skin damage
5525092|NCT01187732|intertrigo|intertrigo
5525093|NCT01187732|dermatitis|dermatitis
5525094|NCT01187732|erythema|erythema
5525095|NCT01187732|aggression|aggression
5525096|NCT01187732|body Wipes|body wipes
5525097|NCT01187732|soaps|soaps
5525098|NCT01187732|no rinse|no rinse
5525100|NCT01187732|nursing home residents|nursing home residents
5525101|NCT01187732|nurse|nurse
5525102|NCT01187719|HIV|hiv
5525103|NCT01187719|pregnancy|pregnancy
5525104|NCT01187719|phenytoin|phenytoin
5525105|NCT01187719|ARV prophylaxis|arv prophylaxis
5525106|NCT01187719|nevirapine|nevirapine
5525107|NCT01187706|gynecological cancer survivors|gynecological cancer survivors
5525108|NCT01187706|quality of life|quality of life
5525109|NCT01187680|Tissue adhesions|tissue adhesions
5525110|NCT01187680|Laparoscopy|laparoscopy
5525111|NCT01187667|delirium|delirium
5525112|NCT01187667|prevention|prevention
5525113|NCT01187667|critical care|critical care
5525114|NCT01187667|haloperidol|haloperidol
5525115|NCT01187654|myocardial infarction|myocardial infarction
5525116|NCT01187654|bone marrow stem cell|bone marrow stem cell
5525117|NCT01187654|AC133|ac133
5525118|NCT01187654|mono nuclear cell|mono nuclear cell
5525119|NCT01187641|cancer, colon, MRI scan|cancer, colon, mri scan
5525120|NCT01187628|Long-term study in Chronic Kidney Disease|long-term study in chronic kidney disease
5525121|NCT01187628|Lanthanum Carbonate|lanthanum carbonate
5525122|NCT01187615|Nonsquamous Non-small cell lung cancer|nonsquamous non-small cell lung cancer
5525123|NCT01187615|Phase I|phase i
5525124|NCT01187576|Physical activity|physical activity
5525125|NCT01187576|Hypertension|hypertension
5525126|NCT01187576|Diabetes mellitus|diabetes mellitus
5525127|NCT01187576|Motivational interviewing|motivational interviewing
5525128|NCT01187563|Rheumatoid arthritis, tocilizumab|rheumatoid arthritis, tocilizumab
5525129|NCT01187550|Dwarfism, pituitary|dwarfism, pituitary
5525130|NCT01187550|Growth hormone|growth hormone
5525131|NCT01187537|Knee Replacement|knee replacement
5525132|NCT01187537|Analgesia|analgesia
5525133|NCT01187537|Analgesics|analgesics
5525134|NCT01187537|Nerve blocks|nerve blocks
5525135|NCT01187537|Recovery of functions|recovery of functions
5525136|NCT01187537|Post operative analgesia|post operative analgesia
5525137|NCT01187524|Patient Registry|patient registry
5525138|NCT01187524|FMR1 Gene|fmr1 gene
5525139|NCT01187524|Fragile X Syndrome|fragile x syndrome
5525140|NCT01187524|Primary Ovarian Insufficiency|primary ovarian insufficiency
5525141|NCT01187524|Premature Ovarian Failure|premature ovarian failure
5525142|NCT01187524|Premature Ovarian Insufficiency|premature ovarian insufficiency
5525143|NCT01187511|Addiction|addiction
5525144|NCT01187511|Alcohol Dependence|alcohol dependence
5525145|NCT01187511|Anxiety|anxiety
5525146|NCT01187511|CRH Antagonist|crh antagonist
5525147|NCT01187511|Stress Induced Craving|stress induced craving
5525148|NCT01187498|Overactive bladder|overactive bladder
5525149|NCT01187498|Behavioral treatment|behavioral treatment
5525150|NCT01187498|Drug therapy|drug therapy
5525644|NCT01185626|patients|patients
5525151|NCT01187498|Lower urinary tract symptoms|lower urinary tract symptoms
5525152|NCT01187498|Urinary incontinence|urinary incontinence
5525154|NCT01187485|Androderm®|androderm®
5525155|NCT01187485|Testosterone|testosterone
5525156|NCT01187485|refractory|refractory
5525157|NCT01187485|prostate|prostate
5525158|NCT01187485|cancer|cancer
5525159|NCT01187485|"Patients with hormone refractory prostate cancer will be treated with a daily testosterone patch Androderm® applied every 24 hours to the skin"|"patients with hormone refractory prostate cancer will be treated with a daily testosterone patch androderm® applied every 24 hours to the skin"
5525160|NCT01187472|Head|head
5525161|NCT01187472|neck|neck
5525162|NCT01187472|cancer|cancer
5525163|NCT01187472|advanced|advanced
5525164|NCT01187472|oral cavity|oral cavity
5525165|NCT01187472|lip|lip
5525166|NCT01187472|larynx|larynx
5525167|NCT01187459|Vitamin D|vitamin d
5525168|NCT01187459|Crohn's Disease|crohn's disease
5525169|NCT01187459|Dose Response|dose response
5525170|NCT01187446|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5525171|NCT01187433|Dengue|dengue
5525172|NCT01187433|Dengue hemorrhagic fever|dengue hemorrhagic fever
5525173|NCT01187433|CYD Dengue Vaccines|cyd dengue vaccines
5525174|NCT01187420|Cerebral vasospasm|cerebral vasospasm
5525175|NCT01187420|delayed cerebral ischemia (DCI)|delayed cerebral ischemia (dci)
5525176|NCT01187420|subarachnoid hemorrhage (SAH) patients|subarachnoid hemorrhage (sah) patients
5525177|NCT01187394|Frozen Plasma|frozen plasma
5525178|NCT01187394|Fresh Frozen Plasma|fresh frozen plasma
5525179|NCT01187394|Cardiac Surgery|cardiac surgery
5525180|NCT01187394|Bleeding|bleeding
5525181|NCT01187394|Knowledge Translation|knowledge translation
5525182|NCT01187368|heart failure|heart failure
5525183|NCT01187368|LVAS|lvas
5525184|NCT01187368|LVAD|lvad
5525185|NCT01187368|bridge-to-transplant|bridge-to-transplant
5525186|NCT01187368|rotary pump|rotary pump
5525187|NCT01187355|Symptomatic, Contact lens care|symptomatic, contact lens care
5525188|NCT01187355|Multi-purpose solution|multi-purpose solution
5525189|NCT01187342|Stroke|stroke
5525190|NCT01187329|Hyperglycemia|hyperglycemia
5525191|NCT01187329|open heart surgery|open heart surgery
5525192|NCT01187329|bypass|bypass
5525193|NCT01187316|Facial Pain|facial pain
5525194|NCT01187316|Temporomandibular Joint Disorders|temporomandibular joint disorders
5525197|NCT01187290|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5525199|NCT01187277|stroke|stroke
5525200|NCT01187277|rehabilitation|rehabilitation
5525201|NCT01187277|gait training|gait training
5525202|NCT01187277|robot-assisted therapy|robot-assisted therapy
5525203|NCT01187251|tinnitus|tinnitus
5525204|NCT01187251|mp3 players|mp3 players
5525205|NCT01187251|noise induced hearing loss|noise induced hearing loss
5525206|NCT01187251|high frequencies audiometry|high frequencies audiometry
5525207|NCT01187251|acoustic otoemissions|acoustic otoemissions
5525208|NCT01187238|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5525209|NCT01187238|Stage II|stage ii
5525210|NCT01187238|Intensity-modulated radiotherapy|intensity-modulated radiotherapy
5525211|NCT01187238|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5525212|NCT01187238|Cisplatin|cisplatin
5525213|NCT01187225|Cardiac surgical procedures|cardiac surgical procedures
5525214|NCT01187225|Fibrinogen|fibrinogen
5525215|NCT01187225|Bleeding|bleeding
5525216|NCT01187225|Cryoprecipitate|cryoprecipitate
5525217|NCT01187212|First line chemotherapy in advanced gastric cancer|first line chemotherapy in advanced gastric cancer
5525218|NCT01187199|Metastatic cancer|metastatic cancer
5525219|NCT01187199|Chemotherapy|chemotherapy
5525220|NCT01187199|Avastin|avastin
5525221|NCT01187199|Carboplatin|carboplatin
5525222|NCT01187199|Paclitaxel|paclitaxel
5525223|NCT01187199|Sorafenib|sorafenib
5525224|NCT01187199|Temsirolimus|temsirolimus
5525225|NCT01187186|Liver disease|liver disease
5525226|NCT01187186|ASP1941|asp1941
5525227|NCT01187160|Obstructive sleep apnea|obstructive sleep apnea
5525228|NCT01187147|Asthma, green tea, antioxidants|asthma, green tea, antioxidants
5525229|NCT01187134|sepsis|sepsis
5525230|NCT01187134|shock, septic|shock, septic
5525231|NCT01187134|quality assurance, health care|quality assurance, health care
5525232|NCT01187134|quality control|quality control
5525233|NCT01187134|Survival Rate|survival rate
5525234|NCT01187134|Follow-Up Studies|follow-up studies
5525235|NCT01187134|Anti-Infective Agents/*therapeutic use|anti-infective agents/*therapeutic use
5525236|NCT01187121|Graduated Sanctions|graduated sanctions
5525237|NCT01187121|Probationary failure|probationary failure
5525238|NCT01187121|recidivism|recidivism
5525239|NCT01187121|drug relapse|drug relapse
5525240|NCT01187121|criminal justice|criminal justice
5525241|NCT01187108|Cobalt|cobalt
5525242|NCT01187108|Excessive Erythrocytosis|excessive erythrocytosis
5525243|NCT01187108|Monge's Disease|monge's disease
5525244|NCT01187108|Acetazolamide|acetazolamide
5525245|NCT01187108|N-acetylcysteine|n-acetylcysteine
5525246|NCT01187108|Altitude Sickness|altitude sickness
5525247|NCT01187108|Chronic Mountain Sickness|chronic mountain sickness
5525248|NCT01187095|Involuntary childlessness|involuntary childlessness
5525249|NCT01187095|Infertility|infertility
5525250|NCT01187095|IVF|ivf
5525251|NCT01187095|EWI|ewi
5525252|NCT01187095|Couples in IVF treatment|couples in ivf treatment
5525253|NCT01187095|Psychosocial intervention|psychosocial intervention
5525254|NCT01187082|overactive bladder|overactive bladder
5525255|NCT01187082|women|women
5525256|NCT01187082|bladder training|bladder training
5525257|NCT01187082|groups|groups
5525258|NCT01187069|Motivation|motivation
5525259|NCT01187069|patients with type 2 diabetes|patients with type 2 diabetes
5525260|NCT01187069|practice nurses|practice nurses
5525261|NCT01187069|general practice|general practice
5525262|NCT01187069|Self-determination Theory|self-determination theory
5525263|NCT01187056|Shared decision-making|shared decision-making
5525264|NCT01187056|Risk information|risk information
5525265|NCT01187056|Decision aids|decision aids
5525266|NCT01187043|Liver Function|liver function
5525267|NCT01187043|Steady State Exposure|steady state exposure
5525268|NCT01187030|Frozen Plasma|frozen plasma
5525269|NCT01187030|Fresh Frozen Plasma|fresh frozen plasma
5525270|NCT01187030|Prothrombin Complex Concentrates|prothrombin complex concentrates
5525271|NCT01187030|RAND UCLA|rand ucla
5525272|NCT01187030|Modified Delphi Methodology|modified delphi methodology
5525273|NCT01187030|Expert Panel|expert panel
5525274|NCT01187030|Appropriateness Rating|appropriateness rating
5525275|NCT01187017|Severe Aplastic Anemia|severe aplastic anemia
5525276|NCT01187017|Aplastic Anemia|aplastic anemia
5525277|NCT01187017|Immunosuppression|immunosuppression
5525278|NCT01187017|Immunosuppressive Therapy|immunosuppressive therapy
5525279|NCT01187017|T-Cells|t-cells
5525280|NCT01186965|Diabetes|diabetes
5525281|NCT01186965|Second Life|second life
5525282|NCT01186965|virtual community|virtual community
5525283|NCT01186965|diabetes education|diabetes education
5525284|NCT01186965|diabetes support group|diabetes support group
5525285|NCT01186952|overweight|overweight
5525286|NCT01186952|obesity|obesity
5525287|NCT01186952|type 2 diabetes|type 2 diabetes
5525288|NCT01186952|caloric restriction|caloric restriction
5525289|NCT01186952|exercise program|exercise program
5525290|NCT01186952|epicardial fat|epicardial fat
5525291|NCT01186939|Myelodysplastic Syndromes|myelodysplastic syndromes
5525293|NCT01186926|Obstructive sleep apnea|obstructive sleep apnea
5525294|NCT01186926|OSA|osa
5525295|NCT01186926|hypoglossal nerve stimulation|hypoglossal nerve stimulation
5525296|NCT01186926|sleep apnea|sleep apnea
5525297|NCT01186913|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
5525298|NCT01186913|natural history study|natural history study
5525299|NCT01186913|SCID treatment|scid treatment
5525300|NCT01186900|skin abscess|skin abscess
5525301|NCT01186900|needle aspiration|needle aspiration
5525302|NCT01186900|incision and drainage|incision and drainage
5525303|NCT01186887|primary ACL reconstruction with a hamstring graft|primary acl reconstruction with a hamstring graft
5525304|NCT01186861|OSI-906|osi-906
5525305|NCT01186861|Erlotinib|erlotinib
5525306|NCT01186861|Platinum-based chemotherapy|platinum-based chemotherapy
5525307|NCT01186861|Placebo|placebo
5525308|NCT01186861|NSCLC|nsclc
5525309|NCT01186848|Stretch marks|stretch marks
5525310|NCT01186848|Striae distensae|striae distensae
5525311|NCT01186809|hematologic malignancies (excluding Chronic Myeloid Leukemia)|hematologic malignancies (excluding chronic myeloid leukemia)
5525312|NCT01186796|Women|women
5525313|NCT01186796|Fulvestrant Study|fulvestrant study
5525314|NCT01186796|Post Menopausal Women|post menopausal women
5525315|NCT01186796|Hormones|hormones
5525316|NCT01186796|Healthy Adult Women|healthy adult women
5525317|NCT01186783|heart rate|heart rate
5525318|NCT01186783|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5525319|NCT01186783|ivabradine|ivabradine
5525320|NCT01186783|sepsis|sepsis
5525321|NCT01186783|cardiogenic shock|cardiogenic shock
5525322|NCT01186770|Treatment of Opioid-Induced Constipation in Participants with Chronic, Non-Malignant Pain|treatment of opioid-induced constipation in participants with chronic, non-malignant pain
5525323|NCT01186744|OPT Retreatment|opt retreatment
5525324|NCT01186744|OPT|opt
5525325|NCT01186744|chronic|chronic
5525326|NCT01186744|moderate|moderate
5525327|NCT01186744|severe|severe
5525328|NCT01186744|treatment|treatment
5525329|NCT01186744|safety|safety
5525330|NCT01186744|treatment withdrawal|treatment withdrawal
5525331|NCT01186744|retreatment|retreatment
5525332|NCT01186744|retreatment withdrawal|retreatment withdrawal
5525333|NCT01186744|CP-690,550|cp-690,550
5525334|NCT01186744|Psoriasis Vulgaris|psoriasis vulgaris
5525335|NCT01186744|Plaque Psoriasis|plaque psoriasis
5525336|NCT01186744|tofacitinib|tofacitinib
5525337|NCT01186744|Xeljanz|xeljanz
5525338|NCT01186744|nail psoriasis|nail psoriasis
5525339|NCT01186744|Jak-inhibitor|jak-inhibitor
5525340|NCT01186744|oral treatment|oral treatment
5525341|NCT01186744|Pruritus|pruritus
5525342|NCT01186744|Itch|itch
5525343|NCT01186744|DLQI|dlqi
5525344|NCT01186744|rebound|rebound
5525345|NCT01186744|intermittent|intermittent
5525346|NCT01186744|retreat|retreat
5525347|NCT01186731|SPARC (secreted protein acid rich in cysteine)|sparc (secreted protein acid rich in cysteine)
5525348|NCT01186731|serum Carbohydrate Antigen CA 19-9|serum carbohydrate antigen ca 19-9
5525349|NCT01186718|Cervical, motions, kinematics|cervical, motions, kinematics
5525351|NCT01186705|colon|colon
5525352|NCT01186705|rectal|rectal
5525353|NCT01186705|10-068|10-068
5525354|NCT01186666|Atherosclerosis|atherosclerosis
5525355|NCT01186666|Vulnerable plaque|vulnerable plaque
5525356|NCT01186666|Intravascular ultrasound|intravascular ultrasound
5525357|NCT01186666|Virtual histology|virtual histology
5525358|NCT01186666|Fluorodeoxyglucose|fluorodeoxyglucose
5525359|NCT01186666|Positron emission tomography|positron emission tomography
5525360|NCT01186666|Multidetector computed tomography|multidetector computed tomography
5525361|NCT01186640|T-PLL|t-pll
5525362|NCT01186640|Polychemotherapy|polychemotherapy
5525363|NCT01186640|Alemtuzumab|alemtuzumab
5525364|NCT01186640|Efficacy|efficacy
5525365|NCT01186627|Neurodevelopmental Impairment|neurodevelopmental impairment
5525366|NCT01186627|Intraventricular hemorrhage|intraventricular hemorrhage
5525367|NCT01186627|Retinopathy of prematurity|retinopathy of prematurity
5525368|NCT01186627|Mortality|mortality
5525369|NCT01186627|Apgar Score|apgar score
5525370|NCT01186614|cardiac arrest|cardiac arrest
5525371|NCT01186614|ECMO|ecmo
5525372|NCT01186614|hypothermia|hypothermia
5525373|NCT01186614|automated CPR|automated cpr
5525374|NCT01186614|coronary intervention|coronary intervention
5525375|NCT01186601|Prostatic Neoplasms|prostatic neoplasms
5525376|NCT01186601|Colorectal Neoplasms|colorectal neoplasms
5525377|NCT01186601|Head and Neck Neoplasms|head and neck neoplasms
5525378|NCT01186601|Melanoma|melanoma
5525379|NCT01186601|Neoplasm Metastasis|neoplasm metastasis
5525380|NCT01186588|Canagliflozin|canagliflozin
5525381|NCT01186588|JNJ-28431754|jnj-28431754
5525382|NCT01186588|Liver diseases|liver diseases
5525383|NCT01186588|Hepatic impairment|hepatic impairment
5525384|NCT01186588|Pharmacokinetic|pharmacokinetic
5525385|NCT01186588|Normal hepatic function|normal hepatic function
5525386|NCT01186575|HIV Infections|hiv infections
5525387|NCT01186575|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5525388|NCT01186575|Circumcision, Male|circumcision, male
5525390|NCT01186575|Patient Compliance|patient compliance
5525391|NCT01186575|Cellular Phone|cellular phone
5525392|NCT01186562|Pancreatitis|pancreatitis
5525393|NCT01186562|Pancreatectomy|pancreatectomy
5525394|NCT01186562|Islet autotransplant|islet autotransplant
5525395|NCT01186562|Sitagliptin|sitagliptin
5525396|NCT01186562|Diabetes|diabetes
5525397|NCT01186549|propofol|propofol
5525398|NCT01186549|ephedrine|ephedrine
5525399|NCT01186549|pain|pain
5525400|NCT01186536|Whey Protein|whey protein
5525401|NCT01186536|Soy Protein|soy protein
5525402|NCT01186536|Resistance training|resistance training
5525403|NCT01186536|Weight Management|weight management
5525404|NCT01186523|Obesity|obesity
5525405|NCT01186523|Weight Management|weight management
5525406|NCT01186523|Physical Activity|physical activity
5525407|NCT01186497|Healthy|healthy
5525408|NCT01186497|Rabeprazole sodium|rabeprazole sodium
5525409|NCT01186497|Rabeprazole sprinkle capsule granule formulation|rabeprazole sprinkle capsule granule formulation
5525410|NCT01186497|Pharmacokinetics|pharmacokinetics
5525411|NCT01186497|Bioavailability|bioavailability
5525412|NCT01186497|Safety|safety
5525413|NCT01186497|Adult|adult
5525414|NCT01186484|Castration-resistant prostate cancer|castration-resistant prostate cancer
5525415|NCT01186484|Abiraterone acetate|abiraterone acetate
5525416|NCT01186484|JNJ-212082|jnj-212082
5525417|NCT01186471|Symptomatic treatment|symptomatic treatment
5525418|NCT01186471|Cognition|cognition
5525419|NCT01186471|Cognitive deficits|cognitive deficits
5525420|NCT01186471|Schizophrenia|schizophrenia
5525421|NCT01186445|Acute Myocardial Infarction|acute myocardial infarction
5525422|NCT01186445|Cardioprotective effect|cardioprotective effect
5525423|NCT01186445|Pharmacological postconditioning|pharmacological postconditioning
5525424|NCT01186445|Morphine Chlorhydrate|morphine chlorhydrate
5525425|NCT01186445|Cardiac MRI|cardiac mri
5525426|NCT01186419|Beta-thalassemia|beta-thalassemia
5525427|NCT01186419|Sickle cell anemia|sickle cell anemia
5525428|NCT01186419|Transfusional iron overload|transfusional iron overload
5525429|NCT01186419|Iron overload|iron overload
5525430|NCT01186419|Iron chelation|iron chelation
5525431|NCT01186406|glioblastoma multiforme|glioblastoma multiforme
5525432|NCT01186406|gliosarcoma|gliosarcoma
5525433|NCT01186406|malignant glioma|malignant glioma
5525434|NCT01186406|glioma|glioma
5525435|NCT01186406|Gliadel|gliadel
5525436|NCT01186406|carmustine wafers|carmustine wafers
5525437|NCT01186406|Avastin|avastin
5525438|NCT01186406|bevacizumab|bevacizumab
5525439|NCT01186406|Temodar|temodar
5525440|NCT01186406|temozolomide|temozolomide
5525441|NCT01186406|Pro00025180|pro00025180
5525442|NCT01186406|Desjardins|desjardins
5525443|NCT01186406|Duke|duke
5525444|NCT01186406|Preston Robert Tisch Brain Tumor Center|preston robert tisch brain tumor center
5525445|NCT01186393|Weight Loss|weight loss
5525446|NCT01186393|Potatoes|potatoes
5525447|NCT01186393|Dietary Meetings|dietary meetings
5525448|NCT01186393|Glycemic Control|glycemic control
5525450|NCT01186380|Transesophageal|transesophageal
5525451|NCT01186380|Transducer|transducer
5525452|NCT01186380|Esophagus|esophagus
5525453|NCT01186380|Ease of passage and during transitioning into and down the esophagus to complete a normal TEE study|ease of passage and during transitioning into and down the esophagus to complete a normal tee study
5525454|NCT01186367|breast cancer|breast cancer
5525455|NCT01186367|Linear Versus Nonlinear Aerobic Training|linear versus nonlinear aerobic training
5525456|NCT01186367|15-147|15-147
5525457|NCT01186354|Type 2 diabetes|type 2 diabetes
5525458|NCT01186354|health literacy|health literacy
5525459|NCT01186354|genetic literacy|genetic literacy
5525460|NCT01186354|genetic risk|genetic risk
5525461|NCT01186341|Chronic Pain|chronic pain
5525462|NCT01186328|Relapse|relapse
5525463|NCT01186328|T cell|t cell
5525464|NCT01186328|Lymphoblastic|lymphoblastic
5525465|NCT01186328|Leukemia|leukemia
5525466|NCT01186328|EZN3042|ezn3042
5525467|NCT01186328|Refractory|refractory
5525468|NCT01186328|Precursor B|precursor b
5525469|NCT01186328|Pre B cell|pre b cell
5525470|NCT01186328|Survivin|survivin
5525471|NCT01186328|Acute|acute
5525472|NCT01186328|Childhood|childhood
5525473|NCT01186328|Pediatric|pediatric
5525474|NCT01186315|Addiction|addiction
5525475|NCT01186315|Posttraumatic Stress|posttraumatic stress
5525476|NCT01186315|substance abuse and posttraumatic stress|substance abuse and posttraumatic stress
5525477|NCT01186302|medical abortion|medical abortion
5525478|NCT01186302|Nepal|nepal
5525479|NCT01186302|midlevel providers|midlevel providers
5525480|NCT01186289|Neurocognitive Dysfunction|neurocognitive dysfunction
5525481|NCT01186263|liver metastases|liver metastases
5525482|NCT01186263|MAA|maa
5525483|NCT01186263|B20|b20
5525484|NCT01186263|SIR spheres|sir spheres
5525485|NCT01186263|SPECT|spect
5525486|NCT01186263|intra-hepatic distribution|intra-hepatic distribution
5525487|NCT01186250|cardiac allograft vasculopathy|cardiac allograft vasculopathy
5525488|NCT01186250|pioglitazone|pioglitazone
5525489|NCT01186250|insulin resistance|insulin resistance
5525490|NCT01186250|heart transplant|heart transplant
5798712|NCT00111293|Parietal|parietal
5525491|NCT01186237|Colon/Rectal Cancer Rectal Cancer|colon/rectal cancer rectal cancer
5525493|NCT01186211|knee, joint|knee, joint
5525494|NCT01186198|Coronary Dilatation Catheter|coronary dilatation catheter
5525495|NCT01186198|Balloon Dilatation Catheter|balloon dilatation catheter
5525496|NCT01186198|Predilatation Balloon|predilatation balloon
5525497|NCT01186198|Angioplasty|angioplasty
5525498|NCT01186198|Myocardial Ischemia|myocardial ischemia
5525499|NCT01186198|Coronary Stenosis|coronary stenosis
5525500|NCT01186198|PCI|pci
5525501|NCT01186198|PTCA|ptca
5525502|NCT01186198|CTO|cto
5525503|NCT01186185|sudden|sudden
5525504|NCT01186185|sensorineural|sensorineural
5525505|NCT01186185|hearing loss|hearing loss
5525506|NCT01186185|fludrocortisone|fludrocortisone
5525507|NCT01186185|mineralocorticoid|mineralocorticoid
5525508|NCT01186185|steroid|steroid
5525509|NCT01186172|ethanol|ethanol
5525510|NCT01186172|lock therapy|lock therapy
5525511|NCT01186172|vascular access|vascular access
5525512|NCT01186172|central venous catheter|central venous catheter
5525513|NCT01186172|sepsis|sepsis
5525514|NCT01186159|COX-2|cox-2
5525515|NCT01186159|PMNL|pmnl
5525516|NCT01186159|pain|pain
5525517|NCT01186159|macrophages|macrophages
5525518|NCT01186159|NSAIDs|nsaids
5525519|NCT01186146|coronary disease|coronary disease
5525520|NCT01186146|stents|stents
5525521|NCT01186146|antiplatelet drugs|antiplatelet drugs
5525522|NCT01186146|drug-eluting stents|drug-eluting stents
5525523|NCT01186133|coronary disease|coronary disease
5525524|NCT01186133|drug eluting stent|drug eluting stent
5525525|NCT01186120|coronary disease|coronary disease
5525526|NCT01186120|stent|stent
5525527|NCT01186107|coronary disease|coronary disease
5525528|NCT01186107|stent|stent
5525529|NCT01186094|Coronary Artery Disease|coronary artery disease
5525530|NCT01186094|Stent|stent
5525531|NCT01186081|Rectal cancer|rectal cancer
5525532|NCT01186081|Preoperative CCRT|preoperative ccrt
5525533|NCT01186081|Postoperative CCRT|postoperative ccrt
5525534|NCT01186081|Capecitabine|capecitabine
5525535|NCT01186068|Rosacea, erythema|rosacea, erythema
5525536|NCT01186055|Smoking Relapse|smoking relapse
5525537|NCT01186055|Nicotine Abstinence|nicotine abstinence
5525538|NCT01186042|HIV|hiv
5525539|NCT01186042|Aging|aging
5525540|NCT01186042|Neuropsychological function|neuropsychological function
5525541|NCT01186042|Activity|activity
5525542|NCT01186042|Sleep patterns|sleep patterns
5525543|NCT01186042|Frailty|frailty
5525544|NCT01186042|Emotional well-being|emotional well-being
5525545|NCT01186042|Sexual health|sexual health
5525546|NCT01186029|Looking at adding drug to already established treatment regimen for|looking at adding drug to already established treatment regimen for
5525547|NCT01186029|Nausea and Vomiting|nausea and vomiting
5525548|NCT01186016|Genetic Education|genetic education
5525549|NCT01186016|Smoking Cessation|smoking cessation
5525550|NCT01186016|Quitting Smoking|quitting smoking
5525551|NCT01186016|Standard Smoking Cessation Program|standard smoking cessation program
5525552|NCT01186016|Genetic Education for Smoking Cessation|genetic education for smoking cessation
5525553|NCT01186003|Diabetes|diabetes
5525554|NCT01185977|Major Depressive Disorder|major depressive disorder
5525555|NCT01185977|Fluoxetine|fluoxetine
5525556|NCT01185977|QEEG|qeeg
5525557|NCT01185977|cordance|cordance
5525558|NCT01185977|ATR|atr
5525559|NCT01185964|Sarcoma, Soft Tissue|sarcoma, soft tissue
5525560|NCT01185964|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
5525561|NCT01185951|Achilles Tendon|achilles tendon
5525562|NCT01185951|Patella|patella
5525563|NCT01185951|Allergy|allergy
5525564|NCT01185951|Necrosis|necrosis
5525565|NCT01185951|Infection|infection
5525566|NCT01185938|statin|statin
5525567|NCT01185938|CIN|cin
5525568|NCT01185938|periprocedural damage|periprocedural damage
5525569|NCT01185925|PDE5-inhibition|pde5-inhibition
5525570|NCT01185925|exercise ventilation|exercise ventilation
5525571|NCT01185925|heart failure|heart failure
5525572|NCT01185925|sildenafil|sildenafil
5525573|NCT01185925|pulmonary hemodynamics|pulmonary hemodynamics
5525574|NCT01185912|Cardiac MRI|cardiac mri
5525575|NCT01185912|Cardiac ultrasound|cardiac ultrasound
5525576|NCT01185912|Cardiac surgery|cardiac surgery
5525577|NCT01185899|heart attack|heart attack
5525578|NCT01185899|acute myocardial infarction|acute myocardial infarction
5525579|NCT01185899|STEMI|stemi
5525580|NCT01185899|NSTEMI|nstemi
5525581|NCT01185899|Unstable Angina|unstable angina
5525582|NCT01185899|suspected acute coronary syndrome|suspected acute coronary syndrome
5525583|NCT01185899|Non-ischemic chest pain|non-ischemic chest pain
5525584|NCT01185886|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5525585|NCT01185886|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5525586|NCT01185886|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5525587|NCT01185886|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5525588|NCT01185886|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5525589|NCT01185886|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5525593|NCT01185886|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
5525596|NCT01185821|Multiple Sclerosis|multiple sclerosis
5525597|NCT01185821|Relapsing remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5525598|NCT01185821|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
5525600|NCT01185821|RRMS|rrms
5525601|NCT01185821|inflammatory disease|inflammatory disease
5525602|NCT01185808|sinusitis|sinusitis
5525603|NCT01185808|chronic sinusitis with polyps|chronic sinusitis with polyps
5525604|NCT01185795|yogurt|yogurt
5525605|NCT01185795|probiotic|probiotic
5525606|NCT01185795|cholesterol|cholesterol
5525607|NCT01185782|Infertility|infertility
5525608|NCT01185782|Ovulation induction|ovulation induction
5525609|NCT01185782|Gonalef® (Follitropin alfa)|gonalef® (follitropin alfa)
5525610|NCT01185782|Purified pituitary gonadotropin (Fertinorm-P®)|purified pituitary gonadotropin (fertinorm-p®)
5525611|NCT01185782|gonadotropin|gonadotropin
5525612|NCT01185782|Reproductive technologies, assisted|reproductive technologies, assisted
5525613|NCT01185782|Polycystic ovary syndrome|polycystic ovary syndrome
5525614|NCT01185769|Vitamin E|vitamin e
5525615|NCT01185769|Absorption|absorption
5525616|NCT01185756|Heart failure|heart failure
5525617|NCT01185756|Sudden death|sudden death
5525618|NCT01185756|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5525619|NCT01185756|MIBG scintigraphy|mibg scintigraphy
5525620|NCT01185743|healthy volunteers|healthy volunteers
5525621|NCT01185743|antipsychotics|antipsychotics
5525622|NCT01185743|gene expression|gene expression
5525623|NCT01185730|Pulmonary hypertension|pulmonary hypertension
5525624|NCT01185730|Prognostic factors|prognostic factors
5525625|NCT01185730|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
5525626|NCT01185730|Family pulmonary hypertension|family pulmonary hypertension
5525627|NCT01185730|use anorectics|use anorectics
5525628|NCT01185704|Cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation|cetrorelix acetate; follitropin alfa; human chorionic-gonadotropin alfa; follicular maturation; pregnancy; ovarian stimulation
5525629|NCT01185678|Contraception|contraception
5525630|NCT01185678|Compliance|compliance
5525631|NCT01185665|FBSS|fbss
5525632|NCT01185652|Smoking|smoking
5525633|NCT01185652|airflow obstruction|airflow obstruction
5525634|NCT01185652|pulmonary function tests|pulmonary function tests
5525635|NCT01185639|lung cancer|lung cancer
5525636|NCT01185639|metastatic|metastatic
5525637|NCT01185639|SBRT|sbrt
5525638|NCT01185639|Stereotactic body radiation therapy|stereotactic body radiation therapy
5525639|NCT01185639|liver|liver
5525640|NCT01185639|spine|spine
5525641|NCT01185639|adrenal|adrenal
5525642|NCT01185639|bone cancer|bone cancer
5525645|NCT01185600|transfusion complications|transfusion complications
5525646|NCT01185600|washed RBC|washed rbc
5525647|NCT01185600|microparticles|microparticles
5525648|NCT01185600|storage lesion|storage lesion
5525649|NCT01185587|SCN5A protein|scn5a protein
5525650|NCT01185587|voltage-gated Na+ channel|voltage-gated na+ channel
5525651|NCT01185561|Diabetes|diabetes
5525652|NCT01185561|SWEEP|sweep
5525653|NCT01185561|Dysphoria|dysphoria
5789052|NCT00150111|Graves disease|graves disease
5789053|NCT00150111|thyroid|thyroid
5525654|NCT01185548|Advanced or Metastatic Solid Tumors or Lymphoma|advanced or metastatic solid tumors or lymphoma
5525655|NCT01185535|topical anesthesia|topical anesthesia
5525656|NCT01185535|tracheal intubation|tracheal intubation
5525657|NCT01185535|difficult airway|difficult airway
5525658|NCT01185509|HER2 negative|her2 negative
5525659|NCT01185509|HER2 positive|her2 positive
5525660|NCT01185496|diabetes mellitus|diabetes mellitus
5525661|NCT01185483|Endoscopic submucosal dissection|endoscopic submucosal dissection
5525662|NCT01185483|Submucosal tumor|submucosal tumor
5525663|NCT01185483|Minimal invasive|minimal invasive
5525664|NCT01185483|Gastroscopy|gastroscopy
5525665|NCT01185470|Chronic pain|chronic pain
5525666|NCT01185470|Morphine Sufate|morphine sufate
5525667|NCT01185470|Intrathecal|intrathecal
5525668|NCT01185470|Implantable drug delivery pumps|implantable drug delivery pumps
5525669|NCT01185457|Shoulder surgery|shoulder surgery
5525670|NCT01185457|Beach chair position|beach chair position
5525671|NCT01185457|Interscalene block|interscalene block
5525673|NCT01185457|Autonomic nervous system|autonomic nervous system
5525674|NCT01185444|Knee Balance|knee balance
5525676|NCT01185444|Osteoarthritis|osteoarthritis
5525677|NCT01185444|Viscosupplementation|viscosupplementation
5525678|NCT01185431|Ficus Carica|ficus carica
5525679|NCT01185431|Functional Constipation|functional constipation
5525680|NCT01185431|Dietary Supplement|dietary supplement
5525681|NCT01185431|Fig Paste|fig paste
5525682|NCT01185405|Voriconazole|voriconazole
5525683|NCT01185405|Therapeutic drug monitoring|therapeutic drug monitoring
5525684|NCT01185405|Intensive care unit|intensive care unit
5525685|NCT01185392|Cardiac Resynchronisation Therapy in Heart Failure|cardiac resynchronisation therapy in heart failure
5525686|NCT01185379|Docosahexaenoic acid|docosahexaenoic acid
5525687|NCT01185379|omega 3|omega 3
5525688|NCT01185379|cerebral blood flow|cerebral blood flow
5525689|NCT01185379|Near Infrared spectroscopy|near infrared spectroscopy
5525690|NCT01185379|cognitive function|cognitive function
5525691|NCT01185379|mood|mood
5525692|NCT01185366|Advanced non-clear cell renal cell cancer (RCC)|advanced non-clear cell renal cell cancer (rcc)
5525693|NCT01185366|Clear-cell renal cell carcinoma|clear-cell renal cell carcinoma
5525694|NCT01185366|Collecting duct carcinoma|collecting duct carcinoma
5525695|NCT01185366|Translocation carcinoma|translocation carcinoma
5525696|NCT01185366|Chromophobe|chromophobe
5525697|NCT01185366|Everolimus|everolimus
5525698|NCT01185366|Sunitinib|sunitinib
5525699|NCT01185366|Afinitor|afinitor
5525700|NCT01185366|RAD001|rad001
5525701|NCT01185366|Sunitinib Malate|sunitinib malate
5525702|NCT01185366|SUO11248|suo11248
5525703|NCT01185366|Sutent|sutent
5525704|NCT01185366|ESPN|espn
5525705|NCT01185353|Rheumatoid Arthritis|rheumatoid arthritis
5525706|NCT01185353|RA|ra
5525707|NCT01185340|Depression|depression
5525708|NCT01185340|MDD|mdd
5525709|NCT01185327|Regurgitation|regurgitation
5525710|NCT01185327|Infants to Israeli Ethiopian-origin mothers|infants to israeli ethiopian-origin mothers
5525711|NCT01185314|NSCLC, EGFR mutation|nsclc, egfr mutation
5525712|NCT01185301|Arthritis|arthritis
5525713|NCT01185301|Erosion|erosion
5525714|NCT01185301|Humira|humira
5525715|NCT01185301|Adalimumab|adalimumab
5525716|NCT01185301|Injection|injection
5525717|NCT01185301|Rheumatoid|rheumatoid
5525718|NCT01185301|Methotrexate|methotrexate
5525719|NCT01185288|Rheumatoid Arthritis|rheumatoid arthritis
5525720|NCT01185262|Recurrent and refractory chronic lymphocytic leukemia|recurrent and refractory chronic lymphocytic leukemia
5525721|NCT01185249|CHF|chf
5525722|NCT01185249|congestive heart failure|congestive heart failure
5525723|NCT01185236|Diabetes mellitus|diabetes mellitus
5525724|NCT01185223|Valganciclovir|valganciclovir
5525725|NCT01185223|Ganciclovir|ganciclovir
5525726|NCT01185223|Antiviral Drug|antiviral drug
5525727|NCT01185223|CMV disease|cmv disease
5525728|NCT01185197|Minimal Change Nephrotic Syndrome|minimal change nephrotic syndrome
5525729|NCT01185197|Corticosteroid|corticosteroid
5525730|NCT01185197|Mycophenolate|mycophenolate
5525731|NCT01185197|Remission|remission
5525732|NCT01185197|Safety|safety
5525733|NCT01185184|Relative bioavailability|relative bioavailability
5525734|NCT01185184|controlled release|controlled release
5525735|NCT01185184|Phase 1|phase 1
5525736|NCT01185184|CP-690|cp-690
5525738|NCT01185171|Larynx|larynx
5525739|NCT01185171|Lip|lip
5525740|NCT01185171|Oral Cavity and Pharynx|oral cavity and pharynx
5525741|NCT01185158|Larynx|larynx
5525742|NCT01185158|Lip|lip
5525743|NCT01185158|Oral Cavity and Pharynx|oral cavity and pharynx
5525744|NCT01185145|breast-conservation|breast-conservation
5525745|NCT01185145|accelerated partial breast irradiation|accelerated partial breast irradiation
5525746|NCT01185145|APBI|apbi
5525747|NCT01185145|IMRT|imrt
5525748|NCT01185145|Intensity modulated radiotherapy|intensity modulated radiotherapy
5525749|NCT01185145|breast brachytherapy|breast brachytherapy
5525750|NCT01185145|lumpectomy|lumpectomy
5525751|NCT01185145|early stage breast cancer|early stage breast cancer
5525752|NCT01185145|DCIS|dcis
5525753|NCT01185145|Mammosite|mammosite
5525754|NCT01185132|breast-conservation|breast-conservation
5525755|NCT01185132|adjuvant radiotherapy|adjuvant radiotherapy
5525756|NCT01185132|breast cancer|breast cancer
5525757|NCT01185132|early-stage breast cancer|early-stage breast cancer
5525758|NCT01185132|DCIS|dcis
5525759|NCT01185132|lumpectomy|lumpectomy
5525760|NCT01185132|accelerated partial breast irradiation|accelerated partial breast irradiation
5525761|NCT01185132|APBI|apbi
5525762|NCT01185132|three dimensional conformal external radiotherapy|three dimensional conformal external radiotherapy
5525763|NCT01185132|intensity modulated radiotherapy|intensity modulated radiotherapy
5525764|NCT01185132|3D CRT|3d crt
5525765|NCT01185132|IMRT|imrt
5525766|NCT01185119|glucose uptake and metabolism in brain|glucose uptake and metabolism in brain
5525767|NCT01185093|Cells|cells
5525768|NCT01185093|Prevention|prevention
5525769|NCT01185093|Cancer education|cancer education
5525770|NCT01185093|Nutrition|nutrition
5525771|NCT01185093|Healthy living|healthy living
5525772|NCT01185093|Physical activity|physical activity
5525773|NCT01185093|Dangers of tobacco|dangers of tobacco
5525774|NCT01185093|Sun protection|sun protection
5525776|NCT01185080|allergic rhinitis|allergic rhinitis
5525777|NCT01185080|efficacy|efficacy
5525778|NCT01185080|tolerability|tolerability
5525779|NCT01185080|safety|safety
5525780|NCT01185080|nasal symptoms|nasal symptoms
5525781|NCT01185067|Hypertension|hypertension
5525782|NCT01185067|Endothelial function|endothelial function
5525783|NCT01185067|Antioxidants|antioxidants
5525784|NCT01185067|Oxidative stress|oxidative stress
5525785|NCT01185067|Grapes|grapes
5525786|NCT01185067|Polyphenols|polyphenols
5525787|NCT01185067|Resveratrol|resveratrol
5525788|NCT01185067|Quercetin|quercetin
5525789|NCT01185067|Anthocyanins|anthocyanins
5525790|NCT01185067|Flavanols|flavanols
5525791|NCT01185067|Flavonols|flavonols
5525792|NCT01185067|Congestive heart failure|congestive heart failure
5525793|NCT01185067|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5525794|NCT01185067|Heart failure with preserved systolic function|heart failure with preserved systolic function
5525795|NCT01185067|HFNEF|hfnef
5525796|NCT01185067|HFPSF|hfpsf
5525797|NCT01185067|HFPEF|hfpef
5525799|NCT01185054|Pediatrics|pediatrics
5525800|NCT01185054|Gastroenteritis|gastroenteritis
5525801|NCT01185054|Oral Rehydration|oral rehydration
5525802|NCT01185054|Electrolyte Maintenance Solution|electrolyte maintenance solution
5525803|NCT01185041|Arterial Stiffness|arterial stiffness
5525804|NCT01185041|Wave Reflection|wave reflection
5525805|NCT01185041|Watermelon Supplementation|watermelon supplementation
5525806|NCT01185041|Aortic Blood Pressure|aortic blood pressure
5525807|NCT01185041|Obesity|obesity
5525808|NCT01185028|Chronic HCV|chronic hcv
5525809|NCT01185028|HCV Treatment Nonresponders|hcv treatment nonresponders
5525810|NCT01185028|HCV Treatment Relapsers|hcv treatment relapsers
5525811|NCT01185028|HIV-HCV Co-Infection|hiv-hcv co-infection
5525812|NCT01185028|Nitazoxanide|nitazoxanide
5525813|NCT01185028|Hepatitis C|hepatitis c
5525814|NCT01185015|Angina Pectoris, Coronary disease|angina pectoris, coronary disease
5525815|NCT01185002|CE|ce
5525816|NCT01185002|colonoscopy|colonoscopy
5525817|NCT01185002|colon|colon
5525818|NCT01185002|Eligable for colon evaluation|eligable for colon evaluation
5525819|NCT01184976|H5N1|h5n1
5525820|NCT01184976|Avian Influenza|avian influenza
5525821|NCT01184976|DNA Vaccine|dna vaccine
5525822|NCT01184976|Electroporation|electroporation
5525823|NCT01184976|Intramuscular (IM) Injection|intramuscular (im) injection
5525824|NCT01184963|PCOS|pcos
5525825|NCT01184963|High protein diet|high protein diet
5525826|NCT01184924|Arthritis|arthritis
5525827|NCT01184924|Tai Chi|tai chi
5525828|NCT01184911|Malaria|malaria
5525829|NCT01184911|Pregnancy|pregnancy
5525830|NCT01184898|AML|aml
5525831|NCT01184898|mTOR|mtor
5525832|NCT01184898|rapamycin|rapamycin
5525833|NCT01184885|hyperCVAD|hypercvad
5525834|NCT01184885|rapamycin|rapamycin
5525835|NCT01184885|lymphoid malignancies|lymphoid malignancies
5525836|NCT01184885|lymphoblastic leukemia|lymphoblastic leukemia
5525837|NCT01184885|B and T cell|b and t cell
5525838|NCT01184885|philadelphia chromosome negative|philadelphia chromosome negative
5525839|NCT01184885|burkitt lymphoma|burkitt lymphoma
5525840|NCT01184885|burkitt-type lymphoma|burkitt-type lymphoma
5525841|NCT01184885|lymphoblastic lymphoma|lymphoblastic lymphoma
5525842|NCT01184885|mantle cell lymphoma|mantle cell lymphoma
5525843|NCT01184885|adult t cell leukemia|adult t cell leukemia
5525844|NCT01184885|adult t cell lymphoma|adult t cell lymphoma
5525845|NCT01184872|Skin infection|skin infection
5525847|NCT01184872|Elderly|elderly
5525848|NCT01184872|Gram positive|gram positive
5525849|NCT01184872|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
5525850|NCT01184859|nocturia|nocturia
5525851|NCT01184859|bladder function|bladder function
5525852|NCT01184846|Chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5525853|NCT01184846|CIDP|cidp
5525854|NCT01184833|Multiple sclerosis|multiple sclerosis
5525855|NCT01184833|Interferon beta-1b|interferon beta-1b
5525856|NCT01184833|Compliance to treatment|compliance to treatment
5525857|NCT01184833|Premature treatment discontinuation|premature treatment discontinuation
5525858|NCT01184820|Pharmacokinetics|pharmacokinetics
5525859|NCT01184820|Safety|safety
5525860|NCT01184807|Advanced solid tumor|advanced solid tumor
5525861|NCT01184794|Analgesia laparoscopy|analgesia laparoscopy
5525862|NCT01184768|type 2 diabetes|type 2 diabetes
5525863|NCT01184768|HbA1c|hba1c
5525864|NCT01184768|vitamin D|vitamin d
5525865|NCT01184768|diagnosis|diagnosis
5525866|NCT01184755|Device-guided breathing|device-guided breathing
5525867|NCT01184755|hypertension|hypertension
5525868|NCT01184755|behavioral intervention|behavioral intervention
5525869|NCT01184755|stress reduction|stress reduction
5525870|NCT01184755|Heart Rate Variability (HRV) biofeedback|heart rate variability (hrv) biofeedback
5525871|NCT01184729|aerobic capacity|aerobic capacity
5525872|NCT01184716|Vitamin D status (serum 25-hydroxyvitamin D)|vitamin d status (serum 25-hydroxyvitamin d)
5525873|NCT01184703|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5525874|NCT01184703|Glycemic Index Diet|glycemic index diet
5525875|NCT01184703|HbA1c|hba1c
5525876|NCT01184703|Lipids|lipids
5525877|NCT01184690|double-balloon endoscopy|double-balloon endoscopy
5525878|NCT01184690|diagnostic yield|diagnostic yield
5525879|NCT01184664|Smoking cessation|smoking cessation
5525880|NCT01184664|Tobacco dependence|tobacco dependence
5525881|NCT01184664|Varenicline|varenicline
5525882|NCT01184664|Nicotine Replacement Therapy|nicotine replacement therapy
5525883|NCT01184664|Combination therapy|combination therapy
5525884|NCT01184651|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5525885|NCT01184651|CAH|cah
5525886|NCT01184651|sex differences|sex differences
5525887|NCT01184651|adolescence|adolescence
5525888|NCT01184651|androgen|androgen
5525889|NCT01184651|behavior|behavior
5525890|NCT01184651|gender development|gender development
5525891|NCT01184638|Cognitive Disorders|cognitive disorders
5525892|NCT01184638|General anesthesia|general anesthesia
5525893|NCT01184638|Sevoflurane|sevoflurane
5525894|NCT01184638|Propofol|propofol
5525895|NCT01184638|Memory|memory
5525896|NCT01184625|Myositis|myositis
5525897|NCT01184625|Physical exercise|physical exercise
5525898|NCT01184625|Disability|disability
5525899|NCT01184612|Inmates with heavy use of alcohol or drugs|inmates with heavy use of alcohol or drugs
5525900|NCT01184599|Aliskiren|aliskiren
5525901|NCT01184599|Albuminuria|albuminuria
5525902|NCT01184599|Angiotensinogen|angiotensinogen
5525903|NCT01184599|collagen type IV|collagen type iv
5525904|NCT01184599|Transforming Growth Factor beta|transforming growth factor beta
5525905|NCT01184599|aldosterone|aldosterone
5525906|NCT01184599|renin|renin
5525907|NCT01184599|prorenin receptor|prorenin receptor
5525908|NCT01184599|des-angiotensin I renin substrate|des-angiotensin i renin substrate
5525909|NCT01184599|oxidative stress|oxidative stress
5525910|NCT01184599|advanced glycosylation end-product receptor|advanced glycosylation end-product receptor
5525911|NCT01184599|N,N-dimethylarginine|n,n-dimethylarginine
5525912|NCT01184586|function|function
5525913|NCT01184586|DASH|dash
5525914|NCT01184586|MHQ|mhq
5525915|NCT01184586|pain|pain
5525916|NCT01184586|strength|strength
5525917|NCT01184573|chronic pancreatitis|chronic pancreatitis
5525918|NCT01184573|breath test|breath test
5525919|NCT01184573|bicarbonate|bicarbonate
5525920|NCT01184560|obesity|obesity
5525921|NCT01184534|Lung Biopsy|lung biopsy
5525922|NCT01184534|Multimedia patient education tool|multimedia patient education tool
5525923|NCT01184534|Multimedia Education Tool|multimedia education tool
5525924|NCT01184534|Computed tomography guided lung biopsy|computed tomography guided lung biopsy
5525925|NCT01184534|Computerized Tomography|computerized tomography
5525926|NCT01184534|CT|ct
5525927|NCT01184534|Questionnaire|questionnaire
5525928|NCT01184534|Lung nodules|lung nodules
5525929|NCT01184508|classic with aura|classic with aura
5525930|NCT01184508|common without aura|common without aura
5525931|NCT01184508|migraine|migraine
5525932|NCT01184508|headache|headache
5525933|NCT01184495|Erythropoietin|erythropoietin
5525934|NCT01184495|Chronic renal failure|chronic renal failure
5525935|NCT01184495|Hemodialysis|hemodialysis
5525936|NCT01184495|Anemia|anemia
5525937|NCT01184482|recurrent colorectal cancer|recurrent colorectal cancer
5525938|NCT01184482|recurrent head and neck cancer|recurrent head and neck cancer
5525939|NCT01184482|recurrent lung cancer|recurrent lung cancer
5525940|NCT01184482|cetuximab|cetuximab
5525941|NCT01184482|lapatinib|lapatinib
5525942|NCT01184456|AIDS|aids
5525943|NCT01184456|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5525944|NCT01184456|HIV|hiv
5525945|NCT01184456|Human Immunodeficiency Virus|human immunodeficiency virus
5525946|NCT01184443|Anorexia Nervosa|anorexia nervosa
5525947|NCT01184443|Eating Disorder Not Otherwise Specified|eating disorder not otherwise specified
5525949|NCT01184443|Pediatric|pediatric
5525950|NCT01184430|advanced hemodynamic monitoring|advanced hemodynamic monitoring
5525951|NCT01184430|goal-directed therapy|goal-directed therapy
5525952|NCT01184430|cardiac surgery|cardiac surgery
5525953|NCT01184430|hemodynamic monitoring|hemodynamic monitoring
5525954|NCT01184404|Congenital heart disease|congenital heart disease
5525955|NCT01184404|Cardiac surgery|cardiac surgery
5525956|NCT01184404|Bosentan|bosentan
5525957|NCT01184378|infant formula|infant formula
5525958|NCT01184378|dairy fat|dairy fat
5525959|NCT01184378|soluble milk protein|soluble milk protein
5525961|NCT01184365|energy management|energy management
5525962|NCT01184365|spinal cord injury|spinal cord injury
5525963|NCT01184365|self-efficacy|self-efficacy
5525964|NCT01184365|environment|environment
5525965|NCT01184339|Staphylococcus|staphylococcus
5525966|NCT01184339|aureus|aureus
5525967|NCT01184339|methicillin|methicillin
5525968|NCT01184339|resistant|resistant
5525969|NCT01184339|MRSA|mrsa
5525970|NCT01184339|MSSA|mssa
5525971|NCT01184339|Blood Culture|blood culture
5525972|NCT01184339|diagnostic|diagnostic
5525973|NCT01184326|RAD001|rad001
5525974|NCT01184326|pazopanib|pazopanib
5525975|NCT01184326|everolimus|everolimus
5525976|NCT01184326|advanced cancer|advanced cancer
5525977|NCT01184313|aortic valve surgery|aortic valve surgery
5525979|NCT01184313|lung injury|lung injury
5525980|NCT01184300|CYP2C19*2|cyp2c19*2
5525981|NCT01184300|Pharmacogenomics|pharmacogenomics
5525982|NCT01184300|Clopidogrel|clopidogrel
5525983|NCT01184300|Prasugrel|prasugrel
5798713|NCT00111293|Focal Brain Lesion|focal brain lesion
5525984|NCT01184300|Percutaneous Coronary Intervention|percutaneous coronary intervention
5525985|NCT01184287|Non Small Cell Lung Cancer, NSCLC, Lung Cancer|non small cell lung cancer, nsclc, lung cancer
5525986|NCT01184287|Previously untreated Non-Squamous, Non-Small Cell Lung Cancer|previously untreated non-squamous, non-small cell lung cancer
5525987|NCT01184235|Circadian Disorders|circadian disorders
5525988|NCT01184235|Autism Spectrum Disorders|autism spectrum disorders
5525989|NCT01184235|Mood Disorders|mood disorders
5525990|NCT01184235|Executive Functioning|executive functioning
5525991|NCT01184235|Pediatric Mood Disorders|pediatric mood disorders
5525992|NCT01184196|knee replacement|knee replacement
5525993|NCT01184196|knee arthroplasty|knee arthroplasty
5525994|NCT01184196|total knee replacement|total knee replacement
5525995|NCT01184196|arthroplasty, knee replacement|arthroplasty, knee replacement
5525997|NCT01184170|obesity|obesity
5525998|NCT01184170|metabolism|metabolism
5525999|NCT01184170|cardiovascular metabolic syndrome|cardiovascular metabolic syndrome
5526000|NCT01184144|Endometriosis|endometriosis
5526001|NCT01184144|Peritoneal fluid|peritoneal fluid
5526002|NCT01184144|Cytokines|cytokines
5526003|NCT01184144|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5526004|NCT01184131|Mentor Training|mentor training
5526005|NCT01184131|Randomized trial of mentoring effectiveness|randomized trial of mentoring effectiveness
5526006|NCT01184131|Mentoring clinical researchers|mentoring clinical researchers
5526007|NCT01184118|asthma|asthma
5526008|NCT01184118|sleep apnea|sleep apnea
5526009|NCT01184092|Bioequivalence|bioequivalence
5526010|NCT01184092|healthy volunteer study|healthy volunteer study
5526011|NCT01184092|Rheumatoid Arthritis|rheumatoid arthritis
5526012|NCT01184079|human papillomavirus vaccine L1, type 6,11,16,18|human papillomavirus vaccine l1, type 6,11,16,18
5526013|NCT01184079|HPV Vaccines|hpv vaccines
5526014|NCT01184079|HPV L1 vaccine, quadrivalent 6,11,16,18|hpv l1 vaccine, quadrivalent 6,11,16,18
5526015|NCT01184066|Chemotherapy|chemotherapy
5526016|NCT01184066|Patient Adherence|patient adherence
5526017|NCT01184066|African Americans|african americans
5526018|NCT01184066|Cancer Survivor|cancer survivor
5526019|NCT01184066|Decision Making|decision making
5526020|NCT01184066|Communication|communication
5526021|NCT01184066|Quality of Life|quality of life
5526022|NCT01184066|Social Support|social support
5526023|NCT01184066|Patient Education|patient education
5526024|NCT01184053|endometrial|endometrial
5526025|NCT01184053|carcinoma|carcinoma
5526026|NCT01184053|recurrent|recurrent
5526027|NCT01184053|metastatic|metastatic
5526028|NCT01184053|Trisenox|trisenox
5526029|NCT01184053|arsenic trioxide|arsenic trioxide
5526030|NCT01184053|Phase II|phase ii
5526031|NCT01184053|VEGF|vegf
5526032|NCT01184053|gynecology|gynecology
5526033|NCT01184053|Lineberger|lineberger
5526035|NCT01184053|vascular endothelial growth factor|vascular endothelial growth factor
5526036|NCT01184053|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5526037|NCT01184027|head and neck cancer|head and neck cancer
5526038|NCT01184027|surgery|surgery
5526039|NCT01184027|nutrition|nutrition
5526040|NCT01184014|corticosteroid|corticosteroid
5526041|NCT01184014|hyperglycemia|hyperglycemia
5526042|NCT01184014|hospital|hospital
5526043|NCT01184014|corticosteroid induced hyperglycemia in the hospital|corticosteroid induced hyperglycemia in the hospital
5526145|NCT01183663|Nexavar|nexavar
5526044|NCT01184001|Healthy subjects|healthy subjects
5526045|NCT01184001|Food Effect Study|food effect study
5526047|NCT01183962|Vitamin D|vitamin d
5526049|NCT01183949|Neoplasms|neoplasms
5526050|NCT01183949|Neoplasms, Plasma Cell|neoplasms, plasma cell
5526051|NCT01183949|Neoplasms by Histologic Type|neoplasms by histologic type
5526052|NCT01183949|Hemostatic Disorders|hemostatic disorders
5526053|NCT01183949|Paraproteinemias|paraproteinemias
5526054|NCT01183949|Blood Protein Disorders|blood protein disorders
5526055|NCT01183949|Hematologic Diseases|hematologic diseases
5526056|NCT01183949|Hemorrhagic Disorders|hemorrhagic disorders
5526057|NCT01183949|Lymphoproliferative Disorders|lymphoproliferative disorders
5526058|NCT01183949|Immunoproliferative Disorders|immunoproliferative disorders
5526060|NCT01183949|Bortezomib|bortezomib
5526061|NCT01183949|Antineoplastic Agents|antineoplastic agents
5526062|NCT01183936|Melanoma/mortality/pathology/*surgery|melanoma/mortality/pathology/*surgery
5526063|NCT01183936|Randomized Controlled Trials as Topic|randomized controlled trials as topic
5526064|NCT01183936|Survival|survival
5526065|NCT01183936|Disease-Free Survival|disease-free survival
5526066|NCT01183923|asthma|asthma
5526067|NCT01183923|dietary interventions|dietary interventions
5526068|NCT01183923|mouse allergy|mouse allergy
5526069|NCT01183910|PURPURA|purpura
5526070|NCT01183910|SENILE PURPURA|senile purpura
5526071|NCT01183910|BATEMAN'S PURPURA|bateman's purpura
5526072|NCT01183897|GM-CSF|gm-csf
5526073|NCT01183897|MAB 3F8|mab 3f8
5526074|NCT01183897|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5526075|NCT01183897|09-161|09-161
5526076|NCT01183884|GM-CSF|gm-csf
5526077|NCT01183884|MAB 3F8|mab 3f8
5526078|NCT01183884|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5526079|NCT01183884|09-160|09-160
5526080|NCT01183871|Cerebral oxygenation|cerebral oxygenation
5526081|NCT01183871|thoracotomy|thoracotomy
5526082|NCT01183871|lung resection|lung resection
5526083|NCT01183871|pulmonary dysfunction|pulmonary dysfunction
5526084|NCT01183845|Crohn Disease|crohn disease
5526085|NCT01183845|Crohn's Disease Endoscopy Index of Severity|crohn's disease endoscopy index of severity
5526086|NCT01183845|Colon Capsule Endoscopy|colon capsule endoscopy
5526087|NCT01183845|Crohn's Disease located in colon and/or ileum|crohn's disease located in colon and/or ileum
5526088|NCT01183832|Breast cancer|breast cancer
5526089|NCT01183832|radiotherapy|radiotherapy
5526090|NCT01183832|hormonotherapy|hormonotherapy
5526091|NCT01183819|cognitive function|cognitive function
5526092|NCT01183819|fMRI|fmri
5526093|NCT01183819|apoE|apoe
5526094|NCT01183819|inflammatory markers|inflammatory markers
5526095|NCT01183819|exercise|exercise
5526096|NCT01183819|cognitive intervention|cognitive intervention
5526097|NCT01183819|Space Fortress|space fortress
5526098|NCT01183806|Alzheimer's disease|alzheimer's disease
5526099|NCT01183806|Exercise|exercise
5526100|NCT01183806|Rivastigmine|rivastigmine
5526101|NCT01183806|Quality of life|quality of life
5526102|NCT01183793|Gastrointestinal Tract [A03.556]|gastrointestinal tract [a03.556]
5526103|NCT01183780|second line|second line
5526104|NCT01183780|metastatic colorectal cancer|metastatic colorectal cancer
5526105|NCT01183780|FOLFIRI|folfiri
5526106|NCT01183780|ramucirumab|ramucirumab
5526108|NCT01183780|mCRC|mcrc
5526109|NCT01183767|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5526110|NCT01183767|Epigallocatechin-Gallate|epigallocatechin-gallate
5526111|NCT01183767|Green tea extract|green tea extract
5526112|NCT01183754|coronary disease|coronary disease
5526113|NCT01183754|platelet reactivity|platelet reactivity
5526114|NCT01183754|drug-eluting stent|drug-eluting stent
5526115|NCT01183741|Hypertension|hypertension
5526116|NCT01183741|Hypotension|hypotension
5526117|NCT01183741|Blood pressure|blood pressure
5526118|NCT01183728|Knee degenerative disease|knee degenerative disease
5526119|NCT01183728|osteoarthritis|osteoarthritis
5526120|NCT01183728|gonarthrosis|gonarthrosis
5526121|NCT01183728|stem cell|stem cell
5526122|NCT01183728|cellular therapy|cellular therapy
5526123|NCT01183728|regenerative therapy|regenerative therapy
5526124|NCT01183728|Mesenchymal stem cells|mesenchymal stem cells
5526125|NCT01183728|Bone marrow|bone marrow
5526126|NCT01183728|musculoskeletal Diseases|musculoskeletal diseases
5526127|NCT01183715|Single Ascending Dose|single ascending dose
5526128|NCT01183715|Phase 1|phase 1
5526129|NCT01183715|Safety and Tolerability|safety and tolerability
5526130|NCT01183715|PK|pk
5526131|NCT01183715|Healthy Subjects|healthy subjects
5526132|NCT01183702|LASIK vs. non-LASIK|lasik vs. non-lasik
5526133|NCT01183663|Lenalidomide|lenalidomide
5526134|NCT01183663|Bevacizumab|bevacizumab
5526135|NCT01183663|Sorafenib|sorafenib
5526136|NCT01183663|Temsirolimus|temsirolimus
5526137|NCT01183663|5-Fluorouracil|5-fluorouracil
5526138|NCT01183663|Leucovorin|leucovorin
5526139|NCT01183663|Oxaliplatin|oxaliplatin
5526140|NCT01183663|Avastin|avastin
5526141|NCT01183663|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5526142|NCT01183663|rhuMAB-VEGF|rhumab-vegf
5526143|NCT01183663|CC-5013|cc-5013
5526144|NCT01183663|Revlimid|revlimid
5526146|NCT01183663|BAY 43-90006|bay 43-90006
5526147|NCT01183663|Metastatic cancer|metastatic cancer
5526148|NCT01183663|Metastatic colorectal cancer|metastatic colorectal cancer
5526149|NCT01183663|Advanced solid tumors|advanced solid tumors
5526150|NCT01183663|Hematologic malignancies|hematologic malignancies
5526151|NCT01183663|Colon cancer|colon cancer
5526152|NCT01183663|Advanced colorectal cancer|advanced colorectal cancer
5526153|NCT01183663|Breast cancer|breast cancer
5526154|NCT01183663|Pancreatic cancer|pancreatic cancer
5526155|NCT01183663|Gastric cancer|gastric cancer
5526156|NCT01183663|Advanced renal cell carcinoma|advanced renal cell carcinoma
5526157|NCT01183663|Prostate cancer|prostate cancer
5526158|NCT01183663|Melanoma|melanoma
5526159|NCT01183663|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5526161|NCT01183663|Metastatic breast cancer|metastatic breast cancer
5526162|NCT01183663|Glioblastoma|glioblastoma
5526163|NCT01183663|Multiple myeloma|multiple myeloma
5526164|NCT01183637|Cartilage|cartilage
5526165|NCT01183637|Knee|knee
5526166|NCT01183637|Osteochondral|osteochondral
5526167|NCT01183624|Osteoarthritis|osteoarthritis
5526168|NCT01183624|Pain|pain
5526169|NCT01183624|Herbal medicine|herbal medicine
5526170|NCT01183624|Topical administration|topical administration
5526172|NCT01183611|immunogenicity|immunogenicity
5526173|NCT01183611|HBV vaccine|hbv vaccine
5526174|NCT01183611|perinatal transmission|perinatal transmission
5526175|NCT01183572|multivitamins|multivitamins
5526177|NCT01183572|iron|iron
5526178|NCT01183572|periconception|periconception
5526179|NCT01183546|rehabilitation|rehabilitation
5526180|NCT01183546|spinal cord injury|spinal cord injury
5526181|NCT01183546|wheelchairs|wheelchairs
5526182|NCT01183533|Wake-Up Stroke|wake-up stroke
5526183|NCT01183533|Ischemic stroke|ischemic stroke
5526184|NCT01183533|ischemic stroke patients who wake-up with their symptoms|ischemic stroke patients who wake-up with their symptoms
5526186|NCT01183481|vomiting|vomiting
5526187|NCT01183481|antiemetics|antiemetics
5526188|NCT01183481|radiotherapy|radiotherapy
5526189|NCT01183481|Radiation-induced nausea and vomiting|radiation-induced nausea and vomiting
5526190|NCT01183468|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
5526191|NCT01183468|Diabetes Mellitus, Insulin-Dependent (new-onset)|diabetes mellitus, insulin-dependent (new-onset)
5526192|NCT01183468|new-onset T1DM|new-onset t1dm
5526193|NCT01183468|new-onset T1D|new-onset t1d
5526194|NCT01183468|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
5526195|NCT01183468|Diabetes, Autoimmune|diabetes, autoimmune
5526196|NCT01183468|Aralast NP|aralast np
5526197|NCT01183468|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5526198|NCT01183468|AAT|aat
5526199|NCT01183455|Diabetes Mellitus, Type 1 (new-onset)|diabetes mellitus, type 1 (new-onset)
5526200|NCT01183455|T1DM (new-onset)|t1dm (new-onset)
5526201|NCT01183455|T1D (new-onset)|t1d (new-onset)
5526202|NCT01183455|Diabetes, Autoimmune|diabetes, autoimmune
5526203|NCT01183455|Alpha1-Proteinase Inhibitor|alpha1-proteinase inhibitor
5526204|NCT01183455|Alpha-1 Antitrypsin|alpha-1 antitrypsin
5526205|NCT01183455|AAT|aat
5526206|NCT01183442|endothelial function|endothelial function
5526207|NCT01183442|insulin sensitivity|insulin sensitivity
5526208|NCT01183429|MAB 3F8|mab 3f8
5526209|NCT01183429|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5526210|NCT01183429|Bone Marrow|bone marrow
5526211|NCT01183429|09-159|09-159
5526212|NCT01183416|GM-CSF|gm-csf
5526213|NCT01183416|MAB 3F8|mab 3f8
5526214|NCT01183416|RETINOIC ACID (CIS-9 & 13)|retinoic acid (cis-9 & 13)
5526215|NCT01183416|09-158|09-158
5526216|NCT01183403|stricture|stricture
5526217|NCT01183403|anti-TNF|anti-tnf
5526218|NCT01183403|ileal Crohn'Disease|ileal crohn'disease
5526219|NCT01183403|patients with ileal Crohn's disease complicated by|patients with ileal crohn's disease complicated by
5526220|NCT01183403|symptomatic stricture after failure of corticosteroids|symptomatic stricture after failure of corticosteroids
5526221|NCT01183403|and/or immunosuppressives|and/or immunosuppressives
5526222|NCT01183390|Bioequivalence|bioequivalence
5526223|NCT01183390|Healthy Subjects|healthy subjects
5526224|NCT01183377|Female Athlete Triad syndrom|female athlete triad syndrom
5526225|NCT01183377|Eating disorder|eating disorder
5526226|NCT01183377|osteoprosis|osteoprosis
5526227|NCT01183364|solid tumor malignancies|solid tumor malignancies
5526228|NCT01183364|tumor|tumor
5526229|NCT01183364|cancer|cancer
5526230|NCT01183364|STA-9090|sta-9090
5526231|NCT01183364|ganetespib|ganetespib
5526232|NCT01183364|HSP90 inhibitor|hsp90 inhibitor
5526233|NCT01183351|Dementia|dementia
5526234|NCT01183351|Agitation|agitation
5526235|NCT01183351|Challenging behaviour|challenging behaviour
5526236|NCT01183351|Behavioural and psychological symptoms in dementia (BPSD)|behavioural and psychological symptoms in dementia (bpsd)
5526237|NCT01183338|SpO2|spo2
5526238|NCT01183338|Oxygen saturation|oxygen saturation
5526239|NCT01183325|Umbilical and small ventral hernias less than 3cm diameter|umbilical and small ventral hernias less than 3cm diameter
5526240|NCT01183312|Hypersomnia|hypersomnia
5526241|NCT01183312|Primary Hypersomnia|primary hypersomnia
5526242|NCT01183312|Idiopathic Hypersomnia|idiopathic hypersomnia
5526243|NCT01183312|Narcolepsy without Cataplexy|narcolepsy without cataplexy
5526244|NCT01183312|Flumazenil|flumazenil
5526245|NCT01183299|bone metabolism|bone metabolism
5526246|NCT01183299|salt intake|salt intake
5526247|NCT01183299|acid base balance|acid base balance
5526248|NCT01183299|bed rest|bed rest
5526249|NCT01183260|revision total hip arthroplasty|revision total hip arthroplasty
5526250|NCT01183260|bone mineral density|bone mineral density
5526251|NCT01183260|trabecular metal|trabecular metal
5526252|NCT01183260|DEXA|dexa
5526253|NCT01183247|Everolimus,|everolimus,
5526254|NCT01183247|rapamycin,|rapamycin,
5526255|NCT01183247|prednisone,|prednisone,
5526256|NCT01183247|tacrolimus,|tacrolimus,
5526258|NCT01183247|steroid-free,|steroid-free,
5526259|NCT01183247|protocol biopsy|protocol biopsy
5526260|NCT01183182|Lung nodule|lung nodule
5526261|NCT01183182|Lung lesion|lung lesion
5526262|NCT01183169|Chronic hepatitis C|chronic hepatitis c
5526263|NCT01183169|Cyclophilin inhibitor|cyclophilin inhibitor
5526264|NCT01183156|Colorectal Cancer|colorectal cancer
5526265|NCT01183156|Screening|screening
5526266|NCT01183156|Colonoscopy|colonoscopy
5526267|NCT01183156|Attendance|attendance
5526268|NCT01183156|Participation|participation
5526269|NCT01183143|Infertility|infertility
5526270|NCT01183143|Ovulation induction|ovulation induction
5526271|NCT01183143|Gonal-F|gonal-f
5526272|NCT01183143|Follitropin alpha|follitropin alpha
5526273|NCT01183143|Controlled ovarian stimulation|controlled ovarian stimulation
5526274|NCT01183130|opiate dependence|opiate dependence
5526275|NCT01183130|compliance monitoring|compliance monitoring
5526276|NCT01183130|substitution treatment|substitution treatment
5526277|NCT01183104|Type 2 Diabetes|type 2 diabetes
5526278|NCT01183104|Sitagliptin|sitagliptin
5526279|NCT01183104|Glimepiride|glimepiride
5526280|NCT01183104|Elderly patients|elderly patients
5526281|NCT01183104|Japanese|japanese
5526282|NCT01183091|Atrial fibrillation|atrial fibrillation
5526283|NCT01183091|Ablation|ablation
5526284|NCT01183078|efficacy|efficacy
5526285|NCT01183078|drill placement|drill placement
5526286|NCT01183078|nail placement|nail placement
5526287|NCT01183078|radiation|radiation
5526288|NCT01183078|Operative time|operative time
5526289|NCT01183078|Reduction in exposure to radiation|reduction in exposure to radiation
5526290|NCT01183078|Accuracy for nail placement|accuracy for nail placement
5526291|NCT01183065|Pralatrexate|pralatrexate
5526292|NCT01183065|Vitamin B12|vitamin b12
5526293|NCT01183065|Folic Acid|folic acid
5526294|NCT01183065|10-112|10-112
5526295|NCT01183052|COPD|copd
5526296|NCT01183052|exercise tolerance|exercise tolerance
5526297|NCT01183052|oxidative stress|oxidative stress
5526298|NCT01183039|Sedentary|sedentary
5526299|NCT01183000|Formation of adhesions assessed at subsequent cs|formation of adhesions assessed at subsequent cs
5526300|NCT01182987|Quality improvement|quality improvement
5526301|NCT01182987|Quality of care|quality of care
5526302|NCT01182987|Health care utilization|health care utilization
5526303|NCT01182987|Behavioral change|behavioral change
5526304|NCT01182974|fever in severe sepsis|fever in severe sepsis
5526305|NCT01182961|Gait|gait
5526306|NCT01182961|Falls|falls
5526307|NCT01182961|Virtual reality|virtual reality
5526308|NCT01182948|aerobic training|aerobic training
5526309|NCT01182948|resistance training|resistance training
5526310|NCT01182948|type 2 diabetes|type 2 diabetes
5526311|NCT01182948|therapy|therapy
5526312|NCT01182935|vitamin D|vitamin d
5526313|NCT01182935|triglycerides|triglycerides
5526314|NCT01182935|type 2 diabetes|type 2 diabetes
5526315|NCT01182922|Attendance|attendance
5526316|NCT01182922|Colorectal cancer|colorectal cancer
5526317|NCT01182922|Screening|screening
5526318|NCT01182922|Invitation letter|invitation letter
5526320|NCT01182909|Environmental and Genetic|environmental and genetic
5526321|NCT01182909|evaluate putative environmental exposures and NPC|evaluate putative environmental exposures and npc
5526322|NCT01182909|assess the effect of genetic factors|assess the effect of genetic factors
5526323|NCT01182909|investigate gene-environment interactions|investigate gene-environment interactions
5526324|NCT01182909|examine the natural history of EBV infection|examine the natural history of ebv infection
5526325|NCT01182883|Maximum Tolerated Dose|maximum tolerated dose
5526326|NCT01182883|Dose Escalation|dose escalation
5526327|NCT01182883|Pharmacokinetics|pharmacokinetics
5526328|NCT01182883|Antitumor Activity|antitumor activity
5526329|NCT01182883|Biologic Activity|biologic activity
5526330|NCT01182870|vitamin D|vitamin d
5526331|NCT01182870|influenza|influenza
5526332|NCT01182870|prevention|prevention
5526333|NCT01182857|Quality of Life|quality of life
5526334|NCT01182857|Gene Therapy|gene therapy
5526335|NCT01182857|ADA-SCID|ada-scid
5526336|NCT01182857|SCID-ADA|scid-ada
5526337|NCT01182857|Severe Combined Immunodeficiency|severe combined immunodeficiency
5526338|NCT01182844|metabolic syndrome, probiotic|metabolic syndrome, probiotic
5526339|NCT01182831|carcinoma pancreas|carcinoma pancreas
5526340|NCT01182831|percutaneous celiac plexus neurolysis|percutaneous celiac plexus neurolysis
5526438|NCT01182402|monitoring|monitoring
5526344|NCT01182818|Fabry Disease|fabry disease
5526345|NCT01182818|Fabry´s Disease|fabry´s disease
5526346|NCT01182818|Anderson-Fabry Disease|anderson-fabry disease
5526347|NCT01182818|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5526348|NCT01182818|Stroke, Acute|stroke, acute
5526349|NCT01182818|Cerebral Stroke|cerebral stroke
5526350|NCT01182792|Endothelial Function|endothelial function
5526351|NCT01182792|Chronic Hypoxia|chronic hypoxia
5526352|NCT01182792|Oxidative Stress|oxidative stress
5526353|NCT01182779|base of skull chordoma|base of skull chordoma
5526354|NCT01182779|radiation|radiation
5526355|NCT01182779|carbon ions|carbon ions
5526356|NCT01182779|protons|protons
5526357|NCT01182766|alcohol|alcohol
5526358|NCT01182766|alcoholism|alcoholism
5526360|NCT01182766|cigarette|cigarette
5526361|NCT01182753|Chondrosarcoma|chondrosarcoma
5526362|NCT01182753|Radiation|radiation
5526363|NCT01182753|carbon ion|carbon ion
5526364|NCT01182727|schizophrenia|schizophrenia
5526365|NCT01182727|salsalate|salsalate
5526366|NCT01182727|obesity|obesity
5526367|NCT01182714|Hysterectomy|hysterectomy
5526368|NCT01182714|Catheterisation|catheterisation
5526369|NCT01182701|Type 2 Diabetes|type 2 diabetes
5526370|NCT01182701|Asian Pacific Islanders|asian pacific islanders
5526371|NCT01182701|Cognitive behavioral intervention|cognitive behavioral intervention
5526372|NCT01182688|utilization of Procalcitonin in the cardiac setting|utilization of procalcitonin in the cardiac setting
5526373|NCT01182675|SCID|scid
5526374|NCT01182675|Transplant|transplant
5526375|NCT01182675|Alemtuzumab|alemtuzumab
5526376|NCT01182675|Plerixafor|plerixafor
5526377|NCT01182662|Bone Marrow Disease|bone marrow disease
5526378|NCT01182662|Aplastic Anemia|aplastic anemia
5526379|NCT01182662|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5526380|NCT01182662|Transplantation|transplantation
5526381|NCT01182649|Drug Eluting Stents|drug eluting stents
5526382|NCT01182649|Everolimus Eluting Stent|everolimus eluting stent
5526383|NCT01182649|Coronary Angioplasty|coronary angioplasty
5526384|NCT01182636|Bioequivalence|bioequivalence
5526385|NCT01182636|Acne Vulgaris|acne vulgaris
5526386|NCT01182623|FICE|fice
5526387|NCT01182623|Chromoendoscopy|chromoendoscopy
5526388|NCT01182623|Colonic polyps|colonic polyps
5526389|NCT01182623|Adenomas|adenomas
5526390|NCT01182623|Hyperplastic polyps|hyperplastic polyps
5526391|NCT01182597|Oral PPI treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis|oral ppi treatment has similar benefit as proton pump inhibitor infusion in patient with bleeding ulcers after combined endoscopic hemostasis
5526392|NCT01182571|Heart Transplantation|heart transplantation
5526393|NCT01182571|Symptom Distress|symptom distress
5526394|NCT01182571|Fatigue|fatigue
5526395|NCT01182571|Depression|depression
5526396|NCT01182571|Quality Of Life.|quality of life.
5526397|NCT01182558|Muscle|muscle
5526398|NCT01182558|Activation|activation
5526399|NCT01182558|Effect|effect
5526400|NCT01182558|Compound muscle action potential|compound muscle action potential
5526401|NCT01182545|Anaesthesia|anaesthesia
5526402|NCT01182545|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5526403|NCT01182545|CO2 insufflation|co2 insufflation
5526404|NCT01182545|hemodynamic|hemodynamic
5526405|NCT01182545|hyperventilation|hyperventilation
5526406|NCT01182532|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5526407|NCT01182532|Traditional Chinese Medicine|traditional chinese medicine
5526408|NCT01182532|Effectiveness|effectiveness
5526409|NCT01182532|Safety|safety
5526410|NCT01182519|lung inflammation|lung inflammation
5526411|NCT01182519|lung metastases|lung metastases
5526412|NCT01182519|10-115|10-115
5526417|NCT01182493|Diabetes Mellitus|diabetes mellitus
5526418|NCT01182493|MDI|mdi
5526419|NCT01182493|pump therapy|pump therapy
5526420|NCT01182467|Inflammatory bowel disease, PET scan, Crohn's disease|inflammatory bowel disease, pet scan, crohn's disease
5526421|NCT01182454|blood pressure|blood pressure
5526422|NCT01182441|atrial fibrillation|atrial fibrillation
5526423|NCT01182441|stroke|stroke
5526424|NCT01182441|TIA|tia
5526425|NCT01182441|trans ischemic attack|trans ischemic attack
5526426|NCT01182441|warfarin|warfarin
5526427|NCT01182441|Coumadin|coumadin
5526428|NCT01182428|Stents|stents
5526429|NCT01182428|Angioplasty|angioplasty
5508397|NCT01260272|BMI|bmi
5526430|NCT01182428|Total coronary occlusions|total coronary occlusions
5526431|NCT01182428|Coronary restenosis|coronary restenosis
5526432|NCT01182428|Stent thrombosis|stent thrombosis
5526433|NCT01182428|Everolimus|everolimus
5526434|NCT01182415|CNS involvement|cns involvement
5526435|NCT01182402|opiate dependence|opiate dependence
5526436|NCT01182402|substitution treatment|substitution treatment
5526437|NCT01182402|unsupervised dosing|unsupervised dosing
5526446|NCT01182363|maternal depression|maternal depression
5526447|NCT01182363|prematurity|prematurity
5526448|NCT01182363|early intervention|early intervention
5526449|NCT01182363|developmental delay|developmental delay
5526450|NCT01182350|Molecularly Determined Treatment|molecularly determined treatment
5526451|NCT01182324|Expectations|expectations
5526452|NCT01182324|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5526453|NCT01182324|Clinical Trial|clinical trial
5526454|NCT01182324|Motivations|motivations
5526462|NCT01182298|Latino|latino
5526463|NCT01182298|HCV|hcv
5526464|NCT01182298|pegIFN|pegifn
5526465|NCT01182298|Viral Kinetics|viral kinetics
5526466|NCT01182298|IL-28 Haplotype|il-28 haplotype
5526467|NCT01182285|Depakote|depakote
5526468|NCT01182285|Poorly Differentiated Thyroid Cancer|poorly differentiated thyroid cancer
5526469|NCT01182285|RAI Uptake|rai uptake
5526470|NCT01182285|Thyrogen|thyrogen
5526471|NCT01182272|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5526472|NCT01182272|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5526473|NCT01182246|adenocarcinoma|adenocarcinoma
5526474|NCT01182246|Pancreatic cancer|pancreatic cancer
5526475|NCT01182233|Multiple Myeloma|multiple myeloma
5526476|NCT01182233|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
5526477|NCT01182233|Total Skeletal Irradiation|total skeletal irradiation
5526478|NCT01182233|High dose chemotherapy|high dose chemotherapy
5526479|NCT01182220|epidural|epidural
5526480|NCT01182220|labor pain|labor pain
5526481|NCT01182220|ultrasound|ultrasound
5526482|NCT01182207|Bioequivalence|bioequivalence
5526483|NCT01182207|Healthy Subjects|healthy subjects
5526484|NCT01182194|Bioequivalence|bioequivalence
5526485|NCT01182194|Healthy Subjects|healthy subjects
5526486|NCT01182181|Healthy Subjects|healthy subjects
5526487|NCT01182181|Bioequivalence|bioequivalence
5526488|NCT01182168|CISPLATIN|cisplatin
5526489|NCT01182168|GEMCITABINE|gemcitabine
5526490|NCT01182168|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5526491|NCT01182168|10-106|10-106
5526492|NCT01182155|Lung Cancer Non-Small Cell Cancer (NSCLC)|lung cancer non-small cell cancer (nsclc)
5526493|NCT01182155|Lung Cancer Small Cell Lung Cancer (SCLC)|lung cancer small cell lung cancer (sclc)
5526494|NCT01182129|Nicotine Polacrilex chewing gum versus Swedish Snus|nicotine polacrilex chewing gum versus swedish snus
5526496|NCT01182116|colorectal|colorectal
5526497|NCT01182116|rectal cancer|rectal cancer
5526498|NCT01182116|coloplasty|coloplasty
5526499|NCT01182103|Major depression|major depression
5526500|NCT01182103|BDNF|bdnf
5526501|NCT01182103|DNA methylation|dna methylation
5526502|NCT01182103|Histone modification|histone modification
5526503|NCT01182090|pelvic organ prolapse|pelvic organ prolapse
5526504|NCT01182090|colposacropexy|colposacropexy
5526505|NCT01182090|surgery|surgery
5526506|NCT01182077|ASP015K|asp015k
5526507|NCT01182077|midazolam|midazolam
5526508|NCT01182077|healthy volunteers|healthy volunteers
5526509|NCT01182064|Heart injuries|heart injuries
5526510|NCT01182064|Posttraumatic myocardial infarction|posttraumatic myocardial infarction
5526511|NCT01182064|Echocardiography|echocardiography
5526512|NCT01182064|Coronary angiography|coronary angiography
5526513|NCT01182051|headache|headache
5526514|NCT01182051|anxiety|anxiety
5526515|NCT01182051|pediatric headache and anxiety|pediatric headache and anxiety
5526516|NCT01182038|birth seat|birth seat
5526517|NCT01182038|childbirth|childbirth
5526518|NCT01182038|instrumental delivery|instrumental delivery
5526519|NCT01182038|upright position|upright position
5526520|NCT01182025|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5526521|NCT01182025|Xiyanping Injection|xiyanping injection
5526522|NCT01182025|Effectiveness|effectiveness
5526523|NCT01182025|Safety|safety
5526524|NCT01182012|Cardiovascular risk factor|cardiovascular risk factor
5526525|NCT01182012|Severe mental illness|severe mental illness
5526526|NCT01182012|Drug appropriateness|drug appropriateness
5526527|NCT01182012|Drug compliance|drug compliance
5526528|NCT01182012|Lifestyle counseling|lifestyle counseling
5526529|NCT01181999|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5526530|NCT01181999|elderly patients|elderly patients
5526531|NCT01181999|rituximab augmentation|rituximab augmentation
5526532|NCT01181986|Type 2 diabetes mellitus, Impaired glucose tolerance|type 2 diabetes mellitus, impaired glucose tolerance
5526533|NCT01181973|Relative bioavailability|relative bioavailability
5526534|NCT01181973|pegvisomant|pegvisomant
5526535|NCT01181960|Risperidone long acting injectable|risperidone long acting injectable
5526536|NCT01181960|Risperdal Consta|risperdal consta
5526537|NCT01181960|Paliperidone Palmitate|paliperidone palmitate
5526538|NCT01181960|Invega Sustenna|invega sustenna
5526539|NCT01181947|Stent graft|stent graft
5526540|NCT01181947|thoracic aorta|thoracic aorta
5526541|NCT01181947|dissection|dissection
5526542|NCT01181947|aneurysm|aneurysm
5526543|NCT01181947|TEVAR|tevar
5526544|NCT01181947|VALIANT|valiant
5526545|NCT01181947|CAPTIVIA|captivia
5526546|NCT01181947|endovascular|endovascular
5526547|NCT01181934|symptomatic treatment|symptomatic treatment
5526548|NCT01181934|cognition|cognition
5526549|NCT01181934|cognitive deficits|cognitive deficits
5526550|NCT01181934|Schizophrenia|schizophrenia
5526551|NCT01181921|Alzheimer Disease|alzheimer disease
5526552|NCT01181921|Dementia|dementia
5526553|NCT01181921|Sleep Disorders|sleep disorders
5526554|NCT01181921|Galantamine|galantamine
5526555|NCT01181921|Reminyl|reminyl
5526556|NCT01181908|alcohol|alcohol
5526557|NCT01181908|drug interaction|drug interaction
5526558|NCT01181908|pharmacodynamic|pharmacodynamic
5526559|NCT01181895|asthma|asthma
5526560|NCT01181882|Cardiovascular Disease|cardiovascular disease
5526561|NCT01181882|Aspirin Resistance|aspirin resistance
5526562|NCT01181882|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5526563|NCT01181882|Platelet Function|platelet function
5526564|NCT01181882|Omega-3 Fatty Acids|omega-3 fatty acids
5526565|NCT01181882|Aspirin|aspirin
5526566|NCT01181882|Lysophospholipids|lysophospholipids
5526567|NCT01181882|Lysophosphatidic Acid|lysophosphatidic acid
5526568|NCT01181882|Lysophosphatidylcholine|lysophosphatidylcholine
5526569|NCT01181869|respiratory failure|respiratory failure
5526570|NCT01181869|oxygen|oxygen
5526571|NCT01181869|sleep apnoea|sleep apnoea
5526572|NCT01181869|ventilation|ventilation
5526573|NCT01181856|Vaccine|vaccine
5526574|NCT01181856|MVA 85A|mva 85a
5526575|NCT01181843|postoperative pain management|postoperative pain management
5526577|NCT01181843|capnography|capnography
5526578|NCT01181843|duramorph|duramorph
5526579|NCT01181830|magnesium|magnesium
5526581|NCT01181830|diabetes|diabetes
5526582|NCT01181830|family history|family history
5526583|NCT01181817|FBSS|fbss
5526584|NCT01181817|at least one prior spinal surgery|at least one prior spinal surgery
5526585|NCT01181804|boceprevir|boceprevir
5526586|NCT01181804|hepatitis C|hepatitis c
5526587|NCT01181804|bioequivalence|bioequivalence
5526588|NCT01181804|SCH 503034|sch 503034
5526589|NCT01181791|probiotics|probiotics
5526590|NCT01181791|premature infants|premature infants
5526591|NCT01181791|feeding tolerance|feeding tolerance
5526592|NCT01181778|hormonal contraceptive methods|hormonal contraceptive methods
5526593|NCT01181778|combined hormonal contraceptive methods|combined hormonal contraceptive methods
5526594|NCT01181778|physician counseling|physician counseling
5526595|NCT01181765|Crohn's Disease|crohn's disease
5526596|NCT01181765|infliximab|infliximab
5526597|NCT01181765|capsule endoscopy|capsule endoscopy
5526598|NCT01181752|proficiency|proficiency
5526599|NCT01181752|eye drop instillation|eye drop instillation
5526600|NCT01181752|postoperative cataract surgery|postoperative cataract surgery
5526602|NCT01181739|Colonoscopy|colonoscopy
5526603|NCT01181739|Virtual Colonoscopy|virtual colonoscopy
5526604|NCT01181739|Colonography|colonography
5526605|NCT01181739|Colorectal Cancer|colorectal cancer
5526606|NCT01181739|Colonic Polyps|colonic polyps
5526607|NCT01181739|Screening|screening
5526608|NCT01181726|Bioequivalence|bioequivalence
5526609|NCT01181726|Healthy Subjects|healthy subjects
5526610|NCT01181687|COMFORT behavioral scale|comfort behavioral scale
5526611|NCT01181687|pain assessment scale|pain assessment scale
5526612|NCT01181687|child|child
5526613|NCT01181687|validity|validity
5526614|NCT01181687|reliability|reliability
5526615|NCT01181674|Diabetes|diabetes
5526616|NCT01181674|Insulin|insulin
5526617|NCT01181674|Glargine|glargine
5526618|NCT01181674|Metformin|metformin
5526619|NCT01181674|Acarbose|acarbose
5526620|NCT01181674|Diet|diet
5526621|NCT01181674|Exercise|exercise
5526622|NCT01181674|Lifestyle|lifestyle
5526623|NCT01181661|Cigarette|cigarette
5526624|NCT01181661|Smoking|smoking
5526625|NCT01181661|Nicotine|nicotine
5526626|NCT01181661|Contingency Management|contingency management
5526627|NCT01181661|Voucher Reinforcement|voucher reinforcement
5526628|NCT01181661|Smoking Abstinence|smoking abstinence
5526629|NCT01181661|Internet|internet
5526630|NCT01181661|Internet-based Treatment|internet-based treatment
5526631|NCT01181661|Group Contingencies|group contingencies
5526632|NCT01181648|Survivor|survivor
5526633|NCT01181648|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5526634|NCT01181648|Quality of Life|quality of life
5526635|NCT01181648|Surviving Oropharynx Cancer|surviving oropharynx cancer
5526636|NCT01181648|10-111|10-111
5526637|NCT01181596|neonates and infants, from the 23-week gestational (0.5 kg)|neonates and infants, from the 23-week gestational (0.5 kg)
5526734|NCT01181232|zolpidem|zolpidem
5526638|NCT01181596|up to a 6 month old born at term (7 kg), for whom the PIV,|up to a 6 month old born at term (7 kg), for whom the piv,
5526639|NCT01181596|PAC, UAC, UVC or PICC catheter insertion is medically|pac, uac, uvc or picc catheter insertion is medically
5526640|NCT01181596|indicated.|indicated.
5526641|NCT01181570|psoriasis|psoriasis
5526642|NCT01181570|adalimumab|adalimumab
5526643|NCT01181570|obstructive sleep apnea|obstructive sleep apnea
5526644|NCT01181570|obesity|obesity
5526645|NCT01181557|quality of life|quality of life
5526646|NCT01181544|Anticoagulation|anticoagulation
5526647|NCT01181544|Heparin|heparin
5526648|NCT01181544|Hemodialysis|hemodialysis
5526649|NCT01181544|Dialysis|dialysis
5526650|NCT01181544|Renal Dialysis|renal dialysis
5526651|NCT01181531|Secondary Hyperthyroidism|secondary hyperthyroidism
5526652|NCT01181531|Hemodialysis|hemodialysis
5526653|NCT01181531|Parathyroid|parathyroid
5526654|NCT01181531|PARADIGM|paradigm
5526655|NCT01181518|Tamoxifen|tamoxifen
5526656|NCT01181518|Pharmacogenomics|pharmacogenomics
5526657|NCT01181518|Breast cancer|breast cancer
5526658|NCT01181505|HNF4a|hnf4a
5526659|NCT01181505|CYP2D6|cyp2d6
5526660|NCT01181505|Toterodine|toterodine
5526661|NCT01181505|Genetic polymorphism|genetic polymorphism
5526662|NCT01181492|gene polymorphism|gene polymorphism
5526663|NCT01181492|CYP3A4|cyp3a4
5526664|NCT01181492|fentanyl|fentanyl
5526665|NCT01181492|HPLC|hplc
5526666|NCT01181492|Analgesics|analgesics
5526667|NCT01181479|Contraceptive|contraceptive
5526668|NCT01181466|PLVR|plvr
5526669|NCT01181466|BLVR|blvr
5526670|NCT01181466|AeriSeal|aeriseal
5526671|NCT01181466|treatment|treatment
5526672|NCT01181466|device|device
5526673|NCT01181466|breathing|breathing
5526674|NCT01181466|COPD|copd
5526675|NCT01181466|emphysema|emphysema
5526676|NCT01181466|polymeric lung volume reduction|polymeric lung volume reduction
5526677|NCT01181466|biologic lung volume reduction|biologic lung volume reduction
5526678|NCT01181466|heterogeneous|heterogeneous
5526680|NCT01181466|Pathologic Processes|pathologic processes
5526681|NCT01181466|Respiratory Tract Diseases|respiratory tract diseases
5526682|NCT01181466|Lung Diseases|lung diseases
5526683|NCT01181466|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5526684|NCT01181453|Diabetic foot ulcer|diabetic foot ulcer
5526685|NCT01181453|Randomized trial|randomized trial
5526686|NCT01181453|Clinical trial|clinical trial
5526687|NCT01181453|Dermagraft|dermagraft
5526688|NCT01181453|Standard care|standard care
5526689|NCT01181440|Diabetic foot ulcer|diabetic foot ulcer
5526690|NCT01181440|Randomized trial|randomized trial
5526691|NCT01181440|Clinical trial|clinical trial
5526693|NCT01181440|Conventional care|conventional care
5526694|NCT01181414|Permanent Atrial Fibrillation|permanent atrial fibrillation
5526695|NCT01181414|Resynchronization therapy|resynchronization therapy
5526696|NCT01181414|Ablation|ablation
5526697|NCT01181401|induction chemotherapy|induction chemotherapy
5526698|NCT01181401|radiotherapy|radiotherapy
5526699|NCT01181401|locally advanced head neck tumor|locally advanced head neck tumor
5526700|NCT01181401|toxicity|toxicity
5526701|NCT01181401|LA SCCHN|la scchn
5526702|NCT01181401|Unresectable squamous cell cancer of the head and neck,|unresectable squamous cell cancer of the head and neck,
5526703|NCT01181401|Stage IV (UICC)|stage iv (uicc)
5526704|NCT01181375|cervical cancer|cervical cancer
5526705|NCT01181375|assay|assay
5526706|NCT01181375|hypoxia|hypoxia
5526707|NCT01181362|Endoscopy|endoscopy
5526708|NCT01181362|Head and Neck region|head and neck region
5526709|NCT01181362|Scope|scope
5526710|NCT01181349|neuromuscular blockade; general anesthesia|neuromuscular blockade; general anesthesia
5526711|NCT01181336|Safety|safety
5526712|NCT01181336|Tolerability|tolerability
5526713|NCT01181336|Immunogenicity|immunogenicity
5526714|NCT01181336|Influenza|influenza
5526715|NCT01181336|Virus|virus
5526716|NCT01181336|Vaccine|vaccine
5526717|NCT01181323|influenza, vaccine, breastfeeding, post-partum women, infant, LAIV, TIV, parent protocol|influenza, vaccine, breastfeeding, post-partum women, infant, laiv, tiv, parent protocol
5526718|NCT01181310|dementia, cognitive impairment, neurodegeneration, Alzheimer's, acetylcholine, AchE|dementia, cognitive impairment, neurodegeneration, alzheimer's, acetylcholine, ache
5526719|NCT01181297|Confirmed milk allergy|confirmed milk allergy
5526720|NCT01181284|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5526721|NCT01181271|Lymphoma|lymphoma
5526722|NCT01181271|non-hodgkins lymphoma|non-hodgkins lymphoma
5526723|NCT01181271|Hodgkin's lymphoma|hodgkin's lymphoma
5526724|NCT01181271|Hodgkin's disease|hodgkin's disease
5526725|NCT01181271|stem cell transplant|stem cell transplant
5526726|NCT01181271|High-risk diffuse large B cell|high-risk diffuse large b cell
5526727|NCT01181271|Transformed low grade lymphoma|transformed low grade lymphoma
5526728|NCT01181271|T-cell non-Hodgkin's lymphoma|t-cell non-hodgkin's lymphoma
5526729|NCT01181271|Mantle cell lymphoma at any time in therapy|mantle cell lymphoma at any time in therapy
5526730|NCT01181271|"Double-hit lymphoma"|"double-hit lymphoma"
5526731|NCT01181258|related HLA-haploidentical donor|related hla-haploidentical donor
5526732|NCT01181245|Pancreatic Cancer|pancreatic cancer
5526733|NCT01181232|insomnia|insomnia
5526736|NCT01181206|Covering the abdominal wound edge in laparotomies|covering the abdominal wound edge in laparotomies
5526738|NCT01181193|chemoradiotherapy|chemoradiotherapy
5526739|NCT01181193|vitamin D|vitamin d
5526740|NCT01181180|Ageing|ageing
5526741|NCT01181180|Balance control|balance control
5526742|NCT01181180|Falls|falls
5526743|NCT01181180|dehydration|dehydration
5526744|NCT01181167|Anticoagulants|anticoagulants
5526745|NCT01181167|Venous thromboembolism|venous thromboembolism
5526746|NCT01181167|Thromboembolism|thromboembolism
5526747|NCT01181167|Thrombosis|thrombosis
5526748|NCT01181167|enoxaparin sodium|enoxaparin sodium
5526749|NCT01181167|Embolism|embolism
5526750|NCT01181167|Deep vein thrombosis|deep vein thrombosis
5526751|NCT01181167|DU-176b|du-176b
5526752|NCT01181167|edoxaban|edoxaban
5526753|NCT01181167|factor Xa|factor xa
5526754|NCT01181167|total hip arthroplasty|total hip arthroplasty
5526755|NCT01181154|Auto-Immune|auto-immune
5526756|NCT01181154|Hemolytic|hemolytic
5526757|NCT01181154|Anemia|anemia
5526758|NCT01181154|AHA|aha
5526759|NCT01181154|AIHA|aiha
5526760|NCT01181154|Rituximab|rituximab
5526761|NCT01181141|Anticoagulants|anticoagulants
5526762|NCT01181141|Enoxaparin sodium|enoxaparin sodium
5526763|NCT01181141|venous thromboembolism.|venous thromboembolism.
5526764|NCT01181141|thromboembolism|thromboembolism
5526765|NCT01181141|Thrombosis|thrombosis
5526766|NCT01181141|deep vein thrombosis|deep vein thrombosis
5526767|NCT01181141|DU-176b|du-176b
5526768|NCT01181141|Edoxaban|edoxaban
5526769|NCT01181141|factor Xa|factor xa
5526770|NCT01181141|hip fracture surgery|hip fracture surgery
5526771|NCT01181141|embolism|embolism
5526772|NCT01181115|Chinese Patients|chinese patients
5526773|NCT01181115|Relapsing MS|relapsing ms
5526774|NCT01181115|Safety|safety
5526775|NCT01181115|Avonex|avonex
5526776|NCT01181115|Tolerability|tolerability
5526781|NCT01181102|thrombosis|thrombosis
5526782|NCT01181102|thromboembolism|thromboembolism
5526783|NCT01181102|embolism and thrombosis|embolism and thrombosis
5526784|NCT01181102|deep vein thrombosis|deep vein thrombosis
5526785|NCT01181102|DU-176b|du-176b
5526786|NCT01181102|Edoxaban|edoxaban
5526787|NCT01181102|factor Xa|factor xa
5526788|NCT01181102|total knee arthroplasty|total knee arthroplasty
5526789|NCT01181102|Enoxaparin sodium|enoxaparin sodium
5526790|NCT01181076|Stem cell transplantation|stem cell transplantation
5526791|NCT01181076|Individualized Nutrition|individualized nutrition
5526792|NCT01181076|Quality of life|quality of life
5526793|NCT01181076|Oral Mucositis|oral mucositis
5526795|NCT01181063|Asthma|asthma
5526796|NCT01181063|Easyhaler|easyhaler
5526797|NCT01181037|Displaced subcapital femoral fracture|displaced subcapital femoral fracture
5526798|NCT01181037|Bbipolar H.A.|bbipolar h.a.
5526799|NCT01181037|CRIF with Ttrochanteric Antegrade Nail|crif with ttrochanteric antegrade nail
5526800|NCT01180972|Obesity, diabetes, hispanic, physical activity, nutrition|obesity, diabetes, hispanic, physical activity, nutrition
5526801|NCT01180959|Advanced Liver Cancer|advanced liver cancer
5526802|NCT01180959|primary neoplasm of the liver|primary neoplasm of the liver
5526803|NCT01180959|Erlotinib|erlotinib
5526804|NCT01180959|Bevacizumab|bevacizumab
5526805|NCT01180959|Hepatocellular Carcinoma|hepatocellular carcinoma
5526807|NCT01180959|Avastin|avastin
5526808|NCT01180959|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5526809|NCT01180959|rhuMAb-VEGF|rhumab-vegf
5526810|NCT01180959|OSI-774|osi-774
5526811|NCT01180959|Tarceva|tarceva
5526812|NCT01180946|FGF23|fgf23
5526813|NCT01180946|FGF-23|fgf-23
5526814|NCT01180946|vitamin D|vitamin d
5526815|NCT01180946|vitamin D deficiency|vitamin d deficiency
5526816|NCT01180946|insulin resistance|insulin resistance
5526817|NCT01180946|Healthy volunteers|healthy volunteers
5526818|NCT01180933|docosahexaenoic acid|docosahexaenoic acid
5526819|NCT01180933|folate|folate
5526820|NCT01180933|neurological development|neurological development
5526821|NCT01180933|allergies|allergies
5526822|NCT01180933|long term consequences for the offspring|long term consequences for the offspring
5526823|NCT01180933|allergy risk|allergy risk
5526824|NCT01180920|Dental|dental
5526825|NCT01180920|Periodontal|periodontal
5526826|NCT01180920|Surgery|surgery
5526827|NCT01180920|Gums|gums
5526828|NCT01180907|18F-FAC|18f-fac
5526829|NCT01180907|imaging|imaging
5526830|NCT01180907|cancer|cancer
5526831|NCT01180907|inflammation|inflammation
5526833|NCT01180894|Trauma|trauma
5526834|NCT01180894|Anemia|anemia
5526835|NCT01180894|Iron|iron
5526836|NCT01180894|Erythropoeisis|erythropoeisis
5527622|NCT01177410|Bloating|bloating
5526842|NCT01180868|cancer|cancer
5526843|NCT01180868|inflammatory tissue|inflammatory tissue
5526844|NCT01180868|inflammatory diseases|inflammatory diseases
5526845|NCT01180855|Melatonin|melatonin
5526846|NCT01180855|Cognitive Behavior Therapy|cognitive behavior therapy
5526847|NCT01180842|CF|cf
5526848|NCT01180816|GBM|gbm
5526849|NCT01180816|AA|aa
5526850|NCT01180816|AO|ao
5526851|NCT01180816|Brain|brain
5526852|NCT01180816|Tumors|tumors
5526853|NCT01180816|Malignant|malignant
5526854|NCT01180816|Glioblastoma|glioblastoma
5526855|NCT01180816|Multiforme|multiforme
5526856|NCT01180816|Anaplastic|anaplastic
5526857|NCT01180816|Astrocytoma|astrocytoma
5526858|NCT01180803|COPD - long term oxygenotherapy|copd - long term oxygenotherapy
5526859|NCT01180803|COPD patients with respiratory failure|copd patients with respiratory failure
5526860|NCT01180790|HCV|hcv
5526861|NCT01180790|Hepatitis C Genotype 1|hepatitis c genotype 1
5526862|NCT01180764|hypertriglyceridemia|hypertriglyceridemia
5526863|NCT01180764|omega-3 acid ethyl esters|omega-3 acid ethyl esters
5526864|NCT01180764|high-density lipoproteins|high-density lipoproteins
5526865|NCT01180764|fish oil|fish oil
5526866|NCT01180751|Positron Emission Tomography|positron emission tomography
5526867|NCT01180751|Fluorodeoxyglucose|fluorodeoxyglucose
5526868|NCT01180751|FDG (18F-Fluorodeoxyglucose)|fdg (18f-fluorodeoxyglucose)
5526869|NCT01180751|Oncology|oncology
5526870|NCT01180751|Neurology|neurology
5526871|NCT01180738|chronic stroke|chronic stroke
5526872|NCT01180738|walking training|walking training
5526873|NCT01180738|rehabilitation|rehabilitation
5526874|NCT01180738|body weight supported treadmill training|body weight supported treadmill training
5526875|NCT01180738|physical therapy|physical therapy
5526876|NCT01180738|balance|balance
5526877|NCT01180725|To investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms|to investigate and compare the effects of dried plums and psyllium on the overall relief of constipation symptoms
5520975|NCT01204749|Primary Peritoneal Cancer|primary peritoneal cancer
5526879|NCT01180725|To investigate and compare the quality of life of dried plums and psyllium|to investigate and compare the quality of life of dried plums and psyllium
5526880|NCT01180712|anthocyanin|anthocyanin
5526881|NCT01180712|blaeberries|blaeberries
5526882|NCT01180712|bilberries|bilberries
5526883|NCT01180712|blueberries|blueberries
5526884|NCT01180712|mirtoselect|mirtoselect
5526885|NCT01180712|type 2 diabetes|type 2 diabetes
5526886|NCT01180712|insulin resistance|insulin resistance
5526887|NCT01180712|Adipose tissue|adipose tissue
5526888|NCT01180712|inflammation|inflammation
5526889|NCT01180699|adult solid organ transplant patients|adult solid organ transplant patients
5526890|NCT01180686|low back pain|low back pain
5526891|NCT01180686|chiropractic|chiropractic
5526892|NCT01180686|manipulation|manipulation
5526893|NCT01180673|Hypertension|hypertension
5526894|NCT01180673|Older Adults|older adults
5526895|NCT01180673|Motivational Interviewing|motivational interviewing
5526896|NCT01180673|Lifestyle Counseling|lifestyle counseling
5526897|NCT01180673|Senior Centers|senior centers
5526898|NCT01180660|Gastric Surgery|gastric surgery
5526900|NCT01180660|Recovery|recovery
5526901|NCT01180660|Laparoscopic Surgery|laparoscopic surgery
5526902|NCT01180647|Extended-release naltrexone|extended-release naltrexone
5526903|NCT01180647|Prisoners|prisoners
5526904|NCT01180647|Opioid addiction prevention|opioid addiction prevention
5526905|NCT01180647|Medication Treatment Alternatives|medication treatment alternatives
5526906|NCT01180647|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
5526907|NCT01180621|vaccine|vaccine
5526908|NCT01180621|Seasonal Influenza Vaccine|seasonal influenza vaccine
5526909|NCT01180621|Influenza Vaccine|influenza vaccine
5526910|NCT01180621|Vaccine Safety|vaccine safety
5526911|NCT01180621|Vaccine Immunogenicity|vaccine immunogenicity
5526912|NCT01180621|Fluviral 2010-2011|fluviral 2010-2011
5526913|NCT01180608|neuropathic pain|neuropathic pain
5526914|NCT01180608|Diabetic Polyneuropathy|diabetic polyneuropathy
5526915|NCT01180595|osteoarthritis|osteoarthritis
5526916|NCT01180595|arthroplasty|arthroplasty
5526917|NCT01180595|knee joint|knee joint
5526918|NCT01180595|radiography|radiography
5526919|NCT01180595|surgery|surgery
5526920|NCT01180595|Bone Density|bone density
5526921|NCT01180595|Outcome Assessment (Health Care)|outcome assessment (health care)
5526922|NCT01180582|knee|knee
5526923|NCT01180582|arthroplasty|arthroplasty
5526925|NCT01180582|migration|migration
5526926|NCT01180582|micromotion|micromotion
5526927|NCT01180582|osteoarthritis|osteoarthritis
5526928|NCT01180569|Lenalidomide|lenalidomide
5526929|NCT01180569|10-022|10-022
5526930|NCT01180556|childhood|childhood
5526931|NCT01180556|abdominal pain|abdominal pain
5526932|NCT01180556|probiotics|probiotics
5526933|NCT01180517|Angioplasty Balloon|angioplasty balloon
5526934|NCT01180504|ovarian cancer|ovarian cancer
5526935|NCT01180504|whole-abdominal radiotherapy|whole-abdominal radiotherapy
5526936|NCT01180504|consolidation treatment|consolidation treatment
5526937|NCT01180504|helical tomotherapy|helical tomotherapy
5526938|NCT01180491|Discoloured and deformed nails resulting from onychomycosis|discoloured and deformed nails resulting from onychomycosis
5526939|NCT01180478|Bladder Cancer|bladder cancer
5526940|NCT01180478|Urothelial carcinoma|urothelial carcinoma
5526941|NCT01180478|Stage pTa or pT1|stage pta or pt1
5526942|NCT01180478|NMIBC Ta/T1|nmibc ta/t1
5526943|NCT01180478|Narrow Band Imaging|narrow band imaging
5526944|NCT01180478|White Light Cystoscopy|white light cystoscopy
5526945|NCT01180478|Transurethral resection|transurethral resection
5526946|NCT01180478|Superficial bladder tumor|superficial bladder tumor
5526947|NCT01180478|Positive urine cytology|positive urine cytology
5526948|NCT01180465|Treatment of abdominal adiposity|treatment of abdominal adiposity
5526949|NCT01180452|Crohn disease|crohn disease
5526950|NCT01180452|dysplasia|dysplasia
5526951|NCT01180452|adenocarcinoma|adenocarcinoma
5526952|NCT01180452|endoscopy|endoscopy
5526953|NCT01180452|jejunum|jejunum
5526954|NCT01180452|ileum|ileum
5526955|NCT01180439|Non-invasive ventilation|non-invasive ventilation
5526956|NCT01180439|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5526957|NCT01180439|Patient-ventilator synchronisation|patient-ventilator synchronisation
5526958|NCT01180439|Sleep study|sleep study
5526959|NCT01180439|Polysomnography|polysomnography
5526960|NCT01180426|Relapse Refractory Acute Myeloid Leukemia|relapse refractory acute myeloid leukemia
5526961|NCT01180413|Inward eutrophic remodelling|inward eutrophic remodelling
5526962|NCT01180400|Major Depressive Disorder|major depressive disorder
5526963|NCT01180400|MDD|mdd
5526964|NCT01180400|Depression|depression
5526965|NCT01180400|Safety|safety
5526966|NCT01180400|add-on therapy|add-on therapy
5526967|NCT01180374|Cannabis|cannabis
5526968|NCT01180374|Marijuana|marijuana
5526969|NCT01180374|Cannabidiol|cannabidiol
5526970|NCT01180374|CBD|cbd
5526971|NCT01180374|THC|thc
5526972|NCT01180374|Psychotic Disorders|psychotic disorders
5526973|NCT01180361|rheumatoid arthritis|rheumatoid arthritis
5526974|NCT01180361|systemic lupus erythematosus|systemic lupus erythematosus
5526975|NCT01180361|atherosclerosis|atherosclerosis
5526976|NCT01180361|adenosine|adenosine
5526977|NCT01180348|Wrinkles, glabellar, facial.|wrinkles, glabellar, facial.
5526978|NCT01180335|Genomic driven chemotherapy|genomic driven chemotherapy
5526979|NCT01180322|azacitidine|azacitidine
5526980|NCT01180322|Acute myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5526981|NCT01180309|Tongue frenum|tongue frenum
5526982|NCT01180309|Lingual frenum|lingual frenum
5526983|NCT01180309|Audio Phonology|audio phonology
5526984|NCT01180309|Speech disorders|speech disorders
5526985|NCT01180296|Preterm birth, prevention, progesterone, oral|preterm birth, prevention, progesterone, oral
5526986|NCT01180283|Erectile dysfunction|erectile dysfunction
5526987|NCT01180283|Lodenafil carbonate|lodenafil carbonate
5526988|NCT01180283|Diabetes|diabetes
5526989|NCT01180270|Cervical dystonia|cervical dystonia
5526990|NCT01180270|torticollis spasmodicus|torticollis spasmodicus
5526991|NCT01180270|botulinum toxin|botulinum toxin
5526992|NCT01180270|Subjective visual vertical (SVV)|subjective visual vertical (svv)
5526994|NCT01180270|static graviceptive function|static graviceptive function
5526995|NCT01180244|fibromyalgia|fibromyalgia
5526996|NCT01180244|noninvasive|noninvasive
5526997|NCT01180244|electrical|electrical
5526998|NCT01180244|cortical|cortical
5526999|NCT01180244|stimulation|stimulation
5527001|NCT01180244|brain|brain
5527002|NCT01180244|tender point|tender point
5527003|NCT01180231|Overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications|overweight or obese young adults (18 to 30 years old) with no previous history of cardiovascular disease/psychiatric illness, and not on medications
5527004|NCT01180218|myocardial revascularization|myocardial revascularization
5527005|NCT01180218|myocardial infarction|myocardial infarction
5527006|NCT01180205|FMD|fmd
5527007|NCT01180205|hypertension|hypertension
5527008|NCT01180205|Telmisartan|telmisartan
5527009|NCT01180205|Amlodipine|amlodipine
5527010|NCT01180192|blood loss|blood loss
5527011|NCT01180192|oxygen inhalation|oxygen inhalation
5527012|NCT01180179|H. pylori-negative idiopathic peptic ulcers|h. pylori-negative idiopathic peptic ulcers
5527013|NCT01180179|Recurrent ulcer bleeding|recurrent ulcer bleeding
5527014|NCT01180166|Gastric cancer|gastric cancer
5527015|NCT01180166|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5527016|NCT01180166|target therapy|target therapy
5527017|NCT01180153|40 S-1/L-OHP|40 s-1/l-ohp
5527018|NCT01180153|biliary tract|biliary tract
5527019|NCT01180153|ampullary carcinoma|ampullary carcinoma
5527020|NCT01180140|Seamguard|seamguard
5527021|NCT01180140|staple-line reinforcement|staple-line reinforcement
5527022|NCT01180140|leak|leak
5527023|NCT01180140|bleeding|bleeding
5527024|NCT01180127|flavonol|flavonol
5527025|NCT01180127|exercise|exercise
5527026|NCT01180127|dentate gyrus|dentate gyrus
5527027|NCT01180127|cerebral blood volume|cerebral blood volume
5527028|NCT01180127|dentate gyrus CBV|dentate gyrus cbv
5527029|NCT01180114|economic empowerment model,|economic empowerment model,
5527030|NCT01180114|orphaned children and youth,|orphaned children and youth,
5527031|NCT01180114|Uganda,|uganda,
5527032|NCT01180114|sub-Saharan Africa|sub-saharan africa
5527034|NCT01180101|Chronic Kidney Disease|chronic kidney disease
5527035|NCT01180088|LIVER TUMOURS|liver tumours
5527036|NCT01180062|Latanoprost subconjunctival insert|latanoprost subconjunctival insert
5527037|NCT01180049|Mantle Cell Lymphoma|mantle cell lymphoma
5527038|NCT01180049|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5527039|NCT01180049|temsirolimus|temsirolimus
5527040|NCT01180036|Membranous Nephropathy|membranous nephropathy
5527041|NCT01180023|GBS|gbs
5527042|NCT01180023|Membrane sweeping|membrane sweeping
5527043|NCT01180010|Hodgkin's Lymphoma|hodgkin's lymphoma
5527045|NCT01180010|Lung Nodule|lung nodule
5527046|NCT01180010|CT scan|ct scan
5527047|NCT01179971|n-3 fatty acids|n-3 fatty acids
5508984|NCT01257672|domperidon|domperidon
5527048|NCT01179971|n-6 fatty acids|n-6 fatty acids
5527049|NCT01179971|anti-inflammatory action|anti-inflammatory action
5527050|NCT01179971|clinical trial|clinical trial
5527051|NCT01179971|randomized double-blinded|randomized double-blinded
5527052|NCT01179971|incorporation of fatty acids|incorporation of fatty acids
5527053|NCT01179958|cognitive function|cognitive function
5527054|NCT01179958|fMRI|fmri
5527055|NCT01179958|apoE|apoe
5527056|NCT01179958|inflammatory markers|inflammatory markers
5527057|NCT01179958|exercise|exercise
5527058|NCT01179945|diabetes|diabetes
5527059|NCT01179945|benzoic acid|benzoic acid
5527060|NCT01179945|benzoate|benzoate
5527061|NCT01179945|soda|soda
5527062|NCT01179945|soft drink|soft drink
5527063|NCT01179945|preservative|preservative
5527064|NCT01179945|blood sugar|blood sugar
5527065|NCT01179932|Pilot|pilot
5527066|NCT01179932|Charting|charting
5527067|NCT01179932|Anesthesia Record|anesthesia record
5527068|NCT01179932|Cardiac surgical operating room|cardiac surgical operating room
5527069|NCT01179932|Cardiac surgical intensive care unit|cardiac surgical intensive care unit
5527070|NCT01179932|Electrophysiology lab|electrophysiology lab
5527071|NCT01179919|Oseltamivir|oseltamivir
5527072|NCT01179919|Obesity|obesity
5527073|NCT01179919|Influenza|influenza
5527080|NCT01179880|Atopic|atopic
5527081|NCT01179867|Medication reconciliation|medication reconciliation
5527082|NCT01179867|Adverse drug events|adverse drug events
5527083|NCT01179867|Hospital readmission|hospital readmission
5527084|NCT01179867|Medication management|medication management
5527085|NCT01179841|Autism Spectrum Disorder|autism spectrum disorder
5527086|NCT01179841|language|language
5527087|NCT01179841|social|social
5527088|NCT01179841|toddlers|toddlers
5527089|NCT01179828|Quantitative sensory testing|quantitative sensory testing
5527090|NCT01179828|Drug efficacy|drug efficacy
5527091|NCT01179828|Low back pain syndrome|low back pain syndrome
5527092|NCT01179828|Imipramine|imipramine
5527093|NCT01179828|Oxycodone|oxycodone
5527094|NCT01179828|Clobazam|clobazam
5527095|NCT01179828|Tolterodine|tolterodine
5527096|NCT01179815|Patients with type 1 or type 2 diabetes mellitus|patients with type 1 or type 2 diabetes mellitus
5527097|NCT01179815|Monogenetic diabetes|monogenetic diabetes
5527098|NCT01179815|Pancreatogenic diabetes,|pancreatogenic diabetes,
5527099|NCT01179815|Drug-induced diabetes, other forms|drug-induced diabetes, other forms
5527101|NCT01179789|Healthy Elderly People|healthy elderly people
5527102|NCT01179776|ST-eleveation|st-eleveation
5527103|NCT01179776|Myocardial infarct|myocardial infarct
5527104|NCT01179776|Percutaneous coronary intervention|percutaneous coronary intervention
5527105|NCT01179776|Myocardial infarct STEMI patients|myocardial infarct stemi patients
5527106|NCT01179763|Amblyopia|amblyopia
5527107|NCT01179763|Retinal layer thickness|retinal layer thickness
5527108|NCT01179750|Ultrasonic coagulating shears in gastrectomy|ultrasonic coagulating shears in gastrectomy
5527109|NCT01179737|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5527110|NCT01179737|Nilotinib|nilotinib
5527111|NCT01179737|6MWD|6mwd
5527112|NCT01179737|Pulmonary Hypertension|pulmonary hypertension
5527113|NCT01179711|accommodative esotropia|accommodative esotropia
5527114|NCT01179698|computer-assisted surgery|computer-assisted surgery
5527115|NCT01179698|bone tumor|bone tumor
5527116|NCT01179698|We will evaluate whether computer-assisted surgery|we will evaluate whether computer-assisted surgery
5527117|NCT01179698|will be feasible and safe for bone tumor resection|will be feasible and safe for bone tumor resection
5527118|NCT01179672|Diabetic Peripheral Neuropathic Pain|diabetic peripheral neuropathic pain
5527119|NCT01179659|Single dose crossover BE study|single dose crossover be study
5527120|NCT01179646|Bioequivalency|bioequivalency
5527121|NCT01179620|Hemodialysis, Certoparin|hemodialysis, certoparin
5527122|NCT01179581|Safety|safety
5527123|NCT01179581|Tolerability|tolerability
5527124|NCT01179581|Pharmacokinetics|pharmacokinetics
5527125|NCT01179568|Grief|grief
5527126|NCT01179568|Bereavement|bereavement
5527127|NCT01179568|Psychotherapy|psychotherapy
5527128|NCT01179568|Medication|medication
5527129|NCT01179568|Treatment study|treatment study
5527130|NCT01179555|Diabetic Complications|diabetic complications
5527131|NCT01179555|Intervention Studies|intervention studies
5527132|NCT01179555|African Americans|african americans
5527133|NCT01179555|Vision Screening|vision screening
5527134|NCT01179555|Vision, Low|vision, low
5527135|NCT01179555|Geriatric Assessment|geriatric assessment
5527136|NCT01179555|Outcomes Assessment|outcomes assessment
5527137|NCT01179555|Cultural Characteristics|cultural characteristics
5527138|NCT01179555|Cultural Competency|cultural competency
5527139|NCT01179555|Appointment Adherence|appointment adherence
5527140|NCT01179555|Cost-effectiveness|cost-effectiveness
5527141|NCT01179555|Personalization of care|personalization of care
5527142|NCT01179555|Follow-up Care|follow-up care
5527143|NCT01179542|iugr pet eIF4E Translation Initiation Factor|iugr pet eif4e translation initiation factor
5527144|NCT01179542|4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR|4e (eif4e) in human placental implantation and in the pathological pregnancies: preeclampsia and iugr
5509093|NCT01257087|Glycaemic control|glycaemic control
5527145|NCT01179529|Atopic dermatitis (atopic eczema)|atopic dermatitis (atopic eczema)
5527146|NCT01179516|Major Depressive Disorder|major depressive disorder
5527147|NCT01179516|Depression|depression
5527148|NCT01179516|Drug Therapy|drug therapy
5527149|NCT01179503|vitamin D|vitamin d
5527150|NCT01179503|physical performance|physical performance
5527151|NCT01179490|Multiple Myeloma|multiple myeloma
5527152|NCT01179477|Left heart pacing lead|left heart pacing lead
5527153|NCT01179477|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5527154|NCT01179477|Heart failure|heart failure
5527155|NCT01179425|marijuana|marijuana
5527156|NCT01179425|dependence|dependence
5527157|NCT01179425|cognition|cognition
5527158|NCT01179425|stress|stress
5527159|NCT01179386|methylphenidate|methylphenidate
5527160|NCT01179386|ADHD|adhd
5527161|NCT01179386|driving|driving
5527162|NCT01179386|simulator|simulator
5527163|NCT01179386|pressure|pressure
5527164|NCT01179386|adolescent|adolescent
5527165|NCT01179360|Locally advanced|locally advanced
5527166|NCT01179360|HNSCC|hnscc
5527167|NCT01179334|Pulmonary Hypertension|pulmonary hypertension
5527168|NCT01179334|Riociguat|riociguat
5527169|NCT01179334|Blood Pressure|blood pressure
5527170|NCT01179308|regional analgesia|regional analgesia
5527171|NCT01179308|routine general anesthesia|routine general anesthesia
5527172|NCT01179308|immune system response|immune system response
5527173|NCT01179308|lung cancer (stage 1-3)|lung cancer (stage 1-3)
5527174|NCT01179295|MEK inhibitor|mek inhibitor
5527175|NCT01179295|BAY86-9766|bay86-9766
5527176|NCT01179295|RDEA 119|rdea 119
5527177|NCT01179295|Solid tumor|solid tumor
5527178|NCT01179282|DUST MITE ALLERGIES|dust mite allergies
5527179|NCT01179269|Non-small cell lung cancer|non-small cell lung cancer
5527180|NCT01179269|Pazopanib|pazopanib
5527181|NCT01179269|Stage IIIB/IV non small cell lung cancer|stage iiib/iv non small cell lung cancer
5527182|NCT01179256|ASTHMA|asthma
5527183|NCT01179243|microcirculatory alterations|microcirculatory alterations
5527184|NCT01179243|SDF imaging|sdf imaging
5497885|NCT01304823|gut|gut
5513489|NCT01237743|Aorta|aorta
5527186|NCT01179230|chest pain|chest pain
5527187|NCT01179230|acute coronary syndrome|acute coronary syndrome
5527188|NCT01179230|Myocardial perfusion imaging|myocardial perfusion imaging
5527189|NCT01179217|Sickle Cell Anemia|sickle cell anemia
5527197|NCT01179191|moderate pain|moderate pain
5527198|NCT01179191|severe pain|severe pain
5527199|NCT01179191|conversion|conversion
5527200|NCT01179191|converting|converting
5527201|NCT01179191|switching|switching
5527202|NCT01179191|morphine|morphine
5527203|NCT01179191|aberrant behavior|aberrant behavior
5527204|NCT01179191|Pain (DT) + Chronic Disease (DT)|pain (dt) + chronic disease (dt)
5527205|NCT01179152|asthma, september epidemic, children, preventive|asthma, september epidemic, children, preventive
5527206|NCT01179139|CRS|crs
5527207|NCT01179126|myocardial infarction|myocardial infarction
5527208|NCT01179126|primary angioplasty|primary angioplasty
5527209|NCT01179126|multivessel disease|multivessel disease
5527210|NCT01179126|stress echocardiography|stress echocardiography
5527211|NCT01179113|Laminectomy|laminectomy
5527212|NCT01179113|Esmolol Infusion|esmolol infusion
5527213|NCT01179113|Quality of recovery|quality of recovery
5527214|NCT01179113|beta-blockers|beta-blockers
5527215|NCT01179113|Pain management|pain management
5527216|NCT01179113|Postoperative pain|postoperative pain
5527217|NCT01179113|Opioid requirements|opioid requirements
5527218|NCT01179113|Intraoperative esmolol infusion|intraoperative esmolol infusion
5527219|NCT01179113|Return to normal activities of daily living|return to normal activities of daily living
5527220|NCT01179100|elderly|elderly
5527221|NCT01179100|general anesthesia|general anesthesia
5527222|NCT01179100|lidocaine infusion|lidocaine infusion
5527223|NCT01179100|lidocaine|lidocaine
5527224|NCT01179100|local anesthetic|local anesthetic
5527225|NCT01179100|pain management|pain management
5527226|NCT01179100|cognitive function|cognitive function
5527227|NCT01179087|sleep disordered breathing|sleep disordered breathing
5527228|NCT01179087|lung transplantation|lung transplantation
5527229|NCT01179074|palliation inoperable oesophageal cancer|palliation inoperable oesophageal cancer
5527230|NCT01179061|Apelin|apelin
5527231|NCT01179061|Heart failure|heart failure
5527232|NCT01179061|Pulmonary artery pressure|pulmonary artery pressure
5527233|NCT01179061|Inotropic|inotropic
5527234|NCT01179061|Diuretic|diuretic
5527235|NCT01179035|Post-release, community health|post-release, community health
5527236|NCT01179022|Bacteremia|bacteremia
5527237|NCT01179022|Argon Plasma Coagulation|argon plasma coagulation
5527238|NCT01179022|Endobronchial Lesions|endobronchial lesions
5527239|NCT01179009|depression|depression
5527240|NCT01178983|work related musculoskeletal disorders (WRMSD) among computer operators|work related musculoskeletal disorders (wrmsd) among computer operators
5527241|NCT01178957|Type 1 diabetes|type 1 diabetes
5527242|NCT01178957|Very-Low-Density-Lipoprotein(VLDL)|very-low-density-lipoprotein(vldl)
5527243|NCT01178957|Hyperglycemia|hyperglycemia
5527244|NCT01178931|IVF|ivf
5527245|NCT01178931|luteal phase support|luteal phase support
5527246|NCT01178931|oral progesterone|oral progesterone
5527247|NCT01178931|vaginal progesterone|vaginal progesterone
5790016|NCT00146146|estradiol|estradiol
5527248|NCT01178931|pregnancy rate|pregnancy rate
5527249|NCT01178931|safety|safety
5527250|NCT01178931|tolerability|tolerability
5527258|NCT01178905|Postnatal CMV infection of preterm infants|postnatal cmv infection of preterm infants
5527259|NCT01178905|breast milk|breast milk
5527260|NCT01178892|Hot Flashes|hot flashes
5527261|NCT01178892|Menopause|menopause
5527262|NCT01178892|Vasomotor symptoms|vasomotor symptoms
5527263|NCT01178892|Yoga|yoga
5527264|NCT01178892|Exercise|exercise
5527265|NCT01178892|Omega-3|omega-3
5527266|NCT01178892|Fish oil|fish oil
5527267|NCT01178879|Telehealth|telehealth
5527268|NCT01178879|nurse consultation|nurse consultation
5527269|NCT01178879|outpatient clinic|outpatient clinic
5527270|NCT01178866|thoracic surgery|thoracic surgery
5527271|NCT01178866|myocardial revascularization|myocardial revascularization
5527272|NCT01178866|left ventricular dysfunction|left ventricular dysfunction
5527273|NCT01178866|tissue perfusion|tissue perfusion
5527274|NCT01178866|prognosis|prognosis
5527275|NCT01178853|Healthy Volunteers|healthy volunteers
5527276|NCT01178840|female condom|female condom
5527277|NCT01178840|condom|condom
5527278|NCT01178840|clinical failure|clinical failure
5527279|NCT01178840|prostate-specific antigen|prostate-specific antigen
5527280|NCT01178840|semen exposure|semen exposure
5527281|NCT01178840|acceptability|acceptability
5527282|NCT01178840|Prevention of semen exposure|prevention of semen exposure
5527283|NCT01178801|liver cancer|liver cancer
5527284|NCT01178801|data mining|data mining
5527285|NCT01178801|knowledge discovering|knowledge discovering
5527286|NCT01178801|The clinical data of the patients with liver cancer.|the clinical data of the patients with liver cancer.
5527287|NCT01178788|Progestagens|progestagens
5527288|NCT01178788|Tertiary Prophylaxis|tertiary prophylaxis
5527289|NCT01178788|Micronized Progesterone|micronized progesterone
5527290|NCT01178788|17 alpha hydroxy P|17 alpha hydroxy p
5527291|NCT01178788|Preterm Delivery|preterm delivery
5498021|NCT01304186|HIV|hiv
5513575|NCT01237366|Trauma|trauma
5527292|NCT01178788|Cervical shortening|cervical shortening
5527293|NCT01178775|fatigue|fatigue
5527294|NCT01178775|meaning|meaning
5527295|NCT01178775|education|education
5527296|NCT01178775|walking program|walking program
5527297|NCT01178762|Oral Azithromycin|oral azithromycin
5527298|NCT01178762|Chlamydial Conjunctivitis|chlamydial conjunctivitis
5527299|NCT01178749|Hepatitis C|hepatitis c
5527300|NCT01178749|Interferon|interferon
5527301|NCT01178749|Symptom Distress|symptom distress
5527302|NCT01178749|Quality of Life|quality of life
5527303|NCT01178736|neoplasms|neoplasms
5527304|NCT01178723|breakfast size|breakfast size
5527305|NCT01178723|blood glucose balance|blood glucose balance
5527306|NCT01178723|hormonal profile|hormonal profile
5527307|NCT01178723|appetite hormones|appetite hormones
5527308|NCT01178723|adipokines|adipokines
5527309|NCT01178723|pro-inflammatory cytokines|pro-inflammatory cytokines
5527310|NCT01178684|ENFD|enfd
5527311|NCT01178684|epidermal nerve fiber density|epidermal nerve fiber density
5527313|NCT01178684|HIV-infection|hiv-infection
5527314|NCT01178671|PTSD|ptsd
5527315|NCT01178671|trauma|trauma
5527316|NCT01178671|anxiety disorder|anxiety disorder
5527317|NCT01178671|medication|medication
5527318|NCT01178671|sertraline|sertraline
5527319|NCT01178671|mirtazapine|mirtazapine
5527320|NCT01178671|pharmacotherapy|pharmacotherapy
5527321|NCT01178632|Herbal|herbal
5527322|NCT01178632|Phytotherapy|phytotherapy
5527323|NCT01178632|Passiflora|passiflora
5527324|NCT01178632|Valeriana|valeriana
5527325|NCT01178632|Anxiety|anxiety
5527326|NCT01178619|IUGR fetuses|iugr fetuses
5527327|NCT01178619|symmetrical IUGR|symmetrical iugr
5527328|NCT01178619|asymmetrical IUGR|asymmetrical iugr
5527329|NCT01178606|echogenic halo around lateral fetal ventricles|echogenic halo around lateral fetal ventricles
5527330|NCT01178593|IBS|ibs
5527331|NCT01178593|RCT|rct
5527332|NCT01178593|psychology|psychology
5527334|NCT01178593|psychotherapy|psychotherapy
5527335|NCT01178593|group therapy|group therapy
5527336|NCT01178580|fibrinolytic activity|fibrinolytic activity
5527337|NCT01178580|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
5527338|NCT01178580|Pleural effusion|pleural effusion
5527339|NCT01178567|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5527340|NCT01178567|Gastrectomy|gastrectomy
5527341|NCT01178567|Pulmonary Complications|pulmonary complications
5527342|NCT01178554|anxiety disorders|anxiety disorders
5527343|NCT01178554|depression|depression
5527344|NCT01178554|depressive disorders|depressive disorders
5527345|NCT01178554|disruptive behavioral problems|disruptive behavioral problems
5527346|NCT01178554|conduct problems|conduct problems
5527347|NCT01178541|ventricles|ventricles
5527348|NCT01178541|fetal|fetal
5527349|NCT01178541|brain|brain
5527350|NCT01178541|asymmetry|asymmetry
5527351|NCT01178528|heart failure|heart failure
5527352|NCT01178528|heart rate|heart rate
5527353|NCT01178528|ivabradine|ivabradine
5527354|NCT01178528|carvedilol|carvedilol
5527355|NCT01178515|epidemiological risk|epidemiological risk
5527356|NCT01178515|diet|diet
5527357|NCT01178515|fat intake|fat intake
5527358|NCT01178450|Renal transplant|renal transplant
5527359|NCT01178450|Hypercalcemia|hypercalcemia
5527360|NCT01178437|seizure disorder,|seizure disorder,
5527361|NCT01178437|seizures,|seizures,
5527362|NCT01178437|convulsions,|convulsions,
5527363|NCT01178437|grand mal,|grand mal,
5527364|NCT01178437|petit mal,|petit mal,
5527365|NCT01178437|absence seizures,|absence seizures,
5527366|NCT01178437|repeated seizures,|repeated seizures,
5527367|NCT01178437|children's seizures,|children's seizures,
5527368|NCT01178437|secondary epilepsy,|secondary epilepsy,
5527369|NCT01178437|symptomatic epilepsy,|symptomatic epilepsy,
5527370|NCT01178437|generalized seizures,|generalized seizures,
5527371|NCT01178437|partial seizure,|partial seizure,
5527372|NCT01178437|focal seizure,|focal seizure,
5527373|NCT01178437|partial complex seizure,|partial complex seizure,
5527374|NCT01178437|anticonvulsant medication|anticonvulsant medication
5527375|NCT01178424|Unipolar depression|unipolar depression
5527376|NCT01178424|Mindfulness based cognitive therapy|mindfulness based cognitive therapy
5527377|NCT01178424|Cognitive behavioural Therapy|cognitive behavioural therapy
5680307|NCT00578292|iron chelating agents|iron chelating agents
5527378|NCT01178424|Functional magnetic resonance imaging|functional magnetic resonance imaging
5527380|NCT01178424|Depressive relapse|depressive relapse
5527381|NCT01178424|Dysphoric|dysphoric
5527382|NCT01178424|Cognitive reactivity|cognitive reactivity
5527383|NCT01178424|Serotonin transporter gene|serotonin transporter gene
5527384|NCT01178411|hepatocellular carcinoma|hepatocellular carcinoma
5527385|NCT01178411|renal cell carcinoma|renal cell carcinoma
5527386|NCT01178411|melanoma|melanoma
5527387|NCT01178411|non-small cell lung cancer|non-small cell lung cancer
5527388|NCT01178411|breast cancer|breast cancer
5527389|NCT01178411|ovarian cancer|ovarian cancer
5527390|NCT01178411|MiT tumors|mit tumors
5527391|NCT01178398|fish|fish
5527392|NCT01178398|pregnancy|pregnancy
5527393|NCT01178398|nutrition|nutrition
5527394|NCT01178398|mercury|mercury
5527395|NCT01178398|focus group|focus group
5527396|NCT01178398|omega-3 fatty acid|omega-3 fatty acid
5527397|NCT01178398|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5527398|NCT01178385|Autism|autism
5527399|NCT01178385|Asperger's Syndrome|asperger's syndrome
5527400|NCT01178385|Treatment|treatment
5527401|NCT01178385|Cognitive-behavioral therapy|cognitive-behavioral therapy
5527402|NCT01178385|Anxiety|anxiety
5527403|NCT01178385|Children|children
5527404|NCT01178385|Therapy|therapy
5527405|NCT01178372|hepatic encephalopathy|hepatic encephalopathy
5527406|NCT01178372|lactulose|lactulose
5527407|NCT01178372|probiotics|probiotics
5527408|NCT01178359|cardiac arrest|cardiac arrest
5527409|NCT01178359|ventricular fibrillation|ventricular fibrillation
5527410|NCT01178359|nitrite|nitrite
5527411|NCT01178346|Pharmacoeconomic|pharmacoeconomic
5527412|NCT01178346|Quality of Life|quality of life
5527413|NCT01178346|Health Outcomes|health outcomes
5527414|NCT01178346|Smoking|smoking
5527415|NCT01178346|NicVAX|nicvax
5527416|NCT01178346|Smoking vaccine|smoking vaccine
5527417|NCT01178346|Smoking cessation|smoking cessation
5527418|NCT01178333|Thrombocytopenia|thrombocytopenia
5527419|NCT01178333|Heparin|heparin
5527420|NCT01178320|Magnetic Resonance Imaging|magnetic resonance imaging
5527421|NCT01178320|Atherosclerotic Plaque|atherosclerotic plaque
5527422|NCT01178320|Lipid Lowering Therapy|lipid lowering therapy
5527423|NCT01178307|GI cancers|gi cancers
5527424|NCT01178307|GIST|gist
5527425|NCT01178307|Symptom Severity|symptom severity
5527426|NCT01178307|Quality of Life|quality of life
5527427|NCT01178307|Questionnaire|questionnaire
5527428|NCT01178307|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5527429|NCT01178307|MDASI-GIST|mdasi-gist
5527430|NCT01178307|patient-reported outcomes|patient-reported outcomes
5527431|NCT01178294|haemophilia A|haemophilia a
5527432|NCT01178294|blood coagulation disorders|blood coagulation disorders
5527433|NCT01178294|coagulation protein disorder|coagulation protein disorder
5527435|NCT01178294|Acquired Hemophilia A|acquired hemophilia a
5527436|NCT01178294|hematologic diseases|hematologic diseases
5527437|NCT01178294|hemorrhagic disorders|hemorrhagic disorders
5527438|NCT01178281|Myelofibrosis|myelofibrosis
5527439|NCT01178281|Post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
5527440|NCT01178281|Post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5527441|NCT01178281|RBC-transfusion-dependence|rbc-transfusion-dependence
5527442|NCT01178281|Primary Myelofibrosis|primary myelofibrosis
5527443|NCT01178268|Drug eluting stents|drug eluting stents
5527445|NCT01178268|Angioplasty|angioplasty
5527446|NCT01178255|depression|depression
5527447|NCT01178255|homoeopathy|homoeopathy
5527448|NCT01178242|Labial mucous membrane|labial mucous membrane
5527449|NCT01178242|symblepharon|symblepharon
5527450|NCT01178242|dry eye|dry eye
5527451|NCT01178242|Stevens -Johnson syndrome|stevens -johnson syndrome
5527452|NCT01178242|salivary gland|salivary gland
5527453|NCT01178242|ocular surface disease|ocular surface disease
5527454|NCT01178242|transplantation|transplantation
5527455|NCT01178229|Sleep bruxism|sleep bruxism
5527456|NCT01178229|Airway remodeling|airway remodeling
5527457|NCT01178229|Physical therapy modalities|physical therapy modalities
5527458|NCT01178229|Child preschool.|child preschool.
5527459|NCT01178216|Kidney transplant|kidney transplant
5527460|NCT01178216|highly sensitized|highly sensitized
5527461|NCT01178203|Endodontics|endodontics
5527462|NCT01178203|pain|pain
5527463|NCT01178203|visual analogue scale|visual analogue scale
5527464|NCT01178203|NSAIDs|nsaids
5527465|NCT01178190|narrow band imaging|narrow band imaging
5527466|NCT01178190|malignant lesion|malignant lesion
5527467|NCT01178190|lung cancer|lung cancer
5527468|NCT01178190|NBI|nbi
5527469|NCT01178177|Invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5527470|NCT01178177|Solid organ transplantation|solid organ transplantation
5527471|NCT01178177|Hematologic disease|hematologic disease
5527472|NCT01178164|chronic pains|chronic pains
5527473|NCT01178164|unknown aetiology|unknown aetiology
5527474|NCT01178151|Peutz-Jeghers syndrome|peutz-jeghers syndrome
5527475|NCT01178151|mTOR inhibition|mtor inhibition
5527476|NCT01178151|cancer|cancer
5527477|NCT01178138|substance abuse|substance abuse
5527478|NCT01178125|Pregnancy Prevention|pregnancy prevention
5527479|NCT01178125|Oral Contraceptives|oral contraceptives
5527480|NCT01178112|Metastasis|metastasis
5527481|NCT01178112|Carboplatin|carboplatin
5527482|NCT01178112|Trientine|trientine
5527483|NCT01178112|Chemotherapy|chemotherapy
5527484|NCT01178073|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5527485|NCT01178073|Ambrisentan|ambrisentan
5527486|NCT01178073|Sponsor Rest of World: GSK|sponsor rest of world: gsk
5527487|NCT01178073|Tadalafil|tadalafil
5527489|NCT01178073|Sponsor US: Gilead|sponsor us: gilead
5527490|NCT01178060|Stroke|stroke
5527491|NCT01178060|Risk|risk
5527492|NCT01178060|Communication|communication
5798714|NCT00111293|Healthy Volunteer|healthy volunteer
5685358|NCT00556439|Temporal Arteritis|temporal arteritis
5527493|NCT01178060|Cardiovascular Disease Knowledge|cardiovascular disease knowledge
5527494|NCT01178060|Improve Risk Communication|improve risk communication
5527495|NCT01178034|Warfarin|warfarin
5527496|NCT01178034|Dose|dose
5527497|NCT01178034|Pharmacogenetic|pharmacogenetic
5527498|NCT01178034|INR|inr
5527499|NCT01178021|malaria|malaria
5527500|NCT01178021|vivax|vivax
5527501|NCT01178021|relapse|relapse
5527502|NCT01178008|Insomnia|insomnia
5527503|NCT01178008|Post-partum Depression|post-partum depression
5527504|NCT01178008|Electroacupuncture|electroacupuncture
5527505|NCT01178008|Acupuncture|acupuncture
5527506|NCT01178008|Randomized Clinical Trial|randomized clinical trial
5527507|NCT01178008|Traditional Chinese Medicine|traditional chinese medicine
5527508|NCT01177982|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate|pregnancy, opioid, cocaine, alcohol, benzodiazepines, neonate
5527509|NCT01177969|Autism|autism
5527510|NCT01177969|Anxiety|anxiety
5527511|NCT01177969|Asperger's Syndrome|asperger's syndrome
5527512|NCT01177969|Cognitive-behavioral therapy|cognitive-behavioral therapy
5527513|NCT01177969|Treatment|treatment
5527514|NCT01177969|Obsessive-compulsive disorder|obsessive-compulsive disorder
5527515|NCT01177969|Fears|fears
5527516|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck|recurrent and/or metastatic squamous cell carcinoma of the head and neck
5527517|NCT01177956|1st-line|1st-line
5527518|NCT01177956|Cetuximab|cetuximab
5527519|NCT01177956|Chemotherapy|chemotherapy
5527520|NCT01177956|EMR 62241 -055|emr 62241 -055
5527521|NCT01177956|Merck KGaA|merck kgaa
5527522|NCT01177956|Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)|recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn)
5527523|NCT01177865|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5527524|NCT01177865|stage I prostate cancer|stage i prostate cancer
5527525|NCT01177865|stage IIB prostate cancer|stage iib prostate cancer
5527526|NCT01177865|stage IIA prostate cancer|stage iia prostate cancer
5527527|NCT01177865|stage III prostate cancer|stage iii prostate cancer
5527528|NCT01177852|cough, acute rhinitis, common cold, nasal symptoms, children.|cough, acute rhinitis, common cold, nasal symptoms, children.
5527529|NCT01177852|Acute inflammation upper airway|acute inflammation upper airway
5527530|NCT01177826|Hospitalized|hospitalized
5527531|NCT01177826|Rotavirus|rotavirus
5527532|NCT01177826|Children|children
5527533|NCT01177826|effectiveness|effectiveness
5527534|NCT01177826|Gastroenteritis|gastroenteritis
5527535|NCT01177800|Psoriasis|psoriasis
5527536|NCT01177800|Infliximab|infliximab
5527537|NCT01177800|Remicade|remicade
5527538|NCT01177787|cryolipolysis fat zeltiq thigh Korean women|cryolipolysis fat zeltiq thigh korean women
5527539|NCT01177774|functional connectivity MRI|functional connectivity mri
5527540|NCT01177774|brain volumetry|brain volumetry
5527541|NCT01177774|negative reinforcement|negative reinforcement
5527543|NCT01177774|ADHD|adhd
5527544|NCT01177761|Osteoporosis|osteoporosis
5527545|NCT01177761|exercise|exercise
5527546|NCT01177761|fractures|fractures
5527547|NCT01177761|Bone Mineral Density|bone mineral density
5527548|NCT01177761|CHD-risk|chd-risk
5527549|NCT01177748|Stroke|stroke
5527550|NCT01177748|Cardiac Monitoring|cardiac monitoring
5527551|NCT01177735|Pomalidomide|pomalidomide
5527552|NCT01177735|multiple myeloma|multiple myeloma
5527553|NCT01177735|relapsed|relapsed
5527554|NCT01177722|Diphtheria|diphtheria
5527555|NCT01177722|Tetanus|tetanus
5527556|NCT01177722|Whooping cough|whooping cough
5527557|NCT01177722|Hepatitis B|hepatitis b
5527558|NCT01177722|Poliomyelitis|poliomyelitis
5527559|NCT01177722|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5527560|NCT01177709|schizophrenia|schizophrenia
5527561|NCT01177709|antipsychotics|antipsychotics
5527562|NCT01177709|obesity|obesity
5527563|NCT01177709|diabetes|diabetes
5527564|NCT01177696|caregivers|caregivers
5527565|NCT01177696|Family Health|family health
5527566|NCT01177696|Psychotherapeutic|psychotherapeutic
5527567|NCT01177696|Primary Health Care|primary health care
5527568|NCT01177670|Adiana Permanent Contraception System|adiana permanent contraception system
5527569|NCT01177670|women seeking permanent sterilization.|women seeking permanent sterilization.
5527570|NCT01177631|Carcinoma, hepatocellular|carcinoma, hepatocellular
5527571|NCT01177631|Portal vein|portal vein
5527572|NCT01177631|Proteomics|proteomics
5527575|NCT01177618|Emphysema|emphysema
5527576|NCT01177618|Chronic Bronchitis|chronic bronchitis
5527577|NCT01177618|Genetics|genetics
5527578|NCT01177618|Association Studies|association studies
5527579|NCT01177579|Bariatric surgery, copper deficiency, biomarkers|bariatric surgery, copper deficiency, biomarkers
5527580|NCT01177566|Atopic dermatitis|atopic dermatitis
5527582|NCT01177566|pimecrolimus cream 1%|pimecrolimus cream 1%
5527583|NCT01177566|Eletone|eletone
5527584|NCT01177566|medical device cream|medical device cream
5527585|NCT01177566|topical calcineurin inhibitor|topical calcineurin inhibitor
5527586|NCT01177553|Intrauterine Growth Retardation in Monochorionic Twins|intrauterine growth retardation in monochorionic twins
5527587|NCT01177527|Waldenstrom|waldenstrom
5527588|NCT01177527|myeloma|myeloma
5527589|NCT01177527|smoldering|smoldering
5527590|NCT01177527|lymphoma|lymphoma
5527591|NCT01177527|MGUS|mgus
5527592|NCT01177527|distinct B-cell lymphoproliferative disorder|distinct b-cell lymphoproliferative disorder
5527593|NCT01177514|Refractive surgery|refractive surgery
5527595|NCT01177514|PAIN|pain
5527596|NCT01177514|Gabapentin|gabapentin
5527597|NCT01177501|Ovarian cancer|ovarian cancer
5527598|NCT01177501|Topotecan|topotecan
5527599|NCT01177501|Carboplatine|carboplatine
5527600|NCT01177501|Higt dose chemotherapy|higt dose chemotherapy
5527601|NCT01177488|Military|military
5527602|NCT01177488|Health Service Delivery|health service delivery
5527603|NCT01177488|Behavioral Symptoms|behavioral symptoms
5527604|NCT01177488|Telepsychology|telepsychology
5527605|NCT01177488|Behavioral Activation|behavioral activation
5527606|NCT01177488|Exposure Therapy|exposure therapy
5527607|NCT01177488|Veterans|veterans
5527608|NCT01177488|Telemedicine|telemedicine
5527609|NCT01177475|kidney-transplant recipients|kidney-transplant recipients
5527610|NCT01177462|coordinate system|coordinate system
5527611|NCT01177462|normal|normal
5527612|NCT01177449|prolotherapy|prolotherapy
5527613|NCT01177436|prostate cancer|prostate cancer
5527614|NCT01177436|benign prostatic hypertrophy|benign prostatic hypertrophy
5527615|NCT01177423|restorative odontology|restorative odontology
5527616|NCT01177423|Patients cared in restorative odontology department|patients cared in restorative odontology department
5527617|NCT01177410|IBS|ibs
5527618|NCT01177410|Diarrhea|diarrhea
5527619|NCT01177410|IBS-D|ibs-d
5527620|NCT01177410|Irritable Bowel Syndrome|irritable bowel syndrome
5527621|NCT01177410|Abdominal pain|abdominal pain
5527623|NCT01177397|Advanced solid malignant neoplasms,Non-Hodgkin Lymphoma,|advanced solid malignant neoplasms,non-hodgkin lymphoma,
5527624|NCT01177397|Multiple Myeloma|multiple myeloma
5527625|NCT01177384|Type 2 diabetes mellitus|type 2 diabetes mellitus
5527626|NCT01177384|T2DM|t2dm
5527627|NCT01177358|Scar|scar
5527628|NCT01177358|Botox|botox
5527629|NCT01177332|FFA|ffa
5527630|NCT01177332|Liver|liver
5527631|NCT01177332|steatosis|steatosis
5527632|NCT01177332|exercise|exercise
5527633|NCT01177319|Parkinson's Disease|parkinson's disease
5527634|NCT01177319|Glutathione|glutathione
5527635|NCT01177306|ADHD, working memory|adhd, working memory
5527636|NCT01177293|biological availability|biological availability
5527637|NCT01177293|bioavailability|bioavailability
5527638|NCT01177293|amlodipine|amlodipine
5527639|NCT01177293|orally disintegrating tablet|orally disintegrating tablet
5527640|NCT01177293|ODT|odt
5527641|NCT01177293|tablets|tablets
5527642|NCT01177280|retrospective chronic low back pain|retrospective chronic low back pain
5527643|NCT01177267|retrospective database analysis in osteoarthritis patients|retrospective database analysis in osteoarthritis patients
5527644|NCT01177254|retrospective chronic low back pain|retrospective chronic low back pain
5527645|NCT01177241|retrospective chronic low back pain|retrospective chronic low back pain
5527646|NCT01177215|Algorithm|algorithm
5527647|NCT01177215|Treatment Protocol|treatment protocol
5527648|NCT01177215|Thoracic Drainage Device|thoracic drainage device
5527649|NCT01177202|HAC1, H1N1|hac1, h1n1
5527650|NCT01177189|Oxidative Stress|oxidative stress
5527651|NCT01177189|Free radicals|free radicals
5527652|NCT01177189|Aging|aging
5527653|NCT01177176|Cigarette smoking|cigarette smoking
5527654|NCT01177176|Tobacco smoking|tobacco smoking
5527655|NCT01177163|Type 2 diabetes mellitus|type 2 diabetes mellitus
5527656|NCT01177163|Canagliflozin|canagliflozin
5527657|NCT01177163|JNJ-28431754|jnj-28431754
5527658|NCT01177163|Insulin|insulin
5527659|NCT01177163|Pharmacokinetic|pharmacokinetic
5527660|NCT01177163|Pharmacodynamic|pharmacodynamic
5527661|NCT01177163|SGLT-1|sglt-1
5527662|NCT01177150|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
5527663|NCT01177150|Canagliflozin|canagliflozin
5527664|NCT01177150|Pharmacodynamic|pharmacodynamic
5527665|NCT01177150|Pharmacokinetic|pharmacokinetic
5527666|NCT01177150|Safety|safety
5527667|NCT01177150|Tolerability|tolerability
5527668|NCT01177137|tinnitus|tinnitus
5521766|NCT01201707|Vein|vein
5527671|NCT01177137|directive counseling|directive counseling
5527672|NCT01177137|sound therapy|sound therapy
5527673|NCT01177137|tinnitus questionnaire|tinnitus questionnaire
5527674|NCT01177137|tinnitus handicap inventory|tinnitus handicap inventory
5527675|NCT01177124|Breast cancer|breast cancer
5527676|NCT01177124|Survivors|survivors
5527677|NCT01177124|Mindfulness-Based Stress Reduction (MBSR)|mindfulness-based stress reduction (mbsr)
5527678|NCT01177124|Symptoms|symptoms
5527679|NCT01177124|Immune markers|immune markers
5527680|NCT01177085|obesity|obesity
5527681|NCT01177085|weight|weight
5527682|NCT01177085|weight-loss|weight-loss
5527683|NCT01177085|mushroom|mushroom
5527684|NCT01177085|oxidative|oxidative
5527685|NCT01177085|stress|stress
5527686|NCT01177085|immune|immune
5527687|NCT01177085|function|function
5527688|NCT01177085|inflammation|inflammation
5527689|NCT01177072|PTSD|ptsd
5527690|NCT01177059|Gene Therapy|gene therapy
5527691|NCT01177059|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
5527693|NCT01177059|HIV-1 Infections|hiv-1 infections
5527694|NCT01177046|Women receiving labour epidural for most recent delivery|women receiving labour epidural for most recent delivery
5527695|NCT01177007|Gastrointestinal Diseases|gastrointestinal diseases
5527696|NCT01177007|Colonic Diseases|colonic diseases
5527697|NCT01177007|Intestinal Diseases|intestinal diseases
5527698|NCT01177007|Rectal Diseases|rectal diseases
5527699|NCT01177007|Neoplastic Processes|neoplastic processes
5527700|NCT01177007|Pathologic Processes|pathologic processes
5527701|NCT01177007|Neuroendocrine Tumors|neuroendocrine tumors
5527702|NCT01177007|Neuroectodermal Tumors|neuroectodermal tumors
5527703|NCT01177007|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5527704|NCT01177007|Adenocarcinoma|adenocarcinoma
5527705|NCT01177007|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5527706|NCT01177007|Liver Diseases|liver diseases
5527707|NCT01177007|Neoplasms|neoplasms
5527708|NCT01177007|Carcinoma|carcinoma
5527709|NCT01177007|Colorectal Neoplasms|colorectal neoplasms
5527710|NCT01177007|Neoplasm Metastasis|neoplasm metastasis
5527711|NCT01177007|Carcinoma, Neuroendocrine|carcinoma, neuroendocrine
5527712|NCT01177007|Liver Neoplasms|liver neoplasms
5527713|NCT01177007|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5527714|NCT01177007|Neoplasms by Histologic Type|neoplasms by histologic type
5527715|NCT01177007|Intestinal Neoplasms|intestinal neoplasms
5527716|NCT01177007|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5527717|NCT01177007|Digestive System Neoplasms|digestive system neoplasms
5527718|NCT01177007|Neoplasms by Site|neoplasms by site
5527719|NCT01177007|Digestive System Diseases|digestive system diseases
5528313|NCT01174810|PD|pd
5671229|NCT00616590|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5527720|NCT01176994|Patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.|patients with skin lesions that are treated by dermatologists with destructive modalities without histological evaluation.
5527721|NCT01176981|pediatrics|pediatrics
5527722|NCT01176981|Osteosarcoma|osteosarcoma
5527723|NCT01176981|Methotrexate|methotrexate
5527724|NCT01176981|Outpatient|outpatient
5527725|NCT01176968|Eplerenone|eplerenone
5527726|NCT01176968|myocardial infarction|myocardial infarction
5527727|NCT01176968|mortality|mortality
5527728|NCT01176968|morbidity|morbidity
5527729|NCT01176955|Acne|acne
5527730|NCT01176955|Acne vulgaris|acne vulgaris
5527731|NCT01176955|Adherence|adherence
5527732|NCT01176955|Compliance|compliance
5527733|NCT01176955|MEMS|mems
5527734|NCT01176955|Benzoyl peroxide|benzoyl peroxide
5527735|NCT01176929|Suicide, Attempted|suicide, attempted
5527736|NCT01176929|prevention suicidal act|prevention suicidal act
5527737|NCT01176929|telephone contact|telephone contact
5527738|NCT01176929|professional coordination|professional coordination
5527739|NCT01176916|breast cancer|breast cancer
5527740|NCT01176916|Aromasin|aromasin
5527741|NCT01176916|adjuvant chemotherapy|adjuvant chemotherapy
5527742|NCT01176916|endocrine therapy|endocrine therapy
5527743|NCT01176890|truncal vagotomy|truncal vagotomy
5527744|NCT01176890|GLP-1|glp-1
5527745|NCT01176890|gastric emptying|gastric emptying
5527746|NCT01176890|appetite|appetite
5527747|NCT01176890|food intake|food intake
5527748|NCT01176864|Small-Bowel Disorders|small-bowel disorders
5527749|NCT01176864|Double-balloon enteroscopy|double-balloon enteroscopy
5527750|NCT01176864|Single-balloon enteroscopy|single-balloon enteroscopy
5527870|NCT01176461|stage IIIA melanoma|stage iiia melanoma
5527751|NCT01176851|None (study in healthy volunteers)|none (study in healthy volunteers)
5527752|NCT01176838|Breast Cancer Quality of Life Survey|breast cancer quality of life survey
5527753|NCT01176825|bipolar disorder|bipolar disorder
5527754|NCT01176825|cognitive behavior therapy|cognitive behavior therapy
5527755|NCT01176825|alcohol abuse|alcohol abuse
5527756|NCT01176825|drug abuse|drug abuse
5527757|NCT01176825|high risk behaviors|high risk behaviors
5680308|NCT00578292|severe|severe
5527758|NCT01176825|medication adherence|medication adherence
5527759|NCT01176825|psychosocial functioning|psychosocial functioning
5527760|NCT01176812|Facialwasting|facialwasting
5527761|NCT01176812|Juvederm|juvederm
5527762|NCT01176812|Restylane|restylane
5527763|NCT01176799|Breast cancer patients with measurable primary breast cancer tumor.|breast cancer patients with measurable primary breast cancer tumor.
5527764|NCT01176786|infection|infection
5527765|NCT01176786|tissue expander|tissue expander
5527766|NCT01176786|breast implant|breast implant
5527767|NCT01176786|breast reconstruction|breast reconstruction
5527768|NCT01176786|Infections rates|infections rates
5527769|NCT01176760|vagotomy|vagotomy
5527770|NCT01176760|vagus|vagus
5527771|NCT01176760|GLP-1|glp-1
5527772|NCT01176760|Insulin secretion|insulin secretion
5527773|NCT01176734|Pulsatile Tinnitus|pulsatile tinnitus
5527774|NCT01176734|Ringing-Buzzing-Tinnitus|ringing-buzzing-tinnitus
5527775|NCT01176734|Spontaneous Oto-Acoustic Emission Tinnitus|spontaneous oto-acoustic emission tinnitus
5527776|NCT01176734|Tensor Palatini Induced Tinnitus|tensor palatini induced tinnitus
5685359|NCT00556439|Abatacept|abatacept
5527777|NCT01176734|Tensor Tympani Induced Tinnitus|tensor tympani induced tinnitus
5527778|NCT01176734|Tinnitus of Vascular Origin|tinnitus of vascular origin
5527784|NCT01176734|Tinnitus, Spontaneous Oto-Acoustic Emission|tinnitus, spontaneous oto-acoustic emission
5527785|NCT01176734|Tinnitus, Subjective|tinnitus, subjective
5527786|NCT01176734|Tinnitus, Tensor Palatini Induced|tinnitus, tensor palatini induced
5527787|NCT01176734|Tinnitus, Tensor Tympani Induced|tinnitus, tensor tympani induced
5527788|NCT01176734|Vascular Origin Tinnitus|vascular origin tinnitus
5527789|NCT01176721|schizophrenic disorders|schizophrenic disorders
5527791|NCT01176721|psychotic|psychotic
5527792|NCT01176721|dementia|dementia
5527793|NCT01176721|delusional|delusional
5527794|NCT01176721|delusions|delusions
5527795|NCT01176721|hallucinations|hallucinations
5527796|NCT01176721|residual-type schizophrenia|residual-type schizophrenia
5527797|NCT01176721|illusions|illusions
5527798|NCT01176721|split mind|split mind
5527799|NCT01176721|mental health disorder|mental health disorder
5527800|NCT01176721|schizoid|schizoid
5527801|NCT01176721|paranoid-type schizophrenia|paranoid-type schizophrenia
5527802|NCT01176721|disorganized-type schizophrenia|disorganized-type schizophrenia
5527803|NCT01176721|undifferentiated-type schizophrenia|undifferentiated-type schizophrenia
5527804|NCT01176721|catatonic-type schizophrenia|catatonic-type schizophrenia
5527805|NCT01176721|mental illness|mental illness
5527806|NCT01176721|tardive dyskinesia|tardive dyskinesia
5527807|NCT01176721|neuroleptic malignant syndrome|neuroleptic malignant syndrome
5527808|NCT01176721|NMS|nms
5527809|NCT01176721|antipsychotics|antipsychotics
5527810|NCT01176721|atypical antipsychotics|atypical antipsychotics
5527811|NCT01176721|psychosocial treatments|psychosocial treatments
5527812|NCT01176721|rehabilitation|rehabilitation
5527813|NCT01176708|liver transplantation|liver transplantation
5527814|NCT01176708|kidney transplanted|kidney transplanted
5527815|NCT01176708|glucagon-like peptide-1|glucagon-like peptide-1
5527816|NCT01176708|insulin secretion|insulin secretion
5527817|NCT01176708|vagotomy|vagotomy
5527818|NCT01176682|NSAID-treated patients|nsaid-treated patients
5527819|NCT01176682|gastrointestinal events|gastrointestinal events
5527820|NCT01176682|Non-steroid anti-inflammatory drug (NSAID)|non-steroid anti-inflammatory drug (nsaid)
5527821|NCT01176682|Gastrointestinal events (GI events)|gastrointestinal events (gi events)
5527822|NCT01176682|Proton Pump Inhibitors (PPI)|proton pump inhibitors (ppi)
5527823|NCT01176669|Apatinib|apatinib
5527824|NCT01176669|Triple-Negative Breast Cancer|triple-negative breast cancer
5527825|NCT01176669|Metastatic Breast Cancer|metastatic breast cancer
5527826|NCT01176669|ER/PR Negative|er/pr negative
5527827|NCT01176669|Her2/Neu Negative|her2/neu negative
5527828|NCT01176656|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5527829|NCT01176656|Hypoglycemia|hypoglycemia
5527830|NCT01176643|SLE|sle
5527831|NCT01176643|Yoga|yoga
5527832|NCT01176630|metabolic syndrome, ESRD patient|metabolic syndrome, esrd patient
5527833|NCT01176617|Atrial Fibrillation|atrial fibrillation
5527834|NCT01176617|A-Fib|a-fib
5527835|NCT01176617|AF|af
5527836|NCT01176617|Persistent|persistent
5527837|NCT01176617|Permanent|permanent
5527838|NCT01176617|Pulmonary Vein isolation|pulmonary vein isolation
5527839|NCT01176617|Ablation|ablation
5527840|NCT01176591|Cocaine and alcohol dependence (CAD)|cocaine and alcohol dependence (cad)
5527841|NCT01176565|Acute hypertensive response|acute hypertensive response
5527842|NCT01176565|intracerebral hemorrhage|intracerebral hemorrhage
5527843|NCT01176565|blood pressure|blood pressure
5527844|NCT01176565|outcome|outcome
5527845|NCT01176565|nicardipine|nicardipine
5527846|NCT01176552|Kidney Cancer|kidney cancer
5527847|NCT01176552|Renal cell carcinoma|renal cell carcinoma
5527848|NCT01176552|High risk|high risk
5527849|NCT01176552|Adjuvant therapy|adjuvant therapy
5527850|NCT01176526|Coping|coping
5527851|NCT01176526|Quality of Life|quality of life
5527852|NCT01176526|Prostate Cancer|prostate cancer
5527853|NCT01176513|Prostate Cancer|prostate cancer
5527854|NCT01176513|MRI|mri
5527855|NCT01176513|PET|pet
5527856|NCT01176513|GE-148 (18F)|ge-148 (18f)
5527858|NCT01176500|(18F)Fluciclatide|(18f)fluciclatide
5527859|NCT01176500|Anti-Angiogenic Therapies|anti-angiogenic therapies
5527860|NCT01176500|Solid Tumors|solid tumors
5527861|NCT01176487|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5527862|NCT01176487|recurrent small cell lung cancer|recurrent small cell lung cancer
5527863|NCT01176487|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5527864|NCT01176487|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5527865|NCT01176487|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5530540|NCT01165840|Tuberculosis|tuberculosis
5527866|NCT01176487|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5527867|NCT01176474|stage IV melanoma|stage iv melanoma
5527868|NCT01176474|stage IIIC melanoma|stage iiic melanoma
5527869|NCT01176461|recurrent melanoma|recurrent melanoma
5527871|NCT01176461|stage IIIB melanoma|stage iiib melanoma
5527872|NCT01176461|stage IIIC melanoma|stage iiic melanoma
5527873|NCT01176461|stage IV melanoma|stage iv melanoma
5527874|NCT01176448|Cicatrix|cicatrix
5527875|NCT01176448|Dermabrasion|dermabrasion
5527876|NCT01176448|Coagulation, Laser|coagulation, laser
5527877|NCT01176435|Levodopa|levodopa
5527878|NCT01176435|Albinism|albinism
5527880|NCT01176422|AML|aml
5527881|NCT01176422|MDS|mds
5527882|NCT01176396|Dental Caries|dental caries
5527883|NCT01176396|Preventive Dentistry|preventive dentistry
5527884|NCT01176396|Dental Prophylaxis|dental prophylaxis
5527885|NCT01176396|Dental Care|dental care
5527886|NCT01176383|Nicotine addiction|nicotine addiction
5527887|NCT01176383|Behaviour|behaviour
5527888|NCT01176383|Gene test|gene test
5527889|NCT01176383|Lung cancer|lung cancer
5527890|NCT01176383|Lifetime risk of lung cancer in smokers|lifetime risk of lung cancer in smokers
5527891|NCT01176370|Heart Failure|heart failure
5527892|NCT01176370|Device|device
5527893|NCT01176370|Implantable|implantable
5527894|NCT01176370|Active|active
5527895|NCT01176370|Class III and Class IV|class iii and class iv
5527896|NCT01176370|Counterpulsation|counterpulsation
5527897|NCT01176357|Coronary artery disease (CAD)|coronary artery disease (cad)
5527898|NCT01176357|atherosclerosis|atherosclerosis
5527899|NCT01176357|mediastinal adipose tissue|mediastinal adipose tissue
5527900|NCT01176357|adiponectin, inflammatory mediators|adiponectin, inflammatory mediators
5527901|NCT01176344|Vitamin D supplementation|vitamin d supplementation
5527902|NCT01176344|Osteoarthritis|osteoarthritis
5527903|NCT01176344|Knee|knee
5527904|NCT01176344|Randomised clinical trial (RCT)|randomised clinical trial (rct)
5527905|NCT01176344|Cartilage|cartilage
5527906|NCT01176344|MRI|mri
5527907|NCT01176318|cough|cough
5527908|NCT01176318|exacerbation|exacerbation
5527909|NCT01176318|quality of life|quality of life
5527910|NCT01176305|Thromboembolic event|thromboembolic event
5527911|NCT01176292|total knee replacement|total knee replacement
5527912|NCT01176292|high flexion|high flexion
5527913|NCT01176292|range of motion|range of motion
5527914|NCT01176292|rotating platform|rotating platform
5527916|NCT01176279|Critical illness|critical illness
5527917|NCT01176279|Hyperglycemia|hyperglycemia
5527918|NCT01176279|Catheters, Indwelling|catheters, indwelling
5527919|NCT01176279|Intensive care unit|intensive care unit
5527920|NCT01176266|Hypophosphatasia|hypophosphatasia
5527921|NCT01176266|HPP|hpp
5527922|NCT01176266|Bone Disease|bone disease
5527923|NCT01176266|Soft Bones|soft bones
5527924|NCT01176266|Low Alkaline Phosphatase|low alkaline phosphatase
5527925|NCT01176266|Genetic metabolic disorder|genetic metabolic disorder
5527926|NCT01176266|Alkaline phosphatase|alkaline phosphatase
5527927|NCT01176266|Tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
5527928|NCT01176266|Rickets|rickets
5527929|NCT01176266|Osteomalacia|osteomalacia
5527930|NCT01176253|Type I DM|type i dm
5527931|NCT01176240|lightheadedness|lightheadedness
5527932|NCT01176240|unsteadiness|unsteadiness
5527933|NCT01176240|dizziness|dizziness
5527934|NCT01176240|weak|weak
5527935|NCT01176240|fatigue|fatigue
5527936|NCT01176240|concentration|concentration
5527937|NCT01176240|head & neck pain|head & neck pain
5527938|NCT01176240|standing/walking for a short time|standing/walking for a short time
5527939|NCT01176240|standing/walking for a long time|standing/walking for a long time
5527940|NCT01176240|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5527941|NCT01176240|falls|falls
5527942|NCT01176240|NOH|noh
5527943|NCT01176240|Parkinson's disease|parkinson's disease
5527944|NCT01176240|weakness|weakness
5527945|NCT01176227|bloating|bloating
5527946|NCT01176227|constipation|constipation
5527947|NCT01176227|diarrhea|diarrhea
5527948|NCT01176227|gas|gas
5527949|NCT01176227|mucous|mucous
5527950|NCT01176227|cramping|cramping
5527951|NCT01176214|supratentorial intracerebral hemorrhage|supratentorial intracerebral hemorrhage
5527952|NCT01176214|tracheostomy|tracheostomy
5527953|NCT01176214|sedation|sedation
5527954|NCT01176214|weaning|weaning
5527955|NCT01176201|SLV337|slv337
5527956|NCT01176201|Diabetes|diabetes
5527957|NCT01176201|Relative bioavailability|relative bioavailability
5527958|NCT01176201|ADME|adme
5527959|NCT01176188|Pediatric Intensive Care Unit|pediatric intensive care unit
5527960|NCT01176188|Environmental Stressors|environmental stressors
5527961|NCT01176188|Sleep|sleep
5527962|NCT01176188|Psychological Outcomes|psychological outcomes
5527963|NCT01176188|Pediatrics|pediatrics
5527964|NCT01176175|Progesterone|progesterone
5527965|NCT01176175|Microspheres|microspheres
5527966|NCT01176175|postmenopausal|postmenopausal
5527967|NCT01176175|Luteal phase support|luteal phase support
5527968|NCT01176162|Non Invasive measurement|non invasive measurement
5527969|NCT01176162|Preterm infants|preterm infants
5527970|NCT01176162|Aldosterone resistance|aldosterone resistance
5527971|NCT01176149|Diabetes|diabetes
5527972|NCT01176149|Self monitoring blood glucose|self monitoring blood glucose
5527973|NCT01176136|ADHD|adhd
5527974|NCT01176136|School-Based|school-based
5527975|NCT01176136|Organizational Skills|organizational skills
5527976|NCT01176136|Homework|homework
5527977|NCT01176136|Time Management|time management
5527978|NCT01176123|Cognitive behavioral therapy|cognitive behavioral therapy
5527979|NCT01176123|Insomnia|insomnia
5527980|NCT01176123|Traumatic Stress|traumatic stress
5527981|NCT01176110|hypothermia|hypothermia
5527982|NCT01176110|minimal invasive valve replacement|minimal invasive valve replacement
5527983|NCT01176097|First in man study evaluating AZD5658 in Type 2 Diabetics.|first in man study evaluating azd5658 in type 2 diabetics.
5527984|NCT01176097|Effect of fasting|effect of fasting
5527985|NCT01176097|Safety|safety
5527986|NCT01176097|Tolerability|tolerability
5527987|NCT01176084|low carbohydrate diet|low carbohydrate diet
5527988|NCT01176084|obesity|obesity
5527989|NCT01176084|moderate exercise|moderate exercise
5527990|NCT01176084|men|men
5527991|NCT01176071|galactomannan|galactomannan
5527992|NCT01176071|beta-D-glucan|beta-d-glucan
5527993|NCT01176071|aspergillosis|aspergillosis
5527994|NCT01176071|outcome|outcome
5527995|NCT01176058|Phase 3b|phase 3b
5527996|NCT01176058|Efficacy and Safety evaluation of Anidulafungin|efficacy and safety evaluation of anidulafungin
5527997|NCT01176058|ICC|icc
5527998|NCT01176045|Dry Eye Disease|dry eye disease
5527999|NCT01176045|Osmolarity|osmolarity
5528000|NCT01176045|Refractive Surgery|refractive surgery
5528001|NCT01176045|Lasik|lasik
5528002|NCT01176045|TearLab|tearlab
5528003|NCT01176032|Aliskiren|aliskiren
5528004|NCT01176032|hypertension|hypertension
5528005|NCT01176032|concentric LVH|concentric lvh
5528006|NCT01176032|LV remodeling|lv remodeling
5528007|NCT01176032|LVMI|lvmi
5528008|NCT01176032|biomarkers|biomarkers
5528009|NCT01176032|PICP|picp
5528010|NCT01176032|CT-1|ct-1
5528011|NCT01176032|MMP-1|mmp-1
5528012|NCT01176032|TIMP-1|timp-1
5528013|NCT01176032|AnxA5|anxa5
5528014|NCT01176032|Aldosterone|aldosterone
5528017|NCT01176019|Chorionic Villus Sampling|chorionic villus sampling
5528018|NCT01176019|First trimester screening|first trimester screening
5528019|NCT01176019|Down syndrome|down syndrome
5528020|NCT01176006|DOCK8|dock8
5528021|NCT01176006|Molluscum|molluscum
5528022|NCT01176006|Transplant|transplant
5528023|NCT01176006|Immunodeficiency|immunodeficiency
5528027|NCT01175967|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5528028|NCT01175967|perioperative/postoperative complications|perioperative/postoperative complications
5528029|NCT01175967|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5528030|NCT01175967|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5528031|NCT01175954|Partial Epilepsy|partial epilepsy
5528032|NCT01175928|Diabetic polyneuropathy|diabetic polyneuropathy
5528033|NCT01175928|Pneumatic Compression Device|pneumatic compression device
5528034|NCT01175915|Mild type of hand, foot and mouth disease|mild type of hand, foot and mouth disease
5528035|NCT01175915|Reduning Injection|reduning injection
5528036|NCT01175915|Effectiveness|effectiveness
5528037|NCT01175915|Safety|safety
5528038|NCT01175902|Normal tension glaucoma|normal tension glaucoma
5528039|NCT01175876|MMSE|mmse
5528040|NCT01175876|NSE|nse
5528041|NCT01175876|S100B|s100b
5528042|NCT01175876|hsCRP|hscrp
5528043|NCT01175876|DWI-MRI|dwi-mri
5528044|NCT01175863|intravascular ultrasound|intravascular ultrasound
5528045|NCT01175863|fractional flow reserve|fractional flow reserve
5528046|NCT01175824|Metabolic Diseases|metabolic diseases
5528047|NCT01175824|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5528048|NCT01175824|Glargine|glargine
5528049|NCT01175824|Diabetes Mellitus|diabetes mellitus
5528050|NCT01175824|Insulin LISPRO|insulin lispro
5528051|NCT01175824|Insulin|insulin
5528052|NCT01175811|Metabolic Diseases|metabolic diseases
5528053|NCT01175811|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5528054|NCT01175811|Glargine|glargine
5528055|NCT01175811|Diabetes Mellitus|diabetes mellitus
5528056|NCT01175811|Insulin LISPRO|insulin lispro
5528057|NCT01175811|Insulin|insulin
5528058|NCT01175798|Vitamin D deficiency|vitamin d deficiency
5528059|NCT01175798|End-stage renal disease|end-stage renal disease
5528060|NCT01175798|Immunity|immunity
5528061|NCT01175772|Ovary|ovary
5528062|NCT01175772|Carcinoma|carcinoma
5528063|NCT01175772|Maintenance|maintenance
5528064|NCT01175772|Metronomic|metronomic
5528065|NCT01175772|Chemotherapy|chemotherapy
5528066|NCT01175772|Time to Progression|time to progression
5528067|NCT01175772|overall survival|overall survival
5528068|NCT01175759|Unexplained Recurrent Pregnancy Loss|unexplained recurrent pregnancy loss
5528069|NCT01175759|Recurrent Abortions|recurrent abortions
5528070|NCT01175759|Recurrent Miscarriages|recurrent miscarriages
5528072|NCT01175759|Skin tests|skin tests
5528073|NCT01175759|Allergen|allergen
5528074|NCT01175759|Immunotherapy|immunotherapy
5528075|NCT01175759|Hypersensitivity|hypersensitivity
5528076|NCT01175759|Skin reaction|skin reaction
5528077|NCT01175746|healthy adult patients|healthy adult patients
5528078|NCT01175746|ASA class I|asa class i
5528079|NCT01175746|hypotensive anesthesia|hypotensive anesthesia
5528080|NCT01175733|Panitumumab|panitumumab
5528081|NCT01175733|Chemoradiation|chemoradiation
5528082|NCT01175733|Pancreatic cancer|pancreatic cancer
5528083|NCT01175733|Locally advanced|locally advanced
5528084|NCT01175733|Inoperable|inoperable
5528085|NCT01175720|gingival recession|gingival recession
5528086|NCT01175720|acellular dermal matrix graft|acellular dermal matrix graft
5528087|NCT01175720|root coverage|root coverage
5528088|NCT01175694|Brachytherapy|brachytherapy
5528090|NCT01175694|dose modification|dose modification
5528091|NCT01175694|local recurrences|local recurrences
5528092|NCT01175694|side effects|side effects
5528093|NCT01175694|cosmetic result|cosmetic result
5528094|NCT01175681|rheumatic heart disease|rheumatic heart disease
5528095|NCT01175681|degenerated heart valve disease|degenerated heart valve disease
5528096|NCT01175681|heart valve prolapse|heart valve prolapse
5528097|NCT01175655|Mesenchymal stromal cells|mesenchymal stromal cells
5528098|NCT01175655|Bronchiolitis obliterans|bronchiolitis obliterans
5528099|NCT01175655|Lung transplant|lung transplant
5528100|NCT01175642|Schizophrenia|schizophrenia
5528101|NCT01175642|Psychosis|psychosis
5528102|NCT01175642|Schizoaffective Disorder|schizoaffective disorder
5528103|NCT01175629|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5528104|NCT01175629|Depression|depression
5528105|NCT01175629|Diabetes|diabetes
5528106|NCT01175629|Cardiovascular Disease|cardiovascular disease
5528107|NCT01175629|Depressive Disorder|depressive disorder
5528108|NCT01175629|Behavioral Symptoms|behavioral symptoms
5528109|NCT01175629|Metabolic Diseases|metabolic diseases
5528110|NCT01175629|Mental Disorders|mental disorders
5528111|NCT01175629|Anxiety Disorders|anxiety disorders
5528112|NCT01175616|Depression|depression
5528113|NCT01175616|Adults|adults
5528114|NCT01175603|depression, African American, home visiting, prevention|depression, african american, home visiting, prevention
5528115|NCT01175577|mixed carotenes|mixed carotenes
5528116|NCT01175564|TC-5214|tc-5214
5528117|NCT01175564|safety|safety
5528118|NCT01175564|pharmacokinetics|pharmacokinetics
5528119|NCT01175564|single dose|single dose
5528120|NCT01175564|repeated dose|repeated dose
5528121|NCT01175564|Japanese|japanese
5528122|NCT01175564|healthy subjects|healthy subjects
5528123|NCT01175551|Preterm Birth|preterm birth
5528124|NCT01175551|Cervix|cervix
5528125|NCT01175551|Cervical Shortening|cervical shortening
5528126|NCT01175551|Cervical remodeling|cervical remodeling
5528127|NCT01175551|PTB|ptb
5528128|NCT01175538|Hepatic encephalopathy|hepatic encephalopathy
5528129|NCT01175538|Lactulose|lactulose
5528130|NCT01175499|laryngoscopy|laryngoscopy
5528131|NCT01175499|Laryngoscopic Surgery|laryngoscopic surgery
5528132|NCT01175499|laryngoscopes|laryngoscopes
5528133|NCT01175499|upper aerodigestive tract lesions|upper aerodigestive tract lesions
5528134|NCT01175499|endoscopy|endoscopy
5528135|NCT01175499|biopsy|biopsy
5528136|NCT01175486|thiazolidinediones|thiazolidinediones
5528137|NCT01175486|diabetes|diabetes
5528138|NCT01175486|retinopathy|retinopathy
5528139|NCT01175486|nephropathy|nephropathy
5528140|NCT01175460|esophageal Cancer|esophageal cancer
5528141|NCT01175460|radiation|radiation
5528142|NCT01175460|s-1|s-1
5528143|NCT01175460|nedaplatin|nedaplatin
5528144|NCT01175447|S-1|s-1
5528145|NCT01175447|radiation|radiation
5528146|NCT01175447|esophageal Cancer|esophageal cancer
5528147|NCT01175434|Asthma|asthma
5528148|NCT01175421|snoring|snoring
5528149|NCT01175421|sleep apnea|sleep apnea
5528150|NCT01175421|sleep study|sleep study
5528151|NCT01175421|cardiovascular outcomes|cardiovascular outcomes
5528152|NCT01175408|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
5528153|NCT01175408|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
5528154|NCT01175408|Self Monitoring Blood Glucose,|self monitoring blood glucose,
5528155|NCT01175408|Strip Counting,|strip counting,
5528156|NCT01175408|Type 2 Diabetes|type 2 diabetes
5528157|NCT01175395|Choroidal neovascular membranes|choroidal neovascular membranes
5528158|NCT01175395|CNV|cnv
5528159|NCT01175395|AMD|amd
5528160|NCT01175395|Age-relate Macular Degeneration|age-relate macular degeneration
5528161|NCT01175395|CNVM|cnvm
5528162|NCT01175395|subfoveal|subfoveal
5528163|NCT01175382|Male Urogenital Diseases|male urogenital diseases
5528164|NCT01175382|Urinary Bladder, overactive|urinary bladder, overactive
5528165|NCT01175382|Behavioral Medicine|behavioral medicine
5528166|NCT01175382|Drug Therapy|drug therapy
5528167|NCT01175369|Asthma|asthma
5528168|NCT01175330|Omega-3 fatty acid|omega-3 fatty acid
5528169|NCT01175330|Ischemic Heart Disease|ischemic heart disease
5528170|NCT01175330|Atrial Fibrillation|atrial fibrillation
5528171|NCT01175330|Subcutaneous cardiac monitoring|subcutaneous cardiac monitoring
5528172|NCT01175317|Hemodynamic optimization|hemodynamic optimization
5528173|NCT01175317|Enhanced recovery after surgery|enhanced recovery after surgery
5528174|NCT01175317|Goal-directed fluid|goal-directed fluid
5528176|NCT01175304|sleep apnea|sleep apnea
5528178|NCT01175304|sleep habits|sleep habits
5528179|NCT01175304|sleepiness|sleepiness
5528180|NCT01175291|colon|colon
5528181|NCT01175291|rectum|rectum
5528182|NCT01175291|colorectal|colorectal
5528183|NCT01175291|metastatic|metastatic
5528184|NCT01175291|adenocarcinoma|adenocarcinoma
5528185|NCT01175278|vertebral|vertebral
5528186|NCT01175278|compression|compression
5528188|NCT01175278|VCF|vcf
5528189|NCT01175278|kyphoplasty|kyphoplasty
5528190|NCT01175278|spine|spine
5528191|NCT01175265|clinically stable|clinically stable
5528192|NCT01175265|COPD (GOLD-classification I-IV)|copd (gold-classification i-iv)
5528193|NCT01175265|COPD|copd
5528194|NCT01175265|breathing retraining|breathing retraining
5528195|NCT01175265|pulmonary rehabilitation|pulmonary rehabilitation
5528196|NCT01175265|cardiac autonomic function|cardiac autonomic function
5528197|NCT01175265|quality of life|quality of life
5528198|NCT01175265|exercise capacity|exercise capacity
5528199|NCT01175265|pulmonary function|pulmonary function
5528200|NCT01175252|Gastroenteritis|gastroenteritis
5528201|NCT01175239|X-linked severe combined immunodeficiency, gene therapy|x-linked severe combined immunodeficiency, gene therapy
5528202|NCT01175239|Patients will be enrolled following diagnosis and referral to Great Ormond Street Immunology Service.|patients will be enrolled following diagnosis and referral to great ormond street immunology service.
5528203|NCT01175226|Human rhinovirus|human rhinovirus
5528204|NCT01175226|Aviragen Therapeutics, Inc.|aviragen therapeutics, inc.
5528205|NCT01175226|Aviragen Therapeutics|aviragen therapeutics
5528206|NCT01175226|Aviragen|aviragen
5528207|NCT01175187|evron|evron
5528208|NCT01175174|asthma|asthma
5528209|NCT01175174|preschool children|preschool children
5528210|NCT01175174|adenosine provocation test|adenosine provocation test
5528312|NCT01174810|Parkinson's Disease|parkinson's disease
5528211|NCT01175174|metacholine provocation test|metacholine provocation test
5528212|NCT01175174|pediatric emergency department|pediatric emergency department
5528213|NCT01175161|Postpartum Contraception|postpartum contraception
5528214|NCT01175161|Intrauterine device|intrauterine device
5528215|NCT01175161|feasibility|feasibility
5528216|NCT01175161|IUD|iud
5528217|NCT01175161|Immediate postpartum IUD|immediate postpartum iud
5528218|NCT01175148|HSCT|hsct
5528219|NCT01175148|HPC|hpc
5528220|NCT01175148|HCT|hct
5528221|NCT01175148|BMT|bmt
5528222|NCT01175148|lipitor|lipitor
5528223|NCT01175148|atorvastatin|atorvastatin
5528224|NCT01175148|HMG-CoA Reductase Inhibitor|hmg-coa reductase inhibitor
5528225|NCT01175148|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5528226|NCT01175148|allogeneic transplant|allogeneic transplant
5528227|NCT01175148|GVHD|gvhd
5528228|NCT01175148|graft-versus-host-disease|graft-versus-host-disease
5510188|NCT01252251|eye|eye
5528229|NCT01175148|Graft vs Host Disease|graft vs host disease
5528230|NCT01175135|schizophrenia|schizophrenia
5528231|NCT01175135|acute exacerbation|acute exacerbation
5528232|NCT01175135|inpatient|inpatient
5528233|NCT01175109|Chordoma|chordoma
5528234|NCT01175096|neuroendocrine tumors|neuroendocrine tumors
5528235|NCT01175096|carcinoid tumor|carcinoid tumor
5528236|NCT01175096|RAD001 (everolimus, Afinitor®)|rad001 (everolimus, afinitor®)
5528237|NCT01175083|Immunogenicity|immunogenicity
5528238|NCT01175083|Booster vaccination|booster vaccination
5528239|NCT01175083|Catch-up vaccination|catch-up vaccination
5528240|NCT01175083|Pneumococcal vaccine|pneumococcal vaccine
5528241|NCT01175083|Pneumococcal disease|pneumococcal disease
5528242|NCT01175083|Sickle cell disease|sickle cell disease
5528243|NCT01175083|Safety|safety
5528244|NCT01175070|diabetic macular oedema|diabetic macular oedema
5528245|NCT01175070|ischaemia|ischaemia
5528246|NCT01175070|anti VEGF|anti vegf
5528247|NCT01175070|pegaptanib|pegaptanib
5528248|NCT01175070|Ischaemic diabetic macular oedema|ischaemic diabetic macular oedema
5528249|NCT01175057|feasibility|feasibility
5528250|NCT01175057|compliance|compliance
5528251|NCT01175057|telemedical home monitoring|telemedical home monitoring
5528252|NCT01175057|post stationary rehabilitation|post stationary rehabilitation
5528253|NCT01175057|patients with myocardial infarction|patients with myocardial infarction
5528254|NCT01175044|Revision|revision
5528255|NCT01175044|Knee|knee
5528256|NCT01175044|Arthroplasty|arthroplasty
5528257|NCT01175044|Betadine|betadine
5528258|NCT01175044|Lavage|lavage
5528259|NCT01175044|Infection|infection
5528260|NCT01175018|Acute myocardial infarction|acute myocardial infarction
5528262|NCT01175018|Cardiac Remodeling|cardiac remodeling
5528263|NCT01175005|Fever|fever
5528264|NCT01175005|Central venous catheter|central venous catheter
5528265|NCT01175005|Procalcitonin|procalcitonin
5522358|NCT01199471|Chinese|chinese
5528266|NCT01175005|Fever with a central venous catheter|fever with a central venous catheter
5528267|NCT01174992|Fibrin sealant|fibrin sealant
5528268|NCT01174992|CSF leak|csf leak
5528269|NCT01174979|Morbus Meniere|morbus meniere
5528270|NCT01174979|Sudden hearing loss|sudden hearing loss
5528271|NCT01174979|Blast injury|blast injury
5528272|NCT01174979|Presbyacusis|presbyacusis
5528273|NCT01174979|Chron. Otitis Media|chron. otitis media
5530940|NCT01164124|growth|growth
5528275|NCT01174966|shock|shock
5528276|NCT01174966|mortality|mortality
5528277|NCT01174966|Oxygen Delivery Index|oxygen delivery index
5528278|NCT01174966|cardiac output index|cardiac output index
5528279|NCT01174953|prostate cancer|prostate cancer
5528280|NCT01174940|myelogenous leukemia|myelogenous leukemia
5528281|NCT01174940|lymphocytic leukemia|lymphocytic leukemia
5514552|NCT01233180|neck pain|neck pain
5528282|NCT01174940|lymphoblastic leukemia|lymphoblastic leukemia
5528283|NCT01174940|myelodysplastic syndrome|myelodysplastic syndrome
5528284|NCT01174940|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5528285|NCT01174940|Hodgkin's disease|hodgkin's disease
5528286|NCT01174927|Substance use disorder|substance use disorder
5528287|NCT01174927|Stress|stress
5528288|NCT01174901|cephalalgia|cephalalgia
5528289|NCT01174901|copeptins|copeptins
5528290|NCT01174901|biomarkers|biomarkers
5528291|NCT01174901|headache|headache
5528292|NCT01174901|C-terminal provasopression|c-terminal provasopression
5528293|NCT01174901|physiological stress response|physiological stress response
5528294|NCT01174888|Acute Myeloid Leukemia|acute myeloid leukemia
5528296|NCT01174875|Epigenetics|epigenetics
5528297|NCT01174875|Development|development
5528298|NCT01174875|Metabolic|metabolic
5528299|NCT01174875|Neurodevelopment|neurodevelopment
5528300|NCT01174862|aspirin|aspirin
5528301|NCT01174862|aspirin responsiveness|aspirin responsiveness
5528302|NCT01174862|long-term outcome|long-term outcome
5528303|NCT01174862|CABG|cabg
5528304|NCT01174849|otitis media|otitis media
5528305|NCT01174849|pneumococcal vaccines|pneumococcal vaccines
5528306|NCT01174849|randomised controlled trial|randomised controlled trial
5528307|NCT01174849|high-risk children|high-risk children
5528308|NCT01174849|indigenous|indigenous
5528309|NCT01174849|Australia|australia
5528310|NCT01174836|CT utilization|ct utilization
5528311|NCT01174836|physician attitudes|physician attitudes
5528314|NCT01174810|Moderate Parkinson's Disease|moderate parkinson's disease
5528315|NCT01174784|Chronic Total Occlusions|chronic total occlusions
5528316|NCT01174784|Superficial Femoral Artery|superficial femoral artery
5528317|NCT01174784|Popliteal Artery|popliteal artery
5689935|NCT00538590|ologen|ologen
5528318|NCT01174771|Transcranial magnetic stimulation|transcranial magnetic stimulation
5528319|NCT01174771|Cortical excitability|cortical excitability
5528320|NCT01174771|parkinsonism|parkinsonism
5528321|NCT01174771|Progressive Supranuclear Palsy|progressive supranuclear palsy
5528322|NCT01174771|Corticobasal Degeneration|corticobasal degeneration
5528323|NCT01174771|PSP|psp
5528324|NCT01174771|CBD|cbd
5528325|NCT01174771|CBGD|cbgd
5528326|NCT01174758|balance|balance
5528327|NCT01174758|mobility|mobility
5528328|NCT01174758|ON/OFF Levodopa|on/off levodopa
5528329|NCT01174732|asthma|asthma
5528330|NCT01174732|bronchospasm|bronchospasm
5528331|NCT01174732|COPD|copd
5528332|NCT01174732|chronic respiratory disease|chronic respiratory disease
5528333|NCT01174719|Hydroxyethylstarch|hydroxyethylstarch
5528334|NCT01174719|Humanalbumin|humanalbumin
5528335|NCT01174719|Ringer Lactate|ringer lactate
5528336|NCT01174719|patients undergoing cardiac surgery|patients undergoing cardiac surgery
5528337|NCT01174706|infections|infections
5528338|NCT01174706|flu|flu
5528339|NCT01174706|abdominal pain|abdominal pain
5528340|NCT01174706|chest pain|chest pain
5528341|NCT01174706|cold|cold
5528342|NCT01174706|fever|fever
5528343|NCT01174706|different acute care conditions|different acute care conditions
5528344|NCT01174693|prospective|prospective
5528345|NCT01174693|randomized|randomized
5528346|NCT01174693|open label|open label
5528347|NCT01174693|multi-center|multi-center
5528348|NCT01174693|double-blind for CYP2C19 genotypes|double-blind for cyp2c19 genotypes
5528349|NCT01174680|cardiogoniometry|cardiogoniometry
5528350|NCT01174680|stable angina pectoris patients|stable angina pectoris patients
5528351|NCT01174667|Myofascial pain|myofascial pain
5528352|NCT01174667|Trigger points|trigger points
5528353|NCT01174641|unilateral neglect|unilateral neglect
5528354|NCT01174641|TMS intervention|tms intervention
5528355|NCT01174628|Exercise Tolerance|exercise tolerance
5528356|NCT01174628|Venous Thrombosis|venous thrombosis
5528357|NCT01174628|Pulmonary Embolism|pulmonary embolism
5528358|NCT01174628|Quality of Life (QOL)|quality of life (qol)
5528359|NCT01174615|Blood/bone marrow collection, hematologic diseases, leukemia|blood/bone marrow collection, hematologic diseases, leukemia
5528360|NCT01174589|Lower limb strength training|lower limb strength training
5528361|NCT01174589|Randomized clinical trial|randomized clinical trial
5528362|NCT01174589|Patients with Hip fracture|patients with hip fracture
5528363|NCT01174589|6 vs. 12 weeks physical strength training|6 vs. 12 weeks physical strength training
5528364|NCT01174576|coffee|coffee
5528365|NCT01174576|appetite|appetite
5528366|NCT01174576|energy intake|energy intake
5528368|NCT01174576|cortisol|cortisol
5528369|NCT01174576|glucose|glucose
5528370|NCT01174576|randomized controlled trial|randomized controlled trial
5528371|NCT01174550|chest pain|chest pain
5531000|NCT01163903|Pantoprazole|pantoprazole
5528372|NCT01174550|coronary artery disease|coronary artery disease
5528373|NCT01174550|CAD|cad
5528374|NCT01174537|NDV|ndv
5528375|NCT01174537|Metastatic|metastatic
5528376|NCT01174537|Refractory|refractory
5528377|NCT01174537|Cancer|cancer
5528378|NCT01174537|Progression-free|progression-free
5528379|NCT01174537|survival|survival
5528380|NCT01174537|recurrent|recurrent
5528381|NCT01174524|Quality of life|quality of life
5528382|NCT01174524|Menopause|menopause
5528383|NCT01174524|Contraception|contraception
5528384|NCT01174511|ATOPIC DERMATITIS|atopic dermatitis
5528385|NCT01174511|A-1 COOL CREAM|a-1 cool cream
5528386|NCT01174498|discomfort|discomfort
5528387|NCT01174498|distress|distress
5528388|NCT01174498|hurt|hurt
5528389|NCT01174498|sting|sting
5528390|NCT01174485|Liposuction|liposuction
5528391|NCT01174485|exercise|exercise
5528392|NCT01174485|metabolism|metabolism
5528393|NCT01174485|adiposity|adiposity
5528394|NCT01174472|Dialysis access|dialysis access
5528395|NCT01174472|angioplasty|angioplasty
5528396|NCT01174472|drug eluting balloon|drug eluting balloon
5528397|NCT01174433|Bifurcation coronary artery disease|bifurcation coronary artery disease
5528398|NCT01174433|Percutaneous coronary intervention|percutaneous coronary intervention
5528399|NCT01174433|Tryton Stent|tryton stent
5528400|NCT01174420|ologen|ologen
5528401|NCT01174420|Mitomycin-C|mitomycin-c
5528402|NCT01174420|Collagen Matrix|collagen matrix
5528403|NCT01174420|trabeculectomy|trabeculectomy
5528404|NCT01174420|glaucoma|glaucoma
5528405|NCT01174420|filtering surgery|filtering surgery
5528406|NCT01174394|Acupuncture|acupuncture
5528407|NCT01174394|Post Stroke Depression|post stroke depression
5528408|NCT01174394|Depressive Disorder|depressive disorder
5528409|NCT01174394|Cardiovascular Accident|cardiovascular accident
5528410|NCT01174394|Stroke|stroke
5528411|NCT01174394|Apoplexy|apoplexy
5528413|NCT01174381|Non communicable disease|non communicable disease
5528414|NCT01174381|Lifestyle Modification|lifestyle modification
5528415|NCT01174381|Community Based organization|community based organization
5529280|NCT01171092|lymphoma|lymphoma
5528422|NCT01174316|Respiratory failure|respiratory failure
5528423|NCT01174316|Hypercapnia|hypercapnia
5904040|NCT00007813|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5528424|NCT01174316|Hypoventilation|hypoventilation
5528425|NCT01174316|Sleep|sleep
5528426|NCT01174316|Hypoxia|hypoxia
5528427|NCT01174316|Titration|titration
5528428|NCT01174316|Non Invasive Ventilation|non invasive ventilation
5528429|NCT01174290|subsyndromal delirium|subsyndromal delirium
5528430|NCT01174290|delirium|delirium
5528431|NCT01174290|haloperidol|haloperidol
5528432|NCT01174290|antipsychotic|antipsychotic
5528433|NCT01174290|randomized controlled trial|randomized controlled trial
5528434|NCT01174290|placebo-controlled|placebo-controlled
5528435|NCT01174290|intensive care unit|intensive care unit
5528436|NCT01174290|critical care|critical care
5528437|NCT01174290|subsyndromal delirium in the intensive care unit|subsyndromal delirium in the intensive care unit
5528438|NCT01174277|chronic graft versus host disease|chronic graft versus host disease
5528439|NCT01174277|transplant|transplant
5528440|NCT01174277|stem cell|stem cell
5528441|NCT01174251|general anesthesia|general anesthesia
5528442|NCT01174251|electrocardiography|electrocardiography
5528443|NCT01174251|long QT syndrome, acquired|long qt syndrome, acquired
5528444|NCT01174238|Melanoma|melanoma
5528445|NCT01174238|Axitinib|axitinib
5528446|NCT01174238|Carboplatin|carboplatin
5528447|NCT01174238|Paclitaxel|paclitaxel
5528448|NCT01174225|Copper IUD|copper iud
5528449|NCT01174225|Nova T 200|nova t 200
5528450|NCT01174225|Flexi T 380|flexi t 380
5528451|NCT01174225|expulsion|expulsion
5528452|NCT01174225|contraception satisfaction|contraception satisfaction
5528453|NCT01174225|post-abortion contraception|post-abortion contraception
5528454|NCT01174212|revision|revision
5528455|NCT01174212|infection|infection
5528456|NCT01174212|knee|knee
5528458|NCT01174212|replacement|replacement
5528459|NCT01174212|antibiotics|antibiotics
5528460|NCT01174173|Angina|angina
5528461|NCT01174173|Right Ventricular Ischemia|right ventricular ischemia
5528462|NCT01174173|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5528463|NCT01174173|Pulmonary Hypertension|pulmonary hypertension
5528464|NCT01174160|Atrial Fibrillation|atrial fibrillation
5528465|NCT01174121|Digestive Tract Cancers|digestive tract cancers
5528466|NCT01174121|Breast Cancer|breast cancer
5528467|NCT01174121|Glioblastoma|glioblastoma
5528468|NCT01174121|Ovarian/Endometrial Cancer|ovarian/endometrial cancer
5528469|NCT01174121|Genitourinary Cancer|genitourinary cancer
5528475|NCT01174095|Diffuse Coronary Artery Disease|diffuse coronary artery disease
5528476|NCT01174095|Ischemic Myocardium|ischemic myocardium
5528477|NCT01174095|Ischemia|ischemia
5528478|NCT01174082|Multiple Myeloma|multiple myeloma
5528480|NCT01174082|Lymphocyte Infusion|lymphocyte infusion
5528481|NCT01174069|NOTES|notes
5528482|NCT01174069|cholecystectomy|cholecystectomy
5528483|NCT01174069|endoscopic|endoscopic
5528484|NCT01174056|Lung inflammation|lung inflammation
5528485|NCT01174056|positron emission tomography|positron emission tomography
5528486|NCT01174056|fluorodeoxyglucose|fluorodeoxyglucose
5528487|NCT01174056|rosiglitazone|rosiglitazone
5528489|NCT01174056|lung anti-inflammatory therapy|lung anti-inflammatory therapy
5528490|NCT01174043|Leukemia, Myelomonocytic, Acute|leukemia, myelomonocytic, acute
5528491|NCT01174043|Erlotinib|erlotinib
5528492|NCT01174017|prostate cancer|prostate cancer
5528493|NCT01174017|Iodine 125 brachytherapy|iodine 125 brachytherapy
5528494|NCT01174017|seed migration|seed migration
5528495|NCT01174017|seed migration in the first month after brachytherapy|seed migration in the first month after brachytherapy
5528496|NCT01173991|carbohydrate counting|carbohydrate counting
5528497|NCT01173991|continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5528498|NCT01173991|type 1 diabetes mellitus|type 1 diabetes mellitus
5528499|NCT01173978|Incretin hormones|incretin hormones
5528500|NCT01173978|Glucagon|glucagon
5528501|NCT01173978|Insulin/c-peptide|insulin/c-peptide
5528502|NCT01173978|Plasma glucose|plasma glucose
5528503|NCT01173978|Insulin resistance|insulin resistance
5528504|NCT01173978|Deteriorated glucose homeostasis|deteriorated glucose homeostasis
5528505|NCT01173978|Inactivity|inactivity
5528506|NCT01173939|Hypercholesterolemia with concomitant type 2 diabetes and hypertension|hypercholesterolemia with concomitant type 2 diabetes and hypertension
5528507|NCT01173913|oral docetaxel|oral docetaxel
5528508|NCT01173913|ModraDoc|modradoc
5528509|NCT01173913|pharmacokinetics|pharmacokinetics
5528510|NCT01173913|safety|safety
5528513|NCT01173900|human papillomavirus|human papillomavirus
5528514|NCT01173900|vaccine|vaccine
5528515|NCT01173900|school girls|school girls
5528516|NCT01173900|Tanzania|tanzania
5528517|NCT01173900|acceptability|acceptability
5528518|NCT01173900|vaccine coverage|vaccine coverage
5528519|NCT01173900|Cervical cancer prevention|cervical cancer prevention
5528520|NCT01173874|Cognition|cognition
5528521|NCT01173874|Function|function
5528522|NCT01173874|Attention|attention
5528523|NCT01173874|Vigilance|vigilance
5528524|NCT01173874|Verbal Memory|verbal memory
5528525|NCT01173874|Visual Memory|visual memory
5528526|NCT01173874|Processing Speed|processing speed
5528527|NCT01173874|Problem Solving|problem solving
5528528|NCT01173874|Social Cognition|social cognition
5528530|NCT01173848|Vitamin D|vitamin d
5528531|NCT01173835|Adolescent tobacco use|adolescent tobacco use
5528532|NCT01173835|Tobacco Free and Win|tobacco free and win
5528533|NCT01173835|Incentive-based intervention|incentive-based intervention
5528534|NCT01173835|Contingency Management|contingency management
5528535|NCT01173835|Smoking Prevention|smoking prevention
5528536|NCT01173835|Smoking cessation|smoking cessation
5528537|NCT01173822|cardiopulmonary bypass|cardiopulmonary bypass
5528538|NCT01173822|hemorrhage|hemorrhage
5528539|NCT01173822|trials|trials
5528540|NCT01173822|surgery|surgery
5528541|NCT01173809|AF|af
5528542|NCT01173809|Catheter Ablation|catheter ablation
5528543|NCT01173809|Recurrence of AF|recurrence of af
5528544|NCT01173809|Amiodarone|amiodarone
5528545|NCT01173783|Heart failure|heart failure
5528546|NCT01173783|Cardiac insufficiency|cardiac insufficiency
5528547|NCT01173783|Implantable Cardioverter/Defibrillator|implantable cardioverter/defibrillator
5528548|NCT01173783|Cardiac Resynchronization therapy|cardiac resynchronization therapy
5528549|NCT01173783|ICD|icd
5528550|NCT01173783|CRT|crt
5528551|NCT01173783|Register|register
5528552|NCT01173757|Healthy Volunteers|healthy volunteers
5528553|NCT01173744|Intertrochanteric femoral fractures - unstable|intertrochanteric femoral fractures - unstable
5528554|NCT01173731|Parkinson Disease|parkinson disease
5528555|NCT01173731|L-dopa|l-dopa
5528556|NCT01173731|Levodopa|levodopa
5528557|NCT01173731|Dyskinesia|dyskinesia
5528558|NCT01173731|involuntary movement|involuntary movement
5528559|NCT01173731|motor complication|motor complication
5528560|NCT01173718|Hemodialysis|hemodialysis
5528561|NCT01173718|Vascular Graft|vascular graft
5528562|NCT01173705|Obesity|obesity
5528563|NCT01173705|Insulin Resistance|insulin resistance
5528564|NCT01173705|Inflammation|inflammation
5528565|NCT01173692|Oropharynx Cancer|oropharynx cancer
5528566|NCT01173692|Radiation Therapy|radiation therapy
5528567|NCT01173692|XRT|xrt
5528568|NCT01173692|Radiotherapy|radiotherapy
5528569|NCT01173692|Minocycline|minocycline
5528570|NCT01173692|Symptoms|symptoms
5528571|NCT01173692|Head and Neck|head and neck
5528572|NCT01173679|CLL|cll
5528573|NCT01173679|fludarabine|fludarabine
5528574|NCT01173679|rituximab|rituximab
5528575|NCT01173679|dasatinib|dasatinib
5528576|NCT01173679|refractory|refractory
5528577|NCT01173679|relapsed|relapsed
5528578|NCT01173666|RAS|ras
5528579|NCT01173666|LVMI|lvmi
5528580|NCT01173666|Renal revascularization|renal revascularization
5528581|NCT01173653|smoking|smoking
5528582|NCT01173653|smoking cessation|smoking cessation
5522665|NCT01198054|AML|aml
5528583|NCT01173653|health behavior|health behavior
5528584|NCT01173640|drug interactions|drug interactions
5528585|NCT01173640|midazolam|midazolam
5528586|NCT01173640|cytochrome P450|cytochrome p450
5528587|NCT01173640|resveratrol|resveratrol
5528588|NCT01173640|pharmacokinetics|pharmacokinetics
5528589|NCT01173627|Bioequivalence|bioequivalence
5528590|NCT01173627|Fentanyl|fentanyl
5528591|NCT01173588|bowel function|bowel function
5528592|NCT01173588|functional foods|functional foods
5528593|NCT01173562|Healthy volunteers|healthy volunteers
5528594|NCT01173562|Parasitic Diseases|parasitic diseases
5528595|NCT01173562|Mebendazole (VERMOX)|mebendazole (vermox)
5528596|NCT01173562|Anthelmintics|anthelmintics
5528597|NCT01173562|Antiparasitic Agents|antiparasitic agents
5528598|NCT01173562|Soil-transmitted helminth (STH) infections|soil-transmitted helminth (sth) infections
5528599|NCT01173562|Pediatric|pediatric
5528600|NCT01173549|Canagliflozin|canagliflozin
5528601|NCT01173549|Pharmacodynamic|pharmacodynamic
5528602|NCT01173549|Glucose absorption|glucose absorption
5528603|NCT01173549|Glucose metabolism|glucose metabolism
5528604|NCT01173523|Hsp90 Inhibitor|hsp90 inhibitor
5528605|NCT01173523|relapsed|relapsed
5528606|NCT01173523|refractory|refractory
5528608|NCT01173510|AIDS|aids
5528609|NCT01173510|Atripla|atripla
5528610|NCT01173510|Truvada|truvada
5528611|NCT01173510|Raltegravir|raltegravir
5528612|NCT01173510|Human Immunodeficiency Virus|human immunodeficiency virus
5528613|NCT01173510|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5528614|NCT01173497|Triple negative breast cancer|triple negative breast cancer
5528615|NCT01173497|Brain metastasis|brain metastasis
5528616|NCT01173497|BSI-201|bsi-201
5528617|NCT01173497|iniparib|iniparib
5528618|NCT01173484|Idiopathic gastroparesis|idiopathic gastroparesis
5528619|NCT01173484|Vomiting|vomiting
5528620|NCT01173484|Dyspepsia|dyspepsia
5528621|NCT01173484|GERD|gerd
5528622|NCT01173471|Raised intraocular pressure|raised intraocular pressure
5528623|NCT01173458|cancer|cancer
5528624|NCT01173458|lung|lung
5528625|NCT01173458|small cell|small cell
5528626|NCT01173445|cancer|cancer
5528627|NCT01173445|kidney|kidney
5528628|NCT01173445|renal cell|renal cell
5528629|NCT01173445|tumor cells|tumor cells
5528630|NCT01173445|circulating tumor cells|circulating tumor cells
5528631|NCT01173445|circulating endothelial cells|circulating endothelial cells
5528632|NCT01173432|obstructive sleep apnea|obstructive sleep apnea
5528633|NCT01173432|metabolic dysfunction|metabolic dysfunction
5528634|NCT01173432|metabolic syndrome|metabolic syndrome
5528635|NCT01173432|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
5528636|NCT01173419|Great Saphenous Vein|great saphenous vein
5528637|NCT01173406|Continuous Positive Airway Pressure treatment|continuous positive airway pressure treatment
5528639|NCT01173406|Education|education
5528640|NCT01173393|out of hospital cardiac arrest|out of hospital cardiac arrest
5528641|NCT01173393|OHCA|ohca
5528642|NCT01173393|EMS|ems
5528643|NCT01173393|Emergency medical System|emergency medical system
5528644|NCT01173393|non-VF|non-vf
5528645|NCT01173393|non-ventricular fibrillation|non-ventricular fibrillation
5528646|NCT01173380|Soy|soy
5528647|NCT01173380|Equol|equol
5528648|NCT01173380|Metabolic syndrome|metabolic syndrome
5528649|NCT01173380|Endothelial function|endothelial function
5528650|NCT01173367|Fever|fever
5528651|NCT01173367|ICU|icu
5528652|NCT01173367|Acetaminophen|acetaminophen
5528653|NCT01173367|Inflammatory mediators|inflammatory mediators
5528654|NCT01173367|Safety|safety
5528655|NCT01173354|COPD|copd
5528656|NCT01173354|Protein metabolism|protein metabolism
5528657|NCT01173354|Essential amino acid intake|essential amino acid intake
5528658|NCT01173341|Chemotherapy-induced cardiotoxicity|chemotherapy-induced cardiotoxicity
5528659|NCT01173341|Anthracycline|anthracycline
5528660|NCT01173341|Trastuzumab|trastuzumab
5528661|NCT01173328|exercise tolerance|exercise tolerance
5528662|NCT01173328|dynamic hyperinflation|dynamic hyperinflation
5528663|NCT01173328|respiratory mechanics|respiratory mechanics
5528664|NCT01173315|Type 2 diabetes|type 2 diabetes
5528665|NCT01173315|micronutrients|micronutrients
5528666|NCT01173315|nephropathy|nephropathy
5528667|NCT01173315|neuropathy|neuropathy
5528668|NCT01173302|Rabies|rabies
5528669|NCT01173302|Anti-rabies antibody|anti-rabies antibody
5528670|NCT01173302|Persistence|persistence
5528671|NCT01173289|Thyroid Carcinoma|thyroid carcinoma
5528672|NCT01173289|External Beam Radiotherapy|external beam radiotherapy
5528673|NCT01173276|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5528674|NCT01173276|Assisted Reproductive Technology|assisted reproductive technology
5528675|NCT01173276|Fertility|fertility
5528676|NCT01173276|HIV|hiv
5528677|NCT01173276|HIV Discordant|hiv discordant
5528678|NCT01173276|Infertility|infertility
5528679|NCT01173276|Intrauterine Insemination|intrauterine insemination
5528680|NCT01173276|Sexually Transmitted Diseases|sexually transmitted diseases
5528681|NCT01173276|Sperm Washing|sperm washing
5528682|NCT01173263|breathing machine|breathing machine
5528683|NCT01173263|mechanical ventilator|mechanical ventilator
5789054|NCT00150111|ophthalmopathy|ophthalmopathy
5528684|NCT01173250|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy|total proctocolectomy with ileal pouch anal anastomosis with and without ileostomy
5528685|NCT01173237|tracheal intubation|tracheal intubation
5528686|NCT01173237|proseal laryngeal mask airway|proseal laryngeal mask airway
5528688|NCT01173237|surfactant|surfactant
5528689|NCT01173237|respiratory distress syndrome|respiratory distress syndrome
5528690|NCT01173224|influenza, DAS181, antiviral|influenza, das181, antiviral
5528691|NCT01173211|pregnant, women, influenza, vaccine|pregnant, women, influenza, vaccine
5528692|NCT01173198|LOW TO MODERATE MYOPIC PATIENTS|low to moderate myopic patients
5514957|NCT01231360|PAD|pad
5528693|NCT01173172|Boron neutron capture therapy (BNCT)|boron neutron capture therapy (bnct)
5528694|NCT01173172|Head and neck cancer|head and neck cancer
5528695|NCT01173172|toxicities|toxicities
5528696|NCT01173172|response rate|response rate
5528697|NCT01173159|Parenteral Nutrition|parenteral nutrition
5528698|NCT01173159|Cholestasis|cholestasis
5528699|NCT01173146|Primary prostate cancer undergoing prostatectomy|primary prostate cancer undergoing prostatectomy
5528700|NCT01173133|Free Flap|free flap
5528701|NCT01173133|Surgery|surgery
5528702|NCT01173133|Ischemia|ischemia
5528703|NCT01173133|Outcome|outcome
5528704|NCT01173133|Reconstructive Plastic Surgery|reconstructive plastic surgery
5528705|NCT01173133|Monitoring|monitoring
5528706|NCT01173094|Critical limb ischemia|critical limb ischemia
5528707|NCT01173094|Diabetes Mellitus|diabetes mellitus
5528708|NCT01173094|Diabetes foot|diabetes foot
5528709|NCT01173081|Jones fracture|jones fracture
5528710|NCT01173081|fifth metatarsal fracture|fifth metatarsal fracture
5528711|NCT01173081|teriparatide|teriparatide
5528712|NCT01173081|fracture healing|fracture healing
5528713|NCT01173068|Ertapenem|ertapenem
5528714|NCT01173068|Clinical outcome|clinical outcome
5528715|NCT01173068|Complicated Urinary Tract Infections|complicated urinary tract infections
5528716|NCT01173042|Overweight|overweight
5528717|NCT01173042|Obese|obese
5528718|NCT01173029|Systemic arterial hypertension|systemic arterial hypertension
5528719|NCT01173029|Hypertension Resistant to Conventional Therapy|hypertension resistant to conventional therapy
5528720|NCT01173029|Genetic polymorphisms|genetic polymorphisms
5528721|NCT01173029|Renin-angiotensin-aldosterone system genetic polymorphism|renin-angiotensin-aldosterone system genetic polymorphism
5528722|NCT01173029|Risk markers|risk markers
5528723|NCT01173029|Adverse events|adverse events
5528724|NCT01173029|Acute myocardial infarction|acute myocardial infarction
5528725|NCT01173029|Stroke|stroke
5528726|NCT01173016|mucopolysaccharide IH (MPS IH)|mucopolysaccharide ih (mps ih)
5528727|NCT01173003|Medical abortion|medical abortion
5528728|NCT01173003|mifepristone|mifepristone
5528729|NCT01173003|misoprostol|misoprostol
5528730|NCT01173003|Tunisia|tunisia
5528731|NCT01172990|ST Depression|st depression
5528732|NCT01172977|Diabetes mellitus|diabetes mellitus
5528733|NCT01172977|Stroke|stroke
5528734|NCT01172964|Los Angeles|los angeles
5528735|NCT01172951|Post-prandial|post-prandial
5528736|NCT01172951|Nutrigenomic|nutrigenomic
5528737|NCT01172951|Test meal|test meal
5528738|NCT01172951|Oral glucose tolerance test|oral glucose tolerance test
5528739|NCT01172951|Oral lipid tolerance test|oral lipid tolerance test
5528740|NCT01172938|Psoriatic Arthritis|psoriatic arthritis
5528741|NCT01172938|Psoriasis|psoriasis
5528742|NCT01172938|Arthritis|arthritis
5528743|NCT01172938|inflammation|inflammation
5528744|NCT01172938|skin condition|skin condition
5528745|NCT01172938|inflammatory cells|inflammatory cells
5528746|NCT01172938|apremilast|apremilast
5528747|NCT01172938|CC-10004|cc-10004
5528748|NCT01172938|phosphodiesterase type 4|phosphodiesterase type 4
5528749|NCT01172925|NSCLC|nsclc
5528750|NCT01172925|dyspnea|dyspnea
5528751|NCT01172925|phase II|phase ii
5528752|NCT01172925|crossover|crossover
5528753|NCT01172925|tiotropium|tiotropium
5528754|NCT01172912|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5528755|NCT01172912|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5528756|NCT01172912|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5528757|NCT01172912|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5528758|NCT01172912|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5528759|NCT01172912|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5528760|NCT01172912|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5528761|NCT01172912|testicular mature teratoma|testicular mature teratoma
5528762|NCT01172912|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5528763|NCT01172912|testicular immature teratoma|testicular immature teratoma
5528764|NCT01172899|Bariatric Surgery|bariatric surgery
5528765|NCT01172899|Adolescent|adolescent
5528766|NCT01172886|Metabolic Syndrome obesity visceral adiposity breast cancer|metabolic syndrome obesity visceral adiposity breast cancer
5528767|NCT01172873|OCD|ocd
5528768|NCT01172873|DCS|dcs
5528769|NCT01172873|D-cycloserine|d-cycloserine
5528770|NCT01172873|CBT|cbt
5528771|NCT01172873|E/RP|e/rp
5528772|NCT01172873|exposure response prevention|exposure response prevention
5528773|NCT01172860|Inoperable|inoperable
5528775|NCT01172860|Endoscopic|endoscopic
5528776|NCT01172860|Electroporation|electroporation
5528777|NCT01172860|Outpatient|outpatient
5528778|NCT01172834|Nurses|nurses
5528779|NCT01172795|Whiplash associated disorder|whiplash associated disorder
5528780|NCT01172795|chronic pain|chronic pain
5528781|NCT01172795|neural inhibition|neural inhibition
5528782|NCT01172795|neuropsychological tests|neuropsychological tests
5528783|NCT01172769|HNSCC|hnscc
5528784|NCT01172756|Pulmonary Hypertension|pulmonary hypertension
5515062|NCT01230840|fiber|fiber
5528785|NCT01172756|Left ventricular dysfunction|left ventricular dysfunction
5528786|NCT01172743|Diabetes Mellitus|diabetes mellitus
5528787|NCT01172743|Diabetes|diabetes
5528788|NCT01172743|Type-2|type-2
5528789|NCT01172743|Adult Onset|adult onset
5528790|NCT01172730|Post operative pain|post operative pain
5528791|NCT01172730|thoracic epidural|thoracic epidural
5528792|NCT01172730|acute pain|acute pain
5528793|NCT01172730|Ultrasound scanning of the thoracic spine|ultrasound scanning of the thoracic spine
5528794|NCT01172717|Carcinoid|carcinoid
5528795|NCT01172717|Carcinoid syndrome|carcinoid syndrome
5528796|NCT01172704|Motivational Interviewing|motivational interviewing
5528797|NCT01172704|Serious Mental Illness|serious mental illness
5528798|NCT01172704|HIV/AIDS|hiv/aids
5528799|NCT01172704|HIV Testing|hiv testing
5528800|NCT01172691|Liver transplant|liver transplant
5528801|NCT01172665|Celiac Disease|celiac disease
5528802|NCT01172652|Bipolar disorder|bipolar disorder
5528803|NCT01172652|Anxiety|anxiety
5528804|NCT01172652|Panic|panic
5528805|NCT01172652|GAD|gad
5528806|NCT01172652|Generalized Anxiety Disorder|generalized anxiety disorder
5528807|NCT01172639|CoBRA|cobra
5528808|NCT01172626|epilepsy|epilepsy
5528809|NCT01172626|valproate sodium|valproate sodium
5528810|NCT01172626|metabolic enzymes|metabolic enzymes
5528811|NCT01172626|adverse effects|adverse effects
5528812|NCT01172626|systemic adverse effects|systemic adverse effects
5528813|NCT01172613|allergic rhinitis|allergic rhinitis
5528814|NCT01172613|concentration of diagnostic reagent|concentration of diagnostic reagent
5528815|NCT01172613|allergen extract, house dust mites (Dp)|allergen extract, house dust mites (dp)
5528816|NCT01172613|skin prick test|skin prick test
5528817|NCT01172613|nasal allergen provocation test|nasal allergen provocation test
5528818|NCT01172600|radiating back pain|radiating back pain
5528820|NCT01172600|steroid|steroid
5528821|NCT01172600|recurrent low back pain|recurrent low back pain
5528822|NCT01172600|Lumbar Epidural Steroid Block with 3 injections|lumbar epidural steroid block with 3 injections
5528823|NCT01172587|Cognitive Behavioral Therapy|cognitive behavioral therapy
5528824|NCT01172587|Couples Treatment|couples treatment
5528825|NCT01172587|Alcohol Use|alcohol use
5528826|NCT01172587|Effects on Youth|effects on youth
5528827|NCT01172574|Osteoporosis|osteoporosis
5528828|NCT01172574|Pain|pain
5528829|NCT01172574|Kyphosis|kyphosis
5528830|NCT01172574|Posture|posture
5528831|NCT01172574|Exercise therapy|exercise therapy
5528832|NCT01172548|Resected GIST|resected gist
5528833|NCT01172548|primary GIST|primary gist
5528834|NCT01172548|tumor recurrence|tumor recurrence
5528835|NCT01172548|KIT receptor|kit receptor
5528836|NCT01172548|KIT positive|kit positive
5528837|NCT01172548|advanced GIST|advanced gist
5528838|NCT01172548|minimal toxicity|minimal toxicity
5528839|NCT01172548|GIST|gist
5528840|NCT01172535|Lopinavir/ritonavir|lopinavir/ritonavir
5528841|NCT01172535|Pediatric dosing|pediatric dosing
5528842|NCT01172535|World Health Organization|world health organization
5528843|NCT01172522|Under eye dark circles|under eye dark circles
5528844|NCT01172522|Under eye puffiness|under eye puffiness
5528845|NCT01172509|plasticity|plasticity
5528846|NCT01172509|excitatory|excitatory
5528847|NCT01172509|inhibitory|inhibitory
5528848|NCT01172509|synaptic plasticity|synaptic plasticity
5528849|NCT01172509|R-Baclofen|r-baclofen
5528850|NCT01172509|TMS|tms
5528851|NCT01172509|transcranial magnetic stimulation|transcranial magnetic stimulation
5528852|NCT01172509|biomarker|biomarker
5528853|NCT01172509|autism|autism
5528854|NCT01172483|primary care|primary care
5528855|NCT01172483|physical and aquatic exercises|physical and aquatic exercises
5528856|NCT01172483|promotion physical activity|promotion physical activity
5528857|NCT01172483|chronic disorders|chronic disorders
5528858|NCT01172470|Recurrent head and neck cancer|recurrent head and neck cancer
5528859|NCT01172470|larynx, lip, oral cavity and pharynx|larynx, lip, oral cavity and pharynx
5528860|NCT01172457|low back pain|low back pain
5528861|NCT01172457|failed back surgery syndrome (FBSS)|failed back surgery syndrome (fbss)
5528862|NCT01172457|epidural fibrosis|epidural fibrosis
5528863|NCT01172457|ozone therapy|ozone therapy
5528864|NCT01172457|oxygen therapy|oxygen therapy
5528865|NCT01172457|epiduroscopy|epiduroscopy
5528866|NCT01172457|spinal endoscopy|spinal endoscopy
5528867|NCT01172444|Mild to Moderate Ulcerative Proctitis|mild to moderate ulcerative proctitis
5528868|NCT01172431|hypertension|hypertension
5528869|NCT01172431|renal insufficiency|renal insufficiency
5528870|NCT01172431|indapamide|indapamide
5528871|NCT01172431|hydrochlorothiazide|hydrochlorothiazide
5528872|NCT01172418|adult|adult
5528873|NCT01172418|primary kidney transplant recipient|primary kidney transplant recipient
5528874|NCT01172405|Headache|headache
5528875|NCT01172405|Migraine|migraine
5528876|NCT01172405|Ibuprofen|ibuprofen
5528877|NCT01172405|Caffeine|caffeine
5528878|NCT01172366|Open label, single dose, pharmacokinetic study|open label, single dose, pharmacokinetic study
5528879|NCT01172353|contras-induced nephropathy|contras-induced nephropathy
5528881|NCT01172340|diet|diet
5528883|NCT01172314|NSCLC|nsclc
5528884|NCT01172314|Weight loss|weight loss
5528885|NCT01172314|protein metabolism|protein metabolism
5528886|NCT01172314|essential amino acid intake|essential amino acid intake
5528888|NCT01172301|protein metabolism|protein metabolism
5528889|NCT01172301|essential amino acid intake|essential amino acid intake
5528890|NCT01172288|Tic disorders,|tic disorders,
5528891|NCT01172288|Tourette syndrome|tourette syndrome
5528892|NCT01172288|Chronic Tic Disorders|chronic tic disorders
5528893|NCT01172275|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5528894|NCT01172275|OCD|ocd
5528895|NCT01172262|Tinnitus|tinnitus
5528896|NCT01172262|MRI|mri
5528897|NCT01172262|fMRI|fmri
5528898|NCT01172262|task based MRI|task based mri
5528899|NCT01172262|Otolaryngology|otolaryngology
5528900|NCT01172249|Osteoarthritis|osteoarthritis
5528901|NCT01172249|Knee|knee
5528902|NCT01172249|Glucosamine|glucosamine
5528903|NCT01172249|Chondroitin|chondroitin
5528904|NCT01172223|HER2-positive|her2-positive
5528905|NCT01172223|early breast cancer|early breast cancer
5528906|NCT01172197|local anesthetic|local anesthetic
5528907|NCT01172197|levobupivacaine|levobupivacaine
5528908|NCT01172197|ropivacaine|ropivacaine
5528909|NCT01172197|femoral perineural block|femoral perineural block
5529281|NCT01171092|BMT|bmt
5528910|NCT01172184|Left atrial distensibility|left atrial distensibility
5528911|NCT01172184|Left ventricular filling pressure|left ventricular filling pressure
5528912|NCT01172184|Severe mitral regurgitation|severe mitral regurgitation
5528913|NCT01172184|Prognosis|prognosis
5528914|NCT01172184|Post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation|post-operation (mitral valve replacement or valvuloplasty) atrial fibrillation
5528915|NCT01172171|Ischemia-reperfusion injury|ischemia-reperfusion injury
5528916|NCT01172171|Acute Myocardial Infarction|acute myocardial infarction
5528917|NCT01172171|Intracoronary melatonin|intracoronary melatonin
5528918|NCT01172158|forgotten ureteral stents, SMS Reminder|forgotten ureteral stents, sms reminder
5528919|NCT01172145|apathy|apathy
5528920|NCT01172145|Alzheimer's disease|alzheimer's disease
5528921|NCT01172145|activities of daily living performance|activities of daily living performance
5528922|NCT01172145|caregiver burden|caregiver burden
5528923|NCT01172132|Leukemia|leukemia
5528924|NCT01172132|Lymphoma|lymphoma
5528925|NCT01172132|Bone-Marrow Transplant|bone-marrow transplant
5528926|NCT01172132|Neutropenia|neutropenia
5528927|NCT01172132|Acute respiratory failure|acute respiratory failure
5528928|NCT01172132|Mechanical ventilation|mechanical ventilation
5528929|NCT01172132|Post ICU burden|post icu burden
5528930|NCT01172132|ICU triage|icu triage
5528931|NCT01172132|Dialysis|dialysis
5528932|NCT01172132|Septic shock|septic shock
5528933|NCT01172119|Coronary Disease, Coronary Stenosis, Angioplasty, Coronary restenosis, Drug Eluting Stent|coronary disease, coronary stenosis, angioplasty, coronary restenosis, drug eluting stent
5528934|NCT01172106|Postpartum psychosis|postpartum psychosis
5528935|NCT01172106|Perceived social support|perceived social support
5528936|NCT01172106|Family psychoeducation|family psychoeducation
5528937|NCT01172093|obstructive sleep apnea|obstructive sleep apnea
5528938|NCT01172093|prevalence|prevalence
5528939|NCT01172093|diabetes mellitus|diabetes mellitus
5528940|NCT01172093|Chinese|chinese
5528941|NCT01172080|colonoscopy|colonoscopy
5528942|NCT01172080|adherence|adherence
5528943|NCT01172080|reminders|reminders
5528944|NCT01172080|quality|quality
5528945|NCT01172067|CRT|crt
5528946|NCT01172067|heart failure|heart failure
5528947|NCT01172067|optimization|optimization
5528948|NCT01172067|Timing cycle optimization methods|timing cycle optimization methods
5528949|NCT01172054|influenza vaccine recombinant|influenza vaccine recombinant
5528950|NCT01172028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5528951|NCT01172028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5528952|NCT01172028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5528953|NCT01172028|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5528954|NCT01172028|male breast cancer|male breast cancer
5528955|NCT01172028|stage IIIA breast cancer|stage iiia breast cancer
5528956|NCT01172028|stage IIIB breast cancer|stage iiib breast cancer
5528957|NCT01172028|stage IIIC breast cancer|stage iiic breast cancer
5528958|NCT01172028|stage IV breast cancer|stage iv breast cancer
5528959|NCT01172028|recurrent breast cancer|recurrent breast cancer
5528960|NCT01172028|stage III prostate cancer|stage iii prostate cancer
5528961|NCT01172028|stage IV prostate cancer|stage iv prostate cancer
5528962|NCT01172028|recurrent prostate cancer|recurrent prostate cancer
5528963|NCT01172028|stage III esophageal cancer|stage iii esophageal cancer
5528964|NCT01172028|stage IV esophageal cancer|stage iv esophageal cancer
5528965|NCT01172028|recurrent esophageal cancer|recurrent esophageal cancer
5528966|NCT01172028|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5528967|NCT01172028|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5528968|NCT01172028|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5528973|NCT01172028|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5528974|NCT01172028|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5528975|NCT01172028|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5528976|NCT01172028|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5528977|NCT01172028|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5528978|NCT01172028|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5528979|NCT01172028|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5528980|NCT01172028|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5528981|NCT01172028|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5528982|NCT01172028|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5528983|NCT01172028|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5528984|NCT01172028|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671480|NCT00615888|fast track patient management|fast track patient management
5528985|NCT01172028|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5528986|NCT01172028|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5528987|NCT01172028|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5528988|NCT01172028|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5528989|NCT01172028|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5528990|NCT01172028|recurrent salivary gland cancer|recurrent salivary gland cancer
5528991|NCT01172028|stage III salivary gland cancer|stage iii salivary gland cancer
5528992|NCT01172028|stage IV salivary gland cancer|stage iv salivary gland cancer
5528993|NCT01172028|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5528994|NCT01172028|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5528995|NCT01172028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5528996|NCT01172028|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5528997|NCT01172028|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5528998|NCT01172028|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5528999|NCT01172028|stage III gastric cancer|stage iii gastric cancer
5529000|NCT01172028|stage IV gastric cancer|stage iv gastric cancer
5529001|NCT01172028|recurrent gastric cancer|recurrent gastric cancer
5529002|NCT01172028|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5529003|NCT01172028|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5529004|NCT01172028|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5529005|NCT01172028|recurrent laryngeal cancer|recurrent laryngeal cancer
5529006|NCT01172028|stage III laryngeal cancer|stage iii laryngeal cancer
5529007|NCT01172028|stage IV laryngeal cancer|stage iv laryngeal cancer
5529008|NCT01172002|Lupus Nephritis|lupus nephritis
5529009|NCT01172002|Leflunomide|leflunomide
5529010|NCT01172002|Azathioprine|azathioprine
5529011|NCT01171989|booster vaccination|booster vaccination
5529012|NCT01171989|combined vaccine|combined vaccine
5529013|NCT01171976|DME|dme
5529014|NCT01171976|Diabetic macula edema|diabetic macula edema
5529015|NCT01171976|RETAIN|retain
5529016|NCT01171976|ranibizumab|ranibizumab
5529017|NCT01171963|Liquid human retrovirus vaccine|liquid human retrovirus vaccine
5529018|NCT01171950|Thoratec Corporation|thoratec corporation
5529019|NCT01171937|ages 8-16|ages 8-16
5529020|NCT01171937|Repetitive Behaviors|repetitive behaviors
5529021|NCT01171924|Head and Neck Cancer|head and neck cancer
5529022|NCT01171924|Liver Cancer|liver cancer
5529023|NCT01171924|Breast Cancer|breast cancer
5529024|NCT01171924|Gastric Cancer|gastric cancer
5529025|NCT01171924|Non-Small Cell Lung Cancer|non-small cell lung cancer
5529026|NCT01171924|EGFR|egfr
5529027|NCT01171924|HDAC|hdac
5529028|NCT01171924|Her2|her2
5529029|NCT01171924|CUDC-101|cudc-101
5529030|NCT01171911|Endothelial shear stress|endothelial shear stress
5529031|NCT01171911|Calcium channel blocker|calcium channel blocker
5529032|NCT01171898|Non-Metastatic|non-metastatic
5529033|NCT01171898|Rising PSA|rising psa
5529034|NCT01171898|Castration-Resistant|castration-resistant
5529035|NCT01171898|Treatment-Naive|treatment-naive
5529036|NCT01171898|Post-abiraterone|post-abiraterone
5529037|NCT01171885|Superficial cervical block|superficial cervical block
5529038|NCT01171885|Thyroidectomy|thyroidectomy
5529040|NCT01171872|Inflammatory Bowel Disease|inflammatory bowel disease
5529041|NCT01171872|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5529042|NCT01171872|Crohn's Disease|crohn's disease
5529043|NCT01171872|Ulcerative Colitis|ulcerative colitis
5529044|NCT01171872|Indeterminate Colitis|indeterminate colitis
5529045|NCT01171872|IBD|ibd
5529046|NCT01171872|CD|cd
5529047|NCT01171872|UC|uc
5529048|NCT01171872|IC|ic
5529049|NCT01171859|amyloidosis|amyloidosis
5529050|NCT01171859|transthyretin|transthyretin
5529051|NCT01171859|doxycycline|doxycycline
5529052|NCT01171859|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
5529053|NCT01171846|prevention|prevention
5529054|NCT01171846|pelvic floor muscle training|pelvic floor muscle training
5529055|NCT01171846|prolapse symptoms|prolapse symptoms
5529056|NCT01171846|urinary symptoms|urinary symptoms
5529057|NCT01171846|sexual function|sexual function
5529058|NCT01171846|randomised controlled trial|randomised controlled trial
5529059|NCT01171833|Anesthetic induction|anesthetic induction
5529060|NCT01171833|Desflurane|desflurane
5529061|NCT01171833|Isoflurane|isoflurane
5529062|NCT01171833|Sevoflurane|sevoflurane
5529063|NCT01171833|Ventilation|ventilation
5529064|NCT01171820|drug eluting stents|drug eluting stents
5529065|NCT01171820|stents|stents
5529066|NCT01171820|Angioplasty|angioplasty
5529067|NCT01171820|coronary artery disease|coronary artery disease
5529068|NCT01171820|total coronary occlusion|total coronary occlusion
5529069|NCT01171820|coronary artery restenosis|coronary artery restenosis
5529070|NCT01171820|stent thrombosis|stent thrombosis
5529071|NCT01171820|vascular disease|vascular disease
5529073|NCT01171820|coronary artery stenosis|coronary artery stenosis
5529074|NCT01171807|Ulcerative colitis|ulcerative colitis
5529075|NCT01171807|Steroid-dependency|steroid-dependency
5529076|NCT01171807|Steroid adverse events|steroid adverse events
5529077|NCT01171807|Erythrocytes|erythrocytes
5529078|NCT01171768|Vascular endothelial growth factor|vascular endothelial growth factor
5529079|NCT01171768|angiopoietin-2|angiopoietin-2
5529080|NCT01171729|Prostate cancer|prostate cancer
5529081|NCT01171729|PSA|psa
5529082|NCT01171729|Hormone refractory prostatic cancer|hormone refractory prostatic cancer
5529083|NCT01171716|overweight, protein intake, satiety, eating, meal patterns|overweight, protein intake, satiety, eating, meal patterns
5529084|NCT01171703|Critical limb ischemia|critical limb ischemia
5529085|NCT01171703|Diabetes|diabetes
5529086|NCT01171703|Femoropopliteal artery bypass|femoropopliteal artery bypass
5529087|NCT01171703|Stent|stent
5529088|NCT01171690|Hypoparathyroidism|hypoparathyroidism
5529089|NCT01171677|addiction|addiction
5529090|NCT01171677|exercise|exercise
5529091|NCT01171677|cognitive function|cognitive function
5529092|NCT01171677|mood|mood
5529093|NCT01171677|self efficacy|self efficacy
5529094|NCT01171664|Phase 2|phase 2
5529095|NCT01171664|SAR|sar
5529096|NCT01171664|STAHIST|stahist
5529097|NCT01171651|Vaccinia|vaccinia
5529098|NCT01171651|Vaccinia Virus|vaccinia virus
5529099|NCT01171651|JX-594|jx-594
5529100|NCT01171651|Jennerex|jennerex
5529101|NCT01171651|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
5529102|NCT01171651|Primary Liver Cancer|primary liver cancer
5529103|NCT01171651|Liver Cancer|liver cancer
5529104|NCT01171651|Sorafenib|sorafenib
5529105|NCT01171651|Nexavar|nexavar
5529106|NCT01171651|Pexa-Vec|pexa-vec
5529107|NCT01171638|near infrared spectroscopy|near infrared spectroscopy
5529108|NCT01171638|compartment syndrome|compartment syndrome
5529109|NCT01171638|fasciotomy|fasciotomy
5529110|NCT01171638|INVOS|invos
5529111|NCT01171625|PERIMOUNT, Aortic valve replacement/regurgitation|perimount, aortic valve replacement/regurgitation
5529112|NCT01171612|Coronary Stent|coronary stent
5529113|NCT01171612|BMS stent|bms stent
5529114|NCT01171612|DES stent|des stent
5529115|NCT01171612|Date of stent implantation|date of stent implantation
5529116|NCT01171612|cardiac event|cardiac event
5529117|NCT01171612|neurovascular event|neurovascular event
5529118|NCT01171612|Bleeding|bleeding
5529119|NCT01171612|transfusion|transfusion
5529120|NCT01171599|Weight Loss|weight loss
5529121|NCT01171599|Obesity|obesity
5529122|NCT01171599|Overweight|overweight
5529123|NCT01171599|Physical Activity|physical activity
5529124|NCT01171599|Nutrition|nutrition
5529125|NCT01171599|Youth|youth
5529126|NCT01171599|Adolescent|adolescent
5672080|NCT00613054|ZD6474|zd6474
5529127|NCT01171599|Technology|technology
5529128|NCT01171586|Obesity|obesity
5529129|NCT01171586|overweight|overweight
5529130|NCT01171586|weight loss|weight loss
5529131|NCT01171586|weight maintenance|weight maintenance
5529132|NCT01171586|SMS|sms
5529133|NCT01171586|technology|technology
5529134|NCT01171586|cell phone|cell phone
5529135|NCT01171586|physical activity|physical activity
5529136|NCT01171586|nutrition|nutrition
5529137|NCT01171573|Polymyositis|polymyositis
5529138|NCT01171573|Dermatomyositis|dermatomyositis
5529139|NCT01171573|Inclusion Body Myositis|inclusion body myositis
5529140|NCT01171560|EZ Blocker|ez blocker
5529141|NCT01171560|Double-lumen Tube|double-lumen tube
5529142|NCT01171560|Airway|airway
5529143|NCT01171560|thoracic surgery|thoracic surgery
5529144|NCT01171560|time for intubation|time for intubation
5529145|NCT01171560|blind insertion|blind insertion
5529146|NCT01171560|conditions of surgery|conditions of surgery
5529147|NCT01171560|postoperative sore throat|postoperative sore throat
5529148|NCT01171560|postoperative hoarseness|postoperative hoarseness
5529149|NCT01171547|pharmacokinetics|pharmacokinetics
5529150|NCT01171508|Circadian Rhythm Disorders|circadian rhythm disorders
5529151|NCT01171508|Breast Neoplasms Surgery|breast neoplasms surgery
5529152|NCT01171508|Sleep|sleep
5529153|NCT01171508|Heart Rate|heart rate
5529154|NCT01171495|HIV/AIDS|hiv/aids
5529155|NCT01171495|Nutrition Therapy|nutrition therapy
5529156|NCT01171495|Dietary Supplement|dietary supplement
5529157|NCT01171495|Antioxidant|antioxidant
5529158|NCT01171495|Immunity|immunity
5529159|NCT01171495|CD4 count|cd4 count
5529160|NCT01171495|Anthropometry|anthropometry
5529161|NCT01171495|Body Mass Index|body mass index
5529162|NCT01171469|Brain tumor|brain tumor
5529163|NCT01171469|Immunotherapy|immunotherapy
5529164|NCT01171469|Glioma|glioma
5529165|NCT01171456|GDM|gdm
5529166|NCT01171456|Gestational Diabetes|gestational diabetes
5529167|NCT01171456|Diabetes|diabetes
5529168|NCT01171456|Pregnancy|pregnancy
5529169|NCT01171430|multiple myeloma|multiple myeloma
5529170|NCT01171430|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5529171|NCT01171417|Fulvestrant|fulvestrant
5529172|NCT01171417|Exemestane|exemestane
5529173|NCT01171417|postmenopausal patients|postmenopausal patients
5529174|NCT01171417|advanced HR+ breast cancer|advanced hr+ breast cancer
5529175|NCT01171417|Hormone Receptor positive|hormone receptor positive
5529279|NCT01171092|myeloma|myeloma
5529176|NCT01171417|advanced breast cancer|advanced breast cancer
5529177|NCT01171404|Acute coronary syndrome|acute coronary syndrome
5529178|NCT01171404|heart attack|heart attack
5529179|NCT01171404|myocardial infarction|myocardial infarction
5529180|NCT01171404|ACS long-tem follow up|acs long-tem follow up
5529181|NCT01171404|antithrombotic management|antithrombotic management
5529182|NCT01171404|quality of life|quality of life
5529183|NCT01171404|Antithrombotic|antithrombotic
5529184|NCT01171391|Nocturia|nocturia
5529185|NCT01171391|Pharmacokinetics|pharmacokinetics
5529186|NCT01171391|Pharmacodynamics|pharmacodynamics
5529187|NCT01171391|Water-loading|water-loading
5529188|NCT01171391|Females|females
5529189|NCT01171378|Richter's Syndrome|richter's syndrome
5529190|NCT01171378|High-grade transformation in patients with B cell chronic lymphocytic leukemia|high-grade transformation in patients with b cell chronic lymphocytic leukemia
5529191|NCT01171378|Feasibility|feasibility
5529192|NCT01171378|Ofatumumab Induction and maintenance|ofatumumab induction and maintenance
5529193|NCT01171378|CHOP|chop
5529194|NCT01171378|CHOP-0|chop-0
5529195|NCT01171378|CHOP-OR|chop-or
5529196|NCT01171378|Non Hodgkin's lymphoma|non hodgkin's lymphoma
5529197|NCT01171365|Ciclesonide|ciclesonide
5529198|NCT01171365|Asthma|asthma
5529199|NCT01171365|Therapeutic Uses|therapeutic uses
5529200|NCT01171365|Pulmonary Eosinophilia|pulmonary eosinophilia
5529201|NCT01171365|Nitric Oxide|nitric oxide
5529202|NCT01171365|Lung Diseases|lung diseases
5529203|NCT01171365|Respiratory Tract Diseases|respiratory tract diseases
5529204|NCT01171352|hemodialysis|hemodialysis
5529205|NCT01171352|dialysis|dialysis
5529206|NCT01171352|hypotension|hypotension
5529207|NCT01171352|CritLine|critline
5529208|NCT01171352|PiCCO|picco
5529209|NCT01171352|Thermodilution|thermodilution
5529210|NCT01171352|CVVHDF|cvvhdf
5529211|NCT01171352|IHD|ihd
5529212|NCT01171339|elderly|elderly
5529213|NCT01171339|multimorbidity|multimorbidity
5529214|NCT01171339|polypharmacy|polypharmacy
5529215|NCT01171339|multimedication|multimedication
5529216|NCT01171339|medication appropriateness|medication appropriateness
5529217|NCT01171339|medication appropriateness index|medication appropriateness index
5529218|NCT01171339|cluster-randomised controlled trial|cluster-randomised controlled trial
5529219|NCT01171339|pragmatic trial|pragmatic trial
5529220|NCT01171326|topical|topical
5529221|NCT01171326|minocycline|minocycline
5529222|NCT01171326|foam|foam
5529223|NCT01171326|phase II|phase ii
5529224|NCT01171326|impetigo|impetigo
5529225|NCT01171300|staged T3-4 N0 and T1-4N1-2|staged t3-4 n0 and t1-4n1-2
5529226|NCT01171300|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5529228|NCT01171287|Automobile Driving|automobile driving
5529229|NCT01171287|Fracture Fixation/instrumentation|fracture fixation/instrumentation
5529230|NCT01171287|Lower Extremity|lower extremity
5529231|NCT01171287|Orthopedic Fixation Devices|orthopedic fixation devices
5529232|NCT01171287|Orthopedic Procedures|orthopedic procedures
5529233|NCT01171287|Reaction Time|reaction time
5529234|NCT01171287|Task Performance and Analysis|task performance and analysis
5529235|NCT01171287|Time Factors|time factors
5529236|NCT01171274|neck pain|neck pain
5529237|NCT01171274|yoga|yoga
5529238|NCT01171274|proprioception|proprioception
5529239|NCT01171274|sensory thresholds|sensory thresholds
5529240|NCT01171274|randomized controlled trial|randomized controlled trial
5529241|NCT01171261|Physical Activity|physical activity
5529242|NCT01171261|Sedentary Behavior|sedentary behavior
5529244|NCT01171261|Exergames|exergames
5529245|NCT01171248|nocturnal blood pressure dip|nocturnal blood pressure dip
5529246|NCT01171248|complications|complications
5529247|NCT01171248|ambulatory blood pressure|ambulatory blood pressure
5529248|NCT01171235|Laryngeal Neoplasms|laryngeal neoplasms
5529249|NCT01171235|Pharyngeal Neoplasms|pharyngeal neoplasms
5529250|NCT01171222|soccer|soccer
5529251|NCT01171222|prevention|prevention
5529252|NCT01171222|veteran athletes|veteran athletes
5529253|NCT01171222|exercise|exercise
5529254|NCT01171222|Cardiovascular|cardiovascular
5529255|NCT01171209|MS|ms
5529256|NCT01171196|Sleep Apnea|sleep apnea
5529257|NCT01171196|Questionnaire|questionnaire
5529258|NCT01171183|cocaine dependence|cocaine dependence
5529259|NCT01171183|cocaine withdrawal|cocaine withdrawal
5529260|NCT01171170|non small cell lung cancer|non small cell lung cancer
5529261|NCT01171170|stage IV|stage iv
5529262|NCT01171170|nitroglycerin|nitroglycerin
5529263|NCT01171170|carboplatin|carboplatin
5529264|NCT01171170|paclitaxel|paclitaxel
5529265|NCT01171170|bevacizumab|bevacizumab
5529266|NCT01171157|Influenza-like illness|influenza-like illness
5529267|NCT01171157|vaccine effectiveness|vaccine effectiveness
5529268|NCT01171157|elderly|elderly
5529269|NCT01171157|Influenza|influenza
5529270|NCT01171131|TBI|tbi
5529271|NCT01171131|Brain Injury|brain injury
5529272|NCT01171118|Breathing|breathing
5529273|NCT01171118|Sedation|sedation
5529274|NCT01171105|AZD5213 Phase 1|azd5213 phase 1
5529275|NCT01171105|Safety|safety
5529276|NCT01171105|tolerability|tolerability
5529277|NCT01171092|stem cell|stem cell
5529278|NCT01171092|transplant|transplant
5529282|NCT01171092|autologous|autologous
5691207|NCT00533416|MDS|mds
5529283|NCT01171079|postoperative adhesion after thyroidectomy|postoperative adhesion after thyroidectomy
5529284|NCT01171053|Cognitive behavior therapy|cognitive behavior therapy
5529285|NCT01171053|Internet|internet
5529286|NCT01171053|Cost-effectiveness|cost-effectiveness
5529287|NCT01171053|Irritable bowel syndrome|irritable bowel syndrome
5529288|NCT01171040|left atrial distensibility|left atrial distensibility
5529289|NCT01171040|mortality|mortality
5529290|NCT01171040|heart failure|heart failure
5529291|NCT01171040|atrial fibrillation|atrial fibrillation
5529292|NCT01171040|stroke|stroke
5529293|NCT01171040|prognosis|prognosis
5529294|NCT01171027|Cholecystectomy|cholecystectomy
5529295|NCT01171027|NOTES|notes
5529296|NCT01171027|Transvaginal|transvaginal
5529297|NCT01171027|Transgastric|transgastric
5529298|NCT01171027|Natural orifice|natural orifice
5529299|NCT01171027|Gallbladder removal|gallbladder removal
5529300|NCT01170988|patients scheduled for bypass grafting|patients scheduled for bypass grafting
5529301|NCT01170975|Advanced solid tumors|advanced solid tumors
5529302|NCT01170949|urticaria|urticaria
5529303|NCT01170936|Urticarial vasculitis|urticarial vasculitis
5529304|NCT01170936|anti-IL1ß therapy|anti-il1ß therapy
5529305|NCT01170923|non small cell lung cancer|non small cell lung cancer
5529306|NCT01170923|FDG PET|fdg pet
5529307|NCT01170910|Chronic renal failure|chronic renal failure
5511320|NCT01247090|AVP|avp
5529308|NCT01170910|Transplantation|transplantation
5529309|NCT01170910|Marginal kidney graft|marginal kidney graft
5529310|NCT01170910|Pulsatile perfusion machine|pulsatile perfusion machine
5529311|NCT01170897|PEGPH20|pegph20
5529312|NCT01170897|PEGylated Recombinant Human Hyaluronidase|pegylated recombinant human hyaluronidase
5529313|NCT01170897|Metastatic or Locally Advanced Solid Tumors|metastatic or locally advanced solid tumors
5529314|NCT01170845|Esophagectomy|esophagectomy
5529315|NCT01170845|Postoperative respiratory complications|postoperative respiratory complications
5529316|NCT01170845|neutrophil elastase inhibitor|neutrophil elastase inhibitor
5529317|NCT01170819|Cervical ripening|cervical ripening
5529318|NCT01170819|Induction of labor|induction of labor
5529319|NCT01170819|Prostaglandins|prostaglandins
5529320|NCT01170819|Mechanical methods|mechanical methods
5529321|NCT01170819|Balloon catheter|balloon catheter
5529322|NCT01170806|Intestinal lipase|intestinal lipase
5529323|NCT01170806|Orlistat|orlistat
5529324|NCT01170806|fecal fat|fecal fat
5529325|NCT01170806|obesity|obesity
5529326|NCT01170793|education, quality of life|education, quality of life
5529327|NCT01170780|Inguinal hernia|inguinal hernia
5529328|NCT01170780|Transabdominal preperitoneal hernia repair|transabdominal preperitoneal hernia repair
5529329|NCT01170780|TAPP|tapp
5529330|NCT01170780|Dexamethasone|dexamethasone
5529331|NCT01170780|Pain|pain
5529332|NCT01170767|Age-related Macular Degeneration|age-related macular degeneration
5529333|NCT01170767|Bevacizumab|bevacizumab
5529334|NCT01170767|Ranibizumab|ranibizumab
5529335|NCT01170754|PEG-3350, polyethylene glycol, colonoscopy|peg-3350, polyethylene glycol, colonoscopy
5529336|NCT01170728|Male Sling|male sling
5529337|NCT01170728|Fixation|fixation
5529338|NCT01170728|Stress Urinary Incontinence|stress urinary incontinence
5529339|NCT01170728|Urinary incontinence|urinary incontinence
5529341|NCT01170715|Co morbidities|co morbidities
5529342|NCT01170715|Inflammation|inflammation
5529343|NCT01170702|Cesarean Delivery|cesarean delivery
5529344|NCT01170702|Ropivicaine|ropivicaine
5529345|NCT01170702|TAP block|tap block
5529352|NCT01170676|teens|teens
5529353|NCT01170663|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5529354|NCT01170663|Gastric Adenocarcinoma|gastric adenocarcinoma
5685539|NCT00555685|Heart Failure|heart failure
5529355|NCT01170663|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5529356|NCT01170650|cancer|cancer
5529357|NCT01170650|ovarian|ovarian
5529358|NCT01170650|platinum-resistant|platinum-resistant
5529359|NCT01170650|Phase III|phase iii
5529360|NCT01170650|EC145|ec145
5529361|NCT01170650|EC20|ec20
5529364|NCT01170624|CRT-D|crt-d
5529365|NCT01170624|The study will particularly focus on a new-based diagnostic feature, called PhD-Clinical Status (PhD)|the study will particularly focus on a new-based diagnostic feature, called phd-clinical status (phd)
5529366|NCT01170598|acute myeloid leukemia|acute myeloid leukemia
5529367|NCT01170598|AML|aml
5529368|NCT01170598|chemotherapy|chemotherapy
5529369|NCT01170598|exercise|exercise
5529370|NCT01170598|quality of life|quality of life
5529371|NCT01170598|cancer-related fatigue|cancer-related fatigue
5529372|NCT01170598|elderly|elderly
5529373|NCT01170598|physical fitness|physical fitness
5529374|NCT01170598|muscular strength|muscular strength
5529375|NCT01170598|Feasibility|feasibility
5529376|NCT01170598|Efficacy|efficacy
5529377|NCT01170598|Safety|safety
5529378|NCT01170546|anterior cruciate ligament|anterior cruciate ligament
5529379|NCT01170546|agility|agility
5904041|NCT00007813|extragonadal germ cell tumor|extragonadal germ cell tumor
5529380|NCT01170546|knee stability|knee stability
5529381|NCT01170546|hamstring|hamstring
5529382|NCT01170546|knee internal rotator|knee internal rotator
5529383|NCT01170533|proton pump inhibitor|proton pump inhibitor
5529384|NCT01170533|clopidogrel|clopidogrel
5529385|NCT01170533|platelet function|platelet function
5529386|NCT01170520|adolescent resistant depression|adolescent resistant depression
5529387|NCT01170520|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5529388|NCT01170520|treatment of resistant adolescent depression|treatment of resistant adolescent depression
5529389|NCT01170507|vitamin D3, 25 OH vitamin D3 level|vitamin d3, 25 oh vitamin d3 level
5529390|NCT01170494|vitamin D2, vitamin D3, 25 Oh vitamin D2, 25 Oh vitamin D3|vitamin d2, vitamin d3, 25 oh vitamin d2, 25 oh vitamin d3
5529391|NCT01170481|anterior and intermediate uveitis|anterior and intermediate uveitis
5529392|NCT01170481|papilloedema|papilloedema
5529393|NCT01170468|Prediabetics|prediabetics
5529394|NCT01170468|DM|dm
5529395|NCT01170468|vitamin D|vitamin d
5529396|NCT01170455|nasal|nasal
5529397|NCT01170455|intubation|intubation
5529398|NCT01170455|direct laryngoscope|direct laryngoscope
5529399|NCT01170455|blind|blind
5529400|NCT01170455|normal airway|normal airway
5529401|NCT01170429|Cough Variant Asthma|cough variant asthma
5529402|NCT01170429|Procaterol Hydrochloride|procaterol hydrochloride
5529403|NCT01170416|Ventricular Tachycardia|ventricular tachycardia
5529404|NCT01170416|Body Surface Mapping|body surface mapping
5529405|NCT01170403|coronary heart disease|coronary heart disease
5529406|NCT01170403|Multidetector row cardiac computed tomography|multidetector row cardiac computed tomography
5529407|NCT01170403|type 2 diabetes|type 2 diabetes
5529408|NCT01170403|metabolic syndrome|metabolic syndrome
5529409|NCT01170390|Obesity|obesity
5529410|NCT01170390|Body weight|body weight
5529411|NCT01170390|Oral contraception|oral contraception
5529412|NCT01170390|Efficacy|efficacy
5529413|NCT01170377|Intravenous sedation|intravenous sedation
5529414|NCT01170377|Dental treatment|dental treatment
5529415|NCT01170377|Mental retardation|mental retardation
5529416|NCT01170377|Antiepileptic drug|antiepileptic drug
5529417|NCT01170377|Valproate|valproate
5529418|NCT01170377|Propofol|propofol
5529419|NCT01170364|Obesity|obesity
5529420|NCT01170364|sibutramine|sibutramine
5529421|NCT01170364|eating behavior|eating behavior
5529422|NCT01170351|autoimmune hepatitis|autoimmune hepatitis
5529423|NCT01170351|corticosteroids|corticosteroids
5529424|NCT01170351|cysclosporine-A|cysclosporine-a
5514099|NCT01235260|Cancer|cancer
5529425|NCT01170351|treatment|treatment
5529426|NCT01170351|treatment-naive|treatment-naive
5529427|NCT01170351|induction of remossion|induction of remossion
5529428|NCT01170351|efficacy|efficacy
5529429|NCT01170351|tolerability|tolerability
5529430|NCT01170338|smoking|smoking
5529431|NCT01170338|tobacco abuse|tobacco abuse
5529432|NCT01170325|Valproic Acid|valproic acid
5529433|NCT01170325|Divalproex|divalproex
5529434|NCT01170325|Autism|autism
5529435|NCT01170325|EEG|eeg
5529436|NCT01170325|Electroencephalogram (EEG)|electroencephalogram (eeg)
5529437|NCT01170325|Depakote|depakote
5529438|NCT01170312|Arthroscopic repair|arthroscopic repair
5529439|NCT01170312|Rotator cuff|rotator cuff
5529440|NCT01170312|Platelet rich plasma|platelet rich plasma
5529447|NCT01170299|ovarian epithelial cancer|ovarian epithelial cancer
5529448|NCT01170299|ovarian germ cell tumor|ovarian germ cell tumor
5529450|NCT01170299|ovarian stromal cancer|ovarian stromal cancer
5529451|NCT01170299|uterine sarcoma|uterine sarcoma
5529452|NCT01170299|bladder cancer|bladder cancer
5529453|NCT01170299|colon cancer|colon cancer
5529454|NCT01170299|rectal cancer|rectal cancer
5529455|NCT01170299|anal cancer|anal cancer
5529456|NCT01170286|Food allergy|food allergy
5529457|NCT01170286|Immediate hypersensitivity|immediate hypersensitivity
5529458|NCT01170286|Whole peanut extract|whole peanut extract
5529459|NCT01170286|Allergenic product|allergenic product
5529460|NCT01170286|Specific Immunotherapy|specific immunotherapy
5529461|NCT01170286|Epicutaneous Immunotherapy (EPIT)|epicutaneous immunotherapy (epit)
5529463|NCT01170273|aged|aged
5529464|NCT01170273|vitamin d deficiency|vitamin d deficiency
5529465|NCT01170247|Procedural Sedation|procedural sedation
5529466|NCT01170234|Exhaled nitric oxide|exhaled nitric oxide
5529467|NCT01170234|Eosinophilic esophagitis|eosinophilic esophagitis
5529468|NCT01170221|ABSSSI|absssi
5529469|NCT01170221|Tedizolid Phosphate|tedizolid phosphate
5529470|NCT01170221|TR-701|tr-701
5529471|NCT01170221|Acute Bacterial Skin and Skin Structure Infections|acute bacterial skin and skin structure infections
5529472|NCT01170208|insulin|insulin
5529473|NCT01170208|dosage software|dosage software
5529474|NCT01170195|Postmenopausal|postmenopausal
5529475|NCT01170195|licorice|licorice
5529476|NCT01170195|vaginal complaints|vaginal complaints
5529477|NCT01170156|deep sedation|deep sedation
5529478|NCT01170156|respiratory resuscitation|respiratory resuscitation
5529479|NCT01170156|Hi-Lo Evac tube|hi-lo evac tube
5529480|NCT01170156|suctioning manoeuvre|suctioning manoeuvre
5529481|NCT01170143|IIB-IIIB Breast Cancer|iib-iiib breast cancer
5529482|NCT01170143|Her2 positive|her2 positive
5529483|NCT01170130|Cataract|cataract
5529484|NCT01170130|Mydriasis|mydriasis
5529485|NCT01170130|Lidocaine|lidocaine
5529486|NCT01170117|Eating Disorders|eating disorders
5529487|NCT01170117|Anorexia Nervosa|anorexia nervosa
5529488|NCT01170104|Hepatocellular Carcinoma|hepatocellular carcinoma
5529489|NCT01170104|Sorafenib|sorafenib
5529490|NCT01170104|TACE|tace
5529491|NCT01170104|locally, advanced Hepatocellular Carcinoma|locally, advanced hepatocellular carcinoma
5529492|NCT01170078|chronic renal failure requiring hemodialysis|chronic renal failure requiring hemodialysis
5529493|NCT01170052|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5529494|NCT01170052|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
5529495|NCT01170052|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5529496|NCT01170052|Temsirolimus|temsirolimus
5529497|NCT01170052|Bendamustine|bendamustine
5529498|NCT01170052|Phase 1/2|phase 1/2
5529499|NCT01170039|Constipation|constipation
5529500|NCT01170039|Diabetes|diabetes
5529501|NCT01170039|Lubiprostone|lubiprostone
5529502|NCT01170039|Amitiza|amitiza
5529503|NCT01170039|African Americans|african americans
5529504|NCT01170026|substance use|substance use
5529505|NCT01170026|adolescents|adolescents
5529506|NCT01170026|intervention|intervention
5529507|NCT01170026|truancy|truancy
5529508|NCT01170026|sexual risk behavior|sexual risk behavior
5529509|NCT01170013|substance use|substance use
5529510|NCT01170013|adolescents|adolescents
5529511|NCT01170013|initiation|initiation
5529512|NCT01169987|Multicenter study|multicenter study
5529513|NCT01169974|Microcirculation|microcirculation
5529514|NCT01169974|laser flowmetry|laser flowmetry
5529515|NCT01169974|Skin|skin
5529516|NCT01169974|Physiology|physiology
5529517|NCT01169961|IRON OVERLOAD IN HEMODIALYSIS PATIENTS|iron overload in hemodialysis patients
5529518|NCT01169948|Coronary disease|coronary disease
5529519|NCT01169948|Coronary artery bypass|coronary artery bypass
5529520|NCT01169948|Cardiac surgery|cardiac surgery
5529521|NCT01169948|Computed tomography|computed tomography
5529522|NCT01169948|Coronary angiography|coronary angiography
5529524|NCT01169935|SPIO|spio
5529525|NCT01169935|Healthy Volunteer|healthy volunteer
5529526|NCT01169909|Pterygium|pterygium
5529527|NCT01169896|Impact of ventricular pacing on the incidence of VT/VF episodes for each models|impact of ventricular pacing on the incidence of vt/vf episodes for each models
5529528|NCT01169883|adherence|adherence
5529529|NCT01169883|asthma|asthma
5529530|NCT01169883|pediatrics|pediatrics
5529531|NCT01169883|behavioral intervention|behavioral intervention
5529532|NCT01169883|inner city|inner city
5529533|NCT01169870|metastatic|metastatic
5529534|NCT01169857|Proliferative lupus nephritis|proliferative lupus nephritis
5529535|NCT01169857|WHO class III/IV/V lupus nephritis|who class iii/iv/v lupus nephritis
5529536|NCT01169857|Proteinuria|proteinuria
5529537|NCT01169857|Hematuria|hematuria
5529540|NCT01169857|Bortezomib|bortezomib
5529541|NCT01169857|Proteasome inhibitor|proteasome inhibitor
5529542|NCT01169844|Psoriatic arthritis|psoriatic arthritis
5529543|NCT01169844|IgG1K monoclonal antibody|igg1k monoclonal antibody
5529544|NCT01169844|Interleukin -17A neutralizing|interleukin -17a neutralizing
5529545|NCT01169792|Tamoxifen|tamoxifen
5529546|NCT01169792|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
5529547|NCT01169792|Polymorphism|polymorphism
5529548|NCT01169792|Single nucleotide|single nucleotide
5529549|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5529550|NCT01169753|Chronic Myeloid Leukemia|chronic myeloid leukemia
5529552|NCT01169753|Nuvigil|nuvigil
5529553|NCT01169753|Armodafinil|armodafinil
5529554|NCT01169753|Fatigue|fatigue
5529555|NCT01169740|Hyperbilirubinemia|hyperbilirubinemia
5529556|NCT01169740|Neonatal|neonatal
5529557|NCT01169740|Serum bilirubin|serum bilirubin
5529558|NCT01169740|Transcutaneous bilirubin|transcutaneous bilirubin
5529559|NCT01169740|Skin color|skin color
5529560|NCT01169727|COPD and CCQ score|copd and ccq score
5529561|NCT01169727|Changes in PEF,overall CCQ score|changes in pef,overall ccq score
5529562|NCT01169714|multiple dose|multiple dose
5529563|NCT01169714|healthy volunteer|healthy volunteer
5529564|NCT01169714|healthy elderly volunteer|healthy elderly volunteer
5529565|NCT01169714|safety|safety
5529566|NCT01169714|pharmacokinetic|pharmacokinetic
5529567|NCT01169701|Renal transplant, everolimus, cardiovascular profile, CNI-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (BPAR)|renal transplant, everolimus, cardiovascular profile, cni-free immunosuppression, left ventricular hypertrophy, biopsy proved acute rejection (bpar)
5529568|NCT01169688|Cataract Surgery|cataract surgery
5529569|NCT01169688|Pupillary Dilation|pupillary dilation
5529570|NCT01169649|MK-2206|mk-2206
5529571|NCT01169649|Neuroendocrine Tumors|neuroendocrine tumors
5529572|NCT01169649|10-067|10-067
5529573|NCT01169636|Chemotherapy|chemotherapy
5529574|NCT01169636|Panobinostat|panobinostat
5529575|NCT01169636|Ifosfamide|ifosfamide
5529576|NCT01169636|Mesna|mesna
5529577|NCT01169636|Etoposide|etoposide
5529578|NCT01169636|Carboplatin|carboplatin
5529579|NCT01169636|Pegfilgrastim|pegfilgrastim
5529581|NCT01169623|Supportive leadership behaviour|supportive leadership behaviour
5529582|NCT01169623|Nurse Performance|nurse performance
5529583|NCT01169623|Educational Intervention|educational intervention
5529584|NCT01169610|Alcohol|alcohol
5529585|NCT01169610|Smoking|smoking
5529586|NCT01169597|polymyalgia rheumatica|polymyalgia rheumatica
5529587|NCT01169597|prednisone|prednisone
5529588|NCT01169597|clinical examination|clinical examination
5529589|NCT01169597|remission|remission
5529590|NCT01169597|ultrasonography|ultrasonography
5529591|NCT01169584|Phase I|phase i
5529592|NCT01169584|advanced metastatic pediatric solid tumors|advanced metastatic pediatric solid tumors
5529593|NCT01169584|pediatric|pediatric
5529594|NCT01169584|vaccinia virus|vaccinia virus
5529595|NCT01169584|oncolytic virus|oncolytic virus
5529596|NCT01169584|neuroblastoma|neuroblastoma
5529597|NCT01169584|rhabdomyosarcoma|rhabdomyosarcoma
5529598|NCT01169584|lymphoma|lymphoma
5529599|NCT01169584|Wilm's tumor|wilm's tumor
5529600|NCT01169584|Ewing's sarcoma|ewing's sarcoma
5529601|NCT01169584|osteosarcoma|osteosarcoma
5529602|NCT01169584|non-rhabdomyosarcoma soft tissue sarcomas|non-rhabdomyosarcoma soft tissue sarcomas
5529603|NCT01169584|malignant peripheral nerve sheath tumors|malignant peripheral nerve sheath tumors
5529604|NCT01169584|Pexa-Vec|pexa-vec
5529605|NCT01169571|Initially intubated|initially intubated
5529606|NCT01169571|Mechanically ventilated|mechanically ventilated
5529607|NCT01169571|Post-surgical|post-surgical
5529608|NCT01169545|any type of cancer|any type of cancer
5529609|NCT01169519|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5529610|NCT01169519|Hypoplastic right heart syndrome|hypoplastic right heart syndrome
5529611|NCT01169519|Superior cavopulmonary anastomosis|superior cavopulmonary anastomosis
5529612|NCT01169519|Total cavopulmonary anastomosis|total cavopulmonary anastomosis
5529613|NCT01169519|Children with single ventricle anatomy|children with single ventricle anatomy
5529614|NCT01169506|blood gas analysis|blood gas analysis
5529615|NCT01169506|ventilatory insufficiency|ventilatory insufficiency
5529616|NCT01169493|Heart Failure|heart failure
5529617|NCT01169493|Right Bundle-Branch Block|right bundle-branch block
5529618|NCT01169493|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5529619|NCT01169480|Massage|massage
5529620|NCT01169480|Therapist, Massage|therapist, massage
5529621|NCT01169480|DASS|dass
5529622|NCT01169480|Depression|depression
5529623|NCT01169480|Anxiety, State|anxiety, state
5529624|NCT01169480|Anxiety, Trait|anxiety, trait
5529625|NCT01169480|Stress|stress
5529626|NCT01169480|Touch|touch
5529627|NCT01169480|Therapeutic Relationship|therapeutic relationship
5529628|NCT01169454|Cerebral Spinal Fluid|cerebral spinal fluid
5529629|NCT01169454|Ventriculostomy|ventriculostomy
5529630|NCT01169454|Subarachnoid hemorrhage|subarachnoid hemorrhage
5529631|NCT01169454|Vasospasm|vasospasm
5529632|NCT01169454|Human Subjects|human subjects
5529633|NCT01169441|ICD leads|icd leads
5529635|NCT01169441|Extraction|extraction
5529636|NCT01169441|Ventricular leads|ventricular leads
5529637|NCT01169441|Extract|extract
5529638|NCT01169441|laser|laser
5529639|NCT01169441|Observe the lead with x-ray during movement and collect information on current ways of removing an ICD lead.|observe the lead with x-ray during movement and collect information on current ways of removing an icd lead.
5529640|NCT01169428|Mindfulness-Based Weight Loss Maintenance|mindfulness-based weight loss maintenance
5529641|NCT01169428|prevention of weight regain|prevention of weight regain
5529642|NCT01169428|Obesity|obesity
5529643|NCT01169415|Randomized|randomized
5529644|NCT01169415|Dexamethasone|dexamethasone
5529645|NCT01169415|Abbreviated|abbreviated
5529646|NCT01169415|Protracted|protracted
5529647|NCT01169415|Post-operatively|post-operatively
5529648|NCT01169402|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5529649|NCT01169402|ECMO|ecmo
5529650|NCT01169402|extracorporeal life support|extracorporeal life support
5529651|NCT01169402|fluconazole|fluconazole
5529652|NCT01169402|diflucan|diflucan
5529653|NCT01169402|pharmacokinetics|pharmacokinetics
5529654|NCT01169402|pharmacodynamics|pharmacodynamics
5529655|NCT01169376|disseminated neuroblastoma|disseminated neuroblastoma
5529656|NCT01169376|localized resectable neuroblastoma|localized resectable neuroblastoma
5529657|NCT01169376|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5529658|NCT01169376|regional neuroblastoma|regional neuroblastoma
5529659|NCT01169376|stage 4S neuroblastoma|stage 4s neuroblastoma
5529660|NCT01169363|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5529661|NCT01169363|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5529662|NCT01169363|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5529663|NCT01169363|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5671481|NCT00615875|naproxen|naproxen
5529664|NCT01169363|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5529665|NCT01169363|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5529666|NCT01169363|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5531191|NCT01162980|ARBs|arbs
5529667|NCT01169363|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5529668|NCT01169363|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5529669|NCT01169363|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5529670|NCT01169363|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5529671|NCT01169363|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5529672|NCT01169363|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5529673|NCT01169363|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5529674|NCT01169363|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5529675|NCT01169363|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5529676|NCT01169324|Parkinson's disease|parkinson's disease
5529677|NCT01169324|Tremor|tremor
5529678|NCT01169324|Dystonia|dystonia
5529679|NCT01169324|DBS|dbs
5529680|NCT01169324|Sleep|sleep
5529681|NCT01169311|Hemorrhoids|hemorrhoids
5529682|NCT01169311|Hemorrhoid|hemorrhoid
5529683|NCT01169311|grade II, III, IV|grade ii, iii, iv
5529684|NCT01169298|Adult T-cell Leukemia-Lymphoma|adult t-cell leukemia-lymphoma
5529685|NCT01169298|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5529686|NCT01169298|PTCL|ptcl
5529687|NCT01169298|HTLV-1|htlv-1
5529688|NCT01169285|Burn Department Nursing Staff|burn department nursing staff
5529689|NCT01169272|ICD CRT 9770 - PARADYM RF ICD - SonR atrial lead|icd crt 9770 - paradym rf icd - sonr atrial lead
5529690|NCT01169259|vitamin D3|vitamin d3
5529691|NCT01169259|omega-3 fatty acids|omega-3 fatty acids
5529692|NCT01169259|fish oil|fish oil
5529693|NCT01169259|cardiovascular disease|cardiovascular disease
5529694|NCT01169259|cancer|cancer
5529695|NCT01169259|primary prevention|primary prevention
5511697|NCT01245270|anthocyanin|anthocyanin
5529696|NCT01169246|ATP,CRT, ICD PARADYM|atp,crt, icd paradym
5529697|NCT01169233|Sleep|sleep
5529698|NCT01169233|Alertness|alertness
5529699|NCT01169233|fatigue|fatigue
5529700|NCT01169233|performance|performance
5529701|NCT01169233|spaceflight|spaceflight
5529702|NCT01169233|isolation|isolation
5529703|NCT01169233|light|light
5529704|NCT01169233|Sleep , alertness and performance during a simulated spaceflight mission|sleep , alertness and performance during a simulated spaceflight mission
5529706|NCT01169220|Bowel preparation|bowel preparation
5529707|NCT01169207|Inflammatory Bowel Disease|inflammatory bowel disease
5529708|NCT01169207|Crohn's Disease|crohn's disease
5529709|NCT01169207|Ulcerative Colitis|ulcerative colitis
5529710|NCT01169207|Indeterminate Colitis|indeterminate colitis
5529711|NCT01169207|IBD|ibd
5529712|NCT01169207|CD|cd
5529713|NCT01169207|UC|uc
5529714|NCT01169207|IC|ic
5529715|NCT01169194|Inflammatory Bowel Disease|inflammatory bowel disease
5529716|NCT01169194|Crohn's Disease|crohn's disease
5529719|NCT01169194|IBD|ibd
5529720|NCT01169194|CD|cd
5529721|NCT01169194|UC|uc
5529722|NCT01169194|IC|ic
5529723|NCT01169194|African American IBD|african american ibd
5529724|NCT01169194|African American CD|african american cd
5529725|NCT01169194|African American UC|african american uc
5529726|NCT01169194|African American IC|african american ic
5529727|NCT01169194|Black IBD|black ibd
5529728|NCT01169194|Black CD|black cd
5529729|NCT01169194|Black UC|black uc
5529730|NCT01169194|Black IC|black ic
5529731|NCT01169194|African American Inflammatory Bowel Disease|african american inflammatory bowel disease
5529732|NCT01169194|African American Crohn's Disease|african american crohn's disease
5529733|NCT01169194|African American Ulcerative Colitis|african american ulcerative colitis
5529734|NCT01169194|African American Indeterminate Colitis|african american indeterminate colitis
5529735|NCT01169194|Black Inflammatory Bowel Disease|black inflammatory bowel disease
5529736|NCT01169194|Black Crohn's Disease|black crohn's disease
5515992|NCT01226420|GVHD|gvhd
5529737|NCT01169194|Black Ulcerative Colitis|black ulcerative colitis
5529738|NCT01169194|Black Indeterminate Colitis|black indeterminate colitis
5529739|NCT01169181|Stroke|stroke
5529740|NCT01169181|Cerebrovascular Accident|cerebrovascular accident
5529741|NCT01169181|Plegia|plegia
5529742|NCT01169181|Upper Extremity|upper extremity
5529743|NCT01169181|rTMS|rtms
5529744|NCT01169181|tDCS|tdcs
5529745|NCT01169168|fibrinogen|fibrinogen
5529746|NCT01169168|SIRS|sirs
5529747|NCT01169168|sepsis|sepsis
5529748|NCT01169168|liver disease|liver disease
5529749|NCT01169168|chronic liver disease|chronic liver disease
5529750|NCT01169168|septic shock|septic shock
5529751|NCT01169155|Smoke inhalation injury|smoke inhalation injury
5529752|NCT01169155|Burns|burns
5529753|NCT01169155|Injuries|injuries
5529754|NCT01169142|Vitamin D|vitamin d
5529755|NCT01169142|Schizophrenia|schizophrenia
5529756|NCT01169142|Severely Mentally Ill|severely mentally ill
5529757|NCT01169129|brain metastases|brain metastases
5529758|NCT01169129|radiosurgery|radiosurgery
5529759|NCT01169129|neurosurgery|neurosurgery
5529761|NCT01169129|radiotherapy|radiotherapy
5531485|NCT01161589|S-ICD|s-icd
5529762|NCT01169129|resectable brain metastases|resectable brain metastases
5529763|NCT01169116|radiotherapy|radiotherapy
5529764|NCT01169116|radiation oncology|radiation oncology
5529765|NCT01169116|brain metastasis|brain metastasis
5529766|NCT01169116|metastases|metastases
5529767|NCT01169116|radiosurgery|radiosurgery
5529768|NCT01169116|neurosurgery|neurosurgery
5529769|NCT01169116|hypofractionation|hypofractionation
5529770|NCT01169116|stereotaxy|stereotaxy
5529771|NCT01169103|Obesity|obesity
5529772|NCT01169103|Adolescent|adolescent
5529773|NCT01169103|Insulin resistance|insulin resistance
5529774|NCT01169103|Growth hormone|growth hormone
5529775|NCT01169103|Visceral fat|visceral fat
5529776|NCT01169103|Adolescent obesity|adolescent obesity
5529777|NCT01169077|malaria, plasmodium falciparum, electroporation|malaria, plasmodium falciparum, electroporation
5529778|NCT01169064|Wound infection prevention|wound infection prevention
5529779|NCT01169064|Silver-containing surgical dressing|silver-containing surgical dressing
5529780|NCT01169064|Cesarean delivery infection prevention|cesarean delivery infection prevention
5529781|NCT01169051|Esophagectomy|esophagectomy
5529782|NCT01169051|Pulmonary wedge resection|pulmonary wedge resection
5529783|NCT01169051|Pulmonary lobectomy|pulmonary lobectomy
5529784|NCT01169051|Pulmonary pneumonectomy|pulmonary pneumonectomy
5529785|NCT01169051|Thoracic Surgery|thoracic surgery
5529786|NCT01169051|Lung Cancer|lung cancer
5529787|NCT01169051|Esophageal Cancer|esophageal cancer
5529788|NCT01169038|sarcoidosis|sarcoidosis
5529789|NCT01169038|mycobacteria|mycobacteria
5529790|NCT01169038|lung|lung
5529791|NCT01169038|pulmonary|pulmonary
5529792|NCT01169038|radiographic improvement|radiographic improvement
5529793|NCT01169025|Analgesia|analgesia
5529794|NCT01169025|Pain|pain
5529795|NCT01169012|Myelodysplastic syndrome|myelodysplastic syndrome
5529796|NCT01169012|Acute Myeloid Leukemia|acute myeloid leukemia
5529797|NCT01169012|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5529798|NCT01169012|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5529799|NCT01169012|Clofarabine|clofarabine
5529800|NCT01169012|Clolar|clolar
5529801|NCT01169012|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5529802|NCT01169012|Lineberger Comprehensive Cancer Center|lineberger comprehensive cancer center
5529803|NCT01168999|low back pain|low back pain
5529804|NCT01168999|spinal manipulation|spinal manipulation
5529805|NCT01168999|manual therapy|manual therapy
5529806|NCT01168999|placebo|placebo
5529807|NCT01168986|neck pain|neck pain
5529808|NCT01168986|manual therapy|manual therapy
5529809|NCT01168986|exercise|exercise
5529810|NCT01168973|second line|second line
5529811|NCT01168973|non small cell lung cancer|non small cell lung cancer
5529812|NCT01168973|NSCLC|nsclc
5529814|NCT01168973|ramucirumab|ramucirumab
5529815|NCT01168973|lung cancer|lung cancer
5529816|NCT01168973|docetaxel|docetaxel
5529817|NCT01168973|taxotere|taxotere
5529818|NCT01168947|sodium|sodium
5529819|NCT01168947|hypertension|hypertension
5529820|NCT01168947|fluid overload|fluid overload
5529821|NCT01168947|hemodialysis|hemodialysis
5529822|NCT01168947|dialysate|dialysate
5529823|NCT01168947|interdialytic weight gain|interdialytic weight gain
5529824|NCT01168947|intradialytic hypotension|intradialytic hypotension
5529825|NCT01168934|healthy volunteers|healthy volunteers
5529826|NCT01168934|crizotinib|crizotinib
5529827|NCT01168934|absolute bioavailability|absolute bioavailability
5529828|NCT01168934|pharmacokinetics|pharmacokinetics
5529829|NCT01168921|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5529830|NCT01168921|CLL|cll
5529831|NCT01168921|Thrombocytopenia|thrombocytopenia
5529832|NCT01168921|Small lymphocytic lymphoma|small lymphocytic lymphoma
5529833|NCT01168921|SLL|sll
5529834|NCT01168921|Eltrombopag|eltrombopag
5529835|NCT01168921|Promacta|promacta
5685540|NCT00555685|Renal failure|renal failure
5529836|NCT01168921|thrombopoietin (TPO)-receptor agonist|thrombopoietin (tpo)-receptor agonist
5529837|NCT01168921|platelets|platelets
5529838|NCT01168908|Clinical trial|clinical trial
5529839|NCT01168908|Revatio|revatio
5529840|NCT01168908|Sildenafil|sildenafil
5529841|NCT01168908|Muscular Dystrophy|muscular dystrophy
5529842|NCT01168908|Duchenne|duchenne
5529843|NCT01168908|Becker|becker
5529844|NCT01168908|Adult|adult
5529845|NCT01168908|Adolescent|adolescent
5529846|NCT01168895|75 mg dose strength|75 mg dose strength
5529847|NCT01168895|Safety|safety
5529848|NCT01168895|Pharmacokinetics|pharmacokinetics
5529849|NCT01168882|RGB-286638|rgb-286638
5529850|NCT01168882|Hematological Malignancies|hematological malignancies
5529851|NCT01168869|Manifestation|manifestation
5529852|NCT01168869|Coronary Heart Disease|coronary heart disease
5529853|NCT01168869|Myocardial infarction|myocardial infarction
5529854|NCT01168869|Angina pectoris|angina pectoris
5529855|NCT01168869|Unheralded|unheralded
5529856|NCT01168869|General Practice Research Database|general practice research database
5529857|NCT01168869|Myocardial Ischaemia National Audit Project|myocardial ischaemia national audit project
5529858|NCT01168869|CALIBER|caliber
5529859|NCT01168817|Combination Drug Therapy|combination drug therapy
5529860|NCT01168817|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5529861|NCT01168804|multiple myeloma|multiple myeloma
5529862|NCT01168804|bendamustine|bendamustine
5529863|NCT01168804|bortezomib|bortezomib
5529864|NCT01168804|dexamethasone|dexamethasone
5529865|NCT01168791|Metastatic|metastatic
5529866|NCT01168791|Front line|front line
5529867|NCT01168765|Physical Activity, Mexican-American, Obesity, Diabetes, Nutrition, Border Health|physical activity, mexican-american, obesity, diabetes, nutrition, border health
5529868|NCT01168752|Cancer|cancer
5529869|NCT01168752|solid tumour|solid tumour
5529870|NCT01168752|lymphoma|lymphoma
5529871|NCT01168752|dose-escalation|dose-escalation
5529872|NCT01168752|Hsp90 inhibitor|hsp90 inhibitor
5529873|NCT01168739|thermotolerance|thermotolerance
5529874|NCT01168739|heat acclimation|heat acclimation
5529875|NCT01168739|quercetin|quercetin
5529876|NCT01168739|exertional heat illness|exertional heat illness
5529877|NCT01168739|gastrointestinal barrier permeability|gastrointestinal barrier permeability
5529878|NCT01168713|Adults with Community-Acquired Bacterial Pneumonia|adults with community-acquired bacterial pneumonia
5529879|NCT01168700|Metabolic syndrome, Aged Garlic Extract, Insulin, inflammation, endothelium.|metabolic syndrome, aged garlic extract, insulin, inflammation, endothelium.
5529880|NCT01168687|keppra|keppra
5529881|NCT01168687|levetiracetam|levetiracetam
5529882|NCT01168687|alcoholism|alcoholism
5529883|NCT01168687|genetics|genetics
5529884|NCT01168687|subjective report|subjective report
5529885|NCT01168674|Major Depressive Disorder|major depressive disorder
5529886|NCT01168674|MDD|mdd
5529887|NCT01168674|Bipolar Disorder|bipolar disorder
5529888|NCT01168674|BD|bd
5529889|NCT01168674|Depression|depression
5529890|NCT01168674|Major Depressive Disorder with Bipolar features|major depressive disorder with bipolar features
5529891|NCT01168661|Stress|stress
5529892|NCT01168661|Burnout|burnout
5529893|NCT01168661|Anxiety|anxiety
5529894|NCT01168661|Depression|depression
5529895|NCT01168648|Yoga|yoga
5529896|NCT01168648|Stress|stress
5529897|NCT01168648|Stress management|stress management
5529898|NCT01168648|Hypothalamus-pituitary-adrenal axis|hypothalamus-pituitary-adrenal axis
5529900|NCT01168635|Spirometry|spirometry
5529901|NCT01168635|Pediatric|pediatric
5529902|NCT01168635|Primary Health Care|primary health care
5529903|NCT01168635|Education, Distance|education, distance
5529904|NCT01168609|Left atrial distensibility|left atrial distensibility
5529905|NCT01168609|left ventricular filling pressure|left ventricular filling pressure
5529906|NCT01168609|tissue Doppler|tissue doppler
5529907|NCT01168609|prognosis|prognosis
5529908|NCT01168609|acute myocardial infarction|acute myocardial infarction
5529909|NCT01168596|Parkinson's Disease|parkinson's disease
5529910|NCT01168596|Fatigue|fatigue
5529911|NCT01168570|familial Mediterranean fever|familial mediterranean fever
5529912|NCT01168570|amyloidosis AA|amyloidosis aa
5529913|NCT01168570|serum amyloid A|serum amyloid a
5529914|NCT01168570|renal failure|renal failure
5529915|NCT01168570|nephrotic syndrome|nephrotic syndrome
5529916|NCT01168557|electric impedance tomography|electric impedance tomography
5529917|NCT01168557|stress-echocardiography|stress-echocardiography
5529919|NCT01168557|perfusion|perfusion
5529920|NCT01168544|Vitamin D|vitamin d
5529921|NCT01168544|Colecalciferol|colecalciferol
5529922|NCT01168544|Nursing home|nursing home
5529923|NCT01168544|Loading dose|loading dose
5529924|NCT01168531|patients undergoing lumbar spinal surgery|patients undergoing lumbar spinal surgery
5529925|NCT01168518|Evaluate the Sorin Group new passive- and active- fixation pacing leads|evaluate the sorin group new passive- and active- fixation pacing leads
5529926|NCT01168492|pediatric|pediatric
5529927|NCT01168492|gastroscopy|gastroscopy
5529928|NCT01168492|colonoscopy|colonoscopy
5529929|NCT01168492|sedation|sedation
5529930|NCT01168492|ketamine|ketamine
5529931|NCT01168479|prostate cancer|prostate cancer
5529932|NCT01168479|external beam radiotherapy|external beam radiotherapy
5529933|NCT01168479|dose escalation|dose escalation
5529934|NCT01168479|dose painting|dose painting
5529935|NCT01168479|95Gy in 35 fractions|95gy in 35 fractions
5529936|NCT01168479|MRI|mri
5529937|NCT01168479|FLAME|flame
5529938|NCT01168466|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5529939|NCT01168466|EEG Biofeedback|eeg biofeedback
5529940|NCT01168466|Cerebral oxygenation biofeedback|cerebral oxygenation biofeedback
5529941|NCT01168466|Frontotemporal Dementia|frontotemporal dementia
5529942|NCT01168466|Peak Alpha Amplitude|peak alpha amplitude
5529943|NCT01168466|Quantitative EEG Assessment|quantitative eeg assessment
5529944|NCT01168453|jugular vein|jugular vein
5529945|NCT01168453|anatomy|anatomy
5529946|NCT01168453|ultrasonography|ultrasonography
5529947|NCT01168440|von Hippel-Lindau|von hippel-lindau
5529948|NCT01168440|VHL|vhl
5529949|NCT01168440|sunitinib|sunitinib
5529950|NCT01168401|Vaccine, norovirus, acute gastroenteritis|vaccine, norovirus, acute gastroenteritis
5529951|NCT01168388|Dystonia|dystonia
5529952|NCT01168388|Hemifacial spasm|hemifacial spasm
5529953|NCT01168388|Cervical dystonia|cervical dystonia
5529954|NCT01168388|Blepharospasm|blepharospasm
5529955|NCT01168362|coronary artery disease|coronary artery disease
5529956|NCT01168362|cardiovascular risk|cardiovascular risk
5529957|NCT01168362|pericardial fat|pericardial fat
5530049|NCT01167946|Oral Pulse steroid|oral pulse steroid
5529958|NCT01168336|betahistine olanzapine weight sleepiness|betahistine olanzapine weight sleepiness
5529959|NCT01168336|olanzapine induced weight gain and sleepiness|olanzapine induced weight gain and sleepiness
5529960|NCT01168323|Medical Education|medical education
5529961|NCT01168323|Educational Technology|educational technology
5529962|NCT01168323|Clinical Practice Guideline|clinical practice guideline
5529963|NCT01168323|Prostate specific antigen|prostate specific antigen
5529964|NCT01168310|Pulmonary, Obstructive, lungs, COPD|pulmonary, obstructive, lungs, copd
5529965|NCT01168297|Obesity|obesity
5529966|NCT01168297|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5529967|NCT01168297|Genetics|genetics
5529968|NCT01168297|Energy Expenditure|energy expenditure
5529969|NCT01168297|Physical Activity|physical activity
5529970|NCT01168284|Autism Spectrum Disorders|autism spectrum disorders
5529971|NCT01168271|Observational|observational
5529972|NCT01168271|Newborns|newborns
5529973|NCT01168271|Hospitalized|hospitalized
5529974|NCT01168271|Febrile|febrile
5529975|NCT01168271|Resistance|resistance
5529976|NCT01168258|Diabetic Retinopathy|diabetic retinopathy
5529977|NCT01168258|Diabetes|diabetes
5529978|NCT01168258|Single Nucleotide Polymorphism (SNP)|single nucleotide polymorphism (snp)
5529979|NCT01168258|Diabetic Macular Edema|diabetic macular edema
5529980|NCT01168245|Alzheimer Disease|alzheimer disease
5529981|NCT01168245|Dementia|dementia
5529982|NCT01168245|Brain Diseases|brain diseases
5529983|NCT01168245|Central Nervous System Diseases|central nervous system diseases
5529984|NCT01168245|Nervous System Disease|nervous system disease
5529985|NCT01168245|Cognitive Training|cognitive training
5529986|NCT01168245|Cortical Reorganization|cortical reorganization
5529987|NCT01168245|Brain Plasticity|brain plasticity
5529988|NCT01168193|surgery|surgery
5529989|NCT01168193|post operative|post operative
5529990|NCT01168193|complications|complications
5529991|NCT01168193|length of stay|length of stay
5529992|NCT01168180|Traditional Thai Massage|traditional thai massage
5529993|NCT01168180|Scapulocostal Syndrome|scapulocostal syndrome
5529994|NCT01168167|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5529995|NCT01168167|MK 0518|mk 0518
5529996|NCT01168167|HIV-1 DNA species|hiv-1 dna species
5529997|NCT01168167|viral slope|viral slope
5529998|NCT01168167|Ribonucleic Acid|ribonucleic acid
5529999|NCT01168167|DNA, Complementary|dna, complementary
5530000|NCT01168154|Diverticula|diverticula
5530001|NCT01168154|Diverticular disease|diverticular disease
5530002|NCT01168154|Diverticulitis|diverticulitis
5530003|NCT01168154|Probiotics|probiotics
5530004|NCT01168141|Castrate-resistant prostate cancer with bone metastasis|castrate-resistant prostate cancer with bone metastasis
5530005|NCT01168128|Enteral Nutrition|enteral nutrition
5530006|NCT01168128|Parenteral Nutrition|parenteral nutrition
5530008|NCT01168128|Nutrition Therapy|nutrition therapy
5530009|NCT01168128|Nutrition Support|nutrition support
5530010|NCT01168128|Practice Guidelines as Topic|practice guidelines as topic
5530011|NCT01168128|Guideline Adherence|guideline adherence
5530012|NCT01168128|Quality Assurance, Health Care|quality assurance, health care
5530013|NCT01168128|Nutrition Surveys|nutrition surveys
5530014|NCT01168128|Questionnaires|questionnaires
5530015|NCT01168063|Helicobacter pylori|helicobacter pylori
5530016|NCT01168063|Diagnostic molecular testing|diagnostic molecular testing
5530017|NCT01168063|Antibiotic resistance|antibiotic resistance
5530018|NCT01168063|Treatment protocols|treatment protocols
5530019|NCT01168050|Malignant Skin Melanoma T0|malignant skin melanoma t0
5530020|NCT01168050|stage III unresectable melanomas,|stage iii unresectable melanomas,
5530021|NCT01168050|or stage IV melanomas with c-KIT mutation|or stage iv melanomas with c-kit mutation
5530022|NCT01168050|or amplification.|or amplification.
5530023|NCT01168037|Aorta|aorta
5530024|NCT01168037|Aneurysm|aneurysm
5530025|NCT01168037|endovascular|endovascular
5530026|NCT01168037|stent-graft|stent-graft
5530027|NCT01168024|Acute Kidney Injury|acute kidney injury
5530028|NCT01168024|Iodinated Contrast Agent Retrieval|iodinated contrast agent retrieval
5530029|NCT01168024|Coronary Sinus Cannulation|coronary sinus cannulation
5530030|NCT01167985|antibacterial polyethyleneimine nanoparticles|antibacterial polyethyleneimine nanoparticles
5530031|NCT01167985|quaternary ammonium|quaternary ammonium
5530032|NCT01167985|dental|dental
5530033|NCT01167985|Endodotnic|endodotnic
5530034|NCT01167985|pulp|pulp
5530035|NCT01167985|bacteria|bacteria
5530036|NCT01167985|Root canal sealer|root canal sealer
5530037|NCT01167985|temporary filling|temporary filling
5530038|NCT01167985|provisional restoration|provisional restoration
5530039|NCT01167972|M + mutation|m + mutation
5530040|NCT01167972|Non Small Cell Lung Cancer adenocarcinoma|non small cell lung cancer adenocarcinoma
5530041|NCT01167972|To determine the proportion of patients with M + mutation status among patients with NSCLC adenocarcinoma|to determine the proportion of patients with m + mutation status among patients with nsclc adenocarcinoma
5530042|NCT01167959|Obesity|obesity
5530043|NCT01167959|Diabetes|diabetes
5530044|NCT01167959|Bariatric surgery|bariatric surgery
5530045|NCT01167946|Alopecia Areata|alopecia areata
5530046|NCT01167946|Alopecia totalis|alopecia totalis
5530047|NCT01167946|Alopecia Universalis|alopecia universalis
5530048|NCT01167946|Ophiasic alopecia|ophiasic alopecia
5530050|NCT01167946|Methylprednisolone|methylprednisolone
5530051|NCT01167933|Bioequivalence|bioequivalence
5530052|NCT01167933|Crossover|crossover
5530053|NCT01167933|Simvastatin|simvastatin
5530054|NCT01167920|High Blood Pressure|high blood pressure
5530055|NCT01167920|Hypertension|hypertension
5530056|NCT01167920|Home Blood Pressure Measurements|home blood pressure measurements
5530057|NCT01167920|Wireless communication of measurements|wireless communication of measurements
5530058|NCT01167920|Wireless communication of blood pressure measurements|wireless communication of blood pressure measurements
5530059|NCT01167907|ankle|ankle
5530060|NCT01167907|arthrodesis|arthrodesis
5530061|NCT01167907|internal fixation|internal fixation
5530062|NCT01167907|bi/tri malleolar fracture|bi/tri malleolar fracture
5530063|NCT01167894|Bioequivalence|bioequivalence
5530064|NCT01167894|Crossover|crossover
5530065|NCT01167894|Simvastatin|simvastatin
5530066|NCT01167868|fostamatinib disodium|fostamatinib disodium
5530067|NCT01167868|FosD|fosd
5530068|NCT01167868|Japanese|japanese
5530069|NCT01167868|Healthy volunteers|healthy volunteers
5530070|NCT01167868|Phase 1|phase 1
5530071|NCT01167868|Single and Multiple Ascending Dose Study|single and multiple ascending dose study
5530072|NCT01167868|Healthy Japanese volunteers|healthy japanese volunteers
5530073|NCT01167868|Healthy White volunteers|healthy white volunteers
5530074|NCT01167855|Pediatric Asthma|pediatric asthma
5530075|NCT01167855|Low-income|low-income
5530076|NCT01167855|Arkansas Delta Region|arkansas delta region
5530077|NCT01167829|Experimental|experimental
5530078|NCT01167829|Acyline plus 27 oral testosterone pills|acyline plus 27 oral testosterone pills
5530079|NCT01167829|taken 3x/day|taken 3x/day
5530080|NCT01167803|Bariatric surgery|bariatric surgery
5530081|NCT01167803|Anesthesia|anesthesia
5530082|NCT01167790|Precancerous lesions of the oral mucosa|precancerous lesions of the oral mucosa
5514758|NCT01232218|Shoulder pain|shoulder pain
5530083|NCT01167790|Fluorescence visualization|fluorescence visualization
5530086|NCT01167777|NG|ng
5530087|NCT01167777|chlamydia|chlamydia
5530088|NCT01167777|gonorrhoeae|gonorrhoeae
5530089|NCT01167764|hemoptysis|hemoptysis
5530090|NCT01167764|recurrence|recurrence
5530091|NCT01167751|Myocardial infarction|myocardial infarction
5530092|NCT01167751|Bone marrow stem cells|bone marrow stem cells
5530093|NCT01167751|AC133|ac133
5530094|NCT01167738|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5530095|NCT01167738|stage IV pancreatic cancer|stage iv pancreatic cancer
5530096|NCT01167725|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5530097|NCT01167725|stage III colon cancer|stage iii colon cancer
5530098|NCT01167725|stage IV colon cancer|stage iv colon cancer
5530099|NCT01167699|Oxycodone/naloxone|oxycodone/naloxone
5530101|NCT01167699|WHO step I/II|who step i/ii
5530102|NCT01167699|Moderate to severe non-malignant pain|moderate to severe non-malignant pain
5530103|NCT01167686|Respiratory infection|respiratory infection
5530104|NCT01167686|Viral infection|viral infection
5530105|NCT01167686|Food supplement|food supplement
5530106|NCT01167686|Goldtrain Plus (GT+)|goldtrain plus (gt+)
5530107|NCT01167673|irritable bowel syndrome|irritable bowel syndrome
5530108|NCT01167673|selenium|selenium
5530109|NCT01167673|curcumin|curcumin
5530110|NCT01167673|green tea|green tea
5530111|NCT01167660|Coagulation tests|coagulation tests
5530112|NCT01167660|Neonates|neonates
5530113|NCT01167660|Non invasive|non invasive
5530114|NCT01167647|Tuberculosis, culture, bronchoscopy|tuberculosis, culture, bronchoscopy
5530115|NCT01167634|Weight Loss|weight loss
5530116|NCT01167634|Motivation|motivation
5530117|NCT01167634|Contracts|contracts
5685360|NCT00556426|Venous Thromboembolic Disease|venous thromboembolic disease
5530118|NCT01167621|Refractory Acute Respiratory Distress Syndrome|refractory acute respiratory distress syndrome
5530119|NCT01167621|Indexed Extra-vascular Lung Water|indexed extra-vascular lung water
5530120|NCT01167621|HFO-ventilation|hfo-ventilation
5530121|NCT01167608|Parkinson's disease|parkinson's disease
5530122|NCT01167608|Depression|depression
5530124|NCT01167608|Treatment|treatment
5530125|NCT01167595|Critically ill|critically ill
5530126|NCT01167595|Nutrition therapy|nutrition therapy
5530127|NCT01167595|Enteral nutrition|enteral nutrition
5530128|NCT01167582|blood transfusion|blood transfusion
5530129|NCT01167582|red blood cell transfusion|red blood cell transfusion
5530130|NCT01167582|myocardial infarction|myocardial infarction
5530131|NCT01167582|acute coronary syndrome|acute coronary syndrome
5530132|NCT01167582|anemia|anemia
5530133|NCT01167569|Free Radicals|free radicals
5530134|NCT01167569|Ascorbic Acid|ascorbic acid
5530135|NCT01167569|Cardiac Surgery|cardiac surgery
5530136|NCT01167569|Prevention of Reperfusion Injury|prevention of reperfusion injury
5530137|NCT01167556|Family intervention|family intervention
5530138|NCT01167556|Recent-onset schizophrenia|recent-onset schizophrenia
5530139|NCT01167556|Motivational Interviewing|motivational interviewing
5530140|NCT01167556|Cannabis use|cannabis use
5530141|NCT01167530|Everolimus|everolimus
5530142|NCT01167530|Radiotherapy|radiotherapy
5530143|NCT01167530|Chemotherapy|chemotherapy
5530144|NCT01167517|Breast milk|breast milk
5530145|NCT01167517|Feeding|feeding
5530146|NCT01167517|Prematurity|prematurity
5530147|NCT01167517|Low birth weight infant|low birth weight infant
5530148|NCT01167517|Low maternal breast milk feeding|low maternal breast milk feeding
5530149|NCT01167504|saliva|saliva
5530150|NCT01167504|food|food
5530151|NCT01167504|sensory|sensory
5530152|NCT01167504|oral health|oral health
5530153|NCT01167504|film|film
5530154|NCT01167504|pellicle|pellicle
5530155|NCT01167491|Wegener|wegener
5530156|NCT01167491|CD4+ T cells|cd4+ t cells
5530157|NCT01167491|DAP12|dap12
5530158|NCT01167491|NKG2D|nkg2d
5530159|NCT01167478|Exercise|exercise
5530160|NCT01167478|Caffeine|caffeine
5530161|NCT01167478|Reserve|reserve
5530162|NCT01167465|Diaper Dermatitis|diaper dermatitis
5530163|NCT01167465|Diaper Rash|diaper rash
5530164|NCT01167465|Erythema|erythema
5530165|NCT01167452|Obesity|obesity
5530166|NCT01167452|Pharmacokinetics|pharmacokinetics
5530167|NCT01167452|MRSA|mrsa
5530168|NCT01167452|Tuberculosis|tuberculosis
5530169|NCT01167452|PCP|pcp
5530170|NCT01167439|OPMD, dysphagia|opmd, dysphagia
5530171|NCT01167439|Dysphagia severity|dysphagia severity
5530172|NCT01167439|Nutritional state|nutritional state
5530173|NCT01167439|Speech quality|speech quality
5530174|NCT01167439|Upper esophageal sphincter myotomy|upper esophageal sphincter myotomy
5530175|NCT01167426|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5530176|NCT01167426|RRMS|rrms
5530177|NCT01167426|Clinically Isolated Syndrome|clinically isolated syndrome
5530178|NCT01167426|CIS|cis
5530179|NCT01167426|Copaxone|copaxone
5530180|NCT01167426|glatiramer acetate|glatiramer acetate
5530181|NCT01167426|Autoject 2|autoject 2
5530182|NCT01167400|exercise|exercise
5512191|NCT01242930|myeloma|myeloma
5530183|NCT01167400|executive function|executive function
5530184|NCT01167400|older adults|older adults
5530185|NCT01167387|carbohydrate|carbohydrate
5530186|NCT01167387|glucose metabolism|glucose metabolism
5530187|NCT01167387|surgery, outcome|surgery, outcome
5530188|NCT01167387|major elective surgery|major elective surgery
5530189|NCT01167387|urology|urology
5530190|NCT01167387|hyperglicemia|hyperglicemia
5530191|NCT01167374|HCC|hcc
5530192|NCT01167361|upper respiratory tract infection|upper respiratory tract infection
5530193|NCT01167361|lower respiratory tract infection|lower respiratory tract infection
5530194|NCT01167348|auricular acupressure|auricular acupressure
5530195|NCT01167348|obesity|obesity
5530196|NCT01167348|schizophrenia|schizophrenia
5530197|NCT01167348|body weight|body weight
5530198|NCT01167335|partial onset seizure|partial onset seizure
5530199|NCT01167335|seizure frequency|seizure frequency
5530200|NCT01167335|nervous system diseases|nervous system diseases
5530201|NCT01167335|central nervous system diseases|central nervous system diseases
5530203|NCT01167335|brain diseases|brain diseases
5530204|NCT01167335|neurologic manifestations|neurologic manifestations
5530205|NCT01167335|adjunctive treatment|adjunctive treatment
5530206|NCT01167335|AEDs|aeds
5530207|NCT01167335|antiepileptic drug|antiepileptic drug
5530208|NCT01167322|NPC-07, 5-ALA, photodynamic diagnosis, pharmacokinetics|npc-07, 5-ala, photodynamic diagnosis, pharmacokinetics
5530209|NCT01167309|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
5530210|NCT01167296|Intrauterine adhesion|intrauterine adhesion
5530211|NCT01167296|Cook balloon uterine stent|cook balloon uterine stent
5530213|NCT01167270|Infant Diet|infant diet
5530214|NCT01167270|Toddler Diet|toddler diet
5530215|NCT01167270|Responsive Feeding|responsive feeding
5530216|NCT01167270|Infant Temperament|infant temperament
5530217|NCT01167270|Parent competency|parent competency
5530218|NCT01167270|Childhood Obesity prevention|childhood obesity prevention
5530219|NCT01167270|Rapid infant weight gain|rapid infant weight gain
5530220|NCT01167257|Overactive bladder|overactive bladder
5530221|NCT01167257|Detrusor overactivity|detrusor overactivity
5530222|NCT01167257|Liposome|liposome
5530223|NCT01167257|Botulinum toxin A|botulinum toxin a
5530224|NCT01167231|Diabetes|diabetes
5530225|NCT01167231|Acarbose|acarbose
5530226|NCT01167218|verify now assay for hematological disorders|verify now assay for hematological disorders
5530227|NCT01167205|Healthy adults with BMI over 25.0 kg/m2|healthy adults with bmi over 25.0 kg/m2
5530228|NCT01167179|head and neck cancer|head and neck cancer
5530229|NCT01167179|nurse-led care|nurse-led care
5530230|NCT01167179|follow-up care|follow-up care
5530231|NCT01167179|professional-patient relations|professional-patient relations
5530232|NCT01167179|psychosocial adjustment|psychosocial adjustment
5530233|NCT01167179|quasi-experimental|quasi-experimental
5530234|NCT01167179|prospective|prospective
5530235|NCT01167179|quality of life|quality of life
5530236|NCT01167166|Acute Myelocytic Leukemia|acute myelocytic leukemia
5530237|NCT01167166|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5530238|NCT01167166|Myeloproliferative Disease|myeloproliferative disease
5530239|NCT01167166|Myelofibrosis|myelofibrosis
5530240|NCT01167166|Essential thrombocythemia|essential thrombocythemia
5530241|NCT01167166|Polycythemia vera|polycythemia vera
5530242|NCT01167166|Chronic Myeloid Leukemia|chronic myeloid leukemia
5530243|NCT01167153|Hypertension|hypertension
5530244|NCT01167153|Valsartan Amlodipine single pill combination|valsartan amlodipine single pill combination
5530245|NCT01167153|BP control|bp control
5531486|NCT01161589|ICD|icd
5530247|NCT01167153|Hypertensive patients not adequately controlled by mono antihypertensive drugs|hypertensive patients not adequately controlled by mono antihypertensive drugs
5530248|NCT01167127|Oxycodone/naloxone|oxycodone/naloxone
5530249|NCT01167127|pain relief|pain relief
5530250|NCT01167127|bowel function|bowel function
5530251|NCT01167127|moderate to severe non-malignant pain|moderate to severe non-malignant pain
5530252|NCT01167114|STA-9090|sta-9090
5530253|NCT01167101|Rebamipide|rebamipide
5530254|NCT01167101|gastric ulcer|gastric ulcer
5530255|NCT01167101|healing rate|healing rate
5530256|NCT01167101|iatrogenic gastric ulcer after endoscopic submucosal dissection|iatrogenic gastric ulcer after endoscopic submucosal dissection
5530257|NCT01167088|Double-blind|double-blind
5530258|NCT01167088|Placebo-controlled|placebo-controlled
5530259|NCT01167088|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5530260|NCT01167088|NAFLD|nafld
5530261|NCT01167075|critically ill|critically ill
5530262|NCT01167075|sepsis|sepsis
5530263|NCT01167075|antioxidants|antioxidants
5530264|NCT01167075|enteral nutrition|enteral nutrition
5530265|NCT01167075|SIRS (APACHE score 10-30)|sirs (apache score 10-30)
5530266|NCT01167075|enteral feeding within 48 h of admission|enteral feeding within 48 h of admission
5530267|NCT01167049|gastric cancer with liver metastasis|gastric cancer with liver metastasis
5530268|NCT01167036|Myofascial pain syndrome|myofascial pain syndrome
5530269|NCT01167036|Trigger points, Myofascial|trigger points, myofascial
5530270|NCT01167036|Chiropractic|chiropractic
5530271|NCT01167036|Massage|massage
5530272|NCT01167036|Musculoskeletal manipulation|musculoskeletal manipulation
5530273|NCT01167023|Sickle Cell Disease|sickle cell disease
5512365|NCT01242111|LSD|lsd
5530274|NCT01167023|Sickle Cell Anemia|sickle cell anemia
5530275|NCT01167023|Adult|adult
5530276|NCT01166997|Pulmonary embolism|pulmonary embolism
5530277|NCT01166997|Pulmonary thromboembolism|pulmonary thromboembolism
5530278|NCT01166997|anticoagulation|anticoagulation
5530279|NCT01166997|thrombolysis|thrombolysis
5530280|NCT01166997|ultrasound accelerated thrombolysis|ultrasound accelerated thrombolysis
5530281|NCT01166984|sepsis|sepsis
5530282|NCT01166984|septic shock|septic shock
5530283|NCT01166971|presbyopia|presbyopia
5530284|NCT01166971|intraocular lens|intraocular lens
5530285|NCT01166945|Child|child
5530286|NCT01166945|Child, preschool|child, preschool
5530287|NCT01166945|Sinusitis|sinusitis
5530288|NCT01166945|Antimicrobial agents|antimicrobial agents
5530289|NCT01166932|pneumonia|pneumonia
5530290|NCT01166932|children|children
5530291|NCT01166932|antibiotics|antibiotics
5530292|NCT01166906|pain blocking|pain blocking
5530293|NCT01166893|burn wound|burn wound
5530294|NCT01166880|assessment|assessment
5530295|NCT01166867|assessment|assessment
5530296|NCT01166854|muscle and bone disease|muscle and bone disease
5530297|NCT01166841|minimally invasive cardiac surgery|minimally invasive cardiac surgery
5530298|NCT01166841|cardiac surgery|cardiac surgery
5530299|NCT01166841|near infrared spectroscopy|near infrared spectroscopy
5530300|NCT01166841|mitral valve repair|mitral valve repair
5530301|NCT01166841|mitral valve replacement|mitral valve replacement
5530302|NCT01166828|Spinal cord injury|spinal cord injury
5530303|NCT01166828|telehealth|telehealth
5530304|NCT01166828|pressure ulcers|pressure ulcers
5530305|NCT01166828|quality of life|quality of life
5530306|NCT01166815|diarrhea morbidity|diarrhea morbidity
5530307|NCT01166815|malaria incidence|malaria incidence
5530308|NCT01166815|zinc supplementation|zinc supplementation
5530309|NCT01166802|questionnaire development|questionnaire development
5530310|NCT01166802|hypervigilance|hypervigilance
5530311|NCT01166802|pain sensitivity|pain sensitivity
5530312|NCT01166789|IBS|ibs
5530313|NCT01166789|pain threshold|pain threshold
5530314|NCT01166789|constipation|constipation
5530315|NCT01166776|Wharton's jelly|wharton's jelly
5530316|NCT01166776|umbilical cord|umbilical cord
5530317|NCT01166776|decellularization|decellularization
5530318|NCT01166763|breast atypia|breast atypia
5530319|NCT01166763|high risk for breast cancer|high risk for breast cancer
5530320|NCT01166763|random periareolar fine needle aspiration|random periareolar fine needle aspiration
5530321|NCT01166763|RPFNA|rpfna
5530322|NCT01166763|breast epithelial hyperplasia|breast epithelial hyperplasia
5530323|NCT01166763|ki-67|ki-67
5530324|NCT01166763|chemoprevention|chemoprevention
5530325|NCT01166763|vitamin D3|vitamin d3
5530326|NCT01166763|Additional relevant MeSH terms:|additional relevant mesh terms:
5530327|NCT01166763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5530328|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs
5530329|NCT01166763|Breast Neoplasms|breast neoplasms
5530330|NCT01166763|Pharmacologic Actions|pharmacologic actions
5530331|NCT01166763|Hyperplasia|hyperplasia
5530332|NCT01166763|high risk for development of breast cancer|high risk for development of breast cancer
5530333|NCT01166763|Neoplasms|neoplasms
5530334|NCT01166763|Neoplasms by Site|neoplasms by site
5530335|NCT01166763|Pathologic Processes|pathologic processes
5530336|NCT01166763|Antirheumatic Agents|antirheumatic agents
5530337|NCT01166763|Breast Diseases|breast diseases
5530338|NCT01166737|Ovarian Cancer|ovarian cancer
5530339|NCT01166737|Cancer of the fallopian tube|cancer of the fallopian tube
5530340|NCT01166737|Primary peritoneal cancer|primary peritoneal cancer
5530341|NCT01166737|Recurrent disease|recurrent disease
5530342|NCT01166737|Platinum-sensitive|platinum-sensitive
5530343|NCT01166737|Surgery|surgery
5530344|NCT01166737|Chemotherapy|chemotherapy
5530345|NCT01166737|Quality of Life|quality of life
5530346|NCT01166737|First recurrence of platinum sensitive:|first recurrence of platinum sensitive:
5530347|NCT01166737|Fallopian Tube Cancer|fallopian tube cancer
5530348|NCT01166737|or Ovarian Cancer|or ovarian cancer
5530349|NCT01166737|or Peritoneal Cavity Cancer|or peritoneal cavity cancer
5530350|NCT01166724|Kidney transplant|kidney transplant
5530351|NCT01166698|Safety|safety
5530352|NCT01166698|tolerability|tolerability
5530353|NCT01166698|healthy|healthy
5530354|NCT01166698|inhalation|inhalation
5530355|NCT01166685|coronary artery disease|coronary artery disease
5530356|NCT01166685|drug-eluting stent|drug-eluting stent
5530357|NCT01166685|anti-thrombotic therapy|anti-thrombotic therapy
5530358|NCT01166685|bare-metal stent|bare-metal stent
5530359|NCT01166685|long-term outcome|long-term outcome
5530360|NCT01166672|obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done|obese women (bmi greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done
5530361|NCT01166672|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the|with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the
5530362|NCT01166672|past 2 years will be invited to participate.|past 2 years will be invited to participate.
5530363|NCT01166659|Glaucoma|glaucoma
5515057|NCT01230879|Aging lung|aging lung
5530364|NCT01166659|Glaucoma device|glaucoma device
5530365|NCT01166659|Glaucoma surgery|glaucoma surgery
5530366|NCT01166659|Intraocular pressure|intraocular pressure
5530367|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5530368|NCT01166633|hyperlipidemia|hyperlipidemia
5530369|NCT01166594|Glaucoma|glaucoma
5530370|NCT01166594|Elevated Intraocular Pressure (IOP)|elevated intraocular pressure (iop)
5530371|NCT01166594|Optic Neuropathy|optic neuropathy
5530372|NCT01166594|Bleb Failure|bleb failure
5530373|NCT01166594|Avastin (Bevacizumab)|avastin (bevacizumab)
5530374|NCT01166581|early stage breast cancer|early stage breast cancer
5530375|NCT01166581|preoperative breast MRI|preoperative breast mri
5530376|NCT01166581|mastectomy|mastectomy
5530377|NCT01166568|Presbyopia|presbyopia
5530378|NCT01166568|Reading Vision|reading vision
5530379|NCT01166568|Near Vision|near vision
5530380|NCT01166555|Safety and tolerability|safety and tolerability
5530381|NCT01166555|Pharmacokinetics|pharmacokinetics
5530382|NCT01166555|PF-04236921|pf-04236921
5530383|NCT01166555|Rheumatoid Arthritis|rheumatoid arthritis
5530385|NCT01166542|squamous cell|squamous cell
5530386|NCT01166542|head|head
5530387|NCT01166542|neck|neck
5530388|NCT01166542|REOLYSIN (Reovirus Type 3 Dearing)|reolysin (reovirus type 3 dearing)
5530389|NCT01166542|chemotherapy|chemotherapy
5530390|NCT01166542|Carboplatin|carboplatin
5530391|NCT01166542|Paclitaxel|paclitaxel
5530392|NCT01166542|metastatic|metastatic
5530393|NCT01166542|recurrent|recurrent
5530394|NCT01166516|Prolonged air leak|prolonged air leak
5530395|NCT01166516|lobectomy|lobectomy
5530396|NCT01166516|segmentectomy|segmentectomy
5530397|NCT01166516|lung volume reduction surgery (LVRS)|lung volume reduction surgery (lvrs)
5530398|NCT01166503|pediatrics|pediatrics
5530399|NCT01166503|Esotropia|esotropia
5530400|NCT01166503|Surgery|surgery
5530401|NCT01166490|Monomethyl auristatin E (MMAE)|monomethyl auristatin e (mmae)
5530402|NCT01166490|Immunotherapy|immunotherapy
5530403|NCT01166490|AGS-5 Antigen|ags-5 antigen
5530404|NCT01166490|SLC44A4 Antigen|slc44a4 antigen
5530405|NCT01166490|Gastric Neoplasms|gastric neoplasms
5530406|NCT01166490|Pancreatic Neoplasms|pancreatic neoplasms
5530407|NCT01166490|Antibody-Drug Conjugate|antibody-drug conjugate
5530408|NCT01166490|Antibodies, Monoclonal|antibodies, monoclonal
5530409|NCT01166490|Drug Therapy|drug therapy
5530410|NCT01166464|tobacco|tobacco
5530411|NCT01166464|smoking|smoking
5530412|NCT01166464|text message|text message
5530413|NCT01166464|therapy|therapy
5530414|NCT01166451|iron deficiency anemia|iron deficiency anemia
5530415|NCT01166451|cognitive development|cognitive development
5530416|NCT01166451|motor development|motor development
5530417|NCT01166438|incontinence|incontinence
5530418|NCT01166438|overactive bladder|overactive bladder
5530419|NCT01166438|botox|botox
5530420|NCT01166438|anticholinergic|anticholinergic
5530421|NCT01166399|Fecal Incontinence,|fecal incontinence,
5530422|NCT01166399|bowel incontinence,|bowel incontinence,
5530423|NCT01166399|pelvic floor disorder|pelvic floor disorder
5530424|NCT01166386|rehabilitation|rehabilitation
5530425|NCT01166386|brain injury|brain injury
5530426|NCT01166373|prolapse|prolapse
5530427|NCT01166373|urinary incontinence|urinary incontinence
5530428|NCT01166373|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
5530429|NCT01166373|sacrospinous ligament fixation|sacrospinous ligament fixation
5530430|NCT01166373|behavioral therapy|behavioral therapy
5530431|NCT01166373|pelvic muscle training|pelvic muscle training
5530432|NCT01166360|Risk prediction|risk prediction
5530433|NCT01166360|Euroscore|euroscore
5530434|NCT01166360|GDF-15|gdf-15
5530435|NCT01166360|hsTnT|hstnt
5530436|NCT01166360|cardiac surgery|cardiac surgery
5530437|NCT01166334|Smoking|smoking
5530438|NCT01166334|Smoke|smoke
5530439|NCT01166334|Cigarette|cigarette
5530440|NCT01166334|Cessation|cessation
5530441|NCT01166334|Quit|quit
5530442|NCT01166334|Online|online
5530444|NCT01166334|Stop|stop
5530445|NCT01166321|Atypical Meningioma|atypical meningioma
5530446|NCT01166308|Recurrent Glioma|recurrent glioma
5530447|NCT01166282|inflammatory back pain|inflammatory back pain
5530448|NCT01166282|ankylosing spondylitis|ankylosing spondylitis
5530449|NCT01166282|sacroiliitis|sacroiliitis
5530450|NCT01166282|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5530451|NCT01166282|enthesitis|enthesitis
5530452|NCT01166282|arthritis|arthritis
5530453|NCT01166269|grass-pollen allergy|grass-pollen allergy
5530454|NCT01166256|respiratory failure|respiratory failure
5530455|NCT01166243|Hemostasis|hemostasis
5530456|NCT01166217|Single Dose Study in Healthy Subjects|single dose study in healthy subjects
5530457|NCT01166204|Radiotherapy|radiotherapy
5530458|NCT01166204|NSCLC|nsclc
5530459|NCT01166191|Radiotherapy|radiotherapy
5530460|NCT01166191|SCLC|sclc
5530461|NCT01166178|Multiple Sclerosis|multiple sclerosis
5530462|NCT01166178|Osteoporosis|osteoporosis
5530463|NCT01166178|Zoledronic Acid|zoledronic acid
5530464|NCT01166165|Hypertension|hypertension
5530465|NCT01166165|blood pressure|blood pressure
5530466|NCT01166165|vitamin d|vitamin d
5530467|NCT01166165|winter|winter
5530468|NCT01166165|cholecalciferol|cholecalciferol
5530469|NCT01166165|arterial stiffness|arterial stiffness
5530470|NCT01166165|renin|renin
5530471|NCT01166165|angiotensin|angiotensin
5530472|NCT01166165|aldosterone|aldosterone
5530473|NCT01166165|calcium|calcium
5530474|NCT01166152|autistic spectrum disorders|autistic spectrum disorders
5530475|NCT01166152|developmental disorders|developmental disorders
5530476|NCT01166139|Systemic Sclerosis|systemic sclerosis
5530477|NCT01166113|Pomalidomide|pomalidomide
5530478|NCT01166113|Relapsed/Refractory to Lenalidomide|relapsed/refractory to lenalidomide
5530479|NCT01166100|Bioequivalence|bioequivalence
5530480|NCT01166100|Crossover|crossover
5530481|NCT01166100|Fluoxetine Hydrochloride|fluoxetine hydrochloride
5530482|NCT01166087|Bioequivalence|bioequivalence
5530483|NCT01166087|Crossover|crossover
5530484|NCT01166087|Fluoxetine Hydrochloride|fluoxetine hydrochloride
5530485|NCT01166061|Grass Allergy|grass allergy
5530486|NCT01166061|Immunotherapy|immunotherapy
5530487|NCT01166061|Rhinoconjunctivitis|rhinoconjunctivitis
5530488|NCT01166061|ToleroMune Grass|toleromune grass
5530489|NCT01166048|Chronic Low Back Pain|chronic low back pain
5530490|NCT01166048|Radicular component|radicular component
5530491|NCT01166048|neuropathic pain|neuropathic pain
5530492|NCT01166048|duloxetine|duloxetine
5530493|NCT01166048|CLBP|clbp
5530494|NCT01166035|Solid tumors|solid tumors
5530495|NCT01166035|Lenalidomide|lenalidomide
5530496|NCT01166035|Cetuximab|cetuximab
5530497|NCT01166035|Colorectal Cancer|colorectal cancer
5530498|NCT01166035|Non-Small Cell Lung Cancer|non-small cell lung cancer
5530499|NCT01166035|Head and Neck Cancer|head and neck cancer
5530500|NCT01166022|Spinal Muscular Atrophy|spinal muscular atrophy
5530501|NCT01166022|Exercise|exercise
5530502|NCT01166022|Conditioning|conditioning
5530503|NCT01166022|Strengthening|strengthening
5516767|NCT01222650|I-PSS|i-pss
5530504|NCT01166009|Data Collection|data collection
5530505|NCT01166009|CIBMTR|cibmtr
5530506|NCT01166009|NMDP|nmdp
5530507|NCT01166009|Stem Cell Transplantation|stem cell transplantation
5530508|NCT01165996|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5530509|NCT01165996|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5530510|NCT01165970|enamel|enamel
5530511|NCT01165970|dentin|dentin
5530512|NCT01165970|saliva substitute|saliva substitute
5530513|NCT01165970|demineralization|demineralization
5530514|NCT01165970|remineralization|remineralization
5530515|NCT01165957|Knee replacement|knee replacement
5530516|NCT01165957|Mobile and fixed bearings|mobile and fixed bearings
5530517|NCT01165957|Volumetric wear|volumetric wear
5530518|NCT01165957|Micro-CT analysis|micro-ct analysis
5530519|NCT01165957|Articular and backside wear|articular and backside wear
5530520|NCT01165944|Post transplant diabetes mellitus|post transplant diabetes mellitus
5530521|NCT01165931|Coronary artery disease|coronary artery disease
5530522|NCT01165905|cancer|cancer
5530523|NCT01165905|solid malignancy|solid malignancy
5530524|NCT01165905|tumor|tumor
5530525|NCT01165905|malignant neoplasm|malignant neoplasm
5530526|NCT01165905|histologically confirmed solid malignancy|histologically confirmed solid malignancy
5530527|NCT01165892|Pulmonary embolism|pulmonary embolism
5530528|NCT01165892|contrast agent|contrast agent
5530529|NCT01165879|Pregnancy|pregnancy
5530530|NCT01165879|Term|term
5530531|NCT01165879|Preterm|preterm
5530532|NCT01165879|Uterine Contractions|uterine contractions
5530533|NCT01165866|Ondansetron|ondansetron
5530534|NCT01165866|Metoclopramide|metoclopramide
5530535|NCT01165866|Gastroenteritis|gastroenteritis
5530536|NCT01165840|Obesity|obesity
5530537|NCT01165840|Pharmacokinetics|pharmacokinetics
5530538|NCT01165840|Dapsone|dapsone
5530539|NCT01165840|Leprosy|leprosy
5530550|NCT01165801|Influence of cataract surgery on AMD Size|influence of cataract surgery on amd size
5530552|NCT01165736|pharmacokinetics|pharmacokinetics
5530553|NCT01165736|safety|safety
5530554|NCT01165736|tolerability|tolerability
5530555|NCT01165736|Chronic Pain|chronic pain
5530556|NCT01165723|safety|safety
5530557|NCT01165723|tolerability|tolerability
5530558|NCT01165723|pharmacokinetics|pharmacokinetics
5530559|NCT01165723|pharmacodynamics|pharmacodynamics
5530560|NCT01165723|chronic pain|chronic pain
5530561|NCT01165710|Irregular heart beat|irregular heart beat
5530562|NCT01165697|Fabry Disease|fabry disease
5530563|NCT01165697|vascular disease|vascular disease
5530564|NCT01165697|storage endotheliopathy|storage endotheliopathy
5530565|NCT01165671|Primary Glioblastoma|primary glioblastoma
5530566|NCT01165658|non-small cell lung cancer|non-small cell lung cancer
5530567|NCT01165658|NSCLC|nsclc
5530568|NCT01165658|small cell lung cancer|small cell lung cancer
5530569|NCT01165658|SCLC|sclc
5530570|NCT01165658|carcinoid|carcinoid
5530571|NCT01165658|thymic cancer|thymic cancer
5530572|NCT01165658|lung cancer|lung cancer
5530573|NCT01165658|radiation therapy|radiation therapy
5530574|NCT01165658|radiotherapy|radiotherapy
5530575|NCT01165658|proton therapy|proton therapy
5530576|NCT01165645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5530577|NCT01165554|Amyloid|amyloid
5530578|NCT01165554|PET-Positron Emission Tomography|pet-positron emission tomography
5530579|NCT01165554|SUVR-Standard uptake value ratios|suvr-standard uptake value ratios
5530580|NCT01165502|MAD study CM3.1-AC100|mad study cm3.1-ac100
5530581|NCT01165502|Healthy men, age 18 - 50|healthy men, age 18 - 50
5530582|NCT01165489|Laryngomalacia|laryngomalacia
5530583|NCT01165489|Congenital Anomalies|congenital anomalies
5530584|NCT01165489|Associated Health Problems|associated health problems
5530585|NCT01165476|treprostinil|treprostinil
5530586|NCT01165476|bioavailability|bioavailability
5530587|NCT01165476|bioequivalence|bioequivalence
5530588|NCT01165463|Aging|aging
5530589|NCT01165463|Healthy|healthy
5530590|NCT01165450|persistent epithelial defect|persistent epithelial defect
5530591|NCT01165450|cornea|cornea
5530592|NCT01165437|Peripheral|peripheral
5530593|NCT01165437|Arterial|arterial
5530594|NCT01165437|Vascular|vascular
5530595|NCT01165411|Central Catheterization|central catheterization
5530596|NCT01165411|Central Line|central line
5530597|NCT01165411|Database|database
5530598|NCT01165411|Registry|registry
5530599|NCT01165411|Registries|registries
5530600|NCT01165398|Education|education
5530601|NCT01165398|central lines|central lines
5530602|NCT01165398|infections|infections
5530603|NCT01165398|complications|complications
5530604|NCT01165398|Bundles|bundles
5530605|NCT01165385|Relapsed or refractory solid tumors|relapsed or refractory solid tumors
5530606|NCT01165385|Pazopanib|pazopanib
5530607|NCT01165385|Cisplatin|cisplatin
5530608|NCT01165372|Malaria|malaria
5530609|NCT01165372|Drug resistance|drug resistance
5530610|NCT01165346|liver cancer|liver cancer
5530611|NCT01165346|hepatocellular carcinoma|hepatocellular carcinoma
5530612|NCT01165333|Paediatric oncology|paediatric oncology
5530613|NCT01165333|Cilengitide|cilengitide
5501352|NCT01290510|tendon|tendon
5530614|NCT01165333|Glioma|glioma
5530615|NCT01165307|Menorrhagia|menorrhagia
5530616|NCT01165307|Endometrial ablation|endometrial ablation
5530617|NCT01165307|Heavy menstrual bleeding|heavy menstrual bleeding
5530618|NCT01165294|Ketamine|ketamine
5530619|NCT01165281|Pain|pain
5530620|NCT01165281|R331333 (JNS024ER, CG5503), tapentadol (NUCYNTA)|r331333 (jns024er, cg5503), tapentadol (nucynta)
5530621|NCT01165281|Opioid analgesic|opioid analgesic
5530622|NCT01165281|Oxycodone CR (OXYCONTIN CR)|oxycodone cr (oxycontin cr)
5530623|NCT01165281|Chronic malignant tumor related cancer pain|chronic malignant tumor related cancer pain
5530624|NCT01165255|congenital malformation|congenital malformation
5530625|NCT01165255|cardiovascular malformation|cardiovascular malformation
5530626|NCT01165255|cardiovascular defect|cardiovascular defect
5530627|NCT01165255|antidepressants|antidepressants
5530628|NCT01165255|pregnancy|pregnancy
5530629|NCT01165255|first trimester|first trimester
5530630|NCT01165255|Bupropion|bupropion
5530631|NCT01165255|prevalence|prevalence
5530632|NCT01165242|Neisseria meningitidis|neisseria meningitidis
5530634|NCT01165242|Adolescent|adolescent
5530635|NCT01165242|Safety|safety
5530636|NCT01165242|Vaccines, conjugate|vaccines, conjugate
5530637|NCT01165242|Meningococcal vaccines|meningococcal vaccines
5530638|NCT01165242|Immunogenicity|immunogenicity
5530639|NCT01165229|Immunogenicity|immunogenicity
5530640|NCT01165229|Subjects 70 years and older|subjects 70 years and older
5530641|NCT01165229|Efficacy|efficacy
5530642|NCT01165229|Herpes Zoster|herpes zoster
5530643|NCT01165229|Safety|safety
5530644|NCT01165229|Adults|adults
5530645|NCT01165229|Vaccine|vaccine
5530646|NCT01165203|immunogenicity|immunogenicity
5530647|NCT01165203|vaccine|vaccine
5530648|NCT01165203|safety|safety
5530649|NCT01165203|HIV|hiv
5530650|NCT01165203|Herpes Zoster|herpes zoster
5530651|NCT01165177|subjects 50 years and older|subjects 50 years and older
5530652|NCT01165177|vaccine|vaccine
5530653|NCT01165177|immunogenicity|immunogenicity
5530654|NCT01165177|efficacy|efficacy
5530655|NCT01165177|Herpes Zoster|herpes zoster
5530656|NCT01165177|safety|safety
5530657|NCT01165164|Dry eye|dry eye
5530658|NCT01165164|artificial tears|artificial tears
5530659|NCT01165151|obesity|obesity
5530660|NCT01165151|weight loss|weight loss
5530661|NCT01165151|group size|group size
5530662|NCT01165138|GW642444|gw642444
5530663|NCT01165138|Vilanterol|vilanterol
5530664|NCT01165138|Asthma|asthma
5530665|NCT01165138|Fluticasone Furoate|fluticasone furoate
5530666|NCT01165125|pharmacodynamics|pharmacodynamics
5530667|NCT01165125|drug interaction|drug interaction
5530668|NCT01165125|ketoconazole|ketoconazole
5530669|NCT01165125|pharmacokinetics|pharmacokinetics
5530670|NCT01165125|Fluticasone furoate|fluticasone furoate
5530671|NCT01165125|GW642444|gw642444
5530672|NCT01165099|acupuncture|acupuncture
5530673|NCT01165099|induced labour|induced labour
5530674|NCT01165099|labour outcome|labour outcome
5530675|NCT01165099|nulliparae|nulliparae
5530676|NCT01165099|pain-relief|pain-relief
5530677|NCT01165099|epidural during labour|epidural during labour
5515348|NCT01229592|ethanol|ethanol
5530678|NCT01165073|Cirrhosis|cirrhosis
5530679|NCT01165073|Malnutrition|malnutrition
5530680|NCT01165073|Enteral nutrition|enteral nutrition
5530681|NCT01165060|X-ALD|x-ald
5530682|NCT01165060|AMN|amn
5530683|NCT01165060|adrenomyeloneuropathy phenotype|adrenomyeloneuropathy phenotype
5530684|NCT01164995|MK-1775|mk-1775
5530685|NCT01164995|Carboplatin|carboplatin
5530686|NCT01164995|epithelial ovarian cancer|epithelial ovarian cancer
5530687|NCT01164995|p53|p53
5530688|NCT01164956|methylphenidate|methylphenidate
5530689|NCT01164956|fatigue|fatigue
5530690|NCT01164917|Lupus|lupus
5530691|NCT01164917|Discoid Lupus|discoid lupus
5530692|NCT01164917|Cutaneous Lupus|cutaneous lupus
5530693|NCT01164904|Inflammatory Bowel Disease|inflammatory bowel disease
5530694|NCT01164904|Amgen|amgen
5530695|NCT01164878|Cholestasis|cholestasis
5530696|NCT01164878|Liver damage|liver damage
5530697|NCT01164878|Parenteral Nutrition|parenteral nutrition
5530698|NCT01164878|Aggressive Nutrition|aggressive nutrition
5530699|NCT01164878|Preterm|preterm
5530700|NCT01164878|Extreme low birth weight infant|extreme low birth weight infant
5530701|NCT01164878|Parenteral Nutrition Associated Cholestasis|parenteral nutrition associated cholestasis
5530702|NCT01164865|Soft Contact lens|soft contact lens
5530703|NCT01164865|Multi-Purpose Solution|multi-purpose solution
5530704|NCT01164865|Hydrogen Peroxide|hydrogen peroxide
5530705|NCT01164839|coronary artery|coronary artery
5530706|NCT01164839|CT angiography|ct angiography
5530707|NCT01164839|image quality|image quality
5530708|NCT01164839|multicenter trial|multicenter trial
5530709|NCT01164826|Bioequivalence|bioequivalence
5530710|NCT01164826|Crossover|crossover
5530711|NCT01164826|Nabumetone|nabumetone
5530712|NCT01164813|Bioequivalence|bioequivalence
5530713|NCT01164813|Crossover|crossover
5530714|NCT01164813|Nabumetone|nabumetone
5530715|NCT01164800|Bioequivalence|bioequivalence
5530716|NCT01164800|Crossover|crossover
5530717|NCT01164800|Trandolapril|trandolapril
5530718|NCT01164787|Bioequivalence|bioequivalence
5530719|NCT01164787|Crossover|crossover
5530720|NCT01164787|Trandolapril|trandolapril
5530721|NCT01164774|Bioavailability|bioavailability
5530722|NCT01164774|Crossover|crossover
5530723|NCT01164774|Ramipril|ramipril
5530724|NCT01164761|Bioavailability|bioavailability
5530725|NCT01164761|Crossover|crossover
5530726|NCT01164761|Ramipril|ramipril
5530727|NCT01164722|anal cancer|anal cancer
5530728|NCT01164722|HIV infection|hiv infection
5530729|NCT01164722|human papilloma virus infection|human papilloma virus infection
5530730|NCT01164722|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5530731|NCT01164722|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5530732|NCT01164709|refractory multiple myeloma|refractory multiple myeloma
5530733|NCT01164709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5671482|NCT00615875|acute pain|acute pain
5530734|NCT01164709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5530735|NCT01164709|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5530736|NCT01164709|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5530737|NCT01164709|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5530738|NCT01164709|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5530739|NCT01164709|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5530740|NCT01164709|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5530741|NCT01164709|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5530742|NCT01164709|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5530743|NCT01164709|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5530744|NCT01164709|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5530745|NCT01164709|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5530746|NCT01164709|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5530747|NCT01164709|aggressive NK-cell leukemia|aggressive nk-cell leukemia
5530748|NCT01164709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5530749|NCT01164709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5530750|NCT01164709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5530751|NCT01164709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5530752|NCT01164709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5530753|NCT01164709|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5530754|NCT01164709|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5530755|NCT01164709|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5530756|NCT01164709|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5530757|NCT01164709|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5530758|NCT01164709|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5530759|NCT01164709|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5530760|NCT01164709|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5530761|NCT01164709|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5530762|NCT01164709|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5530763|NCT01164709|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5530764|NCT01164709|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5530765|NCT01164709|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5530766|NCT01164709|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5530767|NCT01164709|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5530768|NCT01164709|prolymphocytic leukemia|prolymphocytic leukemia
5530769|NCT01164696|Quality of Life, Health Care Costs|quality of life, health care costs
5530770|NCT01164683|sleep apnea|sleep apnea
5530771|NCT01164683|adherence|adherence
5530772|NCT01164657|upright position|upright position
5530773|NCT01164657|birth position|birth position
5530774|NCT01164657|childbirth|childbirth
5530775|NCT01164657|instrumental deliveries|instrumental deliveries
5530776|NCT01164657|primiparous|primiparous
5530777|NCT01164644|ecchymosis|ecchymosis
5530778|NCT01164644|bruising|bruising
5530779|NCT01164644|rhinoplasty|rhinoplasty
5530780|NCT01164644|nose job|nose job
5530781|NCT01164644|arnica|arnica
5530782|NCT01164644|arnica montana|arnica montana
5530783|NCT01164631|Sleep Apnea Syndrome|sleep apnea syndrome
5530784|NCT01164631|Orthodontics|orthodontics
5530785|NCT01164631|Tonsillectomy|tonsillectomy
5530786|NCT01164631|Child|child
5530787|NCT01164618|pediatrics|pediatrics
5530788|NCT01164618|Remote ischemic preconditioning|remote ischemic preconditioning
5530789|NCT01164605|NRTI-regimen|nrti-regimen
5530790|NCT01164605|Raltegravir|raltegravir
5530791|NCT01164605|Elvitegravir|elvitegravir
5530792|NCT01164605|HIV-1 integrase inhibitor|hiv-1 integrase inhibitor
5530793|NCT01164605|Fat Waste|fat waste
5530794|NCT01164592|Heart failure (HF)|heart failure (hf)
5530795|NCT01164592|Sleep disordered breathing (SDB)|sleep disordered breathing (sdb)
5530796|NCT01164592|Cheyne Stokes Respiration (CSR)|cheyne stokes respiration (csr)
5530797|NCT01164592|Adaptive Servoventilation (ASV)|adaptive servoventilation (asv)
5530798|NCT01164579|Early Rheumatoid Arthritis|early rheumatoid arthritis
5530800|NCT01164579|Magnetic Resonance Imaging|magnetic resonance imaging
5530801|NCT01164579|Janus Kinase (JAK) Inhibitor|janus kinase (jak) inhibitor
5530802|NCT01164579|Tasocitinib|tasocitinib
5530803|NCT01164579|Tofacitinib|tofacitinib
5530804|NCT01164553|influenza, pediatric, vaccine|influenza, pediatric, vaccine
5530805|NCT01164540|Deep venous thrombosis|deep venous thrombosis
5530806|NCT01164540|Pulmonary embolism|pulmonary embolism
5530807|NCT01164540|rosuvastatin treatment|rosuvastatin treatment
5530808|NCT01164514|bacterial sepsis, septicemia, vaccine|bacterial sepsis, septicemia, vaccine
5530809|NCT01164449|algorithm|algorithm
5530810|NCT01164449|tight glycemic control|tight glycemic control
5530812|NCT01164449|intensive care|intensive care
5530813|NCT01164449|insulin|insulin
5530814|NCT01164449|ICU|icu
5530815|NCT01164423|algorithm|algorithm
5530816|NCT01164423|tight glycemic control|tight glycemic control
5530817|NCT01164423|glucose control|glucose control
5530818|NCT01164423|intensive care|intensive care
5530819|NCT01164423|insulin|insulin
5530820|NCT01164423|ICU|icu
5530821|NCT01164397|Hypercholesterolemia|hypercholesterolemia
5530822|NCT01164397|Statins|statins
5530823|NCT01164371|coronary disease|coronary disease
5530824|NCT01164371|cardiovascular disease|cardiovascular disease
5530825|NCT01164371|cardiovascular risk|cardiovascular risk
5530826|NCT01164371|cardiovascular risk management|cardiovascular risk management
5530827|NCT01164371|primary care|primary care
5530828|NCT01164371|angina|angina
5530829|NCT01164371|stable angina|stable angina
5530830|NCT01164371|angina pectoris|angina pectoris
5530831|NCT01164371|acute coronary syndrome|acute coronary syndrome
5530832|NCT01164371|coronary death|coronary death
5530833|NCT01164371|unheralded acute coronary syndrome|unheralded acute coronary syndrome
5530834|NCT01164371|unheralded coronary death|unheralded coronary death
5530835|NCT01164371|gender differences|gender differences
5530836|NCT01164371|sex differences|sex differences
5530837|NCT01164371|myocardial infarction|myocardial infarction
5530838|NCT01164371|ST elevation myocardial infarction|st elevation myocardial infarction
5530839|NCT01164371|non ST elevation myocardial infarction|non st elevation myocardial infarction
5530840|NCT01164371|STEMI|stemi
5530841|NCT01164371|nSTEMI|nstemi
5530842|NCT01164371|unstable angina|unstable angina
5530843|NCT01164358|Presbyopia|presbyopia
5530844|NCT01164358|INTRACOR|intracor
5530845|NCT01164358|patient satisfaction|patient satisfaction
5530846|NCT01164358|long term|long term
5530847|NCT01164345|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5530848|NCT01164345|Hodgkin's lymphoma|hodgkin's lymphoma
5530849|NCT01164345|stem cell mobilization|stem cell mobilization
5530850|NCT01164345|autologous stem cell transplantation|autologous stem cell transplantation
5530851|NCT01164319|Atrial fibrillation|atrial fibrillation
5530852|NCT01164319|Percutaneous continous monitoring|percutaneous continous monitoring
5530853|NCT01164319|ablation|ablation
5530854|NCT01164306|LifeSkills Training|lifeskills training
5530855|NCT01164306|Tobacco prevention|tobacco prevention
5530856|NCT01164306|Tobacco cessation|tobacco cessation
5530857|NCT01164306|Healthy lifestyles|healthy lifestyles
5530858|NCT01164306|Tobacco control|tobacco control
5530859|NCT01164293|Atopy patch test|atopy patch test
5530860|NCT01164254|Exposure Assessment|exposure assessment
5530861|NCT01164254|Web-Based Dietary Assessment|web-based dietary assessment
5530862|NCT01164254|Web-Based Physical Activity Assessment|web-based physical activity assessment
5530863|NCT01164241|CARD14|card14
5530864|NCT01164241|Tryptase|tryptase
5530865|NCT01164241|CARD11|card11
5530866|NCT01164241|Genetics|genetics
5530867|NCT01164241|Atopy|atopy
5530868|NCT01164228|recurrent renal cell cancer|recurrent renal cell cancer
5530869|NCT01164228|stage IV renal cell cancer|stage iv renal cell cancer
5530870|NCT01164228|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5530871|NCT01164228|papillary renal cell carcinoma|papillary renal cell carcinoma
5530872|NCT01164228|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5530873|NCT01164215|neutropenia|neutropenia
5530874|NCT01164215|diarrhea|diarrhea
5530875|NCT01164215|stage I colon cancer|stage i colon cancer
5530876|NCT01164215|stage II colon cancer|stage ii colon cancer
5530877|NCT01164215|stage III colon cancer|stage iii colon cancer
5530878|NCT01164215|stage IV colon cancer|stage iv colon cancer
5530879|NCT01164215|recurrent colon cancer|recurrent colon cancer
5530880|NCT01164215|stage I rectal cancer|stage i rectal cancer
5530881|NCT01164215|stage II rectal cancer|stage ii rectal cancer
5530883|NCT01164215|stage IV rectal cancer|stage iv rectal cancer
5530884|NCT01164215|recurrent rectal cancer|recurrent rectal cancer
5530885|NCT01164202|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5530886|NCT01164202|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5530887|NCT01164202|advanced adult primary liver cancer|advanced adult primary liver cancer
5530888|NCT01164189|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5530889|NCT01164189|adult diffuse astrocytoma|adult diffuse astrocytoma
5530890|NCT01164189|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5530891|NCT01164189|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5530892|NCT01164189|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5530893|NCT01164189|adult oligodendroglioma|adult oligodendroglioma
5530894|NCT01164189|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5530895|NCT01164189|recurrent adult brain tumor|recurrent adult brain tumor
5530896|NCT01164189|adult giant cell glioblastoma|adult giant cell glioblastoma
5530897|NCT01164189|adult glioblastoma|adult glioblastoma
5530898|NCT01164189|adult gliosarcoma|adult gliosarcoma
5530899|NCT01164189|adult mixed glioma|adult mixed glioma
5530900|NCT01164176|anaplastic thyroid cancer|anaplastic thyroid cancer
5530901|NCT01164176|insular thyroid cancer|insular thyroid cancer
5530902|NCT01164176|recurrent thyroid cancer|recurrent thyroid cancer
5530903|NCT01164176|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5530904|NCT01164176|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5530905|NCT01164176|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5530906|NCT01164176|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5530907|NCT01164176|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5530908|NCT01164163|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5530909|NCT01164163|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5530910|NCT01164163|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5530999|NCT01163903|Advanced solid tumours|advanced solid tumours
5530911|NCT01164163|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5530912|NCT01164163|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5530913|NCT01164163|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5530914|NCT01164163|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5530915|NCT01164163|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5530916|NCT01164163|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5530917|NCT01164163|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5530918|NCT01164163|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5530920|NCT01164163|essential thrombocythemia|essential thrombocythemia
5530921|NCT01164163|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5530922|NCT01164163|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
5530923|NCT01164163|primary myelofibrosis|primary myelofibrosis
5530924|NCT01164150|gastrointestinal complications|gastrointestinal complications
5530925|NCT01164150|urinary complications|urinary complications
5530926|NCT01164150|radiation toxicity|radiation toxicity
5530927|NCT01164150|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5530928|NCT01164150|endometrial adenocarcinoma|endometrial adenocarcinoma
5530929|NCT01164150|stage IA endometrial carcinoma|stage ia endometrial carcinoma
5530930|NCT01164150|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5530931|NCT01164150|stage II endometrial carcinoma|stage ii endometrial carcinoma
5530932|NCT01164150|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5530933|NCT01164150|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5530934|NCT01164150|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5530935|NCT01164137|Adverse Drug Events|adverse drug events
5530936|NCT01164137|Medication Reconciliation|medication reconciliation
5530937|NCT01164137|Pharmacist-led Intervention|pharmacist-led intervention
5530938|NCT01164124|extremely low birth weight|extremely low birth weight
5530939|NCT01164124|probiotics|probiotics
5530941|NCT01164124|nutrition|nutrition
5530942|NCT01164124|premature infants|premature infants
5530943|NCT01164124|growth in extremely low birth weight infants|growth in extremely low birth weight infants
5530944|NCT01164111|osteoarthritis|osteoarthritis
5530945|NCT01164111|hip arthroplasty|hip arthroplasty
5530946|NCT01164111|resistance training|resistance training
5530947|NCT01164111|preoperative training|preoperative training
5530948|NCT01164085|Inflammation|inflammation
5530949|NCT01164085|Macular Edema|macular edema
5530950|NCT01164072|electronic cigarette|electronic cigarette
5530951|NCT01164072|nicotine|nicotine
5530952|NCT01164072|smoking cessation|smoking cessation
5530953|NCT01164072|smoking reduction|smoking reduction
5530954|NCT01164059|Schizophrenia|schizophrenia
5530955|NCT01164059|atypical antipsychotic drugs|atypical antipsychotic drugs
5530956|NCT01164059|conventional antipsychotic drugs|conventional antipsychotic drugs
5530957|NCT01164059|olanzapine|olanzapine
5530962|NCT01164046|anticoagulants|anticoagulants
5530963|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5530964|NCT01164046|4-Hydroxycoumarins|4-hydroxycoumarins
5530965|NCT01164046|recurrent venous thrombosis|recurrent venous thrombosis
5530966|NCT01164020|cognition|cognition
5530967|NCT01164020|supplementation creatine|supplementation creatine
5530970|NCT01163994|erythema migrans|erythema migrans
5530971|NCT01163994|Lyme borreliosis|lyme borreliosis
5530972|NCT01163994|ceftriaxone treatment|ceftriaxone treatment
5530973|NCT01163994|doxycycline treatment|doxycycline treatment
5530974|NCT01163994|outcome|outcome
5530975|NCT01163994|subjective symptoms|subjective symptoms
5530976|NCT01163981|duplex Ultrasound|duplex ultrasound
5530977|NCT01163981|Haemodialysis|haemodialysis
5530978|NCT01163981|Vascular Access|vascular access
5530979|NCT01163968|Weight reduction|weight reduction
5530980|NCT01163968|Cardiac revascularization|cardiac revascularization
5530981|NCT01163968|Percutaneous Coronary Intervention|percutaneous coronary intervention
5530982|NCT01163968|Cardiac Rehabilitation|cardiac rehabilitation
5530984|NCT01163955|Posture analysis|posture analysis
5530985|NCT01163955|Video gaming|video gaming
5530986|NCT01163955|Forward Head Position|forward head position
5530987|NCT01163955|Rounded Shoulder Position|rounded shoulder position
5530988|NCT01163955|Spine Posture|spine posture
5530989|NCT01163929|breast cancer|breast cancer
5530990|NCT01163929|HER2 positive|her2 positive
5530991|NCT01163929|Phase II|phase ii
5530992|NCT01163929|RAD001|rad001
5530993|NCT01163929|paclitaxel|paclitaxel
5530994|NCT01163929|trastuzumab|trastuzumab
5530995|NCT01163929|everolimus|everolimus
5530996|NCT01163916|Rheumatoid Arthritis|rheumatoid arthritis
5530997|NCT01163916|Psoriatic Arthritis|psoriatic arthritis
5530998|NCT01163916|Ankylosing Spondylitis|ankylosing spondylitis
5531002|NCT01163903|PANTO IV|panto iv
5531003|NCT01163903|Adriamycin|adriamycin
5531004|NCT01163903|no standard treatment options|no standard treatment options
5531005|NCT01163903|dose-escalation schedule|dose-escalation schedule
5531006|NCT01163903|Phase I|phase i
5531007|NCT01163903|single-centre|single-centre
5531008|NCT01163903|open label|open label
5531009|NCT01163903|dose finding|dose finding
5531010|NCT01163903|recommended phase II dose|recommended phase ii dose
5531011|NCT01163903|proton pump inhibitor|proton pump inhibitor
5531012|NCT01163903|advanced cancer|advanced cancer
5531013|NCT01163903|anthracycline|anthracycline
5531014|NCT01163903|gastric acid secretion|gastric acid secretion
5531015|NCT01163890|Depression|depression
5531016|NCT01163890|Work Performance and Productivity|work performance and productivity
5531017|NCT01163890|Worksite Intervention|worksite intervention
5531018|NCT01163877|iron absorption|iron absorption
5531019|NCT01163877|iron utilization|iron utilization
5531020|NCT01163877|malaria|malaria
5531021|NCT01163877|helminth|helminth
5531022|NCT01163877|Ivory Coast|ivory coast
5531023|NCT01163877|Acute symptomatic uncomplicated falciparum malaria|acute symptomatic uncomplicated falciparum malaria
5531024|NCT01163877|Asymptomatic falciparum malaria|asymptomatic falciparum malaria
5531025|NCT01163877|Moderate to heavy hookworm infection|moderate to heavy hookworm infection
5531026|NCT01163877|Heavy Schistosoma haematobium infection|heavy schistosoma haematobium infection
5531028|NCT01163864|smoking relapse|smoking relapse
5531029|NCT01163864|smoking cessation|smoking cessation
5531030|NCT01163864|pregnancy|pregnancy
5531031|NCT01163864|smoking cessation in pregnant women|smoking cessation in pregnant women
5531032|NCT01163851|Hypercholesterolemia|hypercholesterolemia
5531033|NCT01163851|Dyslipidemia|dyslipidemia
5531034|NCT01163851|LDL|ldl
5531035|NCT01163851|Cholesterol|cholesterol
5531036|NCT01163851|High Cholesterol|high cholesterol
5531037|NCT01163851|PF-04950615|pf-04950615
5531038|NCT01163851|RN316|rn316
5531039|NCT01163838|Hypercholesterolemia|hypercholesterolemia
5531040|NCT01163838|Dyslipidemia|dyslipidemia
5531041|NCT01163838|LDL|ldl
5531042|NCT01163838|Cholesterol|cholesterol
5531043|NCT01163838|High Cholesterol|high cholesterol
5531044|NCT01163812|D2 lymph node dissection|d2 lymph node dissection
5531045|NCT01163799|Kidney|kidney
5531046|NCT01163799|Transplant|transplant
5531047|NCT01163799|Northwestern|northwestern
5531048|NCT01163799|Calcineurin Inhibitor|calcineurin inhibitor
5531049|NCT01163799|Corticosteroids|corticosteroids
5531050|NCT01163799|Steroid avoidance|steroid avoidance
5531052|NCT01163773|Cardiovascular disease|cardiovascular disease
5531053|NCT01163773|Milk|milk
5531054|NCT01163773|Metabolic syndrome|metabolic syndrome
5531055|NCT01163773|Blood lipids|blood lipids
5531056|NCT01163773|Menopausal women|menopausal women
5531057|NCT01163734|Heart Failure with Preserved Ejection Fraction (HFpEF)|heart failure with preserved ejection fraction (hfpef)
5531058|NCT01163734|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5525196|NCT01187316|Adolescent|adolescent
5531059|NCT01163721|Type 2 diabetes mellitus|type 2 diabetes mellitus
5531060|NCT01163721|T2DM|t2dm
5531061|NCT01163721|Ranolazine|ranolazine
5531062|NCT01163721|Ranexa|ranexa
5531063|NCT01163721|HbA1c|hba1c
5531064|NCT01163695|economic empowerment model, orphans, sub-Saharan Africa|economic empowerment model, orphans, sub-saharan africa
5531065|NCT01163682|Taxane induced neuropathy|taxane induced neuropathy
5531066|NCT01163669|hyperparathyroidism|hyperparathyroidism
5531067|NCT01163656|Neonate|neonate
5531068|NCT01163656|Laryngoscopes|laryngoscopes
5531069|NCT01163630|open label, randomized|open label, randomized
5531071|NCT01163630|2-way crossover|2-way crossover
5531072|NCT01163630|food interaction study|food interaction study
5531073|NCT01163617|Rheumatoid|rheumatoid
5531074|NCT01163617|Arthritis|arthritis
5531075|NCT01163604|Argatroban|argatroban
5531076|NCT01163604|intracranial artery stenting|intracranial artery stenting
5531077|NCT01163604|extracranial artery stenting|extracranial artery stenting
5531078|NCT01163604|occlusion|occlusion
5531079|NCT01163604|restenosis|restenosis
5531080|NCT01163591|Diabetes|diabetes
5531081|NCT01163591|Nephropathy|nephropathy
5531082|NCT01163591|Screening|screening
5531083|NCT01163578|Transplantation|transplantation
5531084|NCT01163578|Rejection|rejection
5531085|NCT01163565|Thyroidectomy|thyroidectomy
5531086|NCT01163552|pleural metastases|pleural metastases
5531087|NCT01163513|ethnicity|ethnicity
5531088|NCT01163513|prognosis|prognosis
5531089|NCT01163474|Telemedicine|telemedicine
5531090|NCT01163474|Surgery, Cardiac|surgery, cardiac
5531091|NCT01163448|Prostate|prostate
5531092|NCT01163448|Radiation|radiation
5531093|NCT01163448|Radical prostatectomy|radical prostatectomy
5531094|NCT01163448|09-013|09-013
5531095|NCT01163435|Helicobacter pylori|helicobacter pylori
5531096|NCT01163435|antibiotic resistance|antibiotic resistance
5531097|NCT01163435|high dose dual therapy|high dose dual therapy
5531098|NCT01163435|sequential therapy|sequential therapy
5531099|NCT01163435|clarithromycin-based triple therapy|clarithromycin-based triple therapy
5531100|NCT01163435|levofloxacin-based triple therapy|levofloxacin-based triple therapy
5531101|NCT01163422|Right ventricular failure|right ventricular failure
5531102|NCT01163422|Pacemaker|pacemaker
5531103|NCT01163422|Cardiac resynchronization therapy|cardiac resynchronization therapy
5531104|NCT01163422|Pulmonary hypertension|pulmonary hypertension
5531105|NCT01163409|juvenile fibromyalgia|juvenile fibromyalgia
5531106|NCT01163409|acupuncture|acupuncture
5531107|NCT01163409|exercise training|exercise training
5531108|NCT01163383|Refractory Neuroblastoma|refractory neuroblastoma
5531109|NCT01163383|Recurrent Neuroblastoma|recurrent neuroblastoma
5531110|NCT01163383|Neuroblastoma|neuroblastoma
5531111|NCT01163383|stage IV neuroblastoma|stage iv neuroblastoma
5531112|NCT01163383|metastatic pheochromocytoma|metastatic pheochromocytoma
5531113|NCT01163383|paraganglioma|paraganglioma
5531114|NCT01163370|creatine supplementation|creatine supplementation
5531115|NCT01163370|resistance training|resistance training
5531116|NCT01163370|osteopenia|osteopenia
5531117|NCT01163370|osteoporosis|osteoporosis
5531118|NCT01163370|bone mineral density|bone mineral density
5531119|NCT01163344|Gait, balance, Parkinson's Disease|gait, balance, parkinson's disease
5531120|NCT01163331|Parkinson's Disease, voice quality, vocal strength, voice loudness|parkinson's disease, voice quality, vocal strength, voice loudness
5531121|NCT01163318|Rheumatoid Arthritis|rheumatoid arthritis
5531122|NCT01163305|Identifying an early indicator of drug efficacy|identifying an early indicator of drug efficacy
5531123|NCT01163292|Rheumatoid Arthritis|rheumatoid arthritis
5531124|NCT01163279|Age-related changes|age-related changes
5531125|NCT01163266|Major Depressive Disorder|major depressive disorder
5531126|NCT01163266|Depression|depression
5531127|NCT01163266|Melancholia|melancholia
5531128|NCT01163266|Drug Therapy|drug therapy
5531129|NCT01163253|chronic|chronic
5531130|NCT01163253|severe|severe
5531131|NCT01163253|treatment|treatment
5531132|NCT01163253|safety|safety
5531133|NCT01163253|CP-690,55|cp-690,55
5531134|NCT01163253|Plaque Psoriasis|plaque psoriasis
5531135|NCT01163253|Psoriasis Vulgaris|psoriasis vulgaris
5531136|NCT01163253|Xeljanz|xeljanz
5531137|NCT01163253|Tofacitinib|tofacitinib
5531138|NCT01163240|hepatitis B|hepatitis b
5531140|NCT01163240|chronic hepatitis B|chronic hepatitis b
5531141|NCT01163240|pediatric|pediatric
5531142|NCT01163227|Hallucinations,|hallucinations,
5531143|NCT01163227|psychotic,|psychotic,
5531144|NCT01163227|delusions,|delusions,
5531145|NCT01163227|cognitive deficits|cognitive deficits
5531146|NCT01163188|very low birthweight/ very preterm children|very low birthweight/ very preterm children
5531147|NCT01163188|Bavarian Longitudinal Study (BLS)|bavarian longitudinal study (bls)
5531148|NCT01163188|Quality of life and social adjustment in adulthood|quality of life and social adjustment in adulthood
5531149|NCT01163175|Cardiovascular disease|cardiovascular disease
5531150|NCT01163175|Trans fatty acids|trans fatty acids
5531151|NCT01163175|Ruminant|ruminant
5531152|NCT01163175|Blood lipids|blood lipids
5531153|NCT01163162|Chronic Kidney Disease|chronic kidney disease
5531154|NCT01163162|Vitamin D|vitamin d
5531155|NCT01163149|Hypophosphatasia|hypophosphatasia
5531156|NCT01163149|HPP|hpp
5531157|NCT01163149|Bone Disease|bone disease
5531158|NCT01163149|Soft Bones|soft bones
5531159|NCT01163149|Low Alkaline Phosphatase|low alkaline phosphatase
5531160|NCT01163149|genetic metabolic disorder|genetic metabolic disorder
5531161|NCT01163149|alkaline phosphatase|alkaline phosphatase
5685361|NCT00556426|IVC Filter|ivc filter
5531162|NCT01163149|tissue-specific alkaline phosphatase (TNSALP)|tissue-specific alkaline phosphatase (tnsalp)
5531163|NCT01163149|rickets|rickets
5531164|NCT01163149|osteomalacia|osteomalacia
5531165|NCT01163136|Parental decision making|parental decision making
5531166|NCT01163136|Decision Making in Serious Pediatric Illness (DSPI)|decision making in serious pediatric illness (dspi)
5531167|NCT01163136|palliative care decision making|palliative care decision making
5531168|NCT01163123|Subclinical infection of Japanese encephalitis virus|subclinical infection of japanese encephalitis virus
5531170|NCT01163045|intraoperative neuromonitoring|intraoperative neuromonitoring
5531171|NCT01163045|recurrent laryngeal nerve|recurrent laryngeal nerve
5904042|NCT00007813|childhood oligodendroglioma|childhood oligodendroglioma
5531172|NCT01163045|palsy of recurrent laryngeal nerve|palsy of recurrent laryngeal nerve
5531174|NCT01163032|Blindness|blindness
5531175|NCT01163032|Eye Diseases|eye diseases
5531176|NCT01163032|Nap Disorders|nap disorders
5531177|NCT01163032|Circadian Rhythm Disorders|circadian rhythm disorders
5531178|NCT01163032|Sleep disorders|sleep disorders
5531179|NCT01163032|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5531180|NCT01163032|Dyssomnias|dyssomnias
5531181|NCT01163032|Nervous System Diseases|nervous system diseases
5531182|NCT01163019|Chest pain|chest pain
5531183|NCT01163019|acute coronary syndrome|acute coronary syndrome
5531184|NCT01163019|Emergency department|emergency department
5531185|NCT01163019|speckle tracking imaging|speckle tracking imaging
5531186|NCT01163019|2D strain|2d strain
5531187|NCT01163019|Echocardiography|echocardiography
5531188|NCT01162993|Electric stimulation therapy|electric stimulation therapy
5531189|NCT01162993|Diabetic Neuropathies|diabetic neuropathies
5531190|NCT01162980|ACE inhibitors|ace inhibitors
5531192|NCT01162954|Eye drop, Dry eye|eye drop, dry eye
5531193|NCT01162941|ITP|itp
5531194|NCT01162928|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support|critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support
5531195|NCT01162915|Spinal Cord Injury|spinal cord injury
5531196|NCT01162889|pharmacokinetics|pharmacokinetics
5531197|NCT01162889|Crohn's disease|crohn's disease
5531198|NCT01162876|Diabetes, Type 2|diabetes, type 2
5531199|NCT01162863|IBSC|ibsc
5531200|NCT01162863|irritable bowel syndrome|irritable bowel syndrome
5531201|NCT01162863|constipation|constipation
5531202|NCT01162850|Melasma|melasma
5531203|NCT01162837|Acne|acne
5531204|NCT01162824|Endothelial Dysfunction|endothelial dysfunction
5531205|NCT01162824|Microvascular dysfunction|microvascular dysfunction
5531206|NCT01162824|Coronary artery spasm|coronary artery spasm
5531207|NCT01162824|Inflammation|inflammation
5531208|NCT01162824|CD4+CD28null T cells|cd4+cd28null t cells
5531209|NCT01162824|Myocardial ischemia|myocardial ischemia
5531210|NCT01162824|Early atherosclerosis|early atherosclerosis
5531211|NCT01162811|Visualization|visualization
5531212|NCT01162811|relaxation|relaxation
5531213|NCT01162811|self hypnotic relaxation|self hypnotic relaxation
5531214|NCT01162811|hypnosis|hypnosis
5531215|NCT01162811|invasive medical procedures|invasive medical procedures
5531216|NCT01162811|atrial fibrillation|atrial fibrillation
5531217|NCT01162811|ablation|ablation
5531218|NCT01162811|catheter ablation|catheter ablation
5531219|NCT01162811|pain|pain
5531220|NCT01162811|anxiety|anxiety
5531221|NCT01162798|infant formula|infant formula
5531222|NCT01162798|premature infants|premature infants
5531223|NCT01162798|Growth and Development|growth and development
5531224|NCT01162785|BCG Refractory Superficial Bladder Cancer|bcg refractory superficial bladder cancer
5531225|NCT01162785|SCH 721015|sch 721015
5531226|NCT01162785|Syn3|syn3
5531227|NCT01162785|novel excipient|novel excipient
5531228|NCT01162785|interferon -alpha-2b|interferon -alpha-2b
5531229|NCT01162785|Intravesical|intravesical
5531230|NCT01162785|urine IFNa|urine ifna
5531231|NCT01162785|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5531232|NCT01162785|superficial non-muscle invasive tumor|superficial non-muscle invasive tumor
5531233|NCT01162759|hypertension, intervention|hypertension, intervention
5531234|NCT01162733|Vancomycin|vancomycin
5531235|NCT01162733|Therapeutic Levels|therapeutic levels
5531236|NCT01162733|Infectious Disease|infectious disease
5531237|NCT01162733|Recommendations|recommendations
5531238|NCT01162720|Primary knee replacement|primary knee replacement
5531239|NCT01162720|Unilateral knee replacement|unilateral knee replacement
5531240|NCT01162694|Remote Blood Glucose Monitoring System,|remote blood glucose monitoring system,
5531241|NCT01162694|Continuous Glucose Monitoring System,|continuous glucose monitoring system,
5531242|NCT01162694|Type 2 Diabetes|type 2 diabetes
5531243|NCT01162681|SLE|sle
5531244|NCT01162681|Lupus|lupus
5531245|NCT01162681|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5531246|NCT01162681|Autoimmune Diseases|autoimmune diseases
5531247|NCT01162681|A-623|a-623
5531248|NCT01162681|Blisibimod|blisibimod
5531249|NCT01162668|bariatric surgery|bariatric surgery
5531251|NCT01162668|outcomes|outcomes
5531252|NCT01162655|Insomnia|insomnia
5531253|NCT01162655|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5531254|NCT01162655|Internet|internet
5531255|NCT01162655|Telehealth|telehealth
5531256|NCT01162642|Healthy moderately heavy smokers|healthy moderately heavy smokers
5531257|NCT01162629|bounded saddles|bounded saddles
5531259|NCT01162629|dental implants|dental implants
5531260|NCT01162629|Tooth, Nonvital|tooth, nonvital
5531261|NCT01162616|iron absorption|iron absorption
5531262|NCT01162616|polyphenols|polyphenols
5531263|NCT01162616|sodium iron EDTA|sodium iron edta
5531264|NCT01162616|sorghum|sorghum
5531265|NCT01162590|Human Rotavirus vaccine|human rotavirus vaccine
5531266|NCT01162577|Weight|weight
5531267|NCT01162577|Smoking|smoking
5531268|NCT01162577|Quitline|quitline
5693702|NCT00523640|kidney|kidney
5531269|NCT01162551|Leukemia|leukemia
5531270|NCT01162551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5531271|NCT01162538|Raltegravir, non B subtype, naive patients|raltegravir, non b subtype, naive patients
5531272|NCT01162525|Fecal Incontinence|fecal incontinence
5531273|NCT01162525|Fecal Urge Incontinence|fecal urge incontinence
5531274|NCT01162525|Percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
5531275|NCT01162512|physical activity|physical activity
5531276|NCT01162512|obesity|obesity
5531277|NCT01162512|adolescents|adolescents
5531278|NCT01162512|telephone|telephone
5531279|NCT01162512|BMI|bmi
5531280|NCT01162512|body mass index|body mass index
5531281|NCT01162499|Post prandial hypoglycemia|post prandial hypoglycemia
5531282|NCT01162499|hypoglycemia|hypoglycemia
5531283|NCT01162499|Nissen fundoplication|nissen fundoplication
5531284|NCT01162499|Dumping|dumping
5531285|NCT01162486|Anti-infective agents|anti-infective agents
5531286|NCT01162486|Anti-bacterial agents|anti-bacterial agents
5531287|NCT01162486|Rifampin|rifampin
5531288|NCT01162486|Rifapentine|rifapentine
5531289|NCT01162486|Midazolam|midazolam
5531290|NCT01162486|Molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
5531291|NCT01162486|Antitubercular agents|antitubercular agents
5531292|NCT01162486|Pharmacologic actions|pharmacologic actions
5531293|NCT01162473|Food hypersensitivity|food hypersensitivity
5531294|NCT01162473|Milk hypersensitivity|milk hypersensitivity
5531295|NCT01162473|Milk allergy|milk allergy
5531296|NCT01162473|Food allergy|food allergy
5531297|NCT01162447|BMP- 4 and 7, polycystic ovarian syndrome|bmp- 4 and 7, polycystic ovarian syndrome
5531298|NCT01162434|Treatment resistant depression|treatment resistant depression
5531299|NCT01162434|Deep brain stimulation|deep brain stimulation
5531300|NCT01162434|Brain volumetric analysis|brain volumetric analysis
5531301|NCT01162421|Rheumatoid Arthritis|rheumatoid arthritis
5531302|NCT01162421|Anti-Inflammatory|anti-inflammatory
5531303|NCT01162421|Biological Therapy|biological therapy
5531304|NCT01162421|adalimumab|adalimumab
5531305|NCT01162421|Disease-Modifying Antirheumatic Drugs|disease-modifying antirheumatic drugs
5531306|NCT01162421|Antirheumatic Agents|antirheumatic agents
5531307|NCT01162421|Agents|agents
5531308|NCT01162408|ICU|icu
5531309|NCT01162395|Prostate Cancer|prostate cancer
5531310|NCT01162395|Tumour|tumour
5531311|NCT01162395|Castration Resistant|castration resistant
5531312|NCT01162395|Prostate Androgen Receptor Down Regulator|prostate androgen receptor down regulator
5531313|NCT01162395|Metastatic|metastatic
5531314|NCT01162382|transcranial magnetic stimulation|transcranial magnetic stimulation
5531315|NCT01162382|TMS|tms
5531316|NCT01162382|rTMS|rtms
5531317|NCT01162382|depression|depression
5531318|NCT01162382|fcMRI|fcmri
5531319|NCT01162382|EEG|eeg
5531320|NCT01162369|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
5531321|NCT01162356|Vitrectomy|vitrectomy
5531322|NCT01162356|Glaucoma|glaucoma
5531323|NCT01162356|Macula|macula
5531324|NCT01162356|Optic nerve|optic nerve
5531325|NCT01162356|Ocular Coherence Tomography|ocular coherence tomography
5531326|NCT01162343|Delirium, diagnosis, elderly, hospitalization|delirium, diagnosis, elderly, hospitalization
5531327|NCT01162330|Screening|screening
5531328|NCT01162330|Congenital Cytomegalovirus|congenital cytomegalovirus
5531329|NCT01162330|CMV|cmv
5531330|NCT01162330|Hearing loss|hearing loss
5531331|NCT01162317|Acupuncture|acupuncture
5531332|NCT01162317|Sleep|sleep
5531333|NCT01162317|Traumatic brain injury|traumatic brain injury
5531334|NCT01162304|Chronic Pain|chronic pain
5531335|NCT01162304|This clinical trial will compare immediate-release (IR)|this clinical trial will compare immediate-release (ir)
5531336|NCT01162304|oxycodone and extended-release (ER) oxycodone in the|oxycodone and extended-release (er) oxycodone in the
5531337|NCT01162304|management of chronic pain|management of chronic pain
5531338|NCT01162291|intramuscular|intramuscular
5531339|NCT01162291|distribution|distribution
5531340|NCT01162291|NaCl|nacl
5531341|NCT01162291|botulinum toxin|botulinum toxin
5531342|NCT01162291|muscle|muscle
5531343|NCT01162291|volume|volume
5531344|NCT01162291|movement|movement
5531345|NCT01162291|biceps brachii|biceps brachii
5525492|NCT01186237|Quality of Life|quality of life
5531349|NCT01162291|effect of muscle movement|effect of muscle movement
5531350|NCT01162278|liver metastases|liver metastases
5531361|NCT01162239|tobacco|tobacco
5531362|NCT01162239|nicotine|nicotine
5531363|NCT01162239|smoking cessation|smoking cessation
5531364|NCT01162226|gait|gait
5531365|NCT01162226|movement disorders|movement disorders
5531366|NCT01162226|balance|balance
5531367|NCT01162226|function|function
5531368|NCT01162213|Postmenopausal Women|postmenopausal women
5531369|NCT01162213|Healthy Males|healthy males
5531370|NCT01162213|Cardiovascular|cardiovascular
5531371|NCT01162213|Flavanols|flavanols
5531372|NCT01162187|secondary prevention|secondary prevention
5531373|NCT01162187|aspirin|aspirin
5531374|NCT01162187|beta blocker|beta blocker
5531375|NCT01162187|ACE inhibitor|ace inhibitor
5531376|NCT01162187|statin|statin
5531377|NCT01162187|acute coronary syndrome|acute coronary syndrome
5531378|NCT01162187|myocardial infarction|myocardial infarction
5531379|NCT01162187|unstable angina|unstable angina
5531380|NCT01162187|trends|trends
5531381|NCT01162174|Flavanols|flavanols
5531382|NCT01162174|cardiovascular|cardiovascular
5531383|NCT01162161|sphingolipid|sphingolipid
5531384|NCT01162161|ceramide|ceramide
5531385|NCT01162161|sphingomyelinase|sphingomyelinase
5531386|NCT01162148|inspiratory muscle training|inspiratory muscle training
5531387|NCT01162148|pulmonary rehabilitation|pulmonary rehabilitation
5531388|NCT01162135|Digoxin|digoxin
5531389|NCT01162135|Recurrent Prostate Cancer|recurrent prostate cancer
5531390|NCT01162135|Prostate Specific Antigen|prostate specific antigen
5531391|NCT01162122|Elderly|elderly
5531392|NCT01162122|Influenza|influenza
5531393|NCT01162122|Immunogenicity|immunogenicity
5531394|NCT01162122|Safety|safety
5531395|NCT01162122|Adjuvant|adjuvant
5531396|NCT01162122|Adjuvanted|adjuvanted
5531397|NCT01162122|Adjuvants|adjuvants
5531398|NCT01162122|Vaccines|vaccines
5531399|NCT01162109|Zinc|zinc
5531400|NCT01162109|sepsis|sepsis
5531401|NCT01162109|critical illness|critical illness
5531402|NCT01162109|mechanical ventilation|mechanical ventilation
5531403|NCT01162109|ICU|icu
5531404|NCT01162096|Reduced Intensity Haploidentical Transplant|reduced intensity haploidentical transplant
5531405|NCT01162083|Exercise Physiology|exercise physiology
5531406|NCT01162083|Cardiopulmonary Interaction|cardiopulmonary interaction
5531407|NCT01162083|Heart Failure|heart failure
5531408|NCT01162070|Uveitis|uveitis
5531409|NCT01162070|etiological diagnosis|etiological diagnosis
5531410|NCT01162070|standardized strategy|standardized strategy
5531411|NCT01162057|Hemodialysis|hemodialysis
5531412|NCT01162057|Hearing|hearing
5531413|NCT01162057|Hemodialysis patients|hemodialysis patients
5531414|NCT01162044|PTSD|ptsd
5531415|NCT01162044|prevention|prevention
5531416|NCT01162005|Primary Nephrotic syndrome|primary nephrotic syndrome
5531417|NCT01161992|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5531418|NCT01161992|PSC|psc
5531419|NCT01161992|Cholestatic Liver Disease|cholestatic liver disease
5531420|NCT01161953|Primary Biliary Cirrhosis|primary biliary cirrhosis
5531421|NCT01161953|PBC|pbc
5531422|NCT01161953|Cholestatic Liver Disease|cholestatic liver disease
5531423|NCT01161940|Bioavailability|bioavailability
5531424|NCT01161940|Nizatidine|nizatidine
5531425|NCT01161940|Crossover|crossover
5531426|NCT01161927|Bioavailability|bioavailability
5531427|NCT01161927|Nizatidine|nizatidine
5531428|NCT01161927|Crossover|crossover
5531429|NCT01161914|Type I Gaucher|type i gaucher
5531430|NCT01161901|ARDS|ards
5531431|NCT01161901|Plasmatic biomarkers|plasmatic biomarkers
5531432|NCT01161901|Lung Morphology|lung morphology
5531433|NCT01161901|Mechanical ventilation|mechanical ventilation
5531434|NCT01161901|CT scan|ct scan
5531435|NCT01161862|Closed-loop|closed-loop
5531436|NCT01161862|Artificial pancreas|artificial pancreas
5531437|NCT01161862|Bi-hormonal|bi-hormonal
5531438|NCT01161862|Insulin|insulin
5531439|NCT01161862|Glucagon|glucagon
5531440|NCT01161862|Diabetes mellitus type 1|diabetes mellitus type 1
5531441|NCT01161849|lactate|lactate
5531442|NCT01161849|urgent surgery|urgent surgery
5531443|NCT01161849|major surgery|major surgery
5531444|NCT01161849|surgical complications|surgical complications
5531445|NCT01161849|possum|possum
5531446|NCT01161849|sapsII|sapsii
5531447|NCT01161849|relaparotomy|relaparotomy
5531449|NCT01161810|Rehabilitation|rehabilitation
5531450|NCT01161797|1,5-Anhydroglucitol|1,5-anhydroglucitol
5525599|NCT01185821|MS|ms
5531451|NCT01161784|Functional constipation|functional constipation
5531452|NCT01161784|Probiotic|probiotic
5531453|NCT01161784|Probiotic microorganism|probiotic microorganism
5531454|NCT01161784|Lactobacillus casei Shirota (LcS)|lactobacillus casei shirota (lcs)
5531455|NCT01161758|physical therapy|physical therapy
5531456|NCT01161758|pain threshold|pain threshold
5531457|NCT01161758|electromyography|electromyography
5531458|NCT01161758|musculoskeletal manipulation|musculoskeletal manipulation
5531459|NCT01161758|neck muscles|neck muscles
5531460|NCT01161745|sepsis|sepsis
5531461|NCT01161732|aortic stenosis|aortic stenosis
5531462|NCT01161732|surgery, survival|surgery, survival
5531463|NCT01161719|ADHD|adhd
5531464|NCT01161719|Parent training|parent training
5531465|NCT01161719|Videoconference|videoconference
5531466|NCT01161706|vegetable juice|vegetable juice
5531467|NCT01161706|cardiovascular|cardiovascular
5531468|NCT01161706|blood pressure|blood pressure
5531469|NCT01161693|Cesarean section|cesarean section
5531470|NCT01161693|spinal anesthesia|spinal anesthesia
5531472|NCT01161693|ramped up position|ramped up position
5531473|NCT01161693|TROOP pillow|troop pillow
5531474|NCT01161693|elevation pillow|elevation pillow
5531475|NCT01161693|maternal comfort|maternal comfort
5531476|NCT01161693|Maternal Comfort after CSE during elective Cesarean Section in relation to adequate height of Anesthetic Block|maternal comfort after cse during elective cesarean section in relation to adequate height of anesthetic block
5531477|NCT01161680|Cross sectional and Longitudinal Observational study|cross sectional and longitudinal observational study
5531478|NCT01161641|Protein Losing Enteropathy|protein losing enteropathy
5531479|NCT01161628|Chronic Graft versus Host Disease|chronic graft versus host disease
5531480|NCT01161628|allogeneic stem cell transplant|allogeneic stem cell transplant
5531481|NCT01161615|tendonitis and/or bursitis of the shoulder|tendonitis and/or bursitis of the shoulder
5531482|NCT01161615|acute tendonitis and/or bursitis of the shoulder|acute tendonitis and/or bursitis of the shoulder
5531483|NCT01161602|Symptoms of Gastroesophageal Reflux Disease (GERD)|symptoms of gastroesophageal reflux disease (gerd)
5531484|NCT01161589|sensing|sensing
5531487|NCT01161589|CRT D|crt d
5531488|NCT01161576|Batten Disease|batten disease
5531489|NCT01161576|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5531490|NCT01161576|gene transfer|gene transfer
5531491|NCT01161563|palliative treatment|palliative treatment
5531492|NCT01161563|prostate cancer|prostate cancer
5531493|NCT01161511|CLL|cll
5531494|NCT01161511|SLL|sll
5531495|NCT01161511|CD19|cd19
5531496|NCT01161498|squamous cell|squamous cell
5531497|NCT01161498|OncoVEX^GM-CSF|oncovex^gm-csf
5531498|NCT01161498|Oncovex|oncovex
5531499|NCT01161498|chemoradiation|chemoradiation
5531500|NCT01161498|Cisplatin|cisplatin
5531501|NCT01161485|HIV Infections|hiv infections
5531502|NCT01161485|Treatment|treatment
5531503|NCT01161485|Methamphetamine|methamphetamine
5531504|NCT01161459|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5531505|NCT01161459|Treatment|treatment
5531506|NCT01161459|FK506|fk506
5531507|NCT01161459|Tripterygium wilfordii|tripterygium wilfordii
5531508|NCT01161446|HIV|hiv
5531509|NCT01161446|Home testing|home testing
5531510|NCT01161446|Self-testing|self-testing
5531511|NCT01161446|HIV Infections/diagnosis|hiv infections/diagnosis
5531512|NCT01161446|HIV Infections/prevention and control|hiv infections/prevention and control
5531513|NCT01161446|AIDS Serodiagnosis|aids serodiagnosis
5531514|NCT01161446|Oral fluids|oral fluids
5531515|NCT01161446|Homosexuality, Male|homosexuality, male
5531516|NCT01161446|Sexually transmitted diseases|sexually transmitted diseases
5531517|NCT01161446|Sexual behavior|sexual behavior
5531518|NCT01161433|Asthma|asthma
5531519|NCT01161433|Spirometry|spirometry
5531520|NCT01161433|Pediatric|pediatric
5531521|NCT01161433|Primary Health Care|primary health care
5531522|NCT01161433|Education, Distance|education, distance
5531523|NCT01161420|tongue|tongue
5531524|NCT01161420|surgery|surgery
5531525|NCT01161420|neurostimulation|neurostimulation
5531526|NCT01161420|hypoglossal nerve|hypoglossal nerve
5531527|NCT01161420|upper airway stimulation|upper airway stimulation
5531528|NCT01161381|OSAHS|osahs
5531529|NCT01161381|nonlinear analysis|nonlinear analysis
5531530|NCT01161381|polysomnography|polysomnography
5531531|NCT01161381|biosignal analysis|biosignal analysis
5531532|NCT01161381|DFA|dfa
5531533|NCT01161381|APEN|apen
5531534|NCT01161381|LLE|lle
5531535|NCT01161368|Metastatic Breast Cancer|metastatic breast cancer
5531536|NCT01161355|Safety|safety
5531537|NCT01161355|tolerability|tolerability
5531538|NCT01161355|healthy|healthy
5531539|NCT01161355|microdose|microdose
5531540|NCT01161342|Malnutrition|malnutrition
5531541|NCT01161342|Aged|aged
5531542|NCT01161342|Aged 80 and over|aged 80 and over
5531543|NCT01161342|Prevalence|prevalence
5531544|NCT01161342|Mortality|mortality
5531545|NCT01161329|stroke|stroke
5531546|NCT01161329|physical activity|physical activity
5531547|NCT01161329|balance|balance
5531548|NCT01161329|muscle-strength|muscle-strength
5531549|NCT01161316|metastatic colorectal cancer|metastatic colorectal cancer
5531550|NCT01161316|wild-type KRAS tumours|wild-type kras tumours
5531552|NCT01161316|mFOLFOX-6|mfolfox-6
5531553|NCT01161303|Asthma|asthma
5531554|NCT01161303|TNF alpha|tnf alpha
5531555|NCT01161303|epithelial cell culture|epithelial cell culture
5531556|NCT01161290|Telemedicine|telemedicine
5531557|NCT01161290|Internet|internet
5531558|NCT01161290|Dyspnea|dyspnea
5531559|NCT01161290|Self care|self care
5531560|NCT01161290|Breathing Exercises|breathing exercises
5531561|NCT01161290|Real-Time Systems|real-time systems
5531562|NCT01161277|Aripiprazole|aripiprazole
5531563|NCT01161277|Haloperidol|haloperidol
5531564|NCT01161277|Ventral striatum|ventral striatum
5531565|NCT01161277|Reward|reward
5531566|NCT01161277|fMRI|fmri
5531567|NCT01161264|Elderly|elderly
5531568|NCT01161264|Influenza|influenza
5531570|NCT01161264|Safety|safety
5531571|NCT01161264|Influenza vaccine|influenza vaccine
5531572|NCT01161251|Atrial Fibrillation|atrial fibrillation
5531574|NCT01161251|PAD|pad
5531575|NCT01161251|Registry|registry
5531576|NCT01161251|Italian|italian
5531577|NCT01161225|Adolescents|adolescents
5531578|NCT01161225|Peer leader program|peer leader program
5531579|NCT01161225|asthma camp|asthma camp
5531580|NCT01161225|asthma control|asthma control
5531581|NCT01161225|quality of life|quality of life
5531582|NCT01161225|self-efficacy|self-efficacy
5531583|NCT01161225|knowledge|knowledge
5531584|NCT01161225|attitudes|attitudes
5531585|NCT01161225|barrier perceptions|barrier perceptions
5531586|NCT01161212|body mass index|body mass index
5531587|NCT01161212|health-related quality of life|health-related quality of life
5531588|NCT01161212|physical education|physical education
5531589|NCT01161212|children|children
5531590|NCT01161212|cluster randomized controlled trial|cluster randomized controlled trial
5531591|NCT01161212|prevention|prevention
5531592|NCT01161212|Child|child
5531593|NCT01161212|French|french
5531594|NCT01161212|Schoolchildren|schoolchildren
5531595|NCT01161199|HIV|hiv
5533763|NCT01152021|pediatric|pediatric
5531596|NCT01161199|latent reservoir|latent reservoir
5531597|NCT01161199|functional cure|functional cure
5531598|NCT01161199|leukapheresis|leukapheresis
5531599|NCT01161186|pancreas|pancreas
5531600|NCT01161186|cancer|cancer
5531601|NCT01161186|abraxane|abraxane
5531602|NCT01161186|metastatic|metastatic
5531603|NCT01161186|gemcitabine|gemcitabine
5531604|NCT01161186|capecitabine|capecitabine
5531605|NCT01161186|adenocarcinoma|adenocarcinoma
5531606|NCT01161160|H1N1|h1n1
5531607|NCT01161160|Influenza|influenza
5531608|NCT01161160|Pandemic|pandemic
5531609|NCT01161160|GSK Bio's influenza vaccines GSK2340274A and GSK234072A|gsk bio's influenza vaccines gsk2340274a and gsk234072a
5531610|NCT01161121|Fractional flow reserve|fractional flow reserve
5531611|NCT01161121|adenosine|adenosine
5531612|NCT01161121|regadenoson|regadenoson
5531613|NCT01161108|Pediatrics|pediatrics
5531614|NCT01161108|Epilepsy|epilepsy
5531615|NCT01161108|Insomnia|insomnia
5531616|NCT01161108|Melatonin|melatonin
5531617|NCT01161095|Intrauterine Device|intrauterine device
5531618|NCT01161095|Postpartum contraception|postpartum contraception
5531619|NCT01161095|Long-acting reversible contraception|long-acting reversible contraception
5531620|NCT01161069|phase 1|phase 1
5531621|NCT01161069|healthy young adult volunteers|healthy young adult volunteers
5531622|NCT01161069|healthy elderly adult volunteers|healthy elderly adult volunteers
5531623|NCT01161043|diabetes|diabetes
5531624|NCT01161043|glucose|glucose
5531626|NCT01161017|migraine patients|migraine patients
5531627|NCT01160991|schizophrenia|schizophrenia
5531628|NCT01160991|olanzapine|olanzapine
5531629|NCT01160991|atypical antipsychotic drugs|atypical antipsychotic drugs
5531630|NCT01160991|amisulpride|amisulpride
5531631|NCT01160991|diabetes|diabetes
5531632|NCT01160991|insulin resistance|insulin resistance
5531633|NCT01160991|insulin secretion|insulin secretion
5531634|NCT01160991|glucose|glucose
5531635|NCT01160991|euglycemic hyperinsulinemic clamp|euglycemic hyperinsulinemic clamp
5531636|NCT01160991|hyperglycemic clamp|hyperglycemic clamp
5531637|NCT01160978|Transplantation|transplantation
5531638|NCT01160978|Simvastatin treatment|simvastatin treatment
5531639|NCT01160978|Ischemia-reperfusion injury|ischemia-reperfusion injury
5531640|NCT01160978|Rejection|rejection
5531641|NCT01160965|epidural top-up|epidural top-up
5531642|NCT01160965|emergency Caesarean section|emergency caesarean section
5531643|NCT01160952|primary prophylaxis|primary prophylaxis
5531644|NCT01160952|itraconazole|itraconazole
5513788|NCT01236391|Mantle|mantle
5531645|NCT01160952|stem cell transplantation|stem cell transplantation
5531646|NCT01160939|Exercise|exercise
5531647|NCT01160939|heart failure|heart failure
5531648|NCT01160939|rehabilitation|rehabilitation
5531649|NCT01160926|rectal cancer|rectal cancer
5531650|NCT01160926|capecitabine|capecitabine
5531651|NCT01160926|radiotherapy|radiotherapy
5531652|NCT01160926|AZD6244|azd6244
5531654|NCT01160926|AZD2171|azd2171
5531655|NCT01160926|Cediranib|cediranib
5531656|NCT01160926|VEGFR inhibitor|vegfr inhibitor
5525798|NCT01185067|DHF|dhf
5531657|NCT01160926|FLT-PET (fluoro-l-pyrimidine positron emission tomography)|flt-pet (fluoro-l-pyrimidine positron emission tomography)
5531658|NCT01160926|DCE-MRI (dynamic contrast enhanced magnetic resonance imaging)|dce-mri (dynamic contrast enhanced magnetic resonance imaging)
5531659|NCT01160900|cardiovascular diseases|cardiovascular diseases
5531660|NCT01160900|heart disease|heart disease
5531661|NCT01160900|hemorrhage|hemorrhage
5531662|NCT01160900|coronary angioplasty|coronary angioplasty
5531663|NCT01160900|drug eluting stents|drug eluting stents
5531664|NCT01160874|Attention Deficit Disorder / Hyperactivity (ADHD)|attention deficit disorder / hyperactivity (adhd)
5531665|NCT01160874|Cognition|cognition
5531666|NCT01160874|Sleepiness|sleepiness
5531667|NCT01160874|Driving|driving
5531668|NCT01160848|Moderate to severe Acne Vulgaris|moderate to severe acne vulgaris
5531669|NCT01160835|total knee arthroplasty|total knee arthroplasty
5531670|NCT01160835|minimally invasive|minimally invasive
5531671|NCT01160835|quadriceps-sparing|quadriceps-sparing
5531672|NCT01160835|Quadriceps-sparing total knee arthroplasty|quadriceps-sparing total knee arthroplasty
5531673|NCT01160822|Osteo arthritis|osteo arthritis
5531674|NCT01160822|pain control|pain control
5531675|NCT01160822|intra- articular injections|intra- articular injections
5531676|NCT01160822|Knee OA|knee oa
5531677|NCT01160809|Malaria|malaria
5531678|NCT01160809|Mosquito repellent|mosquito repellent
5531679|NCT01160809|LLINs|llins
5531680|NCT01160783|Autism|autism
5531681|NCT01160783|Asperger's Syndrome|asperger's syndrome
5531682|NCT01160783|Asperger Syndrome|asperger syndrome
5531683|NCT01160783|Autistic Disorder|autistic disorder
5531684|NCT01160783|Autism Spectrum Disorder|autism spectrum disorder
5531685|NCT01160783|Pervasive Developmental Disorders|pervasive developmental disorders
5531686|NCT01160783|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
5531687|NCT01160783|Child Development Disorders, Pervasive|child development disorders, pervasive
5531688|NCT01160783|PDD-NOS|pdd-nos
5531689|NCT01160770|Lennox-Gastaut Syndrome (LGS)|lennox-gastaut syndrome (lgs)
5531690|NCT01160770|Epilepsy|epilepsy
5531691|NCT01160770|Drop Seizures|drop seizures
5531692|NCT01160770|Clobazam|clobazam
5531699|NCT01160731|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5531700|NCT01160718|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5531701|NCT01160718|HER2-positive breast cancer|her2-positive breast cancer
5531702|NCT01160718|HER2-negative breast cancer|her2-negative breast cancer
5531703|NCT01160718|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5531704|NCT01160718|recurrent breast cancer|recurrent breast cancer
5531705|NCT01160718|stage IIIA breast cancer|stage iiia breast cancer
5531706|NCT01160718|stage IIIB breast cancer|stage iiib breast cancer
5531707|NCT01160718|stage IIIC breast cancer|stage iiic breast cancer
5531708|NCT01160718|stage IV breast cancer|stage iv breast cancer
5531709|NCT01160705|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5531710|NCT01160705|recurrent prostate cancer|recurrent prostate cancer
5531711|NCT01160705|stage III prostate cancer|stage iii prostate cancer
5531712|NCT01160705|stage IV prostate cancer|stage iv prostate cancer
5531714|NCT01160705|liver metastases|liver metastases
5531715|NCT01160705|lung metastases|lung metastases
5531716|NCT01160705|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5531717|NCT01160692|Memory|memory
5531718|NCT01160692|Cognitive Function|cognitive function
5531719|NCT01160692|Elderly|elderly
5531720|NCT01160692|Gingko|gingko
5531721|NCT01160692|Age Associated Memory Impairment (AAMI)|age associated memory impairment (aami)
5531722|NCT01160679|anhedonic features in patients with schizophrenia|anhedonic features in patients with schizophrenia
5531723|NCT01160666|Belimumab|belimumab
5531724|NCT01160666|Sjögren's syndrome|sjögren's syndrome
5531725|NCT01160666|Sjögren disease|sjögren disease
5531727|NCT01160653|Gait training|gait training
5531728|NCT01160653|Cognitive Training|cognitive training
5531729|NCT01160640|PID|pid
5531730|NCT01160640|Pelvic Inflammatory Disease|pelvic inflammatory disease
5531731|NCT01160627|CIN STEMI|cin stemi
5531732|NCT01160614|Pediatric|pediatric
5531733|NCT01160614|Post-operative|post-operative
5531734|NCT01160614|Nonsurgical|nonsurgical
5531735|NCT01160614|patients|patients
5531736|NCT01160614|Opioid|opioid
5531737|NCT01160601|NSCLC|nsclc
5531738|NCT01160601|lung cancer|lung cancer
5531739|NCT01160601|non small cell lung cancer|non small cell lung cancer
5531740|NCT01160601|bavituximab|bavituximab
5531741|NCT01160601|monoclonal antibody|monoclonal antibody
5531742|NCT01160588|Anxiety|anxiety
5531743|NCT01160588|Social Phobia|social phobia
5531744|NCT01160588|Social Anxiety|social anxiety
5531745|NCT01160588|Generalized Anxiety|generalized anxiety
5531746|NCT01160588|Separation Anxiety|separation anxiety
5531747|NCT01160575|Counseling|counseling
5531748|NCT01160575|Epidemiology|epidemiology
5531749|NCT01160575|HIV|hiv
5531750|NCT01160575|AIDS|aids
5531751|NCT01160575|Prevention|prevention
5531752|NCT01160562|Prevalence|prevalence
5531756|NCT01160562|Global Positioning system|global positioning system
5531762|NCT01160536|Hypertrophic Cardiomyopathy (HCM)|hypertrophic cardiomyopathy (hcm)
5531764|NCT01160523|Podoconiosis|podoconiosis
5531765|NCT01160523|Genetic Education|genetic education
5531766|NCT01160523|Primary Prevention|primary prevention
5531768|NCT01160523|Youth|youth
5531771|NCT01160484|multiple myeloma|multiple myeloma
5531772|NCT01160484|refractory|refractory
5531773|NCT01160484|relapsed|relapsed
5531774|NCT01160484|bortezomib|bortezomib
5531775|NCT01160484|doxil|doxil
5531776|NCT01160471|Heart Failure|heart failure
5531777|NCT01160471|MRI|mri
5531778|NCT01160471|Ultrasound|ultrasound
5531779|NCT01160471|Fibrosis|fibrosis
5531780|NCT01160471|Biomarker|biomarker
5531781|NCT01160458|Monoclonal Antibody|monoclonal antibody
5531782|NCT01160458|Pleural Mesothelioma|pleural mesothelioma
5531783|NCT01160458|Peritoneal Mesothelioma|peritoneal mesothelioma
5531784|NCT01160445|Metastatic Melanoma|metastatic melanoma
5531785|NCT01160445|Metastatic Kidney Cancer|metastatic kidney cancer
5531786|NCT01160445|Clinical Performance|clinical performance
5531787|NCT01160445|Tumor Regression|tumor regression
5531788|NCT01160445|Toxicity|toxicity
5531789|NCT01160432|opiate dependence|opiate dependence
5531790|NCT01160432|methadone|methadone
5531791|NCT01160432|naloxone|naloxone
5531792|NCT01160432|withdrawal symptom|withdrawal symptom
5531793|NCT01160432|substitution treatment|substitution treatment
5531794|NCT01160406|silent paroxysmal atrial fibrillation|silent paroxysmal atrial fibrillation
5531795|NCT01160406|stroke|stroke
5531796|NCT01160406|tele ECG|tele ecg
5531797|NCT01160393|Atrial fibrillation|atrial fibrillation
5531798|NCT01160393|Cardiac surgery|cardiac surgery
5531799|NCT01160393|Prevention|prevention
5531800|NCT01160393|Conventional bypass system|conventional bypass system
5531801|NCT01160393|Miniaturized bypass system|miniaturized bypass system
5531802|NCT01160393|Arrhythmia|arrhythmia
5531803|NCT01160393|The Incidence of atrial fibrillation after cardiac surgery|the incidence of atrial fibrillation after cardiac surgery
5531804|NCT01160380|cancer related fatigue|cancer related fatigue
5531805|NCT01160380|fatigue|fatigue
5531806|NCT01160380|multiple myeloma|multiple myeloma
5531807|NCT01160380|cancer|cancer
5531808|NCT01160380|quality of life|quality of life
5531809|NCT01160354|Leukemia|leukemia
5531811|NCT01160354|Clofarabine|clofarabine
5531812|NCT01160354|Plerixafor|plerixafor
5531813|NCT01160354|elderly patients|elderly patients
5531814|NCT01160354|previously untreated|previously untreated
5531815|NCT01160354|unfavorable prognostic factors|unfavorable prognostic factors
5531816|NCT01160341|Metabolic syndrome|metabolic syndrome
5531817|NCT01160341|Hypogonadism|hypogonadism
5531818|NCT01160341|Testosterone|testosterone
5531819|NCT01160328|Regional Fat Storage|regional fat storage
5531820|NCT01160328|Fat Oxidation|fat oxidation
5531821|NCT01160328|Testosterone|testosterone
5531822|NCT01160328|Male|male
5531823|NCT01160315|ovarian failure, chemotherapy, lymphoma, GnRH agonist|ovarian failure, chemotherapy, lymphoma, gnrh agonist
5531824|NCT01160302|cancer|cancer
5531825|NCT01160276|renal graft|renal graft
5531826|NCT01160276|colchicine|colchicine
5531827|NCT01160276|drug interaction|drug interaction
5531828|NCT01160276|cyclosporine|cyclosporine
5531829|NCT01160276|tacrolimus|tacrolimus
5531830|NCT01160276|renal transplantation|renal transplantation
5531831|NCT01160276|renal transplant|renal transplant
5531832|NCT01160276|ABCB1|abcb1
5531833|NCT01160276|CYP3A5|cyp3a5
5531834|NCT01160276|SLCO1B1|slco1b1
5531835|NCT01160263|ALS|als
5531836|NCT01160263|serotonin|serotonin
5531837|NCT01160263|dopamine|dopamine
5531838|NCT01160237|H1N1|h1n1
5531839|NCT01160237|Pandemrix|pandemrix
5531840|NCT01160237|Fluarix|fluarix
5531841|NCT01160237|Influenza|influenza
5531842|NCT01160224|Asthma|asthma
5531843|NCT01160224|CCR3 receptor antagonists|ccr3 receptor antagonists
5531844|NCT01160224|GW766944|gw766944
5531845|NCT01160211|1st line MBC|1st line mbc
5531846|NCT01160211|MBC|mbc
5531847|NCT01160211|hormone receptor positive|hormone receptor positive
5531848|NCT01160211|lapatinib|lapatinib
5531849|NCT01160211|trastuzumab|trastuzumab
5531850|NCT01160211|HER2 positive|her2 positive
5531851|NCT01160211|aromatase inhibitor|aromatase inhibitor
5531852|NCT01160172|vaccine|vaccine
5531853|NCT01160172|young adults|young adults
5531854|NCT01160172|Staphylococcus aureus|staphylococcus aureus
5531855|NCT01160159|Venous thrombosis|venous thrombosis
5531856|NCT01160159|Women|women
5531857|NCT01160159|Vasodilatation endothelium-dependent|vasodilatation endothelium-dependent
5531858|NCT01160159|IMT|imt
5531859|NCT01160159|Arterial stiffness|arterial stiffness
5531860|NCT01160159|Arterial compliance|arterial compliance
5531861|NCT01160159|Capillary density|capillary density
5531866|NCT01160133|Systane|systane
5531867|NCT01160133|Refresh Tears|refresh tears
5531868|NCT01160133|Dry Eye|dry eye
5531869|NCT01160133|Moderate to Severe Dry Eye|moderate to severe dry eye
5531870|NCT01160120|fixed dose combinations|fixed dose combinations
5531871|NCT01160120|tenofovir|tenofovir
5531872|NCT01160120|lamivudine|lamivudine
5531873|NCT01160120|efavirenz|efavirenz
5531874|NCT01160120|therapeutic drug levels|therapeutic drug levels
5531875|NCT01160120|safety and efficacy|safety and efficacy
5531876|NCT01160120|HIV|hiv
5526046|NCT01183962|CAD|cad
5531877|NCT01160120|To evaluation new formulations of FDC of TDF/3TC/EFV|to evaluation new formulations of fdc of tdf/3tc/efv
5531878|NCT01160107|Diagnosis|diagnosis
5531879|NCT01160107|Elderly Patients|elderly patients
5531880|NCT01160107|Imids|imids
5531881|NCT01160107|Chemotherapy|chemotherapy
5531882|NCT01160094|Trastuzumab|trastuzumab
5531883|NCT01160094|Metastatic Breast Cancer|metastatic breast cancer
5531884|NCT01160094|Breast Cancer|breast cancer
5531885|NCT01160094|Observational Study|observational study
5531886|NCT01160094|Lapatinib|lapatinib
5531887|NCT01160003|ACTH stimulation test|acth stimulation test
5518111|NCT01217034|TACE|tace
5531888|NCT01160003|Pharmacokinetics|pharmacokinetics
5531889|NCT01160003|Nebules|nebules
5531890|NCT01160003|Cortisol|cortisol
5531891|NCT01159990|HIV Preventive Vaccine|hiv preventive vaccine
5531892|NCT01159990|HIV Seronegativity|hiv seronegativity
5531893|NCT01159964|Antigen-Specific Cancer Immunotherapeutic (ASCI)|antigen-specific cancer immunotherapeutic (asci)
5531894|NCT01159964|PRAME|prame
5531995|NCT01159444|noninvasive ventilation|noninvasive ventilation
5531996|NCT01159444|ventilator software|ventilator software
5531895|NCT01159964|PRAME-positive stage IB, II or IIIA Non-Small Cell Lung Cancer patients after complete surgical resection|prame-positive stage ib, ii or iiia non-small cell lung cancer patients after complete surgical resection
5531896|NCT01159964|Non-Small Cell Lung Cancer|non-small cell lung cancer
5531897|NCT01159912|fluticasone propionate|fluticasone propionate
5531898|NCT01159912|Fluticasone furoate|fluticasone furoate
5531899|NCT01159899|Osteoarthritis|osteoarthritis
5531900|NCT01159899|knee arthritis|knee arthritis
5531901|NCT01159899|Knee arthrosis|knee arthrosis
5531902|NCT01159899|articular cartilage defects|articular cartilage defects
5531903|NCT01159899|osteochondral defects|osteochondral defects
5531904|NCT01159899|mesenchymal stem cells|mesenchymal stem cells
5531905|NCT01159899|stem cells|stem cells
5531906|NCT01159899|cellules souches,|cellules souches,
5531907|NCT01159899|genou|genou
5531908|NCT01159899|arthrose genou|arthrose genou
5531909|NCT01159899|PRP platelet rich plasma|prp platelet rich plasma
5531910|NCT01159899|thérapie cellulaire|thérapie cellulaire
5531911|NCT01159899|implantation cellules souches mésenchymateuses|implantation cellules souches mésenchymateuses
5531912|NCT01159899|régénération cartilage|régénération cartilage
5531913|NCT01159899|cicatrisation ménisque|cicatrisation ménisque
5531914|NCT01159899|ligament|ligament
5531915|NCT01159899|plasma riche plaquettaire|plasma riche plaquettaire
5531916|NCT01159899|platelet rich plasma|platelet rich plasma
5531917|NCT01159899|stem cell|stem cell
5531918|NCT01159899|regrowt cartilage|regrowt cartilage
5531919|NCT01159899|cellules souches|cellules souches
5531921|NCT01159886|Tuberculosis|tuberculosis
5531923|NCT01159886|endoscopy|endoscopy
5531924|NCT01159860|seborrheic keratoses|seborrheic keratoses
5531925|NCT01159860|cryosurgery|cryosurgery
5531926|NCT01159860|curettage|curettage
5531927|NCT01159847|sitagliptin|sitagliptin
5531928|NCT01159847|LADA|lada
5531929|NCT01159847|C-Peptide|c-peptide
5531930|NCT01159847|Flow Cytometry|flow cytometry
5531931|NCT01159847|ELISPOT|elispot
5531932|NCT01159834|HPV infection|hpv infection
5531933|NCT01159834|Cervical cancer|cervical cancer
5531934|NCT01159834|HPV vaccine|hpv vaccine
5531935|NCT01159821|31001074|31001074
5531936|NCT01159821|Paroxetine|paroxetine
5531938|NCT01159808|Safety and Pharmacokinetics|safety and pharmacokinetics
5531939|NCT01159795|Respiratory Syncytial Virus|respiratory syncytial virus
5531940|NCT01159795|Infant|infant
5531941|NCT01159795|Interferon|interferon
5531942|NCT01159769|Allergic conjunctivitis|allergic conjunctivitis
5531943|NCT01159756|Travacom|travacom
5531944|NCT01159756|Glaucoma|glaucoma
5531945|NCT01159756|Travoprost|travoprost
5531946|NCT01159756|Timolol|timolol
5531947|NCT01159743|lipodystrophy|lipodystrophy
5531948|NCT01159743|Lipoatrophy|lipoatrophy
5531949|NCT01159743|antiretroviral treatment|antiretroviral treatment
5531950|NCT01159704|HIV infection|hiv infection
5531951|NCT01159704|Intervention|intervention
5531952|NCT01159704|Risk-reduction|risk-reduction
5531953|NCT01159704|Injection drug users|injection drug users
5531954|NCT01159691|Rotigotine|rotigotine
5531955|NCT01159691|Neupro®|neupro®
5531956|NCT01159691|Parkinson's disease|parkinson's disease
5531957|NCT01159691|Gastrointestinal|gastrointestinal
5531958|NCT01159691|Switch from oral therapy to patch|switch from oral therapy to patch
5531959|NCT01159652|sleep|sleep
5531960|NCT01159652|memory|memory
5531961|NCT01159652|hypnotics|hypnotics
5531962|NCT01159652|zaleplon|zaleplon
5531963|NCT01159652|zolpidem|zolpidem
5531964|NCT01159652|Sonata|sonata
5531965|NCT01159652|Ambien|ambien
5531966|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives
5531967|NCT01159652|Polysomnography|polysomnography
5531968|NCT01159652|Monitoring, sleep|monitoring, sleep
5531969|NCT01159639|aspirin resistance|aspirin resistance
5531970|NCT01159639|coronary artery bypass grafting|coronary artery bypass grafting
5531971|NCT01159639|multiple electrode aggregometry|multiple electrode aggregometry
5531972|NCT01159639|multiplate|multiplate
5531973|NCT01159626|Phase1|phase1
5531974|NCT01159626|Pharmacokinetics|pharmacokinetics
5531975|NCT01159626|Healthy Male|healthy male
5531976|NCT01159626|Japanese|japanese
5531977|NCT01159626|Schizophrenia|schizophrenia
5531979|NCT01159613|Cholesterol level|cholesterol level
5531980|NCT01159613|fibrosis score|fibrosis score
5531981|NCT01159613|HDL|hdl
5531982|NCT01159535|substance use|substance use
5531983|NCT01159535|addiction|addiction
5531984|NCT01159535|meditation|meditation
5531985|NCT01159535|mindfulness|mindfulness
5531986|NCT01159535|relapse prevention|relapse prevention
5531987|NCT01159522|Advanced Solid Tumors Who Have Failed Standard Therapy|advanced solid tumors who have failed standard therapy
5531988|NCT01159509|hypertrophic pyloric stenosis|hypertrophic pyloric stenosis
5531989|NCT01159509|sodium intake|sodium intake
5531990|NCT01159509|Healthy children with no chronic diseases|healthy children with no chronic diseases
5531991|NCT01159509|Status post HPS|status post hps
5531992|NCT01159470|CRP velocity|crp velocity
5531993|NCT01159457|Celiac Disease|celiac disease
5531994|NCT01159457|Hepatitis B vaccination|hepatitis b vaccination
5531997|NCT01159444|ventilator settings|ventilator settings
5531998|NCT01159444|domiciliary ventilation|domiciliary ventilation
5531999|NCT01159431|partial seizures|partial seizures
5532000|NCT01159431|poorly controlled epilepsy|poorly controlled epilepsy
5532001|NCT01159431|intractable epilepsy|intractable epilepsy
5532002|NCT01159431|treatment resistant epilepsy|treatment resistant epilepsy
5532003|NCT01159431|Trigeminal Nerve|trigeminal nerve
5532004|NCT01159431|Trigeminal Nerve Stimulation|trigeminal nerve stimulation
5532005|NCT01159418|solid tumors|solid tumors
5532006|NCT01159418|Panobinostat|panobinostat
5532007|NCT01159418|histone deacetylase inhibitors|histone deacetylase inhibitors
5532008|NCT01159392|brain injury|brain injury
5532009|NCT01159392|mechanical ventilation|mechanical ventilation
5532010|NCT01159392|acute lung injury|acute lung injury
5532011|NCT01159392|lung recruitment|lung recruitment
5532012|NCT01159379|IgE-mediated allergy|ige-mediated allergy
5532013|NCT01159379|Beta-lactams|beta-lactams
5532015|NCT01159379|Cross-reactivity|cross-reactivity
5532016|NCT01159379|Immediate-type skin tests|immediate-type skin tests
5532017|NCT01159379|Intravenous tolerance tests|intravenous tolerance tests
5532018|NCT01159366|myocardial infarction|myocardial infarction
5532019|NCT01159366|coronary occlusion|coronary occlusion
5532020|NCT01159366|myocardial revascularization|myocardial revascularization
5532021|NCT01159366|collaterals|collaterals
5532022|NCT01159366|prognosis|prognosis
5532023|NCT01159327|Sorafenib (nexavar)|sorafenib (nexavar)
5532024|NCT01159327|ED-SCLC|ed-sclc
5532025|NCT01159327|Maintenance|maintenance
5532026|NCT01159327|Extensive Disease Small cell lung cancer|extensive disease small cell lung cancer
5532027|NCT01159314|glaucoma|glaucoma
5532028|NCT01159314|Baerveldt Implants|baerveldt implants
5532029|NCT01159288|Advanced unresectable non small cell lung cancer|advanced unresectable non small cell lung cancer
5532030|NCT01159288|Responding or stabilized after induction chemotherapy|responding or stabilized after induction chemotherapy
5532031|NCT01159275|lopinavir/ritonavir|lopinavir/ritonavir
5532032|NCT01159275|pharmacokinetics|pharmacokinetics
5532033|NCT01159275|HIV-1 infected adults|hiv-1 infected adults
5532034|NCT01159275|aim to investigate the lower dose of boosted lopinavir in Thais and to compare the levels of lopinavir/ritonavir from Abbot and GPO|aim to investigate the lower dose of boosted lopinavir in thais and to compare the levels of lopinavir/ritonavir from abbot and gpo
5532035|NCT01159262|Initially intubated and mechanically ventilated neonates|initially intubated and mechanically ventilated neonates
5532036|NCT01159249|Vildagliptin, Type 2 Diabetes, HbA1c, Fasting Plasma Glucose, Long-Term Safety|vildagliptin, type 2 diabetes, hba1c, fasting plasma glucose, long-term safety
5532037|NCT01159236|Gene signatures|gene signatures
5532038|NCT01159236|HER-2 normal stage I-III breast cancer|her-2 normal stage i-iii breast cancer
5532039|NCT01159236|Estrogen Receptor|estrogen receptor
5532040|NCT01159236|ER-positive|er-positive
5532041|NCT01159236|ER-negative|er-negative
5532042|NCT01159236|RCB categories II-III|rcb categories ii-iii
5532043|NCT01159236|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5532044|NCT01159236|adjuvant systemic therapy|adjuvant systemic therapy
5532045|NCT01159236|molecular testing|molecular testing
5532046|NCT01159236|Fluorouracil|fluorouracil
5532047|NCT01159236|5-fluorouracil|5-fluorouracil
5532049|NCT01159236|Doxorubicin|doxorubicin
5532050|NCT01159236|Adriamycin|adriamycin
5532051|NCT01159236|Rubex|rubex
5532052|NCT01159236|Epirubicin|epirubicin
5532053|NCT01159236|Ellence|ellence
5532054|NCT01159236|Cyclophosphamide|cyclophosphamide
5532055|NCT01159236|Cytoxan|cytoxan
5532056|NCT01159236|Neosar|neosar
5532057|NCT01159236|Bevacizumab|bevacizumab
5532058|NCT01159236|Avastin|avastin
5532059|NCT01159236|Anti-VEGF monoclonal|anti-vegf monoclonal
5532060|NCT01159236|rhu-MAb-VEGF|rhu-mab-vegf
5532061|NCT01159223|atazanavir / ritonavir|atazanavir / ritonavir
5532062|NCT01159223|low dose|low dose
5532063|NCT01159223|noninferiority|noninferiority
5532064|NCT01159223|safety and efficacy|safety and efficacy
5532295|NCT01158066|Calcium score|calcium score
5532065|NCT01159223|efficacy and safety of lower dose atazanavir/ritonavir in suppressed HIV-infected adults|efficacy and safety of lower dose atazanavir/ritonavir in suppressed hiv-infected adults
5532066|NCT01159197|sleep disturbance|sleep disturbance
5532067|NCT01159197|cognitive behavioral therapy|cognitive behavioral therapy
5532068|NCT01159197|inflammation|inflammation
5532069|NCT01159197|oxidative stress|oxidative stress
5532070|NCT01159197|hemodialysis|hemodialysis
5532071|NCT01159184|stress|stress
5532072|NCT01159184|coping methods|coping methods
5532073|NCT01159184|social support|social support
5532074|NCT01159184|diabetes mellitus|diabetes mellitus
5532075|NCT01159145|Healthy volunteer|healthy volunteer
5532076|NCT01159145|Japanese males|japanese males
5532077|NCT01159145|homo-EM/hetero-EM/PM|homo-em/hetero-em/pm
5532078|NCT01159132|pharmacokinetics|pharmacokinetics
5532079|NCT01159132|low dose raltegravir|low dose raltegravir
5532081|NCT01159132|To study the pharmacokinetics profile of low dose raltegravir (RAL) (400mg OD and 800mg OD) and standard dose of 400mg BID in Thai HIV-infected patients.|to study the pharmacokinetics profile of low dose raltegravir (ral) (400mg od and 800mg od) and standard dose of 400mg bid in thai hiv-infected patients.
5532082|NCT01159119|Chronic Abdominal Pain|chronic abdominal pain
5532083|NCT01159119|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5532084|NCT01159106|Positive Pressure Ventilation|positive pressure ventilation
5532085|NCT01159106|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5532086|NCT01159106|Patient/ventilator Asynchrony|patient/ventilator asynchrony
5532087|NCT01159106|Pediatric patient|pediatric patient
5532088|NCT01159106|Infant|infant
5532089|NCT01159093|Clinical Decision Support Systems|clinical decision support systems
5532090|NCT01159080|immunosuppression control in kidney transplantation|immunosuppression control in kidney transplantation
5532091|NCT01159067|HSCT, iron overload, deferasirox, labile plasma iron|hsct, iron overload, deferasirox, labile plasma iron
5532092|NCT01159041|Depression, children, adolescent, family|depression, children, adolescent, family
5532093|NCT01159028|Liposomal Grb-2 treatment of CML, AML, CLL, MDS|liposomal grb-2 treatment of cml, aml, cll, mds
5532094|NCT01159028|Liposomal Grb-2 with LDAC for AML|liposomal grb-2 with ldac for aml
5532095|NCT01159002|Endoscopy, Video Capsule|endoscopy, video capsule
5532096|NCT01159002|Motility, Gastrointestinal|motility, gastrointestinal
5532097|NCT01158989|Critical care|critical care
5532098|NCT01158989|Endoscopy, Video Capsule|endoscopy, video capsule
5532099|NCT01158989|Nutrition, Enteral|nutrition, enteral
5532100|NCT01158937|meropenem|meropenem
5532101|NCT01158937|cystic fibrosis|cystic fibrosis
5532102|NCT01158937|extended infusion|extended infusion
5532103|NCT01158937|pharmacokinetic|pharmacokinetic
5532104|NCT01158911|kidney disease|kidney disease
5532105|NCT01158911|uric acid|uric acid
5532106|NCT01158911|outcomes|outcomes
5532107|NCT01158911|cardiovascular|cardiovascular
5532108|NCT01158911|mortality|mortality
5532109|NCT01158911|kidney failure|kidney failure
5532110|NCT01158911|Uric Acid levels in patients with Chronic Kidney Disease|uric acid levels in patients with chronic kidney disease
5532111|NCT01158898|Mild to moderate asthma|mild to moderate asthma
5532112|NCT01158898|Allergen inhalation challenge|allergen inhalation challenge
5532113|NCT01158885|relapsed|relapsed
5532114|NCT01158885|relapse|relapse
5532115|NCT01158885|refractory|refractory
5532116|NCT01158885|Minimal Residual disease|minimal residual disease
5532117|NCT01158885|MRD|mrd
5532118|NCT01158885|MRD positive|mrd positive
5532119|NCT01158885|MRD+|mrd+
5532120|NCT01158885|ALL|all
5532121|NCT01158885|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5532122|NCT01158885|AML|aml
5532123|NCT01158885|Acute myelogenous leukemia|acute myelogenous leukemia
5532124|NCT01158885|Relapsed AML|relapsed aml
5532125|NCT01158859|Anesthesia, General|anesthesia, general
5532126|NCT01158859|Propofol|propofol
5532127|NCT01158859|Pregabalin|pregabalin
5532128|NCT01158859|Preoperative care|preoperative care
5532129|NCT01158859|Laparoscopic surgery|laparoscopic surgery
5532130|NCT01158846|STEMI|stemi
5532131|NCT01158846|Primary PCI|primary pci
5532132|NCT01158846|anticoagulants|anticoagulants
5532133|NCT01158846|antiplatelets|antiplatelets
5532134|NCT01158833|Cerebral palsy|cerebral palsy
5532135|NCT01158833|diplegia|diplegia
5532136|NCT01158833|gait|gait
5532137|NCT01158833|classification|classification
5532138|NCT01158820|bronchoscopy|bronchoscopy
5534729|NCT01148004|HIV|hiv
5532139|NCT01158807|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5532140|NCT01158807|Cerebral arteriovenous malformations|cerebral arteriovenous malformations
5532141|NCT01158794|Iron overload|iron overload
5532142|NCT01158794|Blood Transfusion|blood transfusion
5532144|NCT01158781|motor learning|motor learning
5532145|NCT01158781|robotics|robotics
5532146|NCT01158781|Functional electrical stimulation|functional electrical stimulation
5532147|NCT01158768|domestic violence in childhood/adolescence|domestic violence in childhood/adolescence
5532148|NCT01158768|comorbidities|comorbidities
5532149|NCT01158768|climactery|climactery
5532150|NCT01158768|domestic violence against women|domestic violence against women
5532151|NCT01158768|trauma questionnaire|trauma questionnaire
5532152|NCT01158768|Violence|violence
5532153|NCT01158755|Meningitis, tuberculous|meningitis, tuberculous
5532154|NCT01158755|Intensified Regimen|intensified regimen
5532155|NCT01158755|PK/PD and tolerability|pk/pd and tolerability
5532156|NCT01158755|Outcome|outcome
5532157|NCT01158742|Glomerular Filtration Rate|glomerular filtration rate
5532158|NCT01158729|Antithrombin III|antithrombin iii
5532159|NCT01158729|Postoperative Hemorrhage|postoperative hemorrhage
5532160|NCT01158729|Cardiopulmonary Bypass|cardiopulmonary bypass
5532162|NCT01158729|Blood Transfusion|blood transfusion
5532163|NCT01158716|percutaneous coronary intervention|percutaneous coronary intervention
5532164|NCT01158716|remote ischemic preconditioning|remote ischemic preconditioning
5532165|NCT01158703|aspirin|aspirin
5532166|NCT01158703|clopidogrel|clopidogrel
5532167|NCT01158703|coronary artery bypass graft|coronary artery bypass graft
5532168|NCT01158703|Plavix|plavix
5532169|NCT01158690|Intimate partner violence|intimate partner violence
5532170|NCT01158677|meniscectomy|meniscectomy
5532171|NCT01158664|dental implants|dental implants
5532172|NCT01158664|different tread pitch design|different tread pitch design
5532174|NCT01158651|low-grade glioma|low-grade glioma
5532175|NCT01158651|progressive|progressive
5532176|NCT01158651|children|children
5532177|NCT01158651|NF Type 1 - low grade glioma - not responded to treatments|nf type 1 - low grade glioma - not responded to treatments
5532178|NCT01158638|Physical Activity Enhancement|physical activity enhancement
5532179|NCT01158599|Japanese Encephalitis|japanese encephalitis
5532180|NCT01158599|Vaccination|vaccination
5532181|NCT01158599|Ixiaro|ixiaro
5532182|NCT01158599|elderly population|elderly population
5532183|NCT01158586|post total knee replacement|post total knee replacement
5532184|NCT01158586|patient control|patient control
5532185|NCT01158586|epidural analgesia|epidural analgesia
5532186|NCT01158573|Asthma|asthma
5532187|NCT01158573|Obesity|obesity
5532188|NCT01158560|upper respiratory tract infections|upper respiratory tract infections
5532189|NCT01158560|rhinovirus infections|rhinovirus infections
5532190|NCT01158560|vitamin D|vitamin d
5532191|NCT01158534|recurrent renal cell cancer|recurrent renal cell cancer
5532192|NCT01158508|cerebral aneurysm|cerebral aneurysm
5532193|NCT01158508|cerebral vasospasm|cerebral vasospasm
5532194|NCT01158508|subarachnoid hemorrhage|subarachnoid hemorrhage
5532195|NCT01158508|remote ischemic preconditioning|remote ischemic preconditioning
5532196|NCT01158456|smoking|smoking
5532197|NCT01158456|lung cancer|lung cancer
5532198|NCT01158456|ethnic racial differences|ethnic racial differences
5532199|NCT01158456|tobacco specific nitrosamines|tobacco specific nitrosamines
5532200|NCT01158456|metabolism of carcinogens|metabolism of carcinogens
5532201|NCT01158443|HIV+|hiv+
5532202|NCT01158443|fatigue|fatigue
5532203|NCT01158443|return to work|return to work
5532204|NCT01158430|Hypochondriasis|hypochondriasis
5532205|NCT01158430|Acceptance and Commitment Therapy|acceptance and commitment therapy
5532206|NCT01158430|ACT|act
5532207|NCT01158417|Type 2 Diabetes|type 2 diabetes
5532208|NCT01158417|Obesity|obesity
5532209|NCT01158417|Insulin Resistance|insulin resistance
5532210|NCT01158417|Resveratrol|resveratrol
5532211|NCT01158417|Inflammation|inflammation
5532212|NCT01158404|Metastatic Cancer|metastatic cancer
5532213|NCT01158404|Solid Tumors|solid tumors
5532214|NCT01158391|Premature Birth|premature birth
5532215|NCT01158378|Adherus Dural Sealant|adherus dural sealant
5532216|NCT01158378|Adherus AutoSpray Dural Sealant|adherus autospray dural sealant
5532218|NCT01158352|Low weight|low weight
5532219|NCT01158352|Low height|low height
5532220|NCT01158352|Nutritional Formula|nutritional formula
5532221|NCT01158339|Low back pain|low back pain
5532222|NCT01158339|Cognitive behavioural therapy|cognitive behavioural therapy
5532223|NCT01158339|Group therapy|group therapy
5532224|NCT01158339|Exposure in session|exposure in session
5532225|NCT01158326|reducing symptoms|reducing symptoms
5532226|NCT01158326|events|events
5532227|NCT01158326|Common Cold|common cold
5532228|NCT01158326|flu syndrome|flu syndrome
5532229|NCT01158326|Symptomatic treatment of the Common Cold and Flu syndrome|symptomatic treatment of the common cold and flu syndrome
5532230|NCT01158300|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5532231|NCT01158300|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5534860|NCT01147666|CKD|ckd
5532232|NCT01158300|recurrent childhood brain tumor|recurrent childhood brain tumor
5514388|NCT01233934|Gel|gel
5532233|NCT01158300|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5532234|NCT01158300|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5532235|NCT01158300|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5532236|NCT01158300|recurrent childhood ependymoma|recurrent childhood ependymoma
5532237|NCT01158300|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5532238|NCT01158300|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5532239|NCT01158300|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5532240|NCT01158300|recurrent childhood spinal cord neoplasm|recurrent childhood spinal cord neoplasm
5532241|NCT01158300|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5532242|NCT01158300|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5671483|NCT00615875|postoperative pain|postoperative pain
5532243|NCT01158300|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5532244|NCT01158300|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5532245|NCT01158300|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5532246|NCT01158300|childhood central nervous system germinoma|childhood central nervous system germinoma
5532247|NCT01158300|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5532248|NCT01158300|childhood central nervous system teratoma|childhood central nervous system teratoma
5532249|NCT01158300|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5532250|NCT01158300|childhood astrocytoma|childhood astrocytoma
5532251|NCT01158300|childhood medulloepithelioma|childhood medulloepithelioma
5532252|NCT01158300|childhood meningioma|childhood meningioma
5532253|NCT01158300|childhood mixed glioma|childhood mixed glioma
5532254|NCT01158300|childhood oligodendroglioma|childhood oligodendroglioma
5532255|NCT01158300|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5532256|NCT01158287|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5532257|NCT01158287|recurrent esophageal cancer|recurrent esophageal cancer
5532258|NCT01158287|recurrent gastric cancer|recurrent gastric cancer
5532352|NCT01157767|post-operative chemotherapy|post-operative chemotherapy
5532259|NCT01158287|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5532260|NCT01158261|hemostasis|hemostasis
5532261|NCT01158248|cervical adenocarcinoma|cervical adenocarcinoma
5532262|NCT01158248|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5532263|NCT01158248|cervical small cell carcinoma|cervical small cell carcinoma
5532264|NCT01158248|stage IB cervical cancer|stage ib cervical cancer
5532265|NCT01158248|stage IIA cervical cancer|stage iia cervical cancer
5532266|NCT01158248|stage IIB cervical cancer|stage iib cervical cancer
5532267|NCT01158248|stage III cervical cancer|stage iii cervical cancer
5532268|NCT01158248|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5532272|NCT01158196|keloid|keloid
5532273|NCT01158196|scar|scar
5532274|NCT01158183|Outcomes|outcomes
5532275|NCT01158183|real world and web tool|real world and web tool
5532276|NCT01158183|electronic data capture|electronic data capture
5532277|NCT01158170|nonsmall cell lung cancer|nonsmall cell lung cancer
5532278|NCT01158170|brain metastasis|brain metastasis
5532279|NCT01158170|prophylactic cranial irradiation|prophylactic cranial irradiation
5532280|NCT01158144|Non-small cell lung cancer|non-small cell lung cancer
5532281|NCT01158144|Locally advanced|locally advanced
5532282|NCT01158144|Radiotherapy|radiotherapy
5532283|NCT01158144|Concomitant Chemotherapy|concomitant chemotherapy
5532284|NCT01158144|Endostar|endostar
5532285|NCT01158131|Gestational diabetes mellitus (GDM) in the most recent pregnancy|gestational diabetes mellitus (gdm) in the most recent pregnancy
5532286|NCT01158118|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5532287|NCT01158118|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5532288|NCT01158105|Steroid refractory chronic graft vs host disease (cGVHD)|steroid refractory chronic graft vs host disease (cgvhd)
5532289|NCT01158105|Bortezomib|bortezomib
5532290|NCT01158105|Velcade|velcade
5532291|NCT01158079|Liver|liver
5532292|NCT01158079|Solid Tumors|solid tumors
5532293|NCT01158079|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
5532294|NCT01158066|NAFLD|nafld
5532296|NCT01158066|Liver Fat|liver fat
5532297|NCT01158066|Visceral fat|visceral fat
5532298|NCT01158066|excessive visceral fat|excessive visceral fat
5532299|NCT01158066|excessive liver fat accumulation|excessive liver fat accumulation
5532300|NCT01158066|Biomarkers of insulin resistance (HOMA), inflammation (CRP) and (MDA-Paraoxonase)|biomarkers of insulin resistance (homa), inflammation (crp) and (mda-paraoxonase)
5532301|NCT01158040|Maternal intrapartum glycemic control|maternal intrapartum glycemic control
5532302|NCT01158040|Pregestational diabetes|pregestational diabetes
5532303|NCT01158014|pterygium|pterygium
5532304|NCT01158014|conjunctival graft|conjunctival graft
5532305|NCT01158014|recurrence|recurrence
5532306|NCT01158014|primary pterygium|primary pterygium
5532307|NCT01158001|Posttraumatic stress disorders|posttraumatic stress disorders
5532309|NCT01158001|Psychotherapy|psychotherapy
5532310|NCT01158001|Neuropsychological test|neuropsychological test
5532311|NCT01158001|Depression|depression
5532312|NCT01157988|bulky diffuse large B cell lymphoma|bulky diffuse large b cell lymphoma
5532313|NCT01157988|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
5532314|NCT01157988|clinical response|clinical response
5532315|NCT01157988|Safety and toxicity|safety and toxicity
5532316|NCT01157962|Sentinel Concept|sentinel concept
5532317|NCT01157962|Lymphadenectomy|lymphadenectomy
5532318|NCT01157962|Early Stage Cervical Cancer|early stage cervical cancer
5532319|NCT01157962|Overall Survive|overall survive
5532320|NCT01157962|Improvement Therapy|improvement therapy
5532321|NCT01157936|hypertension|hypertension
5532322|NCT01157936|hyperuricemia|hyperuricemia
5532323|NCT01157936|metabolic syndrome|metabolic syndrome
5532324|NCT01157923|Type 1 diabetes|type 1 diabetes
5532325|NCT01157923|Insulin Pump Therapy|insulin pump therapy
5532326|NCT01157910|Ear infection|ear infection
5532327|NCT01157910|Chronic|chronic
5532328|NCT01157897|Malaria|malaria
5532329|NCT01157897|Plasmodium Vivax|plasmodium vivax
5532331|NCT01157884|body composition|body composition
5532332|NCT01157884|obesity|obesity
5532333|NCT01157884|kidney transplantation|kidney transplantation
5518599|NCT01214928|vitamin D|vitamin d
5532334|NCT01157858|liver cyst|liver cyst
5532335|NCT01157832|water pipe smoking acute effect|water pipe smoking acute effect
5532336|NCT01157819|swimmer's ear|swimmer's ear
5532337|NCT01157819|ear drops|ear drops
5532338|NCT01157819|ear foam|ear foam
5532339|NCT01157819|otic foam|otic foam
5532340|NCT01157819|ear infection|ear infection
5532341|NCT01157819|ear pain|ear pain
5532342|NCT01157819|ear inflammation|ear inflammation
5532343|NCT01157806|rectal cancer|rectal cancer
5532344|NCT01157806|unresectable synchronous metastases|unresectable synchronous metastases
5532345|NCT01157806|pelvic radiochemotherapy|pelvic radiochemotherapy
5532346|NCT01157793|Dwarfism|dwarfism
5532347|NCT01157793|Growth hormone deficiency|growth hormone deficiency
5532348|NCT01157793|Growth hormone|growth hormone
5532349|NCT01157780|Fish oil|fish oil
5532350|NCT01157767|exercise|exercise
5532351|NCT01157767|lymphedema|lymphedema
5532353|NCT01157767|post-operative radiation|post-operative radiation
5532355|NCT01157754|Infertility patients requiring IVF|infertility patients requiring ivf
5532356|NCT01157754|good prognosis|good prognosis
5532357|NCT01157741|Community based follow up, severely underweight children|community based follow up, severely underweight children
5532358|NCT01157728|Multiple sclerosis|multiple sclerosis
5532359|NCT01157728|Cognitive impairment|cognitive impairment
5532360|NCT01157715|KH902|kh902
5532361|NCT01157715|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5532362|NCT01157715|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5532363|NCT01157715|intravitreal injection|intravitreal injection
5532364|NCT01157715|best corrected visual acuity (BCVA)|best corrected visual acuity (bcva)
5532365|NCT01157715|central retinal thickness|central retinal thickness
5532366|NCT01157689|malaria|malaria
5532367|NCT01157689|children|children
5532368|NCT01157689|Guinea-Bissau|guinea-bissau
5532369|NCT01157689|artemether|artemether
5532370|NCT01157689|lumefantrine|lumefantrine
5532371|NCT01157689|effectiveness|effectiveness
5532372|NCT01157676|open cystectomy|open cystectomy
5532373|NCT01157676|robotic assisted radical cystectomy|robotic assisted radical cystectomy
5532374|NCT01157676|bladder cancer|bladder cancer
5532375|NCT01157663|Functional ankle instability|functional ankle instability
5532376|NCT01157650|Fistulizing Crohn's disease|fistulizing crohn's disease
5532377|NCT01157650|stem cells implant|stem cells implant
5532378|NCT01157624|hypoxia or hypercarbia during surgery under the drape|hypoxia or hypercarbia during surgery under the drape
5532379|NCT01157611|online based mentoring program,|online based mentoring program,
5532380|NCT01157611|type 1 diabetes,|type 1 diabetes,
5532381|NCT01157611|blood glucose,|blood glucose,
5532382|NCT01157611|satisfaction score|satisfaction score
5532383|NCT01157598|gastric adenoma|gastric adenoma
5532384|NCT01157598|early gastric cancer|early gastric cancer
5532385|NCT01157572|Aortic valve insufficiency|aortic valve insufficiency
5532386|NCT01157572|Beta-blocker|beta-blocker
5532387|NCT01157533|Vancomycin|vancomycin
5532388|NCT01157533|Pharmacokinetic testing|pharmacokinetic testing
5532389|NCT01157533|PK|pk
5532390|NCT01157507|Botulinum A toxin|botulinum a toxin
5532391|NCT01157507|Painful Bladder Syndrome (PBS)|painful bladder syndrome (pbs)
5532392|NCT01157507|Bladder overdistention|bladder overdistention
5532393|NCT01157494|cerebral palsy|cerebral palsy
5532394|NCT01157494|hemiplegia|hemiplegia
5532395|NCT01157494|upper limb|upper limb
5532396|NCT01157494|assessment|assessment
5532397|NCT01157494|classification system|classification system
5532398|NCT01157481|Diastolic Heart Failure|diastolic heart failure
5532399|NCT01157481|Heart failure with preserved ejection fraction|heart failure with preserved ejection fraction
5532400|NCT01157481|nifedipine|nifedipine
5532401|NCT01157468|Systemic Lupus Erythematosus in Martinique|systemic lupus erythematosus in martinique
5532402|NCT01157468|Hydrolase and DNase activities|hydrolase and dnase activities
5532403|NCT01157455|Stent|stent
5532404|NCT01157455|Coronary artery diseases|coronary artery diseases
5532405|NCT01157442|prevention of maternal to child transmission of HIV|prevention of maternal to child transmission of hiv
5532406|NCT01157442|mhealth|mhealth
5532407|NCT01157442|access to antenatal care|access to antenatal care
5532408|NCT01157442|pregnancy|pregnancy
5532409|NCT01157429|Cognitive Behavior Therapy|cognitive behavior therapy
5532410|NCT01157429|Children|children
5532411|NCT01157429|Adolescents|adolescents
5532412|NCT01157429|Pharmacotherapy|pharmacotherapy
5532413|NCT01157416|Cognitive Behavior Therapy|cognitive behavior therapy
5532414|NCT01157416|Children|children
5532415|NCT01157416|Pharmacotherapy|pharmacotherapy
5532416|NCT01157403|mesenchymal stem cells|mesenchymal stem cells
5532417|NCT01157390|Term-infant|term-infant
5532418|NCT01157390|sn-2 palmitic acid|sn-2 palmitic acid
5532419|NCT01157390|infant formula|infant formula
5532420|NCT01157351|Schizophrenia|schizophrenia
5532421|NCT01157351|Risperidone|risperidone
5532422|NCT01157351|Risperdal|risperdal
5532423|NCT01157351|Paliperidone palmitate|paliperidone palmitate
5526601|NCT01181752|Ghana|ghana
5532424|NCT01157351|Aripiprazole|aripiprazole
5532425|NCT01157351|Haloperidol|haloperidol
5532426|NCT01157351|Olanzapine|olanzapine
5532427|NCT01157351|Paliperidone|paliperidone
5532428|NCT01157351|Perphenazine|perphenazine
5532429|NCT01157351|Quetiapine|quetiapine
5532430|NCT01157338|Catheter|catheter
5532431|NCT01157338|coronary artery disease|coronary artery disease
5532433|NCT01157338|stroke|stroke
5532434|NCT01157338|retinal emboli|retinal emboli
5532435|NCT01157325|Epidural analgesia|epidural analgesia
5532436|NCT01157325|Latent analgesia|latent analgesia
5532437|NCT01157325|Active analgesia|active analgesia
5532438|NCT01157325|Cesarean section|cesarean section
5532439|NCT01157312|Polycystic ovary syndrome|polycystic ovary syndrome
5532440|NCT01157312|clomiphene citrate|clomiphene citrate
5532441|NCT01157312|minimal stimulation|minimal stimulation
5532442|NCT01157312|infertility treatment|infertility treatment
5532443|NCT01157299|Hemodynamics|hemodynamics
5532444|NCT01157299|Pediatric Intensive Care Unit|pediatric intensive care unit
5532445|NCT01157299|Low cardiac output|low cardiac output
5532446|NCT01157299|Thermodilution|thermodilution
5532447|NCT01157299|Stroke volume|stroke volume
5532448|NCT01157299|Global end-diastolic volume|global end-diastolic volume
5532449|NCT01157299|Fluid responsiveness|fluid responsiveness
5532450|NCT01157299|Passive leg raising|passive leg raising
5532451|NCT01157299|Infant|infant
5532452|NCT01157286|OBSTRUCTIVE SLEEP APNEA LARINGECTOMY CPAP|obstructive sleep apnea laringectomy cpap
5532453|NCT01157273|Behavior|behavior
5532454|NCT01157273|Anxiety|anxiety
5532455|NCT01157273|Communication|communication
5532456|NCT01157273|Voice|voice
5532457|NCT01157260|Indoxyl sulfate|indoxyl sulfate
5532458|NCT01157260|AST-120|ast-120
5532459|NCT01157247|Anesthetic techniques|anesthetic techniques
5532460|NCT01157247|regional, spinal|regional, spinal
5532461|NCT01157247|Pain|pain
5532462|NCT01157247|lumbar puncture|lumbar puncture
5532463|NCT01157247|Analgesia, local|analgesia, local
5532464|NCT01157247|Analgesia, intravenous|analgesia, intravenous
5532465|NCT01157234|Hypertension|hypertension
5532466|NCT01157234|Kidney transplantation|kidney transplantation
5532467|NCT01157234|Renal function|renal function
5532468|NCT01157234|Nitric Oxide|nitric oxide
5532469|NCT01157234|Nebivolol|nebivolol
5532470|NCT01157208|chronic pain|chronic pain
5532471|NCT01157208|headache|headache
5532472|NCT01157208|nutrition|nutrition
5532473|NCT01157208|inflammation|inflammation
5532474|NCT01157208|complementary medicine|complementary medicine
5532475|NCT01157195|stroke|stroke
5532476|NCT01157195|chronic|chronic
5532477|NCT01157195|arm|arm
5532478|NCT01157195|rehabilitation|rehabilitation
5532479|NCT01157195|tele-health|tele-health
5532480|NCT01157182|Healthy|healthy
5532481|NCT01157182|Bioequivalence|bioequivalence
5532482|NCT01157182|Post-Menopausal|post-menopausal
5532483|NCT01157169|Bioequivalence|bioequivalence
5532485|NCT01157130|Breast Cancer|breast cancer
5532486|NCT01157130|Exercise|exercise
5532487|NCT01157130|CRP|crp
5532488|NCT01157130|C-reactive protein|c-reactive protein
5532489|NCT01157130|BMI|bmi
5532490|NCT01157130|Nevada Cancer Institute|nevada cancer institute
5532491|NCT01157130|Rehabilitation|rehabilitation
5532492|NCT01157130|Prescriptive exercise|prescriptive exercise
5532493|NCT01157130|Physical Activity|physical activity
5532494|NCT01157130|DEXA|dexa
5532495|NCT01157130|Obesity|obesity
5532496|NCT01157130|lifestyle intervention|lifestyle intervention
5532497|NCT01157130|Early Stage Breast Cancer Patients (stage 0-III)|early stage breast cancer patients (stage 0-iii)
5532498|NCT01157117|food allergy|food allergy
5532499|NCT01157104|HCV|hcv
5532500|NCT01157104|Hepatitis C|hepatitis c
5532501|NCT01157078|Major Depressive Disorder|major depressive disorder
5532502|NCT01157078|MDD|mdd
5532503|NCT01157078|Depression|depression
5532504|NCT01157078|Safety|safety
5532505|NCT01157078|add-on therapy|add-on therapy
5532506|NCT01157065|Wet AMD|wet amd
5532507|NCT01157065|Intravitreal Injection|intravitreal injection
5532508|NCT01157065|Macular Degeneration|macular degeneration
5532509|NCT01157065|VEGF treatment|vegf treatment
5532510|NCT01157052|magnesium|magnesium
5532511|NCT01157052|calcium|calcium
5532512|NCT01157052|adverse effects|adverse effects
5532513|NCT01157052|kinetics, drug|kinetics, drug
5532514|NCT01157039|glutamine|glutamine
5532515|NCT01157039|oxaliplatin|oxaliplatin
5532516|NCT01157039|adverse effects|adverse effects
5532517|NCT01157026|Breast cancer|breast cancer
5532518|NCT01157026|Tocotrienol-rich fraction with tamoxifen|tocotrienol-rich fraction with tamoxifen
5532519|NCT01157013|Positron Emission Tomography|positron emission tomography
5532520|NCT01157013|Hepatocellular carcinoma|hepatocellular carcinoma
5532521|NCT01157013|Liver Cancer|liver cancer
5532522|NCT01157013|Sorafenib|sorafenib
5532523|NCT01157013|Response Evaluation|response evaluation
5532524|NCT01157000|Canagliflozin|canagliflozin
5532525|NCT01157000|Pharmacokinetic|pharmacokinetic
5532526|NCT01157000|Bioavailability|bioavailability
5532527|NCT01156974|care management|care management
5532528|NCT01156974|chronic disease|chronic disease
5532529|NCT01156974|outpatient|outpatient
5532530|NCT01156948|misoprostol|misoprostol
5532531|NCT01156948|nulliparous|nulliparous
5532532|NCT01156948|hysteroscopy|hysteroscopy
5503347|NCT01281657|MS|ms
5532533|NCT01156935|Neoplasm|neoplasm
5532534|NCT01156935|Laugh-Yoga|laugh-yoga
5532535|NCT01156935|Mood|mood
5532536|NCT01156935|Quality of life|quality of life
5532537|NCT01156922|Chronic fatigue syndrome|chronic fatigue syndrome
5532539|NCT01156922|Myalgic encephalomyelitis|myalgic encephalomyelitis
5532540|NCT01156922|Rituximab|rituximab
5532541|NCT01156922|B-cell depletion|b-cell depletion
5532542|NCT01156909|Chronic fatigue syndrome|chronic fatigue syndrome
5532543|NCT01156909|CFS|cfs
5532544|NCT01156909|Myalgic encephalomyelitis|myalgic encephalomyelitis
5532545|NCT01156909|Rituximab|rituximab
5532546|NCT01156909|B-cell depletion|b-cell depletion
5532547|NCT01156896|Non-transferrin-bound iron|non-transferrin-bound iron
5532548|NCT01156896|Iron stable isotopes|iron stable isotopes
5532549|NCT01156896|Iron deficiency|iron deficiency
5532550|NCT01156896|Malaria|malaria
5532551|NCT01156896|Iron supplementation|iron supplementation
5532552|NCT01156896|Iron fortification|iron fortification
5533764|NCT01152021|children|children
5532553|NCT01156883|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5532554|NCT01156883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5532555|NCT01156883|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5532556|NCT01156883|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5532557|NCT01156844|Indacaterol|indacaterol
5532558|NCT01156844|Asthma|asthma
5532559|NCT01156844|Bronchodilation|bronchodilation
5532560|NCT01156844|Beta-agonist|beta-agonist
5532561|NCT01156831|Esophageal cancer|esophageal cancer
5532562|NCT01156831|PET-CT planning|pet-ct planning
5532563|NCT01156818|Wheeze measurements|wheeze measurements
5532564|NCT01156805|Children|children
5532565|NCT01156805|School-based program|school-based program
5532566|NCT01156805|Obesity|obesity
5532567|NCT01156792|asthma|asthma
5532568|NCT01156792|GSK2190915|gsk2190915
5532569|NCT01156779|SR-Exenatide|sr-exenatide
5532570|NCT01156766|Fracture|fracture
5532571|NCT01156766|Radius|radius
5532572|NCT01156766|Osteosynthesis|osteosynthesis
5532573|NCT01156766|Metaphyseal|metaphyseal
5532574|NCT01156766|Pinning|pinning
5532575|NCT01156766|Locking anterior plate|locking anterior plate
5532576|NCT01156753|CR011-vcMMAE|cr011-vcmmae
5532577|NCT01156753|locally advanced breast cancer|locally advanced breast cancer
5532578|NCT01156753|metastatic breast cancer|metastatic breast cancer
5532579|NCT01156753|breast cancer|breast cancer
5532580|NCT01156753|CDX-011|cdx-011
5532581|NCT01156753|GPNMB|gpnmb
5532582|NCT01156753|Targeted treatment for breast cancer|targeted treatment for breast cancer
5517244|NCT01220726|OAB|oab
5532583|NCT01156753|Locally advanced or metastatic breast cancer|locally advanced or metastatic breast cancer
5532584|NCT01156740|streptococcal pharyngitis|streptococcal pharyngitis
5532585|NCT01156740|randomized clinical trial|randomized clinical trial
5532586|NCT01156740|amoxicillin|amoxicillin
5532587|NCT01156740|intramuscular benzathine penicillin G.|intramuscular benzathine penicillin g.
5532588|NCT01156727|OEF/OIF|oef/oif
5532589|NCT01156727|Mental Health|mental health
5532590|NCT01156727|Veterans|veterans
5532591|NCT01156714|Parkinson's Disease|parkinson's disease
5532592|NCT01156714|Treadmill Training|treadmill training
5532593|NCT01156714|Exercise|exercise
5532594|NCT01156714|Cognitive Training|cognitive training
5532595|NCT01156714|Executive Function|executive function
5532596|NCT01156714|Dual Task|dual task
5532597|NCT01156701|Influenza|influenza
5532598|NCT01156701|Zanamivir|zanamivir
5532599|NCT01156701|Influenza prophylaxis|influenza prophylaxis
5532600|NCT01156701|Relenza|relenza
5532601|NCT01156688|medical abortion for pregnancy of less than 9 weeks gestation|medical abortion for pregnancy of less than 9 weeks gestation
5532602|NCT01156675|Back pain|back pain
5532603|NCT01156675|Pain|pain
5532604|NCT01156675|Spinal Diseases|spinal diseases
5532605|NCT01156675|Spinal Stenosis|spinal stenosis
5532606|NCT01156675|Lumbar Vertebrae|lumbar vertebrae
5532607|NCT01156675|Spinal Canal|spinal canal
5532609|NCT01156662|Percutaneous coronary intervention|percutaneous coronary intervention
5532611|NCT01156649|neurocognitive function|neurocognitive function
5532612|NCT01156649|cognition|cognition
5532613|NCT01156649|pediatrics|pediatrics
5532614|NCT01156649|children|children
5532615|NCT01156649|continuous positive airway pressure therapy|continuous positive airway pressure therapy
5532616|NCT01156649|sham treatment|sham treatment
5532617|NCT01156649|randomized clinical trial|randomized clinical trial
5532618|NCT01156649|behavior|behavior
5532619|NCT01156649|treatment|treatment
5532620|NCT01156636|Diastolic Heart Failure|diastolic heart failure
5532621|NCT01156636|Pulmonary Hypertension|pulmonary hypertension
5532622|NCT01156623|EBUS-TBNA|ebus-tbna
5532623|NCT01156623|NSCLC|nsclc
5532624|NCT01156623|Mediastinal lymph node|mediastinal lymph node
5532625|NCT01156623|tuberculosis|tuberculosis
5532626|NCT01156610|Smoking|smoking
5532627|NCT01156610|Smoking Cessation|smoking cessation
5532628|NCT01156610|Electronic Health Record|electronic health record
5526806|NCT01180959|HCC|hcc
5532630|NCT01156597|diabetes|diabetes
5532631|NCT01156597|dyslipidemia|dyslipidemia
5532632|NCT01156597|pioglitazone|pioglitazone
5532633|NCT01156597|HDL-Cholesterol|hdl-cholesterol
5532634|NCT01156597|Reverse cholesterol transport|reverse cholesterol transport
5532635|NCT01156584|glioma|glioma
5532636|NCT01156584|glioblastoma|glioblastoma
5532637|NCT01156584|glioblastoma multiforme|glioblastoma multiforme
5532638|NCT01156584|Grade IV astrocytoma|grade iv astrocytoma
5532639|NCT01156584|brain cancer|brain cancer
5532640|NCT01156584|recurrent glioblastoma|recurrent glioblastoma
5532642|NCT01156584|AA|aa
5532643|NCT01156584|AOD|aod
5532644|NCT01156584|anaplastic astrocytoma|anaplastic astrocytoma
5532645|NCT01156584|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5532646|NCT01156584|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5532647|NCT01156584|malignant glioma|malignant glioma
5532648|NCT01156584|high grade glioma|high grade glioma
5532649|NCT01156545|BIBW 2992|bibw 2992
5532650|NCT01156545|Simvastatin|simvastatin
5532651|NCT01156545|NSCLC|nsclc
5532652|NCT01156545|advanced stage|advanced stage
5532653|NCT01156545|previously treated patients|previously treated patients
5532654|NCT01156545|non-adenocarcinoma|non-adenocarcinoma
5532655|NCT01156532|adalimumab therapy|adalimumab therapy
5532656|NCT01156532|Psoriasis|psoriasis
5532657|NCT01156532|observational study|observational study
5532658|NCT01156519|Infra-clinic cortisol adenoma|infra-clinic cortisol adenoma
5532659|NCT01156519|Salivary cortisol|salivary cortisol
5532660|NCT01156519|Obesity|obesity
5532661|NCT01156506|quality of life|quality of life
5532662|NCT01156506|patient education|patient education
5532663|NCT01156506|rehabilitation|rehabilitation
5532664|NCT01156506|focus group interview|focus group interview
5532665|NCT01156493|feeding intolerance|feeding intolerance
5532666|NCT01156493|prematurity|prematurity
5532667|NCT01156480|necrotizing enterocolitis|necrotizing enterocolitis
5532669|NCT01156480|premature|premature
5532670|NCT01156480|hydrocortisone|hydrocortisone
5532671|NCT01156480|steroids|steroids
5532672|NCT01156480|anti-inflammatory|anti-inflammatory
5532673|NCT01156467|Neurally adjusted ventilatory assist NAVA|neurally adjusted ventilatory assist nava
5532674|NCT01156467|Premature infant|premature infant
5532675|NCT01156467|Edi-signal|edi-signal
5532676|NCT01156454|sentinel lymph node dissection|sentinel lymph node dissection
5532677|NCT01156454|radiology|radiology
5532678|NCT01156454|X-ray identification of nodes in a surgical specimen|x-ray identification of nodes in a surgical specimen
5532679|NCT01156441|Myocardial Infarction|myocardial infarction
5532680|NCT01156441|Mitral Regurgitation|mitral regurgitation
5532681|NCT01156441|Percutaneous Coronary Intervention|percutaneous coronary intervention
5532682|NCT01156428|Nephritic syndrome|nephritic syndrome
5532683|NCT01156428|Nephrotic syndrome|nephrotic syndrome
5532684|NCT01156428|Proteinuria|proteinuria
5532685|NCT01156428|Acute kidney injury|acute kidney injury
5532686|NCT01156428|Chronic kidney disease|chronic kidney disease
5532687|NCT01156428|Lupus nephritis|lupus nephritis
5532688|NCT01156415|agomelatine|agomelatine
5532689|NCT01156415|Major Depressive Disorder|major depressive disorder
5532690|NCT01156415|MDD|mdd
5532691|NCT01156415|depression|depression
5532692|NCT01156402|Obesity|obesity
5532693|NCT01156402|Pediatric Obesity|pediatric obesity
5532694|NCT01156389|malaria|malaria
5532695|NCT01156389|artemisinin-based combination therapy|artemisinin-based combination therapy
5532696|NCT01156350|Neuroblastoma - Haplo HSCT - Reduced Intensity Conditioning - immunotherapy NK|neuroblastoma - haplo hsct - reduced intensity conditioning - immunotherapy nk
5532697|NCT01156337|Heart failure III NYHA class|heart failure iii nyha class
5532698|NCT01156337|Furosemide|furosemide
5532699|NCT01156337|Sodium|sodium
5532700|NCT01156337|water restriction|water restriction
5532701|NCT01156337|decompensated heart failure|decompensated heart failure
5532702|NCT01156337|Hypertonic saline solution|hypertonic saline solution
5514862|NCT01231685|HIV|hiv
5532703|NCT01156337|Moderate sodium restriction|moderate sodium restriction
5532704|NCT01156324|IVF|ivf
5532705|NCT01156324|Stress management|stress management
5532706|NCT01156311|BG00012|bg00012
5532707|NCT01156311|MS|ms
5532708|NCT01156311|RRMS|rrms
5532709|NCT01156272|Isolated aortic valve replacement|isolated aortic valve replacement
5532710|NCT01156272|heart valve|heart valve
5532711|NCT01156259|B cell cll/lymphoma, human|b cell cll/lymphoma, human
5532712|NCT01156246|Healthy volunteers|healthy volunteers
5532713|NCT01156246|Dapagliflozin|dapagliflozin
5532714|NCT01156246|Diabetes Type 2|diabetes type 2
5532715|NCT01156246|Food interaction|food interaction
5532716|NCT01156233|evaluating precision of tube tip position with two methods|evaluating precision of tube tip position with two methods
5532717|NCT01156220|gender, diuretics, furosemide, aminohippuric acid|gender, diuretics, furosemide, aminohippuric acid
5532718|NCT01156207|To establish the coupling between components of arterial load ( and components of LV myocardial deformations at baseline and 6 months after randomization.|to establish the coupling between components of arterial load ( and components of lv myocardial deformations at baseline and 6 months after randomization.
5526924|NCT01180582|RSA|rsa
5789055|NCT00150111|autoimmunity|autoimmunity
5789056|NCT00150111|B lymphocyte depletion|b lymphocyte depletion
5789057|NCT00150111|rituximab|rituximab
5532719|NCT01156207|To establish the role of EPCs on modulation of the components of arterial load and LV myocardial deformations and their coupling.|to establish the role of epcs on modulation of the components of arterial load and lv myocardial deformations and their coupling.
5532720|NCT01156194|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis|third stage, labor, postpartum hemorrhage, homeopathy, arnica, bellis perennis
5532721|NCT01156181|Cervical mucus, Embryo transfer, ICSI cycle, Pregnancy rate|cervical mucus, embryo transfer, icsi cycle, pregnancy rate
5532722|NCT01156168|male breast cancer|male breast cancer
5532723|NCT01156168|stage IV breast cancer|stage iv breast cancer
5532724|NCT01156168|recurrent breast cancer|recurrent breast cancer
5532725|NCT01156155|rheumatoid arthritis|rheumatoid arthritis
5532727|NCT01156155|periodontal disease|periodontal disease
5532728|NCT01156142|oral complications of radiation therapy|oral complications of radiation therapy
5532729|NCT01156142|mucositis|mucositis
5532730|NCT01156142|pain|pain
5532731|NCT01156142|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5532732|NCT01156142|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5532733|NCT01156142|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
5532899|NCT01155544|Aripiprazole|aripiprazole
5532734|NCT01156142|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5532735|NCT01156142|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5532736|NCT01156142|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
5532737|NCT01156142|verrucous carcinoma of the larynx|verrucous carcinoma of the larynx
5532738|NCT01156142|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5532739|NCT01156142|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5532740|NCT01156142|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5532741|NCT01156142|adenoid cystic carcinoma of the oral cavity|adenoid cystic carcinoma of the oral cavity
5532742|NCT01156142|mucoepidermoid carcinoma of the oral cavity|mucoepidermoid carcinoma of the oral cavity
5532743|NCT01156142|verrucous carcinoma of the oral cavity|verrucous carcinoma of the oral cavity
5532744|NCT01156142|squamous cell carcinoma of the lip and oral cavity|squamous cell carcinoma of the lip and oral cavity
5532745|NCT01156142|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5532746|NCT01156142|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5532747|NCT01156142|basal cell carcinoma of the lip|basal cell carcinoma of the lip
5532748|NCT01156142|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5532749|NCT01156142|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5532750|NCT01156142|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5532751|NCT01156142|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5532752|NCT01156142|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5532753|NCT01156142|lymphoepithelioma of the nasopharynx|lymphoepithelioma of the nasopharynx
5532754|NCT01156142|squamous cell carcinoma of the nasopharynx|squamous cell carcinoma of the nasopharynx
5532755|NCT01156142|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5532756|NCT01156142|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5532757|NCT01156142|lymphoepithelioma of the oropharynx|lymphoepithelioma of the oropharynx
5532758|NCT01156142|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5514963|NCT01231256|Quality of life|quality of life
5514966|NCT01231256|resources|resources
5532759|NCT01156142|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5532760|NCT01156142|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5532761|NCT01156142|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5532762|NCT01156142|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5798715|NCT00111280|HIV infection|hiv infection
5532763|NCT01156142|esthesioneuroblastoma of the paranasal sinus and nasal cavity|esthesioneuroblastoma of the paranasal sinus and nasal cavity
5532764|NCT01156142|inverted papilloma of the paranasal sinus and nasal cavity|inverted papilloma of the paranasal sinus and nasal cavity
5532765|NCT01156142|midline lethal granuloma of the paranasal sinus and nasal cavity|midline lethal granuloma of the paranasal sinus and nasal cavity
5532766|NCT01156142|squamous cell carcinoma of the paranasal sinus and nasal cavity|squamous cell carcinoma of the paranasal sinus and nasal cavity
5532890|NCT01155622|Ventricular function|ventricular function
5532767|NCT01156142|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5532768|NCT01156142|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5532769|NCT01156142|recurrent salivary gland cancer|recurrent salivary gland cancer
5695680|NCT00515554|PET|pet
5532770|NCT01156142|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5532771|NCT01156142|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5527000|NCT01180244|pain|pain
5532772|NCT01156142|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5532773|NCT01156142|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5532774|NCT01156142|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5532775|NCT01156142|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5532776|NCT01156142|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5532778|NCT01156142|tongue cancer|tongue cancer
5532779|NCT01156129|liver transplant|liver transplant
5532780|NCT01156129|liver resection|liver resection
5532781|NCT01156116|CPAP|cpap
5532782|NCT01156116|diabetes|diabetes
5532783|NCT01156116|sleep apnea|sleep apnea
5532784|NCT01156103|obesity|obesity
5532785|NCT01156103|minority|minority
5532786|NCT01156103|child|child
5532787|NCT01156103|physical fitness|physical fitness
5532788|NCT01156103|school|school
5532789|NCT01156103|physical activity|physical activity
5532790|NCT01156090|vectibix|vectibix
5532791|NCT01156077|antibiotic|antibiotic
5532792|NCT01156077|Adolescents receiving antibiotics|adolescents receiving antibiotics
5532793|NCT01156064|Endoscopy|endoscopy
5532794|NCT01156064|Confocal laser endomicroscopy|confocal laser endomicroscopy
5532795|NCT01156064|Digestive Diseases|digestive diseases
5532796|NCT01156051|ADHD|adhd
5532797|NCT01156051|ADD|add
5532798|NCT01156051|sleep disturbance|sleep disturbance
5532799|NCT01156038|Atopy patch test|atopy patch test
5532800|NCT01156025|GV550|gv550
5532801|NCT01156025|Acute adenoviral keratoconjunctivitis|acute adenoviral keratoconjunctivitis
5532802|NCT01155986|analgesic|analgesic
5532803|NCT01155986|analgesics|analgesics
5532804|NCT01155986|pain|pain
5532805|NCT01155986|chronic pain|chronic pain
5532806|NCT01155986|localized pain|localized pain
5532807|NCT01155986|focal pain|focal pain
5532808|NCT01155986|neuropathic pain|neuropathic pain
5532809|NCT01155986|postoperative pain|postoperative pain
5532810|NCT01155986|topical analgesia|topical analgesia
5532811|NCT01155973|Hypertension.|hypertension.
5532812|NCT01155973|Cardiovascular risk.|cardiovascular risk.
5532813|NCT01155973|Monitoring.|monitoring.
5532814|NCT01155973|Primary health care.|primary health care.
5532815|NCT01155973|Randomised controlled trial.|randomised controlled trial.
5532816|NCT01155973|Cluster analysis|cluster analysis
5532817|NCT01155960|Bioavailability|bioavailability
5532818|NCT01155960|Anastrozole|anastrozole
5532819|NCT01155960|Crossover|crossover
5532820|NCT01155947|Bioavailability|bioavailability
5532821|NCT01155947|Anastrozole|anastrozole
5532822|NCT01155947|Crossover|crossover
5532823|NCT01155934|Bioavailability|bioavailability
5532824|NCT01155934|Crossover|crossover
5532825|NCT01155934|Risperidone|risperidone
5532826|NCT01155921|Bioavailability|bioavailability
5532827|NCT01155921|Crossover|crossover
5532828|NCT01155921|Risperidone|risperidone
5532829|NCT01155908|Bioavailability|bioavailability
5532830|NCT01155908|10 mg Amlodipine besylate/20 mg benazepril hydrochloride capsules|10 mg amlodipine besylate/20 mg benazepril hydrochloride capsules
5532831|NCT01155908|Crossover|crossover
5532832|NCT01155895|Bioavailability|bioavailability
5532833|NCT01155895|10 mg Amlopdipine besylate /20 mg Benazepril Hydrochloride|10 mg amlopdipine besylate /20 mg benazepril hydrochloride
5532834|NCT01155895|Crossover|crossover
5532835|NCT01155869|alcohol dependence|alcohol dependence
5532836|NCT01155869|homelessness|homelessness
5532837|NCT01155869|naltrexone|naltrexone
5532838|NCT01155856|telemedicine|telemedicine
5532839|NCT01155856|COPD|copd
5532840|NCT01155830|inflammatory cytokines|inflammatory cytokines
5532841|NCT01155830|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5532842|NCT01155830|ECMO|ecmo
5532843|NCT01155804|preparation of the delivery|preparation of the delivery
5532844|NCT01155804|lumbago|lumbago
5532845|NCT01155804|anxiety|anxiety
5532846|NCT01155804|urinary incontinence|urinary incontinence
5532847|NCT01155778|Mucopolysaccharidosis (MPS) IIIA|mucopolysaccharidosis (mps) iiia
5532848|NCT01155778|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
5532849|NCT01155778|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
5532850|NCT01155778|Lysosomal Storage Disease (LSD)|lysosomal storage disease (lsd)
5532851|NCT01155778|Intrathecal Drug Delivery Device (IDDD)|intrathecal drug delivery device (iddd)
5532852|NCT01155765|Clopidogrel Resistance|clopidogrel resistance
5532853|NCT01155765|prasugrel|prasugrel
5532854|NCT01155765|Hemodialysis|hemodialysis
5532855|NCT01155752|sinusitis|sinusitis
5532856|NCT01155752|cystic fibrosis|cystic fibrosis
5532857|NCT01155752|therapy|therapy
5532858|NCT01155713|Neoplasms|neoplasms
5532859|NCT01155713|Cancer|cancer
5532860|NCT01155713|Tumors|tumors
5532861|NCT01155713|Administration, oral|administration, oral
5532862|NCT01155713|Capsules|capsules
5671484|NCT00615875|thoracic surgery|thoracic surgery
5904044|NCT00007813|childhood grade III meningioma|childhood grade iii meningioma
5685362|NCT00556426|Pulmonary Embolism|pulmonary embolism
5532863|NCT01155713|CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,|chir258, chir-258, chir 258, tki258, tki-258, tki 258,
5532864|NCT01155713|Bioavailability,|bioavailability,
5532865|NCT01155713|Food|food
5532874|NCT01155687|medication|medication
5532875|NCT01155687|psychotherapy|psychotherapy
5532876|NCT01155687|mental health|mental health
5532877|NCT01155674|Innate immunity|innate immunity
5532878|NCT01155674|Neutrophils|neutrophils
5532879|NCT01155674|Band forms|band forms
5532880|NCT01155648|Mechanical ventilation|mechanical ventilation
5532881|NCT01155648|Chest physiotherapy|chest physiotherapy
5532882|NCT01155648|Chest wall compression|chest wall compression
5532883|NCT01155635|Myocardial infarction|myocardial infarction
5532884|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5532885|NCT01155635|Percutaneous coronary intervention|percutaneous coronary intervention
5532886|NCT01155622|Hypothermia, induced|hypothermia, induced
5532887|NCT01155622|Cardiac arrest|cardiac arrest
5532888|NCT01155622|Disability evaluation|disability evaluation
5532889|NCT01155622|Cardiac arrhythmia|cardiac arrhythmia
5532891|NCT01155622|Internal cooling|internal cooling
5532892|NCT01155622|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5532893|NCT01155622|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
5532894|NCT01155596|Acute respiratory failure patients in medical ICUs.|acute respiratory failure patients in medical icus.
5532895|NCT01155570|Psoriasis|psoriasis
5532896|NCT01155557|Tension-Type Headache|tension-type headache
5532897|NCT01155557|Strength Capacity|strength capacity
5532898|NCT01155557|Neck and Shoulder|neck and shoulder
5532900|NCT01155544|Psychotic experiences|psychotic experiences
5532901|NCT01155544|Substance abuse|substance abuse
5532902|NCT01155544|Substance dependence|substance dependence
5532903|NCT01155544|Craving|craving
5532904|NCT01155544|Mood|mood
5532905|NCT01155544|Substance use|substance use
5532906|NCT01155531|Obesity|obesity
5532907|NCT01155531|Overweight|overweight
5532908|NCT01155531|Sertraline|sertraline
5532909|NCT01155531|Telenzepine|telenzepine
5532910|NCT01155531|Decrease appetite|decrease appetite
5532911|NCT01155531|Reduce appetite|reduce appetite
5532912|NCT01155531|Lose weight|lose weight
5532913|NCT01155518|hypogonadism|hypogonadism
5532914|NCT01155518|diabetes|diabetes
5532915|NCT01155518|spermatogenesis|spermatogenesis
5532916|NCT01155518|insulin resistance|insulin resistance
5532917|NCT01155492|lipopolysaccharides|lipopolysaccharides
5532918|NCT01155492|etiology|etiology
5532919|NCT01155492|inflammation|inflammation
5532920|NCT01155492|colonic bacteria|colonic bacteria
5532921|NCT01155492|intestinal permeability|intestinal permeability
5532922|NCT01155466|Idiopathic Parkinson Disease|idiopathic parkinson disease
5532923|NCT01155466|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5532924|NCT01155453|BKM120|bkm120
5532925|NCT01155453|RAS RAF mutations,|ras raf mutations,
5532926|NCT01155453|triple negative breast cancer,|triple negative breast cancer,
5532927|NCT01155453|pancreatic cancer,|pancreatic cancer,
5532928|NCT01155453|PI3K inhibitor,|pi3k inhibitor,
5532929|NCT01155453|MEK inhibitor|mek inhibitor
5532930|NCT01155440|60 patients scheduled to have a colorectal surgery|60 patients scheduled to have a colorectal surgery
5532931|NCT01155440|recruit at Montreal General Hospital|recruit at montreal general hospital
5532932|NCT01155401|acute upper gastrointestinal bleeding|acute upper gastrointestinal bleeding
5532933|NCT01155401|patients with drug-induced upper gastrointestinal bleeding|patients with drug-induced upper gastrointestinal bleeding
5532934|NCT01155401|routine management|routine management
5532935|NCT01155388|Iron deficiency anemia|iron deficiency anemia
5532936|NCT01155388|Feraheme|feraheme
5532937|NCT01155388|ferumoxytol|ferumoxytol
5532939|NCT01155388|pediatric|pediatric
5532940|NCT01155388|nondialysis-dependent|nondialysis-dependent
5515143|NCT01230424|OA|oa
5532941|NCT01155375|Iron deficiency anemia|iron deficiency anemia
5532942|NCT01155375|Feraheme|feraheme
5532943|NCT01155375|ferumoxytol|ferumoxytol
5532944|NCT01155375|CKD|ckd
5532945|NCT01155375|pediatric|pediatric
5532946|NCT01155375|dialysis-dependent|dialysis-dependent
5532947|NCT01155375|nondialysis-dependent|nondialysis-dependent
5798859|NCT00110799|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5532954|NCT01155336|Acute Coronary Syndrome|acute coronary syndrome
5532956|NCT01155336|Platelet Function Tests|platelet function tests
5532957|NCT01155336|Cardiac Electrophysiology|cardiac electrophysiology
5532958|NCT01155310|Exacerbation of COPD|exacerbation of copd
5532959|NCT01155310|Helium/Oxygen|helium/oxygen
5532960|NCT01155310|ICU|icu
5532961|NCT01155310|Non-Invasive Ventilation|non-invasive ventilation
5532962|NCT01155310|Patient with known or suspected COPD|patient with known or suspected copd
5532963|NCT01155310|patient Admitted in an ICU|patient admitted in an icu
5532964|NCT01155310|Patient presenting current exacerbation of COPD|patient presenting current exacerbation of copd
5532965|NCT01155297|Quality of Life|quality of life
5532966|NCT01155297|Biological Markers|biological markers
5532967|NCT01155297|Renal Insufficiency|renal insufficiency
5532968|NCT01155297|Resistance Training|resistance training
5532969|NCT01155297|Exercise|exercise
5532970|NCT01155297|Chronic Kidney Failure|chronic kidney failure
5532971|NCT01155284|diabetes|diabetes
5532972|NCT01155284|HGB A1C|hgb a1c
5532973|NCT01155284|Beta Cell Regeneration|beta cell regeneration
5532974|NCT01155245|osteoporosis|osteoporosis
5532975|NCT01155245|HR-pQCT|hr-pqct
5532977|NCT01155232|osteoporosis|osteoporosis
5532978|NCT01155232|Forteo|forteo
5532979|NCT01155232|Parathyroid hormone|parathyroid hormone
5532980|NCT01155232|HR-pQCT|hr-pqct
5532981|NCT01155219|Bilateral Glaucoma|bilateral glaucoma
5532982|NCT01155219|Bilateral ocular hypertension|bilateral ocular hypertension
5532983|NCT01155219|Bilateral primary open angle glaucoma|bilateral primary open angle glaucoma
5532984|NCT01155219|Bilateral ocular hypertension already treated and controlled by mono-therapy of Xalatan® (1drop per day)|bilateral ocular hypertension already treated and controlled by mono-therapy of xalatan® (1drop per day)
5532985|NCT01155219|With local intolerance signs in at least one eye|with local intolerance signs in at least one eye
5532986|NCT01155206|glucagon,|glucagon,
5532987|NCT01155206|high physiological dose and basal dose of glucagon|high physiological dose and basal dose of glucagon
5532988|NCT01155206|hepatic lipoprotein production,|hepatic lipoprotein production,
5532989|NCT01155206|free fatty acid|free fatty acid
5532990|NCT01155206|intestinal lipoprotein production|intestinal lipoprotein production
5532991|NCT01155206|particle|particle
5532992|NCT01155206|glucagon affects production of fat in intestine and liver.|glucagon affects production of fat in intestine and liver.
5532993|NCT01155193|Children|children
5532994|NCT01155193|Pre-term infants|pre-term infants
5532995|NCT01155193|Congenital heart disease|congenital heart disease
5532996|NCT01155193|Infection|infection
5532997|NCT01155193|Respiratory syncytial virus|respiratory syncytial virus
5532998|NCT01155193|Bronchopulmonary dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5532999|NCT01155193|Chronic lung disease (CLD)|chronic lung disease (cld)
5533000|NCT01155167|radial artery spasm|radial artery spasm
5533001|NCT01155154|wounds and lacerations|wounds and lacerations
5533002|NCT01155154|hand|hand
5533003|NCT01155154|infection|infection
5533004|NCT01155154|Antibiotics|antibiotics
5533005|NCT01155154|antibacterial agents|antibacterial agents
5533006|NCT01155128|physical activity|physical activity
5533007|NCT01155128|exercise|exercise
5533008|NCT01155128|sedentarism|sedentarism
5533009|NCT01155128|chronic renal disease|chronic renal disease
5533010|NCT01155128|failure renal chronic|failure renal chronic
5533011|NCT01155128|proteinuria|proteinuria
5533012|NCT01155128|progression|progression
5533013|NCT01155128|Renal Protective Effects of Exercise|renal protective effects of exercise
5533014|NCT01155128|quality of life changes with exercise in CKD|quality of life changes with exercise in ckd
5533015|NCT01155128|Endothelial progenitor cells in CKD|endothelial progenitor cells in ckd
5533016|NCT01155128|Chronic Kidney Disease and Ankle Brachial Index|chronic kidney disease and ankle brachial index
5533017|NCT01155115|pediatrics|pediatrics
5533018|NCT01155115|CF|cf
5533019|NCT01155115|PCD|pcd
5533020|NCT01155115|exacerbation|exacerbation
5533021|NCT01155115|inflammatory markers|inflammatory markers
5533022|NCT01155115|induced sputum|induced sputum
5533023|NCT01155063|Exemestane|exemestane
5533024|NCT01155063|Adjuvant Treatment In Postmenopausal Women|adjuvant treatment in postmenopausal women
5533025|NCT01155063|Estrogen Receptor Positive Early Breast Cancer|estrogen receptor positive early breast cancer
5533026|NCT01155063|Tamoxifen|tamoxifen
5533029|NCT01155050|type II diabetes|type ii diabetes
5533030|NCT01155050|hypertension|hypertension
5533031|NCT01155037|HIV, influenza A H1N1, vaccine|hiv, influenza a h1n1, vaccine
5533032|NCT01155024|Lower extremity amputation|lower extremity amputation
5533033|NCT01155024|Prosthetic Sockets|prosthetic sockets
5533034|NCT01155024|Direct Manufactured (DM)|direct manufactured (dm)
5533035|NCT01155011|Older adults|older adults
5533036|NCT01155011|physical activity|physical activity
5533037|NCT01155011|sedentary|sedentary
5533038|NCT01155011|retirement communities|retirement communities
5533039|NCT01155011|advocacy|advocacy
5533040|NCT01155011|built environment|built environment
5533041|NCT01155011|peer mentoring|peer mentoring
5533042|NCT01155011|walkability|walkability
5533043|NCT01154998|non-specific interstitial pneumonia|non-specific interstitial pneumonia
5533044|NCT01154985|omega-3 fatty acids|omega-3 fatty acids
5533045|NCT01154985|alanine transaminase|alanine transaminase
5533046|NCT01154985|triglycerides|triglycerides
5533047|NCT01154985|lipids|lipids
5533048|NCT01154985|EPA|epa
5533049|NCT01154985|ethyl-EPA|ethyl-epa
5533050|NCT01154985|ethyl icosapentate|ethyl icosapentate
5533051|NCT01154985|Non Alcoholic steatohepatitis|non alcoholic steatohepatitis
5533052|NCT01154985|Non Alcoholic fatty liver disease|non alcoholic fatty liver disease
5533053|NCT01154985|fatty acids|fatty acids
5533054|NCT01154972|breast|breast
5533055|NCT01154972|cancer|cancer
5533056|NCT01154972|sentinel lymph node|sentinel lymph node
5533057|NCT01154959|Pulmonary TB|pulmonary tb
5533058|NCT01154959|Immune response|immune response
5533059|NCT01154959|ATT|att
5533060|NCT01154959|Immune responses in pulmonary tuberculosis|immune responses in pulmonary tuberculosis
5533061|NCT01154959|Predictors for relapse|predictors for relapse
5533062|NCT01154946|detrusor after-contraction|detrusor after-contraction
5533063|NCT01154946|urodynamic|urodynamic
5533064|NCT01154946|LUTS|luts
5533065|NCT01154946|urinary bladder, overactive|urinary bladder, overactive
5533066|NCT01154946|bladder dysfunction|bladder dysfunction
5533067|NCT01154933|type 2 diabetes|type 2 diabetes
5533068|NCT01154933|obesity|obesity
5533069|NCT01154920|Head and Neck Cancer|head and neck cancer
5533070|NCT01154920|HNSCC|hnscc
5533071|NCT01154920|Paclitaxel|paclitaxel
5533072|NCT01154920|Carboplatin|carboplatin
5533073|NCT01154920|Cetuximab|cetuximab
5533074|NCT01154920|Docetaxel|docetaxel
5533075|NCT01154920|Taxotere|taxotere
5533076|NCT01154920|Cisplatin|cisplatin
5533077|NCT01154920|Platinol-AQ|platinol-aq
5533078|NCT01154920|Platinol|platinol
5533079|NCT01154920|CDDP|cddp
5533080|NCT01154920|Fluorouracil|fluorouracil
5533081|NCT01154920|5-FU|5-fu
5533082|NCT01154920|Adrucil|adrucil
5533083|NCT01154920|Efudex|efudex
5533084|NCT01154920|chemotherapy|chemotherapy
5533085|NCT01154920|radiation|radiation
5533086|NCT01154920|Chemoradiotherapy|chemoradiotherapy
5533087|NCT01154907|Uro-genital schistosomiasis|uro-genital schistosomiasis
5533088|NCT01154907|Female|female
5533089|NCT01154907|South Africa|south africa
5533090|NCT01154907|Rural|rural
5533282|NCT01154114|darapladib|darapladib
5533091|NCT01154907|Sexually transmitted diseases|sexually transmitted diseases
5533092|NCT01154894|arachidonic acid|arachidonic acid
5533093|NCT01154894|autism spectrum disorders|autism spectrum disorders
5533094|NCT01154894|social interaction|social interaction
5533095|NCT01154894|randomized controlled trial|randomized controlled trial
5533096|NCT01154894|DHA|dha
5533097|NCT01154855|Periodontal disease|periodontal disease
5533098|NCT01154855|Gum disease|gum disease
5533099|NCT01154855|Dental|dental
5533100|NCT01154855|Inflammation|inflammation
5533101|NCT01154855|Microorganisms|microorganisms
5533102|NCT01154855|Bacteria|bacteria
5533103|NCT01154842|FGF-23|fgf-23
5533104|NCT01154842|Dialysis|dialysis
5533105|NCT01154842|plasma FGF-23 levels|plasma fgf-23 levels
5533106|NCT01154842|echocardiography|echocardiography
5533107|NCT01154829|dopamine|dopamine
5533108|NCT01154829|first episode|first episode
5533109|NCT01154829|reward|reward
5533110|NCT01154829|cognition|cognition
5533111|NCT01154829|MRI|mri
5533112|NCT01154829|fMRI|fmri
5533113|NCT01154829|PPI|ppi
5533114|NCT01154829|P300|p300
5533115|NCT01154829|P50 gating|p50 gating
5533116|NCT01154829|endophenotypes|endophenotypes
5533117|NCT01154803|Supplementation|supplementation
5533118|NCT01154803|RUTF|rutf
5533119|NCT01154803|Micronutrients|micronutrients
5533120|NCT01154803|Plumpynut|plumpynut
5533121|NCT01154803|Mixme|mixme
5533122|NCT01154803|sprinkles|sprinkles
5533123|NCT01154803|convalescence|convalescence
5533124|NCT01154803|weight|weight
5533125|NCT01154803|morbidity|morbidity
5533126|NCT01154790|healthy volunteers|healthy volunteers
5533127|NCT01154777|Neurofeedback|neurofeedback
5533128|NCT01154777|Braintraining|braintraining
5533129|NCT01154777|Autism|autism
5533130|NCT01154777|Mild|mild
5533131|NCT01154777|Moderate|moderate
5533132|NCT01154777|Mild to Moderate Autism|mild to moderate autism
5533135|NCT01154751|Peripheral vascular Disease|peripheral vascular disease
5533136|NCT01154725|Patient education|patient education
5533137|NCT01154725|Health-Related Quality of Life|health-related quality of life
5533138|NCT01154725|patients with stomas|patients with stomas
5533139|NCT01154725|stomatherapy|stomatherapy
5533140|NCT01154725|health economics|health economics
5533141|NCT01154712|Gambling|gambling
5533142|NCT01154712|Deep TMS|deep tms
5533143|NCT01154712|addiction|addiction
5533144|NCT01154712|Brain stimulation|brain stimulation
5533145|NCT01154699|Asthma|asthma
5533146|NCT01154699|Nocturnal Asthma|nocturnal asthma
5533147|NCT01154699|Lung volumes|lung volumes
5533148|NCT01154699|Deep inspiration|deep inspiration
5533149|NCT01154699|Obstructive sleep apnea|obstructive sleep apnea
5533150|NCT01154660|any operation that required for general anesthesia|any operation that required for general anesthesia
5533151|NCT01154634|Pharmacodynamic effect|pharmacodynamic effect
5533152|NCT01154634|Reflux inhibition|reflux inhibition
5533153|NCT01154621|Phase I|phase i
5696187|NCT00513734|eye|eye
5533154|NCT01154621|Double-blind|double-blind
5533155|NCT01154621|Randomized|randomized
5533156|NCT01154621|Placebo-controlled study|placebo-controlled study
5533157|NCT01154621|Safety and tolerability of single intravenous dose of AZD9742 in healthy elderly volunteers|safety and tolerability of single intravenous dose of azd9742 in healthy elderly volunteers
5533158|NCT01154608|Protein absorption in pancreatitis|protein absorption in pancreatitis
5533159|NCT01154608|Protein metabolism in pancreatitis|protein metabolism in pancreatitis
5533160|NCT01154595|moderate acute malnutrition, prevention, Lipid-based supplement|moderate acute malnutrition, prevention, lipid-based supplement
5533161|NCT01154582|ingestive behavior|ingestive behavior
5533162|NCT01154569|drug absorption|drug absorption
5533163|NCT01154569|azithromycin|azithromycin
5533164|NCT01154569|obesity|obesity
5533165|NCT01154569|bariatric surgery|bariatric surgery
5685363|NCT00556413|stage IV colon cancer|stage iv colon cancer
5533166|NCT01154556|Antiretroviral therapy experienced|antiretroviral therapy experienced
5533168|NCT01154543|Recurrent genital Herpes Simplex Virus|recurrent genital herpes simplex virus
5533169|NCT01154530|Gastroscopy|gastroscopy
5533170|NCT01154530|Bacteria|bacteria
5533171|NCT01154530|Chlorhexidine|chlorhexidine
5533172|NCT01154530|General surgery|general surgery
5533173|NCT01154504|adrenomedullin|adrenomedullin
5533174|NCT01154504|heart failure|heart failure
5533175|NCT01154504|ultrafiltration|ultrafiltration
5533176|NCT01154504|hemofiltration|hemofiltration
5533177|NCT01154491|hip fractures|hip fractures
5533178|NCT01154491|blood substitutes|blood substitutes
5533179|NCT01154491|blood transfusion|blood transfusion
5533180|NCT01154491|intravenous infusion|intravenous infusion
5533181|NCT01154491|erythropoietin, recombinant|erythropoietin, recombinant
5533182|NCT01154491|frail elderly|frail elderly
5533183|NCT01154478|polyphenols omega-3 postprandial lipemia adipose tissue|polyphenols omega-3 postprandial lipemia adipose tissue
5533184|NCT01154465|Central venous catheterization|central venous catheterization
5533185|NCT01154465|Obese|obese
5533186|NCT01154465|Ultrasound guidance|ultrasound guidance
5533187|NCT01154465|Jugular|jugular
5533188|NCT01154465|Randomized|randomized
5533189|NCT01154465|Intensive Care Unit|intensive care unit
5533190|NCT01154439|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5533191|NCT01154439|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5533192|NCT01154439|adult acute basophilic leukemia|adult acute basophilic leukemia
5533193|NCT01154439|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5533194|NCT01154439|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5533195|NCT01154439|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5533196|NCT01154439|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5533197|NCT01154439|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5533198|NCT01154439|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5533199|NCT01154439|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5533200|NCT01154439|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5533201|NCT01154439|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5533202|NCT01154439|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5680435|NCT00577798|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5533203|NCT01154439|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5533204|NCT01154439|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5533205|NCT01154439|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5533206|NCT01154439|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5533207|NCT01154400|casein protein|casein protein
5533208|NCT01154400|whey protein|whey protein
5533209|NCT01154400|hydrolysates|hydrolysates
5533210|NCT01154400|leucine|leucine
5533211|NCT01154400|protein metabolism|protein metabolism
5533212|NCT01154400|COPD|copd
5533213|NCT01154387|Kidney|kidney
5533214|NCT01154387|Renal|renal
5533215|NCT01154387|Transplant|transplant
5533216|NCT01154387|Kidney Transplant|kidney transplant
5533217|NCT01154387|Kidney Failure|kidney failure
5533218|NCT01154387|Induction|induction
5533219|NCT01154387|Monoclonal|monoclonal
5533220|NCT01154387|Antibody|antibody
5533221|NCT01154387|T cell|t cell
5533222|NCT01154387|Anti-rejection|anti-rejection
5533223|NCT01154387|Immunosuppression|immunosuppression
5533224|NCT01154374|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
5533225|NCT01154361|ACE inhibitor induced angioedema|ace inhibitor induced angioedema
5533226|NCT01154361|Bradykinin|bradykinin
5533227|NCT01154361|Non-itching edema|non-itching edema
5533228|NCT01154361|Non-allergic angioedema|non-allergic angioedema
5533229|NCT01154361|Quincke edema|quincke edema
5533230|NCT01154361|Drug induced angioedema|drug induced angioedema
5533231|NCT01154361|Bradykinin B2 receptor antagonist|bradykinin b2 receptor antagonist
5533232|NCT01154361|Icatibant|icatibant
5533233|NCT01154361|HOE 140|hoe 140
5533234|NCT01154348|Metformin|metformin
5533235|NCT01154335|refractory metastatic colorectal cancer|refractory metastatic colorectal cancer
5904045|NCT00007813|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5533236|NCT01154309|Depression|depression
5533237|NCT01154309|Substance Use|substance use
5533238|NCT01154309|Group Cognitive Behavioral Therapy|group cognitive behavioral therapy
5533240|NCT01154296|Rapid Testing|rapid testing
5533241|NCT01154296|Counseling|counseling
5533243|NCT01154296|U.S.|u.s.
5533244|NCT01154270|cancer of the salivary glands|cancer of the salivary glands
5533245|NCT01154270|radiation|radiation
5533246|NCT01154270|carbon ion therapy|carbon ion therapy
5533247|NCT01154257|Dental plaque|dental plaque
5533248|NCT01154257|Gingivitis|gingivitis
5533249|NCT01154244|Insulin resistance|insulin resistance
5533250|NCT01154244|Insulin deficiency|insulin deficiency
5533251|NCT01154244|HOMA-IR|homa-ir
5533252|NCT01154244|Drug naive|drug naive
5533253|NCT01154244|Diabetes mellitus, type II|diabetes mellitus, type ii
5533254|NCT01154231|BeneFIX Regulatory Post Marketing Commitment Plan|benefix regulatory post marketing commitment plan
5533255|NCT01154218|bioequivalence|bioequivalence
5533256|NCT01154218|food effect|food effect
5533257|NCT01154218|pharmacokinetics|pharmacokinetics
5533258|NCT01154218|crizotinib|crizotinib
5533259|NCT01154192|PCOS|pcos
5533260|NCT01154192|oligomenorrhea|oligomenorrhea
5533261|NCT01154192|irregular menses|irregular menses
5533262|NCT01154192|hyperandrogenemia|hyperandrogenemia
5533263|NCT01154192|elevated testosterone|elevated testosterone
5533264|NCT01154192|adolescents|adolescents
5533265|NCT01154192|androgens|androgens
5533266|NCT01154192|ovary|ovary
5533268|NCT01154179|permissive underfeeding|permissive underfeeding
5533269|NCT01154179|hypocaloric feeding|hypocaloric feeding
5533270|NCT01154179|artificial nutrition|artificial nutrition
5533271|NCT01154140|open label|open label
5533272|NCT01154140|randomized Phase 3|randomized phase 3
5533273|NCT01154140|first line treatment|first line treatment
5533274|NCT01154140|non squamous lung cancer|non squamous lung cancer
5533275|NCT01154140|ALK translocation event positive|alk translocation event positive
5533276|NCT01154127|NVA237|nva237
5533277|NCT01154127|COPD|copd
5533278|NCT01154127|bronchodilator|bronchodilator
5533279|NCT01154127|exercise endurance|exercise endurance
5533280|NCT01154114|healthy volunteer|healthy volunteer
5533281|NCT01154114|hepatic impairment|hepatic impairment
5533283|NCT01154114|atherosclerosis|atherosclerosis
5533284|NCT01154088|Adolescent|adolescent
5533285|NCT01154088|Vaccine, conjugate|vaccine, conjugate
5533286|NCT01154088|Adult|adult
5533287|NCT01154088|Neisseria meningitidis|neisseria meningitidis
5533288|NCT01154088|Immunogenicity|immunogenicity
5533289|NCT01154088|Meningococcal vaccine|meningococcal vaccine
5533290|NCT01154088|Safety|safety
5533291|NCT01154075|Liver transplant|liver transplant
5533292|NCT01154075|Adherence|adherence
5533293|NCT01154075|Compliance|compliance
5533294|NCT01154075|Tacrolimus|tacrolimus
5533295|NCT01154062|age-related macular degeneration|age-related macular degeneration
5533296|NCT01154062|pazopanib|pazopanib
5533297|NCT01154062|choroidal neovascularization|choroidal neovascularization
5533298|NCT01154062|GW786034|gw786034
5533299|NCT01154049|Schistosomiasis|schistosomiasis
5533300|NCT01154049|Vaccine|vaccine
5533301|NCT01154049|sm14|sm14
5533302|NCT01154023|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5533303|NCT01154023|Behavior Therapy|behavior therapy
5533305|NCT01154010|iritis|iritis
5533306|NCT01154010|anterior uveitis|anterior uveitis
5533307|NCT01153958|Vaginosis, Bacterial|vaginosis, bacterial
5533308|NCT01153958|Colposeptine|colposeptine
5533309|NCT01153958|Metronidazole|metronidazole
5533310|NCT01153945|Hypothyroid and non hypothyroid|hypothyroid and non hypothyroid
5533311|NCT01153932|968|968
5533312|NCT01153932|muscular dystrophy|muscular dystrophy
5533313|NCT01153932|duchenne|duchenne
5533314|NCT01153932|DMD|dmd
5533315|NCT01153906|autoimmune diseases|autoimmune diseases
5533316|NCT01153906|HPV vaccine|hpv vaccine
5533317|NCT01153906|papillomavirus|papillomavirus
5533318|NCT01153906|human papillomavirus|human papillomavirus
5533319|NCT01153906|HPV|hpv
5533320|NCT01153893|Pneumococcal disease|pneumococcal disease
5533321|NCT01153893|Pneumococcal vaccine|pneumococcal vaccine
5533322|NCT01153893|Catch-up vaccination|catch-up vaccination
5533323|NCT01153893|Immunogenicity|immunogenicity
5533324|NCT01153893|Booster vaccination|booster vaccination
5533325|NCT01153893|Safety|safety
5533326|NCT01153880|Altabax|altabax
5533327|NCT01153880|United States|united states
5533328|NCT01153880|topical|topical
5533329|NCT01153880|Mupirocin|mupirocin
5533330|NCT01153880|Retapamulin|retapamulin
5533331|NCT01153880|Bactroban|bactroban
5533332|NCT01153867|Schema Focused Therapy|schema focused therapy
5533333|NCT01153867|Chronic Depression|chronic depression
5533334|NCT01153867|Mechanisms of Change|mechanisms of change
5533335|NCT01153854|acute diarrhea|acute diarrhea
5533336|NCT01153854|Acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)|acute diarrhea (three or more watery or semi-watery bowel movements for at least one day lasting no more than 5 days before being admitted)
5533337|NCT01153841|Pneumococcal vaccine|pneumococcal vaccine
5533338|NCT01153828|Altargo|altargo
5533339|NCT01153828|Bactroban|bactroban
5533340|NCT01153828|Fucidin|fucidin
5533341|NCT01153828|Fusidic acid|fusidic acid
5533342|NCT01153828|Mupirocin|mupirocin
5533343|NCT01153828|topical|topical
5533344|NCT01153828|Retapamulin|retapamulin
5533345|NCT01153828|United Kingdom|united kingdom
5533346|NCT01153815|efficacy|efficacy
5533347|NCT01153815|Spasticity, Post-Stroke|spasticity, post-stroke
5533348|NCT01153815|safety|safety
5533349|NCT01153815|Botulinum toxin type A|botulinum toxin type a
5533350|NCT01153815|placebo|placebo
5533351|NCT01153815|spasticity|spasticity
5533352|NCT01153802|Positron Emission Tomography|positron emission tomography
5533353|NCT01153802|serotonin|serotonin
5533354|NCT01153802|inhibitor of the neurotransmitters|inhibitor of the neurotransmitters
5533355|NCT01153802|safety of single oral doses|safety of single oral doses
5533356|NCT01153802|norepinephrine|norepinephrine
5533357|NCT01153802|dopamine|dopamine
5533358|NCT01153789|Vergence-accommodation evaluation|vergence-accommodation evaluation
5533359|NCT01153789|Vergence and postural control|vergence and postural control
5533360|NCT01153789|Dynamic visual acuity|dynamic visual acuity
5533361|NCT01153776|Arterial switch operation|arterial switch operation
5533362|NCT01153776|Transposition of the great arteries|transposition of the great arteries
5533363|NCT01153776|Congenital heart diseases|congenital heart diseases
5533364|NCT01153776|CT coronary angiography|ct coronary angiography
5533365|NCT01153763|Metastatic melanoma|metastatic melanoma
5533366|NCT01153763|BRAF mutant|braf mutant
5533367|NCT01153763|Melanoma|melanoma
5533368|NCT01153763|BRAF mutant metastatic melanoma|braf mutant metastatic melanoma
5533369|NCT01153750|cholangiocellular carcinoma|cholangiocellular carcinoma
5533370|NCT01153750|bile duct cancer|bile duct cancer
5533371|NCT01153737|Neck pain|neck pain
5533372|NCT01153737|Primary Health Care|primary health care
5533373|NCT01153737|Manual Therapy|manual therapy
5533374|NCT01153737|TENS|tens
5533375|NCT01153685|Fluviral®Influenza|fluviral®influenza
5533376|NCT01153659|rabeprazole|rabeprazole
5533377|NCT01153659|esomeprazole|esomeprazole
5533378|NCT01153659|h. pylori-negative|h. pylori-negative
5533379|NCT01153659|nocturnal acid breakthrough|nocturnal acid breakthrough
5533380|NCT01153659|intragastric pH, PK/PD|intragastric ph, pk/pd
5533479|NCT01153126|Diagnostic Imaging|diagnostic imaging
5533381|NCT01153659|effect on gastric pH in healthy, H. pylori-Negative subjects|effect on gastric ph in healthy, h. pylori-negative subjects
5533382|NCT01153646|HIV|hiv
5533383|NCT01153646|Gene Transfer|gene transfer
5533384|NCT01153646|T-Cell Immunotherapy|t-cell immunotherapy
5533385|NCT01153646|HIV-1 infected patients who have failed anti-retroviral therapy|hiv-1 infected patients who have failed anti-retroviral therapy
5533386|NCT01153620|Acute traumatic wounds|acute traumatic wounds
5533387|NCT01153607|Alzheimer's disease|alzheimer's disease
5533388|NCT01153607|Diagnostic imaging|diagnostic imaging
5533389|NCT01153607|PET diagnosis|pet diagnosis
5533390|NCT01153607|PET tracer|pet tracer
5533391|NCT01153594|Substance Use Disorders|substance use disorders
5533392|NCT01153594|Relapse|relapse
5533393|NCT01153594|Recovery|recovery
5533394|NCT01153594|Disease Management|disease management
5533395|NCT01153594|Long term outcomes|long term outcomes
5533396|NCT01153594|Addiction Treatment|addiction treatment
5533397|NCT01153568|Vitamin D|vitamin d
5533398|NCT01153568|osteoporosis|osteoporosis
5533399|NCT01153568|african american women|african american women
5533400|NCT01153529|PTSD|ptsd
5533401|NCT01153516|Type 2 diabetes|type 2 diabetes
5533402|NCT01153516|Bariatric surgery|bariatric surgery
5533403|NCT01153516|Obesity|obesity
5533404|NCT01153516|Weight loss|weight loss
5533405|NCT01153503|Postoperative pain, TAP block, Hysterectomy|postoperative pain, tap block, hysterectomy
5533406|NCT01153490|Quetiapine|quetiapine
5533407|NCT01153490|Psychotic experiences|psychotic experiences
5533408|NCT01153490|Cannabis dependence|cannabis dependence
5533409|NCT01153490|Craving|craving
5533410|NCT01153490|Mood|mood
5533412|NCT01153451|Pending tests|pending tests
5533413|NCT01153451|Discharge|discharge
5533414|NCT01153451|Awareness|awareness
5533415|NCT01153451|Care transitions|care transitions
5533416|NCT01153438|Diabetes|diabetes
5533417|NCT01153438|Obesity|obesity
5533418|NCT01153438|Bariatric surgery|bariatric surgery
5533419|NCT01153438|Gut hormones|gut hormones
5533420|NCT01153438|Glucagon like peptide 1|glucagon like peptide 1
5533421|NCT01153438|Insulin|insulin
5533422|NCT01153425|Osteoporosis|osteoporosis
5533423|NCT01153425|Osteopenia|osteopenia
5533424|NCT01153425|Fracture Risk|fracture risk
5533425|NCT01153425|teriparatide or Forteo|teriparatide or forteo
5533426|NCT01153425|zoledronic acid or Reclast|zoledronic acid or reclast
5533427|NCT01153399|Non Small Cell Lung Cancer|non small cell lung cancer
5533428|NCT01153399|EGFR mutations|egfr mutations
5533429|NCT01153386|Pulmonary arterial hypertension|pulmonary arterial hypertension
5533430|NCT01153386|Treprostinil|treprostinil
5533431|NCT01153386|Pharmacokinetics|pharmacokinetics
5533432|NCT01153373|Detection of tobacco, alcohol, and drug use.|detection of tobacco, alcohol, and drug use.
5533433|NCT01153347|Major Depressive Disorder|major depressive disorder
5533434|NCT01153347|MDD|mdd
5533435|NCT01153347|Depression|depression
5533436|NCT01153347|Safety|safety
5533437|NCT01153347|add-on therapy|add-on therapy
5533438|NCT01153321|Respiratory disease|respiratory disease
5533439|NCT01153321|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5533440|NCT01153308|Morbid Obesity|morbid obesity
5533441|NCT01153308|Obesity|obesity
5533442|NCT01153308|Weight Loss|weight loss
5533443|NCT01153308|Bariatric Surgery|bariatric surgery
5533444|NCT01153295|IBS|ibs
5533445|NCT01153295|Irritable bowel syndrome|irritable bowel syndrome
5533446|NCT01153295|diagnosis|diagnosis
5533447|NCT01153295|safety|safety
5533448|NCT01153295|Health related quality of life|health related quality of life
5533449|NCT01153282|Breast Cancer patients|breast cancer patients
5533455|NCT01153230|PQ|pq
5533456|NCT01153217|Tenofovir|tenofovir
5533457|NCT01153217|HIV-infection|hiv-infection
5533458|NCT01153217|BMD|bmd
5533459|NCT01153217|Osteoporosis|osteoporosis
5533460|NCT01153217|Osteopenia|osteopenia
5533461|NCT01153204|Erectile Dysfunction|erectile dysfunction
5533462|NCT01153204|Group Psychotherapy|group psychotherapy
5533463|NCT01153204|Sildenafil [Substance Name]|sildenafil [substance name]
5533464|NCT01153204|Patient Satisfaction|patient satisfaction
5533465|NCT01153204|Efficacy|efficacy
5533466|NCT01153204|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
5533467|NCT01153191|colorectal surgery|colorectal surgery
5533468|NCT01153165|Refractory|refractory
5533469|NCT01153165|Asthma|asthma
5533470|NCT01153165|Depression|depression
5533471|NCT01153152|wisdom teeth|wisdom teeth
5533472|NCT01153152|acute pulpitis|acute pulpitis
5533473|NCT01153152|extraction|extraction
5533474|NCT01153152|pain|pain
5533475|NCT01153152|Pain Following Removal of Wisdom Teeth with Acute Pulpitis|pain following removal of wisdom teeth with acute pulpitis
5533476|NCT01153139|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5533477|NCT01153139|Depression|depression
5533478|NCT01153139|Theta Burst Stimulation|theta burst stimulation
5533480|NCT01153126|Breast Screening|breast screening
5533481|NCT01153126|Breast Cancer|breast cancer
5533482|NCT01153126|To be eligible for the study, subjects must:|to be eligible for the study, subjects must:
5533483|NCT01153126|Be females at least 18 years of age,|be females at least 18 years of age,
5533484|NCT01153126|Have had their screening mammogram performed at the UW Breast Center,|have had their screening mammogram performed at the uw breast center,
5533485|NCT01153126|Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),|be able to read and write english at the 6th grade level (as shown by their, ability to understand the informed consent),
5533486|NCT01153126|Have access to a computer with internet capability.|have access to a computer with internet capability.
5533487|NCT01153113|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5533488|NCT01153113|metastatic prostate adenocarcinoma, Stage (T1-4, N+, M0) or (T1-4, N0-3, M+)|metastatic prostate adenocarcinoma, stage (t1-4, n+, m0) or (t1-4, n0-3, m+)
5533489|NCT01153113|rising PSA levels while maintained on LHRH analogues|rising psa levels while maintained on lhrh analogues
5533490|NCT01153100|Diabetes|diabetes
5533491|NCT01153074|Bronchopleural fistula|bronchopleural fistula
5533492|NCT01153074|Bronchoscopy|bronchoscopy
5533493|NCT01153048|Intensification of Education|intensification of education
5533494|NCT01153048|learning nest methodology|learning nest methodology
5533495|NCT01153048|peer educators|peer educators
5533496|NCT01153048|type 2 diabetes|type 2 diabetes
5533497|NCT01153048|Mali|mali
5533498|NCT01153048|the focus of this study is on the intensification of education on the treatment of type 2 diabetes|the focus of this study is on the intensification of education on the treatment of type 2 diabetes
5533499|NCT01153035|Breast Conservation Therapy|breast conservation therapy
5533500|NCT01153035|Lumpectomy|lumpectomy
5533501|NCT01153035|Radiofrequency Ablation|radiofrequency ablation
5533502|NCT01153035|Radiation|radiation
5533503|NCT01153022|Musculoskeletal manipulations|musculoskeletal manipulations
5533504|NCT01153022|Muscle spasticity|muscle spasticity
5533505|NCT01153009|Major Depressive Disorder|major depressive disorder
5533506|NCT01153009|Depression|depression
5533507|NCT01153009|Melancholia|melancholia
5533508|NCT01153009|Drug Therapy|drug therapy
5533509|NCT01152996|Depression|depression
5533510|NCT01152996|Melancholia|melancholia
5533511|NCT01152996|Paraphrenia|paraphrenia
5533512|NCT01152996|Drug Therapy|drug therapy
5533513|NCT01152983|Finger sticks|finger sticks
5533514|NCT01152983|Rapid Ring|rapid ring
5533515|NCT01152983|Finger sticks method of obtaining blood for diagnostic testing|finger sticks method of obtaining blood for diagnostic testing
5533516|NCT01152957|diabetes|diabetes
5533517|NCT01152957|cardiovascular|cardiovascular
5533518|NCT01152957|chronic|chronic
5533519|NCT01152957|Community Health Workers|community health workers
5533520|NCT01152957|behavioral|behavioral
5533521|NCT01152957|social|social
5533522|NCT01152957|diet|diet
5533523|NCT01152957|exercise|exercise
5533524|NCT01152957|patient|patient
5533525|NCT01152957|cholesterol|cholesterol
5533526|NCT01152957|A1C|a1c
5533527|NCT01152957|blood pressure|blood pressure
5533528|NCT01152944|Symptomatic intracranial atherosclerotic disease enrolled in the medical arm of SAMMPRIS|symptomatic intracranial atherosclerotic disease enrolled in the medical arm of sammpris
5533529|NCT01152931|Antioxidants|antioxidants
5533530|NCT01152931|Micronutrients|micronutrients
5533531|NCT01152931|Malaria|malaria
5533532|NCT01152931|focus is to determine the effect of antioxidant micronutrients in malaria|focus is to determine the effect of antioxidant micronutrients in malaria
5533534|NCT01152918|HIV Treatment|hiv treatment
5533535|NCT01152918|HIV Test and Treat Model of Prevention|hiv test and treat model of prevention
5533536|NCT01152918|ART for Prevention|art for prevention
5533537|NCT01152918|Prevention for HIV Positives|prevention for hiv positives
5533538|NCT01152918|Financial Incentives|financial incentives
5533539|NCT01152918|Computer-delivered risk-reduction counseling|computer-delivered risk-reduction counseling
5533540|NCT01152905|Neuromuscular blockade|neuromuscular blockade
5533541|NCT01152905|Neuromuscular blocking agents|neuromuscular blocking agents
5533542|NCT01152905|Atracurium|atracurium
5519907|NCT01209364|non-inferior|non-inferior
5533543|NCT01152905|Nitrous oxide|nitrous oxide
5533544|NCT01152892|end stage renal disease|end stage renal disease
5533545|NCT01152892|chronic kidney disease|chronic kidney disease
5533546|NCT01152892|cardiovascular event|cardiovascular event
5533547|NCT01152892|sudden cardiac death|sudden cardiac death
5533548|NCT01152892|autonomic function|autonomic function
5533549|NCT01152879|Parenteral Nutrition|parenteral nutrition
5533550|NCT01152879|Quality of Life|quality of life
5533551|NCT01152866|Multifollicular stimulation|multifollicular stimulation
5533552|NCT01152866|Pregnancy|pregnancy
5533553|NCT01152866|Reproductive Techniques, Assisted|reproductive techniques, assisted
5533554|NCT01152866|Fertilization in Vitro|fertilization in vitro
5533555|NCT01152866|Infertility|infertility
5533556|NCT01152853|advanced gastric cancer|advanced gastric cancer
5533557|NCT01152853|HER2|her2
5533558|NCT01152853|PF00299804|pf00299804
5533559|NCT01152840|Adenoid cystic carcinoma|adenoid cystic carcinoma
5533560|NCT01152840|RAD001|rad001
5533561|NCT01152827|Pheochromocytoma|pheochromocytoma
5533562|NCT01152827|extra-adrenal paraganglioma|extra-adrenal paraganglioma
5533563|NCT01152827|non-functioning carcinoid|non-functioning carcinoid
5533564|NCT01152827|RAD001|rad001
5533565|NCT01152814|Seasonal influenza|seasonal influenza
5533566|NCT01152814|Vaccine|vaccine
5533567|NCT01152801|mRCC,|mrcc,
5533568|NCT01152801|everolimus,|everolimus,
5533569|NCT01152801|mTOR,|mtor,
5533570|NCT01152801|intolerant of VEGF-therapies|intolerant of vegf-therapies
5533571|NCT01152775|partnered surgical decision-making|partnered surgical decision-making
5533572|NCT01152775|impact of multimedia-based teaching|impact of multimedia-based teaching
5533573|NCT01152775|patient education|patient education
5533574|NCT01152775|understanding and retention by patients|understanding and retention by patients
5533575|NCT01152762|Physiotherapy, COPD, effectiveness, primary care|physiotherapy, copd, effectiveness, primary care
5533576|NCT01152749|Smoking Cessation|smoking cessation
5533577|NCT01152749|Nicotine pharmacokinetics|nicotine pharmacokinetics
5533578|NCT01152736|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5533579|NCT01152723|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5533580|NCT01152710|capecitabine|capecitabine
5533581|NCT01152710|chemoradiation|chemoradiation
5533582|NCT01152710|rectal cancer|rectal cancer
5533583|NCT01152710|phase II study|phase ii study
5533584|NCT01152697|nonadherence|nonadherence
5533585|NCT01152697|noncompliance|noncompliance
5533586|NCT01152697|homeless|homeless
5533587|NCT01152697|schizophrenia|schizophrenia
5533588|NCT01152697|schizoaffective|schizoaffective
5533589|NCT01152684|CAM|cam
5533590|NCT01152684|HIV-Positive|hiv-positive
5533591|NCT01152684|Latinos|latinos
5798860|NCT00110799|Hepatitis C|hepatitis c
5533592|NCT01152684|US-Mexico Border region|us-mexico border region
5533593|NCT01152684|San Diego-Tijuana|san diego-tijuana
5533594|NCT01152684|Identify the nature and extent of complementary and alternative medicine use among HIV-positive Latinos in the US-Mexico border region|identify the nature and extent of complementary and alternative medicine use among hiv-positive latinos in the us-mexico border region
5533595|NCT01152658|Partial supraspinatus tear|partial supraspinatus tear
5533596|NCT01152658|partial tear ssp per echo|partial tear ssp per echo
5533597|NCT01152645|Advanced/recurrent gastric cancer|advanced/recurrent gastric cancer
5533598|NCT01152632|acupuncture|acupuncture
5533599|NCT01152632|migraine|migraine
5533600|NCT01152632|specific acupoints|specific acupoints
5533601|NCT01152632|brain network|brain network
5533602|NCT01152580|melatonin|melatonin
5533603|NCT01152580|menopause|menopause
5533604|NCT01152580|perimenopause|perimenopause
5533605|NCT01152580|sleep|sleep
5533606|NCT01152580|osteoporosis|osteoporosis
5533607|NCT01152580|osteopenia|osteopenia
5533608|NCT01152580|anxiety|anxiety
5533609|NCT01152580|depression|depression
5533610|NCT01152580|hypertension|hypertension
5533611|NCT01152567|Hypertension|hypertension
5533613|NCT01152567|ARB|arb
5533614|NCT01152567|real life data|real life data
5533615|NCT01152567|CVD|cvd
5533616|NCT01152567|cost effectiveness|cost effectiveness
5533617|NCT01152554|Major Depressive Disorder|major depressive disorder
5533618|NCT01152554|MDD|mdd
5533619|NCT01152554|Depression|depression
5533620|NCT01152554|Safety|safety
5533621|NCT01152554|add-on therapy|add-on therapy
5533622|NCT01152541|Keratoconus|keratoconus
5533623|NCT01152541|Corneal Ectasia|corneal ectasia
5533624|NCT01152541|Collagen Crosslinking|collagen crosslinking
5533625|NCT01152541|Riboflavin|riboflavin
5533626|NCT01152528|bacterial vaginosis|bacterial vaginosis
5533627|NCT01152528|screening|screening
5533628|NCT01152528|abortion|abortion
5533629|NCT01152528|preterm delivery|preterm delivery
5533630|NCT01152515|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery|safety and efficacy of maintaining a remifentanil infusion during extubation in propofol-remifentanil sedated patients after surgery
5533631|NCT01152502|Post operative conditions, paracetamol metabolites|post operative conditions, paracetamol metabolites
5533632|NCT01152489|Pain|pain
5533633|NCT01152476|healthy pediatric patients undergoing tonsillectomy and adenoidectomy|healthy pediatric patients undergoing tonsillectomy and adenoidectomy
5533634|NCT01152463|thoracic ultrasound (US)|thoracic ultrasound (us)
5533635|NCT01152463|post-op care|post-op care
5533636|NCT01152463|pneumothorax|pneumothorax
5533637|NCT01152463|pleural effusion|pleural effusion
5533638|NCT01152424|Acute eosinophilic pneumonia|acute eosinophilic pneumonia
5533639|NCT01152424|Exhaled nitric oxide|exhaled nitric oxide
5533640|NCT01152411|Renal Failure|renal failure
5533641|NCT01152411|Chronic Kidney Disease|chronic kidney disease
5533642|NCT01152411|Chronic Renal Failure|chronic renal failure
5533643|NCT01152398|Breast cancer|breast cancer
5533644|NCT01152398|Vaccine|vaccine
5533645|NCT01152398|Metastatic|metastatic
5533646|NCT01152398|HER-2-positive|her-2-positive
5533647|NCT01152398|Phase I|phase i
5533648|NCT01152398|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5533649|NCT01152385|Type 2 diabetes mellitus|type 2 diabetes mellitus
5533650|NCT01152385|Japanese|japanese
5533651|NCT01152385|phase 2|phase 2
5533652|NCT01152385|AZD1656|azd1656
5533653|NCT01152385|efficacy|efficacy
5533654|NCT01152385|dose regimen|dose regimen
5533655|NCT01152385|pharmacokinetics|pharmacokinetics
5533656|NCT01152359|obesity|obesity
5533657|NCT01152359|diet, low carbohydrate|diet, low carbohydrate
5533658|NCT01152359|diet, fat-restricted|diet, fat-restricted
5533659|NCT01152359|food preferences|food preferences
5533660|NCT01152359|quality of life|quality of life
5533661|NCT01152359|patient compliance|patient compliance
5533662|NCT01152346|Bioequivalence|bioequivalence
5533663|NCT01152346|Myelodysplastic Syndrome|myelodysplastic syndrome
5533665|NCT01152346|Azacitidine|azacitidine
5533666|NCT01152320|Asthma|asthma
5533667|NCT01152320|Spirometry|spirometry
5533668|NCT01152320|Pediatric|pediatric
5533669|NCT01152320|Primary Health Care|primary health care
5533670|NCT01152320|Education, Distance|education, distance
5533671|NCT01152307|Depression|depression
5533672|NCT01152307|Depressive disorder|depressive disorder
5533673|NCT01152307|Decision Making|decision making
5533674|NCT01152307|Decision Aids|decision aids
5533675|NCT01152307|Decision Quality Instrument|decision quality instrument
5533676|NCT01152294|Menopause|menopause
5533677|NCT01152294|Decision making|decision making
5533678|NCT01152294|Decision aids|decision aids
5533679|NCT01152294|Decision quality instrument|decision quality instrument
5533680|NCT01152281|retention|retention
5533681|NCT01152281|attrition|attrition
5533682|NCT01152281|empowering|empowering
5533683|NCT01152281|reactance|reactance
5533684|NCT01152281|motivational|motivational
5533685|NCT01152281|goals|goals
5533686|NCT01152281|Basic control|basic control
5533687|NCT01152281|Control with stories of people with AIDS|control with stories of people with aids
5533688|NCT01152281|Instrumental|instrumental
5533689|NCT01152281|Instrumental and Empowering|instrumental and empowering
5533691|NCT01152268|Adolescent males|adolescent males
5533692|NCT01152268|Infertility|infertility
5533693|NCT01152268|Adolescents diagnosed with cancer|adolescents diagnosed with cancer
5533694|NCT01152255|Treatment of HIV-1 Infection|treatment of hiv-1 infection
5533695|NCT01152242|Insulin|insulin
5533696|NCT01152203|Bendamustine|bendamustine
5533697|NCT01152203|Bevacizumab|bevacizumab
5533698|NCT01152177|Heading Health Plan Implementation|heading health plan implementation
5533699|NCT01152177|General Practice|general practice
5533700|NCT01152177|Point of care testing|point of care testing
5533701|NCT01152177|education|education
5533702|NCT01152164|quality of life|quality of life
5533703|NCT01152164|rectal cancer|rectal cancer
5533704|NCT01152151|Heading Health Plan Implementation|heading health plan implementation
5533705|NCT01152151|General Practice|general practice
5533706|NCT01152151|Point of care testing|point of care testing
5533707|NCT01152151|education|education
5533708|NCT01152138|Acute myocardial infarction|acute myocardial infarction
5533709|NCT01152138|Closed cell stent|closed cell stent
5533710|NCT01152138|Open cell stent|open cell stent
5533711|NCT01152138|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5533712|NCT01152125|Osteoarthritis|osteoarthritis
5533713|NCT01152125|stem cell implantation|stem cell implantation
5533714|NCT01152125|bone marrow|bone marrow
5533715|NCT01152125|autologous|autologous
5533716|NCT01152112|morcellator|morcellator
5533717|NCT01152112|hysteroscope|hysteroscope
5533718|NCT01152112|myomectomy|myomectomy
5533719|NCT01152112|polypectomy|polypectomy
5533720|NCT01152112|uterine fibroids|uterine fibroids
5533721|NCT01152112|uterine polyps|uterine polyps
5533722|NCT01152112|office|office
5533723|NCT01152112|cost|cost
5533724|NCT01152112|local anesthetic|local anesthetic
5533725|NCT01152112|cervical block|cervical block
5533726|NCT01152112|pain management|pain management
5533727|NCT01152099|Postmastectomy|postmastectomy
5533728|NCT01152086|Physical activity|physical activity
5533729|NCT01152086|mountain hiking|mountain hiking
5533730|NCT01152086|exercise|exercise
5533731|NCT01152086|training program|training program
5533732|NCT01152086|hopelessness|hopelessness
5533733|NCT01152086|chronic suicidality|chronic suicidality
5533734|NCT01152086|depression|depression
5533735|NCT01152086|suicide attempt|suicide attempt
5533736|NCT01152086|suicide|suicide
5533737|NCT01152073|Cholesterol|cholesterol
5533738|NCT01152073|Statin|statin
5533739|NCT01152073|Nutraceuticals|nutraceuticals
5533740|NCT01152073|Niacin|niacin
5533741|NCT01152073|Hyperlipidemia|hyperlipidemia
5533742|NCT01152073|Liquid|liquid
5533743|NCT01152060|remission of proteinuria|remission of proteinuria
5533744|NCT01152060|HBVe-antigen|hbve-antigen
5533745|NCT01152047|oxytocin|oxytocin
5533746|NCT01152047|satiety|satiety
5533747|NCT01152047|dyspepsia|dyspepsia
5533748|NCT01152034|Bipolar disorder|bipolar disorder
5533749|NCT01152034|psychosocial intervention|psychosocial intervention
5533750|NCT01152034|group therapy|group therapy
5533751|NCT01152034|relapse prevention|relapse prevention
5533752|NCT01152034|parasuicide|parasuicide
5533753|NCT01152034|Recurrence|recurrence
5533754|NCT01152034|hospitalization|hospitalization
5533755|NCT01152034|Medication adherence|medication adherence
5533756|NCT01152034|Self-Injurious Behavior|self-injurious behavior
5533757|NCT01152034|Quality of Life|quality of life
5533758|NCT01152021|dexmedetomidine|dexmedetomidine
5533759|NCT01152021|propofol|propofol
5533760|NCT01152021|sedation|sedation
5533762|NCT01152021|scanning|scanning
5533765|NCT01152021|Magnetic Resonance Imaging|magnetic resonance imaging
5533766|NCT01152008|Microcirculation|microcirculation
5533767|NCT01152008|laser flowmetry|laser flowmetry
5533768|NCT01152008|Skin|skin
5533769|NCT01152008|Physiology|physiology
5533770|NCT01151995|Clinical Trial Monitoring|clinical trial monitoring
5533771|NCT01151995|Effectiveness of remote monitoring|effectiveness of remote monitoring
5533772|NCT01151995|Efficiency of remote monitoring|efficiency of remote monitoring
5533773|NCT01151995|Costs of remote monitoring|costs of remote monitoring
5533774|NCT01151982|Depression|depression
5533775|NCT01151982|Primary prevention.|primary prevention.
5533776|NCT01151982|Primary health care.|primary health care.
5533777|NCT01151982|Randomised controlled trial.|randomised controlled trial.
5533778|NCT01151969|Health Service Misuse|health service misuse
5533779|NCT01151969|Overutilization of Health Services|overutilization of health services
5533780|NCT01151969|Primary Health Care|primary health care
5533781|NCT01151969|Cost Effectiveness|cost effectiveness
5533782|NCT01151969|Quality of life|quality of life
5533783|NCT01151969|Randomised Controlled Trial|randomised controlled trial
5533784|NCT01151969|Multilevel analysis|multilevel analysis
5533785|NCT01151956|observational study|observational study
5533786|NCT01151956|actinic keratosis|actinic keratosis
5533787|NCT01151956|imiquimod|imiquimod
5533788|NCT01151943|cesarean section|cesarean section
5533789|NCT01151943|continuous wound infiltration|continuous wound infiltration
5533790|NCT01151943|transversus abdominis plane block|transversus abdominis plane block
5533791|NCT01151930|Advanced solid tumor failed with standard therapy|advanced solid tumor failed with standard therapy
5533792|NCT01151917|Bilio-pancreatic diversion|bilio-pancreatic diversion
5533793|NCT01151917|morbid obesity|morbid obesity
5533794|NCT01151917|insulin resistance|insulin resistance
5533795|NCT01151917|proteomics|proteomics
5533796|NCT01151891|Pedal puncture wounds|pedal puncture wounds
5533797|NCT01151891|Infection in pedal puncture wounds|infection in pedal puncture wounds
5533798|NCT01151891|Diabetes education and pedal puncture wounds|diabetes education and pedal puncture wounds
5533799|NCT01151878|constipation|constipation
5533800|NCT01151878|children|children
5533801|NCT01151865|Delirium|delirium
5533802|NCT01151865|Intensive Care Unit|intensive care unit
5533803|NCT01151865|Dexmedetomidine|dexmedetomidine
5533804|NCT01151852|Imatinib|imatinib
5533805|NCT01151852|Re-challenge|re-challenge
5533806|NCT01151839|Esophagus|esophagus
5533807|NCT01151839|squamous cell carcinoma|squamous cell carcinoma
5533808|NCT01151839|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5533809|NCT01151826|Lung transplantation|lung transplantation
5533810|NCT01151826|Primary Graft Dysfunction|primary graft dysfunction
5533811|NCT01151826|Extravascular Lung Water|extravascular lung water
5533812|NCT01151826|Receptor for Advanced Glycation Endproducts (RAGE)|receptor for advanced glycation endproducts (rage)
5533813|NCT01151826|Intercellular Adhesion Molecule-1 (ICAM-1)|intercellular adhesion molecule-1 (icam-1)
5533815|NCT01151800|Interactive Voice Response Technology|interactive voice response technology
5533816|NCT01151800|Best Practice Guidelines|best practice guidelines
5533817|NCT01151800|Health Care Utilization|health care utilization
5533818|NCT01151800|Outcome Assessment|outcome assessment
5533819|NCT01151787|migraine|migraine
5533820|NCT01151735|Angioedema|angioedema
5533821|NCT01151735|Hereditary Diseases|hereditary diseases
5533822|NCT01151735|Orphan Disease|orphan disease
5533825|NCT01151709|Chronic condition management|chronic condition management
5533826|NCT01151709|Gout management|gout management
5533827|NCT01151696|Pain|pain
5533828|NCT01151696|morphine|morphine
5533829|NCT01151696|hydroxyzine|hydroxyzine
5533830|NCT01151696|acute pain|acute pain
5533831|NCT01151696|traumatic pain|traumatic pain
5533832|NCT01151696|anxiety|anxiety
5533833|NCT01151696|post trauma stress|post trauma stress
5533834|NCT01151696|post trauma anxiety|post trauma anxiety
5533835|NCT01151696|post trauma disorders|post trauma disorders
5533836|NCT01151683|hypertension|hypertension
5533837|NCT01151683|endothelial dysfunction|endothelial dysfunction
5533838|NCT01151670|radiation therapy|radiation therapy
5533839|NCT01151670|cognitive dysfunction|cognitive dysfunction
5533840|NCT01151670|brain tumor|brain tumor
5533841|NCT01151670|memory problems|memory problems
5533842|NCT01151670|short term memory loss|short term memory loss
5533844|NCT01151657|Irritable bowel syndrome|irritable bowel syndrome
5533845|NCT01151657|Probiotics|probiotics
5533846|NCT01151657|Treatment|treatment
5533847|NCT01151657|Adequate relief|adequate relief
5533848|NCT01151644|H1N1 VACCINE|h1n1 vaccine
5533849|NCT01151644|INFLUENZA|influenza
5533850|NCT01151644|RHEUMATIC DISEASES|rheumatic diseases
5533851|NCT01151644|ANTI-H1N1 IMMUNIZATION|anti-h1n1 immunization
5533852|NCT01151618|COPD|copd
5533853|NCT01151592|Iron deficiency anemia in Chronic Kidney Disease Patients|iron deficiency anemia in chronic kidney disease patients
5533854|NCT01151579|Tachycardia|tachycardia
5533855|NCT01151579|tachyarrhythmias|tachyarrhythmias
5533856|NCT01151579|bronchodilator therapy|bronchodilator therapy
5533857|NCT01151579|Critically ill patients|critically ill patients
5533858|NCT01151566|Ultrasound|ultrasound
5533859|NCT01151566|Contrast enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5533860|NCT01151566|Nephrotoxicity|nephrotoxicity
5533861|NCT01151566|CT contrast agents|ct contrast agents
5533862|NCT01151553|Cardiology|cardiology
5533863|NCT01151553|Cardiomyopathy|cardiomyopathy
5533864|NCT01151553|Cardiovascular Disease|cardiovascular disease
5533865|NCT01151553|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5533866|NCT01151540|Epilepsy|epilepsy
5533867|NCT01151540|Seizures|seizures
5533868|NCT01151514|No referral|no referral
5533869|NCT01151514|Late referral|late referral
5533870|NCT01151514|Acute kidney injury|acute kidney injury
5533871|NCT01151514|Intensive care unit|intensive care unit
5533872|NCT01151514|In-hospital mortality|in-hospital mortality
5533873|NCT01151514|Renal outcome|renal outcome
5533874|NCT01151514|Requirement for renal replacement therapy|requirement for renal replacement therapy
5533875|NCT01151514|Length of hospital stay|length of hospital stay
5533877|NCT01151514|Incidence|incidence
5533878|NCT01151501|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5533879|NCT01151501|intermittent positive-pressure ventilation|intermittent positive-pressure ventilation
5533880|NCT01151501|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5533881|NCT01151501|ventilator weaning|ventilator weaning
5533882|NCT01151475|liver cirrhosis|liver cirrhosis
5533883|NCT01151475|hepatic encephalopathy|hepatic encephalopathy
5533885|NCT01151475|cerebral blood flow|cerebral blood flow
5798861|NCT00110786|Allergy|allergy
5533886|NCT01151462|Postnatal HCMV infection in very preterm infants|postnatal hcmv infection in very preterm infants
5533887|NCT01151462|Neurodevelopmental disabilities|neurodevelopmental disabilities
5533888|NCT01151462|Hearing loss|hearing loss
5533889|NCT01151462|Mental retardation|mental retardation
5533890|NCT01151462|Microcephaly|microcephaly
5533891|NCT01151462|Chorioretinitis|chorioretinitis
5533892|NCT01151462|Growth|growth
5533893|NCT01151436|Facial wrinkle correction|facial wrinkle correction
5533894|NCT01151410|Pediatric hypertension|pediatric hypertension
5533895|NCT01151410|primary hypertension|primary hypertension
5533896|NCT01151410|secondary|secondary
5533897|NCT01151410|hypertension|hypertension
5533899|NCT01151397|VITAMIN D|vitamin d
5533900|NCT01151397|Hepatitis C|hepatitis c
5533901|NCT01151397|Genotype 2,3|genotype 2,3
5533902|NCT01151397|Naive|naive
5533903|NCT01151397|RVR|rvr
5533904|NCT01151384|Cancer Patients|cancer patients
5533905|NCT01151358|radioimmunotherapy|radioimmunotherapy
5533906|NCT01151358|follicular non-Hodgkin´s lymphoma|follicular non-hodgkin´s lymphoma
5533907|NCT01151358|FDG-PET|fdg-pet
5533908|NCT01151358|prognostic factors|prognostic factors
5533909|NCT01151358|multicenter study|multicenter study
5533910|NCT01151345|diltiazem|diltiazem
5533911|NCT01151345|angiotrofin|angiotrofin
5533912|NCT01151345|bioequivalence|bioequivalence
5533913|NCT01151293|Type D personality|type d personality
5533914|NCT01151293|diabetes|diabetes
5533915|NCT01151293|medical compliance|medical compliance
5533916|NCT01151293|HbA1c|hba1c
5533917|NCT01151293|complication|complication
5533918|NCT01151293|mortality|mortality
5533919|NCT01151293|T2DM|t2dm
5533920|NCT01151267|Isocapnic hyperpnoea (IH)|isocapnic hyperpnoea (ih)
5533921|NCT01151267|Anesthesia|anesthesia
5533922|NCT01151267|Accelerate elimination of inhalation agents|accelerate elimination of inhalation agents
5528177|NCT01175304|work|work
5533924|NCT01151254|Cardiac Surgery|cardiac surgery
5533925|NCT01151254|Sedation|sedation
5533926|NCT01151254|Intensive care|intensive care
5533927|NCT01151254|Volatile anesthesia|volatile anesthesia
5533928|NCT01151254|Intravenous anesthesia|intravenous anesthesia
5533929|NCT01151254|Pre and post conditioning after cardiac surgery|pre and post conditioning after cardiac surgery
5533930|NCT01151241|elbow surgery|elbow surgery
5533931|NCT01151241|infraclavicular nerve block|infraclavicular nerve block
5533932|NCT01151241|continuous passive motion|continuous passive motion
5533933|NCT01151241|ultrasound guided regional anesthesia|ultrasound guided regional anesthesia
5533934|NCT01151241|early discharge|early discharge
5533935|NCT01151228|gastroscopy|gastroscopy
5533936|NCT01151228|ultrasound|ultrasound
5533937|NCT01151228|stomach volume|stomach volume
5533938|NCT01151228|patients having gastroscopy|patients having gastroscopy
5533940|NCT01151215|tumour|tumour
5533941|NCT01151215|breast cancer|breast cancer
5533942|NCT01151215|metastatic|metastatic
5533943|NCT01151215|secondary|secondary
5533944|NCT01151215|locally advanced|locally advanced
5533945|NCT01151202|acute upper respiratory tract infection, chronic inflamatory bronchitis|acute upper respiratory tract infection, chronic inflamatory bronchitis
5533947|NCT01151189|Tuberculosis|tuberculosis
5533948|NCT01151189|Vaccine|vaccine
5533949|NCT01151176|Intensive Insulin Therapy|intensive insulin therapy
5533950|NCT01151176|Glucose control|glucose control
5533951|NCT01151176|Acute Coronary Syndrome|acute coronary syndrome
5533952|NCT01151176|Intensive Care|intensive care
5533953|NCT01150916|natriuretic peptide|natriuretic peptide
5533954|NCT01150916|heart failure|heart failure
5533955|NCT01150916|ascites|ascites
5533957|NCT01150838|intubation of children without neuromuscular blockade|intubation of children without neuromuscular blockade
5533958|NCT01149226|pediatric patients|pediatric patients
5533959|NCT01149226|ASA physical status I or II|asa physical status i or ii
5533960|NCT01149226|aged between 1-5 yrs|aged between 1-5 yrs
5533961|NCT01151163|Fibromyalgia, Peripheral arterial tonometry, sleep|fibromyalgia, peripheral arterial tonometry, sleep
5533962|NCT01151111|Parkinson's disease|parkinson's disease
5533963|NCT01151111|Relaxation|relaxation
5533964|NCT01151111|Visual imagery|visual imagery
5533965|NCT01151111|Motor fluctuations|motor fluctuations
5533966|NCT01151111|Treatment|treatment
5533967|NCT01151098|Chronic nonmalignant pain|chronic nonmalignant pain
5533968|NCT01151098|Opioid|opioid
5533969|NCT01151098|Transdermal|transdermal
5533970|NCT01151098|Butrans (BTDS)|butrans (btds)
5533971|NCT01151085|Systemic Mycosis|systemic mycosis
5533972|NCT01151085|Aspergillus infection|aspergillus infection
5533973|NCT01151085|Candidiasis|candidiasis
5533974|NCT01151085|Cryptococcal infections|cryptococcal infections
5533975|NCT01151085|Japanese|japanese
5533976|NCT01151085|voriconazole|voriconazole
5533977|NCT01151085|VFEND|vfend
5533978|NCT01151085|Regulatory Post Marketing Commitment Plan.|regulatory post marketing commitment plan.
5533979|NCT01151059|seasonal influenza|seasonal influenza
5533980|NCT01151059|vaccine|vaccine
5533981|NCT01151046|Breast Cancer|breast cancer
5533982|NCT01151046|Her2 negative|her2 negative
5533983|NCT01151046|Estrogen Receptor Positive|estrogen receptor positive
5533984|NCT01151046|Progesterone Receptor Positive|progesterone receptor positive
5533985|NCT01151046|MM-121|mm-121
5533986|NCT01151046|Exemestane|exemestane
5533987|NCT01151046|Postmenopausal Women|postmenopausal women
5533988|NCT01151033|ProNOVA XR Polymer Free Drug Eluting Coronary Stent System|pronova xr polymer free drug eluting coronary stent system
5533989|NCT01151033|DES|des
5533990|NCT01151033|stent|stent
5533991|NCT01151033|coronary artery lesions|coronary artery lesions
5533992|NCT01151033|ProNOVA|pronova
5533993|NCT01151033|stent implantation|stent implantation
5533994|NCT01151020|Aortic Aneurysm|aortic aneurysm
5533995|NCT01151020|Aneurysm|aneurysm
5533996|NCT01151020|Vascular Prosthesis|vascular prosthesis
5533997|NCT01151020|Vascular Disease|vascular disease
5533998|NCT01151020|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5533999|NCT01151007|Kras mutation|kras mutation
5534000|NCT01151007|colorectal carcinoma|colorectal carcinoma
5534001|NCT01151007|Martinique|martinique
5534002|NCT01150994|Suicide screening among ED patients|suicide screening among ed patients
5534003|NCT01150955|Resveratrol|resveratrol
5534004|NCT01150955|Diabetes|diabetes
5534005|NCT01150955|SIRT1|sirt1
5534006|NCT01150955|STAT5|stat5
5534007|NCT01150955|IGF-I|igf-i
5534008|NCT01150955|Growth hormone|growth hormone
5534009|NCT01150955|NAFLD|nafld
5534010|NCT01150955|Longevity|longevity
5534011|NCT01150955|Substrate metabolism|substrate metabolism
5534012|NCT01150955|Calorie restriction|calorie restriction
5534014|NCT01150942|vero cell|vero cell
5534015|NCT01150929|Knee arthroplasty|knee arthroplasty
5534016|NCT01150929|RSA|rsa
5534017|NCT01150929|DXA|dxa
5534018|NCT01150929|Gait analysis|gait analysis
5534019|NCT01150929|Motion analysis|motion analysis
5534020|NCT01150903|erectile dysfunction|erectile dysfunction
5534021|NCT01150903|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5534022|NCT01150903|cardiovascular diseases|cardiovascular diseases
5534023|NCT01150890|Ileal Crohn's Disease|ileal crohn's disease
5534024|NCT01150890|Ileo-colonic Crohn's Disease|ileo-colonic crohn's disease
5534025|NCT01150890|Colonic Chron's Disease|colonic chron's disease
5534026|NCT01150877|Vitamin D|vitamin d
5534027|NCT01150877|Vitamin D3|vitamin d3
5534028|NCT01150877|colon cancer|colon cancer
5534029|NCT01150877|rectal cancer|rectal cancer
5534030|NCT01150877|Cholecalciferol|cholecalciferol
5534031|NCT01150864|Hot water humidifier, Passive heat and moisture exchangers|hot water humidifier, passive heat and moisture exchangers
5534032|NCT01150825|STEMI|stemi
5534033|NCT01150825|NSTEMI|nstemi
5534034|NCT01150825|acute ischemia|acute ischemia
5534035|NCT01150825|non-invasive diagnosis|non-invasive diagnosis
5534036|NCT01150825|elevated troponin|elevated troponin
5534037|NCT01150812|First time in man|first time in man
5534038|NCT01150812|healthy|healthy
5534039|NCT01150812|thrombin inhibitor|thrombin inhibitor
5534040|NCT01150786|inflammation|inflammation
5534041|NCT01150786|oxidative stress|oxidative stress
5534042|NCT01150786|selenium|selenium
5534043|NCT01150786|hemodialysis|hemodialysis
5534044|NCT01150760|GI recovery after bowel resection|gi recovery after bowel resection
5534045|NCT01150760|morbidity after bowel resection|morbidity after bowel resection
5534046|NCT01150760|mortality|mortality
5534047|NCT01150760|readmission|readmission
5534048|NCT01150760|length of stay|length of stay
5534049|NCT01150734|differences of Muscle evoked potentials (MEP) in psychiatric illnesses|differences of muscle evoked potentials (mep) in psychiatric illnesses
5534050|NCT01150734|differences in neuromodulation|differences in neuromodulation
5534051|NCT01150734|normalization of neuromodulation after pharmacological treatment|normalization of neuromodulation after pharmacological treatment
5534066|NCT01150682|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5534067|NCT01150682|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5534068|NCT01150682|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5534069|NCT01150656|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5534070|NCT01150643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5534071|NCT01150643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5534072|NCT01150643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5848026|NCT00036595|Motor Function|motor function
5534073|NCT01150643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5534075|NCT01150630|stage I pancreatic cancer|stage i pancreatic cancer
5516253|NCT01224925|MTA|mta
5534076|NCT01150630|stage II pancreatic cancer|stage ii pancreatic cancer
5534077|NCT01150617|Type 2 diabetes mellitus|type 2 diabetes mellitus
5534079|NCT01150617|Peripheral angioplasty|peripheral angioplasty
5534080|NCT01150604|Cognitive Behavioral Therapy|cognitive behavioral therapy
5534081|NCT01150604|Mood Management|mood management
5534082|NCT01150604|Self-help|self-help
5534083|NCT01150604|Internet|internet
5534084|NCT01150578|Echocardiography, 2D|echocardiography, 2d
5534085|NCT01150578|speckle tracking|speckle tracking
5534086|NCT01150578|Lexiscan|lexiscan
5534087|NCT01150578|regadenoson|regadenoson
5534088|NCT01150578|Myocardial ischemia|myocardial ischemia
5534089|NCT01150578|Myocardial perfusion imaging|myocardial perfusion imaging
5534090|NCT01150578|cost and cost analysis|cost and cost analysis
5534091|NCT01150578|Cardiac-Gated SPECT Imaging|cardiac-gated spect imaging
5534092|NCT01150578|Echocardiography|echocardiography
5534093|NCT01150552|Serology|serology
5534094|NCT01150552|Poultry|poultry
5534095|NCT01150552|H5N1 virus|h5n1 virus
5534096|NCT01150552|HPAI virus|hpai virus
5534097|NCT01150526|Acute Exercise|acute exercise
5534098|NCT01150526|Muscle Inflammation|muscle inflammation
5534099|NCT01150526|CaHMB|cahmb
5534100|NCT01150526|HMB Free Acid Gel|hmb free acid gel
5534101|NCT01150526|Healthy Subjects|healthy subjects
5534102|NCT01150513|TRIPLE-NEGATIVE|triple-negative
5534103|NCT01150513|BREAST CANCER|breast cancer
5534104|NCT01150500|Medtronic|medtronic
5534105|NCT01150500|Japan|japan
5534106|NCT01150500|Arterial Occlusive Diseases|arterial occlusive diseases
5534107|NCT01150500|Myocardial Ischemia|myocardial ischemia
5534108|NCT01150500|Cardiovascular Diseases|cardiovascular diseases
5534109|NCT01150500|Coronary Artery Disease|coronary artery disease
5534110|NCT01150500|Small Vessel Stent|small vessel stent
5534111|NCT01150487|kidney transplant|kidney transplant
5534112|NCT01150474|Belladonna|belladonna
5534113|NCT01150474|Morphine|morphine
5534114|NCT01150474|Suppositories|suppositories
5534115|NCT01150474|Vaginal|vaginal
5534116|NCT01150474|Surgery|surgery
5534117|NCT01150474|Postoperative|postoperative
5534118|NCT01150474|Pain|pain
5534119|NCT01150461|Hypertrophic nonobstructive cardiomyopathy|hypertrophic nonobstructive cardiomyopathy
5534120|NCT01150448|Paliperidone palmitate|paliperidone palmitate
5534121|NCT01150448|paliperidone ER (INVEGA)|paliperidone er (invega)
5534122|NCT01150448|R092670PSY1008|r092670psy1008
5534123|NCT01150448|Risperidone|risperidone
5534124|NCT01150448|Risperdal (RISPERDAL CONSTA)|risperdal (risperdal consta)
5534125|NCT01150448|Pharmacokinetics|pharmacokinetics
5534126|NCT01150422|medical abortion|medical abortion
5534127|NCT01150409|Sepsis|sepsis
5534128|NCT01150409|hydrocortisone|hydrocortisone
5534129|NCT01150396|extremely premature infant|extremely premature infant
5534131|NCT01150396|follow-up|follow-up
5534132|NCT01150383|Lung Diseases, Obstructive|lung diseases, obstructive
5534133|NCT01150383|Respiratory Tract Diseases|respiratory tract diseases
5534134|NCT01150383|Lung Diseases|lung diseases
5534135|NCT01150383|Respiration Disorders|respiration disorders
5534136|NCT01150383|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5534137|NCT01150383|COPD|copd
5534138|NCT01150383|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5534139|NCT01150383|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5534140|NCT01150383|Chronic Airflow Obstruction|chronic airflow obstruction
5534141|NCT01150383|oxygen|oxygen
5534142|NCT01150383|oxygen supplementation|oxygen supplementation
5534143|NCT01150370|male circumcision|male circumcision
5534145|NCT01150370|Rwanda|rwanda
5534146|NCT01150370|HIV Seronegativity|hiv seronegativity
5534147|NCT01150357|Pediatric hypertension|pediatric hypertension
5534148|NCT01150357|primary hypertension|primary hypertension
5534149|NCT01150357|secondary hypertension|secondary hypertension
5534150|NCT01150344|Multicentric study|multicentric study
5534151|NCT01150344|Antimalarial|antimalarial
5534152|NCT01150344|P. falciparum|p. falciparum
5534153|NCT01150344|Efficacy|efficacy
5534154|NCT01150344|Failures|failures
5534155|NCT01150344|Malarone|malarone
5534156|NCT01150344|RIAMET|riamet
5534157|NCT01150331|status epilepticus|status epilepticus
5534158|NCT01150331|generalised convulsive status epilepticus|generalised convulsive status epilepticus
5534159|NCT01150331|first line treatments|first line treatments
5534160|NCT01150331|double-blind randomized controlled trial|double-blind randomized controlled trial
5534161|NCT01150331|prehospital treatment|prehospital treatment
5534162|NCT01150318|Male|male
5534163|NCT01150318|Infertility|infertility
5534164|NCT01150318|Radioisotopes Therapy|radioisotopes therapy
5534165|NCT01150318|Follicular thyroid cancer|follicular thyroid cancer
5534166|NCT01150305|Autosomal dominant inheritance|autosomal dominant inheritance
5534167|NCT01150305|Mutation|mutation
5534168|NCT01150305|Prevalence|prevalence
5534169|NCT01150292|DHA supplementation|dha supplementation
5534170|NCT01150292|Type 2 diabetic patient|type 2 diabetic patient
5534171|NCT01150292|Platelet function|platelet function
5534172|NCT01150279|medical abortion|medical abortion
5534173|NCT01150279|Medical Abortion Follow Up Care|medical abortion follow up care
5534175|NCT01150266|ischemia|ischemia
5534176|NCT01150266|thrombolysis|thrombolysis
5534177|NCT01150266|thrombolytics|thrombolytics
5534179|NCT01150266|rt-PA|rt-pa
5534180|NCT01150266|t-PA|t-pa
5534181|NCT01150266|Activase®|activase®
5534182|NCT01150266|Alteplase|alteplase
5534183|NCT01150266|wake-up stroke|wake-up stroke
5534184|NCT01150266|waking onset stroke|waking onset stroke
5534185|NCT01150266|sleep|sleep
5534186|NCT01150240|Primary Immunodeficiency Disease|primary immunodeficiency disease
5534187|NCT01150214|atrial fibrillation|atrial fibrillation
5534189|NCT01150214|magnetic resonance imaging|magnetic resonance imaging
5534190|NCT01150214|mri|mri
5534191|NCT01150214|left atrium|left atrium
5534192|NCT01150214|fibrosis|fibrosis
5534193|NCT01150214|structural remodeling|structural remodeling
5534194|NCT01150201|CKD|ckd
5534195|NCT01150201|proteinuria|proteinuria
5534196|NCT01150201|eGFR|egfr
5534197|NCT01150201|Progression of chronic kidney disease|progression of chronic kidney disease
5534198|NCT01150188|aging|aging
5534199|NCT01150188|lipid metabolism|lipid metabolism
5534200|NCT01150188|very low density lipoproteins|very low density lipoproteins
5534201|NCT01150188|amino acids|amino acids
5534202|NCT01150188|dietary supplements|dietary supplements
5534203|NCT01150175|END-HF|end-hf
5534204|NCT01150149|Influenza|influenza
5534205|NCT01150149|Humans|humans
5534206|NCT01150149|Experimental|experimental
5534207|NCT01150149|Challenge|challenge
5534208|NCT01150136|choline|choline
5534209|NCT01150136|cystic fibrosis|cystic fibrosis
5534210|NCT01150136|methyl metabolism|methyl metabolism
5534211|NCT01150136|oxidative stress|oxidative stress
5534212|NCT01150123|Group B streptococcus|group b streptococcus
5534213|NCT01150123|GBS|gbs
5534214|NCT01150123|Vaccine|vaccine
5534215|NCT01150123|Group B streptococcus (GBS) disease|group b streptococcus (gbs) disease
5534216|NCT01150110|Temporomandibular disorders|temporomandibular disorders
5534217|NCT01150110|occlusal splints|occlusal splints
5534218|NCT01150110|electromyography|electromyography
5534219|NCT01150110|TMD (muscle and joint dysfunction)|tmd (muscle and joint dysfunction)
5534220|NCT01150110|masseteres e anterior temporalis muscles.|masseteres e anterior temporalis muscles.
5534221|NCT01150097|Liver transplantation|liver transplantation
5534222|NCT01150097|Everolimus|everolimus
5534223|NCT01150097|Calcineurin inhibitors|calcineurin inhibitors
5534224|NCT01150097|Tacrolimus|tacrolimus
5534225|NCT01150097|Renal function|renal function
5534226|NCT01150097|Progression of HCV related allograft fibrosis|progression of hcv related allograft fibrosis
5528488|NCT01174056|zileuton|zileuton
5789058|NCT00150111|immunization|immunization
5534227|NCT01150084|increasing physical activity in sedentary employees|increasing physical activity in sedentary employees
5534228|NCT01150071|extremely premature infant|extremely premature infant
5534229|NCT01150071|follow-up|follow-up
5534230|NCT01150071|behavior|behavior
5534231|NCT01150071|growth|growth
5534232|NCT01150071|mental health|mental health
5534233|NCT01150071|lung function|lung function
5534234|NCT01150071|spirometry|spirometry
5534235|NCT01150071|muscle mass|muscle mass
5505066|NCT01274429|OIT|oit
5520580|NCT01206270|LH|lh
5534236|NCT01150071|bone density|bone density
5534237|NCT01150071|magnetic Resonance imaging|magnetic resonance imaging
5534238|NCT01150058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5534239|NCT01150058|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5534240|NCT01150058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5534341|NCT01149655|Adolescent|adolescent
5534241|NCT01150058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5534242|NCT01150058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5534243|NCT01150058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5534244|NCT01150058|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5534245|NCT01150058|adult acute myeloid leukemia|adult acute myeloid leukemia
5534246|NCT01150045|adenocarcinoma of the colon|adenocarcinoma of the colon
5534247|NCT01150045|stage III colon cancer|stage iii colon cancer
5534248|NCT01150032|Osteoporosis|osteoporosis
5534249|NCT01150032|Fracture|fracture
5534250|NCT01150032|Bone microarchitecture|bone microarchitecture
5534251|NCT01150019|atherosclerosis|atherosclerosis
5534252|NCT01150019|vascular inflammation|vascular inflammation
5534253|NCT01150019|resistin|resistin
5534254|NCT01150019|adiponectin|adiponectin
5534255|NCT01150019|18FDG-PET|18fdg-pet
5534256|NCT01150006|atherosclerosis|atherosclerosis
5534257|NCT01150006|vascular inflammation|vascular inflammation
5534258|NCT01150006|adipocyte fatty acid binding protein|adipocyte fatty acid binding protein
5534259|NCT01150006|adiponectin|adiponectin
5534260|NCT01150006|leptin|leptin
5534261|NCT01150006|18FDG-PET|18fdg-pet
5534262|NCT01149993|living donation|living donation
5518993|NCT01213147|Fertilization|fertilization
5534263|NCT01149993|kidney transplantation|kidney transplantation
5534264|NCT01149993|delayed graft function|delayed graft function
5534265|NCT01149993|ischemia reperfusion injury|ischemia reperfusion injury
5534266|NCT01149980|Bioequivalence|bioequivalence
5534267|NCT01149980|Crossover|crossover
5534268|NCT01149980|Citalopram|citalopram
5534269|NCT01149967|Bioequivalence|bioequivalence
5534270|NCT01149967|Citalopram|citalopram
5534271|NCT01149967|Crossover|crossover
5534272|NCT01149954|Bioequivalence|bioequivalence
5534273|NCT01149954|Crossover|crossover
5534274|NCT01149954|Ibuprofen|ibuprofen
5534275|NCT01149941|Bioequivalence|bioequivalence
5534276|NCT01149941|Crossover|crossover
5534277|NCT01149941|Ibuprofen|ibuprofen
5534278|NCT01149928|Fetal lung fluid|fetal lung fluid
5534279|NCT01149928|Pulmonary adaptation|pulmonary adaptation
5534280|NCT01149928|Transient tachypnea of the newborn|transient tachypnea of the newborn
5534281|NCT01149928|Epinephrine|epinephrine
5534282|NCT01149928|Stress hormones|stress hormones
5534283|NCT01149915|Advanced Leukemias|advanced leukemias
5534284|NCT01149915|Relapsed/Refractory Leukemias|relapsed/refractory leukemias
5534285|NCT01149915|AML|aml
5534286|NCT01149915|ALL|all
5534287|NCT01149915|CML|cml
5534288|NCT01149915|MDS|mds
5534289|NCT01149915|CLL|cll
5534290|NCT01149915|MF|mf
5534291|NCT01149915|Evofosfamide|evofosfamide
5534292|NCT01149863|Autologous Transplantation|autologous transplantation
5534293|NCT01149850|adult giant cell glioblastoma|adult giant cell glioblastoma
5534294|NCT01149850|adult glioblastoma|adult glioblastoma
5534295|NCT01149850|adult gliosarcoma|adult gliosarcoma
5534296|NCT01149837|HTLV|htlv
5534297|NCT01149837|HTLV I|htlv i
5534298|NCT01149837|HTLV II|htlv ii
5534299|NCT01149837|HTLV Type I and/or HTLV Type II antibody|htlv type i and/or htlv type ii antibody
5534300|NCT01149824|Salvia divinorum|salvia divinorum
5534301|NCT01149824|Salvinorin A|salvinorin a
5534302|NCT01149811|Dyskinesia|dyskinesia
5534303|NCT01149798|metastatic breast cancer|metastatic breast cancer
5534304|NCT01149798|combined chemotherapy|combined chemotherapy
5534306|NCT01149785|healthy volunteers|healthy volunteers
5534307|NCT01149785|ketoconazole|ketoconazole
5534308|NCT01149785|pharmacokinetics|pharmacokinetics
5534309|NCT01149785|single dose|single dose
5534310|NCT01149772|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5534311|NCT01149772|Heart Failure|heart failure
5534312|NCT01149772|Anxiety|anxiety
5534313|NCT01149772|Depression|depression
5534314|NCT01149759|Atopic Dermatitis|atopic dermatitis
5534315|NCT01149759|Eczema|eczema
5534316|NCT01149720|Relative bioavailability|relative bioavailability
5534317|NCT01149720|ARQ 197|arq 197
5534318|NCT01149707|PUR 0110|pur 0110
5534319|NCT01149707|PUR 0110 Rectal Enema|pur 0110 rectal enema
5534320|NCT01149707|Distal Ulcerative Colitis|distal ulcerative colitis
5534321|NCT01149707|Left-Sided Ulcerative Colitis|left-sided ulcerative colitis
5534322|NCT01149707|Mild|mild
5534323|NCT01149707|Moderate|moderate
5534324|NCT01149694|PurGenesis Technologies Inc.|purgenesis technologies inc.
5534325|NCT01149694|PUR 0110 rectal enema|pur 0110 rectal enema
5534326|NCT01149694|Ulcerative colitis|ulcerative colitis
5520674|NCT01205919|Tinnitus|tinnitus
5534327|NCT01149694|Distal|distal
5534328|NCT01149694|Normal healthy volunteers|normal healthy volunteers
5534329|NCT01149681|Aplidin|aplidin
5534330|NCT01149681|Plitidepsin|plitidepsin
5534331|NCT01149681|Myelofibrosis|myelofibrosis
5534332|NCT01149681|Pharma Mar|pharma mar
5534333|NCT01149668|PCI-24781|pci-24781
5534334|NCT01149668|Lymphoma|lymphoma
5534335|NCT01149668|Non-Hodgkin's|non-hodgkin's
5534336|NCT01149668|Hodgkin Disease|hodgkin disease
5534337|NCT01149668|Multiple Myeloma|multiple myeloma
5534338|NCT01149668|Leukemia|leukemia
5534339|NCT01149668|Lymphocytic|lymphocytic
5534340|NCT01149668|Chronic|chronic
5534342|NCT01149655|Schizophrenia|schizophrenia
5534343|NCT01149629|Droxidopa|droxidopa
5534344|NCT01149629|Randomized|randomized
5534345|NCT01149629|Crossover|crossover
5534346|NCT01149629|Open Label|open label
5534347|NCT01149629|Bioequivalence|bioequivalence
5534348|NCT01149629|Fed Fast|fed fast
5534350|NCT01149603|failing Fontan|failing fontan
5534351|NCT01149603|single-ventricle|single-ventricle
5534352|NCT01149603|destination therapy|destination therapy
5534353|NCT01149603|HeartMate II|heartmate ii
5534354|NCT01149603|HMII|hmii
5534355|NCT01149603|cardiac congenital anomaly|cardiac congenital anomaly
5534356|NCT01149603|ventricular assist device|ventricular assist device
5534358|NCT01149590|Angina|angina
5534359|NCT01149590|Coronary Heart Disease|coronary heart disease
5534360|NCT01149590|Computed Tomography|computed tomography
5534361|NCT01149590|Angiogram|angiogram
5534362|NCT01149590|Coronary Artery Calcium Score|coronary artery calcium score
5534363|NCT01149590|Chest Pain|chest pain
5534364|NCT01149590|Angina Pectoris due to Coronary Heart Disease|angina pectoris due to coronary heart disease
5534365|NCT01149577|Olanzapine|olanzapine
5534366|NCT01149577|Schizophrenia|schizophrenia
5519096|NCT01212835|GERD|gerd
5534367|NCT01149577|Polysomnography|polysomnography
5534368|NCT01149577|Slow wave sleep|slow wave sleep
5534369|NCT01149551|Schizophrenia|schizophrenia
5534370|NCT01149551|Bipolar disorder|bipolar disorder
5534371|NCT01149551|Genetic research|genetic research
5534372|NCT01149538|FASD|fasd
5534373|NCT01149538|FAS|fas
5534374|NCT01149538|Alcohol|alcohol
5534375|NCT01149538|Prenatal Alcohol|prenatal alcohol
5534376|NCT01149525|Multiple Sclerosis/complications|multiple sclerosis/complications
5534377|NCT01149525|Fatigue Syndrome|fatigue syndrome
5534378|NCT01149525|Chronic/drug therapy|chronic/drug therapy
5534379|NCT01149486|Bioequivalence|bioequivalence
5534380|NCT01149486|Healthy Subjects|healthy subjects
5534381|NCT01149473|Bioequivalence|bioequivalence
5534382|NCT01149473|Healthy Subjects|healthy subjects
5534383|NCT01149447|cryptogenic stroke|cryptogenic stroke
5534384|NCT01149447|percutaneous closure of PFO|percutaneous closure of pfo
5534385|NCT01149447|follow-up exams|follow-up exams
5534386|NCT01149434|Low grade endocrine tumors|low grade endocrine tumors
5534387|NCT01149434|ovarian cancers|ovarian cancers
5534388|NCT01149434|K-RAS mutant colon cancers|k-ras mutant colon cancers
5534389|NCT01149421|Type 2 Diabetes|type 2 diabetes
5534390|NCT01149421|Diabetes|diabetes
5534391|NCT01149421|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5534392|NCT01149421|ABPM|abpm
5534393|NCT01149421|Blood Pressure|blood pressure
5534394|NCT01149421|Heart Rate|heart rate
5534395|NCT01149408|AML|aml
5534397|NCT01149408|Acute Myeloid Leukemia|acute myeloid leukemia
5534398|NCT01149408|Elderly Patients|elderly patients
5534399|NCT01149408|Cancer|cancer
5534400|NCT01149395|Heartburn|heartburn
5534401|NCT01149395|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5534402|NCT01149382|flu shot|flu shot
5534403|NCT01149382|islet cell transplant recipients|islet cell transplant recipients
5534404|NCT01149369|gastroparesis|gastroparesis
5534405|NCT01149369|nausea|nausea
5534406|NCT01149369|vomiting|vomiting
5534407|NCT01149343|PRAME|prame
5534408|NCT01149343|Cancer immunotherapeutic|cancer immunotherapeutic
5534410|NCT01149343|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
5534411|NCT01149330|Adapalene|adapalene
5534412|NCT01149330|Benzoyl Peroxide|benzoyl peroxide
5534413|NCT01149330|Acne Vulgaris|acne vulgaris
5534414|NCT01149317|acupuncture|acupuncture
5534415|NCT01149317|health services research|health services research
5534416|NCT01149317|chronic pain|chronic pain
5534417|NCT01149317|health disparities|health disparities
5534418|NCT01149304|brachytherapy|brachytherapy
5534419|NCT01149304|liver metastases|liver metastases
5534420|NCT01149304|irradiation|irradiation
5534421|NCT01149304|radiation induced liver disease|radiation induced liver disease
5534422|NCT01149304|dosimetry|dosimetry
5534423|NCT01149291|high sensitivity C-reactive protein (hsCRP)|high sensitivity c-reactive protein (hscrp)
5534424|NCT01149291|cardiorenal|cardiorenal
5534425|NCT01149291|end stage renal disease (ESRD)|end stage renal disease (esrd)
5789059|NCT00150098|HIV|hiv
5534426|NCT01149291|Secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5534427|NCT01149291|dialysis|dialysis
5534428|NCT01149291|paricalcitol|paricalcitol
5520774|NCT01205425|IVUS|ivus
5534429|NCT01149291|osteodystrophy|osteodystrophy
5534430|NCT01149291|selective Vitamin D receptor activators (sVDRA)|selective vitamin d receptor activators (svdra)
5534431|NCT01149291|chronic kidney disease|chronic kidney disease
5534432|NCT01149252|Psoriasis|psoriasis
5534433|NCT01149213|Major depressive disorder|major depressive disorder
5534434|NCT01149213|follow-up|follow-up
5534435|NCT01149213|relapse|relapse
5534436|NCT01149213|remission|remission
5534437|NCT01149213|transcranial direct current stimulation|transcranial direct current stimulation
5534438|NCT01149200|Irritable Bowel Syndrome|irritable bowel syndrome
5534439|NCT01149200|IBS-C|ibs-c
5534440|NCT01149174|intravesical chemotherapy|intravesical chemotherapy
5534443|NCT01149174|electromotive drug administration|electromotive drug administration
5534445|NCT01149161|sentinel lymph node|sentinel lymph node
5534446|NCT01149161|Carcinoma|carcinoma
5534447|NCT01149161|Papillary|papillary
5534448|NCT01149161|thyroid|thyroid
5534449|NCT01149161|dissection|dissection
5534450|NCT01149148|Aortic Surgeries|aortic surgeries
5534451|NCT01149148|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5534452|NCT01149135|Seasonal Affective Disorder|seasonal affective disorder
5534453|NCT01149135|phototherapy|phototherapy
5534454|NCT01149135|circadian rhythms|circadian rhythms
5534455|NCT01149135|blue enriched light|blue enriched light
5534456|NCT01149135|melanopsin|melanopsin
5534457|NCT01149135|low intensity|low intensity
5534458|NCT01149122|unresectable, metastatic biliary tract carcinoma|unresectable, metastatic biliary tract carcinoma
5534459|NCT01149122|Gemcitabine/Oxaliplatin (GEMOX)|gemcitabine/oxaliplatin (gemox)
5534460|NCT01149122|Erlotinib|erlotinib
5534461|NCT01149109|MGMT promotor status|mgmt promotor status
5534462|NCT01149109|overall survival|overall survival
5534463|NCT01149070|Infertility|infertility
5534464|NCT01149070|Controlled ovarian stimulation|controlled ovarian stimulation
5534465|NCT01149070|Reproductive techniques, assisted|reproductive techniques, assisted
5534466|NCT01149070|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5534468|NCT01149070|Ovitrelle|ovitrelle
5534469|NCT01149044|Acute Coronary Syndrome|acute coronary syndrome
5534470|NCT01149044|PCI|pci
5534471|NCT01149044|Percutaneous Coronary Intervention|percutaneous coronary intervention
5534472|NCT01149044|STEMI|stemi
5534473|NCT01149044|Thrombectomy|thrombectomy
5534474|NCT01149031|Provoked Vestibulodynia|provoked vestibulodynia
5534475|NCT01149031|Low Level Laser Therapy|low level laser therapy
5534476|NCT01149018|Fibromyalgia|fibromyalgia
5534477|NCT01149018|Tetrahydrocannabinol|tetrahydrocannabinol
5534478|NCT01149018|Chronic Widespread Pain|chronic widespread pain
5534479|NCT01149005|Normal Glucose Tolerance Test|normal glucose tolerance test
5534480|NCT01149005|Mixed Meal Tolerance Test|mixed meal tolerance test
5534481|NCT01149005|Cystic Fibrosis|cystic fibrosis
5534482|NCT01149005|Pulmonary Exacerbation|pulmonary exacerbation
5534483|NCT01149005|Impaired Glucose Tolerance Test|impaired glucose tolerance test
5534484|NCT01149005|Insulin Therapy|insulin therapy
5534485|NCT01148979|Major Depressive Disorder|major depressive disorder
5534486|NCT01148979|Cognitive Impairment|cognitive impairment
5534487|NCT01148979|Partial Response|partial response
5534488|NCT01148979|Residual Symptoms|residual symptoms
5534489|NCT01148940|sickle cell trait|sickle cell trait
5534490|NCT01148940|thrombosis|thrombosis
5534491|NCT01148940|D-Dimer|d-dimer
5534492|NCT01148914|Inflammatory biomarkers|inflammatory biomarkers
5537150|NCT01138046|ErbB2|erbb2
5534493|NCT01148914|Atrial fibrillation|atrial fibrillation
5534494|NCT01148914|Catheter ablation|catheter ablation
5534495|NCT01148914|To assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome|to assess if pre-ablation levels of inflammatory biomarkers serve as independent predictors of procedure outcome
5534496|NCT01148914|To evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success|to evaluate the inflammatory activation following catheter ablation and examine its predictive role in procedure success
5534497|NCT01148914|To determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome|to determine if a change in the baseline level of biomarkers at 3-months follow-up has any correlation with long-term outcome
5534498|NCT01148914|To study the association of certain biomarkers with specific types of AF (paroxysmal or persistent or long standing persistent)|to study the association of certain biomarkers with specific types of af (paroxysmal or persistent or long standing persistent)
5534499|NCT01148901|Ankylosing spondylitis|ankylosing spondylitis
5534500|NCT01148901|Hip arthritis|hip arthritis
5534501|NCT01148901|Infliximab|infliximab
5534502|NCT01148888|pediatrics|pediatrics
5534503|NCT01148888|Anaesthesia|anaesthesia
5534504|NCT01148888|Scoliosis|scoliosis
5534505|NCT01148888|Magnesium|magnesium
5534506|NCT01148875|breast cancer screening|breast cancer screening
5534507|NCT01148875|mammography adherence|mammography adherence
5534508|NCT01148875|non-adherent|non-adherent
5534509|NCT01148862|ASPIRE (Automation to Simulate Pancreatic Insulin Response)|aspire (automation to simulate pancreatic insulin response)
5534511|NCT01148862|Medtronic Diabetes|medtronic diabetes
5534512|NCT01148862|Diabetes Mellitus|diabetes mellitus
5534517|NCT01148836|Coenzyme Q-10|coenzyme q-10
5534518|NCT01148836|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5534519|NCT01148836|Pulmonary Arterial Hypertension Class I (Venice 2003)|pulmonary arterial hypertension class i (venice 2003)
5534521|NCT01148823|plastic surgery|plastic surgery
5534522|NCT01148823|bandages|bandages
5534523|NCT01148823|surgical site infection|surgical site infection
5534524|NCT01148823|skin colonization|skin colonization
5534625|NCT01148355|Moods|moods
5534626|NCT01148355|Adolescents|adolescents
5534525|NCT01148810|Inflammatory muscle disease, Muscle weakness, Myositis, inflammatory myopathy, inclusion body myositis, skin rash, autoimmune, difficulty swallowing, dysphagia|inflammatory muscle disease, muscle weakness, myositis, inflammatory myopathy, inclusion body myositis, skin rash, autoimmune, difficulty swallowing, dysphagia
5534529|NCT01148797|Canakinumab|canakinumab
5534530|NCT01148784|anterior cruciate ligament tear|anterior cruciate ligament tear
5534531|NCT01148784|ACL|acl
5534532|NCT01148784|ligament|ligament
5534533|NCT01148784|knee|knee
5534534|NCT01148784|allograft|allograft
5534535|NCT01148771|Pharmacokinetics|pharmacokinetics
5534536|NCT01148771|Safety|safety
5534537|NCT01148732|Endotracheal tube|endotracheal tube
5534538|NCT01148732|ultrasonography|ultrasonography
5534539|NCT01148719|Heart Failure|heart failure
5534540|NCT01148719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5534541|NCT01148719|Dyspnea|dyspnea
5534542|NCT01148719|Elderly|elderly
5534543|NCT01148719|Diagnosis|diagnosis
5534544|NCT01148719|Primary health care|primary health care
5534545|NCT01148706|thorax|thorax
5534546|NCT01148706|abdomen|abdomen
5534547|NCT01148693|Cholangitis; Cholangiopancreatography, Endoscopic Retrograde; stents; cholestasis|cholangitis; cholangiopancreatography, endoscopic retrograde; stents; cholestasis
5534548|NCT01148680|Islet Cell Transplantation|islet cell transplantation
5534549|NCT01148680|Metabolic Diseases|metabolic diseases
5534550|NCT01148680|Endocrine System Diseases|endocrine system diseases
5534551|NCT01148667|atopic dermatitis|atopic dermatitis
5534552|NCT01148667|barrier function|barrier function
5534554|NCT01148667|probiotics|probiotics
5534555|NCT01148667|skin|skin
5534556|NCT01148654|preterm birth|preterm birth
5534557|NCT01148654|preterm labor|preterm labor
5534558|NCT01148654|PTB|ptb
5534559|NCT01148654|PTL|ptl
5534560|NCT01148641|Lipid-based supplements|lipid-based supplements
5534561|NCT01148641|LNS|lns
5534562|NCT01148641|Acceptability|acceptability
5534563|NCT01148641|Infant nutrition|infant nutrition
5534564|NCT01148641|Guatemala|guatemala
5534565|NCT01148641|Malnutrition|malnutrition
5534566|NCT01148602|Acute stroke|acute stroke
5534567|NCT01148602|Emergency departments|emergency departments
5534568|NCT01148602|Quality Improvement|quality improvement
5534569|NCT01148602|Improved Processes|improved processes
5534570|NCT01148602|tPA|tpa
5534571|NCT01148602|door-to-needle|door-to-needle
5534572|NCT01148602|door-to-treatment|door-to-treatment
5534573|NCT01148576|hepatic steatosis, chronic hepatitis B, entecavir|hepatic steatosis, chronic hepatitis b, entecavir
5534574|NCT01148563|congestive heart failure|congestive heart failure
5534575|NCT01148563|systolic|systolic
5534576|NCT01148563|chronic disease|chronic disease
5534577|NCT01148563|heart failure|heart failure
5534578|NCT01148550|neonatal acute liver failure|neonatal acute liver failure
5534579|NCT01148550|late-onset liver failure|late-onset liver failure
5534580|NCT01148550|cholestasis,|cholestasis,
5534581|NCT01148550|fatty liver,|fatty liver,
5534582|NCT01148550|liver dysfunction,|liver dysfunction,
5534583|NCT01148550|cirrhosis|cirrhosis
5534584|NCT01148537|Healthy subjects|healthy subjects
5534585|NCT01148537|Opioid|opioid
5534586|NCT01148537|Transdermal|transdermal
5534587|NCT01148524|Meningococcal disease|meningococcal disease
5534588|NCT01148524|Vaccines|vaccines
5534589|NCT01148524|Adolescents|adolescents
5534590|NCT01148511|Macula degeneration|macula degeneration
5534591|NCT01148511|Ranibizumab|ranibizumab
5534592|NCT01148511|Choroidal neovascularisation|choroidal neovascularisation
5534593|NCT01148511|Treat and extend|treat and extend
5534594|NCT01148511|Treat and observe|treat and observe
5534595|NCT01148485|- Staphylococcus aureus Carriage among Athletes|- staphylococcus aureus carriage among athletes
5534596|NCT01148472|Depressive disorder, major|depressive disorder, major
5534597|NCT01148472|Randomized controlled trials|randomized controlled trials
5534598|NCT01148472|Antidepressive agents|antidepressive agents
5534599|NCT01148459|Plasmodium falciparum|plasmodium falciparum
5534600|NCT01148459|schedule|schedule
5534602|NCT01148459|malaria vaccine|malaria vaccine
5534604|NCT01148459|Africa|africa
5534605|NCT01148446|DLBCL|dlbcl
5534606|NCT01148446|R-CHOP|r-chop
5534607|NCT01148446|R-CEOP|r-ceop
5534608|NCT01148446|Elderly patients|elderly patients
5534609|NCT01148407|breast cancer|breast cancer
5534610|NCT01148407|platelets|platelets
5534611|NCT01148407|metastatic cancer|metastatic cancer
5534612|NCT01148407|malignancy|malignancy
5534613|NCT01148394|Colorectal surgery|colorectal surgery
5534614|NCT01148394|multimodal rehabilitation|multimodal rehabilitation
5534615|NCT01148394|fast track|fast track
5534629|NCT01148342|Ecstacy|ecstacy
5534630|NCT01148342|fMRI|fmri
5534631|NCT01148342|Alternative Matrices|alternative matrices
5534632|NCT01148342|Cognitive Training|cognitive training
5534633|NCT01148342|Brain Imaging|brain imaging
5534634|NCT01148329|Coronary stenting|coronary stenting
5534635|NCT01148329|Drug-eluting stent|drug-eluting stent
5534636|NCT01148329|Post-market surveillance study|post-market surveillance study
5534637|NCT01148329|Promus Element stent|promus element stent
5534638|NCT01148316|Developmental Psychiatry|developmental psychiatry
5534639|NCT01148316|Sequential Randomized Clinical Trial|sequential randomized clinical trial
5534640|NCT01148316|Obsessive-Compulsive Disorder D009771|obsessive-compulsive disorder d009771
5534641|NCT01148303|Headache|headache
5534642|NCT01148303|Fasting|fasting
5534643|NCT01148303|Fasting Headache|fasting headache
5534644|NCT01148303|Ramadan|ramadan
5534645|NCT01148303|Ramadan Headache|ramadan headache
5534646|NCT01148303|Yom Kippur|yom kippur
5534647|NCT01148303|Yom Kippur Headache|yom kippur headache
5534648|NCT01148290|bulking agent|bulking agent
5534649|NCT01148290|emivulvectomy|emivulvectomy
5534650|NCT01148290|radical vulvectomy|radical vulvectomy
5534651|NCT01148290|TVT|tvt
5534652|NCT01148290|urinary incontinence|urinary incontinence
5534653|NCT01148290|vulvar cancer|vulvar cancer
5534654|NCT01148277|Endoscopies|endoscopies
5534655|NCT01148277|Liver diseases|liver diseases
5534656|NCT01148277|Propofol|propofol
5534657|NCT01148277|Midazolam and remifentanyl|midazolam and remifentanyl
5519413|NCT01211496|elderly|elderly
5534658|NCT01148264|break-through|break-through
5534659|NCT01148264|emesis|emesis
5534660|NCT01148264|break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant|break through emesis after prophylaxis with dexamethasone, 5-ht 3ra and aprepitant
5534661|NCT01148238|Autoimmune diabetes|autoimmune diabetes
5534662|NCT01148238|LADA|lada
5534663|NCT01148238|T-reg|t-reg
5534664|NCT01148238|cytokine|cytokine
5534665|NCT01148225|Intermediate-Uveitis|intermediate-uveitis
5534666|NCT01148225|Non-infectious Uveitis|non-infectious uveitis
5534667|NCT01148225|Posterior-Uveitis|posterior-uveitis
5534668|NCT01148225|Active Uveitis|active uveitis
5534669|NCT01148225|Pan-uveitis|pan-uveitis
5534670|NCT01148225|Uveitis|uveitis
5534671|NCT01148199|biliary anastomotic stricture|biliary anastomotic stricture
5534672|NCT01148199|orthotopic liver transplantation|orthotopic liver transplantation
5534673|NCT01148199|ERCP|ercp
5534674|NCT01148186|Polypharmacy|polypharmacy
5534675|NCT01148186|Benzodiazepine use|benzodiazepine use
5534676|NCT01148186|Oxybutynin use|oxybutynin use
5534677|NCT01148186|cognition disorders/drug therapy|cognition disorders/drug therapy
5534678|NCT01148186|incontinence|incontinence
5534679|NCT01148173|CNS relapse|cns relapse
5534680|NCT01148173|aggressive lymphoma|aggressive lymphoma
5534681|NCT01148173|HD-ASCT|hd-asct
5534682|NCT01148160|voriconazole|voriconazole
5534683|NCT01148160|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
5534684|NCT01148160|hematologic malignancy|hematologic malignancy
5534685|NCT01148160|therapeutic drug monitoring|therapeutic drug monitoring
5534686|NCT01148160|genetic polymorphism|genetic polymorphism
5534687|NCT01148160|efficacy|efficacy
5534688|NCT01148160|safety|safety
5534689|NCT01148147|Adenosine|adenosine
5534690|NCT01148147|randomized trial|randomized trial
5534691|NCT01148147|periprocedural myocardial necrosis|periprocedural myocardial necrosis
5534692|NCT01148147|elective coronary angioplasty|elective coronary angioplasty
5534694|NCT01148108|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5534695|NCT01148108|Lymphoma|lymphoma
5534696|NCT01148108|Mantle Cell|mantle cell
5534697|NCT01148108|Diffuse Large B Cell|diffuse large b cell
5534698|NCT01148108|Multiple Myeloma|multiple myeloma
5534699|NCT01148108|Telcyta|telcyta
5534700|NCT01148108|canfosfamide|canfosfamide
5534701|NCT01148108|TLK286|tlk286
5534702|NCT01148108|Prodrug|prodrug
5534703|NCT01148108|Enzyme activated drug|enzyme activated drug
5534704|NCT01148108|Glutathione Transferase P1-1 activated drug|glutathione transferase p1-1 activated drug
5534705|NCT01148108|GSTp1-1 activated drug|gstp1-1 activated drug
5534706|NCT01148108|Glutathione Transferase activated drug|glutathione transferase activated drug
5534707|NCT01148108|Glutathione|glutathione
5534708|NCT01148108|Glutathione analong|glutathione analong
5534709|NCT01148095|AZD2516|azd2516
5534710|NCT01148095|Phase 1|phase 1
5534711|NCT01148095|Healthy volunteer|healthy volunteer
5534712|NCT01148095|pharmacokinetics|pharmacokinetics
5534713|NCT01148095|safety|safety
5534714|NCT01148095|tolerability|tolerability
5534715|NCT01148095|Multiple ascending doses|multiple ascending doses
5534716|NCT01148082|Carcinomas (including Squamous Cell and Adenocarcinoma)|carcinomas (including squamous cell and adenocarcinoma)
5534717|NCT01148069|IMRT-IGRT|imrt-igrt
5534718|NCT01148069|radiotherapy toxicity|radiotherapy toxicity
5534719|NCT01148069|seminal vesicles|seminal vesicles
5534720|NCT01148056|IMRT|imrt
5534721|NCT01148056|radiation therapy|radiation therapy
5534722|NCT01148017|Meningococcal|meningococcal
5534723|NCT01148017|ACWY|acwy
5534724|NCT01148017|Conjugate Vaccine|conjugate vaccine
5534725|NCT01148017|Meningitis|meningitis
5534726|NCT01148017|Children|children
5534727|NCT01148017|Persistence|persistence
5534728|NCT01148017|Booster dose|booster dose
5534730|NCT01148004|Hypertriglyceridemia|hypertriglyceridemia
5534731|NCT01148004|Protease Inhibitors|protease inhibitors
5534732|NCT01148004|Healthy Volunteer|healthy volunteer
5534733|NCT01148004|HV|hv
5534734|NCT01147991|Epstein-Barr virus infection|epstein-barr virus infection
5534735|NCT01147991|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5534736|NCT01147991|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5534737|NCT01147991|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5534738|NCT01147991|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5534739|NCT01147991|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5534740|NCT01147991|stage I gastric cancer|stage i gastric cancer
5534741|NCT01147991|stage II gastric cancer|stage ii gastric cancer
5534742|NCT01147991|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5534743|NCT01147991|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5534744|NCT01147991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5534745|NCT01147991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5534746|NCT01147991|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5534747|NCT01147991|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5534748|NCT01147978|ICU|icu
5679265|NCT00582829|Cancer|cancer
5534749|NCT01147978|Anxiety|anxiety
5534750|NCT01147978|Depression|depression
5534751|NCT01147978|PTSD|ptsd
5534752|NCT01147965|Colon Cancer|colon cancer
5534753|NCT01147965|Lung Cancer|lung cancer
5534754|NCT01147965|Breast Cancer|breast cancer
5534755|NCT01147965|CEA|cea
5534756|NCT01147952|angina|angina
5534757|NCT01147952|gene expression|gene expression
5534758|NCT01147952|depression|depression
5534759|NCT01147952|anxiety|anxiety
5534760|NCT01147939|Acute Myeloid Leukaemia|acute myeloid leukaemia
5534761|NCT01147939|AML|aml
5534762|NCT01147939|Haematology|haematology
5534763|NCT01147939|Investigator's Choice|investigator's choice
5534764|NCT01147939|Elacytarabine|elacytarabine
5534765|NCT01147939|Refractory or relapsed AML|refractory or relapsed aml
5534766|NCT01147939|Phase III|phase iii
5534767|NCT01147939|Randomized|randomized
5534768|NCT01147939|CLAVELA|clavela
5534769|NCT01147939|CP4055-306|cp4055-306
5534770|NCT01147939|Elacyt|elacyt
5534771|NCT01147926|Constipation|constipation
5534772|NCT01147926|Male|male
5534773|NCT01147913|Major Depression|major depression
5534774|NCT01147913|Depression|depression
5534775|NCT01147913|Anxiety|anxiety
5534776|NCT01147913|Dysthymia|dysthymia
5534777|NCT01147900|Immune persistence|immune persistence
5534778|NCT01147900|Boostrix|boostrix
5534779|NCT01147900|dTpa booster study|dtpa booster study
5534780|NCT01147887|26489112|26489112
5534781|NCT01147887|Omeprazole|omeprazole
5534782|NCT01147887|Tolbutamide|tolbutamide
5534783|NCT01147874|non-therapeutic|non-therapeutic
5534784|NCT01147874|interventional|interventional
5534785|NCT01147861|T2DM|t2dm
5534786|NCT01147861|Pharmacodynamics|pharmacodynamics
5534787|NCT01147861|GSK256073|gsk256073
5534788|NCT01147848|Salmeterol|salmeterol
5534789|NCT01147848|fluticasone furoate|fluticasone furoate
5534790|NCT01147848|Vilanterol|vilanterol
5534791|NCT01147848|fluticasone propionate|fluticasone propionate
5534792|NCT01147848|GW642444|gw642444
5534793|NCT01147835|Herbal lollipops|herbal lollipops
5534794|NCT01147835|Asthma|asthma
5534795|NCT01147835|Dental Caries|dental caries
5534796|NCT01147835|Streptococcus mutans levels|streptococcus mutans levels
5534797|NCT01147835|DMFT/dmft scores|dmft/dmft scores
5534798|NCT01147822|SUTENT|sutent
5534799|NCT01147822|GW76034|gw76034
5534800|NCT01147822|Sunitinib|sunitinib
5534801|NCT01147822|Renal cell carcinoma|renal cell carcinoma
5534802|NCT01147822|Pazopanib|pazopanib
5534803|NCT01147809|Solid Tumor|solid tumor
5534804|NCT01147809|Eltrombopag|eltrombopag
5534805|NCT01147809|chemotherapy-induced thrombocytopenia|chemotherapy-induced thrombocytopenia
5534806|NCT01147809|Thrombocytopenia|thrombocytopenia
5534807|NCT01147796|Thrombus|thrombus
5534808|NCT01147796|computed tomography|computed tomography
5534809|NCT01147796|Transoesophageal echocardiography|transoesophageal echocardiography
5534810|NCT01147770|progesterone|progesterone
5534811|NCT01147770|antagonist|antagonist
5534812|NCT01147770|rec FSH|rec fsh
5534813|NCT01147770|IVF|ivf
5534814|NCT01147770|pregnancy|pregnancy
5789060|NCT00150098|vaccines|vaccines
5534815|NCT01147757|pediatric patients (ASA physical status I or II) aged between|pediatric patients (asa physical status i or ii) aged between
5534816|NCT01147744|Efficacy|efficacy
5534817|NCT01147744|Asthma|asthma
5534818|NCT01147744|Safety|safety
5534819|NCT01147744|Fluticasone Propionate|fluticasone propionate
5534820|NCT01147744|FLAP|flap
5534821|NCT01147744|Beta-agonists|beta-agonists
5534822|NCT01147744|GSK2190915|gsk2190915
5534823|NCT01147744|Montelukast|montelukast
5534824|NCT01147744|Placebo|placebo
5534825|NCT01147744|FLAIR|flair
5534826|NCT01147731|pharmacokinetics|pharmacokinetics
5534827|NCT01147731|albiglutide|albiglutide
5534828|NCT01147731|warfarin|warfarin
5534829|NCT01147731|Healthy volunteers|healthy volunteers
5534830|NCT01147718|pharmacokinetics|pharmacokinetics
5534831|NCT01147718|albiglutide|albiglutide
5534832|NCT01147718|Healthy volunteer|healthy volunteer
5534833|NCT01147718|digoxin|digoxin
5534834|NCT01147705|Peripheral arterial disease|peripheral arterial disease
5534835|NCT01147705|Allopurinol|allopurinol
5534836|NCT01147692|albiglutide|albiglutide
5534837|NCT01147692|simvastatin|simvastatin
5534838|NCT01147692|healthy volunteers|healthy volunteers
5534839|NCT01147692|pharmacokinetics|pharmacokinetics
5534840|NCT01147679|Frontotemporal dementia|frontotemporal dementia
5534841|NCT01147679|Alzheimer's disease|alzheimer's disease
5534842|NCT01147679|Young-Onset|young-onset
5534843|NCT01147679|Frontotemporal degeneration|frontotemporal degeneration
5534844|NCT01147679|control|control
5534845|NCT01147679|social|social
5534846|NCT01147679|behavior|behavior
5534847|NCT01147679|observation|observation
5534848|NCT01147679|emotion|emotion
5534849|NCT01147679|morality|morality
5534850|NCT01147679|dementia|dementia
5534851|NCT01147679|brain|brain
5534852|NCT01147679|relationships|relationships
5534853|NCT01147679|caregiver|caregiver
5534855|NCT01147679|neurology|neurology
5534856|NCT01147666|Kidney|kidney
5534857|NCT01147666|End Stage Renal Disease|end stage renal disease
5534858|NCT01147666|ESRD|esrd
5534859|NCT01147666|Chronic Kidney Disease|chronic kidney disease
5534861|NCT01147666|Renal|renal
5534862|NCT01147666|Anemia|anemia
5534863|NCT01147666|Oral anemia treatment|oral anemia treatment
5534864|NCT01147666|Hemoglobin levels|hemoglobin levels
5534865|NCT01147666|Blood count|blood count
5534866|NCT01147666|Erythropoietin|erythropoietin
5534867|NCT01147666|Hemodialysis|hemodialysis
5534868|NCT01147666|Normoresponder|normoresponder
5534869|NCT01147666|Hyporesponder|hyporesponder
5534870|NCT01147653|Cerebral Palsy|cerebral palsy
5534871|NCT01147653|CP|cp
5534872|NCT01147653|Spastic Cerebral Palsy|spastic cerebral palsy
5534873|NCT01147653|Cord Blood|cord blood
5534874|NCT01147653|Umbilical Cord Blood|umbilical cord blood
5534875|NCT01147653|Autologous Cord Blood|autologous cord blood
5534876|NCT01147627|diabetes mellitus, type 2|diabetes mellitus, type 2
5534877|NCT01147627|newly diagnosed|newly diagnosed
5534878|NCT01147627|exenatide|exenatide
5534879|NCT01147627|premixed insulin analog|premixed insulin analog
5534880|NCT01147627|thiazolidinedione|thiazolidinedione
5534881|NCT01147627|β-cell function|β-cell function
5534882|NCT01147627|glycemic control|glycemic control
5534883|NCT01147614|Child|child
5534884|NCT01147614|adolescent|adolescent
5534885|NCT01147614|anxiety|anxiety
5534886|NCT01147614|depression|depression
5534887|NCT01147614|internalizing|internalizing
5534888|NCT01147614|cognitive behavioral therapy|cognitive behavioral therapy
5534889|NCT01147614|pediatric primary care|pediatric primary care
5534890|NCT01147601|topical 0.5% Timolol|topical 0.5% timolol
5534891|NCT01147601|infantile hemangioma (IH)|infantile hemangioma (ih)
5534892|NCT01147588|open label|open label
5534893|NCT01147588|randomized|randomized
5534894|NCT01147588|4-treatment|4-treatment
5534895|NCT01147588|3-period|3-period
5534896|NCT01147588|crossover|crossover
5534897|NCT01147588|interaction study|interaction study
5534898|NCT01147588|Safety|safety
5534899|NCT01147588|tolerability|tolerability
5534900|NCT01147588|pharmacokinetics|pharmacokinetics
5534901|NCT01147588|pharmacodynamics|pharmacodynamics
5534902|NCT01147575|Rett Syndrome, Randomized, Methylation|rett syndrome, randomized, methylation
5534903|NCT01147562|Lung cancer|lung cancer
5534904|NCT01147562|Biopsy|biopsy
5534905|NCT01147562|Biomarker|biomarker
5534906|NCT01147562|Tissue Collection|tissue collection
5534907|NCT01147549|ADME|adme
5534908|NCT01147523|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5534909|NCT01147523|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5534910|NCT01147523|adipokines|adipokines
5534911|NCT01147523|spironolactone|spironolactone
5534912|NCT01147523|vitamin E|vitamin e
5534913|NCT01147523|adiponectin|adiponectin
5534914|NCT01147523|visfatin|visfatin
5534915|NCT01147523|leptin|leptin
5534916|NCT01147523|resistin|resistin
5534917|NCT01147523|TNF-alpha|tnf-alpha
5534918|NCT01147523|IL-6|il-6
5534919|NCT01147523|IL-1|il-1
5534920|NCT01147510|asthma control in elderly patients|asthma control in elderly patients
5534921|NCT01147510|age 60-75|age 60-75
5534922|NCT01147497|IUD insertion|iud insertion
5534923|NCT01147497|nulliparous women|nulliparous women
5534924|NCT01147497|contraception|contraception
5534925|NCT01147497|family planning|family planning
5534926|NCT01147497|IUD insertion in nulliparous women|iud insertion in nulliparous women
5534927|NCT01147484|Breast Cancer|breast cancer
5534928|NCT01147471|flail chest|flail chest
5534929|NCT01147471|rib fixation|rib fixation
5534930|NCT01147458|Cross-over|cross-over
5534931|NCT01147458|safety|safety
5505767|NCT01271855|Belladonna|belladonna
5521262|NCT01203670|Lipase|lipase
5534932|NCT01147458|efficacy|efficacy
5534933|NCT01147458|tolerability|tolerability
5534934|NCT01147458|osteoarthritis|osteoarthritis
5534935|NCT01147458|knee|knee
5534936|NCT01147458|pain|pain
5534937|NCT01147445|Enterotoxigenic Escherichia coli, vaccine|enterotoxigenic escherichia coli, vaccine
5534938|NCT01147432|Healthy male volunteers|healthy male volunteers
5534939|NCT01147432|capsaicin challenge|capsaicin challenge
5534940|NCT01147432|safety|safety
5534941|NCT01147432|toleration|toleration
5534942|NCT01147419|critical limb ischemia|critical limb ischemia
5534943|NCT01147419|peripheral artery occlusive disease|peripheral artery occlusive disease
5534944|NCT01147419|femoropopliteal artery bypass|femoropopliteal artery bypass
5534945|NCT01147419|Stent|stent
5534946|NCT01147367|exercise|exercise
5534947|NCT01147367|breast cancer|breast cancer
5534948|NCT01147367|physical activity|physical activity
5534949|NCT01147367|fatigue|fatigue
5534950|NCT01147367|sleep dysfunction|sleep dysfunction
5534951|NCT01147367|cytokines|cytokines
5534952|NCT01147367|muscle strength|muscle strength
5534953|NCT01147367|inflammation|inflammation
5534954|NCT01147354|Hemodialysis|hemodialysis
5534955|NCT01147354|oxidative stress|oxidative stress
5534956|NCT01147354|selenium|selenium
5534957|NCT01147354|inflammation|inflammation
5534958|NCT01147341|rheumatoid arthritis|rheumatoid arthritis
5534959|NCT01147341|anti-TNF therapy|anti-tnf therapy
5534960|NCT01147328|Health information technology|health information technology
5519693|NCT01210378|Hypoxia|hypoxia
5534961|NCT01147328|Health information exchange|health information exchange
5534962|NCT01147328|Virtual health record|virtual health record
5534963|NCT01147328|Health care utilization|health care utilization
5534964|NCT01147315|mandibular osteoradionecrosis|mandibular osteoradionecrosis
5534965|NCT01147315|hybrid bone substitution|hybrid bone substitution
5534966|NCT01147315|calcium-phosphate ceramic biomaterial|calcium-phosphate ceramic biomaterial
5534967|NCT01147315|autologous bone marrow|autologous bone marrow
5534968|NCT01147289|lumbar sciatic pain|lumbar sciatic pain
5534969|NCT01147289|moderate to severe lumbar sciatic pain within the last three days|moderate to severe lumbar sciatic pain within the last three days
5534970|NCT01147276|DPP-4|dpp-4
5534971|NCT01147276|GLP-1|glp-1
5534972|NCT01147276|Glucagon|glucagon
5534973|NCT01147276|Catecholamines|catecholamines
5534974|NCT01147276|Counterregulation|counterregulation
5534975|NCT01147276|Type 1 diabetes|type 1 diabetes
5534976|NCT01147263|Fibromyalgia|fibromyalgia
5534977|NCT01147263|Autonomic dysfunction|autonomic dysfunction
5534978|NCT01147263|Tachycardia|tachycardia
5534979|NCT01147263|Palpitations|palpitations
5534980|NCT01147224|Asthma|asthma
5534981|NCT01147224|Allergy|allergy
5534982|NCT01147224|Ciclesonide|ciclesonide
5534983|NCT01147224|Alvesco|alvesco
5534984|NCT01147224|Inhaled steroids|inhaled steroids
5534985|NCT01147211|dose defining|dose defining
5534986|NCT01147211|MK-2206|mk-2206
5534987|NCT01147211|NSCLC With EGFR Mutation|nsclc with egfr mutation
5534988|NCT01147211|NSCLC|nsclc
5534989|NCT01147198|Moderate|moderate
5534990|NCT01147198|Wasting|wasting
5534991|NCT01147198|Malnutrition|malnutrition
5534992|NCT01147198|Ready to Use Food|ready to use food
5534993|NCT01147198|Fortified Blended Flour|fortified blended flour
5534994|NCT01147185|Spinal Cord Injuries, Locomotor training, Dose-Response|spinal cord injuries, locomotor training, dose-response
5534995|NCT01147172|Nasolabial Folds|nasolabial folds
5534996|NCT01147172|Cosmetic|cosmetic
5534997|NCT01147172|Injectable Dermal Filler|injectable dermal filler
5534998|NCT01147172|Hyaluronic Acid with Lidocaine|hyaluronic acid with lidocaine
5534999|NCT01147146|transurethral surgery|transurethral surgery
5535000|NCT01147133|Platelet aggregation|platelet aggregation
5535001|NCT01147133|Generic|generic
5535002|NCT01147133|Clopidogrel|clopidogrel
5535003|NCT01147133|Comparison|comparison
5535004|NCT01147133|VASP-PRI|vasp-pri
5535005|NCT01147107|HIV/HCV co-infection|hiv/hcv co-infection
5535006|NCT01147107|Antiretroviral therapy|antiretroviral therapy
5535007|NCT01147081|Influenza vaccine|influenza vaccine
5535008|NCT01147081|Vaccine|vaccine
5535009|NCT01147068|Influenza|influenza
5535010|NCT01147055|crizotinib|crizotinib
5535011|NCT01147055|healthy volunteers|healthy volunteers
5535012|NCT01147055|rifampin|rifampin
5535013|NCT01147055|pharmacokinetics|pharmacokinetics
5535014|NCT01147055|single dose|single dose
5535015|NCT01147042|NADPH Oxidase-Nicotinamide Adenine Dinucleotide Phosphate|nadph oxidase-nicotinamide adenine dinucleotide phosphate
5535016|NCT01147042|Chronic Granulomatous Disease|chronic granulomatous disease
5535017|NCT01147042|Gene Mutation|gene mutation
5535018|NCT01147042|Superoxide by Phagocytes|superoxide by phagocytes
5535019|NCT01147042|Interferon-Gamma|interferon-gamma
5535020|NCT01147029|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5535021|NCT01147016|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5535022|NCT01147016|HER2-negative breast cancer|her2-negative breast cancer
5662525|NCT00653419|fasting|fasting
5535023|NCT01147016|male breast cancer|male breast cancer
5535024|NCT01147016|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5535025|NCT01147016|recurrent breast cancer|recurrent breast cancer
5535026|NCT01147016|stage IIA breast cancer|stage iia breast cancer
5535027|NCT01147016|stage IIB breast cancer|stage iib breast cancer
5535028|NCT01147016|stage IIIA breast cancer|stage iiia breast cancer
5535029|NCT01147016|stage IIIB breast cancer|stage iiib breast cancer
5535030|NCT01147016|triple-negative breast cancer|triple-negative breast cancer
5535031|NCT01147003|Seizure frequency|seizure frequency
5535032|NCT01147003|nervous system diseases|nervous system diseases
5535034|NCT01147003|neurologic manifestations|neurologic manifestations
5535035|NCT01147003|adjunctive treatment|adjunctive treatment
5535036|NCT01147003|AEDs|aeds
5535037|NCT01147003|antiepileptic drug|antiepileptic drug
5535038|NCT01146990|17P Efficacy Trial Follow up|17p efficacy trial follow up
5535039|NCT01146977|CBF(+)|cbf(+)
5535040|NCT01146964|Age related cataract|age related cataract
5535041|NCT01146964|Phacoemulsification|phacoemulsification
5535042|NCT01146964|Manual super small incision cataract surgery|manual super small incision cataract surgery
5535043|NCT01146951|Epilepsy|epilepsy
5535044|NCT01146951|Seizures|seizures
5535045|NCT01146938|fimasartan|fimasartan
5535046|NCT01146938|hepatic impairment|hepatic impairment
5535047|NCT01146925|Acute Kidney Injury|acute kidney injury
5535048|NCT01146925|Contrast-Induced Nephropathy|contrast-induced nephropathy
5535049|NCT01146925|Labile Iron|labile iron
5535050|NCT01146925|Iron Chelation|iron chelation
5535051|NCT01146925|Deferiprone|deferiprone
5535052|NCT01146912|Influenza, text message, vaccination|influenza, text message, vaccination
5535053|NCT01146899|influenza, vaccine, clinical decision support|influenza, vaccine, clinical decision support
5535054|NCT01146860|BNO 1016, acute rhinosinusitis|bno 1016, acute rhinosinusitis
5535055|NCT01146847|algorithm|algorithm
5535056|NCT01146847|tight glycemic control|tight glycemic control
5535057|NCT01146847|glucose control|glucose control
5535058|NCT01146847|intensive care|intensive care
5535060|NCT01146847|ICU|icu
5535061|NCT01146808|Vaccination|vaccination
5535062|NCT01146808|Immunocompromised Host|immunocompromised host
5535063|NCT01146808|Antiviral Agents|antiviral agents
5535064|NCT01146808|Drug Resistance, Viral|drug resistance, viral
5535065|NCT01146808|Resource Allocation|resource allocation
5535066|NCT01146769|Cancer of rectum|cancer of rectum
5535067|NCT01146769|Physiotherapy|physiotherapy
5535068|NCT01146756|MEK inhibitor|mek inhibitor
5535069|NCT01146756|thoracic radiotherapy|thoracic radiotherapy
5535070|NCT01146756|lung cancer|lung cancer
5535071|NCT01146743|EUS-guided transmural cholecystostomy|eus-guided transmural cholecystostomy
5535072|NCT01146730|Anxiety|anxiety
5535073|NCT01146730|Depression|depression
5535074|NCT01146730|Vocational Rehabilitation|vocational rehabilitation
5535075|NCT01146730|Common Mental Disorders|common mental disorders
5535076|NCT01146730|Mental Health Problems|mental health problems
5535077|NCT01146730|Work Related Therapy|work related therapy
5535078|NCT01146717|Mild Cognitive Impairment|mild cognitive impairment
5535079|NCT01146717|Exercise|exercise
5535080|NCT01146704|Obesity|obesity
5535081|NCT01146691|Organizational models|organizational models
5535082|NCT01146691|Intensive care units|intensive care units
5535083|NCT01146691|Physicians|physicians
5535084|NCT01146691|Staffing and scheduling|staffing and scheduling
5535085|NCT01146691|Burnout, professional|burnout, professional
5535086|NCT01146691|Job satisfaction|job satisfaction
5535087|NCT01146691|Education, medical|education, medical
5535088|NCT01146691|Patient satisfaction|patient satisfaction
5535089|NCT01146665|alcohol consumption|alcohol consumption
5535090|NCT01146665|personalized assessment feedback|personalized assessment feedback
5535091|NCT01146665|youth|youth
5535092|NCT01146665|emergency department|emergency department
5535094|NCT01146626|Vitamin D|vitamin d
5535095|NCT01146626|Hepatitis C|hepatitis c
5535096|NCT01146626|Genotype2,3|genotype2,3
5535098|NCT01146626|Naive|naive
5535099|NCT01146626|RVR rate|rvr rate
5535100|NCT01146626|EVR rate|evr rate
5535101|NCT01146626|SVR rate|svr rate
5535102|NCT01146613|Alcohol|alcohol
5535103|NCT01146613|Alcohol abuse|alcohol abuse
5535104|NCT01146613|Alcoholism|alcoholism
5535105|NCT01146613|Alcohol Dependence|alcohol dependence
5535106|NCT01146613|Varenicline|varenicline
5535107|NCT01146613|Drinking|drinking
5535108|NCT01146600|Primary hypersomnia|primary hypersomnia
5535109|NCT01146600|CNS hypersomnia|cns hypersomnia
5535110|NCT01146600|hypersomnia|hypersomnia
5535111|NCT01146600|idiopathic hypersomnia|idiopathic hypersomnia
5535112|NCT01146600|clarithromycin|clarithromycin
5535113|NCT01146600|Narcolepsy without Cataplexy|narcolepsy without cataplexy
5535114|NCT01146587|Stroke|stroke
5535115|NCT01146587|Robotics|robotics
5535116|NCT01146587|Gait|gait
5535117|NCT01146587|Rehabilitation|rehabilitation
5535118|NCT01146574|End-Stage Renal Disease|end-stage renal disease
5535119|NCT01146574|Anemia|anemia
5535120|NCT01146574|Hemodialysis|hemodialysis
5535121|NCT01146574|Renal Anemia|renal anemia
5535123|NCT01146548|Fluoxetine effect|fluoxetine effect
5535124|NCT01146548|Multiple System Atrophy|multiple system atrophy
5535125|NCT01146548|MSA|msa
5535126|NCT01146535|interferon-alpha|interferon-alpha
5535127|NCT01146535|oseltamivir|oseltamivir
5535128|NCT01146535|drug therapy, combination|drug therapy, combination
5535129|NCT01146535|influenza|influenza
5535423|NCT01145105|Pain|pain
5535130|NCT01146535|therapies, investigational|therapies, investigational
5535131|NCT01146522|Familial hyperchylomicronemia|familial hyperchylomicronemia
5535132|NCT01146522|Lipoprotein lipase deficiency|lipoprotein lipase deficiency
5535133|NCT01146522|Hyperlipoproteinemia|hyperlipoproteinemia
5535134|NCT01146522|Triglycerides|triglycerides
5535135|NCT01146522|Hypertriglyceridemia|hypertriglyceridemia
5535136|NCT01146522|LCQ908|lcq908
5535137|NCT01146522|Hyperlipoproteinemia associated with lipoprotein lipase deficiency|hyperlipoproteinemia associated with lipoprotein lipase deficiency
5535138|NCT01146509|migraine|migraine
5535139|NCT01146509|headache|headache
5535140|NCT01146496|Pesticide poisoning|pesticide poisoning
5535141|NCT01146496|Suicide|suicide
5535142|NCT01146496|Unintentional poisoning|unintentional poisoning
5535143|NCT01146496|Prevention|prevention
5535144|NCT01146496|Cluster randomised controlled trial|cluster randomised controlled trial
5535145|NCT01146457|Obstetric anesthesia|obstetric anesthesia
5535146|NCT01146457|labor analgesia|labor analgesia
5535147|NCT01146457|morphine|morphine
5535148|NCT01146457|epidural analgesia|epidural analgesia
5535149|NCT01146444|Sunscreening Agents|sunscreening agents
5535150|NCT01146418|Reproductive Techniques, Assisted|reproductive techniques, assisted
5535151|NCT01146418|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
5535152|NCT01146418|Fertilization In Vitro|fertilization in vitro
5535153|NCT01146405|Laparoscopic|laparoscopic
5535154|NCT01146392|Epidemiological|epidemiological
5535155|NCT01146392|COPD health care|copd health care
5535156|NCT01146392|treatment in primary care|treatment in primary care
5535157|NCT01146379|stroke|stroke
5535158|NCT01146379|upper extremity|upper extremity
5535159|NCT01146379|paresis|paresis
5535160|NCT01146379|function|function
5535161|NCT01146379|translational research|translational research
5535162|NCT01146366|Early stage lung cancer|early stage lung cancer
5535163|NCT01146366|Cervical mediastinoscopy|cervical mediastinoscopy
5535164|NCT01146366|Observational study|observational study
5535165|NCT01146366|clinical stage T2N0M0 and select T1N0M0 (suvMAX on FDG-PET of >/=10)|clinical stage t2n0m0 and select t1n0m0 (suvmax on fdg-pet of >/=10)
5535166|NCT01146353|peramivir|peramivir
5535167|NCT01146353|CVVH|cvvh
5535168|NCT01146353|CRRT|crrt
5535169|NCT01146353|CVVHD|cvvhd
5535170|NCT01146353|influenza|influenza
5535171|NCT01146353|sieving coefficient|sieving coefficient
5535172|NCT01146353|clearance|clearance
5535173|NCT01146340|Prostatic Neoplasms|prostatic neoplasms
5535174|NCT01146340|Radiotherapy|radiotherapy
5535175|NCT01146340|Hypofractionation|hypofractionation
5535176|NCT01146340|Low and Intermediate Risk Prostate Cancer|low and intermediate risk prostate cancer
5535177|NCT01146327|Multiple Dose Study in Overweight Healthy Subjects|multiple dose study in overweight healthy subjects
5535178|NCT01146327|body weight|body weight
5535179|NCT01146314|family-focused intervention|family-focused intervention
5535180|NCT01146314|pediatric obesity|pediatric obesity
5535181|NCT01146314|diabetes prevention|diabetes prevention
5535182|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5535183|NCT01146301|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5535184|NCT01146288|obesity|obesity
5535185|NCT01146288|acetazolamide|acetazolamide
5535186|NCT01146288|furosemide|furosemide
5671485|NCT00615875|head and neck surgery|head and neck surgery
5535187|NCT01146275|Patients who participated in pilot study (31GB0601) and performed breast augmentation with previous formulation of Macrolane|patients who participated in pilot study (31gb0601) and performed breast augmentation with previous formulation of macrolane
5535188|NCT01146262|Antitumoral immune response after autologous dendritic cells vaccination|antitumoral immune response after autologous dendritic cells vaccination
5535189|NCT01146249|Multisensorial integration|multisensorial integration
5535190|NCT01146249|Postural control|postural control
5535192|NCT01146236|Surgical|surgical
5535193|NCT01146236|Infection|infection
5535194|NCT01146236|Post-operative|post-operative
5535195|NCT01146236|Sutures|sutures
5535196|NCT01146236|Staples|staples
5535197|NCT01146197|Hypokalemia|hypokalemia
5535198|NCT01146197|Hypomagnesemia|hypomagnesemia
5535199|NCT01146197|Salt loosing nephropathy|salt loosing nephropathy
5535200|NCT01146184|Cholelithiasis|cholelithiasis
5535201|NCT01146184|Single Incision|single incision
5535202|NCT01146184|Flexible Endoscope|flexible endoscope
5535203|NCT01146184|Ethicon Manually Articulating Device|ethicon manually articulating device
5535204|NCT01146184|Pain|pain
5535205|NCT01146158|Axillary dissection|axillary dissection
5535206|NCT01146145|postoperative|postoperative
5535207|NCT01146145|pain|pain
5535208|NCT01146145|analgesia|analgesia
5535209|NCT01146145|morphine|morphine
5535210|NCT01146145|titration|titration
5535211|NCT01146145|ketamine|ketamine
5535213|NCT01146132|Physical activity|physical activity
5521557|NCT01202591|Exemestane|exemestane
5535214|NCT01146132|Cerebrovascular disease|cerebrovascular disease
5535215|NCT01146132|wine consumption|wine consumption
5535217|NCT01146132|Pulse transit time|pulse transit time
5535218|NCT01146132|transcranial Doppler sonography|transcranial doppler sonography
5535219|NCT01146119|HAI|hai
5535220|NCT01146119|Influenza|influenza
5535221|NCT01146119|prime|prime
5535222|NCT01146119|boost|boost
5535223|NCT01146119|immune response|immune response
5535224|NCT01146119|seroconversion|seroconversion
5535225|NCT01146119|universal|universal
5535226|NCT01146119|vaccine|vaccine
5535227|NCT01146080|drug eluting stent|drug eluting stent
5535228|NCT01146080|everolimus eluting stent|everolimus eluting stent
5535229|NCT01146080|optical coherence tomography|optical coherence tomography
5535230|NCT01146080|intravascular ultrasound|intravascular ultrasound
5535231|NCT01146067|Bioequivalence|bioequivalence
5535232|NCT01146041|Bioequivalence|bioequivalence
5535233|NCT01146015|Influenza|influenza
5535234|NCT01146015|Vaccine|vaccine
5535235|NCT01146015|CHMP criteria|chmp criteria
5535236|NCT01146002|Attention-deficit/hyperactivity disorder, primarily inattentive or combined type.|attention-deficit/hyperactivity disorder, primarily inattentive or combined type.
5535237|NCT01145989|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5535238|NCT01145976|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin|aplastic anemia, fludarabine, cyclophosphamide, thymoglobulin
5519994|NCT01209000|NEPTUNE|neptune
5535239|NCT01145963|pasta|pasta
5535240|NCT01145963|appetite|appetite
5535241|NCT01145963|hunger|hunger
5535242|NCT01145963|satiation|satiation
5535243|NCT01145963|nutrition|nutrition
5535244|NCT01145963|Psychological Phenomena and Processes|psychological phenomena and processes
5535245|NCT01145950|Etanercept|etanercept
5535246|NCT01145950|Enbrel|enbrel
5535247|NCT01145950|healthy volunteers|healthy volunteers
5535248|NCT01145937|Keratoconus|keratoconus
5535249|NCT01145937|Corneal grafting|corneal grafting
5535250|NCT01145937|Corneal transplantation|corneal transplantation
5535251|NCT01145937|Anterior Lamellar Keratoplasty|anterior lamellar keratoplasty
5535252|NCT01145924|bronchoscopy|bronchoscopy
5535253|NCT01145924|endobronchial ultrasound|endobronchial ultrasound
5535254|NCT01145924|transbronchial needle aspiration|transbronchial needle aspiration
5535255|NCT01145924|lung cancer|lung cancer
5535256|NCT01145924|staging|staging
5535257|NCT01145911|Glaucoma|glaucoma
5535258|NCT01145911|Blood Flow|blood flow
5535259|NCT01145911|Progression|progression
5535260|NCT01145898|Glaucoma|glaucoma
5535261|NCT01145898|Cosopt|cosopt
5535262|NCT01145898|blood flow|blood flow
5535263|NCT01145898|progression|progression
5535264|NCT01145872|Mindfulness|mindfulness
5535265|NCT01145872|clinical trial|clinical trial
5535266|NCT01145872|intervention|intervention
5535267|NCT01145872|prevention|prevention
5535268|NCT01145859|Venous Thrombosis|venous thrombosis
5535269|NCT01145859|Pediatrics|pediatrics
5535270|NCT01145833|obesity|obesity
5535271|NCT01145833|guided self help treatment|guided self help treatment
5535272|NCT01145833|treatment method|treatment method
5535273|NCT01145833|overweight|overweight
5535274|NCT01145833|overweight children and parents|overweight children and parents
5535275|NCT01145833|families with overweight child|families with overweight child
5535276|NCT01145833|efficacy|efficacy
5535277|NCT01145833|body mass index|body mass index
5535278|NCT01145833|weight|weight
5535279|NCT01145820|third molar|third molar
5535280|NCT01145820|trauma|trauma
5535281|NCT01145820|pain|pain
5535282|NCT01145820|wound healing|wound healing
5535283|NCT01145820|post operative morbidity|post operative morbidity
5535284|NCT01145820|acute trauma|acute trauma
5535285|NCT01145820|short-term wound healing|short-term wound healing
5535286|NCT01145807|Distal Subungual Toenail Onychomycosis|distal subungual toenail onychomycosis
5537803|NCT01136577|LED|led
5535288|NCT01145781|ectocervical CIN lesions|ectocervical cin lesions
5535290|NCT01145768|randomized|randomized
5535291|NCT01145768|placebo-controlled|placebo-controlled
5535292|NCT01145768|parallel-group study|parallel-group study
5535293|NCT01145768|Safety|safety
5535294|NCT01145768|pharmacokinetics|pharmacokinetics
5535295|NCT01145755|Depression|depression
5535296|NCT01145742|Type 2 diabetes|type 2 diabetes
5535297|NCT01145742|Hypertension|hypertension
5535298|NCT01145742|Health services research|health services research
5535299|NCT01145742|Health disparities|health disparities
5535300|NCT01145742|Behavior change|behavior change
5535301|NCT01145729|Biomarker feedback|biomarker feedback
5535302|NCT01145729|Smoking cessation|smoking cessation
5535303|NCT01145729|Childhood secondhand smoke exposure|childhood secondhand smoke exposure
5535304|NCT01145716|TFCC injuries|tfcc injuries
5535305|NCT01145716|Distal radius fractures|distal radius fractures
5535306|NCT01145703|Body Composition|body composition
5535307|NCT01145703|Cardiovascular Risk|cardiovascular risk
5535308|NCT01145703|Cognitive Function|cognitive function
5535309|NCT01145690|cognitive behaviour therapy|cognitive behaviour therapy
5529538|NCT01169857|Velcade|velcade
5535311|NCT01145677|Alcoholism|alcoholism
5521670|NCT01202149|eczema|eczema
5535312|NCT01145677|Topiramate|topiramate
5535313|NCT01145664|Chinese medicines|chinese medicines
5535314|NCT01145664|Severe hand-foot-mouth diseases|severe hand-foot-mouth diseases
5535315|NCT01145664|effectiveness|effectiveness
5535316|NCT01145664|safety|safety
5535317|NCT01145638|cancer|cancer
5535318|NCT01145638|chemotherapy induced anaemia|chemotherapy induced anaemia
5535319|NCT01145638|iron|iron
5535320|NCT01145638|Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA)|patients with non-myeloid malignancies and chemotherapy induced anaemia (cia)
5535321|NCT01145638|CIA|cia
5535324|NCT01145612|Marfan syndrome|marfan syndrome
5535325|NCT01145612|Losartan|losartan
5535326|NCT01145612|Atenolol|atenolol
5535327|NCT01145573|calcium|calcium
5535328|NCT01145573|vitamin D|vitamin d
5535329|NCT01145573|bone|bone
5535330|NCT01145573|pregnancy|pregnancy
5535331|NCT01145560|severe sepsis|severe sepsis
5535332|NCT01145560|TNF neutralisation|tnf neutralisation
5535333|NCT01145560|septic shock patients|septic shock patients
5535334|NCT01145547|glycemic index|glycemic index
5535335|NCT01145547|Diabetes Mellitus|diabetes mellitus
5535336|NCT01145547|continuous glucose monitoring|continuous glucose monitoring
5535337|NCT01145534|diabetes,|diabetes,
5535338|NCT01145534|medicinal plants,|medicinal plants,
5535339|NCT01145534|glucose|glucose
5535340|NCT01145482|Memory Disorders|memory disorders
5535341|NCT01145482|Alzheimer's Disease|alzheimer's disease
5535342|NCT01145469|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5535343|NCT01145469|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5535344|NCT01145469|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5535345|NCT01145469|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5535346|NCT01145469|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5535347|NCT01145443|Organizational models|organizational models
5535348|NCT01145443|Intensive care units|intensive care units
5535349|NCT01145443|Physicians|physicians
5535350|NCT01145443|Staffing and scheduling|staffing and scheduling
5535351|NCT01145443|Burnout, professional|burnout, professional
5535352|NCT01145443|Job satisfaction|job satisfaction
5535353|NCT01145417|peripheral neuropathic pain|peripheral neuropathic pain
5535354|NCT01145417|pregabalin|pregabalin
5535355|NCT01145417|safety|safety
5535356|NCT01145404|Her2 Gastro Gastric Esophageal Cancer|her2 gastro gastric esophageal cancer
5535357|NCT01145391|hypertension|hypertension
5535358|NCT01145391|blood pressure|blood pressure
5535359|NCT01145391|primary care|primary care
5535360|NCT01145391|patient centered medical home|patient centered medical home
5535361|NCT01145391|health information technology|health information technology
5535362|NCT01145391|clinical inertia|clinical inertia
5535363|NCT01145365|Crohns|crohns
5535364|NCT01145365|Fistula|fistula
5535365|NCT01145365|Perianal Abscess|perianal abscess
5535366|NCT01145365|Perianal|perianal
5535367|NCT01145352|Enbrel-JIA|enbrel-jia
5535368|NCT01145326|venipuncture|venipuncture
5535369|NCT01145326|phlebotomy|phlebotomy
5535370|NCT01145326|pain perception|pain perception
5535371|NCT01145300|COPD|copd
5535372|NCT01145300|Inflammation|inflammation
5535373|NCT01145300|Small airways|small airways
5535374|NCT01145287|Celiac disease|celiac disease
5535375|NCT01145287|Gluten-free diet|gluten-free diet
5535376|NCT01145287|Screen-detected|screen-detected
5535377|NCT01145287|Asymptomatic|asymptomatic
5535378|NCT01145287|Quality of life|quality of life
5535379|NCT01145287|Self-perceived health|self-perceived health
5535380|NCT01145287|Healthcare resource utilization|healthcare resource utilization
5535381|NCT01145274|allopurinol|allopurinol
5535382|NCT01145274|chronic kidney diseae|chronic kidney diseae
5535383|NCT01145261|Anxiety,|anxiety,
5535384|NCT01145261|Emotional Regulation|emotional regulation
5535385|NCT01145248|Cholangiocellular Carcinoma|cholangiocellular carcinoma
5535386|NCT01145235|Breast augmentation with Macrolane|breast augmentation with macrolane
5535388|NCT01145222|Procedural Sedation|procedural sedation
5535389|NCT01145222|Colonoscopy|colonoscopy
5535391|NCT01145209|Chemoimmunotherapy|chemoimmunotherapy
5535392|NCT01145209|SLL|sll
5535393|NCT01145209|Monoclonal Antibody Therapy|monoclonal antibody therapy
5535394|NCT01145209|CLL|cll
5535395|NCT01145209|Ofatumumab|ofatumumab
5535398|NCT01145183|Cocaine Dependence|cocaine dependence
5535399|NCT01145183|Substance Related Disorders|substance related disorders
5535400|NCT01145183|genotype|genotype
5535401|NCT01145170|brainstem gliomas|brainstem gliomas
5535402|NCT01145170|pediatric patients|pediatric patients
5535403|NCT01145157|knee|knee
5535404|NCT01145157|arthroplasty|arthroplasty
5535405|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone
5535406|NCT01145144|DHEA|dhea
5535407|NCT01145144|IVF outcome|ivf outcome
5535408|NCT01145144|long protocol IVF|long protocol ivf
5535409|NCT01145144|poor-responder|poor-responder
5535410|NCT01145144|recombinant LH|recombinant lh
5535411|NCT01145144|embryo quality|embryo quality
5535412|NCT01145144|pregnancy rate|pregnancy rate
5535413|NCT01145144|live birth rate|live birth rate
5535414|NCT01145144|poor response to ovarian stimulation|poor response to ovarian stimulation
5535416|NCT01145131|FSR|fsr
5535417|NCT01145131|protein|protein
5535418|NCT01145131|meat|meat
5535419|NCT01145118|Plantar Fasciitis|plantar fasciitis
5535420|NCT01145118|Physiotherapy|physiotherapy
5535421|NCT01145105|Low back pain|low back pain
5535422|NCT01145105|Sciatica|sciatica
5535424|NCT01145105|Physiotherapy|physiotherapy
5535425|NCT01145092|type 2 diabetes|type 2 diabetes
5535426|NCT01145092|exercise training|exercise training
5535427|NCT01145092|ATP-synthesis|atp-synthesis
5535428|NCT01145092|intramyocellular lipids|intramyocellular lipids
5535429|NCT01145092|hepatocellular lipids|hepatocellular lipids
5535430|NCT01145092|first degree relatives of T2DM patients|first degree relatives of t2dm patients
5535431|NCT01145066|diabetes|diabetes
5535432|NCT01145066|metabolic syndrome|metabolic syndrome
5535433|NCT01145066|inflammation|inflammation
5535434|NCT01145066|botanical oils|botanical oils
5535435|NCT01145040|Overt primary hypothyroidism|overt primary hypothyroidism
5535436|NCT01145040|Overt primary hyperthyroidism|overt primary hyperthyroidism
5535437|NCT01145040|Thyrotropic feedback control|thyrotropic feedback control
5535438|NCT01145040|Mathematical modelling|mathematical modelling
5535439|NCT01145040|Nonlinear modelling|nonlinear modelling
5535440|NCT01145040|Thyroid|thyroid
5535441|NCT01145040|Pituitary|pituitary
5535442|NCT01145040|Physiological cybernetics|physiological cybernetics
5535443|NCT01145040|Full-dose levothyroxine substitution therapy|full-dose levothyroxine substitution therapy
5535444|NCT01145040|Syndrome T|syndrome t
5535445|NCT01145027|Capillary recruitment|capillary recruitment
5535446|NCT01145027|Cephalic Phase of Insulin Secretion|cephalic phase of insulin secretion
5535447|NCT01145027|Dietary Intake|dietary intake
5535448|NCT01145001|smoking|smoking
5535449|NCT01145001|adolescents|adolescents
5535450|NCT01145001|contingency management|contingency management
5535451|NCT01145001|nicotine replacement therapy|nicotine replacement therapy
5535452|NCT01144988|Recurrent Malignant Glioma|recurrent malignant glioma
5535453|NCT01144988|Bevacizumab / Irinotecan|bevacizumab / irinotecan
5535454|NCT01144988|Functional MR Imaging|functional mr imaging
5535455|NCT01144988|Metabolic Imaging (FET/FLT-PET)|metabolic imaging (fet/flt-pet)
5535456|NCT01144975|Diabetes|diabetes
5535457|NCT01144975|Type 2|type 2
5535458|NCT01144975|Mellitus|mellitus
5535459|NCT01144962|Crohn's Disease|crohn's disease
5535460|NCT01144962|Fistula|fistula
5535461|NCT01144962|Mesenchymal Stem Cell|mesenchymal stem cell
5535462|NCT01144962|Mesenchymal Stromal Cell|mesenchymal stromal cell
5535463|NCT01144962|MSC|msc
5535464|NCT01144962|IBD|ibd
5535465|NCT01144949|ureteral calculi|ureteral calculi
5535466|NCT01144949|renal colic|renal colic
5535467|NCT01144949|ureteral stones|ureteral stones
5535468|NCT01144949|kidney stones|kidney stones
5535469|NCT01144949|medical expulsive therapy|medical expulsive therapy
5517624|NCT01219244|elderly|elderly
5535470|NCT01144923|epidural steroid injection|epidural steroid injection
5535471|NCT01144923|neck pain|neck pain
5535472|NCT01144923|pharmacotherapy|pharmacotherapy
5535473|NCT01144923|radiculopathy|radiculopathy
5535474|NCT01144910|asthma|asthma
5535475|NCT01144910|preschool child|preschool child
5535476|NCT01144910|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5535477|NCT01144910|methacholine challenge test|methacholine challenge test
5535479|NCT01144897|Castrate resistant|castrate resistant
5535480|NCT01144897|Prostate cancer|prostate cancer
5535481|NCT01144897|Docetaxel|docetaxel
5535482|NCT01144897|Taxotere|taxotere
5535483|NCT01144897|PET Acetate|pet acetate
5535484|NCT01144884|Neck pain|neck pain
5535485|NCT01144884|education|education
5535486|NCT01144884|exercise|exercise
5535487|NCT01144884|clinical prediction rule|clinical prediction rule
5535488|NCT01144871|adolescent|adolescent
5535489|NCT01144871|reproductive health|reproductive health
5535490|NCT01144871|parents|parents
5535491|NCT01144871|STIs|stis
5535492|NCT01144871|confidentiality|confidentiality
5535493|NCT01144871|Examine parental knowledge/attitudes of confidential health services/STI care for adolescents.|examine parental knowledge/attitudes of confidential health services/sti care for adolescents.
5535494|NCT01144871|Examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.|examine how parental knowledge/attitudes affects parent's behavioral intentions to support adolescent's access to confidential care.
5535495|NCT01144871|Identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential STI services.|identify key mechanisms to form an intervention to parents knowledge/skills to facilitate teen's access to confidential sti services.
5535496|NCT01144858|atrial fibrillation|atrial fibrillation
5535497|NCT01144858|ablation catheter|ablation catheter
5535498|NCT01144858|left atrial appendage peak emptying velocity|left atrial appendage peak emptying velocity
5535499|NCT01144858|tool for predicting successful catheter ablation|tool for predicting successful catheter ablation
5535501|NCT01144845|Thoracic Surgery|thoracic surgery
5535502|NCT01144845|Thoracic Surgical Procedures|thoracic surgical procedures
5535503|NCT01144845|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5535504|NCT01144845|Lung Neoplasms|lung neoplasms
5535505|NCT01144845|Thoracic Nerves|thoracic nerves
5535506|NCT01144832|visceral hypersensitivity|visceral hypersensitivity
5535507|NCT01144832|mast cells|mast cells
5535508|NCT01144819|STEMI|stemi
5535509|NCT01144819|Acute myocardial infarction|acute myocardial infarction
5535510|NCT01144819|Antiplatelet therapy|antiplatelet therapy
5535511|NCT01144819|aspirin|aspirin
5535512|NCT01144819|clopidogrel|clopidogrel
5535513|NCT01144819|VerifyNow aggregometry|verifynow aggregometry
5535606|NCT01144351|SPMS|spms
5535514|NCT01144819|Multiplate aggregometry|multiplate aggregometry
5535515|NCT01144806|SAM|sam
5535516|NCT01144806|RUTF|rutf
5535517|NCT01144806|BIA|bia
5535518|NCT01144806|D2O|d2o
5535519|NCT01144806|Children with severe malnutrition|children with severe malnutrition
5535520|NCT01144741|rehabilitation|rehabilitation
5535521|NCT01144741|surgery|surgery
5535522|NCT01144741|therapy|therapy
5535523|NCT01144741|Quality Of Life|quality of life
5535524|NCT01144741|Health-Related Quality Of Life|health-related quality of life
5535525|NCT01144741|Health Status|health status
5535526|NCT01144741|Depressive Symptoms|depressive symptoms
5535527|NCT01144741|Situational Depression|situational depression
5535528|NCT01144715|Stroke Rehabilitation|stroke rehabilitation
5535529|NCT01144715|Home rehabilitation|home rehabilitation
5535530|NCT01144715|robotic therapy|robotic therapy
5535531|NCT01144702|malaria|malaria
5535532|NCT01144702|Plasmodium falciparum|plasmodium falciparum
5535533|NCT01144702|artesunate and mefloquine combination (ASMQ)|artesunate and mefloquine combination (asmq)
5535534|NCT01144702|treatment|treatment
5535535|NCT01144702|Juruá Valley|juruá valley
5535536|NCT01144702|Brazil|brazil
5535537|NCT01144702|multidrug resistance 1 gene of Plasmodium falciparum -Pfmdr1|multidrug resistance 1 gene of plasmodium falciparum -pfmdr1
5535538|NCT01144689|mindfulness|mindfulness
5535539|NCT01144689|smoking|smoking
5535540|NCT01144689|stress|stress
5535541|NCT01144663|Infants|infants
5535542|NCT01144663|conjugate vaccine|conjugate vaccine
5535543|NCT01144663|immunogenicity|immunogenicity
5535544|NCT01144663|meningococcal vaccine|meningococcal vaccine
5535545|NCT01144663|non-inferiority|non-inferiority
5535546|NCT01144663|co-administration|co-administration
5535547|NCT01144650|Dapsone|dapsone
5535548|NCT01144650|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5535549|NCT01144650|Neuroprotection|neuroprotection
5535550|NCT01144624|TNF neutralisation|tnf neutralisation
5535551|NCT01144611|valve replacement|valve replacement
5535552|NCT01144611|CABG|cabg
5535553|NCT01144611|SIRTS|sirts
5535554|NCT01144611|Combined aortic valve replacement and CABG surgery|combined aortic valve replacement and cabg surgery
5535555|NCT01144598|Rheumatoid Arthritis|rheumatoid arthritis
5535556|NCT01144598|Disease-Modifying Anti-Rheumatic Drug|disease-modifying anti-rheumatic drug
5535557|NCT01144598|Work Limitation|work limitation
5535558|NCT01144585|RIPC|ripc
5535559|NCT01144585|lung protection|lung protection
5535560|NCT01144585|ischemic reperfusion injury|ischemic reperfusion injury
5535561|NCT01144585|cardiopulmonary bypass|cardiopulmonary bypass
5535562|NCT01144572|Quality of Life|quality of life
5535563|NCT01144572|postmenopausal HR(+)|postmenopausal hr(+)
5535564|NCT01144572|Early Breast Cancer|early breast cancer
5535565|NCT01144572|adjuvant AI treatment|adjuvant ai treatment
5535566|NCT01144572|Quality of Life in Chinese postmenopausal HR(+) EBC patients during adjuvant Aromatase Inhibitors(AIs) treatment|quality of life in chinese postmenopausal hr(+) ebc patients during adjuvant aromatase inhibitors(ais) treatment
5535567|NCT01144559|Femoral|femoral
5535568|NCT01144559|Nerve Block|nerve block
5535569|NCT01144559|Bolus|bolus
5535571|NCT01144559|UCSD|ucsd
5535572|NCT01144559|Perineural Catheter|perineural catheter
5535573|NCT01144559|Volunteer|volunteer
5535574|NCT01144559|lower extremity nerve blocks|lower extremity nerve blocks
5535575|NCT01144546|Passive leg raising|passive leg raising
5535576|NCT01144546|FloTrac/Vigileo|flotrac/vigileo
5535577|NCT01144546|Anesthesia hypotension|anesthesia hypotension
5535578|NCT01144507|Cystic Fibrosis|cystic fibrosis
5538087|NCT01135251|AIDS|aids
5535579|NCT01144507|Pancreatic insufficiency|pancreatic insufficiency
5535580|NCT01144494|Aqueous Humor Dynamics|aqueous humor dynamics
5535581|NCT01144494|Aqueous Humor Dynamics and Circadian Rhythms|aqueous humor dynamics and circadian rhythms
5535582|NCT01144481|bone metastasis|bone metastasis
5535583|NCT01144481|breast cancer|breast cancer
5535584|NCT01144481|skeletal related event|skeletal related event
5535586|NCT01144481|VFA|vfa
5535587|NCT01144468|breast cancer prevention|breast cancer prevention
5535588|NCT01144468|osteoporosis|osteoporosis
5535589|NCT01144455|Locally Advanced Unresectable Pancreatic Adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
5535590|NCT01144455|Metastatic Pancreatic Adenocarcinoma|metastatic pancreatic adenocarcinoma
5535591|NCT01144455|Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma|locally advanced unresectable or metastatic pancreatic adenocarcinoma
5535592|NCT01144442|recurrent ovarian cancer|recurrent ovarian cancer
5535593|NCT01144442|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5535594|NCT01144442|recurrent peritoneal carcinoma|recurrent peritoneal carcinoma
5535595|NCT01144429|Allergic Rhinitis +- intermittent asthma|allergic rhinitis +- intermittent asthma
5535596|NCT01144429|Allergic Rhinoconjunctivitis +- intermittent asthma|allergic rhinoconjunctivitis +- intermittent asthma
5521986|NCT01200771|FUO|fuo
5535597|NCT01144429|Specific Immunotherapy|specific immunotherapy
5535598|NCT01144416|Reproductive Techniques, Assisted|reproductive techniques, assisted
5535599|NCT01144416|Follicle Stimulating Hormone, Human|follicle stimulating hormone, human
5535601|NCT01144390|heroin dependence|heroin dependence
5535602|NCT01144390|community-based|community-based
5535603|NCT01144390|MMT|mmt
5535604|NCT01144377|osteoporosis|osteoporosis
5535605|NCT01144351|MS|ms
5535607|NCT01144351|RRMS|rrms
5535608|NCT01144351|Relapsing Forms of Secondary Progressive Multiple Sclerosis (SPMS)|relapsing forms of secondary progressive multiple sclerosis (spms)
5535609|NCT01144351|or Relapsing-Remitting Multiple Sclerosis (RRMS)|or relapsing-remitting multiple sclerosis (rrms)
5535610|NCT01144338|exenatide once weekly|exenatide once weekly
5535611|NCT01144338|cardiovascular|cardiovascular
5535612|NCT01144338|Bydureon|bydureon
5535613|NCT01144338|Amylin|amylin
5535614|NCT01144325|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5535615|NCT01144312|LDLT|ldlt
5535616|NCT01144299|Influenza|influenza
5535617|NCT01144286|VVC|vvc
5535618|NCT01144286|candidiasis|candidiasis
5535619|NCT01144286|vaginal candidiasis|vaginal candidiasis
5535620|NCT01144260|CLL|cll
5535621|NCT01144260|leukemia|leukemia
5535622|NCT01144260|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5520375|NCT01207310|smoking|smoking
5535623|NCT01144247|Recurrent Grade III or Grade IV Gliomas|recurrent grade iii or grade iv gliomas
5535624|NCT01144247|anaplastic astrocytoma|anaplastic astrocytoma
5535625|NCT01144247|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5535626|NCT01144247|anaplastic mixed glioma|anaplastic mixed glioma
5535627|NCT01144247|glioblastoma multiforme|glioblastoma multiforme
5535628|NCT01144247|biotherapy|biotherapy
5535629|NCT01144247|malignant meningioma|malignant meningioma
5535630|NCT01144234|Prevention of mother-to-child transmission of HIV-1|prevention of mother-to-child transmission of hiv-1
5535631|NCT01144221|Chronic Ischemic Heart Disease|chronic ischemic heart disease
5535632|NCT01144208|Radius fracture|radius fracture
5535633|NCT01144208|Adverse effects|adverse effects
5535634|NCT01144208|Wrist|wrist
5535635|NCT01144208|Postoperative complications|postoperative complications
5535636|NCT01144208|Colles' fracture|colles' fracture
5535637|NCT01144208|Intraoperative complications|intraoperative complications
5535638|NCT01144208|Osteoporosis|osteoporosis
5535639|NCT01144208|Dual-energy x-ray absorptiometry (DXA)|dual-energy x-ray absorptiometry (dxa)
5535640|NCT01144208|Bone Density|bone density
5535641|NCT01144182|heart failure|heart failure
5535642|NCT01144182|quality of life|quality of life
5535643|NCT01144182|readmissions|readmissions
5535644|NCT01144169|Renal cell carcinoma|renal cell carcinoma
5535645|NCT01144169|Hydroxychloroquine|hydroxychloroquine
5535646|NCT01144169|Nephrectomy|nephrectomy
5535647|NCT01144169|Autophagy|autophagy
5535648|NCT01144156|Crohn's disease|crohn's disease
5535649|NCT01144156|Small bowel|small bowel
5535650|NCT01144156|Mucosal healing|mucosal healing
5535651|NCT01144156|Capsule endoscopy|capsule endoscopy
5535652|NCT01144156|Adalimumab|adalimumab
5535653|NCT01144156|Small bowel Crohn's disease|small bowel crohn's disease
5535654|NCT01144143|Mild to moderate osteoarthritis of the knee|mild to moderate osteoarthritis of the knee
5535655|NCT01144117|Progressive Multiple Sclerosis|progressive multiple sclerosis
5535656|NCT01144091|diabetes mellitus|diabetes mellitus
5535657|NCT01144091|creatinin level|creatinin level
5535658|NCT01144091|contrast induced nephropathy|contrast induced nephropathy
5535659|NCT01144091|prevention contrast induced nephropathy in high risk patients|prevention contrast induced nephropathy in high risk patients
5535660|NCT01144078|Adiposity|adiposity
5535661|NCT01144078|Exercise training|exercise training
5535662|NCT01144078|Older adults|older adults
5535663|NCT01144065|Myocardial infarction|myocardial infarction
5535664|NCT01144065|Cortisol|cortisol
5535665|NCT01144065|Testosterone|testosterone
5535666|NCT01144052|Natalizumab|natalizumab
5535667|NCT01144052|Interferon-beta 1b|interferon-beta 1b
5535668|NCT01144052|De-escalation|de-escalation
5535669|NCT01144052|Ticino|ticino
5535670|NCT01144026|HIV|hiv
5535671|NCT01144026|vaccine|vaccine
5535672|NCT01144026|lipopeptide|lipopeptide
5535673|NCT01144026|Tat|tat
5535674|NCT01144026|TUTI-16|tuti-16
5535675|NCT01144026|THYMON|thymon
5535676|NCT01144000|Prosthetic joint infection|prosthetic joint infection
5535677|NCT01144000|daptomycin|daptomycin
5535678|NCT01144000|staphylococcus|staphylococcus
5535679|NCT01143987|hyperparathyroidism|hyperparathyroidism
5535680|NCT01143987|pulse wave velocity|pulse wave velocity
5535681|NCT01143987|end-stage renal disease|end-stage renal disease
5535682|NCT01143987|arterial stiffness|arterial stiffness
5535683|NCT01143974|progress free survival|progress free survival
5535684|NCT01143974|response rate|response rate
5535685|NCT01143974|safety|safety
5535686|NCT01143961|Positive pressure ventilation|positive pressure ventilation
5535687|NCT01143961|Electrical impedance tomography|electrical impedance tomography
5535688|NCT01143948|Diabetes|diabetes
5535689|NCT01143948|Cirrhosis|cirrhosis
5535690|NCT01143948|Insulin|insulin
5535691|NCT01143948|Inpatient|inpatient
5535692|NCT01143935|Liver volume estimation|liver volume estimation
5535693|NCT01143935|Indian population|indian population
5535694|NCT01143922|Intraoperative ultrasound|intraoperative ultrasound
5535696|NCT01143922|modality|modality
5535697|NCT01143922|ultrasound|ultrasound
5535698|NCT01143922|staging modality|staging modality
5535699|NCT01143909|Fresh frozen plasma|fresh frozen plasma
5535700|NCT01143909|Coagulopathy|coagulopathy
5535701|NCT01143909|Intensive care|intensive care
5535702|NCT01143909|Adverse effects|adverse effects
5535703|NCT01143909|Lung injury|lung injury
5535712|NCT01143844|Late effects|late effects
5535713|NCT01143844|cancer|cancer
5535714|NCT01143844|chemotherapy|chemotherapy
5535715|NCT01143844|radiation therapy|radiation therapy
5535716|NCT01143844|survivor|survivor
5535717|NCT01143844|ovarian reserve|ovarian reserve
5535718|NCT01143844|premature ovarian failure|premature ovarian failure
5535719|NCT01143844|early menopause|early menopause
5535720|NCT01143844|healthy volunteers|healthy volunteers
5535721|NCT01143844|perimenopause|perimenopause
5535722|NCT01143844|middle age|middle age
5535723|NCT01143844|pediatric survivors|pediatric survivors
5535724|NCT01143844|healthy women|healthy women
5535725|NCT01143831|Vitamin K|vitamin k
5535726|NCT01143831|Thrombosis|thrombosis
5535727|NCT01143818|Male hypogonadism|male hypogonadism
5535728|NCT01143805|Absolute Bioavailability|absolute bioavailability
5535729|NCT01143805|Rheumatoid Arthritis|rheumatoid arthritis
5535730|NCT01143792|Substance abuse|substance abuse
5535731|NCT01143792|Homelessness|homelessness
5535732|NCT01143792|HIV risk behavior|hiv risk behavior
5535733|NCT01143779|Advanced Malignancy|advanced malignancy
5535734|NCT01143779|FLT-PET Scan|flt-pet scan
5535735|NCT01143779|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
5535736|NCT01143779|FLT|flt
5535737|NCT01143779|Positron emission tomography|positron emission tomography
5535738|NCT01143779|PET|pet
5535739|NCT01143779|Imaging Biomarker|imaging biomarker
5535740|NCT01143779|Temsirolimus|temsirolimus
5535741|NCT01143779|Topotecan|topotecan
5535742|NCT01143779|Bortezomib|bortezomib
5535743|NCT01143766|Sedation|sedation
5535744|NCT01143766|Gabapentin|gabapentin
5535745|NCT01143766|ERCP|ercp
5535746|NCT01143766|Endoscopy|endoscopy
5535747|NCT01143675|Humerus fractures|humerus fractures
5535748|NCT01143675|Tomography, x-ray computed|tomography, x-ray computed
5535749|NCT01143675|Bone and bones|bone and bones
5535750|NCT01143675|Orthopedic fixation devices|orthopedic fixation devices
5535751|NCT01143675|Surgery|surgery
5535752|NCT01143675|Postoperative complications|postoperative complications
5535753|NCT01143675|Osteoporosis|osteoporosis
5535754|NCT01143675|Intraoperative complications|intraoperative complications
5535755|NCT01143675|Bone density|bone density
5535756|NCT01143675|Radiography, dual-energy scanned projection|radiography, dual-energy scanned projection
5535757|NCT01143662|peginterferon|peginterferon
5535758|NCT01143662|interferon|interferon
5535759|NCT01143662|Pegasys|pegasys
5535760|NCT01143662|HBV|hbv
5535761|NCT01143662|Hepatitis B|hepatitis b
5535762|NCT01143662|HBeAg positive|hbeag positive
5535763|NCT01143649|Stroke|stroke
5535764|NCT01143649|Transcranial direct current stimulation|transcranial direct current stimulation
5535765|NCT01143649|Motor function|motor function
5535766|NCT01143636|Transcranial direct current stimulation|transcranial direct current stimulation
5535767|NCT01143636|Chronic Pelvic Pain|chronic pelvic pain
5535768|NCT01143623|antibiotic|antibiotic
5535769|NCT01143623|diarrhea|diarrhea
5535770|NCT01143623|probiotic|probiotic
5535771|NCT01143610|Root coverage|root coverage
5535772|NCT01143610|Graft|graft
5535773|NCT01143610|Soft tissue|soft tissue
5535774|NCT01143610|Periodontal regeneration|periodontal regeneration
5535775|NCT01143597|task-specific training|task-specific training
5535776|NCT01143597|arm and hand function|arm and hand function
5535777|NCT01143597|corticomotor plasticity|corticomotor plasticity
5535778|NCT01143597|individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
5535779|NCT01143584|Prolactin|prolactin
5535780|NCT01143584|Cabergoline|cabergoline
5535781|NCT01143584|Macroadenomas|macroadenomas
5535782|NCT01143584|escalation|escalation
5535785|NCT01143558|Borrelia Burgdorferi|borrelia burgdorferi
5535786|NCT01143558|Xenodiagnosis|xenodiagnosis
5535787|NCT01143558|Ticks|ticks
5535788|NCT01143558|Skin Biopsy|skin biopsy
5535789|NCT01143558|Lyme Disease|lyme disease
5535790|NCT01143545|Cancer Vaccine|cancer vaccine
5535791|NCT01143545|Immunotherapy|immunotherapy
5535792|NCT01143545|Adjuvant Therapy|adjuvant therapy
5535793|NCT01143545|Surgical Intervention|surgical intervention
5535794|NCT01143545|Lung Cancer|lung cancer
5535795|NCT01143545|Esophageal Cancer|esophageal cancer
5535796|NCT01143545|Thymic Carcinoma|thymic carcinoma
5535797|NCT01143545|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5535807|NCT01143519|Apoptosis|apoptosis
5535808|NCT01143519|Lymphocytes|lymphocytes
5535809|NCT01143519|Environmental Factors|environmental factors
5522235|NCT01199939|HIV|hiv
5535810|NCT01143519|Single Nucleotide Polymorphism|single nucleotide polymorphism
5535811|NCT01143519|Healthy Volunteer|healthy volunteer
5535812|NCT01143519|HV|hv
5535813|NCT01143506|Sense of Agency|sense of agency
5535814|NCT01143506|Ulnar Nerve Block|ulnar nerve block
5535815|NCT01143506|Healthy Volunteer|healthy volunteer
5535816|NCT01143506|fMRI|fmri
5535817|NCT01143506|EEG|eeg
5535818|NCT01143493|Genetic Polymorphism|genetic polymorphism
5535819|NCT01143493|Glucocorticoid|glucocorticoid
5535820|NCT01143493|Health Volunteer|health volunteer
5535821|NCT01143493|HV|hv
5535822|NCT01143480|Endotoxin|endotoxin
5535823|NCT01143480|Innate Immunity|innate immunity
5535824|NCT01143480|Healthy Volunteer|healthy volunteer
5535825|NCT01143480|HV|hv
5535826|NCT01143467|Fatigue|fatigue
5535827|NCT01143467|Mitochondria|mitochondria
5535828|NCT01143467|Mitochondrial Abnormality|mitochondrial abnormality
5535829|NCT01143467|Oxidative Stress|oxidative stress
5535830|NCT01143467|Gene Expression|gene expression
5535831|NCT01143467|Prostate Cancer|prostate cancer
5535832|NCT01143454|Cardiac Disease|cardiac disease
5535833|NCT01143454|iPS Cells|ips cells
5535834|NCT01143454|Cardiac Risk Factors|cardiac risk factors
5535835|NCT01143454|Cardiac Disease Discovery|cardiac disease discovery
5535836|NCT01143454|Heart Disease|heart disease
5535837|NCT01143454|Heart Disease Risk|heart disease risk
5535838|NCT01143441|Multiple Sclerosis|multiple sclerosis
5535839|NCT01143441|Daclizumab|daclizumab
5535840|NCT01143428|Motor Neuron Disease|motor neuron disease
5535841|NCT01143428|Primary Lateral Sclerosis|primary lateral sclerosis
5535842|NCT01143428|Oxidative Stress|oxidative stress
5535843|NCT01143428|Physiology|physiology
5535844|NCT01143428|PLS|pls
5535845|NCT01143389|Keratoconus|keratoconus
5535846|NCT01143389|Ectasia|ectasia
5535847|NCT01143389|cross linking|cross linking
5535848|NCT01143389|collagen cross linking|collagen cross linking
5535849|NCT01143376|Obesity|obesity
5535850|NCT01143376|exercise|exercise
5535851|NCT01143376|body composition|body composition
5535852|NCT01143376|insulin sensitivity|insulin sensitivity
5535853|NCT01143376|appetite|appetite
5535854|NCT01143376|food intake|food intake
5535855|NCT01143363|Obesity|obesity
5535856|NCT01143363|exercise|exercise
5535857|NCT01143363|appetite|appetite
5535858|NCT01143363|hunger|hunger
5535859|NCT01143363|satiety|satiety
5535860|NCT01143363|food intake|food intake
5535861|NCT01143337|Rheumatoid Arthritis|rheumatoid arthritis
5535862|NCT01143324|Single or double level instrumented fusion|single or double level instrumented fusion
5535863|NCT01143324|Degenerative lumbar spine|degenerative lumbar spine
5535864|NCT01143324|PLIF|plif
5535865|NCT01143324|TLIF|tlif
5535866|NCT01143324|MAST procedure|mast procedure
5535867|NCT01143285|Active nutritional and dietary management|active nutritional and dietary management
5535868|NCT01143285|Metastatic colorectal cancer|metastatic colorectal cancer
5535869|NCT01143285|Non surgical metastatic colorectal cancer|non surgical metastatic colorectal cancer
5535870|NCT01143272|antibiotic|antibiotic
5535871|NCT01143272|associated|associated
5535872|NCT01143272|diarrhoea|diarrhoea
5535873|NCT01143272|saccharomyces boulardii|saccharomyces boulardii
5535874|NCT01143272|Antibiotic-associated diarrhoea (AAD)|antibiotic-associated diarrhoea (aad)
5535875|NCT01143272|Clostridium difficile-associated-diarrhoea (CDAD)|clostridium difficile-associated-diarrhoea (cdad)
5535876|NCT01143259|Ileus|ileus
5535877|NCT01143259|Post operative ileus|post operative ileus
5535878|NCT01143246|Hepatorenal syndrome|hepatorenal syndrome
5535879|NCT01143246|Renal failure|renal failure
5535880|NCT01143246|Cirrhosis|cirrhosis
5535881|NCT01143246|Alcoholic hepatitis|alcoholic hepatitis
5535882|NCT01143246|Ascites|ascites
5535883|NCT01143220|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5535884|NCT01143220|Heart Failure|heart failure
5535885|NCT01143220|Pathologic Processes|pathologic processes
5535886|NCT01143220|Heart Diseases|heart diseases
5535887|NCT01143220|Tachycardia|tachycardia
5535888|NCT01143220|Cardiovascular Diseases|cardiovascular diseases
5535889|NCT01143220|Ventricular Flutter|ventricular flutter
5535890|NCT01143220|Tachycardia, Ventricular|tachycardia, ventricular
5535891|NCT01143220|Ventricular Fibrillation|ventricular fibrillation
5535896|NCT01143207|DMC Data Monitoring Committee|dmc data monitoring committee
5535897|NCT01143207|FDA U.S.) Food and Drug Administration|fda u.s.) food and drug administration
5535898|NCT01143207|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5535899|NCT01143207|ICH International Conference of Harmonisation|ich international conference of harmonisation
5535900|NCT01143207|IND Investigational New Drug Application|ind investigational new drug application
5535901|NCT01143207|IRB Institutional Review Board|irb institutional review board
5535902|NCT01143207|IU International units|iu international units
5535905|NCT01143207|µg microgram|µg microgram
5535906|NCT01143207|ULN upper limit of the normal range|uln upper limit of the normal range
5535907|NCT01143194|Attention|attention
5535908|NCT01143194|Vigilance|vigilance
5535909|NCT01143194|Concentration|concentration
5535911|NCT01143194|Healthy Volunteer|healthy volunteer
5535914|NCT01143168|stem cells;|stem cells;
5535915|NCT01143168|diabetes mellitus;|diabetes mellitus;
5535916|NCT01143168|treatment.|treatment.
5535917|NCT01143155|Pneumonia|pneumonia
5535918|NCT01143155|Community-acquired pneumonia|community-acquired pneumonia
5535919|NCT01143155|Healthcare-associated pneumonia|healthcare-associated pneumonia
5535921|NCT01143155|Cardiovascular events|cardiovascular events
5535922|NCT01143155|Outcome|outcome
5535923|NCT01143142|Human papillomavirus|human papillomavirus
5535925|NCT01143142|Prevention|prevention
5535926|NCT01143142|Tailoring|tailoring
5535927|NCT01143142|Persuasive communication|persuasive communication
5535928|NCT01143142|Adolescent|adolescent
5535929|NCT01143129|Atrial fibrillation|atrial fibrillation
5535930|NCT01143129|Cardiac surgery|cardiac surgery
5535931|NCT01143129|Cardiopulmonary bypass|cardiopulmonary bypass
5535932|NCT01143129|New-onset|new-onset
5535933|NCT01143103|Respiratory therapy in neurologic disorder|respiratory therapy in neurologic disorder
5535934|NCT01143090|Schizophrenia|schizophrenia
5535935|NCT01143090|Lurasidone|lurasidone
5535936|NCT01143090|Latuda|latuda
5535937|NCT01143077|Lurasidone|lurasidone
5535938|NCT01143077|Schizophrenia|schizophrenia
5535939|NCT01143077|Latuda|latuda
5535940|NCT01143064|Brain Injury|brain injury
5535941|NCT01143064|Trauma|trauma
5535942|NCT01143051|Asthma|asthma
5535943|NCT01143051|Pharmacokinetics|pharmacokinetics
5535944|NCT01143051|Epinephrine|epinephrine
5535945|NCT01143051|Bronchodilator|bronchodilator
5535946|NCT01143051|metered dose inhaler|metered dose inhaler
5535947|NCT01143038|ITP|itp
5535948|NCT01143025|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5535949|NCT01143025|Nebulization|nebulization
5535950|NCT01143025|Ropivacaine|ropivacaine
5535951|NCT01143012|Group eczema education|group eczema education
5535952|NCT01142986|Methadone|methadone
5535953|NCT01142986|Syringe exchange|syringe exchange
5535954|NCT01142986|Treatment retention|treatment retention
5535955|NCT01142986|Voucher incentives|voucher incentives
5535956|NCT01142947|Inhaled corticosteroids|inhaled corticosteroids
5535957|NCT01142947|Asthma|asthma
5535958|NCT01142947|Pharmacogenomics|pharmacogenomics
5535959|NCT01142947|Genome wide association study|genome wide association study
5535960|NCT01142947|Admixture mapping|admixture mapping
5535961|NCT01142947|Continental population groups|continental population groups
5535962|NCT01142934|Catheter-related bloodstream infections|catheter-related bloodstream infections
5535963|NCT01142934|Chlorhexidine|chlorhexidine
5535964|NCT01142934|Transparent dressings|transparent dressings
5535965|NCT01142921|Stent Occlusion|stent occlusion
5535966|NCT01142921|Biliary Bleeding|biliary bleeding
5535967|NCT01142921|Biliary Perforation|biliary perforation
5535968|NCT01142908|Cardiovascular Disease|cardiovascular disease
5535969|NCT01142908|Hypertension|hypertension
5535970|NCT01142908|Diabetes|diabetes
5535971|NCT01142908|Hyperlipidemia|hyperlipidemia
5535972|NCT01142908|Adherence|adherence
5535973|NCT01142882|adolescent HIV prevention|adolescent hiv prevention
5535974|NCT01142882|web-based interventions|web-based interventions
5535975|NCT01142882|adolescent substance abuse treatment|adolescent substance abuse treatment
5535976|NCT01142882|comparative effectiveness research|comparative effectiveness research
5535977|NCT01142882|HIV prevention|hiv prevention
5535978|NCT01142882|hepatitis prevention|hepatitis prevention
5535979|NCT01142882|STI prevention|sti prevention
5535980|NCT01142869|Carcinoma, Squamous Cell|carcinoma, squamous cell
5535981|NCT01142869|Erbitux|erbitux
5535982|NCT01142869|Neoplasms, Squamous Cell|neoplasms, squamous cell
5535983|NCT01142843|clinical trial|clinical trial
5535984|NCT01142843|mouthwash|mouthwash
5535985|NCT01142843|green propolis|green propolis
5535986|NCT01142843|dental plaque|dental plaque
5535987|NCT01142843|gingivitis|gingivitis
5535988|NCT01142830|Craniotomy|craniotomy
5535993|NCT01142817|Menopause|menopause
5535994|NCT01142817|Dyslipidemia|dyslipidemia
5535995|NCT01142817|Bone Mineral Density|bone mineral density
5535996|NCT01142804|Walking programs|walking programs
5535997|NCT01142804|Physical Activity|physical activity
5535998|NCT01142804|Behavior Modification|behavior modification
5535999|NCT01142804|Social Support|social support
5536000|NCT01142791|Uterine fibroids|uterine fibroids
5536002|NCT01142791|ExAblate|exablate
5536003|NCT01142791|Focused Ultrasound|focused ultrasound
5536004|NCT01142791|Symptomatic uterine fibroids|symptomatic uterine fibroids
5536005|NCT01142765|Vaccine|vaccine
5536006|NCT01142765|Safety|safety
5536007|NCT01142765|Immunogenicity|immunogenicity
5536008|NCT01142765|Protection|protection
5536009|NCT01142765|Sporozoite challenge|sporozoite challenge
5536010|NCT01142713|Small Bowel Radiotherapy Dose|small bowel radiotherapy dose
5536011|NCT01142713|This is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy|this is a prospective non-randomized open study to evaluate the impact of patient's positioning and use of belly board in rectal radiotherapy
5536012|NCT01142687|Resting energy expenditure (REE)|resting energy expenditure (ree)
5536013|NCT01142687|metabolic rate|metabolic rate
5685364|NCT00556413|stage IV rectal cancer|stage iv rectal cancer
5522391|NCT01199315|AD|ad
5536014|NCT01142674|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5536015|NCT01142674|Prognosis|prognosis
5536016|NCT01142674|Outcome|outcome
5536017|NCT01142674|International Cooperation|international cooperation
5536018|NCT01142674|Biological Characteristics|biological characteristics
5536019|NCT01142674|Heterogeneity|heterogeneity
5536020|NCT01142674|Rare Diseases|rare diseases
5530212|NCT01167283|COPD|copd
5536021|NCT01142661|Advanced breast cancer refractory to all commercially available therapies|advanced breast cancer refractory to all commercially available therapies
5536022|NCT01142648|Electroencephalogram|electroencephalogram
5536023|NCT01142648|Electromyogram|electromyogram
5536024|NCT01142648|Entropy Index|entropy index
5536025|NCT01142648|Bispectral Index|bispectral index
5536026|NCT01142648|Reversal of neuromuscular blockade|reversal of neuromuscular blockade
5536027|NCT01142635|Electroencephalogram|electroencephalogram
5536028|NCT01142635|Electromyogram|electromyogram
5536029|NCT01142635|Entropy Index|entropy index
5536030|NCT01142635|Bispectral Index|bispectral index
5536031|NCT01142635|Neuromuscular blockade; rocuronium|neuromuscular blockade; rocuronium
5536032|NCT01142635|Propofol|propofol
5536033|NCT01142635|Intubation|intubation
5536034|NCT01142622|Ovarian Cysts|ovarian cysts
5536035|NCT01142622|Nebulization|nebulization
5536036|NCT01142622|Ropivacaine|ropivacaine
5536037|NCT01142609|Web based videoconferencing|web based videoconferencing
5536038|NCT01142609|methadone|methadone
5536039|NCT01142609|substance abuse counseling|substance abuse counseling
5536040|NCT01142583|Multiple sclerosis|multiple sclerosis
5536041|NCT01142583|Expanded Disability Status Scale|expanded disability status scale
5536042|NCT01142583|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5536043|NCT01142570|Mechanical Ventilation|mechanical ventilation
5536044|NCT01142557|Multiple sclerosis|multiple sclerosis
5536045|NCT01142557|Rebif|rebif
5536046|NCT01142557|Interferon-beta|interferon-beta
5536047|NCT01142544|acute lung injury|acute lung injury
5536048|NCT01142544|incidence|incidence
5536049|NCT01142544|lung damage|lung damage
5536050|NCT01142544|PaO2/FiO2 ratio|pao2/fio2 ratio
5536051|NCT01142518|Interferon beta-1a|interferon beta-1a
5536052|NCT01142518|Multiple Sclerosis|multiple sclerosis
5536053|NCT01142505|wheeze|wheeze
5536054|NCT01142505|preschool|preschool
5536055|NCT01142505|leukotriene|leukotriene
5536056|NCT01142505|montelukast|montelukast
5536057|NCT01142505|5-lipoxygenase|5-lipoxygenase
5536058|NCT01142492|Interferon beta|interferon beta
5536059|NCT01142492|Multiple Sclerosis|multiple sclerosis
5536060|NCT01142479|Breast Cancer|breast cancer
5536061|NCT01142479|Radiotherapy|radiotherapy
5536062|NCT01142479|Chinese herbal medicine|chinese herbal medicine
5536063|NCT01142479|TPE-1|tpe-1
5536064|NCT01142479|Leukopenia|leukopenia
5536065|NCT01142466|Multiple sclerosis|multiple sclerosis
5536066|NCT01142466|Expanded Disability Status Scale|expanded disability status scale
5536067|NCT01142466|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5536068|NCT01142466|Rebif|rebif
5536069|NCT01142466|Beta-1, interferon|beta-1, interferon
5536070|NCT01142453|Multiple sclerosis|multiple sclerosis
5536071|NCT01142453|Rebif|rebif
5536072|NCT01142453|Interferon|interferon
5671486|NCT00615875|opiate sparing|opiate sparing
5536073|NCT01142414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5518213|NCT01216631|infliximab|infliximab
5536074|NCT01142414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5536075|NCT01142414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5536076|NCT01142414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5536077|NCT01142414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5536078|NCT01142414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5536079|NCT01142414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5536080|NCT01142414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5536081|NCT01142414|tongue cancer|tongue cancer
5536083|NCT01142362|H5N1|h5n1
5536084|NCT01142362|Avian Influenza|avian influenza
5536085|NCT01142362|DNA Vaccine|dna vaccine
5536086|NCT01142362|Intramuscular (IM) Injection|intramuscular (im) injection
5536087|NCT01142362|Electroporation|electroporation
5536088|NCT01142362|Healthy Adults|healthy adults
5536089|NCT01142349|Arthritis|arthritis
5536090|NCT01142349|Group Program|group program
5536091|NCT01142349|Pain|pain
5536092|NCT01142349|Insomnia|insomnia
5536195|NCT01141933|Cancer|cancer
5536196|NCT01141933|Oncology|oncology
5536093|NCT01142349|Pain dysfunction and sleep disturbance among older adults with osteoarthritis.|pain dysfunction and sleep disturbance among older adults with osteoarthritis.
5536094|NCT01142336|Alzheimer's Disease|alzheimer's disease
5536095|NCT01142336|Prevention|prevention
5536096|NCT01142336|Spinal Fluid|spinal fluid
5536097|NCT01142336|Biomarkers|biomarkers
5536098|NCT01142336|Simvastatin|simvastatin
5536099|NCT01142297|dental implant|dental implant
5522521|NCT01198743|DNA|dna
5536100|NCT01142297|implant stabilization|implant stabilization
5536101|NCT01142297|type 2 diabetes|type 2 diabetes
5536102|NCT01142297|glycated hemoglobin 8.0-12.0%|glycated hemoglobin 8.0-12.0%
5536103|NCT01142284|Biomarker|biomarker
5536104|NCT01142284|Endothelial Function|endothelial function
5536105|NCT01142284|Peripheral Artery Disease|peripheral artery disease
5536106|NCT01142284|Coronary Artery Disease|coronary artery disease
5536107|NCT01142284|Flow Mediated Dilation|flow mediated dilation
5536108|NCT01142284|Cilostazol|cilostazol
5536109|NCT01142284|Probucol|probucol
5536110|NCT01142271|Distal gastrectomy|distal gastrectomy
5536111|NCT01142271|Reconstruction|reconstruction
5536112|NCT01142271|Reflux|reflux
5536113|NCT01142271|subtotal gastrectomy|subtotal gastrectomy
5536114|NCT01142258|Sleep Disturbances|sleep disturbances
5536115|NCT01142258|Alzheimer disease|alzheimer disease
5536116|NCT01142258|Insomnia|insomnia
5536117|NCT01142258|Trazodone|trazodone
5536118|NCT01142258|Treatment|treatment
5536119|NCT01142245|ulcer bleeding|ulcer bleeding
5536120|NCT01142245|endoscopic therapy|endoscopic therapy
5536121|NCT01142232|autologous stem cell transplantation|autologous stem cell transplantation
5536122|NCT01142219|sickle cell disease|sickle cell disease
5536123|NCT01142219|L-arginine|l-arginine
5536124|NCT01142219|hemolysis|hemolysis
5536125|NCT01142219|nitric oxide|nitric oxide
5536126|NCT01142219|pulmonary arterial hypertension|pulmonary arterial hypertension
5536127|NCT01142206|Obesity|obesity
5536128|NCT01142206|Weight Loss|weight loss
5536129|NCT01142206|Leisure-time activities|leisure-time activities
5536130|NCT01142206|Physical Activity|physical activity
5536131|NCT01142206|Television watching|television watching
5536132|NCT01142206|Dietary Intake|dietary intake
5520891|NCT01204918|MDD|mdd
5536133|NCT01142206|Energy|energy
5536134|NCT01142206|Behavioral|behavioral
5536135|NCT01142206|Healthy Eating|healthy eating
5536136|NCT01142193|Epilepsy|epilepsy
5536137|NCT01142193|partial onset seizure|partial onset seizure
5536138|NCT01142193|adjunctive therapy|adjunctive therapy
5536139|NCT01142180|Bleeding peptic ulcer|bleeding peptic ulcer
5536140|NCT01142180|Active bleeding|active bleeding
5536141|NCT01142180|Trans-arterial angiographic embolization|trans-arterial angiographic embolization
5536142|NCT01142167|Ultra-thin colonoscope|ultra-thin colonoscope
5536143|NCT01142154|Cockayne Syndrome|cockayne syndrome
5536144|NCT01142154|Ageing|ageing
5536145|NCT01142154|pediatrics|pediatrics
5536146|NCT01142154|Pharmacokinetics|pharmacokinetics
5536147|NCT01142154|Prodarsan|prodarsan
5536148|NCT01142154|Dwarfism|dwarfism
5536149|NCT01142154|Genetic disease, inborn|genetic disease, inborn
5536150|NCT01142154|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
5536151|NCT01142154|Tolerability|tolerability
5536152|NCT01142154|Safety|safety
5536153|NCT01142102|Bladder|bladder
5536154|NCT01142102|Radiotherapy|radiotherapy
5536155|NCT01142102|Online|online
5536156|NCT01142102|Adaptive|adaptive
5536157|NCT01142089|traveler's|traveler's
5536158|NCT01142089|diarrhea|diarrhea
5536159|NCT01142089|Rifamycin SV MMX|rifamycin sv mmx
5536160|NCT01142089|Rifamycin|rifamycin
5536161|NCT01142089|MMX|mmx
5536162|NCT01142089|Traveler's Diarrhea|traveler's diarrhea
5536163|NCT01142076|adiposity|adiposity
5536164|NCT01142063|Neratinib|neratinib
5536165|NCT01142050|stem cells;|stem cells;
5536166|NCT01142050|diabetes mellitus;|diabetes mellitus;
5518321|NCT01216176|PR+|pr+
5536167|NCT01142050|treatment.|treatment.
5536168|NCT01142037|Healthy volunteer|healthy volunteer
5536169|NCT01142024|contrast medium induced nephropathy|contrast medium induced nephropathy
5536170|NCT01142024|polymorphism of oxidative stress genes|polymorphism of oxidative stress genes
5536171|NCT01142024|antioxidant prevention|antioxidant prevention
5536172|NCT01142011|Waldenstroms|waldenstroms
5536173|NCT01142011|Belimumab|belimumab
5536174|NCT01142011|anti Blys|anti blys
5536175|NCT01142011|monoclonal antibody|monoclonal antibody
5536176|NCT01141985|cataract|cataract
5536177|NCT01141985|cornea|cornea
5536178|NCT01141985|keratoplasty|keratoplasty
5536179|NCT01141972|Vitamin D|vitamin d
5536180|NCT01141972|Obesity|obesity
5536181|NCT01141972|Menopause|menopause
5536182|NCT01141972|Hot Flashes|hot flashes
5536183|NCT01141959|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5536184|NCT01141959|cyclophosphamide|cyclophosphamide
5536185|NCT01141959|fludarabine|fludarabine
5536186|NCT01141959|mycophenolate mofetil|mycophenolate mofetil
5536187|NCT01141959|mycophenolic acid|mycophenolic acid
5536188|NCT01141959|biomarkers|biomarkers
5536189|NCT01141946|lung cancer|lung cancer
5536190|NCT01141946|pleural effusion|pleural effusion
5536191|NCT01141946|post-op care|post-op care
5536192|NCT01141946|diaphragmatic ultrasound|diaphragmatic ultrasound
5536193|NCT01141933|Creating meaning|creating meaning
5536194|NCT01141933|Therapy|therapy
5536197|NCT01141933|Existential|existential
5536198|NCT01141933|Spirituality|spirituality
5536199|NCT01141933|Quality of life|quality of life
5536201|NCT01141933|Psycho-oncology|psycho-oncology
5536202|NCT01141933|French-canadian|french-canadian
5536203|NCT01141933|Cognitive therapy|cognitive therapy
5536204|NCT01141933|Existentialism|existentialism
5536205|NCT01141920|treatment retention|treatment retention
5536206|NCT01141920|methadone maintenance|methadone maintenance
5536207|NCT01141920|treatment induction|treatment induction
5536208|NCT01141920|Retention in methadone maintenance treatment|retention in methadone maintenance treatment
5536209|NCT01141907|heart failure|heart failure
5536210|NCT01141907|self care|self care
5536211|NCT01141907|decision support|decision support
5536212|NCT01141907|telemonitoring|telemonitoring
5536213|NCT01141907|navigator|navigator
5536214|NCT01141894|Proximal Femoral Fracture|proximal femoral fracture
5536215|NCT01141881|Tissue Plasminogen activator,|tissue plasminogen activator,
5536216|NCT01141881|Clinically significant macular edema,|clinically significant macular edema,
5536217|NCT01141881|Refractory Diabetic macular edema ,|refractory diabetic macular edema ,
5536218|NCT01141881|posterior vitreous detachment|posterior vitreous detachment
5536219|NCT01141868|insomnia|insomnia
5536220|NCT01141868|breast cancer survivor|breast cancer survivor
5536221|NCT01141868|Internet intervention|internet intervention
5536222|NCT01141855|Cardiovascular Diseases|cardiovascular diseases
5536223|NCT01141855|Peripheral Vascular Diseases|peripheral vascular diseases
5536224|NCT01141855|Cerebrovascular Stroke|cerebrovascular stroke
5536225|NCT01141855|Lung Diseases, Obstructive|lung diseases, obstructive
5536226|NCT01141855|Asthma|asthma
5536227|NCT01141855|Tobacco Use Disorder|tobacco use disorder
5536228|NCT01141855|Smoking|smoking
5536229|NCT01141855|Smoking Cessation|smoking cessation
5536230|NCT01141842|lung cancer|lung cancer
5536231|NCT01141842|exhalation analysis|exhalation analysis
5536232|NCT01141842|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5536233|NCT01141842|cancer screening test|cancer screening test
5536234|NCT01141829|NADPH oxidase|nadph oxidase
5536235|NCT01141816|renal cell carcinoma|renal cell carcinoma
5536236|NCT01141816|radiofrequency ablation|radiofrequency ablation
5536237|NCT01141816|contrast enhanced ultrasound|contrast enhanced ultrasound
5536238|NCT01141816|monitoring|monitoring
5536239|NCT01141816|follow up|follow up
5536240|NCT01141803|Apple|apple
5536241|NCT01141803|Apple pomace|apple pomace
5536242|NCT01141803|Metabolomics|metabolomics
5536243|NCT01141803|Gene expression|gene expression
5536244|NCT01141803|Lipid metabolism|lipid metabolism
5536245|NCT01141803|Prevention|prevention
5536246|NCT01141803|Antiinflammatory effect|antiinflammatory effect
5536247|NCT01141790|Glasgow Coma Scale|glasgow coma scale
5536248|NCT01141790|Glasgow Outcome Scale|glasgow outcome scale
5536249|NCT01141790|Ethics|ethics
5536250|NCT01141777|Spirulina platensis|spirulina platensis
5536251|NCT01141777|Insulin resistance|insulin resistance
5536252|NCT01141777|HIV/AIDS|hiv/aids
5536253|NCT01141777|HAART|haart
5536254|NCT01141777|Soya beans|soya beans
5536255|NCT01141764|pediatrics|pediatrics
5536256|NCT01141764|Epilepsy|epilepsy
5536257|NCT01141764|Deep Brain Stimulation|deep brain stimulation
5536258|NCT01141764|Positron Emission Tomography|positron emission tomography
5536259|NCT01141751|Multiple sclerosis|multiple sclerosis
5536260|NCT01141751|Expanded Disability Status Scale|expanded disability status scale
5536261|NCT01141751|Multiple Sclerosis, Relapsing-Remitting; Rebif|multiple sclerosis, relapsing-remitting; rebif
5536262|NCT01141751|Beta-1, interferon|beta-1, interferon
5536263|NCT01141738|stroke|stroke
5536265|NCT01141738|depression|depression
5536266|NCT01141738|mediators|mediators
5536267|NCT01141738|problem-solving|problem-solving
5536268|NCT01141712|HIV|hiv
5536269|NCT01141712|B-cell Lymphoma|b-cell lymphoma
5536270|NCT01141712|Burkitt's Lymphoma|burkitt's lymphoma
5536271|NCT01141712|Follicular Lymphoma|follicular lymphoma
5536272|NCT01141712|Hodgkin's Lymphoma|hodgkin's lymphoma
5536273|NCT01141699|women health behaviors|women health behaviors
5536274|NCT01141686|lung cancer|lung cancer
5536275|NCT01141673|FLT3-ITD|flt3-itd
5536276|NCT01141673|acute myeloid leukemia|acute myeloid leukemia
5536277|NCT01141673|FLT3|flt3
5536278|NCT01141673|D835|d835
5536279|NCT01141647|Adult|adult
5536280|NCT01141647|Depression|depression
5536281|NCT01141647|Supported Employment|supported employment
5536282|NCT01141647|Health Service|health service
5536283|NCT01141647|Humans|humans
5536284|NCT01141647|Outcomes|outcomes
5536285|NCT01141647|Quality of Life|quality of life
5536286|NCT01141647|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
5536287|NCT01141647|Workplace|workplace
5536288|NCT01141647|Spinal Cord Injuries|spinal cord injuries
5536289|NCT01141634|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5536290|NCT01141634|Attention Deficit Disorder|attention deficit disorder
5536291|NCT01141634|ADHD|adhd
5536292|NCT01141634|ADD|add
5536293|NCT01141634|Homeopathy|homeopathy
5536294|NCT01141621|HS|hs
5536295|NCT01141621|congenital hemolytic anemia|congenital hemolytic anemia
5536296|NCT01141621|splenectomy|splenectomy
5536297|NCT01141621|quality of life|quality of life
5536298|NCT01141556|selenium|selenium
5536299|NCT01141556|clinical outcome|clinical outcome
5536300|NCT01141556|heart surgery|heart surgery
5536301|NCT01141543|Plerixafor injection|plerixafor injection
5536302|NCT01141530|Identify novel genes and predict putative proteins in breast cancer.|identify novel genes and predict putative proteins in breast cancer.
5536303|NCT01141530|Find biomarkers that can be used for early detection, diagnosis, and prognosis.|find biomarkers that can be used for early detection, diagnosis, and prognosis.
5536304|NCT01141517|adolescent quit-smoking program.|adolescent quit-smoking program.
5536305|NCT01141504|Supplemental ATP|supplemental atp
5536306|NCT01141504|Muscle Work Performed|muscle work performed
5536307|NCT01141504|Muscle Fatigue|muscle fatigue
5536308|NCT01141491|Sarcoma|sarcoma
5536309|NCT01141491|Metastatic|metastatic
5536310|NCT01141491|Vaccine|vaccine
5536311|NCT01141491|Adjuvant|adjuvant
5789061|NCT00150098|women|women
5536312|NCT01141478|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5536313|NCT01141478|Proton Beam Radiotherapy|proton beam radiotherapy
5536314|NCT01141478|Sorafenib|sorafenib
5536315|NCT01141465|Primary care|primary care
5536316|NCT01141465|Asthma management|asthma management
5536317|NCT01141465|Combined therapy|combined therapy
5536318|NCT01141465|Real-world|real-world
5536319|NCT01141465|Effectiveness|effectiveness
5536320|NCT01141465|Control|control
5536321|NCT01141465|Exacerbations|exacerbations
5536322|NCT01141452|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5536323|NCT01141452|inhaled corticosteroid|inhaled corticosteroid
5536324|NCT01141452|increase|increase
5536325|NCT01141452|initiate|initiate
5536326|NCT01141452|exacerbations|exacerbations
5536327|NCT01141452|treatment success|treatment success
5536328|NCT01141439|Primary care|primary care
5536329|NCT01141439|Asthma management|asthma management
5536330|NCT01141439|Inhaled corticosteroids|inhaled corticosteroids
5536331|NCT01141439|Beclomethasone dipropionate|beclomethasone dipropionate
5536332|NCT01141439|Fluticasone propionate|fluticasone propionate
5536333|NCT01141439|Metred dose inhaler|metred dose inhaler
5536334|NCT01141439|Extra-fine hydrofluoroalkane|extra-fine hydrofluoroalkane
5536335|NCT01141439|Chlorofluorocarbon|chlorofluorocarbon
5536336|NCT01141426|depression|depression
5536337|NCT01141426|treatment-resistance|treatment-resistance
5536460|NCT01140906|Multicenter study|multicenter study
5536338|NCT01141426|psychodynamic psychotherapy|psychodynamic psychotherapy
5536339|NCT01141426|Treatment refractory depression|treatment refractory depression
5536340|NCT01141374|Stress|stress
5536341|NCT01141361|Claudication|claudication
5536342|NCT01141361|Artery|artery
5536343|NCT01141361|Ambulatory technique|ambulatory technique
5536344|NCT01141361|GPS|gps
5536345|NCT01141335|shrinkage|shrinkage
5536346|NCT01141335|postoperative pain and discomfort|postoperative pain and discomfort
5536347|NCT01141322|drug-induced liver injury|drug-induced liver injury
5536348|NCT01141322|hepatitis, toxic|hepatitis, toxic
5536349|NCT01141322|ursodeoxycholic acid|ursodeoxycholic acid
5536350|NCT01141309|Everolimus|everolimus
5536351|NCT01141309|Sorafenib|sorafenib
5536352|NCT01141309|Thyroid|thyroid
5536353|NCT01141309|10-060|10-060
5536354|NCT01141283|Osteoarthritis|osteoarthritis
5536355|NCT01141283|Opioid|opioid
5536356|NCT01141283|Transdermal|transdermal
5536357|NCT01141270|recombinant human follicle stimulating hormone|recombinant human follicle stimulating hormone
5536358|NCT01141270|pharmacokinetics|pharmacokinetics
5536359|NCT01141270|bioequivalence|bioequivalence
5536360|NCT01141257|Angiocal®; PRS-050-PEG40; Solid tumor; Phase I|angiocal®; prs-050-peg40; solid tumor; phase i
5536361|NCT01141218|non-small cell lung cancer|non-small cell lung cancer
5536362|NCT01141205|AIDS vaccines|aids vaccines
5536363|NCT01141205|HIV-1 vaccine|hiv-1 vaccine
5536364|NCT01141205|Therapeutic vaccine|therapeutic vaccine
5536365|NCT01141205|Cellular immunity|cellular immunity
5536366|NCT01141192|vitamin D status|vitamin d status
5536367|NCT01141192|25-OH D|25-oh d
5536368|NCT01141192|ionized calcium|ionized calcium
5536369|NCT01141192|fasting glucose|fasting glucose
5536370|NCT01141192|hemoglobin A1c|hemoglobin a1c
5536371|NCT01141192|fasting insulin|fasting insulin
5536372|NCT01141192|glucose metabolism|glucose metabolism
5536373|NCT01141192|HOMA index|homa index
5536374|NCT01141192|blood lipids|blood lipids
5536375|NCT01141192|type 2 diabetes|type 2 diabetes
5536376|NCT01141192|PTH|pth
5536377|NCT01141192|adiposity|adiposity
5536378|NCT01141192|body fat percentage|body fat percentage
5536379|NCT01141192|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5536380|NCT01141192|pulse wave velocity|pulse wave velocity
5536381|NCT01141192|arterial stiffness|arterial stiffness
5536382|NCT01141192|flow-mediated dilation|flow-mediated dilation
5536383|NCT01141192|African American|african american
5536384|NCT01141192|inflammatory markers|inflammatory markers
5536385|NCT01141166|ELDERLY|elderly
5536386|NCT01141166|NUTRITION|nutrition
5536387|NCT01141153|atrial fibrillation|atrial fibrillation
5536388|NCT01141153|Coronary Stent implantation|coronary stent implantation
5536389|NCT01141153|Low-moderate risk of stroke|low-moderate risk of stroke
5536390|NCT01141153|dual antiplatelet therapy|dual antiplatelet therapy
5536864|NCT01139151|MDS|mds
5536391|NCT01141153|anticoagulation|anticoagulation
5685365|NCT00556413|recurrent colon cancer|recurrent colon cancer
5536392|NCT01141127|tranexamic acid in pediatric surgery|tranexamic acid in pediatric surgery
5536393|NCT01141127|fibrinolysis and paediatric cardiac surgery|fibrinolysis and paediatric cardiac surgery
5536394|NCT01141114|community health centers|community health centers
5536395|NCT01141114|colorectal cancer screening|colorectal cancer screening
5536396|NCT01141114|urban health|urban health
5536397|NCT01141101|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5536398|NCT01141101|Neonatal|neonatal
5536399|NCT01141101|Vertical transmission|vertical transmission
5536400|NCT01141101|Horizontal transmission|horizontal transmission
5536401|NCT01141101|MRSA colonization in enrolled infants|mrsa colonization in enrolled infants
5536402|NCT01141101|MRSA colonization obtained from maternal source|mrsa colonization obtained from maternal source
5536403|NCT01141101|MRSA colonization obtained from source other that mother|mrsa colonization obtained from source other that mother
5536404|NCT01141062|Uterine Fibroids|uterine fibroids
5536405|NCT01141049|Alcohol Withdrawal|alcohol withdrawal
5536406|NCT01141049|Reducing Alcohol Consumption|reducing alcohol consumption
5536407|NCT01141049|Promoting abstinence in alcohol-dependent patients|promoting abstinence in alcohol-dependent patients
5536408|NCT01141049|Gabapentin|gabapentin
5536409|NCT01141036|Propofol|propofol
5536410|NCT01141036|Midazolam|midazolam
5536411|NCT01141036|sedation|sedation
5536412|NCT01141036|cirrhosis|cirrhosis
5536413|NCT01141036|endoscopy|endoscopy
5536414|NCT01141036|recovery time|recovery time
5536415|NCT01141036|efficacy and safety of sedation|efficacy and safety of sedation
5536416|NCT01141036|patient satisfaction|patient satisfaction
5536417|NCT01141036|return to baseline function|return to baseline function
5536418|NCT01141036|saturation of oxygen|saturation of oxygen
5536419|NCT01141023|Parkinson|parkinson
5536420|NCT01141023|Bio-markers|bio-markers
5536421|NCT01141023|Neurodegenerative disorder|neurodegenerative disorder
5536422|NCT01141023|Imaging|imaging
5536423|NCT01141023|Prodromal|prodromal
5536424|NCT01141010|Linguistic|linguistic
5536425|NCT01141010|Stress response|stress response
5536426|NCT01141010|Corticosteroid|corticosteroid
5536427|NCT01141010|Cesarean section|cesarean section
5536428|NCT01141010|Anxiety|anxiety
5536429|NCT01141010|Depression|depression
5536430|NCT01141010|Maternal psychosis|maternal psychosis
5536431|NCT01140997|HCV|hcv
5536432|NCT01140997|CHC|chc
5536433|NCT01140997|Hepatitis C, Chronic|hepatitis c, chronic
5536434|NCT01140997|Liver Diseases|liver diseases
5536435|NCT01140997|Hepatitis, Chronic|hepatitis, chronic
5536436|NCT01140997|Hepatitis, Viral, Human|hepatitis, viral, human
5536437|NCT01140997|Hepadnaviridae Infections|hepadnaviridae infections
5536438|NCT01140997|Antiviral Agents|antiviral agents
5536439|NCT01140997|Virus Diseases|virus diseases
5536440|NCT01140997|Peginterferon alfa|peginterferon alfa
5536441|NCT01140984|acute graft versus host disease|acute graft versus host disease
5536442|NCT01140984|intra arterial steroid infusion|intra arterial steroid infusion
5536443|NCT01140984|steroid resistant acute hepatic graft versus host disease|steroid resistant acute hepatic graft versus host disease
5536444|NCT01140971|Balloon dilatation,|balloon dilatation,
5536445|NCT01140971|misoprostol,|misoprostol,
5536446|NCT01140971|cervical ripening,|cervical ripening,
5536447|NCT01140971|obstetric labor,|obstetric labor,
5536448|NCT01140971|labor induced.|labor induced.
5536449|NCT01140958|lung cancer|lung cancer
5536450|NCT01140958|pharmacoeconomics|pharmacoeconomics
5536451|NCT01140958|new agents|new agents
5536452|NCT01140932|Retina|retina
5536453|NCT01140932|Electroretinography|electroretinography
5536454|NCT01140932|Diabetes Mellitus|diabetes mellitus
5536455|NCT01140932|Glucose Intolerance|glucose intolerance
5536456|NCT01140932|Physiology|physiology
5536457|NCT01140906|Major depressive disorder|major depressive disorder
5536458|NCT01140906|Placebo-controlled|placebo-controlled
5536459|NCT01140906|Active reference|active reference
5536461|NCT01140906|Randomised study|randomised study
5536462|NCT01140906|Acute treatment|acute treatment
5536463|NCT01140893|Type 2 diabetes|type 2 diabetes
5536464|NCT01140893|CSII|csii
5536465|NCT01140893|Exenatide|exenatide
5536466|NCT01140893|Double Blind Placebo Controlled Study|double blind placebo controlled study
5536467|NCT01140880|Methamphetamine|methamphetamine
5536468|NCT01140880|Amphetamine|amphetamine
5536469|NCT01140880|Cocaine|cocaine
5536471|NCT01140880|Post-exposure prophylaxis|post-exposure prophylaxis
5536472|NCT01140880|HIV seronegativity|hiv seronegativity
5536473|NCT01140854|hypertension|hypertension
5536474|NCT01140854|hypotension|hypotension
5536475|NCT01140854|cognitive|cognitive
5536476|NCT01140854|neurocognitive|neurocognitive
5536477|NCT01140854|cognitive dysfunction|cognitive dysfunction
5536478|NCT01140854|postoperative cognitive dysfunction (POCD)|postoperative cognitive dysfunction (pocd)
5536479|NCT01140854|neuropsychometric|neuropsychometric
5536480|NCT01140841|Dyskinesia|dyskinesia
5536481|NCT01140828|Arthritis|arthritis
5536482|NCT01140828|Bone pain|bone pain
5536483|NCT01140828|dyspepsia|dyspepsia
5536484|NCT01140815|Total Knee Arthroplasty|total knee arthroplasty
5536485|NCT01140815|Bicompartmental Knee Arthroplasty|bicompartmental knee arthroplasty
5507402|NCT01264640|Aspirin|aspirin
5536486|NCT01140802|First degree relatives|first degree relatives
5536487|NCT01140802|Crohn's disease|crohn's disease
5536488|NCT01140802|Ulcerative colitis|ulcerative colitis
5536490|NCT01140776|metastasis|metastasis
5536491|NCT01140776|molecular pathology|molecular pathology
5536492|NCT01140763|metastasis|metastasis
5536493|NCT01140750|Heart Rate Variability|heart rate variability
5536494|NCT01140750|Temperature Curve Complexity|temperature curve complexity
5536495|NCT01140750|Autonomic Dysfunction|autonomic dysfunction
5536496|NCT01140750|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
5536497|NCT01140750|Failure to Wean|failure to wean
5536498|NCT01140737|advanced soft tissue sarcoma|advanced soft tissue sarcoma
5536499|NCT01140724|pain|pain
5536500|NCT01140724|genes|genes
5536501|NCT01140724|morphine|morphine
5536502|NCT01140724|respiratory depression|respiratory depression
5536503|NCT01140724|tonsillectomy|tonsillectomy
5536504|NCT01140724|children|children
5536505|NCT01140724|Opioid adverse effects|opioid adverse effects
5536506|NCT01140724|Pharmacogenetics of morphine|pharmacogenetics of morphine
5536507|NCT01140724|Pharmacokinetics of morphine|pharmacokinetics of morphine
5536508|NCT01140724|Personalizing analgesia|personalizing analgesia
5536509|NCT01140685|mucus-stimulated (induced sputum)|mucus-stimulated (induced sputum)
5536510|NCT01140685|lung disease (asthma, COPD, ILD and OLD)|lung disease (asthma, copd, ild and old)
5536511|NCT01140685|HO-1 (heme oxigenase-1)|ho-1 (heme oxigenase-1)
5536512|NCT01140685|oxidative stress|oxidative stress
5536513|NCT01140685|CO (carbon monoxide)|co (carbon monoxide)
5536514|NCT01140685|The oxidative stress in lung diseases|the oxidative stress in lung diseases
5536515|NCT01140672|Healthy volunteers|healthy volunteers
5536516|NCT01140672|pharmacokinetics|pharmacokinetics
5536517|NCT01140672|safety|safety
5536518|NCT01140672|tolerability|tolerability
5536519|NCT01140672|multiple dosing|multiple dosing
5536520|NCT01140672|Diabetic Nephropathies|diabetic nephropathies
5536521|NCT01140659|Hyperhidrosis|hyperhidrosis
5536522|NCT01140659|Thoracic sympathectomy|thoracic sympathectomy
5536523|NCT01140659|Objective measurement of sweat|objective measurement of sweat
5536524|NCT01140646|Hot flashes, dietary supplements, symptom management|hot flashes, dietary supplements, symptom management
5536525|NCT01140633|HIV/AIDS|hiv/aids
5536526|NCT01140633|pediatric|pediatric
5536527|NCT01140633|wireless adherence monitoring|wireless adherence monitoring
5536528|NCT01140633|HIV Infections|hiv infections
5536529|NCT01140620|NMDA receptor antagonism|nmda receptor antagonism
5536530|NCT01140620|cognitive processes|cognitive processes
5536531|NCT01140620|healthy volunteers|healthy volunteers
5536532|NCT01140620|dopamine antagonist|dopamine antagonist
5536533|NCT01140620|schizophrenia|schizophrenia
5536534|NCT01140568|glioma|glioma
5536535|NCT01140568|PDGFR|pdgfr
5536536|NCT01140568|kinase|kinase
5536537|NCT01140568|inhibitor|inhibitor
5536538|NCT01140568|malignant|malignant
5536539|NCT01140568|nilotinib|nilotinib
5536540|NCT01140542|Diabetes Mellitus Type 2|diabetes mellitus type 2
5536541|NCT01140542|Roflumilast|roflumilast
5536542|NCT01140529|Dexmedetomidine|dexmedetomidine
5536544|NCT01140490|Hemodialysis|hemodialysis
5536545|NCT01140490|Sub-total Parathyroidectomy|sub-total parathyroidectomy
5536546|NCT01140464|Adolescents|adolescents
5536547|NCT01140438|Latent autoimmune diabetes|latent autoimmune diabetes
5536548|NCT01140438|adults|adults
5536549|NCT01140438|Beta cell rest|beta cell rest
5536550|NCT01140438|Insulin secretion|insulin secretion
5536551|NCT01140425|PF-00232798|pf-00232798
5536552|NCT01140425|CCR5|ccr5
5536553|NCT01140425|QT|qt
5536554|NCT01140425|QTc|qtc
5536555|NCT01140425|pharmacokinetics|pharmacokinetics
5536556|NCT01140412|maraviroc|maraviroc
5536557|NCT01140412|fosamprenavir|fosamprenavir
5536558|NCT01140412|drug interaction|drug interaction
5536559|NCT01140412|pharmacokinetics|pharmacokinetics
5536560|NCT01140412|HIV|hiv
5536561|NCT01140412|AIDS|aids
5536562|NCT01140412|CCR5|ccr5
5536563|NCT01140412|protease inhibitor|protease inhibitor
5536564|NCT01140399|1 Acute Decompensated Heart Failure|1 acute decompensated heart failure
5536565|NCT01140399|2 Cardiorenal Syndrome|2 cardiorenal syndrome
5536566|NCT01140399|3 Ultrafiltration|3 ultrafiltration
5536567|NCT01140399|4 Dopamine|4 dopamine
5536568|NCT01140386|venous thromboembolism|venous thromboembolism
5536569|NCT01140386|duplex ultrasound|duplex ultrasound
5536570|NCT01140386|pediatric population|pediatric population
5536571|NCT01140386|Vascular lab duplex ultrasound database|vascular lab duplex ultrasound database
5536572|NCT01140386|Inpatient hospital admission/discharge ICD-9 database|inpatient hospital admission/discharge icd-9 database
5536573|NCT01140386|PTSF pediatric trauma database|ptsf pediatric trauma database
5536574|NCT01140373|Prostate|prostate
5536575|NCT01140373|Autologous T Cells|autologous t cells
5536576|NCT01140373|Castrate Metastatic Prostate Cancer|castrate metastatic prostate cancer
5536577|NCT01140373|cyclophosphamide|cyclophosphamide
5536578|NCT01140373|09-036|09-036
5536579|NCT01140360|Neurofibromas|neurofibromas
5536580|NCT01140347|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5536581|NCT01140347|recombinant human immunoglobulin G|recombinant human immunoglobulin g
5536582|NCT01140347|subclass 1 (IgG1) monoclonal antibody (MAb)|subclass 1 (igg1) monoclonal antibody (mab)
5536703|NCT01139788|Cancer|cancer
5536583|NCT01140347|Hepatocellular Carcinoma (HCC) following First-Line Therapy With Sorafenib|hepatocellular carcinoma (hcc) following first-line therapy with sorafenib
5536584|NCT01140334|Psychiatric adherence|psychiatric adherence
5536585|NCT01140334|Voucher incentives|voucher incentives
5536586|NCT01140334|Methadone treatment|methadone treatment
5536587|NCT01140321|Thalassemia|thalassemia
5536588|NCT01140321|Neridronate|neridronate
5536589|NCT01140321|Osteopenia|osteopenia
5536590|NCT01140321|Osteoporosis|osteoporosis
5536591|NCT01140308|Statin Myopathy|statin myopathy
5536592|NCT01140308|CoEnzyme Q10|coenzyme q10
5536593|NCT01140308|CoQ10|coq10
5536594|NCT01140308|Statin Myalgia|statin myalgia
5536595|NCT01140295|Preparation|preparation
5536596|NCT01140295|Pediatric|pediatric
5536597|NCT01140295|Colonoscopy|colonoscopy
5536598|NCT01140282|cancer survivor|cancer survivor
5536599|NCT01140269|Burn|burn
5536600|NCT01140269|Sepsis|sepsis
5536601|NCT01140269|Infection|infection
5536602|NCT01140256|Zinc|zinc
5536604|NCT01140256|AGA|aga
5536605|NCT01140256|stable isotope|stable isotope
5536606|NCT01140243|fat formulation|fat formulation
5536607|NCT01140230|rotator cuff tear|rotator cuff tear
5536608|NCT01140230|rotator cuff repair|rotator cuff repair
5536609|NCT01140230|age|age
5536610|NCT01140230|timing to surgery|timing to surgery
5536611|NCT01140217|contraception|contraception
5536612|NCT01140217|pregnancy|pregnancy
5536613|NCT01140204|stent|stent
5536614|NCT01140204|contrast media|contrast media
5536615|NCT01140204|paclitaxel|paclitaxel
5536616|NCT01140204|stent implantation|stent implantation
5536617|NCT01140191|leishmaniasis|leishmaniasis
5536618|NCT01140191|cutaneous|cutaneous
5536619|NCT01140191|WR 279,396|wr 279,396
5536620|NCT01140191|paromomycin|paromomycin
5536621|NCT01140191|gentamicin|gentamicin
5536622|NCT01140191|pharmacokinetics|pharmacokinetics
5536623|NCT01140191|safety|safety
5536624|NCT01140191|efficacy|efficacy
5536625|NCT01140191|military|military
5536626|NCT01140178|Photodynamic Therapy|photodynamic therapy
5536627|NCT01140178|Oral dysplasia|oral dysplasia
5536628|NCT01140178|oral cavity carcinoma|oral cavity carcinoma
5536629|NCT01140178|oropharynx carcinoma.|oropharynx carcinoma.
5536630|NCT01140152|intestinal transplantation|intestinal transplantation
5536631|NCT01140152|rejection|rejection
5536632|NCT01140152|proteomics|proteomics
5536633|NCT01140152|innate immunity|innate immunity
5536634|NCT01140126|HIV-1, CD4, antibody, immunotherapy|hiv-1, cd4, antibody, immunotherapy
5536635|NCT01140113|hemoconcentration|hemoconcentration
5536636|NCT01140113|ultrafiltration|ultrafiltration
5536637|NCT01140113|coronary artery disease|coronary artery disease
5536638|NCT01140087|Face Transplant|face transplant
5536639|NCT01140087|Composite Tissue Allograft|composite tissue allograft
5536640|NCT01140087|Facial Allotransplantation|facial allotransplantation
5536641|NCT01140074|acute diarrhoea, children|acute diarrhoea, children
5536642|NCT01140048|Asthma|asthma
5536643|NCT01140035|Insulin|insulin
5536644|NCT01140035|Deceased donors|deceased donors
5536645|NCT01140035|Renal Allograft Function|renal allograft function
5536646|NCT01140035|Transplanted Allograft Outcomes|transplanted allograft outcomes
5536647|NCT01140022|Chlamydia, Screening, young women, kiosk, computer module|chlamydia, screening, young women, kiosk, computer module
5536648|NCT01140009|Vaccine|vaccine
5536649|NCT01140009|Seasonal Influenza vaccine|seasonal influenza vaccine
5536650|NCT01140009|Influenza vaccine|influenza vaccine
5536651|NCT01140009|Vaccine safety|vaccine safety
5536652|NCT01140009|Vaccine immunogenicity|vaccine immunogenicity
5536653|NCT01140009|Fluviral 2010/11|fluviral 2010/11
5536654|NCT01139983|osteosarcoma|osteosarcoma
5536655|NCT01139944|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5536656|NCT01139944|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5536657|NCT01139944|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5536658|NCT01139944|squamous cell lung cancer|squamous cell lung cancer
5536659|NCT01139931|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5536660|NCT01139918|psoriatic arthritis|psoriatic arthritis
5536661|NCT01139918|psoriasis|psoriasis
5536662|NCT01139918|Quality of life|quality of life
5536663|NCT01139905|Lopinavir/ritonavir|lopinavir/ritonavir
5536664|NCT01139905|pharmacokinetic|pharmacokinetic
5536665|NCT01139905|low dose|low dose
5536666|NCT01139905|HIV-infected children|hiv-infected children
5536667|NCT01139905|pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.|pharmacokinetics of low-dose lopinavir/ritonavir in hiv-1 infected thai children.
5536668|NCT01139892|Unruptured aneurysm|unruptured aneurysm
5536669|NCT01139892|endovascular treatment|endovascular treatment
5536670|NCT01139892|surgical treatment|surgical treatment
5536671|NCT01139892|randomized|randomized
5536672|NCT01139892|intracranial aneurysm|intracranial aneurysm
5536673|NCT01139879|Pressure Ulcer treatment Mattresses|pressure ulcer treatment mattresses
5536674|NCT01139879|Home Care|home care
5536675|NCT01139879|Extended Care|extended care
5536676|NCT01139879|Wound measurements|wound measurements
5536677|NCT01139866|Long-term Safety|long-term safety
5536678|NCT01139866|Shoulder Surgery|shoulder surgery
5536679|NCT01139866|bupivacaine|bupivacaine
5538348|NCT01134016|NSCLC|nsclc
5536680|NCT01139853|pyloric stenosis|pyloric stenosis
5536681|NCT01139853|nasogastric tube|nasogastric tube
5536682|NCT01139853|pyloromyotomy|pyloromyotomy
5536683|NCT01139840|vitamin D2|vitamin d2
5536684|NCT01139840|vitamin D3|vitamin d3
5536685|NCT01139840|ergocalciferol|ergocalciferol
5536686|NCT01139840|cholecalciferol|cholecalciferol
5536687|NCT01139840|vitamin D status|vitamin d status
5536688|NCT01139840|To determine relative potency of vitamins D2 and D3 under conditions of continuous administration|to determine relative potency of vitamins d2 and d3 under conditions of continuous administration
5536689|NCT01139840|To determine change in vitamin D content of subcutaneous fat after 12 weeks' administration|to determine change in vitamin d content of subcutaneous fat after 12 weeks' administration
5536690|NCT01139827|atherosclerosis|atherosclerosis
5536691|NCT01139827|inflammation|inflammation
5536692|NCT01139827|hsCRP|hscrp
5536693|NCT01139827|Framingham risk score|framingham risk score
5536694|NCT01139827|positron emission tomography|positron emission tomography
5536695|NCT01139827|inflammation in FDG-PET|inflammation in fdg-pet
5536697|NCT01139814|AVNRT|avnrt
5536698|NCT01139814|right sided accessory pathway|right sided accessory pathway
5536699|NCT01139814|ventricular tachycardia|ventricular tachycardia
5536700|NCT01139814|Patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.|patients who have one or more standard indications for a right-sided diagnostic electrophysiology procedure.
5536701|NCT01139801|Cervical Ripening|cervical ripening
5536702|NCT01139801|Rate of Cesearean Section|rate of cesearean section
5536704|NCT01139775|solid tumors|solid tumors
5536705|NCT01139775|Mesothelioma|mesothelioma
5536706|NCT01139775|Carcinoma|carcinoma
5536707|NCT01139762|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5536708|NCT01139762|Enlarged Prostate|enlarged prostate
5536709|NCT01139749|oral isotretinoin|oral isotretinoin
5536710|NCT01139749|sebaceous secretion|sebaceous secretion
5536711|NCT01139749|seborrhea|seborrhea
5536712|NCT01139749|seborrheic dermatitis|seborrheic dermatitis
5536713|NCT01139749|quality of life|quality of life
5536714|NCT01139749|Malassezia|malassezia
5536715|NCT01139736|Irritable bowel syndrome|irritable bowel syndrome
5536717|NCT01139736|probiotics|probiotics
5536718|NCT01139736|rectal sensitivity|rectal sensitivity
5536719|NCT01139736|gut flora|gut flora
5536720|NCT01139736|gut bacteria|gut bacteria
5536721|NCT01139710|SARCOIDOSIS|sarcoidosis
5536722|NCT01139710|PULMONARY HYPERTENSION|pulmonary hypertension
5536723|NCT01139710|outpatients clinic at Meir medical center|outpatients clinic at meir medical center
5536724|NCT01139697|Heart failure|heart failure
5536725|NCT01139697|Cortisol|cortisol
5536726|NCT01139697|Testosterone|testosterone
5536727|NCT01139684|Exercise test|exercise test
5536728|NCT01139671|Remifentanil|remifentanil
5536729|NCT01139671|Sufentanil|sufentanil
5536730|NCT01139671|Surgical removal of three to four wisdom teeth|surgical removal of three to four wisdom teeth
5536731|NCT01139671|General anaesthesia|general anaesthesia
5536732|NCT01139671|Ambulatory oral surgery|ambulatory oral surgery
5536733|NCT01139671|Target Controlled Infusion (TCI)|target controlled infusion (tci)
5536734|NCT01139671|Opioid induced hyperalgesia|opioid induced hyperalgesia
5536735|NCT01139671|Postoperative nausea and vomiting|postoperative nausea and vomiting
5536736|NCT01139671|Postoperative Morphine consumption|postoperative morphine consumption
5536737|NCT01139671|Under General anaesthesia|under general anaesthesia
5536738|NCT01139671|In Ambulatory surgery|in ambulatory surgery
5536739|NCT01139645|Calcium|calcium
5536740|NCT01139645|bone|bone
5536741|NCT01139645|metabolism|metabolism
5536742|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors
5536743|NCT01139645|Rabeprazole|rabeprazole
5536744|NCT01139645|Esomeprazole|esomeprazole
5536745|NCT01139645|Lanzoprazole|lanzoprazole
5536746|NCT01139645|Vitamin D|vitamin d
5536747|NCT01139645|bone and bones|bone and bones
5536748|NCT01139632|NAFLD|nafld
5536749|NCT01139632|lP-pla2|lp-pla2
5536750|NCT01139632|Coronary Arthery Disease|coronary arthery disease
5536751|NCT01139619|Biopsy Mapping|biopsy mapping
5536752|NCT01139619|Non small cell lung cancer|non small cell lung cancer
5536753|NCT01139619|NSCLC|nsclc
5536754|NCT01139619|Lung cancer diagnosis|lung cancer diagnosis
5536755|NCT01139619|Retrospective|retrospective
5536762|NCT01139593|pregnancy|pregnancy
5536763|NCT01139593|implantation|implantation
5536764|NCT01139593|live birth|live birth
5536765|NCT01139580|Plaque Psoriasis|plaque psoriasis
5536766|NCT01139580|Psoriasis|psoriasis
5536767|NCT01139567|Diabetic Wounds|diabetic wounds
5536768|NCT01139567|Hyperbaric Oxygen|hyperbaric oxygen
5536769|NCT01139567|Laser Speckle Imaging|laser speckle imaging
5536770|NCT01139567|Hyperbaric Oxygenation|hyperbaric oxygenation
5536771|NCT01139528|Fracture|fracture
5536772|NCT01139528|5th metacarpal bone|5th metacarpal bone
5536773|NCT01139528|Bouquet pinning|bouquet pinning
5536865|NCT01139151|refractory anemia|refractory anemia
5536774|NCT01139528|Fractures of the neck of the 5th metacarpal bone|fractures of the neck of the 5th metacarpal bone
5536775|NCT01139515|pharmacokinetic|pharmacokinetic
5536776|NCT01139515|eletriptan|eletriptan
5536777|NCT01139515|Korean|korean
5536778|NCT01139515|crossover|crossover
5536779|NCT01139502|schizophrenia spectrum disorders|schizophrenia spectrum disorders
5536780|NCT01139502|work rehabilitation|work rehabilitation
5536781|NCT01139502|cognitive therapy|cognitive therapy
5536782|NCT01139502|cognitive training|cognitive training
5536783|NCT01139502|Adaptation to work|adaptation to work
5536784|NCT01139502|Work as a treatment factor|work as a treatment factor
5536785|NCT01139489|Procalcitonin|procalcitonin
5536786|NCT01139489|antibiotic therapy|antibiotic therapy
5536787|NCT01139489|antibiotics|antibiotics
5536788|NCT01139489|sepsis|sepsis
5536789|NCT01139489|infections|infections
5536790|NCT01139489|biomarker|biomarker
5536791|NCT01139476|Multiple Myeloma|multiple myeloma
5536792|NCT01139476|MGUS|mgus
5536793|NCT01139476|Leukemia|leukemia
5536794|NCT01139476|Biorepository|biorepository
5536795|NCT01139463|antipsychotics|antipsychotics
5536796|NCT01139463|lactates|lactates
5536797|NCT01139463|side effects|side effects
5536799|NCT01139437|Vaccine|vaccine
5536800|NCT01139437|HPIV2|hpiv2
5536801|NCT01139437|Infants|infants
5536802|NCT01139424|surgical leak|surgical leak
5536803|NCT01139424|endoscopic suturing|endoscopic suturing
5536804|NCT01139424|Anastomotic leakage|anastomotic leakage
5536805|NCT01139424|esophageal or gastric resection|esophageal or gastric resection
5536806|NCT01139398|Cholesterol|cholesterol
5536807|NCT01139398|LDL-cholesterol|ldl-cholesterol
5536808|NCT01139398|Coronary artery disease|coronary artery disease
5536809|NCT01139398|Red yeast rice|red yeast rice
5536810|NCT01139398|Plants extract|plants extract
5536811|NCT01139398|Cholesterol excess.|cholesterol excess.
5536812|NCT01139372|Dry eye, artificial tears|dry eye, artificial tears
5536813|NCT01139359|Lymphoma|lymphoma
5536814|NCT01139359|Darinaparsin|darinaparsin
5536815|NCT01139359|CHOP|chop
5536816|NCT01139359|Frontline|frontline
5536817|NCT01139359|PTCL|ptcl
5536818|NCT01139359|B-cell|b-cell
5536819|NCT01139346|carcinoma|carcinoma
5536820|NCT01139346|sarcoma|sarcoma
5536821|NCT01139346|metastatic|metastatic
5536822|NCT01139346|solid tumor|solid tumor
5536823|NCT01139333|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5536824|NCT01139320|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5536825|NCT01139307|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5536826|NCT01139307|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5536827|NCT01139307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5536828|NCT01139307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5536829|NCT01139307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5536830|NCT01139307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5536831|NCT01139294|cardiac output|cardiac output
5536832|NCT01139294|dehydration|dehydration
5536833|NCT01139294|pediatrics|pediatrics
5536834|NCT01139281|Ear protection|ear protection
5536836|NCT01139281|Distortion-product otoacoustic emission|distortion-product otoacoustic emission
5536837|NCT01139281|Ototoxicity|ototoxicity
5536838|NCT01139281|Cisplatin|cisplatin
5536839|NCT01139268|embryo viability|embryo viability
5536840|NCT01139242|CRC screening status|crc screening status
5536841|NCT01139242|physical activity level|physical activity level
5536842|NCT01139242|fruit and vegetable consumption|fruit and vegetable consumption
5536843|NCT01139242|Early Detection of Cancer|early detection of cancer
5519020|NCT01213030|HX4|hx4
5536844|NCT01139242|Colorectal Cancer (CRC) screening status|colorectal cancer (crc) screening status
5536845|NCT01139229|Esophagogastrostomy|esophagogastrostomy
5536847|NCT01139229|Side-side anastomosis|side-side anastomosis
5536848|NCT01139229|Randomized clinical trial|randomized clinical trial
5536849|NCT01139216|Digestive system diseases|digestive system diseases
5536850|NCT01139216|Gastrointestinal diseases|gastrointestinal diseases
5536851|NCT01139216|Intestinal diseases|intestinal diseases
5536852|NCT01139216|Colonic inertia|colonic inertia
5536853|NCT01139203|HBV recurrence|hbv recurrence
5536854|NCT01139203|entecavir|entecavir
5536855|NCT01139190|NSAID-induced gastroduodenal ulcerations or erosion|nsaid-induced gastroduodenal ulcerations or erosion
5536856|NCT01139177|Peripheral vascular disease - SFA and popliteal arteries.|peripheral vascular disease - sfa and popliteal arteries.
5536857|NCT01139164|high-risk hematological malignancies|high-risk hematological malignancies
5536858|NCT01139151|Advanced Hematologic Malignancies|advanced hematologic malignancies
5536859|NCT01139151|4'-Thio-araC|4'-thio-arac
5536860|NCT01139151|Thiarabine|thiarabine
5536861|NCT01139151|4'-thio-â-D-arabinofuranosylcytosine|4'-thio-â-d-arabinofuranosylcytosine
5536862|NCT01139151|deoxycytidine nucleoside analog|deoxycytidine nucleoside analog
5536863|NCT01139151|poor-risk myelodysplasia|poor-risk myelodysplasia
5536866|NCT01139151|Excess blasts|excess blasts
5536867|NCT01139151|RAEB-1|raeb-1
5536868|NCT01139151|RAEB-2|raeb-2
5536869|NCT01139151|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5536870|NCT01139151|CMML|cmml
5536871|NCT01139151|Relapsed/refractory leukemia|relapsed/refractory leukemia
5536872|NCT01139151|Acute non-lymphocytic leukemia|acute non-lymphocytic leukemia
5536874|NCT01139151|Acute lymphocytic leukemia|acute lymphocytic leukemia
5536875|NCT01139151|ALL|all
5536876|NCT01139151|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5536877|NCT01139151|CLL|cll
5536878|NCT01139151|Chronic myelogenous leukemia|chronic myelogenous leukemia
5536879|NCT01139151|CML|cml
5536880|NCT01139151|blast crisis|blast crisis
5536881|NCT01139138|Colorectal Cancer|colorectal cancer
5536882|NCT01139138|Colorectal Carcinoma|colorectal carcinoma
5536883|NCT01139138|Colorectal Tumors|colorectal tumors
5536884|NCT01139138|Neoplasms, Colorectal|neoplasms, colorectal
5536885|NCT01139112|Necrotizing Fasciitis, Klebsiella Pneumoniae|necrotizing fasciitis, klebsiella pneumoniae
5536886|NCT01139086|chronic heart failure|chronic heart failure
5536887|NCT01139086|isokinetic test|isokinetic test
5536888|NCT01139086|near-infrared spectroscopy|near-infrared spectroscopy
5536889|NCT01139086|laser Doppler flowmetry|laser doppler flowmetry
5536890|NCT01139086|endothelial function|endothelial function
5536892|NCT01139060|chronic or recurrent depression|chronic or recurrent depression
5536893|NCT01139021|Children|children
5536894|NCT01139021|Meningococcal disease|meningococcal disease
5536895|NCT01139021|Prevention|prevention
5536896|NCT01139021|Vaccination|vaccination
5536897|NCT01138995|Poststroke/CVA hemiparesis|poststroke/cva hemiparesis
5536898|NCT01138995|Drop Foot|drop foot
5536899|NCT01138995|Gait Disorders, Neurological|gait disorders, neurological
5536901|NCT01138982|Youth mentoring|youth mentoring
5536902|NCT01138982|Effectiveness|effectiveness
5536903|NCT01138982|Sweden|sweden
5536904|NCT01138982|low-risk youth|low-risk youth
5536905|NCT01138969|proton pump inhibitor|proton pump inhibitor
5536906|NCT01138969|peptic ulcer|peptic ulcer
5536907|NCT01138969|clopidogrel|clopidogrel
5536908|NCT01138969|prevention|prevention
5536909|NCT01138956|Visceral leishmaniasis|visceral leishmaniasis
5536910|NCT01138956|N-acetylcysteine|n-acetylcysteine
5536911|NCT01138956|Antimony|antimony
5536912|NCT01138956|Immune response|immune response
5536913|NCT01138943|Chlorhexidine mouthrinse|chlorhexidine mouthrinse
5536914|NCT01138943|Plaque control|plaque control
5536915|NCT01138930|Polycystic Ovary Syndrome|polycystic ovary syndrome
5536916|NCT01138930|Obesity|obesity
5536917|NCT01138917|Second Degree Burn Injuries|second degree burn injuries
5536918|NCT01138904|gastric cancer|gastric cancer
5536919|NCT01138904|oxaliplatin|oxaliplatin
5536920|NCT01138904|irinotecan|irinotecan
5536921|NCT01138904|sequential treatment|sequential treatment
5536922|NCT01138891|Breast implants|breast implants
5536923|NCT01138891|capsular contraction|capsular contraction
5536924|NCT01138891|sonication|sonication
5536925|NCT01138891|biofilm|biofilm
5536926|NCT01138891|Complications|complications
5536927|NCT01138891|surgery|surgery
5536928|NCT01138878|HIV|hiv
5536929|NCT01138878|testing|testing
5536930|NCT01138878|non traditional settings|non traditional settings
5536931|NCT01138878|acceptability|acceptability
5536932|NCT01138878|feasibility|feasibility
5536933|NCT01138865|Obstructive sleep apnea|obstructive sleep apnea
5536934|NCT01138865|Cytokine levels|cytokine levels
5536935|NCT01138865|Insulin resistance|insulin resistance
5536936|NCT01138865|Hypertension|hypertension
5536937|NCT01138865|Dyslipidemia|dyslipidemia
5536938|NCT01138865|Albumin-creatinine ratio|albumin-creatinine ratio
5536939|NCT01138865|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5536940|NCT01138852|post-cesarean infections|post-cesarean infections
5536941|NCT01138852|ampicillin-sulbactam|ampicillin-sulbactam
5536947|NCT01138826|biological availability|biological availability
5536948|NCT01138826|bioavailability|bioavailability
5536949|NCT01138826|amlodipine|amlodipine
5536950|NCT01138826|orally disintegrating tablet|orally disintegrating tablet
5536951|NCT01138826|ODT|odt
5536952|NCT01138826|tablets|tablets
5536953|NCT01138813|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5536954|NCT01138813|lactate editing|lactate editing
5536955|NCT01138813|metabolite content|metabolite content
5536956|NCT01138813|glioma|glioma
5536957|NCT01138774|Obesity|obesity
5536958|NCT01138774|Calorie restriction|calorie restriction
5536959|NCT01138774|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5536960|NCT01138774|Lipoic acid|lipoic acid
5536961|NCT01138774|Weight loss|weight loss
5536962|NCT01138774|Insulin sensitivity|insulin sensitivity
5536963|NCT01138774|Lipid metabolism|lipid metabolism
5536964|NCT01138774|Adipokines|adipokines
5536965|NCT01138774|Inflammation|inflammation
5536966|NCT01138774|Oxidative stress|oxidative stress
5536967|NCT01138774|Adipose tissue gene profile|adipose tissue gene profile
5536968|NCT01138774|Metabolomic profile|metabolomic profile
5536969|NCT01138761|pediatric atopic dermatitis|pediatric atopic dermatitis
5536970|NCT01138761|EASI|easi
5536971|NCT01138761|REALM-SF|realm-sf
5536972|NCT01138761|nurse instruction|nurse instruction
5536973|NCT01138761|health literacy|health literacy
5536974|NCT01138748|inoperable early stage non-small cell lung cancer|inoperable early stage non-small cell lung cancer
5536975|NCT01138748|radiation therapy|radiation therapy
5536976|NCT01138722|early stage non-small cell lung cancer|early stage non-small cell lung cancer
5536977|NCT01138722|hypofractionated radiation therapy|hypofractionated radiation therapy
5536978|NCT01138696|ACL|acl
5536979|NCT01138683|Acute decompensated heart failure|acute decompensated heart failure
5536980|NCT01138683|ultrafiltration|ultrafiltration
5536981|NCT01138683|diuretics|diuretics
5536982|NCT01138683|AKI|aki
5536983|NCT01138657|inflammation of uvea|inflammation of uvea
5536984|NCT01138644|Atrial Fibrillation|atrial fibrillation
5536985|NCT01138644|Atrial Flutter|atrial flutter
5536986|NCT01138631|IVF, Infertility, embryo selection, embryoscope, time-lapse|ivf, infertility, embryo selection, embryoscope, time-lapse
5536987|NCT01138618|Clozapine|clozapine
5536988|NCT01138618|hematological monitoring|hematological monitoring
5536989|NCT01138618|CHEMPAQ|chempaq
5536990|NCT01138618|Granulocytes|granulocytes
5536991|NCT01138618|WBC|wbc
5536992|NCT01138605|TMC114|tmc114
5536993|NCT01138605|TMC114-TiDP29-C232|tmc114-tidp29-c232
5536994|NCT01138605|TMC114-C232|tmc114-c232
5536997|NCT01138579|FBTA05|fbta05
5536998|NCT01138579|CD20|cd20
5536999|NCT01138579|CLL|cll
5537000|NCT01138579|NHL|nhl
5537001|NCT01138579|DLI|dli
5537002|NCT01138579|allogeneic transplantation|allogeneic transplantation
5537003|NCT01138579|CD20 positive chronic lymphocytic leukemia (CLL)|cd20 positive chronic lymphocytic leukemia (cll)
5537004|NCT01138579|low and high grade non-Hodgkin´s lymphoma (NHL) after allogeneic stem cell transplantation with active disease|low and high grade non-hodgkin´s lymphoma (nhl) after allogeneic stem cell transplantation with active disease
5537005|NCT01138566|community-onset urinary tract infections caused by Enterobacteriaceae|community-onset urinary tract infections caused by enterobacteriaceae
5537006|NCT01138553|biomarker|biomarker
5537007|NCT01138553|breast cancer|breast cancer
5537008|NCT01138553|antiprogesterone|antiprogesterone
5537009|NCT01138540|VAP|vap
5537010|NCT01138527|multi-parametric MRI approach|multi-parametric mri approach
5537011|NCT01138475|PTH|pth
5537012|NCT01138475|Gastric bypass surgery|gastric bypass surgery
5537013|NCT01138475|vitamin D|vitamin d
5537014|NCT01138475|paricalcitol|paricalcitol
5537015|NCT01138462|Methicillin-Resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5537016|NCT01138462|Decolonisation|decolonisation
5537017|NCT01138462|Nursing homes|nursing homes
5537018|NCT01138462|Infection Control|infection control
5537019|NCT01138449|Vitamin A|vitamin a
5537020|NCT01138449|Neonatal mortality|neonatal mortality
5537021|NCT01138449|Infant mortality|infant mortality
5537022|NCT01138436|Venous Leg Ulcers, VLU|venous leg ulcers, vlu
5537023|NCT01138423|Hypertension|hypertension
5537024|NCT01138423|Metabolic Syndrome X|metabolic syndrome x
5537026|NCT01138423|Adiposity|adiposity
5537027|NCT01138423|Clinical trial|clinical trial
5537028|NCT01138410|Immunotherapy|immunotherapy
5537029|NCT01138410|Melanoma|melanoma
5537030|NCT01138410|Gene therapy|gene therapy
5537031|NCT01138410|DNA plasmid|dna plasmid
5537032|NCT01138410|Cancer vaccine|cancer vaccine
5537033|NCT01138410|Electroporation|electroporation
5537034|NCT01138410|CTL response|ctl response
5537035|NCT01138397|Influenza|influenza
5537036|NCT01138397|Influenza vaccine|influenza vaccine
5537037|NCT01138397|Influenza virus|influenza virus
5537038|NCT01138397|Intradermal|intradermal
5537039|NCT01138384|Breast Cancer|breast cancer
5537040|NCT01138371|LDL apheresis|ldl apheresis
5537041|NCT01138371|Familial hypercholesterolemia|familial hypercholesterolemia
5537042|NCT01138371|Inflammatory markers|inflammatory markers
5537043|NCT01138371|Hyperlipidemia|hyperlipidemia
5537044|NCT01138371|Cardiovascular disease|cardiovascular disease
5537046|NCT01138358|lung metastases|lung metastases
5537047|NCT01138358|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5537048|NCT01138358|recurrent small cell lung cancer|recurrent small cell lung cancer
5537049|NCT01138358|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5537050|NCT01138358|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5537051|NCT01138358|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5537052|NCT01138358|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5537053|NCT01138345|cancer survivor|cancer survivor
5537054|NCT01138345|stage I breast cancer|stage i breast cancer
5537055|NCT01138345|stage II breast cancer|stage ii breast cancer
5537056|NCT01138345|stage IIIA breast cancer|stage iiia breast cancer
5537057|NCT01138345|stage IIIB breast cancer|stage iiib breast cancer
5537058|NCT01138345|stage IIIC breast cancer|stage iiic breast cancer
5537142|NCT01138085|Oncology|oncology
5537143|NCT01138085|GSK2141795|gsk2141795
5537059|NCT01138332|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5537060|NCT01138319|adult acute myeloid leukemia|adult acute myeloid leukemia
5537061|NCT01138319|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5537062|NCT01138306|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5537063|NCT01138293|differences between patients´ self-assessment and objective perception of physical activity and eating habits|differences between patients´ self-assessment and objective perception of physical activity and eating habits
5537064|NCT01138280|biofilm formation|biofilm formation
5537065|NCT01138280|proinflammatory cytokines|proinflammatory cytokines
5537066|NCT01138280|high sensitive c reactive protein|high sensitive c reactive protein
5537067|NCT01138280|cardiovascular events|cardiovascular events
5537068|NCT01138280|overall mortality|overall mortality
5537069|NCT01138280|hemodialysis|hemodialysis
5537070|NCT01138267|pharmacogenomics|pharmacogenomics
5537072|NCT01138267|EFV|efv
5537073|NCT01138267|pharmacogenomics of ATV and EFV|pharmacogenomics of atv and efv
5537074|NCT01138254|flow,echocardiography,far infrared therapy,nitric oxide|flow,echocardiography,far infrared therapy,nitric oxide
5537075|NCT01138241|HIV|hiv
5537076|NCT01138241|Chronic kidney disease|chronic kidney disease
5537077|NCT01138241|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
5537078|NCT01138241|Tenofovir|tenofovir
5537079|NCT01138241|Serum creatinine (sCr)|serum creatinine (scr)
5537080|NCT01138241|24 hr urine creatinine clearance|24 hr urine creatinine clearance
5537086|NCT01138241|Validate which renal function assessments can accurately detect GFR and assess the effect of TDF concentration on renal function|validate which renal function assessments can accurately detect gfr and assess the effect of tdf concentration on renal function
5537088|NCT01138228|vein identification|vein identification
5537089|NCT01138228|vascular identification|vascular identification
5537090|NCT01138228|vein cannulation|vein cannulation
5537091|NCT01138215|varicella-zoster virus vaccine|varicella-zoster virus vaccine
5537092|NCT01138215|varicella-zoster virus antibody|varicella-zoster virus antibody
5537094|NCT01138215|safety and efficacy|safety and efficacy
5537095|NCT01138215|HIV-infected children|hiv-infected children
5537096|NCT01138215|Assess protective VZV Antibody|assess protective vzv antibody
5537097|NCT01138215|Adverse events from VZV vaccine|adverse events from vzv vaccine
5537098|NCT01138202|pharmacokinetics|pharmacokinetics
5537100|NCT01138202|efficacy|efficacy
5537101|NCT01138202|Lopinavir/ritonavir|lopinavir/ritonavir
5537102|NCT01138202|HIV/TB|hiv/tb
5537103|NCT01138202|rifampicin containing anti-tuberculosis therapy|rifampicin containing anti-tuberculosis therapy
5537104|NCT01138202|Pharmacokinetics and safety of Lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy|pharmacokinetics and safety of lopinavir/ritonavir with rifampicin containing anti-tuberculosis therapy
5537105|NCT01138189|Wavefront-guided LASIK.|wavefront-guided lasik.
5537106|NCT01138189|Wavefront-optimized LASIK.|wavefront-optimized lasik.
5537107|NCT01138189|Custom LASIK|custom lasik
5537108|NCT01138176|Neonatal encephalopathy|neonatal encephalopathy
5537109|NCT01138176|Therapeutic hypothermia|therapeutic hypothermia
5537110|NCT01138176|Phase changing material|phase changing material
5537111|NCT01138176|MR imaging|mr imaging
5537112|NCT01138163|NSCLC|nsclc
5537114|NCT01138163|lung cancer|lung cancer
5537115|NCT01138163|non small cell lung cancer|non small cell lung cancer
5537116|NCT01138163|bavituximab|bavituximab
5537117|NCT01138163|monoclonal antibody|monoclonal antibody
5537118|NCT01138150|migraine, headache, sumatriptan, naproxen sodium|migraine, headache, sumatriptan, naproxen sodium
5537119|NCT01138137|ovarian cancer|ovarian cancer
5537120|NCT01138137|epithelial ovarian cancer|epithelial ovarian cancer
5537121|NCT01138137|peritoneal cancer|peritoneal cancer
5537122|NCT01138124|renal cell carcinoma|renal cell carcinoma
5537123|NCT01138124|epidemiology|epidemiology
5537124|NCT01138124|pancreatic cancer|pancreatic cancer
5537125|NCT01138124|renal cancer|renal cancer
5537126|NCT01138124|renal pelvis cancer|renal pelvis cancer
5537127|NCT01138124|GPRD|gprd
5537128|NCT01138124|case-control|case-control
5537129|NCT01138124|Gapabentin|gapabentin
5537130|NCT01138111|Florbetaben|florbetaben
5537131|NCT01138111|Amyloid beta-protein|amyloid beta-protein
5537132|NCT01138111|MCI|mci
5537133|NCT01138111|Alzheimer's disease|alzheimer's disease
5537134|NCT01138098|Persistence|persistence
5537135|NCT01138098|challenge dose|challenge dose
5537136|NCT01138098|Engerix-B|engerix-b
5537137|NCT01138098|immune response|immune response
5537138|NCT01138085|Triple negative breast cancer|triple negative breast cancer
5537139|NCT01138085|BRAF wild-type melanoma|braf wild-type melanoma
5537140|NCT01138085|Solid tumors|solid tumors
5537141|NCT01138085|Endometrial Cancer|endometrial cancer
5537144|NCT01138085|AKT Inhibitor|akt inhibitor
5537145|NCT01138085|GSK1120212|gsk1120212
5537146|NCT01138072|GSK2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics|gsk2248761, atorvastatin, rosuvastatin, simvastatin, drug interaction, pharmacokinetics
5537147|NCT01138059|Acute ischemic stroke with unclear onset time|acute ischemic stroke with unclear onset time
5537148|NCT01138046|advanced/metastatic breast cancer|advanced/metastatic breast cancer
5537149|NCT01138046|lapatinib|lapatinib
5537151|NCT01138046|ErbB2-overexpressing|erbb2-overexpressing
5537152|NCT01138046|pharmacokinetics|pharmacokinetics
5537153|NCT01138046|dual kinase inhibitor|dual kinase inhibitor
5537154|NCT01138046|HER-2/neu|her-2/neu
5537155|NCT01138046|EGFR|egfr
5537156|NCT01138046|ErbB1|erbb1
5537157|NCT01138033|pharmacodynamics|pharmacodynamics
5537158|NCT01138033|cancer|cancer
5537159|NCT01138033|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
5508109|NCT01261598|SUV|suv
5537160|NCT01138033|pharmacokinetics|pharmacokinetics
5537161|NCT01138033|solid tumors|solid tumors
5537162|NCT01138033|Phase 1|phase 1
5537163|NCT01138020|Rehabilitation Outcome|rehabilitation outcome
5537164|NCT01138020|Cognitive treatment|cognitive treatment
5537166|NCT01138007|Bupropion|bupropion
5537167|NCT01138007|323U66 Sustained Release (SR)|323u66 sustained release (sr)
5537168|NCT01138007|MDD (Major Depressive Disorder)|mdd (major depressive disorder)
5537169|NCT01138007|IVRS HAM-D|ivrs ham-d
5537170|NCT01138007|IDS-SR|ids-sr
5537171|NCT01138007|MADRS|madrs
5537172|NCT01137994|ErbB2|erbb2
5537173|NCT01137994|Trastuzumab|trastuzumab
5537174|NCT01137994|p95HER2|p95her2
5537175|NCT01137994|Metastatic Breast Cancer|metastatic breast cancer
5537176|NCT01137994|HER2|her2
5537177|NCT01137994|Lapatinib|lapatinib
5537178|NCT01137981|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
5537179|NCT01137981|Antiretrovirals|antiretrovirals
5537180|NCT01137981|ARV|arv
5537181|NCT01137981|HAART|haart
5537182|NCT01137981|Maraviroc|maraviroc
5537183|NCT01137981|Delavirdine|delavirdine
5537184|NCT01137981|Lamivudine|lamivudine
5537185|NCT01137981|Antiretroviral Pregnancy Registry|antiretroviral pregnancy registry
5537186|NCT01137981|Fosamprenavir|fosamprenavir
5537187|NCT01137981|APR|apr
5537188|NCT01137981|Zidovudine|zidovudine
5537189|NCT01137981|pregnancy registry|pregnancy registry
5537190|NCT01137981|Amprenavir|amprenavir
5537191|NCT01137981|HIV|hiv
5537192|NCT01137981|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
5537193|NCT01137981|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
5537194|NCT01137968|imetelstat|imetelstat
5537195|NCT01137968|imetelstat sodium|imetelstat sodium
5537196|NCT01137968|GRN163L|grn163l
5537197|NCT01137968|telomerase inhibitor|telomerase inhibitor
5537198|NCT01137968|telomerase inhibition|telomerase inhibition
5537199|NCT01137968|maintenance therapy|maintenance therapy
5537200|NCT01137968|non-small cell lung cancer|non-small cell lung cancer
5537201|NCT01137968|relapsed non-small cell lung cancer|relapsed non-small cell lung cancer
5537202|NCT01137968|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5537203|NCT01137968|NSCLC, cancer stem cells|nsclc, cancer stem cells
5537204|NCT01137968|Bevacizumab|bevacizumab
5537205|NCT01137968|post induction chemotherapy|post induction chemotherapy
5537206|NCT01137955|Gastrointestinal Symptom Rating Scale (GSRS)|gastrointestinal symptom rating scale (gsrs)
5537207|NCT01137955|Poorly responsive|poorly responsive
5537208|NCT01137955|Refractory|refractory
5537209|NCT01137955|Small intestine bacterial overgrowth|small intestine bacterial overgrowth
5537210|NCT01137955|Breath test|breath test
5537211|NCT01137942|helicobacter pylori|helicobacter pylori
5537212|NCT01137942|eradication failure|eradication failure
5537213|NCT01137929|Vesicoureteral reflux|vesicoureteral reflux
5537214|NCT01137929|Kidney|kidney
5537215|NCT01137929|Renal Scar|renal scar
5537216|NCT01137929|Urinary tract infection|urinary tract infection
5537217|NCT01137903|Diabetic foot|diabetic foot
5537218|NCT01137903|Osteomyelitis|osteomyelitis
5537219|NCT01137903|Diabetic foot ulcers|diabetic foot ulcers
5537220|NCT01137903|Foot infections|foot infections
5537221|NCT01137890|cocaine|cocaine
5537222|NCT01137890|addiction|addiction
5537223|NCT01137890|drug dependence|drug dependence
5537224|NCT01137890|anticonvulsant|anticonvulsant
5537225|NCT01137890|zonisamide|zonisamide
5537226|NCT01137890|drug self-administration|drug self-administration
5537227|NCT01137890|nicotine withdrawal|nicotine withdrawal
5537228|NCT01137890|neurocognition|neurocognition
5537229|NCT01137864|Emergency wards|emergency wards
5537230|NCT01137864|Hospitalization|hospitalization
5537231|NCT01137864|Adults|adults
5537232|NCT01137864|Antimicrobial therapy|antimicrobial therapy
5537233|NCT01137825|cognitive/functional effects|cognitive/functional effects
5537234|NCT01137825|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5519442|NCT01211405|Veterans|veterans
5537235|NCT01137825|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5537236|NCT01137825|acute undifferentiated leukemia|acute undifferentiated leukemia
5537237|NCT01137825|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5537238|NCT01137825|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5537239|NCT01137825|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5537240|NCT01137825|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5537241|NCT01137825|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5537242|NCT01137825|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5537243|NCT01137825|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5537244|NCT01137825|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5537245|NCT01137825|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5537246|NCT01137825|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5537247|NCT01137825|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5508180|NCT01261299|Carboplatin|carboplatin
5537248|NCT01137825|mast cell leukemia|mast cell leukemia
5537249|NCT01137825|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5531448|NCT01161810|Burn|burn
5789062|NCT00150098|substance use|substance use
5537250|NCT01137825|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5537251|NCT01137825|prolymphocytic leukemia|prolymphocytic leukemia
5537252|NCT01137825|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5537253|NCT01137825|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5537254|NCT01137825|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5537255|NCT01137825|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5537256|NCT01137825|refractory hairy cell leukemia|refractory hairy cell leukemia
5537257|NCT01137825|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5537258|NCT01137825|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5537259|NCT01137825|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5537260|NCT01137825|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5537261|NCT01137825|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5537262|NCT01137825|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5537263|NCT01137825|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5537264|NCT01137825|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5537265|NCT01137825|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5537266|NCT01137825|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5537267|NCT01137825|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5537268|NCT01137825|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5537269|NCT01137825|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5537270|NCT01137825|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5537271|NCT01137825|untreated hairy cell leukemia|untreated hairy cell leukemia
5537272|NCT01137825|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5537273|NCT01137825|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5537274|NCT01137825|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5537275|NCT01137825|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5537276|NCT01137825|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5537277|NCT01137825|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5537278|NCT01137825|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5537279|NCT01137825|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5537280|NCT01137825|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5537281|NCT01137825|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5537282|NCT01137825|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5537283|NCT01137825|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5537284|NCT01137825|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5537285|NCT01137825|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5537286|NCT01137825|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5537287|NCT01137825|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5537288|NCT01137825|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5537289|NCT01137825|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5537290|NCT01137825|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5537291|NCT01137825|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5537292|NCT01137825|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5537293|NCT01137825|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5537294|NCT01137825|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5537295|NCT01137825|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5537296|NCT01137825|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5537297|NCT01137825|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5537298|NCT01137825|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5537299|NCT01137825|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5537300|NCT01137825|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5537301|NCT01137825|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5537302|NCT01137825|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5537303|NCT01137825|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5537304|NCT01137825|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5537305|NCT01137825|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5537306|NCT01137825|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5537307|NCT01137825|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5537308|NCT01137825|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5537309|NCT01137825|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5537310|NCT01137825|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5537311|NCT01137825|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5537312|NCT01137825|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5537313|NCT01137825|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5537314|NCT01137825|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5537315|NCT01137825|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5537316|NCT01137825|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5537317|NCT01137825|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5537318|NCT01137825|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5537319|NCT01137825|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5537320|NCT01137825|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5537321|NCT01137825|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5537322|NCT01137825|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5537323|NCT01137825|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5537324|NCT01137825|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5537325|NCT01137825|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5537326|NCT01137825|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5537327|NCT01137825|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5537328|NCT01137825|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5537329|NCT01137825|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5537330|NCT01137825|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5537331|NCT01137825|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5537332|NCT01137825|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5537333|NCT01137825|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5537334|NCT01137825|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5537335|NCT01137825|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5537336|NCT01137825|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5537337|NCT01137825|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5537338|NCT01137825|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5537339|NCT01137825|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5537340|NCT01137825|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5537341|NCT01137825|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5537342|NCT01137825|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5537343|NCT01137825|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5537344|NCT01137825|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5537345|NCT01137825|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5537346|NCT01137825|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5537347|NCT01137825|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5537348|NCT01137825|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5537349|NCT01137825|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5537350|NCT01137825|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5537351|NCT01137825|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5537352|NCT01137825|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5537353|NCT01137825|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5537354|NCT01137825|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5537355|NCT01137825|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5537356|NCT01137825|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5537357|NCT01137825|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5537358|NCT01137825|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5537359|NCT01137825|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5537360|NCT01137825|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5537361|NCT01137825|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5537362|NCT01137825|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5537363|NCT01137825|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5537364|NCT01137825|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5685366|NCT00556413|recurrent rectal cancer|recurrent rectal cancer
5537365|NCT01137825|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5537366|NCT01137825|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5537367|NCT01137825|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5537368|NCT01137825|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5537369|NCT01137825|intraocular lymphoma|intraocular lymphoma
5537370|NCT01137825|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5537373|NCT01137825|primary myelofibrosis|primary myelofibrosis
5537374|NCT01137825|essential thrombocythemia|essential thrombocythemia
5537376|NCT01137825|extramedullary plasmacytoma|extramedullary plasmacytoma
5537377|NCT01137825|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5537378|NCT01137825|stage I multiple myeloma|stage i multiple myeloma
5537379|NCT01137825|stage II multiple myeloma|stage ii multiple myeloma
5537380|NCT01137825|stage III multiple myeloma|stage iii multiple myeloma
5537381|NCT01137825|primary systemic amyloidosis|primary systemic amyloidosis
5537382|NCT01137825|refractory multiple myeloma|refractory multiple myeloma
5537383|NCT01137825|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5537384|NCT01137825|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5537385|NCT01137825|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5537386|NCT01137825|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5537388|NCT01137812|Sitagliptin (Januvia)|sitagliptin (januvia)
5537390|NCT01137812|Sulphonylurea|sulphonylurea
5537391|NCT01137812|Hemoglobin A1c|hemoglobin a1c
5537392|NCT01137812|Type 2 diabetes mellitus|type 2 diabetes mellitus
5537393|NCT01137799|symptomatic treatment|symptomatic treatment
5537394|NCT01137799|cognition|cognition
5537395|NCT01137799|cognitive deficits|cognitive deficits
5537396|NCT01137799|schizophrenia|schizophrenia
5537397|NCT01137799|Alzheimer's Disease|alzheimer's disease
5537398|NCT01137773|SAH (Subarachnoid Hemorrhage)|sah (subarachnoid hemorrhage)
5537399|NCT01137773|Brain Hemorrhage|brain hemorrhage
5537400|NCT01137773|Traumatic Brain Injury|traumatic brain injury
5537402|NCT01137773|ICH|ich
5537403|NCT01137760|adults|adults
5537404|NCT01137760|fiber|fiber
5537405|NCT01137760|cold|cold
5537406|NCT01137760|flu|flu
5537407|NCT01137760|stress|stress
5537408|NCT01137760|microbiota|microbiota
5537409|NCT01137747|carfilzomib|carfilzomib
5537410|NCT01137747|acute myeloid leukemia|acute myeloid leukemia
5537411|NCT01137747|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5537412|NCT01137747|phase I|phase i
5537413|NCT01137734|Heart Diseases|heart diseases
5537414|NCT01137734|Heart Valve Diseases|heart valve diseases
5537415|NCT01137734|Cardiovascular Diseases|cardiovascular diseases
5537416|NCT01137721|magnetic resonance imaging|magnetic resonance imaging
5537417|NCT01137721|sickle cell disease|sickle cell disease
5537418|NCT01137721|hydroxyurea therapy|hydroxyurea therapy
5537419|NCT01137708|drug interactions|drug interactions
5537420|NCT01137708|CYP3A|cyp3a
5537421|NCT01137708|oral contraceptive|oral contraceptive
5537422|NCT01137708|anti-rheumatic agents|anti-rheumatic agents
5537424|NCT01137695|glucose|glucose
5537425|NCT01137695|type 2 diabetes mellitus|type 2 diabetes mellitus
5537426|NCT01137695|amylin|amylin
5537427|NCT01137682|Acromegaly|acromegaly
5537428|NCT01137682|hormone disorder|hormone disorder
5537429|NCT01137682|growth hormone|growth hormone
5537430|NCT01137682|insulin like growth factor-1|insulin like growth factor-1
5537431|NCT01137682|pituitary tumor|pituitary tumor
5537432|NCT01137682|pasireotide|pasireotide
5537433|NCT01137682|SOM230|som230
5537434|NCT01137669|immunocompromised,parent protocol,shingles,varicella-zoster virus,ZOSTAVAX®|immunocompromised,parent protocol,shingles,varicella-zoster virus,zostavax®
5537435|NCT01137656|Blood storage|blood storage
5537436|NCT01137656|Blood transfusion|blood transfusion
5537437|NCT01137656|Aged blood|aged blood
5537438|NCT01137656|Blood Forearm|blood forearm
5537439|NCT01137656|Storage lesion in blood|storage lesion in blood
5537440|NCT01137643|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5537441|NCT01137643|acute undifferentiated leukemia|acute undifferentiated leukemia
5537442|NCT01137643|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5537443|NCT01137643|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5537444|NCT01137643|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5537445|NCT01137643|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5537446|NCT01137643|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5537447|NCT01137643|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5537448|NCT01137643|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5537449|NCT01137643|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5537450|NCT01137643|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5537451|NCT01137643|mast cell leukemia|mast cell leukemia
5537452|NCT01137643|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5685367|NCT00556400|Uterine Bleeding|uterine bleeding
5508541|NCT01259713|ALL|all
5523908|NCT01192737|A/H1N1|a/h1n1
5537453|NCT01137643|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5537454|NCT01137643|prolymphocytic leukemia|prolymphocytic leukemia
5531753|NCT01160562|Incidence|incidence
5537457|NCT01137643|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5537458|NCT01137643|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5537459|NCT01137643|refractory hairy cell leukemia|refractory hairy cell leukemia
5537460|NCT01137643|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5537461|NCT01137643|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5537462|NCT01137643|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5537463|NCT01137643|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5537464|NCT01137643|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5537465|NCT01137643|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5537466|NCT01137643|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5537467|NCT01137643|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5537468|NCT01137643|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5537469|NCT01137643|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5537470|NCT01137643|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5537471|NCT01137643|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5537472|NCT01137643|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5537473|NCT01137643|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5537474|NCT01137643|untreated hairy cell leukemia|untreated hairy cell leukemia
5904046|NCT00007813|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5537475|NCT01137643|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5537476|NCT01137643|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5537477|NCT01137643|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5537478|NCT01137643|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5537479|NCT01137643|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5537480|NCT01137643|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5537481|NCT01137643|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5537482|NCT01137643|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5537483|NCT01137643|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5537484|NCT01137643|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5537485|NCT01137643|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5537486|NCT01137643|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5537487|NCT01137643|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5537488|NCT01137643|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5537489|NCT01137643|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5537490|NCT01137643|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5537491|NCT01137643|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5537492|NCT01137643|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5537493|NCT01137643|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5537494|NCT01137643|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5537495|NCT01137643|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5537496|NCT01137643|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5537497|NCT01137643|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5537498|NCT01137643|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5537499|NCT01137643|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5537500|NCT01137643|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5519830|NCT01209624|long-term|long-term
5519833|NCT01209598|10-094|10-094
5537501|NCT01137643|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5537502|NCT01137643|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5537503|NCT01137643|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5537504|NCT01137643|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5537505|NCT01137643|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5537506|NCT01137643|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5537507|NCT01137643|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5537508|NCT01137643|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5537509|NCT01137643|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5537572|NCT01137643|intraocular lymphoma|intraocular lymphoma
5537510|NCT01137643|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5531862|NCT01160146|Obestiy|obestiy
5537511|NCT01137643|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5537512|NCT01137643|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5537513|NCT01137643|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5537514|NCT01137643|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5537515|NCT01137643|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5537516|NCT01137643|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5537517|NCT01137643|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5537518|NCT01137643|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5537519|NCT01137643|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5537520|NCT01137643|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5537521|NCT01137643|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5537522|NCT01137643|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5537523|NCT01137643|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5537524|NCT01137643|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5537525|NCT01137643|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5537526|NCT01137643|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5537527|NCT01137643|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5537528|NCT01137643|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5537529|NCT01137643|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5537530|NCT01137643|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5537531|NCT01137643|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5537532|NCT01137643|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5537533|NCT01137643|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5537534|NCT01137643|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5537535|NCT01137643|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5537536|NCT01137643|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5537537|NCT01137643|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5537538|NCT01137643|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5537539|NCT01137643|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5537540|NCT01137643|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5537541|NCT01137643|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5537542|NCT01137643|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5537543|NCT01137643|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5537544|NCT01137643|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5537545|NCT01137643|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5537546|NCT01137643|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5537547|NCT01137643|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5537548|NCT01137643|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5537549|NCT01137643|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5537550|NCT01137643|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5537551|NCT01137643|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5537552|NCT01137643|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5537553|NCT01137643|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5537554|NCT01137643|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5537555|NCT01137643|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5537556|NCT01137643|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5537557|NCT01137643|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5537558|NCT01137643|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5537559|NCT01137643|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5537560|NCT01137643|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5537561|NCT01137643|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5537562|NCT01137643|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5537563|NCT01137643|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5537564|NCT01137643|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5537565|NCT01137643|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5537566|NCT01137643|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5537567|NCT01137643|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5537568|NCT01137643|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5537569|NCT01137643|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5537570|NCT01137643|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5508665|NCT01259271|nerve|nerve
5537571|NCT01137643|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5537573|NCT01137643|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5537574|NCT01137643|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5537575|NCT01137643|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5537576|NCT01137643|primary myelofibrosis|primary myelofibrosis
5537577|NCT01137643|essential thrombocythemia|essential thrombocythemia
5537578|NCT01137643|polycythemia vera|polycythemia vera
5537579|NCT01137643|extramedullary plasmacytoma|extramedullary plasmacytoma
5537580|NCT01137643|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5537581|NCT01137643|stage I multiple myeloma|stage i multiple myeloma
5537582|NCT01137643|stage II multiple myeloma|stage ii multiple myeloma
5537583|NCT01137643|stage III multiple myeloma|stage iii multiple myeloma
5537584|NCT01137643|primary systemic amyloidosis|primary systemic amyloidosis
5537585|NCT01137643|refractory multiple myeloma|refractory multiple myeloma
5537586|NCT01137643|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5537587|NCT01137643|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5537588|NCT01137643|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5537589|NCT01137643|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5537591|NCT01137630|seborrhoeic dermatitis|seborrhoeic dermatitis
5537593|NCT01137630|K40a|k40a
5537594|NCT01137630|K40b|k40b
5537595|NCT01137617|spinal cord stimualtor|spinal cord stimualtor
5537596|NCT01137591|Acetaminophen|acetaminophen
5537597|NCT01137591|Acetylcysteine|acetylcysteine
5537598|NCT01137591|Antidotes|antidotes
5537599|NCT01137565|Amgen|amgen
5537600|NCT01137565|Adolescent|adolescent
5537601|NCT01137565|Safety|safety
5537602|NCT01137552|First-In-Human|first-in-human
5537603|NCT01137552|Dose Escalation|dose escalation
5537604|NCT01137552|Dose Expansion|dose expansion
5537605|NCT01137552|Advance Solid Tumors|advance solid tumors
5537606|NCT01137552|Anti-Angiopoietin|anti-angiopoietin
5537607|NCT01137552|Advance Malignancy|advance malignancy
5537608|NCT01137552|Cancer|cancer
5537609|NCT01137552|Oncology|oncology
5537610|NCT01137552|Oncology Patients|oncology patients
5537611|NCT01137552|Phase 1|phase 1
5537612|NCT01137552|Clinical Trial|clinical trial
5537613|NCT01137552|Tumors|tumors
5537614|NCT01137552|Solid Tumors|solid tumors
5537615|NCT01137552|Angiogenesis Inhibitors|angiogenesis inhibitors
5537616|NCT01137539|urinary incontinence|urinary incontinence
5537617|NCT01137539|stress urinary incontinence|stress urinary incontinence
5537618|NCT01137539|mid-urethral slings|mid-urethral slings
5537619|NCT01137539|Tension-free vaginal taping|tension-free vaginal taping
5537621|NCT01137513|Chest Pain|chest pain
5537622|NCT01137513|Acute coronary syndrome|acute coronary syndrome
5537623|NCT01137513|AMI|ami
5537624|NCT01137487|mechanical ventilation|mechanical ventilation
5537625|NCT01137487|enteral nutrition|enteral nutrition
5537626|NCT01137487|Ventilation-Associated Pneumonia|ventilation-associated pneumonia
5537627|NCT01137487|residual gastric volume measurement|residual gastric volume measurement
5537628|NCT01137487|vomiting|vomiting
5537629|NCT01137487|gastro-oesophageal reflux|gastro-oesophageal reflux
5537630|NCT01137487|early enteral nutrition|early enteral nutrition
5537631|NCT01137487|Intensive care unit|intensive care unit
5537632|NCT01137487|Enteral Feeding|enteral feeding
5537633|NCT01137474|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5537634|NCT01137474|Diabetes Mellitus|diabetes mellitus
5537635|NCT01137474|Endocrine System Diseases|endocrine system diseases
5537636|NCT01137474|Glucose Metabolism Disorders|glucose metabolism disorders
5537637|NCT01137474|Metabolic Diseases|metabolic diseases
5537638|NCT01137474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists
5537639|NCT01137474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5537640|NCT01137474|Hypoglycemic Agents|hypoglycemic agents
5537641|NCT01137474|Pharmacologic Actions|pharmacologic actions
5537642|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs
5520027|NCT01208831|smoothened inhibitor|smoothened inhibitor
5537643|NCT01137461|Female infertility with indication of oocyte reception|female infertility with indication of oocyte reception
5537644|NCT01137448|Psoriasis|psoriasis
5537645|NCT01137448|Obesity|obesity
5537646|NCT01137435|Adacel|adacel
5537647|NCT01137435|Diphtheria|diphtheria
5537648|NCT01137435|Tetanus|tetanus
5537649|NCT01137435|Pertussis|pertussis
5537650|NCT01137383|Hepatitis C|hepatitis c
5537651|NCT01137331|seborrhoeic eczema|seborrhoeic eczema
5537652|NCT01137331|scalp|scalp
5537653|NCT01137331|dandruff|dandruff
5537654|NCT01137331|K301|k301
5537655|NCT01137331|K40|k40
5537656|NCT01137318|ADHD|adhd
5537657|NCT01137318|Impairment|impairment
5537658|NCT01137318|Treatment|treatment
5537659|NCT01137318|Cognitive Remediation|cognitive remediation
5537660|NCT01137318|Behavioral Parent Training|behavioral parent training
5537661|NCT01137305|Virtual reality|virtual reality
5537662|NCT01137305|surgical training|surgical training
5537663|NCT01137305|Health Care [N]|health care [n]
5537664|NCT01137292|observational study|observational study
5537665|NCT01137292|voriconazole|voriconazole
5537666|NCT01137292|high-risk patients|high-risk patients
5537965|NCT01135771|diabetes|diabetes
5532048|NCT01159236|5-FU|5-fu
5537667|NCT01137266|chronic pain osteo-arthritis in one or both knees, adults|chronic pain osteo-arthritis in one or both knees, adults
5537668|NCT01137253|Nitric Oxide|nitric oxide
5537669|NCT01137253|Autonomic Nervous System|autonomic nervous system
5537670|NCT01137240|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study|subjects suffering from mitochondrial disorders with one or more gastrointestinal symptoms would be the focus of the study
5537671|NCT01137227|Physical activity|physical activity
5537672|NCT01137227|Epidemiology|epidemiology
5537673|NCT01137227|Questionnaire|questionnaire
5537674|NCT01137227|Cross-sectional study|cross-sectional study
5537675|NCT01137214|complex sleep apnea|complex sleep apnea
5537676|NCT01137201|Small bowel obstruction|small bowel obstruction
5537677|NCT01137201|Laparoscopic gastric bypass|laparoscopic gastric bypass
5537678|NCT01137201|Internal Hernia|internal hernia
5537679|NCT01137201|Mesenteric defect|mesenteric defect
5537680|NCT01137201|Morbid obesity|morbid obesity
5537681|NCT01137175|Rickettsioses|rickettsioses
5537682|NCT01137175|Scrub Typhus|scrub typhus
5537684|NCT01137175|Typhus fever|typhus fever
5537685|NCT01137175|Spotted fever|spotted fever
5537686|NCT01137175|Rickettsioses reported cases|rickettsioses reported cases
5537687|NCT01137149|Adolescent Depression|adolescent depression
5537688|NCT01137149|Treatment of depression in adolescents|treatment of depression in adolescents
5537689|NCT01137149|Behavioral activation treatment for depressed adolescents|behavioral activation treatment for depressed adolescents
5537690|NCT01137123|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5537691|NCT01137110|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5537692|NCT01137110|Seizure Prophylaxis|seizure prophylaxis
5537693|NCT01137110|Levetiracetam|levetiracetam
5537694|NCT01137045|rabies vaccine|rabies vaccine
5537695|NCT01137045|vero cells|vero cells
5537696|NCT01137045|serology|serology
5537697|NCT01137045|safety|safety
5537698|NCT01137032|Psoriasis|psoriasis
5537699|NCT01137032|Atopic Dermatitis|atopic dermatitis
5537700|NCT01137019|Drug-eluting stents|drug-eluting stents
5537701|NCT01137019|Tomography, Optical Coherence|tomography, optical coherence
5537702|NCT01137006|Melanoma|melanoma
5537703|NCT01137006|Phase I|phase i
5537704|NCT01137006|antibody|antibody
5537705|NCT01137006|melanin|melanin
5537706|NCT01137006|tyrosinase related protein 1|tyrosinase related protein 1
5537707|NCT01137006|glycoprotein|glycoprotein
5537708|NCT01137006|20D7S|20d7s
5537709|NCT01136993|Stroke|stroke
5537710|NCT01136993|Thrombolysis|thrombolysis
5537711|NCT01136993|Telestroke|telestroke
5537712|NCT01136980|GERD|gerd
5537713|NCT01136980|Esophagitis|esophagitis
5537714|NCT01136980|Fundoplication|fundoplication
5537715|NCT01136980|Anti-reflux surgery|anti-reflux surgery
5537716|NCT01136980|PPI dependent|ppi dependent
5537717|NCT01136928|Antiretroviral therapy|antiretroviral therapy
5537718|NCT01136928|American ginseng|american ginseng
5537719|NCT01136928|Efavirenz|efavirenz
5537720|NCT01136928|Cytochrome P450 enzymes|cytochrome p450 enzymes
5537721|NCT01136928|Complementary and Alternative Medicine|complementary and alternative medicine
5537722|NCT01136928|Herbal|herbal
5537723|NCT01136928|Pharmacikinetics|pharmacikinetics
5537724|NCT01136928|Healthy volunteers|healthy volunteers
5537725|NCT01136902|Diabetes Mellitus|diabetes mellitus
5537726|NCT01136902|Retinal Vessels|retinal vessels
5537727|NCT01136902|Physiology|physiology
5537728|NCT01136889|PFMT|pfmt
5537729|NCT01136889|Vaginal pessary|vaginal pessary
5537730|NCT01136889|Pelvic Organ Prolapse|pelvic organ prolapse
5537731|NCT01136863|hypertension|hypertension
5537732|NCT01136863|felodipine|felodipine
5537733|NCT01136863|moderate to high risk patients|moderate to high risk patients
5537734|NCT01136850|Plasmodium falciparum|plasmodium falciparum
5537735|NCT01136850|Plasmodium vivax|plasmodium vivax
5537736|NCT01136850|azithromycin|azithromycin
5537737|NCT01136850|sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
5537738|NCT01136850|low birth weight|low birth weight
5537739|NCT01136850|haemoglobin|haemoglobin
5537740|NCT01136850|Chlamydia trachomatis|chlamydia trachomatis
5537741|NCT01136850|Neisseria gonorrhoeae|neisseria gonorrhoeae
5537742|NCT01136850|Treponema pallidum|treponema pallidum
5537743|NCT01136824|Sarcoma|sarcoma
5537744|NCT01136824|questionnaire|questionnaire
5537745|NCT01136824|doxorubicin plus ifosfamide (AI)|doxorubicin plus ifosfamide (ai)
5537746|NCT01136798|slow wave sleep|slow wave sleep
5537747|NCT01136798|exenatide and sleep|exenatide and sleep
5537748|NCT01136759|Prevention|prevention
5537749|NCT01136759|Microbicide|microbicide
5537750|NCT01136759|Mother-to-Child-Transmission|mother-to-child-transmission
5537751|NCT01136759|Pregnancy|pregnancy
5537752|NCT01136746|Hyperglycemia|hyperglycemia
5537753|NCT01136746|Diabetes|diabetes
5537754|NCT01136746|Hospital|hospital
5537755|NCT01136746|Diabetic|diabetic
5537756|NCT01136733|Unresectable advanced or metastatic renal cell carcinoma|unresectable advanced or metastatic renal cell carcinoma
5537757|NCT01136681|Anonymised Electronic Cohort|anonymised electronic cohort
5537758|NCT01136681|Record Linkage|record linkage
5537759|NCT01136681|Routine Data|routine data
5537760|NCT01136681|Environment|environment
5537761|NCT01136681|Childhood Obesity|childhood obesity
5537762|NCT01136681|Low birth weight|low birth weight
5537764|NCT01136668|pediatrics|pediatrics
5537765|NCT01136668|Transversus Abdominis Plane Block|transversus abdominis plane block
5537766|NCT01136668|Ostomy Surgery|ostomy surgery
5537767|NCT01136668|Anesthesia|anesthesia
5537768|NCT01136668|Regional Anesthetic|regional anesthetic
5537769|NCT01136655|asthmatic children|asthmatic children
5537770|NCT01136655|Symbicort|symbicort
5537771|NCT01136655|Foradil|foradil
5537772|NCT01136642|Nicotine|nicotine
5537773|NCT01136642|Nicotine Nasal Spray|nicotine nasal spray
5537774|NCT01136642|Attention|attention
5537775|NCT01136642|Smoking|smoking
5537776|NCT01136629|Hyper-pigmented spots|hyper-pigmented spots
5537777|NCT01136629|Lentigines|lentigines
5537778|NCT01136629|Mealsma|mealsma
5537779|NCT01136629|RNA extraction|rna extraction
5537780|NCT01136629|Isolation of Keratinocytes|isolation of keratinocytes
5537781|NCT01136629|Isolation of Melanocytes|isolation of melanocytes
5537782|NCT01136616|Nasal fracture|nasal fracture
5537783|NCT01136616|Nasal buttresses|nasal buttresses
5537784|NCT01136616|Septal deviation|septal deviation
5537785|NCT01136616|Nasal morphology|nasal morphology
5537786|NCT01136616|CT Scan|ct scan
5537787|NCT01136603|Abdominal wall defects|abdominal wall defects
5537788|NCT01136603|Inflammation reactions|inflammation reactions
5537789|NCT01136603|Amount of tissue ingrowth|amount of tissue ingrowth
5537790|NCT01136603|Adhesion formation|adhesion formation
5537791|NCT01136603|Shrinkage profiles of the implant|shrinkage profiles of the implant
5537792|NCT01136590|Spinal deformity correction|spinal deformity correction
5537793|NCT01136590|Surgical bleeding|surgical bleeding
5537794|NCT01136590|Transfusion practice|transfusion practice
5537795|NCT01136590|Spinal Fusion|spinal fusion
5537796|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents
5537797|NCT01136590|Hemorrhage|hemorrhage
5537798|NCT01136590|Blood Transfusion|blood transfusion
5537799|NCT01136577|Jaundice|jaundice
5537800|NCT01136577|Hyperbilirubinemia|hyperbilirubinemia
5537801|NCT01136577|Phototherapy|phototherapy
5537802|NCT01136577|term newborn|term newborn
5537804|NCT01136577|Fluorescent lamps|fluorescent lamps
5537805|NCT01136564|paricalcitol|paricalcitol
5537806|NCT01136564|vitamin d|vitamin d
5537807|NCT01136564|kidney disease|kidney disease
5537808|NCT01136564|renin|renin
5537809|NCT01136564|proteinuria|proteinuria
5537810|NCT01136551|Pharmacokinetic profile of controlled release formulation of Huperzine A|pharmacokinetic profile of controlled release formulation of huperzine a
5537811|NCT01136551|Bioequivalence of Huperzine A IR formulation and CR formulation|bioequivalence of huperzine a ir formulation and cr formulation
5537812|NCT01136538|Bioequivalence|bioequivalence
5537813|NCT01136538|Crossover|crossover
5537814|NCT01136538|Valacyclovir Hydrochloride|valacyclovir hydrochloride
5537815|NCT01136525|Bioequivalence|bioequivalence
5537816|NCT01136525|Crossover|crossover
5537817|NCT01136525|Valacyclovir Hydrochloride|valacyclovir hydrochloride
5537818|NCT01136512|metformin|metformin
5537819|NCT01136512|vitamin B12|vitamin b12
5537820|NCT01136512|type 2 diabetes|type 2 diabetes
5537821|NCT01136512|methylmalonic acid|methylmalonic acid
5537822|NCT01136512|deficiency|deficiency
5537824|NCT01136499|Safety|safety
5537825|NCT01136499|Efficacy|efficacy
5537826|NCT01136499|PANOBINOSTAT|panobinostat
5537827|NCT01136486|head trauma; traumatic brain injury|head trauma; traumatic brain injury
5537828|NCT01136473|congenital cataract|congenital cataract
5537829|NCT01136473|aphakic|aphakic
5537830|NCT01136473|pseudophakic glaucoma|pseudophakic glaucoma
5537831|NCT01136473|pediatric patients|pediatric patients
5537832|NCT01136460|Primary congenital glaucoma|primary congenital glaucoma
5537833|NCT01136460|neonatal|neonatal
5537834|NCT01136460|Genotype correlation|genotype correlation
5537835|NCT01136460|Phenotype correlation|phenotype correlation
5537836|NCT01136447|Brachial plexus|brachial plexus
5537837|NCT01136447|Ultrasound|ultrasound
5537838|NCT01136421|COPD exacerbation|copd exacerbation
5537839|NCT01136421|Magnesium sulfate|magnesium sulfate
5537840|NCT01136421|Ipratropium bromide|ipratropium bromide
5537841|NCT01136421|Emergency departement|emergency departement
5537842|NCT01136395|Kidney Transplantation|kidney transplantation
5537843|NCT01136395|Rituximab|rituximab
5537844|NCT01136395|Living Donor|living donor
5537845|NCT01136395|ABO Incompatible (ABOi) Transplantation|abo incompatible (aboi) transplantation
5537846|NCT01136395|Immunology|immunology
5537847|NCT01136395|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5537848|NCT01136395|Epstein Barr virus (EBV)|epstein barr virus (ebv)
5537849|NCT01136395|Polyomavirus|polyomavirus
5537850|NCT01136382|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
5537851|NCT01136369|metastasis|metastasis
5537852|NCT01136369|molecular pathology|molecular pathology
5524414|NCT01190761|Galantamine|galantamine
5537853|NCT01136356|opioid pharmacology|opioid pharmacology
5537854|NCT01136356|buprenorphine|buprenorphine
5537855|NCT01136356|morphine|morphine
5537856|NCT01136356|withdrawal|withdrawal
5537857|NCT01136356|human research|human research
5537858|NCT01136343|women|women
5537859|NCT01136343|middle age|middle age
5537860|NCT01136343|risk factor|risk factor
5537861|NCT01136330|Myotonic dystrophy|myotonic dystrophy
5537863|NCT01136330|Sudden death|sudden death
5537864|NCT01136330|Respiratory failure|respiratory failure
5537865|NCT01136304|Gaucher disease|gaucher disease
5537866|NCT01136304|Imiglucerase|imiglucerase
5537867|NCT01136304|Cerezyme|cerezyme
5537868|NCT01136304|Severity score|severity score
5537869|NCT01136291|pregnancy|pregnancy
5537870|NCT01136291|obesity|obesity
5537871|NCT01136291|physical exercise|physical exercise
5537872|NCT01136291|quality of life|quality of life
5537873|NCT01136278|MDMA|mdma
5537874|NCT01136278|norepinephrine|norepinephrine
5537875|NCT01136278|alpha2 receptor|alpha2 receptor
5537876|NCT01136278|Ecstasy|ecstasy
5537877|NCT01136278|stimulant|stimulant
5537878|NCT01136265|dual-time PET/CT|dual-time pet/ct
5537879|NCT01136265|sentinel node|sentinel node
5537880|NCT01136239|COPD|copd
5537881|NCT01136239|N-acetylcysteine|n-acetylcysteine
5537882|NCT01136239|airtrapping|airtrapping
5537883|NCT01136239|airway resistance|airway resistance
5537884|NCT01136239|antioxidant|antioxidant
5537885|NCT01136226|Prostate Cancer|prostate cancer
5537886|NCT01136200|Surgical and medical wards|surgical and medical wards
5537887|NCT01136200|Adults|adults
5537888|NCT01136200|Antimicrobial therapy|antimicrobial therapy
5537889|NCT01136187|Myocardial infarction|myocardial infarction
5537890|NCT01136187|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5537891|NCT01136187|Radial|radial
5537892|NCT01136187|Bleeding|bleeding
5537893|NCT01136161|LTBI (Latent Tuberculosis Infection)|ltbi (latent tuberculosis infection)
5537894|NCT01136161|TB (Tuberculosis)|tb (tuberculosis)
5537895|NCT01136161|Vaccine|vaccine
5537896|NCT01136148|Mental Health|mental health
5537897|NCT01136148|Aged|aged
5537898|NCT01136148|Hospitals, general|hospitals, general
5537899|NCT01136148|Dementia|dementia
5537900|NCT01136148|Delirium|delirium
5537901|NCT01136148|Dementia and confusion|dementia and confusion
5537902|NCT01136135|Heart transplant rejection|heart transplant rejection
5537903|NCT01136135|cardiac MRI|cardiac mri
5537904|NCT01136135|diagnosis|diagnosis
5537905|NCT01136096|diabetes|diabetes
5537906|NCT01136096|physical activity|physical activity
5537907|NCT01136096|adiponectin|adiponectin
5537908|NCT01136096|metabolic risks|metabolic risks
5537909|NCT01136096|exercise|exercise
5537910|NCT01136096|primary prevention|primary prevention
5537911|NCT01136083|Tumor|tumor
5537912|NCT01136083|Angiogenesis|angiogenesis
5537913|NCT01136083|Exercise training|exercise training
5537914|NCT01136083|VEGF|vegf
5537915|NCT01136083|Myostatin|myostatin
5537916|NCT01136070|Psychological Functioning in Burn Patients|psychological functioning in burn patients
5537917|NCT01136044|tensor fasciae latae|tensor fasciae latae
5537918|NCT01136044|septocutaneous perforators|septocutaneous perforators
5537919|NCT01136031|advanced gastric cancer|advanced gastric cancer
5537920|NCT01136031|1st-line failure|1st-line failure
5537921|NCT01136005|receptor, epidermal growth factor|receptor, epidermal growth factor
5537922|NCT01136005|skin reactions|skin reactions
5537923|NCT01136005|quality of life|quality of life
5537924|NCT01136005|adherence|adherence
5537925|NCT01135966|COPD|copd
5537926|NCT01135966|Whole Body Vibration training|whole body vibration training
5537927|NCT01135966|Conventional resistance training|conventional resistance training
5537928|NCT01135953|Brain excitation|brain excitation
5537929|NCT01135953|transcranial Direct Stimulation|transcranial direct stimulation
5537930|NCT01135953|administration pattern|administration pattern
5537931|NCT01135940|neuromuscular scoliosis|neuromuscular scoliosis
5537932|NCT01135940|dermabond|dermabond
5537933|NCT01135940|infection|infection
5537934|NCT01135940|wound closure|wound closure
5537935|NCT01135914|DME|dme
5537936|NCT01135914|visual impairment|visual impairment
5537937|NCT01135914|diabetes|diabetes
5537938|NCT01135914|macular edema|macular edema
5537939|NCT01135914|diabetic macular edema|diabetic macular edema
5537940|NCT01135914|ranibizumab|ranibizumab
5537941|NCT01135914|laser|laser
5537942|NCT01135914|photocoagulation|photocoagulation
5537943|NCT01135914|retinopathy|retinopathy
5537944|NCT01135914|retina|retina
5537945|NCT01135901|prevention|prevention
5537946|NCT01135901|public health|public health
5537947|NCT01135901|community health services|community health services
5537948|NCT01135901|Norway|norway
5537949|NCT01135888|hypohidrotic ectodermal dysplasia|hypohidrotic ectodermal dysplasia
5537950|NCT01135888|exertional hyperthermia|exertional hyperthermia
5537951|NCT01135888|cooling device|cooling device
5537952|NCT01135875|GBM|gbm
5537953|NCT01135875|Brain Tumor|brain tumor
5509057|NCT01257269|Thrombocytopenia|thrombocytopenia
5537954|NCT01135875|Brain Neoplasm|brain neoplasm
5537955|NCT01135875|Control|control
5537956|NCT01135875|Normal Control|normal control
5537957|NCT01135875|Volunteer|volunteer
5537958|NCT01135836|Shoulder pain|shoulder pain
5537959|NCT01135836|Gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5537960|NCT01135836|Nausea|nausea
5537961|NCT01135836|Vomiting|vomiting
5537962|NCT01135836|Abdominal fullness|abdominal fullness
5537963|NCT01135810|healthy subjects|healthy subjects
5537964|NCT01135771|glucose monitoring|glucose monitoring
5537966|NCT01135771|glucose monitoring in patients with diabetes|glucose monitoring in patients with diabetes
5537967|NCT01135758|depression, ketamine, fMRI|depression, ketamine, fmri
5537968|NCT01135732|late development cholangiocarcinoma|late development cholangiocarcinoma
5537969|NCT01135719|Myopia|myopia
5537970|NCT01135719|Hyperopia|hyperopia
5537971|NCT01135719|Astigmatism|astigmatism
5537973|NCT01135719|LASIK|lasik
5537974|NCT01135706|Pulmonary Hypertension|pulmonary hypertension
5537975|NCT01135706|Fractal dimension|fractal dimension
5537976|NCT01135693|Section 136|section 136
5537977|NCT01135693|Mental Health Act 1983|mental health act 1983
5537978|NCT01135693|Police|police
5537979|NCT01135693|Detention|detention
5537980|NCT01135693|Failure of community care|failure of community care
5537981|NCT01135667|clopidogrel|clopidogrel
5537982|NCT01135667|prasugrel|prasugrel
5537983|NCT01135667|low responder|low responder
5537984|NCT01135667|multiplate|multiplate
5537985|NCT01135667|verify now|verify now
5537986|NCT01135654|alcohol dependence|alcohol dependence
5537987|NCT01135654|unhealthy drinking|unhealthy drinking
5537988|NCT01135654|SBIRT|sbirt
5537989|NCT01135641|Adult patients (≥18 years)|adult patients (≥18 years)
5537990|NCT01135641|first allogeneic stem cell transplantation|first allogeneic stem cell transplantation
5671585|NCT00615394|cardiomyopathy, stem cell, cardiac failure|cardiomyopathy, stem cell, cardiac failure
5537991|NCT01135641|first episode of chronic GVHD requiring systemic immunosuppressive therapy|first episode of chronic gvhd requiring systemic immunosuppressive therapy
5537992|NCT01135628|Hepatic cirrhosis|hepatic cirrhosis
5537993|NCT01135628|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5537994|NCT01135628|Hyperproteic and fiber-rich diet|hyperproteic and fiber-rich diet
5537995|NCT01135628|Lactobacillus reuteri|lactobacillus reuteri
5537996|NCT01135628|Psychometric Hepatic Encephalopathy Score (PHES)|psychometric hepatic encephalopathy score (phes)
5537997|NCT01135628|Critical Flicker Frequency (CFF)|critical flicker frequency (cff)
5537998|NCT01135615|FGF-23, endothelial dysfunction, sevelamer|fgf-23, endothelial dysfunction, sevelamer
5537999|NCT01135602|Alcohol dependence|alcohol dependence
5538000|NCT01135602|Alcoholism|alcoholism
5538001|NCT01135602|Topiramate|topiramate
5538002|NCT01135589|pediatric|pediatric
5538003|NCT01135589|adolescent|adolescent
5538004|NCT01135589|micafungin|micafungin
5538005|NCT01135576|Ferric pyrophosphate|ferric pyrophosphate
5538006|NCT01135576|Fortification|fortification
5538007|NCT01135576|Fruit juice|fruit juice
5538008|NCT01135576|Functional food|functional food
5538009|NCT01135576|Bioavailability|bioavailability
5538010|NCT01135576|iron status|iron status
5538011|NCT01135576|Women|women
5538012|NCT01135576|iron-deficiency anemia|iron-deficiency anemia
5538013|NCT01135563|pediatrics|pediatrics
5538014|NCT01135563|Solid Tumors|solid tumors
5538015|NCT01135563|CNS Tumors|cns tumors
5538016|NCT01135563|Vinblastine|vinblastine
5538017|NCT01135563|Sirolimus|sirolimus
5538018|NCT01135563|Recurrent|recurrent
5538019|NCT01135563|Refractory|refractory
5538020|NCT01135550|Pediatrics|pediatrics
5538021|NCT01135550|Vomiting|vomiting
5538023|NCT01135550|Radiation Therapy|radiation therapy
5538024|NCT01135537|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5538025|NCT01135537|pharmacokinetics|pharmacokinetics
5538026|NCT01135537|pediatrics|pediatrics
5538027|NCT01135524|Osteoarthritis|osteoarthritis
5538028|NCT01135524|Opioid|opioid
5538029|NCT01135524|Transdermal|transdermal
5538030|NCT01135511|Dry eye|dry eye
5538031|NCT01135472|NEXIUM|nexium
5538032|NCT01135472|HEALTHY VOLUNTEERS|healthy volunteers
5538033|NCT01135472|BLOOD DRAW|blood draw
5538034|NCT01135472|to measure gastrin levels in healthy volunteers while taking nexium|to measure gastrin levels in healthy volunteers while taking nexium
5538035|NCT01135459|Lupus|lupus
5538036|NCT01135433|Diabetes mellitus|diabetes mellitus
5538037|NCT01135433|Metformin|metformin
5538038|NCT01135433|ASP1941|asp1941
5538039|NCT01135407|Parkinson's disease|parkinson's disease
5538040|NCT01135407|Deep brain stimulation|deep brain stimulation
5538041|NCT01135407|Subthalamic nucleus|subthalamic nucleus
5538042|NCT01135407|Levodopa|levodopa
5538043|NCT01135407|Selective visual attention|selective visual attention
5538044|NCT01135407|Basal ganglia diseases|basal ganglia diseases
5538045|NCT01135394|Pioglitazone|pioglitazone
5538046|NCT01135394|Type 2 diabetes|type 2 diabetes
5538047|NCT01135394|Insulin sensitivity|insulin sensitivity
5538048|NCT01135394|Healthy adults|healthy adults
5538049|NCT01135394|Thiazolidinediones|thiazolidinediones
5538050|NCT01135394|Pharmacogenetics|pharmacogenetics
5538051|NCT01135381|care transitions|care transitions
5538052|NCT01135381|information technology|information technology
5538053|NCT01135368|GERD|gerd
5538054|NCT01135368|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5538055|NCT01135368|Drug Therapy|drug therapy
5538056|NCT01135342|Insomnia|insomnia
5538057|NCT01135342|Weight loss|weight loss
5538058|NCT01135342|Adults|adults
5538059|NCT01135329|Lymphoma|lymphoma
5538060|NCT01135329|Hodgkin's lymphoma|hodgkin's lymphoma
5538061|NCT01135329|Non hodgkin's lymphoma|non hodgkin's lymphoma
5538062|NCT01135329|Leukemia|leukemia
5538063|NCT01135329|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5538064|NCT01135329|Acute lymphoblastic leukemia(ALL)|acute lymphoblastic leukemia(all)
5538065|NCT01135329|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5538066|NCT01135329|Chronic Myelomonocytic (CMML)|chronic myelomonocytic (cmml)
5538067|NCT01135329|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5538068|NCT01135329|High-risk acute leukemia in first remission|high-risk acute leukemia in first remission
5538069|NCT01135329|Relapsed leukemia in remission|relapsed leukemia in remission
5538070|NCT01135329|Cyclophosphamide|cyclophosphamide
5538071|NCT01135329|High-dose cyclophosphamide|high-dose cyclophosphamide
5538072|NCT01135329|Fludarabine|fludarabine
5538073|NCT01135329|Busulfan|busulfan
5538074|NCT01135329|Allogeneic|allogeneic
5538075|NCT01135329|Nonmyeloablative|nonmyeloablative
5538076|NCT01135329|Reduced intensity|reduced intensity
5538077|NCT01135329|Haploidentical|haploidentical
5538078|NCT01135329|Bone marrow transplant (BMT)|bone marrow transplant (bmt)
5538079|NCT01135316|NSF, Ablavar, Kidney Disease, Magnetic Resonance Imaging (MRI),|nsf, ablavar, kidney disease, magnetic resonance imaging (mri),
5538080|NCT01135303|Sleep Apnea Syndromes|sleep apnea syndromes
5538081|NCT01135303|Polysomnography|polysomnography
5538082|NCT01135303|Holter ECG|holter ecg
5538083|NCT01135303|Thoracic impedance|thoracic impedance
5538084|NCT01135303|Heart rate variability|heart rate variability
5538085|NCT01135290|The management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing|the management of post-treatment symptoms for subjects that had either a medium grade chemical peel or fractional resurfacing
5538086|NCT01135251|Neuropathic pain|neuropathic pain
5538088|NCT01135251|Dimiracetam|dimiracetam
5538089|NCT01135251|Treatment related painful neuropathy in AIDS patients|treatment related painful neuropathy in aids patients
5538090|NCT01135238|adrenalectomy|adrenalectomy
5538091|NCT01135238|metastasis|metastasis
5538092|NCT01135238|morbidity|morbidity
5538093|NCT01135238|mortality|mortality
5538094|NCT01135238|survival|survival
5538095|NCT01135225|Drug-eluting stent|drug-eluting stent
5538096|NCT01135225|Percutaneous coronary intervention|percutaneous coronary intervention
5538097|NCT01135225|Stent implantation|stent implantation
5538098|NCT01135225|Evolution Stent System|evolution stent system
5538099|NCT01135225|Biodegradable polymer coating|biodegradable polymer coating
5538100|NCT01135225|Feasibility study|feasibility study
5538101|NCT01135212|Hypertension|hypertension
5538102|NCT01135212|ARB|arb
5538103|NCT01135212|Fimasartan|fimasartan
5538104|NCT01135173|Smoking Cessation, Waterpipe|smoking cessation, waterpipe
5538105|NCT01135160|weight bearing|weight bearing
5538106|NCT01135160|pain|pain
5538107|NCT01135160|total hip arthroplasty|total hip arthroplasty
5538108|NCT01135160|total knee arthroplasty|total knee arthroplasty
5538109|NCT01135160|weight bearing after TKA or THA|weight bearing after tka or tha
5538110|NCT01135108|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5538111|NCT01135108|Spinal Cord Injuries|spinal cord injuries
5538112|NCT01135108|Pain|pain
5538113|NCT01135108|Pain measurement / drug effect|pain measurement / drug effect
5538118|NCT01135082|immunogenicity|immunogenicity
5538119|NCT01135082|safety|safety
5538120|NCT01135082|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5538121|NCT01135082|HIV infected children|hiv infected children
5538122|NCT01135082|objective of this study is to assess the safety and immunogenicity of a 7 - valent PCV vaccine among HIV - infected compared with HIV - exposed children|objective of this study is to assess the safety and immunogenicity of a 7 - valent pcv vaccine among hiv - infected compared with hiv - exposed children
5538123|NCT01135056|Hepatocellular Carcinoma|hepatocellular carcinoma
5538124|NCT01135056|Randomized|randomized
5538125|NCT01135056|Open-label|open-label
5538126|NCT01135056|Multi-Centre|multi-centre
5538127|NCT01135056|Phase III|phase iii
5538128|NCT01135056|Sorafenib|sorafenib
5538129|NCT01135056|SIR-Spheres|sir-spheres
5538130|NCT01135043|acceptable sputum|acceptable sputum
5538131|NCT01135043|AFB culture|afb culture
5538132|NCT01135043|pulmonary tuberculosis|pulmonary tuberculosis
5538133|NCT01135030|total knee arthroplasty|total knee arthroplasty
5538134|NCT01135004|pneumothorax|pneumothorax
5538135|NCT01135004|thoracoscopy|thoracoscopy
5538136|NCT01135004|pathogenesis|pathogenesis
5538137|NCT01135004|blebs|blebs
5538138|NCT01135004|surgery|surgery
5538139|NCT01134991|rosacea|rosacea
5538140|NCT01134991|topical|topical
5538141|NCT01134991|minocycline|minocycline
5538142|NCT01134991|foam|foam
5538143|NCT01134991|phase II|phase ii
5538144|NCT01134978|repeated measures design|repeated measures design
5538145|NCT01134978|random assignment to groups|random assignment to groups
5538146|NCT01134952|sirolimus|sirolimus
5538147|NCT01134952|everolimus|everolimus
5538148|NCT01134952|mycophenolic acid|mycophenolic acid
5538149|NCT01134952|hepatitis C virus|hepatitis c virus
5538150|NCT01134952|tacrolimus|tacrolimus
5538151|NCT01134952|viral load|viral load
5538152|NCT01134926|Retained products of conception|retained products of conception
5538153|NCT01134926|residua|residua
5538154|NCT01134926|misoprostol|misoprostol
5538155|NCT01134926|expectant management|expectant management
5538157|NCT01134913|Acute Coronary Syndrome|acute coronary syndrome
5538158|NCT01134913|Emergency Department|emergency department
5538161|NCT01134900|Decision Support Systems, Clinical|decision support systems, clinical
5538162|NCT01134887|hypertension|hypertension
5538163|NCT01134887|physician-patient relations|physician-patient relations
5538164|NCT01134887|communication|communication
5538165|NCT01134861|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5538166|NCT01134861|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5538167|NCT01134861|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5538168|NCT01134848|Bile ducts|bile ducts
5538169|NCT01134848|Sphincter of Oddi|sphincter of oddi
5538170|NCT01134848|Pancreatic ducts|pancreatic ducts
5538171|NCT01134822|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5538172|NCT01134822|IPF|ipf
5538173|NCT01134822|Lung Fibrosis|lung fibrosis
5538174|NCT01134822|Biomarkers|biomarkers
5538175|NCT01134809|Major abdominal surgery|major abdominal surgery
5538176|NCT01134770|Prenatal Substance Use|prenatal substance use
5538177|NCT01134770|Cocaine|cocaine
5538178|NCT01134770|Cigarette Smoking|cigarette smoking
5538179|NCT01134770|Mothers|mothers
5538180|NCT01134770|Pregnant women|pregnant women
5538181|NCT01134770|Smoking Mothers|smoking mothers
5538182|NCT01134757|EAR|ear
5538183|NCT01134757|LAR|lar
5538184|NCT01134757|BHR|bhr
5538185|NCT01134757|house dust mite|house dust mite
5538186|NCT01134757|alternaria|alternaria
5538187|NCT01134744|CXray|cxray
5538188|NCT01134731|depression|depression
5538189|NCT01134731|suicidality|suicidality
5538190|NCT01134731|Major Depressive Disorder, current episode, with suicidality|major depressive disorder, current episode, with suicidality
5538191|NCT01134718|TMC435-TiDP16-C119|tmc435-tidp16-c119
5538192|NCT01134718|TMC435-C119|tmc435-c119
5538193|NCT01134718|TMC435|tmc435
5538194|NCT01134718|Protease inhibitor|protease inhibitor
5538195|NCT01134718|HCV|hcv
5538196|NCT01134718|Hepatitis C|hepatitis c
5538197|NCT01134718|Bioavailability|bioavailability
5538198|NCT01134692|Patients with cirrhosis who have large esophageal varices with No history of upper GI bleeding in the past|patients with cirrhosis who have large esophageal varices with no history of upper gi bleeding in the past
5538199|NCT01134679|Drug Eluting Stent|drug eluting stent
5538200|NCT01134679|Clopidogrel|clopidogrel
5538201|NCT01134679|Aspirin|aspirin
5538202|NCT01134666|Colorectal neoplasms|colorectal neoplasms
5538203|NCT01134666|Intestinal neoplasms|intestinal neoplasms
5538204|NCT01134666|Neoplasms|neoplasms
5538205|NCT01134666|cetuximab|cetuximab
5538207|NCT01134653|Acute ankle sprain in children and young adults|acute ankle sprain in children and young adults
5538208|NCT01134640|metastatic colorectal cancer|metastatic colorectal cancer
5538209|NCT01134640|mCRC|mcrc
5538210|NCT01134640|post marketing surveillance|post marketing surveillance
5538211|NCT01134640|Erbitux|erbitux
5538212|NCT01134640|Cetuximab|cetuximab
5538213|NCT01134640|KRAS|kras
5538214|NCT01134627|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5538215|NCT01134627|Interferon-β|interferon-β
5538216|NCT01134627|Rebif®|rebif®
5538217|NCT01134627|Minocycline|minocycline
5538218|NCT01134601|Rectal Cancer|rectal cancer
5538219|NCT01134601|Radiation Therapy|radiation therapy
5538220|NCT01134601|Capecitabine|capecitabine
5538221|NCT01134601|AZD6244|azd6244
5538222|NCT01134575|Relapsed|relapsed
5538223|NCT01134575|Refractory|refractory
5538224|NCT01134575|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5538225|NCT01134575|ALL|all
5538226|NCT01134575|Burkitt's lymphoma|burkitt's lymphoma
5538227|NCT01134575|Lymphoblastic lymphoma|lymphoblastic lymphoma
5538228|NCT01134575|CMC-544|cmc-544
5538229|NCT01134575|Inotuzumab Ozogamycin|inotuzumab ozogamycin
5538230|NCT01134575|Rituxan|rituxan
5538231|NCT01134575|Rituximab|rituximab
5538232|NCT01134562|Clinical Trial, Phase 1|clinical trial, phase 1
5538233|NCT01134562|Renal Dialysis|renal dialysis
5538234|NCT01134562|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5538235|NCT01134562|Parathyroid hormone|parathyroid hormone
5538236|NCT01134536|Pain, Postoperative|pain, postoperative
5538237|NCT01134536|Postoperative Pain|postoperative pain
5538238|NCT01134536|Tapentadol|tapentadol
5538239|NCT01134536|NUCYNTA|nucynta
5538240|NCT01134536|CG5503|cg5503
5538241|NCT01134536|R331333|r331333
5538242|NCT01134536|Pharmacokinetics|pharmacokinetics
5538243|NCT01134536|Postsurgical pain|postsurgical pain
5538244|NCT01134536|Children|children
5538245|NCT01134536|Adolescents|adolescents
5538246|NCT01134523|positive lymph node|positive lymph node
5538247|NCT01134510|Kidney transplantation|kidney transplantation
5538248|NCT01134484|autologous stem cell transplantation|autologous stem cell transplantation
5538249|NCT01134484|complete remission|complete remission
5538250|NCT01134484|bortezomib|bortezomib
5538251|NCT01134484|thalidomide|thalidomide
5538252|NCT01134484|progression free survival|progression free survival
5538253|NCT01134484|induction and consolidation therapy|induction and consolidation therapy
5538254|NCT01134458|cardiovascular disease|cardiovascular disease
5538255|NCT01134445|Arthroplasty|arthroplasty
5538256|NCT01134445|Replacement|replacement
5538257|NCT01134445|Hip|hip
5538258|NCT01134445|Conservative|conservative
5538259|NCT01134445|Anatomic|anatomic
5538260|NCT01134445|Cementless|cementless
5538261|NCT01134432|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5538262|NCT01134432|hemolytic anemia|hemolytic anemia
5538263|NCT01134432|Rituximab|rituximab
5538264|NCT01134432|Treatment of autoimmune hemolytic anemia|treatment of autoimmune hemolytic anemia
5538265|NCT01134432|warm antibody dependant autoimmune hemolytic anemia|warm antibody dependant autoimmune hemolytic anemia
5538266|NCT01134419|Patient Safety|patient safety
5538267|NCT01134419|Medical Errors|medical errors
5538268|NCT01134419|Handoff|handoff
5538269|NCT01134419|Sign-out|sign-out
5538270|NCT01134419|Resident|resident
5538271|NCT01134419|Intern|intern
5538272|NCT01134419|Graduate Medical Education|graduate medical education
5538273|NCT01134406|Osteoarthritis|osteoarthritis
5538274|NCT01134406|knee|knee
5538275|NCT01134380|Percutaneous coronary intervention|percutaneous coronary intervention
5538276|NCT01134380|Acute coronary syndrome|acute coronary syndrome
5538277|NCT01134380|Dual antiplatelet therapy|dual antiplatelet therapy
5538278|NCT01134380|clopidogrel/prasugrel|clopidogrel/prasugrel
5538279|NCT01134380|genotyping|genotyping
5538280|NCT01134380|stent|stent
5538281|NCT01134380|compliance|compliance
5538282|NCT01134367|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5538283|NCT01134354|Validation study|validation study
5538284|NCT01134354|Outcome Measures|outcome measures
5538285|NCT01134354|Patient Outcomes Assessment|patient outcomes assessment
5538286|NCT01134354|Patient expectations|patient expectations
5538287|NCT01134354|Physician patient relationship|physician patient relationship
5538288|NCT01134341|Relapsed|relapsed
5538289|NCT01134341|Refractory|refractory
5538290|NCT01134315|Evaluating incidence of hypercalcemia in pediatric patients|evaluating incidence of hypercalcemia in pediatric patients
5538291|NCT01134302|Hybrid|hybrid
5538292|NCT01134302|Norwood|norwood
5538293|NCT01134302|congenital heart disease|congenital heart disease
5538294|NCT01134302|single ventricle|single ventricle
5538295|NCT01134289|complex regional pain syndrome|complex regional pain syndrome
5538296|NCT01134289|lumbar sympathetic blockade|lumbar sympathetic blockade
5538297|NCT01134289|photoplethysmography|photoplethysmography
5538298|NCT01134289|diagnostic lumbar sympathetic blockade|diagnostic lumbar sympathetic blockade
5538299|NCT01134263|Dengue Fever|dengue fever
5538300|NCT01134263|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5538301|NCT01134263|CYD Dengue Vaccine|cyd dengue vaccine
5538302|NCT01134263|Lot Consistency|lot consistency
5538303|NCT01134250|Interleukin, IL2, F16, monoclonal, antibody, cytokine Paclitaxel, breast cancer,solid tumour|interleukin, il2, f16, monoclonal, antibody, cytokine paclitaxel, breast cancer,solid tumour
5538304|NCT01134250|metastatic melanoma, non-small cell lung cancer (NSCLC)|metastatic melanoma, non-small cell lung cancer (nsclc)
5538305|NCT01134237|non-surgical rate|non-surgical rate
5538306|NCT01134198|Cocaine Dependence|cocaine dependence
5538307|NCT01134185|Two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects|two groups of 8 hepatically impaired subjects, one group of 8 matched healthy subjects
5538308|NCT01134172|Sociodemographic|sociodemographic
5538309|NCT01134172|Ethnicity|ethnicity
5538310|NCT01134172|Work-related|work-related
5538311|NCT01134172|Health system|health system
5538313|NCT01134172|Questionnaires|questionnaires
5538314|NCT01134172|10-071|10-071
5538315|NCT01134146|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5538316|NCT01134146|IMRT|imrt
5538317|NCT01134146|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5538318|NCT01134146|Radical Pleurectomy|radical pleurectomy
5538319|NCT01134146|Decortication|decortication
5538320|NCT01134146|PD|pd
5538321|NCT01134146|pleurectomy|pleurectomy
5538322|NCT01134146|lung surgery|lung surgery
5538323|NCT01134146|pleura|pleura
5538324|NCT01134094|Undisplaced|undisplaced
5538325|NCT01134094|Ankle Fracture|ankle fracture
5538326|NCT01134094|Weber B|weber b
5538327|NCT01134081|gum|gum
5538328|NCT01134081|recession|recession
5538329|NCT01134068|D-dimer|d-dimer
5538330|NCT01134068|Pulmonary embolism|pulmonary embolism
5538331|NCT01134068|Diagnostic strategy|diagnostic strategy
5538332|NCT01134068|Safety of ruling PE with and age-adjusted DD cut-off|safety of ruling pe with and age-adjusted dd cut-off
5538333|NCT01134055|ranibizumab|ranibizumab
5538334|NCT01134055|wet AMD|wet amd
5538335|NCT01134055|MD7110852|md7110852
5538336|NCT01134055|age related macular degeneration|age related macular degeneration
5538337|NCT01134055|age-related macular degeneration|age-related macular degeneration
5538338|NCT01134055|macular degeneration|macular degeneration
5538339|NCT01134055|pazopanib|pazopanib
5538340|NCT01134042|Fluticasone propionate|fluticasone propionate
5538341|NCT01134042|asthma|asthma
5538342|NCT01134042|vilanterol|vilanterol
5538343|NCT01134042|GW642444|gw642444
5538344|NCT01134042|Fluticasone furoate|fluticasone furoate
5538345|NCT01134029|obesity|obesity
5538346|NCT01134029|weight management and cardiovascular risk factors|weight management and cardiovascular risk factors
5538347|NCT01134016|Lung cancer|lung cancer
5538349|NCT01134003|Gynecare Prolift|gynecare prolift
5538350|NCT01134003|Pelvic organ prolapse|pelvic organ prolapse
5862957|NCT00001451|National Marrow Donor Program (NMDP)|national marrow donor program (nmdp)
5538351|NCT01134003|forming a large database of women who have recieve Gynecare prolift system|forming a large database of women who have recieve gynecare prolift system
5538352|NCT01133964|Dairy proteins|dairy proteins
5538353|NCT01133964|Appetite regulation|appetite regulation
5538354|NCT01133964|Energy expenditure|energy expenditure
5538355|NCT01133951|Helicobacter Infections|helicobacter infections
5538356|NCT01133951|Helicobacter pylori|helicobacter pylori
5538357|NCT01133951|Drug Therapy|drug therapy
5538358|NCT01133951|Precancerous Conditions|precancerous conditions
5538359|NCT01133951|Stomach Neoplasms|stomach neoplasms
5538361|NCT01133925|Coronary Artery Disease|coronary artery disease
5538362|NCT01133925|Percutaneous Coronary Intervention|percutaneous coronary intervention
5538363|NCT01133925|Drug Eluting Stent|drug eluting stent
5538364|NCT01133925|Optical Coherence Tomography|optical coherence tomography
5538365|NCT01133925|Thrombosi|thrombosi
5538366|NCT01133925|Long lesions in native vessels requiring overlap|long lesions in native vessels requiring overlap
5538367|NCT01133912|Patients with HER2 Positive Operable Breast Cancer|patients with her2 positive operable breast cancer
5538368|NCT01133899|strength, anaerobic performance, recovery, ergogenic|strength, anaerobic performance, recovery, ergogenic
5538369|NCT01133860|inherited thrombocytopenia|inherited thrombocytopenia
5538370|NCT01133860|MYH9 mutations|myh9 mutations
5538371|NCT01133860|eltrombopag|eltrombopag
5538372|NCT01133834|meningococcal disease|meningococcal disease
5538373|NCT01133834|cytokines|cytokines
5538374|NCT01133821|Bipolar II Disorder|bipolar ii disorder
5538375|NCT01133821|Bipolar II Depression|bipolar ii depression
5538376|NCT01133821|Psychotherapy|psychotherapy
5538377|NCT01133821|IPSRT|ipsrt
5538378|NCT01133821|Seroquel|seroquel
5538379|NCT01133821|Quetiapine|quetiapine
5538380|NCT01133821|Placebo|placebo
5538381|NCT01133821|Sugar Pill|sugar pill
5538382|NCT01133808|diarrhea|diarrhea
5538383|NCT01133808|childhood|childhood
5538384|NCT01133808|rotavirus|rotavirus
5538385|NCT01133808|vaccine|vaccine
5538386|NCT01133808|Nicaragua|nicaragua
5538387|NCT01133795|cirrhosis|cirrhosis
5538388|NCT01133795|renal failure|renal failure
5538389|NCT01133795|hepatorenal syndrome|hepatorenal syndrome
5538390|NCT01133795|albumine|albumine
5538391|NCT01133795|midodrine|midodrine
5538392|NCT01133769|Clavicle fracture|clavicle fracture
5538393|NCT01133769|fixation|fixation
5538394|NCT01133769|polytrauma|polytrauma
5538395|NCT01133769|Clavicle fracture patients with chest injury|clavicle fracture patients with chest injury
5538396|NCT01133743|Lenalidomide|lenalidomide
5538397|NCT01133743|Dexamethasone|dexamethasone
5538398|NCT01133743|Immunomodulatory Drugs(IMiD™)|immunomodulatory drugs(imid™)
5538399|NCT01133743|Thalidomide analogues|thalidomide analogues
5538400|NCT01133730|supraclavicular nerve block|supraclavicular nerve block
5538401|NCT01133730|regional anesthesia|regional anesthesia
5538402|NCT01133730|transversalis fascia plane block|transversalis fascia plane block
5538403|NCT01133730|ultrasound guided|ultrasound guided
5538404|NCT01133730|opioid consumption|opioid consumption
5538405|NCT01133730|iliac crest bone harvest|iliac crest bone harvest
5538406|NCT01133730|hand surgery|hand surgery
5538407|NCT01133730|wrist surgery|wrist surgery
5538408|NCT01133730|Upper limb surgery combined with iliac crest bone harvest.|upper limb surgery combined with iliac crest bone harvest.
5538409|NCT01133717|Sleep Apnea|sleep apnea
5538410|NCT01133717|Cerebrovascular Reactivity|cerebrovascular reactivity
5538411|NCT01133704|asymptomatic metastatic hormone-refractory prostate cancer|asymptomatic metastatic hormone-refractory prostate cancer
5538412|NCT01133691|gastric emptying|gastric emptying
5538413|NCT01133691|children|children
5538414|NCT01133691|gastric fluid volume|gastric fluid volume
5538415|NCT01133691|preoperative fasting|preoperative fasting
5538416|NCT01133678|Squamous Cell Carcinoma|squamous cell carcinoma
5538417|NCT01133665|Head and Neck, Squamous Cell|head and neck, squamous cell
5538418|NCT01133665|Recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy|recurrent or metastatic squamous cell or undifferentiated carcinoma of the head and neck that is not amenable to curative therapy
5538419|NCT01133652|Venipuncture|venipuncture
5538420|NCT01133652|Randomized Controlled Trial|randomized controlled trial
5538421|NCT01133652|Intravenous access|intravenous access
5538422|NCT01133652|Children|children
5538423|NCT01133652|Pediatric Emergency Department|pediatric emergency department
5538424|NCT01133652|Peripheral intravenous catheterization|peripheral intravenous catheterization
5509560|NCT01255007|liver|liver
5538425|NCT01133652|Catheterization, Peripheral Phlebotomy|catheterization, peripheral phlebotomy
5538426|NCT01133587|Schizophrenia|schizophrenia
5538427|NCT01133587|bipolar disorder|bipolar disorder
5538428|NCT01133587|Long term care|long term care
5538429|NCT01133587|patient admission|patient admission
5538430|NCT01133574|Healthy volunteers|healthy volunteers
5538432|NCT01133574|Phase I|phase i
5538433|NCT01133574|SRDT|srdt
5538434|NCT01133561|psoriasis|psoriasis
5538435|NCT01133561|insulin resistance|insulin resistance
5538436|NCT01133561|metabolic syndrome|metabolic syndrome
5538437|NCT01133561|pioglitazone|pioglitazone
5538634|NCT01132612|dermatology|dermatology
5538442|NCT01133522|Statin|statin
5538443|NCT01133522|Ascending|ascending
5538444|NCT01133496|Bioequivalence|bioequivalence
5538445|NCT01133496|Alendronate Sodium|alendronate sodium
5538446|NCT01133496|crossover|crossover
5538447|NCT01133483|Bioequivalence|bioequivalence
5538448|NCT01133483|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
5538449|NCT01133470|Bioequivalence|bioequivalence
5538450|NCT01133470|Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride|fexofenadine hydrochloride + pseudoephedrine hydrochloride
5538451|NCT01133457|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
5538452|NCT01133444|Bioequivalence,Finasteride,Crossover|bioequivalence,finasteride,crossover
5538453|NCT01133431|CKD-501|ckd-501
5538454|NCT01133431|Glimepiride|glimepiride
5538455|NCT01133431|Placebo|placebo
5538456|NCT01133431|Healthy male volunteer|healthy male volunteer
5538457|NCT01133431|Pharmacokinetic|pharmacokinetic
5538458|NCT01133431|Metabolite|metabolite
5538459|NCT01133392|insulin|insulin
5538460|NCT01133392|lispro|lispro
5538461|NCT01133366|ISIS301012|isis301012
5538462|NCT01133366|antisense|antisense
5538463|NCT01133366|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5538464|NCT01133366|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5538465|NCT01133366|mipomersen|mipomersen
5538466|NCT01133340|RADIOTHERAPY|radiotherapy
5538467|NCT01133340|CT simulation|ct simulation
5538468|NCT01133340|MRI simulation|mri simulation
5538469|NCT01133340|Endoscopic clip placement|endoscopic clip placement
5538470|NCT01133340|Rectal cancer|rectal cancer
5538471|NCT01133340|Accuracy of MRI Simulation for target delineation and planning|accuracy of mri simulation for target delineation and planning
5538472|NCT01133327|Carotid Artery Stenting|carotid artery stenting
5538473|NCT01133327|High Risk patient|high risk patient
5538474|NCT01133327|Carotid artery stenosis|carotid artery stenosis
5538475|NCT01133327|stroke|stroke
5538476|NCT01133327|Carotid artery disease|carotid artery disease
5538477|NCT01133327|ASTI study|asti study
5538478|NCT01133327|Adapt Carotid Stent system|adapt carotid stent system
5538479|NCT01133327|FilterWire EZ Embolic Protection System|filterwire ez embolic protection system
5538480|NCT01133301|Borderline Personality Disorder|borderline personality disorder
5538481|NCT01133301|Dissociation|dissociation
5538482|NCT01133301|Naltrexone|naltrexone
5538483|NCT01133249|total hip|total hip
5538484|NCT01133236|Salt restriction|salt restriction
5538485|NCT01133236|Fluid restriction|fluid restriction
5538486|NCT01133236|Congestion|congestion
5538487|NCT01133236|Heart Failure|heart failure
5538488|NCT01133223|Stroke, mecanical thrombectomy|stroke, mecanical thrombectomy
5538497|NCT01133171|Cardiovascular Disease|cardiovascular disease
5538498|NCT01133171|Stroke|stroke
5538499|NCT01133158|Follicular non-Hodgkin's lymphoma relapse refractory|follicular non-hodgkin's lymphoma relapse refractory
5538500|NCT01133145|composite tissue allotransplantation|composite tissue allotransplantation
5538501|NCT01133145|hand transplantation|hand transplantation
5538502|NCT01133145|knee transplantation|knee transplantation
5538503|NCT01133145|face transplantation|face transplantation
5538504|NCT01133132|Colon cancer patients who have completed treatment|colon cancer patients who have completed treatment
5538505|NCT01133119|cardiac catheterization|cardiac catheterization
5538506|NCT01133119|local anesthetic|local anesthetic
5538507|NCT01133119|pain experienced post-operatively|pain experienced post-operatively
5538508|NCT01133119|pediatric patients|pediatric patients
5538509|NCT01133106|stroke recovery|stroke recovery
5538510|NCT01133106|quality of life|quality of life
5538511|NCT01133093|Cardiovascular risk factors|cardiovascular risk factors
5538512|NCT01133093|Nutritional assessment|nutritional assessment
5538513|NCT01133093|Epidemiology|epidemiology
5538514|NCT01133067|lung cancer|lung cancer
5538515|NCT01133067|followup|followup
5538516|NCT01133067|physical follow up|physical follow up
5538517|NCT01133067|telephonic followup|telephonic followup
5538518|NCT01133054|Coronary Vessel Anomalies|coronary vessel anomalies
5538519|NCT01133028|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5538521|NCT01133015|IVUS|ivus
5538522|NCT01133015|MLA|mla
5538523|NCT01132989|Patients with cutaneous T cell lymphoma|patients with cutaneous t cell lymphoma
5538524|NCT01132976|Personality disorders|personality disorders
5538525|NCT01132976|Personal Concerns Inventory|personal concerns inventory
5538526|NCT01132976|Non completion|non completion
5538539|NCT01132911|Solid Tumors|solid tumors
5538540|NCT01132911|Maximum Tolerated Dose|maximum tolerated dose
5538541|NCT01132911|Lymphoma|lymphoma
5538542|NCT01132911|Dose Escalation|dose escalation
5538543|NCT01132911|Pharmacokinetics|pharmacokinetics
5538544|NCT01132911|Pediatric Cancer|pediatric cancer
5538545|NCT01132911|Solid Tumor|solid tumor
5538546|NCT01132911|Sarcoma|sarcoma
5538547|NCT01132911|Wilms Tumor|wilms tumor
5538548|NCT01132911|Neuroblastoma|neuroblastoma
5538549|NCT01132898|Traumatic Brain Injury|traumatic brain injury
5538550|NCT01132898|Biomarkers|biomarkers
5538551|NCT01132898|Functional Level|functional level
5538552|NCT01132898|DTI|dti
5538553|NCT01132898|Neuropsychological Assessment|neuropsychological assessment
5538554|NCT01132885|MRI|mri
5538555|NCT01132885|Developmental|developmental
5538556|NCT01132885|Genetic abnormalities in chromosome 7q11.23.|genetic abnormalities in chromosome 7q11.23.
5538557|NCT01132885|Duplication|duplication
5538558|NCT01132885|Brain|brain
5538559|NCT01132885|Williams Syndrome|williams syndrome
5538577|NCT01132833|stage II multiple myeloma|stage ii multiple myeloma
5538578|NCT01132833|stage III multiple myeloma|stage iii multiple myeloma
5538579|NCT01132807|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5538580|NCT01132807|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5538581|NCT01132794|Pain relief and sedation condition|pain relief and sedation condition
5538582|NCT01132781|rhinosinusitis|rhinosinusitis
5538583|NCT01132781|asthma|asthma
5538584|NCT01132781|allergic rhinitis|allergic rhinitis
5538585|NCT01132781|theophylline|theophylline
5538586|NCT01132755|gastric|gastric
5538587|NCT01132755|pancreas|pancreas
5538588|NCT01132755|laparoscopy|laparoscopy
5538589|NCT01132755|peritoneal lavage|peritoneal lavage
5538590|NCT01132755|10-011|10-011
5538591|NCT01132755|gastric and pancreatic cancer|gastric and pancreatic cancer
5538592|NCT01132742|Malnutrition|malnutrition
5538593|NCT01132742|children|children
5538594|NCT01132742|Hospital Stay|hospital stay
5538595|NCT01132742|Screening Tools|screening tools
5538596|NCT01132742|Anthropometry|anthropometry
5538597|NCT01132690|gaucher disease|gaucher disease
5538599|NCT01132677|OA of Knee|oa of knee
5538600|NCT01132677|Osteoarthritis of Knee|osteoarthritis of knee
5538601|NCT01132677|Viscosupplementation and Osteoarthritis|viscosupplementation and osteoarthritis
5538602|NCT01132677|Viscosupplementation and OA|viscosupplementation and oa
5538603|NCT01132677|Hyaluronic Acid|hyaluronic acid
5538604|NCT01132677|Corticosteroid injection versus hyaluronic acid|corticosteroid injection versus hyaluronic acid
5538605|NCT01132677|Synvisc One and Knee OA|synvisc one and knee oa
5538606|NCT01132677|viscosupplementation and knee pain|viscosupplementation and knee pain
5538607|NCT01132677|knee Pain from OA|knee pain from oa
5538608|NCT01132664|HER2|her2
5538609|NCT01132664|BKM120|bkm120
5538610|NCT01132664|PIK3|pik3
5538611|NCT01132664|metastatic breast cancer|metastatic breast cancer
5538612|NCT01132664|brain metastases|brain metastases
5538613|NCT01132664|Herceptin|herceptin
5538614|NCT01132664|trastuzumab|trastuzumab
5538615|NCT01132664|capecitabine|capecitabine
5538616|NCT01132664|open-label|open-label
5538617|NCT01132664|maximum tolerated dose|maximum tolerated dose
5538618|NCT01132664|Phase I/Phase ll|phase i/phase ll
5538619|NCT01132651|eczema|eczema
5538620|NCT01132651|itch|itch
5538621|NCT01132651|pruritus|pruritus
5538622|NCT01132651|head|head
5538623|NCT01132651|neck|neck
5538624|NCT01132638|Gastroesophageal|gastroesophageal
5538625|NCT01132638|Pantoprazole|pantoprazole
5538626|NCT01132638|erosive|erosive
5538627|NCT01132638|Erosive GERD grades A-D, acc. to Los Angeles classification|erosive gerd grades a-d, acc. to los angeles classification
5538628|NCT01132625|HSP90|hsp90
5538629|NCT01132625|molecular chaperone|molecular chaperone
5538630|NCT01132625|advanced solid tumors|advanced solid tumors
5538631|NCT01132625|Japan|japan
5538632|NCT01132612|Chronic plaque-type psoriasis|chronic plaque-type psoriasis
5538635|NCT01132612|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5538636|NCT01132599|stage IV prostate cancer|stage iv prostate cancer
5538637|NCT01132560|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5538638|NCT01132547|cachexia|cachexia
5538639|NCT01132547|weight changes|weight changes
5538640|NCT01132547|nausea and vomiting|nausea and vomiting
5538641|NCT01132547|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5538642|NCT01132547|anaplastic osteosarcoma|anaplastic osteosarcoma
5538643|NCT01132547|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5538644|NCT01132547|childhood angiosarcoma|childhood angiosarcoma
5538645|NCT01132547|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5538646|NCT01132547|childhood fibrosarcoma|childhood fibrosarcoma
5521016|NCT01204658|infants|infants
5538647|NCT01132547|childhood gliosarcoma|childhood gliosarcoma
5538648|NCT01132547|childhood leiomyosarcoma|childhood leiomyosarcoma
5538649|NCT01132547|childhood liposarcoma|childhood liposarcoma
5538650|NCT01132547|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5538651|NCT01132547|childhood synovial sarcoma|childhood synovial sarcoma
5538652|NCT01132547|chondrosarcoma|chondrosarcoma
5538653|NCT01132547|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
5685368|NCT00556400|Thrombocytopenia|thrombocytopenia
5538654|NCT01132547|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5538655|NCT01132547|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5538657|NCT01132547|endometrial stromal sarcoma|endometrial stromal sarcoma
5538658|NCT01132547|extraosseous Ewing sarcoma|extraosseous ewing sarcoma
5538659|NCT01132547|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
5538660|NCT01132547|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5538661|NCT01132547|localized Ewing sarcoma|localized ewing sarcoma
5538662|NCT01132547|localized osteosarcoma|localized osteosarcoma
5538663|NCT01132547|mast cell sarcoma|mast cell sarcoma
5538664|NCT01132547|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5538665|NCT01132547|metastatic Ewing sarcoma|metastatic ewing sarcoma
5538666|NCT01132547|metastatic osteosarcoma|metastatic osteosarcoma
5538667|NCT01132547|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5538669|NCT01132547|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5538670|NCT01132547|osteoblastic osteosarcoma|osteoblastic osteosarcoma
5538671|NCT01132547|ovarian carcinosarcoma|ovarian carcinosarcoma
5538672|NCT01132547|ovarian sarcoma|ovarian sarcoma
5538673|NCT01132547|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5538674|NCT01132547|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5538675|NCT01132547|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5538676|NCT01132547|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5538677|NCT01132547|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5538678|NCT01132547|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5538679|NCT01132547|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5538680|NCT01132547|recurrent Ewing sarcoma|recurrent ewing sarcoma
5538681|NCT01132547|recurrent osteosarcoma|recurrent osteosarcoma
5538682|NCT01132547|recurrent uterine sarcoma|recurrent uterine sarcoma
5538683|NCT01132547|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5538684|NCT01132547|stage I uterine sarcoma|stage i uterine sarcoma
5538685|NCT01132547|stage II uterine sarcoma|stage ii uterine sarcoma
5538686|NCT01132547|stage III uterine sarcoma|stage iii uterine sarcoma
5538687|NCT01132547|stage IV uterine sarcoma|stage iv uterine sarcoma
5538688|NCT01132547|telangiectatic osteosarcoma|telangiectatic osteosarcoma
5538689|NCT01132547|untreated childhood gliosarcoma|untreated childhood gliosarcoma
5538690|NCT01132547|uterine carcinosarcoma|uterine carcinosarcoma
5538691|NCT01132547|uterine leiomyosarcoma|uterine leiomyosarcoma
5538692|NCT01132547|localized resectable neuroblastoma|localized resectable neuroblastoma
5538693|NCT01132547|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5538694|NCT01132547|recurrent neuroblastoma|recurrent neuroblastoma
5538695|NCT01132547|regional neuroblastoma|regional neuroblastoma
5538696|NCT01132547|stage 4S neuroblastoma|stage 4s neuroblastoma
5538697|NCT01132547|recurrent Wilms tumor|recurrent wilms tumor
5538698|NCT01132547|childhood kidney tumors|childhood kidney tumors
5538699|NCT01132547|stage III Wilms tumor|stage iii wilms tumor
5538700|NCT01132547|stage IV Wilms tumor|stage iv wilms tumor
5538701|NCT01132547|childhood hepatoblastoma|childhood hepatoblastoma
5538702|NCT01132547|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5538703|NCT01132547|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5538704|NCT01132547|childhood gonadal germ cell tumor|childhood gonadal germ cell tumor
5538705|NCT01132547|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5538706|NCT01132547|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5538707|NCT01132547|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5538708|NCT01132547|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5538709|NCT01132547|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5538710|NCT01132547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5538711|NCT01132547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5538712|NCT01132547|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5538713|NCT01132547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5538714|NCT01132547|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5538715|NCT01132547|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5538716|NCT01132547|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5538717|NCT01132547|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5538718|NCT01132547|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5538719|NCT01132547|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5538720|NCT01132547|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5538721|NCT01132547|childhood ependymoblastoma|childhood ependymoblastoma
5538722|NCT01132547|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5538723|NCT01132547|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5538724|NCT01132547|recurrent childhood ependymoma|recurrent childhood ependymoma
5685369|NCT00556400|Aplastic Anemia|aplastic anemia
5538725|NCT01132547|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5533027|NCT01155050|overweight|overweight
5538727|NCT01132547|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5538728|NCT01132547|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5538729|NCT01132547|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5538730|NCT01132547|recurrent childhood brain tumor|recurrent childhood brain tumor
5538731|NCT01132547|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5538732|NCT01132547|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5538733|NCT01132547|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5538734|NCT01132547|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5538735|NCT01132547|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5538736|NCT01132547|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5538737|NCT01132547|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5538738|NCT01132547|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5538739|NCT01132547|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
5538740|NCT01132547|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
5538741|NCT01132547|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
5538742|NCT01132547|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5538743|NCT01132547|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5538745|NCT01132547|other tumor of glial origin|other tumor of glial origin
5538746|NCT01132547|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5538747|NCT01132547|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5538748|NCT01132547|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5538749|NCT01132547|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5538750|NCT01132547|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5538751|NCT01132547|recurrent childhood oligoastrocytoma|recurrent childhood oligoastrocytoma
5538752|NCT01132547|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5538753|NCT01132547|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5538754|NCT01132547|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5538755|NCT01132547|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5538756|NCT01132547|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5538757|NCT01132547|untreated childhood cerebral astrocytoma|untreated childhood cerebral astrocytoma
5538758|NCT01132547|untreated childhood diffuse astrocytoma|untreated childhood diffuse astrocytoma
5538759|NCT01132547|untreated childhood fibrillary astrocytoma|untreated childhood fibrillary astrocytoma
5538760|NCT01132547|untreated childhood gemistocytic astrocytoma|untreated childhood gemistocytic astrocytoma
5538761|NCT01132547|untreated childhood oligoastrocytoma|untreated childhood oligoastrocytoma
5538762|NCT01132547|untreated childhood pilocytic astrocytoma|untreated childhood pilocytic astrocytoma
5538763|NCT01132547|untreated childhood pilomyxoid astrocytoma|untreated childhood pilomyxoid astrocytoma
5538764|NCT01132547|untreated childhood pleomorphic xanthoastrocytoma|untreated childhood pleomorphic xanthoastrocytoma
5538765|NCT01132547|untreated childhood protoplasmic astrocytoma|untreated childhood protoplasmic astrocytoma
5538766|NCT01132547|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5538767|NCT01132547|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5538768|NCT01132547|recurrent childhood visual pathway|recurrent childhood visual pathway
5538770|NCT01132547|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5538771|NCT01132547|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
5538772|NCT01132547|untreated childhood oligodendroglioma|untreated childhood oligodendroglioma
5538773|NCT01132547|untreated childhood visual pathway|untreated childhood visual pathway
5538774|NCT01132547|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5538775|NCT01132547|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5538776|NCT01132547|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5538777|NCT01132547|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
5538778|NCT01132547|untreated childhood glioblastoma|untreated childhood glioblastoma
5538779|NCT01132547|childhood choroid plexus tumor|childhood choroid plexus tumor
5538780|NCT01132547|childhood grade I meningioma|childhood grade i meningioma
5538781|NCT01132547|childhood grade II meningioma|childhood grade ii meningioma
5538782|NCT01132547|childhood grade III meningioma|childhood grade iii meningioma
5538783|NCT01132547|minimally differentiated myeloid leukemia (M0)|minimally differentiated myeloid leukemia (m0)
5538784|NCT01132547|myeloblastic leukemia with maturation (M2)|myeloblastic leukemia with maturation (m2)
5538785|NCT01132547|myeloblastic leukemia without maturation (M1)|myeloblastic leukemia without maturation (m1)
5538786|NCT01132547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5538787|NCT01132547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5538788|NCT01132547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5538789|NCT01132547|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5538790|NCT01132547|other myeloid malignancies|other myeloid malignancies
5538791|NCT01132547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5538792|NCT01132547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5538793|NCT01132547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5538794|NCT01132547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5538795|NCT01132547|unspecified childhood solid tumor|unspecified childhood solid tumor
5538798|NCT01132534|AFI|afi
5538799|NCT01132534|Videoendoscopy|videoendoscopy
5538800|NCT01132534|Narrow Band Imaging|narrow band imaging
5538801|NCT01132534|Autofluorescence Imaging|autofluorescence imaging
5538802|NCT01132521|ulinastatin|ulinastatin
5538803|NCT01132521|severe acute pancreatitis|severe acute pancreatitis
5538804|NCT01132508|Tibial plateau fracture|tibial plateau fracture
5538805|NCT01132508|Orthopaedic Trauma Association (OTA) B2 B3 C3|orthopaedic trauma association (ota) b2 b3 c3
5538806|NCT01132508|Bone Void|bone void
5538807|NCT01132495|Stable angina|stable angina
5538808|NCT01132495|angina pectoris|angina pectoris
5538809|NCT01132495|PCI|pci
5538810|NCT01132495|FAME|fame
5538811|NCT01132495|FAME II|fame ii
5538812|NCT01132495|FFR|ffr
5538813|NCT01132495|Fractional Flow Reserve|fractional flow reserve
5538814|NCT01132495|Pressure wire|pressure wire
5538815|NCT01132482|Cystic fibrosis|cystic fibrosis
5538816|NCT01132482|CFTR|cftr
5538817|NCT01132482|Phosphodiesterase inhibitor|phosphodiesterase inhibitor
5538818|NCT01132482|Nasal potential difference|nasal potential difference
5538819|NCT01132482|Sweat test|sweat test
5538820|NCT01132456|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5538821|NCT01132456|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5538822|NCT01132456|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5538823|NCT01132456|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5538824|NCT01132456|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5538826|NCT01132456|RESTENOTIC LESION|restenotic lesion
5538827|NCT01132456|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5538828|NCT01132456|LONG LESION|long lesion
5538829|NCT01132456|DUAL VESSEL|dual vessel
5538830|NCT01132430|ADHERENCE|adherence
5538831|NCT01132430|ASTHMA CONTROL|asthma control
5538832|NCT01132430|ASTHMA QUALITY OF LIFE|asthma quality of life
5538833|NCT01132430|MOTIVATIONAL INTERVIEWING|motivational interviewing
5538834|NCT01132417|Tigecycline, MDR|tigecycline, mdr
5538835|NCT01132417|Patient infected with multidrug resistance bacteria|patient infected with multidrug resistance bacteria
5538836|NCT01132391|anal fissure|anal fissure
5538837|NCT01132391|nitroglycerin|nitroglycerin
5538838|NCT01132391|medical treatment|medical treatment
5538839|NCT01132378|Total knee arthroplasty|total knee arthroplasty
5538840|NCT01132365|knee arthroplasty|knee arthroplasty
5538841|NCT01132352|Bioavailability|bioavailability
5538842|NCT01132352|Crossover|crossover
5538843|NCT01132352|Levetiracetam|levetiracetam
5538844|NCT01132339|Adverse reactions to Gadolinium-based contrast agents.|adverse reactions to gadolinium-based contrast agents.
5538845|NCT01132339|Adverse reactions to Iodine-basedcontrast agents.|adverse reactions to iodine-basedcontrast agents.
5538846|NCT01132326|Symptomatic NOH|symptomatic noh
5538847|NCT01132287|Contact lens wear|contact lens wear
5538848|NCT01132287|lubricant eye drops|lubricant eye drops
5538849|NCT01132274|Supraventricular arrhythmia catheter ablation|supraventricular arrhythmia catheter ablation
5538850|NCT01132248|schistosomiasis, schistosoma haematobium|schistosomiasis, schistosoma haematobium
5538851|NCT01132222|Bioequivalence|bioequivalence
5538852|NCT01132222|Crossover|crossover
5538853|NCT01132222|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
5538854|NCT01132209|surgery|surgery
5538855|NCT01132209|incisional hernia|incisional hernia
5539139|NCT01130948|sleep|sleep
5538856|NCT01132209|woundinfection|woundinfection
5538857|NCT01132209|burst abdomen|burst abdomen
5538858|NCT01132209|pain|pain
5538859|NCT01132196|Bioequivalence|bioequivalence
5538860|NCT01132196|Crossover|crossover
5538861|NCT01132196|Divalproex Sodium|divalproex sodium
5538862|NCT01132170|Bioequivalence|bioequivalence
5538863|NCT01132170|Crossover|crossover
5538864|NCT01132170|Divalproex Sodium|divalproex sodium
5538865|NCT01132157|Healthy Kidney Donors and Their Recipients with End Stage Renal Disease|healthy kidney donors and their recipients with end stage renal disease
5538866|NCT01132144|Reproductive Techniques|reproductive techniques
5538867|NCT01132144|Embryo Implantation|embryo implantation
5538868|NCT01132144|Endometrium|endometrium
5538869|NCT01132144|Ultrasonography|ultrasonography
5538870|NCT01132131|Urinary tract infection|urinary tract infection
5538871|NCT01132131|Cystitis|cystitis
5538872|NCT01132131|Bacteruria|bacteruria
5538873|NCT01132118|rheumatoid arthritis|rheumatoid arthritis
5538874|NCT01132118|insulin resistance|insulin resistance
5538875|NCT01132118|hydroxychloroquine|hydroxychloroquine
5533242|NCT01154296|STD|std
5538876|NCT01132118|cholesterol|cholesterol
5538877|NCT01132092|Evoked Potentials, Adult, Hearing Loss|evoked potentials, adult, hearing loss
5538878|NCT01132079|atopic dermatitis|atopic dermatitis
5538879|NCT01132079|barrier function|barrier function
5538880|NCT01132079|pimecrolimus|pimecrolimus
5538881|NCT01132066|swallowing|swallowing
5538882|NCT01132066|stroke|stroke
5538883|NCT01132053|JC Virus|jc virus
5538884|NCT01132040|Bioequivalence|bioequivalence
5538885|NCT01132040|Crossover|crossover
5538886|NCT01132040|Primidone|primidone
5538887|NCT01132027|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
5538888|NCT01132014|Subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,|subjects with recurrent ovarian, fallopian tube or primary peritoneal cancer,
5538889|NCT01132014|from whom solid tumor or ascites have been harvested and are available and|from whom solid tumor or ascites have been harvested and are available and
5538890|NCT01132014|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5|sufficient for tumorlysate preparation;and whose largest tumor nodule is 4.5
5538891|NCT01132014|cm. Subjects may have undergone chemotherapy or other therapy following|cm. subjects may have undergone chemotherapy or other therapy following
5538892|NCT01132014|tumor harvesting and prior to enrollment.|tumor harvesting and prior to enrollment.
5538893|NCT01131988|Bioavailability, crossover, tacrolimus|bioavailability, crossover, tacrolimus
5538894|NCT01131975|Bioequivalence|bioequivalence
5538895|NCT01131975|Crossover|crossover
5538896|NCT01131975|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
5538897|NCT01131962|esophageal varices|esophageal varices
5538898|NCT01131962|hematemesis|hematemesis
5538899|NCT01131962|endoscopy|endoscopy
5538900|NCT01131949|Bioequivalence|bioequivalence
5538901|NCT01131949|Crossover|crossover
5538902|NCT01131949|Lamotrigine (chewable, dispersible)|lamotrigine (chewable, dispersible)
5538903|NCT01131936|Bioequivalence|bioequivalence
5538904|NCT01131936|Amlodipine Besylate|amlodipine besylate
5538905|NCT01131923|Bioequivalence|bioequivalence
5538906|NCT01131923|Amlodipine Besylate|amlodipine besylate
5538907|NCT01131910|Rheumatoid arthritis|rheumatoid arthritis
5538908|NCT01131910|TBE-vaccine|tbe-vaccine
5538909|NCT01131910|Immunosuppression|immunosuppression
5538910|NCT01131897|Bioavailability|bioavailability
5538911|NCT01131897|Crossover|crossover
5538912|NCT01131897|Levetiracetam|levetiracetam
5538913|NCT01131884|ASIA A or ASIA B Spinal Cord Injury|asia a or asia b spinal cord injury
5538914|NCT01131871|obesity|obesity
5538915|NCT01131871|overweight|overweight
5538916|NCT01131832|Cholesterol, Plant sterols, Non-response, SNPs,|cholesterol, plant sterols, non-response, snps,
5538917|NCT01131819|Trans-tibial Amputation|trans-tibial amputation
5538918|NCT01131806|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5538919|NCT01131806|lung function change FEV1 FVC|lung function change fev1 fvc
5538920|NCT01131806|acute exacerbation|acute exacerbation
5538921|NCT01131806|life quality questionnaire|life quality questionnaire
5538922|NCT01131793|Coronary Artery Chronic Total Occlusion In-Stent|coronary artery chronic total occlusion in-stent
5538923|NCT01131780|Bioequivalence|bioequivalence
5538924|NCT01131780|Crossover|crossover
5538925|NCT01131780|Ibuprofen and Pseudoephedrine|ibuprofen and pseudoephedrine
5538926|NCT01131767|Bioequivalence|bioequivalence
5538927|NCT01131767|Crossover|crossover
5538928|NCT01131767|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
5538929|NCT01131754|Peripheral venous catheter complications|peripheral venous catheter complications
5538930|NCT01131754|PVC occlusion|pvc occlusion
5538931|NCT01131754|PVC phlebitis|pvc phlebitis
5538932|NCT01131741|anesthesia, general|anesthesia, general
5538933|NCT01131741|blood pressure|blood pressure
5538934|NCT01131741|epinephrine|epinephrine
5538935|NCT01131741|heart rate|heart rate
5538936|NCT01131741|injections, intravenous|injections, intravenous
5538937|NCT01131728|Bioequivalence|bioequivalence
5538938|NCT01131728|Crossover|crossover
5538939|NCT01131728|Naproxen Sodium and Pseudoephedrine Hydrochloride|naproxen sodium and pseudoephedrine hydrochloride
5538940|NCT01131715|Qualitetive interview|qualitetive interview
5538941|NCT01131715|Coronary heart disease (CHD)|coronary heart disease (chd)
5538942|NCT01131715|Patient experience|patient experience
5538943|NCT01131715|Patient perception|patient perception
5538944|NCT01131702|Bioequivalence|bioequivalence
5538945|NCT01131702|Crossover|crossover
5538946|NCT01131702|Ranitidine|ranitidine
5538947|NCT01131689|metastatic HCC|metastatic hcc
5538948|NCT01131663|Infants, aerosol, acceptance, face mask, drug delivery|infants, aerosol, acceptance, face mask, drug delivery
5538949|NCT01131650|Prevalence of diabetic retinopathy|prevalence of diabetic retinopathy
5538950|NCT01131650|Diabetes|diabetes
5538951|NCT01131650|Retinopathy|retinopathy
5538952|NCT01131650|Prevalence|prevalence
5538953|NCT01131650|Population|population
5538954|NCT01131637|chronic heart failure|chronic heart failure
5538955|NCT01131637|rhNRG-1|rhnrg-1
5538956|NCT01131637|mortality|mortality
5538957|NCT01131624|Iron deficiency|iron deficiency
5538958|NCT01131611|Spinal Stenosis|spinal stenosis
5521395|NCT01203163|PDT|pdt
5538960|NCT01131611|Physical Therapy (specialty)|physical therapy (specialty)
5538961|NCT01131611|Cognitive Behavior Therapy|cognitive behavior therapy
5538962|NCT01131611|Behavioral Research|behavioral research
5538963|NCT01131598|ALI|ali
5538965|NCT01131585|Diabetic macular edema|diabetic macular edema
5538966|NCT01131585|DME|dme
5538967|NCT01131585|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5538968|NCT01131585|PDR|pdr
5538969|NCT01131585|ranibizumab|ranibizumab
5538970|NCT01131585|laser|laser
5538971|NCT01131559|bipolar disorder|bipolar disorder
5538972|NCT01131559|manic depression|manic depression
5538973|NCT01131559|depression|depression
5538974|NCT01131559|Bipolar I or II|bipolar i or ii
5538975|NCT01131546|Essential Hypertension|essential hypertension
5538976|NCT01131546|Levamlodipine Besylate|levamlodipine besylate
5538977|NCT01131546|Amlodipine Maleate|amlodipine maleate
5538979|NCT01131520|Drug abuse|drug abuse
5538980|NCT01131507|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5538981|NCT01131507|Infants with CF|infants with cf
5538982|NCT01131494|Parkinson's disease|parkinson's disease
5538983|NCT01131494|Dysphagia|dysphagia
5538984|NCT01131494|Treatment|treatment
5538985|NCT01131481|cataracts,glistenings,intraocular lenses.|cataracts,glistenings,intraocular lenses.
5538986|NCT01131468|ototoxicity|ototoxicity
5538987|NCT01131468|aminoglycoside|aminoglycoside
5538988|NCT01131468|vancomycine|vancomycine
5538989|NCT01131468|peritoneal dialysis|peritoneal dialysis
5538990|NCT01131468|peritonitis|peritonitis
5538991|NCT01131442|immune|immune
5538992|NCT01131429|mutation analysis|mutation analysis
5538993|NCT01131429|first-line|first-line
5538994|NCT01131429|second-line|second-line
5538995|NCT01131429|targeted therapy|targeted therapy
5538996|NCT01131403|IL-1α, skin care; baby wet wipes; full-term newborn; skin barrier function|il-1α, skin care; baby wet wipes; full-term newborn; skin barrier function
5538997|NCT01131377|mechanical ventilation weaning phase patients with metabolic alkalosis|mechanical ventilation weaning phase patients with metabolic alkalosis
5538998|NCT01131364|Interleukin|interleukin
5538999|NCT01131364|IL2|il2
5539000|NCT01131364|F16|f16
5539001|NCT01131364|monoclonal|monoclonal
5539002|NCT01131364|antibody|antibody
5539003|NCT01131364|cytokine|cytokine
5539004|NCT01131364|doxorubicin|doxorubicin
5539005|NCT01131364|breast cancer|breast cancer
5539006|NCT01131364|solid tumour|solid tumour
5539007|NCT01131364|Phase I: Advanced Solid Tumour Patients|phase i: advanced solid tumour patients
5539008|NCT01131364|Phase II: Breast Cancer Patients Amenable to anthracyclin Therapy|phase ii: breast cancer patients amenable to anthracyclin therapy
5539009|NCT01131351|MDR-TB|mdr-tb
5539010|NCT01131351|Dose Escalation|dose escalation
5539011|NCT01131351|Phase II|phase ii
5539012|NCT01131351|Open Label|open label
5539013|NCT01131351|Non Controlled|non controlled
5539014|NCT01131351|Pulmonary Multidrug-Resistant Tuberculosis (MDR TB)|pulmonary multidrug-resistant tuberculosis (mdr tb)
5539015|NCT01131325|Philadelphia chromosome positive|philadelphia chromosome positive
5539017|NCT01131325|chronic myelogenous leukemia chronic phase|chronic myelogenous leukemia chronic phase
5539018|NCT01131325|CML-CP|cml-cp
5539019|NCT01131325|low imatinib trough levels|low imatinib trough levels
5539020|NCT01131312|Cervix|cervix
5539021|NCT01131312|CIN|cin
5539022|NCT01131312|HPV|hpv
5539023|NCT01131312|Triage|triage
5539024|NCT01131312|ASCUS/LSIL|ascus/lsil
5539025|NCT01131312|Pap Smear|pap smear
5539026|NCT01131312|HPV Test|hpv test
5539027|NCT01131299|HDL|hdl
5539028|NCT01131299|Cholesterol|cholesterol
5539029|NCT01131299|Lipoproteins|lipoproteins
5539030|NCT01131299|Serum Lipids|serum lipids
5539031|NCT01131299|Alpha-Cyclodextrin|alpha-cyclodextrin
5539032|NCT01131299|Atherosclerosis|atherosclerosis
5539033|NCT01131299|Heart Disease|heart disease
5539034|NCT01131273|buprenorphine injecting|buprenorphine injecting
5539035|NCT01131273|opiate dependence|opiate dependence
5539036|NCT01131273|HIV risk|hiv risk
5539037|NCT01131273|treatment outcome|treatment outcome
5539038|NCT01131273|opiate dependence with buprenorphine injecting|opiate dependence with buprenorphine injecting
5539039|NCT01131260|STAN|stan
5539040|NCT01131260|Fetal monitoring|fetal monitoring
5539041|NCT01131260|Fetal acidosis|fetal acidosis
5539042|NCT01131260|Fetal heart rate monitoring|fetal heart rate monitoring
5539043|NCT01131260|Perinatology|perinatology
5539044|NCT01131247|CLL|cll
5539045|NCT01131247|bendamustine|bendamustine
5539046|NCT01131247|ofatumumab|ofatumumab
5539047|NCT01131247|blood cancer|blood cancer
5539048|NCT01131247|leukemia|leukemia
5539049|NCT01131247|lymphoma|lymphoma
5539050|NCT01131247|lymphocyte|lymphocyte
5539051|NCT01131247|refractory|refractory
5539052|NCT01131247|Advanced|advanced
5539053|NCT01131247|relapsed|relapsed
5539054|NCT01131247|hematologic|hematologic
5539055|NCT01131247|hematology|hematology
5539056|NCT01131247|antibody|antibody
5539057|NCT01131247|non-Hodgkin lymphoma|non-hodgkin lymphoma
5539058|NCT01131247|small lymphocytic lymphoma|small lymphocytic lymphoma
5539059|NCT01131247|nevada cancer institute|nevada cancer institute
5539060|NCT01131247|cephalon|cephalon
5539061|NCT01131247|Glaxosmithkline|glaxosmithkline
5521495|NCT01202825|HPC|hpc
5539062|NCT01131221|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5539063|NCT01131221|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5533411|NCT01153490|Substance use|substance use
5539064|NCT01131221|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5539065|NCT01131221|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5539066|NCT01131221|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5539067|NCT01131221|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5539068|NCT01131221|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5539069|NCT01131221|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5539070|NCT01131221|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5539071|NCT01131221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5539072|NCT01131221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5539073|NCT01131221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5539074|NCT01131208|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5539075|NCT01131208|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5539076|NCT01131208|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5539077|NCT01131208|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5539078|NCT01131208|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5539079|NCT01131208|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5539080|NCT01131195|HER2-negative breast cancer|her2-negative breast cancer
5539081|NCT01131195|recurrent breast cancer|recurrent breast cancer
5539082|NCT01131195|stage IIIB breast cancer|stage iiib breast cancer
5539083|NCT01131195|stage IIIC breast cancer|stage iiic breast cancer
5539084|NCT01131195|stage IV breast cancer|stage iv breast cancer
5539085|NCT01131169|Myeloma|myeloma
5539086|NCT01131169|Busulfan|busulfan
5539087|NCT01131169|Melphalan|melphalan
5539088|NCT01131169|Fludarabine|fludarabine
5539089|NCT01131169|T-Cell|t-cell
5539090|NCT01131169|Stem Cell Transplantation|stem cell transplantation
5539091|NCT01131169|10-051|10-051
5539092|NCT01131156|postpartum|postpartum
5539093|NCT01131156|smoking|smoking
5539094|NCT01131156|relapse|relapse
5539095|NCT01131156|breastfeeding|breastfeeding
5539096|NCT01131143|Urban community centers|urban community centers
5539097|NCT01131143|Obesity|obesity
5539098|NCT01131143|Obesity counseling|obesity counseling
5539099|NCT01131143|Low-cost intervention|low-cost intervention
5539100|NCT01131130|Contact lens|contact lens
5539101|NCT01131117|healthy|healthy
5539102|NCT01131117|women|women
5539103|NCT01131117|pregnancy|pregnancy
5539104|NCT01131104|NAION|naion
5539105|NCT01131065|Hepatitis B|hepatitis b
5539106|NCT01131065|HBV|hbv
5539107|NCT01131065|Orthotopic liver transplantation|orthotopic liver transplantation
5539108|NCT01131065|Liver transplantation|liver transplantation
5539109|NCT01131065|Recurrence|recurrence
5539110|NCT01131065|Reinfection|reinfection
5539111|NCT01131065|Protective titers|protective titers
5539112|NCT01131065|HBsAb|hbsab
5539113|NCT01131065|Hepatitis B virus immune globulin|hepatitis b virus immune globulin
5539114|NCT01131065|Niuliva|niuliva
5539115|NCT01131052|elderly populations|elderly populations
5539116|NCT01131052|diabetes|diabetes
5539117|NCT01131039|Ovarian Cancer|ovarian cancer
5539118|NCT01131026|Helicobacter pylori|helicobacter pylori
5539119|NCT01131026|levofloxacin|levofloxacin
5539120|NCT01131026|amoxicillin|amoxicillin
5539121|NCT01131026|lansoprazole|lansoprazole
5539122|NCT01131026|efficacy|efficacy
5539123|NCT01131026|safety|safety
5539124|NCT01131026|triple therapy|triple therapy
5539125|NCT01130987|resident|resident
5539126|NCT01130987|intern|intern
5539127|NCT01130987|patient safety|patient safety
5539128|NCT01130987|medical error|medical error
5539129|NCT01130987|time motion|time motion
5539130|NCT01130987|handoff|handoff
5539131|NCT01130987|sign-out|sign-out
5539132|NCT01130987|Resident Workflow|resident workflow
5539133|NCT01130987|Resident Communications|resident communications
5539134|NCT01130961|Advanced NSCLC|advanced nsclc
5539135|NCT01130961|Gefitinib|gefitinib
5539136|NCT01130961|Thai patient|thai patient
5539137|NCT01130948|hypoxia|hypoxia
5539138|NCT01130948|altitude|altitude
5539140|NCT01130948|sleep apnea|sleep apnea
5539141|NCT01130948|periodic breathing|periodic breathing
5539142|NCT01130948|vigilance|vigilance
5539143|NCT01130948|psychomotor|psychomotor
5539144|NCT01130948|endothelial function|endothelial function
5539145|NCT01130935|GERD|gerd
5539146|NCT01130935|gastric and duodenal ulcers|gastric and duodenal ulcers
5539147|NCT01130935|NSAID therapy|nsaid therapy
5539148|NCT01130922|Roux-and-Y gastric bypass surgery|roux-and-y gastric bypass surgery
5539149|NCT01130922|stable body weight|stable body weight
5539151|NCT01130909|Effect of a single dose on gamma-band qEEG|effect of a single dose on gamma-band qeeg
5539152|NCT01130896|MRI, pacemakers, Defibrillator|mri, pacemakers, defibrillator
5539153|NCT01130883|acute tracheitis|acute tracheitis
5539154|NCT01130883|acute tracheobronchitis or acute bronchitis|acute tracheobronchitis or acute bronchitis
5539155|NCT01130883|acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
5862958|NCT00001451|Unrelated Marrow Donor|unrelated marrow donor
5539156|NCT01130883|mild community-acquired pneumonia|mild community-acquired pneumonia
5539157|NCT01130870|Fecal incontinence|fecal incontinence
5539158|NCT01130870|Sacral nerve stimulation|sacral nerve stimulation
5539159|NCT01130870|Quality of life|quality of life
5539160|NCT01130870|DR15.9 Incontinentia alva|dr15.9 incontinentia alva
5539161|NCT01130818|Safety|safety
5539162|NCT01130818|Tolerability|tolerability
5539163|NCT01130818|Pharmacokinetics|pharmacokinetics
5539164|NCT01130818|Bioavailability (solid vs solution, fasting vs fed)|bioavailability (solid vs solution, fasting vs fed)
5539165|NCT01130818|Young healthy subjects|young healthy subjects
5539166|NCT01130818|Elderly healthy subjects|elderly healthy subjects
5539167|NCT01130805|gastric cancer pazopanib capecitabine, oxaliplatin|gastric cancer pazopanib capecitabine, oxaliplatin
5539168|NCT01130805|Metastatic or recurrent gastric cancer|metastatic or recurrent gastric cancer
5539170|NCT01130792|cryptosporidium|cryptosporidium
5539171|NCT01130792|probiotics|probiotics
5539172|NCT01130792|intestinal function|intestinal function
5539173|NCT01130792|immune response|immune response
5539174|NCT01130779|Non-small Cell Lung Cancer|non-small cell lung cancer
5539175|NCT01130779|Erlotinib|erlotinib
5539176|NCT01130779|brain metastasis|brain metastasis
5539177|NCT01130766|Non-small Cell Lung Cancer|non-small cell lung cancer
5539178|NCT01130766|Asymptomatic brain metastasis|asymptomatic brain metastasis
5539179|NCT01130766|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
5539180|NCT01130740|Osteoarthritis|osteoarthritis
5539181|NCT01130740|Exercise|exercise
5539182|NCT01130740|Diet|diet
5539183|NCT01130740|Coping Skills|coping skills
5539184|NCT01130740|Education, Medical|education, medical
5539185|NCT01130727|diabetes mellitus|diabetes mellitus
5539186|NCT01130727|diabetic nephropathy|diabetic nephropathy
5539187|NCT01130727|hypertension|hypertension
5539188|NCT01130727|green tea|green tea
5539189|NCT01130727|cocoa|cocoa
5539190|NCT01130727|polyphenol|polyphenol
5539191|NCT01130727|nitric oxide|nitric oxide
5539192|NCT01130714|inflammation|inflammation
5539193|NCT01130714|chemotherapy|chemotherapy
5539194|NCT01130714|lung cancer|lung cancer
5539195|NCT01130701|Pancreatic Cancer|pancreatic cancer
5539196|NCT01130701|Neoadjuvant|neoadjuvant
5539197|NCT01130701|Panitumumab|panitumumab
5539198|NCT01130701|Capecitabine|capecitabine
5539199|NCT01130688|Leukemia|leukemia
5539200|NCT01130688|Zileuton|zileuton
5539201|NCT01130688|myeloproliferative neoplasm|myeloproliferative neoplasm
5539202|NCT01130662|acute myeloid leukemia|acute myeloid leukemia
5539204|NCT01130662|Relapsed AML|relapsed aml
5539205|NCT01130662|Refractory AML|refractory aml
5539206|NCT01130649|Epilepsy|epilepsy
5539207|NCT01130649|Tracking|tracking
5539208|NCT01130649|Electronic diary|electronic diary
5539209|NCT01130636|oseltamivir carboxylate|oseltamivir carboxylate
5539210|NCT01130636|oseltamivir phosphate|oseltamivir phosphate
5539211|NCT01130636|Tamiflu pharmacokinetics in lactating women with influenza|tamiflu pharmacokinetics in lactating women with influenza
5539212|NCT01130623|VEGF Inhibitor|vegf inhibitor
5539213|NCT01130623|Maximum Tolerated Dose|maximum tolerated dose
5539214|NCT01130623|Dose Escalation|dose escalation
5539215|NCT01130623|Pharmacokinetics|pharmacokinetics
5539216|NCT01130623|Antitumor Activity|antitumor activity
5539217|NCT01130623|Pediatric Cancer|pediatric cancer
5539218|NCT01130623|Solid Tumor|solid tumor
5539219|NCT01130623|Sarcoma|sarcoma
5539220|NCT01130623|Neuroblastoma|neuroblastoma
5539221|NCT01130623|Wilms Tumor|wilms tumor
5539222|NCT01130623|Osteosarcoma|osteosarcoma
5539223|NCT01130623|Brain Tumor|brain tumor
5539224|NCT01130610|preoperative period|preoperative period
5539225|NCT01130610|preoperative care|preoperative care
5539226|NCT01130610|anesthesia|anesthesia
5539227|NCT01130610|program evaluation|program evaluation
5539228|NCT01130597|HF|hf
5539229|NCT01130597|Heart failure|heart failure
5539230|NCT01130597|hyperkalemia|hyperkalemia
5539231|NCT01130597|chronic kidney disease|chronic kidney disease
5539232|NCT01130597|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
5539233|NCT01130584|Cancer Patients|cancer patients
5539234|NCT01130558|type 2 diabetes mellitus|type 2 diabetes mellitus
5539235|NCT01130558|basal-bolus insulin|basal-bolus insulin
5539242|NCT01130532|ED|ed
5539243|NCT01130532|Impotence|impotence
5539250|NCT01130467|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5539251|NCT01130467|Attention Deficit Disorder|attention deficit disorder
5539252|NCT01130467|Event related potential|event related potential
5539375|NCT01129817|Chronic Low Back Pain|chronic low back pain
5539253|NCT01130454|Unfavorable effect of environmental factors, stressors|unfavorable effect of environmental factors, stressors
5539254|NCT01130441|adolescent behavior|adolescent behavior
5539255|NCT01130441|harm reduction|harm reduction
5539256|NCT01130428|Mechanical stimulation|mechanical stimulation
5539257|NCT01130428|Vibration platform|vibration platform
5539258|NCT01130428|Bone metabolism|bone metabolism
5539259|NCT01130428|ATP release|atp release
5539260|NCT01130415|Sacral neuromodulation|sacral neuromodulation
5539261|NCT01130415|Screening|screening
5539262|NCT01130415|Percutaneous nerve evaluation|percutaneous nerve evaluation
5539263|NCT01130415|Tined lead|tined lead
5539266|NCT01130402|fine needle aspiration|fine needle aspiration
5539268|NCT01130389|ONJ|onj
5539269|NCT01130376|Immune based therapy|immune based therapy
5539270|NCT01130376|Therapeutic vaccination|therapeutic vaccination
5539271|NCT01130376|cytokine therapy|cytokine therapy
5539272|NCT01130376|HIV therapeutic vaccine|hiv therapeutic vaccine
5539273|NCT01130363|Proton Pump Inhibitor|proton pump inhibitor
5539274|NCT01130363|Gastric carcinoid tumors|gastric carcinoid tumors
5539275|NCT01130363|Gastric cancer|gastric cancer
5539276|NCT01130363|Fundic Gland Polyps|fundic gland polyps
5539277|NCT01130324|VIBATIV|vibativ
5539278|NCT01130324|telavancin|telavancin
5539279|NCT01130324|Pregnancy|pregnancy
5539280|NCT01130324|Registry|registry
5539281|NCT01130298|testosterone,|testosterone,
5539282|NCT01130298|Pharmacokinetics|pharmacokinetics
5539283|NCT01130298|replacement,|replacement,
5539284|NCT01130298|therapy|therapy
5539285|NCT01130285|Lung Cancer|lung cancer
5539286|NCT01130272|Irritable bowel syndrome with diarrhea|irritable bowel syndrome with diarrhea
5539287|NCT01130272|Irritable bowel syndrome|irritable bowel syndrome
5539288|NCT01130272|Diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5539289|NCT01130272|Colonic diseases|colonic diseases
5539290|NCT01130272|Colonic diseases, functional|colonic diseases, functional
5539291|NCT01130272|Digestive system disease|digestive system disease
5539292|NCT01130272|Gastrointestinal disease|gastrointestinal disease
5539293|NCT01130272|Intestinal disease|intestinal disease
5539294|NCT01130272|Colonic pseudo-obstruction|colonic pseudo-obstruction
5539295|NCT01130272|Diarrhea|diarrhea
5539296|NCT01130272|Signs and Symptoms, Digestive|signs and symptoms, digestive
5539297|NCT01130259|mTNBC|mtnbc
5539298|NCT01130259|triple negative breast cancer|triple negative breast cancer
5539299|NCT01130259|metastatic triple negative breast cancer|metastatic triple negative breast cancer
5539300|NCT01130259|metastatic breast cancer that is ER-, PR-, and HER2-negative|metastatic breast cancer that is er-, pr-, and her2-negative
5539314|NCT01130155|Access to treatment|access to treatment
5539315|NCT01130155|Quality of care|quality of care
5539316|NCT01130129|Flavonoids|flavonoids
5539317|NCT01130129|Platelets|platelets
5539319|NCT01130103|anxiety disorders|anxiety disorders
5539320|NCT01130103|trauma|trauma
5539321|NCT01130077|Pediatric glioma|pediatric glioma
5539322|NCT01130077|Vaccine therapy|vaccine therapy
5539323|NCT01130064|Asthma|asthma
5539324|NCT01130064|QAX576|qax576
5539325|NCT01130051|bioavailability|bioavailability
5539326|NCT01130038|Characteristic of play|characteristic of play
5539327|NCT01130038|DCD|dcd
5539328|NCT01130038|children|children
5539329|NCT01130038|Typical Development|typical development
5539423|NCT01129518|meningococcal serogroup C|meningococcal serogroup c
5539424|NCT01129518|vaccine|vaccine
5539425|NCT01129518|conjugate|conjugate
5539330|NCT01130038|Whether there are any differences in the issue of Characteristic of play between Children with DCD and Children with Typical Development|whether there are any differences in the issue of characteristic of play between children with dcd and children with typical development
5539331|NCT01130012|Gestational diabetes mellitus|gestational diabetes mellitus
5539332|NCT01130012|Lifestyle intervention|lifestyle intervention
5539333|NCT01130012|Oral glucose tolerance test|oral glucose tolerance test
5539334|NCT01130012|Insulin treatment|insulin treatment
5539335|NCT01130012|Pregnancy outcomes|pregnancy outcomes
5539336|NCT01129999|smoking cessation, CBT, hypnotherapy|smoking cessation, cbt, hypnotherapy
5539337|NCT01129986|venous ulcer Dermastream|venous ulcer dermastream
5539338|NCT01129973|speech and language|speech and language
5539339|NCT01129973|phonoaudiology|phonoaudiology
5539340|NCT01129973|marketing|marketing
5539341|NCT01129960|Diabetic Neuropathic Pain|diabetic neuropathic pain
5539342|NCT01129934|Low Back Pain,|low back pain,
5539343|NCT01129934|Emergency medicine,|emergency medicine,
5539344|NCT01129934|Promethazine,|promethazine,
5539345|NCT01129934|Morphine,|morphine,
5539346|NCT01129934|Pain relief|pain relief
5539347|NCT01129921|Lumbar Spine Stenosis|lumbar spine stenosis
5539348|NCT01129921|Decompression|decompression
5539349|NCT01129908|oral health in children with celiac disease|oral health in children with celiac disease
5539350|NCT01129882|Schizophrenia|schizophrenia
5539352|NCT01129869|Perception|perception
5539353|NCT01129869|Perception of Clinical Research Participation|perception of clinical research participation
5539354|NCT01129869|Research Participant Perception|research participant perception
5539355|NCT01129856|Dry eye|dry eye
5539356|NCT01129856|Keratoconjunctivitis sicca|keratoconjunctivitis sicca
5539357|NCT01129856|Iontophoresis|iontophoresis
5539358|NCT01129856|Ophthalmic drug delivery|ophthalmic drug delivery
5539359|NCT01129856|EGP-437|egp-437
5539360|NCT01129856|Dexamethasone phosphate|dexamethasone phosphate
5539361|NCT01129843|anemia|anemia
5539362|NCT01129843|iron deficiency|iron deficiency
5539363|NCT01129843|nutritional|nutritional
5539364|NCT01129843|iron supplementation|iron supplementation
5521850|NCT01201356|FTY720|fty720
5539365|NCT01129843|cluster randomized control trial|cluster randomized control trial
5539366|NCT01129830|ovarian reserve|ovarian reserve
5539367|NCT01129830|FSH|fsh
5539369|NCT01129830|estradiol|estradiol
5539370|NCT01129830|oocyte|oocyte
5539371|NCT01129830|IVF|ivf
5539372|NCT01129830|embryo transfer|embryo transfer
5539373|NCT01129817|Cognitive Functional Therapy|cognitive functional therapy
5539374|NCT01129817|Manual Therapy and Exercise|manual therapy and exercise
5539376|NCT01129817|Randomized Controlled Trial|randomized controlled trial
5539378|NCT01129804|Alcohol dependence|alcohol dependence
5539379|NCT01129804|Network Support|network support
5539380|NCT01129804|Cognitive-behavioral treatment|cognitive-behavioral treatment
5539381|NCT01129804|Relapse prevention|relapse prevention
5539382|NCT01129804|Consequences of drinking|consequences of drinking
5539383|NCT01129804|Social network development|social network development
5539384|NCT01129791|Lactose intolerance|lactose intolerance
5539385|NCT01129791|Dairy products|dairy products
5539386|NCT01129791|Raw milk|raw milk
5539387|NCT01129791|Adults|adults
5539388|NCT01129765|Nasal suction|nasal suction
5539389|NCT01129765|Nasal aspiration|nasal aspiration
5539390|NCT01129765|Nasal saline irrigation|nasal saline irrigation
5539391|NCT01129765|Nasal lavage|nasal lavage
5539392|NCT01129739|Bone Marrow Disease|bone marrow disease
5539393|NCT01129739|MDS-RA|mds-ra
5539394|NCT01129739|MDS-RARS|mds-rars
5539395|NCT01129739|Umbilical Cord/placenta-Derived MSC|umbilical cord/placenta-derived msc
5539396|NCT01129739|Transplant|transplant
5539397|NCT01129726|Transillumination-guided|transillumination-guided
5539398|NCT01129726|Fiberoptic Intubation|fiberoptic intubation
5539399|NCT01129726|time|time
5539400|NCT01129726|success rate|success rate
5539401|NCT01129726|intubation|intubation
5539402|NCT01129713|GERD|gerd
5539403|NCT01129713|Acid Reflux|acid reflux
5539404|NCT01129713|Heartburn|heartburn
5539405|NCT01129713|Regurgitation|regurgitation
5539406|NCT01129713|Indigestion|indigestion
5539407|NCT01129700|rectal cancer, short-course, chemoradiotherapy|rectal cancer, short-course, chemoradiotherapy
5539408|NCT01129648|Hyperuricemia, gout|hyperuricemia, gout
5539409|NCT01129635|Heart failure|heart failure
5539410|NCT01129635|Cardiac resynchronization therapy|cardiac resynchronization therapy
5539411|NCT01129635|Regional left ventricular dyssynchrony|regional left ventricular dyssynchrony
5539413|NCT01129622|Letrozole|letrozole
5539414|NCT01129622|Breast MRI|breast mri
5539415|NCT01129622|Postmenopausal women|postmenopausal women
5539416|NCT01129609|Post-approval observation of patients being treated according to the indications for use for the Talent Converter Stent Graft|post-approval observation of patients being treated according to the indications for use for the talent converter stent graft
5539417|NCT01129583|Botulinum Toxin|botulinum toxin
5539418|NCT01129583|Elbow Stiffness|elbow stiffness
5539419|NCT01129544|Severe combined immunodeficiency|severe combined immunodeficiency
5539420|NCT01129544|SCID|scid
5539421|NCT01129544|XSCID|xscid
5539422|NCT01129544|SCID-X1|scid-x1
5539431|NCT01129492|Autoimmune Thyroiditis, Laser, Therapy, Thyroid, Ultrasound|autoimmune thyroiditis, laser, therapy, thyroid, ultrasound
5539432|NCT01129479|Aphasia|aphasia
5539433|NCT01129479|treatment|treatment
5539434|NCT01129479|cholinesterase inhibitor|cholinesterase inhibitor
5539435|NCT01129479|stroke|stroke
5539436|NCT01129453|Salmonella|salmonella
5539437|NCT01129453|Vaccine|vaccine
5539442|NCT01129401|methamphetamine|methamphetamine
5539443|NCT01129401|men who have sex with men|men who have sex with men
5539444|NCT01129401|HIV/AIDS|hiv/aids
5539445|NCT01129362|Pertussis|pertussis
5539446|NCT01129362|Whooping Cough|whooping cough
5539447|NCT01129362|Pertussis Vaccine|pertussis vaccine
5539448|NCT01129349|Solid Tumors|solid tumors
5539449|NCT01129336|HER2-negative|her2-negative
5539450|NCT01129336|HER2|her2
5539451|NCT01129336|Metastatic breast cancer|metastatic breast cancer
5539452|NCT01129336|First Line breast cancer|first line breast cancer
5539453|NCT01129336|Second Line breast cancer|second line breast cancer
5539454|NCT01129336|Breast cancer|breast cancer
5539455|NCT01129336|Metastatic|metastatic
5539456|NCT01129336|Stage IV breast cancer|stage iv breast cancer
5539457|NCT01129336|Progression free survival|progression free survival
5539458|NCT01129336|PFS|pfs
5539459|NCT01129336|Circulating Tumor Cells|circulating tumor cells
5539460|NCT01129336|CTCs|ctcs
5539461|NCT01129336|Zoledronic acid|zoledronic acid
5539462|NCT01129336|HER2-negative metastatic breast cancer patients without bone metastasis|her2-negative metastatic breast cancer patients without bone metastasis
5539463|NCT01129323|Anemia, Severe, Aplastic, Reduced-Intensity, Allogeneic, Stem, Cell, Transplantation|anemia, severe, aplastic, reduced-intensity, allogeneic, stem, cell, transplantation
5539464|NCT01129310|irinotecan|irinotecan
5539465|NCT01129310|capecitabine|capecitabine
5539466|NCT01129310|oxaliplatin|oxaliplatin
5539467|NCT01129310|health-related quality of life|health-related quality of life
5539468|NCT01129310|gastroesophageal(GE) junction adenocarcinoma|gastroesophageal(ge) junction adenocarcinoma
5539469|NCT01129297|Obesity|obesity
5539470|NCT01129297|surgery|surgery
5539471|NCT01129297|genetic expression|genetic expression
5539472|NCT01129297|collection of samples|collection of samples
5539473|NCT01129284|Treatment Resistance|treatment resistance
5539474|NCT01129284|Nephrotic Syndrome|nephrotic syndrome
5533823|NCT01151735|HAE|hae
5539476|NCT01129284|lipoid nephrosis|lipoid nephrosis
5539477|NCT01129284|Membranous nephropathy|membranous nephropathy
5539478|NCT01129284|IgA nephropathy|iga nephropathy
5539479|NCT01129284|proteinuria|proteinuria
5539480|NCT01129258|phase 1|phase 1
5539481|NCT01129258|safety and tolerability|safety and tolerability
5539482|NCT01129258|pharmacokinetics|pharmacokinetics
5539484|NCT01129258|pharmacodynamics|pharmacodynamics
5539485|NCT01129258|PD|pd
5539486|NCT01129258|type 2 diabetes mellitus|type 2 diabetes mellitus
5539487|NCT01129245|Celebrex|celebrex
5539488|NCT01129245|prostoglandin inhibitor|prostoglandin inhibitor
5539489|NCT01129245|ovulation|ovulation
5539490|NCT01129245|emergency contraception|emergency contraception
5539491|NCT01129232|insulin|insulin
5539492|NCT01129219|Strength|strength
5539493|NCT01129219|Function|function
5539494|NCT01129219|Mobility|mobility
5539495|NCT01129206|Gastroesophageal Cancer|gastroesophageal cancer
5539496|NCT01129206|Gastroesophageal Carcinoma|gastroesophageal carcinoma
5539497|NCT01129206|Adenocarcinoma|adenocarcinoma
5539498|NCT01129180|T-Cell Lymphoma|t-cell lymphoma
5539499|NCT01129167|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5539500|NCT01129167|Local invasion by pancreatic adenocarcinoma|local invasion by pancreatic adenocarcinoma
5539501|NCT01129167|Recurrence of pancreatic cancer|recurrence of pancreatic cancer
5539502|NCT01129167|Surgical resection of pancreatic cancer|surgical resection of pancreatic cancer
5539503|NCT01129154|Squamous cell carcinoma|squamous cell carcinoma
5539504|NCT01129141|Tinnitus|tinnitus
5539505|NCT01129141|Traumatic Brain Injury Counseling|traumatic brain injury counseling
5539506|NCT01129141|Counseling|counseling
5539507|NCT01129141|Education|education
5539508|NCT01129141|Evaluation studies|evaluation studies
5539509|NCT01129141|Quality of health care|quality of health care
5539510|NCT01129128|Echinacea|echinacea
5539511|NCT01129128|immune modulation|immune modulation
5539512|NCT01129128|prevention|prevention
5539513|NCT01129089|Acceptability|acceptability
5539514|NCT01129089|Lipid-based nutrient supplements|lipid-based nutrient supplements
5539515|NCT01129089|Micronutrient powder|micronutrient powder
5539516|NCT01129089|Malnutrition|malnutrition
5539517|NCT01129076|Thalassemia Major|thalassemia major
5539518|NCT01129076|Stigma|stigma
5539519|NCT01129076|Singapore|singapore
5539520|NCT01129076|Qualitative|qualitative
5539521|NCT01129050|Fish oil|fish oil
5539522|NCT01129050|Omega-3 fatty acids|omega-3 fatty acids
5539523|NCT01129050|Metabolic syndrome|metabolic syndrome
5539524|NCT01129050|Adults|adults
5539525|NCT01129037|Oncology|oncology
5539526|NCT01129024|Splenectomy|splenectomy
5539527|NCT01129024|Low Platelet Count|low platelet count
5539528|NCT01129024|Thrombopoiesis|thrombopoiesis
5539529|NCT01129024|Thrombocytopaenia|thrombocytopaenia
5539530|NCT01129024|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5539531|NCT01129024|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5539532|NCT01129024|Thrombotic Thrombocytopenic Purpura (ITP)|thrombotic thrombocytopenic purpura (itp)
5539533|NCT01129024|Hematologic Disease|hematologic disease
5539534|NCT01129024|Auto-immune Thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
5539535|NCT01129024|S-888711|s-888711
5539536|NCT01129024|Blood Platelet Disorders|blood platelet disorders
5539537|NCT01129024|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
5539539|NCT01129011|NSAID|nsaid
5539540|NCT01129011|gastric ulcers|gastric ulcers
5539541|NCT01129011|Vimovo|vimovo
5539542|NCT01129011|Esomeprazole|esomeprazole
5539543|NCT01129011|Naproxen|naproxen
5539544|NCT01128998|Sorafenib|sorafenib
5539546|NCT01128998|Advanced Solid Tumors|advanced solid tumors
5539547|NCT01128998|RD|rd
5539548|NCT01128998|MTD|mtd
5539549|NCT01128998|DLT|dlt
5539550|NCT01128998|PK|pk
5539551|NCT01128998|PG|pg
5539552|NCT01128998|Biomarker|biomarker
5539553|NCT01128985|Canagliflozin|canagliflozin
5539554|NCT01128985|Placebo|placebo
5539555|NCT01128985|Type 2 diabetes mellitus|type 2 diabetes mellitus
5539556|NCT01128985|Pharmacokinetic|pharmacokinetic
5539557|NCT01128985|Pharmacodynamic|pharmacodynamic
5539558|NCT01128972|enamel erosion|enamel erosion
5539559|NCT01128972|tooth remineralization|tooth remineralization
5539560|NCT01128972|tooth erosion|tooth erosion
5539561|NCT01128959|Epilepsy|epilepsy
5539562|NCT01128959|Intravenous Carbamazepine|intravenous carbamazepine
5539563|NCT01128959|Oral Carbamazepine|oral carbamazepine
5539564|NCT01128946|Enamel remineralization|enamel remineralization
5539565|NCT01128946|Fluoride|fluoride
5539566|NCT01128946|caries|caries
5539567|NCT01128933|Fractional flow reserve|fractional flow reserve
5539568|NCT01128933|Revascularization|revascularization
5539569|NCT01128933|Prognosis|prognosis
5539570|NCT01128933|Hemodynamics|hemodynamics
5539571|NCT01128933|Hypertension|hypertension
5539572|NCT01128920|bacterial infections|bacterial infections
5539573|NCT01128920|skin infections|skin infections
5539574|NCT01128920|HIV|hiv
5539575|NCT01128920|Hepatitis C|hepatitis c
5539576|NCT01128920|risk reduction intervention|risk reduction intervention
5533898|NCT01151397|SVR|svr
5539577|NCT01128907|Invasive Aspergillosis in neutropenic patients|invasive aspergillosis in neutropenic patients
5539578|NCT01128894|GSK716155|gsk716155
5539579|NCT01128894|liraglutide|liraglutide
5539580|NCT01128894|albiglutide|albiglutide
5539581|NCT01128894|open-label|open-label
5539582|NCT01128868|Reverse oblique intertrochanteric fractures|reverse oblique intertrochanteric fractures
5539583|NCT01128868|Reverse oblique subtrochanteric fractures|reverse oblique subtrochanteric fractures
5539584|NCT01128855|Duchenne|duchenne
5539585|NCT01128855|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5539586|NCT01128855|DMD|dmd
5539587|NCT01128855|968|968
5539588|NCT01128842|Neratinib|neratinib
5539589|NCT01128842|Capecitabine|capecitabine
5539590|NCT01128842|Combination|combination
5539591|NCT01128842|Solid Tumor|solid tumor
5539592|NCT01128829|obesity|obesity
5539594|NCT01128829|artificial sweeteners|artificial sweeteners
5539595|NCT01128816|obstructive sleep apnea|obstructive sleep apnea
5539596|NCT01128816|central sleep apnea|central sleep apnea
5539597|NCT01128816|heart failure|heart failure
5539598|NCT01128816|congestive heart failure|congestive heart failure
5539599|NCT01128816|adaptive servo ventilation|adaptive servo ventilation
5539600|NCT01128816|ASV|asv
5539601|NCT01128803|Hepatocellular carcinoma|hepatocellular carcinoma
5539602|NCT01128803|immunotherapy|immunotherapy
5539603|NCT01128803|alpha foetoprotein|alpha foetoprotein
5539604|NCT01128803|dendritic cells|dendritic cells
5539605|NCT01128790|exercise|exercise
5539606|NCT01128790|remote ischemic preconditioning|remote ischemic preconditioning
5539607|NCT01128790|heart failure|heart failure
5539608|NCT01128790|left ventricular dysfunction|left ventricular dysfunction
5539609|NCT01128777|depression|depression
5539610|NCT01128777|anxiety|anxiety
5539611|NCT01128777|family conflict|family conflict
5539612|NCT01128777|behavior problems|behavior problems
5539613|NCT01128751|Cognition|cognition
5539614|NCT01128751|Neuroprotection|neuroprotection
5539615|NCT01128751|Cardiopulmonary bypass|cardiopulmonary bypass
5539616|NCT01128751|Aortic valve replacement|aortic valve replacement
5539617|NCT01128751|Micro-emboli|micro-emboli
5539618|NCT01128738|Neuromuscular Agents|neuromuscular agents
5539619|NCT01128738|Botulinum Toxin Type A|botulinum toxin type a
5539620|NCT01128738|Sweating|sweating
5539621|NCT01128738|Sweat Gland Disease|sweat gland disease
5539622|NCT01128738|Axillary Hyperhidrosis|axillary hyperhidrosis
5539623|NCT01128738|Skin Disease|skin disease
5539624|NCT01128699|Ahmed valve|ahmed valve
5539625|NCT01128699|Neovascular Glaucoma|neovascular glaucoma
5539626|NCT01128699|Uveitic glaucoma|uveitic glaucoma
5539627|NCT01128699|Failed glaucoma|failed glaucoma
5539628|NCT01128699|VEGF-A|vegf-a
5539629|NCT01128699|Intraocular pressure|intraocular pressure
5539630|NCT01128699|Subconjunctival Avastin|subconjunctival avastin
5539631|NCT01128686|retrospective|retrospective
5539632|NCT01128686|naïve Chronic Hepatitis B (CHB) patients|naïve chronic hepatitis b (chb) patients
5539633|NCT01128686|cohort study|cohort study
5539634|NCT01128686|lamivudine|lamivudine
5539635|NCT01128673|Hypoxic Ischemic encephalopathy|hypoxic ischemic encephalopathy
5539636|NCT01128673|Magnet resonance imaging|magnet resonance imaging
5539637|NCT01128673|Selective Head cooling|selective head cooling
5539638|NCT01128673|Therapeutic hypothermia|therapeutic hypothermia
5539639|NCT01128660|Prescription, General practitioner, Pharmacy|prescription, general practitioner, pharmacy
5539640|NCT01128634|Verapamil|verapamil
5539641|NCT01128634|Anticholinergic, β2 agonist|anticholinergic, β2 agonist
5539642|NCT01128634|P-GP|p-gp
5539643|NCT01128634|LABA|laba
5539644|NCT01128634|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
5539645|NCT01128634|LAMA|lama
5539646|NCT01128621|Pharmacokinetics|pharmacokinetics
5539647|NCT01128621|Glucose|glucose
5539648|NCT01128621|Safety|safety
5539649|NCT01128621|Male|male
5539650|NCT01128621|Female|female
5539651|NCT01128621|Metformin|metformin
5539652|NCT01128621|Pharmacodynamics|pharmacodynamics
5539653|NCT01128621|Tolerability|tolerability
5539654|NCT01128621|Type II Diabetes|type ii diabetes
5539656|NCT01128608|Heartburn|heartburn
5539657|NCT01128608|Acid Reflux|acid reflux
5539658|NCT01128595|allergen challenge|allergen challenge
5539659|NCT01128595|early asthmatic response|early asthmatic response
5539660|NCT01128595|mild asthma|mild asthma
5539661|NCT01128595|late asthmatic response|late asthmatic response
5539662|NCT01128582|GERD|gerd
5539663|NCT01128582|Insomnia|insomnia
5539664|NCT01128582|Acid Reflux|acid reflux
5539665|NCT01128582|Heartburn|heartburn
5539666|NCT01128569|mild asthma|mild asthma
5539667|NCT01128569|allergen challenge|allergen challenge
5539668|NCT01128569|early asthmatic response|early asthmatic response
5539669|NCT01128556|allergic conjunctivitis|allergic conjunctivitis
5539670|NCT01128556|histamine skin testing|histamine skin testing
5539671|NCT01128543|lapatinib|lapatinib
5539672|NCT01128543|breast cancer|breast cancer
5539673|NCT01128530|cSSSI|csssi
5539674|NCT01128530|complicated skin and skin structure infections|complicated skin and skin structure infections
5539675|NCT01128530|acute bacterial skin and skin structure infections|acute bacterial skin and skin structure infections
5539676|NCT01128530|abscess|abscess
5539677|NCT01128530|cellulitis|cellulitis
5539678|NCT01128530|bacterial infections|bacterial infections
5539679|NCT01128530|anti-bacterial agents|anti-bacterial agents
5539680|NCT01128530|anti-infective agents|anti-infective agents
5539681|NCT01128530|skin diseases, infectious|skin diseases, infectious
5539682|NCT01128530|skin diseases|skin diseases
5539683|NCT01128530|wound infection|wound infection
5539684|NCT01128517|Maternal education|maternal education
5539685|NCT01128517|Complementary food|complementary food
5539686|NCT01128517|Infant growth|infant growth
5539687|NCT01128478|Acute pancreatitis|acute pancreatitis
5539688|NCT01128478|Enteral nutrition|enteral nutrition
5539689|NCT01128478|Pancreas rest|pancreas rest
5539690|NCT01128465|propofol|propofol
5539691|NCT01128465|awake craniotomy|awake craniotomy
5539692|NCT01128465|patients requiring an awake craniotomy for brain tumor/lesion resection|patients requiring an awake craniotomy for brain tumor/lesion resection
5539693|NCT01128452|Treatment-Resistant Depression|treatment-resistant depression
5539694|NCT01128439|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5539695|NCT01128426|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5539696|NCT01128413|Shock|shock
5539697|NCT01128413|Resuscitation|resuscitation
5539698|NCT01128413|Hemodynamics|hemodynamics
5539699|NCT01128413|Emergencies|emergencies
5539700|NCT01128413|Critical Care|critical care
5539701|NCT01128413|Lactic Acid|lactic acid
5539702|NCT01128413|Plasma volume|plasma volume
5539703|NCT01128400|obesity|obesity
5539704|NCT01128400|orlistat|orlistat
5539705|NCT01128400|taste perception|taste perception
5539706|NCT01128387|esophageal cancer|esophageal cancer
5539707|NCT01128387|Locally advanced esophageal cancer|locally advanced esophageal cancer
5539708|NCT01128374|Periodontal disease|periodontal disease
5539709|NCT01128374|Nonsurgical therapy|nonsurgical therapy
5539710|NCT01128374|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5539711|NCT01128374|Bacterial burden|bacterial burden
5539712|NCT01128374|Gene polymorphisms|gene polymorphisms
5539713|NCT01128348|asthma|asthma
5539714|NCT01128348|adherence|adherence
5539715|NCT01128348|quality of life|quality of life
5539716|NCT01128348|health literacy|health literacy
5539717|NCT01128348|health disparities|health disparities
5539718|NCT01128335|Liver transplantation|liver transplantation
5539719|NCT01128335|HCV-negative recipient|hcv-negative recipient
5539720|NCT01128335|deceased donor|deceased donor
5539721|NCT01128335|sotrastaurin|sotrastaurin
5539722|NCT01128335|oran transplantation|oran transplantation
5539723|NCT01128335|tacrolimus|tacrolimus
5539724|NCT01128322|CKD-828|ckd-828
5539725|NCT01128322|Hypertension|hypertension
5539726|NCT01128322|Primary Hypertension|primary hypertension
5539727|NCT01128322|S-Amlodipine|s-amlodipine
5539728|NCT01128322|Telmisartan|telmisartan
5539729|NCT01128322|Amlodipine|amlodipine
5539730|NCT01128322|Factorial|factorial
5539731|NCT01128322|Phase 2|phase 2
5539732|NCT01128296|high risk stage IIb or III adenocarcinoma of the pancreas|high risk stage iib or iii adenocarcinoma of the pancreas
5539733|NCT01128283|Sepsis|sepsis
5539734|NCT01128283|organ failure|organ failure
5539735|NCT01128283|cytokines|cytokines
5539736|NCT01128283|clotting factors|clotting factors
5539737|NCT01128270|Dichloroacetate|dichloroacetate
5539738|NCT01128270|Chloral Hydrate|chloral hydrate
5539739|NCT01128270|Metabolism|metabolism
5539740|NCT01128244|oral contraceptives|oral contraceptives
5539741|NCT01128244|Vitamin B6|vitamin b6
5539742|NCT01128244|birth control pills|birth control pills
5539743|NCT01128244|amino acids|amino acids
5539744|NCT01128244|Vitamin B6 deficiency|vitamin b6 deficiency
5539745|NCT01128244|Vitamin B6 deficiency in women on oral contraceptives|vitamin b6 deficiency in women on oral contraceptives
5539746|NCT01128218|Brain Neoplasms|brain neoplasms
5539747|NCT01128218|5-ALA|5-ala
5539748|NCT01128218|Aminolevulinic acid|aminolevulinic acid
5539749|NCT01128218|Fluorescence|fluorescence
5539751|NCT01128218|Glioblastoma|glioblastoma
5539752|NCT01128218|Surgery|surgery
5539753|NCT01128205|diabetes|diabetes
5539754|NCT01128205|cardiovascular risk factors|cardiovascular risk factors
5539755|NCT01128205|blood pressure|blood pressure
5539756|NCT01128205|blood lipid|blood lipid
5539757|NCT01128205|blood glucose|blood glucose
5539758|NCT01128166|Heart Failure|heart failure
5539759|NCT01128166|Decompensation|decompensation
5539760|NCT01128166|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5539761|NCT01128153|Type 2 Diabetes|type 2 diabetes
5539762|NCT01128153|Inadequate Glycaemic Control|inadequate glycaemic control
5539764|NCT01128153|Metformin|metformin
5539765|NCT01128153|Sulfonylurea|sulfonylurea
5539766|NCT01128153|Triple Oral Therapy|triple oral therapy
5539767|NCT01128140|motivational enhancement therapy|motivational enhancement therapy
5539768|NCT01128127|knowledge translation|knowledge translation
5539769|NCT01128127|prescription|prescription
5539770|NCT01128127|primary care|primary care
5539771|NCT01128127|NSAID|nsaid
5539772|NCT01128127|PPI|ppi
5539773|NCT01128127|Gastrointestinal damage|gastrointestinal damage
5539774|NCT01128127|Inappropriate prescription|inappropriate prescription
5539775|NCT01128114|Acute bipolar mania|acute bipolar mania
5539776|NCT01128114|Seroquel XR|seroquel xr
5539777|NCT01128114|Quetiapine fumarate|quetiapine fumarate
5539778|NCT01128114|Add-on therapy|add-on therapy
5539779|NCT01128101|spironolactone|spironolactone
5539780|NCT01128101|chronic kidney disease|chronic kidney disease
5539781|NCT01128101|dialysis|dialysis
5539782|NCT01128101|LHV|lhv
5539783|NCT01128088|Enhanced recovery program in laparoscopic surgery|enhanced recovery program in laparoscopic surgery
5539784|NCT01128075|RebiSmart|rebismart
5539785|NCT01128075|Rebif|rebif
5539786|NCT01128075|Adherence|adherence
5539787|NCT01128075|Multidose|multidose
5539788|NCT01128075|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5539789|NCT01128075|RMS|rms
5539790|NCT01128062|Canthaxanthin retinopathy|canthaxanthin retinopathy
5539791|NCT01128049|Aqueous deficient dry eye (ADDE)|aqueous deficient dry eye (adde)
5539792|NCT01128049|Meibomium Gland Dysfunction (MGD)|meibomium gland dysfunction (mgd)
5539793|NCT01128049|Normal/Control (Non Dry Eye)|normal/control (non dry eye)
5539794|NCT01128036|Congestive Heart failure|congestive heart failure
5539795|NCT01128036|Cardiomyopathy|cardiomyopathy
5539796|NCT01128023|myocardial perfusion imaging|myocardial perfusion imaging
5539797|NCT01128023|rubidium-82|rubidium-82
5539798|NCT01128023|medical isotope production|medical isotope production
5539799|NCT01128023|Positron emission tomography|positron emission tomography
5539800|NCT01128023|clinically useful|clinically useful
5539801|NCT01127984|pacemaker|pacemaker
5539802|NCT01127984|pocket haematoma|pocket haematoma
5539803|NCT01127984|antiplatelet therapy|antiplatelet therapy
5539804|NCT01127984|fibrin glue|fibrin glue
5539805|NCT01127971|patients|patients
5539806|NCT01127971|receiving|receiving
5539807|NCT01127971|irradiation|irradiation
5539809|NCT01127971|External Beam|external beam
5539810|NCT01127958|In-stent restenosis|in-stent restenosis
5539811|NCT01127958|Minimal lumen diameter|minimal lumen diameter
5539812|NCT01127958|Drug eluting balloon|drug eluting balloon
5539813|NCT01127958|Drug eluting stent|drug eluting stent
5539814|NCT01127932|Cognitive Behavioral Therapy|cognitive behavioral therapy
5539815|NCT01127919|Exercise|exercise
5539816|NCT01127919|Activity|activity
5539817|NCT01127919|Adherence|adherence
5539818|NCT01127919|Genetics|genetics
5539819|NCT01127906|Healthy Volunteers|healthy volunteers
5539820|NCT01127906|cross-over|cross-over
5539821|NCT01127906|randomized|randomized
5539822|NCT01127906|placebo and active controlled|placebo and active controlled
5539823|NCT01127906|heat pain|heat pain
5539824|NCT01127906|UVB-Induced pain model|uvb-induced pain model
5539825|NCT01127893|Musculoskeletal Diseases|musculoskeletal diseases
5539826|NCT01127893|Joint Diseases|joint diseases
5539827|NCT01127893|Arthritis|arthritis
5539828|NCT01127893|Rheumatic Diseases|rheumatic diseases
5539829|NCT01127880|Traumatic Hemopneumothorax|traumatic hemopneumothorax
5539830|NCT01127880|Thoracotomy|thoracotomy
5539831|NCT01127880|Antibiotics|antibiotics
5539832|NCT01127854|kidney stone|kidney stone
5539833|NCT01127854|urolithiasis|urolithiasis
5539834|NCT01127854|calcium oxalate kidney stone|calcium oxalate kidney stone
5539835|NCT01127854|calcium oxalate stone|calcium oxalate stone
5539836|NCT01127854|calcium oxalate|calcium oxalate
5539837|NCT01127828|IBS (Irritable Bowel Syndrome)|ibs (irritable bowel syndrome)
5539838|NCT01127828|Probiotic yoghurt|probiotic yoghurt
5539839|NCT01127828|Symptom severity|symptom severity
5539840|NCT01127815|Peritoneal washing cytology|peritoneal washing cytology
5539841|NCT01127815|pancreatic cancer|pancreatic cancer
5539842|NCT01127815|peritoneal metastasis|peritoneal metastasis
5539843|NCT01127815|anoikis|anoikis
5539844|NCT01127815|to determine the relationship between PWC results and clinicopathologic parameters of pancreatic cancers|to determine the relationship between pwc results and clinicopathologic parameters of pancreatic cancers
5539845|NCT01127815|to identify the predictive value of PWC and postoperative drainage cytology on the peritoneal recurrence or outcomes|to identify the predictive value of pwc and postoperative drainage cytology on the peritoneal recurrence or outcomes
5539846|NCT01127815|to dissect the molecular mechanism of peritoneal recurrence, especially on the PWC-inducing peritoneal seeding process.|to dissect the molecular mechanism of peritoneal recurrence, especially on the pwc-inducing peritoneal seeding process.
5539847|NCT01127802|CABG|cabg
5539848|NCT01127802|functional status|functional status
5539849|NCT01127802|symptoms distress|symptoms distress
5539850|NCT01127802|quality of life|quality of life
5539851|NCT01127802|the trajectory of functional status|the trajectory of functional status
5539852|NCT01127802|the changes of symptoms distress|the changes of symptoms distress
5539853|NCT01127802|the changes of quality of life|the changes of quality of life
5539854|NCT01127776|patient after bi-trimalleolar fracture of ankle|patient after bi-trimalleolar fracture of ankle
5539855|NCT01127763|metastatic|metastatic
5539856|NCT01127763|breast|breast
5539857|NCT01127763|cancer|cancer
5539858|NCT01127750|Relapsing multiple sclerosis|relapsing multiple sclerosis
5539859|NCT01127750|MS|ms
5539860|NCT01127750|safety|safety
5539861|NCT01127750|tolerability|tolerability
5539862|NCT01127750|health outcomes|health outcomes
5539863|NCT01127737|SCCs|sccs
5539864|NCT01127737|Squamous Cell Carcinoma|squamous cell carcinoma
5539865|NCT01127737|Skin Self Exam|skin self exam
5539867|NCT01127737|Organ Transplant|organ transplant
5539868|NCT01127737|Performance of SSE with our written educational intervention|performance of sse with our written educational intervention
5539992|NCT01127191|biomechanical responses|biomechanical responses
5539869|NCT01127737|Time after organ transplantation to deliver intervention|time after organ transplantation to deliver intervention
5539870|NCT01127737|Evaluate internation information|evaluate internation information
5539872|NCT01127724|Aphthous stomatitis|aphthous stomatitis
5539873|NCT01127724|Cobalamin|cobalamin
5539874|NCT01127724|Doses|doses
5539875|NCT01127685|weight bearing|weight bearing
5539877|NCT01127672|plantar fasciitis|plantar fasciitis
5539878|NCT01127672|PRP|prp
5539879|NCT01127672|platelet rich plasma|platelet rich plasma
5539880|NCT01127659|diabetes|diabetes
5539882|NCT01127659|obesity|obesity
5539883|NCT01127659|testosterone|testosterone
5539884|NCT01127659|insulin sensitivity|insulin sensitivity
5539885|NCT01127659|inflammation|inflammation
5539886|NCT01127620|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5539887|NCT01127620|Persistent allergic rhinitis|persistent allergic rhinitis
5539888|NCT01127620|Hay fever|hay fever
5539889|NCT01127620|Allergic Rhinitis|allergic rhinitis
5539890|NCT01127620|Sneezing|sneezing
5539891|NCT01127620|Nasal congestion|nasal congestion
5539892|NCT01127620|Rhinorrhea|rhinorrhea
5539893|NCT01127620|Nasal itching|nasal itching
5539894|NCT01127620|Ocular itching|ocular itching
5539895|NCT01127620|Ocular tearing|ocular tearing
5539896|NCT01127620|Antihistamine|antihistamine
5539897|NCT01127607|parenting|parenting
5539898|NCT01127594|Melanoma|melanoma
5539899|NCT01127581|Misoprostol vaginal insert|misoprostol vaginal insert
5539900|NCT01127581|Dinoprostone vaginal insert|dinoprostone vaginal insert
5539901|NCT01127581|Cervidil|cervidil
5539902|NCT01127581|Cervical ripening|cervical ripening
5539903|NCT01127581|Induction of labor|induction of labor
5539904|NCT01127581|Rate of cesarean section|rate of cesarean section
5539905|NCT01127568|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5539906|NCT01127568|Posttraumatic Stress Disorders|posttraumatic stress disorders
5539907|NCT01127568|PTSD|ptsd
5539908|NCT01127568|Stress Disorder, Post Traumatic|stress disorder, post traumatic
5539909|NCT01127568|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5539910|NCT01127568|Chronic Post Traumatic Stress Disorder|chronic post traumatic stress disorder
5539911|NCT01127555|Biliary Tract Cancer|biliary tract cancer
5539912|NCT01127555|Salvage therapy|salvage therapy
5539913|NCT01127555|FOLFOX|folfox
5539914|NCT01127516|Susceptibility testing|susceptibility testing
5539915|NCT01127516|Antimicrobial stewardship|antimicrobial stewardship
5539916|NCT01127503|Patients with velocardiofacial syndrome and psychosis|patients with velocardiofacial syndrome and psychosis
5539917|NCT01127477|Hypovolemia, surgical blood loss|hypovolemia, surgical blood loss
5539918|NCT01127464|HIV-1|hiv-1
5539919|NCT01127464|HIV preventative vaccine|hiv preventative vaccine
5539920|NCT01127464|Healthy Volunteers|healthy volunteers
5539921|NCT01127451|Neoplasms|neoplasms
5539922|NCT01127438|Monitored anesthesia care sedation|monitored anesthesia care sedation
5539923|NCT01127425|nursing hours|nursing hours
5539924|NCT01127425|length of hospital stay|length of hospital stay
5539925|NCT01127425|reconvalescence|reconvalescence
5539926|NCT01127425|colorectal surgery|colorectal surgery
5539927|NCT01127425|laparoscopic|laparoscopic
5539928|NCT01127425|sigmoid neoplasms|sigmoid neoplasms
5539929|NCT01127412|overweight|overweight
5539930|NCT01127412|physical activity|physical activity
5539931|NCT01127412|infancy|infancy
5539932|NCT01127412|body composition|body composition
5539933|NCT01127412|motor development|motor development
5539934|NCT01127412|motor activity|motor activity
5539935|NCT01127373|Breast|breast
5539936|NCT01127373|Radiation|radiation
5539937|NCT01127373|Multi-Beam Intensity-Modulated Radiation|multi-beam intensity-modulated radiation
5539938|NCT01127373|post mastectomy|post mastectomy
5539939|NCT01127373|post partial mastectomy|post partial mastectomy
5539940|NCT01127373|node-positive breast cancer|node-positive breast cancer
5539941|NCT01127373|10-025|10-025
5539942|NCT01127360|Anti-VEGF|anti-vegf
5539943|NCT01127360|Ranibizumab|ranibizumab
5539944|NCT01127360|Bevacizumab|bevacizumab
5539945|NCT01127360|exudative|exudative
5539946|NCT01127360|macular degeneration|macular degeneration
5539947|NCT01127334|Dyssynchrony|dyssynchrony
5539948|NCT01127334|Cardiac resynchronization therapy|cardiac resynchronization therapy
5539949|NCT01127321|Systemic lupus erythematosus|systemic lupus erythematosus
5539951|NCT01127321|MEDI-570|medi-570
5539952|NCT01127308|Absorption|absorption
5539953|NCT01127308|Distribution|distribution
5539954|NCT01127308|Metabolism|metabolism
5539955|NCT01127308|and Excretion|and excretion
5539956|NCT01127308|Mass Balance|mass balance
5539957|NCT01127308|Metabolic Profile|metabolic profile
5539958|NCT01127308|Radiolabel Study|radiolabel study
5539959|NCT01127295|Pharmacokinetics|pharmacokinetics
5539960|NCT01127295|Pharmacogenetic|pharmacogenetic
5539961|NCT01127295|tamoxifen|tamoxifen
5539962|NCT01127295|anti-aromatases|anti-aromatases
5539963|NCT01127295|breast cancer|breast cancer
5539964|NCT01127295|pharmacodynamy|pharmacodynamy
5539965|NCT01127295|Observance|observance
5539966|NCT01127282|influenza|influenza
5539967|NCT01127282|vitamin|vitamin
5539969|NCT01127243|Hysterectomy|hysterectomy
5539970|NCT01127243|laparoscopy|laparoscopy
5539971|NCT01127243|day-case surgery|day-case surgery
5539972|NCT01127243|quality of life|quality of life
5539973|NCT01127243|Ambulatory Surgical Procedures|ambulatory surgical procedures
5539974|NCT01127230|ADRC|adrc
5539975|NCT01127230|adipocyte derived regenerative cells|adipocyte derived regenerative cells
5539976|NCT01127230|stem cells|stem cells
5539977|NCT01127230|liposuction|liposuction
5539978|NCT01127230|Cytori|cytori
5539979|NCT01127230|Celution|celution
5539980|NCT01127230|Lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.|lipoaspirate is obtained from patients who have opted for liposuction and consent to donate the lipoasirate for this study, which would otherwise be discarded.
5539981|NCT01127217|amlodipine|amlodipine
5539982|NCT01127217|losartan|losartan
5539983|NCT01127217|hypertension|hypertension
5539984|NCT01127217|stage 2|stage 2
5539986|NCT01127204|Antiretroviral therapy|antiretroviral therapy
5539987|NCT01127204|Infant|infant
5539988|NCT01127204|Sub Saharian Africa|sub saharian africa
5539989|NCT01127191|military exercises|military exercises
5539990|NCT01127191|neuromuscular fatigue|neuromuscular fatigue
5539991|NCT01127191|physiological responses|physiological responses
5539993|NCT01127191|simulated military effort|simulated military effort
5539994|NCT01127191|high load carriage|high load carriage
5539995|NCT01127191|Healthy voluntary|healthy voluntary
5539996|NCT01127152|Noradrenalin relays|noradrenalin relays
5539997|NCT01127152|Automatic relays|automatic relays
5539998|NCT01127152|Manual relays|manual relays
5539999|NCT01127152|Hypotension|hypotension
5540000|NCT01127152|Intensive care unit|intensive care unit
5540001|NCT01127139|Essential hypertension|essential hypertension
5540002|NCT01127113|Myocardial infarction|myocardial infarction
5540003|NCT01127113|Magnetic resonance imaging|magnetic resonance imaging
5540004|NCT01127113|Nanoparticles|nanoparticles
5540005|NCT01127113|Mononuclear cells|mononuclear cells
5540006|NCT01127113|Cell tracking|cell tracking
5540007|NCT01127100|neuropathic pain|neuropathic pain
5540008|NCT01127100|gabapentin|gabapentin
5540009|NCT01127100|transdermal fentanyl matrix|transdermal fentanyl matrix
5540010|NCT01127100|multicenter|multicenter
5540011|NCT01127100|non-inferiority trial|non-inferiority trial
5540012|NCT01127087|Hyperoxaluria|hyperoxaluria
5540013|NCT01127087|Oxazyme|oxazyme
5540014|NCT01127087|oxalate|oxalate
5540015|NCT01127087|enteric hyperoxaluria|enteric hyperoxaluria
5540016|NCT01127074|metastatic breast cancer|metastatic breast cancer
5540017|NCT01127074|breast cancer stage IV|breast cancer stage iv
5540018|NCT01127074|vaccination|vaccination
5540019|NCT01127074|CD80|cd80
5540020|NCT01127074|immunotherapy|immunotherapy
5540021|NCT01127061|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5540022|NCT01127061|Exercise|exercise
5540023|NCT01127061|Oxygen consumption|oxygen consumption
5540024|NCT01127048|bronchitis|bronchitis
5540025|NCT01127048|coughing|coughing
5540026|NCT01127048|children|children
5540027|NCT01127048|Ivy|ivy
5540028|NCT01127048|Hedera helix L.|hedera helix l.
5540029|NCT01127035|allergic rhinitis|allergic rhinitis
5540030|NCT01127035|alternaria alternata|alternaria alternata
5540031|NCT01127035|symptom score|symptom score
5540032|NCT01127022|Pregnancy|pregnancy
5540033|NCT01127022|Lactation|lactation
5540034|NCT01127022|Choline|choline
5540035|NCT01127022|Cognition|cognition
5540036|NCT01127022|Biomarkers|biomarkers
5540037|NCT01126996|MenC conjugate vaccine|menc conjugate vaccine
5540038|NCT01126996|Healthy children previously vaccinated against MenC|healthy children previously vaccinated against menc
5540039|NCT01126970|reduced calorie diet|reduced calorie diet
5540040|NCT01126970|orlistat|orlistat
5540041|NCT01126970|velneperit|velneperit
5540042|NCT01126944|heart failure|heart failure
5540043|NCT01126944|resynchronization|resynchronization
5540044|NCT01126944|left ventricular assist device|left ventricular assist device
5540045|NCT01126931|Crohn disease|crohn disease
5540046|NCT01126931|Involuntary weight loss in cancer|involuntary weight loss in cancer
5540047|NCT01126931|IgA nephropathy|iga nephropathy
5540048|NCT01126931|Depression with reduced appetite|depression with reduced appetite
5540049|NCT01126918|Eating Disorders|eating disorders
5540050|NCT01126918|Obesity|obesity
5540051|NCT01126918|Body Dissatisfaction|body dissatisfaction
5540052|NCT01126918|Female|female
5540053|NCT01126905|Reticulated Haemoglobin Equivalent|reticulated haemoglobin equivalent
5540054|NCT01126905|Functional Iron Deficiency|functional iron deficiency
5540055|NCT01126905|Response to therapy|response to therapy
5540056|NCT01126905|Iron deficiency|iron deficiency
5540057|NCT01126892|Advanced Disease,|advanced disease,
5540058|NCT01126892|Resistance,|resistance,
5540059|NCT01126892|Intolerance|intolerance
5540060|NCT01126866|advanced colorectal carcinoma|advanced colorectal carcinoma
5540061|NCT01126866|CRC|crc
5540062|NCT01126866|UICC Stages IV|uicc stages iv
5540063|NCT01126866|liver and/or lung only metastases|liver and/or lung only metastases
5540064|NCT01126853|Immunization|immunization
5540065|NCT01126853|Immunity|immunity
5540066|NCT01126853|Prevention|prevention
5540067|NCT01126840|Lynch Syndrome|lynch syndrome
5540068|NCT01126840|Families|families
5540069|NCT01126840|Quality of life|quality of life
5540070|NCT01126840|QOL|qol
5540071|NCT01126840|First-degree relatives|first-degree relatives
5540072|NCT01126840|Questionnaire|questionnaire
5540073|NCT01126840|Interview|interview
5540074|NCT01126827|Bipolar Disorder|bipolar disorder
5540075|NCT01126827|Mood Disorders|mood disorders
5540076|NCT01126827|Residual Symptoms|residual symptoms
5540077|NCT01126827|Depression|depression
5540078|NCT01126827|Mania|mania
5540079|NCT01126827|Hypomania|hypomania
5540080|NCT01126827|Bipolar|bipolar
5540081|NCT01126827|Bipolar I|bipolar i
5540082|NCT01126827|Bipolar II|bipolar ii
5540083|NCT01126814|Gleevec|gleevec
5540084|NCT01126814|c-kit|c-kit
5540085|NCT01126814|aml|aml
5540086|NCT01126775|Systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.|systematic prevention, stroke, vascular dementia, silent strokes, cerebral microangiopathy.
5540087|NCT01126762|Docosahexaenoic acid|docosahexaenoic acid
5540088|NCT01126762|fish|fish
5540089|NCT01126762|pregnancy|pregnancy
5540090|NCT01126762|methylmercury|methylmercury
5540091|NCT01126762|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
5540092|NCT01126749|Locally Advanced or Metastatic Bladder Cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)|locally advanced or metastatic bladder cancer, including other transitional cell cancers of the urothelium (prostate, urethra, ureter, and renal pelvis)
5540093|NCT01126736|neoplams|neoplams
5540094|NCT01126736|lung neoplasms|lung neoplasms
5540095|NCT01126736|Stage IIIB|stage iiib
5540096|NCT01126736|IV Nonsquamous Non Small Cell Lung Cancer|iv nonsquamous non small cell lung cancer
5540097|NCT01126710|infiltration|infiltration
5540098|NCT01126710|extravasation|extravasation
5540099|NCT01126710|optical monitoring|optical monitoring
5540100|NCT01126697|Cardiac|cardiac
5540101|NCT01126697|Muscular Dystrophy|muscular dystrophy
5540102|NCT01126697|Randomized|randomized
5540103|NCT01126684|essential hypertension|essential hypertension
5540104|NCT01126671|vitamin D|vitamin d
5540105|NCT01126658|pressure-volume curve|pressure-volume curve
5540106|NCT01126658|intracranial pressure|intracranial pressure
5540107|NCT01126658|volume pressure response|volume pressure response
5540108|NCT01126658|pressure-volume relationship|pressure-volume relationship
5540109|NCT01126658|mathematical model|mathematical model
5540110|NCT01126645|Liver|liver
5540111|NCT01126645|HCC|hcc
5540112|NCT01126632|Colonoscopy|colonoscopy
5540113|NCT01126619|Psoriasis|psoriasis
5540114|NCT01126567|Phase 1 Clinical Trials, Cerebrospinal Fluid, Biomarker|phase 1 clinical trials, cerebrospinal fluid, biomarker
5540115|NCT01126554|Prognostic value|prognostic value
5540116|NCT01126528|Vitamin D|vitamin d
5540117|NCT01126528|cholecalciferol|cholecalciferol
5540118|NCT01126528|Micronutrients|micronutrients
5540119|NCT01126528|Developing countries|developing countries
5540120|NCT01126528|Bangladesh|bangladesh
5540121|NCT01126528|Infant, Newborn|infant, newborn
5540122|NCT01126528|Reproductive Health|reproductive health
5540123|NCT01126528|Infant, Newborn, Diseases|infant, newborn, diseases
5540124|NCT01126528|Perinatology|perinatology
5540125|NCT01126528|Immunology|immunology
5540126|NCT01126528|cathelicidin|cathelicidin
5540127|NCT01126528|Maternal Nutrition Physiology|maternal nutrition physiology
5540128|NCT01126515|brain injury|brain injury
5540129|NCT01126515|sequelae|sequelae
5540130|NCT01126515|stroke|stroke
5540131|NCT01126515|anoxia|anoxia
5540132|NCT01126515|trauma|trauma
5540133|NCT01126476|Adults with non-CNS recurrent tumors who have been previously irradiated|adults with non-cns recurrent tumors who have been previously irradiated
5540134|NCT01126476|and have a tumor recurrence in or near prior radiation fields|and have a tumor recurrence in or near prior radiation fields
5540135|NCT01126463|Hepatocellular carcinomas|hepatocellular carcinomas
5540136|NCT01126463|lipiodol|lipiodol
5540137|NCT01126463|rhenium|rhenium
5540138|NCT01126463|Non operable Hepatocellular carcinomas|non operable hepatocellular carcinomas
5540139|NCT01126450|recurrent colon cancer|recurrent colon cancer
5540140|NCT01126450|recurrent rectal cancer|recurrent rectal cancer
5540141|NCT01126424|Anti-muscarinics|anti-muscarinics
5540142|NCT01126424|Anti-cholinergics|anti-cholinergics
5540143|NCT01126424|Cognition|cognition
5540144|NCT01126424|Solifenacin|solifenacin
5540145|NCT01126411|pulmonary hypertension|pulmonary hypertension
5540146|NCT01126411|autoantibodies|autoantibodies
5540147|NCT01126411|immunoadsorption|immunoadsorption
5540148|NCT01126411|immunoglobulin substitution|immunoglobulin substitution
5540149|NCT01126411|right ventricular function|right ventricular function
5540150|NCT01126385|Spinal Diseases|spinal diseases
5540151|NCT01126385|Bone strength|bone strength
5540152|NCT01126385|Transpedicular fixation|transpedicular fixation
5540153|NCT01126385|Dorsal instrumentation|dorsal instrumentation
5540154|NCT01126385|DensiProbe|densiprobe
5540155|NCT01126372|Prostaglandin-dependent Congenital Heart Disease|prostaglandin-dependent congenital heart disease
5540156|NCT01126372|Prematurity|prematurity
5540157|NCT01126372|Feeding intolerances|feeding intolerances
5540158|NCT01126372|Necrotizing Enterocolitis|necrotizing enterocolitis
5540159|NCT01126372|Regional Oxygen Saturation|regional oxygen saturation
5540160|NCT01126372|Near Infrared Spectroscopy|near infrared spectroscopy
5540161|NCT01126372|Somanetics INVOS Oxyalert|somanetics invos oxyalert
5540162|NCT01126359|Wound Vacuum Assisted Dressings|wound vacuum assisted dressings
5540163|NCT01126359|Lidocaine|lidocaine
5540164|NCT01126359|Dressing change|dressing change
5540165|NCT01126359|Pain management|pain management
5540166|NCT01126359|palliative care|palliative care
5540167|NCT01126333|Nephrotoxicity, Kidney Transplantation, Graft Survival|nephrotoxicity, kidney transplantation, graft survival
5540168|NCT01126333|Kidney transplant survival.|kidney transplant survival.
5798862|NCT00110786|Specific Immunotherapy|specific immunotherapy
5540170|NCT01126307|refractory epilepsy- greater than 4 seizures in 2 month baseline period|refractory epilepsy- greater than 4 seizures in 2 month baseline period
5540171|NCT01126294|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score|lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, vas score
5540173|NCT01126268|Atopic dermatitis|atopic dermatitis
5540174|NCT01126268|Infection|infection
5540175|NCT01126268|Impetigo|impetigo
5540176|NCT01126268|Folliculitis|folliculitis
5540177|NCT01126255|vulvar lichen sclerosus|vulvar lichen sclerosus
5540178|NCT01126255|progesterone|progesterone
5540179|NCT01126255|clobetasol|clobetasol
5540180|NCT01126255|randomized controlled trial|randomized controlled trial
5540181|NCT01126242|Ankle|ankle
5540182|NCT01126242|ligament injuries|ligament injuries
5540183|NCT01126242|non-surgical treatment|non-surgical treatment
5540184|NCT01126242|tape|tape
5540185|NCT01126242|brace|brace
5540186|NCT01126242|orthotic device|orthotic device
5540187|NCT01126242|bandage|bandage
5540188|NCT01126242|cost-effectiveness|cost-effectiveness
5540189|NCT01126242|randomized trial|randomized trial
5540190|NCT01126229|Resveratrol|resveratrol
5540191|NCT01126229|Grape|grape
5540192|NCT01126229|Aging|aging
5540193|NCT01126229|functional MRI (fMRI)|functional mri (fmri)
5540194|NCT01126229|Anti-Aging therapeutic|anti-aging therapeutic
5540195|NCT01126229|Oxidative Stress|oxidative stress
5540196|NCT01126229|Functional Performance|functional performance
5540197|NCT01126216|Radiochemotherapy|radiochemotherapy
5540198|NCT01126216|head and neck cancer|head and neck cancer
5540199|NCT01126216|Paclitaxel|paclitaxel
5540200|NCT01126216|Cisplatin|cisplatin
5540201|NCT01126216|5-FU|5-fu
5540202|NCT01126203|Pseudoexfoliation|pseudoexfoliation
5540203|NCT01126203|Glaucoma|glaucoma
5540204|NCT01126203|Ocular Hypertension|ocular hypertension
5540205|NCT01126203|SLT|slt
5540206|NCT01126203|Selective Laser Trabeculoplasy (SLT)|selective laser trabeculoplasy (slt)
5540207|NCT01126203|Argon Laser Trabeculoplasty (ALT)|argon laser trabeculoplasty (alt)
5540208|NCT01126177|asthma|asthma
5540209|NCT01126164|parents|parents
5540210|NCT01126164|peer|peer
5540211|NCT01126164|basics|basics
5540212|NCT01126164|college student drinking|college student drinking
5540213|NCT01126151|drinking|drinking
5540214|NCT01126151|alcohol consequences|alcohol consequences
5540215|NCT01126138|unresectable|unresectable
5540216|NCT01126138|locally advanced|locally advanced
5540217|NCT01126138|metastatic|metastatic
5540218|NCT01126138|breast cancer|breast cancer
5540219|NCT01126125|iodine|iodine
5540220|NCT01126125|infant|infant
5540221|NCT01126125|breastfeeding|breastfeeding
5540222|NCT01126125|deficiency|deficiency
5671973|NCT00613366|nulliparous women|nulliparous women
5540223|NCT01126112|advanced colorectal cancer; K-RAS; panitumumab|advanced colorectal cancer; k-ras; panitumumab
5540224|NCT01126112|advanced Wild Type K-RAS colorectal cancer|advanced wild type k-ras colorectal cancer
5540225|NCT01126099|double-blind|double-blind
5540226|NCT01126099|treatment|treatment
5540227|NCT01126099|prazosin|prazosin
5540228|NCT01126099|Disruptive behaviors in Alzheimer's Disease|disruptive behaviors in alzheimer's disease
5540229|NCT01126073|niacin/laropiprant|niacin/laropiprant
5540230|NCT01126073|endothelial function|endothelial function
5540231|NCT01126060|Neck dissection|neck dissection
5540232|NCT01126047|Lung Diseases|lung diseases
5540233|NCT01126034|Metoclopramide|metoclopramide
5540234|NCT01126034|Randomized Controlled Trial|randomized controlled trial
5540235|NCT01126021|Senior citizens|senior citizens
5540236|NCT01126021|mental acuity|mental acuity
5540237|NCT01126021|memory|memory
5540238|NCT01126008|locally advanced Squamous cell carcinoma|locally advanced squamous cell carcinoma
5540239|NCT01125995|limited disease|limited disease
5540240|NCT01125969|diabetes|diabetes
5540241|NCT01125969|glucose|glucose
5540242|NCT01125969|peer mentor|peer mentor
5540243|NCT01125969|incentives|incentives
5540244|NCT01125969|behavioral economics|behavioral economics
5540245|NCT01125969|cost-effectiveness|cost-effectiveness
5540247|NCT01125956|Diabetes mellitus|diabetes mellitus
5540248|NCT01125956|HbA1c|hba1c
5540249|NCT01125930|rosacea|rosacea
5540250|NCT01125930|tretinoin|tretinoin
5540251|NCT01125930|atralin|atralin
5540252|NCT01125917|Low back pain|low back pain
5540253|NCT01125917|Opioid|opioid
5540254|NCT01125917|Transdermal|transdermal
5540255|NCT01125904|Crizotinib|crizotinib
5540256|NCT01125891|gemcitabine hydrochloride|gemcitabine hydrochloride
5540257|NCT01125891|Gemzar|gemzar
5534603|NCT01148459|EPI|epi
5540258|NCT01125891|ON 01910.Na|on 01910.na
5540259|NCT01125878|satiety|satiety
5540260|NCT01125878|appetite|appetite
5540261|NCT01125878|fiber|fiber
5540262|NCT01125878|starch|starch
5540263|NCT01125878|nutrition|nutrition
5540264|NCT01125865|Malignant hilar stricture|malignant hilar stricture
5540265|NCT01125852|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5540266|NCT01125852|Peptic ulcer bleeding|peptic ulcer bleeding
5540267|NCT01125852|Angiographic embolization|angiographic embolization
5540268|NCT01125852|Arterial embolization|arterial embolization
5540269|NCT01125852|Angiography|angiography
5540270|NCT01125839|osteomyelitis|osteomyelitis
5540271|NCT01125839|16S rRNA|16s rrna
5540272|NCT01125839|spine|spine
5540273|NCT01125839|Magnetic resonance imaging|magnetic resonance imaging
5540274|NCT01125800|Recurrent,|recurrent,
5540275|NCT01125800|refractory,|refractory,
5540276|NCT01125800|medulloblastoma,|medulloblastoma,
5540277|NCT01125800|rhabdomyosarcoma,|rhabdomyosarcoma,
5540278|NCT01125800|neuroblastoma,|neuroblastoma,
5540279|NCT01125800|hepatoblastoma,|hepatoblastoma,
5540280|NCT01125800|astrocytoma,|astrocytoma,
5540281|NCT01125800|children,|children,
5540282|NCT01125800|pediatric,|pediatric,
5540283|NCT01125800|hedgehog pathway inhibitor, adult|hedgehog pathway inhibitor, adult
5540284|NCT01125787|CLL|cll
5540285|NCT01125787|bendamustine|bendamustine
5540286|NCT01125787|ofatumumab|ofatumumab
5540287|NCT01125787|blood cancer|blood cancer
5540288|NCT01125787|leukemia|leukemia
5540289|NCT01125787|lymphocyte|lymphocyte
5540290|NCT01125787|hematology|hematology
5540291|NCT01125787|non-Hodgkin lymphoma|non-hodgkin lymphoma
5540292|NCT01125787|small lymphocytic lymphoma|small lymphocytic lymphoma
5540293|NCT01125787|nevada cancer institute|nevada cancer institute
5540294|NCT01125787|cephalon|cephalon
5540295|NCT01125787|Glaxosmithkline|glaxosmithkline
5540296|NCT01125774|Menstrually related migraine|menstrually related migraine
5540297|NCT01125774|migraine|migraine
5540298|NCT01125774|Premenstrual migraine|premenstrual migraine
5540299|NCT01125761|Allergic dermatitis|allergic dermatitis
5540300|NCT01125722|Urinary Incontinence|urinary incontinence
5540301|NCT01125722|Overactive Bladder|overactive bladder
5540302|NCT01125722|Frequency|frequency
5540303|NCT01125722|Urgency|urgency
5540304|NCT01125709|Neuromuscular disease|neuromuscular disease
5540305|NCT01125709|Duchenne|duchenne
5540306|NCT01125709|Muscular Dystrophy|muscular dystrophy
5540307|NCT01125709|DMD|dmd
5540308|NCT01125709|Strength assessment|strength assessment
5540309|NCT01125709|CINRG Quantitative Measurement System|cinrg quantitative measurement system
5540310|NCT01125709|CQMS|cqms
5540311|NCT01125709|Hand Held Myometry|hand held myometry
5540312|NCT01125709|HHM|hhm
5540313|NCT01125696|mother-to-child transmission|mother-to-child transmission
5540314|NCT01125696|HIV|hiv
5540315|NCT01125696|Hepatitis B|hepatitis b
5540316|NCT01125696|Pregnant women|pregnant women
5540317|NCT01125696|Tenofovir|tenofovir
5540318|NCT01125696|Infants|infants
5540319|NCT01125683|Phase II|phase ii
5540320|NCT01125683|Alzheimer's disease|alzheimer's disease
5540321|NCT01125683|EEG|eeg
5540322|NCT01125683|cognition|cognition
5540323|NCT01125683|pharmacodynamic|pharmacodynamic
5540324|NCT01125670|YM150|ym150
5540325|NCT01125670|Food effect|food effect
5540326|NCT01125657|YM150|ym150
5540328|NCT01125644|necrotic pulmonary infections|necrotic pulmonary infections
5540329|NCT01125631|Alzheimer's disease|alzheimer's disease
5540330|NCT01125631|amyloid|amyloid
5540331|NCT01125631|antibody|antibody
5540332|NCT01125631|Japanese|japanese
5540333|NCT01125618|child mortality|child mortality
5540334|NCT01125618|intervention|intervention
5540335|NCT01125618|Poverty|poverty
5540336|NCT01125618|Africa|africa
5540337|NCT01125618|Millennium Development Goal|millennium development goal
5540338|NCT01125618|Millennium Development Goals|millennium development goals
5540339|NCT01125605|PASCONAL|pasconal
5540340|NCT01125605|nervousness|nervousness
5540341|NCT01125605|nervosity|nervosity
5540342|NCT01125605|sleep disorder|sleep disorder
5540343|NCT01125592|assess the ability of the IonCleanse machine to remove heavy metals through the feet|assess the ability of the ioncleanse machine to remove heavy metals through the feet
5540344|NCT01125579|nervousness|nervousness
5540345|NCT01125579|restlessness|restlessness
5540346|NCT01125579|depression|depression
5540347|NCT01125579|affective disorder|affective disorder
5540348|NCT01125540|Allergic conjunctivitis|allergic conjunctivitis
5540349|NCT01125527|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5540350|NCT01125527|Vaccine|vaccine
5540351|NCT01125527|Anti PRP antibody|anti prp antibody
5540352|NCT01125514|Heart failure,|heart failure,
5540353|NCT01125514|aliskiren,|aliskiren,
5540354|NCT01125514|furosemide,|furosemide,
5540355|NCT01125514|diuretic efficacy,|diuretic efficacy,
5540356|NCT01125514|interaction|interaction
5540357|NCT01125488|Maintenance therapy|maintenance therapy
5540358|NCT01125488|LNG-IUS|lng-ius
5540359|NCT01125488|recurrence,endometriosis|recurrence,endometriosis
5540360|NCT01125488|Recurrence|recurrence
5540361|NCT01125475|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5534693|NCT01148108|NHL|nhl
5540362|NCT01125475|RebiSmart|rebismart
5540363|NCT01125475|Rebif|rebif
5540364|NCT01125475|Adherence|adherence
5540365|NCT01125462|Ovulation Induction|ovulation induction
5540366|NCT01125462|Infertility|infertility
5540367|NCT01125462|Gonal-f|gonal-f
5540368|NCT01125462|FertiQoL|fertiqol
5540369|NCT01125462|Quality of Life|quality of life
5540370|NCT01125449|ascorbic acid|ascorbic acid
5540371|NCT01125449|vitamin C|vitamin c
5540372|NCT01125449|antioxidants|antioxidants
5540373|NCT01125449|vitamins|vitamins
5540375|NCT01125423|age 18 to 70|age 18 to 70
5540376|NCT01125410|Fluomizin|fluomizin
5540377|NCT01125410|Dequalinium chloride|dequalinium chloride
5540384|NCT01125371|Binge drinking|binge drinking
5540385|NCT01125371|High risk sexual behaviors|high risk sexual behaviors
5540386|NCT01125371|HIV risk reduction|hiv risk reduction
5540387|NCT01125345|hydrophobic acrylic|hydrophobic acrylic
5540389|NCT01125345|posterior capsule opacification|posterior capsule opacification
5540390|NCT01125345|hydrophilic acrylic IO|hydrophilic acrylic io
5540391|NCT01125306|Drug consumption|drug consumption
5540392|NCT01125306|The Xal-Ease device|the xal-ease device
5540393|NCT01125306|Patient's compliance|patient's compliance
5540394|NCT01125306|Using a novel Pfizer-Pharmacia device to facilitate the Xalatan/Xalacom instillation and to avoid loss of eye drops|using a novel pfizer-pharmacia device to facilitate the xalatan/xalacom instillation and to avoid loss of eye drops
5540395|NCT01125293|everolimus|everolimus
5540396|NCT01125293|rituximab|rituximab
5540397|NCT01125293|bortezomib|bortezomib
5540398|NCT01125293|RAD001|rad001
5540399|NCT01125293|Rituxan|rituxan
5540400|NCT01125293|Velcade|velcade
5540401|NCT01125280|Small bowel occlusion|small bowel occlusion
5540402|NCT01125280|Conservative treatment for small bowel occlusion|conservative treatment for small bowel occlusion
5540403|NCT01125280|Surgical treatment for small bowel occlusion|surgical treatment for small bowel occlusion
5540404|NCT01125280|Small bowel resection|small bowel resection
5541599|NCT01120067|Pain|pain
5540405|NCT01125280|Score of severity of small bowel occlusion|score of severity of small bowel occlusion
5540406|NCT01125267|medication adherence|medication adherence
5540407|NCT01125267|schizophrenia|schizophrenia
5540408|NCT01125267|Mexican American|mexican american
5540409|NCT01125267|multifamily groups|multifamily groups
5540410|NCT01125254|thalassemia major|thalassemia major
5540411|NCT01125254|calcium channel blockade|calcium channel blockade
5540412|NCT01125254|magnetic resonance imaging|magnetic resonance imaging
5540413|NCT01125241|wuling capsule|wuling capsule
5540414|NCT01125241|epilepsy|epilepsy
5540415|NCT01125241|depression|depression
5540416|NCT01125241|superiority clinical research|superiority clinical research
5540418|NCT01125215|Painful diabetic neuropathy|painful diabetic neuropathy
5540419|NCT01125215|Capsaicin|capsaicin
5540420|NCT01125215|Nanoparticle|nanoparticle
5540421|NCT01125215|Quantitative Sensory Testing|quantitative sensory testing
5540422|NCT01125202|Intervention studies|intervention studies
5540423|NCT01125202|Computers, handheld|computers, handheld
5540424|NCT01125202|Randomized controlled trial|randomized controlled trial
5540425|NCT01125202|Sodium, dietary|sodium, dietary
5540427|NCT01125163|very low birth weight infants|very low birth weight infants
5540428|NCT01125163|anemia|anemia
5540429|NCT01125163|iron supplementation|iron supplementation
5540430|NCT01125150|diffuse reflectance spectroscopy|diffuse reflectance spectroscopy
5540431|NCT01125137|Keloid|keloid
5540432|NCT01125137|MMP|mmp
5540433|NCT01125137|Matrix metalloproteinase|matrix metalloproteinase
5540434|NCT01125137|dermatology|dermatology
5540435|NCT01125124|Pleurodesis|pleurodesis
5540436|NCT01125124|Malignant pleural effusion|malignant pleural effusion
5540437|NCT01125124|Silver Nitrate|silver nitrate
5540438|NCT01125124|Pain|pain
5540439|NCT01125098|COPD|copd
5540440|NCT01125098|PRO-CT|pro-ct
5540441|NCT01125098|antibiotics|antibiotics
5540442|NCT01125085|I131|i131
5540443|NCT01125085|L19|l19
5540444|NCT01125085|antibody|antibody
5540445|NCT01125085|monoclonal|monoclonal
5540446|NCT01125085|multiple brain metastasis|multiple brain metastasis
5540447|NCT01125085|tumor targeting|tumor targeting
5540448|NCT01125085|radioimmunotherapy|radioimmunotherapy
5540449|NCT01125085|Patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.|patients with brain metastases of solid tumors (>1), who are not amenable for surgical excision or stereotactic radiosurgery.
5540450|NCT01125072|chest pain|chest pain
5540451|NCT01125072|echocardiography|echocardiography
5540452|NCT01125072|strain imaging|strain imaging
5540453|NCT01125059|hydromorphone|hydromorphone
5540454|NCT01125059|lumbar posterior spinal fusion|lumbar posterior spinal fusion
5540455|NCT01125059|lumbosacral spondylosis|lumbosacral spondylosis
5540456|NCT01125059|Spinal Fusion|spinal fusion
5540457|NCT01125033|Dialysis, Restless legs syndrome, Ascorbic acid, Vitamin E|dialysis, restless legs syndrome, ascorbic acid, vitamin e
5540458|NCT01125007|Dental plaque|dental plaque
5540459|NCT01125007|Gingival abrasion|gingival abrasion
5540460|NCT01125007|toothbrushing|toothbrushing
5540461|NCT01124994|Barrett's oesophagus|barrett's oesophagus
5540462|NCT01124994|High grade intraepithelial neoplasia (HGIEN)|high grade intraepithelial neoplasia (hgien)
5540463|NCT01124981|Fibrinogen concentrate|fibrinogen concentrate
5540464|NCT01124981|Coagulopathy|coagulopathy
5540465|NCT01124968|User-Computer Interface|user-computer interface
5540466|NCT01124968|Office Visits|office visits
5540467|NCT01124968|Primary Health Care|primary health care
5540468|NCT01124968|Patient Satisfaction|patient satisfaction
5540469|NCT01124968|Job Satisfaction|job satisfaction
5540470|NCT01124968|Health Services Research|health services research
5540471|NCT01124955|treatment|treatment
5540472|NCT01124955|acupuncture|acupuncture
5540473|NCT01124955|spine|spine
5540474|NCT01124929|Intestinal tuberculosis|intestinal tuberculosis
5540475|NCT01124929|Tuberculous peritonitis|tuberculous peritonitis
5540476|NCT01124929|Abdominal tuberculosis|abdominal tuberculosis
5540477|NCT01124916|incontinence|incontinence
5540478|NCT01124916|prolapse|prolapse
5540479|NCT01124916|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
5540480|NCT01124903|dehydration|dehydration
5540481|NCT01124903|hypohydration|hypohydration
5540482|NCT01124903|diagnostic accuracy|diagnostic accuracy
5540483|NCT01124903|biological variation|biological variation
5540484|NCT01124903|hydration assessment|hydration assessment
5540485|NCT01124903|body mass|body mass
5540486|NCT01124903|osmolality|osmolality
5540487|NCT01124903|plasma|plasma
5540488|NCT01124903|saliva|saliva
5540489|NCT01124903|urine|urine
5540490|NCT01124890|acute myocardial infarction|acute myocardial infarction
5540491|NCT01124890|thrombolysis|thrombolysis
5540492|NCT01124890|percutaneous coronary interention|percutaneous coronary interention
5540493|NCT01124877|Children and Adolescents with Bipolar I Disorder (manic or mixed)|children and adolescents with bipolar i disorder (manic or mixed)
5540494|NCT01124864|Non-small-cell lung cancer|non-small-cell lung cancer
5540495|NCT01124864|HSP90|hsp90
5540496|NCT01124864|2nd to 3rd line treatment|2nd to 3rd line treatment
5540497|NCT01124851|Sleep disorder|sleep disorder
5540498|NCT01124838|Uveitis|uveitis
5540695|NCT01124201|muscle stretching exercises|muscle stretching exercises
5540499|NCT01124825|Anesthesia induction and maintenance|anesthesia induction and maintenance
5540500|NCT01124825|Surgery|surgery
5540501|NCT01124812|I131|i131
5540502|NCT01124812|L19|l19
5540503|NCT01124812|antibody|antibody
5540504|NCT01124812|monoclonal|monoclonal
5540505|NCT01124812|NSCLC|nsclc
5540506|NCT01124812|lung|lung
5540507|NCT01124812|tumor targeting|tumor targeting
5540508|NCT01124812|radioimmunotherapy|radioimmunotherapy
5540509|NCT01124812|Patients with newly diagnosed inoperable, locally-advanced (stage III) NSCLC|patients with newly diagnosed inoperable, locally-advanced (stage iii) nsclc
5540510|NCT01124799|Hepatitis C virus|hepatitis c virus
5540511|NCT01124799|TMC435-TiDP16-C125|tmc435-tidp16-c125
5540512|NCT01124799|TMC435-C125|tmc435-c125
5540513|NCT01124799|TMC435|tmc435
5540514|NCT01124799|TMC435350|tmc435350
5540515|NCT01124799|protease inhibitor|protease inhibitor
5540517|NCT01124799|Hepatitis C|hepatitis c
5540518|NCT01124799|photosensitivity|photosensitivity
5540519|NCT01124799|phototoxicity|phototoxicity
5540520|NCT01124786|cancer|cancer
5540521|NCT01124786|metastatic|metastatic
5540522|NCT01124786|pancreatic|pancreatic
5540523|NCT01124786|pancreas|pancreas
5540524|NCT01124786|adenocarcinoma|adenocarcinoma
5540525|NCT01124786|gemcitabine|gemcitabine
5540526|NCT01124786|human equilibrative nucleoside transporter-1 (hENT1)|human equilibrative nucleoside transporter-1 (hent1)
5540527|NCT01124786|CO-1.01|co-1.01
5540528|NCT01124786|CO-101|co-101
5540529|NCT01124786|CO101|co101
5540530|NCT01124786|Stage 4|stage 4
5540531|NCT01124786|Stage IV|stage iv
5540532|NCT01124773|cognition|cognition
5540533|NCT01124773|memory|memory
5540534|NCT01124773|hormone therapy|hormone therapy
5540535|NCT01124760|open label|open label
5540536|NCT01124760|2-consecutive-group|2-consecutive-group
5540537|NCT01124760|2-period|2-period
5540538|NCT01124760|1-sequence crossover study|1-sequence crossover study
5540539|NCT01124747|ASP1585|asp1585
5540540|NCT01124747|Healthy Volunteers|healthy volunteers
5540541|NCT01124734|Metastatic melanoma|metastatic melanoma
5540542|NCT01124721|Cognitive training|cognitive training
5540543|NCT01124708|ADHD|adhd
5540544|NCT01124708|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
5540545|NCT01124695|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5540546|NCT01124695|male breast cancer|male breast cancer
5540547|NCT01124695|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5540548|NCT01124695|recurrent breast cancer|recurrent breast cancer
5540549|NCT01124695|stage IV breast cancer|stage iv breast cancer
5525643|NCT01185639|Spinal Column|spinal column
5540550|NCT01124682|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5540551|NCT01124682|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5540552|NCT01124682|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5540553|NCT01124682|recurrent bladder cancer|recurrent bladder cancer
5540554|NCT01124682|stage II bladder cancer|stage ii bladder cancer
5540555|NCT01124682|stage III bladder cancer|stage iii bladder cancer
5540556|NCT01124682|stage IV bladder cancer|stage iv bladder cancer
5540557|NCT01124669|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5540558|NCT01124669|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5540559|NCT01124669|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5540560|NCT01124656|angiotensin II receptor blocker|angiotensin ii receptor blocker
5540561|NCT01124656|thiazolidinediones|thiazolidinediones
5540562|NCT01124656|combination|combination
5540565|NCT01124656|Type 2 diabetes|type 2 diabetes
5540566|NCT01124656|Drug Therapy|drug therapy
5540567|NCT01124656|Hypertension|hypertension
5540568|NCT01124643|Agalsidase alfa|agalsidase alfa
5540569|NCT01124643|Alpha-Galactosidase|alpha-galactosidase
5540570|NCT01124643|Replagal|replagal
5540571|NCT01124643|Enzyme Replacement Therapy|enzyme replacement therapy
5540572|NCT01124617|Chronic pain|chronic pain
5540573|NCT01124617|Diabetic Neuropathic Pain|diabetic neuropathic pain
5540574|NCT01124617|Neuralgia, Postherpetic|neuralgia, postherpetic
5540575|NCT01124617|Tapentadol hydrochloride extended-release|tapentadol hydrochloride extended-release
5540576|NCT01124617|JNS024ER|jns024er
5540577|NCT01124617|Placebo|placebo
5540578|NCT01124604|Pain|pain
5540579|NCT01124604|Low Back Pain|low back pain
5540580|NCT01124604|Back Pain|back pain
5540581|NCT01124604|Osteoarthritis, Knee|osteoarthritis, knee
5540582|NCT01124604|Tapentadol|tapentadol
5540583|NCT01124604|Tapentadol Hydrochloride Extended Release|tapentadol hydrochloride extended release
5540584|NCT01124578|Ventilators, Mechanical|ventilators, mechanical
5540585|NCT01124565|Lateral Canthal Lines|lateral canthal lines
5540586|NCT01124565|Crow's Feet|crow's feet
5540587|NCT01124565|Facial Wrinkles|facial wrinkles
5540588|NCT01124552|Lateral Canthal Lines|lateral canthal lines
5540589|NCT01124552|Crow's Feet Wrinkles|crow's feet wrinkles
5540590|NCT01124552|Facial Wrinkles|facial wrinkles
5540591|NCT01124539|Adult Patients|adult patients
5540592|NCT01124539|Recurrence of Glioblastoma Multiforme|recurrence of glioblastoma multiforme
5540593|NCT01124539|Recurrence of GBM|recurrence of gbm
5540594|NCT01124539|Gliosarcoma|gliosarcoma
5540991|NCT01122940|Epamin|epamin
5540595|NCT01124526|R F C treatment in patients with Non Hodgkin Lymphoma|r f c treatment in patients with non hodgkin lymphoma
5540596|NCT01124513|Melanin Index|melanin index
5540597|NCT01124513|Fitzpatrick Skin Phototype|fitzpatrick skin phototype
5540598|NCT01124513|Videodermoscopy|videodermoscopy
5540599|NCT01124513|Spectrophotometry|spectrophotometry
5540600|NCT01124500|methylphenidate|methylphenidate
5540601|NCT01124500|transdermal patch|transdermal patch
5540602|NCT01124500|placebo|placebo
5540603|NCT01124500|fatigue|fatigue
5540604|NCT01124500|10-020|10-020
5540605|NCT01124487|fat|fat
5540606|NCT01124487|inflammation|inflammation
5540607|NCT01124487|lipids|lipids
5540608|NCT01124487|total cholesterol|total cholesterol
5540609|NCT01124487|Triglycerides|triglycerides
5540610|NCT01124487|insulin sensitivity|insulin sensitivity
5540611|NCT01124461|Malignant Brain Tumors|malignant brain tumors
5540612|NCT01124461|Cancer of the Brain|cancer of the brain
5540613|NCT01124435|Carboplatin plus Celecoxib|carboplatin plus celecoxib
5540614|NCT01124435|Pre-treated Recurrent Ovarian Cancer Patients|pre-treated recurrent ovarian cancer patients
5540615|NCT01124435|The antitumor activity and potential adverse effects|the antitumor activity and potential adverse effects
5540616|NCT01124435|tumor response rate|tumor response rate
5540617|NCT01124435|toxicity|toxicity
5540618|NCT01124435|progression free survival|progression free survival
5540619|NCT01124435|duration of response|duration of response
5540620|NCT01124435|quality of life|quality of life
5540621|NCT01124422|endurance shuttle walk test|endurance shuttle walk test
5540622|NCT01124422|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5540623|NCT01124422|fluticasone propionate|fluticasone propionate
5540624|NCT01124422|dyspnea|dyspnea
5540625|NCT01124422|exercise endurance time|exercise endurance time
5540627|NCT01124422|salmeterol|salmeterol
5540628|NCT01124422|exercise inspiratory capacity|exercise inspiratory capacity
5540629|NCT01124422|quality of life|quality of life
5540630|NCT01124409|IGRT|igrt
5540631|NCT01124409|3DCRT|3dcrt
5540632|NCT01124409|EPID|epid
5540633|NCT01124409|CBCT|cbct
5540634|NCT01124409|HNSCC|hnscc
5540635|NCT01124383|Glycine absorption|glycine absorption
5540636|NCT01124383|Operative hysteroscopy|operative hysteroscopy
5540637|NCT01124383|Endometrial resection|endometrial resection
5540638|NCT01124383|General anesthesia|general anesthesia
5540639|NCT01124383|Local anesthesia|local anesthesia
5540640|NCT01124370|Sleep Disordered Breathing|sleep disordered breathing
5540641|NCT01124370|Cheyne Stokes Respiration|cheyne stokes respiration
5540642|NCT01124370|Periodic Breathing|periodic breathing
5540644|NCT01124370|Central Sleep Apnea|central sleep apnea
5540645|NCT01124357|Heavy menstrual bleeding|heavy menstrual bleeding
5540646|NCT01124357|menorrhagia|menorrhagia
5540647|NCT01124357|ThermachoiceTM|thermachoicetm
5540648|NCT01124357|NovaSureTM|novasuretm
5540649|NCT01124357|Endometrail Ablation|endometrail ablation
5540650|NCT01124331|prospective meta-analysis|prospective meta-analysis
5540651|NCT01124331|preterm infant|preterm infant
5540652|NCT01124331|pulse oximetry|pulse oximetry
5540653|NCT01124331|oxygen saturation|oxygen saturation
5540654|NCT01124318|Lactofiltrum|lactofiltrum
5540655|NCT01124318|atopic dermatitis|atopic dermatitis
5540656|NCT01124318|itching|itching
5862959|NCT00001451|Healthy Volunteer|healthy volunteer
5540657|NCT01124318|Dermatological Index of Life Quality|dermatological index of life quality
5540659|NCT01124318|Behavioral Rating Scores|behavioral rating scores
5540660|NCT01124305|Total Knee Arthroplasty|total knee arthroplasty
5540661|NCT01124305|Instrumentation|instrumentation
5540662|NCT01124292|Disability|disability
5540663|NCT01124292|Quadriplegia|quadriplegia
5540664|NCT01124292|Paralysis|paralysis
5540665|NCT01124292|Assistive technology|assistive technology
5540666|NCT01124292|Quality of life|quality of life
5540667|NCT01124292|Computer access|computer access
5540668|NCT01124292|Wheeled mobility|wheeled mobility
5540669|NCT01124279|Amgen|amgen
5540670|NCT01124279|Healthy|healthy
5540671|NCT01124279|Adult|adult
5540672|NCT01124266|polyp|polyp
5540673|NCT01124266|adenoma|adenoma
5540674|NCT01124266|screening|screening
5540675|NCT01124266|colonoscopy|colonoscopy
5540676|NCT01124266|diagnosis|diagnosis
5540677|NCT01124253|adjuvant therapy|adjuvant therapy
5540678|NCT01124253|non-small cell lung cancer|non-small cell lung cancer
5540679|NCT01124253|vinorelbine|vinorelbine
5540680|NCT01124253|cisplatin|cisplatin
5540681|NCT01124253|recombinant human endostatin|recombinant human endostatin
5540682|NCT01124253|endostar|endostar
5540683|NCT01124240|Glioblastoma Multiforme|glioblastoma multiforme
5540684|NCT01124227|Congestive Heart Failure|congestive heart failure
5540685|NCT01124227|Peritoneal Dialysis|peritoneal dialysis
5540686|NCT01124227|Symptomatic improvement|symptomatic improvement
5540687|NCT01124227|Renal function|renal function
5540688|NCT01124214|Barrett's|barrett's
5540689|NCT01124214|BE|be
5540690|NCT01124214|esophageal cancer|esophageal cancer
5540691|NCT01124214|esophageal dysplasia|esophageal dysplasia
5540692|NCT01124201|low back pain|low back pain
5540693|NCT01124201|clinical trial|clinical trial
5540694|NCT01124201|stabilization|stabilization
5540696|NCT01124201|exercise therapy|exercise therapy
5540697|NCT01124188|Geriatric psychiatry|geriatric psychiatry
5540699|NCT01124188|Elderly|elderly
5540700|NCT01124188|Venlafaxine|venlafaxine
5540701|NCT01124188|Self efficacy|self efficacy
5540702|NCT01124188|Pain|pain
5540703|NCT01124188|Psychotherapy|psychotherapy
5540704|NCT01124188|Effexor|effexor
5540705|NCT01124175|Bioequivalence|bioequivalence
5540706|NCT01124175|Healthy Subjects|healthy subjects
5540707|NCT01124162|Bioequivalence|bioequivalence
5540708|NCT01124162|Healthy Subjects|healthy subjects
5540709|NCT01124136|Chronic Heart Failure|chronic heart failure
5540710|NCT01124136|Neurostimulation|neurostimulation
5540711|NCT01124123|Pharmacokinetics|pharmacokinetics
5540712|NCT01124123|Oral bioavailability|oral bioavailability
5540713|NCT01124123|absorption|absorption
5540714|NCT01124123|AUC|auc
5540715|NCT01124123|Bioequivalence|bioequivalence
5540716|NCT01124123|Bioavailability study|bioavailability study
5540717|NCT01124110|Operating Engineers|operating engineers
5540718|NCT01124110|Smoking Cessation|smoking cessation
5540719|NCT01124097|post herpetic neuralgia|post herpetic neuralgia
5540720|NCT01124071|Korean Diet|korean diet
5540721|NCT01124058|restarting warfarin|restarting warfarin
5540722|NCT01124058|time to therapeutic INR|time to therapeutic inr
5540723|NCT01124045|Pediatric|pediatric
5540724|NCT01124045|Cataracts|cataracts
5540725|NCT01124045|Inflammation|inflammation
5540726|NCT01124045|Durezol|durezol
5540727|NCT01124045|Pred Forte|pred forte
5540728|NCT01124045|Difluprednate|difluprednate
5540729|NCT01124045|Prednisolone|prednisolone
5540730|NCT01124019|Women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.|women undergoing screening mammography will be chosen if they are between the ages of 40 and 65.
5540731|NCT01123993|Thai traditional music|thai traditional music
5540732|NCT01123993|dementia|dementia
5540733|NCT01123993|Cognitive function|cognitive function
5540734|NCT01123993|behavioural problem|behavioural problem
5540735|NCT01123993|sleep quality|sleep quality
5540736|NCT01123993|psychological health|psychological health
5540737|NCT01123993|quality of sleep|quality of sleep
5523188|NCT01195701|pelvic MRI|pelvic mri
5540738|NCT01123967|nicotine replacement therapy|nicotine replacement therapy
5540739|NCT01123967|smoking cessation|smoking cessation
5540740|NCT01123967|tobacco dependent|tobacco dependent
5540741|NCT01123954|Seasonal influenza|seasonal influenza
5540742|NCT01123954|Vaccine|vaccine
5540743|NCT01123941|Typhoid fever|typhoid fever
5540744|NCT01123941|Glycoconjugate vaccine|glycoconjugate vaccine
5540745|NCT01123941|Carrier protein|carrier protein
5540746|NCT01123941|Immunogenicity|immunogenicity
5540747|NCT01123928|cataract|cataract
5540748|NCT01123928|counseling|counseling
5540749|NCT01123928|surgical uptake|surgical uptake
5540750|NCT01123928|follow-up|follow-up
5540751|NCT01123915|HIV|hiv
5540752|NCT01123915|Therapeutic|therapeutic
5540753|NCT01123915|Immunotherapy|immunotherapy
5540754|NCT01123915|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5540755|NCT01123915|Virus Diseases|virus diseases
5540756|NCT01123915|Lentivirus Infections|lentivirus infections
5540757|NCT01123915|Human Immunodeficiency Virus|human immunodeficiency virus
5540758|NCT01123902|Breathlessness|breathlessness
5540759|NCT01123902|Dyspnea|dyspnea
5540761|NCT01123902|Palliative Care|palliative care
5540762|NCT01123889|subacromial impingement|subacromial impingement
5540763|NCT01123889|partial thickness rotator cuff|partial thickness rotator cuff
5540764|NCT01123889|PRP|prp
5540765|NCT01123889|platelet rich plasma|platelet rich plasma
5540766|NCT01123876|Gastric Cancer|gastric cancer
5540767|NCT01123863|Neuro cognitive deficits;|neuro cognitive deficits;
5540768|NCT01123863|Brigance pre-school screen;|brigance pre-school screen;
5540769|NCT01123850|CopiOs|copios
5540770|NCT01123850|Degenerative spondylolisthesis,|degenerative spondylolisthesis,
5540771|NCT01123850|stenosis with instability, or|stenosis with instability, or
5540772|NCT01123850|degenerative disc disease as diagnosed by radicular signs and/or imaging studies|degenerative disc disease as diagnosed by radicular signs and/or imaging studies
5540773|NCT01123824|healthy subjects|healthy subjects
5540774|NCT01123811|adenocarcinoma|adenocarcinoma
5540775|NCT01123811|gastric cancer|gastric cancer
5540776|NCT01123811|esophagogastric junction cancer|esophagogastric junction cancer
5540777|NCT01123798|near infrared spectroscopy|near infrared spectroscopy
5540778|NCT01123798|lower extremity injury|lower extremity injury
5540779|NCT01123785|glaucoma|glaucoma
5540780|NCT01123785|ocular hypertension|ocular hypertension
5540781|NCT01123785|adenosine agonist|adenosine agonist
5540782|NCT01123785|eye drop|eye drop
5540783|NCT01123785|primary open angle glaucoma|primary open angle glaucoma
5540784|NCT01123772|adenosine agonist|adenosine agonist
5540785|NCT01123772|eye drop|eye drop
5540786|NCT01123772|elderly volunteer|elderly volunteer
5540787|NCT01123772|older healthy volunteer|older healthy volunteer
5540788|NCT01123759|Fish|fish
5540789|NCT01123759|mercury|mercury
5540790|NCT01123759|omega-3 fatty acids|omega-3 fatty acids
5540791|NCT01123759|infant|infant
5540792|NCT01123759|brain development|brain development
5540793|NCT01123759|pregnancy|pregnancy
5540798|NCT01123759|Recommendations for pregnant or nursing women|recommendations for pregnant or nursing women
5540800|NCT01123746|Seizure|seizure
5540801|NCT01123746|electrolyte|electrolyte
5540802|NCT01123746|risk factor|risk factor
5540803|NCT01123733|Baby-friendly hospitals|baby-friendly hospitals
5540804|NCT01123733|Non baby-friendly hospitals|non baby-friendly hospitals
5540805|NCT01123733|Breastfeeding|breastfeeding
5540806|NCT01123733|Ten steps for successful breastfeeding|ten steps for successful breastfeeding
5540807|NCT01123707|Major Depressive Disorder|major depressive disorder
5540808|NCT01123707|MDD|mdd
5540809|NCT01123707|Depression|depression
5540810|NCT01123694|xeroderma pigmentosum|xeroderma pigmentosum
5540811|NCT01123694|quality of life|quality of life
5540812|NCT01123694|DLQI|dlqi
5540813|NCT01123694|CDLQI|cdlqi
5540814|NCT01123681|Respiration, Artificial|respiration, artificial
5540815|NCT01123681|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5540816|NCT01123681|Critical Illness|critical illness
5540817|NCT01123668|Smoking|smoking
5540818|NCT01123668|ADHD|adhd
5540819|NCT01123668|Nicotine|nicotine
5540820|NCT01123668|Methylphenidate|methylphenidate
5540821|NCT01123668|function Magnetic Resonance Imaging|function magnetic resonance imaging
5540822|NCT01123668|Neurobiological basis of abstinence-induced deficits in response inhibition|neurobiological basis of abstinence-induced deficits in response inhibition
5540823|NCT01123642|post-traumatic stress disorder|post-traumatic stress disorder
5540824|NCT01123642|depressive disorder|depressive disorder
5540825|NCT01123642|alcoholism|alcoholism
5540826|NCT01123642|Longitudinal studies|longitudinal studies
5540827|NCT01123642|readjustment|readjustment
5540828|NCT01123616|surgical site infection|surgical site infection
5540829|NCT01123616|elective colorectal surgery|elective colorectal surgery
5540830|NCT01123616|level of surgical site infection|level of surgical site infection
5540831|NCT01123616|complication of surgical site infection|complication of surgical site infection
5540832|NCT01123616|type of changed bandage|type of changed bandage
5540833|NCT01123616|frequency of bandage changing|frequency of bandage changing
5540834|NCT01123603|frequency|frequency
5540835|NCT01123603|women|women
5540836|NCT01123603|fibroids|fibroids
5540837|NCT01123603|uterine artery embolization|uterine artery embolization
5540838|NCT01123603|myomectomy|myomectomy
5525846|NCT01184872|Daptomycin|daptomycin
5540839|NCT01123603|hysterectomy|hysterectomy
5540840|NCT01123590|Thymoma|thymoma
5540841|NCT01123590|Autoimmune diseases|autoimmune diseases
5540842|NCT01123590|Immunodeficiency|immunodeficiency
5540843|NCT01123577|Self Blood Pressure Monitoring|self blood pressure monitoring
5540844|NCT01123577|SBPM|sbpm
5540845|NCT01123577|Randomized Control Trial|randomized control trial
5540846|NCT01123577|Hypertension (HTN)|hypertension (htn)
5540847|NCT01123577|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5540848|NCT01123577|HTN|htn
5540849|NCT01123577|CVD|cvd
5540850|NCT01123564|macular edema secondary to retinal vein occlusion|macular edema secondary to retinal vein occlusion
5540851|NCT01123551|Nebulized morphine|nebulized morphine
5540852|NCT01123551|Intravenous morphine|intravenous morphine
5540853|NCT01123551|Post traumatic|post traumatic
5540854|NCT01123551|Pain|pain
5540855|NCT01123551|Emergency department|emergency department
5535191|NCT01146249|Visual reliance|visual reliance
5540856|NCT01123512|Vertebral Compression Fracture|vertebral compression fracture
5540859|NCT01123512|Vertebral Body Compression Fracture|vertebral body compression fracture
5540860|NCT01123512|Back Pain|back pain
5540867|NCT01123486|Intravenous opioids|intravenous opioids
5540868|NCT01123486|Patient Controlled Analgesia|patient controlled analgesia
5540869|NCT01123486|volunteer pharmacokinetic-pharmacodynamic study|volunteer pharmacokinetic-pharmacodynamic study
5540870|NCT01123473|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5540871|NCT01123473|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5540872|NCT01123473|stage IIIA gastric cancer|stage iiia gastric cancer
5540873|NCT01123473|stage IIIB gastric cancer|stage iiib gastric cancer
5540874|NCT01123473|stage IIIC gastric cancer|stage iiic gastric cancer
5540875|NCT01123473|stage IV gastric cancer|stage iv gastric cancer
5540876|NCT01123460|non-small cell lung cancer|non-small cell lung cancer
5540877|NCT01123434|prostate cancer|prostate cancer
5540878|NCT01123434|adjuvant|adjuvant
5540879|NCT01123434|hormonal|hormonal
5540880|NCT01123421|osteoporosis|osteoporosis
5540881|NCT01123421|fracture risk|fracture risk
5540882|NCT01123421|aging|aging
5540883|NCT01123421|tibia|tibia
5540884|NCT01123421|sonometer|sonometer
5540885|NCT01123421|ultrasound|ultrasound
5540886|NCT01123421|BMD|bmd
5540887|NCT01123421|bone mineral density|bone mineral density
5540888|NCT01123421|DXA|dxa
5540889|NCT01123421|3D-HRpQT|3d-hrpqt
5540890|NCT01123421|waveform profiles|waveform profiles
5540891|NCT01123408|schizophrenia|schizophrenia
5540892|NCT01123408|aggression|aggression
5540893|NCT01123408|clozapine|clozapine
5540894|NCT01123408|olanzapine|olanzapine
5540895|NCT01123395|bioavailability|bioavailability
5540896|NCT01123382|Stroke|stroke
5540897|NCT01123382|Shoulder pain|shoulder pain
5540898|NCT01123382|Electrical stimulation|electrical stimulation
5540899|NCT01123382|Neuromuscular stimulation|neuromuscular stimulation
5540900|NCT01123382|Intramuscular stimulation|intramuscular stimulation
5540901|NCT01123369|Sickle Cell Disease|sickle cell disease
5540902|NCT01123356|Relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5540903|NCT01123343|limbal relaxing incision|limbal relaxing incision
5540904|NCT01123343|LRI|lri
5540905|NCT01123343|capsulorhexis|capsulorhexis
5540906|NCT01123343|surgical guidance|surgical guidance
5540907|NCT01123343|3d visualization|3d visualization
5540908|NCT01123317|Schizophrenia|schizophrenia
5540910|NCT01123317|Oxytocin|oxytocin
5540911|NCT01123304|melanoma|melanoma
5540912|NCT01123291|follow-up coronary angiography|follow-up coronary angiography
5540913|NCT01123278|Adiponectin|adiponectin
5540914|NCT01123278|Resistin|resistin
5540915|NCT01123278|Adipocytes|adipocytes
5540916|NCT01123278|Testosterone|testosterone
5540917|NCT01123278|Aging|aging
5540918|NCT01123278|HOMA-IR|homa-ir
5540919|NCT01123278|Insulin|insulin
5540920|NCT01123278|Hypogonadism|hypogonadism
5540921|NCT01123278|Metabolic Syndrome|metabolic syndrome
5540922|NCT01123278|Obesity|obesity
5540923|NCT01123278|Erectile Dysfunction|erectile dysfunction
5540924|NCT01123265|PsA|psa
5540925|NCT01123265|methotrexate|methotrexate
5540926|NCT01123265|Anti-TNF|anti-tnf
5540927|NCT01123265|TNF|tnf
5540928|NCT01123265|DC-Stamp|dc-stamp
5540929|NCT01123252|Lactobacillus casei|lactobacillus casei
5540930|NCT01123239|Healthcare Disparities|healthcare disparities
5540931|NCT01123213|pelvic organ prolapse|pelvic organ prolapse
5540932|NCT01123213|pessary fitting|pessary fitting
5540933|NCT01123187|diabetes type 1|diabetes type 1
5540934|NCT01123187|kidney transplantation|kidney transplantation
5540935|NCT01123187|islet|islet
5540936|NCT01123187|hypoglycemia|hypoglycemia
5540937|NCT01123174|Suicide|suicide
5540938|NCT01123174|case management algorithm|case management algorithm
5540939|NCT01123174|suicidal behaviors|suicidal behaviors
5540940|NCT01123174|prevention of suicide|prevention of suicide
5540941|NCT01123161|Hypothermia|hypothermia
5540942|NCT01123161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5540943|NCT01123161|Cerebral Infarction|cerebral infarction
5540944|NCT01123161|Hematologic Agents|hematologic agents
5540945|NCT01123161|Stroke|stroke
5540946|NCT01123161|Nervous System Diseases|nervous system diseases
5540947|NCT01123161|Vascular Diseases|vascular diseases
5540948|NCT01123161|Tissue Plasminogen Activator|tissue plasminogen activator
5540949|NCT01123161|Central Nervous System Diseases|central nervous system diseases
5540950|NCT01123161|Fibrinolytic Agents|fibrinolytic agents
5540951|NCT01123161|Cardiovascular Agents|cardiovascular agents
5540952|NCT01123161|Body Temperature Changes|body temperature changes
5540953|NCT01123161|Brain Diseases|brain diseases
5540954|NCT01123161|Cerebrovascular Disorders|cerebrovascular disorders
5540955|NCT01123161|Pharmacologic Actions|pharmacologic actions
5540956|NCT01123161|Signs and Symptoms|signs and symptoms
5540957|NCT01123161|Fibrin Modulating Agents|fibrin modulating agents
5540958|NCT01123161|Therapeutic Uses|therapeutic uses
5540959|NCT01123161|Brain Ischemia|brain ischemia
5540960|NCT01123161|Cardiovascular Diseases|cardiovascular diseases
5535289|NCT01145768|Double-blind|double-blind
5540962|NCT01123161|Plasminogen|plasminogen
5540963|NCT01123161|cooling|cooling
5540964|NCT01123161|tPA|tpa
5540965|NCT01123161|thrombolysis|thrombolysis
5540966|NCT01123148|Brain computer interface|brain computer interface
5540967|NCT01123148|wheelchair control|wheelchair control
5540968|NCT01123135|urodynamic stress incontinence|urodynamic stress incontinence
5540969|NCT01123135|postmenopausal women|postmenopausal women
5540970|NCT01123109|nulliparous women|nulliparous women
5540971|NCT01123096|Stress urinary incontinence|stress urinary incontinence
5540972|NCT01123083|new onset type 1 diabetes|new onset type 1 diabetes
5540973|NCT01123083|juvenile diabetes|juvenile diabetes
5540974|NCT01123083|T1DM|t1dm
5540975|NCT01123083|Type 1 diabetes|type 1 diabetes
5540976|NCT01123057|keratoconus|keratoconus
5540977|NCT01123057|collagen cross-linking|collagen cross-linking
5540978|NCT01123057|LASIK ectasia|lasik ectasia
5540979|NCT01123057|keratoconus,lasik ectasia|keratoconus,lasik ectasia
5540980|NCT01123018|Memory Loss|memory loss
5540981|NCT01122992|Limbal relaxing incision|limbal relaxing incision
5540982|NCT01122992|Astigmatic correction|astigmatic correction
5540983|NCT01122992|Phacoemulsification surgery|phacoemulsification surgery
5540984|NCT01122992|Chinese eyes|chinese eyes
5540985|NCT01122966|trabeculectomy|trabeculectomy
5540986|NCT01122953|Bioequivalence|bioequivalence
5540987|NCT01122953|EPAMIN|epamin
5540988|NCT01122953|PHENYTOIN|phenytoin
5540989|NCT01122940|Bioequivalence|bioequivalence
5540990|NCT01122940|Phenytoin|phenytoin
5540992|NCT01122927|schizophrenia|schizophrenia
5540993|NCT01122927|adolescent|adolescent
5540994|NCT01122927|bipolar|bipolar
5540995|NCT01122914|Kineret|kineret
5540996|NCT01122914|Anakinra|anakinra
5540997|NCT01122914|Atopic Dermatitis|atopic dermatitis
5540998|NCT01122914|Eczema|eczema
5540999|NCT01122914|Allergic Disease|allergic disease
5541000|NCT01122862|tooth plaque|tooth plaque
5541001|NCT01122849|trouble with sleep|trouble with sleep
5541002|NCT01122849|night time nasal congestion|night time nasal congestion
5541003|NCT01122836|Massage|massage
5541004|NCT01122836|Chronic Neck Pain|chronic neck pain
5541005|NCT01122836|Dosing Study|dosing study
5541006|NCT01122823|Chronic Disease Self-Management Program (CDSMP)|chronic disease self-management program (cdsmp)
5541007|NCT01122810|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
5541008|NCT01122810|Transplant heart patients|transplant heart patients
5541009|NCT01122810|X-Ray and contrast agent exposure|x-ray and contrast agent exposure
5541010|NCT01122810|Coronary stenosis|coronary stenosis
5541011|NCT01122797|PNPLA3|pnpla3
5541012|NCT01122797|fibrosis|fibrosis
5541013|NCT01122797|cirrhosis|cirrhosis
5541014|NCT01122797|alcoholic liver disease|alcoholic liver disease
5541015|NCT01122784|Plague|plague
5541016|NCT01122784|Vaccine|vaccine
5541017|NCT01122771|visceral leishmaniasis|visceral leishmaniasis
5541018|NCT01122771|phase III|phase iii
5541019|NCT01122771|randomised ccontrolled trial|randomised ccontrolled trial
5541020|NCT01122771|Bangladesh|bangladesh
5541021|NCT01122771|Combination treatment|combination treatment
5541022|NCT01122771|Ambisome|ambisome
5541023|NCT01122771|miltefosine|miltefosine
5541024|NCT01122771|paromomycin|paromomycin
5541025|NCT01122758|Cohort|cohort
5541026|NCT01122758|COPD|copd
5541027|NCT01122758|Natural history|natural history
5541028|NCT01122758|Phenotyping|phenotyping
5541029|NCT01122758|Smoking|smoking
5541030|NCT01122745|continuous block|continuous block
5541031|NCT01122745|single shot|single shot
5541032|NCT01122745|interscalene|interscalene
5541033|NCT01122745|rotator cuff surgery|rotator cuff surgery
5541034|NCT01122732|nerve block|nerve block
5541035|NCT01122732|continuous catheter|continuous catheter
5541036|NCT01122732|shoulder surgery|shoulder surgery
5541037|NCT01122732|pain control after total shoulder arthroplasty|pain control after total shoulder arthroplasty
5541038|NCT01122719|Optima|optima
5541039|NCT01122719|Tacrolimus|tacrolimus
5541040|NCT01122719|Drug eluting stent|drug eluting stent
5541041|NCT01122706|tai ji|tai ji
5541042|NCT01122706|psychosocial stress|psychosocial stress
5541043|NCT01122706|primary prevention|primary prevention
5541044|NCT01122706|Trier Social Stress Test|trier social stress test
5541045|NCT01122706|salivary cortisol|salivary cortisol
5541046|NCT01122706|salivary alpha amylase|salivary alpha amylase
5541047|NCT01122706|heart rate variability|heart rate variability
5541048|NCT01122706|stress management|stress management
5541049|NCT01122693|Regional Anesthesia|regional anesthesia
5541050|NCT01122693|Pain Medicine|pain medicine
5541051|NCT01122693|Ultrasound|ultrasound
5541052|NCT01122693|Nerve Blocks|nerve blocks
5541053|NCT01122667|Renal Insufficiency|renal insufficiency
5541054|NCT01122641|Insulin resistance|insulin resistance
5541055|NCT01122641|incretins|incretins
5541056|NCT01122641|DPP4 inhibitors|dpp4 inhibitors
5541057|NCT01122641|vildagliptin|vildagliptin
5541058|NCT01122641|microcirculation|microcirculation
5541059|NCT01122628|Distal Radial Fracture|distal radial fracture
5541060|NCT01122628|Volar Locking Plate|volar locking plate
5541061|NCT01122615|Kidney|kidney
5535387|NCT01145222|CNS 7056|cns 7056
5541063|NCT01122615|RCC|rcc
5541067|NCT01122615|Temsirolimus|temsirolimus
5541069|NCT01122602|Aspirin|aspirin
5541070|NCT01122589|Smoking Abstinence|smoking abstinence
5541071|NCT01122589|Smoking Cessation|smoking cessation
5541072|NCT01122576|Intra Ocular Lens|intra ocular lens
5541073|NCT01122576|Ocular surgery|ocular surgery
5541074|NCT01122576|Phacoemulsification|phacoemulsification
5541075|NCT01122563|OABSS|oabss
5541076|NCT01122563|IPSS|ipss
5541077|NCT01122563|PPBC|ppbc
5541078|NCT01122563|3-day micturition diary|3-day micturition diary
5541079|NCT01122563|Solifenacin|solifenacin
5541080|NCT01122550|OABSS|oabss
5541081|NCT01122550|IPSS|ipss
5541082|NCT01122550|PPBC|ppbc
5541083|NCT01122550|3-day micturition diary|3-day micturition diary
5541084|NCT01122537|Meningitis|meningitis
5541085|NCT01122537|infection|infection
5541086|NCT01122537|cerebrospinal fluid|cerebrospinal fluid
5541087|NCT01122537|procalcitonin|procalcitonin
5541088|NCT01122537|adenosine deaminase|adenosine deaminase
5541089|NCT01122524|Trisomy 21|trisomy 21
5541090|NCT01122472|lenalidomide (Revlimid)|lenalidomide (revlimid)
5541091|NCT01122472|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5541092|NCT01122472|phase III study|phase iii study
5541093|NCT01122472|after R-CHOP|after r-chop
5541094|NCT01122472|Maintenance treatment|maintenance treatment
5541095|NCT01122472|Maintenance|maintenance
5541096|NCT01122459|Perioperative intravenous fluids|perioperative intravenous fluids
5541097|NCT01122446|Alum-GAD|alum-gad
5541098|NCT01122446|Type 1 diabetes|type 1 diabetes
5541099|NCT01122446|prevention|prevention
5541100|NCT01122446|immune tolerance|immune tolerance
5541101|NCT01122446|glucose tolerance|glucose tolerance
5541102|NCT01122446|glutamate decarboxylase autoantibodies|glutamate decarboxylase autoantibodies
5541103|NCT01122433|difficult airway|difficult airway
5541104|NCT01122433|indirect laryngoscopy|indirect laryngoscopy
5541105|NCT01122433|C-MAC video laryngoscope|c-mac video laryngoscope
5541106|NCT01122420|Obesity|obesity
5541107|NCT01122394|stroke|stroke
5541108|NCT01122394|recurrence|recurrence
5541109|NCT01122394|blood pressure|blood pressure
5541110|NCT01122394|prevention|prevention
5541111|NCT01122381|headache, migraine|headache, migraine
5541112|NCT01122381|depression|depression
5541113|NCT01122381|disability evaluation|disability evaluation
5541114|NCT01122381|weight gain|weight gain
5541116|NCT01122368|Micafungin|micafungin
5541117|NCT01122368|intra-abdominal surgery|intra-abdominal surgery
5541118|NCT01122368|invasive fungal infection|invasive fungal infection
5541119|NCT01122368|intra-abdominal infection|intra-abdominal infection
5541120|NCT01122342|Testosterone|testosterone
5541121|NCT01122342|Vaginal administration|vaginal administration
5541122|NCT01122342|Aromatase inhibitors|aromatase inhibitors
5541123|NCT01122329|dementia|dementia
5541124|NCT01122316|Heart Failure|heart failure
5541125|NCT01122316|Diabetes|diabetes
5541126|NCT01122316|Metformin|metformin
5541127|NCT01122303|Autologous serum eye drops|autologous serum eye drops
5541128|NCT01122303|EGF|egf
5541129|NCT01122303|TGF-β1|tgf-β1
5541130|NCT01122303|TGF-β2|tgf-β2
5541131|NCT01122303|Fibronectin|fibronectin
5541132|NCT01122303|Stevens-Johnson syndrome|stevens-johnson syndrome
5541133|NCT01122303|Dry eye|dry eye
5541134|NCT01122290|Emotional eating|emotional eating
5541135|NCT01122290|Eating in the absence of hunger|eating in the absence of hunger
5541136|NCT01122290|emotion induction|emotion induction
5541137|NCT01122277|Volume therapy|volume therapy
5541138|NCT01122277|Fluid therapy|fluid therapy
5541139|NCT01122277|Patients in ICU|patients in icu
5541140|NCT01122264|Erectile Dysfunction|erectile dysfunction
5541141|NCT01122251|hypertension|hypertension
5541142|NCT01122251|lercanidipine|lercanidipine
5541144|NCT01122238|Smoking|smoking
5541145|NCT01122238|Smoking Cessation|smoking cessation
5541146|NCT01122238|Motivation|motivation
5541147|NCT01122238|Nicotine Dependence|nicotine dependence
5541148|NCT01122225|septic shock|septic shock
5541149|NCT01122225|medical intensive care|medical intensive care
5541150|NCT01122212|intracerebral hemorrhage|intracerebral hemorrhage
5541151|NCT01122212|ct scans|ct scans
5541152|NCT01122212|protein s100|protein s100
5541153|NCT01122212|inpatient treatment|inpatient treatment
5541154|NCT01122186|Medication Adherence|medication adherence
5541155|NCT01122186|Methamphetamine Use|methamphetamine use
5541156|NCT01122186|Sexual Risk|sexual risk
5541157|NCT01122186|Poly-substance Use|poly-substance use
5541158|NCT01122186|HIV|hiv
5541159|NCT01122186|Treatment|treatment
5541160|NCT01122186|Motivational Interviewing|motivational interviewing
5541161|NCT01122186|Cognitive Behavioral Skills Training|cognitive behavioral skills training
5541162|NCT01122186|Men Who Have Sex With Men|men who have sex with men
5541163|NCT01122173|Atrial Fibrillation|atrial fibrillation
5541164|NCT01122173|Robotic Control|robotic control
5541165|NCT01122173|Remote Control|remote control
5541166|NCT01122160|anthocyanin|anthocyanin
5541167|NCT01122160|omeprazole|omeprazole
5541168|NCT01122160|Prilosec|prilosec
5541170|NCT01122160|proton pump inhibitor|proton pump inhibitor
5541171|NCT01122160|PPI|ppi
5541172|NCT01122160|nutrition|nutrition
5541173|NCT01122147|Aphthous stomatitis; Herbal medicines; Matricaria Chamomilla|aphthous stomatitis; herbal medicines; matricaria chamomilla
5541174|NCT01122134|severe|severe
5541175|NCT01122134|malaria|malaria
5541176|NCT01122134|artesunate|artesunate
5541177|NCT01122134|intravenous|intravenous
5541178|NCT01122121|Drug Therapy|drug therapy
5541179|NCT01122121|Radiotherapy|radiotherapy
5541180|NCT01122108|Bile Acid Sequestrant|bile acid sequestrant
5541181|NCT01122108|Resin|resin
5541182|NCT01122108|Lipids|lipids
5541183|NCT01122108|Glucose|glucose
5541184|NCT01122108|Cholesterol|cholesterol
5541185|NCT01122108|Diabetes Mellitus|diabetes mellitus
5541186|NCT01122108|Bile Acid Sequestrant Acceptability Scale|bile acid sequestrant acceptability scale
5541187|NCT01122095|Psoriasis|psoriasis
5541188|NCT01122095|Cardiovascular risk|cardiovascular risk
5541189|NCT01122082|energy intake|energy intake
5541190|NCT01122082|energy expenditure|energy expenditure
5541191|NCT01122082|macronutrient selection|macronutrient selection
5541192|NCT01122056|Multiple Sclerosis|multiple sclerosis
5541193|NCT01122056|b1b-interferon|b1b-interferon
5541194|NCT01122056|Fatigue|fatigue
5541195|NCT01122056|Exercise|exercise
5541196|NCT01122043|Endoglide|endoglide
5541197|NCT01122043|Endothelial Keratoplasty|endothelial keratoplasty
5541598|NCT01120067|Psychology|psychology
5541198|NCT01122043|Donor Insertion|donor insertion
5541199|NCT01122043|DSAEK|dsaek
5541200|NCT01122043|Corneal Transplant|corneal transplant
5541201|NCT01122043|Patients with Bullous Keratopathy|patients with bullous keratopathy
5541202|NCT01122030|Chronic pain|chronic pain
5541203|NCT01122030|Opioid physical dependence|opioid physical dependence
5541204|NCT01121991|Infertility|infertility
5541205|NCT01121991|Ovarian Stimulation|ovarian stimulation
5541206|NCT01121991|Luveris|luveris
5541207|NCT01121991|Lutropin alpha|lutropin alpha
5541208|NCT01121991|Controlled ovarian stimulation|controlled ovarian stimulation
5541209|NCT01121991|Reproductive techniques, assisted|reproductive techniques, assisted
5541210|NCT01121978|macular tractional maculopathy|macular tractional maculopathy
5541211|NCT01121978|pathologic myopia|pathologic myopia
5541212|NCT01121965|macular hole|macular hole
5541213|NCT01121965|impending macular hole|impending macular hole
5541214|NCT01121965|stage 1 macular hole|stage 1 macular hole
5541215|NCT01121952|Ankle joint|ankle joint
5541216|NCT01121952|Talo-crural joint|talo-crural joint
5541217|NCT01121952|Vertical jump|vertical jump
5541218|NCT01121952|Chiropractic manipulation (HVLA)|chiropractic manipulation (hvla)
5541219|NCT01121952|ROM|rom
5541220|NCT01121952|Proprioception|proprioception
5541221|NCT01121952|Pain|pain
5541222|NCT01121939|advanced neuroendocrine|advanced neuroendocrine
5541223|NCT01121939|Gastrointestinal|gastrointestinal
5541224|NCT01121939|Bevacizumab|bevacizumab
5541225|NCT01121939|Avastin|avastin
5541226|NCT01121939|Pertuzumab|pertuzumab
5541227|NCT01121939|Omnitarg|omnitarg
5541228|NCT01121939|2C4|2c4
5541229|NCT01121939|Sandostatin|sandostatin
5541230|NCT01121939|Octreotide|octreotide
5541231|NCT01121926|Healthy subjects|healthy subjects
5541232|NCT01121926|Bioavailability|bioavailability
5541233|NCT01121926|Pharmacokinetics|pharmacokinetics
5541234|NCT01121926|Trazodone|trazodone
5541235|NCT01121926|Steady-state|steady-state
5541236|NCT01121913|Healthy subjects|healthy subjects
5541237|NCT01121900|Healthy subjects|healthy subjects
5541238|NCT01121887|smoking cessation|smoking cessation
5541239|NCT01121887|telephone counselling|telephone counselling
5541240|NCT01121887|motivational interviewing|motivational interviewing
5541241|NCT01121887|treatment integrity|treatment integrity
5541242|NCT01121887|Tobacco Smoking|tobacco smoking
5541243|NCT01121874|CMC arthritis|cmc arthritis
5541244|NCT01121874|thumb carpometacarpal arthritis|thumb carpometacarpal arthritis
5541245|NCT01121874|basal joint arthritis|basal joint arthritis
5541246|NCT01121874|thumb CMC arthritis|thumb cmc arthritis
5541247|NCT01121861|efficacy|efficacy
5541248|NCT01121861|safety|safety
5541249|NCT01121861|predictability|predictability
5541251|NCT01121861|toric IOL|toric iol
5541252|NCT01121861|refractive astigmatism|refractive astigmatism
5541253|NCT01121861|phacoemulsification|phacoemulsification
5541254|NCT01121822|Influenza|influenza
5541255|NCT01121822|Influenza vaccine|influenza vaccine
5541256|NCT01121822|Influenza virus|influenza virus
5541257|NCT01121822|Intramuscular|intramuscular
5541258|NCT01121809|Raltegravir|raltegravir
5541259|NCT01121809|etravirine|etravirine
5541260|NCT01121809|pharmacokinetics|pharmacokinetics
5541261|NCT01121809|intracellular|intracellular
5541262|NCT01121757|relapsed|relapsed
5541263|NCT01121757|refractory|refractory
5541264|NCT01121757|lymphoma|lymphoma
5541265|NCT01121757|follicular|follicular
5541266|NCT01121757|marginal zone|marginal zone
5541267|NCT01121744|Coronary Artery Disease|coronary artery disease
5541268|NCT01121744|Drug Eluting Stents (DES)|drug eluting stents (des)
5541269|NCT01121744|Pharmacokinetic (PK)|pharmacokinetic (pk)
5535585|NCT01144481|HR-pQCT|hr-pqct
5541270|NCT01121731|Chronic Hepatitis C Viral Infection|chronic hepatitis c viral infection
5541271|NCT01121731|Interferon alfa-5|interferon alfa-5
5541272|NCT01121731|Interferon|interferon
5541273|NCT01121718|lymph node|lymph node
5541274|NCT01121705|genotype 3|genotype 3
5541275|NCT01121705|Combination treatment|combination treatment
5541276|NCT01121705|Short treatment|short treatment
5541277|NCT01121692|Couples|couples
5541278|NCT01121692|Alcohol use|alcohol use
5541279|NCT01121692|HIV risk|hiv risk
5541280|NCT01121692|Outreach|outreach
5541281|NCT01121679|Older patients|older patients
5541282|NCT01121679|Aged, 80 and Over|aged, 80 and over
5541283|NCT01121679|Cardiology|cardiology
5541284|NCT01121666|Assisted reproductive treatment|assisted reproductive treatment
5541285|NCT01121666|Superovulation|superovulation
5541286|NCT01121666|Follitropin alfa|follitropin alfa
5541287|NCT01121666|r-hFSH|r-hfsh
5541288|NCT01121666|AFOLIA|afolia
5541289|NCT01121653|Neuropathic pain, magnesium|neuropathic pain, magnesium
5541290|NCT01121640|Ovarian Cancer|ovarian cancer
5541291|NCT01121640|Screening|screening
5541292|NCT01121640|Biomarkers|biomarkers
5541293|NCT01121627|Computerized Cognitive training|computerized cognitive training
5541294|NCT01121627|Quality of life|quality of life
5541295|NCT01121627|Gait Function|gait function
5541296|NCT01121627|Executive Function|executive function
5541297|NCT01121614|Harmonic scalpel|harmonic scalpel
5541298|NCT01121614|ultrasonic scalpel|ultrasonic scalpel
5541299|NCT01121614|LOTUS|lotus
5541300|NCT01121614|LigaSure|ligasure
5541301|NCT01121614|vessel sealing|vessel sealing
5541302|NCT01121614|burst pressure|burst pressure
5541303|NCT01121614|collateral damage|collateral damage
5541304|NCT01121588|neoplasm malignant|neoplasm malignant
5541305|NCT01121588|lymphoma|lymphoma
5541306|NCT01121588|neuroblastoma|neuroblastoma
5541307|NCT01121588|Crizotinib|crizotinib
5541308|NCT01121588|anaplastic lymphoma kinase|anaplastic lymphoma kinase
5541310|NCT01121575|Phase 1 acquired resistance to erlotinib or gefitinib cMET inhibitor EGFR inhibitor panHER inhibitor combination trial Crizotinib|phase 1 acquired resistance to erlotinib or gefitinib cmet inhibitor egfr inhibitor panher inhibitor combination trial crizotinib
5541311|NCT01121562|Neuroendocrine tumors|neuroendocrine tumors
5541312|NCT01121549|Prospective|prospective
5541313|NCT01121549|non-comparative|non-comparative
5541314|NCT01121549|NIS|nis
5541315|NCT01121549|600|600
5541316|NCT01121549|postmenopausal|postmenopausal
5541317|NCT01121549|hormone-receptor|hormone-receptor
5541318|NCT01121549|positive|positive
5541319|NCT01121549|EBC|ebc
5541320|NCT01121549|tamoxifen|tamoxifen
5541321|NCT01121549|current medical practice.|current medical practice.
5541322|NCT01121536|Bipolar I Disorder|bipolar i disorder
5541323|NCT01121523|Prematurity|prematurity
5541324|NCT01121523|massage|massage
5541325|NCT01121523|stress|stress
5541326|NCT01121523|parenting|parenting
5541327|NCT01121523|infancy|infancy
5541328|NCT01121523|sleep|sleep
5541329|NCT01121523|intervention|intervention
5541330|NCT01121510|vascular closure device|vascular closure device
5541331|NCT01121497|Sedation|sedation
5541332|NCT01121497|Cognitive decline|cognitive decline
5541333|NCT01121497|Physostigmine|physostigmine
5541334|NCT01121497|Colonoscopy|colonoscopy
5541335|NCT01121471|diabetes|diabetes
5541336|NCT01121471|conjugated linoleic acid|conjugated linoleic acid
5541337|NCT01121458|pulmonary artery|pulmonary artery
5541338|NCT01121458|vascular resistance|vascular resistance
5541339|NCT01121445|Sleep apnea|sleep apnea
5541341|NCT01121445|Saline irrigation|saline irrigation
5541342|NCT01121419|Neuroblastoma|neuroblastoma
5541343|NCT01121419|IMP3|imp3
5541344|NCT01121419|Prognosis|prognosis
5541345|NCT01121380|Healthy|healthy
5541346|NCT01121380|Volunteers|volunteers
5541347|NCT01121367|emphysema; pulmonary fibrosis;chemokine;sputum|emphysema; pulmonary fibrosis;chemokine;sputum
5541348|NCT01121354|Cefazolin|cefazolin
5541349|NCT01121354|Caphalosporin|caphalosporin
5541350|NCT01121354|antibiotic|antibiotic
5541351|NCT01121354|gram positive|gram positive
5541352|NCT01121354|Infection control|infection control
5541353|NCT01121341|Endoscopic vein harvesting|endoscopic vein harvesting
5541354|NCT01121341|Saphenous vein|saphenous vein
5541355|NCT01121341|Conventional vein harvesting|conventional vein harvesting
5541356|NCT01121328|Preterm neonates.|preterm neonates.
5541357|NCT01121328|Autologous cord blood transfusion.|autologous cord blood transfusion.
5541358|NCT01121315|Epidemiological|epidemiological
5541359|NCT01121315|Diabetes|diabetes
5541360|NCT01121315|Glucose Lowering Drug Treatment in Primary care|glucose lowering drug treatment in primary care
5541361|NCT01121315|CVD|cvd
5541362|NCT01121302|AZD5213|azd5213
5541363|NCT01121302|Phase 1|phase 1
5541364|NCT01121302|Safety|safety
5541365|NCT01121263|coronary arteriosclerosis|coronary arteriosclerosis
5541366|NCT01121263|coronary heart disease|coronary heart disease
5541367|NCT01121263|coronary artery bypass|coronary artery bypass
5541368|NCT01121263|coronary artery bypass, off-pump|coronary artery bypass, off-pump
5541369|NCT01121263|coronary angiography|coronary angiography
5541370|NCT01121263|drug-eluting stents|drug-eluting stents
5541371|NCT01121250|Combat disorders|combat disorders
5541373|NCT01121250|Support|support
5541374|NCT01121250|Military personnel|military personnel
5541375|NCT01121237|chronic kidney disease|chronic kidney disease
5541376|NCT01121237|end-stage renal disease|end-stage renal disease
5541377|NCT01121237|renal anaemia|renal anaemia
5541378|NCT01121237|epoetin alfa|epoetin alfa
5541379|NCT01121224|Saphenous vein graft|saphenous vein graft
5541380|NCT01121224|Percutaneous coronary intervention|percutaneous coronary intervention
5541381|NCT01121224|Stents|stents
5541382|NCT01121211|Testosterone|testosterone
5541383|NCT01121211|Hormones|hormones
5541384|NCT01121211|Mental Health|mental health
5541385|NCT01121198|Food effect|food effect
5541386|NCT01121185|Hepatitis C virus (HCV)|hepatitis c virus (hcv)
5541387|NCT01121185|Liver transplantation|liver transplantation
5541388|NCT01121185|Human Monoclonal Antibody|human monoclonal antibody
5541389|NCT01121146|Osteolysis|osteolysis
5541390|NCT01121146|Polyethylene|polyethylene
5541391|NCT01121146|Crosslinked Polyethylene|crosslinked polyethylene
5541392|NCT01121146|Total Hip Replacement|total hip replacement
5541393|NCT01121146|CT|ct
5541394|NCT01121120|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5541395|NCT01121120|Hodgkin Disease|hodgkin disease
5541396|NCT01121120|Multiple myeloma|multiple myeloma
5541397|NCT01121120|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5541398|NCT01121120|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5541399|NCT01121120|Limited re-infusion of CD34+ cells|limited re-infusion of cd34+ cells
5541400|NCT01121107|Heart Failure|heart failure
5541401|NCT01121107|Decompensated Heart Failure|decompensated heart failure
5541402|NCT01121107|Acute Decompensated Heart Failure|acute decompensated heart failure
5541403|NCT01121107|Hemodynamic Monitoring|hemodynamic monitoring
5541404|NCT01121107|Implantable Pressure Monitor|implantable pressure monitor
5541405|NCT01121107|Left Atrial Pressure Monitoring|left atrial pressure monitoring
5541406|NCT01121094|Liver, spleen , T2* , MRI, fetus|liver, spleen , t2* , mri, fetus
5541407|NCT01121081|Male or female subjects|male or female subjects
5541408|NCT01121081|≥18 to ≤75 years of age|≥18 to ≤75 years of age
5541409|NCT01121081|who have a diagnosis of plaque or guttate psoriasis|who have a diagnosis of plaque or guttate psoriasis
5541410|NCT01121068|IGRA|igra
5541411|NCT01121068|variability|variability
5541412|NCT01121068|Long-term variability of IGRA|long-term variability of igra
5541413|NCT01121055|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5541414|NCT01121055|Patient|patient
5541415|NCT01121055|Satisfaction|satisfaction
5541416|NCT01121055|Lorazepam|lorazepam
5541417|NCT01121016|NAEB, chronic cough, montelukast, induced sputum|naeb, chronic cough, montelukast, induced sputum
5541418|NCT01121003|Fructose|fructose
5541419|NCT01121003|VLDL-triglycerides|vldl-triglycerides
5541420|NCT01121003|de novo lipogenesis|de novo lipogenesis
5541421|NCT01121003|Human metabolism|human metabolism
5541422|NCT01120990|Blood pressure measuring devices|blood pressure measuring devices
5541423|NCT01120990|Essential Hypertension|essential hypertension
5541424|NCT01120990|Automated blood pressure measurement|automated blood pressure measurement
5541425|NCT01120951|Respiratory rate R8 Anaxsys|respiratory rate r8 anaxsys
5541426|NCT01120938|AIrways, Patency, Infant death|airways, patency, infant death
5541427|NCT01120925|Cirrhotic|cirrhotic
5541429|NCT01120925|Bone marrow stem cells|bone marrow stem cells
5541430|NCT01120925|Decompensate Cirrhotic Patients|decompensate cirrhotic patients
5541431|NCT01120912|oral insulin|oral insulin
5541432|NCT01120899|Diabetic Macular Edema|diabetic macular edema
5541433|NCT01120899|Microglia|microglia
5541434|NCT01120899|Minocycline|minocycline
5541435|NCT01120899|Diabetes|diabetes
5541436|NCT01120886|Ion channelopathy,|ion channelopathy,
5541437|NCT01120886|Still birth|still birth
5541438|NCT01120886|Sudden death|sudden death
5541439|NCT01120873|Hyperglycemia|hyperglycemia
5541440|NCT01120873|dyslipidemia|dyslipidemia
5541441|NCT01120873|Hypertension|hypertension
5541442|NCT01120873|Obesity|obesity
5541443|NCT01120860|Cognitive Aging|cognitive aging
5541444|NCT01120860|Apolipoproteins E|apolipoproteins e
5541445|NCT01120860|Magnetic Resonance Imaging|magnetic resonance imaging
5541446|NCT01120834|diffuse large b cell lymphoma|diffuse large b cell lymphoma
5541447|NCT01120821|PV|pv
5541448|NCT01120769|Myocardial Infarction|myocardial infarction
5541449|NCT01120769|Percutaneous Coronary Intervention|percutaneous coronary intervention
5541450|NCT01120769|Acetaminophen|acetaminophen
5541451|NCT01120769|Lipid Peroxidation|lipid peroxidation
5541452|NCT01120756|executive dysfunction|executive dysfunction
5541453|NCT01120756|brain injury|brain injury
5541454|NCT01120756|attention|attention
5541455|NCT01120756|rehabilitation|rehabilitation
5541456|NCT01120743|liver failure|liver failure
5541457|NCT01120743|cytokines|cytokines
5541458|NCT01120743|hemodynamic instability|hemodynamic instability
5541459|NCT01120717|QVA149|qva149
5541460|NCT01120717|COPD|copd
5541461|NCT01120717|combination bronchodilator|combination bronchodilator
5541462|NCT01120704|Smoking|smoking
5541463|NCT01120704|Smoking Cessation|smoking cessation
5541464|NCT01120704|Adherence|adherence
5541465|NCT01120704|Nicotine|nicotine
5541466|NCT01120704|Motivation|motivation
5541467|NCT01120691|QVA149|qva149
5541473|NCT01120678|late-onset neonatal sepsis|late-onset neonatal sepsis
5541474|NCT01120678|neonatal sepsis|neonatal sepsis
5541475|NCT01120678|diagnosis of sepsis|diagnosis of sepsis
5541476|NCT01120678|bacteremia|bacteremia
5541477|NCT01120678|blood culture|blood culture
5541478|NCT01120678|clinical sepsis|clinical sepsis
5541479|NCT01120665|women's health|women's health
5541480|NCT01120665|hormone replacement therapy|hormone replacement therapy
5541481|NCT01120665|exercise|exercise
5541482|NCT01120613|Nocturnal Hypertension|nocturnal hypertension
5541483|NCT01120613|Nondipping|nondipping
5541484|NCT01120613|Renal Transplant|renal transplant
5541485|NCT01120613|Chronotherapy|chronotherapy
5541486|NCT01120587|Deglutition|deglutition
5541487|NCT01120587|Fluoroscopy|fluoroscopy
5541488|NCT01120574|Nocturnal hypercapnic response to oxygen|nocturnal hypercapnic response to oxygen
5541489|NCT01120574|Home mechanical ventilation|home mechanical ventilation
5541490|NCT01120574|COPD|copd
5541491|NCT01120561|TDM-1 EAP|tdm-1 eap
5541492|NCT01120561|T-DM1 EAP|t-dm1 eap
5541493|NCT01120561|TDM1 EAP|tdm1 eap
5541494|NCT01120561|Trastuzumab-MCC-DM1 EAP|trastuzumab-mcc-dm1 eap
5541495|NCT01120561|Trastuzumab emtansine|trastuzumab emtansine
5541497|NCT01120561|T-PAS|t-pas
5541498|NCT01120548|CARDIAC REHABILITATION|cardiac rehabilitation
5541499|NCT01120548|Nocturnal Ventilation|nocturnal ventilation
5541500|NCT01120548|Apnea hypopnea index is > 15/h|apnea hypopnea index is > 15/h
5541501|NCT01120535|Vena Cava|vena cava
5541502|NCT01120535|Vena Cava Filter|vena cava filter
5541503|NCT01120535|Pulmonary Embolism|pulmonary embolism
5541504|NCT01120535|Venous Thromboembolism|venous thromboembolism
5541505|NCT01120535|Risk of Pulmonary Embolism|risk of pulmonary embolism
5541506|NCT01120522|Vena Cava|vena cava
5541507|NCT01120522|Vena Cava Filter|vena cava filter
5541508|NCT01120522|Pulmonary Embolism|pulmonary embolism
5541509|NCT01120522|Venous Thromboembolism|venous thromboembolism
5541510|NCT01120522|Risk of Pulmonary Embolism|risk of pulmonary embolism
5541511|NCT01120509|Vena Cava|vena cava
5541512|NCT01120509|Vena Cava Filter|vena cava filter
5541513|NCT01120509|Pulmonary Embolism|pulmonary embolism
5541514|NCT01120509|Venous Thromboembolism|venous thromboembolism
5541515|NCT01120509|Risk of Pulmonary Embolism|risk of pulmonary embolism
5541516|NCT01120496|Hypertonic saline solution, bronchiolitis, RSV|hypertonic saline solution, bronchiolitis, rsv
5541517|NCT01120483|mortality|mortality
5541518|NCT01120483|functional status|functional status
5541519|NCT01120470|Castration Resistant|castration resistant
5541520|NCT01120470|Prostate Cancer|prostate cancer
5541521|NCT01120470|OGX-427|ogx-427
5541522|NCT01120444|Diabetes|diabetes
5541523|NCT01120444|Insulin|insulin
5541524|NCT01120444|Blood Glucose|blood glucose
5541525|NCT01120431|dehydration|dehydration
5541526|NCT01120431|fluid therapy|fluid therapy
5541527|NCT01120431|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5541528|NCT01120431|hyaluronidase|hyaluronidase
5541529|NCT01120431|hypodermoclysis|hypodermoclysis
5541530|NCT01120431|clysis|clysis
5541531|NCT01120431|subcutaneous hydration|subcutaneous hydration
5541532|NCT01120431|subcutaneous rehydration|subcutaneous rehydration
5541533|NCT01120431|hyaluronan|hyaluronan
5541534|NCT01120431|rHuPH20|rhuph20
5541535|NCT01120431|pediatric|pediatric
5541536|NCT01120431|ORT|ort
5541537|NCT01120418|Endothelial cell density|endothelial cell density
5541538|NCT01120418|screening|screening
5541539|NCT01120405|Xenon|xenon
5541540|NCT01120405|Cardiac safety|cardiac safety
5541541|NCT01120405|Cardiovascular risk|cardiovascular risk
5541542|NCT01120405|Non cardiac surgery|non cardiac surgery
5541543|NCT01120405|Atherosclerotic vascular surgery|atherosclerotic vascular surgery
5541544|NCT01120392|Parkinson's disease|parkinson's disease
5541545|NCT01120392|Physical therapy|physical therapy
5541546|NCT01120392|Virtual Reality|virtual reality
5541547|NCT01120392|Quality of life|quality of life
5541548|NCT01120392|Motor performance|motor performance
5541549|NCT01120379|drug eluting stents|drug eluting stents
5541550|NCT01120379|Stents|stents
5541551|NCT01120379|Angioplasty|angioplasty
5541552|NCT01120379|Stent thrombosis|stent thrombosis
5541553|NCT01120353|Childhood cancer|childhood cancer
5541554|NCT01120353|Young Children|young children
5541555|NCT01120353|Adults|adults
5541556|NCT01120301|stroke|stroke
5541557|NCT01120288|Anti-Angiogenesis|anti-angiogenesis
5541558|NCT01120288|Targeted Therapy|targeted therapy
5541559|NCT01120288|HIF|hif
5541560|NCT01120288|Antisense|antisense
5541561|NCT01120288|VEGF|vegf
5541562|NCT01120288|Cancer|cancer
5541563|NCT01120288|Solid Tumor|solid tumor
5541564|NCT01120288|Liver Metastasis|liver metastasis
5535893|NCT01143220|Ease of Use|ease of use
5541567|NCT01120249|stage I renal cell cancer|stage i renal cell cancer
5541568|NCT01120249|stage II renal cell cancer|stage ii renal cell cancer
5541569|NCT01120249|stage III renal cell cancer|stage iii renal cell cancer
5541570|NCT01120249|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5541571|NCT01120249|papillary renal cell carcinoma|papillary renal cell carcinoma
5541573|NCT01120210|Cardiac Failure|cardiac failure
5541574|NCT01120197|randomized controlled trial|randomized controlled trial
5541575|NCT01120197|osteoporosis|osteoporosis
5541576|NCT01120197|moderate-intensity circuit exercises|moderate-intensity circuit exercises
5541577|NCT01120197|balance|balance
5541578|NCT01120197|health-related quality of life|health-related quality of life
5541579|NCT01120171|Breast cancer|breast cancer
5541580|NCT01120171|Elderly|elderly
5541581|NCT01120171|Chemotherapy|chemotherapy
5541582|NCT01120171|Cardiotoxicity|cardiotoxicity
5541583|NCT01120158|Breast cancer|breast cancer
5541584|NCT01120158|Elderly|elderly
5541585|NCT01120158|Chemotherapy|chemotherapy
5541586|NCT01120158|Anti-angiogenesis therapy|anti-angiogenesis therapy
5541587|NCT01120145|Malaria|malaria
5541588|NCT01120145|Pregnancy|pregnancy
5541589|NCT01120145|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5541590|NCT01120106|levosimendan|levosimendan
5541591|NCT01120106|pediatric cardiac surgery|pediatric cardiac surgery
5541592|NCT01120106|low cardiac output syndrome|low cardiac output syndrome
5541593|NCT01120106|transposition of the great arteries|transposition of the great arteries
5541594|NCT01120093|COPD|copd
5541595|NCT01120080|Smoking|smoking
5541596|NCT01120080|Tobacco|tobacco
5541597|NCT01120080|Drinking|drinking
5541600|NCT01120067|Veterans|veterans
5541601|NCT01120067|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5541602|NCT01120054|Traumatic Brain Injury|traumatic brain injury
5541603|NCT01120054|Homelessness|homelessness
5541604|NCT01120028|Kidney transplantation|kidney transplantation
5541605|NCT01120028|Alemtuzumab|alemtuzumab
5541606|NCT01120028|Sirolimus|sirolimus
5541607|NCT01120028|Basiliximab|basiliximab
5541608|NCT01120028|Tacrolimus|tacrolimus
5541609|NCT01120028|Campath-1H|campath-1h
5541611|NCT01120015|knee|knee
5541612|NCT01120002|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5541613|NCT01119989|hepatic fat content|hepatic fat content
5541614|NCT01119989|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5541615|NCT01119963|Preterm delivery|preterm delivery
5541616|NCT01119950|COPD|copd
5541617|NCT01119937|COPD|copd
5541618|NCT01119937|NVA237|nva237
5541619|NCT01119924|Mirtazapine|mirtazapine
5541620|NCT01119924|Smilon|smilon
5541621|NCT01119924|Depression|depression
5541622|NCT01119924|Pain|pain
5541623|NCT01119911|Blood sampling|blood sampling
5541624|NCT01119911|Venipuncture|venipuncture
5541625|NCT01119911|Peripheral venous catheter|peripheral venous catheter
5541626|NCT01119911|Complete blood count|complete blood count
5541627|NCT01119911|Basic chemistry|basic chemistry
5541628|NCT01119911|Hemolysis|hemolysis
5541629|NCT01119911|Peripheral venous catheter replaces venipuncture.|peripheral venous catheter replaces venipuncture.
5541630|NCT01119911|Peripheral venous catheter blood sampling reduces pain.|peripheral venous catheter blood sampling reduces pain.
5541631|NCT01119898|Osteoarthritis|osteoarthritis
5541632|NCT01119898|Arthritis|arthritis
5541633|NCT01119898|NSAIDs|nsaids
5541634|NCT01119898|Topical NSAID|topical nsaid
5541635|NCT01119898|Diclofenac|diclofenac
5541636|NCT01119898|PENNSAID|pennsaid
5541637|NCT01119885|chronic pain|chronic pain
5541638|NCT01119885|fentanyl matrix|fentanyl matrix
5541639|NCT01119885|arthritis|arthritis
5541640|NCT01119885|osteoarthritis|osteoarthritis
5541641|NCT01119872|Positive-Pressure Respiration|positive-pressure respiration
5541642|NCT01119872|Respiration, Artificial|respiration, artificial
5541643|NCT01119846|Tolerability|tolerability
5541644|NCT01119846|Pharmacokinetics|pharmacokinetics
5541645|NCT01119846|Safety|safety
5541646|NCT01119846|Pharmacodynamics|pharmacodynamics
5541647|NCT01119846|Glucose|glucose
5541648|NCT01119833|Sickle Cell Disease|sickle cell disease
5541649|NCT01119820|elective obstetric or gynecologic surgery|elective obstetric or gynecologic surgery
5541650|NCT01119807|Intraosseous infusion|intraosseous infusion
5541651|NCT01119807|Emergency Medical Services|emergency medical services
5541652|NCT01119794|B-cell small lymphocytic lymphoma|b-cell small lymphocytic lymphoma
5541653|NCT01119794|marginal zone lymphoma|marginal zone lymphoma
5541654|NCT01119794|follicular lymphoma|follicular lymphoma
5541655|NCT01119794|mantle cell lymphoma|mantle cell lymphoma
5541656|NCT01119794|Waldenström macroglobulinemia.|waldenström macroglobulinemia.
5541657|NCT01119794|Low Grade B cell Non-Hodgkins Lymphoma|low grade b cell non-hodgkins lymphoma
5541659|NCT01119768|Nexium|nexium
5541660|NCT01119768|Phase IV|phase iv
5541661|NCT01119768|Co-diagnosed NERD|co-diagnosed nerd
5535989|NCT01142830|Pain|pain
5541662|NCT01119755|TREATMENT OF HYPERTENSION|treatment of hypertension
5541663|NCT01119742|Tinea Pedis|tinea pedis
5541664|NCT01119742|Interdigital|interdigital
5541665|NCT01119729|Cardiac Diseases • HIV-Infection • AIDS • Antiretroviral Therapy|cardiac diseases • hiv-infection • aids • antiretroviral therapy
5541666|NCT01119716|Atrial Fibrillation|atrial fibrillation
5541667|NCT01119716|Afib|afib
5541668|NCT01119716|cardioversion|cardioversion
5541669|NCT01119716|normal sinus rhythm|normal sinus rhythm
5541670|NCT01119716|arrhythmia|arrhythmia
5541672|NCT01119703|Vaccine Hyporesponse|vaccine hyporesponse
5541673|NCT01119690|Dietary|dietary
5541674|NCT01119690|Cross-Over Study|cross-over study
5541675|NCT01119690|Lipids|lipids
5541676|NCT01119690|Rapeseed oil|rapeseed oil
5541677|NCT01119690|Butter|butter
5541678|NCT01119690|Milk Fat|milk fat
5541679|NCT01119690|Unsaturated Fat|unsaturated fat
5541680|NCT01119690|Saturated Fat|saturated fat
5541681|NCT01119690|Oxidized LDL|oxidized ldl
5541682|NCT01119690|Platelet Function|platelet function
5541683|NCT01119690|Arterial Elasticity|arterial elasticity
5541684|NCT01119664|Adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,|adult subjects with malignant pleural mesothelioma who present for first (front) line or second line chemotherapy,
5541685|NCT01119651|Healthy Volunteer Subjects|healthy volunteer subjects
5541686|NCT01119638|Alzheimer's disease|alzheimer's disease
5541687|NCT01119638|BPSD|bpsd
5541688|NCT01119638|escitalopram|escitalopram
5541689|NCT01119638|Risperidone|risperidone
5541690|NCT01119638|Agitation|agitation
5541691|NCT01119638|Psychosis|psychosis
5541692|NCT01119638|Dementia|dementia
5541693|NCT01119638|Elderly|elderly
5541694|NCT01119625|safety|safety
5541695|NCT01119625|Streptococcus pneumoniae|streptococcus pneumoniae
5541696|NCT01119625|immunogenicity|immunogenicity
5541697|NCT01119625|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5541698|NCT01119625|Haemophilus influenzae|haemophilus influenzae
5541699|NCT01119612|Malaria|malaria
5541700|NCT01119612|Iron|iron
5541701|NCT01119612|Pregnancy|pregnancy
5541702|NCT01119612|Anemia|anemia
5541703|NCT01119612|Birth Weight|birth weight
5541704|NCT01119586|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5541705|NCT01119586|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5541706|NCT01119586|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5541707|NCT01119586|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5541708|NCT01119573|stage I endometrial carcinoma|stage i endometrial carcinoma
5541709|NCT01119573|stage III endometrial carcinoma|stage iii endometrial carcinoma
5541710|NCT01119547|Musculoskeletal Diseases|musculoskeletal diseases
5541711|NCT01119547|Osteoarthritis|osteoarthritis
5541712|NCT01119547|Joint Diseases|joint diseases
5541714|NCT01119547|Rheumatic Diseases|rheumatic diseases
5541715|NCT01119534|Cough treatment|cough treatment
5541716|NCT01119521|South Africa,tuberculosis,vaccine|south africa,tuberculosis,vaccine
5541717|NCT01119508|Advanced|advanced
5541718|NCT01119508|Inoperable|inoperable
5541719|NCT01119508|Melanoma|melanoma
5541720|NCT01119508|Ipilimumab|ipilimumab
5541721|NCT01119508|MDX010|mdx010
5541722|NCT01119508|BMS-734016|bms-734016
5541723|NCT01119508|Temozolomide|temozolomide
5541724|NCT01119508|Temodar|temodar
5541725|NCT01119508|TMZ|tmz
5541726|NCT01119508|skin|skin
5541727|NCT01119508|mucosal|mucosal
5541728|NCT01119482|Serogroup A meningococcal vaccine|serogroup a meningococcal vaccine
5541729|NCT01119482|meningococcal carriage|meningococcal carriage
5541730|NCT01119482|incidence|incidence
5541731|NCT01119482|prevalence|prevalence
5541732|NCT01119469|Hypochondriasis|hypochondriasis
5541733|NCT01119469|Health Anxiety|health anxiety
5541734|NCT01119469|randomized controlled trial|randomized controlled trial
5541735|NCT01119469|Cognitive Therapy|cognitive therapy
5541736|NCT01119469|Exposure Therapy|exposure therapy
5541737|NCT01119456|Tumors|tumors
5541738|NCT01119456|Macrophage stimulating 1 receptor, human|macrophage stimulating 1 receptor, human
5541739|NCT01119456|RON protein|ron protein
5541740|NCT01119456|RON receptor protein tyrosine kinase|ron receptor protein tyrosine kinase
5541741|NCT01119430|major depression|major depression
5541742|NCT01119430|DU 125530|du 125530
5541743|NCT01119430|Treatment depression|treatment depression
5541744|NCT01119430|Latency antidepressant|latency antidepressant
5541745|NCT01119417|supine Hypertension|supine hypertension
5541746|NCT01119417|autonomic failure|autonomic failure
5541747|NCT01119417|BQ123|bq123
5541748|NCT01119417|BQ-123|bq-123
5541749|NCT01119417|endothelin|endothelin
5541750|NCT01119404|Metabolic Syndrome|metabolic syndrome
5541751|NCT01119404|Coronary Heart Disease|coronary heart disease
5541752|NCT01119404|Erectile Dysfunction|erectile dysfunction
5541753|NCT01119404|Arterial Elasticity|arterial elasticity
5541754|NCT01119404|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
5541755|NCT01119404|Cardiovascular Diseases|cardiovascular diseases
5541756|NCT01119404|Risk Assessment|risk assessment
5541757|NCT01119404|Endothelial Dysfunction|endothelial dysfunction
5541758|NCT01119404|Diabetes Mellitus|diabetes mellitus
5541759|NCT01119404|Surrogate Markers|surrogate markers
5541760|NCT01119404|Risk Factors|risk factors
5541762|NCT01119391|Lifestyle habits|lifestyle habits
5541763|NCT01119378|Post menopausal|post menopausal
5541764|NCT01119378|Vitamin D sufficiency|vitamin d sufficiency
5541765|NCT01119378|Calcium absorption efficiency|calcium absorption efficiency
5798863|NCT00110786|Ragweed|ragweed
5541766|NCT01119378|Dual isotope technique|dual isotope technique
5541767|NCT01119365|Healthy controls|healthy controls
5541768|NCT01119352|Safety|safety
5541769|NCT01119352|tolerability|tolerability
5541770|NCT01119352|PK|pk
5541771|NCT01119352|healthy|healthy
5541772|NCT01119352|overweight|overweight
5541773|NCT01119352|obese|obese
5541774|NCT01119339|psoriasis|psoriasis
5541775|NCT01119339|topical|topical
5541776|NCT01119339|psoriasis plaques test|psoriasis plaques test
5541777|NCT01119326|scar prevention|scar prevention
5541778|NCT01119326|healing|healing
5541779|NCT01119326|tissue|tissue
5541780|NCT01119326|AFT|aft
5541781|NCT01119326|scar analysis|scar analysis
5541782|NCT01119300|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
5541783|NCT01119300|Atrial Fibrillation (AF)|atrial fibrillation (af)
5541784|NCT01119287|Conjunctivitis|conjunctivitis
5541785|NCT01119287|ocular allergy|ocular allergy
5541786|NCT01119261|Venous thromboembolism (VTE)|venous thromboembolism (vte)
5541787|NCT01119261|Atrial fibrillation (AF)|atrial fibrillation (af)
5541788|NCT01119248|Children MRI General Anesthesia|children mri general anesthesia
5541789|NCT01119235|Pharmacokinetics|pharmacokinetics
5541790|NCT01119235|tablet performance|tablet performance
5541791|NCT01119235|healthy volunteers|healthy volunteers
5541792|NCT01119235|open label|open label
5541793|NCT01119222|Cold pain methodology|cold pain methodology
5541794|NCT01119222|Healthy male volunteers|healthy male volunteers
5541795|NCT01119222|gabapentin|gabapentin
5541796|NCT01119222|Diphenhydramine|diphenhydramine
5541797|NCT01119222|morphine|morphine
5541798|NCT01119209|Hip fracture|hip fracture
5541799|NCT01119209|intertrochanteric|intertrochanteric
5541800|NCT01119196|Peritoneal Dialysis|peritoneal dialysis
5541801|NCT01119196|Insulin resistance|insulin resistance
5541802|NCT01119183|Patient understanding and counseling|patient understanding and counseling
5541803|NCT01119170|nutrition|nutrition
5541804|NCT01119170|infant formula|infant formula
5541805|NCT01119170|probiotics|probiotics
5541806|NCT01119157|influenza vaccine|influenza vaccine
5541807|NCT01119157|cellular immune response|cellular immune response
5541808|NCT01119157|humoral immune response|humoral immune response
5541809|NCT01119144|Orbital|orbital
5541810|NCT01119144|fractures|fractures
5541811|NCT01119144|enophthalmos|enophthalmos
5541812|NCT01119144|diplopia|diplopia
5541813|NCT01119144|eye|eye
5541814|NCT01119131|Vitamin D|vitamin d
5541815|NCT01119131|Parkinson disease|parkinson disease
5541816|NCT01119131|accidental falls|accidental falls
5541817|NCT01119118|Metastatic|metastatic
5541818|NCT01119118|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5541819|NCT01119118|bone metastasis|bone metastasis
5541820|NCT01119105|acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
5541821|NCT01119105|bacteria|bacteria
5541822|NCT01119092|Ankle Sprain|ankle sprain
5541823|NCT01119092|Joint Mobilization|joint mobilization
5541824|NCT01119092|Manual Therapy|manual therapy
5541825|NCT01119092|Range of Motion|range of motion
5541826|NCT01119079|labor pain|labor pain
5541827|NCT01119079|epidural|epidural
5541828|NCT01119066|Leukemia|leukemia
5541829|NCT01119066|Multiple Myeloma|multiple myeloma
5541830|NCT01119066|radiation|radiation
5541831|NCT01119066|Thiotepa|thiotepa
5541832|NCT01119066|cyclophosphamide|cyclophosphamide
5541833|NCT01119066|fludarabine|fludarabine
5528479|NCT01174082|Vaccine|vaccine
5541834|NCT01119066|Clofarabine|clofarabine
5541835|NCT01119066|CliniMACS device|clinimacs device
5541836|NCT01119066|GCSF|gcsf
5541837|NCT01119066|10-050|10-050
5541839|NCT01119053|Depression|depression
5541840|NCT01119053|Personality-Disorder|personality-disorder
5541841|NCT01119053|Stimulation|stimulation
5541842|NCT01119040|Dislodged PEG tube|dislodged peg tube
5541843|NCT01119040|NOTES|notes
5541844|NCT01119027|Laparoscopic Colectomy|laparoscopic colectomy
5541845|NCT01119027|Colorectal Skills Training|colorectal skills training
5541846|NCT01119014|Aripiprazole|aripiprazole
5541847|NCT01119014|Quetiapine|quetiapine
5541848|NCT01119014|Psychosis|psychosis
5541849|NCT01119014|Child|child
5541850|NCT01119014|Adolescent|adolescent
5541851|NCT01118988|Peer Support|peer support
5541852|NCT01118988|Social Support|social support
5541853|NCT01118988|Chronic Pain|chronic pain
5541854|NCT01118988|Behavioral Interventions for Pain|behavioral interventions for pain
5541855|NCT01118988|Adolescents|adolescents
5541856|NCT01118988|Children|children
5541857|NCT01118988|Pediatric|pediatric
5541858|NCT01118988|Mentorship|mentorship
5541859|NCT01118988|Complementary and Alternative Medicine|complementary and alternative medicine
5541860|NCT01118988|CAM|cam
5541861|NCT01118988|Pain|pain
5541862|NCT01118988|Pain Management|pain management
5541863|NCT01118988|Behavioral|behavioral
5541864|NCT01118975|lapatinib ditosylate|lapatinib ditosylate
5541865|NCT01118975|Zolinza (vorinostat)|zolinza (vorinostat)
5541866|NCT01118975|Cancer Stem Cells|cancer stem cells
5541867|NCT01118962|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
5541868|NCT01118962|Absence Seizures|absence seizures
5541869|NCT01118962|Myoclonic Seizures|myoclonic seizures
5541870|NCT01118962|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
5541871|NCT01118949|Primary Generalized Tonic-Clonic (PGTC) Seizures|primary generalized tonic-clonic (pgtc) seizures
5541872|NCT01118949|Absence Seizures|absence seizures
5541873|NCT01118949|Myoclonic Seizures|myoclonic seizures
5541874|NCT01118949|Idiopathic Generalized Epilepsy (IGE)|idiopathic generalized epilepsy (ige)
5541875|NCT01118936|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5541876|NCT01118936|Daily magnesium supplement|daily magnesium supplement
5541878|NCT01118923|Bronchial challenge test|bronchial challenge test
5541879|NCT01118923|Hyperreactivity|hyperreactivity
5541880|NCT01118923|PD20 for metacholine|pd20 for metacholine
5541881|NCT01118923|Daily magnesium supplement|daily magnesium supplement
5541882|NCT01118910|Intertrigo|intertrigo
5541883|NCT01118910|Vusion|vusion
5541884|NCT01118897|Gall bladder|gall bladder
5541885|NCT01118897|Pancreatic cancers|pancreatic cancers
5541886|NCT01118897|Tomotherapy|tomotherapy
5541887|NCT01118884|Midazolam|midazolam
5541888|NCT01118884|Nitrous oxide|nitrous oxide
5541889|NCT01118884|Behaviour management|behaviour management
5541890|NCT01118871|Treatment experienced|treatment experienced
5541891|NCT01118858|CYP2D6|cyp2d6
5541892|NCT01118858|CYP3A4|cyp3a4
5541893|NCT01118858|cytochrome P450|cytochrome p450
5541894|NCT01118858|children|children
5541895|NCT01118858|pediatrics|pediatrics
5541896|NCT01118858|dextromethorphan|dextromethorphan
5541897|NCT01118858|phenotype|phenotype
5541898|NCT01118858|genotype|genotype
5541899|NCT01118845|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5541900|NCT01118845|Lymphoma, Large B-Cell|lymphoma, large b-cell
5541901|NCT01118845|Diffuse, Mantle cell lymphoma, Lymphoma|diffuse, mantle cell lymphoma, lymphoma
5541902|NCT01118845|Follicular, Lymphoma|follicular, lymphoma
5541903|NCT01118845|Large B-Cell, Diffuse|large b-cell, diffuse
5541904|NCT01118832|Thermography|thermography
5541905|NCT01118819|Phase I|phase i
5541906|NCT01118819|Metastatic Disease|metastatic disease
5541907|NCT01118819|Solid Tumor|solid tumor
5541908|NCT01118819|Malignancy|malignancy
5541909|NCT01118819|Metastases|metastases
5541910|NCT01118819|Clinical trial|clinical trial
5541911|NCT01118819|Hypoxia|hypoxia
5541912|NCT01118819|Necrosis|necrosis
5541913|NCT01118780|GAD|gad
5541914|NCT01118780|Generalized Anxiety Disorder|generalized anxiety disorder
5541915|NCT01118780|Anxiety|anxiety
5541916|NCT01118767|Adherence|adherence
5541917|NCT01118767|Appointment|appointment
5541918|NCT01118767|Cell Phone|cell phone
5541919|NCT01118767|Cellular Phone|cellular phone
5541920|NCT01118767|Clinic|clinic
5541921|NCT01118767|Computers|computers
5541922|NCT01118767|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5541923|NCT01118767|HIV/AIDS|hiv/aids
5541924|NCT01118767|Health Informatics|health informatics
5541925|NCT01118767|Health behavior|health behavior
5541926|NCT01118767|Information Technology|information technology
5541927|NCT01118767|Internet|internet
5541928|NCT01118767|Intervention|intervention
5541929|NCT01118767|Medication|medication
5541930|NCT01118767|Patient Satisfaction|patient satisfaction
5541931|NCT01118767|Patient Self-Report|patient self-report
5541932|NCT01118767|Patients|patients
5541933|NCT01118767|Peru|peru
5541934|NCT01118767|Phone|phone
5541935|NCT01118767|Public Health|public health
5541936|NCT01118767|Public Health Informatics|public health informatics
5541937|NCT01118767|Randomized|randomized
5541938|NCT01118767|Randomized Controlled Clinical Trials|randomized controlled clinical trials
5541939|NCT01118767|Randomized Controlled Trials|randomized controlled trials
5541940|NCT01118767|Research|research
5541941|NCT01118767|Secondary Prevention|secondary prevention
5541942|NCT01118767|Self-Report|self-report
5541943|NCT01118767|Sex Behavior|sex behavior
5541944|NCT01118767|Sexual Behavior|sexual behavior
5541945|NCT01118767|Sexually Transmitted Diseases|sexually transmitted diseases
5541946|NCT01118767|Sexually Transmitted Infection|sexually transmitted infection
5541947|NCT01118767|Survey Instrument|survey instrument
5541949|NCT01118767|Telephone|telephone
5541950|NCT01118767|Telephone, Cellular|telephone, cellular
5541951|NCT01118767|Text|text
5541952|NCT01118767|Unprotected Sex|unprotected sex
5541953|NCT01118767|Viral Load result|viral load result
5541954|NCT01118767|Vulnerable Populations|vulnerable populations
5541955|NCT01118767|WWW|www
5541956|NCT01118767|anti-retroviral therapy|anti-retroviral therapy
5541957|NCT01118767|consumer informatics|consumer informatics
5541958|NCT01118767|evidence base|evidence base
5541959|NCT01118767|follow-up|follow-up
5541960|NCT01118767|medication adherence|medication adherence
5541961|NCT01118767|medication compliance|medication compliance
5541962|NCT01118767|randomization|randomization
5541963|NCT01118767|randomized controlled study|randomized controlled study
5541964|NCT01118767|randomized trial|randomized trial
5541965|NCT01118767|randomly assigned|randomly assigned
5541966|NCT01118767|safer sex|safer sex
5541967|NCT01118767|treatment adherence|treatment adherence
5541968|NCT01118767|user centered design|user centered design
5541971|NCT01118754|Santen|santen
5541972|NCT01118754|Dry|dry
5541973|NCT01118754|Eye|eye
5541974|NCT01118741|Rising PSA|rising psa
5541975|NCT01118741|Recurrent Non Metastatic Prostate Cancer|recurrent non metastatic prostate cancer
5541976|NCT01118715|distal radius fracture|distal radius fracture
5541977|NCT01118715|post-traumatic carpal tunnel syndrome|post-traumatic carpal tunnel syndrome
5541978|NCT01118715|complex regional pain syndrome|complex regional pain syndrome
5541979|NCT01118715|compression glove|compression glove
5541980|NCT01118715|edema glove|edema glove
5541981|NCT01118702|Pharmacokinetic|pharmacokinetic
5541982|NCT01118702|Methylphenidate|methylphenidate
5541983|NCT01118702|Novo-methylphenidate ER-C|novo-methylphenidate er-c
5541984|NCT01118702|Ritalin-SR|ritalin-sr
5541985|NCT01118702|CONCERTA|concerta
5541986|NCT01118702|Plasma profile|plasma profile
5541987|NCT01118676|locally advanced non small cell lung cancer (NSCLC), locally advanced, Phase I, Cilengitide, concomitant radiochemotherapy|locally advanced non small cell lung cancer (nsclc), locally advanced, phase i, cilengitide, concomitant radiochemotherapy
5541988|NCT01118663|Acetaminophen overdose; induced hepatotoxicity, liver injury|acetaminophen overdose; induced hepatotoxicity, liver injury
5541989|NCT01118650|Inattention|inattention
5541990|NCT01118650|Hyperactivity|hyperactivity
5541991|NCT01118650|Impulsivity|impulsivity
5541992|NCT01118637|trichotillomania|trichotillomania
5541993|NCT01118637|self-help|self-help
5541994|NCT01118637|web-based|web-based
5541995|NCT01118637|habit reversal|habit reversal
5541996|NCT01118637|behavior therapy|behavior therapy
5541997|NCT01118624|Female|female
5541998|NCT01118624|Advanced|advanced
5541999|NCT01118624|Metastatic|metastatic
5542000|NCT01118611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5542001|NCT01118598|PCOS|pcos
5542002|NCT01118585|GERD|gerd
5542003|NCT01118585|Esophagitis|esophagitis
5542004|NCT01118585|Fundoplication|fundoplication
5542005|NCT01118585|Anti-reflux surgery|anti-reflux surgery
5542006|NCT01118585|PPI dependent|ppi dependent
5542007|NCT01118572|Celecoxib|celecoxib
5542008|NCT01118572|Celecox|celecox
5542009|NCT01118572|Pain|pain
5542010|NCT01118572|Surgery|surgery
5542011|NCT01118572|NSAIDs|nsaids
5542012|NCT01118559|YM150|ym150
5542013|NCT01118559|Food effect|food effect
5542014|NCT01118559|Healthy volunteer|healthy volunteer
5542015|NCT01118546|aspirin|aspirin
5542016|NCT01118546|coronary artery disease|coronary artery disease
5542017|NCT01118546|hypersensitivity|hypersensitivity
5542018|NCT01118546|Platelet aggregation|platelet aggregation
5542019|NCT01118533|Intubation|intubation
5542020|NCT01118533|Sore throat|sore throat
5542021|NCT01118533|Blades|blades
5542022|NCT01118533|Laryngoscopy|laryngoscopy
5542023|NCT01118533|Morbidity|morbidity
5542024|NCT01118520|abdominal aortic aneurysm|abdominal aortic aneurysm
5542025|NCT01118520|ACE Inhibition|ace inhibition
5542026|NCT01118507|Trisomy of chromosome 21 diagnosis|trisomy of chromosome 21 diagnosis
5542027|NCT01118507|first trimester of pregnancy|first trimester of pregnancy
5542028|NCT01118507|maternal blood|maternal blood
5542029|NCT01118507|High output shotgun sequencing|high output shotgun sequencing
5542030|NCT01118494|CKD|ckd
5542031|NCT01118494|RAS|ras
5542032|NCT01118494|AGT|agt
5542033|NCT01118481|Coronary stenosis|coronary stenosis
5542034|NCT01118481|Wave intensity analysis|wave intensity analysis
5542035|NCT01118481|Instantaneous Flow Reserve|instantaneous flow reserve
5542037|NCT01118481|Fractional Flow Reserve|fractional flow reserve
5542038|NCT01118468|Competitive Flow|competitive flow
5542039|NCT01118468|Coronary artery bypass|coronary artery bypass
5542040|NCT01118468|Wave Intensity Analysis|wave intensity analysis
5542041|NCT01118442|Aortic Stenosis|aortic stenosis
5542042|NCT01118442|Coronary Flow|coronary flow
5542043|NCT01118442|Wave Intensity Analysis|wave intensity analysis
5542044|NCT01118429|hyperhidrosis|hyperhidrosis
5542045|NCT01118429|axillary|axillary
5542046|NCT01118429|osmidrosis|osmidrosis
5542047|NCT01118429|oxybutynin|oxybutynin
5542048|NCT01118416|sexual risk|sexual risk
5542049|NCT01118416|substance use|substance use
5527044|NCT01180010|Lung Cancer|lung cancer
5542050|NCT01118416|HIV|hiv
5542051|NCT01118416|prevention|prevention
5542052|NCT01118416|intervention|intervention
5542053|NCT01118416|Motivational Enhancement Therapy|motivational enhancement therapy
5542054|NCT01118416|young men who have sex with men|young men who have sex with men
5542055|NCT01118403|Ventilator associated pneumonia|ventilator associated pneumonia
5542056|NCT01118403|Coma|coma
5542057|NCT01118403|Brain Injuries|brain injuries
5542058|NCT01118403|Intensive care units|intensive care units
5542059|NCT01118403|antibiotic prophylaxis|antibiotic prophylaxis
5542060|NCT01118390|telangiectasias|telangiectasias
5542061|NCT01118390|leg|leg
5542062|NCT01118390|sclerotherapy|sclerotherapy
5542063|NCT01118390|laser|laser
5542064|NCT01118390|glycose|glycose
5542065|NCT01118364|Social circumstances|social circumstances
5542066|NCT01118325|Stable Coronary Artery Disease|stable coronary artery disease
5542067|NCT01118325|Platelet Aggregation|platelet aggregation
5542069|NCT01118312|Rhinitis|rhinitis
5542070|NCT01118312|Sinusitis|sinusitis
5542071|NCT01118312|Chronic|chronic
5542072|NCT01118312|ACRC|acrc
5542073|NCT01118312|STAN|stan
5542074|NCT01118312|Nasal steroid|nasal steroid
5542075|NCT01118312|Mometasone|mometasone
5542076|NCT01118312|Nasal spray|nasal spray
5542077|NCT01118299|ACP|acp
5542078|NCT01118299|Atrial Fibrillation|atrial fibrillation
5542079|NCT01118299|AF|af
5542080|NCT01118299|A Fib|a fib
5542081|NCT01118299|Stroke|stroke
5542082|NCT01118299|Coumadin|coumadin
5542083|NCT01118299|Warfarin|warfarin
5542084|NCT01118299|Dabigatran|dabigatran
5542085|NCT01118299|Pradaxa|pradaxa
5542086|NCT01118299|Blood thinning medication|blood thinning medication
5542087|NCT01118299|Left atrial appendage|left atrial appendage
5542088|NCT01118299|LAA|laa
5542089|NCT01118286|Hypertension|hypertension
5542090|NCT01118286|Drug therapy, combination|drug therapy, combination
5542091|NCT01118273|Naproxen sodium|naproxen sodium
5542092|NCT01118273|Diphenhydramine|diphenhydramine
5542093|NCT01118273|Drugs, Investigational|drugs, investigational
5542094|NCT01118260|prostata hyperplasia|prostata hyperplasia
5542095|NCT01118260|transurethral resection|transurethral resection
5542096|NCT01118260|TIVA|tiva
5542097|NCT01118260|spinal anaesthesia|spinal anaesthesia
5542098|NCT01118247|Uncemented THA|uncemented tha
5542099|NCT01118247|alumina-on-alumina|alumina-on-alumina
5542100|NCT01118247|survival|survival
5542101|NCT01118247|HHS|hhs
5542102|NCT01118247|Patient satisfaction|patient satisfaction
5542103|NCT01118234|CLL|cll
5542104|NCT01118234|Rituximab|rituximab
5542117|NCT01118169|Suicidal thoughts|suicidal thoughts
5542118|NCT01118156|Suicide Nomenclature|suicide nomenclature
5542120|NCT01118130|genomics|genomics
5542121|NCT01118130|Multiple Sclerosis|multiple sclerosis
5542122|NCT01118130|beta-interferons|beta-interferons
5542123|NCT01118117|atherosclerotic stenosis|atherosclerotic stenosis
5542124|NCT01118117|occlusions|occlusions
5542125|NCT01118117|Superficial Femoral Artery|superficial femoral artery
5542127|NCT01118091|Immunotherapy|immunotherapy
5542128|NCT01118091|Metastatic Melanoma|metastatic melanoma
5542129|NCT01118091|Randomized|randomized
5542130|NCT01118091|Cell Therapy|cell therapy
5542131|NCT01118091|Skin Cancer|skin cancer
5542132|NCT01118091|Melanoma|melanoma
5542133|NCT01118065|anaplastic thyroid cancer|anaplastic thyroid cancer
5542134|NCT01118065|recurrent thyroid cancer|recurrent thyroid cancer
5542135|NCT01118065|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5542136|NCT01118065|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5542137|NCT01118065|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5542138|NCT01118065|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5542139|NCT01118065|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5542140|NCT01118039|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5542141|NCT01118039|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5542142|NCT01118039|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5542143|NCT01118039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5542144|NCT01118039|distal urethral cancer|distal urethral cancer
5542145|NCT01118039|proximal urethral cancer|proximal urethral cancer
5542146|NCT01118039|recurrent urethral cancer|recurrent urethral cancer
5542147|NCT01118039|recurrent bladder cancer|recurrent bladder cancer
5542148|NCT01118039|stage IV bladder cancer|stage iv bladder cancer
5542149|NCT01118039|stage III bladder cancer|stage iii bladder cancer
5542150|NCT01118039|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5542151|NCT01118039|stage III urethral cancer|stage iii urethral cancer
5542152|NCT01118039|stage IV urethral cancer|stage iv urethral cancer
5542161|NCT01118013|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5542162|NCT01118013|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5542163|NCT01118013|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5542164|NCT01118013|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5542165|NCT01118013|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5542166|NCT01118013|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5542167|NCT01118013|prolymphocytic leukemia|prolymphocytic leukemia
5542168|NCT01118013|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5542169|NCT01118013|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5542170|NCT01118013|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5542171|NCT01118013|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5542172|NCT01118013|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5542173|NCT01118013|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5542174|NCT01118013|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5542175|NCT01118013|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5846760|NCT00043511|HIV Preventive Vaccine|hiv preventive vaccine
5542176|NCT01118013|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5542177|NCT01118013|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5542178|NCT01118013|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5542179|NCT01118013|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5542180|NCT01118013|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5542181|NCT01118013|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5542182|NCT01118013|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5542183|NCT01118013|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5542184|NCT01118013|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5542185|NCT01118013|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5542186|NCT01118013|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5542187|NCT01118013|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5542188|NCT01118013|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5542189|NCT01118013|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5542190|NCT01118013|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5542191|NCT01118013|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5542192|NCT01118013|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5542193|NCT01118013|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5542194|NCT01118013|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5542195|NCT01118013|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5542196|NCT01118013|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5542197|NCT01118013|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5542198|NCT01118013|stage I multiple myeloma|stage i multiple myeloma
5542199|NCT01118013|stage II multiple myeloma|stage ii multiple myeloma
5542200|NCT01118013|stage III multiple myeloma|stage iii multiple myeloma
5542201|NCT01118013|refractory multiple myeloma|refractory multiple myeloma
5542202|NCT01118013|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5542203|NCT01118013|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5542204|NCT01118013|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5542205|NCT01118013|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5542206|NCT01118013|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5542207|NCT01118013|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5542208|NCT01118013|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5542209|NCT01118013|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5542210|NCT01118013|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5542211|NCT01118013|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5685370|NCT00556400|Oral Contraceptive Pills|oral contraceptive pills
5542212|NCT01118013|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5542213|NCT01118013|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5542214|NCT01118013|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5542215|NCT01118013|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5542216|NCT01118013|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5542217|NCT01118013|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5542218|NCT01118013|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5542219|NCT01118013|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5542220|NCT01118013|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5542221|NCT01118013|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5542222|NCT01118013|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5542223|NCT01118013|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5542224|NCT01118013|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5542225|NCT01118013|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5542226|NCT01118013|childhood Burkitt lymphoma|childhood burkitt lymphoma
5542227|NCT01118013|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5542228|NCT01118013|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5542229|NCT01118013|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5542230|NCT01118013|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5542231|NCT01118013|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5542232|NCT01118013|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5542233|NCT01118013|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5542234|NCT01118000|ischemic preconditioning,serum proteins,human|ischemic preconditioning,serum proteins,human
5542235|NCT01117987|Pulmonary arterial hypertension, imatinib, 6MWD, pulmonary hypertension|pulmonary arterial hypertension, imatinib, 6mwd, pulmonary hypertension
5542236|NCT01117961|Excessive gestational weight gain|excessive gestational weight gain
5542237|NCT01117935|IMRT|imrt
5542238|NCT01117935|prostate cancer|prostate cancer
5542239|NCT01117935|radiation therapy|radiation therapy
5542240|NCT01117935|external beam|external beam
5542241|NCT01117935|recurrent prostate cancer|recurrent prostate cancer
5542242|NCT01117922|preterm birth|preterm birth
5542243|NCT01117922|interconceptional intervention|interconceptional intervention
5542244|NCT01117922|pregnancy outcomes|pregnancy outcomes
5542245|NCT01117909|ankle sprain|ankle sprain
5542246|NCT01117909|athletic injury|athletic injury
5542247|NCT01117909|arthritis|arthritis
5542248|NCT01117896|CPR|cpr
5542249|NCT01117896|Rescuer fatigue|rescuer fatigue
5542250|NCT01117896|Chest Compression effectiveness|chest compression effectiveness
5542251|NCT01117883|Perfusion pressures|perfusion pressures
5542252|NCT01117883|central venous pressure|central venous pressure
5542253|NCT01117883|cardiac output|cardiac output
5542254|NCT01117883|CPR|cpr
5542255|NCT01117883|cardiac arrest|cardiac arrest
5542256|NCT01117883|Leaning|leaning
5542257|NCT01117883|incomplete release|incomplete release
5542258|NCT01117870|chronic|chronic
5542259|NCT01117870|pain|pain
5542260|NCT01117870|lumbar|lumbar
5542261|NCT01117870|Radicular|radicular
5542262|NCT01117831|Diabetes mellitus|diabetes mellitus
5542263|NCT01117805|Asthma|asthma
5542264|NCT01117779|kidney tumors|kidney tumors
5542265|NCT01117779|renal tumors|renal tumors
5542266|NCT01117779|renal cell carcinoma|renal cell carcinoma
5542267|NCT01117779|kidney lesions|kidney lesions
5542268|NCT01117779|renal lesions|renal lesions
5542269|NCT01117779|cryoablation|cryoablation
5542270|NCT01117779|cryotherapy|cryotherapy
5542271|NCT01117779|cryosurgery|cryosurgery
5542272|NCT01117766|Methodology|methodology
5542273|NCT01117766|Quantitative Sensory Testing|quantitative sensory testing
5542274|NCT01117766|Neuropathies Pain|neuropathies pain
5542275|NCT01117766|Pregabalin|pregabalin
5542276|NCT01117740|Malignant Pleural Effusions|malignant pleural effusions
5542277|NCT01117740|MPE|mpe
5542278|NCT01117740|Lungs|lungs
5542279|NCT01117740|Quality of Life|quality of life
5542280|NCT01117740|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5542281|NCT01117740|MDASI|mdasi
5542282|NCT01117740|Indwelling Pleural Catheters|indwelling pleural catheters
5542283|NCT01117740|Thoracoscopic Pleurodesis|thoracoscopic pleurodesis
5542284|NCT01117740|Symptom burden|symptom burden
5542285|NCT01117740|Pleurodesis efficacy|pleurodesis efficacy
5542286|NCT01117740|Complications|complications
5542287|NCT01117740|Health care resource utilization|health care resource utilization
5542288|NCT01117714|Lung cancer|lung cancer
5542289|NCT01117714|Lung neoplasm|lung neoplasm
5542290|NCT01117714|Pulmonary cancer|pulmonary cancer
5542291|NCT01117714|Pulmonary neoplasm|pulmonary neoplasm
5542292|NCT01117714|Lung cancer staging|lung cancer staging
5542293|NCT01117688|Ureteroscopy|ureteroscopy
5542294|NCT01117675|Telemedicine|telemedicine
5542295|NCT01117675|Home care|home care
5542296|NCT01117675|Chronic HIV infection|chronic hiv infection
5542297|NCT01117675|HIV-infected patients|hiv-infected patients
5542298|NCT01117662|transplantation|transplantation
5542299|NCT01117662|acute rejection|acute rejection
5542300|NCT01117662|kidney|kidney
5542301|NCT01117649|PVR|pvr
5542302|NCT01117649|HES 130|hes 130
5542303|NCT01117649|pancreatic head|pancreatic head
5542304|NCT01117649|goal-directed|goal-directed
5542305|NCT01117649|intraoperative PVR in elective surgery of the pancreatic head|intraoperative pvr in elective surgery of the pancreatic head
5542306|NCT01117636|Aspirin|aspirin
5542307|NCT01117623|Oncology patients with advanced disease|oncology patients with advanced disease
5542308|NCT01117623|BAY73-4506|bay73-4506
5542309|NCT01117610|pain|pain
5542310|NCT01117610|preemptive|preemptive
5542311|NCT01117610|postoperative|postoperative
5542312|NCT01117610|epidural injection|epidural injection
5542313|NCT01117610|laminectomy|laminectomy
5542314|NCT01117597|Healthy subjects|healthy subjects
5542315|NCT01117584|Type 2 diabetes|type 2 diabetes
5542316|NCT01117584|ASP1941|asp1941
5542317|NCT01117584|diabetes|diabetes
5542318|NCT01117584|metformin|metformin
5542319|NCT01117571|knee|knee
5542320|NCT01117571|osteoarthritis|osteoarthritis
5542321|NCT01117571|unicompartmental|unicompartmental
5542322|NCT01117571|arthroplasty|arthroplasty
5542323|NCT01117571|knee resurfacing|knee resurfacing
5542324|NCT01117571|Conformis|conformis
5542325|NCT01117571|patient specific|patient specific
5542326|NCT01117558|PCOS,|pcos,
5542327|NCT01117558|DM,|dm,
5542328|NCT01117558|Hypertension,|hypertension,
5542329|NCT01117558|CVD|cvd
5542330|NCT01117545|veterans,|veterans,
5542331|NCT01117545|PTSD,|ptsd,
5542332|NCT01117545|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
5542338|NCT01117532|EFT (Emotional Freedom Techniques),|eft (emotional freedom techniques),
5542339|NCT01117532|energy psychology|energy psychology
5542340|NCT01117519|fluid and volume management|fluid and volume management
5542341|NCT01117519|acid-base balance|acid-base balance
5542342|NCT01117519|goal-directed therapy|goal-directed therapy
5542343|NCT01117519|transoesophageal doppler|transoesophageal doppler
5542344|NCT01117506|Angina Pectoris|angina pectoris
5542345|NCT01117506|Myocardial Ischemia|myocardial ischemia
5542346|NCT01117506|Molecular Genetics|molecular genetics
5542347|NCT01117506|Atherosclerosis|atherosclerosis
5542348|NCT01117506|Corus CAD|corus cad
5542350|NCT01117506|Age/Sex/Gene Expression Score|age/sex/gene expression score
5542351|NCT01117506|Gene Expression|gene expression
5542352|NCT01117506|GES|ges
5542353|NCT01117506|CAD|cad
5542354|NCT01117506|CVD|cvd
5542355|NCT01117506|CHD|chd
5542356|NCT01117506|Precision Medicine|precision medicine
5542357|NCT01117506|Clinical Validity|clinical validity
5542358|NCT01117506|Myocardial Perfusion Imaging|myocardial perfusion imaging
5542359|NCT01117506|Coronary Artery Disease|coronary artery disease
5542360|NCT01117506|Chest Pain|chest pain
5542361|NCT01117506|Cardiovascular Disease|cardiovascular disease
5542362|NCT01117506|Coronary Heart Disease|coronary heart disease
5542363|NCT01117506|MPI|mpi
5542364|NCT01117506|COMPASS|compass
5542365|NCT01117480|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5542366|NCT01117480|Rheumatoid Arthritis|rheumatoid arthritis
5542367|NCT01117480|Severe Rheumatoid Arthritis|severe rheumatoid arthritis
5542368|NCT01117480|Adalimumab|adalimumab
5542369|NCT01117480|Clinical Effectiveness|clinical effectiveness
5542370|NCT01117467|Simulation|simulation
5542371|NCT01117467|Learning|learning
5542372|NCT01117467|Medical Students|medical students
5542373|NCT01117467|Empathy|empathy
5542374|NCT01117467|Anxiety|anxiety
5542375|NCT01117454|Catecholaminergic Polymorphic Ventricular Tachycardia|catecholaminergic polymorphic ventricular tachycardia
5542376|NCT01117454|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5542377|NCT01117454|flecainide|flecainide
5542378|NCT01117428|Advanced solid tumors|advanced solid tumors
5542379|NCT01117428|Metastatic colorectal Cancer|metastatic colorectal cancer
5542380|NCT01117415|Gall Bladder|gall bladder
5542381|NCT01117415|Cholecystectomy|cholecystectomy
5542382|NCT01117402|recurrent carcinoma cervix|recurrent carcinoma cervix
5542383|NCT01117402|Vault carcinoma|vault carcinoma
5542384|NCT01117402|Tomotherapy|tomotherapy
5542385|NCT01117402|Brachytherapy|brachytherapy
5542386|NCT01117389|Human Papillomavirus Vaccination|human papillomavirus vaccination
5542387|NCT01117389|Childhood cancer survivors|childhood cancer survivors
5542388|NCT01117389|cervical cancer|cervical cancer
5542389|NCT01117389|sexually transmitted infection|sexually transmitted infection
5542390|NCT01117376|Gastroparesis|gastroparesis
5542391|NCT01117376|Erythromycin|erythromycin
5542392|NCT01117376|Methylnaltrexone|methylnaltrexone
5542393|NCT01117376|ICU|icu
5542394|NCT01117363|Appetite whole grain|appetite whole grain
5542395|NCT01117337|Hernia, laparoscopic, recurrence, pain, inguinal|hernia, laparoscopic, recurrence, pain, inguinal
5542396|NCT01117324|Bone density|bone density
5542397|NCT01117324|infant of diabetic mother|infant of diabetic mother
5542398|NCT01117324|large birth weight|large birth weight
5542399|NCT01117311|Vagus|vagus
5542400|NCT01117311|Diabetes|diabetes
5542401|NCT01117311|Obesity|obesity
5542402|NCT01117298|Raynaud's phenomenon|raynaud's phenomenon
5542403|NCT01117298|ischemic ulcers|ischemic ulcers
5542404|NCT01117298|digital ulcers|digital ulcers
5542405|NCT01117298|digital infarcts|digital infarcts
5542406|NCT01117298|gangrene|gangrene
5542407|NCT01117298|vasodilators|vasodilators
5542408|NCT01117298|endothelial dysfunction|endothelial dysfunction
5542409|NCT01117298|scleroderma|scleroderma
5542410|NCT01117285|Occupational Therapy|occupational therapy
5542411|NCT01117285|Evidence-Based Practice|evidence-based practice
5542412|NCT01117285|Continuing Education|continuing education
5542413|NCT01117285|utilization|utilization
5542414|NCT01117285|Guideline|guideline
5542415|NCT01117285|Dementia|dementia
5542416|NCT01117285|Guideline implementation|guideline implementation
5542417|NCT01117272|PCOS|pcos
5542418|NCT01117272|hyperprolactinemia|hyperprolactinemia
5542419|NCT01117272|obesity|obesity
5542420|NCT01117272|hyperandrogenic|hyperandrogenic
5542421|NCT01117246|bone metastasis|bone metastasis
5542422|NCT01117246|pain palliation|pain palliation
5542423|NCT01117233|Healthy volunteers|healthy volunteers
5542424|NCT01117233|PK|pk
5542425|NCT01117233|PD|pd
5542426|NCT01117233|safety and toleration|safety and toleration
5542428|NCT01117220|bipolar|bipolar
5542429|NCT01117181|Alzheimer's disease|alzheimer's disease
5542430|NCT01117181|Apathy|apathy
5542431|NCT01117181|Methylphenidate|methylphenidate
5542432|NCT01117181|Dopaminergic agents|dopaminergic agents
5542433|NCT01117181|Apathy Evaluation Scale|apathy evaluation scale
5542434|NCT01117181|Dementia|dementia
5542435|NCT01117168|Children's Oncology Group|children's oncology group
5542436|NCT01117168|Pediatric Oncology|pediatric oncology
5542437|NCT01117168|Pediatric Cancer|pediatric cancer
5542439|NCT01117168|Leukemia|leukemia
5542440|NCT01117168|Brain Tumor|brain tumor
5542441|NCT01117168|Sarcoma|sarcoma
5542442|NCT01117155|Brain Tumor|brain tumor
5542443|NCT01117155|Imaging|imaging
5542444|NCT01117155|FLT|flt
5542445|NCT01117155|FDG|fdg
5542446|NCT01117155|Spectroscopy|spectroscopy
5542447|NCT01117155|Glioma|glioma
5542448|NCT01117155|Glioblastoma Multiforme|glioblastoma multiforme
5542449|NCT01117155|Astrocytoma|astrocytoma
5542450|NCT01117142|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5542546|NCT01116791|biliary|biliary
5542451|NCT01117142|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
5542452|NCT01117142|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5542453|NCT01117142|Mantle Cell Lymphoma|mantle cell lymphoma
5542454|NCT01117142|Cellular Proliferation|cellular proliferation
5542455|NCT01117142|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5542456|NCT01117142|CLL|cll
5542457|NCT01117142|Monoclonal B-Cell Lymphocytosis|monoclonal b-cell lymphocytosis
5542458|NCT01117142|MBL|mbl
5542459|NCT01117142|SLL|sll
5542460|NCT01117142|MCL|mcl
5542461|NCT01117142|Healthy Volunteer|healthy volunteer
5542462|NCT01117142|HV|hv
5542463|NCT01117103|Type 2 diabetes|type 2 diabetes
5542464|NCT01117103|Diabetes Mellitus|diabetes mellitus
5542465|NCT01117103|Glucophage|glucophage
5542466|NCT01117103|Metformin|metformin
5542467|NCT01117090|Feasibility|feasibility
5542468|NCT01117090|SynchroMed II|synchromed ii
5542469|NCT01117090|Intrathecal catheter|intrathecal catheter
5542470|NCT01117090|Baclofen|baclofen
5542471|NCT01117077|liver transplantation|liver transplantation
5542472|NCT01117077|aspergillus infection|aspergillus infection
5542473|NCT01117077|interleukin-17|interleukin-17
5542474|NCT01117077|Treg cell|treg cell
5542475|NCT01117077|immune tolerance|immune tolerance
5542476|NCT01117064|Sleep Apnea|sleep apnea
5542478|NCT01117064|CPAP|cpap
5542479|NCT01117051|Opioid induced constipation/prucalopride chronic non-cancer pain|opioid induced constipation/prucalopride chronic non-cancer pain
5542480|NCT01117051|Subjects with chronic non-cancer pain suffering from OIC|subjects with chronic non-cancer pain suffering from oic
5542481|NCT01117038|ED|ed
5542482|NCT01117038|Erectile Dysfunction|erectile dysfunction
5542483|NCT01117025|Resistant hypertension|resistant hypertension
5542484|NCT01117025|Atrial Fibrillation|atrial fibrillation
5542485|NCT01117025|Percutaneous renal denervation|percutaneous renal denervation
5542486|NCT01116986|Smoking|smoking
5542487|NCT01116986|Smoking Cessation|smoking cessation
5542488|NCT01116986|Nicotine|nicotine
5542489|NCT01116973|CVP monitoring compared with peripheral monitoring|cvp monitoring compared with peripheral monitoring
5542490|NCT01116960|P4P|p4p
5542491|NCT01116947|Hypoalbuminemia|hypoalbuminemia
5542492|NCT01116947|Hyperphosphatemia|hyperphosphatemia
5542493|NCT01116947|Phosphorus|phosphorus
5542494|NCT01116947|Protein|protein
5542495|NCT01116947|CKD|ckd
5542496|NCT01116947|Dialysis|dialysis
5542497|NCT01116947|Meals|meals
5542498|NCT01116947|Lanthanum|lanthanum
5542499|NCT01116947|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5542500|NCT01116947|Dietary Protein Intake (DPI)|dietary protein intake (dpi)
5542502|NCT01116947|Protein-Energy Wasting (PEW)|protein-energy wasting (pew)
5542503|NCT01116947|Sources of Dietary Phosphorus|sources of dietary phosphorus
5542504|NCT01116934|blood culture, IL-1β, IL-6, IL-8, IP-10, interferon-gamma|blood culture, il-1β, il-6, il-8, ip-10, interferon-gamma
5542505|NCT01116921|laryngeal mask airway|laryngeal mask airway
5542506|NCT01116921|surfactant|surfactant
5542507|NCT01116921|respiratory distress syndrome|respiratory distress syndrome
5527542|NCT01177774|OCD|ocd
5542508|NCT01116921|neonate|neonate
5542509|NCT01116908|Diarrhea|diarrhea
5542510|NCT01116908|Water|water
5542511|NCT01116908|Household Water Treatment|household water treatment
5542512|NCT01116908|HIV|hiv
5542513|NCT01116908|Infant Health|infant health
5542514|NCT01116895|Psoriasis Vulgaris|psoriasis vulgaris
5542515|NCT01116895|Systemic|systemic
5542516|NCT01116895|Anti-psoriatic|anti-psoriatic
5542517|NCT01116882|PCI|pci
5542518|NCT01116882|heart disease|heart disease
5542519|NCT01116882|ischemic heart disease|ischemic heart disease
5542520|NCT01116869|MBC|mbc
5542521|NCT01116869|Healthy|healthy
5542522|NCT01116869|Benign disease|benign disease
5542523|NCT01116869|Confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the RECIST guideline|confirmed metastatic breast cancer patient with at least one measurable solid tumor according to the recist guideline
5536846|NCT01139229|Circular everted anastomosis|circular everted anastomosis
5542526|NCT01116869|Pathology diagnosed breast benign tumor disease|pathology diagnosed breast benign tumor disease
5542528|NCT01116856|Training|training
5542529|NCT01116856|Obesity|obesity
5542530|NCT01116856|Overweight|overweight
5542531|NCT01116856|Body composition|body composition
5542532|NCT01116856|Lipidic profile|lipidic profile
5542533|NCT01116856|Nutrition|nutrition
5542534|NCT01116856|Polymorphisms|polymorphisms
5542535|NCT01116843|Oral cavity cancer|oral cavity cancer
5542536|NCT01116843|No prior treatment|no prior treatment
5542537|NCT01116817|Long-term Lopinavir/ritonavir monotherapy|long-term lopinavir/ritonavir monotherapy
5542538|NCT01116817|neurocognitive performance|neurocognitive performance
5542539|NCT01116817|ultrasensitive CSF-viraemia|ultrasensitive csf-viraemia
5542540|NCT01116804|Primary liver cancer|primary liver cancer
5542541|NCT01116791|cytoreductive surgery|cytoreductive surgery
5542542|NCT01116791|peritoneal chemotherapy|peritoneal chemotherapy
5542543|NCT01116791|cisplatin|cisplatin
5542544|NCT01116791|cancer|cancer
5542545|NCT01116791|gastric|gastric
5542547|NCT01116791|pancreas|pancreas
5542548|NCT01116791|peritoneal metastases|peritoneal metastases
5542549|NCT01116791|liver metastases|liver metastases
5542550|NCT01116791|peritoneal carcinomatosis from upper gastrointestinal cancer|peritoneal carcinomatosis from upper gastrointestinal cancer
5542551|NCT01116778|perennial allergic rhinitis|perennial allergic rhinitis
5542552|NCT01116778|probiotics|probiotics
5542553|NCT01116778|Lactobacillus paracasei GMNL-32 (eN-Lac®)|lactobacillus paracasei gmnl-32 (en-lac®)
5542554|NCT01116778|efficacy and safety|efficacy and safety
5542555|NCT01116765|preterm infants born between 26 to 29 weeks of gestation age.|preterm infants born between 26 to 29 weeks of gestation age.
5542556|NCT01116752|Intensive Care|intensive care
5542557|NCT01116752|Critical care|critical care
5542558|NCT01116752|Glycemic Control|glycemic control
5542559|NCT01116752|Hypoglycemia|hypoglycemia
5542560|NCT01116752|Hyperglycemia|hyperglycemia
5542561|NCT01116752|Insulin treatment|insulin treatment
5542562|NCT01116752|Organ Function|organ function
5542563|NCT01116752|PELOD|pelod
5542564|NCT01116752|Outcomes|outcomes
5542565|NCT01116752|Pediatrics|pediatrics
5542566|NCT01116713|Mastectomy|mastectomy
5542567|NCT01116713|Breast cancer|breast cancer
5542568|NCT01116713|Postoperative pain|postoperative pain
5542569|NCT01116713|Postoperative nausea and vomiting|postoperative nausea and vomiting
5542570|NCT01116700|Epilepsy|epilepsy
5542571|NCT01116700|Dexmedetomidine|dexmedetomidine
5542572|NCT01116700|Seizure|seizure
5542573|NCT01116674|Intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics|intensive critical care, glycemic control, hypoglycemia, hyperglycemia , insulin treatment, intensive care outcomes, pediatrics
5542574|NCT01116661|glioma|glioma
5542575|NCT01116661|high grade glioma, low grade glioma|high grade glioma, low grade glioma
5542576|NCT01116635|chemoembolization|chemoembolization
5542577|NCT01116635|drug eluting microsphere|drug eluting microsphere
5542578|NCT01116635|hepato|hepato
5542579|NCT01116635|embolotherapy|embolotherapy
5542580|NCT01116635|downstage|downstage
5542581|NCT01116622|Aerodigestive|aerodigestive
5542582|NCT01116622|Targretin|targretin
5542583|NCT01116622|Tarceva|tarceva
5542584|NCT01116609|Phenylalanine|phenylalanine
5542585|NCT01116609|Palmitate|palmitate
5542586|NCT01116609|hyperinsulinemic-euglycemic-clamp|hyperinsulinemic-euglycemic-clamp
5542587|NCT01116609|Effects of epinephrine in healthy volunteers|effects of epinephrine in healthy volunteers
5542588|NCT01116596|Glutathione|glutathione
5542589|NCT01116596|Paracetamol|paracetamol
5542590|NCT01116596|elderly people|elderly people
5542591|NCT01116583|Gabapentin|gabapentin
5542592|NCT01116583|Thoracotomy|thoracotomy
5542593|NCT01116583|Pain, Postoperative|pain, postoperative
5542594|NCT01116583|Analgesia|analgesia
5542595|NCT01116583|Recovery of Function|recovery of function
5542596|NCT01116583|Quality of Life|quality of life
5542597|NCT01116570|Muscular Dystrophy|muscular dystrophy
5542598|NCT01116570|Facioscapulohumeral|facioscapulohumeral
5542599|NCT01116570|Physical training|physical training
5542600|NCT01116570|Exercise|exercise
5542601|NCT01116557|radiofrequency|radiofrequency
5542602|NCT01116557|ablation|ablation
5542603|NCT01116557|atrial fibrillation|atrial fibrillation
5542604|NCT01116557|CARTO|carto
5542605|NCT01116557|THERMOCOOL|thermocool
5542606|NCT01116557|LASSO|lasso
5542607|NCT01116557|PVAC|pvac
5542608|NCT01116544|AMES device|ames device
5542609|NCT01116544|Cerebrovascular Accident|cerebrovascular accident
5542610|NCT01116544|Chronic Stroke|chronic stroke
5542611|NCT01116544|Rehabilitation|rehabilitation
5542612|NCT01116544|Upper Extremity|upper extremity
5542613|NCT01116544|Biofeedback|biofeedback
5542614|NCT01116531|Pharmacokinetics|pharmacokinetics
5542615|NCT01116531|Pharmacodynamics|pharmacodynamics
5542617|NCT01116531|tramadol|tramadol
5542618|NCT01116531|duloxetine|duloxetine
5542619|NCT01116531|pregabalin|pregabalin
5542620|NCT01116505|Celiac disease|celiac disease
5542621|NCT01116505|Endomysial antibodies|endomysial antibodies
5542622|NCT01116505|Gluten-free diet|gluten-free diet
5542623|NCT01116505|Screen-detected|screen-detected
5542624|NCT01116505|Asymptomatic|asymptomatic
5542625|NCT01116505|Bone mineral density|bone mineral density
5542626|NCT01116492|SILS|sils
5542627|NCT01116492|Inflammatory reaction|inflammatory reaction
5542628|NCT01116492|a-defensins|a-defensins
5542629|NCT01116492|SILS vs standard laparoscopic cholecystectomy|sils vs standard laparoscopic cholecystectomy
5542630|NCT01116479|Anaemia, transfusion, cancer, chemotherapy, Quality of life|anaemia, transfusion, cancer, chemotherapy, quality of life
5542631|NCT01116453|dysmenorrhea|dysmenorrhea
5542632|NCT01116453|acupuncture|acupuncture
5542633|NCT01116453|randomized controlled trial|randomized controlled trial
5542634|NCT01116440|Menstrual pain|menstrual pain
5542635|NCT01116440|Refractory endometriosis|refractory endometriosis
5542636|NCT01116440|Pelvic pain|pelvic pain
5542637|NCT01116427|MS|ms
5542638|NCT01116427|multiple sclerosis|multiple sclerosis
5542639|NCT01116427|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5542640|NCT01116427|RRMS|rrms
5542641|NCT01116401|Hot Flashes|hot flashes
5542642|NCT01116401|Sleep disturbance|sleep disturbance
5542643|NCT01116401|Lupron|lupron
5542644|NCT01116401|Menopause|menopause
5542645|NCT01116388|Autism|autism
5542646|NCT01116388|Gastrointestinal Disorders|gastrointestinal disorders
5542647|NCT01116388|Food Allergy|food allergy
5542648|NCT01116388|Gluten free, casein free diet|gluten free, casein free diet
5542649|NCT01116388|Diarrhea|diarrhea
5542650|NCT01116388|Constipation|constipation
5542651|NCT01116388|Reflux|reflux
5542652|NCT01116388|Abdominal pain|abdominal pain
5542653|NCT01116388|Pain after eating|pain after eating
5542654|NCT01116388|Self injurious behavior|self injurious behavior
5542655|NCT01116375|Obesity|obesity
5542656|NCT01116375|OSA|osa
5542657|NCT01116375|PAP therapy|pap therapy
5542658|NCT01116362|ulna|ulna
5542659|NCT01116362|median|median
5542660|NCT01116362|repair|repair
5542661|NCT01116362|primary|primary
5542662|NCT01116349|humeral diaphysis fracture|humeral diaphysis fracture
5671975|NCT00613353|Female|female
5542663|NCT01116349|plate and screws for humeral diaphysis fracture|plate and screws for humeral diaphysis fracture
5542664|NCT01116349|nailing for humerus diaphysis fracture|nailing for humerus diaphysis fracture
5542665|NCT01116349|Hanging Support System|hanging support system
5542666|NCT01116336|Pre-cancerous conditions|pre-cancerous conditions
5542667|NCT01116336|Head and neck tumors|head and neck tumors
5542668|NCT01116336|Cancer of head and neck|cancer of head and neck
5542670|NCT01116323|Adverse effects|adverse effects
5542671|NCT01116323|Emergency Service, Hospital|emergency service, hospital
5542672|NCT01116323|Emergency department|emergency department
5542673|NCT01116323|Crowding|crowding
5542674|NCT01116310|Hot flushes|hot flushes
5542675|NCT01116310|Hot flashes|hot flashes
5542676|NCT01116310|menopause|menopause
5542677|NCT01116310|postmenopause|postmenopause
5542678|NCT01116310|Soy isoflavones|soy isoflavones
5542679|NCT01116310|Red clover|red clover
5542680|NCT01116310|Equol|equol
5542681|NCT01116297|breast reconstruction|breast reconstruction
5542682|NCT01116297|breast cancer|breast cancer
5542683|NCT01116297|near infrared imaging|near infrared imaging
5542684|NCT01116284|Weight Loss|weight loss
5542685|NCT01116284|Obesity|obesity
5542686|NCT01116284|Gastric Bypass|gastric bypass
5542687|NCT01116271|colorectal|colorectal
5542688|NCT01116271|second line therapy|second line therapy
5542689|NCT01116271|K-ras or B-raf mutations|k-ras or b-raf mutations
5542690|NCT01116271|response rate|response rate
5542691|NCT01116271|Progression Free Survival|progression free survival
5542692|NCT01116258|Safety|safety
5685371|NCT00556400|Menorrhagia|menorrhagia
5542693|NCT01116245|Cervical Intraepithelial Neoplasia Stage 2/3|cervical intraepithelial neoplasia stage 2/3
5542694|NCT01116232|graft versus host disease|graft versus host disease
5542695|NCT01116232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5542696|NCT01116232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5542697|NCT01116232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5542698|NCT01116232|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5542699|NCT01116232|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5542700|NCT01116232|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5542701|NCT01116232|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5542702|NCT01116232|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5542703|NCT01116232|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5542704|NCT01116232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5542705|NCT01116232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5537045|NCT01138358|dyspnea|dyspnea
5542706|NCT01116232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5542707|NCT01116232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5542708|NCT01116232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5542710|NCT01116232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5542711|NCT01116232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5542712|NCT01116232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5542713|NCT01116232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5542714|NCT01116232|refractory hairy cell leukemia|refractory hairy cell leukemia
5542715|NCT01116232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5542716|NCT01116232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5542717|NCT01116232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5542718|NCT01116232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5542719|NCT01116232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5542720|NCT01116232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5542721|NCT01116232|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5542722|NCT01116232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5542723|NCT01116232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5542724|NCT01116232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5542855|NCT01116141|MTX|mtx
5542856|NCT01116141|CH-405|ch-405
5542725|NCT01116232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5542726|NCT01116232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5542727|NCT01116232|untreated hairy cell leukemia|untreated hairy cell leukemia
5542728|NCT01116232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5542729|NCT01116232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5542730|NCT01116232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5542731|NCT01116232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5542732|NCT01116232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5542733|NCT01116232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5542734|NCT01116232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5542735|NCT01116232|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5542736|NCT01116232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5542737|NCT01116232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5542738|NCT01116232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5542739|NCT01116232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5542740|NCT01116232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5542741|NCT01116232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5542742|NCT01116232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5542743|NCT01116232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5542744|NCT01116232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5542745|NCT01116232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5542746|NCT01116232|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5542747|NCT01116232|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5542748|NCT01116232|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5542749|NCT01116232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5542750|NCT01116232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5542751|NCT01116232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5542752|NCT01116232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5542753|NCT01116232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5542754|NCT01116232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5542755|NCT01116232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5542756|NCT01116232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5542757|NCT01116232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5542758|NCT01116232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5542759|NCT01116232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5542760|NCT01116232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5542761|NCT01116232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5542762|NCT01116232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5542763|NCT01116232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5542764|NCT01116232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5542765|NCT01116232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5537113|NCT01138163|second-line|second-line
5542766|NCT01116232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5542767|NCT01116232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5542768|NCT01116232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5542769|NCT01116232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5542770|NCT01116232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5525292|NCT01186939|MDS|mds
5542771|NCT01116232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5542772|NCT01116232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5542773|NCT01116232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5542774|NCT01116232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5542775|NCT01116232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5542776|NCT01116232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5846764|NCT00043420|immunotherapy, lymphoma|immunotherapy, lymphoma
5542777|NCT01116232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5542778|NCT01116232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5542779|NCT01116232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5542780|NCT01116232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5542781|NCT01116232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5542782|NCT01116232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5542783|NCT01116232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5542784|NCT01116232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5542857|NCT01116141|antifolates|antifolates
5542785|NCT01116232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5542786|NCT01116232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5542787|NCT01116232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5542788|NCT01116232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5542789|NCT01116232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5542790|NCT01116232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5542791|NCT01116232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5542792|NCT01116232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5542793|NCT01116232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5542794|NCT01116232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5542795|NCT01116232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5542796|NCT01116232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5542797|NCT01116232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5542798|NCT01116232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5542799|NCT01116232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5542800|NCT01116232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5542801|NCT01116232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5542802|NCT01116232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5542803|NCT01116232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5542804|NCT01116232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5542805|NCT01116232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5542806|NCT01116232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5542807|NCT01116232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5542808|NCT01116232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5542809|NCT01116232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5542810|NCT01116232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5542811|NCT01116232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5542812|NCT01116232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5542813|NCT01116232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5542814|NCT01116232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5542815|NCT01116232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5542816|NCT01116232|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5542817|NCT01116232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5542818|NCT01116232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5542819|NCT01116232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5542820|NCT01116232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5542821|NCT01116232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5542822|NCT01116232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5542823|NCT01116232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5542824|NCT01116232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5862960|NCT00001444|Pharmacokinetics|pharmacokinetics
5542826|NCT01116232|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5542827|NCT01116232|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5542828|NCT01116232|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5542829|NCT01116232|primary myelofibrosis|primary myelofibrosis
5542830|NCT01116232|stage I multiple myeloma|stage i multiple myeloma
5525350|NCT01186705|MK-2206|mk-2206
5542831|NCT01116232|stage II multiple myeloma|stage ii multiple myeloma
5542832|NCT01116232|stage III multiple myeloma|stage iii multiple myeloma
5542833|NCT01116232|refractory multiple myeloma|refractory multiple myeloma
5542834|NCT01116232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5542835|NCT01116232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5542836|NCT01116232|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5542837|NCT01116219|adenocarcinoma of the lung|adenocarcinoma of the lung
5542838|NCT01116219|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5542839|NCT01116219|large cell lung cancer|large cell lung cancer
5542840|NCT01116219|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5542841|NCT01116219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5542842|NCT01116206|Constipation|constipation
5542843|NCT01116206|Prucalopride|prucalopride
5542845|NCT01116193|antileukemic therapy|antileukemic therapy
5542846|NCT01116193|lymphoblastic leukemia|lymphoblastic leukemia
5542847|NCT01116193|lenalidomide|lenalidomide
5542848|NCT01116193|dexamethasone|dexamethasone
5542849|NCT01116180|Type 1 diabetes|type 1 diabetes
5542850|NCT01116180|Hypoglycaemia|hypoglycaemia
5542851|NCT01116180|genetic susceptibility|genetic susceptibility
5542852|NCT01116180|Renin angiotensin system activity|renin angiotensin system activity
5542853|NCT01116167|Polycystic Ovary Syndrome|polycystic ovary syndrome
5542854|NCT01116141|rheumatoid arthritis|rheumatoid arthritis
5542858|NCT01116128|relapsed/refractory myeloma patients|relapsed/refractory myeloma patients
5542859|NCT01116128|Progression free survival|progression free survival
5542860|NCT01116128|Overall survival|overall survival
5542862|NCT01116115|Term Infants|term infants
5542863|NCT01116115|Intestine flora|intestine flora
5542864|NCT01116115|Stool characteristics|stool characteristics
5542865|NCT01116102|dehydration|dehydration
5542866|NCT01116102|fluid therapy|fluid therapy
5542867|NCT01116102|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5542868|NCT01116102|hyaluronidase|hyaluronidase
5542869|NCT01116102|hypodermoclysis|hypodermoclysis
5542870|NCT01116102|clysis|clysis
5542871|NCT01116102|subcutaneous hydration|subcutaneous hydration
5542872|NCT01116102|subcutaneous rehydration|subcutaneous rehydration
5542873|NCT01116102|hyaluronan|hyaluronan
5542874|NCT01116102|rHuPH20|rhuph20
5542875|NCT01116089|Cystic fibrosis, tobramycin,nebulizer, PK|cystic fibrosis, tobramycin,nebulizer, pk
5542876|NCT01116063|COPD, Pulmonary hypertension|copd, pulmonary hypertension
5542877|NCT01116037|Diseased Heart Valve, Replacement, Aortic, Stentless|diseased heart valve, replacement, aortic, stentless
5542878|NCT01116024|Diseased Heart Valve, Replacement, Aortic|diseased heart valve, replacement, aortic
5542879|NCT01116011|Phase I|phase i
5542880|NCT01116011|Japanese Healthy volunteer|japanese healthy volunteer
5542881|NCT01115998|cerebral palsy|cerebral palsy
5542882|NCT01115998|wheelchair|wheelchair
5542883|NCT01115998|disabled children|disabled children
5542884|NCT01115985|ASP1585|asp1585
5542885|NCT01115985|Drug-drug interaction|drug-drug interaction
5542886|NCT01115985|Atorvastatin|atorvastatin
5542887|NCT01115985|Healthy volunteer|healthy volunteer
5542888|NCT01115972|ASP1585|asp1585
5542889|NCT01115972|Drug-drug interaction|drug-drug interaction
5542890|NCT01115972|valsartan|valsartan
5542891|NCT01115972|Healthy volunteer|healthy volunteer
5542892|NCT01115946|ASP1585|asp1585
5542893|NCT01115946|Drug-drug interaction|drug-drug interaction
5542894|NCT01115946|enalapril|enalapril
5542895|NCT01115946|Healthy volunteer|healthy volunteer
5542896|NCT01115933|drug eluting stents|drug eluting stents
5542897|NCT01115933|small vessel|small vessel
5542898|NCT01115933|Stents|stents
5542899|NCT01115933|Everolimus|everolimus
5542900|NCT01115933|Angioplasty|angioplasty
5542901|NCT01115920|Drug Safety|drug safety
5542902|NCT01115920|Clinical Trial, Phase I|clinical trial, phase i
5542903|NCT01115920|Nontherapeutic Human Experimentation|nontherapeutic human experimentation
5542904|NCT01115920|Heading Pharmacokinetics|heading pharmacokinetics
5542905|NCT01115920|Phase I Safety and Tolerability|phase i safety and tolerability
5542906|NCT01115907|Aortic|aortic
5542907|NCT01115907|Valve replacement|valve replacement
5542908|NCT01115894|problem drinking|problem drinking
5542909|NCT01115894|alcohol|alcohol
5542910|NCT01115881|To examine the relationship between signal strength and macular thickness measured by stratus OCT|to examine the relationship between signal strength and macular thickness measured by stratus oct
5542911|NCT01115855|Double-blind|double-blind
5542912|NCT01115855|eplerenone|eplerenone
5542913|NCT01115855|Japanese|japanese
5542914|NCT01115842|Vitamin D|vitamin d
5542915|NCT01115842|Acute coronary syndrome|acute coronary syndrome
5542916|NCT01115842|inflammatory cytokines|inflammatory cytokines
5542917|NCT01115803|Advanced Cancer|advanced cancer
5542918|NCT01115803|Metastatic Cancer|metastatic cancer
5542920|NCT01115803|Renal Cell Carcinoma|renal cell carcinoma
5542921|NCT01115803|Neuroendocrine Tumors|neuroendocrine tumors
5542922|NCT01115777|Pediatric patients|pediatric patients
5542923|NCT01115777|treated with|treated with
5542924|NCT01115777|radiation therapy|radiation therapy
5542925|NCT01115777|for brain tumors|for brain tumors
5542926|NCT01115777|and non-CNS malignancies|and non-cns malignancies
5542927|NCT01115764|diastolic dysfunction|diastolic dysfunction
5542928|NCT01115751|Advanced Cancer|advanced cancer
5542929|NCT01115751|Metastatic Cancer|metastatic cancer
5542930|NCT01115751|Solid Tumors|solid tumors
5542931|NCT01115738|Plavix, Effient|plavix, effient
5542932|NCT01115725|Follitropin alfa|follitropin alfa
5542933|NCT01115725|Fertilization in vitro|fertilization in vitro
5542934|NCT01115725|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5542935|NCT01115725|Reproductive techniques, assisted|reproductive techniques, assisted
5542936|NCT01115712|Healthy Volunteers|healthy volunteers
5542937|NCT01115699|Depression|depression
5542938|NCT01115699|rTMS|rtms
5542939|NCT01115660|stroke|stroke
5542940|NCT01115660|patient education|patient education
5542941|NCT01115660|medication adherence|medication adherence
5542942|NCT01115647|Malnutrition|malnutrition
5542943|NCT01115647|Nutritional intervention|nutritional intervention
5542944|NCT01115647|Behavioural intervention|behavioural intervention
5542945|NCT01115647|Burkina Faso|burkina faso
5542946|NCT01115647|Cluster randomize trial|cluster randomize trial
5542947|NCT01115634|Fibroblast|fibroblast
5542948|NCT01115634|Cell transplantation|cell transplantation
5542949|NCT01115634|Facial deformities|facial deformities
5542950|NCT01115608|Preventive Health Services|preventive health services
5542951|NCT01115595|Allergic rhinitis|allergic rhinitis
5544622|NCT01108783|Pollinosis|pollinosis
5542952|NCT01115595|Allergen injection immunotherapy|allergen injection immunotherapy
5542953|NCT01115595|Efficacy|efficacy
5542954|NCT01115582|Inborn Errors|inborn errors
5542955|NCT01115582|Bile Acid|bile acid
5542956|NCT01115582|Pediatrics|pediatrics
5542957|NCT01115582|Liver Disease|liver disease
5542958|NCT01115569|chronic pain|chronic pain
5542960|NCT01115504|heart failure|heart failure
5542961|NCT01115478|Malaria|malaria
5542962|NCT01115478|Low birth weight|low birth weight
5542963|NCT01115478|Anemia|anemia
5542964|NCT01115478|Perinatal mortality|perinatal mortality
5542965|NCT01115478|Vitamin A|vitamin a
5542966|NCT01115478|Zinc|zinc
5542967|NCT01115465|Stress Urinary Incontinence|stress urinary incontinence
5542968|NCT01115465|silicone elastomer|silicone elastomer
5542969|NCT01115452|potassium nitrate|potassium nitrate
5542970|NCT01115452|tooth sensitivity|tooth sensitivity
5542971|NCT01115452|dentin sensitivity|dentin sensitivity
5542972|NCT01115439|falciparum malaria|falciparum malaria
5542973|NCT01115439|artemisinin combination treatments|artemisinin combination treatments
5542974|NCT01115413|teenage|teenage
5542975|NCT01115413|pregnancy|pregnancy
5542976|NCT01115413|obstetrical risk|obstetrical risk
5542977|NCT01115400|Abdominal Wall Hernia|abdominal wall hernia
5542978|NCT01115400|quality of life|quality of life
5542979|NCT01115387|Age-related macular degeneration|age-related macular degeneration
5542980|NCT01115387|AMD|amd
5542981|NCT01115387|Genetic risk|genetic risk
5542982|NCT01115387|Environmental risk factors|environmental risk factors
5542983|NCT01115387|Complex genetic disorder|complex genetic disorder
5542984|NCT01115387|Age-related maculopathy|age-related maculopathy
5542985|NCT01115387|Risk modeling|risk modeling
5542986|NCT01115387|Smoking|smoking
5542987|NCT01115387|Light exposure|light exposure
5542988|NCT01115387|Sleep apnea|sleep apnea
5542989|NCT01115387|Fundus Photography|fundus photography
5529705|NCT01169220|Colonoscopy|colonoscopy
5542990|NCT01115387|Macula|macula
5542991|NCT01115387|Drusen|drusen
5542992|NCT01115387|Wet AMD|wet amd
5542993|NCT01115387|Dry AMD|dry amd
5542994|NCT01115387|Geographic atrophy|geographic atrophy
5542995|NCT01115387|Vitamins & supplements|vitamins & supplements
5542996|NCT01115361|family planning|family planning
5542997|NCT01115361|postpartum|postpartum
5542998|NCT01115361|immunization|immunization
5542999|NCT01115361|integration|integration
5543000|NCT01115361|Contraceptive behavior|contraceptive behavior
5543001|NCT01115335|neonatal male circumcision|neonatal male circumcision
5543003|NCT01115335|Plastibell|plastibell
5543004|NCT01115335|Mogen|mogen
5543005|NCT01115335|Safety|safety
5543006|NCT01115335|Uptake|uptake
5543007|NCT01115335|Acceptability|acceptability
5543008|NCT01115335|Feasibility|feasibility
5543009|NCT01115335|Zambia|zambia
5543010|NCT01115322|Healthy volunteer study|healthy volunteer study
5543011|NCT01115322|phototoxicity|phototoxicity
5543012|NCT01115309|Sinusitis|sinusitis
5543013|NCT01115296|Helicobacter Pylori|helicobacter pylori
5543014|NCT01115296|gastritis|gastritis
5543015|NCT01115296|Probiotics|probiotics
5543016|NCT01115296|Lactobacillus Reuteri|lactobacillus reuteri
5543017|NCT01115283|amblyopia treatment|amblyopia treatment
5543018|NCT01115283|neural plasticity|neural plasticity
5543019|NCT01115283|perceptual learning|perceptual learning
5543021|NCT01115283|spatial vision|spatial vision
5543022|NCT01115283|video games|video games
5543023|NCT01115283|occlusion therapy|occlusion therapy
5543024|NCT01115270|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5543025|NCT01115257|severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
5543026|NCT01115257|vitrectomy|vitrectomy
5543027|NCT01115257|panretinalphotocoagulation|panretinalphotocoagulation
5543028|NCT01115244|Dermatitis herpetiformis|dermatitis herpetiformis
5543029|NCT01115244|Dapsone|dapsone
5543030|NCT01115231|Age-Related Macular Degeneration|age-related macular degeneration
5543031|NCT01115231|Age-Related Maculopathies|age-related maculopathies
5543032|NCT01115231|Age-Related Maculopathy|age-related maculopathy
5543033|NCT01115231|Macular Dystrophy|macular dystrophy
5543034|NCT01115231|Maculopathies, Age-Related|maculopathies, age-related
5543035|NCT01115231|Maculopathy, Age-Related|maculopathy, age-related
5543036|NCT01115218|Glaucoma|glaucoma
5543037|NCT01115205|Exercise, Walking, Type 2 diabetes, Therapy|exercise, walking, type 2 diabetes, therapy
5543038|NCT01115179|propofol|propofol
5543039|NCT01115179|inflammation|inflammation
5543040|NCT01115179|perioperative|perioperative
5543041|NCT01115179|lipids|lipids
5543042|NCT01115179|Apolipoprotein A-I|apolipoprotein a-i
5543043|NCT01115166|blood volume|blood volume
5543044|NCT01115153|Acute appendicitis|acute appendicitis
5543045|NCT01115153|Antibiotic prophylaxis|antibiotic prophylaxis
5543046|NCT01115153|Wound infection|wound infection
5543047|NCT01115153|Nosocomial infection|nosocomial infection
5543048|NCT01115140|Folate|folate
5543049|NCT01115140|Metformin|metformin
5543050|NCT01115140|PCOS|pcos
5543051|NCT01115140|Pregnancy|pregnancy
5543052|NCT01115140|Trophoblastic invasion|trophoblastic invasion
5543053|NCT01115140|Uterine artery velocimetry|uterine artery velocimetry
5543062|NCT01115075|Changes in leptin may precede the|changes in leptin may precede the
5543063|NCT01115075|phasing of oscillations of dietary fat intake|phasing of oscillations of dietary fat intake
5543065|NCT01115062|Children|children
5543066|NCT01115062|Local anesthetics|local anesthetics
5709180|NCT00468078|PET|pet
5543067|NCT01115036|glioblastoma|glioblastoma
5543068|NCT01115036|recurrent|recurrent
5543069|NCT01115036|surgical resection|surgical resection
5543070|NCT01115023|iron deficiency anemia|iron deficiency anemia
5543071|NCT01115023|dietary intervention|dietary intervention
5543072|NCT01115023|To evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.|to evaluate a cheap and sustainable dietary intervention to improve the iron status of the entire family of the index case of non-severe iron deficiency anemia.
5543073|NCT01115010|intubation rate|intubation rate
5543074|NCT01115010|intubation time|intubation time
5543075|NCT01115010|stiffening device|stiffening device
5543076|NCT01115010|stiffening wire|stiffening wire
5543077|NCT01114997|Lidocaine Infusion|lidocaine infusion
5543078|NCT01114997|Esmolol Infusion|esmolol infusion
5543079|NCT01114997|Anesthetic adjuvant|anesthetic adjuvant
5543080|NCT01114997|Abdominal surgery|abdominal surgery
5543081|NCT01114997|Pain management|pain management
5543082|NCT01114997|Hemodynamic stability|hemodynamic stability
5543083|NCT01114997|Perioperative outcomes|perioperative outcomes
5543084|NCT01114984|Pain management|pain management
5543085|NCT01114984|Radical mastectomy|radical mastectomy
5543086|NCT01114984|Breast surgery|breast surgery
5543087|NCT01114984|post-operative pain|post-operative pain
5543097|NCT01114958|Lung cancer|lung cancer
5543098|NCT01114958|Non-small cell lung cancer|non-small cell lung cancer
5543099|NCT01114958|Small-cell lung cancer|small-cell lung cancer
5543100|NCT01114958|Lung metastases|lung metastases
5543101|NCT01114958|Metastatic cancer|metastatic cancer
5543102|NCT01114958|Stage IIIA|stage iiia
5543103|NCT01114958|Stage IIIB|stage iiib
5543104|NCT01114958|Stage III|stage iii
5543105|NCT01114958|Stage 3|stage 3
5543106|NCT01114945|Direct Laryngoscopy|direct laryngoscopy
5543107|NCT01114945|Video-Mac|video-mac
5543108|NCT01114945|GlideScope|glidescope
5543109|NCT01114945|McGrath|mcgrath
5543110|NCT01114945|Laryngoscopy|laryngoscopy
5543111|NCT01114945|Bariatrics|bariatrics
5543112|NCT01114945|Glottic view|glottic view
5543113|NCT01114945|Airway intubating devices|airway intubating devices
5543114|NCT01114945|Tracheal intubation|tracheal intubation
5543115|NCT01114932|pre-oxygenation|pre-oxygenation
5543116|NCT01114932|body mass index|body mass index
5543117|NCT01114932|end-tidal O2|end-tidal o2
5543118|NCT01114932|anesthesia induction|anesthesia induction
5543119|NCT01114919|Problem drinking|problem drinking
5543120|NCT01114919|Alcohol dependence|alcohol dependence
5543121|NCT01114919|Alcohol abuse|alcohol abuse
5543122|NCT01114919|Internet based intervention|internet based intervention
5543123|NCT01114919|Treatment|treatment
5543124|NCT01114919|Alcohol Use Disorders Identification Test|alcohol use disorders identification test
5543125|NCT01114906|Asthma|asthma
5543126|NCT01114906|Resource use|resource use
5543127|NCT01114880|ankylosing spondylitis|ankylosing spondylitis
5543128|NCT01114880|China|china
5543129|NCT01114867|ultrasound|ultrasound
5543130|NCT01114867|penis length|penis length
5543131|NCT01114867|corpus cavernosum|corpus cavernosum
5543132|NCT01114867|length of fetal penis and fetal corpus cavernosum|length of fetal penis and fetal corpus cavernosum
5543133|NCT01114841|Healthy Volunteer Subjects|healthy volunteer subjects
5543134|NCT01114828|Cirrhosis|cirrhosis
5543135|NCT01114828|ascites|ascites
5543136|NCT01114828|Tolvaptan|tolvaptan
5543137|NCT01114828|OPC-41061|opc-41061
5543138|NCT01114815|CADASIL|cadasil
5543139|NCT01114815|cerebral|cerebral
5543140|NCT01114815|autosomal dominant|autosomal dominant
5543141|NCT01114815|arteriopathy|arteriopathy
5543142|NCT01114815|subcortical infarcts|subcortical infarcts
5543143|NCT01114815|leukoencephalopathy|leukoencephalopathy
5543144|NCT01114802|Cancer survivors|cancer survivors
5543145|NCT01114802|Anxiety|anxiety
5543146|NCT01114802|Depression|depression
5543147|NCT01114802|Technology Assisted|technology assisted
5543148|NCT01114802|Internet|internet
5543149|NCT01114789|chronic renal failure|chronic renal failure
5543150|NCT01114789|hemodialysis|hemodialysis
5543152|NCT01114789|proteolysis|proteolysis
5543153|NCT01114763|Metabolic Syndrome|metabolic syndrome
5543154|NCT01114763|Oxidized Low Density Lipoprotein|oxidized low density lipoprotein
5543155|NCT01114763|Arterial Elasticity|arterial elasticity
5543156|NCT01114763|Diabetes Mellitus|diabetes mellitus
5543157|NCT01114763|Cardiovascular Diseases|cardiovascular diseases
5543158|NCT01114750|blood glucose|blood glucose
5543159|NCT01114750|blood insulin|blood insulin
5543160|NCT01114750|dextran|dextran
5543161|NCT01114750|diabetes|diabetes
5543162|NCT01114750|hyperglycemia|hyperglycemia
5543163|NCT01114750|hypoglycemia|hypoglycemia
5543164|NCT01114750|oral delivery|oral delivery
5543165|NCT01114750|portal delivery|portal delivery
5543166|NCT01114737|Phenylketonuria|phenylketonuria
5543167|NCT01114737|PKU|pku
5543168|NCT01114737|Kuvan|kuvan
5543169|NCT01114737|Sapropterin dihydrochloride|sapropterin dihydrochloride
5543170|NCT01114737|Neuropsychiatric disorder|neuropsychiatric disorder
5543171|NCT01114737|ADHD|adhd
5904047|NCT00007813|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5543172|NCT01114724|Thoracic dissection|thoracic dissection
5543173|NCT01114724|Endovascular aortic repair|endovascular aortic repair
5543174|NCT01114711|Menstrual Migraine|menstrual migraine
5543175|NCT01114711|Frova|frova
5543176|NCT01114711|Imaging|imaging
5543177|NCT01114711|fMRI|fmri
5543178|NCT01114711|Pain|pain
5543179|NCT01114698|Depression|depression
5543180|NCT01114698|Major Depressive Disorder|major depressive disorder
5543181|NCT01114698|Venlafaxine XR (EFFEXOR XR)|venlafaxine xr (effexor xr)
5543182|NCT01114698|26489112|26489112
5543183|NCT01114698|JNJ26489112|jnj26489112
5543184|NCT01114672|Pruritis in hemodialysis patients|pruritis in hemodialysis patients
5543185|NCT01114672|25-Vitamin D in chronic kidney disease|25-vitamin d in chronic kidney disease
5543186|NCT01114646|Hemiarthroplasty|hemiarthroplasty
5543187|NCT01114646|Cemented|cemented
5543188|NCT01114646|Press Fit|press fit
5543189|NCT01114646|Mortality|mortality
5543190|NCT01114646|Morbidity|morbidity
5543191|NCT01114646|Functional Status|functional status
5543192|NCT01114646|Displaced femoral neck fracture|displaced femoral neck fracture
5543193|NCT01114633|PCOS|pcos
5543194|NCT01114633|Acne|acne
5543195|NCT01114633|Hirsutism|hirsutism
5543196|NCT01114620|elderly|elderly
5543197|NCT01114620|post-marketing|post-marketing
5543198|NCT01114620|H1N1|h1n1
5543199|NCT01114620|Clinical trial|clinical trial
5543200|NCT01114620|pandemic influenza|pandemic influenza
5543201|NCT01114607|GSK1605786|gsk1605786
5543202|NCT01114607|relative bioavailability|relative bioavailability
5543203|NCT01114607|CCR9 receptor antagonist|ccr9 receptor antagonist
5543204|NCT01114594|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5543205|NCT01114594|Autosomal Dominant Polycystic Kidney Disease (ADPKD)|autosomal dominant polycystic kidney disease (adpkd)
5543206|NCT01114581|Acute Respiratory Infection|acute respiratory infection
5543207|NCT01114581|Mucociliary|mucociliary
5543208|NCT01114581|Cough Clearance|cough clearance
5543209|NCT01114581|Guaifenesin|guaifenesin
5543210|NCT01114568|Relative Bioavailability|relative bioavailability
5543211|NCT01114568|Pharmacokinetics|pharmacokinetics
5543212|NCT01114568|Pharmacodynamics|pharmacodynamics
5543213|NCT01114555|Bevacizumab|bevacizumab
5543214|NCT01114555|Irinotecan|irinotecan
5543215|NCT01114555|Temozolomide|temozolomide
5543216|NCT01114555|10-015|10-015
5543217|NCT01114529|de novo renal allograft recipients|de novo renal allograft recipients
5543218|NCT01114529|renal allograft function|renal allograft function
5543219|NCT01114529|CNI-free regimen|cni-free regimen
5543220|NCT01114516|cervical insufficiency|cervical insufficiency
5543221|NCT01114503|GSK2136525|gsk2136525
5543222|NCT01114503|Pharmacodynamics|pharmacodynamics
5543223|NCT01114503|Safety|safety
5543224|NCT01114503|Otelixizumab|otelixizumab
5543225|NCT01114503|Thyroid eye disease|thyroid eye disease
5543226|NCT01114503|Graves' ophthalmopathy|graves' ophthalmopathy
5543227|NCT01114503|Repeat dose|repeat dose
5543228|NCT01114503|Intravenous infusion|intravenous infusion
5543229|NCT01114503|Tolerability|tolerability
5543230|NCT01114503|EUGOGO|eugogo
5543231|NCT01114490|Hepatic Insufficiency|hepatic insufficiency
5543232|NCT01114477|Transcranial magnetic stimulation|transcranial magnetic stimulation
5543234|NCT01114477|Observational study|observational study
5543235|NCT01114477|Major Depression|major depression
5543236|NCT01114464|Breast cancer|breast cancer
5543237|NCT01114464|Ovarian reserve|ovarian reserve
5543238|NCT01114464|Anti-Mullerian Hormone (AMH)|anti-mullerian hormone (amh)
5543239|NCT01114464|Chemotherapy|chemotherapy
5543240|NCT01114451|Cesarean delivery|cesarean delivery
5543241|NCT01114451|Obesity|obesity
5543242|NCT01114451|Skin staples|skin staples
5543243|NCT01114451|Wound complications|wound complications
5543244|NCT01114425|tolerability of post exposure to HIV infection prophylaxis|tolerability of post exposure to hiv infection prophylaxis
5543245|NCT01114412|focus groups|focus groups
5543246|NCT01114412|overactive bladder|overactive bladder
5543247|NCT01114412|bladder sensations|bladder sensations
5543248|NCT01114399|Cardiovascular Disease|cardiovascular disease
5543249|NCT01114399|Cardiovascular Disease risk (mild to moderate)|cardiovascular disease risk (mild to moderate)
5543251|NCT01114399|Ambulatory blood pressure|ambulatory blood pressure
5543252|NCT01114399|Arterial Stiffness|arterial stiffness
5543253|NCT01114386|Smoking|smoking
5543254|NCT01114386|Dyspnea|dyspnea
5543255|NCT01114386|Cough|cough
5543256|NCT01114386|Exercise|exercise
5543257|NCT01114373|Melatonin|melatonin
5543258|NCT01114373|Hypertension|hypertension
5543259|NCT01114373|Blood Pressure|blood pressure
5543260|NCT01114373|Cardiovascular|cardiovascular
5543261|NCT01114373|Sleep|sleep
5543262|NCT01114373|Nighttime|nighttime
5543263|NCT01114373|Nocturnal|nocturnal
5543264|NCT01114373|Catecholamines|catecholamines
5543265|NCT01114373|Sympathetic Nervous System|sympathetic nervous system
5543266|NCT01114373|Endothelial Function|endothelial function
5543267|NCT01114373|African American|african american
5543268|NCT01114360|Melatonin|melatonin
5543269|NCT01114360|Hypertension|hypertension
5543270|NCT01114360|Blood Pressure|blood pressure
5543271|NCT01114360|Cardiovascular|cardiovascular
5543272|NCT01114360|Sleep|sleep
5543273|NCT01114360|Nighttime|nighttime
5543274|NCT01114360|Nocturnal|nocturnal
5543275|NCT01114360|Catecholamines|catecholamines
5543276|NCT01114360|Sympathetic Nervous System|sympathetic nervous system
5543277|NCT01114360|Endothelial function|endothelial function
5543278|NCT01114360|African American|african american
5543279|NCT01114321|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5543280|NCT01114321|Glucose intolerance|glucose intolerance
5543281|NCT01114321|Diabetes|diabetes
5543282|NCT01114321|OGTT|ogtt
5543283|NCT01114321|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5543284|NCT01114308|opioid dependence|opioid dependence
5543285|NCT01114308|opioid addiction|opioid addiction
5543286|NCT01114308|buprenorphine|buprenorphine
5543287|NCT01114308|implant|implant
5543288|NCT01114308|methadone|methadone
5543289|NCT01114308|heroin|heroin
5543290|NCT01114308|suboxone|suboxone
5543291|NCT01114308|opioid pain medication|opioid pain medication
5543292|NCT01114308|opioid withdrawal|opioid withdrawal
5543293|NCT01114295|overt|overt
5543294|NCT01114295|obscure|obscure
5543295|NCT01114295|gastrointestinal|gastrointestinal
5543296|NCT01114295|bleeding|bleeding
5543297|NCT01114295|hemorrhage|hemorrhage
5543298|NCT01114269|Coronary Artery Disease|coronary artery disease
5543299|NCT01114269|Sudden Cardiac Death|sudden cardiac death
5543300|NCT01114269|Myocardial Infarction|myocardial infarction
5543301|NCT01114269|Percutaneous Coronary Intervention|percutaneous coronary intervention
5543302|NCT01114269|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5543303|NCT01114230|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5543304|NCT01114230|Advanced Kidney Cancer|advanced kidney cancer
5543305|NCT01114230|AGS-16M8F|ags-16m8f
5543306|NCT01114217|Iron deficiency anemia|iron deficiency anemia
5543307|NCT01114217|Feraheme|feraheme
5543308|NCT01114217|Ferumoxytol|ferumoxytol
5543310|NCT01114204|Iron deficiency anemia|iron deficiency anemia
5543311|NCT01114204|Feraheme|feraheme
5543312|NCT01114204|ferumoxytol|ferumoxytol
5543313|NCT01114204|iron sucrose|iron sucrose
5543314|NCT01114204|Venofer|venofer
5543315|NCT01114204|IDA|ida
5543316|NCT01114178|questionnaire|questionnaire
5543317|NCT01114178|peripheral artery disease|peripheral artery disease
5543318|NCT01114178|exercise|exercise
5543319|NCT01114165|Neutropenia|neutropenia
5543320|NCT01114165|Febrile Neutropenia|febrile neutropenia
5543321|NCT01114165|Sepsis|sepsis
5543322|NCT01114165|Polymerase Chain Reaction|polymerase chain reaction
5543323|NCT01114152|AZD9742|azd9742
5543324|NCT01114152|Japanese Healthy Volunteers|japanese healthy volunteers
5543325|NCT01114152|Phase I|phase i
5543326|NCT01114152|Single and Multiple Ascending Dose|single and multiple ascending dose
5543327|NCT01114139|Iron deficiency anemia|iron deficiency anemia
5543328|NCT01114139|Feraheme|feraheme
5543329|NCT01114139|ferumoxytol|ferumoxytol
5543330|NCT01114139|IDA|ida
5543331|NCT01114126|Neu-P11|neu-p11
5543332|NCT01114126|Insomnia|insomnia
5543333|NCT01114126|PSG|psg
5543334|NCT01114126|safety|safety
5543335|NCT01114113|IBS-D|ibs-d
5543336|NCT01114113|Post meal Diarrhea|post meal diarrhea
5543337|NCT01114113|Trigger meals|trigger meals
5543338|NCT01114100|chest pain|chest pain
5543339|NCT01114100|panic attacks|panic attacks
5543340|NCT01114100|palpitations|palpitations
5543341|NCT01114100|depression|depression
5543342|NCT01114100|panic disorder|panic disorder
5543343|NCT01114100|depressive disorder|depressive disorder
5543344|NCT01114100|non cardiac chest pain|non cardiac chest pain
5543345|NCT01114087|Spermatogenesis|spermatogenesis
5543346|NCT01114087|Inhibitors of tyrosine kinase|inhibitors of tyrosine kinase
5543347|NCT01114087|Fragmentation of the spermatic DNA|fragmentation of the spermatic dna
5543348|NCT01114074|Thrombosis|thrombosis
5543349|NCT01114074|Blood coagulation|blood coagulation
5543350|NCT01114074|Perfusion flow experiments|perfusion flow experiments
5543351|NCT01114074|Factor XII|factor xii
5543352|NCT01114074|Factor XI|factor xi
5543353|NCT01114074|Prekallikrein|prekallikrein
5543354|NCT01114074|High molecular weight kininogen|high molecular weight kininogen
5543355|NCT01114061|diabetes|diabetes
5544719|NCT01108328|fibre|fibre
5543356|NCT01114061|postprandial glucose level|postprandial glucose level
5543357|NCT01114061|insulin pharmacodynamics|insulin pharmacodynamics
5543358|NCT01114061|Insulin Pharmacokinetics|insulin pharmacokinetics
5543359|NCT01114048|age under 65|age under 65
5543360|NCT01114048|Previous untreated|previous untreated
5543361|NCT01114035|intestinal epithelial dysplasia|intestinal epithelial dysplasia
5543362|NCT01114035|characterization phenotypic|characterization phenotypic
5543363|NCT01114035|genetic study|genetic study
5543364|NCT01114035|"or  tufting enteropathy "|"or  tufting enteropathy "
5543365|NCT01114022|Acute respiratory failure|acute respiratory failure
5543366|NCT01114009|recruitment maneuvers|recruitment maneuvers
5543367|NCT01114009|ARDS|ards
5543368|NCT01114009|lung protective strategy|lung protective strategy
5543369|NCT01114009|ARDS, Human|ards, human
5543370|NCT01113996|Obesity|obesity
5543371|NCT01113996|Gastric by-pass|gastric by-pass
5543372|NCT01113996|Body composition|body composition
5543373|NCT01113996|Nutrition|nutrition
5543374|NCT01113996|Physical activity|physical activity
5543375|NCT01113983|SAPIEN XT Valve, Cardiovascular Disease, Valvular Heart Disease, Aortic Stenosis, Heart Valve Therapy, Transapical, Transcatheter, Transfemoral|sapien xt valve, cardiovascular disease, valvular heart disease, aortic stenosis, heart valve therapy, transapical, transcatheter, transfemoral
5543376|NCT01113970|breast cancer|breast cancer
5543377|NCT01113970|Indibulin|indibulin
5543378|NCT01113970|unresectable, locally advanced breast cancer|unresectable, locally advanced breast cancer
5543379|NCT01113957|Ovarian Cancer|ovarian cancer
5543380|NCT01113931|Chlamydia|chlamydia
5543381|NCT01113918|Obesity,|obesity,
5543382|NCT01113918|PCOS,|pcos,
5543383|NCT01113918|HA,|ha,
5543384|NCT01113918|CVD|cvd
5543385|NCT01113905|Fatigue|fatigue
5543386|NCT01113905|Breast Cancer|breast cancer
5543387|NCT01113879|rehabilitation|rehabilitation
5543388|NCT01113879|aphasia|aphasia
5543389|NCT01113879|exercise|exercise
5543390|NCT01113879|BDNF|bdnf
5543391|NCT01113853|asthma|asthma
5543392|NCT01113853|exhaled nitric oxide|exhaled nitric oxide
5543393|NCT01113853|lung function|lung function
5543394|NCT01113840|elderly|elderly
5543395|NCT01113840|heart failure|heart failure
5543396|NCT01113840|exercise|exercise
5543397|NCT01113840|diastolic dysfunction|diastolic dysfunction
5543398|NCT01113827|Olive|olive
5543399|NCT01113827|antioxidant|antioxidant
5543400|NCT01113827|exercise|exercise
5530085|NCT01167777|GC|gc
5543401|NCT01113827|inflammation|inflammation
5543402|NCT01113827|recovery|recovery
5543403|NCT01113827|Healthy men|healthy men
5543404|NCT01113801|Chronic Kidney Disease|chronic kidney disease
5543405|NCT01113801|Diabetic Kidney Disease|diabetic kidney disease
5543406|NCT01113801|End-Stage Renal Disease|end-stage renal disease
5543407|NCT01113801|Transforming Growth Factor beta 1 Monoclonal Antibody|transforming growth factor beta 1 monoclonal antibody
5543408|NCT01113801|Type 1 Diabetes|type 1 diabetes
5543409|NCT01113801|Type 2 Diabetes|type 2 diabetes
5543410|NCT01113788|atrial flutter, tricuspid isthmus, ablation|atrial flutter, tricuspid isthmus, ablation
5543411|NCT01113775|pulmonary embolism|pulmonary embolism
5528529|NCT01173848|CKD|ckd
5543412|NCT01113775|computed tomography|computed tomography
5543413|NCT01113762|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5543414|NCT01113762|Bone Density|bone density
5543415|NCT01113762|Rehabilitation|rehabilitation
5543416|NCT01113762|T-Lymphocytes|t-lymphocytes
5543417|NCT01113762|Chromium Alloys|chromium alloys
5543418|NCT01113749|Dementia|dementia
5543419|NCT01113749|Nutrition|nutrition
5543420|NCT01113749|Feeding|feeding
5543421|NCT01113736|Ileostomy|ileostomy
5543422|NCT01113736|Stenosis|stenosis
5543423|NCT01113736|Surgical Wound Dehiscence|surgical wound dehiscence
5543424|NCT01113736|Peritoneal|peritoneal
5543425|NCT01113736|Colorectal Surgery|colorectal surgery
5543426|NCT01113723|C-MAC|c-mac
5543427|NCT01113723|Fiberoptic bronchoscope|fiberoptic bronchoscope
5543428|NCT01113723|Laryngoscopy|laryngoscopy
5543429|NCT01113723|Cervical spine injury|cervical spine injury
5543430|NCT01113723|Glottic view|glottic view
5543431|NCT01113723|Tracheal intubation|tracheal intubation
5543432|NCT01113710|Rotigotine|rotigotine
5543433|NCT01113710|Neupro®|neupro®
5543434|NCT01113710|Restless Legs Syndrome|restless legs syndrome
5543435|NCT01113697|allergen challenge|allergen challenge
5543436|NCT01113697|blood draw|blood draw
5543437|NCT01113697|gene expression analysis|gene expression analysis
5543438|NCT01113697|protein analysis|protein analysis
5543439|NCT01113697|genetics|genetics
5543440|NCT01113671|Diabetes Mellitus type 2|diabetes mellitus type 2
5525960|NCT01184365|fatigue|fatigue
5543441|NCT01113671|Haptoglobin phenotype|haptoglobin phenotype
5543442|NCT01113671|Vitamin E|vitamin e
5543443|NCT01113658|negative pressure wound therapy|negative pressure wound therapy
5543444|NCT01113658|NPWT|npwt
5543445|NCT01113658|Spiracur|spiracur
5543446|NCT01113658|SNaP Wound Care System|snap wound care system
5543447|NCT01113645|Decompressive craniectomy|decompressive craniectomy
5543448|NCT01113645|Cranioplasty|cranioplasty
5543449|NCT01113645|Cerebral blood flow|cerebral blood flow
5543450|NCT01113645|Cerebral hemodynamic|cerebral hemodynamic
5543451|NCT01113645|Neurological-cognitive test GOS, FAB, MMSE,|neurological-cognitive test gos, fab, mmse,
5543452|NCT01113645|Transcranial Doppler|transcranial doppler
5543453|NCT01113632|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5543454|NCT01113632|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5543455|NCT01113632|Ofatumumab|ofatumumab
5543456|NCT01113619|lactose maldigestion|lactose maldigestion
5543457|NCT01113619|dairy intolerance|dairy intolerance
5543458|NCT01113619|intolerance to milk|intolerance to milk
5543459|NCT01113619|intolerance to dairy|intolerance to dairy
5543460|NCT01113619|milk intolerance|milk intolerance
5543461|NCT01113619|GI disorder|gi disorder
5543462|NCT01113619|lactose metabolism|lactose metabolism
5543463|NCT01113619|GI symptoms after dairy ingestion|gi symptoms after dairy ingestion
5543464|NCT01113606|Moderate to severe facial photo damage|moderate to severe facial photo damage
5543465|NCT01113606|Periocular or perioral fine wrinkles|periocular or perioral fine wrinkles
5543466|NCT01113593|COPD|copd
5543467|NCT01113567|Hepatic Encephalopathy|hepatic encephalopathy
5543468|NCT01113567|Liver Cirrhosis|liver cirrhosis
5543469|NCT01113567|Disaccharides|disaccharides
5543470|NCT01113567|Lactose|lactose
5543471|NCT01113567|Quality of Life|quality of life
5543472|NCT01113541|Ziprasidone|ziprasidone
5543473|NCT01113541|Bipolar Disorder|bipolar disorder
5543474|NCT01113541|Metabolic Syndrome|metabolic syndrome
5543475|NCT01113528|Bone allograft|bone allograft
5543476|NCT01113528|IL-1|il-1
5543477|NCT01113528|IL-10|il-10
5543478|NCT01113528|periodontal regeneration|periodontal regeneration
5543479|NCT01113528|omega-3|omega-3
5543480|NCT01113528|aspirin|aspirin
5543481|NCT01113515|Diabetic foot ulcer|diabetic foot ulcer
5543482|NCT01113515|Diabetic wound|diabetic wound
5543483|NCT01113515|chronic non healing ulcer|chronic non healing ulcer
5543484|NCT01113476|Advanced Malignancies|advanced malignancies
5543485|NCT01113476|Nab-paclitaxel|nab-paclitaxel
5543486|NCT01113476|Gemcitabine|gemcitabine
5543487|NCT01113476|Bevacizumab|bevacizumab
5543488|NCT01113463|Brain Tumor|brain tumor
5543489|NCT01113463|Central Nervous System|central nervous system
5543491|NCT01113463|Glioblastoma Multiforme|glioblastoma multiforme
5543492|NCT01113463|GBM|gbm
5543493|NCT01113463|TPI 287|tpi 287
5543494|NCT01113463|Radiation Therapy|radiation therapy
5543495|NCT01113463|Temozolomide|temozolomide
5543496|NCT01113463|Chemotherapy|chemotherapy
5543497|NCT01113463|taxanes|taxanes
5543498|NCT01113450|hearing, newborn, screening|hearing, newborn, screening
5543499|NCT01113437|Bronchial Asthma|bronchial asthma
5543500|NCT01113437|Allergy|allergy
5543501|NCT01113424|Smoking Cessation|smoking cessation
5543502|NCT01113424|Nicotine pharmacokinetics|nicotine pharmacokinetics
5543503|NCT01113411|humerus fracture|humerus fracture
5543504|NCT01113411|locked plate|locked plate
5543505|NCT01113398|glioblastoma multiforme|glioblastoma multiforme
5543506|NCT01113398|gliosarcoma|gliosarcoma
5543507|NCT01113398|malignant glioma|malignant glioma
5543508|NCT01113398|glioma|glioma
5543509|NCT01113398|Avastin|avastin
5543510|NCT01113398|bevacizumab|bevacizumab
5543511|NCT01113398|AMG 102|amg 102
5543512|NCT01113398|rilotumumab|rilotumumab
5543513|NCT01113398|recurrent|recurrent
5543514|NCT01113398|Duke|duke
5543515|NCT01113398|Pro00022491|pro00022491
5543516|NCT01113385|Nephrotic syndrome|nephrotic syndrome
5543517|NCT01113385|Focal Segmental glomerulosclerosis|focal segmental glomerulosclerosis
5543518|NCT01113385|FSGS|fsgs
5543519|NCT01113385|Minimal change|minimal change
5543520|NCT01113385|Steroid resistant|steroid resistant
5543521|NCT01113385|Pediatric|pediatric
5543522|NCT01113385|Proteinuria|proteinuria
5543523|NCT01113385|Galactose|galactose
5543524|NCT01113385|FSPF|fspf
5543525|NCT01113372|Coronary, Disease|coronary, disease
5543526|NCT01113359|HCMV infection|hcmv infection
5543527|NCT01113359|Hypertension|hypertension
5543528|NCT01113359|The Potential Link Between HCMV Infection and Essential Hypertension|the potential link between hcmv infection and essential hypertension
5543529|NCT01113346|enterosorbent|enterosorbent
5543530|NCT01113346|sorbent|sorbent
5543531|NCT01113346|gastrointestinal decontamination|gastrointestinal decontamination
5543532|NCT01113346|viral diarrhea|viral diarrhea
5543534|NCT01113346|Filtrum|filtrum
5543535|NCT01113346|Filtrum-STI|filtrum-sti
5543536|NCT01113346|lignin|lignin
5543537|NCT01113320|Safinamide - Parkinson's disease - Levodopa induced dyskinesia|safinamide - parkinson's disease - levodopa induced dyskinesia
5526059|NCT01183949|Immune System Diseases|immune system diseases
5790017|NCT00146133|Obesity, Aging, Frailty, exercise, weight loss|obesity, aging, frailty, exercise, weight loss
5790018|NCT00146107|obesity|obesity
5543538|NCT01113320|Advanced idiopathic PD patients treated with L-dopa and suffering from temporally predictable L-dopa induced peak-dose dyskinesia.|advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia.
5543539|NCT01113307|Chronic ulcers|chronic ulcers
5543540|NCT01113307|pressure ulcers|pressure ulcers
5543541|NCT01113307|venous ulcers|venous ulcers
5543542|NCT01113307|diabetic foot ulcers|diabetic foot ulcers
5543543|NCT01113307|post operative ulcers|post operative ulcers
5543544|NCT01113307|hard to heal ulcers|hard to heal ulcers
5543545|NCT01113281|Tuberculosis|tuberculosis
5543546|NCT01113281|Vaccine|vaccine
5543547|NCT01113281|Live Vaccine|live vaccine
5543548|NCT01113281|rBCG|rbcg
5543549|NCT01113268|Patient collection|patient collection
5543550|NCT01113268|Cardiac remodelling|cardiac remodelling
5543551|NCT01113268|Echography|echography
5543552|NCT01113268|Magnetic Resonance Imaging|magnetic resonance imaging
5543553|NCT01113268|Gene polymorphisms|gene polymorphisms
5543554|NCT01113268|Biomarkers|biomarkers
5543555|NCT01113255|VENTILATORS|ventilators
5543556|NCT01113255|BENCH EVALUATION|bench evaluation
5543557|NCT01113255|MECHANICAL VENTILATION|mechanical ventilation
5543558|NCT01113242|Parkinson Disease Dementia|parkinson disease dementia
5543559|NCT01113242|Observational|observational
5543560|NCT01113242|Case control|case control
5543561|NCT01113242|Neuropsychological assessment|neuropsychological assessment
5543562|NCT01113229|Post Partum Haemorrhage,|post partum haemorrhage,
5543563|NCT01113229|oxytocin,|oxytocin,
5543564|NCT01113229|misoprostol,|misoprostol,
5543565|NCT01113229|prevention,|prevention,
5543566|NCT01113229|delivery.|delivery.
5543568|NCT01113216|CFRD|cfrd
5543569|NCT01113216|Diabetes|diabetes
5543570|NCT01113216|Genetic Modifiers|genetic modifiers
5543571|NCT01113203|resistance training|resistance training
5543572|NCT01113203|blood pressure|blood pressure
5543573|NCT01113203|hemodynamics|hemodynamics
5543574|NCT01113203|autonomic|autonomic
5543575|NCT01113203|Elderly Subjects|elderly subjects
5543576|NCT01113177|Mandibular growth temporomandibular arthritis|mandibular growth temporomandibular arthritis
5543577|NCT01113164|ondansetron|ondansetron
5543578|NCT01113164|sertraline|sertraline
5543579|NCT01113164|lab studies|lab studies
5543580|NCT01113164|alcoholism|alcoholism
5543581|NCT01113164|alcohol dependence|alcohol dependence
5543582|NCT01113151|Steroid-resistant|steroid-resistant
5543583|NCT01113151|Severe asthmatics|severe asthmatics
5543584|NCT01113151|Annual symptoms|annual symptoms
5543585|NCT01113151|Daily magnesium supplement|daily magnesium supplement
5543586|NCT01113151|ACT (asthma control test)|act (asthma control test)
5543587|NCT01113138|Clearance|clearance
5543588|NCT01113138|Half-life|half-life
5543589|NCT01113138|Absorption fraction|absorption fraction
5543590|NCT01113138|Pharmacokinetics|pharmacokinetics
5543591|NCT01113125|hypertrophic scar|hypertrophic scar
5543592|NCT01113125|keloid|keloid
5543593|NCT01113125|central venous catheter|central venous catheter
5543594|NCT01113125|children|children
5543595|NCT01113125|cancer|cancer
5543596|NCT01113112|Ovarian Neoplasms|ovarian neoplasms
5543598|NCT01113086|Transcranial direct current stimulation|transcranial direct current stimulation
5543599|NCT01113086|Motor function|motor function
5543600|NCT01113086|Cognitive function|cognitive function
5543601|NCT01113086|Affective function|affective function
5543602|NCT01113073|pulse pressure variation|pulse pressure variation
5543603|NCT01113073|hemodynamic monitoring|hemodynamic monitoring
5543604|NCT01113073|fluid responsiveness|fluid responsiveness
5543605|NCT01113073|mechanical ventilation|mechanical ventilation
5543606|NCT01113073|fluid therapy|fluid therapy
5543607|NCT01113060|Coronary Artery Disease|coronary artery disease
5543608|NCT01113060|Aspirin|aspirin
5543609|NCT01113060|Secondary Prevention|secondary prevention
5543610|NCT01113047|Hypertension|hypertension
5543611|NCT01113047|Aliskiren|aliskiren
5543612|NCT01113047|Amlodipine|amlodipine
5543613|NCT01113034|Asthma|asthma
5543614|NCT01113034|Bronchiectasis|bronchiectasis
5543615|NCT01113008|Myocardial Reperfusion Injury/mortality|myocardial reperfusion injury/mortality
5543616|NCT01113008|Coronary angioplasty|coronary angioplasty
5543617|NCT01113008|Reperfusion|reperfusion
5543618|NCT01113008|Myocardial Reperfusion Injury/prevention & control|myocardial reperfusion injury/prevention & control
5543619|NCT01112995|Probiotic|probiotic
5543620|NCT01112995|Lactobacillus|lactobacillus
5543621|NCT01112995|Antibiotic resistance|antibiotic resistance
5543622|NCT01112982|Gout|gout
5543623|NCT01112982|Synovial pannus|synovial pannus
5543624|NCT01112982|Magnetic resonance imaging|magnetic resonance imaging
5543625|NCT01112969|Internet-based supportive coaching|internet-based supportive coaching
5543626|NCT01112969|guided self-help|guided self-help
5543627|NCT01112969|Caregivers|caregivers
5543628|NCT01112969|Brain Injury|brain injury
5537823|NCT01136499|Sarcoma|sarcoma
5543629|NCT01112969|Caregiver Burden|caregiver burden
5543630|NCT01112969|Coping|coping
5543631|NCT01112969|Stress|stress
5543632|NCT01112969|Depression|depression
5543633|NCT01112956|HSV-2|hsv-2
5543634|NCT01112956|HSV-1|hsv-1
5543635|NCT01112956|Sensitivity|sensitivity
5543636|NCT01112956|Specificity|specificity
5543637|NCT01112956|Testing algorithm|testing algorithm
5543638|NCT01112956|Test evaluation|test evaluation
5543639|NCT01112943|Acupuncture, Pulmonary Rehabilitation, Inflammation, COPD|acupuncture, pulmonary rehabilitation, inflammation, copd
5543640|NCT01112930|essential fatty acids|essential fatty acids
5543642|NCT01112930|preschool children|preschool children
5543643|NCT01112930|docosahexanoic acid (DHA)|docosahexanoic acid (dha)
5543644|NCT01112904|essential fatty acids|essential fatty acids
5543645|NCT01112904|DHA status|dha status
5543646|NCT01112904|preschool children|preschool children
5543647|NCT01112904|gestation|gestation
5543648|NCT01112891|Vitamin D|vitamin d
5543649|NCT01112891|Infant|infant
5543650|NCT01112891|Lactation|lactation
5543651|NCT01112891|Dose-Response|dose-response
5543652|NCT01112878|Shoulder arthroscopy|shoulder arthroscopy
5543653|NCT01112878|Knee arthroscopy|knee arthroscopy
5543654|NCT01112878|Clonidine|clonidine
5543655|NCT01112878|Gabapentin|gabapentin
5543656|NCT01112878|Pain management|pain management
5543657|NCT01112878|Ambulatory surgery|ambulatory surgery
5543658|NCT01112878|Perioperative outcome|perioperative outcome
5543659|NCT01112878|Analgesia|analgesia
5543660|NCT01112865|Growth Hormone Deficiency|growth hormone deficiency
5543661|NCT01112865|Somatropin|somatropin
5543662|NCT01112865|Injection Pen|injection pen
5543663|NCT01112865|Medical Device|medical device
5543664|NCT01112865|Cross Over Study|cross over study
5543665|NCT01112865|Preference|preference
5543666|NCT01112865|Convenience|convenience
5543667|NCT01112865|Children|children
5543669|NCT01112865|Adults|adults
5543670|NCT01112852|control of bleed|control of bleed
5543671|NCT01112839|Overweight|overweight
5543672|NCT01112839|Obese|obese
5543673|NCT01112839|Breast cancer survivors|breast cancer survivors
5543674|NCT01112839|Weight loss|weight loss
5543675|NCT01112839|Exercise|exercise
5543676|NCT01112839|Physical activity|physical activity
5543677|NCT01112826|triple-negative breast cancer|triple-negative breast cancer
5543678|NCT01112826|metronomic chemotherapy|metronomic chemotherapy
5543679|NCT01112826|capecitabine (xeloda)|capecitabine (xeloda)
5543680|NCT01112813|Stroke|stroke
5543681|NCT01112813|lithium|lithium
5543683|NCT01112813|gray matter|gray matter
5543684|NCT01112800|Anthracycline|anthracycline
5543685|NCT01112800|Cardiac Muscle Injury|cardiac muscle injury
5543686|NCT01112800|Doxorubicin|doxorubicin
5543687|NCT01112800|Doppler Imaging|doppler imaging
5543688|NCT01112800|Intermediate non-rhabdomyosarcoma soft tissue sarcomas|intermediate non-rhabdomyosarcoma soft tissue sarcomas
5543689|NCT01112800|High-risk non-rhabdomyosarcoma soft tissue sarcomas|high-risk non-rhabdomyosarcoma soft tissue sarcomas
5543690|NCT01112787|Healthy Volunteer Subjects|healthy volunteer subjects
5543691|NCT01112774|Transcranial direct current stimulation|transcranial direct current stimulation
5543692|NCT01112774|Spinal cord injury|spinal cord injury
5543693|NCT01112774|Chronic pain|chronic pain
5543695|NCT01112761|Athletes|athletes
5543696|NCT01112761|Multiple Concussions|multiple concussions
5543697|NCT01112761|Transcranial Stimulation|transcranial stimulation
5543698|NCT01112748|Focal neuropathic pain|focal neuropathic pain
5543699|NCT01112735|Abdominoplasty|abdominoplasty
5543700|NCT01112735|Flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation|flap adherence in subjects undergoing abdominoplasty to eliminate dead space and reduce seroma/hematoma formation
5543701|NCT01112722|honeybee toxin|honeybee toxin
5543702|NCT01112722|Apitox|apitox
5543703|NCT01112722|pain|pain
5543704|NCT01112722|inflammation|inflammation
5543705|NCT01112722|osteoarthritis|osteoarthritis
5543706|NCT01112722|Apitoxin|apitoxin
5543707|NCT01112709|Diabetes|diabetes
5543708|NCT01112709|Prediabetes|prediabetes
5543709|NCT01112709|Resistance training|resistance training
5543710|NCT01112709|behavior|behavior
5543711|NCT01112709|behavioral change theory|behavioral change theory
5543712|NCT01112696|diabetes|diabetes
5543713|NCT01112696|glucose sensor|glucose sensor
5543714|NCT01112696|CGM|cgm
5543715|NCT01112683|Down syndrome|down syndrome
5543716|NCT01112683|Trisomy 21|trisomy 21
5543717|NCT01112683|Pattern Recognition Memory (PRM)|pattern recognition memory (prm)
5543718|NCT01112683|Paired Associates Learning (PAL)|paired associates learning (pal)
5543719|NCT01112683|California Verbal Learning Test (CVLT)|california verbal learning test (cvlt)
5543720|NCT01112683|Test of Reception of Grammar (TROG-II)|test of reception of grammar (trog-ii)
5543721|NCT01112683|Peabody Picture Vocabulary Test (PPVT-III)|peabody picture vocabulary test (ppvt-iii)
5543722|NCT01112683|Scales of Independent Behavior revised (SIB-R)|scales of independent behavior revised (sib-r)
5543723|NCT01112670|Healthy volunteers|healthy volunteers
5543724|NCT01112657|Multiple Sclerosis|multiple sclerosis
5543725|NCT01112657|Clinical isolated syndrome|clinical isolated syndrome
5543726|NCT01112657|Demyelination|demyelination
5543728|NCT01112631|PORT,|port,
5543729|NCT01112631|Quality of Life,|quality of life,
5543730|NCT01112631|Pulmonary function after RT|pulmonary function after rt
5543731|NCT01112618|Infertility|infertility
5543732|NCT01112618|Reproductive technologies, Assisted|reproductive technologies, assisted
5543733|NCT01112618|r-hFSH|r-hfsh
5543734|NCT01112618|r-hLH|r-hlh
5543735|NCT01112618|Pergoveris|pergoveris
5543736|NCT01112605|achilles tendon|achilles tendon
5543737|NCT01112605|sural nerve|sural nerve
5543738|NCT01112605|distance|distance
5543739|NCT01112605|US|us
5543740|NCT01112605|ultrasound|ultrasound
5543741|NCT01112605|Distance between Sural nerve and the Achilles tendon|distance between sural nerve and the achilles tendon
5543742|NCT01112592|NETs|nets
5543743|NCT01112592|Infections|infections
5543744|NCT01112592|Neutrophil function|neutrophil function
5543745|NCT01112553|Acute Migraine|acute migraine
5543746|NCT01112553|Treximet|treximet
5543747|NCT01112553|Imaging|imaging
5543749|NCT01112553|Pain|pain
5543750|NCT01112553|Heat Stimulus|heat stimulus
5543751|NCT01112540|to evaluate the anal. efficacy of IV morph. vs. place. for elderly presenting to the ED with UAP and determine if it has an impact on diag. accu. and phy. exam|to evaluate the anal. efficacy of iv morph. vs. place. for elderly presenting to the ed with uap and determine if it has an impact on diag. accu. and phy. exam
5543756|NCT01112501|Dementia|dementia
5543757|NCT01112501|Imaging|imaging
5543758|NCT01112488|stroke|stroke
5543759|NCT01112488|patient engagement programme|patient engagement programme
5543760|NCT01112488|community rehabilitation|community rehabilitation
5543761|NCT01112488|new carer|new carer
5543762|NCT01112462|Nasal congestion, Headache|nasal congestion, headache
5543763|NCT01112449|selenium|selenium
5543764|NCT01112449|oxidative stress|oxidative stress
5543765|NCT01112449|prostate cancer|prostate cancer
5543766|NCT01112449|PSA|psa
5543767|NCT01112449|glucose|glucose
5543768|NCT01112436|Pain|pain
5543769|NCT01112436|preemptive|preemptive
5543770|NCT01112436|Postoperative|postoperative
5543771|NCT01112436|delirium|delirium
5543772|NCT01112410|Bronchiectasis|bronchiectasis
5543773|NCT01112410|Hypertonic saline|hypertonic saline
5543774|NCT01112397|Jak2|jak2
5543775|NCT01112397|cancer|cancer
5543776|NCT01112397|jak 1|jak 1
5543777|NCT01112397|stat 3|stat 3
5543778|NCT01112397|Phase 1|phase 1
5543779|NCT01112371|scars after abdominal Caesarean section|scars after abdominal caesarean section
5543780|NCT01112358|Lutropin alfa|lutropin alfa
5543781|NCT01112358|Fertilization in vitro|fertilization in vitro
5543782|NCT01112358|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5543783|NCT01112358|Reproductive techniques, assisted|reproductive techniques, assisted
5543784|NCT01112345|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5543785|NCT01112345|Interferon-beta|interferon-beta
5543786|NCT01112319|COLD HOT or Electrotherapy treatment|cold hot or electrotherapy treatment
5543790|NCT01112293|Subjects who have pleural malignant mesothelioma|subjects who have pleural malignant mesothelioma
5543791|NCT01112280|Colorectal neoplasm|colorectal neoplasm
5543792|NCT01112280|Colonoscopy|colonoscopy
5543793|NCT01112280|chromoendoscopy|chromoendoscopy
5543794|NCT01112280|cap-assisted colonoscopy|cap-assisted colonoscopy
5543795|NCT01112267|Chronic low back pain|chronic low back pain
5543796|NCT01112267|Tramadol Hydrochloride (HCl)|tramadol hydrochloride (hcl)
5543797|NCT01112267|acetaminophen|acetaminophen
5543798|NCT01112254|Ductal Carcinoma In Situ (DCIS) breast cancer|ductal carcinoma in situ (dcis) breast cancer
5543799|NCT01112241|Obliterative bronchiolitis|obliterative bronchiolitis
5543800|NCT01112241|Bronchodilator responsiveness|bronchodilator responsiveness
5543801|NCT01112241|Partial forced expiratory flow|partial forced expiratory flow
5543802|NCT01112241|Lung volumes|lung volumes
5543804|NCT01112215|non-renal manifestations|non-renal manifestations
5543805|NCT01112202|direct thrombin inhibitors|direct thrombin inhibitors
5543806|NCT01112202|Dabigatran|dabigatran
5543807|NCT01112202|Coagulation parameters|coagulation parameters
5543808|NCT01112189|Lymphedema|lymphedema
5543809|NCT01112189|Stem cells|stem cells
5543810|NCT01112189|Mastectomy|mastectomy
5543811|NCT01112189|Breast Cancer|breast cancer
5543812|NCT01112176|Strain|strain
5543813|NCT01112176|Ejection fraction|ejection fraction
5543814|NCT01112176|Diastolic function|diastolic function
5543815|NCT01112163|ischemic heart disease|ischemic heart disease
5543816|NCT01112150|Edema|edema
5543817|NCT01112150|Heart failure|heart failure
5543818|NCT01112150|Pulmonary hypertension|pulmonary hypertension
5543819|NCT01112150|Edema in legs|edema in legs
5543820|NCT01112124|Typical|typical
5543821|NCT01112124|Development|development
5543822|NCT01112124|Microwave|microwave
5543823|NCT01112124|Children|children
5543824|NCT01112124|Behavior|behavior
5543825|NCT01112085|Diabetic macular edema|diabetic macular edema
5543826|NCT01112085|Ranibizumab|ranibizumab
5543827|NCT01112072|keratoconus|keratoconus
5543828|NCT01112072|corneal ectasia|corneal ectasia
5543829|NCT01112072|collagen crosslinking|collagen crosslinking
5543830|NCT01112072|riboflavin|riboflavin
5543831|NCT01112072|cornea|cornea
5543832|NCT01112072|ultraviolet|ultraviolet
5543839|NCT01112033|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5543840|NCT01112033|PBMC|pbmc
5543841|NCT01112033|liver|liver
5543842|NCT01112033|genetic polymorphisms|genetic polymorphisms
5543843|NCT01112020|Chlorhexidine digluconate (CHG)|chlorhexidine digluconate (chg)
5543844|NCT01112020|Biopatch Protective Disk|biopatch protective disk
5526359|NCT01182766|nicotine|nicotine
5543845|NCT01112020|Tegaderm CHG IV (intravenous) Securement Dressing|tegaderm chg iv (intravenous) securement dressing
5543846|NCT01112020|parachloroaniline (PCA)|parachloroaniline (pca)
5543847|NCT01112020|No condition being studied.|no condition being studied.
5543848|NCT01112020|Assessing components of CHG-containing dressings after use.|assessing components of chg-containing dressings after use.
5543849|NCT01112007|Insulin Resistance|insulin resistance
5543850|NCT01112007|Hypertension|hypertension
5543851|NCT01112007|Blood pressure|blood pressure
5543852|NCT01112007|Aldosterone|aldosterone
5543853|NCT01112007|Renin|renin
5543854|NCT01111994|hyperpigmentation|hyperpigmentation
5543855|NCT01111981|alopecia|alopecia
5543856|NCT01111981|CCCA - Central Centrifugal Cicatricial Alopecia|ccca - central centrifugal cicatricial alopecia
5543857|NCT01111968|vaccine|vaccine
5543858|NCT01111968|pandemic influenza A|pandemic influenza a
5543859|NCT01111968|adjuvant|adjuvant
5543860|NCT01111968|safety|safety
5543861|NCT01111942|head and neck cancer|head and neck cancer
5543862|NCT01111942|chemotherapy|chemotherapy
5543863|NCT01111942|radiation|radiation
5543864|NCT01111929|Emergency contraception|emergency contraception
5543865|NCT01111929|pregnancy during breastfeeding|pregnancy during breastfeeding
5543866|NCT01111929|Lactational amenorrhea Method|lactational amenorrhea method
5543867|NCT01111929|unplanned pregnancy|unplanned pregnancy
5543868|NCT01111877|ear tubes|ear tubes
5543869|NCT01111877|ear drainage|ear drainage
5543870|NCT01111877|ear infection|ear infection
5543871|NCT01111877|ear drops|ear drops
5543872|NCT01111877|tympanostomy tubes|tympanostomy tubes
5543873|NCT01111877|Pediatric patients|pediatric patients
5543874|NCT01111851|NK1-receptor occupancy|nk1-receptor occupancy
5543875|NCT01111838|STA-9090|sta-9090
5543877|NCT01111838|rectal|rectal
5543878|NCT01111838|10-029|10-029
5543879|NCT01111825|HKI-272 (NERATINIB)|hki-272 (neratinib)
5543880|NCT01111825|TEMSIROLIMUS (CCI-779)|temsirolimus (cci-779)
5543881|NCT01111825|HER2-Amplified|her2-amplified
5543882|NCT01111825|Triple-negative|triple-negative
5543883|NCT01111825|invasive adenocarcinoma|invasive adenocarcinoma
5543884|NCT01111825|10-005|10-005
5543885|NCT01111825|Nerlynx|nerlynx
5543886|NCT01111825|PB-272|pb-272
5543887|NCT01111812|overweight|overweight
5543888|NCT01111812|obese|obese
5543889|NCT01111812|children|children
5543890|NCT01111812|weighing|weighing
5543891|NCT01111812|weight|weight
5543892|NCT01111799|endometrial biopsy|endometrial biopsy
5543893|NCT01111799|implantation|implantation
5543894|NCT01111799|uterine receptivity|uterine receptivity
5543895|NCT01111799|infertility|infertility
5543896|NCT01111799|controled ovarian hyperstimulation|controled ovarian hyperstimulation
5543897|NCT01111799|intra uterine insemination|intra uterine insemination
5543898|NCT01111786|scleroderma|scleroderma
5673858|NCT00606502|Tarceva|tarceva
5543899|NCT01111786|skin|skin
5543900|NCT01111786|tightness|tightness
5543901|NCT01111786|durometer|durometer
5543902|NCT01111773|Patellar tendonitis|patellar tendonitis
5543903|NCT01111760|cardiovascular disease|cardiovascular disease
5543904|NCT01111760|heart CT scan|heart ct scan
5543906|NCT01111760|pulmonary embolisms|pulmonary embolisms
5543907|NCT01111760|aortography|aortography
5543908|NCT01111747|platelet-rich plasma|platelet-rich plasma
5543909|NCT01111747|patellar ligament|patellar ligament
5543910|NCT01111747|regeneration|regeneration
5543911|NCT01111747|growth substances|growth substances
5543912|NCT01111734|self harm|self harm
5543913|NCT01111734|self injury|self injury
5543914|NCT01111734|self mutilation|self mutilation
5543915|NCT01111734|N-Acetylcysteine|n-acetylcysteine
5543916|NCT01111734|adolescents|adolescents
5543917|NCT01111734|impulse control disorder|impulse control disorder
5543918|NCT01111734|borderline personality disorder|borderline personality disorder
5543919|NCT01111734|fMRI|fmri
5543920|NCT01111721|Sexually Transmitted Diseases|sexually transmitted diseases
5543921|NCT01111721|HIV Infections|hiv infections
5543922|NCT01111721|Genital Diseases, Female|genital diseases, female
5543923|NCT01111721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5543924|NCT01111721|Risk Reduction Behavior|risk reduction behavior
5543925|NCT01111721|HIV prevention|hiv prevention
5543926|NCT01111695|wound healing|wound healing
5543927|NCT01111695|granulation tissue|granulation tissue
5543928|NCT01111695|Varicose Ulcer|varicose ulcer
5543930|NCT01111682|hypertonic saline therapy|hypertonic saline therapy
5543931|NCT01111682|intracranial pressure|intracranial pressure
5543932|NCT01111669|Functional Endoscopic Sinus Surgery|functional endoscopic sinus surgery
5543933|NCT01111669|Tranexamic Acid|tranexamic acid
5543934|NCT01111656|Multi-center|multi-center
5543935|NCT01111656|randomized|randomized
5543936|NCT01111656|prospective|prospective
5543937|NCT01111656|parallel-group|parallel-group
5543938|NCT01111656|rater-blinded|rater-blinded
5543939|NCT01111656|RR-MS|rr-ms
5543940|NCT01111630|chronic renal failure|chronic renal failure
5543941|NCT01111630|Anaemia|anaemia
5543942|NCT01111604|Colonic Neoplasms|colonic neoplasms
5543943|NCT01111604|Rectal Neoplasms|rectal neoplasms
5543944|NCT01111604|Adenocarcinoma|adenocarcinoma
5543945|NCT01111604|Antibodies, Monoclonal|antibodies, monoclonal
5790019|NCT00146107|aging|aging
5543946|NCT01111591|Cyclooxygenase-2 inhibitor (Celecoxib)|cyclooxygenase-2 inhibitor (celecoxib)
5545015|NCT01106963|pain|pain
5543947|NCT01111591|Extrahepatic bile duct cancer|extrahepatic bile duct cancer
5543948|NCT01111591|Pancreas cancer|pancreas cancer
5543949|NCT01111565|Major Depressive Disorder|major depressive disorder
5543950|NCT01111565|MDD|mdd
5543951|NCT01111565|Depression|depression
5543952|NCT01111552|Major Depressive Disorder|major depressive disorder
5543953|NCT01111552|MDD|mdd
5543954|NCT01111552|Depression|depression
5543955|NCT01111539|Major Depressive Disorder|major depressive disorder
5543956|NCT01111539|MDD|mdd
5543957|NCT01111539|Depression|depression
5543958|NCT01111526|Graft versus host disease|graft versus host disease
5543959|NCT01111526|GVHD|gvhd
5543960|NCT01111526|allogeneic transplant|allogeneic transplant
5543961|NCT01111526|acute GVHD|acute gvhd
5543962|NCT01111526|chronic GVHD|chronic gvhd
5543963|NCT01111513|knee surgery|knee surgery
5543964|NCT01111513|total knee arthroplasty|total knee arthroplasty
5543965|NCT01111513|total knee replacement|total knee replacement
5543966|NCT01111513|ropivacaine|ropivacaine
5543967|NCT01111513|femoral nerve block|femoral nerve block
5543968|NCT01111487|COPD|copd
5543969|NCT01111487|Electromyography|electromyography
5543970|NCT01111487|Inspiratory muscles|inspiratory muscles
5543971|NCT01111474|dentin hypersensitivity|dentin hypersensitivity
5543972|NCT01111474|cyanoacrylate|cyanoacrylate
5543973|NCT01111474|laser|laser
5543974|NCT01111461|Advanced Endometrial Cancer|advanced endometrial cancer
5543975|NCT01111448|Myelodysplastic Syndromes of all IPSS subgroups|myelodysplastic syndromes of all ipss subgroups
5543976|NCT01111422|Antioxidant|antioxidant
5543977|NCT01111422|Epithelial to Mesenchymal Transition|epithelial to mesenchymal transition
5543978|NCT01111422|peritoneal fibrosis|peritoneal fibrosis
5543979|NCT01111422|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
5543980|NCT01111396|ALL|all
5543981|NCT01111396|GMALL 2003|gmall 2003
5543982|NCT01111396|Chemotherapy|chemotherapy
5543983|NCT01111396|Hippocampus|hippocampus
5543984|NCT01111383|cystic fibrosis|cystic fibrosis
5543985|NCT01111383|P. aeruginosa|p. aeruginosa
5543986|NCT01111383|tobramycin|tobramycin
5543987|NCT01111370|diabetes mellitus requiring insulin|diabetes mellitus requiring insulin
5543988|NCT01111357|Rheumatoid Arthritis|rheumatoid arthritis
5543989|NCT01111357|Rheumatoid Arthritis according to ACR criteria of diagnosis|rheumatoid arthritis according to acr criteria of diagnosis
5543990|NCT01111344|Dietary supplement|dietary supplement
5543991|NCT01111344|Anogenital warts|anogenital warts
5543992|NCT01111344|Viusid|viusid
5543993|NCT01111344|Glizigen|glizigen
5543994|NCT01111305|Filariasis|filariasis
5543996|NCT01111305|Monoclonal Antibody|monoclonal antibody
5543997|NCT01111305|Loa Loa|loa loa
5543998|NCT01111305|Loiasis|loiasis
5543999|NCT01111266|in vivo KUF|in vivo kuf
5544000|NCT01111266|ß2M|ß2m
5544001|NCT01111266|leptin|leptin
5544002|NCT01111253|multicenter randomized, open label, clinical trial|multicenter randomized, open label, clinical trial
5544003|NCT01111253|acute uncomplicated (mild) diverticulitis|acute uncomplicated (mild) diverticulitis
5544004|NCT01111253|treatment strategies|treatment strategies
5544005|NCT01111253|management of diverticulitis|management of diverticulitis
5544006|NCT01111253|antibiotics|antibiotics
5544007|NCT01111253|observation and supportive care|observation and supportive care
5544008|NCT01111253|cost analysis|cost analysis
5544009|NCT01111253|economic evaluation|economic evaluation
5544011|NCT01111240|Long-term safety and effectiveness|long-term safety and effectiveness
5544012|NCT01111240|Psoriatic Arthritis|psoriatic arthritis
5544013|NCT01111227|cytokines|cytokines
5544014|NCT01111227|propofol|propofol
5544015|NCT01111227|isoflurane|isoflurane
5544016|NCT01111227|flow cytometry|flow cytometry
5544017|NCT01111227|Types of General Anesthesia|types of general anesthesia
5544018|NCT01111214|Invasive Pneumococcal Disease (IPD)|invasive pneumococcal disease (ipd)
5544019|NCT01111214|pneumococcal serotypes|pneumococcal serotypes
5544020|NCT01111201|Autologous Bone Marrow Transplant|autologous bone marrow transplant
5544021|NCT01111201|Breast|breast
5544022|NCT01111201|Lymphoma|lymphoma
5544023|NCT01111201|International travel|international travel
5544024|NCT01111201|questionnaire|questionnaire
5544025|NCT01111201|Hematopoietic Stem Cell Transplant (HSCT) recipients|hematopoietic stem cell transplant (hsct) recipients
5544026|NCT01111175|Locally recurrent breast cancer|locally recurrent breast cancer
5544028|NCT01111162|H1N1 vaccination|h1n1 vaccination
5544029|NCT01111162|HIV infected individuals|hiv infected individuals
5544030|NCT01111149|Schizophrenia|schizophrenia
5544031|NCT01111149|Smoking cessation|smoking cessation
5544032|NCT01111149|Varenicline|varenicline
5544033|NCT01111149|Bupropion|bupropion
5544034|NCT01111136|Urticaria|urticaria
5544035|NCT01111136|Hives|hives
5544036|NCT01111136|Stress|stress
5544037|NCT01111123|plaque psoriasis|plaque psoriasis
5544038|NCT01111123|lac-hydrin|lac-hydrin
5544039|NCT01111123|ammonium lactate|ammonium lactate
5544040|NCT01111123|Ultravate|ultravate
5544041|NCT01111123|halobetasol propionate|halobetasol propionate
5544042|NCT01111123|weekend only application|weekend only application
5544043|NCT01111123|topical therapy|topical therapy
5547549|NCT01096706|Urocortin 3|urocortin 3
5544044|NCT01111123|topical corticosteroid|topical corticosteroid
5544045|NCT01111123|class I steroid|class i steroid
5544046|NCT01111097|Brain tumors, Glioblastoma and DCA|brain tumors, glioblastoma and dca
5544047|NCT01111097|Brain tumor,Glioblastoma recurrent|brain tumor,glioblastoma recurrent
5544048|NCT01111084|Ovulation induction|ovulation induction
5544049|NCT01111084|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5544050|NCT01111084|Pregnancy|pregnancy
5544051|NCT01111084|Fertility|fertility
5544052|NCT01111071|hospital variation|hospital variation
5544053|NCT01111071|30 day mortality|30 day mortality
5544054|NCT01111071|in hospital mortality|in hospital mortality
5544055|NCT01111071|acute coronary syndrome|acute coronary syndrome
5544056|NCT01111071|myocardial infarction|myocardial infarction
5544057|NCT01111071|unstable angina|unstable angina
5544058|NCT01111071|hospital performance|hospital performance
5544059|NCT01111071|trends|trends
5544060|NCT01111058|Squamous Cell Cancer|squamous cell cancer
5544061|NCT01111032|Treadmill|treadmill
5544062|NCT01111032|Exercise|exercise
5544063|NCT01111032|Cancer|cancer
5544064|NCT01111032|Validity|validity
5544065|NCT01111032|Reliability|reliability
5544066|NCT01111019|Hypochondroplasia|hypochondroplasia
5544067|NCT01111019|Skeletal dysplasia|skeletal dysplasia
5544068|NCT01111019|Growth|growth
5544069|NCT01111019|Growth Hormone|growth hormone
5544070|NCT01111019|Recombinant-human Growth Hormone|recombinant-human growth hormone
5544071|NCT01111006|Electronic toilet|electronic toilet
5544072|NCT01111006|Bidet|bidet
5544073|NCT01111006|Anorectal resting pressure|anorectal resting pressure
5544074|NCT01110993|Multiple Sclerosis, Interferon-beta 1-a|multiple sclerosis, interferon-beta 1-a
5544075|NCT01110980|Head and Neck neoplasms|head and neck neoplasms
5544076|NCT01110980|Radiotherapy|radiotherapy
5544077|NCT01110980|Diet counselling|diet counselling
5544078|NCT01110980|Swallow therapy|swallow therapy
5544079|NCT01110980|Food intake|food intake
5544080|NCT01110941|S-1|s-1
5544081|NCT01110941|leucovorin|leucovorin
5544082|NCT01110941|oxaliplatin|oxaliplatin
5544083|NCT01110941|colorectal cancer|colorectal cancer
5544084|NCT01110941|SOL|sol
5544085|NCT01110941|unresectable or recurrent colorectal cancer|unresectable or recurrent colorectal cancer
5544086|NCT01110902|Agomelatine|agomelatine
5544087|NCT01110902|Major Depressive Disorder|major depressive disorder
5544088|NCT01110902|MDD|mdd
5544089|NCT01110902|depression|depression
5544090|NCT01110889|Agomelatine|agomelatine
5544092|NCT01110889|MDD|mdd
5544093|NCT01110889|depression|depression
5544094|NCT01110876|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5544095|NCT01110876|GBM|gbm
5544096|NCT01110876|Brain|brain
5544097|NCT01110876|Central Nervous Center|central nervous center
5544098|NCT01110876|Malignant glioma|malignant glioma
5544099|NCT01110876|Glioblastoma multiforme|glioblastoma multiforme
5544100|NCT01110876|Gliosarcoma|gliosarcoma
5544101|NCT01110876|Anaplastic astrocytoma|anaplastic astrocytoma
5544102|NCT01110876|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5544103|NCT01110876|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5544104|NCT01110876|Vorinostat|vorinostat
5544105|NCT01110876|SAHA|saha
5544106|NCT01110876|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5544107|NCT01110876|MSK-390|msk-390
5544108|NCT01110876|Zolinza|zolinza
5544109|NCT01110876|Erlotinib|erlotinib
5544110|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride
5544111|NCT01110876|OSI-774|osi-774
5544112|NCT01110876|Tarceva|tarceva
5544113|NCT01110876|Temozolomide|temozolomide
5544114|NCT01110876|Temodar|temodar
5544115|NCT01110863|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5544116|NCT01110850|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5544117|NCT01110837|Allergic rhinitis|allergic rhinitis
5544118|NCT01110837|Allergen|allergen
5544119|NCT01110824|Prevention|prevention
5544120|NCT01110824|ventricular dysfunction|ventricular dysfunction
5544121|NCT01110824|chemotherapy|chemotherapy
5544122|NCT01110824|acute myeloid leukemia|acute myeloid leukemia
5538312|NCT01134172|QOL|qol
5544123|NCT01110824|precursor-cell lymphoblastic leukemia|precursor-cell lymphoblastic leukemia
5544124|NCT01110824|multiple myeloma|multiple myeloma
5544126|NCT01110824|ejection fraction|ejection fraction
5544127|NCT01110824|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5544128|NCT01110811|GERD|gerd
5544129|NCT01110811|Esophagitis|esophagitis
5544130|NCT01110811|Fundoplication|fundoplication
5544131|NCT01110811|Anti-reflux surgery|anti-reflux surgery
5544132|NCT01110811|PPI dependent|ppi dependent
5544133|NCT01110798|perioperative/postoperative complications|perioperative/postoperative complications
5544134|NCT01110798|gastrointestinal complications|gastrointestinal complications
5544135|NCT01110798|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5544136|NCT01110798|stage I rectal cancer|stage i rectal cancer
5544137|NCT01110798|stage II rectal cancer|stage ii rectal cancer
5544138|NCT01110798|stage III rectal cancer|stage iii rectal cancer
5544139|NCT01110785|recurrent colon cancer|recurrent colon cancer
5526679|NCT01181466|homogeneous|homogeneous
5544140|NCT01110785|stage III colon cancer|stage iii colon cancer
5544141|NCT01110785|stage IV colon cancer|stage iv colon cancer
5544142|NCT01110785|recurrent rectal cancer|recurrent rectal cancer
5544143|NCT01110785|stage III rectal cancer|stage iii rectal cancer
5544144|NCT01110785|stage IV rectal cancer|stage iv rectal cancer
5544145|NCT01110772|Surgical site infection|surgical site infection
5544146|NCT01110772|Skin preparation|skin preparation
5544147|NCT01110772|Cost analysis|cost analysis
5544148|NCT01110759|pain management|pain management
5544149|NCT01110759|ambulatory surgery|ambulatory surgery
5544150|NCT01110759|opioid|opioid
5544151|NCT01110759|local anesthesia|local anesthesia
5544152|NCT01110759|hand surgery|hand surgery
5544153|NCT01110759|postoperative pain|postoperative pain
5544154|NCT01110733|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5544155|NCT01110733|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5544156|NCT01110733|Lymphoma|lymphoma
5544157|NCT01110707|Reproductive technology, Assisted|reproductive technology, assisted
5544158|NCT01110707|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5544159|NCT01110707|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5544160|NCT01110707|Ovulation induction|ovulation induction
5544161|NCT01110707|Infertility|infertility
5544162|NCT01110694|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5544163|NCT01110694|Interstitial lung disease|interstitial lung disease
5544164|NCT01110694|Prognosis|prognosis
5544165|NCT01110694|Biomarkers|biomarkers
5544166|NCT01110694|Mortality|mortality
5544167|NCT01110694|Acute exacerbations|acute exacerbations
5544168|NCT01110668|Unresectable|unresectable
5544169|NCT01110668|metastatic gastrointestinal stromal tumor|metastatic gastrointestinal stromal tumor
5544170|NCT01110668|disease progression|disease progression
5544171|NCT01110668|progression-free survival|progression-free survival
5544172|NCT01110655|Exercise-associated hyponatremia|exercise-associated hyponatremia
5544173|NCT01110655|Randomized treatment trial|randomized treatment trial
5544174|NCT01110655|Endurance runners|endurance runners
5544175|NCT01110629|Chronic kidney disease not on dialysis|chronic kidney disease not on dialysis
5544176|NCT01110629|Lanthanum carbonate|lanthanum carbonate
5544177|NCT01110616|EEG Standardization|eeg standardization
5544179|NCT01110603|Advanced Solid Tumors|advanced solid tumors
5544180|NCT01110590|Erectile Dysfunction|erectile dysfunction
5544181|NCT01110577|MRI|mri
5544182|NCT01110577|Hepatic Steatosis Study|hepatic steatosis study
5544183|NCT01110564|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5544184|NCT01110564|daily symptom variability|daily symptom variability
5544185|NCT01110564|effects of symptom on morning activities|effects of symptom on morning activities
5544186|NCT01110551|Dengue, vaccine, flavivirus|dengue, vaccine, flavivirus
5544187|NCT01110525|Phase I|phase i
5544188|NCT01110525|Drug-drug interaction|drug-drug interaction
5544189|NCT01110525|Oral contraceptives|oral contraceptives
5544190|NCT01110525|AZD 1981|azd 1981
5544191|NCT01110512|Improvement of CVI parameters|improvement of cvi parameters
5544192|NCT01110447|Hepatic Encephalopathy, probiotics|hepatic encephalopathy, probiotics
5544193|NCT01110421|Doripenem|doripenem
5544194|NCT01110421|Child, Hospitalized|child, hospitalized
5544195|NCT01110421|Cefepime|cefepime
5544196|NCT01110421|Infusions, Intravenous|infusions, intravenous
5544197|NCT01110421|Severe community acquired pneumonia|severe community acquired pneumonia
5544198|NCT01110421|Nosocomial pneumonia|nosocomial pneumonia
5544199|NCT01110421|Ventilator associated pneumonia|ventilator associated pneumonia
5544200|NCT01110408|Antibiotic|antibiotic
5544201|NCT01110408|Child, Hospitalized|child, hospitalized
5544202|NCT01110408|Complicated Urinary Tract Infection|complicated urinary tract infection
5544203|NCT01110408|Pyelonephritis|pyelonephritis
5544204|NCT01110408|Doripenem|doripenem
5544205|NCT01110408|Cefepime|cefepime
5544206|NCT01110382|Anti-Infective Agents|anti-infective agents
5544207|NCT01110382|Doripenem|doripenem
5544208|NCT01110382|Meropenem|meropenem
5544209|NCT01110382|Child, Hospitalized|child, hospitalized
5544210|NCT01110382|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5544211|NCT01110369|sarcopenia|sarcopenia
5544212|NCT01110369|frail elderly|frail elderly
5544221|NCT01110343|parent depression|parent depression
5544222|NCT01110330|Tinea Pedis|tinea pedis
5544223|NCT01110330|Ketoconazole (NIZORAL)|ketoconazole (nizoral)
5544224|NCT01110330|Antifungal Agents|antifungal agents
5544225|NCT01110330|Miconazole (DAKTARIN)|miconazole (daktarin)
5544226|NCT01110317|Paliperidone palmitate|paliperidone palmitate
5544227|NCT01110317|R092670PSY1001|r092670psy1001
5544228|NCT01110317|Pharmacokinetics|pharmacokinetics
5544229|NCT01110317|Risperdal (CONSTA)|risperdal (consta)
5544230|NCT01110317|Risperidone, Paliperidone|risperidone, paliperidone
5544231|NCT01110304|acromio-clavicular joint dislocation|acromio-clavicular joint dislocation
5544232|NCT01110304|type III acromio-clavicular joint dislocation|type iii acromio-clavicular joint dislocation
5544233|NCT01110304|joint dislocation|joint dislocation
5544234|NCT01110304|clavicle hook plate|clavicle hook plate
5544235|NCT01110291|docetaxel toxicity|docetaxel toxicity
5544236|NCT01110291|CYP3A activity|cyp3a activity
5544237|NCT01110291|CYP3A5|cyp3a5
5544238|NCT01110291|MDR1|mdr1
5544239|NCT01110291|peroral midazolam|peroral midazolam
5544240|NCT01110278|Urge Urinary Incontinence|urge urinary incontinence
5544241|NCT01110278|Magnetic Resonance Imaging|magnetic resonance imaging
5544242|NCT01110278|Diffusion Tensor Imaging|diffusion tensor imaging
5544243|NCT01110278|Brain Connectivity|brain connectivity
5544244|NCT01110278|Bladder Control|bladder control
5544245|NCT01110278|fMRI|fmri
5544246|NCT01110252|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5544247|NCT01110252|Emphysema|emphysema
5544248|NCT01110252|Cell therapy|cell therapy
5544249|NCT01110252|Bone marrow mononuclear cells|bone marrow mononuclear cells
5544250|NCT01110252|stem cells|stem cells
5544251|NCT01110239|limb preconditioning|limb preconditioning
5544252|NCT01110239|remote preconditioning|remote preconditioning
5544253|NCT01110239|ischemic preconditioning|ischemic preconditioning
5544254|NCT01110226|non small cell lung cancer|non small cell lung cancer
5544255|NCT01110226|small cell lung cancer|small cell lung cancer
5544256|NCT01110226|Platinum Responsive|platinum responsive
5544257|NCT01110226|solid tumor malignancies|solid tumor malignancies
5544258|NCT01110213|Aging|aging
5544259|NCT01110213|physical activity|physical activity
5544260|NCT01110213|diet|diet
5544261|NCT01110213|goal setting|goal setting
5544262|NCT01110200|Hospitalization|hospitalization
5544263|NCT01110200|Exacerbations of COPD|exacerbations of copd
5544264|NCT01110200|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5544265|NCT01110187|Lacosamide|lacosamide
5544266|NCT01110187|Fosphenytoin|fosphenytoin
5544267|NCT01110187|traumatic brain injury|traumatic brain injury
5544268|NCT01110187|Glasgow coma scale|glasgow coma scale
5544269|NCT01110187|Disability Rating Scale|disability rating scale
5544270|NCT01110187|Resource Utilization Questionnaire|resource utilization questionnaire
5544271|NCT01110187|Continuous EEG|continuous eeg
5544272|NCT01110187|seizures|seizures
5544273|NCT01110161|Abdominal Fat|abdominal fat
5544274|NCT01110161|Visceral Fat|visceral fat
5544275|NCT01110161|Subcutaneous Fat|subcutaneous fat
5544276|NCT01110161|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5544278|NCT01110161|Computed Tomography|computed tomography
5544280|NCT01110161|Body Mass Index|body mass index
5544281|NCT01110161|Body composition|body composition
5544282|NCT01110161|Percent fat|percent fat
5544283|NCT01110161|Waist circumference|waist circumference
5544284|NCT01110161|Hip circumference|hip circumference
5544286|NCT01110148|informed consent|informed consent
5544287|NCT01110148|patient education|patient education
5544288|NCT01110148|video education|video education
5544289|NCT01110148|patients requiring skin biopsies|patients requiring skin biopsies
5544290|NCT01110122|Muscle recovery|muscle recovery
5544291|NCT01110122|Intermittent exercise|intermittent exercise
5544292|NCT01110122|Whey protein|whey protein
5544294|NCT01110109|Adult|adult
5544295|NCT01110109|Surgery|surgery
5544296|NCT01110109|Endotracheal Tube|endotracheal tube
5544297|NCT01110109|Ventilator|ventilator
5544298|NCT01110109|Pneumonia|pneumonia
5544299|NCT01110109|Suctioning|suctioning
5544300|NCT01110096|Obesity|obesity
5544301|NCT01110096|Child|child
5544302|NCT01110096|Parent|parent
5544303|NCT01110096|Family|family
5544304|NCT01110083|Phase 1|phase 1
5538493|NCT01133197|thumb|thumb
5544306|NCT01110083|refractory to standard therapy|refractory to standard therapy
5544307|NCT01110083|Patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available|patients with solid tumors, either refractory to standard therapy or for which no effective standard therapy is available
5544308|NCT01110070|articular|articular
5544309|NCT01110070|cartilage|cartilage
5544310|NCT01110070|microfracture|microfracture
5544311|NCT01110070|knee pain|knee pain
5544312|NCT01110070|cartilage repair|cartilage repair
5544313|NCT01110070|Subjects with an articular cartilage defect in the knee.|subjects with an articular cartilage defect in the knee.
5544314|NCT01110057|p38 kinase inhibitor|p38 kinase inhibitor
5544315|NCT01110057|male and female|male and female
5544316|NCT01110057|patients|patients
5544317|NCT01110044|Neonatal vaccination|neonatal vaccination
5544318|NCT01110031|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5544319|NCT01110031|Cardiac Repolarization (QTc)|cardiac repolarization (qtc)
5544320|NCT01110018|Tolerability|tolerability
5544321|NCT01110018|COPD|copd
5544322|NCT01110018|Safety|safety
5544323|NCT01110018|Muscarinic receptor (mAChR) antagonist|muscarinic receptor (machr) antagonist
5544324|NCT01110018|GSK573719|gsk573719
5544325|NCT01110018|Healthy subjects|healthy subjects
5544326|NCT01110018|Pharmacokinetics|pharmacokinetics
5544327|NCT01110018|IV study|iv study
5544328|NCT01110005|D5LR|d5lr
5544329|NCT01110005|glucose containing IV solution|glucose containing iv solution
5544331|NCT01110005|non glucose IV solution|non glucose iv solution
5544332|NCT01109992|coronary artery disease|coronary artery disease
5544333|NCT01109992|exercise|exercise
5544334|NCT01109992|regadenoson|regadenoson
5544335|NCT01109992|positron emission tomography|positron emission tomography
5544336|NCT01109979|Cardiovascular, vascular|cardiovascular, vascular
5544337|NCT01109966|Allergy|allergy
5544338|NCT01109966|Cow's Milk|cow's milk
5544339|NCT01109966|Infants|infants
5544340|NCT01109966|Food Allergy|food allergy
5544341|NCT01109953|Lung|lung
5544342|NCT01109953|PET/CT scan|pet/ct scan
5544343|NCT01109953|10-054|10-054
5544344|NCT01109940|Ankylosing spondylitis|ankylosing spondylitis
5544345|NCT01109940|IgG1K monoclonal antibody|igg1k monoclonal antibody
5544346|NCT01109940|Interleukin -17A neutralizing|interleukin -17a neutralizing
5544347|NCT01109914|Renal transplantation|renal transplantation
5544348|NCT01109914|Immunosuppression|immunosuppression
5544349|NCT01109914|ETEC|etec
5544350|NCT01109914|Dukoral|dukoral
5544351|NCT01109914|Vaccination|vaccination
5544352|NCT01109914|Immunity, Humoral|immunity, humoral
5544353|NCT01109901|Cubital tunnel,subcutaneous transposition,submuscular|cubital tunnel,subcutaneous transposition,submuscular
5544354|NCT01109862|Femoral neck fractures|femoral neck fractures
5544355|NCT01109862|Hip fractures|hip fractures
5544356|NCT01109862|Elderly|elderly
5544357|NCT01109862|Total hip arthroplasty|total hip arthroplasty
5544358|NCT01109862|Bipolar hemiarthroplasty|bipolar hemiarthroplasty
5544359|NCT01109849|ADHD|adhd
5544360|NCT01109849|growth|growth
5544361|NCT01109849|BMI|bmi
5544362|NCT01109849|stimulant medication|stimulant medication
5544363|NCT01109836|prevention|prevention
5544364|NCT01109836|cognitive decline|cognitive decline
5544365|NCT01109836|post-stroke dementia|post-stroke dementia
5544366|NCT01109836|life-style intervention|life-style intervention
5544367|NCT01109836|vascular risk factors|vascular risk factors
5544368|NCT01109836|polyintervention|polyintervention
5544369|NCT01109836|multifactorial treatment|multifactorial treatment
5544370|NCT01109823|Patients hospitalized at Intensive Care Unit treated with levofloxacin IV|patients hospitalized at intensive care unit treated with levofloxacin iv
5544371|NCT01109784|coronary angioplasty|coronary angioplasty
5544372|NCT01109784|clopidogrel resistance|clopidogrel resistance
5544373|NCT01109784|prasugrel|prasugrel
5544374|NCT01109771|Ventral hernia|ventral hernia
5544375|NCT01109758|Fenofibrate|fenofibrate
5544376|NCT01109758|Gene Expression|gene expression
5544377|NCT01109758|DNA methylation|dna methylation
5544378|NCT01109745|Asthma|asthma
5544379|NCT01109745|health-related quality of life|health-related quality of life
5544380|NCT01109745|patient-centred care|patient-centred care
5544381|NCT01109719|Protocol|protocol
5544382|NCT01109719|Critical pathway|critical pathway
5544383|NCT01109719|Intensive care units|intensive care units
5544384|NCT01109706|Acute coronary syndrome|acute coronary syndrome
5544385|NCT01109706|PCSK9|pcsk9
5544386|NCT01109706|cardiovascular safety|cardiovascular safety
5544387|NCT01109667|Thromboplastin, Prothrombin, Diagnostic Reagent Kits, International Normalized Ratio, Laboratory Tests.|thromboplastin, prothrombin, diagnostic reagent kits, international normalized ratio, laboratory tests.
5544388|NCT01109654|Fertilization in Vitro|fertilization in vitro
5544389|NCT01109654|Reproductive Techniques, Assisted|reproductive techniques, assisted
5544390|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone
5544391|NCT01109654|Cetrotide|cetrotide
5544392|NCT01109654|Gonal-f|gonal-f
5544393|NCT01109628|sarcopenia|sarcopenia
5544394|NCT01109628|frail elderly|frail elderly
5544395|NCT01109628|protein drink|protein drink
5544396|NCT01109628|skeletal muscle mass|skeletal muscle mass
5544397|NCT01109628|muscle mass in elderly|muscle mass in elderly
5544398|NCT01109615|Colorectal cancer|colorectal cancer
5544399|NCT01109615|Metastatic colorectal cancer|metastatic colorectal cancer
5544400|NCT01109615|Treatment resistant|treatment resistant
5544401|NCT01109615|Chemotherapy refractory|chemotherapy refractory
5544402|NCT01109615|KRAS mutation|kras mutation
5544404|NCT01109602|accidental falls|accidental falls
5544405|NCT01109602|Yoga|yoga
5544406|NCT01109602|Blood pressure|blood pressure
5544407|NCT01109602|Range of Motion|range of motion
5544408|NCT01109602|Rehabilitation|rehabilitation
5544409|NCT01109602|Exercise|exercise
5544410|NCT01109602|balance|balance
5544411|NCT01109602|quality of life|quality of life
5544412|NCT01109602|mobility|mobility
5544413|NCT01109589|antibiotics|antibiotics
5544414|NCT01109589|prescriptions|prescriptions
5544415|NCT01109589|pregnancy|pregnancy
5544416|NCT01109589|children|children
5544417|NCT01109576|deafness-blindness|deafness-blindness
5544418|NCT01109576|pilot study|pilot study
5544419|NCT01109576|self management education|self management education
5544420|NCT01109576|dual sensory loss|dual sensory loss
5544421|NCT01109576|rehabilitation|rehabilitation
5544422|NCT01109576|peer support groups|peer support groups
5544423|NCT01109576|age related|age related
5544424|NCT01109563|cannabis use disorder|cannabis use disorder
5544425|NCT01109563|marijuana|marijuana
5544426|NCT01109563|motivational enhancement treatment|motivational enhancement treatment
5544427|NCT01109563|cognitive behavioral treatment|cognitive behavioral treatment
5544428|NCT01109563|continuing care|continuing care
5544429|NCT01109537|Restless Legs Syndrome (RLS)|restless legs syndrome (rls)
5544430|NCT01109537|GABA|gaba
5544431|NCT01109537|Glutamate|glutamate
5544432|NCT01109537|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5544433|NCT01109498|LPLD|lpld
5544434|NCT01109498|Lipoprotein Lipase Deficiency|lipoprotein lipase deficiency
5544435|NCT01109498|Chylomicronaemia|chylomicronaemia
5544436|NCT01109498|Genetherapy|genetherapy
5544438|NCT01109498|Alipogene Tiparvovec|alipogene tiparvovec
5544439|NCT01109498|AMT-011|amt-011
5544440|NCT01109498|Lipoprotein Lipase|lipoprotein lipase
5544441|NCT01109485|Allergic conjunctivitis|allergic conjunctivitis
5544442|NCT01109459|preschool|preschool
5544443|NCT01109459|screening|screening
5544444|NCT01109459|cluster randomized|cluster randomized
5544445|NCT01109459|physician practice patterns|physician practice patterns
5544446|NCT01109459|behavior|behavior
5544447|NCT01109459|knowledge|knowledge
5544448|NCT01109459|attitudes|attitudes
5544449|NCT01109459|guideline adherence|guideline adherence
5544450|NCT01109446|Lateral Epicondylitis|lateral epicondylitis
5544451|NCT01109446|Tennis Elbow|tennis elbow
5544452|NCT01109446|Epicondylitis Lateralis|epicondylitis lateralis
5544453|NCT01109433|Behcet's Disease|behcet's disease
5544454|NCT01109433|Intermediate Uveitis|intermediate uveitis
5544455|NCT01109433|Uveitis|uveitis
5544456|NCT01109433|Immunogenetics|immunogenetics
5544457|NCT01109420|Hereditary Cancer|hereditary cancer
5544458|NCT01109420|Susceptibility Gene(s) for Thyroid Cancer|susceptibility gene(s) for thyroid cancer
5544459|NCT01109420|Screening at Risk Family Members|screening at risk family members
5544460|NCT01109420|Inherited Thyroid Cancer|inherited thyroid cancer
5544461|NCT01109420|Thyroid Cancer|thyroid cancer
5544462|NCT01109407|Plasma Cell Neoplasm|plasma cell neoplasm
5544463|NCT01109407|Natural History|natural history
5544464|NCT01109407|Translational Studies|translational studies
5544465|NCT01109407|Gene Expression Profiling|gene expression profiling
5544466|NCT01109407|Protein Markers|protein markers
5544467|NCT01109407|Smoldering Myeloma|smoldering myeloma
5544468|NCT01109407|SMM|smm
5544469|NCT01109407|Monoclonal Gammopathy of Undetermined Significance|monoclonal gammopathy of undetermined significance
5544470|NCT01109407|MGUS|mgus
5544471|NCT01109394|Genomics|genomics
5544472|NCT01109394|Proteomics|proteomics
5544473|NCT01109394|Tissue Repository|tissue repository
5544474|NCT01109394|Omics|omics
5544475|NCT01109394|Cell Lines|cell lines
5544476|NCT01109394|Pediatric Cancer|pediatric cancer
5544477|NCT01109394|Solid Tumor|solid tumor
5544479|NCT01109394|Kidney Cancer|kidney cancer
5544480|NCT01109394|Neuroblastoma|neuroblastoma
5544481|NCT01109381|bacterial infections|bacterial infections
5544482|NCT01109381|anti-infective agents|anti-infective agents
5544483|NCT01109381|gastrointestinal agents|gastrointestinal agents
5544484|NCT01109381|antibacterial agents|antibacterial agents
5544485|NCT01109381|omeprazole|omeprazole
5544486|NCT01109381|lauric acid|lauric acid
5544487|NCT01109381|n-acetylcysteine|n-acetylcysteine
5544488|NCT01109381|helicobacter infections|helicobacter infections
5544489|NCT01109381|helicobacter pylori|helicobacter pylori
5544490|NCT01109381|non-antibiotic treatment|non-antibiotic treatment
5544491|NCT01109368|Autosomal Dominant Familial Hypercholesterolemia|autosomal dominant familial hypercholesterolemia
5544492|NCT01109355|PEEP|peep
5544493|NCT01109355|Patients with hemorrhage stroke under mechanical ventilation|patients with hemorrhage stroke under mechanical ventilation
5544494|NCT01109342|HIV Prevention|hiv prevention
5544495|NCT01109342|Vaccine|vaccine
5544496|NCT01109342|Recombinant Adenovirus-5|recombinant adenovirus-5
5544497|NCT01109342|HIV Preventative Vaccine|hiv preventative vaccine
5544499|NCT01109303|ankle fracture with syndesmotic ligament rupture|ankle fracture with syndesmotic ligament rupture
5544500|NCT01109303|ankle syndesmosis rupture|ankle syndesmosis rupture
5544501|NCT01109264|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5544502|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride
5544503|NCT01109264|Chlorambucil|chlorambucil
5544504|NCT01109238|Refractory Neuroblastoma|refractory neuroblastoma
5544505|NCT01109238|Relapsed Neuroblastoma|relapsed neuroblastoma
5544506|NCT01109225|aldosterone|aldosterone
5544507|NCT01109225|myocardial infarction|myocardial infarction
5544508|NCT01109225|cardiac remodeling|cardiac remodeling
5544509|NCT01109212|Type 2-Diabetic Nephrophaty|type 2-diabetic nephrophaty
5544510|NCT01109212|bindarit|bindarit
5544511|NCT01109212|albuminuria|albuminuria
5544512|NCT01109212|MCP-1|mcp-1
5544513|NCT01109199|viscous|viscous
5544514|NCT01109199|fibre|fibre
5544515|NCT01109199|polysaccharide|polysaccharide
5544516|NCT01109199|appetite|appetite
5544517|NCT01109199|hunger|hunger
5544518|NCT01109199|satiety|satiety
5544519|NCT01109199|weight management|weight management
5544520|NCT01109186|patient with a kidney transplantation since less than 30 days|patient with a kidney transplantation since less than 30 days
5544521|NCT01109160|azithromycin|azithromycin
5544522|NCT01109160|lymphocytic bronchitis or bronchiolitis|lymphocytic bronchitis or bronchiolitis
5544523|NCT01109160|lung transplantation|lung transplantation
5544524|NCT01109160|acute allograft rejection|acute allograft rejection
5544525|NCT01109160|chronic allograft rejection|chronic allograft rejection
5544526|NCT01109160|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5544529|NCT01109147|Affect|affect
5710997|NCT00461422|IVF|ivf
5544530|NCT01109147|Emotional Blunting|emotional blunting
5544531|NCT01109134|primary angioplasty|primary angioplasty
5544532|NCT01109134|tirofiban|tirofiban
5544533|NCT01109134|microcirculation|microcirculation
5544534|NCT01109121|Moderate to severe gout|moderate to severe gout
5544535|NCT01109121|Hyperuricemia|hyperuricemia
5544536|NCT01109108|pneumococcal vaccine|pneumococcal vaccine
5544537|NCT01109108|nasopharyngeal carriage|nasopharyngeal carriage
5544538|NCT01109095|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5544539|NCT01109095|HER2|her2
5544541|NCT01109095|Brain Cancer|brain cancer
5544542|NCT01109095|Autologous HER2.CAR CMV-specific cytotoxic CTL|autologous her2.car cmv-specific cytotoxic ctl
5544543|NCT01109095|CMV-specific cytotoxic CTL|cmv-specific cytotoxic ctl
5544544|NCT01109082|Scoliosis|scoliosis
5544545|NCT01109082|gait|gait
5544546|NCT01109082|posture|posture
5544547|NCT01109082|balance|balance
5544548|NCT01109069|PCI-32765|pci-32765
5544549|NCT01109069|Lymphoma, B-Cell|lymphoma, b-cell
5544550|NCT01109069|Leukemia, Lymphoid|leukemia, lymphoid
5544551|NCT01109069|Leukemia, B-Cell|leukemia, b-cell
5544552|NCT01109069|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5544553|NCT01109043|Hypertension|hypertension
5544554|NCT01109043|Bisoprolol|bisoprolol
5544555|NCT01109043|Antihypertensive drugs|antihypertensive drugs
5544556|NCT01109043|Blood pressure|blood pressure
5544557|NCT01109043|Quality of life|quality of life
5544558|NCT01109043|Diabetes|diabetes
5544559|NCT01109043|Ketohexokinase|ketohexokinase
5544560|NCT01109030|Major depressive disorder|major depressive disorder
5544561|NCT01109030|pioglitazone|pioglitazone
5544562|NCT01109030|double blind|double blind
5544563|NCT01109030|placebo controlled|placebo controlled
5544564|NCT01109004|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
5544565|NCT01109004|Lenalidomide|lenalidomide
5544566|NCT01109004|Anti-Myeloma Agents|anti-myeloma agents
5544567|NCT01109004|Hematologic Disorders|hematologic disorders
5544568|NCT01109004|Maintenance Therapy|maintenance therapy
5544569|NCT01109004|Progression|progression
5544570|NCT01109004|Autologous Transplant|autologous transplant
5544571|NCT01109004|RVD Consolidation|rvd consolidation
5544572|NCT01108991|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5544573|NCT01108991|Randomized controlled trial|randomized controlled trial
5544574|NCT01108991|Self-management support|self-management support
5544575|NCT01108991|Physical activity|physical activity
5544576|NCT01108978|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5544577|NCT01108978|Cardiovascular Disease|cardiovascular disease
5544578|NCT01108978|hypercholesterolemia|hypercholesterolemia
5544579|NCT01108965|Hydrocephalus|hydrocephalus
5544580|NCT01108965|Shunt Dysfunction|shunt dysfunction
5544581|NCT01108965|Shunt Flow|shunt flow
5544582|NCT01108952|Chemotherapy|chemotherapy
5544583|NCT01108952|Memory|memory
5544584|NCT01108952|Methotrexate|methotrexate
5544585|NCT01108952|Glucocorticoids|glucocorticoids
5544586|NCT01108952|Trauma|trauma
5544587|NCT01108952|pediatric oncology|pediatric oncology
5544588|NCT01108952|traumatization|traumatization
5544589|NCT01108939|Malaria, Iron absorption, Iron utilization, Benin|malaria, iron absorption, iron utilization, benin
5544590|NCT01108913|COPD|copd
5544591|NCT01108900|Erectile Dysfunction udenafil sildenafil treatment satisfaction|erectile dysfunction udenafil sildenafil treatment satisfaction
5544592|NCT01108887|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5544594|NCT01108887|Rebif|rebif
5544595|NCT01108887|Interferon beta-1a|interferon beta-1a
5544596|NCT01108874|Cesarean section|cesarean section
5544597|NCT01108874|Hypotension|hypotension
5544598|NCT01108874|Metaraminol|metaraminol
5544599|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents
5544600|NCT01108874|Adult|adult
5544601|NCT01108874|Female|female
5544602|NCT01108874|Pregnancy|pregnancy
5544603|NCT01108874|Anesthesia, Obstetrical/adverse effects|anesthesia, obstetrical/adverse effects
5544604|NCT01108874|Anesthesia,Spinal|anesthesia,spinal
5544605|NCT01108874|Blood Pressure/drug effects|blood pressure/drug effects
5544606|NCT01108874|Nausea|nausea
5544607|NCT01108874|Vomiting|vomiting
5544608|NCT01108861|Peripheral Vascular Disease|peripheral vascular disease
5544609|NCT01108861|In-stent restenosis|in-stent restenosis
5544610|NCT01108861|Endoprosthesis|endoprosthesis
5544611|NCT01108861|Plain old balloon angioplasty|plain old balloon angioplasty
5544612|NCT01108848|C1-esterase Inhibitor|c1-esterase inhibitor
5544613|NCT01108848|Hereditary angioedema|hereditary angioedema
5544614|NCT01108848|Acute HAE attack|acute hae attack
5544615|NCT01108835|COPD|copd
5544616|NCT01108835|Comprehensive care|comprehensive care
5544617|NCT01108783|Rhinitis|rhinitis
5544618|NCT01108783|Allergic|allergic
5544619|NCT01108783|Seasonal|seasonal
5544620|NCT01108783|Hay Fever|hay fever
5544621|NCT01108783|Pollen Allergy|pollen allergy
5544623|NCT01108783|Rhinoconjunctivitis|rhinoconjunctivitis
5527185|NCT01179230|CAD|cad
5544625|NCT01108783|Nasal itching|nasal itching
5544626|NCT01108783|Nasal Congestion|nasal congestion
5544627|NCT01108783|Rhinorrhea|rhinorrhea
5544628|NCT01108783|Ocular itching|ocular itching
5544629|NCT01108783|Ocular redness|ocular redness
5544632|NCT01108770|XLHED|xlhed
5544633|NCT01108770|Hypohidrotic Ectodermal Dysplasia|hypohidrotic ectodermal dysplasia
5544634|NCT01108757|catheter|catheter
5544635|NCT01108757|urinary tract infection|urinary tract infection
5544636|NCT01108744|clinical trial|clinical trial
5544637|NCT01108744|mannitol|mannitol
5544638|NCT01108744|intracranial pressure (ICP)|intracranial pressure (icp)
5544639|NCT01108744|hypertonic saline|hypertonic saline
5544640|NCT01108744|cerebral edema|cerebral edema
5544641|NCT01108744|traumatic brain injury (TBI)|traumatic brain injury (tbi)
5544642|NCT01108718|Mattress|mattress
5544643|NCT01108718|Tempur-Pedic|tempur-pedic
5544644|NCT01108718|Fibromyalgia|fibromyalgia
5544645|NCT01108718|Sleep patterns|sleep patterns
5544646|NCT01108692|atrial fibrillation|atrial fibrillation
5544647|NCT01108692|supraventricular arrhythmia|supraventricular arrhythmia
5544648|NCT01108692|antithrombotic treatment|antithrombotic treatment
5544649|NCT01108692|antiarrhythmic drugs|antiarrhythmic drugs
5544650|NCT01108692|medical reaction time|medical reaction time
5544651|NCT01108692|telecardiology|telecardiology
5544652|NCT01108692|early detection|early detection
5544653|NCT01108692|holters memories|holters memories
5544654|NCT01108692|Pacemaker|pacemaker
5544655|NCT01108666|Stage IIIA or IIIB NSCLC|stage iiia or iiib nsclc
5544656|NCT01108653|Cardiovascular diseases|cardiovascular diseases
5544657|NCT01108653|Heart diseases|heart diseases
5544658|NCT01108653|Myocardial infarction|myocardial infarction
5544659|NCT01108653|Rehabilitation|rehabilitation
5544660|NCT01108653|Health Economy|health economy
5544661|NCT01108653|Randomized controlled trials|randomized controlled trials
5544662|NCT01108653|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
5544663|NCT01108653|Cost analysis|cost analysis
5544664|NCT01108653|Sick-leave|sick-leave
5544665|NCT01108653|Quality of Life|quality of life
5544666|NCT01108614|Methadone maintenance treatment|methadone maintenance treatment
5544667|NCT01108614|drug users|drug users
5544668|NCT01108614|heroin|heroin
5544670|NCT01108614|HCV|hcv
5544671|NCT01108614|Syphilis|syphilis
5544672|NCT01108614|HSV-2|hsv-2
5544673|NCT01108601|Ringer's|ringer's
5544675|NCT01108601|cisplatin|cisplatin
5544676|NCT01108601|ototoxicity|ototoxicity
5544677|NCT01108601|hearing loss|hearing loss
5544678|NCT01108575|Mechanical ventilation|mechanical ventilation
5544679|NCT01108575|mechanical ventilation weaning|mechanical ventilation weaning
5544680|NCT01108575|inspiratory muscle strength training|inspiratory muscle strength training
5544681|NCT01108575|Patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.|patients admitted to a surgical intensive care unit who are expected to receive mechanical ventilation for more than three days.
5544682|NCT01108562|postoperative pain management|postoperative pain management
5544683|NCT01108549|Fibromyalgia|fibromyalgia
5544684|NCT01108549|Chronic Fatigue Syndrome|chronic fatigue syndrome
5544685|NCT01108549|D-ribose|d-ribose
5544686|NCT01108549|fatigue|fatigue
5544687|NCT01108536|prosthetics|prosthetics
5544688|NCT01108536|socket comfort|socket comfort
5544689|NCT01108536|amputation stump|amputation stump
5544690|NCT01108536|amputee rehabilitation|amputee rehabilitation
5544691|NCT01108523|Moisture Associated Skin Damage|moisture associated skin damage
5544692|NCT01108510|Treatment Naive|treatment naive
5544693|NCT01108510|HIV 1 Infected|hiv 1 infected
5544694|NCT01108484|Cancer survivors, exercise, diet, emotional support|cancer survivors, exercise, diet, emotional support
5544695|NCT01108471|cesarean section; hemoglobin; postpartum hemorrhage;|cesarean section; hemoglobin; postpartum hemorrhage;
5544696|NCT01108445|cancer|cancer
5544697|NCT01108445|kidney cancer|kidney cancer
5544698|NCT01108445|sutent|sutent
5544699|NCT01108445|everolimus|everolimus
5544700|NCT01108445|renal cancer|renal cancer
5544701|NCT01108445|papillary renal cell|papillary renal cell
5544702|NCT01108445|chromophobe renal cell|chromophobe renal cell
5544703|NCT01108445|papillary|papillary
5544704|NCT01108445|chromophobe|chromophobe
5544705|NCT01108432|Tobacco cessation counseling|tobacco cessation counseling
5544706|NCT01108419|healthy adults|healthy adults
5544707|NCT01108406|Hearing Loss|hearing loss
5544708|NCT01108406|Unilateral Hearing Loss|unilateral hearing loss
5544709|NCT01108406|Single Sided Deafness|single sided deafness
5544710|NCT01108393|Obsessive Compulsive Disorder|obsessive compulsive disorder
5544711|NCT01108393|Agomelatine|agomelatine
5544712|NCT01108380|Liver cirrhosis|liver cirrhosis
5544713|NCT01108380|liver regeneration|liver regeneration
5544714|NCT01108380|liver volume|liver volume
5544715|NCT01108380|liver function|liver function
5544716|NCT01108380|hepatocellular carcinoma, extensive|hepatocellular carcinoma, extensive
5544717|NCT01108380|hepatectomy|hepatectomy
5544718|NCT01108328|viscous|viscous
5544720|NCT01108328|polysaccharide|polysaccharide
5544721|NCT01108328|blood glucose|blood glucose
5544726|NCT01108315|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
5544727|NCT01108315|Web-based|web-based
5544728|NCT01108315|Phone-based|phone-based
5544729|NCT01108315|Breast Cancer|breast cancer
5544730|NCT01108302|uterotonic|uterotonic
5544731|NCT01108302|oxytocin|oxytocin
5544732|NCT01108302|randomized trial|randomized trial
5544733|NCT01108302|India|india
5544734|NCT01108302|community|community
5544735|NCT01108302|hemorrhage|hemorrhage
5544736|NCT01108289|hemorrhage|hemorrhage
5544737|NCT01108289|uterotonic|uterotonic
5544738|NCT01108289|oxytocin|oxytocin
5544739|NCT01108289|blood loss|blood loss
5544740|NCT01108289|community|community
5544741|NCT01108289|Ghana|ghana
5544742|NCT01108289|randomized trial|randomized trial
5544743|NCT01108237|Arthroplasties, Knee Replacement|arthroplasties, knee replacement
5544744|NCT01108237|Arthroplasties, Replacement, Knee|arthroplasties, replacement, knee
5544745|NCT01108237|Arthroplasty, Knee Replacement|arthroplasty, knee replacement
5544746|NCT01108237|Knee Replacement Arthroplasties|knee replacement arthroplasties
5544747|NCT01108237|Knee Replacement Arthroplasty|knee replacement arthroplasty
5544748|NCT01108237|Knee Replacement, Total|knee replacement, total
5544749|NCT01108237|Replacement Arthroplasties, Knee|replacement arthroplasties, knee
5544750|NCT01108237|Replacement Arthroplasty, Knee|replacement arthroplasty, knee
5544751|NCT01108237|Replacement, Total Knee|replacement, total knee
5544752|NCT01108237|Total Knee Replacement|total knee replacement
5544753|NCT01108224|Quality of life|quality of life
5544754|NCT01108224|Coping|coping
5544755|NCT01108224|Social relations|social relations
5544756|NCT01108224|Survival|survival
5544757|NCT01108224|Psychotherapy|psychotherapy
5544758|NCT01108211|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5544759|NCT01108211|AIS|ais
5544760|NCT01108211|Vibration Therapy|vibration therapy
5544761|NCT01108211|Low bone mass|low bone mass
5544762|NCT01108211|osteopenia|osteopenia
5544763|NCT01108198|phimosis,|phimosis,
5544764|NCT01108198|non-retractable foreskin|non-retractable foreskin
5544765|NCT01108198|topical steroids|topical steroids
5544766|NCT01108198|children|children
5544767|NCT01108185|treatment with Klacid®SR|treatment with klacid®sr
5544768|NCT01108185|tracheitis|tracheitis
5544769|NCT01108185|tracheobronchitis|tracheobronchitis
5544770|NCT01108185|bronchitis|bronchitis
5544771|NCT01108185|chronic bronchitis|chronic bronchitis
5544772|NCT01108185|community-acquired pneumonia|community-acquired pneumonia
5544773|NCT01108133|Posttraumatic Stress Disorder|posttraumatic stress disorder
5544775|NCT01108133|fMRI|fmri
5544776|NCT01108120|diabetic foot ulcer|diabetic foot ulcer
5544777|NCT01108120|artery mini-pump|artery mini-pump
5544778|NCT01108120|continuous infusion of urokinase|continuous infusion of urokinase
5544779|NCT01108120|femoral artery|femoral artery
5544780|NCT01108107|Colon cancer|colon cancer
5544781|NCT01108107|Neoadjuvant treatment|neoadjuvant treatment
5544782|NCT01108107|KRAS mutation|kras mutation
5544783|NCT01108107|BRAF mutation|braf mutation
5544784|NCT01108107|PIK3CA mutation|pik3ca mutation
5544785|NCT01108107|Possibly avoid chemotherapy after operation|possibly avoid chemotherapy after operation
5544786|NCT01108081|Sleep apnea|sleep apnea
5544787|NCT01108081|Sleep symptoms|sleep symptoms
5544788|NCT01108081|Quality of Life|quality of life
5544789|NCT01108068|Osteoporosis-pseudoglioma syndrome, OPPG, LRP5 mutation|osteoporosis-pseudoglioma syndrome, oppg, lrp5 mutation
5544790|NCT01108029|Parkinson's disease|parkinson's disease
5544791|NCT01108029|Freezing of Gait|freezing of gait
5544792|NCT01108029|Memantine|memantine
5544793|NCT01108029|NMDA receptor|nmda receptor
5544794|NCT01108029|glutamate|glutamate
5544795|NCT01108029|No Dementia|no dementia
5544796|NCT01107964|Dry Eye Syndrome|dry eye syndrome
5544797|NCT01107964|Recent Diagnosis of Dry Eye Syndrome|recent diagnosis of dry eye syndrome
5544798|NCT01107951|Rituximab|rituximab
5544799|NCT01107951|Dexamethasone|dexamethasone
5544800|NCT01107951|Low-dose|low-dose
5544802|NCT01107938|GERD|gerd
5544803|NCT01107925|Platelet function|platelet function
5544804|NCT01107912|Platelet function|platelet function
5544805|NCT01107899|Acute Coronary Syndromes|acute coronary syndromes
5544806|NCT01107899|Angina|angina
5544807|NCT01107899|Platelet Function|platelet function
5544808|NCT01107899|Coronary Angiography|coronary angiography
5544809|NCT01107899|Clinical Symptoms of Angina|clinical symptoms of angina
5544810|NCT01107899|Positive Stress Test|positive stress test
5544811|NCT01107886|Risk of cardiovascular disease and death in patients with type 2 diabetes mellitus|risk of cardiovascular disease and death in patients with type 2 diabetes mellitus
5544812|NCT01107873|Twenty (ASA status I) unpremedicated children, ages 1 to 5 yr old|twenty (asa status i) unpremedicated children, ages 1 to 5 yr old
5544813|NCT01107847|electrical impedance tomography|electrical impedance tomography
5544814|NCT01107847|EIT|eit
5544815|NCT01107847|acute lung injury|acute lung injury
5544816|NCT01107847|regional lung opening pressure|regional lung opening pressure
5671976|NCT00613340|Cervical pain|cervical pain
5544817|NCT01107847|regional lung closing pressure|regional lung closing pressure
5544819|NCT01107834|heart function|heart function
5544820|NCT01107834|HAART|haart
5544821|NCT01107834|in utero|in utero
5544822|NCT01107834|children|children
5544823|NCT01107821|Pressure sores grade III and IV|pressure sores grade iii and iv
5544824|NCT01107821|Traumatic wounds with considerable soft tissue loss|traumatic wounds with considerable soft tissue loss
5544825|NCT01107821|Wounds after necrotizing fasciitis|wounds after necrotizing fasciitis
5544826|NCT01107821|Abdominal wounds|abdominal wounds
5544827|NCT01107808|Adolescents|adolescents
5544828|NCT01107808|African American|african american
5544829|NCT01107808|Female|female
5544830|NCT01107782|sildenafil|sildenafil
5544831|NCT01107782|FGR|fgr
5544832|NCT01107743|Hypertension|hypertension
5544833|NCT01107743|Angina pectoris|angina pectoris
5544834|NCT01107743|Hypercholesterolemia|hypercholesterolemia
5544835|NCT01107743|Familial hypercholesterolemia|familial hypercholesterolemia
5544836|NCT01107743|Japanese|japanese
5544837|NCT01107743|caduet|caduet
5544838|NCT01107743|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5544839|NCT01107730|Atrial fibrillation|atrial fibrillation
5544840|NCT01107730|Cardiac valve repair|cardiac valve repair
5544841|NCT01107730|Aneurysm repair|aneurysm repair
5544842|NCT01107730|CABG|cabg
5544843|NCT01107730|On-pump|on-pump
5544844|NCT01107730|Cardiac surgery|cardiac surgery
5544845|NCT01107730|Vitamin C|vitamin c
5544846|NCT01107717|type 2 diabetes|type 2 diabetes
5544847|NCT01107717|new onset|new onset
5544848|NCT01107717|combination therapy|combination therapy
5544849|NCT01107717|new onset type 2 diabetes|new onset type 2 diabetes
5544850|NCT01107704|Intensive Care Units|intensive care units
5544851|NCT01107704|Surrogates|surrogates
5544852|NCT01107704|Family Members|family members
5544853|NCT01107704|Physicians|physicians
5544854|NCT01107704|Critically Ill|critically ill
5544855|NCT01107704|Depression|depression
5544856|NCT01107704|Anxiety|anxiety
5544857|NCT01107704|Emotional|emotional
5544858|NCT01107704|Support|support
5544859|NCT01107704|Multi-faceted communication|multi-faceted communication
5544860|NCT01107704|Grief|grief
5544861|NCT01107704|Prognosis|prognosis
5544862|NCT01107704|Family Support Counselor|family support counselor
5544863|NCT01107691|resistance and weight loss training|resistance and weight loss training
5544864|NCT01107678|YMCA; Preventative child obesity|ymca; preventative child obesity
5544865|NCT01107665|pazopanib|pazopanib
5544866|NCT01107665|paclitaxel|paclitaxel
5544867|NCT01107665|melanoma|melanoma
5544868|NCT01107639|stage IIB esophageal cancer|stage iib esophageal cancer
5544869|NCT01107639|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5544870|NCT01107639|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5544871|NCT01107639|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5544872|NCT01107639|stage IIIA esophageal cancer|stage iiia esophageal cancer
5544873|NCT01107639|stage IIIB esophageal cancer|stage iiib esophageal cancer
5544874|NCT01107639|stage IIIC esophageal cancer|stage iiic esophageal cancer
5544875|NCT01107626|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5544876|NCT01107626|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5544877|NCT01107626|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5544878|NCT01107626|adenocarcinoma of the lung|adenocarcinoma of the lung
5544879|NCT01107626|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5544880|NCT01107626|large cell lung cancer|large cell lung cancer
5544881|NCT01107613|opinion leader|opinion leader
5544883|NCT01107613|Emergency Department|emergency department
5544884|NCT01107613|relapse|relapse
5544885|NCT01107613|follow-up|follow-up
5544886|NCT01107613|evidence-based guidelines|evidence-based guidelines
5544887|NCT01107613|Exacerbation of COPD|exacerbation of copd
5544888|NCT01107600|Dental Implants, Single-Tooth|dental implants, single-tooth
5544890|NCT01107600|Dental Restoration|dental restoration
5544891|NCT01107600|Socket preservation|socket preservation
5544892|NCT01107587|Human rotavirus vaccine|human rotavirus vaccine
5544893|NCT01107574|Chronic Pain, tenderpoints, insomnia, mood disorder, fatigue|chronic pain, tenderpoints, insomnia, mood disorder, fatigue
5544894|NCT01107561|cricothyroidotomy|cricothyroidotomy
5544895|NCT01107561|intubation|intubation
5544896|NCT01107561|airway|airway
5544897|NCT01107561|emergency medicine|emergency medicine
5544898|NCT01107561|education|education
5544899|NCT01107535|Synagis (palivizumab) immunoprophylaxis|synagis (palivizumab) immunoprophylaxis
5544900|NCT01107535|Respiratory syncytial virus infection|respiratory syncytial virus infection
5544901|NCT01107535|Preterm infants|preterm infants
5544902|NCT01107509|Renal cell carcinoma|renal cell carcinoma
5544903|NCT01107509|Metastatic|metastatic
5544904|NCT01107509|everolimus|everolimus
5544905|NCT01107509|neo-adjuvant|neo-adjuvant
5544906|NCT01107509|biomarkers|biomarkers
5544907|NCT01107509|nephrectomy|nephrectomy
5544908|NCT01107509|Locally advanced clear cell renal carcinoma|locally advanced clear cell renal carcinoma
5711493|NCT00459524|Survey|survey
5544909|NCT01107509|Metastatic clear cell renal carcinoma|metastatic clear cell renal carcinoma
5544910|NCT01107509|Clear Cell Renal Carcinoma|clear cell renal carcinoma
5544911|NCT01107483|endotoxaemia|endotoxaemia
5544912|NCT01107470|Infertility IVF ART|infertility ivf art
5544913|NCT01107457|Moderate|moderate
5544914|NCT01107457|Severe|severe
5544915|NCT01107457|Plaque|plaque
5544916|NCT01107457|Chronic|chronic
5544917|NCT01107431|glucose|glucose
5544918|NCT01107431|insulin|insulin
5544919|NCT01107431|L-arabinose|l-arabinose
5544920|NCT01107431|Chromium|chromium
5544921|NCT01107366|lupiae techinque|lupiae techinque
5544922|NCT01107366|aortic aneurism|aortic aneurism
5544923|NCT01107366|aortic dissection|aortic dissection
5544924|NCT01107327|cancer|cancer
5544925|NCT01107301|ADHD|adhd
5544926|NCT01107288|Aged|aged
5544927|NCT01107288|Balance|balance
5544928|NCT01107288|Dual-task|dual-task
5544929|NCT01107288|Exercise|exercise
5544930|NCT01107288|Falls|falls
5544931|NCT01107288|Gait|gait
5544932|NCT01107288|Music|music
5544933|NCT01107275|Rabies|rabies
5544934|NCT01107275|PCECV|pcecv
5544935|NCT01107275|pre-exposure immunization|pre-exposure immunization
5544936|NCT01107275|intradermal|intradermal
5544937|NCT01107275|children|children
5544938|NCT01107262|H5N1 Subtype|h5n1 subtype
5544939|NCT01107262|Avian viruses|avian viruses
5544940|NCT01107262|Highly pathogenic avian influenza (HPAI)|highly pathogenic avian influenza (hpai)
5544941|NCT01107249|esophageal|esophageal
5544942|NCT01107249|stenting|stenting
5544943|NCT01107249|perforations|perforations
5544944|NCT01107249|gastric|gastric
5544945|NCT01107249|esophageal stenting|esophageal stenting
5544946|NCT01107236|Healthy subjects|healthy subjects
5544947|NCT01107223|Antibiotic|antibiotic
5544948|NCT01107223|Prescribing behaviour|prescribing behaviour
5544949|NCT01107223|Guidelines|guidelines
5544950|NCT01107223|Respiratory tract infections|respiratory tract infections
5544951|NCT01107223|Non-antibiotic prescription|non-antibiotic prescription
5544952|NCT01107210|stroke|stroke
5544953|NCT01107210|physical fitness|physical fitness
5544954|NCT01107210|evolution|evolution
5544955|NCT01107210|determinants|determinants
5544956|NCT01107197|Pressure ulcers|pressure ulcers
5544957|NCT01107197|Healing|healing
5544958|NCT01107197|Malnutrition|malnutrition
5544959|NCT01107197|Nutritional support|nutritional support
5544960|NCT01107197|Micronutrients|micronutrients
5544961|NCT01107184|Remote ischemic conditioning|remote ischemic conditioning
5531625|NCT01161043|sensor|sensor
5544962|NCT01107184|CABG surgery|cabg surgery
5544963|NCT01107184|Atrial fibrillation|atrial fibrillation
5544964|NCT01107184|Coronary Artery Bypass|coronary artery bypass
5544965|NCT01107184|Ischemic Preconditioning|ischemic preconditioning
5544966|NCT01107171|Tang-min-ling pills;|tang-min-ling pills;
5544967|NCT01107171|overweight type 2 diabetes mellitus;|overweight type 2 diabetes mellitus;
5544968|NCT01107171|blood glucose|blood glucose
5544969|NCT01107171|Traditional Chinese Medicine|traditional chinese medicine
5544970|NCT01107171|Clinical Trial|clinical trial
5544971|NCT01107171|Intervention Studies|intervention studies
5544972|NCT01107145|Plasmodium|plasmodium
5544973|NCT01107145|Vivax|vivax
5544974|NCT01107145|Malaria|malaria
5544975|NCT01107145|Pregnancy|pregnancy
5544976|NCT01107145|Brazil|brazil
5544977|NCT01107145|Treatment|treatment
5544978|NCT01107119|Frail elderly|frail elderly
5544979|NCT01107119|Chronic illness|chronic illness
5544980|NCT01107119|Integrated care model|integrated care model
5544981|NCT01107119|Clinical pathways|clinical pathways
5544982|NCT01107119|Home care services|home care services
5544983|NCT01107106|Contraceptive Methods|contraceptive methods
5544984|NCT01107106|Female Contraception|female contraception
5544985|NCT01107080|breast cancer|breast cancer
5544986|NCT01107080|breast carcinoma in situ|breast carcinoma in situ
5544987|NCT01107080|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5544989|NCT01107080|invasive ductal carcinoma|invasive ductal carcinoma
5544990|NCT01107080|invasive lobular carcinoma|invasive lobular carcinoma
5544991|NCT01107067|hypogonadism|hypogonadism
5544992|NCT01107067|paraoxonase|paraoxonase
5544993|NCT01107067|Hipogonadism|hipogonadism
5544994|NCT01107054|QTC|qtc
5544995|NCT01107041|Depression|depression
5544996|NCT01107041|Technology Assisted|technology assisted
5544997|NCT01107041|Mobile Phone|mobile phone
5544998|NCT01107028|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5544999|NCT01107028|Dyspnea|dyspnea
5545000|NCT01107028|Functional capacity|functional capacity
5545001|NCT01107028|Quality of life|quality of life
5545002|NCT01107015|Diabetes|diabetes
5545003|NCT01107015|Glucose control|glucose control
5545004|NCT01107015|Diabetes monitoring|diabetes monitoring
5545005|NCT01107015|Care management|care management
5545006|NCT01107015|Electronic communication|electronic communication
5545007|NCT01107015|Mobile phone technology|mobile phone technology
5545008|NCT01107015|Self care|self care
5545009|NCT01107002|infertility|infertility
5545010|NCT01107002|Embryo transfer|embryo transfer
5545011|NCT01106976|PET|pet
5545012|NCT01106976|acetylcholine|acetylcholine
5545013|NCT01106963|knee|knee
5545014|NCT01106963|tibial fractures|tibial fractures
5545016|NCT01106963|osteosynthesis|osteosynthesis
5545017|NCT01106963|intramedullary nailing|intramedullary nailing
5545018|NCT01106950|acute myelogenous leukemia|acute myelogenous leukemia
5545019|NCT01106950|primary acute myelogenous leukemia|primary acute myelogenous leukemia
5545020|NCT01106950|secondary acute myelogenous leukemia|secondary acute myelogenous leukemia
5545021|NCT01106950|relapsed acute myelogenous leukemia|relapsed acute myelogenous leukemia
5545022|NCT01106924|Probiotics, Weight control, Body composition|probiotics, weight control, body composition
5545023|NCT01106911|digital breast tomosynthesis|digital breast tomosynthesis
5545024|NCT01106911|baseline screening mammography|baseline screening mammography
5545025|NCT01106911|recall rates|recall rates
5545026|NCT01106885|Diabetes|diabetes
5545027|NCT01106885|Depression|depression
5545028|NCT01106885|Telephone Care Management|telephone care management
5545029|NCT01106885|Medication Care Management (MCM)|medication care management (mcm)
5545030|NCT01106885|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5545031|NCT01106872|Sarcoma|sarcoma
5545032|NCT01106872|Soft Tissue Sarcoma|soft tissue sarcoma
5545033|NCT01106872|Locally Advanced Sarcoma|locally advanced sarcoma
5545034|NCT01106872|Unresectable Sarcoma|unresectable sarcoma
5545035|NCT01106872|Metastatic Sarcoma|metastatic sarcoma
5545036|NCT01106872|Valproic Acid|valproic acid
5545037|NCT01106872|Bevacizumab|bevacizumab
5545038|NCT01106872|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5545039|NCT01106859|insomnia|insomnia
5545040|NCT01106846|Ketamine|ketamine
5545041|NCT01106846|Anesthesia|anesthesia
5545042|NCT01106846|Pain|pain
5545043|NCT01106846|Outpatient surgery|outpatient surgery
5545044|NCT01106833|Chronic Graft-versus-Host Disease (cGVHD)|chronic graft-versus-host disease (cgvhd)
5545045|NCT01106794|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5545046|NCT01106794|DIPG|dipg
5545047|NCT01106794|childhood brainstem glioma|childhood brainstem glioma
5545048|NCT01106794|pediatric brainstem glioma|pediatric brainstem glioma
5545049|NCT01106794|brainstem glioma|brainstem glioma
5545051|NCT01106781|EGFR mutation test|egfr mutation test
5545052|NCT01106781|NSCLC|nsclc
5545053|NCT01106781|Non-Interventional Study|non-interventional study
5545054|NCT01106781|EGFR mutation status|egfr mutation status
5545055|NCT01106768|oral health needs|oral health needs
5545056|NCT01106768|children|children
5545057|NCT01106768|attention deficit disorder with or without hyperactivity|attention deficit disorder with or without hyperactivity
5545059|NCT01106755|hemiparesis|hemiparesis
5545060|NCT01106755|gait|gait
5545061|NCT01106755|Body weight support|body weight support
5545062|NCT01106755|Functional electrical stimulation|functional electrical stimulation
5545063|NCT01106742|Inflammatory|inflammatory
5545066|NCT01106729|Flavonoids|flavonoids
5545067|NCT01106729|Anthocyanin|anthocyanin
5545068|NCT01106729|Cyanidin 3 glucoside|cyanidin 3 glucoside
5545069|NCT01106729|Acute feeding trial|acute feeding trial
5545070|NCT01106729|Stable isotope|stable isotope
5545071|NCT01106729|Metabolism|metabolism
5545072|NCT01106729|Clearance|clearance
5545073|NCT01106729|Bioavailability|bioavailability
5545074|NCT01106729|Pharmacokinetics|pharmacokinetics
5545075|NCT01106716|Lidocaine|lidocaine
5545076|NCT01106716|Lignocaine|lignocaine
5545077|NCT01106716|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5545078|NCT01106716|Neuralgia, Postherpetic|neuralgia, postherpetic
5545079|NCT01106716|Pain|pain
5545080|NCT01106716|Pain measurement / drug effect|pain measurement / drug effect
5545081|NCT01106716|Pain postoperative / drug therapy|pain postoperative / drug therapy
5545082|NCT01106716|PHN|phn
5545083|NCT01106703|atopy, IgE|atopy, ige
5545084|NCT01106690|Canagliflozin|canagliflozin
5545085|NCT01106690|Placebo|placebo
5545098|NCT01106664|ONO-7746|ono-7746
5545099|NCT01106664|Healthy adult subjects|healthy adult subjects
5545100|NCT01106651|Canagliflozin|canagliflozin
5545101|NCT01106651|Placebo|placebo
5545102|NCT01106651|Hemoglobin A1c|hemoglobin a1c
5545103|NCT01106651|Bone|bone
5545104|NCT01106651|Type 2 diabetes mellitus|type 2 diabetes mellitus
5545106|NCT01106638|AIDS|aids
5545107|NCT01106638|Smoking|smoking
5545108|NCT01106638|Tobacco|tobacco
5545109|NCT01106638|Cessation|cessation
5545110|NCT01106638|Tobacco use in persons living with HIV/AIDS|tobacco use in persons living with hiv/aids
5545111|NCT01106625|Canagliflozin|canagliflozin
5545113|NCT01106625|Metformin|metformin
5548283|NCT01094171|Children|children
5545114|NCT01106625|Sulphonylurea|sulphonylurea
5545115|NCT01106625|Hemoglobin A1c|hemoglobin a1c
5545116|NCT01106625|Type 2 diabetes mellitus|type 2 diabetes mellitus
5545117|NCT01106612|randomized controlled trial|randomized controlled trial
5545118|NCT01106612|controlled clinical trial|controlled clinical trial
5545119|NCT01106612|comparative effectiveness research|comparative effectiveness research
5545120|NCT01106612|chest pain|chest pain
5545121|NCT01106612|angina pectoris|angina pectoris
5545122|NCT01106612|non-invasive cardiac imaging|non-invasive cardiac imaging
5545123|NCT01106612|nuclear stress testing|nuclear stress testing
5545124|NCT01106612|coronary CT angiography|coronary ct angiography
5545125|NCT01106612|coronary catheterization|coronary catheterization
5545126|NCT01106612|coronary revascularization|coronary revascularization
5545127|NCT01106586|HIV 1 Infection|hiv 1 infection
5545128|NCT01106586|Treatment Naive|treatment naive
5545129|NCT01106573|Diabetes Mellitus|diabetes mellitus
5545130|NCT01106573|Arteriosclerosis|arteriosclerosis
5545131|NCT01106573|Intima media thickness|intima media thickness
5545132|NCT01106573|arterial stiffness|arterial stiffness
5545133|NCT01106573|pulsewave velocity|pulsewave velocity
5545134|NCT01106573|fibulin-1|fibulin-1
5545135|NCT01106547|abdominal hysterectomy|abdominal hysterectomy
5545136|NCT01106547|glucocorticoids|glucocorticoids
5545137|NCT01106547|rehabilitation|rehabilitation
5545138|NCT01106547|postoperative pain|postoperative pain
5545139|NCT01106547|analgetics|analgetics
5545140|NCT01106534|drug eluting stents|drug eluting stents
5545141|NCT01106534|Stents|stents
5545142|NCT01106534|Angioplasty|angioplasty
5545143|NCT01106534|Stent thrombosis|stent thrombosis
5545144|NCT01106534|antiplatelet treatment|antiplatelet treatment
5545145|NCT01106521|Infiltrating ductal carcinoma|infiltrating ductal carcinoma
5545146|NCT01106521|Brachytherapy|brachytherapy
5545147|NCT01106508|Advanced solid tumors|advanced solid tumors
5545148|NCT01106508|recurrent or refractory medulloblastoma|recurrent or refractory medulloblastoma
5545149|NCT01106508|locally advanced or metastatic basal cell carcinoma|locally advanced or metastatic basal cell carcinoma
5545150|NCT01106508|hedgehog pathway inhibitor|hedgehog pathway inhibitor
5545151|NCT01106495|Atherosclerosis|atherosclerosis
5545152|NCT01106495|Vascular Endothelium|vascular endothelium
5545153|NCT01106495|Counterpulsation, External|counterpulsation, external
5692346|NCT00528411|CAD|cad
5545155|NCT01106482|Tick Borne Encephalitis|tick borne encephalitis
5545156|NCT01106469|Healthy Volunteers|healthy volunteers
5545157|NCT01106469|Healthy|healthy
5545158|NCT01106469|JNJ-41443532|jnj-41443532
5545159|NCT01106469|Pharmacokinetics|pharmacokinetics
5545160|NCT01106443|Indeterminate thyroid nodule|indeterminate thyroid nodule
5545161|NCT01106443|fine needle aspirate biopsy|fine needle aspirate biopsy
5545162|NCT01106443|thyroidectomy|thyroidectomy
5545163|NCT01106443|central lymph node dissection|central lymph node dissection
5545164|NCT01106430|ADHD|adhd
5545165|NCT01106417|Cervical Degenerative Disc Disease|cervical degenerative disc disease
5545166|NCT01106417|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5545167|NCT01106417|Spinal Stenosis|spinal stenosis
5545168|NCT01106417|Stem cells|stem cells
5545169|NCT01106417|Adult Stem Cells|adult stem cells
5545170|NCT01106417|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5545171|NCT01106417|Anterior Cervical Plate Fixation|anterior cervical plate fixation
5545172|NCT01106391|Abdominal aortic aneurysm|abdominal aortic aneurysm
5545174|NCT01106391|Safety|safety
5545175|NCT01106391|Performance|performance
5545176|NCT01106391|Stent graft system|stent graft system
5545177|NCT01106391|First in Human|first in human
5545178|NCT01106391|Endovascular repair|endovascular repair
5545179|NCT01106378|Coronary artery disease|coronary artery disease
5545180|NCT01106378|drug-eluting stents|drug-eluting stents
5545181|NCT01106378|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
5545182|NCT01106365|multiple sclerosis|multiple sclerosis
5545183|NCT01106365|fatigue|fatigue
5545184|NCT01106365|depressivity|depressivity
5545185|NCT01106365|repetitive deep transcranial magnetic stimulation|repetitive deep transcranial magnetic stimulation
5545186|NCT01106352|The target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel|the target population is patients with bone metastasis from castration-resistant prostate cancer intended for treatment with docetaxel
5545187|NCT01106339|humans|humans
5545188|NCT01106339|patients|patients
5545189|NCT01106339|somatoform disorders|somatoform disorders
5545190|NCT01106339|fibromyalgia|fibromyalgia
5545191|NCT01106339|myofascial pain syndrome diffuse|myofascial pain syndrome diffuse
5545192|NCT01106339|depression|depression
5545193|NCT01106339|chronic fatigue syndrome|chronic fatigue syndrome
5545194|NCT01106339|inflammation|inflammation
5545195|NCT01106339|inflammatory response|inflammatory response
5545196|NCT01106339|biomarkers|biomarkers
5545197|NCT01106339|cytokines|cytokines
5545198|NCT01106339|cell surface markers|cell surface markers
5545199|NCT01106339|functional polymorphisms|functional polymorphisms
5545200|NCT01106326|Asthma|asthma
5545201|NCT01106248|tumor|tumor
5545202|NCT01106209|premature infants|premature infants
5545203|NCT01106209|polymorphonuclear leukocytes|polymorphonuclear leukocytes
5545205|NCT01106209|neutrophil extracellular traps|neutrophil extracellular traps
5545206|NCT01106209|NET formation|net formation
5545207|NCT01106209|necrotizing enterocolitis|necrotizing enterocolitis
5545208|NCT01106196|Influenza, Human|influenza, human
5545209|NCT01106196|Influenza, Human/complications|influenza, human/complications
5545210|NCT01106196|Myocardial infarction/etiology|myocardial infarction/etiology
5545211|NCT01106196|Cardiovascular Diseases/mortality|cardiovascular diseases/mortality
5545212|NCT01106157|Autoimmune, Diabetes Mellitus, Glucose Metabolism|autoimmune, diabetes mellitus, glucose metabolism
5545213|NCT01106079|Early psoriatic arthritis|early psoriatic arthritis
5545214|NCT01106079|Tight control|tight control
5545215|NCT01106079|Intensive management|intensive management
5545216|NCT01106053|Binge eating disorder|binge eating disorder
5545217|NCT01106053|Food craving|food craving
5545218|NCT01106053|Obesity|obesity
5545219|NCT01106053|Pramipexole|pramipexole
5545220|NCT01106053|Mirapex|mirapex
5545221|NCT01106053|Binge|binge
5545222|NCT01106040|Lymphoseek|lymphoseek
5545223|NCT01106040|Breast Cancer|breast cancer
5545224|NCT01106040|Melanoma|melanoma
5545225|NCT01106040|Experimental|experimental
5545226|NCT01106014|pulmonary arterial hypertension|pulmonary arterial hypertension
5545227|NCT01106014|PAH|pah
5545228|NCT01106001|total hip arthroplasty|total hip arthroplasty
5545229|NCT01106001|periarticular injection|periarticular injection
5545230|NCT01106001|pain|pain
5545231|NCT01105988|GBM|gbm
5545232|NCT01105988|PET scans|pet scans
5545233|NCT01105988|MRI scans|mri scans
5545234|NCT01105975|Dyslipidemias|dyslipidemias
5545235|NCT01105975|Mixed dyslipidemia|mixed dyslipidemia
5545236|NCT01105975|Hypercholesterolemia|hypercholesterolemia
5545237|NCT01105975|Atherosclerosis|atherosclerosis
5545238|NCT01105975|Atorvastatin|atorvastatin
5545239|NCT01105975|Simvastatin|simvastatin
5545240|NCT01105975|Rosuvastatin|rosuvastatin
5545241|NCT01105975|Metabolic Diseases|metabolic diseases
5545242|NCT01105975|Antilipemic Agents|antilipemic agents
5545243|NCT01105975|Enzyme Inhibitors|enzyme inhibitors
5545244|NCT01105975|Anticholesteremic Agents|anticholesteremic agents
5545245|NCT01105975|Cholesteryl Ester Transfer Protein Inhibitors|cholesteryl ester transfer protein inhibitors
5545246|NCT01105975|Cholesteryl Ester|cholesteryl ester
5545247|NCT01105975|Lipid Metabolism Disorders|lipid metabolism disorders
5545249|NCT01105962|brain|brain
5545250|NCT01105962|injury|injury
5545251|NCT01105962|post-traumatic|post-traumatic
5545252|NCT01105962|stress|stress
5545253|NCT01105962|hyperbaric|hyperbaric
5545254|NCT01105962|oxygen|oxygen
5545255|NCT01105962|HBOT|hbot
5545256|NCT01105962|TBI|tbi
5545257|NCT01105962|PTSD|ptsd
5545258|NCT01105949|nasal patency|nasal patency
5545259|NCT01105949|acoustic rhinometry|acoustic rhinometry
5545260|NCT01105949|nasal strip|nasal strip
5545261|NCT01105936|osteoarthritis|osteoarthritis
5545262|NCT01105936|pain|pain
5545263|NCT01105936|paracetamol|paracetamol
5545264|NCT01105936|Blood-Oxygen-Level-Dependent functional magnetic resonance imaging|blood-oxygen-level-dependent functional magnetic resonance imaging
5545265|NCT01105910|Dry Eye, Post Menopausal dry eye|dry eye, post menopausal dry eye
5545266|NCT01105897|endometriosis|endometriosis
5545267|NCT01105897|deep endometriosis|deep endometriosis
5545269|NCT01105897|laparoscopy|laparoscopy
5545270|NCT01105897|chronic pain|chronic pain
5545271|NCT01105897|quality of life|quality of life
5545272|NCT01105897|sexual function|sexual function
5545273|NCT01105897|complications|complications
5545274|NCT01105897|recurrence|recurrence
5545275|NCT01105884|Wound healing, type 2 diabetes, diabetic foot ulcers, different dressings|wound healing, type 2 diabetes, diabetic foot ulcers, different dressings
5545276|NCT01105871|Pain relief|pain relief
5545277|NCT01105858|Diabetes Mellitus|diabetes mellitus
5545278|NCT01105858|Obesity|obesity
5545279|NCT01105858|Diabetic Complications|diabetic complications
5545280|NCT01105858|Genetics|genetics
5545281|NCT01105858|Molecular Profiling|molecular profiling
5545282|NCT01105845|Motor Learning|motor learning
5545283|NCT01105845|Genetic Analysis|genetic analysis
5545284|NCT01105845|BDNF|bdnf
5545285|NCT01105845|Parkinson Disease|parkinson disease
5545286|NCT01105845|Movement Disorders|movement disorders
5545287|NCT01105845|Dystonia|dystonia
5545288|NCT01105845|Healthy Volunteer|healthy volunteer
5545290|NCT01105832|Teriparatide|teriparatide
5545291|NCT01105832|fracture healing|fracture healing
5545292|NCT01105832|proximal humeral fractures|proximal humeral fractures
5545293|NCT01105819|Probiotics|probiotics
5545294|NCT01105819|Lactobacillus plantarum 299|lactobacillus plantarum 299
5545295|NCT01105819|Ventilator-associated pneumonia VAP|ventilator-associated pneumonia vap
5545296|NCT01105819|Chlorhexidine|chlorhexidine
5545297|NCT01105819|Tracheal secretions|tracheal secretions
5545298|NCT01105819|Oropharyngeal secretions|oropharyngeal secretions
5545299|NCT01105806|advance directive|advance directive
5545300|NCT01105806|CPR Intervention|cpr intervention
5545302|NCT01105806|Narrative|narrative
5545303|NCT01105806|10-043|10-043
5545304|NCT01105793|cyclic mastalgia|cyclic mastalgia
5545305|NCT01105793|cyclic breast pain|cyclic breast pain
5545306|NCT01105793|fibrocystic breast disease|fibrocystic breast disease
5545307|NCT01105780|Healthy Volunteers|healthy volunteers
5545308|NCT01105780|Healthy|healthy
5545309|NCT01105780|Japanese|japanese
5545310|NCT01105780|Pharmacokinetics|pharmacokinetics
5545311|NCT01105780|JNJ-41443532|jnj-41443532
5545312|NCT01105767|Staphylococcus aureus|staphylococcus aureus
5545313|NCT01105767|MRSA Skin Infection|mrsa skin infection
5545314|NCT01105767|Staphylococcal Skin Infections|staphylococcal skin infections
5545315|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate
5545316|NCT01105741|Crohn's disease|crohn's disease
5545317|NCT01105741|Adalimumab|adalimumab
5545318|NCT01105741|Metabolome|metabolome
5545319|NCT01105728|Gastric subepitelial mass|gastric subepitelial mass
5545320|NCT01105728|Endoscopic full thickness resection|endoscopic full thickness resection
5545321|NCT01105715|Rheumatoid Arthritis|rheumatoid arthritis
5545322|NCT01105715|cLDL|cldl
5545323|NCT01105715|Cardiovascular disease|cardiovascular disease
5545324|NCT01105702|brain tumor|brain tumor
5545325|NCT01105702|brain cancer|brain cancer
5545326|NCT01105702|glioma|glioma
5545327|NCT01105689|Urine Calcium to Creatinine Ratio|urine calcium to creatinine ratio
5545328|NCT01105689|Hypocalciuria|hypocalciuria
5545329|NCT01105689|Infants|infants
5545330|NCT01105689|Toddlers|toddlers
5545331|NCT01105676|vascular malformation|vascular malformation
5545332|NCT01105676|vascular anomalies|vascular anomalies
5545333|NCT01105676|abnormalities of growth|abnormalities of growth
5545334|NCT01105676|overgrowth|overgrowth
5545335|NCT01105676|subjects with vascular malformations abnormalities of growth.|subjects with vascular malformations abnormalities of growth.
5545336|NCT01105663|sedated|sedated
5545337|NCT01105663|intubated|intubated
5545338|NCT01105663|mechanically ventilated|mechanically ventilated
5545339|NCT01105663|pediatric|pediatric
5545340|NCT01105663|lung injury|lung injury
5545341|NCT01105650|recurrent ovarian cancer|recurrent ovarian cancer
5545342|NCT01105650|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5545343|NCT01105650|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
5545344|NCT01105650|refractory ovarian cancer|refractory ovarian cancer
5545345|NCT01105650|refractory fallopian tube cancer|refractory fallopian tube cancer
5545346|NCT01105650|refractory peritoneal cancer|refractory peritoneal cancer
5545347|NCT01105650|metastatic breast cancer|metastatic breast cancer
5545348|NCT01105637|burn injuries|burn injuries
5545349|NCT01105637|exercise|exercise
5545350|NCT01105611|HIV|hiv
5545351|NCT01105611|Hepatitis C|hepatitis c
5545352|NCT01105611|Co-infection|co-infection
5545353|NCT01105611|Intravenous drug users|intravenous drug users
5545354|NCT01105611|Treatment-naïve|treatment-naïve
5545355|NCT01105611|Methadone|methadone
5545356|NCT01105585|Cataracts|cataracts
5545357|NCT01105585|aspheric|aspheric
5545359|NCT01105585|ocular aberrations|ocular aberrations
5545360|NCT01105572|Congestive Heart Failure|congestive heart failure
5545361|NCT01105559|Diphtheria|diphtheria
5545362|NCT01105559|Tetanus|tetanus
5545363|NCT01105559|Whooping cough|whooping cough
5545364|NCT01105559|Hepatitis B|hepatitis b
5545365|NCT01105559|Poliomyelitis|poliomyelitis
5545366|NCT01105559|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5545368|NCT01105546|inhibitors|inhibitors
5545369|NCT01105546|prophylaxis|prophylaxis
5545370|NCT01105546|immune tolerance induction|immune tolerance induction
5545371|NCT01105533|VGEF inhibitor|vgef inhibitor
5545372|NCT01105533|Anti angiogenesis|anti angiogenesis
5545373|NCT01105533|Advanced Solid Tumors|advanced solid tumors
5545374|NCT01105520|Intraspinal processes (tumor or vascular malformation AVM)|intraspinal processes (tumor or vascular malformation avm)
5545375|NCT01105507|Canakinumab|canakinumab
5545376|NCT01105507|Cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
5545377|NCT01105507|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5545378|NCT01105507|Familial Cold Urticaria (FCU)|familial cold urticaria (fcu)
5545379|NCT01105507|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5545380|NCT01105507|Neonatal-Onset Multisystem Inflammatory Disease (NOMID)|neonatal-onset multisystem inflammatory disease (nomid)
5545381|NCT01105507|Chronic Infantile Neurological|chronic infantile neurological
5545382|NCT01105507|Cutaneous|cutaneous
5545383|NCT01105507|Articular Syndrome (CINCA)|articular syndrome (cinca)
5545384|NCT01105507|Treatment of patients diagnosed with CAPS (Cryopyrin associated periodic syndrome)|treatment of patients diagnosed with caps (cryopyrin associated periodic syndrome)
5545385|NCT01105481|treatment-resistant schizophrenia|treatment-resistant schizophrenia
5545386|NCT01105481|clozapine|clozapine
5545387|NCT01105481|amisulpride|amisulpride
5545388|NCT01105468|Breath gas analysis|breath gas analysis
5545389|NCT01105468|Volatile components in exhaled breath|volatile components in exhaled breath
5545390|NCT01105455|Randomized clinical trial|randomized clinical trial
5545391|NCT01105455|Gestational diabetes|gestational diabetes
5545392|NCT01105455|Carbohydrates|carbohydrates
5545393|NCT01105455|Glycemic index|glycemic index
5847105|NCT00041717|muscle spasticity|muscle spasticity
5545394|NCT01105442|Post-operative pain treatment|post-operative pain treatment
5545395|NCT01105442|Fast-track colonic surgery patients|fast-track colonic surgery patients
5548284|NCT01094171|tetanus|tetanus
5545397|NCT01105416|Pediatric Emergency Department|pediatric emergency department
5545398|NCT01105416|Parental monitoring|parental monitoring
5545399|NCT01105416|Adolescent|adolescent
5545400|NCT01105416|Parents|parents
5545401|NCT01105416|Communication|communication
5545402|NCT01105416|Alcohol Drinking|alcohol drinking
5545403|NCT01105403|Hematopoietic stem cells|hematopoietic stem cells
5545404|NCT01105403|Mobilisation|mobilisation
5545405|NCT01105403|Autologous transplantation|autologous transplantation
5545406|NCT01105364|recurrent renal cell cancer|recurrent renal cell cancer
5545407|NCT01105364|stage IV renal cell cancer|stage iv renal cell cancer
5545408|NCT01105364|liver metastases|liver metastases
5545409|NCT01105351|Folate|folate
5545410|NCT01105351|MTHFR|mthfr
5545411|NCT01105351|Homocysteine|homocysteine
5545412|NCT01105338|prostate cancer|prostate cancer
5545413|NCT01105325|acute coronary syndrome|acute coronary syndrome
5545414|NCT01105325|treatment compliance|treatment compliance
5545415|NCT01105325|cardiac intensive care unit|cardiac intensive care unit
5545416|NCT01105325|secondary prevention|secondary prevention
5545417|NCT01105325|cardiac intensive care unit (CIC)|cardiac intensive care unit (cic)
5545418|NCT01105325|compliance|compliance
5545419|NCT01105325|intensive care|intensive care
5545420|NCT01105312|male breast cancer|male breast cancer
5545421|NCT01105312|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5545422|NCT01105312|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5545423|NCT01105312|HER2-negative breast cancer|her2-negative breast cancer
5545424|NCT01105312|HER2-positive breast cancer|her2-positive breast cancer
5545425|NCT01105312|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5545426|NCT01105312|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5545427|NCT01105312|triple-negative breast cancer|triple-negative breast cancer
5545428|NCT01105312|recurrent breast cancer|recurrent breast cancer
5545429|NCT01105312|stage IV breast cancer|stage iv breast cancer
5545430|NCT01105299|bioequivalence|bioequivalence
5545432|NCT01105299|Healthy subjects|healthy subjects
5545433|NCT01105299|Antineoplastic Agents|antineoplastic agents
5545434|NCT01105299|Therapeutic Uses|therapeutic uses
5545435|NCT01105299|Enzyme Inhibitors|enzyme inhibitors
5545436|NCT01105273|Aplastic anemia|aplastic anemia
5545437|NCT01105273|Fludarabine|fludarabine
5545438|NCT01105273|CD3±CD19 depletion|cd3±cd19 depletion
5545439|NCT01105273|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5545440|NCT01105260|early reconditioning program|early reconditioning program
5545441|NCT01105260|spinal cord injury|spinal cord injury
5545442|NCT01105260|early rehabilitation|early rehabilitation
5545443|NCT01105260|wheelchair|wheelchair
5545444|NCT01105247|PCI-32765|pci-32765
5545445|NCT01105247|Lymphoma, B-Cell|lymphoma, b-cell
5545446|NCT01105247|Leukemia, Lymphoid|leukemia, lymphoid
5545447|NCT01105247|Leukemia, B-Cell|leukemia, b-cell
5545448|NCT01105247|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5545449|NCT01105234|Healthy volunteers|healthy volunteers
5545450|NCT01105221|Acupuncture|acupuncture
5545451|NCT01105221|Dry eye|dry eye
5545452|NCT01105221|Artificial tear drop|artificial tear drop
5545453|NCT01105221|Mixed method approach|mixed method approach
5545454|NCT01105221|Qualitative study|qualitative study
5545455|NCT01105221|Cost effectiveness analysis|cost effectiveness analysis
5545456|NCT01105221|Tear cytokine analysis|tear cytokine analysis
5545457|NCT01105195|DuraPrep|duraprep
5545458|NCT01105195|ChloraPrep|chloraprep
5545459|NCT01105195|Lumbar Spine|lumbar spine
5545460|NCT01105182|Radiofrequency Ablation|radiofrequency ablation
5545461|NCT01105169|Personalized prevention|personalized prevention
5545462|NCT01105169|Colorectal cancer|colorectal cancer
5545463|NCT01105169|Investigational Nutrigenetic Studies|investigational nutrigenetic studies
5545464|NCT01105169|Magnesium|magnesium
5545465|NCT01105169|Gene polymorphism|gene polymorphism
5545466|NCT01105156|Gastric band|gastric band
5545467|NCT01105156|Questionnaire|questionnaire
5545468|NCT01105156|Post operative management|post operative management
5545469|NCT01105156|Adjustment|adjustment
5545470|NCT01105143|weight loss|weight loss
5545471|NCT01105143|muscle mass|muscle mass
5545472|NCT01105130|radiation toxicity|radiation toxicity
5545473|NCT01105130|male erectile disorder|male erectile disorder
5545474|NCT01105130|prostate cancer|prostate cancer
5545475|NCT01105117|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5545477|NCT01105117|EPITOME-1|epitome-1
5545478|NCT01105091|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5545480|NCT01105091|EPITOME-1|epitome-1
5545481|NCT01105078|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2|cardiopulmonary bypass flow rate outcome tissue perfusion oxygenation l/min/m2
5545482|NCT01105065|Normal Pressure Glaucoma|normal pressure glaucoma
5545483|NCT01105052|Insomnia|insomnia
5545484|NCT01105052|Co-morbid|co-morbid
5545485|NCT01105052|CBT|cbt
5545486|NCT01105052|Self-help|self-help
5545489|NCT01105039|overall pain|overall pain
5545490|NCT01105039|incisional pain|incisional pain
5545491|NCT01105039|shoulder pain|shoulder pain
5545492|NCT01105039|visceral pain|visceral pain
5545493|NCT01105026|alveolar ridge preservation, bioactive glass, tooth extraction, graft material|alveolar ridge preservation, bioactive glass, tooth extraction, graft material
5545494|NCT01105013|fungal infections|fungal infections
5545495|NCT01105013|tinea|tinea
5545496|NCT01105013|tonaftato|tonaftato
5545497|NCT01105000|HPV|hpv
5545498|NCT01105000|HPV vaccine|hpv vaccine
5545499|NCT01104987|Ankylosing spondylitis|ankylosing spondylitis
5545500|NCT01104987|spondarthritis|spondarthritis
5545501|NCT01104987|Osteoporosis|osteoporosis
5545502|NCT01104987|Bone mineral density|bone mineral density
5545503|NCT01104987|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5545504|NCT01104987|Quantitative computed tomography|quantitative computed tomography
5545505|NCT01104974|HIV|hiv
5545506|NCT01104974|HIV providers|hiv providers
5545507|NCT01104974|Infectious Disease|infectious disease
5545508|NCT01104974|HIV and pregnancy|hiv and pregnancy
5545509|NCT01104961|Bacterial infection|bacterial infection
5545510|NCT01104961|Loss of epithelial cells|loss of epithelial cells
5528071|NCT01175759|Hormones|hormones
5545511|NCT01104922|Re-irradiation with Fractionated Stereotactic Radiosurgery for Head and Neck|re-irradiation with fractionated stereotactic radiosurgery for head and neck
5545512|NCT01104909|Dry weight|dry weight
5545513|NCT01104909|Blood Pressure|blood pressure
5545514|NCT01104909|Chronic Kidney disease|chronic kidney disease
5545515|NCT01104896|Cigarette|cigarette
5545516|NCT01104896|tobacco|tobacco
5545517|NCT01104896|mechanical ventilation|mechanical ventilation
5545518|NCT01104896|nicotine|nicotine
5545519|NCT01104883|Adductor-Canal-Blockade|adductor-canal-blockade
5545520|NCT01104883|postoperative pain|postoperative pain
5545521|NCT01104883|US-guided nerve block|us-guided nerve block
5545522|NCT01104883|total knee arthroplasty|total knee arthroplasty
5545523|NCT01104857|Respiratory muscle|respiratory muscle
5545524|NCT01104857|Myosin|myosin
5545525|NCT01104857|Mechanical ventilation|mechanical ventilation
5545526|NCT01104844|dental pain|dental pain
5545527|NCT01104844|Analgesia|analgesia
5545528|NCT01104831|Tibial Plateau Fracture|tibial plateau fracture
5545529|NCT01104831|AO/OTA 41|ao/ota 41
5545530|NCT01104818|Sibling relationship quality|sibling relationship quality
5545531|NCT01104818|Foster Care|foster care
5545532|NCT01104818|Parent Management Training|parent management training
5545533|NCT01104818|Mental health outcomes|mental health outcomes
5545534|NCT01104805|Drug Abuse|drug abuse
5545535|NCT01104805|Substance Abuse|substance abuse
5545536|NCT01104805|Substance Use Disorder|substance use disorder
5545537|NCT01104805|Addiction|addiction
5545538|NCT01104805|Behavioral Treatment|behavioral treatment
5545539|NCT01104792|Schizophrenia|schizophrenia
5545540|NCT01104792|Acute schizophrenia|acute schizophrenia
5545541|NCT01104792|Psychotropic drugs|psychotropic drugs
5545542|NCT01104792|Antipsychotic agents|antipsychotic agents
5545543|NCT01104792|Mental disorders|mental disorders
5545544|NCT01104792|Dopamine agents|dopamine agents
5545545|NCT01104792|Central nervous system agents|central nervous system agents
5545546|NCT01104779|Schizophrenia|schizophrenia
5545547|NCT01104779|Acute Schizophrenia|acute schizophrenia
5545548|NCT01104779|Psychotropic Drugs|psychotropic drugs
5545549|NCT01104779|Antipsychotic Agents|antipsychotic agents
5545551|NCT01104779|Dopamine Agents|dopamine agents
5545552|NCT01104779|Central Nervous System Agents|central nervous system agents
5545553|NCT01104766|Schizophrenia|schizophrenia
5545554|NCT01104766|Acute Schizophrenia|acute schizophrenia
5545555|NCT01104766|Psychotropic Drugs|psychotropic drugs
5545556|NCT01104766|Aripiprazole|aripiprazole
5545557|NCT01104766|Antipsychotic Agents|antipsychotic agents
5545558|NCT01104766|Mental Disorders|mental disorders
5545559|NCT01104766|Dopamine Agents|dopamine agents
5545560|NCT01104766|Central Nervous System Agents|central nervous system agents
5545561|NCT01104727|SINGLE PORT SURGERY|single port surgery
5545562|NCT01104727|LAPAROSCOPY, CHOLECYSTECTOMY|laparoscopy, cholecystectomy
5545563|NCT01104701|Exenatide|exenatide
5545565|NCT01104701|Lilly|lilly
5545566|NCT01104701|Byetta|byetta
5545567|NCT01104701|Exenatide Once Weekly|exenatide once weekly
5545568|NCT01104688|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5545569|NCT01104688|Wall Stress|wall stress
5545570|NCT01104688|Shear Stress|shear stress
5545571|NCT01104688|Inflammation|inflammation
5545572|NCT01104688|Magnetic Resonance Imaging|magnetic resonance imaging
5545573|NCT01104675|ovarian|ovarian
5545574|NCT01104675|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5545575|NCT01104649|Spinocerebellar ataxia|spinocerebellar ataxia
5545576|NCT01104649|Friedreich ataxia|friedreich ataxia
5545577|NCT01104623|ADHD|adhd
5545578|NCT01104597|Healthy Asian Indians and Caucasians|healthy asian indians and caucasians
5545579|NCT01104584|Breast Cancer|breast cancer
5545580|NCT01104584|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
5545581|NCT01104584|Mammography|mammography
5545582|NCT01104584|Diagnostic Imaging|diagnostic imaging
5545583|NCT01104571|HER2-positive breast cancer|her2-positive breast cancer
5545584|NCT01104571|stage IA breast cancer|stage ia breast cancer
5545585|NCT01104571|stage IB breast cancer|stage ib breast cancer
5548285|NCT01094158|NAFLD|nafld
5545586|NCT01104571|stage II breast cancer|stage ii breast cancer
5545587|NCT01104571|stage IIIA breast cancer|stage iiia breast cancer
5545588|NCT01104571|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5545589|NCT01104571|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5545590|NCT01104558|Bisoprolol|bisoprolol
5545591|NCT01104558|Chronic Heart failure|chronic heart failure
5545592|NCT01104532|ASP1941|asp1941
5545593|NCT01104532|Januvia|januvia
5545594|NCT01104532|sitagliptin|sitagliptin
5545595|NCT01104480|Relapsing Polychondritis|relapsing polychondritis
5545596|NCT01104480|Unremitting|unremitting
5545597|NCT01104480|Inflammation|inflammation
5545598|NCT01104480|IL6|il6
5545599|NCT01104467|Acute Ischemic Stroke|acute ischemic stroke
5545600|NCT01104467|Desmoteplase|desmoteplase
5545601|NCT01104467|Japan|japan
5545602|NCT01104467|Safety|safety
5545603|NCT01104467|Stroke|stroke
5545604|NCT01104467|Tolerability|tolerability
5545605|NCT01104454|healthy pregnant women|healthy pregnant women
5545606|NCT01104441|critical limb ischaemia|critical limb ischaemia
5545607|NCT01104441|Aspirin resistance|aspirin resistance
5545608|NCT01104428|Hench-schonlein purpura|hench-schonlein purpura
5545609|NCT01104428|Renal damage|renal damage
5545610|NCT01104428|Relapse|relapse
5545611|NCT01104428|End event|end event
5545612|NCT01104428|TCM syndrome|tcm syndrome
5545613|NCT01104402|telemedicine|telemedicine
5545614|NCT01104402|spirometer|spirometer
5545615|NCT01104402|CF|cf
5545616|NCT01104402|pulmonary|pulmonary
5545617|NCT01104402|home monitoring|home monitoring
5545618|NCT01104376|Cytochrome P450|cytochrome p450
5545619|NCT01104376|CYP2B6|cyp2b6
5545620|NCT01104376|Voriconazole|voriconazole
5545621|NCT01104376|Efavirenz|efavirenz
5545622|NCT01104376|Pharmacokinetics|pharmacokinetics
5545623|NCT01104376|Drug-Interactions|drug-interactions
5545624|NCT01104376|Pharmacogenetics|pharmacogenetics
5545625|NCT01104376|Healthy volunteers|healthy volunteers
5545626|NCT01104363|Dental implants|dental implants
5545627|NCT01104350|Bladder|bladder
5545628|NCT01104350|Radiotherapy|radiotherapy
5545629|NCT01104350|Gemcitabine|gemcitabine
5545630|NCT01104350|Chemotherapy|chemotherapy
5545631|NCT01104350|10-031|10-031
5545632|NCT01104337|paracetamol|paracetamol
5545633|NCT01104337|warfarin|warfarin
5545634|NCT01104337|drug interaction|drug interaction
5545635|NCT01104337|pathogenic mechanism|pathogenic mechanism
5545636|NCT01104324|bone health|bone health
5545637|NCT01104324|Osteonecrosis|osteonecrosis
5545638|NCT01104324|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5545639|NCT01104311|Blood Pressure|blood pressure
5545640|NCT01104311|Atherosclerosis|atherosclerosis
5545641|NCT01104311|Brain Ischemia|brain ischemia
5545642|NCT01104298|metastatic STS|metastatic sts
5545643|NCT01104298|Trabectedin|trabectedin
5545644|NCT01104298|doxorrubicin|doxorrubicin
5545645|NCT01104298|soft tissue sarcoma|soft tissue sarcoma
5545646|NCT01104298|non operable sarcoma|non operable sarcoma
5545647|NCT01104272|Ultrasound Treatment of Subcutaneous Adipose Tissue|ultrasound treatment of subcutaneous adipose tissue
5545648|NCT01104246|Hypogonadism|hypogonadism
5545650|NCT01104246|Hormone replacement therapy|hormone replacement therapy
5545651|NCT01104233|Video-assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5545652|NCT01104233|Soft spreading|soft spreading
5545653|NCT01104233|LAP Protector|lap protector
5545654|NCT01104220|NAFLD|nafld
5545655|NCT01104220|Obesity|obesity
5545656|NCT01104220|Metabolic syndrome|metabolic syndrome
5545657|NCT01104207|tinnitus|tinnitus
5545658|NCT01104207|TMS|tms
5545659|NCT01104207|transcranial magnetic stimulation|transcranial magnetic stimulation
5545660|NCT01104194|depression|depression
5545661|NCT01104194|cognition|cognition
5545662|NCT01104194|heart rate variability|heart rate variability
5545663|NCT01104194|omega-3 fatty acids|omega-3 fatty acids
5545664|NCT01104194|Depression (in remission) (vulnerability to depression)|depression (in remission) (vulnerability to depression)
5545665|NCT01104181|Anal HPV|anal hpv
5545666|NCT01104181|Anal Dysplasia|anal dysplasia
5545667|NCT01104181|Ana Cancer|ana cancer
5545668|NCT01104168|diabetes|diabetes
5545669|NCT01104168|elderly|elderly
5545670|NCT01104168|nursing home resident|nursing home resident
5545671|NCT01104155|NSCLC|nsclc
5545672|NCT01104155|Eribulin Mesylate|eribulin mesylate
5545673|NCT01104155|Erlotinib|erlotinib
5545674|NCT01104129|Pancreatic Cancer|pancreatic cancer
5545675|NCT01104129|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
5545676|NCT01104129|Stool-based digital melt curve (DMC) assay|stool-based digital melt curve (dmc) assay
5545677|NCT01104129|Surgical resection for pancreatic cancer|surgical resection for pancreatic cancer
5545678|NCT01104129|Hereditary Pancreatic Cancer Syndrome|hereditary pancreatic cancer syndrome
5548200|NCT01094496|hCG|hcg
5545679|NCT01104129|Genetic mutations linked to pancreatic cancer|genetic mutations linked to pancreatic cancer
5545680|NCT01104116|Pancreatic Cancer|pancreatic cancer
5545681|NCT01104116|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5545682|NCT01104116|Pre-cancerous pancreatic lesion|pre-cancerous pancreatic lesion
5545683|NCT01104116|PET Scan|pet scan
5548286|NCT01094158|NASH|nash
5545684|NCT01104116|Pancreatic Cancer Screening|pancreatic cancer screening
5545685|NCT01104103|Catheterization, Peripheral|catheterization, peripheral
5545686|NCT01104103|Disposable Equipment|disposable equipment
5545687|NCT01104103|Emergency Medical Technicians|emergency medical technicians
5545688|NCT01104103|Emergency Nursing|emergency nursing
5545689|NCT01104090|C-MAC|c-mac
5545690|NCT01104090|direct laryngoscopy|direct laryngoscopy
5545691|NCT01104090|indirect laryngoscopy|indirect laryngoscopy
5545692|NCT01104090|to determine the safety and efficacy of the C-MAC|to determine the safety and efficacy of the c-mac
5545693|NCT01104077|Pancreatic Cancer|pancreatic cancer
5545694|NCT01104077|Family History|family history
5545695|NCT01104077|Pre-cancerous lesion|pre-cancerous lesion
5545696|NCT01104077|Intraductal Papillary Mucinous Neoplasm (IPMN)|intraductal papillary mucinous neoplasm (ipmn)
5545697|NCT01104077|Intraductal Papillary Mucinous Neoplasm|intraductal papillary mucinous neoplasm
5545698|NCT01104064|Stroke|stroke
5545699|NCT01104038|physical activity|physical activity
5545700|NCT01104038|cardiometabolic risk|cardiometabolic risk
5545701|NCT01104038|children|children
5545702|NCT01104025|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5545703|NCT01104025|hybrid immunotherapy|hybrid immunotherapy
5545704|NCT01104025|dexamethasone|dexamethasone
5545705|NCT01104025|Etoposide|etoposide
5545706|NCT01104025|ATG,rabbit|atg,rabbit
5545707|NCT01103999|spleen|spleen
5545708|NCT01103986|health literacy|health literacy
5545709|NCT01103986|consumer health information|consumer health information
5545710|NCT01103986|patient education as topics/methods|patient education as topics/methods
5545711|NCT01103986|patient participation|patient participation
5545712|NCT01103973|IVF, Mind/Body|ivf, mind/body
5545713|NCT01103947|Anesthesia induction|anesthesia induction
5545714|NCT01103947|Facemask|facemask
5545715|NCT01103947|surgery|surgery
5545716|NCT01103921|sugar|sugar
5545717|NCT01103921|fructose|fructose
5545718|NCT01103921|glucose|glucose
5545719|NCT01103921|HFCS|hfcs
5545720|NCT01103921|metabolism|metabolism
5545721|NCT01103908|cardiac output|cardiac output
5545722|NCT01103908|cardiopulmonary bypass|cardiopulmonary bypass
5545723|NCT01103908|ultrasound dilution|ultrasound dilution
5545724|NCT01103895|cardiac output|cardiac output
5545725|NCT01103895|cardiopulmonary bypass|cardiopulmonary bypass
5545726|NCT01103895|ultrasound dilution|ultrasound dilution
5545727|NCT01103856|HIV|hiv
5545728|NCT01103856|adherence to care|adherence to care
5545729|NCT01103856|retention in care|retention in care
5545730|NCT01103856|patient navigation|patient navigation
5545731|NCT01103843|Coronary artery disease|coronary artery disease
5545732|NCT01103843|clopidogrel|clopidogrel
5545733|NCT01103843|prasugrel|prasugrel
5545734|NCT01103843|Verify Now|verify now
5545735|NCT01103843|PRU measurements|pru measurements
5545736|NCT01103843|Drug eluting stents (EDS)|drug eluting stents (eds)
5545737|NCT01103843|P2Y12|p2y12
5545738|NCT01103843|Platelet reactivity|platelet reactivity
5545739|NCT01103830|P. falciparum Malaria, Eurartesim, ACT|p. falciparum malaria, eurartesim, act
5545740|NCT01103817|Type 1 Diabetes|type 1 diabetes
5545741|NCT01103817|Adolescents and Young Adults|adolescents and young adults
5545743|NCT01103817|Cardiovascular Disease|cardiovascular disease
5545744|NCT01103804|GerdQ questionnaire|gerdq questionnaire
5545745|NCT01103778|Chronic kidney disease|chronic kidney disease
5545746|NCT01103778|IgA nephropathy|iga nephropathy
5545747|NCT01103778|Velcade®|velcade®
5545748|NCT01103778|Proteinuria|proteinuria
5545749|NCT01103778|Bortezomib|bortezomib
5545750|NCT01103778|Proteasome inhibitor|proteasome inhibitor
5545751|NCT01103765|Post-dilatation|post-dilatation
5545752|NCT01103765|noncompliant balloon|noncompliant balloon
5545753|NCT01103765|optimal stent deployment of drug-eluting stent|optimal stent deployment of drug-eluting stent
5545754|NCT01103765|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
5545755|NCT01103765|Optimal stent deployment defined by intravascular ultrasound analysis|optimal stent deployment defined by intravascular ultrasound analysis
5545756|NCT01103739|pharmacokinetics|pharmacokinetics
5545757|NCT01103739|drug-drug interaction|drug-drug interaction
5545759|NCT01103726|regional cerebral glucose metabolism|regional cerebral glucose metabolism
5545760|NCT01103726|striatum|striatum
5545761|NCT01103726|PDE10 inhibitor|pde10 inhibitor
5545762|NCT01103713|P. falciparum malaria|p. falciparum malaria
5545763|NCT01103713|asymptomatic parasitemia|asymptomatic parasitemia
5545764|NCT01103713|parasitological clearance|parasitological clearance
5545765|NCT01103713|Intermittent Preventive Treatment of Falciparum Malaria in Pregnant Women (IPTp)|intermittent preventive treatment of falciparum malaria in pregnant women (iptp)
5545766|NCT01103700|Quality of dying and death of terminal cancer patients|quality of dying and death of terminal cancer patients
5545767|NCT01103687|HIV Preventive Vaccine|hiv preventive vaccine
5545768|NCT01103674|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5545769|NCT01103674|AF|af
5545770|NCT01103674|Atrial Fibrillation|atrial fibrillation
5545771|NCT01103674|RF ablation|rf ablation
5545772|NCT01103661|Longstanding Persistent Atrial Fibrillation|longstanding persistent atrial fibrillation
5545773|NCT01103661|AF|af
5545774|NCT01103661|Chronic AF|chronic af
5545775|NCT01103661|RF Ablation|rf ablation
5545776|NCT01103661|nContact Surgical|ncontact surgical
5545777|NCT01103661|Therapy Cool Path Ablation Catheter|therapy cool path ablation catheter
5545778|NCT01103661|St. Jude Medical|st. jude medical
5545779|NCT01103648|Prediabetes|prediabetes
5545780|NCT01103648|Statin|statin
5545781|NCT01103648|Ezetimibe|ezetimibe
5545782|NCT01103648|Pleiotropic effects|pleiotropic effects
5545783|NCT01103648|Cardiometabolic risk|cardiometabolic risk
5545784|NCT01103622|Diabetes|diabetes
5545785|NCT01103622|Type 2|type 2
5545786|NCT01103622|Digoxin|digoxin
5545787|NCT01103622|drug-drug interaction|drug-drug interaction
5545788|NCT01103609|Diabetes|diabetes
5545789|NCT01103609|Type 2|type 2
5545790|NCT01103609|Warfarin|warfarin
5545791|NCT01103609|drug-drug interaction|drug-drug interaction
5545792|NCT01103596|Evaluation of the impact of Kaletra on antiretroviral resistance|evaluation of the impact of kaletra on antiretroviral resistance
5545793|NCT01103570|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5545794|NCT01103570|Intra-operative cholangiography|intra-operative cholangiography
5545795|NCT01103557|Papillary thyroid carcinoma with neck metastasis|papillary thyroid carcinoma with neck metastasis
5545796|NCT01103557|neck dissection|neck dissection
5545797|NCT01103544|TCCU|tccu
5545798|NCT01103544|advanced TCCU|advanced tccu
5545799|NCT01103544|metastatic TCCU|metastatic tccu
5545800|NCT01103544|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5545801|NCT01103544|advanced transitional cell carcinoma of the urothelium|advanced transitional cell carcinoma of the urothelium
5545802|NCT01103544|metastatic transitional cell carcinoma of the urothelium|metastatic transitional cell carcinoma of the urothelium
5545803|NCT01103544|Cisplatinum failure|cisplatinum failure
5545804|NCT01103544|Vinflunine|vinflunine
5545805|NCT01103544|Javlor|javlor
5545806|NCT01103544|daily routine|daily routine
5545807|NCT01103544|concomitant antiemetic treatment|concomitant antiemetic treatment
5545808|NCT01103544|concomitant antiobstipative treatment|concomitant antiobstipative treatment
5545809|NCT01103544|concomitant antiobstipative diet|concomitant antiobstipative diet
5545810|NCT01103544|patient compliance|patient compliance
5545811|NCT01103544|quality of life|quality of life
5545812|NCT01103544|non-interventional study|non-interventional study
5545813|NCT01103544|Germany|germany
5545814|NCT01103544|Advanced / metastatic TCCU after Cisplatinum-failure|advanced / metastatic tccu after cisplatinum-failure
5545815|NCT01103531|Methamphetamine|methamphetamine
5545816|NCT01103531|Methamphetamine Dependence|methamphetamine dependence
5545817|NCT01103531|Methamphetamine Treatment|methamphetamine treatment
5545818|NCT01103531|Aerobic Exercise|aerobic exercise
5532484|NCT01157169|Healthy|healthy
5545819|NCT01103531|Resistance Exercise|resistance exercise
5545820|NCT01103531|Brain Imaging|brain imaging
5545821|NCT01103531|D2 and D3 receptor availability|d2 and d3 receptor availability
5545822|NCT01103518|Menstrual irregularity|menstrual irregularity
5545823|NCT01103518|Menstruation disturbances|menstruation disturbances
5545824|NCT01103518|Hyperandrogenism|hyperandrogenism
5545825|NCT01103505|AMD|amd
5545826|NCT01103505|CNV|cnv
5545827|NCT01103492|prostate cancer|prostate cancer
5545828|NCT01103492|endometrial cancer|endometrial cancer
5545829|NCT01103492|radiation proctitis|radiation proctitis
5545830|NCT01103492|pelvic radiotherapy|pelvic radiotherapy
5545831|NCT01103492|rectal bleeding|rectal bleeding
5545832|NCT01103479|Early Detection of Cancer|early detection of cancer
5545833|NCT01103479|Colorectal Cancer Screening|colorectal cancer screening
5545834|NCT01103466|Ileostomy base plate|ileostomy base plate
5545835|NCT01103453|MCI|mci
5545836|NCT01103453|Executive Function|executive function
5545837|NCT01103453|ADL|adl
5545838|NCT01103453|Virtual Supermarket|virtual supermarket
5545839|NCT01103440|Major Adverse Cardiovascular Event|major adverse cardiovascular event
5545840|NCT01103440|MACE|mace
5545841|NCT01103440|Death|death
5545842|NCT01103440|MI|mi
5545843|NCT01103440|CK MB greater 3x Normal|ck mb greater 3x normal
5545844|NCT01103440|Urgent Revascularization|urgent revascularization
5545845|NCT01103440|Stent Thrombosis|stent thrombosis
5545846|NCT01103440|Bleeding|bleeding
5545847|NCT01103427|smoking cessation|smoking cessation
5545848|NCT01103427|telemedicine|telemedicine
5545849|NCT01103427|smoking|smoking
5545850|NCT01103427|prevention intervention|prevention intervention
5545851|NCT01103427|internet-based|internet-based
5545852|NCT01103427|text messages|text messages
5545853|NCT01103427|behavioral|behavioral
5545854|NCT01103414|Diabetes|diabetes
5545855|NCT01103388|Rituximab|rituximab
5545856|NCT01103388|Rituxan|rituxan
5545857|NCT01103388|Lymphoma|lymphoma
5545858|NCT01103388|High dose chemotherapy|high dose chemotherapy
5545859|NCT01103388|Autologous transplantation|autologous transplantation
5545860|NCT01103388|Autologous stem cell transplant|autologous stem cell transplant
5545861|NCT01103388|ASCT|asct
5545862|NCT01103336|Patients with chronic renal failure undergoing coronary angiography|patients with chronic renal failure undergoing coronary angiography
5545864|NCT01103310|Neoplasm|neoplasm
5545865|NCT01103310|PET/CT diagnosis|pet/ct diagnosis
5545866|NCT01103310|PET tracer|pet tracer
5545867|NCT01103297|Distal radius fracture|distal radius fracture
5545868|NCT01103297|Double row plate|double row plate
5545869|NCT01103297|Volar approach|volar approach
5545870|NCT01103297|DVR plate|dvr plate
5545871|NCT01103297|Postoperative complications [MeSH]|postoperative complications [mesh]
5545872|NCT01103284|beta-cells|beta-cells
5545873|NCT01103284|autoimmune|autoimmune
5545874|NCT01103284|Diabetes|diabetes
5545875|NCT01103284|immunomodulation|immunomodulation
5545876|NCT01103271|depression|depression
5545877|NCT01103271|placebo effect|placebo effect
5545878|NCT01103271|complementary therapies|complementary therapies
5545879|NCT01103271|alternative therapies|alternative therapies
5545880|NCT01103258|Incompetence of the great saphenous vein.|incompetence of the great saphenous vein.
5545881|NCT01103245|Glucose|glucose
5545882|NCT01103245|Insulin|insulin
5545883|NCT01103232|Cross education|cross education
5545884|NCT01103232|Muscle training|muscle training
5545885|NCT01103219|VLBW|vlbw
5545886|NCT01103219|nutrition|nutrition
5545887|NCT01103219|vitamin A|vitamin a
5545888|NCT01103219|long-chain unsaturated fatty acids|long-chain unsaturated fatty acids
5545889|NCT01103219|growth|growth
5545890|NCT01103219|cognitive functions|cognitive functions
5528511|NCT01173913|MTD|mtd
5790020|NCT00146107|exercise|exercise
5545891|NCT01103219|Very low birth weight infants (birth weight below 1,500 grams).|very low birth weight infants (birth weight below 1,500 grams).
5545892|NCT01103206|Parathyroid hormone|parathyroid hormone
5545893|NCT01103206|Cinacalcet|cinacalcet
5545894|NCT01103206|Primary hyperparathyroidism|primary hyperparathyroidism
5545895|NCT01103206|Diagnosis|diagnosis
5545896|NCT01103193|ASA class I/II patients, with surgery under general anesthesia|asa class i/ii patients, with surgery under general anesthesia
5545897|NCT01103180|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5545898|NCT01103180|Escitalopram|escitalopram
5545899|NCT01103180|Borderline Personality Disorder|borderline personality disorder
5545900|NCT01103180|Major Depressive Disorder|major depressive disorder
5545901|NCT01103180|Self-harm|self-harm
5545902|NCT01103167|body composition|body composition
5545903|NCT01103167|blood pressure|blood pressure
5545904|NCT01103167|hemodialysis|hemodialysis
5545905|NCT01103154|beta blocker|beta blocker
5545906|NCT01103154|variceal rebleeding|variceal rebleeding
5545907|NCT01103154|efficacy and safety in reducing variceal rebleeding|efficacy and safety in reducing variceal rebleeding
5545908|NCT01103141|Vascular Surgical Procedures|vascular surgical procedures
5545909|NCT01103141|Angioplasty|angioplasty
5545910|NCT01103141|Radiology, Interventional|radiology, interventional
5545911|NCT01103128|Pancreatic Cancer|pancreatic cancer
5545912|NCT01103128|Pre-neoplastic lesions|pre-neoplastic lesions
5545913|NCT01103128|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
5545914|NCT01103128|BRCA1/2|brca1/2
5545915|NCT01103128|Mouse model for pancreatic cancer|mouse model for pancreatic cancer
5545916|NCT01103115|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5545918|NCT01103115|low bone mass|low bone mass
5545919|NCT01103115|osteopenia|osteopenia
5545920|NCT01103115|bone health|bone health
5545921|NCT01103115|bone density|bone density
5545922|NCT01103102|Gingivitis|gingivitis
5545923|NCT01103102|Biological Markers|biological markers
5545924|NCT01103089|NSCLC|nsclc
5545925|NCT01103089|EGFR|egfr
5545926|NCT01103089|gefitinib|gefitinib
5545927|NCT01103089|observational|observational
5545928|NCT01103076|Immune dysfunction|immune dysfunction
5545929|NCT01103076|Hemodialysis|hemodialysis
5545930|NCT01103076|HBV|hbv
5545931|NCT01103076|Vaccination|vaccination
5545932|NCT01103076|Immune response|immune response
5545933|NCT01103063|P. falciparum malaria|p. falciparum malaria
5545934|NCT01103063|IPTp|iptp
5545935|NCT01103050|Allergic inflammation|allergic inflammation
5545936|NCT01103050|Seasonal rhinitis|seasonal rhinitis
5545937|NCT01103037|Mild|mild
5545938|NCT01103037|Moderate|moderate
5545939|NCT01103037|Asthma|asthma
5545940|NCT01103024|Active uveitis|active uveitis
5545941|NCT01103024|intermediate uveitis|intermediate uveitis
5545942|NCT01103024|panuveitis|panuveitis
5545943|NCT01103024|posterior uveitis|posterior uveitis
5545944|NCT01103024|uveitis|uveitis
5545945|NCT01102998|Sleep complaints|sleep complaints
5545946|NCT01102998|Brain Tumor Survivors|brain tumor survivors
5545947|NCT01102985|exercise|exercise
5545948|NCT01102985|physical activity|physical activity
5545949|NCT01102985|intervention|intervention
5545950|NCT01102985|cancer survivor|cancer survivor
5545951|NCT01102972|HIV-1|hiv-1
5545952|NCT01102972|HIV|hiv
5545953|NCT01102959|EDUCATION|education
5545954|NCT01102959|DIABETES MELLITUS|diabetes mellitus
5545955|NCT01102959|ADOLESCENT|adolescent
5545956|NCT01102959|DIABETIC DIET|diabetic diet
5545957|NCT01102946|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5545958|NCT01102946|retinal neovascularization|retinal neovascularization
5545959|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors
5545960|NCT01102946|ranibizumab|ranibizumab
5545961|NCT01102946|laser|laser
5545962|NCT01102920|Obstructive sleep apnea|obstructive sleep apnea
5545963|NCT01102920|Obesity|obesity
5545964|NCT01102920|Behavioural medicine|behavioural medicine
5545965|NCT01102920|Physical therapy|physical therapy
5545966|NCT01102920|Health behaviour change|health behaviour change
5545967|NCT01102920|Physical activity|physical activity
5545968|NCT01102920|Eating habits|eating habits
5545969|NCT01102907|Appetite|appetite
5545970|NCT01102907|Satiety|satiety
5545971|NCT01102907|Gastric Emptying Time|gastric emptying time
5545972|NCT01102907|Food Intake|food intake
5545973|NCT01102907|Food Form|food form
5545974|NCT01102881|Healthy adults|healthy adults
5545975|NCT01102829|Knee Joint|knee joint
5545976|NCT01102829|Arthroplasty|arthroplasty
5545977|NCT01102829|Replacement|replacement
5545978|NCT01102829|Knee|knee
5545979|NCT01102816|hemodialysis|hemodialysis
5545980|NCT01102816|end-stage renal disease|end-stage renal disease
5545981|NCT01102816|pain|pain
5545982|NCT01102816|acupuncture|acupuncture
5545983|NCT01102803|Phobias|phobias
5545984|NCT01102803|Anxiety Disorders|anxiety disorders
5545985|NCT01102803|D-Cycloserine|d-cycloserine
5545986|NCT01102803|Phobic Disorders|phobic disorders
5545987|NCT01102803|Mental Disorders|mental disorders
5545988|NCT01102803|Heights|heights
5545989|NCT01102803|Acrophobia|acrophobia
5545991|NCT01102777|internet|internet
5545992|NCT01102777|walking|walking
5545993|NCT01102764|Anxiety Disorders: PTSD|anxiety disorders: ptsd
5545994|NCT01102764|Prolong Exposure (PE)|prolong exposure (pe)
5545995|NCT01102764|Telemedicine|telemedicine
5545996|NCT01102764|cost effectiveness|cost effectiveness
5545997|NCT01102764|deployment related problems|deployment related problems
5545998|NCT01102764|mental health care delivery|mental health care delivery
5545999|NCT01102751|fibroblast growth factor 23|fibroblast growth factor 23
5546000|NCT01102751|Osteomalacia|osteomalacia
5546001|NCT01102751|vitamin D|vitamin d
5546002|NCT01102725|Colon Surgery|colon surgery
5546003|NCT01102725|Rectal Surgery|rectal surgery
5546004|NCT01102725|Colorectal Surgery|colorectal surgery
5546005|NCT01102712|Emphysema|emphysema
5546006|NCT01102712|COPD|copd
5546007|NCT01102712|Lung Volume Reduction|lung volume reduction
5546008|NCT01102712|BTVA|btva
5546009|NCT01102699|Diabetes|diabetes
5546010|NCT01102699|stem cells|stem cells
5546011|NCT01102699|bone marrow|bone marrow
5546012|NCT01102699|mobilization|mobilization
5546013|NCT01102686|Late-onset GM2-gangliosidosis|late-onset gm2-gangliosidosis
5546014|NCT01102686|pyrimethamine|pyrimethamine
5546015|NCT01102673|phase 1|phase 1
5546016|NCT01102673|safety and tolerability|safety and tolerability
5546018|NCT01102673|T2DM|t2dm
5546019|NCT01102673|type 2 diabetes mellitus|type 2 diabetes mellitus
5546020|NCT01102660|Knee osteoarthritis|knee osteoarthritis
5546021|NCT01102660|clinical trial|clinical trial
5546022|NCT01102660|cross-over|cross-over
5546023|NCT01102621|hearing loss|hearing loss
5546024|NCT01102621|head and neck cancer|head and neck cancer
5546025|NCT01102621|radiotherapy|radiotherapy
5546026|NCT01102621|hearing complaint|hearing complaint
5546027|NCT01102621|Hearing loss due to the exposure of radiotherapy|hearing loss due to the exposure of radiotherapy
5546029|NCT01102608|ifosfamide|ifosfamide
5546030|NCT01102595|Unresectable/inoperable glioblastomas|unresectable/inoperable glioblastomas
5546031|NCT01102582|Parkinson's disease dementia, neuropsychiatric symptoms|parkinson's disease dementia, neuropsychiatric symptoms
5862961|NCT00001444|Natural Products|natural products
5546032|NCT01102569|Hereditary pancreatic cancer|hereditary pancreatic cancer
5546033|NCT01102569|Breast and Ovarian Cancer Syndrome|breast and ovarian cancer syndrome
5546034|NCT01102569|BRCA1/2|brca1/2
5546035|NCT01102569|Ashkenazi Jewish patients|ashkenazi jewish patients
5546036|NCT01102556|Pancreatic Cancer|pancreatic cancer
5546037|NCT01102556|Pre-Neoplastic Lesions|pre-neoplastic lesions
5546038|NCT01102556|Pancreatic Cancer Surgery|pancreatic cancer surgery
5546039|NCT01102556|High-Risk for Pancreatic Cancer|high-risk for pancreatic cancer
5546040|NCT01102556|Tissue and Blood Bank for Pancreatic Cancer|tissue and blood bank for pancreatic cancer
5546041|NCT01102556|Pancreatic Cancer Questionnaire|pancreatic cancer questionnaire
5546042|NCT01102543|pulmonary surfactant|pulmonary surfactant
5546043|NCT01102543|Respiratory distress syndrome|respiratory distress syndrome
5546044|NCT01102543|Newborn|newborn
5546045|NCT01102543|prophylaxis|prophylaxis
5546046|NCT01102517|NSCLC|nsclc
5546047|NCT01102517|Clinical|clinical
5546048|NCT01102517|Early-stage|early-stage
5546049|NCT01102504|carotid atheroma|carotid atheroma
5546050|NCT01102504|plaque vulnerability|plaque vulnerability
5546052|NCT01102491|postoperative nausea and vomiting|postoperative nausea and vomiting
5546053|NCT01102439|Clopidogrel|clopidogrel
5546054|NCT01102439|Aspirin|aspirin
5546055|NCT01102439|Interaction|interaction
5546056|NCT01102426|Multiple Myeloma|multiple myeloma
5546057|NCT01102426|Aplidin|aplidin
5546058|NCT01102426|plitidepsin|plitidepsin
5546059|NCT01102426|dexamethasone|dexamethasone
5546060|NCT01102400|cancer|cancer
5546061|NCT01102400|tumor|tumor
5546062|NCT01102400|hepatocellular carcinoma|hepatocellular carcinoma
5847206|NCT00040508|Renal Failure|renal failure
5546063|NCT01102387|Candida infections in intertriginous areas|candida infections in intertriginous areas
5546064|NCT01102374|Vitamin D Deficiency|vitamin d deficiency
5546065|NCT01102374|Respiratory Infection|respiratory infection
5546066|NCT01102374|Nursing Home Residents|nursing home residents
5546068|NCT01102374|Immunosenescence|immunosenescence
5546069|NCT01102374|Prevention|prevention
5546070|NCT01102348|Critically Ill|critically ill
5546071|NCT01102348|Nutrition Therapy|nutrition therapy
5546072|NCT01102348|Enteral Nutrition|enteral nutrition
5546073|NCT01102335|hepatitis B virus|hepatitis b virus
5546074|NCT01102335|Antiviral Agents|antiviral agents
5546075|NCT01102335|Liver Neoplasms|liver neoplasms
5546076|NCT01102335|Drug Toxicity|drug toxicity
5546077|NCT01102335|Survival|survival
5546078|NCT01102322|Acute respiratory distress syndrome|acute respiratory distress syndrome
5546079|NCT01102309|cerebrovascular accident|cerebrovascular accident
5546080|NCT01102309|hemiparesis|hemiparesis
5546081|NCT01102309|recovery of function|recovery of function
5546082|NCT01102309|rehabilitation|rehabilitation
5546083|NCT01102309|robotics|robotics
5546084|NCT01102309|subacute therapy|subacute therapy
5546085|NCT01102309|training|training
5546086|NCT01102296|hepatitis A vaccine|hepatitis a vaccine
5546087|NCT01102296|male homosexual|male homosexual
5546088|NCT01102296|HIV infection|hiv infection
5546089|NCT01102296|male homosexuals who are seronegative for hepatitis A virus|male homosexuals who are seronegative for hepatitis a virus
5546090|NCT01102283|Colonic obstruction|colonic obstruction
5546091|NCT01102270|Obstructive sleep apnea|obstructive sleep apnea
5546092|NCT01102270|Arousal threshold|arousal threshold
5546093|NCT01102270|Sedative medication|sedative medication
5546094|NCT01102270|upper airway|upper airway
5546095|NCT01102257|Dry Eye Disease|dry eye disease
5546097|NCT01102257|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5546098|NCT01102257|Omega-3|omega-3
5546099|NCT01102244|blepharitis|blepharitis
5546100|NCT01102244|moderate to severe chronic blepharitis|moderate to severe chronic blepharitis
5546101|NCT01102218|Anemia, ESRD|anemia, esrd
5546102|NCT01102192|Myasthenia gravis|myasthenia gravis
5546103|NCT01102192|Thymoma|thymoma
5546104|NCT01102192|T-cells|t-cells
5546105|NCT01102192|Thymectomy|thymectomy
5546106|NCT01102166|This study was conducted in healthy subjects|this study was conducted in healthy subjects
5546107|NCT01102153|sudden cardiac arrest|sudden cardiac arrest
5546108|NCT01102153|Hypothermia|hypothermia
5546109|NCT01102153|Coolgard|coolgard
5546110|NCT01102153|arctic sun|arctic sun
5546111|NCT01102153|neurological outcome|neurological outcome
5546112|NCT01102153|neuron specific enolase|neuron specific enolase
5798716|NCT00111280|TMC125|tmc125
5546113|NCT01102140|Cardiomyopathy|cardiomyopathy
5546114|NCT01102140|Heart Failure|heart failure
5546115|NCT01102127|elastography|elastography
5546116|NCT01102127|thyroid nodule|thyroid nodule
5546117|NCT01102127|fine-needle aspiration|fine-needle aspiration
5546118|NCT01102114|Smoking Cessation|smoking cessation
5546119|NCT01102114|NicVAX|nicvax
5546120|NCT01102114|Smoking Vaccine|smoking vaccine
5546121|NCT01102114|Smoking Abstinence|smoking abstinence
5546122|NCT01102114|Smoking|smoking
5546123|NCT01102114|Tobacco Cessation|tobacco cessation
5546124|NCT01102101|Remifentanil|remifentanil
5546125|NCT01102101|Hyperalgesia|hyperalgesia
5546126|NCT01102101|Zoster|zoster
5546127|NCT01102101|Postherpetic neuralgia|postherpetic neuralgia
5546128|NCT01102088|Cancer|cancer
5546129|NCT01102088|Gastroesophageal|gastroesophageal
5546130|NCT01102088|Simultaneous Integrated Boost|simultaneous integrated boost
5546131|NCT01102088|SIB|sib
5546142|NCT01102075|Sham electroacupuncture|sham electroacupuncture
5546143|NCT01102075|Waist circumference|waist circumference
5546144|NCT01102075|Thickness of subcutaneous fat|thickness of subcutaneous fat
5546145|NCT01102036|Transit time|transit time
5546146|NCT01102036|constipation|constipation
5546147|NCT01102036|gut regularity|gut regularity
5546148|NCT01102036|defecation frequency|defecation frequency
5546149|NCT01102036|Colonic transit time|colonic transit time
5546150|NCT01102010|Blood transfusion|blood transfusion
5546151|NCT01102010|Hip fracture|hip fracture
5546152|NCT01102010|Elderly|elderly
5546153|NCT01102010|Geriatrics|geriatrics
5546154|NCT01102010|Hospitalization|hospitalization
5546155|NCT01102010|Frail elderly|frail elderly
5546156|NCT01101997|Lipolysis|lipolysis
5546157|NCT01101997|Cryolipolysis|cryolipolysis
5546158|NCT01101997|Fat Reduction|fat reduction
5546159|NCT01101971|Education, Medical|education, medical
5546160|NCT01101971|Students, Medical|students, medical
5546161|NCT01101971|Gynecology|gynecology
5546162|NCT01101971|Physical Examination|physical examination
5548680|NCT01092546|Amyloid|amyloid
5546163|NCT01101971|Computer-Assisted Instruction|computer-assisted instruction
5546164|NCT01101945|diabetes|diabetes
5546165|NCT01101945|DPP4 inhibitor|dpp4 inhibitor
5546166|NCT01101945|dutogliptin|dutogliptin
5546167|NCT01101945|PHX1149|phx1149
5546168|NCT01101932|Safety|safety
5546169|NCT01101932|Tolerability|tolerability
5546170|NCT01101932|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5546171|NCT01101932|Rheumatoid Arthritis|rheumatoid arthritis
5546172|NCT01101932|healthy volunteers|healthy volunteers
5546173|NCT01101919|Rheumatoid Arthritis|rheumatoid arthritis
5546175|NCT01101906|OSI-906|osi-906
5546176|NCT01101906|Hepatocellular Carcinoma|hepatocellular carcinoma
5546177|NCT01101893|GSK2248761, raltegravir, drug interaction, pharmacokinetics|gsk2248761, raltegravir, drug interaction, pharmacokinetics
5546178|NCT01101867|diabetes|diabetes
5546179|NCT01101867|glucose|glucose
5546180|NCT01101867|hospital|hospital
5546181|NCT01101854|gene expression in wounds|gene expression in wounds
5546182|NCT01101854|healing wounds|healing wounds
5546183|NCT01101854|non-healing wounds|non-healing wounds
5546184|NCT01101854|punch biopsy|punch biopsy
5546185|NCT01101854|debridement|debridement
5546186|NCT01101841|Vasomotor Symptoms|vasomotor symptoms
5546187|NCT01101841|Menopause|menopause
5546188|NCT01101841|Hot Flashes|hot flashes
5546189|NCT01101841|Perimenopause|perimenopause
5546190|NCT01101841|Nonhormonal therapies|nonhormonal therapies
5546191|NCT01101841|Climacteric symptoms|climacteric symptoms
5546192|NCT01101841|Mesafem|mesafem
5546193|NCT01101841|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5546194|NCT01101815|Viral Loads|viral loads
5546195|NCT01101815|Naltrexone|naltrexone
5546196|NCT01101815|HIV Risk|hiv risk
5546198|NCT01101802|SLE|sle
5546199|NCT01101802|Atherosclerosis|atherosclerosis
5546200|NCT01101802|Endothelial function|endothelial function
5546201|NCT01101802|Mycophenolate mofetil|mycophenolate mofetil
5528774|NCT01172860|Colorectal|colorectal
5546202|NCT01101789|surgical wound infection|surgical wound infection
5546203|NCT01101789|triclosan-coated suture|triclosan-coated suture
5546204|NCT01101776|Multiple Sclerosis, relapsing|multiple sclerosis, relapsing
5546205|NCT01101776|Rebif New Formulation|rebif new formulation
5546206|NCT01101776|Interferon beta-1a|interferon beta-1a
5546207|NCT01101750|Gardasil|gardasil
5546208|NCT01101750|HPV|hpv
5546209|NCT01101750|transplant|transplant
5546210|NCT01101750|adolescent|adolescent
5546211|NCT01101750|prevention|prevention
5546212|NCT01101750|vaccine|vaccine
5546213|NCT01101750|immunogenicity|immunogenicity
5546214|NCT01101750|vaccination|vaccination
5546215|NCT01101737|Hypertension, clinical trial, nurse-led clinic, primary care|hypertension, clinical trial, nurse-led clinic, primary care
5546216|NCT01101724|mild traumatic brain injury|mild traumatic brain injury
5546217|NCT01101724|Concussion|concussion
5546218|NCT01101724|postconcussive syndrome|postconcussive syndrome
5546219|NCT01101698|Vitamin K|vitamin k
5546220|NCT01101698|chronic kidney disease|chronic kidney disease
5546221|NCT01101698|coronary artery calcification|coronary artery calcification
5517534|NCT01219595|UTI|uti
5546222|NCT01101698|intima media thickness|intima media thickness
5546223|NCT01101685|non-dysphoric|non-dysphoric
5546224|NCT01101685|Dysphoric|dysphoric
5540378|NCT01125410|Bacterial vaginosis|bacterial vaginosis
5546225|NCT01101672|Single port laparoscopic colectomy|single port laparoscopic colectomy
5546226|NCT01101659|Activity of JNJ-40411813|activity of jnj-40411813
5546227|NCT01101659|Challenge study|challenge study
5546228|NCT01101646|Rabeprazole sodium|rabeprazole sodium
5546229|NCT01101646|Pharmacokinetics|pharmacokinetics
5546230|NCT01101646|Biological Availability|biological availability
5546231|NCT01101646|Safety|safety
5546232|NCT01101646|Adult|adult
5546233|NCT01101633|Appetite|appetite
5546234|NCT01101633|Energy intake|energy intake
5546235|NCT01101633|gastric emptying|gastric emptying
5546236|NCT01101633|well being|well being
5546237|NCT01101633|Body weight|body weight
5546238|NCT01101607|Pediatrics|pediatrics
5546239|NCT01101607|Distal Forearm fractures|distal forearm fractures
5546240|NCT01101607|Pediatric Emergency Medicine|pediatric emergency medicine
5546241|NCT01101607|Pediatric Orthopedics|pediatric orthopedics
5546242|NCT01101594|Treatment|treatment
5546243|NCT01101594|Multiple Myeloma|multiple myeloma
5546244|NCT01101594|Relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
5546245|NCT01101581|Diffuse Large cell NHL|diffuse large cell nhl
5546246|NCT01101581|Mantle cell NHL|mantle cell nhl
5546247|NCT01101581|Lymphoblastic lymphoma|lymphoblastic lymphoma
5546248|NCT01101581|Diffuse mixed cell lymphoma|diffuse mixed cell lymphoma
5546249|NCT01101581|Diffuse large cell lymphoma|diffuse large cell lymphoma
5546250|NCT01101581|large noncleaved cell lymphoma|large noncleaved cell lymphoma
5546251|NCT01101568|GSK1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction|gsk1292263, rosuvastatin, simvastatin, pharmacokinetics, drug interaction
5546252|NCT01101555|Rheumatoid arthritis|rheumatoid arthritis
5546253|NCT01101555|repeat dose|repeat dose
5546254|NCT01101555|pharmacodynamics|pharmacodynamics
5546255|NCT01101555|pharmacokinetics|pharmacokinetics
5546256|NCT01101555|subcutaneous|subcutaneous
5546257|NCT01101555|safety|safety
5546258|NCT01101555|Otelixizumab|otelixizumab
5546259|NCT01101555|long term follow up|long term follow up
5847207|NCT00040508|Fibrosis|fibrosis
5546260|NCT01101555|tolerability|tolerability
5546261|NCT01101542|Post-marketing surveillance|post-marketing surveillance
5546262|NCT01101542|Human papillomavirus|human papillomavirus
5546263|NCT01101542|Korea|korea
5546264|NCT01101542|Safety|safety
5546265|NCT01101542|Prescribing Information|prescribing information
5546266|NCT01101529|Chemotherapy-induced nausea and vomiting CINV|chemotherapy-induced nausea and vomiting cinv
5546267|NCT01101503|Newly diagnosed type 2 diabetes|newly diagnosed type 2 diabetes
5546268|NCT01101503|Endothelial dysfunction|endothelial dysfunction
5546269|NCT01101503|Intensive therapy|intensive therapy
5546270|NCT01101503|Metabolic Memorial Effect|metabolic memorial effect
5546271|NCT01101490|To compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy|to compare the change of cerebral oxygen saturation and blood flow between right and left side in lateral decubitus position during nephrectomy
5546272|NCT01101477|Target-controlled infusion,|target-controlled infusion,
5546273|NCT01101477|bronchoscopy,|bronchoscopy,
5546274|NCT01101477|sedation,|sedation,
5546275|NCT01101477|propofol|propofol
5546276|NCT01101438|stage I breast cancer|stage i breast cancer
5546277|NCT01101438|stage II breast cancer|stage ii breast cancer
5546278|NCT01101438|stage IIIA breast cancer|stage iiia breast cancer
5546279|NCT01101438|stage IIIC breast cancer|stage iiic breast cancer
5546280|NCT01101438|male breast cancer|male breast cancer
5546281|NCT01101438|HER2-negative breast cancer|her2-negative breast cancer
5546282|NCT01101438|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5546283|NCT01101438|HER2-positive breast cancer|her2-positive breast cancer
5546284|NCT01101438|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5546285|NCT01101425|male|male
5546286|NCT01101425|breast cancer|breast cancer
5546287|NCT01101412|infection|infection
5790021|NCT00146107|diet|diet
5546288|NCT01101412|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5546289|NCT01101412|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5546290|NCT01101412|acute undifferentiated leukemia|acute undifferentiated leukemia
5546291|NCT01101412|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5546292|NCT01101412|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5546293|NCT01101412|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5546294|NCT01101412|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5546295|NCT01101412|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5546296|NCT01101412|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5546297|NCT01101412|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5546298|NCT01101412|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5517671|NCT01219010|QT|qt
5546299|NCT01101412|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5546300|NCT01101412|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5546301|NCT01101412|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5546302|NCT01101412|mast cell leukemia|mast cell leukemia
5546303|NCT01101412|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5546304|NCT01101412|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5546305|NCT01101412|prolymphocytic leukemia|prolymphocytic leukemia
5546306|NCT01101412|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5546307|NCT01101412|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5546308|NCT01101412|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5546309|NCT01101412|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5546310|NCT01101412|refractory hairy cell leukemia|refractory hairy cell leukemia
5546311|NCT01101412|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5546312|NCT01101412|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5546313|NCT01101412|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5546314|NCT01101412|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5546315|NCT01101412|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5546316|NCT01101412|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5546317|NCT01101412|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5546318|NCT01101412|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5546319|NCT01101412|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5546320|NCT01101412|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5546321|NCT01101412|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5546322|NCT01101412|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5546323|NCT01101412|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5546324|NCT01101412|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5546325|NCT01101412|untreated hairy cell leukemia|untreated hairy cell leukemia
5546326|NCT01101412|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5546327|NCT01101412|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5546328|NCT01101412|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5546329|NCT01101412|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5546330|NCT01101412|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5546331|NCT01101412|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5546332|NCT01101412|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5546333|NCT01101412|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5546334|NCT01101412|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5546335|NCT01101412|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5546475|NCT01101282|physical Therapy modalities|physical therapy modalities
5546336|NCT01101412|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5546337|NCT01101412|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5546338|NCT01101412|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5546339|NCT01101412|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5546340|NCT01101412|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5546341|NCT01101412|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5546342|NCT01101412|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5546343|NCT01101412|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5546344|NCT01101412|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5546345|NCT01101412|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5546347|NCT01101412|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5790022|NCT00146107|weight loss|weight loss
5546348|NCT01101412|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5546349|NCT01101412|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5546350|NCT01101412|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5546351|NCT01101412|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5546352|NCT01101412|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5546353|NCT01101412|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5546354|NCT01101412|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5546355|NCT01101412|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5546356|NCT01101412|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5546357|NCT01101412|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5546358|NCT01101412|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5546359|NCT01101412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5546360|NCT01101412|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5546361|NCT01101412|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5546362|NCT01101412|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5546363|NCT01101412|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5546364|NCT01101412|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5546365|NCT01101412|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5546366|NCT01101412|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5546367|NCT01101412|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5546368|NCT01101412|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5546369|NCT01101412|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5546370|NCT01101412|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5546371|NCT01101412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5546372|NCT01101412|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5546373|NCT01101412|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5546374|NCT01101412|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5546375|NCT01101412|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5546376|NCT01101412|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5546377|NCT01101412|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5546378|NCT01101412|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5546379|NCT01101412|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5546380|NCT01101412|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5546381|NCT01101412|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5546382|NCT01101412|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5546383|NCT01101412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5546384|NCT01101412|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5546385|NCT01101412|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5546386|NCT01101412|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5546387|NCT01101412|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5546388|NCT01101412|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5546389|NCT01101412|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5546390|NCT01101412|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5546391|NCT01101412|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5546392|NCT01101412|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5546393|NCT01101412|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5546394|NCT01101412|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5546395|NCT01101412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5546396|NCT01101412|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5546397|NCT01101412|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5546398|NCT01101412|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5546399|NCT01101412|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5546400|NCT01101412|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5546401|NCT01101412|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5546402|NCT01101412|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5546403|NCT01101412|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5546404|NCT01101412|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5546405|NCT01101412|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5529039|NCT01171885|Pain|pain
5546406|NCT01101412|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5546407|NCT01101412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5546408|NCT01101412|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5546409|NCT01101412|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5546410|NCT01101412|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5546411|NCT01101412|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5546412|NCT01101412|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5546413|NCT01101412|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5546414|NCT01101412|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5546415|NCT01101412|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5546416|NCT01101412|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5546417|NCT01101412|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5685372|NCT00556387|traumatic brain injury|traumatic brain injury
5546418|NCT01101412|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5546419|NCT01101412|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5546420|NCT01101412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5546421|NCT01101412|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5546422|NCT01101412|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5546424|NCT01101412|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5546425|NCT01101412|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5546426|NCT01101412|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5546427|NCT01101412|primary myelofibrosis|primary myelofibrosis
5546428|NCT01101412|essential thrombocythemia|essential thrombocythemia
5546430|NCT01101412|extramedullary plasmacytoma|extramedullary plasmacytoma
5546431|NCT01101412|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5546432|NCT01101412|stage I multiple myeloma|stage i multiple myeloma
5546433|NCT01101412|stage II multiple myeloma|stage ii multiple myeloma
5546434|NCT01101412|stage III multiple myeloma|stage iii multiple myeloma
5546435|NCT01101412|primary systemic amyloidosis|primary systemic amyloidosis
5546436|NCT01101412|refractory multiple myeloma|refractory multiple myeloma
5546437|NCT01101412|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5546438|NCT01101412|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5546439|NCT01101412|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5546440|NCT01101412|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5546442|NCT01101399|Lymphoproliferative Disorders|lymphoproliferative disorders
5546443|NCT01101399|Chemotherapy|chemotherapy
5546444|NCT01101399|ferric carboxymaltose|ferric carboxymaltose
5546445|NCT01101399|iron|iron
5546446|NCT01101386|Voriconazole|voriconazole
5546447|NCT01101386|SBECD|sbecd
5546448|NCT01101386|pharmacokinetics|pharmacokinetics
5546449|NCT01101386|Renal Failure|renal failure
5546450|NCT01101373|Limbic surgery|limbic surgery
5546451|NCT01101373|Stereotactic surgery|stereotactic surgery
5546452|NCT01101373|Major Depressive Disorder: Treatment Refractory|major depressive disorder: treatment refractory
5546453|NCT01101360|port wine stains|port wine stains
5546454|NCT01101360|radiofrequency|radiofrequency
5546455|NCT01101360|Pulse Dye Laser|pulse dye laser
5546456|NCT01101334|NSCLC|nsclc
5546457|NCT01101321|Healthy subjects|healthy subjects
5546458|NCT01101321|Opioid|opioid
5546459|NCT01101321|Healthy volunteers|healthy volunteers
5546460|NCT01101308|Healthy subjects|healthy subjects
5546461|NCT01101308|Opioid|opioid
5546462|NCT01101308|Healthy volunteers|healthy volunteers
5546463|NCT01101295|Immune Thrombocytopenia|immune thrombocytopenia
5546464|NCT01101295|Rituximab|rituximab
5546465|NCT01101295|side effects|side effects
5546466|NCT01101295|tolerance|tolerance
5546467|NCT01101295|safety|safety
5546468|NCT01101295|splenectomy|splenectomy
5546469|NCT01101295|serum sickness|serum sickness
5546470|NCT01101282|PEP|pep
5546471|NCT01101282|exacerbation|exacerbation
5546472|NCT01101282|physiotherapy|physiotherapy
5546473|NCT01101282|airway clearance|airway clearance
5546474|NCT01101282|sputum|sputum
5546476|NCT01101269|Diabetic nephropathy|diabetic nephropathy
5546477|NCT01101243|Vitamin D|vitamin d
5546478|NCT01101243|UVB|uvb
5546479|NCT01101243|Frequency|frequency
5546480|NCT01101243|Body surface area|body surface area
5546481|NCT01101243|Dose-Response|dose-response
5546482|NCT01101230|Cardiovascular disease|cardiovascular disease
5546483|NCT01101230|cholesterol|cholesterol
5546484|NCT01101230|low-density|low-density
5546485|NCT01101230|lipoprotein|lipoprotein
5546486|NCT01101230|high-density lipoprotein|high-density lipoprotein
5546487|NCT01101230|triglycerides|triglycerides
5546488|NCT01101217|hemocystein zinc renal failure|hemocystein zinc renal failure
5546490|NCT01101191|Opioid|opioid
5546491|NCT01101191|Healthy volunteers|healthy volunteers
5546492|NCT01101178|Healthy subjects|healthy subjects
5546493|NCT01101178|Opioid|opioid
5546494|NCT01101178|Healthy volunteers|healthy volunteers
5546495|NCT01101165|Healthy subjects|healthy subjects
5546496|NCT01101165|Opioid|opioid
5546497|NCT01101165|Healthy volunteers|healthy volunteers
5546498|NCT01101152|Antidepressant|antidepressant
5546499|NCT01101152|healthy volunteers|healthy volunteers
5546500|NCT01101152|desvenlafaxine succinate|desvenlafaxine succinate
5546501|NCT01101152|norepinephrine reuptake|norepinephrine reuptake
5546502|NCT01101152|serotonin reuptake|serotonin reuptake
5546503|NCT01101152|tyramine test|tyramine test
5546504|NCT01101126|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5546505|NCT01101126|Asthma|asthma
5546506|NCT01101113|peritoneal dialysis|peritoneal dialysis
5546507|NCT01101100|Psoriasis|psoriasis
5546508|NCT01101087|Dialysis|dialysis
5546509|NCT01101074|Swine Flu A (H1N1) vaccine|swine flu a (h1n1) vaccine
5546510|NCT01101074|Adjuvanted flu egg derived|adjuvanted flu egg derived
5546511|NCT01101074|Novel influenza A (H1N1): a new flu virus of swine origin|novel influenza a (h1n1): a new flu virus of swine origin
5546512|NCT01101061|Amgen|amgen
5546513|NCT01101061|Phase 1|phase 1
5546514|NCT01101061|Postmenopausal|postmenopausal
5546515|NCT01101061|Japanese|japanese
5546516|NCT01101048|Amgen|amgen
5546517|NCT01101048|Phase 1b|phase 1b
5546518|NCT01101048|Postmenopausal|postmenopausal
5546519|NCT01101048|Bone Mineral Density|bone mineral density
5546520|NCT01101035|Cardiovascular Outcomes|cardiovascular outcomes
5546521|NCT01101035|Heart Attack|heart attack
5546522|NCT01101035|Stroke|stroke
5546523|NCT01101035|Drug Therapy|drug therapy
5546524|NCT01101035|Physiology|physiology
5546525|NCT01101035|Hyperuricemia|hyperuricemia
5546526|NCT01101035|Uric Acid|uric acid
5546527|NCT01101009|Sevikar®|sevikar®
5546528|NCT01101009|Central Arterial Blood Pressure|central arterial blood pressure
5546529|NCT01100996|enteral nutrition|enteral nutrition
5546531|NCT01100996|innate immunity|innate immunity
5546532|NCT01100996|nutritional anti-inflammatory pathway|nutritional anti-inflammatory pathway
5546533|NCT01100996|intestinal damage|intestinal damage
5546534|NCT01100970|Caesarean section|caesarean section
5546535|NCT01100970|cortisol|cortisol
5546536|NCT01100970|stress|stress
5546537|NCT01100970|unipolar electric needle|unipolar electric needle
5546538|NCT01100970|bipolar electric needle|bipolar electric needle
5546539|NCT01100944|Gene Expression|gene expression
5546540|NCT01100944|HDAC Class I and II enzymes|hdac class i and ii enzymes
5546541|NCT01100944|Thymoma|thymoma
5546542|NCT01100944|Chemotherapy|chemotherapy
5546543|NCT01100944|Hydroxamic Acid Deacetylase Inhibitor|hydroxamic acid deacetylase inhibitor
5546544|NCT01100944|Thymic Cancer|thymic cancer
5546545|NCT01100931|NSCLC|nsclc
5546546|NCT01100931|Solid Tumors|solid tumors
5546547|NCT01100931|YM155|ym155
5546548|NCT01100931|Survivin|survivin
5546549|NCT01100931|Non Small-Cell Lung Cancer|non small-cell lung cancer
5546550|NCT01100931|Solid Tumor|solid tumor
5546551|NCT01100918|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5546552|NCT01100918|Tissue Doppler Imaging|tissue doppler imaging
5546553|NCT01100918|Dyssynchrony|dyssynchrony
5546554|NCT01100905|Iron|iron
5546555|NCT01100905|Iron status|iron status
5546556|NCT01100905|Iron deficiency|iron deficiency
5546557|NCT01100905|Iron deficiency anemia|iron deficiency anemia
5546558|NCT01100892|Pediatrics|pediatrics
5546559|NCT01100892|Pancreas|pancreas
5546560|NCT01100879|Anemia|anemia
5546561|NCT01100879|Lymphoproliferative Disorders|lymphoproliferative disorders
5546562|NCT01100879|Chemotherapy|chemotherapy
5546563|NCT01100879|ferric carboxymaltose|ferric carboxymaltose
5546564|NCT01100879|iron|iron
5546565|NCT01100866|clinically localized Prostate Cancer|clinically localized prostate cancer
5546566|NCT01100866|low and intermediate risk for relapse|low and intermediate risk for relapse
5546567|NCT01100866|candidates for radical prostatectomy|candidates for radical prostatectomy
5546568|NCT01100853|amphetamine dependence|amphetamine dependence
5546569|NCT01100853|amphetamine injection|amphetamine injection
5546570|NCT01100853|VIVITROL/VIVITROL placebo|vivitrol/vivitrol placebo
5546571|NCT01100853|amphetamine craving|amphetamine craving
5546572|NCT01100827|EGFR mutation status in patients with advanced stage adenocarcinoma NSCLC|egfr mutation status in patients with advanced stage adenocarcinoma nsclc
5546767|NCT01099982|Fibrosis|fibrosis
5546573|NCT01100827|The association between EGFR mutation status and demographic data in advanced stage adenocarcinoma NSCLC patients.|the association between egfr mutation status and demographic data in advanced stage adenocarcinoma nsclc patients.
5546574|NCT01100801|advanced|advanced
5546575|NCT01100801|metastatic|metastatic
5546576|NCT01100775|Galantamine|galantamine
5546577|NCT01100775|Schizophrenia|schizophrenia
5546578|NCT01100775|working memory|working memory
5546579|NCT01100775|cognitive|cognitive
5546580|NCT01100762|Parkinson's Disease|parkinson's disease
5546581|NCT01100762|Cranial Electric Stimulation|cranial electric stimulation
5546582|NCT01100762|Gait|gait
5546583|NCT01100749|Hepatitis C|hepatitis c
5546584|NCT01100749|Genotype 3|genotype 3
5546585|NCT01100749|Demographics|demographics
5546586|NCT01100749|Genetics|genetics
5546587|NCT01100749|Metabolic status|metabolic status
5546588|NCT01100736|Forearm Blood Flow|forearm blood flow
5546589|NCT01100736|Vasodilation|vasodilation
5546590|NCT01100736|Vasoconstriction|vasoconstriction
5546591|NCT01100736|Endothelin System|endothelin system
5546592|NCT01100736|Endothelin-1|endothelin-1
5546593|NCT01100736|Endothelin-3|endothelin-3
5546594|NCT01100736|Endothelin antagonists|endothelin antagonists
5546595|NCT01100736|Bosentan|bosentan
5546596|NCT01100736|Sitaxsentan|sitaxsentan
5546597|NCT01100736|Endothelin|endothelin
5546598|NCT01100736|Regional Blood Flow|regional blood flow
5546599|NCT01100723|secondary hyperparathyroidism|secondary hyperparathyroidism
5546600|NCT01100723|calcium|calcium
5546601|NCT01100723|phosphorus|phosphorus
5546602|NCT01100723|ESRD|esrd
5546603|NCT01100723|CKD|ckd
5546604|NCT01100723|mineral disorder|mineral disorder
5546605|NCT01100710|Age Gender left ventricular mass high sensitive Troponin T|age gender left ventricular mass high sensitive troponin t
5546606|NCT01100697|prenatal diagnosis|prenatal diagnosis
5546607|NCT01100697|ultrasound|ultrasound
5546608|NCT01100697|outcome|outcome
5546609|NCT01100697|spina bifida|spina bifida
5546610|NCT01100697|neural tube defect|neural tube defect
5546611|NCT01100684|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome
5546612|NCT01100671|atherosclerosis|atherosclerosis
5546613|NCT01100671|vascular inflammation|vascular inflammation
5546614|NCT01100671|MDCT|mdct
5546615|NCT01100671|18FDG-PET|18fdg-pet
5546616|NCT01100606|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5546617|NCT01100606|Infants with CF|infants with cf
5546618|NCT01100593|Ultrasound|ultrasound
5546619|NCT01100593|IV catheters|iv catheters
5546620|NCT01100593|Extravasation|extravasation
5546621|NCT01100580|Low-salt diet|low-salt diet
5546622|NCT01100580|calciuria|calciuria
5546623|NCT01100580|blood pressure|blood pressure
5546624|NCT01100580|nephrolithiasis|nephrolithiasis
5546625|NCT01100580|hypertension|hypertension
5546626|NCT01100580|BMI|bmi
5546627|NCT01100580|urinary stone risk factors|urinary stone risk factors
5546628|NCT01100567|skeletal health|skeletal health
5546629|NCT01100567|bone turnover|bone turnover
5546630|NCT01100567|bone geometry|bone geometry
5546631|NCT01100567|malnutrition|malnutrition
5546632|NCT01100541|Therapeutic Hyperthermia|therapeutic hyperthermia
5546633|NCT01100541|Thermotherapy|thermotherapy
5546634|NCT01100541|Polymers|polymers
5546635|NCT01100541|Castor Oil|castor oil
5546636|NCT01100515|intoxication|intoxication
5546637|NCT01100515|carbon monoxide|carbon monoxide
5546638|NCT01100515|adults|adults
5546639|NCT01100515|domestic accident|domestic accident
5546640|NCT01100515|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
5546641|NCT01100502|Antigens, CD30|antigens, cd30
5546642|NCT01100502|Antibody-Drug Conjugate|antibody-drug conjugate
5546643|NCT01100502|Antibodies, Monoclonal|antibodies, monoclonal
5546644|NCT01100502|Disease, Hodgkin|disease, hodgkin
5546645|NCT01100502|Drug Therapy|drug therapy
5546646|NCT01100502|Hematologic Diseases|hematologic diseases
5546647|NCT01100502|Immunotherapy|immunotherapy
5546648|NCT01100502|Lymphoma|lymphoma
5546649|NCT01100502|Monomethylauristatin E|monomethylauristatin e
5546650|NCT01100476|Closure Device|closure device
5546651|NCT01100476|endovascular procedures|endovascular procedures
5546652|NCT01100476|sealing femoral arterial access|sealing femoral arterial access
5546654|NCT01100463|HFS, Hand-Foot Syndrome, Capecitabine, Breast Cancer|hfs, hand-foot syndrome, capecitabine, breast cancer
5546655|NCT01100450|bariatric surgery|bariatric surgery
5546656|NCT01100450|class III obesity|class iii obesity
5847208|NCT00040508|Rapamycin|rapamycin
5546658|NCT01100450|strength|strength
5546659|NCT01100450|fitness|fitness
5546660|NCT01100437|opioid|opioid
5546661|NCT01100437|morphine|morphine
5546662|NCT01100437|naltrexone|naltrexone
5546663|NCT01100437|withdrawal signs|withdrawal signs
5546664|NCT01100437|withdrawal symptoms|withdrawal symptoms
5546665|NCT01100424|Contact lenses|contact lenses
5546666|NCT01100424|Contact lens solution|contact lens solution
5546667|NCT01100424|Corneal staining|corneal staining
5546668|NCT01100411|Contact lenses, myopia, lens geometry|contact lenses, myopia, lens geometry
5546669|NCT01100398|Fatty liver disease|fatty liver disease
5546670|NCT01100385|Healthy adults|healthy adults
5546969|NCT01099176|fenofibrate|fenofibrate
5546671|NCT01100372|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5546672|NCT01100372|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5546673|NCT01100372|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5546674|NCT01100359|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5546675|NCT01100359|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5546676|NCT01100359|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5546677|NCT01100359|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5546678|NCT01100359|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5546679|NCT01100359|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
5546680|NCT01100359|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
5546681|NCT01100346|Ovulation induction|ovulation induction
5546682|NCT01100346|Intrauterine insemination|intrauterine insemination
5546684|NCT01100346|Controlled ovarian stimulation|controlled ovarian stimulation
5546685|NCT01100346|Infertility|infertility
5546686|NCT01100333|Infertility|infertility
5546687|NCT01100333|Reproductive technologies, Assisted|reproductive technologies, assisted
5546688|NCT01100333|r-hFSH|r-hfsh
5546689|NCT01100333|Gonal-f|gonal-f
5546690|NCT01100320|Healthy subjects|healthy subjects
5546691|NCT01100320|Opioid|opioid
5546692|NCT01100307|diabetic macular edema|diabetic macular edema
5546693|NCT01100307|Macugen|macugen
5546694|NCT01100307|sham-controlled study|sham-controlled study
5546695|NCT01100294|Influenza|influenza
5546696|NCT01100294|Pandemic vaccine|pandemic vaccine
5546697|NCT01100294|Seasonal vaccine|seasonal vaccine
5546698|NCT01100294|Prevention|prevention
5546699|NCT01100294|Influenza vaccine|influenza vaccine
5546700|NCT01100294|Influenza in humans|influenza in humans
5685373|NCT00556374|confirmed adenocarcinoma|confirmed adenocarcinoma
5546701|NCT01100294|Pandemic influenza in humans|pandemic influenza in humans
5546702|NCT01100294|Influenza vaccine for children|influenza vaccine for children
5546703|NCT01100281|prefrontal cortex|prefrontal cortex
5546704|NCT01100268|Hoarding|hoarding
5546705|NCT01100255|OCD|ocd
5546706|NCT01100242|Renal Cell Carcinoma|renal cell carcinoma
5546707|NCT01100242|metastatic renal cell cancer|metastatic renal cell cancer
5546708|NCT01100242|kidney cancer|kidney cancer
5546709|NCT01100216|smokeless tobacco|smokeless tobacco
5546710|NCT01100216|nicotine|nicotine
5546711|NCT01100216|snus|snus
5546712|NCT01100216|snuff|snuff
5546713|NCT01100216|chewing tobacco|chewing tobacco
5546714|NCT01100216|oral tobacco|oral tobacco
5546715|NCT01100203|aldosterone receptor inhibition|aldosterone receptor inhibition
5546716|NCT01100203|arterial stiffness|arterial stiffness
5546717|NCT01100203|ambulatory arterial stiffness index|ambulatory arterial stiffness index
5546721|NCT01100177|Patients with non resectable Glioblastoma who have only a|patients with non resectable glioblastoma who have only a
5546722|NCT01100177|biopsy as surgical treatment|biopsy as surgical treatment
5546724|NCT01100164|FOR THE TREATMENT OF INSOMNIA|for the treatment of insomnia
5546725|NCT01100151|Opioid-induced constipation|opioid-induced constipation
5546726|NCT01100151|RDC-1036|rdc-1036
5546727|NCT01100151|ALKS 37|alks 37
5546728|NCT01100125|Diabetes|diabetes
5546729|NCT01100125|Sitagliptin|sitagliptin
5546730|NCT01100125|insulin|insulin
5546731|NCT01100125|C-peptide|c-peptide
5546732|NCT01100112|ulcerative colitis|ulcerative colitis
5546733|NCT01100112|Budesonide|budesonide
5546734|NCT01100099|Celiac disease.|celiac disease.
5546735|NCT01100099|Food intolerance.|food intolerance.
5546736|NCT01100099|Gluten intolerance without celiac disease.|gluten intolerance without celiac disease.
5546737|NCT01100086|Healthy subjects|healthy subjects
5546739|NCT01100060|Azithromycin|azithromycin
5546740|NCT01100060|chloroquine|chloroquine
5546741|NCT01100060|microsphere|microsphere
5546742|NCT01100060|pharmacokinetics|pharmacokinetics
5546743|NCT01100060|bioavailability|bioavailability
5546744|NCT01100047|Phase I|phase i
5546745|NCT01100047|Japanese healthy volunteer|japanese healthy volunteer
5546746|NCT01100047|AZD5069|azd5069
5546747|NCT01100034|pediatric psoriasis|pediatric psoriasis
5546748|NCT01100034|etanercept|etanercept
5546749|NCT01100034|PASS|pass
5546750|NCT01100034|safety|safety
5546751|NCT01100034|effectiveness|effectiveness
5546752|NCT01100008|Pulmonary arterial hypertension|pulmonary arterial hypertension
5546753|NCT01100008|cardiac MRI (magnetic resonance imaging)|cardiac mri (magnetic resonance imaging)
5546755|NCT01100008|prognosis|prognosis
5546756|NCT01099995|domestic accident|domestic accident
5546757|NCT01099995|coma|coma
5546758|NCT01099995|carbon monoxide|carbon monoxide
5546759|NCT01099995|intoxication|intoxication
5546760|NCT01099995|acute domestic carbon monoxide poisoning|acute domestic carbon monoxide poisoning
5546761|NCT01099982|Congestive Heart Failure|congestive heart failure
5546762|NCT01099982|Left Ventricular Assist Device|left ventricular assist device
5546763|NCT01099982|LVAD|lvad
5546764|NCT01099982|Myocardium|myocardium
5546765|NCT01099982|Remodeling|remodeling
5546766|NCT01099982|Microvasculature|microvasculature
5546768|NCT01099982|Cardiac Transplant|cardiac transplant
5546769|NCT01099969|Endotrol Endotracheal tube|endotrol endotracheal tube
5546770|NCT01099969|Regular endotracheal tube|regular endotracheal tube
5546771|NCT01099969|gliderite stylet|gliderite stylet
5546772|NCT01099969|McGrath videolaryngoscope|mcgrath videolaryngoscope
5546773|NCT01099969|Glidescope|glidescope
5546774|NCT01099956|type 1 diabetes|type 1 diabetes
5546775|NCT01099956|children|children
5546776|NCT01099956|low grade inflammation|low grade inflammation
5546777|NCT01099956|cytokine|cytokine
5546778|NCT01099956|CRP|crp
5546779|NCT01099930|immunoablation|immunoablation
5546780|NCT01099930|stem cell transplantation|stem cell transplantation
5546781|NCT01099917|MDS|mds
5546782|NCT01099917|Maitake|maitake
5546783|NCT01099917|mushroom|mushroom
5546784|NCT01099917|09-094|09-094
5546785|NCT01099878|Cycling Exercise|cycling exercise
5546786|NCT01099878|Functional Electrical Stimulation|functional electrical stimulation
5546787|NCT01099878|Stroke|stroke
5546788|NCT01099852|dengue|dengue
5546789|NCT01099852|fever|fever
5546790|NCT01099852|dengue hemorrhagic fever|dengue hemorrhagic fever
5546791|NCT01099852|dengue virus|dengue virus
5546792|NCT01099852|Chikungunya virus|chikungunya virus
5546793|NCT01099852|Zika Virus|zika virus
5546794|NCT01099852|Joint pain|joint pain
5546795|NCT01099839|ASP1941|asp1941
5546796|NCT01099839|Miglitol|miglitol
5546797|NCT01099826|colorectal cancer screening|colorectal cancer screening
5546798|NCT01099826|tailored education|tailored education
5546799|NCT01099826|motivational interview|motivational interview
5546800|NCT01099826|patient education|patient education
5546801|NCT01099813|Critical Illness|critical illness
5546802|NCT01099813|Sepsis|sepsis
5546803|NCT01099813|Duration|duration
5546804|NCT01099813|Severity of Illness Scores|severity of illness scores
5546805|NCT01099813|Trajectory|trajectory
5546806|NCT01099800|asthma|asthma
5546807|NCT01099800|health disparities|health disparities
5546808|NCT01099800|illness representations|illness representations
5546810|NCT01099800|Latino|latino
5546811|NCT01099748|Drug interaction|drug interaction
5546812|NCT01099748|pharmacokinetics|pharmacokinetics
5546813|NCT01099748|lersivirine|lersivirine
5546814|NCT01099748|methadone|methadone
5546815|NCT01099735|Bariatric Surgery|bariatric surgery
5546816|NCT01099735|Sleep Apnea|sleep apnea
5546817|NCT01099735|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5546818|NCT01099735|GERD|gerd
5546943|NCT01099228|Neuroendocrine Tumor|neuroendocrine tumor
5546819|NCT01099722|moderate to severe persistent reversible asthma|moderate to severe persistent reversible asthma
5546820|NCT01099709|healthy subjects|healthy subjects
5546821|NCT01099709|opioid|opioid
5546822|NCT01099696|abdominal discomfort and bloating|abdominal discomfort and bloating
5546823|NCT01099644|Peritoneum|peritoneum
5546824|NCT01099644|Desmoplastic Small Round Cell Tumors|desmoplastic small round cell tumors
5546825|NCT01099644|Intraperitoneal Radioimmunotherapy|intraperitoneal radioimmunotherapy
5546826|NCT01099644|131 I-8H9|131 i-8h9
5546827|NCT01099644|09-090|09-090
5546828|NCT01099631|Salmonella typhimurium|salmonella typhimurium
5546829|NCT01099631|unresectable hepatic cancer|unresectable hepatic cancer
5546830|NCT01099631|attenuated Salmonella typhimurium|attenuated salmonella typhimurium
5546831|NCT01099631|IL-2|il-2
5546832|NCT01099605|hemorrhoidectomy|hemorrhoidectomy
5546833|NCT01099605|pain management|pain management
5546834|NCT01099579|HIV, Pediatric|hiv, pediatric
5546835|NCT01099566|human endotoxemia|human endotoxemia
5546836|NCT01099566|tissue factor induced coagulation|tissue factor induced coagulation
5546837|NCT01099566|platelet activation|platelet activation
5546838|NCT01099566|thienopyridines|thienopyridines
5546839|NCT01099553|Educational video|educational video
5546840|NCT01099553|colonoscopy|colonoscopy
5546841|NCT01099553|bowel preparation|bowel preparation
5546842|NCT01099553|Bowel preparation for colonoscopy|bowel preparation for colonoscopy
5546843|NCT01099540|neuroendocrine tumor|neuroendocrine tumor
5546844|NCT01099527|gastric cancer|gastric cancer
5546845|NCT01099527|refractory|refractory
5546846|NCT01099527|metastatic|metastatic
5546847|NCT01099501|Mechanical Ventilation|mechanical ventilation
5546848|NCT01099488|Immunological assays|immunological assays
5546849|NCT01099475|liver surgery|liver surgery
5546850|NCT01099475|pringle manoeuvre|pringle manoeuvre
5546851|NCT01099475|hepatocellular damage|hepatocellular damage
5546852|NCT01099475|surgical complications|surgical complications
5546853|NCT01099475|patients requiring liver surgery|patients requiring liver surgery
5546855|NCT01099462|Ibuprofen|ibuprofen
5546856|NCT01099449|neurotoxicity|neurotoxicity
5546857|NCT01099449|neuropathy|neuropathy
5546858|NCT01099449|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5546859|NCT01099449|stage II colon cancer|stage ii colon cancer
5546860|NCT01099449|stage III colon cancer|stage iii colon cancer
5546861|NCT01099449|stage IV colon cancer|stage iv colon cancer
5546862|NCT01099449|stage II rectal cancer|stage ii rectal cancer
5546863|NCT01099449|stage III rectal cancer|stage iii rectal cancer
5546864|NCT01099449|stage IV rectal cancer|stage iv rectal cancer
5546865|NCT01099449|adenocarcinoma of the colon|adenocarcinoma of the colon
5546866|NCT01099449|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5546867|NCT01099436|HER2-negative breast cancer|her2-negative breast cancer
5546868|NCT01099436|stage II breast cancer|stage ii breast cancer
5546869|NCT01099436|stage IIIA breast cancer|stage iiia breast cancer
5546870|NCT01099436|stage IIIB breast cancer|stage iiib breast cancer
5546871|NCT01099436|stage IIIC breast cancer|stage iiic breast cancer
5546872|NCT01099423|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5546873|NCT01099423|stage IV renal cell cancer|stage iv renal cell cancer
5546874|NCT01099410|macrophages, alveolar|macrophages, alveolar
5546875|NCT01099410|monocytes|monocytes
5546876|NCT01099410|Receptor Protein-Tyrosine Kinases|receptor protein-tyrosine kinases
5546877|NCT01099410|Humans|humans
5546878|NCT01099410|Phagocytosis|phagocytosis
5546879|NCT01099410|Lung|lung
5546880|NCT01099410|in vitro|in vitro
5546881|NCT01099397|Glucose|glucose
5546882|NCT01099397|Glucose Tolerance Test|glucose tolerance test
5546883|NCT01099397|Insulin Resistance|insulin resistance
5546884|NCT01099397|Metabolic adverse effects|metabolic adverse effects
5546885|NCT01099397|Hypertension|hypertension
5546886|NCT01099397|Beta-blocker|beta-blocker
5546887|NCT01099397|Atenolol|atenolol
5546888|NCT01099397|Diuretic|diuretic
5546889|NCT01099397|Hydrochlorothiazide|hydrochlorothiazide
5546890|NCT01099397|Blood pressure|blood pressure
5546891|NCT01099371|Knee|knee
5546892|NCT01099371|Osteoarthritis|osteoarthritis
5546893|NCT01099371|Exercise|exercise
5546894|NCT01099358|Cancer of Head|cancer of head
5546895|NCT01099358|Cancer of Head and Neck|cancer of head and neck
5546896|NCT01099358|Cancer of Neck|cancer of neck
5546897|NCT01099358|Cancer of the Head|cancer of the head
5546898|NCT01099358|Cancer of the Head and Neck|cancer of the head and neck
5546899|NCT01099358|Cancer of the Neck|cancer of the neck
5546900|NCT01099358|Head and Neck Cancer|head and neck cancer
5518312|NCT01216176|Anastrozole|anastrozole
5546901|NCT01099358|Head Cancer|head cancer
5546902|NCT01099358|Head Neoplasms|head neoplasms
5546903|NCT01099358|Head, Neck Neoplasms|head, neck neoplasms
5546904|NCT01099358|Neck Cancer|neck cancer
5546905|NCT01099358|Neck Neoplasms|neck neoplasms
5546906|NCT01099358|Solid Neoplasm|solid neoplasm
5546907|NCT01099358|Carcinoma|carcinoma
5546910|NCT01099345|Nocturia|nocturia
5546911|NCT01099345|Bladder function|bladder function
5546912|NCT01099345|cystometry|cystometry
5546913|NCT01099345|polysomnography|polysomnography
5546914|NCT01099332|Alzheimer's disease|alzheimer's disease
5546915|NCT01099332|Mild Cognitive Impairment|mild cognitive impairment
5546916|NCT01099332|Copper metabolism|copper metabolism
5546917|NCT01099332|Zinc metabolism|zinc metabolism
5546918|NCT01099332|Ceruloplasmin|ceruloplasmin
5546919|NCT01099319|Dietary supplement|dietary supplement
5546920|NCT01099319|Renalof|renalof
5546921|NCT01099319|gallstones|gallstones
5546922|NCT01099319|elderly|elderly
5546923|NCT01099293|Hepatic Encephalopathy|hepatic encephalopathy
5546924|NCT01099293|Psychometric Hepatic Encephalopathy Score|psychometric hepatic encephalopathy score
5546925|NCT01099293|Critical Flicker Frequency|critical flicker frequency
5546926|NCT01099293|Cerebrovascular Reactivity|cerebrovascular reactivity
5546927|NCT01099293|Endotoxemia|endotoxemia
5546928|NCT01099293|Transcranial Doppler|transcranial doppler
5546929|NCT01099293|Liver Cirrhosis|liver cirrhosis
5546930|NCT01099280|induction of labor in term|induction of labor in term
5546931|NCT01099280|premature rupture of membranes|premature rupture of membranes
5546932|NCT01099280|dinoprostone|dinoprostone
5546933|NCT01099280|oxytocin|oxytocin
5546935|NCT01099254|CVP|cvp
5546936|NCT01099254|US|us
5546937|NCT01099254|Trendelenburg position|trendelenburg position
5546938|NCT01099254|Ultrasound|ultrasound
5546939|NCT01099254|Head Down Tilt|head down tilt
5546940|NCT01099241|CVP|cvp
5546941|NCT01099241|US|us
5546942|NCT01099241|Ultrasonography|ultrasonography
5546944|NCT01099228|Imaging|imaging
5546945|NCT01099215|peripheral artery disease|peripheral artery disease
5546946|NCT01099215|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5546947|NCT01099215|stent|stent
5546948|NCT01099215|balloon/stent|balloon/stent
5546949|NCT01099215|superficial femoral artery|superficial femoral artery
5546950|NCT01099202|Procrit|procrit
5546951|NCT01099202|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5546952|NCT01099202|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5546953|NCT01099202|Burkitt's|burkitt's
5546954|NCT01099202|Chemotherapy|chemotherapy
5546964|NCT01099189|vein|vein
5546965|NCT01099176|hyperlipidemia|hyperlipidemia
5546966|NCT01099176|impaired fasting glycemia|impaired fasting glycemia
5546967|NCT01099176|adipokines|adipokines
5546968|NCT01099176|atorvastatin|atorvastatin
5546970|NCT01099163|Diabetes mellitus|diabetes mellitus
5546971|NCT01099163|CLA|cla
5546972|NCT01099163|Antioxidant|antioxidant
5546973|NCT01099163|Glycemic control|glycemic control
5546974|NCT01099150|Platelets|platelets
5546975|NCT01099150|Platelet aggregation|platelet aggregation
5546976|NCT01099150|Platelet activation|platelet activation
5546977|NCT01099150|Platelet function|platelet function
5546978|NCT01099150|Light transmission aggregometry|light transmission aggregometry
5546979|NCT01099150|Platelet Function Analyzer-100 (PFA-100)|platelet function analyzer-100 (pfa-100)
5546980|NCT01099150|P-selectin|p-selectin
5546981|NCT01099150|Fibrinogen receptor|fibrinogen receptor
5546982|NCT01099150|Glycoprotein IIb-IIIa|glycoprotein iib-iiia
5546983|NCT01099150|Chocolate|chocolate
5546984|NCT01099150|Cocoa|cocoa
5546985|NCT01099150|Flavan-3-ols|flavan-3-ols
5546986|NCT01099150|Procyanidins|procyanidins
5546987|NCT01099137|Diabetes|diabetes
5546988|NCT01099137|Vildagliptin|vildagliptin
5546989|NCT01099137|insulin|insulin
5546990|NCT01099137|C-peptide|c-peptide
5546991|NCT01099124|M2ES|m2es
5546992|NCT01099124|NSCLC|nsclc
5546993|NCT01099124|Phase I Trial|phase i trial
5546994|NCT01099124|Advanced NSCLC|advanced nsclc
5546995|NCT01099124|Recurrent NSCLC|recurrent nsclc
5546996|NCT01099111|IBS|ibs
5546997|NCT01099111|UC|uc
5546998|NCT01099111|CD|cd
5546999|NCT01099111|CRAP/CRC|crap/crc
5547000|NCT01099098|People who have fibrosis or nodules in their upper lobe of the lung|people who have fibrosis or nodules in their upper lobe of the lung
5547001|NCT01099085|gastric cancer, unresectable/metastatic|gastric cancer, unresectable/metastatic
5547002|NCT01099072|ADHD|adhd
5547003|NCT01099072|carnitine|carnitine
5547004|NCT01099072|methylphenidate|methylphenidate
5547005|NCT01099059|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5547006|NCT01099059|Clinical Trial|clinical trial
5547007|NCT01099059|Amantadine|amantadine
5547008|NCT01099059|Methylphenidate|methylphenidate
5547009|NCT01099046|Meniere's disease|meniere's disease
5547010|NCT01099046|stress management|stress management
5547011|NCT01099046|vasopressin|vasopressin
5547012|NCT01099046|V2 receptor|v2 receptor
5547013|NCT01099046|water intake|water intake
5547014|NCT01099046|tympanic tubing|tympanic tubing
5547015|NCT01099046|regular sleep under dark|regular sleep under dark
5547016|NCT01099033|hiatal hernia|hiatal hernia
5547017|NCT01099033|paraesophageal hernia|paraesophageal hernia
5547018|NCT01099033|biologic mesh|biologic mesh
5547019|NCT01099033|MMPs|mmps
5547020|NCT01099033|Hiatal/Paraesophageal hernia|hiatal/paraesophageal hernia
5547021|NCT01099020|Subjects receiving large volumes of Radiation|subjects receiving large volumes of radiation
5547022|NCT01099007|Women|women
5547023|NCT01099007|Menopause|menopause
5547024|NCT01099007|Cardiovascular Disease|cardiovascular disease
5547025|NCT01099007|Physical Activity|physical activity
5547026|NCT01099007|Weight Loss|weight loss
5547027|NCT01098994|Type 1 diabetes|type 1 diabetes
5547028|NCT01098994|Haptoglobin genotype|haptoglobin genotype
5547029|NCT01098994|HDL function|hdl function
5547030|NCT01098994|Heart disease|heart disease
5547031|NCT01098994|Feasibility of clinical trial|feasibility of clinical trial
5547041|NCT01098942|bariatric surgery|bariatric surgery
5547042|NCT01098929|genes|genes
5547043|NCT01098929|genetic|genetic
5547044|NCT01098929|chromosome|chromosome
5547045|NCT01098929|chromosome microarray|chromosome microarray
5547046|NCT01098916|hospital at home|hospital at home
5547047|NCT01098916|radiology at home|radiology at home
5547048|NCT01098916|frail elderly|frail elderly
5547049|NCT01098903|sunitinib|sunitinib
5547050|NCT01098903|cancer|cancer
5547051|NCT01098903|pharmacogenomics|pharmacogenomics
5547052|NCT01098903|pharmacokinetics|pharmacokinetics
5547053|NCT01098903|Patients who have a malignancy and are going to be treated with sunitinib|patients who have a malignancy and are going to be treated with sunitinib
5547054|NCT01098903|doseindividualism|doseindividualism
5547055|NCT01098877|Phase1|phase1
5547056|NCT01098877|pharmacokinetics|pharmacokinetics
5547057|NCT01098877|safety|safety
5547058|NCT01098877|toleration|toleration
5547059|NCT01098877|pharmacodynamics|pharmacodynamics
5547060|NCT01098864|Behavior|behavior
5547061|NCT01098864|Impulsivity|impulsivity
5547062|NCT01098864|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5547063|NCT01098851|Obstructive Sleep Apnea|obstructive sleep apnea
5547064|NCT01098851|Pulse Oximetry|pulse oximetry
5547065|NCT01098838|Cancer|cancer
5547066|NCT01098838|adults|adults
5547067|NCT01098838|solid tumor|solid tumor
5547068|NCT01098838|apoptosis|apoptosis
5547069|NCT01098838|programmed cell death|programmed cell death
5547070|NCT01098838|LCL161|lcl161
5547071|NCT01098825|vaccine hesitancy|vaccine hesitancy
5547072|NCT01098825|vaccine refusal|vaccine refusal
5547073|NCT01098812|Cataract, Intraocular lens|cataract, intraocular lens
5547074|NCT01098799|Urotensin II,Chronic renal disease|urotensin ii,chronic renal disease
5547075|NCT01098786|Influenza A|influenza a
5547076|NCT01098786|H1N1 subtype|h1n1 subtype
5547077|NCT01098786|Vaccine|vaccine
5547078|NCT01098786|Adjuvant|adjuvant
5547079|NCT01098786|Cell culture|cell culture
5547080|NCT01098773|Weaning from mechanical ventilation|weaning from mechanical ventilation
5547082|NCT01098773|Lung ultrasound|lung ultrasound
5547083|NCT01098773|Echocardiography|echocardiography
5547084|NCT01098760|Sorafenib|sorafenib
5547085|NCT01098760|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5547086|NCT01098747|Pain following third molar extraction|pain following third molar extraction
5547087|NCT01098734|non-steroid|non-steroid
5547088|NCT01098734|anti-inflammatory|anti-inflammatory
5547089|NCT01098734|skin disease|skin disease
5547090|NCT01098734|topical cream|topical cream
5547091|NCT01098734|small molecule|small molecule
5547092|NCT01098734|atopic dermatitis|atopic dermatitis
5547093|NCT01098734|eczema|eczema
5547094|NCT01098721|plaque psoriasis|plaque psoriasis
5547095|NCT01098721|skin diseases|skin diseases
5547096|NCT01098721|anti-inflammatory|anti-inflammatory
5547097|NCT01098721|non-steroid|non-steroid
5547098|NCT01098721|topical cream|topical cream
5547100|NCT01098708|non ambulatory|non ambulatory
5547101|NCT01098695|parenting interventions|parenting interventions
5547102|NCT01098695|Family Check-Up|family check-up
5547103|NCT01098695|Early Intervention|early intervention
5547104|NCT01098695|Self-Regulation|self-regulation
5547105|NCT01098669|cancer survivor|cancer survivor
5547106|NCT01098669|lymphedema|lymphedema
5547107|NCT01098669|head and neck cancer|head and neck cancer
5547108|NCT01098656|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5547109|NCT01098656|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5547110|NCT01098656|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5547111|NCT01098656|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5547112|NCT01098656|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5547113|NCT01098656|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5547114|NCT01098643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5547115|NCT01098617|endoscopic sphincterotomy|endoscopic sphincterotomy
5547116|NCT01098617|hemorrhage|hemorrhage
5547117|NCT01098617|nonsteroidal antiinflammatory agents|nonsteroidal antiinflammatory agents
5547118|NCT01098617|antiaggregants|antiaggregants
5533843|NCT01151657|IBS|ibs
5547119|NCT01098617|anticoagulants|anticoagulants
5547120|NCT01098617|Endoscopic biliary sphincterotomy induced bleeding|endoscopic biliary sphincterotomy induced bleeding
5547121|NCT01098591|meta-analysis|meta-analysis
5547122|NCT01098591|stem cell|stem cell
5547123|NCT01098591|cardiac|cardiac
5547124|NCT01098591|remodeling|remodeling
5547125|NCT01098591|MESS|mess
5547126|NCT01098578|Posterior Epistaxis|posterior epistaxis
5547127|NCT01098552|Prostate Cancer|prostate cancer
5547128|NCT01098539|sitagliptin|sitagliptin
5547129|NCT01098539|albiglutide|albiglutide
5547130|NCT01098539|renal impairment|renal impairment
5547131|NCT01098526|GSK1349572|gsk1349572
5547132|NCT01098526|efavirenz|efavirenz
5547133|NCT01098526|integrase|integrase
5547134|NCT01098526|pharmacokinetics|pharmacokinetics
5547135|NCT01098513|HIV|hiv
5547136|NCT01098513|healthy|healthy
5547137|NCT01098513|GSK1349572|gsk1349572
5547138|NCT01098500|Liver function|liver function
5547139|NCT01098500|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5547140|NCT01098487|Immune (idiopathic) thrombocytopenic purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5547141|NCT01098487|bone marrow fibers|bone marrow fibers
5547142|NCT01098487|eltrombopag olamine|eltrombopag olamine
5547143|NCT01098487|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5547144|NCT01098474|Tuberculosis vaccine|tuberculosis vaccine
5547145|NCT01098461|dose-ranging|dose-ranging
5547146|NCT01098461|pharmacokinetics|pharmacokinetics
5547147|NCT01098461|GSK716155|gsk716155
5547148|NCT01098461|Japan|japan
5547149|NCT01098461|albiglutide|albiglutide
5547150|NCT01098448|Amoxicillin|amoxicillin
5547151|NCT01098448|antibiotics|antibiotics
5547152|NCT01098448|chronic periodontitis|chronic periodontitis
5547153|NCT01098448|local drug delivery|local drug delivery
5547154|NCT01098448|metronidazol|metronidazol
5547155|NCT01098448|randomized controlled trial|randomized controlled trial
5547156|NCT01098448|subgingival scaling|subgingival scaling
5547157|NCT01098448|surgery|surgery
5547158|NCT01098448|tetracycline|tetracycline
5547159|NCT01098448|moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
5547160|NCT01098435|Binge eating disorder|binge eating disorder
5547161|NCT01098435|RDC-0313|rdc-0313
5547162|NCT01098422|liver|liver
5547163|NCT01098422|colorectal|colorectal
5547164|NCT01098422|metastasis|metastasis
5547165|NCT01098422|carcinoma|carcinoma
5547166|NCT01098422|Yttrium-90|yttrium-90
5547167|NCT01098422|microspheres|microspheres
5547168|NCT01098409|sodium nitrite|sodium nitrite
5547447|NCT01097096|Antibody|antibody
5547171|NCT01098409|myocardial injury|myocardial injury
5547172|NCT01098396|parkinson disease|parkinson disease
5547173|NCT01098396|gait|gait
5547174|NCT01098383|Autism|autism
5547175|NCT01098357|rhPDGF, diabetic foot ulcer,|rhpdgf, diabetic foot ulcer,
5547176|NCT01098344|stage III pancreatic cancer|stage iii pancreatic cancer
5547177|NCT01098344|stage IV pancreatic cancer|stage iv pancreatic cancer
5547178|NCT01098344|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5547179|NCT01098331|stage I prostate cancer|stage i prostate cancer
5547180|NCT01098331|stage IIB prostate cancer|stage iib prostate cancer
5547181|NCT01098331|stage IIA prostate cancer|stage iia prostate cancer
5547182|NCT01098318|Depression|depression
5547183|NCT01098318|Antidepressant Therapy|antidepressant therapy
5547184|NCT01098318|Herbal Treatment|herbal treatment
5547185|NCT01098318|Rhodiola rosea|rhodiola rosea
5547186|NCT01098318|Alternative Therapy|alternative therapy
5547187|NCT01098305|nicotine smokeless tobacco chewing tobacco varenicline|nicotine smokeless tobacco chewing tobacco varenicline
5547188|NCT01098292|Fibromyalgia|fibromyalgia
5547189|NCT01098292|Irritable Bowel Syndrome|irritable bowel syndrome
5547190|NCT01098292|Chronic Fatigue Syndrome|chronic fatigue syndrome
5547191|NCT01098292|Interstitial Cystitis|interstitial cystitis
5547192|NCT01098292|Chronic Prostatitis|chronic prostatitis
5529813|NCT01168973|phase 3|phase 3
5547193|NCT01098292|Urological Chronic Pelvic Pain|urological chronic pelvic pain
5547194|NCT01098292|Painful Bladder Syndrome|painful bladder syndrome
5547195|NCT01098279|Interstitial Cystitis|interstitial cystitis
5547196|NCT01098279|Chronic Prostatitis|chronic prostatitis
5547197|NCT01098279|Urological Chronic Pelvic Pain|urological chronic pelvic pain
5547198|NCT01098279|Painful Bladder Syndrome|painful bladder syndrome
5547199|NCT01098266|MPM|mpm
5547200|NCT01098266|NGR-hTNF|ngr-htnf
5547201|NCT01098266|NGR-hTNF plus BIC|ngr-htnf plus bic
5547202|NCT01098266|Randomized double-blind phase III study|randomized double-blind phase iii study
5547203|NCT01098253|adherence|adherence
5547204|NCT01098253|diabetes mellitus|diabetes mellitus
5547205|NCT01098253|depression|depression
5547206|NCT01098253|primary health care|primary health care
5547207|NCT01098240|Antidepressant Augmentation|antidepressant augmentation
5547208|NCT01098227|RSV Bronchiolitis|rsv bronchiolitis
5547209|NCT01098227|Lower Respiratory Viral infection|lower respiratory viral infection
5547210|NCT01098227|Exhaled Nitric Oxide|exhaled nitric oxide
5547211|NCT01098214|Normal pregnancy|normal pregnancy
5547212|NCT01098214|Amniotic fluid|amniotic fluid
5547213|NCT01098214|Cytokines|cytokines
5533884|NCT01151475|ammonia|ammonia
5547214|NCT01098214|Biomarkers|biomarkers
5547215|NCT01098201|Certolizumab|certolizumab
5547216|NCT01098201|TNF|tnf
5547217|NCT01098201|RA|ra
5547218|NCT01098201|Cizmia|cizmia
5547219|NCT01098175|laparotomy|laparotomy
5547220|NCT01098175|thoracotomy|thoracotomy
5547221|NCT01098175|peritoneal conditioning|peritoneal conditioning
5547222|NCT01098175|humidification|humidification
5547223|NCT01098175|temperature control|temperature control
5547224|NCT01098162|Lacosamide|lacosamide
5547225|NCT01098162|Vimpat®|vimpat®
5547226|NCT01098162|Epilepsy|epilepsy
5547227|NCT01098162|Partial-Onset Seizures|partial-onset seizures
5547228|NCT01098162|Adjunctive therapy|adjunctive therapy
5547229|NCT01098149|Haemodialysis treatment tolerance|haemodialysis treatment tolerance
5547230|NCT01098149|acetate free biofiltration|acetate free biofiltration
5547231|NCT01098149|frequency of hypotensive events during dialysis|frequency of hypotensive events during dialysis
5547232|NCT01098149|nurse intervention during dialysis|nurse intervention during dialysis
5547233|NCT01098136|Pelvic girdle pain|pelvic girdle pain
5547235|NCT01098136|Single-blinded|single-blinded
5547236|NCT01098136|Outcome study|outcome study
5547237|NCT01098084|Decitabine, chronic myelomonocytic leukemia|decitabine, chronic myelomonocytic leukemia
5547238|NCT01098058|Adult attention deficit hyperactivity disorder|adult attention deficit hyperactivity disorder
5547239|NCT01098058|cognitive-behavioural therapy|cognitive-behavioural therapy
5547240|NCT01098058|randomised controlled trial|randomised controlled trial
5547241|NCT01098045|HIV|hiv
5547242|NCT01098045|fat redistribution|fat redistribution
5547243|NCT01098045|brown adipose tissue|brown adipose tissue
5547244|NCT01098045|PET|pet
5547245|NCT01098032|Contrast media|contrast media
5547246|NCT01098032|Kidney|kidney
5547247|NCT01098032|Complication|complication
5547248|NCT01098019|Notalgia paresthetica|notalgia paresthetica
5547249|NCT01098019|Xeomin|xeomin
5547250|NCT01098019|Botulinum Toxin A|botulinum toxin a
5547251|NCT01098019|Pruritus|pruritus
5547252|NCT01098019|Upper Back|upper back
5547272|NCT01097915|BMI|bmi
5547273|NCT01097915|Electrophysiological recording from the tongue|electrophysiological recording from the tongue
5547274|NCT01097889|United Nations World Food Programme|united nations world food programme
5547275|NCT01097889|blended food (CSB)|blended food (csb)
5547276|NCT01097889|ready-to-use supplementary foods (RUSF)|ready-to-use supplementary foods (rusf)
5547277|NCT01097889|Plumpy®|plumpy®
5547278|NCT01097876|healthy volunteer|healthy volunteer
5547279|NCT01097876|pharmacokinetic|pharmacokinetic
5547280|NCT01097876|safety|safety
5547281|NCT01097850|hand foot skin syndrome|hand foot skin syndrome
5547282|NCT01097850|palmar plantar erythrodysesthesia|palmar plantar erythrodysesthesia
5547283|NCT01097850|doxorubicin|doxorubicin
5547284|NCT01097850|capecitabine|capecitabine
5547285|NCT01097837|Epilepsy|epilepsy
5547286|NCT01097837|Contraceptive|contraceptive
5547287|NCT01097837|Birth Control|birth control
5547288|NCT01097837|Seizure|seizure
5547289|NCT01097837|This study is looking at the use of different birth control measures in women with epilepsy.|this study is looking at the use of different birth control measures in women with epilepsy.
5547290|NCT01097811|Hepatic Encephalopathy|hepatic encephalopathy
5547291|NCT01097811|Hypertension, Portal|hypertension, portal
5547292|NCT01097811|Liver Cirrhosis|liver cirrhosis
5547293|NCT01097811|Bacterial Overgrowth Syndrome|bacterial overgrowth syndrome
5547294|NCT01097798|muscle injury|muscle injury
5547295|NCT01097772|abdominal|abdominal
5547296|NCT01097772|aortic|aortic
5547297|NCT01097772|aneurysm|aneurysm
5547298|NCT01097759|hemorrhoids|hemorrhoids
5547299|NCT01097759|prolapsed|prolapsed
5547300|NCT01097759|hemorrhoidectomy|hemorrhoidectomy
5547301|NCT01097759|Hemorrhoidopexy|hemorrhoidopexy
5547302|NCT01097759|LigaSure|ligasure
5547303|NCT01097759|Stapled|stapled
5547304|NCT01097720|Valproate|valproate
5547305|NCT01097720|Lamotrigine|lamotrigine
5547306|NCT01097720|Carbamazepine|carbamazepine
5547307|NCT01097720|Anticonvulsant|anticonvulsant
5547308|NCT01097720|Antiepileptic|antiepileptic
5547309|NCT01097720|Teratogen|teratogen
5547310|NCT01097720|Autism|autism
5547311|NCT01097720|Developmental Delay|developmental delay
5547312|NCT01097694|cKIT inhibition in Asthma|ckit inhibition in asthma
5547313|NCT01097694|Efficacy of Imatinib in severe resistent asthma.|efficacy of imatinib in severe resistent asthma.
5547314|NCT01097681|Urinary glucose excretion|urinary glucose excretion
5547315|NCT01097681|Diabetes mellitus|diabetes mellitus
5547316|NCT01097681|ASP1941|asp1941
5547317|NCT01097668|Multiple sclerosis|multiple sclerosis
5547318|NCT01097668|Immunomodulation|immunomodulation
5547319|NCT01097668|Phase 1|phase 1
5547320|NCT01097655|Tablets|tablets
5547321|NCT01097655|Infection|infection
5547322|NCT01097655|Non Nucleoside Reverse Transcriptase Inhibitor|non nucleoside reverse transcriptase inhibitor
5547323|NCT01097655|Tolerability|tolerability
5547324|NCT01097655|Viral load|viral load
5547325|NCT01097655|Human immunodeficiency Virus|human immunodeficiency virus
5547327|NCT01097655|Treatment-naïve|treatment-naïve
5547328|NCT01097603|Non-Invasive Blood Pressure|non-invasive blood pressure
5547329|NCT01097590|ulcerative colitis|ulcerative colitis
5547330|NCT01097590|leukapheresis treatment|leukapheresis treatment
5547331|NCT01097577|photorefractive keratectomy|photorefractive keratectomy
5547332|NCT01097577|excimer laser|excimer laser
5547333|NCT01097577|PRK|prk
5547334|NCT01097577|pain, postoperative|pain, postoperative
5549942|NCT01087307|Serum|serum
5547335|NCT01097577|pregabalin|pregabalin
5547336|NCT01097564|Genetic|genetic
5547337|NCT01097564|Cerebral angiopathy|cerebral angiopathy
5547338|NCT01097564|Retinal angiopathy|retinal angiopathy
5547339|NCT01097564|COL4A1 gene|col4a1 gene
5547340|NCT01097564|Infantile Cerebral Palsy|infantile cerebral palsy
5547341|NCT01097564|Congenital porencephaly|congenital porencephaly
5547342|NCT01097564|Congenital cataract|congenital cataract
5547343|NCT01097564|Leukoencephalopathy|leukoencephalopathy
5547344|NCT01097564|COL4A1 gene related cerebra-retinal angiopathy|col4a1 gene related cerebra-retinal angiopathy
5547345|NCT01097551|Type 1 diabetes mellitus|type 1 diabetes mellitus
5547346|NCT01097551|Diabetic retinopathy|diabetic retinopathy
5547347|NCT01097551|Pathogenesis|pathogenesis
5547348|NCT01097551|Dynamic Vessel Analyser|dynamic vessel analyser
5547349|NCT01097551|Endothelial dysfunction|endothelial dysfunction
5547350|NCT01097538|exercise|exercise
5547351|NCT01097538|rehabilitation|rehabilitation
5547352|NCT01097538|progressive multiple sclerosis|progressive multiple sclerosis
5547353|NCT01097538|functional ability|functional ability
5547355|NCT01097538|quality of life|quality of life
5547356|NCT01097512|AS703569|as703569
5547357|NCT01097512|MSC1992371A|msc1992371a
5547358|NCT01097512|Aurora kinase inhibitor|aurora kinase inhibitor
5547361|NCT01097499|Initial bone resorption post implant placement|initial bone resorption post implant placement
5547362|NCT01097499|Analgesia effect of LED intervention|analgesia effect of led intervention
5547363|NCT01097486|Cervical Degenerative Disc Disease|cervical degenerative disc disease
5547364|NCT01097486|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5547365|NCT01097486|Spinal Stenosis|spinal stenosis
5547366|NCT01097486|Stem cells|stem cells
5547367|NCT01097486|Adult Stem Cells|adult stem cells
5547368|NCT01097486|Anterior cervical discectomy and Fusion (ACDF)|anterior cervical discectomy and fusion (acdf)
5547369|NCT01097486|Cervical Allograft Spacer|cervical allograft spacer
5547370|NCT01097486|Anterior Cervical Plate Fixation|anterior cervical plate fixation
5547371|NCT01097460|HER2/HER3|her2/her3
5547372|NCT01097460|Bispecific Antibody|bispecific antibody
5547373|NCT01097460|Breast Cancer|breast cancer
5547374|NCT01097460|Advanced Breast Cancer|advanced breast cancer
5547375|NCT01097460|Metastatic Breast Cancer|metastatic breast cancer
5547376|NCT01097460|HER2 Positive Breast Cancer|her2 positive breast cancer
5547377|NCT01097460|Trastuzumab|trastuzumab
5547378|NCT01097460|Herceptin|herceptin
5547379|NCT01097447|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
5547380|NCT01097395|ribavirin|ribavirin
5547381|NCT01097395|pharmacokinetics|pharmacokinetics
5547382|NCT01097395|Hepatitis C virus|hepatitis c virus
5547383|NCT01097343|Clopidogrel pharmacogenomics study|clopidogrel pharmacogenomics study
5547384|NCT01097343|Performing genetic study looking at clopidogrel resistance|performing genetic study looking at clopidogrel resistance
5547385|NCT01097330|Defibrillators, Implantable|defibrillators, implantable
5547386|NCT01097330|Tachycardia, Ventricular|tachycardia, ventricular
5547387|NCT01097330|Catheter Ablation|catheter ablation
5547388|NCT01097330|Amiodarone|amiodarone
5547389|NCT01097317|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5547390|NCT01097317|musculoskeletal complications|musculoskeletal complications
5547391|NCT01097317|fatigue|fatigue
5547392|NCT01097317|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5547393|NCT01097317|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5547394|NCT01097317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5547395|NCT01097317|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5547396|NCT01097317|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5547397|NCT01097317|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5547398|NCT01097278|breast cancer|breast cancer
5547399|NCT01097278|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5547400|NCT01097278|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5547401|NCT01097278|BRCA1 mutation carrier|brca1 mutation carrier
5547402|NCT01097278|BRCA2 mutation carrier|brca2 mutation carrier
5547403|NCT01097265|stage I colon cancer|stage i colon cancer
5547404|NCT01097265|stage II colon cancer|stage ii colon cancer
5547405|NCT01097252|Cervical Neoplasm|cervical neoplasm
5547406|NCT01097252|chemoradiation|chemoradiation
5547407|NCT01097252|compliance|compliance
5547408|NCT01097252|toxicity|toxicity
5547409|NCT01097239|High Intensity Focused Ultrasound|high intensity focused ultrasound
5547410|NCT01097239|HIFU|hifu
5547411|NCT01097239|Rectal Cancer|rectal cancer
5547412|NCT01097239|Sonablate 500|sonablate 500
5547413|NCT01097239|Transrectal|transrectal
5547414|NCT01097226|Dietary intervention|dietary intervention
5547415|NCT01097226|bioavailability|bioavailability
5547416|NCT01097226|Healthy volunteers|healthy volunteers
5547420|NCT01097174|Glaucoma|glaucoma
5547421|NCT01097174|Glaucoma device|glaucoma device
5547422|NCT01097174|Glaucoma surgery|glaucoma surgery
5547423|NCT01097174|Intraocular pressure|intraocular pressure
5547424|NCT01097161|Stuttering|stuttering
5547425|NCT01097161|Apraxia of speech|apraxia of speech
5547426|NCT01097161|Motor control|motor control
5547427|NCT01097161|Prosody|prosody
5547428|NCT01097161|Pitch range|pitch range
5547430|NCT01097161|fluency disorders|fluency disorders
5547431|NCT01097148|Obese|obese
5547432|NCT01097148|Atracurium|atracurium
5547433|NCT01097148|Cefazolin|cefazolin
5547434|NCT01097148|Morfine|morfine
5547435|NCT01097148|Nadroparin|nadroparin
5547436|NCT01097122|bone|bone
5547437|NCT01097122|motor neuron excitability|motor neuron excitability
5547438|NCT01097122|forearm vibration|forearm vibration
5547439|NCT01097122|mechanical loading|mechanical loading
5547440|NCT01097122|muscle electrical activity|muscle electrical activity
5547441|NCT01097109|Effect of Somatic Dysfunctions of Pelvis|effect of somatic dysfunctions of pelvis
5547442|NCT01097109|Effect of Somatic Dysfunctions of Sacrum|effect of somatic dysfunctions of sacrum
5862962|NCT00001444|Salvage Therapy|salvage therapy
5547443|NCT01097109|Effect of Somatic Dysfunctions of Lower Lumbar Spine|effect of somatic dysfunctions of lower lumbar spine
5547444|NCT01097109|Weight-Bearing|weight-bearing
5547445|NCT01097096|Active immunization|active immunization
5547446|NCT01097096|Alzheimer disease|alzheimer disease
5547448|NCT01097096|Central Nervous System Diseases|central nervous system diseases
5547449|NCT01097096|Neurodegenerative diseases|neurodegenerative diseases
5547450|NCT01097096|Vaccine|vaccine
5547451|NCT01097083|Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma|patients with child-pugh c unresectable hepatocellular carcinoma
5547452|NCT01097083|Patients who are unfit for standard therapy|patients who are unfit for standard therapy
5547453|NCT01097044|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5547454|NCT01097044|EPP|epp
5547455|NCT01097044|Afamelanotide|afamelanotide
5547456|NCT01097031|blood pressure|blood pressure
5547457|NCT01097031|pediatric|pediatric
5547458|NCT01097031|nursing|nursing
5547459|NCT01097031|maintenance arterial catheter|maintenance arterial catheter
5547460|NCT01097005|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5547461|NCT01096992|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5547462|NCT01096992|CLL|cll
5547463|NCT01096992|Bendamustine|bendamustine
5547464|NCT01096992|Fludarabine|fludarabine
5547465|NCT01096992|Fludara|fludara
5547466|NCT01096992|Fludarabine Phosphate|fludarabine phosphate
5547467|NCT01096992|Rituximab|rituximab
5547468|NCT01096992|Rituxan|rituxan
5547469|NCT01096979|Subcutaneous Adipose Tissue Reduction|subcutaneous adipose tissue reduction
5547470|NCT01096966|chronic low back pain|chronic low back pain
5547471|NCT01096953|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5547472|NCT01096953|ADHD|adhd
5547473|NCT01096953|attention deficit|attention deficit
5547474|NCT01096940|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5547475|NCT01096940|Glucose lowering|glucose lowering
5547476|NCT01096927|Lower Abdominal Pain|lower abdominal pain
5547477|NCT01096927|Right Iliac Fossa Pain|right iliac fossa pain
5547478|NCT01096927|Acute Appendicitis|acute appendicitis
5547479|NCT01096927|Antibiotic Therapy|antibiotic therapy
5547480|NCT01096927|Conservative Management|conservative management
5547481|NCT01096927|Appendectomy|appendectomy
5547482|NCT01096927|Recurrence|recurrence
5547483|NCT01096927|Length of hospital stay|length of hospital stay
5547484|NCT01096927|Sick leave time|sick leave time
5547485|NCT01096927|Short and Long Term Abdominal pain evaluation|short and long term abdominal pain evaluation
5547486|NCT01096888|WIC|wic
5547487|NCT01096888|Weight loss|weight loss
5547488|NCT01096888|Overweight|overweight
5547489|NCT01096888|Post Partum|post partum
5680436|NCT00577798|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5547490|NCT01096888|Internet based weight loss intervention for Mothers in the WIC program.|internet based weight loss intervention for mothers in the wic program.
5547491|NCT01096875|Endothelial progenitor cells|endothelial progenitor cells
5547492|NCT01096875|Atorvastatin|atorvastatin
5547493|NCT01096875|Coronary surgery|coronary surgery
5547494|NCT01096862|ASP015K|asp015k
5547495|NCT01096862|Psoriasis|psoriasis
5547496|NCT01096849|urinary tract infection|urinary tract infection
5547497|NCT01096849|UTI|uti
5547498|NCT01096849|cUTI|cuti
5547499|NCT01096849|pyelonephritis|pyelonephritis
5547500|NCT01096849|AP|ap
5547501|NCT01096849|ACHN-490|achn-490
5547502|NCT01096836|resistance exercise|resistance exercise
5547503|NCT01096836|body mass index|body mass index
5547504|NCT01096836|hypertrophy|hypertrophy
5547505|NCT01096836|endothelial function|endothelial function
5547506|NCT01096836|blood lipids|blood lipids
5547507|NCT01096823|Rheumatoid Arthritis|rheumatoid arthritis
5547508|NCT01096823|Yoga|yoga
5547509|NCT01096823|Adolescents|adolescents
5547510|NCT01096823|Young Adults|young adults
5547511|NCT01096810|Asymptomatic|asymptomatic
5547512|NCT01096784|insulin-like growth factor|insulin-like growth factor
5547513|NCT01096784|ROP|rop
5547514|NCT01096784|IGF-I|igf-i
5547516|NCT01096784|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5547517|NCT01096784|retinopathy of prematurity|retinopathy of prematurity
5547518|NCT01096771|ARDS|ards
5547519|NCT01096771|Parenteral|parenteral
5547520|NCT01096771|Pharmaconutrition|pharmaconutrition
5547521|NCT01096758|PKU|pku
5547522|NCT01096758|phenylketonuria|phenylketonuria
5547523|NCT01096758|adult|adult
5547524|NCT01096758|patient|patient
5547525|NCT01096758|development|development
5547526|NCT01096758|nutritional deficiencies|nutritional deficiencies
5550107|NCT01086813|Safety|safety
5547530|NCT01096758|longitudinal development|longitudinal development
5547531|NCT01096758|quality of life|quality of life
5547532|NCT01096745|Gemcitabine|gemcitabine
5547533|NCT01096745|Cisplatin|cisplatin
5547534|NCT01096745|S-1|s-1
5547535|NCT01096745|bile duct cancer|bile duct cancer
5547536|NCT01096732|Pancreatic|pancreatic
5547537|NCT01096732|adenocarcinoma|adenocarcinoma
5547538|NCT01096732|cancer|cancer
5547539|NCT01096719|Weight|weight
5547540|NCT01096719|Dietary intake|dietary intake
5547541|NCT01096719|Energy Density|energy density
5547542|NCT01096719|Behavioral|behavioral
5547543|NCT01096719|Satiety|satiety
5547544|NCT01096719|Deprivation|deprivation
5547546|NCT01096719|Fruit|fruit
5547547|NCT01096719|Vegetable|vegetable
5547548|NCT01096706|Urocortin 2|urocortin 2
5547550|NCT01096706|Nitric Oxide|nitric oxide
5547551|NCT01096706|Plethysmography|plethysmography
5547552|NCT01096706|Forearm blood flow|forearm blood flow
5547553|NCT01096706|Vascular|vascular
5547554|NCT01096706|Heart failure|heart failure
5547555|NCT01096706|endothelium|endothelium
5547556|NCT01096706|Cyclo-oxygenase pathway|cyclo-oxygenase pathway
5547557|NCT01096706|EDHF|edhf
5547558|NCT01096693|Urocortin 2|urocortin 2
5547559|NCT01096693|Urocortin 3|urocortin 3
5547560|NCT01096693|Astressin 2B|astressin 2b
5547561|NCT01096693|forearm blood flow|forearm blood flow
5547562|NCT01096693|plethysmography|plethysmography
5547563|NCT01096693|vascular|vascular
5547564|NCT01096693|heart failure|heart failure
5547565|NCT01096667|type 2 diabetes|type 2 diabetes
5547566|NCT01096667|hypertension|hypertension
5547567|NCT01096667|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5547568|NCT01096654|endocrine hypertension|endocrine hypertension
5547569|NCT01096654|primary hyperaldosteronism|primary hyperaldosteronism
5547570|NCT01096654|aldosterone|aldosterone
5547571|NCT01096654|aldosterone-producing adenoma|aldosterone-producing adenoma
5547572|NCT01096654|bilateral adrenal hyperplasia|bilateral adrenal hyperplasia
5547573|NCT01096654|computed tomography|computed tomography
5547574|NCT01096654|adrenal vein sampling|adrenal vein sampling
5547575|NCT01096641|Fatigued disease-free Cancer Patients|fatigued disease-free cancer patients
5547576|NCT01096641|cancer treatment finished > one year and < ten years ago|cancer treatment finished > one year and < ten years ago
5547577|NCT01096628|adolescent|adolescent
5547578|NCT01096628|low back pain|low back pain
5547579|NCT01096628|chiropractic|chiropractic
5547580|NCT01096628|exercise|exercise
5547581|NCT01096615|Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-|allergic rhinitis-probiotic lactobacillus paracasei lp-33-
5547582|NCT01096602|Dendritic Cell/AML vaccine|dendritic cell/aml vaccine
5547584|NCT01096589|lymphoedema|lymphoedema
5547585|NCT01096589|lymphedema|lymphedema
5547586|NCT01096563|Phase I|phase i
5547587|NCT01096563|Japanese healthy volunteer|japanese healthy volunteer
5547588|NCT01096563|AZD9164|azd9164
5547592|NCT01096537|incidence|incidence
5547593|NCT01096537|young workers|young workers
5547594|NCT01096537|occupations at risk|occupations at risk
5547595|NCT01096537|public health|public health
5547596|NCT01096537|epidemiology|epidemiology
5547597|NCT01096537|polymorphisms|polymorphisms
5547598|NCT01096537|gentic|gentic
5547599|NCT01096524|Kneehab|kneehab
5547600|NCT01096524|NMES|nmes
5547601|NCT01096524|Total Knee Arthroplasty|total knee arthroplasty
5547602|NCT01096524|Total Knee Replacement|total knee replacement
5547603|NCT01096524|TKA|tka
5547604|NCT01096524|Disuse atrophy|disuse atrophy
5547605|NCT01096524|muscle hypertrophy|muscle hypertrophy
5547606|NCT01096524|TKR|tkr
5547607|NCT01096524|Atrophy Prevention|atrophy prevention
5530202|NCT01167335|CNS|cns
5547608|NCT01096511|Moxifloxacin,|moxifloxacin,
5547609|NCT01096511|cIAI|ciai
5547610|NCT01096511|non-interventional|non-interventional
5547611|NCT01096472|Tinea pedis|tinea pedis
5547612|NCT01096459|spina|spina
5547613|NCT01096459|bifida|bifida
5547614|NCT01096459|restore|restore
5547615|NCT01096459|urinary|urinary
5547616|NCT01096459|function|function
5547617|NCT01096459|nerve|nerve
5547618|NCT01096459|reroute|reroute
5547619|NCT01096433|Sleep apnea|sleep apnea
5547621|NCT01096433|Prostaglandins|prostaglandins
5547622|NCT01096433|Circadian variations|circadian variations
5547623|NCT01096420|chronic migraine|chronic migraine
5547624|NCT01096420|acupuncture|acupuncture
5547625|NCT01096420|Topiramate|topiramate
5547626|NCT01096420|Randomized trial|randomized trial
5547627|NCT01096407|pain|pain
5547629|NCT01096407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5547630|NCT01096394|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5547631|NCT01096394|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5547632|NCT01096381|cardiovascular complications|cardiovascular complications
5547633|NCT01096381|stage I breast cancer|stage i breast cancer
5547634|NCT01096381|stage II breast cancer|stage ii breast cancer
5547635|NCT01096381|stage IIIA breast cancer|stage iiia breast cancer
5547636|NCT01096381|stage IIIB breast cancer|stage iiib breast cancer
5547637|NCT01096381|stage IIIC breast cancer|stage iiic breast cancer
5547638|NCT01096381|stage IV breast cancer|stage iv breast cancer
5547639|NCT01096381|stage I colon cancer|stage i colon cancer
5547640|NCT01096381|stage II colon cancer|stage ii colon cancer
5547641|NCT01096381|stage III colon cancer|stage iii colon cancer
5547642|NCT01096381|stage IV colon cancer|stage iv colon cancer
5547643|NCT01096381|stage I rectal cancer|stage i rectal cancer
5547644|NCT01096381|stage II rectal cancer|stage ii rectal cancer
5547645|NCT01096381|stage III rectal cancer|stage iii rectal cancer
5547646|NCT01096381|stage IV rectal cancer|stage iv rectal cancer
5547647|NCT01096381|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5547648|NCT01096381|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5547649|NCT01096381|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5547650|NCT01096381|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5547651|NCT01096381|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5547652|NCT01096381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5547653|NCT01096381|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5547654|NCT01096381|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5547655|NCT01096381|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5547656|NCT01096381|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5547657|NCT01096381|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5547658|NCT01096381|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5547659|NCT01096381|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5547660|NCT01096381|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5547661|NCT01096381|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5547662|NCT01096381|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5547663|NCT01096381|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5547664|NCT01096381|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5547665|NCT01096381|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5547666|NCT01096381|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5547667|NCT01096381|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5547668|NCT01096381|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5547669|NCT01096381|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5547670|NCT01096381|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5547671|NCT01096381|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5547672|NCT01096381|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5547673|NCT01096381|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5547674|NCT01096381|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5547675|NCT01096381|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5547676|NCT01096381|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5547677|NCT01096381|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5547678|NCT01096381|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5547679|NCT01096381|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5790023|NCT00146107|physical function|physical function
5547680|NCT01096381|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5547681|NCT01096381|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5547682|NCT01096381|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5547683|NCT01096381|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5547684|NCT01096381|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5547685|NCT01096381|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5547686|NCT01096381|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5547687|NCT01096381|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5547688|NCT01096381|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5547689|NCT01096381|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5547690|NCT01096381|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5547691|NCT01096381|fallopian tube cancer|fallopian tube cancer
5547692|NCT01096381|peritoneal cavity cancer|peritoneal cavity cancer
5547693|NCT01096329|postmenopausal|postmenopausal
5547694|NCT01096329|hormone replacement therapy|hormone replacement therapy
5547695|NCT01096316|mood disorders|mood disorders
5547696|NCT01096316|depressive disorder|depressive disorder
5547698|NCT01096316|depression|depression
5547699|NCT01096303|COPD|copd
5547700|NCT01096303|pulmonary function|pulmonary function
5547701|NCT01096303|tobacco and marihuana smoking|tobacco and marihuana smoking
5547702|NCT01096290|constipation|constipation
5547703|NCT01096290|lubiprostone|lubiprostone
5547704|NCT01096290|healthy volunteers|healthy volunteers
5547705|NCT01096264|Arterial stiffness|arterial stiffness
5547706|NCT01096264|Pulse wave velocity|pulse wave velocity
5547707|NCT01096264|Ultrafastecho|ultrafastecho
5541970|NCT01118767|world wide web|world wide web
5547708|NCT01096264|Supersonic shear imaging|supersonic shear imaging
5547709|NCT01096251|Obesity|obesity
5547710|NCT01096251|Binge Eating Disorder|binge eating disorder
5548287|NCT01094158|Fatty Liver|fatty liver
5547711|NCT01096251|Cognitive Behavioural Therapy|cognitive behavioural therapy
5547712|NCT01096251|Brief Strategic Therapy|brief strategic therapy
5547713|NCT01096251|Telepsychology|telepsychology
5547714|NCT01096238|The immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in adults after half a year will be analyzed and discussed.|the immunogenicity of influenza virus vaccine, adimflu-s (a/h1n1), in adults after half a year will be analyzed and discussed.
5547715|NCT01096225|the antibody response|the antibody response
5547716|NCT01096225|T-cell response|t-cell response
5547717|NCT01096225|S-OIV|s-oiv
5547718|NCT01096225|vaccine|vaccine
5547719|NCT01096225|Immunogenicity assessment|immunogenicity assessment
5547720|NCT01096212|Efficacy|efficacy
5547721|NCT01096212|Minimum alveolar concentration|minimum alveolar concentration
5547722|NCT01096212|Safety|safety
5547723|NCT01096212|Sevoflurane|sevoflurane
5547724|NCT01096199|The purpose of the study is to evaluate the safety and feasibility of combining TS-1/CDDP with RAD001. Primary|the purpose of the study is to evaluate the safety and feasibility of combining ts-1/cddp with rad001. primary
5547725|NCT01096199|Objectives|objectives
5547726|NCT01096199|To determine the MTD/recommended phase II dose of TS-1/CDDP/RAD001 combination —To determine|to determine the mtd/recommended phase ii dose of ts-1/cddp/rad001 combination —to determine
5547727|NCT01096199|the safety of TS-1/CDDP/RAD001 combination Secondary Objectives —To preliminarily describe any clinical activity in|the safety of ts-1/cddp/rad001 combination secondary objectives —to preliminarily describe any clinical activity in
5547728|NCT01096199|platinum refractory disease|platinum refractory disease
5547729|NCT01096199|To assess to effect of concurrent TS-1/CDDP on RAD001 pharmacokinetics —To explore|to assess to effect of concurrent ts-1/cddp on rad001 pharmacokinetics —to explore
5547730|NCT01096199|the relationship of tumour biomarkers and treatment response|the relationship of tumour biomarkers and treatment response
5547731|NCT01096186|motor Symptoms|motor symptoms
5547732|NCT01096186|efficacy|efficacy
5547733|NCT01096186|IPX066|ipx066
5547734|NCT01096186|Parkinson's Disease|parkinson's disease
5547735|NCT01096173|Sputum|sputum
5547736|NCT01096173|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5547737|NCT01096160|Hypertension|hypertension
5547738|NCT01096147|FBSS|fbss
5547739|NCT01096147|chronic pain|chronic pain
5547740|NCT01096147|leg pain|leg pain
5547741|NCT01096147|low back pain|low back pain
5547742|NCT01096147|spinal cord stimulation|spinal cord stimulation
5547743|NCT01096121|Angiotensin-converting enzyme inhibitors (ACE)|angiotensin-converting enzyme inhibitors (ace)
5547744|NCT01096121|Renal disease|renal disease
5547745|NCT01096121|Microalbuminemia|microalbuminemia
5547746|NCT01096108|Smoking cessation|smoking cessation
5547747|NCT01096108|Quit smoking|quit smoking
5547748|NCT01096108|Quit & Win|quit & win
5547750|NCT01096095|Spinocerebellar Ataxia|spinocerebellar ataxia
5547751|NCT01096095|Sodium Phenylbutyrate|sodium phenylbutyrate
5547752|NCT01096095|Machado-Joseph Disease|machado-joseph disease
5547753|NCT01096095|Treatment|treatment
5547754|NCT01096082|spinocerebellar ataxia|spinocerebellar ataxia
5547755|NCT01096082|Treatment|treatment
5547756|NCT01096082|Lithium carbonate|lithium carbonate
5547757|NCT01096069|Rituximab, rheumatoid arthritis, CD55, CD59|rituximab, rheumatoid arthritis, cd55, cd59
5547758|NCT01096056|Children|children
5547759|NCT01096056|Influenza|influenza
5547760|NCT01096056|Safety|safety
5547761|NCT01096056|Immunogenicity|immunogenicity
5547762|NCT01096056|Vaccine|vaccine
5547763|NCT01096043|Heart Failure|heart failure
5547764|NCT01096043|ADHF|adhf
5547765|NCT01096030|Regorafenib|regorafenib
5547766|NCT01096030|Advanced|advanced
5547767|NCT01096030|Refractory solid tumors|refractory solid tumors
5547768|NCT01096017|Terbutaline|terbutaline
5547769|NCT01096017|Turbuhaler|turbuhaler
5547770|NCT01096017|Efficacy|efficacy
5547771|NCT01096017|Asthma|asthma
5547772|NCT01096017|Japanese|japanese
5547773|NCT01096017|salbutamol|salbutamol
5547774|NCT01096017|Bricanyl|bricanyl
5547775|NCT01096004|Pharmacodynamic method evaluation|pharmacodynamic method evaluation
5547776|NCT01095991|Type 2 Diabetes Mellitus, Sitagliptin|type 2 diabetes mellitus, sitagliptin
5547777|NCT01095978|Klacid SR|klacid sr
5547778|NCT01095978|Clarithromycin|clarithromycin
5547779|NCT01095978|Respiratory tract infections|respiratory tract infections
5547780|NCT01095978|Bronchitis|bronchitis
5547781|NCT01095978|Pneumonia|pneumonia
5547782|NCT01095965|Nutrition education intervention|nutrition education intervention
5547783|NCT01095965|Type 2 diabetes mellitus|type 2 diabetes mellitus
5547784|NCT01095952|atrial fibrillation|atrial fibrillation
5547785|NCT01095952|inappropriate shock|inappropriate shock
5547786|NCT01095952|AV-node stimulation|av-node stimulation
5547787|NCT01095952|ventricular arrhythmia|ventricular arrhythmia
5547788|NCT01095939|Renal function consecutive to pre-eclampsia|renal function consecutive to pre-eclampsia
5547789|NCT01095926|pharmacokinetic|pharmacokinetic
5547790|NCT01095926|doxorubicin|doxorubicin
5547791|NCT01095926|cancer|cancer
5547792|NCT01095926|troponin|troponin
5547793|NCT01095926|natriuretic peptide|natriuretic peptide
5547794|NCT01095926|cardiotoxicity|cardiotoxicity
5547795|NCT01095926|anthracyclines|anthracyclines
5547798|NCT01095913|Near-Infrared Imaging|near-infrared imaging
5547799|NCT01095913|Fluorescent Dyes|fluorescent dyes
5547800|NCT01095913|Lymph Node Mapping|lymph node mapping
5547801|NCT01095913|Indocyanine green|indocyanine green
5547802|NCT01095913|IC-Green|ic-green
5547803|NCT01095913|nonradioactive optical imaging|nonradioactive optical imaging
5547804|NCT01095913|fluorescent contrast agent|fluorescent contrast agent
5547806|NCT01095913|lymph nodes|lymph nodes
5547807|NCT01095913|axillary nodal dissection|axillary nodal dissection
5547808|NCT01095900|Pain after treatment|pain after treatment
5547809|NCT01095900|healing of fissure after treatment|healing of fissure after treatment
5547810|NCT01095900|continence scores after treatment|continence scores after treatment
5547811|NCT01095887|ABO incompatibility|abo incompatibility
5547812|NCT01095887|living donor kidney transplant|living donor kidney transplant
5547813|NCT01095887|kidney transplant|kidney transplant
5547814|NCT01095887|ABO blood type incompatible|abo blood type incompatible
5547815|NCT01095874|myelodysplasia|myelodysplasia
5547816|NCT01095874|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5547817|NCT01095874|Survival|survival
5547818|NCT01095874|Transplantation|transplantation
5547819|NCT01095861|endotracheal tube|endotracheal tube
5547821|NCT01095848|cancer|cancer
5547822|NCT01095848|ovarian|ovarian
5547823|NCT01095848|breast|breast
5547824|NCT01095848|prostate|prostate
5547825|NCT01095848|tumor|tumor
5547826|NCT01095848|Immunotherapy|immunotherapy
5547827|NCT01095822|Diabetes|diabetes
5547828|NCT01095822|Hypertension|hypertension
5547829|NCT01095822|Platelets|platelets
5547830|NCT01095822|Hemostasis|hemostasis
5547831|NCT01095822|Aliskiren|aliskiren
5547832|NCT01095822|Valsartan|valsartan
5547833|NCT01095796|Treatment Naive|treatment naive
5547834|NCT01095796|HIV 1 Infected|hiv 1 infected
5547835|NCT01095783|low back pain|low back pain
5547836|NCT01095783|physiotherapy|physiotherapy
5547837|NCT01095783|hemodialysis|hemodialysis
5547838|NCT01095783|end-stage renal disease|end-stage renal disease
5547839|NCT01095770|Atrial Fibrillation|atrial fibrillation
5547840|NCT01095770|Atrial Fibrillation Ablation|atrial fibrillation ablation
5547841|NCT01095770|Atrial Fibrillation monitoring|atrial fibrillation monitoring
5547842|NCT01095770|Ablation Frontiers|ablation frontiers
5547843|NCT01095770|Reveal XT|reveal xt
5547844|NCT01095770|LASSO|lasso
5547846|NCT01095757|Lymphoma|lymphoma
5547847|NCT01095757|Stem cell transplantation|stem cell transplantation
5547848|NCT01095744|PIB imaging,|pib imaging,
5547849|NCT01095744|brain atrophy|brain atrophy
5547850|NCT01095744|cognitive impairment|cognitive impairment
5547851|NCT01095744|Pet imaging|pet imaging
5547852|NCT01095744|Alzheimer's disease|alzheimer's disease
5547853|NCT01095744|amyloid protein|amyloid protein
5547854|NCT01095731|aneurysm|aneurysm
5547855|NCT01095731|aneurysmal|aneurysmal
5547856|NCT01095731|subarachnoid|subarachnoid
5547857|NCT01095731|hemorrhage|hemorrhage
5547858|NCT01095731|haemorrhage|haemorrhage
5547859|NCT01095731|neuroprotection|neuroprotection
5547860|NCT01095731|3-aminopropanal|3-aminopropanal
5547861|NCT01095731|3AP|3ap
5547862|NCT01095731|polyamine oxidase|polyamine oxidase
5547863|NCT01095731|spermine|spermine
5547864|NCT01095731|spermidine|spermidine
5547865|NCT01095731|vasospasm|vasospasm
5547866|NCT01095731|cerebral ischemia|cerebral ischemia
5547867|NCT01095731|neurosurgery|neurosurgery
5547868|NCT01095731|neurological intensive care unit|neurological intensive care unit
5547869|NCT01095731|NICU|nicu
5534553|NCT01148667|gut|gut
5547870|NCT01095731|Tiopronin|tiopronin
5547871|NCT01095731|Thiola|thiola
5547872|NCT01095731|FDA|fda
5547873|NCT01095731|Thiopronin|thiopronin
5547874|NCT01095731|Thiosol|thiosol
5547875|NCT01095731|Tioglis|tioglis
5547876|NCT01095731|Acadione|acadione
5547877|NCT01095731|Capen|capen
5547878|NCT01095731|Captimer|captimer
5547879|NCT01095731|Epatiol|epatiol
5547880|NCT01095731|Vincol|vincol
5547881|NCT01095731|Mucolysin|mucolysin
5547882|NCT01095731|Sutilan|sutilan
5547883|NCT01095731|Meprin|meprin
5547884|NCT01095731|Thiolpropionamidoacetic acid|thiolpropionamidoacetic acid
5547885|NCT01095731|Mercaptopropionyl glycine|mercaptopropionyl glycine
5547886|NCT01095731|2 MPG|2 mpg
5547887|NCT01095705|Hypnosis|hypnosis
5547888|NCT01095705|Transesophageal Echocardiography|transesophageal echocardiography
5547889|NCT01095705|Efficiency of Hypnosis|efficiency of hypnosis
5547890|NCT01095692|Occult stress Incontinence,|occult stress incontinence,
5547891|NCT01095692|Pelvic Organ Prolapse,|pelvic organ prolapse,
5547892|NCT01095692|Prevention of stress urinary incontinence,|prevention of stress urinary incontinence,
5547893|NCT01095692|Postoperative incontinence,|postoperative incontinence,
5547894|NCT01095692|Sub-urethral tape|sub-urethral tape
5547895|NCT01095679|CHEYNE Stokes respiration|cheyne stokes respiration
5547896|NCT01095679|Periodic ventilation|periodic ventilation
5547897|NCT01095679|baclofen|baclofen
5547898|NCT01095679|hypoxia|hypoxia
5547899|NCT01095679|healthy subject|healthy subject
5547900|NCT01095640|acne|acne
5547901|NCT01095640|adapalene|adapalene
5547902|NCT01095640|Differin|differin
5547903|NCT01095614|Women|women
5547904|NCT01095614|Hormonal status|hormonal status
5547905|NCT01095614|Exercise|exercise
5547906|NCT01095614|Substrate utilization|substrate utilization
5548032|NCT01095211|methyl malonic acid|methyl malonic acid
5547907|NCT01095614|Women Hormonal Status (with oral contraception or without any contraception)|women hormonal status (with oral contraception or without any contraception)
5547908|NCT01095601|avanafil|avanafil
5547909|NCT01095601|absoprion|absoprion
5547910|NCT01095601|bioavailability|bioavailability
5547911|NCT01095601|food effect|food effect
5547912|NCT01095601|dose-proportionality|dose-proportionality
5547913|NCT01095601|TA-1790|ta-1790
5547914|NCT01095601|Pharmacokinetics of avanafil|pharmacokinetics of avanafil
5547915|NCT01095588|ED|ed
5547916|NCT01095575|Epidural|epidural
5547917|NCT01095575|Morphine|morphine
5547918|NCT01095575|Preoperative|preoperative
5547919|NCT01095575|Postoperative|postoperative
5547920|NCT01095575|Analgesia|analgesia
5547921|NCT01095575|Tolerance|tolerance
5547922|NCT01095575|Preoperative, Postoperative Analgesia|preoperative, postoperative analgesia
5547923|NCT01095549|ankle-brachial index (ABI)|ankle-brachial index (abi)
5547924|NCT01095549|brachial-ankle pulse wave velocity (baPWV)|brachial-ankle pulse wave velocity (bapwv)
5547925|NCT01095549|far infrared therapy (FIR)|far infrared therapy (fir)
5547926|NCT01095549|hemodialysis (HD)|hemodialysis (hd)
5547927|NCT01095549|peripheral artery disease (PAD)|peripheral artery disease (pad)
5547928|NCT01095549|Peripheral artery disease in hemodialysis|peripheral artery disease in hemodialysis
5547929|NCT01095536|laparoscopic cholecystectomy, elective|laparoscopic cholecystectomy, elective
5547930|NCT01095536|anesthesia, general|anesthesia, general
5547931|NCT01095536|shoulder pain|shoulder pain
5547932|NCT01095536|nausea|nausea
5547933|NCT01095536|vomiting|vomiting
5547934|NCT01095536|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5547935|NCT01095536|general anesthesia|general anesthesia
5547936|NCT01095523|Colon Cancer|colon cancer
5547937|NCT01095523|Rectal Cancer|rectal cancer
5547938|NCT01095523|Peritoneal Perfusion|peritoneal perfusion
5547939|NCT01095523|Metastatic Cancer|metastatic cancer
5547940|NCT01095523|Recurrence|recurrence
5547941|NCT01095523|Colorectal Cancer|colorectal cancer
5547942|NCT01095510|CINRYZE|cinryze
5547943|NCT01095510|C1 INH|c1 inh
5547944|NCT01095510|HAE|hae
5547945|NCT01095510|C1 inhibitor|c1 inhibitor
5547946|NCT01095510|Pediatric|pediatric
5547947|NCT01095510|PK/PD|pk/pd
5547948|NCT01095497|HAE|hae
5547949|NCT01095497|C1 inhibitor (C1INH)|c1 inhibitor (c1inh)
5547950|NCT01095497|Subcutaneous|subcutaneous
5547951|NCT01095484|Rotigotine|rotigotine
5547952|NCT01095484|Neupro®|neupro®
5547953|NCT01095471|7 valent Pneumococcal conjugate vaccine|7 valent pneumococcal conjugate vaccine
5547954|NCT01095471|13 valent Pneumococcal conjugate vaccine|13 valent pneumococcal conjugate vaccine
5547955|NCT01095471|PCV13|pcv13
5547956|NCT01095471|PCV7|pcv7
5547957|NCT01095458|Obesity|obesity
5547958|NCT01095458|Phone vs Clinical methods|phone vs clinical methods
5547959|NCT01095445|hepatitis C|hepatitis c
5547960|NCT01095445|genotype 3|genotype 3
5547961|NCT01095445|end of treatment response|end of treatment response
5547962|NCT01095445|relapse rate|relapse rate
5547963|NCT01095445|rapid virologic response|rapid virologic response
5547964|NCT01095445|complete early virologic response|complete early virologic response
5547965|NCT01095432|Colonoscopy|colonoscopy
5547966|NCT01095432|Flexible Sigmoidoscopy|flexible sigmoidoscopy
5547967|NCT01095419|massage therapy|massage therapy
5547968|NCT01095419|sleep quality|sleep quality
5547969|NCT01095419|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5547970|NCT01095419|Patients after Coronary Artery Bypass Graft Surgery|patients after coronary artery bypass graft surgery
5547971|NCT01095406|Weaning|weaning
5547972|NCT01095406|closed loop|closed loop
5547973|NCT01095406|mechanical ventilation|mechanical ventilation
5547974|NCT01095406|children|children
5547975|NCT01095393|Certolizumab Pegol|certolizumab pegol
5547977|NCT01095393|Cimzia®|cimzia®
5547978|NCT01095393|NDB|ndb
5547979|NCT01095393|registry|registry
5547980|NCT01095380|task-specific training|task-specific training
5547981|NCT01095380|walking|walking
5547982|NCT01095380|locomotion|locomotion
5547983|NCT01095380|function|function
5547984|NCT01095380|body weight support|body weight support
5547985|NCT01095380|Individuals with motor-incomplete spinal cord injury|individuals with motor-incomplete spinal cord injury
5547986|NCT01095367|Adhesion barrier sheets|adhesion barrier sheets
5547987|NCT01095367|ovarian cancer|ovarian cancer
5547988|NCT01095367|Advanced stage epithelial ovarian cancer|advanced stage epithelial ovarian cancer
5547989|NCT01095354|pediatric|pediatric
5547990|NCT01095354|lung ventilation inhomogeneity|lung ventilation inhomogeneity
5547991|NCT01095341|hyperthyroidism|hyperthyroidism
5547992|NCT01095341|tertiary hyperparathyroidism|tertiary hyperparathyroidism
5547993|NCT01095341|palpation thyroiditis|palpation thyroiditis
5547994|NCT01095341|parathyroidectomy|parathyroidectomy
5547995|NCT01095341|thyroglobulin|thyroglobulin
5547996|NCT01095341|rate of postoperative hyperthyroidism|rate of postoperative hyperthyroidism
5547998|NCT01095328|Pregnancy|pregnancy
5547999|NCT01095328|Screening|screening
5548000|NCT01095328|Cost-effectiveness|cost-effectiveness
5548001|NCT01095289|electromyography|electromyography
5548002|NCT01095289|laryngeal neoplasms|laryngeal neoplasms
5548003|NCT01095289|masticatory muscles|masticatory muscles
5548004|NCT01095276|Mechanical Ventilation|mechanical ventilation
5548005|NCT01095276|Extubation|extubation
5548006|NCT01095276|dornase alpha|dornase alpha
5548007|NCT01095276|oxygenation|oxygenation
5548008|NCT01095276|chest x ray|chest x ray
5548009|NCT01095250|Active uveitis|active uveitis
5548010|NCT01095250|intermediate uveitis|intermediate uveitis
5548011|NCT01095250|panuveitis|panuveitis
5548012|NCT01095250|posterior uveitis|posterior uveitis
5548013|NCT01095250|uveitis|uveitis
5548014|NCT01095237|Peripheral Arterial Disease|peripheral arterial disease
5548015|NCT01095237|Peripheral Vascular Disease|peripheral vascular disease
5548016|NCT01095237|PAD|pad
5548017|NCT01095237|vascular prosthesis|vascular prosthesis
5548018|NCT01095237|revascularization|revascularization
5548019|NCT01095237|patency|patency
5548020|NCT01095237|blood vessel|blood vessel
5548021|NCT01095237|Rutherford|rutherford
5548022|NCT01095237|ABI|abi
5548023|NCT01095237|Ankle Brachial Index|ankle brachial index
5548024|NCT01095237|Vascular Graft|vascular graft
5548025|NCT01095237|Carbothane|carbothane
5548026|NCT01095237|ProEndoTecc|proendotecc
5548027|NCT01095237|implantation|implantation
5548028|NCT01095224|HIV Preventive Vaccine|hiv preventive vaccine
5548029|NCT01095211|folic acid|folic acid
5548030|NCT01095211|homocysteine|homocysteine
5548031|NCT01095211|MMSE scores|mmse scores
5548033|NCT01095211|betaine|betaine
5548034|NCT01095198|vaginal self collection|vaginal self collection
5548035|NCT01095198|human papillomavirus (hpv)|human papillomavirus (hpv)
5548036|NCT01095198|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5548037|NCT01095172|Immunosuppression|immunosuppression
5548038|NCT01095172|Rituximab|rituximab
5548039|NCT01095172|B cell|b cell
5548040|NCT01095159|TVTO|tvto
5548041|NCT01095159|TVTSecur|tvtsecur
5548042|NCT01095159|Mini sling|mini sling
5548043|NCT01095159|stress urinary incontinence|stress urinary incontinence
5548044|NCT01095146|MAS|mas
5548045|NCT01095146|Hemophagocytosis|hemophagocytosis
5548046|NCT01095146|Reactive HLH|reactive hlh
5548047|NCT01095146|Macrophage activation syndrome|macrophage activation syndrome
5548048|NCT01095146|Systemic onset juvenile idiopathic arthritis|systemic onset juvenile idiopathic arthritis
5548050|NCT01095146|JIA|jia
5548051|NCT01095133|Gastroesophageal reflux disease|gastroesophageal reflux disease
5548052|NCT01095133|Heartburn|heartburn
5548053|NCT01095107|Determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration|determining whether adjustments in the amounts of fat grams within the current inpatient protocol meal plans will lead to a change in the hospital stay duration
5548054|NCT01095107|Alter their recovery by affecting vital signs|alter their recovery by affecting vital signs
5548055|NCT01095107|Rate of weight change or need for supplemental feeds/medications|rate of weight change or need for supplemental feeds/medications
5548056|NCT01095107|Effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain|effect gastrointestinal symptoms (bloating, gastroesophageal reflux, constipation, diarrhea, abdominal pain
5685374|NCT00556374|non-metastatic breast cancer|non-metastatic breast cancer
5548057|NCT01095107|And/or effect their perceived body image or cause any changes in their mood.|and/or effect their perceived body image or cause any changes in their mood.
5548058|NCT01095094|adult brain tumor|adult brain tumor
5548059|NCT01095094|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5548060|NCT01095094|adult anaplastic ependymoma|adult anaplastic ependymoma
5548061|NCT01095094|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5548062|NCT01095094|adult brain stem glioma|adult brain stem glioma
5548063|NCT01095094|adult giant cell glioblastoma|adult giant cell glioblastoma
5548064|NCT01095094|adult glioblastoma|adult glioblastoma
5548065|NCT01095094|adult gliosarcoma|adult gliosarcoma
5548066|NCT01095094|adult mixed glioma|adult mixed glioma
5548067|NCT01095094|recurrent adult brain tumor|recurrent adult brain tumor
5548069|NCT01095042|emotion|emotion
5548070|NCT01095042|cognition|cognition
5548071|NCT01095042|stress|stress
5548072|NCT01095042|cortisol|cortisol
5548073|NCT01095042|Autonomic nervous system|autonomic nervous system
5548074|NCT01095029|Positron emission tomography (PET)|positron emission tomography (pet)
5548075|NCT01095029|Idiopathic Faecal Incontinence|idiopathic faecal incontinence
5548076|NCT01095029|Bilateral Sacral Nerve Stimulation|bilateral sacral nerve stimulation
5548077|NCT01095029|Sacral Nerve Stimulation|sacral nerve stimulation
5548078|NCT01095029|Sacral Nervemodulation|sacral nervemodulation
5548079|NCT01094990|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting|crossover; double blinded; intrathecal chemotherapy; dexamethasone; ketamine;vomiting
5548080|NCT01094977|Blood Loss and Transfusion|blood loss and transfusion
5548081|NCT01094977|Craniosynostoses|craniosynostoses
5548082|NCT01094977|Tranexamic Acid|tranexamic acid
5548083|NCT01094977|Children|children
5548084|NCT01094964|recurrent bladder cancer|recurrent bladder cancer
5548085|NCT01094964|stage 0 bladder cancer|stage 0 bladder cancer
5548086|NCT01094964|stage I bladder cancer|stage i bladder cancer
5548087|NCT01094964|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5548089|NCT01094951|Depression|depression
5548090|NCT01094938|Aortic aneurysm repair|aortic aneurysm repair
5548091|NCT01094925|Cesarean section|cesarean section
5548092|NCT01094925|Gabapentin|gabapentin
5548093|NCT01094912|Cancer pain|cancer pain
5548094|NCT01094899|diabetes|diabetes
5548095|NCT01094899|osteopenia|osteopenia
5548096|NCT01094899|neuropathy|neuropathy
5548097|NCT01094899|foot|foot
5548098|NCT01094899|AGE|age
5548099|NCT01094886|Total Hip Replacement|total hip replacement
5548100|NCT01094886|Total Knee Replacement|total knee replacement
5548101|NCT01094886|Hip Implant|hip implant
5548102|NCT01094886|Knee Implant|knee implant
5548103|NCT01094886|Joint Prosthesis|joint prosthesis
5548104|NCT01094886|Orthopedic Surgery|orthopedic surgery
5548105|NCT01094886|Rivaroxaban|rivaroxaban
5548106|NCT01094886|Xarelto|xarelto
5548107|NCT01094886|Blood Clot|blood clot
5548108|NCT01094873|Hepatitis C|hepatitis c
5548109|NCT01094873|HCV|hcv
5548110|NCT01094873|Adenovirus|adenovirus
5548111|NCT01094873|Vaccine|vaccine
5548112|NCT01094860|Relapsed/Refractory Lymphoid Malignancies|relapsed/refractory lymphoid malignancies
5548113|NCT01094860|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5548114|NCT01094860|CLL|cll
5548115|NCT01094860|Small lymphocytic lymphoma|small lymphocytic lymphoma
5548116|NCT01094860|SLL|sll
5548117|NCT01094860|B-prolymphocytic leukemia|b-prolymphocytic leukemia
5548118|NCT01094860|Follicular lymphoma|follicular lymphoma
5548119|NCT01094860|Mantle cell lymphoma|mantle cell lymphoma
5548120|NCT01094860|Lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
5548121|NCT01094860|Marginal zone lymphoma|marginal zone lymphoma
5548122|NCT01094860|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
5548123|NCT01094860|large granular lymphocyte leukemia|large granular lymphocyte leukemia
5548124|NCT01094860|mycosis fungoides|mycosis fungoides
5548125|NCT01094860|Sezary syndrome|sezary syndrome
5548126|NCT01094860|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5548127|NCT01094860|Chemotherapy|chemotherapy
5548128|NCT01094860|Monoclonal antibody therapy|monoclonal antibody therapy
5548129|NCT01094860|T-cell or B-cell acute lymphoblastic leukemia (ALL)|t-cell or b-cell acute lymphoblastic leukemia (all)
5548130|NCT01094860|Continuous Infusion Nelarabine|continuous infusion nelarabine
5548131|NCT01094860|Arranon|arranon
5548132|NCT01094821|Healthy volunteers|healthy volunteers
5548133|NCT01094821|ATI-7505|ati-7505
5548134|NCT01094821|Scintigraphy|scintigraphy
5548135|NCT01094821|Gastrointestinal transit|gastrointestinal transit
5548136|NCT01094808|pregabalin|pregabalin
5548137|NCT01094808|motor|motor
5548138|NCT01094808|sensation|sensation
5548139|NCT01094808|colon|colon
5548140|NCT01094808|pain|pain
5548141|NCT01094808|gas|gas
5548144|NCT01094756|Obesity|obesity
5548145|NCT01094717|psoriasis|psoriasis
5548146|NCT01094717|excimer|excimer
5548147|NCT01094717|acitretin|acitretin
5548148|NCT01094717|tazarotene|tazarotene
5548149|NCT01094704|cystic fibrosis|cystic fibrosis
5548150|NCT01094704|mucociliary clearance|mucociliary clearance
5548151|NCT01094704|hypertonic saline|hypertonic saline
5548152|NCT01094678|Peripheral Aterial Disease (PAD)|peripheral aterial disease (pad)
5679425|NCT00582101|HIV|hiv
5548153|NCT01094678|Peripheral Vascular Disease|peripheral vascular disease
5548154|NCT01094678|Drug-Eluting Stent|drug-eluting stent
5548155|NCT01094678|Drug-Coated Stent|drug-coated stent
5548156|NCT01094678|Vascular Diseases|vascular diseases
5548157|NCT01094678|Cardiovascular Diseases|cardiovascular diseases
5548158|NCT01094652|Adolescent|adolescent
5548159|NCT01094652|Whole grain|whole grain
5548160|NCT01094652|Digestive health|digestive health
5548161|NCT01094652|Dietary fiber|dietary fiber
5548162|NCT01094652|Grain|grain
5548163|NCT01094652|Microbiota|microbiota
5548164|NCT01094652|Inflammation|inflammation
5548165|NCT01094652|Mucosal Immunity|mucosal immunity
5548166|NCT01094626|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5548167|NCT01094626|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
5548168|NCT01094626|Imaging techniques|imaging techniques
5548169|NCT01094626|Pancreatic surgical resection|pancreatic surgical resection
5548170|NCT01094626|Synthetic human secretin|synthetic human secretin
5548171|NCT01094613|Crohn's Disease|crohn's disease
5548172|NCT01094613|Delayed Release|delayed release
5548173|NCT01094613|Targeted Ileal Delivery|targeted ileal delivery
5548174|NCT01094600|Pancreatic cancer|pancreatic cancer
5548175|NCT01094600|Pancreatic resection|pancreatic resection
5548176|NCT01094600|Synthetic human secretin|synthetic human secretin
5548177|NCT01094600|Secretin-enhanced MRCP|secretin-enhanced mrcp
5548178|NCT01094600|Endoscopic pancreatic function test|endoscopic pancreatic function test
5548179|NCT01094600|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5548180|NCT01094561|Family history of pancreatic cancer|family history of pancreatic cancer
5548181|NCT01094561|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5548182|NCT01094561|Imaging techniques|imaging techniques
5548183|NCT01094561|Synthetic human secretin|synthetic human secretin
5548184|NCT01094561|Pancreatic abnormalities|pancreatic abnormalities
5542438|NCT01117168|Registration|registration
5548185|NCT01094561|Early detection and prevention|early detection and prevention
5548187|NCT01094548|Multiple myeloma|multiple myeloma
5548188|NCT01094535|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5548189|NCT01094535|Synthetic human secretin|synthetic human secretin
5548190|NCT01094535|Secretin-enhanced MRCP|secretin-enhanced mrcp
5548191|NCT01094535|Pancreatic insufficiency|pancreatic insufficiency
5548192|NCT01094535|Endoscopic Pancreatic Function Test (ePFT)|endoscopic pancreatic function test (epft)
5548193|NCT01094535|Endocrine pancreatic function test|endocrine pancreatic function test
5548194|NCT01094535|Exocrine pancreatic function test|exocrine pancreatic function test
5548195|NCT01094496|bladder cancer|bladder cancer
5548196|NCT01094496|immunotherapy|immunotherapy
5548197|NCT01094496|cystectomy|cystectomy
5548198|NCT01094496|cancer vaccine|cancer vaccine
5548199|NCT01094496|human chorionic gonadotropin|human chorionic gonadotropin
5548201|NCT01094496|urogenital neoplasms|urogenital neoplasms
5548202|NCT01094496|urinary bladder neoplasms|urinary bladder neoplasms
5548203|NCT01094496|muscle invasive|muscle invasive
5548204|NCT01094496|non-metastatic|non-metastatic
5548205|NCT01094496|transitional cell (urothelial) bladder cancer|transitional cell (urothelial) bladder cancer
5548206|NCT01094483|Thromboxane B2|thromboxane b2
5548207|NCT01094470|gait|gait
5548208|NCT01094470|ambulation|ambulation
5548209|NCT01094470|kinematics|kinematics
5548210|NCT01094457|antiplatelet therapy|antiplatelet therapy
5548211|NCT01094457|clopidogrel low responsiveness|clopidogrel low responsiveness
5548212|NCT01094457|acute coronary syndromes|acute coronary syndromes
5548213|NCT01094457|percutaneous coronary intervention|percutaneous coronary intervention
5548214|NCT01094457|cilostazol|cilostazol
5548215|NCT01094444|Vitamin K3 lotion|vitamin k3 lotion
5548216|NCT01094444|Cetuximab induced folliculitis|cetuximab induced folliculitis
5548217|NCT01094431|Fever|fever
5548218|NCT01094431|Etiology|etiology
5548219|NCT01094431|Children under five years of age|children under five years of age
5548220|NCT01094431|IMCI|imci
5548221|NCT01094418|polyneuropathy|polyneuropathy
5548222|NCT01094418|Nerve conduction study|nerve conduction study
5548223|NCT01094418|Impaired glucose tolerance test|impaired glucose tolerance test
5548224|NCT01094418|Diabetes mellitus|diabetes mellitus
5548225|NCT01094405|NPC with persistent, recurrent or metastatic disease patients|npc with persistent, recurrent or metastatic disease patients
5548226|NCT01094392|ALL|all
5548227|NCT01094392|PEG-asparaginase|peg-asparaginase
5548228|NCT01094392|prolonged treatment|prolonged treatment
5548229|NCT01094392|Thrombosis|thrombosis
5548230|NCT01094392|Central venous line|central venous line
5548231|NCT01094392|Echocardiography|echocardiography
5548232|NCT01094379|cholecystectomy|cholecystectomy
5548233|NCT01094379|laparoscopic|laparoscopic
5548234|NCT01094379|pain|pain
5548235|NCT01094379|single incision|single incision
5548236|NCT01094366|Paracervical Block|paracervical block
5548237|NCT01094366|pain control|pain control
5548238|NCT01094366|abortion|abortion
5548239|NCT01094353|Urodynamic Stress urinary incontinence|urodynamic stress urinary incontinence
5548240|NCT01094353|Minisling|minisling
5548241|NCT01094353|Ophira™|ophira™
5548242|NCT01094353|Unitape™|unitape™
5548243|NCT01094327|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5715706|NCT00445679|MDD|mdd
5548244|NCT01094301|electrical stimulation|electrical stimulation
5548245|NCT01094301|neurostimulation|neurostimulation
5548246|NCT01094301|neuromodulation|neuromodulation
5548247|NCT01094301|shoulder pain|shoulder pain
5548248|NCT01094301|post-stroke shoulder pain|post-stroke shoulder pain
5548249|NCT01094301|hemiplegic shoulder pain|hemiplegic shoulder pain
5548250|NCT01094275|drug resistance|drug resistance
5548251|NCT01094275|gene polymorphism|gene polymorphism
5548252|NCT01094262|Osteoarthritis pain of the knee|osteoarthritis pain of the knee
5548253|NCT01094262|Osteoarthritis|osteoarthritis
5548254|NCT01094262|Osteoarthritis, Knee|osteoarthritis, knee
5548255|NCT01094262|Pain|pain
5548256|NCT01094262|Arthralgia|arthralgia
5548257|NCT01094262|Joint Pain|joint pain
5548258|NCT01094262|JNJ-42160443|jnj-42160443
5548259|NCT01094249|Paliperidone ER|paliperidone er
5548260|NCT01094249|INVEGA|invega
5548261|NCT01094249|Divalproex sodium|divalproex sodium
5548262|NCT01094249|Depakote ER|depakote er
5548263|NCT01094249|Valproic acid|valproic acid
5548264|NCT01094249|Pharmacokinetics|pharmacokinetics
5548272|NCT01094223|Addiction|addiction
5548273|NCT01094223|Mindfulness|mindfulness
5548274|NCT01094223|Treatment|treatment
5548275|NCT01094210|Anti-erosion dental benefits|anti-erosion dental benefits
5548276|NCT01094197|Transfusion-associated microchimerism|transfusion-associated microchimerism
5548277|NCT01094197|Injuries|injuries
5548278|NCT01094197|Leukocytes|leukocytes
5548279|NCT01094171|poliomyelitis|poliomyelitis
5548280|NCT01094171|diphtheria|diphtheria
5548281|NCT01094171|Primary immunization|primary immunization
5548282|NCT01094171|pertussis|pertussis
5548288|NCT01094158|Metabolic Syndrome|metabolic syndrome
5548289|NCT01094158|Endothelial Dysfunction|endothelial dysfunction
5548290|NCT01094158|Insulin Resistance|insulin resistance
5548291|NCT01094158|Liver Fat|liver fat
5548292|NCT01094145|(light to moderate)|(light to moderate)
5548293|NCT01094132|cervical cancer|cervical cancer
5548294|NCT01094132|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5548295|NCT01094132|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5548296|NCT01094132|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5548297|NCT01094132|Nonmalignant Condition|nonmalignant condition
5548298|NCT01094119|heated blanket|heated blanket
5548299|NCT01094119|heated pad|heated pad
5548300|NCT01094106|postoperative pain|postoperative pain
5548301|NCT01094106|infiltration analgesia|infiltration analgesia
5548302|NCT01094106|ropivacaine|ropivacaine
5548303|NCT01094106|Caesarean Section|caesarean section
5548304|NCT01094093|Amgen|amgen
5548305|NCT01094093|AMG 139|amg 139
5548306|NCT01094080|fully formula fed|fully formula fed
5548307|NCT01094080|fully breast fed|fully breast fed
5548308|NCT01094041|Gluten|gluten
5548309|NCT01094041|Diarrhea or diarrhea predominant irritable bowel syndrome|diarrhea or diarrhea predominant irritable bowel syndrome
5548310|NCT01094041|Colonic permeability|colonic permeability
5548311|NCT01094041|Small bowel permeability|small bowel permeability
5548312|NCT01094041|Colonic inflammatory response|colonic inflammatory response
5548313|NCT01094041|Small bowel inflammatory response|small bowel inflammatory response
5548314|NCT01094028|Blood loss in the third and fourth stage of labor and the duration of third stage of labor|blood loss in the third and fourth stage of labor and the duration of third stage of labor
5548315|NCT01094015|hysteroscopy|hysteroscopy
5548316|NCT01094015|local anaesthetic|local anaesthetic
5548317|NCT01094015|pain relief|pain relief
5548318|NCT01094015|gynecological pathology|gynecological pathology
5548319|NCT01094002|OCCUPATIONAL THERAPY|occupational therapy
5548320|NCT01094002|RANDOMISED CLINICAL TRIAL|randomised clinical trial
5548321|NCT01094002|AGED|aged
5548322|NCT01094002|PATIENT CARE|patient care
5548323|NCT01093976|Skin Picking|skin picking
5548324|NCT01093976|OCD|ocd
5548325|NCT01093976|Trichotillomania|trichotillomania
5548326|NCT01093976|Pathological Skin Picking|pathological skin picking
5548327|NCT01093950|anthropometric|anthropometric
5548328|NCT01093950|white light scanner|white light scanner
5548329|NCT01093950|extraction profiles|extraction profiles
5548330|NCT01093950|Body lipodystrophy|body lipodystrophy
5548331|NCT01093937|Bipolar disorder|bipolar disorder
5548332|NCT01093937|Bipolar-I|bipolar-i
5548333|NCT01093937|Varenicline|varenicline
5548335|NCT01093937|Chantix|chantix
5548336|NCT01093937|Nicotine|nicotine
5548337|NCT01093937|Nicotinic receptor|nicotinic receptor
5548338|NCT01093937|Nicotinic receptor dysregulation|nicotinic receptor dysregulation
5548339|NCT01093937|Dopamine|dopamine
5548340|NCT01093937|Acetylcholine|acetylcholine
5548341|NCT01093937|Cigarette|cigarette
5548342|NCT01093937|Smoking|smoking
5548343|NCT01093937|Tobacco|tobacco
5548344|NCT01093937|Dependence|dependence
5548345|NCT01093937|Neuropsychological function|neuropsychological function
5530958|NCT01164059|quetiapine|quetiapine
5548346|NCT01093924|Behavioral weight loss maintenance intervention|behavioral weight loss maintenance intervention
5548347|NCT01093924|Weight loss|weight loss
5548348|NCT01093924|Weight loss maintenance|weight loss maintenance
5548349|NCT01093911|Lupus|lupus
5548350|NCT01093911|SLE|sle
5548351|NCT01093859|acetylcholinesterase|acetylcholinesterase
5548352|NCT01093846|uveitis|uveitis
5548353|NCT01093833|Diabetes|diabetes
5548354|NCT01093833|Type 1 diabetes|type 1 diabetes
5548355|NCT01093833|Type 2 diabetes|type 2 diabetes
5548356|NCT01093833|Diabetes mellitus|diabetes mellitus
5548357|NCT01093833|Blood glucose|blood glucose
5548358|NCT01093833|Continuous blood glucose monitoring|continuous blood glucose monitoring
5548359|NCT01093833|CGM|cgm
5548360|NCT01093820|acute myocardial infarction|acute myocardial infarction
5548361|NCT01093820|continuous erythropoetin receptor activator|continuous erythropoetin receptor activator
5548362|NCT01093820|Mircera|mircera
5548363|NCT01093820|hemoglobin kinetics|hemoglobin kinetics
5548364|NCT01093807|Hypertension|hypertension
5548365|NCT01093807|Lercanidipine|lercanidipine
5548366|NCT01093807|Calcium antagonist|calcium antagonist
5548367|NCT01093807|Enalapril|enalapril
5548368|NCT01093794|Type 2 Diabetes|type 2 diabetes
5548369|NCT01093781|membranous nephropathy aliskiren proteinuria, glomerulonephritis|membranous nephropathy aliskiren proteinuria, glomerulonephritis
5548370|NCT01093768|Oxytocin|oxytocin
5548371|NCT01093768|Vasopressin|vasopressin
5548372|NCT01093768|Autism|autism
5548373|NCT01093768|Amygdala|amygdala
5548374|NCT01093768|Social Cognition|social cognition
5548375|NCT01093768|Autism Spectrum Disorders|autism spectrum disorders
5548376|NCT01093768|ASD|asd
5548377|NCT01093768|Healthy Volunteer|healthy volunteer
5548378|NCT01093768|HV|hv
5548379|NCT01093755|Barrett's Esophagus|barrett's esophagus
5548380|NCT01093755|Radiofrequency ablation|radiofrequency ablation
5548381|NCT01093755|Patients post-radiofrequency ablation for Barrett's Esophagus.|patients post-radiofrequency ablation for barrett's esophagus.
5548382|NCT01093742|Healthy|healthy
5548383|NCT01093729|Exendin-4|exendin-4
5548384|NCT01093716|Alcohol dependence|alcohol dependence
5548385|NCT01093716|Craving|craving
5548386|NCT01093716|rTMS|rtms
5548387|NCT01093716|Dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5548388|NCT01093703|kidney transplantation|kidney transplantation
5548389|NCT01093703|hypertension|hypertension
5548390|NCT01093703|chronotherapy|chronotherapy
5548391|NCT01093703|graft function|graft function
5548392|NCT01093703|circadian pattern|circadian pattern
5548393|NCT01093690|chemotherapy induced nausea and vomiting, metoclopramide|chemotherapy induced nausea and vomiting, metoclopramide
5548394|NCT01093612|HER2-positive breast cancer|her2-positive breast cancer
5548395|NCT01093599|Smoking|smoking
5548396|NCT01093599|Smoking cessation|smoking cessation
5548397|NCT01093599|Nicotine|nicotine
5548398|NCT01093599|Tobacco|tobacco
5548399|NCT01093599|Mindfulness|mindfulness
5548400|NCT01093599|Meditation|meditation
5548401|NCT01093599|MBSR|mbsr
5548402|NCT01093599|Mindfulness Training|mindfulness training
5548403|NCT01093599|Behavioral Intervention|behavioral intervention
5548404|NCT01093599|Nicotine Patch|nicotine patch
5548405|NCT01093599|Quit Line|quit line
5548406|NCT01093599|Phone counseling|phone counseling
5548407|NCT01093573|Untreated myelodysplastic syndromes|untreated myelodysplastic syndromes
5548408|NCT01093560|metabolic syndrome|metabolic syndrome
5548409|NCT01093560|premenopausal women|premenopausal women
5548410|NCT01093560|fat feeding|fat feeding
5548411|NCT01093534|Vesicare|vesicare
5548412|NCT01093534|Solifenacin|solifenacin
5548413|NCT01093534|Detrusor Overactivity|detrusor overactivity
5548414|NCT01093534|Urinary Nerve Growth Factor|urinary nerve growth factor
5548415|NCT01093534|Overactive Bladder|overactive bladder
5548416|NCT01093534|Bladder wall thickness|bladder wall thickness
5548417|NCT01093521|IV Gallium|iv gallium
5548418|NCT01093521|Gallium|gallium
5548419|NCT01093521|Ganite|ganite
5548420|NCT01093521|Cystic Fibrosis|cystic fibrosis
5548421|NCT01093521|Gallium Infusion|gallium infusion
5548422|NCT01093495|Nasal Continuous positive Airway pressure|nasal continuous positive airway pressure
5548423|NCT01093495|Nasal Cannula|nasal cannula
5548424|NCT01093495|CPAP|cpap
5548425|NCT01093495|Premature|premature
5548426|NCT01093495|RDS|rds
5548427|NCT01093495|HMD|hmd
5548428|NCT01093495|NICU|nicu
5548429|NCT01093482|mechanical ventilation|mechanical ventilation
5548430|NCT01093482|epidemiology|epidemiology
5548431|NCT01093482|outcomes|outcomes
5548432|NCT01093482|mortality|mortality
5548433|NCT01093482|weaning|weaning
5548434|NCT01093482|sedation|sedation
5548435|NCT01093482|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5548436|NCT01093469|Atopic Dermatitis|atopic dermatitis
5548437|NCT01093469|Wake Forest|wake forest
5548438|NCT01093469|Dermatology|dermatology
5548439|NCT01093469|Skin|skin
5548440|NCT01093469|Over-the-counter|over-the-counter
5548441|NCT01093469|Moisturizer|moisturizer
5548442|NCT01093469|Children|children
5548443|NCT01093456|diurnal variation|diurnal variation
5548444|NCT01093456|peritoneal dialysis|peritoneal dialysis
5548445|NCT01093456|uremic retention solutes|uremic retention solutes
5548446|NCT01093456|phosphorous|phosphorous
5519894|NCT01209390|osteochondral|osteochondral
5548447|NCT01093456|indoxyl sulfate|indoxyl sulfate
5548448|NCT01093456|p-cresol sulfate|p-cresol sulfate
5548450|NCT01093443|ICSI|icsi
5548451|NCT01093443|GnRH antagonist|gnrh antagonist
5548452|NCT01093443|pretreatment|pretreatment
5548453|NCT01093430|Gynecological surgery|gynecological surgery
5548454|NCT01093430|laparoscopic ports|laparoscopic ports
5548455|NCT01093430|neuropathy|neuropathy
5548456|NCT01093417|Vitamin D|vitamin d
5548457|NCT01093417|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5548458|NCT01093417|Complementary Therapies|complementary therapies
5548459|NCT01093404|Heart disease|heart disease
5548460|NCT01093404|Myocardial infarction|myocardial infarction
5548461|NCT01093404|Angioplasty|angioplasty
5548462|NCT01093404|Thrombus aspiration|thrombus aspiration
5548463|NCT01093391|coronary artery|coronary artery
5548464|NCT01093391|thrombosis|thrombosis
5548465|NCT01093391|stent|stent
5548466|NCT01093378|Infertility|infertility
5548467|NCT01093378|Obesity|obesity
5548468|NCT01093378|Dietary intake|dietary intake
5548469|NCT01093378|Fertility|fertility
5548470|NCT01093378|nutrition|nutrition
5548471|NCT01093378|diet|diet
5548472|NCT01093378|weight|weight
5548473|NCT01093365|Schizophrenia|schizophrenia
5548474|NCT01093365|Schizoaffective Disorder|schizoaffective disorder
5548475|NCT01093365|Varenicline|varenicline
5548476|NCT01093365|Champix|champix
5548477|NCT01093365|Chantix|chantix
5548478|NCT01093365|Nicotine|nicotine
5548479|NCT01093365|Nicotinic receptor|nicotinic receptor
5548480|NCT01093365|Dopamine|dopamine
5548481|NCT01093365|Acetylcholine|acetylcholine
5548482|NCT01093365|Cigarette|cigarette
5548483|NCT01093365|Smoking|smoking
5548484|NCT01093365|Tobacco|tobacco
5548485|NCT01093365|Executive function|executive function
5548486|NCT01093365|Working memory|working memory
5548487|NCT01093365|Verbal memory|verbal memory
5548488|NCT01093365|Cognitive function|cognitive function
5548489|NCT01093365|Neuropsychological function|neuropsychological function
5548490|NCT01093352|Alveolar-decortication|alveolar-decortication
5548491|NCT01093352|Corticotomy assisted orthodontics|corticotomy assisted orthodontics
5548492|NCT01093352|Palatally impacted canine|palatally impacted canine
5548493|NCT01093352|Surgical exposure of canines|surgical exposure of canines
5548494|NCT01093352|Velocity of tooth movement|velocity of tooth movement
5548496|NCT01093339|SLEEP DEPRIVATION|sleep deprivation
5548497|NCT01093339|APPETITE REGULATION|appetite regulation
5548498|NCT01093339|GHRELIN|ghrelin
5548499|NCT01093339|LEPTIN|leptin
5548500|NCT01093274|colonoscopy|colonoscopy
5548501|NCT01093274|Cathartics|cathartics
5548502|NCT01093274|Sodium picosulfate|sodium picosulfate
5548503|NCT01093274|Polyethylene Glycol|polyethylene glycol
5548504|NCT01093261|trauma|trauma
5548505|NCT01093261|trauma brain injury|trauma brain injury
5548506|NCT01093261|multiple trauma|multiple trauma
5548507|NCT01093261|head trauma|head trauma
5548508|NCT01093261|hydrocortisone|hydrocortisone
5548509|NCT01093261|fludrocortisone|fludrocortisone
5548510|NCT01093261|glucocorticoid insufficiency related to ICU|glucocorticoid insufficiency related to icu
5548511|NCT01093261|adrenal Insufficiency|adrenal insufficiency
5548512|NCT01093261|pneumonia|pneumonia
5548513|NCT01093261|intensive care unit|intensive care unit
5548514|NCT01093261|shock|shock
5548515|NCT01093261|neurological recovery|neurological recovery
5548516|NCT01093235|cardiac toxicity|cardiac toxicity
5548517|NCT01093235|perioperative/postoperative complications|perioperative/postoperative complications
5548518|NCT01093235|HER2-negative breast cancer|her2-negative breast cancer
5548519|NCT01093235|male breast cancer|male breast cancer
5548520|NCT01093235|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5548521|NCT01093235|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5548522|NCT01093235|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5548523|NCT01093235|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5548524|NCT01093235|stage II breast cancer|stage ii breast cancer
5548525|NCT01093235|stage IIIA breast cancer|stage iiia breast cancer
5548526|NCT01093235|stage IIIB breast cancer|stage iiib breast cancer
5548527|NCT01093235|inflammatory breast cancer|inflammatory breast cancer
5548528|NCT01093209|Carpal Tunnel Syndrome|carpal tunnel syndrome
5548529|NCT01093209|Interferential laser therapy|interferential laser therapy
5548530|NCT01093209|Low-level laser therapy|low-level laser therapy
5548531|NCT01093209|Neuropathic pain|neuropathic pain
5548532|NCT01093209|Median nerve compression|median nerve compression
5548533|NCT01093196|Multiple Myeloma|multiple myeloma
5548534|NCT01093196|Elderly Patients|elderly patients
5548535|NCT01093196|Diagnosis|diagnosis
5548536|NCT01093196|Lenalidomide|lenalidomide
5548537|NCT01093196|Prednisone|prednisone
5548538|NCT01093196|Melphalan|melphalan
5548539|NCT01093196|Dexamethasone|dexamethasone
5548540|NCT01093196|Cyclophosphamide|cyclophosphamide
5548541|NCT01093157|Kidney disease, Glomerulonephritis|kidney disease, glomerulonephritis
5548542|NCT01093144|Delivery mode|delivery mode
5548543|NCT01093144|pelvic measurement|pelvic measurement
5531173|NCT01163045|RCT|rct
5548544|NCT01093131|Contrast induced nephropathy|contrast induced nephropathy
5548545|NCT01093131|Percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5548546|NCT01093131|chronic kidney disease|chronic kidney disease
5548547|NCT01093131|Prevention|prevention
5548548|NCT01093131|Equivalence|equivalence
5548549|NCT01093118|Distal subungual onychomycosis|distal subungual onychomycosis
5548550|NCT01093105|Leukodystrophy, Globoid Cell|leukodystrophy, globoid cell
5548551|NCT01093105|Classic Globoid Cell Leukodystrophy|classic globoid cell leukodystrophy
5548552|NCT01093105|Early-Onset Globoid Cell Leukodystrophy|early-onset globoid cell leukodystrophy
5548553|NCT01093105|Globoid Cell Leukodystrophy|globoid cell leukodystrophy
5548554|NCT01093105|Globoid Cell Leukoencephalopathy|globoid cell leukoencephalopathy
5548555|NCT01093105|Infantile Globoid Cell Leukodystrophy|infantile globoid cell leukodystrophy
5548556|NCT01093105|Late-Onset Globoid Cell Leukodystrophy|late-onset globoid cell leukodystrophy
5548557|NCT01093105|Leukodystrophy, Globoid Cell, Classic|leukodystrophy, globoid cell, classic
5548558|NCT01093105|Leukodystrophy, Globoid Cell, Early-Onset|leukodystrophy, globoid cell, early-onset
5548559|NCT01093105|Leukodystrophy, Globoid Cell, Infantile|leukodystrophy, globoid cell, infantile
5548560|NCT01093105|Leukodystrophy, Globoid Cell, Late-Onset|leukodystrophy, globoid cell, late-onset
5548561|NCT01093105|Psychosine|psychosine
5548562|NCT01093105|galactosylsphingosine (psychosine) beta-galactosidase|galactosylsphingosine (psychosine) beta-galactosidase
5548563|NCT01093105|Psychosine-UDP galactosyltransferase|psychosine-udp galactosyltransferase
5548564|NCT01093105|Krabbe Disease|krabbe disease
5548565|NCT01093105|Krabbe Leukodystrophy|krabbe leukodystrophy
5548566|NCT01093105|Krabbe's Disease|krabbe's disease
5548567|NCT01093105|Krabbe's Leukodystrophy|krabbe's leukodystrophy
5548568|NCT01093079|Renal tumor, RCC, Partial nephrectomy, Laparoscopy|renal tumor, rcc, partial nephrectomy, laparoscopy
5548569|NCT01093066|urothelial carcinoma|urothelial carcinoma
5548570|NCT01093066|TURB|turb
5548571|NCT01093066|chemotherapy|chemotherapy
5548572|NCT01093053|Mind-Body Therapies|mind-body therapies
5548573|NCT01093027|Essential Tremor|essential tremor
5548574|NCT01093027|Cooling|cooling
5548575|NCT01093027|Temperature|temperature
5548576|NCT01093027|Patients with Essential Tremor involving the upper limbs with at least moderate tremor.|patients with essential tremor involving the upper limbs with at least moderate tremor.
5548577|NCT01093014|Quadriceps Muscle|quadriceps muscle
5548578|NCT01093014|RNA, Messenger|rna, messenger
5548579|NCT01093014|Hypertrophy|hypertrophy
5548580|NCT01093014|Electric Stimulation Therapy|electric stimulation therapy
5548581|NCT01093001|Reduce Tricuspid Regurgitation|reduce tricuspid regurgitation
5548582|NCT01093001|Reduce Right Ventricular pacing|reduce right ventricular pacing
5548584|NCT01093001|Lead size|lead size
5548585|NCT01092988|Uterine Fibroids|uterine fibroids
5548586|NCT01092988|Bleeding|bleeding
5548587|NCT01092988|Pain|pain
5548588|NCT01092988|Quality of life|quality of life
5548589|NCT01092988|MR guided focused ultrasound|mr guided focused ultrasound
5548590|NCT01092975|radiotherapy|radiotherapy
5548591|NCT01092962|Children|children
5548592|NCT01092962|Mycophenolate mofetil|mycophenolate mofetil
5548593|NCT01092962|Cyclophosphamide|cyclophosphamide
5548594|NCT01092962|Idiopathic nephrotic steroid sensitive syndrome|idiopathic nephrotic steroid sensitive syndrome
5548595|NCT01092949|Placenta|placenta
5548596|NCT01092949|perfusion|perfusion
5548597|NCT01092949|MRI|mri
5548598|NCT01092949|spin tagging|spin tagging
5548599|NCT01092949|Gadolinium|gadolinium
5548600|NCT01092949|placental insufficiency|placental insufficiency
5548601|NCT01092949|urinary tract, sexual organs and pregnancy conditions|urinary tract, sexual organs and pregnancy conditions
5548602|NCT01092936|Comparative fit index|comparative fit index
5548603|NCT01092936|Movement Disorders' Society|movement disorders' society
5548604|NCT01092936|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
5548605|NCT01092923|Nitrous Oxide|nitrous oxide
5548606|NCT01092923|washin|washin
5548607|NCT01092923|washout|washout
5548608|NCT01092923|second gas effect|second gas effect
5548609|NCT01092923|sevoflurane|sevoflurane
5548610|NCT01092923|induction|induction
5548611|NCT01092923|emergence|emergence
5548612|NCT01092910|Sensorineural|sensorineural
5548613|NCT01092910|Hearing Loss|hearing loss
5548614|NCT01092884|melasma|melasma
5548615|NCT01092884|sunscreen|sunscreen
5548616|NCT01092884|polypodium leucotomos|polypodium leucotomos
5548617|NCT01092858|Testosterone undecanoate|testosterone undecanoate
5548618|NCT01092858|Hypogonadism|hypogonadism
5548619|NCT01092845|Double-Blind|double-blind
5548620|NCT01092845|Randomized|randomized
5548621|NCT01092845|Placebo-Controlled|placebo-controlled
5548622|NCT01092845|2-Way Crossover|2-way crossover
5548623|NCT01092845|Polysomnographic Endpoints|polysomnographic endpoints
5548624|NCT01092832|Invasive Candidiasis Candidemia Esophageal Candidiasis|invasive candidiasis candidemia esophageal candidiasis
5671230|NCT00616590|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5685375|NCT00556374|estrogen receptor positive|estrogen receptor positive
5548625|NCT01092819|acute ischemic stroke, large vessel occlusion, natural history, functional outcome|acute ischemic stroke, large vessel occlusion, natural history, functional outcome
5548626|NCT01092806|tacrolimus|tacrolimus
5548627|NCT01092806|pharmacokinetics|pharmacokinetics
5548628|NCT01092806|formulations|formulations
5548629|NCT01092806|once daily|once daily
5548630|NCT01092806|twice daily|twice daily
5548631|NCT01092806|renal transplant recipients|renal transplant recipients
5548632|NCT01092806|Kidney transplantation|kidney transplantation
5548633|NCT01092793|Fish oil|fish oil
5548635|NCT01092793|CAD|cad
5548636|NCT01092767|Thoracic Aneurysm|thoracic aneurysm
5548637|NCT01092767|Thoracic Transection|thoracic transection
5548638|NCT01092767|Endovascular Aortic Repair|endovascular aortic repair
5548639|NCT01092754|brain, spine, liver, MRI, Pediatric|brain, spine, liver, mri, pediatric
5548640|NCT01092741|Leukemia|leukemia
5548641|NCT01092741|Gleevec|gleevec
5548642|NCT01092741|STI571|sti571
5548643|NCT01092741|CML|cml
5548644|NCT01092741|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5548645|NCT01092728|Acral lentiginous melanoma|acral lentiginous melanoma
5548646|NCT01092728|Mucosal melanoma|mucosal melanoma
5548647|NCT01092728|Chronic sun-damaged melanoma|chronic sun-damaged melanoma
5548648|NCT01092728|Surgically removed tumor|surgically removed tumor
5548649|NCT01092728|biopsied|biopsied
5548650|NCT01092728|Sprycel|sprycel
5548651|NCT01092728|Dasatinib|dasatinib
5548652|NCT01092715|Neck pain|neck pain
5548653|NCT01092715|Spinal manipulation|spinal manipulation
5548654|NCT01092715|Massage|massage
5548655|NCT01092702|Tobacco Dependence|tobacco dependence
5548656|NCT01092702|Smoking|smoking
5548657|NCT01092702|Tobacco Cessation|tobacco cessation
5548658|NCT01092689|heterocyclic amines|heterocyclic amines
5548659|NCT01092689|PhIP|phip
5548660|NCT01092689|Meat|meat
5548661|NCT01092689|pancreas neoplasms|pancreas neoplasms
5548662|NCT01092676|Pediatrics|pediatrics
5548663|NCT01092676|Emergency|emergency
5548664|NCT01092663|Colesevelam|colesevelam
5548665|NCT01092663|type 2 diabetes|type 2 diabetes
5548666|NCT01092663|sitagliptin|sitagliptin
5548667|NCT01092663|glucose metabolism|glucose metabolism
5548668|NCT01092650|Tobacco toxicants|tobacco toxicants
5548669|NCT01092650|Polycyclic aromatic hydrocarbons|polycyclic aromatic hydrocarbons
5548670|NCT01092650|Smoking|smoking
5548671|NCT01092624|voiding dysfunction|voiding dysfunction
5548672|NCT01092624|defecatory dysfunction|defecatory dysfunction
5548673|NCT01092624|vaginal bulge symptoms|vaginal bulge symptoms
5548674|NCT01092611|long-term follow-up study|long-term follow-up study
5548675|NCT01092611|HIV-infected subjects|hiv-infected subjects
5542844|NCT01116206|Resolor|resolor
5548676|NCT01092611|HIV therapeutic vaccine|hiv therapeutic vaccine
5548677|NCT01092572|cystic fibrosis|cystic fibrosis
5548678|NCT01092572|adult cystic fibrosis|adult cystic fibrosis
5548679|NCT01092559|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5548681|NCT01092546|Normal pressure hydrocephalus (NPH)|normal pressure hydrocephalus (nph)
5548682|NCT01092546|Positron Emission Tomography (PET)|positron emission tomography (pet)
5548683|NCT01092546|Standard uptake value ratios (SUVR)|standard uptake value ratios (suvr)
5548684|NCT01092520|Gabapentin|gabapentin
5548685|NCT01092520|Burn Injuries in Children|burn injuries in children
5548686|NCT01092520|pruritus|pruritus
5548687|NCT01092507|Encephalitis|encephalitis
5548688|NCT01092507|Japanese Encephalitis|japanese encephalitis
5548689|NCT01092507|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
5548690|NCT01092507|Infant|infant
5548691|NCT01092494|Endometrioma recurrence|endometrioma recurrence
5548692|NCT01092494|oral contraceptives|oral contraceptives
5548693|NCT01092494|gonadotropin-releasing hormone agonist|gonadotropin-releasing hormone agonist
5548694|NCT01092481|Adjuvant FOLFOX or CAPOX Therapy|adjuvant folfox or capox therapy
5548695|NCT01092481|Stage II/III Colon Cancer|stage ii/iii colon cancer
5548696|NCT01092481|Adjuvant Therapy|adjuvant therapy
5548697|NCT01092468|cancer|cancer
5548698|NCT01092468|reconstruction|reconstruction
5548699|NCT01092468|free flap|free flap
5548700|NCT01092468|surgery|surgery
5548701|NCT01092455|End Stage Renal Disease|end stage renal disease
5548702|NCT01092455|Renal Dialysis|renal dialysis
5548703|NCT01092455|Hemodialysis therapy|hemodialysis therapy
5548704|NCT01092455|Heparin|heparin
5548705|NCT01092455|Citrasate|citrasate
5548706|NCT01092455|Anticoagulant|anticoagulant
5548707|NCT01092442|Pulmonary Valve|pulmonary valve
5548708|NCT01092442|Right Ventricular Outflow Tract Reconstruction|right ventricular outflow tract reconstruction
5548709|NCT01092442|Ross Procedure|ross procedure
5548710|NCT01092429|CAD|cad
5548711|NCT01092416|CAD|cad
5548712|NCT01092416|Severely calcified lesion|severely calcified lesion
5548713|NCT01092390|randomized trial|randomized trial
5548714|NCT01092390|omega three fatty acids|omega three fatty acids
5548715|NCT01092364|Young adults|young adults
5548716|NCT01092351|urinary tract infection|urinary tract infection
5548717|NCT01092351|nitrofurantoin|nitrofurantoin
5548718|NCT01092338|Human Immunodeficiency Virus|human immunodeficiency virus
5548719|NCT01092338|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5520224|NCT01207908|DMD|dmd
5548720|NCT01092338|Vitamin D|vitamin d
5548721|NCT01092338|HIV|hiv
5548722|NCT01092338|Complementary therapies|complementary therapies
5548723|NCT01092325|Heart Failure|heart failure
5548724|NCT01092312|knee|knee
5548725|NCT01092312|arthroplasty|arthroplasty
5548726|NCT01092299|Phase I|phase i
5548727|NCT01092299|Relative bioavailability|relative bioavailability
5548728|NCT01092299|Pharmacokinetic study|pharmacokinetic study
5548729|NCT01092299|AZD1446|azd1446
5548730|NCT01092299|healthy volunteers|healthy volunteers
5548731|NCT01092286|Knee injury|knee injury
5548732|NCT01092286|ankle sprain|ankle sprain
5548733|NCT01092286|anterior cruciate ligament|anterior cruciate ligament
5548734|NCT01092286|adolescent|adolescent
5548735|NCT01092286|soccer|soccer
5548736|NCT01092286|basketball|basketball
5548737|NCT01092286|prevention|prevention
5548738|NCT01092273|Glaucoma and Ocular Hypertension|glaucoma and ocular hypertension
5548739|NCT01092260|Glomerular Filtration Rate|glomerular filtration rate
5548740|NCT01092260|Kidney disease|kidney disease
5548741|NCT01092260|Child|child
5548742|NCT01092260|Iohexol|iohexol
5548743|NCT01092260|Cystatin C|cystatin c
5847209|NCT00040508|Immunosuppression|immunosuppression
5548744|NCT01092260|Measurement of kidney function in children|measurement of kidney function in children
5548745|NCT01092247|Patients with malignant tumors|patients with malignant tumors
5548746|NCT01092234|Observational units|observational units
5548747|NCT01092234|Length of stay (LOS)|length of stay (los)
5548748|NCT01092234|Readmission|readmission
5548749|NCT01092221|mania, allopurinol, add-on treatment|mania, allopurinol, add-on treatment
5548750|NCT01092208|Autism|autism
5548751|NCT01092208|iPS Cells|ips cells
5548752|NCT01092208|Fibroblasts|fibroblasts
5548753|NCT01092208|Gene Networks|gene networks
5548754|NCT01092208|Tuberous Sclerosis|tuberous sclerosis
5548755|NCT01092208|Healthy Volunteer|healthy volunteer
5548757|NCT01092195|Women's Health|women's health
5548758|NCT01092195|Genital Precancer|genital precancer
5548759|NCT01092195|Stem Cell Donor|stem cell donor
5548760|NCT01092195|Cervical Cytology|cervical cytology
5548761|NCT01092195|Healthy Volunteers|healthy volunteers
5548762|NCT01092195|Stem Cell Transplant|stem cell transplant
5548763|NCT01092195|Healthy Volunteer|healthy volunteer
5548764|NCT01092195|HV|hv
5548765|NCT01092182|Microarray|microarray
5548766|NCT01092182|Toxicity|toxicity
5548767|NCT01092182|Therapeutic Index|therapeutic index
5548768|NCT01092182|HIV Positive|hiv positive
5548769|NCT01092182|HIV Negative|hiv negative
5548770|NCT01092182|HIV Infections|hiv infections
5548771|NCT01092156|Nipple pain during lactation|nipple pain during lactation
5548772|NCT01092130|Heart failure|heart failure
5548773|NCT01092130|Vitamin D|vitamin d
5548774|NCT01092130|Plasma renin activity|plasma renin activity
5548775|NCT01092130|Renin angiotensin system|renin angiotensin system
5548776|NCT01092117|abdominal|abdominal
5548777|NCT01092117|aortic|aortic
5548778|NCT01092117|aneurysm|aneurysm
5548779|NCT01092091|Neoplasm|neoplasm
5548780|NCT01092091|Hepatocellular Carcinoma|hepatocellular carcinoma
5548781|NCT01092078|hypertension|hypertension
5548782|NCT01092078|colon cancer screening|colon cancer screening
5548783|NCT01092078|african american|african american
5548785|NCT01092078|motivational interviewing|motivational interviewing
5548786|NCT01092078|patient navigation|patient navigation
5548787|NCT01092065|Parkinson's Disease|parkinson's disease
5548788|NCT01092065|Dyskinesia|dyskinesia
5548789|NCT01092065|Drug-induced|drug-induced
5548790|NCT01092065|Levodopa|levodopa
5548791|NCT01092065|L-dopa|l-dopa
5548792|NCT01092052|Phase I study|phase i study
5548793|NCT01092052|Advanced/Metastatic Solid Tumors|advanced/metastatic solid tumors
5548794|NCT01092052|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
5548795|NCT01092039|Common Cold|common cold
5548796|NCT01092039|Cold Virus|cold virus
5548797|NCT01092039|Feeling sick|feeling sick
5548798|NCT01092039|Influenza|influenza
5548799|NCT01092000|Health Promotion, Dietary Guidelines, Physical Activity Guidelines|health promotion, dietary guidelines, physical activity guidelines
5548800|NCT01091987|Insomnia|insomnia
5548801|NCT01091974|Insomnia|insomnia
5548802|NCT01091974|Fatigue|fatigue
5548803|NCT01091974|QOL|qol
5548804|NCT01091974|CBT|cbt
5548805|NCT01091974|Breast cancer|breast cancer
5548806|NCT01091974|Survivors|survivors
5548807|NCT01091974|Chemotherapy|chemotherapy
5548808|NCT01091961|ACE inhibitor|ace inhibitor
5548809|NCT01091961|ARB|arb
5548810|NCT01091961|Non-cardiac surgery|non-cardiac surgery
5548811|NCT01091961|Perioperative|perioperative
5548812|NCT01091961|Preoperative|preoperative
5548813|NCT01091961|Hypotension|hypotension
5548814|NCT01091961|Congestive heart failure|congestive heart failure
5548815|NCT01091961|Hypertension|hypertension
5548816|NCT01091961|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5548817|NCT01091961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5548818|NCT01091961|Perioperative Care|perioperative care
5548819|NCT01091948|elective general surgery|elective general surgery
5548820|NCT01091948|orotracheal intubation|orotracheal intubation
5671231|NCT00616590|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5548821|NCT01091948|Patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.|patients would be eligible for inclusion if they were at least 18 years old and scheduled for elective surgery requiring orotracheal intubation.
5548822|NCT01091935|Lidocaine,Intravenous Infusions,Neuropathic Pain,Side Effects|lidocaine,intravenous infusions,neuropathic pain,side effects
5548823|NCT01091922|flavonoids|flavonoids
5548824|NCT01091922|flavanols|flavanols
5548825|NCT01091922|bacteria|bacteria
5548826|NCT01091909|type 2 diabetes|type 2 diabetes
5548827|NCT01091909|wound healing|wound healing
5548828|NCT01091909|neutrophil count|neutrophil count
5548829|NCT01091909|dental extraction|dental extraction
5548830|NCT01091896|bevacizumab|bevacizumab
5548831|NCT01091896|vitreous hemorrhage|vitreous hemorrhage
5548832|NCT01091896|diabetes mellitus|diabetes mellitus
5548833|NCT01091883|Bone cancer|bone cancer
5548834|NCT01091883|Bone Metastases|bone metastases
5548835|NCT01091883|pain palliation|pain palliation
5548836|NCT01091883|metastasis|metastasis
5548837|NCT01091883|breast cancer|breast cancer
5551458|NCT01081431|MDS|mds
5548838|NCT01091883|lung cancer|lung cancer
5548839|NCT01091883|prostate cancer|prostate cancer
5548840|NCT01091883|cancer related pain|cancer related pain
5548841|NCT01091883|tumors|tumors
5548842|NCT01091870|Aneurysm|aneurysm
5548843|NCT01091870|Vasospasm|vasospasm
5548844|NCT01091870|sildenafil|sildenafil
5548845|NCT01091870|Viagra|viagra
5548846|NCT01091857|Exercise|exercise
5548847|NCT01091857|Transdisciplinary|transdisciplinary
5548848|NCT01091857|Physiology|physiology
5548849|NCT01091857|Mood|mood
5548850|NCT01091857|Motivation|motivation
5548851|NCT01091844|voiding trial, urinary retention, catheterization|voiding trial, urinary retention, catheterization
5548852|NCT01091844|Urinary retention after gynecologic surgery|urinary retention after gynecologic surgery
5548853|NCT01091831|Multiple Myeloma|multiple myeloma
5548854|NCT01091831|Lenalidomide|lenalidomide
5548855|NCT01091831|High dose melphalan|high dose melphalan
5548856|NCT01091831|Mobilization|mobilization
5548857|NCT01091831|CD 34|cd 34
5548858|NCT01091831|Newly Diagnosed patients|newly diagnosed patients
5548859|NCT01091818|To see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children|to see if sedation with dexmedetomidine results in faster emergence after end of intensive care treatment in children
5548860|NCT01091818|treatment|treatment
5548861|NCT01091792|GBM|gbm
5548862|NCT01091792|Grade IV|grade iv
5548863|NCT01091792|glioma|glioma
5548864|NCT01091779|Male patients scheduled to have spinal anaesthesia for TURP|male patients scheduled to have spinal anaesthesia for turp
5548865|NCT01091766|local anaesthetics toxicity|local anaesthetics toxicity
5548866|NCT01091766|heart arrhythmia|heart arrhythmia
5548868|NCT01091766|heart conduction|heart conduction
5548869|NCT01091766|regional anaesthesia|regional anaesthesia
5548870|NCT01091766|paediatric anaesthesia|paediatric anaesthesia
5548871|NCT01091766|cardio-vascular system|cardio-vascular system
5548873|NCT01091753|Non-dipper HTN patient|non-dipper htn patient
5548874|NCT01091740|Drug eluting stent|drug eluting stent
5548875|NCT01091740|Tomography, optical coherence|tomography, optical coherence
5548876|NCT01091727|Neurogenic|neurogenic
5548877|NCT01091727|Detrusor|detrusor
5548878|NCT01091727|Overactive|overactive
5548879|NCT01091727|Overactivity|overactivity
5548880|NCT01091727|Bladder|bladder
5548881|NCT01091727|Spinal|spinal
5548882|NCT01091727|Cord|cord
5548883|NCT01091727|Injury|injury
5548884|NCT01091701|Ischemic Cerebral Stroke|ischemic cerebral stroke
5548885|NCT01091688|neonatal|neonatal
5548886|NCT01091688|discharge planning|discharge planning
5548887|NCT01091688|health transition|health transition
5548888|NCT01091688|educational needs assessment|educational needs assessment
5548889|NCT01091688|Intensive care, neonatal|intensive care, neonatal
5548890|NCT01091675|ankylosing spondylitis|ankylosing spondylitis
5548891|NCT01091675|biologic therapies|biologic therapies
5548892|NCT01091675|ASAS|asas
5548893|NCT01091675|ASASBIO|asasbio
5548894|NCT01091675|etoricoxib|etoricoxib
5548895|NCT01091675|NSAIDs|nsaids
5548896|NCT01091675|COX-2 Inhibitor|cox-2 inhibitor
5548897|NCT01091675|ARCOXIA 90 mg|arcoxia 90 mg
5548898|NCT01091675|BASDAI Bath Ankylosing Spondylitis Disease Activity Index|basdai bath ankylosing spondylitis disease activity index
5548900|NCT01091662|Epilepsy|epilepsy
5548901|NCT01091662|Anticonvulsant|anticonvulsant
5548902|NCT01091662|Monotherapy|monotherapy
5548903|NCT01091662|Historical control|historical control
5548904|NCT01091649|Pharmacokinetics, Safety|pharmacokinetics, safety
5548905|NCT01091623|improvement of exercise capacity in patients with COPD|improvement of exercise capacity in patients with copd
5548906|NCT01091610|retrospective study|retrospective study
5548907|NCT01091610|wounds and injuries/epidemiology|wounds and injuries/epidemiology
5548908|NCT01091610|emergency medical technicians|emergency medical technicians
5548909|NCT01091610|human|human
5548910|NCT01091610|emergency medical services|emergency medical services
5548911|NCT01091610|ambulance|ambulance
5548913|NCT01091610|emergency medicine|emergency medicine
5548914|NCT01091610|risk factors|risk factors
5548915|NCT01091571|Adenosine|adenosine
5548916|NCT01091571|Endotoxin|endotoxin
5548917|NCT01091571|Innate Immunity|innate immunity
5548918|NCT01091571|Dipyridamole|dipyridamole
5548919|NCT01091558|ulcerative colitis|ulcerative colitis
5548920|NCT01091558|colon cancer|colon cancer
5548921|NCT01091558|endoscopy|endoscopy
5548922|NCT01091558|screening|screening
5548923|NCT01091545|breast cancer|breast cancer
5548924|NCT01091545|screening|screening
5548925|NCT01091545|sensitivity|sensitivity
5548926|NCT01091545|tomosynthesis|tomosynthesis
5548927|NCT01091519|Non-interventional study fesoterodine educational materials|non-interventional study fesoterodine educational materials
5548928|NCT01091506|L-methylfolate|l-methylfolate
5548929|NCT01091506|Deplin|deplin
5548930|NCT01091506|schizophrenia|schizophrenia
5548931|NCT01091506|folate|folate
5548932|NCT01091506|folic acid|folic acid
5548933|NCT01091506|homocysteine|homocysteine
5548934|NCT01091506|methionine|methionine
5548935|NCT01091506|MTHFR genotype|mthfr genotype
5548936|NCT01091506|C677T mutation|c677t mutation
5548942|NCT01091480|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5548943|NCT01091480|Observatory|observatory
5548945|NCT01091467|Heart Failure|heart failure
5548946|NCT01091467|Ejection Fraction|ejection fraction
5548947|NCT01091467|Echocardiography|echocardiography
5548948|NCT01091454|stage IV breast cancer|stage iv breast cancer
5548949|NCT01091454|triple-negative breast cancer|triple-negative breast cancer
5548950|NCT01091454|male breast cancer|male breast cancer
5548951|NCT01091441|therapeutic education|therapeutic education
5548952|NCT01091428|RECIST: Response Evaluation Criteria in Solid Tumors|recist: response evaluation criteria in solid tumors
5548953|NCT01091428|OC: Ovarian Cancer|oc: ovarian cancer
5548954|NCT01091428|GCIG: Gynecologic Cancer Intergroup|gcig: gynecologic cancer intergroup
5548955|NCT01091428|Breast carcinoma (Phase 1)|breast carcinoma (phase 1)
5548956|NCT01091428|Drug therapy|drug therapy
5548957|NCT01091402|autologous serum skin test, IL-18|autologous serum skin test, il-18
5548958|NCT01091389|Atrial Fibrillation|atrial fibrillation
5548959|NCT01091389|Totally Thoracoscopic PV isolation|totally thoracoscopic pv isolation
5548960|NCT01091376|Non-small cell lung cancer|non-small cell lung cancer
5548961|NCT01091376|EGFR-TKI|egfr-tki
5548962|NCT01091376|Erlotinib|erlotinib
5548963|NCT01091376|Radiotherapy|radiotherapy
5548964|NCT01091363|smoking cessation|smoking cessation
5548965|NCT01091363|tobacco dependence treatment|tobacco dependence treatment
5548966|NCT01091363|cultural adaptation|cultural adaptation
5548967|NCT01091363|Asian Americans|asian americans
5548968|NCT01091324|CKD, proteinuria, dextromethorphan, silymarin|ckd, proteinuria, dextromethorphan, silymarin
5543151|NCT01114789|obesity|obesity
5548969|NCT01091324|patients with 15 ml<eGFR< 60ml and 0.5 g/day<proteinuria<3g/day|patients with 15 ml<egfr< 60ml and 0.5 g/day<proteinuria<3g/day
5548971|NCT01091298|Safety of vaccine|safety of vaccine
5548972|NCT01091272|healthy volunteer|healthy volunteer
5548973|NCT01091272|safety|safety
5548974|NCT01091272|pharmacokinetic|pharmacokinetic
5548975|NCT01091259|antibody therapy|antibody therapy
5548976|NCT01091259|chemotherapy|chemotherapy
5548977|NCT01091259|biologic therapy|biologic therapy
5548978|NCT01091259|combination therapy|combination therapy
5548979|NCT01091233|Critically ill patients|critically ill patients
5548980|NCT01091233|liver cirrhosis|liver cirrhosis
5548981|NCT01091233|ascites requiring Paracentesis|ascites requiring paracentesis
5548982|NCT01091220|certolizumab pegol|certolizumab pegol
5548983|NCT01091220|Cimzia®|cimzia®
5548984|NCT01091220|healthy male volunteers|healthy male volunteers
5548985|NCT01091220|sperm|sperm
5548986|NCT01091207|Sorafenib|sorafenib
5548987|NCT01091207|GIST|gist
5548988|NCT01091207|Refractory|refractory
5548989|NCT01091207|advanced GIST failed after both imatinib and sunitinib|advanced gist failed after both imatinib and sunitinib
5548990|NCT01091194|Heart Transplantation|heart transplantation
5548991|NCT01091194|Aerobic Exercise|aerobic exercise
5548992|NCT01091194|Exercise, Physical|exercise, physical
5548993|NCT01091194|Exercise Test|exercise test
5548994|NCT01091194|Treadmill Test|treadmill test
5548995|NCT01091194|VO2 peak|vo2 peak
5548996|NCT01091194|Muscle Strength|muscle strength
5548997|NCT01091194|Quality of Life|quality of life
5548998|NCT01091194|Reinnervation|reinnervation
5548999|NCT01091194|Heart Rate|heart rate
5549000|NCT01091194|Myocardial Function|myocardial function
5549001|NCT01091181|Caesarean|caesarean
5549002|NCT01091155|Colon Anastomosis|colon anastomosis
5549003|NCT01091155|Rectum Anastomosis|rectum anastomosis
5549004|NCT01091155|Intestine|intestine
5549005|NCT01091155|Colorectal Surgery|colorectal surgery
5549006|NCT01091155|Colorectal Anastomosis|colorectal anastomosis
5549007|NCT01091129|hyperhidrosis|hyperhidrosis
5716592|NCT00443131|Malaria|malaria
5549008|NCT01091116|Injections, Intra-Articular|injections, intra-articular
5549009|NCT01091090|Smoking cessation|smoking cessation
5549010|NCT01091090|Nicotine dependence|nicotine dependence
5549011|NCT01091090|Chronic pain|chronic pain
5549012|NCT01091077|dietary supplement|dietary supplement
5790024|NCT00146107|Obesity in the Elderly|obesity in the elderly
5549013|NCT01091051|Ustekinumab, Palmo-Plantar, Pustular Psoriasis, Pustulosis|ustekinumab, palmo-plantar, pustular psoriasis, pustulosis
5549014|NCT01091038|Adverse drug events|adverse drug events
5549015|NCT01091038|medical errors|medical errors
5549016|NCT01091038|computerized physician order entry|computerized physician order entry
5549017|NCT01091038|clinical decision support|clinical decision support
5549018|NCT01091025|Adults|adults
5549019|NCT01091025|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5549020|NCT01091025|Screening|screening
5549021|NCT01091025|Oral glucose tolerance test|oral glucose tolerance test
5549022|NCT01091025|Royal Brompton & Harefield Foundation Trust|royal brompton & harefield foundation trust
5549023|NCT01090999|COPD|copd
5549024|NCT01090999|Pulmonary Rehabilitation|pulmonary rehabilitation
5549025|NCT01090986|Restrictive pulmonary disease with hypercapnic chronic respiratory failure.|restrictive pulmonary disease with hypercapnic chronic respiratory failure.
5549026|NCT01090986|COPD patients who need NIV hypercapnic chronic respiratory failure.|copd patients who need niv hypercapnic chronic respiratory failure.
5549027|NCT01090973|relapsed|relapsed
5549028|NCT01090973|refractory|refractory
5549029|NCT01090973|CLL|cll
5549030|NCT01090973|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5549031|NCT01090973|MCL|mcl
5549032|NCT01090973|mantle cell lymphoma|mantle cell lymphoma
5549033|NCT01090934|Diagnosis|diagnosis
5549034|NCT01090934|Partial Epilepsy|partial epilepsy
5549035|NCT01090921|Multiple Myeloma|multiple myeloma
5549036|NCT01090921|Bortezomib|bortezomib
5549037|NCT01090921|Newly diagnosed|newly diagnosed
5549038|NCT01090921|Newly diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5549039|NCT01090895|Percutaneous Coronary Intervention|percutaneous coronary intervention
5549040|NCT01090895|Vitamin C|vitamin c
5549041|NCT01090895|Biomarkers|biomarkers
5549042|NCT01090895|Magnetic Risonance|magnetic risonance
5549043|NCT01090882|Local anaesthetic|local anaesthetic
5549044|NCT01090882|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5549045|NCT01090882|Pain scores|pain scores
5549046|NCT01090882|Bupivocaine|bupivocaine
5549047|NCT01090882|Day case surgery|day case surgery
5549048|NCT01090856|Bifurcations|bifurcations
5549049|NCT01090856|Drug eluting-stents|drug eluting-stents
5549050|NCT01090856|Provisional stenting|provisional stenting
5549051|NCT01090843|Obscure digestive bleeding (ODB)|obscure digestive bleeding (odb)
5549052|NCT01090843|Chronic anaemia of unknown origin|chronic anaemia of unknown origin
5549053|NCT01090843|Chronic diarrhoea|chronic diarrhoea
5549054|NCT01090830|Non small cell lung cancer|non small cell lung cancer
5549055|NCT01090830|Belinostat|belinostat
5549056|NCT01090830|carboplatin|carboplatin
5549057|NCT01090830|Paclitaxel|paclitaxel
5549058|NCT01090830|Bevacizumab|bevacizumab
5549059|NCT01090830|chemotherapy|chemotherapy
5549060|NCT01090830|Maximum Tolerated Dose|maximum tolerated dose
5549061|NCT01090830|Neoplasms, Pulmonary|neoplasms, pulmonary
5549062|NCT01090830|Lung Cancer|lung cancer
5549063|NCT01090830|Event Free Survival|event free survival
5549064|NCT01090830|Disease free survival|disease free survival
5549065|NCT01090830|Progression Free Survival|progression free survival
5549066|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors
5549067|NCT01090830|Treatment Efficacy|treatment efficacy
5549068|NCT01090817|mesenchymal stromal cells|mesenchymal stromal cells
5549070|NCT01090817|colitis|colitis
5549071|NCT01090804|BreatheMAX breathing device|breathemax breathing device
5549072|NCT01090804|Secretion clearance|secretion clearance
5549073|NCT01090804|Ventilatory dependence|ventilatory dependence
5549074|NCT01090804|Intubated patients|intubated patients
5549075|NCT01090791|critically ill patient|critically ill patient
5549076|NCT01090778|growth hormone deficiency|growth hormone deficiency
5549077|NCT01090778|circadian variation|circadian variation
5549078|NCT01090765|Prostate|prostate
5549079|NCT01090765|Tumor|tumor
5549080|NCT01090765|Cancer|cancer
5549081|NCT01090765|Hormone|hormone
5549082|NCT01090765|Androgen|androgen
5549083|NCT01090765|Prostate Cancer|prostate cancer
5549084|NCT01090752|diabetes|diabetes
5549085|NCT01090752|blood pressure|blood pressure
5549086|NCT01090752|pioglitazone|pioglitazone
5549087|NCT01090752|sodium|sodium
5549088|NCT01090752|insulin resistance, renal function, sodium, pioglitazone|insulin resistance, renal function, sodium, pioglitazone
5549089|NCT01090739|Fecal incontinence|fecal incontinence
5549090|NCT01090739|Accidental bowel leakage|accidental bowel leakage
5549091|NCT01090739|Failure conservative therapy|failure conservative therapy
5549092|NCT01090739|Women|women
5549093|NCT01090739|Class III medical device|class iii medical device
5549094|NCT01090739|Surgical mesh|surgical mesh
5549095|NCT01090700|TMC435-TiDP16-C112|tmc435-tidp16-c112
5549096|NCT01090700|TMC435-C112|tmc435-c112
5549097|NCT01090700|TMC435|tmc435
5549098|NCT01090700|HCV|hcv
5549099|NCT01090700|Hepatitis C|hepatitis c
5549100|NCT01090687|breast cancer, CT scans, mammography|breast cancer, ct scans, mammography
5549101|NCT01090674|Diaphragmatic force|diaphragmatic force
5549103|NCT01090661|antisense|antisense
5549104|NCT01090661|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5549105|NCT01090661|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5549106|NCT01090661|thorough QT|thorough qt
5549107|NCT01090648|TMC125HIV1083|tmc125hiv1083
5549108|NCT01090648|TMC125|tmc125
5549109|NCT01090648|HIV|hiv
5549110|NCT01090648|Etravirine|etravirine
5549111|NCT01090648|ETR|etr
5549112|NCT01090648|Intelence|intelence
5549113|NCT01090648|HIV Infections|hiv infections
5549114|NCT01090635|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5549115|NCT01090609|Coronary Stent|coronary stent
5549116|NCT01090609|Cobalt-Chromium coronary stent|cobalt-chromium coronary stent
5549117|NCT01090583|Cytokines|cytokines
5549118|NCT01090583|Pregnancy|pregnancy
5549119|NCT01090583|Cesarean|cesarean
5549120|NCT01090544|COPD|copd
5549121|NCT01090544|TNI|tni
5549122|NCT01090544|PaCO2|paco2
5549123|NCT01090492|Raynaud's phenomenon|raynaud's phenomenon
5549124|NCT01090492|vasospasm|vasospasm
5549126|NCT01090492|systemic sclerosis|systemic sclerosis
5549127|NCT01090492|CREST|crest
5549128|NCT01090492|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5549129|NCT01090479|Surgical site infections|surgical site infections
5549130|NCT01090479|Chlorhexidine|chlorhexidine
5549131|NCT01090479|Shoulder surgery|shoulder surgery
5549132|NCT01090466|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5549133|NCT01090466|recurrent bladder cancer|recurrent bladder cancer
5549134|NCT01090466|recurrent urethral cancer|recurrent urethral cancer
5549135|NCT01090466|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5549136|NCT01090466|stage IV bladder cancer|stage iv bladder cancer
5549137|NCT01090466|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5549138|NCT01090466|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5549139|NCT01090466|distal urethral cancer|distal urethral cancer
5549140|NCT01090466|proximal urethral cancer|proximal urethral cancer
5549141|NCT01090466|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5549142|NCT01090466|stage IV urethral cancer|stage iv urethral cancer
5549143|NCT01090440|schizophrenia|schizophrenia
5549144|NCT01090440|GSK1144814|gsk1144814
5549145|NCT01090440|effect of food|effect of food
5549146|NCT01090440|healthy subjects|healthy subjects
5549147|NCT01090440|depressive disorder|depressive disorder
5549148|NCT01090440|pharmacokinetics|pharmacokinetics
5549149|NCT01090427|Ustekinumab|ustekinumab
5549150|NCT01090427|Injection|injection
5549151|NCT01090427|CNTO 1275|cnto 1275
5549152|NCT01090427|Stelara|stelara
5549153|NCT01090427|Pediatric psoriasis|pediatric psoriasis
5549154|NCT01090427|Adolescents|adolescents
5549155|NCT01090414|Idelalisib|idelalisib
5549156|NCT01090414|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5549157|NCT01090414|Non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5549158|NCT01090414|Phosphatidylinositol 3-kinase (PI3K)|phosphatidylinositol 3-kinase (pi3k)
5549159|NCT01090388|Cross-sectional survey|cross-sectional survey
5549160|NCT01090388|Health-related quality of life|health-related quality of life
5549161|NCT01090388|Symptom management|symptom management
5549162|NCT01090375|osteoarthritis|osteoarthritis
5549163|NCT01090375|biochemical markers|biochemical markers
5549164|NCT01090375|cartilage|cartilage
5549165|NCT01090375|inflammation|inflammation
5549166|NCT01090375|microdialysis|microdialysis
5549167|NCT01090362|Atrial fibrillation|atrial fibrillation
5549168|NCT01090362|Anticoagulation|anticoagulation
5549169|NCT01090362|Stroke|stroke
5549170|NCT01090362|Stroke prevention|stroke prevention
5549171|NCT01090362|Health Economics|health economics
5549172|NCT01090349|ICD, CRTD, Remote Care|icd, crtd, remote care
5549173|NCT01090336|platelet aggregation inhibition|platelet aggregation inhibition
5549174|NCT01090336|prasugrel|prasugrel
5549175|NCT01090336|clopidogrel|clopidogrel
5549177|NCT01090323|Deferasirox|deferasirox
5549178|NCT01090323|ICL670A|icl670a
5549179|NCT01090323|Iron chelators|iron chelators
5549180|NCT01090323|Sickle Cell Disease|sickle cell disease
5549181|NCT01090323|Transfusional Hemosiderosis|transfusional hemosiderosis
5549182|NCT01090310|Quiescent uveitis|quiescent uveitis
5549183|NCT01090310|intermediate uveitis|intermediate uveitis
5549184|NCT01090310|panuveitis|panuveitis
5549185|NCT01090310|posterior uveitis|posterior uveitis
5549186|NCT01090310|uveitis|uveitis
5680309|NCT00578292|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia|transfusion-dependent homozygous b0/+-thalassemia or severe variants of b0/+-thalassemia
5549187|NCT01090310|NVS Definition: Words or phrases that best describe the protocol. Keywords help users find studies in the database.|nvs definition: words or phrases that best describe the protocol. keywords help users find studies in the database.
5549188|NCT01090310|Avoid acronyms, abbreviations and trade names.|avoid acronyms, abbreviations and trade names.
5549189|NCT01090310|Examples: Heart failure, aliskiren, heart attack, cardiovascular diseases|examples: heart failure, aliskiren, heart attack, cardiovascular diseases
5549190|NCT01090310|Psoriasis, inflammatory skin disease, scaly patches|psoriasis, inflammatory skin disease, scaly patches
5549191|NCT01090297|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5549193|NCT01090297|Continuous Positive Airway Pressure|continuous positive airway pressure
5549194|NCT01090284|Inguinal hernia|inguinal hernia
5549195|NCT01090284|Immune system|immune system
5549196|NCT01090284|Cytokines|cytokines
5520662|NCT01205958|Cervical pain|cervical pain
5549197|NCT01090284|Prosthetic repair|prosthetic repair
5549198|NCT01090284|Oxidative Stress|oxidative stress
5549199|NCT01090271|Subacromial impingement syndrome|subacromial impingement syndrome
5549200|NCT01090271|Muscle Strength|muscle strength
5549201|NCT01090271|Resistance Training|resistance training
5549202|NCT01090258|cardiac surgery|cardiac surgery
5549203|NCT01090258|mechanical ventilation|mechanical ventilation
5549204|NCT01090258|automation|automation
5549206|NCT01090245|contingency management|contingency management
5549207|NCT01090245|substance abuse treatment|substance abuse treatment
5549208|NCT01090245|criminal justice populations|criminal justice populations
5549209|NCT01090245|substance abuse treatment retention|substance abuse treatment retention
5549210|NCT01090245|HIV prevention in criminal justice settings|hiv prevention in criminal justice settings
5551886|NCT01079598|IPV|ipv
5549211|NCT01090245|voucher based reinforcement therapy|voucher based reinforcement therapy
5549212|NCT01090245|Parole treatment admission for substance abusing parolees|parole treatment admission for substance abusing parolees
5549213|NCT01090245|Parole treatment retention for substance abusing parolees|parole treatment retention for substance abusing parolees
5549214|NCT01090245|HIV testing and counseling for substance abusing parolees|hiv testing and counseling for substance abusing parolees
5549215|NCT01090219|Inguinal Hernia|inguinal hernia
5549216|NCT01090219|contraction of two different meshes in the repair of inguinal hernias in men|contraction of two different meshes in the repair of inguinal hernias in men
5549217|NCT01090206|Hemophilia|hemophilia
5549218|NCT01090206|Vitamin D|vitamin d
5549219|NCT01090193|Obstructive jaundice|obstructive jaundice
5549220|NCT01090193|kidney histopathology|kidney histopathology
5549221|NCT01090193|lactulose|lactulose
5549222|NCT01090180|PTSD|ptsd
5549223|NCT01090180|combat|combat
5549224|NCT01090180|stress disorders|stress disorders
5549225|NCT01090180|veteran|veteran
5549226|NCT01090154|Ulcerative colitis|ulcerative colitis
5549227|NCT01090154|UC|uc
5549228|NCT01090154|Inflammatory Bowel Disease|inflammatory bowel disease
5549229|NCT01090141|Micafungin|micafungin
5549230|NCT01090141|Body Weight|body weight
5549231|NCT01090141|Anti-Infective Agents|anti-infective agents
5549232|NCT01090141|Signs and Symptoms|signs and symptoms
5549233|NCT01090141|Mycoses|mycoses
5549234|NCT01090141|Therapeutic Uses|therapeutic uses
5549235|NCT01090141|Antifungal Agents|antifungal agents
5549236|NCT01090141|Overnutrition|overnutrition
5549237|NCT01090141|Pharmacologic Actions|pharmacologic actions
5549238|NCT01090076|Pressure Ulcer Wound|pressure ulcer wound
5549239|NCT01090076|Specialized Amino Acid Mixture|specialized amino acid mixture
5549240|NCT01090063|Palmar Plantar Psoriasis|palmar plantar psoriasis
5549241|NCT01090050|Chronic Migraine|chronic migraine
5549242|NCT01090050|Migraine|migraine
5549243|NCT01090050|Treximet|treximet
5549245|NCT01090050|sumatriptan|sumatriptan
5549246|NCT01090037|ESRD|esrd
5549247|NCT01090037|Chronic Renal Failure|chronic renal failure
5549248|NCT01090037|Prostaglandin|prostaglandin
5549249|NCT01090037|Prostacyclin|prostacyclin
5549250|NCT01090037|Asian Multinational Study|asian multinational study
5549251|NCT01089998|Neoplasm|neoplasm
5549252|NCT01089998|PET/CT diagnosis|pet/ct diagnosis
5549253|NCT01089998|PET tracer|pet tracer
5549254|NCT01089998|Inflammation|inflammation
5549255|NCT01089972|radial artery|radial artery
5549256|NCT01089972|ulnar artery|ulnar artery
5549257|NCT01089972|catheterization|catheterization
5549258|NCT01089972|regional blood flow|regional blood flow
5549259|NCT01089959|Acid re-flux,GERD|acid re-flux,gerd
5549260|NCT01089959|sleep related arousals due to GERD|sleep related arousals due to gerd
5549261|NCT01089959|Treatment of acid reflux during sleep in patients with GERD.|treatment of acid reflux during sleep in patients with gerd.
5549262|NCT01089946|Mobilization|mobilization
5549263|NCT01089946|Hip arthroplasty|hip arthroplasty
5549264|NCT01089946|cardiovascular|cardiovascular
5549265|NCT01089933|Anesthesia|anesthesia
5549266|NCT01089933|Local Anesthetics|local anesthetics
5549267|NCT01089933|Analgesia|analgesia
5549268|NCT01089933|Quality of life|quality of life
5549269|NCT01089933|Paravertebral blocks|paravertebral blocks
5549270|NCT01089933|Arm morbidity|arm morbidity
5549271|NCT01089907|genomic|genomic
5534409|NCT01149343|Malignant melanoma|malignant melanoma
5549272|NCT01089907|childhood|childhood
5549273|NCT01089907|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5549274|NCT01089894|18F-FLT|18f-flt
5549276|NCT01089894|non-small cell lung cancer|non-small cell lung cancer
5549277|NCT01089894|cell proliferation|cell proliferation
5549278|NCT01089894|therapeutic response|therapeutic response
5549279|NCT01089894|18F-3'-fluoro-3'-deoxy-L-thymidine (18F-FLT)|18f-3'-fluoro-3'-deoxy-l-thymidine (18f-flt)
5549280|NCT01089881|prostate cancer|prostate cancer
5549281|NCT01089881|18F-fluorocholine|18f-fluorocholine
5549282|NCT01089881|PET|pet
5549283|NCT01089881|recurrence|recurrence
5549284|NCT01089881|metastases|metastases
5549285|NCT01089868|Glioblastoma multiforme|glioblastoma multiforme
5549286|NCT01089868|Microsurgery|microsurgery
5549287|NCT01089868|Stereotactic biopsy|stereotactic biopsy
5549288|NCT01089868|Radiochemotherapy|radiochemotherapy
5549289|NCT01089868|Temodar|temodar
5549290|NCT01089868|FET PET|fet pet
5549291|NCT01089868|Molecular imaging|molecular imaging
5549292|NCT01089855|Neuropathic Pain|neuropathic pain
5549293|NCT01089855|Brief Pain Inventory|brief pain inventory
5549294|NCT01089855|DN4 questionnaire|dn4 questionnaire
5549295|NCT01089855|ElectroCardioGram|electrocardiogram
5549296|NCT01089842|Secondary Prevention|secondary prevention
5549297|NCT01089842|Health Promotion|health promotion
5549298|NCT01089842|Behavioral Medicine|behavioral medicine
5549299|NCT01089842|Exercise Therapy|exercise therapy
5549301|NCT01089829|Foot Ulceration|foot ulceration
5549302|NCT01089829|Diabetes|diabetes
5549303|NCT01089816|Influenza infections|influenza infections
5549304|NCT01089816|Orthomyxoviridae infections|orthomyxoviridae infections
5549305|NCT01089816|Influenza Human|influenza human
5549306|NCT01089803|laryngectomy|laryngectomy
5549307|NCT01089803|larynx|larynx
5549308|NCT01089803|hypopharynx|hypopharynx
5549309|NCT01089764|breast neoplasm|breast neoplasm
5549310|NCT01089764|breast cancer|breast cancer
5549311|NCT01089764|behavioral intervention|behavioral intervention
5549312|NCT01089764|online support|online support
5549313|NCT01089764|relationship distress|relationship distress
5549314|NCT01089764|dyadic coping|dyadic coping
5549315|NCT01089738|mulitple dose|mulitple dose
5549316|NCT01089738|pharmacokinetics|pharmacokinetics
5549317|NCT01089738|safety|safety
5549318|NCT01089738|healthy elderly volunteers|healthy elderly volunteers
5549319|NCT01089725|safety|safety
5549320|NCT01089725|efficacy|efficacy
5549321|NCT01089725|parallel group|parallel group
5549322|NCT01089725|double-blind|double-blind
5549323|NCT01089725|multicenter|multicenter
5549324|NCT01089725|injection|injection
5549325|NCT01089725|infusion|infusion
5549326|NCT01089725|osteoarthritis|osteoarthritis
5549327|NCT01089725|bridging|bridging
5549328|NCT01089725|subcutaneous|subcutaneous
5549329|NCT01089725|intravenous|intravenous
5549330|NCT01089725|tanezumab|tanezumab
5549331|NCT01089712|Infection|infection
5549332|NCT01089712|Cardiac Surgery|cardiac surgery
5549333|NCT01089712|Post Operative Cardiac Surgery Infection|post operative cardiac surgery infection
5549334|NCT01089712|Management Practices|management practices
5549335|NCT01089699|breast cancer|breast cancer
5549336|NCT01089699|support groups|support groups
5549337|NCT01089699|Primary diagnosis of breast cancer within the past three years.|primary diagnosis of breast cancer within the past three years.
5549338|NCT01089686|Chronic Cerebrospinal Venous Insufficiency|chronic cerebrospinal venous insufficiency
5549339|NCT01089673|retrospective data collection|retrospective data collection
5549340|NCT01089660|Influenza|influenza
5549341|NCT01089660|Pandemic Flu|pandemic flu
5549342|NCT01089660|Swine-origin Influenza|swine-origin influenza
5549343|NCT01089660|Inactivated split-virion vaccine|inactivated split-virion vaccine
5549344|NCT01089647|OSA|osa
5549345|NCT01089647|Medical treatment|medical treatment
5549346|NCT01089634|LV measurement|lv measurement
5549347|NCT01089634|CRT|crt
5549348|NCT01089634|Concerto|concerto
5549349|NCT01089634|LVCM|lvcm
5549350|NCT01089634|LV threshold|lv threshold
5549351|NCT01089634|new CRT|new crt
5549352|NCT01089608|Azyter in patients affected by chronic blepharitis.|azyter in patients affected by chronic blepharitis.
5549353|NCT01089595|Imatinib Resistance|imatinib resistance
5549354|NCT01089595|GIST|gist
5549355|NCT01089595|Advanced Disease|advanced disease
5549356|NCT01089595|Nilotinib|nilotinib
5549357|NCT01089582|non-interventional|non-interventional
5549358|NCT01089582|mild to moderate Alzheimer's|mild to moderate alzheimer's
5549359|NCT01089582|ARICEPT.|aricept.
5549360|NCT01089569|diabetes|diabetes
5549361|NCT01089569|continuous glucose monitoring|continuous glucose monitoring
5549362|NCT01089569|exenatide|exenatide
5549363|NCT01089569|insulin glargine|insulin glargine
5549364|NCT01089543|dyspepsia|dyspepsia
5549365|NCT01089543|rabeprazole|rabeprazole
5549366|NCT01089543|Japan|japan
5549367|NCT01089530|Fibrinogen|fibrinogen
5549368|NCT01089530|Cholesterol|cholesterol
5549369|NCT01089530|Cardiovascular risk factors|cardiovascular risk factors
5549370|NCT01089530|Primary prevention|primary prevention
5549371|NCT01089530|High levels fibrinogen|high levels fibrinogen
5549372|NCT01089530|High plasma fibrinogen|high plasma fibrinogen
5549373|NCT01089504|phenobarbital|phenobarbital
5549375|NCT01089504|antiepileptic drugs|antiepileptic drugs
5549376|NCT01089504|neurodevelopmental outcome|neurodevelopmental outcome
5549377|NCT01089504|seizure|seizure
5549378|NCT01089491|Low back pain|low back pain
5549379|NCT01089491|Epiduroscopy|epiduroscopy
5549380|NCT01089491|Cytology|cytology
5549381|NCT01089491|Electrical stimulation|electrical stimulation
5549382|NCT01089478|Back pain|back pain
5549383|NCT01089478|Low back pain|low back pain
5549384|NCT01089478|Cytology|cytology
5549385|NCT01089478|Epiduroscopy|epiduroscopy
5549386|NCT01089478|Pain|pain
5549387|NCT01089478|Radiculopathy|radiculopathy
5549388|NCT01089465|Bed bugs|bed bugs
5549389|NCT01089465|Cimex|cimex
5549390|NCT01089465|insects|insects
5549391|NCT01089465|bites|bites
5549392|NCT01089452|Mild to moderate hypertension|mild to moderate hypertension
5549393|NCT01089439|Nitric oxide|nitric oxide
5549394|NCT01089426|Pediatric patients with Parenteral Nutrition (PN) induced Liver Injury|pediatric patients with parenteral nutrition (pn) induced liver injury
5549395|NCT01089400|influenza|influenza
5549396|NCT01089400|H1N1|h1n1
5549397|NCT01089400|lymphocytes|lymphocytes
5549398|NCT01089400|T cell|t cell
5549399|NCT01089400|CD4|cd4
5549400|NCT01089400|CD8|cd8
5549401|NCT01089400|cytokine|cytokine
5549402|NCT01089400|serology|serology
5549403|NCT01089400|broncho-alveolar lavage|broncho-alveolar lavage
5549404|NCT01089400|acute respiratory distress syndrome|acute respiratory distress syndrome
5549405|NCT01089400|ventilation|ventilation
5549406|NCT01089400|intensive care unit|intensive care unit
5549407|NCT01089387|radical prostatectomy|radical prostatectomy
5549408|NCT01089374|Phyllodes|phyllodes
5549409|NCT01089361|systemic inflammatory syndrome|systemic inflammatory syndrome
5549410|NCT01089361|sepsis syndrome|sepsis syndrome
5549411|NCT01089361|septic shock|septic shock
5549412|NCT01089361|Cytokine|cytokine
5549413|NCT01089361|Ketamine|ketamine
5549414|NCT01089348|Vaginosis, Bacterial|vaginosis, bacterial
5549415|NCT01089348|Prebiotics|prebiotics
5549416|NCT01089348|Lactofiltrum|lactofiltrum
5549417|NCT01089348|Therapy|therapy
5549418|NCT01089335|Sentinel node|sentinel node
5549419|NCT01089335|Thyroid cancer|thyroid cancer
5549420|NCT01089335|Thyroid neoplasia|thyroid neoplasia
5549421|NCT01089335|Follicular neoplasia|follicular neoplasia
5549422|NCT01089322|SEVERE ASTHMA|severe asthma
5549423|NCT01089322|RISK FACTORS|risk factors
5549424|NCT01089322|CHARACTERIZATION|characterization
5549425|NCT01089322|CLINICAL CONTROL|clinical control
5549426|NCT01089322|INFLAMMATORY MARKERS|inflammatory markers
5549427|NCT01089322|SEVERE|severe
5549428|NCT01089322|CONTROL|control
5549429|NCT01089309|Aldosterone Blockade|aldosterone blockade
5549430|NCT01089309|Arterial elasticity|arterial elasticity
5549431|NCT01089309|Glycemic control|glycemic control
5549432|NCT01089296|Infants born preterm|infants born preterm
5549433|NCT01089296|Early physiotherapy intervention|early physiotherapy intervention
5549434|NCT01089296|Motor development|motor development
5549435|NCT01089296|Parental participation|parental participation
5549436|NCT01089296|Parental competency|parental competency
5549437|NCT01089283|parkinson|parkinson
5549438|NCT01089283|fdg pet-ct|fdg pet-ct
5549439|NCT01089283|i123 dat scan|i123 dat scan
5549440|NCT01089283|LRRK2|lrrk2
5549441|NCT01089283|GBA|gba
5549442|NCT01089283|parkinson patients with known genetic characteristic|parkinson patients with known genetic characteristic
5549443|NCT01089270|Parkinson|parkinson
5549444|NCT01089270|fdg pet-ct|fdg pet-ct
5549445|NCT01089270|i123 dat scan|i123 dat scan
5862963|NCT00001444|Protein Kinase Antagonist|protein kinase antagonist
5549446|NCT01089270|first degree relatives of diagnosed Parkinson patients|first degree relatives of diagnosed parkinson patients
5549447|NCT01089270|with no clinical evidence of movement disorders|with no clinical evidence of movement disorders
5549449|NCT01089257|Oxidative stress|oxidative stress
5549450|NCT01089257|Systemic inflammation|systemic inflammation
5549451|NCT01089257|Endothelial function|endothelial function
5549452|NCT01089257|Peripheral Arterial Tone|peripheral arterial tone
5549453|NCT01089257|Positive Airway Pressure|positive airway pressure
5549454|NCT01089244|Low grade glioma|low grade glioma
5549455|NCT01089244|Astrocytoma|astrocytoma
5549456|NCT01089244|Molecular imaging|molecular imaging
5549457|NCT01089244|FET PET|fet pet
5549458|NCT01089244|Therapy monitoring|therapy monitoring
5549459|NCT01089244|Temodar|temodar
5549460|NCT01089231|Hyperlipidemia|hyperlipidemia
5549461|NCT01089231|coronary heart disease|coronary heart disease
5549462|NCT01089231|gene expression|gene expression
5549463|NCT01089231|fish oil|fish oil
5549464|NCT01089231|DHA, EPA|dha, epa
5549465|NCT01089218|bronchoscopy|bronchoscopy
5549466|NCT01089218|post-bronchoscopy fever|post-bronchoscopy fever
5549467|NCT01089218|pneumonia|pneumonia
5549468|NCT01089218|cytokines|cytokines
5549469|NCT01089218|amoxicillin/clavulanate|amoxicillin/clavulanate
5549470|NCT01089218|prophylaxis|prophylaxis
5549471|NCT01089153|human blood, urine and fecal samples|human blood, urine and fecal samples
5549472|NCT01089140|pediatrics|pediatrics
5549473|NCT01089140|scoliosis|scoliosis
5549474|NCT01089140|tranexamic acid|tranexamic acid
5549475|NCT01089140|Investigating non-idiopathic scoliosis|investigating non-idiopathic scoliosis
5549476|NCT01089127|Indacaterol|indacaterol
5549478|NCT01089127|salmeterol|salmeterol
5549479|NCT01089114|Cardiac Imaging|cardiac imaging
5549480|NCT01089114|MR Spectroscopy|mr spectroscopy
5549481|NCT01089114|HIV|hiv
5549482|NCT01089114|Lipid Metabolism|lipid metabolism
5549483|NCT01089114|HIV Infection|hiv infection
5549484|NCT01089114|Cardiovascular Disease|cardiovascular disease
5549485|NCT01089114|HIV Infections|hiv infections
5549486|NCT01089088|recurrent urethral cancer|recurrent urethral cancer
5685541|NCT00555685|Hyponatremia|hyponatremia
5549487|NCT01089088|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5549488|NCT01089088|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5549489|NCT01089088|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5549490|NCT01089088|posterior urethral cancer|posterior urethral cancer
5549491|NCT01089088|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5549492|NCT01089088|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5549493|NCT01089088|stage IV bladder cancer|stage iv bladder cancer
5549494|NCT01089088|recurrent bladder cancer|recurrent bladder cancer
5549495|NCT01089088|anterior urethral cancer|anterior urethral cancer
5549496|NCT01089075|neuropsychological effects of hydrocortisone replacement|neuropsychological effects of hydrocortisone replacement
5549497|NCT01089062|Healthy volunteers|healthy volunteers
5549498|NCT01089049|Urinary Estrogen Metabolites|urinary estrogen metabolites
5549499|NCT01089049|2-OH Estrone|2-oh estrone
5549500|NCT01089049|16-alpha-OH Estrone|16-alpha-oh estrone
5549501|NCT01089049|Urinary 2/16a Estrogen Metabolite Ratio|urinary 2/16a estrogen metabolite ratio
5549502|NCT01089036|ECMO|ecmo
5549503|NCT01089036|cardiogenic shock|cardiogenic shock
5549505|NCT01089036|GPx|gpx
5549506|NCT01089036|cytokines|cytokines
5549507|NCT01088997|Persistent pulmonary hypertension of newborn|persistent pulmonary hypertension of newborn
5549508|NCT01088997|PPHN|pphn
5549509|NCT01088997|Persistent pulmonary hypertension|persistent pulmonary hypertension
5549510|NCT01088997|Pulmonary hypertension|pulmonary hypertension
5549511|NCT01088997|Pulmonary hypertension of newborn|pulmonary hypertension of newborn
5549512|NCT01088958|Kenya|kenya
5549513|NCT01088958|Child Nutrition Disorders|child nutrition disorders
5549514|NCT01088958|Social marketing|social marketing
5549515|NCT01088945|Infant, Premature, Diseases|infant, premature, diseases
5549516|NCT01088932|Safety in Healthy Volunteers|safety in healthy volunteers
5549517|NCT01088919|ASP1941|asp1941
5549518|NCT01088919|Actos|actos
5549519|NCT01088919|pioglitazone hydrochloride|pioglitazone hydrochloride
5549520|NCT01088906|Phalcis|phalcis
5549521|NCT01088906|BRCA1|brca1
5549522|NCT01088906|RAP80|rap80
5549523|NCT01088906|TS|ts
5549524|NCT01088906|First line|first line
5549525|NCT01088906|Non-squamous|non-squamous
5549526|NCT01088893|everolimus|everolimus
5549527|NCT01088893|neoadjuvant|neoadjuvant
5549528|NCT01088893|m-TOR inhibitor|m-tor inhibitor
5549529|NCT01088880|Familial Mediterranean Fever|familial mediterranean fever
5549530|NCT01088880|canakinumab|canakinumab
5549531|NCT01088880|colchicine resistance|colchicine resistance
5549532|NCT01088867|Pain|pain
5549533|NCT01088867|Acupuncture|acupuncture
5549534|NCT01088867|DNIC|dnic
5549535|NCT01088867|Electroacupuncture|electroacupuncture
5549536|NCT01088828|MRI, clubfoot, CTEV, Congenital Talipes Equinovarus|mri, clubfoot, ctev, congenital talipes equinovarus
5549537|NCT01088815|Adenocarcinoma|adenocarcinoma
5549538|NCT01088815|Hedgehog|hedgehog
5549539|NCT01088815|Neoplasms|neoplasms
5549540|NCT01088815|Digestive System Diseases|digestive system diseases
5549541|NCT01088815|Neoplasms by Site|neoplasms by site
5549542|NCT01088815|Digestive System Neoplasms|digestive system neoplasms
5549543|NCT01088815|Neoplasms by Histologic Type|neoplasms by histologic type
5549544|NCT01088815|Pancreatic Neoplasms|pancreatic neoplasms
5549545|NCT01088815|Pancreatic Diseases|pancreatic diseases
5549546|NCT01088815|Carcinoma|carcinoma
5549547|NCT01088802|Squamous Cell Carcinoma|squamous cell carcinoma
5549548|NCT01088802|Oropharynx|oropharynx
5549549|NCT01088789|Adenocarcinoma|adenocarcinoma
5549550|NCT01088789|Cyclophosphamide|cyclophosphamide
5549551|NCT01088789|Immunotherapy|immunotherapy
5549552|NCT01088789|Neo-Adjuvant|neo-adjuvant
5549553|NCT01088789|Pancreatic tumor vaccine|pancreatic tumor vaccine
5549555|NCT01088789|Randomize|randomize
5549556|NCT01088776|CKD|ckd
5549557|NCT01088776|hypertriglyceridemia|hypertriglyceridemia
5549558|NCT01088776|Fatty Acid Supplementation|fatty acid supplementation
5549559|NCT01088776|Children|children
5549560|NCT01088776|Omega-3|omega-3
5549561|NCT01088750|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5549562|NCT01088750|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5549563|NCT01088750|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5549564|NCT01088737|Lentigo maligna|lentigo maligna
5549566|NCT01088737|imiquimod|imiquimod
5549567|NCT01088737|prevention|prevention
5549568|NCT01088711|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
5549569|NCT01088698|psoriasis|psoriasis
5549570|NCT01088698|golimumab|golimumab
5549571|NCT01088698|TNF-alpha inhibition|tnf-alpha inhibition
5549572|NCT01088698|phototherapy|phototherapy
5549574|NCT01088672|Stroke|stroke
5549575|NCT01088672|Ischemic|ischemic
5549576|NCT01088672|Thrombus|thrombus
5549577|NCT01088672|Embolectomy|embolectomy
5549578|NCT01088672|Thrombectomy|thrombectomy
5549579|NCT01088672|Concentric|concentric
5549580|NCT01088672|Embolus|embolus
5549581|NCT01088672|Mechanical|mechanical
5549582|NCT01088672|Trevo|trevo
5549583|NCT01088646|capsule endoscopy|capsule endoscopy
5549584|NCT01088646|small bowel disease|small bowel disease
5549585|NCT01088646|inflammatory bowel disease|inflammatory bowel disease
5532270|NCT01158235|nose|nose
5549586|NCT01088646|Subjects indicated for EGD endoscopy|subjects indicated for egd endoscopy
5549587|NCT01088633|COPD|copd
5549588|NCT01088620|NSCLC|nsclc
5549589|NCT01088620|Stage IIIb or IV|stage iiib or iv
5549590|NCT01088620|Nonsquamous|nonsquamous
5549591|NCT01088620|KRAS-Wildtype|kras-wildtype
5549592|NCT01088607|Primary sclerosing cholangitis|primary sclerosing cholangitis
5549593|NCT01088607|Autoimmune hepatitis|autoimmune hepatitis
5549594|NCT01088607|Cholestatic liver disease|cholestatic liver disease
5549595|NCT01088607|Cirrhosis|cirrhosis
5549596|NCT01088607|Children|children
5549597|NCT01088607|Primary Sclerosing Cholangitis/Autoimmune Hepatitis Overlap|primary sclerosing cholangitis/autoimmune hepatitis overlap
5549598|NCT01088594|urinary sodium excretion|urinary sodium excretion
5549599|NCT01088594|Pioglitazone|pioglitazone
5549600|NCT01088594|Rosiglitazone|rosiglitazone
5549601|NCT01088594|Methodological study|methodological study
5549602|NCT01088581|hepatocellular carcinoma|hepatocellular carcinoma
5549603|NCT01088581|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5549604|NCT01088581|5-fluorouracil|5-fluorouracil
5549605|NCT01088581|cisplatin|cisplatin
5549606|NCT01088581|adjuvant chemotherapy|adjuvant chemotherapy
5549607|NCT01088581|hepatectomy|hepatectomy
5549608|NCT01088568|Keratomileusis, laser in situ|keratomileusis, laser in situ
5549609|NCT01088568|Phakic Intraocular Lenses|phakic intraocular lenses
5549611|NCT01088568|astigmatism|astigmatism
5549612|NCT01088568|Implantable Collamer Lens, Toric|implantable collamer lens, toric
5549613|NCT01088555|nephrolithiasis|nephrolithiasis
5549614|NCT01088555|calcium stones|calcium stones
5549615|NCT01088555|kidney stones|kidney stones
5549616|NCT01088555|hypercalciuria|hypercalciuria
5549617|NCT01088555|sodium thiosulfate|sodium thiosulfate
5549618|NCT01088555|Calcium containing kidney stones|calcium containing kidney stones
5549619|NCT01088542|substance use|substance use
5549620|NCT01088542|delinquency|delinquency
5549621|NCT01088542|risky sexual behavior|risky sexual behavior
5549622|NCT01088542|risk factors|risk factors
5549623|NCT01088542|protective factors|protective factors
5549624|NCT01088542|prevention|prevention
5549625|NCT01088542|community coalitions|community coalitions
5549626|NCT01088542|systems transformation|systems transformation
5549627|NCT01088542|violence|violence
5549628|NCT01088529|Neoadjuvant Prostate Cancer|neoadjuvant prostate cancer
5549629|NCT01088529|Abiraterone Acetate|abiraterone acetate
5549630|NCT01088529|LHRHa|lhrha
5549631|NCT01088529|high risk prostate cancer|high risk prostate cancer
5549632|NCT01088529|Radical prostatectomy|radical prostatectomy
5549633|NCT01088529|Prednisone|prednisone
5549634|NCT01088529|Luteinizing Hormone-Releasing Hormone|luteinizing hormone-releasing hormone
5549635|NCT01088529|LHRH analogue|lhrh analogue
5549636|NCT01088516|Human Immunodeficiency Virus|human immunodeficiency virus
5549637|NCT01088516|Vertical Transmission|vertical transmission
5549638|NCT01088516|Pregnancy|pregnancy
5549639|NCT01088516|Breastfeeding|breastfeeding
5549640|NCT01088516|Prevention of mother to child transmission|prevention of mother to child transmission
5549641|NCT01088516|HAART|haart
5549642|NCT01088516|Aluvia|aluvia
5549643|NCT01088516|Lopinavir|lopinavir
5549644|NCT01088516|Africa|africa
5549645|NCT01088516|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
5549646|NCT01088490|Hydrogen sulfide|hydrogen sulfide
5549647|NCT01088490|critically ill|critically ill
5549648|NCT01088490|mortality|mortality
5549649|NCT01088477|Acquired anti-hormonal resistant breast cancer|acquired anti-hormonal resistant breast cancer
5549650|NCT01088464|Human Immunoglobulin Gamma-1 (IgG1)|human immunoglobulin gamma-1 (igg1)
5549651|NCT01088464|Monoclonal Antibody (MAb)|monoclonal antibody (mab)
5549652|NCT01088464|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5549653|NCT01088464|Advanced Solid Tumors|advanced solid tumors
5549654|NCT01088451|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5549655|NCT01088451|Prandial Glycemia|prandial glycemia
5549656|NCT01088451|Rapid Acting Insulin Analogue|rapid acting insulin analogue
5549657|NCT01088451|Human Insulin|human insulin
5549658|NCT01088438|medical education|medical education
5549659|NCT01088438|decision making|decision making
5549660|NCT01088438|diagnostic error|diagnostic error
5549661|NCT01088438|contextualization|contextualization
5549662|NCT01088425|vitrification|vitrification
5549663|NCT01088425|2PN oocyte|2pn oocyte
5549664|NCT01088425|maternal and infant health|maternal and infant health
5549665|NCT01088425|embryo survival, clinical pregnancy rate|embryo survival, clinical pregnancy rate
5549666|NCT01088425|mode of delivery|mode of delivery
5549667|NCT01088425|injury during delivery|injury during delivery
5549668|NCT01088425|infant development|infant development
5549669|NCT01088425|infant morbidity|infant morbidity
5549670|NCT01088425|slow- rate freezing|slow- rate freezing
5549671|NCT01088347|TRAIL|trail
5549672|NCT01088347|TRM1|trm1
5549673|NCT01088347|advanced cervical cancer|advanced cervical cancer
5549674|NCT01088347|mapatumumab|mapatumumab
5549675|NCT01088347|Uterine cervical neoplasm|uterine cervical neoplasm
5549676|NCT01088347|Radiotherapy|radiotherapy
5549677|NCT01088347|Cisplatin|cisplatin
5532330|NCT01157897|Vaccine|vaccine
5549678|NCT01088334|Idiopathic venous thromboembolism|idiopathic venous thromboembolism
5549679|NCT01088334|Malignancy|malignancy
5549680|NCT01088334|screening|screening
5549681|NCT01088295|Metabolic|metabolic
5549682|NCT01088295|HIV|hiv
5549683|NCT01088295|Fat accumulation|fat accumulation
5549684|NCT01088295|AIDS|aids
5549685|NCT01088295|Metabolic abnormalities in HIV infection|metabolic abnormalities in hiv infection
5549686|NCT01088295|HIV Infections|hiv infections
5549687|NCT01088282|Diffractive multifocal IOL|diffractive multifocal iol
5549688|NCT01088269|Blood Pressure Measurement|blood pressure measurement
5549689|NCT01088269|Atrial Fibrillation|atrial fibrillation
5549690|NCT01088269|Blood pressure measurement in atrial fibrillation|blood pressure measurement in atrial fibrillation
5549691|NCT01088269|Atrial Fibrillation diagnosis|atrial fibrillation diagnosis
5549692|NCT01088256|CRPS|crps
5549693|NCT01088256|Morbus Sudeck|morbus sudeck
5549694|NCT01088256|Causalgia|causalgia
5549695|NCT01088256|Etoricoxib|etoricoxib
5549696|NCT01088256|Polyneuropathy|polyneuropathy
5549697|NCT01088256|post herpetic neuralgia|post herpetic neuralgia
5549698|NCT01088256|peripheral nerve injury|peripheral nerve injury
5549699|NCT01088256|radiculopathy|radiculopathy
5549700|NCT01088256|Nervenverletzung|nervenverletzung
5549701|NCT01088256|postherpetische Neuralgie|postherpetische neuralgie
5549702|NCT01088256|COX-2-Inhibitor|cox-2-inhibitor
5549703|NCT01088243|Berylliosis|berylliosis
5549704|NCT01088243|Beryllium Disease|beryllium disease
5549705|NCT01088230|hemiparesis|hemiparesis
5549706|NCT01088230|robotics|robotics
5549707|NCT01088230|stroke|stroke
5549708|NCT01088230|Botox®|botox®
5549709|NCT01088230|rehabilitation|rehabilitation
5549710|NCT01088230|wrist spasticity|wrist spasticity
5549711|NCT01088217|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5549712|NCT01088217|Familial Pulmonary Fibrosis|familial pulmonary fibrosis
5549713|NCT01088217|Idiopathic Interstitial Pneumonia|idiopathic interstitial pneumonia
5549714|NCT01088217|Familial Interstitial Pneumonia|familial interstitial pneumonia
5549715|NCT01088217|Pulmonary Fibrosis|pulmonary fibrosis
5549716|NCT01088191|Acute Anterior Cruciate Ligament Injury|acute anterior cruciate ligament injury
5549717|NCT01088191|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
5549718|NCT01088191|Adult Stem Cells|adult stem cells
5549719|NCT01088191|Mesenchymal precursor cells|mesenchymal precursor cells
5549720|NCT01088178|Long-Acting Reversible Contraception|long-acting reversible contraception
5549721|NCT01088178|Contraceptive Agents|contraceptive agents
5549722|NCT01088178|Therapeutic Uses|therapeutic uses
5549723|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female
5549724|NCT01088178|Reproductive Control Agents|reproductive control agents
5549725|NCT01088178|Pharmacologic Actions|pharmacologic actions
5549726|NCT01088178|Levonorgestrel|levonorgestrel
5549727|NCT01088165|Psoriasis|psoriasis
5549927|NCT01087372|GIP|gip
5549728|NCT01088165|Cardiovascular Diseases|cardiovascular diseases
5549729|NCT01088165|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5549730|NCT01088165|Adalimumab|adalimumab
5549731|NCT01088165|Fumaric acid esters|fumaric acid esters
5549732|NCT01088152|Celiac disease|celiac disease
5549733|NCT01088152|Education|education
5549735|NCT01088152|Gluten-free diet|gluten-free diet
5549736|NCT01088139|Nutritional support|nutritional support
5549737|NCT01088139|Rehabilitation outcomes|rehabilitation outcomes
5549738|NCT01088113|Tai Chi|tai chi
5549739|NCT01088113|Qigong|qigong
5549740|NCT01088113|Heart rate variability|heart rate variability
5549741|NCT01088113|Near Infrared Spectroscopy|near infrared spectroscopy
5549742|NCT01088113|blood pressure|blood pressure
5549743|NCT01088100|POCD|pocd
5549744|NCT01088100|clock-gene genotypes|clock-gene genotypes
5549745|NCT01088100|HPER3|hper3
5549746|NCT01088074|Total Knee Replacement|total knee replacement
5549747|NCT01088074|Closure Methods|closure methods
5549748|NCT01088048|CLL|cll
5698389|NCT00506571|S-1|s-1
5549749|NCT01088048|non-Hodgkin lymphoma (NHL)|non-hodgkin lymphoma (nhl)
5549750|NCT01088048|mantle cell lymphoma (MCL)|mantle cell lymphoma (mcl)
5549751|NCT01088048|phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5549752|NCT01088048|bendamustine|bendamustine
5549753|NCT01088048|CD20 mAb|cd20 mab
5549754|NCT01088048|rituximab|rituximab
5549755|NCT01088048|CAL-101|cal-101
5549756|NCT01088048|Ofatumumab|ofatumumab
5549757|NCT01088048|indolent non-Hodgkin lymphoma (iNHL)|indolent non-hodgkin lymphoma (inhl)
5549758|NCT01088048|fludarabine|fludarabine
5549759|NCT01088048|everolimus|everolimus
5549760|NCT01088048|bortezomib|bortezomib
5549761|NCT01088048|chlorambucil|chlorambucil
5549762|NCT01088048|lenalidomide|lenalidomide
5549763|NCT01088035|Childhood ependymoma|childhood ependymoma
5549764|NCT01088035|Ependymoma|ependymoma
5549765|NCT01088035|Survivin|survivin
5685542|NCT00555659|Degeneration|degeneration
5549766|NCT01088022|the complete response (CR) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy|the complete response (cr) rate defined as the number of patients with no emetic episodes and no rescue medication in the first 120 hours post-chemotherapy
5549767|NCT01088009|chronic hepatitis B|chronic hepatitis b
5549768|NCT01087996|Chronic Ischemic Left Ventricular|chronic ischemic left ventricular
5549769|NCT01087983|Metastatic cancer|metastatic cancer
5549770|NCT01087983|Lapatinib|lapatinib
5549771|NCT01087983|Tykerb|tykerb
5549772|NCT01087983|Metformin|metformin
5549773|NCT01087983|Glucophage|glucophage
5549774|NCT01087983|Sirolimus|sirolimus
5549775|NCT01087983|Rapamune|rapamune
5549776|NCT01087970|Pharynx|pharynx
5549777|NCT01087970|Larynx|larynx
5549778|NCT01087970|Nose|nose
5549779|NCT01087970|Parathyroid|parathyroid
5549780|NCT01087931|Local anesthetic|local anesthetic
5549781|NCT01087931|Iliac crest bone harvest|iliac crest bone harvest
5549782|NCT01087931|Patients undergoing spine surgery that require use of iliac crest bone autograft|patients undergoing spine surgery that require use of iliac crest bone autograft
5549783|NCT01087918|ASIA C and D|asia c and d
5549784|NCT01087905|Smoking|smoking
5549785|NCT01087905|Smoking cessation|smoking cessation
5549786|NCT01087905|Medication adherence|medication adherence
5549787|NCT01087879|oral glucose tolerance test|oral glucose tolerance test
5549788|NCT01087879|hormonal contraception|hormonal contraception
5549789|NCT01087879|androgens|androgens
5549790|NCT01087879|crp|crp
5549791|NCT01087866|Gestational diabetes mellitus|gestational diabetes mellitus
5549793|NCT01087866|metformin|metformin
5549794|NCT01087853|Fluid Therapy|fluid therapy
5549795|NCT01087853|Water Electrolyte Imbalance|water electrolyte imbalance
5549796|NCT01087853|Acid Base Imbalance|acid base imbalance
5549797|NCT01087853|Renal Circulation|renal circulation
5549798|NCT01087853|Magnetic Resonance Imaging|magnetic resonance imaging
5549799|NCT01087840|HIV|hiv
5549800|NCT01087840|nonoccupational|nonoccupational
5549801|NCT01087840|postexposure|postexposure
5549802|NCT01087840|prophylaxis|prophylaxis
5549803|NCT01087840|HIV Seronegativity|hiv seronegativity
5549804|NCT01087827|oscillometric blood pressure|oscillometric blood pressure
5549805|NCT01087827|cuff site|cuff site
5549806|NCT01087827|forearm blood pressure|forearm blood pressure
5549807|NCT01087827|upper arm blood pressure|upper arm blood pressure
5549808|NCT01087827|anthropometric measurements|anthropometric measurements
5549809|NCT01087827|tonometry|tonometry
5549810|NCT01087827|site of blood pressure measurement|site of blood pressure measurement
5549811|NCT01087827|measurement accuracy|measurement accuracy
5549812|NCT01087814|efavirenz|efavirenz
5549813|NCT01087814|Sustiva|sustiva
5549814|NCT01087814|pharmacokinetics|pharmacokinetics
5549815|NCT01087801|Genetic End Marker|genetic end marker
5549816|NCT01087788|Certolizumab Pegol|certolizumab pegol
5549817|NCT01087788|Cimzia|cimzia
5549818|NCT01087762|Certolizumab Pegol|certolizumab pegol
5549819|NCT01087762|Cimzia|cimzia
5549820|NCT01087736|PTSD|ptsd
5549821|NCT01087736|Alcohol abuse|alcohol abuse
5549822|NCT01087736|Alcoholism|alcoholism
5549823|NCT01087736|Topiramate|topiramate
5549824|NCT01087736|Stress Disorder, Post Traumatic|stress disorder, post traumatic
5549928|NCT01087372|glucoregulatory hormones|glucoregulatory hormones
5862964|NCT00001442|Taxol|taxol
5549825|NCT01087736|Chronic Post-Traumatic Stress Disorder|chronic post-traumatic stress disorder
5549827|NCT01087723|STEMI|stemi
5549828|NCT01087723|STE-ACS|ste-acs
5549829|NCT01087723|UFH|ufh
5549830|NCT01087723|bivalirudin|bivalirudin
5549831|NCT01087723|PCI|pci
5549832|NCT01087723|ambulance study|ambulance study
5549833|NCT01087723|STE-MI participants|ste-mi participants
5549834|NCT01087697|bladder cancer|bladder cancer
5549835|NCT01087697|radical cystectomy|radical cystectomy
5549836|NCT01087697|incontinent urinary diversion|incontinent urinary diversion
5549837|NCT01087684|Glaucoma|glaucoma
5549838|NCT01087684|laser trabeculoplasty|laser trabeculoplasty
5549839|NCT01087684|intraocular pressure|intraocular pressure
5549840|NCT01087632|Metabolic Syndrome Insulin-resistance Endothelial Function|metabolic syndrome insulin-resistance endothelial function
5549841|NCT01087619|Hyperparathyroidism, primary|hyperparathyroidism, primary
5698477|NCT00506259|SMS|sms
5549842|NCT01087619|Aged 66 years or older|aged 66 years or older
5549843|NCT01087619|Mild hypercalcaemia|mild hypercalcaemia
5549844|NCT01087619|Surgical Procedures, Elective|surgical procedures, elective
5549845|NCT01087619|Indication|indication
5549846|NCT01087619|Osteoporosis|osteoporosis
5549847|NCT01087619|Cognitive function|cognitive function
5549848|NCT01087619|Atherosclerosis|atherosclerosis
5549849|NCT01087619|Follow-up|follow-up
5549850|NCT01087619|Randomized trial|randomized trial
5549851|NCT01087593|estrogen|estrogen
5549852|NCT01087593|substitution|substitution
5549853|NCT01087593|pain|pain
5549854|NCT01087593|hormonal levels|hormonal levels
5549855|NCT01087593|quantitative sensory testing|quantitative sensory testing
5549856|NCT01087580|Prostate Cancer|prostate cancer
5549857|NCT01087580|non metastatic prostate cancer|non metastatic prostate cancer
5549858|NCT01087580|oligometastatic prostate cancer|oligometastatic prostate cancer
5549861|NCT01087567|rescue therapy|rescue therapy
5549862|NCT01087554|Advanced Cancer|advanced cancer
5549863|NCT01087554|Sirolimus|sirolimus
5549864|NCT01087554|Rapamune|rapamune
5549865|NCT01087554|mTOR Inhibitor|mtor inhibitor
5549866|NCT01087554|Histone Deacetylase Inhibitor|histone deacetylase inhibitor
5549867|NCT01087554|Vorinostat|vorinostat
5549868|NCT01087554|SAHA|saha
5532538|NCT01156922|CFS|cfs
5549869|NCT01087554|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5549870|NCT01087554|MSK-390|msk-390
5549871|NCT01087554|Zolinza|zolinza
5549872|NCT01087554|Everolimus|everolimus
5549873|NCT01087554|Afinitor|afinitor
5549874|NCT01087554|Zortress|zortress
5549875|NCT01087554|RAD001|rad001
5549876|NCT01087554|Temsirolimus|temsirolimus
5549877|NCT01087554|CCI-779|cci-779
5549878|NCT01087554|Torisel|torisel
5549879|NCT01087541|Patient's Safety|patient's safety
5549880|NCT01087541|Diabetes mellitus|diabetes mellitus
5549881|NCT01087541|Public Health for professionals|public health for professionals
5549882|NCT01087541|Safety|safety
5549883|NCT01087541|Public health|public health
5549884|NCT01087528|Colonic Diseases|colonic diseases
5549885|NCT01087528|bowel diseases|bowel diseases
5549886|NCT01087528|large bowel diseases|large bowel diseases
5549887|NCT01087489|pain|pain
5549888|NCT01087489|discomfort|discomfort
5549889|NCT01087489|anesthetic drugs|anesthetic drugs
5549890|NCT01087489|topical drug administration|topical drug administration
5552482|NCT01077401|edema|edema
5549892|NCT01087489|lidocaine|lidocaine
5549893|NCT01087489|intraocular pressure|intraocular pressure
5549894|NCT01087489|keratopathy|keratopathy
5549895|NCT01087476|oral mucositis|oral mucositis
5549896|NCT01087476|chemotherapy|chemotherapy
5549897|NCT01087476|acute leukemia|acute leukemia
5549898|NCT01087476|salivary flow.|salivary flow.
5549899|NCT01087450|Erythropoietin|erythropoietin
5549900|NCT01087450|Sepsis|sepsis
5549901|NCT01087450|Septic shock|septic shock
5549902|NCT01087450|Orthogonal Polarization Spectroscopy|orthogonal polarization spectroscopy
5549903|NCT01087450|Severe sepsis or Septic shock|severe sepsis or septic shock
5549904|NCT01087437|Distraction osteogenesis|distraction osteogenesis
5549905|NCT01087424|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5549906|NCT01087411|accelerometry|accelerometry
5549907|NCT01087411|physical activity|physical activity
5549908|NCT01087411|obesity|obesity
5549909|NCT01087411|children|children
5549910|NCT01087411|cardiovascular risk markers|cardiovascular risk markers
5549911|NCT01087411|metabolic risk markers|metabolic risk markers
5549913|NCT01087411|obesity prevention|obesity prevention
5549914|NCT01087411|omega 3|omega 3
5549915|NCT01087411|fish liver oil|fish liver oil
5549916|NCT01087411|motivational interviewing|motivational interviewing
5549917|NCT01087398|Osteopetrosis|osteopetrosis
5549918|NCT01087398|HSCT|hsct
5549919|NCT01087385|peripheral arterial occlusive disease|peripheral arterial occlusive disease
5549920|NCT01087385|mortality|mortality
5549921|NCT01087385|cardiovascular events|cardiovascular events
5549922|NCT01087385|amputation|amputation
5549923|NCT01087385|peripheral arterial revascularization|peripheral arterial revascularization
5549924|NCT01087372|Stress hyperglycemia|stress hyperglycemia
5549925|NCT01087372|Incretins|incretins
5549926|NCT01087372|GLP-1|glp-1
5549963|NCT01087268|stage II rectal cancer|stage ii rectal cancer
5549964|NCT01087268|stage III rectal cancer|stage iii rectal cancer
5549965|NCT01087268|stage I prostate cancer|stage i prostate cancer
5549966|NCT01087268|stage IIB prostate cancer|stage iib prostate cancer
5549967|NCT01087268|stage IIA prostate cancer|stage iia prostate cancer
5549968|NCT01087268|stage III prostate cancer|stage iii prostate cancer
5549969|NCT01087268|stage IV prostate cancer|stage iv prostate cancer
5549970|NCT01087268|stage I bladder cancer|stage i bladder cancer
5549971|NCT01087268|stage II bladder cancer|stage ii bladder cancer
5549972|NCT01087268|stage III bladder cancer|stage iii bladder cancer
5549973|NCT01087268|stage IV bladder cancer|stage iv bladder cancer
5549974|NCT01087268|stage IA cervical cancer|stage ia cervical cancer
5549975|NCT01087268|stage IB cervical cancer|stage ib cervical cancer
5549976|NCT01087268|stage IIA cervical cancer|stage iia cervical cancer
5549977|NCT01087268|stage IIB cervical cancer|stage iib cervical cancer
5549978|NCT01087268|stage III cervical cancer|stage iii cervical cancer
5549979|NCT01087268|stage I vaginal cancer|stage i vaginal cancer
5549980|NCT01087268|stage II vaginal cancer|stage ii vaginal cancer
5549981|NCT01087268|stage III vaginal cancer|stage iii vaginal cancer
5549982|NCT01087268|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5549983|NCT01087268|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5549984|NCT01087268|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5549985|NCT01087268|stage I endometrial carcinoma|stage i endometrial carcinoma
5549986|NCT01087268|stage II endometrial carcinoma|stage ii endometrial carcinoma
5549987|NCT01087268|stage III endometrial carcinoma|stage iii endometrial carcinoma
5549988|NCT01087268|stage I uterine sarcoma|stage i uterine sarcoma
5549989|NCT01087268|stage II uterine sarcoma|stage ii uterine sarcoma
5549990|NCT01087268|stage III uterine sarcoma|stage iii uterine sarcoma
5549991|NCT01087268|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5549992|NCT01087268|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5549993|NCT01087268|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5549994|NCT01087268|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5549995|NCT01087268|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5532629|NCT01156610|Telephone|telephone
5549996|NCT01087268|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5549997|NCT01087268|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5549998|NCT01087268|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5549999|NCT01087268|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5550000|NCT01087268|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5550001|NCT01087268|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5550002|NCT01087268|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5550003|NCT01087268|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5550004|NCT01087268|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5550005|NCT01087268|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5550006|NCT01087268|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5550007|NCT01087268|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5550008|NCT01087268|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5550009|NCT01087255|Caregiver-based interventions|caregiver-based interventions
5550014|NCT01087242|liver and stomach heat retention|liver and stomach heat retention
5550015|NCT01087242|Evaluate the safety and efficacy of Tang-min Lin pills|evaluate the safety and efficacy of tang-min lin pills
5550016|NCT01087203|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5550018|NCT01087203|diabetic neuropathies|diabetic neuropathies
5550019|NCT01087203|diabetic polyneuropathy|diabetic polyneuropathy
5550020|NCT01087203|diabetic neuropathy painful|diabetic neuropathy painful
5550021|NCT01087190|kidney|kidney
5550022|NCT01087190|transplantation|transplantation
5550023|NCT01087190|tuberculosis|tuberculosis
5550024|NCT01087190|ELISPOT|elispot
5550025|NCT01087190|isoniazid|isoniazid
5550026|NCT01087177|Smoking|smoking
5550027|NCT01087177|Tobacco|tobacco
5550028|NCT01087177|Pediatrics|pediatrics
5550029|NCT01087164|Vaccine acceptance|vaccine acceptance
5550030|NCT01087164|human papillomavirus|human papillomavirus
5550031|NCT01087164|brief messages|brief messages
5550032|NCT01087164|social compliance|social compliance
5550033|NCT01087164|Message sidedness|message sidedness
5550034|NCT01087151|Rituxan|rituxan
5550035|NCT01087151|Apoptosis|apoptosis
5550036|NCT01087151|BCl-2|bcl-2
5550037|NCT01087138|bone health|bone health
5550038|NCT01087138|bone density|bone density
5550039|NCT01087138|bone mass|bone mass
5550040|NCT01087112|MIP|mip
5550041|NCT01087112|RCT|rct
5550042|NCT01087112|postnatal depression|postnatal depression
5550043|NCT01087112|Mother-child relationship|mother-child relationship
5550044|NCT01087086|Metabolic syndrome|metabolic syndrome
5550045|NCT01087086|Oxidative stress|oxidative stress
5550046|NCT01087086|Proinflammatory state|proinflammatory state
5550047|NCT01087086|Insulin resistance|insulin resistance
5550048|NCT01087086|Hypertension|hypertension
5550049|NCT01087086|Dyslipidemia|dyslipidemia
5544330|NCT01110005|LR|lr
5550050|NCT01087086|Mediterranean diet|mediterranean diet
5550051|NCT01087086|Glycemic index|glycemic index
5550052|NCT01087086|Hypocaloric diet|hypocaloric diet
5550053|NCT01087086|Hyperproteic diet|hyperproteic diet
5550054|NCT01087086|Macronutrient distribution|macronutrient distribution
5550055|NCT01087086|Antioxidant capacity of the diet|antioxidant capacity of the diet
5550056|NCT01087086|Crononutrition|crononutrition
5550057|NCT01087086|Dietary and psychological support|dietary and psychological support
5550058|NCT01087086|Waist circumference|waist circumference
5550059|NCT01087073|Healthcare Disparities|healthcare disparities
5550060|NCT01087073|Health Care Quality Improvement|health care quality improvement
5550061|NCT01087073|Shared Decision-Making|shared decision-making
5550062|NCT01087073|Patient Education|patient education
5550063|NCT01087073|Patient Activation|patient activation
5550064|NCT01087073|Community Outreach|community outreach
5550065|NCT01087073|Provider Training|provider training
5550066|NCT01087047|Pregnancy|pregnancy
5550067|NCT01087047|Upper airways|upper airways
5550068|NCT01087047|Acoustic reflection method|acoustic reflection method
5550069|NCT01087034|Infantile scoliosis|infantile scoliosis
5550070|NCT01087034|bracing|bracing
5550071|NCT01087034|acoustic reflection method|acoustic reflection method
5550072|NCT01087034|EOS™|eos™
5550073|NCT01087034|noninvasive|noninvasive
5550074|NCT01087034|upper airways|upper airways
5550075|NCT01087034|thoracic penetration index|thoracic penetration index
5550076|NCT01087034|Idiopathic juvenile evolutive thoracic scoliosis|idiopathic juvenile evolutive thoracic scoliosis
5550077|NCT01087008|Multiple Myeloma|multiple myeloma
5550078|NCT01087008|Zoledronic acid|zoledronic acid
5550079|NCT01086995|extubation|extubation
5550080|NCT01086995|weaning|weaning
5550081|NCT01086995|mechanical ventilation|mechanical ventilation
5550082|NCT01086969|Meningococcal Infection|meningococcal infection
5550083|NCT01086969|Meningitis, Bacterial|meningitis, bacterial
5550084|NCT01086969|Menactra®|menactra®
5550085|NCT01086956|patients of prostatic cancer aged more than 65 years|patients of prostatic cancer aged more than 65 years
5550086|NCT01086917|Malaria Challenge|malaria challenge
5550087|NCT01086917|Plasmodium falciparum|plasmodium falciparum
5550088|NCT01086917|Controlled human malaria infection|controlled human malaria infection
5550089|NCT01086917|PfSPZ Challenge|pfspz challenge
5550090|NCT01086904|renal transplantation|renal transplantation
5550091|NCT01086904|immunosuppression|immunosuppression
5550092|NCT01086904|inflenza A (H1N1)|inflenza a (h1n1)
5550093|NCT01086904|vaccine|vaccine
5550094|NCT01086878|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5550095|NCT01086878|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5550096|NCT01086878|anemia|anemia
5550097|NCT01086878|neutropenia|neutropenia
5550098|NCT01086878|safety|safety
5550099|NCT01086878|hematologic toxicity|hematologic toxicity
5550100|NCT01086865|inappetence|inappetence
5550101|NCT01086865|apetiviton BC|apetiviton bc
5550108|NCT01086813|Tolerability|tolerability
5550109|NCT01086813|Pharmacokinetics|pharmacokinetics
5550110|NCT01086813|Sedation|sedation
5550111|NCT01086787|Heart failure|heart failure
5550112|NCT01086787|Bone marrow|bone marrow
5550113|NCT01086787|Bone marrow mononuclear cells|bone marrow mononuclear cells
5550114|NCT01086787|Surgery|surgery
5550115|NCT01086787|Orthopedic surgery|orthopedic surgery
5550116|NCT01086787|Cardiac surgery|cardiac surgery
5550117|NCT01086774|Dry eye|dry eye
5550118|NCT01086774|Tear Film Stability|tear film stability
5550119|NCT01086735|hematological malignancy|hematological malignancy
5550120|NCT01086735|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5550121|NCT01086735|donor lymphocyte infusion|donor lymphocyte infusion
5550122|NCT01086735|antitumor immunotherapy|antitumor immunotherapy
5550123|NCT01086735|graft-versus-tumor effect|graft-versus-tumor effect
5550124|NCT01086735|gene therapy|gene therapy
5550125|NCT01086735|relapse|relapse
5550126|NCT01086735|adult|adult
5550127|NCT01086709|Human Papillomavirus|human papillomavirus
5550128|NCT01086709|Vaccine|vaccine
5550129|NCT01086709|Crossover|crossover
5550130|NCT01086709|Hepatitis A|hepatitis a
5550131|NCT01086709|Hepatitis B|hepatitis b
5550132|NCT01086696|PET Imaging|pet imaging
5550133|NCT01086696|F-18 Paclitaxel (FPAC)|f-18 paclitaxel (fpac)
5550134|NCT01086696|Breast Cancer|breast cancer
5550135|NCT01086696|Lung Cancer|lung cancer
5550136|NCT01086696|Renal and Adrenal Cancers|renal and adrenal cancers
5550137|NCT01086696|Kidney Cancer|kidney cancer
5550138|NCT01086696|Adrenal Cancer|adrenal cancer
5550139|NCT01086683|neoplasms|neoplasms
5550140|NCT01086683|rehabilitation|rehabilitation
5550141|NCT01086683|intervention|intervention
5550142|NCT01086683|quality of life|quality of life
5550143|NCT01086683|lifestyle|lifestyle
5550150|NCT01086657|Bird Flu|bird flu
5550151|NCT01086657|Avian Influenza|avian influenza
5550152|NCT01086657|Healthy|healthy
5550153|NCT01086657|Immunity|immunity
5550154|NCT01086657|Prevention|prevention
5550155|NCT01086657|Healthy Volunteer|healthy volunteer
5550157|NCT01086631|Autoimmune Retinopathy|autoimmune retinopathy
5550158|NCT01086631|RITUXAN|rituxan
5550159|NCT01086631|Rituximab|rituximab
5550160|NCT01086631|Immunosuppression|immunosuppression
5550161|NCT01086618|stage IV colon cancer|stage iv colon cancer
5550162|NCT01086618|stage IV rectal cancer|stage iv rectal cancer
5550163|NCT01086605|HER2-negative breast cancer|her2-negative breast cancer
5550164|NCT01086605|male breast cancer|male breast cancer
5550165|NCT01086605|recurrent breast cancer|recurrent breast cancer
5550166|NCT01086605|stage IV breast cancer|stage iv breast cancer
5550167|NCT01086605|stage IIIC breast cancer|stage iiic breast cancer
5550168|NCT01086592|Aged|aged
5550169|NCT01086592|Strength|strength
5550170|NCT01086592|Balance|balance
5550171|NCT01086592|Electrotherapy|electrotherapy
5550172|NCT01086592|Quality of life|quality of life
5550173|NCT01086579|paclitaxel PTCA drug-eluting balloon|paclitaxel ptca drug-eluting balloon
5550174|NCT01086579|provisional spot stenting|provisional spot stenting
5550175|NCT01086579|coronary artery disease|coronary artery disease
5550176|NCT01086579|Late Lumen Loss|late lumen loss
5550177|NCT01086579|Minimal lumen diameter|minimal lumen diameter
5550178|NCT01086579|coronary artery disease in a small vessel|coronary artery disease in a small vessel
5550179|NCT01086566|Influenza, H5N1, avian influenza, parent protocol|influenza, h5n1, avian influenza, parent protocol
5550180|NCT01086553|Crohn´s disease|crohn´s disease
5550181|NCT01086553|budesonide|budesonide
5550182|NCT01086553|induction of remission|induction of remission
5550183|NCT01086540|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5550184|NCT01086540|Autoimmune Disease|autoimmune disease
5550185|NCT01086540|Systemic Scleroderma|systemic scleroderma
5550186|NCT01086527|Pharmacogenetics|pharmacogenetics
5550187|NCT01086527|Singulair|singulair
5550188|NCT01086527|montelukast|montelukast
5550189|NCT01086527|Leukotriene Antagonists|leukotriene antagonists
5685543|NCT00555659|Spondylosis|spondylosis
5536900|NCT01138995|Gait, Drop foot|gait, drop foot
5550190|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents
5550191|NCT01086527|Intestinal Absorption|intestinal absorption
5550192|NCT01086527|pharmacokinetics|pharmacokinetics
5550193|NCT01086527|absorption|absorption
5550194|NCT01086527|biochemical transport|biochemical transport
5550195|NCT01086527|Membrane Transport Proteins|membrane transport proteins
5550196|NCT01086514|Breast|breast
5550197|NCT01086514|mammography|mammography
5550198|NCT01086514|MRI|mri
5550199|NCT01086514|Digital Mammography|digital mammography
5550200|NCT01086514|10-024|10-024
5550201|NCT01086501|open, non-interventional|open, non-interventional
5550202|NCT01086488|recurrent or persistent Nasopharyngeal Carcinoma|recurrent or persistent nasopharyngeal carcinoma
5550203|NCT01086488|treatment of patients with squamous cell carcinoma of the head and neck|treatment of patients with squamous cell carcinoma of the head and neck
5550204|NCT01086488|Foscan-PDT|foscan-pdt
5550205|NCT01086488|Brachytherapy|brachytherapy
5550206|NCT01086475|Autism Spectrum Disorder|autism spectrum disorder
5550207|NCT01086475|D-cycloserine|d-cycloserine
5550208|NCT01086475|Social Skills Training|social skills training
5550209|NCT01086462|GSK2239633|gsk2239633
5550210|NCT01086462|RADIOLABEL|radiolabel
5550211|NCT01086462|PHARMACOKINETICS|pharmacokinetics
5550212|NCT01086462|INTRAVENOUS|intravenous
5550213|NCT01086462|MICRODOSE|microdose
5550215|NCT01086449|Japanese|japanese
5550216|NCT01086449|Herpes Zoster|herpes zoster
5550217|NCT01086449|immunogenicity|immunogenicity
5550218|NCT01086449|Herpes Zoster in healthy ethnic Japanese adults|herpes zoster in healthy ethnic japanese adults
5550219|NCT01086449|Vaccine|vaccine
5550220|NCT01086436|Human Rotavirus vaccine|human rotavirus vaccine
5550221|NCT01086423|Infanrix-IPV+Hib|infanrix-ipv+hib
5550222|NCT01086410|HPA axis|hpa axis
5550223|NCT01086397|pneumococcal pneumonia|pneumococcal pneumonia
5550224|NCT01086397|community-acquired pneumonia|community-acquired pneumonia
5550225|NCT01086371|Multiple Sclerosis|multiple sclerosis
5550226|NCT01086371|gait|gait
5550227|NCT01086358|Productivity|productivity
5550228|NCT01086358|Migraine|migraine
5550229|NCT01086358|Treximet|treximet
5550230|NCT01086358|Triptan|triptan
5550231|NCT01086345|adult giant cell glioblastoma|adult giant cell glioblastoma
5550232|NCT01086345|adult gliosarcoma|adult gliosarcoma
5550233|NCT01086345|recurrent adult brain tumor|recurrent adult brain tumor
5550234|NCT01086332|radiotherapy|radiotherapy
5550235|NCT01086332|gemcitabine|gemcitabine
5550236|NCT01086332|nelfinavir|nelfinavir
5550237|NCT01086332|neoplasms|neoplasms
5550238|NCT01086241|Tomography|tomography
5550239|NCT01086241|Mammography|mammography
5550240|NCT01086241|Breast Neoplasms|breast neoplasms
5550241|NCT01086241|Prevention and Control|prevention and control
5550242|NCT01086228|Drug eluting stents|drug eluting stents
5550243|NCT01086228|Stents|stents
5550244|NCT01086228|Angioplasty|angioplasty
5550245|NCT01086202|irreparable rotator cuff tears|irreparable rotator cuff tears
5550246|NCT01086163|Omacor|omacor
5550247|NCT01086163|Simvastatin|simvastatin
5550248|NCT01086163|Aspirin|aspirin
5550249|NCT01086163|Platelet activity|platelet activity
5550250|NCT01086163|Coronary artery disease|coronary artery disease
5550251|NCT01086137|salivary biomarker|salivary biomarker
5550252|NCT01086137|metabolic syndrome|metabolic syndrome
5550253|NCT01086137|prediabetes|prediabetes
5550254|NCT01086137|diabetes hypertension|diabetes hypertension
5550255|NCT01086124|echocardiography|echocardiography
5550256|NCT01086124|ST elevation myocardial infarction|st elevation myocardial infarction
5550259|NCT01086124|Cardiovascular diseases|cardiovascular diseases
5550260|NCT01086111|type 2 diabetes|type 2 diabetes
5550261|NCT01086111|gastric bypass|gastric bypass
5550262|NCT01086111|sleeve gastrectomy|sleeve gastrectomy
5550263|NCT01086111|clamp study|clamp study
5550264|NCT01086111|weight loss surgery|weight loss surgery
5550265|NCT01086098|Pacemakers|pacemakers
5550266|NCT01086098|Survival|survival
5550267|NCT01086059|Autoimmune diseases|autoimmune diseases
5550269|NCT01086059|pregnancy|pregnancy
5550270|NCT01086059|birth defects|birth defects
5550271|NCT01086059|TNF|tnf
5550272|NCT01086059|Tumor necrosis factor|tumor necrosis factor
5550273|NCT01086046|platelet|platelet
5550274|NCT01086046|thrombozyme|thrombozyme
5550275|NCT01086046|ASD|asd
5550276|NCT01086046|Heparin|heparin
5550277|NCT01086046|Enoxaparin|enoxaparin
5550278|NCT01086033|Evaluation of safety and efficacy|evaluation of safety and efficacy
5550279|NCT01086033|Adalimumab treatment|adalimumab treatment
5550280|NCT01086033|Rheumatoid Arthritis|rheumatoid arthritis
5550281|NCT01086020|IVUS|ivus
5550282|NCT01086020|coronary plaque|coronary plaque
5550283|NCT01086020|regression|regression
5550284|NCT01086007|Groin hernia|groin hernia
5550285|NCT01086007|chronic pain|chronic pain
5550286|NCT01086007|Persistent postoperative pain|persistent postoperative pain
5550287|NCT01086007|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
5550288|NCT01086007|Sexual dysfunction|sexual dysfunction
5550289|NCT01085994|antibiotics|antibiotics
5550290|NCT01085994|resistance|resistance
5550291|NCT01085994|bio-marker|bio-marker
5521741|NCT01201811|Neoplasms|neoplasms
5550292|NCT01085994|procalcitonin|procalcitonin
5550293|NCT01085994|algorithm|algorithm
5550294|NCT01085994|critically ill|critically ill
5532866|NCT01155700|omalizumab|omalizumab
5550295|NCT01085981|quantitative assessment of the effects of a topically|quantitative assessment of the effects of a topically
5550296|NCT01085981|applied vasodilating cream to the clitoris using doppler|applied vasodilating cream to the clitoris using doppler
5550297|NCT01085981|flow plethysmography|flow plethysmography
5550298|NCT01085968|Parkinson's disease|parkinson's disease
5550299|NCT01085968|Cognitive deficits|cognitive deficits
5550300|NCT01085968|fMRI|fmri
5550301|NCT01085968|neuro rehabilitation|neuro rehabilitation
5550302|NCT01085968|Age Matched Controls|age matched controls
5550303|NCT01085955|peripartum|peripartum
5550304|NCT01085955|cardiomyopathy|cardiomyopathy
5550305|NCT01085955|post pregnancy|post pregnancy
5550306|NCT01085955|myocardial recovery|myocardial recovery
5550307|NCT01085955|pregnant women with peripartum cardiomyopathy|pregnant women with peripartum cardiomyopathy
5550308|NCT01085942|rotator cuff tear|rotator cuff tear
5550309|NCT01085942|asymptomatic|asymptomatic
5550310|NCT01085942|natural course|natural course
5550311|NCT01085942|tear characteristics|tear characteristics
5550312|NCT01085942|Asymptomatic rotator cuff tears|asymptomatic rotator cuff tears
5550313|NCT01085942|Natural course of rotator cuff tears|natural course of rotator cuff tears
5550314|NCT01085929|abscess|abscess
5550315|NCT01085929|infection|infection
5550316|NCT01085929|ultrasound guidance|ultrasound guidance
5550317|NCT01085929|incision and drainage|incision and drainage
5550318|NCT01085929|needle aspiration|needle aspiration
5550319|NCT01085929|skin|skin
5550320|NCT01085929|ultrasound|ultrasound
5550321|NCT01085916|prevalence of asthma and Rhinitis symptoms among secondary school students in Saudi Arabia|prevalence of asthma and rhinitis symptoms among secondary school students in saudi arabia
5550322|NCT01085903|Spatial Neglect|spatial neglect
5550323|NCT01085903|Dysphagia|dysphagia
5550324|NCT01085903|Arousal|arousal
5550325|NCT01085903|Modafinil|modafinil
5550326|NCT01085903|Stroke|stroke
5550327|NCT01085890|Blood Pressure|blood pressure
5550328|NCT01085890|Life Style|life style
5550329|NCT01085890|Body Mass Index|body mass index
5550330|NCT01085890|Obesity, Abdominal|obesity, abdominal
5550331|NCT01085890|Blood Chemical Analysis|blood chemical analysis
5550332|NCT01085864|Lung Nodules|lung nodules
5550333|NCT01085864|A need exists for non-invasive testing to aid in clinical decision-making for CT scan detected lung nodules of indeterminate etiology.|a need exists for non-invasive testing to aid in clinical decision-making for ct scan detected lung nodules of indeterminate etiology.
5550334|NCT01085851|Sunburn|sunburn
5550335|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine
5550336|NCT01085851|Lotion|lotion
5550337|NCT01085851|Cream|cream
5550338|NCT01085838|Erlotinib|erlotinib
5550339|NCT01085838|myelodysplastic syndrome|myelodysplastic syndrome
5550340|NCT01085825|induced abortion|induced abortion
5550341|NCT01085825|termination of pregnancy|termination of pregnancy
5550342|NCT01085825|manual vacuum aspiration|manual vacuum aspiration
5550343|NCT01085825|electric vacuum aspiration|electric vacuum aspiration
5550344|NCT01085799|Educational activities|educational activities
5550345|NCT01085799|Cluster-randomized controlled trial|cluster-randomized controlled trial
5550346|NCT01085799|Albendazole|albendazole
5550347|NCT01085799|Deworming|deworming
5550348|NCT01085799|School-age children|school-age children
5550349|NCT01085799|Peru|peru
5550350|NCT01085799|Ascaris lumbricoides|ascaris lumbricoides
5550351|NCT01085799|Trichuris trichiura|trichuris trichiura
5550353|NCT01085799|STH infections|sth infections
5550354|NCT01085799|Intestinal helminth infections|intestinal helminth infections
5550355|NCT01085786|Helicobacter pylori infection|helicobacter pylori infection
5550356|NCT01085773|HbA1c|hba1c
5550357|NCT01085773|Type 2 Diabetes|type 2 diabetes
5550358|NCT01085773|Lifestyle changes|lifestyle changes
5550359|NCT01085773|Exercise|exercise
5550360|NCT01085747|Chronic pancreatitis|chronic pancreatitis
5550361|NCT01085747|Biliary stricture|biliary stricture
5550362|NCT01085747|Endoscopic treatment|endoscopic treatment
5550364|NCT01085721|allergic rhinitis|allergic rhinitis
5550365|NCT01085721|viral infections of the upper respiratory tract|viral infections of the upper respiratory tract
5550366|NCT01085721|dexchlorpheniramine|dexchlorpheniramine
5550367|NCT01085721|pseudoephedrine|pseudoephedrine
5550368|NCT01085721|guaifenesin|guaifenesin
5550369|NCT01085708|Rabeprazole|rabeprazole
5550370|NCT01085708|Japan|japan
5550371|NCT01085708|healthy Japanese male|healthy japanese male
5550372|NCT01085695|Rabeprazole|rabeprazole
5550373|NCT01085695|Japan|japan
5550374|NCT01085695|healthy Japanese male|healthy japanese male
5550375|NCT01085682|Diabetes prevention|diabetes prevention
5550376|NCT01085682|Lifestyle modification|lifestyle modification
5550377|NCT01085682|Obesity|obesity
5550378|NCT01085682|Impaired glucose tolerance|impaired glucose tolerance
5550379|NCT01085682|Diet|diet
5550380|NCT01085682|Physical activity|physical activity
5550381|NCT01085669|Infection rate of VEPTR-Implants|infection rate of veptr-implants
5550382|NCT01085669|VEPTR. Vertical Expandable|veptr. vertical expandable
5537093|NCT01138215|immunogenicity|immunogenicity
5550383|NCT01085669|Prosthetic Titanium Rib|prosthetic titanium rib
5550384|NCT01085643|IBS|ibs
5550385|NCT01085643|Lubiprostone|lubiprostone
5550386|NCT01085643|Small Bowel|small bowel
5532976|NCT01155245|PTH|pth
5550387|NCT01085643|High Resolution Manometry|high resolution manometry
5550388|NCT01085643|Delayed Intestinal Transit|delayed intestinal transit
5550389|NCT01085630|epithelial mesothelioma|epithelial mesothelioma
5550390|NCT01085630|sarcomatous mesothelioma|sarcomatous mesothelioma
5550391|NCT01085630|stage II malignant mesothelioma|stage ii malignant mesothelioma
5550392|NCT01085630|stage III malignant mesothelioma|stage iii malignant mesothelioma
5550393|NCT01085630|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5550394|NCT01085617|oral complications|oral complications
5550395|NCT01085617|mucositis|mucositis
5550396|NCT01085617|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5550397|NCT01085617|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5550398|NCT01085617|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5550399|NCT01085617|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5550400|NCT01085604|low back pain|low back pain
5550401|NCT01085604|clinical instability|clinical instability
5550402|NCT01085604|neuromuscular control|neuromuscular control
5550403|NCT01085604|core stabilization|core stabilization
5550404|NCT01085604|physical therapy|physical therapy
5550405|NCT01085591|CDI|cdi
5550406|NCT01085591|Clostridium difficile Infection|clostridium difficile infection
5550407|NCT01085591|Diarrhea|diarrhea
5550408|NCT01085578|healthy male volunteers|healthy male volunteers
5550409|NCT01085578|fasted and fed state|fasted and fed state
5550410|NCT01085565|Bone cancer|bone cancer
5550411|NCT01085565|Bone Metastases|bone metastases
5550412|NCT01085565|pain palliation|pain palliation
5550413|NCT01085565|metastasis|metastasis
5550414|NCT01085565|breast cancer|breast cancer
5550415|NCT01085565|lung cancer|lung cancer
5550416|NCT01085565|prostate cancer|prostate cancer
5550417|NCT01085565|cancer related pain|cancer related pain
5550418|NCT01085565|tumors|tumors
5550419|NCT01085552|NeoRecormon®|neorecormon®
5550420|NCT01085552|Caucasian|caucasian
5550421|NCT01085552|Japanese|japanese
5550422|NCT01085552|Bioequivalence|bioequivalence
5550423|NCT01085552|Ethnic|ethnic
5550424|NCT01085539|neonatal intensive care|neonatal intensive care
5550425|NCT01085539|infant pulse oximetry|infant pulse oximetry
5550426|NCT01085526|basophil activity|basophil activity
5550427|NCT01085526|plasma cells|plasma cells
5550428|NCT01085526|IgE|ige
5550429|NCT01085526|IgG1|igg1
5550430|NCT01085526|IgG4|igg4
5550431|NCT01085526|mast cells|mast cells
5550432|NCT01085526|IgE receptor|ige receptor
5550433|NCT01085526|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5550434|NCT01085526|grass pollen allergy|grass pollen allergy
5550435|NCT01085513|intestinal abnormalities|intestinal abnormalities
5550436|NCT01085500|laparoscopic|laparoscopic
5550437|NCT01085500|totally extraperitoneal inguinal hernia repair|totally extraperitoneal inguinal hernia repair
5550438|NCT01085487|Menorrhagia|menorrhagia
5550439|NCT01085474|Asthma|asthma
5550440|NCT01085474|Pharmaceutical intervention|pharmaceutical intervention
5550441|NCT01085474|Effect of a pharmaceutical intervention on the level of control of the asthmatic patient|effect of a pharmaceutical intervention on the level of control of the asthmatic patient
5550442|NCT01085448|low back pain|low back pain
5550443|NCT01085448|core stabilization|core stabilization
5550444|NCT01085448|physical therapy|physical therapy
5550448|NCT01085409|experienced utility|experienced utility
5550449|NCT01085409|decision utility|decision utility
5550450|NCT01085409|subjective well-being|subjective well-being
5550451|NCT01085409|experience sampling method|experience sampling method
5550452|NCT01085409|day reconstruction method|day reconstruction method
5550454|NCT01085396|Fiber Optic|fiber optic
5535570|NCT01144559|Continuous Infusion|continuous infusion
5550455|NCT01085396|Melanoma|melanoma
5550456|NCT01085396|UV Exposure|uv exposure
5550457|NCT01085383|Antipsychotic|antipsychotic
5550458|NCT01085383|hyperprolactinemia|hyperprolactinemia
5550459|NCT01085383|hypogonadism|hypogonadism
5550460|NCT01085383|aripiprazole|aripiprazole
5550461|NCT01085370|posttraumatic stress|posttraumatic stress
5550462|NCT01085370|prevention|prevention
5550463|NCT01085370|children|children
5550464|NCT01085370|acute stress disorder due to burn injury or injuries associated with road traffic accidents|acute stress disorder due to burn injury or injuries associated with road traffic accidents
5550465|NCT01085357|Glaucoma|glaucoma
5550466|NCT01085357|Glaucoma device|glaucoma device
5550467|NCT01085357|Glaucoma surgery|glaucoma surgery
5550468|NCT01085357|Intraocular pressure|intraocular pressure
5550469|NCT01085344|hemophilia, prophylaxis, cost effectiveness|hemophilia, prophylaxis, cost effectiveness
5550470|NCT01085331|Mek Inhibitor|mek inhibitor
5550471|NCT01085331|Metastatic Colorectal Cancer|metastatic colorectal cancer
5550472|NCT01085331|K-Ras Mutation|k-ras mutation
5550473|NCT01085331|Phase II|phase ii
5550474|NCT01085331|Second line K-Ras mutated metastatic colorectal cancer|second line k-ras mutated metastatic colorectal cancer
5550475|NCT01085305|Behavior problems|behavior problems
5550476|NCT01085305|Parent-Child Interaction|parent-child interaction
5550477|NCT01085305|Locus of control|locus of control
5550478|NCT01085305|Psychiatric symptoms|psychiatric symptoms
5550479|NCT01085305|Depressive symptoms|depressive symptoms
5550480|NCT01085305|Attachment|attachment
5550481|NCT01085279|fractional laser|fractional laser
5550483|NCT01085279|topical bleaching|topical bleaching
5550484|NCT01085253|Parkinson's|parkinson's
5550485|NCT01085253|supranuclear palsy|supranuclear palsy
5550486|NCT01085253|substantia nigra|substantia nigra
5550487|NCT01085253|sub thalamic nucleus|sub thalamic nucleus
5550489|NCT01085227|Parkinson's disease|parkinson's disease
5550490|NCT01085227|LRRK2|lrrk2
5550491|NCT01085227|asymptomatic carriers|asymptomatic carriers
5550492|NCT01085201|lexiscan|lexiscan
5550493|NCT01085175|Heart Failure,|heart failure,
5550494|NCT01085175|PET Imaging,|pet imaging,
5550495|NCT01085175|Implantable Cardioverter-Defibrillator,|implantable cardioverter-defibrillator,
5550496|NCT01085175|Sudden Cardiac Death|sudden cardiac death
5550497|NCT01085162|Coronary Artery Disease|coronary artery disease
5550498|NCT01085162|PET imaging|pet imaging
5550499|NCT01085162|SPECT imaging|spect imaging
5550500|NCT01085149|simvastatin|simvastatin
5550501|NCT01085149|alveolar bone|alveolar bone
5550502|NCT01085149|tooth extraction|tooth extraction
5550503|NCT01085149|remodeling|remodeling
5550504|NCT01085149|alveolar bone remodeling|alveolar bone remodeling
5550505|NCT01085123|Migraine|migraine
5550506|NCT01085123|ZOMIG® Rapimelt|zomig® rapimelt
5550507|NCT01085110|Groin hernia|groin hernia
5550508|NCT01085110|Chronic pain|chronic pain
5550510|NCT01085110|Quantitative sensory testing|quantitative sensory testing
5550511|NCT01085110|Persistent postoperative pain|persistent postoperative pain
5550512|NCT01085110|Laparoscopic inguinal herniotomy|laparoscopic inguinal herniotomy
5550513|NCT01085110|Postherniotomy Pain after laparoscopic inguinal herniotomy|postherniotomy pain after laparoscopic inguinal herniotomy
5550514|NCT01085110|laparoscopic inguinal hernia repair|laparoscopic inguinal hernia repair
5550515|NCT01085097|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5550516|NCT01085097|Lupus Nephritis|lupus nephritis
5550517|NCT01085097|Laquinimod|laquinimod
5550518|NCT01085084|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5550519|NCT01085084|Lupus Arthritis|lupus arthritis
5550520|NCT01085084|Laquinimod|laquinimod
5550521|NCT01085071|intensive care unit|intensive care unit
5550522|NCT01085071|potassium|potassium
5550523|NCT01085071|atrial fibrillation|atrial fibrillation
5550524|NCT01085071|cardiac surgery|cardiac surgery
5550525|NCT01085071|Critically ill patients post CABG and/or valvular surgery|critically ill patients post cabg and/or valvular surgery
5550526|NCT01085071|Critically ill patients not post CABG and/or valvular surgery|critically ill patients not post cabg and/or valvular surgery
5550527|NCT01085071|coronary artery bypass graft|coronary artery bypass graft
5550528|NCT01085058|Lymphoproliferative diseases (Hodgkin's disease, non-Hodgkin's lymphomas, multiple myelomas) and high-dose therapy|lymphoproliferative diseases (hodgkin's disease, non-hodgkin's lymphomas, multiple myelomas) and high-dose therapy
5550529|NCT01085045|COPD|copd
5550530|NCT01085032|Smoking Cessation|smoking cessation
5550531|NCT01085032|Substance Withdrawal Syndrome|substance withdrawal syndrome
5550532|NCT01085032|Depression|depression
5544724|NCT01108328|hunger|hunger
5550534|NCT01085019|Cardiovascular risk factors|cardiovascular risk factors
5550535|NCT01085019|Spices|spices
5550536|NCT01085019|Herbs|herbs
5550537|NCT01085019|Antioxidant|antioxidant
5550538|NCT01085006|cesarean delivery|cesarean delivery
5550539|NCT01085006|Tranexamic acid|tranexamic acid
5550540|NCT01085006|hemorrhage|hemorrhage
5550541|NCT01085006|Spinal analgesia|spinal analgesia
5550542|NCT01085006|1-the amount of hemorrhage during cesarean delivery|1-the amount of hemorrhage during cesarean delivery
5550543|NCT01085006|2-the amount of hemorrhage in the first 2 hours of cesarean delivery|2-the amount of hemorrhage in the first 2 hours of cesarean delivery
5550544|NCT01085006|3-the amount of hemorrhage in the first 24 hour after cesarean delivery|3-the amount of hemorrhage in the first 24 hour after cesarean delivery
5550545|NCT01084993|Coronary artery stenting, transradial, intracoronary|coronary artery stenting, transradial, intracoronary
5550546|NCT01084980|minimal change disease|minimal change disease
5550548|NCT01084980|corticosteroid|corticosteroid
5550550|NCT01084967|metabolic syndrome|metabolic syndrome
5550551|NCT01084967|genetic risk markers|genetic risk markers
5550552|NCT01084967|copy number variation|copy number variation
5550553|NCT01084954|HIV validation helicase-dependent amplification|hiv validation helicase-dependent amplification
5550554|NCT01084941|pregnancy|pregnancy
5550555|NCT01084941|weight gain|weight gain
5550556|NCT01084941|obesity|obesity
5550557|NCT01084941|pregnancy and weight gain|pregnancy and weight gain
5550558|NCT01084928|diabetes|diabetes
5550559|NCT01084928|obesity|obesity
5550560|NCT01084928|pre-diabetes|pre-diabetes
5550561|NCT01084928|South Asian|south asian
5550562|NCT01084915|Weight loss after SAGB VC band placement|weight loss after sagb vc band placement
5550563|NCT01084902|POAG|poag
5550565|NCT01084902|Xalatan|xalatan
5550566|NCT01084902|Azopt|azopt
5550567|NCT01084902|Primary Open Angle Study|primary open angle study
5550568|NCT01084889|polypropylene mesh|polypropylene mesh
5550569|NCT01084889|Prolapse|prolapse
5550570|NCT01084889|Cystocele|cystocele
5550571|NCT01084889|Surgical Mesh|surgical mesh
5550572|NCT01084876|Herceptin|herceptin
5550573|NCT01084876|metastatic breast cancer|metastatic breast cancer
5550574|NCT01084876|CT-P6|ct-p6
5550575|NCT01084863|Herceptin|herceptin
5550576|NCT01084863|Her 2-positive|her 2-positive
5550577|NCT01084863|metastatic breast cancer|metastatic breast cancer
5550578|NCT01084863|CT-P6|ct-p6
5550579|NCT01084850|Corneal endothelium|corneal endothelium
5550580|NCT01084850|diabetes mellitus|diabetes mellitus
5550581|NCT01084850|corneal thickness|corneal thickness
5550582|NCT01084837|Multiple myeloma|multiple myeloma
5550583|NCT01084837|Renal failure|renal failure
5550585|NCT01084824|Verruca vulgaris|verruca vulgaris
5550586|NCT01084824|Liquid Nitrogen|liquid nitrogen
5550587|NCT01084824|Cantharidin|cantharidin
5550588|NCT01084824|combination treatment|combination treatment
5550589|NCT01084798|Multiple sclerosis|multiple sclerosis
5550590|NCT01084798|Expanded Disability Status Scale|expanded disability status scale
5550591|NCT01084798|Sclerosis|sclerosis
5550592|NCT01084785|Cancer|cancer
5550593|NCT01084785|genomics|genomics
5550594|NCT01084785|proteomics|proteomics
5550595|NCT01084746|Colorectal Cancer Screening|colorectal cancer screening
5550596|NCT01084746|Computer Interactive Intervention|computer interactive intervention
5550597|NCT01084746|Predictors|predictors
5550598|NCT01084746|Cost Effective Analysis|cost effective analysis
5550599|NCT01084746|Transtheoretical Model|transtheoretical model
5550600|NCT01084707|Smoking Cessation, Nicotine pharmacokinetics|smoking cessation, nicotine pharmacokinetics
5550601|NCT01084694|HSCT|hsct
5550602|NCT01084694|Caregiver|caregiver
5550603|NCT01084694|Caregiver Burden|caregiver burden
5550604|NCT01084694|Allogeneic Transplant|allogeneic transplant
5550605|NCT01084694|Autologous Transplant|autologous transplant
5550606|NCT01084694|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5550607|NCT01084681|SILK flow diverter, intracranial stents, intracranial aneurysms|silk flow diverter, intracranial stents, intracranial aneurysms
5550608|NCT01084668|moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5550609|NCT01084668|adalimumab|adalimumab
5550610|NCT01084668|Psoriasis Area and Severity Index (PASI)|psoriasis area and severity index (pasi)
5550611|NCT01084668|Disease Life Quality Index (DLQI)|disease life quality index (dlqi)
5550612|NCT01084668|Nail Psoriasis Severity Index (NAPSI)|nail psoriasis severity index (napsi)
5550613|NCT01084668|biologic disease modifying anti-rheumatic drug (BDMARD)|biologic disease modifying anti-rheumatic drug (bdmard)
5550614|NCT01084668|antibodies|antibodies
5550615|NCT01084668|monoclonals|monoclonals
5550616|NCT01084642|Survey|survey
5550617|NCT01084642|Sexual Health Issues|sexual health issues
5550618|NCT01084642|10-034|10-034
5550619|NCT01084629|Barrett's Esophagus|barrett's esophagus
5550620|NCT01084629|Surveillance|surveillance
5550621|NCT01084603|Smoking Cessation|smoking cessation
5550622|NCT01084603|Nicotine pharmacokinetics|nicotine pharmacokinetics
5550623|NCT01084590|Prevention|prevention
5550624|NCT01084590|Obesity|obesity
5550625|NCT01084590|Safety|safety
5550626|NCT01084590|Unhealthy weight gain|unhealthy weight gain
5550627|NCT01084590|Injury prevention|injury prevention
5550628|NCT01084564|Cost-effectiveness analysis|cost-effectiveness analysis
5550629|NCT01084564|Colombia|colombia
5550630|NCT01084538|paricalcitol iv|paricalcitol iv
5550631|NCT01084538|vitamin D|vitamin d
5550632|NCT01084538|secondary hyperparathyroidism|secondary hyperparathyroidism
5550633|NCT01084538|hemodialysis|hemodialysis
5550634|NCT01084525|Meniere's Disease|meniere's disease
5550635|NCT01084525|Vertigo|vertigo
5550636|NCT01084525|Definitive vertigo|definitive vertigo
5550638|NCT01084525|Vertigo frequency|vertigo frequency
5550639|NCT01084525|Tinnitus|tinnitus
5550640|NCT01084525|Hearing loss|hearing loss
5550641|NCT01084525|Aural Fullness|aural fullness
5550642|NCT01084512|kinematic analysis,|kinematic analysis,
5550643|NCT01084512|three-compartment model,|three-compartment model,
5550644|NCT01084512|chest wall motion,|chest wall motion,
5550645|NCT01084512|spinal cord injury.|spinal cord injury.
5550646|NCT01084499|Healthy Subjects|healthy subjects
5550647|NCT01084486|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5550648|NCT01084486|Pulse wave velocity|pulse wave velocity
5550649|NCT01084486|augmentation index|augmentation index
5550650|NCT01084486|metformin|metformin
5550651|NCT01084473|Dexmedetomidine|dexmedetomidine
5550652|NCT01084473|gastric emptying|gastric emptying
5550653|NCT01084473|oro-cecal transit time|oro-cecal transit time
5550654|NCT01084473|Sedation in intensive care|sedation in intensive care
5550655|NCT01084473|Gastrointestinal effects of sedation|gastrointestinal effects of sedation
5550656|NCT01084460|Gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor|gastrointestinal stromal tumor,endoscopic ultrasound,submucosal tumor
5550657|NCT01084447|obesity|obesity
5550658|NCT01084447|gastroplasty|gastroplasty
5550659|NCT01084447|respiratory muscle training|respiratory muscle training
5550660|NCT01084447|muscle strength|muscle strength
5550661|NCT01084447|physical therapy|physical therapy
5550662|NCT01084421|Adolescents|adolescents
5550663|NCT01084421|Parents|parents
5550664|NCT01084421|Computer Based|computer based
5550665|NCT01084421|Latino|latino
5550666|NCT01084421|Sexual Communication|sexual communication
5550667|NCT01084408|de-novo|de-novo
5550668|NCT01084408|coronary stenoses|coronary stenoses
5550669|NCT01084408|PEPCAD|pepcad
5550670|NCT01084408|DEBonly|debonly
5550671|NCT01084408|Paclitaxel|paclitaxel
5550672|NCT01084395|Parent|parent
5550673|NCT01084395|Adolescent|adolescent
5550674|NCT01084395|Mexico|mexico
5550675|NCT01084395|Safer Sex Communication|safer sex communication
5550676|NCT01084395|Randomized Controlled Trial|randomized controlled trial
5550677|NCT01084395|HIV/AIDS|hiv/aids
5550678|NCT01084395|STD|std
5550679|NCT01084395|Sexual Behavior|sexual behavior
5550680|NCT01084382|Arthrospira platensis|arthrospira platensis
5550681|NCT01084382|female HIV patient|female hiv patient
5550682|NCT01084382|Yaounde|yaounde
5550683|NCT01084382|Redox potential|redox potential
5550684|NCT01084382|Life quality|life quality
5550685|NCT01084382|female patient infected by HIV in Yaounde: Cameroon|female patient infected by hiv in yaounde: cameroon
5550686|NCT01084369|Type 2 diabetes|type 2 diabetes
5550687|NCT01084369|Hypogonadism|hypogonadism
5550688|NCT01084369|Testosterone|testosterone
5550689|NCT01084369|Endothelial dysfunction|endothelial dysfunction
5550690|NCT01084356|CZT|czt
5550691|NCT01084356|sentinel node|sentinel node
5550692|NCT01084356|osseous processes|osseous processes
5550693|NCT01084343|vaccination|vaccination
5550694|NCT01084343|prophylaxis|prophylaxis
5550695|NCT01084330|gastric cancer|gastric cancer
5550696|NCT01084330|metastatic gastric cancer|metastatic gastric cancer
5550697|NCT01084330|advanced gastric cancer|advanced gastric cancer
5550698|NCT01084317|asthma|asthma
5550699|NCT01084317|children|children
5550700|NCT01084317|delay in asthma diagnosis|delay in asthma diagnosis
5550701|NCT01084304|Pregnancy|pregnancy
5550702|NCT01084304|Ovulation tests|ovulation tests
5550703|NCT01084304|stress|stress
5550704|NCT01084304|Wishing to become pregnant|wishing to become pregnant
5550705|NCT01084291|Vaccine|vaccine
5550706|NCT01084291|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5550707|NCT01084265|Hypogonadism|hypogonadism
5550708|NCT01084265|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5550709|NCT01084265|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5550710|NCT01084239|acute chest pain|acute chest pain
5550711|NCT01084239|emergency department|emergency department
5550712|NCT01084239|cardiac computed tomography|cardiac computed tomography
5550713|NCT01084226|Rye fiber|rye fiber
5550714|NCT01084226|Alkylresorcinols|alkylresorcinols
5550715|NCT01084226|Plant sterols|plant sterols
5550716|NCT01084226|Cholesterol|cholesterol
5550717|NCT01084226|Antioxidant|antioxidant
5550718|NCT01084226|Effects of plant sterols in rye bread on serum lipids|effects of plant sterols in rye bread on serum lipids
5550719|NCT01084226|Effects of alkylresorcinols in rye fiber on LDL particles|effects of alkylresorcinols in rye fiber on ldl particles
5550720|NCT01084213|Low birth weight|low birth weight
5550721|NCT01084213|Placenta malaria|placenta malaria
5550722|NCT01084213|Anaemia|anaemia
5550723|NCT01084213|Intermittent preventive treatment|intermittent preventive treatment
5550724|NCT01084213|Intermittent screening and treatment|intermittent screening and treatment
5550725|NCT01084213|Rapid diagnostic test|rapid diagnostic test
5550726|NCT01084200|Postoperative pain|postoperative pain
5550728|NCT01084200|Propofol|propofol
5550729|NCT01084200|Female|female
5550730|NCT01084200|Elective gynaecological surgery|elective gynaecological surgery
5550731|NCT01084200|Laparoscopic and hysteroscopic surgery|laparoscopic and hysteroscopic surgery
5550733|NCT01084200|Undergoing elective laparoscopic and hysteroscopic surgery|undergoing elective laparoscopic and hysteroscopic surgery
5550734|NCT01084187|erectile dysfunction|erectile dysfunction
5550735|NCT01084187|arterial hypertension|arterial hypertension
5550736|NCT01084187|flow mediated vasodilation|flow mediated vasodilation
5550737|NCT01084187|endothelial dysfunction|endothelial dysfunction
5550738|NCT01084187|carotid intima media thickness|carotid intima media thickness
5550739|NCT01084187|vardenafil|vardenafil
5550740|NCT01084174|Peanut Allergy|peanut allergy
5550741|NCT01084135|Clinical trial|clinical trial
5550742|NCT01084135|Down syndrome|down syndrome
5550743|NCT01084135|adolescents|adolescents
5550744|NCT01084135|cognitive|cognitive
5550745|NCT01084135|rivastigmine|rivastigmine
5550746|NCT01084122|Intravenous iron sucrose|intravenous iron sucrose
5550747|NCT01084122|Anemia|anemia
5550748|NCT01084122|Transfusion|transfusion
5550749|NCT01084109|Complementary feeding|complementary feeding
5550750|NCT01084109|Infant growth|infant growth
5550751|NCT01084109|Developing countries|developing countries
5550752|NCT01084096|Antenatal Corticosteroids, Preterm Birth, Diffusion|antenatal corticosteroids, preterm birth, diffusion
5550753|NCT01084083|human papilloma virus infection|human papilloma virus infection
5550754|NCT01084083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5685544|NCT00555659|Spondylolisthesis|spondylolisthesis
5550755|NCT01084083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5550756|NCT01084083|tongue cancer|tongue cancer
5550757|NCT01084070|early feeding|early feeding
5550758|NCT01084070|postoperative care|postoperative care
5550759|NCT01084070|emergency surgery|emergency surgery
5550760|NCT01084018|acute postoperative pain|acute postoperative pain
5550761|NCT01084018|nursing intervention|nursing intervention
5550762|NCT01083992|NAFLD|nafld
5550763|NCT01083992|Galvus|galvus
5550764|NCT01083992|vitamin D|vitamin d
5550765|NCT01083966|Vestibular|vestibular
5550766|NCT01083966|Schwannoma|schwannoma
5550767|NCT01083966|earing-loss|earing-loss
5550768|NCT01083966|brain-tumor|brain-tumor
5550769|NCT01083966|Acoustic|acoustic
5550770|NCT01083966|Neuroma|neuroma
5550771|NCT01083953|end tidal concentration|end tidal concentration
5550772|NCT01083927|Pterygium|pterygium
5550773|NCT01083914|extracorporeal circulation, off-pump CABG|extracorporeal circulation, off-pump cabg
5550774|NCT01083888|FG-4592|fg-4592
5550775|NCT01083888|ASP1517|asp1517
5550776|NCT01083888|Safety and tolerability|safety and tolerability
5550777|NCT01083888|Plasma concentration|plasma concentration
5550778|NCT01083888|Pharmacokinetics|pharmacokinetics
5550779|NCT01083875|Radiation|radiation
5550780|NCT01083875|mucositis|mucositis
5550781|NCT01083875|head and neck carcinoma|head and neck carcinoma
5550782|NCT01083875|oral rinse|oral rinse
5550783|NCT01083875|amlexanox|amlexanox
5550784|NCT01083875|MuGard|mugard
5550785|NCT01083862|Health literacy|health literacy
5550786|NCT01083862|patient education|patient education
5550787|NCT01083862|health behaviors|health behaviors
5550788|NCT01083862|chronic disease management|chronic disease management
5550789|NCT01083862|shared decision-making|shared decision-making
5550790|NCT01083862|patient-centered decision making|patient-centered decision making
5550791|NCT01083849|Observational study|observational study
5550792|NCT01083849|Paricalcitol|paricalcitol
5550793|NCT01083849|Treatment of Hyperparathyroidism|treatment of hyperparathyroidism
5550794|NCT01083849|Chronic kidney disease stage 3, 4 and 5 (CKD stage 3, 4 and 5)|chronic kidney disease stage 3, 4 and 5 (ckd stage 3, 4 and 5)
5550795|NCT01083849|Chronic Kidney Disease|chronic kidney disease
5550796|NCT01083849|Zemplar|zemplar
5550797|NCT01083849|sHPT|shpt
5550798|NCT01083849|Secondary|secondary
5550799|NCT01083823|Mental health telemetry|mental health telemetry
5550800|NCT01083823|Mood telemetry|mood telemetry
5550801|NCT01083823|Mood|mood
5550802|NCT01083823|Bipolar disorder|bipolar disorder
5550803|NCT01083823|Affective instability|affective instability
5550804|NCT01083823|Cyclothymia|cyclothymia
5550805|NCT01083823|Electronic diaries|electronic diaries
5550806|NCT01083823|Mood diaries|mood diaries
5550807|NCT01083823|Mood swings|mood swings
5550808|NCT01083810|Human Immunodeficiency Virus|human immunodeficiency virus
5550809|NCT01083810|Infection|infection
5550810|NCT01083810|Kaletra|kaletra
5550811|NCT01083810|Resistance|resistance
5550812|NCT01083810|Mutations|mutations
5550813|NCT01083810|alternative Therapy regimen|alternative therapy regimen
5550814|NCT01083797|Sedation|sedation
5550815|NCT01083797|Electroencephalography|electroencephalography
5550816|NCT01083797|Dexmedetomidine|dexmedetomidine
5550817|NCT01083797|Chloral hydrate|chloral hydrate
5550818|NCT01083784|Cardiac arrest|cardiac arrest
5550819|NCT01083784|Prophylactic anticonvulsant|prophylactic anticonvulsant
5550820|NCT01083719|Glioblastoma|glioblastoma
5550821|NCT01083719|FDG-PET|fdg-pet
5550823|NCT01083693|Monoclonals|monoclonals
5550824|NCT01083693|Antibodies|antibodies
5550825|NCT01083693|Ankylosing Spondylitis|ankylosing spondylitis
5550826|NCT01083693|Antirheumatic Agents|antirheumatic agents
5550827|NCT01083693|Quality of Life|quality of life
5550828|NCT01083693|Adalimumab|adalimumab
5550829|NCT01083693|rheumatoid arthritis|rheumatoid arthritis
5550830|NCT01083693|psoriatic arthritis|psoriatic arthritis
5550831|NCT01083680|Routine clinical setting|routine clinical setting
5550832|NCT01083680|Long-term efficacy and safety|long-term efficacy and safety
5550833|NCT01083680|Crohn's Disease|crohn's disease
5550834|NCT01083680|Humira®|humira®
5550835|NCT01083680|Adalimumab|adalimumab
5550837|NCT01083667|Familial ALS|familial als
5550838|NCT01083667|SOD1 Gene Mutation|sod1 gene mutation
5550839|NCT01083654|Smoking|smoking
5550840|NCT01083654|Smoking cessation|smoking cessation
5550841|NCT01083641|Breast Cancer|breast cancer
5550842|NCT01083628|mhealth|mhealth
5550843|NCT01083628|depression|depression
5550844|NCT01083628|latinos|latinos
5550845|NCT01083628|text messaging|text messaging
5550846|NCT01083628|CBT|cbt
5550847|NCT01083628|SMS|sms
5550848|NCT01083615|CRPC patients with cancer related pain|crpc patients with cancer related pain
5550849|NCT01083615|CRPC|crpc
5550850|NCT01083615|HRPC|hrpc
5550851|NCT01083602|Multiple Myeloma|multiple myeloma
5550852|NCT01083602|Relapsed Multiple Myeloma|relapsed multiple myeloma
5550853|NCT01083602|Refractory Multiple Myeloma|refractory multiple myeloma
5550854|NCT01083589|Lung Cancer|lung cancer
5550856|NCT01083589|Tumor|tumor
5550857|NCT01083589|Imatinib Mesylate|imatinib mesylate
5550858|NCT01083589|Gleevec|gleevec
5550859|NCT01083589|Docetaxel|docetaxel
5550860|NCT01083589|Taxotere|taxotere
5550861|NCT01083576|leishmaniasis|leishmaniasis
5550862|NCT01083576|cutaneous|cutaneous
5550863|NCT01083576|WR 279,396|wr 279,396
5550864|NCT01083576|paromomycin|paromomycin
5550865|NCT01083576|gentamicin|gentamicin
5550866|NCT01083576|pharmacokinetics|pharmacokinetics
5550867|NCT01083576|safety|safety
5550868|NCT01083576|efficacy|efficacy
5550869|NCT01083563|TNF|tnf
5550870|NCT01083563|CD20|cd20
5550871|NCT01083563|RA|ra
5550872|NCT01083550|thyroid carcinoma|thyroid carcinoma
5550873|NCT01083550|thyroid cancer|thyroid cancer
5550874|NCT01083550|therapeutic radioisotopes|therapeutic radioisotopes
5550875|NCT01083550|radioactive iodine|radioactive iodine
5550876|NCT01083537|malignant bowel obstruction|malignant bowel obstruction
5550877|NCT01083537|ovarian cancer|ovarian cancer
5550878|NCT01083537|Peritoneal cancer|peritoneal cancer
5550879|NCT01083537|Fallopian Tube cancer|fallopian tube cancer
5550880|NCT01083524|Pulmonary arterial hypertension|pulmonary arterial hypertension
5550881|NCT01083524|Pulmonary hypertension|pulmonary hypertension
5550882|NCT01083524|Dichloroacetate|dichloroacetate
5550883|NCT01083524|Dichloroacetate Sodium|dichloroacetate sodium
5550885|NCT01083511|Influenza|influenza
5550886|NCT01083511|Influenza A|influenza a
5550887|NCT01083511|Influenza B|influenza b
5550888|NCT01083511|Swine Influenza A/H1N1|swine influenza a/h1n1
5550889|NCT01083511|Respiratory Virus|respiratory virus
5550890|NCT01083498|Becker's nevus|becker's nevus
5550891|NCT01083498|ablative fractional laser therapy|ablative fractional laser therapy
5550892|NCT01083498|randomized controlled trial|randomized controlled trial
5550893|NCT01083498|split-lesion design|split-lesion design
5550894|NCT01083485|Oxycodone|oxycodone
5550895|NCT01083485|Naloxone|naloxone
5550896|NCT01083485|Postoperative pain|postoperative pain
5550897|NCT01083485|Arthroplasty|arthroplasty
5550898|NCT01083485|Efficacy|efficacy
5550899|NCT01083472|dehiscence|dehiscence
5550900|NCT01083472|laparotomy|laparotomy
5550901|NCT01083472|Hernia repair|hernia repair
5550902|NCT01083472|surgical wound|surgical wound
5550903|NCT01083472|surgical mesh|surgical mesh
5550904|NCT01083446|Encephalopathy|encephalopathy
5550905|NCT01083446|Cirrhotics|cirrhotics
5550906|NCT01083433|Continuous Glucose Monitor|continuous glucose monitor
5550907|NCT01083433|Adherence|adherence
5550908|NCT01083433|Adolescents|adolescents
5550909|NCT01083433|Diabetes Education|diabetes education
5550910|NCT01083420|Oral lichen planus|oral lichen planus
5550911|NCT01083420|Minocycline|minocycline
5550912|NCT01083420|Dexamethasone|dexamethasone
5550913|NCT01083407|Oral care.|oral care.
5550914|NCT01083407|Chlorhexidine.|chlorhexidine.
5550915|NCT01083407|Pediatric Nursing|pediatric nursing
5550916|NCT01083407|Intensive Care|intensive care
5550917|NCT01083407|Nosocomial infection|nosocomial infection
5550918|NCT01083407|Pneumonia|pneumonia
5550919|NCT01083407|Oropharyngeal colonization|oropharyngeal colonization
5550920|NCT01083407|Tracheal colonization|tracheal colonization
5550921|NCT01083394|PTA|pta
5550922|NCT01083394|paclitaxel|paclitaxel
5550923|NCT01083394|restenosis|restenosis
5550924|NCT01083381|Schizophrenia treatment MS14 randomized clinical trial|schizophrenia treatment ms14 randomized clinical trial
5550925|NCT01083368|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5545112|NCT01106625|Placebo|placebo
5550926|NCT01083368|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5550927|NCT01083368|recurrent prostate cancer|recurrent prostate cancer
5550928|NCT01083368|stage IV prostate cancer|stage iv prostate cancer
5550930|NCT01083355|Pressure regulated volume control ventilation|pressure regulated volume control ventilation
5550931|NCT01083355|Airway pressure release ventilation|airway pressure release ventilation
5550932|NCT01083342|primary CNS lymphoma|primary cns lymphoma
5550933|NCT01083342|MTX: Methotrexate,Leucovorin|mtx: methotrexate,leucovorin
5550934|NCT01083342|MVD: Methotrexate,Vincristine,Dexamethasone|mvd: methotrexate,vincristine,dexamethasone
5550935|NCT01083342|VIA: VP-16 (Etoposide),Ifosfamide,Mesna, Cytarabine (ara-C)|via: vp-16 (etoposide),ifosfamide,mesna, cytarabine (ara-c)
5550936|NCT01083342|Newly diagnosed primary CNS lymphoma patients|newly diagnosed primary cns lymphoma patients
5550937|NCT01083329|nicotinic acid|nicotinic acid
5550938|NCT01083329|lipolysis|lipolysis
5550939|NCT01083329|training program|training program
5550940|NCT01083329|adipose tissue inflammation|adipose tissue inflammation
5550941|NCT01083329|obese|obese
5550942|NCT01083316|Amyloid|amyloid
5550943|NCT01083316|Amyloidosis|amyloidosis
5550944|NCT01083316|AL Amyloidosis|al amyloidosis
5550945|NCT01083316|Primary Amyloidosis|primary amyloidosis
5550946|NCT01083316|Stem Cell Transplant|stem cell transplant
5550947|NCT01083303|energy expenditure|energy expenditure
5550948|NCT01083303|hypothermia|hypothermia
5550949|NCT01083303|body temperature|body temperature
5550950|NCT01083303|weaning|weaning
5550951|NCT01083303|preterm infants|preterm infants
5550952|NCT01083290|spironolactone|spironolactone
5550953|NCT01083290|linearity of pharmacokinetics|linearity of pharmacokinetics
5550954|NCT01083290|Healthy volunteers|healthy volunteers
5550955|NCT01083277|oxygenation|oxygenation
5550956|NCT01083277|ventilation|ventilation
5550957|NCT01083277|tidal volume|tidal volume
5550958|NCT01083277|patterns of breathing|patterns of breathing
5550959|NCT01083277|variable ventilation|variable ventilation
5550960|NCT01083277|mechanical ventilation|mechanical ventilation
5550961|NCT01083264|Pharmacokinetics|pharmacokinetics
5550963|NCT01083251|VITAMIN D|vitamin d
5550964|NCT01083251|PEGITERFERON|pegiterferon
5550965|NCT01083251|Telbivudine|telbivudine
5550966|NCT01083238|pharmacokinetics|pharmacokinetics
5550967|NCT01083238|fasting or after a high fat meal|fasting or after a high fat meal
5550968|NCT01083238|adult|adult
5550969|NCT01083238|elderly adult|elderly adult
5550970|NCT01083238|COPD|copd
5550971|NCT01083212|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5550972|NCT01083212|Gemfibrozil|gemfibrozil
5550979|NCT01083173|HIV-1 infection|hiv-1 infection
5550980|NCT01083173|Kaletra|kaletra
5550981|NCT01083160|Rheumatoid Arthritis|rheumatoid arthritis
5550982|NCT01083160|Anti-TNF|anti-tnf
5550983|NCT01083160|Adalimumab|adalimumab
5550984|NCT01083160|Infliximab|infliximab
5550985|NCT01083160|Etanercept|etanercept
5550986|NCT01083147|Intermediate AMD|intermediate amd
5550987|NCT01083134|CAD|cad
5550988|NCT01083121|Postmarketing Drug Surveillance|postmarketing drug surveillance
5550989|NCT01083108|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5550990|NCT01083108|Bariatric Surgery|bariatric surgery
5550991|NCT01083108|Diabetes Type II|diabetes type ii
5550992|NCT01083108|Obesity|obesity
5550993|NCT01083108|Adult|adult
5550994|NCT01083108|Type 2 Diabetes|type 2 diabetes
5550995|NCT01083095|Malaria|malaria
5550996|NCT01083095|Sporozoite|sporozoite
5550997|NCT01083095|Challenge Model|challenge model
5550998|NCT01083095|Plasmodium vivax|plasmodium vivax
5550999|NCT01083095|Human Volunteers|human volunteers
5551007|NCT01083069|Sudden cardiac arrest|sudden cardiac arrest
5551008|NCT01083069|hypothermia|hypothermia
5551009|NCT01083069|neurological outcome|neurological outcome
5551010|NCT01083056|retina|retina
5551011|NCT01083056|gliosis|gliosis
5551012|NCT01083056|macula|macula
5551013|NCT01083056|membrane|membrane
5551014|NCT01083056|ILM|ilm
5551015|NCT01083043|Glycemic Variability|glycemic variability
5551016|NCT01083043|Endothelial Dysfunction|endothelial dysfunction
5551017|NCT01083030|pAVK|pavk
5551018|NCT01083030|PTA|pta
5551019|NCT01083030|drug coated balloon|drug coated balloon
5551020|NCT01083004|dye|dye
5551021|NCT01083004|internal limiting membrane|internal limiting membrane
5551022|NCT01083004|macular hole|macular hole
5551023|NCT01083004|macular pucker|macular pucker
5551024|NCT01082978|Quality of Life|quality of life
5551025|NCT01082978|Health Care Quality and Safety|health care quality and safety
5551026|NCT01082978|Randomized controlled trial|randomized controlled trial
5551027|NCT01082965|ASL MRI|asl mri
5551028|NCT01082965|perfusion|perfusion
5551029|NCT01082965|cognition|cognition
5551030|NCT01082965|donepezil|donepezil
5551031|NCT01082965|alzheimer's disease|alzheimer's disease
5551032|NCT01082965|translational medicine|translational medicine
5551033|NCT01082939|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5551034|NCT01082939|Refractory CLL|refractory cll
5551035|NCT01082939|CFAR|cfar
5551036|NCT01082939|Alemtuzumab|alemtuzumab
5551037|NCT01082939|Campath-1H|campath-1h
5551038|NCT01082939|Campath|campath
5551039|NCT01082939|Cyclophosphamide|cyclophosphamide
5551041|NCT01082939|Neosar|neosar
5551042|NCT01082939|Fludarabine|fludarabine
5551043|NCT01082939|Fludara|fludara
5551044|NCT01082939|Fludarabine Phosphate|fludarabine phosphate
5551045|NCT01082939|Rituximab|rituximab
5551046|NCT01082939|Rituxan|rituxan
5551047|NCT01082939|CLL|cll
5551048|NCT01082926|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5551049|NCT01082926|adult anaplastic ependymoma|adult anaplastic ependymoma
5551050|NCT01082926|adult anaplastic meningioma|adult anaplastic meningioma
5551051|NCT01082926|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5551052|NCT01082926|adult brain stem glioma|adult brain stem glioma
5551053|NCT01082926|adult ependymoblastoma|adult ependymoblastoma
5551054|NCT01082926|adult giant cell glioblastoma|adult giant cell glioblastoma
5551055|NCT01082926|adult glioblastoma|adult glioblastoma
5551056|NCT01082926|adult gliosarcoma|adult gliosarcoma
5551057|NCT01082926|adult grade III meningioma|adult grade iii meningioma
5551058|NCT01082926|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5551059|NCT01082926|adult mixed glioma|adult mixed glioma
5551060|NCT01082926|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5551061|NCT01082926|recurrent adult brain tumor|recurrent adult brain tumor
5551062|NCT01082926|Los Angeles|los angeles
5551063|NCT01082900|Transient Tachypnea of the Newborn|transient tachypnea of the newborn
5551064|NCT01082900|Elective Cesarean section|elective cesarean section
5551065|NCT01082900|Late preterm|late preterm
5551066|NCT01082900|CPAP|cpap
5551067|NCT01082900|Delivery Room|delivery room
5551068|NCT01082887|Immunotherapy TIL (Tumor Infiltrating Lymphocytes)|immunotherapy til (tumor infiltrating lymphocytes)
5551069|NCT01082887|Intra-tumoral injection|intra-tumoral injection
5551070|NCT01082887|Interferon gamma-adenovirus(Ad-IFNg)|interferon gamma-adenovirus(ad-ifng)
5551071|NCT01082887|Metastatic melanoma|metastatic melanoma
5551072|NCT01082887|A stage IIIc/IV metastatic melanoma with nodal relapse|a stage iiic/iv metastatic melanoma with nodal relapse
5551073|NCT01082887|in transit metastasis|in transit metastasis
5551074|NCT01082887|cutaneous unresectable metastases|cutaneous unresectable metastases
5551075|NCT01082887|visceral metastases|visceral metastases
5551076|NCT01082874|Randomized Controlled Trial|randomized controlled trial
5551077|NCT01082874|Blinded|blinded
5551078|NCT01082874|Clonidine|clonidine
5551079|NCT01082874|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
5551080|NCT01082874|Perioperative vascular complications|perioperative vascular complications
5551081|NCT01082874|Noncardiac surgery|noncardiac surgery
5553629|NCT01072591|OA|oa
5551082|NCT01082861|1998 female birth cohort eligible for HPV vaccination in 2011 within the Dutch NIP|1998 female birth cohort eligible for hpv vaccination in 2011 within the dutch nip
5551083|NCT01082835|Chinese herbs|chinese herbs
5551084|NCT01082822|cell sheet PDLSC periodontitis|cell sheet pdlsc periodontitis
5551085|NCT01082809|advanced biliary tract carcinoma|advanced biliary tract carcinoma
5551086|NCT01082809|Sunitinib|sunitinib
5551087|NCT01082783|stroke-induced immunodepression|stroke-induced immunodepression
5551088|NCT01082783|acute media infarct|acute media infarct
5551089|NCT01082783|acute intracerebral bleeding|acute intracerebral bleeding
5551090|NCT01082783|leucocytes|leucocytes
5551091|NCT01082783|autoaggressive T-cells|autoaggressive t-cells
5551092|NCT01082783|acute media infarct or acute intracerebral bleeding|acute media infarct or acute intracerebral bleeding
5551093|NCT01082757|Colorectal neoplasms|colorectal neoplasms
5551094|NCT01082757|metastasis|metastasis
5551095|NCT01082757|colorectal cancer|colorectal cancer
5551096|NCT01082744|Paravertebral Block|paravertebral block
5551097|NCT01082744|Regional Anesthesia|regional anesthesia
5551098|NCT01082744|Anesthetics Local|anesthetics local
5551099|NCT01082744|Ropivacaine|ropivacaine
5551100|NCT01082744|Sufentanil|sufentanil
5551101|NCT01082744|Pain Postoperative|pain postoperative
5551102|NCT01082744|Chronic Pain|chronic pain
5551103|NCT01082744|Thoracic Surgery Video-Assisted.|thoracic surgery video-assisted.
5551104|NCT01082731|Malaria|malaria
5551105|NCT01082731|Plasmodium falciparum|plasmodium falciparum
5551106|NCT01082731|Treatment|treatment
5551107|NCT01082731|Brazil|brazil
5551108|NCT01082718|Malaria|malaria
5551109|NCT01082718|Pregnancy|pregnancy
5551110|NCT01082718|Pharmacokinetics|pharmacokinetics
5551111|NCT01082718|Brazil|brazil
5551112|NCT01082705|malaria|malaria
5551113|NCT01082705|treatment|treatment
5551114|NCT01082705|artemisinin combination therapy|artemisinin combination therapy
5551115|NCT01082705|Tanzania|tanzania
5551116|NCT01082705|P. falciparum malaria in children age 6-59 months|p. falciparum malaria in children age 6-59 months
5551117|NCT01082692|HIV Infection|hiv infection
5551118|NCT01082692|DNA vaccine|dna vaccine
5551119|NCT01082692|Electroporation|electroporation
5551120|NCT01082692|HIV therapeutic vaccine|hiv therapeutic vaccine
5551121|NCT01082679|opioid dependent|opioid dependent
5551122|NCT01082679|methadone|methadone
5551123|NCT01082679|Suboxone|suboxone
5551124|NCT01082679|buprenorphine|buprenorphine
5551125|NCT01082666|Cuff pressure|cuff pressure
5551126|NCT01082666|microaspiration|microaspiration
5551127|NCT01082666|pepsin|pepsin
5551128|NCT01082666|VAP|vap
5551129|NCT01082666|Mechanical ventilation|mechanical ventilation
5551130|NCT01082653|ALS|als
5551131|NCT01082653|Lou Gehrig's Disease|lou gehrig's disease
5551133|NCT01082640|physiology|physiology
5551134|NCT01082640|Hyperuricemia|hyperuricemia
5551135|NCT01082640|Uric Acid|uric acid
5551136|NCT01082640|Drug Therapy|drug therapy
5551137|NCT01082627|Somatostatin small bowel obstruction|somatostatin small bowel obstruction
5551138|NCT01082601|Catheter Ablation|catheter ablation
5551139|NCT01082601|Atrial Fibrillation|atrial fibrillation
5551140|NCT01082601|Congestive heart failure|congestive heart failure
5551141|NCT01082588|schizophrenia|schizophrenia
5551142|NCT01082588|pravastatin|pravastatin
5551143|NCT01082588|inflammation|inflammation
5551144|NCT01082588|cognition|cognition
5551145|NCT01082588|antipsychotics|antipsychotics
5551146|NCT01082588|cholesterol|cholesterol
5551147|NCT01082575|Post Op Patients|post op patients
5551148|NCT01082575|Continuous Pulse Oximetry Monitoring|continuous pulse oximetry monitoring
5551149|NCT01082575|Major Surgery|major surgery
5551150|NCT01082549|Patients with Previously Untreated Advanced Squamous Cell Lung Cancer|patients with previously untreated advanced squamous cell lung cancer
5551151|NCT01082536|Pediatrics|pediatrics
5551152|NCT01082536|Congenital heart disease|congenital heart disease
5551153|NCT01082536|NIRS|nirs
5551154|NCT01082536|Brain oxygenation|brain oxygenation
5551155|NCT01082510|UFT|uft
5551156|NCT01082510|BCG|bcg
5551157|NCT01082497|Mindfulness|mindfulness
5551158|NCT01082497|Stress|stress
5551159|NCT01082497|Burnout|burnout
5551160|NCT01082497|Ward atmosphere|ward atmosphere
5551161|NCT01082497|Stress and burnout among staff, psychosocial atmosphere at the ward|stress and burnout among staff, psychosocial atmosphere at the ward
5551162|NCT01082484|Healthy volunteers|healthy volunteers
5551163|NCT01082484|iontophoresis|iontophoresis
5551164|NCT01082471|Morphine 6-glucuronide|morphine 6-glucuronide
5551165|NCT01082471|Morphine|morphine
5551166|NCT01082471|Patient Controlled Analgesia|patient controlled analgesia
5551167|NCT01082471|Post Operative Nausea and Vomiting|post operative nausea and vomiting
5551168|NCT01082458|Patients scheduled to undergo thyroidectomy|patients scheduled to undergo thyroidectomy
5551169|NCT01082445|stage C|stage c
5551170|NCT01082445|grade 0 (Texas University)|grade 0 (texas university)
5551171|NCT01082432|thumb|thumb
5551172|NCT01082432|Ulnar collateral ligament|ulnar collateral ligament
5551173|NCT01082432|superimposed electrical stimulation|superimposed electrical stimulation
5551174|NCT01082432|stiffness|stiffness
5551175|NCT01082432|adhesions|adhesions
5551176|NCT01082419|Liver stiffness measurement|liver stiffness measurement
5551178|NCT01082419|fibrosis|fibrosis
5551179|NCT01082419|hepatopathy|hepatopathy
5551180|NCT01082393|vitiligo|vitiligo
5551181|NCT01082380|radiolabeled|radiolabeled
5551182|NCT01082380|healthy volunteers|healthy volunteers
5551183|NCT01082367|Tobramycin Inhalation solution|tobramycin inhalation solution
5551184|NCT01082367|Cystic fibrosis|cystic fibrosis
5551185|NCT01082367|Lung disease|lung disease
5551186|NCT01082367|anti-bacterial agents|anti-bacterial agents
5551187|NCT01082354|Infant, Low birth weight|infant, low birth weight
5551188|NCT01082354|Infant, Low birth height|infant, low birth height
5551189|NCT01082354|Infant, Small for Gestational Age|infant, small for gestational age
5551190|NCT01082341|GCP Good Clinical Practice|gcp good clinical practice
5551191|NCT01082341|IFAT Indirect Immunofluorescence antibody test|ifat indirect immunofluorescence antibody test
5551192|NCT01082341|MFA Membrane Feeding Assay|mfa membrane feeding assay
5551193|NCT01082341|N Number (typically refers to subjects)|n number (typically refers to subjects)
5551194|NCT01082341|RBC Red Blood Cells|rbc red blood cells
5551195|NCT01082341|SOP Standard Operating Procedure|sop standard operating procedure
5551196|NCT01082341|TBS Thick blood smear|tbs thick blood smear
5551197|NCT01082341|P. Vivax|p. vivax
5551198|NCT01082341|irradiated sporozoite vaccination.|irradiated sporozoite vaccination.
5551199|NCT01082328|Phenylketonuria (PKU)|phenylketonuria (pku)
5551200|NCT01082328|Hyperphenylalaninemia (HPA)|hyperphenylalaninemia (hpa)
5551201|NCT01082328|Kuvan®|kuvan®
5551202|NCT01082328|Sapropterin dihydrochloride|sapropterin dihydrochloride
5551203|NCT01082328|Kuvan responder|kuvan responder
5551204|NCT01082328|Tetrahydrobiopterin (BH4)|tetrahydrobiopterin (bh4)
5551205|NCT01082315|Colorectal cancer|colorectal cancer
5551206|NCT01082315|Neoplasm metastasis|neoplasm metastasis
5551207|NCT01082315|Cetuximab|cetuximab
5551208|NCT01082315|Erbitux|erbitux
5551209|NCT01082315|EGFR|egfr
5551210|NCT01082302|green tea extract|green tea extract
5551211|NCT01082302|Polyphenon E|polyphenon e
5551212|NCT01082302|Pharmacokinetics|pharmacokinetics
5551213|NCT01082289|Lurasidone|lurasidone
5551214|NCT01082289|Schizophrenia|schizophrenia
5551215|NCT01082289|Latuda|latuda
5551216|NCT01082276|Rifampin DDI with Lurasidone HCl|rifampin ddi with lurasidone hcl
5551217|NCT01082263|DDI study between Midazolam and Lurasidone HCl|ddi study between midazolam and lurasidone hcl
5551218|NCT01082263|Male and Female|male and female
5551219|NCT01082250|Bioequivalence|bioequivalence
5551220|NCT01082250|Male/Female Patient|male/female patient
5551221|NCT01082250|Reference/Test Formulation|reference/test formulation
5551222|NCT01082250|Schizophrenia Patients|schizophrenia patients
5551223|NCT01082237|Major Depressive Disorder|major depressive disorder
5551226|NCT01082224|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5551227|NCT01082224|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5551228|NCT01082224|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5551229|NCT01082211|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5551230|NCT01082211|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5551231|NCT01082211|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5551232|NCT01082211|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5551233|NCT01082211|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5551234|NCT01082211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5551235|NCT01082211|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5551236|NCT01082211|recurrent breast cancer|recurrent breast cancer
5551237|NCT01082198|stage III melanoma|stage iii melanoma
5551239|NCT01082185|aortic|aortic
5551240|NCT01082185|aneurysm|aneurysm
5551241|NCT01082185|AAA|aaa
5551242|NCT01082172|thoracic|thoracic
5551243|NCT01082172|aortic|aortic
5551244|NCT01082172|aneurysm|aneurysm
5551245|NCT01082172|TAA|taa
5551246|NCT01082159|Spinal Stenosis|spinal stenosis
5551247|NCT01082159|Lumbar Spinal Stenosis|lumbar spinal stenosis
5551248|NCT01082146|pharmacokinetics, lurasidone|pharmacokinetics, lurasidone
5551249|NCT01082133|Fanconi Anemia|fanconi anemia
5551250|NCT01082120|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5551251|NCT01082120|Pioglitazone|pioglitazone
5551252|NCT01082094|Ischemic heart failure|ischemic heart failure
5551253|NCT01082094|Congestive heart failure|congestive heart failure
5551254|NCT01082094|Stromal cell-derived factor 1|stromal cell-derived factor 1
5551255|NCT01082094|SDF-1|sdf-1
5551256|NCT01082094|Gene therapy|gene therapy
5551257|NCT01082081|paracetamol|paracetamol
5551258|NCT01082081|dental pain|dental pain
5551558|NCT01081119|cigarettes|cigarettes
5551259|NCT01082081|Post-surgical dental pain|post-surgical dental pain
5551260|NCT01082068|HER2 negative|her2 negative
5551261|NCT01082068|Hormone Receptor Positive|hormone receptor positive
5551262|NCT01082068|Breast Neoplasms|breast neoplasms
5551263|NCT01082055|Cardiac|cardiac
5551264|NCT01082055|Dysrhythmia|dysrhythmia
5551265|NCT01082055|Safety|safety
5533824|NCT01151709|Gout|gout
5551266|NCT01082042|Balance, postural|balance, postural
5551267|NCT01082042|Aged, over 70|aged, over 70
5551269|NCT01082042|Accidental falls|accidental falls
5551270|NCT01082016|Sleep|sleep
5551271|NCT01082016|Critical Illness|critical illness
5551272|NCT01082016|Sleep promotion during recovery form illness|sleep promotion during recovery form illness
5551273|NCT01082003|Capsular contractures in breast cancer patients|capsular contractures in breast cancer patients
5551274|NCT01081977|Delayed cord clamping|delayed cord clamping
5551275|NCT01081977|Ferritin|ferritin
5551276|NCT01081977|Hemoglobin|hemoglobin
5551277|NCT01081977|Neonatal anemia|neonatal anemia
5551278|NCT01081977|Postpartum haemorrhage|postpartum haemorrhage
5551279|NCT01081977|Neonatal jaundice|neonatal jaundice
5551280|NCT01081964|pneumonia|pneumonia
5551281|NCT01081964|Community acquired pneumonia of moderate severity|community acquired pneumonia of moderate severity
5551282|NCT01081951|Poly(ADP ribose)|poly(adp ribose)
5551283|NCT01081951|polymerisation (PARP)|polymerisation (parp)
5551284|NCT01081951|Platinum sensitive|platinum sensitive
5551285|NCT01081951|Advanced Serous Ovarian cancer|advanced serous ovarian cancer
5551286|NCT01081951|olaparib|olaparib
5551287|NCT01081951|PARP inhibitors|parp inhibitors
5551288|NCT01081951|Platinum Sensitive Advanced Serous Ovarian Cancer|platinum sensitive advanced serous ovarian cancer
5551289|NCT01081925|Congestive Heart Failure|congestive heart failure
5551290|NCT01081925|Cardiac Failure|cardiac failure
5551291|NCT01081912|chronic pain|chronic pain
5551292|NCT01081912|back pain|back pain
5551293|NCT01081899|dying patients|dying patients
5551294|NCT01081899|cancer|cancer
5551295|NCT01081899|hospital|hospital
5551296|NCT01081899|Liverpool Care Pathways|liverpool care pathways
5551297|NCT01081886|Total knee arthroplasty|total knee arthroplasty
5551298|NCT01081886|PlasmaBlade|plasmablade
5551299|NCT01081886|Electrosurgery|electrosurgery
5551300|NCT01081886|PEAK Surgical|peak surgical
5551301|NCT01081886|Medtronic Advanced Energy|medtronic advanced energy
5551302|NCT01081886|Medtronic|medtronic
5551303|NCT01081873|Multicenter study|multicenter study
5551304|NCT01081860|Carpal tunnel syndrome|carpal tunnel syndrome
5551305|NCT01081860|CTS|cts
5551306|NCT01081860|Skinstiffness|skinstiffness
5551307|NCT01081860|Jointstiffness|jointstiffness
5551308|NCT01081847|Malaria|malaria
5551309|NCT01081847|Synthetic peptides|synthetic peptides
5551310|NCT01081847|Plasmodium vivax|plasmodium vivax
5551311|NCT01081847|Human volunteers|human volunteers
5551312|NCT01081834|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5551313|NCT01081834|Canagliflozin|canagliflozin
5551314|NCT01081834|Placebo|placebo
5551315|NCT01081834|Hemoglobin A1c|hemoglobin a1c
5551316|NCT01081834|Type 2 diabetes mellitus|type 2 diabetes mellitus
5551317|NCT01081821|JNJ 39758979|jnj 39758979
5551318|NCT01081821|Japanese descent|japanese descent
5551319|NCT01081808|PhaseI|phasei
5551320|NCT01081808|Solid Tumor|solid tumor
5551321|NCT01081808|biomarkers|biomarkers
5551322|NCT01081808|T cell|t cell
5551323|NCT01081808|Cetuximab|cetuximab
5551324|NCT01081808|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5551325|NCT01081808|Aldesleukin|aldesleukin
5551326|NCT01081808|Lymphocytes|lymphocytes
5551327|NCT01081808|Autologous|autologous
5551328|NCT01081808|Recurrent|recurrent
5551329|NCT01081808|Refractory|refractory
5551330|NCT01081808|Metastatic|metastatic
5551331|NCT01081808|Immunotherapy|immunotherapy
5551332|NCT01081808|Antibodies|antibodies
5551333|NCT01081808|Neoplasms by Site|neoplasms by site
5551334|NCT01081808|Anti-Retroviral Agents|anti-retroviral agents
5551335|NCT01081808|Therapeutic Uses|therapeutic uses
5551336|NCT01081808|Anti-Infective Agents|anti-infective agents
5551337|NCT01081808|Neoplasms by Histologic Type|neoplasms by histologic type
5551338|NCT01081808|Antineoplastic Agents|antineoplastic agents
5551339|NCT01081808|Antiviral Agents|antiviral agents
5551340|NCT01081808|Pharmacologic Actions|pharmacologic actions
5551341|NCT01081808|Carcinoma|carcinoma
5551342|NCT01081808|Neoplasms|neoplasms
5551343|NCT01081795|Topiramate|topiramate
5551344|NCT01081795|Migraine|migraine
5551345|NCT01081782|Multiple Sclerosis|multiple sclerosis
5551346|NCT01081782|ONO-4641|ono-4641
5551347|NCT01081769|Schizophrenia|schizophrenia
5551348|NCT01081769|paliperidone palmitate|paliperidone palmitate
5551349|NCT01081769|Invega|invega
5551350|NCT01081769|Intramuscular injection|intramuscular injection
5551351|NCT01081769|Oral antipsychotics|oral antipsychotics
5551352|NCT01081769|Relapse|relapse
5551353|NCT01081756|Reproductive technology; Assisted|reproductive technology; assisted
5551354|NCT01081756|recombinant human chorionic hormone (r-hCG)|recombinant human chorionic hormone (r-hcg)
5551355|NCT01081743|Alzheimer|alzheimer
5551356|NCT01081743|Dementia|dementia
5551357|NCT01081743|Mild to moderately severe|mild to moderately severe
5551358|NCT01081743|New diagnosis|new diagnosis
5551359|NCT01081743|Prevention of behavioural problems|prevention of behavioural problems
5551360|NCT01081730|psoriasis|psoriasis
5551361|NCT01081730|ustekinumab|ustekinumab
5551362|NCT01081730|anti-TNF biologics|anti-tnf biologics
5551363|NCT01081730|non-anti-TNF biologics|non-anti-tnf biologics
5551364|NCT01081730|systemic non-biological treatments|systemic non-biological treatments
5551365|NCT01081717|Rheumatoid arthritis|rheumatoid arthritis
5551366|NCT01081717|psoriatic arthritis|psoriatic arthritis
5551367|NCT01081717|ankylosing spondylitis|ankylosing spondylitis
5551368|NCT01081717|golimumab|golimumab
5551369|NCT01081717|anti-TNF biologics|anti-tnf biologics
5551370|NCT01081717|non-anti-TNF biologics|non-anti-tnf biologics
5551371|NCT01081717|non-biological treatments|non-biological treatments
5551372|NCT01081704|Healthy volunteer|healthy volunteer
5551373|NCT01081704|Chinese male|chinese male
5551374|NCT01081704|Stelara|stelara
5551375|NCT01081691|CNTO 5825|cnto 5825
5551376|NCT01081691|Safety|safety
5551377|NCT01081691|Phase I|phase i
5551378|NCT01081691|Healthy adults|healthy adults
5551379|NCT01081691|Healthy Atopic adults|healthy atopic adults
5551380|NCT01081678|AMG 785|amg 785
5551381|NCT01081678|Proximal Femur|proximal femur
5551382|NCT01081678|Fracture Healing|fracture healing
5551383|NCT01081678|Hip Fracture|hip fracture
5551384|NCT01081665|Chronic Kidney Failure|chronic kidney failure
5551385|NCT01081665|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5551386|NCT01081665|Paricalcitol IV treatment|paricalcitol iv treatment
5551387|NCT01081665|Safety and efficacy assessment|safety and efficacy assessment
5551388|NCT01081652|Fertilisation, In vitro|fertilisation, in vitro
5551389|NCT01081652|Embryo transfer|embryo transfer
5551390|NCT01081652|progesterone|progesterone
5551391|NCT01081652|Reproductive technologies, Assisted|reproductive technologies, assisted
5551392|NCT01081639|Follitropin alfa|follitropin alfa
5551393|NCT01081639|Follitropin beta|follitropin beta
5551394|NCT01081639|Fertilization, in vitro|fertilization, in vitro
5551395|NCT01081639|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5551396|NCT01081639|Assisted reproductive techniques|assisted reproductive techniques
5551397|NCT01081639|Polycystic ovary syndrome|polycystic ovary syndrome
5551398|NCT01081626|Infertility|infertility
5551399|NCT01081626|Ovulation induction|ovulation induction
5551400|NCT01081626|Gonal-f|gonal-f
5551401|NCT01081626|Follitropin alpha|follitropin alpha
5551402|NCT01081626|Polycystic ovarian syndrome|polycystic ovarian syndrome
5551403|NCT01081626|Anovulatory infertility|anovulatory infertility
5551404|NCT01081613|heat shock protein|heat shock protein
5551405|NCT01081613|breast cancer|breast cancer
5551406|NCT01081613|PET imaging|pet imaging
5551407|NCT01081613|bevacizumab|bevacizumab
5551408|NCT01081600|Heat shock protein|heat shock protein
5551409|NCT01081600|breast cancer|breast cancer
5551410|NCT01081600|PET imaging|pet imaging
5551411|NCT01081600|trastuzumab|trastuzumab
5551412|NCT01081587|Non MeSH terms:|non mesh terms:
5551413|NCT01081587|Children|children
5551414|NCT01081587|Malnutrition|malnutrition
5551415|NCT01081587|Computer Clinical Decision Support System|computer clinical decision support system
5551416|NCT01081587|Cluster randomized trial|cluster randomized trial
5551417|NCT01081587|Healthcare workers|healthcare workers
5551418|NCT01081587|Guideline adherence|guideline adherence
5551419|NCT01081587|Patient safety|patient safety
5551420|NCT01081587|MeSH terms:|mesh terms:
5551421|NCT01081587|Nutrition Surveys|nutrition surveys
5551422|NCT01081587|Secondary Prevention|secondary prevention
5551423|NCT01081587|Pediatrics|pediatrics
5551424|NCT01081587|Child Care|child care
5551425|NCT01081587|Health Personnel|health personnel
5551426|NCT01081587|Reminder Systems|reminder systems
5551427|NCT01081587|Intervention Studies|intervention studies
5551428|NCT01081587|Quality of Health Care|quality of health care
5551429|NCT01081574|Allergic Rhinitis|allergic rhinitis
5551430|NCT01081574|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5551431|NCT01081574|Perennial Allergic Rhinitis|perennial allergic rhinitis
5551432|NCT01081574|Urticaria|urticaria
5551433|NCT01081574|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5551435|NCT01081574|Sneezing|sneezing
5551436|NCT01081574|Nasal Itching|nasal itching
5551437|NCT01081574|Rhinorrhea|rhinorrhea
5551438|NCT01081574|Nasal Congestion|nasal congestion
5551439|NCT01081574|Wheals|wheals
5551440|NCT01081574|Hives|hives
5551441|NCT01081574|Skin itching|skin itching
5551442|NCT01081574|Flare|flare
5551443|NCT01081574|Erythema|erythema
5685545|NCT00555659|Stenosis|stenosis
5551444|NCT01081535|Pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy|pediatric patients (6 months-5 years) scheduled elective ureteroneocystostomy
5551445|NCT01081509|adherence|adherence
5551446|NCT01081509|early breast cancer|early breast cancer
5551447|NCT01081509|Arimidex|arimidex
5551448|NCT01081509|Therapy adherence|therapy adherence
5551449|NCT01081496|EGFR mutation, Non-small cell lung carcinoma, Spain|egfr mutation, non-small cell lung carcinoma, spain
5551577|NCT01081002|Propofol|propofol
5551450|NCT01081496|Evaluate the prevalence of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC|evaluate the prevalence of egfr mutation status in patients with newly diagnosed locally advanced or metastatic nsclc
5551451|NCT01081483|Healthy Volunteers|healthy volunteers
5551452|NCT01081483|HCV Infections|hcv infections
5551453|NCT01081457|Parkinson's disease|parkinson's disease
5551454|NCT01081457|deep brain stimulation|deep brain stimulation
5551455|NCT01081457|GI motility|gi motility
5790025|NCT00146094|Osteopenia|osteopenia
5551456|NCT01081444|repetitive transcranial stimulation|repetitive transcranial stimulation
5551457|NCT01081431|Myelodysplastic Syndromes|myelodysplastic syndromes
5551459|NCT01081431|deletion 5q|deletion 5q
5551462|NCT01081431|low risk|low risk
5551463|NCT01081431|intermediate-1 risk|intermediate-1 risk
5551464|NCT01081431|GMIHO|gmiho
5551465|NCT01081431|ClinAssess|clinassess
5551466|NCT01081431|Germing|germing
5551467|NCT01081431|Düsseldorf|düsseldorf
5551468|NCT01081431|MDS-LE-MON-5|mds-le-mon-5
5551469|NCT01081431|Lenalidomide|lenalidomide
5551470|NCT01081431|Revlimid|revlimid
5551471|NCT01081418|Schizophrenia, assertive community treatment, quetiapine|schizophrenia, assertive community treatment, quetiapine
5551472|NCT01081405|ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION|allogeneic hematopoietic cell transplantation
5551473|NCT01081405|TOTAL LYMPHOID IRRADIATION|total lymphoid irradiation
5551474|NCT01081405|ANTI-THYMOCYTE GLOBULIN|anti-thymocyte globulin
5551475|NCT01081392|LPS|lps
5551476|NCT01081392|endotoxin|endotoxin
5551477|NCT01081392|inflammatory markers|inflammatory markers
5551478|NCT01081392|healthy volunteers|healthy volunteers
5551479|NCT01081392|neutrophils in sputum|neutrophils in sputum
5551480|NCT01081379|Cytomegalovirus Infections|cytomegalovirus infections
5551481|NCT01081379|Pregnancy|pregnancy
5551482|NCT01081379|T-Lymphocytes|t-lymphocytes
5551483|NCT01081379|Transmission|transmission
5551484|NCT01081353|Aspirin|aspirin
5551485|NCT01081353|Acetylsalicylic Acid|acetylsalicylic acid
5551486|NCT01081340|gestational weight gain|gestational weight gain
5551487|NCT01081340|postpartum weight loss|postpartum weight loss
5551488|NCT01081340|breastfeeding|breastfeeding
5551489|NCT01081340|overfeeding|overfeeding
5551490|NCT01081327|Atrial Fibrillation|atrial fibrillation
5551491|NCT01081327|Warfarin|warfarin
5551492|NCT01081327|Safety|safety
5551493|NCT01081301|hope|hope
5551494|NCT01081301|quality of life|quality of life
5551495|NCT01081301|caregivers|caregivers
5551496|NCT01081288|Breast cancer|breast cancer
5551497|NCT01081288|Breast screening|breast screening
5551498|NCT01081288|Mammography|mammography
5551499|NCT01081288|Routine screening programme|routine screening programme
5551500|NCT01081275|Multiple Sclerosis|multiple sclerosis
5551501|NCT01081275|MS|ms
5551502|NCT01081275|CI Therapy|ci therapy
5551503|NCT01081275|CIMT|cimt
5551504|NCT01081275|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5551505|NCT01081275|Complementary and Alternative Medicine|complementary and alternative medicine
5551507|NCT01081275|Physical Therapy|physical therapy
5551508|NCT01081275|Occupational Therapy|occupational therapy
5551509|NCT01081275|Relaxation|relaxation
5551510|NCT01081275|Exercise|exercise
5551511|NCT01081275|Massage|massage
5551512|NCT01081275|Yoga|yoga
5551513|NCT01081275|Pool Therapy|pool therapy
5551514|NCT01081275|Aquatherapy|aquatherapy
5551515|NCT01081275|Aquatic Therapy|aquatic therapy
5551516|NCT01081249|psychotherapy|psychotherapy
5551517|NCT01081236|liver cirrhosis|liver cirrhosis
5551518|NCT01081236|intestinal permeability|intestinal permeability
5551519|NCT01081236|microbiota|microbiota
5551520|NCT01081236|complications|complications
5551521|NCT01081223|Brain Neoplasms|brain neoplasms
5551522|NCT01081223|Central Nervous System Neoplasms|central nervous system neoplasms
5551523|NCT01081223|Brain Diseases|brain diseases
5551524|NCT01081223|Neoplasms|neoplasms
5551525|NCT01081223|Nervous System Neoplasms|nervous system neoplasms
5551526|NCT01081223|Glioblastoma|glioblastoma
5551527|NCT01081223|Astrocytoma|astrocytoma
5551528|NCT01081223|Nervous System Diseases|nervous system diseases
5551529|NCT01081223|Central Nervous System Diseases|central nervous system diseases
5551530|NCT01081223|Glioma|glioma
5551531|NCT01081223|Recurrent astrocytoma|recurrent astrocytoma
5551532|NCT01081223|Recurrent glioma|recurrent glioma
5551533|NCT01081223|Cancer vaccine|cancer vaccine
5551534|NCT01081223|Immunotherapy|immunotherapy
5551535|NCT01081223|Killer T cells|killer t cells
5551536|NCT01081223|Activated T cells|activated t cells
5551537|NCT01081223|GM-CSF|gm-csf
5551538|NCT01081223|Low dose IL-2|low dose il-2
5551539|NCT01081223|Activated lymphocytes|activated lymphocytes
5551540|NCT01081210|Echocardiography|echocardiography
5551541|NCT01081210|Heart failure|heart failure
5551542|NCT01081210|Kidney|kidney
5551543|NCT01081210|Lung|lung
5551544|NCT01081210|Aorta|aorta
5551545|NCT01081197|heart failure|heart failure
5551546|NCT01081197|liver|liver
5551547|NCT01081197|depression|depression
5551548|NCT01081197|neuropathy|neuropathy
5551549|NCT01081184|primary Sjögren syndrome|primary sjögren syndrome
5551550|NCT01081184|neurotrophins|neurotrophins
5551551|NCT01081184|B cell|b cell
5551552|NCT01081184|sicca syndrome|sicca syndrome
5551553|NCT01081184|T cell|t cell
5551554|NCT01081119|adolescent|adolescent
5551555|NCT01081119|middle school|middle school
5551559|NCT01081119|marijuana|marijuana
5551560|NCT01081106|Breast Cancer|breast cancer
5551561|NCT01081093|Hypertrophic Cardiomyopathy Diastolic Ventricular Interaction|hypertrophic cardiomyopathy diastolic ventricular interaction
5551562|NCT01081093|Biventricular Pacemaker cardiac surgery aortic valve replacement|biventricular pacemaker cardiac surgery aortic valve replacement
5551563|NCT01081080|cardiac|cardiac
5551564|NCT01081080|muscle|muscle
5551565|NCT01081080|pediatric|pediatric
5551566|NCT01081080|dystrophy|dystrophy
5551567|NCT01081054|Diverticulitis|diverticulitis
5551568|NCT01081054|Not complicated diverticulitis|not complicated diverticulitis
5551569|NCT01081028|Multiple Myeloma|multiple myeloma
5551571|NCT01081028|disease registry|disease registry
5551572|NCT01081028|Connect®|connect®
5551573|NCT01081015|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5551574|NCT01081015|CLL|cll
5551575|NCT01081015|disease registry|disease registry
5551576|NCT01081015|Connect™|connect™
5551578|NCT01081002|Conscious sedation|conscious sedation
5551579|NCT01081002|Topical pharyngeal anesthesia|topical pharyngeal anesthesia
5551580|NCT01081002|Anesthetics, Local|anesthetics, local
5551581|NCT01081002|Gastrointestinal Endoscopy|gastrointestinal endoscopy
5551582|NCT01080989|solomon islands|solomon islands
5551583|NCT01080989|malaria|malaria
5551584|NCT01080989|flavivirus|flavivirus
5551585|NCT01080989|alphavirus|alphavirus
5551586|NCT01080989|parasite|parasite
5551587|NCT01080989|leptospirosis|leptospirosis
5551588|NCT01080963|Prophylaxis|prophylaxis
5551589|NCT01080963|Antibiotic|antibiotic
5551590|NCT01080963|Sternotomy|sternotomy
5551591|NCT01080963|Heart-Lung Machine|heart-lung machine
5551592|NCT01080950|zinc|zinc
5551593|NCT01080950|sepsis|sepsis
5551594|NCT01080950|fever|fever
5551595|NCT01080950|vitamin d|vitamin d
5551596|NCT01080937|acute heart failure|acute heart failure
5551597|NCT01080911|Spinal morphine|spinal morphine
5551598|NCT01080911|Vaginal hysterectomy|vaginal hysterectomy
5551599|NCT01080898|Age - Related Macular Degeneration|age - related macular degeneration
5551600|NCT01080898|Optical Coherence Tomography|optical coherence tomography
5551601|NCT01080898|Choroidal neovascularization|choroidal neovascularization
5551602|NCT01080898|FLORESCEIN Angiography|florescein angiography
5551603|NCT01080898|Fundus photographs|fundus photographs
5551604|NCT01080885|Prevention|prevention
5551605|NCT01080885|Prevention of unhealthy weight gain|prevention of unhealthy weight gain
5551606|NCT01080872|acute coronary syndrome|acute coronary syndrome
5551607|NCT01080872|coronary flow reserve|coronary flow reserve
5551608|NCT01080872|OCT|oct
5551609|NCT01080872|healing|healing
5551610|NCT01080872|drug eluting stent|drug eluting stent
5551611|NCT01080859|titanium|titanium
5551612|NCT01080859|everolimus|everolimus
5551613|NCT01080859|oct|oct
5551614|NCT01080859|acute coronary syndrome|acute coronary syndrome
5551615|NCT01080859|stent|stent
5551616|NCT01080859|pci|pci
5551617|NCT01080859|stenting|stenting
5551618|NCT01080846|Primary postpartum hemorrhage|primary postpartum hemorrhage
5551619|NCT01080846|PPH|pph
5551620|NCT01080846|uterine atony|uterine atony
5551621|NCT01080846|high fever|high fever
5551622|NCT01080846|hyperpyrexia|hyperpyrexia
5551625|NCT01080833|Training|training
5551626|NCT01080833|Trainees|trainees
5551627|NCT01080820|Healthy adult volunteers|healthy adult volunteers
5551628|NCT01080820|Pharmacokinetics|pharmacokinetics
5551629|NCT01080794|Parkinson's Disease|parkinson's disease
5551630|NCT01080794|Depression|depression
5551631|NCT01080794|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5551632|NCT01080781|Cardiomyopathy|cardiomyopathy
5551633|NCT01080781|Ephrin-B1 expression|ephrin-b1 expression
5551634|NCT01080781|cell-cell junctions|cell-cell junctions
5551635|NCT01080781|heart rate variability|heart rate variability
5551636|NCT01080781|right appendage|right appendage
5551637|NCT01080768|Pedal edema|pedal edema
5551638|NCT01080768|hypertension|hypertension
5551639|NCT01080768|aliskiren|aliskiren
5551640|NCT01080768|amlodipine|amlodipine
5551641|NCT01080755|Adult Growth Hormone Deficiency|adult growth hormone deficiency
5551642|NCT01080755|Pituitary|pituitary
5551643|NCT01080755|Saizen|saizen
5551644|NCT01080755|Somatropin|somatropin
5551645|NCT01080755|Growth Hormone|growth hormone
5551646|NCT01080742|Hypertension|hypertension
5551647|NCT01080742|Lodoz|lodoz
5551648|NCT01080742|Bisoprolol|bisoprolol
5551649|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide
5551650|NCT01080729|Ovulation induction|ovulation induction
5551651|NCT01080729|Ovarian Hyperstimulation Syndrome|ovarian hyperstimulation syndrome
5551652|NCT01080729|Multifollicular stimulation|multifollicular stimulation
5551653|NCT01080729|Pregnancy|pregnancy
5551654|NCT01080729|Sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5551655|NCT01080729|Fertility|fertility
5551656|NCT01080703|Lung Transplant|lung transplant
5551657|NCT01080703|Quadriceps Strength|quadriceps strength
5551658|NCT01080703|Quality of Life|quality of life
5551659|NCT01080703|Patients with pulmonary disease awaiting lung transplant.|patients with pulmonary disease awaiting lung transplant.
5551751|NCT01080157|Diabetes Screening|diabetes screening
5551663|NCT01080664|Aurora Kinase Inhibitor|aurora kinase inhibitor
5551664|NCT01080664|Haematological malignancies|haematological malignancies
5551665|NCT01080638|abciximab|abciximab
5551666|NCT01080638|Myocardial Infarction|myocardial infarction
5551667|NCT01080638|angioplasty|angioplasty
5551668|NCT01080638|Platelet|platelet
5551669|NCT01080625|postreperfusion syndrome|postreperfusion syndrome
5551670|NCT01080625|phenylephrine|phenylephrine
5551672|NCT01080625|liver transplantation|liver transplantation
5551673|NCT01080612|pregabalin|pregabalin
5551674|NCT01080612|pharmacokinetics|pharmacokinetics
5551675|NCT01080612|bioavailability|bioavailability
5551676|NCT01080599|obturator nerve block in TURB|obturator nerve block in turb
5551677|NCT01080586|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551678|NCT01080573|Multiple sclerosis|multiple sclerosis
5551679|NCT01080573|Rebif|rebif
5551680|NCT01080573|Interferon beta-1a|interferon beta-1a
5551681|NCT01080560|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551682|NCT01080534|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551683|NCT01080508|pressure pattern|pressure pattern
5551684|NCT01080508|esophageal and tracheal ventilation.|esophageal and tracheal ventilation.
5551685|NCT01080508|esophageal intubation.|esophageal intubation.
5551686|NCT01080495|left ventricular function|left ventricular function
5551687|NCT01080495|radial strain|radial strain
5551688|NCT01080495|fractional shortening|fractional shortening
5551689|NCT01080495|fractional area change|fractional area change
5551690|NCT01080482|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551691|NCT01080469|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551692|NCT01080456|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551693|NCT01080443|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551694|NCT01080430|vestibular|vestibular
5551695|NCT01080430|vertigo|vertigo
5551696|NCT01080430|rehabilitation|rehabilitation
5551697|NCT01080430|rotation|rotation
5551698|NCT01080430|balance|balance
5551699|NCT01080417|Bioequivalence study in healthy volunteers|bioequivalence study in healthy volunteers
5551705|NCT01080391|Multiple Myeloma|multiple myeloma
5551706|NCT01080352|Prostate cancer|prostate cancer
5551707|NCT01080352|palliative care|palliative care
5551708|NCT01080352|antioxidants|antioxidants
5551709|NCT01080352|ascorbic acid|ascorbic acid
5551710|NCT01080352|rna expression|rna expression
5551711|NCT01080339|insulin resistance|insulin resistance
5551712|NCT01080339|cardiovascular risk|cardiovascular risk
5551713|NCT01080339|physical activity|physical activity
5551714|NCT01080339|child|child
5551715|NCT01080326|ulcer repair surgery|ulcer repair surgery
5551716|NCT01080326|transluminal omental patch|transluminal omental patch
5551717|NCT01080300|Hot Flushes|hot flushes
5551718|NCT01080300|Vasomotor Symptoms|vasomotor symptoms
5551719|NCT01080300|Menopausal Hot Flashes|menopausal hot flashes
5551720|NCT01080287|autonomic|autonomic
5551721|NCT01080287|orthostatic|orthostatic
5536835|NCT01139281|Ginkgo Biloba Extract|ginkgo biloba extract
5551722|NCT01080287|syncope|syncope
5551723|NCT01080287|biopsy|biopsy
5551724|NCT01080287|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance|prevalence of autonomic dysfunction in migraineurs with orthostatic intolerance
5551725|NCT01080287|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis|characterize autonomic findings utilizing neurocardiac testing, neurophysiological testing and skin biopsies to analyze autonomic fibers in the dermis
5551727|NCT01080274|vitamin d|vitamin d
5551728|NCT01080274|zinc|zinc
5551729|NCT01080261|Atherosclerosis|atherosclerosis
5551730|NCT01080261|Coronary Artery Disease|coronary artery disease
5551731|NCT01080248|Pancreas|pancreas
5551732|NCT01080235|quality improvement|quality improvement
5551733|NCT01080235|geriatric care|geriatric care
5551734|NCT01080235|residency training|residency training
5551735|NCT01080222|VX-950|vx-950
5551736|NCT01080196|Falling risk|falling risk
5551737|NCT01080196|muscle conditioning|muscle conditioning
5551738|NCT01080196|muscle size|muscle size
5551739|NCT01080196|isometric strength|isometric strength
5551740|NCT01080196|Incidence in falls|incidence in falls
5551741|NCT01080183|Health-related quality of life|health-related quality of life
5551742|NCT01080183|physical activity|physical activity
5551743|NCT01080170|Aromatase Inhibitor|aromatase inhibitor
5551744|NCT01080170|Anastrazole|anastrazole
5551745|NCT01080170|Arimidex|arimidex
5551746|NCT01080170|Heart disease|heart disease
5551747|NCT01080170|Lipids|lipids
5551748|NCT01080170|Body composition|body composition
5551749|NCT01080170|Breast cancer.|breast cancer.
5551752|NCT01080157|Experimental Medical Device|experimental medical device
5551753|NCT01080144|Cirrhosis|cirrhosis
5551754|NCT01080144|TIPS (Transjugular intrahepatic portosystemic shunt)|tips (transjugular intrahepatic portosystemic shunt)
5551755|NCT01080144|Encephalopathy|encephalopathy
5551756|NCT01080131|Frequent flares|frequent flares
5551757|NCT01080131|Gout|gout
5551758|NCT01080131|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5551759|NCT01080118|Teaching|teaching
5551760|NCT01080118|Video Scope|video scope
5551761|NCT01080118|Intubation|intubation
5551762|NCT01080105|Depression Prevention|depression prevention
5551763|NCT01080105|Prevention|prevention
5551764|NCT01080105|Major Depressive Disorder|major depressive disorder
5551765|NCT01080105|Internet|internet
5551766|NCT01080105|Technology Assisted|technology assisted
5551767|NCT01080092|smokers|smokers
5551768|NCT01080079|Onychomycosis|onychomycosis
5534357|NCT01149603|VAD|vad
5551769|NCT01080066|Carcinoma|carcinoma
5551770|NCT01080066|Squamous cell|squamous cell
5551771|NCT01080066|Erbitux|erbitux
5551772|NCT01080066|cetuximab|cetuximab
5551773|NCT01080066|Head|head
5551774|NCT01080066|Neck|neck
5551775|NCT01080053|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
5551776|NCT01080053|Sexual dysfunction|sexual dysfunction
5551777|NCT01080040|Multiple Sclerosis, Relapsing Remitting|multiple sclerosis, relapsing remitting
5551778|NCT01080040|Quality of life|quality of life
5551779|NCT01080027|Multiple sclerosis|multiple sclerosis
5551780|NCT01080027|Relapsing remitting|relapsing remitting
5551781|NCT01080027|Rebif|rebif
5551782|NCT01080014|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5551783|NCT01080014|primary progressive multiple sclerosis (PPMS)|primary progressive multiple sclerosis (ppms)
5551784|NCT01080014|secondary progressive multiple sclerosis (SPMS)|secondary progressive multiple sclerosis (spms)
5551785|NCT01080014|Multiple Sclerosis Functional Composite (MSFC)|multiple sclerosis functional composite (msfc)
5551786|NCT01080014|Expanded Disability Status Scale (EDSS)|expanded disability status scale (edss)
5551787|NCT01080001|Multiple sclerosis|multiple sclerosis
5551788|NCT01080001|Multiple sclerosis, Relapsing-remitting|multiple sclerosis, relapsing-remitting
5551789|NCT01080001|Expanded Disability Status Scale|expanded disability status scale
5551790|NCT01080001|Fatigue|fatigue
5551791|NCT01080001|Hamilton Depression Inventory|hamilton depression inventory
5551792|NCT01080001|Depression|depression
5551793|NCT01079988|Psoriasis|psoriasis
5551794|NCT01079988|Discontinuation of efalizumab|discontinuation of efalizumab
5551795|NCT01079988|Managing inflammatory recurrence|managing inflammatory recurrence
5551796|NCT01079975|Multiple sclerosis|multiple sclerosis
5551797|NCT01079975|Depression|depression
5551798|NCT01079962|Bisoprolol|bisoprolol
5551799|NCT01079962|Atenolol|atenolol
5551800|NCT01079962|Hypertension|hypertension
5551801|NCT01079962|Blood pressure|blood pressure
5551802|NCT01079949|Infertility|infertility
5551803|NCT01079949|Ovulation induction|ovulation induction
5551804|NCT01079949|Luveris|luveris
5551805|NCT01079949|Lutropin alfa|lutropin alfa
5551806|NCT01079949|Controlled ovarian stimulation|controlled ovarian stimulation
5551807|NCT01079949|Reproductive technologies, Assisted|reproductive technologies, assisted
5551808|NCT01079936|Multiple Myeloma|multiple myeloma
5551809|NCT01079936|Lenalidomide|lenalidomide
5551810|NCT01079936|Revlimid|revlimid
5551811|NCT01079936|Melphalan|melphalan
5551812|NCT01079936|Alkeran|alkeran
5551813|NCT01079936|Autologous stem cell transplantation|autologous stem cell transplantation
5551814|NCT01079936|High-dose chemotherapy|high-dose chemotherapy
5551815|NCT01079923|healthy volunteers|healthy volunteers
5551817|NCT01079923|vitamin D|vitamin d
5551818|NCT01079923|cholecalciferol|cholecalciferol
5551819|NCT01079923|vitamin D3|vitamin d3
5551820|NCT01079923|total vitamin D|total vitamin d
5551821|NCT01079910|Plaque|plaque
5551822|NCT01079910|Toothpaste|toothpaste
5551823|NCT01079910|Gingivitis|gingivitis
5551824|NCT01079897|Atopic dermatitis|atopic dermatitis
5551825|NCT01079897|Ectoine|ectoine
5551826|NCT01079897|Treatment|treatment
5551827|NCT01079897|Atopiclair|atopiclair
5551828|NCT01079897|Medical device|medical device
5551829|NCT01079871|Sjogren's Syndrome|sjogren's syndrome
5551830|NCT01079871|Dry Eye|dry eye
5551831|NCT01079858|Meibomian Gland Dysfunction|meibomian gland dysfunction
5551832|NCT01079858|Dry Eye|dry eye
5551833|NCT01079845|Diet|diet
5551834|NCT01079845|Nutrition|nutrition
5551835|NCT01079845|Adolescent|adolescent
5551836|NCT01079845|Young Adult|young adult
5551837|NCT01079845|Overweight|overweight
5551838|NCT01079845|Obesity|obesity
5551839|NCT01079793|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5551840|NCT01079793|stage III prostate cancer|stage iii prostate cancer
5551841|NCT01079780|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5551842|NCT01079780|recurrent colon cancer|recurrent colon cancer
5551843|NCT01079780|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
5551844|NCT01079780|stage III colon cancer|stage iii colon cancer
5551845|NCT01079780|stage IV colon cancer|stage iv colon cancer
5551846|NCT01079780|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5551847|NCT01079780|recurrent rectal cancer|recurrent rectal cancer
5551848|NCT01079780|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
5551849|NCT01079780|stage III rectal cancer|stage iii rectal cancer
5551850|NCT01079780|stage IV rectal cancer|stage iv rectal cancer
5551851|NCT01079767|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5551852|NCT01079767|advanced adult primary liver cancer|advanced adult primary liver cancer
5551853|NCT01079767|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5551854|NCT01079767|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5551855|NCT01079754|Spinal morphine 0.05 mg|spinal morphine 0.05 mg
5551856|NCT01079754|Spinal morphine|spinal morphine
5551857|NCT01079741|Melanoma|melanoma
5551858|NCT01079741|Skin Cancer|skin cancer
5551859|NCT01079741|Adjuvant Therapy|adjuvant therapy
5551860|NCT01079741|Oncogenesis|oncogenesis
5551861|NCT01079741|LAGE|lage
5551862|NCT01079741|Cancer Immunity|cancer immunity
5551863|NCT01079741|Neoplasms|neoplasms
5551864|NCT01079741|Immunogenicity|immunogenicity
5551865|NCT01079741|Vaccine|vaccine
5551866|NCT01079741|Immunotherapy|immunotherapy
5551867|NCT01079728|ischemic stroke|ischemic stroke
5551868|NCT01079728|stroke-associated pneumonia|stroke-associated pneumonia
5551869|NCT01079728|prediction|prediction
5551870|NCT01079728|immune and infection parameters|immune and infection parameters
5551871|NCT01079715|Newborn|newborn
5551872|NCT01079715|Retinal Diseases|retinal diseases
5551873|NCT01079715|Angiogenesis Modulating Agents|angiogenesis modulating agents
5551874|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5551875|NCT01079689|basic science|basic science
5551876|NCT01079689|healthy volunteers|healthy volunteers
5551877|NCT01079650|children|children
5551878|NCT01079637|Sella and Barrete Stage 0 1 or 2|sella and barrete stage 0 1 or 2
5551879|NCT01079624|Incretin hormones|incretin hormones
5551880|NCT01079624|Glucose-insulinotropic peptide|glucose-insulinotropic peptide
5551881|NCT01079624|Glucagon-like peptide-1|glucagon-like peptide-1
5551882|NCT01079624|Gastric emptying|gastric emptying
5551883|NCT01079624|Appetite|appetite
5551884|NCT01079624|Glucose disposal|glucose disposal
5551885|NCT01079624|Gut hormones|gut hormones
5551887|NCT01079598|RadioFrequency|radiofrequency
5551888|NCT01079598|QOL|qol
5551889|NCT01079572|osteoarthritis|osteoarthritis
5551890|NCT01079572|arthroplasty|arthroplasty
5551891|NCT01079572|web-based|web-based
5551892|NCT01079572|electronic follow-up|electronic follow-up
5551893|NCT01079559|total knee arthroplasty|total knee arthroplasty
5551894|NCT01079559|infection|infection
5551895|NCT01079559|antibiotic bone cement|antibiotic bone cement
5551896|NCT01079546|HPV, Israel, Squamous cell carcinoma of head and neck|hpv, israel, squamous cell carcinoma of head and neck
5551897|NCT01079533|Colorectal Neoplasms|colorectal neoplasms
5551898|NCT01079533|Mass Screening|mass screening
5551899|NCT01079533|Patient Compliance|patient compliance
5551900|NCT01079533|Intervention Studies|intervention studies
5551901|NCT01079533|Clinical Trial|clinical trial
5551902|NCT01079520|Cancer|cancer
5551903|NCT01079520|Lung Cancer|lung cancer
5551904|NCT01079520|Ultrasound|ultrasound
5551905|NCT01079520|Surgery|surgery
5551906|NCT01079507|single nucleotide polymorphism|single nucleotide polymorphism
5551907|NCT01079507|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5537025|NCT01138423|Obesity|obesity
5551908|NCT01079494|Uncontrolled blood pressure|uncontrolled blood pressure
5551909|NCT01079481|Relapsed or Refractory Small Cell Lung Cancer|relapsed or refractory small cell lung cancer
5551910|NCT01079481|Paclitaxel|paclitaxel
5551911|NCT01079481|Everolimus|everolimus
5551912|NCT01079468|Transient cognitive decline following orthopaedic surgery|transient cognitive decline following orthopaedic surgery
5551913|NCT01079455|Coxarthrosis|coxarthrosis
5551914|NCT01079455|Hip|hip
5551915|NCT01079455|Infiltration|infiltration
5551916|NCT01079455|Hyaluronic Acid|hyaluronic acid
5551917|NCT01079455|Corticosterone|corticosterone
5551918|NCT01079442|postoperative ileus after colonic resections|postoperative ileus after colonic resections
5551919|NCT01079429|Monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5551920|NCT01079429|MGUS|mgus
5551921|NCT01079429|Smoldering myeloma|smoldering myeloma
5551922|NCT01079429|SMM|smm
5551923|NCT01079429|Multiple myeloma|multiple myeloma
5551924|NCT01079416|Esophageal Capsule Endoscopy, Screening|esophageal capsule endoscopy, screening
5551925|NCT01079390|acupuncture|acupuncture
5551926|NCT01079390|osteoarthritis|osteoarthritis
5551927|NCT01079390|fMRI|fmri
5551928|NCT01079377|Adolescents|adolescents
5551929|NCT01079377|Bariatric Surgery|bariatric surgery
5551930|NCT01079377|Psychological Symptoms|psychological symptoms
5551931|NCT01079377|Cognitive Behavioral Therapy|cognitive behavioral therapy
5551932|NCT01079377|Telemedicine|telemedicine
5551933|NCT01079377|Longitudinal|longitudinal
5551934|NCT01079351|Epilepsy|epilepsy
5551935|NCT01079351|Intravenous Carbamazepine|intravenous carbamazepine
5551936|NCT01079351|Oral Carbamazepine|oral carbamazepine
5551937|NCT01079338|sensitivity to caffeine|sensitivity to caffeine
5551938|NCT01079325|Diabetic neuropathy|diabetic neuropathy
5551939|NCT01079325|Diabetes Type 1 or 2|diabetes type 1 or 2
5551940|NCT01079325|Moderately severe sensorimotor diabetic polyneuropathy|moderately severe sensorimotor diabetic polyneuropathy
5551941|NCT01079312|ERCP|ercp
5551942|NCT01079312|patient-controlled sedation|patient-controlled sedation
5551943|NCT01079312|propofol|propofol
5551944|NCT01079312|remifentanil|remifentanil
5551945|NCT01079312|sedation level|sedation level
5551946|NCT01079299|venous ulcer|venous ulcer
5551947|NCT01079299|secondary lymphedema|secondary lymphedema
5551948|NCT01079299|chronic lower leg ulceration|chronic lower leg ulceration
5551949|NCT01079286|mTOR inhibition|mtor inhibition
5551950|NCT01079286|advanced malignancies|advanced malignancies
5551951|NCT01079286|pharmacokinetics|pharmacokinetics
5551952|NCT01079286|Akt inhibition|akt inhibition
5551953|NCT01079286|Advanced malignancies, including metastatic renal cell cancer|advanced malignancies, including metastatic renal cell cancer
5551954|NCT01079273|Influenza|influenza
5551955|NCT01079273|Vaccines|vaccines
5551956|NCT01079273|A/H1N1|a/h1n1
5551957|NCT01079273|Influenza Vaccines|influenza vaccines
5551958|NCT01079260|Malnourished|malnourished
5551959|NCT01079260|Elderly|elderly
5551960|NCT01079260|Nutrition support|nutrition support
5551961|NCT01079247|Burn|burn
5551962|NCT01079247|Transfusion|transfusion
5551963|NCT01079247|blood|blood
5551964|NCT01079247|hemoglobin|hemoglobin
5551965|NCT01079221|exercise|exercise
5551966|NCT01079221|Knee extensor|knee extensor
5551967|NCT01079208|infant formula, synbiotics, probiotics, nutrition|infant formula, synbiotics, probiotics, nutrition
5551968|NCT01079195|Effectiveness and tolerability of Tarka|effectiveness and tolerability of tarka
5551969|NCT01079195|Hypertensive patients|hypertensive patients
5551970|NCT01079195|Diabetes mellitus|diabetes mellitus
5551971|NCT01079195|Observational study|observational study
5551972|NCT01079182|Daily practice|daily practice
5551973|NCT01079182|Humira|humira
5551974|NCT01079182|Efficacy|efficacy
5551975|NCT01079182|Safety|safety
5551976|NCT01079182|Ankylosing spondylitis|ankylosing spondylitis
5551977|NCT01079169|urinary tract infection|urinary tract infection
5551978|NCT01079169|prevention|prevention
5551979|NCT01079169|rehabilitation|rehabilitation
5551980|NCT01079169|spinal cord injury|spinal cord injury
5551981|NCT01079143|De Novo renal transplantation|de novo renal transplantation
5551982|NCT01079130|Indacaterol|indacaterol
5551983|NCT01079130|asthma|asthma
5551984|NCT01079130|salmeterol|salmeterol
5551985|NCT01079117|Opiate|opiate
5551986|NCT01079117|Methadone|methadone
5551987|NCT01079117|Slow Release Oral Morphine (SORM)|slow release oral morphine (sorm)
5551988|NCT01079117|Sevre-Long™|sevre-long™
5551989|NCT01079104|Liver failure|liver failure
5551990|NCT01079104|Hepatic insufficiency|hepatic insufficiency
5551991|NCT01079104|Artificial liver|artificial liver
5551992|NCT01079104|Albumin dialysis|albumin dialysis
5551993|NCT01079091|Liver failure|liver failure
5551994|NCT01079091|Hepatic insufficiency|hepatic insufficiency
5551995|NCT01079091|Liver Cirrhosis|liver cirrhosis
5551996|NCT01079091|Artificial liver|artificial liver
5551997|NCT01079091|Albumin dialysis|albumin dialysis
5551998|NCT01079078|Acetaminophen fed study|acetaminophen fed study
5551999|NCT01079065|Famotidine tablets fasting study|famotidine tablets fasting study
5552000|NCT01079052|Famotidine tablets fed study|famotidine tablets fed study
5552001|NCT01079026|biomarker|biomarker
5552002|NCT01079026|epidural steroid|epidural steroid
5552003|NCT01079026|radiculopathy|radiculopathy
5552005|NCT01079000|asthma|asthma
5552006|NCT01079000|exacerbation|exacerbation
5552007|NCT01079000|emergency department|emergency department
5552008|NCT01079000|relapse|relapse
5552009|NCT01078987|Nephrogenic Fibrosing Dermopathy (NFD)|nephrogenic fibrosing dermopathy (nfd)
5552010|NCT01078987|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
5552011|NCT01078974|WM|wm
5552012|NCT01078974|pomalidomide|pomalidomide
5552013|NCT01078974|dexamethasone|dexamethasone
5552014|NCT01078974|rituximab|rituximab
5552015|NCT01078961|bortezomib|bortezomib
5552016|NCT01078961|sorafenib|sorafenib
5552017|NCT01078961|advanced melanoma|advanced melanoma
5552018|NCT01078948|tDCS|tdcs
5552019|NCT01078948|transcranial direct current stimulation|transcranial direct current stimulation
5552020|NCT01078948|major depression|major depression
5552021|NCT01078948|double-blind|double-blind
5552022|NCT01078948|randomized|randomized
5552023|NCT01078948|placebo-controlled|placebo-controlled
5552024|NCT01078948|treatment|treatment
5552025|NCT01078935|Crohn's disease activity index|crohn's disease activity index
5552026|NCT01078935|CDAI|cdai
5552027|NCT01078922|ofatumumab diffuse B cell non hodgkins lymphoma DLBCL|ofatumumab diffuse b cell non hodgkins lymphoma dlbcl
5552028|NCT01078922|refractory DLBCL|refractory dlbcl
5552029|NCT01078922|relapsed DLBCL|relapsed dlbcl
5552030|NCT01078909|Cardiovascular disease|cardiovascular disease
5552031|NCT01078909|Inflammation|inflammation
5552032|NCT01078909|Fish Oil|fish oil
5552033|NCT01078909|Omega-3 Fatty Acids|omega-3 fatty acids
5552034|NCT01078909|LPS|lps
5552035|NCT01078909|Endotoxin|endotoxin
5552036|NCT01078883|Lung cancer|lung cancer
5552037|NCT01078883|Respiratory muscle strength|respiratory muscle strength
5552038|NCT01078883|Dyspnea|dyspnea
5552039|NCT01078883|Functional capacity|functional capacity
5552040|NCT01078870|Negative symptom|negative symptom
5552041|NCT01078857|Chronic kidney disease|chronic kidney disease
5552042|NCT01078857|Small-fiber neuropathy|small-fiber neuropathy
5552043|NCT01078857|Skin biopsy|skin biopsy
5552044|NCT01078857|Contact heat evoked potential|contact heat evoked potential
5552045|NCT01078857|Autonomic neuropathy|autonomic neuropathy
5552046|NCT01078857|Neuropathy in late stage chronic kidney disease|neuropathy in late stage chronic kidney disease
5552047|NCT01078844|Autism|autism
5552048|NCT01078844|Asperger's Disorder|asperger's disorder
5534616|NCT01148394|early feeding|early feeding
5552049|NCT01078844|Pervasive Developmental Disorder NOS|pervasive developmental disorder nos
5552050|NCT01078844|Adult|adult
5552051|NCT01078844|Memantine|memantine
5552052|NCT01078818|Cardiac surgery|cardiac surgery
5552053|NCT01078818|Extracorporeal circulation|extracorporeal circulation
5552054|NCT01078818|Anaemia|anaemia
5552055|NCT01078818|Intravenous iron|intravenous iron
5552056|NCT01078818|Oral Iron|oral iron
5552057|NCT01078779|Influenza|influenza
5552058|NCT01078779|Prevention|prevention
5552059|NCT01078779|Chloroquine|chloroquine
5552060|NCT01078779|Randomised controlled trial|randomised controlled trial
5552061|NCT01078779|Respiratory virus infection|respiratory virus infection
5552062|NCT01078766|cerebral palsy|cerebral palsy
5552063|NCT01078740|cystic fibrosis|cystic fibrosis
5552064|NCT01078740|cystic fibrosis transmembrane conductance regulator|cystic fibrosis transmembrane conductance regulator
5552065|NCT01078740|biomarkers|biomarkers
5552066|NCT01078740|Intestinal Current Measurement|intestinal current measurement
5552067|NCT01078727|Thermal Stimulation|thermal stimulation
5552068|NCT01078727|Upper Extremity|upper extremity
5552069|NCT01078727|Motor Recovery|motor recovery
5552070|NCT01078727|Stroke|stroke
5552071|NCT01078714|Autism|autism
5552072|NCT01078714|Bumetanide|bumetanide
5552073|NCT01078714|GABA|gaba
5552074|NCT01078714|NKCC1|nkcc1
5552075|NCT01078701|live attenuated flu vaccines|live attenuated flu vaccines
5552076|NCT01078701|Influenza A (H1N1)|influenza a (h1n1)
5552077|NCT01078701|intranasal application|intranasal application
5552078|NCT01078701|replication-deficient influenza virus|replication-deficient influenza virus
5552079|NCT01078688|Limitations of activities|limitations of activities
5552080|NCT01078688|persistent asthma|persistent asthma
5552081|NCT01078688|general practitioner|general practitioner
5552082|NCT01078688|frequency of limitations of activities|frequency of limitations of activities
5552083|NCT01078688|depending on gender and age-group|depending on gender and age-group
5552084|NCT01078675|Familial Hypercholesterolaemia|familial hypercholesterolaemia
5552085|NCT01078675|pediatric|pediatric
5552086|NCT01078662|olaparib|olaparib
5552087|NCT01078662|PARP inhibitors|parp inhibitors
5552088|NCT01078662|genetic BRCA1 mutation|genetic brca1 mutation
5552089|NCT01078662|BRCA2 mutation|brca2 mutation
5552090|NCT01078662|solid tumour refractory|solid tumour refractory
5552091|NCT01078649|cancer|cancer
5552092|NCT01078649|solid tumors|solid tumors
5552093|NCT01078649|lymphoma|lymphoma
5552094|NCT01078649|smac mimetic|smac mimetic
5552095|NCT01078649|IAP inhibitor|iap inhibitor
5552096|NCT01078649|Phase I|phase i
5552097|NCT01078649|Dose escalation|dose escalation
5552098|NCT01078636|amyloid|amyloid
5552099|NCT01078636|plaques|plaques
5552100|NCT01078636|imaging|imaging
5552101|NCT01078636|early detection|early detection
5552102|NCT01078636|Amnestic MCI|amnestic mci
5552103|NCT01078636|pre-dementia|pre-dementia
5552104|NCT01078623|Bronchitis|bronchitis
5552105|NCT01078623|Chronic|chronic
5552106|NCT01078623|Emphysema|emphysema
5552107|NCT01078610|Psoriatic Arthritis|psoriatic arthritis
5552108|NCT01078610|Long-term Observation|long-term observation
5552110|NCT01078610|Safety|safety
5552111|NCT01078610|Effectiveness|effectiveness
5552112|NCT01078610|Quality of Life|quality of life
5552113|NCT01078610|Work Productivity|work productivity
5552114|NCT01078597|anti-MCV|anti-mcv
5552115|NCT01078597|anti-CCP|anti-ccp
5552116|NCT01078597|Biomarkers|biomarkers
5552117|NCT01078597|Rheumatoid Arthritis|rheumatoid arthritis
5552118|NCT01078584|Uncontrolled hypertension|uncontrolled hypertension
5552119|NCT01078584|trandolapril|trandolapril
5552120|NCT01078571|Rheumatoid Arthritis|rheumatoid arthritis
5552121|NCT01078571|Biologic|biologic
5552122|NCT01078571|Tumor Necrosis Factors blockers agents Monoclonal antibody|tumor necrosis factors blockers agents monoclonal antibody
5552123|NCT01078558|Multicenter study|multicenter study
5552124|NCT01078545|Prostate cancer|prostate cancer
5552125|NCT01078545|Lower urinary tract symptoms|lower urinary tract symptoms
5552126|NCT01078545|Hormonotherapy|hormonotherapy
5552127|NCT01078545|LHRH analogue|lhrh analogue
5685546|NCT00555633|Photoprotection|photoprotection
5552128|NCT01078545|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
5552129|NCT01078532|medically complex diseases that increase cardiovascular risk|medically complex diseases that increase cardiovascular risk
5552130|NCT01078519|Fever|fever
5552131|NCT01078519|anesthesia|anesthesia
5552132|NCT01078519|Labor|labor
5552133|NCT01078506|Chinese|chinese
5552134|NCT01078506|intracranial aneurysm|intracranial aneurysm
5552135|NCT01078506|magnetic resonance imaging|magnetic resonance imaging
5552136|NCT01078493|Platelet rich plasma|platelet rich plasma
5552138|NCT01078493|wrinkles|wrinkles
5552139|NCT01078493|MyCells®|mycells®
5552140|NCT01078493|CREATE|create
5552141|NCT01078493|Life Source Medical Centre|life source medical centre
5552142|NCT01078493|Dr Tan Kok leong|dr tan kok leong
5552143|NCT01078480|Fracture|fracture
5552144|NCT01078480|Collar bone|collar bone
5552145|NCT01078467|Wound Healing|wound healing
5552146|NCT01078467|Oral Wounds|oral wounds
5552147|NCT01078467|Cutaneous Wounds|cutaneous wounds
5552148|NCT01078467|Gene Array Analysis|gene array analysis
5552149|NCT01078467|Proteomic Analysis|proteomic analysis
5552150|NCT01078467|Healthy Volunteer|healthy volunteer
5552151|NCT01078467|HV|hv
5552152|NCT01078454|Melphalan|melphalan
5552153|NCT01078454|Dexamethasone|dexamethasone
5552154|NCT01078454|Bortezomib|bortezomib
5552155|NCT01078454|Systemic Light-chain (AL) Amyloidosis|systemic light-chain (al) amyloidosis
5552156|NCT01078441|Bortezomib|bortezomib
5552157|NCT01078441|Liposomal Doxorubicin|liposomal doxorubicin
5552159|NCT01078441|Cyclophosphamide|cyclophosphamide
5552160|NCT01078441|refractory multiple myeloma|refractory multiple myeloma
5552161|NCT01078428|Hypertrophic scars|hypertrophic scars
5552162|NCT01078428|Topical silicone gel|topical silicone gel
5552163|NCT01078428|Scar thickness|scar thickness
5552164|NCT01078428|Scar Color|scar color
5552165|NCT01078428|Scar pliability|scar pliability
5552166|NCT01078428|Scar appearance|scar appearance
5552167|NCT01078415|HCC|hcc
5552168|NCT01078415|Hepatocellular Carcinoma|hepatocellular carcinoma
5552169|NCT01078415|Early Stage|early stage
5552170|NCT01078415|Prospective|prospective
5552171|NCT01078415|Multicenter|multicenter
5552172|NCT01078415|Irreversible Electroporation (IRE)|irreversible electroporation (ire)
5552173|NCT01078415|Electroporation|electroporation
5552174|NCT01078415|Low Energy Direct Current|low energy direct current
5552175|NCT01078415|LEDC|ledc
5552176|NCT01078415|Nonthermal ablation|nonthermal ablation
5552177|NCT01078415|NTIRE (nonthermal IRE)|ntire (nonthermal ire)
5552178|NCT01078415|Ablation|ablation
5552179|NCT01078415|Soft Tissue|soft tissue
5552180|NCT01078402|Treatment compliance and tolerability of Humira in patients|treatment compliance and tolerability of humira in patients
5552181|NCT01078402|Eastern European countries|eastern european countries
5552182|NCT01078402|Rheumatoid Arthritis|rheumatoid arthritis
5552183|NCT01078402|Psoriatic Arthritis|psoriatic arthritis
5552184|NCT01078402|Adalimumab|adalimumab
5552185|NCT01078402|Ankylosing Spondylitis|ankylosing spondylitis
5552186|NCT01078402|Evaluation of clinical outcome|evaluation of clinical outcome
5552187|NCT01078389|Gout|gout
5552188|NCT01078389|Hyperuricemia|hyperuricemia
5552189|NCT01078389|Uric Acid|uric acid
5552190|NCT01078389|Drug Therapy|drug therapy
5552191|NCT01078376|Pediatrics|pediatrics
5552192|NCT01078376|Blood Pressure, High|blood pressure, high
5552194|NCT01078363|Heart Transplantation|heart transplantation
5552195|NCT01078350|Lymphoma|lymphoma
5552196|NCT01078350|Hodgkin Disease|hodgkin disease
5552197|NCT01078311|Patients with advanced hepatocellular cancer|patients with advanced hepatocellular cancer
5552198|NCT01078298|smoking|smoking
5552199|NCT01078298|smoking cessation|smoking cessation
5552200|NCT01078298|smoking cessation in depressed subjects|smoking cessation in depressed subjects
5552201|NCT01078285|Integrated program on adherence using counseling|integrated program on adherence using counseling
5552202|NCT01078285|support services including cost-sharing where appropriate and educational materials mailed monthly.|support services including cost-sharing where appropriate and educational materials mailed monthly.
5552203|NCT01078272|Coronary Atherosclerosis|coronary atherosclerosis
5552204|NCT01078272|Percutaneous Coronary Intervention|percutaneous coronary intervention
5552206|NCT01078272|Coronary Stenosis|coronary stenosis
5552207|NCT01078272|Remote Ischemic Preconditioning|remote ischemic preconditioning
5552208|NCT01078246|HIV|hiv
5552209|NCT01078233|HIV|hiv
5552210|NCT01078233|antiretroviral treatment|antiretroviral treatment
5552211|NCT01078233|HIV Cohort|hiv cohort
5552212|NCT01078233|Treatment|treatment
5552213|NCT01078220|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5552214|NCT01078194|Weight regain|weight regain
5552215|NCT01078194|Weight loss failure|weight loss failure
5552216|NCT01078194|Gastric bypass|gastric bypass
5552217|NCT01078181|gastric bypass|gastric bypass
5552218|NCT01078181|banded gastric bypass|banded gastric bypass
5552219|NCT01078181|weight loss|weight loss
5552220|NCT01078181|weight regain|weight regain
5552221|NCT01078181|bariatric surgery|bariatric surgery
5552222|NCT01078168|Alzheimer`s Disease|alzheimer`s disease
5552223|NCT01078155|Bone mineral density|bone mineral density
5538744|NCT01132547|recurrent childhood astrocytoma|recurrent childhood astrocytoma
5552224|NCT01078155|Bone turnover markers|bone turnover markers
5552225|NCT01078155|Rheumatoid arthritis|rheumatoid arthritis
5552226|NCT01078155|Osteoporosis|osteoporosis
5552227|NCT01078142|temsirolimus|temsirolimus
5552228|NCT01078142|bendamustine|bendamustine
5552229|NCT01078142|rituximab|rituximab
5552230|NCT01078142|mantle cell lymphoma|mantle cell lymphoma
5552231|NCT01078142|follicular lymphoma|follicular lymphoma
5552232|NCT01078129|cognitive deficits|cognitive deficits
5552233|NCT01078116|Rheumatoid Arthritis|rheumatoid arthritis
5552234|NCT01078116|Adalimumab treatment|adalimumab treatment
5552320|NCT01077635|paediatrics|paediatrics
5552665|NCT01076504|Amrubicin|amrubicin
5552235|NCT01078116|Evaluation of the patients' Health Related Quality of Life|evaluation of the patients' health related quality of life
5552236|NCT01078116|Cost of the disease management|cost of the disease management
5552237|NCT01078103|Diabetes Mellitus|diabetes mellitus
5552238|NCT01078103|cornea endothelium|cornea endothelium
5552239|NCT01078103|cell loss|cell loss
5552240|NCT01078103|cataract surgery|cataract surgery
5552241|NCT01078090|Safety|safety
5552242|NCT01078090|Rheumatoid Arthritis|rheumatoid arthritis
5552243|NCT01078090|Effectiveness|effectiveness
5552244|NCT01078077|healthy females ages twentyfive through sixty|healthy females ages twentyfive through sixty
5552245|NCT01078064|Gastroesophageal reflux disease, gastric motility|gastroesophageal reflux disease, gastric motility
5552246|NCT01078051|chronic total occlusion|chronic total occlusion
5552247|NCT01078051|stent|stent
5552248|NCT01078051|medical therapy|medical therapy
5552249|NCT01078038|Coronary Artery Disease|coronary artery disease
5552250|NCT01078038|Stent|stent
5552251|NCT01078025|transvaginal access for cholecystectomy|transvaginal access for cholecystectomy
5552252|NCT01077999|chemoradiation|chemoradiation
5552253|NCT01077999|panitumumab|panitumumab
5552254|NCT01077999|esophageal cancer|esophageal cancer
5552255|NCT01077999|Resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction|resectable squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
5552256|NCT01077986|mTOR inhibition|mtor inhibition
5552257|NCT01077986|EGFR inhibition|egfr inhibition
5552258|NCT01077986|pancreatic cancer|pancreatic cancer
5552259|NCT01077986|pharmacodynamics|pharmacodynamics
5552260|NCT01077973|Headache|headache
5552261|NCT01077960|Serostim|serostim
5552262|NCT01077960|HARS|hars
5552263|NCT01077947|low back pain|low back pain
5552264|NCT01077947|spinal fusion|spinal fusion
5552265|NCT01077947|Primarily axial low back pain|primarily axial low back pain
5552266|NCT01077934|All Patients admitted to Grady Memorial Hospital with Unilateral Lower leg injury at risk for compartment syndrome|all patients admitted to grady memorial hospital with unilateral lower leg injury at risk for compartment syndrome
5552267|NCT01077921|sickle|sickle
5552268|NCT01077921|adhesion|adhesion
5552269|NCT01077921|propranolol|propranolol
5552270|NCT01077908|Adoptive cellular therapy|adoptive cellular therapy
5552271|NCT01077908|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5552272|NCT01077895|Critically ill patients with positive fluid balance, IAH and AKI requiring RRT|critically ill patients with positive fluid balance, iah and aki requiring rrt
5552273|NCT01077882|Moderate and severe psoriasis and atopic dermatitis|moderate and severe psoriasis and atopic dermatitis
5552274|NCT01077869|oropharynx and lymph node metastases from an unknown primary tumor|oropharynx and lymph node metastases from an unknown primary tumor
5552275|NCT01077856|congenital anomaly|congenital anomaly
5552276|NCT01077856|pregnancy|pregnancy
5552277|NCT01077856|GARDASIL®|gardasil®
5552278|NCT01077856|Nordic|nordic
5537375|NCT01137825|polycythemia vera|polycythemia vera
5552279|NCT01077856|population-based|population-based
5552280|NCT01077843|Ankylosing Spondylitis|ankylosing spondylitis
5552281|NCT01077830|New Incidence of Cancer|new incidence of cancer
5552282|NCT01077791|Schizophrenia|schizophrenia
5552283|NCT01077791|social cognition|social cognition
5552284|NCT01077791|theory of mind|theory of mind
5552285|NCT01077791|cognitive therapy|cognitive therapy
5552286|NCT01077791|therapeutic trial|therapeutic trial
5552287|NCT01077791|magnetoencephalography (MEG)|magnetoencephalography (meg)
5552288|NCT01077778|Magnetic Resonance Imaging/methods|magnetic resonance imaging/methods
5552289|NCT01077778|Magnetic Resonance Angiography|magnetic resonance angiography
5552290|NCT01077778|Perfusion Imaging|perfusion imaging
5552291|NCT01077778|Pulmonary Embolism/diagnosis|pulmonary embolism/diagnosis
5552292|NCT01077765|HIV-associated Lipodystrophy|hiv-associated lipodystrophy
5552293|NCT01077765|Polyacrylamide hydrogel|polyacrylamide hydrogel
5552294|NCT01077752|Pain, postoperative|pain, postoperative
5552295|NCT01077752|Local infiltration|local infiltration
5552296|NCT01077752|Hyperalgesia, postoperative|hyperalgesia, postoperative
5552297|NCT01077752|Local anesthetic, ropivacaine, lidocaine|local anesthetic, ropivacaine, lidocaine
5552298|NCT01077752|Colorectal laparoscopic surgery|colorectal laparoscopic surgery
5552299|NCT01077752|Pain management after colorectal laparoscopic surgery|pain management after colorectal laparoscopic surgery
5552300|NCT01077687|schizophrenia|schizophrenia
5684607|NCT00559663|HDL|hdl
5552301|NCT01077687|genome-wide association study (GWAS)|genome-wide association study (gwas)
5552302|NCT01077687|single-nucleotide polymorphisms (SNPs)|single-nucleotide polymorphisms (snps)
5552303|NCT01077687|Han Chinese population|han chinese population
5552304|NCT01077687|trio families|trio families
5552305|NCT01077687|Schizophrenia with trio families|schizophrenia with trio families
5552306|NCT01077674|Electroencephalogram|electroencephalogram
5552307|NCT01077674|Entropy|entropy
5552309|NCT01077674|Sevoflurane|sevoflurane
5552310|NCT01077661|Nebivolol|nebivolol
5552311|NCT01077661|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5552312|NCT01077648|Breast Cancer|breast cancer
5552313|NCT01077648|Treatment|treatment
5552314|NCT01077648|Brain metastases|brain metastases
5552315|NCT01077648|ErbB2 expression|erbb2 expression
5552317|NCT01077635|Antiretroviral therapy|antiretroviral therapy
5552318|NCT01077635|protease inbitor|protease inbitor
5552319|NCT01077635|fosamprenavir|fosamprenavir
5552321|NCT01077609|Intranasal steroids|intranasal steroids
5552322|NCT01077609|beclometasone diproprionate|beclometasone diproprionate
5552323|NCT01077609|steroid-related outcomes|steroid-related outcomes
5552324|NCT01077596|Carcinogenicity|carcinogenicity
5552325|NCT01077596|Case control|case control
5552326|NCT01077596|Bupropion|bupropion
5552327|NCT01077583|Pregnancy test|pregnancy test
5552328|NCT01077583|Wishing to become pregnant|wishing to become pregnant
5552329|NCT01077557|Combivir (Zidovudine+Lamivudine)|combivir (zidovudine+lamivudine)
5552330|NCT01077557|Trizivir (Abacavir+Lamivudine+Zidovudine)|trizivir (abacavir+lamivudine+zidovudine)
5552331|NCT01077557|Zidovudine|zidovudine
5552332|NCT01077557|Epzicom (Abacavir+Lamivudine)|epzicom (abacavir+lamivudine)
5552333|NCT01077557|Fracture|fracture
5552334|NCT01077557|Amprenavir|amprenavir
5552335|NCT01077557|human immunodeficiency virus (HIV) infection|human immunodeficiency virus (hiv) infection
5552336|NCT01077557|antiretroviral (ARV) therapy|antiretroviral (arv) therapy
5552337|NCT01077557|Lamivudine|lamivudine
5552338|NCT01077557|incidence|incidence
5552339|NCT01077557|Abacavir|abacavir
5552340|NCT01077557|risk|risk
5552341|NCT01077557|Fosamprenavir|fosamprenavir
5552342|NCT01077544|Chronic Myeloid Leukemia|chronic myeloid leukemia
5552343|NCT01077544|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5552344|NCT01077544|Ph+ CML|ph+ cml
5552345|NCT01077544|Ph+ ALL|ph+ all
5552346|NCT01077544|pediatric|pediatric
5552347|NCT01077544|nilotinib|nilotinib
5552348|NCT01077544|imatinib|imatinib
5552349|NCT01077544|chronic phase|chronic phase
5552350|NCT01077544|accelerated phase|accelerated phase
5552351|NCT01077544|newly diagnosed Ph+ CML|newly diagnosed ph+ cml
5552352|NCT01077544|dasatinib|dasatinib
5552353|NCT01077531|Rheumatoid arthritis|rheumatoid arthritis
5552354|NCT01077531|intravenous infusion|intravenous infusion
5552355|NCT01077531|long-term followup|long-term followup
5552356|NCT01077518|Refractory|refractory
5552357|NCT01077518|Safety|safety
5552358|NCT01077518|Efficacy|efficacy
5552359|NCT01077518|Rituximab refractory|rituximab refractory
5552360|NCT01077518|Oncology|oncology
5552361|NCT01077505|pharmacokinetics|pharmacokinetics
5552362|NCT01077505|GSK716155|gsk716155
5552363|NCT01077505|Brevicon|brevicon
5552364|NCT01077505|albiglutide|albiglutide
5552365|NCT01077505|healthy female volunteers|healthy female volunteers
5552366|NCT01077505|oral contraceptive|oral contraceptive
5552367|NCT01077492|lung cancer|lung cancer
5552369|NCT01077492|TBNA|tbna
5552370|NCT01077492|staging lung cancer|staging lung cancer
5552371|NCT01077479|body fat mass gain|body fat mass gain
5552372|NCT01077479|Insulin resistance|insulin resistance
5552373|NCT01077466|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5552374|NCT01077466|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5552375|NCT01077466|Natalizumab|natalizumab
5552376|NCT01077466|Treatment|treatment
5552377|NCT01077466|Safety|safety
5552378|NCT01077466|Efficacy|efficacy
5552379|NCT01077466|Cerebrospinal fluid|cerebrospinal fluid
5552380|NCT01077466|Osteopontin|osteopontin
5552381|NCT01077440|cancer survivor|cancer survivor
5552382|NCT01077440|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5552383|NCT01077440|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5552384|NCT01077440|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5552385|NCT01077440|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5552386|NCT01077440|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5552387|NCT01077440|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5552388|NCT01077440|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5552389|NCT01077440|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5552390|NCT01077440|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5552391|NCT01077440|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5552392|NCT01077440|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5685547|NCT00555633|Sunscreen|sunscreen
5552393|NCT01077440|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5552394|NCT01077440|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5552395|NCT01077440|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5552396|NCT01077440|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5552397|NCT01077440|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5552398|NCT01077440|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5552399|NCT01077440|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5552400|NCT01077440|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5552401|NCT01077440|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5552402|NCT01077440|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5552403|NCT01077440|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5552404|NCT01077440|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5552405|NCT01077440|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5552406|NCT01077440|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5552407|NCT01077440|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5552408|NCT01077440|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5552409|NCT01077440|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5552410|NCT01077440|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5552411|NCT01077440|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5552412|NCT01077440|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5552413|NCT01077440|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5552414|NCT01077440|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5552415|NCT01077440|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5552416|NCT01077440|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5552417|NCT01077440|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5552418|NCT01077440|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5552419|NCT01077440|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5552420|NCT01077440|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5552421|NCT01077440|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5552422|NCT01077440|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5552423|NCT01077440|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5552424|NCT01077440|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5552425|NCT01077440|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5552426|NCT01077440|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5552427|NCT01077440|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5552428|NCT01077440|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5552429|NCT01077440|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5552430|NCT01077440|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5552431|NCT01077440|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5552432|NCT01077440|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5552433|NCT01077440|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5552434|NCT01077440|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5552435|NCT01077440|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5552436|NCT01077440|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5552437|NCT01077440|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5552438|NCT01077440|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5552439|NCT01077440|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5552440|NCT01077440|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5552441|NCT01077440|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5552442|NCT01077440|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5552443|NCT01077440|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5862965|NCT00001442|Squamous Cell Carcinoma|squamous cell carcinoma
5552445|NCT01077440|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5552446|NCT01077440|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5552447|NCT01077440|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5552448|NCT01077440|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5552449|NCT01077440|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5552450|NCT01077440|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5552451|NCT01077440|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5552452|NCT01077440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5552453|NCT01077440|refractory hairy cell leukemia|refractory hairy cell leukemia
5552454|NCT01077440|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5552455|NCT01077440|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5552456|NCT01077440|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5552457|NCT01077440|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5552458|NCT01077440|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5552459|NCT01077440|primary myelofibrosis|primary myelofibrosis
5552460|NCT01077440|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5552461|NCT01077440|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5552462|NCT01077440|disseminated neuroblastoma|disseminated neuroblastoma
5552463|NCT01077440|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5552464|NCT01077440|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5552465|NCT01077440|recurrent neuroblastoma|recurrent neuroblastoma
5552466|NCT01077440|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5552467|NCT01077440|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5552468|NCT01077440|stage I multiple myeloma|stage i multiple myeloma
5552469|NCT01077440|stage II multiple myeloma|stage ii multiple myeloma
5552470|NCT01077440|stage III multiple myeloma|stage iii multiple myeloma
5552471|NCT01077440|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5552472|NCT01077440|refractory multiple myeloma|refractory multiple myeloma
5552473|NCT01077427|pancreatic cancer|pancreatic cancer
5552474|NCT01077427|adjuvant treatment|adjuvant treatment
5552475|NCT01077427|hyperthermia|hyperthermia
5552476|NCT01077414|Psychosocial Functioning|psychosocial functioning
5552477|NCT01077414|Psychosocial Stress|psychosocial stress
5552478|NCT01077414|Palliative Care|palliative care
5552479|NCT01077414|Spirituality|spirituality
5552481|NCT01077401|Diabetic|diabetic
5552484|NCT01077388|CVD|cvd
5552485|NCT01077388|uncontrolled HTN|uncontrolled htn
5552486|NCT01077375|Milnacipran|milnacipran
5552487|NCT01077375|Duloxetine|duloxetine
5552488|NCT01077375|Switch|switch
5552489|NCT01077375|Forest Research Institute|forest research institute
5552490|NCT01077362|Ustekinumab|ustekinumab
5552491|NCT01077362|CNTO 1275|cnto 1275
5552492|NCT01077362|Stelara|stelara
5552493|NCT01077362|Psoriatic Arthritis|psoriatic arthritis
5552494|NCT01077362|Psoriasis|psoriasis
5552495|NCT01077362|TNF alpha|tnf alpha
5552496|NCT01077349|Cardiac surgery|cardiac surgery
5552497|NCT01077349|Shock|shock
5552498|NCT01077349|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
5552499|NCT01077349|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5552500|NCT01077349|Renal Insufficiency|renal insufficiency
5552501|NCT01077349|Acute|acute
5552502|NCT01077336|susceptibility testing|susceptibility testing
5552503|NCT01077323|pancreatitis|pancreatitis
5552504|NCT01077323|exenatide|exenatide
5552505|NCT01077323|Byetta|byetta
5552506|NCT01077323|Amylin|amylin
5552507|NCT01077323|Lilly|lilly
5552508|NCT01077310|HIV|hiv
5552509|NCT01077310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5552510|NCT01077310|Alcohol dependence|alcohol dependence
5552511|NCT01077310|CD4|cd4
5552512|NCT01077310|HIV-1 RNA|hiv-1 rna
5552513|NCT01077310|Alcohol treatment outcomes|alcohol treatment outcomes
5552514|NCT01077284|Kidney Calculi|kidney calculi
5552515|NCT01077284|Kidney Stones|kidney stones
5552516|NCT01077284|Nephrolithiasis|nephrolithiasis
5552517|NCT01077284|Drug Therapy|drug therapy
5552518|NCT01077284|Uric Acid|uric acid
5552519|NCT01077271|Premature infants|premature infants
5552520|NCT01077271|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5552521|NCT01077271|Compliance|compliance
5552522|NCT01077271|Palivizumab|palivizumab
5552523|NCT01077258|Safety|safety
5552524|NCT01077258|Long-term observation|long-term observation
5552525|NCT01077258|Routine Clinical Setting|routine clinical setting
5552526|NCT01077258|Rheumatoid Arthritis|rheumatoid arthritis
5552527|NCT01077258|Effectiveness|effectiveness
5552528|NCT01077245|Clostridium difficile|clostridium difficile
5552529|NCT01077245|Clostridium Infections|clostridium infections
5552530|NCT01077245|Gram-Positive Bacterial Infections|gram-positive bacterial infections
5552531|NCT01077245|Bacterial Infections|bacterial infections
5552533|NCT01077245|Clostridium butyricum|clostridium butyricum
5552534|NCT01077245|Metronidazole|metronidazole
5552535|NCT01077245|Vancomycin|vancomycin
5552536|NCT01077245|Gastrointestinal Diseases|gastrointestinal diseases
5552537|NCT01077245|Physiological Effects of Drugs|physiological effects of drugs
5552538|NCT01077245|Colonic Diseases|colonic diseases
5552539|NCT01077245|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
5552540|NCT01077245|Intestinal Diseases|intestinal diseases
5552541|NCT01077245|Enterocolitis|enterocolitis
5552542|NCT01077245|Pharmacologic Actions|pharmacologic actions
5552543|NCT01077245|Digestive System Diseases|digestive system diseases
5552544|NCT01077245|Therapeutic Uses|therapeutic uses
5552545|NCT01077245|Gastroenteritis|gastroenteritis
5552546|NCT01077245|Colitis|colitis
5552547|NCT01077245|Diarrhea|diarrhea
5552548|NCT01077245|Probiotics|probiotics
5552549|NCT01077245|Gastrointestinal Agents|gastrointestinal agents
5552550|NCT01077232|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5552551|NCT01077232|Humira|humira
5552552|NCT01077232|Safety|safety
5552553|NCT01077232|Efficacy|efficacy
5552554|NCT01077232|Work Productivity|work productivity
5552555|NCT01077219|healthy female|healthy female
5552556|NCT01077206|Aneurysm|aneurysm
5552557|NCT01077206|statin|statin
5552558|NCT01077206|subarachnoid hemorrhage|subarachnoid hemorrhage
5552559|NCT01077193|Bariatric|bariatric
5552560|NCT01077193|Obesity|obesity
5552561|NCT01077167|Omecamtiv mecarbil|omecamtiv mecarbil
5552562|NCT01077167|pharmacokinetics|pharmacokinetics
5552563|NCT01077154|Early Stage Breast Cancer|early stage breast cancer
5552564|NCT01077154|Bone Metastasis|bone metastasis
5552565|NCT01077154|Adjuvant treatment|adjuvant treatment
5552566|NCT01077154|Neoadjuvant treatment|neoadjuvant treatment
5552567|NCT01077154|Denosumab|denosumab
5552568|NCT01077154|Stage II breast cancer|stage ii breast cancer
5552569|NCT01077154|Stage III breast cancer|stage iii breast cancer
5552570|NCT01077154|Stage IIA breast cancer|stage iia breast cancer
5552571|NCT01077154|Stage IIB breast cancer|stage iib breast cancer
5535216|NCT01146132|BMI|bmi
5552572|NCT01077154|Stage IIIA breast cancer|stage iiia breast cancer
5552573|NCT01077154|Stage IIIB breast cancer|stage iiib breast cancer
5552574|NCT01077154|Stage IIIC breast cancer|stage iiic breast cancer
5552575|NCT01077154|Early breast cancer|early breast cancer
5552576|NCT01077154|Breast Tumors|breast tumors
5552577|NCT01077154|Breast Neoplasms|breast neoplasms
5552578|NCT01077128|Psoriasis|psoriasis
5552579|NCT01077128|Quality of life|quality of life
5552580|NCT01077115|Cholecystectomy|cholecystectomy
5552581|NCT01077115|Cholecystitis|cholecystitis
5552582|NCT01077115|Laparoscopy|laparoscopy
5552583|NCT01077115|Cholelithiasis|cholelithiasis
5552584|NCT01077115|Operative trauma|operative trauma
5552588|NCT01077102|muscle function|muscle function
5552589|NCT01077089|traumatic brain injury|traumatic brain injury
5552590|NCT01077089|In-hospital transport|in-hospital transport
5552591|NCT01077076|Gastric Acid|gastric acid
5552592|NCT01077076|Human Experimentation|human experimentation
5552593|NCT01077063|Pleurx catheter|pleurx catheter
5552594|NCT01077063|malignant ascites|malignant ascites
5552595|NCT01077024|Stimulant treatment|stimulant treatment
5552596|NCT01077024|Smoking Cessation|smoking cessation
5552597|NCT01077011|Dry eye|dry eye
5552598|NCT01077011|artificial tears|artificial tears
5552599|NCT01076998|Dry eye|dry eye
5552600|NCT01076998|artificial tears|artificial tears
5552601|NCT01076985|Human Immunodeficiency Virus|human immunodeficiency virus
5552602|NCT01076972|Human Immunodeficiency Virus|human immunodeficiency virus
5552603|NCT01076959|Rheumatoid Arthritis|rheumatoid arthritis
5552604|NCT01076946|ballooning|ballooning
5552605|NCT01076946|TLVBS|tlvbs
5552606|NCT01076933|Borderline Personality Disorder|borderline personality disorder
5552607|NCT01076933|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5552608|NCT01076933|Neuropsychological Test|neuropsychological test
5552609|NCT01076933|Randomised Control Trial|randomised control trial
5552610|NCT01076907|colonoscopy|colonoscopy
5552611|NCT01076907|polyps|polyps
5552612|NCT01076894|pain|pain
5552613|NCT01076894|thoracotomy|thoracotomy
5552614|NCT01076894|pulmonary function|pulmonary function
5552615|NCT01076894|epidural anesthesia|epidural anesthesia
5552616|NCT01076894|intercostal nerve block|intercostal nerve block
5552617|NCT01076868|vivax|vivax
5552618|NCT01076868|malaria|malaria
5552619|NCT01076868|relapse|relapse
5552620|NCT01076842|Diabetes|diabetes
5552622|NCT01076829|Spice|spice
5552623|NCT01076816|Patients with single-organ failure in need of mechanical ventilation|patients with single-organ failure in need of mechanical ventilation
5552624|NCT01076803|Malignant intestinal obstruction in inoperable patients|malignant intestinal obstruction in inoperable patients
5552625|NCT01076790|Nociception|nociception
5552626|NCT01076790|Dexmedetomidine|dexmedetomidine
5552627|NCT01076790|Electroencephalogram|electroencephalogram
5552628|NCT01076790|Electromyogram|electromyogram
5552629|NCT01076790|Entropy Index|entropy index
5552630|NCT01076790|Bispectral Index|bispectral index
5552631|NCT01076790|Electrocardiogram|electrocardiogram
5552632|NCT01076790|Plethysmogram|plethysmogram
5552634|NCT01076790|Heart rate|heart rate
5552635|NCT01076790|Heart rate variability|heart rate variability
5552636|NCT01076790|Surgery|surgery
5552637|NCT01076777|Panic disorder|panic disorder
5552638|NCT01076777|Physical exercise|physical exercise
5552639|NCT01076777|Cognitive-behavioral therapy|cognitive-behavioral therapy
5552640|NCT01076777|Manualized|manualized
5552641|NCT01076725|ProSeal LMA|proseal lma
5552642|NCT01076725|standard insertion|standard insertion
5552643|NCT01076725|rotational insertion|rotational insertion
5552644|NCT01076699|abdominal pain|abdominal pain
5552645|NCT01076699|bloating|bloating
5552646|NCT01076699|diarrhea|diarrhea
5552647|NCT01076699|irritable bowel|irritable bowel
5552648|NCT01076686|Augmentation mammoplasty|augmentation mammoplasty
5552649|NCT01076686|Breast augmentation|breast augmentation
5552650|NCT01076686|Postoperative pain|postoperative pain
5552651|NCT01076686|Analgesia|analgesia
5552652|NCT01076660|Ischemic cardiomyopathy|ischemic cardiomyopathy
5552653|NCT01076660|Nonischemic cardiomyopathy|nonischemic cardiomyopathy
5552654|NCT01076660|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5552655|NCT01076660|Sudden Cardiac Death|sudden cardiac death
5552656|NCT01076660|Ventricular tachycardia|ventricular tachycardia
5552657|NCT01076660|Ventricular fibrillation|ventricular fibrillation
5552658|NCT01076608|primary care patients|primary care patients
5552659|NCT01076595|Multiple sclerosis|multiple sclerosis
5552660|NCT01076595|BetaPlus program|betaplus program
5552661|NCT01076595|Recurrent/remittent multiple sclerosis patients|recurrent/remittent multiple sclerosis patients
5552662|NCT01076595|Adherence to treatment regimen|adherence to treatment regimen
5552663|NCT01076582|hormone withdrawal associated symptoms|hormone withdrawal associated symptoms
5552664|NCT01076504|SCLC|sclc
5552670|NCT01076465|Heart failure|heart failure
5552671|NCT01076465|Elderly|elderly
5552672|NCT01076465|Disease management|disease management
5552673|NCT01076452|Parkinson's Disease|parkinson's disease
5552674|NCT01076452|levo-dopa|levo-dopa
5552675|NCT01076452|tremor|tremor
5552676|NCT01076452|dyskinesia|dyskinesia
5552677|NCT01076452|subthalamic nucleus|subthalamic nucleus
5552678|NCT01076452|globus pallidus|globus pallidus
5552679|NCT01076426|probiotic|probiotic
5552680|NCT01076426|peritoneal dialysis|peritoneal dialysis
5552681|NCT01076426|peritonitis|peritonitis
5552682|NCT01076426|nutrition status|nutrition status
5552683|NCT01076413|gait|gait
5552684|NCT01076413|exercise|exercise
5552685|NCT01076413|skill-based|skill-based
5552686|NCT01076413|aerobic|aerobic
5552692|NCT01076374|pacemaker|pacemaker
5552693|NCT01076361|Epicardial|epicardial
5552694|NCT01076361|Pacing Lead|pacing lead
5552695|NCT01076348|Epicardial|epicardial
5552696|NCT01076348|Pacing Lead|pacing lead
5552697|NCT01076335|Neoadjuvant Hormonal Therapy|neoadjuvant hormonal therapy
5552698|NCT01076335|Docetaxel|docetaxel
5552699|NCT01076335|Taxotere|taxotere
5552700|NCT01076335|Chemotherapy|chemotherapy
5552701|NCT01076335|Radical Prostatectomy|radical prostatectomy
5552702|NCT01076335|Node-positive Prostate Cancer|node-positive prostate cancer
5552703|NCT01076335|Androgen-dependent prostate cancer|androgen-dependent prostate cancer
5552704|NCT01076335|Lymph node metastases|lymph node metastases
5552705|NCT01076309|cataract surgery|cataract surgery
5552706|NCT01076309|tamsulosin|tamsulosin
5552707|NCT01076309|endothelium cell|endothelium cell
5552708|NCT01076283|baclofen|baclofen
5552709|NCT01076283|alcoholism|alcoholism
5552710|NCT01076283|urge|urge
5552711|NCT01076283|craving|craving
5552712|NCT01076283|alcohol drinking|alcohol drinking
5552713|NCT01076283|biobehavioral mechanisms of baclofen in alcoholism|biobehavioral mechanisms of baclofen in alcoholism
5552714|NCT01076257|brain damage|brain damage
5552715|NCT01076257|constraint induced movement therapy|constraint induced movement therapy
5552716|NCT01076257|kinematic|kinematic
5552717|NCT01076257|function|function
5721366|NCT00426829|PT|pt
5552718|NCT01076257|outcome|outcome
5552719|NCT01076257|Quality of life|quality of life
5552720|NCT01076218|Continuous Glucose Monitoring|continuous glucose monitoring
5552721|NCT01076218|Accuracy|accuracy
5552722|NCT01076218|Continuous Glucose Error-Grid Analysis|continuous glucose error-grid analysis
5552723|NCT01076205|Work Productivity|work productivity
5552724|NCT01076205|Long-term Observation|long-term observation
5552725|NCT01076205|Humira|humira
5552726|NCT01076205|Quality of Life|quality of life
5552727|NCT01076205|Rheumatoid Arthritis|rheumatoid arthritis
5552728|NCT01076192|Moderate Psoriasis|moderate psoriasis
5552729|NCT01076192|Psoriasis|psoriasis
5552730|NCT01076192|Severe Psoriasis|severe psoriasis
5552731|NCT01076192|Adalimumab|adalimumab
5552732|NCT01076192|Effectiveness|effectiveness
5552733|NCT01076192|Safety|safety
5552734|NCT01076192|Clinical practice|clinical practice
5552735|NCT01076179|Infection|infection
5552736|NCT01076179|Rilpivirine|rilpivirine
5552737|NCT01076179|CCR5 antagonists|ccr5 antagonists
5552738|NCT01076179|Etravirine|etravirine
5552739|NCT01076179|Human Immunodeficiency Virus|human immunodeficiency virus
5552740|NCT01076179|Maraviroc|maraviroc
5552741|NCT01076179|Safety and efficacy|safety and efficacy
5552748|NCT01076166|Klacid Granules for Oral Suspension|klacid granules for oral suspension
5552749|NCT01076153|Post-marketing observational study|post-marketing observational study
5552750|NCT01076153|Upper or lower respiratory tract infection|upper or lower respiratory tract infection
5552751|NCT01076153|Klacid MR|klacid mr
5552752|NCT01076140|Hypertension as a result of bevacizumab therapy|hypertension as a result of bevacizumab therapy
5552754|NCT01076101|sister|sister
5552755|NCT01076101|autoimmune disease|autoimmune disease
5552756|NCT01076075|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5552757|NCT01076062|Pregnancy Maintenance|pregnancy maintenance
5552758|NCT01076062|Labor, Induced|labor, induced
5552759|NCT01076062|spontaneous labor|spontaneous labor
5552760|NCT01076062|cesarean delivery|cesarean delivery
5552761|NCT01076036|ischemia|ischemia
5552762|NCT01076036|stent|stent
5552763|NCT01076023|Diabetes|diabetes
5552764|NCT01076023|Cardiovascular disease|cardiovascular disease
5552765|NCT01076023|Observational study|observational study
5552766|NCT01076023|China|china
5552767|NCT01075997|Diabetes Mellitus|diabetes mellitus
5552768|NCT01075984|Antifungal Agents pharmacokinetics|antifungal agents pharmacokinetics
5552769|NCT01075984|Mycoses prevention and control|mycoses prevention and control
5552770|NCT01075971|Buprenorphine tablet|buprenorphine tablet
5552771|NCT01075971|Fast dissolving tablet|fast dissolving tablet
5552772|NCT01075971|Opioid dependant patients|opioid dependant patients
5552773|NCT01075958|n-3 PUFAs|n-3 pufas
5552774|NCT01075958|Fish oil|fish oil
5552775|NCT01075958|Cognitive function|cognitive function
5552776|NCT01075958|Healthy young adults|healthy young adults
5552777|NCT01075945|antimalarials|antimalarials
5552778|NCT01075945|ACTs|acts
5552779|NCT01075945|Piperaquine|piperaquine
5552780|NCT01075945|uncomplicated|uncomplicated
5552781|NCT01075932|cerebral blood flow|cerebral blood flow
5552782|NCT01075932|NIRS|nirs
5552783|NCT01075932|n-3 PUFAs|n-3 pufas
5552784|NCT01075932|fish oil|fish oil
5552785|NCT01075932|cognitive function|cognitive function
5552786|NCT01075919|n-3 PUFAs|n-3 pufas
5552787|NCT01075919|Cognitive function|cognitive function
5535415|NCT01145131|muscle|muscle
5552788|NCT01075919|Healthy young adults|healthy young adults
5552789|NCT01075919|Fish oil|fish oil
5552790|NCT01075919|Mood|mood
5552791|NCT01075906|pharmacokinetics|pharmacokinetics
5552792|NCT01075893|Colorectal cancer|colorectal cancer
5552793|NCT01075893|Stem cells|stem cells
5552794|NCT01075893|Ulcerative colitis|ulcerative colitis
5552795|NCT01075893|Polyps|polyps
5552796|NCT01075880|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5552797|NCT01075880|Rebif|rebif
5552798|NCT01075880|Interferon beta-1a|interferon beta-1a
5552799|NCT01075854|Gonal-F|gonal-f
5552800|NCT01075854|Multifollicular stimulation|multifollicular stimulation
5552801|NCT01075854|Pregnancy|pregnancy
5552802|NCT01075854|Ovarian hyperstimulation|ovarian hyperstimulation
5552803|NCT01075854|In vitro fertilization|in vitro fertilization
5552804|NCT01075854|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5552805|NCT01075854|Infertility|infertility
5552806|NCT01075841|Head and neck neoplasms|head and neck neoplasms
5552807|NCT01075841|Carcinoma, squamous cell|carcinoma, squamous cell
5552808|NCT01075841|Cetuximab|cetuximab
5552809|NCT01075828|Head and Neck Neoplasms|head and neck neoplasms
5552810|NCT01075828|Neoplasms, Squamous Cell|neoplasms, squamous cell
5552811|NCT01075828|Cetuximab|cetuximab
5552812|NCT01075815|Infertility|infertility
5552813|NCT01075815|Ovulation induction|ovulation induction
5552814|NCT01075815|Luveris|luveris
5552815|NCT01075815|Controlled ovarian stimulation|controlled ovarian stimulation
5552816|NCT01075815|Reproductive technologies, assisted|reproductive technologies, assisted
5552817|NCT01075802|Breast cancer|breast cancer
5552818|NCT01075802|Tamoxifen|tamoxifen
5552819|NCT01075802|Endoxifen|endoxifen
5552820|NCT01075802|polymorphism of CYP2D6|polymorphism of cyp2d6
5552821|NCT01075789|Pain|pain
5552822|NCT01075789|Discomfort|discomfort
5552823|NCT01075789|Insertion|insertion
5552824|NCT01075789|Nasogastric tube|nasogastric tube
5552825|NCT01075763|Alzheimer's|alzheimer's
5552826|NCT01075763|Dementia|dementia
5552827|NCT01075763|Interferon beta-1a|interferon beta-1a
5552828|NCT01075763|Rebif|rebif
5552829|NCT01075750|hyperkalaemia|hyperkalaemia
5552830|NCT01075750|metabolic acidosis|metabolic acidosis
5552831|NCT01075750|renal transplantation|renal transplantation
5552832|NCT01075750|normal saline|normal saline
5552833|NCT01075750|elomel isoton|elomel isoton
5552834|NCT01075750|fluid management in renal transplantation|fluid management in renal transplantation
5552835|NCT01075737|Multiple sclerosis|multiple sclerosis
5552836|NCT01075737|Sclerosis|sclerosis
5552837|NCT01075737|Quality of life|quality of life
5552838|NCT01075724|Perioperative Hypothermia Prevention|perioperative hypothermia prevention
5552839|NCT01075724|Accidental Perioperative Hypothermia|accidental perioperative hypothermia
5552840|NCT01075711|Arthritis, Rheumatoid|arthritis, rheumatoid
5552841|NCT01075711|Prednisone|prednisone
5552842|NCT01075698|Type 2 Diabetes|type 2 diabetes
5552843|NCT01075698|Cerebrovascular disease|cerebrovascular disease
5552844|NCT01075698|Coronary Artery Disease|coronary artery disease
5552845|NCT01075698|Chronic Kidney Disease|chronic kidney disease
5552846|NCT01075698|Peripheral Artery Disease|peripheral artery disease
5552848|NCT01075672|BDD|bdd
5552849|NCT01075672|Tourette syndrome|tourette syndrome
5552850|NCT01075672|trichotillomania|trichotillomania
5552851|NCT01075672|Compulsive Skin Picking|compulsive skin picking
5552852|NCT01075672|panic disorder|panic disorder
5552853|NCT01075672|social phobia|social phobia
5552854|NCT01075672|generalized anxiety disorder|generalized anxiety disorder
5552855|NCT01075672|depression|depression
5552856|NCT01075672|PTSD|ptsd
5552857|NCT01075672|ADHD|adhd
5552858|NCT01075672|eating disorder|eating disorder
5552859|NCT01075672|Specific Phobia|specific phobia
5552860|NCT01075659|Smoking Cessation|smoking cessation
5552862|NCT01075659|Urges to smoke|urges to smoke
5552863|NCT01075646|postoperative pain|postoperative pain
5552864|NCT01075646|wound infusion|wound infusion
5552865|NCT01075646|local anesthesia|local anesthesia
5552866|NCT01075633|FOBT|fobt
5552867|NCT01075633|colonoscopy|colonoscopy
5552868|NCT01075633|familiar risk|familiar risk
5552869|NCT01075633|colorectal cancer|colorectal cancer
5552870|NCT01075633|advanced adenoma|advanced adenoma
5552871|NCT01075620|rotating platform|rotating platform
5552872|NCT01075620|posterior stabilized|posterior stabilized
5552873|NCT01075620|non-posterior stabilized|non-posterior stabilized
5552874|NCT01075607|Lymph fluid collection|lymph fluid collection
5552875|NCT01075594|Dyslipidemia|dyslipidemia
5552876|NCT01075594|Target cholesterol|target cholesterol
5552877|NCT01075594|Undertreatment|undertreatment
5552878|NCT01075581|Hemodynamic instability|hemodynamic instability
5552879|NCT01075581|Hemostasis|hemostasis
5552880|NCT01075555|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5552881|NCT01075555|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5552882|NCT01075555|advanced adult primary liver cancer|advanced adult primary liver cancer
5552883|NCT01075555|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5552884|NCT01075542|Corneal astigmatism|corneal astigmatism
5552885|NCT01075542|Intraocular lens|intraocular lens
5790026|NCT00146094|osteoporosis|osteoporosis
5798717|NCT00111280|Nucleoside reverse transcriptase inhibitors (NRTIs)|nucleoside reverse transcriptase inhibitors (nrtis)
5552886|NCT01075529|major depressive disorder, fluoxetine, Hamilton Rating Scale for Depression (HAM-D-17)|major depressive disorder, fluoxetine, hamilton rating scale for depression (ham-d-17)
5552887|NCT01075516|Remote Monitoring|remote monitoring
5552888|NCT01075516|ICD patients|icd patients
5552889|NCT01075516|EQ-5D questionnaire|eq-5d questionnaire
5552890|NCT01075516|remote follow up|remote follow up
5552891|NCT01075503|Supraclavicular|supraclavicular
5552892|NCT01075503|Interscalene|interscalene
5552893|NCT01075503|Infraclavicular|infraclavicular
5552894|NCT01075503|Brachial plexus block|brachial plexus block
5552895|NCT01075503|Ropivacaine|ropivacaine
5552896|NCT01075490|spinal anesthesia|spinal anesthesia
5552897|NCT01075490|neonates|neonates
5552898|NCT01075490|clonidine|clonidine
5552899|NCT01075490|post operative apnea|post operative apnea
5552900|NCT01075464|Solid Tumor|solid tumor
5552901|NCT01075451|Staphylococcus aureus|staphylococcus aureus
5552902|NCT01075451|Antimicrobial Stewardship|antimicrobial stewardship
5552903|NCT01075451|Antibacterial resistance|antibacterial resistance
5552904|NCT01075451|Vancomycin|vancomycin
5552905|NCT01075438|ataxia telangiectasia|ataxia telangiectasia
5552906|NCT01075438|Pneumococcal Vaccines|pneumococcal vaccines
5552907|NCT01075425|leukemia|leukemia
5552908|NCT01075425|acute leukemia|acute leukemia
5552909|NCT01075425|chronic myelogenous leukemia|chronic myelogenous leukemia
5552910|NCT01075425|myelodysplastic syndrome|myelodysplastic syndrome
5702387|NCT00493545|Safety|safety
5552911|NCT01075425|relapsed acute leukemia|relapsed acute leukemia
5552912|NCT01075425|refractory acute leukemia|refractory acute leukemia
5552913|NCT01075425|belinostat|belinostat
5552914|NCT01075425|bortezomib|bortezomib
5552915|NCT01075425|Velcade|velcade
5552916|NCT01075425|PXD-101|pxd-101
5552917|NCT01075412|Positron-Emission Tomography|positron-emission tomography
5552918|NCT01075412|Radiotherapy, Intensity-Modulated|radiotherapy, intensity-modulated
5552919|NCT01075399|[F 18]HX4|[f 18]hx4
5552920|NCT01075399|HX4|hx4
5552921|NCT01075399|Hypoxia|hypoxia
5552922|NCT01075399|Head/Neck Cancer|head/neck cancer
5552923|NCT01075399|Lung Cancer|lung cancer
5552924|NCT01075399|Liver Cancer|liver cancer
5552925|NCT01075399|Rectal Cancer|rectal cancer
5552926|NCT01075399|Cervical Cancer|cervical cancer
5552927|NCT01075399|HIF1 alpha|hif1 alpha
5552928|NCT01075399|CAIX|caix
5552929|NCT01075386|Hysterectomy|hysterectomy
5552930|NCT01075386|Endometrial cancer|endometrial cancer
5552931|NCT01075386|Benign|benign
5552932|NCT01075386|Endocrine system|endocrine system
5552933|NCT01075386|Tissue collection|tissue collection
5552934|NCT01075373|early stage schizophrenia|early stage schizophrenia
5552935|NCT01075373|drug naïve schizophrenia|drug naïve schizophrenia
5552936|NCT01075373|treatment response|treatment response
5552937|NCT01075373|Aripiprazole|aripiprazole
5552938|NCT01075373|pharmacogenetics|pharmacogenetics
5552939|NCT01075373|Disrupted-in-Schizophrenia 1 gene (DISC1)|disrupted-in-schizophrenia 1 gene (disc1)
5552940|NCT01075373|Neuregulin 1 gene (NRG1)|neuregulin 1 gene (nrg1)
5552941|NCT01075373|Dopamine receptor type 2 gene (DRD2)|dopamine receptor type 2 gene (drd2)
5552942|NCT01075373|Catechol-O-Methyltransferase gene (COMT)|catechol-o-methyltransferase gene (comt)
5552943|NCT01075373|neurocognitive function|neurocognitive function
5552944|NCT01075373|event-related evoked potential (ERP)|event-related evoked potential (erp)
5552945|NCT01075373|Niacin skin test|niacin skin test
5552946|NCT01075373|plasma neurotransmitter level|plasma neurotransmitter level
5552947|NCT01075373|plasma cytokine level|plasma cytokine level
5552948|NCT01075373|plasma signaling protein level|plasma signaling protein level
5552949|NCT01075373|AKT1 protein level in the peripheral lymphocytes|akt1 protein level in the peripheral lymphocytes
5552950|NCT01075373|16-45 y/o|16-45 y/o
5552951|NCT01075373|without mental retardation or epilepsy|without mental retardation or epilepsy
5552952|NCT01075360|Neuroblastoma, MYCN, AHR|neuroblastoma, mycn, ahr
5552953|NCT01075347|autoserum|autoserum
5552954|NCT01075347|ocular surgery|ocular surgery
5552955|NCT01075347|corneal epithelium healing|corneal epithelium healing
5552956|NCT01075334|sperm|sperm
5552957|NCT01075334|male infertility|male infertility
5552958|NCT01075334|Carnitine|carnitine
5553151|NCT01074658|Advance|advance
5552959|NCT01075334|food supplementation|food supplementation
5552960|NCT01075334|insemination|insemination
5552961|NCT01075308|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5552962|NCT01075308|recurrent prostate cancer|recurrent prostate cancer
5552963|NCT01075308|stage IV prostate cancer|stage iv prostate cancer
5552964|NCT01075308|stage III prostate cancer|stage iii prostate cancer
5552965|NCT01075308|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5552966|NCT01075295|Schizophreniform Disorder|schizophreniform disorder
5552967|NCT01075295|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
5552968|NCT01075295|Bipolar I Disorder|bipolar i disorder
5552969|NCT01075295|Bipolar II Disorder|bipolar ii disorder
5552970|NCT01075295|Major Depressive Disorder with Psychotic Features,|major depressive disorder with psychotic features,
5552971|NCT01075295|Substance-Induced Psychoses|substance-induced psychoses
5552972|NCT01075295|Psychosis Not Otherwise Specified|psychosis not otherwise specified
5552973|NCT01075295|antipsychotic|antipsychotic
5552974|NCT01075295|weight gain|weight gain
5552975|NCT01075295|body mass index|body mass index
5552977|NCT01075295|waist circumference|waist circumference
5552978|NCT01075295|WC|wc
5552979|NCT01075295|coronary heart disease|coronary heart disease
5552980|NCT01075295|CHD|chd
5552981|NCT01075269|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom|robotic thyroidectomy, comparative study, cosmetic result, postoperative neck discomfort, swallowing symptom
5552982|NCT01075269|Robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome|robotic thyroidectomy, cosmetic effect, postoperative distress, surgical outcome
5552983|NCT01075256|sensitivity|sensitivity
5552984|NCT01075256|occlusion|occlusion
5552985|NCT01075243|dental pain|dental pain
5552986|NCT01075243|paracetamol|paracetamol
5552987|NCT01075243|Post-surgical dental pain|post-surgical dental pain
5552988|NCT01075230|PRP, TKA, pain scale, hemoglobin, hematocrit, narcotics|prp, tka, pain scale, hemoglobin, hematocrit, narcotics
5552989|NCT01075217|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5552990|NCT01075204|Respiratory Tract Infection|respiratory tract infection
5552991|NCT01075204|Clarithromycin|clarithromycin
5552992|NCT01075204|Recovery|recovery
5552993|NCT01075191|Viral load|viral load
5552994|NCT01075191|Resistance|resistance
5552995|NCT01075191|Double protease inhibitors|double protease inhibitors
5552996|NCT01075191|Mutations|mutations
5552997|NCT01075191|Immune system|immune system
5552998|NCT01075191|Infection|infection
5552999|NCT01075191|Nucleoside Reverse Transcriptase Inhibitors-free|nucleoside reverse transcriptase inhibitors-free
5553000|NCT01075191|Human Immunodeficiency Virus|human immunodeficiency virus
5553001|NCT01075178|Infection|infection
5553002|NCT01075178|Arrhythmia|arrhythmia
5553003|NCT01075178|Death|death
5553004|NCT01075178|Palivizumab|palivizumab
5553005|NCT01075178|Safety|safety
5553006|NCT01075178|Hemodynamically Significant Congenital Heart Disease|hemodynamically significant congenital heart disease
5553007|NCT01075178|Pediatric|pediatric
5553008|NCT01075178|Observational|observational
5553009|NCT01075165|silicone|silicone
5553010|NCT01075165|burn scar|burn scar
5553011|NCT01075165|hypertrophic scar|hypertrophic scar
5553012|NCT01075165|keloid|keloid
5553031|NCT01075113|advanced adult primary liver cancer|advanced adult primary liver cancer
5553032|NCT01075113|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5553033|NCT01075100|metastatic|metastatic
5553034|NCT01075100|breast|breast
5553035|NCT01075100|cancer|cancer
5553036|NCT01075087|TAP Block|tap block
5553037|NCT01075087|Pain|pain
5553038|NCT01075087|Obesity|obesity
5553039|NCT01075087|Surgery|surgery
5553040|NCT01075087|Laparoscopic Banding|laparoscopic banding
5553041|NCT01075074|Pain|pain
5553042|NCT01075074|TAP block|tap block
5553043|NCT01075074|Laparoscopic|laparoscopic
5553044|NCT01075074|Gynecologic|gynecologic
5553045|NCT01075061|Congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene|congenital mirror movement, physiopathology, imaging, transcranial magnetic stimulation, candidate gene
5553046|NCT01075048|Colorectal cancer|colorectal cancer
5553047|NCT01075048|wild-type KRAS|wild-type kras
5553048|NCT01075048|irinotecan|irinotecan
5553049|NCT01075048|cetuximab|cetuximab
5553050|NCT01075048|second-line therapy|second-line therapy
5553353|NCT01073787|headache|headache
5553051|NCT01075035|Traumatic Brain Injury|traumatic brain injury
5553052|NCT01075035|TBI|tbi
5553053|NCT01075035|Military|military
5553054|NCT01075035|Imaging|imaging
5553055|NCT01075035|MEG|meg
5553056|NCT01075035|PET/CT|pet/ct
5553057|NCT01075035|MRI|mri
5553058|NCT01075035|fMRI|fmri
5553059|NCT01075035|DTI|dti
5553060|NCT01075035|SANIC|sanic
5553061|NCT01075035|veteran|veteran
5553062|NCT01075009|Antibiotics|antibiotics
5553063|NCT01075009|Resistance|resistance
5553064|NCT01075009|Epidemiology|epidemiology
5553065|NCT01075009|Gram-negative bacteria|gram-negative bacteria
5553066|NCT01075009|Epidemiology of antibiotic use|epidemiology of antibiotic use
5553067|NCT01074996|Pancreatic cancer|pancreatic cancer
5553068|NCT01074996|S-1|s-1
5553069|NCT01074996|S-1 plus Leucovorin|s-1 plus leucovorin
5553070|NCT01074996|second-line therapy|second-line therapy
5553071|NCT01074983|Prehospital, Oxygen, Trauma, Hypoxemia|prehospital, oxygen, trauma, hypoxemia
5553072|NCT01074970|PARP inhibition + breast cancer|parp inhibition + breast cancer
5553073|NCT01074970|breast cancer|breast cancer
5553074|NCT01074970|PARP inhibitor|parp inhibitor
5553075|NCT01074970|Triple negative|triple negative
5553076|NCT01074944|Gaucher disease|gaucher disease
5553077|NCT01074944|Genz-112638|genz-112638
5553078|NCT01074944|beta-glucosidase|beta-glucosidase
5553079|NCT01074944|acid β-glucosidase|acid β-glucosidase
5553080|NCT01074944|glucocerebrosidase|glucocerebrosidase
5553081|NCT01074944|glucosylceramide|glucosylceramide
5553082|NCT01074944|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5553083|NCT01074944|substrate reduction therapy|substrate reduction therapy
5553084|NCT01074931|Lopinavir/ritonavir|lopinavir/ritonavir
5553085|NCT01074918|Pre-hypertension|pre-hypertension
5553086|NCT01074918|Hypertension|hypertension
5553087|NCT01074905|vivax malaria|vivax malaria
5553088|NCT01074905|artesunate|artesunate
5553089|NCT01074905|chloroquine|chloroquine
5553090|NCT01074905|primaquine|primaquine
5553091|NCT01074905|relapse|relapse
5553092|NCT01074892|endometrial hyperplasia treatment MPA per os LNG-IUD|endometrial hyperplasia treatment mpa per os lng-iud
5553093|NCT01074879|Elderly|elderly
5553094|NCT01074879|protein consumption|protein consumption
5553095|NCT01074879|resistance exercise|resistance exercise
5553096|NCT01074879|muscle mass|muscle mass
5553097|NCT01074866|Mechanical ventilation|mechanical ventilation
5553098|NCT01074866|Non invasive Ventilation|non invasive ventilation
5553099|NCT01074866|Patient-ventilator interaction|patient-ventilator interaction
5553100|NCT01074866|Pressure support|pressure support
5553101|NCT01074866|Neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5553102|NCT01074840|Food Hypersensitivity|food hypersensitivity
5553103|NCT01074840|Hypersensitivity|hypersensitivity
5553104|NCT01074840|Immune System Diseases|immune system diseases
5553105|NCT01074840|Hypersensitivity, Immediate|hypersensitivity, immediate
5553106|NCT01074840|Peanut Hypersensitivity|peanut hypersensitivity
5553107|NCT01074840|Food Allergy|food allergy
5553108|NCT01074827|Multiple Sclerosis|multiple sclerosis
5553109|NCT01074827|Walking ability|walking ability
5553110|NCT01074827|Strength|strength
5553111|NCT01074827|Balance|balance
5553112|NCT01074827|Treadmill walking|treadmill walking
5553113|NCT01074814|Metastatic Breast Cancer|metastatic breast cancer
5553114|NCT01074814|Molecular profiling|molecular profiling
5553115|NCT01074801|Closed-loop systems|closed-loop systems
5553116|NCT01074801|day-and-night glucose control|day-and-night glucose control
5553117|NCT01074788|rehabilitation|rehabilitation
5553118|NCT01074788|mind body therapy|mind body therapy
5553119|NCT01074788|integrative medicine|integrative medicine
5553120|NCT01074775|innate immunity|innate immunity
5553121|NCT01074775|mycobacterium bovis|mycobacterium bovis
5553122|NCT01074775|mucosal immunity|mucosal immunity
5553123|NCT01074775|adaptive immunity|adaptive immunity
5553124|NCT01074775|genomics|genomics
5553125|NCT01074762|Diabetes mellitus|diabetes mellitus
5553126|NCT01074762|Quality of health care|quality of health care
5553127|NCT01074762|Health services research|health services research
5553128|NCT01074749|AF|af
5553129|NCT01074749|Automatic Mode Switch|automatic mode switch
5553130|NCT01074749|FFRW|ffrw
5553131|NCT01074749|paroxysmal AF|paroxysmal af
5553132|NCT01074736|influenza A/H5N1|influenza a/h5n1
5553133|NCT01074736|host genetic susceptibility|host genetic susceptibility
5553134|NCT01074736|genotyping|genotyping
5553135|NCT01074723|b-cryptoxanthin|b-cryptoxanthin
5553136|NCT01074723|cholesterol|cholesterol
5553137|NCT01074723|bone markers|bone markers
5553138|NCT01074723|Osteoporosis|osteoporosis
5553139|NCT01074723|cardiovascular risk|cardiovascular risk
5553140|NCT01074723|post-menopausal women|post-menopausal women
5553141|NCT01074697|Randomized Controlled Trial|randomized controlled trial
5553142|NCT01074697|Serotonin Agonists|serotonin agonists
5553143|NCT01074697|Dexamethasone|dexamethasone
5553144|NCT01074697|Receptors, Neurokinin-1|receptors, neurokinin-1
5553145|NCT01074697|Radiotherapy|radiotherapy
5553146|NCT01074697|Cisplatin|cisplatin
5553147|NCT01074697|Prevention & control|prevention & control
5553148|NCT01074684|diagnosis|diagnosis
5553149|NCT01074684|nodules|nodules
5553150|NCT01074684|fine needle aspiration|fine needle aspiration
5553152|NCT01074658|Medtronic CoreValve System|medtronic corevalve system
5553153|NCT01074658|International|international
5553154|NCT01074658|Interventional|interventional
5553155|NCT01074658|Post Market Study|post market study
5553156|NCT01074645|Acute-on -chronic liver failure|acute-on -chronic liver failure
5553157|NCT01074645|Reactivation of hepatitis B|reactivation of hepatitis b
5553158|NCT01074645|Spontaneous reactivation of chronic hepatitis B presenting as to acute-on-chronic liver failure|spontaneous reactivation of chronic hepatitis b presenting as to acute-on-chronic liver failure
5553159|NCT01074606|Cataract|cataract
5553160|NCT01074593|PHARMACOKINETICS AND PHARMACODYNAMICS OF DRUG INTERFERON BETA-1A|pharmacokinetics and pharmacodynamics of drug interferon beta-1a
5553161|NCT01074580|Crohn's disease|crohn's disease
5553162|NCT01074580|sonography|sonography
5553163|NCT01074580|contrast enhanced ultrasound|contrast enhanced ultrasound
5553164|NCT01074554|sarcoidosis|sarcoidosis
5553165|NCT01074554|mycobacteria|mycobacteria
5553166|NCT01074554|cutaneous lesions|cutaneous lesions
5553167|NCT01074541|Vitamin D|vitamin d
5553168|NCT01074541|UVB|uvb
5553169|NCT01074541|Dose-Response|dose-response
5553170|NCT01074541|UV intensity|uv intensity
5553171|NCT01074541|Skin cancer|skin cancer
5553172|NCT01074528|cancer patients|cancer patients
5553173|NCT01074528|relatives or partners of cancer patients|relatives or partners of cancer patients
5553175|NCT01074515|Depression|depression
5553176|NCT01074515|Inflammation|inflammation
5553177|NCT01074515|Genetics|genetics
5553178|NCT01074515|Functioning|functioning
5553179|NCT01074515|Dyspnea|dyspnea
5553180|NCT01074515|Physical activity|physical activity
5553181|NCT01074502|acne|acne
5553182|NCT01074489|GDM|gdm
5553183|NCT01074489|Gestational Diabetes|gestational diabetes
5553184|NCT01074489|GTT|gtt
5553185|NCT01074489|CGMS|cgms
5553186|NCT01074476|Knee osteoarthritis|knee osteoarthritis
5553187|NCT01074476|glucosamine|glucosamine
5553188|NCT01074476|synovial fluid|synovial fluid
5553189|NCT01074476|viscosity|viscosity
5553190|NCT01074476|viscoelasticity|viscoelasticity
5553191|NCT01074476|WOMAC|womac
5553192|NCT01074463|Bioequivalence|bioequivalence
5553193|NCT01074463|Healthy Subjects|healthy subjects
5553194|NCT01074450|Bioequivalence|bioequivalence
5553195|NCT01074450|Healthy Subjects|healthy subjects
5553196|NCT01074424|stage IIB cervical cancer|stage iib cervical cancer
5553197|NCT01074424|stage III cervical cancer|stage iii cervical cancer
5553198|NCT01074424|stage IVA cervical cancer|stage iva cervical cancer
5553199|NCT01074424|cervical adenocarcinoma|cervical adenocarcinoma
5553200|NCT01074424|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5553201|NCT01074424|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5553202|NCT01074398|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5553203|NCT01074398|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5553204|NCT01074398|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5553205|NCT01074398|fallopian tube cancer|fallopian tube cancer
5553206|NCT01074398|peritoneal cavity cancer|peritoneal cavity cancer
5553207|NCT01074385|Stage IV Colorectal Cancer|stage iv colorectal cancer
5553208|NCT01074359|A3243G Mitochondrial DNA Point Mutation|a3243g mitochondrial dna point mutation
5553209|NCT01074346|Multiple sclerosis|multiple sclerosis
5553210|NCT01074346|Interferon-beta 1-a|interferon-beta 1-a
5553211|NCT01074333|Colorectal cancer|colorectal cancer
5553212|NCT01074333|Metastasis|metastasis
5553213|NCT01074333|Cetuximab|cetuximab
5553215|NCT01074333|Epidermal growth factor receptor|epidermal growth factor receptor
5553216|NCT01074320|breast cancer|breast cancer
5553217|NCT01074320|aromatase inhibitors|aromatase inhibitors
5553218|NCT01074320|musculoskeletal symptoms|musculoskeletal symptoms
5553219|NCT01074307|Systolic heart failure|systolic heart failure
5553220|NCT01074307|Bisoprolol|bisoprolol
5553221|NCT01074307|Concor|concor
5553222|NCT01074307|Echocardiogram|echocardiogram
5553223|NCT01074294|Inattention|inattention
5553224|NCT01074294|Hyperactivity|hyperactivity
5553225|NCT01074294|Impulsivity|impulsivity
5553226|NCT01074294|Distractibility|distractibility
5553227|NCT01074294|Procrastination|procrastination
5553228|NCT01074294|Disorganized|disorganized
5553229|NCT01074294|ADHD|adhd
5553230|NCT01074281|Hypertension|hypertension
5553231|NCT01074281|Isolated systolic hypertonia|isolated systolic hypertonia
5553232|NCT01074281|Eneas|eneas
5553233|NCT01074255|Nausea|nausea
5553234|NCT01074255|Vomiting|vomiting
5553235|NCT01074255|Chemotherapy|chemotherapy
5553236|NCT01074255|Post-chemotherapy|post-chemotherapy
5553237|NCT01074242|Gastroenteritis rotavirus|gastroenteritis rotavirus
5553238|NCT01074229|Pain|pain
5553239|NCT01074229|Post Operative|post operative
5553240|NCT01074229|Opioids|opioids
5553241|NCT01074229|Laparoscopic|laparoscopic
5553242|NCT01074229|Surgery|surgery
5553243|NCT01074229|Hysterectomy|hysterectomy
5553244|NCT01074216|Vitamin D|vitamin d
5553245|NCT01074216|Vitamin D3|vitamin d3
5553246|NCT01074216|colon cancer|colon cancer
5553247|NCT01074216|rectum cancer|rectum cancer
5553248|NCT01074216|Cholecalciferol|cholecalciferol
5553249|NCT01074216|09-143|09-143
5553354|NCT01073787|pediatric|pediatric
5553250|NCT01074203|nitazoxanide|nitazoxanide
5553251|NCT01074203|liver transplantation|liver transplantation
5553252|NCT01074203|HCV recurrence|hcv recurrence
5553253|NCT01074190|Epidural Labor Analgesia|epidural labor analgesia
5553254|NCT01074190|Pain|pain
5553255|NCT01074190|Infant|infant
5553256|NCT01074190|Breastfeeding|breastfeeding
5553257|NCT01074177|BIBW 2992|bibw 2992
5553258|NCT01074177|NSCLC|nsclc
5553259|NCT01074164|eczema|eczema
5553260|NCT01074164|atopic dermatitis|atopic dermatitis
5553261|NCT01074164|itch|itch
5553262|NCT01074164|pruritus|pruritus
5553263|NCT01074164|acupressure|acupressure
5553264|NCT01074164|acupuncture|acupuncture
5553265|NCT01074151|Pregnancy|pregnancy
5553266|NCT01074151|pregnant|pregnant
5553267|NCT01074151|Cymbalta|cymbalta
5553268|NCT01074151|Pregnancy Outcomes|pregnancy outcomes
5553269|NCT01074138|CPRC|cprc
5553270|NCT01074125|Hyperphosphatemia|hyperphosphatemia
5553271|NCT01074125|ESRD|esrd
5553272|NCT01074125|Dialysis|dialysis
5553273|NCT01074125|End Stage Renal Disease|end stage renal disease
5553274|NCT01074125|Phosphorus|phosphorus
5553275|NCT01074125|Renal|renal
5553276|NCT01074125|Kidney|kidney
5553277|NCT01074112|Ultrasound|ultrasound
5553278|NCT01074112|Prehospital|prehospital
5553279|NCT01074112|Trauma|trauma
5553280|NCT01074112|EMS|ems
5553281|NCT01074112|Paramedics|paramedics
5553282|NCT01074112|Sonography|sonography
5553283|NCT01074112|Ultrasonography|ultrasonography
5553284|NCT01074112|Ambulance|ambulance
5553285|NCT01074112|FAST|fast
5553286|NCT01074112|EFAST|efast
5535920|NCT01143155|Failure|failure
5553287|NCT01074086|RAD 001 in relapsed AML|rad 001 in relapsed aml
5553288|NCT01074073|Lithium DDI with Lurasidone HCl|lithium ddi with lurasidone hcl
5553289|NCT01074073|Male/Female, Schizophrenia Patients|male/female, schizophrenia patients
5553290|NCT01074047|Acute Myeloid Leukemia|acute myeloid leukemia
5553291|NCT01074047|Cytarabine|cytarabine
5553292|NCT01074047|Vidaza|vidaza
5553293|NCT01074047|azacitidine|azacitidine
5553294|NCT01074047|Intensive Chemotherapy|intensive chemotherapy
5553295|NCT01074047|Low Dose Cytarabine|low dose cytarabine
5553296|NCT01074047|Celgene|celgene
5553297|NCT01074021|Nimotuzumab|nimotuzumab
5547429|NCT01097161|Speech rate|speech rate
5553303|NCT01073995|Surgical Alternative|surgical alternative
5553304|NCT01073982|pain|pain
5553305|NCT01073982|inflammation|inflammation
5553306|NCT01073982|osteoarthritis|osteoarthritis
5553307|NCT01073969|prebiotic study|prebiotic study
5553308|NCT01073969|modulating colonic bacteria|modulating colonic bacteria
5553309|NCT01073956|Subacromial Impingement Syndrome|subacromial impingement syndrome
5553310|NCT01073956|Shoulder Pain|shoulder pain
5553311|NCT01073956|Physical therapy|physical therapy
5553312|NCT01073956|Electrotherapy|electrotherapy
5553313|NCT01073956|Ultrasonic therapy|ultrasonic therapy
5553314|NCT01073956|Medium-wave 448 kHz therapy|medium-wave 448 khz therapy
5553315|NCT01073943|Bowel Preparation|bowel preparation
5553316|NCT01073943|Colonoscopy|colonoscopy
5553317|NCT01073930|Bowel Preparation|bowel preparation
5553318|NCT01073930|Colonoscopy|colonoscopy
5553319|NCT01073917|Ventilation|ventilation
5553320|NCT01073917|General Anesthesia|general anesthesia
5553321|NCT01073917|electrical impedance tomography|electrical impedance tomography
5553322|NCT01073917|pressure support|pressure support
5553323|NCT01073917|spontaneous breathing|spontaneous breathing
5553324|NCT01073917|laryngeal mask|laryngeal mask
5553325|NCT01073917|Patients who are scheduled for elective knee or ankle surgery|patients who are scheduled for elective knee or ankle surgery
5553326|NCT01073891|Pharmacokinetics|pharmacokinetics
5553327|NCT01073891|Bioavailability|bioavailability
5553328|NCT01073891|Food effect|food effect
5553329|NCT01073891|Oral liquid formulation|oral liquid formulation
5553330|NCT01073878|Urinary Urge Incontinence|urinary urge incontinence
5553331|NCT01073878|Urinary Stress Incontinence|urinary stress incontinence
5553332|NCT01073878|Urinary Mixed Incontinence|urinary mixed incontinence
5553333|NCT01073865|ZOLADEX|zoladex
5553334|NCT01073865|Pre-menopausal|pre-menopausal
5553335|NCT01073865|Oestrogen Receptor|oestrogen receptor
5553336|NCT01073865|Advanced Breast Cancer|advanced breast cancer
5553337|NCT01073865|Progression Free Survival|progression free survival
5553338|NCT01073852|Chronic Urticaria|chronic urticaria
5553339|NCT01073852|Hives|hives
5553340|NCT01073852|Hydroxychloroquine|hydroxychloroquine
5553341|NCT01073813|Minocycline|minocycline
5553342|NCT01073813|Retinal nerve fibre layer thickness|retinal nerve fibre layer thickness
5553343|NCT01073813|Macular volume|macular volume
5553344|NCT01073813|Visual outcomes|visual outcomes
5553345|NCT01073800|atorvastatin|atorvastatin
5553346|NCT01073800|vascular occlusion|vascular occlusion
5553347|NCT01073800|myocardial infarction|myocardial infarction
5553348|NCT01073800|stroke|stroke
5553349|NCT01073800|renal failure|renal failure
5553350|NCT01073800|critically ill|critically ill
5553351|NCT01073800|Vascular occlusive events among the critically ill|vascular occlusive events among the critically ill
5553352|NCT01073787|migraine|migraine
5553355|NCT01073787|children|children
5553356|NCT01073787|Emergency Department|emergency department
5553357|NCT01073774|breast cancer couples coping|breast cancer couples coping
5553358|NCT01073748|Asthma|asthma
5553359|NCT01073748|Acetaminophen|acetaminophen
5553360|NCT01073748|paracetamol|paracetamol
5553361|NCT01073748|FeNO|feno
5553362|NCT01073748|Spirometry|spirometry
5553363|NCT01073748|Lung function|lung function
5553364|NCT01073735|Needs assessment|needs assessment
5553365|NCT01073735|Health-related needs|health-related needs
5553366|NCT01073735|Childhood cancer survivors|childhood cancer survivors
5553367|NCT01073722|thoracic surgery|thoracic surgery
5553368|NCT01073722|one-lung ventilation|one-lung ventilation
5553369|NCT01073722|double lumen tube|double lumen tube
5553370|NCT01073722|endobronchial blocker|endobronchial blocker
5553371|NCT01073709|Acetaminophen fasting study|acetaminophen fasting study
5553372|NCT01073696|Sancuso|sancuso
5553373|NCT01073696|granisetron|granisetron
5553374|NCT01073696|Pharmacokinetics|pharmacokinetics
5553375|NCT01073683|TPF|tpf
5553376|NCT01073683|INDUCTION CHEMOTHERAPY|induction chemotherapy
5553377|NCT01073683|LARYNX PRESERVATION|larynx preservation
5553378|NCT01073683|SUPACRICOID LARYNGECTOMY|supacricoid laryngectomy
5553379|NCT01073683|Stage 3 and 4 larynx cancer|stage 3 and 4 larynx cancer
5553380|NCT01073670|NSAIDs|nsaids
5553381|NCT01073670|bleeding|bleeding
5553382|NCT01073670|thromboelastography|thromboelastography
5553383|NCT01073670|cardiac surgery|cardiac surgery
5553384|NCT01073670|Indomethacin|indomethacin
5553385|NCT01073670|acetaminophen|acetaminophen
5553386|NCT01073657|Rehabilitation|rehabilitation
5553387|NCT01073644|imatinib resistant or intolerant|imatinib resistant or intolerant
5553388|NCT01073631|voriconazole|voriconazole
5553389|NCT01073631|Korea|korea
5553390|NCT01073631|invasive fungal infection|invasive fungal infection
5553391|NCT01073618|voriconazole|voriconazole
5553392|NCT01073618|Korea|korea
5553393|NCT01073618|invasive fungal infection|invasive fungal infection
5553394|NCT01073605|Short height|short height
5553508|NCT01073176|ADHD|adhd
5553395|NCT01073605|intra-uterine growth retardation|intra-uterine growth retardation
5553396|NCT01073605|Genotonorm|genotonorm
5553397|NCT01073605|continuous treatment|continuous treatment
5553398|NCT01073605|intermittent treatment|intermittent treatment
5553400|NCT01073592|CNV|cnv
5553401|NCT01073592|AMD|amd
5553402|NCT01073592|PHP|php
5553403|NCT01073592|HPHP|hphp
5553404|NCT01073592|FORESEE HOME|foresee home
5553405|NCT01073579|Cryptogenic Infantile Spasms|cryptogenic infantile spasms
5553406|NCT01073579|Cryptogenic West Syndrome|cryptogenic west syndrome
5553407|NCT01073579|Hypsarrhythmia|hypsarrhythmia
5553408|NCT01073579|Infantile Spasms|infantile spasms
5553409|NCT01073579|Symptomatic Infantile Spasms|symptomatic infantile spasms
5553410|NCT01073579|Symptomatic West Syndrome|symptomatic west syndrome
5553411|NCT01073579|West Syndrome|west syndrome
5553412|NCT01073579|Refractory Complex Partial Seizures|refractory complex partial seizures
5553413|NCT01073579|Complex Partial Epilepsy|complex partial epilepsy
5553414|NCT01073579|Complex Partial Seizure Disorder|complex partial seizure disorder
5553415|NCT01073579|Cryptogenic Partial Complex Epilepsy|cryptogenic partial complex epilepsy
5553416|NCT01073579|Disorder, Complex Partial Seizures|disorder, complex partial seizures
5553417|NCT01073579|Epilepsy, Cryptogenic, Partial Complex|epilepsy, cryptogenic, partial complex
5553418|NCT01073579|Epilepsy, Psychic Equivalent|epilepsy, psychic equivalent
5553419|NCT01073579|Epilepsy, Psychomotor|epilepsy, psychomotor
5553420|NCT01073579|Epilepsy, Symptomatic, Partial Complex|epilepsy, symptomatic, partial complex
5553421|NCT01073579|Partial Complex Epilepsy, Cryptogenic|partial complex epilepsy, cryptogenic
5553422|NCT01073579|Partial Complex Epilepsy, Symptomatic|partial complex epilepsy, symptomatic
5553423|NCT01073579|Seizure Disorder, Complex Partial|seizure disorder, complex partial
5553424|NCT01073579|Symptomatic Partial Complex Epilepsy|symptomatic partial complex epilepsy
5553425|NCT01073566|Autoimmune Diseases|autoimmune diseases
5553426|NCT01073566|Diabetes Mellitus|diabetes mellitus
5553427|NCT01073566|Endocrine System Diseases|endocrine system diseases
5553428|NCT01073566|Glucose Metabolism Disorders|glucose metabolism disorders
5553429|NCT01073566|Immune System Diseases|immune system diseases
5553430|NCT01073566|Insulin|insulin
5553431|NCT01073566|Metabolic Diseases|metabolic diseases
5553432|NCT01073527|Child, preschool|child, preschool
5553433|NCT01073527|Pediatric emergency department|pediatric emergency department
5553434|NCT01073514|Malignant biliary obstruction (MBO)|malignant biliary obstruction (mbo)
5553435|NCT01073501|UREMIC PRURITUS|uremic pruritus
5553436|NCT01073501|PREGABALIN|pregabalin
5553437|NCT01073501|UP|up
5553438|NCT01073488|Pregnancy|pregnancy
5553439|NCT01073488|Maternal child health|maternal child health
5553440|NCT01073488|Developing countries|developing countries
5553441|NCT01073488|Stillbirth|stillbirth
5553442|NCT01073488|Neonatal mortality|neonatal mortality
5553443|NCT01073488|Maternal mortality|maternal mortality
5553444|NCT01073488|Community intervention|community intervention
5553445|NCT01073488|Community mobilization|community mobilization
5553446|NCT01073488|Home-based Life Saving Skills|home-based life saving skills
5553447|NCT01073475|Pregnancy|pregnancy
5553448|NCT01073475|Maternal mortality|maternal mortality
5553449|NCT01073475|Neonatal mortality|neonatal mortality
5553450|NCT01073475|Stillbirth|stillbirth
5553451|NCT01073475|Maternal Cause of Death|maternal cause of death
5553452|NCT01073475|Neonatal Cause of Death|neonatal cause of death
5553453|NCT01073462|Secondary Hyperparathyroidism (sHPT)|secondary hyperparathyroidism (shpt)
5553454|NCT01073462|Paricalcitol|paricalcitol
5553455|NCT01073462|Chronic kidney disease stage 5 (CKD stage 5)|chronic kidney disease stage 5 (ckd stage 5)
5553456|NCT01073449|Cardiac devices|cardiac devices
5553457|NCT01073449|In-Hospital Follow-up|in-hospital follow-up
5553458|NCT01073449|Analytical|analytical
5553459|NCT01073436|diagnosis of Ph+) CML in chronic phase.|diagnosis of ph+) cml in chronic phase.
5553460|NCT01073436|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response|prior therapy with interferon-alpha for at least 2 years, and achieved at least a partial cytogenetic response
5553461|NCT01073436|receiving a TKI (imatinib mesylate, dasatinib, nilotinib)|receiving a tki (imatinib mesylate, dasatinib, nilotinib)
5553464|NCT01073436|No blasts or promyelocytes in peripheral blood.|no blasts or promyelocytes in peripheral blood.
5553465|NCT01073436|No evidence of disease-related symptoms and extramedullary disease|no evidence of disease-related symptoms and extramedullary disease
5553466|NCT01073436|complete cytogenetic response (CCyR) on a TKI for a minimum of 1 yr|complete cytogenetic response (ccyr) on a tki for a minimum of 1 yr
5553467|NCT01073436|major molecular remission on a TKI for a minimum of 1 yr|major molecular remission on a tki for a minimum of 1 yr
5553468|NCT01073436|18 years of age or older|18 years of age or older
5553469|NCT01073436|ECOG performance status of 0-2 (Appendix 13.1)|ecog performance status of 0-2 (appendix 13.1)
5553470|NCT01073436|Informed Consent|informed consent
5553473|NCT01073423|insomnia|insomnia
5553474|NCT01073423|yoga|yoga
5553475|NCT01073423|music|music
5553476|NCT01073397|Menopause|menopause
5553477|NCT01073397|Hot Flashes|hot flashes
5553478|NCT01073397|Vasomotor symptoms|vasomotor symptoms
5553480|NCT01073371|Liposome|liposome
5553481|NCT01073371|Prilocaine|prilocaine
5553482|NCT01073371|Dental anesthesia|dental anesthesia
5553483|NCT01073358|resectable hepatic metastases of colorectal cancer|resectable hepatic metastases of colorectal cancer
5553484|NCT01073345|Patients undergoing elective hepatic resection|patients undergoing elective hepatic resection
5553485|NCT01073319|Methamphetamine|methamphetamine
5553486|NCT01073319|Rivastigmine|rivastigmine
5553487|NCT01073306|Vaccine|vaccine
5553488|NCT01073306|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5553489|NCT01073280|Cerebral and subarachnoid biopsy|cerebral and subarachnoid biopsy
5553490|NCT01073280|flexible endoscopy|flexible endoscopy
5553491|NCT01073280|Patients with neurological findings without diagnosis.|patients with neurological findings without diagnosis.
5553492|NCT01073267|Stage IB-IIIA Mycosis fungoides|stage ib-iiia mycosis fungoides
5553493|NCT01073267|Total Skin Electron Beam Therapy|total skin electron beam therapy
5553494|NCT01073267|TSEBT|tsebt
5553495|NCT01073241|benign prostatic hyperplasia|benign prostatic hyperplasia
5553496|NCT01073241|Transurethral Resection of Prostate|transurethral resection of prostate
5553497|NCT01073241|transurethral enucleation of prostate|transurethral enucleation of prostate
5553498|NCT01073228|Alzheimer's disease|alzheimer's disease
5553499|NCT01073228|Central Nervous System diseases|central nervous system diseases
5553500|NCT01073228|Cognition|cognition
5553501|NCT01073215|Adolescents|adolescents
5553502|NCT01073215|Obesity|obesity
5553503|NCT01073215|Weight Management|weight management
5553504|NCT01073215|Family-based Lifestyle Modification|family-based lifestyle modification
5553505|NCT01073189|Acute kidney injury|acute kidney injury
5553506|NCT01073189|Fenoldopam mesylate|fenoldopam mesylate
5553507|NCT01073189|Benephit catheter|benephit catheter
5553509|NCT01073176|Executive function|executive function
5553510|NCT01073176|Preschool children|preschool children
5553511|NCT01073176|Treatment|treatment
5553512|NCT01073176|Memory|memory
5553513|NCT01073176|Attention|attention
5553514|NCT01073176|Training|training
5553515|NCT01073176|Cognitive enhancement|cognitive enhancement
5553516|NCT01073150|Tea Tree Oil|tea tree oil
5553517|NCT01073150|Chronic Blepharitis|chronic blepharitis
5553518|NCT01073137|diabetes|diabetes
5553519|NCT01073072|bovine pericardium bioprosthesis|bovine pericardium bioprosthesis
5553520|NCT01073072|contamination|contamination
5553521|NCT01073072|hernia repair|hernia repair
5553522|NCT01073072|abdominal wall reconstruction|abdominal wall reconstruction
5553523|NCT01073072|Tutomesh|tutomesh
5553524|NCT01073072|Tutopatch|tutopatch
5553525|NCT01073072|Potentially Contaminated Hernia Repair|potentially contaminated hernia repair
5553526|NCT01073072|Potentially Contaminated Abdominal Wall Reconstruction|potentially contaminated abdominal wall reconstruction
5553527|NCT01073059|valproic acid|valproic acid
5553528|NCT01073059|ertapenem|ertapenem
5553529|NCT01073046|Naso-Gastric/Jejunal Tube|naso-gastric/jejunal tube
5553530|NCT01073046|Sub-total Gastrectomy|sub-total gastrectomy
5553531|NCT01073046|Gastric Cancer|gastric cancer
5553532|NCT01073046|Decompression|decompression
5553533|NCT01073046|Discomfort|discomfort
5553534|NCT01073046|Complications|complications
5553535|NCT01073033|pregnancy|pregnancy
5553536|NCT01073033|lactation|lactation
5553537|NCT01073033|oral supplement|oral supplement
5553538|NCT01073033|probiotics|probiotics
5553539|NCT01073033|early infections|early infections
5553540|NCT01073020|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5553541|NCT01073020|Obesity|obesity
5553542|NCT01073020|Lifestyle|lifestyle
5553543|NCT01073020|Bariatric Surgery|bariatric surgery
5553544|NCT01073020|Laparoscopic Adjustable Gastric Band|laparoscopic adjustable gastric band
5553545|NCT01073020|Laparoscopic Roux-en-Y Gastric Bypass|laparoscopic roux-en-y gastric bypass
5553546|NCT01073007|Acute Stroke|acute stroke
5553547|NCT01073007|tissue plasminogen activator|tissue plasminogen activator
5553548|NCT01073007|simvastatin|simvastatin
5556182|NCT01061788|RAD001|rad001
5553549|NCT01072994|Myocardium|myocardium
5553550|NCT01072994|Phospholipid|phospholipid
5553551|NCT01072994|Fish oil|fish oil
5553552|NCT01072994|Cardiolipin|cardiolipin
5553553|NCT01072994|Transplantation|transplantation
5553554|NCT01072981|Pancreatic Cancer|pancreatic cancer
5553555|NCT01072981|Vaccine Therapy|vaccine therapy
5553556|NCT01072968|Multicenter|multicenter
5553557|NCT01072968|Randomized|randomized
5553558|NCT01072968|Double-blind|double-blind
5553559|NCT01072968|Efficacy and safety study|efficacy and safety study
5553560|NCT01072968|BF2.649 versus placebo|bf2.649 versus placebo
5553561|NCT01072968|Patients suffering from Obstructive Sleep Apnea|patients suffering from obstructive sleep apnea
5553562|NCT01072968|Complaining from Excessive Daytime Sleepiness|complaining from excessive daytime sleepiness
5553563|NCT01072968|Refusing nasal Continuous Positive Airway Pressure|refusing nasal continuous positive airway pressure
5553564|NCT01072942|Chronic Obstructive|chronic obstructive
5553565|NCT01072942|Phase I|phase i
5553566|NCT01072942|Pharmacokinetics|pharmacokinetics
5553567|NCT01072942|Microbiology|microbiology
5553568|NCT01072929|Bipolar I Disorder|bipolar i disorder
5553569|NCT01072916|Colon, Irritable|colon, irritable
5553570|NCT01072916|Microbiota|microbiota
5553571|NCT01072903|inflammation|inflammation
5553572|NCT01072903|colon, irritable|colon, irritable
5553573|NCT01072903|Colonic Diseases, Functional|colonic diseases, functional
5553574|NCT01072903|Irritable Bowel Syndrome|irritable bowel syndrome
5553575|NCT01072890|Temsirolimus, Pazopanib|temsirolimus, pazopanib
5553576|NCT01072877|Varicose Veins|varicose veins
5553577|NCT01072864|Postmenopausal|postmenopausal
5553578|NCT01072851|colorectal cancer screening|colorectal cancer screening
5553579|NCT01072851|multimedia education|multimedia education
5553580|NCT01072851|print education|print education
5553581|NCT01072851|culturally competent|culturally competent
5553582|NCT01072838|breast cancer|breast cancer
5553583|NCT01072838|APBI|apbi
5553584|NCT01072838|brachytherapy|brachytherapy
5553585|NCT01072838|Contura|contura
5553586|NCT01072812|Alzheimer's|alzheimer's
5553587|NCT01072812|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5553588|NCT01072812|Pharmacokinetics|pharmacokinetics
5553589|NCT01072812|Pharmacodynamics|pharmacodynamics
5553590|NCT01072812|Biomarkers|biomarkers
5553591|NCT01072799|A (H1N1)|a (h1n1)
5553592|NCT01072786|Dengue Virus|dengue virus
5553593|NCT01072786|Dengue Fever|dengue fever
5553594|NCT01072786|Dengue Vaccine|dengue vaccine
5553595|NCT01072786|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5553596|NCT01072786|Dengue Shock Syndrome|dengue shock syndrome
5553597|NCT01072760|Mallet finger|mallet finger
5553598|NCT01072760|extensor tendon|extensor tendon
5553599|NCT01072760|Kirschner wire|kirschner wire
5553600|NCT01072760|Fracture Fixation|fracture fixation
5553601|NCT01072734|Lupus|lupus
5553602|NCT01072734|CXCR4 on leucocytes of patients with SLE|cxcr4 on leucocytes of patients with sle
5553603|NCT01072734|Influenza vaccine|influenza vaccine
5553604|NCT01072721|Liver|liver
5553605|NCT01072721|Fibrosis|fibrosis
5553606|NCT01072721|Elastometry|elastometry
5553607|NCT01072721|FIBROSCANN|fibroscann
5553608|NCT01072721|Children|children
5553609|NCT01072708|Cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors|cystic fibrosis -diabetes - glucose tolerance - reversibility - oral glucose tolerance test - predictive factors
5553610|NCT01072695|Hepatitis C|hepatitis c
5553611|NCT01072695|HCV|hcv
5553612|NCT01072695|GS-9256|gs-9256
5553613|NCT01072695|GS-9190|gs-9190
5553614|NCT01072695|Genotype 1|genotype 1
5553615|NCT01072682|Acute Renal Failure|acute renal failure
5553616|NCT01072682|Acute tubular necrosis|acute tubular necrosis
5553617|NCT01072682|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5553618|NCT01072682|Selective cytopheretic device|selective cytopheretic device
5685376|NCT00556374|progesterone receptor positive|progesterone receptor positive
5685377|NCT00556374|non-steroidal aromatase|non-steroidal aromatase
5685378|NCT00556374|aromatase inhibitor therapy|aromatase inhibitor therapy
5553619|NCT01072669|Ambrisentan increases digital micro-vascular flow (measured by LDPI) in patients with Raynaud's phenomenon (RP) and digital ischemia secondary to SSc.|ambrisentan increases digital micro-vascular flow (measured by ldpi) in patients with raynaud's phenomenon (rp) and digital ischemia secondary to ssc.
5553620|NCT01072643|Sedation|sedation
5553621|NCT01072643|Pulmonary Hypertension|pulmonary hypertension
5553622|NCT01072643|Pediatric|pediatric
5553623|NCT01072643|Cardiac Catheterization|cardiac catheterization
5553624|NCT01072643|Pulmonary Vascular Resistance|pulmonary vascular resistance
5553625|NCT01072630|Bipolar I Disorder|bipolar i disorder
5553626|NCT01072604|Aspirin|aspirin
5553627|NCT01072604|Acetylsalicylic Acid|acetylsalicylic acid
5553628|NCT01072591|anti-NGF|anti-ngf
5553630|NCT01072591|pain|pain
5553631|NCT01072578|Healthy volunteers|healthy volunteers
5553632|NCT01072578|Inhibition of glucose re-absorption|inhibition of glucose re-absorption
5553633|NCT01072578|diabetes|diabetes
5553634|NCT01072578|dapagliflozin|dapagliflozin
5553635|NCT01072565|Type 2 Diabetes|type 2 diabetes
5553636|NCT01072565|A1c|a1c
5553637|NCT01072565|Continuous Glucose Monitoring|continuous glucose monitoring
5553638|NCT01072565|Blood Glucose|blood glucose
5553639|NCT01072552|recurrent wheezing|recurrent wheezing
5553640|NCT01072552|asthma|asthma
5553641|NCT01072552|preterm infants|preterm infants
5553642|NCT01072552|palivizumab|palivizumab
5553643|NCT01072552|atopic diseases|atopic diseases
5553644|NCT01072539|infection|infection
5553645|NCT01072539|Tygacil|tygacil
5553646|NCT01072539|PMS|pms
5553647|NCT01072526|Dry Eye Syndromes|dry eye syndromes
5553648|NCT01072526|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
5553649|NCT01072513|Semen Analysis, Prostate Cancer, Proton Radiation|semen analysis, prostate cancer, proton radiation
5553650|NCT01072500|Aging|aging
5553651|NCT01072500|Physical Activity|physical activity
5553652|NCT01072500|Exercise|exercise
5553653|NCT01072500|Sedentary Lifestyle|sedentary lifestyle
5553654|NCT01072500|Mobility|mobility
5553655|NCT01072500|Disability|disability
5553656|NCT01072500|Falls|falls
5553657|NCT01072500|Cost effectiveness|cost effectiveness
5553658|NCT01072500|Behavioral counseling|behavioral counseling
5553659|NCT01072487|Safety|safety
5553660|NCT01072487|Sedation|sedation
5553661|NCT01072487|Gastrointestinal endoscopy|gastrointestinal endoscopy
5553662|NCT01072487|Colonoscopy|colonoscopy
5553664|NCT01072474|Sedation|sedation
5553665|NCT01072474|Gastrointestinal endoscopy|gastrointestinal endoscopy
5553666|NCT01072474|Colonoscopy|colonoscopy
5553667|NCT01072461|Cerebrovascular Accident|cerebrovascular accident
5553668|NCT01072461|Robotics|robotics
5553669|NCT01072461|Virtual Reality|virtual reality
5553670|NCT01072461|Rehabilitation|rehabilitation
5553671|NCT01072461|Neuroplasticity|neuroplasticity
5553673|NCT01072448|indacaterol|indacaterol
5553674|NCT01072435|ERCP|ercp
5553675|NCT01072435|patient-controlled sedation|patient-controlled sedation
5553676|NCT01072435|target-controlled infusion|target-controlled infusion
5553677|NCT01072435|propofol|propofol
5553678|NCT01072435|Sedation with propofol for ERCP|sedation with propofol for ercp
5553679|NCT01072435|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5553680|NCT01072422|Smoking|smoking
5553681|NCT01072422|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5553682|NCT01072422|Questionnaires|questionnaires
5553683|NCT01072422|Nurses|nurses
5553684|NCT01072422|Primary Health Care|primary health care
5553685|NCT01072409|Speech perception ability in the CI alone condition|speech perception ability in the ci alone condition
5553686|NCT01072383|chronic plaque psoriasis|chronic plaque psoriasis
5553687|NCT01072383|psoriasis vulgaris|psoriasis vulgaris
5553688|NCT01072383|autoimmune disease|autoimmune disease
5553689|NCT01072370|Umbilical Cord Blood|umbilical cord blood
5553690|NCT01072370|Stem Cells|stem cells
5553691|NCT01072370|Autologous Blood Transfusion|autologous blood transfusion
5553692|NCT01072370|Cerebral Palsy|cerebral palsy
5553693|NCT01072357|High-Risk Corneal Transplantation|high-risk corneal transplantation
5553694|NCT01072357|Penetrating Keratoplasty|penetrating keratoplasty
5553695|NCT01072357|Neovascularization|neovascularization
5553696|NCT01072357|Corneal Blood Vessels|corneal blood vessels
5553697|NCT01072357|Avastin|avastin
5553698|NCT01072357|Bevacizumab|bevacizumab
5553699|NCT01072357|Corneal Graft|corneal graft
5553700|NCT01072344|Anxiety|anxiety
5553701|NCT01072344|Chamomile|chamomile
5553702|NCT01072344|Herbal Remedy|herbal remedy
5553703|NCT01072344|Complementary and Alternative Medicine|complementary and alternative medicine
5553704|NCT01072331|insulin resistance|insulin resistance
5553705|NCT01072318|Breast cancer|breast cancer
5553706|NCT01072318|extended adjuvant hormonal therapy|extended adjuvant hormonal therapy
5553707|NCT01072318|letrozole|letrozole
5553708|NCT01072318|Toremifene|toremifene
5553709|NCT01072305|fluid restriction|fluid restriction
5553710|NCT01072305|fluid therapy|fluid therapy
5553711|NCT01072305|intraoperative care|intraoperative care
5553712|NCT01072279|Malnutrition;|malnutrition;
5553713|NCT01072279|Infant nutrition;|infant nutrition;
5553714|NCT01072279|Fortified food|fortified food
5553715|NCT01072279|Linear growth|linear growth
5553716|NCT01072279|Cluster randomized controlled trials|cluster randomized controlled trials
5553717|NCT01072279|Effectiveness|effectiveness
5553718|NCT01072279|Impact evaluation studies|impact evaluation studies
5553719|NCT01072279|Burundi|burundi
5553720|NCT01072279|Guatemala|guatemala
5553721|NCT01072266|Refractory, Advanced malignancies|refractory, advanced malignancies
5553722|NCT01072227|Non-typeable Haemophilus Influenzae|non-typeable haemophilus influenzae
5553723|NCT01072227|Acute Otitis Media|acute otitis media
5553724|NCT01072227|Streptococcus Pneumoniae|streptococcus pneumoniae
5553725|NCT01072227|Etiology|etiology
5553726|NCT01072214|Pazopanib|pazopanib
5553727|NCT01072214|Tolerability|tolerability
5553728|NCT01072214|Pharmacokinetics|pharmacokinetics
5553729|NCT01072214|GW786034|gw786034
5553730|NCT01072214|Safety|safety
5553731|NCT01072175|drug-drug interaction|drug-drug interaction
5553732|NCT01072175|BRAF inhibitor|braf inhibitor
5553733|NCT01072175|expansion cohorts|expansion cohorts
5553734|NCT01072175|melanoma|melanoma
5553735|NCT01072175|dose escalation|dose escalation
5553736|NCT01072175|MEK inhibitor|mek inhibitor
5553737|NCT01072162|healthy|healthy
5553738|NCT01072162|powder for suspension|powder for suspension
5553739|NCT01072162|tablets|tablets
5553740|NCT01072162|bioavailibility|bioavailibility
5553741|NCT01072162|eltrombopag|eltrombopag
5553742|NCT01072149|COPD|copd
5553743|NCT01072149|Safety|safety
5553744|NCT01072149|FEV1|fev1
5553745|NCT01072149|Efficacy|efficacy
5553746|NCT01072136|mucopurulent cervicitis, chlamydia, gonorrhea, women|mucopurulent cervicitis, chlamydia, gonorrhea, women
5553747|NCT01072110|Patients with diarrhea|patients with diarrhea
5553748|NCT01072097|PCOS|pcos
5553749|NCT01072097|Atorvastatin|atorvastatin
5553750|NCT01072097|Androgens|androgens
5553751|NCT01072097|Glucose metabolism|glucose metabolism
5553752|NCT01072097|Inflammatory markers|inflammatory markers
5553753|NCT01072084|food allergy|food allergy
5553754|NCT01072084|confocal laser endoscope|confocal laser endoscope
5553755|NCT01072084|diagnosis|diagnosis
5553756|NCT01072084|Diagnosis of food allergy|diagnosis of food allergy
5553757|NCT01072071|abdominal compartment syndrome|abdominal compartment syndrome
5553758|NCT01072071|intra-abdominal pressure|intra-abdominal pressure
5538769|NCT01132547|hypothalamic glioma|hypothalamic glioma
5553759|NCT01072071|furosemide|furosemide
5553760|NCT01072071|fluid balance|fluid balance
5553761|NCT01072058|Infliximab|infliximab
5553762|NCT01072058|Adalimumab|adalimumab
5553763|NCT01072058|Etanercept|etanercept
5553764|NCT01072058|Heart failure|heart failure
5553765|NCT01072058|Diastolic disfunction|diastolic disfunction
5553766|NCT01072058|TNF blocker|tnf blocker
5553767|NCT01072058|Anti-TNF|anti-tnf
5553768|NCT01072058|Echocardiography|echocardiography
5553769|NCT01072058|Tissue doppler imaging|tissue doppler imaging
5553770|NCT01072058|Brain Natriuretic Peptide|brain natriuretic peptide
5553771|NCT01072058|NT-proBNP|nt-probnp
5553772|NCT01072045|Hemangioma|hemangioma
5553773|NCT01072045|Proliferative hemangioma|proliferative hemangioma
5553774|NCT01072045|Treatment|treatment
5553775|NCT01072045|Propranolol|propranolol
5553776|NCT01072045|Corticosteroid|corticosteroid
5553778|NCT01072032|Robotics (ankle)|robotics (ankle)
5553779|NCT01072032|Motor-learning|motor-learning
5553780|NCT01072032|Brain Plasticity|brain plasticity
5553781|NCT01072006|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5553782|NCT01072006|PTSD|ptsd
5553783|NCT01072006|fMRI|fmri
5553784|NCT01072006|attention|attention
5553785|NCT01071993|prevention|prevention
5553786|NCT01071993|nephropathy|nephropathy
5553787|NCT01071967|Community Health Nursing|community health nursing
5553788|NCT01071967|Nursing Care Management|nursing care management
5553789|NCT01071967|Aged|aged
5553790|NCT01071967|Aged, 80 and over|aged, 80 and over
5553791|NCT01071967|Health Services for the Aged|health services for the aged
5553792|NCT01071967|Geriatric Nursing|geriatric nursing
5553793|NCT01071967|Geriatric Assessment|geriatric assessment
5553794|NCT01071967|Longevity|longevity
5553795|NCT01071967|Mortality|mortality
5553796|NCT01071954|Immune thrombocytopenic Purpura|immune thrombocytopenic purpura
5553797|NCT01071954|Pediatric|pediatric
5553798|NCT01071954|Thrombocytopenia|thrombocytopenia
5553799|NCT01071941|rRp450|rrp450
5553800|NCT01071941|Herpes virus|herpes virus
5553801|NCT01071941|Gene therapy|gene therapy
5553802|NCT01071928|Advanced Urothelial Carcinoma|advanced urothelial carcinoma
5553803|NCT01071902|ear tubes|ear tubes
5553804|NCT01071902|ear drainage|ear drainage
5553805|NCT01071902|ear infection|ear infection
5553806|NCT01071902|ear drops|ear drops
5553807|NCT01071902|acute otitis media|acute otitis media
5553808|NCT01071889|Healthy Volunteers|healthy volunteers
5553809|NCT01071876|Sleep disorder|sleep disorder
5553810|NCT01071876|obstructive sleep apnea|obstructive sleep apnea
5553811|NCT01071876|excessive daytime sleepiness|excessive daytime sleepiness
5685379|NCT00556374|postmenopausal woman|postmenopausal woman
5553812|NCT01071876|patients with OSA treated by CPAP presenting EDS|patients with osa treated by cpap presenting eds
5553813|NCT01071850|ASP1941|asp1941
5553814|NCT01071850|Metformin|metformin
5553815|NCT01071850|Type 2 diabetes|type 2 diabetes
5553816|NCT01071850|diabetes|diabetes
5553817|NCT01071837|Glioblastoma Multiforme|glioblastoma multiforme
5553818|NCT01071824|size|size
5553819|NCT01071824|limb|limb
5553820|NCT01071824|transverse coloplasty pouch|transverse coloplasty pouch
5553821|NCT01071824|rectal resection|rectal resection
5553822|NCT01071824|mesorectal excision|mesorectal excision
5553823|NCT01071824|treatment outcome|treatment outcome
5553824|NCT01071811|Randomized controlled trial|randomized controlled trial
5553825|NCT01071811|Pedometer|pedometer
5553826|NCT01071811|Physical activity|physical activity
5553827|NCT01071811|Health measurement|health measurement
5553828|NCT01071811|Self-rated health|self-rated health
5553829|NCT01071811|Stress|stress
5553830|NCT01071811|Sleep quality|sleep quality
5553831|NCT01071785|Metabolic Syndrome|metabolic syndrome
5553832|NCT01071785|diet|diet
5553833|NCT01071785|fiber|fiber
5553834|NCT01071785|Serum lipids|serum lipids
5553835|NCT01071785|Albuminuria|albuminuria
5553836|NCT01071759|Pregnancy|pregnancy
5553837|NCT01071759|anemia|anemia
5553838|NCT01071759|Helicobacter pylori|helicobacter pylori
5553839|NCT01071759|Hemoglobin|hemoglobin
5553840|NCT01071759|Iron|iron
5553841|NCT01071759|Ferritin|ferritin
5553842|NCT01071720|Healthy subjects|healthy subjects
5553844|NCT01071707|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5553845|NCT01071694|Multiple Sclerosis,|multiple sclerosis,
5553846|NCT01071694|Relapsing-Remitting,|relapsing-remitting,
5553847|NCT01071694|Interferon beta-1b,|interferon beta-1b,
5553848|NCT01071694|Quality of life|quality of life
5553849|NCT01071681|Arterial hypertension|arterial hypertension
5553850|NCT01071668|onset of labor|onset of labor
5553851|NCT01071668|metabolomics|metabolomics
5553852|NCT01071668|vaginal secretions|vaginal secretions
5553853|NCT01071668|urine|urine
5553854|NCT01071668|blood|blood
5553855|NCT01071655|colorectal cancer|colorectal cancer
5553856|NCT01071655|Bevacizumab|bevacizumab
5553857|NCT01071655|Oxaliplatin|oxaliplatin
5553858|NCT01071655|Irinotecan|irinotecan
5553859|NCT01071655|5FU|5fu
5553860|NCT01071655|capecitabine|capecitabine
5553861|NCT01071642|Change in eGFR from baseline to 72 hours following the exposure to the contrast.|change in egfr from baseline to 72 hours following the exposure to the contrast.
5553862|NCT01071642|Rate of eGFR decrease>25% from the baseline|rate of egfr decrease>25% from the baseline
5553863|NCT01071642|Length of hospitalization.|length of hospitalization.
5790027|NCT00146094|bone mineral density|bone mineral density
5553864|NCT01071642|Requirement of unplanned therapy for elevated blood pressure|requirement of unplanned therapy for elevated blood pressure
5553865|NCT01071629|interval training|interval training
5553866|NCT01071629|strength training|strength training
5553867|NCT01071629|exercise capacity|exercise capacity
5553868|NCT01071629|chronic heart failure|chronic heart failure
5553869|NCT01071629|Cardiac rehabilitation|cardiac rehabilitation
5553870|NCT01071616|Cannabinoids|cannabinoids
5553871|NCT01071616|Oral Fluid|oral fluid
5553872|NCT01071616|Pharmacokinetics|pharmacokinetics
5553873|NCT01071616|Stability|stability
5553874|NCT01071616|Smoked Cannabis|smoked cannabis
5553875|NCT01071603|Biomarkers|biomarkers
5553876|NCT01071603|Extrapulmonary TB|extrapulmonary tb
5553877|NCT01071603|NTM|ntm
5553878|NCT01071603|HRCT|hrct
5553879|NCT01071603|MDRTB|mdrtb
5553880|NCT01071603|Tuberculosis|tuberculosis
5553881|NCT01071590|Parkinson's Disease|parkinson's disease
5553882|NCT01071590|Sensory Input|sensory input
5553883|NCT01071590|Gait|gait
5553884|NCT01071590|Imagery|imagery
5553885|NCT01071590|Parkinson Disease|parkinson disease
5553886|NCT01071590|PD|pd
5553887|NCT01071577|Bone Marrow Stromal Cells|bone marrow stromal cells
5553888|NCT01071577|Mesenchymal Stem Cells|mesenchymal stem cells
5553889|NCT01071577|Immune Modulation|immune modulation
5553890|NCT01071577|Tissue Regeneration|tissue regeneration
5553891|NCT01071551|Children|children
5553892|NCT01071551|Obesity|obesity
5553893|NCT01071551|Lifestyle|lifestyle
5553894|NCT01071551|LSES|lses
5553895|NCT01071551|Caries|caries
5553896|NCT01071538|Depressive Disorder, Major|depressive disorder, major
5553897|NCT01071538|Late-Life Depression|late-life depression
5553898|NCT01071538|Geriatrics|geriatrics
5553899|NCT01071538|Buprenorphine|buprenorphine
5553900|NCT01071512|MRI|mri
5553901|NCT01071512|OCT|oct
5553902|NCT01071512|Tysabri|tysabri
5553903|NCT01071512|Multiple Sclerosis|multiple sclerosis
5553904|NCT01071512|cognition|cognition
5553905|NCT01071499|pharmacokinetics|pharmacokinetics
5553906|NCT01071499|pharmacogenetics|pharmacogenetics
5553907|NCT01071499|morphine|morphine
5553908|NCT01071499|children|children
5553909|NCT01071486|Busulfan|busulfan
5553910|NCT01071486|Glutathione S-transferase|glutathione s-transferase
5553911|NCT01071486|Genetic polymorphism|genetic polymorphism
5553912|NCT01071486|HVOD|hvod
5553913|NCT01071486|GVHD|gvhd
5553914|NCT01071473|Childhood cancer|childhood cancer
5553915|NCT01071473|Anthracyclines|anthracyclines
5553916|NCT01071473|Cardiomyopathy|cardiomyopathy
5553917|NCT01071460|PAD|pad
5553918|NCT01071447|Rheumatic diseases|rheumatic diseases
5553919|NCT01071447|Biologic treatment|biologic treatment
5553920|NCT01071447|Nurse-led|nurse-led
5553921|NCT01071421|Sleep apnea syndrome|sleep apnea syndrome
5553922|NCT01071421|community acquired pneumonia|community acquired pneumonia
5553923|NCT01071421|prevalence|prevalence
5553924|NCT01071408|chronic care model|chronic care model
5553925|NCT01071408|stroke prevention|stroke prevention
5553926|NCT01071408|health services research|health services research
5553927|NCT01071395|Parkinson's disease|parkinson's disease
5553928|NCT01071395|Dyskinesia|dyskinesia
5553929|NCT01071395|Dyskinesia Rating Scales|dyskinesia rating scales
5553930|NCT01071395|Amantadine|amantadine
5553931|NCT01071395|Placebo|placebo
5553932|NCT01071382|Aeromedical Evacuation|aeromedical evacuation
5553933|NCT01071382|Repatriation|repatriation
5553934|NCT01071356|methamphetamine|methamphetamine
5553935|NCT01071356|motivational interviewing|motivational interviewing
5553936|NCT01071343|muscular atrophy|muscular atrophy
5553937|NCT01071343|recovery of function|recovery of function
5553938|NCT01071343|rehabilitation|rehabilitation
5553939|NCT01071343|Intensive care unit|intensive care unit
5553940|NCT01071304|Relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer|relapsed or refractory advanced cancer, metastatic cancer, locally advanced cancer
5553941|NCT01071278|Lipid metabolism disorder|lipid metabolism disorder
5553942|NCT01071252|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5553943|NCT01071252|AIN457|ain457
5553944|NCT01071252|dermatology|dermatology
5553945|NCT01071239|Fanconi Anemia|fanconi anemia
5798718|NCT00111280|roll-over trial|roll-over trial
5553946|NCT01071239|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5553947|NCT01071226|Malignant and non-malignant diseases|malignant and non-malignant diseases
5553948|NCT01071226|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5553949|NCT01071226|Peripheral blood progenitor cell transplant|peripheral blood progenitor cell transplant
5553950|NCT01071226|CliniMACS device|clinimacs device
5553951|NCT01071226|T cell depletion|t cell depletion
5553952|NCT01071200|Reproductive Techniques, Assisted|reproductive techniques, assisted
5680310|NCT00578266|Severe Aplastic Anemia (SAA)|severe aplastic anemia (saa)
5553953|NCT01071200|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5553954|NCT01071200|Recombinant leutinizing hormone (r-hLH)|recombinant leutinizing hormone (r-hlh)
5553955|NCT01071187|alcohol dependence|alcohol dependence
5553956|NCT01071187|addiction|addiction
5553957|NCT01071187|alcohol|alcohol
5553958|NCT01071187|relapse prevention|relapse prevention
5553959|NCT01071174|HIV infections|hiv infections
5553960|NCT01071174|Anti-HIV agents|anti-hiv agents
5553961|NCT01071174|HIV-1|hiv-1
5553962|NCT01071161|chronic cough|chronic cough
5553963|NCT01071161|COPD|copd
5553964|NCT01071161|Azithromycin|azithromycin
5553965|NCT01071161|Zithromax|zithromax
5553967|NCT01071148|Infertility|infertility
5553968|NCT01071148|Gonal-f|gonal-f
5553969|NCT01071148|Pergoveris|pergoveris
5553970|NCT01071148|Luveris|luveris
5553971|NCT01071122|Central blood pressure|central blood pressure
5553972|NCT01071122|Nifedipine|nifedipine
5553973|NCT01071122|Valsartan|valsartan
5553974|NCT01071109|Therapeutic massage|therapeutic massage
5553975|NCT01071109|massage|massage
5553976|NCT01071109|inflammation|inflammation
5553977|NCT01071109|fatigue|fatigue
5553978|NCT01071109|insomnia|insomnia
5553979|NCT01071109|radiation therapy|radiation therapy
5553980|NCT01071109|breast cancer|breast cancer
5553981|NCT01071109|Breast Cancer patients receiving radiation therapy|breast cancer patients receiving radiation therapy
5553982|NCT01071096|Botox|botox
5553983|NCT01071096|OnabotulinumtoxinA|onabotulinumtoxina
5553984|NCT01071096|Chronic Migraine|chronic migraine
5553985|NCT01071096|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide
5553986|NCT01071096|Saliva|saliva
5553988|NCT01071070|Chronic Kidney Disease|chronic kidney disease
5553989|NCT01071070|Secondary hyperparathyroidism|secondary hyperparathyroidism
5553990|NCT01071057|opioid-induced pruritus|opioid-induced pruritus
5553991|NCT01071057|naloxone|naloxone
5553992|NCT01071044|Chronic Fatigue Syndrome|chronic fatigue syndrome
5553993|NCT01071031|Safety|safety
5553994|NCT01071031|Tolerability|tolerability
5553995|NCT01071031|Immunogenicity|immunogenicity
5553996|NCT01071031|Human Immunodeficiency Virus|human immunodeficiency virus
5553997|NCT01071031|HIV-1|hiv-1
5553998|NCT01071031|Vaccine|vaccine
5554000|NCT01071031|Viral Load|viral load
5554001|NCT01071031|HIV|hiv
5554002|NCT01071018|locally advanced or metastatic solid tumors|locally advanced or metastatic solid tumors
5554003|NCT01071005|Decrease serum levels of luteinizing hormone, FSH and Testosterone|decrease serum levels of luteinizing hormone, fsh and testosterone
5554004|NCT01070966|Atherosclerosis|atherosclerosis
5554005|NCT01070953|Hypercholesterolemia|hypercholesterolemia
5554006|NCT01070940|L-NMMA|l-nmma
5554007|NCT01070940|blood pressure|blood pressure
5554008|NCT01070940|arterial stiffness|arterial stiffness
5554009|NCT01070940|pulse wave velocity|pulse wave velocity
5554012|NCT01070940|healthy subjects|healthy subjects
5554013|NCT01070940|GFR|gfr
5554014|NCT01070914|Cilia|cilia
5554015|NCT01070914|Phenotyping|phenotyping
5554016|NCT01070914|Diagnosis|diagnosis
5554017|NCT01070914|Nitric Oxide|nitric oxide
5554018|NCT01070914|Bronchiectasis|bronchiectasis
5554019|NCT01070888|Asthma|asthma
5554020|NCT01070888|Exercise Induced Asthma|exercise induced asthma
5554021|NCT01070875|Antithrombotic prophylaxis|antithrombotic prophylaxis
5554022|NCT01070862|multiple myeloma, treatment, first line|multiple myeloma, treatment, first line
5554023|NCT01070849|exercise|exercise
5554024|NCT01070849|physical activity|physical activity
5554025|NCT01070836|JCV|jcv
5554026|NCT01070836|Sample Collection|sample collection
5554027|NCT01070836|PML|pml
5554028|NCT01070836|Antibody|antibody
5554029|NCT01070823|Sample Collection|sample collection
5554030|NCT01070823|JCV|jcv
5554031|NCT01070823|PML|pml
5554032|NCT01070810|Septic Shock|septic shock
5554033|NCT01070810|Sepsis|sepsis
5554034|NCT01070797|Epstein-Barr virus|epstein-barr virus
5554035|NCT01070797|CTL|ctl
5554036|NCT01070797|cytotoxic T Lymphocytes|cytotoxic t lymphocytes
5554037|NCT01070797|CMV|cmv
5554038|NCT01070797|Adenovirus Infection|adenovirus infection
5554039|NCT01070797|viral infection|viral infection
5554040|NCT01070797|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5554041|NCT01070784|Symbicort|symbicort
5554042|NCT01070784|Safety|safety
5554043|NCT01070784|Efficacy|efficacy
5554044|NCT01070784|COPD|copd
5554045|NCT01070784|Japanese|japanese
5554046|NCT01070771|Pressure wire|pressure wire
5554047|NCT01070771|Fractional flow reserve|fractional flow reserve
5554048|NCT01070758|Congenital hyperinsulinism|congenital hyperinsulinism
5554049|NCT01070758|Somatostatin analog|somatostatin analog
5554050|NCT01070758|Lanreotide autogel|lanreotide autogel
5554051|NCT01070758|Hypoglycemia|hypoglycemia
5554052|NCT01070745|PDA|pda
5554053|NCT01070745|Indomethacin|indomethacin
5554054|NCT01070745|Ibuprofen|ibuprofen
5554055|NCT01070732|Fever|fever
5554056|NCT01070732|Infectious diseases|infectious diseases
5554057|NCT01070732|Neoplasia|neoplasia
5554058|NCT01070732|Pain|pain
5554059|NCT01070732|cholecystectomy|cholecystectomy
5554060|NCT01070732|Colectomy|colectomy
5554061|NCT01070719|Multiple Sclerosis, relapsing forms|multiple sclerosis, relapsing forms
5554062|NCT01070706|Patients with HER2- stage II/III breast cancer|patients with her2- stage ii/iii breast cancer
5554063|NCT01070693|Inguinal hernia|inguinal hernia
5554064|NCT01070693|Open mesh repair|open mesh repair
5554065|NCT01070693|Long term outcome|long term outcome
5554066|NCT01070693|Recurrence|recurrence
5554067|NCT01070693|Discomfort|discomfort
5554068|NCT01070680|ERCP|ercp
5554069|NCT01070680|dexmedetomidine|dexmedetomidine
5554070|NCT01070680|propofol|propofol
5554071|NCT01070680|patient-controlled sedation|patient-controlled sedation
5554080|NCT01070667|Atrial Fibrillation Burden in Paroxysmal Atrial Fibrillation|atrial fibrillation burden in paroxysmal atrial fibrillation
5554082|NCT01070654|Recruitment Manoeuvres|recruitment manoeuvres
5554083|NCT01070654|PEEP|peep
5554084|NCT01070654|Cytokines|cytokines
5554085|NCT01070654|Respiratory Insufficiency|respiratory insufficiency
5554086|NCT01070641|CARVEDILOL|carvedilol
5554087|NCT01070641|VARICEAL BAND LIGATION|variceal band ligation
5554088|NCT01070641|PRIMARY PROPHYLAXIS|primary prophylaxis
5554089|NCT01070628|Pharmacokinetic|pharmacokinetic
5554090|NCT01070602|IFIS|ifis
5554091|NCT01070589|Obesity|obesity
5554092|NCT01070589|Growth hormone secretion|growth hormone secretion
5554093|NCT01070589|Anaerobic exercise|anaerobic exercise
5554094|NCT01070576|non union|non union
5554095|NCT01070576|fracture|fracture
5554096|NCT01070576|healing|healing
5554097|NCT01070576|arginine|arginine
5554098|NCT01070576|NO|no
5554099|NCT01070563|Brain death|brain death
5554100|NCT01070563|CT angiography|ct angiography
5554101|NCT01070563|Ultrasonography, doppler, transcranial|ultrasonography, doppler, transcranial
5554102|NCT01070537|Otolaryngology|otolaryngology
5554103|NCT01070537|Equipment and Supplies|equipment and supplies
5554104|NCT01070537|Intubation|intubation
5554105|NCT01070511|Muscular Dystrophy|muscular dystrophy
5554106|NCT01070511|Tadalafil|tadalafil
5554107|NCT01070498|peanut hypersensitivity|peanut hypersensitivity
5554108|NCT01070498|tree nut hypersensitivity|tree nut hypersensitivity
5554109|NCT01070498|allergy|allergy
5554110|NCT01070498|Trichuris suis|trichuris suis
5554111|NCT01070498|hygiene hypothesis|hygiene hypothesis
5554112|NCT01070498|treatment|treatment
5554113|NCT01070498|clinical trial|clinical trial
5554114|NCT01070498|food/adverse effect|food/adverse effect
5554115|NCT01070498|peanut allergy (mild to moderate)|peanut allergy (mild to moderate)
5554116|NCT01070498|tree nut allergy (mild to moderate)|tree nut allergy (mild to moderate)
5685380|NCT00556374|adjuvant chemotherapy|adjuvant chemotherapy
5554117|NCT01070472|labor induction at term using a titrated oral misoprostol solution|labor induction at term using a titrated oral misoprostol solution
5554118|NCT01070459|Stroke aerobic exercise daily functioning rehabilitation|stroke aerobic exercise daily functioning rehabilitation
5554119|NCT01070446|choline|choline
5554120|NCT01070446|cystic fibrosis|cystic fibrosis
5554121|NCT01070446|methyl metabolism|methyl metabolism
5554122|NCT01070446|fatty acids|fatty acids
5554123|NCT01070446|oxidative stress|oxidative stress
5554124|NCT01070446|pulmonary function|pulmonary function
5554125|NCT01070433|Diabetic Foot Ulcers (DFUs)|diabetic foot ulcers (dfus)
5554126|NCT01070420|Adenosine|adenosine
5554127|NCT01070420|Fractional flow reserve, Hyperemia|fractional flow reserve, hyperemia
5554128|NCT01070420|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5554129|NCT01070407|Hepatitis C virus|hepatitis c virus
5554130|NCT01070407|HCV|hcv
5554131|NCT01070407|Adenovirus|adenovirus
5554132|NCT01070407|Vaccine|vaccine
5554133|NCT01070394|ADHD|adhd
5554134|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate
5554135|NCT01070394|Amphetamine|amphetamine
5554136|NCT01070368|skin test|skin test
5554137|NCT01070368|open wheat challenge|open wheat challenge
5554138|NCT01070355|Colorectal Neoplasms|colorectal neoplasms
5554139|NCT01070355|Fish Oils|fish oils
5554140|NCT01070355|Fatty Acids, Omega-3|fatty acids, omega-3
5554141|NCT01070355|Eicosapentaenoic Acid|eicosapentaenoic acid
5554142|NCT01070355|Liver Metastases|liver metastases
5554143|NCT01070355|Randomised Controlled Trial|randomised controlled trial
5554144|NCT01070316|Epilepsy|epilepsy
5554145|NCT01070316|Tuberous Sclerosis Complex|tuberous sclerosis complex
5554146|NCT01070316|Everolimus|everolimus
5554147|NCT01070316|RAD001|rad001
5554148|NCT01070316|Mammalian Target of Rapamycin (MTOR)|mammalian target of rapamycin (mtor)
5554149|NCT01070303|HUMIRA|humira
5554150|NCT01070303|adalimumab|adalimumab
5554151|NCT01070303|Inflammatory Bowel Disease|inflammatory bowel disease
5554152|NCT01070290|gastric carcinoma|gastric carcinoma
5554153|NCT01070290|Locally Advanced or Metastatic Gastric Cancer|locally advanced or metastatic gastric cancer
5554154|NCT01070277|chronic diarrhea|chronic diarrhea
5554155|NCT01070277|travelers|travelers
5554156|NCT01070277|Parasites|parasites
5554157|NCT01070277|albendazole|albendazole
5554158|NCT01070277|tinidazole|tinidazole
5554159|NCT01070264|Osteoarthritis|osteoarthritis
5554160|NCT01070238|Isomaltulose|isomaltulose
5554161|NCT01070238|Slow Released Carbohydrates|slow released carbohydrates
5554162|NCT01070238|Postprandial Glucose Metabolism|postprandial glucose metabolism
5554163|NCT01070238|Type 2 diabetes|type 2 diabetes
5554164|NCT01070212|human, chewing, appetite,|human, chewing, appetite,
5554165|NCT01070199|obese, liquid, solid, fitness, humans, appetite|obese, liquid, solid, fitness, humans, appetite
5554166|NCT01070186|nephrectomy|nephrectomy
5554168|NCT01070186|T2|t2
5554169|NCT01070186|T3|t3
5554170|NCT01070186|T4|t4
5554171|NCT01070186|N1|n1
5554172|NCT01070186|Kidney Cancer|kidney cancer
5554173|NCT01070173|Ghrelin|ghrelin
5554174|NCT01070173|short stature|short stature
5554175|NCT01070173|failure to thrive|failure to thrive
5554176|NCT01070160|Polycystic Ovarian Syndrome (PCOS)|polycystic ovarian syndrome (pcos)
5554177|NCT01070160|Metformin|metformin
5554178|NCT01070160|Endometrin|endometrin
5554179|NCT01070147|asthma|asthma
5554180|NCT01070147|emergency medicine|emergency medicine
5554181|NCT01070147|medical informatics|medical informatics
5554182|NCT01070147|computerized reminder systems|computerized reminder systems
5554183|NCT01070121|Rheumatoid Arthritis|rheumatoid arthritis
5554184|NCT01070121|RA|ra
5554185|NCT01070121|Autoimmune Disease|autoimmune disease
5554186|NCT01070121|Muscular Skeletal Disease|muscular skeletal disease
5554187|NCT01070108|Preemption, ketamine, escalating, dose, pain, analgesia|preemption, ketamine, escalating, dose, pain, analgesia
5554188|NCT01070082|adult ICU patients|adult icu patients
5554189|NCT01070082|procedural pain|procedural pain
5554190|NCT01070082|pain intensity|pain intensity
5554191|NCT01070082|pain distress|pain distress
5554192|NCT01070082|pain behaviors|pain behaviors
5554193|NCT01070082|pain|pain
5554194|NCT01070082|ICU procedures|icu procedures
5554195|NCT01070069|Percutaneous|percutaneous
5554196|NCT01070069|Preclose|preclose
5554197|NCT01070069|Endologix|endologix
5554198|NCT01070069|Abbott Vascular|abbott vascular
5554199|NCT01070069|Endovascular|endovascular
5554200|NCT01070069|PEVAR|pevar
5554201|NCT01070069|Stent graft|stent graft
5554202|NCT01070069|Suture mediated closure devices|suture mediated closure devices
5554203|NCT01070056|Blood Pressure|blood pressure
5554204|NCT01070056|Lifestyle Changes|lifestyle changes
5554205|NCT01070056|African American|african american
5554206|NCT01070043|Hypertension|hypertension
5554207|NCT01070043|valsartan|valsartan
5554208|NCT01070043|amlodipine|amlodipine
5554209|NCT01070043|high blood pressure|high blood pressure
5554210|NCT01070030|Stage II Hypertension, Aliskiren, Amlodipine, Hydrochlorothiazide|stage ii hypertension, aliskiren, amlodipine, hydrochlorothiazide
5554211|NCT01070017|Peru|peru
5554212|NCT01070017|DOT|dot
5554213|NCT01070017|HIV|hiv
5554214|NCT01070017|AIDS|aids
5554215|NCT01070017|Community based|community based
5554216|NCT01070017|social capital|social capital
5554217|NCT01070004|sleepiness|sleepiness
5554218|NCT01070004|driving|driving
5554219|NCT01070004|countermeasures|countermeasures
5554220|NCT01070004|coffee|coffee
5554221|NCT01070004|blue light exposure|blue light exposure
5554222|NCT01070004|physical activity|physical activity
5554223|NCT01069991|Asthma|asthma
5554224|NCT01069991|Adolescents|adolescents
5554225|NCT01069991|Patient Education|patient education
5554226|NCT01069991|Schools|schools
5554227|NCT01069965|Type 2|type 2
5554228|NCT01069952|Deep Brain Stimulation|deep brain stimulation
5554229|NCT01069952|Treatment Refractory|treatment refractory
5554230|NCT01069952|Neurosurgery|neurosurgery
5554231|NCT01069952|Implantable Neurostimulator (INS)|implantable neurostimulator (ins)
5554232|NCT01069952|Internal Capsule|internal capsule
5554233|NCT01069939|Gastric ulcer|gastric ulcer
5554234|NCT01069939|Duodenal ulcer|duodenal ulcer
5554235|NCT01069939|Low-dose aspirin|low-dose aspirin
5554236|NCT01069926|Diabetes|diabetes
5554237|NCT01069913|Healthy Volunteer|healthy volunteer
5554238|NCT01069900|Intra-abdominal infection|intra-abdominal infection
5554239|NCT01069900|Pediatric infection|pediatric infection
5554240|NCT01069887|febrile events|febrile events
5554241|NCT01069887|invasive fungal infections|invasive fungal infections
5554242|NCT01069887|hematological patients|hematological patients
5554243|NCT01069874|Bone Density Conservation Agents|bone density conservation agents
5554244|NCT01069874|Cholecalciferol|cholecalciferol
5554245|NCT01069874|Communicable Diseases|communicable diseases
5554246|NCT01069874|Growth Substances|growth substances
5554247|NCT01069874|Housing for the Elderly|housing for the elderly
5554248|NCT01069874|Infection|infection
5554249|NCT01069874|Micronutrients|micronutrients
5554250|NCT01069874|Pharmacologic Actions|pharmacologic actions
5554251|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs
5554252|NCT01069874|Respiratory Tract Diseases|respiratory tract diseases
5554253|NCT01069874|Vitamins|vitamins
5554254|NCT01069874|Respiratory Tract Infections/prevention & control*|respiratory tract infections/prevention & control*
5554255|NCT01069874|Vitamin D|vitamin d
5554256|NCT01069861|PPHN|pphn
5554257|NCT01069861|neonates|neonates
5554258|NCT01069861|sildanefil IV|sildanefil iv
5554259|NCT01069835|Non small cell lung cancer|non small cell lung cancer
5554260|NCT01069835|EGFR mutation|egfr mutation
5554261|NCT01069835|NSCLC|nsclc
5554262|NCT01069822|Midazolam|midazolam
5554263|NCT01069822|Pharmacokinetics|pharmacokinetics
5554264|NCT01069796|triple negative|triple negative
5554265|NCT01069796|metastatic|metastatic
5554266|NCT01069796|breast cancer|breast cancer
5554267|NCT01069796|First line chemotherapy|first line chemotherapy
5554268|NCT01069783|dyslipidemia|dyslipidemia
5554269|NCT01069783|cholesterol|cholesterol
5554270|NCT01069783|LDL|ldl
5554271|NCT01069770|Neoadjuvant Therapy|neoadjuvant therapy
5554272|NCT01069770|Sunitinib|sunitinib
5536891|NCT01139073|Halitosis|halitosis
5554273|NCT01069770|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
5554274|NCT01069770|Metastasis|metastasis
5554275|NCT01069757|Advanced/recurrent non-small-cell lung cancer|advanced/recurrent non-small-cell lung cancer
5554276|NCT01069705|Tobramycin Inhalation Powder|tobramycin inhalation powder
5554277|NCT01069705|Cystic fibrosis|cystic fibrosis
5554278|NCT01069705|Lung diseases|lung diseases
5554279|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents
5554280|NCT01069705|Treatment of pulmonary infections with P. aeruginosa in cystic fibrosis patients|treatment of pulmonary infections with p. aeruginosa in cystic fibrosis patients
5554281|NCT01069692|Chronic Kidney Disease|chronic kidney disease
5554282|NCT01069692|Hemodialysis|hemodialysis
5554283|NCT01069692|Hyperphosphatemia|hyperphosphatemia
5554284|NCT01069692|Hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis|hyperphosphatemia patients with chronic kidney disease on 3x/week hemodialysis
5554285|NCT01069666|atopic dermatitis|atopic dermatitis
5554286|NCT01069666|Thai pediatricians|thai pediatricians
5554287|NCT01069653|CDCA1|cdca1
5554288|NCT01069653|KIF20A|kif20a
5554289|NCT01069653|lung cancer|lung cancer
5554290|NCT01069653|vaccine|vaccine
5554291|NCT01069653|HLA-A*2402|hla-a*2402
5554292|NCT01069640|URLC10|urlc10
5554293|NCT01069640|lung cancer|lung cancer
5554294|NCT01069640|vaccine|vaccine
5554295|NCT01069640|HLA-A*0201|hla-a*0201
5554296|NCT01069640|HLA-A*0206|hla-a*0206
5554297|NCT01069614|Equipment and supplies|equipment and supplies
5554298|NCT01069601|solid organ transplantation|solid organ transplantation
5554299|NCT01069601|bone marrow transplantation|bone marrow transplantation
5554300|NCT01069601|adults|adults
5554301|NCT01069601|adults with solid organ transplantation|adults with solid organ transplantation
5554302|NCT01069601|adults with bone marrow transplantation|adults with bone marrow transplantation
5554303|NCT01069588|bioabsorbable screw|bioabsorbable screw
5554304|NCT01069588|acl reconstruction|acl reconstruction
5554305|NCT01069575|URLC10|urlc10
5554306|NCT01069575|CDCA1|cdca1
5554307|NCT01069575|KIF20A|kif20a
5554308|NCT01069575|lung cancer|lung cancer
5554311|NCT01069562|closed loop control of anesthesia|closed loop control of anesthesia
5554312|NCT01069562|isoflurane|isoflurane
5554313|NCT01069562|open heart surgery|open heart surgery
5554314|NCT01069549|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5554315|NCT01069549|Diabetic Nephropathy|diabetic nephropathy
5554316|NCT01069549|Angiotensin II type 1 receptor gene polymorphism|angiotensin ii type 1 receptor gene polymorphism
5554317|NCT01069549|Acetyl coA carboxylase beta gene polymorphism.|acetyl coa carboxylase beta gene polymorphism.
5554318|NCT01069536|metoclopramide|metoclopramide
5554319|NCT01069536|akathisia|akathisia
5554320|NCT01069536|nausea|nausea
5554321|NCT01069536|vomiting|vomiting
5554322|NCT01069536|antiemetic|antiemetic
5554323|NCT01069536|improvement of nausea|improvement of nausea
5554324|NCT01069523|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5554325|NCT01069523|Guanfacine|guanfacine
5554326|NCT01069523|Event Related Potentials|event related potentials
5554327|NCT01069497|Infection control|infection control
5554328|NCT01069497|Urinary Tract Infections|urinary tract infections
5554525|NCT01068782|Astrocytoma|astrocytoma
5554329|NCT01069497|Respiratory Tract Infections|respiratory tract infections
5554330|NCT01069484|Randomized controlled trial|randomized controlled trial
5554331|NCT01069484|Post partum pelvic floor muscle training|post partum pelvic floor muscle training
5554332|NCT01069484|Urinary incontinence|urinary incontinence
5554333|NCT01069484|Pelvic floor dysfunction|pelvic floor dysfunction
5554334|NCT01069484|Pelvic floor muscle injury|pelvic floor muscle injury
5554335|NCT01069484|Pelvic floor muscle strength|pelvic floor muscle strength
5554336|NCT01069484|Pelvic floor muscle morphology|pelvic floor muscle morphology
5554337|NCT01069471|S.dysenteriae|s.dysenteriae
5554338|NCT01069471|Healthy volunteers|healthy volunteers
5554339|NCT01069471|Conjugate vaccine|conjugate vaccine
5554340|NCT01069471|Safety|safety
5554341|NCT01069471|Immunogenicity|immunogenicity
5554342|NCT01069471|Dose scaling|dose scaling
5554343|NCT01069458|Dietary intervention|dietary intervention
5554344|NCT01069458|Smoking cessation|smoking cessation
5554346|NCT01069445|diet|diet
5554347|NCT01069445|probiotics|probiotics
5554348|NCT01069445|inflammaging|inflammaging
5554349|NCT01069445|oxidative stress|oxidative stress
5554350|NCT01069445|gut microbiota|gut microbiota
5554351|NCT01069445|food complements|food complements
5554352|NCT01069432|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5554354|NCT01069432|Normal Volunteers|normal volunteers
5554355|NCT01069419|Certolizumab Pegol|certolizumab pegol
5554356|NCT01069419|Cimzia|cimzia
5554357|NCT01069406|notch|notch
5554358|NCT01069406|uterine|uterine
5554359|NCT01069406|first|first
5554360|NCT01069406|bleeding|bleeding
5554361|NCT01069380|resting metabolic rate|resting metabolic rate
5554362|NCT01069380|bed ridden, vegetative|bed ridden, vegetative
5554363|NCT01069380|low conscious|low conscious
5554364|NCT01069380|minimal conscious state|minimal conscious state
5554365|NCT01069380|immobilized|immobilized
5554366|NCT01069380|resting energy expenditure|resting energy expenditure
5554367|NCT01069367|Influenza A|influenza a
5554368|NCT01069367|H1N1 subtype|h1n1 subtype
5554369|NCT01069367|Children/adolescent|children/adolescent
5554371|NCT01069367|Adjuvant|adjuvant
5554372|NCT01069367|Cell culture|cell culture
5554373|NCT01069354|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5554374|NCT01069341|Rubeosis|rubeosis
5554375|NCT01069341|Neovascularization of iris|neovascularization of iris
5554376|NCT01069341|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5554378|NCT01069341|Cataract|cataract
5554379|NCT01069328|Lung|lung
5554380|NCT01069328|cancer|cancer
5554381|NCT01069328|NSCLC|nsclc
5554382|NCT01069315|open wound|open wound
5554383|NCT01069315|solution|solution
5554384|NCT01069315|pressure|pressure
5554385|NCT01069315|randomized|randomized
5554386|NCT01069302|Coronary artery disease|coronary artery disease
5554387|NCT01069289|Symbicort|symbicort
5554388|NCT01069289|Oxis|oxis
5554389|NCT01069289|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5554390|NCT01069289|COPD|copd
5554391|NCT01069289|Efficacy|efficacy
5554392|NCT01069276|Stroke|stroke
5554393|NCT01069276|prehospital ultrasound|prehospital ultrasound
5554394|NCT01069263|Interstitial cystitis|interstitial cystitis
5554395|NCT01069263|Painful bladder syndrome|painful bladder syndrome
5554396|NCT01069263|Chronic pelvic pain|chronic pelvic pain
5554397|NCT01069263|DMSO|dmso
5554398|NCT01069263|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5554399|NCT01069250|dynamic cerebrovascular autoregulation|dynamic cerebrovascular autoregulation
5554400|NCT01069250|static cerebrovascular autoregulation|static cerebrovascular autoregulation
5554401|NCT01069250|acute brain injury|acute brain injury
5554402|NCT01069250|transcranial Doppler ultrasound|transcranial doppler ultrasound
5554403|NCT01069250|critical care|critical care
5554404|NCT01069237|contact lens wear|contact lens wear
5554405|NCT01069237|multi-purpose solution|multi-purpose solution
5554406|NCT01069237|corneal staining|corneal staining
5554407|NCT01069224|rotator cuff|rotator cuff
5554408|NCT01069224|synovial fluid|synovial fluid
5554409|NCT01069224|proinflammatory cytokines|proinflammatory cytokines
5554410|NCT01069211|Breast cancer, Letrozole|breast cancer, letrozole
5554411|NCT01069211|postmenopause|postmenopause
5554412|NCT01069211|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5554413|NCT01069198|Visceral leishmaniasis|visceral leishmaniasis
5554414|NCT01069198|Kala-azar|kala-azar
5554415|NCT01069198|Bangladesh|bangladesh
5554416|NCT01069198|Malnutrition|malnutrition
5554417|NCT01069198|Asymptomatic|asymptomatic
5554418|NCT01069198|Albendazole|albendazole
5554419|NCT01069198|Iron|iron
5554420|NCT01069198|Zinc|zinc
5554421|NCT01069198|Vitamin A|vitamin a
5554422|NCT01069185|Unplanned extubation|unplanned extubation
5554423|NCT01069185|Length of stay in PICU|length of stay in picu
5554424|NCT01069185|Length of mechanical ventilation|length of mechanical ventilation
5554425|NCT01069172|Cataract|cataract
5554426|NCT01069172|Surgery, cataract extraction|surgery, cataract extraction
5554427|NCT01069172|Optical devices, laser|optical devices, laser
5554428|NCT01069159|Traumatic memory|traumatic memory
5554429|NCT01069159|Traumatic memories|traumatic memories
5554430|NCT01069159|Traumatic memories and associated symptoms|traumatic memories and associated symptoms
5554431|NCT01069159|Posttraumatic Stress Disorder|posttraumatic stress disorder
5554432|NCT01069159|PTSD|ptsd
5554433|NCT01069146|sepsis,|sepsis,
5554434|NCT01069146|septic shock,|septic shock,
5554435|NCT01069146|therapeutic hypothermia|therapeutic hypothermia
5554436|NCT01069133|minimal hepatic encephalopathy|minimal hepatic encephalopathy
5554437|NCT01069133|cirrhosis|cirrhosis
5554438|NCT01069133|complications|complications
5554439|NCT01069120|Uterine Fibroids|uterine fibroids
5554440|NCT01069107|community hospital|community hospital
5554441|NCT01069107|alternative acute admissions|alternative acute admissions
5554444|NCT01069081|Proton Pump Inhibitor|proton pump inhibitor
5554445|NCT01069081|Chemotherapy|chemotherapy
5554446|NCT01069081|Phase II study|phase ii study
5554447|NCT01069081|TTP|ttp
5554448|NCT01069068|To evaluate the effect of advancing Jaw on airway dimension|to evaluate the effect of advancing jaw on airway dimension
5554449|NCT01069055|inguinal hernia|inguinal hernia
5554450|NCT01069055|surgery|surgery
5554451|NCT01069055|general anesthesia|general anesthesia
5554452|NCT01069055|analgesia|analgesia
5554453|NCT01069055|pre-emptive|pre-emptive
5554454|NCT01069055|SF36|sf36
5554455|NCT01069042|Rho kinase activity|rho kinase activity
5554456|NCT01069042|Heart failure|heart failure
5554457|NCT01069042|ACE inhibitor|ace inhibitor
5554458|NCT01069042|LVEF change|lvef change
5554459|NCT01069042|Rho kinase activity change|rho kinase activity change
5554460|NCT01069029|Macular Hole|macular hole
5554461|NCT01069029|Cataract surgery|cataract surgery
5554462|NCT01069029|Vitreoretinal surgery|vitreoretinal surgery
5554463|NCT01069029|Combined surgery|combined surgery
5554464|NCT01069029|Idiopathic|idiopathic
5554465|NCT01069016|Fecal Incontinence|fecal incontinence
5554466|NCT01069016|Colorectal surgery|colorectal surgery
5554467|NCT01069016|Sacral nerve stimulation|sacral nerve stimulation
5554468|NCT01069016|Pudendal nerve stimulation|pudendal nerve stimulation
5554469|NCT01069003|Heart Disease|heart disease
5554470|NCT01069003|Cardiovascular Disease|cardiovascular disease
5554471|NCT01069003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5554472|NCT01069003|Dual Antiplatelet Therapy|dual antiplatelet therapy
5554473|NCT01069003|Clopidogrel|clopidogrel
5554474|NCT01069003|Prasugrel|prasugrel
5554475|NCT01069003|Vascular Disease|vascular disease
5554476|NCT01069003|Myocardial Ischemia|myocardial ischemia
5554477|NCT01068990|pneumonia|pneumonia
5554478|NCT01068951|type 1 diabetes|type 1 diabetes
5554479|NCT01068951|mesenchymal stem cells|mesenchymal stem cells
5554480|NCT01068951|intervention|intervention
5554481|NCT01068938|visual field|visual field
5554482|NCT01068938|perimetry|perimetry
5554483|NCT01068938|glaucoma progression|glaucoma progression
5554484|NCT01068938|grid|grid
5554485|NCT01068938|POAG and glaucoma suspects with prostaglandin monotherapy|poag and glaucoma suspects with prostaglandin monotherapy
5554486|NCT01068925|healthy volunteer|healthy volunteer
5554487|NCT01068925|pharmacokinetics|pharmacokinetics
5554488|NCT01068925|HIV, GSK1349572, tipranavir, ritonavir, drug interaction|hiv, gsk1349572, tipranavir, ritonavir, drug interaction
5554489|NCT01068912|Influenza|influenza
5554490|NCT01068899|healthy adults|healthy adults
5554491|NCT01068899|healthy children|healthy children
5554492|NCT01068886|Pancreaticoduodenectomy|pancreaticoduodenectomy
5554493|NCT01068873|HIV|hiv
5554494|NCT01068873|Protease Inhibitor|protease inhibitor
5554495|NCT01068873|CCR5 Co-receptor Antagonist|ccr5 co-receptor antagonist
5554496|NCT01068873|treatment naive|treatment naive
5554497|NCT01068860|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5554498|NCT01068860|canakinumab|canakinumab
5554499|NCT01068860|Pre diabetic|pre diabetic
5554500|NCT01068860|glucose intolerant|glucose intolerant
5554501|NCT01068860|oral anti diabetic medication|oral anti diabetic medication
5554502|NCT01068860|insulin treatment|insulin treatment
5554503|NCT01068860|metabolic syndrome|metabolic syndrome
5554504|NCT01068847|Opioid dependence|opioid dependence
5554505|NCT01068847|methadone|methadone
5554507|NCT01068834|Adherence|adherence
5554508|NCT01068834|Statins|statins
5554509|NCT01068834|Kinesin-like protein 6|kinesin-like protein 6
5554510|NCT01068821|Slide|slide
5554511|NCT01068821|Trendelenburg's position|trendelenburg's position
5554512|NCT01068821|Postoperative|postoperative
5554513|NCT01068821|neurologic complaints|neurologic complaints
5554514|NCT01068808|Nonallergic rhinitis|nonallergic rhinitis
5554515|NCT01068808|Allergic rhinitis|allergic rhinitis
5554516|NCT01068808|Development|development
5554517|NCT01068795|placental syndrome|placental syndrome
5554518|NCT01068795|maternal thromboembolic event|maternal thromboembolic event
5554519|NCT01068795|enoxaparin|enoxaparin
5554520|NCT01068795|anti-factor Xa|anti-factor xa
5554521|NCT01068782|Glioblastoma|glioblastoma
5554522|NCT01068782|Glioma|glioma
5554523|NCT01068782|Brain Cancer|brain cancer
5554524|NCT01068782|Brain Tumor|brain tumor
5554526|NCT01068769|regorafenib|regorafenib
5554527|NCT01068769|GIST|gist
5554528|NCT01068691|aortic dissection|aortic dissection
5554529|NCT01068691|ambulatory blood pressure|ambulatory blood pressure
5554530|NCT01068691|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5554531|NCT01068691|patients undergoing surgery for a dissection of the thoracic aorta|patients undergoing surgery for a dissection of the thoracic aorta
5554532|NCT01068613|COPD|copd
5554533|NCT01068613|Long acting muscarinic antagonist|long acting muscarinic antagonist
5554534|NCT01068600|COPD|copd
5554535|NCT01068600|Indacaterol|indacaterol
5554536|NCT01068587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5557165|NCT01057628|Diabetes mellitus|diabetes mellitus
5554537|NCT01068587|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5554538|NCT01068587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5554539|NCT01068587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5554540|NCT01068574|Acute illnesses in children under five|acute illnesses in children under five
5554541|NCT01068561|Retinitis pigmentosa|retinitis pigmentosa
5554542|NCT01068561|stem cell|stem cell
5554543|NCT01068561|bone marrow|bone marrow
5554544|NCT01068535|metabolic syndrome|metabolic syndrome
5554546|NCT01068535|premenopausal women|premenopausal women
5554547|NCT01068535|vascular risk|vascular risk
5554548|NCT01068535|atherosclerosis detection|atherosclerosis detection
5554549|NCT01068522|Intracranial pressure|intracranial pressure
5554550|NCT01068522|Intracranial pressure monitoring|intracranial pressure monitoring
5554551|NCT01068522|Head injury|head injury
5554552|NCT01068509|Cvac|cvac
5554553|NCT01068483|Advanced solid tumors|advanced solid tumors
5554554|NCT01068483|Breast Cancer|breast cancer
5554555|NCT01068483|Colon Cancer|colon cancer
5554556|NCT01068483|Ovarian Cancer|ovarian cancer
5554557|NCT01068483|Endometrium cancer|endometrium cancer
5554559|NCT01068470|Melanoma|melanoma
5554560|NCT01068470|Kidney Cancer|kidney cancer
5554561|NCT01068470|Lymphokine Activated Killer cells|lymphokine activated killer cells
5554562|NCT01068457|persistent pain|persistent pain
5554563|NCT01068457|neuropathic pain|neuropathic pain
5554564|NCT01068457|Thoracic Surgery, Video Assisted|thoracic surgery, video assisted
5554565|NCT01068457|Chronic Pain|chronic pain
5554566|NCT01068444|NASH|nash
5554567|NCT01068444|Pioglitazone|pioglitazone
5554568|NCT01068444|Treatment|treatment
5554569|NCT01068431|lymphedema|lymphedema
5554570|NCT01068431|conservative treatment|conservative treatment
5554571|NCT01068431|compression therapy|compression therapy
5554572|NCT01068431|interface pressure|interface pressure
5554573|NCT01068418|Obesity|obesity
5554574|NCT01068418|Renin Angiotensin System|renin angiotensin system
5554575|NCT01068418|Vitamin D deficiency|vitamin d deficiency
5554576|NCT01068418|Hypertension|hypertension
5554577|NCT01068392|relapsed|relapsed
5554578|NCT01068392|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5554579|NCT01068392|oxaliplatin|oxaliplatin
5554580|NCT01068392|prednisolone|prednisolone
5554581|NCT01068379|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5554582|NCT01068379|cryopexy|cryopexy
5554583|NCT01068379|photocoagulation|photocoagulation
5554584|NCT01068366|Nickel Allergic Syndrome|nickel allergic syndrome
5554585|NCT01068366|Septal Closure Devices|septal closure devices
5554586|NCT01068353|Alzheimer's disease|alzheimer's disease
5554587|NCT01068353|Dementia|dementia
5554588|NCT01068353|TNF-alpha|tnf-alpha
5554589|NCT01068353|Etanercept|etanercept
5554590|NCT01068340|Adhesions|adhesions
5554591|NCT01068340|Small Bowel Obstruction|small bowel obstruction
5554592|NCT01068340|Ileus|ileus
5554593|NCT01068314|Endothelium|endothelium
5554594|NCT01068314|Vasodilatation|vasodilatation
5554595|NCT01068314|Vein|vein
5554596|NCT01068314|Compliance|compliance
5554597|NCT01068314|Arteriovenous shunt, surgical|arteriovenous shunt, surgical
5554598|NCT01068301|Allogeneic Stem Cell transplantation|allogeneic stem cell transplantation
5554599|NCT01068301|Plerixafor|plerixafor
5554600|NCT01068301|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5554601|NCT01068301|Acute Myeloid leukemia|acute myeloid leukemia
5554602|NCT01068301|Chronic Myeloid leukemia|chronic myeloid leukemia
5554603|NCT01068301|Myelodysplastic Syndrome|myelodysplastic syndrome
5554604|NCT01068301|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5554605|NCT01068301|Other Leukemia|other leukemia
5554606|NCT01068288|laparoscopic appendectomy|laparoscopic appendectomy
5554607|NCT01068288|open appendectomy|open appendectomy
5554608|NCT01068288|expectant management|expectant management
5554609|NCT01068288|paediatric|paediatric
5554610|NCT01068275|anterior cruciate ligament|anterior cruciate ligament
5554611|NCT01068275|pain, postoperative|pain, postoperative
5554612|NCT01068275|peripheral nerve catheter|peripheral nerve catheter
5554613|NCT01068275|nerve block|nerve block
5554614|NCT01068275|Children undergoing anterior cruciate ligament repair|children undergoing anterior cruciate ligament repair
5554615|NCT01068249|Advanced|advanced
5554616|NCT01068249|Recurrent|recurrent
5554617|NCT01068249|Progressive|progressive
5554618|NCT01068249|Endometrial Cancer|endometrial cancer
5554619|NCT01068249|Letrozole|letrozole
5554620|NCT01068249|RAD001|rad001
5554621|NCT01068249|Afinitor|afinitor
5554622|NCT01068249|Everolimus|everolimus
5554623|NCT01068249|Femara|femara
5554624|NCT01068236|Teen girls|teen girls
5554625|NCT01068236|weightloss|weightloss
5554626|NCT01068236|healthy lifestyle|healthy lifestyle
5554627|NCT01068236|yoga|yoga
5554628|NCT01068236|Weight loss and healthy lifestyle|weight loss and healthy lifestyle
5554629|NCT01068223|Cetirizine, CR016609|cetirizine, cr016609
5554630|NCT01068210|Exercise Intervention|exercise intervention
5554631|NCT01068210|Lung Cancer|lung cancer
5554632|NCT01068210|15-215|15-215
5554633|NCT01068197|Low Glycemic Load diet|low glycemic load diet
5554634|NCT01068197|Low Glycemic Index diet|low glycemic index diet
5554635|NCT01068197|Low Fat diet|low fat diet
5554636|NCT01068197|Obese Hispanic American children and adolescents|obese hispanic american children and adolescents
5554637|NCT01068197|At risk for type 2 diabetes mellitus|at risk for type 2 diabetes mellitus
5554638|NCT01068184|AZD6553|azd6553
5554639|NCT01068184|Chronic|chronic
5554640|NCT01068184|obstructive|obstructive
5554641|NCT01068184|pulmonary|pulmonary
5554642|NCT01068184|lung|lung
5554643|NCT01068184|respiratory disease|respiratory disease
5554644|NCT01068184|placebo-controlled|placebo-controlled
5554645|NCT01068184|COPD|copd
5554646|NCT01068184|Healthy Volunteers|healthy volunteers
5554647|NCT01068184|COPD Patients|copd patients
5554648|NCT01068171|diabetes|diabetes
5554649|NCT01068171|foot ulcers|foot ulcers
5554650|NCT01068171|off-loading|off-loading
5554651|NCT01068171|collagen|collagen
5554652|NCT01068171|Wagner 1|wagner 1
5554653|NCT01068158|Head lice infestation|head lice infestation
5554654|NCT01068158|Pediculus humanus capitis|pediculus humanus capitis
5554655|NCT01068145|COPD|copd
5554656|NCT01068132|Colorectal Neoplasms|colorectal neoplasms
5554657|NCT01068132|KRAS|kras
5554658|NCT01068132|PTEN|pten
5554659|NCT01068119|Acute coronary syndrome|acute coronary syndrome
5554660|NCT01068119|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5554661|NCT01068119|Troponin negative|troponin negative
5554662|NCT01068119|cardiac|cardiac
5554663|NCT01068080|fatty acid metabolism|fatty acid metabolism
5554664|NCT01068080|insulin resistance|insulin resistance
5554665|NCT01068080|cardiac death|cardiac death
5554666|NCT01068080|hemodialysis|hemodialysis
5554667|NCT01068080|normal coronary arteries|normal coronary arteries
5554668|NCT01068080|Predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries|predictive values of impaired myocardial fatty acid metabolism or insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries
5554669|NCT01068054|vernal keratoconjunctivitis|vernal keratoconjunctivitis
5554670|NCT01068054|FK-506|fk-506
5554671|NCT01068054|tacrolimus|tacrolimus
5554672|NCT01068054|cyclosporine|cyclosporine
5554673|NCT01068054|children|children
5554674|NCT01068028|Healthy volunteer study|healthy volunteer study
5554676|NCT01068015|Intervention|intervention
5554677|NCT01068015|Popular Opinion Leader|popular opinion leader
5554678|NCT01068015|Male Circumcision|male circumcision
5554679|NCT01068015|HIV|hiv
5554680|NCT01068015|Syphilis|syphilis
5554681|NCT01068015|HSV-2|hsv-2
5554682|NCT01068002|Hypertension Pregnancy|hypertension pregnancy
5554683|NCT01067989|metronomic chemotherapy|metronomic chemotherapy
5554684|NCT01067989|anti-angiogenic effect|anti-angiogenic effect
5554685|NCT01067989|Breast cancer|breast cancer
5554686|NCT01067976|Breast Cancer|breast cancer
5554687|NCT01067976|Gadobutrol-enhanced MRI|gadobutrol-enhanced mri
5554688|NCT01067976|Mammography|mammography
5554689|NCT01067963|self-care|self-care
5554690|NCT01067963|self-management|self-management
5554691|NCT01067963|health behavior change|health behavior change
5554692|NCT01067963|motivational interviewing|motivational interviewing
5554693|NCT01067963|computer assisted learning|computer assisted learning
5554694|NCT01067950|isolated pancreas transplant|isolated pancreas transplant
5554695|NCT01067950|intensive insulin therapy|intensive insulin therapy
5554696|NCT01067937|Appendicitis|appendicitis
5554697|NCT01067937|children|children
5554698|NCT01067924|Type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence|type 2 diabetes, motivational interviewing, physical activity maintenance, physical activity adherence
5554699|NCT01067911|Postprandial lipids|postprandial lipids
5554700|NCT01067911|test meal|test meal
5554701|NCT01067911|fatty acids|fatty acids
5554702|NCT01067898|vitamin D supplementation|vitamin d supplementation
5554703|NCT01067898|cholecalciferol|cholecalciferol
5554704|NCT01067898|PTH|pth
5554705|NCT01067898|bone turnover markers|bone turnover markers
5554706|NCT01067898|elderly women|elderly women
5554707|NCT01067885|Nitinol Stent|nitinol stent
5554708|NCT01067885|Superficial femoral artery|superficial femoral artery
5554709|NCT01067885|SFA|sfa
5554710|NCT01067885|Angioplasty|angioplasty
5554711|NCT01067885|peripheral artery disease|peripheral artery disease
5554712|NCT01067885|peripheral artery obstructive disease|peripheral artery obstructive disease
5554713|NCT01067885|PAOD|paod
5554714|NCT01067885|PAD|pad
5554715|NCT01067885|Peripheral Vascular Disease|peripheral vascular disease
5554716|NCT01067859|Heart Failure|heart failure
5555397|NCT01065116|Malaria|malaria
5554717|NCT01067846|cocaine dependence|cocaine dependence
5554718|NCT01067846|relapse prevention|relapse prevention
5554719|NCT01067846|computerized cognitive behavioral therapy (CBT)|computerized cognitive behavioral therapy (cbt)
5554720|NCT01067846|D-cycloserine (DCS)|d-cycloserine (dcs)
5554721|NCT01067833|atrial fibrillation|atrial fibrillation
5554722|NCT01067833|AF|af
5554723|NCT01067820|ApolipoproteinA1|apolipoproteina1
5554724|NCT01067820|HDL-C|hdl-c
5554725|NCT01067820|Atherosclerosis|atherosclerosis
5554726|NCT01067807|Pharmacokinetics|pharmacokinetics
5554727|NCT01067794|Metastatic|metastatic
5554728|NCT01067794|Advanced|advanced
5554730|NCT01067794|daily|daily
5554731|NCT01067794|hospital|hospital
5554732|NCT01067794|practice|practice
5554733|NCT01067794|setting|setting
5554734|NCT01067781|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
5554735|NCT01067768|Urinary Tract Infections|urinary tract infections
5539655|NCT01128608|GERD|gerd
5554736|NCT01067768|Catheter-associated urinary tract infections|catheter-associated urinary tract infections
5554737|NCT01067768|Prevention and control|prevention and control
5554738|NCT01067768|Controlled clinical trial|controlled clinical trial
5554739|NCT01067755|navigation|navigation
5554740|NCT01067755|bronchoscopy|bronchoscopy
5554741|NCT01067755|lymphadenopathy|lymphadenopathy
5554742|NCT01067742|Mucolipidosis, retinal dystrophy, mucolipin-1,|mucolipidosis, retinal dystrophy, mucolipin-1,
5554743|NCT01067742|lysosomal storage disease, gastrin, mental retardation,|lysosomal storage disease, gastrin, mental retardation,
5554744|NCT01067742|dysmyelination, dysplastic corpus callosum,corneal clouding|dysmyelination, dysplastic corpus callosum,corneal clouding
5554745|NCT01067729|Burn|burn
5554746|NCT01067729|Superficial burns|superficial burns
5554747|NCT01067729|Partial thickness burns|partial thickness burns
5554753|NCT01067703|remote ischaemic preconditioning, cardiac surgery|remote ischaemic preconditioning, cardiac surgery
5554754|NCT01067690|classical Kaposi's sarcoma|classical kaposi's sarcoma
5554755|NCT01067690|chemotherapy|chemotherapy
5554756|NCT01067690|indinavir|indinavir
5554757|NCT01067690|HIV protease inhibitor|hiv protease inhibitor
5554758|NCT01067690|Advanced classical (non HIV-associated) Kaposi's sarcoma|advanced classical (non hiv-associated) kaposi's sarcoma
5554759|NCT01067677|PONV|ponv
5554760|NCT01067677|Post operative nausea and vomiting|post operative nausea and vomiting
5554761|NCT01067677|rescue emetic therapy|rescue emetic therapy
5554762|NCT01067599|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5554763|NCT01067599|Smokeless Tobacco|smokeless tobacco
5554764|NCT01067586|Smokeless Tobacco|smokeless tobacco
5554765|NCT01067586|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5554766|NCT01067573|MS|ms
5554767|NCT01067573|Serum Leptin Levels during relapse|serum leptin levels during relapse
5554768|NCT01067573|Multiple sclerosis|multiple sclerosis
5554769|NCT01067573|relapse|relapse
5554770|NCT01067560|Glucose|glucose
5554771|NCT01067560|CSF|csf
5554772|NCT01067560|Cesarean section, spinal anesthesia|cesarean section, spinal anesthesia
5554773|NCT01067560|Nova Stat Strip|nova stat strip
5554774|NCT01067560|Abbott Precision Xtra|abbott precision xtra
5554775|NCT01067560|Roche Accucheck Inform 2|roche accucheck inform 2
5554776|NCT01067547|Iron deficiency|iron deficiency
5554777|NCT01067547|Inflammatory Bowel Disease|inflammatory bowel disease
5554778|NCT01067547|Crohn's Disease|crohn's disease
5554779|NCT01067547|Ulcerative colitis|ulcerative colitis
5554780|NCT01067521|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5554781|NCT01067521|Glatiramer Acetate|glatiramer acetate
5554782|NCT01067495|stroke|stroke
5554783|NCT01067495|rehabilitation|rehabilitation
5554784|NCT01067495|exercise|exercise
5554785|NCT01067495|walking|walking
5554786|NCT01067495|risk factors|risk factors
5554787|NCT01067482|OCT|oct
5554788|NCT01067482|spectral domain cirrus|spectral domain cirrus
5554789|NCT01067482|glaucoma|glaucoma
5554790|NCT01067482|glaucoma suspect|glaucoma suspect
5554791|NCT01067482|normal population|normal population
5554792|NCT01067469|CNS|cns
5554793|NCT01067469|Central Nervous System|central nervous system
5554794|NCT01067469|malignant brain tumor|malignant brain tumor
5554795|NCT01067469|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5554796|NCT01067469|GBM|gbm
5554797|NCT01067469|Bevacizumab|bevacizumab
5554798|NCT01067469|Lomustine|lomustine
5554799|NCT01067469|CCNU|ccnu
5554800|NCT01067443|Phase II|phase ii
5554801|NCT01067443|Randomised clinical trial|randomised clinical trial
5554802|NCT01067443|Visceral Leishmaniasis|visceral leishmaniasis
5554803|NCT01067430|Rheumatoid Arthritis|rheumatoid arthritis
5554804|NCT01067430|Etoricoxib|etoricoxib
5554805|NCT01067430|Diclofenac|diclofenac
5554806|NCT01067430|Pain|pain
5554807|NCT01067430|Stiffness|stiffness
5554808|NCT01067417|Hydroxychloroquine|hydroxychloroquine
5554809|NCT01067417|Chloroquine|chloroquine
5554810|NCT01067417|HIV Infection|hiv infection
5554811|NCT01067417|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5554812|NCT01067417|Immune Activation|immune activation
5554813|NCT01067417|inflammation|inflammation
5554814|NCT01067417|treatment naive|treatment naive
5554815|NCT01067417|disease progression|disease progression
5554816|NCT01067404|Influenza vaccines|influenza vaccines
5554817|NCT01067404|Infant|infant
5554818|NCT01067404|Dose-Response relationship, immunologic|dose-response relationship, immunologic
5554819|NCT01067391|Hypotension in SCI males|hypotension in sci males
5554820|NCT01067391|Erectile Dysfunction|erectile dysfunction
5554821|NCT01067378|Interdisciplinary Health Team|interdisciplinary health team
5554822|NCT01067378|Training|training
5554823|NCT01067365|Secondary Hypogonadism|secondary hypogonadism
5554824|NCT01067352|Infant, small for gestational age|infant, small for gestational age
5554825|NCT01067352|Growth hormone|growth hormone
5554827|NCT01067339|coronary endothelial dysfunction|coronary endothelial dysfunction
5539750|NCT01128218|Gliomas|gliomas
5554828|NCT01067339|coronary vasospasm|coronary vasospasm
5554829|NCT01067326|Endothelial Dysfunction|endothelial dysfunction
5554830|NCT01067326|Endothelial Function|endothelial function
5554831|NCT01067326|Tekturna|tekturna
5554832|NCT01067326|Endothelial Peripheral Arterial Tomography (EndoPAT)|endothelial peripheral arterial tomography (endopat)
5554833|NCT01067326|Progenitor Cells|progenitor cells
5554834|NCT01067326|renin inhibition|renin inhibition
5554835|NCT01067326|endothelial progenitor cells|endothelial progenitor cells
5554836|NCT01067326|early atherosclerosis|early atherosclerosis
5554837|NCT01067313|Intensive Care Unit|intensive care unit
5554838|NCT01067313|continuous hemodialysis|continuous hemodialysis
5554839|NCT01067313|continuous hemofiltration|continuous hemofiltration
5554840|NCT01067313|High Cut-off membrane|high cut-off membrane
5554841|NCT01067313|"Enhanced middle molecule clearance membrane"|"enhanced middle molecule clearance membrane"
5554842|NCT01067313|Septic shock|septic shock
5554843|NCT01067313|Acute kidney injury|acute kidney injury
5554844|NCT01067313|Blood purification|blood purification
5554845|NCT01067313|Renal replacement therapy|renal replacement therapy
5554847|NCT01067300|acute leukemia in remission|acute leukemia in remission
5554848|NCT01067300|Children or young adults (< 35 years) with acute leukemia in remission|children or young adults (< 35 years) with acute leukemia in remission
5554849|NCT01067287|dendritic cell fusion vaccine|dendritic cell fusion vaccine
5554850|NCT01067287|CT-011|ct-011
5554851|NCT01067287|autologous stem cell transplant|autologous stem cell transplant
5554852|NCT01067274|Acute Myeloid Leukemia|acute myeloid leukemia
5554853|NCT01067274|Aged of 65 to 79 years|aged of 65 to 79 years
5554854|NCT01067274|Older Patients with Acute Myeloblastic Leukemia|older patients with acute myeloblastic leukemia
5554855|NCT01067261|Nerve stimulation|nerve stimulation
5554856|NCT01067261|TMNS|tmns
5554857|NCT01067261|Prostatectomy|prostatectomy
5554858|NCT01067261|Prevention|prevention
5554859|NCT01067261|Restoration|restoration
5554860|NCT01067261|Treatment|treatment
5554861|NCT01067261|Vibration|vibration
5554862|NCT01067261|Non-invasive|non-invasive
5554863|NCT01067248|COPD|copd
5554864|NCT01067248|Osteoporosis|osteoporosis
5554865|NCT01067248|Pathophysiology|pathophysiology
5554866|NCT01067248|Mechanism|mechanism
5554867|NCT01067248|Bone markers|bone markers
5554868|NCT01067248|Bone turnover|bone turnover
5554869|NCT01067248|Protein turnover|protein turnover
5554870|NCT01067248|Ageing|ageing
5554871|NCT01067248|Endocrinology|endocrinology
5554872|NCT01067248|Vitamin D|vitamin d
5554873|NCT01067235|Narcolespy|narcolespy
5554874|NCT01067235|Cataplexy|cataplexy
5554875|NCT01067235|Excesssive daytime Sleepiness|excesssive daytime sleepiness
5554876|NCT01067235|Sleep Disorders|sleep disorders
5554877|NCT01067235|Sleep attacks|sleep attacks
5554878|NCT01067235|Orphan Drug|orphan drug
5554879|NCT01067235|Pitolisant|pitolisant
5554880|NCT01067222|Narcolepsy|narcolepsy
5554881|NCT01067222|Excessive daytime Sleepiness|excessive daytime sleepiness
5554882|NCT01067222|Cataplexy|cataplexy
5554883|NCT01067222|Sleep Disorders|sleep disorders
5554884|NCT01067222|Sleep attacks|sleep attacks
5554885|NCT01067222|Orphan Drug|orphan drug
5554886|NCT01067222|Pitolisant|pitolisant
5554887|NCT01067209|Reversal of Obesity-related and Diabetic Cardiomyopathy|reversal of obesity-related and diabetic cardiomyopathy
5554888|NCT01067196|Proton Radiation|proton radiation
5554889|NCT01067196|Central Nervous System (CNS) Tumors|central nervous system (cns) tumors
5554890|NCT01067196|Brain|brain
5554891|NCT01067196|Spine|spine
5554892|NCT01067196|Cancer|cancer
5554893|NCT01067196|Radiation Therapy (RT)|radiation therapy (rt)
5554894|NCT01067183|stress reduction|stress reduction
5554895|NCT01067183|physician wellness|physician wellness
5554896|NCT01067170|Hemodialysis|hemodialysis
5554897|NCT01067170|Intradialytic hypotension|intradialytic hypotension
5554898|NCT01067157|Obesity|obesity
5554899|NCT01067157|overweight|overweight
5554900|NCT01067157|childhood|childhood
5554901|NCT01067157|adolescence|adolescence
5554902|NCT01067157|inpatient therapy|inpatient therapy
5554903|NCT01067157|lifestyle intervention|lifestyle intervention
5554904|NCT01067157|cardiovascular risk|cardiovascular risk
5554905|NCT01067157|gene-lifestyle-interaction|gene-lifestyle-interaction
5554906|NCT01067157|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
5554907|NCT01067157|health behaviour|health behaviour
5554908|NCT01067131|Candida albicans|candida albicans
5554909|NCT01067131|Fungal vaginal infection|fungal vaginal infection
5554910|NCT01067131|Vulvovaginal candidiasis|vulvovaginal candidiasis
5554911|NCT01067131|Candidose|candidose
5554912|NCT01067131|Vaccine|vaccine
5554913|NCT01067131|Virosome|virosome
5554914|NCT01067105|Perennial allergic rhinitis|perennial allergic rhinitis
5554915|NCT01067105|allergic rhinitis|allergic rhinitis
5554916|NCT01067105|ciclesonide|ciclesonide
5554917|NCT01067079|Rabies vaccine|rabies vaccine
5554918|NCT01067079|Long-term Immunogenicity|long-term immunogenicity
5554919|NCT01067066|TPI 287|tpi 287
5554920|NCT01067066|microtubule inhibitor|microtubule inhibitor
5554921|NCT01067066|Temozolomide|temozolomide
5554922|NCT01067066|Temodar|temodar
5554923|NCT01067066|cytotoxic agent|cytotoxic agent
5554924|NCT01067066|unresectable Stage III|unresectable stage iii
5554925|NCT01067066|Stage IV|stage iv
5554926|NCT01067066|Metastatic Melanoma|metastatic melanoma
5554927|NCT01067053|Bevacizumab|bevacizumab
5554928|NCT01067053|Capecitabine|capecitabine
5554929|NCT01067053|Oxaliplatin|oxaliplatin
5671977|NCT00613340|Zygapophysial joint|zygapophysial joint
5554930|NCT01067053|Metastatic colorectal cancer|metastatic colorectal cancer
5554931|NCT01067027|Colic|colic
5554932|NCT01067027|Colic in Breast-fed Infants|colic in breast-fed infants
5554933|NCT01067014|Lumbar spinal stenosis|lumbar spinal stenosis
5554934|NCT01067014|Decompression|decompression
5554936|NCT01067014|Lumbar spinal decompressive surgery|lumbar spinal decompressive surgery
5554937|NCT01066988|lipid layer thickness|lipid layer thickness
5554938|NCT01066975|loaded backpack|loaded backpack
5554939|NCT01066975|unloaded backpack|unloaded backpack
5554940|NCT01066962|HIV-infected antiretroviral naïve subjects|hiv-infected antiretroviral naïve subjects
5554941|NCT01066949|hemodialysis|hemodialysis
5554942|NCT01066949|behavior change|behavior change
5554943|NCT01066949|patient adherence|patient adherence
5554944|NCT01066949|self management|self management
5554945|NCT01066923|firefighter|firefighter
5554946|NCT01066923|heat stress|heat stress
5554947|NCT01066923|platelet activation|platelet activation
5554948|NCT01066923|aspirin|aspirin
5554949|NCT01066910|Obesity|obesity
5554950|NCT01066910|Childhood Obesity|childhood obesity
5554951|NCT01066910|Exercise|exercise
5554952|NCT01066910|Nutrition|nutrition
5554953|NCT01066871|Knee cartilage injury|knee cartilage injury
5554954|NCT01066871|fibroblast growth factor 18|fibroblast growth factor 18
5554955|NCT01066871|FGF18|fgf18
5554956|NCT01066858|tenofovir|tenofovir
5554957|NCT01066858|renal and bone toxicity|renal and bone toxicity
5554958|NCT01066858|pregnancy|pregnancy
5554959|NCT01066858|breastfeeding|breastfeeding
5554960|NCT01066858|mother to child transmission|mother to child transmission
5554961|NCT01066832|Drug-eluting balloon|drug-eluting balloon
5554962|NCT01066832|Paclitaxel|paclitaxel
5554963|NCT01066832|DIOR|dior
5554964|NCT01066832|short term registry|short term registry
5554965|NCT01066832|Valentines Trial|valentines trial
5554966|NCT01066832|Drug-eluting balloon treatment of in-stent restenosis|drug-eluting balloon treatment of in-stent restenosis
5554967|NCT01066780|cochlear implant|cochlear implant
5554968|NCT01066780|adults|adults
5554969|NCT01066780|HiResolution|hiresolution
5554970|NCT01066780|Fidelity 120|fidelity 120
5554971|NCT01066780|listening benefits|listening benefits
5554972|NCT01066780|noise|noise
5554973|NCT01066780|cochlear implant benefit|cochlear implant benefit
5554974|NCT01066741|Epidermoid carcinoma|epidermoid carcinoma
5554975|NCT01066741|Hypopharynx|hypopharynx
5554976|NCT01066741|Oropharynx|oropharynx
5554977|NCT01066741|Oral cavity|oral cavity
5554978|NCT01066741|Oral mucosa|oral mucosa
5554979|NCT01066741|Cavum|cavum
5554980|NCT01066741|Severe Oral mucositis|severe oral mucositis
5554981|NCT01066741|Radiotherapy|radiotherapy
5554982|NCT01066741|Phytotherapy|phytotherapy
5554983|NCT01066728|apnea|apnea
5554984|NCT01066728|premature|premature
5554985|NCT01066728|infant|infant
5554986|NCT01066728|prematurity|prematurity
5554987|NCT01066715|Diabetes|diabetes
5554988|NCT01066715|Type 2|type 2
5554989|NCT01066715|Mellitus|mellitus
5554990|NCT01066689|kidney transplantation, acute humoral rejection, rituximab|kidney transplantation, acute humoral rejection, rituximab
5554993|NCT01066663|relapsed|relapsed
5554994|NCT01066663|pyrimethamine|pyrimethamine
5554995|NCT01066650|TWENTE|twente
5554996|NCT01066650|randomized study|randomized study
5554997|NCT01066650|stent|stent
5554998|NCT01066650|coronary stent|coronary stent
5554999|NCT01066650|drug-eluting stent|drug-eluting stent
5555000|NCT01066650|Zotarolimus|zotarolimus
5555001|NCT01066650|Everolimus|everolimus
5555002|NCT01066650|Xience V|xience v
5555003|NCT01066650|Endeavor Resolute|endeavor resolute
5555004|NCT01066650|head to head comparison|head to head comparison
5555005|NCT01066650|real world patients|real world patients
5555006|NCT01066650|target vessel failure|target vessel failure
5555007|NCT01066650|investigator initiated study|investigator initiated study
5555008|NCT01066650|coronary artery disease|coronary artery disease
5555009|NCT01066650|coronary arteries|coronary arteries
5555010|NCT01066650|atherosclerosis|atherosclerosis
5555011|NCT01066650|non inferiority|non inferiority
5555012|NCT01066637|Heart transplant patients|heart transplant patients
5555013|NCT01066624|Mucositis|mucositis
5555014|NCT01066624|Multiple myeloma|multiple myeloma
5555015|NCT01066624|Autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5555016|NCT01066611|Allergic Rhinitis|allergic rhinitis
5555017|NCT01066611|Allergy|allergy
5555018|NCT01066611|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5555019|NCT01066598|graft versus host disease|graft versus host disease
5555020|NCT01066598|chronic graft versus host disease|chronic graft versus host disease
5555022|NCT01066585|Head lice|head lice
5555023|NCT01066585|Pediculus humanus capitis|pediculus humanus capitis
5555024|NCT01066546|Delirium|delirium
5555025|NCT01066546|Dementia|dementia
5555026|NCT01066546|Amnestic|amnestic
5555027|NCT01066546|Cognitive Disorders|cognitive disorders
5555028|NCT01066546|Mental Disorders|mental disorders
5555029|NCT01066546|Nervous System Diseases|nervous system diseases
5555030|NCT01066546|Central Nervous System Diseases|central nervous system diseases
5555032|NCT01066533|NEC|nec
5555033|NCT01066533|Immunohistochemistry|immunohistochemistry
5555034|NCT01066533|fibronectin|fibronectin
5555035|NCT01066533|tenascin|tenascin
5555036|NCT01066520|ankle sprain|ankle sprain
5555037|NCT01066520|traumeel|traumeel
5555038|NCT01066520|diclofenac|diclofenac
5555039|NCT01066520|antiinflammatory|antiinflammatory
5555040|NCT01066520|time to normal function|time to normal function
5555041|NCT01066507|Her2|her2
5555042|NCT01066507|FISH|fish
5555043|NCT01066507|Breast cancer|breast cancer
5555044|NCT01066507|Amplification|amplification
5555045|NCT01066494|AML|aml
5555046|NCT01066494|Pgp|pgp
5555047|NCT01066494|MDR|mdr
5555048|NCT01066494|sAML|saml
5555049|NCT01066494|AS1413|as1413
5555050|NCT01066494|Amonafide|amonafide
5555051|NCT01066481|Alzheimer's disease|alzheimer's disease
5555052|NCT01066481|clinical trial|clinical trial
5555053|NCT01066481|memory loss|memory loss
5555054|NCT01066481|investigational drug|investigational drug
5555055|NCT01066481|neurodegenerative disease|neurodegenerative disease
5555056|NCT01066481|dementia|dementia
5555057|NCT01066468|Chronic myeloid leukemia|chronic myeloid leukemia
5555058|NCT01066468|CML|cml
5555059|NCT01066468|Philadelphia chromosome positive|philadelphia chromosome positive
5555060|NCT01066468|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5555061|NCT01066468|PhGlivec,|phglivec,
5555062|NCT01066468|Gleevec,|gleevec,
5555063|NCT01066468|hypereosinophilic syndrome,|hypereosinophilic syndrome,
5555064|NCT01066468|HES,|hes,
5555065|NCT01066468|chronic eosinophilic leukemia,|chronic eosinophilic leukemia,
5555066|NCT01066468|CEL,|cel,
5555067|NCT01066468|myelodysplastic syndrome,|myelodysplastic syndrome,
5555068|NCT01066468|MDS,|mds,
5555069|NCT01066468|myeloproliferative disease,|myeloproliferative disease,
5555070|NCT01066468|MPD+ ALL|mpd+ all
5555071|NCT01066455|Cardiac|cardiac
5555072|NCT01066455|Muscular Dystrophy|muscular dystrophy
5555073|NCT01066455|Prospective|prospective
5555074|NCT01066455|Pediatric|pediatric
5555075|NCT01066455|Echocardiogram|echocardiogram
5555076|NCT01066442|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
5555077|NCT01066442|Parkinson's Disease|parkinson's disease
5555078|NCT01066429|poor-prognosis diffuse large B-cell lymphoma|poor-prognosis diffuse large b-cell lymphoma
5555079|NCT01066429|dose-adjusted|dose-adjusted
5555080|NCT01066429|R-EDOCH-14|r-edoch-14
5555081|NCT01066429|rituximab|rituximab
5555082|NCT01066429|age-adjusted IPI|age-adjusted ipi
5555083|NCT01066429|toxicity|toxicity
5555084|NCT01066403|schizophrenia|schizophrenia
5555085|NCT01066403|cognitive deficits|cognitive deficits
5555086|NCT01066403|dopamine|dopamine
5555087|NCT01066403|dopamine agonists|dopamine agonists
5555088|NCT01066403|prefrontal cortex|prefrontal cortex
5555089|NCT01066403|D1 specific modulation|d1 specific modulation
5555090|NCT01066403|pergolide|pergolide
5555091|NCT01066403|executive control|executive control
5555092|NCT01066403|working memory|working memory
5555093|NCT01066403|Influence of pergolide on cognition in Schizophrenia|influence of pergolide on cognition in schizophrenia
5555094|NCT01066403|D1-specific modulation of prefrontal functions|d1-specific modulation of prefrontal functions
5555095|NCT01066403|Influence of pergolide on psychopathology and depression|influence of pergolide on psychopathology and depression
5555096|NCT01066403|Influence of pergolide on extrapyramidal symptoms|influence of pergolide on extrapyramidal symptoms
5555097|NCT01066390|stage IIIC/IV melanoma|stage iiic/iv melanoma
5555098|NCT01066377|prebiotic|prebiotic
5555099|NCT01066377|probiotic|probiotic
5555100|NCT01066377|influenza|influenza
5555101|NCT01066377|vaccination|vaccination
5555102|NCT01066377|ageing|ageing
5555103|NCT01066377|immunosenescence|immunosenescence
5555104|NCT01066364|NASH|nash
5555105|NCT01066364|NAFLD|nafld
5555106|NCT01066364|Steatohepatitis|steatohepatitis
5555107|NCT01066364|Nonalcoholic|nonalcoholic
5555108|NCT01066364|Fatty Liver Disease|fatty liver disease
5555109|NCT01066351|acute kidney injury|acute kidney injury
5555110|NCT01066351|erythropoietin|erythropoietin
5555111|NCT01066351|cardiac surgery|cardiac surgery
5555112|NCT01066338|SNP array|snp array
5555113|NCT01066338|prognosis|prognosis
5555114|NCT01066338|acute myeloid leukemia|acute myeloid leukemia
5555115|NCT01066338|normal karyotype|normal karyotype
5555116|NCT01066338|acute myeloid leukemia with normal karyotype|acute myeloid leukemia with normal karyotype
5555117|NCT01066325|Sit-n-Reach Test|sit-n-reach test
5555118|NCT01066325|Flexibility|flexibility
5555119|NCT01066325|Hamstring|hamstring
5555120|NCT01066325|Mindbody|mindbody
5555121|NCT01066325|Complementary and Alternative Medicine|complementary and alternative medicine
5555122|NCT01066325|Neuro Emotional Technique (NET)|neuro emotional technique (net)
5555123|NCT01066312|Muscle testing|muscle testing
5555124|NCT01066312|Kinesiology|kinesiology
5555125|NCT01066312|Muscles|muscles
5555126|NCT01066312|Complementary and Alternative Medicine|complementary and alternative medicine
5555127|NCT01066312|Practitioner Experience|practitioner experience
5555128|NCT01066312|This study is actually not a randomised controlled trial,|this study is actually not a randomised controlled trial,
5671978|NCT00613340|Specificity|specificity
5555129|NCT01066312|but an assessment of diagnostic test accuracy. We will be|but an assessment of diagnostic test accuracy. we will be
5555130|NCT01066312|looking at the accuracy of MMT to distinguish congruent from|looking at the accuracy of mmt to distinguish congruent from
5555131|NCT01066312|incongruent statements under varying levels of blinding.|incongruent statements under varying levels of blinding.
5555132|NCT01066299|oxytocin|oxytocin
5555133|NCT01066299|psychophysiology|psychophysiology
5555135|NCT01066299|anxiety|anxiety
5555136|NCT01066299|emotion|emotion
5555137|NCT01066299|physiology|physiology
5555138|NCT01066286|genome wide SNP-array|genome wide snp-array
5555139|NCT01066286|micro-cytogenetic lesion|micro-cytogenetic lesion
5555140|NCT01066286|KIT mutation|kit mutation
5555141|NCT01066286|core binding factor|core binding factor
5555142|NCT01066286|acute myeloid leukemia|acute myeloid leukemia
5555143|NCT01066286|The Approval status was changed from Pending to Approved.|the approval status was changed from pending to approved.
5555144|NCT01066260|Probiotics|probiotics
5555145|NCT01066260|Energy balance|energy balance
5555146|NCT01066247|spinal anesthesia|spinal anesthesia
5555147|NCT01066247|heart rate variability|heart rate variability
5555148|NCT01066247|premedication|premedication
5555149|NCT01066247|heart rate|heart rate
5555150|NCT01066247|blood pressure|blood pressure
5555151|NCT01066234|Microscopic N2 Non-small Cell Lung Cancer|microscopic n2 non-small cell lung cancer
5555152|NCT01066234|Paclitaxel|paclitaxel
5555153|NCT01066234|Carboplatin|carboplatin
5555154|NCT01066234|Cisplatin|cisplatin
5555155|NCT01066221|clostridium difficile|clostridium difficile
5555156|NCT01066208|Classification criteria|classification criteria
5555157|NCT01066208|Diagnostic criteria|diagnostic criteria
5555158|NCT01066195|Non-Small Cell Lung Cancer|non-small cell lung cancer
5555159|NCT01066195|Never-Smoker and Adenocarcinoma patients|never-smoker and adenocarcinoma patients
5555160|NCT01066195|Pemetrexed (ALIMTA)|pemetrexed (alimta)
5555161|NCT01066195|Gefitinib (IRESSA®)|gefitinib (iressa®)
5555162|NCT01066182|DHA|dha
5555163|NCT01066182|Learning|learning
5555164|NCT01066182|Reading|reading
5555165|NCT01066182|Memory|memory
5555166|NCT01066182|Children|children
5555167|NCT01066182|Omega 3|omega 3
5555168|NCT01066182|Education|education
5555169|NCT01066182|Learning and behaviour in children|learning and behaviour in children
5555170|NCT01066169|Pandemic Influenza A/H1N1|pandemic influenza a/h1n1
5555171|NCT01066169|HIV|hiv
5555172|NCT01066169|Antibodies|antibodies
5555173|NCT01066169|Replicaton|replicaton
5555174|NCT01066156|Post-traumatic Stress Disorder|post-traumatic stress disorder
5555175|NCT01066156|PTSD|ptsd
5555176|NCT01066156|Seroquel|seroquel
5555177|NCT01066156|fMRI|fmri
5555178|NCT01066143|Seroquel|seroquel
5555179|NCT01066143|Generalized Anxiety Disorder|generalized anxiety disorder
5555180|NCT01066143|fMRI|fmri
5555181|NCT01066130|Diabetes Mellitus|diabetes mellitus
5555182|NCT01066130|Arthritis, Rheumatoid|arthritis, rheumatoid
5555183|NCT01066130|psychosocial aspects|psychosocial aspects
5555184|NCT01066130|Patient Adherence|patient adherence
5555185|NCT01066130|Social Work|social work
5555186|NCT01066130|Coping Behavior|coping behavior
5555187|NCT01066130|Coping Skills|coping skills
5555188|NCT01066130|Adaptation, Psychological|adaptation, psychological
5555189|NCT01066117|urinary incontinent|urinary incontinent
5555190|NCT01066091|Inflammatory response|inflammatory response
5555191|NCT01066091|High-fat meal|high-fat meal
5555192|NCT01066091|cytokines|cytokines
5555193|NCT01066091|Body composition|body composition
5555194|NCT01066078|heart failure - congestive|heart failure - congestive
5555195|NCT01066078|Cardiovascular imaging agents/Techniques]|cardiovascular imaging agents/techniques]
5555196|NCT01066078|Echocardiography|echocardiography
5555197|NCT01066078|Other diagnostic testing|other diagnostic testing
5555198|NCT01066078|Other Treatment|other treatment
5555199|NCT01066078|Recipients of cardiac resynchronization therapy systems|recipients of cardiac resynchronization therapy systems
5555200|NCT01066065|cardiovascular disease|cardiovascular disease
5555201|NCT01066065|HIV|hiv
5555202|NCT01066065|metabolic disorder|metabolic disorder
5555398|NCT01065103|STEMI|stemi
5555203|NCT01066065|HIV naive patients initiating HAART with Raltegravir or boosted Darunavir|hiv naive patients initiating haart with raltegravir or boosted darunavir
5555204|NCT01066052|Growth hormone|growth hormone
5555205|NCT01066052|Turner syndrome|turner syndrome
5555206|NCT01066052|r-hGH|r-hgh
5555207|NCT01066052|early treatment|early treatment
5555208|NCT01066039|Bisoprolol|bisoprolol
5555209|NCT01066039|Hypertension|hypertension
5555210|NCT01066039|Diabetes mellitus, Type II|diabetes mellitus, type ii
5555211|NCT01066039|Blood pressure|blood pressure
5555212|NCT01066039|Glycemic level|glycemic level
5555213|NCT01066026|metallic cannula|metallic cannula
5555214|NCT01066026|Hyaluronic acid|hyaluronic acid
5555215|NCT01066013|Antimicrobial De escalation|antimicrobial de escalation
5555216|NCT01066013|Meropenem|meropenem
5555217|NCT01066013|Piperacillin tazobactam|piperacillin tazobactam
5555218|NCT01066013|Medical patients|medical patients
5555219|NCT01066013|Appropriate use|appropriate use
5555220|NCT01066013|Cost savings|cost savings
5555221|NCT01066013|Antimicrobial De-escalation strategy|antimicrobial de-escalation strategy
5555222|NCT01065974|Nutritional Intake|nutritional intake
5555223|NCT01065974|Psychosocial Outcome|psychosocial outcome
5555224|NCT01065961|anterior|anterior
5555225|NCT01065961|cervical|cervical
5555226|NCT01065961|fusion|fusion
5555227|NCT01065961|swallowing|swallowing
5862966|NCT00001442|Radiosensitizer|radiosensitizer
5537683|NCT01137175|Q fever|q fever
5862967|NCT00001442|Radiotherapy|radiotherapy
5555228|NCT01065961|Swallowing after anterior cervical discectomy and fusion|swallowing after anterior cervical discectomy and fusion
5555229|NCT01065961|Bony fusion rates post anterior cervical discectomy and fusion|bony fusion rates post anterior cervical discectomy and fusion
5555230|NCT01065948|subcutaneous glucose monitoring|subcutaneous glucose monitoring
5555232|NCT01065948|fluorescence|fluorescence
5555233|NCT01065948|affinity|affinity
5555234|NCT01065948|biosensor|biosensor
5555235|NCT01065948|type I Diabetes|type i diabetes
5555236|NCT01065948|type II diabetes|type ii diabetes
5555237|NCT01065935|ALN-RSV01|aln-rsv01
5555239|NCT01065935|Respiratory Syncytial Virus|respiratory syncytial virus
5555240|NCT01065896|spinal cord injury|spinal cord injury
5555241|NCT01065896|coronary artery disease|coronary artery disease
5555242|NCT01065857|Colonoscopy, Preparation, Evacuating, Bowel Cleansing.|colonoscopy, preparation, evacuating, bowel cleansing.
5555243|NCT01065844|Nelfinavir|nelfinavir
5555244|NCT01065831|motivational interviewing, lay health advisers|motivational interviewing, lay health advisers
5555245|NCT01065818|Esophageal cancer|esophageal cancer
5555246|NCT01065818|Non-small cell lung cancer|non-small cell lung cancer
5555247|NCT01065818|FLT-PET|flt-pet
5555248|NCT01065818|Chemoradiotherapy|chemoradiotherapy
5555249|NCT01065805|18F-FLT|18f-flt
5555250|NCT01065805|Positive Emission Tomography|positive emission tomography
5555251|NCT01065805|Cancer|cancer
5555252|NCT01065792|HIV Infection|hiv infection
5555253|NCT01065766|Diabetes Mellitus|diabetes mellitus
5555254|NCT01065766|Non-Insulin-Dependent|non-insulin-dependent
5555255|NCT01065753|Rho kinase|rho kinase
5555256|NCT01065753|Brain-derived neurotrophic factor|brain-derived neurotrophic factor
5555257|NCT01065740|Peripheral arterial disease|peripheral arterial disease
5555258|NCT01065740|Patient education|patient education
5555259|NCT01065740|Physical activity coaching|physical activity coaching
5555260|NCT01065740|Lifestyle modifications|lifestyle modifications
5555261|NCT01065740|Walking capacity|walking capacity
5555262|NCT01065740|6 minutes walking test|6 minutes walking test
5555263|NCT01065727|Reemitting aggressive multiple sclerosis|reemitting aggressive multiple sclerosis
5555264|NCT01065714|Transepidermal water loss|transepidermal water loss
5555265|NCT01065714|Epidermal barrier|epidermal barrier
5555266|NCT01065714|Skin hydration|skin hydration
5555267|NCT01065688|distal gastrectomy|distal gastrectomy
5555268|NCT01065688|Billroth-I reconstruction|billroth-i reconstruction
5555269|NCT01065688|gastric cancer|gastric cancer
5555270|NCT01065688|QOL|qol
5555271|NCT01065675|Medication Reconciliation|medication reconciliation
5555272|NCT01065675|Emergency Department|emergency department
5555273|NCT01065675|Nurse|nurse
5555274|NCT01065675|Pharmacist|pharmacist
5555275|NCT01065675|Certified Pharmacy Technician|certified pharmacy technician
5555276|NCT01065675|Medication reconciliation: inpatients admitted from the ED|medication reconciliation: inpatients admitted from the ed
5555277|NCT01065662|AZD2171|azd2171
5555278|NCT01065662|temsirolimus|temsirolimus
5555279|NCT01065662|advanced gynecological malignancies|advanced gynecological malignancies
5555280|NCT01065649|reflux disease|reflux disease
5555281|NCT01065649|heartburn|heartburn
5555282|NCT01065623|Phase I|phase i
5555283|NCT01065623|Dose escalation|dose escalation
5555284|NCT01065623|Immunoconjugate|immunoconjugate
5555285|NCT01065597|electroconvulsive therapy|electroconvulsive therapy
5555286|NCT01065597|seizure|seizure
5555287|NCT01065597|nonconvulsive|nonconvulsive
5555288|NCT01065597|subconvulsive|subconvulsive
5555289|NCT01065597|major depression|major depression
5555290|NCT01065597|bipolar disorder|bipolar disorder
5555291|NCT01065584|liver transplantation|liver transplantation
5555292|NCT01065584|Patients undergoing liver transplantation|patients undergoing liver transplantation
5555293|NCT01065571|relapse|relapse
5555294|NCT01065571|carrageenan|carrageenan
5555295|NCT01065571|inflammation|inflammation
5555296|NCT01065558|Ecopipam|ecopipam
5555299|NCT01065558|Self-Injurious Behavior|self-injurious behavior
5555301|NCT01065532|Restenosis|restenosis
5555302|NCT01065532|PCI|pci
5555303|NCT01065532|Drug-eluting stent|drug-eluting stent
5555304|NCT01065532|Drug-eluting balloon|drug-eluting balloon
5555305|NCT01065532|Optical Coherence Tomography|optical coherence tomography
5555306|NCT01065519|Coronary stent|coronary stent
5555307|NCT01065519|Optical coherence tomography|optical coherence tomography
5555308|NCT01065519|Intravascular ultrasound|intravascular ultrasound
5555310|NCT01065480|Substance Abuse|substance abuse
5555311|NCT01065480|Counseling|counseling
5555312|NCT01065480|Motivational Interviewing|motivational interviewing
5555314|NCT01065467|panobinostat|panobinostat
5555317|NCT01065441|breast cancer|breast cancer
5555318|NCT01065441|colorectal cancer|colorectal cancer
5555319|NCT01065441|prostate cancer|prostate cancer
5555320|NCT01065441|melanoma|melanoma
5555321|NCT01065441|ovarian cancer|ovarian cancer
5555322|NCT01065441|GI cancer|gi cancer
5555323|NCT01065441|Sarcoma|sarcoma
5555324|NCT01065441|Renal Cell Carcinoma|renal cell carcinoma
5555325|NCT01065428|neuromechanical efficiency|neuromechanical efficiency
5555326|NCT01065428|neuroventilatory efficiency|neuroventilatory efficiency
5555327|NCT01065428|weaning|weaning
5537763|NCT01136681|Premature birth|premature birth
5555328|NCT01065428|Respiration, Artificial|respiration, artificial
5555329|NCT01065415|Magnetic Resonance Imaging/Positron Emission Tomography|magnetic resonance imaging/positron emission tomography
5555330|NCT01065415|Whole body imaging|whole body imaging
5555331|NCT01065415|Non-small cell lung cancer|non-small cell lung cancer
5555332|NCT01065415|staging|staging
5555333|NCT01065415|Diagnostic accuracy|diagnostic accuracy
5555334|NCT01065402|Diabetes mellitus|diabetes mellitus
5555335|NCT01065402|continuous glucose monitoring system (CGMS)|continuous glucose monitoring system (cgms)
5555336|NCT01065389|Intradialysis|intradialysis
5555337|NCT01065389|Resistance training|resistance training
5555338|NCT01065389|Protein Catabolic Rate|protein catabolic rate
5555339|NCT01065389|Urea kinetics|urea kinetics
5555340|NCT01065389|Quality of life|quality of life
5555341|NCT01065389|VO2 max|vo2 max
5555343|NCT01065376|OHSS|ohss
5555344|NCT01065376|cabergoline|cabergoline
5555345|NCT01065363|Hepatitis B virus DNA|hepatitis b virus dna
5555346|NCT01065363|Metabolic factor|metabolic factor
5555347|NCT01065363|Body mass index|body mass index
5555348|NCT01065363|Obesity|obesity
5555349|NCT01065363|Insulin resistance|insulin resistance
5555350|NCT01065363|Lifestyle factor|lifestyle factor
5555351|NCT01065363|Preventive Medicine|preventive medicine
5555352|NCT01065363|Health Promotion|health promotion
5555353|NCT01065350|ketofol|ketofol
5555354|NCT01065350|hemodynamics|hemodynamics
5555355|NCT01065350|propofol|propofol
5555356|NCT01065350|anesthesia|anesthesia
5555357|NCT01065337|peripheral arterial occlusion disease (PAD)|peripheral arterial occlusion disease (pad)
5555358|NCT01065337|diabetic foot|diabetic foot
5555359|NCT01065337|critical limb ischemia (CLI)|critical limb ischemia (cli)
5555360|NCT01065337|stem cell therapy|stem cell therapy
5555361|NCT01065324|balloon|balloon
5555362|NCT01065324|enteroscopy|enteroscopy
5555363|NCT01065324|bacteremia|bacteremia
5555364|NCT01065311|Depressive Disorder|depressive disorder
5555365|NCT01065311|Psychotherapy|psychotherapy
5555366|NCT01065285|Influenza|influenza
5555367|NCT01065285|autoimmune diseases|autoimmune diseases
5555368|NCT01065285|vaccination|vaccination
5555369|NCT01065285|H1N1|h1n1
5555370|NCT01065272|Dexamethasone|dexamethasone
5555371|NCT01065272|Bronchiolitis|bronchiolitis
5555372|NCT01065259|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5555373|NCT01065259|executive function|executive function
5555374|NCT01065259|OROS MPH|oros mph
5555375|NCT01065259|atomoxetine|atomoxetine
5555376|NCT01065246|malignant ascites|malignant ascites
5555377|NCT01065246|second cycle|second cycle
5555378|NCT01065246|trifunctional|trifunctional
5555379|NCT01065220|Serotonin Transporter|serotonin transporter
5555380|NCT01065220|Hormone therapy|hormone therapy
5555381|NCT01065220|Gender Dysphoria|gender dysphoria
5555382|NCT01065220|Transsexualism|transsexualism
5555383|NCT01065181|shoulder|shoulder
5555384|NCT01065181|posterior inferior glenohumeral ligament|posterior inferior glenohumeral ligament
5555385|NCT01065181|posterior capsule|posterior capsule
5555386|NCT01065181|capsular contracture|capsular contracture
5555387|NCT01065181|baseball|baseball
5555388|NCT01065181|throwing injury|throwing injury
5555389|NCT01065168|endometriosis|endometriosis
5555390|NCT01065168|endometrioma|endometrioma
5555391|NCT01065168|antimullerian hormone|antimullerian hormone
5555392|NCT01065168|cystectomy|cystectomy
5555393|NCT01065142|Heart Failure|heart failure
5555394|NCT01065142|Patient Education as Topic|patient education as topic
5555395|NCT01065142|Primary Health Care|primary health care
5555396|NCT01065142|Quality of Life|quality of life
5555399|NCT01065103|Primary angioplasty|primary angioplasty
5555400|NCT01065103|Non-culprit vessel at STEMI|non-culprit vessel at stemi
5555401|NCT01065103|Fractional Flow Reserve|fractional flow reserve
5555402|NCT01065103|ST-elevation myocardial infarction|st-elevation myocardial infarction
5555403|NCT01065103|Fractional Flow Reserve in non-culprit vessel at STEMI|fractional flow reserve in non-culprit vessel at stemi
5555404|NCT01065090|Capacity for Work Questionnaire|capacity for work questionnaire
5555405|NCT01065090|exercise|exercise
5555406|NCT01065090|AVONEX|avonex
5555407|NCT01065090|SDMT: Symbol Digit Modalities Test|sdmt: symbol digit modalities test
5540327|NCT01125657|bioequivalence study|bioequivalence study
5555408|NCT01065090|FSMC: Fatigue Scale for Motor and Cognitive functions|fsmc: fatigue scale for motor and cognitive functions
5555409|NCT01065090|effects of exercise|effects of exercise
5555410|NCT01065090|EDSS: Expanded Disability Status Scale|edss: expanded disability status scale
5555411|NCT01065077|Heart Failure|heart failure
5555412|NCT01065064|Multifocal IOL|multifocal iol
5555413|NCT01065064|ReSTOR IOL|restor iol
5555414|NCT01065051|Pulmonary Hypertension|pulmonary hypertension
5555415|NCT01065051|Left ventricular dysfunction|left ventricular dysfunction
5555416|NCT01065025|4SC-205|4sc-205
5555417|NCT01065025|Solid tumors|solid tumors
5555418|NCT01065025|Lymphomas|lymphomas
5555419|NCT01065025|Phase I|phase i
5555420|NCT01064999|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5555421|NCT01064999|locally advanced rectal cancer|locally advanced rectal cancer
5555422|NCT01064999|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5555423|NCT01064999|pathological complete response|pathological complete response
5555424|NCT01064986|Immune System|immune system
5555426|NCT01064960|Neoplasms, Connective and Soft Tissue|neoplasms, connective and soft tissue
5555427|NCT01064960|Neoplasms, Muscle Tissue|neoplasms, muscle tissue
5555428|NCT01064960|Neoplasms|neoplasms
5555429|NCT01064960|Myofibroma|myofibroma
5555430|NCT01064960|Neoplasms by Histologic Type|neoplasms by histologic type
5555431|NCT01064960|Connective Tissue Diseases|connective tissue diseases
5555432|NCT01064960|Neoplasms, Connective Tissue|neoplasms, connective tissue
5555433|NCT01064960|Leiomyoma|leiomyoma
5555434|NCT01064934|coronary heart disease|coronary heart disease
5555435|NCT01064934|cerebrovascular disease|cerebrovascular disease
5555436|NCT01064934|peripheral arterial disease|peripheral arterial disease
5555437|NCT01064934|atherosclerosis|atherosclerosis
5555438|NCT01064934|hyperlipoproteinemia|hyperlipoproteinemia
5555439|NCT01064921|oropharyngeal cancer|oropharyngeal cancer
5555440|NCT01064921|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5555441|NCT01064908|Endarterectomy, Carotid|endarterectomy, carotid
5555442|NCT01064908|Carotid stenosis|carotid stenosis
5555443|NCT01064908|Oxygen mask|oxygen mask
5555444|NCT01064895|Benephit|benephit
5555445|NCT01064895|Acute Kidney Injury|acute kidney injury
5555446|NCT01064895|Acute Renal Failure|acute renal failure
5555447|NCT01064895|Contrast Induced Nephropathy|contrast induced nephropathy
5555448|NCT01064895|Chronic Kidney Disease|chronic kidney disease
5555449|NCT01064869|Adherence|adherence
5555450|NCT01064869|Asthma|asthma
5555451|NCT01064869|medication|medication
5555452|NCT01064856|peripheral spondyloarthritis|peripheral spondyloarthritis
5555453|NCT01064856|adalimumab|adalimumab
5555454|NCT01064856|humira|humira
5555455|NCT01064843|Edentulous|edentulous
5555456|NCT01064843|Edentulism|edentulism
5555457|NCT01064843|Lower denture|lower denture
5555458|NCT01064843|Mini dental implant|mini dental implant
5555459|NCT01064843|Imtec MDI|imtec mdi
5555460|NCT01064843|Denture stabilization|denture stabilization
5555461|NCT01064843|Case success rate of overdentures stabilized by MDI|case success rate of overdentures stabilized by mdi
5555462|NCT01064843|General satisfaction of patients with this treatment|general satisfaction of patients with this treatment
5555463|NCT01064843|Oral health-related quality of life of these patients|oral health-related quality of life of these patients
5555464|NCT01064843|Cost estimates|cost estimates
5555465|NCT01064830|brittle nail|brittle nail
5555466|NCT01064817|glaucoma, trabeculectomy|glaucoma, trabeculectomy
5555467|NCT01064791|Renal transplantation|renal transplantation
5555468|NCT01064778|Glycemic Index|glycemic index
5555469|NCT01064778|Brain|brain
5555473|NCT01064778|Diet|diet
5555474|NCT01064765|Heart failure|heart failure
5555475|NCT01064765|Self management|self management
5555476|NCT01064765|cognitive dysfunction|cognitive dysfunction
5555477|NCT01064765|Self management of heart failure|self management of heart failure
5555478|NCT01064752|Minocycline|minocycline
5555479|NCT01064752|HIV-1|hiv-1
5555480|NCT01064752|Immune activation|immune activation
5555481|NCT01064752|Cerebrospinal fluid|cerebrospinal fluid
5555482|NCT01064752|Observational|observational
5555483|NCT01064739|Healthy Volunteers|healthy volunteers
5555484|NCT01064739|Fava bean consumption|fava bean consumption
5555485|NCT01064739|L-Dopa content in Fava Beans|l-dopa content in fava beans
5555486|NCT01064739|Sodium|sodium
5555487|NCT01064739|Potassium|potassium
5555488|NCT01064739|Electrolyte Balance|electrolyte balance
5555489|NCT01064739|Natriuresis|natriuresis
5555587|NCT01064310|patient preference|patient preference
5555490|NCT01064726|Allergic Rhinitis Nasal Allergen Challenge Inflammatory Markers|allergic rhinitis nasal allergen challenge inflammatory markers
5555491|NCT01064713|Tesetaxel|tesetaxel
5555492|NCT01064713|Second-line therapy|second-line therapy
5555493|NCT01064713|Metastatic melanoma|metastatic melanoma
5555494|NCT01064713|Normal serum LDH|normal serum ldh
5555495|NCT01064700|Anxiety|anxiety
5555496|NCT01064700|Phototherapy|phototherapy
5555497|NCT01064700|Psychic Anxiety|psychic anxiety
5555498|NCT01064674|renal transplantation|renal transplantation
5555499|NCT01064674|cardiovascular morbidity|cardiovascular morbidity
5555500|NCT01064674|evaluation before renal transplantation|evaluation before renal transplantation
5555502|NCT01064661|abdominal pain|abdominal pain
5555503|NCT01064661|abdominal discomfort|abdominal discomfort
5555504|NCT01064661|bloating|bloating
5555505|NCT01064661|Functional Bowel Disorders|functional bowel disorders
5555506|NCT01064635|stage IA breast cancer|stage ia breast cancer
5555507|NCT01064635|stage IB breast cancer|stage ib breast cancer
5555508|NCT01064635|stage II breast cancer|stage ii breast cancer
5555509|NCT01064635|stage IIIA breast cancer|stage iiia breast cancer
5555510|NCT01064635|stage IIIB breast cancer|stage iiib breast cancer
5555511|NCT01064635|stage IIIC breast cancer|stage iiic breast cancer
5555512|NCT01064596|obesity|obesity
5555513|NCT01064596|fondaparinux|fondaparinux
5555514|NCT01064596|surgery|surgery
5555515|NCT01064596|anti-Xa activity|anti-xa activity
5555516|NCT01064570|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5555517|NCT01064570|APL|apl
5549610|NCT01088568|myopia|myopia
5555518|NCT01064557|Acute promyelocytic Leukemia|acute promyelocytic leukemia
5555519|NCT01064544|Sleep problems|sleep problems
5555520|NCT01064544|melatonin|melatonin
5555521|NCT01064544|mood|mood
5555522|NCT01064544|Hemodialysis|hemodialysis
5555523|NCT01064518|Lateral Canthal Lines|lateral canthal lines
5555524|NCT01064518|Crow's Feet Wrinkles|crow's feet wrinkles
5555525|NCT01064518|Facial Wrinkles|facial wrinkles
5555526|NCT01064505|Ocular Neuroprotection|ocular neuroprotection
5555527|NCT01064505|ocular neuroprotectant|ocular neuroprotectant
5555528|NCT01064505|NAION|naion
5555529|NCT01064505|NAAION|naaion
5555530|NCT01064505|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
5555531|NCT01064505|Non-arteritic anterior ischemic optic neuropathy|non-arteritic anterior ischemic optic neuropathy
5555532|NCT01064505|chronic optic nerve atrophy|chronic optic nerve atrophy
5555533|NCT01064505|optic nerve atrophy|optic nerve atrophy
5555534|NCT01064505|retinal degeneration|retinal degeneration
5555535|NCT01064505|optic neuritis|optic neuritis
5555536|NCT01064505|end stage glaucoma|end stage glaucoma
5555537|NCT01064505|Leber's hereditary optic neuropathy|leber's hereditary optic neuropathy
5555538|NCT01064466|SCLC|sclc
5555539|NCT01064466|Etoposide|etoposide
5555540|NCT01064466|SNP|snp
5555541|NCT01064466|Topo|topo
5555542|NCT01064466|CYP|cyp
5555543|NCT01064466|Genotype|genotype
5555544|NCT01064466|Oncology|oncology
5555545|NCT01064466|Genetics|genetics
5555546|NCT01064466|Lung|lung
5555547|NCT01064466|Cancer|cancer
5555548|NCT01064453|Menopause|menopause
5555549|NCT01064453|Menopausal symptoms|menopausal symptoms
5555550|NCT01064453|Prevention of osteoporosis in menopausal women|prevention of osteoporosis in menopausal women
5555551|NCT01064453|Estrogen deficiency symptoms|estrogen deficiency symptoms
5555552|NCT01064453|Hormone replacement therapy|hormone replacement therapy
5555553|NCT01064440|Painful legs|painful legs
5555554|NCT01064440|Ischemic legs|ischemic legs
5555555|NCT01064440|Treatment for Claudication|treatment for claudication
5555556|NCT01064440|Gene therapy|gene therapy
5555557|NCT01064427|breast cancer|breast cancer
5555558|NCT01064427|fatigue|fatigue
5555559|NCT01064427|adjuvant chemotherapy|adjuvant chemotherapy
5555560|NCT01064427|quality of life|quality of life
5555561|NCT01064414|Canagliflozin|canagliflozin
5555562|NCT01064414|JNJ 28431754|jnj 28431754
5555563|NCT01064414|Placebo|placebo
5555564|NCT01064414|Sodium-Glucose Transporter 2|sodium-glucose transporter 2
5555565|NCT01064414|hemoglobin A1c protein, Blood Glucose|hemoglobin a1c protein, blood glucose
5555566|NCT01064414|reduced kidney function, Type 2 diabetes mellitus|reduced kidney function, type 2 diabetes mellitus
5555568|NCT01064375|DNA vaccine|dna vaccine
5555569|NCT01064375|Electroporation|electroporation
5555570|NCT01064362|Haemorrhage|haemorrhage
5555571|NCT01064362|Thromboprophylaxis|thromboprophylaxis
5555572|NCT01064349|ErbB2+ breast cancer|erbb2+ breast cancer
5555573|NCT01064349|ErbB2 treatment|erbb2 treatment
5555574|NCT01064349|brain metastases|brain metastases
5555575|NCT01064336|Thrombocytopenia|thrombocytopenia
5555576|NCT01064336|Pregnancy|pregnancy
5555577|NCT01064323|intermittent pneumatic leg compression|intermittent pneumatic leg compression
5555578|NCT01064323|nitric oxide|nitric oxide
5555579|NCT01064323|vascular endothelial cells|vascular endothelial cells
5555580|NCT01064323|IPC|ipc
5555581|NCT01064323|EECP|eecp
5555582|NCT01064323|atherosclerosis|atherosclerosis
5555583|NCT01064310|renal cell carcinoma|renal cell carcinoma
5555584|NCT01064310|Votrient|votrient
5555585|NCT01064310|cancer|cancer
5555586|NCT01064310|pazopanib|pazopanib
5555982|NCT01062633|prevention|prevention
5555588|NCT01064310|quality of life|quality of life
5555589|NCT01064297|Pregnancy registry|pregnancy registry
5555590|NCT01064297|Major congenital malformations|major congenital malformations
5555591|NCT01064297|Pregnancy outcomes|pregnancy outcomes
5555592|NCT01064297|Pregnancy|pregnancy
5555593|NCT01064297|First trimester|first trimester
5555594|NCT01064297|Lamotrigine|lamotrigine
5555595|NCT01064284|Hemophilia A|hemophilia a
5555596|NCT01064284|Factor VIII inhibitors|factor viii inhibitors
5555597|NCT01064284|vWF/FVIII|vwf/fviii
5555598|NCT01064284|rFVIII|rfviii
5555599|NCT01064258|treatment|treatment
5555600|NCT01064258|CPAP|cpap
5555601|NCT01064258|sleep apnea|sleep apnea
5555602|NCT01064245|Asthma|asthma
5555603|NCT01064245|Cough Variant Asthma|cough variant asthma
5555604|NCT01064245|Mannitol|mannitol
5555605|NCT01064245|Methacholine|methacholine
5555606|NCT01064245|Cough|cough
5555607|NCT01064245|Hypersensitivity|hypersensitivity
5555609|NCT01064219|Treg cells|treg cells
5555610|NCT01064219|implantation|implantation
5555611|NCT01064219|pinopodes|pinopodes
5555612|NCT01064219|endometrium|endometrium
5555613|NCT01064206|thrombangiitis obliterans|thrombangiitis obliterans
5555614|NCT01064206|Buerger's disease|buerger's disease
5555615|NCT01064206|atheromatous arteritis|atheromatous arteritis
5555616|NCT01064206|psychiatric disorders|psychiatric disorders
5555617|NCT01064206|personality disorders|personality disorders
5555618|NCT01064206|addictive profile|addictive profile
5555619|NCT01064206|addiction|addiction
5555620|NCT01064206|tobacco|tobacco
5555622|NCT01064193|In Vitro Fertilization|in vitro fertilization
5555623|NCT01064193|biopsy|biopsy
5555624|NCT01064193|pregnancy|pregnancy
5555625|NCT01064193|Implantation|implantation
5555626|NCT01064193|Embryo|embryo
5555627|NCT01064193|first or second IVF tentative|first or second ivf tentative
5555628|NCT01064167|Tranexamic Acid|tranexamic acid
5555629|NCT01064167|off-pump coronary Artery Bypass|off-pump coronary artery bypass
5555630|NCT01064141|Dengue Fever|dengue fever
5555631|NCT01064141|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5555632|NCT01064141|CYD Dengue Vaccine|cyd dengue vaccine
5555633|NCT01064141|Toddlers|toddlers
5555634|NCT01064128|Single-port|single-port
5555635|NCT01064128|Laparoscopy|laparoscopy
5555636|NCT01064128|Hysterectomy|hysterectomy
5555637|NCT01064128|Pain|pain
5555638|NCT01064128|Cosmesis|cosmesis
5555639|NCT01064128|Analgesics|analgesics
5555640|NCT01064089|HSP990|hsp990
5555641|NCT01064089|HSP90|hsp90
5555642|NCT01064089|Japan/Korea|japan/korea
5555643|NCT01064089|Phase I|phase i
5555644|NCT01064089|advanced solid tumors|advanced solid tumors
5555645|NCT01064089|dose escalation|dose escalation
5555646|NCT01064089|maximum tolerated dose|maximum tolerated dose
5555648|NCT01064089|Japanese paatients|japanese paatients
5555649|NCT01064089|Korean patients|korean patients
5555650|NCT01064076|ICD, defibrillator|icd, defibrillator
5555651|NCT01064050|tumoral obstruction of the main stem bronchus|tumoral obstruction of the main stem bronchus
5555652|NCT01064050|bronchoscopy|bronchoscopy
5555653|NCT01064050|silicone stent|silicone stent
5555654|NCT01064037|Heart Failure|heart failure
5555655|NCT01064024|uUTI|uuti
5555656|NCT01064024|Pain or burning associated with Uncomplicated Urinary Tract Infections|pain or burning associated with uncomplicated urinary tract infections
5555657|NCT01063998|Renal cell|renal cell
5555658|NCT01063998|Carcinoma|carcinoma
5555659|NCT01063998|Biomarkers|biomarkers
5555660|NCT01063985|Skin testing for mouse allergies|skin testing for mouse allergies
5555661|NCT01063959|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
5555662|NCT01063959|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5555663|NCT01063933|influenza, Peramivir, children, pharmacokinetic, pharmacodynamic|influenza, peramivir, children, pharmacokinetic, pharmacodynamic
5555664|NCT01063920|LT-NS001|lt-ns001
5555665|NCT01063920|Gastric Ulcers|gastric ulcers
5555666|NCT01063920|NSAID|nsaid
5555667|NCT01063920|Osteoarthritis|osteoarthritis
5555668|NCT01063920|Naproxen|naproxen
5555669|NCT01063907|Leukemia|leukemia
5555670|NCT01063907|Immunoproliferative Disorder|immunoproliferative disorder
5555671|NCT01063907|Neoplasma by Histologic Type|neoplasma by histologic type
5555672|NCT01063907|Immune System Diseases|immune system diseases
5555673|NCT01063907|Hematologic Diseases|hematologic diseases
5555674|NCT01063907|Blood Protein Disorders|blood protein disorders
5555675|NCT01063907|Paraproteinemias|paraproteinemias
5555676|NCT01063907|Multiple Myeloma|multiple myeloma
5555677|NCT01063907|Hematologic Disorders|hematologic disorders
5555678|NCT01063907|Leukemia, Chronic, B-cell|leukemia, chronic, b-cell
5555679|NCT01063907|Leukemia, B-cell|leukemia, b-cell
5555680|NCT01063907|Leukemia, Chronic|leukemia, chronic
5555681|NCT01063907|Neoplasms, Plasma Cell|neoplasms, plasma cell
5555682|NCT01063907|Monoclonal Gammopathy of unknown significance (MGUS)|monoclonal gammopathy of unknown significance (mgus)
5555683|NCT01063881|Sexual Dysfunction, physiological|sexual dysfunction, physiological
5555684|NCT01063881|R096769|r096769
5555685|NCT01063881|Dapoxetine|dapoxetine
5555686|NCT01063881|Phase 3b|phase 3b
5555687|NCT01063881|Premature Ejaculation|premature ejaculation
5555688|NCT01063868|Diabetic neuropathy|diabetic neuropathy
5555689|NCT01063868|Painful|painful
5555690|NCT01063868|Polyneuropathy|polyneuropathy
5555691|NCT01063868|Peripheral neuropathy|peripheral neuropathy
5555692|NCT01063855|Erectile Dysfunction|erectile dysfunction
5555693|NCT01063855|Sexual Dysfunction|sexual dysfunction
5555694|NCT01063855|Dapoxetine hydrochloride|dapoxetine hydrochloride
5555695|NCT01063855|PRILIGY|priligy
5555696|NCT01063855|Premature ejaculation|premature ejaculation
5555707|NCT01063816|PARP Inhibitors|parp inhibitors
5555708|NCT01063803|Open-label|open-label
5555709|NCT01063803|Long-term safety study of ATN-103 in RA|long-term safety study of atn-103 in ra
5555710|NCT01063790|Post-operative pain|post-operative pain
5555711|NCT01063790|inguinal hernia repair surgery|inguinal hernia repair surgery
5555712|NCT01063790|Patient education|patient education
5555713|NCT01063777|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
5555714|NCT01063764|Keppra|keppra
5555715|NCT01063764|Levetiracetam|levetiracetam
5555716|NCT01063764|Children|children
5555717|NCT01063764|Epilepsy|epilepsy
5555718|NCT01063764|Partial Seizures|partial seizures
5555719|NCT01063751|Osteoarthritis|osteoarthritis
5555720|NCT01063751|Traumatic arthritis|traumatic arthritis
5555721|NCT01063751|Avascular Necrosis|avascular necrosis
5555722|NCT01063738|Rehabilitation|rehabilitation
5555723|NCT01063738|Intensive Care|intensive care
5555724|NCT01063738|Critical illness|critical illness
5555725|NCT01063738|Physiotherapy|physiotherapy
5555726|NCT01063738|Nutritional supplementation|nutritional supplementation
5555728|NCT01063725|hot flashes|hot flashes
5555729|NCT01063725|vasomotor symptoms|vasomotor symptoms
5555730|NCT01063725|femarelle|femarelle
5555731|NCT01063725|soy extract|soy extract
5555732|NCT01063725|SERM|serm
5555733|NCT01063712|Ductus|ductus
5555734|NCT01063712|Patent ductus Arterious|patent ductus arterious
5555735|NCT01063712|"Nit-Occlud® PDA-R"|"nit-occlud® pda-r"
5555736|NCT01063712|Interventional closure of PDA|interventional closure of pda
5555737|NCT01063712|Percutaneous closure|percutaneous closure
5555738|NCT01063699|biliary atresia - laparoscopy - kasai - portoenterostomy|biliary atresia - laparoscopy - kasai - portoenterostomy
5555739|NCT01063686|Pregnancy|pregnancy
5555740|NCT01063673|Running, overuse injury, limits humans|running, overuse injury, limits humans
5555741|NCT01063660|Treosulfan|treosulfan
5555742|NCT01063660|Fludarabine|fludarabine
5555745|NCT01063647|Treosulfan|treosulfan
5555746|NCT01063647|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5555747|NCT01063647|Conditioning therapy|conditioning therapy
5555748|NCT01063634|malignant biliary obstruction|malignant biliary obstruction
5555749|NCT01063634|viaduct|viaduct
5555750|NCT01063634|self-expandable metal stents|self-expandable metal stents
5555751|NCT01063595|Octaplas LG|octaplas lg
5555752|NCT01063595|Octaplas SD|octaplas sd
5555753|NCT01063582|echocardiogram|echocardiogram
5555754|NCT01063582|electrocardiographic|electrocardiographic
5555755|NCT01063582|risk factors|risk factors
5555756|NCT01063582|noise|noise
5555757|NCT01063569|Addison's disease|addison's disease
5555758|NCT01063569|Glucocorticoid treatment|glucocorticoid treatment
5555759|NCT01063569|Continuous subcutaneous hydrocortisone infusion|continuous subcutaneous hydrocortisone infusion
5555760|NCT01063569|CSHI|cshi
5555761|NCT01063569|Quality of Life|quality of life
5555762|NCT01063569|Sleep|sleep
5555763|NCT01063556|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics Cross-Over Study|end-stage renal disease hemodialysis donepezil hydrochloride pharmacokinetics cross-over study
5555764|NCT01063543|fondaparinux|fondaparinux
5555765|NCT01063543|orthopedic surgery|orthopedic surgery
5555766|NCT01063543|patients with major orthopedic surgery|patients with major orthopedic surgery
5555767|NCT01063530|FLuoride|fluoride
5555768|NCT01063530|Dental Sensitivity|dental sensitivity
5555769|NCT01063530|Abfraction|abfraction
5555770|NCT01063530|Cervical lesions|cervical lesions
5555781|NCT01063491|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5555782|NCT01063491|bypass grafts|bypass grafts
5555783|NCT01063491|angiography|angiography
5555784|NCT01063491|percutaneous coronary intervention|percutaneous coronary intervention
5555785|NCT01063491|coronary imaging|coronary imaging
5555786|NCT01063491|coronary artery bypass graft surgery, bypass graft patency|coronary artery bypass graft surgery, bypass graft patency
5555787|NCT01063478|Non-Small Cell|non-small cell
5555788|NCT01063478|Lung Cancer|lung cancer
5555789|NCT01063478|Unresectable advanced NSCLC|unresectable advanced nsclc
5555790|NCT01063465|Achilles|achilles
5555792|NCT01063465|weightbearing|weightbearing
5555793|NCT01063452|Urinary Catheterization|urinary catheterization
5555794|NCT01063452|Urinary Tract Infections|urinary tract infections
5555795|NCT01063439|DLBCL|dlbcl
5555796|NCT01063439|NHL|nhl
5555797|NCT01063426|Statin|statin
5555798|NCT01063426|Vein|vein
5555799|NCT01063413|Behavioral Research|behavioral research
5555800|NCT01063413|Community-Based Participatory Research|community-based participatory research
5725097|NCT00413478|CLL|cll
5555801|NCT01063387|cervical cancer,semaphorin 4C (Sema4C),|cervical cancer,semaphorin 4c (sema4c),
5555802|NCT01063387|Prophylactic Irradiation|prophylactic irradiation
5555803|NCT01063348|N-Acetyl Cysteine|n-acetyl cysteine
5555805|NCT01063348|Impulse Control Disorder|impulse control disorder
5555806|NCT01063348|Obsessive Compulsive Disorder|obsessive compulsive disorder
5555807|NCT01063335|CB1 Receptor|cb1 receptor
5555808|NCT01063335|Schizophrenia|schizophrenia
5555809|NCT01063335|Positron Emission Tomography (PET)|positron emission tomography (pet)
5555810|NCT01063335|Healthy Volunteers|healthy volunteers
5555811|NCT01063335|HV|hv
5555812|NCT01063322|Mitral Regurgitation|mitral regurgitation
5555813|NCT01063322|Echocardiography|echocardiography
5555814|NCT01063322|Cardiac Magnetic Resonance|cardiac magnetic resonance
5555815|NCT01063322|Regurgitant Volume|regurgitant volume
5555816|NCT01063322|Mitral Valve Regurgitation|mitral valve regurgitation
5555817|NCT01063309|CAT SCAN|cat scan
5555818|NCT01063309|Heart Disease|heart disease
5555819|NCT01063309|Magnetic Resonance Imaging|magnetic resonance imaging
5555820|NCT01063309|Electrocardiogram|electrocardiogram
5555821|NCT01063309|Superoxide|superoxide
5555822|NCT01063296|cervical cancer|cervical cancer
5555823|NCT01063283|Non-squamous Non-Small Cell Lung Cancer|non-squamous non-small cell lung cancer
5555824|NCT01063283|Bevacizumab|bevacizumab
5555825|NCT01063283|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5555826|NCT01063270|Hidradenitis Suppurativa|hidradenitis suppurativa
5555827|NCT01063270|Antibiotics|antibiotics
5555828|NCT01063270|Laser|laser
5555829|NCT01063257|Myelodysplastic Syndrome|myelodysplastic syndrome
5555834|NCT01063231|Colonic Diseases|colonic diseases
5555835|NCT01063231|bowel diseases|bowel diseases
5555836|NCT01063218|Dermatitis, Atopic|dermatitis, atopic
5555837|NCT01063218|Corticoids, topic|corticoids, topic
5555838|NCT01063218|Corticosteroids|corticosteroids
5555839|NCT01063205|Methamphetamine|methamphetamine
5555841|NCT01063205|N-acetylcysteine|n-acetylcysteine
5555842|NCT01063192|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5555843|NCT01063179|Elderly patients|elderly patients
5555844|NCT01063179|Bortezomib|bortezomib
5555845|NCT01063179|Thalidomide|thalidomide
5555846|NCT01063153|ADHD|adhd
5555847|NCT01063153|Adults|adults
5555848|NCT01063153|Electroencephalography (EEG)|electroencephalography (eeg)
5555849|NCT01063153|Concerta|concerta
5555850|NCT01063140|Rabies Immune Globulin|rabies immune globulin
5555851|NCT01063140|Source Plasma Donors|source plasma donors
5555852|NCT01063140|Booster Immunization|booster immunization
5555853|NCT01063127|Morbid obesity|morbid obesity
5555854|NCT01063127|Insulin resistance|insulin resistance
5555855|NCT01063127|Euglycemic clamp|euglycemic clamp
5555856|NCT01063114|proton beam radiation|proton beam radiation
5555857|NCT01063088|Prophylaxis of seasonal influenza in adults|prophylaxis of seasonal influenza in adults
5555858|NCT01063075|Cancer of Head|cancer of head
5555859|NCT01063075|Cancer of Head and Neck|cancer of head and neck
5555860|NCT01063075|Cancer of Neck|cancer of neck
5555861|NCT01063075|Head and Neck Cancer|head and neck cancer
5555862|NCT01063075|Head Cancer|head cancer
5555863|NCT01063075|Head Neoplasms|head neoplasms
5555864|NCT01063075|Head, Neck Neoplasms|head, neck neoplasms
5555865|NCT01063075|Neck Cancer|neck cancer
5555866|NCT01063075|Neck Neoplasms|neck neoplasms
5555867|NCT01063075|Solid Neoplasm|solid neoplasm
5555868|NCT01063075|Carcinoma|carcinoma
5555869|NCT01063075|Sarcoma|sarcoma
5555870|NCT01063010|sepsis|sepsis
5555871|NCT01063010|septic shock|septic shock
5555872|NCT01063010|Bevacizumab|bevacizumab
5555873|NCT01063010|Avastin|avastin
5555874|NCT01062984|Renal Replacement Therapy|renal replacement therapy
5555875|NCT01062971|Open-angle glaucoma|open-angle glaucoma
5555876|NCT01062971|Ocular hypertension|ocular hypertension
5555877|NCT01062971|POAG|poag
5555878|NCT01062971|Treatment|treatment
5555879|NCT01062958|Neevo|neevo
5555881|NCT01062958|L-methylfolate|l-methylfolate
5556181|NCT01061788|Everolimus|everolimus
5555882|NCT01062958|anemia during pregnancy|anemia during pregnancy
5555883|NCT01062958|folic acid|folic acid
5555884|NCT01062958|vitamin B12|vitamin b12
5555885|NCT01062958|prenatal vitamins|prenatal vitamins
5555886|NCT01062958|hemoglobin|hemoglobin
5555887|NCT01062958|iron deficiency|iron deficiency
5555888|NCT01062958|Pregnancy|pregnancy
5555889|NCT01062945|Cocaine|cocaine
5555890|NCT01062945|Doxazosin|doxazosin
5555891|NCT01062932|Cycloserine|cycloserine
5555892|NCT01062932|Nicotine|nicotine
5555893|NCT01062932|Smoking|smoking
5555894|NCT01062906|intravenous lidocaine|intravenous lidocaine
5555895|NCT01062906|postoperative pain|postoperative pain
5555896|NCT01062906|laparoscopic surgery|laparoscopic surgery
5555897|NCT01062906|opioids|opioids
5555898|NCT01062906|opioids side-effects|opioids side-effects
5555899|NCT01062893|labor pain treatment|labor pain treatment
5555900|NCT01062893|duration analgesia|duration analgesia
5555901|NCT01062893|Analgesic duration with normal saline injection.|analgesic duration with normal saline injection.
5555902|NCT01062893|Analgesic duration without normal saline injection|analgesic duration without normal saline injection
5555903|NCT01062867|Anaesthetic|anaesthetic
5555904|NCT01062854|snoring, sleep disordered breathing, polysomnography, sleep fragmentation|snoring, sleep disordered breathing, polysomnography, sleep fragmentation
5555905|NCT01062841|Long-Term Care|long-term care
5555906|NCT01062841|Nursing Homes|nursing homes
5555907|NCT01062841|Infection Control|infection control
5555908|NCT01062841|Multi-drug resistant pathogens|multi-drug resistant pathogens
5555909|NCT01062841|Long-term care residents with in-dwelling devices|long-term care residents with in-dwelling devices
5555910|NCT01062828|Prematurity|prematurity
5555911|NCT01062828|Necrotizing Enterocolitis|necrotizing enterocolitis
5555912|NCT01062828|Feeding Intolerance|feeding intolerance
5555913|NCT01062815|PNALD|pnald
5555914|NCT01062815|PNAC|pnac
5555915|NCT01062815|Parenteral Nutrition-Associated Cholestasis|parenteral nutrition-associated cholestasis
5555916|NCT01062815|Congenital Anomalies of Gastrointestinal Tract|congenital anomalies of gastrointestinal tract
5555917|NCT01062789|lung biopsy|lung biopsy
5555918|NCT01062789|computed tomograph|computed tomograph
5555919|NCT01062789|respiratory motion|respiratory motion
5555920|NCT01062789|Controlling respiratory motion in CT guided lung biopsies|controlling respiratory motion in ct guided lung biopsies
5555921|NCT01062789|biopsy|biopsy
5555928|NCT01062763|antihypertensive treatment|antihypertensive treatment
5555929|NCT01062763|Type-2 diabetes|type-2 diabetes
5555930|NCT01062750|Liver Cirrhosis|liver cirrhosis
5555931|NCT01062724|Cholestasis|cholestasis
5555933|NCT01062724|Neonates|neonates
5555934|NCT01062724|Primene|primene
5555935|NCT01062724|Trophamine|trophamine
5555936|NCT01062724|Methionine|methionine
5555937|NCT01062724|Cysteine|cysteine
5555938|NCT01062724|Taurine|taurine
5555939|NCT01062724|Total Parenteral Nutrition|total parenteral nutrition
5555940|NCT01062711|sarcopenia|sarcopenia
5555941|NCT01062711|muscle|muscle
5555942|NCT01062711|protein|protein
5555943|NCT01062711|muscle protein synthesis|muscle protein synthesis
5555944|NCT01062711|muscle protein breakdown|muscle protein breakdown
5555945|NCT01062711|whey|whey
5555946|NCT01062711|soy|soy
5555947|NCT01062711|casein|casein
5555948|NCT01062711|dose response|dose response
5555949|NCT01062711|resistance exercise|resistance exercise
5555950|NCT01062711|unilateral|unilateral
5555951|NCT01062711|knee extension|knee extension
5555952|NCT01062711|whole body protein|whole body protein
5555953|NCT01062698|mechanical Thrombectomy|mechanical thrombectomy
5555954|NCT01062698|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5555955|NCT01062698|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5555956|NCT01062685|septic shock|septic shock
5555957|NCT01062685|sepsis|sepsis
5555958|NCT01062685|St02|st02
5555959|NCT01062685|Near Infrared Spectroscopy|near infrared spectroscopy
5555960|NCT01062685|NIRS|nirs
5555961|NCT01062672|plasticity|plasticity
5555962|NCT01062672|reorganization|reorganization
5555963|NCT01062672|cortical|cortical
5555964|NCT01062672|fMRI|fmri
5555965|NCT01062672|rehabilitation|rehabilitation
5555966|NCT01062659|HCV|hcv
5555967|NCT01062659|hepatitis C virus|hepatitis c virus
5555968|NCT01062659|CHC|chc
5555969|NCT01062659|chronic hepatitis c|chronic hepatitis c
5555970|NCT01062659|interferon|interferon
5555971|NCT01062659|ribavirin|ribavirin
5555972|NCT01062659|Hepatitis, Viral, Human|hepatitis, viral, human
5555973|NCT01062659|Anti-Infective Agents|anti-infective agents
5555974|NCT01062659|peginterferon alfa-2a|peginterferon alfa-2a
5555975|NCT01062659|peginterferon alfa-2b|peginterferon alfa-2b
5555976|NCT01062646|music therapy|music therapy
5555977|NCT01062646|multimodal psychotherapy|multimodal psychotherapy
5555978|NCT01062646|children|children
5555979|NCT01062646|anxiety disorders|anxiety disorders
5555980|NCT01062646|pediatric anxiety|pediatric anxiety
5555981|NCT01062633|dental caries|dental caries
5555984|NCT01062607|bipolar disorders|bipolar disorders
5555985|NCT01062607|everyday setting|everyday setting
5555986|NCT01062607|treatment adherence|treatment adherence
5555987|NCT01062607|global|global
5555988|NCT01062581|Recipient|recipient
5555989|NCT01062581|Donor|donor
5555990|NCT01062581|Organ Transplant|organ transplant
5555991|NCT01062581|Registry|registry
5555992|NCT01062581|University of Minnesota|university of minnesota
5555993|NCT01062568|adolescents|adolescents
5555994|NCT01062568|puberty|puberty
5555995|NCT01062568|androgens|androgens
5555996|NCT01062568|hyperandrogenemia|hyperandrogenemia
5555997|NCT01062529|GH signalling|gh signalling
5555998|NCT01062529|insulin resistance|insulin resistance
5555999|NCT01062529|somatostatin|somatostatin
5556000|NCT01062529|acromegaly|acromegaly
5556001|NCT01062516|acute coronary syndrome|acute coronary syndrome
5556002|NCT01062516|acute myocardial infarction|acute myocardial infarction
5540909|NCT01123317|PET|pet
5556003|NCT01062516|percutaneous coronary intervention|percutaneous coronary intervention
5556004|NCT01062516|aspirin|aspirin
5556005|NCT01062516|clopidogrel|clopidogrel
5556006|NCT01062516|esomeprazole|esomeprazole
5556007|NCT01062516|famotidine|famotidine
5556008|NCT01062516|platelet function|platelet function
5556009|NCT01062503|Cancer|cancer
5556010|NCT01062503|Prostate|prostate
5556011|NCT01062503|metastatic|metastatic
5556012|NCT01062490|Treosulfan|treosulfan
5556013|NCT01062490|MDS|mds
5556014|NCT01062490|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5556015|NCT01062490|leukemia|leukemia
5556016|NCT01062490|Conditioning|conditioning
5556017|NCT01062477|Diphtheria Tetanus Pertussis Haemophilus Influenzae Type B|diphtheria tetanus pertussis haemophilus influenzae type b
5556018|NCT01062451|Methamphetamine|methamphetamine
5556019|NCT01062451|Perindopril|perindopril
5556020|NCT01062451|Candesartan|candesartan
5556021|NCT01062451|Angiotensin receptor blocker|angiotensin receptor blocker
5556022|NCT01062451|ACE Inhibitor|ace inhibitor
5556023|NCT01062438|localized osteosarcoma|localized osteosarcoma
5556024|NCT01062438|metastatic osteosarcoma|metastatic osteosarcoma
5556025|NCT01062399|adult glioblastoma|adult glioblastoma
5556026|NCT01062399|adult giant cell glioblastoma|adult giant cell glioblastoma
5556027|NCT01062399|adult gliosarcoma|adult gliosarcoma
5556028|NCT01062386|prevalence|prevalence
5556029|NCT01062386|transmission|transmission
5556030|NCT01062386|knowledge|knowledge
5556031|NCT01062386|attitude|attitude
5556032|NCT01062386|practice|practice
5556033|NCT01062373|Premature Newborns|premature newborns
5556034|NCT01062373|Human Milk|human milk
5556035|NCT01062373|DHA|dha
5556036|NCT01062373|Mother-child|mother-child
5556037|NCT01062360|Sore Throat|sore throat
5556038|NCT01062360|Upper Respiratory Tract Infections|upper respiratory tract infections
5556039|NCT01062360|Nasal Congestion|nasal congestion
5556040|NCT01062347|To identify a new bio-marker for zinc status|to identify a new bio-marker for zinc status
5556041|NCT01062334|Anastomotic leakage after LAR|anastomotic leakage after lar
5556042|NCT01062321|Hepatitis E Virus|hepatitis e virus
5556043|NCT01062321|Cytokines|cytokines
5556044|NCT01062321|Pregnancy|pregnancy
5556045|NCT01062308|Stroke|stroke
5556046|NCT01062308|Taping|taping
5556047|NCT01062308|Pain|pain
5556048|NCT01062308|Shoulder Injury|shoulder injury
5556049|NCT01062295|passenger,|passenger,
5556050|NCT01062295|sleep,|sleep,
5556051|NCT01062295|rest,|rest,
5556052|NCT01062282|Pulmonary Hypertension|pulmonary hypertension
5556053|NCT01062269|Bile acid sequestrant|bile acid sequestrant
5556054|NCT01062269|Resin|resin
5556055|NCT01062269|Cholesterol|cholesterol
5556056|NCT01062269|Diabetes mellitus|diabetes mellitus
5556057|NCT01062269|Lipids|lipids
5556058|NCT01062269|Glucose|glucose
5556059|NCT01062269|Bile Acid Sequestrant Acceptability Scale (BASA)validation study|bile acid sequestrant acceptability scale (basa)validation study
5556060|NCT01062256|Cough assessment in upper respiratory infection|cough assessment in upper respiratory infection
5556061|NCT01062256|guaifenesin|guaifenesin
5556062|NCT01062256|honey|honey
5556063|NCT01062243|brain injury|brain injury
5556064|NCT01062243|family treatment|family treatment
5556065|NCT01062230|Cancer|cancer
5556066|NCT01062230|Hematologic malignancy|hematologic malignancy
5556067|NCT01062204|Skin Graft donor sites|skin graft donor sites
5556068|NCT01062191|hydrogel|hydrogel
5556069|NCT01062191|dressing|dressing
5556070|NCT01062191|burn|burn
5556071|NCT01062191|joint|joint
5556072|NCT01062178|Small renal Mass|small renal mass
5556073|NCT01062178|Contrast Enhanced Ultrasound|contrast enhanced ultrasound
5556074|NCT01062178|Renal Cell Carcinoma|renal cell carcinoma
5556075|NCT01062178|noninvasive diagnosis of RCC|noninvasive diagnosis of rcc
5556076|NCT01062165|Echinocandin|echinocandin
5556077|NCT01062165|Obesity|obesity
5556078|NCT01062165|Pharmacokinetics|pharmacokinetics
5556079|NCT01062165|Pharmacodynamics|pharmacodynamics
5556080|NCT01062165|Fungal infection|fungal infection
5556081|NCT01062152|Hematology|hematology
5556083|NCT01062152|Myelodysplastic Syndrome|myelodysplastic syndrome
5556085|NCT01062152|Patients with non-deletion(5q)|patients with non-deletion(5q)
5556086|NCT01062152|Non-deletion 5q|non-deletion 5q
5556087|NCT01062152|Non del(5q)|non del(5q)
5556088|NCT01062152|Revlimid|revlimid
5556089|NCT01062152|lenalidomide|lenalidomide
5556090|NCT01062152|Telintra|telintra
5556091|NCT01062152|ezatiostat hydrochloride|ezatiostat hydrochloride
5556092|NCT01062152|ezatiostat|ezatiostat
5556093|NCT01062152|TLK199|tlk199
5556094|NCT01062152|Glutathione|glutathione
5556098|NCT01062152|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5556100|NCT01062152|Apoptosis|apoptosis
5556101|NCT01062152|Differentiation|differentiation
5556102|NCT01062152|Enzyme inhibitor|enzyme inhibitor
5556103|NCT01062126|Pacemaker|pacemaker
5556104|NCT01062126|Advanced Features|advanced features
5556105|NCT01062126|Clinical Outcomes|clinical outcomes
5556106|NCT01062113|Acute pain after oral surgery lateral mandibular Impacted third molar tooth extraction|acute pain after oral surgery lateral mandibular impacted third molar tooth extraction
5556107|NCT01062100|breast cancer|breast cancer
5556108|NCT01062100|molecular breast imaging|molecular breast imaging
5556110|NCT01062100|gamma camera|gamma camera
5556111|NCT01062087|postoperative pain|postoperative pain
5556112|NCT01062087|tubal ligation|tubal ligation
5556113|NCT01062087|local anesthetic|local anesthetic
5556114|NCT01062061|Varicella|varicella
5556115|NCT01062035|Advanced colon polyp|advanced colon polyp
5556116|NCT01062035|Adenomatous colon polyp|adenomatous colon polyp
5556117|NCT01062035|Adenoma, villous colon polyp|adenoma, villous colon polyp
5556118|NCT01062035|Advanced colorectal adenomas|advanced colorectal adenomas
5556119|NCT01062035|Colonic neoplasms|colonic neoplasms
5556120|NCT01062035|High grade dysplasia|high grade dysplasia
5556121|NCT01062035|Telomere blood testing|telomere blood testing
5556122|NCT01062022|intervention|intervention
5556123|NCT01062022|combat wounded|combat wounded
5556124|NCT01062022|family|family
5556125|NCT01062022|Focus-CI|focus-ci
5556126|NCT01061996|Ulcerative Colitis|ulcerative colitis
5556127|NCT01061983|Deep brain stimulation|deep brain stimulation
5556128|NCT01061983|Treatment refractory|treatment refractory
5556129|NCT01061983|Ventral internal capsule/ventral striatum|ventral internal capsule/ventral striatum
5556130|NCT01061983|Neurosurgery|neurosurgery
5556131|NCT01061983|Neuroimaging|neuroimaging
5556132|NCT01061970|Hypogonadism|hypogonadism
5556133|NCT01061970|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5556134|NCT01061970|COPD|copd
5556135|NCT01061957|Treatment outcome|treatment outcome
5556136|NCT01061957|HIV treatment|hiv treatment
5556137|NCT01061944|biopsy|biopsy
5556138|NCT01061944|tumor biopsy|tumor biopsy
5556139|NCT01061944|genetic studies|genetic studies
5556141|NCT01061931|left-sided atrial catheter ablation|left-sided atrial catheter ablation
5556142|NCT01061931|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5556143|NCT01061931|cryoballoon technique|cryoballoon technique
5556144|NCT01061931|mesh ablator catheter|mesh ablator catheter
5556145|NCT01061931|stroke|stroke
5556146|NCT01061931|silent stroke|silent stroke
5556147|NCT01061931|major complications|major complications
5556148|NCT01061918|Compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs 6 months post cataract surgery.|compare the visual outcomes with bilateral implantation of tecnis mf and restor iols 6 months post cataract surgery.
5556149|NCT01061905|health behavior|health behavior
5556150|NCT01061905|behavioral economics|behavioral economics
5556151|NCT01061905|calorie labeling|calorie labeling
5556152|NCT01061905|exercise|exercise
5556153|NCT01061879|umbilical cord|umbilical cord
5556154|NCT01061879|umbilical cord blood collection|umbilical cord blood collection
5556155|NCT01061879|pregnancy|pregnancy
5556156|NCT01061866|Thalidomide|thalidomide
5556157|NCT01061866|Antiepileptic drugs|antiepileptic drugs
5556158|NCT01061866|Refractory epilepsy|refractory epilepsy
5556159|NCT01061866|Sedative drugs|sedative drugs
5556160|NCT01061853|Oral lichen planus|oral lichen planus
5556161|NCT01061853|chronic inflammatory|chronic inflammatory
5556162|NCT01061853|mucous membranes|mucous membranes
5556163|NCT01061853|erosive lesions|erosive lesions
5556164|NCT01061840|Ewings Sarcoma|ewings sarcoma
5556165|NCT01061840|Non Small Cell Lung Cancer|non small cell lung cancer
5556166|NCT01061840|Liver Cancer|liver cancer
5556167|NCT01061827|GMS-package;dementia;depression|gms-package;dementia;depression
5556168|NCT01061814|ApoB (Apolipoprotein B)|apob (apolipoprotein b)
5556169|NCT01061814|LDL (low density lipoprotein)|ldl (low density lipoprotein)
5556170|NCT01061814|mipomersen|mipomersen
5556171|NCT01061814|ISIS301012|isis301012
5556172|NCT01061814|antisense|antisense
5556173|NCT01061801|caregivers|caregivers
5556174|NCT01061801|cancer|cancer
5556175|NCT01061801|emotion|emotion
5556176|NCT01061801|protective buffering|protective buffering
5556177|NCT01061788|Phase I|phase i
5556178|NCT01061788|Solid Tumor|solid tumor
5556179|NCT01061788|AMG 479|amg 479
5556180|NCT01061788|Panitumumab|panitumumab
5556185|NCT01061788|non-small cell lung cancer|non-small cell lung cancer
5556186|NCT01061775|Hypothalamic Obesity|hypothalamic obesity
5556187|NCT01061775|Exenatide|exenatide
5556188|NCT01061775|Byetta|byetta
5556189|NCT01061775|Craniopharyngioma|craniopharyngioma
5556190|NCT01061762|Treatment adherence|treatment adherence
5556191|NCT01061762|Low literacy skills|low literacy skills
5556192|NCT01061762|HIV treatment|hiv treatment
5556193|NCT01061710|Smoking|smoking
5556194|NCT01061710|smoking cessation|smoking cessation
5556195|NCT01061710|Japanese|japanese
5556196|NCT01061710|varenicline|varenicline
5556197|NCT01061710|retreatment|retreatment
5556198|NCT01061710|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5556203|NCT01061671|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5556205|NCT01061671|Exacerbation|exacerbation
5556206|NCT01061671|Lung function|lung function
5556207|NCT01061671|Cardiovascular|cardiovascular
5556208|NCT01061671|Smoking|smoking
5556209|NCT01061671|Statins|statins
5556210|NCT01061671|Simvastatin|simvastatin
5556211|NCT01061645|MDT and DLT|mdt and dlt
5556212|NCT01061632|deadlift|deadlift
5556213|NCT01061632|motor control|motor control
5556214|NCT01061632|exercises|exercises
5556215|NCT01061632|pain|pain
5556216|NCT01061632|function|function
5556217|NCT01061632|functional capacity|functional capacity
5556218|NCT01061619|prediagnostic symptoms|prediagnostic symptoms
5556219|NCT01061619|sentinel events|sentinel events
5556220|NCT01061619|pathway to diagnosis|pathway to diagnosis
5556221|NCT01061593|TB|tb
5556222|NCT01061593|MDR-TB|mdr-tb
5556223|NCT01061593|XDR-TB|xdr-tb
5556224|NCT01061593|TB/HIV|tb/hiv
5556225|NCT01061580|Bone Marrow Concentrate|bone marrow concentrate
5556226|NCT01061580|CABG|cabg
5556227|NCT01061580|Cardiac|cardiac
5556228|NCT01061580|Stem Cell|stem cell
5556229|NCT01061554|Bioavailability|bioavailability
5556230|NCT01061554|Eicosapentaenoic acid|eicosapentaenoic acid
5556231|NCT01061554|Docosahexaenoic acid|docosahexaenoic acid
5556232|NCT01061554|Soft gel capsules|soft gel capsules
5556233|NCT01061554|Gastric stable emulsion|gastric stable emulsion
5556234|NCT01061554|Omega-3|omega-3
5556235|NCT01061554|Tri-glycerides|tri-glycerides
5556236|NCT01061554|Marine phospholipids|marine phospholipids
5556237|NCT01061541|Pertussis|pertussis
5556238|NCT01061541|Tetanus|tetanus
5556239|NCT01061541|Hiberix™|hiberix™
5556240|NCT01061541|Hepatitis B|hepatitis b
5556241|NCT01061541|DTPw-HBV vaccine|dtpw-hbv vaccine
5556242|NCT01061541|Tritanrix™-HepB|tritanrix™-hepb
5556243|NCT01061541|Haemophilus influenzae type b|haemophilus influenzae type b
5556244|NCT01061541|Diphtheria|diphtheria
5556245|NCT01061541|Hib vaccine|hib vaccine
5556246|NCT01061528|cigarette smoking|cigarette smoking
5556247|NCT01061528|smoking cessation|smoking cessation
5556248|NCT01061528|nicotine dependence|nicotine dependence
5556249|NCT01061502|Burns|burns
5556250|NCT01061502|Wounds and Injuries|wounds and injuries
5556251|NCT01061502|Skin Grafts, Bioelectric|skin grafts, bioelectric
5556252|NCT01061502|Grafting, skin|grafting, skin
5556253|NCT01061489|neuroplasticity|neuroplasticity
5556254|NCT01061489|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5556255|NCT01061489|Alzheimer|alzheimer
5556256|NCT01061489|sensory-cognitive training|sensory-cognitive training
5556257|NCT01061489|physical fitness|physical fitness
5556258|NCT01061476|sleep apnea|sleep apnea
5556259|NCT01061476|treatment|treatment
5556260|NCT01061476|collapsibility|collapsibility
5556261|NCT01061476|expiratory nasal resistance|expiratory nasal resistance
5556262|NCT01061463|Radiation cataracts|radiation cataracts
5556263|NCT01061463|Lens opacities|lens opacities
5556264|NCT01061463|X-rays|x-rays
5556265|NCT01061463|Interventional Cardiologists|interventional cardiologists
5556266|NCT01061463|Electrophysiologists|electrophysiologists
5556267|NCT01061450|Diastolic dysfunction|diastolic dysfunction
5556268|NCT01061450|hypertension|hypertension
5556269|NCT01061450|Statins|statins
5556270|NCT01061450|ACE inhibitor|ace inhibitor
5556271|NCT01061450|Echocardiography|echocardiography
5556272|NCT01061437|H. pylori|h. pylori
5556273|NCT01061424|pediatric asthma|pediatric asthma
5556274|NCT01061398|cardiac ct|cardiac ct
5556275|NCT01061398|stress testing|stress testing
5556276|NCT01061398|coronary artery disease|coronary artery disease
5556277|NCT01061372|RLS|rls
5556278|NCT01061359|Breast Cancer|breast cancer
5556279|NCT01061359|Neoadjuvant Treatment|neoadjuvant treatment
5556280|NCT01061359|Chemotherapy|chemotherapy
5556281|NCT01061359|Adjuvant|adjuvant
5556282|NCT01061359|Epirubicin|epirubicin
5556283|NCT01061346|Fructose|fructose
5556284|NCT01061346|Glucose|glucose
5556285|NCT01061320|Alpha-Tocopherol (Vitamin E)|alpha-tocopherol (vitamin e)
5556966|NCT01058577|diabetes|diabetes
5556286|NCT01061320|Contrast induced nephropathy|contrast induced nephropathy
5556287|NCT01061320|Chronic kidney disease|chronic kidney disease
5556288|NCT01061320|Coronary procedures|coronary procedures
5685381|NCT00556374|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5556289|NCT01061307|Fe deficiency, Zn deficiency, vitamin A deficiency|fe deficiency, zn deficiency, vitamin a deficiency
5556290|NCT01061294|Assess the efficacy, predictability and safety of the Advanced CustomVue™ iLASIK procedure.|assess the efficacy, predictability and safety of the advanced customvue™ ilasik procedure.
5556291|NCT01061281|Aphakia following refractive lensectomy to treat presbyopia|aphakia following refractive lensectomy to treat presbyopia
5556292|NCT01061268|Relief of dry eye symptoms following implantation of TMF IOL|relief of dry eye symptoms following implantation of tmf iol
5556293|NCT01061255|Stress|stress
5556294|NCT01061255|Cortisol|cortisol
5556295|NCT01061255|Clinical reasoning|clinical reasoning
5556296|NCT01061255|Ambulatory setting|ambulatory setting
5556297|NCT01061255|Medical students|medical students
5556298|NCT01061255|Year 6 medical students|year 6 medical students
5556299|NCT01061242|Neurocognitive function|neurocognitive function
5556301|NCT01061242|Critical care|critical care
5556302|NCT01061242|Quality Assurance, health care|quality assurance, health care
5556303|NCT01061216|Diabetes|diabetes
5556304|NCT01061216|Insulin Therapy|insulin therapy
5556305|NCT01061216|Blood Glucose|blood glucose
5556306|NCT01061216|Basal insulin|basal insulin
5556307|NCT01061216|Diabetics|diabetics
5556308|NCT01061203|Rhinitis|rhinitis
5556309|NCT01061203|allergic|allergic
5556310|NCT01061203|Seasonal|seasonal
5556311|NCT01061203|grass|grass
5556312|NCT01061203|Asthma|asthma
5556313|NCT01061190|Stroke|stroke
5556314|NCT01061177|Leukemia|leukemia
5556315|NCT01061177|myeloid|myeloid
5556316|NCT01061177|myelogenous|myelogenous
5556317|NCT01061177|chronic BCR-ABL positive|chronic bcr-abl positive
5556318|NCT01061177|Nilotinib|nilotinib
5556319|NCT01061177|Philadelphia chromosome|philadelphia chromosome
5556320|NCT01061177|CML in chronic phase|cml in chronic phase
5556321|NCT01061151|Mother to Child Transmission|mother to child transmission
5556322|NCT01061151|HIV Infection|hiv infection
5556323|NCT01061151|HAART|haart
5556324|NCT01061151|Maternal Health|maternal health
5556325|NCT01061151|Breastfeeding|breastfeeding
5556326|NCT01061151|Perinatal transmission|perinatal transmission
5556327|NCT01061138|breast cancer|breast cancer
5556328|NCT01061138|screening mammograms|screening mammograms
5556329|NCT01061138|breast biopsy|breast biopsy
5556330|NCT01061125|atrial fibrillation|atrial fibrillation
5556331|NCT01061125|implantable loop recorder|implantable loop recorder
5556332|NCT01061125|TTM|ttm
5556333|NCT01061112|Drug Interactions|drug interactions
5556334|NCT01061112|Genetics|genetics
5556335|NCT01061112|CYP2C9|cyp2c9
5556337|NCT01061099|Type II or Type III Osteogenesis imperfecta|type ii or type iii osteogenesis imperfecta
5556338|NCT01061099|OI|oi
5556339|NCT01061099|Mesenchymal Stromal Cells|mesenchymal stromal cells
5556340|NCT01061099|MSC|msc
5556341|NCT01061086|Acute Coronary Syndromes|acute coronary syndromes
5556342|NCT01061086|Epidemiology|epidemiology
5556343|NCT01061086|Management of disease|management of disease
5556344|NCT01061086|Outcomes|outcomes
5556345|NCT01061086|Greece|greece
5556346|NCT01061060|Prostaglandin I2|prostaglandin i2
5556347|NCT01061060|Beraprost Na|beraprost na
5556348|NCT01061060|Endothelial cell function|endothelial cell function
5556349|NCT01061047|patients infected with a bacteria sensible to ertapeneme|patients infected with a bacteria sensible to ertapeneme
5556350|NCT01061034|pharmacokinetics|pharmacokinetics
5556351|NCT01061034|aspirin|aspirin
5556352|NCT01061034|proton pump inhiditor|proton pump inhiditor
5556353|NCT01061021|HIV prevention|hiv prevention
5556354|NCT01061021|Treatment adherence|treatment adherence
5556355|NCT01061021|Treatment for Prevention|treatment for prevention
5556356|NCT01061008|Exercise; arteriovenous fistula; chronic kidney disease|exercise; arteriovenous fistula; chronic kidney disease
5556357|NCT01060995|Informed Consent|informed consent
5556358|NCT01060995|Oral Health|oral health
5556359|NCT01060995|Patient Decision-making|patient decision-making
5556360|NCT01060982|Primary hyperparathyroidism|primary hyperparathyroidism
5556361|NCT01060982|High Intensity Focused Ultrasound|high intensity focused ultrasound
5556362|NCT01060982|Parathyroid tumor|parathyroid tumor
5556363|NCT01060982|Parathyroid hormone|parathyroid hormone
5556365|NCT01060969|Acute Mountain Sickness|acute mountain sickness
5556366|NCT01060969|travellers|travellers
5556367|NCT01060969|Acetazolamide|acetazolamide
5556368|NCT01060969|Tadalafil|tadalafil
5556369|NCT01060969|Acute Mountain Sickness assessed by Lake Louise score|acute mountain sickness assessed by lake louise score
5556370|NCT01060969|High altitude pulmonary edema|high altitude pulmonary edema
5556371|NCT01060969|High altitude cerebral edema|high altitude cerebral edema
5556372|NCT01060956|Urinary tract infection with two bacteria in culture|urinary tract infection with two bacteria in culture
5556373|NCT01060943|injectable collagen filler|injectable collagen filler
5556374|NCT01060943|correction of wrinkles and folds|correction of wrinkles and folds
5556375|NCT01060943|enrolled : 73|enrolled : 73
5556376|NCT01060943|withdrawal : 4|withdrawal : 4
5556377|NCT01060943|ongoing : 0|ongoing : 0
5556378|NCT01060943|completed : 69|completed : 69
5556379|NCT01060930|Nitric oxide|nitric oxide
5556380|NCT01060930|Diesel exhaust|diesel exhaust
5556381|NCT01060930|Air pollution|air pollution
5556382|NCT01060930|Cardiac output|cardiac output
5556383|NCT01060930|Healthy volunteers|healthy volunteers
5556384|NCT01060917|diabetes|diabetes
5556385|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal
5556386|NCT01060904|Antibody-Drug Conjugate|antibody-drug conjugate
5556387|NCT01060904|Antigens, CD30|antigens, cd30
5556388|NCT01060904|Disease, Hodgkin|disease, hodgkin
5556389|NCT01060904|Hematologic Diseases|hematologic diseases
5556390|NCT01060904|Immunotherapy|immunotherapy
5556391|NCT01060904|Lymphoma|lymphoma
5556393|NCT01060891|patients infected with with multiresistant gram-negative bacteria|patients infected with with multiresistant gram-negative bacteria
5556394|NCT01060878|Early-stage|early-stage
5556395|NCT01060865|hypertension|hypertension
5556396|NCT01060865|aliskiren|aliskiren
5556397|NCT01060865|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5556398|NCT01060839|counseling|counseling
5556399|NCT01060826|acute pancreatits|acute pancreatits
5556400|NCT01060813|cirrhosis|cirrhosis
5556401|NCT01060813|exercise|exercise
5556402|NCT01060813|leucin|leucin
5556403|NCT01060813|glutamine synthetase|glutamine synthetase
5556404|NCT01060800|Chiari|chiari
5556405|NCT01060800|Chiari Type I|chiari type i
5556406|NCT01060800|Chiari Type I Malformation|chiari type i malformation
5556407|NCT01060800|Familial Chiari|familial chiari
5556408|NCT01060774|Bupivacaine|bupivacaine
5556409|NCT01060774|Inflammation|inflammation
5556410|NCT01060774|Pain|pain
5556411|NCT01060774|Local Anesthetic|local anesthetic
5556412|NCT01060774|peripheral sensitization|peripheral sensitization
5556413|NCT01060761|cancer|cancer
5556414|NCT01060761|Rehabilitation program (patient and a relative together)|rehabilitation program (patient and a relative together)
5556415|NCT01060761|counselling|counselling
5556416|NCT01060761|retreat weekend|retreat weekend
5556417|NCT01060748|Vaccination|vaccination
5556418|NCT01060748|Challenge|challenge
5556419|NCT01060748|Diarrhea|diarrhea
5556420|NCT01060748|ETEC illness|etec illness
5556421|NCT01060748|Travelers diarrhea|travelers diarrhea
5556422|NCT01060748|ETEC|etec
5556423|NCT01060748|Enterotoxigenic E.coli|enterotoxigenic e.coli
5556424|NCT01060735|Vitamin D|vitamin d
5556425|NCT01060735|pregnancy|pregnancy
5556426|NCT01060735|children|children
5556427|NCT01060735|bone|bone
5556428|NCT01060735|quantitative ultrasound|quantitative ultrasound
5556429|NCT01060735|Healthy pregnant women|healthy pregnant women
5556430|NCT01060722|Healthy Male Volunteers|healthy male volunteers
5556431|NCT01060709|Carbon dioxide|carbon dioxide
5556433|NCT01060709|Hypoventilation|hypoventilation
5556434|NCT01060709|endoscopic|endoscopic
5556435|NCT01060709|elective colonoscopy and requiring sedation|elective colonoscopy and requiring sedation
5556436|NCT01060696|Infertility|infertility
5556437|NCT01060696|Saline infusion sonohysterography|saline infusion sonohysterography
5556438|NCT01060696|Pain|pain
5556439|NCT01060696|Hyoscine|hyoscine
5556440|NCT01060696|Mefenamic acid|mefenamic acid
5556441|NCT01060696|women|women
5556442|NCT01060683|hemoglobin|hemoglobin
5556443|NCT01060683|Coagulation variables|coagulation variables
5556444|NCT01060683|blood chemistry|blood chemistry
5556445|NCT01060683|Blood gas analysis|blood gas analysis
5556446|NCT01060670|Foot Ulcer|foot ulcer
5556447|NCT01060670|Diabetic|diabetic
5556448|NCT01060670|Wound Healing|wound healing
5556449|NCT01060670|Integra Dermal Regeneration Template|integra dermal regeneration template
5556450|NCT01060670|Full Thickness|full thickness
5556451|NCT01060670|Neuropathic|neuropathic
5556452|NCT01060670|Omnigraft|omnigraft
5556453|NCT01060657|X-ray Computed Tomography|x-ray computed tomography
5556454|NCT01060657|Coronary vessels|coronary vessels
5556455|NCT01060657|Radiation dosage|radiation dosage
5556456|NCT01060644|Maxillary Sinus|maxillary sinus
5556457|NCT01060644|Bone Augmentation|bone augmentation
5556458|NCT01060644|Dental Implant|dental implant
5556459|NCT01060644|Sinus Membrane|sinus membrane
5556460|NCT01060631|bispectral index|bispectral index
5556461|NCT01060631|lesions|lesions
5556462|NCT01060631|consciousness|consciousness
5556463|NCT01060605|islet transplantation|islet transplantation
5556464|NCT01060605|insulin independence|insulin independence
5556465|NCT01060605|C-peptide secretion|c-peptide secretion
5556466|NCT01060592|Gastric Band|gastric band
5556467|NCT01060592|LapBand|lapband
5556468|NCT01060592|Bariatric Surgery|bariatric surgery
5556469|NCT01060579|Glaucoma|glaucoma
5556470|NCT01060553|Post-traumatic stress disorders|post-traumatic stress disorders
5556471|NCT01060553|Acupuncture|acupuncture
5556472|NCT01060553|Quality of life|quality of life
5556473|NCT01060553|sleep disorder|sleep disorder
5556474|NCT01060540|genetic screening|genetic screening
5556475|NCT01060527|irritable bowel syndrome,protease activity,China|irritable bowel syndrome,protease activity,china
5556476|NCT01060514|Lung cancer|lung cancer
5556477|NCT01060514|Breast cancer|breast cancer
5556478|NCT01060501|rectal cancer|rectal cancer
5556967|NCT01058564|GERD|gerd
5556479|NCT01060501|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5556480|NCT01060501|5-FU, interferon-alpha|5-fu, interferon-alpha
5685384|NCT00556348|Complications|complications
5685385|NCT00556348|Visual acuity|visual acuity
5556481|NCT01060501|Locally advanced resectable rectal cancer (UICC stage II and III)|locally advanced resectable rectal cancer (uicc stage ii and iii)
5556482|NCT01060488|GH secretion tests|gh secretion tests
5556483|NCT01060488|adverse effects|adverse effects
5556484|NCT01060488|adult growth hormone deficiency|adult growth hormone deficiency
5556485|NCT01060488|growth-hormone releasing hormone and arginine test|growth-hormone releasing hormone and arginine test
5556486|NCT01060488|insulin tolerance test|insulin tolerance test
5556487|NCT01060488|GHRH + Arginine test|ghrh + arginine test
5556488|NCT01060475|Transplant|transplant
5556489|NCT01060462|Defervescence rate|defervescence rate
5556490|NCT01060462|Defervescence timing|defervescence timing
5556491|NCT01060462|Itraconazole|itraconazole
5556492|NCT01060449|cardiac resynchronization therapy|cardiac resynchronization therapy
5556493|NCT01060449|congestive heart failure|congestive heart failure
5556494|NCT01060436|sleep apnea|sleep apnea
5556495|NCT01060436|sleep disordered breathing|sleep disordered breathing
5556496|NCT01060436|CPAP|cpap
5556497|NCT01060436|BiPAP|bipap
5556498|NCT01060436|treatment outcomes|treatment outcomes
5556499|NCT01060423|colorectal|colorectal
5556500|NCT01060423|liver metastasis|liver metastasis
5556501|NCT01060423|KRAS wildtype|kras wildtype
5556502|NCT01060423|chemoembolization|chemoembolization
5556503|NCT01060423|irinotecan eluting beads|irinotecan eluting beads
5556504|NCT01060410|Myelosuppression|myelosuppression
5556505|NCT01060410|Infection|infection
5556506|NCT01060410|Nausea|nausea
5556507|NCT01060397|Alcohol|alcohol
5556508|NCT01060397|nurse|nurse
5556509|NCT01060397|alcohol dependence|alcohol dependence
5556510|NCT01060397|acute hospital|acute hospital
5556511|NCT01060397|brief interventions|brief interventions
5556512|NCT01060371|Spinocerebellar Ataxia|spinocerebellar ataxia
5556513|NCT01060371|Natural History|natural history
5556514|NCT01060371|Genetic Modifiers|genetic modifiers
5556515|NCT01060371|DNA testing|dna testing
5556516|NCT01060358|lumbar spine|lumbar spine
5556517|NCT01060358|low back pain|low back pain
5556518|NCT01060345|DCIS|dcis
5556519|NCT01060293|Heart Failure|heart failure
5556520|NCT01060293|Dopamine|dopamine
5556521|NCT01060293|Furosemide|furosemide
5556522|NCT01060293|Worsening Renal Function|worsening renal function
5556523|NCT01060293|Hypokalemia|hypokalemia
5556524|NCT01060293|Outcomes|outcomes
5556525|NCT01060293|Prognosis|prognosis
5556526|NCT01060280|low back pain|low back pain
5556527|NCT01060280|physiotherapy|physiotherapy
5556528|NCT01060280|exercise|exercise
5556529|NCT01060280|active management|active management
5556530|NCT01060254|Interstitial cystitis (IC) and/or painful bladder syndrome (PBS)-related pain|interstitial cystitis (ic) and/or painful bladder syndrome (pbs)-related pain
5556531|NCT01060254|Moderate to severe chronic bladder pain|moderate to severe chronic bladder pain
5556532|NCT01060254|JNJ-42160443|jnj-42160443
5556533|NCT01060241|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
5556534|NCT01060228|Paliperidone ER|paliperidone er
5556535|NCT01060228|INVEGA|invega
5556536|NCT01060228|Divalproex sodium|divalproex sodium
5556537|NCT01060228|Depakote ER|depakote er
5556538|NCT01060228|Pharmacokinetics|pharmacokinetics
5556539|NCT01060228|Valproic Acid|valproic acid
5556540|NCT01060228|Human Experimentation|human experimentation
5556541|NCT01060215|effusion|effusion
5556542|NCT01060215|osteoarthritis|osteoarthritis
5556543|NCT01060215|knee|knee
5556544|NCT01060202|Multiple Myeloma|multiple myeloma
5556545|NCT01060202|Bortezomib|bortezomib
5556546|NCT01060202|Velcade|velcade
5556548|NCT01060202|Proteasome inhibitor|proteasome inhibitor
5556549|NCT01060202|EORTC QLQ C30|eortc qlq c30
5556550|NCT01060202|EQ 5D|eq 5d
5556551|NCT01060189|ulinastatin|ulinastatin
5556552|NCT01060189|tranexamic acid|tranexamic acid
5556553|NCT01060189|cardiac surgery procedures|cardiac surgery procedures
5556554|NCT01060189|hemostasis|hemostasis
5556555|NCT01060176|tranexamic acid|tranexamic acid
5556556|NCT01060176|cardiac surgery procedures|cardiac surgery procedures
5556557|NCT01060176|hemostasis|hemostasis
5556558|NCT01060163|Clopidogrel|clopidogrel
5556559|NCT01060163|Tranexamic Acid|tranexamic acid
5556560|NCT01060163|Cardiac Surgical Procedures|cardiac surgical procedures
5556561|NCT01060163|Hemostasis|hemostasis
5556562|NCT01060150|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5556563|NCT01060150|Methylphenidate hydrochloride|methylphenidate hydrochloride
5556564|NCT01060150|Methylphenidate|methylphenidate
5556565|NCT01060150|CONCERTA|concerta
5556566|NCT01060137|fentanyl matrix|fentanyl matrix
5556567|NCT01060124|Pain; Cancer|pain; cancer
5556568|NCT01060124|TTS-Fentanyl D-trans|tts-fentanyl d-trans
5556569|NCT01060124|Durogesic D-trans|durogesic d-trans
5556570|NCT01060111|Migraine|migraine
5556571|NCT01060111|Topiramate|topiramate
5556572|NCT01060111|Propranolol|propranolol
5556573|NCT01060098|Rheumatoid arthritis|rheumatoid arthritis
5556574|NCT01060085|Breast Cancer|breast cancer
5556575|NCT01060059|diabetes; exenatide; Byetta; basal insulin; Amylin; Lilly|diabetes; exenatide; byetta; basal insulin; amylin; lilly
5556576|NCT01060046|biologic mesh|biologic mesh
5556577|NCT01060046|ventral hernia repair|ventral hernia repair
5556578|NCT01060046|breast reconstruction|breast reconstruction
5556579|NCT01060046|MMPs|mmps
5556580|NCT01060033|Squamous cell cervical cancer|squamous cell cervical cancer
5556581|NCT01060020|Aortic valve stenosis|aortic valve stenosis
5556582|NCT01060020|Sildenafil|sildenafil
5556583|NCT01060020|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5556584|NCT01060020|Hypertension, Pulmonary|hypertension, pulmonary
5556585|NCT01059994|fatigue|fatigue
5556586|NCT01059994|aging|aging
5556587|NCT01059968|bone density|bone density
5556594|NCT01059955|nodular anterior scleritis|nodular anterior scleritis
5556595|NCT01059955|diffuse anterior scleritis|diffuse anterior scleritis
5556596|NCT01059942|communication barriers|communication barriers
5556597|NCT01059942|clinical competence|clinical competence
5556598|NCT01059942|medical education|medical education
5556599|NCT01059942|internship and residency|internship and residency
5556600|NCT01059942|hospitalist|hospitalist
5556601|NCT01059942|Quality Assurance, Healthcare|quality assurance, healthcare
5556602|NCT01059942|Patient Care|patient care
5556603|NCT01059942|Internal Medicine|internal medicine
5556604|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives
5556605|NCT01059929|Respiration, Artificial|respiration, artificial
5556606|NCT01059929|Ventilators, Mechanical|ventilators, mechanical
5556607|NCT01059929|Critical care|critical care
5556608|NCT01059929|Intensive care|intensive care
5556609|NCT01059929|Physical therapy|physical therapy
5556610|NCT01059929|Occupational therapy|occupational therapy
5556611|NCT01059929|Sedative medications|sedative medications
5556612|NCT01059903|Rotigotine|rotigotine
5556613|NCT01059903|Neupro®|neupro®
5556614|NCT01059903|Transdermal Patch|transdermal patch
5556615|NCT01059877|dementia alzheimers frontotemporal lyme,|dementia alzheimers frontotemporal lyme,
5556616|NCT01059877|lewy body cognitive impairment|lewy body cognitive impairment
5556617|NCT01059864|cholesterol|cholesterol
5556618|NCT01059864|lipids|lipids
5556619|NCT01059864|rheumatoid arthritis|rheumatoid arthritis
5556620|NCT01059864|CP-690|cp-690
5556621|NCT01059864|550|550
5556622|NCT01059838|pediatrics|pediatrics
5556623|NCT01059838|cochlear implant|cochlear implant
5556624|NCT01059825|Phase 2|phase 2
5556625|NCT01059825|safety and efficacy study with ertugliflozin (PF-04971729, MK-8835)|safety and efficacy study with ertugliflozin (pf-04971729, mk-8835)
5556626|NCT01059825|Type 2 diabetes mellitus|type 2 diabetes mellitus
5556632|NCT01059773|Psoriasis|psoriasis
5556633|NCT01059773|Ustekinumab|ustekinumab
5556634|NCT01059773|Stelara|stelara
5556635|NCT01059773|Methotrexate|methotrexate
5556636|NCT01059773|Biologic|biologic
5556638|NCT01059760|Short-term starvation|short-term starvation
5556639|NCT01059760|Diet|diet
5556640|NCT01059760|Coronary artery disease|coronary artery disease
5556641|NCT01059734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5556642|NCT01059734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5556643|NCT01059734|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5556644|NCT01059734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5556645|NCT01059734|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5556646|NCT01059734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5538964|NCT01131598|SDRA|sdra
5556647|NCT01059734|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5556648|NCT01059734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5556649|NCT01059734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5556650|NCT01059734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5556651|NCT01059734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5556652|NCT01059734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5556653|NCT01059734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5556654|NCT01059734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5556655|NCT01059734|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5556656|NCT01059734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5556657|NCT01059734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5556658|NCT01059721|Centralisation|centralisation
5556659|NCT01059721|Patella dislocation|patella dislocation
5556660|NCT01059721|Open epiphyses|open epiphyses
5556661|NCT01059721|Malalignment syndrome|malalignment syndrome
5556662|NCT01059721|Relapse rate|relapse rate
5556968|NCT01058551|Sleep Apnea|sleep apnea
5556663|NCT01059708|outcomes carbon monoxide poisoning children pediatric|outcomes carbon monoxide poisoning children pediatric
5556664|NCT01059695|cervical cancer|cervical cancer
5556665|NCT01059695|retrospective|retrospective
5556666|NCT01059695|quality of life|quality of life
5556667|NCT01059695|treatment|treatment
5556668|NCT01059669|Chronic pancreatitis|chronic pancreatitis
5556669|NCT01059669|Pain|pain
5556670|NCT01059669|Exocrine insufficiency|exocrine insufficiency
5556671|NCT01059669|Diabetes|diabetes
5556672|NCT01059669|Nutrition|nutrition
5556673|NCT01059669|Ultrasound|ultrasound
5556675|NCT01059656|Pazopanib¨|pazopanib¨
5556676|NCT01059656|Phase II|phase ii
5556677|NCT01059630|follicular|follicular
5556678|NCT01059630|follicular lymphoma|follicular lymphoma
5556679|NCT01059617|Pandemic|pandemic
5556680|NCT01059617|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5556681|NCT01059617|H1N1|h1n1
5556682|NCT01059617|Influenza|influenza
5556683|NCT01059604|pregnancy outcomes|pregnancy outcomes
5556684|NCT01059604|pregnancy|pregnancy
5556685|NCT01059604|first trimester|first trimester
5556686|NCT01059604|Sumatriptan|sumatriptan
5556687|NCT01059604|major congenital malformations|major congenital malformations
5556688|NCT01059604|naratriptan|naratriptan
5556689|NCT01059604|sumatriptan-naproxen combination|sumatriptan-naproxen combination
5556690|NCT01059604|pregnancy registry|pregnancy registry
5556691|NCT01059591|NK1 antagonist and SSRI|nk1 antagonist and ssri
5556692|NCT01059591|Healthy subjects|healthy subjects
5556693|NCT01059591|Safety|safety
5556694|NCT01059591|First time in Human|first time in human
5556695|NCT01059578|Nk1 Antagonist and SSRI|nk1 antagonist and ssri
5556696|NCT01059578|Safety|safety
5556697|NCT01059578|First Time in Humans|first time in humans
5556698|NCT01059578|Healthy Subjects|healthy subjects
5556699|NCT01059565|Cystic Fibrosis|cystic fibrosis
5556700|NCT01059565|Aztreonam Lysine|aztreonam lysine
5556701|NCT01059565|lung infection|lung infection
5556702|NCT01059565|Burkholderia|burkholderia
5556703|NCT01059565|CFQ-R|cfq-r
5556704|NCT01059565|inhaled antibiotic|inhaled antibiotic
5556705|NCT01059552|lung cancer|lung cancer
5556706|NCT01059552|locally advanced lung cancer|locally advanced lung cancer
5556707|NCT01059539|Mania|mania
5556708|NCT01059539|Acute mania|acute mania
5556709|NCT01059539|Bipolar I disorder|bipolar i disorder
5556710|NCT01059526|HAE|hae
5556711|NCT01059513|T1c|t1c
5556712|NCT01059513|T2a|t2a
5556713|NCT01059513|T2b|t2b
5556714|NCT01059500|Computer-derived, quantitative pretest probability (PTP)|computer-derived, quantitative pretest probability (ptp)
5556715|NCT01059500|Overtesting|overtesting
5556716|NCT01059500|Radiation|radiation
5556717|NCT01059500|Intravenous Contrast|intravenous contrast
5556718|NCT01059500|Anticoagulation|anticoagulation
5556719|NCT01059487|Traditional Chinese Medicine|traditional chinese medicine
5556720|NCT01059487|Acupuncture|acupuncture
5556721|NCT01059474|DMPS|dmps
5556722|NCT01059474|mercury|mercury
5556723|NCT01059461|Hypoxic Ischemic Encephalopathy (HIE)|hypoxic ischemic encephalopathy (hie)
5556724|NCT01059461|Perinatal Asphyxia|perinatal asphyxia
5556725|NCT01059461|Nerve growth factor|nerve growth factor
5556727|NCT01059461|Cerebral palsy|cerebral palsy
5556728|NCT01059448|Amgen|amgen
5556729|NCT01059448|RA|ra
5556730|NCT01059448|AMG 827|amg 827
5556731|NCT01059448|20090061|20090061
5556732|NCT01059435|Amgen|amgen
5556733|NCT01059435|First in Human|first in human
5556734|NCT01059435|Postmenopausal|postmenopausal
5556735|NCT01059435|Phase 1|phase 1
5556736|NCT01059409|Meniscal Allografts|meniscal allografts
5556737|NCT01059409|Osteoarthritis|osteoarthritis
5556738|NCT01059383|Gastroesophageal Reflux|gastroesophageal reflux
5556739|NCT01059383|GERD|gerd
5556740|NCT01059383|Nocturnal GERD|nocturnal gerd
5556741|NCT01059383|Heartburn|heartburn
5556742|NCT01059383|Nighttime Heartburn|nighttime heartburn
5556743|NCT01059370|Autonomic dysfunction|autonomic dysfunction
5556744|NCT01059370|Spinal cord injured|spinal cord injured
5556745|NCT01059370|Neurogenic bowel|neurogenic bowel
5556746|NCT01059370|Neurogenic bladder|neurogenic bladder
5556747|NCT01059344|Mesalamine|mesalamine
5556748|NCT01059344|Asacol|asacol
5556749|NCT01059344|Ulcerative colitis|ulcerative colitis
5556750|NCT01059344|induction therapy|induction therapy
5556751|NCT01059344|acute disease|acute disease
5556752|NCT01059344|mild to moderate|mild to moderate
5556753|NCT01059344|Active Ulcerative Colitis (mild to moderate)|active ulcerative colitis (mild to moderate)
5556754|NCT01059331|Kidney|kidney
5556755|NCT01059318|Lymphangioleiomyomatosis,|lymphangioleiomyomatosis,
5556756|NCT01059318|High Resolution CT scan,|high resolution ct scan,
5556757|NCT01059318|chest x-ray,|chest x-ray,
5556758|NCT01059318|6 minute walk test,|6 minute walk test,
5556759|NCT01059318|pulse oximetry,|pulse oximetry,
5556760|NCT01059318|renal MRI,|renal mri,
5556761|NCT01059318|Pikometer|pikometer
5556762|NCT01059305|Erlotinib|erlotinib
5556763|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride
5556764|NCT01059305|OSI-774|osi-774
5556765|NCT01059305|Tarceva|tarceva
5557060|NCT01058096|Acute Mania|acute mania
5556766|NCT01059305|Squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5556767|NCT01059305|Aggressive cutaneous squamous cell carcinoma|aggressive cutaneous squamous cell carcinoma
5556768|NCT01059305|CSCC|cscc
5556769|NCT01059305|Local surgery|local surgery
5556770|NCT01059305|Radiation therapy|radiation therapy
5556771|NCT01059305|Epidermal growth factor receptor|epidermal growth factor receptor
5556772|NCT01059305|EGFR|egfr
5671979|NCT00613327|Overactive bladder|overactive bladder
5559411|NCT01048853|ECC|ecc
5556773|NCT01059305|Small Molecule Tyrosine Kinase Inhibitor|small molecule tyrosine kinase inhibitor
5556774|NCT01059292|we have complieted party research|we have complieted party research
5685386|NCT00556348|OCt|oct
5556775|NCT01059279|Familial Mediterranean fever|familial mediterranean fever
5556776|NCT01059279|Cytokines|cytokines
5556777|NCT01059279|Inflammatory proteins|inflammatory proteins
5556779|NCT01059279|mutations|mutations
5556780|NCT01059279|Heat Intolerance|heat intolerance
5556781|NCT01059279|Heat Tolerance Test|heat tolerance test
5556782|NCT01059266|immunotherapy|immunotherapy
5556783|NCT01059266|grass pollen|grass pollen
5556784|NCT01059266|seasonal allergy|seasonal allergy
5556785|NCT01059266|dose tolerability|dose tolerability
5556786|NCT01059253|Falls|falls
5556787|NCT01059253|Balance|balance
5556788|NCT01059253|Elderly|elderly
5556789|NCT01059253|Aged|aged
5556790|NCT01059240|Survival Motor Neuron 1 (SMN1)|survival motor neuron 1 (smn1)
5556791|NCT01059240|Survival Motor Neuron 2 (SMN2)|survival motor neuron 2 (smn2)
5556792|NCT01059240|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5556793|NCT01059240|SMN Copy Number in Mali|smn copy number in mali
5556794|NCT01059240|Spinal Muscular Antrophy|spinal muscular antrophy
5556795|NCT01059240|SMA|sma
5556796|NCT01059227|Treatment|treatment
5556797|NCT01059227|Anxiety|anxiety
5556798|NCT01059227|Fear|fear
5556799|NCT01059227|Fear Potentiated Startle|fear potentiated startle
5556800|NCT01059227|Healthy Volunteer|healthy volunteer
5556801|NCT01059227|HV|hv
5556802|NCT01059214|Acute Myocardial Infarction|acute myocardial infarction
5556803|NCT01059214|Reperfusion|reperfusion
5556804|NCT01059214|MRI|mri
5556805|NCT01059214|Heart Attack|heart attack
5556806|NCT01059201|Autism Spectrum Disorder|autism spectrum disorder
5556807|NCT01059201|Cholesterol|cholesterol
5556808|NCT01059201|Exome Sequencing|exome sequencing
5556809|NCT01059201|Autistic Spectrum Disorder|autistic spectrum disorder
5556810|NCT01059201|ASD|asd
5556811|NCT01059188|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5556812|NCT01059188|adenocarcinoma of the lung|adenocarcinoma of the lung
5556813|NCT01059188|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5556814|NCT01059188|large cell lung cancer|large cell lung cancer
5556815|NCT01059188|squamous cell lung cancer|squamous cell lung cancer
5556816|NCT01059175|Heart failure|heart failure
5556817|NCT01059175|Cardiac resynchronization therapy|cardiac resynchronization therapy
5556818|NCT01059175|Biventricular stimulation|biventricular stimulation
5556819|NCT01059175|Multisite stimulation|multisite stimulation
5556820|NCT01059175|Non responders|non responders
5556821|NCT01059162|Glaucoma Surgery|glaucoma surgery
5556822|NCT01059162|Filtering Surgery|filtering surgery
5556824|NCT01059149|Rehabilitation|rehabilitation
5556825|NCT01059149|Transcranial magnetic stimulation|transcranial magnetic stimulation
5556826|NCT01059149|Brain magnetic stimulation|brain magnetic stimulation
5556827|NCT01059149|Repetitive|repetitive
5556828|NCT01059149|Stroke|stroke
5556829|NCT01059149|Subacute|subacute
5556830|NCT01059136|Myocardial infarction|myocardial infarction
5556831|NCT01059136|Outcome|outcome
5556832|NCT01059136|Aldosterone|aldosterone
5556833|NCT01059136|Spironolactone|spironolactone
5556834|NCT01059123|Amoxicillin|amoxicillin
5556835|NCT01059123|Erysipelas|erysipelas
5556836|NCT01059123|Short course|short course
5556837|NCT01059110|Occlusive dressings|occlusive dressings
5556838|NCT01059110|Salicylate ointment|salicylate ointment
5556839|NCT01059110|Cryotherapy|cryotherapy
5556840|NCT01059110|Topical 5-fluoro-uracil|topical 5-fluoro-uracil
5556841|NCT01059110|Imiquimod|imiquimod
5556842|NCT01059110|Randomized clinical trial|randomized clinical trial
5556843|NCT01059110|Plantar warts|plantar warts
5556844|NCT01059084|HIV|hiv
5556845|NCT01059084|Valacyclovir|valacyclovir
5556846|NCT01059084|Valtrex®|valtrex®
5556847|NCT01059071|Refractory Neuroblastoma|refractory neuroblastoma
5556848|NCT01059071|Relapsed neuroblastoma|relapsed neuroblastoma
5556849|NCT01059058|MI Paste Plus|mi paste plus
5556850|NCT01059058|Fluoride Varnish|fluoride varnish
5556851|NCT01059058|CPP-ACP|cpp-acp
5556852|NCT01059058|White Spot Lesions|white spot lesions
5556853|NCT01059058|Remineralization|remineralization
5556854|NCT01059058|Orthodontic Treatment|orthodontic treatment
5556855|NCT01059019|Refractive Surgery|refractive surgery
5556856|NCT01059019|PRK|prk
5556857|NCT01059019|Photorefractive Keratectomy|photorefractive keratectomy
5556858|NCT01059019|Omega 3 Fatty Acids|omega 3 fatty acids
5556859|NCT01059019|Cornea|cornea
5556860|NCT01059006|Reflective Surgery|reflective surgery
5556861|NCT01059006|Presbyopia|presbyopia
5556862|NCT01059006|PresbyLASIK|presbylasik
5556863|NCT01058993|neutropenia|neutropenia
5556864|NCT01058993|myelokathexis|myelokathexis
5556865|NCT01058993|WHIM syndrome|whim syndrome
5556866|NCT01058993|AMD 3100|amd 3100
5556867|NCT01058993|plerixafor|plerixafor
5556868|NCT01058993|Myelokathexis syndrome|myelokathexis syndrome
5556869|NCT01058993|Neutropenia due to mutations of CXCR-4|neutropenia due to mutations of cxcr-4
5556870|NCT01058980|catheter ablation|catheter ablation
5556871|NCT01058980|atrial fibrillation|atrial fibrillation
5556873|NCT01058967|Code III trauma (highest acuity)|code iii trauma (highest acuity)
5556874|NCT01058967|Life Flight aeromedical ambulance service|life flight aeromedical ambulance service
5556875|NCT01058941|Alzheimer's disease|alzheimer's disease
5556876|NCT01058941|fish oil|fish oil
5556877|NCT01058941|lipoic acid|lipoic acid
5556878|NCT01058928|Tracheal tube|tracheal tube
5556879|NCT01058928|Size|size
5556880|NCT01058915|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5556881|NCT01058902|Non small cell lung cancer|non small cell lung cancer
5556882|NCT01058902|survival|survival
5556883|NCT01058902|aspirin|aspirin
5556884|NCT01058889|Diabetes mellitus Type 2|diabetes mellitus type 2
5556885|NCT01058889|Telemedicine|telemedicine
5556886|NCT01058889|Insulin|insulin
5556887|NCT01058876|Smoking|smoking
5556888|NCT01058876|nicotine|nicotine
5556889|NCT01058837|Sudden Cardiac Death|sudden cardiac death
5556890|NCT01058837|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5556891|NCT01058837|Ventricular Fibrillation|ventricular fibrillation
5556892|NCT01058824|Bioequivalence|bioequivalence
5556893|NCT01058824|Lincomycin Hydrocloride|lincomycin hydrocloride
5556894|NCT01058811|lung cancer|lung cancer
5556895|NCT01058798|Neuroblastoma|neuroblastoma
5556896|NCT01058798|B4GALNT3|b4galnt3
5556897|NCT01058798|Prognosis|prognosis
5556898|NCT01058785|Gene therapy|gene therapy
5556899|NCT01058785|Flow cytometry|flow cytometry
5556900|NCT01058785|Immunoenzyme technique|immunoenzyme technique
5556901|NCT01058785|Laboratory biomarker analysis|laboratory biomarker analysis
5556902|NCT01058785|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
5556903|NCT01058772|Induced Labour|induced labour
5556904|NCT01058772|Expectant Management|expectant management
5556905|NCT01058772|C-section rate|c-section rate
5556906|NCT01058772|Maternal Outcomes|maternal outcomes
5556907|NCT01058772|Neonatal Outcomes|neonatal outcomes
5556908|NCT01058759|non-small cell lung cancer|non-small cell lung cancer
5556909|NCT01058759|NSCLC|nsclc
5556910|NCT01058759|Enoxaparin|enoxaparin
5556911|NCT01058759|Locally Advanced or Metastatic Non-small Cell Lung Cancer stadium IIIb/IV|locally advanced or metastatic non-small cell lung cancer stadium iiib/iv
5556912|NCT01058746|pancreas|pancreas
5556913|NCT01058746|surgery|surgery
5556914|NCT01058746|Pancreaticoduodenectomy|pancreaticoduodenectomy
5556915|NCT01058746|Central Pancreatectomy|central pancreatectomy
5556916|NCT01058746|Distal Pancreatectomy|distal pancreatectomy
5556917|NCT01058746|resection|resection
5556918|NCT01058746|IV fluids|iv fluids
5556919|NCT01058746|09-185|09-185
5556920|NCT01058733|semi-automatic response system (SARS)|semi-automatic response system (sars)
5556921|NCT01058733|Diabetes Mellitus|diabetes mellitus
5556922|NCT01058733|Internet|internet
5556923|NCT01058733|ubiquitous health care system|ubiquitous health care system
5556924|NCT01058720|Vitamin D|vitamin d
5556925|NCT01058720|Supplementation|supplementation
5556926|NCT01058720|Adolescence|adolescence
5556927|NCT01058707|Solid tumors, MLN0128, TORC1/2 inhibitors|solid tumors, mln0128, torc1/2 inhibitors
5556928|NCT01058694|Mobile phones,|mobile phones,
5556929|NCT01058694|Medication Adherence|medication adherence
5556930|NCT01058694|Micro-Electrical-Mechanical Systems|micro-electrical-mechanical systems
5556931|NCT01058694|HIV Infections|hiv infections
5556932|NCT01058681|LH pulsatility|lh pulsatility
5556933|NCT01058681|GnRH regulation|gnrh regulation
5556934|NCT01058681|isocaloric nutrition|isocaloric nutrition
5556935|NCT01058681|hypercaloric nutrition|hypercaloric nutrition
5556936|NCT01058681|euglycemic clamps|euglycemic clamps
5556937|NCT01058681|hyperinsulinemic clamps|hyperinsulinemic clamps
5556938|NCT01058681|testosterone|testosterone
5556939|NCT01058681|LH|lh
5556940|NCT01058681|leptine|leptine
5556941|NCT01058681|ghrelin|ghrelin
5556942|NCT01058681|PYY|pyy
5556943|NCT01058681|CCK|cck
5556944|NCT01058681|GLP-1|glp-1
5556945|NCT01058681|GIP|gip
5556946|NCT01058681|cortisol|cortisol
5556947|NCT01058668|Acute Mania|acute mania
5556948|NCT01058668|Bipolar I Disorder|bipolar i disorder
5556949|NCT01058655|Colorectal Cancer|colorectal cancer
5556950|NCT01058642|pain|pain
5556951|NCT01058642|delta opioid receptor agonist|delta opioid receptor agonist
5556952|NCT01058629|Hybrid|hybrid
5556953|NCT01058629|contact lens|contact lens
5556954|NCT01058629|myopia|myopia
5556955|NCT01058629|hyperopia|hyperopia
5556956|NCT01058629|near sighted|near sighted
5556957|NCT01058629|astigmatism|astigmatism
5556958|NCT01058629|far sighted|far sighted
5556959|NCT01058603|Infertility|infertility
5556960|NCT01058603|Cell Culture|cell culture
5556961|NCT01058603|AECC|aecc
5556962|NCT01058603|Endocell|endocell
5556963|NCT01058603|IVF|ivf
5556964|NCT01058590|Inflammation|inflammation
5556965|NCT01058590|Adenotonsillectomy|adenotonsillectomy
5556969|NCT01058551|Atrial Fibrillation|atrial fibrillation
5671232|NCT00616590|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5671233|NCT00616590|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5559617|NCT01047982|HOMA-IR|homa-ir
5798719|NCT00111280|antiretrovirals (ARVs)|antiretrovirals (arvs)
5685387|NCT00556348|Age Macular Degeneration|age macular degeneration
5685388|NCT00556335|manual aspiration|manual aspiration
5685389|NCT00556335|conventional|conventional
5556970|NCT01058538|Interleukin, IL2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, RCC,|interleukin, il2, monoclonal, antibody, cytokine, tumour targeting, solid tumours, dose finding, renal cell carcinoma, fusion protein, rcc,
5556973|NCT01058512|chronic HCV|chronic hcv
5556974|NCT01058512|viral HCV|viral hcv
5556975|NCT01058512|genotype 1|genotype 1
5556976|NCT01058512|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
5556977|NCT01058499|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5556979|NCT01058486|Chronic Disease Management|chronic disease management
5556980|NCT01058486|Physical Activity|physical activity
5556981|NCT01058486|Self-efficacy|self-efficacy
5556982|NCT01058486|Self management|self management
5556983|NCT01058473|Sickle Cell Disease|sickle cell disease
5556984|NCT01058473|Pain|pain
5556985|NCT01058473|Assessment|assessment
5556986|NCT01058460|Cervical Intraepithelial Neoplasia, Grade III|cervical intraepithelial neoplasia, grade iii
5556987|NCT01058460|Cervical Intraepithelial Neoplasia, Grade II|cervical intraepithelial neoplasia, grade ii
5556988|NCT01058447|ADME|adme
5556989|NCT01058447|Healthy volunteers|healthy volunteers
5556990|NCT01058434|Multiple myeloma|multiple myeloma
5556991|NCT01058434|relapsed|relapsed
5556992|NCT01058434|refractory|refractory
5556993|NCT01058434|t(4;14)|t(4;14)
5556994|NCT01058434|FGFR3|fgfr3
5556995|NCT01058421|mechanical ventilation|mechanical ventilation
5556996|NCT01058421|acute respiratory failure|acute respiratory failure
5556997|NCT01058421|physical therapy|physical therapy
5556998|NCT01058421|critical illness neuropathy|critical illness neuropathy
5556999|NCT01058421|critical illness myopathy|critical illness myopathy
5557000|NCT01058408|advanced head and neck cancer|advanced head and neck cancer
5557001|NCT01058408|cisplatin|cisplatin
5557002|NCT01058408|RAD001|rad001
5557003|NCT01058408|radiation|radiation
5557004|NCT01058408|HNSCC|hnscc
5557005|NCT01058395|Traumatic Brain Injury|traumatic brain injury
5557006|NCT01058395|Minocycline|minocycline
5557007|NCT01058395|Outcome|outcome
5557008|NCT01058382|FET|fet
5557009|NCT01058382|Progesterone Support|progesterone support
5557010|NCT01058382|Frozen Embryo Transfer|frozen embryo transfer
5557011|NCT01058356|antibiotics associated colitis|antibiotics associated colitis
5557012|NCT01058356|lactobacilli|lactobacilli
5557013|NCT01058356|probiotics|probiotics
5557014|NCT01058356|prevention|prevention
5557015|NCT01058356|pulmonary infection|pulmonary infection
5557016|NCT01058356|Prevention of antibiotics associated colitis|prevention of antibiotics associated colitis
5862968|NCT00001442|Tumor Potential Doubling Time (Tpot)|tumor potential doubling time (tpot)
5557017|NCT01058356|the role of probiotics for prevention of antibiotics associated colitis|the role of probiotics for prevention of antibiotics associated colitis
5557018|NCT01058356|the lactobacilli effect for antibiotics associated colitis|the lactobacilli effect for antibiotics associated colitis
5557019|NCT01058356|antibiotic associated colitis on pulmonary infectious disease|antibiotic associated colitis on pulmonary infectious disease
5557021|NCT01058330|Neurofibromatosis type 1|neurofibromatosis type 1
5557022|NCT01058330|NF1|nf1
5557023|NCT01058317|respiratory, papilloma, pediatric, juvenile|respiratory, papilloma, pediatric, juvenile
5557024|NCT01058304|osteoarthritis|osteoarthritis
5557025|NCT01058304|knee|knee
5557026|NCT01058304|physical therapy (specialty)|physical therapy (specialty)
5557027|NCT01058304|veterans|veterans
5557028|NCT01058278|Glaucoma|glaucoma
5557029|NCT01058278|Ocular Hypertension|ocular hypertension
5557030|NCT01058278|Intraocular Pressure|intraocular pressure
5557031|NCT01058278|Trabeculectomy|trabeculectomy
5557032|NCT01058239|bortezomib|bortezomib
5557033|NCT01058239|rituximab|rituximab
5557034|NCT01058239|PTLD|ptld
5557035|NCT01058239|EBV|ebv
5557036|NCT01058239|transplantation|transplantation
5557037|NCT01058226|Experimental malaria challenge|experimental malaria challenge
5557038|NCT01058213|COPD|copd
5557039|NCT01058213|Pulmonary rehabilitation|pulmonary rehabilitation
5557040|NCT01058213|Resistance Training|resistance training
5557041|NCT01058213|Aerobic Training|aerobic training
5557042|NCT01058213|Dyspnea|dyspnea
5557043|NCT01058174|Prophylaxis|prophylaxis
5557044|NCT01058174|Liver transplantation|liver transplantation
5557045|NCT01058174|Invasive Fungal Infection|invasive fungal infection
5557046|NCT01058174|Micafungin|micafungin
5557047|NCT01058174|Prevention|prevention
5557048|NCT01058174|Mycoses|mycoses
5557049|NCT01058161|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms|wrist and hand cartilage abnormalities in inflammatory and chronic rheumatisms
5557050|NCT01058148|Cervical Cancer Screening|cervical cancer screening
5557051|NCT01058148|Cervical Precancer|cervical precancer
5557052|NCT01058148|Self-Collection|self-collection
5557053|NCT01058148|Cytology|cytology
5557054|NCT01058148|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5557055|NCT01058135|insulin resistance|insulin resistance
5557056|NCT01058135|dietary fiber|dietary fiber
5557057|NCT01058135|resistant starch|resistant starch
5685390|NCT00556335|length of stay|length of stay
5557058|NCT01058122|Adverse drug reactions in patients on the oncology ward|adverse drug reactions in patients on the oncology ward
5557059|NCT01058109|bone health, bone density, bone mass|bone health, bone density, bone mass
5557062|NCT01058070|GERD|gerd
5557063|NCT01058057|atorvastatin|atorvastatin
5557064|NCT01058057|percutaneous coronary intervention|percutaneous coronary intervention
5557065|NCT01058057|periprocedural myocardial infarction|periprocedural myocardial infarction
5557066|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5557067|NCT01058044|Cancer, Sunitinib, capecitabine, anastrozole, letrozole|cancer, sunitinib, capecitabine, anastrozole, letrozole
5557068|NCT01058044|adherence, anticancer treatment|adherence, anticancer treatment
5557069|NCT01058018|Cholesterol|cholesterol
5557070|NCT01058018|High density lipoprotein|high density lipoprotein
5557071|NCT01058018|Atherosclerosis|atherosclerosis
5557072|NCT01058018|ApolipoproteinA1|apolipoproteina1
5557073|NCT01058018|Stable angina artery disease|stable angina artery disease
5557074|NCT01058005|MS|ms
5557075|NCT01057979|exercise|exercise
5557076|NCT01057979|college students|college students
5557077|NCT01057979|Sedentary college students|sedentary college students
5557078|NCT01057966|Bioavailability|bioavailability
5557079|NCT01057966|Ocular Vitamins|ocular vitamins
5557080|NCT01057953|Colo-Rectal Cancer|colo-rectal cancer
5557081|NCT01057914|Randomized controlled trial|randomized controlled trial
5557082|NCT01057914|Malnutrition|malnutrition
5557083|NCT01057914|Aged|aged
5557084|NCT01057914|Aged 80 and over|aged 80 and over
5557085|NCT01057914|Nutrition therapy|nutrition therapy
5557086|NCT01057888|Immunization status for:|immunization status for:
5557087|NCT01057888|Tdap|tdap
5557088|NCT01057888|Menactra|menactra
5557089|NCT01057888|HPV (if female)|hpv (if female)
5557090|NCT01057888|Well child care visit|well child care visit
5557091|NCT01057862|Naltrexone|naltrexone
5557092|NCT01057862|Pathological Gambling|pathological gambling
5557093|NCT01057862|Opioid Antagonist|opioid antagonist
5557094|NCT01057849|schizophrenia|schizophrenia
5557095|NCT01057849|first episode|first episode
5557096|NCT01057849|atypical antipsychotics|atypical antipsychotics
5557097|NCT01057849|psychosocial intervention|psychosocial intervention
5557098|NCT01057849|outcome|outcome
5557099|NCT01057849|effectiveness|effectiveness
5557100|NCT01057823|aged|aged
5557101|NCT01057823|sleep deprivation|sleep deprivation
5557102|NCT01057823|actigraphy|actigraphy
5557103|NCT01057823|ambulatory monitoring|ambulatory monitoring
5557104|NCT01057797|COPD|copd
5557105|NCT01057797|Pulmonary rehabilitation|pulmonary rehabilitation
5557106|NCT01057797|Self-efficacy|self-efficacy
5557107|NCT01057797|Muscle strength|muscle strength
5557108|NCT01057797|Dyspnea|dyspnea
5557109|NCT01057797|Exercise adherence|exercise adherence
5557111|NCT01057784|bariatric|bariatric
5557112|NCT01057784|surgery|surgery
5557113|NCT01057784|sleeve|sleeve
5557114|NCT01057784|gastric bypass|gastric bypass
5557115|NCT01057784|vitamin D|vitamin d
5557116|NCT01057784|quality of life|quality of life
5557117|NCT01057784|body composition|body composition
5557118|NCT01057784|bone density|bone density
5557119|NCT01057784|adolescent|adolescent
5557120|NCT01057784|child|child
5557121|NCT01057784|teenager|teenager
5557122|NCT01057784|fertility|fertility
5557123|NCT01057784|offspring|offspring
5557124|NCT01057784|biomarker|biomarker
5557125|NCT01057784|epigenome|epigenome
5557126|NCT01057784|gene expression|gene expression
5557127|NCT01057771|meditation|meditation
5557128|NCT01057771|exercise|exercise
5557129|NCT01057771|immunity|immunity
5557130|NCT01057771|respiratory infection|respiratory infection
5557131|NCT01057771|influenza|influenza
5557132|NCT01057771|flu shot|flu shot
5557133|NCT01057771|immunomodulation|immunomodulation
5557134|NCT01057758|Suspicion of ventilator-associated pneumonia|suspicion of ventilator-associated pneumonia
5557135|NCT01057745|woman|woman
5557136|NCT01057745|chemotherapy|chemotherapy
5557137|NCT01057745|radiation|radiation
5557138|NCT01057745|fertility preservation|fertility preservation
5557139|NCT01057745|cryobank|cryobank
5557140|NCT01057719|cross-over design|cross-over design
5557141|NCT01057719|mixed model|mixed model
5557142|NCT01057719|multiple sclerosis|multiple sclerosis
5557143|NCT01057719|physical performance measures|physical performance measures
5557144|NCT01057719|physical therapy|physical therapy
5557145|NCT01057719|the Bobath concept|the bobath concept
5557146|NCT01057719|warm climate|warm climate
5557147|NCT01057719|6-minute walk test|6-minute walk test
5557148|NCT01057706|chiropractic|chiropractic
5557149|NCT01057706|exercise|exercise
5557150|NCT01057706|seniors|seniors
5557151|NCT01057693|Diabetic peripheral neuropathy|diabetic peripheral neuropathy
5557152|NCT01057693|Lyrica|lyrica
5557153|NCT01057693|pregabalin|pregabalin
5557154|NCT01057693|pain|pain
5557155|NCT01057680|Bone|bone
5557156|NCT01057680|Muscle|muscle
5557157|NCT01057680|Strength|strength
5557158|NCT01057680|Kidney|kidney
5557159|NCT01057680|Liver|liver
5557160|NCT01057680|Creatine|creatine
5557161|NCT01057654|Cholesterol|cholesterol
5557162|NCT01057641|PIDLSS, Spacer|pidlss, spacer
5557163|NCT01057628|Blood glucose|blood glucose
5557167|NCT01057615|Exercise-Induced Bronchoconstriction|exercise-induced bronchoconstriction
5557169|NCT01057615|Airway|airway
5557170|NCT01057615|Fish Oil|fish oil
5557171|NCT01057615|Ascorbic Acid|ascorbic acid
5557172|NCT01057602|Dementia|dementia
5557173|NCT01057602|Screening Tests|screening tests
5557174|NCT01057602|Cognition|cognition
5557175|NCT01057602|Memory|memory
5557176|NCT01057602|MOST|most
5557177|NCT01057589|Pharynx|pharynx
5557178|NCT01057589|Larynx|larynx
5557179|NCT01057589|Cervical esophagus|cervical esophagus
5557180|NCT01057589|Nose|nose
5557181|NCT01057589|Thyroid Gland|thyroid gland
5557182|NCT01057589|Parathyroid Gland|parathyroid gland
5557183|NCT01057576|bioactives|bioactives
5557184|NCT01057576|insulin|insulin
5557185|NCT01057576|botanicals|botanicals
5557186|NCT01057563|Coronary artery disease|coronary artery disease
5557187|NCT01057563|Neointimal hyperplasia|neointimal hyperplasia
5557188|NCT01057563|Drug-eluting balloon|drug-eluting balloon
5557189|NCT01057563|Optical coherence tomography|optical coherence tomography
5557190|NCT01057550|Stress urinary Incontinence|stress urinary incontinence
5557191|NCT01057550|autologous slings|autologous slings
5557192|NCT01057550|slings|slings
5557193|NCT01057550|tvt|tvt
5557194|NCT01057550|grafts|grafts
5557195|NCT01057550|surgery|surgery
5557196|NCT01057537|Polypill|polypill
5557197|NCT01057537|Red Heart Pill|red heart pill
5557198|NCT01057537|Cardiovascular disease|cardiovascular disease
5557199|NCT01057537|Adherence|adherence
5557200|NCT01057537|Secondary prevention|secondary prevention
5557201|NCT01057524|Airway clearance|airway clearance
5557202|NCT01057524|Cystic fibrosis|cystic fibrosis
5557203|NCT01057524|High frequency chest wall oscillation|high frequency chest wall oscillation
5557204|NCT01057511|Crinone|crinone
5557205|NCT01057511|progesterone|progesterone
5557206|NCT01057511|endometrial progesterone concentration|endometrial progesterone concentration
5557207|NCT01057485|Atrial Fibrillation|atrial fibrillation
5557208|NCT01057485|Ablation|ablation
5557209|NCT01057472|Repeatability of measurements|repeatability of measurements
5557210|NCT01057459|Stage II Grade 1 Contiguous Follicular Lymphoma|stage ii grade 1 contiguous follicular lymphoma
5557211|NCT01057459|Stage II Grade 1 Non-Contiguous Follicular Lymphoma|stage ii grade 1 non-contiguous follicular lymphoma
5557212|NCT01057459|Stage II Grade 2 Contiguous Follicular Lymphoma|stage ii grade 2 contiguous follicular lymphoma
5557213|NCT01057459|Stage II Grade 2 Non-Contiguous Follicular Lymphoma|stage ii grade 2 non-contiguous follicular lymphoma
5557214|NCT01057459|Stage II Grade 3 Contiguous Follicular Lymphoma|stage ii grade 3 contiguous follicular lymphoma
5551268|NCT01082042|Exercise|exercise
5862969|NCT00001440|p53|p53
5557215|NCT01057459|Stage II Grade 3 Non-Contiguous Follicular Lymphoma|stage ii grade 3 non-contiguous follicular lymphoma
5557216|NCT01057459|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5557217|NCT01057459|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5557218|NCT01057459|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5557219|NCT01057459|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5557220|NCT01057459|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5557221|NCT01057459|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5557222|NCT01057446|Colonoscopy preparation|colonoscopy preparation
5557223|NCT01057446|sennoside|sennoside
5557224|NCT01057446|sodium phosphate|sodium phosphate
5557225|NCT01057446|the aim is to assess the bowel cleansing effects of two different agents|the aim is to assess the bowel cleansing effects of two different agents
5557226|NCT01057433|Healthy Volunteers|healthy volunteers
5557227|NCT01057407|Hyperphosphatemia|hyperphosphatemia
5557228|NCT01057407|hemodialysis|hemodialysis
5557229|NCT01057407|CKD|ckd
5557230|NCT01057407|ASP1585|asp1585
5557231|NCT01057394|Atrial Fibrillation|atrial fibrillation
5557232|NCT01057381|Adenotonsillectomy|adenotonsillectomy
5557233|NCT01057381|Postoperative analgesia|postoperative analgesia
5557234|NCT01057381|Pediatrics|pediatrics
5557235|NCT01057355|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
5557236|NCT01057355|Mucinous cystic neoplasm|mucinous cystic neoplasm
5557237|NCT01057355|Endoscopic ultrasound|endoscopic ultrasound
5557238|NCT01057355|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5557239|NCT01057355|Pancreatic cyst|pancreatic cyst
5557240|NCT01057355|Pancreas cyst|pancreas cyst
5557241|NCT01057355|Alcohol|alcohol
5557242|NCT01057342|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5557243|NCT01057329|TDM|tdm
5557244|NCT01057329|Drug|drug
5557245|NCT01057329|Psychopharmacology|psychopharmacology
5557246|NCT01057329|children|children
5557247|NCT01057329|adolescents|adolescents
5557248|NCT01057303|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5557249|NCT01057290|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5557252|NCT01057264|Liver|liver
5557253|NCT01057264|Cancer|cancer
5557254|NCT01057264|Hepatic arterial infusion|hepatic arterial infusion
5557256|NCT01057264|Abraxane|abraxane
5557257|NCT01057264|Nab-Paclitaxel|nab-paclitaxel
5557258|NCT01057264|Paclitaxel|paclitaxel
5557259|NCT01057264|ABI-007|abi-007
5557260|NCT01057264|Gemcitabine|gemcitabine
5557261|NCT01057264|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5557262|NCT01057264|Gemzar|gemzar
5557263|NCT01057264|Bevacizumab|bevacizumab
5557264|NCT01057264|Avastin|avastin
5557265|NCT01057264|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5557266|NCT01057264|rhuMAb-VEGF|rhumab-vegf
5557267|NCT01057264|Filgrastim|filgrastim
5557268|NCT01057264|G-CSF|g-csf
5557269|NCT01057264|Neupogen|neupogen
5557270|NCT01057251|Nebivolol|nebivolol
5557271|NCT01057251|Bystolic TM|bystolic tm
5557272|NCT01057251|Hypertension|hypertension
5557273|NCT01057251|Stage 2 Hypertension|stage 2 hypertension
5557274|NCT01057238|mechanical ventilation|mechanical ventilation
5557275|NCT01057238|critical care|critical care
5557276|NCT01057212|advanced or metastatic non-squamous non-small cell lung cancer (NSCLC)|advanced or metastatic non-squamous non-small cell lung cancer (nsclc)
5557277|NCT01057199|adult acute myeloid leukemia|adult acute myeloid leukemia
5557278|NCT01057199|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5557279|NCT01057173|Heart Valve Disease|heart valve disease
5557280|NCT01057173|Heart Valve Prosthesis|heart valve prosthesis
5557281|NCT01057173|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5557282|NCT01057173|Randomized Controlled Trial|randomized controlled trial
5557283|NCT01057121|HIV Infections|hiv infections
5557284|NCT01057108|Hyperphosphatemia|hyperphosphatemia
5557285|NCT01057108|chronic kidney disease|chronic kidney disease
5557286|NCT01057108|salivary phosphorus|salivary phosphorus
5557287|NCT01057095|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5557288|NCT01057095|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5557289|NCT01057095|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5557290|NCT01057095|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5557291|NCT01057095|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5557292|NCT01057095|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5557293|NCT01057095|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5557294|NCT01057095|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5557295|NCT01057095|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5557296|NCT01057095|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5557297|NCT01057082|Sarcopenia|sarcopenia
5557298|NCT01057082|Aging|aging
5557299|NCT01057082|Muscle|muscle
5557300|NCT01057082|Dietary Supplement|dietary supplement
5557302|NCT01057082|Arginine|arginine
5557303|NCT01057082|Glutamine|glutamine
5557304|NCT01057069|Neo adjuvant|neo adjuvant
5557305|NCT01057069|Triple negative|triple negative
5557306|NCT01057069|primary tumor over 2 cm and/or positive lymphnodes|primary tumor over 2 cm and/or positive lymphnodes
5557307|NCT01057056|patients in a sub-acute geriatric rehabilitation department|patients in a sub-acute geriatric rehabilitation department
5557308|NCT01057043|Osteoarthritis|osteoarthritis
5557310|NCT01057004|heart failure|heart failure
5557311|NCT01056978|palliative care unit|palliative care unit
5557312|NCT01056978|bleeding|bleeding
5557313|NCT01056978|thromboembolic|thromboembolic
5557314|NCT01056978|hemorrhagic risk|hemorrhagic risk
5557315|NCT01056978|antithrombotic prophylaxis|antithrombotic prophylaxis
5557316|NCT01056965|Frontotemporal Dementia|frontotemporal dementia
5557317|NCT01056965|Corticobasal Degeneration|corticobasal degeneration
5790028|NCT00146094|HIV infection|hiv infection
5557318|NCT01056965|Progressive Nonfluent Aphasia|progressive nonfluent aphasia
5557319|NCT01056965|Progressive Supranuclear Palsy|progressive supranuclear palsy
5557320|NCT01056965|FTLD|ftld
5557321|NCT01056965|FTD|ftd
5557322|NCT01056965|PNFA|pnfa
5557323|NCT01056965|CBD|cbd
5557324|NCT01056965|PSP|psp
5557325|NCT01056965|Predicted tauopathies, including:|predicted tauopathies, including:
5557326|NCT01056965|Progressive Supranuclear Palsy (PSP)|progressive supranuclear palsy (psp)
5557327|NCT01056965|(CBS)|(cbs)
5557328|NCT01056965|Progressive Nonfluent Aphasia (PNFA)|progressive nonfluent aphasia (pnfa)
5557329|NCT01056939|Ventilatory care, children, intensive care, NAVA|ventilatory care, children, intensive care, nava
5557330|NCT01056939|Children needing ventilatory care|children needing ventilatory care
5557331|NCT01056926|smoking|smoking
5557332|NCT01056926|nicotine|nicotine
5557333|NCT01056926|Effects of nicotine and non-nicotine factors on continuous working memory.|effects of nicotine and non-nicotine factors on continuous working memory.
5557334|NCT01056926|Effects of nicotine and non-nicotine factors on cue reactivity.|effects of nicotine and non-nicotine factors on cue reactivity.
5557335|NCT01056926|Use of nicotine patches, placebo patches, and denicotinized cigarettes.|use of nicotine patches, placebo patches, and denicotinized cigarettes.
5557336|NCT01056926|memory|memory
5557337|NCT01056913|anastomotic leakage|anastomotic leakage
5557338|NCT01056913|bleeding from the anastomotic region|bleeding from the anastomotic region
5557339|NCT01056913|anastomotic stenosis|anastomotic stenosis
5557340|NCT01056900|articular cartilage defects|articular cartilage defects
5557464|NCT01056354|respiratory virus|respiratory virus
5557342|NCT01056900|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5557343|NCT01056900|Knee joint|knee joint
5557344|NCT01056900|chondron|chondron
5557345|NCT01056887|diabetes insipidus|diabetes insipidus
5557346|NCT01056887|primary polydipsia|primary polydipsia
5557347|NCT01056887|copeptin|copeptin
5557348|NCT01056887|Utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test|utility of plasma copeptin in differential diagnosis of polyuria/ polydipsia while performing a traditional deprivation test
5557349|NCT01056874|Maraviroc|maraviroc
5557350|NCT01056874|Digoxin|digoxin
5557351|NCT01056874|P-glycoprotein|p-glycoprotein
5557352|NCT01056874|Pharmacokinetics|pharmacokinetics
5557353|NCT01056874|Drug Interaction|drug interaction
5557354|NCT01056874|HIV|hiv
5557355|NCT01056861|cervical dystonia|cervical dystonia
5557356|NCT01056861|torticollis|torticollis
5557357|NCT01056861|Botulinum toxin|botulinum toxin
5557358|NCT01056861|magnetoencephalography|magnetoencephalography
5557359|NCT01056861|MEG|meg
5557360|NCT01056861|cortical organizational changes detected by MEG after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms|cortical organizational changes detected by meg after botulinum toxin in patients with torticollis, correlating with improvement in the symptoms
5557361|NCT01056848|Euvolemic Hyponatremia|euvolemic hyponatremia
5557362|NCT01056848|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5557363|NCT01056848|SIADH|siadh
5557364|NCT01056848|Serum Sodium|serum sodium
5557365|NCT01056809|Colorectal cancer|colorectal cancer
5557366|NCT01056809|Metastases|metastases
5557367|NCT01056809|Treatment strategies|treatment strategies
5557368|NCT01056809|Colorectal cancer with synchronous metastases|colorectal cancer with synchronous metastases
5557369|NCT01056796|compression anastomosis|compression anastomosis
5557370|NCT01056796|Colorectal cancer|colorectal cancer
5557371|NCT01056796|Low anterior resection|low anterior resection
5557372|NCT01056796|Radiated to the pelvic area|radiated to the pelvic area
5557373|NCT01056796|Radiotherapy|radiotherapy
5557374|NCT01056783|EoE|eoe
5557375|NCT01056770|Smallpox vaccine efficacy|smallpox vaccine efficacy
5557376|NCT01056757|metastatic breast cancer|metastatic breast cancer
5557377|NCT01056757|ribavirin|ribavirin
5557378|NCT01056757|eIF4E|eif4e
5557379|NCT01056744|coronary stent|coronary stent
5557380|NCT01056744|optical coherence tomography|optical coherence tomography
5557381|NCT01056744|drug-eluting|drug-eluting
5557382|NCT01056744|neointimal proliferation|neointimal proliferation
5557383|NCT01056731|high blood pressure|high blood pressure
5557384|NCT01056731|aliskiren|aliskiren
5557385|NCT01056731|hydrochlorothiazide|hydrochlorothiazide
5557386|NCT01056731|control rate|control rate
5551460|NCT01081431|del 5q|del 5q
5557387|NCT01056718|Diastolic Function|diastolic function
5557389|NCT01056705|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5557390|NCT01056705|Sabin Strains|sabin strains
5557391|NCT01056705|poliomyelitis|poliomyelitis
5557392|NCT01056692|Asthma|asthma
5557393|NCT01056692|bronchial allergen challenge|bronchial allergen challenge
5557394|NCT01056692|sputum eosinophiilia|sputum eosinophiilia
5557395|NCT01056653|father-child relations|father-child relations
5557396|NCT01056653|paternal behaviour|paternal behaviour
5557397|NCT01056653|early intervention|early intervention
5557398|NCT01056653|child-rearing|child-rearing
5557399|NCT01056640|telemonitoring|telemonitoring
5557400|NCT01056640|usual care|usual care
5557401|NCT01056640|elderly|elderly
5557402|NCT01056640|hospitalization|hospitalization
5557403|NCT01056640|Emergency room visits|emergency room visits
5557404|NCT01056601|insulinoma|insulinoma
5557405|NCT01056601|cancer of pancreas|cancer of pancreas
5557406|NCT01056601|neoplasms, pancreas|neoplasms, pancreas
5557407|NCT01056601|alpha-cell tumor|alpha-cell tumor
5557408|NCT01056601|glucagonoma|glucagonoma
5557409|NCT01056601|beta-cell tumor|beta-cell tumor
5557410|NCT01056601|somatostatinoma|somatostatinoma
5557411|NCT01056588|adolescent smoking|adolescent smoking
5557412|NCT01056588|Contingency management|contingency management
5557413|NCT01056588|Quit smoking|quit smoking
5557414|NCT01056562|Prostate|prostate
5557415|NCT01056562|GU|gu
5557416|NCT01056562|Urological Oncology|urological oncology
5557417|NCT01056549|Intestinal lipoprotein|intestinal lipoprotein
5557418|NCT01056549|Apo B48 and apoB100|apo b48 and apob100
5557419|NCT01056549|Pancreatic clamp|pancreatic clamp
5557420|NCT01056549|GLP-1 agonist|glp-1 agonist
5557421|NCT01056536|Travel|travel
5557422|NCT01056536|casual sexual relationships|casual sexual relationships
5557423|NCT01056536|condoms|condoms
5557424|NCT01056536|Structured intervention|structured intervention
5557425|NCT01056523|AML|aml
5557426|NCT01056497|diabetes|diabetes
5557427|NCT01056497|alpha lipoic acid|alpha lipoic acid
5557428|NCT01056497|endoplasmic reticulum (ER) stress|endoplasmic reticulum (er) stress
5557429|NCT01056497|insulin secretion|insulin secretion
5557430|NCT01056497|insulin sensitivity|insulin sensitivity
5557431|NCT01056484|Alcohol Dependence|alcohol dependence
5557432|NCT01056484|Alcoholism|alcoholism
5557433|NCT01056484|Substance Use Disorders|substance use disorders
5557434|NCT01056484|Substance Abuse|substance abuse
5557435|NCT01056471|Multiple Sclerosis|multiple sclerosis
5557436|NCT01056471|Mesenchymal Stem Cells|mesenchymal stem cells
5557437|NCT01056471|Autologous|autologous
5557438|NCT01056458|acupressure|acupressure
5557439|NCT01056458|perimenopause|perimenopause
5557440|NCT01056458|menopause|menopause
5557441|NCT01056458|anxiety|anxiety
5557442|NCT01056458|life quality|life quality
5557443|NCT01056458|insomnia|insomnia
5557444|NCT01056445|Carotid artery stenting|carotid artery stenting
5557445|NCT01056445|Hemodynamic Instability|hemodynamic instability
5557446|NCT01056445|Valsalva Ratio|valsalva ratio
5557447|NCT01056432|osteoporosis, bone fracture risk, bone ultrasonometry|osteoporosis, bone fracture risk, bone ultrasonometry
5557448|NCT01056419|Graves' ophthalmopathy|graves' ophthalmopathy
5557449|NCT01056419|Total thyroidectomy|total thyroidectomy
5557450|NCT01056419|Anti-thyroid drug treatment|anti-thyroid drug treatment
5557451|NCT01056419|Clinical activity score|clinical activity score
5557452|NCT01056406|Pregnancy|pregnancy
5557453|NCT01056406|Overweight|overweight
5557454|NCT01056406|Obese|obese
5557455|NCT01056406|Nutrition intervention|nutrition intervention
5557457|NCT01056380|influenza|influenza
5557458|NCT01056380|influenza like illness|influenza like illness
5557459|NCT01056367|Resistant hypertension|resistant hypertension
5557460|NCT01056367|Type-II-Diabetes Mellitus|type-ii-diabetes mellitus
5557461|NCT01056367|Arterial stiffness|arterial stiffness
5557462|NCT01056367|Ventricular function|ventricular function
5557463|NCT01056354|Influenza|influenza
5557465|NCT01056354|pandemic|pandemic
5557466|NCT01056354|swine flu|swine flu
5557467|NCT01056354|infection|infection
5557468|NCT01056354|MERS-CoV|mers-cov
5557469|NCT01056354|SARS-CoV|sars-cov
5557470|NCT01056341|Infantile Hemangioma|infantile hemangioma
5557471|NCT01056341|Propranolol|propranolol
5557472|NCT01056315|Analgesia|analgesia
5557473|NCT01056315|Diabetic Neuropathy|diabetic neuropathy
5557474|NCT01056315|Neuropathic pain|neuropathic pain
5557475|NCT01056315|Painful|painful
5557476|NCT01056315|Chronic pain|chronic pain
5557477|NCT01056302|Reconstructive surgical procedures|reconstructive surgical procedures
5557478|NCT01056302|visuohaptic|visuohaptic
5557479|NCT01056276|Multiple Myeloma|multiple myeloma
5557480|NCT01056276|Bendamustine|bendamustine
5557481|NCT01056276|Bortezomib|bortezomib
5557482|NCT01056276|Dexamethasone|dexamethasone
5557483|NCT01056263|retrospective trial|retrospective trial
5557484|NCT01056263|5-year survival|5-year survival
5557485|NCT01056263|metastatic renal cancer cell|metastatic renal cancer cell
5557486|NCT01056250|cholelithiasis|cholelithiasis
5557487|NCT01056224|skull pin insertion|skull pin insertion
5557488|NCT01056224|remifentanil|remifentanil
5551570|NCT01081028|MM|mm
5557490|NCT01056224|craniotomy|craniotomy
5557491|NCT01056224|cervical spine surgery|cervical spine surgery
5557492|NCT01056224|hemodynamic changes|hemodynamic changes
5557493|NCT01056224|dose requirement|dose requirement
5557494|NCT01056224|age related|age related
5557495|NCT01056198|Diabetic Foot Ulcers|diabetic foot ulcers
5557496|NCT01056198|Diabetic Foot Wounds|diabetic foot wounds
5557497|NCT01056185|influenza|influenza
5557499|NCT01056185|swine flu|swine flu
5557500|NCT01056185|respiratory virus|respiratory virus
5557501|NCT01056185|hospitalization|hospitalization
5557502|NCT01056185|MERS-CoV|mers-cov
5557503|NCT01056185|SARS-CoV|sars-cov
5557504|NCT01056172|Chronic hepatitis C|chronic hepatitis c
5557505|NCT01056172|Genotype 2|genotype 2
5557506|NCT01056172|Rapid virologic response|rapid virologic response
5557507|NCT01056172|Sustained virologic response|sustained virologic response
5557508|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a
5557509|NCT01056172|Ribavirin|ribavirin
5557510|NCT01056159|asthma|asthma
5557511|NCT01056159|dry powder inhaler|dry powder inhaler
5557512|NCT01056159|short-acting beta2-agonist|short-acting beta2-agonist
5557513|NCT01056159|SABA|saba
5557514|NCT01056159|bronchoconstriction|bronchoconstriction
5557515|NCT01056159|bronchodilation|bronchodilation
5557516|NCT01056159|bronchodilator|bronchodilator
5557517|NCT01056159|metered dose inhaler|metered dose inhaler
5557519|NCT01056146|intracranial edema|intracranial edema
5557520|NCT01056146|brain edema|brain edema
5557521|NCT01056146|craniocerebral trauma|craniocerebral trauma
5557522|NCT01056146|head injury|head injury
5557523|NCT01056146|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5557524|NCT01056146|subdural hematoma|subdural hematoma
5557525|NCT01056146|brain concussion|brain concussion
5557526|NCT01056146|head injuries, closed|head injuries, closed
5557527|NCT01056146|epidural hematoma|epidural hematoma
5557528|NCT01056146|extra-axial hemorrhage|extra-axial hemorrhage
5557529|NCT01056146|cortical contusion|cortical contusion
5557530|NCT01056146|Additional relevant MeSH terms:|additional relevant mesh terms:
5557531|NCT01056146|Nervous System Diseases|nervous system diseases
5557532|NCT01056146|Wounds and Injuries|wounds and injuries
5557533|NCT01056146|Disorders of Environmental Origin|disorders of environmental origin
5557534|NCT01056146|Central Nervous System Diseases|central nervous system diseases
5557535|NCT01056146|Trauma, Nervous System|trauma, nervous system
5557536|NCT01056146|Brain Diseases|brain diseases
5557537|NCT01056146|Brain Injuries|brain injuries
5557538|NCT01056133|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5557539|NCT01056133|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5557540|NCT01056107|Constipation, Irritable Bowel Syndrome (IBS), Glucagon Like Peptide analogue|constipation, irritable bowel syndrome (ibs), glucagon like peptide analogue
5557542|NCT01056081|inspiratory muscles|inspiratory muscles
5557543|NCT01056081|diaphragm|diaphragm
5557544|NCT01056055|Ankle|ankle
5557545|NCT01056055|Chronic lateral instability|chronic lateral instability
5557546|NCT01056055|Modified Brostrom procedure|modified brostrom procedure
5557547|NCT01056055|Suture anchor|suture anchor
5557548|NCT01056055|Bone tunnel|bone tunnel
5557549|NCT01056042|pelvic pain|pelvic pain
5557550|NCT01056042|postoperative|postoperative
5557551|NCT01056042|medical therapy|medical therapy
5557552|NCT01056029|Solid Tumors|solid tumors
5557553|NCT01056016|ADHD|adhd
5557554|NCT01056003|gastric inlet patch|gastric inlet patch
5557555|NCT01056003|prevalence|prevalence
5557556|NCT01056003|globus sensations|globus sensations
5557557|NCT01055990|pandemic influenza A (H1N1) 2009|pandemic influenza a (h1n1) 2009
5557558|NCT01055990|blood fix treatment|blood fix treatment
5557559|NCT01055990|influenza A (H1N1) 2009 monovalent vaccine|influenza a (h1n1) 2009 monovalent vaccine
5557560|NCT01055990|effectiveness|effectiveness
5557561|NCT01055990|immunogenicity|immunogenicity
5557562|NCT01055990|safety|safety
5557563|NCT01055977|statin therapy|statin therapy
5557564|NCT01055977|treatment goal|treatment goal
5557565|NCT01055977|dyslipidaemia|dyslipidaemia
5557566|NCT01055951|Insulin pumps|insulin pumps
5557567|NCT01055951|Diabetes|diabetes
5557568|NCT01055912|Congestive Heart Failure|congestive heart failure
5557569|NCT01055912|Volume Overload|volume overload
5557571|NCT01055886|PTSD|ptsd
5557572|NCT01055886|smoking cessation|smoking cessation
5557573|NCT01055886|nicotine patch|nicotine patch
5557574|NCT01055873|immune status|immune status
5557575|NCT01055873|adolescents or young adults infected|adolescents or young adults infected
5557576|NCT01055873|impact of viral replication|impact of viral replication
5557577|NCT01055860|uterine Prolapse|uterine prolapse
5557578|NCT01055860|vaginal prolapse|vaginal prolapse
5557579|NCT01055860|mesh erosion|mesh erosion
5557580|NCT01055860|urinary incontinence|urinary incontinence
5557581|NCT01055860|bowel symptoms|bowel symptoms
5557582|NCT01055847|cystic fibrosis|cystic fibrosis
5557583|NCT01055847|CF|cf
5557584|NCT01055847|aztreonam|aztreonam
5557585|NCT01055847|lung infection|lung infection
5557586|NCT01055847|Pseudomonas aeruginosa|pseudomonas aeruginosa
5557587|NCT01055834|Insomnia|insomnia
5557588|NCT01055834|primary insomnia|primary insomnia
5557713|NCT01055392|early Alzheimer`s disease|early alzheimer`s disease
5557589|NCT01055834|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
5557591|NCT01055821|Vaccine|vaccine
5557592|NCT01055821|HCVac|hcvac
5557593|NCT01055821|MVA-HCV|mva-hcv
5557594|NCT01055808|Insulin|insulin
5557595|NCT01055808|ITR-QOL|itr-qol
5557596|NCT01055808|DTSQ|dtsq
5557597|NCT01055808|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5557598|NCT01055782|Colonoscopy|colonoscopy
5557599|NCT01055782|Endoguide|endoguide
5557600|NCT01055782|Pain perception|pain perception
5557601|NCT01055782|Colonoscopy to the coecum (success rate)|colonoscopy to the coecum (success rate)
5557602|NCT01055782|Patient's perception of pain|patient's perception of pain
5557603|NCT01055782|Duration of successful colonoscopies|duration of successful colonoscopies
5557604|NCT01055769|Bio-equivalence|bio-equivalence
5557605|NCT01055769|Linezolid OS|linezolid os
5557606|NCT01055769|Linezolid tablet|linezolid tablet
5557607|NCT01055756|Reduction of signs and symptoms and enhanced nasal flow|reduction of signs and symptoms and enhanced nasal flow
5557608|NCT01055756|Nasal Flow|nasal flow
5557609|NCT01055743|Fluorouracil Implants|fluorouracil implants
5557610|NCT01055743|Hepatocellular carcinoma|hepatocellular carcinoma
5557611|NCT01055743|Radical resection|radical resection
5557612|NCT01055730|Pulmonary rehabilitation|pulmonary rehabilitation
5557613|NCT01055730|Exercise therapy|exercise therapy
5557614|NCT01055730|Interstitial lung disease|interstitial lung disease
5557615|NCT01055730|Pulmonary fibrosis|pulmonary fibrosis
5557616|NCT01055730|Mobility limitation|mobility limitation
5557617|NCT01055730|Dyspnea|dyspnea
5557618|NCT01055730|Mental health|mental health
5557619|NCT01055717|avenanthramide|avenanthramide
5557620|NCT01055717|enriched|enriched
5557621|NCT01055717|oat|oat
5557622|NCT01055717|phytochemical|phytochemical
5557623|NCT01055717|bioavailability|bioavailability
5557624|NCT01055704|Methylnaltrexone|methylnaltrexone
5557625|NCT01055704|Codeine|codeine
5557626|NCT01055704|Gastrointestinal motility|gastrointestinal motility
5557628|NCT01055691|healthy volunteers|healthy volunteers
5557629|NCT01055691|bioequivalence|bioequivalence
5557630|NCT01055691|dapagliflozin|dapagliflozin
5557631|NCT01055691|metformin|metformin
5557632|NCT01055678|breast cancer|breast cancer
5557633|NCT01055678|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5557634|NCT01055678|breast cancer in situ|breast cancer in situ
5557635|NCT01055678|invasive carcinoma|invasive carcinoma
5557636|NCT01055678|invasive ductal carcinoma|invasive ductal carcinoma
5557637|NCT01055678|invasive lobular carcinoma|invasive lobular carcinoma
5557638|NCT01055652|Type 2 diabetes mellitus|type 2 diabetes mellitus
5557639|NCT01055652|Japanese|japanese
5557640|NCT01055652|phase 1|phase 1
5557641|NCT01055652|safety|safety
5557642|NCT01055652|dapagliflozin|dapagliflozin
5557643|NCT01055652|Pharmacokinetics|pharmacokinetics
5557644|NCT01055652|Drug-drug Interaction|drug-drug interaction
5557645|NCT01055652|voglibose|voglibose
5557646|NCT01055639|Chronic Pain|chronic pain
5557647|NCT01055639|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5557648|NCT01055626|Body mass index|body mass index
5557649|NCT01055626|Body fat|body fat
5557650|NCT01055626|Obesity|obesity
5557651|NCT01055626|Overweight|overweight
5708452|NCT00470483|PET|pet
5557652|NCT01055626|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5557653|NCT01055626|Air displacement plethysmography|air displacement plethysmography
5557654|NCT01055600|eltrombopag|eltrombopag
5557655|NCT01055600|pharmacokinetics|pharmacokinetics
5557656|NCT01055600|PROMACTA|promacta
5557657|NCT01055600|lactation|lactation
5557658|NCT01055600|milk-only study|milk-only study
5557659|NCT01055587|major abdominal surgery|major abdominal surgery
5557660|NCT01055587|severe burn injury|severe burn injury
5557661|NCT01055587|infection|infection
5557662|NCT01055587|diagnostic|diagnostic
5557663|NCT01055574|lumbar disc arthroplasty|lumbar disc arthroplasty
5557664|NCT01055574|total disc replacement|total disc replacement
5557665|NCT01055574|ProDisc L|prodisc l
5557666|NCT01055574|anterior lumbar interbody fusion|anterior lumbar interbody fusion
5557667|NCT01055574|lumbar spine surgery outcomes|lumbar spine surgery outcomes
5557668|NCT01055561|Acupuncture|acupuncture
5557669|NCT01055561|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5557670|NCT01055561|BPSD|bpsd
5557671|NCT01055561|MMSE|mmse
5557672|NCT01055561|BEHAVE-AD|behave-ad
5557673|NCT01055561|The Questionnaire of Acupuncture Events|the questionnaire of acupuncture events
5557674|NCT01055561|healthy volunteers|healthy volunteers
5557675|NCT01055548|Preterm|preterm
5557676|NCT01055548|Perinatal|perinatal
5557677|NCT01055548|Ultrasound|ultrasound
5557678|NCT01055548|Cerebral palsy|cerebral palsy
5557679|NCT01055548|Anxiety|anxiety
5557680|NCT01055548|Parents|parents
5557681|NCT01055522|Interleukin, IL2, monoclonal, antibody, cytokine, Dacarbazine, metastatic, melanoma, tumor targeting, Dose definition|interleukin, il2, monoclonal, antibody, cytokine, dacarbazine, metastatic, melanoma, tumor targeting, dose definition
5557682|NCT01055522|, L19|, l19
5557683|NCT01055509|Social Adjustment|social adjustment
5557684|NCT01055509|Quality of life|quality of life
5557685|NCT01055509|Recurrence|recurrence
5557686|NCT01055509|Hospitalization|hospitalization
5557687|NCT01055496|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5557688|NCT01055483|Acute myeloid leukemia|acute myeloid leukemia
5557690|NCT01055483|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5557691|NCT01055483|refractory acute myeloid leukemia|refractory acute myeloid leukemia
5557692|NCT01055431|iron|iron
5557693|NCT01055431|bioavailability|bioavailability
5557694|NCT01055431|status|status
5557695|NCT01055431|deficiency|deficiency
5557696|NCT01055431|anaemia|anaemia
5557697|NCT01055431|functional foods|functional foods
5557698|NCT01055431|child bearing|child bearing
5557699|NCT01055418|Vitamin C|vitamin c
5557700|NCT01055418|Cognitive performance|cognitive performance
5557701|NCT01055418|Cerebral blood flow|cerebral blood flow
5557702|NCT01055418|Trans cranial doppler|trans cranial doppler
5557703|NCT01055418|Near infrared spectroscopy|near infrared spectroscopy
5557704|NCT01055405|Exercise tolerance|exercise tolerance
5557705|NCT01055405|COPD|copd
5557706|NCT01055405|Pulmonary hypertension|pulmonary hypertension
5557707|NCT01055405|Sildenafil|sildenafil
5557708|NCT01055392|mild cognitive impairment|mild cognitive impairment
5557709|NCT01055392|Alzheimer's disease|alzheimer's disease
5557710|NCT01055392|Lithium|lithium
5557711|NCT01055392|disease-modification|disease-modification
5557712|NCT01055392|cognition|cognition
5557714|NCT01055379|Rasagiline|rasagiline
5557715|NCT01055379|Depressive Symptoms|depressive symptoms
5557716|NCT01055379|Cognition|cognition
5557717|NCT01055366|Open angle glaucoma|open angle glaucoma
5557719|NCT01055366|Elazop|elazop
5557720|NCT01055366|Azarga|azarga
5557721|NCT01055366|Brinzolamide/Timolol combination|brinzolamide/timolol combination
5557722|NCT01055353|Target organs damage|target organs damage
5557723|NCT01055353|hypertensive patients|hypertensive patients
5557724|NCT01055340|Ketogenesis|ketogenesis
5557725|NCT01055340|Glucose-Dependent Insulin Secretion|glucose-dependent insulin secretion
5557726|NCT01055340|Graded Glucose Infusion|graded glucose infusion
5557727|NCT01055340|Oxyntomodulin|oxyntomodulin
5557728|NCT01055327|Isolated oral clefts|isolated oral clefts
5557729|NCT01055327|lamotrigine|lamotrigine
5557730|NCT01055327|EUROCAT|eurocat
5557731|NCT01055327|congenital malformations|congenital malformations
5557732|NCT01055327|anti-epileptic drugs|anti-epileptic drugs
5557733|NCT01055301|stage I multiple myeloma|stage i multiple myeloma
5557734|NCT01055301|stage II multiple myeloma|stage ii multiple myeloma
5557735|NCT01055301|stage III multiple myeloma|stage iii multiple myeloma
5557736|NCT01055275|iliac aneurysm|iliac aneurysm
5557737|NCT01055275|aortic aneurysm|aortic aneurysm
5557738|NCT01055275|endovascular grafts|endovascular grafts
5557739|NCT01055262|Safety|safety
5557740|NCT01055262|tolerability|tolerability
5557741|NCT01055262|heatwrap|heatwrap
5557742|NCT01055262|lower back|lower back
5557743|NCT01055262|healthy subjects|healthy subjects
5557745|NCT01055249|pain|pain
5557746|NCT01055249|inflammation|inflammation
5557747|NCT01055249|model|model
5557748|NCT01055249|healthy volunteers|healthy volunteers
5557749|NCT01055249|Ultraviolet radiation (UVR) induced pain and inflammation in healthy volunteers|ultraviolet radiation (uvr) induced pain and inflammation in healthy volunteers
5557750|NCT01055236|sedation|sedation
5557751|NCT01055223|thiazolidinediones|thiazolidinediones
5557752|NCT01055223|rosiglitazone|rosiglitazone
5557753|NCT01055223|amiloride|amiloride
5557754|NCT01055223|pioglitazone|pioglitazone
5557755|NCT01055223|fracture|fracture
5557756|NCT01055223|Spironolactone|spironolactone
5557757|NCT01055210|Heart Failure|heart failure
5557758|NCT01055210|Pacemakers|pacemakers
5557759|NCT01055197|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5557760|NCT01055184|Influenza|influenza
5557761|NCT01055184|H1N1|h1n1
5557762|NCT01055171|alcohol dependence|alcohol dependence
5557763|NCT01055171|PTSD|ptsd
5557764|NCT01055171|propanolol|propanolol
5557765|NCT01055171|craving|craving
5557766|NCT01055171|beta-block|beta-block
5557767|NCT01055171|cue exposure|cue exposure
5557768|NCT01055171|addiction|addiction
5557769|NCT01055171|memory|memory
5557770|NCT01055171|trauma|trauma
5557771|NCT01055171|addictive behavior|addictive behavior
5557772|NCT01055158|HIV|hiv
5557773|NCT01055145|Multidrug-resistant TB, sensitive to levofloxacin and moxifloxacin|multidrug-resistant tb, sensitive to levofloxacin and moxifloxacin
5557774|NCT01055106|bacterial vaginosis|bacterial vaginosis
5557775|NCT01055106|vaginal infection|vaginal infection
5557776|NCT01055106|vaginal discharge|vaginal discharge
5557777|NCT01055106|vaginal disease|vaginal disease
5557778|NCT01055093|diabetes mellitus|diabetes mellitus
5557779|NCT01055093|prospective observational study|prospective observational study
5557780|NCT01055093|diabetic complications|diabetic complications
5557781|NCT01055080|type 1 diabetes|type 1 diabetes
5557782|NCT01055080|beta-cell autoantibodies|beta-cell autoantibodies
5557783|NCT01055080|cow's milk formula|cow's milk formula
5557784|NCT01055080|bovine insulin|bovine insulin
5557785|NCT01055054|bariatrics|bariatrics
5557786|NCT01055015|total knee arthroplasty|total knee arthroplasty
5557787|NCT01055002|Health male volunteers|health male volunteers
5557788|NCT01055002|Male volunteers aged 18-45 years|male volunteers aged 18-45 years
5557789|NCT01055002|Non-smokers and in good health|non-smokers and in good health
5557790|NCT01054989|Healthy adults|healthy adults
5557791|NCT01054989|Insulin sensitivity|insulin sensitivity
5557792|NCT01054976|Alzheimer's disease|alzheimer's disease
5557793|NCT01054976|Galantamine|galantamine
5557794|NCT01054976|Dementia|dementia
5557795|NCT01054963|early inflammatory arthritis|early inflammatory arthritis
5557796|NCT01054963|chronic disease|chronic disease
5557797|NCT01054963|peer support|peer support
5557798|NCT01054963|peer mentor|peer mentor
5557799|NCT01054963|peer counselling|peer counselling
5557800|NCT01054937|4SC-203|4sc-203
5557801|NCT01054937|Phase I|phase i
5557802|NCT01054937|single dose|single dose
5557803|NCT01054937|healthy volunteers|healthy volunteers
5557804|NCT01054911|GIST|gist
5557805|NCT01054911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5557806|NCT01054911|gastrointestinal stomach tumor|gastrointestinal stomach tumor
5557807|NCT01054911|Sunitinib|sunitinib
5557808|NCT01054898|depression|depression
5557809|NCT01054898|spouse abuse|spouse abuse
5557810|NCT01054898|intervention studies|intervention studies
5557811|NCT01054885|COPD|copd
5557812|NCT01054885|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5557813|NCT01054885|Efficacy|efficacy
5557814|NCT01054885|FEV1|fev1
5557815|NCT01054885|Safety|safety
5557816|NCT01054872|HIV Seronegativity|hiv seronegativity
5557817|NCT01054872|HIV Preventive Vaccine|hiv preventive vaccine
5557818|NCT01054846|Bicycle helmet|bicycle helmet
5557819|NCT01054820|FLECTORÂ® Patch|flectorâ® patch
5557820|NCT01054820|acute back strain|acute back strain
5557821|NCT01054794|Gastroparesis|gastroparesis
5557822|NCT01054794|Gastric Electrical Stimulation|gastric electrical stimulation
5557823|NCT01054781|Diffuse Large B-Cell Lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5557824|NCT01054781|rituximab|rituximab
5557825|NCT01054781|CHOP|chop
5557826|NCT01054768|Antioxidant|antioxidant
5557827|NCT01054768|Inflammation|inflammation
5557828|NCT01054768|Sickle Cell Disease|sickle cell disease
5557829|NCT01054768|Oxidative Stress|oxidative stress
5557830|NCT01054768|Cytokines|cytokines
5557831|NCT01054768|anti-inflammatory|anti-inflammatory
5557832|NCT01054768|Acetylcarnitine|acetylcarnitine
5557833|NCT01054729|Chronic Hepatitis C infection Genotype 1|chronic hepatitis c infection genotype 1
5557836|NCT01054729|GT 1|gt 1
5557837|NCT01054716|RhD negative|rhd negative
5557838|NCT01054716|RhD disease|rhd disease
5557839|NCT01054716|fetal nucleic acid|fetal nucleic acid
5557840|NCT01054716|fetal DNA|fetal dna
5557841|NCT01054716|cell free fetal DNA|cell free fetal dna
5557842|NCT01054716|Fetal RHD genotype|fetal rhd genotype
5557843|NCT01054690|Catheterization|catheterization
5557844|NCT01054690|Urinary Tract Infection|urinary tract infection
5557845|NCT01054690|Elective Surgery|elective surgery
5557846|NCT01054677|Infections in nursing homes|infections in nursing homes
5557847|NCT01054677|especially urinary tract infections|especially urinary tract infections
5557848|NCT01054664|liver enzymes|liver enzymes
5557849|NCT01054664|peripheral mononuclear blood cells|peripheral mononuclear blood cells
5557850|NCT01054664|hemodialysis|hemodialysis
5557851|NCT01054664|hepatitis C|hepatitis c
5557853|NCT01054651|Schistosoma mansoni|schistosoma mansoni
5557854|NCT01054651|Praziquantel|praziquantel
5557855|NCT01054651|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
5557856|NCT01054651|Randomized open-label controlled clinical trial|randomized open-label controlled clinical trial
5557857|NCT01054638|amprenavir|amprenavir
5557858|NCT01054638|fosamprenavir|fosamprenavir
5557859|NCT01054638|HIV|hiv
5557860|NCT01054638|HAART treatment|haart treatment
5557861|NCT01054638|Epzicom|epzicom
5557862|NCT01054638|Trizivir|trizivir
5557863|NCT01054638|Combivir|combivir
5557864|NCT01054638|zidovudine|zidovudine
5557865|NCT01054638|lamivudine|lamivudine
5557866|NCT01054638|cardiovascular disease|cardiovascular disease
5557867|NCT01054638|HIV Infections|hiv infections
5557868|NCT01054625|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5557869|NCT01054625|Head and Neck Cancer|head and neck cancer
5557870|NCT01054625|Head and Neck Neoplasms|head and neck neoplasms
5557871|NCT01054625|anti-EGFr monoclonal antibody|anti-egfr monoclonal antibody
5557872|NCT01054625|Zalutumumab|zalutumumab
5557873|NCT01054612|Histology|histology
5557874|NCT01054612|Immunohistochemical|immunohistochemical
5557875|NCT01054612|Gene Expression|gene expression
5557876|NCT01054612|Tissue Sectioning|tissue sectioning
5557877|NCT01054599|epilepsy|epilepsy
5557878|NCT01054599|memory|memory
5557879|NCT01054599|memantine|memantine
5557880|NCT01054599|localization related epilepsy|localization related epilepsy
5557881|NCT01054599|focal epilepsy|focal epilepsy
5557882|NCT01054586|antiretroviral therapy|antiretroviral therapy
5557883|NCT01054586|hepatic impairment|hepatic impairment
5557884|NCT01054586|HIV|hiv
5557885|NCT01054573|Hepatitis C, Chronic|hepatitis c, chronic
5557886|NCT01054573|Telaprevir|telaprevir
5557887|NCT01054573|Roll-over study|roll-over study
5557888|NCT01054560|Ischemic Stroke|ischemic stroke
5557889|NCT01054560|SOLITAIRE™ Device|solitaire™ device
5557890|NCT01054560|SOLITAIRE™|solitaire™
5557891|NCT01054560|MERCI® Device|merci® device
5557892|NCT01054560|MERCI®|merci®
5557893|NCT01054560|Stroke|stroke
5557894|NCT01054560|Ischemic|ischemic
5557895|NCT01054560|Mechanical Thrombectomy|mechanical thrombectomy
5557896|NCT01054560|Brain|brain
5557897|NCT01054560|Brain Clot|brain clot
5557898|NCT01054560|Brain Artery Revascularization|brain artery revascularization
5557899|NCT01054560|Recanalization|recanalization
5557900|NCT01054560|Brain Stroke|brain stroke
5557901|NCT01054560|Clot Retriever|clot retriever
5557902|NCT01054560|Device|device
5557903|NCT01054560|Neurosurgery|neurosurgery
5557904|NCT01054560|Neurovascular Intervention|neurovascular intervention
5557905|NCT01054560|Interventional Neuroradiology|interventional neuroradiology
5557906|NCT01054560|Brain study|brain study
5557907|NCT01054560|neurovascular clinical trial|neurovascular clinical trial
5557908|NCT01054547|topical anesthetic|topical anesthetic
5557909|NCT01054547|liposomal ropivacaine|liposomal ropivacaine
5557910|NCT01054547|dentistry|dentistry
5557911|NCT01054534|urinary incontinence|urinary incontinence
5557912|NCT01054521|radiofrequency turbinate reduction|radiofrequency turbinate reduction
5557913|NCT01054521|nasal obstruction|nasal obstruction
5557914|NCT01054521|Temperature-controlled radiofrequency|temperature-controlled radiofrequency
5557915|NCT01054521|Bipolar radiofrequency|bipolar radiofrequency
5557916|NCT01054521|chronic rhinitis.|chronic rhinitis.
5557917|NCT01054495|Acupuncture|acupuncture
5557918|NCT01054495|Sham acupuncture|sham acupuncture
5557919|NCT01054495|Laser|laser
5557920|NCT01054495|Methodology|methodology
5557921|NCT01054495|Control intervention|control intervention
5557922|NCT01054495|Pilot|pilot
5557923|NCT01054495|Nausea and vomiting in early pregnancy|nausea and vomiting in early pregnancy
5557924|NCT01054495|Patient's experience of different acu-stimulation|patient's experience of different acu-stimulation
5557925|NCT01054495|Blinding in acupuncture research|blinding in acupuncture research
5557926|NCT01054482|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5557927|NCT01054482|neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5557929|NCT01054456|LEC|lec
5557930|NCT01054456|Low Emetogenic Chemotherapy|low emetogenic chemotherapy
5557931|NCT01054456|Nausea and Vomiting|nausea and vomiting
5557932|NCT01054456|Nausea|nausea
5557933|NCT01054456|Vomiting|vomiting
5557934|NCT01054456|Anti- emetic|anti- emetic
5557935|NCT01054443|Blood Platelet Disorders|blood platelet disorders
5557936|NCT01054443|Immune Thrombocytopenia (ITP)|immune thrombocytopenia (itp)
5557937|NCT01054443|Low Platelet Count|low platelet count
5557938|NCT01054443|Thrombocytopaenia|thrombocytopaenia
5557939|NCT01054443|S-888711|s-888711
5557940|NCT01054443|Splenectomy|splenectomy
5557941|NCT01054443|Thrombopoiesis|thrombopoiesis
5557942|NCT01054443|Hematologic Disease|hematologic disease
5557943|NCT01054443|Auto-immune thrombocytopenic Purpura|auto-immune thrombocytopenic purpura
5557944|NCT01054443|Relapsed Persistent or Chronic ITP|relapsed persistent or chronic itp
5557945|NCT01054443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5557946|NCT01054443|Thrombotic Thrombocytopenic Purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5557947|NCT01054430|Avanafil|avanafil
5557949|NCT01054430|Erectile Dysfunction|erectile dysfunction
5557950|NCT01054430|Impairment|impairment
5557951|NCT01054417|Appendicitis|appendicitis
5557952|NCT01054417|Laparoscopy|laparoscopy
5557953|NCT01054417|Appendectomy|appendectomy
5557954|NCT01054404|Brain Swelling|brain swelling
5557955|NCT01054404|Brain Edema|brain edema
5557956|NCT01054404|Dehydration|dehydration
5557957|NCT01054352|Seasonal allergies|seasonal allergies
5557958|NCT01054352|Allergic rhinitis|allergic rhinitis
5557959|NCT01054339|Alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5557960|NCT01054339|Adeno-associated virus vector|adeno-associated virus vector
5557961|NCT01054339|AAV|aav
5557962|NCT01054339|Gene therapy|gene therapy
5557963|NCT01054339|Human gene transfer|human gene transfer
5557964|NCT01054326|arthroscopic subacromial decompression|arthroscopic subacromial decompression
5557965|NCT01054326|exercise|exercise
5557966|NCT01054326|physical therapy|physical therapy
5557967|NCT01054326|rotator cuff|rotator cuff
5557968|NCT01054326|shoulder impingement syndrome|shoulder impingement syndrome
5557969|NCT01054326|Subacromial impingement after arthroscopic subacromial decompression|subacromial impingement after arthroscopic subacromial decompression
5557970|NCT01054313|Advanced Malignancies|advanced malignancies
5557971|NCT01054313|Taxotere|taxotere
5557972|NCT01054313|Docetaxel|docetaxel
5557973|NCT01054313|Rapamycin|rapamycin
5557974|NCT01054313|Sirolimus|sirolimus
5557975|NCT01054313|Rapamune|rapamune
5557976|NCT01054313|Prednisone|prednisone
5557977|NCT01054313|Resistant to standard therapy|resistant to standard therapy
5557978|NCT01054274|esophageal cancer|esophageal cancer
5557979|NCT01054274|dysphagia|dysphagia
5557980|NCT01054274|stent|stent
5557981|NCT01054274|brachytherapy|brachytherapy
5557982|NCT01054261|avanafil, renal, impairment, TA-1790|avanafil, renal, impairment, ta-1790
5557983|NCT01054248|pregnancy, malaria, artemisinin, vivax, falciparum|pregnancy, malaria, artemisinin, vivax, falciparum
5557985|NCT01054235|community-based randomized controlled trial|community-based randomized controlled trial
5557986|NCT01054235|perinatal mortality|perinatal mortality
5557987|NCT01054235|China|china
5557988|NCT01054222|overactive bladder idiopathic|overactive bladder idiopathic
5557989|NCT01054222|elderly fesoterodine SOFIA Portugal extension study|elderly fesoterodine sofia portugal extension study
5557990|NCT01054209|Inadvertent Peri-operative Hypothermia|inadvertent peri-operative hypothermia
5557991|NCT01054209|Shivering|shivering
5557992|NCT01054209|Caesarean Section|caesarean section
5557993|NCT01054209|Elective|elective
5557994|NCT01054209|Warming Mattress|warming mattress
5557995|NCT01054209|Regional Anaesthesia|regional anaesthesia
5557996|NCT01054183|respiratory failure, intubation, GlideScope, pediatric|respiratory failure, intubation, glidescope, pediatric
5557997|NCT01054170|Chronic|chronic
5557998|NCT01054170|obstructive|obstructive
5557999|NCT01054170|pulmonary|pulmonary
5558000|NCT01054170|lung|lung
5558001|NCT01054170|respiratory disease|respiratory disease
5558002|NCT01054170|efficacy|efficacy
5558003|NCT01054170|placebo-controlled|placebo-controlled
5558004|NCT01054170|COPD|copd
5558005|NCT01054170|FEV1|fev1
5558006|NCT01054170|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
5558007|NCT01054170|Computed Tomography|computed tomography
5558008|NCT01054170|MSCT|msct
5558009|NCT01054144|Newly Diagnosed Standard Risk Multiple Myeloma|newly diagnosed standard risk multiple myeloma
5558010|NCT01054144|Senior Adults|senior adults
5558011|NCT01054131|peer support|peer support
5558012|NCT01054131|peer mentor|peer mentor
5558013|NCT01054131|self-management|self-management
5558014|NCT01054131|early inflammatory arthritis|early inflammatory arthritis
5558017|NCT01054105|Pulmonary hypertension|pulmonary hypertension
5558019|NCT01054105|mutation|mutation
5558020|NCT01054105|drug therapy|drug therapy
5558021|NCT01054092|Blood glucose|blood glucose
5558022|NCT01054092|ASP1941|asp1941
5558023|NCT01054092|Food effect|food effect
5558024|NCT01054092|Diabetes mellitus|diabetes mellitus
5558025|NCT01054066|Chronic Kidney Disease|chronic kidney disease
5558026|NCT01054066|Cardiovascular Disease|cardiovascular disease
5558027|NCT01054066|Hypertension|hypertension
5558028|NCT01054066|Anemia|anemia
5558029|NCT01054053|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5558030|NCT01054053|Serum bactericidal activity|serum bactericidal activity
5558031|NCT01054053|Menbvac|menbvac
5558032|NCT01054040|cardiovascular disease, portion plate|cardiovascular disease, portion plate
5558033|NCT01054027|Retinopathy of Prematurity (ROP)|retinopathy of prematurity (rop)
5558034|NCT01054027|Eye exams|eye exams
5560717|NCT01044823|RA|ra
5558035|NCT01054027|Premature infants|premature infants
5558036|NCT01054027|cyclomydril|cyclomydril
5558037|NCT01054014|CR016795|cr016795
5558038|NCT01054001|prostate cancer|prostate cancer
5708921|NCT00469144|MDS|mds
5558039|NCT01054001|prostatectomy|prostatectomy
5558040|NCT01054001|erectile dysfunction|erectile dysfunction
5558041|NCT01053988|Safety|safety
5558042|NCT01053988|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5558043|NCT01053988|Efficacy|efficacy
5558044|NCT01053988|FEV1|fev1
5558045|NCT01053988|COPD|copd
5558046|NCT01053975|RSR|rsr
5558047|NCT01053975|SECG|secg
5558048|NCT01053975|SPECT|spect
5558049|NCT01053975|QCA|qca
5558050|NCT01053975|SCAD|scad
5558051|NCT01053962|Chronic Idiopathic Constipation|chronic idiopathic constipation
5558052|NCT01053962|Constipation|constipation
5558053|NCT01053962|Irritable Bowel Syndrome|irritable bowel syndrome
5558054|NCT01053949|Multiple myeloma|multiple myeloma
5558055|NCT01053949|dexamethasone|dexamethasone
5558056|NCT01053949|pomalidomide|pomalidomide
5558057|NCT01053949|response|response
5558058|NCT01053949|safety|safety
5558059|NCT01053936|Chronic Kidney Disease|chronic kidney disease
5558060|NCT01053936|Type 2 diabetes|type 2 diabetes
5558061|NCT01053936|Diabetic Nephropathy|diabetic nephropathy
5558062|NCT01053923|Perianal Cancer|perianal cancer
5558063|NCT01053923|Anal Cancer|anal cancer
5558064|NCT01053923|MRI scan|mri scan
5558065|NCT01053897|GBT009|gbt009
5558066|NCT01053897|incisional scar|incisional scar
5558067|NCT01053897|breast reconstruction|breast reconstruction
5558068|NCT01053884|Invasive Candidiasis|invasive candidiasis
5558069|NCT01053884|invasive fungal disease|invasive fungal disease
5558070|NCT01053884|Anidulafungin|anidulafungin
5558071|NCT01053871|normal|normal
5558072|NCT01053858|bevacizumab,triamcinolone, intravitreal injection|bevacizumab,triamcinolone, intravitreal injection
5558073|NCT01053845|Neuropathic pain|neuropathic pain
5558074|NCT01053832|ventricular pace suppression|ventricular pace suppression
5558075|NCT01053832|pacemaker|pacemaker
5558076|NCT01053832|efficacy|efficacy
5558077|NCT01053832|safety|safety
5558078|NCT01053832|support of intrinsic heart rhythm|support of intrinsic heart rhythm
5558079|NCT01053819|psoriasis|psoriasis
5558081|NCT01053819|non-melanoma skin cancer|non-melanoma skin cancer
5558082|NCT01053819|etanercept|etanercept
5558083|NCT01053819|Enbrel|enbrel
5558084|NCT01053806|MDS|mds
5558085|NCT01053806|Lenalidomide|lenalidomide
5558086|NCT01053806|5-Azacytidine.|5-azacytidine.
5558087|NCT01053806|ORR|orr
5558088|NCT01053806|PFS|pfs
5558089|NCT01053806|myelodysplastic syndrome.High risk.|myelodysplastic syndrome.high risk.
5558090|NCT01053793|Glycemic index|glycemic index
5558091|NCT01053793|Anthocyanin|anthocyanin
5558092|NCT01053793|Potato|potato
5558093|NCT01053793|Polyphenol|polyphenol
5558094|NCT01053780|Intercessory Prayer, pregnants|intercessory prayer, pregnants
5558095|NCT01053767|Group B streptococcus|group b streptococcus
5558096|NCT01053767|GBS|gbs
5558097|NCT01053767|Vaccine|vaccine
5558098|NCT01053754|adrenocortical insufficiency|adrenocortical insufficiency
5558099|NCT01053754|prolonged corticotherapy|prolonged corticotherapy
5558100|NCT01053715|Hemophilia|hemophilia
5558101|NCT01053715|Quality of Life|quality of life
5558102|NCT01053689|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
5558103|NCT01053676|Hyperphosphatemia|hyperphosphatemia
5558104|NCT01053676|BE|be
5558105|NCT01053676|Granule|granule
5558106|NCT01053676|Healthy volunteers|healthy volunteers
5558107|NCT01053650|Healthy volunteers|healthy volunteers
5558108|NCT01053650|Open / hidden|open / hidden
5558109|NCT01053650|Placebo effect|placebo effect
5558110|NCT01053637|lacerations|lacerations
5558111|NCT01053637|sutures|sutures
5558112|NCT01053637|pediatrics|pediatrics
5558113|NCT01053637|child|child
5558114|NCT01053637|pain|pain
5558115|NCT01053637|Anxiety|anxiety
5558116|NCT01053624|Tracheostomy and thoracic surgery|tracheostomy and thoracic surgery
5558117|NCT01053624|postoperative complications|postoperative complications
5558118|NCT01053624|pulmonary surgical procedures|pulmonary surgical procedures
5558119|NCT01053624|respiratory failure|respiratory failure
5558120|NCT01053611|composite variability index|composite variability index
5558121|NCT01053611|bispectral index|bispectral index
5558123|NCT01053598|Mycobacterium tuberculosis|mycobacterium tuberculosis
5558124|NCT01053598|Nitrate Reductase Assay|nitrate reductase assay
5558125|NCT01053598|NRA|nra
5558126|NCT01053598|REMA|rema
5558127|NCT01053598|RETA|reta
5558128|NCT01053598|Rezazurine|rezazurine
5558315|NCT01052844|Antiemetics|antiemetics
5558129|NCT01053585|Gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry|gastro-esophageal junction, reflux, insertion angle, magnetic resonance imaging, manometry
5558130|NCT01053572|Chronic low back pain|chronic low back pain
5558131|NCT01053572|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
5558132|NCT01053572|Lower extremity pain|lower extremity pain
5558133|NCT01053572|Local anesthetic|local anesthetic
5558134|NCT01053572|Steroid|steroid
5558135|NCT01053572|Percutaneous lumbar adhesiolysis|percutaneous lumbar adhesiolysis
5558136|NCT01053559|Crohn's|crohn's
5542959|NCT01115504|Thiamine|thiamine
5558137|NCT01053559|Inflammatory Bowel Disease|inflammatory bowel disease
5558138|NCT01053533|Chinese herbal medicines|chinese herbal medicines
5558139|NCT01053533|pandemic H1N1 influenza|pandemic h1n1 influenza
5558140|NCT01053533|effectiveness|effectiveness
5558141|NCT01053533|safety|safety
5558142|NCT01053507|Headache|headache
5558143|NCT01053507|Post-traumatic headache|post-traumatic headache
5558144|NCT01053507|Brain injury|brain injury
5558145|NCT01053507|Cognitive impairment|cognitive impairment
5558146|NCT01053468|breast cancer|breast cancer
5558147|NCT01053468|physical activity|physical activity
5558148|NCT01053468|quality of life|quality of life
5558149|NCT01053468|theory of planned behavior|theory of planned behavior
5558150|NCT01053468|behavior change|behavior change
5558151|NCT01053468|health promotion|health promotion
5558152|NCT01053455|Non-invasive ventilation|non-invasive ventilation
5558153|NCT01053455|SiPAP|sipap
5558154|NCT01053455|CPAP|cpap
5558155|NCT01053455|low birth weight infants|low birth weight infants
5558156|NCT01053455|respiratory distress syndrome|respiratory distress syndrome
5558157|NCT01053442|iron absorption|iron absorption
5558158|NCT01053442|stable isotopes|stable isotopes
5558159|NCT01053442|NaFeEDTA|nafeedta
5558160|NCT01053442|Non-transferrin-bound iron (NTBI)|non-transferrin-bound iron (ntbi)
5558161|NCT01053442|Hepcidin|hepcidin
5558162|NCT01053429|Regulatory Post-Marketing Surveillance|regulatory post-marketing surveillance
5558163|NCT01053429|Regulatory Pharmacovigilance|regulatory pharmacovigilance
5558164|NCT01053429|ziprasidone|ziprasidone
5558165|NCT01053416|glaucoma|glaucoma
5558166|NCT01053416|pigmentary glaucoma|pigmentary glaucoma
5558167|NCT01053416|laser iridotomy|laser iridotomy
5558168|NCT01053403|MDMA|mdma
5558169|NCT01053403|Ecstasy|ecstasy
5558170|NCT01053403|MDMA effect on sleep|mdma effect on sleep
5558171|NCT01053403|MDMA effect on water homeostasis|mdma effect on water homeostasis
5558172|NCT01053403|MDMA effect on neurocognitive function|mdma effect on neurocognitive function
5558173|NCT01053403|Recreational Drug Use|recreational drug use
5558174|NCT01053403|Drug Abuse|drug abuse
5558175|NCT01053390|gallbladder neoplasmas|gallbladder neoplasmas
5558176|NCT01053390|Gallbladder Neoplasms,Advanced Stage,Chemotherapy,Somatostatin|gallbladder neoplasms,advanced stage,chemotherapy,somatostatin
5558177|NCT01053377|Influenza|influenza
5558178|NCT01053377|Tamiflu|tamiflu
5558179|NCT01053377|Osteltamivir|osteltamivir
5558180|NCT01053377|Transmission|transmission
5558181|NCT01053377|Prevention|prevention
5558182|NCT01053377|Resistance|resistance
5558183|NCT01053377|Post-Exposure Profylaxe|post-exposure profylaxe
5558184|NCT01053338|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
5558185|NCT01053325|Malaria|malaria
5558186|NCT01053325|Pregnancy|pregnancy
5558187|NCT01053325|Prevention|prevention
5558188|NCT01053325|HIV|hiv
5558189|NCT01053325|Sub-Sahara Africa|sub-sahara africa
5558190|NCT01053312|Amyloid|amyloid
5558191|NCT01053312|NPH Normal pressure hydrocephalus|nph normal pressure hydrocephalus
5558192|NCT01053312|PET Positron Emission Tomography|pet positron emission tomography
5558193|NCT01053312|SUVR Standard uptake value ratios|suvr standard uptake value ratios
5558194|NCT01053299|Developmental dysplasia of the hip (DDH)|developmental dysplasia of the hip (ddh)
5558195|NCT01053299|newborn|newborn
5558196|NCT01053299|universal screening|universal screening
5558197|NCT01053299|Universal ultrasound-screening for DDH in newborns|universal ultrasound-screening for ddh in newborns
5558198|NCT01053299|The accuracy of ultrasound-recording of the hip in newborns|the accuracy of ultrasound-recording of the hip in newborns
5558199|NCT01053286|Dysphagia|dysphagia
5558200|NCT01053286|Globus|globus
5558201|NCT01053286|Gastroesophageal reflux|gastroesophageal reflux
5558202|NCT01053273|Low back pain|low back pain
5558203|NCT01053273|Post lumbar laminectomy syndrome|post lumbar laminectomy syndrome
5558204|NCT01053273|Lumbar spinal stenosis|lumbar spinal stenosis
5558205|NCT01053273|Local anesthetic steroid|local anesthetic steroid
5558206|NCT01053273|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
5558207|NCT01053273|Percutaneous epidural adhesiolysis|percutaneous epidural adhesiolysis
5558208|NCT01053273|Caudal epidural injection|caudal epidural injection
5558209|NCT01053260|Contingency Management|contingency management
5558210|NCT01053260|Weight Loss|weight loss
5558211|NCT01053247|Atopic Dermatitis|atopic dermatitis
5558212|NCT01053234|Hyperglycaemia|hyperglycaemia
5558213|NCT01053234|Postprandial|postprandial
5558214|NCT01053234|Type 2 diabetes|type 2 diabetes
5558215|NCT01053234|Cardiovascular risk markers|cardiovascular risk markers
5558216|NCT01053221|mycophenolate|mycophenolate
5558217|NCT01053221|living donor|living donor
5558316|NCT01052844|Dexamethasone|dexamethasone
5558317|NCT01052844|Cisplatin|cisplatin
5558218|NCT01053208|Bioequivalence,Ibuprofen Diphenhydramine Citrate,Crossover|bioequivalence,ibuprofen diphenhydramine citrate,crossover
5558219|NCT01053195|Diabetes|diabetes
5558220|NCT01053195|prevention|prevention
5558221|NCT01053195|intervention|intervention
5558222|NCT01053182|esophageal cancer|esophageal cancer
5558223|NCT01053182|postoperative complications|postoperative complications
5558224|NCT01053182|diaphragm|diaphragm
5558225|NCT01053182|pulmonary function|pulmonary function
5558226|NCT01053169|Coagulopathy|coagulopathy
5558227|NCT01053169|Perioperative bleeding|perioperative bleeding
5558228|NCT01053169|Prothrombin complex|prothrombin complex
5558229|NCT01053169|Liver disease|liver disease
5558230|NCT01053156|Fragile X syndrome|fragile x syndrome
5558231|NCT01053156|minocycline|minocycline
5558232|NCT01053156|targeted treatment|targeted treatment
5558233|NCT01053143|Influenza|influenza
5558234|NCT01053143|Pandemic Influenza|pandemic influenza
5558235|NCT01053143|Swine-Origin Influenza A/H1N1 Non-adjuvanted Vaccine|swine-origin influenza a/h1n1 non-adjuvanted vaccine
5558236|NCT01053143|Influenza A Virus, H1N1 subtype|influenza a virus, h1n1 subtype
5558239|NCT01053130|bariatric surgery|bariatric surgery
5558240|NCT01053130|chronic kidney disease|chronic kidney disease
5558241|NCT01053130|weight loss|weight loss
5558242|NCT01053130|exercise|exercise
5558243|NCT01053117|central venous catheter|central venous catheter
5558244|NCT01053117|arteriovenous fistula|arteriovenous fistula
5558245|NCT01053117|hemodialysis|hemodialysis
5558246|NCT01053117|vascular access|vascular access
5558247|NCT01053117|dialysis|dialysis
5558248|NCT01053104|Colorectal cancer|colorectal cancer
5558249|NCT01053104|Breast cancer|breast cancer
5558250|NCT01053104|Capecitabine|capecitabine
5558251|NCT01053104|Docetaxel|docetaxel
5558252|NCT01053104|Mobile phone|mobile phone
5558253|NCT01053104|Toxicity|toxicity
5558254|NCT01053104|Metastatic|metastatic
5558255|NCT01053091|exercise-base rehabilitation|exercise-base rehabilitation
5558256|NCT01053091|diastolic heart failure|diastolic heart failure
5558257|NCT01053091|cardiovascular function|cardiovascular function
5558258|NCT01053091|aerobic fitness|aerobic fitness
5558259|NCT01053078|Type 1 diabetes|type 1 diabetes
5558260|NCT01053078|Hypoglycemia unawareness|hypoglycemia unawareness
5558261|NCT01053078|low blood sugar|low blood sugar
5558262|NCT01053065|Atherosclerosis|atherosclerosis
5558263|NCT01053065|Macrophages|macrophages
5558264|NCT01053065|Carotid arteries|carotid arteries
5558266|NCT01053052|Patency Tests, Fallopian Tubes|patency tests, fallopian tubes
5558267|NCT01053052|Hysterosalpingography|hysterosalpingography
5558268|NCT01053052|Sonography, Medical|sonography, medical
5558269|NCT01053026|Angiotensin receptor II antagonist|angiotensin receptor ii antagonist
5558270|NCT01053013|macrobead|macrobead
5558271|NCT01053013|biological|biological
5558272|NCT01053013|mouse cells|mouse cells
5558273|NCT01053000|ACTINIC KERATOSES|actinic keratoses
5558274|NCT01053000|HAND|hand
5558275|NCT01053000|FOREARM|forearm
5558276|NCT01052987|Gout|gout
5558277|NCT01052987|Hyperuricemia|hyperuricemia
5558278|NCT01052974|femoral neck fracture|femoral neck fracture
5558279|NCT01052974|analgesia|analgesia
5558280|NCT01052961|severe influenza|severe influenza
5558281|NCT01052961|hospitalized adults|hospitalized adults
5558282|NCT01052961|oseltamivir treatment|oseltamivir treatment
5558283|NCT01052948|dopamine agonists|dopamine agonists
5558284|NCT01052948|cabergoline|cabergoline
5558285|NCT01052948|Parkinson's disease|parkinson's disease
5558286|NCT01052948|hyperprolactinemia|hyperprolactinemia
5558287|NCT01052948|epidemiology|epidemiology
5558288|NCT01052948|cardiac valvulopathy|cardiac valvulopathy
5558289|NCT01052935|Group B streptococcus|group b streptococcus
5558290|NCT01052935|GBS|gbs
5558291|NCT01052935|Vaccine|vaccine
5558292|NCT01052922|Colorectal Neoplasms|colorectal neoplasms
5558293|NCT01052922|Mass Screening|mass screening
5558294|NCT01052922|Population Surveillance|population surveillance
5558295|NCT01052922|Randomized controlled trial|randomized controlled trial
5558296|NCT01052922|Occult Blood|occult blood
5558297|NCT01052922|Colonoscopy|colonoscopy
5540658|NCT01124318|SCORAD|scorad
5558298|NCT01052922|Sigmoidoscopy|sigmoidoscopy
5558299|NCT01052922|Health Behavior|health behavior
5558300|NCT01052909|Bioequivalence, Glimepiride, Crossover|bioequivalence, glimepiride, crossover
5558301|NCT01052896|Dyspepsia|dyspepsia
5558302|NCT01052896|Functional|functional
5558303|NCT01052883|TMC114-TiDP3-C182|tmc114-tidp3-c182
5558304|NCT01052883|TMC114-C182|tmc114-c182
5558305|NCT01052883|TMC114|tmc114
5558306|NCT01052883|HIV|hiv
5558307|NCT01052883|HIV Infections|hiv infections
5558308|NCT01052870|pharmacogenomics, androgen receptor gene, androgen sensitivity, CAG repeats, androgenetic alopecia|pharmacogenomics, androgen receptor gene, androgen sensitivity, cag repeats, androgenetic alopecia
5558309|NCT01052870|Pharmacogenomics in treatment for androgenetic alopecia in women|pharmacogenomics in treatment for androgenetic alopecia in women
5558310|NCT01052857|to evaluate acupuncture as possible alternative treatment for induction of labor|to evaluate acupuncture as possible alternative treatment for induction of labor
5558311|NCT01052857|Induction|induction
5558312|NCT01052857|treatment|treatment
5558313|NCT01052857|posterm|posterm
5558314|NCT01052844|Vomiting|vomiting
5558318|NCT01052844|Antineoplastic combined chemotherapy protocols|antineoplastic combined chemotherapy protocols
5558319|NCT01052831|Compulsive Gambling|compulsive gambling
5558320|NCT01052831|Compulsive Buying|compulsive buying
5558321|NCT01052831|Compulsive Shopping|compulsive shopping
5558322|NCT01052831|Compulsive Eating|compulsive eating
5558323|NCT01052831|Hypersexuality|hypersexuality
5558324|NCT01052831|Dopamine Agonists|dopamine agonists
5558325|NCT01052831|Mirapex|mirapex
5558326|NCT01052831|Pramipexole|pramipexole
5558327|NCT01052831|Requip|requip
5558328|NCT01052831|Ropinirole|ropinirole
5558329|NCT01052831|Impulse Control Disorders|impulse control disorders
5558330|NCT01052818|Non small-cell lung cancer|non small-cell lung cancer
5558331|NCT01052818|Circulating tumor cells|circulating tumor cells
5558332|NCT01052818|Carcinoembryonic antigen|carcinoembryonic antigen
5558333|NCT01052818|Cytokeratin|cytokeratin
5558334|NCT01052805|nerve|nerve
5558335|NCT01052805|myelinated nerve|myelinated nerve
5558336|NCT01052805|unmyelinated nerve|unmyelinated nerve
5558337|NCT01052792|Bioequivalence|bioequivalence
5558338|NCT01052792|Naproxen|naproxen
5558339|NCT01052792|crossover|crossover
5558340|NCT01052779|Iron deficiency anemia|iron deficiency anemia
5558341|NCT01052779|Chronic kidney disease|chronic kidney disease
5558342|NCT01052779|Feraheme|feraheme
5558343|NCT01052779|Ferumoxytol|ferumoxytol
5558344|NCT01052779|Iron sucrose|iron sucrose
5558346|NCT01052779|CKD|ckd
5558347|NCT01052779|Venofer|venofer
5558348|NCT01052766|lung cancer|lung cancer
5558349|NCT01052766|PET Scan|pet scan
5558350|NCT01052766|CT Scan|ct scan
5558351|NCT01052766|BH-PET scan|bh-pet scan
5558352|NCT01052766|09-134|09-134
5558353|NCT01052753|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5558354|NCT01052753|executive function|executive function
5558355|NCT01052753|endophenotype|endophenotype
5558356|NCT01052753|dopaminergic system|dopaminergic system
5558357|NCT01052753|noradrenergic system|noradrenergic system
5558358|NCT01052753|candidate gene|candidate gene
5558359|NCT01052753|Family-based association study|family-based association study
5558360|NCT01052740|Breast Cancer|breast cancer
5558361|NCT01052740|Mammography|mammography
5558362|NCT01052740|Screening|screening
5558363|NCT01052727|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5558364|NCT01052727|quality of life|quality of life
5558365|NCT01052714|Antipsychotic|antipsychotic
5558366|NCT01052714|Bipolar|bipolar
5558367|NCT01052714|Diabetes|diabetes
5558368|NCT01052714|Mental Illness|mental illness
5558369|NCT01052714|Nutrition|nutrition
5558370|NCT01052714|Obesity|obesity
5558371|NCT01052714|Schizoaffective|schizoaffective
5558372|NCT01052714|Schizophrenia|schizophrenia
5558374|NCT01052714|Weight Loss|weight loss
5558375|NCT01052688|Down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, Trisomy|down syndrome, aneuploidy, amniocentesis, chorionic villus sampling, trisomy
5558376|NCT01052675|Drug and substance problematic use, abuse or dependence|drug and substance problematic use, abuse or dependence
5558377|NCT01052662|Drug Abuse|drug abuse
5558378|NCT01052649|MNC subpopulations|mnc subpopulations
5558379|NCT01052649|Gene Expression|gene expression
5558380|NCT01052649|Metabolomics|metabolomics
5558381|NCT01052649|Immunological Status|immunological status
5558382|NCT01052636|Hip fracture|hip fracture
5558383|NCT01052636|Intervention program|intervention program
5558384|NCT01052636|Elderly|elderly
5558385|NCT01052623|GH/IGF-1|gh/igf-1
5558386|NCT01052623|Ataxia telangiectasia (AT)|ataxia telangiectasia (at)
5558387|NCT01052623|IGF-1 Generation Test|igf-1 generation test
5558388|NCT01052623|Growth hormone|growth hormone
5558389|NCT01052610|SLIT|slit
5558390|NCT01052610|bronchial asthma|bronchial asthma
5558391|NCT01052610|allergic rhinitis|allergic rhinitis
5558392|NCT01052597|Type 2 diabetes|type 2 diabetes
5558393|NCT01052597|Metabolic syndrome|metabolic syndrome
5558394|NCT01052597|cardiovascular risk|cardiovascular risk
5558395|NCT01052584|malaria|malaria
5558396|NCT01052584|therapeutic efficacy|therapeutic efficacy
5558397|NCT01052584|in vivo|in vivo
5558398|NCT01052584|artemether lumefantrine|artemether lumefantrine
5558399|NCT01052584|coartem|coartem
5558400|NCT01052584|chloroquine|chloroquine
5558401|NCT01052584|Plasmodium falciparum|plasmodium falciparum
5558402|NCT01052584|Plasmodium vivax|plasmodium vivax
5558403|NCT01052571|Chronic low back pain|chronic low back pain
5558404|NCT01052571|Lumbar disc herniation|lumbar disc herniation
5558405|NCT01052571|Lower extremity pain|lower extremity pain
5558406|NCT01052571|Lumbar radiculitis|lumbar radiculitis
5558407|NCT01052571|Local anesthetic|local anesthetic
5558408|NCT01052571|Steroid|steroid
5558409|NCT01052571|Lumbar transforaminal epidural injection|lumbar transforaminal epidural injection
5558410|NCT01052558|Open angle|open angle
5558411|NCT01052558|Glaucoma|glaucoma
5558412|NCT01052558|Cataract|cataract
5558413|NCT01052558|Surgery|surgery
5558414|NCT01052558|Intraocular Pressure|intraocular pressure
5558415|NCT01052545|urinary tract infection|urinary tract infection
5558416|NCT01052545|urinary catheter|urinary catheter
5558417|NCT01052545|bacteriuria|bacteriuria
5558418|NCT01052545|clinical guidelines|clinical guidelines
5558419|NCT01052545|audit-feedback|audit-feedback
5558420|NCT01052545|guidelines implementation|guidelines implementation
5558421|NCT01052532|Mitral Regurgitation|mitral regurgitation
5558422|NCT01052532|LV remodeling|lv remodeling
5558423|NCT01052532|Reactive nitrogen species|reactive nitrogen species
5558424|NCT01052532|Cardiac MRI|cardiac mri
5558425|NCT01052532|Adrenergic overdrive|adrenergic overdrive
5558426|NCT01052519|Obesity|obesity
5558427|NCT01052519|Esophageal Doppler monitoring|esophageal doppler monitoring
5558428|NCT01052519|tissue oxygen tension|tissue oxygen tension
5558429|NCT01052506|Human volunteers|human volunteers
5558430|NCT01052493|obesity|obesity
5558431|NCT01052493|pancreatic polypeptide|pancreatic polypeptide
5558432|NCT01052493|gut hormones|gut hormones
5558433|NCT01052480|Antiviral|antiviral
5558434|NCT01052480|Anti-Influenza Immune Plasma|anti-influenza immune plasma
5558435|NCT01052480|Emerging Infectious Disease|emerging infectious disease
5558436|NCT01052480|Swine Flu|swine flu
5558437|NCT01052454|hot flashes|hot flashes
5558438|NCT01052454|mindfulness|mindfulness
5558439|NCT01052454|stress|stress
5558440|NCT01052441|CCTA|ccta
5558441|NCT01052441|Coronary Artery Stenosis|coronary artery stenosis
5558442|NCT01052441|Iodinated Contrast|iodinated contrast
5558443|NCT01052441|Invasive Coronary Angiography|invasive coronary angiography
5558444|NCT01052428|Chronic MR|chronic mr
5558445|NCT01052428|Volume Overload|volume overload
5558446|NCT01052428|Beta-1 receptor blocker|beta-1 receptor blocker
5558447|NCT01052428|LV remodelling, LV dimensions|lv remodelling, lv dimensions
5558448|NCT01052428|LV systolic function|lv systolic function
5558449|NCT01052428|LV diastolic dysfunction|lv diastolic dysfunction
5558450|NCT01052428|Cardiac MRI|cardiac mri
5558452|NCT01052415|Stigma|stigma
5558453|NCT01052415|POL|pol
5558454|NCT01052415|Service providers|service providers
5558455|NCT01052415|China|china
5558456|NCT01052415|Universal precaution|universal precaution
5558457|NCT01052389|Schizophrenia|schizophrenia
5558458|NCT01052389|Pragmatic RCT|pragmatic rct
5558459|NCT01052389|Aripiprazole|aripiprazole
5558460|NCT01052389|Olanzapine|olanzapine
5558461|NCT01052389|Haloperidol|haloperidol
5558462|NCT01052389|Metabolic syndrome|metabolic syndrome
5558463|NCT01052389|Drug discontinuation|drug discontinuation
5558464|NCT01052376|nflammatory bowel diseases (IBD)|nflammatory bowel diseases (ibd)
5558465|NCT01052376|Familial adenomatous polyposis (FAP)|familial adenomatous polyposis (fap)
5558466|NCT01052363|CNS tumors|cns tumors
5558467|NCT01052350|Parkinson disease|parkinson disease
5558468|NCT01052350|PET imaging|pet imaging
5558469|NCT01052350|PIB|pib
5558470|NCT01052350|dementia|dementia
5558471|NCT01052311|Coronary artery disease|coronary artery disease
5558475|NCT01052311|Niacin|niacin
5558476|NCT01052298|Ciprofloxacin|ciprofloxacin
5558477|NCT01052298|Inhalation|inhalation
5558478|NCT01052298|Pharmacokinetics|pharmacokinetics
5558479|NCT01052298|Safety|safety
5558480|NCT01052298|Tolerability|tolerability
5558481|NCT01052298|COPD|copd
5558482|NCT01052285|Transversus abdominis plane block|transversus abdominis plane block
5558483|NCT01052272|Diabetes|diabetes
5558484|NCT01052272|Acute MI|acute mi
5558485|NCT01052272|Ang II type-1 receptor blockade (AT1RB)|ang ii type-1 receptor blockade (at1rb)
5558486|NCT01052272|LV remodeling|lv remodeling
5558487|NCT01052272|ACE inhibitor therapy|ace inhibitor therapy
5558488|NCT01052272|XO inhibitor, Allopurinol|xo inhibitor, allopurinol
5558489|NCT01052272|Systolic dysfunction|systolic dysfunction
5558490|NCT01052272|Diastolic dysfunction|diastolic dysfunction
5558491|NCT01052272|LV dimensions|lv dimensions
5558492|NCT01052272|Cardiac MRI|cardiac mri
5558493|NCT01052259|Chronic rejection|chronic rejection
5558494|NCT01052259|Kidney|kidney
5558495|NCT01052259|Transplantation|transplantation
5558496|NCT01052259|Immunosuppressive|immunosuppressive
5558497|NCT01052246|acne vulgaris|acne vulgaris
5558498|NCT01052246|laser surgery|laser surgery
5558499|NCT01052246|pulsed dye lasers|pulsed dye lasers
5558500|NCT01052246|benzoyl peroxidase|benzoyl peroxidase
5558501|NCT01052246|clindamycin|clindamycin
5540857|NCT01123512|Kyphoplasty|kyphoplasty
5558502|NCT01052246|randomized controlled trial|randomized controlled trial
5558504|NCT01052233|Development of osteoarthritis|development of osteoarthritis
5671980|NCT00613327|Oxybutynin chloride|oxybutynin chloride
5558505|NCT01052233|Randomized, double-blinded, placebo-controlled|randomized, double-blinded, placebo-controlled
5558506|NCT01052220|Hypertension|hypertension
5558507|NCT01052220|Blood Pressure|blood pressure
5558508|NCT01052220|End Stage Renal Disease|end stage renal disease
5558509|NCT01052220|Hemodialysis|hemodialysis
5558510|NCT01052220|Interdialytic Weight Gain|interdialytic weight gain
5558511|NCT01052220|Self-Regulation|self-regulation
5558512|NCT01052207|Biological Response Modifiers|biological response modifiers
5558513|NCT01052207|Endocrinology|endocrinology
5558514|NCT01052207|Hormone Dysfunction|hormone dysfunction
5558515|NCT01052207|Hormones|hormones
5558516|NCT01052207|Neuroendocrinology|neuroendocrinology
5558517|NCT01052194|Rheumatoid Arthritis|rheumatoid arthritis
5558518|NCT01052181|Vitamin D|vitamin d
5558621|NCT01051739|glaucoma|glaucoma
5558519|NCT01052181|Insulin sensitivity|insulin sensitivity
5558520|NCT01052181|Centrally obese|centrally obese
5558521|NCT01052168|simulation|simulation
5558522|NCT01052168|simulators|simulators
5558523|NCT01052168|motion metrics|motion metrics
5558524|NCT01052168|performance metrics|performance metrics
5558525|NCT01052168|skills training|skills training
5558526|NCT01052168|proficiency|proficiency
5561222|NCT01042860|AMD|amd
5558527|NCT01052168|laparoscopic|laparoscopic
5558528|NCT01052155|Controlled substances|controlled substances
5558529|NCT01052155|Opioids|opioids
5558530|NCT01052155|Benzodiazepines|benzodiazepines
5558531|NCT01052155|Illicit drugs|illicit drugs
5558532|NCT01052155|Immunoassay drug testing|immunoassay drug testing
5558533|NCT01052155|Point of care (POC) testing|point of care (poc) testing
5558534|NCT01052155|Liquid Chromatography Tandem Mass Spectometry|liquid chromatography tandem mass spectometry
5558535|NCT01052142|Melanoma|melanoma
5558536|NCT01052142|Cancer vaccines|cancer vaccines
5558537|NCT01052129|Bioequivalence|bioequivalence
5558538|NCT01052129|Naproxen|naproxen
5558539|NCT01052129|crossover|crossover
5558540|NCT01052116|Asthma|asthma
5558542|NCT01052116|Supplement|supplement
5558543|NCT01052116|ACRC|acrc
5558544|NCT01052116|SOYA|soya
5558545|NCT01052090|HCV|hcv
5558546|NCT01052077|OPC-34712|opc-34712
5558547|NCT01052077|Major Depressive Disorder|major depressive disorder
5558548|NCT01052077|Adjunctive Treatment|adjunctive treatment
5558549|NCT01052064|Children|children
5558550|NCT01052064|ADHD|adhd
5558551|NCT01052064|rTMS|rtms
5558552|NCT01052064|Safety|safety
5558553|NCT01052038|Sore throat|sore throat
5558554|NCT01052038|Dexamethasone|dexamethasone
5558555|NCT01052038|Pain|pain
5558556|NCT01052012|Postoperative pain|postoperative pain
5558557|NCT01052012|Post-operative pain|post-operative pain
5558558|NCT01052012|Opioid|opioid
5558559|NCT01052012|Laparoscopic surgery|laparoscopic surgery
5558560|NCT01052012|Bupivacaine|bupivacaine
5558561|NCT01052012|Local anesthetic|local anesthetic
5558562|NCT01051999|Glutamine|glutamine
5558563|NCT01051986|coronary artery bypass|coronary artery bypass
5558564|NCT01051986|off-pump surgery|off-pump surgery
5558565|NCT01051986|composite graft|composite graft
5558566|NCT01051986|saphenous vein|saphenous vein
5558567|NCT01051986|internal thoracic artery|internal thoracic artery
5558568|NCT01051973|Cognitive behavior therapy|cognitive behavior therapy
5558569|NCT01051973|exposure|exposure
5558570|NCT01051973|stress management|stress management
5558571|NCT01051960|Systemic Sclerosis|systemic sclerosis
5558572|NCT01051960|connective tissue disease|connective tissue disease
5558573|NCT01051960|Shortness of breath|shortness of breath
5558574|NCT01051960|Pulmonary Hypertension|pulmonary hypertension
5558575|NCT01051947|Nebivolol|nebivolol
5558576|NCT01051947|Metoprolol|metoprolol
5558577|NCT01051947|central aortic pressure|central aortic pressure
5558578|NCT01051947|hypertension|hypertension
5558579|NCT01051934|Recombinant Immunotoxin|recombinant immunotoxin
5558580|NCT01051934|Monoclonal Antibody|monoclonal antibody
5558581|NCT01051934|Pseudomonas Exotoxin|pseudomonas exotoxin
5558582|NCT01051934|Targeted Therapy|targeted therapy
5558583|NCT01051934|Lung Cancer|lung cancer
5558584|NCT01051934|Non-Small Cell Lung Cancer|non-small cell lung cancer
5558585|NCT01051921|HCV|hcv
5558586|NCT01051921|Null Responder|null responder
5558587|NCT01051895|Cervical intra-epithelial neoplasia|cervical intra-epithelial neoplasia
5558588|NCT01051895|Colposcopy|colposcopy
5558589|NCT01051895|HPV DNA testing|hpv dna testing
5558590|NCT01051895|treatment failure|treatment failure
5558591|NCT01051882|Mesenchymal Stromal Cells (MSC)|mesenchymal stromal cells (msc)
5558592|NCT01051882|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5558593|NCT01051882|Neuroprotection|neuroprotection
5558594|NCT01051882|Neurodegeneration|neurodegeneration
5558595|NCT01051882|Stem cells|stem cells
5558596|NCT01051882|ALS|als
5558597|NCT01051869|distal humerus|distal humerus
5558598|NCT01051869|fractures|fractures
5558599|NCT01051869|ulnar nerve|ulnar nerve
5558600|NCT01051869|simple decompression|simple decompression
5558601|NCT01051869|anterior transposition|anterior transposition
5558602|NCT01051843|Maternal Breastfeeding|maternal breastfeeding
5558603|NCT01051843|Orofacial Difficulties|orofacial difficulties
5558604|NCT01051843|Rooming-in|rooming-in
5558605|NCT01051843|Speech and Language Therapy|speech and language therapy
5558606|NCT01051817|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5558607|NCT01051817|RRMS|rrms
5558608|NCT01051804|Dry eye|dry eye
5558609|NCT01051804|Visual Performance|visual performance
5558610|NCT01051791|RAD001|rad001
5558611|NCT01051791|Everolimus|everolimus
5558612|NCT01051778|Recurrent abortion|recurrent abortion
5558613|NCT01051778|Antiphospholipid syndrome|antiphospholipid syndrome
5558614|NCT01051778|unfractionated heparin|unfractionated heparin
5558615|NCT01051778|Low Molecular Weight Heparin|low molecular weight heparin
5558616|NCT01051752|Nontuberculous mycobacterial diseases|nontuberculous mycobacterial diseases
5558617|NCT01051752|pharmacokinetics|pharmacokinetics
5558618|NCT01051752|pharmacodynamics|pharmacodynamics
5558619|NCT01051739|vision testing|vision testing
5558620|NCT01051739|perimetry|perimetry
5558622|NCT01051739|test variability|test variability
5558623|NCT01051726|aromatherapy|aromatherapy
5558624|NCT01051726|childbirth|childbirth
5558625|NCT01051726|Obstetrics|obstetrics
5558626|NCT01051726|Labour|labour
5558627|NCT01051726|Complementary Medicine|complementary medicine
5558628|NCT01051726|delivery, obstetric|delivery, obstetric
5558629|NCT01051713|obesity|obesity
5798720|NCT00111267|vitamin B12|vitamin b12
5558630|NCT01051713|behavioraladherence|behavioraladherence
5558631|NCT01051713|weight loss|weight loss
5558632|NCT01051713|smartphone|smartphone
5558633|NCT01051700|repeat-dose|repeat-dose
5558634|NCT01051700|pharmacokinetics|pharmacokinetics
5558635|NCT01051700|choroidal neovascularization|choroidal neovascularization
5558636|NCT01051700|safety|safety
5558637|NCT01051700|GW786034|gw786034
5558638|NCT01051700|tolerability|tolerability
5558639|NCT01051700|age-related macular degeneration|age-related macular degeneration
5558640|NCT01051700|stem cell growth factor|stem cell growth factor
5558641|NCT01051700|pazopanib|pazopanib
5558642|NCT01051700|platelet derived growth factor|platelet derived growth factor
5558643|NCT01051700|vascular endothelial growth factor|vascular endothelial growth factor
5558644|NCT01051687|vitiligo|vitiligo
5558645|NCT01051674|Obesity|obesity
5558646|NCT01051674|Type 2 diabetes|type 2 diabetes
5558647|NCT01051674|Fiber|fiber
5558648|NCT01051674|Dietary fiber|dietary fiber
5558649|NCT01051674|Low-carbohydrate diet|low-carbohydrate diet
5558650|NCT01051674|High protein diet|high protein diet
5558651|NCT01051661|Influenza|influenza
5558652|NCT01051661|H1N1|h1n1
5558653|NCT01051661|Pandemic|pandemic
5558654|NCT01051648|Triamcinolone acetenoide|triamcinolone acetenoide
5558655|NCT01051648|anterior vitrectomy|anterior vitrectomy
5558656|NCT01051648|presence of vitreous in the anterior chamber.|presence of vitreous in the anterior chamber.
5558657|NCT01051648|effect of triamcinolone injection on IOP,intraocular infection|effect of triamcinolone injection on iop,intraocular infection
5558658|NCT01051635|DNA Repair|dna repair
5558659|NCT01051635|DNA Damage|dna damage
5558660|NCT01051635|Advanced Cancer|advanced cancer
5558661|NCT01051635|Advanced Malignancies|advanced malignancies
5558662|NCT01051635|Topoisomerase Inhibitor|topoisomerase inhibitor
5558663|NCT01051622|PBMC (Peripheral Blood Mononuclear Cells)|pbmc (peripheral blood mononuclear cells)
5558664|NCT01051622|Crohn's Disease|crohn's disease
5558665|NCT01051622|SPECT (Single Photon Emission Computerized Tomography)|spect (single photon emission computerized tomography)
5558666|NCT01051609|Post Menopausal|post menopausal
5558667|NCT01051609|Breast Cancer|breast cancer
5558668|NCT01051596|metastatic|metastatic
5558669|NCT01051596|colorectal cancer|colorectal cancer
5558670|NCT01051583|Neovascular glaucoma|neovascular glaucoma
5558671|NCT01051583|diode laser|diode laser
5558672|NCT01051583|cyclophotocoagulation|cyclophotocoagulation
5558673|NCT01051583|Avastin|avastin
5558674|NCT01051570|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5558675|NCT01051570|recurrent prostate cancer|recurrent prostate cancer
5558676|NCT01051570|stage IV prostate cancer|stage iv prostate cancer
5558677|NCT01051570|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5558679|NCT01051544|HAEMOPHILIA A|haemophilia a
5558680|NCT01051544|INHIBITORS|inhibitors
5558681|NCT01051544|VWF/FVIII Concentrates|vwf/fviii concentrates
5558682|NCT01051531|Schizophrenia|schizophrenia
5558683|NCT01051531|R092670|r092670
5558684|NCT01051531|Paliperidone palmitate|paliperidone palmitate
5558685|NCT01051531|Diagnostic and Statistical Manual of Mental Disorders, 4th Edition|diagnostic and statistical manual of mental disorders, 4th edition
5558686|NCT01051531|Intramuscular injection|intramuscular injection
5558687|NCT01051505|Phase I|phase i
5558688|NCT01051505|multiple ascending dose|multiple ascending dose
5558689|NCT01051505|Safety|safety
5558690|NCT01051505|Tolerability|tolerability
5558691|NCT01051505|Healthy Volunteer|healthy volunteer
5558692|NCT01051479|PET Positron emission tomography|pet positron emission tomography
5558693|NCT01051479|CT X-ray computed tomography|ct x-ray computed tomography
5541062|NCT01122615|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5558694|NCT01051479|Patients with Locally Advanced Esophageal Cancer|patients with locally advanced esophageal cancer
5558695|NCT01051440|lisdexamfetamine|lisdexamfetamine
5558697|NCT01051440|bipolar disorder|bipolar disorder
5558698|NCT01051440|depression|depression
5558699|NCT01051440|stimulant|stimulant
5558700|NCT01051440|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5558701|NCT01051440|functional magnetic resonance imaging|functional magnetic resonance imaging
5558702|NCT01051440|neuropsychological testing|neuropsychological testing
5558703|NCT01051427|Nasal packing|nasal packing
5558704|NCT01051427|Haemostatic matrix|haemostatic matrix
5558705|NCT01051427|Epistaxis control|epistaxis control
5558706|NCT01051388|The efficacy of PPI|the efficacy of ppi
5558957|NCT01050387|VDD|vdd
5558707|NCT01051388|Patients receiving low-dose aspirin for vascular protection|patients receiving low-dose aspirin for vascular protection
5558708|NCT01051375|anorexia nervosa|anorexia nervosa
5558709|NCT01051375|bulimia nervosa|bulimia nervosa
5558710|NCT01051375|EDNOS|ednos
5558711|NCT01051362|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5558712|NCT01051362|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5558713|NCT01051362|Carboplatin|carboplatin
5558714|NCT01051362|Chemotherapy|chemotherapy
5558715|NCT01051349|MS|ms
5558716|NCT01051349|Multiple Sclerosis|multiple sclerosis
5558717|NCT01051336|TARIS Placebo|taris placebo
5558718|NCT01051336|Bladder|bladder
5558719|NCT01051336|Interstitial Cystitis|interstitial cystitis
5558720|NCT01051336|Normal Healthy Volunteers|normal healthy volunteers
5558721|NCT01051297|Obstructive sleep apnea|obstructive sleep apnea
5558722|NCT01051297|venous thrombosis|venous thrombosis
5558723|NCT01051297|pulmonary embolism|pulmonary embolism
5558724|NCT01051297|venous thromboembolism|venous thromboembolism
5558725|NCT01051284|Pancreas|pancreas
5558726|NCT01051284|Newly diagnosed|newly diagnosed
5558727|NCT01051284|Cyberknife|cyberknife
5558728|NCT01051284|Gemcitabine|gemcitabine
5558729|NCT01051271|metoclopramide|metoclopramide
5558730|NCT01051271|akathisia|akathisia
5558731|NCT01051271|midazolam|midazolam
5558732|NCT01051271|diphenhydramine|diphenhydramine
5558733|NCT01051271|metoclopramide induced akathisia|metoclopramide induced akathisia
5558734|NCT01051258|Polymeric Lung Volume Reduction (PLVR)|polymeric lung volume reduction (plvr)
5558735|NCT01051258|Biologic Lung Volume Reduction (BLVR)|biologic lung volume reduction (blvr)
5558736|NCT01051258|AeriSeal|aeriseal
5558737|NCT01051258|treatment|treatment
5558738|NCT01051258|device|device
5558739|NCT01051258|breathing|breathing
5558740|NCT01051258|COPD|copd
5558741|NCT01051258|emphysema|emphysema
5558742|NCT01051258|heterogeneous|heterogeneous
5558743|NCT01051258|homogeneous|homogeneous
5558744|NCT01051258|Pathologic Processes|pathologic processes
5558745|NCT01051258|Respiratory Tract Diseases|respiratory tract diseases
5558746|NCT01051258|Lung Diseases|lung diseases
5558747|NCT01051258|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5558748|NCT01051245|Diabetes Mellitus, Type 2 [C18.452.394.750.149]|diabetes mellitus, type 2 [c18.452.394.750.149]
5558749|NCT01051245|Case Management [N04.590.233.624.250]|case management [n04.590.233.624.250]
5558750|NCT01051245|Disease Management [N04.590.607]|disease management [n04.590.607]
5558751|NCT01051245|Diabetes Complications [C19.246.099]|diabetes complications [c19.246.099]
5558752|NCT01051232|filibuvir|filibuvir
5558753|NCT01051232|pharmacokinetics|pharmacokinetics
5558754|NCT01051232|Japanese|japanese
5558755|NCT01051232|Asian|asian
5558756|NCT01051219|Losartan|losartan
5558757|NCT01051219|Liver fibrosis|liver fibrosis
5558758|NCT01051219|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5558759|NCT01051193|Seizures|seizures
5558760|NCT01051193|oxcarbazepine|oxcarbazepine
5558761|NCT01051193|child|child
5558762|NCT01051180|HEMORRHOIDS|hemorrhoids
5558763|NCT01051180|TREATMENT|treatment
5558764|NCT01051180|PILES|piles
5558765|NCT01051180|BLEEDING|bleeding
5558766|NCT01051180|HALO|halo
5558767|NCT01051154|Docosahexaenoic acid|docosahexaenoic acid
5558768|NCT01051154|Nutritional status|nutritional status
5558769|NCT01051154|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5558770|NCT01051154|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5558771|NCT01051154|n-3 fatty acids|n-3 fatty acids
5558772|NCT01051154|Remission-induction phase|remission-induction phase
5558773|NCT01051141|alcohol use|alcohol use
5558774|NCT01051141|brief intervention|brief intervention
5558775|NCT01051141|risk behaviors|risk behaviors
5558776|NCT01051128|neurological disorders|neurological disorders
5558777|NCT01051128|multiple sclerosis|multiple sclerosis
5558778|NCT01051128|stroke|stroke
5558779|NCT01051128|cerebral palsy|cerebral palsy
5558780|NCT01051128|spinal cord|spinal cord
5558781|NCT01051128|brain injuries|brain injuries
5558782|NCT01051128|neurodegenerative diseases|neurodegenerative diseases
5558784|NCT01051115|refractory|refractory
5558785|NCT01051115|dasatinib|dasatinib
5558786|NCT01051115|fludarabine|fludarabine
5558787|NCT01051089|type 2 diabetes mellitus|type 2 diabetes mellitus
5558788|NCT01051089|lifestyle modification|lifestyle modification
5558790|NCT01051076|Haemophilia A|haemophilia a
5558791|NCT01051076|Inhibitors|inhibitors
5558792|NCT01051076|Failed ITI|failed iti
5558793|NCT01051076|VWF/FVIII concentrates|vwf/fviii concentrates
5558794|NCT01051063|adult|adult
5558796|NCT01051063|ASCI|asci
5558797|NCT01051063|complete remission with incomplete blood count recovery|complete remission with incomplete blood count recovery
5558798|NCT01051063|partial remission|partial remission
5558799|NCT01051063|post-induction therapy|post-induction therapy
5558800|NCT01051063|tumor antigen|tumor antigen
5558801|NCT01051063|Acute Myeloid Leukemia|acute myeloid leukemia
5558802|NCT01051063|Immunotherapy|immunotherapy
5558803|NCT01051050|Evidence based medicine|evidence based medicine
5558804|NCT01051050|Improving surgical residents skills and application of EBM in surgical practice|improving surgical residents skills and application of ebm in surgical practice
5558805|NCT01051037|lung tumors|lung tumors
5558806|NCT01051037|central airways|central airways
5558807|NCT01051024|Dietary supplement|dietary supplement
5558808|NCT01051024|Diamel|diamel
5558809|NCT01051024|Polycystic Ovary Syndrome|polycystic ovary syndrome
5558810|NCT01051024|Female Infertility|female infertility
5558811|NCT01050998|Rheumatoid Arthritis|rheumatoid arthritis
5558812|NCT01050998|Mavrilimumab|mavrilimumab
5558813|NCT01050998|CAM-3001|cam-3001
5558819|NCT01050972|Cognitive treatment|cognitive treatment
5558820|NCT01050972|Relaxation|relaxation
5558821|NCT01050972|Exercise|exercise
5558822|NCT01050946|Unrelated Umbilical Cord Blood Transplant(UCB)|unrelated umbilical cord blood transplant(ucb)
5558823|NCT01050946|CD34+ Selected mismatched related donor|cd34+ selected mismatched related donor
5558824|NCT01050946|Haploidentical donor|haploidentical donor
5798721|NCT00111267|cognitive function|cognitive function
5558825|NCT01050946|hematopoietic stem cell transplantation(HSCT)|hematopoietic stem cell transplantation(hsct)
5558826|NCT01050946|ALL|all
5558827|NCT01050946|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5558828|NCT01050946|AML|aml
5558829|NCT01050946|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
5558830|NCT01050946|CML|cml
5558831|NCT01050946|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5558832|NCT01050946|NHL|nhl
5558833|NCT01050946|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5558834|NCT01050946|HL|hl
5558835|NCT01050946|Lymphoma, Hodgkins|lymphoma, hodgkins
5558836|NCT01050933|Healthy volunteer|healthy volunteer
5558837|NCT01050907|leishmaniasis|leishmaniasis
5558838|NCT01050907|cutaneous disease|cutaneous disease
5558839|NCT01050907|mucosal disease|mucosal disease
5558840|NCT01050907|miltefosine|miltefosine
5558841|NCT01050894|osteoarthritis|osteoarthritis
5558842|NCT01050881|blood donor notification|blood donor notification
5558843|NCT01050881|emotional response|emotional response
5558844|NCT01050881|variant Creutzfeldt-Jacob Disease|variant creutzfeldt-jacob disease
5558849|NCT01050829|Magnetic resonance imaging|magnetic resonance imaging
5558850|NCT01050829|Tumor|tumor
5558851|NCT01050829|Contrast media|contrast media
5558852|NCT01050829|Gadobutrol|gadobutrol
5558853|NCT01050816|articular cartilage defects|articular cartilage defects
5558854|NCT01050816|ACI|aci
5558855|NCT01050816|ankle joint|ankle joint
5558856|NCT01050816|chondron|chondron
5558857|NCT01050803|Diabetes Mellitus|diabetes mellitus
5558858|NCT01050803|Intervention studies|intervention studies
5558859|NCT01050803|Program effectiveness|program effectiveness
5558860|NCT01050790|stage I multiple myeloma|stage i multiple myeloma
5558861|NCT01050790|stage II multiple myeloma|stage ii multiple myeloma
5558862|NCT01050790|stage III multiple myeloma|stage iii multiple myeloma
5558863|NCT01050777|Cutaneous Leishmaniasis caused by l. tropica|cutaneous leishmaniasis caused by l. tropica
5558864|NCT01050751|Bioavailability|bioavailability
5558865|NCT01050751|Bioequivalence|bioequivalence
5558866|NCT01050751|Lersivirine|lersivirine
5558867|NCT01050751|UK-453|uk-453
5558868|NCT01050751|061|061
5558869|NCT01050751|Pharmacokinetics|pharmacokinetics
5558871|NCT01050725|biomarkers|biomarkers
5558872|NCT01050725|radiotherapy|radiotherapy
5558873|NCT01050725|cancer|cancer
5558874|NCT01050699|critical illness|critical illness
5558875|NCT01050699|sleep|sleep
5558876|NCT01050699|polysomnography|polysomnography
5558877|NCT01050699|inflammatory cytokines|inflammatory cytokines
5558878|NCT01050699|dexmedetomidine|dexmedetomidine
5558879|NCT01050699|acute lung injury|acute lung injury
5558880|NCT01050699|acute respiratory distress syndrome|acute respiratory distress syndrome
5558881|NCT01050699|midazolam|midazolam
5558882|NCT01050699|fentanyl|fentanyl
5558883|NCT01050699|cytokines|cytokines
5558884|NCT01050686|ileostomy reversal|ileostomy reversal
5558885|NCT01050686|subcutaneous drain|subcutaneous drain
5558886|NCT01050686|hospital stay|hospital stay
5558887|NCT01050686|postoperative wound infection|postoperative wound infection
5558888|NCT01050686|patients with elective ileostomy reversal|patients with elective ileostomy reversal
5558889|NCT01050673|VERSAJET hydro-surgical debridement|versajet hydro-surgical debridement
5558890|NCT01050673|traumatic wound|traumatic wound
5558891|NCT01050660|Parenteral nutrition associated liver disease|parenteral nutrition associated liver disease
5558892|NCT01050660|Direct bilirubin|direct bilirubin
5558893|NCT01050660|Intravenous fat emulsion|intravenous fat emulsion
5558894|NCT01050660|Very low birth weight infants|very low birth weight infants
5558896|NCT01050634|Aromatase inhibitor|aromatase inhibitor
5558897|NCT01050634|Switch after Tamoxifen|switch after tamoxifen
5558898|NCT01050634|Quality of Life|quality of life
5558899|NCT01050634|Safety|safety
5558900|NCT01050621|ascorbic acid|ascorbic acid
5558901|NCT01050621|vitamin C|vitamin c
5558902|NCT01050621|antioxidants|antioxidants
5558903|NCT01050621|redox therapy|redox therapy
5558904|NCT01050621|cytotoxic chemotherapy|cytotoxic chemotherapy
5558905|NCT01050608|Alcohol Rub|alcohol rub
5558906|NCT01050608|Hand Hygiene|hand hygiene
5558907|NCT01050608|Provider Feedback|provider feedback
5558908|NCT01050608|Health Care Associated Infections|health care associated infections
5558909|NCT01050595|Intensive Care Unit|intensive care unit
5558910|NCT01050595|Constipation|constipation
5558911|NCT01050595|Bowel Management|bowel management
5558912|NCT01050582|Schizophrenia|schizophrenia
5558913|NCT01050582|Bipolar Disorder|bipolar disorder
5558914|NCT01050582|Autistic Disorder|autistic disorder
5558915|NCT01050582|Conduct and Other Disruptive Behavior Disorders|conduct and other disruptive behavior disorders
5558916|NCT01050582|Risperidone|risperidone
5558917|NCT01050582|RISPERDAL|risperdal
5558918|NCT01050582|Antipsychotic Agents|antipsychotic agents
5558919|NCT01050582|Prolactin|prolactin
5558920|NCT01050582|Pediatrics|pediatrics
5558921|NCT01050569|Smoking Cessation|smoking cessation
5558922|NCT01050569|Nicotine Free Cigarettes|nicotine free cigarettes
5558923|NCT01050556|arsenic|arsenic
5558924|NCT01050556|folate|folate
5558925|NCT01050556|folic acid|folic acid
5558926|NCT01050556|creatine|creatine
5558927|NCT01050556|arsenicosis|arsenicosis
5558928|NCT01050556|nutrition|nutrition
5558929|NCT01050530|Cirrhosis|cirrhosis
5558930|NCT01050530|ascites|ascites
5558931|NCT01050530|Tolvaptan|tolvaptan
5558932|NCT01050530|OPC-41061|opc-41061
5558933|NCT01050491|asthma|asthma
5558934|NCT01050491|airway remodeling|airway remodeling
5558935|NCT01050491|airway obstruction|airway obstruction
5558936|NCT01050478|acute agitation|acute agitation
5558937|NCT01050478|aggression|aggression
5558938|NCT01050478|psychosis|psychosis
5558939|NCT01050478|paliperidone extended release|paliperidone extended release
5558941|NCT01050465|Knee pain|knee pain
5558942|NCT01050465|Colonoscopy|colonoscopy
5558943|NCT01050465|Mammography|mammography
5558944|NCT01050465|Vaccination|vaccination
5558945|NCT01050439|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5558946|NCT01050439|Unrelated donor|unrelated donor
5558947|NCT01050439|Cord blood donor|cord blood donor
5558948|NCT01050413|Thymidine Kinase 1 activity|thymidine kinase 1 activity
5558949|NCT01050413|diagnosis|diagnosis
5558950|NCT01050413|prognosis|prognosis
5558951|NCT01050413|follow-up|follow-up
5558952|NCT01050400|CYP2D6|cyp2d6
5558953|NCT01050400|Genetic Polymorphism|genetic polymorphism
5558954|NCT01050400|codeine|codeine
5558955|NCT01050400|breastfeeding|breastfeeding
5558956|NCT01050387|Vitamin D Deficiency|vitamin d deficiency
5558958|NCT01050387|Vitamin D Supplementation|vitamin d supplementation
5558959|NCT01050387|Vitamin D Binding Protein|vitamin d binding protein
5558960|NCT01050387|DBP|dbp
5558961|NCT01050387|Nutritional rickets|nutritional rickets
5558962|NCT01050387|rickets|rickets
5558963|NCT01050387|25hydroxyvitamin D|25hydroxyvitamin d
5558964|NCT01050387|25OHD|25ohd
5558965|NCT01050387|1,25OH2D|1,25oh2d
5558966|NCT01050387|vitamin D metabolites|vitamin d metabolites
5558967|NCT01050387|PTH|pth
5558968|NCT01050387|vitamin D homeostasis|vitamin d homeostasis
5558969|NCT01050361|To reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries|to reduce perioperative morbidity and mortality associated with congestive heart failure for non-cardiac surgeries
5558970|NCT01050322|receptor HER two positive|receptor her two positive
5558971|NCT01050322|lapatinib|lapatinib
5558972|NCT01050322|metastatic breast cancer|metastatic breast cancer
5558973|NCT01050296|Neuroblastoma|neuroblastoma
5558974|NCT01050296|Retinoblastoma|retinoblastoma
5558975|NCT01050296|Osteosarcoma|osteosarcoma
5558976|NCT01050296|Rhabdomyosarcoma|rhabdomyosarcoma
5558977|NCT01050296|Ewing sarcoma|ewing sarcoma
5558978|NCT01050296|Non-rhabdomyosarcoma soft tissue sarcoma|non-rhabdomyosarcoma soft tissue sarcoma
5558979|NCT01050296|Adrenocortical tumors|adrenocortical tumors
5558980|NCT01050296|Liver malignancies|liver malignancies
5558981|NCT01050283|Advanced pancreatic adenocarcinoma|advanced pancreatic adenocarcinoma
5558982|NCT01050244|Soy protein|soy protein
5558983|NCT01050244|Milk protein|milk protein
5558984|NCT01050244|Neuropathic pain|neuropathic pain
5558985|NCT01050231|stroke|stroke
5558986|NCT01050231|cerebrovascular accident|cerebrovascular accident
5558987|NCT01050231|robot|robot
5558988|NCT01050218|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5558989|NCT01050205|Diabetes Prevention|diabetes prevention
5558990|NCT01050205|Cardiovascular Risk Reduction|cardiovascular risk reduction
5558991|NCT01050205|Lifestyle Intervention|lifestyle intervention
5558992|NCT01050205|Group Lifestyle Balance|group lifestyle balance
5558993|NCT01050192|Prematurity|prematurity
5558994|NCT01050192|Nutrition|nutrition
5558995|NCT01050192|Breast Feeding|breast feeding
5558996|NCT01050179|chemosensitivity|chemosensitivity
5558997|NCT01050166|islet transplantation|islet transplantation
5558998|NCT01050166|magnetic resonance|magnetic resonance
5558999|NCT01050166|Type 1 DM|type 1 dm
5559000|NCT01050153|Prevention of venous thromboembolism|prevention of venous thromboembolism
5559001|NCT01050140|fructose|fructose
5559002|NCT01050140|fatty liver disease|fatty liver disease
5559004|NCT01050127|Pharmacokinetics|pharmacokinetics
5559005|NCT01050127|Pharmacodynamics|pharmacodynamics
5559006|NCT01050127|Drug Safety|drug safety
5559007|NCT01050127|Phase 1 Clinical Trial|phase 1 clinical trial
5559008|NCT01050114|Botulinum Toxin|botulinum toxin
5559009|NCT01050114|Oxybutynin|oxybutynin
5559010|NCT01050114|Overactive Bladder|overactive bladder
5559011|NCT01050114|Spinal Cord Injury|spinal cord injury
5559012|NCT01050114|Urinary Incontinence|urinary incontinence
5559013|NCT01050114|Nerve Growth Factor|nerve growth factor
5559014|NCT01050114|Urine Biomarkers|urine biomarkers
5559015|NCT01050101|Satiety|satiety
5559016|NCT01050101|Fiber|fiber
5559017|NCT01050101|Nutrition|nutrition
5559018|NCT01050101|Pre- and post-menopausal women|pre- and post-menopausal women
5559019|NCT01050101|overweight|overweight
5559020|NCT01050088|clubfoot|clubfoot
5559021|NCT01050088|casting|casting
5559022|NCT01050088|ponseti|ponseti
5559023|NCT01050088|discomfort|discomfort
5559024|NCT01050075|male breast cancer|male breast cancer
5559025|NCT01050075|neurotoxicity|neurotoxicity
5559026|NCT01050075|recurrent breast cancer|recurrent breast cancer
5559027|NCT01050036|Leukemia, Myeloid|leukemia, myeloid
5559028|NCT01050036|Primary complete remission|primary complete remission
5559029|NCT01050036|Favorable karyotype|favorable karyotype
5559030|NCT01050036|Autologous hematopoietic cell transplantation|autologous hematopoietic cell transplantation
5559031|NCT01050036|Hematopoietic cell transplantation|hematopoietic cell transplantation
5559032|NCT01050023|venous stasis ulcer|venous stasis ulcer
5559033|NCT01050023|wound healing|wound healing
5559034|NCT01050023|Provant Wound Closure System|provant wound closure system
5559035|NCT01050023|radiofrequency|radiofrequency
5559036|NCT01050023|Provant|provant
5559037|NCT01050023|pain relief|pain relief
5559038|NCT01050010|rheumatoid arthritis|rheumatoid arthritis
5559039|NCT01050010|clinical remission|clinical remission
5559040|NCT01050010|synovitis|synovitis
5559041|NCT01050010|dedicated extremity MRI|dedicated extremity mri
5559042|NCT01049997|Non ST Elevation Myocardial Infarction (NSTEMI)|non st elevation myocardial infarction (nstemi)
5559043|NCT01049997|Elderly|elderly
5559044|NCT01049997|Frailty|frailty
5559045|NCT01049984|Parkinson's Disease|parkinson's disease
5559046|NCT01049984|UPDRS|updrs
5559047|NCT01049984|Clinical Global Evaluation Illness Severity score|clinical global evaluation illness severity score
5559048|NCT01049984|Clinical Global Evaluation Improvement|clinical global evaluation improvement
5559049|NCT01049984|B-SIT|b-sit
5559050|NCT01049984|SCOPA - Sleep Daytime Sleepiness|scopa - sleep daytime sleepiness
5559051|NCT01049984|PDQ -39|pdq -39
5559052|NCT01049984|SCOPA - Cognition|scopa - cognition
5559053|NCT01049984|Levodopa|levodopa
5559054|NCT01049984|rasagiline|rasagiline
5559055|NCT01049984|Dopamine Agonist Therapy|dopamine agonist therapy
5559056|NCT01049984|monoamine oxidase type B inhibitor|monoamine oxidase type b inhibitor
5559057|NCT01049971|colorectal surgery|colorectal surgery
5559058|NCT01049971|wound infection|wound infection
5559059|NCT01049971|wound protector|wound protector
5559060|NCT01049971|laparoscopy|laparoscopy
5559061|NCT01049971|surgical site infection after laparoscopic colorectal surgery with minilaparotomy|surgical site infection after laparoscopic colorectal surgery with minilaparotomy
5559062|NCT01049958|asynchrony|asynchrony
5559063|NCT01049958|mechanical ventilation|mechanical ventilation
5559064|NCT01049958|blunt trauma|blunt trauma
5559065|NCT01049932|HIV|hiv
5559066|NCT01049932|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5559068|NCT01049919|Critical Limb Ischemia|critical limb ischemia
5559069|NCT01049919|Peripheral Arterial Disease|peripheral arterial disease
5559070|NCT01049919|Peripheral Vascular Disease|peripheral vascular disease
5559071|NCT01049919|CLI|cli
5559072|NCT01049919|PAD|pad
5559073|NCT01049919|PVD|pvd
5559074|NCT01049919|Angiogenesis|angiogenesis
5559075|NCT01049919|Stem Cells|stem cells
5559076|NCT01049919|Cell Therapy|cell therapy
5559077|NCT01049919|Limb Salvage|limb salvage
5559078|NCT01049919|Amputation|amputation
5559079|NCT01049919|Leg Pain|leg pain
5559080|NCT01049906|foot surgery|foot surgery
5559081|NCT01049906|ankle surgery|ankle surgery
5559082|NCT01049906|Patients scheduled for foot and ankle surgery|patients scheduled for foot and ankle surgery
5559083|NCT01049880|Ascorbic Acid|ascorbic acid
5559084|NCT01049880|Gemcitabine|gemcitabine
5559085|NCT01049854|unrelated donor transplant|unrelated donor transplant
5559086|NCT01049854|CD34 selection|cd34 selection
5559088|NCT01049841|children|children
5559089|NCT01049841|perifosine|perifosine
5559090|NCT01049841|temsirolimus|temsirolimus
5559091|NCT01049841|recurrent|recurrent
5559092|NCT01049841|progressive|progressive
5559093|NCT01049841|09-124|09-124
5559094|NCT01049828|Tinnitus|tinnitus
5729226|NCT00397462|APG|apg
5559095|NCT01049828|fcMRI|fcmri
5559096|NCT01049828|Neural Connectivity|neural connectivity
5559097|NCT01049828|Bother|bother
5559098|NCT01049815|hemodialysis|hemodialysis
5559099|NCT01049815|intimal media thickness|intimal media thickness
5559100|NCT01049802|stroke|stroke
5559101|NCT01049802|hemiplegia|hemiplegia
5559102|NCT01049802|TMS|tms
5559103|NCT01049789|youth|youth
5559104|NCT01049789|HIV|hiv
5559105|NCT01049789|Depression|depression
5559106|NCT01049789|Cognitive Behavioral Therapy|cognitive behavioral therapy
5559107|NCT01049789|Medication management|medication management
5559108|NCT01049776|Lung Cancer Non Small Cell|lung cancer non small cell
5559109|NCT01049763|obese adult|obese adult
5559110|NCT01049763|non obese healthy volunteers|non obese healthy volunteers
5559111|NCT01049763|oseltamivir carboxylate|oseltamivir carboxylate
5559112|NCT01049763|pharmacokinetics|pharmacokinetics
5559113|NCT01049763|healthy volunteers|healthy volunteers
5559114|NCT01049750|type 2 diabetes mellitus|type 2 diabetes mellitus
5559116|NCT01049750|erectile dysfunction|erectile dysfunction
5559117|NCT01049724|Myopia|myopia
5559118|NCT01049724|refractive surgery|refractive surgery
5559119|NCT01049724|LASIK|lasik
5559121|NCT01049724|Lacritin|lacritin
5559122|NCT01049724|Heparanase|heparanase
5559123|NCT01049711|erythropoietin|erythropoietin
5559124|NCT01049711|hemodialysis|hemodialysis
5559125|NCT01049711|cost utility|cost utility
5559126|NCT01049711|incremental cost-effectiveness ratio|incremental cost-effectiveness ratio
5559127|NCT01049711|Quality adjusted life year|quality adjusted life year
5559128|NCT01049711|quality of life|quality of life
5559129|NCT01049698|Obesity|obesity
5559130|NCT01049698|Overweight|overweight
5559131|NCT01049698|Older adults|older adults
5559132|NCT01049698|resistance training|resistance training
5559133|NCT01049698|exercise|exercise
5559134|NCT01049685|HIV|hiv
5559135|NCT01049685|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5559136|NCT01049685|Efavirenz|efavirenz
5559137|NCT01049685|Lopinavir|lopinavir
5559138|NCT01049685|Comparative Effectiveness Research|comparative effectiveness research
5559139|NCT01049685|Treatment Naive|treatment naive
5559140|NCT01049659|pregnancy|pregnancy
5559141|NCT01049659|iodine deficiency|iodine deficiency
5559142|NCT01049659|neuropsychological development|neuropsychological development
5559143|NCT01049646|renin-angiotensin system|renin-angiotensin system
5559144|NCT01049646|apelin|apelin
5559145|NCT01049646|systemic haemodynamics|systemic haemodynamics
5559146|NCT01049633|Insulin dependence|insulin dependence
5559147|NCT01049633|Hypoglycemia|hypoglycemia
5559148|NCT01049633|Hypoglycemia unawareness|hypoglycemia unawareness
5559149|NCT01049633|Islet transplantation|islet transplantation
5559150|NCT01049620|XELOX|xelox
5559151|NCT01049620|RAD001|rad001
5559152|NCT01049620|phase 1|phase 1
5559153|NCT01049607|Patients undergoing hepatic resection|patients undergoing hepatic resection
5559154|NCT01049581|Gross motor function performance|gross motor function performance
5559155|NCT01049581|pediatric aquatic therapy|pediatric aquatic therapy
5559156|NCT01049581|spastic cerebral palsy|spastic cerebral palsy
5559157|NCT01049568|HIV|hiv
5559158|NCT01049568|Cell phone|cell phone
5559159|NCT01049568|HAART|haart
5559160|NCT01049555|alzheimer|alzheimer
5559161|NCT01049555|apathy|apathy
5559162|NCT01049555|actigraphy|actigraphy
5559163|NCT01049542|Astressin 2B|astressin 2b
5559164|NCT01049542|Forearm blood flow|forearm blood flow
5559165|NCT01049542|vascular|vascular
5559166|NCT01049542|plethysmography|plethysmography
5559167|NCT01049542|heart failure|heart failure
5559168|NCT01049529|Docosahexaenoic acid|docosahexaenoic acid
5553174|NCT01074515|COPD|copd
5559169|NCT01049529|n-3 Long Chain Polyunsaturated Fatty Acids|n-3 long chain polyunsaturated fatty acids
5559170|NCT01049529|omega 3 fatty acids|omega 3 fatty acids
5559171|NCT01049529|neonates|neonates
5559172|NCT01049529|clinical outcomes|clinical outcomes
5559173|NCT01049529|critically ill patients|critically ill patients
5559174|NCT01049529|Inflammatory and antiinflammatory cytokines|inflammatory and antiinflammatory cytokines
5559175|NCT01049529|Length of intensive care stay|length of intensive care stay
5559176|NCT01049516|Military|military
5559177|NCT01049516|Combat|combat
5559178|NCT01049516|Psychological Treatment|psychological treatment
5559179|NCT01049516|Psychotherapy|psychotherapy
5559180|NCT01049516|Trauma|trauma
5559181|NCT01049516|Posttraumatic Stress|posttraumatic stress
5559182|NCT01049516|Posttraumatic Stress Disorder|posttraumatic stress disorder
5559183|NCT01049516|PTSD|ptsd
5559184|NCT01049516|Prolonged Exposure|prolonged exposure
5559185|NCT01049516|Exposure therapy|exposure therapy
5559186|NCT01049516|Behavior Therapy|behavior therapy
5559187|NCT01049516|Cognitive Behavior Therapy|cognitive behavior therapy
5559188|NCT01049516|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5559189|NCT01049516|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5559190|NCT01049503|Dentifrices|dentifrices
5559191|NCT01049503|Fluoride|fluoride
5559193|NCT01049503|Plaque|plaque
5559194|NCT01049490|Intradermal vaccination, H1N1, microneedle|intradermal vaccination, h1n1, microneedle
5559195|NCT01049477|Pregnancy|pregnancy
5559196|NCT01049477|Cesarean Section|cesarean section
5559197|NCT01049464|Atrial fibrillation|atrial fibrillation
5559198|NCT01049464|Hemodynamically unstable patients|hemodynamically unstable patients
5559199|NCT01049464|Magnesium sulfate|magnesium sulfate
5559200|NCT01049464|Septic shock|septic shock
5559201|NCT01049464|Medical intensive care unit|medical intensive care unit
5559202|NCT01049464|New onset atrial fibrillation|new onset atrial fibrillation
5559203|NCT01049464|Critically ill patients|critically ill patients
5559204|NCT01049451|Multiple Sclerosis|multiple sclerosis
5559205|NCT01049451|ACTH|acth
5559206|NCT01049451|Steroids|steroids
5559207|NCT01049438|MRSA|mrsa
5559208|NCT01049438|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5559209|NCT01049438|Staphylococcus aureus|staphylococcus aureus
5559210|NCT01049438|Skin Infections|skin infections
5559211|NCT01049438|Body Decolonization|body decolonization
5559212|NCT01049425|anthracycline-free|anthracycline-free
5559213|NCT01049425|OncotypDX|oncotypdx
5559215|NCT01049425|Her2 negative breast cancer|her2 negative breast cancer
5559216|NCT01049386|intestinal permeability|intestinal permeability
5559217|NCT01049386|health|health
5559218|NCT01049386|sugar absorption|sugar absorption
5559219|NCT01049386|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)|intestinal permeability examined in different men (lean vs obese) and different conditions (no breakfast and high-fat breakfast)
5559220|NCT01049373|low-back|low-back
5559221|NCT01049373|pain|pain
5559222|NCT01049373|chronic|chronic
5559223|NCT01049373|constitution|constitution
5559224|NCT01049373|diathesism|diathesism
5559225|NCT01049373|homoeopathy|homoeopathy
5559226|NCT01049373|fixed combination|fixed combination
5559227|NCT01049373|herbal preparation|herbal preparation
5559228|NCT01049373|chronic low back pain lasting more than 6 months|chronic low back pain lasting more than 6 months
5559229|NCT01049360|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5559231|NCT01049360|Chronic Bronchitis|chronic bronchitis
5559232|NCT01049360|Emphysema|emphysema
5559233|NCT01049360|Airflow Obstruction, Chronic|airflow obstruction, chronic
5559234|NCT01049360|Chronic Airflow Obstruction|chronic airflow obstruction
5559235|NCT01049360|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5559236|NCT01049360|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5559237|NCT01049347|depression|depression
5559238|NCT01049321|Dietary Approach to Stop Hypertension|dietary approach to stop hypertension
5559239|NCT01049321|weight|weight
5559240|NCT01049321|coagulation|coagulation
5559241|NCT01049321|DASH eating pattern.|dash eating pattern.
5559242|NCT01049308|heart failure|heart failure
5559243|NCT01049308|cognitive disorders|cognitive disorders
5559244|NCT01049308|medication adherence|medication adherence
5559245|NCT01049308|patient readmissions|patient readmissions
5559246|NCT01049295|taxanes|taxanes
5559247|NCT01049295|breast cancer|breast cancer
5559248|NCT01049295|n3 fatty acids|n3 fatty acids
5559249|NCT01049295|inflammation|inflammation
5559250|NCT01049282|safety|safety
5559251|NCT01049282|immunogenicity|immunogenicity
5559252|NCT01049282|adjuvanted TB subunit vaccine|adjuvanted tb subunit vaccine
5559253|NCT01049269|Body Scanning|body scanning
5559254|NCT01049269|Body Fat|body fat
5559255|NCT01049269|Body Volume|body volume
5559256|NCT01049269|Obesity|obesity
5559257|NCT01049269|No Conditions|no conditions
5559258|NCT01049256|Periodic breathing|periodic breathing
5559259|NCT01049256|Heart Failure|heart failure
5559260|NCT01049256|Chemoreflex|chemoreflex
5559261|NCT01049256|Chemosensitivity|chemosensitivity
5559262|NCT01049243|Atopic Dermatitis|atopic dermatitis
5559263|NCT01049243|Open-Label|open-label
5559265|NCT01049243|Cream|cream
5559266|NCT01049243|Eczema|eczema
5559267|NCT01049243|Vanos|vanos
5559268|NCT01049230|proton beam radiation|proton beam radiation
5559269|NCT01049230|CNS germ cell tumor|cns germ cell tumor
5559270|NCT01049217|neuropathy|neuropathy
5559271|NCT01049217|pain|pain
5559272|NCT01049217|HIV-1|hiv-1
5559273|NCT01049217|HIV Infections|hiv infections
5559274|NCT01049204|HIV|hiv
5559275|NCT01049204|HIV-1 Infections|hiv-1 infections
5559276|NCT01049191|Osteoporosis|osteoporosis
5559277|NCT01049191|Fracture|fracture
5559278|NCT01049191|microMRI|micromri
5559279|NCT01049191|Bone architecture|bone architecture
5559280|NCT01049191|Bone matrix|bone matrix
5559281|NCT01049191|Bone and Bones|bone and bones
5559282|NCT01049191|Magnetic Resonance Imaging|magnetic resonance imaging
5559283|NCT01049178|antioxidant enzymes|antioxidant enzymes
5559284|NCT01049178|asthma|asthma
5559285|NCT01049178|silymarin|silymarin
5559286|NCT01049178|RCT|rct
5559287|NCT01049152|Diabetes mellitus|diabetes mellitus
5559288|NCT01049152|ESRD|esrd
5559289|NCT01049152|CGM|cgm
5559290|NCT01049152|Inflammation markers|inflammation markers
5559291|NCT01049152|Hemodialysis|hemodialysis
5559292|NCT01049152|Diabetic patients|diabetic patients
5559293|NCT01049152|Nondiabetic patients|nondiabetic patients
5559294|NCT01049152|All with ESRD|all with esrd
5559295|NCT01049152|All undergone hemodialysis|all undergone hemodialysis
5559296|NCT01049139|vaccination|vaccination
5559297|NCT01049139|HIV prevention|hiv prevention
5559298|NCT01049139|YMSM|ymsm
5559299|NCT01049139|youth|youth
5559300|NCT01049139|HIV Preventative Vaccine|hiv preventative vaccine
5559301|NCT01049126|Late Stage|late stage
5559302|NCT01049113|Lymphoma|lymphoma
5559303|NCT01049113|B-cell Acute Lymphocytic Leukemia|b-cell acute lymphocytic leukemia
5559304|NCT01049113|ALL|all
5559305|NCT01049100|Surgical Staging|surgical staging
5559306|NCT01049100|Cervical Cancer|cervical cancer
5559307|NCT01049100|Chemoradiation|chemoradiation
5559308|NCT01049100|Outcome|outcome
5559309|NCT01049100|Toxicity|toxicity
5559310|NCT01049087|plasma volume|plasma volume
5559311|NCT01049087|technetium-labeled albumin|technetium-labeled albumin
5559312|NCT01049087|radioiodine-labeled albumin|radioiodine-labeled albumin
5559313|NCT01049087|Healthy volunteers|healthy volunteers
5559314|NCT01049074|Low Back Pain|low back pain
5559315|NCT01049074|Acupuncture|acupuncture
5559317|NCT01049061|Cancer|cancer
5559318|NCT01049061|FRα|frα
5559319|NCT01049048|Endothelial Function|endothelial function
5559320|NCT01049048|Arterial stiffness|arterial stiffness
5559321|NCT01049048|Vitamin D|vitamin d
5559322|NCT01049035|Meningitis|meningitis
5559323|NCT01049035|Meningococcal Infection|meningococcal infection
5559324|NCT01049035|Neisseria meningitidis|neisseria meningitidis
5559325|NCT01049035|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
5559326|NCT01049022|Pharmacokinetics|pharmacokinetics
5559327|NCT01049009|Nitric Oxide|nitric oxide
5559328|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5559329|NCT01049009|Antihypertensive Agents|antihypertensive agents
5559330|NCT01049009|Vasodilator Agents|vasodilator agents
5559331|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents
5559332|NCT01049009|Sympatholytics|sympatholytics
5559333|NCT01049009|Vascular Resistance|vascular resistance
5559334|NCT01049009|Neurotransmitter Agents|neurotransmitter agents
5559335|NCT01049009|Cardiovascular Diseases|cardiovascular diseases
5559336|NCT01049009|Metoprolol succinate|metoprolol succinate
5559337|NCT01049009|Therapeutic Uses|therapeutic uses
5559338|NCT01049009|Metoprolol|metoprolol
5559339|NCT01049009|Vascular Diseases|vascular diseases
5559340|NCT01049009|Nebivolol|nebivolol
5559341|NCT01049009|Cardiovascular Agents|cardiovascular agents
5559342|NCT01049009|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors
5559343|NCT01048996|Acute Lung Injury|acute lung injury
5559344|NCT01048996|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5559345|NCT01048996|Genetic Variability|genetic variability
5559346|NCT01048996|Plasma Biomarkers|plasma biomarkers
5559347|NCT01048996|Pediatrics|pediatrics
5559348|NCT01048983|Lung Cancer|lung cancer
5559349|NCT01048983|NSCLC|nsclc
5559350|NCT01048983|Concurrent Chemoradiation Therapy|concurrent chemoradiation therapy
5559351|NCT01048983|Side Effects|side effects
5559352|NCT01048983|Armodafinil|armodafinil
5559353|NCT01048983|Nuvigil|nuvigil
5559354|NCT01048983|Bupropion|bupropion
5559355|NCT01048983|Wellbutrin|wellbutrin
5559356|NCT01048983|Wellbutrin SR|wellbutrin sr
5559357|NCT01048983|Zyban|zyban
5559358|NCT01048983|Curcumin|curcumin
5559359|NCT01048983|Minocycline|minocycline
5559360|NCT01048983|Dynacin|dynacin
5559361|NCT01048983|Minocin|minocin
5559362|NCT01048983|Minocin PAC|minocin pac
5559363|NCT01048983|Myrac|myrac
5559364|NCT01048983|Solodyn|solodyn
5559365|NCT01048970|Lung cancer|lung cancer
5559366|NCT01048970|Eicosapentaenoic acid oral supplementation|eicosapentaenoic acid oral supplementation
5559367|NCT01048970|Weight loss|weight loss
5559368|NCT01048970|Toxicity|toxicity
5559369|NCT01048970|Body composition|body composition
5559373|NCT01048957|fMRI|fmri
5559374|NCT01048957|EEG|eeg
5559375|NCT01048957|Real Time fMRI Feedback|real time fmri feedback
5559376|NCT01048944|Electroencephalography|electroencephalography
5559377|NCT01048944|nicotine|nicotine
5559378|NCT01048944|bupropion|bupropion
5559379|NCT01048944|attention|attention
5559380|NCT01048944|drug withdrawal symptoms|drug withdrawal symptoms
5559381|NCT01048931|Single-port, laparoscopic-assisted, vaginal hysterectomy|single-port, laparoscopic-assisted, vaginal hysterectomy
5559382|NCT01048918|Circulating tumor cells in breast cancer|circulating tumor cells in breast cancer
5559383|NCT01048905|Pulmonary Hypertension|pulmonary hypertension
5559384|NCT01048905|Sickle Cell Disease|sickle cell disease
5559385|NCT01048905|Thalassemia|thalassemia
5559386|NCT01048892|recurrent neuroblastoma|recurrent neuroblastoma
5559387|NCT01048892|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5559388|NCT01048892|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5671234|NCT00616590|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5559389|NCT01048892|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5559390|NCT01048892|recurrent retinoblastoma|recurrent retinoblastoma
5559391|NCT01048892|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5559392|NCT01048892|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5559393|NCT01048879|oseltamivir|oseltamivir
5559394|NCT01048879|influenza|influenza
5559395|NCT01048879|continuous renal replacement therapy|continuous renal replacement therapy
5559396|NCT01048879|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5559397|NCT01048879|pharmacokinetics|pharmacokinetics
5559398|NCT01048866|pharyngitis|pharyngitis
5559399|NCT01048866|swollen throat|swollen throat
5559400|NCT01048866|difficulty swallowing|difficulty swallowing
5559401|NCT01048853|Cervix|cervix
5559402|NCT01048853|Stage IA2 or IB1 Carcinoma|stage ia2 or ib1 carcinoma
5559403|NCT01048853|Conservative Surgery|conservative surgery
5559404|NCT01048853|Cervix Cancer recurrence|cervix cancer recurrence
5559405|NCT01048853|Quality of Life Factors|quality of life factors
5559406|NCT01048853|Pelvic lymph nodes|pelvic lymph nodes
5559407|NCT01048853|Pelvic Lymphadenectomy|pelvic lymphadenectomy
5559408|NCT01048853|parametrium|parametrium
5559409|NCT01048853|Cervical cone biopsy|cervical cone biopsy
5559410|NCT01048853|Endocervical curettage|endocervical curettage
5559412|NCT01048840|Gastroesophageal Reflux|gastroesophageal reflux
5559413|NCT01048827|AML|aml
5559414|NCT01048827|autologous transplant|autologous transplant
5559415|NCT01048801|History of fever|history of fever
5559416|NCT01048801|measured fever|measured fever
5559417|NCT01048788|Cirrhosis|cirrhosis
5559418|NCT01048788|ascites|ascites
5559419|NCT01048788|Tolvaptan|tolvaptan
5559420|NCT01048788|OPC-41061|opc-41061
5559421|NCT01048775|bispectral index|bispectral index
5559422|NCT01048775|cardiac surgery|cardiac surgery
5559423|NCT01048775|asymmetry|asymmetry
5559424|NCT01048762|pulmonary cancer|pulmonary cancer
5559429|NCT01048762|physical therapy|physical therapy
5559430|NCT01048749|Low back pain|low back pain
5559431|NCT01048749|nerve root compression|nerve root compression
5559432|NCT01048749|spinal height|spinal height
5559434|NCT01048736|exercise|exercise
5559435|NCT01048736|intensity|intensity
5559436|NCT01048736|weight loss|weight loss
5559437|NCT01048736|diet|diet
5559438|NCT01048723|Soft Tissue|soft tissue
5559439|NCT01048723|Retroperitoneal|retroperitoneal
5559440|NCT01048723|resectable|resectable
5559441|NCT01048710|Knee osteoarthritis|knee osteoarthritis
5559442|NCT01048710|knee osteonecrosis|knee osteonecrosis
5559443|NCT01048710|osteotomy|osteotomy
5559444|NCT01048697|Obesity|obesity
5559445|NCT01048697|Pharmacokinetics|pharmacokinetics
5559446|NCT01048697|Pharmacodynamics|pharmacodynamics
5559447|NCT01048697|Dose individualization|dose individualization
5559448|NCT01048697|Tuberculosis|tuberculosis
5559449|NCT01048684|Brain tumor|brain tumor
5559450|NCT01048684|Intracranial pressure|intracranial pressure
5559451|NCT01048671|HIV|hiv
5559452|NCT01048658|Sevoflurane|sevoflurane
5559453|NCT01048658|anesthesia|anesthesia
5559454|NCT01048658|abortion|abortion
5559455|NCT01048658|blood loss|blood loss
5559456|NCT01048645|All-trans retinoic acid|all-trans retinoic acid
5559457|NCT01048645|non-small cell lung cancer|non-small cell lung cancer
5559458|NCT01048645|retinoic acid receptor beta|retinoic acid receptor beta
5559459|NCT01048645|chemotherapy|chemotherapy
5559460|NCT01048632|Neonates with HLHS or variant with plan to undergo Norwood Procedure|neonates with hlhs or variant with plan to undergo norwood procedure
5559461|NCT01048619|Myelodysplastic Syndrome|myelodysplastic syndrome
5559462|NCT01048619|MDS|mds
5559463|NCT01048606|Postmenopause|postmenopause
5559464|NCT01048606|Overweight|overweight
5559465|NCT01048606|Women|women
5559466|NCT01048606|Phytoestrogens|phytoestrogens
5553471|NCT01073423|HIV|hiv
5559467|NCT01048606|Exercise|exercise
5559468|NCT01048606|Cardiovascular Diseases|cardiovascular diseases
5559469|NCT01048606|Risk Factors|risk factors
5559470|NCT01048606|Aging|aging
5559471|NCT01048593|ocular inflammation cataract surgery|ocular inflammation cataract surgery
5559472|NCT01048593|post cataract surgery inflammation|post cataract surgery inflammation
5559473|NCT01048580|Perifosine|perifosine
5559474|NCT01048580|Capecitabine|capecitabine
5559475|NCT01048580|Colon Cancer|colon cancer
5559476|NCT01048567|Antibiotics|antibiotics
5559477|NCT01048567|Diarrhea|diarrhea
5559478|NCT01048567|Clostridium difficile|clostridium difficile
5559479|NCT01048567|Probiotics|probiotics
5559480|NCT01048567|Prevention & control|prevention & control
5559481|NCT01048554|Melanoma|melanoma
5559482|NCT01048554|Brain mets|brain mets
5559483|NCT01048554|Bevacizumab|bevacizumab
5559484|NCT01048554|Temozolomide|temozolomide
5559485|NCT01048554|Avastin|avastin
5559486|NCT01048554|Temodar|temodar
5559487|NCT01048554|Melanoma with brain mets|melanoma with brain mets
5671981|NCT00613327|OROS|oros
5559488|NCT01048528|immune response to vaccines|immune response to vaccines
5559489|NCT01048528|stress management|stress management
5559490|NCT01048528|perceived risk for breast cancer|perceived risk for breast cancer
5559491|NCT01048515|Caffeine|caffeine
5559492|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs
5559493|NCT01048515|Central Nervous System Agents|central nervous system agents
5559494|NCT01048502|healthy volunteer|healthy volunteer
5559496|NCT01048463|gastric cancer|gastric cancer
5559497|NCT01048463|colorectal cancer|colorectal cancer
5559498|NCT01048463|chemotherapy|chemotherapy
5559499|NCT01048463|eicosapentaenoic acid|eicosapentaenoic acid
5559500|NCT01048463|enteral nutrition|enteral nutrition
5559501|NCT01048450|arthritis|arthritis
5559502|NCT01048450|degeneration|degeneration
5559503|NCT01048424|Urinary incontinence|urinary incontinence
5559504|NCT01048424|Paced respiration|paced respiration
5559505|NCT01048411|stroke rehabilitation|stroke rehabilitation
5559506|NCT01048411|outcome|outcome
5559507|NCT01048411|barthel-index|barthel-index
5559508|NCT01048411|geriatrics|geriatrics
5559509|NCT01048411|elderly|elderly
5559510|NCT01048398|ceophalic version|ceophalic version
5559511|NCT01048398|breech presentation|breech presentation
5559512|NCT01048398|pregnancy|pregnancy
5559513|NCT01048398|remifentanil|remifentanil
5559514|NCT01048398|paracetamol|paracetamol
5559515|NCT01048385|Mitochondrial dysfunction|mitochondrial dysfunction
5559516|NCT01048385|Mitochondrial nutrients|mitochondrial nutrients
5559517|NCT01048385|Aneuploidy|aneuploidy
5559518|NCT01048385|Meiotic Spindle|meiotic spindle
5559519|NCT01048385|Coenzyme Q10|coenzyme q10
5559520|NCT01048385|Electron transfer chain|electron transfer chain
5559521|NCT01048372|HIV|hiv
5559523|NCT01048372|immune therapy|immune therapy
5559524|NCT01048372|pathogenesis|pathogenesis
5559525|NCT01048372|cytotoxic T lymphocyte|cytotoxic t lymphocyte
5559526|NCT01048372|anti-CD4|anti-cd4
5559527|NCT01048372|anti-self|anti-self
5559528|NCT01048372|viral replication|viral replication
5559529|NCT01048372|Acute Infection|acute infection
5559530|NCT01048359|Drug abuse, injury, trauma, screening, brief intervention.|drug abuse, injury, trauma, screening, brief intervention.
5559531|NCT01048346|employment, disabilities|employment, disabilities
5559532|NCT01048333|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5559533|NCT01048333|Onset of effect|onset of effect
5559534|NCT01048333|COPD|copd
5559535|NCT01048333|Oxis Turbuhaler|oxis turbuhaler
5559536|NCT01048320|pancreatic cancer|pancreatic cancer
5559537|NCT01048320|toxicity|toxicity
5559538|NCT01048320|chemotherapy|chemotherapy
5559539|NCT01048320|dose finding|dose finding
5559540|NCT01048307|prontosan|prontosan
5559541|NCT01048307|wound cleansing|wound cleansing
5559542|NCT01048307|wound irrigation|wound irrigation
5559543|NCT01048307|phmb|phmb
5559544|NCT01048307|polihexanide|polihexanide
5559545|NCT01048307|betaine|betaine
5559546|NCT01048294|Seasonal affective disorder|seasonal affective disorder
5559547|NCT01048294|phototherapy|phototherapy
5559548|NCT01048294|circadian rhythms|circadian rhythms
5559549|NCT01048294|blue enriched light|blue enriched light
5559550|NCT01048294|melanopsin|melanopsin
5559551|NCT01048294|Primary disease: Seasonal Affective Disorder, winter type|primary disease: seasonal affective disorder, winter type
5559552|NCT01048268|T1DM|t1dm
5559553|NCT01048268|T2DM|t2dm
5559554|NCT01048268|GIP|gip
5559555|NCT01048268|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5559556|NCT01048268|Incretin|incretin
5559557|NCT01048216|colorectal liver cancer|colorectal liver cancer
5559558|NCT01048216|metastatic|metastatic
5559559|NCT01048216|radiation therapy|radiation therapy
5559560|NCT01048203|14C ABR 215050 Metabolism and Mass Balance Study|14c abr 215050 metabolism and mass balance study
5559561|NCT01048203|tasquinimod|tasquinimod
5559562|NCT01048203|Metabolic pattern of 14C ABR-215050|metabolic pattern of 14c abr-215050
5559563|NCT01048190|Inactivated Poliomyelitis Vaccine|inactivated poliomyelitis vaccine
5559564|NCT01048190|Sabin Strains|sabin strains
5559565|NCT01048190|poliomyelitis|poliomyelitis
5559567|NCT01048177|interstitial cystitis|interstitial cystitis
5559568|NCT01048177|pelvic pain|pelvic pain
5559569|NCT01048164|Massage|massage
5559570|NCT01048164|Relaxation|relaxation
5559571|NCT01048151|Prostate|prostate
5559572|NCT01048151|TNFerade Biologic|tnferade biologic
5559573|NCT01048138|Biperiden|biperiden
5559574|NCT01048138|Post-traumatic Epilepsy|post-traumatic epilepsy
5559575|NCT01048138|Traumatic Brain Injury|traumatic brain injury
5559576|NCT01048125|Stress-induced cardiomyopathy|stress-induced cardiomyopathy
5559577|NCT01048125|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5559578|NCT01048112|campylobacter|campylobacter
5559579|NCT01048112|gastroenteritis|gastroenteritis
5559580|NCT01048112|challenge models|challenge models
5559581|NCT01048099|Breast Cancer|breast cancer
5559582|NCT01048099|Metastatic|metastatic
5559583|NCT01048099|PRO Onc Assay|pro onc assay
5559584|NCT01048099|FISH Testing|fish testing
5559585|NCT01048099|HER Negative|her negative
5559586|NCT01048099|HER Overexpression|her overexpression
5559587|NCT01048099|HER Activation|her activation
5559588|NCT01048086|neuroblastoma|neuroblastoma
5559589|NCT01048086|neuroendocrine tumor|neuroendocrine tumor
5559590|NCT01048086|NET|net
5559591|NCT01048086|retinoic acid|retinoic acid
5559592|NCT01048073|lower respiratory tract infection|lower respiratory tract infection
5559593|NCT01048073|non influenza|non influenza
5559594|NCT01048073|PCR assay|pcr assay
5559595|NCT01048047|aliskiren|aliskiren
5559596|NCT01048047|amlodipine|amlodipine
5559597|NCT01048047|hypertension|hypertension
5559598|NCT01048047|ankle-foot volume|ankle-foot volume
5541969|NCT01118767|web|web
5559599|NCT01048047|mild and moderate hypertension|mild and moderate hypertension
5559600|NCT01048034|Myelodysplastic syndrome|myelodysplastic syndrome
5559601|NCT01048034|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5559602|NCT01048034|Transfusion therapy|transfusion therapy
5559603|NCT01048034|Transfusion dependency|transfusion dependency
5559604|NCT01048034|Hypomethylating therapy|hypomethylating therapy
5559605|NCT01048034|Azacitidine|azacitidine
5559606|NCT01048034|DNA-methylation|dna-methylation
5559607|NCT01048034|Epigenetic modifications|epigenetic modifications
5559608|NCT01048021|Measurement of lung mechanics (FEV1, FVC and PEF)|measurement of lung mechanics (fev1, fvc and pef)
5559609|NCT01048008|Glioblastoma multiforme|glioblastoma multiforme
5559610|NCT01048008|Advanced cancers|advanced cancers
5559611|NCT01048008|Brain Neoplasms, Malignant, Primary|brain neoplasms, malignant, primary
5559612|NCT01048008|Brain Tumor, Recurrent|brain tumor, recurrent
5559613|NCT01048008|Advanced cancer|advanced cancer
5559614|NCT01047982|gestational diabetes|gestational diabetes
5559615|NCT01047982|macrosomia|macrosomia
5559616|NCT01047982|hypertension in pregnancy|hypertension in pregnancy
5559619|NCT01047969|locally invasive high-risk rectal adenocarcinoma|locally invasive high-risk rectal adenocarcinoma
5559620|NCT01047956|Methadone|methadone
5559621|NCT01047956|NAC|nac
5559622|NCT01047956|opioids|opioids
5559623|NCT01047930|Insomnia|insomnia
5559624|NCT01047930|Smoking|smoking
5559625|NCT01047930|Cue reactivity|cue reactivity
5559626|NCT01047930|Exercise timing|exercise timing
5559627|NCT01047930|Acute nicotine withdrawal|acute nicotine withdrawal
5559628|NCT01047930|Mood disturbances|mood disturbances
5559629|NCT01047930|Smoking abstinence|smoking abstinence
5559630|NCT01047930|Exercise intensity|exercise intensity
5559631|NCT01047930|Altered sleep|altered sleep
5559632|NCT01047930|Exercise duration|exercise duration
5559633|NCT01047930|Nonpharmacologic behavioral treatment|nonpharmacologic behavioral treatment
5559634|NCT01047930|Smoking cessation|smoking cessation
5559635|NCT01047930|Exercise Test|exercise test
5559636|NCT01047930|Polysomnography|polysomnography
5559637|NCT01047917|Meditation|meditation
5559638|NCT01047917|Relaxation Therapy|relaxation therapy
5559639|NCT01047917|Quality of Life|quality of life
5559640|NCT01047865|Type 1 Diabetes (T1D)|type 1 diabetes (t1d)
5559641|NCT01047865|Autoimmunity|autoimmunity
5559642|NCT01047852|chronic respiratory disorders|chronic respiratory disorders
5559643|NCT01047852|hypercapnic respiratory failure|hypercapnic respiratory failure
5559644|NCT01047852|noninvasive ventilation|noninvasive ventilation
5559645|NCT01047839|Pediatric|pediatric
5559646|NCT01047839|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5559647|NCT01047839|non-endemic countries|non-endemic countries
5559648|NCT01047839|to assess immunogenicity of purified inactivated Japanese Encephalitis (JE) vaccine IC51|to assess immunogenicity of purified inactivated japanese encephalitis (je) vaccine ic51
5559649|NCT01047826|Fractured Tibia|fractured tibia
5559650|NCT01047826|Expert Tibial Nail|expert tibial nail
5559651|NCT01047826|Minimally Invasive Plate Osteosynthesis (M.I.P.O)|minimally invasive plate osteosynthesis (m.i.p.o)
5559652|NCT01047826|Intramedullary Nailing|intramedullary nailing
5559653|NCT01047826|Locked Plate|locked plate
5559654|NCT01047826|distal third|distal third
5559655|NCT01047826|43-A|43-a
5559656|NCT01047813|Cognitive performance|cognitive performance
5559657|NCT01047813|Type 2 diabetes|type 2 diabetes
5559658|NCT01047813|Blood glucose|blood glucose
5559659|NCT01047800|Functional gastrointestinal disorder|functional gastrointestinal disorder
5559660|NCT01047800|GERD|gerd
5559661|NCT01047800|reflux|reflux
5559662|NCT01047800|irritable bowel syndrome|irritable bowel syndrome
5559663|NCT01047800|Functional dyspepsia|functional dyspepsia
5559664|NCT01047800|postprandial fullness|postprandial fullness
5559665|NCT01047800|counseling|counseling
5559666|NCT01047800|service|service
5559667|NCT01047787|Sleep apnea|sleep apnea
5559668|NCT01047787|Cheyne-Stokes Respiration|cheyne-stokes respiration
5559669|NCT01047787|Congestive Heart Failure|congestive heart failure
5559670|NCT01047774|soy protein|soy protein
5559671|NCT01047774|diet|diet
5559672|NCT01047761|Myasthenia Gravis|myasthenia gravis
5559673|NCT01047761|Exercise|exercise
5559674|NCT01047761|Fitness|fitness
5559675|NCT01047761|Body Composition|body composition
5559676|NCT01047761|Physical Activity|physical activity
5559677|NCT01047761|Pulmonary Function|pulmonary function
5559678|NCT01047761|Balance|balance
5559679|NCT01047748|abortion|abortion
5559680|NCT01047735|21+ years old|21+ years old
5559682|NCT01047735|Adult|adult
5559683|NCT01047735|Amputation|amputation
5559684|NCT01047735|Area|area
5559685|NCT01047735|Arm|arm
5559686|NCT01047735|Atheroscleroses|atheroscleroses
5559687|NCT01047735|Atherosclerosis|atherosclerosis
5559688|NCT01047735|Atherosclerotic|atherosclerotic
5559689|NCT01047735|Cardiovascular Disease|cardiovascular disease
5559690|NCT01047735|Bariatrics|bariatrics
5559691|NCT01047735|Behavior Conditioning Therapy|behavior conditioning therapy
5559692|NCT01047735|Behavior Modification|behavior modification
5559693|NCT01047735|Behavior Therapy|behavior therapy
5559694|NCT01047735|Behavior Treatment|behavior treatment
5559695|NCT01047735|Behavior or Life Style Modifications|behavior or life style modifications
5559696|NCT01047735|Behavioral|behavioral
5559697|NCT01047735|Behavioral Conditioning Therapy|behavioral conditioning therapy
5559698|NCT01047735|Behavioral Modification|behavioral modification
5559699|NCT01047735|Behavioral Therapy|behavioral therapy
5559700|NCT01047735|Behavioral Treatment|behavioral treatment
5559701|NCT01047735|Beta Cell|beta cell
5559702|NCT01047735|Blindness|blindness
5559703|NCT01047735|Blood Pressure, High|blood pressure, high
5559704|NCT01047735|Blood Vessels|blood vessels
5559705|NCT01047735|Body Composition|body composition
5559706|NCT01047735|Body Weight decreased|body weight decreased
5559707|NCT01047735|Cancers|cancers
5559708|NCT01047735|Cardiac infarction|cardiac infarction
5559709|NCT01047735|Cardiovascular Diseases|cardiovascular diseases
5559710|NCT01047735|Care, Health|care, health
5559711|NCT01047735|Cause of Death|cause of death
5559712|NCT01047735|Cell Function|cell function
5559713|NCT01047735|Cell Process|cell process
5559714|NCT01047735|Cell physiology|cell physiology
5559715|NCT01047735|Cellular Function|cellular function
5559717|NCT01047735|Cellular Process|cellular process
5559718|NCT01047735|Cessation of life|cessation of life
5559719|NCT01047735|Clinical|clinical
5559720|NCT01047735|Clinical Trials Design|clinical trials design
5559721|NCT01047735|Communities|communities
5559722|NCT01047735|Conditioning Therapy|conditioning therapy
5559723|NCT01047735|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5559724|NCT01047735|Controlled Study|controlled study
5559725|NCT01047735|Country|country
5559726|NCT01047735|D-Glucose|d-glucose
5559727|NCT01047735|Death|death
5559728|NCT01047735|Decision Making|decision making
5559729|NCT01047735|Dextrose|dextrose
5559730|NCT01047735|Diabetes Mellitus|diabetes mellitus
5559731|NCT01047735|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5559732|NCT01047735|Diabetes Mellitus, Ketosis-Resistant|diabetes mellitus, ketosis-resistant
5559733|NCT01047735|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5559734|NCT01047735|Diabetes Mellitus, Noninsulin Dependent|diabetes mellitus, noninsulin dependent
5559735|NCT01047735|Diabetes Mellitus, Slow-Onset|diabetes mellitus, slow-onset
5559736|NCT01047735|Diabetes Mellitus, Stable|diabetes mellitus, stable
5559737|NCT01047735|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5559738|NCT01047735|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5559739|NCT01047735|Diet|diet
5559740|NCT01047735|Disease|disease
5559741|NCT01047735|Disease remission|disease remission
5559742|NCT01047735|Disorder|disorder
5559743|NCT01047735|Drugs|drugs
5559744|NCT01047735|Dysfunction|dysfunction
5559745|NCT01047735|Effectiveness|effectiveness
5559746|NCT01047735|Epidemic|epidemic
5559747|NCT01047735|Functional disorder|functional disorder
5559748|NCT01047735|Future|future
5559749|NCT01047735|Gastric Bypass|gastric bypass
5559750|NCT01047735|Glucose|glucose
5559751|NCT01047735|Health|health
5559752|NCT01047735|Healthcare|healthcare
5559753|NCT01047735|Hepatic Disorder|hepatic disorder
5559754|NCT01047735|Human, Adult|human, adult
5559755|NCT01047735|Hypertension|hypertension
5559756|NCT01047735|INFLM|inflm
5559757|NCT01047735|Incidence|incidence
5559758|NCT01047735|Inflammation|inflammation
5559759|NCT01047735|Insulin Cell|insulin cell
5559760|NCT01047735|Insulin Resistance|insulin resistance
5559761|NCT01047735|Insulin Secreting Cell|insulin secreting cell
5559762|NCT01047735|Intestinal|intestinal
5559763|NCT01047735|Intestines|intestines
5559764|NCT01047735|Intravenous Glucose Tolerance|intravenous glucose tolerance
5559765|NCT01047735|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
5559766|NCT01047735|Kidney Failure|kidney failure
5559767|NCT01047735|Kidney Insufficiency|kidney insufficiency
5559768|NCT01047735|Learning|learning
5559769|NCT01047735|Life Style|life style
5559770|NCT01047735|Life Style Modification|life style modification
5559771|NCT01047735|Lifestyle|lifestyle
5559772|NCT01047735|Link|link
5559773|NCT01047735|Liver diseases|liver diseases
5559774|NCT01047735|Longitudinal Studies|longitudinal studies
5559775|NCT01047735|MODY|mody
5559776|NCT01047735|Malignant Neoplasms|malignant neoplasms
5559778|NCT01047735|Maturity-Onset Diabetes Mellitus|maturity-onset diabetes mellitus
5559779|NCT01047735|Measures|measures
5559780|NCT01047735|Medical|medical
5559781|NCT01047735|Medication|medication
5559782|NCT01047735|Metabolic|metabolic
5559783|NCT01047735|Methods|methods
5559784|NCT01047735|Modification|modification
5559785|NCT01047735|Morbid Obesity|morbid obesity
5559786|NCT01047735|Morbidity|morbidity
5559787|NCT01047735|Morbidity - disease rate|morbidity - disease rate
5559788|NCT01047735|Mortality|mortality
5559789|NCT01047735|Mortality Vital Statistics|mortality vital statistics
5559790|NCT01047735|Myocardial Infarct|myocardial infarct
5559791|NCT01047735|Myocardial Infarction|myocardial infarction
5559792|NCT01047735|NAFLD|nafld
5559793|NCT01047735|NASH|nash
5559794|NCT01047735|NIDDM|niddm
5559795|NCT01047735|Non-Insulin Dependent Diabetes|non-insulin dependent diabetes
5559796|NCT01047735|Non-Insulin-Dependent Diabetes Mellitus|non-insulin-dependent diabetes mellitus
5559797|NCT01047735|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5559798|NCT01047735|Obesity|obesity
5559799|NCT01047735|Obesity, Morbid|obesity, morbid
5559800|NCT01047735|Operation|operation
5559801|NCT01047735|Operative Procedures|operative procedures
5559802|NCT01047735|Operative Surgical Procedures|operative surgical procedures
5559804|NCT01047735|Outcome Measure|outcome measure
5559805|NCT01047735|PROV|prov
5559806|NCT01047735|Participant|participant
5559807|NCT01047735|Patients|patients
5559808|NCT01047735|Pharmaceutic Preparations|pharmaceutic preparations
5559809|NCT01047735|Pharmaceutical Preparations|pharmaceutical preparations
5559810|NCT01047735|Physical activity|physical activity
5559811|NCT01047735|Physiopathology|physiopathology
5559812|NCT01047735|Pilot Projects|pilot projects
5559813|NCT01047735|Population|population
5559814|NCT01047735|Procedures|procedures
5559815|NCT01047735|Programs (PT)|programs (pt)
5562472|NCT01037946|HIV|hiv
5559816|NCT01047735|Programs [Publication Type]|programs [publication type]
5559817|NCT01047735|Provider|provider
5559818|NCT01047735|Psychosocial Factor|psychosocial factor
5559819|NCT01047735|Public Health|public health
5559820|NCT01047735|RMSN|rmsn
5559821|NCT01047735|Randomized|randomized
5559822|NCT01047735|Randomized Controlled Clinical Trials|randomized controlled clinical trials
5559823|NCT01047735|Randomized Controlled Trials|randomized controlled trials
5559824|NCT01047735|Remission|remission
5559825|NCT01047735|Renal Failure|renal failure
5559826|NCT01047735|Renal Insufficiency|renal insufficiency
5559827|NCT01047735|Reporting|reporting
5559828|NCT01047735|Resolution|resolution
5559829|NCT01047735|Science|science
5559830|NCT01047735|Severe obesity|severe obesity
5559831|NCT01047735|Structure|structure
5559832|NCT01047735|Subcellular Process|subcellular process
5559833|NCT01047735|Surgical|surgical
5559834|NCT01047735|Surgical Interventions|surgical interventions
5559835|NCT01047735|Surgical Procedure|surgical procedure
5559836|NCT01047735|T2D|t2d
5559837|NCT01047735|T2DM|t2dm
5559838|NCT01047735|Testing|testing
5559839|NCT01047735|Type 2 diabetes|type 2 diabetes
5559840|NCT01047735|Type II diabetes|type ii diabetes
5559841|NCT01047735|United States|united states
5559842|NCT01047735|Upper arm|upper arm
5559843|NCT01047735|Vascular Hypertensive Disease|vascular hypertensive disease
5559844|NCT01047735|Vascular Hypertensive Disorder|vascular hypertensive disorder
5559845|NCT01047735|Weight|weight
5559846|NCT01047735|Weight Loss|weight loss
5559847|NCT01047735|Weight Reduction|weight reduction
5559848|NCT01047735|Work|work
5559849|NCT01047735|adiposity|adiposity
5559850|NCT01047735|adult human (21+)|adult human (21+)
5559851|NCT01047735|adult onset diabetes|adult onset diabetes
5559852|NCT01047735|atheromatosis|atheromatosis
5559853|NCT01047735|atherosclerotic vascular disease|atherosclerotic vascular disease
5559854|NCT01047735|bariatric surgery|bariatric surgery
5559855|NCT01047735|behavior intervention|behavior intervention
5559856|NCT01047735|behavioral intervention|behavioral intervention
5559857|NCT01047735|blood glucose regulation|blood glucose regulation
5559858|NCT01047735|body weight loss|body weight loss
5559859|NCT01047735|bowel|bowel
5559860|NCT01047735|cardiac infarct|cardiac infarct
5559861|NCT01047735|cardiovascular disorder|cardiovascular disorder
5559862|NCT01047735|cardiovascular risk|cardiovascular risk
5559863|NCT01047735|cardiovascular risk factor|cardiovascular risk factor
5559864|NCT01047735|clinical practice|clinical practice
5559865|NCT01047735|comparative effectiveness|comparative effectiveness
5559866|NCT01047735|coronary attack|coronary attack
5559867|NCT01047735|coronary infarct|coronary infarct
5559868|NCT01047735|coronary infarction|coronary infarction
5559869|NCT01047735|corpulence|corpulence
5559870|NCT01047735|corpulency|corpulency
5559871|NCT01047735|corpulentia|corpulentia
5559872|NCT01047735|design|design
5559873|NCT01047735|designing|designing
5559874|NCT01047735|diabetes|diabetes
5559875|NCT01047735|diabetic patient|diabetic patient
5559876|NCT01047735|disease/disorder|disease/disorder
5559877|NCT01047735|drug/agent|drug/agent
5559878|NCT01047735|effective therapy|effective therapy
5559879|NCT01047735|effectiveness research|effectiveness research
5559880|NCT01047735|fitness|fitness
5559881|NCT01047735|gastric banding|gastric banding
5559882|NCT01047735|gastric bypass surgery|gastric bypass surgery
5559883|NCT01047735|glucose control|glucose control
5559884|NCT01047735|glucose homeostasis|glucose homeostasis
5559885|NCT01047735|glucose metabolism|glucose metabolism
5559886|NCT01047735|glucose regulation|glucose regulation
5559887|NCT01047735|heart attack|heart attack
5559888|NCT01047735|heart infarct|heart infarct
5559889|NCT01047735|heart infarction|heart infarction
5559890|NCT01047735|hepatopathy|hepatopathy
5559891|NCT01047735|hyperpiesia|hyperpiesia
5559892|NCT01047735|hyperpiesis|hyperpiesis
5559893|NCT01047735|hypertensive disease|hypertensive disease
5559894|NCT01047735|implantable gastric stimulation banding|implantable gastric stimulation banding
5559895|NCT01047735|insulin resistant|insulin resistant
5559896|NCT01047735|interest|interest
5559897|NCT01047735|ketosis resistant diabetes|ketosis resistant diabetes
5559898|NCT01047735|life style intervention|life style intervention
5559899|NCT01047735|lifestyle intervention|lifestyle intervention
5559900|NCT01047735|liver disorder|liver disorder
5559901|NCT01047735|long-term study|long-term study
5559902|NCT01047735|malignancy|malignancy
5559903|NCT01047735|maturity onset diabetes|maturity onset diabetes
5559904|NCT01047735|moderate obesity|moderate obesity
5559905|NCT01047735|neoplasm/cancer|neoplasm/cancer
5559906|NCT01047735|non-alcohol fatty liver|non-alcohol fatty liver
5559907|NCT01047735|non-alcohol induced steatohepatitis|non-alcohol induced steatohepatitis
5559908|NCT01047735|non-alcoholic fatty liver|non-alcoholic fatty liver
5559909|NCT01047735|non-alcoholic steato-hepatitis|non-alcoholic steato-hepatitis
5559910|NCT01047735|nonalcohol fatty liver|nonalcohol fatty liver
5559911|NCT01047735|nonalcoholic fatty liver|nonalcoholic fatty liver
5559912|NCT01047735|nonalcoholic steato-hepatitis|nonalcoholic steato-hepatitis
5559913|NCT01047735|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5559914|NCT01047735|obese|obese
5559915|NCT01047735|obese people|obese people
5559917|NCT01047735|obese population|obese population
5559918|NCT01047735|obesity surgery|obesity surgery
5559919|NCT01047735|obesity, extreme|obesity, extreme
5559920|NCT01047735|pathophysiology|pathophysiology
5559921|NCT01047735|pilot study|pilot study
5559922|NCT01047735|programs|programs
5559923|NCT01047735|psychosocial|psychosocial
5559924|NCT01047735|psychosocial variables|psychosocial variables
5559925|NCT01047735|public health medicine (field)|public health medicine (field)
5559926|NCT01047735|public health relevance|public health relevance
5559927|NCT01047735|randomisation|randomisation
5559928|NCT01047735|randomization|randomization
5559929|NCT01047735|randomized controlled study|randomized controlled study
5559930|NCT01047735|randomized trial|randomized trial
5559931|NCT01047735|randomly assigned|randomly assigned
5559932|NCT01047735|respiratory|respiratory
5559933|NCT01047735|response|response
5559934|NCT01047735|stomach bypass|stomach bypass
5559935|NCT01047735|stomach stapling|stomach stapling
5559936|NCT01047735|surgery|surgery
5559937|NCT01047735|trial comparing|trial comparing
5559938|NCT01047735|vascular|vascular
5559939|NCT01047735|weight loss intervention|weight loss intervention
5559940|NCT01047735|weight loss surgery|weight loss surgery
5559941|NCT01047735|wt-loss|wt-loss
5559942|NCT01047722|platelet function test|platelet function test
5559943|NCT01047722|platelets|platelets
5559944|NCT01047722|in vivo test|in vivo test
5559945|NCT01047722|aspirin|aspirin
5559946|NCT01047722|aspirin resistance|aspirin resistance
5559947|NCT01047722|aspirin non-responsiveness|aspirin non-responsiveness
5559948|NCT01047722|in-vivo|in-vivo
5559949|NCT01047722|To assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function|to assess the specificity and sensitivity of a novel in-vivo diagnostic test of platelet function
5559950|NCT01047722|"To use this test to define and assess aspirin resistance"|"to use this test to define and assess aspirin resistance"
5559951|NCT01047683|hypertriglyceridemia|hypertriglyceridemia
5559952|NCT01047683|omega-3 fatty acids|omega-3 fatty acids
5559953|NCT01047683|statin|statin
5559954|NCT01047683|triglycerides|triglycerides
5559955|NCT01047683|lipids|lipids
5559957|NCT01047683|docosahexaenoic acid|docosahexaenoic acid
5559958|NCT01047683|fish|fish
5559959|NCT01047683|fatty acids|fatty acids
5559960|NCT01047683|fibrates|fibrates
5559962|NCT01047683|lipid|lipid
5559963|NCT01047683|atorvastatin|atorvastatin
5559964|NCT01047683|Lovaza|lovaza
5559965|NCT01047683|simvastatin|simvastatin
5559966|NCT01047683|lovastatin|lovastatin
5559968|NCT01047683|fluvastatin|fluvastatin
5559969|NCT01047683|rosuvastatin|rosuvastatin
5559970|NCT01047683|Trilipix|trilipix
5559971|NCT01047683|Vytorin|vytorin
5559972|NCT01047683|Simcor|simcor
5559973|NCT01047683|Niaspan|niaspan
5559974|NCT01047683|ezetimibe|ezetimibe
5559975|NCT01047683|Zetia|zetia
5559976|NCT01047683|ethyl-EPA|ethyl-epa
5559977|NCT01047683|ethyl icosapentate|ethyl icosapentate
5559978|NCT01047683|Crestor|crestor
5559979|NCT01047683|Zocor|zocor
5559980|NCT01047683|Lipitor|lipitor
5559981|NCT01047683|LDL|ldl
5559982|NCT01047683|HDL|hdl
5559983|NCT01047683|cholesterol|cholesterol
5559984|NCT01047683|dyslipidemia|dyslipidemia
5559985|NCT01047683|VASCEPA|vascepa
5559986|NCT01047683|icosapent ethyl|icosapent ethyl
5559987|NCT01047670|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.|sepsis, shock, adrenal insufficiency, hydrocortisone, children, paediatric intensive care.
5559988|NCT01047670|number of days free of vasoactive support in 7 days|number of days free of vasoactive support in 7 days
5559989|NCT01047670|days free of mechanical ventilation|days free of mechanical ventilation
5559990|NCT01047670|PICU mortality|picu mortality
5559991|NCT01047670|mortality among patient with inappropriate response to the ACTH test|mortality among patient with inappropriate response to the acth test
5559992|NCT01047670|baseline cortisol/ PIM2 correlation|baseline cortisol/ pim2 correlation
5559993|NCT01047657|Asthma|asthma
5559994|NCT01047657|Obesity|obesity
5559995|NCT01047657|weight loss|weight loss
5559996|NCT01047644|port|port
5559997|NCT01047644|catheter|catheter
5559998|NCT01047644|infusion|infusion
5559999|NCT01047644|flush|flush
5560000|NCT01047644|cleanse|cleanse
5560001|NCT01047644|chemotherapy|chemotherapy
5560002|NCT01047618|venous thromboembolism|venous thromboembolism
5560003|NCT01047605|qEEG|qeeg
5560004|NCT01047605|herbal medicine|herbal medicine
5560005|NCT01047605|cognitive function|cognitive function
5560006|NCT01047605|Neurapas balance|neurapas balance
5560007|NCT01047605|Pascoflair|pascoflair
5560008|NCT01047605|hypericum|hypericum
5560009|NCT01047605|passionflower|passionflower
5560010|NCT01047605|valerian|valerian
5560011|NCT01047605|Healthy volunteers|healthy volunteers
5560012|NCT01047605|Influence on quantitative electro-encephalogram (qEEG).|influence on quantitative electro-encephalogram (qeeg).
5560013|NCT01047592|Schizophrenia|schizophrenia
5560014|NCT01047592|cognitive function|cognitive function
5560015|NCT01047592|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5560016|NCT01047579|Alzheimer's Disease|alzheimer's disease
5560017|NCT01047579|Rivastigmine transdermal|rivastigmine transdermal
5560018|NCT01047579|caregiver preference|caregiver preference
5560019|NCT01047553|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5560021|NCT01047553|Japanese|japanese
5560022|NCT01047553|Phase 3|phase 3
5560023|NCT01047553|Safety|safety
5560024|NCT01047553|OT|ot
5560025|NCT01047553|Oxis|oxis
5560026|NCT01047527|nicotine replacement therapy, smoking cessation, transdermal nicotine|nicotine replacement therapy, smoking cessation, transdermal nicotine
5560027|NCT01047501|hypertriglyceridemia|hypertriglyceridemia
5560028|NCT01047501|omega-3 fatty acids|omega-3 fatty acids
5560029|NCT01047501|statin|statin
5560030|NCT01047501|triglycerides|triglycerides
5560031|NCT01047501|lipids|lipids
5560032|NCT01047501|EPA|epa
5560033|NCT01047501|docosahexaenoic acid|docosahexaenoic acid
5560034|NCT01047501|fish|fish
5560035|NCT01047501|fatty acids|fatty acids
5560036|NCT01047501|fibrates|fibrates
5560037|NCT01047501|niacin|niacin
5560038|NCT01047501|lipid|lipid
5560039|NCT01047501|atorvastatin|atorvastatin
5560040|NCT01047501|Lovaza|lovaza
5560041|NCT01047501|simvastatin|simvastatin
5560042|NCT01047501|lovastatin|lovastatin
5560043|NCT01047501|pravastatin|pravastatin
5560044|NCT01047501|fluvastatin|fluvastatin
5560045|NCT01047501|rosuvastatin|rosuvastatin
5560046|NCT01047501|Trilipix|trilipix
5560047|NCT01047501|Vytorin|vytorin
5560048|NCT01047501|Simcor|simcor
5560049|NCT01047501|Niaspan|niaspan
5560050|NCT01047501|ezetimibe|ezetimibe
5560051|NCT01047501|Zetia|zetia
5560052|NCT01047501|ethyl-EPA|ethyl-epa
5560053|NCT01047501|ethyl icosapentate|ethyl icosapentate
5560054|NCT01047501|Crestor|crestor
5560055|NCT01047501|Zocor|zocor
5560056|NCT01047501|Lipitor|lipitor
5560057|NCT01047501|LDL|ldl
5560058|NCT01047501|HDL|hdl
5560059|NCT01047501|cholesterol|cholesterol
5560060|NCT01047501|dyslipidemia|dyslipidemia
5560061|NCT01047501|VASCEPA|vascepa
5560062|NCT01047501|icosapent ethyl|icosapent ethyl
5560063|NCT01047488|polyneuropathy|polyneuropathy
5560064|NCT01047488|neuropathic pain|neuropathic pain
5560065|NCT01047488|treatment|treatment
5560066|NCT01047475|MB-6|mb-6
5560067|NCT01047475|FOLFOX4|folfox4
5560068|NCT01047475|Metastatic Colorectal Cancer|metastatic colorectal cancer
5560069|NCT01047449|saphenous vein graft patency|saphenous vein graft patency
5560070|NCT01047449|fish oil supplementation|fish oil supplementation
5560071|NCT01047449|coronary artery bypass surgery|coronary artery bypass surgery
5560072|NCT01047449|coronary artery disease|coronary artery disease
5560073|NCT01047436|Plasmodium infections|plasmodium infections
5560074|NCT01047436|Remittent fever|remittent fever
5560075|NCT01047436|Artemether|artemether
5560076|NCT01047436|Artemisinins|artemisinins
5560078|NCT01047436|Malaria|malaria
5560079|NCT01047436|Protozoan Infections|protozoan infections
5560080|NCT01047436|Anti-Infective Agents|anti-infective agents
5560081|NCT01047436|Antiprotozoal Agents|antiprotozoal agents
5560082|NCT01047436|Schistosomicides|schistosomicides
5560083|NCT01047436|Pharmacologic Actions|pharmacologic actions
5560084|NCT01047436|Malaria, Falciparum|malaria, falciparum
5560085|NCT01047436|Antimalarials|antimalarials
5560086|NCT01047436|Antiparasitic Agents|antiparasitic agents
5560087|NCT01047436|Parasitic Diseases|parasitic diseases
5560088|NCT01047436|sublingual|sublingual
5560089|NCT01047423|Hypertension endothelial dysfunction statin prevention|hypertension endothelial dysfunction statin prevention
5560090|NCT01047410|physical exercise training|physical exercise training
5560091|NCT01047410|quality of life|quality of life
5560092|NCT01047410|exercise capacity|exercise capacity
5560093|NCT01047410|skeletal muscle strength|skeletal muscle strength
5560094|NCT01047410|physical activity level|physical activity level
5560095|NCT01047410|costeffectiveness|costeffectiveness
5560096|NCT01047410|renal transplantation|renal transplantation
5560097|NCT01047410|hemodialysis|hemodialysis
5560098|NCT01047410|peritoneal dialysis|peritoneal dialysis
5560099|NCT01047410|diet|diet
5560100|NCT01047397|hemodialysis|hemodialysis
5560101|NCT01047397|tolerability|tolerability
5560102|NCT01047397|pharmacokinetics|pharmacokinetics
5560103|NCT01047397|safety|safety
5560104|NCT01047397|anemia|anemia
5560105|NCT01047397|renal impairment|renal impairment
5560106|NCT01047397|repeat dose|repeat dose
5560107|NCT01047345|Cervical cancer|cervical cancer
5560108|NCT01047345|Genital warts|genital warts
5560109|NCT01047345|Human papillomavirus vaccine|human papillomavirus vaccine
5560110|NCT01047345|GARDASIL™|gardasil™
5560111|NCT01047319|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5560112|NCT01047293|colorectal cancer|colorectal cancer
5560113|NCT01047280|Conjugated linoleic acid|conjugated linoleic acid
5560114|NCT01047280|Body weight|body weight
5560115|NCT01047280|Body composition|body composition
5560116|NCT01047280|Blood lipid profile|blood lipid profile
5560117|NCT01047280|Body inflammatory and oxidative status|body inflammatory and oxidative status
5560118|NCT01047267|candidiasis|candidiasis
5560119|NCT01047267|invasive fungal disease|invasive fungal disease
5560121|NCT01047267|anidulafungin|anidulafungin
5560122|NCT01047267|pharmacokinetics|pharmacokinetics
5560123|NCT01047241|Painful medical procedures|painful medical procedures
5560124|NCT01047215|schizophrenia|schizophrenia
5560125|NCT01047215|bipolar|bipolar
5560126|NCT01047215|aripiprazole|aripiprazole
5560127|NCT01047215|quetiapine|quetiapine
5560128|NCT01047189|Mild to moderate acne vulgaris|mild to moderate acne vulgaris
5560129|NCT01047176|Statins|statins
5560130|NCT01047176|Coronary Heart Disease|coronary heart disease
5560131|NCT01047176|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5560132|NCT01047163|Muscle soreness|muscle soreness
5560133|NCT01047163|Simvastatin|simvastatin
5560135|NCT01047163|Muscle Atrophy|muscle atrophy
5560136|NCT01047150|Myocardial Perfusion Imaging|myocardial perfusion imaging
5560137|NCT01047150|Repeat studies|repeat studies
5560138|NCT01047150|Tetrofosmin|tetrofosmin
5560139|NCT01047150|Sestamibi|sestamibi
5560140|NCT01047137|Urticaria|urticaria
5560141|NCT01047137|Hives|hives
5560142|NCT01047137|Stress|stress
5560143|NCT01047137|Immune dysregulation|immune dysregulation
5560144|NCT01047124|Depression|depression
5560145|NCT01047124|Collaborative Care|collaborative care
5560146|NCT01047124|Cognitive Behaviour Therapy|cognitive behaviour therapy
5560147|NCT01047124|Mental Health Services|mental health services
5560148|NCT01047124|Antidepressants|antidepressants
5560149|NCT01047111|Esophageal Neoplasms|esophageal neoplasms
5560150|NCT01047111|Esophagectomy|esophagectomy
5560151|NCT01047098|Lactation|lactation
5560152|NCT01047098|Breastfeeding|breastfeeding
5560153|NCT01047098|Iron|iron
5560154|NCT01047098|Oxidative stress|oxidative stress
5560155|NCT01047098|Iron status and oxidative stress during lactation|iron status and oxidative stress during lactation
5560156|NCT01047085|cholecystolithiasis|cholecystolithiasis
5560157|NCT01047085|cholecystectomy|cholecystectomy
5560158|NCT01047085|gastroesophageal reflux|gastroesophageal reflux
5560159|NCT01047085|impedance pH|impedance ph
5560160|NCT01047085|The relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance pH-method.|the relationship between cholecystolithiasis, cholecystectomy and gastroesophageal reflux by impedance ph-method.
5560161|NCT01047072|Scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation|scleroderma, systemic sclerosis, allogeneic hematopoietic stem cell transplantation
5560162|NCT01047059|NSCLC|nsclc
5560163|NCT01047059|Lung Cancer|lung cancer
5560164|NCT01047046|SNM device|snm device
5560165|NCT01047046|Chart review of patients with surgical placed SNM device|chart review of patients with surgical placed snm device
5560166|NCT01047033|Poverty|poverty
5560167|NCT01047033|Global health|global health
5560168|NCT01047033|International health|international health
5560169|NCT01047033|Latin America|latin america
5560171|NCT01047033|Child health|child health
5560172|NCT01047033|Microcredit|microcredit
5560173|NCT01047033|Microenterprise|microenterprise
5560174|NCT01047033|Microfinance|microfinance
5560175|NCT01047020|Impairments of musculoskeletal Health;|impairments of musculoskeletal health;
5560176|NCT01047020|Physical activity;|physical activity;
5671982|NCT00613288|acute|acute
5560177|NCT01047020|Motor Proficiency;|motor proficiency;
5560178|NCT01047007|Head and Neck Cancer|head and neck cancer
5560179|NCT01047007|Esophageal Cancer|esophageal cancer
5560180|NCT01047007|Gastric Cancer|gastric cancer
5560181|NCT01046981|Surgical site infections|surgical site infections
5560182|NCT01046981|Prevention|prevention
5560183|NCT01046981|Prophylaxis|prophylaxis
5560184|NCT01046981|Tumescent|tumescent
5560185|NCT01046981|Intravenous|intravenous
5560186|NCT01046981|Antibiotic|antibiotic
5560187|NCT01046981|Absorption|absorption
5560188|NCT01046981|Pharmacokinetics|pharmacokinetics
5560189|NCT01046981|Bioavailability|bioavailability
5560190|NCT01046968|Obesity|obesity
5560191|NCT01046968|metabolic syndrome|metabolic syndrome
5560192|NCT01046968|C-reactive protein|c-reactive protein
5560193|NCT01046968|Leptin|leptin
5560194|NCT01046955|ESRD|esrd
5560195|NCT01046942|Saphenous vein|saphenous vein
5560196|NCT01046942|Antiplatelet therapy|antiplatelet therapy
5560197|NCT01046942|Hypercoagulable|hypercoagulable
5560198|NCT01046942|Clopidogrel resistance|clopidogrel resistance
5560199|NCT01046942|Aspirin resistance|aspirin resistance
5560200|NCT01046942|Clopidogrel|clopidogrel
5560201|NCT01046942|Aspirin|aspirin
5560202|NCT01046942|Saphenous vein graft disease|saphenous vein graft disease
5560203|NCT01046942|TEG|teg
5560204|NCT01046942|Thrombelastography|thrombelastography
5560205|NCT01046942|Multiplate aggregometry|multiplate aggregometry
5560206|NCT01046942|Multislice CT|multislice ct
5560207|NCT01046942|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5560208|NCT01046942|coagulation status|coagulation status
5560209|NCT01046942|graft patency|graft patency
5560210|NCT01046942|CABG|cabg
5560211|NCT01046929|limonene|limonene
5560212|NCT01046929|breast cancer|breast cancer
5560213|NCT01046929|cancer prevention|cancer prevention
5560214|NCT01046903|observational prolonged thromboprophylaxis|observational prolonged thromboprophylaxis
5560215|NCT01046890|Darunavir|darunavir
5560216|NCT01046890|Echinacea purpurea|echinacea purpurea
5560217|NCT01046890|Interaction|interaction
5560218|NCT01046890|Complementary Therapies|complementary therapies
5560219|NCT01046864|Gastro-Intestinal Cancer, NOS|gastro-intestinal cancer, nos
5560220|NCT01046838|Diastolic Heart Failure|diastolic heart failure
5560221|NCT01046825|Lymphoma|lymphoma
5560222|NCT01046825|Leukemia|leukemia
5560223|NCT01046825|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5560224|NCT01046812|questionnaire|questionnaire
5560225|NCT01046812|halitosis|halitosis
5560226|NCT01046812|caphosol|caphosol
5560227|NCT01046812|Quality of life questionnaire assessing halitosis|quality of life questionnaire assessing halitosis
5560228|NCT01046799|hepatitis B|hepatitis b
5560229|NCT01046799|liver transplantation|liver transplantation
5560230|NCT01046799|shortterm HBIg|shortterm hbig
5560231|NCT01046799|lamivudine resistance|lamivudine resistance
5560232|NCT01046786|spinal cord injury|spinal cord injury
5560233|NCT01046786|cord blood mononuclear cell|cord blood mononuclear cell
5560234|NCT01046786|Methylprednisolone|methylprednisolone
5560235|NCT01046786|Lithium Carbonate|lithium carbonate
5560236|NCT01046773|Children|children
5560237|NCT01046773|Crohn's disease|crohn's disease
5560238|NCT01046773|Vitamin D|vitamin d
5560239|NCT01046760|epilepsy|epilepsy
5560240|NCT01046760|language|language
5560241|NCT01046760|childhood|childhood
5560242|NCT01046760|praxis|praxis
5560243|NCT01046747|external fixation|external fixation
5560244|NCT01046747|pin tract infection|pin tract infection
5560245|NCT01046747|self drilling|self drilling
5560246|NCT01046734|Influenza|influenza
5560247|NCT01046734|virus shedding|virus shedding
5560248|NCT01046734|infection control|infection control
5560249|NCT01046734|swine flu|swine flu
5560250|NCT01046721|blood pressure|blood pressure
5560251|NCT01046721|superior mesenteric artery blood flow|superior mesenteric artery blood flow
5560252|NCT01046721|cardiovascular effects|cardiovascular effects
5560253|NCT01046721|Exenatide|exenatide
5560254|NCT01046708|IUI|iui
5560255|NCT01046708|clomiphene citrate|clomiphene citrate
5560256|NCT01046708|utrogestan|utrogestan
5560257|NCT01046695|VATS|vats
5560258|NCT01046695|Video-Assisted Thoracotomy|video-assisted thoracotomy
5560259|NCT01046695|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5560260|NCT01046682|HIV|hiv
5560261|NCT01046682|Endothelial dysfunction|endothelial dysfunction
5560262|NCT01046682|Inflammation|inflammation
5560263|NCT01046682|Insulin resistance|insulin resistance
5560264|NCT01046656|nosocomial infection|nosocomial infection
5560265|NCT01046656|diarrhea|diarrhea
5560266|NCT01046656|Lactobacillus reuteri|lactobacillus reuteri
5560267|NCT01046656|gastroenteritis|gastroenteritis
5560268|NCT01046656|rotavirus|rotavirus
5560270|NCT01046643|Healthy|healthy
5560271|NCT01046643|Menopausal|menopausal
5560272|NCT01046643|Hormone treatment|hormone treatment
5560273|NCT01046630|Phase I|phase i
5560274|NCT01046630|BOLD signal|bold signal
5560275|NCT01046630|fMRI|fmri
5560276|NCT01046630|AZD6765|azd6765
5560277|NCT01046630|BOLD signal measured by fMRI|bold signal measured by fmri
5560278|NCT01046617|infantile colic|infantile colic
5560279|NCT01046617|Lactobacillus reuteri|lactobacillus reuteri
5560280|NCT01046617|duration of crying|duration of crying
5560281|NCT01046604|mitral valve regurgitation|mitral valve regurgitation
5560282|NCT01046604|omega 3 fatty acids|omega 3 fatty acids
5560283|NCT01046604|fish oil|fish oil
5560284|NCT01046604|cardiac|cardiac
5560285|NCT01046604|mitochondria|mitochondria
5560286|NCT01046604|apoptosis|apoptosis
5560287|NCT01046604|human heart|human heart
5560288|NCT01046591|Cleft Palate|cleft palate
5560289|NCT01046591|Cleft Lip|cleft lip
5560290|NCT01046591|Obstructive Sleep Apnea|obstructive sleep apnea
5560291|NCT01046591|Sleep-Disordered Breathing|sleep-disordered breathing
5560292|NCT01046591|Behavior|behavior
5560293|NCT01046591|Learning|learning
5560294|NCT01046578|Folliculogenesis|folliculogenesis
5560295|NCT01046578|Letrozole|letrozole
5560296|NCT01046578|Aromatase Inhibitor|aromatase inhibitor
5560297|NCT01046578|Estrogen|estrogen
5560298|NCT01046552|Choledocholithias|choledocholithias
5560299|NCT01046552|Common bile duct stones|common bile duct stones
5560300|NCT01046552|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5560301|NCT01046552|endoscopic sphincterotomy|endoscopic sphincterotomy
5560302|NCT01046552|Preoperative|preoperative
5560303|NCT01046552|intraoperative|intraoperative
5560304|NCT01046552|Laparoscopic common bile duct exploration|laparoscopic common bile duct exploration
5560305|NCT01046526|Psychopathology|psychopathology
5560306|NCT01046526|Nicotine Patch|nicotine patch
5560307|NCT01046526|Eye Tracking|eye tracking
5560308|NCT01046526|Attention|attention
5560309|NCT01046526|Schizophrenic Participants|schizophrenic participants
5560310|NCT01046513|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5560311|NCT01046513|Neuroimaging|neuroimaging
5560312|NCT01046513|Positron Emission Tomography (PET)|positron emission tomography (pet)
5560313|NCT01046513|Alpha4beta2|alpha4beta2
5560314|NCT01046513|Nicotine|nicotine
5560315|NCT01046513|Receptor Upregulation|receptor upregulation
5560316|NCT01046500|insulin resistance|insulin resistance
5560317|NCT01046500|body mass index|body mass index
5560318|NCT01046500|myo-inositol|myo-inositol
5560319|NCT01046500|serum triglycerides and cholesterol|serum triglycerides and cholesterol
5560320|NCT01046500|blood pressure|blood pressure
5560321|NCT01046500|metformin|metformin
5560322|NCT01046487|dermatofibrosarcoma|dermatofibrosarcoma
5560323|NCT01046487|cylindroma|cylindroma
5560324|NCT01046487|choroid melanoma|choroid melanoma
5560325|NCT01046487|gastrointestinal stroma tumor|gastrointestinal stroma tumor
5560326|NCT01046487|chordoma|chordoma
5560327|NCT01046487|ocular melanoma|ocular melanoma
5560328|NCT01046487|conjunctival melanoma|conjunctival melanoma
5560329|NCT01046487|malignant melanoma of the anus|malignant melanoma of the anus
5560330|NCT01046487|gastric melanoma|gastric melanoma
5560331|NCT01046487|desmoid tumor|desmoid tumor
5560332|NCT01046474|school children|school children
5560333|NCT01046474|body mass index|body mass index
5560334|NCT01046474|sugar intake|sugar intake
5560335|NCT01046474|beverage intake|beverage intake
5560336|NCT01046461|Ramosetron|ramosetron
5560337|NCT01046461|aprepitant|aprepitant
5560338|NCT01046461|dexamethasone|dexamethasone
5560339|NCT01046461|cancer|cancer
5560340|NCT01046461|chemotherapy|chemotherapy
5560341|NCT01046461|antiemetics|antiemetics
5560342|NCT01046461|cisplatin|cisplatin
5560343|NCT01046461|nausea|nausea
5560344|NCT01046461|vomiting|vomiting
5560345|NCT01046461|high dose cisplatin|high dose cisplatin
5560346|NCT01046448|Children|children
5560347|NCT01046448|chronic renal failure|chronic renal failure
5560348|NCT01046448|chronic kidney disease|chronic kidney disease
5560349|NCT01046448|cardiovascular disease|cardiovascular disease
5560350|NCT01046448|cardiovascular morbidity|cardiovascular morbidity
5560351|NCT01046448|left ventricular hypertrophy|left ventricular hypertrophy
5560352|NCT01046448|carotid intima media thickness|carotid intima media thickness
5560353|NCT01046448|arterial stiffness|arterial stiffness
5560354|NCT01046448|pulse wave velocity|pulse wave velocity
5560355|NCT01046448|augmentation index|augmentation index
5560356|NCT01046448|left ventricular cardiac function|left ventricular cardiac function
5560357|NCT01046448|progression|progression
5560358|NCT01046448|genetic risk factors|genetic risk factors
5560359|NCT01046448|vasculopathy|vasculopathy
5560360|NCT01046448|cardiopathy|cardiopathy
5560361|NCT01046448|whole genome analysis|whole genome analysis
5560362|NCT01046448|haplotype analysis|haplotype analysis
5560363|NCT01046448|SNP-screening|snp-screening
5560364|NCT01046435|periodontitis|periodontitis
5560365|NCT01046435|cardiovascular disease|cardiovascular disease
5560366|NCT01046435|diabetes|diabetes
5560367|NCT01046409|Coronary artery disease|coronary artery disease
5560370|NCT01046409|Myocardial ischemia|myocardial ischemia
5560371|NCT01046409|Collateral|collateral
5560372|NCT01046383|NON-SMALL CELL LUNG CANCER PATIENTS|non-small cell lung cancer patients
5560373|NCT01046383|WEIGHT LOSS|weight loss
5560374|NCT01046383|QUALITY OF LIFE|quality of life
5560375|NCT01046383|SURVIVAL|survival
5560376|NCT01046383|CHEMOTHERAPY|chemotherapy
5560377|NCT01046383|RADIOTHERAPY|radiotherapy
5560378|NCT01046383|SURGERY|surgery
5560379|NCT01046383|CYSTEINE-RICH WHEY PROTEIN ISOLATE|cysteine-rich whey protein isolate
5560380|NCT01046383|IMN1207|imn1207
5560381|NCT01046383|CANCER-RELATED WASTING (CACHEXIA)|cancer-related wasting (cachexia)
5560382|NCT01046383|BODY WEIGHT|body weight
5560383|NCT01046383|NUTRITIONAL PROTEIN SUPPLEMENT|nutritional protein supplement
5560384|NCT01046357|First in human|first in human
5560385|NCT01046357|Safety|safety
5560386|NCT01046305|Chronic Myeloid Leukemia|chronic myeloid leukemia
5560388|NCT01046305|Symptom Burden|symptom burden
5560389|NCT01046305|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5560390|NCT01046305|MDASI-CML|mdasi-cml
5560391|NCT01046305|Severity|severity
5560392|NCT01046305|Interference|interference
5560393|NCT01046305|Questionnaire|questionnaire
5560394|NCT01046305|Interview|interview
5560395|NCT01046292|Gait, Ginkgo biloba, mild cognitive impairment|gait, ginkgo biloba, mild cognitive impairment
5846763|NCT00043433|HCC|hcc
5560396|NCT01046253|Bioequivalence|bioequivalence
5560397|NCT01046253|Healthy Subjects|healthy subjects
5560398|NCT01046240|chemotherapy|chemotherapy
5560400|NCT01046240|palonosetron|palonosetron
5560401|NCT01046227|Serology|serology
5560402|NCT01046227|Monovalent inactivated H1N1 vaccine|monovalent inactivated h1n1 vaccine
5560403|NCT01046227|Pediatric haemato-oncology patients|pediatric haemato-oncology patients
5560404|NCT01046188|Education|education
5560405|NCT01046188|Internet|internet
5560406|NCT01046188|In vitro fertilization|in vitro fertilization
5560407|NCT01046175|Respiratory complications|respiratory complications
5560408|NCT01046175|respiratory insufficiency|respiratory insufficiency
5560409|NCT01046175|respiratory therapy|respiratory therapy
5560410|NCT01046162|Alprazolam|alprazolam
5560411|NCT01046162|Tafil|tafil
5560412|NCT01046162|Xanax|xanax
5560413|NCT01046162|Bioequivalence|bioequivalence
5560414|NCT01046162|Drug Kinetics|drug kinetics
5560415|NCT01046149|Depression|depression
5560416|NCT01046149|Depressive Symptoms|depressive symptoms
5560418|NCT01046149|RSA biofeedback|rsa biofeedback
5560419|NCT01046136|common cold|common cold
5560420|NCT01046097|Pneumococcal vaccine|pneumococcal vaccine
5560421|NCT01046084|Bioequivalence|bioequivalence
5560422|NCT01046084|Healthy Subjects|healthy subjects
5560423|NCT01046071|Transversus abdominis plane block, postoperative pain.|transversus abdominis plane block, postoperative pain.
5560424|NCT01046058|TMC435-TiDP16-C113|tmc435-tidp16-c113
5560425|NCT01046058|TMC435-C113|tmc435-c113
5560426|NCT01046058|TMC435|tmc435
5560427|NCT01046058|HCV|hcv
5560428|NCT01046058|Protease Inhibitor|protease inhibitor
5560429|NCT01046058|Hepatitis C|hepatitis c
5560430|NCT01046045|mammalian target-of-rapamycin inhibitors|mammalian target-of-rapamycin inhibitors
5560431|NCT01046045|chronic allograft dysfunction|chronic allograft dysfunction
5560432|NCT01046045|everolimus|everolimus
5560433|NCT01046045|calcineurin inhibitors|calcineurin inhibitors
5560434|NCT01046032|Polycystic ovaries|polycystic ovaries
5560435|NCT01046032|Ovarian stimulation|ovarian stimulation
5560436|NCT01046032|IVF|ivf
5560437|NCT01046032|Ovarian hyperstimulation|ovarian hyperstimulation
5560438|NCT01046032|Metformin|metformin
5560439|NCT01046019|DXA|dxa
5560440|NCT01046019|Hip|hip
5560441|NCT01046019|Arthroplasty|arthroplasty
5560442|NCT01046006|lymphoma|lymphoma
5560443|NCT01046006|Bortezomib|bortezomib
5560444|NCT01046006|Rituximab|rituximab
5560445|NCT01045993|Pilot Study to Assess Methodologies|pilot study to assess methodologies
5560446|NCT01045980|Peritoneal dialysis|peritoneal dialysis
5560447|NCT01045980|Impedance, bioelectric|impedance, bioelectric
5560448|NCT01045980|Hypertrophy, left ventricular|hypertrophy, left ventricular
5560449|NCT01045980|Fluid status|fluid status
5560450|NCT01045980|Volume overload|volume overload
5560451|NCT01045980|Congestive heart failure|congestive heart failure
5560452|NCT01045980|Cardiovascular outcomes|cardiovascular outcomes
5560453|NCT01045980|Randomized controlled trial|randomized controlled trial
5560454|NCT01045967|Bioequivalence|bioequivalence
5560455|NCT01045967|Healthy Subjects|healthy subjects
5560456|NCT01045954|diabetes mellitus type 1|diabetes mellitus type 1
5560457|NCT01045954|continuous glucose monitoring|continuous glucose monitoring
5560458|NCT01045941|Distal Pancreas|distal pancreas
5560459|NCT01045941|Adenocarcinoma|adenocarcinoma
5560460|NCT01045941|Laparoscopic|laparoscopic
5560461|NCT01045941|Gemcitabine|gemcitabine
5560462|NCT01045915|Stage IIIB, stage IIIC or stage IV melanoma|stage iiib, stage iiic or stage iv melanoma
5560463|NCT01045915|Progressive melanoma not responding to previous treatments|progressive melanoma not responding to previous treatments
5560464|NCT01045902|Pulmonary Abscess|pulmonary abscess
5560465|NCT01045902|Aspiration Pneumonia|aspiration pneumonia
5560467|NCT01045889|non hodgkin lymphoma|non hodgkin lymphoma
5560468|NCT01045889|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5560469|NCT01045876|Randomized controlled trial|randomized controlled trial
5560470|NCT01045876|Dexamethasone|dexamethasone
5560471|NCT01045876|Single dose|single dose
5730949|NCT00390845|P38|p38
5560472|NCT01045876|Preoperative|preoperative
5560473|NCT01045876|Plasma Cortisol level|plasma cortisol level
5560474|NCT01045863|volunteer|volunteer
5560475|NCT01045850|coronary stents|coronary stents
5560476|NCT01045850|non cardiac surgery|non cardiac surgery
5560477|NCT01045850|cardiovascular complications|cardiovascular complications
5560478|NCT01045850|hemorrhagic complications|hemorrhagic complications
5560479|NCT01045850|antiplatelet agents|antiplatelet agents
5560480|NCT01045850|bare metal stent|bare metal stent
5560481|NCT01045850|drug eluting stent|drug eluting stent
5560482|NCT01045850|surgery|surgery
5560483|NCT01045837|Celiac disease, steroids, immunohistochemistry|celiac disease, steroids, immunohistochemistry
5560484|NCT01045824|Schizophrenia|schizophrenia
5560485|NCT01045824|DNA|dna
5560486|NCT01045824|MRI|mri
5560487|NCT01045811|Depression|depression
5560488|NCT01045811|Depressive Symptoms|depressive symptoms
5560489|NCT01045811|postmenopause|postmenopause
5560490|NCT01045811|RSA biofeedback|rsa biofeedback
5560491|NCT01045798|Candidiasis|candidiasis
5560492|NCT01045798|Invasive Candidiasis|invasive candidiasis
5560493|NCT01045798|Fungal Infection|fungal infection
5560494|NCT01045798|Empirical Therapy|empirical therapy
5560495|NCT01045785|aspirin resistance, platelet function assay, dialysis, end stage renal disease|aspirin resistance, platelet function assay, dialysis, end stage renal disease
5560496|NCT01045772|Schnitler syndrome, Muckle-Wells syndrome, anti-IL-1|schnitler syndrome, muckle-wells syndrome, anti-il-1
5560497|NCT01045759|VENOUS THROMBOSIS|venous thrombosis
5560498|NCT01045759|ultrasonography|ultrasonography
5560499|NCT01045759|intensive care unit|intensive care unit
5560500|NCT01045746|whole-body vibration|whole-body vibration
5560501|NCT01045746|stochastic resonance Therapy|stochastic resonance therapy
5560502|NCT01045746|static balance|static balance
5560503|NCT01045746|balance, mobility|balance, mobility
5560504|NCT01045746|elderly, reaction time|elderly, reaction time
5560608|NCT01045317|pharmacokinetics|pharmacokinetics
5560505|NCT01045746|The focus of the study is effect of SRT on postural balance|the focus of the study is effect of srt on postural balance
5560506|NCT01045733|Cataract|cataract
5560507|NCT01045733|Toric|toric
5560508|NCT01045733|IOL|iol
5560509|NCT01045733|AcrySof|acrysof
5560510|NCT01045733|LRI|lri
5560511|NCT01045733|Astigmatism|astigmatism
5560512|NCT01045720|Schizophrenia|schizophrenia
5560513|NCT01045720|clozapine|clozapine
5560514|NCT01045720|hypersalivation|hypersalivation
5560515|NCT01045720|Suo Quan Wan|suo quan wan
5560516|NCT01045720|Wu Lin San|wu lin san
5560517|NCT01045694|Carpometacarpal Joints|carpometacarpal joints
5560518|NCT01045694|Osteoarthritis|osteoarthritis
5560519|NCT01045694|Basal thumb joint arthritis|basal thumb joint arthritis
5560520|NCT01045694|Trapeziometacarpal arthritis|trapeziometacarpal arthritis
5560521|NCT01045681|Multiple Myeloma|multiple myeloma
5560522|NCT01045681|Elderly patients|elderly patients
5560523|NCT01045681|first relapse|first relapse
5560524|NCT01045681|refractory to first line therapy|refractory to first line therapy
5560525|NCT01045681|Bendamustine Velcade Dexamethasone Association|bendamustine velcade dexamethasone association
5560526|NCT01045655|Depression|depression
5560527|NCT01045655|Perinatal care|perinatal care
5560528|NCT01045655|Postpartum period|postpartum period
5560529|NCT01045655|Pregnancy|pregnancy
5560530|NCT01045655|Female|female
5560531|NCT01045655|Low-income population|low-income population
5560532|NCT01045642|Bioequivalence|bioequivalence
5560533|NCT01045642|Omeprazole|omeprazole
5560534|NCT01045642|Crossover|crossover
5560535|NCT01045629|schizophrenia|schizophrenia
5560536|NCT01045629|PANSS|panss
5560537|NCT01045603|Instanyl|instanyl
5560538|NCT01045603|non-interventional|non-interventional
5560539|NCT01045603|breakthrough cancer pain|breakthrough cancer pain
5560540|NCT01045603|BTP|btp
5560541|NCT01045603|BTCP|btcp
5560542|NCT01045603|Intranasal fentanyl spray|intranasal fentanyl spray
5560543|NCT01045577|Severe Psoriasis|severe psoriasis
5560544|NCT01045577|Kinase Inhibitor|kinase inhibitor
5560545|NCT01045577|Masitinib|masitinib
5560546|NCT01045564|Immunogenicity|immunogenicity
5560547|NCT01045564|Vaccines|vaccines
5560548|NCT01045564|H5N1|h5n1
5560549|NCT01045564|Influenza|influenza
5560550|NCT01045564|Pandemic|pandemic
5560551|NCT01045564|Human|human
5560552|NCT01045564|Avian|avian
5560553|NCT01045564|Safety|safety
5560554|NCT01045551|Inflammatory rosacea|inflammatory rosacea
5560555|NCT01045551|Papules and pustules|papules and pustules
5560556|NCT01045551|Moderate to severe erythema|moderate to severe erythema
5560557|NCT01045551|Telangiectasia|telangiectasia
5560558|NCT01045538|gastric cancer|gastric cancer
5560559|NCT01045538|histone deacetylase inhibitor|histone deacetylase inhibitor
5560560|NCT01045538|1st line chemotherapy|1st line chemotherapy
5560561|NCT01045525|Phlebotomy|phlebotomy
5560562|NCT01045525|Dysmetabolic liversiderosis|dysmetabolic liversiderosis
5560563|NCT01045525|Hepatic Iron overload|hepatic iron overload
5560564|NCT01045512|immunosenescence|immunosenescence
5560565|NCT01045512|heart rate variability|heart rate variability
5904048|NCT00007813|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5560566|NCT01045512|autonomic nervous system|autonomic nervous system
5560567|NCT01045512|ageing|ageing
5560568|NCT01045512|inflammatory/pathogen burden|inflammatory/pathogen burden
5560569|NCT01045512|physical activity|physical activity
5560570|NCT01045499|adolescent obesity surgery|adolescent obesity surgery
5560571|NCT01045499|bariatric surgery|bariatric surgery
5560572|NCT01045499|adjustable gastric banding|adjustable gastric banding
5560573|NCT01045486|Atopic dermatitis|atopic dermatitis
5560574|NCT01045486|Food allergy|food allergy
5560575|NCT01045486|Probiotics|probiotics
5560576|NCT01045473|MIS|mis
5560577|NCT01045473|Minimally Invasive Spine Surgery|minimally invasive spine surgery
5560578|NCT01045473|Fusion|fusion
5560579|NCT01045473|Spine|spine
5560580|NCT01045473|SMISS|smiss
5560581|NCT01045460|multiple myeloma|multiple myeloma
5560582|NCT01045434|Bioequivalence|bioequivalence
5560583|NCT01045434|omeprazole|omeprazole
5560584|NCT01045434|crossover|crossover
5560585|NCT01045421|NSCLC|nsclc
5560586|NCT01045421|SCLC|sclc
5560587|NCT01045421|HNSCC|hnscc
5560588|NCT01045408|Helicobacter pylori|helicobacter pylori
5560589|NCT01045408|Berry extract|berry extract
5560590|NCT01045408|Triple therapy|triple therapy
5560591|NCT01045395|Algae|algae
5560592|NCT01045395|Psoriasis|psoriasis
5560593|NCT01045395|Lipid metabolism|lipid metabolism
5560594|NCT01045395|Inflammation|inflammation
5560595|NCT01045395|Oxidative stress|oxidative stress
5560596|NCT01045382|HSC transplantation|hsc transplantation
5560597|NCT01045382|HLA-mismatched|hla-mismatched
5560598|NCT01045382|Mesenchymal stem cells|mesenchymal stem cells
5560599|NCT01045382|GVHD|gvhd
5560600|NCT01045382|co-infusion|co-infusion
5560601|NCT01045369|HIV|hiv
5560602|NCT01045369|Treatment Naive|treatment naive
5560603|NCT01045343|heart failure|heart failure
5560604|NCT01045343|home monitoring|home monitoring
5560605|NCT01045343|integrated diagnostics|integrated diagnostics
5560606|NCT01045343|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
5560607|NCT01045317|micro-dose|micro-dose
5560609|NCT01045317|open label|open label
5560610|NCT01045317|PF-04776548|pf-04776548
5560611|NCT01045278|Hepatitis C patients|hepatitis c patients
5560612|NCT01045278|Hepacivirus|hepacivirus
5560613|NCT01045252|hemodynamics|hemodynamics
5560614|NCT01045252|neonatal|neonatal
5560615|NCT01045239|Diabetic macular edema|diabetic macular edema
5560616|NCT01045239|Diabetic macular oedema|diabetic macular oedema
5560617|NCT01045239|micropulse laser|micropulse laser
5560618|NCT01045239|laser treatment|laser treatment
5560619|NCT01045239|macular thickness|macular thickness
5560620|NCT01045213|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5560621|NCT01045213|COPD|copd
5560622|NCT01045200|rectal cancer|rectal cancer
5560623|NCT01045200|follow-up|follow-up
5560624|NCT01045200|specialist nurse|specialist nurse
5560625|NCT01045187|endometrial cancer|endometrial cancer
5560626|NCT01045187|Uterine cancer|uterine cancer
5560627|NCT01045187|electronic brachytherapy|electronic brachytherapy
5560628|NCT01045187|Xoft|xoft
5560629|NCT01045174|Asthma|asthma
5560630|NCT01045174|Pediatric|pediatric
5560631|NCT01045174|Emergency department|emergency department
5560632|NCT01045174|Nebulizer|nebulizer
5560633|NCT01045161|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5560634|NCT01045161|COPD|copd
5560635|NCT01045161|Chronic Bronchitis|chronic bronchitis
5560636|NCT01045161|Emphysema|emphysema
5560637|NCT01045161|Airflow Obstruction, Chronic|airflow obstruction, chronic
5560638|NCT01045161|Chronic Airflow Obstruction|chronic airflow obstruction
5560639|NCT01045161|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5560640|NCT01045161|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5560641|NCT01045148|Prostatic Cancer|prostatic cancer
5560642|NCT01045148|Prostatic Neoplasms|prostatic neoplasms
5560643|NCT01045148|Prostate Neoplasms|prostate neoplasms
5560644|NCT01045148|Cancer of the Prostate|cancer of the prostate
5560645|NCT01045135|Pelvic organ prolapse|pelvic organ prolapse
5560646|NCT01045135|Levator hiatus|levator hiatus
5560647|NCT01045135|3 and 4 dimensional ultrasound|3 and 4 dimensional ultrasound
5560648|NCT01045122|Obstructive Sleep Apnea|obstructive sleep apnea
5560649|NCT01045109|prostate|prostate
5560650|NCT01045109|cancer|cancer
5560651|NCT01045109|vitamin D3|vitamin d3
5560652|NCT01045109|early stage|early stage
5560653|NCT01045109|active surveillance|active surveillance
5560654|NCT01045096|Gastroesophageal Reflux|gastroesophageal reflux
5560655|NCT01045096|Erosive Esophagitis|erosive esophagitis
5560656|NCT01045096|Pharmacokinetics|pharmacokinetics
5560657|NCT01045096|Pediatrics|pediatrics
5560658|NCT01045096|Drug Therapy|drug therapy
5560659|NCT01045070|periodontitis and coronary heart disease|periodontitis and coronary heart disease
5560660|NCT01045057|voice prosthesis, larynx cancer, laryngectomy|voice prosthesis, larynx cancer, laryngectomy
5560662|NCT01045044|Magnetic Resonance Imaging|magnetic resonance imaging
5560663|NCT01045044|Anthracycline based systemic chemotherapy|anthracycline based systemic chemotherapy
5560664|NCT01045044|Tumor response|tumor response
5560665|NCT01045044|Cognitive Impairment|cognitive impairment
5560666|NCT01045044|Chemo Brain|chemo brain
5560667|NCT01045031|cognitive function, aging, brain-derived neurotrophic factor|cognitive function, aging, brain-derived neurotrophic factor
5560668|NCT01045018|colitis|colitis
5560669|NCT01045018|ulcerative|ulcerative
5560670|NCT01045018|ulcerative colitis|ulcerative colitis
5560671|NCT01045005|Type 1 diabetes|type 1 diabetes
5560672|NCT01045005|Endothelial dysfunction|endothelial dysfunction
5560673|NCT01045005|Doppler Ultrasound Velocity Waveforms|doppler ultrasound velocity waveforms
5560674|NCT01044992|Multi systemic atrophy|multi systemic atrophy
5560675|NCT01044992|Parkinson Disease|parkinson disease
5560676|NCT01044992|PET investigation|pet investigation
5560677|NCT01044992|Motor control|motor control
5560678|NCT01044992|levodopa|levodopa
5560679|NCT01044992|MSA|msa
5560680|NCT01044992|Comparison with Parkinson disease and dopaminergic challenge.|comparison with parkinson disease and dopaminergic challenge.
5560681|NCT01044979|Colloid osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5560682|NCT01044979|Colloid osmotic pressure in plasma|colloid osmotic pressure in plasma
5560683|NCT01044979|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5560684|NCT01044966|Glioblastoma|glioblastoma
5560685|NCT01044966|Subventricular|subventricular
5560686|NCT01044966|gliomagenesis|gliomagenesis
5560687|NCT01044966|temozolomide|temozolomide
5560688|NCT01044966|depocyt|depocyt
5560689|NCT01044953|injury incidence|injury incidence
5560690|NCT01044953|male professional soccer|male professional soccer
5560691|NCT01044953|Change of injury incidence in professional soccer|change of injury incidence in professional soccer
5560692|NCT01044940|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5560693|NCT01044940|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
5560694|NCT01044940|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5560695|NCT01044927|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5560696|NCT01044927|telemedicine|telemedicine
5560697|NCT01044927|COPD|copd
5560698|NCT01044901|Sickle Cell Disease|sickle cell disease
5560699|NCT01044901|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5560701|NCT01044901|Pulmonary Hypertension|pulmonary hypertension
5560702|NCT01044888|Heparin responsiveness|heparin responsiveness
5560703|NCT01044888|Off-pump coronary artery bypass graft surgery|off-pump coronary artery bypass graft surgery
5560704|NCT01044888|Risk factors|risk factors
5560705|NCT01044888|Myocardial infarction|myocardial infarction
5560706|NCT01044875|Diabetic retinopathy|diabetic retinopathy
5560707|NCT01044875|Laser treatment|laser treatment
5560708|NCT01044875|Complications|complications
5560709|NCT01044875|Laser wavelength|laser wavelength
5560710|NCT01044862|Pregnancy|pregnancy
5560711|NCT01044862|Infertility|infertility
5560712|NCT01044862|Ovarian stimulation|ovarian stimulation
5560713|NCT01044862|Aromatase inhibitors|aromatase inhibitors
5560714|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone
5560715|NCT01044849|Blood Pressure|blood pressure
5560716|NCT01044836|Healthy volunteer|healthy volunteer
5560718|NCT01044823|JRA|jra
5560719|NCT01044810|HIV|hiv
5560720|NCT01044810|efavirenz|efavirenz
5560721|NCT01044810|nevirapine|nevirapine
5560722|NCT01044810|allergy|allergy
5560723|NCT01044810|rash|rash
5560724|NCT01044810|Cohort Studies, Historical|cohort studies, historical
5560725|NCT01044810|Retrospective Study|retrospective study
5560726|NCT01044810|exanthem|exanthem
5560727|NCT01044810|Antiretroviral Agents|antiretroviral agents
5560728|NCT01044810|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5560729|NCT01044810|HAART|haart
5560730|NCT01044810|treatment failure|treatment failure
5560731|NCT01044797|Healthy Volunteer|healthy volunteer
5560732|NCT01044797|Given Capsule Manipulation|given capsule manipulation
5560733|NCT01044784|CRT|crt
5560734|NCT01044771|HIV|hiv
5560735|NCT01044771|Human immunodeficiency virus|human immunodeficiency virus
5560736|NCT01044771|tenofovir|tenofovir
5560737|NCT01044771|viread|viread
5560738|NCT01044771|truvada|truvada
5560739|NCT01044771|proteinuria|proteinuria
5560740|NCT01044758|Mild Cognitive Impairment|mild cognitive impairment
5560741|NCT01044758|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5560742|NCT01044758|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5560743|NCT01044758|Levetiracetam|levetiracetam
5560744|NCT01044758|Keppra|keppra
5560745|NCT01044758|Medial Temporal Lobe|medial temporal lobe
5560746|NCT01044758|Memory Impairment|memory impairment
5560747|NCT01044758|Alzheimer's Disease|alzheimer's disease
5560748|NCT01044758|AD|ad
5560749|NCT01044732|Colorectal|colorectal
5560751|NCT01044732|Adenomas|adenomas
5560752|NCT01044732|Polyps|polyps
5560753|NCT01044732|Miss rates|miss rates
5560754|NCT01044732|Detection rates|detection rates
5560755|NCT01044732|Colonoscope|colonoscope
5560756|NCT01044732|Third Eye Retroscope|third eye retroscope
5560757|NCT01044706|Bioequivalency|bioequivalency
5904049|NCT00007813|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5560758|NCT01044693|supine Hypertension|supine hypertension
5560759|NCT01044693|autonomic failure|autonomic failure
5560760|NCT01044693|nitric oxide|nitric oxide
5560761|NCT01044693|nebivolol|nebivolol
5560762|NCT01044680|fiber|fiber
5560763|NCT01044680|metabolic syndrome|metabolic syndrome
5560764|NCT01044680|overweight|overweight
5560765|NCT01044680|satiety|satiety
5560766|NCT01044654|HIV|hiv
5560767|NCT01044654|Treatment Experienced|treatment experienced
5560768|NCT01044641|Colloid Osmotic pressure in interstitial fluid|colloid osmotic pressure in interstitial fluid
5560769|NCT01044641|Colloid Osmotic pressure in plasma|colloid osmotic pressure in plasma
5560770|NCT01044641|Protein fractions in interstitial fluid|protein fractions in interstitial fluid
5560772|NCT01044628|Oxygen therapy|oxygen therapy
5560773|NCT01044628|Nocturnal|nocturnal
5560774|NCT01044628|Desaturation|desaturation
5560775|NCT01044628|INOX|inox
5560776|NCT01044615|Mild Traumatic Brain Injury|mild traumatic brain injury
5560777|NCT01044615|Concussion|concussion
5560778|NCT01044615|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5560779|NCT01044615|Positron Emission Tomography(PET)|positron emission tomography(pet)
5560780|NCT01044615|Computed Tomography (CT)|computed tomography (ct)
5560781|NCT01044602|Obesity|obesity
5560782|NCT01044602|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5560783|NCT01044602|Roux-en-Y Gastric Bypass Surgery|roux-en-y gastric bypass surgery
5560784|NCT01044576|Multiple Sclerosis|multiple sclerosis
5560785|NCT01044563|Depression|depression
5560786|NCT01044563|Depressive Symptoms|depressive symptoms
5560787|NCT01044563|postmenopause|postmenopause
5560788|NCT01044563|RSA biofeedback|rsa biofeedback
5560789|NCT01044550|Diaphragm injury|diaphragm injury
5560790|NCT01044550|Herniation|herniation
5560791|NCT01044537|phase 1|phase 1
5560792|NCT01044537|safety and tolerability|safety and tolerability
5560793|NCT01044537|PK|pk
5560794|NCT01044537|PD|pd
5560795|NCT01044537|type 2 diabetes mellitus|type 2 diabetes mellitus
5560796|NCT01044537|T2DM|t2dm
5563462|NCT01033058|PCI|pci
5798722|NCT00111267|oral supplementation|oral supplementation
5560797|NCT01044524|14C labeled ADME (Aborption Distribution Metabolism and Elimination) study|14c labeled adme (aborption distribution metabolism and elimination) study
5560799|NCT01044511|Esophageal cancer|esophageal cancer
5560800|NCT01044511|Cardia cancer|cardia cancer
5560801|NCT01044511|Health Related quality of Life|health related quality of life
5560802|NCT01044511|SEMS|sems
5560803|NCT01044511|Home visits|home visits
5560804|NCT01044485|HER-2 positive advanced or metastatic breast cancer|her-2 positive advanced or metastatic breast cancer
5560805|NCT01044485|dose escalation study|dose escalation study
5560806|NCT01044485|lapatinib|lapatinib
5560807|NCT01044485|docetaxel|docetaxel
5560808|NCT01044472|CRT-D|crt-d
5560809|NCT01044459|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5560810|NCT01044459|COPD|copd
5560811|NCT01044459|Chronic Bronchitis|chronic bronchitis
5560812|NCT01044459|Emphysema|emphysema
5560813|NCT01044459|Airflow Obstruction, Chronic|airflow obstruction, chronic
5560814|NCT01044459|Chronic Airflow Obstruction|chronic airflow obstruction
5560815|NCT01044459|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5560816|NCT01044459|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5560817|NCT01044446|peritoneal dialysis|peritoneal dialysis
5560818|NCT01044446|peritonitis|peritonitis
5560819|NCT01044446|CAPD|capd
5560820|NCT01044446|end-stage renal disease|end-stage renal disease
5560821|NCT01044446|peritonitis outcome and ultrafiltration|peritonitis outcome and ultrafiltration
5560822|NCT01044407|respiration|respiration
5560823|NCT01044407|sleep apnea|sleep apnea
5560824|NCT01044407|pacemaker|pacemaker
5560825|NCT01044394|colonoscopy|colonoscopy
5560826|NCT01044394|bowel preparation|bowel preparation
5560827|NCT01044394|polyethylene glycol|polyethylene glycol
5560828|NCT01044394|Quality in endoscopy|quality in endoscopy
5560829|NCT01044394|Bowel Preparation for colonoscopy|bowel preparation for colonoscopy
5560830|NCT01044381|Toenail|toenail
5560831|NCT01044381|Fungal Infections|fungal infections
5560832|NCT01044381|DSO|dso
5560960|NCT01043887|Hepatic Insufficiency|hepatic insufficiency
5560833|NCT01044368|Remote Blood Glucose Monitoring System, Type 2 Diabetes|remote blood glucose monitoring system, type 2 diabetes
5560834|NCT01044355|Resistant Hypertension|resistant hypertension
5560835|NCT01044355|Obstructive Sleep Apnea|obstructive sleep apnea
5560836|NCT01044355|24 Hour Blood Pressure|24 hour blood pressure
5560837|NCT01044355|Arterial Stiffness|arterial stiffness
5560838|NCT01044355|Insulin Resistance|insulin resistance
5560839|NCT01044355|CPAP|cpap
5560840|NCT01044355|APAP|apap
5560841|NCT01044342|Healthy Volunteers|healthy volunteers
5560842|NCT01044342|EEG|eeg
5560843|NCT01044316|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5560844|NCT01044316|Vaccine|vaccine
5560845|NCT01044316|Booster|booster
5560846|NCT01044303|Kidney Transplantation|kidney transplantation
5560847|NCT01044303|Mycophenolic Acid|mycophenolic acid
5560848|NCT01044303|Donor-Specific Antibodies|donor-specific antibodies
5560849|NCT01044303|Kidney Rejection|kidney rejection
5560850|NCT01044290|quality of life|quality of life
5560851|NCT01044290|end of life|end of life
5560852|NCT01044290|self-disclosure|self-disclosure
5560853|NCT01044290|palliative care|palliative care
5560854|NCT01044277|glutathione|glutathione
5560855|NCT01044277|gluthathione peroxidases|gluthathione peroxidases
5560856|NCT01044277|GSH|gsh
5560857|NCT01044264|Acne Vulgaris|acne vulgaris
5560858|NCT01044264|bioequivalency|bioequivalency
5560859|NCT01044264|clindamycin|clindamycin
5560860|NCT01044264|benzoyl peroxide|benzoyl peroxide
5560861|NCT01044251|Medication overuse headache|medication overuse headache
5560862|NCT01044251|Rebound headache|rebound headache
5560863|NCT01044251|Analgesic overuse headache|analgesic overuse headache
5560864|NCT01044251|Transitional therapy|transitional therapy
5560865|NCT01044251|Frovatriptan|frovatriptan
5560866|NCT01044251|Migraine|migraine
5560867|NCT01044238|methamphetamine|methamphetamine
5560868|NCT01044238|methylphenidate|methylphenidate
5560869|NCT01044238|clinical trial|clinical trial
5560870|NCT01044238|random assignment|random assignment
5560871|NCT01044238|double blind|double blind
5560872|NCT01044238|abstinence|abstinence
5560873|NCT01044238|reduction in methamphetamine use|reduction in methamphetamine use
5560874|NCT01044225|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5560875|NCT01044212|Urogynecology|urogynecology
5560876|NCT01044199|rabies|rabies
5560877|NCT01044199|rabies vaccine|rabies vaccine
5560878|NCT01044199|purified cultured embryo chicken rabies vaccine|purified cultured embryo chicken rabies vaccine
5560879|NCT01044186|Deferasirox|deferasirox
5560880|NCT01044186|ICL670A|icl670a
5560881|NCT01044186|Iron chelators|iron chelators
5560882|NCT01044186|Deferiprone|deferiprone
5560883|NCT01044186|Transfusional hemosiderosis|transfusional hemosiderosis
5560884|NCT01044186|Congenital aplastic anemia (Diamond Blackfan anemia)|congenital aplastic anemia (diamond blackfan anemia)
5560885|NCT01044186|Red cell aplasia|red cell aplasia
5560886|NCT01044186|Thalassemia|thalassemia
5560887|NCT01044186|β thalassemia|β thalassemia
5560888|NCT01044173|acute abdomen|acute abdomen
5560889|NCT01044173|CT|ct
5560890|NCT01044173|MRI|mri
5560891|NCT01044173|fast imaging|fast imaging
5560892|NCT01044160|cancer as trauma in children|cancer as trauma in children
5560893|NCT01044160|PTG/PTSS/ PTSD in children with cancer vs healthy children|ptg/ptss/ ptsd in children with cancer vs healthy children
5560894|NCT01044147|Obesity|obesity
5560895|NCT01044147|Internet|internet
5560896|NCT01044121|mattress|mattress
5560897|NCT01044121|pain|pain
5560898|NCT01044121|sleep|sleep
5560899|NCT01044121|low back pain|low back pain
5560900|NCT01044121|back|back
5560901|NCT01044121|neck|neck
5560902|NCT01044121|arousal|arousal
5560903|NCT01044121|pillow|pillow
5560904|NCT01044121|kingsdown|kingsdown
5560905|NCT01044121|sleep to live|sleep to live
5560906|NCT01044121|duke university|duke university
5560907|NCT01044121|sleep to live institute|sleep to live institute
5560908|NCT01044121|missouri|missouri
5560909|NCT01044121|springfield|springfield
5560910|NCT01044121|joplin|joplin
5560911|NCT01044121|body diagnostic|body diagnostic
5560912|NCT01044121|dormo diagnostic|dormo diagnostic
5560913|NCT01044121|morning pain|morning pain
5560914|NCT01044095|seasonal influenza vaccine|seasonal influenza vaccine
5560915|NCT01044095|avian influenza H5N1|avian influenza h5n1
5560916|NCT01044095|cross reactivity|cross reactivity
5560917|NCT01044095|prime boost|prime boost
5560918|NCT01044082|Postpartum haemorrhage|postpartum haemorrhage
5560919|NCT01044082|Third stage of labour|third stage of labour
5560920|NCT01044082|Controlled cord traction|controlled cord traction
5560921|NCT01044082|Randomized controlled trial|randomized controlled trial
5560922|NCT01044082|Prevention|prevention
5560923|NCT01044069|Cyclophosphamide|cyclophosphamide
5560924|NCT01044069|T cell|t cell
5560925|NCT01044069|leukapheresis|leukapheresis
5560926|NCT01044069|stem cell transplant|stem cell transplant
5560927|NCT01044069|bone marrow transplant|bone marrow transplant
5560928|NCT01044069|09-114|09-114
5560929|NCT01044030|otitis media|otitis media
5560930|NCT01044030|ear infection|ear infection
5560931|NCT01043991|STEMI|stemi
5560932|NCT01043991|AMI,|ami,
5560933|NCT01043991|acute myocardial infarct|acute myocardial infarct
5560934|NCT01043991|Epo|epo
5560935|NCT01043991|Erythropoietin|erythropoietin
5560936|NCT01043991|ischemia-reperfusion|ischemia-reperfusion
5560937|NCT01043991|apoptosis|apoptosis
5560938|NCT01043965|Diabetes Mellitus|diabetes mellitus
5560939|NCT01043965|Myocardial perfusion imaging|myocardial perfusion imaging
5560940|NCT01043965|Heart diseases|heart diseases
5560941|NCT01043965|Echocardiography|echocardiography
5560942|NCT01043965|Endothelium|endothelium
5560943|NCT01043952|Propofol|propofol
5560944|NCT01043952|Remifentanil|remifentanil
5560945|NCT01043952|Bispectral Index Monitor|bispectral index monitor
5560946|NCT01043939|childhood cancers|childhood cancers
5554992|NCT01066663|SLL|sll
5560948|NCT01043939|childhood cancer survivor|childhood cancer survivor
5560949|NCT01043926|Hepatic Insufficiency|hepatic insufficiency
5560950|NCT01043913|Fatigue|fatigue
5560951|NCT01043913|Breast Neoplasms|breast neoplasms
5560952|NCT01043913|Quality of Life|quality of life
5560953|NCT01043913|Paullinia|paullinia
5560954|NCT01043900|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5560955|NCT01043900|rTMS|rtms
5560956|NCT01043900|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5560957|NCT01043900|treatment|treatment
5560958|NCT01043900|randomized controlled trials|randomized controlled trials
5560959|NCT01043887|Healthy Volunteers|healthy volunteers
5560961|NCT01043874|Chronic phase|chronic phase
5560962|NCT01043874|Chronic myelogenous leukemia|chronic myelogenous leukemia
5560963|NCT01043874|CML|cml
5560964|NCT01043874|Philadelphia chromosome positive|philadelphia chromosome positive
5560965|NCT01043874|Ph+|ph+
5560966|NCT01043874|Nilotinib|nilotinib
5560967|NCT01043874|CML-CP|cml-cp
5560968|NCT01043874|Suboptimal molecular response|suboptimal molecular response
5560969|NCT01043848|neurogenic detrusor overactivity|neurogenic detrusor overactivity
5560970|NCT01043848|neuromodulation|neuromodulation
5560971|NCT01043848|spinal cord injury|spinal cord injury
5560972|NCT01043848|pudendal nerve stimulation|pudendal nerve stimulation
5560973|NCT01043848|videocystometry|videocystometry
5560974|NCT01043848|neurophysiology|neurophysiology
5560975|NCT01043848|neuroplasticity|neuroplasticity
5560976|NCT01043835|Stomach Neoplasm|stomach neoplasm
5560977|NCT01043835|Laparoscopy|laparoscopy
5560978|NCT01043835|gastrectomy|gastrectomy
5560979|NCT01043822|Autism|autism
5560980|NCT01043822|mental retardation|mental retardation
5560981|NCT01043822|pain|pain
5560982|NCT01043822|emotion|emotion
5560983|NCT01043822|sensory profile|sensory profile
5560984|NCT01043822|children|children
5560985|NCT01043809|schools|schools
5560986|NCT01043809|handwashing|handwashing
5560987|NCT01043809|prevention and control|prevention and control
5560988|NCT01043809|communicable diseases|communicable diseases
5560989|NCT01043809|absenteeism|absenteeism
5560990|NCT01043796|Insecticide treated wall liners|insecticide treated wall liners
5560991|NCT01043796|Insecticide treated nets|insecticide treated nets
5560992|NCT01043796|Incidence cohort|incidence cohort
5560993|NCT01043783|Obesity|obesity
5560994|NCT01043770|Metabolic syndrome|metabolic syndrome
5560995|NCT01043770|Primary prevention|primary prevention
5560996|NCT01043770|Diabetes|diabetes
5560997|NCT01043770|Cardiovascular disease|cardiovascular disease
5560998|NCT01043770|Patient education|patient education
5560999|NCT01043757|Sedentary lifestyle|sedentary lifestyle
5561000|NCT01043757|physical exercise|physical exercise
5561001|NCT01043757|behavioral economics|behavioral economics
5561002|NCT01043757|financial incentives|financial incentives
5561003|NCT01043757|obesity|obesity
5561004|NCT01043744|malaria|malaria
5561005|NCT01043744|presumptive treatment|presumptive treatment
5561006|NCT01043744|Integrated Management of Childhood Illness|integrated management of childhood illness
5561007|NCT01043744|fever|fever
5561008|NCT01043718|Obesity|obesity
5561009|NCT01043718|Internet|internet
5561010|NCT01043705|Pacemaker infection|pacemaker infection
5561011|NCT01043705|Defibrillator infection|defibrillator infection
5561012|NCT01043705|ICD infection|icd infection
5561013|NCT01043705|CRT infection|crt infection
5561014|NCT01043705|Cardiovascular implantable electronic device infection|cardiovascular implantable electronic device infection
5561015|NCT01043705|Infection|infection
5561016|NCT01043705|Pacemaker, Artificial|pacemaker, artificial
5561017|NCT01043705|Defibrillators|defibrillators
5561018|NCT01043692|Chronic Pain > 3 months|chronic pain > 3 months
5561019|NCT01043692|Acupuncture|acupuncture
5561020|NCT01043692|Acceptability|acceptability
5561021|NCT01043692|Geriatrics|geriatrics
5561022|NCT01043679|Bipolar, Mania|bipolar, mania
5561023|NCT01043679|Utapine|utapine
5561024|NCT01043679|Seroquel|seroquel
5561025|NCT01043666|Micturition|micturition
5561026|NCT01043666|YM178|ym178
5561027|NCT01043666|Urinary incontinence|urinary incontinence
5561028|NCT01043666|Frequency|frequency
5561029|NCT01043666|Overactive Bladder|overactive bladder
5561030|NCT01043666|Urgency|urgency
5561031|NCT01043666|Urinary urge incontinence|urinary urge incontinence
5561032|NCT01043653|recovery|recovery
5561033|NCT01043653|serious mental illness|serious mental illness
5561034|NCT01043640|inherited metabolic disorders|inherited metabolic disorders
5561035|NCT01043614|Obesity|obesity
5561036|NCT01043614|Obesity Prevention|obesity prevention
5561037|NCT01043614|Freshman women|freshman women
5561038|NCT01043614|Freshman 15 weight gain|freshman 15 weight gain
5561039|NCT01043614|Self efficacy|self efficacy
5561040|NCT01043614|Activity and nutrition intervention|activity and nutrition intervention
5561041|NCT01043614|Peer education|peer education
5561042|NCT01043588|Surgery|surgery
5561043|NCT01043588|Prostate|prostate
5561044|NCT01043588|Laser 532 nm|laser 532 nm
5561045|NCT01043588|Photo selective Vaporization of the Prostate (PVP)|photo selective vaporization of the prostate (pvp)
5555021|NCT01066598|cGVHD|cgvhd
5561046|NCT01043588|TransUrethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5561048|NCT01043575|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis|rifapentine, pharmacokinetics, pharmacodynamics, tuberculosis
5561049|NCT01043549|Gilles de la Tourette syndrome|gilles de la tourette syndrome
5561050|NCT01043549|Tics|tics
5561051|NCT01043549|Transcranial magnetic stimulation|transcranial magnetic stimulation
5561052|NCT01043536|IMRT|imrt
5561053|NCT01043536|Radiotherapy escalation dose|radiotherapy escalation dose
5561054|NCT01043536|glioblastoma|glioblastoma
5561055|NCT01043536|escalation radiotherapy dose|escalation radiotherapy dose
5561056|NCT01043523|Liver neoplasms|liver neoplasms
5561057|NCT01043523|Adenoma|adenoma
5561058|NCT01043523|Liver cell carcinoma|liver cell carcinoma
5561059|NCT01043523|Hepatocellular|hepatocellular
5561060|NCT01043523|Liver abscess|liver abscess
5561061|NCT01043484|Resectable rectal cancer|resectable rectal cancer
5561062|NCT01043484|Radiotherapy|radiotherapy
5561063|NCT01043484|Bevacizumab|bevacizumab
5561064|NCT01043484|Capecitabine|capecitabine
5561065|NCT01043471|Obesity|obesity
5561066|NCT01043458|Pharmacokinetics|pharmacokinetics
5561067|NCT01043445|GPR 119|gpr 119
5561068|NCT01043445|GLP-1 secretion|glp-1 secretion
5561069|NCT01043445|2-oleoyl-glycerol|2-oleoyl-glycerol
5561070|NCT01043445|Dietary supplementation|dietary supplementation
5561071|NCT01043432|Traumatic Brain Injury|traumatic brain injury
5561072|NCT01043432|Suicide|suicide
5561073|NCT01043432|Executive Function|executive function
5561074|NCT01043419|Xenon Anesthesia|xenon anesthesia
5561075|NCT01043419|LENOXe™ (xénon 100 % v/v) anesthesia|lenoxe™ (xénon 100 % v/v) anesthesia
5561076|NCT01043419|Muscle Sympathetic Activity|muscle sympathetic activity
5561077|NCT01043419|Baroreflex reagibility|baroreflex reagibility
5561078|NCT01043406|Epilepsy|epilepsy
5561079|NCT01043406|Seizures|seizures
5561080|NCT01043406|Advisory|advisory
5561081|NCT01043406|Prediction|prediction
5561082|NCT01043393|Plaque psoriasis|plaque psoriasis
5561083|NCT01043380|Heart Diseases|heart diseases
5561084|NCT01043380|Hyperlipidemia|hyperlipidemia
5561085|NCT01043380|Atorvastatin|atorvastatin
5561086|NCT01043380|Ezetimibe|ezetimibe
5561087|NCT01043380|Cardiovascular Diseases|cardiovascular diseases
5561088|NCT01043380|Hypercholesterolemia|hypercholesterolemia
5561089|NCT01043380|Coronary Artery Disease|coronary artery disease
5561090|NCT01043380|Dyslipidemias|dyslipidemias
5561091|NCT01043380|Intravascular Ultrasound|intravascular ultrasound
5561092|NCT01043367|Depression|depression
5561101|NCT01043341|attitude|attitude
5561102|NCT01043328|human papillomavirus|human papillomavirus
5561103|NCT01043328|nested PCR|nested pcr
5561104|NCT01043328|saliva|saliva
5561105|NCT01043328|serum|serum
5561106|NCT01043328|oral tissues|oral tissues
5561107|NCT01043315|Cognitive Function|cognitive function
5561108|NCT01043315|Cognitive Impairment|cognitive impairment
5561109|NCT01043315|Hospitalization|hospitalization
5561110|NCT01043315|Cardiac Disease|cardiac disease
5561111|NCT01043302|lymphoma, intestine, outcome, quality of life|lymphoma, intestine, outcome, quality of life
5561112|NCT01043289|light therapy|light therapy
5561113|NCT01043289|antepartum depression|antepartum depression
5561114|NCT01043289|controlled trial|controlled trial
5561115|NCT01043276|Healthy|healthy
5561116|NCT01043250|schizophrenia|schizophrenia
5561117|NCT01043250|atypical antipsychotics|atypical antipsychotics
5561118|NCT01043250|appetite|appetite
5561119|NCT01043250|eating behavior|eating behavior
5561120|NCT01043237|acoustic|acoustic
5561121|NCT01043237|digital|digital
5561122|NCT01043237|sound|sound
5561123|NCT01043237|vibration|vibration
5561124|NCT01043237|coronary|coronary
5561125|NCT01043237|auscultation|auscultation
5561126|NCT01043237|artery|artery
5561127|NCT01043237|diagnosis|diagnosis
5561128|NCT01043211|Back Pain|back pain
5561129|NCT01043211|Lidocaine|lidocaine
5561130|NCT01043198|CGH array technology|cgh array technology
5561131|NCT01043198|mental retardation|mental retardation
5561132|NCT01043198|chromosomal abnormalities|chromosomal abnormalities
5561133|NCT01043198|syndromic obesity|syndromic obesity
5561134|NCT01043198|obesity|obesity
5561135|NCT01043185|GERD|gerd
5561136|NCT01043185|lesogaberan|lesogaberan
5561137|NCT01043185|impedance|impedance
5561139|NCT01043185|pharmacokinetics|pharmacokinetics
5561140|NCT01043185|safety|safety
5561141|NCT01043185|tolerability|tolerability
5561142|NCT01043146|anti-beta1 adrenergic receptor|anti-beta1 adrenergic receptor
5561143|NCT01043146|autoantibody|autoantibody
5561144|NCT01043146|cyclic peptide|cyclic peptide
5561145|NCT01043146|heart failure|heart failure
5561146|NCT01043133|electronic medical records|electronic medical records
5561147|NCT01043133|documentation templates|documentation templates
5561148|NCT01043133|clinical encounter notes|clinical encounter notes
5685391|NCT00556283|outlet obstruction|outlet obstruction
5561149|NCT01043081|African American women who have sex with women|african american women who have sex with women
5561150|NCT01043081|Sexually transmitted infections|sexually transmitted infections
5561151|NCT01043081|Homosexuality|homosexuality
5561152|NCT01043081|Human papillomavirus|human papillomavirus
5561153|NCT01043081|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5561154|NCT01043081|Herpes simplex virus types 1 and 2|herpes simplex virus types 1 and 2
5561156|NCT01043081|Gonorrhea|gonorrhea
5561157|NCT01043081|Trichomoniasis|trichomoniasis
5561158|NCT01043081|Bacterial vaginosis|bacterial vaginosis
5561159|NCT01043081|Syphilis|syphilis
5561160|NCT01043081|Human immunodeficiency virus|human immunodeficiency virus
5561161|NCT01043068|cancer pain|cancer pain
5561163|NCT01043068|guideline|guideline
5561164|NCT01043055|Breast Cancer Screening|breast cancer screening
5561165|NCT01043042|hypoglycemia among inpatients|hypoglycemia among inpatients
5561166|NCT01043042|hyperglycemia among inpatients|hyperglycemia among inpatients
5561167|NCT01043016|skin cancer|skin cancer
5561168|NCT01043016|esophageal cancer|esophageal cancer
5561169|NCT01043016|photodynamic therapy|photodynamic therapy
5561171|NCT01042990|Exercise|exercise
5561172|NCT01042990|Balance|balance
5561173|NCT01042990|Dynamic Gait|dynamic gait
5561174|NCT01042990|Cardiovascular Fitness|cardiovascular fitness
5561175|NCT01042977|dapagliflozin|dapagliflozin
5561176|NCT01042977|diabetes|diabetes
5561177|NCT01042977|cardiovascular disease|cardiovascular disease
5561178|NCT01042964|platelet adhesion and aggregation|platelet adhesion and aggregation
5561179|NCT01042964|acute coronary syndrome|acute coronary syndrome
5561180|NCT01042964|myocardial infarction|myocardial infarction
5561181|NCT01042964|stroke|stroke
5561182|NCT01042964|inhibition of platelet adhesion to plaques|inhibition of platelet adhesion to plaques
5561183|NCT01042964|collagen-induced platelet aggregation|collagen-induced platelet aggregation
5561184|NCT01042951|safety|safety
5561185|NCT01042951|immunogenicity|immunogenicity
5561186|NCT01042951|Healthy Participants|healthy participants
5543490|NCT01113463|CNS|cns
5563826|NCT01031862|reverse cholesterol transport|reverse cholesterol transport
5561187|NCT01042938|Radiation dermatitis in breast cancer patients|radiation dermatitis in breast cancer patients
5561188|NCT01042925|HER2 positive breast cancer|her2 positive breast cancer
5561189|NCT01042925|breast cancer|breast cancer
5561190|NCT01042925|breast tumors|breast tumors
5561191|NCT01042925|human mammary carcinoma|human mammary carcinoma
5561192|NCT01042912|diagnosis|diagnosis
5561193|NCT01042912|carotid|carotid
5561194|NCT01042912|artery|artery
5561195|NCT01042912|disease|disease
5561196|NCT01042912|auscultation|auscultation
5561197|NCT01042912|sound|sound
5561198|NCT01042899|TBI|tbi
5561199|NCT01042899|intracranial edema|intracranial edema
5561200|NCT01042899|brain edema|brain edema
5561201|NCT01042899|craniocerebral trauma|craniocerebral trauma
5561202|NCT01042899|head injury|head injury
5561203|NCT01042899|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5561204|NCT01042899|subdural hematoma|subdural hematoma
5561205|NCT01042899|brain concussion|brain concussion
5561206|NCT01042899|head injuries, closed|head injuries, closed
5561207|NCT01042899|epidural hematoma|epidural hematoma
5561208|NCT01042899|extra-axial hemorrhage|extra-axial hemorrhage
5561209|NCT01042899|cortical contusion|cortical contusion
5561210|NCT01042899|wounds and injuries|wounds and injuries
5561211|NCT01042899|disorders of environmental origin|disorders of environmental origin
5561212|NCT01042899|trauma, nervous system|trauma, nervous system
5561213|NCT01042899|brain injuries|brain injuries
5561214|NCT01042886|Non-blind, randomized controlled trial|non-blind, randomized controlled trial
5561215|NCT01042886|Pilot study|pilot study
5561216|NCT01042873|Desensitization|desensitization
5561217|NCT01042873|beta adrenergic receptors|beta adrenergic receptors
5561218|NCT01042873|Healthy subjects|healthy subjects
5561219|NCT01042860|macular pigment|macular pigment
5561220|NCT01042860|lutein|lutein
5561221|NCT01042860|age-related macular degeneration|age-related macular degeneration
5561223|NCT01042847|ovarian|ovarian
5561224|NCT01042834|air pollution|air pollution
5561225|NCT01042834|autonomic nervous system|autonomic nervous system
5561226|NCT01042834|sleep apnea|sleep apnea
5561227|NCT01042834|Heart rate variability|heart rate variability
5561228|NCT01042834|Healthy volunteers|healthy volunteers
5561229|NCT01042821|anal fistula|anal fistula
5561230|NCT01042821|advancement flap|advancement flap
5561231|NCT01042821|incontinence|incontinence
5561232|NCT01042795|sunitinib|sunitinib
5561233|NCT01042795|bladder neoplasm|bladder neoplasm
5561234|NCT01042795|adjuvant treatment|adjuvant treatment
5561235|NCT01042795|disease free survival|disease free survival
5561236|NCT01042795|cystectomy|cystectomy
5561237|NCT01042782|gastric cancer|gastric cancer
5561238|NCT01042782|RAD001|rad001
5561239|NCT01042782|Mitomycin C|mitomycin c
5561240|NCT01042782|MTD|mtd
5561241|NCT01042743|colon cancer|colon cancer
5561242|NCT01042743|robot|robot
5561243|NCT01042743|laparoscopy|laparoscopy
5561244|NCT01042743|primary, right-side colon cancer|primary, right-side colon cancer
5561245|NCT01042743|robot-assisted surgery|robot-assisted surgery
5561246|NCT01042730|Pitavastatin|pitavastatin
5561247|NCT01042730|Coronary Artery Disease|coronary artery disease
5561248|NCT01042730|Cardiovascular Disease|cardiovascular disease
5561249|NCT01042717|plerixafor|plerixafor
5561250|NCT01042717|autologous transplantation|autologous transplantation
5555238|NCT01065935|RSV|rsv
5561251|NCT01042717|hematopoietic stem cell mobilization|hematopoietic stem cell mobilization
5561253|NCT01042717|non-Hodgkins lymphoma|non-hodgkins lymphoma
5561254|NCT01042704|Relapsed Myeloma|relapsed myeloma
5561255|NCT01042704|Refractory Myeloma|refractory myeloma
5561256|NCT01042665|Glaucoma|glaucoma
5561257|NCT01042665|intraocular pressure|intraocular pressure
5561258|NCT01042665|latanoprost|latanoprost
5561259|NCT01042665|retinal ganglion cell|retinal ganglion cell
5561260|NCT01042665|pattern electroretinogram|pattern electroretinogram
5561261|NCT01042652|Methadone|methadone
5561262|NCT01042652|HIV|hiv
5561263|NCT01042652|Raltegravir|raltegravir
5561264|NCT01042652|Antiretroviral|antiretroviral
5561265|NCT01042652|Intravenous Drug User|intravenous drug user
5561266|NCT01042652|Methadone Maintenance|methadone maintenance
5546051|NCT01102504|stroke risk|stroke risk
5561267|NCT01042652|Treatment Naive|treatment naive
5561268|NCT01042639|osteopenia|osteopenia
5561269|NCT01042639|very low birthweight infants|very low birthweight infants
5561270|NCT01042639|bone speed of sound|bone speed of sound
5561271|NCT01042639|quantitative ultrasound|quantitative ultrasound
5561272|NCT01042626|Receptors, Calcium sensing|receptors, calcium sensing
5561273|NCT01042626|Parathyroid Hormone|parathyroid hormone
5561274|NCT01042613|AccuVein AV300 device;|accuvein av300 device;
5561275|NCT01042613|Intravenous cannulation|intravenous cannulation
5561276|NCT01042600|Respiratory distress syndrome|respiratory distress syndrome
5561277|NCT01042600|Surfactant|surfactant
5561278|NCT01042600|Tracheal intubation|tracheal intubation
5561279|NCT01042600|Laryngeal mask airway|laryngeal mask airway
5561280|NCT01042600|Newborn|newborn
5561281|NCT01042587|bright light therapy|bright light therapy
5561282|NCT01042587|circadian rhythm,|circadian rhythm,
5561283|NCT01042587|entrainment|entrainment
5561284|NCT01042574|intracranial hemorrhage (ICH)|intracranial hemorrhage (ich)
5561285|NCT01042574|subarachnoid hemorrhage (SAH)|subarachnoid hemorrhage (sah)
5561291|NCT01042561|25(OH)D|25(oh)d
5561292|NCT01042561|infant|infant
5561293|NCT01042561|CRP|crp
5561294|NCT01042561|PTH|pth
5561295|NCT01042548|Proteomics|proteomics
5561296|NCT01042548|Breast Cancer Markers|breast cancer markers
5561297|NCT01042548|Tissue Interstitial Fluid|tissue interstitial fluid
5561298|NCT01042509|Chronic Graft vs Host Disease|chronic graft vs host disease
5561299|NCT01042509|Alemtuzumab|alemtuzumab
5561300|NCT01042509|Rituximab|rituximab
5561301|NCT01042509|Low-dose|low-dose
5561302|NCT01042509|Alemtuzumab and rituximab combination|alemtuzumab and rituximab combination
5561303|NCT01042496|Bipolar|bipolar
5561304|NCT01042496|depression|depression
5561305|NCT01042483|active stage|active stage
5561306|NCT01042483|labor|labor
5561307|NCT01042483|progression|progression
5561308|NCT01042483|pregnant women during active phases of labor|pregnant women during active phases of labor
5561309|NCT01042470|pelvic organ prolapse|pelvic organ prolapse
5561310|NCT01042470|pelvic floor dysfunction|pelvic floor dysfunction
5561311|NCT01042470|biomechanics|biomechanics
5561312|NCT01042470|aspiration device|aspiration device
5561313|NCT01042470|connective tissue|connective tissue
5561314|NCT01042457|trough level|trough level
5561315|NCT01042457|therapeutic drug monitoring|therapeutic drug monitoring
5561316|NCT01042457|Mycophenolate mofetil|mycophenolate mofetil
5561317|NCT01042457|Mycophenolic acid|mycophenolic acid
5561318|NCT01042457|lupus nephritis|lupus nephritis
5561319|NCT01042444|Heart disease|heart disease
5561320|NCT01042444|Embolic Protection Device|embolic protection device
5561321|NCT01042444|PCI|pci
5561322|NCT01042444|SVG|svg
5561323|NCT01042431|Nutritional status of ward patients and hospitalization outcome|nutritional status of ward patients and hospitalization outcome
5561324|NCT01042418|satiety|satiety
5561325|NCT01042418|grain structure|grain structure
5561326|NCT01042418|rye|rye
5561327|NCT01042392|Moderate systolic hypertension - adults - aliskiren -ramipril|moderate systolic hypertension - adults - aliskiren -ramipril
5561328|NCT01042379|I-SPY 2|i-spy 2
5561329|NCT01042379|Neoadjuvant|neoadjuvant
5561330|NCT01042379|Breast|breast
5561331|NCT01042379|Cancer|cancer
5561332|NCT01042379|Neoplasm|neoplasm
5561333|NCT01042379|Adaptive|adaptive
5561334|NCT01042379|pCR|pcr
5561335|NCT01042379|Pathologic Complete Response|pathologic complete response
5561336|NCT01042379|Biomarkers signature|biomarkers signature
5561337|NCT01042379|MRI Volume|mri volume
5561338|NCT01042366|Melanoma|melanoma
5561339|NCT01042340|nutrition|nutrition
5561340|NCT01042340|geriatric|geriatric
5561341|NCT01042340|supplement|supplement
5561342|NCT01042340|energy|energy
5561343|NCT01042327|solute clearances|solute clearances
5561344|NCT01042288|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5561345|NCT01042288|NSCLC|nsclc
5561346|NCT01042288|Panitumumab|panitumumab
5561347|NCT01042288|Vectibix|vectibix
5561349|NCT01042288|Alimta|alimta
5561350|NCT01042288|Carboplatin|carboplatin
5561351|NCT01042275|stress urinary incontinence|stress urinary incontinence
5561352|NCT01042275|retropubic sling|retropubic sling
5561353|NCT01042275|transobturator sling|transobturator sling
5561354|NCT01042275|tension-free vaginal tape|tension-free vaginal tape
5561355|NCT01042275|transobturator tape|transobturator tape
5561357|NCT01042275|TVT-O|tvt-o
5561359|NCT01042275|REMEEX|remeex
5561360|NCT01042275|IVS|ivs
5561361|NCT01042262|Superoxide dismutase|superoxide dismutase
5561362|NCT01042262|Oxygen|oxygen
5561363|NCT01042262|Oxygen free radicals|oxygen free radicals
5561364|NCT01042262|Labor and delivery|labor and delivery
5561365|NCT01042249|PFMT|pfmt
5561366|NCT01042249|Stroke|stroke
5561367|NCT01042249|LUTS|luts
5561368|NCT01042249|Men|men
5561369|NCT01042236|Phase 2 stress urinary incontinence Fesoterodine|phase 2 stress urinary incontinence fesoterodine
5561370|NCT01042223|Factors Predisposing or Causing|factors predisposing or causing
5561371|NCT01042210|preeclampsia|preeclampsia
5546174|NCT01101906|HCC|hcc
5561372|NCT01042210|agouti-related peptide|agouti-related peptide
5561373|NCT01042210|intrauterine growth|intrauterine growth
5561374|NCT01042210|birth weight|birth weight
5561375|NCT01042210|Intrauterine growth restriction due to preeclampsia|intrauterine growth restriction due to preeclampsia
5561376|NCT01042197|Vitamin D|vitamin d
5561377|NCT01042197|UVB|uvb
5561378|NCT01042197|Dose-Response|dose-response
5561379|NCT01042197|Body surface area|body surface area
5561380|NCT01042184|H. pylori infected patients without prior eradication therapy|h. pylori infected patients without prior eradication therapy
5561381|NCT01042158|Tadalafil|tadalafil
5561382|NCT01042158|Ambrisentan|ambrisentan
5561383|NCT01042158|Quality of Life|quality of life
5561387|NCT01042145|Corticosteroids|corticosteroids
5561388|NCT01042145|Prednisone|prednisone
5561389|NCT01042145|Dexamethasone|dexamethasone
5561390|NCT01042145|Randomized trial|randomized trial
5561391|NCT01042132|intramedullary reaming|intramedullary reaming
5561392|NCT01042132|inflammatory response|inflammatory response
5561394|NCT01042132|femoral shaft fracture|femoral shaft fracture
5543682|NCT01112813|MRI|mri
5561395|NCT01042132|Reamer-irrigator-aspirator|reamer-irrigator-aspirator
5561396|NCT01042119|botulinum neurotoxin type A|botulinum neurotoxin type a
5561397|NCT01042119|BoNT/A|bont/a
5561398|NCT01042119|Botox|botox
5561399|NCT01042119|overactive bladder syndrome|overactive bladder syndrome
5561400|NCT01042106|diabetes|diabetes
5561401|NCT01042093|Analgesia|analgesia
5561402|NCT01042093|postoperative pain|postoperative pain
5561403|NCT01042093|periarticular|periarticular
5561404|NCT01042093|arthroplasty|arthroplasty
5561405|NCT01042093|pain management|pain management
5561406|NCT01042080|Mechanical ventilation|mechanical ventilation
5561407|NCT01042080|Neurally adjusted ventilatory assist (NAVA)|neurally adjusted ventilatory assist (nava)
5561408|NCT01042080|Acute respiratory failure|acute respiratory failure
5561409|NCT01042080|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5561410|NCT01042080|Weaning|weaning
5561411|NCT01042080|Invasive mechanical ventilation|invasive mechanical ventilation
5561412|NCT01042080|Positive Pressure support Ventilation|positive pressure support ventilation
5561413|NCT01042067|warfarin|warfarin
5561414|NCT01042067|genotyping|genotyping
5561415|NCT01042067|vitamin K|vitamin k
5561416|NCT01042067|dosing|dosing
5561417|NCT01042067|adverse events|adverse events
5561418|NCT01042067|initial phase of treatment|initial phase of treatment
5561419|NCT01042067|algorithm|algorithm
5561420|NCT01042054|Postoperative Care|postoperative care
5561421|NCT01042054|Enhanced|enhanced
5561422|NCT01042054|Recovery|recovery
5561423|NCT01042054|Hepatectomy|hepatectomy
5561424|NCT01042054|Analgesia|analgesia
5561425|NCT01042028|Pancreas cancer|pancreas cancer
5561426|NCT01042028|Everolimus|everolimus
5561427|NCT01042028|Irinotecan|irinotecan
5561428|NCT01042028|Cetuximab|cetuximab
5561429|NCT01042028|Capecitabine|capecitabine
5561430|NCT01042028|Oxaliplatin|oxaliplatin
5561431|NCT01042028|Gemcitabine resistant pancreascancer|gemcitabine resistant pancreascancer
5561432|NCT01042015|trauma|trauma
5561433|NCT01042015|cardiac arrest|cardiac arrest
5561434|NCT01042015|hemorrhagic shock|hemorrhagic shock
5561435|NCT01042002|High intensity exercise|high intensity exercise
5561436|NCT01042002|morbid obesity|morbid obesity
5561437|NCT01042002|gastric bypass|gastric bypass
5561438|NCT01041989|dementia|dementia
5561439|NCT01041989|cognitive impairment|cognitive impairment
5561440|NCT01041989|disability|disability
5561441|NCT01041989|intervention|intervention
5561442|NCT01041989|elderly|elderly
5561443|NCT01041989|lifestyle counseling|lifestyle counseling
5561444|NCT01041976|Veterans|veterans
5561445|NCT01041976|Vocational Rehabilitation|vocational rehabilitation
5561446|NCT01041963|ACEI|acei
5561447|NCT01041963|ARB|arb
5561448|NCT01041963|CAPD|capd
5561449|NCT01041963|Peritoneal membrane transport|peritoneal membrane transport
5561450|NCT01041950|intracerebral hemorrhage|intracerebral hemorrhage
5561451|NCT01041950|intraventricular hemorrhage|intraventricular hemorrhage
5561452|NCT01041950|hydrocephalus|hydrocephalus
5561453|NCT01041950|Intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus|intracerebral hemorrhage with severe ventricular involvement and obstructive hydrocephalus
5561454|NCT01041924|Sleep apnea|sleep apnea
5561455|NCT01041924|Periodic breathing|periodic breathing
5561456|NCT01041924|Heart Failure|heart failure
5561457|NCT01041911|Hemorrhoids|hemorrhoids
5561458|NCT01041898|osteocalcin|osteocalcin
5561460|NCT01041898|body composition|body composition
5561461|NCT01041898|bone mineral density|bone mineral density
5561462|NCT01041898|Evaluate the effect of osteocalcin on bone mineral density|evaluate the effect of osteocalcin on bone mineral density
5561463|NCT01041898|Evaluate the effect of osteocalcin on body fat distribution|evaluate the effect of osteocalcin on body fat distribution
5561464|NCT01041898|Evaluate the effect of osteocalcin on insulin homeostasis|evaluate the effect of osteocalcin on insulin homeostasis
5561465|NCT01041885|knee cartilage defect repair|knee cartilage defect repair
5561466|NCT01041885|cartilage lesion|cartilage lesion
5561467|NCT01041885|autologous chondrocyte|autologous chondrocyte
5561468|NCT01041885|scaffold|scaffold
5561469|NCT01041885|INSTRUCT|instruct
5561470|NCT01041859|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5561471|NCT01041859|Painful|painful
5561472|NCT01041859|Polyneuropathy|polyneuropathy
5561473|NCT01041859|Peripheral neuropathy|peripheral neuropathy
5561474|NCT01041846|Myelodysplastic Syndrome|myelodysplastic syndrome
5561475|NCT01041846|Dacogen|dacogen
5561476|NCT01041846|Decitabine|decitabine
5561477|NCT01041846|Epigenetic therapy|epigenetic therapy
5561479|NCT01041833|All-trans retinoic acid|all-trans retinoic acid
5561480|NCT01041833|non-small cell lung cancer|non-small cell lung cancer
5561481|NCT01041833|retinoic acid receptor beta|retinoic acid receptor beta
5561482|NCT01041820|exercise|exercise
5561483|NCT01041820|bone marrow adipose tissue|bone marrow adipose tissue
5561484|NCT01041820|bone mineral density|bone mineral density
5561485|NCT01041820|Children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks|children in the intervention condition will complete a supervised physical activity program 3 days/wk for 10 weeks
5561486|NCT01041820|Control treatment will be provided no intervention|control treatment will be provided no intervention
5543727|NCT01112631|NSCLC,|nsclc,
5561487|NCT01041820|All participants will be instructed not to change their current dietary habits during the study period.|all participants will be instructed not to change their current dietary habits during the study period.
5561488|NCT01041807|Hypertension|hypertension
5561489|NCT01041794|body composition|body composition
5561490|NCT01041794|fat distribution|fat distribution
5561491|NCT01041794|exercise|exercise
5561492|NCT01041794|diet|diet
5561493|NCT01041781|adenocarcinoma of the lung|adenocarcinoma of the lung
5561494|NCT01041781|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5561495|NCT01041781|large cell lung cancer|large cell lung cancer
5561496|NCT01041781|squamous cell lung cancer|squamous cell lung cancer
5561497|NCT01041781|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5561498|NCT01041781|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5561499|NCT01041781|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5561500|NCT01041768|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5561501|NCT01041755|Encephalopathy|encephalopathy
5561502|NCT01041755|Cirrhosis|cirrhosis
5561503|NCT01041716|Carbapenem|carbapenem
5561504|NCT01041716|Klebsiella pneumoniae carbapenemase|klebsiella pneumoniae carbapenemase
5561505|NCT01041716|Acinetobacter baumannii|acinetobacter baumannii
5561506|NCT01041716|Pseudomonas aeruginosa|pseudomonas aeruginosa
5561507|NCT01041690|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5561508|NCT01041690|Vitrectomy|vitrectomy
5561509|NCT01041690|Bevacizumab|bevacizumab
5561510|NCT01041677|Obesity|obesity
5561511|NCT01041677|Overweight|overweight
5561512|NCT01041677|Body Weight|body weight
5561513|NCT01041677|Body Size|body size
5561514|NCT01041677|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5561515|NCT01041664|nutrigenomics|nutrigenomics
5561516|NCT01041664|admixture|admixture
5561517|NCT01041664|Hispanic American|hispanic american
5561518|NCT01041664|body composition|body composition
5561519|NCT01041664|Association of diet and body composition|association of diet and body composition
5561520|NCT01041664|Association between genes and body composition|association between genes and body composition
5561521|NCT01041664|Association between gen by diet interaction and body composition|association between gen by diet interaction and body composition
5561522|NCT01041625|Lichen Planus|lichen planus
5561524|NCT01041612|HBD|hbd
5561525|NCT01041612|cancer of bile duct|cancer of bile duct
5561526|NCT01041612|pancreatic cancer|pancreatic cancer
5561527|NCT01041599|Diabetes Mellitus|diabetes mellitus
5561528|NCT01041599|Hypertension|hypertension
5561529|NCT01041599|Albuminuria|albuminuria
5561530|NCT01041599|vascular stiffness|vascular stiffness
5561531|NCT01041586|Emphysema|emphysema
5561532|NCT01041586|COPD|copd
5561533|NCT01041586|Lung Volume Reduction|lung volume reduction
5561534|NCT01041586|BTVA|btva
5561535|NCT01041573|Pediatric|pediatric
5561536|NCT01041573|Japanese Encephalitis Vaccine|japanese encephalitis vaccine
5561537|NCT01041573|endemic countries|endemic countries
5561538|NCT01041573|to assess the systemic and local safety profile of purified inactivated Japanese Encephalitis Virus (JEV) vaccine IC51|to assess the systemic and local safety profile of purified inactivated japanese encephalitis virus (jev) vaccine ic51
5561539|NCT01041560|Stroke|stroke
5561540|NCT01041560|Tone|tone
5561541|NCT01041560|Strength|strength
5561542|NCT01041547|Insulin sensitivity|insulin sensitivity
5561543|NCT01041547|Vascular function|vascular function
5555501|NCT01064661|Probiotics|probiotics
5561545|NCT01041547|Arterial stiffness|arterial stiffness
5561546|NCT01041547|Glucose tolerance|glucose tolerance
5561547|NCT01041547|Hypertension|hypertension
5561548|NCT01041534|Adjustable gastric band, morbid obesity, bariatric surgery|adjustable gastric band, morbid obesity, bariatric surgery
5561549|NCT01041521|HIV infection|hiv infection
5561550|NCT01041521|Dyslipidemia|dyslipidemia
5561551|NCT01041521|Elevated Triglyceride level|elevated triglyceride level
5561552|NCT01041521|vascular function (BART)|vascular function (bart)
5561553|NCT01041521|arterial stiffness|arterial stiffness
5561554|NCT01041521|omega three fatty acids|omega three fatty acids
5561555|NCT01041521|complementary therapies|complementary therapies
5561556|NCT01041508|ALL|all
5561557|NCT01041508|AML|aml
5561558|NCT01041508|Recurrence|recurrence
5561559|NCT01041508|Relapsed|relapsed
5561560|NCT01041508|Stem Cell Transplant|stem cell transplant
5561561|NCT01041508|Non-myeloablastive|non-myeloablastive
5561562|NCT01041495|fibromyalgia|fibromyalgia
5561563|NCT01041495|Pain|pain
5561564|NCT01041495|Sleep|sleep
5561565|NCT01041495|Fatigue|fatigue
5561566|NCT01041482|sorafenib|sorafenib
5561567|NCT01041482|renal cell carcinoma|renal cell carcinoma
5561568|NCT01041482|disease free survival|disease free survival
5561569|NCT01041482|Hand food skin reaction|hand food skin reaction
5561570|NCT01041469|Down syndrome, Humans,Clinical study,Immunity, Autoimmunity,|down syndrome, humans,clinical study,immunity, autoimmunity,
5561571|NCT01041456|complicated biliopancreatic diversion|complicated biliopancreatic diversion
5543833|NCT01112059|cystic fibrosis|cystic fibrosis
5561572|NCT01041456|failed biliopancreatic diversion|failed biliopancreatic diversion
5561573|NCT01041456|revision gastric bypass|revision gastric bypass
5561574|NCT01041456|conversion bariatric surgery|conversion bariatric surgery
5561575|NCT01041456|revision bariatric surgery|revision bariatric surgery
5561576|NCT01041456|re-operative bariatric surgery|re-operative bariatric surgery
5561577|NCT01041456|malabsorptive syndrome|malabsorptive syndrome
5561578|NCT01041456|protein malnutrition|protein malnutrition
5561579|NCT01041456|metabolic bone disease|metabolic bone disease
5561580|NCT01041430|Ambulatory Surgery|ambulatory surgery
5561581|NCT01041430|Aged|aged
5561582|NCT01041417|claudication|claudication
5561583|NCT01041391|Surgical intervention vs Non-Surgical intervention|surgical intervention vs non-surgical intervention
5561584|NCT01041378|Pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy|pediatric patients (6 months-5 years) scheduled elective day-case orchiopexy
5561585|NCT01041365|insulin sensitivity|insulin sensitivity
5561586|NCT01041365|vascular function|vascular function
5561587|NCT01041365|flow-mediated dilation|flow-mediated dilation
5561588|NCT01041365|arterial stiffness|arterial stiffness
5561589|NCT01041365|ethnicity|ethnicity
5561590|NCT01041365|adolescents|adolescents
5561591|NCT01041365|females|females
5561592|NCT01041365|glucose tolerance|glucose tolerance
5561593|NCT01041365|diabetes|diabetes
5561594|NCT01041365|hypertension|hypertension
5561595|NCT01041365|cardiovascular|cardiovascular
5561596|NCT01041352|anaesthesia|anaesthesia
5561597|NCT01041352|laryngeal mask|laryngeal mask
5561598|NCT01041352|prone position|prone position
5561599|NCT01041339|LpPLA2|lppla2
5561600|NCT01041339|ST elevation|st elevation
5561601|NCT01041339|acute pericarditis|acute pericarditis
5561602|NCT01041326|prostatectomy|prostatectomy
5561603|NCT01041326|radiation|radiation
5561604|NCT01041326|neoadjuvant|neoadjuvant
5561605|NCT01041313|Adjuvants, pharmaceuticals|adjuvants, pharmaceuticals
5561606|NCT01041313|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5561607|NCT01041313|Drug tolerance|drug tolerance
5561608|NCT01041313|Pain Measurement|pain measurement
5561609|NCT01041300|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5561611|NCT01041300|Motor Threashold|motor threashold
5561612|NCT01041300|Multiway|multiway
5561613|NCT01041300|Magstim Rapid 2|magstim rapid 2
5561614|NCT01041300|Abductor policis brevis|abductor policis brevis
5561615|NCT01041300|Figure 8 coil|figure 8 coil
5561616|NCT01041300|Double cone coil|double cone coil
5561617|NCT01041300|Circular coil|circular coil
5561618|NCT01041300|Brainsway|brainsway
5561619|NCT01041300|Healthy participants.|healthy participants.
5561620|NCT01041274|Schizophrenia|schizophrenia
5561621|NCT01041274|Citalopram|citalopram
5561622|NCT01041274|First episode|first episode
5561623|NCT01041274|fMRI|fmri
5561624|NCT01041274|Cognitive behavioral therapy|cognitive behavioral therapy
5561625|NCT01041274|Psychoeducation|psychoeducation
5561626|NCT01041261|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
5561627|NCT01041261|Medical food|medical food
5561628|NCT01041261|Body composition|body composition
5685392|NCT00556283|rectocele|rectocele
5561629|NCT01041261|Dietary intervention|dietary intervention
5561630|NCT01041248|Relapsing Polychondritis|relapsing polychondritis
5561631|NCT01041248|Single Patient Study|single patient study
5561632|NCT01041248|Tocilizumab|tocilizumab
5561633|NCT01041235|Solid Neoplasms|solid neoplasms
5561634|NCT01041235|Carcinoma|carcinoma
5561635|NCT01041235|Breast|breast
5561636|NCT01041235|Ovarian|ovarian
5561637|NCT01041235|Ovary|ovary
5561638|NCT01041235|Pancreas|pancreas
5561639|NCT01041235|Pancreatic|pancreatic
5561652|NCT01041209|Children|children
5561653|NCT01041196|obesity|obesity
5561654|NCT01041196|ulcer disease|ulcer disease
5561655|NCT01041196|marginal ulcer|marginal ulcer
5561656|NCT01041196|perforation|perforation
5561657|NCT01041196|abdominal pain|abdominal pain
5561658|NCT01041196|bariatric surgery|bariatric surgery
5561659|NCT01041196|weight loss surgery|weight loss surgery
5561660|NCT01041183|Oral plus IV ramosetron may be more effective than|oral plus iv ramosetron may be more effective than
5561661|NCT01041183|IV ramosetron and oral ramosetron for the prophylaxis of|iv ramosetron and oral ramosetron for the prophylaxis of
5561662|NCT01041183|PONV after laparoscopic cholecystectomy|ponv after laparoscopic cholecystectomy
5561663|NCT01041170|Rimonabant|rimonabant
5561664|NCT01041170|fMRI|fmri
5561665|NCT01041170|Alternative Matrices|alternative matrices
5561666|NCT01041170|Brain Imaging|brain imaging
5561667|NCT01041170|THC|thc
5561668|NCT01041157|Torticollis|torticollis
5561669|NCT01041157|Botulinum Toxins|botulinum toxins
5561670|NCT01041144|Diabetes|diabetes
5561671|NCT01041144|PDA|pda
5561672|NCT01041144|Internet|internet
5561673|NCT01041144|HbA1c|hba1c
5561674|NCT01041131|Obesity|obesity
5561675|NCT01041131|Obesity recidivism|obesity recidivism
5561676|NCT01041131|Inadequate Initial Weight Loss|inadequate initial weight loss
5561677|NCT01041131|Technical bariatric complications|technical bariatric complications
5561678|NCT01041131|Complicated gastroplasty|complicated gastroplasty
5561679|NCT01041131|Failed gastroplasty|failed gastroplasty
5561680|NCT01041131|Gastroesophageal reflux disease|gastroesophageal reflux disease
5561681|NCT01041131|Revisional gastric bypass|revisional gastric bypass
5561682|NCT01041131|Conversion bariatric surgery|conversion bariatric surgery
5561683|NCT01041131|Re-operative bariatric surgery|re-operative bariatric surgery
5561684|NCT01041131|Technical complications of vertical gastroplasty|technical complications of vertical gastroplasty
5561685|NCT01041131|Complicated vertical gastroplasty|complicated vertical gastroplasty
5561686|NCT01041105|Obesity|obesity
5561687|NCT01041105|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5561688|NCT01041105|Nissen funduplication|nissen funduplication
5561689|NCT01041105|Antireflux surgery|antireflux surgery
5561690|NCT01041105|Revisional Gastric Bypass|revisional gastric bypass
5561691|NCT01041105|Re-operative bariatric surgery|re-operative bariatric surgery
5561692|NCT01041105|Bariatric surgery|bariatric surgery
5561693|NCT01041105|Nissen|nissen
5561694|NCT01041105|Conversion of Nissen to Gastric Bypass|conversion of nissen to gastric bypass
5561695|NCT01041079|ulcer disease|ulcer disease
5561696|NCT01041079|marginal ulcer|marginal ulcer
5561697|NCT01041079|morbidity of gastric bypass|morbidity of gastric bypass
5561698|NCT01041079|late morbidity of gastric bypass|late morbidity of gastric bypass
5561699|NCT01041079|chronic abdominal pain|chronic abdominal pain
5561700|NCT01041079|GI hemorrhage|gi hemorrhage
5561701|NCT01041079|Perforation|perforation
5561702|NCT01041079|Penetration|penetration
5561703|NCT01041079|Obstruction|obstruction
5561704|NCT01041066|patients who are intubated for general anesthesia|patients who are intubated for general anesthesia
5561705|NCT01041040|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5561706|NCT01041014|Limited English proficiency|limited english proficiency
5561707|NCT01041014|Cost-effectiveness|cost-effectiveness
5561708|NCT01041014|Emergency Departments|emergency departments
5561709|NCT01041014|Language Discordance|language discordance
5561710|NCT01041014|Satisfaction|satisfaction
5561711|NCT01041014|Limited English proficient patients|limited english proficient patients
5561712|NCT01041014|Spanish-speaking patients|spanish-speaking patients
5561713|NCT01041001|Umbilical Cord Blood|umbilical cord blood
5561714|NCT01041001|Mesenchymal Stem Cells|mesenchymal stem cells
5561715|NCT01041001|cartilage injury|cartilage injury
5561716|NCT01041001|osteoarthritis|osteoarthritis
5561717|NCT01040988|Pacemaker|pacemaker
5561718|NCT01040988|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5561719|NCT01040962|neuropathy|neuropathy
5561720|NCT01040962|diabetes|diabetes
5561721|NCT01040949|smoking cessation|smoking cessation
5561722|NCT01040949|pregnant Latinas|pregnant latinas
5561723|NCT01040949|couples communication|couples communication
5561724|NCT01040949|Latino community|latino community
5561725|NCT01040949|couples communication in Latino couples|couples communication in latino couples
5561726|NCT01040936|acute coronary syndrome|acute coronary syndrome
5561727|NCT01040936|intervention|intervention
5561728|NCT01040936|outcome|outcome
5561729|NCT01040936|patients diagnosed ad Non-ST elevation ACS|patients diagnosed ad non-st elevation acs
5561730|NCT01040936|patients received PCI therapy|patients received pci therapy
5561731|NCT01040923|CAD|cad
5561732|NCT01040923|Diagnostic|diagnostic
5561733|NCT01040910|cannabis|cannabis
5561734|NCT01040910|Crohn's disease|crohn's disease
5561735|NCT01040910|Ulcerative colitis|ulcerative colitis
5561736|NCT01040910|IBD|ibd
5561737|NCT01040897|Obesity prevention|obesity prevention
5561738|NCT01040897|Health Literacy|health literacy
5561739|NCT01040897|Health Communication|health communication
5561740|NCT01040858|cognitive strategy intervention|cognitive strategy intervention
5561741|NCT01040858|cognitive disorders|cognitive disorders
5561742|NCT01040845|healthy|healthy
5561743|NCT01040845|pharmacokinetics|pharmacokinetics
5561744|NCT01040845|drug-interaction|drug-interaction
5561745|NCT01040832|Head and Neck Cancer|head and neck cancer
5680311|NCT00578266|Transplant for Severe Aplastic Anemia (SAA)|transplant for severe aplastic anemia (saa)
5005924|NCT03959696|Shared Decision Making|shared decision making
5561746|NCT01040832|Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer|recurrent or metastatic squamous cell carcinoma of the head and neck cancer
5561747|NCT01040832|Cetuximab|cetuximab
5561748|NCT01040832|EMD 1201081|emd 1201081
5561749|NCT01040819|Diabetes Mellitus|diabetes mellitus
5561750|NCT01040819|6-Ketoprostaglandin F1 alpha|6-ketoprostaglandin f1 alpha
5561751|NCT01040819|15-epi-lipoxin A4|15-epi-lipoxin a4
5561752|NCT01040819|Thiazolidinediones|thiazolidinediones
5561753|NCT01040819|Pioglitazone|pioglitazone
5561754|NCT01040806|Diabetes|diabetes
5561755|NCT01040780|Efficacy|efficacy
5561756|NCT01040780|Safety|safety
5561757|NCT01040780|EGFR-TKI|egfr-tki
5561758|NCT01040780|phase III|phase iii
5561759|NCT01040780|NSCLC|nsclc
5561760|NCT01040767|Ultrasound education|ultrasound education
5561761|NCT01040767|Blended learning|blended learning
5561762|NCT01040767|Distance education|distance education
5561763|NCT01040767|Trauma ultrasound|trauma ultrasound
5561764|NCT01040767|FAST|fast
5561765|NCT01040741|Pandemic influenza A (H1N1) vaccine|pandemic influenza a (h1n1) vaccine
5561766|NCT01040741|Adjuvanted|adjuvanted
5561767|NCT01040715|Rheumatoid arthritis|rheumatoid arthritis
5544027|NCT01111162|HIV|hiv
5561768|NCT01040715|anti-drug antibodies|anti-drug antibodies
5561769|NCT01040715|Rheumatoid arthritis with secondary loss of efficacy to anti-TNFa antagonists and anti-drug antibodies|rheumatoid arthritis with secondary loss of efficacy to anti-tnfa antagonists and anti-drug antibodies
5561770|NCT01040676|Diabetes Mellitus|diabetes mellitus
5561771|NCT01040676|Telephone|telephone
5561772|NCT01040676|Nutrition Support|nutrition support
5561773|NCT01040676|Automated|automated
5561774|NCT01040676|Low English Proficiency|low english proficiency
5561775|NCT01040676|Hispanic|hispanic
5561776|NCT01040676|Latino|latino
5561777|NCT01040637|Healthy subjects|healthy subjects
5561778|NCT01040624|Prostate Cancer, Proton Radiation|prostate cancer, proton radiation
5561779|NCT01040611|music therapy|music therapy
5561780|NCT01040611|Tuberculosis|tuberculosis
5561781|NCT01040611|anxiety|anxiety
5561782|NCT01040611|physiological response|physiological response
5561783|NCT01040598|Eosinophilic Esophagitis|eosinophilic esophagitis
5561784|NCT01040598|Xolair|xolair
5561785|NCT01040598|Omalizumab|omalizumab
5561786|NCT01040598|Esophagitis|esophagitis
5561787|NCT01040598|Eosinophils|eosinophils
5561788|NCT01040598|monoclonal antibody|monoclonal antibody
5561789|NCT01040585|cost effectiveness|cost effectiveness
5561790|NCT01040585|linezolid|linezolid
5561791|NCT01040585|ventilator acquired pneumonia|ventilator acquired pneumonia
5561792|NCT01040585|central america|central america
5561793|NCT01040572|Obesity recidivism|obesity recidivism
5561794|NCT01040572|Weight Regain|weight regain
5561795|NCT01040572|Weight recidivism|weight recidivism
5561796|NCT01040572|Morbidity|morbidity
5561797|NCT01040572|Complication|complication
5561798|NCT01040572|Late complications|late complications
5561799|NCT01040572|Revisional gastric bypass|revisional gastric bypass
5561800|NCT01040572|Re-operative gastric bypass|re-operative gastric bypass
5561801|NCT01040572|Revisional bariatric surgery|revisional bariatric surgery
5561802|NCT01040572|Re-operative bariatric surgery|re-operative bariatric surgery
5561803|NCT01040546|Obesity|obesity
5561804|NCT01040546|Metabolic syndrome|metabolic syndrome
5561805|NCT01040546|Weight control educational intervention|weight control educational intervention
5561806|NCT01040546|Food intake|food intake
5561807|NCT01040533|Failed jejunoileal bypass|failed jejunoileal bypass
5561808|NCT01040533|Complicated jejunoileal bypass|complicated jejunoileal bypass
5561809|NCT01040533|Revision gastric bypass|revision gastric bypass
5561810|NCT01040533|Revisional surgery|revisional surgery
5561811|NCT01040533|Reoperations|reoperations
5671983|NCT00613288|testosterone|testosterone
5561812|NCT01040533|Metabolic and nutritional complications|metabolic and nutritional complications
5561813|NCT01040520|CT-based autopsy|ct-based autopsy
5561814|NCT01040520|virtual autopsy|virtual autopsy
5561815|NCT01040520|medical autopsy|medical autopsy
5561816|NCT01040520|quality control|quality control
5561817|NCT01040507|severe obesity|severe obesity
5561818|NCT01040507|morbid obesity|morbid obesity
5561819|NCT01040507|gastric bypass|gastric bypass
5561820|NCT01040507|efficacy of gastric bypass|efficacy of gastric bypass
5561821|NCT01040494|Aliskiren|aliskiren
5685393|NCT00556270|pain|pain
5561822|NCT01040494|Congestive heart failure|congestive heart failure
5561823|NCT01040494|Central hemodynamics|central hemodynamics
5561824|NCT01040481|Failed gastric bypass|failed gastric bypass
5561825|NCT01040481|Malabsorptive distal gastric bypass|malabsorptive distal gastric bypass
5561826|NCT01040481|Distal gastric bypass|distal gastric bypass
5561827|NCT01040481|Malabsorptive gastric bypass|malabsorptive gastric bypass
5561828|NCT01040481|Adding malabsorption|adding malabsorption
5561829|NCT01040481|Increasing malabsorption|increasing malabsorption
5561830|NCT01040481|Re-operative bariatric surgery|re-operative bariatric surgery
5561831|NCT01040481|Revisional bariatric surgery|revisional bariatric surgery
5561832|NCT01040481|Revisional gastric bypass|revisional gastric bypass
5561833|NCT01040481|Reoperations|reoperations
5561834|NCT01040481|Conversions|conversions
5561835|NCT01040468|Type 2 Diabetes|type 2 diabetes
5561836|NCT01040468|Bariatric Surgery|bariatric surgery
5561837|NCT01040468|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5561838|NCT01040468|Gastric Banding|gastric banding
5561839|NCT01040468|Obesity|obesity
5561840|NCT01040468|Weight loss|weight loss
5561841|NCT01040468|Insulin sensitivity|insulin sensitivity
5561842|NCT01040468|GLP-1|glp-1
5561843|NCT01040468|Meal Challenge|meal challenge
5561844|NCT01040468|Euglycemic Clamp|euglycemic clamp
5561845|NCT01040455|functional dyspepsia|functional dyspepsia
5561846|NCT01040455|lansoprazole|lansoprazole
5561847|NCT01040455|placebo effect|placebo effect
5561848|NCT01040442|Postural Balance|postural balance
5561849|NCT01040442|Aging|aging
5561851|NCT01040442|Vibration|vibration
5561852|NCT01040429|Adolescent|adolescent
5561853|NCT01040429|Clonidine|clonidine
5561854|NCT01040429|Autonomic nervous system|autonomic nervous system
5561855|NCT01040429|Stress|stress
5561856|NCT01040416|complicated marginal ulcer|complicated marginal ulcer
5561857|NCT01040416|complex marginal ulcer|complex marginal ulcer
5561858|NCT01040416|complication after gastric bypass|complication after gastric bypass
5561859|NCT01040416|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5561860|NCT01040390|Acne Vulgaris|acne vulgaris
5561861|NCT01040390|Homoeopathy|homoeopathy
5561862|NCT01040390|Lappa Arctium|lappa arctium
5561863|NCT01040377|Inadequate Initial Weight Loss|inadequate initial weight loss
5561864|NCT01040377|Inadequate weight loss|inadequate weight loss
5561865|NCT01040377|Poor weight loss|poor weight loss
5561866|NCT01040377|Failed gastric bypass|failed gastric bypass
5561867|NCT01040377|Revision gastric bypass|revision gastric bypass
5561868|NCT01040364|Internal hernia|internal hernia
5561869|NCT01040364|Mesocolic hernia|mesocolic hernia
5561870|NCT01040364|Petersen´s hernia|petersen´s hernia
5561871|NCT01040364|Jejunojejunostomy hernia|jejunojejunostomy hernia
5561872|NCT01040364|Bowel obstruction|bowel obstruction
5561873|NCT01040364|Ischemic bowel|ischemic bowel
5561874|NCT01040364|Complication after gastric bypass|complication after gastric bypass
5561875|NCT01040364|Re-operative bariatric surgery|re-operative bariatric surgery
5561876|NCT01040364|Chronic pain after gastric bypass|chronic pain after gastric bypass
5561877|NCT01040351|Infertility|infertility
5561878|NCT01040351|Hydrosalpinx|hydrosalpinx
5561879|NCT01040351|IVF-ET|ivf-et
5561880|NCT01040338|Smoking|smoking
5561881|NCT01040338|Tobacco|tobacco
5561882|NCT01040338|Nicotine|nicotine
5561883|NCT01040338|Dependence|dependence
5561884|NCT01040338|Genetics|genetics
5561885|NCT01040312|UGT1A1, irinotecan|ugt1a1, irinotecan
5561886|NCT01040299|GangTrainer|gangtrainer
5561887|NCT01040299|Gait Rehabilitation|gait rehabilitation
5561888|NCT01040299|Cerebrovascular Disorders|cerebrovascular disorders
5561889|NCT01040299|Robot assisted|robot assisted
5561890|NCT01040299|Transcranial direct current stimulation|transcranial direct current stimulation
5561891|NCT01040286|Subjects, age>21, with Chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal|subjects, age>21, with chronic periodontal disease on natural teeth characterized by the presence of at least 2 teeth with periodontal
5561892|NCT01040286|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the|pockets of 5-9 mm in depth demonstrating bleeding on probing without involving the
5561893|NCT01040286|apex of the tooth and confirmed by dental X-ray.|apex of the tooth and confirmed by dental x-ray.
5561894|NCT01040260|tobacco use disorder|tobacco use disorder
5561895|NCT01040247|Infertility|infertility
5561896|NCT01040247|Low Responder|low responder
5561897|NCT01040247|IVF|ivf
5561898|NCT01040247|Embryo Transfer|embryo transfer
5561899|NCT01040234|postoperative pain|postoperative pain
5561900|NCT01040234|abdominal surgery|abdominal surgery
5561901|NCT01040234|bilateral dual TAP block|bilateral dual tap block
5561902|NCT01040221|Autism, Autism Spectrum Disorder|autism, autism spectrum disorder
5561903|NCT01040221|ASD|asd
5561904|NCT01040221|Trichuris Suis Ova|trichuris suis ova
5561905|NCT01040221|TSO|tso
5561906|NCT01040221|Treatment|treatment
5561907|NCT01040221|Clinical Trial|clinical trial
5561908|NCT01040195|ankylosing spondylitis|ankylosing spondylitis
5561909|NCT01040195|undifferentiated spondyloarthropathy|undifferentiated spondyloarthropathy
5561910|NCT01040195|spondyloarthropathy|spondyloarthropathy
5561911|NCT01040195|inflammatory back pain|inflammatory back pain
5561912|NCT01040195|methotrexate|methotrexate
5561913|NCT01040195|sulfasalazine|sulfasalazine
5561914|NCT01040195|hydroxychloroquine|hydroxychloroquine
5561915|NCT01040182|ischemic stroke patients|ischemic stroke patients
5561916|NCT01040143|Pneumococci|pneumococci
5561917|NCT01040143|Streptococcus pneumoniae|streptococcus pneumoniae
5561918|NCT01040117|Equilibrium|equilibrium
5561919|NCT01040117|Rehabilitation|rehabilitation
5561920|NCT01040117|Randomized Controlled Trial|randomized controlled trial
5561921|NCT01040117|Postural instability|postural instability
5561922|NCT01040117|Sensory-motor integration|sensory-motor integration
5561923|NCT01040104|wound healing|wound healing
5561924|NCT01040104|hypertrophic scar|hypertrophic scar
5561925|NCT01040104|skin transplantation|skin transplantation
5561926|NCT01040104|diabetes mellitus|diabetes mellitus
5546653|NCT01100476|Mynx M5|mynx m5
5561927|NCT01040091|HIV Seronegativity|hiv seronegativity
5561928|NCT01040091|Treatment Experienced|treatment experienced
5561929|NCT01040065|Acromioclavicular joint arthritis|acromioclavicular joint arthritis
5561930|NCT01040065|distal clavicle resection|distal clavicle resection
5561931|NCT01040065|Mumford procedure|mumford procedure
5561932|NCT01040052|Diphtheria|diphtheria
5561933|NCT01040052|Tetanus|tetanus
5561934|NCT01040052|Pertussis|pertussis
5561935|NCT01040052|Adacel®|adacel®
5561937|NCT01040039|HIV|hiv
5561938|NCT01040013|LAPAROSCOPY,|laparoscopy,
5561939|NCT01040013|LAPAROTOMY,|laparotomy,
5561940|NCT01040013|OXYGENATION,|oxygenation,
5561941|NCT01040013|ISCHEMIA-REPERFUSION INJURY|ischemia-reperfusion injury
5561942|NCT01040000|NPC-1C|npc-1c
5561943|NCT01040000|Monoclonal antibody|monoclonal antibody
5561944|NCT01040000|Pancreatic Cancer|pancreatic cancer
5561945|NCT01040000|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5561946|NCT01040000|Ductal carcinoma of the pancreas|ductal carcinoma of the pancreas
5561947|NCT01040000|Duct cell carcinomas, pancreas|duct cell carcinomas, pancreas
5561948|NCT01040000|Carcinomas, pancreas duct cell|carcinomas, pancreas duct cell
5561949|NCT01040000|Pancreas duct cell carcinoma|pancreas duct cell carcinoma
5561950|NCT01040000|Pancreatic duct cell carcinoma|pancreatic duct cell carcinoma
5561951|NCT01040000|Adenocarcinoma of the colon|adenocarcinoma of the colon
5561952|NCT01040000|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
5561953|NCT01040000|Colorectal cancer|colorectal cancer
5561954|NCT01040000|Colorectal tumor|colorectal tumor
5561955|NCT01040000|Colorectal neoplasm|colorectal neoplasm
5561956|NCT01039987|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5561957|NCT01039987|ADPKD|adpkd
5561958|NCT01039987|kidney|kidney
5561959|NCT01039987|Biomarker|biomarker
5561960|NCT01039987|MRI|mri
5561961|NCT01039974|ketoconazole|ketoconazole
5561962|NCT01039974|GSK962040|gsk962040
5561963|NCT01039974|Drug-Drug Interaction|drug-drug interaction
5561964|NCT01039974|Phase I|phase i
5561965|NCT01039961|healthy volunteers|healthy volunteers
5561966|NCT01039961|IV formulation study|iv formulation study
5561967|NCT01039948|Neoplasms|neoplasms
5561968|NCT01039948|Carcinoma|carcinoma
5561969|NCT01039948|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5561970|NCT01039948|Lung Neoplasms|lung neoplasms
5561971|NCT01039948|Respiratory Tract Neoplasms|respiratory tract neoplasms
5561972|NCT01039948|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5561973|NCT01039948|Neoplasms by Histological Type|neoplasms by histological type
5561974|NCT01039948|Thoracic Neoplasms|thoracic neoplasms
5561975|NCT01039948|Neoplasms by Site|neoplasms by site
5561976|NCT01039948|Lung Diseases|lung diseases
5561977|NCT01039948|Respiratory Tract Diseases|respiratory tract diseases
5561978|NCT01039948|Gefitinib|gefitinib
5561979|NCT01039948|Antineoplastic Agents|antineoplastic agents
5561980|NCT01039948|Therapeutic Uses|therapeutic uses
5561981|NCT01039948|Pharmacologic Actions|pharmacologic actions
5561982|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors
5561983|NCT01039948|Enzyme Inhibitors|enzyme inhibitors
5561984|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5561985|NCT01039935|Odor Discrimination|odor discrimination
5561986|NCT01039922|Neuroendocrine Tumors|neuroendocrine tumors
5561987|NCT01039922|Registries|registries
5561988|NCT01039883|Healthy Volunteers|healthy volunteers
5561989|NCT01039870|postthoracotomy pain|postthoracotomy pain
5561990|NCT01039857|Psychotherapy|psychotherapy
5561991|NCT01039857|Depression|depression
5561992|NCT01039857|Adjustment Disorders|adjustment disorders
5561993|NCT01039857|Neuropsychology|neuropsychology
5561994|NCT01039857|Rehabilitation|rehabilitation
5561995|NCT01039857|Coping Skills|coping skills
5561996|NCT01039857|Stroke|stroke
5561997|NCT01039857|Caregivers|caregivers
5561998|NCT01039844|LOC-paclitaxel Injection|loc-paclitaxel injection
5561999|NCT01039844|metastatic Melanoma|metastatic melanoma
5562000|NCT01039831|PIGD|pigd
5562001|NCT01039831|tremor|tremor
5562002|NCT01039831|falls|falls
5562008|NCT01039805|GSK962040|gsk962040
5562009|NCT01039805|13C octanoic acid breath test|13c octanoic acid breath test
5562010|NCT01039805|pharmacokinetics|pharmacokinetics
5562011|NCT01039805|critically ill patients|critically ill patients
5562012|NCT01039805|gut motility|gut motility
5562013|NCT01039805|pharmacodynamics|pharmacodynamics
5562014|NCT01039805|tolerability|tolerability
5562015|NCT01039805|single dose|single dose
5562016|NCT01039805|gastric emtpying|gastric emtpying
5562017|NCT01039792|Autism|autism
5562018|NCT01039792|Pervasive Developmental Disorders|pervasive developmental disorders
5562019|NCT01039779|older fallers|older fallers
5562020|NCT01039779|tai chi|tai chi
5562021|NCT01039766|post traumatic stress disorder|post traumatic stress disorder
5562022|NCT01039766|prevention|prevention
5562023|NCT01039766|oxytocin|oxytocin
5562024|NCT01039753|acute kidney injury|acute kidney injury
5562025|NCT01039753|renal replacement therapy|renal replacement therapy
5562026|NCT01039753|biomarkers|biomarkers
5562027|NCT01039740|Pharmacogenomics|pharmacogenomics
5562028|NCT01039740|Prediction of Mirtazapine response|prediction of mirtazapine response
5562029|NCT01039740|Depressed patients|depressed patients
5562030|NCT01039740|Mirtazapine response|mirtazapine response
5562031|NCT01039740|Adverse event|adverse event
5562032|NCT01039727|Pain [C10.597.617]|pain [c10.597.617]
5562033|NCT01039714|Hypocalcemia|hypocalcemia
5562034|NCT01039714|Hypoparathyroidism|hypoparathyroidism
5562035|NCT01039714|Vitamin D deficiency|vitamin d deficiency
5562036|NCT01039714|Total thyroidectomy|total thyroidectomy
5562037|NCT01039714|calcium|calcium
5562038|NCT01039714|PTH|pth
5562039|NCT01039701|safety|safety
5562040|NCT01039701|tolerability|tolerability
5562041|NCT01039701|mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5562042|NCT01039701|To determine the safety and tolerability of AZD1446 vs Placebo given as an add-on treatment to Donepezil in patients with mild to moderate Alzheimer's disease|to determine the safety and tolerability of azd1446 vs placebo given as an add-on treatment to donepezil in patients with mild to moderate alzheimer's disease
5562043|NCT01039688|oral JAK inhibitor|oral jak inhibitor
5562044|NCT01039688|MTX|mtx
5562045|NCT01039688|DMARD|dmard
5562046|NCT01039688|clinical trial|clinical trial
5562047|NCT01039688|joint diseases|joint diseases
5562048|NCT01039688|autoimmune diseases|autoimmune diseases
5562049|NCT01039688|anti-Inflammatory agents|anti-inflammatory agents
5562050|NCT01039688|rheumatic diseases|rheumatic diseases
5562051|NCT01039675|long-acting beta2-receptor agonist|long-acting beta2-receptor agonist
5562052|NCT01039675|Safety and tolerability|safety and tolerability
5562053|NCT01039675|pharmacodynamics|pharmacodynamics
5562054|NCT01039675|pharmacokinetics|pharmacokinetics
5562055|NCT01039675|long-acting muscarinic receptor antagonist|long-acting muscarinic receptor antagonist
5562056|NCT01039675|COPD|copd
5562057|NCT01039649|radiation|radiation
5562058|NCT01039649|Tomography, Spiral Computed|tomography, spiral computed
5562059|NCT01039649|Four-Dimensional Computed Tomography|four-dimensional computed tomography
5562060|NCT01039649|Respiratory Function Tests|respiratory function tests
5562061|NCT01039636|Beta-thalassemia|beta-thalassemia
5562062|NCT01039636|Sickle cell anemia|sickle cell anemia
5562063|NCT01039636|Transfusional iron overload|transfusional iron overload
5562064|NCT01039636|Iron overload|iron overload
5562065|NCT01039636|Iron chelation|iron chelation
5562066|NCT01039623|Healthy volunteers|healthy volunteers
5562067|NCT01039610|single dose|single dose
5562068|NCT01039610|pharmacokinetics|pharmacokinetics
5562069|NCT01039610|GSK945237|gsk945237
5562070|NCT01039610|tolerability|tolerability
5562071|NCT01039610|safety|safety
5562072|NCT01039610|antibiotics|antibiotics
5562073|NCT01039610|linezolid|linezolid
5562074|NCT01039610|QTc|qtc
5562075|NCT01039610|bacterial type II topoisomerase Inhibitors (BTI)|bacterial type ii topoisomerase inhibitors (bti)
5562076|NCT01039610|moxifloxacin|moxifloxacin
5562077|NCT01039610|repeat dose|repeat dose
5562078|NCT01039597|IBD|ibd
5562079|NCT01039597|Ulcerative colitis|ulcerative colitis
5562080|NCT01039584|bioequivalence|bioequivalence
5562081|NCT01039584|butoconazole|butoconazole
5562082|NCT01039584|vulvovaginal|vulvovaginal
5562083|NCT01039584|candidiasis|candidiasis
5562084|NCT01039571|rotator cuff tear|rotator cuff tear
5562085|NCT01039571|arthroscopic repair|arthroscopic repair
5562086|NCT01039571|single row repair|single row repair
5562087|NCT01039571|double row repair|double row repair
5562088|NCT01039571|retear rate|retear rate
5562089|NCT01039558|gastroesophageal reflux disease|gastroesophageal reflux disease
5562090|NCT01039558|lansoprazole|lansoprazole
5562091|NCT01039558|ecabet sodium|ecabet sodium
5562092|NCT01039545|Urinary tract infections|urinary tract infections
5562093|NCT01039545|Anti-bacterial agents|anti-bacterial agents
5562094|NCT01039532|Type 2 diabetes mellitus|type 2 diabetes mellitus
5562095|NCT01039532|Biphasic human insulin thrice a day|biphasic human insulin thrice a day
5562096|NCT01039532|Basal bolus insulin|basal bolus insulin
5562097|NCT01039519|G.I. Stromal Tumor|g.i. stromal tumor
5562098|NCT01039519|GIST|gist
5562099|NCT01039506|UGT1A1, irinotecan|ugt1a1, irinotecan
5562100|NCT01039480|pharmacological biomarker|pharmacological biomarker
5562101|NCT01039480|compliance monitoring|compliance monitoring
5562102|NCT01039480|platelet aggregometry|platelet aggregometry
5562103|NCT01039480|resistance|resistance
5685394|NCT00556270|fentanyl|fentanyl
5562104|NCT01039480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5562105|NCT01039480|Medication Non-Compliance|medication non-compliance
5562106|NCT01039467|Managed Ventricular Pacing|managed ventricular pacing
5562107|NCT01039454|Food Reward|food reward
5562108|NCT01039454|fMRI|fmri
5562109|NCT01039454|Obese|obese
5562110|NCT01039454|Cognition|cognition
5562111|NCT01039454|Food Addiction|food addiction
5562112|NCT01039454|Behaviour|behaviour
5562113|NCT01039454|Overweight|overweight
5562114|NCT01039454|Food Reinforcement|food reinforcement
5562115|NCT01039454|Metabolic endpoints|metabolic endpoints
5562116|NCT01039428|hyperphosphatemia|hyperphosphatemia
5562117|NCT01039428|hemodialysis|hemodialysis
5562118|NCT01039428|chitosan|chitosan
5562119|NCT01039415|marijuana|marijuana
5562120|NCT01039415|marijuana abuse|marijuana abuse
5562121|NCT01039415|marijuana dependence|marijuana dependence
5562122|NCT01039415|cannabis|cannabis
5562123|NCT01039415|substance-related disorder|substance-related disorder
5562124|NCT01039415|abstinence|abstinence
5562125|NCT01039402|cardiovascular risk|cardiovascular risk
5562126|NCT01039402|France|france
5562127|NCT01039402|Observational, descriptive study|observational, descriptive study
5562128|NCT01039389|Coronary Artery Disease|coronary artery disease
5562129|NCT01039389|Stable|stable
5562130|NCT01039389|Coronary Collaterals|coronary collaterals
5562131|NCT01039389|Therapeutic Collateral Promotion|therapeutic collateral promotion
5562132|NCT01039389|Arteriogenesis|arteriogenesis
5562133|NCT01039389|Bradycardia|bradycardia
5562134|NCT01039376|maintenance therapy|maintenance therapy
5562135|NCT01039376|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5562136|NCT01039376|ofatumumab|ofatumumab
5562137|NCT01039363|Relapse or refractory acute myeloid leukemia|relapse or refractory acute myeloid leukemia
5562138|NCT01039350|Myelodysplastic syndrome|myelodysplastic syndrome
5562139|NCT01039337|osteoarthritis|osteoarthritis
5562140|NCT01039337|manual therapy|manual therapy
5562141|NCT01039337|manipulation|manipulation
5562142|NCT01039337|hip school|hip school
5562143|NCT01039337|chiropractic|chiropractic
5562144|NCT01039337|patient education|patient education
5562145|NCT01039324|Complex patients|complex patients
5562146|NCT01039324|Care transitions|care transitions
5562147|NCT01039324|Patient safety|patient safety
5562148|NCT01039324|Patient care|patient care
5562149|NCT01039324|Health Information Technology|health information technology
5562150|NCT01039324|Health Information Exchange|health information exchange
5562151|NCT01039324|Clinical Decision Support|clinical decision support
5562152|NCT01039324|Care coordination|care coordination
5562153|NCT01039324|Data sharing|data sharing
5562155|NCT01039311|cancer|cancer
5562156|NCT01039311|bronchoscopy|bronchoscopy
5562157|NCT01039311|optical|optical
5562162|NCT01039298|surgical margin|surgical margin
5562163|NCT01039298|recurrence|recurrence
5562168|NCT01039272|oral cancer|oral cancer
5562170|NCT01039272|PCR|pcr
5562171|NCT01039259|adolescent|adolescent
5562172|NCT01039259|body piercing/adverse effects|body piercing/adverse effects
5562173|NCT01039259|tongue piercing|tongue piercing
5562174|NCT01039259|tongue/microbiology|tongue/microbiology
5562175|NCT01039181|Vitamin D|vitamin d
5562176|NCT01039181|Calcitriol|calcitriol
5562177|NCT01039181|cholangiocarcinoma|cholangiocarcinoma
5562178|NCT01039181|Clinical trial|clinical trial
5562179|NCT01039168|Burnout|burnout
5562180|NCT01039168|Sick leave|sick leave
5562181|NCT01039168|Intervention study|intervention study
5562182|NCT01039168|Prospective study|prospective study
5562183|NCT01039168|Work|work
5562184|NCT01039142|Psoriasis|psoriasis
5562185|NCT01039129|Gallstones|gallstones
5562186|NCT01039129|Appendicitis|appendicitis
5562187|NCT01039129|Pelvic pain|pelvic pain
5562188|NCT01039129|Peritoneal mass|peritoneal mass
5562189|NCT01039116|obesity|obesity
5562190|NCT01039116|nutrition|nutrition
5562191|NCT01039116|type 2 diabetes|type 2 diabetes
5562192|NCT01039116|community-based.|community-based.
5562193|NCT01039103|PEG-liposomal prednisolone sodium phosphate|peg-liposomal prednisolone sodium phosphate
5562194|NCT01039090|Not eligible for deep brain stimulation|not eligible for deep brain stimulation
5562195|NCT01039090|Parkinsons's patients|parkinsons's patients
5562196|NCT01039038|prostate|prostate
5562197|NCT01039038|curietherapy|curietherapy
5562198|NCT01039038|radiotherapy|radiotherapy
5562199|NCT01039038|intermediate risk|intermediate risk
5562201|NCT01039025|Topotecan|topotecan
5562202|NCT01039025|Hycamtin|hycamtin
5562203|NCT01039025|Melphalan|melphalan
5562204|NCT01039025|Alkeran|alkeran
5562205|NCT01039025|Cyclophosphamide|cyclophosphamide
5562206|NCT01039025|Cytoxan|cytoxan
5562207|NCT01039025|Neosar|neosar
5562208|NCT01039025|Stem Cell Harvest|stem cell harvest
5562209|NCT01039025|Peripheral Blood Stem Cells|peripheral blood stem cells
5562210|NCT01039012|bone mineral density|bone mineral density
5562211|NCT01039012|osteoporosis|osteoporosis
5562212|NCT01039012|exercise|exercise
5562213|NCT01039012|bone remodeling|bone remodeling
5562214|NCT01039012|biomotion analysis|biomotion analysis
5562215|NCT01038999|Complementary Therapies|complementary therapies
5562216|NCT01038986|chronic wound|chronic wound
5562217|NCT01038986|refractory wound|refractory wound
5562218|NCT01038986|CureXcell|curexcell
5562219|NCT01038986|activated cell suspension|activated cell suspension
5562220|NCT01038960|ICD, training|icd, training
5562221|NCT01038934|Buccal Mucosa|buccal mucosa
5562223|NCT01038934|Polymerase Chain Reaction|polymerase chain reaction
5562224|NCT01038921|Blood Pressure|blood pressure
5562225|NCT01038921|Glucose levels|glucose levels
5562226|NCT01038921|HDL levels|hdl levels
5562227|NCT01038921|Triglyceride levels|triglyceride levels
5562228|NCT01038921|Waist Circumference|waist circumference
5562229|NCT01038908|sentinel lymph node biopsy (SLNB)|sentinel lymph node biopsy (slnb)
5562230|NCT01038908|axillary lymph node dissection (ALND)|axillary lymph node dissection (alnd)
5562231|NCT01038908|lymphatics|lymphatics
5562232|NCT01038908|blue dye|blue dye
5562233|NCT01038895|Hypertension|hypertension
5562234|NCT01038895|type 2 diabetes|type 2 diabetes
5562235|NCT01038895|aliskiren|aliskiren
5562236|NCT01038895|ramipril|ramipril
5562237|NCT01038895|microalbuminuria|microalbuminuria
5562238|NCT01038895|blood pressure> 130/80 <180/105 mmHg at the end of the wash−out|blood pressure> 130/80 <180/105 mmhg at the end of the wash−out
5562239|NCT01038895|type 2 diabetes mellitus well controlled by medication and / or|type 2 diabetes mellitus well controlled by medication and / or
5562240|NCT01038895|compliance with diet (HbA1c <7%)|compliance with diet (hba1c <7%)
5562241|NCT01038895|Microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)|microalbuminuria in the upper range of normal (> 200 <300 mg/24 h)
5562243|NCT01038882|midazolam|midazolam
5562244|NCT01038882|flexible bronchoscopy|flexible bronchoscopy
5562245|NCT01038882|tolerance|tolerance
5562246|NCT01038843|VA106483|va106483
5562247|NCT01038843|Nocturia|nocturia
5562248|NCT01038843|males|males
5562249|NCT01038843|nocturnal voids|nocturnal voids
5562250|NCT01038843|anti-diuretic|anti-diuretic
5562251|NCT01038843|hyponatraemia|hyponatraemia
5562252|NCT01038817|tooth-decay|tooth-decay
5562253|NCT01038817|prevention|prevention
5562254|NCT01038817|fluoride-varnish|fluoride-varnish
5562255|NCT01038817|institutionalised elderly people|institutionalised elderly people
5562256|NCT01038804|Breast Cancer|breast cancer
5562257|NCT01038804|Metastatic|metastatic
5562258|NCT01038804|HER2 Negative|her2 negative
5562259|NCT01038804|YM155|ym155
5562260|NCT01038791|chronic hypercapnic respiratory failure|chronic hypercapnic respiratory failure
5562262|NCT01038791|RTD|rtd
5562263|NCT01038791|sleep architecture|sleep architecture
5562264|NCT01038791|humidification|humidification
5562265|NCT01038765|Recurrent Major Depressive Disorder|recurrent major depressive disorder
5562266|NCT01038765|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5562267|NCT01038765|Randomized Controlled Trial|randomized controlled trial
5562268|NCT01038752|NSCLC|nsclc
5562269|NCT01038752|suramin|suramin
5562270|NCT01038752|lung cancer|lung cancer
5562271|NCT01038752|chemotherapy|chemotherapy
5562272|NCT01038726|Healthy Aging|healthy aging
5562273|NCT01038700|Circulating endothelial compartment|circulating endothelial compartment
5562274|NCT01038700|microparticles|microparticles
5562275|NCT01038700|endothelial progenitors cells|endothelial progenitors cells
5562276|NCT01038700|circulating endothelial cells|circulating endothelial cells
5562277|NCT01038700|transcriptome|transcriptome
5562278|NCT01038700|aging|aging
5562279|NCT01038700|Healthy volunteers|healthy volunteers
5562280|NCT01038687|functional constipation|functional constipation
5562281|NCT01038687|bile acid|bile acid
5562282|NCT01038648|Sitagliptin|sitagliptin
5562283|NCT01038648|Type 2 diabetes|type 2 diabetes
5562284|NCT01038648|Prevention of type 2 diabetes|prevention of type 2 diabetes
5562285|NCT01038635|5-Azacytidine|5-azacytidine
5562286|NCT01038635|5-Aza|5-aza
5562287|NCT01038635|Lenalidomide|lenalidomide
5562288|NCT01038635|Revlimid|revlimid
5562289|NCT01038635|CC-5103|cc-5103
5562290|NCT01038635|Myelodysplastic Syndrome|myelodysplastic syndrome
5562291|NCT01038635|MDS|mds
5562292|NCT01038635|Acute Myelogenous Leukemia|acute myelogenous leukemia
5562293|NCT01038635|AML|aml
5562294|NCT01038622|L-arginine|l-arginine
5562295|NCT01038622|Nasal NO|nasal no
5562296|NCT01038622|Nosocomial infection|nosocomial infection
5562297|NCT01038622|Immune function|immune function
5562298|NCT01038622|HLA-DR expression|hla-dr expression
5562299|NCT01038622|Critically ill|critically ill
5562300|NCT01038622|Medical ICU patients|medical icu patients
5562301|NCT01038609|Postoperative Pain|postoperative pain
5562302|NCT01038596|osteoarthritis, mesenchymal stromal cells, proliferation|osteoarthritis, mesenchymal stromal cells, proliferation
5562303|NCT01038583|Aspirin|aspirin
5562304|NCT01038583|Prevention|prevention
5562306|NCT01038583|Over 70 years old|over 70 years old
5562308|NCT01038583|Aspirin in Reducing Events in the Elderly|aspirin in reducing events in the elderly
5562309|NCT01038583|Australia|australia
5562310|NCT01038583|Functional disability|functional disability
5562311|NCT01038583|Dementia|dementia
5562312|NCT01038583|Heart Disease/ Stroke|heart disease/ stroke
5562313|NCT01038583|Cancer|cancer
5562314|NCT01038583|Bleeding|bleeding
5562315|NCT01038570|Prader Willi syndrome|prader willi syndrome
5562316|NCT01038570|adults|adults
5562317|NCT01038570|social behaviour|social behaviour
5562318|NCT01038570|stress|stress
5562319|NCT01038570|anxiety|anxiety
5562320|NCT01038570|psychological tests|psychological tests
5562321|NCT01038557|frozen|frozen
5562322|NCT01038557|red blood cells|red blood cells
5562323|NCT01038557|transfusion|transfusion
5562324|NCT01038557|trauma|trauma
5562325|NCT01038544|Esophageal Cancer|esophageal cancer
5562326|NCT01038544|Mediastinal lymph nodes|mediastinal lymph nodes
5562327|NCT01038544|Staging|staging
5562328|NCT01038544|EBUS|ebus
5562329|NCT01038544|EUS|eus
5562330|NCT01038544|Endobronchial Ultrasound|endobronchial ultrasound
5562331|NCT01038544|Endoscopic Ultrasound|endoscopic ultrasound
5562332|NCT01038531|Acute lung injury (ALI)|acute lung injury (ali)
5562333|NCT01038531|Adult respiratory distress syndrome (ARDS)|adult respiratory distress syndrome (ards)
5562334|NCT01038531|Low-tidal-volume strategy|low-tidal-volume strategy
5562335|NCT01038531|ARDS Net|ards net
5562336|NCT01038531|airway pressure release ventilation (APRV)|airway pressure release ventilation (aprv)
5562337|NCT01038531|biomarkers of lung injury|biomarkers of lung injury
5562338|NCT01038518|epidemiology|epidemiology
5562339|NCT01038518|risk factors|risk factors
5562340|NCT01038518|micronutrients|micronutrients
5562341|NCT01038479|Xylitol|xylitol
5562342|NCT01038479|Mutans streptococci|mutans streptococci
5562343|NCT01038479|Maternal consumption|maternal consumption
5562344|NCT01038479|Early childhood tooth decay|early childhood tooth decay
5562345|NCT01038479|Early childhood caries|early childhood caries
5562346|NCT01038479|Childsmile|childsmile
5562347|NCT01038466|CHAT|chat
5562348|NCT01038466|breast cancer|breast cancer
5562349|NCT01038466|non interventional observational study|non interventional observational study
5562350|NCT01038440|Omega 3 fatty acids|omega 3 fatty acids
5562351|NCT01038440|Omega 3 Index|omega 3 index
5562352|NCT01038440|Stearidonic acid (SDA)|stearidonic acid (sda)
5562353|NCT01038440|Eicosapentaenoic acid (EPA)|eicosapentaenoic acid (epa)
5562354|NCT01038440|Red blood cells|red blood cells
5562355|NCT01038440|Lipids|lipids
5562356|NCT01038440|Inflammation markers|inflammation markers
5562357|NCT01038427|Rhinitis|rhinitis
5562358|NCT01038427|Allergic|allergic
5562359|NCT01038427|Seasonal|seasonal
5562360|NCT01038427|Mometasone Furoate|mometasone furoate
5562361|NCT01038427|Equivalence|equivalence
5562362|NCT01038401|HIV infection|hiv infection
5562364|NCT01038401|Viral DNA test positive-10063306|viral dna test positive-10063306
5562365|NCT01038401|Blood HIV RNA 10049826|blood hiv rna 10049826
5562366|NCT01038401|Treatment Experienced|treatment experienced
5562367|NCT01038388|Multiple Myeloma|multiple myeloma
5562368|NCT01038375|hypertension|hypertension
5562369|NCT01038375|stroke|stroke
5562370|NCT01038375|adherence|adherence
5562371|NCT01038362|endothelium|endothelium
5562372|NCT01038362|almonds|almonds
5562373|NCT01038362|dietary interventions|dietary interventions
5562374|NCT01038362|coronary artery disease|coronary artery disease
5562375|NCT01038336|Hearing Loss - Noise-Induced|hearing loss - noise-induced
5562376|NCT01038336|Prevention|prevention
5562377|NCT01038336|Computer-assisted instruction|computer-assisted instruction
5562378|NCT01038323|Fibromyalgia|fibromyalgia
5562379|NCT01038323|FMS|fms
5562380|NCT01038310|Parkinson´s disease|parkinson´s disease
5562381|NCT01038310|FP-CIT-SPECT|fp-cit-spect
5562382|NCT01038297|Scarring|scarring
5562383|NCT01038284|Patient Education|patient education
5562384|NCT01038284|Drug Toxicity|drug toxicity
5562385|NCT01038271|palliative care|palliative care
5562386|NCT01038258|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5562387|NCT01038245|Receptor Up-Regulation|receptor up-regulation
5562388|NCT01038245|Smoking|smoking
5562389|NCT01038245|Nicotine|nicotine
5562390|NCT01038245|Neuroimaging|neuroimaging
5562391|NCT01038232|Distress Tolerance|distress tolerance
5562392|NCT01038232|Cocaine Dependence|cocaine dependence
5562393|NCT01038232|Relapse|relapse
5562394|NCT01038232|Limbic System|limbic system
5562395|NCT01038232|Prefrontal Cortex|prefrontal cortex
5562396|NCT01038232|Healthy Volunteer|healthy volunteer
5562397|NCT01038232|HV|hv
5562398|NCT01038219|fever|fever
5562399|NCT01038219|children|children
5562400|NCT01038219|SUBJECTIVE ASSESSMENT|subjective assessment
5562401|NCT01038206|prevention|prevention
5562402|NCT01038206|HIV|hiv
5562403|NCT01038206|drugs|drugs
5562404|NCT01038206|smoking|smoking
5562405|NCT01038206|Hispanic|hispanic
5562406|NCT01038206|Adolescent|adolescent
5562407|NCT01038206|Familias Unidas|familias unidas
5562408|NCT01038206|Parent-Preadolescent Training|parent-preadolescent training
5562409|NCT01038206|parent-centered|parent-centered
5562410|NCT01038206|unsafe sexual behavior|unsafe sexual behavior
5562411|NCT01038206|efficacy|efficacy
5562412|NCT01038206|intervention|intervention
5562413|NCT01038193|Cognition, subarachnoid hemorrhage.|cognition, subarachnoid hemorrhage.
5562414|NCT01038180|pacemaker|pacemaker
5562415|NCT01038180|adverse effects|adverse effects
5562416|NCT01038167|VX-950|vx-950
5562417|NCT01038154|advanced esophageal cancer and stomach cancer|advanced esophageal cancer and stomach cancer
5562418|NCT01038154|Pravastatin|pravastatin
5562419|NCT01038154|Survival|survival
5562420|NCT01038154|adverse effects|adverse effects
5562421|NCT01038128|Bulimia nervosa|bulimia nervosa
5562422|NCT01038128|Bulimia|bulimia
5562423|NCT01038128|Body dysmorphic disorder|body dysmorphic disorder
5562424|NCT01038128|Eating disorders|eating disorders
5562425|NCT01038128|Body image|body image
5562426|NCT01038128|Binge eating|binge eating
5562427|NCT01038128|purging|purging
5562428|NCT01038115|Catheter Ablation|catheter ablation
5562429|NCT01038102|Obesity|obesity
5562430|NCT01038102|Diabetes|diabetes
5562431|NCT01038102|Insulin resistance|insulin resistance
5562432|NCT01038102|Fatty liver|fatty liver
5562433|NCT01038102|NAFLD|nafld
5562434|NCT01038102|Steatosis|steatosis
5562435|NCT01038102|Dietary fatty acids|dietary fatty acids
5562436|NCT01038089|endothelium|endothelium
5562437|NCT01038089|resveratrol|resveratrol
5562438|NCT01038089|diabetes mellitus|diabetes mellitus
5562439|NCT01038076|HIV|hiv
5562440|NCT01038076|AIDS|aids
5562441|NCT01038076|adherence|adherence
5562442|NCT01038076|antiretroviral|antiretroviral
5562443|NCT01038076|aCASI|acasi
5562444|NCT01038076|HAART|haart
5562445|NCT01038076|Complementary Therapies|complementary therapies
5562446|NCT01038076|Adherence Care Manager|adherence care manager
5562447|NCT01038050|Endothelial progenitor cell|endothelial progenitor cell
5562448|NCT01038050|endothelial function(FMD)|endothelial function(fmd)
5798723|NCT00111267|elderly|elderly
5562449|NCT01038050|Gingko Biloba Extract|gingko biloba extract
5562450|NCT01038050|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5562451|NCT01038050|Stable coronary artery disease|stable coronary artery disease
5562452|NCT01038050|Endothelial progenitor cells Numbers|endothelial progenitor cells numbers
5562453|NCT01038037|Lung Cancer|lung cancer
5562454|NCT01038037|Non small cell lung cancer|non small cell lung cancer
5562455|NCT01038037|Triple mutational status|triple mutational status
5562456|NCT01038037|KRAS|kras
5562457|NCT01038037|BRAF|braf
5562458|NCT01038037|PI3K|pi3k
5562459|NCT01038024|antioxidant supplement|antioxidant supplement
5562460|NCT01037998|adenocarcinoma|adenocarcinoma
5562461|NCT01037998|non-small-cell lung cancer|non-small-cell lung cancer
5562462|NCT01037998|gefitinib|gefitinib
5562463|NCT01037998|UFUR|ufur
5562464|NCT01037985|Scarring|scarring
5562465|NCT01037972|Galileo|galileo
5562466|NCT01037972|Whole body vibration|whole body vibration
5562467|NCT01037972|Osteoarthritis|osteoarthritis
5562468|NCT01037972|Knee|knee
5562469|NCT01037972|Physiotherapy|physiotherapy
5562470|NCT01037959|severe cirrhosis|severe cirrhosis
5562471|NCT01037959|Patients with severe cirrhosis|patients with severe cirrhosis
5562473|NCT01037946|Family interventions|family interventions
5562474|NCT01037946|Thailand|thailand
5562475|NCT01037933|Cancer|cancer
5562476|NCT01037933|Humor|humor
5562477|NCT01037933|Distraction|distraction
5562478|NCT01037933|Comedy|comedy
5562479|NCT01037933|Chemotherapy|chemotherapy
5562480|NCT01037907|Oral treatment for MS|oral treatment for ms
5562481|NCT01037907|Oral drug for multiple sclerosis|oral drug for multiple sclerosis
5562482|NCT01037907|Oral RRMS|oral rrms
5562483|NCT01037907|Oral relapsing remitting multiple sclerosis|oral relapsing remitting multiple sclerosis
5562484|NCT01037907|Gamma Linolenic Acid|gamma linolenic acid
5562485|NCT01037907|GLA|gla
5562486|NCT01037907|Fatty acid|fatty acid
5562487|NCT01037907|Triglyceride|triglyceride
5562488|NCT01037907|Structured lipid|structured lipid
5562489|NCT01037907|MRI|mri
5562490|NCT01037907|Magnetic resonance imaging|magnetic resonance imaging
5562491|NCT01037907|gadolinium enhancing lesions|gadolinium enhancing lesions
5562492|NCT01037907|expanded disability status scale|expanded disability status scale
5562493|NCT01037907|EDSS|edss
5562494|NCT01037907|Demyelination|demyelination
5562495|NCT01037907|Remyelination|remyelination
5562496|NCT01037907|TGFB1|tgfb1
5562497|NCT01037907|Transforming growth factor beta 1|transforming growth factor beta 1
5562498|NCT01037907|cytokines|cytokines
5562499|NCT01037907|disease modifying therapy|disease modifying therapy
5562500|NCT01037907|immunomodulator|immunomodulator
5562501|NCT01037907|Anti inflammatory|anti inflammatory
5562502|NCT01037907|Pro inflammatory|pro inflammatory
5562504|NCT01037907|interleukin 1 beta|interleukin 1 beta
5562505|NCT01037907|interferon gamma|interferon gamma
5562506|NCT01037907|Fayaz Master|fayaz master
5562507|NCT01037907|Omega 6|omega 6
5562508|NCT01037907|Polyunsaturated fatty acid|polyunsaturated fatty acid
5562509|NCT01037907|Cytokine balance|cytokine balance
5562510|NCT01037907|Pleneva TM|pleneva tm
5562516|NCT01037868|dual diagnosis|dual diagnosis
5562517|NCT01037868|SMS text messages|sms text messages
5562518|NCT01037855|Swine Flu H1N1 vaccine|swine flu h1n1 vaccine
5562519|NCT01037855|Adjuvanted flu cell culture derived|adjuvanted flu cell culture derived
5562520|NCT01037816|Ankle Sprain|ankle sprain
5562521|NCT01037803|perioperative sublingual microcirculation SDF|perioperative sublingual microcirculation sdf
5562522|NCT01037777|individuals at risk for SCA1, SCA2, SCA3, SCA6 and SCA7|individuals at risk for sca1, sca2, sca3, sca6 and sca7
5562523|NCT01037764|acute lymphoid leukemia|acute lymphoid leukemia
5562524|NCT01037764|primary complete remission|primary complete remission
5562525|NCT01037764|secondary complete remission|secondary complete remission
5562526|NCT01037764|postremission therapy|postremission therapy
5562527|NCT01037764|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5562529|NCT01037751|Symptom burden|symptom burden
5562530|NCT01037751|M. D. Anderson Symptom Inventory|m. d. anderson symptom inventory
5562531|NCT01037751|MDASI-Ovarian Cancer|mdasi-ovarian cancer
5562532|NCT01037751|Symptoms|symptoms
5562533|NCT01037751|Daily functioning|daily functioning
5562534|NCT01037751|Symptom severity|symptom severity
5562535|NCT01037751|Questionnaire|questionnaire
5562536|NCT01037751|Interview|interview
5562537|NCT01037738|ACL reconstruction|acl reconstruction
5562538|NCT01037738|autologous conditioned serum|autologous conditioned serum
5562539|NCT01037738|Orthokine|orthokine
5562540|NCT01037738|osteoarthritis|osteoarthritis
5562541|NCT01037738|interleukin receptor antagonist|interleukin receptor antagonist
5562542|NCT01037738|growth factors|growth factors
5562543|NCT01037738|WOMAC|womac
5562544|NCT01037738|IKDC|ikdc
5562545|NCT01037725|Healthy volunteer|healthy volunteer
5562546|NCT01037725|first time in human|first time in human
5562547|NCT01037725|food effect|food effect
5562548|NCT01037712|Foetuses infection with CMV|foetuses infection with cmv
5562549|NCT01037712|neurological handicap of infectious origin.|neurological handicap of infectious origin.
5562550|NCT01037699|Ovarian stimulation|ovarian stimulation
5562551|NCT01037699|In Vitro Fertilization|in vitro fertilization
5562552|NCT01037699|Luteinizing Hormone|luteinizing hormone
5562553|NCT01037699|GnRH antagonist|gnrh antagonist
5562554|NCT01037699|Implantation rate in infertile patients undergoing In vitro fertilization and embryo transfer.|implantation rate in infertile patients undergoing in vitro fertilization and embryo transfer.
5562556|NCT01037686|DBS|dbs
5562557|NCT01037660|endothelium|endothelium
5562558|NCT01037660|cardiovascular disease|cardiovascular disease
5562559|NCT01037660|dietary fat|dietary fat
5562560|NCT01037660|insulin resistance|insulin resistance
5562561|NCT01037647|Type 2 diabetes|type 2 diabetes
5562562|NCT01037647|Diabetic dyslipidemia|diabetic dyslipidemia
5562563|NCT01037647|VLDL-TG kinetics|vldl-tg kinetics
5562564|NCT01037647|VLDL-TG metabolism|vldl-tg metabolism
5562565|NCT01037634|Avian Influenza|avian influenza
5562566|NCT01037634|H1N1 Influenza|h1n1 influenza
5562567|NCT01037634|Seasonal Influenza|seasonal influenza
5562568|NCT01037621|Herpes simplex type 2|herpes simplex type 2
5562569|NCT01037621|Hepatitis C virus|hepatitis c virus
5562570|NCT01037621|Valacyclovir|valacyclovir
5562571|NCT01037621|Herpes Simplex virus type 2 infection|herpes simplex virus type 2 infection
5562572|NCT01037608|Sativex|sativex
5562573|NCT01037608|fMRI|fmri
5562574|NCT01037608|Alternative Matrices|alternative matrices
5562575|NCT01037608|Brain Imaging|brain imaging
5562576|NCT01037608|THC|thc
5562577|NCT01037595|hemodialysis|hemodialysis
5562578|NCT01037595|turmeric|turmeric
5562579|NCT01037595|pruritus|pruritus
5562580|NCT01037569|Toxicological Screening|toxicological screening
5562581|NCT01037569|Drugs|drugs
5562582|NCT01037569|Alternative Matrices|alternative matrices
5562583|NCT01037569|Urine|urine
5562584|NCT01037569|Children|children
5562585|NCT01037556|AML|aml
5562586|NCT01037556|Acute Myeloid Leukemia|acute myeloid leukemia
5562587|NCT01037556|Acute Myelogenous Leukemia|acute myelogenous leukemia
5562588|NCT01037556|Refractory AML|refractory aml
5562589|NCT01037556|Relapsed AML|relapsed aml
5562590|NCT01037556|Refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5562591|NCT01037556|Relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5562592|NCT01037556|Refractory Acute Myelogenous Leukemia|refractory acute myelogenous leukemia
5562593|NCT01037556|Relapsed Acute Myelogenous Leukemia|relapsed acute myelogenous leukemia
5562594|NCT01037556|ALL|all
5562595|NCT01037556|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5562596|NCT01037556|Relapsed Acute Lymphocytic Leukemia|relapsed acute lymphocytic leukemia
5562597|NCT01037556|Refractory Acute Lymphocytic Leukemia|refractory acute lymphocytic leukemia
5562598|NCT01037556|Relapsed ALL|relapsed all
5562600|NCT01037530|ACE inhibitors|ace inhibitors
5562601|NCT01037530|Intermittent claudication|intermittent claudication
5562602|NCT01037530|Ramipril|ramipril
5562603|NCT01037517|Myeloma|myeloma
5562604|NCT01037517|Multiple Myeloma or Lymphoma Patients undergoing|multiple myeloma or lymphoma patients undergoing
5562605|NCT01037517|mobilization for the purpose of autologous stem cell collection|mobilization for the purpose of autologous stem cell collection
5562606|NCT01037504|safety|safety
5562607|NCT01037504|tolerability|tolerability
5562608|NCT01037504|healthy|healthy
5562609|NCT01037504|inhalation|inhalation
5562610|NCT01037504|Healthy volunteers|healthy volunteers
5562611|NCT01037491|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding|aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding
5562612|NCT01037478|Hodgkin's Lymphoma|hodgkin's lymphoma
5562613|NCT01037478|HDAC|hdac
5562614|NCT01037478|4SC-201|4sc-201
5562615|NCT01037478|Resminostat|resminostat
5562616|NCT01037478|Phase II|phase ii
5562617|NCT01037465|endothelium|endothelium
5562618|NCT01037465|cell signaling|cell signaling
5562619|NCT01037465|N-acetylcysteine|n-acetylcysteine
5547326|NCT01097655|Effectiveness|effectiveness
5562620|NCT01037465|reactive oxygen species|reactive oxygen species
5562621|NCT01037452|Heartburn|heartburn
5562622|NCT01037452|antacid|antacid
5562623|NCT01037452|PPI|ppi
5562624|NCT01037452|Lansoprazole|lansoprazole
5562625|NCT01037452|calcium carbonate|calcium carbonate
5562626|NCT01037452|magnesium hydroxide|magnesium hydroxide
5562627|NCT01037452|Relief of heartburn following ingestion of a heartburn-inducing meal|relief of heartburn following ingestion of a heartburn-inducing meal
5562628|NCT01037426|SND Sinus Node Disease|snd sinus node disease
5562629|NCT01037426|Falls|falls
5562630|NCT01037426|Fractures|fractures
5562631|NCT01037413|Scarring|scarring
5562632|NCT01037400|Knee Replacement|knee replacement
5562633|NCT01037400|Arthroplasty|arthroplasty
5562634|NCT01037374|risk|risk
5562635|NCT01037374|assessment|assessment
5562636|NCT01037374|difficult|difficult
5562637|NCT01037374|endotracheal|endotracheal
5562638|NCT01037374|intubation|intubation
5562639|NCT01037361|Children and Adolescents|children and adolescents
5562640|NCT01037361|Motor Control|motor control
5562641|NCT01037361|Movement-Related Potential|movement-related potential
5562642|NCT01037361|Stereotypic Movement Disorder|stereotypic movement disorder
5562643|NCT01037361|Electroencephalogram (EEG)|electroencephalogram (eeg)
5562644|NCT01037348|Choroidal Neovascularisation|choroidal neovascularisation
5562645|NCT01037348|Pathological Myopia|pathological myopia
5562646|NCT01037335|bone graft|bone graft
5562647|NCT01037335|pain|pain
5562648|NCT01037335|chronic|chronic
5562649|NCT01037322|crohn's disease|crohn's disease
5562650|NCT01037322|ulcerative colitis|ulcerative colitis
5562651|NCT01037322|cannabis|cannabis
5562652|NCT01037322|cannabidiol|cannabidiol
5562653|NCT01037296|catheter ablation|catheter ablation
5562654|NCT01037296|robotic navigation|robotic navigation
5562655|NCT01037283|Bipolar|bipolar
5562656|NCT01037283|Depressed|depressed
5562657|NCT01037270|Patients with conditions (PE, Afib, DVT) requiring ongoing INR measurements.|patients with conditions (pe, afib, dvt) requiring ongoing inr measurements.
5562658|NCT01037231|hyperoxaluria|hyperoxaluria
5562659|NCT01037231|oxalate|oxalate
5562661|NCT01037192|outpatient|outpatient
5562662|NCT01037192|skin and soft tissue infections|skin and soft tissue infections
5562663|NCT01037192|vancomycin intravenous|vancomycin intravenous
5562664|NCT01037153|Intravenous|intravenous
5562665|NCT01037153|Rate of Delivery|rate of delivery
5562666|NCT01037153|Dose Responses|dose responses
5562667|NCT01037153|Variable Intervals|variable intervals
5562668|NCT01037153|Multiple Rapid Injections|multiple rapid injections
5562669|NCT01037127|GSK1120212|gsk1120212
5562670|NCT01037127|BRAF Inhibitor|braf inhibitor
5562671|NCT01037127|melanoma|melanoma
5562672|NCT01037127|MEK Inhibitor|mek inhibitor
5562673|NCT01037114|Hepatitis A and hepatitis B|hepatitis a and hepatitis b
5562674|NCT01037101|acrophobia|acrophobia
5562675|NCT01037101|virtual reality|virtual reality
5562676|NCT01037101|exposure therapy|exposure therapy
5562677|NCT01037101|In Vivo Exposure Therapy plus D-Cycloserine|in vivo exposure therapy plus d-cycloserine
5562678|NCT01037101|In Vivo Exposure Therapy plus Placebo|in vivo exposure therapy plus placebo
5562679|NCT01037101|Virtual Reality Exposure Therapy plus D-Cycloserine|virtual reality exposure therapy plus d-cycloserine
5562680|NCT01037101|Virtual Reality Exposure Therapy plus Placebo|virtual reality exposure therapy plus placebo
5562681|NCT01037101|Wait-List|wait-list
5562682|NCT01037088|cannabis|cannabis
5562683|NCT01037088|marijuana|marijuana
5562684|NCT01037088|neuropathy|neuropathy
5562685|NCT01037088|antinociception|antinociception
5562686|NCT01037088|mood|mood
5562687|NCT01037088|cognition|cognition
5562688|NCT01037088|neuropathic pain|neuropathic pain
5562689|NCT01037075|Schizophrenia|schizophrenia
5562690|NCT01037075|Dual Diagnosis|dual diagnosis
5562691|NCT01037075|Nicotine Nasal Spray|nicotine nasal spray
5562692|NCT01037075|Drug Abuse/Dependence|drug abuse/dependence
5562693|NCT01037075|Cognitive Processes|cognitive processes
5562695|NCT01037049|6vs12|6vs12
5562696|NCT01037049|6 vs 12|6 vs 12
5562697|NCT01037049|Cancer|cancer
5562698|NCT01037049|CRM|crm
5562699|NCT01037049|Circumferential Resection Margin|circumferential resection margin
5562700|NCT01037049|Quality of Life|quality of life
5562701|NCT01037049|MRI|mri
5562702|NCT01037049|Radiology|radiology
5562703|NCT01037049|Abdominoperineal Excision|abdominoperineal excision
5562704|NCT01037049|Anterior Resection|anterior resection
5562705|NCT01037049|Surgery|surgery
5562706|NCT01037049|Pathology|pathology
5562707|NCT01037049|Radiotherapy|radiotherapy
5562708|NCT01037036|Ocular Hypertension|ocular hypertension
5562709|NCT01037036|Open-Angle Glaucoma|open-angle glaucoma
5562710|NCT01037036|Xalatan|xalatan
5562711|NCT01037036|IOP|iop
5562712|NCT01037023|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5562713|NCT01037023|Topotecan|topotecan
5562714|NCT01036971|Physical Examination|physical examination
5562715|NCT01036971|Medical Information|medical information
5562716|NCT01036971|Assessment|assessment
5562717|NCT01036971|Blood Work|blood work
5562718|NCT01036971|Screening|screening
5562719|NCT01036958|Pediatric cGVHD|pediatric cgvhd
5562720|NCT01036958|Response Criteria|response criteria
5562721|NCT01036958|Symptoms|symptoms
5562722|NCT01036958|Quality of Life|quality of life
5562723|NCT01036958|Graft-Versus-Host Disease|graft-versus-host disease
5562724|NCT01036958|GVHD|gvhd
5562725|NCT01036958|Pediatric GVHD|pediatric gvhd
5562726|NCT01036854|Ondansetron, EUR-1025|ondansetron, eur-1025
5562727|NCT01036841|MNE with nocturnal polyuria|mne with nocturnal polyuria
5562728|NCT01036841|monosymptomatic nocturnal enuresis with nocturnal polyuria|monosymptomatic nocturnal enuresis with nocturnal polyuria
5562729|NCT01036802|sickle cell disease|sickle cell disease
5562730|NCT01036802|pulmonary hypertension|pulmonary hypertension
5562731|NCT01036802|coagulation activation|coagulation activation
5562732|NCT01036802|platelet activation|platelet activation
5562733|NCT01036802|endothelial activation|endothelial activation
5562734|NCT01036711|Attention|attention
5562735|NCT01036711|Working Memory|working memory
5562736|NCT01036711|Central Executive Processes|central executive processes
5562737|NCT01036711|Response Preparation|response preparation
5562738|NCT01036711|Cigarettes|cigarettes
5562739|NCT01036685|Adolescents|adolescents
5562740|NCT01036685|Affect|affect
5562741|NCT01036685|fMRI|fmri
5562742|NCT01036685|Task Development|task development
5562744|NCT01036659|acute angiotensin converting enzyme inhibitor angioedema|acute angiotensin converting enzyme inhibitor angioedema
5562745|NCT01036646|Patients on stable OAT therapy for at least 3 months.|patients on stable oat therapy for at least 3 months.
5562746|NCT01036633|mucositis|mucositis
5562747|NCT01036594|Ketoconazole|ketoconazole
5562748|NCT01036594|Dexamethasone|dexamethasone
5562749|NCT01036581|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5562750|NCT01036581|Functional Brain Imaging|functional brain imaging
5562751|NCT01036581|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5562752|NCT01036581|Diffusion Tensor Imaging|diffusion tensor imaging
5562753|NCT01036581|Drug Abuse|drug abuse
5562754|NCT01036568|Psychosis|psychosis
5562755|NCT01036568|Smooth Pursuit|smooth pursuit
5562756|NCT01036568|Motion Perception|motion perception
5562757|NCT01036568|Neurophysiology|neurophysiology
5562758|NCT01036568|fMRI|fmri
5562759|NCT01036529|Spinal Cord Stimulation|spinal cord stimulation
5562760|NCT01036529|Decompression|decompression
5562761|NCT01036529|Fusion with or without instrumentation|fusion with or without instrumentation
5562762|NCT01036529|Discectomy|discectomy
5562763|NCT01036529|Laminectomy|laminectomy
5562764|NCT01036529|Laminotomy|laminotomy
5562765|NCT01036529|Foraminotomy|foraminotomy
5562766|NCT01036516|Drug Cues|drug cues
5562767|NCT01036516|Dopamine Release|dopamine release
5562768|NCT01036516|Psychomotor Stimulants|psychomotor stimulants
5562769|NCT01036516|D2 Dopamine Receptor Subtype|d2 dopamine receptor subtype
5562770|NCT01036516|Neuroimaging|neuroimaging
5562771|NCT01036412|Chlorhexidine|chlorhexidine
5562772|NCT01036412|Chlorhexidine Gel Therapy|chlorhexidine gel therapy
5562773|NCT01036412|1% chlorhexidine gluconate gel|1% chlorhexidine gluconate gel
5562774|NCT01036412|Cariogenic Oral Microflora|cariogenic oral microflora
5562775|NCT01036412|Irradiated Head and Neck Cancer Patients|irradiated head and neck cancer patients
5562776|NCT01036412|caries-forming organisms|caries-forming organisms
5562777|NCT01036412|Radiation treatment|radiation treatment
5562778|NCT01036412|Mouth Cancer|mouth cancer
5562779|NCT01036412|Throat Cancer|throat cancer
5562780|NCT01036412|Tooth decay|tooth decay
5562781|NCT01036399|PTCL|ptcl
5562782|NCT01036360|Obesity|obesity
5562783|NCT01036360|Acute exercise|acute exercise
5562784|NCT01036360|Intensity of exercise|intensity of exercise
5562785|NCT01036360|Energy balance regulation|energy balance regulation
5562786|NCT01036360|Appetite|appetite
5733916|NCT00379210|MMT|mmt
5562787|NCT01036308|dietary fibre|dietary fibre
5562788|NCT01036308|legumes|legumes
5562789|NCT01036308|lupin kernel fibre|lupin kernel fibre
5562790|NCT01036308|soy fibre|soy fibre
5562791|NCT01036308|bile acids|bile acids
5562793|NCT01036308|cholesterol metabolism|cholesterol metabolism
5562794|NCT01036308|Subjects|subjects
5562795|NCT01036243|digestive tolerance|digestive tolerance
5562796|NCT01036243|night sleep|night sleep
5562797|NCT01036243|crying|crying
5562798|NCT01036243|growth|growth
5562799|NCT01036230|fMRI|fmri
5562800|NCT01036230|Methylphenidate|methylphenidate
5562801|NCT01036230|Taste|taste
5562802|NCT01036230|Olfaction|olfaction
5562803|NCT01036230|Addiction|addiction
5562804|NCT01036217|Recruitment|recruitment
5562805|NCT01036217|Adult|adult
5562806|NCT01036217|Telephone|telephone
5562807|NCT01036217|Selection|selection
5562808|NCT01036217|Testing|testing
5562809|NCT01036139|EDS in Parkinson's Disease|eds in parkinson's disease
5562810|NCT01036126|Nicotine|nicotine
5562811|NCT01036126|Cocaine|cocaine
5562812|NCT01036126|N-Back|n-back
5562813|NCT01036126|Craving|craving
5562814|NCT01036126|Dependence|dependence
5562815|NCT01036113|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
5562816|NCT01036087|Inflammatory Breast Cancer|inflammatory breast cancer
5562817|NCT01036087|IBC|ibc
5562818|NCT01036087|Primary breast carcinoma|primary breast carcinoma
5547515|NCT01096784|BPD|bpd
5562819|NCT01036087|HER2 negative overexpression|her2 negative overexpression
5562820|NCT01036087|Panitumumab|panitumumab
5562821|NCT01036087|Vectibix|vectibix
5562822|NCT01036087|Nab-paclitaxel|nab-paclitaxel
5562823|NCT01036087|Paclitaxel|paclitaxel
5562824|NCT01036087|Abraxane|abraxane
5562825|NCT01036087|Carboplatin|carboplatin
5562826|NCT01036087|Paraplatin|paraplatin
5562827|NCT01036087|PNC|pnc
5562828|NCT01036087|5-fluorouracil|5-fluorouracil
5562829|NCT01036087|5-FU|5-fu
5562830|NCT01036087|Adrucil|adrucil
5562831|NCT01036087|Efudex|efudex
5562832|NCT01036087|Epirubicin|epirubicin
5562833|NCT01036087|Ellence|ellence
5562834|NCT01036087|Cyclophosphamide|cyclophosphamide
5562835|NCT01036087|Cytoxan|cytoxan
5562836|NCT01036087|Neosar|neosar
5562837|NCT01036087|FEC|fec
5562838|NCT01036074|Drug Abuse|drug abuse
5562839|NCT01036074|Cocaine|cocaine
5562840|NCT01036074|Cocaine Dependence|cocaine dependence
5562841|NCT01036074|Functional MRI|functional mri
5562842|NCT01036074|Pharmalogical MRI|pharmalogical mri
5562843|NCT01036074|Conditioning|conditioning
5562844|NCT01036061|compulsive discorders|compulsive discorders
5562846|NCT01036048|saphenous vein graft|saphenous vein graft
5545105|NCT01106638|HIV|hiv
5562847|NCT01036048|stent|stent
5562848|NCT01036035|Tolterodine|tolterodine
5562849|NCT01036035|Over active Bladder (OAB)|over active bladder (oab)
5562850|NCT01036035|Incontinence|incontinence
5562851|NCT01036022|mesalazine|mesalazine
5562852|NCT01036022|ulcerative colitis|ulcerative colitis
5562853|NCT01036022|pharmacokinetics/dynamics|pharmacokinetics/dynamics
5562854|NCT01036022|GSK1399686|gsk1399686
5562855|NCT01036009|Hematologic|hematologic
5562856|NCT01036009|Malignancy|malignancy
5562857|NCT01036009|Leukemia|leukemia
5562858|NCT01036009|Pre-leukemic|pre-leukemic
5562859|NCT01036009|Allogeneic|allogeneic
5562860|NCT01036009|Transplant|transplant
5562861|NCT01036009|Pediatric|pediatric
5562862|NCT01035996|Classical Conditioning|classical conditioning
5562863|NCT01035996|fMRI|fmri
5562864|NCT01035996|Schizophrenia|schizophrenia
5562865|NCT01035996|TD Model|td model
5562866|NCT01035996|Incentive Salience|incentive salience
5562867|NCT01035983|menstrually associated migraine (MAM), Migraines,Menstrual Migraines, menstrually related migraines|menstrually associated migraine (mam), migraines,menstrual migraines, menstrually related migraines
5562868|NCT01035944|Chronic wounds|chronic wounds
5562869|NCT01035944|Chronic wound debridement|chronic wound debridement
5562870|NCT01035944|Debridement|debridement
5562871|NCT01035944|Bedside debridement|bedside debridement
5562872|NCT01035944|Surgical debridement|surgical debridement
5562873|NCT01035944|Wound debridement|wound debridement
5562874|NCT01035944|Minimize bacterial re-colonization of wounds|minimize bacterial re-colonization of wounds
5562875|NCT01035944|HemCon ChitoGauze Dressings|hemcon chitogauze dressings
5562876|NCT01035944|HemCon Dressings|hemcon dressings
5562877|NCT01035944|Chitosan-based dressings|chitosan-based dressings
5562878|NCT01035788|PTSD|ptsd
5562879|NCT01035788|mindfulness meditation|mindfulness meditation
5562880|NCT01035788|cognitive behavior therapy|cognitive behavior therapy
5562881|NCT01035788|relationship function|relationship function
5562882|NCT01035788|couple therapy|couple therapy
5562883|NCT01035775|Colonoscopy|colonoscopy
5562884|NCT01035775|Adenoma detection|adenoma detection
5562885|NCT01035775|Colorectal polyps|colorectal polyps
5562886|NCT01035749|pandemic influenza|pandemic influenza
5562887|NCT01035749|Clinical trial|clinical trial
5562888|NCT01035749|H1N1|h1n1
5562889|NCT01035749|children|children
5562890|NCT01035723|Prefrontal Cortex|prefrontal cortex
5562891|NCT01035723|Hippocampus|hippocampus
5562892|NCT01035723|Amygdala|amygdala
5562893|NCT01035723|MRI|mri
5562894|NCT01035723|Cognitive Tasks|cognitive tasks
5562895|NCT01035697|NICHD Neonatal Research Network|nichd neonatal research network
5562896|NCT01035697|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5562897|NCT01035697|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5562898|NCT01035697|Prematurity|prematurity
5562899|NCT01035697|Pro-inflammatory cytokines|pro-inflammatory cytokines
5562900|NCT01035697|Anti-inflammatory cytokines|anti-inflammatory cytokines
5562901|NCT01035697|Interleukin-1 (IL-1β)|interleukin-1 (il-1β)
5562902|NCT01035697|Interleukin-2 (IL-2)|interleukin-2 (il-2)
5562903|NCT01035697|Interleukin-3 (IL-3)|interleukin-3 (il-3)
5562904|NCT01035697|Interleukin-8 (IL-8)|interleukin-8 (il-8)
5562905|NCT01035697|Interleukin-9 (IL-9)|interleukin-9 (il-9)
5562906|NCT01035697|Tumor necrosis factor-α (TNF-α)|tumor necrosis factor-α (tnf-α)
5562907|NCT01035697|Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)|regulated upon activation, normal t-cell expressed and secreted (rantes)
5562908|NCT01035658|Pazopanib|pazopanib
5562909|NCT01035658|Doxil|doxil
5562910|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin
5562911|NCT01035658|Advanced relapsed|advanced relapsed
5562912|NCT01035658|platinum-sensitive|platinum-sensitive
5562913|NCT01035658|platinum-resistant|platinum-resistant
5562914|NCT01035645|First time in human|first time in human
5562915|NCT01035645|Interleukin-18|interleukin-18
5562916|NCT01035645|Healthy male subjects|healthy male subjects
5562917|NCT01035645|Obese male subjects|obese male subjects
5562918|NCT01035645|Monoclonal antibody|monoclonal antibody
5562919|NCT01035645|Pharmacokinetics|pharmacokinetics
5562920|NCT01035645|Tolerability|tolerability
5562921|NCT01035645|Safety|safety
5562922|NCT01035645|Pharmacodynamics|pharmacodynamics
5562923|NCT01035632|Craving|craving
5562924|NCT01035632|Incubation|incubation
5562925|NCT01035632|Relapse|relapse
5562926|NCT01035632|Smoking Cues|smoking cues
5562927|NCT01035632|Cortisol|cortisol
5562928|NCT01035619|onchocerciasis; river blindness; moxidectin; pediatric|onchocerciasis; river blindness; moxidectin; pediatric
5562929|NCT01035606|attention|attention
5562930|NCT01035606|rehabilitation|rehabilitation
5562931|NCT01035606|training|training
5562932|NCT01035606|functional MRI|functional mri
5562933|NCT01035606|executive function|executive function
5562934|NCT01035606|brain injury|brain injury
5562935|NCT01035580|chemoprevention|chemoprevention
5562936|NCT01035580|curcumin|curcumin
5562937|NCT01035580|pharmacokinetics|pharmacokinetics
5562938|NCT01035580|safety|safety
5562939|NCT01035567|Multivessel coronary artery disease|multivessel coronary artery disease
5565580|NCT01024673|H1N1|h1n1
5562940|NCT01035567|Hybrid revascularization|hybrid revascularization
5545173|NCT01106391|AAA|aaa
5562941|NCT01035567|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5562942|NCT01035567|Percutaneous Coronary Interventions|percutaneous coronary interventions
5562943|NCT01035567|Drug eluting stents|drug eluting stents
5562944|NCT01035554|high blood pressure|high blood pressure
5562945|NCT01035541|Major non-cardiac surgery,|major non-cardiac surgery,
5562946|NCT01035541|hemodynamic management,|hemodynamic management,
5562947|NCT01035541|PiCCO,|picco,
5562948|NCT01035541|acute kidney injury,|acute kidney injury,
5562949|NCT01035541|renal outcome|renal outcome
5562950|NCT01035528|diastolic function, postmeal glucose, insulin glargine|diastolic function, postmeal glucose, insulin glargine
5562951|NCT01035515|Healthy subjects|healthy subjects
5562952|NCT01035502|Cancer|cancer
5562953|NCT01035502|CP-4055|cp-4055
5562954|NCT01035502|elacytarabine|elacytarabine
5562955|NCT01035502|combination|combination
5562956|NCT01035502|idarubicin|idarubicin
5562957|NCT01035502|Acute myeloid leukaemia (AML)|acute myeloid leukaemia (aml)
5562958|NCT01035489|Pacemaker treatment in heart failure|pacemaker treatment in heart failure
5562959|NCT01035489|Cardiac resynchronization therapy|cardiac resynchronization therapy
5562960|NCT01035489|DDD pacemakers|ddd pacemakers
5562962|NCT01035476|nasal ventilation|nasal ventilation
5562963|NCT01035476|data card recording|data card recording
5562964|NCT01035450|Coronary stent|coronary stent
5562965|NCT01035437|obstructing|obstructing
5562966|NCT01035424|Batten Disease|batten disease
5562967|NCT01035424|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5562968|NCT01035424|LINCL|lincl
5562969|NCT01035411|COPD|copd
5562970|NCT01035398|stage 0 esophageal cancer|stage 0 esophageal cancer
5562971|NCT01035398|stage I esophageal cancer|stage i esophageal cancer
5562972|NCT01035398|stage II esophageal cancer|stage ii esophageal cancer
5562973|NCT01035398|stage III esophageal cancer|stage iii esophageal cancer
5562974|NCT01035398|stage IV esophageal cancer|stage iv esophageal cancer
5562975|NCT01035385|FOFLOX4|foflox4
5562976|NCT01035385|resectable liver metastasis from colorectal cancer|resectable liver metastasis from colorectal cancer
5562977|NCT01035372|healthy older people|healthy older people
5562978|NCT01035359|radius|radius
5562979|NCT01035359|fracture|fracture
5562980|NCT01035359|wrist|wrist
5562981|NCT01035359|external|external
5562982|NCT01035359|fixation|fixation
5562983|NCT01035359|volar|volar
5562984|NCT01035359|plate|plate
5562985|NCT01035359|DASH|dash
5562986|NCT01035359|PRWE|prwe
5562987|NCT01035346|Fever|fever
5562988|NCT01035346|antipyretic|antipyretic
5562989|NCT01035346|uncomplicated acute viral infection|uncomplicated acute viral infection
5562990|NCT01035346|uncomplicated acute bacterial infections|uncomplicated acute bacterial infections
5562991|NCT01035333|gastric bypass surgery|gastric bypass surgery
5562992|NCT01035307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5562993|NCT01035307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5562994|NCT01035281|Diabetic Neuropathies|diabetic neuropathies
5562995|NCT01035281|Neuropathic Pain|neuropathic pain
5562996|NCT01035281|Cannabinoids|cannabinoids
5562997|NCT01035281|Tree Number C10.668.829.300|tree number c10.668.829.300
5562998|NCT01035268|breast cancer treated by conservative surgery|breast cancer treated by conservative surgery
5562999|NCT01035255|chronic heart failure|chronic heart failure
5563000|NCT01035255|cardiovascular death|cardiovascular death
5563001|NCT01035255|hospitalization|hospitalization
5563004|NCT01035255|KCCQ|kccq
5563005|NCT01035255|eGFR|egfr
5563006|NCT01035242|OCD|ocd
5563007|NCT01035242|obsessions|obsessions
5563008|NCT01035242|cognitive|cognitive
5563009|NCT01035229|Hepatocellular carcinoma|hepatocellular carcinoma
5563010|NCT01035229|randomized trial|randomized trial
5563011|NCT01035229|medical treatment|medical treatment
5563012|NCT01035229|RAD001|rad001
5563013|NCT01035229|placebo|placebo
5563014|NCT01035229|Advanced Hepatocellular Carcinoma (HCC)|advanced hepatocellular carcinoma (hcc)
5563015|NCT01035216|Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)|relapsed or refractory b-cell chronic lymphocytic leukemia (b-cll)
5563016|NCT01035190|Preterm Infants|preterm infants
5563017|NCT01035190|Inhaled Corticosteroids|inhaled corticosteroids
5563018|NCT01035190|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5563019|NCT01035177|Bone Mineral Density (BMD);|bone mineral density (bmd);
5563020|NCT01035177|Cortical bone;|cortical bone;
5563021|NCT01035177|Hip fracture;|hip fracture;
5563022|NCT01035177|Osteoporosis;|osteoporosis;
5563023|NCT01035177|Quantitative Computed Tomography (QCT).|quantitative computed tomography (qct).
5563024|NCT01035164|Alzheimer's Disease|alzheimer's disease
5563025|NCT01035164|Diagnostic Imaging|diagnostic imaging
5563026|NCT01035164|Neuroinflammation|neuroinflammation
5563027|NCT01035164|PET Diagnosis|pet diagnosis
5563028|NCT01035164|PET Tracer|pet tracer
5563029|NCT01035151|randomized cluster design|randomized cluster design
5563030|NCT01035151|tobacco cessation|tobacco cessation
5563031|NCT01035151|smoking cessation|smoking cessation
5563032|NCT01035151|African American|african american
5565673|NCT01024166|PRO|pro
5563033|NCT01035125|Self-management|self-management
5563034|NCT01035125|Self-efficacy|self-efficacy
5563035|NCT01035125|Coping|coping
5563036|NCT01035125|Health consumer|health consumer
5563037|NCT01035125|Patient education|patient education
5563038|NCT01035125|Health related quality of life|health related quality of life
5563039|NCT01035099|Letrozole|letrozole
5563040|NCT01035099|IVF (in vitro fertilization)|ivf (in vitro fertilization)
5563041|NCT01035099|Cryopreservation|cryopreservation
5563042|NCT01035099|Fertility Preservation|fertility preservation
5563043|NCT01035099|Breast Cancer|breast cancer
5563044|NCT01035086|dietary fibre|dietary fibre
5563045|NCT01035086|lupin kernel fibre|lupin kernel fibre
5563046|NCT01035086|bile acids|bile acids
5563047|NCT01035086|cholesterol metabolism|cholesterol metabolism
5563048|NCT01035086|blood lipids|blood lipids
5563049|NCT01035086|hypercholesterolemia|hypercholesterolemia
5563340|NCT01033656|anakinra|anakinra
5563050|NCT01035086|fibre-enriched food|fibre-enriched food
5563051|NCT01035086|moderate hypercholesterolemia|moderate hypercholesterolemia
5563052|NCT01035047|Acute Coronary Syndrome|acute coronary syndrome
5563053|NCT01035047|Chest pain|chest pain
5563054|NCT01035047|Cardiac MRI|cardiac mri
5563055|NCT01035047|Risk Stratification|risk stratification
5563056|NCT01035047|Emergency Department|emergency department
5563057|NCT01035008|pancreatic cysts|pancreatic cysts
5563058|NCT01034982|COPD|copd
5563059|NCT01034969|Hereditary angioedema|hereditary angioedema
5563060|NCT01034956|Soft tissue filler|soft tissue filler
5563061|NCT01034956|Dermal filler|dermal filler
5563062|NCT01034956|Complications|complications
5563063|NCT01034956|Patient satisfaction|patient satisfaction
5563064|NCT01034943|radius|radius
5563065|NCT01034943|fracture|fracture
5563066|NCT01034943|wrist|wrist
5563067|NCT01034943|external|external
5563068|NCT01034943|fixation|fixation
5563069|NCT01034943|volar|volar
5563070|NCT01034943|plate|plate
5563071|NCT01034943|DASH|dash
5563072|NCT01034943|PRWE|prwe
5563073|NCT01034930|MANDIBLE|mandible
5563074|NCT01034930|IMPLANTS|implants
5563075|NCT01034930|OVERDENTURE|overdenture
5563076|NCT01034917|Active Comparator|active comparator
5563077|NCT01034917|Placebo Comparator|placebo comparator
5563078|NCT01034917|Sham Comparator|sham comparator
5563079|NCT01034917|No intervention|no intervention
5563080|NCT01034917|Other|other
5563081|NCT01034917|Treatment Experienced|treatment experienced
5563082|NCT01034904|Quality of Life|quality of life
5563083|NCT01034904|HRQoL|hrqol
5563084|NCT01034904|Hemophilia A|hemophilia a
5734299|NCT00378534|CML|cml
5563085|NCT01034904|Helixate FS|helixate fs
5563086|NCT01034891|BRCA mutation|brca mutation
5563087|NCT01034891|benign breast disease|benign breast disease
5563088|NCT01034891|family history of breast cancer|family history of breast cancer
5563089|NCT01034891|strong family history of breast cancer|strong family history of breast cancer
5563090|NCT01034891|atypical ductal hyperplasia|atypical ductal hyperplasia
5563091|NCT01034891|atypical lobular hyperplasia|atypical lobular hyperplasia
5563092|NCT01034891|high risk for breast cancer|high risk for breast cancer
5563093|NCT01034852|Atrial Fibrillation|atrial fibrillation
5563095|NCT01034852|Ablation|ablation
5563096|NCT01034839|acute myeloid leukemia|acute myeloid leukemia
5563097|NCT01034839|prognosis|prognosis
5563098|NCT01034839|cytarabine|cytarabine
5563099|NCT01034826|NGT, IGT, diabetes|ngt, igt, diabetes
5563100|NCT01034813|contractures, range of motion, scar formation|contractures, range of motion, scar formation
5563101|NCT01034800|HIV Positive|hiv positive
5563102|NCT01034787|CP-675,206|cp-675,206
5563103|NCT01034787|Immunotherapy|immunotherapy
5563104|NCT01034787|AntiCTLA4|antictla4
5563105|NCT01034787|Clinical Trial|clinical trial
5563106|NCT01034787|Unresectable or Metastatic|unresectable or metastatic
5563107|NCT01034774|Human volunteers|human volunteers
5563108|NCT01034761|Electronic prescribing|electronic prescribing
5563109|NCT01034761|Inappropriate medications|inappropriate medications
5563110|NCT01034761|Patient safety|patient safety
5563111|NCT01034761|Elderly patients in the hospital|elderly patients in the hospital
5563112|NCT01034748|Radiolabelled|radiolabelled
5563113|NCT01034748|Mass Balance|mass balance
5563114|NCT01034748|Healthy Volunteers|healthy volunteers
5563115|NCT01034748|Pharmacokinetics|pharmacokinetics
5563116|NCT01034735|Saizen®|saizen®
5563117|NCT01034735|bioequivalence|bioequivalence
5563118|NCT01034735|recombinant human|recombinant human
5563119|NCT01034735|Growth Hormone|growth hormone
5563120|NCT01034735|treatment of growth failure in children|treatment of growth failure in children
5563121|NCT01034735|growth hormone deficiency in adults|growth hormone deficiency in adults
5563122|NCT01034722|Breast Milk|breast milk
5563123|NCT01034722|Fat Globules|fat globules
5563124|NCT01034709|Cytomegalovirus|cytomegalovirus
5563126|NCT01034657|MDS|mds
5563127|NCT01034657|bone marrow|bone marrow
5563128|NCT01034657|anemia|anemia
5563129|NCT01034657|cytopenia|cytopenia
5563130|NCT01034657|transfusion dependance|transfusion dependance
5563131|NCT01034657|EPO|epo
5563132|NCT01034657|ESA|esa
5563133|NCT01034657|erythropoietin|erythropoietin
5563134|NCT01034657|LBH589|lbh589
5563135|NCT01034657|Myelodysplastic Syndromes|myelodysplastic syndromes
5545367|NCT01105546|hemophilia A|hemophilia a
5563136|NCT01034657|hematopoietic improvement|hematopoietic improvement
5563137|NCT01034657|IPSS Low|ipss low
5563138|NCT01034657|IPSS Int-1|ipss int-1
5563139|NCT01034657|HI-E|hi-e
5563140|NCT01034657|HDAC Inhibitor|hdac inhibitor
5563141|NCT01034657|HDAC-I|hdac-i
5563142|NCT01034657|DAC-I|dac-i
5563143|NCT01034657|Deacetylase-Inhibitor|deacetylase-inhibitor
5563144|NCT01034657|Histone Deacetylase-Inhibitor|histone deacetylase-inhibitor
5563145|NCT01034657|red blood cell transfusions|red blood cell transfusions
5563146|NCT01034644|Biomarkers|biomarkers
5563147|NCT01034644|Genetic markers|genetic markers
5563148|NCT01034631|Metastatic Kidney Cancer|metastatic kidney cancer
5563149|NCT01034631|BNC105P|bnc105p
5563150|NCT01034618|Diabetes|diabetes
5563151|NCT01034618|protein|protein
5563152|NCT01034618|protein hydrolysate|protein hydrolysate
5563153|NCT01034579|Biomarkers|biomarkers
5563154|NCT01034579|Genetic markers|genetic markers
5563155|NCT01034527|Anterior Cruciate Ligament|anterior cruciate ligament
5563156|NCT01034527|Female Athlete|female athlete
5563157|NCT01034527|Sports Injuries|sports injuries
5563158|NCT01034527|Injury Prevention|injury prevention
5563159|NCT01034501|periodontitis|periodontitis
5563160|NCT01034501|photodynamic therapy|photodynamic therapy
5563161|NCT01034475|acute myeloid leukemia|acute myeloid leukemia
5563162|NCT01034475|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5563163|NCT01034475|multiple myeloma|multiple myeloma
5563164|NCT01034475|chronic myeloid\ leukemia in blast phase|chronic myeloid\ leukemia in blast phase
5563165|NCT01034462|Depression|depression
5563166|NCT01034462|Major Depressive Disorder|major depressive disorder
5563167|NCT01034449|allo graft|allo graft
5563168|NCT01034449|cord blood|cord blood
5563169|NCT01034449|expansion|expansion
5563170|NCT01034449|reduced-intensity conditioning|reduced-intensity conditioning
5563171|NCT01034423|Focus: health effects from omega-3 fatty acids, from fish oil with different quality|focus: health effects from omega-3 fatty acids, from fish oil with different quality
5563172|NCT01034410|AS1411|as1411
5563174|NCT01034410|relapsed|relapsed
5563175|NCT01034410|refractory|refractory
5563176|NCT01034410|aptamer|aptamer
5563177|NCT01034410|nucleolin|nucleolin
5563178|NCT01034384|fMRI|fmri
5563179|NCT01034384|Smoking Withdrawal|smoking withdrawal
5563180|NCT01034384|Imaging|imaging
5563181|NCT01034384|Memory|memory
5563182|NCT01034384|Mood|mood
5671984|NCT00613288|experimental|experimental
5563183|NCT01034371|Coronary Artery Disease; Hybrid Revascularization;|coronary artery disease; hybrid revascularization;
5563184|NCT01034371|Percutaneous Coronary Intervention; Coronary Artery Bypass|percutaneous coronary intervention; coronary artery bypass
5563185|NCT01034358|inflammatory bowel disease|inflammatory bowel disease
5563187|NCT01034358|ulcerative colitis|ulcerative colitis
5563188|NCT01034358|Papillomavirus vaccines|papillomavirus vaccines
5563189|NCT01034345|Sirolimus|sirolimus
5563190|NCT01034345|Liver Transplantation|liver transplantation
5563191|NCT01034345|Tolerance|tolerance
5563192|NCT01034345|Immune responses|immune responses
5563193|NCT01034345|Allograft tolerance|allograft tolerance
5563194|NCT01034332|Esophageal cancer|esophageal cancer
5563195|NCT01034332|Esophagectomy|esophagectomy
5563196|NCT01034332|Paclitaxel|paclitaxel
5563197|NCT01034332|Induction chemotherapy|induction chemotherapy
5563198|NCT01034319|type 2 diabetes|type 2 diabetes
5563200|NCT01034319|genetic counseling|genetic counseling
5563201|NCT01034319|diabetes prevention|diabetes prevention
5563202|NCT01034293|feeding frequency|feeding frequency
5563203|NCT01034293|insulin metabolism|insulin metabolism
5563204|NCT01034293|glucose metabolism|glucose metabolism
5563205|NCT01034293|substrate partitioning|substrate partitioning
5563206|NCT01034280|Down Syndrome|down syndrome
5563207|NCT01034280|phenotype|phenotype
5563208|NCT01034280|genotype|genotype
5563209|NCT01034280|patient family|patient family
5563210|NCT01034267|Depression|depression
5563211|NCT01034267|Major Depressive Disorder|major depressive disorder
5563212|NCT01034254|influenza|influenza
5563213|NCT01034254|immunization|immunization
5563214|NCT01034254|pregnancy|pregnancy
5563215|NCT01034254|efficacy|efficacy
5563216|NCT01034254|pertussis|pertussis
5563217|NCT01034254|hepatitis E|hepatitis e
5563218|NCT01034241|milk protein|milk protein
5563219|NCT01034241|overweight|overweight
5563220|NCT01034241|insulin metabolism|insulin metabolism
5563221|NCT01034241|substrate partitioning|substrate partitioning
5563222|NCT01034228|Diarrhoea|diarrhoea
5563223|NCT01034228|L-isoleucine|l-isoleucine
5563224|NCT01034228|children|children
5563226|NCT01034228|Antibacterial peptide|antibacterial peptide
5563227|NCT01034215|Behavioral|behavioral
5563228|NCT01034215|Quality of Life|quality of life
5563229|NCT01034215|Breast Cancer|breast cancer
5563230|NCT01034189|Esophageal cancer|esophageal cancer
5563231|NCT01034189|Chemoradiotherapy|chemoradiotherapy
5563232|NCT01034189|Paclitaxel|paclitaxel
5563233|NCT01034189|Cetuximab|cetuximab
5563234|NCT01034176|BK viremia|bk viremia
5563235|NCT01034176|kidney transplantation|kidney transplantation
5563236|NCT01034176|BK viremia in kidney transplant recipients|bk viremia in kidney transplant recipients
5563237|NCT01034163|Phase III randomized|phase iii randomized
5563238|NCT01034163|double blind|double blind
5563239|NCT01034163|placebo controlled multi-center study|placebo controlled multi-center study
5563240|NCT01034163|panobinostat|panobinostat
5563241|NCT01034163|Hodgkin's lymphoma|hodgkin's lymphoma
5563242|NCT01034163|at risk for relapse|at risk for relapse
5563243|NCT01034163|autologous stem cell transplant|autologous stem cell transplant
5563244|NCT01034137|Treat-to-target, tight control, strategy study, TCZ, MTX|treat-to-target, tight control, strategy study, tcz, mtx
5563245|NCT01034124|warfarin|warfarin
5563246|NCT01034124|midazolam|midazolam
5563247|NCT01034124|cranberry juice|cranberry juice
5563248|NCT01034124|pharmacokinetics|pharmacokinetics
5563249|NCT01034098|Obesity|obesity
5563250|NCT01034098|Postmenopausal women|postmenopausal women
5563251|NCT01034098|Mechanical ventilatory constraints|mechanical ventilatory constraints
5563252|NCT01034098|Dynamic lung volume|dynamic lung volume
5563253|NCT01034098|Expiratory flow limitation|expiratory flow limitation
5563254|NCT01034085|Nicotine|nicotine
5563255|NCT01034085|Schizophrenia|schizophrenia
5563256|NCT01034085|Cognition|cognition
5563257|NCT01034085|Genes|genes
5563258|NCT01034085|Smoking|smoking
5563259|NCT01034085|Cigarette Smoking|cigarette smoking
5563260|NCT01034046|Obesity|obesity
5563261|NCT01034033|quality of life|quality of life
5563262|NCT01034020|Nasal Spray|nasal spray
5563263|NCT01034020|Attention Network Test|attention network test
5563264|NCT01034020|Continuous Performance Test|continuous performance test
5563265|NCT01034020|Attentional Blink Test|attentional blink test
5563266|NCT01034007|tissue engineered vascular graft|tissue engineered vascular graft
5563267|NCT01033994|Knee osteoarthritis|knee osteoarthritis
5563268|NCT01033994|Fibroblast growth factor 18|fibroblast growth factor 18
5563269|NCT01033994|Sprifermin|sprifermin
5563270|NCT01033981|cost effectiveness|cost effectiveness
5563271|NCT01033981|Sunitinib Central America and Caribbean Metastatic Renal Cell Carcinoma|sunitinib central america and caribbean metastatic renal cell carcinoma
5563272|NCT01033968|lasers|lasers
5563273|NCT01033968|pain measurement|pain measurement
5563274|NCT01033968|photocoagulation|photocoagulation
5563275|NCT01033968|retina|retina
5563276|NCT01033955|critical care|critical care
5563277|NCT01033955|H1N1/influenza infection|h1n1/influenza infection
5563278|NCT01033955|respiration|respiration
5563279|NCT01033955|ventilation, artificial|ventilation, artificial
5563280|NCT01033955|critically ill patients|critically ill patients
5563281|NCT01033955|invasive mechanical ventilation|invasive mechanical ventilation
5563282|NCT01033955|H1N1/influenza infection (suspected, probable or confirmed)|h1n1/influenza infection (suspected, probable or confirmed)
5563283|NCT01033942|Pre-exposure prophylaxis|pre-exposure prophylaxis
5563284|NCT01033942|HIV Prevention|hiv prevention
5563285|NCT01033942|Truvada|truvada
5563286|NCT01033942|Many Men, Many Voices|many men, many voices
5563287|NCT01033942|Emtricitabine|emtricitabine
5563288|NCT01033942|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5563289|NCT01033942|Young men who have sex with men|young men who have sex with men
5563290|NCT01033942|HIV Seronegativity|hiv seronegativity
5563291|NCT01033929|tuberculosis|tuberculosis
5563292|NCT01033929|ESAT-6|esat-6
5563293|NCT01033929|CFP-10|cfp-10
5563294|NCT01033929|skin test|skin test
5563295|NCT01033929|diagnostic test|diagnostic test
5563296|NCT01033916|Blood Glucose|blood glucose
5563297|NCT01033916|Insulin/Administration and Dosage|insulin/administration and dosage
5563298|NCT01033916|Coronary Artery Bypass|coronary artery bypass
5563299|NCT01033903|Abortion, Spontaneous|abortion, spontaneous
5563300|NCT01033903|Randomized Controlled Trial|randomized controlled trial
5563301|NCT01033890|local anesthesia|local anesthesia
5563302|NCT01033890|cochlear implant|cochlear implant
5563303|NCT01033890|sedation|sedation
5563304|NCT01033890|3 patients submitted to cochlear implant surgery with local anesthesia with sedation|3 patients submitted to cochlear implant surgery with local anesthesia with sedation
5563305|NCT01033877|Immunisation, active|immunisation, active
5563306|NCT01033812|Networks|networks
5563307|NCT01033812|Index recruiter|index recruiter
5563308|NCT01033799|Probiotic - Lactobacillus casei DN114-001|probiotic - lactobacillus casei dn114-001
5563309|NCT01033799|dairy product - infections - shiftworkers|dairy product - infections - shiftworkers
5563310|NCT01033799|Common infectious diseases,|common infectious diseases,
5563311|NCT01033799|occuring in healthy subjects,|occuring in healthy subjects,
5563312|NCT01033799|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),|including upper respiratory tract infections (defined as rhinopharyngitis, sore throat, sinusitis and otitis),
5563313|NCT01033799|lower respiratory tract infections (defined as bronchitis,|lower respiratory tract infections (defined as bronchitis,
5563314|NCT01033799|pneumopathy and flu and flu-like syndromes), and|pneumopathy and flu and flu-like syndromes), and
5563315|NCT01033799|gastrointestinal tract infection defined as gastroenteritis.|gastrointestinal tract infection defined as gastroenteritis.
5563316|NCT01033773|Type 2 diabetes mellitus|type 2 diabetes mellitus
5563317|NCT01033773|Uncontrolled hyperglycemia|uncontrolled hyperglycemia
5563318|NCT01033773|Emergency Department|emergency department
5563319|NCT01033760|Primary HIV-1 infection|primary hiv-1 infection
5563320|NCT01033760|antiretroviral treatment|antiretroviral treatment
5563321|NCT01033760|HIV reservoirs|hiv reservoirs
5563322|NCT01033760|HIV-DNA levels|hiv-dna levels
5563323|NCT01033760|randomized|randomized
5563324|NCT01033760|Treatment Naive|treatment naive
5563325|NCT01033747|iron overload|iron overload
5563326|NCT01033747|iron chelation therapy|iron chelation therapy
5563327|NCT01033747|B-thalassemia|b-thalassemia
5563328|NCT01033708|Psychotherapy|psychotherapy
5563329|NCT01033708|PTSD|ptsd
5563330|NCT01033708|Borderline personality disorders|borderline personality disorders
5563331|NCT01033695|Endoscopy|endoscopy
5563332|NCT01033695|Endoscopic Ultrasound|endoscopic ultrasound
5563333|NCT01033695|Endoscopic Sonoelastography|endoscopic sonoelastography
5563334|NCT01033695|Cancer|cancer
5563335|NCT01033695|Interobserver agreement|interobserver agreement
5563336|NCT01033669|Inhalation profiles|inhalation profiles
5563337|NCT01033669|asthma|asthma
5563338|NCT01033669|COPD|copd
5563339|NCT01033656|adult-onset Still's disease|adult-onset still's disease
5563341|NCT01033656|prednisolone|prednisolone
5563342|NCT01033656|disease-modifying antirheumatic drug|disease-modifying antirheumatic drug
5563343|NCT01033656|methotrexate|methotrexate
5563344|NCT01033656|efficacy|efficacy
5563345|NCT01033656|patients|patients
5563346|NCT01033617|Stem cells|stem cells
5563347|NCT01033617|Cellular therapy|cellular therapy
5563348|NCT01033617|Myocardial repair|myocardial repair
5563349|NCT01033591|Primary Health Care|primary health care
5563350|NCT01033591|Family PractiCe|family practice
5563351|NCT01033591|Hearth Failure|hearth failure
5563352|NCT01033591|Exercise|exercise
5563353|NCT01033591|Randomized Controlled Trials|randomized controlled trials
5563354|NCT01033591|Multicenter Study|multicenter study
5563355|NCT01033591|Quality of life|quality of life
5563356|NCT01033565|Impaired sleep maintenance|impaired sleep maintenance
5563357|NCT01033565|Autism Spectrum Disorders|autism spectrum disorders
5563358|NCT01033565|Pediatric|pediatric
5563359|NCT01033539|Survive|survive
5563360|NCT01033539|safety|safety
5563361|NCT01033539|lactobacillus Reuteri|lactobacillus reuteri
5563362|NCT01033526|Symptomatic treatment of Common Cold symptoms|symptomatic treatment of common cold symptoms
5563363|NCT01033487|Safety|safety
5563364|NCT01033487|Pharmacokinetics|pharmacokinetics
5563365|NCT01033487|Pharmacodynamics|pharmacodynamics
5563366|NCT01033487|PF-03635659|pf-03635659
5563367|NCT01033487|COPD|copd
5563368|NCT01033474|Infertile Patients|infertile patients
5563369|NCT01033461|probiotic|probiotic
5563370|NCT01033461|lactobacillus paracasei|lactobacillus paracasei
5563371|NCT01033461|calcium|calcium
5563372|NCT01033461|faecal microbiota|faecal microbiota
5563373|NCT01033461|cholesterol metabolism|cholesterol metabolism
5563374|NCT01033435|Inflammation|inflammation
5563375|NCT01033435|Oxidative stress|oxidative stress
5563376|NCT01033435|HbA1c|hba1c
5563378|NCT01033422|Glaucoma|glaucoma
5563379|NCT01033422|Ocular hypertension|ocular hypertension
5563380|NCT01033422|Intraocular hypertension|intraocular hypertension
5563381|NCT01033409|Salmonella Typhi|salmonella typhi
5563383|NCT01033409|oral|oral
5563384|NCT01033409|vaccine|vaccine
5563385|NCT01033396|Allergic rhinitis Environmental exposure unit|allergic rhinitis environmental exposure unit
5563386|NCT01033370|acute|acute
5563387|NCT01033370|aortic|aortic
5563388|NCT01033370|emergencies|emergencies
5563389|NCT01033370|Aortic dissection|aortic dissection
5563390|NCT01033357|dialysis|dialysis
5680313|NCT00578240|Rising PSA|rising psa
5548068|NCT01095042|HRV|hrv
5563391|NCT01033357|hemodialysis|hemodialysis
5563392|NCT01033357|neointimal hyperplasia|neointimal hyperplasia
5563393|NCT01033344|Cat allergy|cat allergy
5563394|NCT01033344|Rhinoconjunctivitis|rhinoconjunctivitis
5563395|NCT01033344|Exposure chamber|exposure chamber
5563396|NCT01033344|Immunotherapy|immunotherapy
5563397|NCT01033344|Cat-PAD|cat-pad
5563398|NCT01033331|Spinal Muscular atrophy|spinal muscular atrophy
5563399|NCT01033331|Valproic acid|valproic acid
5563400|NCT01033331|HMAS|hmas
5563401|NCT01033331|MRC scale|mrc scale
5563402|NCT01033318|Hypertension|hypertension
5563403|NCT01033305|UC|uc
5563404|NCT01033292|ovarian|ovarian
5563405|NCT01033292|cancer|cancer
5563406|NCT01033292|sensitive|sensitive
5563407|NCT01033292|PARP|parp
5563408|NCT01033292|recurrent|recurrent
5563409|NCT01033292|platinum-resistant recurrent ovarian cancer|platinum-resistant recurrent ovarian cancer
5563410|NCT01033279|Coaguchek|coaguchek
5563411|NCT01033279|Portable coagulometer|portable coagulometer
5563412|NCT01033279|Self-monitoring|self-monitoring
5563413|NCT01033279|Coumadin|coumadin
5563414|NCT01033279|Warfarin|warfarin
5563415|NCT01033279|Quality of life|quality of life
5563416|NCT01033279|Pharmacist|pharmacist
5563417|NCT01033227|sickle cell disease|sickle cell disease
5563418|NCT01033227|sickle cell anemia|sickle cell anemia
5563419|NCT01033227|pain crisis|pain crisis
5563420|NCT01033227|nitric oxide|nitric oxide
5563421|NCT01033227|nitrite|nitrite
5563422|NCT01033227|vaso occlusive crisis|vaso occlusive crisis
5563423|NCT01033227|pain medication|pain medication
5563424|NCT01033227|sickled cells|sickled cells
5563425|NCT01033227|blood flow|blood flow
5563426|NCT01033227|microcirculation|microcirculation
5563427|NCT01033214|TAA|taa
5563428|NCT01033214|Thoracic|thoracic
5563429|NCT01033214|Descending Thoracic Aorta|descending thoracic aorta
5563430|NCT01033214|TAArget|taarget
5563431|NCT01033201|Lung rejection|lung rejection
5563432|NCT01033188|double bundle|double bundle
5563433|NCT01033188|hamstring graft|hamstring graft
5563434|NCT01033188|ACL reconstruction|acl reconstruction
5563435|NCT01033188|single bundle|single bundle
5563436|NCT01033175|COPD|copd
5563437|NCT01033175|anemia|anemia
5563438|NCT01033175|exercise|exercise
5563439|NCT01033175|cytokines|cytokines
5563440|NCT01033175|erythropoietin|erythropoietin
5563441|NCT01033123|ovarian|ovarian
5563442|NCT01033123|cancer|cancer
5563443|NCT01033123|sensitive|sensitive
5563444|NCT01033123|PARP|parp
5563445|NCT01033123|recurrent|recurrent
5563446|NCT01033123|platinum-sensitive recurrent ovarian cancer|platinum-sensitive recurrent ovarian cancer
5563447|NCT01033110|inactive|inactive
5563448|NCT01033110|>45 years|>45 years
5563449|NCT01033110|female|female
5563450|NCT01033097|Dermatitis|dermatitis
5563451|NCT01033097|inflammatory skin disease|inflammatory skin disease
5563452|NCT01033097|itch|itch
5563453|NCT01033097|eczema|eczema
5563454|NCT01033084|Depressive Disorder, Major|depressive disorder, major
5563455|NCT01033071|Hypertensive|hypertensive
5563456|NCT01033071|Blood Pressure, High|blood pressure, high
5563457|NCT01033071|Cardiovascular disease|cardiovascular disease
5563458|NCT01033071|Vascular Disease|vascular disease
5563459|NCT01033071|Drug Therapy|drug therapy
5563460|NCT01033058|STEMI|stemi
5563461|NCT01033058|atorvastatin|atorvastatin
5563463|NCT01033045|Hepatitis C|hepatitis c
5563464|NCT01033045|Viral|viral
5563465|NCT01033045|Non-A|non-a
5563466|NCT01033045|Non-B|non-b
5563467|NCT01033045|Parenterally-Transmitted|parenterally-transmitted
5563468|NCT01033032|Metastatic Breast Cancer|metastatic breast cancer
5563469|NCT01033032|Amrubicin|amrubicin
5563470|NCT01033019|Basal cell carcinomas,|basal cell carcinomas,
5563471|NCT01033019|sporadic,|sporadic,
5563472|NCT01033019|superficial and nodular,|superficial and nodular,
5563473|NCT01033019|skin|skin
5563474|NCT01033006|Peripheral Nerves|peripheral nerves
5563476|NCT01033006|MRI|mri
5563477|NCT01032993|CoQ10|coq10
5563478|NCT01032993|Statins|statins
5563479|NCT01032993|Myalgia|myalgia
5563480|NCT01032993|Muscle Pain|muscle pain
5563481|NCT01032993|Muscle Weakness|muscle weakness
5563482|NCT01032980|HUMENZA|humenza
5563483|NCT01032980|PANENZA|panenza
5563484|NCT01032980|Influenza|influenza
5563485|NCT01032980|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
5563486|NCT01032980|Influenza virus vaccines|influenza virus vaccines
5563487|NCT01032967|squamous cell carcinoma|squamous cell carcinoma
5563488|NCT01032967|esophagectomy|esophagectomy
5563490|NCT01032967|chemoradiation|chemoradiation
5563491|NCT01032967|Squamous cell carcinomas of the esophagus|squamous cell carcinomas of the esophagus
5563492|NCT01032954|Botulinum Toxin|botulinum toxin
5563493|NCT01032954|Rejuvenation|rejuvenation
5563494|NCT01032954|Facial dynamic wrinkles|facial dynamic wrinkles
5563495|NCT01032941|Portal Hypertension|portal hypertension
5563496|NCT01032941|Portal Pressure Measurement|portal pressure measurement
5563498|NCT01032941|Cirrhosis|cirrhosis
5563499|NCT01032941|End Stage Liver Disease|end stage liver disease
5563501|NCT01032928|Swallowing|swallowing
5563502|NCT01032928|Dysphagia|dysphagia
5563503|NCT01032928|Breathing and swallowing|breathing and swallowing
5563504|NCT01032928|Oropharyngeal cancer|oropharyngeal cancer
5563505|NCT01032915|Quiescent uveitis|quiescent uveitis
5563506|NCT01032915|intermediate uveitis|intermediate uveitis
5563507|NCT01032915|panuveitis|panuveitis
5563508|NCT01032915|posterior uveitis|posterior uveitis
5563509|NCT01032915|uveitis|uveitis
5563510|NCT01032902|Human immunodeficiency virus|human immunodeficiency virus
5563511|NCT01032902|Rapid Test|rapid test
5563512|NCT01032902|HIV|hiv
5563513|NCT01032902|HIV Seronegativity|hiv seronegativity
5563514|NCT01032876|Congenital Heart disease|congenital heart disease
5563515|NCT01032876|Cardiopulmonary bypass|cardiopulmonary bypass
5563516|NCT01032876|Neonatal brain injury|neonatal brain injury
5563517|NCT01032876|Deep Hypothermic Circulatory Arrest|deep hypothermic circulatory arrest
5563518|NCT01032876|Antegrade Cerebral Perfusion|antegrade cerebral perfusion
5563519|NCT01032863|Chronic musculoskeletal pain|chronic musculoskeletal pain
5563520|NCT01032863|Benign joint hypermobility syndrome|benign joint hypermobility syndrome
5563521|NCT01032863|Fibromyalgia|fibromyalgia
5563522|NCT01032850|INST 0820|inst 0820
5563523|NCT01032850|sorafenib|sorafenib
5563524|NCT01032850|capecitabine|capecitabine
5563525|NCT01032850|hepatocellular carcinoma|hepatocellular carcinoma
5563526|NCT01032850|lung|lung
5563527|NCT01032850|nexavar|nexavar
5563528|NCT01032850|xeloda|xeloda
5563529|NCT01032850|liver cancer|liver cancer
5563530|NCT01032824|Complementary Therapies|complementary therapies
5563531|NCT01032811|ADHD, childhood cancer|adhd, childhood cancer
5563532|NCT01032811|ADHD/Secondary ADHD Among Survivors of Childhood Cancer|adhd/secondary adhd among survivors of childhood cancer
5563533|NCT01032785|Patent Foramen Ovale|patent foramen ovale
5563534|NCT01032785|Patent Ductus Arteriosus|patent ductus arteriosus
5563535|NCT01032785|PFO|pfo
5563536|NCT01032785|PDA|pda
5563537|NCT01032772|alcohol-exposed pregnancy|alcohol-exposed pregnancy
5563538|NCT01032772|tobacco-exposed pregnancy|tobacco-exposed pregnancy
5563539|NCT01032772|alcohol|alcohol
5563540|NCT01032772|contraception|contraception
5563541|NCT01032772|smoking|smoking
5563542|NCT01032772|pregnancy|pregnancy
5563543|NCT01032746|colon cancer|colon cancer
5563544|NCT01032746|rectal cancer|rectal cancer
5563545|NCT01032733|Weight Loss|weight loss
5563546|NCT01032733|Physical Function|physical function
5563547|NCT01032733|Oxidative Stress|oxidative stress
5563548|NCT01032733|Inflammation|inflammation
5563549|NCT01032720|ultrasound|ultrasound
5563550|NCT01032720|osteoarthritis|osteoarthritis
5563551|NCT01032720|knee|knee
5563552|NCT01032720|corticosteroids|corticosteroids
5563553|NCT01032720|intra-articular|intra-articular
5563554|NCT01032720|injections|injections
5563555|NCT01032694|Community-Acquired Pneumonia|community-acquired pneumonia
5563556|NCT01032694|Azithromycin SR|azithromycin sr
5563557|NCT01032694|Amoxiclav|amoxiclav
5563558|NCT01032681|Solid tumor|solid tumor
5563559|NCT01032681|B-Cell Non-Hodgkin Lymphoma|b-cell non-hodgkin lymphoma
5563560|NCT01032681|Immunocytokine|immunocytokine
5563561|NCT01032681|interleukin-2|interleukin-2
5563562|NCT01032681|immunotherapy|immunotherapy
5563563|NCT01032681|Metastatic or Locally Advanced Solid Tumors or B-Cell Non-Hodgkin Lymphoma|metastatic or locally advanced solid tumors or b-cell non-hodgkin lymphoma
5563564|NCT01032668|percutaneous coronary intervention, clopidogrel resistance, ASA resistance|percutaneous coronary intervention, clopidogrel resistance, asa resistance
5563565|NCT01032655|Helicobacter pylori|helicobacter pylori
5563566|NCT01032655|sequential therapy|sequential therapy
5563567|NCT01032655|susceptibility-driven|susceptibility-driven
5563568|NCT01032655|rescue|rescue
5563569|NCT01032655|levofloxacin|levofloxacin
5563570|NCT01032655|clarithromycin|clarithromycin
5563571|NCT01032655|salvage|salvage
5563572|NCT01032655|treatment failure|treatment failure
5563573|NCT01032655|those who fail from two standard eradication therapies|those who fail from two standard eradication therapies
5563574|NCT01032642|infertility fallopian tubes|infertility fallopian tubes
5563575|NCT01032629|Diabetes|diabetes
5563576|NCT01032629|Type 2 diabetes mellitus|type 2 diabetes mellitus
5563577|NCT01032629|Cardiovascular risk|cardiovascular risk
5563578|NCT01032629|Cardiovascular outcomes|cardiovascular outcomes
5563579|NCT01032629|Canagliflozin (JNJ-28431754)|canagliflozin (jnj-28431754)
5563580|NCT01032629|Placebo|placebo
5557570|NCT01055899|RA|ra
5563581|NCT01032616|splanchnic bed|splanchnic bed
5563582|NCT01032616|theronine and lysine metabolism uptake|theronine and lysine metabolism uptake
5563584|NCT01032616|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by Healthy Males|metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed by healthy males
5563586|NCT01032603|Exotropia|exotropia
5563587|NCT01032603|Strabismus|strabismus
5563588|NCT01032603|Intermittent exotropia|intermittent exotropia
5563589|NCT01032590|weight changes|weight changes
5563590|NCT01032590|cancer survivor|cancer survivor
5563591|NCT01032590|stage I colon cancer|stage i colon cancer
5563592|NCT01032590|stage II colon cancer|stage ii colon cancer
5563593|NCT01032590|stage III colon cancer|stage iii colon cancer
5563594|NCT01032590|stage I rectal cancer|stage i rectal cancer
5563595|NCT01032590|stage II rectal cancer|stage ii rectal cancer
5563596|NCT01032590|stage III rectal cancer|stage iii rectal cancer
5563597|NCT01032577|ischemic cardiomyopathy|ischemic cardiomyopathy
5563598|NCT01032577|nonischemic cardiomyopathy|nonischemic cardiomyopathy
5563599|NCT01032577|implant|implant
5563600|NCT01032577|bipolar sensing|bipolar sensing
5563601|NCT01032577|extended bipolar sensing|extended bipolar sensing
5563602|NCT01032564|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women|estimate the interest of the measure of cervix elasticity degree by elastography in prediction of premature birth within a population of pregnant women
5563603|NCT01032551|Coronary Angiogram|coronary angiogram
5563604|NCT01032551|Decision Aid|decision aid
5563605|NCT01032551|Vascular Access|vascular access
5563606|NCT01032551|Radial|radial
5563607|NCT01032551|Femoral|femoral
5563608|NCT01032538|Unicondylar Knee Replacement|unicondylar knee replacement
5563609|NCT01032525|Crohn's Disease|crohn's disease
5563610|NCT01032525|Ulcerative Colitis|ulcerative colitis
5563611|NCT01032525|IBD|ibd
5563612|NCT01032525|Inflammatory Bowel Disease in Monroe County, NY|inflammatory bowel disease in monroe county, ny
5563613|NCT01032512|IMMUNE-ENHANCING|immune-enhancing
5563614|NCT01032512|GLUTAMINE|glutamine
5563615|NCT01032512|ARGININE|arginine
5563616|NCT01032512|OMEGA 3 FATTY ACIDS|omega 3 fatty acids
5563617|NCT01032512|ONCOLOGIC SURGERY|oncologic surgery
5563618|NCT01032512|PREOPERATIVE NUTRITION|preoperative nutrition
5563619|NCT01032499|Acne Vulgaris|acne vulgaris
5563620|NCT01032499|Boil|boil
5563621|NCT01032499|Taro Elixir|taro elixir
5563622|NCT01032486|Rasagiline|rasagiline
5563623|NCT01032486|Sleep|sleep
5563624|NCT01032486|Sleepiness|sleepiness
5563625|NCT01032486|Parkinson's Disease Sleep Scale|parkinson's disease sleep scale
5563626|NCT01032486|Epworth Sleepiness Scale|epworth sleepiness scale
5563627|NCT01032460|airway|airway
5563628|NCT01032460|airway device|airway device
5563629|NCT01032460|cervical spine immobilisation|cervical spine immobilisation
5563630|NCT01032434|sertraline|sertraline
5563631|NCT01032434|Polysomnograph|polysomnograph
5563632|NCT01032421|women admitted to the In Vitro Fertilization unit|women admitted to the in vitro fertilization unit
5563633|NCT01032408|Influenza A Virus|influenza a virus
5563634|NCT01032408|Virus Diseases|virus diseases
5563635|NCT01032408|Influenza, Human|influenza, human
5563636|NCT01032408|HIV-1|hiv-1
5563637|NCT01032408|Immunodeficiency Virus|immunodeficiency virus
5563638|NCT01032408|H1N1|h1n1
5563639|NCT01032408|HIV Infection|hiv infection
5563640|NCT01032408|Immunogenicity|immunogenicity
5563641|NCT01032408|safety|safety
5563642|NCT01032408|tolerability|tolerability
5563643|NCT01032395|H1N1|h1n1
5563644|NCT01032395|Pulmonary Disease|pulmonary disease
5563645|NCT01032395|Heart Disease|heart disease
5563646|NCT01032395|Diabetes|diabetes
5563647|NCT01032395|Influenza|influenza
5563648|NCT01032395|immunogenicity|immunogenicity
5563649|NCT01032395|safety|safety
5563650|NCT01032395|tolerability|tolerability
5563651|NCT01032382|leishmaniasis|leishmaniasis
5563652|NCT01032382|cutaneous|cutaneous
5563653|NCT01032382|WR 279,396|wr 279,396
5563654|NCT01032382|paromomycin|paromomycin
5563655|NCT01032382|gentamicin|gentamicin
5563656|NCT01032382|pharmacokinetics|pharmacokinetics
5563657|NCT01032382|safety|safety
5563658|NCT01032382|efficacy|efficacy
5563659|NCT01032369|"Over-weight or obese subjects with learning disability who have completed Nitzan Onim two-year training program and live in housing within the community"|"over-weight or obese subjects with learning disability who have completed nitzan onim two-year training program and live in housing within the community"
5563660|NCT01032356|Distal Radius fracture|distal radius fracture
5563661|NCT01032343|Immunosuppression|immunosuppression
5563662|NCT01032343|Ultraviolet radiation|ultraviolet radiation
5563663|NCT01032343|Nickel|nickel
5563664|NCT01032343|Contact hypersensitivity|contact hypersensitivity
5563665|NCT01032330|intermittent exotropia|intermittent exotropia
5563666|NCT01032330|IXT|ixt
5563667|NCT01032330|natural history|natural history
5563668|NCT01032330|occlusion therapy|occlusion therapy
5563669|NCT01032330|occlusion|occlusion
5563670|NCT01032330|patching|patching
5563671|NCT01032330|strabismus|strabismus
5563672|NCT01032330|strabismus treatment|strabismus treatment
5563673|NCT01032330|stereoacuity|stereoacuity
5563674|NCT01032330|motor alignment|motor alignment
5563676|NCT01032317|Electrophysiology|electrophysiology
5563677|NCT01032317|Fibrillation|fibrillation
5563678|NCT01032317|Tachycardia|tachycardia
5563679|NCT01032317|Ablation|ablation
5563680|NCT01032317|Atrial Fibrillation (AF)|atrial fibrillation (af)
5563681|NCT01032317|Ischemic Ventricular Tachycardia (VT)|ischemic ventricular tachycardia (vt)
5563682|NCT01032291|Colorectal cancer|colorectal cancer
5563683|NCT01032291|Revlimid|revlimid
5563684|NCT01032291|Lenalidomide|lenalidomide
5563685|NCT01032291|Cetuximab|cetuximab
5563687|NCT01032291|KRAS|kras
5563688|NCT01032278|cardiac toxicity|cardiac toxicity
5563689|NCT01032278|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5563690|NCT01032265|female|female
5563691|NCT01032265|stress urinary incontinence|stress urinary incontinence
5563692|NCT01032265|treatment|treatment
5563693|NCT01032265|pelvic floor muscle training|pelvic floor muscle training
5563694|NCT01032265|cognitive behavioral therapy|cognitive behavioral therapy
5563695|NCT01032265|internet|internet
5563696|NCT01032265|life style|life style
5563697|NCT01032265|pamphlet|pamphlet
5563698|NCT01032265|eHealth|ehealth
5563699|NCT01032252|fall prevention|fall prevention
5563700|NCT01032252|general practitioners setting|general practitioners setting
5563701|NCT01032252|implementation|implementation
5563702|NCT01032252|network|network
5563703|NCT01032252|community dwelling older adults|community dwelling older adults
5563704|NCT01032252|exercise intervention|exercise intervention
5563705|NCT01032239|Severe spasticity in post-stroke patients|severe spasticity in post-stroke patients
5563706|NCT01032200|fatigue|fatigue
5563707|NCT01032200|cognitive/functional effects|cognitive/functional effects
5563708|NCT01032200|adult giant cell glioblastoma|adult giant cell glioblastoma
5563709|NCT01032200|adult glioblastoma|adult glioblastoma
5563710|NCT01032200|adult gliosarcoma|adult gliosarcoma
5563711|NCT01032200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5563712|NCT01032200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5563713|NCT01032200|adult mixed glioma|adult mixed glioma
5563714|NCT01032200|adult diffuse astrocytoma|adult diffuse astrocytoma
5563715|NCT01032200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5563716|NCT01032200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5563717|NCT01032200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5563718|NCT01032200|adult oligodendroglioma|adult oligodendroglioma
5563719|NCT01032200|adult anaplastic ependymoma|adult anaplastic ependymoma
5563720|NCT01032200|adult ependymoma|adult ependymoma
5563723|NCT01032200|adult anaplastic meningioma|adult anaplastic meningioma
5563724|NCT01032200|adult grade I meningioma|adult grade i meningioma
5563725|NCT01032200|adult grade II meningioma|adult grade ii meningioma
5563726|NCT01032200|adult grade III meningioma|adult grade iii meningioma
5563727|NCT01032200|adult papillary meningioma|adult papillary meningioma
5563728|NCT01032200|adult brain stem glioma|adult brain stem glioma
5563729|NCT01032187|Visceral leishmaniasis|visceral leishmaniasis
5563730|NCT01032187|Amphotericin B deoxycholate|amphotericin b deoxycholate
5563731|NCT01032187|Meglumine antimoniate|meglumine antimoniate
5563732|NCT01032187|Children|children
5563733|NCT01032187|Brazil|brazil
5563734|NCT01032174|Azithromycin SR Amoxiclav 1000 mg Maxillary Sinusitis|azithromycin sr amoxiclav 1000 mg maxillary sinusitis
5563735|NCT01032161|Delirium|delirium
5563736|NCT01032161|Postoperative|postoperative
5563737|NCT01032161|Non-cardiovascular surgery|non-cardiovascular surgery
5563738|NCT01032161|Post-anaesthesia care unit|post-anaesthesia care unit
5563739|NCT01032161|patients between 3 to 12 years old|patients between 3 to 12 years old
5563740|NCT01032161|undergoing selective non-cardiac surgery|undergoing selective non-cardiac surgery
5563741|NCT01032161|under general anesthesia|under general anesthesia
5563742|NCT01032161|surgery|surgery
5563743|NCT01032161|general anesthesia|general anesthesia
5563744|NCT01032148|Recurrent|recurrent
5563745|NCT01032148|Refractory|refractory
5563746|NCT01032122|melanoma|melanoma
5563747|NCT01032122|rituximab|rituximab
5563748|NCT01032122|metastatic|metastatic
5563749|NCT01032122|stage IIIc/IV|stage iiic/iv
5563750|NCT01032122|stem cell|stem cell
5563751|NCT01032122|overall survival|overall survival
5563752|NCT01032122|disease free interval|disease free interval
5563753|NCT01032122|anti-CD20 therapy|anti-cd20 therapy
5563754|NCT01032083|SSRI antidepressant|ssri antidepressant
5563755|NCT01032083|Negative symptoms|negative symptoms
5563756|NCT01032083|Schizophrenia|schizophrenia
5563757|NCT01032070|pediatric|pediatric
5563759|NCT01032070|erlotinib|erlotinib
5563760|NCT01032070|phase 2|phase 2
5563761|NCT01032070|ependymoma|ependymoma
5563762|NCT01032057|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5563763|NCT01032057|stage II pancreatic cancer|stage ii pancreatic cancer
5563764|NCT01032057|stage III pancreatic cancer|stage iii pancreatic cancer
5563765|NCT01032044|Barrett's esophagus|barrett's esophagus
5563766|NCT01032044|EsoGastroDuodenoscopy|esogastroduodenoscopy
5563767|NCT01032044|Barrett's carcinoma|barrett's carcinoma
5563768|NCT01032044|adenocarcinoma|adenocarcinoma
5563769|NCT01032044|Cellvizio|cellvizio
5563770|NCT01032044|endomicroscopy|endomicroscopy
5563771|NCT01032044|probe-based Confocal Laser Endomicroscopy|probe-based confocal laser endomicroscopy
5563772|NCT01032044|pCLE|pcle
5563773|NCT01032044|Radio-frequency ablation|radio-frequency ablation
5563774|NCT01032044|Endoscopic mucosal resection|endoscopic mucosal resection
5563775|NCT01032044|Photodynamic therapy|photodynamic therapy
5563776|NCT01032031|Green tea|green tea
5563777|NCT01032031|Vitamin C|vitamin c
5563778|NCT01032031|Ultraviolet radiation|ultraviolet radiation
5563779|NCT01032031|Inflammation|inflammation
5563780|NCT01032031|Photoageing|photoageing
5563781|NCT01032018|Acute coronary syndrome|acute coronary syndrome
5563782|NCT01032018|Depression|depression
5563783|NCT01032018|Satisfaction with care|satisfaction with care
5563784|NCT01031992|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5563785|NCT01031992|Rendu-Osler-Weber syndrome|rendu-osler-weber syndrome
5563786|NCT01031992|Epistaxis|epistaxis
5563787|NCT01031992|Nosebleeds|nosebleeds
5563788|NCT01031992|Anemia|anemia
5563789|NCT01031992|Tranexamic acid|tranexamic acid
5563790|NCT01031992|Antifibrinolytics|antifibrinolytics
5563791|NCT01031979|PTSD|ptsd
5563792|NCT01031979|Prolonged Exposure|prolonged exposure
5563793|NCT01031979|extinction|extinction
5563794|NCT01031979|habituation|habituation
5563795|NCT01031979|psychophysiology|psychophysiology
5563796|NCT01031966|ESRD|esrd
5563797|NCT01031953|nausea and vomiting|nausea and vomiting
5563798|NCT01031953|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5563799|NCT01031927|obsessive compulsive disorder|obsessive compulsive disorder
5563800|NCT01031927|sarcosine|sarcosine
5563801|NCT01031927|glycine transporter I|glycine transporter i
5563802|NCT01031927|NMDA receptor|nmda receptor
5563803|NCT01031914|Paced Breathing|paced breathing
5563804|NCT01031914|OSA|osa
5563805|NCT01031914|sleep/wake detection|sleep/wake detection
5563806|NCT01031901|Tuberous Sclerosis|tuberous sclerosis
5563807|NCT01031901|Neurofibromatoses|neurofibromatoses
5563808|NCT01031901|Angiofibroma|angiofibroma
5563809|NCT01031901|Neurofibroma|neurofibroma
5563810|NCT01031901|Sirolimus|sirolimus
5563811|NCT01031888|Corneal re-epithelialization|corneal re-epithelialization
5563812|NCT01031888|Topical insulin application|topical insulin application
5563813|NCT01031888|pars planar vitrectomy|pars planar vitrectomy
5563814|NCT01031888|diabetic retinopathy|diabetic retinopathy
5563815|NCT01031888|penetrating keratoplasty|penetrating keratoplasty
5563816|NCT01031875|recurrent bladder cancer|recurrent bladder cancer
5563817|NCT01031875|stage IV bladder cancer|stage iv bladder cancer
5563818|NCT01031875|recurrent urethral cancer|recurrent urethral cancer
5563819|NCT01031875|distal urethral cancer|distal urethral cancer
5563820|NCT01031875|proximal urethral cancer|proximal urethral cancer
5563821|NCT01031875|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5563822|NCT01031875|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5563823|NCT01031875|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5563824|NCT01031875|stage IV urethral cancer|stage iv urethral cancer
5563825|NCT01031862|healthy volunteer|healthy volunteer
5563926|NCT01031563|Comorbidity|comorbidity
5563833|NCT01031836|safety|safety
5563834|NCT01031836|tolerability|tolerability
5563835|NCT01031836|MEDI-545|medi-545
5563836|NCT01031836|Autoimmune Disease|autoimmune disease
5563837|NCT01031836|Immune System Diseases|immune system diseases
5563838|NCT01031823|Autism Spectrum Disorder|autism spectrum disorder
5563839|NCT01031810|Treatment Resistant depression|treatment resistant depression
5563840|NCT01031810|Major Depression|major depression
5563841|NCT01031810|MDD|mdd
5563842|NCT01031810|Depression|depression
5563843|NCT01031797|SLE|sle
5563844|NCT01031797|Disease activity score|disease activity score
5563845|NCT01031797|QT dispersion|qt dispersion
5563846|NCT01031784|liver metastasis|liver metastasis
5563847|NCT01031784|Liver tumors|liver tumors
5563848|NCT01031784|microspheres|microspheres
5563849|NCT01031784|holmium|holmium
5563850|NCT01031784|toxicity|toxicity
5563851|NCT01031771|Cerebral Palsy|cerebral palsy
5563852|NCT01031771|Deglutition|deglutition
5563853|NCT01031771|Deglutition disorders|deglutition disorders
5563854|NCT01031771|Endoscopy|endoscopy
5563855|NCT01031758|Low HDL|low hdl
5563856|NCT01031758|High HDL|high hdl
5563857|NCT01031758|HDL|hdl
5563858|NCT01031758|Reverse Cholesterol Transport|reverse cholesterol transport
5563860|NCT01031758|healthy volunteer|healthy volunteer
5563861|NCT01031758|3H|3h
5563862|NCT01031758|Average HDL|average hdl
5563863|NCT01031745|Complementary Therapies|complementary therapies
5563864|NCT01031745|Drug Users|drug users
5563865|NCT01031732|Minimally invasive|minimally invasive
5563866|NCT01031732|Total hip arthroplasty|total hip arthroplasty
5563867|NCT01031732|Functional outcome|functional outcome
5685395|NCT00556270|transdermal patch|transdermal patch
5563868|NCT01031732|To compare the surgical results of 4 MIS THA techniques|to compare the surgical results of 4 mis tha techniques
5563869|NCT01031732|To investigate the functional outcomes of 4 MIS THA techniques|to investigate the functional outcomes of 4 mis tha techniques
5563870|NCT01031732|To study the biochemical parameters after the MIS surgeries.|to study the biochemical parameters after the mis surgeries.
5563871|NCT01031719|Influenza A Virus|influenza a virus
5563873|NCT01031719|Influenza, Human|influenza, human
5563874|NCT01031719|H1N1|h1n1
5563875|NCT01031719|Immunogenicity|immunogenicity
5563876|NCT01031719|safety|safety
5563877|NCT01031719|tolerability|tolerability
5563878|NCT01031719|tumors|tumors
5563879|NCT01031719|oncology|oncology
5563880|NCT01031706|Hypertonic Saline|hypertonic saline
5563881|NCT01031706|Pediatrics|pediatrics
5563882|NCT01031706|Cystic Fibrosis|cystic fibrosis
5563883|NCT01031706|Mucociliary Clearance|mucociliary clearance
5563884|NCT01031706|Lung Clearance Index|lung clearance index
5563885|NCT01031693|Nicotine|nicotine
5563886|NCT01031693|Cigarettes|cigarettes
5563887|NCT01031693|Tobacco|tobacco
5563888|NCT01031693|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5563889|NCT01031693|Cue-Induced Craving|cue-induced craving
5563890|NCT01031693|Smoking|smoking
5563891|NCT01031680|dapagliflozin|dapagliflozin
5563892|NCT01031680|diabetes|diabetes
5563893|NCT01031680|cardiovascular disease|cardiovascular disease
5563894|NCT01031680|hypertension|hypertension
5563895|NCT01031667|Patients treated with PCI with stent|patients treated with pci with stent
5563902|NCT01031628|GIST|gist
5563903|NCT01031628|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5563904|NCT01031628|Exon 9|exon 9
5563905|NCT01031628|Gleevec|gleevec
5563906|NCT01031628|Imatinib blood levels|imatinib blood levels
5563907|NCT01031615|School age children and adolescents exposed to a potentially traumatic event|school age children and adolescents exposed to a potentially traumatic event
5563908|NCT01031602|Cancer|cancer
5563909|NCT01031602|Gynecology|gynecology
5563910|NCT01031602|Sexual Dysfunction|sexual dysfunction
5563911|NCT01031602|Depression|depression
5563912|NCT01031602|Anxiety|anxiety
5563913|NCT01031602|Underserved|underserved
5563914|NCT01031602|Minority|minority
5563915|NCT01031602|Psychological distress|psychological distress
5563916|NCT01031589|TMC278-TiDP15-C158|tmc278-tidp15-c158
5563917|NCT01031589|TMC278-C158|tmc278-c158
5563918|NCT01031589|TMC278|tmc278
5563919|NCT01031589|HIV|hiv
5563920|NCT01031589|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5546133|NCT01102088|5-FU|5-fu
5563921|NCT01031589|HIV Seronegativity|hiv seronegativity
5563922|NCT01031576|Osteoarthritis, posture, knee|osteoarthritis, posture, knee
5563924|NCT01031563|Schizophrenia|schizophrenia
5563925|NCT01031563|Drug Abuse/Dependence|drug abuse/dependence
5563927|NCT01031563|Impulsivity|impulsivity
5563928|NCT01031563|Drug Abuse|drug abuse
5563929|NCT01031550|liver resection for liver disease|liver resection for liver disease
5563930|NCT01031537|FSME-Immun|fsme-immun
5563931|NCT01031537|TBEV|tbev
5563932|NCT01031537|TBE Researcher|tbe researcher
5563933|NCT01031537|Plavivirus|plavivirus
5563934|NCT01031537|Anti-TBEV Levels|anti-tbev levels
5563935|NCT01031537|Tic-Borne Encephalitis|tic-borne encephalitis
5563936|NCT01031524|Plasmodium falciparum malaria|plasmodium falciparum malaria
5563937|NCT01031511|High-Functioning Autistic Spectrum Disorder|high-functioning autistic spectrum disorder
5563938|NCT01031511|Anxiety|anxiety
5563939|NCT01031511|Cognitive Behavioural Therapy|cognitive behavioural therapy
5563940|NCT01031511|Social Recreational|social recreational
5563941|NCT01031511|Parent Stress|parent stress
5563942|NCT01031498|Nausea|nausea
5563943|NCT01031498|Vomiting|vomiting
5563944|NCT01031498|CINV|cinv
5563945|NCT01031498|Leukemia|leukemia
5563946|NCT01031498|High-risk Myelodysplastic syndrome|high-risk myelodysplastic syndrome
5563947|NCT01031498|AML|aml
5563948|NCT01031498|Hematologic malignancies|hematologic malignancies
5563949|NCT01031498|Hematologic Disorder|hematologic disorder
5563950|NCT01031498|Continuous multi-day chemotherapy|continuous multi-day chemotherapy
5563951|NCT01031498|High-dose cytarabine|high-dose cytarabine
5563952|NCT01031498|Palonosetron|palonosetron
5563953|NCT01031498|Aloxi|aloxi
5563954|NCT01031498|Ondansetron|ondansetron
5563955|NCT01031498|Zofran|zofran
5563956|NCT01031485|hypertension|hypertension
5563957|NCT01031485|blood pressure|blood pressure
5563958|NCT01031485|milk peptides|milk peptides
5563959|NCT01031485|bioactive peptides|bioactive peptides
5563960|NCT01031485|randomized controlled trial|randomized controlled trial
5563961|NCT01031472|HIV, relative bioavailability, food effect, GSK2248761, healthy subjects|hiv, relative bioavailability, food effect, gsk2248761, healthy subjects
5563962|NCT01031472|HIV Seronegativity|hiv seronegativity
5563963|NCT01031446|stage IV breast cancer|stage iv breast cancer
5563964|NCT01031446|Human epidermal growth factor (HER2)-negative breast cancer|human epidermal growth factor (her2)-negative breast cancer
5563965|NCT01031446|triple-negative breast cancer|triple-negative breast cancer
5563966|NCT01031446|hormone-resistant breast cancer|hormone-resistant breast cancer
5563968|NCT01031433|Virtual Reality|virtual reality
5563969|NCT01031433|Schizophrenia|schizophrenia
5563970|NCT01031433|Smoking|smoking
5563971|NCT01031420|bladder|bladder
5563972|NCT01031420|cancer|cancer
5563973|NCT01031420|invasive|invasive
5563974|NCT01031407|Social Cognition|social cognition
5563975|NCT01031407|Autism|autism
5563976|NCT01031407|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5563977|NCT01031407|MEG|meg
5563978|NCT01031407|Structural MRI|structural mri
5563979|NCT01031394|exercise|exercise
5563980|NCT01031394|resistance training|resistance training
5563981|NCT01031381|Recurrent|recurrent
5563982|NCT01031381|ovarian|ovarian
5563983|NCT01031381|fallopian tube|fallopian tube
5563984|NCT01031381|primary peritoneal|primary peritoneal
5563985|NCT01031381|cancer|cancer
5563986|NCT01031381|Recurrent ovarian, fallopian tube, primary peritoneal cancer|recurrent ovarian, fallopian tube, primary peritoneal cancer
5563987|NCT01031355|Female Contraception|female contraception
5563988|NCT01031355|Contraceptives, Oral|contraceptives, oral
5563989|NCT01031342|Colonoscopy|colonoscopy
5563990|NCT01031342|Gastrointestinal bleeding|gastrointestinal bleeding
5563991|NCT01031316|Echocardiography|echocardiography
5563992|NCT01031316|Infant, Premature|infant, premature
5563993|NCT01031316|Infant, Very Low Birth Weight|infant, very low birth weight
5563994|NCT01031303|Diphtheria|diphtheria
5563995|NCT01031303|Tetanus|tetanus
5563996|NCT01031303|Pertussis|pertussis
5563997|NCT01031303|Poliomyelitis|poliomyelitis
5563998|NCT01031303|PENTAXIM™|pentaxim™
5563999|NCT01031303|TETRAXIM™|tetraxim™
5564000|NCT01031290|Cue-Induced Craving|cue-induced craving
5564001|NCT01031290|Cannabis|cannabis
5564002|NCT01031290|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5564003|NCT01031290|Repetitive TMS (rTMS)|repetitive tms (rtms)
5564004|NCT01031290|Cannabis Craving|cannabis craving
5564005|NCT01031277|Hypercholesterolemia|hypercholesterolemia
5564006|NCT01031277|Update NCEP ATP111|update ncep atp111
5564007|NCT01031277|Survey|survey
5564008|NCT01031264|social drinkers|social drinkers
5564009|NCT01031238|PEM Uptake Value|pem uptake value
5564010|NCT01031238|PUV|puv
5564011|NCT01031238|Standardized Uptake Value|standardized uptake value
5564012|NCT01031238|SUV|suv
5564013|NCT01031238|Malignancies of the Breast|malignancies of the breast
5564014|NCT01031238|[18F]-FDG-PET/CT scanning|[18f]-fdg-pet/ct scanning
5564015|NCT01031238|Tumor|tumor
5564016|NCT01031238|positron emission tomography/computed tomography|positron emission tomography/computed tomography
5564017|NCT01031238|PET/CT scan|pet/ct scan
5564018|NCT01031225|Synta|synta
5564019|NCT01031225|STA 9090|sta 9090
5564020|NCT01031225|ganetespib)|ganetespib)
5564021|NCT01031225|Lung Cancer|lung cancer
5564022|NCT01031225|Non Small Cell Lung Cancer|non small cell lung cancer
5564024|NCT01031212|cancer|cancer
5564030|NCT01031199|Neuroinflammation|neuroinflammation
5564031|NCT01031199|PET diagnosis|pet diagnosis
5564032|NCT01031199|PET tracer|pet tracer
5564033|NCT01031186|healthy male volunteers|healthy male volunteers
5564034|NCT01031186|GSK356278|gsk356278
5564035|NCT01031186|first time in man|first time in man
5564036|NCT01031186|major depressive disorder|major depressive disorder
5564037|NCT01031173|α galactosidase A|α galactosidase a
5564038|NCT01031173|glycosphingolipid storage disorder|glycosphingolipid storage disorder
5564039|NCT01031173|agalsidase alfa|agalsidase alfa
5564040|NCT01031173|enzyme replacement therapy|enzyme replacement therapy
5564041|NCT01031173|Replagal|replagal
5564042|NCT01031173|agalsidase beta|agalsidase beta
5564043|NCT01031173|Fabrazyme|fabrazyme
5564050|NCT01031147|Magnetic resonance angiography|magnetic resonance angiography
5564051|NCT01031147|Intracranial aneurysm|intracranial aneurysm
5564052|NCT01031147|Digital subtraction angiography|digital subtraction angiography
5564053|NCT01031147|Volume rendering|volume rendering
5564054|NCT01031121|Cigarette Smoking|cigarette smoking
5564055|NCT01031121|Biomarkers|biomarkers
5564056|NCT01031121|Nicotine|nicotine
5564057|NCT01031121|Cotinine|cotinine
5564058|NCT01031121|Metabolites|metabolites
5564059|NCT01031095|percutaneous coronary intervention|percutaneous coronary intervention
5564060|NCT01031095|low dose intracoronary heparin|low dose intracoronary heparin
5564061|NCT01031069|Cervarix|cervarix
5564062|NCT01031069|Gardasil|gardasil
5564063|NCT01031069|Immunogenicity|immunogenicity
5564064|NCT01031069|Cervical cancer|cervical cancer
5564065|NCT01031069|Safety|safety
5564066|NCT01031069|HPV vaccine|hpv vaccine
5564067|NCT01031043|IEM|iem
5564068|NCT01031030|stage I breast cancer|stage i breast cancer
5564069|NCT01031030|stage II breast cancer|stage ii breast cancer
5564070|NCT01031030|stage IIIA breast cancer|stage iiia breast cancer
5564071|NCT01031030|stage IIIB breast cancer|stage iiib breast cancer
5564072|NCT01031030|stage IIIC breast cancer|stage iiic breast cancer
5564073|NCT01031017|twin pregnancies|twin pregnancies
5564074|NCT01031017|preterm delivery|preterm delivery
5564075|NCT01031017|progesterone|progesterone
5564076|NCT01030991|Heart failure|heart failure
5564077|NCT01030991|Ejection fraction|ejection fraction
5564078|NCT01030991|Diastolic heart failure|diastolic heart failure
5564079|NCT01030991|Diastolic dysfunction|diastolic dysfunction
5564080|NCT01030991|Ventricular-arterial coupling|ventricular-arterial coupling
5564081|NCT01030991|Exercise testing|exercise testing
5564082|NCT01030991|Echocardiography|echocardiography
5564083|NCT01030991|Tissue Doppler imaging|tissue doppler imaging
5564084|NCT01030991|Arterial tonometry|arterial tonometry
5564087|NCT01030978|Impaired Glucose Tolerance|impaired glucose tolerance
5564088|NCT01030978|PreDiabetes|prediabetes
5564089|NCT01030978|Diabetes Prevention|diabetes prevention
5564090|NCT01030965|Chronic Bronchitis|chronic bronchitis
5564091|NCT01030965|Anticholinergic|anticholinergic
5564092|NCT01030965|Emphysema|emphysema
5564093|NCT01030965|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5564094|NCT01030965|COPD|copd
5564095|NCT01030952|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5564096|NCT01030952|Nateglinide|nateglinide
5564097|NCT01030952|Acarbose|acarbose
5564098|NCT01030952|glucose fluctuation|glucose fluctuation
5564099|NCT01030939|Healthy volunteers|healthy volunteers
5564100|NCT01030939|Men and women|men and women
5564101|NCT01030939|adults and elderly|adults and elderly
5564102|NCT01030939|repeat dose|repeat dose
5564103|NCT01030913|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5564104|NCT01030900|Immunosuppression|immunosuppression
5564105|NCT01030900|Microenvironment|microenvironment
5564106|NCT01030900|Hodgkin Lymphoma|hodgkin lymphoma
5564107|NCT01030900|B-Cell Lymphoma|b-cell lymphoma
5564108|NCT01030900|Microarray|microarray
5564109|NCT01030900|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5564110|NCT01030887|Cancer|cancer
5564111|NCT01030887|Exercise|exercise
5564112|NCT01030887|Physical Activity|physical activity
5564113|NCT01030887|Randomized controlled trial|randomized controlled trial
5564114|NCT01030874|hypotension, orthostatic|hypotension, orthostatic
5564115|NCT01030874|falls|falls
5564116|NCT01030874|rehabilitation|rehabilitation
5564117|NCT01030874|blood pressure|blood pressure
5564118|NCT01030874|aging|aging
5564119|NCT01030861|type 1 diabetes|type 1 diabetes
5564120|NCT01030861|pre-diabetic|pre-diabetic
5564121|NCT01030861|autoantibody positive|autoantibody positive
5564122|NCT01030861|at risk for type 1 diabetes|at risk for type 1 diabetes
5564123|NCT01030861|glucose intolerance|glucose intolerance
5564126|NCT01030835|Comorbidity|comorbidity
5564127|NCT01030835|Normal Controls|normal controls
5564128|NCT01030835|Substance Use Disorders|substance use disorders
5564129|NCT01030835|Substance Abuse Disorders|substance abuse disorders
5564130|NCT01030822|Catch-up vaccination|catch-up vaccination
5564131|NCT01030822|Safety|safety
5564132|NCT01030822|Pneumococcal vaccine|pneumococcal vaccine
5564133|NCT01030822|Pneumococcal disease|pneumococcal disease
5564135|NCT01030822|Immunogenicity|immunogenicity
5564136|NCT01030809|Crohn's disease|crohn's disease
5564137|NCT01030809|community based gastroenterology practices Canada and Belgium|community based gastroenterology practices canada and belgium
5564138|NCT01030809|Cluster randomization controlled trial|cluster randomization controlled trial
5564139|NCT01030809|Remission|remission
5564140|NCT01030809|Corticosteroids|corticosteroids
5564141|NCT01030809|Documented diagnosis of Crohn's disease|documented diagnosis of crohn's disease
5564142|NCT01030770|Diabetes|diabetes
5564143|NCT01030770|Vitreous Haemorrhages|vitreous haemorrhages
5564144|NCT01030757|Liver Cancer|liver cancer
5564145|NCT01030757|Metastatic Liver Cancer|metastatic liver cancer
5564146|NCT01030757|Tomotherapy|tomotherapy
5564147|NCT01030757|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5564148|NCT01030744|Gestational Diabetes|gestational diabetes
5564149|NCT01030744|Self-Monitoring of Blood Glucose|self-monitoring of blood glucose
5564150|NCT01030731|Renal Dialysis, Ceftobiprole|renal dialysis, ceftobiprole
5564151|NCT01030731|Skin and soft tissue Infections|skin and soft tissue infections
5564152|NCT01030731|Staphylococcal Skin Infections|staphylococcal skin infections
5564153|NCT01030731|Streptococcal Infection|streptococcal infection
5564154|NCT01030705|Bradycardia|bradycardia
5564155|NCT01030705|pacemaker|pacemaker
5564156|NCT01030692|Cocaine|cocaine
5564157|NCT01030692|Rivastigmine|rivastigmine
5564158|NCT01030692|Huperzine A|huperzine a
5564159|NCT01030679|Diabetes Mellitus, type 2|diabetes mellitus, type 2
5564160|NCT01030679|Glitazone|glitazone
5564161|NCT01030666|periodontal regeneration|periodontal regeneration
5564162|NCT01030666|radiographic bone fill|radiographic bone fill
5564163|NCT01030666|infrabony defects|infrabony defects
5564164|NCT01030666|randomized placebo-controlled clinical trial|randomized placebo-controlled clinical trial
5564165|NCT01030666|guided tissue regeneration, periodontal|guided tissue regeneration, periodontal
5564166|NCT01030653|Voriconazole|voriconazole
5564167|NCT01030653|Pharmacokinetics|pharmacokinetics
5564168|NCT01030653|Obese|obese
5564169|NCT01030653|Healthy Volunteer|healthy volunteer
5564170|NCT01030640|intraepidermal nerve fiber density|intraepidermal nerve fiber density
5564171|NCT01030640|IENF|ienf
5564172|NCT01030640|tanezumab|tanezumab
5564173|NCT01030640|subcutaneous|subcutaneous
5564176|NCT01030627|Preeclampsia|preeclampsia
5564177|NCT01030627|Magnesium sulfate|magnesium sulfate
5564178|NCT01030614|Laparoscopic cholecystectomy,postoperative symptoms|laparoscopic cholecystectomy,postoperative symptoms
5564179|NCT01030601|Diabetic|diabetic
5564180|NCT01030601|Macular Edema|macular edema
5564181|NCT01030601|Pseudophakic|pseudophakic
5564182|NCT01030601|Dexamethasone|dexamethasone
5564183|NCT01030601|Intravitreal|intravitreal
5564184|NCT01030601|Cataract surgery|cataract surgery
5564185|NCT01030575|NICHD Neonatal Research Network|nichd neonatal research network
5564186|NCT01030575|Pharmacokinetics|pharmacokinetics
5564187|NCT01030575|Inositol|inositol
5564188|NCT01030575|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5680314|NCT00578240|Clinical Metastases|clinical metastases
5564189|NCT01030575|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5564190|NCT01030575|Prematurity|prematurity
5564191|NCT01030562|adolescent|adolescent
5564192|NCT01030562|children|children
5564194|NCT01030562|human papillomavirus|human papillomavirus
5564195|NCT01030562|vaccine|vaccine
5564196|NCT01030562|women|women
5564197|NCT01030549|cardiovascular magnetic resonance|cardiovascular magnetic resonance
5564198|NCT01030549|ventricular volumes|ventricular volumes
5564199|NCT01030549|ventricular function|ventricular function
5564200|NCT01030549|Healthy normal individuals from 20 to 80 years of age|healthy normal individuals from 20 to 80 years of age
5564201|NCT01030536|NHL|nhl
5564202|NCT01030536|CLL|cll
5564203|NCT01030497|Cancer|cancer
5564204|NCT01030497|Cervical Lymph Node Metastases|cervical lymph node metastases
5564205|NCT01030497|High-Resolution PET Imaging System|high-resolution pet imaging system
5564206|NCT01030497|Upper Aerodigestive Tract|upper aerodigestive tract
5564207|NCT01030497|Head|head
5564208|NCT01030497|Neck|neck
5564209|NCT01030497|HR PET Imaging System|hr pet imaging system
5564210|NCT01030497|High-Resolution PET|high-resolution pet
5564211|NCT01030497|PET/CT|pet/ct
5564212|NCT01030497|PEMFlex Solo II|pemflex solo ii
5564213|NCT01030497|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
5564219|NCT01030471|depression|depression
5564220|NCT01030471|adherence|adherence
5564221|NCT01030471|family functioning|family functioning
5564222|NCT01030471|intervention|intervention
5564223|NCT01030458|Blood pressure|blood pressure
5564224|NCT01030458|Hypertension|hypertension
5564225|NCT01030458|Blacks|blacks
5564226|NCT01030458|Africa|africa
5564227|NCT01030458|Blood pressure control|blood pressure control
5564228|NCT01030458|Side-effects|side-effects
5564229|NCT01030445|non-invasive cardiac output monitor|non-invasive cardiac output monitor
5564230|NCT01030445|electrical velocimetry|electrical velocimetry
5564231|NCT01030445|Aesculon|aesculon
5564232|NCT01030445|Icon|icon
5564233|NCT01030445|pediatrics|pediatrics
5564234|NCT01030445|normal reference|normal reference
5564235|NCT01030419|Aging|aging
5564236|NCT01030419|Quality of Life|quality of life
5564237|NCT01030419|Functional fitness|functional fitness
5564238|NCT01030406|Abuse Liability|abuse liability
5564239|NCT01030406|Abuse Prevention|abuse prevention
5564240|NCT01030406|Abuse Resistance|abuse resistance
5564241|NCT01030406|Abuse Deterrence|abuse deterrence
5564242|NCT01030393|hCG|hcg
5564243|NCT01030393|pregnancy|pregnancy
5564244|NCT01030393|implantation|implantation
5564245|NCT01030393|ICSI|icsi
5564246|NCT01030393|IVF|ivf
5564247|NCT01030380|Facial toning|facial toning
5564248|NCT01030380|Facial lift|facial lift
5564249|NCT01030380|Improve facial complexion|improve facial complexion
5564250|NCT01030380|Improve facial tone|improve facial tone
5564251|NCT01030380|Improve radiance of the face|improve radiance of the face
5564252|NCT01030380|Reduce signs of facial aging|reduce signs of facial aging
5564253|NCT01030380|firming, lift, tone face|firming, lift, tone face
5564254|NCT01030367|Coronary artery disease|coronary artery disease
5564255|NCT01030354|Satiety|satiety
5564256|NCT01030354|Meal Replacements|meal replacements
5564257|NCT01030354|High Protein|high protein
5564258|NCT01030354|Standard Protein|standard protein
5564259|NCT01030341|Diabetes|diabetes
5564260|NCT01030341|Gastroparesis|gastroparesis
5564261|NCT01030315|Erythropoietin|erythropoietin
5564262|NCT01030315|Long-acting|long-acting
5564263|NCT01030315|EPO|epo
5564264|NCT01030302|Bortezomib retreatment|bortezomib retreatment
5564265|NCT01030302|Velcade|velcade
5564266|NCT01030302|Proteasome inhibitor|proteasome inhibitor
5564267|NCT01030302|Bortezomib|bortezomib
5564268|NCT01030289|food cravings|food cravings
5564269|NCT01030250|Breast Cancer|breast cancer
5564270|NCT01030250|Adjuvant Chemotherapy|adjuvant chemotherapy
5564271|NCT01030237|Dry eye|dry eye
5564272|NCT01030237|artificial tears|artificial tears
5564273|NCT01030224|Healthy volunteer|healthy volunteer
5564274|NCT01030224|First time in human|first time in human
5564275|NCT01030211|Dengue|dengue
5564276|NCT01030211|Platelet transfusion|platelet transfusion
5564277|NCT01030211|Bleeding|bleeding
5564278|NCT01030211|Prevention|prevention
5564279|NCT01030185|ascites|ascites
5564280|NCT01030185|liver cirrhosis|liver cirrhosis
5564281|NCT01030159|Cancer Anemia Survey|cancer anemia survey
5564282|NCT01030159|Thai National Cancer Institute|thai national cancer institute
5564283|NCT01030133|Pain|pain
5564284|NCT01030120|chronic idiopathic urticaria|chronic idiopathic urticaria
5564285|NCT01030120|etanercept|etanercept
5564286|NCT01030107|sleep|sleep
5564287|NCT01030107|obesity|obesity
5564288|NCT01030107|children|children
5564289|NCT01030107|eating behaviors|eating behaviors
5564290|NCT01030107|activity|activity
5564291|NCT01030107|leptin|leptin
5564292|NCT01030107|ghrelin|ghrelin
5564293|NCT01030094|Topiramate|topiramate
5564294|NCT01030094|Carbamazepine|carbamazepine
5564295|NCT01030094|Valproic acid|valproic acid
5548912|NCT01091610|health personnel|health personnel
5564296|NCT01030094|Epilepsy|epilepsy
5564297|NCT01030094|Bone mineral density|bone mineral density
5564298|NCT01030094|Monotherapy|monotherapy
5564299|NCT01030081|24 hour blood pressure|24 hour blood pressure
5564300|NCT01030081|morning blood pressure surge|morning blood pressure surge
5564301|NCT01030081|amlodipine|amlodipine
5564302|NCT01030081|nifedipine GITS|nifedipine gits
5564303|NCT01030068|Smoking Cessation|smoking cessation
5564304|NCT01030068|Yoga|yoga
5564305|NCT01030068|Wellness|wellness
5564306|NCT01030068|Feasibility|feasibility
5564307|NCT01030068|Smoking Cessation Therapy|smoking cessation therapy
5564308|NCT01030055|Neoplasms|neoplasms
5564309|NCT01030055|Cancer|cancer
5564310|NCT01030055|Tumors|tumors
5564311|NCT01030055|Administration, oral|administration, oral
5564312|NCT01030055|Capsules|capsules
5564313|NCT01030055|CHIR258|chir258
5564314|NCT01030055|CHIR-258|chir-258
5564315|NCT01030055|CHIR 258|chir 258
5564316|NCT01030055|TKI258|tki258
5564317|NCT01030055|TKI-258|tki-258
5564318|NCT01030055|TKI 258|tki 258
5564319|NCT01030055|Bioavailability|bioavailability
5564320|NCT01030055|Food|food
5564321|NCT01030042|metastatic|metastatic
5564322|NCT01030042|colorectal cancer|colorectal cancer
5564323|NCT01030042|two sequences therapy|two sequences therapy
5564324|NCT01030029|auricular acupuncture|auricular acupuncture
5564325|NCT01030029|postoperative pain|postoperative pain
5564326|NCT01030029|opioid consumption|opioid consumption
5564327|NCT01030029|laparoscopic surgery|laparoscopic surgery
5564328|NCT01030029|ACUPUNCTURE THERAPY (IM) + EAR, EXTERNAL (IM)|acupuncture therapy (im) + ear, external (im)
5564329|NCT01030016|resistance exercise|resistance exercise
5564330|NCT01030016|beta-blockers|beta-blockers
5564331|NCT01030016|blood pressure|blood pressure
5564332|NCT01030003|Sleep-Disordered Breathing|sleep-disordered breathing
5564333|NCT01030003|Snoring|snoring
5564334|NCT01030003|Pregnancy|pregnancy
5564335|NCT01030003|Fetal Growth Retardation|fetal growth retardation
5564336|NCT01030003|Pre-Eclampsia|pre-eclampsia
5564337|NCT01029990|participation|participation
5564338|NCT01029990|mass screening|mass screening
5564339|NCT01029990|cervical neoplasia|cervical neoplasia
5564340|NCT01029990|health economics|health economics
5564341|NCT01029990|cost-benefit|cost-benefit
5564342|NCT01029964|Childhood obesity|childhood obesity
5564343|NCT01029964|Age-dependent|age-dependent
5564344|NCT01029964|Long-term treatment|long-term treatment
5564345|NCT01029964|BMI SDS|bmi sds
5564346|NCT01029964|Dropouts|dropouts
5564347|NCT01029951|Chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial|chiropractic; osteopathic physicians; manipulation; neck pain; adverse effects; randomized clinical trial
5564348|NCT01029951|Subacute non-specific neck pain|subacute non-specific neck pain
5564349|NCT01029938|Intracranial aneurysms;|intracranial aneurysms;
5564350|NCT01029938|Covered stent;|covered stent;
5564351|NCT01029938|Coil embolization|coil embolization
5564352|NCT01029925|metastatic breast cancer|metastatic breast cancer
5564353|NCT01029925|lung cancer|lung cancer
5564354|NCT01029925|Previously treated metastatic breast cancer|previously treated metastatic breast cancer
5564355|NCT01029925|stage IIIb lung cancer|stage iiib lung cancer
5564356|NCT01029925|stage IV lung cancer|stage iv lung cancer
5564357|NCT01029912|Stroke|stroke
5564358|NCT01029912|Hemiplegia|hemiplegia
5564359|NCT01029912|Footdrop|footdrop
5564360|NCT01029912|Electrical Stimulation|electrical stimulation
5564361|NCT01029912|Motor Relearning|motor relearning
5564362|NCT01029912|Neuroplasticity|neuroplasticity
5564363|NCT01029899|Colonoscopy|colonoscopy
5564364|NCT01029899|Force|force
5564365|NCT01029899|Monitor|monitor
5564366|NCT01029899|Endoscopist|endoscopist
5564367|NCT01029899|Trainee|trainee
5564368|NCT01029886|diabetes|diabetes
5564369|NCT01029886|exenatide once weekly|exenatide once weekly
5564370|NCT01029886|Byetta|byetta
5564371|NCT01029886|liraglutide|liraglutide
5564372|NCT01029886|Victoza|victoza
5564373|NCT01029886|Amylin|amylin
5564374|NCT01029886|Lilly|lilly
5564375|NCT01029873|cancer|cancer
5564376|NCT01029873|immunotherapy|immunotherapy
5564377|NCT01029873|targeted|targeted
5564378|NCT01029873|metastatic|metastatic
5564379|NCT01029873|interleukin-2|interleukin-2
5564380|NCT01029873|IL-2|il-2
5564381|NCT01029873|Cisplatin|cisplatin
5564382|NCT01029873|antitumor|antitumor
5564383|NCT01029873|melanoma|melanoma
5564384|NCT01029873|TCR|tcr
5564385|NCT01029873|T-cell receptor|t-cell receptor
5564386|NCT01029873|p53|p53
5564387|NCT01029873|p53 gene|p53 gene
5564388|NCT01029873|p53 tumor suppressor protein|p53 tumor suppressor protein
5564389|NCT01029860|Hypertension|hypertension
5564390|NCT01029860|Ambulatory measurement|ambulatory measurement
5564391|NCT01029847|Patients with axial spondyloarthritis|patients with axial spondyloarthritis
5564392|NCT01029834|BMI >85%for age and gender|bmi >85%for age and gender
5564393|NCT01029821|Low-Molecular-Weight-Heparin|low-molecular-weight-heparin
5564394|NCT01029821|Open Reduction and Internal Fixation|open reduction and internal fixation
5564395|NCT01029821|Thromboprophylaxis|thromboprophylaxis
5564396|NCT01029808|carriers of hemophilia|carriers of hemophilia
5564397|NCT01029782|Cellulitis|cellulitis
5564398|NCT01029782|Emergency Department|emergency department
5564399|NCT01029782|Cefazolin|cefazolin
5564400|NCT01029782|Probenecid|probenecid
5564401|NCT01029782|Cephalexin|cephalexin
5564402|NCT01029756|Pentax Airway Scope AWS S100|pentax airway scope aws s100
5564403|NCT01029756|Pentax AWS|pentax aws
5564404|NCT01029756|Macintosh|macintosh
5564405|NCT01029756|Laryngoscope|laryngoscope
5564406|NCT01029756|Video Laryngoscope|video laryngoscope
5564407|NCT01029743|TKR (Total Knee Replacement)|tkr (total knee replacement)
5564408|NCT01029743|THR (Total Hip Replacement)|thr (total hip replacement)
5564409|NCT01029743|VTE (Venous Thromboembolism)|vte (venous thromboembolism)
5564410|NCT01029743|LMWH (Low Molecular Weight Heparin)|lmwh (low molecular weight heparin)
5564411|NCT01029743|VKA (Vitamin K antagonist)|vka (vitamin k antagonist)
5564412|NCT01029730|Low grade lymphoma|low grade lymphoma
5564413|NCT01029730|Previously untreated lymphoma|previously untreated lymphoma
5564414|NCT01029730|Lymphoma first line|lymphoma first line
5564415|NCT01029730|bendamustine|bendamustine
5564417|NCT01029730|bortezomib|bortezomib
5564418|NCT01029730|Velcade|velcade
5564419|NCT01029730|rituximab|rituximab
5564420|NCT01029730|Rituxan|rituxan
5564421|NCT01029717|Central Venous Catheters|central venous catheters
5564422|NCT01029717|blood stream infection|blood stream infection
5564515|NCT01029353|Laparotomy|laparotomy
5564423|NCT01029717|children, intensive care|children, intensive care
5564424|NCT01029717|Heparin bonded|heparin bonded
5564425|NCT01029717|antibiotic coated|antibiotic coated
5564426|NCT01029717|Children in Paediatric Intensive Care Unit|children in paediatric intensive care unit
5564427|NCT01029704|Diabetes Mellitus Type 2|diabetes mellitus type 2
5564428|NCT01029691|Sleep disordered breathing|sleep disordered breathing
5564429|NCT01029691|Preeclampsia|preeclampsia
5564430|NCT01029691|Positive Airway Pressure|positive airway pressure
5564431|NCT01029678|Locally advanced lung cancer|locally advanced lung cancer
5564432|NCT01029678|Elderly patients|elderly patients
5564433|NCT01029678|NSCLC|nsclc
5564434|NCT01029665|Hernia, Diaphragmatic|hernia, diaphragmatic
5564435|NCT01029665|Asthma|asthma
5564436|NCT01029665|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5564437|NCT01029665|Growth & Development|growth & development
5564438|NCT01029652|frequent flares|frequent flares
5564440|NCT01029652|anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5564441|NCT01029639|Pulsatile intravenous insulin|pulsatile intravenous insulin
5564442|NCT01029639|Oral carbohydrate loading|oral carbohydrate loading
5564443|NCT01029639|Respiratory Quotients|respiratory quotients
5564444|NCT01029639|Hypoglycemia|hypoglycemia
5564445|NCT01029639|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5564446|NCT01029600|Randomized study capsulotomy vs distention with steroid|randomized study capsulotomy vs distention with steroid
5564447|NCT01029587|CAPS|caps
5564448|NCT01029587|Kidney transplant|kidney transplant
5564449|NCT01029587|Renal transplant|renal transplant
5564450|NCT01029587|Catastrophic Antiphospholipid Antibody Syndrome|catastrophic antiphospholipid antibody syndrome
5564451|NCT01029574|Rotator cuff lesions|rotator cuff lesions
5564452|NCT01029574|Platelet rich plasma|platelet rich plasma
5564453|NCT01029574|Arthroscopic repair|arthroscopic repair
5564454|NCT01029561|Metabolic syndrome|metabolic syndrome
5564455|NCT01029561|Insulin Resistance|insulin resistance
5564456|NCT01029561|Adipokines|adipokines
5564457|NCT01029561|Proinflammatory markers|proinflammatory markers
5564458|NCT01029561|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5671985|NCT00613288|hypogonadism|hypogonadism
5564459|NCT01029561|Continuous Positive Airway Pressure|continuous positive airway pressure
5564460|NCT01029561|Obesity|obesity
5564461|NCT01029561|Bariatric surgery|bariatric surgery
5564463|NCT01029548|Therapeutic Vaccine|therapeutic vaccine
5564464|NCT01029522|Dyslipidemia|dyslipidemia
5564465|NCT01029509|Advanced Leukemia|advanced leukemia
5564466|NCT01029509|Acute myeloid leukemia|acute myeloid leukemia
5564467|NCT01029509|ALL|all
5685548|NCT00555633|After-sun-lotion|after-sun-lotion
5564468|NCT01029509|Chronic myeloid leukemia blast crisis|chronic myeloid leukemia blast crisis
5564469|NCT01029509|CMS|cms
5564470|NCT01029509|Acute lymphocytic leukemia|acute lymphocytic leukemia
5564471|NCT01029509|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5564472|NCT01029509|Myelodysplastic syndromes|myelodysplastic syndromes
5564473|NCT01029509|MDS|mds
5564474|NCT01029509|OPB 31121|opb 31121
5564475|NCT01029496|umbilical CORD CLAMPING|umbilical cord clamping
5564476|NCT01029496|Neonatal anemia|neonatal anemia
5564477|NCT01029496|Omphalitis|omphalitis
5564478|NCT01029483|Obesity|obesity
5564479|NCT01029483|Weight loss|weight loss
5564480|NCT01029483|low carbohydrate diets|low carbohydrate diets
5564481|NCT01029483|high complex carbohydrate diets|high complex carbohydrate diets
5564482|NCT01029483|Healthy adults|healthy adults
5564483|NCT01029483|Body composition|body composition
5564484|NCT01029483|Energy Expenditure|energy expenditure
5564485|NCT01029470|Luveris|luveris
5564486|NCT01029470|hyporesponse|hyporesponse
5558451|NCT01052415|HIV|hiv
5564487|NCT01029470|pituitary downregulation|pituitary downregulation
5564488|NCT01029470|IVF|ivf
5564489|NCT01029470|Infertility women|infertility women
5564490|NCT01029444|Diabetes|diabetes
5564491|NCT01029444|Pulsatile intravenous insulin|pulsatile intravenous insulin
5564492|NCT01029444|Oral carbohydrate loading|oral carbohydrate loading
5564493|NCT01029444|Respiratory Quotients|respiratory quotients
5564494|NCT01029444|Hypoglycemia|hypoglycemia
5564495|NCT01029444|Hyperglycemia|hyperglycemia
5564496|NCT01029444|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5564497|NCT01029431|intubating laryngeal airway|intubating laryngeal airway
5564498|NCT01029431|pediatric|pediatric
5564499|NCT01029418|HCC|hcc
5564500|NCT01029418|hepatocellular carcinoma|hepatocellular carcinoma
5564501|NCT01029418|liver cancer|liver cancer
5564502|NCT01029405|Topical|topical
5564503|NCT01029405|Plaque type psoriasis|plaque type psoriasis
5564504|NCT01029392|Diabetes|diabetes
5564505|NCT01029392|Type I|type i
5564506|NCT01029392|Newly Diagnosis Type I Diabetes Mellitus|newly diagnosis type i diabetes mellitus
5564507|NCT01029379|propofol|propofol
5564508|NCT01029379|depth of anesthesia|depth of anesthesia
5564509|NCT01029379|pharmacogenetics|pharmacogenetics
5564510|NCT01029379|Depth of anesthesia in correlation to plasma concentrations of propofol|depth of anesthesia in correlation to plasma concentrations of propofol
5564511|NCT01029353|NICHD Neonatal Research Network|nichd neonatal research network
5564512|NCT01029353|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5564513|NCT01029353|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5564514|NCT01029353|Prematurity|prematurity
5564516|NCT01029353|Drainage|drainage
5564517|NCT01029353|Isolated intestinal perforation|isolated intestinal perforation
5564518|NCT01029353|Focal intestinal perforation|focal intestinal perforation
5564519|NCT01029340|Hemophilia A|hemophilia a
5564520|NCT01029340|Factor VIII|factor viii
5564521|NCT01029340|Prophylaxis|prophylaxis
5564522|NCT01029314|Thermometry|thermometry
5564523|NCT01029301|Skin aging|skin aging
5564524|NCT01029301|Skin Wrinkling|skin wrinkling
5564525|NCT01029288|Diabetes|diabetes
5564526|NCT01029288|Decision aid|decision aid
5564527|NCT01029288|Cardiovascular risk|cardiovascular risk
5564528|NCT01029288|Patient education|patient education
5564529|NCT01029275|Acromegaly|acromegaly
5564530|NCT01029275|pituitary adenoma|pituitary adenoma
5564531|NCT01029275|octreotide|octreotide
5564532|NCT01029275|transsphenoïdal surgery|transsphenoïdal surgery
5564533|NCT01029275|GH|gh
5564534|NCT01029275|IGF-1|igf-1
5564535|NCT01029262|Myelodysplastic Syndromes|myelodysplastic syndromes
5564536|NCT01029262|MDS|mds
5564537|NCT01029262|transfusion dependent anemia|transfusion dependent anemia
5564538|NCT01029262|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5564539|NCT01029262|non-del 5q|non-del 5q
5564540|NCT01029236|obesity|obesity
5564541|NCT01029236|metabolism|metabolism
5564542|NCT01029236|weight loss|weight loss
5564543|NCT01029236|energy expenditure|energy expenditure
5564544|NCT01029236|thermogenesis|thermogenesis
5564545|NCT01029236|Metabolism-Boosting Beverages effect on REE|metabolism-boosting beverages effect on ree
5564546|NCT01029236|Metabolism-Boosting Beverages effect on appetite|metabolism-boosting beverages effect on appetite
5564547|NCT01029210|osteoporosis|osteoporosis
5564548|NCT01029210|temporomandibular disorders|temporomandibular disorders
5564549|NCT01029210|resonance magnetic|resonance magnetic
5564550|NCT01029184|weaning|weaning
5564551|NCT01029184|cereals|cereals
5564552|NCT01029184|allergy|allergy
5564553|NCT01029184|atopy|atopy
5564554|NCT01029184|open allergenic test|open allergenic test
5564555|NCT01029171|falls|falls
5564556|NCT01029171|balance training|balance training
5564557|NCT01029171|strength training|strength training
5564558|NCT01029158|Healthy volunteers|healthy volunteers
5564559|NCT01029158|Comparison of two formulations|comparison of two formulations
5564560|NCT01029158|Improvement of scar appearance|improvement of scar appearance
5564561|NCT01029145|Bipolar disorder|bipolar disorder
5564562|NCT01029145|New occured episode: manic depressive or mixed|new occured episode: manic depressive or mixed
5564563|NCT01029132|Alzheimer's disease|alzheimer's disease
5564564|NCT01029132|Galantamine|galantamine
5564565|NCT01029132|Treatment response|treatment response
5564566|NCT01029132|Efficacy|efficacy
5564567|NCT01029132|Adverse Event|adverse event
5564568|NCT01029119|blood pressure|blood pressure
5564570|NCT01029106|Stress Urinary Incontinence|stress urinary incontinence
5564571|NCT01029106|Patients with Stress Urinary Incontinence|patients with stress urinary incontinence
5564572|NCT01029093|extremity with immobilisation|extremity with immobilisation
5564573|NCT01029093|brain platicity|brain platicity
5564574|NCT01029093|deprivation|deprivation
5564575|NCT01029093|MRI|mri
5564576|NCT01029080|Brain, blood flow|brain, blood flow
5564577|NCT01029080|Measurement techniques, flow velocity waveform analysis|measurement techniques, flow velocity waveform analysis
5564578|NCT01029080|Monitoring, intensive care|monitoring, intensive care
5564579|NCT01029080|Sepsis|sepsis
5564580|NCT01029080|transcranial doppler ultrasound (TCD)|transcranial doppler ultrasound (tcd)
5564581|NCT01029080|Cerebrovascular autoregulation|cerebrovascular autoregulation
5564582|NCT01029080|sepsis-associated delir|sepsis-associated delir
5564583|NCT01029067|schizophrenia|schizophrenia
5564584|NCT01029067|delusion|delusion
5564585|NCT01029067|paranoia|paranoia
5564586|NCT01029067|psychosis|psychosis
5564587|NCT01029054|Multiple Myeloma|multiple myeloma
5564588|NCT01029041|fibromyalgia, exercise, strength, stretch|fibromyalgia, exercise, strength, stretch
5564590|NCT01029015|Insomnia|insomnia
5564591|NCT01029015|Bladder function|bladder function
5564592|NCT01029015|cystometry|cystometry
5564593|NCT01029015|polysomnography|polysomnography
5564594|NCT01029002|Vitamin D|vitamin d
5564595|NCT01029002|CKD|ckd
5564596|NCT01029002|proteinuria|proteinuria
5564597|NCT01028989|Polycystic Ovary Syndrome|polycystic ovary syndrome
5564598|NCT01028989|Insulin|insulin
5564599|NCT01028989|Diet|diet
5564600|NCT01028989|Glycemic Load|glycemic load
5564601|NCT01028976|randomized controlled trial|randomized controlled trial
5564602|NCT01028976|primary prevention|primary prevention
5564603|NCT01028976|Vitamin C|vitamin c
5564604|NCT01028976|Antioxidants|antioxidants
5564605|NCT01028976|C-reactive protein|c-reactive protein
5564606|NCT01028976|inflammation|inflammation
5564607|NCT01028976|anti-inflammatory agents|anti-inflammatory agents
5564608|NCT01028976|obesity|obesity
5564609|NCT01028950|YM150|ym150
5564610|NCT01028950|Bleeding|bleeding
5564611|NCT01028950|VTE|vte
5564612|NCT01028950|FXa inhibitor|fxa inhibitor
5564613|NCT01028950|Deep Vein Thrombosis|deep vein thrombosis
5564614|NCT01028950|Venous thromboembolism|venous thromboembolism
5564615|NCT01028937|Hyperopia correction|hyperopia correction
5564616|NCT01028937|Laser vision correction|laser vision correction
5564617|NCT01028937|Optimal keratoplasty|optimal keratoplasty
5564618|NCT01028924|Thorough QTc-Study|thorough qtc-study
5564619|NCT01028924|Short Bowel Syndrome|short bowel syndrome
5564620|NCT01028924|Cardiac safety|cardiac safety
5564621|NCT01028911|Phase 1 Alzheimer's disease Safety Tolerability Pharmacokinetics|phase 1 alzheimer's disease safety tolerability pharmacokinetics
5564623|NCT01028898|proteomics|proteomics
5564624|NCT01028898|fluorescent quantitation polymerase chain reaction|fluorescent quantitation polymerase chain reaction
5564625|NCT01028898|Western blot|western blot
5546720|NCT01100190|Ptosis|ptosis
5564626|NCT01028898|immunohistochemistry staining (IHC)|immunohistochemistry staining (ihc)
5564627|NCT01028898|ATP content|atp content
5564629|NCT01028872|higher-order aberrations, contrast sensitivity|higher-order aberrations, contrast sensitivity
5564630|NCT01028859|Tubulin polymerization inhibitor|tubulin polymerization inhibitor
5564631|NCT01028859|CKD-516|ckd-516
5564632|NCT01028859|Phase I|phase i
5564633|NCT01028859|Vascular disrupting agent|vascular disrupting agent
5564634|NCT01028859|DCE MRI|dce mri
5564635|NCT01028846|Type 2 Diabetes|type 2 diabetes
5564636|NCT01028833|power wheelchairs|power wheelchairs
5564637|NCT01028833|power mobility|power mobility
5564638|NCT01028833|young children|young children
5564639|NCT01028820|autism|autism
5564640|NCT01028820|asperger's|asperger's
5564641|NCT01028820|repetitive|repetitive
5564642|NCT01028820|restricted|restricted
5564643|NCT01028820|compulsions|compulsions
5564644|NCT01028807|Early feeding|early feeding
5564645|NCT01028807|Bowel anastomosis|bowel anastomosis
5564646|NCT01028807|Children|children
5564647|NCT01028794|stroke|stroke
5564648|NCT01028794|bone marrow|bone marrow
5564649|NCT01028794|mononuclear cell|mononuclear cell
5564650|NCT01028794|angiogenesis|angiogenesis
5564651|NCT01028794|neurogenesis|neurogenesis
5564652|NCT01028768|Renal impairment|renal impairment
5564653|NCT01028768|Renal impairment study|renal impairment study
5564654|NCT01028755|Maximum Tolerated Dose|maximum tolerated dose
5564655|NCT01028742|Traumatic brain injury|traumatic brain injury
5564656|NCT01028742|Hypopituitarism|hypopituitarism
5564657|NCT01028742|Incidence|incidence
5564658|NCT01028703|Chronic kidney disease|chronic kidney disease
5564659|NCT01028703|left ventricular dysfunction|left ventricular dysfunction
5564660|NCT01028703|diastolic dysfunction|diastolic dysfunction
5564661|NCT01028703|hypertension|hypertension
5564662|NCT01028690|Helicobacter pylori|helicobacter pylori
5564663|NCT01028690|Eradication therapy|eradication therapy
5564664|NCT01028690|Lactobacillus reuteri|lactobacillus reuteri
5564665|NCT01028690|Dyspeptic symptoms|dyspeptic symptoms
5564666|NCT01028677|oxytocin|oxytocin
5564667|NCT01028677|social cognition|social cognition
5564668|NCT01028677|social skill|social skill
5564669|NCT01028677|social functioning|social functioning
5564670|NCT01028677|paranoia|paranoia
5564671|NCT01028677|psychotic symptoms|psychotic symptoms
5564672|NCT01028677|schizophrenia|schizophrenia
5564673|NCT01028677|social deficits|social deficits
5564674|NCT01028677|intranasal administration|intranasal administration
5564915|NCT01027494|ear infection|ear infection
5564675|NCT01028664|Glaucoma and ocular hypertension patients|glaucoma and ocular hypertension patients
5564677|NCT01028651|Pulmonary Hypertension|pulmonary hypertension
5564678|NCT01028651|Remodulin|remodulin
5564679|NCT01028651|Treprostinil|treprostinil
5564680|NCT01028651|Quality of Life|quality of life
5564681|NCT01028638|VEGF imaging|vegf imaging
5564682|NCT01028638|everolimus|everolimus
5564683|NCT01028638|renal cell carcinoma|renal cell carcinoma
5564685|NCT01028638|bevacizumab|bevacizumab
5564686|NCT01028625|Heart failure|heart failure
5564687|NCT01028625|Depression|depression
5564688|NCT01028625|Self Care|self care
5564689|NCT01028625|Cognitive behavior therapy|cognitive behavior therapy
5564690|NCT01028599|Heart transplantation|heart transplantation
5564691|NCT01028599|Exercise capacity|exercise capacity
5564692|NCT01028599|Endothelial function|endothelial function
5564693|NCT01028573|bowel preparation|bowel preparation
5564694|NCT01028573|colonoscopy|colonoscopy
5564695|NCT01028560|Wheezing|wheezing
5564696|NCT01028560|Asthma|asthma
5564697|NCT01028560|Allergy|allergy
5564698|NCT01028560|Immunotherapy|immunotherapy
5564699|NCT01028547|PONV|ponv
5564700|NCT01028534|Continuous positive pressure ventilation|continuous positive pressure ventilation
5564701|NCT01028534|Blood pressure|blood pressure
5564702|NCT01028534|Oxygen desaturation index|oxygen desaturation index
5564703|NCT01028534|Endothelial dysfunction|endothelial dysfunction
5564704|NCT01028534|Patient reported measurement|patient reported measurement
5564705|NCT01028521|First time in man, safety study, Cm3.1-AC100|first time in man, safety study, cm3.1-ac100
5564706|NCT01028521|Male volunteer aged 18 to 50 years at Screening|male volunteer aged 18 to 50 years at screening
5564707|NCT01028508|Depression|depression
5564708|NCT01028508|ECT|ect
5564709|NCT01028508|electroconvulsive therapy|electroconvulsive therapy
5564710|NCT01028508|mood disorders|mood disorders
5564711|NCT01028508|continuation ECT|continuation ect
5564712|NCT01028508|continuation pharmacotherapy|continuation pharmacotherapy
5564713|NCT01028508|geriatric|geriatric
5564714|NCT01028508|elderly|elderly
5564715|NCT01028508|lithium|lithium
5564716|NCT01028508|venlafaxine|venlafaxine
5564717|NCT01028495|AKT-1|akt-1
5564718|NCT01028482|severity of depression measured by MADRS and CGI|severity of depression measured by madrs and cgi
5564719|NCT01028456|Seizures|seizures
5564720|NCT01028456|Light Therapy|light therapy
5564721|NCT01028430|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5564722|NCT01028417|subcentimetre nodules|subcentimetre nodules
5564723|NCT01028365|Fertility|fertility
5564724|NCT01028365|Trying to Conceive|trying to conceive
5564725|NCT01028365|Trying to Get Pregnant|trying to get pregnant
5564726|NCT01028365|Pregnancy|pregnancy
5564727|NCT01028339|traumatic brain injury|traumatic brain injury
5564729|NCT01028339|Cerebral microdialysis|cerebral microdialysis
5564730|NCT01028339|Osmotherapy|osmotherapy
5564731|NCT01028339|hypertonic saline|hypertonic saline
5564732|NCT01028339|mannitol|mannitol
5564733|NCT01028326|Pneumococcal pneumonia vaccine|pneumococcal pneumonia vaccine
5564734|NCT01028313|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5564735|NCT01028313|GVHD|gvhd
5564736|NCT01028313|LBH589|lbh589
5564737|NCT01028313|Panobinostat|panobinostat
5564738|NCT01028300|DDD|ddd
5564739|NCT01028287|Diabetic Nephropathy|diabetic nephropathy
5564740|NCT01028287|Nephrotic syndrome|nephrotic syndrome
5564741|NCT01028274|Hypercholesterolemia|hypercholesterolemia
5564742|NCT01028274|Hypertriglyceridemia|hypertriglyceridemia
5564743|NCT01028274|Fish Oil|fish oil
5564744|NCT01028274|Red Yeast Rice|red yeast rice
5564745|NCT01028261|Obese|obese
5564746|NCT01028261|Obesity|obesity
5564747|NCT01028261|Overweight|overweight
5564748|NCT01028248|Central Retinal Vein Occlusion|central retinal vein occlusion
5564749|NCT01028248|Retinal Vein Occlusive disease|retinal vein occlusive disease
5564750|NCT01028235|Eosinophilic Esophagitis|eosinophilic esophagitis
5564751|NCT01028222|Melanoma|melanoma
5564752|NCT01028222|AMN107|amn107
5564753|NCT01028222|c-Kit|c-kit
5564754|NCT01028222|c-Kit mutated metastatic and/or inoperable melanoma|c-kit mutated metastatic and/or inoperable melanoma
5564755|NCT01028196|schizophrenia|schizophrenia
5564756|NCT01028196|schizoaffective disorder|schizoaffective disorder
5564757|NCT01028196|recurrent depression|recurrent depression
5564758|NCT01028196|Bipolar disorders|bipolar disorders
5564759|NCT01028183|therapeutics|therapeutics
5564760|NCT01028183|safety|safety
5564761|NCT01028183|maternal|maternal
5564762|NCT01028183|neonatal|neonatal
5564763|NCT01028170|Congestive Heart Failure|congestive heart failure
5564764|NCT01028170|Renal Insufficiency|renal insufficiency
5564765|NCT01028170|Cardio-renal Syndrome|cardio-renal syndrome
5564767|NCT01028157|risk reduction|risk reduction
5564768|NCT01028157|behavioral intervention|behavioral intervention
5564769|NCT01028144|Exercise|exercise
5564770|NCT01028144|Physical Activity|physical activity
5564771|NCT01028144|Adolescent|adolescent
5564772|NCT01028144|Minority Health|minority health
5564773|NCT01028131|cigarette smoking|cigarette smoking
5564774|NCT01028131|pregnancy|pregnancy
5564775|NCT01028131|intervention|intervention
5564776|NCT01028131|efficacy|efficacy
5564777|NCT01028131|Motivational Interviewing|motivational interviewing
5564778|NCT01028131|Contingency Management|contingency management
5564779|NCT01028118|domestic and sexual violence|domestic and sexual violence
5564780|NCT01028118|menopause|menopause
5564781|NCT01028118|professional improvement|professional improvement
5564782|NCT01028118|social support network|social support network
5564783|NCT01028105|Preoperative screening|preoperative screening
5564784|NCT01028105|MRSA|mrsa
5564785|NCT01028105|Incidence|incidence
5564786|NCT01028105|Postoperative infection|postoperative infection
5564787|NCT01028105|Preoperative MRSA Screening Incidence|preoperative mrsa screening incidence
5564788|NCT01028105|Postoperative MRSA Infection Rate|postoperative mrsa infection rate
5564789|NCT01028079|Back Pain|back pain
5564790|NCT01028079|Acute low back pain|acute low back pain
5564791|NCT01028066|nutritional intervention|nutritional intervention
5564792|NCT01028066|nutritional counseling|nutritional counseling
5564793|NCT01028066|feeding behavior|feeding behavior
5564794|NCT01028066|food consumption|food consumption
5564795|NCT01028066|angioplasty|angioplasty
5564796|NCT01028053|Mild Cognitive Impairment|mild cognitive impairment
5564797|NCT01028053|Positron Emission Tomography|positron emission tomography
5564916|NCT01027494|ear drops|ear drops
5564798|NCT01028053|National Institute of Neurological and Communicative Disorders and Stroke|national institute of neurological and communicative disorders and stroke
5564799|NCT01028053|Alzheimer's Disease and Related Disorders Association|alzheimer's disease and related disorders association
5564800|NCT01028053|Assess Prognostic Usefulness of Flutemetamol Injection for Identifying Subjects who will Convert to Clinically Probable Alzheimer's Disease|assess prognostic usefulness of flutemetamol injection for identifying subjects who will convert to clinically probable alzheimer's disease
5564801|NCT01028040|Phase I|phase i
5564802|NCT01028040|AZD3043|azd3043
5564803|NCT01028040|Japanese healthy volunteer|japanese healthy volunteer
5564804|NCT01028027|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
5564897|NCT01027598|Pazopanib|pazopanib
5564805|NCT01027988|Retinal Microvascularisation|retinal microvascularisation
5564806|NCT01027988|Fundus|fundus
5564807|NCT01027988|mfERGs|mfergs
5564808|NCT01027988|CHF|chf
5564809|NCT01027988|Cardiovascular Disease|cardiovascular disease
5564810|NCT01027988|Coronarography|coronarography
5564811|NCT01027988|Macrovascularisation|macrovascularisation
5564812|NCT01027988|The objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality|the objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality
5564813|NCT01027975|laparoscopy|laparoscopy
5567436|NCT01016613|biobank|biobank
5564814|NCT01027975|fundoplication|fundoplication
5564815|NCT01027975|Nissen|nissen
5564816|NCT01027975|Thal|thal
5564817|NCT01027975|children|children
5564818|NCT01027975|operative treatment of gastro-oesophageal reflux disease in children|operative treatment of gastro-oesophageal reflux disease in children
5564819|NCT01027962|Early Onset Psychosis|early onset psychosis
5564820|NCT01027962|Laptop Computer|laptop computer
5564821|NCT01027962|Brain Training|brain training
5564822|NCT01027936|Healthy Volunteers|healthy volunteers
5564823|NCT01027910|PCI-24781|pci-24781
5564824|NCT01027910|doxorubicin|doxorubicin
5564825|NCT01027897|Pharmacokinetics|pharmacokinetics
5564826|NCT01027897|Pharmacodynamics|pharmacodynamics
5564827|NCT01027897|Doripenem|doripenem
5564828|NCT01027897|Trauma|trauma
5564829|NCT01027897|sepsis|sepsis
5564830|NCT01027897|Trauma patients with sepsis|trauma patients with sepsis
5564831|NCT01027884|Idebenone|idebenone
5564832|NCT01027884|Duchenne Muscular Dystrophy (DMD)|duchenne muscular dystrophy (dmd)
5564833|NCT01027884|Respiratory function|respiratory function
5564834|NCT01027884|Ambulatory and non-ambulatory patients|ambulatory and non-ambulatory patients
5564835|NCT01027884|Subjects not using glucocorticoids|subjects not using glucocorticoids
5564836|NCT01027858|exercise|exercise
5564837|NCT01027858|aerobic exercise training|aerobic exercise training
5564838|NCT01027858|vascular cognitive impairment|vascular cognitive impairment
5564839|NCT01027858|Mild Sub-cortical Ischaemic Vascular Cognitive Impairment (SIVCI)|mild sub-cortical ischaemic vascular cognitive impairment (sivci)
5564840|NCT01027845|Pneumococcal disease|pneumococcal disease
5564842|NCT01027845|Booster vaccination|booster vaccination
5564843|NCT01027845|Pneumococcal vaccine|pneumococcal vaccine
5564844|NCT01027845|Primary vaccination|primary vaccination
5564845|NCT01027845|Safety|safety
5564846|NCT01027832|tracheobronchitis|tracheobronchitis
5564847|NCT01027819|Total knee arthroplasty|total knee arthroplasty
5564848|NCT01027819|Mobile bearing|mobile bearing
5564849|NCT01027819|Fixed bearing|fixed bearing
5564850|NCT01027819|Range of motion|range of motion
5564851|NCT01027819|Knee Society Score|knee society score
5564852|NCT01027806|Children|children
5564853|NCT01027806|Sleep|sleep
5564854|NCT01027806|Obstructive Sleep Apnea|obstructive sleep apnea
5564855|NCT01027793|Stretch marks|stretch marks
5564856|NCT01027793|Striae|striae
5564857|NCT01027793|Tretinoin|tretinoin
5564858|NCT01027793|Superficial dermabrasion|superficial dermabrasion
5564859|NCT01027780|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5564860|NCT01027780|MBSR|mbsr
5564861|NCT01027780|Seniors|seniors
5564862|NCT01027780|immune system|immune system
5564863|NCT01027780|keyhole limpet hemocyanin (KLH)|keyhole limpet hemocyanin (klh)
5564864|NCT01027767|Breast|breast
5564865|NCT01027767|MBI|mbi
5564866|NCT01027767|Molecular|molecular
5564867|NCT01027767|Molecular Breast Imaging|molecular breast imaging
5564868|NCT01027767|Dense breast tissue|dense breast tissue
5564869|NCT01027767|Surgery|surgery
5564870|NCT01027767|Radiation|radiation
5564871|NCT01027767|BCT|bct
5564872|NCT01027754|methadone maintenance|methadone maintenance
5564873|NCT01027715|Neonatal Seizures|neonatal seizures
5564874|NCT01027715|Neonatal encephalopathy|neonatal encephalopathy
5564875|NCT01027702|Donor Lymphocyte Infusion|donor lymphocyte infusion
5564876|NCT01027702|Immune Recovery|immune recovery
5564877|NCT01027702|T cell depleted transplant|t cell depleted transplant
5564878|NCT01027702|Mismatched related donor transplants|mismatched related donor transplants
5564879|NCT01027702|Unrelated donor transplants|unrelated donor transplants
5564880|NCT01027689|alprazolam|alprazolam
5564881|NCT01027689|bioequivalence|bioequivalence
5564882|NCT01027689|sublingual|sublingual
5564883|NCT01027676|Gefitinib|gefitinib
5564884|NCT01027676|Vorinostat|vorinostat
5564885|NCT01027663|anemia|anemia
5564886|NCT01027663|malaria|malaria
5564887|NCT01027637|breast reconstruction|breast reconstruction
5564888|NCT01027637|tissue expander|tissue expander
5564889|NCT01027637|Alloderm|alloderm
5564890|NCT01027637|tissue matrix|tissue matrix
5564891|NCT01027624|Pan South African Survey on the Undertreatment of Hypercholesterolaemia|pan south african survey on the undertreatment of hypercholesterolaemia
5564892|NCT01027611|Effectiveness of topical pain medicine for control of pain associated with intravitreal injections|effectiveness of topical pain medicine for control of pain associated with intravitreal injections
5564893|NCT01027611|Eye discomfort|eye discomfort
5564894|NCT01027598|Lung Cancer|lung cancer
5564895|NCT01027598|Previously Treated Advanced Non Small Cell Lung Cancer|previously treated advanced non small cell lung cancer
5564896|NCT01027598|Erlotinib|erlotinib
5564898|NCT01027572|Vegetative state|vegetative state
5564899|NCT01027572|Minimally conscious state|minimally conscious state
5564900|NCT01027572|Thalamic stimulation|thalamic stimulation
5564901|NCT01027559|Major Depression|major depression
5564902|NCT01027559|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5564903|NCT01027559|Emotional Circuitry|emotional circuitry
5564904|NCT01027559|Cognitive Behavioral Therapy|cognitive behavioral therapy
5564905|NCT01027546|perioperative blood loss, spinal surgery|perioperative blood loss, spinal surgery
5564906|NCT01027533|multifocal intraocular lens|multifocal intraocular lens
5564907|NCT01027533|visual acuity|visual acuity
5564908|NCT01027533|presbiopia|presbiopia
5564909|NCT01027520|Hand burn|hand burn
5564910|NCT01027520|skin graft|skin graft
5564911|NCT01027520|coban dressing|coban dressing
5564912|NCT01027520|range of motion|range of motion
5564913|NCT01027494|ear tubes|ear tubes
5564914|NCT01027494|ear drainage|ear drainage
5564917|NCT01027494|tympanostomy tubes|tympanostomy tubes
5564918|NCT01027481|lucentis, macular edema, branch retinal vein occlusion|lucentis, macular edema, branch retinal vein occlusion
5564919|NCT01027468|bevacizumab, choroidal neovascularization|bevacizumab, choroidal neovascularization
5564920|NCT01027442|Stereolithography|stereolithography
5564921|NCT01027442|Dental implants,|dental implants,
5564922|NCT01027442|Prosthetics|prosthetics
5564923|NCT01027442|positioning-errors|positioning-errors
5564924|NCT01027442|logistic regression analysis|logistic regression analysis
5564925|NCT01027429|infant|infant
5564926|NCT01027429|newborn|newborn
5564927|NCT01027429|sepsis|sepsis
5564928|NCT01027429|infection|infection
5564929|NCT01027429|community|community
5564930|NCT01027416|ER positive|er positive
5564931|NCT01027416|Tamoxifen|tamoxifen
5564932|NCT01027403|Heart failure|heart failure
5564933|NCT01027403|Adult stem cells|adult stem cells
5564934|NCT01027403|Circulating stem cells|circulating stem cells
5685549|NCT00555633|DNA repair enzymes|dna repair enzymes
5564935|NCT01027403|Acute decompensated heart failure|acute decompensated heart failure
5564936|NCT01027390|neck/shoulder|neck/shoulder
5564937|NCT01027351|Children|children
5564938|NCT01027351|Pre-school|pre-school
5564939|NCT01027351|Meningococcal disease|meningococcal disease
5564940|NCT01027351|Prevention|prevention
5564941|NCT01027351|Vaccination|vaccination
5564942|NCT01027325|Resistant Starch|resistant starch
5564943|NCT01027325|Amylose|amylose
5564944|NCT01027325|Amylopectin|amylopectin
5564945|NCT01027325|LDL subclasses|ldl subclasses
5564946|NCT01027325|Dietary carbohydrate|dietary carbohydrate
5564947|NCT01027325|Postprandial insulinemia|postprandial insulinemia
5564948|NCT01027312|Glaucoma|glaucoma
5564949|NCT01027312|quality of life|quality of life
5564950|NCT01027312|daily living activities|daily living activities
5564951|NCT01027312|visual fields|visual fields
5564952|NCT01027312|contrast sensitivity|contrast sensitivity
5564953|NCT01027299|cardiac failure|cardiac failure
5564954|NCT01027299|thoracic surgery|thoracic surgery
5564955|NCT01027299|cardiac pacing, artificial|cardiac pacing, artificial
5564956|NCT01027273|Stroke|stroke
5564957|NCT01027273|Ischemic Stroke|ischemic stroke
5680315|NCT00578240|90-040|90-040
5564958|NCT01027273|Transient Ischemic Attack|transient ischemic attack
5564959|NCT01027273|Stroke Recurrence Prevention|stroke recurrence prevention
5564960|NCT01027273|Cerebrovascular Disorders|cerebrovascular disorders
5564961|NCT01027273|Brain Ischemia|brain ischemia
5564962|NCT01027273|Brain Infraction|brain infraction
5564963|NCT01027273|Brain Diseases|brain diseases
5564964|NCT01027273|Cerebral Infraction|cerebral infraction
5564965|NCT01027273|Self-management|self-management
5564966|NCT01027273|Peer-led|peer-led
5564967|NCT01027273|Community Based|community based
5564968|NCT01027247|Primary Glaucoma|primary glaucoma
5564969|NCT01027234|Healthy volunteers|healthy volunteers
5564970|NCT01027221|Low Dose Radiation|low dose radiation
5564971|NCT01027221|pancreatic cancer|pancreatic cancer
5564972|NCT01027221|Immunostimulation|immunostimulation
5564974|NCT01027169|Hepatic impairment|hepatic impairment
5564975|NCT01027169|Liver diseases|liver diseases
5564976|NCT01027169|Pharmacokinetics|pharmacokinetics
5564977|NCT01027169|To Investigate Pharmacokinetics of Safinamide in Subjects With Mild and Moderate Hepatic Impairment as Compared to Healthy Subjects With Normal Hepatic Function|to investigate pharmacokinetics of safinamide in subjects with mild and moderate hepatic impairment as compared to healthy subjects with normal hepatic function
5564978|NCT01027156|Public Health|public health
5564979|NCT01027156|Biochemistry|biochemistry
5564980|NCT01027156|Ecological|ecological
5564981|NCT01027143|Asthma|asthma
5564982|NCT01027143|Obesity|obesity
5564983|NCT01027143|Pharmacogenetics|pharmacogenetics
5564984|NCT01027143|Nutrigenetics|nutrigenetics
5564985|NCT01027117|Bioavailability|bioavailability
5564986|NCT01027117|Revatio|revatio
5564987|NCT01027117|Healthy Volunteers|healthy volunteers
5564988|NCT01027104|injury prevention|injury prevention
5564989|NCT01027104|firearms|firearms
5564990|NCT01027104|training|training
5564991|NCT01027104|counseling|counseling
5564992|NCT01027104|medical education|medical education
5564993|NCT01027104|safety|safety
5564994|NCT01027104|anticipatory guidance|anticipatory guidance
5564995|NCT01027104|Firearm injury prevention anticipatory guidance|firearm injury prevention anticipatory guidance
5564996|NCT01027091|hypocalcemia|hypocalcemia
5564997|NCT01027091|total thyroidectomy|total thyroidectomy
5564998|NCT01027065|interleukin-7|interleukin-7
5564999|NCT01027065|immune-based therapies|immune-based therapies
5565000|NCT01027065|hepatitis B|hepatitis b
5565001|NCT01027065|HBe negative|hbe negative
5565002|NCT01027065|HBV vaccination|hbv vaccination
5565003|NCT01027065|entecavir|entecavir
5565004|NCT01027065|tenofovir|tenofovir
5565005|NCT01027065|chronic hepatitis|chronic hepatitis
5565006|NCT01027065|immune specific responses to HBV|immune specific responses to hbv
5565007|NCT01027065|phase 1/2a|phase 1/2a
5565008|NCT01027065|viral disease|viral disease
5565009|NCT01027065|liver disease|liver disease
5565011|NCT01027052|Spice|spice
5565012|NCT01027039|primary open angle glaucoma|primary open angle glaucoma
5565013|NCT01027039|pigmentary glaucoma|pigmentary glaucoma
5565014|NCT01027039|exfoliative glaucoma|exfoliative glaucoma
5565015|NCT01027039|angle closure glaucoma|angle closure glaucoma
5565016|NCT01027039|low tension glaucoma|low tension glaucoma
5565017|NCT01027026|Cost analysis|cost analysis
5565018|NCT01027026|Safety|safety
5565019|NCT01027026|Length of stay|length of stay
5565020|NCT01027026|Randomized controlled trials|randomized controlled trials
5565021|NCT01027026|Early discharge|early discharge
5565022|NCT01027000|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5565023|NCT01027000|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5565024|NCT01027000|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5565025|NCT01027000|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5565026|NCT01027000|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5671986|NCT00613288|lipolysis|lipolysis
5565027|NCT01027000|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5565028|NCT01027000|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5565029|NCT01027000|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5565030|NCT01027000|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5565031|NCT01027000|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5565032|NCT01027000|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5565033|NCT01027000|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5565034|NCT01026974|Children|children
5565035|NCT01026974|Pre-school|pre-school
5565036|NCT01026974|Meningococcal disease|meningococcal disease
5565037|NCT01026974|Prevention|prevention
5565038|NCT01026974|Vaccination|vaccination
5565039|NCT01026961|Safety|safety
5565040|NCT01026961|heart rate|heart rate
5565041|NCT01026961|systolic and diastolic blood pressure|systolic and diastolic blood pressure
5565042|NCT01026961|arrhythmias|arrhythmias
5565043|NCT01026948|Induction of labour|induction of labour
5565044|NCT01026948|Intraprtum fetal monitoring|intraprtum fetal monitoring
5565045|NCT01026935|open mesh repair|open mesh repair
5565046|NCT01026935|sutured|sutured
5565047|NCT01026935|non-sutured|non-sutured
5565048|NCT01026935|pro-grip|pro-grip
5565049|NCT01026935|postoperative pain|postoperative pain
5565050|NCT01026922|antroduodenal manometry|antroduodenal manometry
5565051|NCT01026922|gastric dysmotility|gastric dysmotility
5565052|NCT01026922|intestinal dysmotility|intestinal dysmotility
5565053|NCT01026883|hematocrit|hematocrit
5565054|NCT01026883|layered resonant piezoelectric sensors|layered resonant piezoelectric sensors
5565055|NCT01026844|erlotinib|erlotinib
5565057|NCT01026844|hydroxychloroquine|hydroxychloroquine
5565058|NCT01026844|NSCLC|nsclc
5565059|NCT01026818|Erectile Dysfunction|erectile dysfunction
5565060|NCT01026818|Radical Prostatectomy|radical prostatectomy
5565061|NCT01026805|morcellator|morcellator
5565062|NCT01026805|hysteroscope|hysteroscope
5565063|NCT01026805|myomectomy|myomectomy
5565064|NCT01026805|polypectomy|polypectomy
5565065|NCT01026805|uterine fibroids|uterine fibroids
5565066|NCT01026779|rotavirus|rotavirus
5565067|NCT01026779|gastroenteritis|gastroenteritis
5565068|NCT01026779|vaccine|vaccine
5565069|NCT01026779|case-control study|case-control study
5565070|NCT01026779|serotype|serotype
5565071|NCT01026766|Hypothermia|hypothermia
5565072|NCT01026766|Obesity|obesity
5565073|NCT01026766|Heat and moisture exchanger|heat and moisture exchanger
5565074|NCT01026766|Warming blanket|warming blanket
5565075|NCT01026766|Warming fluids|warming fluids
5565076|NCT01026766|Gynecological surgery|gynecological surgery
5565077|NCT01026766|Intravenous anesthesia|intravenous anesthesia
5565078|NCT01026766|Obese patients|obese patients
5565079|NCT01026766|Non obese patients|non obese patients
5565080|NCT01026753|colorectal cancer|colorectal cancer
5565081|NCT01026753|screening|screening
5565082|NCT01026753|fecal occult blood test|fecal occult blood test
5565083|NCT01026753|randomized control trial|randomized control trial
5565084|NCT01026753|primary care oncology|primary care oncology
5565085|NCT01026753|web site|web site
5565086|NCT01026753|provincial health contact center|provincial health contact center
5565087|NCT01026740|Staphylococcal Skin Infections|staphylococcal skin infections
5565088|NCT01026740|Streptococcal Infections|streptococcal infections
5565089|NCT01026727|HIV Infections|hiv infections
5565090|NCT01026727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5565091|NCT01026727|Virus Diseases|virus diseases
5565092|NCT01026727|Sexually Transmitted Diseases, Viral|sexually transmitted diseases, viral
5565093|NCT01026727|RNA Virus Infections|rna virus infections
5565094|NCT01026727|Slow Virus Diseases|slow virus diseases
5565095|NCT01026727|Immune System Diseases|immune system diseases
5565096|NCT01026727|Sexually Transmitted Diseases|sexually transmitted diseases
5565097|NCT01026727|Lentivirus Infections|lentivirus infections
5565098|NCT01026727|Infection|infection
5565099|NCT01026727|Retroviridae Infections|retroviridae infections
5565100|NCT01026727|Immunologic Deficiency Syndromes|immunologic deficiency syndromes
5565102|NCT01026727|treatment experienced|treatment experienced
5565103|NCT01026727|bevirimat|bevirimat
5565104|NCT01026701|Osteoblst effect|osteoblst effect
5565105|NCT01026701|Velcade|velcade
5565106|NCT01026701|Proteasome inhibitor|proteasome inhibitor
5565107|NCT01026701|Bortezomib|bortezomib
5565108|NCT01026701|Multjple Myeloma|multjple myeloma
5565109|NCT01026688|Pragmatic randomized controlled trial|pragmatic randomized controlled trial
5565110|NCT01026688|Cardiovascular risk reduction|cardiovascular risk reduction
5565111|NCT01026688|Knowledge translation|knowledge translation
5565112|NCT01026688|Clinical practice guidelines|clinical practice guidelines
5565113|NCT01026662|Aesthetic dermatology|aesthetic dermatology
5565114|NCT01026649|hematoma formation|hematoma formation
5565115|NCT01026649|success rate|success rate
5565116|NCT01026636|Staphylococcal Skin Infections|staphylococcal skin infections
5565117|NCT01026636|Skin Infections|skin infections
5565118|NCT01026636|Streptococcal Infections|streptococcal infections
5565119|NCT01026610|Chronic hepatitis B|chronic hepatitis b
5565120|NCT01026610|LB80380|lb80380
5565121|NCT01026610|treatment-naive|treatment-naive
5565122|NCT01026610|entecavir|entecavir
5565123|NCT01026571|Bicuspid aortic valve|bicuspid aortic valve
5565124|NCT01026558|Obesity, Ceftobiprole|obesity, ceftobiprole
5565125|NCT01026558|Skin Infections|skin infections
5565126|NCT01026558|Staphylococcal Skin Infections|staphylococcal skin infections
5565127|NCT01026558|Bacterial Skin Infections|bacterial skin infections
5565128|NCT01026558|Streptococcal Infection|streptococcal infection
5565129|NCT01026545|safety|safety
5565130|NCT01026545|tolerability|tolerability
5565131|NCT01026545|pharmacokinetics|pharmacokinetics
5565132|NCT01026545|multiple-dose|multiple-dose
5565133|NCT01026545|macrolide|macrolide
5565134|NCT01026506|c9,t11-CLA|c9,t11-cla
5565135|NCT01026506|allergic bronchial asthma|allergic bronchial asthma
5565136|NCT01026506|children and adolescents|children and adolescents
5565137|NCT01026493|adult giant cell glioblastoma|adult giant cell glioblastoma
5565138|NCT01026493|adult glioblastoma|adult glioblastoma
5565139|NCT01026493|adult gliosarcoma|adult gliosarcoma
5565140|NCT01026493|recurrent adult brain tumor|recurrent adult brain tumor
5565141|NCT01026493|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5565142|NCT01026493|adult anaplastic ependymoma|adult anaplastic ependymoma
5565143|NCT01026493|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5565144|NCT01026493|adult brain stem glioma|adult brain stem glioma
5565145|NCT01026493|adult mixed glioma|adult mixed glioma
5565146|NCT01026493|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5565147|NCT01026480|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
5565148|NCT01026480|IPAA|ipaa
5565149|NCT01026480|Pull through|pull through
5565150|NCT01026480|IBD|ibd
5565151|NCT01026480|Ulcerative colitis|ulcerative colitis
5565152|NCT01026480|Familial adenomatous polyposis|familial adenomatous polyposis
5565153|NCT01026480|FAP|fap
5565154|NCT01026480|Hereditary nonpolyposis colorectal cancer|hereditary nonpolyposis colorectal cancer
5565156|NCT01026454|HSV|hsv
5565157|NCT01026454|HIV|hiv
5565158|NCT01026441|Aesthetic|aesthetic
5565159|NCT01026428|safinamide|safinamide
5565160|NCT01026428|levodopa|levodopa
5565161|NCT01026428|drug -drug interaction|drug -drug interaction
5565162|NCT01026428|pharmacokinetics|pharmacokinetics
5565163|NCT01026428|Patients diagnosed with idiopathic Parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa|patients diagnosed with idiopathic parkinson's disease, levodopa-responsive, treated with a stable dose of levodopa/carbidopa
5565164|NCT01026415|Antibody-Drug Conjugate|antibody-drug conjugate
5565165|NCT01026415|Antigens, CD30|antigens, cd30
5565166|NCT01026415|Disease, Hodgkin|disease, hodgkin
5565167|NCT01026415|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5565168|NCT01026415|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5565169|NCT01026415|monomethyl auristatin E|monomethyl auristatin e
5565170|NCT01026415|Drug Therapy|drug therapy
5565171|NCT01026415|Immunotherapy|immunotherapy
5565172|NCT01026415|Hematologic Diseases|hematologic diseases
5565173|NCT01026415|Lymphoma|lymphoma
5565174|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal
5565175|NCT01026402|Phase I|phase i
5565176|NCT01026402|cancer|cancer
5565177|NCT01026402|advanced solid malignancies|advanced solid malignancies
5565178|NCT01026402|dose escalation|dose escalation
5565179|NCT01026402|AZD2014|azd2014
5565180|NCT01026402|mTor kinase inhibitor|mtor kinase inhibitor
5565181|NCT01026402|safety|safety
5565182|NCT01026402|pharmacokinetics|pharmacokinetics
5565277|NCT01025830|HIV;Bioequivalence;Triomune|hiv;bioequivalence;triomune
5565183|NCT01026389|MRA-Contrast agent comparison in peripheral disease|mra-contrast agent comparison in peripheral disease
5565184|NCT01026376|Myelodysplastic Syndromes|myelodysplastic syndromes
5565185|NCT01026376|Decitabine|decitabine
5565186|NCT01026363|Vitamin D|vitamin d
5565187|NCT01026363|Chronic Kidney Disease|chronic kidney disease
5565188|NCT01026350|modulating immune response to flu antigen|modulating immune response to flu antigen
5565189|NCT01026337|recurrent renal cell cancer|recurrent renal cell cancer
5565190|NCT01026311|Coenzyme q10|coenzyme q10
5565191|NCT01026311|statins|statins
5565192|NCT01026311|myalgias|myalgias
5565193|NCT01026311|anaerobic threshold|anaerobic threshold
5565194|NCT01026311|athletic performance|athletic performance
5565195|NCT01026298|asthma|asthma
5565196|NCT01026298|obstructive sleep apnea|obstructive sleep apnea
5565197|NCT01026298|severe asthma|severe asthma
5565199|NCT01026285|Risperdal Consta|risperdal consta
5565200|NCT01026272|Endocannabinoid|endocannabinoid
5565201|NCT01026272|Fish Oil|fish oil
5565202|NCT01026272|Multiple Sclerosis|multiple sclerosis
5565203|NCT01026272|Monocyte Migration|monocyte migration
5565204|NCT01026259|Surgical site infection|surgical site infection
5565205|NCT01026259|wound healing|wound healing
5565206|NCT01026259|tissue oxygen|tissue oxygen
5565207|NCT01026259|angiogenesis|angiogenesis
5565208|NCT01026259|flow cytometry|flow cytometry
5565209|NCT01026259|immunohistochemistry|immunohistochemistry
5565210|NCT01026246|Ghana, malaria, vaccine, Plasmodium falciparum|ghana, malaria, vaccine, plasmodium falciparum
5565211|NCT01026233|Antibodies, Monoclonal|antibodies, monoclonal
5565212|NCT01026233|Antibody-Drug Conjugate|antibody-drug conjugate
5565213|NCT01026233|Antigens, CD30|antigens, cd30
5565214|NCT01026233|Disease, Hodgkin|disease, hodgkin
5565215|NCT01026233|Drug Therapy|drug therapy
5565216|NCT01026233|Hematologic Diseases|hematologic diseases
5565217|NCT01026233|Immunotherapy|immunotherapy
5565218|NCT01026233|Lymphoma|lymphoma
5565219|NCT01026233|monomethylauristatin E|monomethylauristatin e
5565220|NCT01026233|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5565221|NCT01026207|Diagnostic test|diagnostic test
5565222|NCT01026207|polysomnography|polysomnography
5565223|NCT01026207|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5565224|NCT01026207|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5565225|NCT01026194|insulin resistance|insulin resistance
5565226|NCT01026155|Obese patients (BMI > 30 kg / m²)|obese patients (bmi > 30 kg / m²)
5565227|NCT01026103|gastric bypass|gastric bypass
5565228|NCT01026103|Gastric bypass surgery|gastric bypass surgery
5565229|NCT01026077|Savella pregnant|savella pregnant
5565230|NCT01026077|savella pregnancy|savella pregnancy
5565231|NCT01026077|fibromyalgia pregnant|fibromyalgia pregnant
5565232|NCT01026077|fibromyalgia pregnancy|fibromyalgia pregnancy
5565233|NCT01026077|pregnancy registry savella|pregnancy registry savella
5565234|NCT01026064|Macrolides|macrolides
5565235|NCT01026064|Inflammation|inflammation
5565236|NCT01026064|Azithromycin|azithromycin
5565237|NCT01026064|Cantharidin induced skin blister model|cantharidin induced skin blister model
5565238|NCT01026051|Cancer Vaccine, Immunotherapy, Melanoma|cancer vaccine, immunotherapy, melanoma
5565239|NCT01026038|Pneumococcal vaccine 13-valent|pneumococcal vaccine 13-valent
5565240|NCT01026025|lobectomy|lobectomy
5565241|NCT01026025|segmentectomy|segmentectomy
5565242|NCT01026025|pulmonary resection|pulmonary resection
5565243|NCT01026012|Regadenoson|regadenoson
5565244|NCT01026012|85% predicted heart rate|85% predicted heart rate
5565245|NCT01026012|Myocardial perfusion stress testing|myocardial perfusion stress testing
5559230|NCT01049360|COPD|copd
5565247|NCT01025999|Gastrostomy tube|gastrostomy tube
5565249|NCT01025999|Gastric Bypass|gastric bypass
5565250|NCT01025960|colonoscopy|colonoscopy
5565251|NCT01025960|adenoma detection|adenoma detection
5565252|NCT01025960|polyps|polyps
5565253|NCT01025947|Atrial fibrillation|atrial fibrillation
5565254|NCT01025947|Cryptogenic stroke|cryptogenic stroke
5565255|NCT01025947|Implantable loop recorder|implantable loop recorder
5565256|NCT01025921|Tracheobronchitis|tracheobronchitis
5565257|NCT01025921|pneumonia|pneumonia
5565258|NCT01025921|inhaled antibiotics|inhaled antibiotics
5565259|NCT01025921|colistin|colistin
5565260|NCT01025921|Ventilator associated tracheobronchitis|ventilator associated tracheobronchitis
5565261|NCT01025921|Ventilator associated pneumonia|ventilator associated pneumonia
5565262|NCT01025908|psychotherapy|psychotherapy
5565263|NCT01025908|panic disorder|panic disorder
5565264|NCT01025908|anxiety|anxiety
5565265|NCT01025908|behavior|behavior
5565266|NCT01025908|cognition|cognition
5565267|NCT01025895|arthroscopic surgical procedure|arthroscopic surgical procedure
5565268|NCT01025882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5565269|NCT01025882|stage I pancreatic cancer|stage i pancreatic cancer
5565270|NCT01025882|stage II pancreatic cancer|stage ii pancreatic cancer
5565271|NCT01025882|stage III pancreatic cancer|stage iii pancreatic cancer
5565272|NCT01025856|liver fat|liver fat
5565273|NCT01025856|postprandial lipids metabolism|postprandial lipids metabolism
5565274|NCT01025856|diet|diet
5565275|NCT01025856|exercise|exercise
5565276|NCT01025856|type 2 diabetes|type 2 diabetes
5565477|NCT01025141|anchorage|anchorage
5565278|NCT01025817|Kidney transplant|kidney transplant
5565279|NCT01025817|renal transplant|renal transplant
5565280|NCT01025817|immunosuppression|immunosuppression
5565281|NCT01025817|mycophenolate mofetil|mycophenolate mofetil
5565282|NCT01025817|tacrolimus|tacrolimus
5565283|NCT01025817|everolimus|everolimus
5565284|NCT01025804|Interfant-06|interfant-06
5565285|NCT01025804|Infant ALL|infant all
5565286|NCT01025804|Asparaginase|asparaginase
5565287|NCT01025804|Pharmacokinetics of asparaginase|pharmacokinetics of asparaginase
5565288|NCT01025804|Antibody formation|antibody formation
5565289|NCT01025778|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5565290|NCT01025778|Graft versus host disease|graft versus host disease
5565291|NCT01025778|Donor lymphocyte infusion|donor lymphocyte infusion
5565292|NCT01025778|Graft versus leukemia effect|graft versus leukemia effect
5565293|NCT01025778|Immunological recovery|immunological recovery
5565294|NCT01025778|Bridge to transplant approach|bridge to transplant approach
5565295|NCT01025778|Therapy resistant leukemia|therapy resistant leukemia
5565296|NCT01025778|Hematological malignancy|hematological malignancy
5565297|NCT01025752|chronic pain|chronic pain
5565298|NCT01025752|cognitive behavior therapy|cognitive behavior therapy
5565299|NCT01025752|low back pain|low back pain
5565300|NCT01025739|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5565301|NCT01025739|EsophyX|esophyx
5565302|NCT01025713|Cystic Fibrosis|cystic fibrosis
5565304|NCT01025713|Mucociliary Clearance|mucociliary clearance
5565305|NCT01025713|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5565306|NCT01025713|ENaC Inhibitor|enac inhibitor
5565307|NCT01025713|Airway Hydration|airway hydration
5565308|NCT01025713|Amiloride|amiloride
5565309|NCT01025700|Efficacy|efficacy
5565310|NCT01025700|Marijuana|marijuana
5565311|NCT01025700|Reduction|reduction
5565312|NCT01025700|Craving|craving
5565313|NCT01025687|girls|girls
5565314|NCT01025687|obesity|obesity
5565315|NCT01025687|television viewing|television viewing
5565316|NCT01025687|puberty|puberty
5565317|NCT01025674|School health program|school health program
5565318|NCT01025674|Positive health behavior|positive health behavior
5565319|NCT01025674|School-wide climate|school-wide climate
5565320|NCT01025674|Mental health|mental health
5565321|NCT01025674|Self-esteem|self-esteem
5565322|NCT01025674|Social support|social support
5565323|NCT01025674|Exercise|exercise
5565324|NCT01025674|Nutrition|nutrition
5565325|NCT01025674|Parent involvement|parent involvement
5565326|NCT01025674|Community involvement|community involvement
5565327|NCT01025661|chiropractic|chiropractic
5565328|NCT01025661|hip osteoarthritis|hip osteoarthritis
5565329|NCT01025661|hip arthroplasty|hip arthroplasty
5565331|NCT01025661|activities of daily living.|activities of daily living.
5565332|NCT01025648|Mild to Moderate Asthma|mild to moderate asthma
5565333|NCT01025648|Dyspnea|dyspnea
5565334|NCT01025648|Wheezing|wheezing
5565335|NCT01025648|Status Asthmaticus|status asthmaticus
5565336|NCT01025635|rosacea|rosacea
5565337|NCT01025635|papulopustular|papulopustular
5565338|NCT01025635|azelaic acid|azelaic acid
5565339|NCT01025635|foam|foam
5565340|NCT01025622|Stem Cells|stem cells
5565341|NCT01025622|Liver Cirrhosis|liver cirrhosis
5565342|NCT01025622|Cell Therapy|cell therapy
5565343|NCT01025609|spinal cord injury|spinal cord injury
5565344|NCT01025609|cardiovascular disease|cardiovascular disease
5565345|NCT01025609|dietary patterns|dietary patterns
5565346|NCT01025596|interleukin-7|interleukin-7
5565347|NCT01025596|immune-based therapies|immune-based therapies
5565351|NCT01025596|immune specific responses to HCV|immune specific responses to hcv
5565353|NCT01025596|viral disease|viral disease
5565354|NCT01025596|liver disease|liver disease
5565355|NCT01025583|acute gastroenteritis|acute gastroenteritis
5565356|NCT01025583|intestinal infection|intestinal infection
5565357|NCT01025583|intestinal fluid secretion|intestinal fluid secretion
5565358|NCT01025583|intestinal microflora|intestinal microflora
5565359|NCT01025583|treatment of childhood acute diarrhea|treatment of childhood acute diarrhea
5565360|NCT01025570|pancreas|pancreas
5565361|NCT01025570|pancreatic|pancreatic
5565362|NCT01025570|bosutinib|bosutinib
5565363|NCT01025570|SKI-606|ski-606
5565364|NCT01025570|gemcitabine|gemcitabine
5565365|NCT01025570|gemzar|gemzar
5565366|NCT01025570|Patients with resected pancreatic cancer|patients with resected pancreatic cancer
5565367|NCT01025557|Food intake|food intake
5565368|NCT01025557|Blood glucose|blood glucose
5565369|NCT01025557|Milk|milk
5565370|NCT01025544|Haemophilus influenzae type b (Hib)|haemophilus influenzae type b (hib)
5565371|NCT01025544|Vaccine|vaccine
5565372|NCT01025544|Booster|booster
5565373|NCT01025531|Hepatitis C|hepatitis c
5565374|NCT01025518|Head and Neck Neoplasms|head and neck neoplasms
5565375|NCT01025518|Resistance training|resistance training
5565376|NCT01025518|Muscle mass|muscle mass
5565377|NCT01025518|Functional capacity|functional capacity
5565378|NCT01025505|Untreated Ph+ ALL unfit for intense therapy and allo SCT|untreated ph+ all unfit for intense therapy and allo sct
5565379|NCT01025492|high density lipoprotein|high density lipoprotein
5565380|NCT01025492|arterial compliance|arterial compliance
5565381|NCT01025492|brachial artery flow-mediated dilatation|brachial artery flow-mediated dilatation
5565382|NCT01025479|Osteoporosis|osteoporosis
5565383|NCT01025479|Prostate cancer|prostate cancer
5565384|NCT01025479|LHRH agonist and/or anti-androgen agent|lhrh agonist and/or anti-androgen agent
5565388|NCT01025453|papillary cell|papillary cell
5565389|NCT01025453|Hurthle cell|hurthle cell
5565390|NCT01025453|BAY 43-9006|bay 43-9006
5565391|NCT01025453|Temsirolimus|temsirolimus
5565392|NCT01025453|Sorafenib|sorafenib
5565394|NCT01025427|HIV|hiv
5565395|NCT01025427|HIV persistence|hiv persistence
5565396|NCT01025427|HIV reservoirs|hiv reservoirs
5565397|NCT01025414|pancreatic fistula|pancreatic fistula
5565398|NCT01025401|epilepsy|epilepsy
5565399|NCT01025401|seizures|seizures
5565400|NCT01025401|movement|movement
5565401|NCT01025388|Hypercholesterolemia|hypercholesterolemia
5671987|NCT00613288|insulin sensitivity|insulin sensitivity
5565402|NCT01025388|The study is focusing on the undertreatment of hypercholesterolemia|the study is focusing on the undertreatment of hypercholesterolemia
5565403|NCT01025375|overweight|overweight
5565404|NCT01025349|bevacizumab|bevacizumab
5565405|NCT01025349|metastatic breast cancer|metastatic breast cancer
5565406|NCT01025349|docetaxel|docetaxel
5565407|NCT01025336|Antibody persistence|antibody persistence
5565408|NCT01025323|Pre hypertension|pre hypertension
5565409|NCT01025323|Lifestyle modification|lifestyle modification
5565410|NCT01025323|DASH diet|dash diet
5565411|NCT01025310|eye movements|eye movements
5565412|NCT01025310|saccades|saccades
5565414|NCT01025310|stress|stress
5565415|NCT01025310|search coil|search coil
5565417|NCT01025310|Saccadic eye movements|saccadic eye movements
5565418|NCT01025310|Urban environment|urban environment
5565419|NCT01025297|interleukin-7|interleukin-7
5565420|NCT01025297|immune-based therapies|immune-based therapies
5565421|NCT01025297|hepatitis C|hepatitis c
5565422|NCT01025297|chronic hepatitis|chronic hepatitis
5565423|NCT01025297|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
5565424|NCT01025297|immune specific responses to HCV|immune specific responses to hcv
5565425|NCT01025297|phase 1/2a|phase 1/2a
5565426|NCT01025297|viral disease|viral disease
5565427|NCT01025297|liver disease|liver disease
5565428|NCT01025271|meningitis|meningitis
5565429|NCT01025258|Cystic Fibrosis|cystic fibrosis
5565430|NCT01025258|Medication Adherence|medication adherence
5565431|NCT01025258|Multidisciplinary Team|multidisciplinary team
5565432|NCT01025258|Clinical Outcomes|clinical outcomes
5565433|NCT01025245|Remifentanil induced postoperative hyperalgesia|remifentanil induced postoperative hyperalgesia
5565434|NCT01025232|Antibodies, Monoclonal|antibodies, monoclonal
5565435|NCT01025232|Immunologic Factors|immunologic factors
5565436|NCT01025232|Eye Diseases|eye diseases
5565437|NCT01025232|Retinal Degeneration|retinal degeneration
5565438|NCT01025232|Macular Degeneration|macular degeneration
5565439|NCT01025232|Pharmacologic Actions|pharmacologic actions
5565440|NCT01025232|Retinal Diseases|retinal diseases
5559428|NCT01048762|quality of life|quality of life
5565441|NCT01025219|Diagnosis of dependence on cocaine according to DSM-IV-TR criteria|diagnosis of dependence on cocaine according to dsm-iv-tr criteria
5565443|NCT01025206|monoclonal antibody|monoclonal antibody
5565445|NCT01025206|pharmacokinetic|pharmacokinetic
5565446|NCT01025193|belimumab|belimumab
5565447|NCT01025193|Benlysta|benlysta
5565448|NCT01025193|LymphoStat B|lymphostat b
5565449|NCT01025193|BLyS specific inhibitors|blys specific inhibitors
5565450|NCT01025180|safety|safety
5565451|NCT01025180|Procalcitonin|procalcitonin
5565452|NCT01025180|PCT|pct
5565453|NCT01025180|SOFA|sofa
5565454|NCT01025180|Sepsis|sepsis
5565455|NCT01025180|Antibiotic|antibiotic
5565456|NCT01025180|Strategy|strategy
5565457|NCT01025180|SIRS|sirs
5565458|NCT01025180|severe sepsis without obvious infection|severe sepsis without obvious infection
5565459|NCT01025167|cancer|cancer
5565460|NCT01025167|enteral nutrition|enteral nutrition
5565461|NCT01025167|omega-3-fatty acids|omega-3-fatty acids
5565462|NCT01025154|Leukemia|leukemia
5565463|NCT01025154|AML|aml
5565464|NCT01025154|chemotherapy-naïve|chemotherapy-naïve
5565465|NCT01025154|Clofarabine|clofarabine
5565466|NCT01025154|Clofarex|clofarex
5565467|NCT01025154|Clolar|clolar
5565468|NCT01025154|Idarubicin|idarubicin
5565469|NCT01025154|Idamycin|idamycin
5565470|NCT01025154|Cytarabine|cytarabine
5565471|NCT01025154|Ara-C|ara-c
5565472|NCT01025154|Cytosar|cytosar
5565473|NCT01025154|DepoCyt|depocyt
5565474|NCT01025154|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5565475|NCT01025141|MINISCREW|miniscrew
5565476|NCT01025141|space extraction closure|space extraction closure
5565478|NCT01025141|Orthodontic Treatment|orthodontic treatment
5565479|NCT01025141|Extraction of 2 Maxillary Premolar|extraction of 2 maxillary premolar
5565480|NCT01025141|closing of extraction space|closing of extraction space
5565481|NCT01025141|patient aged from 12 to 50 years old|patient aged from 12 to 50 years old
5565482|NCT01025115|Dietary supplement|dietary supplement
5565484|NCT01025115|Metabolic Syndrome|metabolic syndrome
5565485|NCT01025089|Cetuximab|cetuximab
5565486|NCT01025089|Cisplatin|cisplatin
5565487|NCT01025089|Cyclophosphamide|cyclophosphamide
5565488|NCT01025089|09-038|09-038
5565489|NCT01025076|Enlarged gastric pouch and stoma|enlarged gastric pouch and stoma
5565490|NCT01025076|Post bariatric surgery|post bariatric surgery
5565491|NCT01025063|Spectral OCT|spectral oct
5565492|NCT01025063|Choroidal Neovascularization|choroidal neovascularization
5565493|NCT01025063|Lucentis|lucentis
5565494|NCT01025063|Visudyne|visudyne
5565496|NCT01025063|anti-VEGF|anti-vegf
5565497|NCT01025050|Presbyopia|presbyopia
5565498|NCT01025050|Intrastromal|intrastromal
5565499|NCT01025050|Femtosecond Laser|femtosecond laser
5565500|NCT01025050|minimal-invasive|minimal-invasive
5565501|NCT01025050|INTRACOR|intracor
5565502|NCT01025050|Enhance Near Visual Acuity|enhance near visual acuity
5565503|NCT01025037|Rotator Cuff Tear, Large, Massive, Rotator, Cuff. Tear|rotator cuff tear, large, massive, rotator, cuff. tear
5565505|NCT01025024|single-nucleotide polymorphism|single-nucleotide polymorphism
5565506|NCT01025024|glaucoma|glaucoma
5565507|NCT01025024|primary open angle glaucoma|primary open angle glaucoma
5565508|NCT01025011|retinal hemoglobin concentration|retinal hemoglobin concentration
5565509|NCT01025011|non-invasive hemoglobin measurement|non-invasive hemoglobin measurement
5565510|NCT01024998|Age-Related Macular Degeneration|age-related macular degeneration
5565511|NCT01024998|AMD|amd
5565512|NCT01024998|Wet AMD|wet amd
5565513|NCT01024998|Neovascular AMD|neovascular amd
5565514|NCT01024998|Ocular|ocular
5565515|NCT01024998|Ocular gene therapy|ocular gene therapy
5565516|NCT01024998|Subretinal neovascularization|subretinal neovascularization
5565517|NCT01024985|optic neuritis|optic neuritis
5565518|NCT01024985|longitudinally extensive transverse myelitis|longitudinally extensive transverse myelitis
5565519|NCT01024985|retinal nerve fiber layer|retinal nerve fiber layer
5565520|NCT01024985|macular thickness|macular thickness
5565521|NCT01024959|Prostate Cancer|prostate cancer
5565522|NCT01024959|Prostate Biopsy|prostate biopsy
5565524|NCT01024946|mesothelioma|mesothelioma
5565525|NCT01024946|pleural|pleural
5565526|NCT01024946|RAD001|rad001
5565527|NCT01024946|Everolimus|everolimus
5565528|NCT01024946|09-142|09-142
5565529|NCT01024946|thoracic|thoracic
5565530|NCT01024946|lung|lung
5565531|NCT01024946|epithelioid|epithelioid
5565532|NCT01024946|sarcomatoid|sarcomatoid
5565533|NCT01024933|Hypertension|hypertension
5565534|NCT01024933|High Blood Pressure|high blood pressure
5565535|NCT01024894|interleukin-7|interleukin-7
5565536|NCT01024894|immune-based therapies|immune-based therapies
5565537|NCT01024894|hepatitis C|hepatitis c
5565538|NCT01024894|chronic hepatitis|chronic hepatitis
5565539|NCT01024894|resistance to Peg-interferon and ribavirin bitherapy|resistance to peg-interferon and ribavirin bitherapy
5565540|NCT01024894|immune specific responses to HCV|immune specific responses to hcv
5565542|NCT01024894|phase 1/2a|phase 1/2a
5565543|NCT01024894|viral disease|viral disease
5565544|NCT01024894|liver disease|liver disease
5565545|NCT01024881|catheterization success rate|catheterization success rate
5565546|NCT01024868|Transversus Abdominis Plane Block|transversus abdominis plane block
5565547|NCT01024829|Non small cell lung cancer|non small cell lung cancer
5565548|NCT01024829|Inoperable|inoperable
5565550|NCT01024816|Metabolic Syndrome|metabolic syndrome
5565551|NCT01024816|Restorative Yoga|restorative yoga
5565552|NCT01024816|Stretching|stretching
5565553|NCT01024816|Visceral adiposity|visceral adiposity
5565554|NCT01024816|Randomized controlled trial|randomized controlled trial
5565555|NCT01024803|Retina implant, Subretinal|retina implant, subretinal
5565556|NCT01024803|Legal blindness|legal blindness
5565557|NCT01024803|Genetic Diseases, Inborn|genetic diseases, inborn
5565558|NCT01024803|Eye Diseases|eye diseases
5565559|NCT01024803|Retinitis Pigmentosa|retinitis pigmentosa
5565560|NCT01024803|Retinitis|retinitis
5565561|NCT01024803|Retinal Degeneration|retinal degeneration
5565562|NCT01024803|Eye Diseases, Hereditary|eye diseases, hereditary
5565563|NCT01024803|Retinal Diseases|retinal diseases
5565564|NCT01024777|cholecalciferol|cholecalciferol
5565565|NCT01024777|multiple sclerosis|multiple sclerosis
5565566|NCT01024777|vitamin D|vitamin d
5565567|NCT01024777|D3|d3
5565568|NCT01024764|HIV|hiv
5565569|NCT01024764|Tat protein|tat protein
5565570|NCT01024764|Preventive vaccine|preventive vaccine
5565571|NCT01024725|A(H1N1)v influenza|a(h1n1)v influenza
5565572|NCT01024725|vaccination|vaccination
5565573|NCT01024725|pandemic|pandemic
5565574|NCT01024712|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5565575|NCT01024712|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5565576|NCT01024712|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5565577|NCT01024712|adenocarcinoma of the lung|adenocarcinoma of the lung
5565578|NCT01024712|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5565579|NCT01024712|large cell lung cancer|large cell lung cancer
5565581|NCT01024660|Patients with Mild to Moderate Alzheimer's Disease|patients with mild to moderate alzheimer's disease
5565582|NCT01024634|Arterial stiffness|arterial stiffness
5565583|NCT01024634|Endothelial function|endothelial function
5565584|NCT01024634|Autonomic function|autonomic function
5565585|NCT01024634|Inflammation|inflammation
5565586|NCT01024621|gastric intestinal metaplasia|gastric intestinal metaplasia
5565587|NCT01024621|Confocal laser endomicroscopy|confocal laser endomicroscopy
5565589|NCT01024595|Tat protein|tat protein
5565590|NCT01024582|breast cancer|breast cancer
5565591|NCT01024582|invasive breast cancer|invasive breast cancer
5565592|NCT01024582|adenocarcinoma of the breast|adenocarcinoma of the breast
5565593|NCT01024569|Severe Mental Illness|severe mental illness
5565594|NCT01024569|Recovery|recovery
5565595|NCT01024569|Psychiatric Disability|psychiatric disability
5565596|NCT01024569|Wellness|wellness
5565597|NCT01024569|Peer Service|peer service
5565598|NCT01024569|WRAP|wrap
5565599|NCT01024556|HIV, HAART|hiv, haart
5565600|NCT01024543|Angiotensin II|angiotensin ii
5565601|NCT01024517|Safety|safety
5565602|NCT01024517|Tolerability|tolerability
5565603|NCT01024517|Pharmacokinetics|pharmacokinetics
5565604|NCT01024504|Cancer|cancer
5565605|NCT01024504|Colorectal cancer|colorectal cancer
5565606|NCT01024504|Elderly|elderly
5565607|NCT01024504|Chemotherapy|chemotherapy
5565608|NCT01024504|Capecitabine|capecitabine
5565609|NCT01024504|Oxaliplatin|oxaliplatin
5565610|NCT01024504|Bevacizumab|bevacizumab
5565611|NCT01024491|premature ejaculation|premature ejaculation
5565612|NCT01024491|paroxetine|paroxetine
5565613|NCT01024491|daily treatment|daily treatment
5565614|NCT01024478|Coronary Artery|coronary artery
5565616|NCT01024478|Coronary Artery disease|coronary artery disease
5565617|NCT01024478|Multicenter Trial|multicenter trial
5565618|NCT01024478|Cardiac MRI|cardiac mri
5565619|NCT01024465|obesity|obesity
5565620|NCT01024465|intragastric balloon|intragastric balloon
5565621|NCT01024452|anticoagulation|anticoagulation
5565622|NCT01024452|warfarin|warfarin
5565623|NCT01024452|computer systems|computer systems
5565624|NCT01024452|international normalized ratio|international normalized ratio
5565625|NCT01024452|nomograms|nomograms
5565626|NCT01024426|Uganda|uganda
5565627|NCT01024426|malaria|malaria
5565628|NCT01024426|enhanced health facility-based care|enhanced health facility-based care
5565629|NCT01024426|febrile illnesses|febrile illnesses
5565630|NCT01024426|health services|health services
5565631|NCT01024413|Thoracic Neoplasms|thoracic neoplasms
5565632|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5565633|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors
5565634|NCT01024413|Respiratory Tract Diseases|respiratory tract diseases
5565635|NCT01024413|Lung Neoplasms|lung neoplasms
5565636|NCT01024413|Erlotinib|erlotinib
5565637|NCT01024413|Gefitinib|gefitinib
5565638|NCT01024413|Epidermal growth factor receptor genes|epidermal growth factor receptor genes
5565639|NCT01024400|Influenza|influenza
5565640|NCT01024400|Vaccine|vaccine
5565641|NCT01024400|Pregnancy|pregnancy
5565642|NCT01024387|AMG 479|amg 479
5559618|NCT01047982|obesity|obesity
5565645|NCT01024361|Delivery room|delivery room
5565646|NCT01024361|Newborn|newborn
5565647|NCT01024348|Surgery, knee arthroscopy|surgery, knee arthroscopy
5565648|NCT01024348|Pain, postoperative|pain, postoperative
5565649|NCT01024348|tramadol, extended release|tramadol, extended release
5565650|NCT01024335|opioid dependence|opioid dependence
5565651|NCT01024335|naltrexone|naltrexone
5565652|NCT01024335|vivitrol|vivitrol
5565653|NCT01024335|dronabinol|dronabinol
5565654|NCT01024335|marinol|marinol
5565655|NCT01024322|Diagnosis of keratoconus, post-LASIK ectasia, FFKC, or pellucid marginal degeneration|diagnosis of keratoconus, post-lasik ectasia, ffkc, or pellucid marginal degeneration
5565656|NCT01024309|total hip arthroplasty|total hip arthroplasty
5565657|NCT01024283|Heat Shock Protein 90 Inhibitor (HSP90)|heat shock protein 90 inhibitor (hsp90)
5565658|NCT01024283|Pharmacodynamic|pharmacodynamic
5565659|NCT01024283|Blood|blood
5565660|NCT01024283|Biopsy|biopsy
5565661|NCT01024283|Solid malignancies|solid malignancies
5565662|NCT01024270|endometrial pathology of uterus|endometrial pathology of uterus
5565663|NCT01024270|operative hysteroscopy|operative hysteroscopy
5565664|NCT01024270|efficacy of misoprostol per different routes|efficacy of misoprostol per different routes
5565665|NCT01024257|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial|beta-irradiation;conjunctival autograft;pterygium;recurrence; clinical trial
5565666|NCT01024205|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5565667|NCT01024205|stage IV renal cell cancer|stage iv renal cell cancer
5565668|NCT01024179|Optical Coherence Tomography|optical coherence tomography
5565669|NCT01024179|Coronary artery disease|coronary artery disease
5565670|NCT01024179|Chronic total occlusion|chronic total occlusion
5565671|NCT01024166|Cancer|cancer
5565672|NCT01024166|Patient-Reported Outcomes Computer System|patient-reported outcomes computer system
5565674|NCT01024166|Palliative Care|palliative care
5565675|NCT01024166|Symptoms|symptoms
5565676|NCT01024166|Questionnaire|questionnaire
5565677|NCT01024166|Patients|patients
5565678|NCT01024166|Caregivers|caregivers
5565679|NCT01024166|Palliative Care Physicians|palliative care physicians
5565680|NCT01024166|Palliative Care Nurses|palliative care nurses
5565681|NCT01024153|active video games|active video games
5565683|NCT01024153|physical activity|physical activity
5565684|NCT01024140|Posttraumatic Stress Disorder|posttraumatic stress disorder
5565685|NCT01024140|Escitalopram|escitalopram
5565686|NCT01024140|Efficacy|efficacy
5565687|NCT01024114|MBI|mbi
5565688|NCT01024114|Molecular Breast Imaging|molecular breast imaging
5565689|NCT01024114|Breast Cancer|breast cancer
5565690|NCT01024114|Positive Molecular Breast Imaging scan.|positive molecular breast imaging scan.
5565691|NCT01024088|Guillain Barré syndrome|guillain barré syndrome
5671988|NCT00613288|protein|protein
5565692|NCT01024088|Swallowing disorders|swallowing disorders
5565693|NCT01024088|Respiratory failure|respiratory failure
5565694|NCT01024075|Chronic Rhinosinusitis|chronic rhinosinusitis
5565695|NCT01024075|Endoscopic sinus surgery|endoscopic sinus surgery
5565696|NCT01024075|Sinufoam|sinufoam
5565697|NCT01024075|Dexamethasone|dexamethasone
5565698|NCT01024075|For patients with Chronic Rhinosinusitis without nasal polyps|for patients with chronic rhinosinusitis without nasal polyps
5565699|NCT01024075|Focus: Define the postoperative sinonasal mucosal healing status of 2 Sinufoam mixtures|focus: define the postoperative sinonasal mucosal healing status of 2 sinufoam mixtures
5565700|NCT01024049|heart failure blood left ventricular dysfunction|heart failure blood left ventricular dysfunction
5565701|NCT01024036|Multicentric Castleman's Disease|multicentric castleman's disease
5565702|NCT01024036|MCD|mcd
5565703|NCT01024036|CNTO 328|cnto 328
5565704|NCT01024036|Best Supportive Care|best supportive care
5565705|NCT01024036|Tumor|tumor
5565706|NCT01024036|Symptomatic response|symptomatic response
5565707|NCT01024036|Pharmacokinetics|pharmacokinetics
5565708|NCT01024036|Interleukin-6|interleukin-6
5565709|NCT01024036|IL6|il6
5565710|NCT01024023|Early Walking Aid|early walking aid
5565711|NCT01024023|Amputee|amputee
5565712|NCT01024023|Trans-tibial|trans-tibial
5565713|NCT01024023|Quality of life|quality of life
5565714|NCT01023997|corneal thickness|corneal thickness
5565715|NCT01023997|exfoliation|exfoliation
5565716|NCT01023984|RECTAL NEOPLASMS|rectal neoplasms
5565717|NCT01023945|ASP1941|asp1941
5565718|NCT01023945|Diabetes mellitus|diabetes mellitus
5565719|NCT01023945|Blood glucose|blood glucose
5565720|NCT01023919|Optical coherence tomography|optical coherence tomography
5565721|NCT01023919|Drug eluting stent|drug eluting stent
5565722|NCT01023919|Coronary Artery Disease|coronary artery disease
5565723|NCT01023919|Diabetes Mellitus|diabetes mellitus
5565724|NCT01023906|Taste|taste
5565725|NCT01023906|general Labeled Magnitude Scale|general labeled magnitude scale
5565726|NCT01023906|Aging|aging
5565727|NCT01023906|Chronic Disease Risk|chronic disease risk
5565728|NCT01023906|Smell|smell
5565729|NCT01023867|Alzheimer's disease|alzheimer's disease
5565730|NCT01023867|Mixed Dementia|mixed dementia
5565731|NCT01023867|Donepezil|donepezil
5565732|NCT01023867|Efficacy|efficacy
5565733|NCT01023867|Adverse Event|adverse event
5565734|NCT01023854|Paravertebral block|paravertebral block
5565735|NCT01023854|loco regional anesthesia|loco regional anesthesia
5565736|NCT01023854|renal surgery|renal surgery
5565737|NCT01023854|PCA morphine|pca morphine
5565738|NCT01023828|K-RAS ONCOGENE MUTATION|k-ras oncogene mutation
5565739|NCT01023828|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
5565740|NCT01023828|WOOD SMOKE|wood smoke
5565741|NCT01023815|Immunosuppression|immunosuppression
5565742|NCT01023815|renal transplantation|renal transplantation
5565743|NCT01023815|once-a-day regimen|once-a-day regimen
5565744|NCT01023815|steroid withdrawal|steroid withdrawal
5565745|NCT01023815|drug minimization|drug minimization
5565746|NCT01023815|immunosuppression for prevention of acute rejections|immunosuppression for prevention of acute rejections
5565747|NCT01023802|neoadjuvant therapy|neoadjuvant therapy
5565748|NCT01023802|chemotherapy|chemotherapy
5565749|NCT01023802|hormone therapy|hormone therapy
5565750|NCT01023802|breast cancer|breast cancer
5565751|NCT01023802|MBI|mbi
5565752|NCT01023802|Molecular Breast Imaging|molecular breast imaging
5565753|NCT01023789|Drug eluting stent|drug eluting stent
5565754|NCT01023789|Stents|stents
5565755|NCT01023789|Angioplasty|angioplasty
5565756|NCT01023789|Bioabsorbable|bioabsorbable
5565757|NCT01023789|Bioresorbable|bioresorbable
5565758|NCT01023789|Scaffold|scaffold
5565759|NCT01023776|Swine Flu|swine flu
5565760|NCT01023776|H1N1|h1n1
5565761|NCT01023763|Nursing homes|nursing homes
5565762|NCT01023763|Intravenous|intravenous
5565763|NCT01023763|Treatment|treatment
5565764|NCT01023763|Patient trajectory|patient trajectory
5565765|NCT01023763|Hospital admissions|hospital admissions
5565766|NCT01023750|hypertriglyceridemia|hypertriglyceridemia
5565767|NCT01023750|Triglycerides|triglycerides
5565768|NCT01023750|HDL|hdl
5565769|NCT01023750|Insulin resistance|insulin resistance
5565770|NCT01023737|Malignant Solid Tumor|malignant solid tumor
5565771|NCT01023737|Solid Tumor|solid tumor
5565772|NCT01023737|Hydroxychloroquine|hydroxychloroquine
5565773|NCT01023737|Vorinostat|vorinostat
5565774|NCT01023711|Influenza|influenza
5565775|NCT01023698|Diabetic retinopathy|diabetic retinopathy
5565776|NCT01023698|Diabetic macular edema|diabetic macular edema
5565777|NCT01023698|Panretinal photocoagulation|panretinal photocoagulation
5565778|NCT01023685|Active immunization|active immunization
5565779|NCT01023685|Alzheimer disease|alzheimer disease
5565780|NCT01023685|Antibody|antibody
5565781|NCT01023685|Central Nervous System diseases|central nervous system diseases
5565782|NCT01023685|Neurodegenerative diseases|neurodegenerative diseases
5565783|NCT01023685|Vaccine|vaccine
5565784|NCT01023672|Dementia with Lewy Bodies|dementia with lewy bodies
5565785|NCT01023672|hypersomnolence|hypersomnolence
5565786|NCT01023672|cognition|cognition
5565787|NCT01023672|neuropsychiatric morbidity|neuropsychiatric morbidity
5565788|NCT01023672|quality of life|quality of life
5565789|NCT01023659|Smoking cessation|smoking cessation
5565790|NCT01023659|Bupropion|bupropion
5565791|NCT01023659|Varenicline|varenicline
5565792|NCT01023659|Population-level|population-level
5565793|NCT01023659|Mass distribution|mass distribution
5565794|NCT01023659|Drug Therapy|drug therapy
5565795|NCT01023646|Glycemic Index|glycemic index
5565796|NCT01023646|Glycemic Load|glycemic load
5565797|NCT01023646|Glucose|glucose
5565798|NCT01023646|Insulin|insulin
5565799|NCT01023646|Lipoproteins|lipoproteins
5565800|NCT01023646|Free fatty acids|free fatty acids
5565801|NCT01023633|to investigate the efficacy and feasibility of this novel treatment strategy in Chinese mCRC patients|to investigate the efficacy and feasibility of this novel treatment strategy in chinese mcrc patients
5565802|NCT01023633|Primary Endpoint:DDC|primary endpoint:ddc
5565803|NCT01023633|Secondary Endpoint:OS, RR,DCR, PFS,safety|secondary endpoint:os, rr,dcr, pfs,safety
5565804|NCT01023620|HIV|hiv
5565805|NCT01023620|Lipodystrophy|lipodystrophy
5565806|NCT01023620|Lipoatrophy|lipoatrophy
5565807|NCT01023620|Lipohypertrophy|lipohypertrophy
5565808|NCT01023620|Human Immunodeficiency Virus|human immunodeficiency virus
5565809|NCT01023607|optical coherence tomography|optical coherence tomography
5565810|NCT01023607|intravascular ultrasound|intravascular ultrasound
5565811|NCT01023607|Coronary artery disease|coronary artery disease
5565812|NCT01023607|Hyperlipidemia|hyperlipidemia
5565813|NCT01023594|Pancreatic fistula|pancreatic fistula
5565814|NCT01023594|Pancreatic leakage|pancreatic leakage
5565815|NCT01023594|Pancreatoduodenectomy|pancreatoduodenectomy
5565816|NCT01023594|Pancreatic stent|pancreatic stent
5565817|NCT01023581|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5565818|NCT01023581|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
5565819|NCT01023581|Drug Therapy|drug therapy
5565820|NCT01023581|Hypoglycemia,|hypoglycemia,
5565821|NCT01023581|Hyperglycemia|hyperglycemia
5565822|NCT01023568|intubation|intubation
5565823|NCT01023568|pediatric|pediatric
5565824|NCT01023568|videolaryngoscope devices|videolaryngoscope devices
5565825|NCT01023555|Bacteremia|bacteremia
5565826|NCT01023555|Blood Cultures|blood cultures
5565827|NCT01023555|Sepsis|sepsis
5565828|NCT01023542|renal impairment|renal impairment
5565829|NCT01023542|MELD>25|meld>25
5565830|NCT01023542|Liver transplantation|liver transplantation
5565831|NCT01023542|CNI-free|cni-free
5565833|NCT01023542|Everolimus|everolimus
5565834|NCT01023529|Prostatic Neoplasms|prostatic neoplasms
5565835|NCT01023529|Rectal Neoplasms|rectal neoplasms
5565836|NCT01023529|Palliative treatment|palliative treatment
5565837|NCT01023529|Radiotherapy|radiotherapy
5565838|NCT01023529|Quality of life|quality of life
5565839|NCT01023516|Chronic|chronic
5565840|NCT01023516|obstructive|obstructive
5565841|NCT01023516|pulmonary|pulmonary
5565842|NCT01023516|lung|lung
5565843|NCT01023516|respiratory disease|respiratory disease
5565844|NCT01023516|efficacy|efficacy
5565845|NCT01023516|placebo-controlled|placebo-controlled
5565846|NCT01023516|COPD|copd
5565847|NCT01023516|FEV1|fev1
5565848|NCT01023516|St Georges Respiratory Questionnaire|st georges respiratory questionnaire
5565849|NCT01023503|Statins|statins
5565850|NCT01023503|Dyslipidemia|dyslipidemia
5565851|NCT01023503|Spain|spain
5565852|NCT01023503|Rosuvastatin|rosuvastatin
5565853|NCT01023503|Naive|naive
5565854|NCT01023503|Switching|switching
5565855|NCT01023503|New statins prescriptions in Spain (naive patients and switching)|new statins prescriptions in spain (naive patients and switching)
5565856|NCT01023490|back pain|back pain
5565857|NCT01023490|hypovitaminosis D|hypovitaminosis d
5565858|NCT01023477|Carcinoma, Intraductal, Noninfiltrating|carcinoma, intraductal, noninfiltrating
5565859|NCT01023477|Ductal Carcinoma In Situ|ductal carcinoma in situ
5565860|NCT01023477|DCIS|dcis
5565861|NCT01023477|Carcinoma, Intraductal|carcinoma, intraductal
5565862|NCT01023477|Breast Cancer|breast cancer
5565863|NCT01023477|Breast Tumors|breast tumors
5565864|NCT01023477|chloroquine|chloroquine
5565865|NCT01023477|autophagy|autophagy
5565866|NCT01023477|Autophagic Cell Death|autophagic cell death
5565867|NCT01023477|Autophagocytosis|autophagocytosis
5565868|NCT01023477|Programmed Cell Death, Type II|programmed cell death, type ii
5565869|NCT01023477|Autophagy, Cellular|autophagy, cellular
5565870|NCT01023477|Autophagic Programmed Cell Death|autophagic programmed cell death
5565871|NCT01023464|tear film break-up time|tear film break-up time
5565872|NCT01023451|Pulmonary hypertension|pulmonary hypertension
5565873|NCT01023451|Sickle cell disease|sickle cell disease
5565874|NCT01023451|Pediatric patients|pediatric patients
5565875|NCT01023451|Brain Natriuretic Peptide levels|brain natriuretic peptide levels
5565876|NCT01023425|naive group|naive group
5565877|NCT01023425|switching group|switching group
5565878|NCT01023425|treatment response|treatment response
5565879|NCT01023425|Efficacy|efficacy
5565880|NCT01023425|Adverse event|adverse event
5565881|NCT01023412|Immunonutrition|immunonutrition
5565882|NCT01023412|cancer|cancer
5565883|NCT01023412|GI cancer surgery|gi cancer surgery
5565884|NCT01023386|YM155|ym155
5565885|NCT01023386|Mass-balance|mass-balance
5565886|NCT01023386|Phase I|phase i
5565887|NCT01023386|Pharmacokinetics|pharmacokinetics
5565888|NCT01023373|Angioplasty|angioplasty
5565889|NCT01023373|Atherosclerotic reno vascular disease (ARVD)|atherosclerotic reno vascular disease (arvd)
5565890|NCT01023373|Cardio- and cerebro- vascular comorbidity|cardio- and cerebro- vascular comorbidity
5565891|NCT01023373|End stage renal disease (ERSD)|end stage renal disease (ersd)
5565892|NCT01023373|kidney diseases|kidney diseases
5565893|NCT01023373|High blood pressure|high blood pressure
5565894|NCT01023373|Hypertension|hypertension
5565895|NCT01023373|Ischemic nephropathy|ischemic nephropathy
5565896|NCT01023373|Percutaneous transluminal renal artery stenting (PTRS)|percutaneous transluminal renal artery stenting (ptrs)
5565897|NCT01023373|Randomized controlled trials|randomized controlled trials
5565898|NCT01023373|Renal artery stenosis (RAS)|renal artery stenosis (ras)
5565899|NCT01023373|Renal insufficiency|renal insufficiency
5565900|NCT01023373|Vascular diseases|vascular diseases
5565901|NCT01023347|NSCLC|nsclc
5565902|NCT01023334|Topical analgesia|topical analgesia
5565903|NCT01023334|FlACC Pain Scale|flacc pain scale
5565904|NCT01023334|intracameral lignocaine|intracameral lignocaine
5565905|NCT01023334|Anesthetics|anesthetics
5565906|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs
5565907|NCT01023334|Lidocaine|lidocaine
5565909|NCT01023321|Tolerability|tolerability
5565910|NCT01023321|Pharmacokinetics|pharmacokinetics
5565911|NCT01023308|Myeloma|myeloma
5565912|NCT01023308|DACi|daci
5565913|NCT01023308|Bortezomib|bortezomib
5565914|NCT01023308|Combination|combination
5565915|NCT01023308|Panobinostat|panobinostat
5565916|NCT01023308|LBH589D|lbh589d
5565917|NCT01023308|relapsed|relapsed
5565918|NCT01023308|Velcade®|velcade®
5565919|NCT01023295|Polypoidal Choroidal Vasculopathy|polypoidal choroidal vasculopathy
5565921|NCT01023295|Polypoid|polypoid
5565922|NCT01023295|oxigene|oxigene
5565923|NCT01023295|VDA|vda
5565924|NCT01023295|vascular disrupting agent|vascular disrupting agent
5565925|NCT01023295|combretastatin|combretastatin
5565926|NCT01023295|fosbretabulin|fosbretabulin
5565927|NCT01023282|Parkinson's disease|parkinson's disease
5565928|NCT01023282|Levodopa|levodopa
5565929|NCT01023282|Dyskinesia|dyskinesia
5565930|NCT01023282|ACR325|acr325
5565931|NCT01023269|Neurogenic overactive bladder|neurogenic overactive bladder
5559916|NCT01047735|obese person|obese person
5565932|NCT01023269|Urinary incontinence due to incomplete spinal cord injury|urinary incontinence due to incomplete spinal cord injury
5565933|NCT01023269|Neuromodulation|neuromodulation
5565934|NCT01023269|Neuromodulation for treatment of neurogenic overactive bladder|neuromodulation for treatment of neurogenic overactive bladder
5565935|NCT01023269|Patients with Urge urinary incontinence and detrusor overactivity|patients with urge urinary incontinence and detrusor overactivity
5565936|NCT01023256|Rheumatoid arthritis|rheumatoid arthritis
5565938|NCT01023256|MOR103|mor103
5565939|NCT01023243|foot exam|foot exam
5565940|NCT01023243|health services|health services
5565941|NCT01023243|practice improvement|practice improvement
5565942|NCT01023243|quality|quality
5565943|NCT01023243|preventive services|preventive services
5565944|NCT01023243|Natural Language Processing|natural language processing
5565945|NCT01023230|DV-601|dv-601
5565946|NCT01023230|hepatitis B|hepatitis b
5565947|NCT01023230|entecavir|entecavir
5565948|NCT01023230|therapeutic vaccine|therapeutic vaccine
5565949|NCT01023217|Chronic hepatitis B|chronic hepatitis b
5565950|NCT01023217|lamivudine|lamivudine
5565951|NCT01023217|adefovir|adefovir
5565952|NCT01023217|entecavir|entecavir
5565953|NCT01023191|Dialysis|dialysis
5565954|NCT01023191|Peritoneal|peritoneal
5565955|NCT01023191|Catheter|catheter
5565956|NCT01023191|Surgery|surgery
5565957|NCT01023165|Diabetes Mellitus|diabetes mellitus
5565958|NCT01023165|Metabolic Integrity|metabolic integrity
5565959|NCT01023165|Intravenous Bolus Insulin|intravenous bolus insulin
5565960|NCT01023139|Adolescent|adolescent
5565961|NCT01023139|Obesity|obesity
5565962|NCT01023139|Pharmacotherapy|pharmacotherapy
5565963|NCT01023139|Sibutramine|sibutramine
5565964|NCT01023126|Obesity|obesity
5565965|NCT01023126|Exercise|exercise
5565966|NCT01023126|Psychotherapy|psychotherapy
5565967|NCT01023113|Diabetic retinopathy|diabetic retinopathy
5565968|NCT01023113|laser|laser
5565969|NCT01023113|field loss|field loss
5565970|NCT01023113|macular edema|macular edema
5565971|NCT01023113|Visual field loss|visual field loss
5798724|NCT00111254|microdermabrasion|microdermabrasion
5565982|NCT01023009|small gauge vitrectomy|small gauge vitrectomy
5565983|NCT01023009|Postoperative occlusion|postoperative occlusion
5565984|NCT01022996|Hodgkin's Lymphoma|hodgkin's lymphoma
5565985|NCT01022996|Hodgkin Lymphoma|hodgkin lymphoma
5565986|NCT01022996|Hodgkin's Disease|hodgkin's disease
5565987|NCT01022996|Hodgkin Disease|hodgkin disease
5565988|NCT01022996|Lymphoma|lymphoma
5565989|NCT01022996|Lymphoproliferative Disorders|lymphoproliferative disorders
5565990|NCT01022996|Neoplasms by Histological type|neoplasms by histological type
5565991|NCT01022996|Lymphatic Diseases|lymphatic diseases
5565992|NCT01022996|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
5565993|NCT01022996|Recurrent Lymphoma|recurrent lymphoma
5565994|NCT01022996|Refractory Lymphoma|refractory lymphoma
5565995|NCT01022996|Relapsed Lymphoma|relapsed lymphoma
5565996|NCT01022996|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5565997|NCT01022996|Classical Hodgkin's Disease|classical hodgkin's disease
5565998|NCT01022996|Nodular sclerosing Hodgkin Lymphoma|nodular sclerosing hodgkin lymphoma
5565999|NCT01022996|Mixed-cellularity Hodgkin Lymphoma|mixed-cellularity hodgkin lymphoma
5548186|NCT01094548|L-BLP25 liposome|l-blp25 liposome
5566000|NCT01022996|Lymphocyte-rich Hodgkin Lymphoma|lymphocyte-rich hodgkin lymphoma
5566001|NCT01022996|Lymphocyte depleted Hodgkin Lymphoma|lymphocyte depleted hodgkin lymphoma
5566002|NCT01022970|Esophagitis|esophagitis
5566003|NCT01022970|Digestive System Diseases|digestive system diseases
5566004|NCT01022970|Esophageal disorder|esophageal disorder
5685550|NCT00555633|liposomes|liposomes
5566005|NCT01022970|Eosinophilic esophagitis|eosinophilic esophagitis
5566007|NCT01022944|Serous otitis media|serous otitis media
5566008|NCT01022944|Biofilm|biofilm
5566009|NCT01022944|Adenoidectomy|adenoidectomy
5566010|NCT01022944|Chronic otitis media|chronic otitis media
5566011|NCT01022931|Influenza A H1N1|influenza a h1n1
5566012|NCT01022931|Children|children
5566013|NCT01022931|Epidemiology|epidemiology
5566014|NCT01022931|Treatment|treatment
5566015|NCT01022931|Oseltamivir|oseltamivir
5566016|NCT01022931|Genetics|genetics
5566017|NCT01022918|unresectable glioblastoma|unresectable glioblastoma
5566018|NCT01022905|HIV infection|hiv infection
5566019|NCT01022905|transplant|transplant
5566020|NCT01022905|rheumatic disease|rheumatic disease
5566021|NCT01022905|cancer|cancer
5566022|NCT01022905|children|children
5566023|NCT01022892|Endovascular|endovascular
5566024|NCT01022892|Abdominal|abdominal
5566025|NCT01022892|Aortic|aortic
5566026|NCT01022892|Aneurysm|aneurysm
5566027|NCT01022892|Repair|repair
5566028|NCT01022892|Surveillance|surveillance
5566029|NCT01022892|EVAR|evar
5566031|NCT01022892|Scan|scan
5566032|NCT01022892|Endoleaks|endoleaks
5566033|NCT01022892|Contrast|contrast
5566034|NCT01022892|Enhanced|enhanced
5566035|NCT01022892|Ultrasound|ultrasound
5566036|NCT01022892|Definity|definity
5566037|NCT01022892|AAA|aaa
5566038|NCT01022892|imaging|imaging
5566039|NCT01022892|No Endoleaks|no endoleaks
5566040|NCT01022879|Pain scale of pain|pain scale of pain
5566041|NCT01022866|falls|falls
5566043|NCT01022827|stiff shoulder|stiff shoulder
5566045|NCT01022827|muscle stiffness|muscle stiffness
5566046|NCT01022775|Degenerative rotator cuff disease|degenerative rotator cuff disease
5566047|NCT01022775|Impingement syndrome|impingement syndrome
5566048|NCT01022775|Dynamic humeral centering|dynamic humeral centering
5566049|NCT01022775|Randomized clinical trial|randomized clinical trial
5566050|NCT01022749|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5566051|NCT01022749|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
5566052|NCT01022749|influenza vaccine|influenza vaccine
5566053|NCT01022749|antibody titers|antibody titers
5566054|NCT01022749|seroprotective titers|seroprotective titers
5566055|NCT01022749|vaccine-associated adverse events|vaccine-associated adverse events
5566056|NCT01022736|gabapentin|gabapentin
5566057|NCT01022736|pharmacokinetics|pharmacokinetics
5568652|NCT01011829|meth|meth
5566058|NCT01022736|visual analogue pain scale|visual analogue pain scale
5566059|NCT01022736|cardiopulmonary bypass|cardiopulmonary bypass
5566060|NCT01022723|Circulating tumor cells|circulating tumor cells
5566061|NCT01022723|metastasis|metastasis
5566062|NCT01022723|cancer|cancer
5566063|NCT01022723|cell isolation|cell isolation
5566064|NCT01022723|mircofludics|mircofludics
5566065|NCT01022723|cell detection|cell detection
5566066|NCT01022710|hearing loss|hearing loss
5566067|NCT01022710|otoacoustic emissions|otoacoustic emissions
5566068|NCT01022684|atherosclerosis|atherosclerosis
5566069|NCT01022684|vascular inflammation|vascular inflammation
5566070|NCT01022684|LpPLA2|lppla2
5566071|NCT01022684|hsCRP|hscrp
5566072|NCT01022684|MCP-1|mcp-1
5566073|NCT01022684|18FDG-PET|18fdg-pet
5566074|NCT01022671|Belotecan|belotecan
5566075|NCT01022671|Camtobell inj|camtobell inj
5566076|NCT01022671|NSCLC|nsclc
5566077|NCT01022658|Insulin Therapy|insulin therapy
5566078|NCT01022658|Vago-sympathetic activity|vago-sympathetic activity
5566079|NCT01022658|arterial stiffness|arterial stiffness
5566080|NCT01022658|endothelial function|endothelial function
5566081|NCT01022645|Intrauterine device|intrauterine device
5566082|NCT01022645|Gestational diabetes|gestational diabetes
5671989|NCT00613288|metabolism|metabolism
5566083|NCT01022645|Postpartum contraception|postpartum contraception
5566084|NCT01022645|Postpartum birth control|postpartum birth control
5566085|NCT01022632|Depression|depression
5566086|NCT01022619|Sleep apnea|sleep apnea
5566087|NCT01022619|high risk pregnancy|high risk pregnancy
5566088|NCT01022619|fetal outcome|fetal outcome
5566089|NCT01022619|cord blood|cord blood
5566090|NCT01022580|nitric oxide|nitric oxide
5566091|NCT01022580|surfactant|surfactant
5566092|NCT01022580|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5566094|NCT01022580|prematurity|prematurity
5566095|NCT01022580|neonates|neonates
5566096|NCT01022580|iNO|ino
5566097|NCT01022580|pulmonary outcome|pulmonary outcome
5566098|NCT01022580|neurodevelopmental outcome|neurodevelopmental outcome
5566099|NCT01022580|Infasurf|infasurf
5566100|NCT01022580|lung function|lung function
5566101|NCT01022580|Surfactant Dysfunction|surfactant dysfunction
5790029|NCT00146094|bone metabolism|bone metabolism
5790031|NCT00146081|African Americans|african americans
5790032|NCT00146081|weight control|weight control
5566102|NCT01022528|Elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy|elective total abdominal hysterectomy (with or without salpingo-oophorectomy or minor bladder repair) or myomectomy
5566103|NCT01022528|through a lower transverse or low midline incision under general anesthesia|through a lower transverse or low midline incision under general anesthesia
5685551|NCT00555633|skin cancer|skin cancer
5566106|NCT01022515|hypertension|hypertension
5566107|NCT01022502|psoriasis, indigo naturalis|psoriasis, indigo naturalis
5566108|NCT01022489|Schizophrenia, auditory hallucinations, TMS|schizophrenia, auditory hallucinations, tms
5566109|NCT01022476|Pharmacokinetics|pharmacokinetics
5566110|NCT01022476|Raltegravir|raltegravir
5566111|NCT01022476|Immunosuppressive Agents|immunosuppressive agents
5566112|NCT01022476|Severe hepatic insufficiency|severe hepatic insufficiency
5566113|NCT01022476|Liver Transplantation|liver transplantation
5566114|NCT01022476|Additional Keywords|additional keywords
5566115|NCT01022476|HIV Infection|hiv infection
5566116|NCT01022476|Hepatocarcinoma|hepatocarcinoma
5566117|NCT01022476|Hepatitis C|hepatitis c
5566118|NCT01022476|Hepatitis B|hepatitis b
5566119|NCT01022450|rhabdomyolysis|rhabdomyolysis
5566120|NCT01022450|myopathy|myopathy
5566121|NCT01022450|acute renal failure|acute renal failure
5566122|NCT01022450|neuroleptic malignant syndrome|neuroleptic malignant syndrome
5566123|NCT01022450|Pharmaceutical Preparations|pharmaceutical preparations
5566124|NCT01022450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5566125|NCT01022450|fibrates|fibrates
5566126|NCT01022450|creatine kinase|creatine kinase
5566127|NCT01022424|ADPKD|adpkd
5566128|NCT01022424|Tolvaptan|tolvaptan
5566129|NCT01022424|OPC-41061|opc-41061
5566130|NCT01022411|brown rice|brown rice
5566131|NCT01022411|white rice|white rice
5566132|NCT01022411|diabetes risk|diabetes risk
5566133|NCT01022398|Vitamin D3|vitamin d3
5560120|NCT01047267|critically ill|critically ill
5566134|NCT01022398|HMG-CoA reductase inhibitors (statin)-related myalgias|hmg-coa reductase inhibitors (statin)-related myalgias
5566135|NCT01022359|haemodialysis|haemodialysis
5566136|NCT01022359|vascular access|vascular access
5566137|NCT01022359|central venous catheter|central venous catheter
5566138|NCT01022346|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5566139|NCT01022346|RO5217790|ro5217790
5566140|NCT01022333|BRCA1|brca1
5566141|NCT01022333|breast cancer|breast cancer
5566142|NCT01022333|3,3'-di-indolylmethane|3,3'-di-indolylmethane
5566143|NCT01022333|dietary intervention|dietary intervention
5566144|NCT01022333|estrogen metabolites|estrogen metabolites
5566145|NCT01022333|mRNA expression|mrna expression
5566146|NCT01022333|BRCA1 protein|brca1 protein
5566147|NCT01022333|Estrogen|estrogen
5566149|NCT01022320|Blood pressure|blood pressure
5566150|NCT01022320|Lateral Pharyngoplasty|lateral pharyngoplasty
5566151|NCT01022307|behavioral data acquisition|behavioral data acquisition
5566152|NCT01022307|MRI|mri
5566153|NCT01022294|children|children
5566154|NCT01022294|analgesia|analgesia
5566155|NCT01022294|dental treatment|dental treatment
5566156|NCT01022294|inhalation|inhalation
5566157|NCT01022281|Exfoliation|exfoliation
5566158|NCT01022281|Scanning Laser Polarimetry|scanning laser polarimetry
5566159|NCT01022281|Corneal Thickness|corneal thickness
5566160|NCT01022268|Inflammation|inflammation
5566161|NCT01022268|Children|children
5566162|NCT01022268|Observational|observational
5566163|NCT01022255|autologous vaccine|autologous vaccine
5566164|NCT01022255|follicular lymphoma|follicular lymphoma
5566165|NCT01022255|magnICON|magnicon
5566166|NCT01022255|plant-made vaccines|plant-made vaccines
5566167|NCT01022255|immune response|immune response
5566168|NCT01022242|Surgical Adhesions|surgical adhesions
5566169|NCT01022242|Post-surgical adhesions|post-surgical adhesions
5566170|NCT01022242|Flexor tendon|flexor tendon
5566171|NCT01022229|Attention Deficit Disorder|attention deficit disorder
5566172|NCT01022229|Pediatrics|pediatrics
5566173|NCT01022229|Attention|attention
5566174|NCT01022229|Impulsivity|impulsivity
5566175|NCT01022229|Complementary Therapies|complementary therapies
5566176|NCT01022216|Wound|wound
5566177|NCT01022216|Skin lesion|skin lesion
5566178|NCT01022216|Antimicrobial|antimicrobial
5566179|NCT01022216|Bioelectric|bioelectric
5566180|NCT01022216|Diabetic foot|diabetic foot
5566182|NCT01022203|Couples Therapy|couples therapy
5566183|NCT01022203|PTSD|ptsd
5566184|NCT01022190|Arthroplasty|arthroplasty
5566186|NCT01022190|Cemented|cemented
5566187|NCT01022190|Heterotopic ossification|heterotopic ossification
5566188|NCT01022190|Selective Cyclooxygenase-2 Inhibitors|selective cyclooxygenase-2 inhibitors
5566189|NCT01022190|Arthroplasty, Replacement|arthroplasty, replacement
5566190|NCT01022190|Hip Prosthesis|hip prosthesis
5566191|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5566192|NCT01022164|fibrin glue|fibrin glue
5566193|NCT01022164|vitrectomy|vitrectomy
5566194|NCT01022164|safety and efficacy of fibrin glue|safety and efficacy of fibrin glue
5566195|NCT01022151|Aminophylline|aminophylline
5566196|NCT01022151|sevoflurane|sevoflurane
5566197|NCT01022151|anaesthesia|anaesthesia
5566198|NCT01022151|recovery|recovery
5566199|NCT01022151|cognitive function|cognitive function
5566200|NCT01022151|entropy|entropy
5566201|NCT01022138|HER2-negative breast cancer|her2-negative breast cancer
5566202|NCT01022138|stage IV breast cancer|stage iv breast cancer
5566203|NCT01022138|recurrent breast cancer|recurrent breast cancer
5566204|NCT01022125|TMC435-TiDP16-C121|tmc435-tidp16-c121
5566205|NCT01022125|TMC435-C121|tmc435-c121
5566206|NCT01022125|TMC435|tmc435
5566207|NCT01022125|TMC435350|tmc435350
5566208|NCT01022125|Protease inhibitor|protease inhibitor
5566210|NCT01022125|Hepatitis C|hepatitis c
5566211|NCT01022112|TA-7284|ta-7284
5566212|NCT01022112|JNJ-28431754|jnj-28431754
5566213|NCT01022112|Canagliflozin|canagliflozin
5566214|NCT01022112|Type 2 diabetes mellitus|type 2 diabetes mellitus
5566215|NCT01022112|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5566216|NCT01022099|Total Knee Arthroplasty|total knee arthroplasty
5566218|NCT01022086|Breast Cancer|breast cancer
5566219|NCT01022086|Cardiotoxicity|cardiotoxicity
5566220|NCT01022086|Trastuzumab|trastuzumab
5566221|NCT01022086|Cardiac MRI|cardiac mri
5566222|NCT01022073|Deep Brain Stimulation|deep brain stimulation
5566223|NCT01022073|Subthalamic Nucleus|subthalamic nucleus
5566224|NCT01022073|Globus Pallidus|globus pallidus
5566225|NCT01022073|Parkinson Disease|parkinson disease
5566226|NCT01022060|Dietary supplement|dietary supplement
5566227|NCT01022060|Renalof|renalof
5566228|NCT01022060|Recurrent calcic urolithiasis|recurrent calcic urolithiasis
5566229|NCT01022060|Renal calculi|renal calculi
5566230|NCT01022034|Rectal prolapse|rectal prolapse
5566231|NCT01022034|mesh|mesh
5566232|NCT01022034|recurrence|recurrence
5566233|NCT01022021|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5566234|NCT01022021|autologous stem cell transplant|autologous stem cell transplant
5566235|NCT01022008|Exorbitism|exorbitism
5566236|NCT01022008|Upper respiratory airways|upper respiratory airways
5566237|NCT01022008|Osteodistraction|osteodistraction
5566238|NCT01022008|Polysomnography|polysomnography
5566239|NCT01021995|Safety of Echinacea in comparison to placebo|safety of echinacea in comparison to placebo
5566240|NCT01021982|Pupillometer|pupillometer
5566241|NCT01021982|Retinitis Pigmentosa|retinitis pigmentosa
5566242|NCT01021982|Glaucoma|glaucoma
5566243|NCT01021982|Objective perimetry|objective perimetry
5566244|NCT01021956|Macular Degeneration|macular degeneration
5566245|NCT01021956|Age Related Macular Degeneration|age related macular degeneration
5566246|NCT01021956|Choroidal Neovascularization|choroidal neovascularization
5566248|NCT01021956|CNV|cnv
5566249|NCT01021956|WST11|wst11
5566250|NCT01021956|Stakel|stakel
5566251|NCT01021956|Photodynamic therapy|photodynamic therapy
5566252|NCT01021956|Vascular Targeted Photodynamic therapy|vascular targeted photodynamic therapy
5566253|NCT01021956|VTP|vtp
5566254|NCT01021943|calcineurin inhibitors|calcineurin inhibitors
5566255|NCT01021943|fibrosis|fibrosis
5566256|NCT01021943|spironolactone|spironolactone
5566257|NCT01021943|Focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients|focus of the study is to assess if aldosterone blockade has an effect on interstitial fibrosis amongst kidney transplant recipients
5566258|NCT01021930|Optical coherence tomography|optical coherence tomography
5566259|NCT01021930|Drug eluting stent|drug eluting stent
5566260|NCT01021930|Coronary heart disease|coronary heart disease
5566261|NCT01021930|Diabetes mellitus|diabetes mellitus
5566262|NCT01021917|Obesity|obesity
5566263|NCT01021917|Weight Loss|weight loss
5566264|NCT01021917|Meal Replacements|meal replacements
5566265|NCT01021904|Primary prevention|primary prevention
5566266|NCT01021904|HPV Vaccination|hpv vaccination
5566267|NCT01021904|HPV Infection|hpv infection
5566268|NCT01021904|Cervical Cancer|cervical cancer
5566269|NCT01021904|HPV Related Diseases|hpv related diseases
5566270|NCT01021891|Technosphere® Insulin Inhalation Powder|technosphere® insulin inhalation powder
5566271|NCT01021878|Peritoneal dialysis|peritoneal dialysis
5566272|NCT01021878|Renal replacement therapy|renal replacement therapy
5566273|NCT01021878|Dialysis solutions|dialysis solutions
5566274|NCT01021878|Icodextrin|icodextrin
5566275|NCT01021865|GLP-1|glp-1
5566276|NCT01021865|Myocardial contrast echocardiography|myocardial contrast echocardiography
5566277|NCT01021865|Myocardial perfusion|myocardial perfusion
5566278|NCT01021839|renal dialysis|renal dialysis
5566279|NCT01021839|bioprosthesis|bioprosthesis
5566280|NCT01021839|arteriovenous shunt|arteriovenous shunt
5566281|NCT01021839|surgical|surgical
5566282|NCT01021826|knee replacement|knee replacement
5566283|NCT01021826|hip replacement|hip replacement
5566284|NCT01021826|hyperglycemia|hyperglycemia
5566285|NCT01021826|diabetes|diabetes
5566286|NCT01021826|osteoarthritis|osteoarthritis
5566287|NCT01021800|Pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
5566288|NCT01021787|Sun Protection|sun protection
5566289|NCT01021735|Rheumatoid|rheumatoid
5566290|NCT01021735|Outcome|outcome
5566291|NCT01021735|Cost effectiveness|cost effectiveness
5566292|NCT01021735|Safety|safety
5566293|NCT01021722|sphincter|sphincter
5566294|NCT01021722|obstetric tears|obstetric tears
5566295|NCT01021722|long-term follow-up|long-term follow-up
5566296|NCT01021709|depression|depression
5566297|NCT01021709|direct current stimulation|direct current stimulation
5566298|NCT01021709|extracephalic electrode|extracephalic electrode
5566299|NCT01021696|Dementia|dementia
5566300|NCT01021696|Nursing home|nursing home
5566301|NCT01021696|Pain treatment|pain treatment
5566302|NCT01021696|Pain assessment|pain assessment
5566303|NCT01021696|Agitation|agitation
5566304|NCT01021683|Hematological neoplasms|hematological neoplasms
5566305|NCT01021683|Neutropenia|neutropenia
5566307|NCT01021683|Itraconazole|itraconazole
5566308|NCT01021683|Sporanox|sporanox
5566309|NCT01021683|Antifungal prophylaxis|antifungal prophylaxis
5566310|NCT01021683|Defeverscence|defeverscence
5566311|NCT01021670|Dapoxetine hydrochloride|dapoxetine hydrochloride
5566313|NCT01021670|Premature ejaculation|premature ejaculation
5566314|NCT01021670|Non-dapoxetine hydrochloride treatment(s)|non-dapoxetine hydrochloride treatment(s)
5566315|NCT01021657|Glaucoma|glaucoma
5566316|NCT01021657|Tenon's Capsule|tenon's capsule
5566317|NCT01021657|Lipid profile|lipid profile
5566318|NCT01021657|Assessment of lipid profile in Tenon's capsule in patients with Glaucoma|assessment of lipid profile in tenon's capsule in patients with glaucoma
5566319|NCT01021644|APOE|apoe
5566320|NCT01021644|Apolipoprotein E|apolipoprotein e
5566321|NCT01021644|Cognition Disorders|cognition disorders
5566322|NCT01021644|Neurocognition|neurocognition
5566323|NCT01021631|Cardiac surgery|cardiac surgery
5566324|NCT01021631|Strategies of transfusion|strategies of transfusion
5566325|NCT01021631|Red blood cells|red blood cells
5566326|NCT01021631|Liberal|liberal
5566327|NCT01021631|Restrictive|restrictive
5566328|NCT01021631|Anemia|anemia
5566329|NCT01021605|hypercapnic respiratory failure, COPD, ARDS|hypercapnic respiratory failure, copd, ards
5566330|NCT01021592|Velcade|velcade
5566331|NCT01021592|QoL|qol
5566332|NCT01021592|Proteasome inhibitor|proteasome inhibitor
5566333|NCT01021592|Bortezomib|bortezomib
5566336|NCT01021579|Polycystic ovary syndrome|polycystic ovary syndrome
5566337|NCT01021579|Metformin|metformin
5566338|NCT01021579|Simvastatin|simvastatin
5566339|NCT01021566|Opiate addiction|opiate addiction
5566340|NCT01021566|Withdrawal symptoms|withdrawal symptoms
5566341|NCT01021566|hemoperfusion|hemoperfusion
5566342|NCT01021566|hemodialysis|hemodialysis
5566343|NCT01021566|methadone|methadone
5566344|NCT01021553|Proof of Concept|proof of concept
5566345|NCT01021553|Double Blind|double blind
5566346|NCT01021540|Nephritis,Nephropathy|nephritis,nephropathy
5566347|NCT01021514|sRAGE|srage
5566348|NCT01021514|SUV|suv
5566349|NCT01021514|TBR|tbr
5566350|NCT01021514|FDG PET CT|fdg pet ct
5566351|NCT01021514|Type 2 DM|type 2 dm
5566352|NCT01021501|nifedipine controlled release tablets|nifedipine controlled release tablets
5566353|NCT01021501|hypertensive|hypertensive
5566355|NCT01021501|Pharmacokinetics|pharmacokinetics
5566356|NCT01021488|Thrombosis|thrombosis
5566357|NCT01021488|Vein|vein
5566358|NCT01021488|Statin|statin
5566359|NCT01021488|Prevention|prevention
5566360|NCT01021475|Functional Dyspepsia, Visceral Manipulation|functional dyspepsia, visceral manipulation
5566460|NCT01021098|Influenza-like-illnesses|influenza-like-illnesses
5566361|NCT01021449|schizophrenia, BDNF, DNA methylation, histone modification|schizophrenia, bdnf, dna methylation, histone modification
5566362|NCT01021436|Pneumonia|pneumonia
5566363|NCT01021436|Gram-negative bacteria|gram-negative bacteria
5566364|NCT01021423|Mantle Cell Lymphoma|mantle cell lymphoma
5566365|NCT01021423|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5566366|NCT01021423|CC-5013|cc-5013
5566367|NCT01021423|Revlimid|revlimid
5566368|NCT01021423|Lenalidomide|lenalidomide
5566369|NCT01021410|acetaminophen|acetaminophen
5566370|NCT01021410|paracetamol|paracetamol
5566371|NCT01021410|protein adduct|protein adduct
5566372|NCT01021410|healthy volunteer|healthy volunteer
5671990|NCT00613288|Experimental hypogonadism|experimental hypogonadism
5566373|NCT01021410|acetaminophen-protein adduct formation|acetaminophen-protein adduct formation
5566374|NCT01021397|Respiratory Tract Infection|respiratory tract infection
5566375|NCT01021384|Depression,|depression,
5566376|NCT01021384|Early Intervention,|early intervention,
5566377|NCT01021384|Behavior Disorder,|behavior disorder,
5566378|NCT01021384|Parenting Skills,|parenting skills,
5566379|NCT01021384|Children with Special Health Care Needs,|children with special health care needs,
5566380|NCT01021384|Developmental Disabilities,|developmental disabilities,
5566381|NCT01021384|Family Support Programs|family support programs
5566382|NCT01021371|HRQOL|hrqol
5566383|NCT01021371|Rehabilitation|rehabilitation
5566384|NCT01021371|Cancer Patients|cancer patients
5566385|NCT01021371|General Practice|general practice
5566386|NCT01021332|Vesomni|vesomni
5566387|NCT01021332|Solifenacin succinate|solifenacin succinate
5566388|NCT01021332|EC905|ec905
5566389|NCT01021332|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
5566390|NCT01021332|Treatment|treatment
5566391|NCT01021332|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5566392|NCT01021332|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5566393|NCT01021319|ischemic stroke|ischemic stroke
5566394|NCT01021319|thrombolysis|thrombolysis
5566396|NCT01021319|diffusion weighted imaging|diffusion weighted imaging
5566397|NCT01021319|fluid attenuated inversion recovery|fluid attenuated inversion recovery
5566398|NCT01021319|time window|time window
5566399|NCT01021293|Poliorix|poliorix
5566400|NCT01021293|IPV|ipv
5566401|NCT01021280|Bartter syndrome,|bartter syndrome,
5566402|NCT01021280|parathyroid hormone,|parathyroid hormone,
5566403|NCT01021280|calcium sensing receptor,|calcium sensing receptor,
5566404|NCT01021280|ROMK channel|romk channel
5566405|NCT01021280|Barttin gene|barttin gene
5566406|NCT01021280|PTH response to hypo- and hypercalcemia|pth response to hypo- and hypercalcemia
5566407|NCT01021267|sexual dysfunctions|sexual dysfunctions
5566408|NCT01021267|benign prostatic hyperplasia|benign prostatic hyperplasia
5566409|NCT01021267|saw palmetto|saw palmetto
5566410|NCT01021228|Liver resection|liver resection
5566411|NCT01021228|Continuous volatile anesthesia|continuous volatile anesthesia
5566412|NCT01021228|Continuous intravenous anesthesia|continuous intravenous anesthesia
5566413|NCT01021228|Preconditioning volatile anesthesia|preconditioning volatile anesthesia
5566414|NCT01021228|Comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.|comparing three groups of anesthesia during the liver surgery according to their benefit on liver and outcome.
5566415|NCT01021215|Cancer Prevention|cancer prevention
5566416|NCT01021215|Smoking-related lung disease|smoking-related lung disease
5566418|NCT01021215|Celecoxib|celecoxib
5566419|NCT01021215|Celebrex|celebrex
5566420|NCT01021215|Zileuton|zileuton
5566421|NCT01021215|Zyflo CR|zyflo cr
5566422|NCT01021215|Prevention|prevention
5566423|NCT01021202|tracheostomy|tracheostomy
5566424|NCT01021202|tracheotomy|tracheotomy
5566425|NCT01021202|dilational|dilational
5566426|NCT01021202|dilatative|dilatative
5566427|NCT01021202|critical care|critical care
5566428|NCT01021202|intensive care|intensive care
5566429|NCT01021202|COPD|copd
5566430|NCT01021202|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5566431|NCT01021202|lung disease|lung disease
5566432|NCT01021202|pneumonia|pneumonia
5566433|NCT01021202|prospective study|prospective study
5566434|NCT01021202|questionnaire|questionnaire
5566435|NCT01021202|quality of life|quality of life
5566436|NCT01021202|outcome|outcome
5566437|NCT01021202|mortality|mortality
5566438|NCT01021189|safety|safety
5566439|NCT01021189|tolerability|tolerability
5566440|NCT01021189|AZD1446|azd1446
5566441|NCT01021189|AD|ad
5566442|NCT01021189|Japanese|japanese
5566443|NCT01021176|Food Intake|food intake
5566444|NCT01021176|Hunger|hunger
5566445|NCT01021176|Lidocaine|lidocaine
5566446|NCT01021176|Nose|nose
5566447|NCT01021176|smell|smell
5566448|NCT01021137|vestibular function tests|vestibular function tests
5566449|NCT01021137|postural balance|postural balance
5566450|NCT01021137|neuroimaging|neuroimaging
5566451|NCT01021124|tuberculosis|tuberculosis
5566452|NCT01021124|bone marrow transplant|bone marrow transplant
5566453|NCT01021124|diagnosis|diagnosis
5566454|NCT01021098|influenza|influenza
5566455|NCT01021098|illness|illness
5566456|NCT01021098|active-duty|active-duty
5566457|NCT01021098|virus|virus
5566458|NCT01021098|flu|flu
5566459|NCT01021098|military|military
5566463|NCT01021085|First trimester|first trimester
5566464|NCT01021059|Biological Effects of rhIL-15|biological effects of rhil-15
5566465|NCT01021059|Estimate Antitumor Activity|estimate antitumor activity
5566466|NCT01021059|rhIL-15 Pharmacokinetics|rhil-15 pharmacokinetics
5566467|NCT01021059|Dose and Safety Determination of IL-15|dose and safety determination of il-15
5566468|NCT01021059|Kidney Cancer|kidney cancer
5566469|NCT01021059|Melanoma|melanoma
5566470|NCT01021059|Renal Cell Cancer|renal cell cancer
5566471|NCT01021046|deep anterior lamellar keratoplasty|deep anterior lamellar keratoplasty
5566472|NCT01021046|rejection|rejection
5566473|NCT01021046|high risk patients|high risk patients
5566474|NCT01021046|acellular corneal tissue|acellular corneal tissue
5566479|NCT01021020|bioequivalence|bioequivalence
5566480|NCT01021020|fasting|fasting
5566481|NCT01021020|fed|fed
5566482|NCT01021020|healthy|healthy
5566483|NCT01020994|Superficial infected eczema|superficial infected eczema
5566484|NCT01020994|Superinfected eczema|superinfected eczema
5566485|NCT01020981|OEF/OIF|oef/oif
5566486|NCT01020981|Peer Group|peer group
5566487|NCT01020981|Veterans|veterans
5566488|NCT01020968|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
5566489|NCT01020968|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
5566490|NCT01020968|ixmyelocel-T|ixmyelocel-t
5566491|NCT01020955|GH and IGF-I|gh and igf-i
5566492|NCT01020955|growth hormone deficiency and IGT or diabetes|growth hormone deficiency and igt or diabetes
5566493|NCT01020942|ischemia|ischemia
5566494|NCT01020942|myocardial infarction|myocardial infarction
5566495|NCT01020942|prognosis|prognosis
5566496|NCT01020942|pretreatment|pretreatment
5566497|NCT01020942|electroacupuncture|electroacupuncture
5566498|NCT01020942|stents|stents
5566499|NCT01020942|troponin|troponin
5566500|NCT01020942|percutaneous coronary intervention|percutaneous coronary intervention
5566501|NCT01020916|Induced hypothermia|induced hypothermia
5566502|NCT01020916|Mild induced hypothermia|mild induced hypothermia
5566503|NCT01020916|Therapeutic hypothermia|therapeutic hypothermia
5566504|NCT01020916|Cardiac arrest|cardiac arrest
5566505|NCT01020916|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5566506|NCT01020916|Mortality|mortality
5566507|NCT01020916|Neurological function|neurological function
5566508|NCT01020916|Randomised clinical trial|randomised clinical trial
5566509|NCT01020890|GERD diagnosis|gerd diagnosis
5566510|NCT01020890|GERD-Q|gerd-q
5566511|NCT01020890|GERD patients' characteristics|gerd patients' characteristics
5566512|NCT01020890|GERD|gerd
5566513|NCT01020877|Bioequivalence|bioequivalence
5566514|NCT01020877|Healthy Subjects|healthy subjects
5566515|NCT01020877|Healthy, Normal Subjects|healthy, normal subjects
5566516|NCT01020864|Platinum-resistent head and neck cancer|platinum-resistent head and neck cancer
5566517|NCT01020864|Cetuximab|cetuximab
5566518|NCT01020864|Carboplatin|carboplatin
5566519|NCT01020864|Navelbine|navelbine
5566520|NCT01020864|Phase II trial|phase ii trial
5566521|NCT01020864|Combination chemotherapy|combination chemotherapy
5566522|NCT01020851|hypertension|hypertension
5566523|NCT01020851|stroke|stroke
5566524|NCT01020851|cholesterol|cholesterol
5566525|NCT01020851|adherence|adherence
5566526|NCT01020838|Florbetaben|florbetaben
5566527|NCT01020838|Amyloid beta-protein|amyloid beta-protein
5566528|NCT01020838|Alzheimer's disease|alzheimer's disease
5566529|NCT01020825|Complex perianal fistula|complex perianal fistula
5566530|NCT01020825|Adipose-derived adult stem cells|adipose-derived adult stem cells
5566531|NCT01020825|Fibrin glue|fibrin glue
5566532|NCT01020799|Depression|depression
5566533|NCT01020786|Non-squamous|non-squamous
5566534|NCT01020773|extubation,Respiration, Artificial|extubation,respiration, artificial
5566535|NCT01020760|Macular hole|macular hole
5566536|NCT01020760|Vitrectomy|vitrectomy
5566537|NCT01020760|Prone posturing|prone posturing
5566538|NCT01020734|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5566539|NCT01020734|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5566540|NCT01020734|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5566541|NCT01020734|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5566542|NCT01020734|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5566543|NCT01020734|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5566544|NCT01020734|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5566545|NCT01020734|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5798725|NCT00111254|skin|skin
5798726|NCT00111254|wrinkles|wrinkles
5566546|NCT01020734|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5566547|NCT01020734|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5566548|NCT01020734|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5566734|NCT01019928|pain|pain
5566549|NCT01020734|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5566550|NCT01020734|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5566551|NCT01020734|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5566552|NCT01020734|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5566553|NCT01020734|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5566554|NCT01020734|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5566555|NCT01020734|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5566556|NCT01020734|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5566557|NCT01020734|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5566558|NCT01020734|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5566559|NCT01020734|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5566560|NCT01020734|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5566561|NCT01020734|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5566562|NCT01020721|CYP1B1 gene|cyp1b1 gene
5566563|NCT01020695|PTSD|ptsd
5566565|NCT01020695|QEEG|qeeg
5566566|NCT01020695|LORETA|loreta
5566567|NCT01020682|apathy|apathy
5566568|NCT01020682|parkinson|parkinson
5566569|NCT01020682|agonist dopaminergic|agonist dopaminergic
5566570|NCT01020669|fMRI|fmri
5566571|NCT01020669|Prenatal Drug Exposure|prenatal drug exposure
5566572|NCT01020669|Decision Making|decision making
5566573|NCT01020669|Working Memory|working memory
5566574|NCT01020669|Vulnerability|vulnerability
5566575|NCT01020656|anticoagulant agents|anticoagulant agents
5566576|NCT01020656|antiplatelet agents|antiplatelet agents
5566577|NCT01020656|vitreoretinal surgery|vitreoretinal surgery
5566578|NCT01020656|Patients suffered from retinal detachment|patients suffered from retinal detachment
5566579|NCT01020630|adenocarcinoma of stomach|adenocarcinoma of stomach
5566580|NCT01020630|adenocarcinoma of lower oesophagus|adenocarcinoma of lower oesophagus
5566581|NCT01020630|sunitinib|sunitinib
5566582|NCT01020630|FOLFIRI|folfiri
5566583|NCT01020604|BMI|bmi
5566584|NCT01020604|Prostate cancer|prostate cancer
5566585|NCT01020604|Recurrence|recurrence
5566586|NCT01020591|knee osteoarthritis|knee osteoarthritis
5566587|NCT01020591|manual therapy|manual therapy
5566588|NCT01020591|osteopathy|osteopathy
5566589|NCT01020552|APHIA II|aphia ii
5566590|NCT01020552|AIDS, Population, and Health Integrated Assistance project|aids, population, and health integrated assistance project
5566591|NCT01020552|DCF|dcf
5566592|NCT01020552|data collection forms|data collection forms
5566593|NCT01020552|FDA|fda
5566594|NCT01020552|Federal Drug Administration|federal drug administration
5566595|NCT01020552|FP|fp
5566596|NCT01020552|family planning|family planning
5566597|NCT01020552|IRB|irb
5566598|NCT01020552|Institutional Review Board|institutional review board
5566599|NCT01020552|PAC|pac
5566600|NCT01020552|postabortion care|postabortion care
5566601|NCT01020552|To document the ESD PAC svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards PAC services|to document the esd pac svc pkg including the provision of services, client satisfaction with those services and provider attitudes towards pac services
5566602|NCT01020552|To examine any differences in implementation of the ESD PAC services package for youth and adult clients|to examine any differences in implementation of the esd pac services package for youth and adult clients
5566603|NCT01020552|To assess the usefulness of five Youth-Friendly PAC Job Aids developed by ESD|to assess the usefulness of five youth-friendly pac job aids developed by esd
5566604|NCT01020539|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5566605|NCT01020539|Targeted Immune Therapy|targeted immune therapy
5566606|NCT01020539|Acute Myelogenous Leukemia|acute myelogenous leukemia
5566607|NCT01020539|Myelodysplastic Syndrome|myelodysplastic syndrome
5566608|NCT01020539|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5566609|NCT01020539|AML|aml
5566610|NCT01020539|MDS|mds
5566612|NCT01020474|juvenile primary fibromyalgia syndrome|juvenile primary fibromyalgia syndrome
5566613|NCT01020474|pediatric fibromyalgia|pediatric fibromyalgia
5566615|NCT01020474|and Lyrica|and lyrica
5566616|NCT01020448|Locally advanced or metastatic Prostate Cancer|locally advanced or metastatic prostate cancer
5566617|NCT01020435|Hypertension|hypertension
5566618|NCT01020422|breast hypertrophy|breast hypertrophy
5566619|NCT01020422|mammaplasty|mammaplasty
5566620|NCT01020422|sexuality|sexuality
5566621|NCT01020422|depression|depression
5566622|NCT01020409|cardiac surgery|cardiac surgery
5566623|NCT01020409|cardiopulmonary bypass|cardiopulmonary bypass
5566624|NCT01020409|acute lung injury|acute lung injury
5566625|NCT01020409|acute respiratory distress syndrome|acute respiratory distress syndrome
5566626|NCT01020409|acute kidney injury|acute kidney injury
5566627|NCT01020409|atrial fibrillation|atrial fibrillation
5566628|NCT01020409|postoperative psychosis|postoperative psychosis
5566629|NCT01020409|myocardial infarct|myocardial infarct
5566630|NCT01020409|sepsis|sepsis
5566631|NCT01020396|Bioequivalence|bioequivalence
5566632|NCT01020396|Metronidazole|metronidazole
5566633|NCT01020396|Vaginosis|vaginosis
5566735|NCT01019915|CRT|crt
5566736|NCT01019915|heart failure|heart failure
5566634|NCT01020370|Patients with RRMS who are participating in the CARE MS I and CARE MS II|patients with rrms who are participating in the care ms i and care ms ii
5566635|NCT01020357|preterm infants|preterm infants
5566636|NCT01020357|very low birthweight|very low birthweight
5566637|NCT01020357|apnea of prematurity|apnea of prematurity
5566638|NCT01020357|methylxanthines|methylxanthines
5566639|NCT01020357|sleep disturbance|sleep disturbance
5566640|NCT01020357|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5566641|NCT01020357|polysomnography|polysomnography
5566642|NCT01020357|sleep disruption|sleep disruption
5566643|NCT01020331|ALS|als
5566644|NCT01020318|Traumatic Brain Injury|traumatic brain injury
5566645|NCT01020318|TBI|tbi
5566646|NCT01020318|Brain Injuries|brain injuries
5566647|NCT01020279|muscle pain|muscle pain
5566648|NCT01020279|model|model
5566649|NCT01020266|brain protection|brain protection
5566650|NCT01020266|cardiac surgery|cardiac surgery
5566651|NCT01020266|heart valve replacement|heart valve replacement
5566652|NCT01020266|electroacupuncture|electroacupuncture
5566653|NCT01020266|pretreatment|pretreatment
5566654|NCT01020266|preconditioning|preconditioning
5566655|NCT01020266|Thoracic Surgery|thoracic surgery
5566656|NCT01020253|bisphosphonate, vitamin D3|bisphosphonate, vitamin d3
5566657|NCT01020253|Total Hip arthroplasty|total hip arthroplasty
5566658|NCT01020240|Immediate puerperium|immediate puerperium
5566659|NCT01020240|physiotherapy in postpartum|physiotherapy in postpartum
5566660|NCT01020240|cesarean complications|cesarean complications
5566661|NCT01020227|Postoperative Care|postoperative care
5566662|NCT01020227|Quality of Life|quality of life
5566663|NCT01020227|Integrative Medicine|integrative medicine
5566664|NCT01020227|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5566665|NCT01020201|Anesthesia, General|anesthesia, general
5566666|NCT01020201|Elective Gynecological Operation|elective gynecological operation
5566668|NCT01020201|Adult|adult
5566669|NCT01020175|allogeneic transplantation|allogeneic transplantation
5566670|NCT01020175|Leukemia|leukemia
5566671|NCT01020175|GvHD|gvhd
5566672|NCT01020175|MDS|mds
5566673|NCT01020162|Chronic pelvic pain|chronic pelvic pain
5566674|NCT01020162|ilioinguinal nerve entrapment|ilioinguinal nerve entrapment
5566675|NCT01020162|randomized study|randomized study
5566676|NCT01020162|Chronic pelvic pain in women|chronic pelvic pain in women
5548784|NCT01092078|men|men
5566677|NCT01020149|Nerve transsection|nerve transsection
5566678|NCT01020136|Bioequivalence Pharmacokinetics|bioequivalence pharmacokinetics
5566679|NCT01020123|Type II Diabetes Mellitus|type ii diabetes mellitus
5566680|NCT01020123|metformin|metformin
5566681|NCT01020123|glipizide|glipizide
5566682|NCT01020110|perfusion chamber|perfusion chamber
5566683|NCT01020110|thrombus D-Dimer|thrombus d-dimer
5566684|NCT01020110|HUVEC|huvec
5566685|NCT01020084|Saliva|saliva
5566686|NCT01020084|Mastication|mastication
5566687|NCT01020084|Communication|communication
5566688|NCT01020071|iridotomy|iridotomy
5566689|NCT01020071|iridoplasty|iridoplasty
5566690|NCT01020071|angle closure glaucoma|angle closure glaucoma
5566691|NCT01020045|HIV|hiv
5566692|NCT01020045|Osteopenia|osteopenia
5566693|NCT01020045|Osteoporosis|osteoporosis
5566694|NCT01020032|Music therapy|music therapy
5566695|NCT01020032|Pain|pain
5566696|NCT01020032|Anxiety|anxiety
5566697|NCT01020032|Depression|depression
5566698|NCT01020032|Controlled randomized trial|controlled randomized trial
5566699|NCT01020019|Cannabis Dependence|cannabis dependence
5566700|NCT01020019|Marijuana Dependence|marijuana dependence
5566701|NCT01020019|Marinol|marinol
5566702|NCT01020019|Lofexidine|lofexidine
5566703|NCT01020006|PCI-27483|pci-27483
5566704|NCT01020006|Factor VIIa|factor viia
5566705|NCT01020006|Gemcitabine|gemcitabine
5566706|NCT01020006|4 months life expectancy|4 months life expectancy
5566708|NCT01020006|Locally Advanced|locally advanced
5566709|NCT01020006|Metastatic disease|metastatic disease
5566710|NCT01019993|Thoracotomy|thoracotomy
5566711|NCT01019993|one lung ventilation|one lung ventilation
5566712|NCT01019993|HFPPV|hfppv
5566713|NCT01019993|right ventricular function.|right ventricular function.
5566714|NCT01019980|Antipyretics|antipyretics
5566715|NCT01019980|fever|fever
5566716|NCT01019980|diclofenac|diclofenac
5566717|NCT01019980|acetaminophen|acetaminophen
5566718|NCT01019980|children|children
5566719|NCT01019980|acute upper respiratory tract infections|acute upper respiratory tract infections
5566720|NCT01019967|Children and Adolescents|children and adolescents
5566721|NCT01019967|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5566722|NCT01019967|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5566723|NCT01019967|Autism|autism
5566724|NCT01019967|OCD|ocd
5566737|NCT01019915|left bundle branch block|left bundle branch block
5566739|NCT01019915|cytokines|cytokines
5566740|NCT01019915|VO2|vo2
5566741|NCT01019915|pgc1alpha|pgc1alpha
5566742|NCT01019902|iron|iron
5566743|NCT01019902|pregnancy|pregnancy
5566744|NCT01019902|adolescents|adolescents
5566745|NCT01019902|auditory brainstem responses|auditory brainstem responses
5566746|NCT01019902|anemia|anemia
5566747|NCT01019902|neonate|neonate
5566748|NCT01019889|upper respiratory tract infections|upper respiratory tract infections
5566749|NCT01019889|herbal medicine|herbal medicine
5566750|NCT01019876|Bone marrow Failure|bone marrow failure
5566751|NCT01019876|Fanconi|fanconi
5566752|NCT01019876|SCID|scid
5566753|NCT01019850|disseminated neuroblastoma|disseminated neuroblastoma
5566754|NCT01019850|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5566755|NCT01019850|recurrent neuroblastoma|recurrent neuroblastoma
5566756|NCT01019850|regional neuroblastoma|regional neuroblastoma
5566757|NCT01019837|Vaccine|vaccine
5566758|NCT01019824|nerve compression|nerve compression
5566759|NCT01019824|compression radiculopathy|compression radiculopathy
5566760|NCT01019824|post-traumatic/post-surgical lumbar radiculopathy|post-traumatic/post-surgical lumbar radiculopathy
5566761|NCT01019811|Cross-finger flap|cross-finger flap
5566762|NCT01019811|finger injuries|finger injuries
5566763|NCT01019811|fingertip reconstruction|fingertip reconstruction
5566764|NCT01019811|proper digital artery|proper digital artery
5566765|NCT01019811|proper digital nerve.|proper digital nerve.
5566766|NCT01019798|non small cell lung cancer|non small cell lung cancer
5566767|NCT01019798|sunitinib|sunitinib
5566768|NCT01019798|docetaxel|docetaxel
5566769|NCT01019785|Pregnancy rate (pos test, live fetus at 12 weeks, baby home)|pregnancy rate (pos test, live fetus at 12 weeks, baby home)
5566770|NCT01019785|Pregnancy complication (Pregnancy hypertension, SGA, diab)|pregnancy complication (pregnancy hypertension, sga, diab)
5566771|NCT01019785|Thrombin generation|thrombin generation
5566772|NCT01019759|Atrial fibrillation|atrial fibrillation
5566773|NCT01019759|cardiac surgery|cardiac surgery
5566774|NCT01019759|ablation|ablation
5566775|NCT01019759|pulmonary veins|pulmonary veins
5566776|NCT01019746|Hypnosis with propofol|hypnosis with propofol
5566777|NCT01019733|Hypoxia|hypoxia
5566780|NCT01019733|Children|children
5566781|NCT01019733|Cerebral Palsy|cerebral palsy
5566782|NCT01019707|crystal meth|crystal meth
5566783|NCT01019707|methamphetamine|methamphetamine
5566784|NCT01019707|substance abuse|substance abuse
5566785|NCT01019681|Cord blood injection in peripheral vascular disease|cord blood injection in peripheral vascular disease
5566786|NCT01019668|chorioretinopathy|chorioretinopathy
5566787|NCT01019668|photodynamic therapy|photodynamic therapy
5566788|NCT01019668|reduced fluence|reduced fluence
5566789|NCT01019668|reduced dose|reduced dose
5566790|NCT01019655|thrombophilia|thrombophilia
5566791|NCT01019655|pregnancy|pregnancy
5566792|NCT01019655|heparin|heparin
5566793|NCT01019642|vitamin D|vitamin d
5566794|NCT01019642|diabetes|diabetes
5566795|NCT01019642|C-reactive protein|c-reactive protein
5566796|NCT01019642|insulin resistance|insulin resistance
5566797|NCT01019629|Fabry, Fabry Disease, Alpha-galactosidase A deficiency, GLA gene, mutations|fabry, fabry disease, alpha-galactosidase a deficiency, gla gene, mutations
5566798|NCT01019603|Acne|acne
5566799|NCT01019551|Controlled viremia|controlled viremia
5566800|NCT01019551|Viral reservoirs|viral reservoirs
5566801|NCT01019551|Virus eradication|virus eradication
5566802|NCT01019551|Therapeutic intensification|therapeutic intensification
5566803|NCT01019551|Immunointervention|immunointervention
5566804|NCT01019538|Oxygen|oxygen
5566805|NCT01019538|Hypoxemia|hypoxemia
5566806|NCT01019538|Air travel|air travel
5566807|NCT01019525|respiration|respiration
5566808|NCT01019525|respiratory disorders|respiratory disorders
5566809|NCT01019525|Otolaryngology|otolaryngology
5566810|NCT01019525|Otorhinolaryngology|otorhinolaryngology
5566811|NCT01019525|Posture|posture
5566812|NCT01019499|human|human
5566813|NCT01019499|intervention|intervention
5566814|NCT01019499|blood pressure|blood pressure
5566815|NCT01019499|cardiovascular risk factors|cardiovascular risk factors
5566816|NCT01019499|polyphenols|polyphenols
5566817|NCT01019499|bioavailability|bioavailability
5566818|NCT01019486|Myocardial blood flow|myocardial blood flow
5566819|NCT01019486|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5566820|NCT01019486|Myocardial perfusion imaging|myocardial perfusion imaging
5566821|NCT01019486|Coronary artery flow reserve|coronary artery flow reserve
5566822|NCT01019486|Regadenoson|regadenoson
5566823|NCT01019473|Huntington's disease|huntington's disease
5566824|NCT01019473|Chorea|chorea
5566825|NCT01019473|Dyskinesia|dyskinesia
5566826|NCT01019460|Small intestine|small intestine
5566827|NCT01019460|Magnetic resonance imaging|magnetic resonance imaging
5566828|NCT01019460|Computed tomography scanning|computed tomography scanning
5566829|NCT01019460|Capsule endoscopy|capsule endoscopy
5566830|NCT01019447|Surgical site infection|surgical site infection
5566831|NCT01019447|Antimicrobial triclosan-coated polyglactin 910 suture|antimicrobial triclosan-coated polyglactin 910 suture
5566832|NCT01019447|Length of hospital stay|length of hospital stay
5566834|NCT01019434|adult glioblastoma|adult glioblastoma
5566835|NCT01019421|Cognition|cognition
5566836|NCT01019408|Clinical Trial|clinical trial
5566837|NCT01019408|Chloroquine|chloroquine
5566838|NCT01019408|Refugees|refugees
5566839|NCT01019408|Afghanistan|afghanistan
5566840|NCT01019408|Pakistan|pakistan
5566841|NCT01019395|Gram Positive Infection|gram positive infection
5566842|NCT01019395|Concurrent Antibiotic Treatment|concurrent antibiotic treatment
5566843|NCT01019382|pancreatic|pancreatic
5566844|NCT01019382|carcinoma|carcinoma
5566845|NCT01019382|cancer|cancer
5566846|NCT01019382|fish|fish
5566847|NCT01019382|alternative|alternative
5566848|NCT01019369|Contraception|contraception
5566849|NCT01019369|Medroxyprogesterone 17-acetate|medroxyprogesterone 17-acetate
5566850|NCT01019369|Self administration|self administration
5566851|NCT01019356|PCOS|pcos
5566852|NCT01019343|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5566853|NCT01019343|Magnetoencephalogram|magnetoencephalogram
5566854|NCT01019343|Electroencephalogram (EEG)|electroencephalogram (eeg)
5566855|NCT01019343|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5566856|NCT01019343|Motor Deficit|motor deficit
5566857|NCT01019343|Dystonia|dystonia
5566858|NCT01019343|Movement Disorder|movement disorder
5566859|NCT01019343|Parkinson Disease|parkinson disease
5566861|NCT01019343|Tourette Syndrome|tourette syndrome
5566863|NCT01019343|Tic Disorder|tic disorder
5566864|NCT01019330|radial vs femoral|radial vs femoral
5566865|NCT01019330|radial artery cardiac catheterization|radial artery cardiac catheterization
5566866|NCT01019317|Acute Myelogenous Leukemia|acute myelogenous leukemia
5566867|NCT01019317|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5566868|NCT01019317|Chronic myeloid leukemia|chronic myeloid leukemia
5566869|NCT01019317|CML|cml
5566870|NCT01019317|Blast crisis|blast crisis
5566871|NCT01019317|Cytarabine|cytarabine
5566872|NCT01019317|Ara-C|ara-c
5566873|NCT01019317|Cytosar|cytosar
5566874|NCT01019317|DepoCyt|depocyt
5566875|NCT01019317|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5566876|NCT01019317|Arabinosine Hydrochloride|arabinosine hydrochloride
5566877|NCT01019317|Fludarabine|fludarabine
5566878|NCT01019317|Fludarabine Phosphate|fludarabine phosphate
5566879|NCT01019317|Fludara|fludara
5566880|NCT01019317|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5566881|NCT01019317|Mylotarg|mylotarg
5566882|NCT01019291|Indoor pollutants|indoor pollutants
5566883|NCT01019265|Norspan patch|norspan patch
5566884|NCT01019265|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
5566885|NCT01019265|efficacy|efficacy
5566886|NCT01019265|buprenorphine|buprenorphine
5566887|NCT01019252|Adolescent|adolescent
5566889|NCT01019239|Non-faeculant|non-faeculant
5566890|NCT01019239|Perforated|perforated
5566891|NCT01019239|Diverticulitis|diverticulitis
5566892|NCT01019226|myocardium|myocardium
5566893|NCT01019226|Magnetic resonance imaging|magnetic resonance imaging
5566894|NCT01019213|His-pacing|his-pacing
5566895|NCT01019200|psoriasis|psoriasis
5566896|NCT01019200|heart disease|heart disease
5566897|NCT01019200|cardiovascular disease|cardiovascular disease
5566898|NCT01019200|hyperlipidemia|hyperlipidemia
5566899|NCT01019161|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5566900|NCT01019161|AML|aml
5566901|NCT01019161|AZD1152|azd1152
5566902|NCT01019161|Pharmacokinetics|pharmacokinetics
5566903|NCT01019135|Women|women
5566904|NCT01019135|Cardiac Care Facilities|cardiac care facilities
5566905|NCT01019135|Patient satisfaction|patient satisfaction
5566906|NCT01019135|Patient participation|patient participation
5566907|NCT01019135|Patient compliance|patient compliance
5566908|NCT01019135|Randomized Control Trial|randomized control trial
5566909|NCT01019135|Coronary artery bypass|coronary artery bypass
5566910|NCT01019135|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5566911|NCT01019109|scoliosis|scoliosis
5566912|NCT01019096|iron|iron
5566913|NCT01019096|pregnancy|pregnancy
5566914|NCT01019096|heme iron|heme iron
5566915|NCT01019096|non-heme iron|non-heme iron
5566916|NCT01019096|stable isotopes|stable isotopes
5566918|NCT01019083|Cholera|cholera
5566919|NCT01019083|Typhoid|typhoid
5566920|NCT01019083|Oral Vaccine|oral vaccine
5566921|NCT01019083|Immune response|immune response
5566922|NCT01019083|Vaccine Evaluation|vaccine evaluation
5566923|NCT01019083|Nutrition|nutrition
5566924|NCT01019083|Child Health|child health
5566925|NCT01019057|DDD|ddd
5566926|NCT01019057|decompression|decompression
5566927|NCT01019057|spinous process plate|spinous process plate
5566928|NCT01019044|HIV|hiv
5566929|NCT01019044|Viral reservoirs|viral reservoirs
5566930|NCT01019044|Viral load|viral load
5566931|NCT01019018|subtenon block|subtenon block
5566932|NCT01019005|post-operative analgesia|post-operative analgesia
5566933|NCT01019005|opioid|opioid
5566934|NCT01019005|catheter|catheter
5566935|NCT01019005|tibial nerve block|tibial nerve block
5566936|NCT01018992|PTSD|ptsd
5566937|NCT01018992|Anxiety Disorder|anxiety disorder
5566938|NCT01018992|Corticotropin releasing factor|corticotropin releasing factor
5566939|NCT01018992|Women|women
5566940|NCT01018927|Cardiac MR (CMR)|cardiac mr (cmr)
5566941|NCT01018927|Early Myocardial Infiltration|early myocardial infiltration
5566942|NCT01018927|Amyloid|amyloid
5566943|NCT01018927|Light Chain Deposition Disease|light chain deposition disease
5566944|NCT01018927|Multiple Myeloma|multiple myeloma
5566945|NCT01018914|Prograf|prograf
5566946|NCT01018914|Advagraf|advagraf
5566947|NCT01018914|Myfortic|myfortic
5566948|NCT01018888|Cornea|cornea
5566949|NCT01018888|Transplantation, Cornea|transplantation, cornea
5566950|NCT01018888|Keratoplasty|keratoplasty
5566951|NCT01018888|Grafting, Corneal|grafting, corneal
5566952|NCT01018849|Vitamin D|vitamin d
5566953|NCT01018849|Cardiac Catheterization|cardiac catheterization
5566954|NCT01018849|Cardiovascular event|cardiovascular event
5566955|NCT01018849|Cardiovascular Disease|cardiovascular disease
5566956|NCT01018836|tumors metastatic to brain|tumors metastatic to brain
5566957|NCT01018836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5566958|NCT01018810|Psoriasis|psoriasis
5566959|NCT01018797|INTRASTROMAL CORNEAL RING|intrastromal corneal ring
5566960|NCT01018797|ASTIGMATISM|astigmatism
5566961|NCT01018797|POSTKERATOPLASTY|postkeratoplasty
5566962|NCT01018797|EYES|eyes
5566963|NCT01018797|To evaluate the clinical outcomes of ICRS implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (PK)|to evaluate the clinical outcomes of icrs implantation to correct high-degree astigmatism on eyes with prior penetrating keratoplasty (pk)
5566964|NCT01018784|Cancer|cancer
5566965|NCT01018784|Mesothelin-positive|mesothelin-positive
5566966|NCT01018771|actifuse|actifuse
5566967|NCT01018771|INFUSE|infuse
5566968|NCT01018771|InductOs|inductos
5566969|NCT01018771|DDD|ddd
5566970|NCT01018771|Degenerative disc disease|degenerative disc disease
5566971|NCT01018771|PLF|plf
5566972|NCT01018771|posterolateral lumbar fusion|posterolateral lumbar fusion
5566973|NCT01018771|bone substitute|bone substitute
5566974|NCT01018771|bone graft|bone graft
5566975|NCT01018771|synthetic bone substitute|synthetic bone substitute
5566976|NCT01018771|spinal surgery|spinal surgery
5566977|NCT01018758|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5566978|NCT01018758|Quality of life|quality of life
5566979|NCT01018758|Chemotherapy toxicity|chemotherapy toxicity
5566980|NCT01018758|aggressive Non Hodgkin's Lymphomas treated with moderately emetogenic chemotherapy|aggressive non hodgkin's lymphomas treated with moderately emetogenic chemotherapy
5566981|NCT01018732|Meningococcal|meningococcal
5566983|NCT01018732|Conjugate Vaccine|conjugate vaccine
5566984|NCT01018732|Meningitis|meningitis
5566985|NCT01018732|Adolescents|adolescents
5566986|NCT01018732|Persistence|persistence
5566987|NCT01018719|breast cancer radiotherapy cardiotoxicity multidetector CT|breast cancer radiotherapy cardiotoxicity multidetector ct
5566988|NCT01018719|Radiotherapy|radiotherapy
5566989|NCT01018706|Primary pci|primary pci
5566990|NCT01018706|Stent|stent
5566991|NCT01018706|Medical Hystory|medical hystory
5566992|NCT01018706|Antiplatelet therapy|antiplatelet therapy
5566993|NCT01018706|Compliance|compliance
5566994|NCT01018693|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
5566995|NCT01018693|late phase response,|late phase response,
5566996|NCT01018693|alutard avanz,|alutard avanz,
5566997|NCT01018693|immunotherapy,|immunotherapy,
5566998|NCT01018693|visual analogue scale,|visual analogue scale,
5566999|NCT01018693|mini rhinitis quality of life,|mini rhinitis quality of life,
5567000|NCT01018693|immune modulation|immune modulation
5567001|NCT01018667|Heart Failure|heart failure
5567002|NCT01018667|clinical trial|clinical trial
5567003|NCT01018667|biventricular pacing|biventricular pacing
5567004|NCT01018667|cardiac device|cardiac device
5567005|NCT01018654|Substance Abuse|substance abuse
5567006|NCT01018654|Substance Addiction|substance addiction
5567007|NCT01020708|colitis|colitis
5567008|NCT01020708|inflammatory bowel disease|inflammatory bowel disease
5567009|NCT01020708|ulcerative colitis|ulcerative colitis
5567010|NCT01020708|rectal administration|rectal administration
5567011|NCT01020708|enema|enema
5567012|NCT01020708|mesalamine|mesalamine
5569637|NCT01008111|tissue|tissue
5567013|NCT01020487|Reduction of parathyroid hormone levels in pediatric patients with Chronic Kidney Disease Stage 3 and 4|reduction of parathyroid hormone levels in pediatric patients with chronic kidney disease stage 3 and 4
5567016|NCT01019954|Adults with premalignant head and neck tumors and adults who have Carcinoma in situ of the head and neck in whom standard therapy is not indicated|adults with premalignant head and neck tumors and adults who have carcinoma in situ of the head and neck in whom standard therapy is not indicated
5567020|NCT01018641|Staphylococcus aureus|staphylococcus aureus
5567021|NCT01018641|Vaccine|vaccine
5567022|NCT01018615|chronic hepatitis C|chronic hepatitis c
5567023|NCT01018615|silymarin|silymarin
5567024|NCT01018615|green tea catechins|green tea catechins
5567025|NCT01018615|green tea extract|green tea extract
5567026|NCT01018615|pharmacokinetics|pharmacokinetics
5567027|NCT01018615|antioxidant activity|antioxidant activity
5567028|NCT01018589|Post surgical scars|post surgical scars
5567029|NCT01018589|Epidermic burn|epidermic burn
5567030|NCT01018589|Cicatrix cream|cicatrix cream
5567031|NCT01018576|delayed cord clamping|delayed cord clamping
5567032|NCT01018576|premature infants|premature infants
5567033|NCT01018576|hypothermia|hypothermia
5567034|NCT01018576|anemia|anemia
5567035|NCT01018576|intraventricular hemorrhage|intraventricular hemorrhage
5567036|NCT01018576|Anemia in premature infants|anemia in premature infants
5567037|NCT01018563|Extension study|extension study
5567038|NCT01018563|Epithelial ovarian cancer|epithelial ovarian cancer
5567039|NCT01018537|Multiple Sclerosis|multiple sclerosis
5567040|NCT01018537|NARCOMS|narcoms
5567041|NCT01018537|Global Patient Registry|global patient registry
5567042|NCT01018524|position of the mesh|position of the mesh
5567043|NCT01018524|recurrence rate|recurrence rate
5567044|NCT01018524|surgical procedure|surgical procedure
5567045|NCT01018524|long time outcome|long time outcome
5567046|NCT01018511|EC905|ec905
5567047|NCT01018511|Solifenacin succinate|solifenacin succinate
5567048|NCT01018511|Tamsulosin hydrochloride OCAS|tamsulosin hydrochloride ocas
5567049|NCT01018511|Treatment|treatment
5567050|NCT01018511|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5567051|NCT01018511|Vesomni|vesomni
5567052|NCT01018511|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5567053|NCT01018498|Irritable Bowel Syndrome|irritable bowel syndrome
5567054|NCT01018498|Children|children
5567055|NCT01018472|cyanotic heart disease|cyanotic heart disease
5567056|NCT01018472|congenital heart disease|congenital heart disease
5567057|NCT01018472|intestinal microbiota|intestinal microbiota
5567058|NCT01018472|probiotics|probiotics
5567059|NCT01018459|malaria, vaccine, Burkina Faso|malaria, vaccine, burkina faso
5567060|NCT01018446|Hematopoietic stem cell transplantation with busulfan based conditioning|hematopoietic stem cell transplantation with busulfan based conditioning
5567061|NCT01018433|self-injury|self-injury
5567062|NCT01018433|non-suicidal self-injury|non-suicidal self-injury
5567063|NCT01018433|deliberate self-harm|deliberate self-harm
5567064|NCT01018433|self-mutilation|self-mutilation
5567065|NCT01018420|healthy|healthy
5567066|NCT01018394|tobacco dependence|tobacco dependence
5567067|NCT01018394|tobacco reduction|tobacco reduction
5567068|NCT01018394|chewing tobacco|chewing tobacco
5567069|NCT01018394|snuff|snuff
5567070|NCT01018394|moist snuff|moist snuff
5567071|NCT01018381|HCC|hcc
5567072|NCT01018381|HBV|hbv
5567073|NCT01018381|MGN-3|mgn-3
5567074|NCT01018381|BioBran|biobran
5567075|NCT01018381|Alternative Therapy|alternative therapy
5567076|NCT01018355|Patent foramen ovale|patent foramen ovale
5567077|NCT01018355|PFO|pfo
5567078|NCT01018355|Stroke|stroke
5567079|NCT01018355|TIA|tia
5567080|NCT01018355|Percutaneus closure|percutaneus closure
5567081|NCT01018355|Intervention|intervention
5567082|NCT01018329|Adult Brain Tumor|adult brain tumor
5567083|NCT01018316|preoxygenation|preoxygenation
5567084|NCT01018316|UMOX|umox
5567085|NCT01018303|cystic fibrosis|cystic fibrosis
5567086|NCT01018303|vitamins|vitamins
5567087|NCT01018303|antioxidants|antioxidants
5567088|NCT01018303|anthropometric measurements|anthropometric measurements
5567089|NCT01018303|pulmonary function|pulmonary function
5567090|NCT01018264|Overactive bladder|overactive bladder
5567091|NCT01018264|Urinary incontinence|urinary incontinence
5567092|NCT01018264|Urinary frequency|urinary frequency
5567093|NCT01018264|Parkinson's disease|parkinson's disease
5567094|NCT01018212|Cutaneous Groves|cutaneous groves
5567095|NCT01018199|C-reactive protein|c-reactive protein
5567096|NCT01018199|procalcitonin|procalcitonin
5567097|NCT01018199|community-acquired pneumonia|community-acquired pneumonia
5567098|NCT01018199|antibiotic therapy|antibiotic therapy
5567099|NCT01018160|Rabeprazole sodium|rabeprazole sodium
5567100|NCT01018160|Gastroesophageal Reflux|gastroesophageal reflux
5567101|NCT01018160|GERD|gerd
5567102|NCT01018160|Observational|observational
5567103|NCT01018147|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5567104|NCT01018147|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5567105|NCT01018147|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5567106|NCT01018147|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5567107|NCT01018147|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5567108|NCT01018147|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5567110|NCT01018134|Topical corticosteroids|topical corticosteroids
5567111|NCT01018134|Plaque psoriasis|plaque psoriasis
5567112|NCT01018121|Behavioral Treatment|behavioral treatment
5567113|NCT01018121|Preschool Children|preschool children
5567114|NCT01018121|Obesity Treatment|obesity treatment
5567115|NCT01018069|Acute|acute
5567116|NCT01018069|myeloid|myeloid
5567117|NCT01018069|leukemia|leukemia
5567118|NCT01018069|antisense|antisense
5567119|NCT01018069|chemotherapy|chemotherapy
5567120|NCT01018069|idarubicin|idarubicin
5567121|NCT01018069|cytarabine|cytarabine
5567215|NCT01017653|Vectibix|vectibix
5567216|NCT01017653|Irinotecan|irinotecan
5567122|NCT01018069|Patients with AML, except those with APL (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.|patients with aml, except those with apl (acute promyelocytic leukemia), failing a single standard dose cytarabine based frontline induction regimen.
5567123|NCT01018056|Tourette syndrome|tourette syndrome
5567124|NCT01018056|glutamatergic therapy|glutamatergic therapy
5567125|NCT01018056|D-serine|d-serine
5567126|NCT01018056|riluzole|riluzole
5567127|NCT01018056|glutamate|glutamate
5567128|NCT01018056|glutamate agonist|glutamate agonist
5567129|NCT01018056|glutamate antagonist|glutamate antagonist
5567130|NCT01018056|Tourette syndrome treatment study|tourette syndrome treatment study
5567131|NCT01018056|OCD|ocd
5567132|NCT01018056|tics|tics
5567133|NCT01018043|Cancer Anemia Survey|cancer anemia survey
5567134|NCT01018043|Chulalongkorn hospital|chulalongkorn hospital
5567135|NCT01018030|uncomplicated acute rhinosinusitis|uncomplicated acute rhinosinusitis
5567136|NCT01018030|fluticasone furoate|fluticasone furoate
5567137|NCT01018030|sinusitis|sinusitis
5567138|NCT01018004|stage IB melanoma|stage ib melanoma
5567139|NCT01018004|stage II melanoma|stage ii melanoma
5567140|NCT01017991|infants|infants
5567141|NCT01017991|formula|formula
5567142|NCT01017991|probiotic|probiotic
5567143|NCT01017991|crying|crying
5567144|NCT01017965|Type 1 diabetes|type 1 diabetes
5567145|NCT01017952|Safety|safety
5567146|NCT01017952|COPD|copd
5567147|NCT01017952|FEV1|fev1
5567148|NCT01017952|Efficacy|efficacy
5567149|NCT01017939|Prostate neoplasms|prostate neoplasms
5567150|NCT01017939|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5567151|NCT01017939|Metastatic castration refractory prostate cancer|metastatic castration refractory prostate cancer
5567152|NCT01017939|Prostate cancer|prostate cancer
5567153|NCT01017939|Abiraterone acetate|abiraterone acetate
5567154|NCT01017939|CB7630|cb7630
5567155|NCT01017926|Triazolam bioequivalence|triazolam bioequivalence
5567156|NCT01017913|rehabilitation|rehabilitation
5567157|NCT01017913|electrotherapy|electrotherapy
5567158|NCT01017913|back pain|back pain
5567159|NCT01017900|surgery|surgery
5567160|NCT01017900|manual rupture|manual rupture
5567161|NCT01017900|dorsal carpal ganglion|dorsal carpal ganglion
5567162|NCT01017887|laparoscopy|laparoscopy
5567163|NCT01017887|airseal|airseal
5567164|NCT01017887|carbon dioxide|carbon dioxide
5567165|NCT01017887|insufflation|insufflation
5567166|NCT01017887|pneumoperitoneum|pneumoperitoneum
5567167|NCT01017861|Temporal summation|temporal summation
5567168|NCT01017861|Venipuncture pain|venipuncture pain
5567169|NCT01017848|diabetes|diabetes
5567170|NCT01017848|urine pH|urine ph
5567171|NCT01017848|insulin resistance|insulin resistance
5567172|NCT01017848|metabolic syndrome|metabolic syndrome
5567173|NCT01017848|development of diabetes|development of diabetes
5567174|NCT01017835|statins|statins
5567175|NCT01017835|isolated hypertension|isolated hypertension
5567176|NCT01017835|atherosclerosis|atherosclerosis
5567177|NCT01017835|lipid profile|lipid profile
5567178|NCT01017822|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5567179|NCT01017822|stage III pancreatic cancer|stage iii pancreatic cancer
5567180|NCT01017809|ovarian|ovarian
5567181|NCT01017809|chemotherapy|chemotherapy
5567182|NCT01017809|nausea|nausea
5567183|NCT01017796|Contrast induced nephropathy|contrast induced nephropathy
5567184|NCT01017770|Uncomplicated malaria|uncomplicated malaria
5567185|NCT01017757|Interstitial lung disease|interstitial lung disease
5567186|NCT01017757|Immunosuppressive therapy|immunosuppressive therapy
5567187|NCT01017757|Renal transplant|renal transplant
5567188|NCT01017744|Anesthetic Conserving Device|anesthetic conserving device
5567189|NCT01017744|Anaconda®|anaconda®
5567190|NCT01017744|Sevoflurane|sevoflurane
5567191|NCT01017744|Remifentanil|remifentanil
5567192|NCT01017744|Sedation|sedation
5567193|NCT01017744|Pressure support ventilation|pressure support ventilation
5567194|NCT01017744|Work of breathing|work of breathing
5567198|NCT01017744|Weaning of mechanical ventilation|weaning of mechanical ventilation
5567199|NCT01017744|Ventilated ICU patients in PSV|ventilated icu patients in psv
5567201|NCT01017744|No respiratory distress|no respiratory distress
5567202|NCT01017744|Sedated by intravenous remifentanil|sedated by intravenous remifentanil
5567203|NCT01017744|In light sedation as define by a Richmond Agitation Sedation Scale (RASS) of - 1 to - 2.|in light sedation as define by a richmond agitation sedation scale (rass) of - 1 to - 2.
5567204|NCT01017731|Advanced Solid tumor|advanced solid tumor
5567205|NCT01017731|Antibodies, Monoclonal|antibodies, monoclonal
5567207|NCT01017731|Metastatic|metastatic
5567208|NCT01017731|Malignant|malignant
5567209|NCT01017718|Diabetes mellitus type I|diabetes mellitus type i
5567210|NCT01017718|nerve conduction velocity|nerve conduction velocity
5567211|NCT01017718|Young score|young score
5567212|NCT01017718|long term vascular complications|long term vascular complications
5567213|NCT01017666|Healthy Volunteer|healthy volunteer
5567214|NCT01017653|Panitumumab|panitumumab
5567217|NCT01017653|CPT-11|cpt-11
5567218|NCT01017653|Camptosar|camptosar
5567219|NCT01017653|Malignant glioma|malignant glioma
5567220|NCT01017653|Glioblastoma multiforme|glioblastoma multiforme
5567221|NCT01017653|Gliosarcoma|gliosarcoma
5567222|NCT01017653|Duke|duke
5567223|NCT01017653|Vredenburgh|vredenburgh
5567224|NCT01017653|Pro00015447|pro00015447
5567225|NCT01017627|ESRD|esrd
5739404|NCT00360087|SCD|scd
5567226|NCT01017627|Anemia|anemia
5567227|NCT01017627|Hospitalizations|hospitalizations
5567228|NCT01017627|Mortality|mortality
5567229|NCT01017614|Inflammatory Bowel Disease|inflammatory bowel disease
5567230|NCT01017614|Iron deficiency|iron deficiency
5567231|NCT01017614|Iron deficiency anaemia|iron deficiency anaemia
5567232|NCT01017614|Anaemia|anaemia
5567233|NCT01017601|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5567234|NCT01017588|lumbar support|lumbar support
5567235|NCT01017588|rubber tapper|rubber tapper
5567236|NCT01017562|To clarify the 18F-fluoride uptake patterns associated with aseptic or septic loosening|to clarify the 18f-fluoride uptake patterns associated with aseptic or septic loosening
5567237|NCT01017549|Stage I|stage i
5567238|NCT01017549|Stage II|stage ii
5567239|NCT01017549|Breast|breast
5567240|NCT01017549|Cancer|cancer
5567241|NCT01017536|HIV|hiv
5567242|NCT01017536|Tuberculosis|tuberculosis
5567243|NCT01017536|Vaccine|vaccine
5567244|NCT01017523|diabetes|diabetes
5567245|NCT01017523|relationship|relationship
5567246|NCT01017523|social support|social support
5567247|NCT01017523|telemedicine|telemedicine
5567248|NCT01017497|Brain Metastases|brain metastases
5567249|NCT01017484|blood pressure|blood pressure
5567250|NCT01017484|DASH diet|dash diet
5567251|NCT01017484|hypertension|hypertension
5567252|NCT01017471|carpal tunnel syndrome|carpal tunnel syndrome
5567253|NCT01017471|surgery|surgery
5567254|NCT01017471|PSU retractor|psu retractor
5567255|NCT01017471|carpal tunnel syndrome who failed to conservative treatment|carpal tunnel syndrome who failed to conservative treatment
5567256|NCT01017458|Healthy Adults|healthy adults
5567257|NCT01017445|osteoarthritis, exercise|osteoarthritis, exercise
5567258|NCT01017419|hearing aids|hearing aids
5567259|NCT01017419|counseling|counseling
5567260|NCT01017406|plantar fasciitis|plantar fasciitis
5567261|NCT01017406|heel cushion|heel cushion
5567262|NCT01017406|treatment|treatment
5567263|NCT01017393|preemptive epidural ketamine|preemptive epidural ketamine
5567264|NCT01017393|prevention of chronic post-thoracotomy pain|prevention of chronic post-thoracotomy pain
5567265|NCT01017380|preemptive analgesia|preemptive analgesia
5567266|NCT01017380|cruciate ligament|cruciate ligament
5567267|NCT01017367|RA|ra
5567268|NCT01017367|inflammatory joint disease|inflammatory joint disease
5567269|NCT01017354|vitamin D|vitamin d
5567270|NCT01017354|function|function
5567271|NCT01017354|falls|falls
5567272|NCT01017354|25-hydroxyvitamin D|25-hydroxyvitamin d
5567273|NCT01017354|disability|disability
5567274|NCT01017341|hip fracture|hip fracture
5567275|NCT01017341|back support|back support
5567276|NCT01017328|infants and children undergoing surgery with general anesthesia|infants and children undergoing surgery with general anesthesia
5567277|NCT01017315|baby talcum|baby talcum
5567278|NCT01017315|pruritus|pruritus
5567279|NCT01017315|cast|cast
5567280|NCT01017276|Hyperphosphatemia|hyperphosphatemia
5567281|NCT01017276|Peritoneal dialysis|peritoneal dialysis
5567282|NCT01017276|CKD|ckd
5567283|NCT01017276|ASP1585|asp1585
5567284|NCT01017263|ADHD|adhd
5567285|NCT01017263|Glucose Intolerance|glucose intolerance
5567286|NCT01017263|Obesity|obesity
5567287|NCT01017263|Vyvanse|vyvanse
5567288|NCT01017250|Recurrent|recurrent
5567291|NCT01017237|Dexmedetomidine amnesia|dexmedetomidine amnesia
5567293|NCT01017211|Electromyography|electromyography
5567294|NCT01017211|Acupuncture|acupuncture
5567295|NCT01017211|Randomized controlled trial|randomized controlled trial
5567296|NCT01017211|Rehabilitation|rehabilitation
5567297|NCT01017159|Polyradiculoneuropathy, Chronic Inflammatory Demyelinating|polyradiculoneuropathy, chronic inflammatory demyelinating
5567298|NCT01017159|Subcutaneous immunoglobulin|subcutaneous immunoglobulin
5567300|NCT01017120|Acne|acne
5567301|NCT01017107|acute pancreatitis|acute pancreatitis
5567302|NCT01017107|treatment|treatment
5567303|NCT01017107|organ failure|organ failure
5567304|NCT01017107|activated protein c|activated protein c
5567305|NCT01017094|Pin-site infection|pin-site infection
5567306|NCT01017094|silversulfadiazine|silversulfadiazine
5567307|NCT01017094|open fracture|open fracture
5567308|NCT01017094|open tibial fracture underwent external fixator|open tibial fracture underwent external fixator
5567309|NCT01017081|physiotherapy|physiotherapy
5567310|NCT01017081|children|children
5567311|NCT01017081|clinical trial|clinical trial
5567312|NCT01017068|GLAUCOMA|glaucoma
5567313|NCT01017042|healthy|healthy
5567314|NCT01017042|blood levels|blood levels
5567315|NCT01017003|healthy|healthy
5567316|NCT01017003|pharmacokinetics|pharmacokinetics
5567317|NCT01016990|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5567318|NCT01016990|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5567319|NCT01016990|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5567320|NCT01016990|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5567321|NCT01016990|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5567322|NCT01016990|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5567323|NCT01016990|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5567324|NCT01016990|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5567325|NCT01016990|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5567326|NCT01016990|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5567327|NCT01016990|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5567328|NCT01016990|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5567329|NCT01016990|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5567330|NCT01016990|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5567331|NCT01016990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5567332|NCT01016990|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5567333|NCT01016990|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5567334|NCT01016990|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5567335|NCT01016990|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5567336|NCT01016990|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5567337|NCT01016990|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5567338|NCT01016990|Waldenström macroglobulinemia|waldenström macroglobulinemia
5567339|NCT01016964|Androgenetic Alopecia|androgenetic alopecia
5567340|NCT01016964|Hair Loss|hair loss
5567341|NCT01016964|Female Pattern Baldness|female pattern baldness
5567342|NCT01016951|Phase I|phase i
5567343|NCT01016951|Safety study|safety study
5567344|NCT01016951|AZD9164|azd9164
5720370|NCT00430313|CINV|cinv
5567345|NCT01016925|femoral perineural catheter|femoral perineural catheter
5567346|NCT01016925|tunnelization|tunnelization
5567347|NCT01016925|complication|complication
5567348|NCT01016925|colonization|colonization
5567349|NCT01016925|infection|infection
5567350|NCT01016899|Electronic|electronic
5567351|NCT01016899|Brachytherapy|brachytherapy
5567352|NCT01016899|Nonmelanoma|nonmelanoma
5567353|NCT01016899|cancer|cancer
5567354|NCT01016886|trastuzumab|trastuzumab
5567355|NCT01016886|cardiac MRI|cardiac mri
5567356|NCT01016886|beta-blocker|beta-blocker
5567357|NCT01016886|biomarkers|biomarkers
5567358|NCT01016886|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5567359|NCT01016886|cardiotoxicity|cardiotoxicity
5567360|NCT01016886|HER2 positive|her2 positive
5567362|NCT01016873|Oraya Therapeutics, Inc.|oraya therapeutics, inc.
5567363|NCT01016873|low voltage stereotactic radiotherapy|low voltage stereotactic radiotherapy
5567364|NCT01016873|radiotherapy|radiotherapy
5567365|NCT01016873|IRay|iray
5567366|NCT01016873|Ranibizumab|ranibizumab
5567367|NCT01016873|Lucentis|lucentis
5567368|NCT01016873|AMD|amd
5567369|NCT01016873|Macular Degeneration|macular degeneration
5567370|NCT01016873|xray|xray
5567371|NCT01016873|radiation|radiation
5567372|NCT01016873|x ray|x ray
5567373|NCT01016873|external beam radiation|external beam radiation
5567374|NCT01016873|radiosurgery|radiosurgery
5561384|NCT01042145|Primary Care|primary care
5567376|NCT01016834|migraine|migraine
5567377|NCT01016834|treatment satisfaction|treatment satisfaction
5567378|NCT01016821|Oxycodone|oxycodone
5567379|NCT01016821|Labour pain|labour pain
5567380|NCT01016821|Pregnancy|pregnancy
5567381|NCT01016821|Pregnant women|pregnant women
5567382|NCT01016808|Bunionectomy|bunionectomy
5567383|NCT01016808|Opioids|opioids
5567384|NCT01016795|SCF|scf
5567385|NCT01016795|Priming|priming
5567386|NCT01016795|Mobilization|mobilization
5567387|NCT01016795|Lymphoma|lymphoma
5567393|NCT01016769|Temsirolimus|temsirolimus
5567394|NCT01016769|Head and Neck|head and neck
5567395|NCT01016769|recurrent and/or metastatic|recurrent and/or metastatic
5567396|NCT01016769|09-131|09-131
5567397|NCT01016756|PHACE syndrome|phace syndrome
5567398|NCT01016756|Hemangioma|hemangioma
5567399|NCT01016756|Coarctation of aorta|coarctation of aorta
5567400|NCT01016756|Dandy Walker|dandy walker
5567401|NCT01016756|Brain malformation|brain malformation
5567402|NCT01016756|Eye anomaly|eye anomaly
5567403|NCT01016756|Sternal malformation|sternal malformation
5567404|NCT01016756|Genetic analysis|genetic analysis
5567405|NCT01016756|Cerebral artery anomaly|cerebral artery anomaly
5567406|NCT01016743|parkinson|parkinson
5567407|NCT01016743|rTMS|rtms
5567408|NCT01016717|clopidogrel|clopidogrel
5567409|NCT01016717|platelet function|platelet function
5567410|NCT01016717|omeprazole|omeprazole
5567411|NCT01016717|pantoprazole|pantoprazole
5567412|NCT01016717|coronary disease|coronary disease
5567413|NCT01016665|Breast cancer|breast cancer
5739654|NCT00359164|AMD|amd
5567414|NCT01016665|Short Term|short term
5567415|NCT01016665|Homontherapy|homontherapy
5567416|NCT01016665|aromatase inhibitor|aromatase inhibitor
5567417|NCT01016665|Short term hormonetherapy in breast cancer|short term hormonetherapy in breast cancer
5567418|NCT01016639|Stomach cancer|stomach cancer
5567419|NCT01016639|Gall bladder cancer|gall bladder cancer
5567420|NCT01016639|Bile ductus cancer|bile ductus cancer
5567421|NCT01016639|Pancreas cancer|pancreas cancer
5567422|NCT01016639|Colorectal cancer|colorectal cancer
5567423|NCT01016639|Chemo radiotherapy|chemo radiotherapy
5567424|NCT01016639|Phase I-II|phase i-ii
5567425|NCT01016639|Oxaliplatin|oxaliplatin
5567426|NCT01016639|Capecitabine|capecitabine
5567427|NCT01016639|Response|response
5567428|NCT01016626|Pharmacokinetics|pharmacokinetics
5567429|NCT01016626|Healthy volunteers|healthy volunteers
5567430|NCT01016626|Mycophenolate Mofetil|mycophenolate mofetil
5567431|NCT01016613|chronic kidney disease|chronic kidney disease
5567432|NCT01016613|glomerulonephritis|glomerulonephritis
5567433|NCT01016613|proteinuria|proteinuria
5567434|NCT01016613|nephrotic syndrome|nephrotic syndrome
5567435|NCT01016613|nephropathy|nephropathy
5567437|NCT01016587|symptoms|symptoms
5567438|NCT01016587|dyspnea|dyspnea
5567439|NCT01016587|pain|pain
5567440|NCT01016587|fatigue|fatigue
5567441|NCT01016587|anxiety|anxiety
5567442|NCT01016587|depression|depression
5567443|NCT01016587|sleeplessness|sleeplessness
5567444|NCT01016587|genetic markers|genetic markers
5567445|NCT01016587|immune markers|immune markers
5567446|NCT01016587|COPD|copd
5567447|NCT01016587|Quality of Life|quality of life
5567448|NCT01016548|Lymphoma|lymphoma
5567449|NCT01016548|Multiple myeloma|multiple myeloma
5567450|NCT01016548|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5567451|NCT01016548|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5567452|NCT01016548|Influenza Vaccines|influenza vaccines
5567453|NCT01016548|Bone Marrow Transplantation|bone marrow transplantation
5567454|NCT01016535|Family Health Program|family health program
5567455|NCT01016535|Hygiene|hygiene
5567456|NCT01016535|Child Health|child health
5567457|NCT01016522|ALS|als
5567458|NCT01016522|Ketogenic Diet|ketogenic diet
5567459|NCT01016509|restenosis|restenosis
5567460|NCT01016509|insulin|insulin
5567461|NCT01016509|hyperglycemia|hyperglycemia
5567462|NCT01016496|Cerebral Palsy|cerebral palsy
5567463|NCT01016496|Mirror neurons|mirror neurons
5567464|NCT01016496|hemiplegia|hemiplegia
5567465|NCT01016496|action observation therapy|action observation therapy
5567466|NCT01016496|children affected by hemiplegia as a consequence of Cerebral Palsy|children affected by hemiplegia as a consequence of cerebral palsy
5567467|NCT01016483|MEK inhibitor|mek inhibitor
5567468|NCT01016483|cancer|cancer
5567469|NCT01016483|pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5567470|NCT01016483|metastatic|metastatic
5567471|NCT01016483|chemo-naive|chemo-naive
5567472|NCT01016483|phase II|phase ii
5567473|NCT01016457|Diabetes Mellitus|diabetes mellitus
5567474|NCT01016444|asthma|asthma
5567475|NCT01016444|albuterol|albuterol
5567476|NCT01016444|B2AR receptors|b2ar receptors
5567477|NCT01016444|Acute asthma responsive and unresponsive to albuterol|acute asthma responsive and unresponsive to albuterol
5567478|NCT01016431|cardiac pacing|cardiac pacing
5567479|NCT01016431|heart failure|heart failure
5567480|NCT01016431|oxygen consumption|oxygen consumption
5567481|NCT01016431|ventricular dysfunction|ventricular dysfunction
5567482|NCT01016431|left, exercise tolerance|left, exercise tolerance
5567483|NCT01016431|chronotropic incompetence|chronotropic incompetence
5567484|NCT01016431|pacemaker programming|pacemaker programming
5567485|NCT01016418|NASH|nash
5567486|NCT01016418|fatty liver disease|fatty liver disease
5567488|NCT01016405|Dry eye|dry eye
5567489|NCT01016405|incidence and severity|incidence and severity
5567490|NCT01016405|cataract surgery|cataract surgery
5567491|NCT01016392|Observational post-authorization safety study on Kuvan®.|observational post-authorization safety study on kuvan®.
5567492|NCT01016379|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5567493|NCT01016379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5567494|NCT01016366|Friedreich's Ataxia|friedreich's ataxia
5567495|NCT01016366|FRDA|frda
5567496|NCT01016366|Neurodegenerative|neurodegenerative
5567497|NCT01016366|Erythropoietin|erythropoietin
5567498|NCT01016366|Carbamylated|carbamylated
5567499|NCT01016366|Neuroprotection|neuroprotection
5567500|NCT01016366|Frataxin|frataxin
5567501|NCT01016353|ABThera|abthera
5567502|NCT01016353|Barker's Vacuum Packing Technique|barker's vacuum packing technique
5567503|NCT01016340|Male Oligoasthenospermia|male oligoasthenospermia
5567505|NCT01016327|Phase I study|phase i study
5567506|NCT01016327|Advanced Solid Tumors|advanced solid tumors
5567507|NCT01016327|Cdc7 kinase inhibitor|cdc7 kinase inhibitor
5567508|NCT01016288|EUS-FNA|eus-fna
5567509|NCT01016288|22 Gauge Needle|22 gauge needle
5567510|NCT01016288|25 Gauge Needle|25 gauge needle
5567511|NCT01016275|To obtain the first iliac long-term results for a patient cohort treated with nitinol stents only|to obtain the first iliac long-term results for a patient cohort treated with nitinol stents only
5567512|NCT01016262|Ulcerative proctitis|ulcerative proctitis
5567513|NCT01016262|Proctocolitis|proctocolitis
5567514|NCT01016262|Inflammatory Bowel Disease|inflammatory bowel disease
5567515|NCT01016262|Gastrointestinal Diseases|gastrointestinal diseases
5567516|NCT01016262|Colonic Diseases|colonic diseases
5567517|NCT01016262|Mesalamine|mesalamine
5567518|NCT01016262|5-ASA|5-asa
5567519|NCT01016249|Bronchiolitis, Viral|bronchiolitis, viral
5567520|NCT01016249|An acute inflammation of the upper RESPIRATORY TRACT|an acute inflammation of the upper respiratory tract
5567521|NCT01016223|Eosinophilic esophagitis|eosinophilic esophagitis
5567522|NCT01016223|Beclomethasone|beclomethasone
5567523|NCT01016223|Ultrasensitive CRP|ultrasensitive crp
5567524|NCT01016210|pregnancy|pregnancy
5567525|NCT01016210|IVF|ivf
5567526|NCT01016197|Soft tissue mallet finger|soft tissue mallet finger
5567527|NCT01016184|Quality of life|quality of life
5567528|NCT01016158|Umbilical cord serum|umbilical cord serum
5567529|NCT01016158|Recurrent corneal erosion|recurrent corneal erosion
5567530|NCT01016145|Schizophrenia|schizophrenia
5567531|NCT01016145|predictors of response|predictors of response
5567532|NCT01016145|antipsychotics|antipsychotics
5567533|NCT01016145|18-45 years old|18-45 years old
5567534|NCT01016145|non-refractory|non-refractory
5567535|NCT01016106|eczema|eczema
5567536|NCT01016106|atopic dermatitis|atopic dermatitis
5567537|NCT01016106|dry skin|dry skin
5567538|NCT01016106|ichthyosis vulgaris|ichthyosis vulgaris
5567539|NCT01016093|Thalassemia|thalassemia
5567540|NCT01016093|BMT|bmt
5567541|NCT01016093|HSCT|hsct
5567542|NCT01016080|glutathione|glutathione
5567543|NCT01016080|melanin|melanin
5567544|NCT01016080|whitening|whitening
5567545|NCT01016080|UV spots|uv spots
5567546|NCT01016080|skin pigment|skin pigment
5567547|NCT01016067|Tibia|tibia
5567548|NCT01016067|Tibial|tibial
5567549|NCT01016067|Fracture|fracture
5567550|NCT01016067|Nonunion|nonunion
5567551|NCT01016067|delayed|delayed
5567552|NCT01016067|healing|healing
5567553|NCT01016067|iliac|iliac
5567554|NCT01016067|crest|crest
5567555|NCT01016067|autograft|autograft
5567556|NCT01016067|INFUSE|infuse
5567557|NCT01016067|MASTERGRAFT|mastergraft
5567558|NCT01016067|Fixation|fixation
5567559|NCT01016067|Internal|internal
5567560|NCT01016054|Clinical Trial, Phase1|clinical trial, phase1
5567562|NCT01016054|pharmacokinetics|pharmacokinetics
5567564|NCT01016054|Ovarian|ovarian
5567565|NCT01016041|drug-eluting stent|drug-eluting stent
5567566|NCT01016041|stable angina|stable angina
5567567|NCT01016041|ACS|acs
5567568|NCT01016041|MACE|mace
5567569|NCT01016041|safety|safety
5567570|NCT01016041|stent thrombosis|stent thrombosis
5567571|NCT01016028|Cancer|cancer
5567572|NCT01016028|Colorectum Cancer|colorectum cancer
5567573|NCT01016028|Colorectal disease|colorectal disease
5567574|NCT01016028|neuropathic symptom tool|neuropathic symptom tool
5567575|NCT01016028|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5567576|NCT01016028|CIPN|cipn
5567577|NCT01016028|Pain|pain
5567578|NCT01016028|Quantitative Sensory Testing|quantitative sensory testing
5567579|NCT01016028|QST|qst
5567580|NCT01016028|symptom measurement tools|symptom measurement tools
5567581|NCT01016028|platinum agents|platinum agents
5567582|NCT01016028|cisplatin|cisplatin
5567583|NCT01016028|oxaliplatin|oxaliplatin
5567584|NCT01016028|taxanes|taxanes
5567585|NCT01016028|bortezomib|bortezomib
5567586|NCT01015989|HIV treatment|hiv treatment
5567587|NCT01015989|ART adherence|art adherence
5567588|NCT01015989|Using new technology to improve adherence|using new technology to improve adherence
5567589|NCT01015989|CARE+|care+
5567590|NCT01015989|HIV-1 viral loads|hiv-1 viral loads
5567591|NCT01015976|Gastric Bypass|gastric bypass
5567592|NCT01015976|Sertraline|sertraline
5567593|NCT01015976|Pharmacokinetics|pharmacokinetics
5567594|NCT01015963|recurrent breast cancer|recurrent breast cancer
5567595|NCT01015963|stage IIIA breast cancer|stage iiia breast cancer
5567596|NCT01015963|stage IIIB breast cancer|stage iiib breast cancer
5567597|NCT01015963|stage IIIC breast cancer|stage iiic breast cancer
5567598|NCT01015963|stage IV breast cancer|stage iv breast cancer
5567599|NCT01015963|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5567600|NCT01015963|recurrent small cell lung cancer|recurrent small cell lung cancer
5567601|NCT01015963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5567602|NCT01015963|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5567603|NCT01015963|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5567604|NCT01015963|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5567605|NCT01015963|stage IV bladder cancer|stage iv bladder cancer
5567606|NCT01015963|recurrent bladder cancer|recurrent bladder cancer
5567607|NCT01015963|stage III bladder cancer|stage iii bladder cancer
5739927|NCT00358202|nhap|nhap
5567608|NCT01015963|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5567609|NCT01015963|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5567610|NCT01015963|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5567611|NCT01015963|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5567612|NCT01015963|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5567613|NCT01015963|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5567614|NCT01015963|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5567615|NCT01015963|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5567616|NCT01015963|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5567617|NCT01015963|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5567618|NCT01015963|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5567619|NCT01015963|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5567620|NCT01015963|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5567621|NCT01015963|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5567622|NCT01015963|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5567623|NCT01015963|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5567624|NCT01015963|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5567625|NCT01015963|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5567626|NCT01015963|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5567627|NCT01015963|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5567628|NCT01015963|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5567629|NCT01015963|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5567630|NCT01015963|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5567631|NCT01015963|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5567632|NCT01015963|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5567633|NCT01015963|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5567634|NCT01015963|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5567635|NCT01015963|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5567636|NCT01015963|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5567637|NCT01015963|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5567638|NCT01015963|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5567639|NCT01015963|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5567640|NCT01015963|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5567641|NCT01015963|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5567642|NCT01015963|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5567643|NCT01015963|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5567644|NCT01015963|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5567645|NCT01015963|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5567646|NCT01015963|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5798729|NCT00111254|wrinkled skin|wrinkled skin
5798730|NCT00111241|bone fracture|bone fracture
5549734|NCT01088152|Sweden|sweden
5790033|NCT00146081|social support|social support
5567647|NCT01015963|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5567648|NCT01015963|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5567649|NCT01015963|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5567650|NCT01015963|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5567651|NCT01015963|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5567652|NCT01015963|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5567653|NCT01015963|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5567654|NCT01015963|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5567655|NCT01015963|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5567656|NCT01015963|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5567657|NCT01015963|recurrent salivary gland cancer|recurrent salivary gland cancer
5567658|NCT01015963|stage III salivary gland cancer|stage iii salivary gland cancer
5567659|NCT01015963|stage IV salivary gland cancer|stage iv salivary gland cancer
5567660|NCT01015963|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5567763|NCT01015586|Bipolar Disorder|bipolar disorder
5567661|NCT01015963|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5567662|NCT01015963|tongue cancer|tongue cancer
5567663|NCT01015937|diabetes|diabetes
5567664|NCT01015937|nephropathy|nephropathy
5567665|NCT01015937|turmeric|turmeric
5567666|NCT01015937|serum IL8|serum il8
5567667|NCT01015937|serum TGFb|serum tgfb
5567668|NCT01015937|serumINF|seruminf
5567669|NCT01015937|urinary IL8|urinary il8
5567670|NCT01015937|urine TGFb|urine tgfb
5567671|NCT01015924|clavicle|clavicle
5567673|NCT01015924|Plate osteosynthesis|plate osteosynthesis
5567674|NCT01015924|displaced|displaced
5567675|NCT01015924|ESIN|esin
5567676|NCT01015924|displaced midshaft clavicular fractures|displaced midshaft clavicular fractures
5567677|NCT01015911|Antibodies, Monoclonal|antibodies, monoclonal
5567678|NCT01015911|Antibody-Drug Conjugate|antibody-drug conjugate
5567679|NCT01015911|Antigens, CD70|antigens, cd70
5567680|NCT01015911|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5567681|NCT01015911|Carcinoma, Renal Cell|carcinoma, renal cell
5567682|NCT01015911|Immunotherapy|immunotherapy
5567683|NCT01015911|Drug Therapy|drug therapy
5567684|NCT01015911|monomethylauristatin F|monomethylauristatin f
5567685|NCT01015898|basal cell carcinoma|basal cell carcinoma
5567686|NCT01015898|photodynamic therapy|photodynamic therapy
5567687|NCT01015898|photo chemotherapy|photo chemotherapy
5567688|NCT01015898|basal cell epithelioma|basal cell epithelioma
5567689|NCT01015872|sleep apnea syndrome|sleep apnea syndrome
5567690|NCT01015872|CPAP|cpap
5552368|NCT01077492|mediastinal lymph nodes|mediastinal lymph nodes
5567691|NCT01015872|prostanoids|prostanoids
5567692|NCT01015859|AV conduction|av conduction
5567693|NCT01015859|Atrial fibrillation|atrial fibrillation
5567694|NCT01015846|Core|core
5567695|NCT01015846|Redcord|redcord
5567696|NCT01015846|RUSI|rusi
5567697|NCT01015846|low back|low back
5567698|NCT01015820|Pancreatic Cancer|pancreatic cancer
5567699|NCT01015820|Duodenum|duodenum
5567700|NCT01015820|Spectroscopy|spectroscopy
5567701|NCT01015820|Fiberoptic probe|fiberoptic probe
5567702|NCT01015820|4D-ELF|4d-elf
5567703|NCT01015807|postoperative|postoperative
5567704|NCT01015807|hyperalgesia|hyperalgesia
5567705|NCT01015807|pain|pain
5567706|NCT01015807|transversus abdominis plane block|transversus abdominis plane block
5567707|NCT01015807|TAP block|tap block
5567708|NCT01015807|cesarean section|cesarean section
5567709|NCT01015781|Tinnitus|tinnitus
5567710|NCT01015781|Counseling|counseling
5567711|NCT01015781|Education|education
5567712|NCT01015781|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5567713|NCT01015781|Triage|triage
5567714|NCT01015781|Evaluation studies|evaluation studies
5567715|NCT01015781|Quality of health care|quality of health care
5567716|NCT01015768|corneal staining|corneal staining
5567717|NCT01015768|barrier function|barrier function
5567718|NCT01015768|contact lenses|contact lenses
5567719|NCT01015768|contact lens care solutions|contact lens care solutions
5567720|NCT01015768|contact lens material and care solution bioincompatibility|contact lens material and care solution bioincompatibility
5567721|NCT01015755|thirst palliation and intensive care unit|thirst palliation and intensive care unit
5567722|NCT01015755|thirst intensity and distress|thirst intensity and distress
5567723|NCT01015755|predictors of thirst|predictors of thirst
5567725|NCT01015742|ALL|all
5567726|NCT01015742|CML|cml
5567727|NCT01015729|Bioequivalence|bioequivalence
5567728|NCT01015729|ASA|asa
5567729|NCT01015729|Esomeprazole|esomeprazole
5567730|NCT01015729|peptic ulcer disease|peptic ulcer disease
5567731|NCT01015729|pH measurements|ph measurements
5567732|NCT01015716|Weight loss|weight loss
5567733|NCT01015716|Physical activity|physical activity
5567734|NCT01015716|Cognitive Behavioral Training|cognitive behavioral training
5567735|NCT01015703|Vaccine, hypertension|vaccine, hypertension
5567736|NCT01015690|unexplained infertility|unexplained infertility
5567737|NCT01015690|hCG|hcg
5567738|NCT01015690|early pregnancy loss|early pregnancy loss
5567739|NCT01015651|nociception, intraoperative, baroreflex|nociception, intraoperative, baroreflex
5567740|NCT01015638|Healthy volunteers|healthy volunteers
5567741|NCT01015625|breast cancer|breast cancer
5567742|NCT01015625|ABCSG|abcsg
5567743|NCT01015625|POSYTIVE|posytive
5567744|NCT01015625|growth factor|growth factor
5567745|NCT01015625|median survival|median survival
5567746|NCT01015625|surgery on demand|surgery on demand
5567747|NCT01015625|surgical therapy|surgical therapy
5567748|NCT01015625|blood specimen|blood specimen
5567749|NCT01015625|tissue specimen|tissue specimen
5567750|NCT01015625|VEGF|vegf
5567751|NCT01015625|TGF|tgf
5567752|NCT01015625|circulating tumor cells|circulating tumor cells
5567753|NCT01015625|stem cells|stem cells
5567754|NCT01015612|Aortic Valve Stenosis|aortic valve stenosis
5567755|NCT01015612|Aortic Valve Insufficiency|aortic valve insufficiency
5567756|NCT01015599|Obesity prevention|obesity prevention
5567757|NCT01015599|after-school|after-school
5567758|NCT01015599|physical activity|physical activity
5567759|NCT01015599|fruit|fruit
5567760|NCT01015599|vegetable|vegetable
5567761|NCT01015599|children|children
5567762|NCT01015586|Alcohol|alcohol
5567764|NCT01015586|Manic depression|manic depression
5567765|NCT01015586|Addiction|addiction
5567766|NCT01015586|Alcoholism|alcoholism
5567767|NCT01015586|Cognitive impairment|cognitive impairment
5567768|NCT01015586|Executive function|executive function
5567769|NCT01015586|Anxiety|anxiety
5567770|NCT01015586|Depression|depression
5567771|NCT01015586|Mania|mania
5567772|NCT01015586|Affective disorder|affective disorder
5567773|NCT01015586|Psychosis|psychosis
5567774|NCT01015586|Carbohydrate deficient transferrin|carbohydrate deficient transferrin
5567775|NCT01015586|Gammaglutamyltransferase|gammaglutamyltransferase
5567776|NCT01015586|California Verbal Learning Test|california verbal learning test
5567777|NCT01015586|Montgomery Asberg Depression Rating Scale|montgomery asberg depression rating scale
5567778|NCT01015586|Young Mania Rating Scale|young mania rating scale
5567779|NCT01015586|Timeline Follow Back|timeline follow back
5567780|NCT01015560|bone metastases|bone metastases
5567781|NCT01015560|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5567782|NCT01015547|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5567783|NCT01015547|polyarthritis|polyarthritis
5567784|NCT01015547|combination therapy|combination therapy
5567785|NCT01015547|biologic agents|biologic agents
5567786|NCT01015547|TNF antagonists|tnf antagonists
5567787|NCT01015547|infliximab|infliximab
5567788|NCT01015534|Brain metastases|brain metastases
5567789|NCT01015534|Temozolomide|temozolomide
5567790|NCT01015534|Whole-brain radiotherapy|whole-brain radiotherapy
5567791|NCT01015534|Phase II trial|phase ii trial
5567792|NCT01015521|breast cancer|breast cancer
5567793|NCT01015508|Weight loss and maintenance|weight loss and maintenance
5567794|NCT01015508|body composition|body composition
5567795|NCT01015508|energy expenditure|energy expenditure
5567796|NCT01015508|adipogenic capacity|adipogenic capacity
5567797|NCT01015508|physical activity|physical activity
5567798|NCT01015495|angioid streaks|angioid streaks
5567800|NCT01015495|intra vitreal ranibizumab|intra vitreal ranibizumab
5567801|NCT01015482|Sunburn|sunburn
5567802|NCT01015482|Remifentanil|remifentanil
5567803|NCT01015482|Hyperalgesia|hyperalgesia
5567804|NCT01015469|bariatric|bariatric
5567805|NCT01015469|surgery|surgery
5567806|NCT01015469|obesity|obesity
5567807|NCT01015469|Roux-en-Y|roux-en-y
5567808|NCT01015469|gastric|gastric
5567809|NCT01015469|medical device|medical device
5567810|NCT01015469|bypass|bypass
5567811|NCT01015469|adiposity|adiposity
5567812|NCT01015469|GaBP-Ring|gabp-ring
5567813|NCT01015469|BMI|bmi
5567814|NCT01015469|banded|banded
5567815|NCT01015469|laparoscopic|laparoscopic
5567816|NCT01015456|lupus nephritis|lupus nephritis
5567817|NCT01015456|mycophenolate sodium|mycophenolate sodium
5567818|NCT01015456|cyclophosphamide|cyclophosphamide
5567819|NCT01015443|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5567820|NCT01015443|Tecemotide|tecemotide
5567821|NCT01015443|L-BLP25|l-blp25
5567822|NCT01015443|Cyclophosphamide|cyclophosphamide
5567823|NCT01015443|placebo controlled|placebo controlled
5567824|NCT01015443|Non-Small Cell Lung Cancer|non-small cell lung cancer
5567825|NCT01015417|Acute lithiasic cholecystitis|acute lithiasic cholecystitis
5567826|NCT01015417|Cholecystectomy|cholecystectomy
5567827|NCT01015417|Postoperative antibiotherapy|postoperative antibiotherapy
5567828|NCT01015417|Surgical site infection|surgical site infection
5567829|NCT01015417|Remote surgical site infection|remote surgical site infection
5567830|NCT01015404|Trafermin|trafermin
5567831|NCT01015404|Periodontitis|periodontitis
5567833|NCT01015391|AZA|aza
5567834|NCT01015391|remission|remission
5567835|NCT01015391|Crohn's disease|crohn's disease
5567836|NCT01015378|Recurrent sigmoid diverticulitis|recurrent sigmoid diverticulitis
5567837|NCT01015378|diverticulitis|diverticulitis
5567838|NCT01015378|Colon|colon
5567839|NCT01015378|sigmoid|sigmoid
5567840|NCT01015378|recurrence|recurrence
5567841|NCT01015365|Chronic infected hip arthroplasty|chronic infected hip arthroplasty
5567842|NCT01015365|Fast-track|fast-track
5567843|NCT01015365|One-stage cementless revision|one-stage cementless revision
5567844|NCT01015352|Myelodysplastic Syndromes|myelodysplastic syndromes
5567845|NCT01015326|EGFRI|egfri
5567846|NCT01015326|HRQL|hrql
5567847|NCT01015326|Quality of Life|quality of life
5567848|NCT01015326|Development of a standardized HRQL instrument for anti-EGFR therapy induced|development of a standardized hrql instrument for anti-egfr therapy induced
5567849|NCT01015313|sodium, hypertension, volume overload|sodium, hypertension, volume overload
5567850|NCT01015300|Hemangioblastoma|hemangioblastoma
5567851|NCT01015300|Von Hippel Lindau|von hippel lindau
5567852|NCT01015300|VHL|vhl
5567853|NCT01015300|lesion|lesion
5567854|NCT01015300|EGFR|egfr
5567855|NCT01015287|Acute Coronary Syndromes|acute coronary syndromes
5567856|NCT01015287|Heart Disease|heart disease
5567857|NCT01015287|Percutaneous Coronary Intervention|percutaneous coronary intervention
5567858|NCT01015287|P2Y12|p2y12
5567859|NCT01015287|NSTEMI|nstemi
5567861|NCT01015261|BMT|bmt
5567862|NCT01015261|Chemotherapy|chemotherapy
5567863|NCT01015261|Allogenic|allogenic
5567864|NCT01015248|CD 20 positive|cd 20 positive
5567865|NCT01015235|Ketorolac / therapeutic use|ketorolac / therapeutic use
5567866|NCT01015235|Analgesics. Non-narcotic / therapeutic use|analgesics. non-narcotic / therapeutic use
5567867|NCT01015235|Arthroplasty, replacement hip|arthroplasty, replacement hip
5567868|NCT01015235|Arthroplasty, replacement knee|arthroplasty, replacement knee
5567869|NCT01015235|Pain measurement / drug effect|pain measurement / drug effect
5567870|NCT01015235|Pain postoperative / drug therapy|pain postoperative / drug therapy
5567871|NCT01015222|Advanced Malignancies|advanced malignancies
5567872|NCT01015222|Metastatic cancer|metastatic cancer
5567873|NCT01015222|Bevacizumab|bevacizumab
5567874|NCT01015222|Avastin|avastin
5567875|NCT01015222|Dasatinib|dasatinib
5567876|NCT01015222|Sprycel|sprycel
5567877|NCT01015222|Paclitaxel|paclitaxel
5567878|NCT01015222|Taxol|taxol
5567879|NCT01015209|Dry eye syndromes|dry eye syndromes
5567880|NCT01015196|acute myeloid leukemia in first complete remission|acute myeloid leukemia in first complete remission
5567881|NCT01015183|Mucositis|mucositis
5567882|NCT01015183|Bone Marrow Transplantation|bone marrow transplantation
5567883|NCT01015183|BMT|bmt
5567884|NCT01015183|HSCT|hsct
5567885|NCT01015170|smoking cessation|smoking cessation
5567886|NCT01015170|nicotine addiction|nicotine addiction
5567887|NCT01015170|Zyban|zyban
5567888|NCT01015170|bupropion hydrochloride|bupropion hydrochloride
5567889|NCT01015157|Gastric bypass|gastric bypass
5567890|NCT01015157|staple line reinforcement|staple line reinforcement
5567891|NCT01015157|outcomes|outcomes
5567892|NCT01015157|per and postoperative blood loss|per and postoperative blood loss
5567893|NCT01015144|atorvastatin|atorvastatin
5567894|NCT01015144|dilated cardiomyopathy|dilated cardiomyopathy
5567895|NCT01015144|heart failure|heart failure
5567896|NCT01015144|inflammation|inflammation
5567897|NCT01015105|patients with hip fracture|patients with hip fracture
5567898|NCT01015092|HIV|hiv
5567899|NCT01015092|Cardiovascular|cardiovascular
5567900|NCT01015092|Coronary hear disease|coronary hear disease
5567902|NCT01015092|antiretroviral|antiretroviral
5567903|NCT01015079|Pap smear screening|pap smear screening
5567904|NCT01015066|drug dependence|drug dependence
5567905|NCT01015066|substance abuse|substance abuse
5567906|NCT01015066|substance use disorders|substance use disorders
5567907|NCT01015066|buprenorphine|buprenorphine
5567908|NCT01015066|naltrexone|naltrexone
5567909|NCT01015066|adolescents|adolescents
5567910|NCT01015053|postoperative pain|postoperative pain
5567911|NCT01015053|pediatric|pediatric
5567912|NCT01015053|umbilical hernia|umbilical hernia
5567913|NCT01015053|ropivacaine|ropivacaine
5567914|NCT01015053|rectus sheath block|rectus sheath block
5567915|NCT01015053|regional block|regional block
5567916|NCT01015053|ultrasound-guided regional block|ultrasound-guided regional block
5567917|NCT01015053|local infiltration|local infiltration
5567918|NCT01015053|ambulatory surgery|ambulatory surgery
5567919|NCT01015040|solifenacin succinate|solifenacin succinate
5567920|NCT01015040|VESIcare|vesicare
5567921|NCT01015040|Healthy Volunteers|healthy volunteers
5567922|NCT01015014|Gram negative|gram negative
5567923|NCT01015014|bacteria|bacteria
5567924|NCT01015014|infection|infection
5567925|NCT01015001|refractory schizophrenia|refractory schizophrenia
5567926|NCT01015001|rTMS|rtms
5567927|NCT01015001|auditory hallucinations|auditory hallucinations
5567928|NCT01014988|pandemic|pandemic
5567929|NCT01014988|seasonal influenza|seasonal influenza
5567930|NCT01014988|Influenza B virus|influenza b virus
5567931|NCT01014988|H1N1|h1n1
5567932|NCT01014988|zanamivir|zanamivir
5567933|NCT01014988|Influenza A virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5567934|NCT01014988|Relenza|relenza
5567935|NCT01014988|influenza|influenza
5567936|NCT01014988|neuraminidase inhibitor|neuraminidase inhibitor
5567937|NCT01014975|stroke|stroke
5567938|NCT01014975|plasmin|plasmin
5567939|NCT01014975|thrombus|thrombus
5567940|NCT01014975|ischemic|ischemic
5567941|NCT01014975|middle cerebral artery|middle cerebral artery
5567942|NCT01014975|thrombolysis|thrombolysis
5567943|NCT01014975|intra-arterial|intra-arterial
5567944|NCT01014975|fibrin|fibrin
5567945|NCT01014962|Pharmacokinetic|pharmacokinetic
5567946|NCT01014962|tolerability|tolerability
5567947|NCT01014962|multiple escalating doses|multiple escalating doses
5567948|NCT01014936|Phase 1|phase 1
5567949|NCT01014936|advanced solid tumors|advanced solid tumors
5567950|NCT01014936|refractory to standard therapy|refractory to standard therapy
5567951|NCT01014923|motor vehicle|motor vehicle
5567952|NCT01014923|accidents, traffic|accidents, traffic
5567953|NCT01014923|prevention and control|prevention and control
5567954|NCT01014910|Bronchiolitis|bronchiolitis
5567955|NCT01014910|Hypoxia|hypoxia
5567956|NCT01014910|Pulse|pulse
5567957|NCT01014910|Oximetry|oximetry
5567958|NCT01014910|Hospitalized|hospitalized
5567959|NCT01014897|stroke|stroke
5567960|NCT01014897|recovery|recovery
5567961|NCT01014897|tDCS|tdcs
5567962|NCT01014897|direct current|direct current
5567963|NCT01014897|electric stimulation|electric stimulation
5567964|NCT01014871|Forehead Wrinkles Toxin|forehead wrinkles toxin
5567965|NCT01014858|Parkinson's disease|parkinson's disease
5567966|NCT01014858|mild dementia|mild dementia
5567967|NCT01014858|donepezil|donepezil
5567968|NCT01014858|NIHR HTA|nihr hta
5567969|NCT01014845|hepatitis E|hepatitis e
5567970|NCT01014845|vaccine|vaccine
5567971|NCT01014845|efficacy|efficacy
5567972|NCT01014832|Diabetes, insulin.|diabetes, insulin.
5567973|NCT01014819|Dermacorder|dermacorder
5567974|NCT01014819|Electric field|electric field
5567975|NCT01014819|basal cell carcinoma|basal cell carcinoma
5567976|NCT01014819|Gorlin Syndrome|gorlin syndrome
5567977|NCT01014793|Acromegaly resistant|acromegaly resistant
5567978|NCT01014793|combined-treatment|combined-treatment
5567979|NCT01014793|dopamine agonist|dopamine agonist
5567980|NCT01014780|dry eye|dry eye
5567981|NCT01014780|tear film|tear film
5567982|NCT01014780|thickness|thickness
5567983|NCT01014780|artificial tears|artificial tears
5567984|NCT01014767|Choroid Plexus Tumors|choroid plexus tumors
5567985|NCT01014767|Brain Tumor|brain tumor
5567986|NCT01014767|Chemotherapy|chemotherapy
5567987|NCT01014767|Etoposide|etoposide
5567988|NCT01014767|Carboplatin|carboplatin
5567989|NCT01014767|Vincristine|vincristine
5567990|NCT01014767|Cyclophosphamide|cyclophosphamide
5567991|NCT01014767|Methotrexate|methotrexate
5567992|NCT01014767|Doxorubicin|doxorubicin
5567993|NCT01014767|Cisplatin|cisplatin
5567994|NCT01014767|Dactinomycin|dactinomycin
5567995|NCT01014767|temozolomide|temozolomide
5567996|NCT01014767|irinotecan|irinotecan
5567997|NCT01014767|Pediatrics|pediatrics
5567998|NCT01014741|Atrial Fibrillation|atrial fibrillation
5567999|NCT01014741|Catheter Ablation|catheter ablation
5568000|NCT01014741|Complex Fractionate Electrograms|complex fractionate electrograms
5568001|NCT01014715|Breast Cancer|breast cancer
5568002|NCT01014702|Cataract|cataract
5568003|NCT01014702|Capsulotomy|capsulotomy
5568004|NCT01014702|Capsulorrhexis|capsulorrhexis
5568005|NCT01014702|lens fragmentation|lens fragmentation
5568006|NCT01014702|phacoemulsification|phacoemulsification
5568007|NCT01014689|acne vulgaris|acne vulgaris
5568008|NCT01014676|Costs and Cost Analysis|costs and cost analysis
5568009|NCT01014663|Parkinson's disease|parkinson's disease
5568010|NCT01014663|exercise|exercise
5568011|NCT01014663|training program|training program
5568012|NCT01014663|rehabilitation|rehabilitation
5568013|NCT01014663|boxing|boxing
5568014|NCT01014650|glycine site partial agonist|glycine site partial agonist
5568015|NCT01014650|normal volunteers|normal volunteers
5568016|NCT01014650|safety in normal volunteers|safety in normal volunteers
5568017|NCT01014637|Dermatomycoses|dermatomycoses
5568018|NCT01014637|Infection|infection
5568019|NCT01014637|Mycoses|mycoses
5568020|NCT01014637|Nail diseases|nail diseases
5568021|NCT01014637|Ski diseases|ski diseases
5568022|NCT01014637|Skin diseases/infectious|skin diseases/infectious
5568023|NCT01014624|thienopyridine|thienopyridine
5568024|NCT01014624|pharmacologic action|pharmacologic action
5568025|NCT01014624|prasugrel|prasugrel
5568026|NCT01014624|clopidogrel|clopidogrel
5568027|NCT01014611|Heart failure|heart failure
5568028|NCT01014611|Skeletal muscle|skeletal muscle
5568029|NCT01014611|Calcium|calcium
5568030|NCT01014611|Ryanodine receptor|ryanodine receptor
5568031|NCT01014611|Mitochondria|mitochondria
5568032|NCT01014611|Exercise training|exercise training
5568034|NCT01014611|Healthy volunteers|healthy volunteers
5568035|NCT01014585|Milnacipran|milnacipran
5568036|NCT01014585|Pain|pain
5568037|NCT01014585|Durability of Effect|durability of effect
5568038|NCT01014585|Loss of Therapeutic Response|loss of therapeutic response
5568039|NCT01014585|Fatigue|fatigue
5568040|NCT01014585|Forest Research Institute|forest research institute
5568041|NCT01014585|Savella ®|savella ®
5568042|NCT01014572|Clinical Trials, Phase II|clinical trials, phase ii
5568043|NCT01014572|Exercise|exercise
5568044|NCT01014572|Exercise Tolerance|exercise tolerance
5568045|NCT01014572|Aging|aging
5568046|NCT01014559|Constipation|constipation
5568047|NCT01014559|Oxycodone|oxycodone
5568048|NCT01014559|Oxycodone hydrochloride|oxycodone hydrochloride
5568049|NCT01014559|Naloxone hydrochloride|naloxone hydrochloride
5568050|NCT01014559|Naloxone|naloxone
5568051|NCT01014533|Alcoholism|alcoholism
5568052|NCT01014533|Alcohol dependence|alcohol dependence
5568053|NCT01014533|Insomnia|insomnia
5568054|NCT01014533|Dim light melatonin onset|dim light melatonin onset
5568055|NCT01014533|Gabapentin|gabapentin
5568056|NCT01014520|Lumbar|lumbar
5568057|NCT01014520|Diskectomy|diskectomy
5568058|NCT01014520|Laminectomy|laminectomy
5568060|NCT01014481|tuberculosis|tuberculosis
5568061|NCT01014481|antiretroviral treatment|antiretroviral treatment
5568062|NCT01014481|timing|timing
5568063|NCT01014468|ranibizumab|ranibizumab
5740480|NCT00356291|HIV|hiv
5568064|NCT01014468|bevacizumab|bevacizumab
5568065|NCT01014468|AMD|amd
5568066|NCT01014468|Complications|complications
5568067|NCT01014468|Visual acuity|visual acuity
5568068|NCT01014468|OCt|oct
5568069|NCT01014468|Age Macular Degeneration|age macular degeneration
5568070|NCT01014455|surgery|surgery
5568071|NCT01014429|Phase I dose escalation study|phase i dose escalation study
5568072|NCT01014429|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5568162|NCT01014065|cardiac MRI|cardiac mri
5568076|NCT01014403|venous thromboembolism|venous thromboembolism
5568077|NCT01014403|enoxaparin|enoxaparin
5568078|NCT01014403|traumatic brain injury|traumatic brain injury
5568079|NCT01014403|Venous thromboembolism prophylaxis after traumatic brain injury|venous thromboembolism prophylaxis after traumatic brain injury
5568081|NCT01014364|Acute lung injury|acute lung injury
5568082|NCT01014364|Acute respiratory distress syndrome|acute respiratory distress syndrome
5568083|NCT01014364|corticosteroids|corticosteroids
5568084|NCT01014364|inflammation|inflammation
5568085|NCT01014351|Metastatic Melanoma|metastatic melanoma
5568086|NCT01014351|Everolimus|everolimus
5568087|NCT01014351|Paclitaxel|paclitaxel
5568088|NCT01014351|Carboplatin|carboplatin
5568089|NCT01014312|Depression|depression
5568090|NCT01014299|Intubation|intubation
5568091|NCT01014299|Hypoxemia|hypoxemia
5568092|NCT01014299|Mechanical ventilation|mechanical ventilation
5568093|NCT01014299|Recruitment maneuver|recruitment maneuver
5568094|NCT01014299|Acute lung injury|acute lung injury
5568095|NCT01014299|Bacterial translocation|bacterial translocation
5680316|NCT00578227|Human papillomavirus infection,|human papillomavirus infection,
5006015|NCT03959007|Aesthetic care|aesthetic care
5568096|NCT01014299|Hypoxemic ICU patients requiring invasive mechanical ventilation|hypoxemic icu patients requiring invasive mechanical ventilation
5568097|NCT01014273|Acute Coronary Syndrome|acute coronary syndrome
5568098|NCT01014273|PCI|pci
5568099|NCT01014273|Percutaneous Coronary Intervention|percutaneous coronary intervention
5568100|NCT01014273|Radial Access|radial access
5568101|NCT01014260|Inflammatory markers of cardiovascular disease|inflammatory markers of cardiovascular disease
5568102|NCT01014247|Moxifloxacin|moxifloxacin
5568103|NCT01014234|Immunosuppressive Agents|immunosuppressive agents
5568104|NCT01014234|Immune system regulation|immune system regulation
5568106|NCT01014234|Rapamycin|rapamycin
5568107|NCT01014234|Tolerance|tolerance
5568108|NCT01014221|acupuncture|acupuncture
5568109|NCT01014221|carpal tunnel syndrome|carpal tunnel syndrome
5568110|NCT01014221|CTS|cts
5568111|NCT01014221|steroid|steroid
5568112|NCT01014221|global symptom score (GSS)|global symptom score (gss)
5568113|NCT01014208|The All Ireland Cooperative Oncology Research Group|the all ireland cooperative oncology research group
5568114|NCT01014208|GELTAMO|geltamo
5568115|NCT01014208|National Cancer Research Institute Lymphoma Clinical Studies Group|national cancer research institute lymphoma clinical studies group
5568116|NCT01014208|Genmab|genmab
5568117|NCT01014208|ofatumumab|ofatumumab
5568118|NCT01014208|Japan Clinical Oncology Group|japan clinical oncology group
5568119|NCT01014208|Oncology|oncology
5568120|NCT01014208|Polish Lymphoma Research Group|polish lymphoma research group
5568121|NCT01014208|Salvage chemotherapy|salvage chemotherapy
5568122|NCT01014208|refractory|refractory
5568123|NCT01014208|HOVON|hovon
5568124|NCT01014208|DVD|dvd
5568125|NCT01014208|relapsed|relapsed
5568126|NCT01014208|safety|safety
5568127|NCT01014208|efficacy|efficacy
5568128|NCT01014208|DHAP|dhap
5568129|NCT01014208|rituximab|rituximab
5568130|NCT01014208|Autologous Stem Cell Transplant|autologous stem cell transplant
5562154|NCT01039311|Lung|lung
5568131|NCT01014208|Dutch-Belgian Cooperative Trial Group for Hematology-Oncology|dutch-belgian cooperative trial group for hematology-oncology
5568133|NCT01014208|Nordic Lymphoma Group|nordic lymphoma group
5568134|NCT01014195|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5568135|NCT01014195|Neurocognitive function|neurocognitive function
5568136|NCT01014195|ADHD|adhd
5568137|NCT01014195|brain imaging|brain imaging
5568138|NCT01014195|genetic polymorphisms|genetic polymorphisms
5798731|NCT00111241|cartilage|cartilage
5568139|NCT01014195|Psychopathology and neurocognitive Impairment in Leukemia Survivors|psychopathology and neurocognitive impairment in leukemia survivors
5568140|NCT01014182|Early PCI|early pci
5568141|NCT01014182|Myocardial Infarction|myocardial infarction
5568142|NCT01014182|Thrombolysis|thrombolysis
5568143|NCT01014182|Optimal revascularization therapy in STEMI patients|optimal revascularization therapy in stemi patients
5568144|NCT01014169|Health education|health education
5568145|NCT01014169|Sudden Infant Death|sudden infant death
5568146|NCT01014169|Breast Feeding|breast feeding
5568147|NCT01014169|Infant Equipment|infant equipment
5568148|NCT01014156|pulmonary embolism|pulmonary embolism
5568149|NCT01014156|vasoconstriction|vasoconstriction
5568150|NCT01014156|right ventricular dysfunction|right ventricular dysfunction
5568151|NCT01014156|epoprostenol|epoprostenol
5568152|NCT01014156|acute pulmonary embolism with right ventricular dysfunction|acute pulmonary embolism with right ventricular dysfunction
5568153|NCT01014130|Non Small Cell Lung Cancer|non small cell lung cancer
5568154|NCT01014130|Hypofractionated|hypofractionated
5904050|NCT00007813|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5568155|NCT01014130|Stereotactic Radiotherapy|stereotactic radiotherapy
5568156|NCT01014104|Ovarian hyper stimulation syndrome|ovarian hyper stimulation syndrome
5568157|NCT01014104|Methylprednisolone|methylprednisolone
5568158|NCT01014104|IVF|ivf
5568159|NCT01014091|influenza infection|influenza infection
5568160|NCT01014091|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5568161|NCT01014065|sunitinib|sunitinib
5568163|NCT01014065|maximal exercise testing|maximal exercise testing
5568164|NCT01014065|biomarkers|biomarkers
5568165|NCT01014065|pharmacokinetics|pharmacokinetics
5568166|NCT01014026|Mass Screening|mass screening
5568167|NCT01014026|Polymerase Chain Reaction|polymerase chain reaction
5568168|NCT01014026|Vaginal Smears|vaginal smears
5568169|NCT01013987|HIV-1|hiv-1
5568170|NCT01013987|triple class failure|triple class failure
5568171|NCT01013987|Maraviroc|maraviroc
5568172|NCT01013987|Raltegravir|raltegravir
5568173|NCT01013987|Darunavir/ritonavir|darunavir/ritonavir
5568174|NCT01013987|Maraviroc with raltegravir and darunavir/ritonavir|maraviroc with raltegravir and darunavir/ritonavir
5568175|NCT01013961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5568176|NCT01013961|small lymphocytic lymphoma|small lymphocytic lymphoma
5568177|NCT01013961|CLL|cll
5568178|NCT01013961|elderly|elderly
5568179|NCT01013961|low dose rituximab|low dose rituximab
5568180|NCT01013961|alemtuzumab|alemtuzumab
5568181|NCT01013961|monoclonal antibodies|monoclonal antibodies
5568182|NCT01013948|Spirometry|spirometry
5568183|NCT01013948|Bronchitis|bronchitis
5568184|NCT01013948|COPD|copd
5568185|NCT01013948|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5568186|NCT01013948|Emphysema|emphysema
5568187|NCT01013948|Chronic Bronchitis|chronic bronchitis
5568188|NCT01013935|HIV treatment|hiv treatment
5568189|NCT01013935|ART adherence|art adherence
5568190|NCT01013935|Using new technology to improve adherence|using new technology to improve adherence
5568191|NCT01013935|CARE+|care+
5568192|NCT01013935|HIV-1 viral loads|hiv-1 viral loads
5568193|NCT01013922|COPD|copd
5568194|NCT01013922|COPD-6|copd-6
5568195|NCT01013922|Spirometry|spirometry
5568197|NCT01013922|FEV|fev
5568198|NCT01013922|FEV1|fev1
5568199|NCT01013909|Bifonazole|bifonazole
5568200|NCT01013909|Terbinafine|terbinafine
5568201|NCT01013909|Reduced treatment duration|reduced treatment duration
5568202|NCT01013909|Efficacy|efficacy
5568203|NCT01013909|Safety|safety
5568204|NCT01013909|Athlete's foot|athlete's foot
5568205|NCT01013909|Moderate severity|moderate severity
5568206|NCT01013883|systolic dysfunction|systolic dysfunction
5568207|NCT01013883|diastolic dysfunction|diastolic dysfunction
5568208|NCT01013883|mortality|mortality
5568209|NCT01013883|treatment|treatment
5568210|NCT01013883|heart rate|heart rate
5568211|NCT01013870|mild traumatic brain injury|mild traumatic brain injury
5568212|NCT01013870|post-concussion syndrome|post-concussion syndrome
5568213|NCT01013870|acute stress disorder|acute stress disorder
5568214|NCT01013870|post-traumatic stress disorder|post-traumatic stress disorder
5568215|NCT01013870|atorvastatin|atorvastatin
5568216|NCT01013844|skin self-examination|skin self-examination
5568217|NCT01013844|SSE|sse
5568218|NCT01013844|melanoma|melanoma
5568219|NCT01013805|Rectal Cancer|rectal cancer
5568220|NCT01013805|Chemotherapy|chemotherapy
5568221|NCT01013805|Radiotherapy|radiotherapy
5568222|NCT01013792|Diabetic|diabetic
5568223|NCT01013792|Foot|foot
5568224|NCT01013792|Ulcer|ulcer
5568225|NCT01013792|Neuropathic|neuropathic
5568226|NCT01013792|Tegaderm Matrix Dressing|tegaderm matrix dressing
5568228|NCT01013792|Wound Care|wound care
5568229|NCT01013792|PHI|phi
5568230|NCT01013779|Merkel Cell Cancer|merkel cell cancer
5568231|NCT01013779|PET scanning|pet scanning
5568232|NCT01013766|GSK1362885|gsk1362885
5568233|NCT01013766|Pharmacodynamics|pharmacodynamics
5568234|NCT01013766|Safety|safety
5568235|NCT01013766|Pharmacokinetics|pharmacokinetics
5568236|NCT01013766|T2DM|t2dm
5568237|NCT01013766|Tolerability|tolerability
5568238|NCT01013740|Neoplasms, Breast|neoplasms, breast
5568240|NCT01013727|healthy subjects|healthy subjects
5568241|NCT01013714|Sudden cardiac death|sudden cardiac death
5568242|NCT01013714|Ventricular tachycardia|ventricular tachycardia
5568243|NCT01013714|Ventricular fibrillation|ventricular fibrillation
5568244|NCT01013714|Cardiomyopathy|cardiomyopathy
5568245|NCT01013714|Internal cardiac defibrillator shocks|internal cardiac defibrillator shocks
5568246|NCT01013714|Internal cardiac defibrillator therapies|internal cardiac defibrillator therapies
5568247|NCT01013701|nasal polyps|nasal polyps
5568248|NCT01013701|nasal steroid|nasal steroid
5568249|NCT01013701|fluticasone furoate|fluticasone furoate
5568250|NCT01013688|Radiofrequency ablation|radiofrequency ablation
5568251|NCT01013688|Maze|maze
5568252|NCT01013688|Atrial fibrillation|atrial fibrillation
5568253|NCT01013675|influenza|influenza
5568254|NCT01013675|active-controlled|active-controlled
5568255|NCT01013675|Phase 2|phase 2
5568256|NCT01013662|septic shock|septic shock
5568257|NCT01013662|glycemic control|glycemic control
5568258|NCT01013662|icu|icu
5568259|NCT01013662|lipid metabolism|lipid metabolism
5568260|NCT01013662|septic patients|septic patients
5568261|NCT01013623|melanoma|melanoma
5568262|NCT01013623|stage IV|stage iv
5568263|NCT01013623|resectable|resectable
5568264|NCT01013623|surgery|surgery
5568265|NCT01013623|medical therapy|medical therapy
5568266|NCT01013610|Healthy Elderly Volunteers|healthy elderly volunteers
5568267|NCT01013597|thyroid|thyroid
5568268|NCT01013597|medullary|medullary
5568269|NCT01013597|differentiated|differentiated
5568270|NCT01013597|radioiodine-resistant|radioiodine-resistant
5568271|NCT01013597|LBH589|lbh589
5568272|NCT01013597|panobinostat|panobinostat
5568273|NCT01013584|vitamin D|vitamin d
5568274|NCT01013558|fetal pain|fetal pain
5568275|NCT01013558|intrauterine|intrauterine
5568276|NCT01013558|needling|needling
5568277|NCT01013545|joint engagement|joint engagement
5568278|NCT01013545|augmentative communication (AAC)|augmentative communication (aac)
5568279|NCT01013545|enhanced milieu training|enhanced milieu training
5568280|NCT01013545|autism spectrum disorder|autism spectrum disorder
5568281|NCT01013545|language|language
5568282|NCT01013532|Ischemic Stroke|ischemic stroke
5568283|NCT01013532|Intracranial Hemorrhage|intracranial hemorrhage
5568284|NCT01013532|Cilostazol|cilostazol
5568285|NCT01013532|Probucol|probucol
5568286|NCT01013506|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5568287|NCT01013506|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5568288|NCT01013506|stage IV breast cancer|stage iv breast cancer
5568289|NCT01013506|recurrent breast cancer|recurrent breast cancer
5568290|NCT01013493|breastfeeding|breastfeeding
5568291|NCT01013493|myopia|myopia
5568292|NCT01013493|nearsightedness|nearsightedness
5568293|NCT01013493|children|children
5568294|NCT01013480|Fragile X Syndrome|fragile x syndrome
5568295|NCT01013467|blood pressure|blood pressure
5568296|NCT01013467|control|control
5568297|NCT01013467|adherence|adherence
5568298|NCT01013467|behaviour|behaviour
5568299|NCT01013454|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch|varenicline percutaneous transcutaneous topical transdermal transdermal delivery system patch
5568300|NCT01013441|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5568301|NCT01013428|Traumatic Rupture of Tendon|traumatic rupture of tendon
5568302|NCT01013415|HIV-1|hiv-1
5568303|NCT01013402|Hypoglycemia|hypoglycemia
5568304|NCT01013402|Home Blood Glucose Monitoring|home blood glucose monitoring
5568305|NCT01013402|Subjects are being investigated for the integrity of|subjects are being investigated for the integrity of
5568306|NCT01013402|pituitary-adrenal functions by insulin hypoglycemia test.|pituitary-adrenal functions by insulin hypoglycemia test.
5568307|NCT01013389|actifuse|actifuse
5568308|NCT01013389|INFUSE|infuse
5568309|NCT01013389|InductOs|inductos
5568310|NCT01013389|DDD|ddd
5568311|NCT01013389|degenerative disk disease|degenerative disk disease
5568312|NCT01013389|PLIF|plif
5568313|NCT01013389|PITF|pitf
5568314|NCT01013389|PLF|plf
5568315|NCT01013389|poterolateral lumber fusion|poterolateral lumber fusion
5568316|NCT01013389|Bone substitute|bone substitute
5568317|NCT01013389|bone graft|bone graft
5568318|NCT01013389|synthetic bone substitute|synthetic bone substitute
5568319|NCT01013363|abortion|abortion
5568320|NCT01013363|first trimester|first trimester
5568321|NCT01013363|suction aspiration|suction aspiration
5568322|NCT01013363|vacuum aspiration|vacuum aspiration
5568323|NCT01013363|music|music
5568325|NCT01013363|analgesia|analgesia
5568326|NCT01013363|anxiolytic|anxiolytic
5568327|NCT01013363|pain|pain
5568328|NCT01013363|anxiety|anxiety
5568329|NCT01013363|blood pressure|blood pressure
5568330|NCT01013363|heart rate|heart rate
5568331|NCT01013363|satisfaction|satisfaction
5568332|NCT01013350|Multiple Sclerosis|multiple sclerosis
5568333|NCT01013350|Cladribine|cladribine
5568334|NCT01013350|PREMIERE|premiere
5568335|NCT01013350|Observational study|observational study
5568336|NCT01013324|endometrial cancer|endometrial cancer
5568337|NCT01013324|endometrial carcinoma|endometrial carcinoma
5568338|NCT01013324|carcinoma of the endometrium|carcinoma of the endometrium
5568339|NCT01013324|cancer of the endometrium|cancer of the endometrium
5568340|NCT01013311|Implantable Cardioverter-Defibrillator (ICD)- pre-existing|implantable cardioverter-defibrillator (icd)- pre-existing
5568341|NCT01013298|percutaneous tracheostomy|percutaneous tracheostomy
5568342|NCT01013298|paratracheal insertion|paratracheal insertion
5568343|NCT01013298|tracheal injury|tracheal injury
5568344|NCT01013298|transtracheal needle|transtracheal needle
5568345|NCT01013298|ventilatory parameters|ventilatory parameters
5568346|NCT01013285|adult giant cell glioblastoma|adult giant cell glioblastoma
5568347|NCT01013285|adult gliosarcoma|adult gliosarcoma
5568348|NCT01013285|adult glioblastoma|adult glioblastoma
5568349|NCT01013272|entecavir|entecavir
5568350|NCT01013272|lamivudine|lamivudine
5568351|NCT01013272|sequential therapy|sequential therapy
5568352|NCT01013259|E.coli|e.coli
5568353|NCT01013259|Mutaflor|mutaflor
5568354|NCT01013259|grass pollen|grass pollen
5568355|NCT01013259|rhinoconjunctivitis|rhinoconjunctivitis
5568356|NCT01013259|rhinoconjunctivitis caused by grass pollen|rhinoconjunctivitis caused by grass pollen
5568358|NCT01013246|Energy balance|energy balance
5568359|NCT01013246|Metabolism|metabolism
5568360|NCT01013246|Appetite control|appetite control
5568361|NCT01013233|cognitive dysfunction chemotherapy|cognitive dysfunction chemotherapy
5568362|NCT01013220|depression|depression
5568363|NCT01013220|depression care management|depression care management
5568364|NCT01013220|financing|financing
5568365|NCT01013220|absenteeism|absenteeism
5568366|NCT01013220|presenteeism|presenteeism
5568367|NCT01013220|employer decisions to purchase health care benefits|employer decisions to purchase health care benefits
5568368|NCT01013207|CPAP compliance|cpap compliance
5568369|NCT01013194|Liver cirrhosis|liver cirrhosis
5568370|NCT01013194|Fetal stem cells|fetal stem cells
5568371|NCT01013194|Stem cell transplantation|stem cell transplantation
5568372|NCT01013194|Liver transplant candidate|liver transplant candidate
5568373|NCT01013181|Immune Thrombopenia|immune thrombopenia
5568374|NCT01013181|Thrombocytopenia|thrombocytopenia
5568375|NCT01013181|romiplostim|romiplostim
5568376|NCT01013181|compassionate program|compassionate program
5568377|NCT01013168|OncoSorb|oncosorb
5568378|NCT01013168|immune apheresis|immune apheresis
5568379|NCT01013168|sTNF-R1|stnf-r1
5568381|NCT01013168|sIL-2R|sil-2r
5568382|NCT01013168|TNF|tnf
5568383|NCT01013142|COPD|copd
5568384|NCT01013129|hereditary prostate cancer|hereditary prostate cancer
5568385|NCT01013129|prostate cancer|prostate cancer
5568386|NCT01013090|Epidural anesthesia|epidural anesthesia
5568387|NCT01013090|Spinal anesthesia|spinal anesthesia
5568388|NCT01013090|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
5568389|NCT01013090|Fluid therapy|fluid therapy
5568390|NCT01013090|Crystalloid|crystalloid
5568391|NCT01013090|Colloid|colloid
5568392|NCT01013077|functional vision|functional vision
5568393|NCT01013077|contrast sensitivity|contrast sensitivity
5568394|NCT01013077|aberrometry|aberrometry
5568395|NCT01013077|reading ability|reading ability
5568396|NCT01013064|Erythropoietin|erythropoietin
5568397|NCT01013064|Long acting|long acting
5568398|NCT01013064|EPO|epo
5568399|NCT01013051|obesity|obesity
5568400|NCT01013051|gastric bypass|gastric bypass
5568401|NCT01013051|metformin|metformin
5568402|NCT01013051|pharmacokinetics|pharmacokinetics
5568403|NCT01013051|absorption|absorption
5568404|NCT01013038|myocardial infarction|myocardial infarction
5568405|NCT01013038|percutaneous coronary intervention|percutaneous coronary intervention
5568406|NCT01013038|thrombus aspiration|thrombus aspiration
5568407|NCT01013025|prostate cancer|prostate cancer
5568408|NCT01013025|implant retrieval|implant retrieval
5568409|NCT01013012|highly susceptible patients following spine surgery|highly susceptible patients following spine surgery
5568410|NCT01012999|acute pain, intranasal, sufentanil,|acute pain, intranasal, sufentanil,
5568411|NCT01012999|Acute pain control with an intranasal opiate|acute pain control with an intranasal opiate
5568412|NCT01012973|Macular Edema|macular edema
5568413|NCT01012973|Central Retinal Vein Occlusion|central retinal vein occlusion
5568414|NCT01012973|CRVO|crvo
5568415|NCT01012973|VEGF Trap-Eye|vegf trap-eye
5568416|NCT01012973|best-corrected visual acuity|best-corrected visual acuity
5568417|NCT01012960|methylnaltrexone|methylnaltrexone
5568418|NCT01012960|upper esophageal sphincter|upper esophageal sphincter
5568419|NCT01012960|lower esophageal sphincter|lower esophageal sphincter
5568420|NCT01012960|high resolution solid state manometry|high resolution solid state manometry
5862970|NCT00001440|Interleukin-2|interleukin-2
5568421|NCT01012960|opioid induced pharyngeal and esophageal dysfunction|opioid induced pharyngeal and esophageal dysfunction
5568423|NCT01012947|activity|activity
5568424|NCT01012921|GBR|gbr
5568425|NCT01012921|GTR|gtr
5568426|NCT01012921|Dental Implant surgery|dental implant surgery
5568427|NCT01012869|Coronary chronic total occlusions|coronary chronic total occlusions
5568428|NCT01012856|depressive episode|depressive episode
5568429|NCT01012856|psychotherapy|psychotherapy
5568430|NCT01012856|cognitive therapy|cognitive therapy
5568431|NCT01012856|emotional processing|emotional processing
5568433|NCT01012856|exposure|exposure
5568434|NCT01012856|dual process model|dual process model
5568435|NCT01012856|Implicit Association Test|implicit association test
5568436|NCT01012856|mechanism of change|mechanism of change
5568437|NCT01012843|Perianal|perianal
5568438|NCT01012843|Abscess|abscess
5568439|NCT01012843|Fistulae in ano|fistulae in ano
5568440|NCT01012843|Antibiotic|antibiotic
5568441|NCT01012843|Anorectal|anorectal
5568442|NCT01012830|Schizophrenia|schizophrenia
5568443|NCT01012830|Cognitive Disorders|cognitive disorders
5568444|NCT01012830|Dementia|dementia
5568445|NCT01012830|Huperzine A|huperzine a
5568446|NCT01012830|HupA|hupa
5568447|NCT01012804|stage IV colon cancer|stage iv colon cancer
5568448|NCT01012804|recurrent colon cancer|recurrent colon cancer
5568449|NCT01012791|Zumba exercise|zumba exercise
5568450|NCT01012791|ApoE|apoe
5568451|NCT01012778|Performance impairment|performance impairment
5568453|NCT01012778|Meditation|meditation
5568454|NCT01012778|Peer mediated|peer mediated
5568455|NCT01012765|COPD|copd
5568456|NCT01012765|indacaterol|indacaterol
5568457|NCT01012765|QAB149|qab149
5568458|NCT01012765|inspiratory capacity|inspiratory capacity
5568459|NCT01012739|asthma|asthma
5568460|NCT01012739|QAB149|qab149
5568461|NCT01012739|indacaterol|indacaterol
5568462|NCT01012739|pulmonary function|pulmonary function
5568463|NCT01012713|Psoriasis|psoriasis
5568464|NCT01012713|Excimer|excimer
5568465|NCT01012713|Laser|laser
5568466|NCT01012713|Clobex|clobex
5568467|NCT01012713|Vectical|vectical
5568468|NCT01012713|clobetasol spray|clobetasol spray
5568469|NCT01012713|calcitriol|calcitriol
5568470|NCT01012713|Generalized plaque type psoriasis|generalized plaque type psoriasis
5568471|NCT01012674|carotid or vertebral artery disease|carotid or vertebral artery disease
5568472|NCT01012674|Contrast agent|contrast agent
5568473|NCT01012674|MRA|mra
5568474|NCT01012661|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5568475|NCT01012635|spinal cord injury|spinal cord injury
5568476|NCT01012635|chronic pain|chronic pain
5568477|NCT01012622|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5568478|NCT01012622|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5568479|NCT01012609|high-grade astrocytomas|high-grade astrocytomas
5568480|NCT01012609|newly diagnosed diffuse pontine tumors|newly diagnosed diffuse pontine tumors
5568481|NCT01012609|External beam radiation therapy|external beam radiation therapy
5568482|NCT01012609|cetuximab|cetuximab
5568483|NCT01012609|irinotecan|irinotecan
5568484|NCT01012609|POETIC|poetic
5568485|NCT01012596|Natural Family Planning Methods|natural family planning methods
5568486|NCT01012596|Ovulation Detection|ovulation detection
5568487|NCT01012596|Cervix Mucus|cervix mucus
5568488|NCT01012596|Intention|intention
5568489|NCT01012596|Behavior|behavior
5568490|NCT01012596|Birth Control|birth control
5568491|NCT01012596|Contraception|contraception
5568492|NCT01012596|Pregnancy|pregnancy
5568493|NCT01012596|Fertility|fertility
5568494|NCT01012583|Optical coherence tomography|optical coherence tomography
5568496|NCT01012583|Biodegradable polymer|biodegradable polymer
5568497|NCT01012583|Intimal|intimal
5568498|NCT01012583|Coverage|coverage
5568499|NCT01012583|assess intimal hyperplasia of drug eluting stent with biodegradable polymer|assess intimal hyperplasia of drug eluting stent with biodegradable polymer
5568500|NCT01012557|H1N1v|h1n1v
5568501|NCT01012557|vaccine|vaccine
5568502|NCT01012557|pregnant|pregnant
5568503|NCT01012557|women|women
5568504|NCT01012557|Assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.|assess whether the adjuvanted vaccine offers a meaningful benefit in pregnant women in terms of immune response over the non-adjuvanted vaccine.
5568505|NCT01012557|Assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.|assess the persistence of immune response over a 15 month time period after one single vaccination of the pregnant mother.
5568506|NCT01012557|Assess whether the immune response to H1N1 in pregnant women is different from that of non-pregnant women of similar age.|assess whether the immune response to h1n1 in pregnant women is different from that of non-pregnant women of similar age.
5568507|NCT01012557|Gain insight on safety of the Novartis egg-based MF59 adjuvanted H1N1 vaccine Focetria in pregnant women and their babies.|gain insight on safety of the novartis egg-based mf59 adjuvanted h1n1 vaccine focetria in pregnant women and their babies.
5568508|NCT01012557|Assess the maternally transferred specific antibodies against H1N1v in the newborn|assess the maternally transferred specific antibodies against h1n1v in the newborn
5568509|NCT01012557|Passive immunity transferred to the infant.|passive immunity transferred to the infant.
5568511|NCT01012544|pharmacokinetics|pharmacokinetics
5568512|NCT01012544|platelet function tests|platelet function tests
5568513|NCT01012544|platelet reactivity|platelet reactivity
5568514|NCT01012518|percutaneous tracheostomy|percutaneous tracheostomy
5568515|NCT01012518|paratracheal insertion|paratracheal insertion
5568516|NCT01012518|tracheal injury|tracheal injury
5568517|NCT01012518|transtracheal needle|transtracheal needle
5568518|NCT01012518|ventilatory parameters|ventilatory parameters
5568519|NCT01012492|cancer|cancer
5568520|NCT01012492|leukemia|leukemia
5568521|NCT01012492|transplant|transplant
5568522|NCT01012492|bone marrow|bone marrow
5568523|NCT01012479|Blood Pressure|blood pressure
5568524|NCT01012479|Blood Pressure, High|blood pressure, high
5568525|NCT01012479|Drug Therapy|drug therapy
5568526|NCT01012466|pregnancy|pregnancy
5568527|NCT01012466|birth|birth
5568528|NCT01012466|labor|labor
5568529|NCT01012466|labor pain|labor pain
5568530|NCT01012466|catastrophizing|catastrophizing
5568531|NCT01012453|Hand eczema|hand eczema
5568532|NCT01012453|Hand dermatitis|hand dermatitis
5568533|NCT01012453|Occupational skin disease|occupational skin disease
5568534|NCT01012453|skindisease in health care workers|skindisease in health care workers
5568535|NCT01012453|occupational hand dermatitis|occupational hand dermatitis
5568536|NCT01012453|occupational hand eczema|occupational hand eczema
5568537|NCT01012427|Kidney|kidney
5568538|NCT01012427|Cryoablation|cryoablation
5568539|NCT01012427|09-108|09-108
5568540|NCT01012414|Vitamin D|vitamin d
5568541|NCT01012414|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5568542|NCT01012414|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5568543|NCT01012401|Lung cancer|lung cancer
5568544|NCT01012401|Quality of life|quality of life
5568545|NCT01012401|Communication with physician|communication with physician
5568546|NCT01012388|Moderate to severe wrinkles and folds such as nasolabial folds|moderate to severe wrinkles and folds such as nasolabial folds
5568547|NCT01012375|Adult ADHD|adult adhd
5568548|NCT01012362|Solid tumor malignancy|solid tumor malignancy
5568549|NCT01012362|breast cancer|breast cancer
5568550|NCT01012362|lung cancer|lung cancer
5568551|NCT01012362|colon cancer|colon cancer
5568552|NCT01012362|pancreatic cancer|pancreatic cancer
5568553|NCT01012362|head and neck cancer|head and neck cancer
5568554|NCT01012362|kidney cancer|kidney cancer
5568555|NCT01012362|sarcoma|sarcoma
5568556|NCT01012362|hepatocellular cancer|hepatocellular cancer
5568557|NCT01012336|efficacy and safety of Aprepitant/Ramosetron/Dexamethasone in ovary cancer patients with taxol and carboplatin|efficacy and safety of aprepitant/ramosetron/dexamethasone in ovary cancer patients with taxol and carboplatin
5568558|NCT01012323|PID|pid
5568559|NCT01012310|pharmacokinetics safety tolerability multiple dosing|pharmacokinetics safety tolerability multiple dosing
5568560|NCT01012284|Moderate Hepatic Impairment|moderate hepatic impairment
5568562|NCT01012284|TMC207|tmc207
5568563|NCT01012284|Mycobacterial adenosine triphosphate (ATP)-synthase|mycobacterial adenosine triphosphate (atp)-synthase
5568564|NCT01012271|Wrist abnormalities|wrist abnormalities
5568565|NCT01012258|antitumor activity|antitumor activity
5568566|NCT01012258|safety|safety
5568567|NCT01012258|cetuximab in combination with radiotherapy|cetuximab in combination with radiotherapy
5568568|NCT01012258|locally advanced squamous cell head & neck carcinoma|locally advanced squamous cell head & neck carcinoma
5568569|NCT01012245|Xchange|xchange
5568570|NCT01012245|Xalatan|xalatan
5568571|NCT01012245|Xalacom|xalacom
5568572|NCT01012245|Betablocker|betablocker
5568573|NCT01012245|observational|observational
5568574|NCT01012245|longterm|longterm
5568576|NCT01012232|postoperative pain|postoperative pain
5568577|NCT01012206|Children|children
5568578|NCT01012206|Overweight|overweight
5568579|NCT01012206|Obesity|obesity
5568580|NCT01012206|Food habits|food habits
5568581|NCT01012206|Dietary assessment|dietary assessment
5568582|NCT01012206|Physical activity|physical activity
5568583|NCT01012193|adjunctive cilostazol|adjunctive cilostazol
5568584|NCT01012193|high-MD clopidogrel|high-md clopidogrel
5568585|NCT01012193|CYP 2C19 polymorphism|cyp 2c19 polymorphism
5568586|NCT01012193|high risk patients|high risk patients
5568587|NCT01012180|Bipolar Disorder|bipolar disorder
5568588|NCT01012180|Adaptation|adaptation
5568589|NCT01012180|Parents|parents
5568590|NCT01012180|Risk|risk
5568591|NCT01012180|Coping|coping
5568592|NCT01012180|Survey|survey
5568593|NCT01012167|Schizophrenia, oxytocin, galantamine|schizophrenia, oxytocin, galantamine
5568594|NCT01012128|Temporal Artery Thermometer|temporal artery thermometer
5568595|NCT01012128|Temperature|temperature
5568596|NCT01012128|Preterm Infants|preterm infants
5568597|NCT01012115|Histones|histones
5568598|NCT01012115|organ failure|organ failure
5568599|NCT01012115|sepsis|sepsis
5568600|NCT01012102|EMD 640744|emd 640744
5568601|NCT01012102|Montanide|montanide
5568602|NCT01012102|Advanced solid tumours|advanced solid tumours
5568603|NCT01012089|Hemodialysis|hemodialysis
5568604|NCT01012089|Peritoneal dialysis|peritoneal dialysis
5568605|NCT01012089|Daptomycin|daptomycin
5568606|NCT01012089|Pharmacokinetics|pharmacokinetics
5568607|NCT01012076|maternal synchrony|maternal synchrony
5568609|NCT01012076|parent child play|parent child play
5568610|NCT01012076|social communication|social communication
5568611|NCT01012063|iron|iron
5568612|NCT01012063|erythropoietin|erythropoietin
5568613|NCT01012063|hemoglobin|hemoglobin
5568614|NCT01012063|Total knee replacement arthroplasty|total knee replacement arthroplasty
5568615|NCT01012050|Asthma|asthma
5568616|NCT01012050|status asthmatics|status asthmatics
5568617|NCT01012011|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5568618|NCT01012011|Carcinoma, Renal Cell|carcinoma, renal cell
5568620|NCT01011998|Chronic Myelogenous leukemia|chronic myelogenous leukemia
5568621|NCT01011998|INST 0901|inst 0901
5568622|NCT01011998|imatinib|imatinib
5568623|NCT01011998|valproic acid|valproic acid
5568624|NCT01011998|Gleevec|gleevec
5568625|NCT01011985|end stage renal disease|end stage renal disease
5568626|NCT01011985|inflammation|inflammation
5568627|NCT01011985|vascular access|vascular access
5568628|NCT01011985|hemodialysis|hemodialysis
5568629|NCT01011972|Dose escalation|dose escalation
5568630|NCT01011972|XMT-1107|xmt-1107
5568631|NCT01011972|1107|1107
5568632|NCT01011972|Tumor|tumor
5568634|NCT01011972|Fumagillol|fumagillol
5568635|NCT01011972|PHF|phf
5568636|NCT01011972|Fleximer|fleximer
5568637|NCT01011972|cancer|cancer
5568638|NCT01011972|maximum tolerated dose|maximum tolerated dose
5568639|NCT01011972|MTD|mtd
5568640|NCT01011920|newly diagnosed primary central nervous system lymphoma|newly diagnosed primary central nervous system lymphoma
5568641|NCT01011894|Lenalidomide|lenalidomide
5568642|NCT01011894|CLL|cll
5568643|NCT01011894|09-045|09-045
5568644|NCT01011881|pleuritis|pleuritis
5568645|NCT01011881|empyema|empyema
5568646|NCT01011881|procalcitonin|procalcitonin
5568647|NCT01011829|methamphetamine|methamphetamine
5568648|NCT01011829|crystal meth|crystal meth
5568649|NCT01011829|addiction|addiction
5568650|NCT01011829|los angeles|los angeles
5568651|NCT01011829|medication|medication
5568663|NCT01011777|stem cells|stem cells
5568664|NCT01011764|social networks|social networks
5568665|NCT01011764|friendships|friendships
5568666|NCT01011764|autism spectrum disorder|autism spectrum disorder
5568667|NCT01011751|Drug Therapy|drug therapy
5568678|NCT01011699|nicotinamide|nicotinamide
5568679|NCT01011699|sevelamer hydrochloride|sevelamer hydrochloride
5568680|NCT01011699|phosphatemia|phosphatemia
5568681|NCT01011699|cinacalcet|cinacalcet
5568682|NCT01011699|dyslipidemia|dyslipidemia
5568683|NCT01011699|vascular calcification|vascular calcification
5568684|NCT01011699|bone mass loss|bone mass loss
5568685|NCT01011673|headache|headache
5568686|NCT01011673|tension-type headache|tension-type headache
5568687|NCT01011660|hypertension|hypertension
5568688|NCT01011660|cardiovascular risk factors|cardiovascular risk factors
5568689|NCT01011660|drugs intervention|drugs intervention
5568690|NCT01011660|lipid-lowering therapy|lipid-lowering therapy
5568691|NCT01011660|50-79 years of age|50-79 years of age
5568693|NCT01011660|the informed|the informed
5568694|NCT01011660|consent|consent
5568695|NCT01011660|forms|forms
5568696|NCT01011634|abortion|abortion
5568697|NCT01011634|uterine aspiration|uterine aspiration
5568698|NCT01011634|pain control|pain control
5568699|NCT01011621|Prednisolone acetate|prednisolone acetate
5568700|NCT01011621|Betamethasone valerate|betamethasone valerate
5568701|NCT01011595|lung cancer|lung cancer
5568702|NCT01011595|mediastinoscopy|mediastinoscopy
5568703|NCT01011595|mediastinal lymph nodes|mediastinal lymph nodes
5568705|NCT01011595|EBUS|ebus
5568706|NCT01011595|EUS|eus
5568707|NCT01011595|Endobronchial Ultrasound|endobronchial ultrasound
5568708|NCT01011595|Endoscopic Ultrasound|endoscopic ultrasound
5568709|NCT01011582|To evaluate biomarkers that cause critical illness in patients with novel H1N1 influenza and with seasonal influenza.|to evaluate biomarkers that cause critical illness in patients with novel h1n1 influenza and with seasonal influenza.
5568710|NCT01011569|difference|difference
5568711|NCT01011556|Age Related Osteoporosis|age related osteoporosis
5568712|NCT01011556|Senile Osteoporosis|senile osteoporosis
5568713|NCT01011543|pulmonary tuberculosis|pulmonary tuberculosis
5568714|NCT01011543|negative sputum exam|negative sputum exam
5568715|NCT01011543|induced sputum|induced sputum
5568716|NCT01011543|endoscopy|endoscopy
5568717|NCT01011530|Melanoma|melanoma
5568718|NCT01011517|muscadine grapes|muscadine grapes
5568719|NCT01011517|endothelial function|endothelial function
5568720|NCT01011491|Obesity|obesity
5568721|NCT01011491|Weight loss|weight loss
5568722|NCT01011491|meal replacements|meal replacements
5568723|NCT01011491|inflammation|inflammation
5568724|NCT01011491|oxidative stress|oxidative stress
5568725|NCT01011491|visceral fat|visceral fat
5568726|NCT01011478|adenomatous polyp|adenomatous polyp
5568727|NCT01011478|stage I colon cancer|stage i colon cancer
5568728|NCT01011478|stage II colon cancer|stage ii colon cancer
5568729|NCT01011478|adenocarcinoma of the colon|adenocarcinoma of the colon
5568730|NCT01011465|Stress|stress
5568732|NCT01011465|Social Support|social support
5568733|NCT01011465|Resilience|resilience
5568734|NCT01011452|Acute Asthma Exacerbation|acute asthma exacerbation
5568735|NCT01011452|Montelukast|montelukast
5568736|NCT01011452|Management of acute asthma exacerbation|management of acute asthma exacerbation
5568737|NCT01011439|B3 and C malignant thymoma|b3 and c malignant thymoma
5568738|NCT01011426|laxative|laxative
5568739|NCT01011426|postoperative care|postoperative care
5568740|NCT01011426|ob-Gyn population|ob-gyn population
5568741|NCT01011426|post-operative patients|post-operative patients
5550822|NCT01083719|MRI|mri
5568742|NCT01011426|obstetrical and gynecological surgery|obstetrical and gynecological surgery
5568748|NCT01011387|Diabetic foot ulcers|diabetic foot ulcers
5568749|NCT01011374|Retinal vein occlusion|retinal vein occlusion
5568750|NCT01011374|Ranibizumab|ranibizumab
5568751|NCT01011374|Lucentis|lucentis
5568752|NCT01011374|Depression|depression
5568753|NCT01011348|Gulf War Illness|gulf war illness
5568754|NCT01011348|Coenzyme Q10|coenzyme q10
5568755|NCT01011348|Quality of Life|quality of life
5568756|NCT01011348|Fatigue|fatigue
5568757|NCT01011348|oxidative stress|oxidative stress
5568758|NCT01011335|Staphylococcus aureus|staphylococcus aureus
5568759|NCT01011335|Skin and soft tissue infection|skin and soft tissue infection
5568760|NCT01011335|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5568761|NCT01011335|Recombinant alpha-toxoid (rAT)|recombinant alpha-toxoid (rat)
5568762|NCT01011335|Recombinant LukS subunit of Panton-Valentine Leukocidin (rLukS-PV)|recombinant luks subunit of panton-valentine leukocidin (rluks-pv)
5568763|NCT01011309|Leishmaniasis|leishmaniasis
5568764|NCT01011309|vaccine|vaccine
5568765|NCT01011309|immunotherapy|immunotherapy
5568767|NCT01011283|Myelodysplastic Syndromes|myelodysplastic syndromes
5568768|NCT01011270|Back pain|back pain
5568769|NCT01011270|postural balance|postural balance
5568771|NCT01011270|industrial operators|industrial operators
5568772|NCT01011257|CAD|cad
5568773|NCT01011231|Gamma Knife radiosurgery|gamma knife radiosurgery
5568774|NCT01011231|recurrent glioma|recurrent glioma
5568775|NCT01011231|MRI|mri
5568776|NCT01011231|Spectroscopy|spectroscopy
5568777|NCT01011231|Recurrent grade IV glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade II and grade III gliomas|recurrent grade iv glioma (glioblastoma), with two additional exploratory arms for patients with recurrent grade ii and grade iii gliomas
5568778|NCT01011205|Immunosuppression|immunosuppression
5568779|NCT01011205|Liver|liver
5568780|NCT01011205|Transplant|transplant
5568781|NCT01011205|Advagraf|advagraf
5568782|NCT01011192|Intravenous anesthesia|intravenous anesthesia
5568783|NCT01011192|propofol|propofol
5568784|NCT01011192|pharmacokinetic model|pharmacokinetic model
5568785|NCT01011192|Monitoring|monitoring
5568786|NCT01011192|bispectral index.|bispectral index.
5568787|NCT01011179|Teens Taking Charge|teens taking charge
5568788|NCT01011179|Managing Arthritis Online|managing arthritis online
5568789|NCT01011179|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5568790|NCT01011179|internet|internet
5568791|NCT01011179|self-management|self-management
5568792|NCT01011166|Chronic Hepatitis C|chronic hepatitis c
5568793|NCT01011166|HepC|hepc
5568794|NCT01011166|Hep C|hep c
5568795|NCT01011140|Parenteral Hydration|parenteral hydration
5568796|NCT01011140|Latin American Association for Palliative Care|latin american association for palliative care
5568797|NCT01011140|ALCP|alcp
5568798|NCT01011140|Spanish Society for Palliative Care|spanish society for palliative care
5568799|NCT01011140|SECPAL|secpal
5568800|NCT01011140|Online survey|online survey
5568801|NCT01011140|Palliative care|palliative care
5568802|NCT01011140|Physicians' attitudes|physicians' attitudes
5568803|NCT01011140|End of life|end of life
5568804|NCT01011140|Latin America|latin america
5568805|NCT01011140|Spain|spain
5568806|NCT01011127|Statins|statins
5568807|NCT01011127|Insulin resistance|insulin resistance
5568808|NCT01011114|hypophosphatemia|hypophosphatemia
5568809|NCT01011114|hyperparathyroidism|hyperparathyroidism
5568810|NCT01011114|renal transplant|renal transplant
5568811|NCT01011101|Saccadic Eye Movements|saccadic eye movements
5568812|NCT01011101|Schizophrenia|schizophrenia
5568813|NCT01011101|Healthy Volunteer|healthy volunteer
5568814|NCT01011101|HV|hv
5568815|NCT01011088|Paternity|paternity
5568816|NCT01011088|Psychology|psychology
5568817|NCT01011088|Risk factor|risk factor
5568818|NCT01011075|Lung cancer,|lung cancer,
5568819|NCT01011075|Non-small cell lung cancer|non-small cell lung cancer
5568820|NCT01011075|NSCLC|nsclc
5568821|NCT01011075|Metastatic|metastatic
5568822|NCT01011075|Gleevec|gleevec
5568823|NCT01011075|elderly|elderly
5568824|NCT01011062|Adipose tissue|adipose tissue
5568825|NCT01011062|Adipokines|adipokines
5568826|NCT01011049|Influenza|influenza
5568827|NCT01011049|Fluzone Vaccine|fluzone vaccine
5568828|NCT01011049|Intradermal Injections|intradermal injections
5568829|NCT01011049|Adults|adults
5568830|NCT01011036|healthy study subjects, no disease|healthy study subjects, no disease
5568831|NCT01011023|Bowel anastomosis|bowel anastomosis
5568832|NCT01011023|nasogastric tube|nasogastric tube
5568833|NCT01011023|children|children
5568834|NCT01011010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5568835|NCT01011010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5568836|NCT01011010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5568837|NCT01010997|AMD, CNV|amd, cnv
5568838|NCT01010984|metastatic melanoma|metastatic melanoma
5568839|NCT01010984|stage IV melanoma|stage iv melanoma
5568840|NCT01010984|metastatic melanoma to the liver|metastatic melanoma to the liver
5568842|NCT01010945|erlotinib|erlotinib
5568843|NCT01010945|nab-paclitaxel|nab-paclitaxel
5568844|NCT01010945|gemcitabine|gemcitabine
5568845|NCT01010945|Adenocarcinoma|adenocarcinoma
5568846|NCT01010945|Advanced Pancreatic Cancer|advanced pancreatic cancer
5568847|NCT01010945|Phase 1b|phase 1b
5568848|NCT01010932|carotid or vertebral artery disease|carotid or vertebral artery disease
5568849|NCT01010932|Contrast agent|contrast agent
5568850|NCT01010932|MRA|mra
5568851|NCT01010893|pandemic|pandemic
5568852|NCT01010893|prevention|prevention
5568853|NCT01010893|influenza|influenza
5568854|NCT01010893|infection|infection
5568855|NCT01010893|influenza vaccine|influenza vaccine
5568856|NCT01010893|vaccine|vaccine
5568857|NCT01010893|influenza in humans|influenza in humans
5568858|NCT01010880|Multiple Myeloma|multiple myeloma
5568859|NCT01010880|CXCR4|cxcr4
5568860|NCT01010880|Stem Cells|stem cells
5568861|NCT01010880|Mobilization|mobilization
5568862|NCT01010880|Transplantation|transplantation
5568863|NCT01010880|Chemotherapy|chemotherapy
5568864|NCT01010867|Probiotics|probiotics
5568865|NCT01010867|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5568866|NCT01010867|Pediatrics|pediatrics
5568867|NCT01010854|breast cancer|breast cancer
5568868|NCT01010854|advanced|advanced
5568869|NCT01010854|local|local
5568870|NCT01010841|Metabolic syndrome|metabolic syndrome
5568871|NCT01010841|Serum lipid|serum lipid
5568872|NCT01010841|Dietary intervention|dietary intervention
5568873|NCT01010841|Lifestyle modification|lifestyle modification
5568874|NCT01010841|Glycemic load|glycemic load
5568875|NCT01010841|Phytochemical|phytochemical
5568876|NCT01010841|Hops|hops
5568877|NCT01010841|Acacia|acacia
5568878|NCT01010841|Mediterranean diet|mediterranean diet
5568879|NCT01010841|Kinase modulator|kinase modulator
5568880|NCT01010815|ulcerative colitis|ulcerative colitis
5568881|NCT01010815|gut microbiome|gut microbiome
5568882|NCT01010815|metagenomics|metagenomics
5568883|NCT01010802|Neuroprotection|neuroprotection
5568884|NCT01010802|Parkinson Disease|parkinson disease
5568885|NCT01010802|Erythropoietin|erythropoietin
5568886|NCT01010776|Schizophrenia|schizophrenia
5568887|NCT01010776|Paliperidone|paliperidone
5568888|NCT01010750|ADHD|adhd
5568889|NCT01010737|Multimeric|multimeric
5568890|NCT01010737|Vaccine|vaccine
5568891|NCT01010737|Influenza|influenza
5568892|NCT01010737|elderly|elderly
5568893|NCT01010737|phase 1/2|phase 1/2
5568895|NCT01010737|efficacy|efficacy
5568896|NCT01010737|tolerability|tolerability
5568897|NCT01010737|reactogenicity|reactogenicity
5568898|NCT01010737|Montanide|montanide
5568899|NCT01010737|hemagglutinin inhibition|hemagglutinin inhibition
5568900|NCT01010737|HAI|hai
5568901|NCT01010737|TIV|tiv
5568902|NCT01010711|migraine|migraine
5568903|NCT01010711|children|children
5568904|NCT01010711|dietary supplement|dietary supplement
5568905|NCT01010711|q10|q10
5568906|NCT01010711|prevention|prevention
5568907|NCT01010698|cimetidine|cimetidine
5568908|NCT01010698|acyclovir|acyclovir
5568909|NCT01010698|pharmacokinetics|pharmacokinetics
5568910|NCT01010698|excipient|excipient
5568911|NCT01010698|formulation|formulation
5568912|NCT01010685|Natural Orifice Transluminal Endoscopic Surgery (NOTES)|natural orifice transluminal endoscopic surgery (notes)
5568913|NCT01010685|Transgastric surgery|transgastric surgery
5568914|NCT01010685|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5568915|NCT01010659|Dacryocystorhinostomy|dacryocystorhinostomy
5568916|NCT01010646|hepatitis C|hepatitis c
5568917|NCT01010646|viral kinetics|viral kinetics
5568918|NCT01010646|antiviral response|antiviral response
5568919|NCT01010646|Genotype 1 or 4|genotype 1 or 4
5568920|NCT01010620|screening|screening
5568921|NCT01010620|research participation|research participation
5568922|NCT01010620|substance abuse|substance abuse
5568923|NCT01010620|Schizophrenia|schizophrenia
5568924|NCT01010620|nicotine|nicotine
5568925|NCT01010620|Healthy|healthy
5568926|NCT01010620|cigarettes|cigarettes
5568927|NCT01010620|smoking|smoking
5568928|NCT01010620|marijuana|marijuana
5568929|NCT01010620|cocaine|cocaine
5568930|NCT01010581|Rheumatoid Arthritis|rheumatoid arthritis
5568931|NCT01010581|SC12267|sc12267
5568932|NCT01010581|4SC-101|4sc-101
5568933|NCT01010581|Methotrexate|methotrexate
5568934|NCT01010581|Phase II|phase ii
5568935|NCT01010568|CLL|cll
5568936|NCT01010568|SLL|sll
5568937|NCT01010568|Bendamustine|bendamustine
5568938|NCT01010568|Ofatumumab|ofatumumab
5568939|NCT01010542|Single dose psoriasis study|single dose psoriasis study
5562961|NCT01035476|ALS|als
5568940|NCT01010529|Occupational Therapy|occupational therapy
5568941|NCT01010529|Parkinson's Disease|parkinson's disease
5568942|NCT01010529|Feasibility|feasibility
5568943|NCT01010529|Effectiveness|effectiveness
5568944|NCT01010529|RCT|rct
5568945|NCT01010529|Activities of daily living|activities of daily living
5568946|NCT01010529|Participation|participation
5568947|NCT01010529|Caregiver's Burden|caregiver's burden
5568948|NCT01010490|PACHYMETRY|pachymetry
5568949|NCT01010490|CELL LOSS|cell loss
5568951|NCT01010490|EFFICACY|efficacy
5568952|NCT01010490|PHACOEMULSIFICATION|phacoemulsification
5568953|NCT01010490|Intraoperative complications|intraoperative complications
5568954|NCT01010490|CLOCK TIME|clock time
5568955|NCT01010490|FLUID USED|fluid used
5568956|NCT01010490|CORNEAL THICKNESS|corneal thickness
5568957|NCT01010490|ENDOTHELIUM CELL LOSS|endothelium cell loss
5568958|NCT01010477|smoking cessation|smoking cessation
5568959|NCT01010477|schizophrenia|schizophrenia
5568960|NCT01010477|nicotine nasal spray|nicotine nasal spray
5568961|NCT01010477|behavioral counseling|behavioral counseling
5568962|NCT01010464|Adhesions|adhesions
5568963|NCT01010464|Open abdomen|open abdomen
5568964|NCT01010464|Laparotomy|laparotomy
5568965|NCT01010451|pulpotomy|pulpotomy
5568966|NCT01010451|pulpectomy|pulpectomy
5568967|NCT01010451|primary teeth|primary teeth
5568968|NCT01010451|dental care for children|dental care for children
5568969|NCT01010438|sleep studies|sleep studies
5568970|NCT01010438|sleep apnea|sleep apnea
5568972|NCT01010438|Referred for sleep studies by a medical professional|referred for sleep studies by a medical professional
5568973|NCT01010412|Ultrasound|ultrasound
5568974|NCT01010412|Nerve blocks|nerve blocks
5568975|NCT01010412|Upper extremity|upper extremity
5568977|NCT01010399|triglycerides|triglycerides
5568978|NCT01010399|fosamprenavir|fosamprenavir
5568979|NCT01010386|Pregnancy|pregnancy
5568980|NCT01010386|Infertility|infertility
5568981|NCT01010386|Physiologic Oxygen Tension|physiologic oxygen tension
5568982|NCT01010386|Atmospheric Oxygen Tension|atmospheric oxygen tension
5568983|NCT01010373|Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.|primary acute myeloid leukemia (aml) and myelodysplastic syndrome (mds) induced aml.
5568984|NCT01010360|celiac ganglia|celiac ganglia
5568985|NCT01010347|fractures|fractures
5568986|NCT01010347|casting|casting
5568987|NCT01010347|splinting|splinting
5568988|NCT01010347|pediatrics|pediatrics
5568989|NCT01010334|INST 0813|inst 0813
5568990|NCT01010334|Standard of Care|standard of care
5568991|NCT01010321|skin lesion suspect as BCC or SCC or others|skin lesion suspect as bcc or scc or others
5568992|NCT01010308|infantile hemangioma|infantile hemangioma
5568993|NCT01010308|nadolol|nadolol
5568994|NCT01010295|NHL of the ocular adnexae|nhl of the ocular adnexae
5680317|NCT00578227|cervical cancer|cervical cancer
5680318|NCT00578227|HPV vaccine,|hpv vaccine,
5680319|NCT00578214|mohs micrographic surgery|mohs micrographic surgery
5568995|NCT01010256|To evaluate the phosphate and tension homolog deleted on chromosome ten (PTEN) protein level in leukemia cells from patients with CMML.|to evaluate the phosphate and tension homolog deleted on chromosome ten (pten) protein level in leukemia cells from patients with cmml.
5568996|NCT01010256|To identify the PTEN genetic defect in patients with deficient PTEN protein levels.|to identify the pten genetic defect in patients with deficient pten protein levels.
5568997|NCT01010256|To evaluate the role of PTEN deregulation in CMML pathogenesis.|to evaluate the role of pten deregulation in cmml pathogenesis.
5568998|NCT01010243|multiple myeloma|multiple myeloma
5568999|NCT01010243|anti-inflammatory|anti-inflammatory
5569000|NCT01010243|relapsed|relapsed
5569001|NCT01010243|refractory|refractory
5569002|NCT01010243|progressive|progressive
5569003|NCT01010230|Childhood cancer survivors|childhood cancer survivors
5569004|NCT01010217|Hematologic Neoplasms|hematologic neoplasms
5569005|NCT01010217|Blood Disorders|blood disorders
5569006|NCT01010217|Blood Cancer|blood cancer
5569007|NCT01010217|Transplantation, Blood And Marrow|transplantation, blood and marrow
5569008|NCT01010217|Acute myelogenous leukemia|acute myelogenous leukemia
5569009|NCT01010217|Myelodysplastic syndrome|myelodysplastic syndrome
5569010|NCT01010217|Acute lymphocytic leukemia|acute lymphocytic leukemia
5569011|NCT01010217|Aplastic anemia|aplastic anemia
5569012|NCT01010217|Chronic myelogenous leukemia|chronic myelogenous leukemia
5569013|NCT01010217|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5569014|NCT01010217|Myeloproliferative disease|myeloproliferative disease
5569015|NCT01010217|Hodgkin's disease|hodgkin's disease
5569016|NCT01010217|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5569017|NCT01010217|Multiple myeloma|multiple myeloma
5569018|NCT01010217|Cyclophosphamide|cyclophosphamide
5569019|NCT01010217|Fludarabine|fludarabine
5569020|NCT01010217|Melphalan|melphalan
5569021|NCT01010217|Mesna|mesna
5569022|NCT01010217|Rituximab|rituximab
5569023|NCT01010217|Tacrolimus|tacrolimus
5569024|NCT01010217|Prograf|prograf
5569025|NCT01010217|Mycofenolate mofetil|mycofenolate mofetil
5569027|NCT01010217|CellCept|cellcept
5569028|NCT01010217|G-CSF|g-csf
5569029|NCT01010217|Filgrastim|filgrastim
5569030|NCT01010217|Neupogen|neupogen
5569031|NCT01010204|Varenicline|varenicline
5569032|NCT01010204|Chantix|chantix
5569033|NCT01010204|Smoking|smoking
5569034|NCT01010204|Bipolar Disorder|bipolar disorder
5569035|NCT01010191|irritable bowel syndrome|irritable bowel syndrome
5569036|NCT01010191|no organic digestive disease|no organic digestive disease
5569037|NCT01010178|COPD|copd
5569038|NCT01010178|Macrolid|macrolid
5569039|NCT01010178|reversibility|reversibility
5569040|NCT01010178|Theophylline|theophylline
5569041|NCT01010178|Corticosteroids|corticosteroids
5569042|NCT01010178|symptoms PFT|symptoms pft
5569043|NCT01010165|acute arthritis|acute arthritis
5569044|NCT01010165|bacteria|bacteria
5551132|NCT01082640|Gout|gout
5569045|NCT01010165|crystal arthritis|crystal arthritis
5569046|NCT01010165|proteomic|proteomic
5569047|NCT01010165|SELDI-TOF|seldi-tof
5569048|NCT01010113|infants|infants
5569049|NCT01010113|prebiotics|prebiotics
5569050|NCT01010113|probiotics|probiotics
5569051|NCT01010113|safety|safety
5569052|NCT01010100|Metabolic Disease|metabolic disease
5569053|NCT01010100|IGT Impaired Glucose Tolerance|igt impaired glucose tolerance
5569055|NCT01010074|retina, Parkinson's disease, ganglion cell, pupillary|retina, parkinson's disease, ganglion cell, pupillary
5569056|NCT01010048|ESWL|eswl
5569057|NCT01010048|urinary calculus|urinary calculus
5569058|NCT01010048|drugs treat|drugs treat
5569059|NCT01010035|type 2 diabetes mellitus|type 2 diabetes mellitus
5569060|NCT01010035|dyslipidemia|dyslipidemia
5569061|NCT01010035|kinetics|kinetics
5569062|NCT01010022|hypovolemia|hypovolemia
5569063|NCT01010022|surgical blood loss|surgical blood loss
5569064|NCT01010022|orthopedic procedures|orthopedic procedures
5569065|NCT01010022|Treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage|treatment of reduced circulating blood volume (hypovolemia) including massive hemorrhage
5569066|NCT01010009|resveratrol|resveratrol
5569067|NCT01010009|cerebral blood flow|cerebral blood flow
5569068|NCT01010009|NIRS|nirs
5569069|NCT01010009|cognitive performance|cognitive performance
5569071|NCT01009983|triple-negative breast cancer|triple-negative breast cancer
5569072|NCT01009970|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5569073|NCT01009957|ADPKD|adpkd
5569074|NCT01009957|CKD|ckd
5569075|NCT01009957|Renal disease progression|renal disease progression
5569076|NCT01009957|Everolimus|everolimus
5569077|NCT01009944|High blood pressure|high blood pressure
5569078|NCT01009931|Acute Myelogenous Leukemia|acute myelogenous leukemia
5569079|NCT01009931|Relapsed AML|relapsed aml
5569080|NCT01009931|Refractory AML|refractory aml
5569081|NCT01009918|cardiac toxicity|cardiac toxicity
5569082|NCT01009918|HER2-positive breast cancer|her2-positive breast cancer
5569083|NCT01009918|recurrent breast cancer|recurrent breast cancer
5569084|NCT01009918|stage IA breast cancer|stage ia breast cancer
5569085|NCT01009918|stage IB breast cancer|stage ib breast cancer
5569086|NCT01009918|stage II breast cancer|stage ii breast cancer
5569087|NCT01009918|stage IIIA breast cancer|stage iiia breast cancer
5569088|NCT01009918|stage IIIB breast cancer|stage iiib breast cancer
5569089|NCT01009918|stage IIIC breast cancer|stage iiic breast cancer
5569090|NCT01009918|male breast cancer|male breast cancer
5569091|NCT01009879|rheumatoid arthritis|rheumatoid arthritis
5569092|NCT01009879|B lymphocytes|b lymphocytes
5569093|NCT01009866|Malignant brain tumor|malignant brain tumor
5569095|NCT01009866|recurrent brain tumor|recurrent brain tumor
5569096|NCT01009866|Supratentorial malignant brain tumor|supratentorial malignant brain tumor
5569097|NCT01009866|astrocytomas|astrocytomas
5569098|NCT01009866|ependymomas|ependymomas
5685552|NCT00555633|Xeroderma pigmentosum|xeroderma pigmentosum
5569099|NCT01009866|Residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable|residual, progressive, or recurrent supratentorial malignant brain tumor based on imaging studies with measurable
5569100|NCT01009866|disease (>0.5cm).|disease (>0.5cm).
5569101|NCT01009840|Multiple Myeloma|multiple myeloma
5569102|NCT01009840|Bone marrow transplant|bone marrow transplant
5569103|NCT01009840|Stem cell transplant|stem cell transplant
5569104|NCT01009840|Busulfan|busulfan
5569105|NCT01009840|Bortezomib|bortezomib
5569106|NCT01009827|Medication adherence|medication adherence
5569107|NCT01009827|Substance use|substance use
5569108|NCT01009827|Sexual risk behaviors|sexual risk behaviors
5569109|NCT01009814|HIV, HIV attachment inhibitor, attachment inhibitor|hiv, hiv attachment inhibitor, attachment inhibitor
5569110|NCT01009801|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5569111|NCT01009801|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5569112|NCT01009801|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5569113|NCT01009788|ABT-888|abt-888
5569114|NCT01009788|temozolomide|temozolomide
5569115|NCT01009788|TMZ|tmz
5569116|NCT01009775|Melanoma, Stage III|melanoma, stage iii
5569117|NCT01009775|Melanoma, Stage IV|melanoma, stage iv
5569118|NCT01009775|YM 155|ym 155
5569119|NCT01009775|Metastatic Melanoma|metastatic melanoma
5569120|NCT01009762|VACCINE|vaccine
5569121|NCT01009762|THERAPY|therapy
5569122|NCT01009762|CELLULAR IMMUNITY|cellular immunity
5569123|NCT01009762|IMMUNITY|immunity
5569124|NCT01009749|HAART|haart
5569125|NCT01009749|HIV|hiv
5569126|NCT01009749|Adherence|adherence
5569127|NCT01009736|stage I prostate cancer|stage i prostate cancer
5569128|NCT01009736|stage IIB prostate cancer|stage iib prostate cancer
5569129|NCT01009736|stage IIA prostate cancer|stage iia prostate cancer
5569130|NCT01009736|stage III prostate cancer|stage iii prostate cancer
5569131|NCT01009736|stage IV prostate cancer|stage iv prostate cancer
5569132|NCT01009723|Preterm delivery|preterm delivery
5569133|NCT01009723|preterm labor|preterm labor
5569134|NCT01009723|maternal-fetal care|maternal-fetal care
5569135|NCT01009723|maternal serum screening biomarkers|maternal serum screening biomarkers
5551224|NCT01082237|EEG|eeg
5569136|NCT01009723|alphafetoprotein|alphafetoprotein
5569137|NCT01009723|AFP|afp
5569138|NCT01009723|human chorionic gonadotropin|human chorionic gonadotropin
5569139|NCT01009723|hCG|hcg
5569140|NCT01009723|unconjugated estriol|unconjugated estriol
5569142|NCT01009723|pregnancy associated plasma protein|pregnancy associated plasma protein
5569143|NCT01009723|PAPP-A|papp-a
5569144|NCT01009723|maternal screening|maternal screening
5569145|NCT01009684|Contraception|contraception
5569146|NCT01009684|Estradiol valerate|estradiol valerate
5569147|NCT01009671|knee osteoarthritis|knee osteoarthritis
5569148|NCT01009658|Gastrointestinal motility|gastrointestinal motility
5569149|NCT01009658|Gastroesophageal reflux|gastroesophageal reflux
5569150|NCT01009658|Gastric emptying|gastric emptying
5569151|NCT01009658|Sodium glutamate|sodium glutamate
5569152|NCT01009658|Lower esophageal sphincter|lower esophageal sphincter
5569153|NCT01009645|education|education
5569154|NCT01009645|vaccination|vaccination
5569155|NCT01009645|preventive service|preventive service
5569156|NCT01009645|Prevention & Control|prevention & control
5569157|NCT01009619|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5569158|NCT01009619|Acute allograft Rejection|acute allograft rejection
5569159|NCT01009619|Lymphocytic bronchiolitis|lymphocytic bronchiolitis
5569160|NCT01009619|Respiratory infection|respiratory infection
5569161|NCT01009619|Survival|survival
5569162|NCT01009619|Mortality|mortality
5569163|NCT01009619|Pulmonary function|pulmonary function
5569164|NCT01009619|FEV1|fev1
5569165|NCT01009619|Broncho-alveolar lavage|broncho-alveolar lavage
5569166|NCT01009619|Neutrophils|neutrophils
5569167|NCT01009619|Interleukin|interleukin
5569168|NCT01009619|Culture|culture
5569169|NCT01009619|Azithromycin|azithromycin
5569170|NCT01009606|Out-of-hospital|out-of-hospital
5569171|NCT01009606|Emergency|emergency
5569172|NCT01009606|Cardiac arrest|cardiac arrest
5569173|NCT01009606|Post-traumatic stress disorder|post-traumatic stress disorder
5569174|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5569175|NCT01009593|Antineoplastic Agents|antineoplastic agents
5569176|NCT01009593|Growth Substances|growth substances
5569177|NCT01009593|Physiological Effects of Drugs|physiological effects of drugs
5569178|NCT01009593|Enzyme Inhibitors|enzyme inhibitors
5569179|NCT01009593|Angiogenesis Inhibitors|angiogenesis inhibitors
5569180|NCT01009593|Inhibitors, Angiogenesis|inhibitors, angiogenesis
5680320|NCT00578214|skin cancer|skin cancer
5569181|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors
5569182|NCT01009593|Pharmacologic Actions|pharmacologic actions
5569183|NCT01009593|Growth Inhibitors|growth inhibitors
5569184|NCT01009593|Angiogenesis Modulating Agents|angiogenesis modulating agents
5569185|NCT01009593|Sorafenib|sorafenib
5569186|NCT01009567|OHSS|ohss
5569187|NCT01009554|Mouthwashes|mouthwashes
5685553|NCT00555633|Basal cell nevus syndrome|basal cell nevus syndrome
5569188|NCT01009541|pregabalin pharmacokinetics bioavailability bioequivalence|pregabalin pharmacokinetics bioavailability bioequivalence
5569190|NCT01009528|General Practice|general practice
5569191|NCT01009528|Electronic Feedback System|electronic feedback system
5569193|NCT01009515|melanoma|melanoma
5569194|NCT01009515|skin cancer|skin cancer
5569195|NCT01009515|paclitaxel|paclitaxel
5569196|NCT01009515|carboplatin|carboplatin
5569197|NCT01009515|temozolomide|temozolomide
5569198|NCT01009476|Dementia|dementia
5569199|NCT01009476|Galantamine|galantamine
5569200|NCT01009476|Cholinesterase inhibitors|cholinesterase inhibitors
5569201|NCT01009476|Nootropic agents|nootropic agents
5569202|NCT01009476|Alzheimer|alzheimer
5569203|NCT01009476|Vascular dementia|vascular dementia
5569204|NCT01009476|Cognitive symptoms|cognitive symptoms
5569205|NCT01009476|Behavioural symptoms|behavioural symptoms
5569206|NCT01009476|Care giving times|care giving times
5569207|NCT01009463|COPD|copd
5569208|NCT01009463|Safety|safety
5569209|NCT01009463|FEV1|fev1
5569210|NCT01009463|Efficacy|efficacy
5569211|NCT01009450|cirrhotic liver, gall bladder stone|cirrhotic liver, gall bladder stone
5569212|NCT01009437|HER2-negative breast cancer|her2-negative breast cancer
5569213|NCT01009437|HER2-positive breast cancer|her2-positive breast cancer
5569214|NCT01009437|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5569215|NCT01009437|triple-negative breast cancer|triple-negative breast cancer
5569216|NCT01009437|stage I breast cancer|stage i breast cancer
5569217|NCT01009437|stage II breast cancer|stage ii breast cancer
5569218|NCT01009437|stage IIIA breast cancer|stage iiia breast cancer
5569219|NCT01009437|stage IIIB breast cancer|stage iiib breast cancer
5569220|NCT01009437|stage IIIC breast cancer|stage iiic breast cancer
5569221|NCT01009437|stage IV breast cancer|stage iv breast cancer
5569222|NCT01009437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5569223|NCT01009398|Anesthesia and Analgesia|anesthesia and analgesia
5569225|NCT01009398|Thoracic Paravertebral block|thoracic paravertebral block
5569226|NCT01009398|Catheter location|catheter location
5569227|NCT01009385|cervical|cervical
5569228|NCT01009385|epidural|epidural
5569229|NCT01009385|epidural pressure|epidural pressure
5569230|NCT01009385|monitoring|monitoring
5569231|NCT01009372|surgeon's physiology|surgeon's physiology
5569232|NCT01009372|stress response|stress response
5569233|NCT01009372|break scheme|break scheme
5569234|NCT01009359|Alzheimers disease|alzheimers disease
5569235|NCT01009359|Diagnostic imaging|diagnostic imaging
5569236|NCT01009359|PET/CT diagnosis|pet/ct diagnosis
5569238|NCT01009333|urgency frequency|urgency frequency
5569239|NCT01009333|urinary urge incontinence|urinary urge incontinence
5569240|NCT01009333|InterStim Therapy|interstim therapy
5569241|NCT01009320|Pacemaker|pacemaker
5569242|NCT01009320|Magnets|magnets
5569243|NCT01009320|Drape|drape
5569244|NCT01009320|Ferrite|ferrite
5569245|NCT01009320|Magnetic field|magnetic field
5569246|NCT01009320|Pacemaker interference|pacemaker interference
5569247|NCT01009307|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5569248|NCT01009307|adult diffuse astrocytoma|adult diffuse astrocytoma
5569249|NCT01009307|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5569250|NCT01009307|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5569251|NCT01009307|adult anaplastic ependymoma|adult anaplastic ependymoma
5569252|NCT01009307|adult ependymoma|adult ependymoma
5569253|NCT01009307|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5569254|NCT01009307|adult subependymoma|adult subependymoma
5569255|NCT01009307|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5569256|NCT01009307|adult oligodendroglioma|adult oligodendroglioma
5569257|NCT01009307|adult brain stem glioma|adult brain stem glioma
5569258|NCT01009307|adult giant cell glioblastoma|adult giant cell glioblastoma
5569259|NCT01009307|adult glioblastoma|adult glioblastoma
5569260|NCT01009307|recurrent adult brain tumor|recurrent adult brain tumor
5569261|NCT01009307|adult gliosarcoma|adult gliosarcoma
5569262|NCT01009307|adult mixed glioma|adult mixed glioma
5569263|NCT01009307|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5569264|NCT01009307|adult ependymoblastoma|adult ependymoblastoma
5569265|NCT01009307|adult medulloblastoma|adult medulloblastoma
5569266|NCT01009307|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5569267|NCT01009307|adult pineoblastoma|adult pineoblastoma
5569268|NCT01009307|adult pineocytoma|adult pineocytoma
5569269|NCT01009294|Duchenne muscular dystrophy|duchenne muscular dystrophy
5569270|NCT01009294|Becker muscular dystrophy|becker muscular dystrophy
5569271|NCT01009294|Nonsense mutation|nonsense mutation
5569272|NCT01009294|Premature stop codon|premature stop codon
5569274|NCT01009294|BMD|bmd
5569275|NCT01009294|Ataluren|ataluren
5569276|NCT01009294|PTC124|ptc124
5569277|NCT01009281|Crohn's Disease|crohn's disease
5569278|NCT01009281|Crohns|crohns
5569279|NCT01009281|Bowel disease|bowel disease
5569280|NCT01009281|digestive disorders|digestive disorders
5569281|NCT01009281|auto immune|auto immune
5569282|NCT01009281|diarrhea|diarrhea
5569283|NCT01009281|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5569284|NCT01009281|gastrointestinal diseases|gastrointestinal diseases
5569285|NCT01009281|digestive system diseases|digestive system diseases
5569286|NCT01009281|Antibody|antibody
5569287|NCT01009281|IL 17|il 17
5569288|NCT01009281|anti IL-17|anti il-17
5569289|NCT01009281|monoclonal antibody|monoclonal antibody
5569290|NCT01009281|Crohn's Disease (Chron's, CD)|crohn's disease (chron's, cd)
5569291|NCT01009255|Alzheimer's disease|alzheimer's disease
5569292|NCT01009255|placebo controlled|placebo controlled
5569293|NCT01009255|randomised|randomised
5569294|NCT01009255|Histamine|histamine
5569295|NCT01009255|H3 Antagonist|h3 antagonist
5569296|NCT01009255|double blind|double blind
5569297|NCT01009255|Cognition|cognition
5569298|NCT01009242|CDP6038|cdp6038
5569299|NCT01009216|Pharmacokinetics|pharmacokinetics
5569300|NCT01009216|Pharmacology|pharmacology
5569301|NCT01009216|Drug Safety|drug safety
5569302|NCT01009216|Phase 1 Clinical Trials|phase 1 clinical trials
5569303|NCT01009203|squamous cell carcinoma|squamous cell carcinoma
5569304|NCT01009203|head|head
5569305|NCT01009203|neck|neck
5569306|NCT01009203|aerodigestive|aerodigestive
5569307|NCT01009190|Dose finding PARPi Chemotherapy|dose finding parpi chemotherapy
5569308|NCT01009177|Melanoma|melanoma
5569309|NCT01009177|Metastatic|metastatic
5569310|NCT01009177|DTIC|dtic
5569311|NCT01009177|Bosentan|bosentan
5569312|NCT01009151|telemonitoring|telemonitoring
5569313|NCT01009151|internet|internet
5569314|NCT01009151|home monitoring system|home monitoring system
5569315|NCT01009151|heart failure|heart failure
5569316|NCT01009151|self management plan|self management plan
5569317|NCT01009151|web portal|web portal
5569318|NCT01009138|Subthreshold Depression|subthreshold depression
5569319|NCT01009138|Diabetes-related Distress|diabetes-related distress
5569320|NCT01009138|Minor Depression|minor depression
5569321|NCT01009138|Light affective Disorder|light affective disorder
5569322|NCT01009138|Subclinical depressive Symptoms|subclinical depressive symptoms
5569323|NCT01009138|Diabetes mellitus|diabetes mellitus
5569324|NCT01009138|Late Complications|late complications
5569325|NCT01009138|Markers of Inflammation|markers of inflammation
5569326|NCT01009125|questionnaires|questionnaires
5569327|NCT01009125|health care surveys/methods|health care surveys/methods
5569329|NCT01009125|living donors|living donors
5571977|NCT00998530|MLST|mlst
5569330|NCT01009125|living kidney donation|living kidney donation
5569331|NCT01009112|Sleep|sleep
5569332|NCT01009112|Sleep Disorder|sleep disorder
5569333|NCT01009112|Veterans|veterans
5569334|NCT01009112|Active Duty|active duty
5569335|NCT01009112|OEF|oef
5569336|NCT01009112|OIF|oif
5569337|NCT01009112|PTSD|ptsd
5569338|NCT01009099|pulmonary disease|pulmonary disease
5569339|NCT01009099|COPD|copd
5569733|NCT01007643|adolescents|adolescents
5569340|NCT01009086|Arthritis, Psoriatic|arthritis, psoriatic
5569341|NCT01009086|Ustekinumab|ustekinumab
5569342|NCT01009086|CNTO 1275|cnto 1275
5569343|NCT01009086|Stelara|stelara
5569344|NCT01009086|Psoriasis|psoriasis
5569345|NCT01009060|H3 Antagonist|h3 antagonist
5569346|NCT01009060|Schizophrenia|schizophrenia
5569347|NCT01009060|double blind|double blind
5569348|NCT01009060|Histamine|histamine
5569349|NCT01009060|randomised|randomised
5569350|NCT01009060|placebo controlled|placebo controlled
5569351|NCT01009060|Cognition|cognition
5569352|NCT01009047|Schizophrenia|schizophrenia
5569353|NCT01009047|Paliperidone|paliperidone
5569354|NCT01009047|Aripiprazole|aripiprazole
5569355|NCT01009021|pain|pain
5569356|NCT01009021|retinal photocoagulation|retinal photocoagulation
5569357|NCT01009021|potassium diclofenac|potassium diclofenac
5569358|NCT01009008|cancer|cancer
5569359|NCT01009008|breast cancer|breast cancer
5569360|NCT01009008|mastectomy|mastectomy
5569361|NCT01009008|breast reconstruction|breast reconstruction
5569362|NCT01009008|reconstruction|reconstruction
5569363|NCT01009008|tissue expansion|tissue expansion
5569364|NCT01009008|two-stage breast reconstruction|two-stage breast reconstruction
5569365|NCT01009008|tissue expander|tissue expander
5569366|NCT01009008|AeroForm|aeroform
5569367|NCT01009008|AirXpander|airxpander
5569368|NCT01008995|psoriasis|psoriasis
5569369|NCT01008995|asian patients|asian patients
5569370|NCT01008995|Chinese|chinese
5569371|NCT01008995|ustekinumab|ustekinumab
5569372|NCT01008995|CNTO 1275|cnto 1275
5569373|NCT01008995|Stelara|stelara
5553966|NCT01071161|LCQ|lcq
5569374|NCT01008982|Belimumab,Sjögren's Syndrome.|belimumab,sjögren's syndrome.
5569375|NCT01008982|Have a diagnosis of primary SS according to the updated American European Consensus Group Criteria|have a diagnosis of primary ss according to the updated american european consensus group criteria
5569376|NCT01008969|Prostate|prostate
5569377|NCT01008969|SPECT/CT|spect/ct
5569378|NCT01008956|Influenza|influenza
5569379|NCT01008956|H1N1|h1n1
5569380|NCT01008956|Pandemic|pandemic
5569381|NCT01008956|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5569382|NCT01008930|Peripheral Tumors|peripheral tumors
5569383|NCT01008930|Arm|arm
5569384|NCT01008930|Leg|leg
5569385|NCT01008930|Head|head
5569386|NCT01008930|Neck|neck
5569387|NCT01008930|HR PET Imaging System|hr pet imaging system
5569388|NCT01008930|High-Resolution PET|high-resolution pet
5569389|NCT01008930|PET/CT|pet/ct
5569390|NCT01008930|PEMFlex Solo II|pemflex solo ii
5569391|NCT01008930|positron emission tomography/computed tomography (PET/CT)|positron emission tomography/computed tomography (pet/ct)
5569392|NCT01008917|Hepatocellular carcinoma|hepatocellular carcinoma
5569393|NCT01008917|HCC|hcc
5569394|NCT01008917|Liver cancer|liver cancer
5569395|NCT01008917|Hepatoma|hepatoma
5569396|NCT01008904|cancer survivor|cancer survivor
5569397|NCT01008904|hot flashes|hot flashes
5569398|NCT01008904|breast cancer|breast cancer
5569399|NCT01008904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5569400|NCT01008852|rheumatoid arthritis|rheumatoid arthritis
5569401|NCT01008852|seropositive|seropositive
5569402|NCT01008852|methotrexate|methotrexate
5569403|NCT01008839|study sarcopenia, which muscle becomes weaker with age|study sarcopenia, which muscle becomes weaker with age
5569404|NCT01008826|sulforaphane|sulforaphane
5569405|NCT01008826|pharmacokinetics|pharmacokinetics
5569406|NCT01008813|HIV infection|hiv infection
5569407|NCT01008813|adjuvanted and non-adjuvanted A(H1N1)v influenza vaccine|adjuvanted and non-adjuvanted a(h1n1)v influenza vaccine
5569408|NCT01008813|immunogenicity|immunogenicity
5569409|NCT01008813|safety|safety
5569410|NCT01008800|Autism Spectrum Disorder|autism spectrum disorder
5569411|NCT01008800|language|language
5569412|NCT01008800|social|social
5569413|NCT01008800|toddlers|toddlers
5569414|NCT01008787|Cancer Prevention|cancer prevention
5569415|NCT01008787|Focus Group|focus group
5569416|NCT01008787|Interview|interview
5569417|NCT01008787|Physical Activity|physical activity
5569418|NCT01008787|African American women|african american women
5569419|NCT01008787|Exercise|exercise
5569420|NCT01008787|Exercise habits|exercise habits
5569421|NCT01008787|Health behavior|health behavior
5569422|NCT01008761|Pre-school child|pre-school child
5569423|NCT01008761|Wheezy episode|wheezy episode
5569424|NCT01008748|Smoking|smoking
5569425|NCT01008748|Latinos|latinos
5569426|NCT01008748|Mexican American|mexican american
5569427|NCT01008748|Spanish-speaking smokers|spanish-speaking smokers
5569428|NCT01008748|Ecological momentary assessment|ecological momentary assessment
5569429|NCT01008748|Nicotine patch|nicotine patch
5569430|NCT01008748|Smoking cessation counseling|smoking cessation counseling
5569431|NCT01008748|Questionnaire|questionnaire
5569432|NCT01008748|EMA|ema
5569433|NCT01008722|Atrial Fibrillation|atrial fibrillation
5569434|NCT01008722|Ablation|ablation
5569435|NCT01008696|Reflux esophagitis|reflux esophagitis
5569436|NCT01008696|Rabeprazole|rabeprazole
5569437|NCT01008696|Lansoprazole|lansoprazole
5671235|NCT00616590|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5569438|NCT01008683|Stem cell and and heart transplant patients who will receive pandemic H1N1 influenza vaccinations|stem cell and and heart transplant patients who will receive pandemic h1n1 influenza vaccinations
5569448|NCT01008631|sodium Thiosulfate|sodium thiosulfate
5569449|NCT01008631|pharmakokinetic|pharmakokinetic
5569450|NCT01008618|Chronic pain|chronic pain
5569451|NCT01008618|Osteoarthritis|osteoarthritis
5569452|NCT01008618|Low back pain|low back pain
5569453|NCT01008618|Fentanyl|fentanyl
5569454|NCT01008618|JNS020QD|jns020qd
5569455|NCT01008618|Patch, transdermal|patch, transdermal
5569456|NCT01008618|Opioid analgesics|opioid analgesics
5569457|NCT01008605|Erectile Dysfunction|erectile dysfunction
5569458|NCT01008592|dermatographism, levocetirizine (Xyzal)|dermatographism, levocetirizine (xyzal)
5569459|NCT01008592|chronic idiopathic urticaria, dermatographism|chronic idiopathic urticaria, dermatographism
5569460|NCT01008579|Patient Reported Outcome Measures|patient reported outcome measures
5569461|NCT01008579|falls|falls
5569462|NCT01008579|older adults|older adults
5569463|NCT01008553|Postherpetic Neuralgia|postherpetic neuralgia
5569464|NCT01008553|Complex Regional Pain Syndromes (CRPS)|complex regional pain syndromes (crps)
5569465|NCT01008553|Postoperative Pain|postoperative pain
5569466|NCT01008553|Fentanyl|fentanyl
5569467|NCT01008553|Patch, transdermal|patch, transdermal
5569468|NCT01008553|Opioid analgesics|opioid analgesics
5569469|NCT01008540|cytomegalovirus|cytomegalovirus
5569470|NCT01008540|resistance|resistance
5569471|NCT01008540|transplantation|transplantation
5680321|NCT00578214|anxiety|anxiety
5569472|NCT01008540|Patient coming to an French transplantation center for solid organ or bone marrow transplant, with information and signed consent|patient coming to an french transplantation center for solid organ or bone marrow transplant, with information and signed consent
5569473|NCT01008527|skin|skin
5569474|NCT01008527|cutaneous|cutaneous
5569475|NCT01008527|immunotherapy|immunotherapy
5569476|NCT01008527|immunology|immunology
5569477|NCT01008527|dose escalation|dose escalation
5569478|NCT01008514|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5569479|NCT01008514|stage IA breast cancer|stage ia breast cancer
5569480|NCT01008514|stage IB breast cancer|stage ib breast cancer
5569481|NCT01008514|stage II breast cancer|stage ii breast cancer
5569491|NCT01008488|colonic diverticulitis|colonic diverticulitis
5569492|NCT01008488|diverticular disease|diverticular disease
5569493|NCT01008488|antibiotic therapy|antibiotic therapy
5569494|NCT01008475|EMD 525797|emd 525797
5569495|NCT01008475|Cetuximab|cetuximab
5569496|NCT01008475|Irinotecan|irinotecan
5569497|NCT01008475|metastatic colorectal cancer|metastatic colorectal cancer
5569498|NCT01008449|Staples|staples
5569499|NCT01008449|Sutures|sutures
5569500|NCT01008449|Cesarean Delivery|cesarean delivery
5569501|NCT01008449|Wound|wound
5569502|NCT01008449|Skin Closure|skin closure
5569503|NCT01008449|Wound infection|wound infection
5569504|NCT01008449|Wound disruption|wound disruption
5569505|NCT01008436|Ability of topical drug to reduce acute and overall bleeding as well as blood transfusions|ability of topical drug to reduce acute and overall bleeding as well as blood transfusions
5569506|NCT01008423|Proctitis|proctitis
5569507|NCT01008423|Proctosigmoiditis|proctosigmoiditis
5569508|NCT01008423|Ulcerative|ulcerative
5569509|NCT01008423|Salix|salix
5569510|NCT01008423|Budesonide foam|budesonide foam
5569511|NCT01008423|Budesonide|budesonide
5569512|NCT01008423|Rectal|rectal
5569513|NCT01008423|Gastrointestinal|gastrointestinal
5569514|NCT01008423|Colitis|colitis
5569515|NCT01008423|UC|uc
5569516|NCT01008423|UP|up
5569517|NCT01008423|UPS|ups
5569518|NCT01008423|Additional relevant MeSH terms:|additional relevant mesh terms:
5569519|NCT01008423|Proctocolitis|proctocolitis
5569520|NCT01008423|Ulcer|ulcer
5569521|NCT01008423|Colitis, Ulcerative|colitis, ulcerative
5569522|NCT01008423|Gastroenteritis|gastroenteritis
5569523|NCT01008423|Gastrointestinal Diseases|gastrointestinal diseases
5569524|NCT01008423|Digestive System Diseases|digestive system diseases
5569525|NCT01008423|Rectal Diseases|rectal diseases
5569526|NCT01008423|Intestinal Diseases|intestinal diseases
5569527|NCT01008423|Colonic Diseases|colonic diseases
5569528|NCT01008423|Sigmoid Diseases|sigmoid diseases
5569529|NCT01008423|Pathologic Processes|pathologic processes
5569530|NCT01008423|Inflammatory Bowel Diseases|inflammatory bowel diseases
5569531|NCT01008423|Bronchodilator Agents|bronchodilator agents
5569532|NCT01008423|Autonomic Agents|autonomic agents
5569533|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents
5569534|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs
5569535|NCT01008423|Pharmacologic Actions|pharmacologic actions
5569536|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents
5551623|NCT01080833|EMS|ems
5569537|NCT01008423|Respiratory System Agents|respiratory system agents
5569538|NCT01008423|Therapeutic Uses|therapeutic uses
5569539|NCT01008423|Glucocorticoids|glucocorticoids
5569540|NCT01008423|Hormones|hormones
5569541|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5569542|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents
5569543|NCT01008410|Proctitis|proctitis
5569544|NCT01008410|Proctosigmoiditis|proctosigmoiditis
5569545|NCT01008410|Ulcerative|ulcerative
5569546|NCT01008410|Salix|salix
5569547|NCT01008410|Budesonide foam|budesonide foam
5569548|NCT01008410|Budesonide|budesonide
5569549|NCT01008410|Rectal|rectal
5569550|NCT01008410|Gastrointestinal|gastrointestinal
5569551|NCT01008410|Colitis|colitis
5569553|NCT01008410|UP|up
5569554|NCT01008410|UPS|ups
5569555|NCT01008410|Additional relevant MeSH terms:|additional relevant mesh terms:
5569556|NCT01008410|Proctocolitis|proctocolitis
5569557|NCT01008410|Ulcer|ulcer
5569558|NCT01008410|Colitis, Ulcerative|colitis, ulcerative
5569559|NCT01008410|Gastroenteritis|gastroenteritis
5569560|NCT01008410|Gastrointestinal Diseases|gastrointestinal diseases
5569561|NCT01008410|Digestive System Diseases|digestive system diseases
5569562|NCT01008410|Rectal Diseases|rectal diseases
5569563|NCT01008410|Intestinal Diseases|intestinal diseases
5569564|NCT01008410|Colonic Diseases|colonic diseases
5569565|NCT01008410|Sigmoid Diseases|sigmoid diseases
5569566|NCT01008410|Pathologic Processes|pathologic processes
5569567|NCT01008410|Inflammatory Bowel Diseases|inflammatory bowel diseases
5569568|NCT01008410|Bronchodilator Agents|bronchodilator agents
5569569|NCT01008410|Autonomic Agents|autonomic agents
5569570|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents
5569571|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs
5569572|NCT01008410|Pharmacologic Actions|pharmacologic actions
5569573|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents
5569574|NCT01008410|Respiratory System Agents|respiratory system agents
5569575|NCT01008410|Therapeutic Uses|therapeutic uses
5569576|NCT01008410|Glucocorticoids|glucocorticoids
5569577|NCT01008410|Hormones|hormones
5569578|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5569579|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents
5569580|NCT01008397|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5569581|NCT01008371|Obesity|obesity
5569582|NCT01008371|Cholecystokinin|cholecystokinin
5569583|NCT01008371|Oxytocin|oxytocin
5569584|NCT01008371|Satiety|satiety
5569585|NCT01008371|Gastric emptying|gastric emptying
5569586|NCT01008371|Anxiety|anxiety
5569587|NCT01008371|Depression|depression
5569588|NCT01008371|Panic Disorder|panic disorder
5569589|NCT01008332|House Dust Mite Allergy|house dust mite allergy
5569590|NCT01008332|Immunotherapy|immunotherapy
5569591|NCT01008332|Rhinoconjunctivitis|rhinoconjunctivitis
5569592|NCT01008332|Toleromune HDM|toleromune hdm
5569593|NCT01008319|Anovulation|anovulation
5569594|NCT01008319|Ovulation induction|ovulation induction
5569595|NCT01008306|Cardiorespiratory fitness|cardiorespiratory fitness
5569596|NCT01008306|physical activity|physical activity
5569597|NCT01008306|hypertension|hypertension
5569598|NCT01008306|overweight and obesity|overweight and obesity
5569599|NCT01008306|metabolic syndrome|metabolic syndrome
5569600|NCT01008306|Body composition|body composition
5569601|NCT01008241|Hospice|hospice
5569602|NCT01008241|End of Life|end of life
5569603|NCT01008241|Knowledge|knowledge
5569604|NCT01008241|Attitudes|attitudes
5569605|NCT01008241|Opinions|opinions
5569606|NCT01008241|Advanced Care Planning|advanced care planning
5569607|NCT01008241|Death and Dying|death and dying
5569608|NCT01008241|Communication|communication
5569609|NCT01008241|Knowledge and Attitudes of South Florida Residents on Hospice Care|knowledge and attitudes of south florida residents on hospice care
5569610|NCT01008228|spontaneous|spontaneous
5569611|NCT01008228|primary|primary
5569612|NCT01008228|first episode|first episode
5569613|NCT01008215|INR Control|inr control
5569614|NCT01008215|Warfarin dosing|warfarin dosing
5569615|NCT01008215|Family physicians|family physicians
5569616|NCT01008215|Cluster randomization|cluster randomization
5569617|NCT01008176|Hypertension|hypertension
5569618|NCT01008176|Sleep|sleep
5569619|NCT01008176|Blood Pressure|blood pressure
5569620|NCT01008176|Inflammatory Markers|inflammatory markers
5569621|NCT01008150|breast cancer|breast cancer
5569622|NCT01008150|neoadjuvant|neoadjuvant
5569623|NCT01008150|neratinib|neratinib
5569624|NCT01008150|paclitaxel|paclitaxel
5569625|NCT01008150|trastuzumab|trastuzumab
5569626|NCT01008150|doxorubicin|doxorubicin
5569627|NCT01008150|cyclophosphamide|cyclophosphamide
5569628|NCT01008124|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5569632|NCT01008124|Vertigo|vertigo
5569633|NCT01008111|regeneration|regeneration
5569634|NCT01008111|tissue survival|tissue survival
5569635|NCT01008111|biological processes|biological processes
5569636|NCT01008111|connective tissue|connective tissue
5569638|NCT01008098|Posttraumatic Stress Disorder|posttraumatic stress disorder
5569639|NCT01008098|Escitalopram|escitalopram
5569640|NCT01008098|Magnetic Resonance Imaging|magnetic resonance imaging
5569641|NCT01008098|BDNF|bdnf
5569642|NCT01008085|STEMI|stemi
5569643|NCT01008085|self-expandable|self-expandable
5569644|NCT01008085|balloon-expandable|balloon-expandable
5569645|NCT01008046|Polycystic ovary syndrome|polycystic ovary syndrome
5569646|NCT01008046|clomiphene resistance|clomiphene resistance
5569647|NCT01008046|metformin|metformin
5569648|NCT01008046|N-acetyl cysteine|n-acetyl cysteine
5569649|NCT01008020|tea catechin extracts|tea catechin extracts
5569650|NCT01008020|influenza infection|influenza infection
5569651|NCT01008020|prophylaxis|prophylaxis
5569652|NCT01008020|supplements|supplements
5569653|NCT01008020|adults over 20 years old|adults over 20 years old
5569654|NCT01008020|both men and women|both men and women
5569655|NCT01008007|Viusid|viusid
5569656|NCT01008007|Dietary supplements|dietary supplements
5569657|NCT01008007|Acute fever|acute fever
5569658|NCT01008007|Viral etiology|viral etiology
5569659|NCT01007994|Nocturnal hypertension|nocturnal hypertension
5569660|NCT01007994|Pediatric|pediatric
5569661|NCT01007994|Renal Transplant|renal transplant
5569662|NCT01007994|Pulse Wave Velocity|pulse wave velocity
5569663|NCT01007994|Echocardiogram|echocardiogram
5569664|NCT01007994|Pediatric Renal Transplant Recipient|pediatric renal transplant recipient
5569665|NCT01007968|solid tumors|solid tumors
5569666|NCT01007968|hepatic function|hepatic function
5569667|NCT01007968|advanced|advanced
5569668|NCT01007968|panobinostat|panobinostat
5569669|NCT01007929|ADME|adme
5569670|NCT01007929|safety|safety
5569671|NCT01007929|oral solution|oral solution
5569672|NCT01007890|ChemoFX|chemofx
5569673|NCT01007890|Operable|operable
5569674|NCT01007890|Breast|breast
5569675|NCT01007890|Cancer|cancer
5569676|NCT01007890|Measurable|measurable
5569677|NCT01007890|Disease|disease
5569678|NCT01008163|diabetes|diabetes
5569679|NCT01007942|Metastatic breast cancer|metastatic breast cancer
5569680|NCT01007942|locally advanced breast cancer|locally advanced breast cancer
5569681|NCT01007942|HER2/neu positive breast cancer|her2/neu positive breast cancer
5569682|NCT01007942|HER2/neu over-expressing|her2/neu over-expressing
5569683|NCT01007942|progressive-free survival (PFS)|progressive-free survival (pfs)
5569684|NCT01007942|over survival (OS)|over survival (os)
5569686|NCT01007942|bolero 3|bolero 3
5569687|NCT01007942|Breast cancer|breast cancer
5569688|NCT01007942|everolimus|everolimus
5569689|NCT01007942|HER+|her+
5569690|NCT01007942|vinorelbine|vinorelbine
5569691|NCT01007942|herceptin|herceptin
5569692|NCT01007942|trastuzumab|trastuzumab
5569693|NCT01007942|RAD001|rad001
5569694|NCT01007877|sleepiness|sleepiness
5569695|NCT01007877|driving|driving
5569696|NCT01007864|Parkinson|parkinson
5569697|NCT01007864|piribedil|piribedil
5569698|NCT01007864|vigilance|vigilance
5569699|NCT01007864|dopamine agonist|dopamine agonist
5569700|NCT01007864|cognition|cognition
5569701|NCT01007851|GnRH agonist|gnrh agonist
5569702|NCT01007851|GnRH antagonist|gnrh antagonist
5569703|NCT01007851|IVF|ivf
5569704|NCT01007851|ICSI|icsi
5569705|NCT01007851|assisted reproduction|assisted reproduction
5569706|NCT01007851|luteal phase|luteal phase
5569707|NCT01007838|Progressive Resistance Training/Exercise|progressive resistance training/exercise
5569708|NCT01007838|Muscle wasting|muscle wasting
5569709|NCT01007838|Chronic Kidney Disease|chronic kidney disease
5569710|NCT01007786|Pediatric Hydrocephalus|pediatric hydrocephalus
5569711|NCT01007786|Ultrasound Guided Surgery|ultrasound guided surgery
5569712|NCT01007773|Dexmedetomidine|dexmedetomidine
5569713|NCT01007773|Intracranial Pressure|intracranial pressure
5569714|NCT01007773|Traumatic Brain Injury|traumatic brain injury
5569715|NCT01007760|Tobacco smoke|tobacco smoke
5569716|NCT01007760|Oxidative stress|oxidative stress
5569717|NCT01007760|Endothelial Function|endothelial function
5569718|NCT01007760|Atherosclerosis|atherosclerosis
5569719|NCT01007760|Arterial Stiffness|arterial stiffness
5569720|NCT01007760|Microvascular Function|microvascular function
5569721|NCT01007747|Geranium oil|geranium oil
5569722|NCT01007747|Neuropathy|neuropathy
5569723|NCT01007734|Quality of life|quality of life
5569724|NCT01007734|COPD patients|copd patients
5569725|NCT01007734|Evaluation According to Gender the Determining Independent Factors of Quality of Life Related to Respiratory Status of Patient With Moderate to Severe COPD|evaluation according to gender the determining independent factors of quality of life related to respiratory status of patient with moderate to severe copd
5569726|NCT01007695|breast cancer|breast cancer
5569727|NCT01007682|intrusive memories|intrusive memories
5569728|NCT01007669|Physical activity|physical activity
5569729|NCT01007656|healthy adult subjects|healthy adult subjects
5569730|NCT01007656|safety evaluation|safety evaluation
5569731|NCT01007656|GD Antrodia camphorata|gd antrodia camphorata
5569732|NCT01007643|anterior knee pain|anterior knee pain
5569734|NCT01007643|female|female
5569735|NCT01007643|interactive video games|interactive video games
5569736|NCT01007643|patellofemoral syndrome|patellofemoral syndrome
5569737|NCT01007643|treatment|treatment
5569738|NCT01007643|compliance|compliance
5569739|NCT01007643|home exercises|home exercises
5569740|NCT01007630|Parkinson's|parkinson's
5569741|NCT01007630|Parkinsons|parkinsons
5569742|NCT01007630|Parkinson|parkinson
5569743|NCT01007630|Parkinson's Disease|parkinson's disease
5569756|NCT01007617|Children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis|children with malignancies receiving chemotherapy and/or radiotherapy inducing severe mucositis
5569759|NCT01007578|Paclitaxel|paclitaxel
5569760|NCT01007578|Paclitaxel-coated balloon catheters|paclitaxel-coated balloon catheters
5569761|NCT01007578|Peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5569762|NCT01007578|Plasma levels|plasma levels
5569763|NCT01007578|Femoral artery|femoral artery
5569764|NCT01007578|Popliteal artery|popliteal artery
5569765|NCT01007578|Peripheral arterial disease (PAD) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis|peripheral arterial disease (pad) including stenotic or occluded femoro-popliteal arteries due to atherosclerosis
5569766|NCT01007565|periarticular injection|periarticular injection
5569767|NCT01007552|Biliary Duct Cancer|biliary duct cancer
5569768|NCT01007552|Cancer of the Gallbladder|cancer of the gallbladder
5569769|NCT01007552|Adenocarcinoma of the Gall Bladder|adenocarcinoma of the gall bladder
5569770|NCT01007552|Adenocarcinoma of the Biliary Ducts|adenocarcinoma of the biliary ducts
5569771|NCT01007552|Cholangiocarcinoma|cholangiocarcinoma
5569772|NCT01007552|Extrahepatic cholangiocarcinoma|extrahepatic cholangiocarcinoma
5569773|NCT01007526|Extranodal Lymphoma|extranodal lymphoma
5569774|NCT01007526|Natural killer cell|natural killer cell
5569775|NCT01007526|T cell|t cell
5569776|NCT01007526|Radiotherapy|radiotherapy
5569777|NCT01007526|Chemotherapy|chemotherapy
5569778|NCT01007513|Prematurity|prematurity
5569779|NCT01007513|Inflammation|inflammation
5569780|NCT01007513|Transvaginal ultrasound|transvaginal ultrasound
5569781|NCT01007513|Vaginal secretion|vaginal secretion
5569782|NCT01007513|Inflammatory process|inflammatory process
5569783|NCT01007513|Neonatal morbidity|neonatal morbidity
5569784|NCT01007500|Postoperative nausea and vomiting after video-assisted thoracoscopic surgery|postoperative nausea and vomiting after video-assisted thoracoscopic surgery
5569785|NCT01007487|Plastic wound protector|plastic wound protector
5569786|NCT01007487|Plastic wound retractor|plastic wound retractor
5569787|NCT01007487|Bacterial translocation|bacterial translocation
5569788|NCT01007487|Surgical site infection|surgical site infection
5569789|NCT01007487|Abdominal surgery|abdominal surgery
5569790|NCT01007487|Wound infection|wound infection
5569791|NCT01007461|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5569793|NCT01007461|Acute ST-Segment Elevation Myocardial Infraction (STEMI)|acute st-segment elevation myocardial infraction (stemi)
5569795|NCT01007448|bexarotene|bexarotene
5569796|NCT01007448|Targretin|targretin
5569797|NCT01007448|Refractory Cutaneous T-cell Lymphoma|refractory cutaneous t-cell lymphoma
5569798|NCT01007448|cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5569799|NCT01007448|MF|mf
5569800|NCT01007448|Mycoses fungoides|mycoses fungoides
5569801|NCT01007422|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5569802|NCT01007422|pain|pain
5569803|NCT01007409|To assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers|to assess food effect on the pharmacokinetics of fimasartan in healthy male volunteers
5569804|NCT01007396|Interferon-gamma release assay|interferon-gamma release assay
5569805|NCT01007383|Safety and tolerability of LEO 27847|safety and tolerability of leo 27847
5569806|NCT01007370|tracheal intubation|tracheal intubation
5569807|NCT01007370|supraglottic airway devices|supraglottic airway devices
5569808|NCT01007344|flaxseed|flaxseed
5569809|NCT01007344|hypercholesterolemia|hypercholesterolemia
5569810|NCT01007344|children|children
5569811|NCT01007331|Infants|infants
5569812|NCT01007331|Atopic Dermatitis|atopic dermatitis
5569813|NCT01007331|SCORAD|scorad
5569814|NCT01007331|IgE|ige
5569815|NCT01007331|Eosinophil Cation Protein|eosinophil cation protein
5569816|NCT01007331|Calprotectin|calprotectin
5569817|NCT01007331|Intestinal microflora|intestinal microflora
5569818|NCT01007292|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5569819|NCT01007292|relapsed|relapsed
5569820|NCT01007292|CD20-Positive|cd20-positive
5569821|NCT01007292|YM155|ym155
5569822|NCT01007279|Percutaneous angioplasty|percutaneous angioplasty
5569823|NCT01007279|Myocardial Infarction|myocardial infarction
5569927|NCT01006863|hypotension|hypotension
5569824|NCT01007266|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5569825|NCT01007266|Adolescents|adolescents
5569826|NCT01007266|Pediatric|pediatric
5569827|NCT01007266|Patient Partner|patient partner
5569828|NCT01007266|Buddy|buddy
5569829|NCT01007266|Obesity|obesity
5569830|NCT01007266|Type 2 Diabetes|type 2 diabetes
5569831|NCT01007240|head and neck carcinoma|head and neck carcinoma
5569833|NCT01007240|maxillectomy|maxillectomy
5569834|NCT01007240|soft liner|soft liner
5569835|NCT01007240|nano particles|nano particles
5569836|NCT01007240|antibacterial properties|antibacterial properties
5569837|NCT01007240|patients post maxillectomy|patients post maxillectomy
5569838|NCT01007214|Prostate cancer|prostate cancer
5569839|NCT01007214|Prostatectomy|prostatectomy
5569840|NCT01007201|Influenza|influenza
5569841|NCT01007201|H1N1|h1n1
5569842|NCT01007201|vaccine|vaccine
5569843|NCT01007201|Immunogenicity|immunogenicity
5569844|NCT01007188|almond|almond
5569845|NCT01007188|nuts|nuts
5569846|NCT01007188|energy value|energy value
5569847|NCT01007188|cardiovascular disease|cardiovascular disease
5569848|NCT01007188|phytonutrient|phytonutrient
5569849|NCT01007188|gene expression|gene expression
5569850|NCT01007188|energy value of almonds|energy value of almonds
5569851|NCT01007188|energy|energy
5569852|NCT01007175|TNF inhibitor|tnf inhibitor
5569853|NCT01007175|Multiple ascending dose study|multiple ascending dose study
5569854|NCT01007149|Severe asthma,|severe asthma,
5569855|NCT01007149|non-atopic,|non-atopic,
5569856|NCT01007149|omalizumab|omalizumab
5569857|NCT01007136|tDCS|tdcs
5569858|NCT01007136|stroke|stroke
5569859|NCT01007136|functional MRI|functional mri
5569861|NCT01007123|Chronic idiopathic constipation|chronic idiopathic constipation
5569862|NCT01007123|A3309|a3309
5569863|NCT01007110|DHA|dha
5569864|NCT01007097|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5569865|NCT01007097|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5569866|NCT01007097|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5569867|NCT01007097|Drug Therapy|drug therapy
5569868|NCT01007084|pain|pain
5569869|NCT01007084|trauma|trauma
5569870|NCT01007084|propranolol|propranolol
5569871|NCT01007058|Urinary Bladder|urinary bladder
5569872|NCT01007058|Non-muscle-invasive transitional cell carcinoma|non-muscle-invasive transitional cell carcinoma
5569873|NCT01007058|Intact bladder|intact bladder
5569874|NCT01007058|Intravesical Bladder Cancer Therapy|intravesical bladder cancer therapy
5569875|NCT01007058|Tumor Recurrence|tumor recurrence
5569876|NCT01007058|Surrogate markers of response|surrogate markers of response
5569877|NCT01007058|BCG|bcg
5569878|NCT01007058|Bacillus Calmette Guérin|bacillus calmette guérin
5569879|NCT01007058|Interferon-alfa-2b|interferon-alfa-2b
5569880|NCT01007058|IFN-alfa-2b|ifn-alfa-2b
5569881|NCT01007058|Interferon|interferon
5569882|NCT01007058|Fluorescence in situ hybridization|fluorescence in situ hybridization
5569883|NCT01007058|FISH|fish
5569884|NCT01007045|deep vein thrombosis|deep vein thrombosis
5569885|NCT01007045|venous thromboembolic disorders|venous thromboembolic disorders
5569886|NCT01007045|diagnostic ultrasound|diagnostic ultrasound
5569887|NCT01007032|anti-IGF-IR|anti-igf-ir
5569888|NCT01007032|monoclonal|monoclonal
5569889|NCT01007032|solid tumor|solid tumor
5569890|NCT01007032|insulin-like growth factor|insulin-like growth factor
5569891|NCT01007019|Safety, tolerability and PK/PD|safety, tolerability and pk/pd
5569892|NCT01007006|Telepharmacy Robotic Medicine Delivery Unit|telepharmacy robotic medicine delivery unit
5569893|NCT01007006|Brain Injuries|brain injuries
5569894|NCT01007006|Stress Disorders|stress disorders
5569895|NCT01007006|Combat disorders|combat disorders
5569896|NCT01007006|Polytrauma|polytrauma
5569897|NCT01007006|Adherence|adherence
5569898|NCT01006967|balance|balance
5569899|NCT01006967|accidental falls|accidental falls
5569900|NCT01006967|physical therapy|physical therapy
5569901|NCT01006967|ActiveStep|activestep
5569902|NCT01006967|older adults|older adults
5569903|NCT01006954|Poor responder|poor responder
5569904|NCT01006954|Flare up|flare up
5569905|NCT01006954|Micro dose GnRH agonist flare up|micro dose gnrh agonist flare up
5569906|NCT01006954|IVF/ICSI|ivf/icsi
5569907|NCT01006941|Multiple sclerosis|multiple sclerosis
5569908|NCT01006941|safety|safety
5569909|NCT01006941|MRI|mri
5569910|NCT01006941|immunological|immunological
5569911|NCT01006941|Helminths|helminths
5569912|NCT01006941|Trichuris suis|trichuris suis
5569913|NCT01006928|Subjective health feeling|subjective health feeling
5569914|NCT01006928|NICU|nicu
5569915|NCT01006928|team support|team support
5569916|NCT01006915|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
5569917|NCT01006902|Elderly|elderly
5569918|NCT01006902|Function|function
5569919|NCT01006902|Oncologic therapy|oncologic therapy
5569920|NCT01006902|Functional change with chemotherapy|functional change with chemotherapy
5569921|NCT01006876|coumadin|coumadin
5569922|NCT01006876|peri-procedural thromboembolism|peri-procedural thromboembolism
5569923|NCT01006876|RFCA|rfca
5569924|NCT01006876|high risk atrial fibrillation|high risk atrial fibrillation
5569926|NCT01006863|phenylephrine|phenylephrine
5569928|NCT01006863|propofol|propofol
5569929|NCT01006863|anesthesia|anesthesia
5569930|NCT01006863|cardiac valve surgery|cardiac valve surgery
5569931|NCT01006837|trauma patients|trauma patients
5569932|NCT01006837|severe injury|severe injury
5569933|NCT01006837|ISS ≥9|iss ≥9
5569934|NCT01006824|Capsule endoscopy|capsule endoscopy
5563923|NCT01031563|Risk Taking|risk taking
5569935|NCT01006824|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5569937|NCT01006811|Hypsarrhythmia|hypsarrhythmia
5569938|NCT01006798|Virus Diseases|virus diseases
5569939|NCT01006798|Respiratory Tract Diseases|respiratory tract diseases
5569940|NCT01006798|Vaccine|vaccine
5569941|NCT01006785|Breast Cancer|breast cancer
5569942|NCT01006785|DLBS 1425|dlbs 1425
5569943|NCT01006785|Cancer|cancer
5569944|NCT01006785|Advanced/Metastatic (Stage IIIB/IV) Breast Cancer|advanced/metastatic (stage iiib/iv) breast cancer
5569945|NCT01006772|Stroke|stroke
5569946|NCT01006772|Ankle Foot Orthosis|ankle foot orthosis
5569947|NCT01006772|Walking Speed|walking speed
5569948|NCT01006772|Gait|gait
5569949|NCT01006772|Rehabilitation|rehabilitation
5569950|NCT01006772|Hemiplegia|hemiplegia
5569951|NCT01006759|Leprosy|leprosy
5569952|NCT01006759|Disability Evaluation|disability evaluation
5569953|NCT01006759|Quality of Life|quality of life
5569954|NCT01006759|Sensation|sensation
5569955|NCT01006746|Remote monitoring|remote monitoring
5569956|NCT01006746|Defibrillators|defibrillators
5569957|NCT01006746|Survey|survey
5569958|NCT01006746|Indication for ICD (primary and secondary prevention)|indication for icd (primary and secondary prevention)
5569959|NCT01006733|pharmacogenetics|pharmacogenetics
5569960|NCT01006733|arthroplasty|arthroplasty
5569961|NCT01006733|VKORC1|vkorc1
5569962|NCT01006733|thromboembolism|thromboembolism
5569963|NCT01006733|warfarin|warfarin
5569964|NCT01006720|Residual neuromuscular block|residual neuromuscular block
5569965|NCT01006720|post-operative residual curarization|post-operative residual curarization
5569966|NCT01006720|PORC|porc
5569967|NCT01006720|sugammadex|sugammadex
5569968|NCT01006720|neostigmine|neostigmine
5569969|NCT01006694|depression|depression
5569970|NCT01006694|collaborative care|collaborative care
5569971|NCT01006694|Vietnam|vietnam
5569972|NCT01006694|behavioral activation|behavioral activation
5569973|NCT01006681|rheumatoid|rheumatoid
5569974|NCT01006681|SLE|sle
5569975|NCT01006681|Psoriatic arthritis|psoriatic arthritis
5569976|NCT01006681|Ankylosing|ankylosing
5569977|NCT01006681|Influenza H1N1|influenza h1n1
5569978|NCT01006681|Vaccine|vaccine
5569979|NCT01006681|Vaccination against H1N1 in rheumatic diseases|vaccination against h1n1 in rheumatic diseases
5569980|NCT01006668|Neonates|neonates
5569981|NCT01006668|Intensive care|intensive care
5569982|NCT01006668|Endotracheal intubation|endotracheal intubation
5569983|NCT01006668|Neonates in intensive care|neonates in intensive care
5569984|NCT01006655|asthma|asthma
5569985|NCT01006655|preschool children|preschool children
5569986|NCT01006655|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5569987|NCT01006655|beclometasone dipropionate - HFA|beclometasone dipropionate - hfa
5569988|NCT01006655|Qvar|qvar
5569989|NCT01006655|Adenosine Challenge test|adenosine challenge test
5569990|NCT01006629|Efficacy of palivizumab|efficacy of palivizumab
5569991|NCT01006629|Respiratory syncytial virus (RSV) infection|respiratory syncytial virus (rsv) infection
5569992|NCT01006629|Prevention of severe RSV infection|prevention of severe rsv infection
5569993|NCT01006629|Preterm infants|preterm infants
5569994|NCT01006629|Infants with bronchopulmonary dysplasia|infants with bronchopulmonary dysplasia
5569995|NCT01006629|Infants with hemodynamically significant congenital heart disease|infants with hemodynamically significant congenital heart disease
5569996|NCT01006603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5569997|NCT01006603|elderly patients|elderly patients
5569998|NCT01006603|saxagliptin|saxagliptin
5569999|NCT01006603|randomised|randomised
5570000|NCT01006603|double-blind|double-blind
5570001|NCT01006590|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5570002|NCT01006590|Saxagliptin|saxagliptin
5570003|NCT01006590|Randomised|randomised
5570004|NCT01006590|Double-blind|double-blind
5570005|NCT01006577|rectal cancer|rectal cancer
5570006|NCT01006577|side-to-end anastomosis|side-to-end anastomosis
5570007|NCT01006577|colon J pouch|colon j pouch
5570008|NCT01006577|fecal incontinence|fecal incontinence
5570009|NCT01006577|anorectal function|anorectal function
5570010|NCT01006577|Are there differences between side-to-end anastomosis and colon J pouch in|are there differences between side-to-end anastomosis and colon j pouch in
5570011|NCT01006577|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)|bowel function (fecal incontinence, frequency of bowel movements, rectal urgency, incomplete evacuation)
5570012|NCT01006577|quality of life|quality of life
5570013|NCT01006577|postoperative complications|postoperative complications
5570014|NCT01006577|operation time/ institutional costs|operation time/ institutional costs
5570015|NCT01006564|Magnetic Resonance Imaging|magnetic resonance imaging
5570016|NCT01006564|Prostate Cancer|prostate cancer
5570017|NCT01006564|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5570018|NCT01006564|Radiotherapy planning|radiotherapy planning
5570019|NCT01006551|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
5570209|NCT01005641|hormone-responsive|hormone-responsive
5570020|NCT01006538|Wet Age-related Macular Degeneration|wet age-related macular degeneration
5570021|NCT01006538|Predominantly classic|predominantly classic
5570022|NCT01006538|Minimally classic|minimally classic
5570023|NCT01006538|Occult with no classic|occult with no classic
5564023|NCT01031225|NSCLC|nsclc
5570024|NCT01006538|Retinal Angiomatous Proliferation (RAP) lesions|retinal angiomatous proliferation (rap) lesions
5570027|NCT01006447|older adults|older adults
5570028|NCT01006447|exercise persistence|exercise persistence
5570029|NCT01006278|biomarker|biomarker
5570030|NCT01006278|knee arthroscopy|knee arthroscopy
5570031|NCT01006278|pain|pain
5570032|NCT01006213|Motivational Intervention|motivational intervention
5570033|NCT01006200|granulation tissue|granulation tissue
5570034|NCT01006200|benign|benign
5570035|NCT01006200|tracheal stenosis|tracheal stenosis
5570036|NCT01006200|ultraflex|ultraflex
5570037|NCT01006200|COPD|copd
5570038|NCT01006083|Aspirin|aspirin
5570039|NCT01006083|Plavix|plavix
5570040|NCT01006083|antiplatelet therapy|antiplatelet therapy
5570041|NCT01006083|Hemorrhage|hemorrhage
5570042|NCT01006083|ischemic events|ischemic events
5570043|NCT01005992|Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.|scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent.
5570044|NCT01005784|GnRH antagonists|gnrh antagonists
5570045|NCT01006499|neonatal sepsis|neonatal sepsis
5570046|NCT01006499|pentoxyfilline|pentoxyfilline
5570047|NCT01006499|pentaglobin|pentaglobin
5570048|NCT01006499|biomarker|biomarker
5570049|NCT01006499|To reduce mortality in neonatal sepsis|to reduce mortality in neonatal sepsis
5570050|NCT01006486|Oral anticoagulants|oral anticoagulants
5570051|NCT01006486|Warfarin|warfarin
5570052|NCT01006486|Anticoagulation clinic|anticoagulation clinic
5570053|NCT01006486|Thrombosis|thrombosis
5570054|NCT01006486|Hemorrhage|hemorrhage
5570055|NCT01006473|Chagas Disease|chagas disease
5570056|NCT01006473|Chagas Cardiomyopathy|chagas cardiomyopathy
5570057|NCT01006473|Exercise Movement Techniques|exercise movement techniques
5570058|NCT01006460|Quality of life and subjective well-being in middle aged women|quality of life and subjective well-being in middle aged women
5570059|NCT01006434|Stroke|stroke
5570060|NCT01006434|Thrombolysis|thrombolysis
5570061|NCT01006421|phototherapy|phototherapy
5570062|NCT01006421|Gingko biloba|gingko biloba
5570063|NCT01006421|repigmentation|repigmentation
5570064|NCT01006408|Neuropathy|neuropathy
5570065|NCT01006395|Prostate Cancer|prostate cancer
5570066|NCT01006395|Androgen deprivation|androgen deprivation
5570068|NCT01006395|Insulin resistance|insulin resistance
5570069|NCT01006395|Men with nonmetastatic prostate cancer receiving androgen deprivation|men with nonmetastatic prostate cancer receiving androgen deprivation
5570070|NCT01006369|stage IV colon cancer|stage iv colon cancer
5570071|NCT01006369|stage IV rectal cancer|stage iv rectal cancer
5570072|NCT01006369|recurrent colon cancer|recurrent colon cancer
5570073|NCT01006369|recurrent rectal cancer|recurrent rectal cancer
5570074|NCT01006356|Hydromorphone hydrochloride Oral Osmotic System|hydromorphone hydrochloride oral osmotic system
5570075|NCT01006356|Jurnista|jurnista
5570076|NCT01006317|Maternal health services|maternal health services
5570077|NCT01006317|utilization|utilization
5570078|NCT01006317|education|education
5570079|NCT01006317|randomized controlled trial|randomized controlled trial
5570080|NCT01006317|cost|cost
5570081|NCT01006317|clinical skills|clinical skills
5570082|NCT01006317|rural China|rural china
5570083|NCT01006304|JNJ-39439335|jnj-39439335
5570084|NCT01006304|Placebo|placebo
5570085|NCT01006304|Pain|pain
5570086|NCT01006304|Pain Measurements|pain measurements
5570087|NCT01006304|Adults|adults
5570089|NCT01006252|metastatic|metastatic
5570090|NCT01006252|second-line|second-line
5570091|NCT01006239|Cancer|cancer
5570092|NCT01006187|Analgesics|analgesics
5570093|NCT01006187|Influenza|influenza
5570094|NCT01006187|Vapocoolant|vapocoolant
5570095|NCT01006187|vaccination|vaccination
5570096|NCT01006187|pain|pain
5570097|NCT01006148|Metopic Craniosynostosis|metopic craniosynostosis
5570098|NCT01006122|Randomized|randomized
5570099|NCT01006122|double-blind|double-blind
5570100|NCT01006122|placebo-controlled|placebo-controlled
5570101|NCT01006122|crossover study of PF-03654746 in Excessive Daytime Sleepiness associated with Narcolepsy|crossover study of pf-03654746 in excessive daytime sleepiness associated with narcolepsy
5570103|NCT01006109|Repetitive TMS (rTMS)|repetitive tms (rtms)
5570104|NCT01006109|Decision-Making|decision-making
5570105|NCT01006109|Healthy Volunteers|healthy volunteers
5570106|NCT01006109|HV|hv
5570107|NCT01006109|Healthy Volunteer|healthy volunteer
5570108|NCT01006096|Psoriasis|psoriasis
5570109|NCT01006096|double-blind|double-blind
5570110|NCT01006096|randomized|randomized
5570111|NCT01006096|placebo-controlled|placebo-controlled
5570112|NCT01006096|erlotinib|erlotinib
5570113|NCT01006096|efficacy|efficacy
5570114|NCT01006070|multiple myeloma|multiple myeloma
5570115|NCT01006070|spinal disease|spinal disease
5570210|NCT01005641|metastatic breast cancer|metastatic breast cancer
5570119|NCT01006031|HIV infection|hiv infection
5570120|NCT01006031|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
5570121|NCT01006031|Ribavirin|ribavirin
5570122|NCT01006031|Treatment experienced|treatment experienced
5570123|NCT01006018|Prediabetic State|prediabetic state
5570126|NCT01005979|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5570127|NCT01005979|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5570128|NCT01005979|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
5570129|NCT01005979|Lymphoma|lymphoma
5570130|NCT01005979|Leukemia|leukemia
5570131|NCT01005966|remineralization|remineralization
5570132|NCT01005966|enamel|enamel
5570133|NCT01005966|in situ|in situ
5570134|NCT01005966|fluoride|fluoride
5570135|NCT01005966|caries|caries
5570136|NCT01005953|Autism|autism
5570137|NCT01005953|Behavioral Observations|behavioral observations
5570138|NCT01005953|Electronic diaries|electronic diaries
5570139|NCT01005953|Professionals treating children 3-10 with lower functioning autism|professionals treating children 3-10 with lower functioning autism
5570140|NCT01005940|Sleep Apnea Syndromes|sleep apnea syndromes
5570141|NCT01005940|Insulin Resistance|insulin resistance
5570142|NCT01005940|Mandibular advancement device|mandibular advancement device
5570143|NCT01005927|Calcium|calcium
5570144|NCT01005927|Bone and Bones|bone and bones
5570145|NCT01005927|Girls|girls
5570146|NCT01005927|Bone Mineralization|bone mineralization
5570147|NCT01005927|Fiber|fiber
5570148|NCT01005927|Fructooligosaccharide|fructooligosaccharide
5570149|NCT01005927|Female|female
5570150|NCT01005927|Healthy|healthy
5570151|NCT01005927|Adolescents|adolescents
5570152|NCT01005914|adults|adults
5570153|NCT01005914|Philadelphia chromosome precursor ALL,|philadelphia chromosome precursor all,
5570154|NCT01005914|T-cell ALL|t-cell all
5570155|NCT01005914|untreated ALL|untreated all
5570156|NCT01005901|COPD|copd
5570157|NCT01005901|NVA|nva
5570158|NCT01005901|FEV1|fev1
5570159|NCT01005888|Hereditary angioedema|hereditary angioedema
5570160|NCT01005888|HAE|hae
5570161|NCT01005888|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5570162|NCT01005888|C1INH-nf|c1inh-nf
5570163|NCT01005875|Hepatocellular carcinoma|hepatocellular carcinoma
5570164|NCT01005875|HCC|hcc
5570165|NCT01005875|Liver Cancer|liver cancer
5570166|NCT01005875|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5570167|NCT01005862|Alzheimer's disease antibody leucine ABeta|alzheimer's disease antibody leucine abeta
5570168|NCT01005849|Probiotics|probiotics
5570169|NCT01005849|Traveler's diarrhea|traveler's diarrhea
5570170|NCT01005849|Prevention|prevention
5570171|NCT01005836|Cognitive behavioral therapy|cognitive behavioral therapy
5570172|NCT01005836|Anxiety treatment|anxiety treatment
5570173|NCT01005836|Depression treatment|depression treatment
5570174|NCT01005836|Child treatment|child treatment
5570175|NCT01005836|Usual care|usual care
5570176|NCT01005797|Renal Cancer|renal cancer
5570177|NCT01005797|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5570178|NCT01005797|Solid Tumor|solid tumor
5570179|NCT01005797|Soft tissue sarcoma|soft tissue sarcoma
5570180|NCT01005797|Sorafenib|sorafenib
5570181|NCT01005797|Panobinostat|panobinostat
5570182|NCT01005771|Secondarily infected traumatic lesions|secondarily infected traumatic lesions
5570183|NCT01005758|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5570184|NCT01005758|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5570185|NCT01005758|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5570186|NCT01005758|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5570187|NCT01005758|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5570192|NCT01005732|hypertrophic|hypertrophic
5570193|NCT01005732|scar|scar
5570194|NCT01005732|burn|burn
5570195|NCT01005732|cicatrix|cicatrix
5570196|NCT01005732|pressure|pressure
5570197|NCT01005732|garment|garment
5570198|NCT01005693|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5570199|NCT01005667|Nulliparous women in spontaneous labor|nulliparous women in spontaneous labor
5570200|NCT01005654|Gene Expression|gene expression
5570201|NCT01005654|Epigenetic (methylation)|epigenetic (methylation)
5570202|NCT01005654|Tissues Histological Evaluations|tissues histological evaluations
5570203|NCT01005654|Establishment of Tumor Cell Lines|establishment of tumor cell lines
5570204|NCT01005654|Metabolite and Protein Expression|metabolite and protein expression
5570205|NCT01005654|Adrenal Cancer|adrenal cancer
5570206|NCT01005654|Endocrine Tumor|endocrine tumor
5570207|NCT01005654|Thyroid Cancer|thyroid cancer
5570208|NCT01005641|advanced breast cancer|advanced breast cancer
5570211|NCT01005628|Bortezomib postmarketing surveillance|bortezomib postmarketing surveillance
5570212|NCT01005628|Korea bortezomib PMS|korea bortezomib pms
5570213|NCT01005602|Digoxin|digoxin
5570214|NCT01005602|Pharmacokinetics|pharmacokinetics
5570215|NCT01005602|Dosing|dosing
5570216|NCT01005602|Heart Failure|heart failure
5570217|NCT01005589|Neonatal sepsis|neonatal sepsis
5570218|NCT01005589|Necrotizing enterocolitis|necrotizing enterocolitis
5570219|NCT01005589|CD64 antigen|cd64 antigen
5570220|NCT01005589|Receptors, IgG|receptors, igg
5570221|NCT01005576|Thalassemia|thalassemia
5570222|NCT01005576|Alemtuzumab|alemtuzumab
5570223|NCT01005576|Hematopoietic cell transplant|hematopoietic cell transplant
5570224|NCT01005576|non-myeloablative|non-myeloablative
5570225|NCT01005550|Unilateral spinal anaesthesia|unilateral spinal anaesthesia
5570226|NCT01005550|Hypobaric anaesthesia|hypobaric anaesthesia
5570227|NCT01005550|Ropivacaine|ropivacaine
5570228|NCT01005550|Traumatic hip surgery|traumatic hip surgery
5570229|NCT01005537|stage IV melanoma|stage iv melanoma
5570230|NCT01005524|brain computer interface|brain computer interface
5570231|NCT01005524|P3Speller|p3speller
5570232|NCT01005524|P300|p300
5570233|NCT01005524|Event Related potential|event related potential
5570234|NCT01005524|tetraplegia|tetraplegia
5570235|NCT01005524|Guillain barre syndrome|guillain barre syndrome
5570236|NCT01005524|Feasibility|feasibility
5570237|NCT01005524|Speed of spelling|speed of spelling
5570238|NCT01005524|Accuracy|accuracy
5570239|NCT01005511|Bruxism|bruxism
5552316|NCT01077635|HIV|hiv
5570240|NCT01005498|Low carbohydrate diet. Dietary treatment of diabetes mellitus.|low carbohydrate diet. dietary treatment of diabetes mellitus.
5570241|NCT01005498|Diabetes mellitus type 2 and dietary treatment.|diabetes mellitus type 2 and dietary treatment.
5570242|NCT01005485|Myocardial Infarction (MI)|myocardial infarction (mi)
5570243|NCT01005485|Circulating Endothelial Cells (CEC)|circulating endothelial cells (cec)
5570244|NCT01005485|Control Group A: (Vascular Surgery)|control group a: (vascular surgery)
5570245|NCT01005485|Control Group B: (Healthy controls)|control group b: (healthy controls)
5570246|NCT01005472|stage III melanoma|stage iii melanoma
5570247|NCT01005472|stage IV melanoma|stage iv melanoma
5570248|NCT01005472|recurrent melanoma|recurrent melanoma
5570249|NCT01005472|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5570250|NCT01005472|extraocular extension melanoma|extraocular extension melanoma
5570251|NCT01005472|iris melanoma|iris melanoma
5570252|NCT01005472|metastatic intraocular melanoma|metastatic intraocular melanoma
5570253|NCT01005472|recurrent intraocular melanoma|recurrent intraocular melanoma
5570254|NCT01005459|labor pain|labor pain
5570255|NCT01005459|combined spinal epidural labor analgesia|combined spinal epidural labor analgesia
5570256|NCT01005459|CSE analgesia|cse analgesia
5570257|NCT01005459|labor analgesia|labor analgesia
5570258|NCT01005433|dexmedetomidine|dexmedetomidine
5570259|NCT01005433|stress response|stress response
5570260|NCT01005433|cesarean delivery|cesarean delivery
5570261|NCT01005420|Insulin Sensitivity|insulin sensitivity
5570262|NCT01005420|Pre-diabetes|pre-diabetes
5570263|NCT01005420|Diabetes|diabetes
5570264|NCT01005420|Blueberries|blueberries
5570265|NCT01005420|Anthocyanins|anthocyanins
5570266|NCT01005407|HBV vaccine|hbv vaccine
5570267|NCT01005407|Hepatitis B vaccine|hepatitis b vaccine
5570268|NCT01005407|Hepatitis B|hepatitis b
5570269|NCT01005407|Hepatitis|hepatitis
5570271|NCT01005407|Prevention & Control|prevention & control
5570272|NCT01005407|Healthy|healthy
5570273|NCT01005407|Healthy volunteers|healthy volunteers
5570274|NCT01005381|Calcium|calcium
5570275|NCT01005381|Vitamin D|vitamin d
5570276|NCT01005381|Particle Size|particle size
5570277|NCT01005381|Adolescents|adolescents
5570278|NCT01005381|Bone|bone
5570279|NCT01005381|Osteoporosis|osteoporosis
5570280|NCT01005368|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5570281|NCT01005355|Solid tumor|solid tumor
5570282|NCT01005355|recombinant human IgG1|recombinant human igg1
5570283|NCT01005355|MAB|mab
5570284|NCT01005355|monoclonal antibody|monoclonal antibody
5570285|NCT01005355|VEGFR 2|vegfr 2
5570286|NCT01005355|human vascular endothelial growth factor receptor 2|human vascular endothelial growth factor receptor 2
5570287|NCT01005342|gene expression|gene expression
5570288|NCT01005342|oats|oats
5570289|NCT01005342|rye|rye
5570290|NCT01005342|sugar beet fiber|sugar beet fiber
5570291|NCT01005342|glucose|glucose
5570292|NCT01005342|insulin|insulin
5570293|NCT01005342|triglyceride|triglyceride
5570294|NCT01005342|decreased postprandial glucose|decreased postprandial glucose
5570295|NCT01005342|decreased postprandial insulin|decreased postprandial insulin
5570296|NCT01005342|glycemic index|glycemic index
5570297|NCT01005316|cohort study|cohort study
5570298|NCT01005316|allo-antibodies|allo-antibodies
5570299|NCT01005316|allosensitization|allosensitization
5570300|NCT01005303|Heart Failure|heart failure
5570301|NCT01005303|Micronutrients|micronutrients
5570302|NCT01005303|Vitamin D|vitamin d
5570303|NCT01005303|Inflammation|inflammation
5570304|NCT01005303|Oxidative Stress|oxidative stress
5570305|NCT01005303|Quality of Life|quality of life
5570306|NCT01005303|Physical Functioning|physical functioning
5570307|NCT01005290|cardiovascular|cardiovascular
5570308|NCT01005290|fixed|fixed
5570309|NCT01005290|dose|dose
5570310|NCT01005290|combination|combination
5570311|NCT01005290|pill|pill
5570312|NCT01005290|hypertension|hypertension
5570313|NCT01005277|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5570314|NCT01005277|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5570315|NCT01005277|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5570316|NCT01005277|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5570317|NCT01005277|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5570318|NCT01005277|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5570319|NCT01005277|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5570320|NCT01005277|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5570321|NCT01005277|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5570323|NCT01005264|neuropathic plantar ulcer|neuropathic plantar ulcer
5570324|NCT01005264|ulcer healing|ulcer healing
5570325|NCT01005264|non-removable total contact cast|non-removable total contact cast
5570326|NCT01005264|removable cast walker|removable cast walker
5570327|NCT01005251|GERD treatment|gerd treatment
5570328|NCT01005251|Acid and non-acid Reflux|acid and non-acid reflux
5570330|NCT01005251|Regurgitation|regurgitation
5570331|NCT01005251|Add-on treatment to PPI|add-on treatment to ppi
5570332|NCT01005225|Solid tumor|solid tumor
5570333|NCT01005225|prostate cancer|prostate cancer
5570334|NCT01005225|colon cancer|colon cancer
5570336|NCT01005212|Ultrasounds|ultrasounds
5570338|NCT01005212|endoleaks after endovascular repair of AAA|endoleaks after endovascular repair of aaa
5570339|NCT01005199|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5570340|NCT01005199|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5570341|NCT01005173|Acetaminophen|acetaminophen
5570342|NCT01005173|APAP|apap
5570343|NCT01005160|Mellitus, type 2|mellitus, type 2
5570344|NCT01005160|pharmacokinetic evaluation|pharmacokinetic evaluation
5570345|NCT01005160|drug interaction between CKD-501 and metformin|drug interaction between ckd-501 and metformin
5570346|NCT01005147|tranexamic acid|tranexamic acid
5570347|NCT01005147|upper GI bleeding|upper gi bleeding
5570348|NCT01005147|blood transfusion|blood transfusion
5570349|NCT01005147|GI bleeding|gi bleeding
5570350|NCT01005108|Hot Flashes for Breast Cancer Patients|hot flashes for breast cancer patients
5570351|NCT01005082|Low salt diet, idiopathic hypercalciuria, calcium stone formers|low salt diet, idiopathic hypercalciuria, calcium stone formers
5570352|NCT01005082|Calcium stone formers with idiopathic hypercalciuria|calcium stone formers with idiopathic hypercalciuria
5570353|NCT01005069|diabetes mellitus|diabetes mellitus
5570354|NCT01005069|DLBS-32|dlbs-32
5570355|NCT01005069|fasting plasma glucose|fasting plasma glucose
5570356|NCT01005069|insulin resistance|insulin resistance
5570357|NCT01005043|non-resectable osteosarcoma|non-resectable osteosarcoma
5570358|NCT01005043|heavy ion radiotherapy|heavy ion radiotherapy
5570359|NCT01005043|particle therapy|particle therapy
5570360|NCT01005043|safety|safety
5570361|NCT01005043|toxicity|toxicity
5570362|NCT01005043|survival|survival
5570363|NCT01005043|radiotherapy|radiotherapy
5570364|NCT01005030|Parkinson Disease|parkinson disease
5570365|NCT01005030|blood|blood
5570366|NCT01005030|plasma|plasma
5570367|NCT01005030|metabolomics|metabolomics
5570368|NCT01005030|spectroscopy|spectroscopy
5570369|NCT01005030|oxidative stress.|oxidative stress.
5570370|NCT01005017|Radiofrequent ablation|radiofrequent ablation
5570371|NCT01005017|Percutaneous radiofrequent therapy|percutaneous radiofrequent therapy
5570372|NCT01005004|PMD|pmd
5570373|NCT01005004|stem cells|stem cells
5570374|NCT01005004|Pelizaeus-Merzbacher Disease|pelizaeus-merzbacher disease
5570375|NCT01005004|human stem cells|human stem cells
5570376|NCT01005004|central nervous system stem cells|central nervous system stem cells
5570377|NCT01004965|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5570378|NCT01004965|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5570379|NCT01004965|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5570380|NCT01004965|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5570381|NCT01004965|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5570382|NCT01004965|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5570383|NCT01004965|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5570384|NCT01004952|Skin|skin
5570385|NCT01004952|Sunscreen|sunscreen
5570386|NCT01004952|UVR Protection|uvr protection
5570387|NCT01004952|09-137|09-137
5570388|NCT01004939|prophylaxis|prophylaxis
5570389|NCT01004939|venous thromboembolism|venous thromboembolism
5570390|NCT01004939|postpartum|postpartum
5570391|NCT01004939|fondaparinux|fondaparinux
5570392|NCT01004939|pregnancy|pregnancy
5570393|NCT01004926|Unilateral trans-tibial amputees|unilateral trans-tibial amputees
5570394|NCT01004913|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5570395|NCT01004913|Vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5570396|NCT01004913|Sacculo-colic reflex|sacculo-colic reflex
5570397|NCT01004900|Glaucoma, Angle Closure|glaucoma, angle closure
5570398|NCT01004900|Selective laser trabeculoplasty|selective laser trabeculoplasty
5570399|NCT01004900|Primary Angle Closure Disease|primary angle closure disease
5570400|NCT01004887|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5570401|NCT01004887|adult giant cell glioblastoma|adult giant cell glioblastoma
5570402|NCT01004887|adult gliosarcoma|adult gliosarcoma
5570403|NCT01004887|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5570404|NCT01004887|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5570405|NCT01004874|malignant glioma|malignant glioma
5570406|NCT01004874|glioblastoma|glioblastoma
5570407|NCT01004874|gliosarcoma|gliosarcoma
5570408|NCT01004874|Avastin|avastin
5570409|NCT01004874|bevacizumab|bevacizumab
5570410|NCT01004874|Topotecan|topotecan
5570411|NCT01004874|Hycamtin|hycamtin
5570412|NCT01004874|Temozolomide|temozolomide
5570413|NCT01004874|Temodar|temodar
5570414|NCT01004874|Pro00019960|pro00019960
5570415|NCT01004874|Vredenburgh|vredenburgh
5570416|NCT01004874|Duke|duke
5570417|NCT01004874|Desjardins|desjardins
5570418|NCT01004861|PVNS|pvns
5570419|NCT01004848|Pre-diabetes|pre-diabetes
5570420|NCT01004848|pre-diabetic state|pre-diabetic state
5570421|NCT01004848|community-based participatory research|community-based participatory research
5570422|NCT01004848|overweight|overweight
5570423|NCT01004848|weight loss intervention, peer-led lifestyle education|weight loss intervention, peer-led lifestyle education
5570424|NCT01004835|migraine|migraine
5570425|NCT01004822|Treatment Non-Randomized Single Group Assignment Safety Study Neoplasms Carcinoma Cancer Malignancy|treatment non-randomized single group assignment safety study neoplasms carcinoma cancer malignancy
5570426|NCT01004809|Dutasteride|dutasteride
5570427|NCT01004796|breast cancer|breast cancer
5570428|NCT01004783|stage I Wilms tumor|stage i wilms tumor
5570429|NCT01004783|stage II Wilms tumor|stage ii wilms tumor
5570430|NCT01004783|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
5570431|NCT01004770|CECT - Contrast-enhanced computed tomography|cect - contrast-enhanced computed tomography
5570432|NCT01004770|HCG - Human Chorionic Gonadotropin|hcg - human chorionic gonadotropin
5570433|NCT01004770|HU - Hounsfield Units|hu - hounsfield units
5570434|NCT01004770|Patient Safety|patient safety
5570435|NCT01004770|Tolerance|tolerance
5570436|NCT01004770|Pharmacokinetic|pharmacokinetic
5570437|NCT01004757|diastolic function|diastolic function
5570438|NCT01004757|postmeal glucose|postmeal glucose
5570439|NCT01004757|insulin resistance|insulin resistance
5570440|NCT01004757|low carb diet|low carb diet
5570441|NCT01004757|type 2 diabetes|type 2 diabetes
5570442|NCT01004744|Postmenopausal women|postmenopausal women
5570443|NCT01004744|ER+|er+
5570444|NCT01004744|Estrogen positive|estrogen positive
5570445|NCT01004744|PR+|pr+
5570446|NCT01004744|Progesterone positive|progesterone positive
5570447|NCT01004731|EGFr|egfr
5570448|NCT01004731|cetuximab|cetuximab
5570449|NCT01004731|gemcitabine|gemcitabine
5570450|NCT01004731|carboplatin|carboplatin
5570451|NCT01004731|NSCLC|nsclc
5570452|NCT01004705|cardiovascular|cardiovascular
5570453|NCT01004705|fixed|fixed
5570454|NCT01004705|dose|dose
5570455|NCT01004705|combination|combination
5570456|NCT01004705|pill|pill
5570457|NCT01004705|LDL|ldl
5570458|NCT01004705|cholesterol|cholesterol
5570459|NCT01004666|Breast cancer|breast cancer
5570460|NCT01004666|Scintimammography|scintimammography
5570461|NCT01004666|CZT|czt
5570462|NCT01004666|High-risk|high-risk
5570463|NCT01004640|chronic myelogenous leukemia|chronic myelogenous leukemia
5570464|NCT01004627|fistula|fistula
5570465|NCT01004627|ultrasound|ultrasound
5570466|NCT01004627|angioaccess|angioaccess
5570467|NCT01004627|preoperative vein mapping|preoperative vein mapping
5570468|NCT01004627|Haemodialysis|haemodialysis
5570469|NCT01004627|Angioaccess surgery|angioaccess surgery
5570470|NCT01004601|pretreated failure advanced stage IIIb/IV NSCLC|pretreated failure advanced stage iiib/iv nsclc
5570471|NCT01004588|elderly|elderly
5570472|NCT01004588|sarcopenia|sarcopenia
5570473|NCT01004588|protein drink|protein drink
5570474|NCT01004588|resistance training|resistance training
5570475|NCT01004575|stents|stents
5570476|NCT01004575|bare metal stents|bare metal stents
5570477|NCT01004562|breast cancer|breast cancer
5570478|NCT01004549|Patients who have previously undergone bilateral intraocular lens implantation|patients who have previously undergone bilateral intraocular lens implantation
5570479|NCT01004523|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5570480|NCT01004523|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5570481|NCT01004523|childhood mixed glioma|childhood mixed glioma
5570482|NCT01004523|adult mixed glioma|adult mixed glioma
5570483|NCT01004523|adult diffuse astrocytoma|adult diffuse astrocytoma
5570484|NCT01004523|childhood oligodendroglioma|childhood oligodendroglioma
5570485|NCT01004523|adult oligodendroglioma|adult oligodendroglioma
5570486|NCT01004510|malignant pleural effusion|malignant pleural effusion
5570487|NCT01004510|non small cell lung cancer|non small cell lung cancer
5570488|NCT01004497|Acute lymphoblastic leukemia, adult, dasatinib|acute lymphoblastic leukemia, adult, dasatinib
5570489|NCT01004484|non-patients|non-patients
5570490|NCT01004484|non-diarrhea functional bowel symptoms|non-diarrhea functional bowel symptoms
5570491|NCT01004458|fibromyalgia|fibromyalgia
5570492|NCT01004458|cognitive behavioral therapy|cognitive behavioral therapy
5570493|NCT01004458|women|women
5570494|NCT01004458|pain|pain
5570495|NCT01004458|stress|stress
5570496|NCT01004458|type A behavior|type a behavior
5570497|NCT01004445|Pneumonia|pneumonia
5570498|NCT01004445|Adjunctive treatment|adjunctive treatment
5570499|NCT01004445|Gram-negative bacteria|gram-negative bacteria
5570500|NCT01004432|humira, remicade|humira, remicade
5570501|NCT01004432|rheumatoid arthritis|rheumatoid arthritis
5570502|NCT01004432|enbrel failure|enbrel failure
5570503|NCT01004432|humira failure|humira failure
5570505|NCT01004432|enbrel|enbrel
5570506|NCT01004419|non small cell lung cancer|non small cell lung cancer
5570507|NCT01004419|vandetanib|vandetanib
5570508|NCT01004419|ZD6474|zd6474
5570509|NCT01004419|fulvestrant|fulvestrant
5570510|NCT01004419|faslodex|faslodex
5570511|NCT01004419|phase 1|phase 1
5570512|NCT01004406|plaque|plaque
5570514|NCT01004406|statin|statin
5570515|NCT01004406|endothelial|endothelial
5570516|NCT01004406|apheresis|apheresis
5570517|NCT01004406|acute coronary syndrome|acute coronary syndrome
5570518|NCT01004393|Methylnaltrexone|methylnaltrexone
5570519|NCT01004393|Constipation|constipation
5570520|NCT01004393|Narcotic Antagonists|narcotic antagonists
5570521|NCT01004393|Analgesics, Opioid|analgesics, opioid
5570522|NCT01004393|Neoplasms|neoplasms
5570523|NCT01004380|Epithelial Ovarian Cancer|epithelial ovarian cancer
5570524|NCT01004380|Ovarian Cancer|ovarian cancer
5570525|NCT01004367|Promoting healthy lifestyles in adolescents in Ecuador to prevent overweight|promoting healthy lifestyles in adolescents in ecuador to prevent overweight
5570526|NCT01004354|Psychiatric illnesses|psychiatric illnesses
5570527|NCT01004354|Vitamin D deficiency|vitamin d deficiency
5570528|NCT01004354|Obesity|obesity
5570529|NCT01004341|pediatric obesity|pediatric obesity
5570530|NCT01004341|parenting style|parenting style
5570531|NCT01004341|feeding style|feeding style
5570532|NCT01004341|behavioral skills|behavioral skills
5570533|NCT01004341|parenting skills|parenting skills
5570534|NCT01004341|family meals|family meals
5570535|NCT01004328|patient safety|patient safety
5570536|NCT01004328|care transitions|care transitions
5570537|NCT01004328|therapeutic monitoring|therapeutic monitoring
5570538|NCT01004328|skilled nursing facilities|skilled nursing facilities
5570539|NCT01004328|Adverse outcomes after discharge from a SNF to home|adverse outcomes after discharge from a snf to home
5555134|NCT01066299|startle|startle
5570540|NCT01004315|Overactive bladder|overactive bladder
5570541|NCT01004315|Frequency|frequency
5570542|NCT01004315|Micturition|micturition
5570543|NCT01004315|Urgency|urgency
5570544|NCT01004315|Urge urinary incontinence|urge urinary incontinence
5570545|NCT01004315|OAB|oab
5570546|NCT01004302|Obsessive-compulsive disorder|obsessive-compulsive disorder
5570547|NCT01004302|Radiosurgery|radiosurgery
5570548|NCT01004302|Psychosurgery|psychosurgery
5570549|NCT01004302|Treatment outcome|treatment outcome
5570550|NCT01004302|Randomized Controlled Trials|randomized controlled trials
5570551|NCT01004289|Acute myocardial infarction|acute myocardial infarction
5570552|NCT01004289|Primary percutaneous coronary intervention|primary percutaneous coronary intervention
5570553|NCT01004289|Postconditioning|postconditioning
5570554|NCT01004276|primary health care|primary health care
5570555|NCT01004276|delivery of health care|delivery of health care
5570556|NCT01004276|smoking cessation|smoking cessation
5570557|NCT01004276|chronic disease|chronic disease
5570558|NCT01004276|disease management|disease management
5570559|NCT01004276|pilot projects|pilot projects
5570560|NCT01004263|acute migraine with or without aura in adolescents|acute migraine with or without aura in adolescents
5570561|NCT01004237|insulin resistance|insulin resistance
5570562|NCT01004237|hypertensive|hypertensive
5570563|NCT01004237|hypercholesterolemic patients|hypercholesterolemic patients
5570564|NCT01004224|advanced solid tumors|advanced solid tumors
5570565|NCT01004224|lung cancer|lung cancer
5570566|NCT01004224|bladder cancer|bladder cancer
5570567|NCT01004224|BGJ398|bgj398
5570568|NCT01004224|FGFR|fgfr
5570569|NCT01004224|kinase inhibitor|kinase inhibitor
5570570|NCT01004224|advanced solid malignancies|advanced solid malignancies
5570571|NCT01004211|bladder cancer|bladder cancer
5570572|NCT01004211|recurrence|recurrence
5570573|NCT01004198|Trauma|trauma
5570574|NCT01004198|Hemorrhage|hemorrhage
5570575|NCT01004198|Hemorrhagic shock|hemorrhagic shock
5570576|NCT01004198|Lactic acidosis|lactic acidosis
5570577|NCT01004198|Oxygen carriers|oxygen carriers
5570578|NCT01004198|Oxygen therapeutics|oxygen therapeutics
5570579|NCT01004198|Hemoglobin solutions|hemoglobin solutions
5570580|NCT01004198|Hemoglobin substitutes|hemoglobin substitutes
5570581|NCT01004198|Red cell substitutes|red cell substitutes
5570582|NCT01004198|PEG-hemoglobin|peg-hemoglobin
5570583|NCT01004172|carboplatin|carboplatin
5570584|NCT01004172|bevacizumab|bevacizumab
5570585|NCT01004159|Colorectal cancer|colorectal cancer
5570586|NCT01004159|KRAS wild type tumors|kras wild type tumors
5570587|NCT01004146|incentive spirometry|incentive spirometry
5570588|NCT01004146|bariatric surgery|bariatric surgery
5570589|NCT01004146|obesity|obesity
5570590|NCT01004133|Age 80 or older|age 80 or older
5570591|NCT01004133|No chronic disease|no chronic disease
5570592|NCT01004094|children|children
5570593|NCT01004094|video games|video games
5570594|NCT01004094|internet|internet
5570596|NCT01004094|fruit|fruit
5570597|NCT01004094|vegetable|vegetable
5570598|NCT01004094|implementation intention|implementation intention
5564628|NCT01028898|micRNA|micrna
5570600|NCT01004094|fruit and vegetable consumption|fruit and vegetable consumption
5570601|NCT01004094|obesity prevention|obesity prevention
5570602|NCT01004094|cancer prevention|cancer prevention
5570603|NCT01004081|Cancer of Breast|cancer of breast
5570604|NCT01004081|Cancer of the Breast|cancer of the breast
5570605|NCT01004068|Clomiphene|clomiphene
5570606|NCT01004068|Diet|diet
5570607|NCT01004068|Exercise|exercise
5570608|NCT01004068|Infertility|infertility
5570609|NCT01004068|PCOS|pcos
5570610|NCT01004068|Physical activity|physical activity
5570611|NCT01004068|Treatment|treatment
5570612|NCT01004055|Wound|wound
5570613|NCT01004055|Skin lesion|skin lesion
5570614|NCT01004055|Antimicrobial|antimicrobial
5570615|NCT01004055|Bioelectric|bioelectric
5570616|NCT01004042|Depression|depression
5570617|NCT01004042|Botulinum toxin|botulinum toxin
5570618|NCT01004042|Glabella|glabella
5570619|NCT01004042|Quality of life|quality of life
5570620|NCT01004042|Self-steem|self-steem
5570622|NCT01004029|hydroxyprogesterone caproate|hydroxyprogesterone caproate
5570623|NCT01004029|preterm birth|preterm birth
5570624|NCT01004029|progesterone|progesterone
5570625|NCT01004029|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery|women with a singleton pregnancy aged 18 years or older with a history of a previous singleton spontaneous preterm delivery
5570626|NCT01004016|Spinocerebellar degeneration|spinocerebellar degeneration
5570627|NCT01004016|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5570629|NCT01003990|Treatment experienced|treatment experienced
5570630|NCT01003964|NON-SMALL CELL LUNG CANCER|non-small cell lung cancer
5570631|NCT01003964|excision repair cross-complementing 1|excision repair cross-complementing 1
5570632|NCT01003964|Gemcitabine and cisplatin|gemcitabine and cisplatin
5570633|NCT01003964|Irinotecan and cisplatin|irinotecan and cisplatin
5570634|NCT01003964|Pemetrexed|pemetrexed
5570635|NCT01003964|Docetaxel|docetaxel
5570636|NCT01003964|advanced NSCLC|advanced nsclc
5570637|NCT01003951|Lymphedema|lymphedema
5570638|NCT01003951|Acupuncture|acupuncture
5570639|NCT01003951|09-136|09-136
5570640|NCT01003938|chemotherapy|chemotherapy
5570641|NCT01003938|combination therapy|combination therapy
5570642|NCT01003938|targeted therapy|targeted therapy
5570643|NCT01003938|second-line|second-line
5570644|NCT01003925|Knee pain, osteoarthritis, non-surgical treatment, age 65+|knee pain, osteoarthritis, non-surgical treatment, age 65+
5570645|NCT01003912|Lysosomal Storage Diseases|lysosomal storage diseases
5570646|NCT01003912|Inborn Errors of Metabolism|inborn errors of metabolism
5570647|NCT01003912|Krabbe|krabbe
5685554|NCT00555607|asthma|asthma
5570648|NCT01003912|Infantile metachromatic leukodystrophy disease|infantile metachromatic leukodystrophy disease
5570650|NCT01003912|Tay Sachs|tay sachs
5570651|NCT01003912|Sandhoff|sandhoff
5570652|NCT01003912|GM2 gangliosidoses|gm2 gangliosidoses
5570653|NCT01003912|Pelizaeus-Merzbacher disease|pelizaeus-merzbacher disease
5570654|NCT01003912|PMD|pmd
5570655|NCT01003886|post marketing surveillance Filipino benign prostatic hyperplasia BPH Doxazosin GITS|post marketing surveillance filipino benign prostatic hyperplasia bph doxazosin gits
5570656|NCT01003873|morbid obesity|morbid obesity
5570657|NCT01003873|bariatric surgery|bariatric surgery
5570658|NCT01003873|lifestyle intervention|lifestyle intervention
5570659|NCT01003873|endocannabinoids system|endocannabinoids system
5570660|NCT01003860|postoperative analgesia|postoperative analgesia
5570661|NCT01003847|Insulin resistance|insulin resistance
5570662|NCT01003834|substance use|substance use
5570663|NCT01003834|drug use|drug use
5570664|NCT01003834|drug abuse|drug abuse
5570665|NCT01003782|cholangitis|cholangitis
5570666|NCT01003782|antibiotic|antibiotic
5570667|NCT01003782|bacteriobilia|bacteriobilia
5570668|NCT01003782|bile|bile
5570669|NCT01003782|ERCP|ercp
5570670|NCT01003756|Preoperative|preoperative
5570671|NCT01003756|Exercise|exercise
5570672|NCT01003756|Joint Replacement|joint replacement
5570673|NCT01003756|Hip|hip
5570674|NCT01003756|Knee|knee
5570675|NCT01003730|Intraoperative protective ventilation strategies|intraoperative protective ventilation strategies
5570676|NCT01003691|Phase 1b Advanced Dry Age-Related Macular Degeneration RN6G|phase 1b advanced dry age-related macular degeneration rn6g
5570677|NCT01003678|Myelodysplastic syndrome|myelodysplastic syndrome
5570678|NCT01003678|Clofarabine|clofarabine
5570679|NCT01003678|low-dose oral clofarabine|low-dose oral clofarabine
5570680|NCT01003678|intermediate risk Myelodysplastic syndrome|intermediate risk myelodysplastic syndrome
5570681|NCT01003678|high risk Myelodysplastic syndrome|high risk myelodysplastic syndrome
5570682|NCT01003652|goiter|goiter
5570683|NCT01003639|papilledema|papilledema
5570684|NCT01003639|vision loss|vision loss
5570685|NCT01003639|headache|headache
5570686|NCT01003639|obesity|obesity
5570687|NCT01003639|women|women
5570688|NCT01003639|diplopia|diplopia
5570689|NCT01003639|tinnitus|tinnitus
5570690|NCT01003626|Advanced cutaneous melanoma|advanced cutaneous melanoma
5570691|NCT01003626|Tumor Pressure|tumor pressure
5570692|NCT01003626|Tumor IFP|tumor ifp
5570693|NCT01003626|Interstitial Fluid Pressure|interstitial fluid pressure
5570694|NCT01003626|IFP|ifp
5564728|NCT01028339|PtiO2|ptio2
5570695|NCT01003626|Transducer-tipped catheter Mikro-Tip SPC-320|transducer-tipped catheter mikro-tip spc-320
5570696|NCT01003626|Transducer Millar|transducer millar
5570697|NCT01003626|Power Lab 8/30 amplifier|power lab 8/30 amplifier
5570699|NCT01003613|fibrin glue|fibrin glue
5570700|NCT01003613|primary pterygium|primary pterygium
5570701|NCT01003613|conjunctival autograft|conjunctival autograft
5570702|NCT01003600|Survivorship|survivorship
5570703|NCT01003600|Quality of Life|quality of life
5570704|NCT01003600|Questionnaire|questionnaire
5570705|NCT01003600|09-133|09-133
5570706|NCT01003587|India|india
5570707|NCT01003587|evidence-based policy|evidence-based policy
5570708|NCT01003587|knowledge translation|knowledge translation
5570709|NCT01003587|disease control priorities|disease control priorities
5570710|NCT01003587|decision-makers|decision-makers
5570711|NCT01003587|health spending|health spending
5570712|NCT01003587|health services delivery|health services delivery
5570713|NCT01003587|maternal and child health|maternal and child health
5570714|NCT01003587|policy making|policy making
5570715|NCT01003587|delivery of health care|delivery of health care
5570716|NCT01003574|cardiovascular health outcomes in cancer survivors|cardiovascular health outcomes in cancer survivors
5570717|NCT01003561|ultrasonographic exam on upper and lower extremities|ultrasonographic exam on upper and lower extremities
5570718|NCT01003548|Embryo culture|embryo culture
5570719|NCT01003548|IVF|ivf
5570720|NCT01003548|Microfluidics|microfluidics
5570721|NCT01003548|infertility|infertility
5570722|NCT01003535|Parkinson´s disease|parkinson´s disease
5570723|NCT01003535|Acetylcholine receptors|acetylcholine receptors
5570724|NCT01003522|Bronchial stents|bronchial stents
5570725|NCT01003522|Airway obstruction|airway obstruction
5570726|NCT01003522|Non-small cell lung cancer|non-small cell lung cancer
5570727|NCT01003509|inguinal|inguinal
5570728|NCT01003509|hernia|hernia
5570729|NCT01003509|new|new
5570730|NCT01003509|repair|repair
5570731|NCT01003509|modified shouldice|modified shouldice
5570732|NCT01003509|double|double
5570733|NCT01003496|Cocaine|cocaine
5570734|NCT01003496|crack|crack
5570735|NCT01003496|heroin|heroin
5570736|NCT01003496|non-prescribed opioids|non-prescribed opioids
5570737|NCT01003496|contingency management|contingency management
5570738|NCT01003496|community reinforcement approach|community reinforcement approach
5570739|NCT01003496|facilitated therapeutic alliance|facilitated therapeutic alliance
5570740|NCT01003496|chronic disease treatment models|chronic disease treatment models
5570741|NCT01003483|metformin|metformin
5570742|NCT01003483|orlistat|orlistat
5570743|NCT01003483|pcos|pcos
5570744|NCT01003483|obese|obese
5570745|NCT01003470|cerebral infarction|cerebral infarction
5570746|NCT01003470|Paralysis|paralysis
5570747|NCT01003470|acupuncture|acupuncture
5570748|NCT01003470|rehabilitation|rehabilitation
5570749|NCT01003470|trial|trial
5570750|NCT01003444|Muscle biopsy Malonyl CoA Biomarker assay|muscle biopsy malonyl coa biomarker assay
5570751|NCT01003418|GSK2340272A|gsk2340272a
5570752|NCT01003418|H1N1 pandemic influenza|h1n1 pandemic influenza
5570753|NCT01003405|Overactive bladder|overactive bladder
5570754|NCT01003405|Frequency|frequency
5570755|NCT01003405|Micturition|micturition
5570756|NCT01003405|Urgency|urgency
5570757|NCT01003405|Urge urinary incontinence|urge urinary incontinence
5570758|NCT01003405|OAB|oab
5570759|NCT01003392|Coronary artery disease|coronary artery disease
5570760|NCT01003392|Coffee|coffee
5570761|NCT01003392|Heart system|heart system
5570762|NCT01003379|cognitive dysfunction|cognitive dysfunction
5570763|NCT01003379|schizophrenia|schizophrenia
5570764|NCT01003379|Phase 2|phase 2
5570765|NCT01003366|safety during central venous catheterization|safety during central venous catheterization
5570766|NCT01003353|Stroke|stroke
5570767|NCT01003353|Strength training|strength training
5570768|NCT01003353|exercise therapy|exercise therapy
5570769|NCT01003340|asthma|asthma
5570770|NCT01003340|children|children
5570771|NCT01003340|community health workers|community health workers
5570772|NCT01003340|home intervention|home intervention
5570773|NCT01003327|laryngeal mask, leak pressure|laryngeal mask, leak pressure
5570774|NCT01003327|leak pressure|leak pressure
5570775|NCT01003314|Vaccine|vaccine
5570776|NCT01003314|Safety|safety
5570777|NCT01003314|Immunogenicity|immunogenicity
5570778|NCT01003314|Protection|protection
5570779|NCT01003314|Sporozoite challenge|sporozoite challenge
5570780|NCT01003301|cat allergy|cat allergy
5570781|NCT01003288|H1N1 pandemic vaccine immunogenicity safety|h1n1 pandemic vaccine immunogenicity safety
5570782|NCT01003288|Health employees|health employees
5570783|NCT01003275|Chronic kidney disease|chronic kidney disease
5570784|NCT01003275|Vitamin D|vitamin d
5570785|NCT01003275|Paricalcitol|paricalcitol
5570787|NCT01003275|Kidney|kidney
5570789|NCT01003275|Oxidative Stress|oxidative stress
5570790|NCT01003275|Immune cell function|immune cell function
5570791|NCT01003275|Glucose|glucose
5570792|NCT01003275|Glucose tolerance|glucose tolerance
5570793|NCT01003262|Observation Unit|observation unit
5570794|NCT01003262|Emergency Department|emergency department
5570795|NCT01003249|over distention of bladder|over distention of bladder
5570796|NCT01003249|Dysfunctional voiding|dysfunctional voiding
5570797|NCT01003249|dysfunctional elimination syndrome|dysfunctional elimination syndrome
5570798|NCT01003236|Diabetic nephropathy|diabetic nephropathy
5570799|NCT01003236|Type II Diabetes|type ii diabetes
5570800|NCT01003236|Milk Thistle extract|milk thistle extract
5570801|NCT01003236|Silymarin|silymarin
5570802|NCT01003223|phosphorus|phosphorus
5570803|NCT01003223|dialysis|dialysis
5570804|NCT01003223|PhosLo|phoslo
5570805|NCT01003223|CKD stage V|ckd stage v
5570806|NCT01003210|otitis media|otitis media
5570807|NCT01003210|children|children
5570808|NCT01003210|homeopathy|homeopathy
5570809|NCT01003197|Development|development
5570810|NCT01003197|Validation|validation
5570811|NCT01003197|Prediction Score|prediction score
5570812|NCT01003197|Complication|complication
5570813|NCT01003197|Liver resection|liver resection
5570814|NCT01003197|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.|develop and validate a score to predict serious complications following liver resection using pre-operative risk factors.
5570815|NCT01003184|diabetes|diabetes
5570816|NCT01003184|exenatide once weekly|exenatide once weekly
5570817|NCT01003184|Byetta|byetta
5570818|NCT01003184|insulin detemir|insulin detemir
5570819|NCT01003184|Levemir|levemir
5570820|NCT01003184|Amylin|amylin
5570821|NCT01003184|Lilly|lilly
5570822|NCT01003171|Pharmacokinetics|pharmacokinetics
5570824|NCT01003171|MCS|mcs
5570825|NCT01003171|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5570826|NCT01003171|Multi-Carotenoids|multi-carotenoids
5570827|NCT01003171|Healthy subjects|healthy subjects
5570828|NCT01003158|Cancer|cancer
5570829|NCT01003158|tumour|tumour
5570830|NCT01003158|metastatic|metastatic
5570831|NCT01003158|breast cancer|breast cancer
5570832|NCT01003145|Influenza|influenza
5570833|NCT01003145|vaccine|vaccine
5570834|NCT01003145|Immunogenicity|immunogenicity
5570835|NCT01003132|Psychosis|psychosis
5570836|NCT01003132|Distress|distress
5570837|NCT01003132|Mindfulness|mindfulness
5570838|NCT01003132|Acceptance|acceptance
5570839|NCT01003132|Values|values
5570840|NCT01003119|Alcohol addiction|alcohol addiction
5570841|NCT01003119|Alcohol treatment|alcohol treatment
5570842|NCT01003119|Alcohol recovery|alcohol recovery
5570843|NCT01003119|Post residential treatment DSM-IV diagnosis of alcohol dependence|post residential treatment dsm-iv diagnosis of alcohol dependence
5570844|NCT01003106|RVO|rvo
5570845|NCT01003106|BRVO|brvo
5570846|NCT01003106|CRVO|crvo
5570847|NCT01003106|Vein occlusion|vein occlusion
5570848|NCT01003093|Tuberculosis|tuberculosis
5570849|NCT01003093|Vaccine|vaccine
5570850|NCT01003093|Ag85B|ag85b
5570851|NCT01003093|ESAT-6|esat-6
5570852|NCT01003093|IC31|ic31
5570853|NCT01003080|The evaluation of hemostasis during total knee arthroplasty using the aquamantys device.|the evaluation of hemostasis during total knee arthroplasty using the aquamantys device.
5570854|NCT01003054|Leukemia|leukemia
5570855|NCT01003054|CML|cml
5570856|NCT01003054|Busulfan|busulfan
5570857|NCT01003054|Busulfex|busulfex
5570858|NCT01003054|Myleran|myleran
5570859|NCT01003054|Cyclophosphamide|cyclophosphamide
5570860|NCT01003054|Cytoxan|cytoxan
5570861|NCT01003054|Neosar|neosar
5570862|NCT01003054|Imatinib Mesylate|imatinib mesylate
5570863|NCT01003054|Gleevec|gleevec
5570864|NCT01003054|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5570865|NCT01003054|Stem Cell Transplant|stem cell transplant
5570866|NCT01003041|healthy normal infants|healthy normal infants
5570867|NCT01003028|Total intravenous anesthesia|total intravenous anesthesia
5570868|NCT01003028|Maximum plasma concentration of remifentanil|maximum plasma concentration of remifentanil
5570869|NCT01003015|HCC|hcc
5570870|NCT01003015|Safety|safety
5570871|NCT01003015|BAY73-4506|bay73-4506
5570872|NCT01003002|Parkinson's disease|parkinson's disease
5570873|NCT01003002|Dyskinesia|dyskinesia
5570874|NCT01003002|Movement Disorders|movement disorders
5570875|NCT01002989|ankle brachial index|ankle brachial index
5570876|NCT01002989|WatchBP Office|watchbp office
5570877|NCT01002989|oscillometric measurement|oscillometric measurement
5570878|NCT01002937|Biomarkers|biomarkers
5570879|NCT01002937|Prognosis response to treatment|prognosis response to treatment
5570880|NCT01002937|Renal cancer|renal cancer
5570881|NCT01002924|Cancer|cancer
5570882|NCT01002924|Adenocarcinoma|adenocarcinoma
5570883|NCT01002924|Phase II|phase ii
5570884|NCT01002924|Lung|lung
5570987|NCT01002521|impaired|impaired
5570885|NCT01002924|Non-small cell lung cancer|non-small cell lung cancer
5570886|NCT01002924|NSCLC|nsclc
5570887|NCT01002924|extension|extension
5570888|NCT01002924|EC145|ec145
5570889|NCT01002924|Prior exposure to EC145|prior exposure to ec145
5570890|NCT01002911|Device procedure|device procedure
5570891|NCT01002911|pacemaker|pacemaker
5570892|NCT01002911|ICD|icd
5570893|NCT01002911|antibiotics|antibiotics
5570894|NCT01002898|HIV-1 RNA|hiv-1 rna
5570895|NCT01002898|Treatment experienced|treatment experienced
5570896|NCT01002885|Infertility|infertility
5570897|NCT01002885|FSH Receptor Polymorphisms|fsh receptor polymorphisms
5570898|NCT01002872|FGF23|fgf23
5570899|NCT01002872|CKD|ckd
5570900|NCT01002872|Fosrenol|fosrenol
5570901|NCT01002872|Hyperphosphatemia|hyperphosphatemia
5570902|NCT01002859|Coronary artery bypass graft surgery (CABG)|coronary artery bypass graft surgery (cabg)
5570903|NCT01002859|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5570904|NCT01002859|Cyclosporine|cyclosporine
5570905|NCT01002859|ischaemia reperfusion|ischaemia reperfusion
5570906|NCT01002846|Efficacy|efficacy
5570907|NCT01002846|Acupuncture|acupuncture
5570908|NCT01002846|Hypertension|hypertension
5570909|NCT01002833|Plasmodium falciparum|plasmodium falciparum
5570910|NCT01002833|Malaria|malaria
5570911|NCT01002820|Epileptic Seizures|epileptic seizures
5570912|NCT01002820|Seizure Disorder|seizure disorder
5570913|NCT01002820|Seizures|seizures
5570914|NCT01002820|Convulsions|convulsions
5570915|NCT01002820|Anticonvulsant|anticonvulsant
5570916|NCT01002820|Anticonvulsive|anticonvulsive
5570917|NCT01002820|Antiepileptic|antiepileptic
5570918|NCT01002820|Ganaxolone|ganaxolone
5570919|NCT01002794|Degenerative meniscal tear|degenerative meniscal tear
5570920|NCT01002794|Arthroscopy|arthroscopy
5570921|NCT01002794|Exercise therapy|exercise therapy
5570922|NCT01002781|Tocilizumab Still|tocilizumab still
5570923|NCT01002742|GVHD|gvhd
5570924|NCT01002729|Oseltamivir Pharmacokinetics Obesity|oseltamivir pharmacokinetics obesity
5570925|NCT01002729|Oseltamivir Pharmacokinetics in Obesity|oseltamivir pharmacokinetics in obesity
5570926|NCT01002716|rheumatoid influenza vaccine cell immunity|rheumatoid influenza vaccine cell immunity
5570927|NCT01002703|Lenalidomide|lenalidomide
5570928|NCT01002703|Bendamustine|bendamustine
5570929|NCT01002703|Multiple Myeloma|multiple myeloma
5570930|NCT01002703|Myeloma|myeloma
5570931|NCT01002703|Revlimid|revlimid
5570932|NCT01002703|Phase I/II|phase i/ii
5570933|NCT01002703|refractory Myeloma|refractory myeloma
5570934|NCT01002703|relapsed Myeloma|relapsed myeloma
5570935|NCT01002690|Asthma|asthma
5570936|NCT01002690|Allergen challenge|allergen challenge
5570937|NCT01002690|Airway responsiveness|airway responsiveness
5570938|NCT01002690|Prostaglandins|prostaglandins
5570939|NCT01002690|Eicosanoids|eicosanoids
5570940|NCT01002677|brain injury|brain injury
5570941|NCT01002677|traumatic brain injury|traumatic brain injury
5570942|NCT01002677|training|training
5570943|NCT01002677|teaching|teaching
5570944|NCT01002677|curriculum|curriculum
5570945|NCT01002664|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5570946|NCT01002664|Multi-carotenoids|multi-carotenoids
5570947|NCT01002664|MCS-2|mcs-2
5570948|NCT01002664|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5570949|NCT01002664|International prostate symptom scores|international prostate symptom scores
5570950|NCT01002651|gastrointestinal health|gastrointestinal health
5570951|NCT01002651|healthy subjects|healthy subjects
5570952|NCT01002625|Double-Blind Randomized Placebo-Controlled 2-Way Crossover Polysomnographic Endpoints|double-blind randomized placebo-controlled 2-way crossover polysomnographic endpoints
5570953|NCT01002612|Nutritional status|nutritional status
5570954|NCT01002612|Thai HIV-infected children|thai hiv-infected children
5570955|NCT01002599|bariatric surgery|bariatric surgery
5570956|NCT01002599|morbidly obese|morbidly obese
5570957|NCT01002599|BMI >35|bmi >35
5570958|NCT01002599|CPAP|cpap
5570959|NCT01002599|Venturi|venturi
5570960|NCT01002599|Boussignac|boussignac
5570961|NCT01002599|Ventilation|ventilation
5570962|NCT01002599|Pulmonary function|pulmonary function
5570963|NCT01002599|Morbidly Obese Patients undergoing bariatric surgery|morbidly obese patients undergoing bariatric surgery
5570964|NCT01002586|Alzheimer's dementia|alzheimer's dementia
5570965|NCT01002586|Wii-Fit|wii-fit
5570966|NCT01002586|Walking|walking
5570967|NCT01002586|Falls|falls
5570968|NCT01002573|Pediatric|pediatric
5570969|NCT01002573|Fever|fever
5570970|NCT01002560|Melanoma|melanoma
5570971|NCT01002560|Novel Prognostic Markers|novel prognostic markers
5570972|NCT01002547|steatohepatitis|steatohepatitis
5570973|NCT01002547|type 2 diabetes|type 2 diabetes
5570974|NCT01002547|fatty liver|fatty liver
5570975|NCT01002534|Cystic Fibrosis|cystic fibrosis
5570976|NCT01002534|Vardenafil|vardenafil
5570977|NCT01002534|Nasal instillation|nasal instillation
5570978|NCT01002534|Nasal Potential difference|nasal potential difference
5570979|NCT01002521|Diabetes|diabetes
5570980|NCT01002521|vascular|vascular
5570981|NCT01002521|haptoglobin|haptoglobin
5570982|NCT01002521|tumor|tumor
5570983|NCT01002521|necrosis|necrosis
5570984|NCT01002521|factor|factor
5570985|NCT01002521|alpha|alpha
5570986|NCT01002521|traps|traps
5570988|NCT01002521|wound|wound
5570989|NCT01002521|healing|healing
5570990|NCT01002521|Impaired wound healing in patients with diabetes mellitus|impaired wound healing in patients with diabetes mellitus
5570991|NCT01002508|influenza vaccine scleroderma immunogenicity safety|influenza vaccine scleroderma immunogenicity safety
5570992|NCT01002495|myocardial|myocardial
5570993|NCT01002495|ischemia|ischemia
5570994|NCT01002495|coronary disease|coronary disease
5570995|NCT01002495|angina|angina
5570996|NCT01002482|Hyperglycemia|hyperglycemia
5570997|NCT01002482|Hypoglycemia|hypoglycemia
5570998|NCT01002482|Intensive Care Unit|intensive care unit
5571000|NCT01002482|Insulin|insulin
5571001|NCT01002482|Computer Protocol|computer protocol
5571002|NCT01002482|Metabolic Disorders|metabolic disorders
5571003|NCT01002469|isotope ratio measurement|isotope ratio measurement
5571004|NCT01002469|urea cycle|urea cycle
5571005|NCT01002469|13C acetate|13c acetate
5571006|NCT01002469|Healthy adults|healthy adults
5571007|NCT01002456|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5571008|NCT01002456|Guideline Adherence|guideline adherence
5571009|NCT01002456|Drug Prescriptions|drug prescriptions
5571010|NCT01002456|target dose|target dose
5571011|NCT01002443|Helicobacter pylori|helicobacter pylori
5571012|NCT01002443|glandular atrophy|glandular atrophy
5571013|NCT01002443|intestinal metaplasia|intestinal metaplasia
5571014|NCT01002443|subtotal gastrectomy|subtotal gastrectomy
5571015|NCT01002443|gastric cancer|gastric cancer
5571016|NCT01002443|Precancerous lesion of gastric cancer|precancerous lesion of gastric cancer
5571017|NCT01002430|Myocardial ischemia|myocardial ischemia
5571018|NCT01002430|Refractory angina pectoris|refractory angina pectoris
5571019|NCT01002430|Vascular endothelial growth factor|vascular endothelial growth factor
5571020|NCT01002430|Gene therapy|gene therapy
5571021|NCT01002430|Perfusion|perfusion
5571022|NCT01002417|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5571023|NCT01002417|Multi-carotenoids|multi-carotenoids
5571024|NCT01002417|MCS-2|mcs-2
5571025|NCT01002417|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5571026|NCT01002417|International prostate symptom scores|international prostate symptom scores
5571027|NCT01002404|ERCP|ercp
5571028|NCT01002404|deep biliary cannulation|deep biliary cannulation
5571029|NCT01002404|guide wire cannulation|guide wire cannulation
5571030|NCT01002404|post-ERCP pancreatitis|post-ercp pancreatitis
5571031|NCT01002404|Success of deep biliary cannulation|success of deep biliary cannulation
5571032|NCT01002404|Rate of post-ERCP pancreatitis|rate of post-ercp pancreatitis
5571033|NCT01002404|Time used to deep biliary cannulation|time used to deep biliary cannulation
5571034|NCT01002391|breast hypertrophy|breast hypertrophy
5571035|NCT01002391|mammaplasty|mammaplasty
5571036|NCT01002391|bandages|bandages
5571037|NCT01002391|surgical site infection|surgical site infection
5571038|NCT01002391|skin colonization|skin colonization
5571039|NCT01002352|obesity|obesity
5571040|NCT01002352|bariatric|bariatric
5571041|NCT01002352|BOLD|bold
5571042|NCT01002352|weightloss|weightloss
5571043|NCT01002352|database|database
5685555|NCT00555607|COPD|copd
5571044|NCT01002352|data registry|data registry
5571045|NCT01002326|Pediatric|pediatric
5571046|NCT01002326|Body Dysmorphic Disorder|body dysmorphic disorder
5571048|NCT01002326|CBT|cbt
5571049|NCT01002326|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5571050|NCT01002300|Social Cognition|social cognition
5571051|NCT01002300|Oxytocin|oxytocin
5571052|NCT01002274|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5571053|NCT01002274|BPH|bph
5571054|NCT01002274|MCS-2|mcs-2
5571055|NCT01002274|Multi-Carotenoids|multi-carotenoids
5571056|NCT01002274|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5571179|NCT01001754|Liver Diseases|liver diseases
5571057|NCT01002274|International prostate symptom score|international prostate symptom score
5571058|NCT01002261|Galactose|galactose
5571059|NCT01002261|PET/CT|pet/ct
5571060|NCT01002261|Liver physiology|liver physiology
5571061|NCT01002261|Liver pathophysiology|liver pathophysiology
5571062|NCT01002248|Multiple Myeloma|multiple myeloma
5571063|NCT01002248|Relapsed multiple myeloma|relapsed multiple myeloma
5571064|NCT01002248|Refractory multiple myeloma|refractory multiple myeloma
5571065|NCT01002248|Relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
5571066|NCT01002235|Diabetic|diabetic
5571067|NCT01002235|Neuropathy|neuropathy
5571068|NCT01002235|peripheral|peripheral
5571069|NCT01002235|diabetes|diabetes
5571070|NCT01002222|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5571071|NCT01002222|MCS-2|mcs-2
5571072|NCT01002222|Multi-Carotenoids|multi-carotenoids
5571073|NCT01002222|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5571074|NCT01002222|International prostate symptom score|international prostate symptom score
5571075|NCT01002209|Diabetes|diabetes
5571076|NCT01002209|Vascular Surgery|vascular surgery
5571077|NCT01002209|Hyperbaric oxygen|hyperbaric oxygen
5571078|NCT01002209|Surgical complications|surgical complications
5571079|NCT01002209|Wound complication|wound complication
5571080|NCT01002209|Randomized|randomized
5571081|NCT01002209|Controlled|controlled
5571082|NCT01002196|Selective Mutism|selective mutism
5571083|NCT01002196|Intervention|intervention
5571084|NCT01002183|Malaria|malaria
5571085|NCT01002183|Plasmodium falciparum|plasmodium falciparum
5571086|NCT01002183|acute uncomplicated|acute uncomplicated
5571087|NCT01002170|Tuberculosis|tuberculosis
5571089|NCT01002170|Pharmacokinetics|pharmacokinetics
5571090|NCT01002157|Coronary Artery Calcification|coronary artery calcification
5571091|NCT01002157|Vitamin K|vitamin k
5571092|NCT01002157|Trial|trial
5571093|NCT01002157|Treatment|treatment
5571094|NCT01002131|Digital Volume Tomography|digital volume tomography
5571095|NCT01002131|Cone Beam CT|cone beam ct
5571096|NCT01002131|impacted and supernumerary teeth|impacted and supernumerary teeth
5571097|NCT01002131|dental and maxillofacial radiology|dental and maxillofacial radiology
5571098|NCT01002118|heart rate variability|heart rate variability
5571099|NCT01002118|Dialysis|dialysis
5571100|NCT01002105|Baclofen|baclofen
5571101|NCT01002105|Alcohol|alcohol
5571102|NCT01002105|Baclofen as add-on to standard treatment of alcohol|baclofen as add-on to standard treatment of alcohol
5571103|NCT01002092|Osteosarcoma|osteosarcoma
5571104|NCT01002092|Endostar|endostar
5571105|NCT01002092|Chemotherapy|chemotherapy
5571106|NCT01002066|Fever|fever
5571107|NCT01002066|Malaria|malaria
5571109|NCT01002066|IMCI|imci
5571110|NCT01002066|Children<5 years of age|children<5 years of age
5571111|NCT01002066|ACT|act
5571112|NCT01002053|diabetes|diabetes
5571113|NCT01002053|neuropathy|neuropathy
5571114|NCT01002053|ankle block|ankle block
5571115|NCT01002053|regional anesthesia|regional anesthesia
5571116|NCT01002053|ultrasound|ultrasound
5571117|NCT01002053|nerve localization|nerve localization
5571118|NCT01002053|Nerve localization in patients undergoing foot surgery and having ankle block|nerve localization in patients undergoing foot surgery and having ankle block
5571119|NCT01002040|HIV|hiv
5571120|NCT01002040|vaccine,|vaccine,
5571121|NCT01002040|H1N1|h1n1
5571122|NCT01002040|influenza|influenza
5571123|NCT01002040|H1N1 Influenza vaccine|h1n1 influenza vaccine
5571124|NCT01002040|Arepanrix|arepanrix
5571125|NCT01002040|Pandemic|pandemic
5571126|NCT01002040|H1N1 2009 Influenza|h1n1 2009 influenza
5571127|NCT01002040|HIV preventive vaccine|hiv preventive vaccine
5571128|NCT01002027|Postnatal Depression|postnatal depression
5571129|NCT01002027|CBT-Counselling|cbt-counselling
5571130|NCT01002027|Primary care|primary care
5571131|NCT01002014|Breast Cancer|breast cancer
5571132|NCT01002014|Skin Sparing Mastectomy|skin sparing mastectomy
5571133|NCT01002014|Breast Cancer Prophylaxis|breast cancer prophylaxis
5571134|NCT01002014|Nipple Sparing Mastectomy|nipple sparing mastectomy
5571135|NCT01002014|Nipple Areolar Complex|nipple areolar complex
5571136|NCT01002014|Mastectomy|mastectomy
5571137|NCT01002014|Breast Reconstruction|breast reconstruction
5571138|NCT01002014|Local recurrence following nipple sparing mastectomy|local recurrence following nipple sparing mastectomy
5571139|NCT01002014|Cosmetic outcomes following nipple sparing mastectomy|cosmetic outcomes following nipple sparing mastectomy
5685556|NCT00555607|severe|severe
5685557|NCT00555607|controlled|controlled
5571140|NCT01002014|Complications following nipple sparing mastectomy|complications following nipple sparing mastectomy
5571141|NCT01001988|Encephalitis|encephalitis
5571142|NCT01001988|Japanese Encephalitis|japanese encephalitis
5571143|NCT01001988|Japanese Encephalitis Chimeric Virus Vaccine|japanese encephalitis chimeric virus vaccine
5571144|NCT01001988|Toddlers|toddlers
5571145|NCT01001975|Sunscreens|sunscreens
5571146|NCT01001962|Hypertension in type II diabetes|hypertension in type ii diabetes
5571147|NCT01001962|Cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5571148|NCT01001936|PHASE 1 SKI-606 Solid tumor|phase 1 ski-606 solid tumor
5571149|NCT01001897|IUD insertion|iud insertion
5571150|NCT01001897|nulliparous women|nulliparous women
5571151|NCT01001897|contraception|contraception
5571152|NCT01001884|caregiver, psychoeducational, colon|caregiver, psychoeducational, colon
5571153|NCT01001871|Iron deficiency anemia|iron deficiency anemia
5571154|NCT01001871|Sprinkles®|sprinkles®
5571155|NCT01001871|micronutrients|micronutrients
5571156|NCT01001871|malaria incidence|malaria incidence
5571157|NCT01001871|iron supplement|iron supplement
5571159|NCT01001858|CPAP compliance|cpap compliance
5571160|NCT01001858|nurse domiciliary led|nurse domiciliary led
5571161|NCT01001858|sleep disease|sleep disease
5571162|NCT01001845|hemodialysis|hemodialysis
5571163|NCT01001845|oxidative stress|oxidative stress
5571164|NCT01001845|plasma malondialdehyde|plasma malondialdehyde
5571165|NCT01001845|Glutathion peroxidase|glutathion peroxidase
5571166|NCT01001780|Graft versus Host Disease|graft versus host disease
5571167|NCT01001780|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5571168|NCT01001767|Omega-3 Fatty Acids|omega-3 fatty acids
5571169|NCT01001767|HIV|hiv
5571170|NCT01001767|Heart Disease|heart disease
5571171|NCT01001767|Treatment experienced|treatment experienced
5571172|NCT01001754|Hepatitis C|hepatitis c
5571173|NCT01001754|Hepatitis C, Chronic|hepatitis c, chronic
5571174|NCT01001754|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
5571175|NCT01001754|PEG-interferon lambda|peg-interferon lambda
5571176|NCT01001754|Interleukin 29|interleukin 29
5571177|NCT01001754|Virus|virus
5571178|NCT01001754|Infection|infection
5571181|NCT01001741|Antiretrovirals|antiretrovirals
5571182|NCT01001741|Adherence|adherence
5571183|NCT01001741|Text messaging|text messaging
5553214|NCT01074333|Erbitux|erbitux
5571184|NCT01001741|Antiretroviral adherence|antiretroviral adherence
5571185|NCT01001741|Treatment experienced|treatment experienced
5571186|NCT01001728|Breast Cancer|breast cancer
5571187|NCT01001728|Radiotherapy|radiotherapy
5571188|NCT01001728|Prone position|prone position
5571189|NCT01001702|Open Label|open label
5571190|NCT01001702|Aripiprazole|aripiprazole
5571191|NCT01001689|Pregnancy|pregnancy
5565198|NCT01026298|OSA|osa
5571192|NCT01001689|Preventive health care|preventive health care
5571194|NCT01001689|Nutrition|nutrition
5571195|NCT01001689|Obesity|obesity
5571196|NCT01001689|Diabetes|diabetes
5571197|NCT01001689|Weight gain|weight gain
5571198|NCT01001676|renal failure|renal failure
5571199|NCT01001676|Restenosis|restenosis
5571200|NCT01001676|Dialysis access|dialysis access
5571201|NCT01001676|Paclitaxel|paclitaxel
5571202|NCT01001676|Angioplasty|angioplasty
5571203|NCT01001676|Intimal hyperplasia|intimal hyperplasia
5571205|NCT01001650|Malaria Vaccine|malaria vaccine
5571206|NCT01001650|Plasmodium falciparum|plasmodium falciparum
5571207|NCT01001637|curcumin|curcumin
5571208|NCT01001637|alzheimer's|alzheimer's
5571209|NCT01001637|longVida|longvida
5571210|NCT01001637|dementia|dementia
5571211|NCT01001624|Cosmetic|cosmetic
5571212|NCT01001624|Facial cream|facial cream
5571213|NCT01001624|Melasma|melasma
5571214|NCT01001624|Melanil|melanil
5571215|NCT01001611|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5571216|NCT01001611|glitazone|glitazone
5571217|NCT01001611|Type II Diabetes|type ii diabetes
5571218|NCT01001611|Hypolipidemic|hypolipidemic
5571219|NCT01001611|oral hypoglycemic agent|oral hypoglycemic agent
5571220|NCT01001585|mitochondrial disease|mitochondrial disease
5571221|NCT01001585|sevoflurane|sevoflurane
5571222|NCT01001585|mitochondrial disease and sevoflurane sensitivity|mitochondrial disease and sevoflurane sensitivity
5571223|NCT01001572|Blood pressure|blood pressure
5571224|NCT01001572|hypertension|hypertension
5571225|NCT01001572|Exforge|exforge
5571226|NCT01001572|valsartan/amlodipine|valsartan/amlodipine
5571227|NCT01001559|Depression|depression
5571228|NCT01001559|Combination therapy|combination therapy
5571229|NCT01001559|antidepressant|antidepressant
5571230|NCT01001559|Deplin|deplin
5571231|NCT01001559|folate|folate
5006019|NCT03959007|Supportive care|supportive care
5571232|NCT01001559|methylfolate|methylfolate
5571233|NCT01001546|Veterans|veterans
5571234|NCT01001546|Smoking cessation|smoking cessation
5571235|NCT01001546|Operation Enduring Freedom|operation enduring freedom
5571236|NCT01001546|Operation Iraqi Freedom|operation iraqi freedom
5571237|NCT01001533|Electrical Cardiometry|electrical cardiometry
5571238|NCT01001533|Dexmedetomidine|dexmedetomidine
5571239|NCT01001533|ICON|icon
5571240|NCT01001533|bio-impedance|bio-impedance
5571241|NCT01001533|cardiac monitor|cardiac monitor
5571242|NCT01001520|Genetics|genetics
5571243|NCT01001520|Nicotine|nicotine
5571244|NCT01001520|Cognition|cognition
5571245|NCT01001520|fMRI|fmri
5571246|NCT01001507|Family planning|family planning
5571248|NCT01001507|Integrated services|integrated services
5571249|NCT01001507|Unintended pregnancy|unintended pregnancy
5571250|NCT01001507|Kenya|kenya
5571251|NCT01001494|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5571252|NCT01001494|antimuscarinic|antimuscarinic
5571253|NCT01001494|COPD|copd
5571254|NCT01001481|Treatment review|treatment review
5571255|NCT01001481|Schizophrenia|schizophrenia
5571256|NCT01001481|Observational|observational
5571257|NCT01001481|Prospective studies|prospective studies
5571258|NCT01001481|Australia|australia
5571259|NCT01001468|Psoriasis|psoriasis
5571260|NCT01001455|BP|bp
5571261|NCT01001442|Multiple myeloma|multiple myeloma
5571262|NCT01001442|Relapsed|relapsed
5571263|NCT01001442|Refractory|refractory
5571264|NCT01001429|sedation for vitreoretinal surgery|sedation for vitreoretinal surgery
5571265|NCT01001390|Acute Lymphoblastic leukemia|acute lymphoblastic leukemia
5571266|NCT01001377|Panitumumab|panitumumab
5571267|NCT01001377|Vectibix|vectibix
5571268|NCT01001377|Colon Cancer|colon cancer
5571269|NCT01001377|Colorectal Cancer|colorectal cancer
5571270|NCT01001377|Rectal Cancer|rectal cancer
5571271|NCT01001377|Cetuximab|cetuximab
5571272|NCT01001377|Erbitux|erbitux
5571273|NCT01001377|Metastatic|metastatic
5571274|NCT01001351|Chronic Kidney Disease|chronic kidney disease
5571275|NCT01001351|Arteriovenous Grafts (AVG)|arteriovenous grafts (avg)
5571276|NCT01001351|Hemodialysis|hemodialysis
5571277|NCT01001351|Vascular Access|vascular access
5571278|NCT01001351|Dialysis|dialysis
5571279|NCT01001351|Graft|graft
5571280|NCT01001351|Access|access
5571281|NCT01001351|vonapanitase|vonapanitase
5571282|NCT01001351|kidney|kidney
5571283|NCT01001351|renal|renal
5571284|NCT01001325|influenza|influenza
5571285|NCT01001325|vaccine|vaccine
5571286|NCT01001325|observer blind|observer blind
5571287|NCT01001312|Heart Failure|heart failure
5571288|NCT01001312|Therapeutics|therapeutics
5571289|NCT01001312|Blood volume|blood volume
5571290|NCT01001286|dropout youth in low income communities in Amman, Jordan|dropout youth in low income communities in amman, jordan
5571291|NCT01001273|Pancreas Transplantation|pancreas transplantation
5571292|NCT01001273|Kidney Transplantation|kidney transplantation
5571293|NCT01001273|Organ Transplantation|organ transplantation
5571294|NCT01001273|Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients|pancreas and simultaneous pancreas/kidney transplant recipients
5571296|NCT01001260|vascular injury|vascular injury
5571297|NCT01001247|TMC278-TiDP6-C154|tmc278-tidp6-c154
5571302|NCT01001247|proton pump inhibitor|proton pump inhibitor
5571304|NCT01001208|Etanercept|etanercept
5571305|NCT01001208|Methotrexate|methotrexate
5571306|NCT01001208|Psoriasis|psoriasis
5571307|NCT01001182|observational|observational
5571308|NCT01001182|non-interventional|non-interventional
5571309|NCT01001182|prospective|prospective
5571435|NCT01000662|tumor bed boost|tumor bed boost
5571310|NCT01001169|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5571311|NCT01001169|influenza infection|influenza infection
5571312|NCT01001156|Aged|aged
5571313|NCT01001156|Breathing Muscles|breathing muscles
5571314|NCT01001156|Strength Muscles|strength muscles
5571315|NCT01001156|Institution of long Permanence for elderly|institution of long permanence for elderly
5571316|NCT01001130|avamys|avamys
5571317|NCT01001130|Allergic Rhinitis|allergic rhinitis
5571318|NCT01001130|post marketing surveillance|post marketing surveillance
5571319|NCT01001130|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5571320|NCT01001130|Perennial Allergic Rhinitis (PAR)|perennial allergic rhinitis (par)
5571321|NCT01001117|Cataract|cataract
5571322|NCT01001117|Capsulotomy|capsulotomy
5571323|NCT01001117|Capsulorrhexis|capsulorrhexis
5571324|NCT01001117|Phacoemulsification|phacoemulsification
5571325|NCT01001104|Metabolic Diseases|metabolic diseases
5571326|NCT01001104|Glucose Metabolism Disorders|glucose metabolism disorders
5571327|NCT01001104|Diabetes|diabetes
5571328|NCT01001104|GLP-1|glp-1
5571329|NCT01001104|Lilly|lilly
5571330|NCT01001091|Conjunctivitis|conjunctivitis
5555932|NCT01062724|TPN|tpn
5571331|NCT01001091|conjunctival inflammation|conjunctival inflammation
5571332|NCT01001091|ocular allergies|ocular allergies
5571333|NCT01001078|supraglottic airway devices|supraglottic airway devices
5571334|NCT01001078|I-Gel|i-gel
5571335|NCT01001078|Supreme Laryngeal mask airway|supreme laryngeal mask airway
5571336|NCT01001078|Airway leak pressure|airway leak pressure
5571337|NCT01001078|peak airway pressure|peak airway pressure
5571338|NCT01001052|Healthy|healthy
5571339|NCT01001052|bioavailability|bioavailability
5571340|NCT01001039|chronic sinusitis|chronic sinusitis
5571341|NCT01001039|facial pain|facial pain
5571342|NCT01001026|vaccine|vaccine
5571343|NCT01001026|H1N1|h1n1
5571344|NCT01001026|influenza|influenza
5571345|NCT01001026|H1N1 influenza vaccine|h1n1 influenza vaccine
5571346|NCT01001026|pandemic|pandemic
5571347|NCT01000987|alcohol|alcohol
5571348|NCT01000987|reactivity|reactivity
5571349|NCT01000987|smoking cessation medications|smoking cessation medications
5571350|NCT01000974|primary vaccination course|primary vaccination course
5571351|NCT01000974|Haemophilus influenzae type b|haemophilus influenzae type b
5571352|NCT01000974|infants, children|infants, children
5571353|NCT01000974|booster vaccination|booster vaccination
5571354|NCT01000974|immunogenicity|immunogenicity
5571355|NCT01000974|safety|safety
5571356|NCT01000974|Gram-negative bacterial infections|gram-negative bacterial infections
5571357|NCT01000974|vaccines, conjugate|vaccines, conjugate
5571358|NCT01000961|cystinosis|cystinosis
5571359|NCT01000961|cysteamine|cysteamine
5571360|NCT01000961|inheritable disease|inheritable disease
5571361|NCT01000961|orphan disease|orphan disease
5571362|NCT01000961|CTNS protein, human|ctns protein, human
5571363|NCT01000961|metabolic disease|metabolic disease
5571364|NCT01000961|nephropathic cystinosis|nephropathic cystinosis
5571365|NCT01000948|Prostate cancer|prostate cancer
5571366|NCT01000948|Castration resistant|castration resistant
5571367|NCT01000948|Chemotherapy resistant|chemotherapy resistant
5571368|NCT01000948|Endothelial receptor A inhibitor|endothelial receptor a inhibitor
5571369|NCT01000948|ZD4054|zd4054
5571370|NCT01000935|Rotator Cuff Decompression Repair|rotator cuff decompression repair
5571371|NCT01000922|Mealtime Insulin|mealtime insulin
5571372|NCT01000922|Rapid acting insulin|rapid acting insulin
5571373|NCT01000922|Ultra fast VIAject|ultra fast viaject
5571374|NCT01000922|prandial insulin|prandial insulin
5571375|NCT01000896|Phase I|phase i
5571376|NCT01000896|cancer|cancer
5571377|NCT01000896|solid tumors|solid tumors
5571378|NCT01000896|advanced solid malignancies|advanced solid malignancies
5571379|NCT01000896|NSCLC|nsclc
5571380|NCT01000896|epithelial ovarian cancer|epithelial ovarian cancer
5571381|NCT01000896|dose escalation|dose escalation
5571382|NCT01000896|combination treatment|combination treatment
5571869|NCT00999089|Off pump|off pump
5571383|NCT01000896|src inhibitor|src inhibitor
5571384|NCT01000896|Japanese|japanese
5571385|NCT01000883|stage IIIA breast cancer|stage iiia breast cancer
5573924|NCT00991666|AMD|amd
5571386|NCT01000883|stage IIIB breast cancer|stage iiib breast cancer
5571387|NCT01000883|stage IIIC breast cancer|stage iiic breast cancer
5571388|NCT01000883|stage IV breast cancer|stage iv breast cancer
5571389|NCT01000883|recurrent breast cancer|recurrent breast cancer
5571390|NCT01000857|controlled-release tablet|controlled-release tablet
5571392|NCT01000857|immediate-release tablet|immediate-release tablet
5571393|NCT01000857|paroxetine|paroxetine
5571394|NCT01000857|safety|safety
5571395|NCT01000857|crossover|crossover
5571396|NCT01000857|pharmacokinetics|pharmacokinetics
5571397|NCT01000857|steady-state|steady-state
5571398|NCT01000857|Japanese healthy male volunteers|japanese healthy male volunteers
5571399|NCT01000857|tolerance|tolerance
5571400|NCT01000844|Hemophilia|hemophilia
5571401|NCT01000844|Joint|joint
5571402|NCT01000844|Cartilage|cartilage
5571403|NCT01000844|Damage|damage
5571404|NCT01000844|Prophylaxis|prophylaxis
5571405|NCT01000844|Factor VIII|factor viii
5571406|NCT01000844|FVIII|fviii
5571407|NCT01000844|Disease|disease
5571408|NCT01000844|Arthropathy|arthropathy
5571409|NCT01000831|vaccine|vaccine
5571410|NCT01000831|influenza|influenza
5571411|NCT01000831|H1N1 influenza vaccine|h1n1 influenza vaccine
5571412|NCT01000831|influenza vaccine|influenza vaccine
5571413|NCT01000831|Arepanrix|arepanrix
5571414|NCT01000818|Treatment experienced|treatment experienced
5571415|NCT01000779|Non Cirrhotic Portal Hypertension, secondary prophylaxis|non cirrhotic portal hypertension, secondary prophylaxis
5571416|NCT01000740|EAP|eap
5571417|NCT01000740|Long term survival (3 years)|long term survival (3 years)
5571418|NCT01000740|Gefitinib|gefitinib
5571419|NCT01000740|efficacy|efficacy
5571420|NCT01000727|Atherosclerosis|atherosclerosis
5571421|NCT01000727|Heart disease|heart disease
5571422|NCT01000727|Cardiovascular disease|cardiovascular disease
5571423|NCT01000727|Lp-PLA2 inhibitor|lp-pla2 inhibitor
5571424|NCT01000727|The TIMI Study Group|the timi study group
5571425|NCT01000727|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5571426|NCT01000727|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5571427|NCT01000701|Inflammation|inflammation
5571428|NCT01000701|ACS|acs
5571429|NCT01000701|Prevention|prevention
5571430|NCT01000701|Education|education
5571431|NCT01000701|Clinical management|clinical management
5571432|NCT01000675|aneurysm|aneurysm
5571433|NCT01000675|coils|coils
5571434|NCT01000662|whole breast radiotherapy|whole breast radiotherapy
5571436|NCT01000649|V1a agonist|v1a agonist
5571437|NCT01000636|Renal transplant patients|renal transplant patients
5571438|NCT01000636|Actinic Keratoses|actinic keratoses
5571439|NCT01000636|Metvix PDT|metvix pdt
5571440|NCT01000636|Field cancerisation|field cancerisation
5571441|NCT01000636|Gene expression|gene expression
5571442|NCT01000597|pharmacokinetics|pharmacokinetics
5571443|NCT01000597|serum cortisol|serum cortisol
5571444|NCT01000597|pharmacodynamics|pharmacodynamics
5571446|NCT01000597|healthy Caucasian, Japanese, Korean and Chinese subjects|healthy caucasian, japanese, korean and chinese subjects
5571448|NCT01000584|H1N1|h1n1
5571449|NCT01000584|influenza|influenza
5571450|NCT01000584|H1N1 influenza vaccine|h1n1 influenza vaccine
5571451|NCT01000584|influenza vaccine|influenza vaccine
5571452|NCT01000584|seasonal Influenza|seasonal influenza
5571453|NCT01000571|H1N1 pandemic flu|h1n1 pandemic flu
5571454|NCT01000558|non-Hodgkin lymphoma|non-hodgkin lymphoma
5571455|NCT01000545|Diabetes Mellitus|diabetes mellitus
5571456|NCT01000545|Chronic Kidney Disease|chronic kidney disease
5571457|NCT01000545|Glycosaminoglycans|glycosaminoglycans
5571458|NCT01000545|Sulodexide|sulodexide
5571459|NCT01000545|Macroalbuminuria|macroalbuminuria
5571460|NCT01000545|Safety and Efficacy|safety and efficacy
5571461|NCT01000532|steroid, leads, threshold, pacemaker|steroid, leads, threshold, pacemaker
5571462|NCT01000519|Diabetes mellitus|diabetes mellitus
5571463|NCT01000519|Randomized control trial|randomized control trial
5571464|NCT01000519|Exercise|exercise
5571465|NCT01000519|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5571466|NCT01000506|Dose-ranging|dose-ranging
5571467|NCT01000506|Safety|safety
5571468|NCT01000506|Pharmacodynamics|pharmacodynamics
5571469|NCT01000506|eosinophils|eosinophils
5571470|NCT01000506|SB-240563|sb-240563
5571471|NCT01000506|Efficacy|efficacy
5571472|NCT01000506|Severe refractory asthma|severe refractory asthma
5571473|NCT01000506|mepolizumab|mepolizumab
5571475|NCT01000493|efficacy|efficacy
5571476|NCT01000493|double-blind|double-blind
5571477|NCT01000493|Clinician Administered PTSD Scale|clinician administered ptsd scale
5571478|NCT01000493|placebo|placebo
5571479|NCT01000493|Sleep|sleep
5571480|NCT01000493|safety|safety
5571481|NCT01000493|CAPS|caps
5571482|NCT01000493|neurokinin-1 antagonist|neurokinin-1 antagonist
5571483|NCT01000493|orvepitant|orvepitant
5571484|NCT01000493|PTSD|ptsd
5571485|NCT01000493|randomized|randomized
5571486|NCT01000493|Post traumatic stress disorder|post traumatic stress disorder
5571487|NCT01000493|Phase II|phase ii
5571488|NCT01000467|PK assessment for healthy male volunteer|pk assessment for healthy male volunteer
5571489|NCT01000467|Healthy male subjects aged 20 to 40 years|healthy male subjects aged 20 to 40 years
5571490|NCT01000441|Rheumatoid arthritis with inadequate response to 1 anti-TNF|rheumatoid arthritis with inadequate response to 1 anti-tnf
5571493|NCT01000428|Positron emission technology|positron emission technology
5571494|NCT01000428|FLT|flt
5571495|NCT01000428|FDG|fdg
5571496|NCT01000415|Stage Ib2-early IIb of cervical cancer|stage ib2-early iib of cervical cancer
5571497|NCT01000415|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5571498|NCT01000415|Cisplatin plus gemcitabine|cisplatin plus gemcitabine
5571499|NCT01000415|Radical hysterectomy with pelvic lymphadenectomy|radical hysterectomy with pelvic lymphadenectomy
5571500|NCT01000415|Quality of life|quality of life
5571501|NCT01000415|Stage Ib2-IIb of cervical cancer patients|stage ib2-iib of cervical cancer patients
5571502|NCT01000402|Bipolar Disorder|bipolar disorder
5571503|NCT01000402|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5571504|NCT01000402|Genetics|genetics
5571505|NCT01000402|Environmental Factors|environmental factors
5571506|NCT01000402|Family Factors|family factors
5571507|NCT01000376|Cancer|cancer
5571508|NCT01000376|solid tumors|solid tumors
5571509|NCT01000350|orthostatic intolerance|orthostatic intolerance
5571510|NCT01000350|exercise capacity|exercise capacity
5571511|NCT01000350|tachycardia|tachycardia
5571512|NCT01000350|POTS|pots
5571513|NCT01000337|Liver Apoptosis|liver apoptosis
5571514|NCT01000324|Hepatitis A|hepatitis a
5571515|NCT01000324|Hepatitis B|hepatitis b
5571516|NCT01000311|MenACWY conjugate vaccine in infants|menacwy conjugate vaccine in infants
5571517|NCT01000311|Meningococcal vaccine in infants|meningococcal vaccine in infants
5571518|NCT01000311|MenACWY|menacwy
5571519|NCT01000246|mammacarcinoma|mammacarcinoma
5571520|NCT01000246|breastcancer|breastcancer
5571521|NCT01000246|chemotherapy|chemotherapy
5571522|NCT01000246|heart failure|heart failure
5571523|NCT01000246|influenza virus vaccine|influenza virus vaccine
5571524|NCT01000233|PATOLOGIC CALCIFICATION|patologic calcification
5571525|NCT01000233|AORTIC VALVE STENOSIS|aortic valve stenosis
5571526|NCT01000233|INOSITOL HEXAPHOSPHATE|inositol hexaphosphate
5571527|NCT01000207|Influenza A|influenza a
5571528|NCT01000207|H1N1 subtype|h1n1 subtype
5571529|NCT01000207|Children/adolescent|children/adolescent
5571530|NCT01000207|Vaccine|vaccine
5571531|NCT01000207|Adjuvant|adjuvant
5571532|NCT01000194|postprandial|postprandial
5571533|NCT01000194|gene expression profiles|gene expression profiles
5571534|NCT01000194|microarray|microarray
5571535|NCT01000168|Brain Injury|brain injury
5571536|NCT01000168|Rehabilitation|rehabilitation
5571537|NCT01000168|Treadmill therapy|treadmill therapy
5571538|NCT01000155|fetal hemoglobin|fetal hemoglobin
5571539|NCT01000155|vorinostat|vorinostat
5571540|NCT01000155|HDAC inhibitor|hdac inhibitor
5571541|NCT01000155|SAHA|saha
5571542|NCT01000142|Osteopathic|osteopathic
5571544|NCT01000142|Preventative|preventative
5571545|NCT01000142|Elderly|elderly
5571546|NCT01000142|Nursing Home|nursing home
5571547|NCT01000142|Prevention: General Health Status|prevention: general health status
5571548|NCT01000129|Radiotherapy|radiotherapy
5571549|NCT01000129|Bladder cancer|bladder cancer
5571550|NCT01000129|Adaptive planning|adaptive planning
5571551|NCT01000116|Tapp|tapp
5571552|NCT01000116|Early pain|early pain
5571553|NCT01000116|well-being|well-being
5571554|NCT01000116|Seroma|seroma
5571555|NCT01000116|Haematoma|haematoma
5571556|NCT01000116|Fibrin glue|fibrin glue
5571557|NCT01000116|tacks|tacks
5571558|NCT01000103|Stroke|stroke
5571559|NCT01000103|Visuospatial neglect|visuospatial neglect
5571560|NCT01000103|Visuospatial extinction|visuospatial extinction
5571561|NCT01000103|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5571562|NCT01000103|Non-invasive brain stimulation|non-invasive brain stimulation
5571563|NCT01000103|Neuromodulation|neuromodulation
5571564|NCT01000103|Brain parietal cortex|brain parietal cortex
5571565|NCT01000103|Neurological sequels|neurological sequels
5571566|NCT01000103|Cognitive rehabilitation|cognitive rehabilitation
5571567|NCT01000090|Acromegaly|acromegaly
5571568|NCT01000090|Somatostatin analogues|somatostatin analogues
5571569|NCT01000090|Treatment|treatment
5571570|NCT01000077|Regenerative Medicine|regenerative medicine
5571571|NCT01000077|Tissue Collection|tissue collection
5571572|NCT01000077|Cell Culture Systems|cell culture systems
5571574|NCT01000064|Traumatic Brain Injury|traumatic brain injury
5571575|NCT01000064|Attention Deficit|attention deficit
5571576|NCT01000064|TBI|tbi
5571577|NCT01000051|Transplant Thrombocytopenia|transplant thrombocytopenia
5571578|NCT01000051|Hematopoietic cell transplantation|hematopoietic cell transplantation
5571579|NCT01000051|HCT|hct
5571580|NCT01000051|Low platelet count|low platelet count
5571581|NCT01000051|Bleeding|bleeding
5571582|NCT01000051|Blood clot|blood clot
5571870|NCT00999063|GerdQ|gerdq
5571583|NCT01000051|Stem Cell Transplant|stem cell transplant
5571584|NCT01000051|Blood And Marrow Transplantation|blood and marrow transplantation
5571585|NCT01000051|Eltrombopag|eltrombopag
5571586|NCT01000051|Promacta|promacta
5571588|NCT01000038|Assisted living|assisted living
5571589|NCT01000038|Alzheimer's dementia|alzheimer's dementia
5565588|NCT01024595|HIV|hiv
5571590|NCT01000025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5571591|NCT01000025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5571592|NCT01000025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5571594|NCT00999999|CSF leakage|csf leakage
5571595|NCT00999999|Dural sealant|dural sealant
5571596|NCT00999960|Laparoscopy|laparoscopy
5571597|NCT00999960|Prostate|prostate
5571599|NCT00999960|Learning|learning
5571600|NCT00999960|Simulation|simulation
5571601|NCT00999960|Simulator|simulator
5571602|NCT00999947|genetics|genetics
5571603|NCT00999947|mutation screening|mutation screening
5571604|NCT00999947|phenotype-genotype analysis|phenotype-genotype analysis
5571605|NCT00999947|desmosomal genes|desmosomal genes
5571606|NCT00999921|Fibrocystic Breast Disease|fibrocystic breast disease
5571607|NCT00999921|Fibroadenoma|fibroadenoma
5571608|NCT00999921|Mastalgia|mastalgia
5571609|NCT00999908|COPD|copd
5571610|NCT00999908|indacaterol|indacaterol
5571611|NCT00999908|tiotropium|tiotropium
5571612|NCT00999895|Schizophrenia|schizophrenia
5571613|NCT00999895|Switch of antipsychotic treatment|switch of antipsychotic treatment
5571614|NCT00999895|Outcome evaluation|outcome evaluation
5571615|NCT00999895|monotherapy|monotherapy
5571616|NCT00999895|Greece|greece
5571617|NCT00999882|mTor Kinase Inhibitor|mtor kinase inhibitor
5571618|NCT00999882|Phase I/II|phase i/ii
5571619|NCT00999882|Dose escalation|dose escalation
5571620|NCT00999882|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5571621|NCT00999882|Asia|asia
5571622|NCT00999882|HCC|hcc
5571623|NCT00999882|Safety and pharmacokinetics|safety and pharmacokinetics
5556204|NCT01061671|COPD|copd
5571624|NCT00999869|Newly diagnosed|newly diagnosed
5571625|NCT00999869|Alopecia areata|alopecia areata
5571626|NCT00999869|Botulinum toxin A|botulinum toxin a
5571627|NCT00999869|Corticosteroid|corticosteroid
5571628|NCT00999869|Intralesional injection|intralesional injection
5571629|NCT00999856|medical device,|medical device,
5571630|NCT00999856|sub-conjunctival insert|sub-conjunctival insert
5571631|NCT00999856|photometer|photometer
5571632|NCT00999856|fluorescence|fluorescence
5571633|NCT00999856|subconjunctival interstitial fluid glucose|subconjunctival interstitial fluid glucose
5571634|NCT00999856|non-invasive measurement|non-invasive measurement
5571635|NCT00999843|Sorafenib|sorafenib
5571636|NCT00999843|Three-dimensional conformal radiation therapy|three-dimensional conformal radiation therapy
5571637|NCT00999843|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5571638|NCT00999843|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5685558|NCT00555607|mild|mild
5571639|NCT00999817|Drug-Drug interaction Study CYP2D6 inhibition Healthy Subjects|drug-drug interaction study cyp2d6 inhibition healthy subjects
5571640|NCT00999804|Locally Advanced Breast Cancer Neoadjuvant Endocrine|locally advanced breast cancer neoadjuvant endocrine
5571642|NCT00999778|Social and Communication Deficits in Autism|social and communication deficits in autism
5571643|NCT00999778|Parent and Caregiver interventions with children with Autism|parent and caregiver interventions with children with autism
5571644|NCT00999778|Autism Spectrum Disorder|autism spectrum disorder
5571646|NCT00999765|Bipolar Disorder|bipolar disorder
5571647|NCT00999765|Bipolar Depression|bipolar depression
5571648|NCT00999765|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5571649|NCT00999765|MBCT|mbct
5571650|NCT00999765|Maintenance|maintenance
5571651|NCT00999765|Euthymic|euthymic
5571652|NCT00999765|Efficacy|efficacy
5571653|NCT00999765|Feasibility|feasibility
5571654|NCT00999752|Hypertension|hypertension
5571655|NCT00999752|African Americans|african americans
5571656|NCT00999752|Arterial Stiffness|arterial stiffness
5571657|NCT00999752|Vascular Resistance|vascular resistance
5571658|NCT00999739|pneumococcal vaccines|pneumococcal vaccines
5571659|NCT00999739|HIV|hiv
5571660|NCT00999739|antibody response|antibody response
5571661|NCT00999739|antibody affinity|antibody affinity
5571662|NCT00999739|Antibody formation|antibody formation
5571663|NCT00999739|Phagocytosis|phagocytosis
5571664|NCT00999713|Acute Lung Injury|acute lung injury
5571665|NCT00999713|Cancer|cancer
5571666|NCT00999713|Pediatrics|pediatrics
5571667|NCT00999700|Locally advanced HNSCC|locally advanced hnscc
5571668|NCT00999700|Chemo-radiation|chemo-radiation
5571669|NCT00999700|Induction chemotherapy|induction chemotherapy
5571670|NCT00999700|Stage III/IV|stage iii/iv
5571671|NCT00999700|Unresectable disease|unresectable disease
5571672|NCT00999687|Nail psoriasis|nail psoriasis
5571673|NCT00999687|Indigo naturalis|indigo naturalis
5571674|NCT00999674|Exercise|exercise
5571675|NCT00999648|Tinnitus|tinnitus
5571676|NCT00999648|Myofascial Trigger Points|myofascial trigger points
5571677|NCT00999648|Myofascial Pain Syndrome|myofascial pain syndrome
5571678|NCT00999648|Controlled Clinical Trial|controlled clinical trial
5571679|NCT00999635|Insoles|insoles
5571680|NCT00999635|Prevention of Ulceration|prevention of ulceration
5571681|NCT00999635|Diabetic Foot|diabetic foot
5571682|NCT00999635|Neuropathic|neuropathic
5571684|NCT00999622|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5571685|NCT00999622|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5553672|NCT01072448|COPD|copd
5571686|NCT00999622|adult giant cell glioblastoma|adult giant cell glioblastoma
5571687|NCT00999622|adult gliosarcoma|adult gliosarcoma
5571688|NCT00999622|adult oligodendroglioma|adult oligodendroglioma
5571689|NCT00999622|adult glioblastoma|adult glioblastoma
5571690|NCT00999622|adult diffuse astrocytoma|adult diffuse astrocytoma
5571691|NCT00999622|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5571692|NCT00999622|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5571693|NCT00999622|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5571694|NCT00999609|Adeno-associated virus|adeno-associated virus
5571695|NCT00999609|AAV|aav
5571696|NCT00999609|Leber congenital amaurosis|leber congenital amaurosis
5571697|NCT00999609|RPE65|rpe65
5571698|NCT00999609|Gene therapy|gene therapy
5571699|NCT00999609|Gene transfer|gene transfer
5571700|NCT00999609|voretigene neparvovec-rzyl|voretigene neparvovec-rzyl
5571701|NCT00999609|Retinitis pigmentosa|retinitis pigmentosa
5571702|NCT00999596|Breast Cancer|breast cancer
5571703|NCT00999596|Digital Mammography|digital mammography
5571704|NCT00999583|Cardiac arrest|cardiac arrest
5571705|NCT00999583|erythropoietin|erythropoietin
5571706|NCT00999583|post-anoxic encephalopathy|post-anoxic encephalopathy
5571707|NCT00999583|neuroprotective drugs|neuroprotective drugs
5571708|NCT00999570|outcome|outcome
5571709|NCT00999570|quality of life|quality of life
5571710|NCT00999570|total knee arthroplasty|total knee arthroplasty
5571711|NCT00999570|clinical outcome scores post total knee arthroplasty|clinical outcome scores post total knee arthroplasty
5680322|NCT00578214|basal cell carcinoma|basal cell carcinoma
5571712|NCT00999570|quality of life scores post total knee arthroplasty|quality of life scores post total knee arthroplasty
5571713|NCT00999557|breast cancer|breast cancer
5571714|NCT00999557|male breast cancer|male breast cancer
5571715|NCT00999557|alopecia|alopecia
5571716|NCT00999544|opioid|opioid
5571717|NCT00999544|oxycodone|oxycodone
5571718|NCT00999544|NK1 antagonist|nk1 antagonist
5571719|NCT00999544|aprepitant|aprepitant
5571720|NCT00999544|intranasal|intranasal
5571721|NCT00999544|abuse|abuse
5571722|NCT00999531|Cystic Fibrosis|cystic fibrosis
5571723|NCT00999531|CF|cf
5571724|NCT00999531|Mucociliary Clearance|mucociliary clearance
5571725|NCT00999531|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5571726|NCT00999531|ENaC Inhibitor|enac inhibitor
5571727|NCT00999531|Airway Hydration|airway hydration
5571728|NCT00999531|Amiloride|amiloride
5685396|NCT00556257|Immunosuppression, JAK3 inhibitor, kidney transplantation|immunosuppression, jak3 inhibitor, kidney transplantation
5571729|NCT00999518|Randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety|randomized double blind placebo-controlled parallel-group dose-range finding interstitial cystitis efficacy pain urinary symptoms safety
5571730|NCT00999505|Schizophrenia|schizophrenia
5571731|NCT00999505|Amantadine|amantadine
5571732|NCT00999505|Residual symptoms|residual symptoms
5571733|NCT00999492|Tecnis Multifocal|tecnis multifocal
5571734|NCT00999492|Patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses|patients scheduled for cataract or lens replacement surgery with implantation of multifocal intraocular lenses
5571735|NCT00999453|LDL-cholesterol|ldl-cholesterol
5571736|NCT00999453|Prevalent peritoneal dialysis patients with hypercholesterolemia|prevalent peritoneal dialysis patients with hypercholesterolemia
5571737|NCT00999440|Chronic Pain|chronic pain
5571738|NCT00999440|Methadone|methadone
5571739|NCT00999440|Perceived Sleep|perceived sleep
5571740|NCT00999440|QTc|qtc
5571741|NCT00999427|Povidone-iodine|povidone-iodine
5571742|NCT00999427|prostate cancer|prostate cancer
5571743|NCT00999427|biopsy|biopsy
5571744|NCT00999427|transrectal ultrasound|transrectal ultrasound
5571745|NCT00999427|urinary tract infection|urinary tract infection
5571746|NCT00999427|fever|fever
5571747|NCT00999427|sepsis|sepsis
5571748|NCT00999427|antisepsis|antisepsis
5571749|NCT00999427|prevention|prevention
5571750|NCT00999427|complications|complications
5571751|NCT00999414|MM|mm
5571752|NCT00999388|Lifestyle|lifestyle
5571753|NCT00999388|Environment|environment
5571754|NCT00999388|Neurodegenerative Diseases|neurodegenerative diseases
5571756|NCT00999388|Public Health|public health
5571757|NCT00999388|PD|pd
5571758|NCT00999388|Parkinson Disease|parkinson disease
5571759|NCT00999375|Type 1 Diabetes|type 1 diabetes
5571760|NCT00999375|Diet|diet
5571761|NCT00999375|Behavioral Intervention|behavioral intervention
5571762|NCT00999375|Children|children
5571763|NCT00999375|Adolescents|adolescents
5571764|NCT00999362|calcineurin activity|calcineurin activity
5571765|NCT00999362|real-time PCR|real-time pcr
5571766|NCT00999362|Gene expression of calcineurin|gene expression of calcineurin
5571767|NCT00999362|T-lymphocytes|t-lymphocytes
5571768|NCT00999362|interferon-gamma|interferon-gamma
5571769|NCT00999362|Pharmacodynamics|pharmacodynamics
5571770|NCT00999362|Pharmacokinetics|pharmacokinetics
5571771|NCT00999362|tacrolimus|tacrolimus
5571772|NCT00999362|western blot|western blot
5571773|NCT00999362|Hoechst|hoechst
5571774|NCT00999349|iron overload condition|iron overload condition
5571775|NCT00999349|regular desferrioxamine administration|regular desferrioxamine administration
5574307|NCT00990249|HCT|hct
5571776|NCT00999349|receiving continuous blood transfusions|receiving continuous blood transfusions
5571777|NCT00999336|Betrixaban|betrixaban
5571778|NCT00999336|Renal impairment|renal impairment
5571779|NCT00999336|Healthy|healthy
5571780|NCT00999336|Kidney dysfunction|kidney dysfunction
5571781|NCT00999310|Klinefelter syndrome|klinefelter syndrome
5571782|NCT00999310|Neuropsychology|neuropsychology
5571783|NCT00999310|Neuroradiology|neuroradiology
5571784|NCT00999310|Genetics|genetics
5571785|NCT00999297|thermogenesis|thermogenesis
5571786|NCT00999297|respiratory quotient|respiratory quotient
5571787|NCT00999297|fat oxidation|fat oxidation
5571788|NCT00999284|ZK200775 is tested for its effects on vision on healthy probands.|zk200775 is tested for its effects on vision on healthy probands.
5571789|NCT00999271|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5571790|NCT00999271|gastric emptying|gastric emptying
5571791|NCT00999271|appetite|appetite
5571792|NCT00999271|energy intake|energy intake
5571793|NCT00999271|lipid metabolism|lipid metabolism
5571794|NCT00999258|glomerular filtration rate|glomerular filtration rate
5571795|NCT00999258|chronic allograft nephropathy|chronic allograft nephropathy
5571796|NCT00999258|Kidney transplantation|kidney transplantation
5571797|NCT00999258|African American|african american
5571798|NCT00999232|erythromycin|erythromycin
5571799|NCT00999232|prokinetics|prokinetics
5571800|NCT00999232|nasojejunal tubes|nasojejunal tubes
5571801|NCT00999232|Bengmark feeding tube|bengmark feeding tube
5571802|NCT00999232|post-pyloric feeding|post-pyloric feeding
5571803|NCT00999232|pancreatitis|pancreatitis
5571804|NCT00999232|Non-critically ill patients having pancreatitis who require jejunal enteral nutrition|non-critically ill patients having pancreatitis who require jejunal enteral nutrition
5571805|NCT00999219|FK199B|fk199b
5571806|NCT00999219|Zolpidem|zolpidem
5571807|NCT00999206|Influenza|influenza
5571808|NCT00999206|Vaccine|vaccine
5571809|NCT00999206|CHMP criteria|chmp criteria
5571810|NCT00999193|Shoulder|shoulder
5571811|NCT00999193|Fracture|fracture
5571812|NCT00999193|Locking Plate|locking plate
5571813|NCT00999193|Hemiarthroplasty|hemiarthroplasty
5571814|NCT00999193|Conservative|conservative
5571815|NCT00999193|Comminuted Proximal Humerus Fracture|comminuted proximal humerus fracture
5571816|NCT00999180|Botulinum Toxin|botulinum toxin
5571817|NCT00999180|Rehabilitation|rehabilitation
5571818|NCT00999180|Stroke|stroke
5571819|NCT00999167|Cirrhosis|cirrhosis
5571820|NCT00999167|Episodic Hepatic Encephalopathy|episodic hepatic encephalopathy
5571824|NCT00999167|glycerol phenylbutyrate|glycerol phenylbutyrate
5571825|NCT00999154|Energy Expenditure|energy expenditure
5571826|NCT00999154|Dietary Intake|dietary intake
5571827|NCT00999154|Physical Activity|physical activity
5571828|NCT00999154|Body Weight Regulation|body weight regulation
5571829|NCT00999154|Sedentary|sedentary
5571830|NCT00999154|HV|hv
5571831|NCT00999154|Healthy Volunteer|healthy volunteer
5571832|NCT00999128|PI3K inhibitor|pi3k inhibitor
5571833|NCT00999128|PI3 kinase|pi3 kinase
5571834|NCT00999128|PI3 kinase inhibitor|pi3 kinase inhibitor
5571835|NCT00999115|Rectovaginal Fistula|rectovaginal fistula
5571836|NCT00999115|Crohn Disease|crohn disease
5571837|NCT00999115|Allogenic|allogenic
5571838|NCT00999115|Adipose-Derived Stem Cells|adipose-derived stem cells
5571839|NCT00999102|hypertension|hypertension
5571840|NCT00999102|beta blockers|beta blockers
5571841|NCT00999102|Metoprolol|metoprolol
5571842|NCT00999102|blood pressure, high|blood pressure, high
5571843|NCT00999102|antihypertensive agents|antihypertensive agents
5571844|NCT00999102|vascular resistance|vascular resistance
5571845|NCT00999102|adrenergic beta-receptor blockaders|adrenergic beta-receptor blockaders
5571846|NCT00999102|beta-Adrenergic blockers|beta-adrenergic blockers
5571847|NCT00999102|beta-Adrenergic Blocking Agents|beta-adrenergic blocking agents
5571848|NCT00999102|beta-Adrenergic Receptor Blockaders|beta-adrenergic receptor blockaders
5571849|NCT00999102|beta-Blockers, Adrenergic|beta-blockers, adrenergic
5571850|NCT00999102|Bystolic|bystolic
5571851|NCT00999102|Nebivolol|nebivolol
5571852|NCT00999102|Nebivololum|nebivololum
5571853|NCT00999102|Nebivololum [Latin]|nebivololum [latin]
5571854|NCT00999102|R65,824|r65,824
5571855|NCT00999102|Beloc- Zok|beloc- zok
5571856|NCT00999102|H 93/26 succinate|h 93/26 succinate
5571857|NCT00999102|Metoprolol succinate|metoprolol succinate
5571858|NCT00999102|Seloken ZOC|seloken zoc
5571859|NCT00999102|Selozok|selozok
5571860|NCT00999102|Spesicor Dos|spesicor dos
5571861|NCT00999102|Toprol XL|toprol xl
5571862|NCT00999102|Toprol-XL|toprol-xl
5571863|NCT00999102|UNII-TH25PD4CCB|unii-th25pd4ccb
5571864|NCT00999089|Coronary disease|coronary disease
5571865|NCT00999089|Coronary artery bypass grafting|coronary artery bypass grafting
5571866|NCT00999089|Cardiopulmonary bypass|cardiopulmonary bypass
5571867|NCT00999089|Extracorporeal circulation|extracorporeal circulation
5571868|NCT00999089|Cardioplegia|cardioplegia
5571871|NCT00999050|type two diabetes|type two diabetes
5571872|NCT00999050|gastric bypass surgery|gastric bypass surgery
5571873|NCT00999050|overweight or moderately obese|overweight or moderately obese
5571874|NCT00999011|critical care|critical care
5571875|NCT00999011|inflammatory biomarkers|inflammatory biomarkers
5571886|NCT00998972|N-acetylcysteine|n-acetylcysteine
5571887|NCT00998959|Depression|depression
5571888|NCT00998959|Major Depression|major depression
5571889|NCT00998946|Relapsed|relapsed
5571890|NCT00998946|Refractory|refractory
5571891|NCT00998946|Non-Hodgkin's|non-hodgkin's
5571892|NCT00998933|Testosterone replacement therapy|testosterone replacement therapy
5571893|NCT00998920|Healthy volunteers|healthy volunteers
5571894|NCT00998907|Open Abdominal Surgery|open abdominal surgery
5571895|NCT00998907|Fascial Closure|fascial closure
5571896|NCT00998894|BIS|bis
5571897|NCT00998894|MAC|mac
5571898|NCT00998894|MAP|map
5571899|NCT00998881|insulin resistance|insulin resistance
5571900|NCT00998868|Rotator Cuff|rotator cuff
5571901|NCT00998868|Tendinopathy|tendinopathy
5571902|NCT00998868|ultrasonography|ultrasonography
5571903|NCT00998855|Exercise in obesity|exercise in obesity
5571905|NCT00998842|EKG|ekg
5571906|NCT00998842|healthy subjects|healthy subjects
5571907|NCT00998842|electrocardiography, ambulatory|electrocardiography, ambulatory
5571908|NCT00998829|psoriasis|psoriasis
5571909|NCT00998829|psoriatic arthritis|psoriatic arthritis
5571910|NCT00998829|epidemiology|epidemiology
5571911|NCT00998829|prevalence|prevalence
5571912|NCT00998816|thoracotomy|thoracotomy
5571913|NCT00998816|chronic|chronic
5571914|NCT00998816|pain|pain
5571915|NCT00998816|pregabalin|pregabalin
5571916|NCT00998816|Lyrica|lyrica
5571917|NCT00998803|Influenza virus|influenza virus
5571918|NCT00998790|Urinary Incontinence, Stress|urinary incontinence, stress
5571919|NCT00998790|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
5571920|NCT00998790|Secondary|secondary
5571921|NCT00998790|TUR|tur
5571922|NCT00998790|TURP|turp
5571923|NCT00998790|Radical prostatectomy|radical prostatectomy
5571924|NCT00998790|Open prostatectomy|open prostatectomy
5571925|NCT00998790|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
5571926|NCT00998777|tubing program|tubing program
5571927|NCT00998777|shoulder strengthening|shoulder strengthening
5571928|NCT00998777|injury prevention|injury prevention
5571929|NCT00998764|antibody|antibody
5571930|NCT00998764|immunotherapy|immunotherapy
5571931|NCT00998751|cKIT inhibitor|ckit inhibitor
5571932|NCT00998751|GIST|gist
5685397|NCT00556231|NIRS|nirs
5571933|NCT00998712|gestational diabetes mellitus|gestational diabetes mellitus
5571935|NCT00998712|cardiovascular disease risk|cardiovascular disease risk
5571936|NCT00998699|Diabetes|diabetes
5571937|NCT00998699|Type 1|type 1
5571938|NCT00998686|diabetes|diabetes
5571939|NCT00998686|DPP4 inhibitor|dpp4 inhibitor
5571940|NCT00998686|dutogliptin|dutogliptin
5571941|NCT00998673|Silica gel fiber|silica gel fiber
5571942|NCT00998673|Chronic venous leg ulcers|chronic venous leg ulcers
5571943|NCT00998673|Venous ulcer|venous ulcer
5571944|NCT00998673|Stasis ulcer|stasis ulcer
5571945|NCT00998673|Varicose ulcer|varicose ulcer
5571946|NCT00998660|Parkinson's disease|parkinson's disease
5571947|NCT00998660|Essential Tremor|essential tremor
5571948|NCT00998660|Dystonia (where indication is approved)|dystonia (where indication is approved)
5571949|NCT00998660|Deep brain stimulation|deep brain stimulation
5571950|NCT00998660|Activa RC|activa rc
5571951|NCT00998647|modified ultrafiltration|modified ultrafiltration
5571952|NCT00998647|cardiac surgery|cardiac surgery
5571954|NCT00998647|Multiple Electrode Aggregometry|multiple electrode aggregometry
5571955|NCT00998634|SCA2|sca2
5571956|NCT00998634|Lithium|lithium
5571957|NCT00998621|Hepatitis C, Chronic|hepatitis c, chronic
5571958|NCT00998621|HIV Infection|hiv infection
5571959|NCT00998621|Medication Adherence|medication adherence
5571960|NCT00998621|Questionnaire Design|questionnaire design
5571961|NCT00998621|Treatment experienced|treatment experienced
5571962|NCT00998595|Diabetes, Gestational|diabetes, gestational
5571963|NCT00998595|Postpartum Period|postpartum period
5571964|NCT00998595|Reproductive Health Services|reproductive health services
5571965|NCT00998595|Health Promotion|health promotion
5571966|NCT00998595|Health Personnel|health personnel
5565973|NCT01023074|MS|ms
5571967|NCT00998582|Cardiovascular Disease|cardiovascular disease
5571968|NCT00998582|HIV Infection|hiv infection
5571969|NCT00998582|Abacavir|abacavir
5571970|NCT00998582|Artery Elasticity|artery elasticity
5571971|NCT00998582|Treatment experienced|treatment experienced
5571972|NCT00998556|Peripartum cardiomyopathy|peripartum cardiomyopathy
5571973|NCT00998556|Bromocriptine|bromocriptine
5571974|NCT00998543|Smallpox Vaccinia Virus Smallpox Vaccine Variola Virus|smallpox vaccinia virus smallpox vaccine variola virus
5571975|NCT00998530|Trichomonas vaginalis|trichomonas vaginalis
5571976|NCT00998530|trichomoniasis|trichomoniasis
5571978|NCT00998530|Multilocus sequence typing|multilocus sequence typing
5571979|NCT00998517|Malnutrition|malnutrition
5571980|NCT00998517|Supplemental Food|supplemental food
5571982|NCT00998517|Supplementary Plumpy|supplementary plumpy
5571983|NCT00998504|impaired fat oxidation|impaired fat oxidation
5571984|NCT00998504|fat accumulation|fat accumulation
5571985|NCT00998504|mitochondrial dysfunction|mitochondrial dysfunction
5571986|NCT00998504|mitochondrial biogenesis|mitochondrial biogenesis
5571988|NCT00998465|Hypertension|hypertension
5571989|NCT00998465|Salt sensitivity|salt sensitivity
5571990|NCT00998465|Laparoscopic gastric bypass|laparoscopic gastric bypass
5571991|NCT00998465|Bariatric surgery|bariatric surgery
5571992|NCT00998452|Weight|weight
5571993|NCT00998452|Diet|diet
5571994|NCT00998452|Physical Activity|physical activity
5571995|NCT00998452|Veterans|veterans
5571996|NCT00998452|MOVE! Program|move! program
5571997|NCT00998439|in stent restenosis|in stent restenosis
5571998|NCT00998439|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5571999|NCT00998439|pepcad|pepcad
5572000|NCT00998439|drug eluting balloon|drug eluting balloon
5572001|NCT00998426|hepatitis B immune globulin|hepatitis b immune globulin
5572002|NCT00998426|HBIG|hbig
5572003|NCT00998426|HepaGam B|hepagam b
5572004|NCT00998426|orthotopic liver transplant|orthotopic liver transplant
5572005|NCT00998413|asthma|asthma
5572006|NCT00998413|overweight|overweight
5572007|NCT00998413|obesity|obesity
5572008|NCT00998413|children|children
5572009|NCT00998400|Cognitive-behavioral treatment|cognitive-behavioral treatment
5572010|NCT00998400|Well-being therapy|well-being therapy
5572011|NCT00998400|Depression|depression
5572012|NCT00998400|Demoralization|demoralization
5572013|NCT00998400|Acute coronary syndrome|acute coronary syndrome
5572014|NCT00998361|Sarcoma|sarcoma
5572015|NCT00998361|allogeneic|allogeneic
5572016|NCT00998361|Hemopoietic stem cell transplant|hemopoietic stem cell transplant
5572017|NCT00998348|parenting|parenting
5572018|NCT00998348|diet|diet
5572019|NCT00998348|physical activity|physical activity
5572020|NCT00998348|family|family
5572021|NCT00998348|home|home
5572022|NCT00998348|child|child
5572023|NCT00998335|Type 2 diabetes mellitus|type 2 diabetes mellitus
5572024|NCT00998335|Insulin therapy|insulin therapy
5572025|NCT00998335|Detemir (Levemir)|detemir (levemir)
5572026|NCT00998335|Aspart (Novolog)|aspart (novolog)
5572027|NCT00998335|Hepatic steatosis|hepatic steatosis
5572028|NCT00998322|metastatic|metastatic
5572029|NCT00998322|pancreatic|pancreatic
5572030|NCT00998322|adenocarcinoma|adenocarcinoma
5572031|NCT00998322|REOLYSIN|reolysin
5572032|NCT00998322|chemotherapy|chemotherapy
5572034|NCT00998309|skin infection|skin infection
5572035|NCT00998309|soft tissue infection|soft tissue infection
5572036|NCT00998309|sexually-transmitted infection|sexually-transmitted infection
5572037|NCT00998309|infection oral|infection oral
5572038|NCT00998309|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5572040|NCT00998257|Contraception|contraception
5572041|NCT00998257|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5572042|NCT00998257|PMDD|pmdd
5572043|NCT00998257|Acne|acne
5572044|NCT00998244|low carbohydrate|low carbohydrate
5572045|NCT00998244|low fat|low fat
5572046|NCT00998244|diet|diet
5572047|NCT00998244|overweight|overweight
5572048|NCT00998244|GERD|gerd
5572049|NCT00998244|gastroesophageal reflux disease|gastroesophageal reflux disease
5572050|NCT00998244|acid reflux|acid reflux
5572051|NCT00998244|heartburn|heartburn
5572052|NCT00998218|Sudden Cardiac Death|sudden cardiac death
5572053|NCT00998218|Arrythmias|arrythmias
5572054|NCT00998218|Triggered activity|triggered activity
5572055|NCT00998218|left ventricular dysfunction|left ventricular dysfunction
5572056|NCT00998192|carcinoma|carcinoma
5572057|NCT00998192|squamous cell|squamous cell
5572058|NCT00998192|lung|lung
5572059|NCT00998192|REOLYSIN|reolysin
5572060|NCT00998192|chemotherapy|chemotherapy
5572061|NCT00998192|carboplatin|carboplatin
5572062|NCT00998192|paclitaxel|paclitaxel
5572063|NCT00998192|Carcinoma, Squamous Cell of the Lung|carcinoma, squamous cell of the lung
5572064|NCT00998179|TENS|tens
5572065|NCT00998179|acupuncture|acupuncture
5572066|NCT00998179|FEV1|fev1
5572067|NCT00998179|Normal Healthy subjects|normal healthy subjects
5572068|NCT00998166|NSCLC|nsclc
5572069|NCT00998153|substance use|substance use
5572070|NCT00998153|PTSD|ptsd
5572071|NCT00998153|risky behaviors|risky behaviors
5572072|NCT00998153|revictimization|revictimization
5572073|NCT00998140|resuscitation|resuscitation
5572074|NCT00998140|sudden death|sudden death
5572075|NCT00998140|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5572076|NCT00998140|emergency medical services|emergency medical services
5572077|NCT00998140|termination of resuscitation|termination of resuscitation
5572078|NCT00998140|ventricular fibrillation|ventricular fibrillation
5572079|NCT00998140|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5572080|NCT00998140|asystole|asystole
5572081|NCT00998140|medical futility|medical futility
5572082|NCT00998140|withdrawing treatment|withdrawing treatment
5572083|NCT00998140|transportation of patients|transportation of patients
5572084|NCT00998140|health expenditures|health expenditures
5572085|NCT00998140|healthcare costs|healthcare costs
5554073|NCT01070667|PAF|paf
5572086|NCT00998127|Dual Anti-Platelet Therapy|dual anti-platelet therapy
5572087|NCT00998127|Non-adherence|non-adherence
5572088|NCT00998127|MACE|mace
5572089|NCT00998127|NACE|nace
5572090|NCT00998114|Early Cardiac Diastolic Dysfunction|early cardiac diastolic dysfunction
5572091|NCT00998114|Aerobic Exercise|aerobic exercise
5572092|NCT00998114|Weight Reduction|weight reduction
5572093|NCT00998101|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5572094|NCT00998101|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5572095|NCT00998101|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5572096|NCT00998088|Blood management|blood management
5572097|NCT00998088|Orthopedic surgery|orthopedic surgery
5572098|NCT00998088|elective|elective
5572099|NCT00998088|randomized study|randomized study
5572100|NCT00998088|adults|adults
5572101|NCT00998088|hip replacement|hip replacement
5572102|NCT00998088|knee replacement|knee replacement
5572103|NCT00998075|Bioequivalence|bioequivalence
5572105|NCT00998075|Esomeprazole|esomeprazole
5572106|NCT00998075|peptic ulcer disease|peptic ulcer disease
5572107|NCT00998075|primary cardiovascular protection|primary cardiovascular protection
5572108|NCT00998075|healthy volunteers|healthy volunteers
5572109|NCT00998062|Dyslipaemia|dyslipaemia
5572110|NCT00998062|atherosclerosis risk|atherosclerosis risk
5572111|NCT00998062|increased hsCRP|increased hscrp
5572112|NCT00998062|inflammatory and oxidative status in the Spanish population|inflammatory and oxidative status in the spanish population
5572114|NCT00998036|Temsirolimus|temsirolimus
5572115|NCT00998036|Erlotinib|erlotinib
5572116|NCT00998036|Cisplatin|cisplatin
5572117|NCT00998036|Breast Cancer|breast cancer
5572118|NCT00998023|Angiogram|angiogram
5572119|NCT00998023|Catheter Angiogram|catheter angiogram
5572120|NCT00998010|adult giant cell glioblastoma|adult giant cell glioblastoma
5572121|NCT00998010|adult glioblastoma|adult glioblastoma
5572122|NCT00998010|adult gliosarcoma|adult gliosarcoma
5572123|NCT00997997|Skin Diseases, Bacterial|skin diseases, bacterial
5572124|NCT00997997|Product Surveillance|product surveillance
5572125|NCT00997997|Postmarketing|postmarketing
5572126|NCT00997984|ADHD|adhd
5572127|NCT00997971|Hydrolysed rice protein formula|hydrolysed rice protein formula
5572128|NCT00997971|Cow's milk protein allergy|cow's milk protein allergy
5572129|NCT00997971|Infant formula|infant formula
5572130|NCT00997971|Gastrointestinal tolerance|gastrointestinal tolerance
5572131|NCT00997945|Phase I, advanced solid malignancies, advance solid tumour|phase i, advanced solid malignancies, advance solid tumour
5572132|NCT00997945|advanced cancer|advanced cancer
5572133|NCT00997945|ZD4054 (Zibotentan)|zd4054 (zibotentan)
5572134|NCT00997945|china|china
5572136|NCT00997945|pharmacokinetics|pharmacokinetics
5572137|NCT00997932|levonorgestrel releasing intrauterine device|levonorgestrel releasing intrauterine device
5572138|NCT00997932|levonorgestrel releasing intrauterine contraception|levonorgestrel releasing intrauterine contraception
5572139|NCT00997932|unintended pregnancy prevention|unintended pregnancy prevention
5572140|NCT00997932|postpartum contraception|postpartum contraception
5572141|NCT00997906|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5572142|NCT00997906|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5671991|NCT00613288|Testosterone substitution|testosterone substitution
5572143|NCT00997906|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5572144|NCT00997906|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5572145|NCT00997893|menopause|menopause
5572146|NCT00997893|hot flashes|hot flashes
5572147|NCT00997893|soy|soy
5572148|NCT00997893|estrogen|estrogen
5572149|NCT00997893|anxiety|anxiety
5572150|NCT00997880|rosuvastatin|rosuvastatin
5572151|NCT00997867|Pain|pain
5572152|NCT00997867|Surgery|surgery
5572153|NCT00997867|Catheter|catheter
5572154|NCT00997867|Nerve Block|nerve block
5572155|NCT00997867|Popliteal|popliteal
5572156|NCT00997867|Sciatic|sciatic
5572157|NCT00997867|Femoral|femoral
5572158|NCT00997867|Interscalene|interscalene
5572159|NCT00997867|UCSD|ucsd
5572160|NCT00997867|Moderate-to-severe pain|moderate-to-severe pain
5572161|NCT00997867|Perineural Catheter|perineural catheter
5566185|NCT01022190|Hip|hip
5572162|NCT00997867|Orthopedic Surgery|orthopedic surgery
5572163|NCT00997854|Feeding|feeding
5572164|NCT00997854|Intolerance|intolerance
5572165|NCT00997854|Preterm|preterm
5572166|NCT00997854|Bolus|bolus
5572167|NCT00997841|POC|poc
5572168|NCT00997841|ROTEM|rotem
5572169|NCT00997841|Multiplate|multiplate
5572170|NCT00997841|bleeding tendency|bleeding tendency
5572171|NCT00997841|coagulation management|coagulation management
5798732|NCT00111241|osteoporosis|osteoporosis
5572172|NCT00997841|amount of transfused red blood cell concentrates,|amount of transfused red blood cell concentrates,
5572173|NCT00997841|FFP|ffp
5572174|NCT00997841|platelet concentrates|platelet concentrates
5572175|NCT00997841|rate of rethoracotomy|rate of rethoracotomy
5572176|NCT00997841|ventilation time|ventilation time
5572177|NCT00997828|Coronary Artery Disease|coronary artery disease
5572178|NCT00997828|stent|stent
5572179|NCT00997828|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5572180|NCT00997828|multivessel coronary artery disease|multivessel coronary artery disease
5572181|NCT00997815|Recalcitrant|recalcitrant
5572182|NCT00997815|Alopecia totalis|alopecia totalis
5572183|NCT00997815|Alopecia universalis|alopecia universalis
5572184|NCT00997815|Botulinum toxin A|botulinum toxin a
5572185|NCT00997802|Computed Tomographic Colonography|computed tomographic colonography
5572186|NCT00997802|Colonic Polyps|colonic polyps
5572187|NCT00997802|Colonic Neoplasms|colonic neoplasms
5572188|NCT00997802|Computer Aided Diagnosis|computer aided diagnosis
5572189|NCT00997789|Rebamipide|rebamipide
5572190|NCT00997789|Bioequivalence|bioequivalence
5572191|NCT00997789|ABCB1 genetic polymorphisms|abcb1 genetic polymorphisms
5572192|NCT00997776|Hip Fracture|hip fracture
5572193|NCT00997776|Exercise|exercise
5572194|NCT00997776|Rehabilitation|rehabilitation
5572195|NCT00997776|Functional Performance|functional performance
5572196|NCT00997763|stenting, XIENCE V, CYPHER|stenting, xience v, cypher
5572197|NCT00997750|ACS|acs
5572198|NCT00997750|Acute Coronary Syndrome|acute coronary syndrome
5572199|NCT00997750|NSAID|nsaid
5572200|NCT00997750|Lornoxicam|lornoxicam
5572201|NCT00997750|Xefocam|xefocam
5572202|NCT00997737|incentive spirometry|incentive spirometry
5572203|NCT00997737|diaphragm mobility|diaphragm mobility
5572204|NCT00997737|ultrasound|ultrasound
5572205|NCT00997737|diaphragmatic breathing|diaphragmatic breathing
5572206|NCT00997724|assisted-VATS (video-assisted thoracoscopic surgery)|assisted-vats (video-assisted thoracoscopic surgery)
5572207|NCT00997724|sleeve lobectomy|sleeve lobectomy
5572208|NCT00997724|bronchoplasty|bronchoplasty
5572209|NCT00997711|Diabetes|diabetes
5572210|NCT00997711|death|death
5572211|NCT00997711|MI|mi
5572212|NCT00997711|TVR|tvr
5572213|NCT00997698|Intracranial aneurysm|intracranial aneurysm
5572214|NCT00997698|Magnetic resonance angiography|magnetic resonance angiography
5572215|NCT00997698|Epidemiology|epidemiology
5572216|NCT00997685|XELOX|xelox
5572217|NCT00997685|potentially resectable liver metastasis from CRC|potentially resectable liver metastasis from crc
5572218|NCT00997672|MSA|msa
5572219|NCT00997672|Lithium|lithium
5572220|NCT00997672|Lithium carbonate|lithium carbonate
5572221|NCT00997672|MSA-P|msa-p
5572222|NCT00997672|MSA-C|msa-c
5572223|NCT00997659|chromium picolinate|chromium picolinate
5572224|NCT00997659|insulin resistance|insulin resistance
5572225|NCT00997659|obesity|obesity
5572226|NCT00997646|Performance|performance
5572227|NCT00997646|hospitalist|hospitalist
5572228|NCT00997646|ward|ward
5572229|NCT00997646|hospitalization|hospitalization
5572230|NCT00997633|Intraperitoneal volume|intraperitoneal volume
5572231|NCT00997633|peritoneal carcinomatosis|peritoneal carcinomatosis
5572232|NCT00997633|cytoreductive surgery|cytoreductive surgery
5572233|NCT00997633|SPECT|spect
5572234|NCT00997633|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5572235|NCT00997620|Hay Fever|hay fever
5572236|NCT00997620|Daytime somnolence|daytime somnolence
5572237|NCT00997620|Cognition|cognition
5572238|NCT00997607|Vaccine|vaccine
5572239|NCT00997594|adrenal gland|adrenal gland
5572240|NCT00997581|Gout|gout
5572241|NCT00997568|transesophageal|transesophageal
5572242|NCT00997568|transducer|transducer
5572243|NCT00997568|TEE|tee
5572244|NCT00997555|inhalation|inhalation
5572245|NCT00997555|bronchoscopy|bronchoscopy
5572246|NCT00997555|burn|burn
5572247|NCT00997555|pneumonia|pneumonia
5572248|NCT00997529|Stem cell transplant|stem cell transplant
5572249|NCT00997529|Non-myeloablative|non-myeloablative
5572250|NCT00997529|Metastatic Solid Tumor|metastatic solid tumor
5572251|NCT00997529|Donor Leukocyte Infusion|donor leukocyte infusion
5572252|NCT00997516|Laparoscopy|laparoscopy
5572253|NCT00997516|Appendicitis|appendicitis
5572254|NCT00997516|Single-incision laparoscopic surgery|single-incision laparoscopic surgery
5572255|NCT00997516|SILS|sils
5572256|NCT00997490|depression|depression
5572257|NCT00997490|HAMD 21|hamd 21
5572258|NCT00997490|anxiety|anxiety
5572259|NCT00997490|HAMA|hama
5572260|NCT00997490|Hypericum|hypericum
5572261|NCT00997490|Valerian|valerian
5572262|NCT00997490|Passionflower|passionflower
5572263|NCT00997490|F32.0|f32.0
5572264|NCT00997490|F33.0|f33.0
5572267|NCT00997477|budesonide|budesonide
5572268|NCT00997477|asthma|asthma
5572269|NCT00997451|Medically unexplained chronic fatigue|medically unexplained chronic fatigue
5572270|NCT00997451|Chronic fatigue syndrome|chronic fatigue syndrome
5572271|NCT00997451|Cognitive-behavior therapy|cognitive-behavior therapy
5572272|NCT00997451|Self-management|self-management
5572273|NCT00997451|Primary care|primary care
5572274|NCT00997451|Nurses|nurses
5572275|NCT00997451|Economic analysis|economic analysis
5572276|NCT00997451|Cost effectiveness|cost effectiveness
5572277|NCT00997451|One year follow-up|one year follow-up
5572278|NCT00997425|wandering|wandering
5572279|NCT00997425|subjective exit barriers|subjective exit barriers
5572280|NCT00997399|Ph I|ph i
5572281|NCT00997399|panobinostat (DACi)|panobinostat (daci)
5572282|NCT00997399|PK & safety|pk & safety
5572283|NCT00997399|solid tumors|solid tumors
5572284|NCT00997399|varying renal function|varying renal function
5572285|NCT00997399|advanced|advanced
5572286|NCT00997386|Hematologic malignancies|hematologic malignancies
5572287|NCT00997386|lymphoma, leukemia, MDS (myelodysplastic syndrome)|lymphoma, leukemia, mds (myelodysplastic syndrome)
5572288|NCT00997386|reduced-intensity preparative regimen|reduced-intensity preparative regimen
5572289|NCT00997386|allogeneic peripheral blood stem cell transplant|allogeneic peripheral blood stem cell transplant
5572290|NCT00997386|myelofibrosis or other myeloproliferative syndromes|myelofibrosis or other myeloproliferative syndromes
5572291|NCT00997373|Endometrial Cancer|endometrial cancer
5572292|NCT00997373|Endometrial Carcinoma|endometrial carcinoma
5572293|NCT00997373|Aromatase Inhibitor|aromatase inhibitor
5572294|NCT00997373|Letrozole|letrozole
5572295|NCT00997373|Femara|femara
5572296|NCT00997360|Phase 1|phase 1
5572297|NCT00997360|Maximum tolerated dose|maximum tolerated dose
5572298|NCT00997360|Solid tumors|solid tumors
5572299|NCT00997334|erlotinib|erlotinib
5572300|NCT00997334|EGFR mutation|egfr mutation
5572301|NCT00997334|NSCLC|nsclc
5572302|NCT00997321|ketamine|ketamine
5572303|NCT00997321|propofol|propofol
5572304|NCT00997321|procedural sedation|procedural sedation
5572305|NCT00997321|moderate procedural sedation in the ED|moderate procedural sedation in the ed
5572306|NCT00997308|AZD1446|azd1446
5572544|NCT00996359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5572307|NCT00997308|to investigate safety and tolerability in Healthy subjects during 4 weeks of administration|to investigate safety and tolerability in healthy subjects during 4 weeks of administration
5572308|NCT00997295|low flow gas|low flow gas
5572309|NCT00997295|Heat and moisture exchanger|heat and moisture exchanger
5572310|NCT00997295|Humidity|humidity
5572311|NCT00997295|Temperature|temperature
5572312|NCT00997295|Core temperature|core temperature
5572313|NCT00997295|Women|women
5572314|NCT00997269|CoQ-10|coq-10
5572315|NCT00997269|statin|statin
5572316|NCT00997269|muscle pain|muscle pain
5572317|NCT00997269|cardiovascular|cardiovascular
5572318|NCT00997256|sleep-EEG|sleep-eeg
5572319|NCT00997256|sleep architecture|sleep architecture
5572320|NCT00997256|sleep duration|sleep duration
5572321|NCT00997256|sleep continuity|sleep continuity
5572322|NCT00997256|REM-sleep|rem-sleep
5572323|NCT00997256|vigilance|vigilance
5572324|NCT00997256|well-being|well-being
5572325|NCT00997256|Healthy volunteers|healthy volunteers
5572326|NCT00997243|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5572327|NCT00997243|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5572328|NCT00997243|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5572329|NCT00997243|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5572330|NCT00997243|refractory anemia with excess blasts|refractory anemia with excess blasts
5572331|NCT00997243|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5572332|NCT00997243|refractory anemia|refractory anemia
5572333|NCT00997243|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5572334|NCT00997230|EGFR mutation ,newly diagnosed NSCLC, locally advanced or metastatic NSCLC|egfr mutation ,newly diagnosed nsclc, locally advanced or metastatic nsclc
5572335|NCT00997217|RIPC|ripc
5572336|NCT00997217|cardiac surgery|cardiac surgery
5572337|NCT00997217|ischemic preconditioning|ischemic preconditioning
5572338|NCT00997217|cardiac surgical procedures|cardiac surgical procedures
5572339|NCT00997204|HAE|hae
5572340|NCT00997204|Type I HAE|type i hae
5572341|NCT00997204|Type II HAE|type ii hae
5572342|NCT00997191|Bevacizumab|bevacizumab
5572343|NCT00997191|Diabetes|diabetes
5572344|NCT00997191|Intravitreal|intravitreal
5572345|NCT00997191|Macular edema|macular edema
5572346|NCT00997191|triamcinolone|triamcinolone
5572347|NCT00997191|VEGF|vegf
5572348|NCT00997178|Diabetes|diabetes
5572349|NCT00997178|Diabetes Mellitus|diabetes mellitus
5572350|NCT00997178|Periodontal Disease|periodontal disease
5572351|NCT00997178|Periodontitis|periodontitis
5572352|NCT00997178|Glycosylated Hemoglobin|glycosylated hemoglobin
5572353|NCT00997178|HbA1c|hba1c
5572354|NCT00997165|fatty liver|fatty liver
5572355|NCT00997165|adipose tissue|adipose tissue
5572356|NCT00997152|Diabetes|diabetes
5572357|NCT00997139|healthcare|healthcare
5572358|NCT00997139|staphylococcus aureus|staphylococcus aureus
5572359|NCT00997139|nasal|nasal
5572360|NCT00997126|propofol|propofol
5572361|NCT00997126|alfentanil|alfentanil
5572362|NCT00997126|nitrous oxide|nitrous oxide
5572363|NCT00997126|moderate procedural sedation|moderate procedural sedation
5572462|NCT00996593|Bexxar|bexxar
5572463|NCT00996593|iodine|iodine
5572364|NCT00997126|Moderate Procedural Sedation in the Emergency Department|moderate procedural sedation in the emergency department
5572365|NCT00997113|propofol|propofol
5572366|NCT00997113|alfentanil|alfentanil
5572367|NCT00997113|procedural sedation|procedural sedation
5572368|NCT00997113|stress biomarkers|stress biomarkers
5572369|NCT00997113|Deep procedural sedation in the ED|deep procedural sedation in the ed
5572370|NCT00997100|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5572371|NCT00997100|ABR-215757|abr-215757
5572372|NCT00997100|Change in Biomarkers|change in biomarkers
5572373|NCT00997087|OCD|ocd
5572374|NCT00997074|pain after abortion|pain after abortion
5572375|NCT00997074|abortion|abortion
5572376|NCT00997035|Fungal Infections|fungal infections
5572377|NCT00997035|Eye Disease|eye disease
5572378|NCT00997035|Fungal Keratitis|fungal keratitis
5572379|NCT00997035|Visual Acuity|visual acuity
5572380|NCT00997022|HCC|hcc
5572381|NCT00997022|High-risk Hepatocellular Cancer|high-risk hepatocellular cancer
5572382|NCT00997009|EGFR|egfr
5572383|NCT00997009|chemotherapy|chemotherapy
5572384|NCT00996996|Radioimmunotherapy|radioimmunotherapy
5572385|NCT00996996|Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody|anti-b1 antibody and iodine-131 anti-b1 antibody
5572386|NCT00996996|Tositumomab and Iodine I 131 Tositumomab|tositumomab and iodine i 131 tositumomab
5572387|NCT00996996|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5572388|NCT00996996|Bexxar|bexxar
5572389|NCT00996970|HIV|hiv
5572390|NCT00996970|H1N1|h1n1
5572391|NCT00996970|Influenza|influenza
5572392|NCT00996970|Vaccination|vaccination
5572393|NCT00996970|Seroresponse|seroresponse
5572394|NCT00996970|Immunogenicity|immunogenicity
5572395|NCT00996970|Vaccine|vaccine
5572396|NCT00996944|ropinirole|ropinirole
5572397|NCT00996944|haemodialysis|haemodialysis
5572398|NCT00996944|restless legs syndrome|restless legs syndrome
5572399|NCT00996931|autistic spectrum disorder|autistic spectrum disorder
5572400|NCT00996931|lenalidomide|lenalidomide
5572401|NCT00996918|antibody|antibody
5572402|NCT00996905|Epidural Analgesia|epidural analgesia
5572403|NCT00996905|Ultrasound|ultrasound
5572404|NCT00996905|Training, Inservice|training, inservice
5572405|NCT00996892|GDC0941|gdc0941
5572406|NCT00996892|GDC0973|gdc0973
5572407|NCT00996892|MEK|mek
5572408|NCT00996892|MEK Inhibitor|mek inhibitor
5572409|NCT00996892|PI3K|pi3k
5572410|NCT00996892|PI3K Inhibitor|pi3k inhibitor
5572411|NCT00996892|PI3 Kinase|pi3 kinase
5572412|NCT00996892|PI3 Kinase Inhibitor|pi3 kinase inhibitor
5572413|NCT00996879|Human Volunteers|human volunteers
5572414|NCT00996853|safety|safety
5572415|NCT00996853|Influenza|influenza
5572416|NCT00996853|vaccine|vaccine
5572417|NCT00996853|reactogenicity|reactogenicity
5572418|NCT00996853|swine flu|swine flu
5572419|NCT00996840|dilmapimod|dilmapimod
5572420|NCT00996840|p38|p38
5572421|NCT00996840|SB-681323|sb-681323
5572422|NCT00996840|Acute Lung Injury (ALI)|acute lung injury (ali)
5572423|NCT00996840|Acute Respiratory Distress Syndrome (ARDS)|acute respiratory distress syndrome (ards)
5572424|NCT00996827|Melanoma|melanoma
5572425|NCT00996827|Skin cancer|skin cancer
5572426|NCT00996827|Vitamin D|vitamin d
5572427|NCT00996827|Vitamin D receptor|vitamin d receptor
5572428|NCT00996827|Sunlight|sunlight
5572429|NCT00996827|Cytokine|cytokine
5572430|NCT00996814|Bioethics|bioethics
5572661|NCT00996099|critically ill|critically ill
5572431|NCT00996788|Patients suffering of dyspepsia due to chronic gastritis|patients suffering of dyspepsia due to chronic gastritis
5572432|NCT00996775|Alcohol Consumption|alcohol consumption
5572433|NCT00996762|bioequivalence, lapatinib, GW572016|bioequivalence, lapatinib, gw572016
5572434|NCT00996736|Fungal Infections|fungal infections
5572435|NCT00996736|Eye Disease|eye disease
5572436|NCT00996736|Fungal Keratitis|fungal keratitis
5572437|NCT00996736|Visual Acuity|visual acuity
5572438|NCT00996710|Genome-wide|genome-wide
5572439|NCT00996710|09-068|09-068
5572440|NCT00996697|COPD (chronic obstructive pulmonary disease)|copd (chronic obstructive pulmonary disease)
5572441|NCT00996684|Wet age related macular degeneration (AMD)|wet age related macular degeneration (amd)
5572442|NCT00996684|Wet AMD|wet amd
5572443|NCT00996684|Vitreomacular adhesion (VMA)|vitreomacular adhesion (vma)
5572444|NCT00996684|Vitreomacular traction (VMT)|vitreomacular traction (vmt)
5572445|NCT00996684|Neovascular age related macular degeneration|neovascular age related macular degeneration
5572446|NCT00996671|focal adhesion kinase inhibitor|focal adhesion kinase inhibitor
5572447|NCT00996671|healthy volunteers|healthy volunteers
5572448|NCT00996671|first time in human|first time in human
5572449|NCT00996645|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5572450|NCT00996645|Coronary Artery Disease|coronary artery disease
5572451|NCT00996645|Primary Health Care|primary health care
5572452|NCT00996645|Feedback, Psychological|feedback, psychological
5572453|NCT00996645|Quality Assurance, Health Care|quality assurance, health care
5572454|NCT00996632|breast cancer|breast cancer
5572455|NCT00996632|ultrasonic knife|ultrasonic knife
5572456|NCT00996632|volume drainage|volume drainage
5572457|NCT00996593|Tositumomab|tositumomab
5572458|NCT00996593|radioimmunotherapy|radioimmunotherapy
5572459|NCT00996593|rituximab|rituximab
5572460|NCT00996593|anti-B1|anti-b1
5572461|NCT00996593|I 131|i 131
5572474|NCT00996541|HIV Seronegativity|hiv seronegativity
5572487|NCT00996515|Advanced Solid Tumor Malignancies|advanced solid tumor malignancies
5572488|NCT00996515|Erlotinib|erlotinib
5572490|NCT00996515|Tarceva|tarceva
5572491|NCT00996515|5-azacytidine|5-azacytidine
5572492|NCT00996476|Hepatitis C|hepatitis c
5572493|NCT00996476|Hepatitis C virus|hepatitis c virus
5572494|NCT00996476|Interferon Alfa-2a|interferon alfa-2a
5572495|NCT00996476|Ribavirin|ribavirin
5572496|NCT00996476|Viral RNA|viral rna
5572497|NCT00996450|brain tumour|brain tumour
5572498|NCT00996437|vitreous|vitreous
5572499|NCT00996437|hemorrhage|hemorrhage
5572500|NCT00996437|proliferative|proliferative
5572501|NCT00996437|diabetic|diabetic
5572502|NCT00996437|retinopathy|retinopathy
5572503|NCT00996437|intravitreal|intravitreal
5572504|NCT00996437|ranibizumab|ranibizumab
5572505|NCT00996437|Lucentis|lucentis
5572506|NCT00996437|saline|saline
5572507|NCT00996437|vitrectomy|vitrectomy
5572508|NCT00996411|Healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin A|healthy volunteers are being studied to evaluate the subject-rated, behavioral, and abuse liability effects of salvinorin a
5572509|NCT00996398|Cryotherapy|cryotherapy
5572510|NCT00996398|Joint Position Sense|joint position sense
5572511|NCT00996398|Proprioception|proprioception
5572512|NCT00996398|Pre Cooling|pre cooling
5572513|NCT00996398|Knee Injury|knee injury
5572514|NCT00996398|Physical Therapy Modalities|physical therapy modalities
5572515|NCT00996398|Physical Therapy Techniques|physical therapy techniques
5572516|NCT00996398|Weightbearing|weightbearing
5572517|NCT00996398|NonWeightbearing|nonweightbearing
5572518|NCT00996398|Randomised Control Trial|randomised control trial
5572519|NCT00996385|Pleural Mesothelioma|pleural mesothelioma
5572520|NCT00996385|Peritoneal Mesothelioma|peritoneal mesothelioma
5572521|NCT00996359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5572522|NCT00996359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5572523|NCT00996359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5572524|NCT00996359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5572525|NCT00996359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5572526|NCT00996359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5572527|NCT00996359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5572528|NCT00996359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5572529|NCT00996359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5572530|NCT00996359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5685559|NCT00555607|biomarker|biomarker
5572531|NCT00996359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5572532|NCT00996359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5572533|NCT00996359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5572534|NCT00996359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5572535|NCT00996359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5572536|NCT00996359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5572537|NCT00996359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5572538|NCT00996359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5572539|NCT00996359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5572540|NCT00996359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5572541|NCT00996359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5572542|NCT00996359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5572543|NCT00996359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5572545|NCT00996359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5572546|NCT00996359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5572547|NCT00996359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5572548|NCT00996359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5572549|NCT00996359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5572550|NCT00996359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5572551|NCT00996359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5572552|NCT00996359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5572553|NCT00996359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5572554|NCT00996359|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5572555|NCT00996359|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5572556|NCT00996359|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5572557|NCT00996359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5572558|NCT00996359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5572559|NCT00996359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5572560|NCT00996359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5572561|NCT00996359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5572562|NCT00996359|refractory multiple myeloma|refractory multiple myeloma
5572563|NCT00996359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5572564|NCT00996359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5572565|NCT00996359|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5572566|NCT00996359|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5572567|NCT00996359|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5572568|NCT00996359|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5572569|NCT00996359|Burkitt lymphoma|burkitt lymphoma
5572570|NCT00996359|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5572571|NCT00996359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5572572|NCT00996359|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5572573|NCT00996359|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5572574|NCT00996359|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5572575|NCT00996359|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5572576|NCT00996359|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5572577|NCT00996346|INST 0909|inst 0909
5572578|NCT00996346|Irinotecan|irinotecan
5572579|NCT00996346|Temsirolimus|temsirolimus
5572580|NCT00996346|refractory sarcomas|refractory sarcomas
5572582|NCT00996346|3066K1-1208|3066k1-1208
5572583|NCT00996346|20091334|20091334
5572584|NCT00996333|Stage IVB|stage ivb
5572585|NCT00996320|Internship and Residency|internship and residency
5572586|NCT00996320|Medical Errors|medical errors
5572587|NCT00996320|Burnout, Professional|burnout, professional
5572588|NCT00996320|Burnout|burnout
5572589|NCT00996320|Depression|depression
5572590|NCT00996320|Actigraphy|actigraphy
5572591|NCT00996320|Personnel Staffing and Scheduling|personnel staffing and scheduling
5572592|NCT00996320|Sleep Deprivation|sleep deprivation
5572593|NCT00996320|Workload|workload
5572594|NCT00996320|Humans|humans
5572595|NCT00996320|Adult|adult
5572596|NCT00996320|Male|male
5572597|NCT00996320|Female|female
5572598|NCT00996320|Intensive Care Units|intensive care units
5572599|NCT00996320|Prospective Studies|prospective studies
5572600|NCT00996320|Crossover Studies|crossover studies
5572601|NCT00996320|Work Schedule Tolerance|work schedule tolerance
5572602|NCT00996320|Disorders of Excessive Somnolence|disorders of excessive somnolence
5572604|NCT00996320|Internal Medicine Education|internal medicine education
5572605|NCT00996307|Swine Flu|swine flu
5572606|NCT00996307|Flu|flu
5572607|NCT00996307|Vaccine|vaccine
5572608|NCT00996307|Children|children
5572609|NCT00996307|Adjuvant|adjuvant
5572610|NCT00996307|A/H1N1 2009 Influenza|a/h1n1 2009 influenza
5572611|NCT00996281|Hypertensive|hypertensive
5572612|NCT00996281|Blood Pressure, High|blood pressure, high
5572613|NCT00996281|Cardiovascular disease|cardiovascular disease
5572614|NCT00996281|Vascular Disease|vascular disease
5572615|NCT00996281|Drug Therapy|drug therapy
5572616|NCT00996268|hypertriglyceridemia|hypertriglyceridemia
5572617|NCT00996268|GSK2212836|gsk2212836
5572618|NCT00996268|relative bioavailability|relative bioavailability
5572619|NCT00996242|Schizophrenia|schizophrenia
5572620|NCT00996242|L-lysine|l-lysine
5572621|NCT00996242|PANSS|panss
5572622|NCT00996229|Diet|diet
5572623|NCT00996229|elderly|elderly
5572624|NCT00996229|cognition|cognition
5572625|NCT00996229|prevention|prevention
5572626|NCT00996229|cognitive decline|cognitive decline
5572627|NCT00996229|Lifestyle|lifestyle
5572628|NCT00996216|Peginterferon|peginterferon
5572629|NCT00996216|Platelets|platelets
5572630|NCT00996216|Ribavirin|ribavirin
5572631|NCT00996216|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5572632|NCT00996216|Thrombocytopenia|thrombocytopenia
5572633|NCT00996216|Hepatitis C|hepatitis c
5572634|NCT00996216|Thrombopoietin|thrombopoietin
5572635|NCT00996190|transthoracic bioreactance|transthoracic bioreactance
5572636|NCT00996190|noninvasive monitoring|noninvasive monitoring
5572637|NCT00996190|vasopressor|vasopressor
5572638|NCT00996190|blood pressure|blood pressure
5572640|NCT00996177|Patient-controlled analgesia|patient-controlled analgesia
5572641|NCT00996177|Postoperative pain|postoperative pain
5572642|NCT00996177|Transdermal fentanyl|transdermal fentanyl
5572643|NCT00996177|Surgical pain|surgical pain
5572644|NCT00996177|Opioid analgesics|opioid analgesics
5572645|NCT00996151|Hypergonadism|hypergonadism
5572646|NCT00996151|Testosterone Transfer|testosterone transfer
5572657|NCT00996125|HPV vaccine|hpv vaccine
5572658|NCT00996112|primary health care|primary health care
5572659|NCT00996099|continuous glucose monitoring|continuous glucose monitoring
5572660|NCT00996099|intensive insulin therapy|intensive insulin therapy
5572662|NCT00996099|cardiac surgery|cardiac surgery
5572663|NCT00996099|hyperglycemia of critically ill|hyperglycemia of critically ill
5572664|NCT00996073|Degenerative disc disease|degenerative disc disease
5572665|NCT00996073|Spondylolisthesis|spondylolisthesis
5572666|NCT00996073|Spinal stenosis|spinal stenosis
5572667|NCT00996073|Stem cells|stem cells
5572668|NCT00996073|Adult Stem Cells|adult stem cells
5572669|NCT00996073|Spinal Fusion|spinal fusion
5572670|NCT00996073|Lumbar Spinal Fusion|lumbar spinal fusion
5572672|NCT00996073|PLIF|plif
5572673|NCT00996073|Mesoblast|mesoblast
5572674|NCT00996060|Lung Cancer|lung cancer
5572675|NCT00996060|Advanced Lung Cancer|advanced lung cancer
5572676|NCT00996060|Unresectable Lung cancer|unresectable lung cancer
5572677|NCT00996060|Previously treated lung cancer|previously treated lung cancer
5680323|NCT00578214|squamous cell carcinoma|squamous cell carcinoma
5572678|NCT00996047|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5572679|NCT00996047|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5572680|NCT00996047|acute undifferentiated leukemia|acute undifferentiated leukemia
5572681|NCT00996047|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5572682|NCT00996047|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5572683|NCT00996047|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5572684|NCT00996047|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5572685|NCT00996047|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5572686|NCT00996047|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5572687|NCT00996047|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5572688|NCT00996047|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5572689|NCT00996047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5572690|NCT00996047|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5572691|NCT00996047|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5572692|NCT00996047|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5572693|NCT00996047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5572694|NCT00996047|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5572695|NCT00996047|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5572696|NCT00996047|mast cell leukemia|mast cell leukemia
5572697|NCT00996047|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5572698|NCT00996047|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5572699|NCT00996047|prolymphocytic leukemia|prolymphocytic leukemia
5572700|NCT00996047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5572701|NCT00996047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5572702|NCT00996047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5572703|NCT00996047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5572704|NCT00996047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5572705|NCT00996047|refractory hairy cell leukemia|refractory hairy cell leukemia
5572706|NCT00996047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5572707|NCT00996047|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5572708|NCT00996047|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5572709|NCT00996047|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5572710|NCT00996047|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5572711|NCT00996047|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5572808|NCT00995709|uveitis|uveitis
5572712|NCT00996047|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5572713|NCT00996047|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5566726|NCT01019941|Docetaxel|docetaxel
5572714|NCT00996047|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5572715|NCT00996047|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5572716|NCT00996047|untreated hairy cell leukemia|untreated hairy cell leukemia
5572717|NCT00996047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5572718|NCT00996047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5572719|NCT00996047|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5572720|NCT00996047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5572721|NCT00996047|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5572722|NCT00996047|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
5572723|NCT00996034|Nicotine, SPECT, vaccine, receptor|nicotine, spect, vaccine, receptor
5572725|NCT00996021|moxifloxacin|moxifloxacin
5572726|NCT00996021|Avelox|avelox
5572728|NCT00995982|Influenza|influenza
5572729|NCT00995982|Healthy|healthy
5575297|NCT00986323|TLA|tla
5572730|NCT00995982|Immunity|immunity
5572731|NCT00995982|Preventive|preventive
5572732|NCT00995982|Flu|flu
5572733|NCT00995982|HV|hv
5572734|NCT00995982|Healthy Volunteer|healthy volunteer
5572735|NCT00995969|Mild to moderate psoriasis vulgaris|mild to moderate psoriasis vulgaris
5572736|NCT00995956|Albumin|albumin
5572737|NCT00995956|Mycophenolic acid|mycophenolic acid
5572738|NCT00995956|IMPDH|impdh
5572739|NCT00995956|Free fraction|free fraction
5572740|NCT00995930|Atherosclerosis,|atherosclerosis,
5572741|NCT00995930|Type 2 Diabetes Mellitus, T2DM,|type 2 diabetes mellitus, t2dm,
5554748|NCT01067729|Rate of healing|rate of healing
5554749|NCT01067729|Infection rate|infection rate
5572742|NCT00995930|Cardiovascular Diseases, ACZ885, impaired glucose tolerance, IGT, Canakinumab|cardiovascular diseases, acz885, impaired glucose tolerance, igt, canakinumab
5572743|NCT00995917|acupuncture|acupuncture
5572744|NCT00995917|menstrual pain|menstrual pain
5572745|NCT00995917|dysmenorrhea|dysmenorrhea
5572746|NCT00995917|menstrual cramps|menstrual cramps
5572747|NCT00995917|vitamin K1|vitamin k1
5572748|NCT00995904|asthmatic children|asthmatic children
5572749|NCT00995891|Laboratory Research Specimens|laboratory research specimens
5572750|NCT00995891|Biologic Samples|biologic samples
5572751|NCT00995891|Sample Collection|sample collection
5572752|NCT00995891|Tissue Procurement|tissue procurement
5572753|NCT00995891|HV|hv
5572754|NCT00995891|Healthy Volunteer|healthy volunteer
5572755|NCT00995878|Uterine fibroids|uterine fibroids
5572756|NCT00995878|Fibroids|fibroids
5572757|NCT00995878|Uterine leiomyomas|uterine leiomyomas
5572758|NCT00995878|UAE|uae
5572759|NCT00995878|UFE|ufe
5572760|NCT00995878|Magnetic resonance guided focused ultrasound|magnetic resonance guided focused ultrasound
5572761|NCT00995878|MRgFUS|mrgfus
5572762|NCT00995878|Pelvic pain|pelvic pain
5572763|NCT00995865|Prevention of yellow fever virus infection|prevention of yellow fever virus infection
5572764|NCT00995852|Endoscopic lung volume reduction|endoscopic lung volume reduction
5572765|NCT00995852|emphysema|emphysema
5572766|NCT00995852|COPD|copd
5572767|NCT00995852|Patients with bilateral heterogeneous pulmonary emphysema|patients with bilateral heterogeneous pulmonary emphysema
5572768|NCT00995839|terlipressin|terlipressin
5572769|NCT00995839|vasopressin|vasopressin
5572770|NCT00995839|sepsis|sepsis
5572771|NCT00995839|septic shock|septic shock
5572772|NCT00995839|norepinephrine|norepinephrine
5572773|NCT00995813|Intestinal failure|intestinal failure
5572774|NCT00995813|Rotavirus vaccine|rotavirus vaccine
5572775|NCT00995813|Infants|infants
5572776|NCT00995800|Asthma|asthma
5572777|NCT00995787|Type II diabetes mellitus|type ii diabetes mellitus
5572778|NCT00995787|metformin|metformin
5572779|NCT00995787|sulfonylurea|sulfonylurea
5572780|NCT00995774|stroke|stroke
5572781|NCT00995774|function|function
5572783|NCT00995774|hand|hand
5572784|NCT00995774|robotic|robotic
5572785|NCT00995774|therapy|therapy
5572786|NCT00995774|motor|motor
5572787|NCT00995774|movement|movement
5572788|NCT00995774|treatment|treatment
5572789|NCT00995761|biweekly|biweekly
5572790|NCT00995761|docetaxel|docetaxel
5572791|NCT00995761|cisplatin|cisplatin
5572792|NCT00995761|non-small cell lung cancer|non-small cell lung cancer
5572793|NCT00995735|NOTES|notes
5572794|NCT00995735|Natural Orifice Translumenal Endoscopic surgery|natural orifice translumenal endoscopic surgery
5572795|NCT00995735|Cholecystectomy|cholecystectomy
5572796|NCT00995735|Appendectomy|appendectomy
5572797|NCT00995735|Endoscopy|endoscopy
5572798|NCT00995735|Laparoscopy|laparoscopy
5572799|NCT00995735|Minimally invasive surgery|minimally invasive surgery
5572800|NCT00995735|clinical trials|clinical trials
5572801|NCT00995722|Ocular myasthenia gravis|ocular myasthenia gravis
5572802|NCT00995722|Prednisone|prednisone
5572803|NCT00995722|Steroids|steroids
5572804|NCT00995709|Behçet's disease,|behçet's disease,
5572805|NCT00995709|intermediate uveitis|intermediate uveitis
5572806|NCT00995709|panuveitis|panuveitis
5572807|NCT00995709|posterior uveitis|posterior uveitis
5572809|NCT00995696|Interactive Voice Response (IVR)|interactive voice response (ivr)
5572811|NCT00995683|intracranial hypertension|intracranial hypertension
5572812|NCT00995683|neurological outcome|neurological outcome
5572813|NCT00995683|osmotherapy|osmotherapy
5572814|NCT00995670|hyperglycemia|hyperglycemia
5572815|NCT00995670|statin|statin
5572816|NCT00995670|blood vessels|blood vessels
5572817|NCT00995670|ischemic preconditioning|ischemic preconditioning
5572818|NCT00995670|Anesthesia, inhalational|anesthesia, inhalational
5572819|NCT00995670|endothelium|endothelium
5572820|NCT00995670|5% dextrose|5% dextrose
5572821|NCT00995644|smoking|smoking
5572822|NCT00995644|smoking cessation|smoking cessation
5572823|NCT00995644|tobacco use cessation|tobacco use cessation
5572824|NCT00995644|tobacco use disorder|tobacco use disorder
5572825|NCT00995631|liposuction|liposuction
5572826|NCT00995631|adipose tissue|adipose tissue
5572827|NCT00995631|dietary fatty acids|dietary fatty acids
5572828|NCT00995631|triglyceride storage|triglyceride storage
5572829|NCT00995631|Normal healthy aging|normal healthy aging
5572830|NCT00995618|Gout|gout
5572831|NCT00995618|Hyperuricemia|hyperuricemia
5572832|NCT00995592|nutrition|nutrition
5572833|NCT00995592|child weight|child weight
5572834|NCT00995592|undernourishment|undernourishment
5572835|NCT00995592|mentor mother|mentor mother
5572836|NCT00995592|South Africa|south africa
5572837|NCT00995579|Physical Activity|physical activity
5572838|NCT00995579|Energy Expenditure|energy expenditure
5572840|NCT00995540|Regeneration|regeneration
5572841|NCT00995540|Islet|islet
5572842|NCT00995540|Beta cell|beta cell
5572843|NCT00995540|INGAP Peptide|ingap peptide
5572844|NCT00995527|Post Swine Flu Blood Samples|post swine flu blood samples
5572845|NCT00995527|Biologic Sample Collection|biologic sample collection
5572846|NCT00995527|Laboratory Research Samples|laboratory research samples
5572847|NCT00995527|H1N1 Vaccine Samples|h1n1 vaccine samples
5572849|NCT00995527|Healthy Volunteer|healthy volunteer
5572850|NCT00995514|acute coronary syndrome|acute coronary syndrome
5572851|NCT00995514|cardiovascular death|cardiovascular death
5572852|NCT00995514|non-fatal MI|non-fatal mi
5572853|NCT00995514|non-fatal stroke|non-fatal stroke
5572854|NCT00995514|genetic testing|genetic testing
5572855|NCT00995514|CYP2C19|cyp2c19
5572856|NCT00995514|clopidogrel|clopidogrel
5572857|NCT00995514|prasugrel|prasugrel
5572858|NCT00995514|antiplatelet therapy|antiplatelet therapy
5572859|NCT00995514|genotyping|genotyping
5572860|NCT00995514|bleeding|bleeding
5572861|NCT00995501|steroid administration|steroid administration
5572862|NCT00995501|tight glucose control|tight glucose control
5572863|NCT00995501|light anesthesiReducing inflammatory response to surgical stress|light anesthesireducing inflammatory response to surgical stress
5572864|NCT00995501|a|a
5572865|NCT00995488|Urothelial Cancer|urothelial cancer
5572866|NCT00995488|ABI-007|abi-007
5572867|NCT00995488|Bladder Cancer|bladder cancer
5572868|NCT00995488|front-line|front-line
5572869|NCT00995449|Rheumatoid Arthritis|rheumatoid arthritis
5572870|NCT00995449|Biologics-Inadequate|biologics-inadequate
5572871|NCT00995449|KB003|kb003
5572872|NCT00995449|GM-CSF|gm-csf
5572873|NCT00995436|Extractions|extractions
5572874|NCT00995436|Anchorage supplementation|anchorage supplementation
5572875|NCT00995423|Coronary Artery Disease|coronary artery disease
5572876|NCT00995423|stent|stent
5572877|NCT00995410|Subjects Who are at Risk for Developing Aspirin-ASA|subjects who are at risk for developing aspirin-asa
5572878|NCT00995410|Subject must have a pre-existing condition for which aspirin is already indicated|subject must have a pre-existing condition for which aspirin is already indicated
5572879|NCT00995410|Gastric Ulcers|gastric ulcers
5572880|NCT00995397|Insect bites|insect bites
5572881|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine
5572882|NCT00995397|Lotion|lotion
5572883|NCT00995397|Cream|cream
5572884|NCT00995371|Spinal Stenosis|spinal stenosis
5572885|NCT00995371|Lumbar Spinal Stenosis|lumbar spinal stenosis
5572886|NCT00995371|Laminotomy|laminotomy
5572887|NCT00995371|Laminectomy|laminectomy
5572888|NCT00995371|Spine Surgery|spine surgery
5572889|NCT00995358|Epitope peptide|epitope peptide
5572890|NCT00995358|CTL|ctl
5572891|NCT00995358|Esophageal cancer|esophageal cancer
5572892|NCT00995358|Vaccination|vaccination
5572893|NCT00995345|Type 2 Diabetes|type 2 diabetes
5572894|NCT00995345|Metformin|metformin
5671993|NCT00613275|Navigation|navigation
5572895|NCT00995332|Acute myelogenous leukemia|acute myelogenous leukemia
5572896|NCT00995332|all-trans retinoic acid|all-trans retinoic acid
5572897|NCT00995332|valproic acid|valproic acid
5572898|NCT00995332|cytarabine|cytarabine
5572899|NCT00995332|Disease stabilization|disease stabilization
5572900|NCT00995332|survival|survival
5572901|NCT00995332|toxicity|toxicity
5572902|NCT00995319|mouth|mouth
5572903|NCT00995319|Mucositis|mucositis
5572904|NCT00995319|Dysphagia|dysphagia
5572905|NCT00995319|malnutrition|malnutrition
5572906|NCT00995319|Xerostomia|xerostomia
5572907|NCT00995319|saliva|saliva
5572908|NCT00995319|tooth injuries|tooth injuries
5572909|NCT00995306|Active comparator|active comparator
5572910|NCT00995306|Active civamide cream, 0.075%|active civamide cream, 0.075%
5572911|NCT00995306|Active civamide cream, 0.01%|active civamide cream, 0.01%
5572912|NCT00995280|follicle flushing|follicle flushing
5572913|NCT00995280|oocyte retrieval|oocyte retrieval
5572915|NCT00995267|childhood obesity|childhood obesity
5572916|NCT00995267|nutrition|nutrition
5572917|NCT00995267|exercise|exercise
5572918|NCT00995267|Alfred Adler|alfred adler
5572919|NCT00995267|schoolchildren|schoolchildren
5572920|NCT00995267|intervention study|intervention study
5572921|NCT00995267|community-based trial|community-based trial
5572922|NCT00995267|parent-child interaction|parent-child interaction
5572923|NCT00995267|nutritional behaviors|nutritional behaviors
5572924|NCT00995254|secondhand smoke|secondhand smoke
5572925|NCT00995254|children|children
5572926|NCT00995254|Chinese|chinese
5572927|NCT00995254|respiratory symptoms|respiratory symptoms
5572928|NCT00995254|household smoking policy|household smoking policy
5572929|NCT00995254|Respiratory illnesses among children|respiratory illnesses among children
5572930|NCT00995241|Raltegravir|raltegravir
5572931|NCT00995241|intracellular concentration|intracellular concentration
5572932|NCT00995241|plasmatic concentration|plasmatic concentration
5572934|NCT00995241|Treatment experienced|treatment experienced
5572935|NCT00995228|overhydration|overhydration
5572936|NCT00995228|fluid restriction|fluid restriction
5572937|NCT00995228|post-anesthesia care unit|post-anesthesia care unit
5572938|NCT00995215|spinal cord injury|spinal cord injury
5572939|NCT00995215|SCI|sci
5572940|NCT00995215|paralysis|paralysis
5572941|NCT00995215|cough|cough
5572942|NCT00995215|cervical spinal cord injury|cervical spinal cord injury
5572943|NCT00995215|thoracic spinal cord injury|thoracic spinal cord injury
5572944|NCT00995202|stage II colon cancer|stage ii colon cancer
5572945|NCT00995202|stage II rectal cancer|stage ii rectal cancer
5680324|NCT00578214|midazolam|midazolam
5572946|NCT00995202|stage III colon cancer|stage iii colon cancer
5572947|NCT00995202|stage III rectal cancer|stage iii rectal cancer
5572948|NCT00995202|adenocarcinoma of the colon|adenocarcinoma of the colon
5572949|NCT00995202|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5572950|NCT00995189|contact lens wear|contact lens wear
5572951|NCT00995189|multi-purpose solution|multi-purpose solution
5572952|NCT00995189|corneal staining|corneal staining
5572953|NCT00995176|Prevention|prevention
5572954|NCT00995176|HIV|hiv
5572955|NCT00995176|HIV seronegativity|hiv seronegativity
5572956|NCT00995163|outcomes study|outcomes study
5572957|NCT00995163|hemodialysis|hemodialysis
5572958|NCT00995163|CKD-MBD|ckd-mbd
5572959|NCT00995150|contraception|contraception
5572960|NCT00995150|intrauterine|intrauterine
5572961|NCT00995150|long-term|long-term
5572962|NCT00995150|reversible|reversible
5572963|NCT00995137|Relapsed or refractory B-Lineage ALL|relapsed or refractory b-lineage all
5572964|NCT00995124|ovicide|ovicide
5572965|NCT00995124|head lice infestation|head lice infestation
5572966|NCT00995098|Acute severe pancreatitis|acute severe pancreatitis
5572967|NCT00995098|nutritional support|nutritional support
5572968|NCT00995098|enteral nutrition|enteral nutrition
5572969|NCT00995098|parenteral nutrition|parenteral nutrition
5572970|NCT00995085|ADHD|adhd
5572971|NCT00995085|ADD|add
5572972|NCT00995085|TOVA|tova
5572973|NCT00995085|METADOXINE|metadoxine
5572974|NCT00995072|sexual dysfunction|sexual dysfunction
5572975|NCT00995072|female|female
5572976|NCT00995072|hypertension|hypertension
5572977|NCT00995072|high blood pressure|high blood pressure
5572978|NCT00995072|beta blockers|beta blockers
5572979|NCT00995072|metoprolol|metoprolol
5572980|NCT00995072|nebivolol|nebivolol
5572981|NCT00995072|Bystolic|bystolic
5572982|NCT00995072|Toprol XL|toprol xl
5572983|NCT00995059|stage I multiple myeloma|stage i multiple myeloma
5572984|NCT00995059|stage II multiple myeloma|stage ii multiple myeloma
5572985|NCT00995059|stage III multiple myeloma|stage iii multiple myeloma
5572986|NCT00995046|Hemophilia A|hemophilia a
5572987|NCT00995046|prophylaxis|prophylaxis
5572988|NCT00995046|thrombin generation test (TGT)|thrombin generation test (tgt)
5572989|NCT00995033|Smoking cessation|smoking cessation
5572990|NCT00995033|Smoking lapse behavior|smoking lapse behavior
5572991|NCT00995033|Smoking Relapse behavior|smoking relapse behavior
5572992|NCT00995033|Varenicline|varenicline
5572993|NCT00995033|Nicotine conjugate vaccine|nicotine conjugate vaccine
5572994|NCT00995033|Medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5572995|NCT00995020|Cone biopsy|cone biopsy
5572996|NCT00995020|Conization|conization
5572997|NCT00995020|Loop electrosurgical excisional procedures|loop electrosurgical excisional procedures
5572998|NCT00995020|Large Loop Excision of Transformation Zone|large loop excision of transformation zone
5572999|NCT00995020|Needle Excision of Transformation Zone|needle excision of transformation zone
5573000|NCT00995020|Straight Wire Excision of Transformation Zone|straight wire excision of transformation zone
5573001|NCT00995020|Electrosurgery|electrosurgery
5573002|NCT00995007|Brain Tumor|brain tumor
5573003|NCT00995007|Chemotherapy|chemotherapy
5573004|NCT00995007|Antiangiogenesis|antiangiogenesis
5573005|NCT00995007|Radiation|radiation
5573006|NCT00995007|Progression|progression
5573007|NCT00995007|Glioma|glioma
5573008|NCT00995007|Glioblastoma Multiforme|glioblastoma multiforme
5573009|NCT00994994|pediatric cardiac surgery|pediatric cardiac surgery
5573010|NCT00994994|bleeding|bleeding
5573011|NCT00994994|tranexamic acid|tranexamic acid
5573012|NCT00994994|fibrinolysis|fibrinolysis
5573013|NCT00994994|blood loss in pediatric cardiac surgery|blood loss in pediatric cardiac surgery
5573014|NCT00994981|magnesium and reperfusion injury|magnesium and reperfusion injury
5573015|NCT00994968|stage II breast cancer|stage ii breast cancer
5573016|NCT00994968|stage III breast cancer|stage iii breast cancer
5573019|NCT00994955|diabetic macular edema|diabetic macular edema
5573020|NCT00994955|diabetes|diabetes
5573021|NCT00994955|Clinically significant diabetic macular edema|clinically significant diabetic macular edema
5573022|NCT00994929|biologic effects|biologic effects
5573023|NCT00994929|von Willebrand disease|von willebrand disease
5573024|NCT00994929|hemophilia|hemophilia
5573025|NCT00994929|interleukin-11|interleukin-11
5573026|NCT00994929|DDAVp|ddavp
5573027|NCT00994916|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
5573028|NCT00994916|3,4 diaminopyridine|3,4 diaminopyridine
5573029|NCT00994903|Statin|statin
5573030|NCT00994903|Colon|colon
5573031|NCT00994903|Colorectal|colorectal
5573032|NCT00994903|Intestinal Neoplasms|intestinal neoplasms
5573033|NCT00994903|ERAS|eras
5573034|NCT00994903|Perioperative Care|perioperative care
5573035|NCT00994890|Double-blind safety|double-blind safety
5573036|NCT00994825|levosimendan|levosimendan
5573037|NCT00994825|cardiac surgery|cardiac surgery
5573038|NCT00994825|cardiac anesthesia|cardiac anesthesia
5573039|NCT00994825|mortality|mortality
5573040|NCT00994825|survival|survival
5573041|NCT00994825|inotropic drugs|inotropic drugs
5573042|NCT00994812|Polycystic ovary syndrome|polycystic ovary syndrome
5573043|NCT00994812|PCOS|pcos
5573044|NCT00994812|Metformin|metformin
5573045|NCT00994812|Miscarriage|miscarriage
5573046|NCT00994812|Infertility|infertility
5573047|NCT00994812|Complications of pregnancy|complications of pregnancy
5573048|NCT00994786|treatment-resistant|treatment-resistant
5573049|NCT00994786|refractory|refractory
5573050|NCT00994786|obsessive compulsive disorder|obsessive compulsive disorder
5573051|NCT00994786|Lyrica|lyrica
5573052|NCT00994786|pregabalin|pregabalin
5573053|NCT00994786|Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder|serotonin reuptake inhibitor-refractory obsessive-compulsive disorder
5573054|NCT00994773|Hepatitis B|hepatitis b
5573055|NCT00994773|simvastatin|simvastatin
5573056|NCT00994773|HBV DNA|hbv dna
5573057|NCT00994760|intranasal fentanyl spray|intranasal fentanyl spray
5573058|NCT00994747|infancy|infancy
5573059|NCT00994747|nutrition|nutrition
5573060|NCT00994747|protein hydrolysate formula|protein hydrolysate formula
5573061|NCT00994747|flavor preferences|flavor preferences
5573062|NCT00994747|food preferences|food preferences
5573063|NCT00994747|growth|growth
5573064|NCT00994747|emotional development|emotional development
5573065|NCT00994747|mother-infant interaction|mother-infant interaction
5573066|NCT00994747|infant temperament|infant temperament
5573067|NCT00994747|feeding patterning|feeding patterning
5573068|NCT00994747|taste receptor and obesity genotype|taste receptor and obesity genotype
5573069|NCT00994747|sensitive period|sensitive period
5573070|NCT00994721|Pancreatic Cancer|pancreatic cancer
5573071|NCT00994695|Trivalent meningococcal polysaccharide vaccine|trivalent meningococcal polysaccharide vaccine
5573072|NCT00994695|Children|children
5573073|NCT00994695|Safety|safety
5573074|NCT00994695|Immunogenicity|immunogenicity
5685398|NCT00556231|cardiac output|cardiac output
5573075|NCT00994695|To assess Safety of trivalent meningococcal polysaccharide vaccine in children|to assess safety of trivalent meningococcal polysaccharide vaccine in children
5573076|NCT00994695|To assess the immunogenicity of the trivalent polysaccharide vaccine in children|to assess the immunogenicity of the trivalent polysaccharide vaccine in children
5573077|NCT00994682|Additional relevant MeSH terms:|additional relevant mesh terms:
5573078|NCT00994682|Hypoglycemic Agents|hypoglycemic agents
5573079|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs
5573080|NCT00994682|Pharmacologic Actions|pharmacologic actions
5573081|NCT00994682|Pioglitazone|pioglitazone
5573082|NCT00994656|invasive procedures|invasive procedures
5573083|NCT00994656|hypovolemia|hypovolemia
5573084|NCT00994643|NHL|nhl
5573085|NCT00994643|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5573086|NCT00994643|Lymphoma|lymphoma
5573087|NCT00994591|Nicotine|nicotine
5573088|NCT00994591|Cotinine|cotinine
5573089|NCT00994591|CYP2A6|cyp2a6
5573090|NCT00994578|Advanced cancer|advanced cancer
5573091|NCT00994565|Physical activity|physical activity
5573092|NCT00994565|health behaviour|health behaviour
5573093|NCT00994565|lifestyle|lifestyle
5573094|NCT00994565|productivity|productivity
5573095|NCT00994565|outcomes|outcomes
5573096|NCT00994526|Colorectal cancer|colorectal cancer
5573097|NCT00994526|Processed meat|processed meat
5573098|NCT00994526|Calcium|calcium
5573099|NCT00994526|Vitamin E|vitamin e
5573100|NCT00994526|Preventive strategies|preventive strategies
5573101|NCT00994513|Antioxidant|antioxidant
5573102|NCT00994513|Obesity|obesity
5573103|NCT00994487|Childhood Obesity|childhood obesity
5573104|NCT00994487|Breastfeeding|breastfeeding
5573106|NCT00994487|Dietary Intake|dietary intake
5573108|NCT00994487|Compensation|compensation
5573109|NCT00994487|Parental Feeding Style|parental feeding style
5573110|NCT00994474|Laser surgery|laser surgery
5573111|NCT00994474|Profilometry|profilometry
5573112|NCT00994474|Fitzpatrick wrinkle score|fitzpatrick wrinkle score
5573113|NCT00994474|Patient Benefit Index|patient benefit index
5573114|NCT00994474|Patient satisfaction|patient satisfaction
5573115|NCT00994461|Endoscopy|endoscopy
5573116|NCT00994448|Adolescents|adolescents
5573117|NCT00994448|Methamphetamine abuse|methamphetamine abuse
5573118|NCT00994448|Bupropion|bupropion
5573119|NCT00994448|Addiction|addiction
5573120|NCT00994448|Pharmacotherapy|pharmacotherapy
5573121|NCT00994448|Cognitive Behavioral Therapy|cognitive behavioral therapy
5573122|NCT00994448|Contingency Management|contingency management
5573123|NCT00994448|Teens|teens
5573124|NCT00994435|obesity|obesity
5573125|NCT00994422|PEDICULUS HUMANUS CAPITIS|pediculus humanus capitis
5573126|NCT00994422|Head Lice|head lice
5573127|NCT00994409|Stroke|stroke
5573128|NCT00994370|Pro-angiogenic markers|pro-angiogenic markers
5573129|NCT00994370|SIRT|sirt
5573130|NCT00994370|hepatic metastases|hepatic metastases
5573131|NCT00994357|Real-time Continuous Glucose Monitoring|real-time continuous glucose monitoring
5573132|NCT00994357|Macrosomia|macrosomia
5573133|NCT00994344|Darunavir|darunavir
5573134|NCT00994344|Lopinavir|lopinavir
5573135|NCT00994344|Monotherapy|monotherapy
5573136|NCT00994344|Antiretroviral simplification strategy|antiretroviral simplification strategy
5573137|NCT00994344|HIV|hiv
5573138|NCT00994344|Treatment experienced|treatment experienced
5680325|NCT00578214|versed|versed
5573139|NCT00994331|Percutaneous Coronary Intervention|percutaneous coronary intervention
5573141|NCT00994331|Computed Tomography|computed tomography
5573142|NCT00994318|Ferinject Iron Deficiency Anaemia Chronic Kidney Disease|ferinject iron deficiency anaemia chronic kidney disease
5573143|NCT00994305|kidney transplantation|kidney transplantation
5573144|NCT00994305|oxidative stress|oxidative stress
5573145|NCT00994305|acetylcysteine|acetylcysteine
5573146|NCT00994305|graft rejection|graft rejection
5573147|NCT00994292|Factor Xa|factor xa
5573148|NCT00994292|Anticoagulant|anticoagulant
5573149|NCT00994292|YM150|ym150
5573150|NCT00994292|Acute Coronary Syndrome|acute coronary syndrome
5573151|NCT00994279|fatigue|fatigue
5573152|NCT00994279|depression|depression
5573153|NCT00994279|sleep disorders|sleep disorders
5573154|NCT00994279|stage IA breast cancer|stage ia breast cancer
5573155|NCT00994279|stage IB breast cancer|stage ib breast cancer
5573156|NCT00994279|stage II breast cancer|stage ii breast cancer
5573157|NCT00994279|stage IIIA breast cancer|stage iiia breast cancer
5573158|NCT00994279|stage IIIB breast cancer|stage iiib breast cancer
5573159|NCT00994279|stage IIIC breast cancer|stage iiic breast cancer
5573160|NCT00994279|recurrent breast cancer|recurrent breast cancer
5573161|NCT00994266|Type 2 diabetes|type 2 diabetes
5573162|NCT00994266|Diamel|diamel
5573163|NCT00994266|Dietary supplement|dietary supplement
5573164|NCT00994227|electron microscopy|electron microscopy
5573165|NCT00994227|internal limiting membrane|internal limiting membrane
5573166|NCT00994227|macular disease|macular disease
5573167|NCT00994227|optical coherence tomography|optical coherence tomography
5573168|NCT00994188|Renal tumor|renal tumor
5573169|NCT00994188|Ureteral tumor|ureteral tumor
5573170|NCT00994188|Ureteral stricture|ureteral stricture
5573171|NCT00994188|Restored kidney|restored kidney
5573172|NCT00994188|Renal transplantation|renal transplantation
5573173|NCT00994188|Family members|family members
5573174|NCT00994175|Pioglitazone|pioglitazone
5573175|NCT00994175|Severe, Refractory Asthma|severe, refractory asthma
5573176|NCT00994175|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
5573177|NCT00994175|Airflow Obstruction|airflow obstruction
5573178|NCT00994175|Airway Inflammation|airway inflammation
5573179|NCT00994175|Asthma|asthma
5573180|NCT00994162|NPWT|npwt
5573181|NCT00994162|Gauze-based filler|gauze-based filler
5573182|NCT00994162|Acute or Chronic Wounds|acute or chronic wounds
5573183|NCT00994162|Efficacy|efficacy
5573184|NCT00994149|Infants of Diabetic Mothers|infants of diabetic mothers
5573185|NCT00994149|Hypoglycemia|hypoglycemia
5573186|NCT00994149|Diazoxide|diazoxide
5573187|NCT00994149|Large for Gestation Infants|large for gestation infants
5573188|NCT00994136|Catheters, indwelling|catheters, indwelling
5573189|NCT00994136|Catheterization, Central Venous|catheterization, central venous
5573190|NCT00994136|Withdrawal occlusion|withdrawal occlusion
5573191|NCT00994136|Heparin lock|heparin lock
5573192|NCT00994123|Non-Small Cell Lung Cancer|non-small cell lung cancer
5573193|NCT00994123|NSCLC|nsclc
5573194|NCT00994123|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5573195|NCT00994123|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5573196|NCT00994123|Lung Cancer|lung cancer
5573197|NCT00994123|Erlotinib|erlotinib
5573198|NCT00994123|Tarceva|tarceva
5573199|NCT00994123|MM-121|mm-121
5573200|NCT00994123|ErbB3|erbb3
5573201|NCT00994123|Her3|her3
5573202|NCT00994123|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5573203|NCT00994123|anti-ErbB3 human monoclonal antibody|anti-erbb3 human monoclonal antibody
5573205|NCT00994110|PANCREAS|pancreas
5573206|NCT00994110|Pasireotide|pasireotide
5573207|NCT00994110|SOM230|som230
5573208|NCT00994110|saline placebo|saline placebo
5573209|NCT00994110|09-039|09-039
5573210|NCT00994097|NGR-hTNF|ngr-htnf
5573211|NCT00994097|Randomized controlled trial|randomized controlled trial
5573212|NCT00994097|Gemcitabine|gemcitabine
5573213|NCT00994097|Cisplatin|cisplatin
5573214|NCT00994097|Pemetrexed|pemetrexed
5573215|NCT00994097|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
5573216|NCT00994084|Obesity|obesity
5573217|NCT00994084|Minority children|minority children
5573218|NCT00994084|Community intervention program|community intervention program
5573219|NCT00994084|Lifestyle changes|lifestyle changes
5573220|NCT00994084|Physical activities|physical activities
5573221|NCT00994084|Nutrition lessons|nutrition lessons
5573222|NCT00994084|Behavior modification|behavior modification
5573223|NCT00994071|Brain Tumor|brain tumor
5573224|NCT00994071|CNC Tumor|cnc tumor
5573225|NCT00994071|Pediatric|pediatric
5573226|NCT00994071|PARP Inhibitor|parp inhibitor
5573227|NCT00994071|Oral Chemotherapy|oral chemotherapy
5573228|NCT00994058|Preterm Labor|preterm labor
5573229|NCT00994058|Uterine Inhibitor|uterine inhibitor
5573230|NCT00994058|Electro-Inhibition|electro-inhibition
5573231|NCT00994045|Thoraco-Abdominal Aneurysm (TAAA)|thoraco-abdominal aneurysm (taaa)
5573232|NCT00994045|Coagulopathy|coagulopathy
5573233|NCT00994045|Fresh Frozen Plasma|fresh frozen plasma
5573234|NCT00994045|Fibrinogen Concentrate|fibrinogen concentrate
5573235|NCT00994032|vertebroplasty|vertebroplasty
5573236|NCT00994032|disability evaluation|disability evaluation
5573237|NCT00994032|outcome assessment|outcome assessment
5555231|NCT01065948|diabetes|diabetes
5573238|NCT00994032|pain measurement|pain measurement
5573240|NCT00994019|oral cancer|oral cancer
5573241|NCT00994019|young adults|young adults
5573242|NCT00994006|Magnesium|magnesium
5573243|NCT00994006|nutrition|nutrition
5573244|NCT00994006|platelets|platelets
5573245|NCT00994006|aggregation|aggregation
5573246|NCT00993993|cleft palate|cleft palate
5573247|NCT00993980|qigong|qigong
5573248|NCT00993980|traditional chinese medicine|traditional chinese medicine
5573249|NCT00993980|exercise therapy|exercise therapy
5573250|NCT00993980|low back pain|low back pain
5573251|NCT00993967|FRDA|frda
5573252|NCT00993967|idebenone|idebenone
5573253|NCT00993967|FRDA disease|frda disease
5573254|NCT00993954|Nurse Treatment|nurse treatment
5573255|NCT00993954|Pulled Elbow|pulled elbow
5573256|NCT00993941|BMSC|bmsc
5573257|NCT00993941|Stem cells|stem cells
5573258|NCT00993941|Liver cirrhosis|liver cirrhosis
5573259|NCT00993941|Transplantation|transplantation
5573260|NCT00993928|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5573261|NCT00993928|fatigue|fatigue
5573262|NCT00993928|sleep disorders|sleep disorders
5573263|NCT00993928|cancer survivor|cancer survivor
5573264|NCT00993915|Coronary Artery Disease|coronary artery disease
5573265|NCT00993915|Hyperlipidemia|hyperlipidemia
5573266|NCT00993915|Atorvastatin|atorvastatin
5573267|NCT00993902|Double IUI|double iui
5573268|NCT00993902|Intrauterine insemination|intrauterine insemination
5573269|NCT00993902|Unexplained infertility|unexplained infertility
5573270|NCT00993889|Virtual Reality Peds|virtual reality peds
5573271|NCT00993876|Depression|depression
5573272|NCT00993876|CREB|creb
5573273|NCT00993876|cognitive performance|cognitive performance
5573274|NCT00993876|psychotherapy|psychotherapy
5573275|NCT00993876|SSRI|ssri
5573276|NCT00993876|SNRI|snri
5573277|NCT00993863|delta opioid agonist|delta opioid agonist
5573278|NCT00993863|dental pain|dental pain
5573279|NCT00993850|Bipolar disorder|bipolar disorder
5573280|NCT00993850|Insomnia|insomnia
5573281|NCT00993850|Sleep disturbance|sleep disturbance
5573282|NCT00993850|Cognitive behavioral therapy|cognitive behavioral therapy
5573283|NCT00993837|endoscopic thyroidectomy|endoscopic thyroidectomy
5573284|NCT00993837|thyroid carcinoma|thyroid carcinoma
5573285|NCT00993811|male circumcision|male circumcision
5573287|NCT00993811|Africa|africa
5573288|NCT00993811|HIV Seronegativity|hiv seronegativity
5573289|NCT00993798|Post operative pain|post operative pain
5573290|NCT00993798|Local anaesthesia|local anaesthesia
5573291|NCT00993798|Postoperative pain after arthroscopic shoulder surgery|postoperative pain after arthroscopic shoulder surgery
5573292|NCT00993759|common cold|common cold
5573293|NCT00993759|rhinovirus|rhinovirus
5573294|NCT00993759|prevention|prevention
5573295|NCT00993746|Ultrasound guided infraclavicular brachial plexus block|ultrasound guided infraclavicular brachial plexus block
5573296|NCT00993746|Bupivacaine|bupivacaine
5573297|NCT00993746|Bupivacaine plus lidocaine|bupivacaine plus lidocaine
5573298|NCT00993746|End stage renal disease|end stage renal disease
5573299|NCT00993746|Arteriovenous fistula|arteriovenous fistula
5573300|NCT00993733|hemodiafiltration|hemodiafiltration
5573301|NCT00993733|cost|cost
5573302|NCT00993733|dialysis solution|dialysis solution
5573306|NCT00993707|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5573307|NCT00993694|methemoglobinemia|methemoglobinemia
5573309|NCT00993694|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5573310|NCT00993694|acute undifferentiated leukemia|acute undifferentiated leukemia
5573311|NCT00993694|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5573312|NCT00993694|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5573313|NCT00993694|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5573314|NCT00993694|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5573315|NCT00993694|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5573316|NCT00993694|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5573317|NCT00993694|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5573318|NCT00993694|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5573319|NCT00993694|mast cell leukemia|mast cell leukemia
5573320|NCT00993694|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5573321|NCT00993694|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5573322|NCT00993694|prolymphocytic leukemia|prolymphocytic leukemia
5573323|NCT00993694|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5557928|NCT01054469|nephrectomy|nephrectomy
5573324|NCT00993694|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5573325|NCT00993694|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5573326|NCT00993694|refractory hairy cell leukemia|refractory hairy cell leukemia
5573327|NCT00993694|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5573328|NCT00993694|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5573329|NCT00993694|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5555342|NCT01065376|IVF|ivf
5573330|NCT00993694|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5573331|NCT00993694|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5573332|NCT00993694|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5573333|NCT00993694|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5573334|NCT00993694|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5573335|NCT00993694|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5573336|NCT00993694|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5573337|NCT00993694|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5573338|NCT00993694|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5573339|NCT00993694|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5573340|NCT00993694|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5573341|NCT00993694|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5573342|NCT00993694|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5573343|NCT00993694|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5573344|NCT00993694|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5573345|NCT00993694|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5573346|NCT00993694|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5573347|NCT00993694|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5573348|NCT00993694|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5573349|NCT00993694|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5573350|NCT00993694|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5573351|NCT00993694|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5573352|NCT00993694|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5671994|NCT00613275|Navigator|navigator
5573353|NCT00993694|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5573354|NCT00993694|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5573355|NCT00993694|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5573356|NCT00993694|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5573357|NCT00993694|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5573358|NCT00993694|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5573359|NCT00993694|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5573360|NCT00993694|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5573361|NCT00993694|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5573362|NCT00993694|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5573363|NCT00993694|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5573364|NCT00993694|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5573365|NCT00993694|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5573366|NCT00993694|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5573367|NCT00993694|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5573368|NCT00993694|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5573369|NCT00993694|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5573370|NCT00993694|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5573371|NCT00993694|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5573372|NCT00993694|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5573373|NCT00993694|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5573374|NCT00993694|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5573375|NCT00993694|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5573376|NCT00993694|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5573377|NCT00993694|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5573378|NCT00993694|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5573379|NCT00993694|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5573380|NCT00993694|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5573381|NCT00993694|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5573382|NCT00993694|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5573383|NCT00993694|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5573384|NCT00993694|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5573385|NCT00993694|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5573386|NCT00993694|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5573387|NCT00993694|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5573388|NCT00993694|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5573389|NCT00993694|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5555425|NCT01064973|autism|autism
5573390|NCT00993694|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5573391|NCT00993694|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5573392|NCT00993694|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5573393|NCT00993694|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5573394|NCT00993694|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5573395|NCT00993694|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5573396|NCT00993694|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5573397|NCT00993694|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5573398|NCT00993694|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5573399|NCT00993694|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5573400|NCT00993694|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5573401|NCT00993694|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5573402|NCT00993694|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5573403|NCT00993694|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5573404|NCT00993694|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5573405|NCT00993694|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5573406|NCT00993694|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5573407|NCT00993694|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5573408|NCT00993694|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5573409|NCT00993694|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5573410|NCT00993694|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5573411|NCT00993694|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5573412|NCT00993694|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5573413|NCT00993694|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5573414|NCT00993694|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5573415|NCT00993694|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5573416|NCT00993694|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5573417|NCT00993694|Burkitt lymphoma|burkitt lymphoma
5573418|NCT00993694|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5573419|NCT00993694|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5573420|NCT00993694|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5573421|NCT00993694|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5573422|NCT00993694|intraocular lymphoma|intraocular lymphoma
5573423|NCT00993694|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5567487|NCT01016418|colostrum|colostrum
5573424|NCT00993694|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5573425|NCT00993694|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5573426|NCT00993694|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5573427|NCT00993694|primary myelofibrosis|primary myelofibrosis
5573428|NCT00993694|essential thrombocythemia|essential thrombocythemia
5573429|NCT00993694|polycythemia vera|polycythemia vera
5573430|NCT00993694|extramedullary plasmacytoma|extramedullary plasmacytoma
5573431|NCT00993694|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5573432|NCT00993694|stage I multiple myeloma|stage i multiple myeloma
5573433|NCT00993694|stage II multiple myeloma|stage ii multiple myeloma
5573434|NCT00993694|stage III multiple myeloma|stage iii multiple myeloma
5573435|NCT00993694|primary systemic amyloidosis|primary systemic amyloidosis
5573436|NCT00993694|refractory multiple myeloma|refractory multiple myeloma
5573437|NCT00993694|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5573438|NCT00993694|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5573439|NCT00993694|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5573440|NCT00993694|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5573441|NCT00993694|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5573442|NCT00993694|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5573443|NCT00993694|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5573444|NCT00993694|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5573445|NCT00993694|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5573446|NCT00993694|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5573447|NCT00993694|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5573448|NCT00993681|Prevention of Travelers' Diarrhea|prevention of travelers' diarrhea
5573450|NCT00993668|vaccine|vaccine
5573451|NCT00993668|pneumococcal vaccine|pneumococcal vaccine
5573452|NCT00993668|certolizumab pegol|certolizumab pegol
5573453|NCT00993668|Cimzia|cimzia
5573454|NCT00993655|peritoneal cavity cancer|peritoneal cavity cancer
5573455|NCT00993655|fallopian tube cancer|fallopian tube cancer
5573456|NCT00993655|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5573457|NCT00993655|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5573458|NCT00993655|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5573459|NCT00993655|malignant pleural effusion|malignant pleural effusion
5573460|NCT00993655|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5573461|NCT00993655|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
5573462|NCT00993642|estrogen receptor positive tamoxifen resistant breast cancer|estrogen receptor positive tamoxifen resistant breast cancer
5573463|NCT00993629|PTSD|ptsd
5573464|NCT00993629|Depression|depression
5573465|NCT00993629|Neurosteroids|neurosteroids
5573466|NCT00993603|Lifestyle|lifestyle
5573467|NCT00993603|Diabetes Mellitus|diabetes mellitus
5573468|NCT00993603|prevention/onset delay.|prevention/onset delay.
5573469|NCT00993590|Persistent asthma|persistent asthma
5573470|NCT00993590|Asthma related emergency room visits|asthma related emergency room visits
5573471|NCT00993590|Asthma control, adolescents|asthma control, adolescents
5573472|NCT00993590|Adherence, asthma control medications|adherence, asthma control medications
5573473|NCT00993577|Stretching|stretching
5573474|NCT00993577|Pain|pain
5573475|NCT00993551|cleft palate|cleft palate
5573476|NCT00993551|paediatric|paediatric
5573477|NCT00993551|pediatric|pediatric
5573478|NCT00993551|surgery|surgery
5573479|NCT00993551|speech|speech
5573480|NCT00993551|velopharyngeal|velopharyngeal
5573481|NCT00993538|Leukaemia|leukaemia
5573482|NCT00993538|Blood and marrow cells culture|blood and marrow cells culture
5573483|NCT00993538|Cell growth|cell growth
5573484|NCT00993538|Cell differentiation|cell differentiation
5573485|NCT00993525|diabetic retinopathy|diabetic retinopathy
5573486|NCT00993525|ranibizumab|ranibizumab
5573487|NCT00993525|new vessels|new vessels
5671996|NCT00613275|Disparities|disparities
5573488|NCT00993525|intravitreal injection|intravitreal injection
5573489|NCT00993525|Persistent retina new vessels|persistent retina new vessels
5573490|NCT00993512|photochemical internalisation|photochemical internalisation
5573491|NCT00993512|photosensitiser|photosensitiser
5573492|NCT00993512|cutaneous tumour|cutaneous tumour
5573493|NCT00993512|sub-cutaneous tumour|sub-cutaneous tumour
5573494|NCT00993512|dose escalation|dose escalation
5573495|NCT00993486|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5573496|NCT00993486|Graft-versus-host disease|graft-versus-host disease
5573497|NCT00993486|Immune reconstitution|immune reconstitution
5573498|NCT00993486|Alloreactive T-cells|alloreactive t-cells
5573499|NCT00993486|Photodepletion|photodepletion
5573501|NCT00993486|Transplant related mortality|transplant related mortality
5573502|NCT00993486|Hematologic malignancy|hematologic malignancy
5573504|NCT00993460|Insulin sensitivity|insulin sensitivity
5573505|NCT00993460|Inflammation|inflammation
5573506|NCT00993447|Dengue|dengue
5573507|NCT00993447|Dengue hemorrhagic fever|dengue hemorrhagic fever
5573509|NCT00993447|Dengue fever|dengue fever
5573510|NCT00993447|Sanofi pasteur's CYD Dengue vaccine|sanofi pasteur's cyd dengue vaccine
5573511|NCT00993434|Child|child
5573512|NCT00993395|addiction|addiction
5573513|NCT00993395|peer mentor|peer mentor
5573514|NCT00993395|adherence|adherence
5573515|NCT00993369|Prediction of neuro developmental delay|prediction of neuro developmental delay
5573516|NCT00993356|Acromegaly|acromegaly
5573517|NCT00993356|Macroadenomas|macroadenomas
5573518|NCT00993356|Lanreotide|lanreotide
5573519|NCT00993356|Transsphenoidal neurosurgery|transsphenoidal neurosurgery
5573520|NCT00993356|Preoperative|preoperative
5573521|NCT00993343|GVHD|gvhd
5573522|NCT00993343|tacrolimus|tacrolimus
5573523|NCT00993343|sirolimus|sirolimus
5573524|NCT00993343|cyclosporine|cyclosporine
5573525|NCT00993343|allogeneic|allogeneic
5573526|NCT00993343|stem cell transplantation|stem cell transplantation
5573527|NCT00993343|Relapse-free survival|relapse-free survival
5573528|NCT00993330|macular pigment|macular pigment
5573529|NCT00993330|to measure macular pigment in the retina|to measure macular pigment in the retina
5573530|NCT00993317|CDP870|cdp870
5573531|NCT00993317|Korea|korea
5573532|NCT00993317|CIMZIA|cimzia
5573533|NCT00993291|Parkinson's Disease|parkinson's disease
5573534|NCT00993291|DBS|dbs
5573535|NCT00993291|Frequency|frequency
5573536|NCT00993291|Deep brain stimulation|deep brain stimulation
5573537|NCT00993265|Trichotillomania|trichotillomania
5573538|NCT00993265|Hair pulling|hair pulling
5573539|NCT00993265|glutamate|glutamate
5573540|NCT00993265|N-Acetylcysteine|n-acetylcysteine
5573541|NCT00993265|Children|children
5573542|NCT00993252|head injury|head injury
5573543|NCT00993252|radiography|radiography
5573544|NCT00993252|clinical impact|clinical impact
5573545|NCT00993252|dissemination|dissemination
5573546|NCT00993226|Postoperative pain|postoperative pain
5573547|NCT00993226|Local anaesthesia|local anaesthesia
5573548|NCT00993226|Postoperative pain after open abdominal hysterectomy surgery|postoperative pain after open abdominal hysterectomy surgery
5573549|NCT00993213|fat mass|fat mass
5573550|NCT00993213|body composition|body composition
5573551|NCT00993200|Warfarin|warfarin
5573552|NCT00993200|Pharmacogenetic|pharmacogenetic
5573553|NCT00993161|Neuromuscular disorders|neuromuscular disorders
5573554|NCT00993161|Evaluation|evaluation
5573555|NCT00993161|Strength|strength
5573556|NCT00993161|Upper limb|upper limb
5573557|NCT00993148|Treatment naive|treatment naive
5573558|NCT00993135|renal toxicity|renal toxicity
5573559|NCT00993135|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5573560|NCT00993135|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5573561|NCT00993122|pre treatment|pre treatment
5573562|NCT00993122|therapy compliance|therapy compliance
5573563|NCT00993122|SVR|svr
5573564|NCT00993122|sustained virological response|sustained virological response
5573565|NCT00993122|TH1 TH2 ratio|th1 th2 ratio
5573566|NCT00993109|Nifedipine GITS/OROS (Adalat®)|nifedipine gits/oros (adalat®)
5573567|NCT00993109|Valsartan (Diovan®)|valsartan (diovan®)
5573568|NCT00993109|Hypertension|hypertension
5573569|NCT00993083|Influenza|influenza
5573570|NCT00993083|Vaccine|vaccine
5573571|NCT00993070|capsaicin|capsaicin
5573572|NCT00993070|placebo|placebo
5573573|NCT00993070|trial|trial
5573574|NCT00993070|diabetic polyneuropathy|diabetic polyneuropathy
5573575|NCT00993070|neuropathic pain|neuropathic pain
5573576|NCT00993057|Euglycemia|euglycemia
5573577|NCT00993057|craniotomy|craniotomy
5573578|NCT00993057|neurosurgery|neurosurgery
5573579|NCT00993057|hypoglycemia|hypoglycemia
5573580|NCT00993057|insulin|insulin
5573581|NCT00993031|HIV|hiv
5573582|NCT00993031|Placental Malaria|placental malaria
5573583|NCT00993031|Pregnancy|pregnancy
5573584|NCT00993031|Uganda|uganda
5573585|NCT00993031|Protease inhibitors|protease inhibitors
5573586|NCT00993031|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5573587|NCT00993031|Treatment experienced|treatment experienced
5573588|NCT00993018|Diabetic Neuropathy|diabetic neuropathy
5573589|NCT00993018|Diabetic painful neuropathy|diabetic painful neuropathy
5573590|NCT00993018|JNJ-42160443|jnj-42160443
5573591|NCT00993018|Neuropathic pain|neuropathic pain
5573592|NCT00993018|Pain|pain
5573593|NCT00993018|Pharmacokinetics|pharmacokinetics
5573594|NCT00993005|Hypertrophic scars|hypertrophic scars
5573595|NCT00993005|Keloids|keloids
5573596|NCT00993005|Asian Gotu Kola|asian gotu kola
5573598|NCT00992992|Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)|cyclophosphamide, doxorubicin, vincristine, and prednisone (chop)
5573599|NCT00992992|Tositumomab|tositumomab
5573600|NCT00992992|Tositumomab and Iodine I-131 tostumomab|tositumomab and iodine i-131 tostumomab
5573601|NCT00992992|Bexxar|bexxar
5573602|NCT00992992|Iodine-131 Anti-B1 Antibody|iodine-131 anti-b1 antibody
5573603|NCT00992992|Mantle Cell|mantle cell
5573604|NCT00992992|radioimmunotherapy|radioimmunotherapy
5573605|NCT00992979|Addiction|addiction
5573606|NCT00992979|Anxiety|anxiety
5573607|NCT00992979|Withdrawal|withdrawal
5573608|NCT00992979|Psychoactive Drugs|psychoactive drugs
5573609|NCT00992979|Therapeutic Massage|therapeutic massage
5573610|NCT00992966|to acquire database of pneumonia cases in children|to acquire database of pneumonia cases in children
5573611|NCT00992953|Virtual Reality|virtual reality
5573612|NCT00992953|Post Traumatic Stress Disorder|post traumatic stress disorder
5573613|NCT00992953|Combat|combat
5573614|NCT00992953|Military|military
5573615|NCT00992953|Major Depressive Disorder|major depressive disorder
5573616|NCT00992953|Anxiety|anxiety
5573617|NCT00992953|Virtual Reality Exposure with Stimulus Control|virtual reality exposure with stimulus control
5573618|NCT00992953|Treatment as Usual|treatment as usual
5573619|NCT00992940|awake craniotomy|awake craniotomy
5573620|NCT00992940|patient-controlled sedation analgesia|patient-controlled sedation analgesia
5573621|NCT00992940|anesthetist-controlled sedation analgesia|anesthetist-controlled sedation analgesia
5573622|NCT00992940|remifentanil-propofol|remifentanil-propofol
5573623|NCT00992940|tumour surgery|tumour surgery
5573624|NCT00992927|Injections, Intra-Articular|injections, intra-articular
5573625|NCT00992927|Range of Motion, Articular|range of motion, articular
5573626|NCT00992927|Pain|pain
5573627|NCT00992914|Hot flushes (vasomotor symptoms)|hot flushes (vasomotor symptoms)
5573628|NCT00992901|gastric bypass surgery|gastric bypass surgery
5573629|NCT00992901|glucose tolerance|glucose tolerance
5573630|NCT00992901|Insulin response to meal ingestion|insulin response to meal ingestion
5573631|NCT00992901|Gut hormone and neural response to meal ingestion|gut hormone and neural response to meal ingestion
5573632|NCT00992888|Alcoholic Hepatitis|alcoholic hepatitis
5573633|NCT00992888|Alcohol|alcohol
5573634|NCT00992888|Endotoxin|endotoxin
5573635|NCT00992888|LPS|lps
5573636|NCT00992888|Liver dialysis|liver dialysis
5573637|NCT00992888|Innate immunity|innate immunity
5573638|NCT00992888|Toll Like receptors|toll like receptors
5573639|NCT00992875|Healthy but stressed individuals|healthy but stressed individuals
5573640|NCT00992849|Corneal neovascularization|corneal neovascularization
5573641|NCT00992849|bevacizumab|bevacizumab
5573642|NCT00992836|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5573643|NCT00992836|Vaccine|vaccine
5573644|NCT00992836|Children|children
5573645|NCT00992836|Adolescents|adolescents
5573646|NCT00992836|HIV-Infected|hiv-infected
5573647|NCT00992836|Perinatal HIV Infection|perinatal hiv infection
5573648|NCT00992836|Treatment experienced|treatment experienced
5573649|NCT00992823|Iron|iron
5573650|NCT00992823|anemia|anemia
5573651|NCT00992823|supplementation|supplementation
5573652|NCT00992823|preschoolers|preschoolers
5573653|NCT00992823|prevalence|prevalence
5573654|NCT00992823|preschoolers children from public day care centers|preschoolers children from public day care centers
5573655|NCT00992810|upper limb|upper limb
5573656|NCT00992810|hand|hand
5573657|NCT00992810|arm|arm
5573658|NCT00992810|surgery|surgery
5573659|NCT00992810|supraclavicular nerve block|supraclavicular nerve block
5573660|NCT00992810|brachial plexus nerve block|brachial plexus nerve block
5573661|NCT00992810|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5573662|NCT00992797|Insulin resistance|insulin resistance
5573663|NCT00992797|Insulin secretory dysfunction|insulin secretory dysfunction
5573664|NCT00992797|Inflammation|inflammation
5573665|NCT00992797|Vascular stiffness|vascular stiffness
5573666|NCT00992784|Influenza Vaccines|influenza vaccines
5573667|NCT00992784|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
5573668|NCT00992784|influenza infection|influenza infection
5573669|NCT00992758|bone marrow|bone marrow
5573670|NCT00992758|Radioimmunotherapy|radioimmunotherapy
5573671|NCT00992758|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5573672|NCT00992758|Bexxar|bexxar
5573674|NCT00992758|tositumomab and iodine I-131 tositumomab|tositumomab and iodine i-131 tositumomab
5573675|NCT00992758|NHL|nhl
5573676|NCT00992758|tositumomab|tositumomab
5573677|NCT00992745|prostate cancer|prostate cancer
5573678|NCT00992745|imaging|imaging
5573679|NCT00992745|metastases|metastases
5573680|NCT00992745|PSMA|psma
5573681|NCT00992745|ProstaScint®|prostascint®
5573682|NCT00992719|H1N1, influenza A viruses, vaccine, pregnant women|h1n1, influenza a viruses, vaccine, pregnant women
5573683|NCT00992706|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5573684|NCT00992706|stage IV breast cancer|stage iv breast cancer
5573685|NCT00992706|male breast cancer|male breast cancer
5573686|NCT00992693|Crimean-Congo Hemorrhagic Fever|crimean-congo hemorrhagic fever
5573687|NCT00992693|Lassa Fever|lassa fever
5573688|NCT00992693|CCHF|cchf
5573690|NCT00992693|Viral Hemorrhagic Fever|viral hemorrhagic fever
5573691|NCT00992693|VHF|vhf
5573692|NCT00992693|Ribavirin|ribavirin
5573693|NCT00992680|Lung Disease|lung disease
5573694|NCT00992680|Chronic Airflow Obstruction|chronic airflow obstruction
5573695|NCT00992680|Chronic Bronchitis|chronic bronchitis
5573696|NCT00992680|Pulmonary Emphysema|pulmonary emphysema
5573697|NCT00992680|Walk|walk
5573698|NCT00992667|apocynin|apocynin
5573699|NCT00992667|asthma|asthma
5573700|NCT00992654|Open Label Access Program|open label access program
5573701|NCT00992654|Treatment experienced|treatment experienced
5573702|NCT00992641|Systems biology|systems biology
5573703|NCT00992641|Nutrition|nutrition
5573704|NCT00992641|Nordic diet|nordic diet
5573705|NCT00992641|Dietary recommendations|dietary recommendations
5573706|NCT00992641|Metabolic syndrome|metabolic syndrome
5573707|NCT00992641|Features of metabolic syndrome|features of metabolic syndrome
5573708|NCT00992628|GlideScope Video Laryngoscope|glidescope video laryngoscope
5573709|NCT00992628|Macintosh Direct Laryngoscope|macintosh direct laryngoscope
5573710|NCT00992628|Intubation|intubation
5573711|NCT00992628|Applied Forces|applied forces
5573712|NCT00992628|Elective surgery where endotracheal intubation required|elective surgery where endotracheal intubation required
5573713|NCT00992589|Gastroesophageal Reflux|gastroesophageal reflux
5573714|NCT00992589|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5573716|NCT00992589|Proton Pump Inhibitor|proton pump inhibitor
5573717|NCT00992589|PPI|ppi
5573718|NCT00992589|Regurgitation|regurgitation
5573719|NCT00992589|Infants|infants
5573720|NCT00992589|AcipHex, PARIET|aciphex, pariet
5573721|NCT00992589|ALFENCE|alfence
5573722|NCT00992576|Confirmatory|confirmatory
5573723|NCT00992576|Constipation|constipation
5573724|NCT00992576|Pain|pain
5573725|NCT00992576|Hydromorphone|hydromorphone
5573726|NCT00992576|Naloxone|naloxone
5573727|NCT00992563|wet age-related macular degeneration, exudative|wet age-related macular degeneration, exudative
5573728|NCT00992550|hookah|hookah
5573729|NCT00992550|cigarette|cigarette
5573730|NCT00992550|smoking|smoking
5573731|NCT00992524|Misoprostol|misoprostol
5573732|NCT00992524|Labor, Obstetric|labor, obstetric
5573733|NCT00992524|Labor, Induced|labor, induced
5573734|NCT00992511|influenza infection|influenza infection
5573735|NCT00992511|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5573736|NCT00992498|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5573737|NCT00992498|outpatients|outpatients
5573738|NCT00992498|rehabilitation|rehabilitation
5573739|NCT00992498|comorbidities|comorbidities
5573740|NCT00992498|patient-centered outcome|patient-centered outcome
5573741|NCT00992459|Urea Cycle Disorder (UCD)|urea cycle disorder (ucd)
5573743|NCT00992459|hyperammonemia|hyperammonemia
5573744|NCT00992459|Buphenyl (NaPBA)|buphenyl (napba)
5573745|NCT00992459|glycerol phenylbutyrate (GPB)|glycerol phenylbutyrate (gpb)
5555840|NCT01063205|NAC|nac
5573746|NCT00992459|Sodium Phenylbutyrate (NaPBA)|sodium phenylbutyrate (napba)
5573747|NCT00992446|Autologous stem cell transplant|autologous stem cell transplant
5573748|NCT00992446|NHL|nhl
5573749|NCT00992446|maintenance therapy|maintenance therapy
5573750|NCT00992433|influenza, H1N1, vaccine, human immunodeficiency virus|influenza, h1n1, vaccine, human immunodeficiency virus
5573751|NCT00992420|thienopyridine|thienopyridine
5573752|NCT00992420|platelets|platelets
5573753|NCT00992420|CYP2C19|cyp2c19
5573754|NCT00992420|clopidogrel|clopidogrel
5573755|NCT00992420|platelet function tests|platelet function tests
5573756|NCT00992420|platelet|platelet
5573757|NCT00992420|genes|genes
5573758|NCT00992420|cytochrome P450|cytochrome p450
5573759|NCT00992420|single nucleotide polymorphisms|single nucleotide polymorphisms
5573760|NCT00992420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5573761|NCT00992407|Schizophrenia|schizophrenia
5573762|NCT00992407|Risperidone|risperidone
5573763|NCT00992407|Risperdal|risperdal
5573764|NCT00992394|Plaque psoriasis - etanercept - response maintenance|plaque psoriasis - etanercept - response maintenance
5573765|NCT00992381|GI Pain|gi pain
5573766|NCT00992381|healthy participants|healthy participants
5573767|NCT00992381|Safety|safety
5573768|NCT00992381|bioavailability|bioavailability
5573769|NCT00992368|Quality-Adjusted Life Years:A measurement index|quality-adjusted life years:a measurement index
5573770|NCT00992368|Cost-Benefit Analysis:A method of comparing costs|cost-benefit analysis:a method of comparing costs
5573771|NCT00992368|Mammaplasty|mammaplasty
5573772|NCT00992368|QALY|qaly
5573773|NCT00992368|Health-related quality of life|health-related quality of life
5573774|NCT00992368|Cost-effectiveness|cost-effectiveness
5573776|NCT00992355|Cataract|cataract
5573777|NCT00992355|Phacoemulsification|phacoemulsification
5573778|NCT00992355|Treatment duration|treatment duration
5573779|NCT00992329|ciprofloxacin|ciprofloxacin
5573780|NCT00992329|pharmacokinetics|pharmacokinetics
5573781|NCT00992329|formulation|formulation
5573782|NCT00992316|Inflammatory pain|inflammatory pain
5573783|NCT00992303|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5573784|NCT00992290|cirrhosis|cirrhosis
5573785|NCT00992290|hepatic encephalopathy|hepatic encephalopathy
5573786|NCT00992290|complications|complications
5573787|NCT00992290|probiotic|probiotic
5573788|NCT00992290|lactobacillus GG|lactobacillus gg
5573789|NCT00992264|Cigarette Smoking|cigarette smoking
5573790|NCT00992264|Health Behavior|health behavior
5573791|NCT00992264|Intervention Studies|intervention studies
5573792|NCT00992264|Personal Communication|personal communication
5573793|NCT00992251|prostate cancer|prostate cancer
5573794|NCT00992225|Metastatic|metastatic
5573795|NCT00992212|Pandemic influenza|pandemic influenza
5573796|NCT00992212|vaccine|vaccine
5573797|NCT00992199|intraperitoneal chemotherapy|intraperitoneal chemotherapy
5573798|NCT00992199|cisplatin|cisplatin
5573799|NCT00992199|fluorouracil|fluorouracil
5573800|NCT00992199|advanced gastric cancer|advanced gastric cancer
5573801|NCT00992186|Prostate cancer|prostate cancer
5573802|NCT00992186|Infusion|infusion
5573803|NCT00992186|Carlumab|carlumab
5573804|NCT00992186|CNTO 888|cnto 888
5573805|NCT00992173|Neuroblastoma|neuroblastoma
5573806|NCT00992173|MIBG|mibg
5573807|NCT00992173|Iobenguane|iobenguane
5573808|NCT00992160|Polysomnography (PSG)|polysomnography (psg)
5573809|NCT00992160|Adults|adults
5573810|NCT00992160|Primary Insomnia|primary insomnia
5573811|NCT00992134|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5573812|NCT00992134|Bendamustine|bendamustine
5573813|NCT00992134|Cytarabine|cytarabine
5573814|NCT00992134|Rituximab|rituximab
5573815|NCT00992134|Treatment|treatment
5573816|NCT00992134|Combination chemotherapy|combination chemotherapy
5573817|NCT00992121|pazopanib|pazopanib
5573818|NCT00992121|Renal Cell Carcinoma|renal cell carcinoma
5573819|NCT00992121|Kidney|kidney
5573820|NCT00992121|cancer|cancer
5573821|NCT00992121|bevacizumab|bevacizumab
5573822|NCT00992108|Bruxism|bruxism
5573823|NCT00992108|Myofascial pain|myofascial pain
5573824|NCT00992108|EMG|emg
5573825|NCT00992108|Ultrasound|ultrasound
5573826|NCT00992108|Masticatory myofascial face pain from bruxism and clenching|masticatory myofascial face pain from bruxism and clenching
5573827|NCT00992082|Postoperative pain|postoperative pain
5573828|NCT00992082|Local Infiltration Analgesia|local infiltration analgesia
5573829|NCT00992082|Knee arthroplasty|knee arthroplasty
5573830|NCT00992069|ARV|arv
5573831|NCT00992069|Pharmacokinetics|pharmacokinetics
5573832|NCT00992069|TMC207|tmc207
5573833|NCT00992069|Efavirenz|efavirenz
5573834|NCT00992043|creatine supplementation|creatine supplementation
5573837|NCT00992017|Pregnant|pregnant
5573838|NCT00992017|Perinatal|perinatal
5573839|NCT00992004|Osteoarthritis, Knee|osteoarthritis, knee
5573840|NCT00992004|Osteoarthritis|osteoarthritis
5573841|NCT00992004|Joint Diseases|joint diseases
5573842|NCT00992004|Arthritis|arthritis
5573843|NCT00992004|Rheumatic Diseases|rheumatic diseases
5573844|NCT00991991|stage I melanoma|stage i melanoma
5573845|NCT00991991|stage II melanoma|stage ii melanoma
5573846|NCT00991991|stage III melanoma|stage iii melanoma
5573847|NCT00991978|breast cancer|breast cancer
5573848|NCT00991978|VEGF|vegf
5573849|NCT00991978|Screening|screening
5573850|NCT00991965|Alveolar Ridge Augmentation|alveolar ridge augmentation
5573851|NCT00991965|Dental Implantation, Endosseous|dental implantation, endosseous
5573852|NCT00991965|Osseointegration|osseointegration
5573853|NCT00991965|Bone Morphogenetic Proteins|bone morphogenetic proteins
5573854|NCT00991939|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
5573855|NCT00991939|ITP|itp
5573856|NCT00991939|Dexamethasone|dexamethasone
5573857|NCT00991939|Prednisone|prednisone
5573858|NCT00991926|obesity|obesity
5573859|NCT00991926|GH/IGF-1 axis|gh/igf-1 axis
5573860|NCT00991926|postprandial NEFA|postprandial nefa
5573861|NCT00991913|Delirium|delirium
5573862|NCT00991913|Postoperative|postoperative
5573863|NCT00991913|Non-cardiovascular surgery|non-cardiovascular surgery
5573864|NCT00991913|Post-anaesthesia care unit|post-anaesthesia care unit
5573865|NCT00991887|Heterotopic Ossification|heterotopic ossification
5573866|NCT00991887|Distal humerus Fracture-dislocations of the elbow|distal humerus fracture-dislocations of the elbow
5573867|NCT00991887|Radiation Therapy|radiation therapy
5573868|NCT00991874|Nitric oxide|nitric oxide
5573869|NCT00991874|Asthma|asthma
5573870|NCT00991874|Longitudinal studies|longitudinal studies
5573871|NCT00991874|Child|child
5573872|NCT00991861|Actinic Keratosis|actinic keratosis
5573873|NCT00991861|AK|ak
5573874|NCT00991861|NMSC|nmsc
5573875|NCT00991848|Lidocaine;|lidocaine;
5573876|NCT00991848|Fibromyalgia|fibromyalgia
5573877|NCT00991848|signs|signs
5573878|NCT00991848|symptoms|symptoms
5573879|NCT00991822|open angle glaucoma|open angle glaucoma
5573880|NCT00991822|timolol|timolol
5573881|NCT00991822|dorzolamide|dorzolamide
5573882|NCT00991809|opioid induced hyperalgesia|opioid induced hyperalgesia
5573883|NCT00991783|Fimasartan|fimasartan
5573884|NCT00991783|Drug interaction|drug interaction
5573885|NCT00991770|Discomfort|discomfort
5573886|NCT00991770|Port-a-Catheters|port-a-catheters
5573887|NCT00991770|Complementary and Alternative Medicine|complementary and alternative medicine
5573888|NCT00991770|Massage|massage
5573889|NCT00991757|RWJ-333369|rwj-333369
5573890|NCT00991757|Anticonvulsants|anticonvulsants
5573891|NCT00991757|Antiepileptic drugs|antiepileptic drugs
5573892|NCT00991757|Epilepsy, Focal|epilepsy, focal
5573893|NCT00991757|Seizure Disorder|seizure disorder
5573894|NCT00991744|Leukemia|leukemia
5573895|NCT00991744|Central nervous system|central nervous system
5573896|NCT00991744|Neurotoxicity|neurotoxicity
5573897|NCT00991744|Liposomal cytarabine|liposomal cytarabine
5573898|NCT00991744|Children|children
5573899|NCT00991744|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5573900|NCT00991744|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5573901|NCT00991744|Intrathecal|intrathecal
5573902|NCT00991744|Efficacy|efficacy
5573903|NCT00991744|Safety|safety
5573904|NCT00991731|Physical Activity|physical activity
5573905|NCT00991731|Faith based|faith based
5573906|NCT00991731|Non faith based|non faith based
5573907|NCT00991731|African American|african american
5573908|NCT00991731|Female|female
5573909|NCT00991731|Pedometers|pedometers
5573910|NCT00991718|GDC0449|gdc0449
5573911|NCT00991705|Fimasartan, Atorvastatin|fimasartan, atorvastatin
5573912|NCT00991692|Pediatric CI Therapy|pediatric ci therapy
5573913|NCT00991692|ACQUIREc Therapy|acquirec therapy
5573914|NCT00991692|Dosage|dosage
5573915|NCT00991692|Occupational Therapy|occupational therapy
5573916|NCT00991692|Physical Therapy|physical therapy
5573917|NCT00991692|Cerebral Palsy|cerebral palsy
5573918|NCT00991692|Hemiparesis|hemiparesis
5573919|NCT00991679|Dry eye syndrome|dry eye syndrome
5573920|NCT00991679|CXCL9 chemokine|cxcl9 chemokine
5573921|NCT00991679|CXCL10 chemokine|cxcl10 chemokine
5573922|NCT00991679|CXCL11 chemokine|cxcl11 chemokine
5573923|NCT00991679|CXCR3 receptor|cxcr3 receptor
5573925|NCT00991666|rigidity|rigidity
5573926|NCT00991666|pulsatile ocular blood flow|pulsatile ocular blood flow
5573927|NCT00991666|Physiology of the eye|physiology of the eye
5573928|NCT00991653|Weight|weight
5573929|NCT00991653|Breast|breast
5573930|NCT00991653|Cancer|cancer
5573931|NCT00991627|Ephedrine|ephedrine
5573932|NCT00991627|Adrenergic Agents|adrenergic agents
5573933|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants
5573934|NCT00991627|Sympathomimetics|sympathomimetics
5573935|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents
5573936|NCT00991627|Bupivacaine|bupivacaine
5573937|NCT00991627|Anesthetics, Local|anesthetics, local
5573938|NCT00991627|Atropine|atropine
5573939|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia
5573940|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents
5573941|NCT00991627|Bronchodilator Agents|bronchodilator agents
5573942|NCT00991627|Muscarinic Antagonists|muscarinic antagonists
5573943|NCT00991627|Mydriatics|mydriatics
5573944|NCT00991627|Parasympatholytics|parasympatholytics
5573945|NCT00991627|Morphine|morphine
5573946|NCT00991627|Analgesics, Opioid|analgesics, opioid
5573947|NCT00991627|Narcotics|narcotics
5573948|NCT00991627|Ringer's Lactate|ringer's lactate
5573949|NCT00991627|Isotonic Solutions|isotonic solutions
5573950|NCT00991627|Hypotension|hypotension
5573951|NCT00991627|Blood pressure|blood pressure
5573952|NCT00991627|Signs and Symptoms|signs and symptoms
5573953|NCT00991627|Pregnancy|pregnancy
5573954|NCT00991627|Anesthesia, Obstetrical|anesthesia, obstetrical
5573955|NCT00991627|Inferior Vena Cava|inferior vena cava
5573957|NCT00991601|pancreas|pancreas
5573958|NCT00991601|cancer|cancer
5573959|NCT00991601|tumor|tumor
5573960|NCT00991601|FNAC|fnac
5573962|NCT00991588|Posterolateral|posterolateral
5573963|NCT00991575|Diabetes mellitus, type1|diabetes mellitus, type1
5573964|NCT00991575|cardiovascular disease|cardiovascular disease
5573965|NCT00991575|diabetes complications|diabetes complications
5573966|NCT00991575|Glycation end products, advanced|glycation end products, advanced
5573967|NCT00991562|relapsed or relapsed/refractory multiple myeloma|relapsed or relapsed/refractory multiple myeloma
5573968|NCT00991549|overweight|overweight
5573969|NCT00991549|obesity|obesity
5573970|NCT00991549|glucose intolerance|glucose intolerance
5573971|NCT00991549|pre-diabetes|pre-diabetes
5573972|NCT00991523|resistance|resistance
5573973|NCT00991523|exercise|exercise
5573974|NCT00991523|protein|protein
5573975|NCT00991523|recovery|recovery
5573976|NCT00991510|renal transplantation|renal transplantation
5573977|NCT00991510|mycophenolate mofetil|mycophenolate mofetil
5573978|NCT00991510|pharmacokinetics|pharmacokinetics
5573979|NCT00991510|immunosuppression|immunosuppression
5573980|NCT00991497|varicose veins|varicose veins
5573981|NCT00991497|foam sclerotherapy|foam sclerotherapy
5573982|NCT00991497|compression bandaging|compression bandaging
5573983|NCT00991497|duration|duration
5573984|NCT00991484|ventral|ventral
5573985|NCT00991484|inguinal|inguinal
5573986|NCT00991484|hernia|hernia
5573987|NCT00991484|inheritance|inheritance
5573988|NCT00991484|genetics|genetics
5573989|NCT00991471|Emergency Department Wait Times|emergency department wait times
5573990|NCT00991471|Physician Nurse at Triage|physician nurse at triage
5573991|NCT00991471|Overcrowding|overcrowding
5573992|NCT00991471|CostEffectiveness|costeffectiveness
5573993|NCT00991445|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5573994|NCT00991445|Surgical exposure|surgical exposure
5573995|NCT00991445|Minimal invasive surgery|minimal invasive surgery
5573996|NCT00991445|Local Infiltration Analgesia|local infiltration analgesia
5573997|NCT00991445|Knee Arthroplasty|knee arthroplasty
5573998|NCT00991432|Alveolar Ridge Augmentation|alveolar ridge augmentation
5573999|NCT00991432|Dental Implantation, Endosseous|dental implantation, endosseous
5574000|NCT00991432|Osseointegration|osseointegration
5574001|NCT00991432|Space Maintenance|space maintenance
5574002|NCT00991432|Bone Morphogenetic Proteins|bone morphogenetic proteins
5574004|NCT00991419|Alzheimer's disease|alzheimer's disease
5574005|NCT00991419|diagnostic|diagnostic
5574006|NCT00991406|Electric Stimulation|electric stimulation
5574007|NCT00991406|Hemiplegia|hemiplegia
5574008|NCT00991406|walking|walking
5574009|NCT00991393|Maxillary Sinus Augmentation|maxillary sinus augmentation
5574010|NCT00991393|Dental Implantation|dental implantation
5574011|NCT00991393|Osseointegration|osseointegration
5574012|NCT00991393|Bone Morphogenetic Proteins|bone morphogenetic proteins
5574013|NCT00991367|Post-surgical scars|post-surgical scars
5574014|NCT00991367|Asian Gotu Kola|asian gotu kola
5574015|NCT00991367|Asian Pennywort|asian pennywort
5574016|NCT00991354|HIV Seronegativity|hiv seronegativity
5574017|NCT00991354|HIV Preventive Vaccine|hiv preventive vaccine
5574018|NCT00991341|Cardiac surgery|cardiac surgery
5574019|NCT00991341|Red blood cell|red blood cell
5574020|NCT00991341|Transfusion|transfusion
5574021|NCT00991328|PD|pd
5574022|NCT00991328|POCD|pocd
5574023|NCT00991328|Post-op Delirium (PD)|post-op delirium (pd)
5574024|NCT00991328|Post-op Cognitive Dysfunction (POCD)|post-op cognitive dysfunction (pocd)
5574025|NCT00991315|prostate cancer|prostate cancer
5574026|NCT00991302|Adherence|adherence
5574027|NCT00991302|Behavioral Intervention|behavioral intervention
5574028|NCT00991302|Antiretroviral Therapy|antiretroviral therapy
5574029|NCT00991302|ART|art
5574030|NCT00991302|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5574031|NCT00991302|HAART|haart
5574032|NCT00991302|Treatment experienced|treatment experienced
5574033|NCT00991289|Hepatitis C genotype 1|hepatitis c genotype 1
5574034|NCT00991289|HCV treatment naive|hcv treatment naive
5574035|NCT00991289|HCV/HIV coinfection|hcv/hiv coinfection
5574036|NCT00991289|Antiretroviral|antiretroviral
5574037|NCT00991289|Ribavirin|ribavirin
5574038|NCT00991289|Pegylated Interferon alfa|pegylated interferon alfa
5574039|NCT00991289|Nitazoxanide|nitazoxanide
5574040|NCT00991276|restless legs syndrome RLS polysomnography PSG sleep disturbance patient reported outcome|restless legs syndrome rls polysomnography psg sleep disturbance patient reported outcome
5574041|NCT00991263|stage II breast cancer|stage ii breast cancer
5574042|NCT00991263|stage IIIA breast cancer|stage iiia breast cancer
5574043|NCT00991250|Malignant melanoma|malignant melanoma
5574044|NCT00991237|NRS|nrs
5574045|NCT00991237|GPE|gpe
5574046|NCT00991237|pain reduction|pain reduction
5574047|NCT00991237|quality of life|quality of life
5574048|NCT00991224|HIV|hiv
5574049|NCT00991224|HIV therapeutic vaccine|hiv therapeutic vaccine
5574050|NCT00991211|Comparison|comparison
5574051|NCT00991211|Bendamustine + Rituximab|bendamustine + rituximab
5574052|NCT00991211|CHOP + Rituximab|chop + rituximab
5574053|NCT00991211|Progression free survival|progression free survival
5574054|NCT00991211|Overall survival|overall survival
5574055|NCT00991211|Toxicity|toxicity
5574056|NCT00991211|Safety|safety
5574057|NCT00991198|Topically dissolved oxygen|topically dissolved oxygen
5574058|NCT00991198|inflammatory cutaneous disease|inflammatory cutaneous disease
5574059|NCT00991198|rosacea|rosacea
5574060|NCT00991198|acne vulgaris|acne vulgaris
5574061|NCT00991198|atopic dermatitis|atopic dermatitis
5574062|NCT00991198|seborrheic dermatitis|seborrheic dermatitis
5574063|NCT00991198|photodamage|photodamage
5574064|NCT00991185|Infections in Children|infections in children
5574065|NCT00991172|sciatica|sciatica
5574066|NCT00991172|sciatic pain|sciatic pain
5574067|NCT00991172|pain|pain
5574068|NCT00991172|back pain|back pain
5685399|NCT00556231|anaerobic threshold|anaerobic threshold
5685400|NCT00556231|exercise stress|exercise stress
5574069|NCT00991159|Endocrinology; Hypercholesterolemia; Hyperlipidemia; Lipid Metabolism Disorders RN316 PF-04950615|endocrinology; hypercholesterolemia; hyperlipidemia; lipid metabolism disorders rn316 pf-04950615
5574070|NCT00991146|CAPS|caps
5574071|NCT00991146|FCAS|fcas
5574072|NCT00991146|MWS|mws
5574073|NCT00991146|NOMID|nomid
5574074|NCT00991146|cryopyrin-associated periodic syndromes|cryopyrin-associated periodic syndromes
5574075|NCT00991146|Familial Cold Autoinflammatory Syndrome|familial cold autoinflammatory syndrome
5574076|NCT00991146|Muckle-Wells Syndrome|muckle-wells syndrome
5574077|NCT00991146|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
5574078|NCT00991146|canakinumab|canakinumab
5574079|NCT00991146|ACZ885|acz885
5574080|NCT00991146|children|children
5574081|NCT00991146|systemic autoinflammatory disease|systemic autoinflammatory disease
5574082|NCT00991146|NALP-3|nalp-3
5574083|NCT00991146|human monoclonal anti-human interleukin-1beta (IL-1beta)antibody|human monoclonal anti-human interleukin-1beta (il-1beta)antibody
5574084|NCT00991146|autosomal dominant|autosomal dominant
5574085|NCT00991146|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5574086|NCT00991107|phase I|phase i
5574087|NCT00991107|safety|safety
5574088|NCT00991107|tolerance|tolerance
5574089|NCT00991107|insulin resistance|insulin resistance
5574090|NCT00991107|obese|obese
5574091|NCT00991094|Proton Therapy|proton therapy
5574092|NCT00991094|Proton Therapy Treatment Plan|proton therapy treatment plan
5574093|NCT00991094|Proton Dose Distributions|proton dose distributions
5574094|NCT00991094|Side Effects|side effects
5574095|NCT00991094|Symptoms|symptoms
5574096|NCT00991094|Normal Tissue Toxicity|normal tissue toxicity
5574097|NCT00991094|Dose Response Relationship|dose response relationship
5574098|NCT00991081|pharmacogenetics|pharmacogenetics
5574099|NCT00991081|genetic counseling|genetic counseling
5574100|NCT00991081|genetic feedback|genetic feedback
5574101|NCT00991081|nicotine replacement|nicotine replacement
5574102|NCT00991081|bupropion|bupropion
5574103|NCT00991081|smoking cessation|smoking cessation
5574104|NCT00991081|primary care|primary care
5574105|NCT00991081|telehealth|telehealth
5574107|NCT00991068|Pain|pain
5574108|NCT00991068|Mild to moderate Carpal Tunnel Syndrome|mild to moderate carpal tunnel syndrome
5574109|NCT00991042|Cytokines|cytokines
5574110|NCT00991042|Low back pain|low back pain
5574111|NCT00991042|Intervertebral disk displacement|intervertebral disk displacement
5574112|NCT00991042|Interleukins|interleukins
5574113|NCT00991042|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5574114|NCT00991029|Transient Ischemic Attack|transient ischemic attack
5574115|NCT00991029|TIA|tia
5574116|NCT00991029|minor stroke|minor stroke
5574117|NCT00991003|Colon Capsule Endoscopy|colon capsule endoscopy
5574118|NCT00991003|Colorectal Cancer|colorectal cancer
5574119|NCT00991003|Colonoscopy|colonoscopy
5574120|NCT00990990|Safety tolerability pharmacokinetics (PK) pharmacodynamics whole blood activity (WBA) PNU-100480 linezolid pyrazinamide multiple dose|safety tolerability pharmacokinetics (pk) pharmacodynamics whole blood activity (wba) pnu-100480 linezolid pyrazinamide multiple dose
5574121|NCT00990977|breast cancer|breast cancer
5574122|NCT00990977|supportive care|supportive care
5574123|NCT00990977|post-treatment|post-treatment
5574124|NCT00990977|intervention|intervention
5574125|NCT00990977|MBSR|mbsr
5574126|NCT00990977|mindfulness|mindfulness
5574127|NCT00990977|anxiety|anxiety
5574128|NCT00990977|depression|depression
5574129|NCT00990977|lifestyle|lifestyle
5574130|NCT00990977|diet|diet
5574131|NCT00990977|alcohol consumption|alcohol consumption
5574132|NCT00990977|smoking|smoking
5574133|NCT00990977|exercise|exercise
5574134|NCT00990977|spirituality|spirituality
5574135|NCT00990977|existential well-being|existential well-being
5574136|NCT00990977|physical symptoms|physical symptoms
5574137|NCT00990977|women|women
5574138|NCT00990925|Obesity|obesity
5574139|NCT00990925|Schizophrenia|schizophrenia
5574140|NCT00990925|Schizoaffective disorder|schizoaffective disorder
5574141|NCT00990925|weight loss|weight loss
5574142|NCT00990899|hypertension|hypertension
5574143|NCT00990899|obstructive sleep apnea|obstructive sleep apnea
5574144|NCT00990899|pediatrics|pediatrics
5574145|NCT00990886|Oxybutynin|oxybutynin
5574146|NCT00990886|Ditropan|ditropan
5574147|NCT00990886|Menopause Treatment|menopause treatment
5574148|NCT00990886|Vasomotor symptoms|vasomotor symptoms
5574149|NCT00990886|Hot Flashes|hot flashes
5574150|NCT00990886|Non-hormonal therapy for Vasomotor symptoms|non-hormonal therapy for vasomotor symptoms
5574151|NCT00990873|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5574152|NCT00990860|Combination of TACE With Sorafenib|combination of tace with sorafenib
5574153|NCT00990834|Statin|statin
5574154|NCT00990834|Myopathy|myopathy
5574155|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5574156|NCT00990834|Atrogin-1|atrogin-1
5574157|NCT00990795|open heart surgery|open heart surgery
5574158|NCT00990795|cyclosporine|cyclosporine
5574159|NCT00990795|myocardial protection|myocardial protection
5574160|NCT00990769|Emergence delirium|emergence delirium
5574161|NCT00990769|Bispectral Index|bispectral index
5574162|NCT00990769|Depth of anesthesia|depth of anesthesia
5574163|NCT00990743|Ocular hypertension|ocular hypertension
5574164|NCT00990743|Glaucoma|glaucoma
5574165|NCT00990743|Beta-blocker|beta-blocker
5574166|NCT00990730|rheumatoid arthritis|rheumatoid arthritis
5574167|NCT00990730|endothelial dysfunction|endothelial dysfunction
5574168|NCT00990730|lipoproteins|lipoproteins
5574169|NCT00990730|inflammation|inflammation
5574170|NCT00990730|oxidative stress|oxidative stress
5574171|NCT00990730|arterial stiffness|arterial stiffness
5574172|NCT00990717|natural killer cells|natural killer cells
5574173|NCT00990717|leukemia|leukemia
5574174|NCT00990717|lymphoma|lymphoma
5574175|NCT00990717|myeloma|myeloma
5574176|NCT00990717|Hodgkin's disease|hodgkin's disease
5574177|NCT00990717|cell therapy|cell therapy
5574178|NCT00990704|Secondary hyperparathyroidism|secondary hyperparathyroidism
5574179|NCT00990704|Hemodialysis|hemodialysis
5574180|NCT00990704|paricalcitol|paricalcitol
5574181|NCT00990704|maxacalcitol|maxacalcitol
5574182|NCT00990691|Rett syndrome|rett syndrome
5574183|NCT00990678|HIV-1|hiv-1
5574184|NCT00990678|humans|humans
5574185|NCT00990678|vitamin D|vitamin d
5574186|NCT00990678|1-hydroxy-vitamin D|1-hydroxy-vitamin d
5574187|NCT00990678|Rocaltrol|rocaltrol
5574188|NCT00990678|calcium|calcium
5574189|NCT00990678|complementary therapies|complementary therapies
5574190|NCT00990665|CRT|crt
5574191|NCT00990665|Heart Failure|heart failure
5574192|NCT00990665|LV Leads|lv leads
5574193|NCT00990652|brain tumor|brain tumor
5574194|NCT00990639|hepatic fibrosis|hepatic fibrosis
5574195|NCT00990639|angiotensin II blocking agents|angiotensin ii blocking agents
5574196|NCT00990639|alcoholic liver disease|alcoholic liver disease
5574197|NCT00990626|Seroquel XR|seroquel xr
5574198|NCT00990626|schizophrenia relapse prevention|schizophrenia relapse prevention
5574199|NCT00990613|percutaneous transcutaneous dimebon transdermal pharmacokinetics|percutaneous transcutaneous dimebon transdermal pharmacokinetics
5574200|NCT00990600|adherence|adherence
5574201|NCT00990600|Qol|qol
5574202|NCT00990600|virologic efficacy|virologic efficacy
5574204|NCT00990600|patients' preference|patients' preference
5574205|NCT00990600|once-daily|once-daily
5574206|NCT00990600|HAART|haart
5574207|NCT00990600|treatment experienced|treatment experienced
5574208|NCT00990587|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
5574209|NCT00990587|ALL (acute lymphoid leukemia)|all (acute lymphoid leukemia)
5574601|NCT00989092|Aranesp|aranesp
5574210|NCT00990587|CLL (chronic lymphoid leukemia)|cll (chronic lymphoid leukemia)
5574211|NCT00990587|High risk myelodysplasia (MDS) with an IPSS (International Prognostic Scoring System) score >2.5|high risk myelodysplasia (mds) with an ipss (international prognostic scoring system) score >2.5
5574212|NCT00990587|CML (chronic myelogenous leukemia) blast crisis|cml (chronic myelogenous leukemia) blast crisis
5574213|NCT00990587|Relapsed or refractory acute myeloid leukemia (AML)|relapsed or refractory acute myeloid leukemia (aml)
5574214|NCT00990548|Cardiac Caregivers|cardiac caregivers
5574215|NCT00990548|Cardiac Patient Clinical Outcomes|cardiac patient clinical outcomes
5574216|NCT00990548|Prevention of CVD|prevention of cvd
5574217|NCT00990535|neuroendocrine tumors|neuroendocrine tumors
5574218|NCT00990535|octreotide|octreotide
5574219|NCT00990535|somatostatin analogues|somatostatin analogues
5574220|NCT00990522|sharp debridment|sharp debridment
5574221|NCT00990522|patients with full thickness wounds of greater than 30 days duration|patients with full thickness wounds of greater than 30 days duration
5574222|NCT00990509|Primary ICH|primary ich
5574223|NCT00990509|Albumin|albumin
5574225|NCT00990509|Neuroimaging outcome|neuroimaging outcome
5574226|NCT00990509|Placebo-controlled|placebo-controlled
5574228|NCT00990509|Blinded|blinded
5574229|NCT00990509|Safety|safety
5574230|NCT00990509|Acute ICH|acute ich
5574231|NCT00990509|ICH|ich
5574232|NCT00990509|Primary acute (< 48 hours) supratentorial ICH|primary acute (< 48 hours) supratentorial ich
5574233|NCT00990496|Glioblastoma multiforme|glioblastoma multiforme
5574234|NCT00990496|GBM|gbm
5574235|NCT00990496|Cytomegalovirus|cytomegalovirus
5574236|NCT00990496|CMV|cmv
5574237|NCT00990496|Cytotoxic T lymphocyte|cytotoxic t lymphocyte
5574238|NCT00990496|CTL|ctl
5574239|NCT00990470|Transplantation|transplantation
5574240|NCT00990470|Liver|liver
5574241|NCT00990470|Endoscopy|endoscopy
5574242|NCT00990470|Colonoscopy|colonoscopy
5574243|NCT00990470|Gastroscopy|gastroscopy
5574244|NCT00990457|Exercise|exercise
5574245|NCT00990457|Weight loss diet|weight loss diet
5574246|NCT00990457|Obesity|obesity
5574247|NCT00990457|Overweight|overweight
5574248|NCT00990457|Abdominal obesity|abdominal obesity
5574249|NCT00990457|Cardiovascular function|cardiovascular function
5574250|NCT00990457|Body composition|body composition
5574251|NCT00990444|blood glucose|blood glucose
5574252|NCT00990444|blood insulin|blood insulin
5574253|NCT00990444|dextran|dextran
5574254|NCT00990444|diabetes|diabetes
5574255|NCT00990444|hyperglycemia|hyperglycemia
5574256|NCT00990444|hypoglycemia|hypoglycemia
5574257|NCT00990444|oral delivery|oral delivery
5574258|NCT00990444|portal delivery|portal delivery
5574259|NCT00990431|skin aging|skin aging
5574260|NCT00990431|laser surgery|laser surgery
5574261|NCT00990431|fractional photothermolysis|fractional photothermolysis
5574262|NCT00990431|comparative study|comparative study
5574263|NCT00990431|Ablative fractional treatment of peri-orbital rhytides|ablative fractional treatment of peri-orbital rhytides
5574264|NCT00990418|Postoperative pain|postoperative pain
5574265|NCT00990418|E-TRANS System, fentanyl HCl System|e-trans system, fentanyl hcl system
5574266|NCT00990418|E-TRANSS (fentanyl HCl) System|e-transs (fentanyl hcl) system
5574267|NCT00990418|Acute postoperative pain|acute postoperative pain
5574268|NCT00990405|Rome III criteria|rome iii criteria
5574269|NCT00990392|Blood stream infections|blood stream infections
5574270|NCT00990392|Catheter related infections|catheter related infections
5574271|NCT00990392|Central venous catheter related infections|central venous catheter related infections
5574272|NCT00990392|Line sepsis|line sepsis
5574273|NCT00990392|Topical antibiotics|topical antibiotics
5574274|NCT00990392|Bacitracin|bacitracin
5574275|NCT00990392|Polymixin|polymixin
5574276|NCT00990392|Gramicidin|gramicidin
5574277|NCT00990392|Polysporin Triple Therapy|polysporin triple therapy
5574278|NCT00990392|Intensive care unit|intensive care unit
5574279|NCT00990379|HIV|hiv
5574280|NCT00990379|brain diseases|brain diseases
5574281|NCT00990379|spinal fluid|spinal fluid
5574282|NCT00990379|HIV positive|hiv positive
5574283|NCT00990366|antireflux valve|antireflux valve
5574284|NCT00990366|biliary obstruction|biliary obstruction
5574285|NCT00990366|cholangitis|cholangitis
5574286|NCT00990366|biliary stent|biliary stent
5574287|NCT00990353|Spatial neglect|spatial neglect
5574288|NCT00990353|hemineglect|hemineglect
5574289|NCT00990353|stroke|stroke
5574290|NCT00990353|cognition|cognition
5574291|NCT00990353|prism adaptation|prism adaptation
5574292|NCT00990353|Hierarchical linear modeling|hierarchical linear modeling
5574293|NCT00990353|growth curve modeling|growth curve modeling
5574294|NCT00990327|Coronary artery disease|coronary artery disease
5574295|NCT00990327|Myocardial Perfusion Imaging|myocardial perfusion imaging
5574296|NCT00990301|Healthy Subjects|healthy subjects
5574297|NCT00990301|Bioequivalence|bioequivalence
5574298|NCT00990288|To decrease blood loss during knee surgery|to decrease blood loss during knee surgery
5574299|NCT00990262|acute chest pain|acute chest pain
5574300|NCT00990262|emergency department|emergency department
5574301|NCT00990262|cardiac computed tomography|cardiac computed tomography
5574302|NCT00990249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5574304|NCT00990249|Acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
5574305|NCT00990249|acute biphenotypic leukemia|acute biphenotypic leukemia
5574306|NCT00990249|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5574308|NCT00990249|Stem Cell Transplant|stem cell transplant
5574309|NCT00990249|Treatment-related mortality|treatment-related mortality
5574310|NCT00990249|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5574311|NCT00990249|TKI|tki
5574312|NCT00990249|Busulfan|busulfan
5574313|NCT00990249|Busulfex|busulfex
5574314|NCT00990249|Myleran|myleran
5574315|NCT00990249|Clofarabine|clofarabine
5574316|NCT00990249|Clolar|clolar
5574317|NCT00990249|Clofarex|clofarex
5574318|NCT00990249|Gleevec|gleevec
5574319|NCT00990249|Imatinib Mesylate|imatinib mesylate
5574320|NCT00990236|deep vein thrombosis|deep vein thrombosis
5574321|NCT00990236|superficial venous thrombosis|superficial venous thrombosis
5574322|NCT00990236|pulmonary embolus|pulmonary embolus
5576884|NCT00980382|S-1|s-1
5574325|NCT00990197|Randomized clinical trial|randomized clinical trial
5574326|NCT00990197|Smoking cessation|smoking cessation
5574327|NCT00990197|Acute coronary syndrome|acute coronary syndrome
5574328|NCT00990197|Transdermal nicotine patch|transdermal nicotine patch
5574329|NCT00990184|Impaired Fasting Glucose|impaired fasting glucose
5574330|NCT00990184|PreDiabetes|prediabetes
5574331|NCT00990171|peritoneal Dialysis|peritoneal dialysis
5574332|NCT00990171|wasting and malnutrition|wasting and malnutrition
5574333|NCT00990171|nutrition status|nutrition status
5574334|NCT00990171|bioelectrical impedance analysis|bioelectrical impedance analysis
5556432|NCT01060709|TcC02|tcc02
5574335|NCT00990171|body composition|body composition
5574336|NCT00990158|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
5574337|NCT00990158|Randomized controlled trial|randomized controlled trial
5574338|NCT00990158|Warfarin|warfarin
5574339|NCT00990158|Coagulopathy|coagulopathy
5574340|NCT00990158|Time in therapeutic range|time in therapeutic range
5574341|NCT00990158|Bleeding|bleeding
5574342|NCT00990158|Thrombosis|thrombosis
5574343|NCT00990158|VKORC1 and CYP2C9 genotypes|vkorc1 and cyp2c9 genotypes
5574344|NCT00990158|Time INR in therapeutic range|time inr in therapeutic range
5574345|NCT00990132|COPD|copd
5574346|NCT00990132|Respiratory failure|respiratory failure
5574347|NCT00990132|Non-invasive ventilation|non-invasive ventilation
5574348|NCT00990132|Home mechanical ventilation|home mechanical ventilation
5574349|NCT00990119|high flow therapy|high flow therapy
5574350|NCT00990119|high flow nasal cannula|high flow nasal cannula
5685401|NCT00556231|congenital heart defect|congenital heart defect
5574351|NCT00990119|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5574352|NCT00990119|respiratory insufficiency|respiratory insufficiency
5574353|NCT00990106|posttraumatic stress disorder|posttraumatic stress disorder
5574354|NCT00990106|PTSD|ptsd
5574355|NCT00990106|nightmares|nightmares
5574356|NCT00990106|prazosin|prazosin
5574357|NCT00990106|sleep disturbance|sleep disturbance
5574358|NCT00990106|combat trauma|combat trauma
5574359|NCT00990067|MDMA|mdma
5574360|NCT00990067|serotonin|serotonin
5574361|NCT00990067|norepinephrine|norepinephrine
5574362|NCT00990067|Ecstasy|ecstasy
5574363|NCT00990067|stimulant|stimulant
5574364|NCT00990054|Cytarabine,|cytarabine,
5574365|NCT00990054|Daunorubicin,|daunorubicin,
5574366|NCT00990054|De Novo,|de novo,
5574367|NCT00990054|Acute Myeloid Leukemia,|acute myeloid leukemia,
5574368|NCT00990054|AML|aml
5574369|NCT00990041|periodontitis|periodontitis
5574370|NCT00990041|find cytokines in blood of periodontal patients|find cytokines in blood of periodontal patients
5574371|NCT00990028|moderate head injury|moderate head injury
5574372|NCT00990028|rosuvastatin|rosuvastatin
5574373|NCT00990028|statin|statin
5574374|NCT00990028|amnesia|amnesia
5574375|NCT00990028|orientation|orientation
5574376|NCT00990015|Safety; tolerability; pharmacokinetics/pharmacodynamics|safety; tolerability; pharmacokinetics/pharmacodynamics
5574377|NCT00989989|DME|dme
5574378|NCT00989989|Diabetic|diabetic
5574379|NCT00989989|macula|macula
5574380|NCT00989989|edema|edema
5574381|NCT00989989|ranibizumab|ranibizumab
5574382|NCT00989989|REVEAL|reveal
5574383|NCT00989976|Sleep|sleep
5574384|NCT00989976|Diabetes Risk|diabetes risk
5574385|NCT00989963|PAH|pah
5574386|NCT00989950|daytrana|daytrana
5574387|NCT00989950|sleep latency|sleep latency
5574388|NCT00989950|adhd rating scales|adhd rating scales
5574389|NCT00989950|ADHD|adhd
5574390|NCT00989937|oxytocin|oxytocin
5574391|NCT00989924|Diabetes mellitus|diabetes mellitus
5574392|NCT00989924|Coronary heart disease|coronary heart disease
5574393|NCT00989924|Magnetocardiography|magnetocardiography
5574394|NCT00989911|Single ventricle congenital heart disease|single ventricle congenital heart disease
5574395|NCT00989898|T1D, closed-loop systems, overnight hypoglycaemia|t1d, closed-loop systems, overnight hypoglycaemia
5568432|NCT01012856|RCT|rct
5574396|NCT00989885|Evaluation|evaluation
5574397|NCT00989885|Obstructive sleep apnea|obstructive sleep apnea
5574398|NCT00989885|Polysomnography|polysomnography
5574399|NCT00989872|Macrolides|macrolides
5574400|NCT00989872|Antibiotics|antibiotics
5574402|NCT00989872|Tolerability|tolerability
5574403|NCT00989872|Pharmacokinetics|pharmacokinetics
5574404|NCT00989872|Phase I|phase i
5574405|NCT00989872|MRSA/SSTI|mrsa/ssti
5574406|NCT00989859|monitoring|monitoring
5574407|NCT00989846|biomarker|biomarker
5574408|NCT00989846|lung disease|lung disease
5574409|NCT00989833|Exercise induced asthma|exercise induced asthma
5574410|NCT00989833|Mild intermittent asthma|mild intermittent asthma
5574411|NCT00989833|Exercise induced bronchoconstriction|exercise induced bronchoconstriction
5574412|NCT00989820|osteoradionecrosis|osteoradionecrosis
5574413|NCT00989820|mandible|mandible
5574414|NCT00989820|radiotherapy|radiotherapy
5574415|NCT00989820|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5574416|NCT00989807|CF|cf
5576986|NCT00980018|CML|cml
5574417|NCT00989807|Cystic fibrosis|cystic fibrosis
5006020|NCT03958929|glaucoma surgery|glaucoma surgery
5574418|NCT00989807|Pseudomonas aeruginosa|pseudomonas aeruginosa
5574420|NCT00989807|Expanded access|expanded access
5574421|NCT00989807|AZLI|azli
5574422|NCT00989807|Aztreonam lysine|aztreonam lysine
5574423|NCT00989794|cartilage|cartilage
5574424|NCT00989794|implantation|implantation
5574425|NCT00989794|chondrocyte|chondrocyte
5574426|NCT00989794|condyle|condyle
5574427|NCT00989781|PCOS, Androgens, ovary, polycystic|pcos, androgens, ovary, polycystic
5574428|NCT00989768|Botulinum toxin type A|botulinum toxin type a
5574429|NCT00989768|field effects|field effects
5574430|NCT00989768|dose-equivalence|dose-equivalence
5574431|NCT00989768|anhydrotic action halos|anhydrotic action halos
5574432|NCT00989755|Tobacco dependence treatment in primary health care setting|tobacco dependence treatment in primary health care setting
5574433|NCT00989755|Fax to Quit|fax to quit
5574434|NCT00989755|Fax to Quit plus Enhanced Academic Detailing|fax to quit plus enhanced academic detailing
5574435|NCT00989755|Fax referral|fax referral
5574436|NCT00989755|Quitline|quitline
5574437|NCT00989742|lymphangioleiomatosis|lymphangioleiomatosis
5574438|NCT00989742|LAM|lam
5574439|NCT00989742|tuberous sclerosis|tuberous sclerosis
5574440|NCT00989742|doxycycline|doxycycline
5574441|NCT00989742|matrix metalloproteinases|matrix metalloproteinases
5574442|NCT00989742|MMP|mmp
5574443|NCT00989729|Endovascular Aortic Repair|endovascular aortic repair
5574444|NCT00989729|Methylprednisolone|methylprednisolone
5574445|NCT00989729|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5574446|NCT00989703|Safety|safety
5574447|NCT00989703|Tolerability|tolerability
5574448|NCT00989703|Pharmacokinetics|pharmacokinetics
5574449|NCT00989690|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5574450|NCT00989690|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5574451|NCT00989690|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5574452|NCT00989664|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5574453|NCT00989664|radioimmunotherapy|radioimmunotherapy
5574455|NCT00989664|Bexxar|bexxar
5574456|NCT00989664|lymphoma|lymphoma
5574457|NCT00989664|Tositumomab|tositumomab
5574458|NCT00989625|migraine|migraine
5574459|NCT00989625|single dose|single dose
5574460|NCT00989625|healthy volunteer|healthy volunteer
5574461|NCT00989625|adolescence|adolescence
5574462|NCT00989625|pharmacokinetics|pharmacokinetics
5574463|NCT00989612|influenza infection|influenza infection
5574589|NCT00989157|Pharmacokinetics|pharmacokinetics
5574464|NCT00989612|GSK Biologicals' influenza vaccine GSK2340272A|gsk biologicals' influenza vaccine gsk2340272a
5574465|NCT00989599|phlebitis|phlebitis
5574466|NCT00989599|Chamomilla recutita|chamomilla recutita
5574467|NCT00989599|Catheterization peripheral|catheterization peripheral
5574468|NCT00989586|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5574469|NCT00989586|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5574470|NCT00989586|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5574471|NCT00989586|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5574472|NCT00989586|MALT lymphoma|malt lymphoma
5574473|NCT00989586|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5574474|NCT00989586|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5574475|NCT00989586|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5574476|NCT00989586|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5574477|NCT00989534|shift work|shift work
5574478|NCT00989534|diabetes|diabetes
5574479|NCT00989534|Affects of shift work and sleep loss on health|affects of shift work and sleep loss on health
5574480|NCT00989521|Asthma|asthma
5574481|NCT00989521|bronchial diseases|bronchial diseases
5574482|NCT00989521|lung diseases|lung diseases
5574483|NCT00989521|bronchitis|bronchitis
5574484|NCT00989521|respiratory tract diseases|respiratory tract diseases
5574485|NCT00989508|Perhexiline|perhexiline
5574486|NCT00989508|Aortic Valve Stenosis|aortic valve stenosis
5574487|NCT00989508|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5574488|NCT00989508|Myocardial Reperfusion Injury|myocardial reperfusion injury
5574489|NCT00989508|Cardiac Output, Low|cardiac output, low
5574492|NCT00989456|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5574493|NCT00989456|Heart failure|heart failure
5574494|NCT00989456|Stroke|stroke
5574495|NCT00989456|quality of life|quality of life
5574496|NCT00989456|self management education|self management education
5574497|NCT00989456|physical exercise|physical exercise
5574498|NCT00989456|primary health care|primary health care
5574499|NCT00989443|Cervix Intraepithelial Neoplasia grades 2 and 3|cervix intraepithelial neoplasia grades 2 and 3
5574500|NCT00989430|stroke|stroke
5574501|NCT00989430|CVA|cva
5574502|NCT00989430|cerebrovascular accident|cerebrovascular accident
5574503|NCT00989430|rehabilitation|rehabilitation
5574504|NCT00989417|Remote monitoring|remote monitoring
5574505|NCT00989417|Defibrillators, Implantable|defibrillators, implantable
5574506|NCT00989417|Home monitoring|home monitoring
5574507|NCT00989417|Shock|shock
5680326|NCT00578201|Esophageal neoplasms|esophageal neoplasms
5574508|NCT00989417|Implantable cardioverter-defibrillator Therapy|implantable cardioverter-defibrillator therapy
5574511|NCT00989404|influenza virus|influenza virus
5574512|NCT00989404|Safety|safety
5574513|NCT00989404|pandemic|pandemic
5574514|NCT00989391|Phase 1 multiple dose safety toleration pharmacokinetic|phase 1 multiple dose safety toleration pharmacokinetic
5574515|NCT00989378|sleep|sleep
5574516|NCT00989378|insulin|insulin
5574517|NCT00989378|diabetes|diabetes
5574518|NCT00989378|determine association between sleep characteristics and diabetes risk|determine association between sleep characteristics and diabetes risk
5574519|NCT00989365|Aerobic Exercise|aerobic exercise
5574520|NCT00989365|Exercise|exercise
5574521|NCT00989352|PCNSL|pcnsl
5574522|NCT00989352|Lymphoma|lymphoma
5574523|NCT00989352|Methotrexate|methotrexate
5574524|NCT00989352|Lomustine|lomustine
5574525|NCT00989352|Procarbazine|procarbazine
5574526|NCT00989352|Rituximab|rituximab
5574527|NCT00989352|Elderly|elderly
5574528|NCT00989352|Chemotherapy|chemotherapy
5574529|NCT00989339|lipid emulsion|lipid emulsion
5574530|NCT00989339|endothelial function|endothelial function
5574531|NCT00989339|inflammatory markers|inflammatory markers
5574532|NCT00989339|oxidative stress|oxidative stress
5574533|NCT00989339|insulin sensitivity|insulin sensitivity
5574534|NCT00989339|carbohydrate metabolism|carbohydrate metabolism
5574535|NCT00989326|Remote monitoring|remote monitoring
5574536|NCT00989326|Pacemaker|pacemaker
5574537|NCT00989326|Follow up|follow up
5574538|NCT00989326|Follow-up studies|follow-up studies
5574539|NCT00989313|Peplin|peplin
5574540|NCT00989313|Actinic keratosis|actinic keratosis
5574541|NCT00989313|PEP005|pep005
5574542|NCT00989300|Drug-Drug interaction|drug-drug interaction
5574544|NCT00989300|Rabeprazol|rabeprazol
5574545|NCT00989300|Omeprazol|omeprazol
5574546|NCT00989300|Pharmacodynamic Study|pharmacodynamic study
5574547|NCT00989287|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5574548|NCT00989287|influenza infection|influenza infection
5574549|NCT00989274|Influenza|influenza
5574550|NCT00989274|Vaccination|vaccination
5574551|NCT00989274|Immunology|immunology
5574552|NCT00989274|Immunogenicity|immunogenicity
5574553|NCT00989274|Reactogenicity|reactogenicity
5574554|NCT00989274|Safety|safety
5574555|NCT00989274|Influenza vaccine|influenza vaccine
5574556|NCT00989274|Immune response|immune response
5574557|NCT00989274|Adverse effects|adverse effects
5574558|NCT00989261|AML|aml
5574559|NCT00989261|AC220|ac220
5574560|NCT00989261|acute|acute
5574561|NCT00989261|FLT3|flt3
5574562|NCT00989261|inhibitor|inhibitor
5574563|NCT00989261|kinase|kinase
5574564|NCT00989261|leukemia|leukemia
5574565|NCT00989261|leukaemia|leukaemia
5574566|NCT00989261|myeloid|myeloid
5574567|NCT00989261|relapsed|relapsed
5574568|NCT00989261|refractory|refractory
5574569|NCT00989248|Ergospirometry|ergospirometry
5574570|NCT00989248|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5574571|NCT00989248|Exercises|exercises
5574572|NCT00989248|Immersion|immersion
5574573|NCT00989235|NOS|nos
5574574|NCT00989222|Distal radius fractures|distal radius fractures
5574575|NCT00989222|Fractures of the distal radius|fractures of the distal radius
5574576|NCT00989222|Volar plate|volar plate
5574577|NCT00989222|External fixation|external fixation
5574578|NCT00989209|facial paralysis|facial paralysis
5574579|NCT00989209|asymmetry|asymmetry
5574580|NCT00989209|myofunctional therapy|myofunctional therapy
5574581|NCT00989209|botulinum toxin|botulinum toxin
5574582|NCT00989209|facial evaluation|facial evaluation
5574583|NCT00989183|Ovaries|ovaries
5574584|NCT00989183|Reproductive Age|reproductive age
5574585|NCT00989183|Oophorectomy|oophorectomy
5574586|NCT00989157|Gastric Bypass|gastric bypass
5574587|NCT00989157|Duloxetine|duloxetine
5574588|NCT00989157|Cymbalta|cymbalta
5574590|NCT00989144|HIV seronegative|hiv seronegative
5574591|NCT00989144|acute infection|acute infection
5574592|NCT00989131|Ovarian Cancer|ovarian cancer
5574593|NCT00989105|stage I prostate cancer|stage i prostate cancer
5568619|NCT01011998|CML|cml
5574594|NCT00989105|stage IIB prostate cancer|stage iib prostate cancer
5574595|NCT00989105|stage IIA prostate cancer|stage iia prostate cancer
5574596|NCT00989105|stage III prostate cancer|stage iii prostate cancer
5574597|NCT00989105|stage IV prostate cancer|stage iv prostate cancer
5574598|NCT00989105|recurrent prostate cancer|recurrent prostate cancer
5574600|NCT00989092|darbepoetin alfa|darbepoetin alfa
5574602|NCT00989079|Single Ascending Dose Study in healthy subjects|single ascending dose study in healthy subjects
5574603|NCT00989066|Xience V|xience v
5574604|NCT00989066|stent|stent
5574605|NCT00989066|coronary disease|coronary disease
5574606|NCT00989053|depression|depression
5574607|NCT00989053|anxiety|anxiety
5574608|NCT00989053|stress|stress
5574609|NCT00989053|antidepressant therapy|antidepressant therapy
5574610|NCT00989053|SSRI|ssri
5574611|NCT00989053|infertility|infertility
5574612|NCT00989053|in vitro fertilization (IVF)|in vitro fertilization (ivf)
5574613|NCT00989053|immunological factors|immunological factors
5798733|NCT00111241|breast cancer|breast cancer
5574614|NCT00989053|depressive and anxiety symptoms in women undergoing IVF treatment|depressive and anxiety symptoms in women undergoing ivf treatment
5574617|NCT00989027|Uterine contraction|uterine contraction
5574618|NCT00989027|Dose-response|dose-response
5574619|NCT00989027|Oxytocin pre-treatment|oxytocin pre-treatment
5574620|NCT00989014|Erythematotelangiectatic|erythematotelangiectatic
5574621|NCT00989014|Rosacea|rosacea
5574622|NCT00989001|Atrial Fibrillation|atrial fibrillation
5574623|NCT00989001|RSD1235|rsd1235
5574624|NCT00989001|Vernakalant|vernakalant
5574625|NCT00989001|conversion|conversion
5574626|NCT00988988|Multiple Sclerosis|multiple sclerosis
5574627|NCT00988988|AGEE|agee
5574628|NCT00988988|histamine response|histamine response
5574629|NCT00988962|pain|pain
5574630|NCT00988962|opioids|opioids
5574631|NCT00988949|Proof of mechanism study|proof of mechanism study
5574632|NCT00988936|[F-18]RGD-K5|[f-18]rgd-k5
5574633|NCT00988936|RGD-K5|rgd-k5
5574634|NCT00988936|K5-101|k5-101
5574635|NCT00988936|Avastin|avastin
5574636|NCT00988936|angiogenesis|angiogenesis
5574637|NCT00988936|anti-angiogenesis|anti-angiogenesis
5574638|NCT00988936|chemotherapy|chemotherapy
5574639|NCT00988936|breast cancer|breast cancer
5574640|NCT00988936|colon cancer|colon cancer
5574641|NCT00988936|rectal cancer|rectal cancer
5574642|NCT00988936|lung cancer|lung cancer
5574643|NCT00988936|non-squamous|non-squamous
5574644|NCT00988936|non small cell|non small cell
5574645|NCT00988910|Combined Oral Contraceptives|combined oral contraceptives
5574646|NCT00988910|COC|coc
5685402|NCT00556218|Breast Cancer|breast cancer
5574647|NCT00988871|PICC (peripherally inserted central venous catheter)|picc (peripherally inserted central venous catheter)
5574648|NCT00988871|CICC (centrally inserted central venous catheter|cicc (centrally inserted central venous catheter
5574649|NCT00988871|CVP (central venous pressure)|cvp (central venous pressure)
5574650|NCT00988871|LT (liver transplantation)|lt (liver transplantation)
5574651|NCT00988871|agreement|agreement
5574652|NCT00988845|dietary supplement|dietary supplement
5574653|NCT00988845|indole 3 carbinol|indole 3 carbinol
5574654|NCT00988845|estrogen|estrogen
5574655|NCT00988806|Advanced heart failure|advanced heart failure
5574656|NCT00988806|Levosimendan|levosimendan
5574657|NCT00988806|Intermittent long-term infusions|intermittent long-term infusions
5574658|NCT00988780|Immune reconstitution inflammatory syndrome|immune reconstitution inflammatory syndrome
5574659|NCT00988780|CCR5 antagonist|ccr5 antagonist
5574660|NCT00988780|Maraviroc|maraviroc
5574661|NCT00988780|HIV|hiv
5574662|NCT00988780|treatment naive|treatment naive
5574663|NCT00988767|Hepatitis B|hepatitis b
5574664|NCT00988767|DNA vaccine|dna vaccine
5574665|NCT00988767|immunotherapy|immunotherapy
5574666|NCT00988754|Obesity|obesity
5574667|NCT00988754|childhood and adolescence|childhood and adolescence
5574668|NCT00988754|school and family-based lifestyle intervention|school and family-based lifestyle intervention
5574669|NCT00988754|cardiovascular risk|cardiovascular risk
5574670|NCT00988754|Obesity and associated cardiovascular risk in childhood and adolescence,|obesity and associated cardiovascular risk in childhood and adolescence,
5574671|NCT00988754|health behaviour|health behaviour
5574672|NCT00988741|Unresectable|unresectable
5574673|NCT00988741|Hepatocellular|hepatocellular
5574674|NCT00988741|Carcinoma|carcinoma
5574675|NCT00988702|Dan Tian Breathing|dan tian breathing
5574676|NCT00988702|Physiological measurement|physiological measurement
5574677|NCT00988702|progressive muscle relaxation|progressive muscle relaxation
5574678|NCT00988702|Monitoring, Physiologic|monitoring, physiologic
5574679|NCT00988689|starch|starch
5574680|NCT00988689|carbohydrates|carbohydrates
5574681|NCT00988689|blood glucose|blood glucose
5574682|NCT00988689|food intake|food intake
5574683|NCT00988689|satiety|satiety
5574684|NCT00988689|appetite|appetite
5574685|NCT00988663|electroconvulsive therapy|electroconvulsive therapy
5574686|NCT00988663|memantine|memantine
5574687|NCT00988663|cognitive function|cognitive function
5574688|NCT00988663|memory|memory
5574689|NCT00988650|Metabolic syndrome|metabolic syndrome
5574690|NCT00988650|Mediterranean diet|mediterranean diet
5574691|NCT00988650|Blood lipids|blood lipids
5574693|NCT00988650|Apolipoprotein|apolipoprotein
5574694|NCT00988624|bioavailability pharmacokinetics Alzheimer's Disease Huntington Disease|bioavailability pharmacokinetics alzheimer's disease huntington disease
5574695|NCT00988611|Reproductive aging|reproductive aging
5574696|NCT00988598|phase 1 Alzheimer's disease donepezil|phase 1 alzheimer's disease donepezil
5574697|NCT00988585|Heart Disease Risk Reduction|heart disease risk reduction
5574698|NCT00988572|Wrist fractures|wrist fractures
5574699|NCT00988572|Vestibular asymmetry|vestibular asymmetry
5574700|NCT00988572|Vestibular rehabilitation|vestibular rehabilitation
5574701|NCT00988572|Fall-related wrist fractures|fall-related wrist fractures
5574702|NCT00988572|Patients 50 years or older|patients 50 years or older
5574703|NCT00988559|high grade cervical dysplasia|high grade cervical dysplasia
5574704|NCT00988559|treatment vaccine|treatment vaccine
5574705|NCT00988559|therapeutic|therapeutic
5574707|NCT00988559|DNA vaccine|dna vaccine
5574708|NCT00988559|gene therapy|gene therapy
5574709|NCT00988559|gene gun|gene gun
5574715|NCT00988533|Pediculus|pediculus
5574716|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents
5574717|NCT00988481|Bulimia Nervosa|bulimia nervosa
5574718|NCT00988481|Topiramate|topiramate
5574719|NCT00988481|Augmentation|augmentation
5574720|NCT00988468|Knee Osteoarthritis|knee osteoarthritis
5574721|NCT00988468|Manual Therapy|manual therapy
5574722|NCT00988468|Therapeutic Exercise|therapeutic exercise
5574723|NCT00988468|Ultrasound|ultrasound
5574724|NCT00988468|Effusion|effusion
5574725|NCT00988455|basal cell carcinoma|basal cell carcinoma
5574726|NCT00988455|photodynamic therapy|photodynamic therapy
5574727|NCT00988455|photo chemotherapy|photo chemotherapy
5574728|NCT00988455|basal cell epithelioma|basal cell epithelioma
5574729|NCT00988442|Adherence|adherence
5574730|NCT00988442|Treatment|treatment
5574731|NCT00988442|Adherence Intervention|adherence intervention
5574732|NCT00988442|Telephone Intervention|telephone intervention
5574733|NCT00988442|treatment experienced|treatment experienced
5574734|NCT00988429|Refractory|refractory
5574736|NCT00988429|epilepsy|epilepsy
5574737|NCT00988429|efficacy|efficacy
5574738|NCT00988429|eslicarbazepine|eslicarbazepine
5574739|NCT00988429|safety|safety
5574740|NCT00988416|IPMN|ipmn
5574741|NCT00988390|mothers living with HIV|mothers living with hiv
5574742|NCT00988390|family intervention|family intervention
5574743|NCT00988390|family functioning|family functioning
5574744|NCT00988390|conflict|conflict
5574745|NCT00988390|Mental health|mental health
5574746|NCT00988390|and physical health|and physical health
5685403|NCT00556218|Tibetan Meditation|tibetan meditation
5574747|NCT00988390|Family relationships (functioning and conflict)|family relationships (functioning and conflict)
5574748|NCT00988377|whey protein|whey protein
5574749|NCT00988377|subjective appetite|subjective appetite
5574750|NCT00988377|shor-term food intake|shor-term food intake
5574752|NCT00988364|Metabolic Syndrome|metabolic syndrome
5574753|NCT00988364|LDL subfraction L5|ldl subfraction l5
5574754|NCT00988364|The reduction of LDL Chol in patients with Metabolic Syndrome|the reduction of ldl chol in patients with metabolic syndrome
5574755|NCT00988364|The prevalence of L5 in patients with Metabolic Syndrome|the prevalence of l5 in patients with metabolic syndrome
5574756|NCT00988364|The reduction of L5 subfraction in patients with Metabolic Syndrome|the reduction of l5 subfraction in patients with metabolic syndrome
5574757|NCT00988351|sleep apnea|sleep apnea
5574758|NCT00988351|positive airway pressure|positive airway pressure
5574759|NCT00988351|portable monitoring|portable monitoring
5574760|NCT00988351|auto positive airway pressure|auto positive airway pressure
5574761|NCT00988338|Trinity Evolution|trinity evolution
5574762|NCT00988338|Arthrodesis|arthrodesis
5574763|NCT00988338|Foot Fusion|foot fusion
5574764|NCT00988338|Ankle Fusion|ankle fusion
5574765|NCT00988338|Allograft|allograft
5574766|NCT00988312|dendritic cells (DC)|dendritic cells (dc)
5574767|NCT00988312|idiotype (Id)|idiotype (id)
5574768|NCT00988312|immunotherapy|immunotherapy
5574769|NCT00988299|older|older
5574770|NCT00988299|NEAT|neat
5574771|NCT00988299|exercise|exercise
5574772|NCT00988299|RMR|rmr
5574773|NCT00988299|energy expenditure|energy expenditure
5574774|NCT00988273|Crohn's disease|crohn's disease
5574775|NCT00988273|Ulcerative colitis|ulcerative colitis
5574776|NCT00988273|dysplasia|dysplasia
5574777|NCT00988247|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
5574778|NCT00988247|BDP-HFA|bdp-hfa
5574779|NCT00988247|Hay fever|hay fever
5574780|NCT00988247|Allergic rhinitis|allergic rhinitis
5574781|NCT00988234|Lumbar plexus block|lumbar plexus block
5574782|NCT00988234|sciatic nerve block|sciatic nerve block
5574783|NCT00988234|position|position
5574784|NCT00988234|ultrasound guidance|ultrasound guidance
5574785|NCT00988234|elective lower limb surgery|elective lower limb surgery
5574786|NCT00988208|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5574787|NCT00988208|Revlimid|revlimid
5574788|NCT00988208|Lenalidomide|lenalidomide
5574789|NCT00988195|Neoplasm|neoplasm
5574790|NCT00988195|Hepatocellular Carcinoma|hepatocellular carcinoma
5574791|NCT00988182|Whey protein|whey protein
5574793|NCT00988182|Blood glucose|blood glucose
5574794|NCT00988182|Insulin|insulin
5574795|NCT00988169|AT-101|at-101
5574796|NCT00988169|erlotinib|erlotinib
5574797|NCT00988169|Unresectable Stage IIIB|unresectable stage iiib
5574798|NCT00988169|09-026|09-026
5574799|NCT00988156|Epilepsy|epilepsy
5574800|NCT00988156|Partial|partial
5574801|NCT00988156|Refractory|refractory
5574802|NCT00988156|Children|children
5574803|NCT00988156|Adolescents|adolescents
5574804|NCT00988156|Adjunctive|adjunctive
5574805|NCT00988156|Randomised|randomised
5577386|NCT00978484|Combat|combat
5574810|NCT00988143|Trivalent Influenza Virus Vaccine|trivalent influenza virus vaccine
5574811|NCT00988143|Quadrivalent Influenza Virus Vaccine|quadrivalent influenza virus vaccine
5574813|NCT00988130|stage I prostate cancer|stage i prostate cancer
5574814|NCT00988130|stage IIB prostate cancer|stage iib prostate cancer
5680327|NCT00578201|Cetuximab|cetuximab
5574815|NCT00988130|stage IIA prostate cancer|stage iia prostate cancer
5574816|NCT00988130|stage III prostate cancer|stage iii prostate cancer
5574817|NCT00988117|PDD|pdd
5574818|NCT00988117|Parkinson's Disease with Dementia|parkinson's disease with dementia
5574819|NCT00988117|rivastigmine|rivastigmine
5574820|NCT00988117|rivastigmine patch|rivastigmine patch
5574821|NCT00988117|open label|open label
5574822|NCT00988117|Parkinson's Disease|parkinson's disease
5574823|NCT00988117|Parkinsons Disease|parkinsons disease
5574824|NCT00988117|memory|memory
5574825|NCT00988117|Exelon|exelon
5574826|NCT00988117|Exelon Patch|exelon patch
5574827|NCT00988104|Behavior Therapy|behavior therapy
5574828|NCT00988104|Randomized Controlled Trial|randomized controlled trial
5574829|NCT00988078|metformin|metformin
5574830|NCT00988078|Hyperandrogenism|hyperandrogenism
5574831|NCT00988078|Metabolic Syndrome X|metabolic syndrome x
5574832|NCT00988078|adolescents|adolescents
5574833|NCT00988078|melatonin|melatonin
5574834|NCT00988078|Polycystic Ovary Syndrome|polycystic ovary syndrome
5574835|NCT00988078|Insulin Resistance|insulin resistance
5574836|NCT00988078|Menstrual Cycle|menstrual cycle
5574837|NCT00988052|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5574838|NCT00988039|Human Immunodeficiency virus|human immunodeficiency virus
5574839|NCT00988039|second line therapy|second line therapy
5574840|NCT00988039|raltegravir|raltegravir
5574841|NCT00988039|aluvia|aluvia
5574842|NCT00988039|monotherapy|monotherapy
5574843|NCT00988039|integrase inhibitor|integrase inhibitor
5574844|NCT00988039|protease inhibitor|protease inhibitor
5574845|NCT00988039|Randomized Controlled Trial|randomized controlled trial
5574846|NCT00988013|total marrow irradiation|total marrow irradiation
5574847|NCT00988013|intensity modulated radiation|intensity modulated radiation
5574848|NCT00988013|leukemia|leukemia
5574849|NCT00988013|hematologic diseases|hematologic diseases
5574850|NCT00988000|outpatients|outpatients
5574851|NCT00987987|hematological malignancy|hematological malignancy
5574852|NCT00987987|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5574853|NCT00987987|donor lymphocyte infusion|donor lymphocyte infusion
5574854|NCT00987987|antitumor immunotherapy|antitumor immunotherapy
5574855|NCT00987987|graft-versus-tumor effect|graft-versus-tumor effect
5574856|NCT00987987|regulatory T cells|regulatory t cells
5574857|NCT00987987|adult|adult
5574858|NCT00987974|ischemia reperfusion injury|ischemia reperfusion injury
5574859|NCT00987974|endothelial dysfunction|endothelial dysfunction
5574860|NCT00987974|statins|statins
5574861|NCT00987974|rosuvastatin|rosuvastatin
5574862|NCT00987974|atorvastatin|atorvastatin
5574863|NCT00987974|placebo|placebo
5574864|NCT00987974|ecto-5'-nucleotidase|ecto-5'-nucleotidase
5574865|NCT00987974|flow mediated dilation|flow mediated dilation
5574866|NCT00987961|opioid dependence|opioid dependence
5574867|NCT00987961|suboxone|suboxone
5574868|NCT00987961|HIV risk behavior|hiv risk behavior
5574869|NCT00987948|HIV|hiv
5574870|NCT00987948|dementia|dementia
5574871|NCT00987948|High HIV DNA within CD14+ PBMCs|high hiv dna within cd14+ pbmcs
5574872|NCT00987948|treatment experienced|treatment experienced
5574873|NCT00987922|Stroke|stroke
5574874|NCT00987922|Acute|acute
5574875|NCT00987922|Infarction|infarction
5574876|NCT00987922|Ischemic|ischemic
5574877|NCT00987922|Thrombolysis|thrombolysis
5574878|NCT00987922|Mild|mild
5574879|NCT00987922|Hypothermia|hypothermia
5574880|NCT00987909|Cat|cat
5574881|NCT00987909|Allergy|allergy
5574882|NCT00987909|Immunotherapy|immunotherapy
5574883|NCT00987909|Sublingual|sublingual
5574884|NCT00987909|Exposure chamber|exposure chamber
5574885|NCT00987909|Safety|safety
5574886|NCT00987909|Rhinoconjunctivitis|rhinoconjunctivitis
5574887|NCT00987896|colonoscopy|colonoscopy
5574888|NCT00987896|polypectomy|polypectomy
5574889|NCT00987896|NOTES|notes
5574890|NCT00987883|Nutritional Support|nutritional support
5574891|NCT00987870|Stable plaque Psoriasis|stable plaque psoriasis
5574892|NCT00987870|inflammatory skin|inflammatory skin
5574893|NCT00987870|with or without arthritis|with or without arthritis
5574894|NCT00987857|esophageal cancer|esophageal cancer
5568950|NCT01010490|SAFETY|safety
5574895|NCT00987857|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5574896|NCT00987857|Barrett esophagus|barrett esophagus
5574897|NCT00987831|SLE|sle
5574898|NCT00987831|lupus|lupus
5574899|NCT00987831|biomarkers|biomarkers
5574900|NCT00987831|depomedrol|depomedrol
5574902|NCT00987831|disease activity|disease activity
5574903|NCT00987818|Biomarkers|biomarkers
5574904|NCT00987818|Antibiotic therapy|antibiotic therapy
5574905|NCT00987805|Functional dyspepsia|functional dyspepsia
5574906|NCT00987805|Banhasasim-tang|banhasasim-tang
5574907|NCT00987805|Gastrointestinal Symptom score|gastrointestinal symptom score
5574908|NCT00987805|Visual Analogue Scale|visual analogue scale
5574909|NCT00987805|Functional Dyspepsia-related Quality of Life|functional dyspepsia-related quality of life
5574910|NCT00987805|Electrogastrography|electrogastrography
5574911|NCT00987792|Community Acquired Pneumonia|community acquired pneumonia
5574912|NCT00987779|Bioequivalence study|bioequivalence study
5574913|NCT00987779|Food effect study|food effect study
5574914|NCT00987779|Pharmacokinetics|pharmacokinetics
5574915|NCT00987779|Gabapentin|gabapentin
5574916|NCT00987766|advanced adult primary liver cancer|advanced adult primary liver cancer
5574917|NCT00987766|stage III pancreatic cancer|stage iii pancreatic cancer
5574918|NCT00987766|stage IV pancreatic cancer|stage iv pancreatic cancer
5574919|NCT00987766|periampullary adenocarcinoma|periampullary adenocarcinoma
5574920|NCT00987766|small intestine adenocarcinoma|small intestine adenocarcinoma
5574921|NCT00987766|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5574922|NCT00987766|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5574923|NCT00987766|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5574924|NCT00987766|unresectable gallbladder cancer|unresectable gallbladder cancer
5574925|NCT00987753|L-377202, prostate cancer, PSA|l-377202, prostate cancer, psa
5574926|NCT00987740|hypercapnic respiratory failure, COPD|hypercapnic respiratory failure, copd
5574927|NCT00987714|Organ Donors|organ donors
5574928|NCT00987714|Recipients|recipients
5574929|NCT00987701|Neurobehavior|neurobehavior
5574930|NCT00987701|Development|development
5574931|NCT00987701|Fluid management|fluid management
5574932|NCT00987701|Neuraxial anesthesia|neuraxial anesthesia
5574934|NCT00987688|Brain injury|brain injury
5574935|NCT00987688|Pre-hospital|pre-hospital
5574936|NCT00987688|cooling|cooling
5574937|NCT00987675|stage I prostate cancer|stage i prostate cancer
5574938|NCT00987675|stage IIB prostate cancer|stage iib prostate cancer
5574939|NCT00987675|stage IIA prostate cancer|stage iia prostate cancer
5574940|NCT00987675|stage III prostate cancer|stage iii prostate cancer
5574941|NCT00987662|irbesartan|irbesartan
5574942|NCT00987662|amlodipine|amlodipine
5574944|NCT00987662|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5574946|NCT00987649|pelvic mass|pelvic mass
5574947|NCT00987649|ovarian cancer|ovarian cancer
5574948|NCT00987649|adnexal mass|adnexal mass
5574949|NCT00987649|CA125|ca125
5574951|NCT00987636|Ewing Sarcoma|ewing sarcoma
5574952|NCT00987636|localized|localized
5574953|NCT00987636|disseminated|disseminated
5574954|NCT00987636|metastases|metastases
5574955|NCT00987636|bone|bone
5574956|NCT00987636|soft tissue|soft tissue
5574957|NCT00987610|Percutaneous coronary intervention|percutaneous coronary intervention
5574958|NCT00987610|chronic total occlusion|chronic total occlusion
5574959|NCT00987610|guidewire|guidewire
5575084|NCT00987207|aortic valvulopathy|aortic valvulopathy
5574960|NCT00987610|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5574961|NCT00987610|Angioplasty|angioplasty
5574962|NCT00987610|Percutaneous Coronary|percutaneous coronary
5574963|NCT00987597|Smoking|smoking
5574964|NCT00987597|nicotine replacement|nicotine replacement
5574965|NCT00987597|psychological behaviour|psychological behaviour
5574966|NCT00987597|Smoking > 5 cigarettes per day|smoking > 5 cigarettes per day
5574967|NCT00987597|Hospitalisation for acute coronary syndrome|hospitalisation for acute coronary syndrome
5574968|NCT00987571|carpal tunnel syndrome|carpal tunnel syndrome
5574969|NCT00987571|median nerve|median nerve
5574970|NCT00987571|ultrasound|ultrasound
5574971|NCT00987571|electrodiagnosis|electrodiagnosis
5574972|NCT00987571|Normal subjects|normal subjects
5574973|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate
5574974|NCT00987558|simvastatin|simvastatin
5574975|NCT00987545|Keloids|keloids
5574976|NCT00987545|recurrence|recurrence
5574977|NCT00987532|preschool|preschool
5574978|NCT00987532|participatory intervention|participatory intervention
5574979|NCT00987532|cluster-randomization|cluster-randomization
5574980|NCT00987532|children|children
5574981|NCT00987532|obesity prevention|obesity prevention
5574982|NCT00987519|acute bronchiolitis|acute bronchiolitis
5574983|NCT00987519|acute gastroenteritis|acute gastroenteritis
5574984|NCT00987519|febrile convulsion|febrile convulsion
5574985|NCT00987519|viral agents|viral agents
5574986|NCT00987519|molecular methods|molecular methods
5574987|NCT00987506|drug eluting stents|drug eluting stents
5574988|NCT00987506|Stents|stents
5574989|NCT00987506|Angioplasty|angioplasty
5574990|NCT00987506|Chronic coronary occlusion|chronic coronary occlusion
5574991|NCT00987506|Stent thrombosis|stent thrombosis
5574992|NCT00987506|Vascular disease|vascular disease
5574993|NCT00987506|Myocardial ischemia|myocardial ischemia
5574994|NCT00987506|Coronary artery stenosis|coronary artery stenosis
5574995|NCT00987506|Coronary Disease|coronary disease
5574996|NCT00987506|Coronary Artery Disease|coronary artery disease
5574997|NCT00987506|Coronary Restenosis|coronary restenosis
5574998|NCT00987493|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5574999|NCT00987493|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5575000|NCT00987480|Stem Cell Transplantation|stem cell transplantation
5575002|NCT00987480|Busulfan|busulfan
5575003|NCT00987480|Cyclophosphamide|cyclophosphamide
5575004|NCT00987480|Fludarabine|fludarabine
5575005|NCT00987480|08-031|08-031
5575006|NCT00987467|Atopic|atopic
5575007|NCT00987467|Keratoconjunctivitis|keratoconjunctivitis
5575008|NCT00987467|Restasis|restasis
5575009|NCT00987467|Cyclosporine|cyclosporine
5575010|NCT00987441|Neurobehavior|neurobehavior
5575011|NCT00987441|Epidural analgesia|epidural analgesia
5575012|NCT00987441|Local anesthetic|local anesthetic
5575013|NCT00987441|Opioid|opioid
5575014|NCT00987428|ERCP|ercp
5575015|NCT00987428|EUS|eus
5575016|NCT00987428|Pancreatitis biliary|pancreatitis biliary
5575017|NCT00987428|Severe|severe
5575018|NCT00987428|Interventional endoscopy|interventional endoscopy
5575019|NCT00987428|Choledocolithiasis|choledocolithiasis
5575020|NCT00987402|Surgery|surgery
5575021|NCT00987402|hand scrubbing|hand scrubbing
5575022|NCT00987402|post-operative infection|post-operative infection
5575023|NCT00987402|surgical site infection|surgical site infection
5575024|NCT00987402|surgical hand preparation|surgical hand preparation
5575025|NCT00987402|plain soap and water|plain soap and water
5575026|NCT00987402|alcohol-based hand rub|alcohol-based hand rub
5575027|NCT00987402|Cost of surgical hand preparation agent|cost of surgical hand preparation agent
5575028|NCT00987402|Side effects of use of hand preparation agent|side effects of use of hand preparation agent
5575029|NCT00987389|Vasculitis|vasculitis
5575030|NCT00987389|Granulomatosis with Polyangiitis|granulomatosis with polyangiitis
5557110|NCT01057784|obesity|obesity
5575031|NCT00987389|Microscopic Polyangiitis|microscopic polyangiitis
5575032|NCT00987389|Wegener's|wegener's
5575033|NCT00987389|ANCA-Associated Vasculitis|anca-associated vasculitis
5575034|NCT00987389|GPA|gpa
5575035|NCT00987389|MPA|mpa
5575036|NCT00987389|Treatment|treatment
5575037|NCT00987389|Plasma exchange|plasma exchange
5575038|NCT00987389|Glucocorticoids|glucocorticoids
5575040|NCT00987363|critical limb ischemia (CLI)|critical limb ischemia (cli)
5575041|NCT00987363|diabetic foot|diabetic foot
5575042|NCT00987363|bone marrow derived mononuclear cells|bone marrow derived mononuclear cells
5575043|NCT00987363|cell therapy|cell therapy
5575044|NCT00987350|Jet Injector|jet injector
5575046|NCT00987350|Influenza|influenza
5575047|NCT00987337|Hepatitis C Polymerase Inhibitor PF-00868554 Filibuvir|hepatitis c polymerase inhibitor pf-00868554 filibuvir
5575048|NCT00987311|Probiotics|probiotics
5575049|NCT00987311|intestinal immune system|intestinal immune system
5575050|NCT00987311|human|human
5575051|NCT00987311|healthy subjects|healthy subjects
5575052|NCT00987311|dairy drink|dairy drink
5575053|NCT00987311|Healthy adults|healthy adults
5575054|NCT00987298|Abdominal Fat|abdominal fat
5575055|NCT00987298|Visceral Fat|visceral fat
5575056|NCT00987298|Subcutaneous Fat|subcutaneous fat
5575057|NCT00987298|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5575059|NCT00987298|Computed Tomography|computed tomography
5575060|NCT00987298|CT|ct
5575061|NCT00987298|Body Mass Index|body mass index
5575062|NCT00987298|Body composition|body composition
5575063|NCT00987298|Percent fat|percent fat
5575064|NCT00987298|Waist circumference|waist circumference
5575065|NCT00987298|Hip circumference|hip circumference
5575066|NCT00987285|RE AIM model|re aim model
5575067|NCT00987285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5575068|NCT00987285|Interactive voice recognition|interactive voice recognition
5575069|NCT00987285|Computer Assisted Self Management|computer assisted self management
5575070|NCT00987272|Allergies|allergies
5575071|NCT00987272|Ocular|ocular
5575072|NCT00987259|Myocardial infarction|myocardial infarction
5575073|NCT00987259|Myocardial oedema|myocardial oedema
5575074|NCT00987259|Magnetic resonance|magnetic resonance
5575075|NCT00987246|Actinic Keratosis|actinic keratosis
5575076|NCT00987246|AK|ak
5575077|NCT00987246|NMSC|nmsc
5575078|NCT00987246|Combination|combination
5575079|NCT00987220|CSF Biomarkers Acetylcholine|csf biomarkers acetylcholine
5575080|NCT00987207|Postconditioning|postconditioning
5575081|NCT00987207|cyclosporine A|cyclosporine a
5575082|NCT00987207|myocardial ischemia|myocardial ischemia
5575083|NCT00987207|cardiac surgery|cardiac surgery
5575085|NCT00987194|HIV|hiv
5575086|NCT00987194|rapid testing|rapid testing
5575087|NCT00987194|HIV seronegativity|hiv seronegativity
5575088|NCT00987181|Pulse wave velocity|pulse wave velocity
5575089|NCT00987181|Non contact|non contact
5575090|NCT00987181|Non-invasive|non-invasive
5575091|NCT00987181|Photoplethysmography|photoplethysmography
5575092|NCT00987181|Doppler flow velocimetry|doppler flow velocimetry
5575093|NCT00987168|Congenital Hyperinsulinism|congenital hyperinsulinism
5575095|NCT00987168|Sandostatine subcutaneous in 3 daily injections|sandostatine subcutaneous in 3 daily injections
5575096|NCT00987168|Intramuscular injection of Sandostatine® LP per month|intramuscular injection of sandostatine® lp per month
5575097|NCT00987155|Functional electrical stimulation cycling|functional electrical stimulation cycling
5575099|NCT00987155|wheelchair|wheelchair
5575100|NCT00987155|ergometry|ergometry
5575101|NCT00987155|paraplegia|paraplegia
5575102|NCT00987155|spinal cord injury|spinal cord injury
5575103|NCT00987155|exercise testing|exercise testing
5575104|NCT00987129|DHA|dha
5575105|NCT00987129|EPA|epa
5575106|NCT00987129|AMD|amd
5575107|NCT00987129|drusen|drusen
5575108|NCT00987129|omega-3 fatty acids|omega-3 fatty acids
5575109|NCT00987129|omega6:omega3 ratio|omega6:omega3 ratio
5575110|NCT00987116|Myasthenia gravis|myasthenia gravis
5575111|NCT00987116|Steroids side effects|steroids side effects
5575112|NCT00987116|Comparison of strategies for tapering steroids|comparison of strategies for tapering steroids
5575113|NCT00987116|Generalized MG corresponding to grade III, IV or V of MGFA|generalized mg corresponding to grade iii, iv or v of mgfa
5575114|NCT00987103|renal transplantation|renal transplantation
5575115|NCT00987103|tacrolimus|tacrolimus
5575116|NCT00987103|pharmacokinetics|pharmacokinetics
5575117|NCT00987103|rectal|rectal
5575118|NCT00987103|sublingual|sublingual
5575119|NCT00987103|rectal administration|rectal administration
5575120|NCT00987103|sublingual administration|sublingual administration
5575121|NCT00987090|subjects developing symptoms of Alzheimer Disease|subjects developing symptoms of alzheimer disease
5575122|NCT00987077|CSC|csc
5575123|NCT00987077|SRT|srt
5575124|NCT00987064|Protexo|protexo
5575125|NCT00987064|Asthma|asthma
5575126|NCT00987064|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
5575127|NCT00987064|Perennial allergy|perennial allergy
5575128|NCT00987064|Quality of life|quality of life
5575129|NCT00987064|MiniAQLQ|miniaqlq
5575130|NCT00987064|FeNO|feno
5575131|NCT00987064|FEV1|fev1
5575132|NCT00987064|PEF|pef
5575133|NCT00987051|sentinel node procedure|sentinel node procedure
5575134|NCT00987051|radiocolloid|radiocolloid
5575135|NCT00987051|patent blue|patent blue
5575136|NCT00987038|drug interaction CYP3A4 glucocorticoids midazolam|drug interaction cyp3a4 glucocorticoids midazolam
5575138|NCT00987025|telehealth|telehealth
5575139|NCT00987025|nurse monitor|nurse monitor
5575140|NCT00987025|nutrition center|nutrition center
5575141|NCT00986999|HIV infected|hiv infected
5575142|NCT00986999|treatment experienced|treatment experienced
5575143|NCT00986986|Human immunodeficiency virus|human immunodeficiency virus
5575144|NCT00986986|Low high density lipoprotein|low high density lipoprotein
5575145|NCT00986986|Endothelial function|endothelial function
5575146|NCT00986986|Flow-mediated vasodilation|flow-mediated vasodilation
5575147|NCT00986973|PKU|pku
5575148|NCT00986973|BH4|bh4
5575149|NCT00986973|KUVAN|kuvan
5575150|NCT00986973|PET scan|pet scan
5575151|NCT00986973|Neurodevelopment|neurodevelopment
5575152|NCT00986960|multiple sclerosis|multiple sclerosis
5575153|NCT00986960|relapsing remitting|relapsing remitting
5575154|NCT00986960|RRMS|rrms
5575155|NCT00986921|Length of time for procedure to be completed|length of time for procedure to be completed
5575156|NCT00986921|Need for additional dilation|need for additional dilation
5575157|NCT00986921|Subject satisfaction with procedure|subject satisfaction with procedure
5575158|NCT00986895|HPN-100|hpn-100
5575159|NCT00986895|GT4P|gt4p
5575160|NCT00986895|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5575161|NCT00986882|Postoperative pain|postoperative pain
5575162|NCT00986869|Safety|safety
5575163|NCT00986869|Bronchoscopy|bronchoscopy
5575164|NCT00986869|Pulmonary|pulmonary
5575165|NCT00986869|Hypertension|hypertension
5575166|NCT00986843|HM30181A|hm30181a
5575167|NCT00986843|Irinotecan|irinotecan
5575168|NCT00986843|MTD|mtd
5575169|NCT00986843|DLT|dlt
5575170|NCT00986830|Rhinosinusitis|rhinosinusitis
5575171|NCT00986830|Balloon catheters|balloon catheters
5575172|NCT00986830|Office treatment|office treatment
5575173|NCT00986830|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5575174|NCT00986830|Respiratory Tract Infections|respiratory tract infections
5575175|NCT00986830|Respiratory Tract Diseases|respiratory tract diseases
5575176|NCT00986830|FinESS Sinus Treatment|finess sinus treatment
5575177|NCT00986830|endoscopic sinus surgery|endoscopic sinus surgery
5575178|NCT00986817|Refractory ascites|refractory ascites
5575179|NCT00986817|Cirrhosis Terlipressin|cirrhosis terlipressin
5575180|NCT00986817|Paracentesis|paracentesis
5575181|NCT00986791|risk reduction|risk reduction
5575182|NCT00986765|Fetal growth restriction|fetal growth restriction
5575183|NCT00986765|Abruptio placentae|abruptio placentae
5575184|NCT00986765|Perinatal death|perinatal death
5575185|NCT00986752|stent|stent
5575186|NCT00986752|atherectomy|atherectomy
5575187|NCT00986752|paclitaxel-eluting balloon|paclitaxel-eluting balloon
5569237|NCT01009359|PET tracer|pet tracer
5575188|NCT00986739|Chronic pathologies|chronic pathologies
5575189|NCT00986739|elderly|elderly
5575190|NCT00986739|atmospheric pollution|atmospheric pollution
5575191|NCT00986739|unplanned hospitalization|unplanned hospitalization
5575192|NCT00986739|case-crossover|case-crossover
5575193|NCT00986687|Oocyte cryopreservation|oocyte cryopreservation
5575194|NCT00986687|vitrification|vitrification
5575195|NCT00986674|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5575196|NCT00986674|Carboplatin|carboplatin
5575197|NCT00986674|Paclitaxel|paclitaxel
5575198|NCT00986674|Cetuximab|cetuximab
5575199|NCT00986674|IMC-A12|imc-a12
5575200|NCT00986661|melanoma|melanoma
5575201|NCT00986661|uveal|uveal
5575202|NCT00986661|ocular|ocular
5575203|NCT00986661|mUM|mum
5575204|NCT00986661|mOM|mom
5575205|NCT00986661|OM|om
5575206|NCT00986661|UM|um
5575207|NCT00986661|pancreatic|pancreatic
5575208|NCT00986661|colon|colon
5575209|NCT00986661|colorectal|colorectal
5575210|NCT00986661|lung|lung
5575211|NCT00986661|metastatic|metastatic
5575212|NCT00986661|carcinoid|carcinoid
5575213|NCT00986661|neuroendocrine|neuroendocrine
5575214|NCT00986661|liver|liver
5575215|NCT00986661|hepatic|hepatic
5575216|NCT00986648|acute liver failure|acute liver failure
5575217|NCT00986648|hepatic encephalopathy|hepatic encephalopathy
5575218|NCT00986648|acetaminophen toxicity|acetaminophen toxicity
5575219|NCT00986635|Activated partial thromboplastin time|activated partial thromboplastin time
5575220|NCT00986635|Thrombin clotting Time|thrombin clotting time
5575221|NCT00986635|Anti-Xa-activity|anti-xa-activity
5575222|NCT00986635|Factor X-activity|factor x-activity
5575223|NCT00986635|Factor XIII-activity|factor xiii-activity
5575224|NCT00986635|Antithrombin (based on factor II)|antithrombin (based on factor ii)
5575225|NCT00986635|Antithrombin (based on factor X<9|antithrombin (based on factor x<9
5575226|NCT00986596|vitamin D|vitamin d
5575227|NCT00986596|skeletal muscle|skeletal muscle
5575228|NCT00986596|vitamin D receptor|vitamin d receptor
5575229|NCT00986583|Succinylcholine|succinylcholine
5575230|NCT00986583|Statins|statins
5575231|NCT00986583|myalgias|myalgias
5575232|NCT00986583|statins with succinylcholine and pain|statins with succinylcholine and pain
5575233|NCT00986570|Botulinum Toxin A|botulinum toxin a
5575234|NCT00986570|Wrinkles|wrinkles
5557301|NCT01057082|HMB|hmb
5575235|NCT00986557|cytomegalovirus infection|cytomegalovirus infection
5575236|NCT00986557|graft versus host disease|graft versus host disease
5575237|NCT00986544|Laparoscopy|laparoscopy
5575238|NCT00986544|cholecystectomy|cholecystectomy
5575239|NCT00986544|drainage|drainage
5575240|NCT00986531|schizophrenia|schizophrenia
5575242|NCT00986518|Advanced Colorectal Cancer|advanced colorectal cancer
5575243|NCT00986518|Hepatic and/or lung metastasis|hepatic and/or lung metastasis
5575244|NCT00986518|Adaptive autologous cell immunotherapy|adaptive autologous cell immunotherapy
5575245|NCT00986518|T- regulatory lymphocyte depletion|t- regulatory lymphocyte depletion
5575246|NCT00986518|Neo-adjuvant reduced intensity chemotherapeutic conditioning|neo-adjuvant reduced intensity chemotherapeutic conditioning
5575248|NCT00986505|fibromyalgia|fibromyalgia
5575249|NCT00986505|intravenous lidocaine|intravenous lidocaine
5575250|NCT00986505|manifestations|manifestations
5575251|NCT00986492|Sleep deprivation|sleep deprivation
5575252|NCT00986492|Food intake|food intake
5575253|NCT00986492|Motor activity|motor activity
5575254|NCT00986492|Normal, healthy subjects|normal, healthy subjects
5575255|NCT00986479|Patients|patients
5575256|NCT00986466|exercise|exercise
5575257|NCT00986466|falls|falls
5575258|NCT00986466|physical functioning|physical functioning
5575259|NCT00986466|vitamin D|vitamin d
5575260|NCT00986466|mobility function|mobility function
5575261|NCT00986466|neuromuscular functioning¨|neuromuscular functioning¨
5575262|NCT00986466|quality of life|quality of life
5575263|NCT00986466|number of fallers|number of fallers
5575264|NCT00986466|fall-related injuries including bone fractures|fall-related injuries including bone fractures
5575265|NCT00986466|bone mass|bone mass
5575266|NCT00986453|Breast Reduction|breast reduction
5575267|NCT00986453|PlasmaBlade|plasmablade
5575268|NCT00986453|Electrosurgery|electrosurgery
5575269|NCT00986453|PEAK Surgical|peak surgical
5575270|NCT00986453|Medtronic Advanced Energy|medtronic advanced energy
5575271|NCT00986453|Medtronic|medtronic
5575272|NCT00986414|Parkinson Disease|parkinson disease
5575273|NCT00986414|L-dopa|l-dopa
5575274|NCT00986414|Levodopa|levodopa
5575275|NCT00986414|dyskinesia|dyskinesia
5575276|NCT00986401|Adults|adults
5575277|NCT00986375|Randomized Controlled Trial|randomized controlled trial
5575278|NCT00986375|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5575279|NCT00986375|expert system|expert system
5575280|NCT00986375|stages of change|stages of change
5575281|NCT00986375|motivational interviewing|motivational interviewing
5575282|NCT00986375|tailoring|tailoring
5575283|NCT00986375|Self Care|self care
5575284|NCT00986375|Rehabilitation|rehabilitation
5575285|NCT00986375|Expert Systems|expert systems
5575286|NCT00986375|Behavior|behavior
5575287|NCT00986375|Motivation|motivation
5575288|NCT00986362|Safety in pediatrics|safety in pediatrics
5575289|NCT00986349|Diabetes|diabetes
5575290|NCT00986349|Weight Loss|weight loss
5575291|NCT00986349|GI Dynamics|gi dynamics
5575292|NCT00986349|EndoBarrier|endobarrier
5575293|NCT00986336|topiramate|topiramate
5575294|NCT00986336|risperidone, bipolar disorder|risperidone, bipolar disorder
5575295|NCT00986323|Asthma|asthma
5575296|NCT00986323|Temperature controlled Laminar Airflow|temperature controlled laminar airflow
5575298|NCT00986323|Perennial allergy|perennial allergy
5575299|NCT00986323|Quality of life|quality of life
5575300|NCT00986323|Environmental control|environmental control
5575301|NCT00986310|fluoxetine|fluoxetine
5575302|NCT00986310|epilepsy|epilepsy
5575303|NCT00986310|Prozac|prozac
5575304|NCT00986297|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5575305|NCT00986297|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5575306|NCT00986297|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5575307|NCT00986297|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5575308|NCT00986297|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5575309|NCT00986297|adenocarcinoma of the lung|adenocarcinoma of the lung
5575310|NCT00986297|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5575311|NCT00986297|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5575312|NCT00986297|large cell lung cancer|large cell lung cancer
5575313|NCT00986297|squamous cell lung cancer|squamous cell lung cancer
5575314|NCT00986284|Non Small Cell Lung Cancer|non small cell lung cancer
5575315|NCT00986284|Gefitinib|gefitinib
5575316|NCT00986284|Neoadjuvant Therapy|neoadjuvant therapy
5575317|NCT00986271|severe sepsis, intensive care units|severe sepsis, intensive care units
5575318|NCT00986258|pain assessment|pain assessment
5575319|NCT00986258|tapentadol|tapentadol
5575320|NCT00986258|centrally acting analgesic|centrally acting analgesic
5575321|NCT00986245|Parkinson disease|parkinson disease
5575322|NCT00986245|Ropinirole|ropinirole
5575323|NCT00986219|Asthma|asthma
5575324|NCT00986219|Language|language
5575325|NCT00986219|Symptoms,|symptoms,
5575326|NCT00986219|Limitation of Daily activities|limitation of daily activities
5575327|NCT00986219|Patients|patients
5575328|NCT00986219|Physicians|physicians
5575329|NCT00986219|Greece|greece
5575330|NCT00986206|ovarian epithelial cancer|ovarian epithelial cancer
5557388|NCT01056718|Nebivolol|nebivolol
5575331|NCT00986206|BRCA1 mutation carrier|brca1 mutation carrier
5575332|NCT00986206|BRCA2 mutation carrier|brca2 mutation carrier
5575333|NCT00986206|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5575334|NCT00986206|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5575335|NCT00986206|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5575336|NCT00986206|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5575337|NCT00986206|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5575338|NCT00986206|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5575339|NCT00986206|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5575340|NCT00986206|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5575341|NCT00986206|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5575342|NCT00986206|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5575343|NCT00986193|Aortic Valve Stenosis|aortic valve stenosis
5575344|NCT00986193|Stent Valve|stent valve
5575345|NCT00986193|Biological Aortic Valve Prosthesis|biological aortic valve prosthesis
5575346|NCT00986180|Acute Low Back Pain|acute low back pain
5575347|NCT00986180|Low Back Pain With Leg Pain Below The Knee|low back pain with leg pain below the knee
5575348|NCT00986180|Radiculopathy, Oxycodone|radiculopathy, oxycodone
5575349|NCT00986180|Tapentadol|tapentadol
5575350|NCT00986180|NUCYNTA|nucynta
5575351|NCT00986167|Psychosis|psychosis
5575352|NCT00986167|Aggression|aggression
5575353|NCT00986167|Acute|acute
5575354|NCT00986167|Quetiapine XR|quetiapine xr
5575355|NCT00986154|Recurrent Thrombosis|recurrent thrombosis
5575356|NCT00986154|Recurrent Pulmonary Embolism|recurrent pulmonary embolism
5575357|NCT00986154|Symptomatic Deep Vein Thrombosis|symptomatic deep vein thrombosis
5575358|NCT00986154|Symptomatic Pulmonary Embolism|symptomatic pulmonary embolism
5575359|NCT00986154|Venous Thromboembolism (VTE)|venous thromboembolism (vte)
5575360|NCT00986128|Topiramate|topiramate
5575361|NCT00986128|Lithium|lithium
5575362|NCT00986128|Bipolar disorder|bipolar disorder
5575363|NCT00986115|epilepsy|epilepsy
5575364|NCT00986115|memory|memory
5575365|NCT00986115|cognition|cognition
5575366|NCT00986115|memantine|memantine
5575367|NCT00986102|Carbapenem|carbapenem
5575368|NCT00986102|Doripenem|doripenem
5575369|NCT00986102|Doribax|doribax
5575370|NCT00986102|Nosocomial pneumonia, Intra-abdominal infections|nosocomial pneumonia, intra-abdominal infections
5575371|NCT00986102|Urinary tract infection|urinary tract infection
5575372|NCT00986089|post-placental|post-placental
5575374|NCT00986089|Copper IUD|copper iud
5575375|NCT00986089|cesarean section|cesarean section
5575376|NCT00986089|immediate post-partum|immediate post-partum
5575377|NCT00986089|continuation|continuation
5575378|NCT00986076|Pediatric Cataract Surgery|pediatric cataract surgery
5575379|NCT00986076|Low-Molecular weight Heparin|low-molecular weight heparin
5575380|NCT00986076|Intraocular infusion|intraocular infusion
5575381|NCT00986076|Anti-inflammatory effect|anti-inflammatory effect
5575382|NCT00986063|Nevirapine induced rash|nevirapine induced rash
5575383|NCT00986063|Hepatitis|hepatitis
5575384|NCT00986063|Pharmacogenomics|pharmacogenomics
5575386|NCT00986063|HIV|hiv
5575387|NCT00986063|treatment naive|treatment naive
5575388|NCT00986050|STEMI|stemi
5575389|NCT00986050|DES|des
5575390|NCT00986050|BMS|bms
5575391|NCT00986050|abciximab|abciximab
5575392|NCT00986037|Adverse events|adverse events
5575393|NCT00986037|Pharmacokinetics|pharmacokinetics
5575394|NCT00986024|Exercise therapy|exercise therapy
5575395|NCT00986011|obesity|obesity
5680328|NCT00578201|Oxaliplatin|oxaliplatin
5575396|NCT00986011|weight changes|weight changes
5575397|NCT00986011|healthy, no evidence of disease|healthy, no evidence of disease
5575398|NCT00985998|nimotuzumab|nimotuzumab
5575399|NCT00985998|non-small cell lung cancer|non-small cell lung cancer
5575400|NCT00985998|chemotherapy|chemotherapy
5575401|NCT00985985|smoking cessation|smoking cessation
5575402|NCT00985985|nicotine lozenge|nicotine lozenge
5575403|NCT00985985|nicotine replacement therapy|nicotine replacement therapy
5575404|NCT00985972|PHYSICAL ACTIVITY|physical activity
5575405|NCT00985972|SCHOOL|school
5575406|NCT00985972|NUTRITION|nutrition
5575407|NCT00985972|EDUCATION|education
5575408|NCT00985972|OVERWEIGHT|overweight
5575409|NCT00985959|Multiple myeloma|multiple myeloma
5575410|NCT00985959|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5575411|NCT00985959|HSCT|hsct
5575412|NCT00985959|Melphalan|melphalan
5575413|NCT00985959|Prednisolone|prednisolone
5575414|NCT00985959|Bortezomib|bortezomib
5575415|NCT00985959|JNJ-26866138|jnj-26866138
5575416|NCT00985933|Healthy normal volunteers|healthy normal volunteers
5575417|NCT00985920|blood loss|blood loss
5575418|NCT00985920|postoperative|postoperative
5575419|NCT00985907|myeloma|myeloma
5575420|NCT00985907|DMV|dmv
5575421|NCT00985894|Teledermatology|teledermatology
5575422|NCT00985894|Telemedicine|telemedicine
5575423|NCT00985894|Atopic Dermatitis|atopic dermatitis
5575424|NCT00985881|Artificial limbs|artificial limbs
5575425|NCT00985881|Gait|gait
5575426|NCT00985881|Posture|posture
5575427|NCT00985881|Prosthesis|prosthesis
5575428|NCT00985881|Vibration|vibration
5575429|NCT00985868|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5575431|NCT00985842|Gait|gait
5575432|NCT00985842|Oximetry|oximetry
5575433|NCT00985842|Prosthesis|prosthesis
5575434|NCT00985842|Rehabilitation|rehabilitation
5575435|NCT00985829|basal cell carcinoma|basal cell carcinoma
5575436|NCT00985829|photodynamic therapy|photodynamic therapy
5575437|NCT00985829|photo chemotherapy|photo chemotherapy
5575438|NCT00985829|basal cell epithelioma|basal cell epithelioma
5575439|NCT00985816|Preterm|preterm
5575440|NCT00985816|newborns|newborns
5575441|NCT00985816|Gastric|gastric
5575442|NCT00985816|Motility|motility
5575443|NCT00985816|Mucosal|mucosal
5575444|NCT00985816|immunity|immunity
5575445|NCT00985803|Systemic Lupus Erythematosus|systemic lupus erythematosus
5575446|NCT00985803|Activity Physical|activity physical
5575447|NCT00985803|Activity Disease,trials randomized|activity disease,trials randomized
5575448|NCT00985790|vaccine|vaccine
5575449|NCT00985790|Influenza|influenza
5575450|NCT00985777|pancreas|pancreas
5575451|NCT00985777|resectable|resectable
5575452|NCT00985777|pancreatic tumor|pancreatic tumor
5575453|NCT00985777|pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5575454|NCT00985777|intraductal papillary mucinous neoplasm of the pancreas|intraductal papillary mucinous neoplasm of the pancreas
5575455|NCT00985777|mucinous cystic neoplasm|mucinous cystic neoplasm
5575456|NCT00985777|pancreatic exocrine neoplasia|pancreatic exocrine neoplasia
5575457|NCT00985751|immunogenicity|immunogenicity
5575458|NCT00985751|toddlers|toddlers
5575459|NCT00985751|Pneumococcal vaccine|pneumococcal vaccine
5575460|NCT00985751|Haemophilus influenzae|haemophilus influenzae
5575461|NCT00985751|safety|safety
5575462|NCT00985751|Streptococcus pneumoniae|streptococcus pneumoniae
5575463|NCT00985751|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
5575464|NCT00985738|Prostate Cancer|prostate cancer
5575465|NCT00985738|Early Stage Prostate Cancer|early stage prostate cancer
5575466|NCT00985725|Major Depressive Disorder|major depressive disorder
5575467|NCT00985699|non-Hodgkin lymphoma|non-hodgkin lymphoma
5575468|NCT00985699|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5575469|NCT00985699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5575470|NCT00985699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5575471|NCT00985686|e-mental health|e-mental health
5575472|NCT00985686|Adolescent mental health|adolescent mental health
5575473|NCT00985686|Spirituality|spirituality
5575474|NCT00985673|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5575475|NCT00985673|influenza infection|influenza infection
5575476|NCT00985673|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5575477|NCT00985647|HIV|hiv
5575478|NCT00985647|HAART|haart
5575479|NCT00985647|ART|art
5575480|NCT00985647|Pharmacokinetic|pharmacokinetic
5575481|NCT00985647|Healthy volunteers|healthy volunteers
5575482|NCT00985647|3TC|3tc
5575483|NCT00985647|Lamivudine|lamivudine
5575484|NCT00985634|off pump bypass OPCAB|off pump bypass opcab
5575485|NCT00985634|OPCAB|opcab
5575486|NCT00985621|monoclonal antibody|monoclonal antibody
5575487|NCT00985621|RN624|rn624
5575488|NCT00985621|PF-04383119|pf-04383119
5575489|NCT00985621|nerve growth factor|nerve growth factor
5575490|NCT00985621|OA|oa
5575491|NCT00985621|pain|pain
5575492|NCT00985621|arthritis|arthritis
5575493|NCT00985608|H pylori|h pylori
5575494|NCT00985608|eradication therapy|eradication therapy
5575495|NCT00985595|Adolescent|adolescent
5575496|NCT00985595|substance abuse|substance abuse
5575497|NCT00985582|Influenza A Virus (H1N1)|influenza a virus (h1n1)
5575498|NCT00985569|Constipation|constipation
5575499|NCT00985569|Nursing Home|nursing home
5575500|NCT00985569|Quality Indicator|quality indicator
5575501|NCT00985556|recurrent gastric cancer|recurrent gastric cancer
5575502|NCT00985556|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5575503|NCT00985556|stage IIIA gastric cancer|stage iiia gastric cancer
5575504|NCT00985556|stage IIIB gastric cancer|stage iiib gastric cancer
5575505|NCT00985556|stage IIIC gastric cancer|stage iiic gastric cancer
5575506|NCT00985556|stage IV gastric cancer|stage iv gastric cancer
5575507|NCT00985543|HIV|hiv
5575508|NCT00985543|ART|art
5575509|NCT00985543|HAART|haart
5575510|NCT00985543|Pharmacokinetics|pharmacokinetics
5575511|NCT00985543|Lopinavir/ritonavir|lopinavir/ritonavir
5575512|NCT00985543|Lower dose selection|lower dose selection
5575513|NCT00985517|Parkinson's disease|parkinson's disease
5575514|NCT00985517|Movement Disorders|movement disorders
5575515|NCT00985517|Gene Therapy|gene therapy
5575516|NCT00985517|Neurotrophic Factors|neurotrophic factors
5575517|NCT00985517|GDNF|gdnf
5575518|NCT00985517|Neurturin|neurturin
5575519|NCT00985517|DBS|dbs
5575520|NCT00985517|Dopamine|dopamine
5575521|NCT00985504|Major Depressive Disorder|major depressive disorder
5575522|NCT00985504|Apathy|apathy
5575523|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride
5575524|NCT00985504|SSRI|ssri
5575525|NCT00985504|Escitalopram|escitalopram
5575526|NCT00985491|obesity|obesity
5575527|NCT00985478|First in Man|first in man
5575528|NCT00985478|SLV342|slv342
5575529|NCT00985478|Atherosclerosis|atherosclerosis
5575530|NCT00985465|Booster vaccination|booster vaccination
5575531|NCT00985465|Pneumococcal vaccine|pneumococcal vaccine
5575532|NCT00985465|Catch-up vaccination|catch-up vaccination
5575533|NCT00985465|Pneumococcal disease|pneumococcal disease
5575534|NCT00985465|Safety|safety
5575535|NCT00985465|Immunogenicity|immunogenicity
5575536|NCT00985452|Medication|medication
5575537|NCT00985452|Adherence|adherence
5575538|NCT00985452|Hypertension|hypertension
5575539|NCT00985426|chronic kidney disease|chronic kidney disease
5575540|NCT00985426|kidney failure|kidney failure
5575541|NCT00985426|kidney failure,chronic|kidney failure,chronic
5575542|NCT00985426|chronic kidney failure|chronic kidney failure
5575543|NCT00985426|hepatitis B virus (HBV) vaccine|hepatitis b virus (hbv) vaccine
5575544|NCT00985426|hepatitis B vaccine|hepatitis b vaccine
5575545|NCT00985426|hepatitis B|hepatitis b
5575546|NCT00985426|hepatitis|hepatitis
5575547|NCT00985426|HBV|hbv
5575548|NCT00985426|prevention and control|prevention and control
5575549|NCT00985426|dialysis|dialysis
5575550|NCT00985413|Cockayne Syndrome|cockayne syndrome
5575551|NCT00985413|pediatrics|pediatrics
5575552|NCT00985413|growth|growth
5575553|NCT00985413|hearing|hearing
5575554|NCT00985413|Ageing|ageing
5575555|NCT00985400|recurrent colon cancer|recurrent colon cancer
5575556|NCT00985400|stage IV colon cancer|stage iv colon cancer
5575557|NCT00985400|Gastrointestinal|gastrointestinal
5575558|NCT00985400|Exercise|exercise
5575559|NCT00985400|Relaxation|relaxation
5575560|NCT00985400|Meditation|meditation
5575561|NCT00985387|Solifenacin|solifenacin
5575562|NCT00985387|Overactive bladder|overactive bladder
5575563|NCT00985387|persistency of the treatment|persistency of the treatment
5575564|NCT00985387|Vesicare|vesicare
5575565|NCT00985348|Levetiracetam|levetiracetam
5575566|NCT00985348|Healthy volunteers|healthy volunteers
5575567|NCT00985348|Healthy Subjects|healthy subjects
5575568|NCT00985322|Hemodialysis|hemodialysis
5575569|NCT00985309|unsatisfactory|unsatisfactory
5575570|NCT00985309|Pap smear|pap smear
5575571|NCT00985296|Allergic rhinitis|allergic rhinitis
5575572|NCT00985296|Allergic conjunctivitis|allergic conjunctivitis
5575573|NCT00985283|prevention|prevention
5575574|NCT00985283|older adults|older adults
5575575|NCT00985283|function|function
5575576|NCT00985283|participation|participation
5575577|NCT00985283|life satisfaction|life satisfaction
5575578|NCT00985283|self-rated health|self-rated health
5575579|NCT00985244|COPD|copd
5575580|NCT00985244|COPD exacerbation|copd exacerbation
5575581|NCT00985244|macrolide|macrolide
5575582|NCT00985244|diseae progression|diseae progression
5575583|NCT00985244|bacterial colonisation|bacterial colonisation
5575595|NCT00985192|recurrent esophageal cancer|recurrent esophageal cancer
5575596|NCT00985192|stage III esophageal cancer|stage iii esophageal cancer
5575597|NCT00985192|stage IV esophageal cancer|stage iv esophageal cancer
5575598|NCT00985192|recurrent gastric cancer|recurrent gastric cancer
5575599|NCT00985192|stage III gastric cancer|stage iii gastric cancer
5575600|NCT00985192|stage IV gastric cancer|stage iv gastric cancer
5575601|NCT00985179|Randomized Controlled Trial|randomized controlled trial
5575602|NCT00985179|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5575603|NCT00985179|expert system|expert system
5575604|NCT00985179|stages of change|stages of change
5575605|NCT00985179|motivational interviewing|motivational interviewing
5575606|NCT00985179|tailoring|tailoring
5575607|NCT00985179|Self Care|self care
5575608|NCT00985179|Expert Systems|expert systems
5575609|NCT00985127|Hyperuricemia|hyperuricemia
5575610|NCT00985127|Gout|gout
5575611|NCT00985114|Type II Diabetes|type ii diabetes
5575612|NCT00985114|Obesity|obesity
5575613|NCT00985088|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5575614|NCT00985088|influenza infection|influenza infection
5575615|NCT00985088|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5575616|NCT00985075|Allergic rhinitis|allergic rhinitis
5575617|NCT00985075|Allergic conjunctivitis|allergic conjunctivitis
5575618|NCT00985062|Folic Acid|folic acid
5575619|NCT00985062|Homocysteine|homocysteine
5575620|NCT00985062|Ovarian response|ovarian response
5575621|NCT00985062|In Vitro Fertilization|in vitro fertilization
5575622|NCT00985036|glioma|glioma
5575623|NCT00985036|meningioma|meningioma
5575624|NCT00985036|VEGF|vegf
5575625|NCT00985023|Unstable|unstable
5575626|NCT00985023|Lisfranc|lisfranc
5575627|NCT00985023|fracture|fracture
5575628|NCT00985023|dislocation|dislocation
5575629|NCT00985023|midfoot|midfoot
5575630|NCT00985010|hepatic encephalopathy|hepatic encephalopathy
5575631|NCT00985010|hepatitis C|hepatitis c
5575632|NCT00985010|manganese|manganese
5575633|NCT00985010|mortality|mortality
5575634|NCT00985010|prognosis.|prognosis.
5575635|NCT00984997|Superior Sulcus Tumor|superior sulcus tumor
5575636|NCT00984997|Lung Cancer|lung cancer
5575637|NCT00984997|Non-Small Cell|non-small cell
5575639|NCT00984997|Surgery|surgery
5575640|NCT00984997|Segmentectomy|segmentectomy
5575641|NCT00984997|Lobectomy|lobectomy
5575642|NCT00984997|Cisplatin|cisplatin
5575643|NCT00984997|CDDP|cddp
5575644|NCT00984997|Etoposide|etoposide
5575645|NCT00984997|VP-16|vp-16
5575646|NCT00984997|VePesid|vepesid
5575647|NCT00984997|Radiation Therapy|radiation therapy
5575648|NCT00984997|Radiotherapy|radiotherapy
5575649|NCT00984997|Chest Irradiation|chest irradiation
5575650|NCT00984997|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5575651|NCT00984997|PCI|pci
5575652|NCT00984971|Microbicides|microbicides
5575653|NCT00984971|Tenofovir|tenofovir
5575654|NCT00984971|HIV seronegativity|hiv seronegativity
5575655|NCT00984945|pandemic vaccine|pandemic vaccine
5575656|NCT00984945|influenza|influenza
5575657|NCT00984945|H5N1|h5n1
5575658|NCT00984945|Virus Like Particle (VLP)|virus like particle (vlp)
5575659|NCT00984932|systemic sclerosis|systemic sclerosis
5575660|NCT00984932|pulmonary hypertension|pulmonary hypertension
5575661|NCT00984932|rosuvastatin|rosuvastatin
5575662|NCT00984919|recurrent prostate cancer|recurrent prostate cancer
5575663|NCT00984919|stage I prostate cancer|stage i prostate cancer
5575664|NCT00984919|stage II prostate cancer|stage ii prostate cancer
5575665|NCT00984919|stage III prostate cancer|stage iii prostate cancer
5575666|NCT00984919|stage IV prostate cancer|stage iv prostate cancer
5575667|NCT00984893|Osteoporosis|osteoporosis
5575668|NCT00984893|Bone Mineral density|bone mineral density
5575669|NCT00984893|fragility fractures|fragility fractures
5575670|NCT00984893|zoledronic acid.|zoledronic acid.
5575671|NCT00984893|Treatment|treatment
5575672|NCT00984880|Sedation|sedation
5575673|NCT00984880|anaesthesia|anaesthesia
5575674|NCT00984880|Safety|safety
5575675|NCT00984880|Tolerability|tolerability
5575676|NCT00984880|Pharmacokinetics|pharmacokinetics
5575677|NCT00984880|Pharmacodynamics|pharmacodynamics
5575678|NCT00984867|Dapagliflozin DPP IV inhibitor add on study|dapagliflozin dpp iv inhibitor add on study
5575679|NCT00984867|Inadequate control|inadequate control
5575680|NCT00984854|Cicatrix|cicatrix
5575681|NCT00984854|Scar|scar
5575682|NCT00984854|Wound-healing|wound-healing
5575683|NCT00984854|Re-epithelialisation|re-epithelialisation
5575684|NCT00984854|RN1004|rn1004
5575685|NCT00984854|Mannose-6-phosphate|mannose-6-phosphate
5575686|NCT00984854|M6P|m6p
5575687|NCT00984854|Juvidex|juvidex
5575688|NCT00984841|Diabetes Mellitus targeted mailing|diabetes mellitus targeted mailing
5575689|NCT00984828|multiple myeloma|multiple myeloma
5575690|NCT00984828|autologous stem cell transplantation|autologous stem cell transplantation
5575691|NCT00984828|velcade|velcade
5575692|NCT00984815|NSAID|nsaid
5575693|NCT00984815|Chronic Pain|chronic pain
5575694|NCT00984815|Osteoarthritis|osteoarthritis
5575695|NCT00984815|Rheumatoid Arthritis|rheumatoid arthritis
5575696|NCT00984789|Transdermal Patch|transdermal patch
5575697|NCT00984789|Bleeding|bleeding
5575698|NCT00984789|Pregnancy|pregnancy
5575699|NCT00984776|coronary artery|coronary artery
5575700|NCT00984776|MRI|mri
5575701|NCT00984776|vessel wall imaging|vessel wall imaging
5575702|NCT00984763|Malaria|malaria
5575703|NCT00984763|Vaccine|vaccine
5575704|NCT00984724|Smoking|smoking
5575705|NCT00984724|Motivation and Problem Solving|motivation and problem solving
5575706|NCT00984724|MAPS|maps
5575707|NCT00984724|Low Income Smokers|low income smokers
5575708|NCT00984724|HCHD community clinics|hchd community clinics
5575709|NCT00984724|Telephone-based counseling|telephone-based counseling
5575710|NCT00984698|Posttraumatic Stress Disorder|posttraumatic stress disorder
5575711|NCT00984698|Depression|depression
5575712|NCT00984698|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5575713|NCT00984698|Insomnia|insomnia
5575714|NCT00984698|Psychotherapy, Group|psychotherapy, group
5575715|NCT00984698|Cognitive Behavioral Therapy|cognitive behavioral therapy
5575716|NCT00984698|Randomized Controlled Trial|randomized controlled trial
5575717|NCT00984698|Veterans|veterans
5575718|NCT00984698|Social Rhythms|social rhythms
5575719|NCT00984672|Lumbar Degenerative Disease|lumbar degenerative disease
5575720|NCT00984672|Bone Morphogenetic Protein|bone morphogenetic protein
5575721|NCT00984672|TLIF|tlif
5575722|NCT00984659|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5575724|NCT00984646|Cicatrix|cicatrix
5575725|NCT00984646|Scar|scar
5575726|NCT00984646|Wound-healing|wound-healing
5575727|NCT00984646|Prevascar|prevascar
5575728|NCT00984646|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5575729|NCT00984646|Ilodecakin|ilodecakin
5575730|NCT00984646|RN1003|rn1003
5575731|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents
5575732|NCT00984607|Laparoscopic Gastric Band|laparoscopic gastric band
5575733|NCT00984607|LAP BAND system|lap band system
5575734|NCT00984594|allograft|allograft
5575735|NCT00984594|knee injury|knee injury
5575736|NCT00984594|cartilage injury|cartilage injury
5575737|NCT00984581|Cicatrix|cicatrix
5575738|NCT00984581|Scar|scar
5575740|NCT00984581|Avotermin|avotermin
5575741|NCT00984581|TGF beta 3|tgf beta 3
5575742|NCT00984581|Juvista|juvista
5575743|NCT00984581|RN1001|rn1001
5575744|NCT00984555|Biomarkers|biomarkers
5575745|NCT00984555|Semen Exposure|semen exposure
5575746|NCT00984542|recurrent small cell lung cancer|recurrent small cell lung cancer
5575747|NCT00984529|Chronic heart failure|chronic heart failure
5575748|NCT00984529|candesartan cilexetil|candesartan cilexetil
5575749|NCT00984529|clinical signs|clinical signs
5575750|NCT00984529|symptoms|symptoms
5575751|NCT00984516|Cicatrix|cicatrix
5575752|NCT00984516|Scar|scar
5575753|NCT00984516|Wound-healing|wound-healing
5575754|NCT00984516|Juvidex|juvidex
5575755|NCT00984516|Mannose-6-phosphate|mannose-6-phosphate
5575756|NCT00984516|M6P|m6p
5575757|NCT00984516|RN1004|rn1004
5575758|NCT00984503|Cicatrix|cicatrix
5575759|NCT00984503|Scar|scar
5575760|NCT00984503|Wound healing|wound healing
5575761|NCT00984503|Avotermin|avotermin
5575762|NCT00984503|TGF beta 3|tgf beta 3
5575763|NCT00984503|Juvista|juvista
5575764|NCT00984503|RN1001|rn1001
5575765|NCT00984490|stage I breast cancer|stage i breast cancer
5575766|NCT00984490|stage II breast cancer|stage ii breast cancer
5575767|NCT00984477|Healthy volunteer|healthy volunteer
5575768|NCT00984477|healthy subjects|healthy subjects
5575769|NCT00984477|AZD5122|azd5122
5575770|NCT00984477|single oral dose|single oral dose
5575771|NCT00984477|phase 1|phase 1
5575772|NCT00984477|Healthy volunteer phase 1 study|healthy volunteer phase 1 study
5575773|NCT00984464|metastatic|metastatic
5575774|NCT00984464|melanoma|melanoma
5575775|NCT00984464|REOLYSIN|reolysin
5575776|NCT00984464|chemotherapy|chemotherapy
5575778|NCT00984464|paclitaxel|paclitaxel
5575779|NCT00984451|Antibody Treatment|antibody treatment
5575780|NCT00984451|Immune Therapy|immune therapy
5575781|NCT00984451|Infectious Diseases|infectious diseases
5575782|NCT00984451|IVIG|ivig
5575783|NCT00984451|Plasma Apheresis|plasma apheresis
5575784|NCT00984451|Influenza A|influenza a
5575785|NCT00984451|Swine Flu|swine flu
5575786|NCT00984399|vaginitis|vaginitis
5575787|NCT00984399|Postmenopausal|postmenopausal
5575788|NCT00984399|17-β estradiol|17-β estradiol
5575789|NCT00984399|09-110|09-110
5575790|NCT00984386|Cicatrix|cicatrix
5575792|NCT00984386|Wound-healing|wound-healing
5575793|NCT00984386|Zesteem|zesteem
5575794|NCT00984386|17β-Estradiol|17β-estradiol
5575795|NCT00984386|RN1002|rn1002
5575796|NCT00984373|Schizophrenia epidemiology|schizophrenia epidemiology
5575797|NCT00984373|Schizophrenic patients' social and health characteristics|schizophrenic patients' social and health characteristics
5575799|NCT00984360|Methamphetamine Addiction|methamphetamine addiction
5575800|NCT00984360|Methamphetamine Treatment|methamphetamine treatment
5575801|NCT00984360|Naltrexone|naltrexone
5575802|NCT00984360|Vivitrol|vivitrol
5575804|NCT00984360|OPRM1|oprm1
5575805|NCT00984347|nipple stimulation|nipple stimulation
5575806|NCT00984347|Oxytocin|oxytocin
5575807|NCT00984347|induction of labor|induction of labor
5575808|NCT00984347|term pregnancies|term pregnancies
5575809|NCT00984347|grandmultipara|grandmultipara
5575810|NCT00984347|VBAC|vbac
5575811|NCT00984347|PROM|prom
5575812|NCT00984347|comparison of two methods for induction of labor|comparison of two methods for induction of labor
5575813|NCT00984334|pain|pain
5575814|NCT00984334|opioid|opioid
5575815|NCT00984334|constipation|constipation
5575816|NCT00984334|Subjects taking opioids for chronic non-cancer pain, who|subjects taking opioids for chronic non-cancer pain, who
5575817|NCT00984334|experience symptoms of opioid induced constipation|experience symptoms of opioid induced constipation
5575818|NCT00984321|Geriatric|geriatric
5575819|NCT00984321|Elderly|elderly
5575820|NCT00984321|Counseling|counseling
5575821|NCT00984321|Depression|depression
5575822|NCT00984321|Anxiety|anxiety
5575823|NCT00984321|Intervention|intervention
5575824|NCT00984321|Psychoeducational|psychoeducational
5575825|NCT00984321|09-116|09-116
5575826|NCT00984308|sleep apnea|sleep apnea
5575827|NCT00984308|hypertension|hypertension
5575828|NCT00984308|brain ischemia|brain ischemia
5575829|NCT00984282|RAI-Refractory|rai-refractory
5575830|NCT00984282|Differentiated|differentiated
5575831|NCT00984282|Follicular|follicular
5575832|NCT00984282|Papillary|papillary
5575833|NCT00984282|Hurthle|hurthle
5575834|NCT00984256|Malaria|malaria
5575835|NCT00984256|Prophylaxis|prophylaxis
5575836|NCT00984256|Atovaquone|atovaquone
5575837|NCT00984256|Malarone|malarone
5575838|NCT00984256|Challenge|challenge
5575839|NCT00984243|lung cancer|lung cancer
5575840|NCT00984230|Infant Formula|infant formula
5575841|NCT00984230|Gut|gut
5575842|NCT00984217|panitumumab|panitumumab
5575843|NCT00984217|salivary gland malignancies|salivary gland malignancies
5575844|NCT00984217|radiotherapy|radiotherapy
5575845|NCT00984204|cavo-tricuspid dependent|cavo-tricuspid dependent
5575846|NCT00984191|Papillary thyroid cancer|papillary thyroid cancer
5575847|NCT00984191|99mTechnetium MIBI SPECT CT|99mtechnetium mibi spect ct
5575849|NCT00984191|cervical lymphadenopathy|cervical lymphadenopathy
5575850|NCT00984191|cervical metastasis|cervical metastasis
5575851|NCT00984178|Reperfusion|reperfusion
5575852|NCT00984178|acute myocardial infarction|acute myocardial infarction
5575853|NCT00984178|stem cell therapy|stem cell therapy
5575854|NCT00984178|GCSF|gcsf
5575855|NCT00984178|bone marrow mononuclear cells|bone marrow mononuclear cells
5575856|NCT00984178|magnetic resonance|magnetic resonance
5575857|NCT00984165|Allotransplant|allotransplant
5575858|NCT00984165|Relapse|relapse
5575859|NCT00984165|Radiation|radiation
5575860|NCT00984165|Donor Lymphocyte Infusion|donor lymphocyte infusion
5575861|NCT00984165|Hematologic Malignancies|hematologic malignancies
5575862|NCT00984165|Multiple Myeloma|multiple myeloma
5575863|NCT00984165|Hodgkin Lymphoma|hodgkin lymphoma
5575864|NCT00984165|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5575865|NCT00984165|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5575866|NCT00984152|HIV|hiv
5575867|NCT00984152|Raltegravir|raltegravir
5575868|NCT00984152|Women|women
5575869|NCT00984152|Viral Suppression|viral suppression
5575870|NCT00984152|Viral Reservoir|viral reservoir
5575871|NCT00984152|Immune Parameters|immune parameters
5575872|NCT00984152|Gut|gut
5575873|NCT00984152|Genital Tract|genital tract
5575874|NCT00984139|persistence|persistence
5575875|NCT00984139|HBV|hbv
5575876|NCT00984139|Long-term|long-term
5575877|NCT00984139|Engerix™-B Kinder|engerix™-b kinder
5575878|NCT00984139|Hepatitis B|hepatitis b
5575879|NCT00984139|adolescent|adolescent
5575880|NCT00984113|Elinogrel|elinogrel
5575881|NCT00984113|Renal impairment|renal impairment
5575882|NCT00984113|Healthy|healthy
5575883|NCT00984113|Kidney dysfunction|kidney dysfunction
5575884|NCT00984100|Cholelithiasis|cholelithiasis
5575885|NCT00984100|Biliary dyskinesia|biliary dyskinesia
5575886|NCT00984087|depression|depression
5575887|NCT00984087|TMS|tms
5575888|NCT00984087|adolescent|adolescent
5575889|NCT00984087|transcranial magnetic stimulation|transcranial magnetic stimulation
5575890|NCT00984087|MDD|mdd
5575891|NCT00984087|Major depression|major depression
5575892|NCT00984087|mood disorders|mood disorders
5575893|NCT00984074|stage III salivary gland cancer|stage iii salivary gland cancer
5575894|NCT00984074|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5575895|NCT00984074|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5578488|NCT00974350|opioid|opioid
5575896|NCT00984074|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5575897|NCT00984074|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5575898|NCT00984074|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5575899|NCT00984074|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5575900|NCT00984074|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5575901|NCT00984074|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5575902|NCT00984074|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5575903|NCT00984074|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5575904|NCT00984074|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5575905|NCT00984074|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5575906|NCT00984074|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5575907|NCT00984074|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5575908|NCT00984074|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5575909|NCT00984074|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5575910|NCT00984074|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5575911|NCT00984074|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5575912|NCT00984074|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5575913|NCT00984074|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5575914|NCT00984074|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5750584|NCT00317720|RAD001|rad001
5575915|NCT00984074|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5575916|NCT00984074|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5575917|NCT00984074|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5575918|NCT00984074|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5575919|NCT00984074|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5575920|NCT00984074|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5575921|NCT00984074|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5575922|NCT00984074|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5575923|NCT00984074|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5575924|NCT00984074|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5575925|NCT00984074|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5557984|NCT01054235|prenatal care|prenatal care
5575926|NCT00984074|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5575927|NCT00984074|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5575928|NCT00984074|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5575929|NCT00984074|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5575930|NCT00984074|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5575931|NCT00984074|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5575932|NCT00984074|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5575933|NCT00984074|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5575934|NCT00984074|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5575935|NCT00984074|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5575936|NCT00984074|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5575937|NCT00984074|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5575938|NCT00984074|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5575939|NCT00984074|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5575940|NCT00984074|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5576164|NCT00983346|multiple myeloma|multiple myeloma
5862971|NCT00001440|T-Cell Repopulation|t-cell repopulation
5575941|NCT00984074|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5575942|NCT00984074|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5575943|NCT00984074|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5575944|NCT00984074|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5575945|NCT00984074|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5575946|NCT00984074|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5575947|NCT00984074|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5798734|NCT00111241|aromatase inhibitors|aromatase inhibitors
5575948|NCT00984074|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5680329|NCT00578201|Fluorouracil|fluorouracil
5680330|NCT00578201|radiotherapy|radiotherapy
5575949|NCT00984074|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5575950|NCT00984074|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5575951|NCT00984074|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5575952|NCT00984074|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5575953|NCT00984074|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5575954|NCT00984074|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5575955|NCT00984074|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5575956|NCT00984074|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5575957|NCT00984074|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5575958|NCT00984074|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5575959|NCT00984074|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5575960|NCT00984074|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5904051|NCT00007813|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5575961|NCT00984074|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5575962|NCT00984074|recurrent salivary gland cancer|recurrent salivary gland cancer
5575963|NCT00984074|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5575964|NCT00984074|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5575965|NCT00984074|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5575966|NCT00984074|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5575967|NCT00984074|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5575968|NCT00984074|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5575969|NCT00984074|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5575970|NCT00984074|stage I salivary gland cancer|stage i salivary gland cancer
5575971|NCT00984074|stage II salivary gland cancer|stage ii salivary gland cancer
5575972|NCT00984074|tongue cancer|tongue cancer
5575974|NCT00984061|pharmacokinetics|pharmacokinetics
5575975|NCT00984061|drug-drug interaction|drug-drug interaction
5575976|NCT00984048|Colorectal cancer|colorectal cancer
5575977|NCT00984048|FOLFOX|folfox
5575978|NCT00984048|FOLFIRI|folfiri
5575979|NCT00984048|Avastin|avastin
5575980|NCT00984048|Metastases|metastases
5575981|NCT00984048|Liver|liver
5575982|NCT00984048|Colon cancer|colon cancer
5575983|NCT00984048|Biomarkers|biomarkers
5575984|NCT00984048|Resistance|resistance
5575985|NCT00984048|Biobanking|biobanking
5575986|NCT00984048|Colorectal cancer with unresectable metastases to the liver|colorectal cancer with unresectable metastases to the liver
5575987|NCT00984022|abscess|abscess
5575988|NCT00984022|MRSA|mrsa
5575989|NCT00984022|Aquacel dressing|aquacel dressing
5575990|NCT00984022|Iodoform dressing|iodoform dressing
5575991|NCT00984009|healthy|healthy
5575992|NCT00984009|pharmacokinetics|pharmacokinetics
5575993|NCT00984009|grapefruit juice|grapefruit juice
5575994|NCT00984009|furanocoumarins|furanocoumarins
5575995|NCT00984009|cytochrome p450 3A4|cytochrome p450 3a4
5575996|NCT00983983|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5575997|NCT00983983|ALS|als
5575998|NCT00983983|Motor Neuron Disease|motor neuron disease
5575999|NCT00983983|MND|mnd
5576000|NCT00983983|Fat|fat
5576001|NCT00983983|Lipid|lipid
5576002|NCT00983983|Cholesterol|cholesterol
5576003|NCT00983983|Omega-3 fatty acid|omega-3 fatty acid
5576004|NCT00983983|Diet|diet
5576005|NCT00983983|Tube feed|tube feed
5576006|NCT00983983|Gastrostomy|gastrostomy
5576007|NCT00983983|PEG|peg
5576008|NCT00983983|Adults with Amyotrophic Lateral Sclerosis (ALS)|adults with amyotrophic lateral sclerosis (als)
5576009|NCT00983970|Adolescents|adolescents
5576010|NCT00983970|Obesity|obesity
5576011|NCT00983970|Exercise|exercise
5576012|NCT00983970|Music|music
5576013|NCT00983970|Virtual Reality|virtual reality
5576014|NCT00983944|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5576015|NCT00983944|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5576016|NCT00983944|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5576017|NCT00983944|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5576018|NCT00983944|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5576019|NCT00983944|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5576020|NCT00983944|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5576021|NCT00983944|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5006021|NCT03958929|educational intervention|educational intervention
5576022|NCT00983944|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5576023|NCT00983944|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5576024|NCT00983931|healthy|healthy
5576025|NCT00983931|adult|adult
5576026|NCT00983931|colchicine|colchicine
5576027|NCT00983931|cyclosporine|cyclosporine
5576028|NCT00983931|blood levels over time|blood levels over time
5576029|NCT00983905|healthy;|healthy;
5576030|NCT00983905|adult;|adult;
5576031|NCT00983905|blood levels over time|blood levels over time
5576032|NCT00983892|Cancer|cancer
5576033|NCT00983892|caregiver|caregiver
5576034|NCT00983892|pain|pain
5576035|NCT00983892|symptom|symptom
5576036|NCT00983892|information technology|information technology
5576037|NCT00983892|palliative care|palliative care
5576038|NCT00983879|Infantile globoid cell leukodystrophy|infantile globoid cell leukodystrophy
5576040|NCT00983879|Krabbe disease|krabbe disease
5576041|NCT00983879|Natural History Study|natural history study
5576042|NCT00983853|VX-950|vx-950
5576043|NCT00983853|INCIVEK|incivek
5576044|NCT00983853|INCIVO|incivo
5576045|NCT00983840|diet|diet
5576046|NCT00983840|African-American families|african-american families
5576047|NCT00983840|web-based|web-based
5576048|NCT00983814|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5576049|NCT00983814|ADHD|adhd
5576050|NCT00983814|Adult ADHD|adult adhd
5576051|NCT00983814|Adult Attention Deficit Hyperactivity Disorder|adult attention deficit hyperactivity disorder
5576052|NCT00983788|CPT II|cpt ii
5750846|NCT00316745|S-1|s-1
5576053|NCT00983788|VLCAD|vlcad
5576054|NCT00983775|Pharmacokinetic profile|pharmacokinetic profile
5576055|NCT00983775|Pharmacodynamic profile|pharmacodynamic profile
5576056|NCT00983775|insulin|insulin
5576057|NCT00983775|jet injector|jet injector
5576058|NCT00983762|Knee osteoarthritis|knee osteoarthritis
5576059|NCT00983762|Leg strength|leg strength
5576060|NCT00983762|Functional outcomes|functional outcomes
5576061|NCT00983762|Minimally Invasive Surgery Mini-Incision (MIS) TKA|minimally invasive surgery mini-incision (mis) tka
5576062|NCT00983762|Unicompartmental knee arthroplasty|unicompartmental knee arthroplasty
5576063|NCT00983762|Standard Para-patellar surgery TKA|standard para-patellar surgery tka
5576064|NCT00983762|gait|gait
5576065|NCT00983762|knee arthroplasty|knee arthroplasty
5576066|NCT00983749|External Counterpulsation|external counterpulsation
5576067|NCT00983749|Counterpulsation, Diastolic|counterpulsation, diastolic
5576068|NCT00983749|Ultrasonography, Doppler, Transcranial|ultrasonography, doppler, transcranial
5576069|NCT00983749|Blood Flow Velocity|blood flow velocity
5576070|NCT00983749|Neurologic Deficit|neurologic deficit
5576071|NCT00983723|Patient Foramen Ovale|patient foramen ovale
5576072|NCT00983723|PFO|pfo
5576073|NCT00983723|Stroke|stroke
5576074|NCT00983723|Ischemic Brain Injury|ischemic brain injury
5576075|NCT00983723|Neurovascular Disease|neurovascular disease
5576076|NCT00983710|prostate neoplasms|prostate neoplasms
5576077|NCT00983697|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5576078|NCT00983697|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5576079|NCT00983697|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5576080|NCT00983697|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5576081|NCT00983697|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5576082|NCT00983697|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5576083|NCT00983697|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5576084|NCT00983697|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5576085|NCT00983697|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5576086|NCT00983697|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5576087|NCT00983697|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5862972|NCT00001440|Apheresis|apheresis
5576088|NCT00983697|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5576090|NCT00983684|Neoplasms by Site|neoplasms by site
5576091|NCT00983684|Breast Neoplasms|breast neoplasms
5576092|NCT00983684|Breast Diseases|breast diseases
5576093|NCT00983684|Breast Cancer|breast cancer
5576094|NCT00983684|Cancer of Breast|cancer of breast
5576095|NCT00983684|Cancer of the Breast|cancer of the breast
5576096|NCT00983684|Carcinoma|carcinoma
5576097|NCT00983671|Asthma|asthma
5576098|NCT00983671|cystic fibrosis|cystic fibrosis
5576099|NCT00983671|chronic lung disease|chronic lung disease
5576100|NCT00983671|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5576101|NCT00983671|pneumonia|pneumonia
5576102|NCT00983658|Anti-OX40L|anti-ox40l
5576103|NCT00983658|Mild Allergic Asthma|mild allergic asthma
5576104|NCT00983658|Allergies|allergies
5576105|NCT00983658|Allergic Asthma|allergic asthma
5576106|NCT00983658|Adult Asthma|adult asthma
5576107|NCT00983645|Kidney Transplantation|kidney transplantation
5576108|NCT00983645|Immunosuppression|immunosuppression
5576109|NCT00983632|vagus nerve stimulation|vagus nerve stimulation
5576110|NCT00983632|heart rate|heart rate
5576111|NCT00983632|systolic arterial pressure|systolic arterial pressure
5576112|NCT00983619|Cancer|cancer
5576114|NCT00983593|Domestic Violence Offender Treatment|domestic violence offender treatment
5576115|NCT00983593|Batterer Treatment|batterer treatment
5576116|NCT00983554|testosterone|testosterone
5576117|NCT00983554|insulin|insulin
5576118|NCT00983554|obesity|obesity
5576119|NCT00983554|aromatase|aromatase
5576120|NCT00983554|5 alpha reductase|5 alpha reductase
5576121|NCT00983541|intra or extrahepatic cholangiocarcinoma|intra or extrahepatic cholangiocarcinoma
5576122|NCT00983541|liver cancer|liver cancer
5576123|NCT00983541|liver|liver
5576124|NCT00983541|HCC|hcc
5576125|NCT00983541|EHCC|ehcc
5576126|NCT00983528|cancer|cancer
5576127|NCT00983528|lymphoblastic|lymphoblastic
5576128|NCT00983528|leukemia|leukemia
5576129|NCT00983502|Idiopathic Chronic Fatigue|idiopathic chronic fatigue
5576130|NCT00983502|Chronic Fatigue Syndrome|chronic fatigue syndrome
5576131|NCT00983502|Myalgic encephalomyelitis|myalgic encephalomyelitis
5576132|NCT00983489|breast feeding|breast feeding
5576133|NCT00983489|counselling|counselling
5576134|NCT00983489|video demonstration|video demonstration
5576135|NCT00983476|Randomized controlled trial|randomized controlled trial
5576136|NCT00983476|Obesity|obesity
5576137|NCT00983476|Comparative Effectiveness|comparative effectiveness
5576138|NCT00983476|Clinical practice guidelines|clinical practice guidelines
5904052|NCT00007813|recurrent childhood ependymoma|recurrent childhood ependymoma
5576139|NCT00983476|Medical Informatics Computing|medical informatics computing
5576140|NCT00983476|Services, Mental Health|services, mental health
5576141|NCT00983476|Self-care|self-care
5576142|NCT00983476|Psychotic disorders|psychotic disorders
5576143|NCT00983476|Mental Health Care|mental health care
5576144|NCT00983476|Veterans|veterans
5576145|NCT00983463|Nonalcoholic fatty liver disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5685404|NCT00556218|Quality of Life|quality of life
5576146|NCT00983463|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5576147|NCT00983463|Obesity|obesity
5576148|NCT00983463|Lipidomics|lipidomics
5576149|NCT00983463|Proteomics|proteomics
5576150|NCT00983424|Breast Cancer|breast cancer
5576151|NCT00983411|non-invasive intermittent positive-pressure ventilation|non-invasive intermittent positive-pressure ventilation
5576152|NCT00983411|work of breathing|work of breathing
5576153|NCT00983411|Pulse transit time|pulse transit time
5576154|NCT00983385|low back pain|low back pain
5576155|NCT00983385|pain|pain
5576156|NCT00983385|assessment|assessment
5576157|NCT00983385|tapentadol|tapentadol
5576158|NCT00983385|centrally acting analgesic|centrally acting analgesic
5576159|NCT00983372|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time|healthy; adult; volunteer; colchicine; diltiazem; blood levels over time
5576160|NCT00983359|tumors metastatic to brain|tumors metastatic to brain
5576161|NCT00983359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5576162|NCT00983346|cancer|cancer
5576163|NCT00983346|myeloma|myeloma
5576165|NCT00983346|smoldering myeloma|smoldering myeloma
5576166|NCT00983333|Health communication|health communication
5576167|NCT00983333|Health literacy|health literacy
5576168|NCT00983333|Patient|patient
5576169|NCT00983333|Health Care Professional|health care professional
5576170|NCT00983333|Satisfaction|satisfaction
5576171|NCT00983320|Fibromyalgia|fibromyalgia
5576172|NCT00983320|pain|pain
5576173|NCT00983320|quetiapine|quetiapine
5576174|NCT00983320|randomized placebo controlled trial|randomized placebo controlled trial
5576175|NCT00983307|Radiation|radiation
5576176|NCT00983307|Erlotinib|erlotinib
5576177|NCT00983307|Tarceva|tarceva
5576178|NCT00983294|blood levels over time;|blood levels over time;
5576179|NCT00983294|colchicine;|colchicine;
5576180|NCT00983294|azithromycin;|azithromycin;
5576181|NCT00983294|healthy|healthy
5576182|NCT00983281|Combat casualty care|combat casualty care
5576183|NCT00983281|Hextend|hextend
5576184|NCT00983281|Colloid|colloid
5570329|NCT01005251|Heartburn|heartburn
5576185|NCT00983268|periampullary adenocarcinoma|periampullary adenocarcinoma
5576186|NCT00983268|stage I pancreatic cancer|stage i pancreatic cancer
5576187|NCT00983268|stage II pancreatic cancer|stage ii pancreatic cancer
5576188|NCT00983268|stage III pancreatic cancer|stage iii pancreatic cancer
5576189|NCT00983229|difficult airway|difficult airway
5576190|NCT00983229|fibreoptic intubation|fibreoptic intubation
5576191|NCT00983229|supraglottic airways|supraglottic airways
5576192|NCT00983229|laryngeal mask airway|laryngeal mask airway
5576193|NCT00983216|blood levels over time;|blood levels over time;
5576194|NCT00983216|pharmacokinetics;|pharmacokinetics;
5576195|NCT00983216|healthy adult;|healthy adult;
5576196|NCT00983216|cytochrome p450|cytochrome p450
5576197|NCT00983203|Dry eye|dry eye
5576198|NCT00983203|artificial tears|artificial tears
5576199|NCT00983190|HeartMate II|heartmate ii
5576200|NCT00983190|BeneMACS|benemacs
5576201|NCT00983190|LVAD|lvad
5576202|NCT00983190|Thoratec Corporation|thoratec corporation
5576203|NCT00983164|antiviral therapy|antiviral therapy
5576204|NCT00983164|antioxidant therapy|antioxidant therapy
5576205|NCT00983164|hepatitis C virus|hepatitis c virus
5576206|NCT00983164|oxidative stress|oxidative stress
5576207|NCT00983164|vitamin E|vitamin e
5576208|NCT00983125|Labour|labour
5576209|NCT00983125|Epidural analgesia|epidural analgesia
5576210|NCT00983125|Clonidine|clonidine
5576211|NCT00983125|Levobupivacaine|levobupivacaine
5576212|NCT00983125|Opiates|opiates
5576213|NCT00983125|Patient-controlled|patient-controlled
5576214|NCT00983125|Active spontaneous labour requiring epidural analgesia|active spontaneous labour requiring epidural analgesia
5576215|NCT00983112|Gonarthrosis|gonarthrosis
5576216|NCT00983112|Knee prosthesis insertion|knee prosthesis insertion
5576217|NCT00983112|Bleeding|bleeding
5576218|NCT00983112|Undergoing a total knee prothesis surgery|undergoing a total knee prothesis surgery
5576219|NCT00983112|knee prothesis surgery|knee prothesis surgery
5576220|NCT00983112|Knee arthrosis|knee arthrosis
5576221|NCT00983112|Thrombosis|thrombosis
5576222|NCT00983086|Flavanones and vascular function|flavanones and vascular function
5576223|NCT00983073|Osteoarthritis|osteoarthritis
5576224|NCT00983073|Pain|pain
5576225|NCT00983073|Assessment|assessment
5576226|NCT00983073|Tapentadol|tapentadol
5576227|NCT00983073|Centrally acting analgesic|centrally acting analgesic
5576228|NCT00983073|Chronic pain due to osteoarthritis|chronic pain due to osteoarthritis
5576229|NCT00983060|NIM811|nim811
5576230|NCT00983060|chronic hepatitis|chronic hepatitis
5576231|NCT00983060|chronic hepatitis C|chronic hepatitis c
5576232|NCT00983060|chronic hepatitis C genotype-1|chronic hepatitis c genotype-1
5576233|NCT00983060|HCV|hcv
5576234|NCT00983060|HCV-1|hcv-1
5576235|NCT00983060|relapser|relapser
5576236|NCT00983047|Nimotuzumab|nimotuzumab
5576237|NCT00983047|NSCLC|nsclc
5576238|NCT00983047|Docetaxel|docetaxel
5576239|NCT00983034|nephrotic syndrome|nephrotic syndrome
5576240|NCT00983034|Helicobacter pylori infection|helicobacter pylori infection
5576241|NCT00983034|proteinuria|proteinuria
5576242|NCT00983034|membranous nephropathy|membranous nephropathy
5576244|NCT00983008|Internship and Residency|internship and residency
5576246|NCT00983008|Medical Errors|medical errors
5576247|NCT00983008|Burnout, Professional|burnout, professional
5576248|NCT00983008|Actigraphy|actigraphy
5576249|NCT00983008|Personnel Staffing and Scheduling|personnel staffing and scheduling
5576250|NCT00983008|Workload|workload
5576251|NCT00983008|Adult|adult
5576252|NCT00983008|Intensive Care Units|intensive care units
5576253|NCT00983008|Prospective Studies|prospective studies
5576254|NCT00983008|Work Schedule Tolerance|work schedule tolerance
5576255|NCT00983008|Disorders of Excessive Somnolence|disorders of excessive somnolence
5576256|NCT00983008|Guideline Adherence|guideline adherence
5576257|NCT00983008|Internal Medicine Education|internal medicine education
5576258|NCT00982982|Schizophrenia|schizophrenia
5576259|NCT00982982|Mental Disorders|mental disorders
5576260|NCT00982982|Psychotic Disorders|psychotic disorders
5576261|NCT00982982|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5576262|NCT00982982|Cannabis|cannabis
5576263|NCT00982969|tuberculosis|tuberculosis
5576264|NCT00982969|pneumonia|pneumonia
5576265|NCT00982969|QuantiFERON-TB Gold in-tube|quantiferon-tb gold in-tube
5576266|NCT00982969|Tuberculin skin test|tuberculin skin test
5576267|NCT00982930|Tobramycin Inhalation Powder|tobramycin inhalation powder
5576268|NCT00982930|Cystic fibrosis|cystic fibrosis
5576269|NCT00982930|Lung diseases|lung diseases
5576270|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents
5576271|NCT00982917|playground|playground
5576272|NCT00982917|injury prevention|injury prevention
5576273|NCT00982904|neglected disease|neglected disease
5576274|NCT00982904|africa|africa
5576275|NCT00982904|new drug|new drug
5576276|NCT00982904|oral drug|oral drug
5576277|NCT00982904|parasite|parasite
5576278|NCT00982891|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5576279|NCT00982891|palliation|palliation
5576280|NCT00982891|opioids|opioids
5576281|NCT00982878|treatment experienced|treatment experienced
5862973|NCT00001440|RAS|ras
5576282|NCT00982865|MEK inhibitor|mek inhibitor
5576284|NCT00982865|Solid tumors|solid tumors
5576285|NCT00982852|Angioplasty|angioplasty
5576286|NCT00982852|Coronary Vessels|coronary vessels
5576287|NCT00982852|Heart Disease|heart disease
5576288|NCT00982852|Cardiology|cardiology
5576289|NCT00982852|Atherosclerosis|atherosclerosis
5576290|NCT00982852|Catheterization|catheterization
5576291|NCT00982826|Phase 1|phase 1
5576292|NCT00982826|Single and Multiple Ascending Dose|single and multiple ascending dose
5576293|NCT00982826|Food Effect|food effect
5576294|NCT00982813|Periodontal disease|periodontal disease
5576295|NCT00982813|Per-term delivery|per-term delivery
5576296|NCT00982813|Sulcular bleeding index|sulcular bleeding index
5576297|NCT00982813|Bacteriological gingival presence|bacteriological gingival presence
5576298|NCT00982813|Cytokines|cytokines
5680331|NCT00578188|Adolescent Health|adolescent health
5576299|NCT00982813|Active periodontal disease with sulcular bleeding index|active periodontal disease with sulcular bleeding index
5576300|NCT00982813|Bacteriological sampling in periodontal pocketing|bacteriological sampling in periodontal pocketing
5576301|NCT00982813|Cytokines in the periodontal pocketing|cytokines in the periodontal pocketing
5576302|NCT00982800|gabapentin|gabapentin
5576303|NCT00982800|opioid consumption|opioid consumption
5576305|NCT00982800|anxiety|anxiety
5576306|NCT00982800|quality of life|quality of life
5576307|NCT00982787|Epilepsy|epilepsy
5576308|NCT00982787|Seizures|seizures
5576309|NCT00982787|Passiflora|passiflora
5576311|NCT00982761|occupational drivers|occupational drivers
5576312|NCT00982761|health status|health status
5576313|NCT00982748|Fatigue|fatigue
5576314|NCT00982748|Chemotherapy|chemotherapy
5576315|NCT00982748|Yoga|yoga
5576316|NCT00982748|Breathing|breathing
5576317|NCT00982748|Cancer|cancer
5576318|NCT00982748|Anxiety|anxiety
5576319|NCT00982748|Pranayama|pranayama
5576320|NCT00982748|Stress|stress
5576321|NCT00982748|Fatigue-associated symptoms in chemotherapy patients|fatigue-associated symptoms in chemotherapy patients
5576322|NCT00982748|Quality of life in chemotherapy patients|quality of life in chemotherapy patients
5576323|NCT00982722|primary hyperparathyroidism|primary hyperparathyroidism
5576324|NCT00982722|postoperative vitamin D supplementation|postoperative vitamin d supplementation
5576325|NCT00982696|head and neck cancer|head and neck cancer
5576326|NCT00982696|opioid growth factor|opioid growth factor
5576327|NCT00982683|Surgery|surgery
5576328|NCT00982683|Moon phases|moon phases
5576329|NCT00982683|hemorrhage|hemorrhage
5576330|NCT00982670|Metabolic syndrome|metabolic syndrome
5904053|NCT00007813|childhood teratoma|childhood teratoma
5576331|NCT00982670|Systemic lupus erythematosus|systemic lupus erythematosus
5576332|NCT00982657|Phase Ib Phase II Advanced solid tumor Clear cell renal cancer Sunitinib plus / minus CVX-060|phase ib phase ii advanced solid tumor clear cell renal cancer sunitinib plus / minus cvx-060
5576333|NCT00982631|temsirolimus (Torisel®)|temsirolimus (torisel®)
5576334|NCT00982631|pegylated liposomal doxorubicin (PLD, Doxil®/ Caelyx®)|pegylated liposomal doxorubicin (pld, doxil®/ caelyx®)
5576335|NCT00982579|HIV preventive vaccine|hiv preventive vaccine
5576336|NCT00982553|Healthy Volunteers|healthy volunteers
5576337|NCT00982540|empiric antifungal therapy|empiric antifungal therapy
5576338|NCT00982540|preemptive antifungal therapy|preemptive antifungal therapy
5576339|NCT00982540|febrile neutropenia|febrile neutropenia
5576340|NCT00982540|risk stratification|risk stratification
5576341|NCT00982540|invasive fungal infection|invasive fungal infection
5576342|NCT00982527|cardiopulmonary bypass|cardiopulmonary bypass
5576343|NCT00982527|pediatric cardiac surgery|pediatric cardiac surgery
5576344|NCT00982527|acute renal failure|acute renal failure
5558474|NCT01052311|Statins|statins
5576345|NCT00982527|renal biomarkers|renal biomarkers
5576347|NCT00982527|Focus on optimization of perfusion during pediatric CPB|focus on optimization of perfusion during pediatric cpb
5576348|NCT00982514|Asparaginase|asparaginase
5576349|NCT00982514|thrombosis|thrombosis
5576351|NCT00982514|central line|central line
5576352|NCT00982501|(BMI 25-29,9 kg/m2)|(bmi 25-29,9 kg/m2)
5576353|NCT00982475|pulmonary vein isolation|pulmonary vein isolation
5576354|NCT00982475|robotic navigation|robotic navigation
5576355|NCT00982475|atrial fibrillation|atrial fibrillation
5576356|NCT00982462|cognition|cognition
5576357|NCT00982462|vision|vision
5576358|NCT00982462|immunology|immunology
5576359|NCT00982462|DHA|dha
5576360|NCT00982462|ARA|ara
5576361|NCT00982462|infant|infant
5576362|NCT00982462|nutrition|nutrition
5576363|NCT00982449|EBV+ malignancies|ebv+ malignancies
5576364|NCT00982449|KSHV+ malignancies|kshv+ malignancies
5576365|NCT00982449|HIV-associated lymphomas|hiv-associated lymphomas
5576366|NCT00982449|Hodgkin Lymphoma|hodgkin lymphoma
5576367|NCT00982449|nonHodgkin Lymphoma or|nonhodgkin lymphoma or
5576368|NCT00982449|nonHodgkins Lymphoproliferative Disease|nonhodgkins lymphoproliferative disease
5576369|NCT00982449|Primary Effusion Lymphoma|primary effusion lymphoma
5576370|NCT00982449|Kaposi's Sarcoma|kaposi's sarcoma
5576371|NCT00982449|Gastric Cancer|gastric cancer
5576372|NCT00982449|Nasopharyngeal Cancer|nasopharyngeal cancer
5576373|NCT00982436|Combined Modality Therapy|combined modality therapy
5576374|NCT00982436|Neoadjuvant Therapy|neoadjuvant therapy
5570513|NCT01004406|LDL|ldl
5576375|NCT00982436|Head and neck neoplasms|head and neck neoplasms
5576376|NCT00982423|heart failure|heart failure
5576377|NCT00982423|heart failure with and without kidney dysfunction|heart failure with and without kidney dysfunction
5576378|NCT00982410|pain|pain
5576379|NCT00982410|alcohol|alcohol
5576380|NCT00982410|illicit drugs|illicit drugs
5576381|NCT00982410|pain management|pain management
5576382|NCT00982384|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5576383|NCT00982384|Disease management|disease management
5576384|NCT00982384|Pulmonary rehabilitation|pulmonary rehabilitation
5576385|NCT00982384|Quality of life|quality of life
5576386|NCT00982371|type 2 diabetes mellitus|type 2 diabetes mellitus
5576387|NCT00982371|osteoporosis|osteoporosis
5576388|NCT00982371|bone quality|bone quality
5576389|NCT00982371|magnetic resonance imaging|magnetic resonance imaging
5576390|NCT00982371|fracture|fracture
5576391|NCT00982371|postmenopausal women >65 years old|postmenopausal women >65 years old
5561162|NCT01043068|opioid|opioid
5576392|NCT00982345|Depression|depression
5576393|NCT00982345|Anxiety|anxiety
5576394|NCT00982345|Seroquel|seroquel
5576395|NCT00982345|Quetiapine|quetiapine
5576396|NCT00982345|fMRI|fmri
5576397|NCT00982345|pictures|pictures
5576398|NCT00982332|polymyalgia rheumatica|polymyalgia rheumatica
5576399|NCT00982319|Broccoli Sprout Extract|broccoli sprout extract
5576400|NCT00982319|Breast Cancer|breast cancer
5576401|NCT00982306|alcohol|alcohol
5576402|NCT00982306|brief interventions|brief interventions
5576403|NCT00982306|counseling|counseling
5576404|NCT00982306|harmful/hazardous alcohol drinkers|harmful/hazardous alcohol drinkers
5576405|NCT00982280|Osteoarthritis|osteoarthritis
5576406|NCT00982280|pain assessment|pain assessment
5576407|NCT00982280|tapentadol|tapentadol
5576408|NCT00982280|centrally acting analgesic|centrally acting analgesic
5576409|NCT00982267|cancer|cancer
5576410|NCT00982254|Type 2 Diabetes|type 2 diabetes
5576411|NCT00982254|Oral Insulin|oral insulin
5576412|NCT00982254|Pharmacokinetics|pharmacokinetics
5576413|NCT00982254|Pharmacodynamics|pharmacodynamics
5576415|NCT00982241|urine|urine
5576416|NCT00982241|osmolality|osmolality
5576417|NCT00982241|urge|urge
5576418|NCT00982241|fluid intake|fluid intake
5576419|NCT00982241|PPIUS|ppius
5576420|NCT00982241|urge score|urge score
5576421|NCT00982241|bladder|bladder
5576422|NCT00982215|Paracetamol|paracetamol
5576423|NCT00982215|per-oral mucosa PMB|per-oral mucosa pmb
5576424|NCT00982215|No disease, healthy volunteers|no disease, healthy volunteers
5576425|NCT00982202|PPAR-gamma|ppar-gamma
5576426|NCT00982202|inflammation|inflammation
5576427|NCT00982189|treatment experienced|treatment experienced
5576428|NCT00982176|Anatomo-functional determinants|anatomo-functional determinants
5576429|NCT00982176|cognitive impairment|cognitive impairment
5576430|NCT00982176|coronary syndrome|coronary syndrome
5576431|NCT00982176|brain MRI|brain mri
5576432|NCT00982176|cerebral perfusion scintigraphy|cerebral perfusion scintigraphy
5576433|NCT00982150|Talampanel|talampanel
5576435|NCT00982150|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5576436|NCT00982137|Japanese Encephalitis|japanese encephalitis
5576437|NCT00982137|Yellow Fever|yellow fever
5576438|NCT00982137|ChimeriVax™-JE|chimerivax™-je
5576439|NCT00982137|STAMARIL®|stamaril®
5576440|NCT00982137|Adult|adult
5576441|NCT00982124|Osteogenesis Imperfecta|osteogenesis imperfecta
5576442|NCT00982124|Infants with moderate to severe Osteogenesis Imperfecta|infants with moderate to severe osteogenesis imperfecta
5576443|NCT00982111|Nonsquamous|nonsquamous
5576444|NCT00982111|Non Small Cell Lung Cancer|non small cell lung cancer
5576445|NCT00982111|First line treatment|first line treatment
5576446|NCT00982111|Monoclonal|monoclonal
5576447|NCT00982111|Antibodies|antibodies
5576448|NCT00982111|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5576449|NCT00982098|Prostatectomy|prostatectomy
5576450|NCT00982098|Prostatic cancer|prostatic cancer
5576451|NCT00982098|Urinary incontinence|urinary incontinence
5576452|NCT00982098|Exercise|exercise
5576453|NCT00982098|Electric stimulation therapy|electric stimulation therapy
5576454|NCT00982098|Counseling|counseling
5576455|NCT00982085|Asthma|asthma
5576456|NCT00982085|Allergic rhinitis|allergic rhinitis
5576457|NCT00982085|Military|military
5576458|NCT00982072|nephrotic minimal change tacrolimus prednisolone|nephrotic minimal change tacrolimus prednisolone
5576459|NCT00982059|Colorectal cancer screening|colorectal cancer screening
5576460|NCT00982059|Cancer survivor|cancer survivor
5576461|NCT00982059|Radiation therapy|radiation therapy
5576462|NCT00982046|contact lenses|contact lenses
5576463|NCT00982046|disinfection solutions|disinfection solutions
5576464|NCT00982046|contact lens care|contact lens care
5576465|NCT00982033|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5576466|NCT00982033|Elderly|elderly
5576467|NCT00982020|safety|safety
5576468|NCT00982020|schizophrenia|schizophrenia
5576469|NCT00982020|bipolar I (manic or mixed)|bipolar i (manic or mixed)
5576470|NCT00982020|adolescents|adolescents
5576471|NCT00982020|weight management|weight management
5576472|NCT00982007|IDA|ida
5576473|NCT00981994|respiratory infection|respiratory infection
5576474|NCT00981994|antimicrobial drugs|antimicrobial drugs
5576475|NCT00981994|decision support|decision support
5576476|NCT00981994|Adult patients|adult patients
5576477|NCT00981981|humans|humans
5576478|NCT00981981|randomized clinical trial|randomized clinical trial
5576479|NCT00981981|dietary fiber|dietary fiber
5576480|NCT00981981|nutrition|nutrition
5576481|NCT00981981|beta-glucan|beta-glucan
5576482|NCT00981981|oats|oats
5576483|NCT00981981|LDL cholesterol|ldl cholesterol
5576484|NCT00981981|coronary heart disease|coronary heart disease
5576485|NCT00981955|Caffeine|caffeine
5576486|NCT00981955|Ltheanine|ltheanine
5576487|NCT00981955|Near Infrared Spectroscopy|near infrared spectroscopy
5576488|NCT00981955|Cerebral Blood Flow|cerebral blood flow
5576489|NCT00981955|Cognitive Function|cognitive function
5576490|NCT00981955|Mood|mood
5576491|NCT00981942|Nephrogenic systemic fibrosis|nephrogenic systemic fibrosis
5576492|NCT00981942|Imatinib mesylate|imatinib mesylate
5576493|NCT00981942|Glivec|glivec
5576494|NCT00981942|Gleevec|gleevec
5576495|NCT00981929|CYP2D6|cyp2d6
5576496|NCT00981929|CYP2C9|cyp2c9
5576497|NCT00981929|CYP2C19|cyp2c19
5576498|NCT00981929|CYP1A2|cyp1a2
5576499|NCT00981916|determination of depth to epidural space using ultrasound|determination of depth to epidural space using ultrasound
5576500|NCT00981903|VTE in cancer patients|vte in cancer patients
5576501|NCT00981890|Brain Metastases|brain metastases
5576502|NCT00981890|Stereotactic radiosurgery|stereotactic radiosurgery
5576503|NCT00981890|Sunitinib|sunitinib
5576504|NCT00981890|Patients with Brain Metastases|patients with brain metastases
5576505|NCT00981877|acute diarrhea|acute diarrhea
5576508|NCT00981877|children|children
5576509|NCT00981864|radiation therapy in breast cancer|radiation therapy in breast cancer
5576510|NCT00981864|concurrent radiation|concurrent radiation
5576511|NCT00981864|Breast cancer patients|breast cancer patients
5576512|NCT00981851|intervention study|intervention study
5576513|NCT00981851|interaction|interaction
5576515|NCT00981812|PET|pet
5576516|NCT00981812|PEM|pem
5576517|NCT00981812|Positron Emission Mammography|positron emission mammography
5576518|NCT00981812|Breast Biopsy|breast biopsy
5576519|NCT00981799|Relapse|relapse
5576520|NCT00981799|T cell|t cell
5576521|NCT00981799|Lymphoblastic|lymphoblastic
5576522|NCT00981799|Leukemia|leukemia
5576523|NCT00981799|Lymphoma|lymphoma
5576524|NCT00981799|Nelarabine|nelarabine
5576525|NCT00981799|TACL|tacl
5751478|NCT00314418|time|time
5576526|NCT00981799|NECTAR|nectar
5576527|NCT00981786|24-hour IOP control|24-hour iop control
5576528|NCT00981786|brinzolamide/timolol|brinzolamide/timolol
5576529|NCT00981786|brimonidine/timolol|brimonidine/timolol
5576530|NCT00981786|travoprost|travoprost
5576531|NCT00981773|HIV switch|hiv switch
5576532|NCT00981773|HIV|hiv
5576533|NCT00981773|treatment experienced|treatment experienced
5576534|NCT00981734|Aging|aging
5576535|NCT00981734|functionality|functionality
5576536|NCT00981734|life style|life style
5576537|NCT00981734|To have more than sixty years|to have more than sixty years
5576538|NCT00981721|Phase I|phase i
5576539|NCT00981721|Advanced solid malignancies|advanced solid malignancies
5576540|NCT00981721|Advanced solid tumour|advanced solid tumour
5576541|NCT00981721|Advanced cancer|advanced cancer
5576542|NCT00981721|Cediranib (RECENTIN™, AZD2171)|cediranib (recentin™, azd2171)
5576545|NCT00981721|pharmacokinetics|pharmacokinetics
5576546|NCT00981708|Amyloidosis|amyloidosis
5576547|NCT00981708|lenalidomide|lenalidomide
5576548|NCT00981708|newly diagnosed|newly diagnosed
5576549|NCT00981708|relapsed|relapsed
5576550|NCT00981708|primary systemic AL amyloidosis|primary systemic al amyloidosis
5576551|NCT00981695|HIV|hiv
5576552|NCT00981695|Vaccine|vaccine
5576553|NCT00981695|MVA|mva
5576554|NCT00981695|PMTCT|pmtct
5576555|NCT00981695|HIV preventive vaccine|hiv preventive vaccine
5576556|NCT00981695|HIV seronegativity|hiv seronegativity
5576557|NCT00981682|decrease in the number of nocturic episodes for patients with nocturia|decrease in the number of nocturic episodes for patients with nocturia
5576558|NCT00981669|brazilian pentavalent rotavirus vaccine|brazilian pentavalent rotavirus vaccine
5576559|NCT00981669|safety|safety
5576560|NCT00981669|tolerability|tolerability
5576561|NCT00981669|immunogenicity|immunogenicity
5576562|NCT00981656|stage I bladder cancer|stage i bladder cancer
5576563|NCT00981656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5576564|NCT00981643|Meditation|meditation
5576565|NCT00981643|Multiple Sclerosis|multiple sclerosis
5576566|NCT00981643|Peripheral Neuropathy|peripheral neuropathy
5576567|NCT00981630|Japanese Encephalitis|japanese encephalitis
5576568|NCT00981630|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
5576569|NCT00981630|Adult|adult
5576570|NCT00981604|SILS|sils
5576571|NCT00981604|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5576572|NCT00981604|Children|children
5576573|NCT00981591|Iloprost|iloprost
5576574|NCT00981591|Nitric oxide|nitric oxide
5576575|NCT00981591|Mechanical ventilator|mechanical ventilator
5576576|NCT00981578|bone cancer|bone cancer
5576577|NCT00981578|pain palliation|pain palliation
5576578|NCT00981578|metastasis|metastasis
5862974|NCT00001432|Purging|purging
5576579|NCT00981578|breast cancer|breast cancer
5576581|NCT00981578|prostate cancer|prostate cancer
5576582|NCT00981578|cancer related pain|cancer related pain
5576583|NCT00981578|tumors|tumors
5576584|NCT00981565|Carpal tunnel syndrome|carpal tunnel syndrome
5576585|NCT00981565|CTS|cts
5576586|NCT00981565|medianus impingement|medianus impingement
5576587|NCT00981552|Cervix Cancer|cervix cancer
5576588|NCT00981552|IMRT|imrt
5576589|NCT00981552|Organ Motion|organ motion
5576590|NCT00981552|Target Definition|target definition
5576591|NCT00981539|The focus of this study is to determine whether it is beneficial to administer enemas before surgery|the focus of this study is to determine whether it is beneficial to administer enemas before surgery
5576592|NCT00981526|Schizophrenia|schizophrenia
5576593|NCT00981526|Cognition|cognition
5561348|NCT01042288|Pemetrexed|pemetrexed
5576594|NCT00981526|Metabolism|metabolism
5576595|NCT00981526|Antipsychotics|antipsychotics
5576596|NCT00981526|Psychopathology|psychopathology
5576597|NCT00981500|obesity|obesity
5576598|NCT00981500|gastric bypass|gastric bypass
5576599|NCT00981500|gastric banding|gastric banding
5576600|NCT00981500|weight loss|weight loss
5576601|NCT00981500|insulin sensitivity|insulin sensitivity
5576602|NCT00981500|sleeve gastrectomy|sleeve gastrectomy
5576603|NCT00981500|fibroblast growth factor 21|fibroblast growth factor 21
5576604|NCT00981500|fibroblast growth factor 19|fibroblast growth factor 19
5576606|NCT00981461|Andregenetic Alopecia|andregenetic alopecia
5576607|NCT00981461|Hair Loss|hair loss
5576608|NCT00981461|Female Pattern Baldness|female pattern baldness
5576610|NCT00981448|diabetes|diabetes
5576611|NCT00981448|genetics|genetics
5576612|NCT00981435|Glaucoma|glaucoma
5576613|NCT00981435|Trabeculoplasty|trabeculoplasty
5576614|NCT00981435|Selective laser trabeculoplasty|selective laser trabeculoplasty
5576615|NCT00981435|Intraocular pressure|intraocular pressure
5576616|NCT00981422|glaucoma|glaucoma
5576617|NCT00981422|immunology|immunology
5576618|NCT00981422|immunophenotype|immunophenotype
5576619|NCT00981409|Fondaparinux sodium|fondaparinux sodium
5576620|NCT00981409|contrast-enhanced MDCT|contrast-enhanced mdct
5576621|NCT00981409|Deep Vein Thrombosis|deep vein thrombosis
5576622|NCT00981409|Pulmonary thromboembolism|pulmonary thromboembolism
5576623|NCT00981396|smoking|smoking
5576624|NCT00981396|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
5904054|NCT00007813|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5576625|NCT00981396|CBT (cognitive behavior therapy)|cbt (cognitive behavior therapy)
5576626|NCT00981396|cravings|cravings
5576627|NCT00981396|trauma|trauma
5576628|NCT00981383|Fatty Acids, Omega-3|fatty acids, omega-3
5576629|NCT00981370|Sickle Cell Disease|sickle cell disease
5576630|NCT00981370|Sickle Cell Anemia|sickle cell anemia
5576631|NCT00981370|Iron Overload|iron overload
5576632|NCT00981370|Chelation Therapy|chelation therapy
5576633|NCT00981370|Iron overload from blood transfusions|iron overload from blood transfusions
5576634|NCT00981370|Heart rate variability|heart rate variability
5576635|NCT00981370|Autonomic dysfunction|autonomic dysfunction
5576636|NCT00981357|Cross-over evaluate the efficacy of PF-04457845 in relieving pain due to osteoarthritis OA knee osteoarthritis of knee pain due to osteoarthritis|cross-over evaluate the efficacy of pf-04457845 in relieving pain due to osteoarthritis oa knee osteoarthritis of knee pain due to osteoarthritis
5576637|NCT00981344|wheelchair|wheelchair
5576638|NCT00981344|mobility disability|mobility disability
5576639|NCT00981344|evidence based practice|evidence based practice
5576640|NCT00981344|self help devices|self help devices
5576641|NCT00981344|Veterans prescribed mobility aids|veterans prescribed mobility aids
5576642|NCT00981331|Subtalar joint|subtalar joint
5576643|NCT00981331|Musculoskeletal Manipulations|musculoskeletal manipulations
5576644|NCT00981331|Manipulation, Chiropractic|manipulation, chiropractic
5576645|NCT00981331|Ankle sprain|ankle sprain
5576646|NCT00981331|Inversion sprain|inversion sprain
5576647|NCT00981331|Range of motion, Articular|range of motion, articular
5576648|NCT00981331|Quaternion|quaternion
5576649|NCT00981331|Eigen analysis|eigen analysis
5576650|NCT00981318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5576651|NCT00981318|HIV|hiv
5576652|NCT00981318|AIDS|aids
5576653|NCT00981318|treatment experienced|treatment experienced
5576654|NCT00981305|dyspareunia|dyspareunia
5576655|NCT00981305|breast cancer|breast cancer
5576656|NCT00981305|sexual dysfunction|sexual dysfunction
5576657|NCT00981305|vaginal lubricant|vaginal lubricant
5576658|NCT00981292|Epigallocatechin Gallate|epigallocatechin gallate
5576659|NCT00981292|cerebral blood flow|cerebral blood flow
5576660|NCT00981292|Near Infrared spectroscopy|near infrared spectroscopy
5576661|NCT00981292|Electroencephalography|electroencephalography
5576662|NCT00981292|cognitive function|cognitive function
5576663|NCT00981292|mood|mood
5576664|NCT00981292|cerebro-electrical activity|cerebro-electrical activity
5576665|NCT00981279|Health Profile|health profile
5576666|NCT00981279|AIDS|aids
5576667|NCT00981279|Health Promotion|health promotion
5576668|NCT00981279|HIV|hiv
5576669|NCT00981279|treatment experienced|treatment experienced
5576670|NCT00981266|Augmentation|augmentation
5570788|NCT01003275|Renal|renal
5576671|NCT00981266|Augmentation Revision|augmentation revision
5576672|NCT00981253|Stress Management Training|stress management training
5576673|NCT00981253|Cardiac Rehabilitation|cardiac rehabilitation
5576675|NCT00981253|Depression|depression
5576676|NCT00981227|pain herpetic neuralgia|pain herpetic neuralgia
5576677|NCT00981214|Cystic fibrosis|cystic fibrosis
5576678|NCT00981214|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5576679|NCT00981214|Zenpep-1009|zenpep-1009
5576680|NCT00981201|Smoking|smoking
5576681|NCT00981201|Cancer Prevention|cancer prevention
5576682|NCT00981201|Celecoxib|celecoxib
5576683|NCT00981201|Celebrex|celebrex
5576684|NCT00981201|Placebo|placebo
5576685|NCT00981175|Japanese Encephalitis|japanese encephalitis
5576686|NCT00981175|Japanese Encephalitis Vaccines|japanese encephalitis vaccines
5576687|NCT00981175|Adult|adult
5576688|NCT00981136|Appendicitis|appendicitis
5576689|NCT00981136|Appendectomy|appendectomy
5576690|NCT00981136|Children|children
5576691|NCT00981136|Laparoscopic|laparoscopic
5576692|NCT00981136|SILS|sils
5576693|NCT00981110|Surgical site infections (SSI)|surgical site infections (ssi)
5576694|NCT00981110|Advanced antimicrobial dressing and clean surgery|advanced antimicrobial dressing and clean surgery
5576695|NCT00981110|Hydrofibre dressing|hydrofibre dressing
5576696|NCT00981097|HIV infection|hiv infection
5576697|NCT00981097|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5576698|NCT00981097|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5576699|NCT00981097|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5576700|NCT00981097|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5576701|NCT00981097|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5576702|NCT00981097|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5576703|NCT00981097|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5576704|NCT00981097|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5576705|NCT00981097|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5576706|NCT00981097|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5576707|NCT00981097|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5576708|NCT00981097|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5576709|NCT00981097|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5576710|NCT00981097|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5576711|NCT00981097|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5576712|NCT00981097|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5685405|NCT00556218|Cognitive Function|cognitive function
5576713|NCT00981097|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5576714|NCT00981097|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5576715|NCT00981097|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5576716|NCT00981097|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5576717|NCT00981071|Tuberculosis|tuberculosis
5576718|NCT00981071|QuantiFERON|quantiferon
5576719|NCT00981071|Outbreak|outbreak
5576720|NCT00981071|Conversion|conversion
5576721|NCT00981058|Squamous|squamous
5576722|NCT00981058|Non Small Cell Lung Cancer|non small cell lung cancer
5576723|NCT00981058|First line treatment|first line treatment
5576724|NCT00981058|Monoclonal|monoclonal
5576725|NCT00981058|Antibodies|antibodies
5576726|NCT00981058|Epidermal Growth Factor Receptor (EGFR)|epidermal growth factor receptor (egfr)
5576728|NCT00981032|Aspirin|aspirin
5576729|NCT00981032|Behavior|behavior
5576730|NCT00981032|Cardiovascular Disease|cardiovascular disease
5576731|NCT00981019|survival rates|survival rates
5576732|NCT00981019|risk communication|risk communication
5576733|NCT00981019|screening counselling|screening counselling
5576734|NCT00981019|screening recommendation|screening recommendation
5576735|NCT00981019|understanding of medical risk|understanding of medical risk
5576736|NCT00981006|ischemic cardiomyopathy (ICM)|ischemic cardiomyopathy (icm)
5576737|NCT00980993|Prostate|prostate
5576738|NCT00980993|Motion|motion
5576739|NCT00980993|Respiration|respiration
5576740|NCT00980980|MRSA infection|mrsa infection
5576741|NCT00980967|Lung transplantation|lung transplantation
5576742|NCT00980967|Chronic lung rejection|chronic lung rejection
5576743|NCT00980967|Obliterative bronchiolitis|obliterative bronchiolitis
5576744|NCT00980967|Predictive factors|predictive factors
5576745|NCT00980954|cervical adenocarcinoma|cervical adenocarcinoma
5576746|NCT00980954|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5576747|NCT00980954|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5576748|NCT00980954|stage IA cervical cancer|stage ia cervical cancer
5576749|NCT00980954|stage IB cervical cancer|stage ib cervical cancer
5576750|NCT00980954|stage IIA cervical cancer|stage iia cervical cancer
5576751|NCT00980941|starch|starch
5576752|NCT00980941|carbohydrates|carbohydrates
5576753|NCT00980941|blood glucose|blood glucose
5576754|NCT00980941|food intake|food intake
5576755|NCT00980941|satiety|satiety
5576756|NCT00980941|appetite|appetite
5576757|NCT00980915|Acute Lung Injury|acute lung injury
5576758|NCT00980915|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5576759|NCT00980915|Respiratory Distress|respiratory distress
5576760|NCT00980915|pneumonia|pneumonia
5576761|NCT00980915|sepsis|sepsis
5576762|NCT00980915|aspiration|aspiration
5576763|NCT00980915|pancreatitis|pancreatitis
5576764|NCT00980889|bile duct obstruction|bile duct obstruction
5576765|NCT00980889|jaundice|jaundice
5576766|NCT00980889|metal stent|metal stent
5576767|NCT00980850|Flu vaccine|flu vaccine
5576768|NCT00980850|H1N1 swine flu virus|h1n1 swine flu virus
5576769|NCT00980850|Immunogenicity|immunogenicity
5576770|NCT00980850|Reactogenicity|reactogenicity
5576771|NCT00980824|cognitive behaviour therapy|cognitive behaviour therapy
5576772|NCT00980824|self harm|self harm
5576773|NCT00980824|personality disorder|personality disorder
5576774|NCT00980824|complex comorbidity|complex comorbidity
5576775|NCT00980824|mental health|mental health
5576776|NCT00980798|Osteoarthritis|osteoarthritis
5576777|NCT00980798|Strong pain killer|strong pain killer
5576778|NCT00980798|Strong opioid|strong opioid
5576779|NCT00980798|Low starting dose|low starting dose
5576780|NCT00980798|Fewer side effects|fewer side effects
5576781|NCT00980798|Physical functioning|physical functioning
5576782|NCT00980798|Pain control|pain control
5576784|NCT00980798|Sleep quality|sleep quality
5576785|NCT00980785|Alzheimer's Disease|alzheimer's disease
5576786|NCT00980785|Hypertension|hypertension
5576787|NCT00980759|Extended-field Irradiation (EFI)|extended-field irradiation (efi)
5576788|NCT00980759|Cervical cancer|cervical cancer
5576789|NCT00980759|Hypoxia|hypoxia
5576790|NCT00980759|Carbonic anhydrase 9 (CA9)|carbonic anhydrase 9 (ca9)
5576791|NCT00980759|locally advanced uterine cervical cancer|locally advanced uterine cervical cancer
5576792|NCT00980746|pain diabetes neuropathy|pain diabetes neuropathy
5576793|NCT00980733|Micronutrients|micronutrients
5576794|NCT00980733|zinc|zinc
5576795|NCT00980733|iron|iron
5576796|NCT00980733|iodine|iodine
5576797|NCT00980733|fortification|fortification
5576798|NCT00980733|school children|school children
5576799|NCT00980707|versican|versican
5576800|NCT00980707|hyaluronan|hyaluronan
5576801|NCT00980707|sputum|sputum
5576802|NCT00980694|ubiquinol|ubiquinol
5576803|NCT00980694|coenzyme Q10|coenzyme q10
5576804|NCT00980694|Huntington disease|huntington disease
5576805|NCT00980681|Renal disease|renal disease
5576806|NCT00980681|Contrast agent|contrast agent
5576807|NCT00980681|MRA|mra
5576808|NCT00980642|surgery|surgery
5576809|NCT00980642|thermometer|thermometer
5576810|NCT00980642|non-invasive|non-invasive
5576811|NCT00980642|interoperative core temperature|interoperative core temperature
5576812|NCT00980642|anesthesia|anesthesia
5576813|NCT00980616|Arthroplasty, hip|arthroplasty, hip
5576814|NCT00980616|blood losses|blood losses
5576815|NCT00980616|pain|pain
5576816|NCT00980616|local analgesia|local analgesia
5576817|NCT00980616|epinephrine|epinephrine
5576818|NCT00980616|Primary total hip arthroplasty|primary total hip arthroplasty
5576819|NCT00980603|gastric cancer|gastric cancer
5576820|NCT00980603|metastatic|metastatic
5576821|NCT00980603|docetaxel|docetaxel
5576822|NCT00980603|cisplatin|cisplatin
5576823|NCT00980603|S-1|s-1
5576824|NCT00980590|supine emergency intubations|supine emergency intubations
5576825|NCT00980590|emergency intubations|emergency intubations
5576826|NCT00980538|TMC125-TiDP35-C239|tmc125-tidp35-c239
5576827|NCT00980538|TMC125-C239|tmc125-c239
5576828|NCT00980538|TMC125|tmc125
5576829|NCT00980538|HIV|hiv
5576830|NCT00980538|Etravirine|etravirine
5576831|NCT00980538|Intelence|intelence
5576832|NCT00980538|IntelenceTM|intelencetm
5576833|NCT00980525|healthy|healthy
5576834|NCT00980512|behavior problems|behavior problems
5576835|NCT00980512|parent training|parent training
5576836|NCT00980512|foster care|foster care
5576837|NCT00980486|Antibiotic Concentration|antibiotic concentration
5576838|NCT00980486|Tissue|tissue
5576839|NCT00980486|Obesity|obesity
5576840|NCT00980486|Cesarean|cesarean
5576841|NCT00980473|Primary Angle Closure Disease|primary angle closure disease
5576842|NCT00980447|H5N1|h5n1
5576843|NCT00980447|Vaccine|vaccine
5576844|NCT00980447|Influenza H5N1|influenza h5n1
5576845|NCT00980447|Avian influenza H5N1|avian influenza h5n1
5576846|NCT00980447|Pandemic|pandemic
5576847|NCT00980434|vertebral fracture|vertebral fracture
5576848|NCT00980434|spinal cord injury|spinal cord injury
5576849|NCT00980421|iron|iron
5576850|NCT00980421|iron toxicity markers|iron toxicity markers
5576851|NCT00980421|oxidative stress markers|oxidative stress markers
5576852|NCT00980421|iron supplementation|iron supplementation
5576853|NCT00980421|NTBI|ntbi
5576854|NCT00980421|iron over load|iron over load
5576855|NCT00980421|interleukin levels|interleukin levels
5576856|NCT00980421|iron status|iron status
5576857|NCT00980421|acut phase reactants|acut phase reactants
5576858|NCT00980421|preschool children|preschool children
5576859|NCT00980395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5576860|NCT00980395|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5576861|NCT00980395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5576862|NCT00980395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5576863|NCT00980395|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5576864|NCT00980395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5576865|NCT00980395|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5576866|NCT00980395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5576867|NCT00980395|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5576868|NCT00980395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5576869|NCT00980395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5576870|NCT00980395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5576871|NCT00980395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5576872|NCT00980395|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5576873|NCT00980395|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5576874|NCT00980395|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5576875|NCT00980395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5576876|NCT00980395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5576877|NCT00980395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5576878|NCT00980395|extranodal marginal zone BCL mucosa assoc lymphoid tissue|extranodal marginal zone bcl mucosa assoc lymphoid tissue
5576879|NCT00980395|nodal marginal zone B Cell lymphoma|nodal marginal zone b cell lymphoma
5576880|NCT00980395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5576883|NCT00980382|Combination chemotherapy|combination chemotherapy
5576885|NCT00980382|Docetaxel|docetaxel
5576886|NCT00980369|Lateral internal sphincterotomy|lateral internal sphincterotomy
5576887|NCT00980369|Anal fissure|anal fissure
5576888|NCT00980369|Surgical technique|surgical technique
5576889|NCT00980369|Incision|incision
5576890|NCT00980369|Wound healing|wound healing
5576891|NCT00980356|Diabetes Kidney transplantation|diabetes kidney transplantation
5576892|NCT00980356|New onset diabetes mellitus after transplantation|new onset diabetes mellitus after transplantation
5576893|NCT00980330|Hepatitis C|hepatitis c
5576894|NCT00980330|Peginterferon alpha-2a|peginterferon alpha-2a
5576895|NCT00980330|PegIFNalpha-2a|pegifnalpha-2a
5576896|NCT00980330|RBV|rbv
5576897|NCT00980330|Ribavirin|ribavirin
5576898|NCT00980330|Placebo|placebo
5576899|NCT00980330|TMC435-TIDP16-C206|tmc435-tidp16-c206
5576900|NCT00980330|TMC435-C206|tmc435-c206
5576901|NCT00980330|TMC435|tmc435
5576902|NCT00980330|HCV|hcv
5576903|NCT00980317|Renal tumor|renal tumor
5576904|NCT00980317|Restored kidney|restored kidney
5576905|NCT00980317|Renal transplantation|renal transplantation
5576906|NCT00980317|Third party|third party
5576907|NCT00980304|Diffuse large B cell lymphomas|diffuse large b cell lymphomas
5576908|NCT00980278|sinus lift|sinus lift
5576909|NCT00980278|tooth extraction|tooth extraction
5576910|NCT00980278|dental implant|dental implant
5576911|NCT00980252|Schizophrenia|schizophrenia
5576912|NCT00980252|Cognitive Behavioral Therapy|cognitive behavioral therapy
5576913|NCT00980252|Compliance|compliance
5576914|NCT00980252|Medication Adherence|medication adherence
5576915|NCT00980252|Psychotic Disorders|psychotic disorders
5576916|NCT00980252|Mental Disorders|mental disorders
5576917|NCT00980252|Outcomes|outcomes
5576918|NCT00980252|Psychoeducation|psychoeducation
5576919|NCT00980252|Adherence Attitudes|adherence attitudes
5576920|NCT00980252|Intervention|intervention
5576921|NCT00980252|Nonadherence|nonadherence
5576922|NCT00980252|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5576923|NCT00980239|Solid Tumors|solid tumors
5576924|NCT00980239|Liver|liver
5576925|NCT00980239|hepatic arterial infusion|hepatic arterial infusion
5576926|NCT00980239|HAI|hai
5576927|NCT00980239|Bevacizumab|bevacizumab
5576928|NCT00980239|Avastin|avastin
5576929|NCT00980239|Cetuximab|cetuximab
5576930|NCT00980239|Erbitux|erbitux
5576931|NCT00980239|Irinotecan|irinotecan
5576932|NCT00980239|Camptosar|camptosar
5576933|NCT00980239|Oxaliplatin|oxaliplatin
5576934|NCT00980239|Eloxatin|eloxatin
5576935|NCT00980213|renal cell cancer|renal cell cancer
5576936|NCT00980213|sunitinib|sunitinib
5576937|NCT00980213|costs|costs
5576938|NCT00980213|quality of life|quality of life
5576939|NCT00980200|GW642444|gw642444
5576940|NCT00980200|once daily dosing|once daily dosing
5576941|NCT00980200|asthma|asthma
5576942|NCT00980200|efficacy|efficacy
5576943|NCT00980200|safety|safety
5576944|NCT00980200|FEV1|fev1
5576945|NCT00980187|blood tests|blood tests
5576946|NCT00980187|cardiac function|cardiac function
5576947|NCT00980187|endothelial function|endothelial function
5576948|NCT00980187|arterial function|arterial function
5576949|NCT00980174|men|men
5576950|NCT00980174|male|male
5576951|NCT00980174|denosumab|denosumab
5576952|NCT00980174|BMD|bmd
5576953|NCT00980174|lumbar spine|lumbar spine
5576954|NCT00980174|ADAMO|adamo
5576955|NCT00980174|The ADAMO Trial|the adamo trial
5576956|NCT00980174|male osteoporosis|male osteoporosis
5576957|NCT00980174|osteoporosis in men|osteoporosis in men
5576958|NCT00980174|males with low bone mineral density|males with low bone mineral density
5576959|NCT00980161|Hepatitis C|hepatitis c
5576960|NCT00980161|Peginterferon|peginterferon
5576961|NCT00980161|Ribavirin|ribavirin
5576962|NCT00980161|MicroRNA|microrna
5576963|NCT00980148|Chlamydia trachomatis, Chlamydia, Doxycycline, Azithromycin|chlamydia trachomatis, chlamydia, doxycycline, azithromycin
5576964|NCT00980135|Sinecort|sinecort
5576965|NCT00980135|Hydrocortison|hydrocortison
5576966|NCT00980135|Mild atopic dermatitis|mild atopic dermatitis
5576967|NCT00980135|Efficacy, safety|efficacy, safety
5576968|NCT00980122|Advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.|advanced cancer patients dying in hospital receive aggressive cancer-specific therapy and supportive measures.
5576969|NCT00980109|Influenza Prophylaxis|influenza prophylaxis
5576970|NCT00980109|Long Term|long term
5576971|NCT00980109|Oral Oseltamivir|oral oseltamivir
5576972|NCT00980109|Inhaled Zanamivir|inhaled zanamivir
5576974|NCT00980083|exendin(9-39)|exendin(9-39)
5576975|NCT00980083|gastric emptying|gastric emptying
5576976|NCT00980083|incretin|incretin
5576977|NCT00980083|human|human
5576981|NCT00980031|cardiac chamber size|cardiac chamber size
5576982|NCT00980031|wall thickness|wall thickness
5576983|NCT00980031|left ventricular ejection fraction|left ventricular ejection fraction
5576988|NCT00980018|Tasigna|tasigna
5576989|NCT00980018|nilotinib|nilotinib
5576990|NCT00980018|AMN107|amn107
5576991|NCT00980018|CML-CP|cml-cp
5576992|NCT00980018|Chronic Phase|chronic phase
5576993|NCT00980005|GSK Biologicals influenza vaccine GSK1557482A|gsk biologicals influenza vaccine gsk1557482a
5576994|NCT00980005|influenza infection|influenza infection
5576995|NCT00979979|Hepatitis C|hepatitis c
5576996|NCT00979979|Genotype|genotype
5576997|NCT00979979|Realtime PCR|realtime pcr
5576998|NCT00979966|Locally advanced or metastatic non-clear cell renal cell cancer (ncc-RCC)|locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
5576999|NCT00979953|delta opioid receptor agonist|delta opioid receptor agonist
5577000|NCT00979953|osteoarthritis|osteoarthritis
5577001|NCT00979953|pain|pain
5577002|NCT00979940|atorvastatin|atorvastatin
5577003|NCT00979940|clopidogrel|clopidogrel
5577004|NCT00979940|percutaneous intervention|percutaneous intervention
5577005|NCT00979940|periprocedural myonecrosis|periprocedural myonecrosis
5577006|NCT00979927|Antisense|antisense
5577007|NCT00979927|miR-122 antagonist|mir-122 antagonist
5577008|NCT00979927|safety in healthy Volunteers|safety in healthy volunteers
5577009|NCT00979927|Hepatitis C|hepatitis c
5577011|NCT00979914|patient education|patient education
5577012|NCT00979914|function|function
5577013|NCT00979914|physio therapy|physio therapy
5577014|NCT00979888|dyspnea|dyspnea
5577015|NCT00979888|depression|depression
5577016|NCT00979888|fatigue|fatigue
5577017|NCT00979888|anxiety disorder|anxiety disorder
5577018|NCT00979888|small cell lung cancer|small cell lung cancer
5577019|NCT00979888|non-small cell lung cancer|non-small cell lung cancer
5577020|NCT00979875|insulin|insulin
5577021|NCT00979875|recombinant human hyaluronidase|recombinant human hyaluronidase
5577022|NCT00979875|Healthy volunteers|healthy volunteers
5577023|NCT00979849|safety|safety
5577024|NCT00979849|tolerability|tolerability
5577025|NCT00979849|healthy|healthy
5577026|NCT00979849|inhalation|inhalation
5577027|NCT00979836|venous|venous
5577028|NCT00979836|ulcer|ulcer
5577029|NCT00979836|phlebotonic|phlebotonic
5577030|NCT00979836|calcium dobesilate|calcium dobesilate
5577031|NCT00979836|clinical trial|clinical trial
5577036|NCT00979797|Community IMCI|community imci
5577037|NCT00979797|C-IMCI|c-imci
5577039|NCT00979797|Children|children
5577040|NCT00979797|Evaluation|evaluation
5577041|NCT00979797|Behaviour|behaviour
5577042|NCT00979797|Counselling|counselling
5577043|NCT00979797|Under 5 mortality|under 5 mortality
5577044|NCT00979797|Under 5 Nutrition|under 5 nutrition
5577045|NCT00979784|obesity|obesity
5577046|NCT00979784|primary care|primary care
5577047|NCT00979771|GSK706769|gsk706769
5577048|NCT00979771|Enbrel|enbrel
5577049|NCT00979771|Rheumatoid Arthritis|rheumatoid arthritis
5577050|NCT00979745|Erythropoietic Protoporphyria|erythropoietic protoporphyria
5577051|NCT00979745|EPP|epp
5577052|NCT00979745|Afamelanotide|afamelanotide
5577053|NCT00979732|high blood pressure|high blood pressure
5577054|NCT00979732|dietary supplements|dietary supplements
5577055|NCT00979732|nutrition|nutrition
5577056|NCT00979719|Randomized Controlled Trial|randomized controlled trial
5577057|NCT00979719|evidence- and theory-based behavioral intervention|evidence- and theory-based behavioral intervention
5577058|NCT00979719|expert system|expert system
5577059|NCT00979719|stages of change|stages of change
5577060|NCT00979719|motivational interviewing|motivational interviewing
5577061|NCT00979719|tailoring|tailoring
5577062|NCT00979719|Self Care|self care
5577063|NCT00979719|Rehabilitation|rehabilitation
5577064|NCT00979719|Expert Systems|expert systems
5577065|NCT00979693|anxiety|anxiety
5577066|NCT00979693|stage IV melanoma|stage iv melanoma
5577067|NCT00979693|depression|depression
5577069|NCT00979693|pain|pain
5577070|NCT00979680|sphincter preservation|sphincter preservation
5577071|NCT00979680|neoadjuvant therapy|neoadjuvant therapy
5577072|NCT00979667|Upper respiratory tract infection|upper respiratory tract infection
5577073|NCT00979667|Influenza A|influenza a
5577074|NCT00979667|Human Swine Influenza|human swine influenza
5577075|NCT00979654|Sifalimumab|sifalimumab
5577076|NCT00979654|MEDI-545|medi-545
5577077|NCT00979641|breast cancer|breast cancer
5577078|NCT00979641|metastatic|metastatic
5577079|NCT00979641|chemotherapy|chemotherapy
5577080|NCT00979641|bevacizumab|bevacizumab
5577081|NCT00979641|docetaxel|docetaxel
5577082|NCT00979641|Phase II|phase ii
5579695|NCT00969397|Birthmark|birthmark
5577083|NCT00979641|first line chemotherapy|first line chemotherapy
5577084|NCT00979641|metastatic breast cancer patients|metastatic breast cancer patients
5577085|NCT00979628|Type 2 Diabetes|type 2 diabetes
5577086|NCT00979628|Inpatient Hyperglycemia|inpatient hyperglycemia
5577087|NCT00979615|vasomotor rhinitis|vasomotor rhinitis
5577088|NCT00979615|chronic non-allergic rhinitis|chronic non-allergic rhinitis
5577090|NCT00979602|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5577091|NCT00979602|Influenza Vaccines|influenza vaccines
5577092|NCT00979602|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5577093|NCT00979602|influenza infection|influenza infection
5577094|NCT00979589|stroke|stroke
5577095|NCT00979589|transient ischemic attack|transient ischemic attack
5577096|NCT00979589|acute treatment|acute treatment
5577097|NCT00979589|acute non-disabling cerebrovascular event|acute non-disabling cerebrovascular event
5577098|NCT00979589|clopidogrel|clopidogrel
5577099|NCT00979589|clopidogrel combined with ASA|clopidogrel combined with asa
5577100|NCT00979589|recurrence of stroke and other vascular events|recurrence of stroke and other vascular events
5577101|NCT00979563|HM30181AK|hm30181ak
5577102|NCT00979563|Irinotecan tablet|irinotecan tablet
5577104|NCT00979563|DLT|dlt
5752218|NCT00311415|infant|infant
5577105|NCT00979550|laser|laser
5577106|NCT00979550|pediatric|pediatric
5577107|NCT00979550|skin pigmentation|skin pigmentation
5577108|NCT00979524|Depressive symptoms|depressive symptoms
5577109|NCT00979524|Mental health services|mental health services
5577110|NCT00979524|Adolescents|adolescents
5577111|NCT00979524|Young adults|young adults
5577112|NCT00979524|African-American|african-american
5577113|NCT00979511|osteoporosis|osteoporosis
5577114|NCT00979511|calcium|calcium
5577115|NCT00979511|weight-bearing exercise|weight-bearing exercise
5577116|NCT00979511|bone mass|bone mass
5577117|NCT00979511|prepubertal girls|prepubertal girls
5577118|NCT00979485|Pediatric IBD|pediatric ibd
5577119|NCT00979485|Microparticles|microparticles
5577120|NCT00979472|Solifenacin|solifenacin
5577121|NCT00979472|Overactive bladder|overactive bladder
5577122|NCT00979472|Micturition|micturition
5577123|NCT00979472|Urinary urgency|urinary urgency
5577124|NCT00979472|Vesicare|vesicare
5577125|NCT00979446|Interactive phone-based intervention with written materials|interactive phone-based intervention with written materials
5577126|NCT00979446|Older adults|older adults
5577127|NCT00979446|Physical activity|physical activity
5577128|NCT00979446|Cognitive stimulation|cognitive stimulation
5577129|NCT00979446|Social engagement|social engagement
5577130|NCT00979433|Extubation failure|extubation failure
5577131|NCT00979433|Continuous positive airway pressure|continuous positive airway pressure
5577132|NCT00979433|Bubble CPAP|bubble cpap
5577133|NCT00979420|treatment experienced|treatment experienced
5577134|NCT00979407|influenza infection|influenza infection
5577135|NCT00979407|GSK Biologicals' influenza vaccine GSK2340272A and GSK2340274A|gsk biologicals' influenza vaccine gsk2340272a and gsk2340274a
5577136|NCT00979394|Diabetes Care at GPs in Austria|diabetes care at gps in austria
5577137|NCT00979394|Characteristic of diabetes patients at GPs in Austria|characteristic of diabetes patients at gps in austria
5577138|NCT00979381|sunitinib|sunitinib
5577139|NCT00979381|sorafenib|sorafenib
5577140|NCT00979381|immune response|immune response
5577141|NCT00979355|Whole body|whole body
5577142|NCT00979355|SPECT|spect
5577143|NCT00979342|morcellator|morcellator
5577144|NCT00979342|hysteroscope|hysteroscope
5577145|NCT00979342|myomectomy|myomectomy
5577146|NCT00979342|polypectomy|polypectomy
5577147|NCT00979342|uterine fibroids|uterine fibroids
5577148|NCT00979342|uterine polyps|uterine polyps
5577149|NCT00979342|local anesthetic|local anesthetic
5577150|NCT00979342|cervical block|cervical block
5577151|NCT00979342|pain management|pain management
5577152|NCT00979329|sunitinib|sunitinib
5577153|NCT00979329|sorafenib|sorafenib
5577154|NCT00979329|fatigue|fatigue
5577155|NCT00979329|depression|depression
5577156|NCT00979329|quality of life|quality of life
5577157|NCT00979329|metastatic RCC|metastatic rcc
5577158|NCT00979329|colorectal cancer|colorectal cancer
5577159|NCT00979329|GIST|gist
5577160|NCT00979303|Pediatric|pediatric
5577161|NCT00979303|Electrophysiology|electrophysiology
5577162|NCT00979303|Ablation|ablation
5577163|NCT00979303|Radiation|radiation
5577164|NCT00979303|Devices|devices
5577166|NCT00979290|Fix-dose combination anti-TB drug|fix-dose combination anti-tb drug
5577167|NCT00979290|adverse effect|adverse effect
5577168|NCT00979290|efficiency|efficiency
5577169|NCT00979264|Quality Improvement|quality improvement
5577170|NCT00979251|Influenza|influenza
5577171|NCT00979251|Immunocompromised|immunocompromised
5577172|NCT00979251|HIV|hiv
5577173|NCT00979251|History of transplant|history of transplant
5577174|NCT00979238|Hemophilia B|hemophilia b
5577175|NCT00979238|Factor IX Gene|factor ix gene
5577176|NCT00979238|Factor IX Protein|factor ix protein
5577177|NCT00979238|Vector|vector
5577178|NCT00979225|health information technology|health information technology
5577179|NCT00979225|clinical decision support|clinical decision support
5577180|NCT00979225|medication management|medication management
5577181|NCT00979225|medication adherence|medication adherence
5577182|NCT00979212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5577183|NCT00979212|adenocarcinoma of the lung|adenocarcinoma of the lung
5577184|NCT00979212|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5577185|NCT00979212|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5577186|NCT00979212|large cell lung cancer|large cell lung cancer
5577187|NCT00979212|squamous cell lung cancer|squamous cell lung cancer
5577188|NCT00979199|IHD|ihd
5577189|NCT00979199|CAD|cad
5577190|NCT00979199|Non invasive imaging|non invasive imaging
5577191|NCT00979199|SPECT|spect
5577192|NCT00979199|PET|pet
5577193|NCT00979199|CMR|cmr
5577194|NCT00979199|Echocardiography|echocardiography
5577195|NCT00979186|transgastric cholecystectomy|transgastric cholecystectomy
5577196|NCT00979173|malignant glioma|malignant glioma
5577197|NCT00979173|glioblastoma multiforme|glioblastoma multiforme
5577198|NCT00979173|gliosarcoma|gliosarcoma
5577199|NCT00979173|anaplastic astrocytoma|anaplastic astrocytoma
5577200|NCT00979173|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5904055|NCT00007813|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5577201|NCT00979173|anaplastic mixed glioma|anaplastic mixed glioma
5577202|NCT00979173|Pro00018751|pro00018751
5577203|NCT00979173|Duke|duke
5577204|NCT00979173|Ambit|ambit
5577205|NCT00979173|AC480|ac480
5577206|NCT00979147|knee arthritis|knee arthritis
5577207|NCT00979147|total knee arthroplasty|total knee arthroplasty
5577208|NCT00979147|total knee replacement|total knee replacement
5577209|NCT00979147|metal backed tibial component|metal backed tibial component
5577210|NCT00979147|all-polyethylene tibia|all-polyethylene tibia
5577211|NCT00979147|modular polished tibial baseplate|modular polished tibial baseplate
5577213|NCT00979134|Tumour|tumour
5577214|NCT00979134|Advanced Solid Malignancies|advanced solid malignancies
5577215|NCT00979134|FGFR|fgfr
5577216|NCT00979134|Squamous NSCLC|squamous nsclc
5577217|NCT00979134|Gastric adenocarcinoma|gastric adenocarcinoma
5577218|NCT00979121|ALI|ali
5577219|NCT00979121|Sepsis|sepsis
5577220|NCT00979121|statin|statin
5577221|NCT00979108|Radiculopathy|radiculopathy
5577222|NCT00979108|Neck pain|neck pain
5577223|NCT00979108|Physical therapy modalities|physical therapy modalities
5577224|NCT00979108|Rehabilitation|rehabilitation
5577225|NCT00979095|multiple hernia|multiple hernia
5577226|NCT00979056|Traveller's diarrhoea|traveller's diarrhoea
5577227|NCT00979056|Prevention|prevention
5577228|NCT00979043|knee osteoarthritis|knee osteoarthritis
5577229|NCT00979043|weight-loss|weight-loss
5577230|NCT00979043|exercise|exercise
5577231|NCT00979043|obesity|obesity
5577232|NCT00979043|physical function|physical function
5577233|NCT00979043|total mortality|total mortality
5577234|NCT00979017|malignant glioma|malignant glioma
5577235|NCT00979017|glioblastoma multiforme|glioblastoma multiforme
5577236|NCT00979017|gliosarcoma|gliosarcoma
5577237|NCT00979017|Avastin|avastin
5577238|NCT00979017|bevacizumab|bevacizumab
5577239|NCT00979017|Temodar|temodar
5577240|NCT00979017|temozolomide|temozolomide
5577241|NCT00979017|Irinotecan|irinotecan
5577242|NCT00979017|CPT-11|cpt-11
5577243|NCT00979017|Pro00019065|pro00019065
5577244|NCT00979017|Vredenburgh|vredenburgh
5577245|NCT00979017|Duke|duke
5577246|NCT00979004|Photosensitivity|photosensitivity
5577247|NCT00979004|Epilepsy|epilepsy
5577248|NCT00979004|Seizures|seizures
5577249|NCT00978991|Benign prostate hyperplasia|benign prostate hyperplasia
5577250|NCT00978991|Erectile dysfunction|erectile dysfunction
5577251|NCT00978965|kidney transplantation|kidney transplantation
5577252|NCT00978965|immunosuppression|immunosuppression
5577253|NCT00978965|single nucleotide polymorphism|single nucleotide polymorphism
5577254|NCT00978965|IMPDH|impdh
5577255|NCT00978926|Anti-Vascular Endothelial growth factor|anti-vascular endothelial growth factor
5577256|NCT00978913|dendritic cell|dendritic cell
5577257|NCT00978913|cancervaccine|cancervaccine
5577258|NCT00978913|breast cancer|breast cancer
5577259|NCT00978913|malignant melanoma|malignant melanoma
5577260|NCT00978913|Cyclophosphamide|cyclophosphamide
5577261|NCT00978900|satiety peptides|satiety peptides
5577262|NCT00978900|GLP-1|glp-1
5577263|NCT00978900|PYY|pyy
5577264|NCT00978900|ghrelin|ghrelin
5577265|NCT00978900|appetite profile|appetite profile
5577266|NCT00978900|Sweetening Agents|sweetening agents
5577267|NCT00978887|Facial cream|facial cream
5577268|NCT00978887|natural product|natural product
5577269|NCT00978887|facial wrinkles|facial wrinkles
5577270|NCT00978874|recurrent cervical cancer|recurrent cervical cancer
5577271|NCT00978874|stage IB cervical cancer|stage ib cervical cancer
5577272|NCT00978874|stage IIA cervical cancer|stage iia cervical cancer
5577273|NCT00978874|stage IIB cervical cancer|stage iib cervical cancer
5577274|NCT00978874|stage III cervical cancer|stage iii cervical cancer
5577275|NCT00978874|stage IVA cervical cancer|stage iva cervical cancer
5577276|NCT00978874|stage IVB cervical cancer|stage ivb cervical cancer
5577278|NCT00978848|chlamydia|chlamydia
5577279|NCT00978848|gonorrhea|gonorrhea
5577280|NCT00978848|emergency contraception|emergency contraception
5577291|NCT00978822|antihypertensive|antihypertensive
5577292|NCT00978822|calcium channel blockers|calcium channel blockers
5577293|NCT00978822|infusion|infusion
5577294|NCT00978822|neurocritical care|neurocritical care
5577295|NCT00978809|BPPV|bppv
5577296|NCT00978809|postural stability|postural stability
5577297|NCT00978809|Epley|epley
5577298|NCT00978809|Semont|semont
5577299|NCT00978796|Diabetes Mellitus|diabetes mellitus
5577300|NCT00978796|Type 1 diabetes|type 1 diabetes
5577301|NCT00978796|glucose variability|glucose variability
5577302|NCT00978783|Phonation|phonation
5577303|NCT00978783|Tracheostomy|tracheostomy
5577304|NCT00978783|phonation valve|phonation valve
5577305|NCT00978783|positive end expiratory pressure|positive end expiratory pressure
5577306|NCT00978770|stage II breast cancer|stage ii breast cancer
5577307|NCT00978770|stage IIIA breast cancer|stage iiia breast cancer
5577308|NCT00978770|stage IIIB breast cancer|stage iiib breast cancer
5577309|NCT00978770|stage IIIC breast cancer|stage iiic breast cancer
5577310|NCT00978757|hepatectomy|hepatectomy
5577311|NCT00978757|IL 6|il 6
5577312|NCT00978757|organ failure|organ failure
5577313|NCT00978757|ketamine|ketamine
5577314|NCT00978757|Pringle|pringle
5577315|NCT00978744|Clinical Health Record|clinical health record
5577316|NCT00978744|Computerized Decision Support|computerized decision support
5577317|NCT00978744|Patient Safety|patient safety
5577318|NCT00978744|Resource Utilization|resource utilization
5577319|NCT00978718|prostate cancer|prostate cancer
5577320|NCT00978705|Keratinocyte Cell|keratinocyte cell
5577321|NCT00978705|severe burn wound|severe burn wound
5577322|NCT00978692|Myopia|myopia
5577323|NCT00978692|Astigmatism|astigmatism
5577324|NCT00978692|Orthokeratology|orthokeratology
5577325|NCT00978692|Corneal thickness|corneal thickness
5577326|NCT00978692|Corneal curvatures|corneal curvatures
5577327|NCT00978692|Corneal biomechanics|corneal biomechanics
5577328|NCT00978679|Children|children
5577329|NCT00978679|Peripheral refraction|peripheral refraction
5577330|NCT00978679|Aberration|aberration
5577331|NCT00978679|Eyeball length|eyeball length
5577332|NCT00978679|Myopic control|myopic control
5577333|NCT00978679|Myopia|myopia
5577334|NCT00978679|Corneal reshaping|corneal reshaping
5577335|NCT00978679|Orthokeratology|orthokeratology
5577336|NCT00978653|allopurinol|allopurinol
5577337|NCT00978653|chronic kidney disease|chronic kidney disease
5577338|NCT00978653|endothelial dysfunction|endothelial dysfunction
5577339|NCT00978653|hyperuricemia|hyperuricemia
5577340|NCT00978653|uric acid|uric acid
5577341|NCT00978653|vascular endothelium|vascular endothelium
5577342|NCT00978653|xanthine oxidase inhibitor|xanthine oxidase inhibitor
5577343|NCT00978640|Sirt1 activity|sirt1 activity
5577344|NCT00978601|post-operative analgesia|post-operative analgesia
5577345|NCT00978601|early discharge,|early discharge,
5577346|NCT00978601|fast recovery,|fast recovery,
5577347|NCT00978601|minimally invasive myomectomy,|minimally invasive myomectomy,
5577348|NCT00978601|laparoscopy,|laparoscopy,
5577349|NCT00978601|laparoscopically assisted myomectomy|laparoscopically assisted myomectomy
5577350|NCT00978601|patient discharge|patient discharge
5577351|NCT00978601|Anesthesia Recovery Period|anesthesia recovery period
5577352|NCT00978575|Iron treatment|iron treatment
5577353|NCT00978575|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5577354|NCT00978549|pain|pain
5577355|NCT00978549|nausea and vomiting|nausea and vomiting
5577356|NCT00978549|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5577357|NCT00978549|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5577358|NCT00978549|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5577359|NCT00978549|recurrent gastric cancer|recurrent gastric cancer
5577360|NCT00978549|stage IIIA gastric cancer|stage iiia gastric cancer
5577361|NCT00978549|stage IIIB gastric cancer|stage iiib gastric cancer
5577362|NCT00978549|stage IIIC gastric cancer|stage iiic gastric cancer
5577363|NCT00978549|stage IV gastric cancer|stage iv gastric cancer
5577364|NCT00978549|recurrent esophageal cancer|recurrent esophageal cancer
5577365|NCT00978549|stage IIIA esophageal cancer|stage iiia esophageal cancer
5579994|NCT00968383|Acute Coronary Syndrome|acute coronary syndrome
5577366|NCT00978549|stage IIIB esophageal cancer|stage iiib esophageal cancer
5577367|NCT00978549|stage IIIC esophageal cancer|stage iiic esophageal cancer
5577368|NCT00978549|stage IV esophageal cancer|stage iv esophageal cancer
5577369|NCT00978536|Multiple sclerosis|multiple sclerosis
5577370|NCT00978536|cognitive deterioration|cognitive deterioration
5577371|NCT00978536|biomarkers|biomarkers
5577372|NCT00978536|cerebrospinal fluid|cerebrospinal fluid
5577373|NCT00978536|Alzheimer disease|alzheimer disease
5577374|NCT00978510|Tuberculosis|tuberculosis
5577375|NCT00978510|Disease transmission|disease transmission
5577376|NCT00978510|Exposure to biological agents|exposure to biological agents
5577377|NCT00978510|Health personnel|health personnel
5577379|NCT00978484|Depression|depression
5577380|NCT00978484|Anxiety|anxiety
5577381|NCT00978484|Virtual Reality|virtual reality
5577382|NCT00978484|Computer Therapy|computer therapy
5577383|NCT00978484|Exposure Therapy|exposure therapy
5577384|NCT00978484|Prolonged Exposure|prolonged exposure
5577390|NCT00978484|Armed Forces Personnel|armed forces personnel
5577391|NCT00978484|Army Personnel|army personnel
5577392|NCT00978484|Coast Guard|coast guard
5577393|NCT00978484|psychology|psychology
5577394|NCT00978484|military psychiatry|military psychiatry
5577395|NCT00978484|combat disorders|combat disorders
5577396|NCT00978484|combat neurosis|combat neurosis
5577398|NCT00978484|Military|military
5577399|NCT00978484|Navy Personnel|navy personnel
5577400|NCT00978484|Sailors|sailors
5577401|NCT00978484|Soldiers|soldiers
5577402|NCT00978471|Conventional chemotherapy|conventional chemotherapy
5577403|NCT00978471|cytapheresis|cytapheresis
5577404|NCT00978471|Peripheral stem cell autograft|peripheral stem cell autograft
5577405|NCT00978471|Surgical resection|surgical resection
5577406|NCT00978471|Thiotepa|thiotepa
5577407|NCT00978458|neurotoxicity|neurotoxicity
5577408|NCT00978458|adult diffuse astrocytoma|adult diffuse astrocytoma
5577409|NCT00978458|adult oligodendroglioma|adult oligodendroglioma
5577410|NCT00978458|recurrent adult brain tumor|recurrent adult brain tumor
5577411|NCT00978458|adult mixed glioma|adult mixed glioma
5577412|NCT00978445|Systemic embolic events|systemic embolic events
5577413|NCT00978445|Thromboembolic Complications with Atrial Fibrillation|thromboembolic complications with atrial fibrillation
5577414|NCT00978445|Prophylaxis with Atrial Fibrillation|prophylaxis with atrial fibrillation
5577415|NCT00978445|Mechanical Cardiac Valve Replacement|mechanical cardiac valve replacement
5577416|NCT00978432|NHL|nhl
5577417|NCT00978432|DLBCL|dlbcl
5577418|NCT00978432|recurrent|recurrent
5577419|NCT00978432|refractory|refractory
5577420|NCT00978432|de novo|de novo
5577421|NCT00978419|Statins|statins
5577422|NCT00978419|Burns|burns
5577423|NCT00978419|Sedatives|sedatives
5577424|NCT00978419|Neurocognitive|neurocognitive
5577425|NCT00978419|Septic|septic
5577426|NCT00978419|Mortality|mortality
5577427|NCT00978419|C Reactive Protein|c reactive protein
5577428|NCT00978419|Septic shock|septic shock
5577429|NCT00978419|Sedation|sedation
5577430|NCT00978419|Neurocognitive function|neurocognitive function
5577436|NCT00978367|Cicatrix|cicatrix
5577437|NCT00978367|Scar|scar
5577438|NCT00978367|Avotermin|avotermin
5577439|NCT00978367|Juvista|juvista
5577440|NCT00978367|RN1001|rn1001
5577441|NCT00978367|TGF beta 3|tgf beta 3
5577442|NCT00978354|acute kidney injury|acute kidney injury
5577443|NCT00978354|acute renal failure|acute renal failure
5577444|NCT00978354|loop diuretic|loop diuretic
5577445|NCT00978354|critical illness|critical illness
5577446|NCT00978354|sepsis|sepsis
5577447|NCT00978354|renal replacement therapy|renal replacement therapy
5577448|NCT00978354|dialysis|dialysis
5577449|NCT00978354|renal recovery|renal recovery
5577450|NCT00978354|survival|survival
5577451|NCT00978341|Clinical Trial Methodology study Neuropathic pain in Spinal cord injury patients Pain endpoints Crossover design|clinical trial methodology study neuropathic pain in spinal cord injury patients pain endpoints crossover design
5577452|NCT00978328|Pain conditions|pain conditions
5577453|NCT00978328|Oxycodone immediate release|oxycodone immediate release
5577454|NCT00978328|Percocet®, Tylox®|percocet®, tylox®
5577455|NCT00978328|Roxicodone®|roxicodone®
5577456|NCT00978328|Registry|registry
5577457|NCT00978328|Side effects|side effects
5577458|NCT00978328|Observational|observational
5577459|NCT00978328|Pain management|pain management
5577460|NCT00978302|Cicatrix|cicatrix
5577461|NCT00978302|Scar|scar
5577462|NCT00978302|Wound healing|wound healing
5577463|NCT00978302|Avotermin|avotermin
5577464|NCT00978302|TGF beta 3|tgf beta 3
5577465|NCT00978302|Juvista|juvista
5577466|NCT00978302|RN1001|rn1001
5577467|NCT00978289|obesity|obesity
5577468|NCT00978289|gastric bypass surgery|gastric bypass surgery
5577469|NCT00978276|Receptors|receptors
5577470|NCT00978276|Immunohistochemistry|immunohistochemistry
5577471|NCT00978276|Breast|breast
5577472|NCT00978276|Over expression of Hormone receptors in carcinoma of the breast sues|over expression of hormone receptors in carcinoma of the breast sues
5577473|NCT00978250|DNA Methylation|dna methylation
5577474|NCT00978250|Advanced Cancer|advanced cancer
5577475|NCT00978250|Methyltransferase Inhibitor|methyltransferase inhibitor
5577476|NCT00978250|Epigenetics|epigenetics
5577477|NCT00978250|Gene Re-Expression|gene re-expression
5577478|NCT00978250|Breast Cancer|breast cancer
5577479|NCT00978250|Head and Neck Cancer|head and neck cancer
5577480|NCT00978250|Lung Cancer|lung cancer
5577481|NCT00978250|Non-Small Cell Lung Cancer|non-small cell lung cancer
5577482|NCT00978250|Bladder Cancer|bladder cancer
5577483|NCT00978237|HIV - Lipoatrophy|hiv - lipoatrophy
5577484|NCT00978237|treatment experienced|treatment experienced
5577485|NCT00978224|dietary supplement|dietary supplement
5577492|NCT00978211|Yttrium|yttrium
5577493|NCT00978211|Lutetium|lutetium
5577494|NCT00978211|neuroendocrine|neuroendocrine
5577495|NCT00978211|cancer|cancer
5577496|NCT00978198|Pharmacokinetics|pharmacokinetics
5577497|NCT00978198|Safety and tolerability|safety and tolerability
5577498|NCT00978198|Plasma concentration|plasma concentration
5577499|NCT00978198|ASP1517|asp1517
5577500|NCT00978198|FG-4592|fg-4592
5577501|NCT00978185|nausea and vomiting|nausea and vomiting
5577502|NCT00978185|anxiety disorder|anxiety disorder
5577503|NCT00978185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5577504|NCT00978159|esomeprazole|esomeprazole
5577505|NCT00978159|famotidine|famotidine
5577506|NCT00978159|aspirin|aspirin
5577507|NCT00978159|dyspepsia|dyspepsia
5577508|NCT00978133|Colectomy|colectomy
5577509|NCT00978133|Closure|closure
5577510|NCT00978133|Wound|wound
5577511|NCT00978133|Dermabond|dermabond
5577512|NCT00978133|Propen|propen
5577513|NCT00978120|Influenza A Virus, H1N1 Subtype|influenza a virus, h1n1 subtype
5577514|NCT00978120|Vaccine|vaccine
5577515|NCT00978107|Hepatic tumors|hepatic tumors
5577516|NCT00978107|Metastatic colorectal cancer|metastatic colorectal cancer
5577517|NCT00978081|precancerous condition|precancerous condition
5577518|NCT00978081|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5577519|NCT00978081|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5577520|NCT00978081|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5577521|NCT00978081|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5577522|NCT00978081|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5577523|NCT00978081|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5577524|NCT00978068|Pediatric HIV|pediatric hiv
5577525|NCT00978068|Malaria|malaria
5577526|NCT00978068|Uganda|uganda
5577527|NCT00978068|Nevirapine|nevirapine
5577528|NCT00978068|Zidovudine|zidovudine
5577529|NCT00978068|Lamivudine|lamivudine
5577530|NCT00978068|Lopinavir/ritonavir|lopinavir/ritonavir
5577531|NCT00978068|Stavudine|stavudine
5577532|NCT00978068|Efavirenz|efavirenz
5577533|NCT00978068|HIV|hiv
5577534|NCT00978029|immunotherapy|immunotherapy
5577535|NCT00978016|GERD|gerd
5577536|NCT00978003|Maltracking|maltracking
5577537|NCT00978003|Anterior Knee Pain|anterior knee pain
5577538|NCT00978003|Knee|knee
5577539|NCT00977990|Skin Swab|skin swab
5577540|NCT00977990|Self-Sample|self-sample
5577546|NCT00977964|Infant|infant
5577547|NCT00977951|Cicatrix|cicatrix
5577548|NCT00977951|Scar|scar
5577549|NCT00977951|Avotermin|avotermin
5577550|NCT00977951|Juvista|juvista
5577551|NCT00977951|RN1001|rn1001
5577552|NCT00977951|TGF beta 3|tgf beta 3
5577553|NCT00977938|Acute Coronary Syndrome|acute coronary syndrome
5577554|NCT00977938|Adverse event|adverse event
5577555|NCT00977938|Antiplatelet therapy|antiplatelet therapy
5577556|NCT00977938|Sirolimus|sirolimus
5577557|NCT00977938|Everolimus|everolimus
5577558|NCT00977938|Paclitaxel|paclitaxel
5577559|NCT00977938|Zotarolimus|zotarolimus
5577560|NCT00977938|Bare Metal Stent|bare metal stent
5577561|NCT00977938|Drug Eluting Stent|drug eluting stent
5577562|NCT00977938|Clinical Events Committee|clinical events committee
5577563|NCT00977938|Dual antiplatelet therapy|dual antiplatelet therapy
5577564|NCT00977938|Harvard Clinical Research Institute|harvard clinical research institute
5577565|NCT00977938|Major Adverse Cardiac and Cerebral Event|major adverse cardiac and cerebral event
5577566|NCT00977938|Major Bleeding|major bleeding
5577567|NCT00977938|Myocardial infarction|myocardial infarction
5577568|NCT00977938|Myocardial ischemia|myocardial ischemia
5577569|NCT00977938|Percutaneous coronary intervention|percutaneous coronary intervention
5577570|NCT00977938|Stent placement|stent placement
5577571|NCT00977938|Stent Thrombosis|stent thrombosis
5577572|NCT00977938|Thienopyridine|thienopyridine
5577573|NCT00977938|Clopidogrel|clopidogrel
5577574|NCT00977938|Prasugrel|prasugrel
5577575|NCT00977925|Hemostasis|hemostasis
5577576|NCT00977912|B. lactis|b. lactis
5577577|NCT00977912|Preterm|preterm
5577578|NCT00977912|Necrotizing Enterocolitis (NEC)|necrotizing enterocolitis (nec)
5577579|NCT00977899|Plasmodium Falciparum|plasmodium falciparum
5577580|NCT00977899|Alum Adsorbed|alum adsorbed
5577581|NCT00977899|Ookinete Surface Protein|ookinete surface protein
5577582|NCT00977899|Malaria Vaccine|malaria vaccine
5577583|NCT00977899|Healthy Volunteer|healthy volunteer
5577584|NCT00977899|HV|hv
5577585|NCT00977860|Prostate|prostate
5577586|NCT00977860|Stereotactic|stereotactic
5577587|NCT00977860|Radiosurgery|radiosurgery
5577588|NCT00977847|Family History|family history
5579992|NCT00968396|Alkeran|alkeran
5577589|NCT00977847|Electronic Health Record|electronic health record
5577590|NCT00977834|Geriatric Assessment|geriatric assessment
5577591|NCT00977808|Artificial pancreas|artificial pancreas
5577592|NCT00977808|Closed-Loop control|closed-loop control
5577593|NCT00977795|Brain Neoplasms|brain neoplasms
5577594|NCT00977795|5-ALA|5-ala
5577595|NCT00977795|Aminolevulinic acid|aminolevulinic acid
5577596|NCT00977795|Fluorescence|fluorescence
5577597|NCT00977795|Gliomas|gliomas
5577598|NCT00977795|Glioblastoma|glioblastoma
5577599|NCT00977795|Surgery|surgery
5577600|NCT00977769|cesarean delivery|cesarean delivery
5577601|NCT00977769|blood pressure|blood pressure
5577602|NCT00977769|cardiac output|cardiac output
5577603|NCT00977756|Treatment|treatment
5577604|NCT00977756|Children|children
5577605|NCT00977756|Integrase Inhibitors|integrase inhibitors
5577606|NCT00977756|Entry Inhibitors|entry inhibitors
5577607|NCT00977756|Treatment Experienced|treatment experienced
5577608|NCT00977730|Hepatitis|hepatitis
5577609|NCT00977730|Fatty Liver|fatty liver
5577610|NCT00977730|Non Alcoholic Steatohepatitis|non alcoholic steatohepatitis
5577611|NCT00977730|Protandim|protandim
5577612|NCT00977717|oxaliplatin|oxaliplatin
5577613|NCT00977717|neuropathy|neuropathy
5577614|NCT00977717|SNPs|snps
5577615|NCT00977704|Correction of peri-oral wrinkles|correction of peri-oral wrinkles
5577616|NCT00977691|Sickle Cell Anemia|sickle cell anemia
5577617|NCT00977691|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5577618|NCT00977691|Graft-Versus-Host Disease|graft-versus-host disease
5577619|NCT00977691|Sirolimus (Rapamune )|sirolimus (rapamune )
5577620|NCT00977691|Alemtuzumab (Campath )|alemtuzumab (campath )
5577621|NCT00977691|Thalassemia|thalassemia
5577622|NCT00977691|Sickle Cell Disease|sickle cell disease
5577623|NCT00977678|open access gastroscopy|open access gastroscopy
5577624|NCT00977652|fecal incontinence|fecal incontinence
5577625|NCT00977626|Safety|safety
5577626|NCT00977626|Tolerability|tolerability
5577627|NCT00977626|Healthy|healthy
5577628|NCT00977626|Pharmacokinetics|pharmacokinetics
5577629|NCT00977626|Healthy volunteers|healthy volunteers
5577630|NCT00977613|Treated Stage 2 and Stage 3 colorectal cancer|treated stage 2 and stage 3 colorectal cancer
5577631|NCT00977600|Ammonul|ammonul
5577632|NCT00977600|Sodium phenylacetate|sodium phenylacetate
5577633|NCT00977600|sodium benzoate|sodium benzoate
5577634|NCT00977600|Buphenyl|buphenyl
5577635|NCT00977600|sodium phenylbutyrate|sodium phenylbutyrate
5577636|NCT00977600|HPN-100|hpn-100
5577637|NCT00977600|GT4P|gt4p
5577638|NCT00977600|Glyceryl tri-(4-phenylbutyrate)|glyceryl tri-(4-phenylbutyrate)
5577639|NCT00977600|Healthy Volunteers|healthy volunteers
5577640|NCT00977587|irritable bowel syndrome|irritable bowel syndrome
5577641|NCT00977587|faecal serine proteases|faecal serine proteases
5577642|NCT00977561|Small Cell Lung Cancer|small cell lung cancer
5577643|NCT00977561|Extensive stage disease|extensive stage disease
5577644|NCT00977561|SCLC|sclc
5577645|NCT00977561|IGF-1R inhibitor|igf-1r inhibitor
5577646|NCT00977548|MDS|mds
5577647|NCT00977548|blood diseases|blood diseases
5577648|NCT00977548|bone marrow|bone marrow
5577649|NCT00977548|hematopoietic|hematopoietic
5577650|NCT00977548|leukemia|leukemia
5577651|NCT00977522|schizophrenia negative symptoms adjunctive|schizophrenia negative symptoms adjunctive
5577652|NCT00977509|genes|genes
5577653|NCT00977509|mutation|mutation
5577654|NCT00977509|non-small cell lung cancer|non-small cell lung cancer
5577655|NCT00977509|cancer cells|cancer cells
5577656|NCT00977496|hemodialysis|hemodialysis
5577657|NCT00977496|microbiota|microbiota
5577658|NCT00977496|Staphylococcus aureus|staphylococcus aureus
5577659|NCT00977470|NSCLC|nsclc
5577660|NCT00977470|HCQ|hcq
5577661|NCT00977470|erlotinib|erlotinib
5577662|NCT00977470|Tarceva|tarceva
5577663|NCT00977457|stage I prostate cancer|stage i prostate cancer
5577664|NCT00977457|stage II prostate cancer|stage ii prostate cancer
5577665|NCT00977457|stage III prostate cancer|stage iii prostate cancer
5577666|NCT00977457|stage IV prostate cancer|stage iv prostate cancer
5577667|NCT00977444|knee|knee
5577668|NCT00977444|osteoarthritis|osteoarthritis
5577669|NCT00977418|Healthy Aging|healthy aging
5577670|NCT00977418|Exercise|exercise
5577671|NCT00977418|Cognition|cognition
5577672|NCT00977418|Cognitive Training|cognitive training
5577673|NCT00977418|Keeping healthy seniors as mentally efficient as possible|keeping healthy seniors as mentally efficient as possible
5577674|NCT00977405|Wound infection|wound infection
5577675|NCT00977405|Gentamicin|gentamicin
5577676|NCT00977405|Contaminated wounds|contaminated wounds
5577677|NCT00977392|human papilloma virus infection|human papilloma virus infection
5577678|NCT00977392|health status unknown|health status unknown
5577679|NCT00977353|Major depressive disorder|major depressive disorder
5577680|NCT00977353|Depression|depression
5577681|NCT00977353|Sarcosine|sarcosine
5577682|NCT00977353|N-methylglycine|n-methylglycine
5577683|NCT00977353|NMDA|nmda
5577684|NCT00977340|Chronic nightmare sufferers|chronic nightmare sufferers
5577685|NCT00977340|nightmares|nightmares
5577686|NCT00977340|Imagery Rehearsal Therapy IRT|imagery rehearsal therapy irt
5577687|NCT00977340|sleep disturbance|sleep disturbance
5577688|NCT00977340|treatment of nightmares|treatment of nightmares
5577689|NCT00977340|confrontation|confrontation
5577690|NCT00977340|People who suffer of chronic nightmares|people who suffer of chronic nightmares
5577691|NCT00977327|Glioma|glioma
5577692|NCT00977327|Intraoperative MR|intraoperative mr
5577693|NCT00977327|Intraoperative Ultrasound|intraoperative ultrasound
5577694|NCT00977327|resection|resection
5577695|NCT00977327|Intraoperative navigation|intraoperative navigation
5577696|NCT00977327|Extent of resection|extent of resection
5577697|NCT00977314|Unilateral Hearing Loss|unilateral hearing loss
5577698|NCT00977301|HIV infection|hiv infection
5577699|NCT00977301|interaction|interaction
5577700|NCT00977301|pharmacokinetics|pharmacokinetics
5577701|NCT00977275|early stage invasive breast cancer|early stage invasive breast cancer
5577702|NCT00977275|Partial breast irradiation|partial breast irradiation
5577703|NCT00977275|interstitial implant|interstitial implant
5577704|NCT00977262|fatty acids|fatty acids
5577705|NCT00977262|peripheral blood mononuclear cells|peripheral blood mononuclear cells
5577706|NCT00977262|inflammation|inflammation
5577707|NCT00977262|nutrigenomics|nutrigenomics
5577708|NCT00977249|long term nicotine gum use|long term nicotine gum use
5577709|NCT00977249|varenicline|varenicline
5577710|NCT00977249|adverse effects|adverse effects
5577711|NCT00977236|children|children
5577712|NCT00977236|corneal reshaping|corneal reshaping
5577713|NCT00977236|myopia|myopia
5577714|NCT00977236|myopia control|myopia control
5577715|NCT00977236|orthokeratology|orthokeratology
5577716|NCT00977223|Aldosterone|aldosterone
5577717|NCT00977223|Substance P|substance p
5577718|NCT00977223|Cortisol|cortisol
5577719|NCT00977223|Aprepitant|aprepitant
5577720|NCT00977223|Adrenal glands|adrenal glands
5577721|NCT00977210|Phase 1|phase 1
5577722|NCT00977210|oxi4503|oxi4503
5577723|NCT00977210|oxigene|oxigene
5577724|NCT00977210|cruk|cruk
5577725|NCT00977210|solid tumors|solid tumors
5577726|NCT00977210|VDA|vda
5577727|NCT00977210|vascular disrupting agent|vascular disrupting agent
5577728|NCT00977184|Parkinson's Disease|parkinson's disease
5577729|NCT00977184|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5577730|NCT00977184|Treatment Study|treatment study
5577731|NCT00977184|PD|pd
5577732|NCT00977184|Parkinson Disease|parkinson disease
5577733|NCT00977171|chronic fatigue syndrome|chronic fatigue syndrome
5577734|NCT00977171|CFS|cfs
5577735|NCT00977171|neurally mediated hypotension|neurally mediated hypotension
5577736|NCT00977171|NMH|nmh
5577737|NCT00977171|neurogenic orthostatic hypotension|neurogenic orthostatic hypotension
5577738|NCT00977171|NOH|noh
5577739|NCT00977171|orthostatic hypotension|orthostatic hypotension
5577740|NCT00977171|droxidopa|droxidopa
5577741|NCT00977158|Cystic Fibrosis|cystic fibrosis
5577742|NCT00977158|Microbiota|microbiota
5577743|NCT00977158|upper respiratory tract|upper respiratory tract
5577744|NCT00977158|16S rRNA sequence analysis|16s rrna sequence analysis
5577745|NCT00977158|Staphylococcus aureus|staphylococcus aureus
5577746|NCT00977158|Pseudomonas aeruginosa|pseudomonas aeruginosa
5577747|NCT00977158|Burkholderia cepacia|burkholderia cepacia
5577748|NCT00977158|Haemophilus influenzae|haemophilus influenzae
5577749|NCT00977158|Streptococcus pneumoniae|streptococcus pneumoniae
5577750|NCT00977145|melanoma|melanoma
5577751|NCT00977145|peptide vaccine|peptide vaccine
5577752|NCT00977145|interferon gamma|interferon gamma
5577753|NCT00977145|immunotherapy|immunotherapy
5577754|NCT00977132|Myelodysplastic Syndromes|myelodysplastic syndromes
5577755|NCT00977132|Valproic acid|valproic acid
5577756|NCT00977132|Lenalidomide|lenalidomide
5577757|NCT00977119|breast cancer|breast cancer
5577758|NCT00977119|capecitabine|capecitabine
5577759|NCT00977093|Coronary artery disease|coronary artery disease
5577760|NCT00977093|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5577761|NCT00977093|single photon emission computed tomography|single photon emission computed tomography
5577762|NCT00977093|invasive coronary angiography|invasive coronary angiography
5577763|NCT00977080|Zemplar|zemplar
5577764|NCT00977080|paricalcitol|paricalcitol
5577765|NCT00977080|IMPACT SHPT|impact shpt
5577766|NCT00977080|Hemodialysis|hemodialysis
5559956|NCT01047683|EPA|epa
5577767|NCT00977080|Chronic Kidney Disease Stage 5|chronic kidney disease stage 5
5577768|NCT00977067|GDC0152|gdc0152
5577769|NCT00977067|IAP|iap
5577770|NCT00977067|IAP Antagonist|iap antagonist
5577771|NCT00977054|Hepatitis C|hepatitis c
5577772|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a
5577773|NCT00977054|Ribavirin|ribavirin
5577774|NCT00977054|Plasmapheresis|plasmapheresis
5577775|NCT00977054|Genotype 1|genotype 1
5577776|NCT00977041|Neurofeedback|neurofeedback
5577777|NCT00977028|Tumescent|tumescent
5577778|NCT00977028|Local Anesthesia|local anesthesia
5577779|NCT00977028|Lidocaine|lidocaine
5577780|NCT00977028|Dosage Maximum|dosage maximum
5577781|NCT00977028|Subcutaneous infiltration|subcutaneous infiltration
5577782|NCT00977028|maximum Safe mg per kg dosage of lidocaine|maximum safe mg per kg dosage of lidocaine
5577783|NCT00977028|Tumescent Local Anesthesia|tumescent local anesthesia
5577784|NCT00977002|noninvasive ventilation|noninvasive ventilation
5577785|NCT00977002|extubation|extubation
5577786|NCT00977002|Respiratory failure|respiratory failure
5577787|NCT00977002|reintubation|reintubation
5579993|NCT00968396|Apheresis|apheresis
5577788|NCT00976976|Resected advanced gastric cancer stage IIIB and IV|resected advanced gastric cancer stage iiib and iv
5577790|NCT00976924|blood glucose|blood glucose
5577791|NCT00976898|proton beam radiation|proton beam radiation
5577792|NCT00976872|omega 3|omega 3
5577793|NCT00976872|inflammation|inflammation
5577794|NCT00976872|augmentation index|augmentation index
5577795|NCT00976872|endothelial function|endothelial function
5577796|NCT00976859|childhood sexual abuse|childhood sexual abuse
5577798|NCT00976859|posttraumatic stress disorder|posttraumatic stress disorder
5577799|NCT00976859|PTSD, feeling of being polluted|ptsd, feeling of being polluted
5577800|NCT00976859|mental pollution, mental contamination|mental pollution, mental contamination
5577801|NCT00976859|feeling of being contaminated|feeling of being contaminated
5577802|NCT00976859|sexual assault|sexual assault
5577803|NCT00976859|disgust, shame|disgust, shame
5577804|NCT00976846|hemodialysis|hemodialysis
5577805|NCT00976846|on line|on line
5577806|NCT00976846|postdilution|postdilution
5577807|NCT00976846|high-flux dialyzer|high-flux dialyzer
5577808|NCT00976846|hemodiafiltration|hemodiafiltration
5577809|NCT00976833|Acute Respiratory Failure|acute respiratory failure
5577810|NCT00976833|Early ICU Mobility|early icu mobility
5577811|NCT00976833|Early Physical Therapy|early physical therapy
5577812|NCT00976833|Critical Care|critical care
5577813|NCT00976833|Intensive Care|intensive care
5577814|NCT00976833|ICU|icu
5577815|NCT00976820|influenza infection|influenza infection
5577816|NCT00976820|Influenza Vaccines|influenza vaccines
5577817|NCT00976820|GSK Bio's influenza vaccine GSK2340273A|gsk bio's influenza vaccine gsk2340273a
5577818|NCT00976820|GSK Bio's influenza vaccine GSK2340274A|gsk bio's influenza vaccine gsk2340274a
5577819|NCT00976807|critical care|critical care
5577820|NCT00976807|intensive care|intensive care
5577821|NCT00976807|weakness|weakness
5577822|NCT00976807|myopathy|myopathy
5577823|NCT00976807|paresis|paresis
5577824|NCT00976807|rehabilitation|rehabilitation
5577825|NCT00976794|BD I|bd i
5577826|NCT00976768|Advanced gastric cancer|advanced gastric cancer
5577827|NCT00976768|FOLFIRI|folfiri
5577828|NCT00976755|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5577829|NCT00976755|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5577830|NCT00976755|stage III prostate cancer|stage iii prostate cancer
5577831|NCT00976755|stage IV prostate cancer|stage iv prostate cancer
5577832|NCT00976742|plasma lipoprotein lipids|plasma lipoprotein lipids
5577833|NCT00976742|body composition|body composition
5577834|NCT00976742|glucose tolerance|glucose tolerance
5577835|NCT00976742|inflammation markers|inflammation markers
5577836|NCT00976742|insulin sensitivity|insulin sensitivity
5577837|NCT00976742|coagulation markers|coagulation markers
5577838|NCT00976729|monocyte chemoattractant protein-1 (MCP-1)|monocyte chemoattractant protein-1 (mcp-1)
5577839|NCT00976729|L-oligonucleotide aptamer|l-oligonucleotide aptamer
5577840|NCT00976729|Spiegelmer|spiegelmer
5577841|NCT00976716|posttraumatic pain|posttraumatic pain
5577842|NCT00976703|cervical foley catheter|cervical foley catheter
5577843|NCT00976690|Crohn's Disease|crohn's disease
5577844|NCT00976690|Ileocolic resection|ileocolic resection
5577845|NCT00976690|Endoscopic recurrence|endoscopic recurrence
5577846|NCT00976690|Ileocolic or colon resection (>50cm)|ileocolic or colon resection (>50cm)
5577847|NCT00976651|infertility|infertility
5577848|NCT00976651|ICSI|icsi
5577849|NCT00976651|hCG|hcg
5577850|NCT00976651|infertility treatment|infertility treatment
5577851|NCT00976638|Antimicrobial Resistant Bacteria|antimicrobial resistant bacteria
5577852|NCT00976638|Hospital acquired infections|hospital acquired infections
5577853|NCT00976638|Colonization|colonization
5577854|NCT00976638|Bacteremia|bacteremia
5577855|NCT00976638|MRSA|mrsa
5577856|NCT00976638|VRE|vre
5577857|NCT00976638|ESBL|esbl
5577858|NCT00976638|Intensive Care|intensive care
5577859|NCT00976638|ICU|icu
5577860|NCT00976625|diastolic function|diastolic function
5577861|NCT00976625|aortic regurgitation|aortic regurgitation
5577862|NCT00976625|aortic valve replacement|aortic valve replacement
5577863|NCT00976625|left ventricular hypertrophy|left ventricular hypertrophy
5577864|NCT00976625|myocardial structure|myocardial structure
5577865|NCT00976625|LV remodeling|lv remodeling
5577866|NCT00976625|Muscular regression|muscular regression
5577867|NCT00976625|LV fibrous tissue|lv fibrous tissue
5577868|NCT00976612|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5577869|NCT00976612|pharmacokinetics|pharmacokinetics
5577870|NCT00976612|nilotinib|nilotinib
5577871|NCT00976586|Incontinentia pigmenti|incontinentia pigmenti
5577872|NCT00976586|recombination|recombination
5577873|NCT00976586|IKBKG|ikbkg
5577874|NCT00976586|IKBKGP|ikbkgp
5577875|NCT00976573|Stage IV Skin Melanoma|stage iv skin melanoma
5577876|NCT00976573|recurrent melanoma|recurrent melanoma
5577877|NCT00976560|Lack of interest and energy|lack of interest and energy
5577878|NCT00976560|Psychomotor retardation|psychomotor retardation
5577879|NCT00976560|Cytokines|cytokines
5577880|NCT00976560|Major Depressive disorder|major depressive disorder
5577881|NCT00976547|tinnitus|tinnitus
5577882|NCT00976547|depression|depression
5577883|NCT00976547|audiometry|audiometry
5577884|NCT00976547|measurement|measurement
5577885|NCT00976534|Analgesic effect|analgesic effect
5577886|NCT00976534|Peripheral Neuropathic pain|peripheral neuropathic pain
5577887|NCT00976534|Posttraumatic Neuralgia (PTN)|posttraumatic neuralgia (ptn)
5577888|NCT00976534|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5577889|NCT00976508|advanced solid tumors cancer refractory cancer figitumumab pegvisomant|advanced solid tumors cancer refractory cancer figitumumab pegvisomant
5577890|NCT00976482|Cardiovascular|cardiovascular
5577891|NCT00976482|Pacemaker|pacemaker
5577892|NCT00976482|Mortality|mortality
5577893|NCT00976482|Physiologic pacing|physiologic pacing
5577894|NCT00976456|lung cancer|lung cancer
5577895|NCT00976456|NSCLC|nsclc
5577896|NCT00976456|elderly|elderly
5577897|NCT00976456|non-squamous|non-squamous
5577898|NCT00976456|Elderly patients at least 65 years old|elderly patients at least 65 years old
5577899|NCT00976456|first line therapy|first line therapy
5577900|NCT00976456|non-squamous non-small cell lung cancer stage IIIb or IV|non-squamous non-small cell lung cancer stage iiib or iv
5577901|NCT00976443|Obesity|obesity
5577902|NCT00976443|Gastric Emptying|gastric emptying
5577903|NCT00976443|Satiation|satiation
5577904|NCT00976443|Endosonography|endosonography
5577905|NCT00976443|Endoscopy|endoscopy
5577906|NCT00976443|Feeding Behavior|feeding behavior
5577907|NCT00976430|Autologous Stem Cells.|autologous stem cells.
5577908|NCT00976404|HIV-1 infection|hiv-1 infection
5577909|NCT00976404|Treatment intensification|treatment intensification
5577910|NCT00976404|Immunomodulation|immunomodulation
5577911|NCT00976404|HIV-rAd5 vaccine|hiv-rad5 vaccine
5577912|NCT00976391|open-label|open-label
5577913|NCT00976391|albiglutide|albiglutide
5577914|NCT00976391|insulin glargine|insulin glargine
5577915|NCT00976391|preprandial insulin|preprandial insulin
5577916|NCT00976378|stromal cell-derived factor-1 (SDF-1)|stromal cell-derived factor-1 (sdf-1)
5577917|NCT00976378|L-oligonucleotide aptamer|l-oligonucleotide aptamer
5577918|NCT00976378|Spiegelmer|spiegelmer
5577919|NCT00976365|Breast Cancer|breast cancer
5577920|NCT00976352|Gene Therapy|gene therapy
5577921|NCT00976352|Pompe Disease|pompe disease
5577922|NCT00976352|Glycogen Storage Disease|glycogen storage disease
5577923|NCT00976339|Breast cancer|breast cancer
5577924|NCT00976339|Vitamin D|vitamin d
5577925|NCT00976339|Premenopausal|premenopausal
5685407|NCT00556205|mRCC|mrcc
5577927|NCT00976313|urinary micturition|urinary micturition
5577928|NCT00976313|thoracotomy|thoracotomy
5577930|NCT00976300|lupus nephritis|lupus nephritis
5577931|NCT00976300|cyclosporine A|cyclosporine a
5577932|NCT00976300|cyclophosphamide|cyclophosphamide
5577933|NCT00976300|active proliferative lupus nephritis (class III or IV according to WHO)|active proliferative lupus nephritis (class iii or iv according to who)
5577934|NCT00976287|Stem cells|stem cells
5577935|NCT00976287|Liver cirrhosis|liver cirrhosis
5577936|NCT00976287|Radiology|radiology
5577937|NCT00976287|Interventional|interventional
5577938|NCT00976287|Transplantation|transplantation
5577939|NCT00976274|Korean red ginseng|korean red ginseng
5577940|NCT00976274|metabolic syndrome|metabolic syndrome
5577941|NCT00976274|blood pressure|blood pressure
5577942|NCT00976274|arterial stiffness|arterial stiffness
5577943|NCT00976274|inflammation|inflammation
5577944|NCT00976274|oxidative stress|oxidative stress
5577945|NCT00976261|type 2 diabetes|type 2 diabetes
5577946|NCT00976261|single dose|single dose
5577947|NCT00976261|3-O-methylglucose|3-o-methylglucose
5577948|NCT00976261|healthy volunteer|healthy volunteer
5577949|NCT00976261|repeat dose|repeat dose
5577950|NCT00976248|everolimus|everolimus
5577951|NCT00976248|RAD001|rad001
5577952|NCT00976248|WM|wm
5577953|NCT00976235|Macular Degeneration|macular degeneration
5577954|NCT00976235|Visual Impairment|visual impairment
5577955|NCT00976235|Quality of Life|quality of life
5577956|NCT00976235|Telescope Prosthesis|telescope prosthesis
5577957|NCT00976196|Aspirin|aspirin
5577958|NCT00976196|Blood platelets|blood platelets
5577959|NCT00976196|proteomics|proteomics
5577960|NCT00976196|Platelet reactivity|platelet reactivity
5577961|NCT00976183|ovarian cancer|ovarian cancer
5577962|NCT00976183|gynecologic oncology|gynecologic oncology
5577963|NCT00976183|vorinostat|vorinostat
5577964|NCT00976183|treatment|treatment
5577965|NCT00976170|Advanced or metastatic HCC|advanced or metastatic hcc
5577966|NCT00976157|STREM-1|strem-1
5577967|NCT00976157|BAL|bal
5577968|NCT00976157|VAP|vap
5577969|NCT00976144|safety|safety
5577970|NCT00976144|LAMA|lama
5577971|NCT00976144|pharmacodynamics|pharmacodynamics
5577972|NCT00976144|tolerability|tolerability
5577973|NCT00976144|Muscarinic receptor antagonist,|muscarinic receptor antagonist,
5577974|NCT00976144|anticholinergic,|anticholinergic,
5577975|NCT00976144|beta-2 agonist|beta-2 agonist
5577976|NCT00976144|healthy Japanese subjects|healthy japanese subjects
5577977|NCT00976144|LABA|laba
5577978|NCT00976144|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5577979|NCT00976144|pharmacokinetics|pharmacokinetics
5577980|NCT00976131|Breast Cancer|breast cancer
5577981|NCT00976131|Early Stage Breast Cancer|early stage breast cancer
5847313|NCT00040196|Healthy Volunteer|healthy volunteer
5577982|NCT00976131|Complementary and Alternative Medicine|complementary and alternative medicine
5577983|NCT00976131|CAM|cam
5577984|NCT00976118|Dementia of Alzheimer's type|dementia of alzheimer's type
5577985|NCT00976118|mild to moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5577986|NCT00976105|Pharmacokinetics|pharmacokinetics
5577987|NCT00976105|Pharmacodynamics|pharmacodynamics
5577988|NCT00976105|Safety and tolerability|safety and tolerability
5577989|NCT00976105|Repeat dose|repeat dose
5577990|NCT00976105|Personality traits|personality traits
5577991|NCT00976105|Fat mass|fat mass
5577992|NCT00976105|Healthy volunteers|healthy volunteers
5577993|NCT00976092|myocardial infarction|myocardial infarction
5577994|NCT00976092|clopidogrel|clopidogrel
5577995|NCT00976092|prasugrel|prasugrel
5577996|NCT00976092|bivalirudin|bivalirudin
5577997|NCT00976092|primary PCI|primary pci
5577998|NCT00976079|Tibial femoral knee osteoarthritis|tibial femoral knee osteoarthritis
5577999|NCT00976079|Osteoarthritis|osteoarthritis
5578000|NCT00976066|Obesity|obesity
5578001|NCT00976066|Naltrexone|naltrexone
5578002|NCT00976066|Carfentanil|carfentanil
5578003|NCT00976066|Receptor Occupancy|receptor occupancy
5578004|NCT00976066|mu-opioid Receptor|mu-opioid receptor
5578005|NCT00976066|PET (Positron Emission Tomography)|pet (positron emission tomography)
5578006|NCT00976066|BOLD-fMRI|bold-fmri
5578007|NCT00976053|Myocardial perfusion imaging|myocardial perfusion imaging
5578008|NCT00976053|Single photon emission computed tomography|single photon emission computed tomography
5578009|NCT00976053|Positron emission tomography|positron emission tomography
5578010|NCT00976040|HIV-1|hiv-1
5578011|NCT00976040|Africa|africa
5578012|NCT00976040|Botswana|botswana
5578013|NCT00976040|Highly active antiretroviral therapy|highly active antiretroviral therapy
5578014|NCT00976040|treatment naive|treatment naive
5578015|NCT00976027|Influenza|influenza
5578016|NCT00976027|Respiratory Tract Infections|respiratory tract infections
5578017|NCT00976027|Influenza-like illness|influenza-like illness
5578018|NCT00976027|Elderly|elderly
5578019|NCT00976027|Fluzone®|fluzone®
5578020|NCT00976027|Efficacy|efficacy
5578021|NCT00976001|Follow-up after stroke|follow-up after stroke
5578022|NCT00975988|PMS (post-marketing surveillance)|pms (post-marketing surveillance)
5578023|NCT00975988|TYKERB® tablets|tykerb® tablets
5578024|NCT00975975|Paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5578025|NCT00975975|severe aplastic anemia|severe aplastic anemia
5578026|NCT00975975|Mantle cell|mantle cell
5578027|NCT00975962|Stroke|stroke
5578028|NCT00975962|Neuroprotection|neuroprotection
5578029|NCT00975962|remote preconditioning|remote preconditioning
5578030|NCT00975962|Salvage index (%): Difference in infarct growth (PWI-DWI)|salvage index (%): difference in infarct growth (pwi-dwi)
5578031|NCT00975949|fluconazole prophylaxis|fluconazole prophylaxis
5578032|NCT00975949|fungal colonization|fungal colonization
5578033|NCT00975949|fungal infection|fungal infection
5578034|NCT00975949|preterm infants|preterm infants
5578035|NCT00975949|long term outcomes|long term outcomes
5578036|NCT00975949|quality of life|quality of life
5578037|NCT00975936|Microdose|microdose
5578038|NCT00975936|Drug-Drug Interaction|drug-drug interaction
5578039|NCT00975936|Ketoconazole|ketoconazole
5578040|NCT00975936|Phase 0|phase 0
5578041|NCT00975923|Quality Improvement|quality improvement
5578042|NCT00975923|Critical Care|critical care
5578043|NCT00975923|Collaboratives|collaboratives
5578044|NCT00975923|Patient Safety|patient safety
5578045|NCT00975923|Tool Kit|tool kit
5578046|NCT00975910|Supratentorial Craniotomy|supratentorial craniotomy
5578047|NCT00975897|adenocarcinoma of the colon|adenocarcinoma of the colon
5578048|NCT00975897|recurrent colon cancer|recurrent colon cancer
5578049|NCT00975897|stage III colon cancer|stage iii colon cancer
5578050|NCT00975897|stage IV colon cancer|stage iv colon cancer
5578051|NCT00975897|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5578052|NCT00975897|recurrent rectal cancer|recurrent rectal cancer
5578053|NCT00975897|stage III rectal cancer|stage iii rectal cancer
5578054|NCT00975897|stage IV rectal cancer|stage iv rectal cancer
5578055|NCT00975884|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5578056|NCT00975884|influenza infection|influenza infection
5578057|NCT00975884|Influenza vaccine|influenza vaccine
5578058|NCT00975871|Livedo vasculitis|livedo vasculitis
5578059|NCT00975871|Genetic pleomorphism|genetic pleomorphism
5578060|NCT00975858|Symptomatic Coronary Artery Disease Patients|symptomatic coronary artery disease patients
5578062|NCT00975845|Anterior Cruciate Ligament|anterior cruciate ligament
5578063|NCT00975845|Torn tendon|torn tendon
5578064|NCT00975845|ACL Repair|acl repair
5578065|NCT00975845|ACL reconstruction|acl reconstruction
5578066|NCT00975832|The independent effect of PCOS and obesity on adipose expression and plasma levels of adipocytokines|the independent effect of pcos and obesity on adipose expression and plasma levels of adipocytokines
5578067|NCT00975793|Sepsis|sepsis
5578068|NCT00975793|Severe sepsis|severe sepsis
5578069|NCT00975793|Septic shock|septic shock
5578070|NCT00975780|Pneumonia|pneumonia
5578071|NCT00975780|Lower respiratory tract infection|lower respiratory tract infection
5578072|NCT00975780|Lower respiratory tract infection other than pneumonia|lower respiratory tract infection other than pneumonia
5578073|NCT00975754|Inhalation|inhalation
5578074|NCT00975754|lung deposition|lung deposition
5578075|NCT00975741|Asthma|asthma
5578076|NCT00975741|Mometasone furoate|mometasone furoate
5578077|NCT00975741|Inhalation devices|inhalation devices
5578078|NCT00975741|Forced expiratory volume|forced expiratory volume
5578079|NCT00975728|Anti-oxidant|anti-oxidant
5578080|NCT00975728|Açai|açai
5578081|NCT00975728|Food supplement|food supplement
5578082|NCT00975728|Sun protection|sun protection
5578083|NCT00975728|Skin erythema prevention|skin erythema prevention
5578084|NCT00975728|Anti-oxidant efficacy|anti-oxidant efficacy
5578085|NCT00975728|Anti-age efficacy|anti-age efficacy
5578086|NCT00975728|Skin photo-induced damage protection|skin photo-induced damage protection
5578087|NCT00975715|Seizures|seizures
5578088|NCT00975715|oxcarbazepine|oxcarbazepine
5578089|NCT00975715|child|child
5578090|NCT00975702|Remote ischemic preconditioning|remote ischemic preconditioning
5578091|NCT00975702|deceased organ donors|deceased organ donors
5578092|NCT00975702|ischemia reperfusion injury|ischemia reperfusion injury
5578093|NCT00975702|Delayed graft function|delayed graft function
5578094|NCT00975702|Clinical outcomes in kidney transplant recipients|clinical outcomes in kidney transplant recipients
5578095|NCT00975702|Clinical outcomes in liver transplant recipients|clinical outcomes in liver transplant recipients
5578096|NCT00975702|Clinical outcomes in pancreas transplant recipients|clinical outcomes in pancreas transplant recipients
5578097|NCT00975689|Niemann-Pick Disease, Type C|niemann-pick disease, type c
5578098|NCT00975689|Biomarkers|biomarkers
5578099|NCT00975689|N-Acetyl Cysteine|n-acetyl cysteine
5578100|NCT00975689|Oxidized Cholesterol|oxidized cholesterol
5578101|NCT00975689|Neurodegeneration|neurodegeneration
5578103|NCT00975676|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5578104|NCT00975676|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5578105|NCT00975676|stage IA breast cancer|stage ia breast cancer
5578106|NCT00975676|stage IB breast cancer|stage ib breast cancer
5578107|NCT00975676|stage II breast cancer|stage ii breast cancer
5578108|NCT00975676|stage IIIA breast cancer|stage iiia breast cancer
5685408|NCT00556205|sunitinib|sunitinib
5578109|NCT00975663|Lung transplantation|lung transplantation
5578110|NCT00975663|heart-lung transplantation|heart-lung transplantation
5578111|NCT00975663|therapeutic drug monitoring|therapeutic drug monitoring
5578112|NCT00975663|tacrolimus|tacrolimus
5578113|NCT00975663|mycophenolate|mycophenolate
5578114|NCT00975663|immunosuppressant|immunosuppressant
5578115|NCT00975663|pharmacokinetics|pharmacokinetics
5578116|NCT00975650|Primary Hypogonadism|primary hypogonadism
5578117|NCT00975650|Secondary Hypogonadism|secondary hypogonadism
5578118|NCT00975611|schizophrenia|schizophrenia
5578119|NCT00975611|schizoaffective disorder|schizoaffective disorder
5578120|NCT00975611|paliperidone ER|paliperidone er
5578121|NCT00975611|risperidone Consta|risperidone consta
5578122|NCT00975611|prolactin|prolactin
5578123|NCT00975611|hyperprolactinemia|hyperprolactinemia
5578125|NCT00975572|adjuvanted H1N1 vaccine|adjuvanted h1n1 vaccine
5578126|NCT00975572|non-adjuvanted H1N1 vaccine|non-adjuvanted h1n1 vaccine
5578127|NCT00975572|Immunogenictiy|immunogenictiy
5578128|NCT00975572|Safety|safety
5578129|NCT00975546|fertility|fertility
5578130|NCT00975546|HIV discordant|hiv discordant
5578131|NCT00975546|HIV|hiv
5578132|NCT00975546|Infertility in HIV-discordant couples|infertility in hiv-discordant couples
5578133|NCT00975546|HIV seronegativity|hiv seronegativity
5578134|NCT00975533|type 2 diabetes mellitus|type 2 diabetes mellitus
5578135|NCT00975533|obesity|obesity
5578136|NCT00975520|Neurotropic|neurotropic
5578137|NCT00975520|Melanoma|melanoma
5578138|NCT00975520|Observation|observation
5578139|NCT00975520|Radiation Therapy|radiation therapy
5578140|NCT00975520|Relapse|relapse
5578141|NCT00975494|pde5-inhibition|pde5-inhibition
5578142|NCT00975494|sildenafil|sildenafil
5578143|NCT00975494|LV diastolic function|lv diastolic function
5578144|NCT00975494|heart failure patients|heart failure patients
5560269|NCT01046643|Women|women
5790034|NCT00146068|Clinically Isolated Syndrome|clinically isolated syndrome
5578145|NCT00975481|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety|oral single-dose 6-way crossover recreational drug users abuse potential pharmacodynamics safety
5578146|NCT00975468|pressure-controlled|pressure-controlled
5578147|NCT00975468|volume-controlled|volume-controlled
5578148|NCT00975468|one lung|one lung
5578149|NCT00975468|ventilation|ventilation
5578150|NCT00975468|lung injury|lung injury
5578151|NCT00975468|thoracotomy|thoracotomy
5578153|NCT00975442|Tendinitis|tendinitis
5578154|NCT00975442|Sports Medicine|sports medicine
5578155|NCT00975442|Athletic injuries|athletic injuries
5578156|NCT00975429|Prostatic Disease|prostatic disease
5578157|NCT00975429|Genital neoplasm, male|genital neoplasm, male
5578158|NCT00975429|Urogenital neoplasm|urogenital neoplasm
5578159|NCT00975429|Genital disease,male|genital disease,male
5578160|NCT00975429|Male urogenital disease|male urogenital disease
5578161|NCT00975429|Neoplasms|neoplasms
5578162|NCT00975429|Neoplasm by site|neoplasm by site
5578163|NCT00975429|Prostatic neoplasm|prostatic neoplasm
5578164|NCT00975429|Carcinoma|carcinoma
5578165|NCT00975416|Drug Dependence|drug dependence
5578166|NCT00975416|Cognitive Behavior|cognitive behavior
5578167|NCT00975416|Oxytocin|oxytocin
5578168|NCT00975416|Cocaine|cocaine
5578169|NCT00975416|Heroin|heroin
5578170|NCT00975416|fMRI|fmri
5578171|NCT00975403|mild COPD|mild copd
5578172|NCT00975403|dyspnea|dyspnea
5578174|NCT00975403|respiratory mechanics|respiratory mechanics
5578175|NCT00975403|COPD|copd
5578176|NCT00975390|Glycogen|glycogen
5578177|NCT00975390|Carbohydrate|carbohydrate
5578178|NCT00975390|Protein|protein
5578179|NCT00975390|Caffeine|caffeine
5578180|NCT00975390|Post exercise muscle glycogen synthesis|post exercise muscle glycogen synthesis
5578181|NCT00975390|Sports nutrition|sports nutrition
5578182|NCT00975377|hair removal|hair removal
5578183|NCT00975377|hair clipping|hair clipping
5578184|NCT00975377|surgical site infection|surgical site infection
5578185|NCT00975377|incisional infection|incisional infection
5578186|NCT00975377|wound infection|wound infection
5578187|NCT00975364|Folate|folate
5578188|NCT00975364|Methylenetetrahydrofolate reductase|methylenetetrahydrofolate reductase
5578189|NCT00975364|Speciation|speciation
5578190|NCT00975364|Nutrient status|nutrient status
5578191|NCT00975364|Bioavailability|bioavailability
5578192|NCT00975364|Polymorphism, single nucleotide|polymorphism, single nucleotide
5578193|NCT00975351|folates|folates
5578194|NCT00975351|5-methyltetrahydrofolic acid|5-methyltetrahydrofolic acid
5578195|NCT00975351|pharmacokinetics|pharmacokinetics
5578196|NCT00975351|bioavailability|bioavailability
5578197|NCT00975351|biotransformation|biotransformation
5578198|NCT00975338|health care transition, young adults, rehabilitation|health care transition, young adults, rehabilitation
5578199|NCT00975325|Bioequivalency|bioequivalency
5578200|NCT00975312|lentigo|lentigo
5578201|NCT00975312|hydroquinone|hydroquinone
5578202|NCT00975312|tretinoin|tretinoin
5578203|NCT00975312|fluocinolone acetonide|fluocinolone acetonide
5578204|NCT00975299|Neoplasm|neoplasm
5578205|NCT00975299|PET/CT diagnosis|pet/ct diagnosis
5578206|NCT00975299|PET tracer|pet tracer
5578207|NCT00975273|Asthma|asthma
5578208|NCT00975273|Dyspnea|dyspnea
5578209|NCT00975273|Paroxysmal|paroxysmal
5578210|NCT00975273|Pulmonary|pulmonary
5578211|NCT00975273|Respiratory hypersensitivity|respiratory hypersensitivity
5578212|NCT00975273|Airway inflammation|airway inflammation
5578213|NCT00975273|Airway obstruction|airway obstruction
5578214|NCT00975273|Wheezing|wheezing
5578215|NCT00975247|Quality Improvement|quality improvement
5578216|NCT00975247|Colonoscopy|colonoscopy
5578217|NCT00975247|Screening|screening
5578218|NCT00975247|Colon Cancer|colon cancer
5578219|NCT00975247|Polyp detection rates|polyp detection rates
5578220|NCT00975247|Colonoscopy completion rates|colonoscopy completion rates
5578221|NCT00975247|Scope Withdrawal time|scope withdrawal time
5578222|NCT00975247|Reduce costs through improving bowel prep quality|reduce costs through improving bowel prep quality
5578223|NCT00975234|Intra-lesion injection of autologous myoblasts|intra-lesion injection of autologous myoblasts
5578224|NCT00975221|Primary hyperparathyroidism|primary hyperparathyroidism
5578225|NCT00975221|Parathyroidectomy|parathyroidectomy
5578226|NCT00975221|Hypercalcemia|hypercalcemia
5578227|NCT00975208|Osteogenesis [G07.700.320.500.325.377.625.100.729]|osteogenesis [g07.700.320.500.325.377.625.100.729]
5578228|NCT00975208|Tooth Eruption [G10.549.235.726]|tooth eruption [g10.549.235.726]
5578229|NCT00975182|PI3K|pi3k
5578230|NCT00975182|NSCLC|nsclc
5578231|NCT00975182|Tarceva|tarceva
5578232|NCT00975143|isotretinoin|isotretinoin
5578233|NCT00975143|dermatology|dermatology
5578234|NCT00975143|skin|skin
5578235|NCT00975117|Dietary supplement|dietary supplement
5578236|NCT00975117|male infertility|male infertility
5578237|NCT00975117|spermatogenesis|spermatogenesis
5578238|NCT00975104|Aging|aging
5578239|NCT00975104|Frailty|frailty
5578240|NCT00975104|Sedentary|sedentary
5578241|NCT00975104|Immobilization|immobilization
5578242|NCT00975104|Atrophy|atrophy
5578243|NCT00975104|Muscle Wasting|muscle wasting
5578244|NCT00975104|Physical Activity|physical activity
5578245|NCT00975078|dexamethasone-suppression-test|dexamethasone-suppression-test
5578246|NCT00975078|high dose glucocorticoid treatment|high dose glucocorticoid treatment
5578247|NCT00975078|Population at Risk|population at risk
5578248|NCT00975065|Galvus|galvus
5578249|NCT00975039|Inoperable|inoperable
5578250|NCT00975039|Inoperable Cholangiocarcinoma|inoperable cholangiocarcinoma
5578251|NCT00975039|Non-resectable|non-resectable
5578252|NCT00975039|Non-resectable Cholangiocarcinoma|non-resectable cholangiocarcinoma
5578253|NCT00975039|Carcinoma|carcinoma
5578254|NCT00975026|Massage|massage
5578255|NCT00975026|Chair Massage|chair massage
5578256|NCT00975026|Pain|pain
5578257|NCT00975026|Discomfort|discomfort
5578258|NCT00975026|Stretching|stretching
5578259|NCT00975026|Stretching Exercises|stretching exercises
5578260|NCT00975026|Sonographer|sonographer
5578261|NCT00975026|Cardiac Sonographer|cardiac sonographer
5578262|NCT00975013|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5578263|NCT00975013|Morbid Obesity|morbid obesity
5578264|NCT00975013|Bone Mineral Density|bone mineral density
5578265|NCT00975000|Intervention|intervention
5578267|NCT00975000|Sensipar|sensipar
5578268|NCT00975000|Mimpara|mimpara
5578269|NCT00975000|hyperparathyroidism|hyperparathyroidism
5578270|NCT00975000|calcium|calcium
5578271|NCT00975000|osteodystrophy|osteodystrophy
5578272|NCT00975000|hypercalcemia|hypercalcemia
5578273|NCT00975000|renal|renal
5578274|NCT00975000|transplant|transplant
5578275|NCT00975000|acute rejection|acute rejection
5578276|NCT00975000|kidney transplant failure|kidney transplant failure
5578277|NCT00975000|hypophosphatemia|hypophosphatemia
5862975|NCT00001432|Apheresis|apheresis
5578278|NCT00974987|adult giant cell glioblastoma|adult giant cell glioblastoma
5578279|NCT00974987|adult glioblastoma|adult glioblastoma
5578280|NCT00974987|adult gliosarcoma|adult gliosarcoma
5578281|NCT00974974|Parkinson's Disease|parkinson's disease
5578284|NCT00974961|Spinal Anesthesia|spinal anesthesia
5578285|NCT00974961|Responses of ANS to these two drugs|responses of ans to these two drugs
5578286|NCT00974948|Pancreatic cancer|pancreatic cancer
5578287|NCT00974948|Therapy|therapy
5578288|NCT00974948|Neurolysis|neurolysis
5578289|NCT00974935|Staphylococcal enterotoxin B, vaccine, Staphylococcus aureus, toxic shock syndrome|staphylococcal enterotoxin b, vaccine, staphylococcus aureus, toxic shock syndrome
5578290|NCT00974922|Vitamin D|vitamin d
5578291|NCT00974922|Hypertension|hypertension
5578292|NCT00974909|Fecal incontinence|fecal incontinence
5578293|NCT00974896|Advanced Solid Tumors|advanced solid tumors
5578294|NCT00974896|AMG 479|amg 479
5578295|NCT00974896|Amgen|amgen
5578296|NCT00974896|Oncology|oncology
5578297|NCT00974896|Phase 1b|phase 1b
5578298|NCT00974883|ultrasound|ultrasound
5578300|NCT00974883|temporal arteritis|temporal arteritis
5578301|NCT00974883|biopsy|biopsy
5578302|NCT00974857|Hemodialysis|hemodialysis
5578303|NCT00974857|Left Ventricular Hypertrophy|left ventricular hypertrophy
5578304|NCT00974857|Body Composition Monitor|body composition monitor
5578305|NCT00974844|posterior assisted levitation|posterior assisted levitation
5578306|NCT00974844|Pars Plana|pars plana
5578307|NCT00974844|Dropped nucleus|dropped nucleus
5578308|NCT00974844|cataract|cataract
5578309|NCT00974844|complication of|complication of
5578310|NCT00974844|surgery|surgery
5578311|NCT00974818|Bladder|bladder
5578312|NCT00974818|Mitomycin C|mitomycin c
5578313|NCT00974818|MMC|mmc
5578314|NCT00974818|TheracysR Bacillus Calmette-Guerin|theracysr bacillus calmette-guerin
5578315|NCT00974818|BCG|bcg
5578316|NCT00974818|intravesical|intravesical
5578317|NCT00974818|09-118|09-118
5578318|NCT00974805|COPD|copd
5578319|NCT00974805|Emphysema|emphysema
5578320|NCT00974805|Bronchitis|bronchitis
5578321|NCT00974792|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5578322|NCT00974792|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5578323|NCT00974779|kidney failure chronic|kidney failure chronic
5578324|NCT00974779|renal dialysis|renal dialysis
5578325|NCT00974779|inflammation|inflammation
5578326|NCT00974779|monocytes|monocytes
5578327|NCT00974779|end stage renal disease on regular thrice weekly hemodialysis|end stage renal disease on regular thrice weekly hemodialysis
5578328|NCT00974766|bronchial asthma|bronchial asthma
5578329|NCT00974766|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis
5578330|NCT00974753|epiretinal membrane|epiretinal membrane
5578331|NCT00974740|type 1 diabetes|type 1 diabetes
5578332|NCT00974727|Childhood overweight|childhood overweight
5578333|NCT00974727|Gardening|gardening
5578334|NCT00974727|Summer weight gain|summer weight gain
5578335|NCT00974714|chronic hypertension in pregnancy|chronic hypertension in pregnancy
5578336|NCT00974701|symptoms of acute overt upper gastrointestinal hemorrhage|symptoms of acute overt upper gastrointestinal hemorrhage
5578337|NCT00974688|Congenital|congenital
5578338|NCT00974688|physical activity participation|physical activity participation
5578339|NCT00974688|Moderate-to-vigorous physical activity|moderate-to-vigorous physical activity
5578340|NCT00974675|Asthma|asthma
5578341|NCT00974675|CAT-354|cat-354
5578342|NCT00974675|Tralokinumab|tralokinumab
5560466|NCT01045889|HIV|hiv
5578343|NCT00974662|Non-Small Cell Lung Cancer|non-small cell lung cancer
5578344|NCT00974662|Lung Cancer|lung cancer
5578345|NCT00974662|NSCLC|nsclc
5578346|NCT00974649|drop-out|drop-out
5578347|NCT00974649|predictors of treatment continuation/discontinuation|predictors of treatment continuation/discontinuation
5578348|NCT00974649|IVF/ICSI|ivf/icsi
5578349|NCT00974649|infertility|infertility
5578350|NCT00974649|counseling|counseling
5578351|NCT00974649|psychology|psychology
5578352|NCT00974649|Assisted Reproduction|assisted reproduction
5578353|NCT00974649|Counselling|counselling
5578354|NCT00974636|Kidney Disease|kidney disease
5578355|NCT00974636|Albuminuria|albuminuria
5578356|NCT00974636|Glomerular filtration rate|glomerular filtration rate
5578357|NCT00974636|Volume status|volume status
5578358|NCT00974636|Bioimpedance analysis|bioimpedance analysis
5578359|NCT00974623|Bone growth substitute|bone growth substitute
5578360|NCT00974623|Autograft|autograft
5578361|NCT00974623|Allograft|allograft
5578362|NCT00974623|Spine fusion|spine fusion
5578363|NCT00974610|stage IV melanoma|stage iv melanoma
5578364|NCT00974610|recurrent melanoma|recurrent melanoma
5578365|NCT00974610|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5578366|NCT00974610|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5578367|NCT00974610|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5578368|NCT00974610|recurrent small cell lung cancer|recurrent small cell lung cancer
5847314|NCT00040196|HV|hv
5578369|NCT00974610|stage IV breast cancer|stage iv breast cancer
5578370|NCT00974610|recurrent breast cancer|recurrent breast cancer
5578371|NCT00974610|male breast cancer|male breast cancer
5572489|NCT00996515|Vidaza|vidaza
5578372|NCT00974610|stage III pancreatic cancer|stage iii pancreatic cancer
5578373|NCT00974610|stage IV pancreatic cancer|stage iv pancreatic cancer
5578374|NCT00974610|recurrent pancreatic cancer|recurrent pancreatic cancer
5578375|NCT00974610|stage IV colon cancer|stage iv colon cancer
5578376|NCT00974610|recurrent colon cancer|recurrent colon cancer
5578377|NCT00974610|stage IV rectal cancer|stage iv rectal cancer
5578378|NCT00974610|recurrent rectal cancer|recurrent rectal cancer
5578379|NCT00974597|burn|burn
5578380|NCT00974597|donor site|donor site
5578381|NCT00974597|treatment of burns|treatment of burns
5578382|NCT00974597|Treatment of Donor Sites|treatment of donor sites
5578383|NCT00974584|NSCLC|nsclc
5578384|NCT00974584|PI3K|pi3k
5578385|NCT00974584|Avastin|avastin
5578386|NCT00974558|dyspnea|dyspnea
5578387|NCT00974558|fan|fan
5578388|NCT00974532|balance|balance
5578389|NCT00974532|chronic kidney disease|chronic kidney disease
5578390|NCT00974532|calcium|calcium
5578391|NCT00974532|phosphorus|phosphorus
5578392|NCT00974519|ADIS|adis
5578393|NCT00974519|complementary therapies|complementary therapies
5578394|NCT00974506|geriatric patients living in residential community (shared flats), multiple disease-conditions|geriatric patients living in residential community (shared flats), multiple disease-conditions
5578395|NCT00974493|oral|oral
5578396|NCT00974493|intravenous|intravenous
5578397|NCT00974493|antibiotics|antibiotics
5578398|NCT00974493|bone|bone
5578399|NCT00974493|joint|joint
5578400|NCT00974493|infection|infection
5578401|NCT00974480|Skin|skin
5578402|NCT00974480|Aging|aging
5578403|NCT00974480|Rejuva-a|rejuva-a
5578404|NCT00974480|Redermic|redermic
5578405|NCT00974454|AIDS|aids
5578406|NCT00974454|complementary therapies|complementary therapies
5578407|NCT00974454|treatment experienced|treatment experienced
5578408|NCT00974441|Bioequivalence|bioequivalence
5578409|NCT00974428|Osteoarthritis|osteoarthritis
5578410|NCT00974428|Disease of joints|disease of joints
5578411|NCT00974428|Wobenzym® N|wobenzym® n
5578412|NCT00974428|WOMAC pain score|womac pain score
5578413|NCT00974428|Subject reported pain (VAS)|subject reported pain (vas)
5578414|NCT00974415|BMI classification-overweight|bmi classification-overweight
5578415|NCT00974402|Active duty|active duty
5578416|NCT00974402|Afghanistan|afghanistan
5578417|NCT00974402|Anger|anger
5578418|NCT00974402|Anxiety|anxiety
5578419|NCT00974402|Avoidance|avoidance
5578420|NCT00974402|BAMC|bamc
5578421|NCT00974402|Brooke Army Medical Center|brooke army medical center
5578422|NCT00974402|Cognitive Behavioral Therapy|cognitive behavioral therapy
5578423|NCT00974402|Combat|combat
5578424|NCT00974402|Combat Disorder|combat disorder
5578425|NCT00974402|Coping|coping
5578426|NCT00974402|Counseling|counseling
5578427|NCT00974402|Counselor|counselor
5578428|NCT00974402|Deployment|deployment
5578429|NCT00974402|Depression|depression
5578430|NCT00974402|Exposure|exposure
5578431|NCT00974402|Fear|fear
5578432|NCT00974402|Feeling alone|feeling alone
5578433|NCT00974402|Flashbacks|flashbacks
5578434|NCT00974402|Guard|guard
5578435|NCT00974402|Guilt|guilt
5578436|NCT00974402|Hospitalization|hospitalization
5578437|NCT00974402|Iraq|iraq
5578438|NCT00974402|Mental Health|mental health
5578439|NCT00974402|Military|military
5578440|NCT00974402|Military member|military member
5578441|NCT00974402|Military personnel|military personnel
5578442|NCT00974402|Neuroses|neuroses
5578443|NCT00974402|Nightmares|nightmares
5578445|NCT00974402|OIF|oif
5578446|NCT00974402|Prolonged Exposure Therapy|prolonged exposure therapy
5578447|NCT00974402|Psychiatric|psychiatric
5578448|NCT00974402|Psychiatric medication|psychiatric medication
5578449|NCT00974402|Psychological distress|psychological distress
5578450|NCT00974402|Psychotherapy|psychotherapy
5578451|NCT00974402|Reserve|reserve
5578452|NCT00974402|Retired|retired
5578453|NCT00974402|Sadness|sadness
5578454|NCT00974402|Separated|separated
5578455|NCT00974402|Sleeplessness|sleeplessness
5578456|NCT00974402|Soldier|soldier
5578457|NCT00974402|Stress|stress
5578458|NCT00974402|Stress disorder|stress disorder
5578459|NCT00974402|Stress management|stress management
5578460|NCT00974402|STRONG STAR|strong star
5578461|NCT00974402|Suicidal|suicidal
5578462|NCT00974402|Suicide|suicide
5578463|NCT00974402|Therapy|therapy
5578464|NCT00974402|Trauma|trauma
5578465|NCT00974402|Traumatic Event|traumatic event
5578466|NCT00974402|Trouble Sleeping|trouble sleeping
5578467|NCT00974402|Veteran|veteran
5578468|NCT00974402|Veterans|veterans
5578469|NCT00974402|War|war
5578470|NCT00974402|WHMC|whmc
5578471|NCT00974402|Wilford Hall Medical Center|wilford hall medical center
5578472|NCT00974402|PTSD|ptsd
5578473|NCT00974402|Posttraumatic Stress Disorders|posttraumatic stress disorders
5578474|NCT00974389|stage III colon cancer|stage iii colon cancer
5578475|NCT00974389|stage III rectal cancer|stage iii rectal cancer
5578476|NCT00974389|stage IV colon cancer|stage iv colon cancer
5578477|NCT00974389|stage IV rectal cancer|stage iv rectal cancer
5578478|NCT00974389|recurrent colon cancer|recurrent colon cancer
5578479|NCT00974389|recurrent rectal cancer|recurrent rectal cancer
5578480|NCT00974376|Cannabis Treatment|cannabis treatment
5578482|NCT00974376|Cannabis Dependence|cannabis dependence
5578483|NCT00974376|Executive Functioning|executive functioning
5578484|NCT00974376|Cognitive Deficits|cognitive deficits
5578485|NCT00974363|meningococcal vaccine GSK 134612|meningococcal vaccine gsk 134612
5578486|NCT00974350|Post-operative pain|post-operative pain
5578487|NCT00974350|hernia surgery|hernia surgery
5578489|NCT00974337|Adrenal insufficiency|adrenal insufficiency
5578490|NCT00974337|cortisol|cortisol
5578491|NCT00974337|preterm|preterm
5578492|NCT00974337|shock|shock
5578493|NCT00974337|neonate|neonate
5578494|NCT00974324|peripheral T cell lymphoma|peripheral t cell lymphoma
5578495|NCT00974324|chemotherapy|chemotherapy
5578496|NCT00974324|anti-angiogeneses|anti-angiogeneses
5578497|NCT00974311|Prostate Cancer|prostate cancer
5578498|NCT00974311|Castration-resistant|castration-resistant
5578499|NCT00974285|AIDS|aids
5578500|NCT00974285|complementary therapies|complementary therapies
5578501|NCT00974259|Hypoxia|hypoxia
5578502|NCT00974259|Ischemia|ischemia
5578503|NCT00974259|Intracranial hypertension|intracranial hypertension
5578504|NCT00974259|Neurocritical care|neurocritical care
5578505|NCT00974246|COPD|copd
5578506|NCT00974246|Depression|depression
5578507|NCT00974246|Nursing Home|nursing home
5578508|NCT00974233|CLL|cll
5578509|NCT00974233|SLL|sll
5578510|NCT00974220|inhaled fentanyl|inhaled fentanyl
5578511|NCT00974220|dyspnea|dyspnea
5578512|NCT00974220|exercise|exercise
5578513|NCT00974220|COPD|copd
5578514|NCT00974194|Cholecystolithiasis|cholecystolithiasis
5578515|NCT00974194|Cholecystectomy|cholecystectomy
5578516|NCT00974194|Laparoscopic surgery|laparoscopic surgery
5578517|NCT00974194|Single port|single port
5578518|NCT00974168|pain|pain
5578519|NCT00974168|radiation toxicity|radiation toxicity
5578520|NCT00974168|spinal cord compression|spinal cord compression
5578521|NCT00974168|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5578522|NCT00974155|Major|major
5578523|NCT00974155|Depression|depression
5578524|NCT00974155|Disorder|disorder
5578525|NCT00974142|COPD|copd
5578526|NCT00974142|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5578527|NCT00974142|Cyclosporine|cyclosporine
5578528|NCT00974142|Oral Immunotherapy|oral immunotherapy
5578529|NCT00974142|Advanced stage|advanced stage
5578530|NCT00974103|low back pain|low back pain
5578531|NCT00974103|pelvic pain|pelvic pain
5578532|NCT00974103|pelvic girdle pain|pelvic girdle pain
5578533|NCT00974103|post partum|post partum
5578534|NCT00974090|insulin resistance|insulin resistance
5578535|NCT00974077|recurrent depression,|recurrent depression,
5578536|NCT00974077|mindfulness training|mindfulness training
5578537|NCT00974077|attention|attention
5578538|NCT00974077|Evoked EEG potentials|evoked eeg potentials
5578539|NCT00974077|Relapse prevention in recurrent depression|relapse prevention in recurrent depression
5578540|NCT00974064|COPD|copd
5578541|NCT00974064|Lung disease|lung disease
5578542|NCT00974064|Chronic bronchitis|chronic bronchitis
5578543|NCT00974064|Emphysema|emphysema
5578544|NCT00974064|Smoking|smoking
5578545|NCT00974064|Smoking cessation|smoking cessation
5578546|NCT00974064|Quit smoking|quit smoking
5578547|NCT00974064|Healthy smoker|healthy smoker
5578548|NCT00974064|Smoker|smoker
5578549|NCT00974064|Non-smoker|non-smoker
5578550|NCT00974051|Children|children
5578551|NCT00974051|Exercise|exercise
5578552|NCT00974051|Hypoglycemia|hypoglycemia
5578553|NCT00974038|Bulimia Nervosa, EDNOS, Adolescents|bulimia nervosa, ednos, adolescents
5578554|NCT00974012|Bioequivalence|bioequivalence
5578555|NCT00973999|Botulinum Toxin|botulinum toxin
5578556|NCT00973999|Saliva|saliva
5578557|NCT00973999|Tracheostomy tube|tracheostomy tube
5578558|NCT00973986|atorvastatin|atorvastatin
5578559|NCT00973986|genetic polymorphisms|genetic polymorphisms
5578560|NCT00973986|coronary heart disease|coronary heart disease
5578561|NCT00973986|pharmacokinetics|pharmacokinetics
5578562|NCT00973986|CYP3A|cyp3a
5578563|NCT00973973|Pelvic Pain,NBI-56418,Endometriosis|pelvic pain,nbi-56418,endometriosis
5578564|NCT00973947|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5578565|NCT00973947|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5578566|NCT00973947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5578567|NCT00973947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5578568|NCT00973947|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5578569|NCT00973947|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5578570|NCT00973947|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5578571|NCT00973947|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5578572|NCT00973947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5578573|NCT00973947|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5578574|NCT00973947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5572671|NCT00996073|TLIF|tlif
5578575|NCT00973947|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5578576|NCT00973947|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5578577|NCT00973947|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5578578|NCT00973947|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5578579|NCT00973947|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5578580|NCT00973947|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5578581|NCT00973947|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5578582|NCT00973947|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5578583|NCT00973947|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5578584|NCT00973947|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5578585|NCT00973947|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5578586|NCT00973947|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5578587|NCT00973947|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5578588|NCT00973947|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5685409|NCT00556205|bevacizumab|bevacizumab
5578589|NCT00973947|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5578590|NCT00973947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5578591|NCT00973947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5578592|NCT00973947|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5578593|NCT00973947|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5578594|NCT00973947|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5578595|NCT00973947|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5578596|NCT00973947|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5578597|NCT00973947|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5578598|NCT00973947|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5578599|NCT00973947|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5578600|NCT00973947|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5578601|NCT00973947|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5578602|NCT00973947|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5578603|NCT00973947|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5578604|NCT00973947|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5578605|NCT00973947|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5578606|NCT00973947|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5578607|NCT00973947|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5578608|NCT00973947|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5578609|NCT00973947|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5731305|NCT00389467|MRI|mri
5578610|NCT00973947|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5578611|NCT00973947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5578612|NCT00973947|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5578613|NCT00973947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5578614|NCT00973947|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5578615|NCT00973947|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5578616|NCT00973947|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5578617|NCT00973947|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5578618|NCT00973947|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5578619|NCT00973947|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5578620|NCT00973947|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5578621|NCT00973947|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5578622|NCT00973947|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5578623|NCT00973947|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5798735|NCT00111241|knee articular cartilage volume|knee articular cartilage volume
5798736|NCT00111228|Diabetes|diabetes
5862976|NCT00001432|Long Term Culture|long term culture
5578624|NCT00973947|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5578798|NCT00973362|Human Papillomavirus Virus (HPV)|human papillomavirus virus (hpv)
5578625|NCT00973947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5578626|NCT00973947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5578627|NCT00973947|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5578628|NCT00973947|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5578629|NCT00973947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5578630|NCT00973947|stage I salivary gland cancer|stage i salivary gland cancer
5578631|NCT00973947|stage II salivary gland cancer|stage ii salivary gland cancer
5578632|NCT00973947|stage III salivary gland cancer|stage iii salivary gland cancer
5578633|NCT00973947|stage IV salivary gland cancer|stage iv salivary gland cancer
5578634|NCT00973947|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5685410|NCT00556192|SLE|sle
5578635|NCT00973947|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5578636|NCT00973947|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5578637|NCT00973947|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5578638|NCT00973947|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5578639|NCT00973947|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5578640|NCT00973947|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5578641|NCT00973947|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5578642|NCT00973947|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5578643|NCT00973947|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5578644|NCT00973947|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5578645|NCT00973947|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5578646|NCT00973947|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5578647|NCT00973947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5578648|NCT00973947|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5578649|NCT00973947|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5578650|NCT00973947|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5578651|NCT00973947|recurrent salivary gland cancer|recurrent salivary gland cancer
5578653|NCT00973921|under-expansion|under-expansion
5578654|NCT00973921|StentOp|stentop
5578655|NCT00973921|StentOptimizer|stentoptimizer
5578656|NCT00973921|IVUS|ivus
5578657|NCT00973921|IC-PRO|ic-pro
5578658|NCT00973921|image enhancement|image enhancement
5578659|NCT00973908|Clostridium difficile associated diarrhoea|clostridium difficile associated diarrhoea
5578660|NCT00973908|antibiotic associated diarrhoea|antibiotic associated diarrhoea
5578661|NCT00973895|Influenza|influenza
5578662|NCT00973895|Healthy|healthy
5578663|NCT00973895|Immunity|immunity
5578664|NCT00973895|Preventive|preventive
5578665|NCT00973895|Pandemic|pandemic
5578666|NCT00973882|Hormone resistant prostate cancer|hormone resistant prostate cancer
5578667|NCT00973882|Neuro-endocrine marker|neuro-endocrine marker
5578668|NCT00973882|Carboplatin-Etoposide combination|carboplatin-etoposide combination
5578669|NCT00973882|Neuro-endocrine differentiation|neuro-endocrine differentiation
5578670|NCT00973869|colon cancer|colon cancer
5578671|NCT00973869|rectal cancer|rectal cancer
5578672|NCT00973830|Changes in HbA1c|changes in hba1c
5578673|NCT00973817|Hepatitis|hepatitis
5578674|NCT00973817|AOCH|aoch
5578675|NCT00973804|Reduced Intensity Conditioning|reduced intensity conditioning
5578676|NCT00973804|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5563475|NCT01033006|Axillary Block|axillary block
5578677|NCT00973804|Targeted Immune Depletion|targeted immune depletion
5578678|NCT00973804|Leukemia|leukemia
5578679|NCT00973804|Lymphoma|lymphoma
5578680|NCT00973804|Multiple Myeloma|multiple myeloma
5578681|NCT00973804|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5578682|NCT00973804|Hodgkins Lymphoma|hodgkins lymphoma
5578683|NCT00973791|Spinal anesthesia|spinal anesthesia
5578684|NCT00973791|Fluid therapy|fluid therapy
5578685|NCT00973778|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5578686|NCT00973778|Capecitabine|capecitabine
5578687|NCT00973778|Resectable Rectal Carcinoma|resectable rectal carcinoma
5578688|NCT00973765|abcess|abcess
5578689|NCT00973765|MRSA|mrsa
5578690|NCT00973765|cellulitis|cellulitis
5578691|NCT00973765|antibiotics|antibiotics
5578692|NCT00973765|uncomplicated abscesses|uncomplicated abscesses
5578694|NCT00973739|NF-2|nf-2
5578695|NCT00973739|NF-2 related tumors|nf-2 related tumors
5798737|NCT00111215|Menorrhagia|menorrhagia
5578696|NCT00973739|Schwannoma, Acoustic, Bilateral|schwannoma, acoustic, bilateral
5578697|NCT00973739|schwannomas|schwannomas
5578698|NCT00973739|Neurilemmoma of other cranial and peripheral nerves|neurilemmoma of other cranial and peripheral nerves
5580292|NCT00967278|OPCAB|opcab
5578699|NCT00973739|NF2 related benign intracranial tumors including|nf2 related benign intracranial tumors including
5578700|NCT00973739|NF2 related meningiomas|nf2 related meningiomas
5578701|NCT00973739|NF2 related ependymomas|nf2 related ependymomas
5578702|NCT00973739|NF2 related spinal neurofibromas|nf2 related spinal neurofibromas
5578703|NCT00973739|NF2 related gliomas|nf2 related gliomas
5578704|NCT00973713|Advanced cholangiocarcinoma|advanced cholangiocarcinoma
5578705|NCT00973700|Swine Flu|swine flu
5578706|NCT00973700|Flu|flu
5578707|NCT00973700|Vaccine|vaccine
5578708|NCT00973700|Adjuvant|adjuvant
5578709|NCT00973687|pediatric|pediatric
5578710|NCT00973687|dexamethasone|dexamethasone
5578711|NCT00973687|management|management
5578712|NCT00973687|corticosteroids|corticosteroids
5578713|NCT00973687|asthma|asthma
5578714|NCT00973661|Overweight|overweight
5578715|NCT00973661|Diagnosis|diagnosis
5578716|NCT00973661|Counseling|counseling
5578717|NCT00973661|Medical Records Systems, Computerized|medical records systems, computerized
5578718|NCT00973648|Tinnitus|tinnitus
5578719|NCT00973648|Ringing in ears|ringing in ears
5578720|NCT00973648|Functional connectivity MRI|functional connectivity mri
5578721|NCT00973648|Voluntary control of tinnitus|voluntary control of tinnitus
5578722|NCT00973635|education|education
5578723|NCT00973635|web-based intervention|web-based intervention
5578724|NCT00973635|patient care|patient care
5578725|NCT00973622|Tobacco cessation|tobacco cessation
5578726|NCT00973622|Tobacco dependence|tobacco dependence
5578727|NCT00973622|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5578728|NCT00973622|Nicotine Dependence|nicotine dependence
5578729|NCT00973622|Delayed Discounting|delayed discounting
5578730|NCT00973609|metastatic colorectal cancer|metastatic colorectal cancer
5578731|NCT00973609|Bevacizumab|bevacizumab
5578732|NCT00973609|Avastin®|avastin®
5578733|NCT00973609|phase 3|phase 3
5578734|NCT00973609|maintenance treatment|maintenance treatment
5578735|NCT00973609|treatment pause|treatment pause
5578736|NCT00973609|drug holiday|drug holiday
5578737|NCT00973609|stage IV|stage iv
5578738|NCT00973583|vitamin D|vitamin d
5578739|NCT00973583|infection|infection
5578740|NCT00973583|Vitamin D for the prevention of respiratory tract infections|vitamin d for the prevention of respiratory tract infections
5578741|NCT00973570|tobacco cessation|tobacco cessation
5578742|NCT00973570|evaluation|evaluation
5578743|NCT00973570|epidémiology|epidémiology
5578744|NCT00973570|adolescent|adolescent
5578745|NCT00973570|apprentices|apprentices
5578746|NCT00973557|bevacizumab|bevacizumab
5578747|NCT00973544|breast reconstruction complications|breast reconstruction complications
5578748|NCT00973544|drains|drains
5578749|NCT00973544|silicone implant|silicone implant
5578750|NCT00973531|Sleep Disordered Breathing|sleep disordered breathing
5578751|NCT00973531|Sleep Apnea|sleep apnea
5578752|NCT00973531|Hypertension|hypertension
5578753|NCT00973531|Continuous Positive Airway Pressure|continuous positive airway pressure
5578754|NCT00973518|Alzheimer's Disease|alzheimer's disease
5578755|NCT00973518|AD|ad
5578756|NCT00973518|Healthy Control|healthy control
5578757|NCT00973505|Breast neoplasms|breast neoplasms
5578758|NCT00973505|Aromatase inhibitors|aromatase inhibitors
5578759|NCT00973505|Genetic polymorphisms|genetic polymorphisms
5578760|NCT00973505|Arthralgia|arthralgia
5578761|NCT00973505|Arthritis|arthritis
5578762|NCT00973492|type 1 diabetes|type 1 diabetes
5578763|NCT00973492|functional insulinotherapy|functional insulinotherapy
5578764|NCT00973479|Arthritis, Rheumatoid|arthritis, rheumatoid
5578765|NCT00973479|Active rheumatoid arthritis|active rheumatoid arthritis
5578766|NCT00973479|Golimumab|golimumab
5578767|NCT00973479|CNTO148|cnto148
5578768|NCT00973479|Anti-TNFalpha monoclonal antibody|anti-tnfalpha monoclonal antibody
5578769|NCT00973479|Methotrexate|methotrexate
5578770|NCT00973479|Intravenous|intravenous
5578771|NCT00973466|HIV-infection|hiv-infection
5578772|NCT00973466|Neisseria gonorrhea|neisseria gonorrhea
5578773|NCT00973466|Chlamydia trachomatis|chlamydia trachomatis
5578774|NCT00973466|Herpes simplex virus|herpes simplex virus
5578775|NCT00973466|prevalence|prevalence
5578776|NCT00973453|non-seasonal allergy|non-seasonal allergy
5578777|NCT00973453|house dust mite|house dust mite
5578778|NCT00973453|immunotherapy|immunotherapy
5578779|NCT00973453|dose tolerability|dose tolerability
5578780|NCT00973440|geriatric assessment|geriatric assessment
5578781|NCT00973427|NSCLC|nsclc
5578782|NCT00973414|Combined epidural spinal anesthesia|combined epidural spinal anesthesia
5578783|NCT00973414|Fluid therapy|fluid therapy
5578784|NCT00973388|VX-950-TiDP24-C136|vx-950-tidp24-c136
5578785|NCT00973388|VX-950-C136|vx-950-c136
5578786|NCT00973388|VX-950|vx-950
5578787|NCT00973388|HEPATITIS|hepatitis
5578788|NCT00973388|Telaprevir|telaprevir
5578789|NCT00973388|Moxifloxacin|moxifloxacin
5578791|NCT00973388|QT|qt
5578792|NCT00973388|QTc|qtc
5578793|NCT00973375|Drug-eluting stent|drug-eluting stent
5578794|NCT00973375|coronary restenosis|coronary restenosis
5578796|NCT00973362|Cervix Cancer|cervix cancer
5578797|NCT00973362|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5578799|NCT00973362|APTIMA HPV Assay|aptima hpv assay
5578800|NCT00973362|FDA-Approved HPV DNA Test|fda-approved hpv dna test
5578801|NCT00973362|TIGRIS DTS (direct tube sampling) System|tigris dts (direct tube sampling) system
5578802|NCT00973362|Clinical Sensitivity (%)|clinical sensitivity (%)
5578803|NCT00973362|Clinical Specificity (%)|clinical specificity (%)
5578804|NCT00973362|Positive Predictive Value [PPV] (%)|positive predictive value [ppv] (%)
5578805|NCT00973362|Negative Predictive Value [NPV] (%)|negative predictive value [npv] (%)
5578806|NCT00973362|Atypical Squamous Cells Undetermined Significance (ASC-US)|atypical squamous cells undetermined significance (asc-us)
5578807|NCT00973362|Relative Risk|relative risk
5578808|NCT00973349|Swine Flu|swine flu
5578809|NCT00973349|Flu|flu
5578810|NCT00973349|Vaccine|vaccine
5578811|NCT00973349|Adults|adults
5578812|NCT00973349|Elderly|elderly
5578813|NCT00973349|Non-Elderly|non-elderly
5578814|NCT00973349|Adjuvant|adjuvant
5578815|NCT00973336|postoperative follow-up|postoperative follow-up
5578816|NCT00973323|BAY59-7939|bay59-7939
5578817|NCT00973323|Rivaroxaban|rivaroxaban
5578818|NCT00973323|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5578819|NCT00973323|Japanese Patients|japanese patients
5578820|NCT00973323|Phase II|phase ii
5578821|NCT00973310|Non-small-cell lung cancer|non-small-cell lung cancer
5578822|NCT00973310|Radiation therapy|radiation therapy
5578823|NCT00973310|Epidermal growth factor receptor|epidermal growth factor receptor
5578824|NCT00973310|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5578825|NCT00973297|Falls|falls
5578826|NCT00973284|Prevention of acute gastroenteritis due to infection with and experimental Norwalk Virus|prevention of acute gastroenteritis due to infection with and experimental norwalk virus
5578827|NCT00973271|hypertriglyceridemia|hypertriglyceridemia
5578828|NCT00973245|BAY59-7939|bay59-7939
5578829|NCT00973245|Rivaroxaban|rivaroxaban
5578830|NCT00973245|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5578831|NCT00973245|Japanese Patients|japanese patients
5578832|NCT00973245|Phase II|phase ii
5578833|NCT00973232|Tramadol|tramadol
5578834|NCT00973232|Acetaminophen|acetaminophen
5578835|NCT00973232|combination|combination
5578836|NCT00973232|pharmacokinetics|pharmacokinetics
5578837|NCT00973232|bioavailability|bioavailability
5578838|NCT00973232|Zaldiar|zaldiar
5578839|NCT00973232|Ultracet|ultracet
5578840|NCT00973232|fed|fed
5578841|NCT00973232|fasted|fasted
5578842|NCT00973232|single-dose|single-dose
5578843|NCT00973232|multiple-dose|multiple-dose
5578844|NCT00973232|healthy|healthy
5578845|NCT00973232|volunteers|volunteers
5578846|NCT00973232|Healthy volunteers|healthy volunteers
5578847|NCT00973219|HBsAg loss|hbsag loss
5578848|NCT00973219|HBsAg seroconversion|hbsag seroconversion
5578849|NCT00973219|chronic hepatitis B|chronic hepatitis b
5578850|NCT00973219|low viral load|low viral load
5578851|NCT00973219|inactive carrier hepatitis B|inactive carrier hepatitis b
5578852|NCT00973206|cardiovascular morbidity|cardiovascular morbidity
5578853|NCT00973206|mortality community study|mortality community study
5578854|NCT00973193|rectum|rectum
5578855|NCT00973193|colorectal|colorectal
5578856|NCT00973193|cancer|cancer
5578857|NCT00973193|adenocarcinoma|adenocarcinoma
5578858|NCT00973193|anti-EGFR|anti-egfr
5578859|NCT00973193|monoclonal antibodies|monoclonal antibodies
5578860|NCT00973193|neoadjuvant therapy|neoadjuvant therapy
5578861|NCT00973193|preoperative radiotherapy|preoperative radiotherapy
5578862|NCT00973180|Prescription medication understanding among diabetic and hypertension patients.|prescription medication understanding among diabetic and hypertension patients.
5578863|NCT00973180|Prescription medication use among diabetic and hypertension patients.|prescription medication use among diabetic and hypertension patients.
5578864|NCT00973180|Hemoglobin A1c changes among diabetic patients.|hemoglobin a1c changes among diabetic patients.
5578865|NCT00973180|Blood pressure changes among hypertension patients.|blood pressure changes among hypertension patients.
5578866|NCT00973167|Fracture rate|fracture rate
5578867|NCT00973167|Fracture risks|fracture risks
5578868|NCT00973154|Pneumonia|pneumonia
5578869|NCT00973154|Corticosteroids|corticosteroids
5578870|NCT00973154|clinical stability|clinical stability
5578871|NCT00973141|Moderate to severe, osteoarthritis-related pain|moderate to severe, osteoarthritis-related pain
5578872|NCT00973141|Osteoarthritis-related pain|osteoarthritis-related pain
5578873|NCT00973141|Moderate to severe chronic pain|moderate to severe chronic pain
5578874|NCT00973141|JNJ-42160443|jnj-42160443
5578875|NCT00973089|Primary tooth|primary tooth
5578876|NCT00973089|Caries, Dental|caries, dental
5578877|NCT00973089|Alternative treatment|alternative treatment
5578878|NCT00973076|Phase I, cancer|phase i, cancer
5578879|NCT00973076|solid tumors|solid tumors
5578880|NCT00973076|advanced solid malignancies|advanced solid malignancies
5578881|NCT00973076|dose escalation|dose escalation
5578882|NCT00973076|mTOR Kinase Inhibitor|mtor kinase inhibitor
5578883|NCT00973076|Japanese|japanese
5578884|NCT00973063|bacteremia|bacteremia
5578885|NCT00973063|blood culture|blood culture
5578886|NCT00973063|contamination|contamination
5578887|NCT00973050|Bioequivalence|bioequivalence
5578888|NCT00973037|Breast neoplasms|breast neoplasms
5578889|NCT00973037|Tamoxifen|tamoxifen
5578890|NCT00973037|Genotype|genotype
5578891|NCT00973037|CYP2D6|cyp2d6
5578892|NCT00973024|JNJ-42160443|jnj-42160443
5579186|NCT00971698|Splenectomy|splenectomy
5578893|NCT00973024|Low back pain-related pain|low back pain-related pain
5578894|NCT00973024|moderate to severe, chronic pain|moderate to severe, chronic pain
5578896|NCT00972998|anal sphincter pressure|anal sphincter pressure
5754450|NCT00303433|Namenda|namenda
5578897|NCT00972998|phenyephrine|phenyephrine
5578898|NCT00972985|Healthy Control subjects|healthy control subjects
5578899|NCT00972972|fruit polyphenols|fruit polyphenols
5578900|NCT00972972|phytochemicals|phytochemicals
5578901|NCT00972972|neurocognition|neurocognition
5578902|NCT00972972|neuropsychology|neuropsychology
5578903|NCT00972972|psychopharmacology|psychopharmacology
5578904|NCT00972972|gene expression|gene expression
5578905|NCT00972972|biochemistry|biochemistry
5578906|NCT00972959|multiple myeloma|multiple myeloma
5578907|NCT00972959|1-3 Prior Lines of Therapy|1-3 prior lines of therapy
5578908|NCT00972959|bortezomib (Velcade)|bortezomib (velcade)
5578909|NCT00972959|zoledronic acid (Zometa)|zoledronic acid (zometa)
5578910|NCT00972959|Dexamethasone|dexamethasone
5578911|NCT00972959|bone mineral density|bone mineral density
5578912|NCT00972959|bone pain|bone pain
5578913|NCT00972959|bone metabolism|bone metabolism
5578914|NCT00972959|osteolytic lesions|osteolytic lesions
5578915|NCT00972959|DEXA-scans|dexa-scans
5578916|NCT00972959|X-ray radiography|x-ray radiography
5578918|NCT00972946|SPIO|spio
5578919|NCT00972933|Immunogenicity Analysis|immunogenicity analysis
5578920|NCT00972933|Biomarker Analysis|biomarker analysis
5578921|NCT00972933|experimental|experimental
5578922|NCT00972920|Transversus abdominis plane|transversus abdominis plane
5578923|NCT00972920|Acute pain service|acute pain service
5578924|NCT00972920|Ultrasound|ultrasound
5578925|NCT00972907|anal fissure|anal fissure
5578926|NCT00972907|pain|pain
5578927|NCT00972907|nifedipine|nifedipine
5578928|NCT00972894|Group B streptococcus|group b streptococcus
5578929|NCT00972894|Polymerase chain reaction|polymerase chain reaction
5578930|NCT00972894|PCR|pcr
5578931|NCT00972894|Intrapartum screening|intrapartum screening
5578932|NCT00972894|Risk factors|risk factors
5578933|NCT00972894|arly onset Group B streptococcus infection|arly onset group b streptococcus infection
5578934|NCT00972881|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5578935|NCT00972881|Locally advanced rectal cancer|locally advanced rectal cancer
5578936|NCT00972868|Unidirectional mask|unidirectional mask
5578937|NCT00972868|NPPV|nppv
5578938|NCT00972868|COPD|copd
5578939|NCT00972868|respiratory physiology|respiratory physiology
5578940|NCT00972855|Bioequivalence|bioequivalence
5578941|NCT00972842|PTCL|ptcl
5578942|NCT00972842|Peripheral T-Cell Non-Hodgkin's Lymphoma|peripheral t-cell non-hodgkin's lymphoma
5578943|NCT00972842|Vorinostat|vorinostat
5578944|NCT00972842|Lenalidomid|lenalidomid
5578945|NCT00972829|Hypercholesterolemia|hypercholesterolemia
5578946|NCT00972816|Swine Flu|swine flu
5578947|NCT00972816|Flu|flu
5578948|NCT00972816|Vaccine|vaccine
5578949|NCT00972816|Children|children
5578950|NCT00972816|Adjuvant|adjuvant
5578951|NCT00972803|gingivitis|gingivitis
5578952|NCT00972803|dental plaque|dental plaque
5578953|NCT00972803|mouthrinse|mouthrinse
5578954|NCT00972790|brain tumor|brain tumor
5578955|NCT00972790|un-ruptured aneurysm|un-ruptured aneurysm
5578956|NCT00972790|arteriovenous malformation|arteriovenous malformation
5578957|NCT00972790|epileptic focus|epileptic focus
5578958|NCT00972790|supratentorial|supratentorial
5578959|NCT00972764|Laryngomalacia|laryngomalacia
5578960|NCT00972764|Factors Associated or Predisposing|factors associated or predisposing
5578961|NCT00972751|stage II rectal cancer|stage ii rectal cancer
5578962|NCT00972751|stage III rectal cancer|stage iii rectal cancer
5578963|NCT00972751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5578964|NCT00972725|Chloroquine|chloroquine
5578965|NCT00972725|Human Immunodeficiency Virus|human immunodeficiency virus
5563758|NCT01032070|etoposide|etoposide
5578966|NCT00972712|Multiple Myeloma|multiple myeloma
5578967|NCT00972699|Human Immunodeficiency Virus|human immunodeficiency virus
5578968|NCT00972699|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5578969|NCT00972699|Tuberculosis|tuberculosis
5578970|NCT00972699|Women|women
5578971|NCT00972699|Pregnancy|pregnancy
5578972|NCT00972699|Vertical Transmission of Human Immunodeficiency Virus|vertical transmission of human immunodeficiency virus
5578973|NCT00972699|South Africa|south africa
5578974|NCT00972699|Low Birth Weight|low birth weight
5578975|NCT00972686|solid tumors|solid tumors
5578976|NCT00972686|lymphoma|lymphoma
5578977|NCT00972686|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
5578978|NCT00972660|Mesenchymal stem cell|mesenchymal stem cell
5578979|NCT00972660|Efficacy|efficacy
5578980|NCT00972660|Safety|safety
5578981|NCT00972647|fracture|fracture
5578982|NCT00972647|fixation|fixation
5578983|NCT00972647|fluoroscopy|fluoroscopy
5578984|NCT00972647|laser|laser
5578985|NCT00972647|radiation|radiation
5578986|NCT00972634|depression|depression
5578987|NCT00972634|cachexia|cachexia
5578988|NCT00972634|pain|pain
5578989|NCT00972634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5578990|NCT00972608|congenital heart disease|congenital heart disease
5578991|NCT00972608|surgical planning|surgical planning
5579590|NCT00969930|cognition|cognition
5904056|NCT00007813|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5578992|NCT00972582|leucine intake|leucine intake
5578993|NCT00972582|tolerable upper limit|tolerable upper limit
5578994|NCT00972582|adults|adults
5578995|NCT00972582|amino acid supplements|amino acid supplements
5578996|NCT00972582|Excessive Leucine Intake|excessive leucine intake
5578997|NCT00972569|BNP with or without PDE-V in heart failure|bnp with or without pde-v in heart failure
5578998|NCT00972556|Mineral Trioxide Aggregate|mineral trioxide aggregate
5578999|NCT00972556|Formocresol|formocresol
5579000|NCT00972556|pulpotomy|pulpotomy
5579001|NCT00972556|primary molar|primary molar
5579002|NCT00972556|treatment outcome|treatment outcome
5579003|NCT00972543|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5579004|NCT00972543|palms and/or soles|palms and/or soles
5579005|NCT00972543|with or without pustules|with or without pustules
5579006|NCT00972530|rheumatoid arthritis|rheumatoid arthritis
5579007|NCT00972530|treatment|treatment
5579008|NCT00972517|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579009|NCT00972517|influenza infection|influenza infection
5579010|NCT00972504|Proof of concept|proof of concept
5579011|NCT00972465|nimotuzumab colorectal cancer chemotherapy|nimotuzumab colorectal cancer chemotherapy
5579012|NCT00972452|Type II Diabetes|type ii diabetes
5579013|NCT00972452|Insulin Resistance|insulin resistance
5579014|NCT00972452|Exercise|exercise
5579015|NCT00972452|Continuous Glucose Monitoring|continuous glucose monitoring
5579016|NCT00972439|Oral Contraceptives|oral contraceptives
5579017|NCT00972439|Breast Tissue|breast tissue
5579018|NCT00972413|breast cancer|breast cancer
5579019|NCT00972413|cone beam computed tomography|cone beam computed tomography
5579020|NCT00972400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5579021|NCT00972400|fatigue|fatigue
5579022|NCT00972400|cancer survivor|cancer survivor
5579023|NCT00972400|breast cancer|breast cancer
5579024|NCT00972387|carbohydrate-protein|carbohydrate-protein
5579025|NCT00972387|endurance exercise|endurance exercise
5579026|NCT00972387|supplement|supplement
5579027|NCT00972361|Adenoidectomy|adenoidectomy
5579028|NCT00972361|Tonsillectomy|tonsillectomy
5579029|NCT00972361|Ventilation Tubes|ventilation tubes
5579030|NCT00972361|Preoperational screening|preoperational screening
5579031|NCT00972361|Coagulation Profile|coagulation profile
5579032|NCT00972361|Lupus anticoagulant|lupus anticoagulant
5579034|NCT00972348|Personal Health Record|personal health record
5579035|NCT00972348|Laboratory values: CD4 cells and HIV Viral load|laboratory values: cd4 cells and hiv viral load
5579036|NCT00972348|Medication Reconciliation|medication reconciliation
5579037|NCT00972335|Avastin|avastin
5579038|NCT00972335|RAD001|rad001
5579039|NCT00972335|Meningioma|meningioma
5579040|NCT00972335|Bevacizumab|bevacizumab
5579041|NCT00972335|Everolimus|everolimus
5579042|NCT00972335|Brain|brain
5579043|NCT00972309|Epotope-Enhanced TARP Peptide|epotope-enhanced tarp peptide
5579044|NCT00972309|Prostate Cancer|prostate cancer
5579045|NCT00972309|TARP Peptide-Pulsed Dendritic Cells|tarp peptide-pulsed dendritic cells
5579046|NCT00972309|PSADT|psadt
5579047|NCT00972309|HLA-A*0201|hla-a*0201
5579048|NCT00972270|Arterial Occlusive Disease|arterial occlusive disease
5579049|NCT00972270|Heart Diseases|heart diseases
5579050|NCT00972270|Myocardial Ischemia|myocardial ischemia
5579051|NCT00972270|Vascular Disease|vascular disease
5579052|NCT00972270|Arteriosclerosis|arteriosclerosis
5579053|NCT00972270|Ischemia|ischemia
5579054|NCT00972257|24-hour IOP control|24-hour iop control
5579055|NCT00972257|primary open-angle glaucoma|primary open-angle glaucoma
5563859|NCT01031758|RCT|rct
5579056|NCT00972257|brimonidine/timolol|brimonidine/timolol
5579057|NCT00972257|dorzolamide/timolol|dorzolamide/timolol
5579058|NCT00972244|Type 2 diabetes mellitus|type 2 diabetes mellitus
5579059|NCT00972244|Japanese|japanese
5579060|NCT00972244|phase 2|phase 2
5579061|NCT00972244|efficacy|efficacy
5579062|NCT00972244|safety|safety
5579063|NCT00972244|dapagliflozin|dapagliflozin
5579064|NCT00972231|Thalassemia Major|thalassemia major
5579065|NCT00972231|Thalassemia Intermedia|thalassemia intermedia
5579066|NCT00972231|Sickle Cell Anemia|sickle cell anemia
5579067|NCT00972231|Sickle Cell Thalassemia|sickle cell thalassemia
5579068|NCT00972231|Iron Overload|iron overload
5579069|NCT00972231|Growth Velocity|growth velocity
5579070|NCT00972218|Spondyloarthritis|spondyloarthritis
5579071|NCT00972218|Ankylosing Spondylitis|ankylosing spondylitis
5579072|NCT00972218|Crohn's disease|crohn's disease
5579073|NCT00972218|adalimumab|adalimumab
5579074|NCT00972218|treatment|treatment
5579075|NCT00972205|Pgp|pgp
5862977|NCT00001432|T Cells|t cells
5579076|NCT00972205|Solid Tumors|solid tumors
5579077|NCT00972205|Drug Resistance|drug resistance
5579078|NCT00972205|Sestamibi|sestamibi
5579079|NCT00972205|Cancer|cancer
5579080|NCT00972205|Solid Tumor|solid tumor
5579082|NCT00972192|HIV risk behavior|hiv risk behavior
5579083|NCT00972192|access to care|access to care
5579084|NCT00972179|healthy volunteers|healthy volunteers
5579085|NCT00972153|Decrease in CFU density at surgery site|decrease in cfu density at surgery site
5579086|NCT00972153|Decrease in airborne particulate at surgery site|decrease in airborne particulate at surgery site
5579087|NCT00972140|Patients with stable COPD|patients with stable copd
5580475|NCT00966498|recurrent|recurrent
5579088|NCT00972101|Blood And Marrow Transplantation|blood and marrow transplantation
5579089|NCT00972101|Leukemia|leukemia
5579090|NCT00972101|Lymphoma|lymphoma
5579091|NCT00972101|Pediatrics|pediatrics
5579092|NCT00972101|Etoposide|etoposide
5579093|NCT00972101|Expanded Cord Blood T Cells|expanded cord blood t cells
5579094|NCT00972101|Filgrastim|filgrastim
5579095|NCT00972101|Fludarabine|fludarabine
5579096|NCT00972101|Melphalan|melphalan
5579097|NCT00972101|Mycophenolate Mofetil|mycophenolate mofetil
5579098|NCT00972101|Rituximab|rituximab
5579099|NCT00972101|Tacrolimus|tacrolimus
5579100|NCT00972101|Thiotepa|thiotepa
5579101|NCT00972101|Thymoglobulin|thymoglobulin
5579102|NCT00972101|Total Body Irradiation|total body irradiation
5579103|NCT00972088|inflammation of the small bowel|inflammation of the small bowel
5579104|NCT00972075|totally blind subjects|totally blind subjects
5579105|NCT00972062|Subcutaneous injections|subcutaneous injections
5579106|NCT00972062|Skin abnormalities|skin abnormalities
5579107|NCT00972049|safety|safety
5579108|NCT00972049|tolerability|tolerability
5579109|NCT00972049|AZD2516|azd2516
5579110|NCT00972049|pain|pain
5579111|NCT00972049|Japanese|japanese
5579112|NCT00972036|COLON|colon
5579113|NCT00972036|LIVER|liver
5579114|NCT00972036|RECTUM|rectum
5579115|NCT00972036|SIR-Spheres|sir-spheres
5579116|NCT00972036|09-030|09-030
5579117|NCT00972023|triple-negative breast cancer|triple-negative breast cancer
5579118|NCT00972023|stage I breast cancer|stage i breast cancer
5579119|NCT00972023|stage II breast cancer|stage ii breast cancer
5579120|NCT00972023|stage IIIA breast cancer|stage iiia breast cancer
5579121|NCT00972023|stage IIIB breast cancer|stage iiib breast cancer
5579122|NCT00972023|stage IIIC breast cancer|stage iiic breast cancer
5579123|NCT00972010|Breast|breast
5579124|NCT00972010|Cancer|cancer
5579125|NCT00972010|Lumpectomies|lumpectomies
5579126|NCT00972010|PlasmaBlade|plasmablade
5579127|NCT00972010|Breast conservation therapy|breast conservation therapy
5579128|NCT00971971|Hypotension|hypotension
5579129|NCT00971971|Acute renal failure|acute renal failure
5579130|NCT00971971|acute kidney injury|acute kidney injury
5579131|NCT00971971|dialysis|dialysis
5579132|NCT00971971|ICU|icu
5579133|NCT00971958|HIV prevention|hiv prevention
5579134|NCT00971958|infant, neonatal, male circumcision|infant, neonatal, male circumcision
5579135|NCT00971932|Recurrent and/or metastatic|recurrent and/or metastatic
5579136|NCT00971932|SCCHN|scchn
5579137|NCT00971919|pain|pain
5579138|NCT00971919|perioperative/postoperative complications|perioperative/postoperative complications
5579139|NCT00971919|breast cancer in situ|breast cancer in situ
5579140|NCT00971919|stage IA breast cancer|stage ia breast cancer
5579141|NCT00971919|stage IB breast cancer|stage ib breast cancer
5579142|NCT00971919|stage II breast cancer|stage ii breast cancer
5579143|NCT00971919|stage IIIA breast cancer|stage iiia breast cancer
5579144|NCT00971919|stage IIIB breast cancer|stage iiib breast cancer
5579145|NCT00971919|stage IIIC breast cancer|stage iiic breast cancer
5579146|NCT00971906|Pandemic influenza|pandemic influenza
5579147|NCT00971906|Vaccine|vaccine
5579148|NCT00971893|Acute Exacerbation of Bronchial Asthma Acute Asthma|acute exacerbation of bronchial asthma acute asthma
5579149|NCT00971880|Blood transfusions|blood transfusions
5579150|NCT00971880|Adverse events|adverse events
5579151|NCT00971880|Hepatitis C|hepatitis c
5579152|NCT00971880|HIV|hiv
5579153|NCT00971854|Dystonia|dystonia
5563967|NCT01031433|Tobacco Craving|tobacco craving
5579154|NCT00971828|Myositis|myositis
5579155|NCT00971828|polymyositis|polymyositis
5579156|NCT00971828|dermatomyositis|dermatomyositis
5579157|NCT00971815|HPA-axis|hpa-axis
5579158|NCT00971815|fetal programming|fetal programming
5579159|NCT00971789|Sirolimus|sirolimus
5579160|NCT00971789|Cowden Syndrome|cowden syndrome
5579161|NCT00971789|PTEN Mutation|pten mutation
5579162|NCT00971789|Hamartoma Syndrome|hamartoma syndrome
5579163|NCT00971776|Patient receiving AB5000 ventricle potentially recoverable|patient receiving ab5000 ventricle potentially recoverable
5579164|NCT00971763|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5579165|NCT00971763|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5579166|NCT00971763|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5579167|NCT00971763|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5579168|NCT00971763|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5579169|NCT00971750|ultrasonography|ultrasonography
5579170|NCT00971750|gallbladder|gallbladder
5579171|NCT00971750|cholelithiasis|cholelithiasis
5579172|NCT00971750|laparoscopic|laparoscopic
5579173|NCT00971750|gastric bypass|gastric bypass
5579175|NCT00971750|bariatric surgery|bariatric surgery
5579176|NCT00971737|stage IV breast cancer|stage iv breast cancer
5579177|NCT00971737|male breast cancer|male breast cancer
5579178|NCT00971724|Prednisolone|prednisolone
5579179|NCT00971724|Glucocorticoids|glucocorticoids
5579181|NCT00971711|irritable bowel syndrome|irritable bowel syndrome
5579182|NCT00971711|abdominal pain|abdominal pain
5579183|NCT00971711|urgency|urgency
5579184|NCT00971711|bloating|bloating
5579185|NCT00971711|diarrhea|diarrhea
5579187|NCT00971698|Thrombocytosis|thrombocytosis
5579188|NCT00971698|Infections|infections
5579189|NCT00971698|Spleen|spleen
5579190|NCT00971698|Sickle Cell Thalassemia|sickle cell thalassemia
5579191|NCT00971672|Infants|infants
5579192|NCT00971672|Iron Deficiency|iron deficiency
5579193|NCT00971672|Anemia|anemia
5579194|NCT00971672|Healthy infants that attend the pediatric community clinics|healthy infants that attend the pediatric community clinics
5579195|NCT00971659|type 2 diabetes|type 2 diabetes
5579196|NCT00971646|overactive bladder|overactive bladder
5579197|NCT00971646|self-consciousness|self-consciousness
5579198|NCT00971646|perceptual urge sensation|perceptual urge sensation
5579199|NCT00971620|Cutaneous Leiomyomas|cutaneous leiomyomas
5579200|NCT00971620|Skin Pain|skin pain
5579201|NCT00971620|Botox Therapy|botox therapy
5579202|NCT00971620|Hereditary Leiomyomatosis|hereditary leiomyomatosis
5579203|NCT00971620|Renal Cell Cancer|renal cell cancer
5579204|NCT00971620|Cutaneous Leiomyoma|cutaneous leiomyoma
5579205|NCT00971607|Acute myocardial infarction|acute myocardial infarction
5579206|NCT00971607|Postconditioning|postconditioning
5579207|NCT00971607|Sevoflurane|sevoflurane
5579208|NCT00971594|weight loss|weight loss
5579209|NCT00971594|glucose metabolism|glucose metabolism
5579210|NCT00971568|Interstitial cystitis|interstitial cystitis
5579211|NCT00971568|Painful bladder syndrome|painful bladder syndrome
5579212|NCT00971555|Transient Hypothyroxinemia|transient hypothyroxinemia
5579213|NCT00971555|Late Preterm Infants|late preterm infants
5579214|NCT00971555|Total T4|total t4
5579215|NCT00971555|TSH|tsh
5579216|NCT00971555|Illness severity|illness severity
5579217|NCT00971555|NICU|nicu
5579218|NCT00971542|Pandemic influenza|pandemic influenza
5579219|NCT00971542|Vaccine|vaccine
5579220|NCT00971529|Smoking cessation|smoking cessation
5579221|NCT00971529|tea filter|tea filter
5579222|NCT00971516|diabetes|diabetes
5579223|NCT00971516|implants|implants
5579224|NCT00971516|cytokines|cytokines
5579225|NCT00971503|Diabetes type 1|diabetes type 1
5579226|NCT00971503|Adult Stem cells|adult stem cells
5579227|NCT00971503|Local injection|local injection
5579228|NCT00971503|Catheter delivery|catheter delivery
5579229|NCT00971503|Bone marrow|bone marrow
5579230|NCT00971490|COPD|copd
5579231|NCT00971490|FEV1|fev1
5579232|NCT00971490|beta endorphin|beta endorphin
5579233|NCT00971490|SGRQ|sgrq
5579234|NCT00971490|Acu-TENS|acu-tens
5579235|NCT00971477|Teledermatology|teledermatology
5579236|NCT00971477|Telemedicine|telemedicine
5579237|NCT00971477|Psoriasis|psoriasis
5579238|NCT00971464|AMD|amd
5579239|NCT00971464|EV|ev
5579240|NCT00971464|CCTV|cctv
5579241|NCT00971464|Reading|reading
5579242|NCT00971464|vision|vision
5579243|NCT00971451|Anterior cruciate ligament|anterior cruciate ligament
5579244|NCT00971451|ACL|acl
5579245|NCT00971438|appendicitis|appendicitis
5579246|NCT00971438|diagnosis|diagnosis
5579247|NCT00971438|diagnostic imaging|diagnostic imaging
5579248|NCT00971438|clinical scoring system|clinical scoring system
5579249|NCT00971425|influenza infection|influenza infection
5579250|NCT00971425|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579251|NCT00971386|Heart Failure|heart failure
5579252|NCT00971373|antimicrobial|antimicrobial
5579253|NCT00971373|epidemiology|epidemiology
5579254|NCT00971373|bacteriology|bacteriology
5579255|NCT00971373|CFU|cfu
5579256|NCT00971360|conversion|conversion
5579257|NCT00971360|cytokine|cytokine
5579258|NCT00971360|inflammation|inflammation
5579259|NCT00971347|obesity|obesity
5579260|NCT00971347|overweight|overweight
5579261|NCT00971347|weight loss|weight loss
5579262|NCT00971347|randomized controlled trial|randomized controlled trial
5579263|NCT00971347|chewing gum|chewing gum
5579264|NCT00971334|Down Syndrome|down syndrome
5579265|NCT00971334|Aneuploidy|aneuploidy
5579266|NCT00971334|Amniocentesis|amniocentesis
5579267|NCT00971334|CVS|cvs
5579268|NCT00971321|influenza infection|influenza infection
5579269|NCT00971321|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579270|NCT00971295|eslicarbazepine acetate|eslicarbazepine acetate
5579271|NCT00971295|zebinix|zebinix
5579272|NCT00971295|metformin|metformin
5579273|NCT00971256|Bladder|bladder
5579274|NCT00971256|Cancer|cancer
5579275|NCT00971256|Cytology|cytology
5579276|NCT00971243|Insulin resistance|insulin resistance
5579277|NCT00971230|HIV|hiv
5579278|NCT00971230|Human Immunodeficiency Virus|human immunodeficiency virus
5579279|NCT00971217|Internet based Cognitive-Behavioural Intervention|internet based cognitive-behavioural intervention
5579280|NCT00971217|Exercise Intervention|exercise intervention
5579281|NCT00971217|Depression|depression
5579282|NCT00971217|Perceived Social Support|perceived social support
5579283|NCT00971217|Physical Self-Concept|physical self-concept
5579284|NCT00971204|atrial fibrillation|atrial fibrillation
5671236|NCT00616590|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5685411|NCT00556192|Rituximab|rituximab
5685412|NCT00556192|Methylprednisolone|methylprednisolone
5579286|NCT00971191|Stage I - III surgical resection molecular change brief pre-operative exposure|stage i - iii surgical resection molecular change brief pre-operative exposure
5579288|NCT00971178|Dental pain|dental pain
5579289|NCT00971178|Dexmedetomidine|dexmedetomidine
5579290|NCT00971178|Pain|pain
5579291|NCT00971178|Peripheral effects|peripheral effects
5579292|NCT00971165|Hypertension|hypertension
5579293|NCT00971165|Chlorthalidone|chlorthalidone
5579294|NCT00971165|Amiloride|amiloride
5579295|NCT00971165|Losartan|losartan
5579296|NCT00971165|treatment|treatment
5579297|NCT00971152|IVF|ivf
5579298|NCT00971152|dose comparison of gonadotrophins|dose comparison of gonadotrophins
5579299|NCT00971152|poor responder to ovarian stimulation|poor responder to ovarian stimulation
5579300|NCT00971139|Online patient-provider communication|online patient-provider communication
5579301|NCT00971139|Organizational change|organizational change
5579302|NCT00971139|Symptom management|symptom management
5579303|NCT00971126|hepatocellular carcinoma|hepatocellular carcinoma
5579304|NCT00971100|Pandemic influenza|pandemic influenza
5579305|NCT00971100|Vaccine|vaccine
5579306|NCT00971087|Breast cancer|breast cancer
5579307|NCT00971087|breast cancer screening|breast cancer screening
5579308|NCT00971074|Arthralgia|arthralgia
5579309|NCT00971074|Viscosupplementation|viscosupplementation
5579310|NCT00971074|Knee|knee
5579311|NCT00971074|Menisci, Tibial|menisci, tibial
5579312|NCT00971074|Surgery, Outpatient|surgery, outpatient
5579313|NCT00971061|Ahmed valve|ahmed valve
5579314|NCT00971061|single-plate Molteno implant|single-plate molteno implant
5579315|NCT00971061|refractory glaucoma|refractory glaucoma
5579316|NCT00971061|surgical treatment|surgical treatment
5579317|NCT00971048|pressure ulcers|pressure ulcers
5579318|NCT00971048|PU|pu
5579319|NCT00971048|diabetic foot ulcers|diabetic foot ulcers
5579320|NCT00971048|DFU|dfu
5579321|NCT00971048|Bates-Jensen Wound Assessment|bates-jensen wound assessment
5579322|NCT00971035|MILR1444A|milr1444a
5579323|NCT00971022|Low-income populations|low-income populations
5579324|NCT00971022|Chronic health condition|chronic health condition
5579325|NCT00971022|Prescription medication|prescription medication
5579326|NCT00971022|Prescription drugs|prescription drugs
5579327|NCT00971022|Discount generic prescription programs|discount generic prescription programs
5579328|NCT00971022|Survey|survey
5579329|NCT00971022|Awareness|awareness
5579330|NCT00971022|Focus Group|focus group
5579331|NCT00971022|Houston|houston
5579332|NCT00971009|Symptom management|symptom management
5579333|NCT00971009|Interactive Health Communication Application|interactive health communication application
5579334|NCT00971009|Patient-provider communication|patient-provider communication
5579335|NCT00971009|Health care costs|health care costs
5579336|NCT00970996|Melanoma|melanoma
5579337|NCT00970996|Abraxane|abraxane
5579338|NCT00970996|Nab-paclitaxel|nab-paclitaxel
5579339|NCT00970996|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
5579340|NCT00970996|ABI-007|abi-007
5579341|NCT00970996|Cisplatin|cisplatin
5579342|NCT00970996|Platinol-AQ|platinol-aq
5579343|NCT00970996|Platinol|platinol
5579344|NCT00970996|CDDP|cddp
5579345|NCT00970996|Interleukin 2|interleukin 2
5579346|NCT00970996|IL-2|il-2
5579347|NCT00970996|Proleukin|proleukin
5579348|NCT00970996|Intron A|intron a
5579349|NCT00970996|Interferon alpha 2b|interferon alpha 2b
5579350|NCT00970996|Interferon alfa-2b|interferon alfa-2b
5579351|NCT00970996|Temodar|temodar
5579352|NCT00970996|Temozolomide|temozolomide
5579353|NCT00970970|Vascular endothelial growth factor|vascular endothelial growth factor
5579354|NCT00970970|von Hippel Lindau disease|von hippel lindau disease
5579355|NCT00970970|molecular imaging|molecular imaging
5579356|NCT00970970|biomarker|biomarker
5579357|NCT00970957|Macular edema|macular edema
5579358|NCT00970957|Retinal Vein Occlusion|retinal vein occlusion
5579359|NCT00970957|Bevacizumab|bevacizumab
5579360|NCT00970944|Traumatic Brain Injury|traumatic brain injury
5579361|NCT00970944|Rehabilitation|rehabilitation
5579362|NCT00970944|Disorders of Consciousness|disorders of consciousness
5579363|NCT00970944|Functional Outcome|functional outcome
5579364|NCT00970944|Amantadine Hydrochloride|amantadine hydrochloride
5579365|NCT00970931|hypertension|hypertension
5579366|NCT00970931|diuretics|diuretics
5579367|NCT00970918|Cardiovascular disease|cardiovascular disease
5579368|NCT00970918|Carotid Intima Media Thickness|carotid intima media thickness
5579369|NCT00970905|Radiation|radiation
5579370|NCT00970905|Nausea|nausea
5579371|NCT00970905|Vomiting|vomiting
5579372|NCT00970905|Ondansetron|ondansetron
5579373|NCT00970905|Aprepitant|aprepitant
5579374|NCT00970892|Anticoagulation|anticoagulation
5579375|NCT00970892|warfarin|warfarin
5579376|NCT00970892|VKORC1|vkorc1
5579377|NCT00970892|CYP2C9|cyp2c9
5579378|NCT00970892|thromboembolism|thromboembolism
5579379|NCT00970892|pharmacogenetics|pharmacogenetics
5579380|NCT00970879|malaria|malaria
5579381|NCT00970879|pregnancy|pregnancy
5579382|NCT00970879|HIV|hiv
5579383|NCT00970879|prevention|prevention
5579385|NCT00970879|mefloquine|mefloquine
5579386|NCT00970866|multiple micronutrients|multiple micronutrients
5579387|NCT00970866|home fortification|home fortification
5579388|NCT00970866|complementary foods|complementary foods
5579389|NCT00970866|infant feeding|infant feeding
5579390|NCT00970866|lipid-based nutrient supplements|lipid-based nutrient supplements
5579391|NCT00970853|Evaluate developmental outcomes|evaluate developmental outcomes
5580476|NCT00966498|high risk|high risk
5579392|NCT00970853|Evaluate child cognitive, academic, and behavioral outcomes|evaluate child cognitive, academic, and behavioral outcomes
5579393|NCT00970840|Acceptability|acceptability
5579394|NCT00970840|Supplements|supplements
5579395|NCT00970840|Home-fortification|home-fortification
5579396|NCT00970827|Coronary artery disease|coronary artery disease
5579398|NCT00970827|Postconditioning|postconditioning
5579399|NCT00970827|Elective or urgent PCI|elective or urgent pci
5579400|NCT00970814|Alcoholism|alcoholism
5579401|NCT00970814|Alcohol Drinking|alcohol drinking
5579402|NCT00970814|Alcoholic Intoxication|alcoholic intoxication
5579403|NCT00970814|Alcohol Abuse|alcohol abuse
5579404|NCT00970801|Atypical mycobacteria|atypical mycobacteria
5579405|NCT00970775|Phase I|phase i
5579406|NCT00970775|Japanese healthy volunteer|japanese healthy volunteer
5579407|NCT00970775|AZD2423|azd2423
5579408|NCT00970749|chlamydia|chlamydia
5579409|NCT00970749|healthy women|healthy women
5579410|NCT00970749|history of endocervical chlamydia|history of endocervical chlamydia
5579411|NCT00970749|no history of endocervical chlamydia|no history of endocervical chlamydia
5579412|NCT00970736|Motor cortex|motor cortex
5579413|NCT00970736|Motor control|motor control
5579414|NCT00970736|Neuroplasticity|neuroplasticity
5579415|NCT00970736|Aging|aging
5579416|NCT00970736|Swallowing|swallowing
5579417|NCT00970723|Diabetic retinopathy|diabetic retinopathy
5579418|NCT00970723|Macula edema|macula edema
5579419|NCT00970723|Sleep apnea|sleep apnea
5579420|NCT00970723|High blood pressure|high blood pressure
5579421|NCT00970697|MARTORELL'S ULCER|martorell's ulcer
5579422|NCT00970697|hydrogel|hydrogel
5579423|NCT00970697|Hypertensive leg ulcer|hypertensive leg ulcer
5579424|NCT00970684|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5579425|NCT00970684|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5579426|NCT00970684|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5579427|NCT00970684|adenocarcinoma of the lung|adenocarcinoma of the lung
5579428|NCT00970684|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5579429|NCT00970684|large cell lung cancer|large cell lung cancer
5579430|NCT00970671|scar|scar
5579431|NCT00970671|laser therapy|laser therapy
5579432|NCT00970671|lasers, pulsed dye|lasers, pulsed dye
5579433|NCT00970658|Plaster|plaster
5579434|NCT00970658|injuries|injuries
5579435|NCT00970658|regions miofasciais articulated|regions miofasciais articulated
5579436|NCT00970658|Reducing signs, symptoms|reducing signs, symptoms
5579437|NCT00970645|Non small cell lung cancer|non small cell lung cancer
5579438|NCT00970645|mediastinum|mediastinum
5579439|NCT00970645|endobronchial ultrasound fine needle aspiration|endobronchial ultrasound fine needle aspiration
5579440|NCT00970645|endoscopic ultrasound|endoscopic ultrasound
5579441|NCT00970645|mediastinoscopy|mediastinoscopy
5579442|NCT00970645|surgical or minimally invasive evaluation of mediastinum|surgical or minimally invasive evaluation of mediastinum
5579443|NCT00970645|NSCLC|nsclc
5579444|NCT00970606|ARDS|ards
5579445|NCT00970606|H1N1|h1n1
5579446|NCT00970606|Influenza|influenza
5579447|NCT00970606|Statin|statin
5579448|NCT00970580|BIIB022|biib022
5579449|NCT00970580|Stage IV|stage iv
5579450|NCT00970580|Taxol|taxol
5579451|NCT00970580|Stage IIIB|stage iiib
5579452|NCT00970580|Carboplatin|carboplatin
5579453|NCT00970580|Paclitaxel|paclitaxel
5579454|NCT00970580|Non Small Cell Lung Cancer|non small cell lung cancer
5579455|NCT00970580|Treatment Naive|treatment naive
5579456|NCT00970580|Anti IGF1R|anti igf1r
5579457|NCT00970580|NSCLC|nsclc
5579458|NCT00970580|Open Label|open label
5579459|NCT00970580|IGF1R|igf1r
5579460|NCT00970580|Paraplatin|paraplatin
5579461|NCT00970580|Cytotoxic|cytotoxic
5579462|NCT00970580|Mitotic Inhibitor|mitotic inhibitor
5579463|NCT00970580|Taxane|taxane
5579464|NCT00970580|Alkylating agent|alkylating agent
5579465|NCT00970567|therapy after positive ketone bodies in the blood|therapy after positive ketone bodies in the blood
5579466|NCT00970567|timepoint of diagnosis|timepoint of diagnosis
5579467|NCT00970567|timepoint of metabolic normalisation|timepoint of metabolic normalisation
5579468|NCT00970554|Amblyopia|amblyopia
5579469|NCT00970554|Telescopic magnification|telescopic magnification
5579470|NCT00970554|Patching|patching
5579471|NCT00970541|Cinnamon|cinnamon
5579472|NCT00970541|PCOS|pcos
5579473|NCT00970541|low blood sugar|low blood sugar
5579474|NCT00970541|Insulin|insulin
5579475|NCT00970541|Glucose|glucose
5579476|NCT00970528|Oral Hypoglycemic Agent|oral hypoglycemic agent
5579477|NCT00970515|Laparoscopy|laparoscopy
5579478|NCT00970515|Incisional hernia|incisional hernia
5579479|NCT00970515|Umbilical hernia|umbilical hernia
5579480|NCT00970515|Mesh repair|mesh repair
5579481|NCT00970515|Postoperative complications|postoperative complications
5579482|NCT00970502|celecoxib|celecoxib
5579483|NCT00970502|erlotinib|erlotinib
5579484|NCT00970502|epidermal growth factor receptor|epidermal growth factor receptor
5579485|NCT00970502|intensity-modulated radiotherapy|intensity-modulated radiotherapy
5579486|NCT00970502|cyclooxygenase-2|cyclooxygenase-2
5579487|NCT00970502|reirradiation|reirradiation
5579488|NCT00970489|atrial fibrillation|atrial fibrillation
5579489|NCT00970489|fish oil|fish oil
5579490|NCT00970463|The GH-system and cardiac function|the gh-system and cardiac function
5579491|NCT00970450|Paracetamol|paracetamol
5579492|NCT00970450|Tropisetron|tropisetron
5579493|NCT00970450|Central analgesic effect|central analgesic effect
5579494|NCT00970450|Area of allodynia|area of allodynia
5579495|NCT00970450|Secondary hyperalgesia|secondary hyperalgesia
5579496|NCT00970398|Infant formula|infant formula
5579497|NCT00970398|Bovine milk Osteopontin|bovine milk osteopontin
5579499|NCT00970398|health|health
5579500|NCT00970398|immune functions|immune functions
5579501|NCT00970372|Coercion|coercion
5579502|NCT00970359|thyroid|thyroid
5579503|NCT00970359|metastases|metastases
5579504|NCT00970359|AZD6244|azd6244
5579505|NCT00970359|09-048|09-048
5579506|NCT00970346|Digestive System Diseases|digestive system diseases
5579507|NCT00970346|Genetic Diseases|genetic diseases
5579508|NCT00970346|Inborn|inborn
5579509|NCT00970346|Respiratory Tract Diseases|respiratory tract diseases
5579510|NCT00970346|Cystic Fibrosis|cystic fibrosis
5579511|NCT00970346|Lung Disease|lung disease
5579512|NCT00970346|Pancreatic Diseases|pancreatic diseases
5579513|NCT00970333|Alzheimer disease|alzheimer disease
5579514|NCT00970333|Parkinson disease|parkinson disease
5579515|NCT00970333|Multiple Sclerosis|multiple sclerosis
5579516|NCT00970320|Anal Incontinence|anal incontinence
5579517|NCT00970320|urinary incontinence|urinary incontinence
5579518|NCT00970320|primiparas|primiparas
5579519|NCT00970320|prevalence|prevalence
5579520|NCT00970320|pelvic floor exercise treatment|pelvic floor exercise treatment
5579521|NCT00970320|Quality of Life (QoL)|quality of life (qol)
5579522|NCT00970294|diabetes|diabetes
5579523|NCT00970268|COPD|copd
5579524|NCT00970268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5579525|NCT00970268|Chronic Bronchitis|chronic bronchitis
5579526|NCT00970268|Emphysema|emphysema
5579527|NCT00970268|Airflow Obstruction, Chronic|airflow obstruction, chronic
5579528|NCT00970268|Chronic Airflow Obstruction|chronic airflow obstruction
5579529|NCT00970268|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5579530|NCT00970268|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5579531|NCT00970255|Breastfeeding difficulties|breastfeeding difficulties
5579532|NCT00970255|lingual frenulum|lingual frenulum
5579533|NCT00970255|labial frenulum|labial frenulum
5579534|NCT00970255|frenotomy|frenotomy
5579535|NCT00970216|HBV DNA non-detectability|hbv dna non-detectability
5579536|NCT00970203|Vaccine|vaccine
5579537|NCT00970203|Androgen Ablation|androgen ablation
5579538|NCT00970203|PSA Progression|psa progression
5579539|NCT00970190|sinusitis|sinusitis
5579540|NCT00970177|Pandemic influenza vaccine|pandemic influenza vaccine
5579541|NCT00970151|Fetal Inflammation|fetal inflammation
5579542|NCT00970151|Birth Outcome|birth outcome
5579543|NCT00970151|Pregnancy|pregnancy
5579544|NCT00970138|Progress free survival|progress free survival
5579545|NCT00970138|Toxicity|toxicity
5579546|NCT00970138|Response rate|response rate
5579547|NCT00970138|Overall survival|overall survival
5579548|NCT00970138|Quality of live|quality of live
5579549|NCT00970125|advance care planning|advance care planning
5579550|NCT00970125|cancer|cancer
5579551|NCT00970112|pain|pain
5579552|NCT00970112|pain assessment|pain assessment
5579553|NCT00970086|measure of postoperative pain|measure of postoperative pain
5579554|NCT00970086|children undergoing groin surgery|children undergoing groin surgery
5579555|NCT00970073|calcineurin inhibitor delay|calcineurin inhibitor delay
5579556|NCT00970073|Kidney|kidney
5579557|NCT00970060|neuropathy|neuropathy
5579558|NCT00970060|diabetes|diabetes
5579559|NCT00970047|pregnant|pregnant
5579560|NCT00970047|fetal sex determination|fetal sex determination
5579561|NCT00970047|gender determination|gender determination
5579562|NCT00970047|noninvasive test|noninvasive test
5579563|NCT00970047|fetal DNA|fetal dna
5579564|NCT00970034|Atrial fibrillation, apoptosis, oligonucleotide microarray|atrial fibrillation, apoptosis, oligonucleotide microarray
5579565|NCT00970008|Osteoarthritis|osteoarthritis
5579566|NCT00970008|Knee|knee
5579567|NCT00969995|inflammation|inflammation
5579568|NCT00969995|migraine|migraine
5579569|NCT00969995|headache|headache
5579570|NCT00969982|Pregnancy termination|pregnancy termination
5579571|NCT00969982|abortion|abortion
5579572|NCT00969982|medical abortion|medical abortion
5579573|NCT00969982|2nd trimester|2nd trimester
5579574|NCT00969982|mifepristone|mifepristone
5579576|NCT00969969|First MTP Joint|first mtp joint
5582156|NCT00960167|HCC|hcc
5579578|NCT00969969|Hallux Limitus|hallux limitus
5579579|NCT00969969|Cartilage Replacement|cartilage replacement
5579580|NCT00969969|Osteoarthritis|osteoarthritis
5579581|NCT00969969|First MTP Joint Osteoarthritis|first mtp joint osteoarthritis
5579582|NCT00969969|Big Toe Pain|big toe pain
5579583|NCT00969956|Diabetes, Complication, Cardio-vascular disease|diabetes, complication, cardio-vascular disease
5579584|NCT00969943|HPA axis|hpa axis
5579585|NCT00969930|COMT|comt
5579586|NCT00969930|ApoE|apoe
5579587|NCT00969930|BDNF|bdnf
5579588|NCT00969930|executive function|executive function
5579589|NCT00969930|bipolar|bipolar
5579591|NCT00969930|Cognitive deficits and Bipolar disease type I|cognitive deficits and bipolar disease type i
5579592|NCT00969878|Cocaine Vaccine, TA-CD 09|cocaine vaccine, ta-cd 09
5579593|NCT00969865|Atherosclerosis|atherosclerosis
5579594|NCT00969852|Sertraline|sertraline
5579595|NCT00969852|PET|pet
5579596|NCT00969852|Serotonin receptor occupancy|serotonin receptor occupancy
5579597|NCT00969852|PK-PD Model|pk-pd model
5579598|NCT00969839|Fracture|fracture
5579599|NCT00969839|Humerus|humerus
5579600|NCT00969839|Intramedullary|intramedullary
5579601|NCT00969839|Fixation|fixation
5579602|NCT00969826|GCPGC|gcpgc
5579603|NCT00969826|Pharmacokinetics|pharmacokinetics
5579604|NCT00969826|Pharmacodynamics|pharmacodynamics
5579605|NCT00969813|Hepatic impairment|hepatic impairment
5579606|NCT00969800|Common cold|common cold
5579607|NCT00969800|Influenza|influenza
5579608|NCT00969800|Pneumonia|pneumonia
5579609|NCT00969774|Face|face
5579610|NCT00969774|Cephalometry|cephalometry
5579611|NCT00969774|Anthropometry|anthropometry
5579612|NCT00969774|Photography|photography
5579613|NCT00969774|Diagnosis|diagnosis
5579614|NCT00969774|Adult|adult
5579615|NCT00969774|Morphology|morphology
5579616|NCT00969774|Comparative Study|comparative study
5579617|NCT00969735|Atrial fibrillation|atrial fibrillation
5579618|NCT00969735|Catheter ablation|catheter ablation
5579619|NCT00969735|Cryoenergy|cryoenergy
5579620|NCT00969735|Implantable loop recorder|implantable loop recorder
5579621|NCT00969735|Pulmonary vein|pulmonary vein
5579622|NCT00969722|Neuroblastoma|neuroblastoma
5579623|NCT00969722|3F8|3f8
5579624|NCT00969722|Primary refractory|primary refractory
5579625|NCT00969709|Depression|depression
5579626|NCT00969709|Major Depressive Disorder|major depressive disorder
5579627|NCT00969696|ability to learn, working memory|ability to learn, working memory
5579628|NCT00969657|rectal cancer stage I-III|rectal cancer stage i-iii
5579629|NCT00969657|concurrent chemoradiotherapie|concurrent chemoradiotherapie
5579630|NCT00969657|response prediction|response prediction
5579631|NCT00969631|Polycystic ovary syndrome|polycystic ovary syndrome
5579632|NCT00969631|clomiphene resistance|clomiphene resistance
5579633|NCT00969631|metformin|metformin
5579634|NCT00969631|laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5579635|NCT00969618|ADHD|adhd
5579636|NCT00969605|weaning|weaning
5579637|NCT00969605|adaptive support ventilation|adaptive support ventilation
5579638|NCT00969605|COPD|copd
5579639|NCT00969592|diabetes|diabetes
5579640|NCT00969579|Cancer|cancer
5579641|NCT00969579|Psychosocial Stress|psychosocial stress
5579642|NCT00969579|Parenting|parenting
5579643|NCT00969566|Diabetes|diabetes
5579644|NCT00969566|Sitagliptin|sitagliptin
5579645|NCT00969566|C-peptide|c-peptide
5579646|NCT00969566|Glucagon|glucagon
5579647|NCT00969540|Back Pain|back pain
5564462|NCT01029548|HIV|hiv
5579648|NCT00969540|Sleep|sleep
5579649|NCT00969527|Oncoxin|oncoxin
5579650|NCT00969527|Viusid|viusid
5579651|NCT00969527|dietary supplements|dietary supplements
5579652|NCT00969527|rheumatoid arthritis|rheumatoid arthritis
5579653|NCT00969514|Robotic cystectomy|robotic cystectomy
5579654|NCT00969514|Bladder|bladder
5579655|NCT00969488|matern diet|matern diet
5579656|NCT00969488|obese|obese
5579657|NCT00969488|postpartum|postpartum
5579658|NCT00969488|body weight change|body weight change
5579659|NCT00969488|Women with overweight|women with overweight
5579660|NCT00969475|scar revision|scar revision
5579661|NCT00969475|intraoperative|intraoperative
5579662|NCT00969475|fractional carbon dioxide laser|fractional carbon dioxide laser
5579663|NCT00969462|Doxorubicin|doxorubicin
5579664|NCT00969462|pharmacokinetics|pharmacokinetics
5579665|NCT00969462|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5579666|NCT00969462|response|response
5579667|NCT00969462|association between response to chemotherapy|association between response to chemotherapy
5579668|NCT00969462|myelosuppression degree|myelosuppression degree
5579669|NCT00969462|doxorubicin pharmacokinetics|doxorubicin pharmacokinetics
5579670|NCT00969449|Naproxen Sodium|naproxen sodium
5579671|NCT00969436|Mumps|mumps
5579672|NCT00969436|Immunogenicity|immunogenicity
5579673|NCT00969436|Vaccines|vaccines
5579674|NCT00969436|Safety|safety
5579675|NCT00969436|Rubella|rubella
5579676|NCT00969436|Combined Vaccine|combined vaccine
5579677|NCT00969436|Varicella Vaccine|varicella vaccine
5579678|NCT00969436|Children|children
5579681|NCT00969423|persistent pain|persistent pain
5579682|NCT00969423|neuropathic pain|neuropathic pain
5579683|NCT00969423|Chronic Pain|chronic pain
5671997|NCT00613275|Primary Care|primary care
5579685|NCT00969423|Primary spontaneous pneumothorax patients|primary spontaneous pneumothorax patients
5579686|NCT00969410|Neoplasms|neoplasms
5579687|NCT00969410|Neoplasm metastasis|neoplasm metastasis
5579688|NCT00969410|Liver neoplasms|liver neoplasms
5579689|NCT00969410|Neoplastic processes|neoplastic processes
5579690|NCT00969410|Pathologic processes|pathologic processes
5579691|NCT00969410|Digestive system neoplasms|digestive system neoplasms
5579692|NCT00969410|Neoplasms by site|neoplasms by site
5579693|NCT00969410|Digestive system diseases|digestive system diseases
5580773|NCT00965263|Cocaine|cocaine
5579699|NCT00969384|prevention|prevention
5579700|NCT00969384|Waist circumference|waist circumference
5579701|NCT00969371|posterior chamber intraocular lens|posterior chamber intraocular lens
5579702|NCT00969371|PCIOL|pciol
5579703|NCT00969371|IOL|iol
5579704|NCT00969345|Healthy Elderly Subjects|healthy elderly subjects
5579705|NCT00969345|Respiratory Yoga Exercises|respiratory yoga exercises
5579706|NCT00969345|Heart Rate Variability|heart rate variability
5579707|NCT00969345|Baroreflex|baroreflex
5579708|NCT00969345|Quality of Life|quality of life
5579714|NCT00969319|Octocog alfa|octocog alfa
5579715|NCT00969319|Hemophilia A|hemophilia a
5579716|NCT00969293|Macular Edema|macular edema
5579717|NCT00969293|Occlusive retinal vascular disease|occlusive retinal vascular disease
5579718|NCT00969293|Central Retinal Vein Occlusion|central retinal vein occlusion
5579719|NCT00969293|CRVO|crvo
5579720|NCT00969280|Acupuncture|acupuncture
5579721|NCT00969280|Dry eye syndrome|dry eye syndrome
5579722|NCT00969280|Ocular Surface Disease Index|ocular surface disease index
5579723|NCT00969280|Schirmer test|schirmer test
5579724|NCT00969280|Tear film Break-up time|tear film break-up time
5579725|NCT00969267|ear acupuncture|ear acupuncture
5579726|NCT00969267|obese|obese
5579727|NCT00969267|obese women|obese women
5579728|NCT00969267|women|women
5579729|NCT00969254|Pílulas de Lussen|pílulas de lussen
5579730|NCT00969254|Efficacy|efficacy
5579731|NCT00969254|Safety|safety
5579732|NCT00969254|Dysuria|dysuria
5579733|NCT00969254|Symptomatic control|symptomatic control
5579734|NCT00969241|saliva|saliva
5579735|NCT00969241|free-radicals|free-radicals
5579736|NCT00969241|periodontitis|periodontitis
5579737|NCT00969228|Gastroenteritis|gastroenteritis
5579738|NCT00969215|burn scar|burn scar
5579739|NCT00969215|fractional carbon dioxide laser|fractional carbon dioxide laser
5579740|NCT00969215|scar revision|scar revision
5579741|NCT00969202|Prostate Cancer|prostate cancer
5579742|NCT00969202|Cancer of the Prostate|cancer of the prostate
5579743|NCT00969202|Prostate Tumor|prostate tumor
5579744|NCT00969202|Novalis Tx|novalis tx
5579745|NCT00969202|Novalis|novalis
5680312|NCT00578240|benign|benign
5579746|NCT00969202|Stereotactic Radiosurgery|stereotactic radiosurgery
5579747|NCT00969202|Radiosurgery|radiosurgery
5579748|NCT00969202|Radiation|radiation
5579749|NCT00969189|anesthesia|anesthesia
5579750|NCT00969189|child|child
5579751|NCT00969189|infant|infant
5579752|NCT00969189|laryngeal mask|laryngeal mask
5579753|NCT00969176|pain|pain
5579754|NCT00969176|fever|fever
5579755|NCT00969176|neonate|neonate
5579756|NCT00969176|preterm|preterm
5579757|NCT00969176|term|term
5579758|NCT00969176|newborn|newborn
5564569|NCT01029106|SUI|sui
5579759|NCT00969163|Biomarkers of Skin Androgenization|biomarkers of skin androgenization
5579760|NCT00969150|Major Depressive Disorder|major depressive disorder
5579761|NCT00969150|Depression|depression
5579762|NCT00969137|smoking, nicotine, cigarettes|smoking, nicotine, cigarettes
5579763|NCT00969124|colonoscopy|colonoscopy
5579764|NCT00969124|polyps|polyps
5579765|NCT00969124|adenomas|adenomas
5579766|NCT00969124|miss rates|miss rates
5579767|NCT00969111|Proton Radiation, Prostate Cancer|proton radiation, prostate cancer
5579768|NCT00969098|Histologically proven of Malignant pleural mesothelioma;|histologically proven of malignant pleural mesothelioma;
5579769|NCT00969098|Patients not candidate to radical surgery;|patients not candidate to radical surgery;
5579770|NCT00969098|Candidate to first-line pemetrexed-based chemotherapy;|candidate to first-line pemetrexed-based chemotherapy;
5579771|NCT00969085|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5579772|NCT00969085|Skin|skin
5579773|NCT00969085|Mycosis fungoides|mycosis fungoides
5579774|NCT00969085|MF|mf
5579775|NCT00969085|Sézary syndrome|sézary syndrome
5579776|NCT00969085|SS|ss
5579777|NCT00969085|Curcumin|curcumin
5579778|NCT00969085|Turmeric|turmeric
5579779|NCT00969072|GI198745|gi198745
5579780|NCT00969072|Long term extension study|long term extension study
5579781|NCT00969072|BPH|bph
5579782|NCT00969059|peripheral nerve injury|peripheral nerve injury
5579783|NCT00969059|p38 kinase inhibitor|p38 kinase inhibitor
5579784|NCT00969059|neuropathic pain|neuropathic pain
5579785|NCT00969046|Colon cancer|colon cancer
5579786|NCT00969046|MTD|mtd
5579788|NCT00969046|EPO906|epo906
5579789|NCT00969046|patupilone|patupilone
5579790|NCT00969020|Length of stay|length of stay
5579791|NCT00969020|Timed up and go|timed up and go
5579792|NCT00968994|Wound Healing|wound healing
5579794|NCT00968981|Hedgehog|hedgehog
5579795|NCT00968981|BCC|bcc
5579796|NCT00968981|basal cell carcinoma|basal cell carcinoma
5579896|NCT00968734|absorption by Vitamin D|absorption by vitamin d
5579897|NCT00968721|Inflammatory bowel disease|inflammatory bowel disease
5579797|NCT00968968|carcinoma, breast lump, Pagets disease, breast cancer positive for human epidermal growth factor receptor 2, breast cancer progression, estrogen-receptor|carcinoma, breast lump, pagets disease, breast cancer positive for human epidermal growth factor receptor 2, breast cancer progression, estrogen-receptor
5579798|NCT00968955|Postoperative acute pain|postoperative acute pain
5579799|NCT00968955|Total hip arthroplasty|total hip arthroplasty
5579800|NCT00968955|Local infiltration analgesia|local infiltration analgesia
5579801|NCT00968942|Lateral Canthal Lines|lateral canthal lines
5579802|NCT00968942|Crow's Feet|crow's feet
5579803|NCT00968942|Facial Wrinkles|facial wrinkles
5579804|NCT00968929|pulmonary embolism|pulmonary embolism
5579805|NCT00968929|thrombolysis|thrombolysis
5579807|NCT00968929|submassive|submassive
5579808|NCT00968929|recombinant streptokinase|recombinant streptokinase
5579809|NCT00968929|urokinase|urokinase
5579810|NCT00968903|Hip arthroplasty|hip arthroplasty
5579811|NCT00968903|Methylprednisolone|methylprednisolone
5579812|NCT00968903|Post-operative pain|post-operative pain
5579813|NCT00968890|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579814|NCT00968890|Influenza infection|influenza infection
5579815|NCT00968877|Renal Insufficiency|renal insufficiency
5579816|NCT00968877|Cholecalciferol|cholecalciferol
5579817|NCT00968877|Kidney Disease|kidney disease
5579818|NCT00968877|Kidney Failure|kidney failure
5579819|NCT00968877|Vitamin D|vitamin d
5579820|NCT00968877|Vitamin D Deficiency|vitamin d deficiency
5579821|NCT00968877|Vitamin D3|vitamin d3
5579822|NCT00968864|T cell depleted|t cell depleted
5579823|NCT00968864|Matched unrelated donors|matched unrelated donors
5579824|NCT00968864|Haplocompatible donors|haplocompatible donors
5579825|NCT00968851|Schizophrenia|schizophrenia
5579826|NCT00968851|Central nervous System Diseases|central nervous system diseases
5579827|NCT00968851|Cognition|cognition
5579828|NCT00968838|White Blood Cell Transfusion|white blood cell transfusion
5579829|NCT00968838|Radiated Cells|radiated cells
5579830|NCT00968838|Unradiated Cells|unradiated cells
5579831|NCT00968838|Leukocyte Transfusions|leukocyte transfusions
5579832|NCT00968838|Life-threatening Infections|life-threatening infections
5579833|NCT00968825|Lateral Canthal Lines|lateral canthal lines
5579834|NCT00968825|Crow's Feet|crow's feet
5579835|NCT00968825|Facial Wrinkles|facial wrinkles
5579836|NCT00968812|Diabetes|diabetes
5579837|NCT00968812|Metformin|metformin
5579838|NCT00968812|Glimepiride|glimepiride
5579839|NCT00968812|Hemoglobin A1c|hemoglobin a1c
5579840|NCT00968812|Type 2 diabetes mellitus|type 2 diabetes mellitus
5579841|NCT00968812|Canagliflozin|canagliflozin
5579842|NCT00968799|Ovarian Neoplasms|ovarian neoplasms
5579843|NCT00968799|Recurrence|recurrence
5579844|NCT00968799|Hyperthermia, Induced|hyperthermia, induced
5579845|NCT00968799|Peritoneal Neoplasms|peritoneal neoplasms
5579846|NCT00968799|recurrent epithelial ovarian cancer|recurrent epithelial ovarian cancer
5579847|NCT00968799|recurrent fallopian tube carcinoma|recurrent fallopian tube carcinoma
5579848|NCT00968786|hypertension|hypertension
5579849|NCT00968786|type 2 diabetes|type 2 diabetes
5579850|NCT00968786|home monitoring|home monitoring
5579852|NCT00968773|mesh|mesh
5579853|NCT00968773|hernia repair device|hernia repair device
5579854|NCT00968760|CD19+ lymphoid malignancies|cd19+ lymphoid malignancies
5579855|NCT00968760|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5579856|NCT00968760|NHL|nhl
5579857|NCT00968760|small lymphocytic lymphoma|small lymphocytic lymphoma
5579858|NCT00968760|SLL|sll
5579859|NCT00968760|follicular lymphoma|follicular lymphoma
5579860|NCT00968760|mantle cell lymphoma|mantle cell lymphoma
5579861|NCT00968760|gene cell transfer|gene cell transfer
5579862|NCT00968760|CD19-specific T cells|cd19-specific t cells
5579863|NCT00968760|Stem Cell Transplant|stem cell transplant
5579864|NCT00968760|T Cell Infusion|t cell infusion
5579865|NCT00968760|Chemotherapy|chemotherapy
5579866|NCT00968760|Leukapheresis|leukapheresis
5579867|NCT00968760|BCNU|bcnu
5579868|NCT00968760|carmustine|carmustine
5579869|NCT00968760|Cytarabine|cytarabine
5579870|NCT00968760|Etoposide|etoposide
5579871|NCT00968760|Interleukin-2|interleukin-2
5579872|NCT00968760|Proleukin|proleukin
5579873|NCT00968760|Melphalan|melphalan
5579874|NCT00968760|Rituximab|rituximab
5579875|NCT00968760|T cell therapy|t cell therapy
5579876|NCT00968747|Fasting|fasting
5579877|NCT00968747|Fast|fast
5579878|NCT00968747|healthy|healthy
5579879|NCT00968747|diet|diet
5579880|NCT00968747|study|study
5579881|NCT00968747|manipulation|manipulation
5579882|NCT00968747|dietary|dietary
5579883|NCT00968747|FGF21|fgf21
5579884|NCT00968747|Fibroblast growth factor|fibroblast growth factor
5579885|NCT00968747|PTRF|ptrf
5579886|NCT00968747|Polymerase 1 and transcript release factor|polymerase 1 and transcript release factor
5579887|NCT00968747|adipose|adipose
5579888|NCT00968747|fat|fat
5579889|NCT00968747|blood|blood
5579890|NCT00968747|inpatient|inpatient
5579891|NCT00968747|outpatient|outpatient
5579892|NCT00968747|NAFLD|nafld
5579893|NCT00968747|metabolism|metabolism
5579894|NCT00968734|Vitamin D|vitamin d
5579895|NCT00968734|colecalciferol|colecalciferol
5579898|NCT00968721|Crohn's disease|crohn's disease
5579899|NCT00968721|Ulcerative colitis|ulcerative colitis
5579900|NCT00968721|medication adherence|medication adherence
5579901|NCT00968721|Decisional influences|decisional influences
5579902|NCT00968708|Diabetes Mellitus - Type 2|diabetes mellitus - type 2
5579903|NCT00968708|Diabetes Mellitus|diabetes mellitus
5579904|NCT00968708|cardiovascular outcomes|cardiovascular outcomes
5579905|NCT00968708|heart attack|heart attack
5579906|NCT00968708|stroke|stroke
5579907|NCT00968708|dipeptidyl-peptidase IV inhibitors|dipeptidyl-peptidase iv inhibitors
5579908|NCT00968708|metabolic disorders|metabolic disorders
5579909|NCT00968708|metabolic diseases|metabolic diseases
5579910|NCT00968708|glucose metabolism disorders|glucose metabolism disorders
5579911|NCT00968682|cardiac toxicity|cardiac toxicity
5579912|NCT00968682|HER2-positive breast cancer|her2-positive breast cancer
5579913|NCT00968682|stage IA breast cancer|stage ia breast cancer
5579914|NCT00968682|stage IB breast cancer|stage ib breast cancer
5579915|NCT00968682|stage II breast cancer|stage ii breast cancer
5579916|NCT00968682|stage IIIA breast cancer|stage iiia breast cancer
5579917|NCT00968682|stage IIIB breast cancer|stage iiib breast cancer
5579918|NCT00968682|stage IIIC breast cancer|stage iiic breast cancer
5579919|NCT00968656|Breast cancer|breast cancer
5579920|NCT00968656|Head and Neck Cancer|head and neck cancer
5579921|NCT00968656|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5579922|NCT00968656|Cellular proliferation|cellular proliferation
5579923|NCT00968643|spinal cord compression|spinal cord compression
5579924|NCT00968643|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5579925|NCT00968617|Anemia|anemia
5579926|NCT00968604|Pancreatic Cancer|pancreatic cancer
5579927|NCT00968604|Pancreas|pancreas
5579928|NCT00968604|Liver|liver
5579929|NCT00968604|Liver Tumor Biopsy|liver tumor biopsy
5579930|NCT00968604|BikDD Nanoparticle|bikdd nanoparticle
5579931|NCT00968604|C-VISA BikDD|c-visa bikdd
5579932|NCT00968591|Hepatic insufficiency|hepatic insufficiency
5579933|NCT00968591|liver disease|liver disease
5579934|NCT00968591|cirrhosis|cirrhosis
5579935|NCT00968591|pharmacokinetics|pharmacokinetics
5579936|NCT00968578|Knee arthroplasty|knee arthroplasty
5579937|NCT00968578|Methylprednisolone|methylprednisolone
5579938|NCT00968578|Post-operative pain|post-operative pain
5579939|NCT00968565|Heart Defects, Congenital|heart defects, congenital
5579940|NCT00968565|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5579941|NCT00968565|Citric Acid|citric acid
5579942|NCT00968565|Heparin|heparin
5579943|NCT00968565|Respiratory Insufficiency|respiratory insufficiency
5579944|NCT00968552|Any Gastrointestinal problem that would require an endoscopically placed stent|any gastrointestinal problem that would require an endoscopically placed stent
5579945|NCT00968539|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579946|NCT00968539|influenza infection|influenza infection
5579947|NCT00968526|influenza infection|influenza infection
5579948|NCT00968526|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5579949|NCT00968513|Smoking Cessation, Inpatient Psychiatry, Stages of Change|smoking cessation, inpatient psychiatry, stages of change
5579950|NCT00968500|Grief|grief
5579951|NCT00968500|bereavement|bereavement
5579952|NCT00968500|questionnaires|questionnaires
5579953|NCT00968500|09-107|09-107
5579954|NCT00968487|Lyophilized Plasma|lyophilized plasma
5579955|NCT00968487|Fresh Frozen Plasma|fresh frozen plasma
5579956|NCT00968487|Hemorrhage|hemorrhage
5579957|NCT00968487|Coagulopathy|coagulopathy
5579958|NCT00968487|Autologous|autologous
5579959|NCT00968487|HemCon|hemcon
5579960|NCT00968487|Plasmapheresis|plasmapheresis
5579961|NCT00968487|Freeze Drying|freeze drying
5579962|NCT00968487|Transfusion|transfusion
5579963|NCT00968487|Resuscitation|resuscitation
5579964|NCT00968487|Safety of Lyophilized Plasma in Normal, Healthy Volunteers|safety of lyophilized plasma in normal, healthy volunteers
5579965|NCT00968461|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5579966|NCT00968461|CLL|cll
5579967|NCT00968461|PEITC|peitc
5579968|NCT00968461|Phenethyl Isothiocyanate|phenethyl isothiocyanate
5579969|NCT00968461|Fludarabine|fludarabine
5579970|NCT00968448|respiratory muscle|respiratory muscle
5579971|NCT00968448|breathing pattern|breathing pattern
5579972|NCT00968448|exercise performance|exercise performance
5579973|NCT00968435|bevacizumab|bevacizumab
5579974|NCT00968435|cisplatin|cisplatin
5579975|NCT00968435|cetuximab|cetuximab
5579976|NCT00968435|radiation therapy|radiation therapy
5579977|NCT00968435|Phase II|phase ii
5579978|NCT00968435|09-083|09-083
5579979|NCT00968422|Pharmacology|pharmacology
5579980|NCT00968422|Drug Safety|drug safety
5579981|NCT00968422|Phase 1 Clinical Trials|phase 1 clinical trials
5579982|NCT00968422|Pharmacokinetics|pharmacokinetics
5579983|NCT00968409|Breast Cancer|breast cancer
5579984|NCT00968409|Hormone Receptor|hormone receptor
5579985|NCT00968396|Myeloma|myeloma
5672107|NCT00613002|menopause|menopause
5579986|NCT00968396|Ex-Vivo Depletion of Myeloma Cells|ex-vivo depletion of myeloma cells
5579987|NCT00968396|Peripheral Blood Progenitor Cell Grafts|peripheral blood progenitor cell grafts
5579989|NCT00968396|Stem Cell Transplant|stem cell transplant
5579990|NCT00968396|Bone marrow stem cells|bone marrow stem cells
5580002|NCT00968370|severe malnutrition|severe malnutrition
5580003|NCT00968370|children|children
5580004|NCT00968370|day-care management|day-care management
5580005|NCT00968370|hospital management|hospital management
5580006|NCT00968357|SCV-07|scv-07
5580007|NCT00968357|relapsers|relapsers
5580008|NCT00968357|Hepatitis C|hepatitis c
5580009|NCT00968331|relapsed and refractory DLBCL|relapsed and refractory dlbcl
5580010|NCT00968318|Tissue expander|tissue expander
5580011|NCT00968318|seroma|seroma
5580012|NCT00968318|extrusion|extrusion
5580013|NCT00968318|lymphatics|lymphatics
5580014|NCT00968318|deep fascia|deep fascia
5580015|NCT00968318|Rate of seroma formation after excision of strip of deep fascia|rate of seroma formation after excision of strip of deep fascia
5580016|NCT00968305|African American children with stable asthma|african american children with stable asthma
5580017|NCT00968305|Asthma severity|asthma severity
5580018|NCT00968305|Interleukin 13 from PHA stimulated PBMC|interleukin 13 from pha stimulated pbmc
5580019|NCT00968305|Lung function (FEV1%)|lung function (fev1%)
5580020|NCT00968305|Total serum IgE|total serum ige
5580021|NCT00968305|Pediatrics|pediatrics
5580022|NCT00968292|K3 Promoter prosthetic foot Tensegrity Prosthetics Jerome Rifkin|k3 promoter prosthetic foot tensegrity prosthetics jerome rifkin
5580023|NCT00968279|Patients with atrial fibrillation|patients with atrial fibrillation
5580024|NCT00968266|Adherence|adherence
5580025|NCT00968266|Compliance|compliance
5580026|NCT00968266|Rheumatoid Arthritis|rheumatoid arthritis
5580027|NCT00968266|Intervention|intervention
5580028|NCT00968266|Beliefs about medication|beliefs about medication
5580029|NCT00968266|Motivational Interviewing|motivational interviewing
5580030|NCT00968266|Medication adherence|medication adherence
5580031|NCT00968266|Patient compliance|patient compliance
5580032|NCT00968266|Intervention studies|intervention studies
5580033|NCT00968253|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5580035|NCT00968253|Hyper-CVAD|hyper-cvad
5580036|NCT00968253|Everolimus|everolimus
5580037|NCT00968253|6-mercaptopurine|6-mercaptopurine
5580038|NCT00968253|Citrovorum|citrovorum
5580039|NCT00968253|Cyclophosphamide|cyclophosphamide
5580040|NCT00968253|Cytarabine|cytarabine
5580041|NCT00968253|Dexamethasone|dexamethasone
5580042|NCT00968253|Doxorubicin|doxorubicin
5580043|NCT00968253|G-CSF|g-csf
5580044|NCT00968253|Methotrexate|methotrexate
5580045|NCT00968253|MESNA|mesna
5580046|NCT00968253|Pegfilgrastim|pegfilgrastim
5580047|NCT00968253|Prednisone|prednisone
5580048|NCT00968253|RAD001|rad001
5580049|NCT00968253|Solumedrol|solumedrol
5580050|NCT00968253|Vincristine Sulfate|vincristine sulfate
5580051|NCT00968240|GBM|gbm
5580052|NCT00968240|AA|aa
5580053|NCT00968240|AO|ao
5580054|NCT00968240|Brain|brain
5580055|NCT00968240|Tumors|tumors
5580056|NCT00968240|Malignant|malignant
5580057|NCT00968240|Glioblastoma|glioblastoma
5580058|NCT00968240|Multiforme|multiforme
5580059|NCT00968240|Anaplastic|anaplastic
5580060|NCT00968240|Astrocytoma|astrocytoma
5580061|NCT00968227|subarachnoid hemorrhage|subarachnoid hemorrhage
5580062|NCT00968227|vasospasm|vasospasm
5580063|NCT00968227|transfusion|transfusion
5580064|NCT00968227|cerebral oxygen delivery|cerebral oxygen delivery
5580065|NCT00968227|hemoglobin|hemoglobin
5580074|NCT00968188|HIV Risk|hiv risk
5580075|NCT00968188|Internet Intervention|internet intervention
5580076|NCT00968188|Homosexuality, Male|homosexuality, male
5580077|NCT00968188|HIV Seronegativity|hiv seronegativity
5580078|NCT00968175|Ultrasound guided celiac plexus neurolysis|ultrasound guided celiac plexus neurolysis
5580079|NCT00968175|CPN|cpn
5580080|NCT00968175|Pancreatic Cancer|pancreatic cancer
5580081|NCT00968175|Pain Management|pain management
5580082|NCT00968162|Bone Marrow Transplant|bone marrow transplant
5580083|NCT00968162|Sickle Cell Disease|sickle cell disease
5580084|NCT00968136|refractory infantile spasms|refractory infantile spasms
5580085|NCT00968110|Milk Allergy|milk allergy
5580086|NCT00968097|Alzheimer' disease|alzheimer' disease
5580087|NCT00968097|SPECT imaging|spect imaging
5580088|NCT00968084|Diagnostic Work Up|diagnostic work up
5580089|NCT00968084|Normal Volunteers|normal volunteers
5580090|NCT00968084|HV|hv
5581117|NCT00964054|depression|depression
5580091|NCT00968084|Inflammatory Disease|inflammatory disease
5580092|NCT00968084|Autoimmune Disease|autoimmune disease
5580093|NCT00968084|Immunologic Disease|immunologic disease
5580094|NCT00968084|Healthy Volunteer|healthy volunteer
5580095|NCT00968071|Leukemia|leukemia
5580096|NCT00968071|AML|aml
5580097|NCT00968071|MDS|mds
5580098|NCT00968071|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5580099|NCT00968071|Decitabine|decitabine
5580100|NCT00968071|5-aza-2 deoxycytidine|5-aza-2 deoxycytidine
5580101|NCT00968071|Dacogen|dacogen
5580102|NCT00968071|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5580103|NCT00968071|Mylotarg|mylotarg
5580106|NCT00968058|Pediatric|pediatric
5580107|NCT00968058|Temporal Variation|temporal variation
5580108|NCT00968045|Fibrinogen|fibrinogen
5580109|NCT00968045|Postoperative bleeding|postoperative bleeding
5580110|NCT00968045|Transfusions|transfusions
5580111|NCT00968045|CABG|cabg
5580113|NCT00968032|Patent Foramen Ovale|patent foramen ovale
5580114|NCT00968006|diabetes|diabetes
5580115|NCT00968006|endothelium|endothelium
5580116|NCT00968006|stem cells|stem cells
5580117|NCT00967993|hyperphosphatemia|hyperphosphatemia
5580118|NCT00967993|end-stage renal disease|end-stage renal disease
5580119|NCT00967993|ESRD|esrd
5580120|NCT00967993|hemodialysis|hemodialysis
5580121|NCT00967993|diabetes|diabetes
5580122|NCT00967993|dialysis|dialysis
5580123|NCT00967980|pain|pain
5580124|NCT00967980|Hip Resurfacing|hip resurfacing
5580125|NCT00967980|catheter|catheter
5580126|NCT00967980|nerve block|nerve block
5580127|NCT00967980|UCSD|ucsd
5580128|NCT00967980|hip surgery|hip surgery
5580129|NCT00967980|psoas|psoas
5580130|NCT00967980|femoral|femoral
5580131|NCT00967980|ambulation|ambulation
5580132|NCT00967980|hip flexion|hip flexion
5580133|NCT00967980|infusion|infusion
5580134|NCT00967967|control|control
5580135|NCT00967967|symptoms|symptoms
5580136|NCT00967954|stage IIB prostate cancer|stage iib prostate cancer
5580137|NCT00967954|stage IIA prostate cancer|stage iia prostate cancer
5580138|NCT00967954|stage III prostate cancer|stage iii prostate cancer
5580139|NCT00967954|stage IV prostate cancer|stage iv prostate cancer
5580141|NCT00967928|Stage IV or Recurrent Cervical cancer|stage iv or recurrent cervical cancer
5580142|NCT00967915|Ankyloglossia|ankyloglossia
5580143|NCT00967915|Tongue tie|tongue tie
5580144|NCT00967915|Frenotomy|frenotomy
5580145|NCT00967915|Frenulectomy|frenulectomy
5580146|NCT00967915|Breast feeding|breast feeding
5580147|NCT00967915|HATLFF|hatlff
5580148|NCT00967915|IBFAT|ibfat
5580149|NCT00967902|intracoronary stent|intracoronary stent
5580150|NCT00967902|drug eluting stent|drug eluting stent
5580151|NCT00967902|sirolimus|sirolimus
5580152|NCT00967902|endothelial progenitor cells|endothelial progenitor cells
5580153|NCT00967889|stage III prostate cancer|stage iii prostate cancer
5580154|NCT00967889|stage IV prostate cancer|stage iv prostate cancer
5580155|NCT00967889|recurrent prostate cancer|recurrent prostate cancer
5580156|NCT00967876|Men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis|men or women of any ethnic group scheduled to undergo conventional coronary angiography for suspected coronary artery stent stenosis
5580157|NCT00967863|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5580158|NCT00967863|stage III prostate cancer|stage iii prostate cancer
5580159|NCT00967863|stage IV prostate cancer|stage iv prostate cancer
5580160|NCT00967850|High Myopia|high myopia
5580161|NCT00967850|Bevacizumab|bevacizumab
5580162|NCT00967850|Photodynamic therapy|photodynamic therapy
5580163|NCT00967837|Diabetes with complications|diabetes with complications
5580164|NCT00967837|Wound healing|wound healing
5580165|NCT00967824|breast cancer|breast cancer
5580166|NCT00967798|cystic fibrosis|cystic fibrosis
5580167|NCT00967798|diabetes|diabetes
5580168|NCT00967798|inflammation|inflammation
5736505|NCT00371020|PVR|pvr
5580169|NCT00967798|oxidative stress|oxidative stress
5580170|NCT00967798|redox balance|redox balance
5580171|NCT00967798|lung disease|lung disease
5580172|NCT00967785|Neutropenia|neutropenia
5580173|NCT00967785|Hypogammaglobulinemia|hypogammaglobulinemia
5580174|NCT00967785|Myelokathexis|myelokathexis
5580175|NCT00967785|Warts|warts
5580176|NCT00967785|Immunodeficiency|immunodeficiency
5580177|NCT00967772|Pharmacokinetics|pharmacokinetics
5580178|NCT00967772|Safety|safety
5580179|NCT00967772|tolerability|tolerability
5580180|NCT00967759|common cold|common cold
5580181|NCT00967759|treatment|treatment
5580182|NCT00967759|inflammatory symptoms of superior air passages affection|inflammatory symptoms of superior air passages affection
5580183|NCT00967694|Glaucoma|glaucoma
5580184|NCT00967694|Nitrous oxide|nitrous oxide
5580185|NCT00967668|Counseling|counseling
5580186|NCT00967668|Veterans|veterans
5580187|NCT00967668|Weight loss|weight loss
5580188|NCT00967668|Physical activity|physical activity
5580189|NCT00967668|Diet|diet
5580190|NCT00967655|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5581370|NCT00963313|Adalimumab|adalimumab
5580191|NCT00967655|stage I rectal cancer|stage i rectal cancer
5580192|NCT00967655|stage II rectal cancer|stage ii rectal cancer
5580193|NCT00967655|stage III rectal cancer|stage iii rectal cancer
5580194|NCT00967642|Patients with Diabetes Mellitus Submitted to Percutaneous Coronary Intervention with Stent|patients with diabetes mellitus submitted to percutaneous coronary intervention with stent
5580195|NCT00967629|Diabetic nephropathy|diabetic nephropathy
5580196|NCT00967629|CKD progression|ckd progression
5580197|NCT00967629|AGEs|ages
5580198|NCT00967629|oxidative stress|oxidative stress
5580199|NCT00967629|dietary AGEs|dietary ages
5580200|NCT00967616|metastatic|metastatic
5580201|NCT00967616|colon|colon
5580206|NCT00967603|stage IV pancreatic cancer|stage iv pancreatic cancer
5580207|NCT00967564|Myelodysplastic Syndrome|myelodysplastic syndrome
5580208|NCT00967564|Quality of Life|quality of life
5580209|NCT00967564|Anemia|anemia
5580210|NCT00967564|Epoetin alfa|epoetin alfa
5580211|NCT00967564|Eprex|eprex
5580212|NCT00967551|Diarrhea|diarrhea
5580213|NCT00967551|Pneumonia|pneumonia
5580214|NCT00967551|Upper respiratory infections|upper respiratory infections
5580215|NCT00967551|Acute gastroenteritis|acute gastroenteritis
5580216|NCT00967538|psoriasis|psoriasis
5580217|NCT00967538|etanercept|etanercept
5580218|NCT00967538|efficacy|efficacy
5580219|NCT00967538|response|response
5580220|NCT00967538|anti-TNF alpha|anti-tnf alpha
5580221|NCT00967538|treatment efficacy|treatment efficacy
5580223|NCT00967525|ALL|all
5580224|NCT00967525|leukemia|leukemia
5580225|NCT00967525|CML|cml
5580226|NCT00967525|Myelodysplastic Syndrome|myelodysplastic syndrome
5580227|NCT00967525|malignancies|malignancies
5580228|NCT00967525|Undifferentiated leukemia|undifferentiated leukemia
5580229|NCT00967525|High risk malignancies|high risk malignancies
5580230|NCT00967512|Oligonucleotides, Antisense|oligonucleotides, antisense
5580231|NCT00967512|Tumor Suppressor Protein p53|tumor suppressor protein p53
5580232|NCT00967512|idarubicin|idarubicin
5580233|NCT00967512|cytarabine|cytarabine
5580234|NCT00967499|PONV|ponv
5580235|NCT00967499|rescue|rescue
5580236|NCT00967473|Astigmatism|astigmatism
5580237|NCT00967473|cataract|cataract
5580238|NCT00967473|corneal astigmatism|corneal astigmatism
5580239|NCT00967473|IOL|iol
5580240|NCT00967473|AcrySof|acrysof
5580241|NCT00967460|Childhood obesity|childhood obesity
5580242|NCT00967460|Children|children
5580243|NCT00967460|Inactivity|inactivity
5580244|NCT00967460|Physical activity|physical activity
5580245|NCT00967460|Motor skills|motor skills
5580246|NCT00967460|Motor fitness|motor fitness
5580247|NCT00967460|Quality of life|quality of life
5580248|NCT00967460|Nutrition|nutrition
5580249|NCT00967460|Family|family
5580250|NCT00967434|infarction|infarction
5580251|NCT00967434|ischemia|ischemia
5580252|NCT00967434|surgery|surgery
5580253|NCT00967434|perioperative|perioperative
5580254|NCT00967434|statins|statins
5580255|NCT00967421|Driving|driving
5580256|NCT00967421|DUI|dui
5580257|NCT00967421|Driving simulation|driving simulation
5580258|NCT00967421|Drugs|drugs
5580259|NCT00967421|Ethanol|ethanol
5580260|NCT00967408|Stroke|stroke
5580261|NCT00967408|Antidepressive Agents,Second-Generation|antidepressive agents,second-generation
5580262|NCT00967408|Treatment Outcome|treatment outcome
5580263|NCT00967408|Rehabilitation|rehabilitation
5580264|NCT00967382|Pregnancy|pregnancy
5580265|NCT00967382|Thrombophilia|thrombophilia
5580266|NCT00967382|High-risk pregnancy|high-risk pregnancy
5580267|NCT00967382|LMWH prophylaxis|lmwh prophylaxis
5580268|NCT00967382|Placenta mediated pregnancy complications|placenta mediated pregnancy complications
5580269|NCT00967356|Healthy volunteers|healthy volunteers
5580270|NCT00967343|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5580271|NCT00967343|Graft-versus-host disease|graft-versus-host disease
5580272|NCT00967343|Immune reconstitution|immune reconstitution
5580273|NCT00967343|Alloreactive T-cells|alloreactive t-cells
5580274|NCT00967343|Photodepletion|photodepletion
5580275|NCT00967343|TH9402|th9402
5580276|NCT00967343|Transplant related mortality|transplant related mortality
5580277|NCT00967343|Hematologic malignancy|hematologic malignancy
5580278|NCT00967317|Auris-Sedina|auris-sedina
5580279|NCT00967317|Otitis|otitis
5580280|NCT00967317|Efficacy|efficacy
5580281|NCT00967317|Tolerability|tolerability
5580282|NCT00967304|Unprovoked Venous thromboembolism|unprovoked venous thromboembolism
5580283|NCT00967304|Clinical decision rule|clinical decision rule
5580284|NCT00967304|Anticoagulants|anticoagulants
5580285|NCT00967304|Recurrence|recurrence
5580286|NCT00967304|Prognostic|prognostic
5580287|NCT00967304|Risk stratification|risk stratification
5580288|NCT00967291|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
5580289|NCT00967291|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5580290|NCT00967291|stage IV pancreatic cancer|stage iv pancreatic cancer
5580291|NCT00967291|recurrent pancreatic cancer|recurrent pancreatic cancer
5580293|NCT00967278|pulmonary artery catheter|pulmonary artery catheter
5580294|NCT00967278|esophageal doppler|esophageal doppler
5580295|NCT00967278|hemodynamics|hemodynamics
5580296|NCT00967265|Introduction seminar|introduction seminar
5580297|NCT00967265|Psychoeducation|psychoeducation
5580298|NCT00967265|Waiting list|waiting list
5580299|NCT00967265|Patient participation|patient participation
5580300|NCT00967265|Mental disorders|mental disorders
5580301|NCT00967252|surgery|surgery
5580303|NCT00967252|infection|infection
5580304|NCT00967252|statins|statins
5580305|NCT00967239|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5580306|NCT00967239|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5580307|NCT00967239|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5580308|NCT00967239|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5580310|NCT00967200|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5580311|NCT00967200|adult diffuse astrocytoma|adult diffuse astrocytoma
5580312|NCT00967200|adult glioblastoma|adult glioblastoma
5580313|NCT00967200|adult giant cell glioblastoma|adult giant cell glioblastoma
5580314|NCT00967200|adult gliosarcoma|adult gliosarcoma
5580315|NCT00967200|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5580316|NCT00967200|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5580317|NCT00967200|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5580318|NCT00967200|adult brain stem glioma|adult brain stem glioma
5580319|NCT00967200|adult choroid plexus tumor|adult choroid plexus tumor
5580320|NCT00967200|adult craniopharyngioma|adult craniopharyngioma
5580321|NCT00967200|adult ependymoblastoma|adult ependymoblastoma
5580322|NCT00967200|adult medulloblastoma|adult medulloblastoma
5580323|NCT00967200|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5580324|NCT00967200|adult anaplastic ependymoma|adult anaplastic ependymoma
5580325|NCT00967200|adult ependymoma|adult ependymoma
5580326|NCT00967200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5580327|NCT00967200|adult subependymoma|adult subependymoma
5580328|NCT00967200|meningeal melanocytoma|meningeal melanocytoma
5580329|NCT00967200|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5580330|NCT00967200|adult grade I meningioma|adult grade i meningioma
5580331|NCT00967200|adult grade II meningioma|adult grade ii meningioma
5580332|NCT00967200|adult anaplastic meningioma|adult anaplastic meningioma
5580333|NCT00967200|adult papillary meningioma|adult papillary meningioma
5580334|NCT00967200|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5580335|NCT00967200|adult oligodendroglioma|adult oligodendroglioma
5580336|NCT00967200|adult pineoblastoma|adult pineoblastoma
5580337|NCT00967200|adult pineocytoma|adult pineocytoma
5580338|NCT00967200|adult mixed glioma|adult mixed glioma
5580339|NCT00967200|recurrent adult brain tumor|recurrent adult brain tumor
5580340|NCT00967161|knee replacement motion analysis|knee replacement motion analysis
5580341|NCT00967135|Thoracotomy|thoracotomy
5580342|NCT00967135|Neuropathic pain|neuropathic pain
5580343|NCT00967122|adjustment, hunger|adjustment, hunger
5580344|NCT00967122|Hunger/satiety changes before and after gastric band adjustment|hunger/satiety changes before and after gastric band adjustment
5580346|NCT00967109|Tissue oxygenation|tissue oxygenation
5580347|NCT00967109|Spine surgery|spine surgery
5580348|NCT00967096|rifaximin|rifaximin
5580349|NCT00967096|acute graft versus host disease|acute graft versus host disease
5580350|NCT00967096|bone marrow transplant|bone marrow transplant
5580351|NCT00967096|non-malignancy requiring BMT|non-malignancy requiring bmt
5580352|NCT00967083|Quality of Life|quality of life
5580353|NCT00967083|Questionnaires|questionnaires
5580354|NCT00967083|Interviews|interviews
5580355|NCT00967083|family members|family members
5580356|NCT00967083|care givers|care givers
5580357|NCT00967083|09-104|09-104
5580358|NCT00967057|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5580359|NCT00967057|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5580360|NCT00967044|Relapsed or Refractory Lymphoma|relapsed or refractory lymphoma
5580361|NCT00967044|Hodgkin's lymphoma|hodgkin's lymphoma
5580362|NCT00967044|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5580363|NCT00967044|NHL|nhl
5580364|NCT00967044|LBH589|lbh589
5580365|NCT00967044|Panobinostat|panobinostat
5580366|NCT00967044|RAD001|rad001
5580367|NCT00967044|Everolimus|everolimus
5580368|NCT00967031|HER2-positive breast cancer|her2-positive breast cancer
5580369|NCT00967031|male breast cancer|male breast cancer
5580370|NCT00967031|stage IV breast cancer|stage iv breast cancer
5580371|NCT00967031|tumors metastatic to brain|tumors metastatic to brain
5580372|NCT00967018|Safety parameters|safety parameters
5580373|NCT00967018|ECG, blood and urine samples|ecg, blood and urine samples
5580374|NCT00967018|general health state|general health state
5580375|NCT00967005|N acetyl cysteine|n acetyl cysteine
5580376|NCT00967005|Pathological gambling|pathological gambling
5580377|NCT00967005|Nicotine dependence|nicotine dependence
5580378|NCT00966992|Uterine Cervical Cancer|uterine cervical cancer
5580379|NCT00966992|Cancer of Cervix|cancer of cervix
5580380|NCT00966992|Cervix Cancer|cervix cancer
5580381|NCT00966979|Osteoarthritis, Post-traumatic arthritis|osteoarthritis, post-traumatic arthritis
5580382|NCT00966966|Alzheimer Disease|alzheimer disease
5580383|NCT00966940|Glaucoma|glaucoma
5580384|NCT00966940|IOP|iop
5580385|NCT00966940|Travoprost|travoprost
5580386|NCT00966927|quality of life|quality of life
5580387|NCT00966927|functional independence|functional independence
5580388|NCT00966927|spina bifid|spina bifid
5574419|NCT00989807|EAP|eap
5580390|NCT00966875|rheumatoid arthritis|rheumatoid arthritis
5580391|NCT00966875|RA|ra
5580392|NCT00966849|Randomized Controlled Trial|randomized controlled trial
5580393|NCT00966849|Financial Support|financial support
5580394|NCT00966849|Poverty|poverty
5580395|NCT00966849|Child, Orphaned|child, orphaned
5580396|NCT00966849|HIV|hiv
5580397|NCT00966836|Heart Transplantation|heart transplantation
5580398|NCT00966836|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5580399|NCT00966836|Cytomegalovirus Infection|cytomegalovirus infection
5580400|NCT00966836|Everolimus|everolimus
5580401|NCT00966836|Valganciclovir|valganciclovir
5580402|NCT00966836|Mycophenolate|mycophenolate
5580403|NCT00966823|Diaphragm|diaphragm
5580404|NCT00966823|Trachea|trachea
5580405|NCT00966823|Lung development|lung development
5580406|NCT00966823|Lung growth|lung growth
5580407|NCT00966823|Tracheal occlusion|tracheal occlusion
5580408|NCT00966823|ECMO|ecmo
5580409|NCT00966823|Neonatal death|neonatal death
5580410|NCT00966810|chronic myelocytic leukemia|chronic myelocytic leukemia
5580411|NCT00966810|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5580412|NCT00966810|T cell depletion|t cell depletion
5580413|NCT00966810|donor lymphocyte infusion|donor lymphocyte infusion
5580414|NCT00966810|GvHD|gvhd
5580415|NCT00966810|transplant related mortality|transplant related mortality
5580416|NCT00966771|contraception|contraception
5580417|NCT00966771|emergency contraception|emergency contraception
5580418|NCT00966771|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
5580419|NCT00966745|surgical field condition|surgical field condition
5580420|NCT00966719|Jaundice|jaundice
5580421|NCT00966719|Breastfeeding|breastfeeding
5580422|NCT00966719|Infants|infants
5580423|NCT00966706|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5580424|NCT00966706|stage III pancreatic cancer|stage iii pancreatic cancer
5580425|NCT00966706|stage IV pancreatic cancer|stage iv pancreatic cancer
5580426|NCT00966680|general anesthesia|general anesthesia
5580427|NCT00966680|spinal anesthesia|spinal anesthesia
5580428|NCT00966680|emergency cesarean delivery|emergency cesarean delivery
5580429|NCT00966667|cancer survivor|cancer survivor
5580430|NCT00966667|stage I colon cancer|stage i colon cancer
5580431|NCT00966667|stage II colon cancer|stage ii colon cancer
5580432|NCT00966667|stage III colon cancer|stage iii colon cancer
5580433|NCT00966667|stage I rectal cancer|stage i rectal cancer
5580434|NCT00966667|stage II rectal cancer|stage ii rectal cancer
5580435|NCT00966667|stage III rectal cancer|stage iii rectal cancer
5580436|NCT00966654|CABG|cabg
5580437|NCT00966654|Cardiac Surgical Patient|cardiac surgical patient
5580438|NCT00966628|pediatric|pediatric
5580439|NCT00966628|dengue|dengue
5580440|NCT00966628|hypertonic sodium lactate|hypertonic sodium lactate
5580441|NCT00966628|fluid resuscitation|fluid resuscitation
5580442|NCT00966628|Ringer's lactate|ringer's lactate
5580443|NCT00966615|malnutrition|malnutrition
5580444|NCT00966615|fluid status|fluid status
5580445|NCT00966615|survival|survival
5580446|NCT00966589|groin pain|groin pain
5580447|NCT00966589|sportsman hernia|sportsman hernia
5580448|NCT00966589|osteitis pubis|osteitis pubis
5580449|NCT00966589|laparoscopic surgery|laparoscopic surgery
5580450|NCT00966576|Glaucoma|glaucoma
5580451|NCT00966576|IOP|iop
5580452|NCT00966576|AZARGA|azarga
5580453|NCT00966563|Mangafodipir|mangafodipir
5580454|NCT00966563|Primary Percutaneous Coronary Intervention|primary percutaneous coronary intervention
5580455|NCT00966563|Myocardial infarction|myocardial infarction
5580456|NCT00966563|Troponin|troponin
5580457|NCT00966563|CK-MB|ck-mb
5580458|NCT00966563|Magnetic Resonance Imaging|magnetic resonance imaging
5580459|NCT00966550|Tomato|tomato
5580460|NCT00966550|Nutrition|nutrition
5580461|NCT00966537|to study the clinical application of 3D/4D ultrasound for fetal scanning|to study the clinical application of 3d/4d ultrasound for fetal scanning
5580462|NCT00966537|to study the clinical application of 3D/4D ultrasound for pelvic scanning;|to study the clinical application of 3d/4d ultrasound for pelvic scanning;
5580463|NCT00966537|to demonstrate how to optimally display the different organs.|to demonstrate how to optimally display the different organs.
5580464|NCT00966537|to correlate our findings with other diagnostic tools like MRI, CT;|to correlate our findings with other diagnostic tools like mri, ct;
5580465|NCT00966537|to correlate our findings with clinical outcome.|to correlate our findings with clinical outcome.
5580466|NCT00966524|Endotracheal intubation|endotracheal intubation
5580467|NCT00966511|lung cancer|lung cancer
5580468|NCT00966511|lung resection|lung resection
5580469|NCT00966511|lobectomy|lobectomy
5580470|NCT00966511|pneumonectomy|pneumonectomy
5580471|NCT00966511|lung function|lung function
5580472|NCT00966511|perfusion|perfusion
5580473|NCT00966498|malignancy|malignancy
5580474|NCT00966498|solid tumor|solid tumor
5580477|NCT00966485|ASA resistance|asa resistance
5580478|NCT00966485|coronary stenting|coronary stenting
5580479|NCT00966485|platelet function|platelet function
5580480|NCT00966485|laboratory ASA resistance|laboratory asa resistance
5580482|NCT00966485|Positive SPECT|positive spect
5580483|NCT00966472|Rosuvastatin|rosuvastatin
5580485|NCT00966472|Squamous Cell Carcinoma|squamous cell carcinoma
5580486|NCT00966472|Nom-Small Cell Lung Cancer|nom-small cell lung cancer
5580487|NCT00966459|COPD|copd
5580488|NCT00966446|MRSA; household; infection; colonization|mrsa; household; infection; colonization
5580489|NCT00966433|Proseal™ LMA|proseal™ lma
5580490|NCT00966433|children|children
5580491|NCT00966433|ventilation|ventilation
5580492|NCT00966433|general anesthesia|general anesthesia
5580493|NCT00966433|Children under general anesthesia for outpatient surgery|children under general anesthesia for outpatient surgery
5580494|NCT00966407|Metabolic Syndrome|metabolic syndrome
5580495|NCT00966407|Obesity|obesity
5580496|NCT00966407|Genetic risk markers|genetic risk markers
5580497|NCT00966407|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5580498|NCT00966407|Young adults|young adults
5580499|NCT00966407|Fitness testing|fitness testing
5580500|NCT00966394|ADHD, saliva, caries|adhd, saliva, caries
5580501|NCT00966381|breastfeeding|breastfeeding
5580502|NCT00966381|bone mineral density|bone mineral density
5580503|NCT00966381|exercise|exercise
5580504|NCT00966381|diet|diet
5580505|NCT00966355|Cirrhosis, Esophagus Disorders, Varicose Veins|cirrhosis, esophagus disorders, varicose veins
5580506|NCT00966342|vaccine|vaccine
5580507|NCT00966342|influenza|influenza
5580508|NCT00966342|influenza vaccine|influenza vaccine
5580509|NCT00966342|pandemic preparedness|pandemic preparedness
5580510|NCT00966329|Switching|switching
5580511|NCT00966329|Maraviroc|maraviroc
5580512|NCT00966329|Virological efficacy|virological efficacy
5580513|NCT00966329|Lipid profile|lipid profile
5580514|NCT00966329|Tropism|tropism
5580515|NCT00966316|Acute Ischemic Stroke；clinical pathway;TCM；|acute ischemic stroke；clinical pathway;tcm；
5580516|NCT00966303|rehabilitation|rehabilitation
5580517|NCT00966303|dyspnea|dyspnea
5580518|NCT00966303|strength|strength
5580519|NCT00966290|anticoagulants|anticoagulants
5580520|NCT00966290|management|management
5580521|NCT00966290|anticoagulation clinics|anticoagulation clinics
5580522|NCT00966290|randomized comparison|randomized comparison
5580523|NCT00966277|Pancreas|pancreas
5580524|NCT00966277|Primary venous thromboembolism|primary venous thromboembolism
5580525|NCT00966277|VTE|vte
5580526|NCT00966277|Chemotherapy|chemotherapy
5580527|NCT00966277|Deep venous thrombosis|deep venous thrombosis
5580528|NCT00966277|Pulmonary embolism|pulmonary embolism
5580529|NCT00966277|Dalteparin|dalteparin
5580530|NCT00966277|Fragmin|fragmin
5580531|NCT00966277|Thromboprophylaxis|thromboprophylaxis
5580532|NCT00966264|randomized controlled trial|randomized controlled trial
5580533|NCT00966264|menorrhagia|menorrhagia
5580534|NCT00966264|LNG-IUS|lng-ius
5580535|NCT00966264|hysterectomy|hysterectomy
5580536|NCT00966251|Primary Hepatocellular Carcinoma|primary hepatocellular carcinoma
5580537|NCT00966238|influenza|influenza
5580538|NCT00966238|vaccine|vaccine
5580539|NCT00966199|blood pressure|blood pressure
5580540|NCT00966199|aging|aging
5580541|NCT00966199|cerebrovascular circulation|cerebrovascular circulation
5580542|NCT00966199|hypertension|hypertension
5580543|NCT00966186|ProSeal Laryngeal Mask Airway|proseal laryngeal mask airway
5580544|NCT00966186|Rotational technique|rotational technique
5580545|NCT00966186|Success rate|success rate
5580546|NCT00966186|Postoperative complications|postoperative complications
5580548|NCT00966134|mountain medicine|mountain medicine
5580549|NCT00966134|ghrelin|ghrelin
5580550|NCT00966134|growth hormone|growth hormone
5580551|NCT00966134|hypoxia|hypoxia
5580552|NCT00966134|physiology of hormonal adaptation to high altitude|physiology of hormonal adaptation to high altitude
5580553|NCT00966121|Cirrhosis|cirrhosis
5580554|NCT00966121|Esophagus Disorders|esophagus disorders
5580555|NCT00966121|Varicose Veins|varicose veins
5580556|NCT00966095|prostate cancer|prostate cancer
5580557|NCT00966082|Cirrhosis|cirrhosis
5580558|NCT00966082|Esophagus Disorders|esophagus disorders
5580559|NCT00966082|Varicose Veins|varicose veins
5580560|NCT00966069|Respiratory tract infections|respiratory tract infections
5580561|NCT00966069|Viral infections|viral infections
5580562|NCT00966069|Pediatrics|pediatrics
5580563|NCT00966069|Specimen collection|specimen collection
5580564|NCT00966056|Nasal adhesions|nasal adhesions
5580565|NCT00966056|Nasal synechiae|nasal synechiae
5580566|NCT00966056|Mitomycin|mitomycin
5580567|NCT00966056|Mitomycin c|mitomycin c
5580568|NCT00966056|Teflon|teflon
5580569|NCT00966056|Splints|splints
5580570|NCT00966056|Septal splints|septal splints
5580571|NCT00966017|PET Scan|pet scan
5580572|NCT00966004|Urge incontinence|urge incontinence
5580573|NCT00966004|YM178|ym178
5580574|NCT00966004|Overactive Bladder|overactive bladder
5580575|NCT00966004|Urgency|urgency
5580576|NCT00966004|Urinary incontinence|urinary incontinence
5580577|NCT00966004|mirabegron|mirabegron
5580578|NCT00966004|Micturition|micturition
5580579|NCT00965991|Gestational diabetes|gestational diabetes
5580580|NCT00965991|Metformin|metformin
5580581|NCT00965991|Glyburide|glyburide
5580582|NCT00965991|oral agents|oral agents
5580583|NCT00965978|ONO-5920|ono-5920
5580584|NCT00965978|YM529|ym529
5580585|NCT00965978|Minodronic Acid|minodronic acid
5580591|NCT00965965|comprehension|comprehension
5580592|NCT00965965|mass screening|mass screening
5580593|NCT00965965|prevention and control|prevention and control
5580594|NCT00965926|Overactive Bladder|overactive bladder
5580595|NCT00965926|Urinary incontinence|urinary incontinence
5580596|NCT00965926|YM178|ym178
5580597|NCT00965926|mirabegron|mirabegron
5580598|NCT00965900|Cirrhosis|cirrhosis
5580599|NCT00965900|Esophagus Disorders|esophagus disorders
5580600|NCT00965900|Varicose Veins|varicose veins
5580601|NCT00965874|Rapid Atrial Fibrillation|rapid atrial fibrillation
5580602|NCT00965874|Magnesium Sulfate|magnesium sulfate
5580603|NCT00965874|Cardiac arrhythmia|cardiac arrhythmia
5580604|NCT00965861|Tissue Registry|tissue registry
5580605|NCT00965861|Tissue Collection|tissue collection
5580606|NCT00965861|Unknown Primary|unknown primary
5580608|NCT00965861|Lung|lung
5580609|NCT00965861|Gastrointestinal|gastrointestinal
5580610|NCT00965861|Bone Marrow Transplant|bone marrow transplant
5580611|NCT00965861|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5580612|NCT00965861|Central Nervous System|central nervous system
5580613|NCT00965861|Head and Neck|head and neck
5580614|NCT00965861|Melanoma|melanoma
5580615|NCT00965861|Myelodysplastic syndrome|myelodysplastic syndrome
5580616|NCT00965861|Multiple Myeloma|multiple myeloma
5580617|NCT00965861|Lymphoma|lymphoma
5580618|NCT00965861|Gynecologic|gynecologic
5580619|NCT00965861|Genitourinary|genitourinary
5580620|NCT00965861|Refractory Malignancy|refractory malignancy
5580621|NCT00965848|Pneumonia, Ventilator-Associated|pneumonia, ventilator-associated
5580622|NCT00965848|Intra-abdominal Infections|intra-abdominal infections
5580623|NCT00965848|Urinary tract Infections|urinary tract infections
5580624|NCT00965848|Doripenem|doripenem
5580625|NCT00965848|Doribax|doribax
5580626|NCT00965835|PET Scan|pet scan
5580627|NCT00965822|URTI|urti
5580628|NCT00965822|Natural Health Products|natural health products
5580629|NCT00965796|Intravenous lidocaine|intravenous lidocaine
5580630|NCT00965796|postoperative analgesia|postoperative analgesia
5580631|NCT00965783|Sleep, Apnea, OSA, obese, middle-aged|sleep, apnea, osa, obese, middle-aged
5580632|NCT00965770|abortion|abortion
5580633|NCT00965770|intrauterine device|intrauterine device
5580634|NCT00965770|cost-effectiveness|cost-effectiveness
5580635|NCT00965744|Ligasure vessel sealing system|ligasure vessel sealing system
5580636|NCT00965744|Azygoportal Disconnection|azygoportal disconnection
5580637|NCT00965744|Splenectomy|splenectomy
5580638|NCT00965744|Portal hypertension|portal hypertension
5580639|NCT00965731|Lung Neoplasms|lung neoplasms
5580640|NCT00965731|Crizotinib|crizotinib
5580641|NCT00965718|advanced pancreatic cancer|advanced pancreatic cancer
5580642|NCT00965705|Binge Eating Disorder|binge eating disorder
5580643|NCT00965705|overeating|overeating
5580644|NCT00965705|binge eating|binge eating
5580645|NCT00965705|women|women
5580646|NCT00965705|overweight|overweight
5580647|NCT00965705|compulsive overeating|compulsive overeating
5580648|NCT00965679|Cardiac CT|cardiac ct
5580649|NCT00965679|Iodinated Radiocontrast|iodinated radiocontrast
5580650|NCT00965679|Ionizing Radiation|ionizing radiation
5580651|NCT00965679|Aortic Valve Stenosis|aortic valve stenosis
5580652|NCT00965679|Percutaneous Aortic Valve Replacement|percutaneous aortic valve replacement
5580653|NCT00965679|Heart Valve|heart valve
5580654|NCT00965666|Fanconi Anemia|fanconi anemia
5580655|NCT00965666|Hemic and Lymphatic Diseases|hemic and lymphatic diseases
5580656|NCT00965666|Anti-Rheumatic Agents|anti-rheumatic agents
5580657|NCT00965666|Anemia, Hypoplastic, Congenital|anemia, hypoplastic, congenital
5580658|NCT00965666|DNA Repair-Deficiency Disorders|dna repair-deficiency disorders
5580659|NCT00965666|Congenital, Hereditary, and|congenital, hereditary, and
5580660|NCT00965666|Neonatal Diseases and Abnormalities|neonatal diseases and abnormalities
5580661|NCT00965640|male pattern baldness|male pattern baldness
5580662|NCT00965640|androgenetic alopecia|androgenetic alopecia
5580663|NCT00965640|hair loss|hair loss
5580664|NCT00965614|diagnose cardiac arrhythmia and CAD.|diagnose cardiac arrhythmia and cad.
5580665|NCT00965614|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and CAD.|we'll try to establish the specific model to detect and diagnose cardiac arrhythmia and cad.
5580666|NCT00965601|Fibromyalgia|fibromyalgia
5580667|NCT00965588|Alzheimer's disease|alzheimer's disease
5580668|NCT00965588|amyloid beta|amyloid beta
5580669|NCT00965588|vaccine|vaccine
5580670|NCT00965575|epilepsy|epilepsy
5580671|NCT00965575|sleep|sleep
5580672|NCT00965575|seizures|seizures
5580673|NCT00965575|cognition|cognition
5580674|NCT00965562|Premenstrual syndrome|premenstrual syndrome
5580676|NCT00965562|calcium|calcium
5580677|NCT00965536|Schizophrenia|schizophrenia
5574710|NCT00988559|pre-cancerous|pre-cancerous
5580683|NCT00965536|Seroquel|seroquel
5580684|NCT00965536|Seroquel Prolong|seroquel prolong
5580685|NCT00965536|Seroquel XR|seroquel xr
5580686|NCT00965536|In-patient|in-patient
5580687|NCT00965523|Cancer|cancer
5580688|NCT00965523|breast cancer|breast cancer
5580689|NCT00965523|neoplasm|neoplasm
5580690|NCT00965523|E7389|e7389
5580691|NCT00965523|Eribulin|eribulin
5580692|NCT00965510|diabetes|diabetes
5580693|NCT00965497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5580695|NCT00965497|Multiple Sclerosis|multiple sclerosis
5580696|NCT00965497|MS|ms
5580697|NCT00965497|Major Depression|major depression
5580698|NCT00965497|Depression|depression
5580699|NCT00965497|Major Depressive Disorder|major depressive disorder
5580700|NCT00965497|antidepressants|antidepressants
5580701|NCT00965497|Escitalopram|escitalopram
5580702|NCT00965497|Lexapro|lexapro
5580703|NCT00965484|Genotropin Medical device Patient reported outcome|genotropin medical device patient reported outcome
5580704|NCT00965471|percutaneous coronary artery intervention|percutaneous coronary artery intervention
5580705|NCT00965471|coronary artery bypass graft|coronary artery bypass graft
5580706|NCT00965471|acute coronary syndrome|acute coronary syndrome
5580707|NCT00965458|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
5580708|NCT00965458|New-onset T1DM|new-onset t1dm
5580709|NCT00965458|New-onset T1D|new-onset t1d
5580710|NCT00965458|Alefacept|alefacept
5580711|NCT00965458|Amevive®|amevive®
5580712|NCT00965445|isoprostanes|isoprostanes
5580713|NCT00965445|mass spectrometry|mass spectrometry
5580714|NCT00965406|acute coronary syndrome|acute coronary syndrome
5580715|NCT00965406|glucose insulin potassium|glucose insulin potassium
5580716|NCT00965393|Ischaemia reperfusion|ischaemia reperfusion
5580717|NCT00965393|Platelet activation|platelet activation
5580718|NCT00965393|Endothelial function|endothelial function
5580719|NCT00965393|Remote ischaemic preconditioning|remote ischaemic preconditioning
5580720|NCT00965393|Bradykinin|bradykinin
5580721|NCT00965380|Trinity Evolution|trinity evolution
5580722|NCT00965380|Symptomatic lumbar degenerative disc disease|symptomatic lumbar degenerative disc disease
5580723|NCT00965380|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5580724|NCT00965380|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
5580725|NCT00965367|POV tonsillectomy adenoidectomy acupuncture acupressure child|pov tonsillectomy adenoidectomy acupuncture acupressure child
5580726|NCT00965367|Effectiveness of acupuncture on|effectiveness of acupuncture on
5580727|NCT00965354|severe|severe
5580728|NCT00965354|acute|acute
5580729|NCT00965354|influenza|influenza
5580730|NCT00965354|consortium|consortium
5580731|NCT00965354|swine|swine
5580732|NCT00965354|flu|flu
5580733|NCT00965354|influenza A|influenza a
5580734|NCT00965354|H1N1|h1n1
5580735|NCT00965354|hospital|hospital
5580736|NCT00965354|admission|admission
5580737|NCT00965341|Cancer|cancer
5580738|NCT00965341|Fatigue|fatigue
5580739|NCT00965341|Testosterone Replacement Therapy|testosterone replacement therapy
5580740|NCT00965341|Depo-Testosterone|depo-testosterone
5580741|NCT00965341|Testosterone cypionate|testosterone cypionate
5565504|NCT01025024|SNP|snp
5580742|NCT00965341|Testosterone enanthate|testosterone enanthate
5580743|NCT00965341|Hypogonadic|hypogonadic
5580744|NCT00965341|Functional Assessment of Cancer Therapy-Fatigue subscale|functional assessment of cancer therapy-fatigue subscale
5580745|NCT00965341|FACIT-F|facit-f
5580746|NCT00965328|anticoagulation|anticoagulation
5580747|NCT00965328|hemofiltration|hemofiltration
5580748|NCT00965328|acute kidney injury|acute kidney injury
5580749|NCT00965328|heparin|heparin
5580750|NCT00965328|hemostasis|hemostasis
5580751|NCT00965328|nadroparin|nadroparin
5580752|NCT00965328|anti-Xa|anti-xa
5580753|NCT00965328|endogenous thrombin potential|endogenous thrombin potential
5580754|NCT00965315|CV (cardiovascular)|cv (cardiovascular)
5580755|NCT00965315|MI (myocardial infarction)|mi (myocardial infarction)
5580756|NCT00965315|fenofibrate|fenofibrate
5580757|NCT00965315|rosuvastatin|rosuvastatin
5580758|NCT00965315|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time|this trial is to test the hypothesis that the addition of fenofibrate on rosuvastatin would provide a further reduction in the time
5580759|NCT00965302|Obesity|obesity
5580760|NCT00965302|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5580761|NCT00965302|Sleeve gastrectomy|sleeve gastrectomy
5580762|NCT00965302|Metabolic surgery|metabolic surgery
5580763|NCT00965289|Aggressive large B-cell lymphoma (DLBCL)|aggressive large b-cell lymphoma (dlbcl)
5580764|NCT00965289|Intensive chemotherapy|intensive chemotherapy
5580765|NCT00965289|Rituximab|rituximab
5580766|NCT00965289|ASCT|asct
5580767|NCT00965276|Adjuvant Therapy|adjuvant therapy
5580769|NCT00965276|Chemoresistance|chemoresistance
5580770|NCT00965276|Serine/Threonine Kinase|serine/threonine kinase
5580771|NCT00965276|Cell Survival|cell survival
5580772|NCT00965276|Breast Cancer|breast cancer
5580774|NCT00965263|immunotherapy|immunotherapy
5580775|NCT00965263|vaccination|vaccination
5580776|NCT00965263|antibody|antibody
5580777|NCT00965263|addiction|addiction
5580778|NCT00965263|dependence|dependence
5580779|NCT00965250|Thymic Malignancies|thymic malignancies
5580780|NCT00965250|IMC-A12|imc-a12
5580781|NCT00965250|Insulin-Like Growth Factor|insulin-like growth factor
5580782|NCT00965224|AML (acute myeloid leukemia)|aml (acute myeloid leukemia)
5580783|NCT00965224|CML (chronic myeloid leukemia)|cml (chronic myeloid leukemia)
5580784|NCT00965224|MM (multiple myeloma)|mm (multiple myeloma)
5798738|NCT00111215|Von Willebrand's Disease|von willebrand's disease
5580785|NCT00965211|Tourette's, OCD, dTMS, YGTSS, YBOCS, supplementary motor cortex|tourette's, ocd, dtms, ygtss, ybocs, supplementary motor cortex
5580786|NCT00965211|Tourette's syndrome and Obsessive compulsive disorder|tourette's syndrome and obsessive compulsive disorder
5580787|NCT00965198|Catheters, Indwelling|catheters, indwelling
5580788|NCT00965198|Biofilms|biofilms
5580789|NCT00965185|Cardiovascular Disease|cardiovascular disease
5580791|NCT00965185|Atherosclerosis|atherosclerosis
5580792|NCT00965185|Inflammation|inflammation
5580793|NCT00965185|Statins|statins
5580794|NCT00965185|treatment experienced|treatment experienced
5580795|NCT00965172|Cancer|cancer
5580796|NCT00965172|Mucositis|mucositis
5580797|NCT00965172|Chemotherapy|chemotherapy
5580798|NCT00965172|Caphosol|caphosol
5580799|NCT00965172|Calcium phosphate|calcium phosphate
5580800|NCT00965172|Sodium Bicarbonate|sodium bicarbonate
5580801|NCT00965172|Baking Soda Solution|baking soda solution
5580802|NCT00965172|Multi-cycle chemotherapy|multi-cycle chemotherapy
5580803|NCT00965146|Osteoarthritis, traumatic arthritis, avascular necrosis|osteoarthritis, traumatic arthritis, avascular necrosis
5580804|NCT00965120|Ischaemia reperfusion|ischaemia reperfusion
5580805|NCT00965120|Bradykinin|bradykinin
5580806|NCT00965120|Platelet activation|platelet activation
5580807|NCT00965120|Endothelial function|endothelial function
5580808|NCT00965068|Autism|autism
5580809|NCT00965068|Autism Spectrum Disorder|autism spectrum disorder
5580810|NCT00965068|Cholesterol|cholesterol
5580811|NCT00965068|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5580812|NCT00965068|ASD|asd
5580813|NCT00965068|Pervasive Developmental Disorder|pervasive developmental disorder
5580814|NCT00965068|PPD-NOS|ppd-nos
5580815|NCT00965042|Ceftobiprole|ceftobiprole
5580816|NCT00965042|ZEVTERA|zevtera
5580817|NCT00965042|ZEFTERA|zeftera
5580818|NCT00965042|Intestinal Microflora|intestinal microflora
5580819|NCT00965029|COPD|copd
5580820|NCT00965029|Spirometry|spirometry
5580821|NCT00965029|Weaning|weaning
5580822|NCT00965016|Extracorporeal membrane oxygenation，induced hypothermia|extracorporeal membrane oxygenation，induced hypothermia
5580823|NCT00964990|Moderate to severe chronic peripheral neuropathic pain|moderate to severe chronic peripheral neuropathic pain
5580824|NCT00964990|Postherpetic neuralgia|postherpetic neuralgia
5580825|NCT00964990|Post-traumatic neuralgia|post-traumatic neuralgia
5580826|NCT00964990|Moderate to severe chronic pain|moderate to severe chronic pain
5580827|NCT00964990|JNJ-42160443|jnj-42160443
5580828|NCT00964977|pN1|pn1
5580829|NCT00964977|head and neck cancer|head and neck cancer
5580830|NCT00964977|radiation|radiation
5580831|NCT00964977|prognosis|prognosis
5580832|NCT00964977|comprehensive cohort design|comprehensive cohort design
5580833|NCT00964951|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5580834|NCT00964938|Hemodynamic response|hemodynamic response
5580835|NCT00964938|Cardiac resynchronization therapy|cardiac resynchronization therapy
5580836|NCT00964886|chronic pain|chronic pain
5580837|NCT00964886|back pain|back pain
5580838|NCT00964886|antidepressants|antidepressants
5580839|NCT00964873|Synta|synta
5580840|NCT00964873|STA-9090|sta-9090
5580841|NCT00964873|ganetespib|ganetespib
5580842|NCT00964873|Hematologic Cancers|hematologic cancers
5580843|NCT00964873|Acute Myeloid Leukemia|acute myeloid leukemia
5580844|NCT00964873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5580845|NCT00964873|Blast-phase Chronic Myelogenous Leukemia|blast-phase chronic myelogenous leukemia
5580846|NCT00964873|AML|aml
5580847|NCT00964873|ALL|all
5580848|NCT00964873|CML|cml
5580849|NCT00964873|HSP90 Inhibitor|hsp90 inhibitor
5580850|NCT00964847|hypertension|hypertension
5580851|NCT00964847|cardiovascular disease|cardiovascular disease
5580852|NCT00964847|yoga|yoga
5580853|NCT00964821|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5580854|NCT00964821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5580855|NCT00964821|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5580856|NCT00964821|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5580857|NCT00964821|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5580858|NCT00964821|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5580859|NCT00964821|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5580860|NCT00964821|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5580861|NCT00964821|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5580862|NCT00964821|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5580863|NCT00964821|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5581371|NCT00963313|Humira|humira
5580864|NCT00964821|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5580865|NCT00964821|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5580866|NCT00964821|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5580867|NCT00964821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5580868|NCT00964821|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5580869|NCT00964821|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5580870|NCT00964821|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5580871|NCT00964821|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5580872|NCT00964821|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5580873|NCT00964821|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5580874|NCT00964821|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5580875|NCT00964821|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5580876|NCT00964821|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5580877|NCT00964821|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5580878|NCT00964821|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5580879|NCT00964821|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5580880|NCT00964821|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5580881|NCT00964821|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5580882|NCT00964821|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5580883|NCT00964821|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5580884|NCT00964821|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5580885|NCT00964821|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5580886|NCT00964821|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5580887|NCT00964821|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5580888|NCT00964821|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5580889|NCT00964821|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5580890|NCT00964821|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5580891|NCT00964821|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5580892|NCT00964821|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5580893|NCT00964821|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5580894|NCT00964821|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5580895|NCT00964821|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5580896|NCT00964821|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5580897|NCT00964821|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5580898|NCT00964821|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5580899|NCT00964821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5680332|NCT00578188|Sexually transmitted infection|sexually transmitted infection
5580900|NCT00964821|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5580901|NCT00964821|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5580902|NCT00964821|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5580903|NCT00964821|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5580904|NCT00964821|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5580905|NCT00964821|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5580906|NCT00964821|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5563094|NCT01034852|Maze|maze
5580907|NCT00964821|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5580908|NCT00964821|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5580909|NCT00964821|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5580910|NCT00964821|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5580911|NCT00964821|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5580912|NCT00964821|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5580913|NCT00964821|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5580914|NCT00964821|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5580915|NCT00964821|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5580916|NCT00964821|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5862978|NCT00001432|Stem Cell|stem cell
5580917|NCT00964821|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5580918|NCT00964821|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5580919|NCT00964821|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5580921|NCT00964821|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5580922|NCT00964821|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5580923|NCT00964821|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5581372|NCT00963313|anti-TNF|anti-tnf
5580924|NCT00964821|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5580925|NCT00964821|refractory hairy cell leukemia|refractory hairy cell leukemia
5580927|NCT00964821|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5580928|NCT00964821|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5580929|NCT00964821|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5580930|NCT00964821|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5580931|NCT00964821|primary myelofibrosis|primary myelofibrosis
5580932|NCT00964821|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5580933|NCT00964821|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5580934|NCT00964821|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5580935|NCT00964821|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5580936|NCT00964821|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5580937|NCT00964821|stage I multiple myeloma|stage i multiple myeloma
5580938|NCT00964821|stage II multiple myeloma|stage ii multiple myeloma
5580939|NCT00964821|stage III multiple myeloma|stage iii multiple myeloma
5580940|NCT00964821|refractory multiple myeloma|refractory multiple myeloma
5580942|NCT00964808|Hip fractures|hip fractures
5580943|NCT00964808|Treatment Outcome|treatment outcome
5580944|NCT00964808|Painkiller|painkiller
5580945|NCT00964795|Eyes|eyes
5580946|NCT00964795|Neovascular|neovascular
5580947|NCT00964795|Macular Degeneration|macular degeneration
5580948|NCT00964795|Retina|retina
5580950|NCT00964795|VEGF Trap-Eye|vegf trap-eye
5580951|NCT00964795|Best Corrected Visual Acuity|best corrected visual acuity
5580952|NCT00964782|Fontan|fontan
5580953|NCT00964782|sildenafil|sildenafil
5580954|NCT00964782|exercise capacity|exercise capacity
5580955|NCT00964782|Patients with Fontan Circulation|patients with fontan circulation
5580956|NCT00964769|Pneumococcal Vaccine|pneumococcal vaccine
5580957|NCT00964769|Aged|aged
5580958|NCT00964756|ovarian cancer|ovarian cancer
5580959|NCT00964756|Recurrent ovarian cancer and other gynecologic cancers|recurrent ovarian cancer and other gynecologic cancers
5580960|NCT00964743|Neurologic Oncology|neurologic oncology
5580961|NCT00964743|Neoplastic Meningitis from solid tumors|neoplastic meningitis from solid tumors
5580962|NCT00964743|Brain and Nervous System|brain and nervous system
5580963|NCT00964743|Breast Cancer|breast cancer
5580964|NCT00964730|Thorough QT Study|thorough qt study
5580965|NCT00964730|Talampanel|talampanel
5580966|NCT00964730|Cardiac Repolarizatiom|cardiac repolarizatiom
5580967|NCT00964730|Healthy Volunteers|healthy volunteers
5580968|NCT00964717|back pain|back pain
5580969|NCT00964717|neck pain|neck pain
5580970|NCT00964717|anxiety|anxiety
5580971|NCT00964717|range of motion|range of motion
5580972|NCT00964691|malaria|malaria
5580973|NCT00964691|IPTp|iptp
5580974|NCT00964691|Fansidar|fansidar
5580975|NCT00964691|Intermittent Preventive Treatment in pregnancy|intermittent preventive treatment in pregnancy
5580976|NCT00964691|pregnancy|pregnancy
5580977|NCT00964691|prophylaxis|prophylaxis
5580978|NCT00964691|Chloroquine|chloroquine
5580979|NCT00964691|Anemia|anemia
5580980|NCT00964691|Prevention|prevention
5580981|NCT00964691|Placental malaria|placental malaria
5580982|NCT00964691|Solomon Islands|solomon islands
5580983|NCT00964691|Low birth weight|low birth weight
5580984|NCT00964665|Hepatitis B,|hepatitis b,
5580985|NCT00964665|Chronic,|chronic,
5580986|NCT00964665|Hepatitis B e Antigens positive|hepatitis b e antigens positive
5580987|NCT00964652|treadmill|treadmill
5580988|NCT00964652|body load|body load
5580989|NCT00964652|Parkinson's disease|parkinson's disease
5580990|NCT00964652|gait|gait
5580991|NCT00964639|Pain|pain
5580992|NCT00964639|Postoperative|postoperative
5580993|NCT00964639|Local infiltration analgesia|local infiltration analgesia
5580994|NCT00964639|Cerebral palsy|cerebral palsy
5580995|NCT00964639|r-FLACC|r-flacc
5580996|NCT00964626|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5580997|NCT00964626|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5580998|NCT00964626|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5580999|NCT00964626|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5581000|NCT00964626|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5581001|NCT00964626|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5581002|NCT00964626|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5581003|NCT00964626|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5581004|NCT00964626|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5581005|NCT00964626|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5581006|NCT00964613|Pars Plana|pars plana
5581007|NCT00964613|Surgical Capsulotomy|surgical capsulotomy
5581008|NCT00964613|Posterior capsule opacification|posterior capsule opacification
5581009|NCT00964613|visual outcome|visual outcome
5581010|NCT00964613|Complications|complications
5581011|NCT00964600|transversus abdominis block|transversus abdominis block
5581012|NCT00964600|postoperative pain|postoperative pain
5581640|NCT00962403|depression|depression
5581014|NCT00964587|diabetes self management education|diabetes self management education
5581015|NCT00964587|problem-solving training|problem-solving training
5581016|NCT00964587|health behavior change|health behavior change
5581017|NCT00964587|health literacy|health literacy
5581018|NCT00964548|vasospasm|vasospasm
5581019|NCT00964548|subarachnoid hemorrhage|subarachnoid hemorrhage
5581020|NCT00964548|neurocritical care|neurocritical care
5581021|NCT00964548|dantrolene|dantrolene
5581022|NCT00964548|vasorelaxation|vasorelaxation
5581023|NCT00964522|Quality of life|quality of life
5581024|NCT00964522|Breast Cancer|breast cancer
5581025|NCT00964522|Nursing Care|nursing care
5581026|NCT00964522|Education|education
5581027|NCT00964522|Chemotherapy|chemotherapy
5581028|NCT00964496|vascular malformation|vascular malformation
5581029|NCT00964496|gastrointestinal bleeding|gastrointestinal bleeding
5581030|NCT00964496|thalidomide|thalidomide
5581031|NCT00964483|Hypertension|hypertension
5581032|NCT00964470|Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™|burn, donor site, skin graft, dressing, awbat™-d, xeroform™, glucan ii™
5581033|NCT00964457|cetuximab|cetuximab
5581034|NCT00964457|rectum cancer|rectum cancer
5581035|NCT00964457|radiation|radiation
5581036|NCT00964457|MRI|mri
5581037|NCT00964444|Labor and delivery|labor and delivery
5581038|NCT00964444|Vaginal delivery|vaginal delivery
5581039|NCT00964379|Intra versus extraperitoneal colostomy|intra versus extraperitoneal colostomy
5581040|NCT00964353|coumadine|coumadine
5581041|NCT00964353|genotype|genotype
5581042|NCT00964353|genes|genes
5581043|NCT00964353|Warfarin|warfarin
5581044|NCT00964327|TMC114-C201|tmc114-c201
5581045|NCT00964327|TMC114|tmc114
5581046|NCT00964327|HIV|hiv
5581047|NCT00964327|darunavir|darunavir
5581048|NCT00964314|advanced cancer|advanced cancer
5581049|NCT00964314|TCM five elements music therapy|tcm five elements music therapy
5581050|NCT00964314|quality of life (QOL)|quality of life (qol)
5581051|NCT00964301|Asthma|asthma
5581052|NCT00964301|Low-income|low-income
5581053|NCT00964301|Quality of life|quality of life
5581054|NCT00964301|Children|children
5581055|NCT00964288|electrical hyperalgesia|electrical hyperalgesia
5581056|NCT00964288|threshold tracking|threshold tracking
5581057|NCT00964288|pain|pain
5581058|NCT00964275|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5581059|NCT00964275|thromboembolism|thromboembolism
5581060|NCT00964262|diabetes|diabetes
5581061|NCT00964262|exenatide|exenatide
5581062|NCT00964262|SR exenatide|sr exenatide
5581063|NCT00964262|Peptron|peptron
5581064|NCT00964236|sapropterin|sapropterin
5581065|NCT00964236|Kuvan|kuvan
5581066|NCT00964236|cognition|cognition
5581067|NCT00964236|brain|brain
5581068|NCT00964223|Acne vulgaris|acne vulgaris
5581069|NCT00964210|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5581070|NCT00964210|Inflammatory Bowel Disease|inflammatory bowel disease
5581071|NCT00964210|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5581072|NCT00964210|Chronic Renal Disease|chronic renal disease
5581073|NCT00964210|Solid Organ Transplant|solid organ transplant
5581074|NCT00964197|FemmeJock|femmejock
5581075|NCT00964197|Pelvic Organ Prolapse|pelvic organ prolapse
5581076|NCT00964184|Maturity onset diabetes of the young 3 protein, human|maturity onset diabetes of the young 3 protein, human
5581077|NCT00964171|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5581078|NCT00964171|recurrent pancreatic cancer|recurrent pancreatic cancer
5581079|NCT00964171|stage IV pancreatic cancer|stage iv pancreatic cancer
5581080|NCT00964158|influenza infection|influenza infection
5581081|NCT00964158|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5581082|NCT00964145|Nulliparous women|nulliparous women
5581083|NCT00964145|ultrasound|ultrasound
5581084|NCT00964132|Non-Small Cell Lung Cancer|non-small cell lung cancer
5581085|NCT00964132|NSCLC|nsclc
5581086|NCT00964132|Rexinoid|rexinoid
5581087|NCT00964132|NRX194204|nrx194204
5581088|NCT00964132|Lung Cancer|lung cancer
5581090|NCT00964106|inducer|inducer
5581091|NCT00964106|midazolam|midazolam
5581092|NCT00964106|inhibitor|inhibitor
5581093|NCT00964106|rosiglitazone|rosiglitazone
5581094|NCT00964106|dextromethorphan|dextromethorphan
5581095|NCT00964106|caffeine|caffeine
5581096|NCT00964106|cocktail|cocktail
5581097|NCT00964106|pioglitazone|pioglitazone
5581098|NCT00964106|omeprazole|omeprazole
5581099|NCT00964106|CYP|cyp
5581100|NCT00964106|rosuvastatin|rosuvastatin
5581101|NCT00964106|probe drug|probe drug
5862979|NCT00001430|IL-2|il-2
5581102|NCT00964106|drug interaction|drug interaction
5581103|NCT00964106|flurbiprofen|flurbiprofen
5581104|NCT00964093|premature|premature
5581105|NCT00964093|infection|infection
5581106|NCT00964093|central line|central line
5581107|NCT00964093|very low birth weight|very low birth weight
5581108|NCT00964093|silver alginate|silver alginate
5581109|NCT00964093|Algidex|algidex
5581110|NCT00964093|neonatal|neonatal
5581111|NCT00964093|NICU|nicu
5581112|NCT00964067|rehabilitation outcome|rehabilitation outcome
5581113|NCT00964067|cardiac patients|cardiac patients
5581114|NCT00964067|exercise intensity|exercise intensity
5581115|NCT00964054|adolescents|adolescents
5581116|NCT00964054|exercise|exercise
5581118|NCT00964054|dose response|dose response
5581119|NCT00964054|pilot study|pilot study
5581120|NCT00964041|Cognitive Impairment|cognitive impairment
5581121|NCT00964041|Neuroplasticity|neuroplasticity
5581122|NCT00964041|D-cycloserine|d-cycloserine
5581123|NCT00964041|N-methyl-D-aspartate (NMDA)|n-methyl-d-aspartate (nmda)
5581124|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents
5581125|NCT00964041|Mental Disorders|mental disorders
5581126|NCT00964041|Psychotic Disorders|psychotic disorders
5581127|NCT00964041|Antitubercular Agents|antitubercular agents
5581128|NCT00964041|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5581129|NCT00964041|Schizoaffective Disorder|schizoaffective disorder
5581130|NCT00964028|Combined vaccine|combined vaccine
5581131|NCT00964015|colloid fluid|colloid fluid
5581132|NCT00964015|crystalloid fluid|crystalloid fluid
5581134|NCT00964015|coronary artery bypass grafting|coronary artery bypass grafting
5581135|NCT00964015|renal function|renal function
5581136|NCT00964015|Patients undergoing coronary artery bypass surgery|patients undergoing coronary artery bypass surgery
5581137|NCT00964002|recurrent prostate cancer|recurrent prostate cancer
5581138|NCT00964002|stage IV prostate cancer|stage iv prostate cancer
5581139|NCT00963989|Acute stroke|acute stroke
5581140|NCT00963989|Large cerebral vessel occlusion|large cerebral vessel occlusion
5581141|NCT00963989|Core infarct volume|core infarct volume
5581142|NCT00963989|Penumbra System|penumbra system
5581143|NCT00963989|Revascularization|revascularization
5581144|NCT00963989|Intracerebral hemorrhage|intracerebral hemorrhage
5581146|NCT00963989|NIHSS|nihss
5581147|NCT00963989|Procedural serious adverse events|procedural serious adverse events
5581148|NCT00963989|All cause mortality|all cause mortality
5581149|NCT00963976|Stroke|stroke
5581150|NCT00963976|Hypertension|hypertension
5581151|NCT00963976|Cerebral Blood Flow|cerebral blood flow
5581152|NCT00963976|CT Perfusion|ct perfusion
5581153|NCT00963963|sexual health|sexual health
5581154|NCT00963963|adolescent health|adolescent health
5581155|NCT00963963|parent education|parent education
5581156|NCT00963963|HIV Seronegativity|hiv seronegativity
5581157|NCT00963963|treatment experienced|treatment experienced
5581158|NCT00963950|cholecystectomy|cholecystectomy
5581159|NCT00963937|adolescent|adolescent
5581160|NCT00963937|sumatriptan|sumatriptan
5581161|NCT00963937|children|children
5581162|NCT00963937|migraine|migraine
5581163|NCT00963924|Cognitive Impairment|cognitive impairment
5581164|NCT00963924|Neuroplasticity|neuroplasticity
5581165|NCT00963924|D-cycloserine|d-cycloserine
5581166|NCT00963924|NMDA|nmda
5581167|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents
5581168|NCT00963924|Mental Disorders|mental disorders
5581169|NCT00963924|Psychotic Disorders|psychotic disorders
5581170|NCT00963924|Antitubercular Agents|antitubercular agents
5581171|NCT00963924|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5581172|NCT00963924|Schizoaffective Disorder|schizoaffective disorder
5581173|NCT00963911|colon cancer|colon cancer
5581174|NCT00963911|rectal cancer|rectal cancer
5581175|NCT00963911|non-small cell lung cancer|non-small cell lung cancer
5581176|NCT00963911|small cell lung cancer|small cell lung cancer
5581177|NCT00963911|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
5581178|NCT00963911|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
5581179|NCT00963911|laryngeal verrucous carcinoma|laryngeal verrucous carcinoma
5581180|NCT00963911|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5581181|NCT00963911|oral cavity verrucous carcinoma|oral cavity verrucous carcinoma
5563377|NCT01033435|Hemodialysis|hemodialysis
5581182|NCT00963911|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
5581183|NCT00963911|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5581184|NCT00963911|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
5581185|NCT00963911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5581186|NCT00963911|prostate cancer|prostate cancer
5581187|NCT00963911|breast cancer|breast cancer
5581188|NCT00963911|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5581189|NCT00963898|Intravenous sedation|intravenous sedation
5581190|NCT00963898|Target controlled infusion|target controlled infusion
5581191|NCT00963898|Bispectral index|bispectral index
5581192|NCT00963898|Dental treatment|dental treatment
5581193|NCT00963898|Mental Retardation|mental retardation
5581194|NCT00963898|Deep sedation|deep sedation
5862980|NCT00001430|Drug Resistance|drug resistance
5581195|NCT00963859|Robotic-assisted laparoscopic surgery|robotic-assisted laparoscopic surgery
5581196|NCT00963859|Extended pelvic lymph node dissection|extended pelvic lymph node dissection
5581198|NCT00963859|Second-look open lymph node dissection|second-look open lymph node dissection
5581199|NCT00963859|O-PLND|o-plnd
5581200|NCT00963859|Radical Cystectomy|radical cystectomy
5581201|NCT00963859|Urinary diversion|urinary diversion
5581202|NCT00963859|Bladder|bladder
5581203|NCT00963846|schizophrenia|schizophrenia
5581205|NCT00963846|functioning|functioning
5581206|NCT00963833|Multiple Sclerosis|multiple sclerosis
5581207|NCT00963833|MS|ms
5581208|NCT00963833|Non-interventional|non-interventional
5581209|NCT00963820|Relapsed multiple myeloma|relapsed multiple myeloma
5581210|NCT00963820|Refractory multiple myeloma|refractory multiple myeloma
5581211|NCT00963820|Drug therapy|drug therapy
5581212|NCT00963794|Rectal cancer|rectal cancer
5581213|NCT00963794|Population screening|population screening
5581214|NCT00963794|Early detection|early detection
5581215|NCT00963781|Coronary Artery Disease|coronary artery disease
5581216|NCT00963781|Drug-Eluting Stents|drug-eluting stents
5581217|NCT00963781|Coronary Thrombosis|coronary thrombosis
5581218|NCT00963781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5581219|NCT00963781|Coronary Restenosis|coronary restenosis
5581220|NCT00963768|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5581221|NCT00963768|JNJ-28431754|jnj-28431754
5581222|NCT00963768|Canagliflozin|canagliflozin
5581223|NCT00963768|Sodium Glucose Co-transporter (SGLT2 inhibitor)|sodium glucose co-transporter (sglt2 inhibitor)
5581224|NCT00963768|Pharmacokinetics|pharmacokinetics
5581225|NCT00963768|Pharmacodynamics|pharmacodynamics
5581226|NCT00963755|Imaging|imaging
5581227|NCT00963755|Positron emission tomography|positron emission tomography
5581228|NCT00963755|F-18-FCH|f-18-fch
5581229|NCT00963755|Magnetic resonance imaging|magnetic resonance imaging
5581230|NCT00963755|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5581231|NCT00963742|cataract surgery|cataract surgery
5581232|NCT00963742|IOL|iol
5581233|NCT00963742|Intraocular lens|intraocular lens
5581234|NCT00963729|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5581235|NCT00963729|recurrent breast cancer|recurrent breast cancer
5581236|NCT00963729|stage II breast cancer|stage ii breast cancer
5581237|NCT00963729|stage IIIA breast cancer|stage iiia breast cancer
5581238|NCT00963729|stage IIIB breast cancer|stage iiib breast cancer
5581239|NCT00963729|stage IIIC breast cancer|stage iiic breast cancer
5581240|NCT00963716|endobronchial biopsy|endobronchial biopsy
5581241|NCT00963716|bronchoscopy|bronchoscopy
5581242|NCT00963716|interventional pulmonology|interventional pulmonology
5581243|NCT00963677|Shikani optical stylet(SOS)|shikani optical stylet(sos)
5581244|NCT00963677|difficult airways|difficult airways
5581245|NCT00963677|intubation|intubation
5581246|NCT00963664|melanoma|melanoma
5581247|NCT00963664|malignant melanoma|malignant melanoma
5581248|NCT00963664|interferon|interferon
5581249|NCT00963664|interferon alfa-2b|interferon alfa-2b
5581250|NCT00963664|Intron-A|intron-a
5581251|NCT00963664|Intron A|intron a
5581252|NCT00963664|Intron|intron
5581253|NCT00963664|lovastatin|lovastatin
5581254|NCT00963664|mevinolin|mevinolin
5581255|NCT00963664|Mevacor|mevacor
5581256|NCT00963664|statin|statin
5581257|NCT00963664|HRI|hri
5581258|NCT00963651|Pulmonary nodule, solitary|pulmonary nodule, solitary
5581259|NCT00963651|Multiple pulmonary nodules|multiple pulmonary nodules
5581260|NCT00963625|Blastocyst transfer|blastocyst transfer
5581261|NCT00963625|endometrial receptivity|endometrial receptivity
5581262|NCT00963625|IVF|ivf
5581263|NCT00963625|in vitro fertilization|in vitro fertilization
5581264|NCT00963625|embryo cryopreservation|embryo cryopreservation
5581265|NCT00963612|Microvascular Invasion|microvascular invasion
5581266|NCT00963612|Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)|blood-oxygen-level dependent magnetic resonance imaging (bold mri)
5581267|NCT00963560|ReSTOR +3|restor +3
5581268|NCT00963547|Documented to be HER2+|documented to be her2+
5581269|NCT00963534|Mantle cell lymphoma|mantle cell lymphoma
5581270|NCT00963534|Lenalidomide|lenalidomide
5581271|NCT00963534|Bendamustine|bendamustine
5581272|NCT00963534|Rituximab|rituximab
5581273|NCT00963534|Nordic Lymphoma Group|nordic lymphoma group
5563497|NCT01032941|VSL3|vsl3
5581274|NCT00963534|MTD for lenalidomide|mtd for lenalidomide
5581275|NCT00963534|Untreated patients|untreated patients
5581276|NCT00963534|Patients with mantle cell lymphoma, age over 65 years|patients with mantle cell lymphoma, age over 65 years
5581277|NCT00963521|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5581278|NCT00963521|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5581279|NCT00963521|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5581280|NCT00963521|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5581281|NCT00963521|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5581282|NCT00963521|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5581283|NCT00963521|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5581284|NCT00963508|Head Lice|head lice
5581285|NCT00963495|clioquinol|clioquinol
5581286|NCT00963495|relapsed and refractory hematologic malignancy|relapsed and refractory hematologic malignancy
5581287|NCT00963495|ALL|all
5581288|NCT00963495|HD|hd
5581289|NCT00963495|CLL|cll
5581290|NCT00963495|High risk myelodysplasia (MDS) with an IPSS score >2.5|high risk myelodysplasia (mds) with an ipss score >2.5
5581291|NCT00963495|CML blast crisis|cml blast crisis
5581294|NCT00963482|Alcohol|alcohol
5581295|NCT00963482|Outcome|outcome
5581296|NCT00963482|Harm reduction|harm reduction
5581297|NCT00963482|Alcohol drinking|alcohol drinking
5581298|NCT00963482|Treatment outcome|treatment outcome
5581299|NCT00963482|Treatment effectiveness|treatment effectiveness
5581300|NCT00963443|Aspirin Complex|aspirin complex
5581301|NCT00963443|Acetylsalicylic Acid|acetylsalicylic acid
5581302|NCT00963443|Pseudoephedrine|pseudoephedrine
5581303|NCT00963443|Common Cold|common cold
5581304|NCT00963430|H1N1, influenza A viruses, pregnant women|h1n1, influenza a viruses, pregnant women
5581305|NCT00963417|osteoporosis|osteoporosis
5581306|NCT00963417|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5581307|NCT00963417|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5581308|NCT00963417|stage IA breast cancer|stage ia breast cancer
5581309|NCT00963417|stage IB breast cancer|stage ib breast cancer
5581310|NCT00963417|stage II breast cancer|stage ii breast cancer
5581311|NCT00963417|stage IIIA breast cancer|stage iiia breast cancer
5581312|NCT00963404|Image-guided Radiotherapy|image-guided radiotherapy
5581313|NCT00963404|Fiducial marker|fiducial marker
5581314|NCT00963404|Adverse effects|adverse effects
5581315|NCT00963391|Health Production|health production
5581316|NCT00963391|Government Policy; Regulation; Public Health|government policy; regulation; public health
5581317|NCT00963391|Government Policy; Provision and Effects of Welfare Programs|government policy; provision and effects of welfare programs
5581318|NCT00963391|Gastrointestinal diseases|gastrointestinal diseases
5581319|NCT00963391|Respiratory Tract Infections|respiratory tract infections
5581320|NCT00963391|Diarrhea|diarrhea
5581321|NCT00963391|Ethanol|ethanol
5581322|NCT00963391|Child, Preschool|child, preschool
5581323|NCT00963391|Handwashing|handwashing
5581324|NCT00963365|Phase 1|phase 1
5581325|NCT00963365|Healthy volunteers|healthy volunteers
5581326|NCT00963352|Colon cancer|colon cancer
5581327|NCT00963352|Open surgery resection|open surgery resection
5581328|NCT00963352|Laparoscopic surgery resection|laparoscopic surgery resection
5581329|NCT00963352|Morbidity|morbidity
5581330|NCT00963352|Mortality|mortality
5581331|NCT00963352|Metastases|metastases
5581332|NCT00963352|Oncology|oncology
5581333|NCT00963352|Freedom of malignant disease recurrence|freedom of malignant disease recurrence
5581334|NCT00963352|Safety of intervention open and laparoscopic|safety of intervention open and laparoscopic
5581335|NCT00963352|Examination of adverse markers|examination of adverse markers
5581336|NCT00963352|Development of metastases in lungs and other organs|development of metastases in lungs and other organs
5581337|NCT00963339|AMD|amd
5581338|NCT00963326|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5581339|NCT00963326|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5581340|NCT00963326|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5566181|NCT01022216|Pressure Ulcer|pressure ulcer
5581341|NCT00963326|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5581342|NCT00963326|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5581343|NCT00963326|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5581344|NCT00963326|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5581345|NCT00963326|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5581346|NCT00963326|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5581347|NCT00963326|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5581348|NCT00963326|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5581349|NCT00963326|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5581350|NCT00963326|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5581351|NCT00963326|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5581352|NCT00963326|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5581353|NCT00963326|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5581354|NCT00963326|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5581355|NCT00963326|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5581356|NCT00963326|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5581357|NCT00963326|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5581358|NCT00963326|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5581359|NCT00963326|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5581360|NCT00963326|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5581361|NCT00963326|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5581362|NCT00963326|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5581363|NCT00963326|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5581364|NCT00963326|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5581365|NCT00963326|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5581366|NCT00963326|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5581367|NCT00963326|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5581369|NCT00963313|Axial psoriatic arthritis|axial psoriatic arthritis
5581373|NCT00963300|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5581375|NCT00963300|stage IIB prostate cancer|stage iib prostate cancer
5581376|NCT00963300|stage IIA prostate cancer|stage iia prostate cancer
5581377|NCT00963300|stage III prostate cancer|stage iii prostate cancer
5581378|NCT00963300|stage IV prostate cancer|stage iv prostate cancer
5581379|NCT00963287|alternative medicine|alternative medicine
5581380|NCT00963287|traditional Chinese medicine|traditional chinese medicine
5581381|NCT00963274|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5581382|NCT00963274|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5581383|NCT00963274|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5581384|NCT00963274|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5581385|NCT00963274|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5581386|NCT00963274|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5581387|NCT00963274|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5581388|NCT00963274|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5581389|NCT00963274|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5581390|NCT00963274|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5581391|NCT00963274|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5581392|NCT00963274|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5581393|NCT00963274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5581394|NCT00963274|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5581395|NCT00963274|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5581396|NCT00963274|hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5581397|NCT00963274|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5581398|NCT00963274|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5581400|NCT00963261|interferon-a|interferon-a
5581401|NCT00963261|quality of life|quality of life
5581402|NCT00963261|psychological distress|psychological distress
5581403|NCT00963261|depressive symptoms|depressive symptoms
5581404|NCT00963261|side effects|side effects
5581405|NCT00963248|EBV|ebv
5581406|NCT00963248|PTLD|ptld
5581407|NCT00963248|RTx|rtx
5581408|NCT00963248|pediatric|pediatric
5581409|NCT00963235|vaccine|vaccine
5581410|NCT00963235|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5581411|NCT00963235|human immunodeficiency virus|human immunodeficiency virus
5581412|NCT00963222|Atherosclerosis|atherosclerosis
5581413|NCT00963222|Coronary Artery Disease|coronary artery disease
5581414|NCT00963222|Vitamin A|vitamin a
5581415|NCT00963222|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5581416|NCT00963222|Th1 Cells|th1 cells
5581417|NCT00963222|Th2 Cells|th2 cells
5581418|NCT00963209|endocrine sensitive|endocrine sensitive
5581419|NCT00963209|breast cancer|breast cancer
5581420|NCT00963209|tamoxifen|tamoxifen
5581421|NCT00963209|genotyping|genotyping
5581422|NCT00963209|phenotyping|phenotyping
5581423|NCT00963209|Pharmacokinetics|pharmacokinetics
5581424|NCT00963209|Endoxifen|endoxifen
5581425|NCT00963183|Safety|safety
5581426|NCT00963183|Tolerability|tolerability
5581427|NCT00963183|Healthy|healthy
5581428|NCT00963183|Inhalation|inhalation
5581429|NCT00963157|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5581430|NCT00963144|Gerd Questionnaire|gerd questionnaire
5581431|NCT00963131|Central serous chorioretinopathy,antioxidants|central serous chorioretinopathy,antioxidants
5581432|NCT00963118|Angelica keiskei|angelica keiskei
5581433|NCT00963118|Glycine max|glycine max
5581434|NCT00963118|metabolic syndrome|metabolic syndrome
5581435|NCT00963092|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5581436|NCT00963092|recurrent gastric cancer|recurrent gastric cancer
5581437|NCT00963092|stage IV gastric cancer|stage iv gastric cancer
5581438|NCT00963092|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5581439|NCT00963092|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5581440|NCT00963092|recurrent esophageal cancer|recurrent esophageal cancer
5575589|NCT00985205|Nutrition|nutrition
5581441|NCT00963092|stage I esophageal cancer|stage i esophageal cancer
5581442|NCT00963092|stage II esophageal cancer|stage ii esophageal cancer
5581443|NCT00963092|stage III esophageal cancer|stage iii esophageal cancer
5581444|NCT00963092|stage IV esophageal cancer|stage iv esophageal cancer
5581445|NCT00963092|stage IA gastric cancer|stage ia gastric cancer
5581446|NCT00963092|stage IB gastric cancer|stage ib gastric cancer
5581447|NCT00963092|stage IIA gastric cancer|stage iia gastric cancer
5581448|NCT00963092|stage IIB gastric cancer|stage iib gastric cancer
5581449|NCT00963092|stage IIIA gastric cancer|stage iiia gastric cancer
5581450|NCT00963092|stage IIIB gastric cancer|stage iiib gastric cancer
5581451|NCT00963092|stage IIIC gastric cancer|stage iiic gastric cancer
5581453|NCT00963079|in vitro fertilization|in vitro fertilization
5581454|NCT00963079|blastocyst transfer|blastocyst transfer
5581455|NCT00963079|endometrial receptivity|endometrial receptivity
5581456|NCT00963079|embryo cryopreservation|embryo cryopreservation
5581457|NCT00963066|NAVA|nava
5581458|NCT00963066|Acute Lung Injury|acute lung injury
5581459|NCT00963066|Pressure Support Ventilation|pressure support ventilation
5581460|NCT00963066|Intubation|intubation
5581461|NCT00963066|Tracheostomy|tracheostomy
5581462|NCT00963066|Mechanical ventilation|mechanical ventilation
5581463|NCT00963053|dysmenorrhoea|dysmenorrhoea
5583968|NCT00953121|Avastin|avastin
5581467|NCT00963040|intranasal oxytocin|intranasal oxytocin
5581468|NCT00963040|acute headache treatment|acute headache treatment
5581469|NCT00963040|chronic daily headache|chronic daily headache
5581470|NCT00963027|Hypertension, Pulmonary|hypertension, pulmonary
5581471|NCT00963027|Treprostinil|treprostinil
5581472|NCT00963027|Pharmacokinetics|pharmacokinetics
5581473|NCT00963027|Treprostinil Diethanolamine|treprostinil diethanolamine
5581474|NCT00963027|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5581475|NCT00963027|Esomeprazole|esomeprazole
5581476|NCT00963001|Hypertension, Pulmonary|hypertension, pulmonary
5581477|NCT00963001|Treprostinil|treprostinil
5581478|NCT00963001|Pharmacokinetics|pharmacokinetics
5581479|NCT00963001|Treprostinil Diethanolamine|treprostinil diethanolamine
5581480|NCT00963001|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5581481|NCT00962988|Cerebrovascular disease|cerebrovascular disease
5581482|NCT00962988|stroke|stroke
5581483|NCT00962988|Transient Ischemic Attack|transient ischemic attack
5581484|NCT00962988|smoking cessation|smoking cessation
5581485|NCT00962988|Pharmacotherapy|pharmacotherapy
5581486|NCT00962962|Abnormal fasting glucose|abnormal fasting glucose
5581487|NCT00962949|POTS|pots
5581488|NCT00962949|Orthostatic intolerance|orthostatic intolerance
5581489|NCT00962936|Chronic Hepatitis C|chronic hepatitis c
5581490|NCT00962936|HCV Genotype I infection|hcv genotype i infection
5581491|NCT00962936|Liver disease|liver disease
5581492|NCT00962923|Systemic sclerosis|systemic sclerosis
5581493|NCT00962923|Mesenchymal Stem Cells|mesenchymal stem cells
5581494|NCT00962923|Transplantation|transplantation
5581495|NCT00962910|Femoral Fractures|femoral fractures
5581496|NCT00962910|Critical Pathway|critical pathway
5581497|NCT00962910|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5581498|NCT00962910|Safety|safety
5581499|NCT00962910|Efficiency|efficiency
5581500|NCT00962897|atherosclerosis|atherosclerosis
5581501|NCT00962897|covered stent|covered stent
5581502|NCT00962897|percutaneous intervention|percutaneous intervention
5581503|NCT00962897|stent|stent
5581504|NCT00962897|angioplasty|angioplasty
5581505|NCT00962884|Orthostatic hypotension|orthostatic hypotension
5581506|NCT00962884|Breathing|breathing
5581507|NCT00962884|Blood pressure|blood pressure
5581508|NCT00962884|standing|standing
5581509|NCT00962845|stage III melanoma|stage iii melanoma
5581510|NCT00962845|stage IV melanoma|stage iv melanoma
5581511|NCT00962832|rhuMAb IFNalpha|rhumab ifnalpha
5581513|NCT00962819|Mumps|mumps
5581514|NCT00962819|Immunity|immunity
5581515|NCT00962819|Vaccine|vaccine
5581516|NCT00962819|Mumps antibodies|mumps antibodies
5581517|NCT00962819|Mumps immunity|mumps immunity
5581518|NCT00962806|Pediatric obesity|pediatric obesity
5581519|NCT00962806|Insulin resistance|insulin resistance
5581520|NCT00962806|Diabetes|diabetes
5581521|NCT00962806|Mitochondria|mitochondria
5581522|NCT00962793|latent tuberculosis prevalence of health care workers|latent tuberculosis prevalence of health care workers
5581523|NCT00962780|vaccine|vaccine
5581524|NCT00962780|13-valent pneumococcal conjugate vaccine|13-valent pneumococcal conjugate vaccine
5581525|NCT00962780|23-valent pneumococcal polysaccharide vaccine|23-valent pneumococcal polysaccharide vaccine
5581526|NCT00962780|human immunodeficiency virus|human immunodeficiency virus
5581527|NCT00962767|Oncology comparison study|oncology comparison study
5581528|NCT00962754|recording fluid balance|recording fluid balance
5581529|NCT00962754|reliability|reliability
5581530|NCT00962754|utility|utility
5581531|NCT00962754|sick neonate|sick neonate
5581532|NCT00962754|fluid balance|fluid balance
5581533|NCT00962754|inpatient|inpatient
5581534|NCT00962754|sick|sick
5581535|NCT00962728|heart rate|heart rate
5581536|NCT00962728|tachycardia|tachycardia
5581537|NCT00962728|orthostatic intolerance|orthostatic intolerance
5581538|NCT00962715|Leukemia|leukemia
5581540|NCT00962715|Influenza Vaccine Trivalent Inactivated|influenza vaccine trivalent inactivated
5581542|NCT00962715|Flu|flu
5581543|NCT00962715|Pegasys|pegasys
5581544|NCT00962715|Pegylated interferon|pegylated interferon
5581545|NCT00962715|Roferon|roferon
5581546|NCT00962715|Interferon|interferon
5581547|NCT00962702|Exclusion|exclusion
5581548|NCT00962702|Left Atrial Appendage|left atrial appendage
5581549|NCT00962702|Surgical|surgical
5581550|NCT00962702|Open chest|open chest
5581551|NCT00962689|chronic rhinosinusitis|chronic rhinosinusitis
5581552|NCT00962689|biofilm|biofilm
5581553|NCT00962689|sinus tissue|sinus tissue
5581554|NCT00962689|nasal secretions|nasal secretions
5581555|NCT00962689|proteomics|proteomics
5581556|NCT00962689|diagnosis|diagnosis
5581557|NCT00962689|decreased antibiotics|decreased antibiotics
5581641|NCT00962403|anxiety|anxiety
5581558|NCT00962689|Develop a test to identify patients with sinusitis subtypes|develop a test to identify patients with sinusitis subtypes
5581559|NCT00962676|suspicious of tuberculosis|suspicious of tuberculosis
5581560|NCT00962676|immunocompromised patients|immunocompromised patients
5581561|NCT00962650|abdominal adhesions|abdominal adhesions
5581562|NCT00962650|diagnostic peritoneoscopy|diagnostic peritoneoscopy
5581563|NCT00962650|Natural Orifice Transluminal Endoscopic Surgery|natural orifice transluminal endoscopic surgery
5581565|NCT00962637|Secondary Hypogonadism|secondary hypogonadism
5581566|NCT00962624|Meningococcal|meningococcal
5581567|NCT00962624|Vaccine|vaccine
5581568|NCT00962624|Meningitis|meningitis
5581569|NCT00962611|Solid tumors|solid tumors
5581570|NCT00962611|Advanced cancer|advanced cancer
5581571|NCT00962598|Adolescents|adolescents
5581572|NCT00962598|Major Depressive Disorder|major depressive disorder
5581573|NCT00962598|Proton Magnetic Resonance Spectroscopy|proton magnetic resonance spectroscopy
5581574|NCT00962598|Immune System Activation|immune system activation
5581575|NCT00962598|Omega-3 Fatty Acids|omega-3 fatty acids
5581576|NCT00962572|Outcomes|outcomes
5581577|NCT00962572|Cancer|cancer
5581578|NCT00962572|Radiotherapy|radiotherapy
5581579|NCT00962572|Socio-economic|socio-economic
5581580|NCT00962546|cerebral aneurysm|cerebral aneurysm
5581581|NCT00962546|subarachnoid hemorrhage|subarachnoid hemorrhage
5581582|NCT00962546|cerebral vasospasm|cerebral vasospasm
5581583|NCT00962546|computed tomographic perfusion|computed tomographic perfusion
5581584|NCT00962546|computed tomographic angiography|computed tomographic angiography
5581585|NCT00962533|Chronic Hepatitis B|chronic hepatitis b
5581586|NCT00962507|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5581587|NCT00962507|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5581588|NCT00962507|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5581589|NCT00962507|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5581590|NCT00962507|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5581591|NCT00962507|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5581592|NCT00962507|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5581593|NCT00962507|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5581594|NCT00962507|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5680333|NCT00578188|Women's Health|women's health
5581595|NCT00962507|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5581596|NCT00962507|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5581597|NCT00962507|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5581598|NCT00962507|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5581599|NCT00962507|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5581600|NCT00962507|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5581601|NCT00962507|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5581602|NCT00962507|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5581603|NCT00962507|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5581604|NCT00962507|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5581605|NCT00962507|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5581606|NCT00962507|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5581607|NCT00962507|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5581608|NCT00962507|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5581609|NCT00962507|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5581610|NCT00962507|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5581611|NCT00962507|refractory multiple myeloma|refractory multiple myeloma
5581612|NCT00962468|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5581613|NCT00962468|Critical Pathway|critical pathway
5581614|NCT00962468|Cluster Randomized Controlled Trial|cluster randomized controlled trial
5581615|NCT00962468|Safety|safety
5581616|NCT00962468|Efficiency|efficiency
5581617|NCT00962455|Spirometry|spirometry
5581618|NCT00962455|Family Practice|family practice
5581619|NCT00962455|Randomized Controlled Trial|randomized controlled trial
5581620|NCT00962455|Feedback|feedback
5581621|NCT00962455|Intervention Studies|intervention studies
5581622|NCT00962442|alcoholic hepatitis|alcoholic hepatitis
5581623|NCT00962442|N-Acetylcysteine|n-acetylcysteine
5581624|NCT00962442|enteral nutrition|enteral nutrition
5581626|NCT00962442|severe acute alcoholic hepatitis|severe acute alcoholic hepatitis
5581628|NCT00962416|Drug eluting stent|drug eluting stent
5581629|NCT00962416|Biolimus|biolimus
5581630|NCT00962416|Biodegradable stent|biodegradable stent
5581631|NCT00962416|ST-elevation myocardial infarction|st-elevation myocardial infarction
5581632|NCT00962416|Coronary artery disease|coronary artery disease
5581633|NCT00962403|post traumatic stress disorder|post traumatic stress disorder
5581634|NCT00962403|yoga|yoga
5581635|NCT00962403|meditation|meditation
5581636|NCT00962403|military|military
5581637|NCT00962403|veteran|veteran
5581638|NCT00962403|trauma|trauma
5581639|NCT00962403|stress|stress
5581642|NCT00962403|insomnia|insomnia
5581643|NCT00962403|autonomic|autonomic
5581644|NCT00962377|molecular expression testing|molecular expression testing
5581645|NCT00962377|right ventricular endomyocardial biopsy|right ventricular endomyocardial biopsy
5581646|NCT00962351|total hip replacement|total hip replacement
5581647|NCT00962351|primary cementless total hip arthroplasty|primary cementless total hip arthroplasty
5581648|NCT00962351|metal ion|metal ion
5581649|NCT00962351|metal-on-metal|metal-on-metal
5581650|NCT00962338|convalescence|convalescence
5581651|NCT00962338|pain|pain
5581652|NCT00962338|nausea|nausea
5581653|NCT00962338|vomiting|vomiting
5581654|NCT00962338|sexual dysfunction|sexual dysfunction
5581655|NCT00962325|Physical activity|physical activity
5581656|NCT00962325|Obesity|obesity
5581657|NCT00962325|Bariatric surgery|bariatric surgery
5581658|NCT00962325|Weight Loss|weight loss
5581659|NCT00962312|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5581660|NCT00962312|recurrent pancreatic cancer|recurrent pancreatic cancer
5581661|NCT00962312|stage IV pancreatic cancer|stage iv pancreatic cancer
5581662|NCT00962299|Child|child
5581663|NCT00962299|Wheezing|wheezing
5581664|NCT00962299|Dyspnea|dyspnea
5581665|NCT00962299|Inhaled corticosteroids|inhaled corticosteroids
5581666|NCT00962286|Furosemide|furosemide
5581667|NCT00962286|obesity|obesity
5581668|NCT00962273|health personnel|health personnel
5581669|NCT00962273|communicable diseases|communicable diseases
5581670|NCT00962273|stress, psychological|stress, psychological
5581671|NCT00962273|resilience, psychological|resilience, psychological
5581672|NCT00962273|disaster planning|disaster planning
5581673|NCT00962273|education|education
5581674|NCT00962273|online|online
5581675|NCT00962260|glucocerebrosidase|glucocerebrosidase
5581676|NCT00962260|enzyme replacement therapy|enzyme replacement therapy
5581677|NCT00962260|Gaucher disease|gaucher disease
5581678|NCT00962260|plant cell culture|plant cell culture
5581679|NCT00962260|splenomegaly|splenomegaly
5581680|NCT00962260|hepatomegaly|hepatomegaly
5581681|NCT00962260|anemia|anemia
5581682|NCT00962260|thrombocytopenia|thrombocytopenia
5581683|NCT00962247|physical activity|physical activity
5581684|NCT00962247|relative reinforcing value|relative reinforcing value
5581685|NCT00962247|sedentary behavior|sedentary behavior
5581686|NCT00962247|obesity|obesity
5581687|NCT00962234|Lipogenesis|lipogenesis
5581688|NCT00962234|Lipolysis|lipolysis
5581689|NCT00962234|Phospholipids|phospholipids
5581690|NCT00962234|Body Composition|body composition
5581691|NCT00962234|Nutritional Status|nutritional status
5581692|NCT00962234|Lipid Metabolism|lipid metabolism
5581693|NCT00962221|LDL lipoprotein subclasses in subclinical hypothyroidism|ldl lipoprotein subclasses in subclinical hypothyroidism
5581694|NCT00962208|children|children
5581695|NCT00962208|corneal reshaping|corneal reshaping
5581696|NCT00962208|myopia|myopia
5581697|NCT00962208|myopia control|myopia control
5581698|NCT00962208|orthokeratology|orthokeratology
5581699|NCT00962195|health|health
5581700|NCT00962195|blood pressure|blood pressure
5581701|NCT00962195|liver enzymes|liver enzymes
5581702|NCT00962195|insulin resistance|insulin resistance
5581703|NCT00962182|celiac disease|celiac disease
5581704|NCT00962182|transglutaminase antibody|transglutaminase antibody
5581705|NCT00962169|Guideline adherence|guideline adherence
5581706|NCT00962169|Implementation|implementation
5581707|NCT00962169|Physical therapy|physical therapy
5581708|NCT00962169|Low back pain|low back pain
5581709|NCT00962169|Health plan implementation|health plan implementation
5581710|NCT00962156|Sepsis|sepsis
5581711|NCT00962156|Shock|shock
5581712|NCT00962156|Fluid therapy|fluid therapy
5581713|NCT00962156|Plasma expanders|plasma expanders
5581714|NCT00962143|Acute Achilles Tendon Tear|acute achilles tendon tear
5581715|NCT00962143|Acute Achilles Tendon Repair|acute achilles tendon repair
5581716|NCT00962130|tissue perfusion|tissue perfusion
5581717|NCT00962130|reconstructive surgery|reconstructive surgery
5581718|NCT00962130|continuous glucose monitoring|continuous glucose monitoring
5581719|NCT00962117|Food Reinforcement|food reinforcement
5581720|NCT00962117|Energy Intake|energy intake
5581721|NCT00962117|Obesity|obesity
5581722|NCT00962117|Dopamine|dopamine
5581723|NCT00962104|ADHD|adhd
5581724|NCT00962091|Drug therapy|drug therapy
5581725|NCT00962078|COPD|copd
5581726|NCT00962078|Pre-Lung-Transplantation|pre-lung-transplantation
5581727|NCT00962078|Intervall versus continuous training|intervall versus continuous training
5581729|NCT00962039|Abdominal Pain|abdominal pain
5581730|NCT00962039|Anxiety|anxiety
5581731|NCT00962026|Interleukin 1|interleukin 1
5581732|NCT00962026|Type 1 diabetes mellitus|type 1 diabetes mellitus
5581733|NCT00962026|Rilonacept|rilonacept
5581734|NCT00962026|Arcalyst|arcalyst
5581735|NCT00962000|Hemodialysis|hemodialysis
5581736|NCT00962000|Dialysis, Renal|dialysis, renal
5581737|NCT00961987|Maternity care|maternity care
5581738|NCT00961987|Interprofessional collaboration|interprofessional collaboration
5581739|NCT00961987|Continuity of Care|continuity of care
5581740|NCT00961987|Integration|integration
5581741|NCT00961974|type 1 diabetes|type 1 diabetes
5581742|NCT00961974|hemoglobin A1c|hemoglobin a1c
5581743|NCT00961974|family|family
5581744|NCT00961974|involvement|involvement
5581745|NCT00961974|responsibility|responsibility
5581746|NCT00961974|conflict|conflict
5581747|NCT00961974|quality of life|quality of life
5581748|NCT00961974|children|children
5581749|NCT00961961|Bipolar Disorder|bipolar disorder
5581750|NCT00961961|Manic Depression|manic depression
5581751|NCT00961961|Major Depressive Episode|major depressive episode
5581752|NCT00961961|Mania|mania
5581753|NCT00961961|Hypomania|hypomania
5581754|NCT00961961|Long Term Treatment|long term treatment
5581755|NCT00961948|Indigo carmine dye spraying|indigo carmine dye spraying
5581756|NCT00961948|Narrow band imaging (NBI)|narrow band imaging (nbi)
5581757|NCT00961948|Confocal Microscopy|confocal microscopy
5581758|NCT00961935|bipolar disorder|bipolar disorder
5581759|NCT00961935|child bipolar disorder|child bipolar disorder
5581760|NCT00961935|adolescent bipolar disorder|adolescent bipolar disorder
5581761|NCT00961935|pediatric bipolar disorder|pediatric bipolar disorder
5581762|NCT00961935|fMRI|fmri
5581763|NCT00961935|MRI|mri
5581764|NCT00961935|EEG|eeg
5581765|NCT00961935|neurocognitive tasks|neurocognitive tasks
5581766|NCT00961922|childhood brain tumour survivors|childhood brain tumour survivors
5581767|NCT00961896|Basal Cell Carcinoma|basal cell carcinoma
5581768|NCT00961896|Gorlin Syndrome,|gorlin syndrome,
5581769|NCT00961896|Gorlin-Goltz Syndrome,|gorlin-goltz syndrome,
5581770|NCT00961896|Basal Cell Nevus Syndrome,|basal cell nevus syndrome,
5581771|NCT00961896|Nevoid Basal Cell Carcinoma Syndrome,|nevoid basal cell carcinoma syndrome,
5581772|NCT00961896|Basal Cell Carcinoma Nevus Syndrome|basal cell carcinoma nevus syndrome
5581773|NCT00961883|HIV|hiv
5581774|NCT00961883|Vaccine|vaccine
5581775|NCT00961883|HIV Seronegativity|hiv seronegativity
5581776|NCT00961883|Preventive Vaccine|preventive vaccine
5581777|NCT00961870|bone|bone
5581778|NCT00961870|motor neuron excitability|motor neuron excitability
5581779|NCT00961870|forearm vibration|forearm vibration
5581780|NCT00961870|Mechanical Loading|mechanical loading
5581781|NCT00961831|Neoplasm|neoplasm
5581782|NCT00961831|PET/CT diagnosis|pet/ct diagnosis
5581783|NCT00961831|PET tracer|pet tracer
5581784|NCT00961818|Voice|voice
5581785|NCT00961818|Voice Quality|voice quality
5581786|NCT00961818|Voice Training|voice training
5581787|NCT00961818|Evaluation|evaluation
5581788|NCT00961805|Fibromyalgia|fibromyalgia
5581789|NCT00961805|Treatment|treatment
5581790|NCT00961805|Dance|dance
5581791|NCT00961805|Randomized controlled study|randomized controlled study
5581792|NCT00961805|Exercise|exercise
5581793|NCT00961753|PDA|pda
5581794|NCT00961753|Ibuprofen|ibuprofen
5581795|NCT00961753|Preterm|preterm
5581796|NCT00961753|Neonate|neonate
5581797|NCT00961740|Childhood Obesity|childhood obesity
5581798|NCT00961740|CBT|cbt
5581799|NCT00961740|Family|family
5581800|NCT00961740|Lifestyle change|lifestyle change
5581801|NCT00961727|Bedside Pews|bedside pews
5581802|NCT00961727|Credit Valley Hospital|credit valley hospital
5581803|NCT00961727|The Bedside Paediatric Early Warning System|the bedside paediatric early warning system
5581804|NCT00961727|clinically deteriorating|clinically deteriorating
5581805|NCT00961714|VCF|vcf
5581806|NCT00961688|PCOS|pcos
5581807|NCT00961688|polycystic ovary syndrome|polycystic ovary syndrome
5581808|NCT00961688|Polycystic ovarian syndrome|polycystic ovarian syndrome
5581809|NCT00961688|infertility|infertility
5581810|NCT00961688|ovulation|ovulation
5581811|NCT00961675|otitis|otitis
5581812|NCT00961675|acute|acute
5581813|NCT00961675|externa|externa
5581814|NCT00961675|ear|ear
5581815|NCT00961649|Open-Angle Glaucoma|open-angle glaucoma
5581816|NCT00961649|Ocular Hypertension|ocular hypertension
5581817|NCT00961649|Brinzolamide|brinzolamide
5581818|NCT00961649|Brimonidine|brimonidine
5581819|NCT00961649|Intraocular Pressure|intraocular pressure
5581820|NCT00961610|internet support|internet support
5581821|NCT00961610|cancer|cancer
5581822|NCT00961610|rehabilitation|rehabilitation
5581823|NCT00961597|Meniscus|meniscus
5581824|NCT00961597|Avascular region|avascular region
5581825|NCT00961597|Platelet rich plasma|platelet rich plasma
5581826|NCT00961571|colorectal cancer|colorectal cancer
5581827|NCT00961571|sunitinib|sunitinib
5581829|NCT00961558|varicocelectomy|varicocelectomy
5581830|NCT00961558|male infertility|male infertility
5581831|NCT00961558|clinical varicoceles|clinical varicoceles
5581832|NCT00961558|randomized control trial|randomized control trial
5581833|NCT00961532|intracerebral hemorrhage|intracerebral hemorrhage
5581834|NCT00961532|platelets|platelets
5581835|NCT00961506|cholecystectomy|cholecystectomy
5581836|NCT00961506|gallbladder|gallbladder
5581837|NCT00961506|laparoscopy|laparoscopy
5581838|NCT00961506|laparoendoscopic|laparoendoscopic
5581839|NCT00961467|Relapsed/ refractory Multiple Myeloma|relapsed/ refractory multiple myeloma
5581840|NCT00961454|Major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow|major depressive disorder, anxiety disorders, treatments, photobiomodulation, near infra-red phototherapy, cerebral blood flow
5581841|NCT00961441|Levetiracetam|levetiracetam
5581842|NCT00961441|Epilepsy|epilepsy
5581843|NCT00961441|Children|children
5581845|NCT00961428|Anorexia Nervosa|anorexia nervosa
5581846|NCT00961428|Eating Disorders|eating disorders
5581847|NCT00961428|Exercise|exercise
5581848|NCT00961428|Physical Activity|physical activity
5581849|NCT00961402|Exercise|exercise
5581850|NCT00961402|PostParum Depression|postparum depression
5581852|NCT00961389|critical care|critical care
5581853|NCT00961389|risk factors|risk factors
5581854|NCT00961389|prediction|prediction
5581855|NCT00961389|inflammation|inflammation
5581856|NCT00961376|melanoma|melanoma
5581857|NCT00961376|unresectable stage III or IV melanoma|unresectable stage iii or iv melanoma
5581858|NCT00961350|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
5581859|NCT00961337|school children|school children
5581860|NCT00961337|influenza vaccination|influenza vaccination
5581861|NCT00961337|vaccine effectiveness|vaccine effectiveness
5581862|NCT00961337|influenza attack rate|influenza attack rate
5581863|NCT00961337|absenteeism|absenteeism
5581864|NCT00961337|Influenza vaccine|influenza vaccine
5581865|NCT00961311|Balloon|balloon
5581866|NCT00961311|Angioplasty|angioplasty
5581867|NCT00961311|Coronary Artery|coronary artery
5581868|NCT00961311|PCI|pci
5581869|NCT00961311|PTCA|ptca
5581870|NCT00961311|Heart Disease|heart disease
5581871|NCT00961311|Myocardial Ischemia|myocardial ischemia
5581872|NCT00961298|IBS|ibs
5581873|NCT00961298|Irritable Bowel Syndrome|irritable bowel syndrome
5581874|NCT00961298|GAD|gad
5581875|NCT00961298|Generalized Anxiety Disorder|generalized anxiety disorder
5581876|NCT00961285|pharmacogenomics|pharmacogenomics
5581877|NCT00961285|genotyping|genotyping
5581878|NCT00961272|Pre-menopausal|pre-menopausal
5581879|NCT00961272|Pharmacokinetics|pharmacokinetics
5581880|NCT00961272|Raltegravir|raltegravir
5581881|NCT00961272|Women|women
5581882|NCT00961272|HIV-infected|hiv-infected
5581883|NCT00961259|healthy|healthy
5581884|NCT00961259|pharmacokinetics|pharmacokinetics
5581885|NCT00961259|therapeutic equivalency|therapeutic equivalency
5581886|NCT00961259|fenofibric acid|fenofibric acid
5581887|NCT00961246|web based intervention|web based intervention
5581888|NCT00961246|individually-tailored|individually-tailored
5581889|NCT00961246|Chinese-American children|chinese-american children
5581890|NCT00961246|compared the changes in physical activity level|compared the changes in physical activity level
5581891|NCT00961246|changes in dietary intake|changes in dietary intake
5581892|NCT00961246|changes in coping strategy used|changes in coping strategy used
5581893|NCT00961246|changes in BMI|changes in bmi
5581894|NCT00961233|eosinophilic esophagitis|eosinophilic esophagitis
5581895|NCT00961194|Ketamine|ketamine
5581896|NCT00961194|pain|pain
5581897|NCT00961194|neuropathic pain|neuropathic pain
5581898|NCT00961194|chronic|chronic
5581899|NCT00961181|paclitaxel|paclitaxel
5581900|NCT00961181|in-stent restenosis|in-stent restenosis
5581901|NCT00961181|BMS-ISR|bms-isr
5581902|NCT00961181|DES-ISR|des-isr
5581903|NCT00961181|drug eluting balloon|drug eluting balloon
5581904|NCT00961168|Mechanical Ventilation|mechanical ventilation
5581905|NCT00961155|asthma|asthma
5581906|NCT00961155|children|children
5581908|NCT00961155|exposure to tabacco|exposure to tabacco
5581909|NCT00961155|antiasthma treatment|antiasthma treatment
5581910|NCT00961142|Haploidentical Transplantation|haploidentical transplantation
5581911|NCT00961142|CD3/CD19 Depletion|cd3/cd19 depletion
5581912|NCT00961142|AML|aml
5581913|NCT00961142|ALL|all
5581914|NCT00961142|Reduced Intensity Conditioning|reduced intensity conditioning
5581915|NCT00961129|colorectal cancer|colorectal cancer
5581916|NCT00961129|needs|needs
5581917|NCT00961129|survivors|survivors
5581918|NCT00961129|any stage|any stage
5581919|NCT00961116|healthy|healthy
5581920|NCT00961116|pharmacokinetics|pharmacokinetics
5581921|NCT00961116|therapeutic equivalency|therapeutic equivalency
5581922|NCT00961116|fasting|fasting
5581923|NCT00961116|procetofen|procetofen
5581924|NCT00961116|fenofibric acid|fenofibric acid
5581926|NCT00961103|motor development|motor development
5581927|NCT00961103|orthoses|orthoses
5581928|NCT00961090|Brain tumor|brain tumor
5581929|NCT00961090|glioma|glioma
5581930|NCT00961090|surgical resection|surgical resection
5581931|NCT00961090|ALA|ala
5581932|NCT00961090|ultraviolet light|ultraviolet light
5581933|NCT00961077|elderly|elderly
5581934|NCT00961077|S-1|s-1
5581935|NCT00961077|Oxaliplatin|oxaliplatin
5581936|NCT00961077|relapsed or metastatic gastric cancer|relapsed or metastatic gastric cancer
5581937|NCT00961064|Hematopoeisis|hematopoeisis
5581938|NCT00961064|Thrombocytopenia|thrombocytopenia
5581939|NCT00961064|Autoimmunity|autoimmunity
5581940|NCT00961064|Megakaryocytes|megakaryocytes
5581941|NCT00961064|Bone Marrow Fibrosis|bone marrow fibrosis
5581942|NCT00961064|Myelodysplastic Syndrome|myelodysplastic syndrome
5581943|NCT00961064|MDS|mds
5581944|NCT00961051|adapted contact lens wearers|adapted contact lens wearers
5581945|NCT00961038|Ciprofloxacin|ciprofloxacin
5581946|NCT00961038|Inhalation|inhalation
5581947|NCT00961038|Pharmacokinetics|pharmacokinetics
5581948|NCT00961038|Safety|safety
5581949|NCT00961038|Tolerability|tolerability
5581950|NCT00961038|COPD|copd
5581951|NCT00961012|Randomized control trial|randomized control trial
5581952|NCT00961012|pressure mapping|pressure mapping
5581953|NCT00961012|High Fowler's position|high fowler's position
5581954|NCT00961012|bed|bed
5581955|NCT00961012|ventilation|ventilation
5581956|NCT00961012|slow vital capacity|slow vital capacity
5581957|NCT00961012|older adult population|older adult population
5581958|NCT00961012|65 years and older|65 years and older
5581959|NCT00960999|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5581960|NCT00960999|squamous cell lung cancer|squamous cell lung cancer
5581961|NCT00960999|adenocarcinoma of the lung|adenocarcinoma of the lung
5581962|NCT00960999|large cell lung cancer|large cell lung cancer
5581963|NCT00960973|vitamin K|vitamin k
5581964|NCT00960973|beta cell|beta cell
5581965|NCT00960973|glucose metabolism|glucose metabolism
5581966|NCT00960973|insulin resistance|insulin resistance
5581967|NCT00960960|MBC|mbc
5581968|NCT00960960|PI3K|pi3k
5581969|NCT00960960|Avastin|avastin
5581970|NCT00960960|Herceptin|herceptin
5581971|NCT00960934|Osteoporosis|osteoporosis
5581972|NCT00960934|Postmenopausal|postmenopausal
5581973|NCT00960934|MK-5442|mk-5442
5581974|NCT00960921|Pulmonary artery pressure|pulmonary artery pressure
5581975|NCT00960921|Hypoxia|hypoxia
5581976|NCT00960921|Iron|iron
5581977|NCT00960921|Hypoxia-inducible factor|hypoxia-inducible factor
5581978|NCT00960921|High altitude|high altitude
5581979|NCT00960908|Zotarolimus|zotarolimus
5581980|NCT00960908|Drug eluting stent|drug eluting stent
5581981|NCT00960908|Endeavor Resolute|endeavor resolute
5581982|NCT00960895|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5581983|NCT00960895|Pulmonary hypertension|pulmonary hypertension
5581984|NCT00960882|Pharmacokinetics|pharmacokinetics
5581985|NCT00960882|Diabetes|diabetes
5581986|NCT00960882|gastric tolerability|gastric tolerability
5680334|NCT00578175|Vaccines|vaccines
5680335|NCT00578175|Rubella|rubella
5581987|NCT00960869|PA32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.|pa32540 is proposed for the secondary prevention of cardio- and cerebrovascular events in patients at risk for developing aspirin-associated gastric ulcers.
5581988|NCT00960856|pharmacokinetics|pharmacokinetics
5581989|NCT00960843|Morbid Obesity|morbid obesity
5581990|NCT00960843|Gastric Banding|gastric banding
5581991|NCT00960843|Bariatric Banding|bariatric banding
5581992|NCT00960843|Swedish Adjustable Gastric Band|swedish adjustable gastric band
5581993|NCT00960817|Normal coronary artery with slow blood flow|normal coronary artery with slow blood flow
5581994|NCT00960804|OA|oa
5581995|NCT00960791|Type II diabetes mellitus|type ii diabetes mellitus
5581996|NCT00960791|absorption|absorption
5581997|NCT00960791|distribution|distribution
5581998|NCT00960791|metabolism|metabolism
5581999|NCT00960791|excretion|excretion
5582000|NCT00960791|14C-labelled|14c-labelled
5582001|NCT00960778|gender|gender
5582002|NCT00960778|nicotine dependence|nicotine dependence
5582003|NCT00960778|nicotine replacement therapy|nicotine replacement therapy
5582004|NCT00960778|extinction|extinction
5582005|NCT00960778|denicotinized cigarettes|denicotinized cigarettes
5582006|NCT00960765|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5582007|NCT00960765|Gastric Bypass|gastric bypass
5582008|NCT00960765|Gastric Banding|gastric banding
5582009|NCT00960765|Endotoxin|endotoxin
5582010|NCT00960752|gp100 peptide|gp100 peptide
5582011|NCT00960752|MAGE-3 peptide|mage-3 peptide
5582012|NCT00960752|R848|r848
5582013|NCT00960752|Resiquimod|resiquimod
5582014|NCT00960752|Toll Like Receptor|toll like receptor
5582015|NCT00960752|TLR|tlr
5582016|NCT00960752|T-cells|t-cells
5582017|NCT00960752|Tumor|tumor
5582018|NCT00960752|Metastatic|metastatic
5582019|NCT00960752|Lesions|lesions
5582020|NCT00960752|Injection Site|injection site
5582021|NCT00960739|disseminated neuroblastoma|disseminated neuroblastoma
5582022|NCT00960739|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5582023|NCT00960739|recurrent neuroblastoma|recurrent neuroblastoma
5582025|NCT00960726|Leukemia|leukemia
5582026|NCT00960726|NOV-002|nov-002
5582027|NCT00960726|Myelodysplastic Syndrome|myelodysplastic syndrome
5582029|NCT00960713|observational cohort|observational cohort
5582030|NCT00960713|rituximab|rituximab
5582031|NCT00960713|off-label use|off-label use
5582032|NCT00960713|auto-immunity|auto-immunity
5582033|NCT00960713|cytopenia|cytopenia
5582034|NCT00960700|MFlex|mflex
5582035|NCT00960700|Multifocal|multifocal
5582036|NCT00960700|630F|630f
5582037|NCT00960687|healthy|healthy
5582038|NCT00960687|pharmacokinetics|pharmacokinetics
5582039|NCT00960687|therapeutic equivalency|therapeutic equivalency
5582040|NCT00960661|diabetes|diabetes
5582041|NCT00960661|exenatide|exenatide
5582042|NCT00960661|Byetta|byetta
5582043|NCT00960661|insulin lispro|insulin lispro
5582044|NCT00960661|Humalog|humalog
5582045|NCT00960661|insulin glargine|insulin glargine
5582046|NCT00960661|Lantus|lantus
5582047|NCT00960661|Amylin|amylin
5582048|NCT00960661|Lilly|lilly
5582049|NCT00960648|Everolimus|everolimus
5582050|NCT00960648|Sirolimus|sirolimus
5582051|NCT00960648|Drug eluting stent|drug eluting stent
5582052|NCT00960635|new-onset|new-onset
5582054|NCT00960609|Communicating veins|communicating veins
5582055|NCT00960609|hepatic venous anastomosis|hepatic venous anastomosis
5582056|NCT00960609|intra-operative ultrasonography|intra-operative ultrasonography
5582057|NCT00960609|hepatic resection|hepatic resection
5582058|NCT00960609|hepatic neoplasm|hepatic neoplasm
5582059|NCT00960609|Primary and metastatic liver tumors|primary and metastatic liver tumors
5582060|NCT00960596|educational intervention|educational intervention
5582061|NCT00960596|asthma|asthma
5582062|NCT00960596|Environmental Tobacco Smoke(ETS)|environmental tobacco smoke(ets)
5582063|NCT00960596|children|children
5582064|NCT00960583|Chronic low back pain|chronic low back pain
5582065|NCT00960583|Multidisciplinary rehabilitation|multidisciplinary rehabilitation
5582066|NCT00960583|Exercise|exercise
5582067|NCT00960583|Cost-effectiveness|cost-effectiveness
5582068|NCT00960570|healthy|healthy
5582069|NCT00960570|adult|adult
5582070|NCT00960570|efavirenz|efavirenz
5582071|NCT00960570|fenofibric acid|fenofibric acid
5582072|NCT00960570|blood levels|blood levels
5582073|NCT00960557|hepatic tumor burden|hepatic tumor burden
5582074|NCT00960557|liver cancer|liver cancer
5582075|NCT00960557|liver carcinoma|liver carcinoma
5582076|NCT00960557|carcinoma|carcinoma
5582077|NCT00960557|hepatic cancer|hepatic cancer
5582078|NCT00960557|hepatic carcinoma|hepatic carcinoma
5582079|NCT00960557|VDA|vda
5582080|NCT00960557|Vascular Disrupting Agent|vascular disrupting agent
5582081|NCT00960544|Capecitabine|capecitabine
5582082|NCT00960544|Xeloda|xeloda
5582083|NCT00960544|Gene expression|gene expression
5582084|NCT00960544|Pharmacokinetic testing|pharmacokinetic testing
5582085|NCT00960544|PK sampling|pk sampling
5582086|NCT00960544|DNA analysis|dna analysis
5582087|NCT00960518|HBV-related unresectable HCC|hbv-related unresectable hcc
5582088|NCT00960518|TACE|tace
5582089|NCT00960518|adefovir|adefovir
5582090|NCT00960518|recurrence rate|recurrence rate
5582091|NCT00960505|Diet|diet
5582092|NCT00960505|Coronary heart disease|coronary heart disease
5582093|NCT00960505|Obesity|obesity
5582094|NCT00960505|Weight loss|weight loss
5582095|NCT00960505|Weight maintenance|weight maintenance
5582096|NCT00960492|Astrocytic tumor|astrocytic tumor
5582097|NCT00960492|Glioblastoma with oligodendroglial components|glioblastoma with oligodendroglial components
5582098|NCT00960466|Stress, Psychological|stress, psychological
5582099|NCT00960466|Neoplasms/psychology|neoplasms/psychology
5582100|NCT00960466|Psychology|psychology
5582101|NCT00960440|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy|randomized double-blind placebo-controlled investigational drug oral therapy safety and efficacy
5582102|NCT00960427|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5582103|NCT00960427|stage II rectal cancer|stage ii rectal cancer
5582104|NCT00960427|stage III rectal cancer|stage iii rectal cancer
5582105|NCT00960414|obesity|obesity
5582106|NCT00960414|randomized controlled trial|randomized controlled trial
5582107|NCT00960414|weight loss|weight loss
5582108|NCT00960414|metabolic syndrome|metabolic syndrome
5582109|NCT00960401|coronary calcium scoring|coronary calcium scoring
5582110|NCT00960401|breast cancer patients|breast cancer patients
5582111|NCT00960401|radiation treatment|radiation treatment
5582112|NCT00960375|smoking cessation|smoking cessation
5582113|NCT00960375|serious mental illness|serious mental illness
5582114|NCT00960349|Gastric cancer|gastric cancer
5582115|NCT00960349|Japanese|japanese
5582116|NCT00960349|PhI|phi
5582117|NCT00960349|Safety and tolerability|safety and tolerability
5582118|NCT00960349|Cediranib in combination with cisplatin plus a fluoropyrimidine|cediranib in combination with cisplatin plus a fluoropyrimidine
5582119|NCT00960349|Cediranib|cediranib
5582120|NCT00960349|Capecitabine|capecitabine
5582121|NCT00960349|S-1|s-1
5582122|NCT00960349|Cisplatin|cisplatin
5582123|NCT00960349|Untreated locally advanced or metastatic unresectable gastric cancer (GC)|untreated locally advanced or metastatic unresectable gastric cancer (gc)
5582124|NCT00960336|HER2-negative breast cancer|her2-negative breast cancer
5582125|NCT00960336|recurrent breast cancer|recurrent breast cancer
5582126|NCT00960336|stage IV breast cancer|stage iv breast cancer
5582127|NCT00960336|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5582128|NCT00960336|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5582129|NCT00960323|pharmacokinetics|pharmacokinetics
5582131|NCT00960297|Non-Small Cell Lung Cancer|non-small cell lung cancer
5582132|NCT00960297|NSCLC|nsclc
5582133|NCT00960297|Preoperative chemotherapy|preoperative chemotherapy
5582134|NCT00960297|Bevacizumab|bevacizumab
5582135|NCT00960297|Avastin|avastin
5582136|NCT00960284|stage IB pancreatic cancer|stage ib pancreatic cancer
5582137|NCT00960284|stage II pancreatic cancer|stage ii pancreatic cancer
5582138|NCT00960284|stage III pancreatic cancer|stage iii pancreatic cancer
5582139|NCT00960284|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5582140|NCT00960271|Non-small cell lung cancer|non-small cell lung cancer
5582141|NCT00960271|mediastinal lymph node|mediastinal lymph node
5582142|NCT00960271|resectable|resectable
5582143|NCT00960271|EBUS|ebus
5582144|NCT00960271|stage IIIA|stage iiia
5584558|NCT00951574|cancer|cancer
5582145|NCT00960271|significant mediastinal lymph node at thoracic CT Scan|significant mediastinal lymph node at thoracic ct scan
5582146|NCT00960258|Solid Tumors|solid tumors
5582147|NCT00960232|vitamin D|vitamin d
5582148|NCT00960232|blood pressure|blood pressure
5582149|NCT00960232|lipids|lipids
5582150|NCT00960232|infection|infection
5582151|NCT00960232|depression|depression
5582152|NCT00960193|blood levels over time|blood levels over time
5582153|NCT00960193|colchicine|colchicine
5582154|NCT00960193|seville orange juice|seville orange juice
5582155|NCT00960193|pharmacokinetics|pharmacokinetics
5582157|NCT00960167|radiotherapy|radiotherapy
5582158|NCT00960167|dose escalation|dose escalation
5582159|NCT00960167|Toxicity|toxicity
5582160|NCT00960167|Local control|local control
5582161|NCT00960154|Lumpectomy|lumpectomy
5582162|NCT00960154|PlasmaBlade|plasmablade
5582163|NCT00960154|Electrosurgery|electrosurgery
5582164|NCT00960154|PEAK Surgical|peak surgical
5582165|NCT00960154|Medtronic Advanced Energy|medtronic advanced energy
5582166|NCT00960154|Medtronic|medtronic
5582167|NCT00960115|NSCLC|nsclc
5582168|NCT00960115|Stage III|stage iii
5582169|NCT00960115|EMD531444|emd531444
5582170|NCT00960115|L-BLP25|l-blp25
5582171|NCT00960115|Cyclophosphamide|cyclophosphamide
5582172|NCT00960115|Immunotherapy|immunotherapy
5582173|NCT00960115|Tecemotide|tecemotide
5582174|NCT00960102|cochlear implantation|cochlear implantation
5582175|NCT00960102|hearing aid|hearing aid
5582176|NCT00960089|Toenail|toenail
5582177|NCT00960089|Fungus|fungus
5582178|NCT00960089|Onychomycosis|onychomycosis
5582179|NCT00960089|Dermatophyte|dermatophyte
5582180|NCT00960076|T2DM|t2dm
5582181|NCT00960076|Metformin|metformin
5582182|NCT00960076|A1c|a1c
5582183|NCT00960037|Vitamin D3|vitamin d3
5582184|NCT00960037|obesity|obesity
5582185|NCT00960037|cholecalciferol|cholecalciferol
5582186|NCT00960024|Vocational rehabilitation|vocational rehabilitation
5582187|NCT00960024|Severe mental illness|severe mental illness
5582188|NCT00960024|Psychosis|psychosis
5582189|NCT00960024|Mental Health|mental health
5582190|NCT00960011|Inguinal hernia|inguinal hernia
5582191|NCT00960011|mesh|mesh
5582192|NCT00960011|progrip|progrip
5582193|NCT00959998|Persistent Cancer-Related Fatigue|persistent cancer-related fatigue
5582194|NCT00959985|compression sleeve|compression sleeve
5582195|NCT00959985|compression bandage|compression bandage
5582196|NCT00959972|Varenicline|varenicline
5582197|NCT00959972|transdermal nicotine patch|transdermal nicotine patch
5582198|NCT00959972|cardiovascular disease|cardiovascular disease
5582199|NCT00959972|prevention|prevention
5582200|NCT00959972|coronary heart disease|coronary heart disease
5582201|NCT00959972|Smoking cessation|smoking cessation
5582202|NCT00959959|CRPC|crpc
5582203|NCT00959959|HRPC|hrpc
5582204|NCT00959959|TOK-001|tok-001
5582205|NCT00959959|ARMOR|armor
5582206|NCT00959959|ARMOR1|armor1
5582207|NCT00959946|Phase 1/2|phase 1/2
5582208|NCT00959946|2-part study|2-part study
5582209|NCT00959946|bosutinib and capecitabine|bosutinib and capecitabine
5582210|NCT00959920|Indwelling bladder catheter|indwelling bladder catheter
5582211|NCT00959920|Intermittent straight catheterization|intermittent straight catheterization
5582212|NCT00959920|Labor and Delivery|labor and delivery
5582213|NCT00959920|Time to delivery during labor|time to delivery during labor
5582214|NCT00959907|Muscular activity|muscular activity
5582215|NCT00959907|wrinkles in frontal area|wrinkles in frontal area
5582216|NCT00959907|action halos|action halos
5582217|NCT00959894|HIV|hiv
5582218|NCT00959894|Infection|infection
5582219|NCT00959894|Treatment Naive|treatment naive
5582220|NCT00959894|Adults|adults
5582221|NCT00959894|Once|once
5582222|NCT00959894|Daily|daily
5582223|NCT00959894|Etravirine|etravirine
5582224|NCT00959894|HIV-1 Infection|hiv-1 infection
5582225|NCT00959881|Alzheimer Disease|alzheimer disease
5582226|NCT00959868|Bladder cancer|bladder cancer
5582227|NCT00959868|Superficial bladder cancer (Ta or T1)|superficial bladder cancer (ta or t1)
5582228|NCT00959868|Muscle invasive bladder cancer (T2)|muscle invasive bladder cancer (t2)
5582229|NCT00959868|Transurethral resection|transurethral resection
5758515|NCT00290108|BIS|bis
5582231|NCT00959868|OGX-427|ogx-427
5582232|NCT00959868|Antisense oligonucleotide|antisense oligonucleotide
5582233|NCT00959868|Heat shock protein 27|heat shock protein 27
5582234|NCT00959868|superficial bladder tumour (Ta or T1) or CIS prior to a transurethral resection|superficial bladder tumour (ta or t1) or cis prior to a transurethral resection
5582235|NCT00959868|Muscle invasive (T2) bladder cancer prior to radical cystectomy|muscle invasive (t2) bladder cancer prior to radical cystectomy
5582236|NCT00959855|COPD|copd
5582237|NCT00959855|Pulmonary Rehabilitation|pulmonary rehabilitation
5582238|NCT00959855|Inflammation|inflammation
5582239|NCT00959855|Oxidative Stress|oxidative stress
5582240|NCT00959855|Steps|steps
5582241|NCT00959855|Free Living Activities|free living activities
5582242|NCT00959855|Exacerbation|exacerbation
5582243|NCT00959842|hypertriglyceridemia|hypertriglyceridemia
5582244|NCT00959842|Omega-3 Fatty Acids|omega-3 fatty acids
5582245|NCT00959842|Lipoprotein|lipoprotein
5582246|NCT00959842|Statin|statin
5582248|NCT00959829|Communication|communication
5582249|NCT00959829|Complementary Therapies|complementary therapies
5582250|NCT00959829|Intensive Care|intensive care
5582251|NCT00959829|Ethics|ethics
5582252|NCT00959816|Volunteers|volunteers
5582253|NCT00959803|Phase 1|phase 1
5582254|NCT00959803|Pharmacokinetics|pharmacokinetics
5582255|NCT00959803|Healthy Young Adult|healthy young adult
5582256|NCT00959803|Japanese|japanese
5582257|NCT00959803|Healthy Elderly|healthy elderly
5582258|NCT00959803|Alzheimer disease|alzheimer disease
5582259|NCT00959790|Health|health
5582260|NCT00959790|Obesity|obesity
5582261|NCT00959790|Oxidative stress|oxidative stress
5582262|NCT00959790|Challenge concept|challenge concept
5582263|NCT00959790|Vegetables|vegetables
5582264|NCT00959751|migraine|migraine
5582265|NCT00959738|loop ileostomy|loop ileostomy
5582266|NCT00959738|quality of life|quality of life
5582267|NCT00959738|morbidity|morbidity
5582268|NCT00959738|Rectal Neoplasms|rectal neoplasms
5582269|NCT00959725|Infliximab|infliximab
5582270|NCT00959725|Diabetes|diabetes
5582271|NCT00959725|Macular Edema|macular edema
5582272|NCT00959699|coinfection|coinfection
5582273|NCT00959699|protease inhibitor|protease inhibitor
5582274|NCT00959699|HIV|hiv
5582275|NCT00959686|Bendamustine refractory or relapsed T-cell lymphoma.|bendamustine refractory or relapsed t-cell lymphoma.
5582276|NCT00959660|Diastolic heart failure|diastolic heart failure
5582277|NCT00959660|Heart Failure|heart failure
5582278|NCT00959660|Elderly|elderly
5582279|NCT00959660|Obesity|obesity
5582280|NCT00959647|Hedgehog pathway inhibitor|hedgehog pathway inhibitor
5582281|NCT00959621|Habitual abortion|habitual abortion
5582282|NCT00959621|recurrent abortion|recurrent abortion
5582283|NCT00959621|hereditary and acquired|hereditary and acquired
5582284|NCT00959621|thrombophilia|thrombophilia
5582285|NCT00959621|preeclampsia|preeclampsia
5582286|NCT00959621|premature birth|premature birth
5582287|NCT00959621|miscarriage|miscarriage
5582288|NCT00959621|stillbirth|stillbirth
5582289|NCT00959621|LMWH (low molecular weigh heparin)|lmwh (low molecular weigh heparin)
5582291|NCT00959621|aspirin|aspirin
5582292|NCT00959608|Weight Management in adults|weight management in adults
5582293|NCT00959608|Reducing Health Disparities|reducing health disparities
5582294|NCT00959595|Diabetes mellitus|diabetes mellitus
5582295|NCT00959595|neuropathy|neuropathy
5582296|NCT00959595|foot|foot
5582297|NCT00959595|sensibility|sensibility
5582298|NCT00959595|brain plasticity|brain plasticity
5582299|NCT00959582|Relapsed ovarian cancer|relapsed ovarian cancer
5582300|NCT00959569|esmolol|esmolol
5582301|NCT00959569|cardiac surgery|cardiac surgery
5582302|NCT00959569|cardiac anesthesia|cardiac anesthesia
5582303|NCT00959569|mortality|mortality
5582304|NCT00959569|beta blockers|beta blockers
5582305|NCT00959569|beta-blockers|beta-blockers
5582306|NCT00959569|cardiac protection|cardiac protection
5582307|NCT00959556|recurrent breast cancer|recurrent breast cancer
5582308|NCT00959556|stage IA breast cancer|stage ia breast cancer
5582309|NCT00959556|stage IB breast cancer|stage ib breast cancer
5582310|NCT00959556|stage II breast cancer|stage ii breast cancer
5582311|NCT00959556|stage IIIA breast cancer|stage iiia breast cancer
5582312|NCT00959556|stage IIIB breast cancer|stage iiib breast cancer
5582313|NCT00959556|stage IIIC breast cancer|stage iiic breast cancer
5582314|NCT00959556|stage IV breast cancer|stage iv breast cancer
5582315|NCT00959530|complete dentures|complete dentures
5582316|NCT00959530|patient satisfaction|patient satisfaction
5582317|NCT00959530|treatment cost|treatment cost
5582318|NCT00959517|Placebo controlled|placebo controlled
5582319|NCT00959517|Efficacy|efficacy
5582320|NCT00959517|Artemisinin-based combination therapy|artemisinin-based combination therapy
5582321|NCT00959517|Primaquine|primaquine
5582322|NCT00959517|Gametocytes|gametocytes
5582323|NCT00959491|Colonoscopy|colonoscopy
5582324|NCT00959491|Occult Blood|occult blood
5582325|NCT00959491|Fecal|fecal
5582326|NCT00959478|Carbon Monoxide (CO)|carbon monoxide (co)
5582327|NCT00959478|Carbon Monoxide Poisoning|carbon monoxide poisoning
5904057|NCT00007813|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5582328|NCT00959478|Carbon Monoxide Alarm/Detector|carbon monoxide alarm/detector
5582329|NCT00959478|Precaution Adoption Process Model (PAPM)|precaution adoption process model (papm)
5582330|NCT00959478|Injury Prevention|injury prevention
5582331|NCT00959478|Emergency Department|emergency department
5582333|NCT00959452|Cognitive behavioural therapy|cognitive behavioural therapy
5582334|NCT00959452|Long term follow-up|long term follow-up
5582335|NCT00959452|Psychosomatics|psychosomatics
5582336|NCT00959452|Psychotherapy|psychotherapy
5582337|NCT00959426|- Mutliple Ascending Dose Study in Overweight Subjects - Body Weight - Signs and Symptoms|- mutliple ascending dose study in overweight subjects - body weight - signs and symptoms
5582338|NCT00959400|Fentanyl Transdermal|fentanyl transdermal
5582339|NCT00959400|Pain|pain
5582340|NCT00959400|Cancer|cancer
5582341|NCT00959387|head and neck cancer|head and neck cancer
5582645|NCT00957996|antiviral|antiviral
5582342|NCT00959387|induction chemotherapy|induction chemotherapy
5582343|NCT00959374|Abdominoplasty|abdominoplasty
5582344|NCT00959374|Reduction Mammaplasty|reduction mammaplasty
5582345|NCT00959374|Mastopexy|mastopexy
5582346|NCT00959361|patient compliance|patient compliance
5582347|NCT00959361|guidelines adherence|guidelines adherence
5582348|NCT00959361|advance directive adherence|advance directive adherence
5582349|NCT00959361|treatment refusal|treatment refusal
5582350|NCT00959361|directly observed therapy|directly observed therapy
5582351|NCT00959361|anti-retroviral agents|anti-retroviral agents
5582352|NCT00959361|HIV seropositivity|hiv seropositivity
5582353|NCT00959361|HIV infections|hiv infections
5582355|NCT00959361|pharmaceutical services|pharmaceutical services
5582356|NCT00959361|HIV-positives patients|hiv-positives patients
5582357|NCT00959361|treatment experienced|treatment experienced
5582358|NCT00959348|Asthma|asthma
5582359|NCT00959348|Diabetes|diabetes
5582360|NCT00959348|Impaired glucose tolerance|impaired glucose tolerance
5582361|NCT00959348|Insulin resistance|insulin resistance
5582362|NCT00959335|treatment|treatment
5582363|NCT00959322|Capsulotomy|capsulotomy
5582364|NCT00959309|pediatrics|pediatrics
5582365|NCT00959309|media|media
5582366|NCT00959309|MUPS|mups
5582367|NCT00959296|Registry|registry
5582368|NCT00959296|Pain|pain
5582369|NCT00959296|Chronic Pain|chronic pain
5582370|NCT00959296|Back Pain|back pain
5582371|NCT00959296|Intractable Spasticity|intractable spasticity
5582372|NCT00959296|Parkinson's Disease|parkinson's disease
5582373|NCT00959296|Essential Tremor|essential tremor
5582374|NCT00959296|Dystonia|dystonia
5582375|NCT00959296|Implantable Pumps|implantable pumps
5582376|NCT00959296|Incontinence|incontinence
5582377|NCT00959257|Asthma|asthma
5582378|NCT00959257|Inhaled corticosteroids|inhaled corticosteroids
5582379|NCT00959257|Cardiovascular morbidities|cardiovascular morbidities
5006024|NCT03958903|Responsive neurostimulation|responsive neurostimulation
5582380|NCT00959257|Systemic inflammation|systemic inflammation
5582381|NCT00959244|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5582382|NCT00959244|stage I breast cancer|stage i breast cancer
5582383|NCT00959244|stage II breast cancer|stage ii breast cancer
5582384|NCT00959244|stage IIIA breast cancer|stage iiia breast cancer
5582385|NCT00959244|stage IIIB breast cancer|stage iiib breast cancer
5582386|NCT00959244|stage IIIC breast cancer|stage iiic breast cancer
5582387|NCT00959244|stage IV breast cancer|stage iv breast cancer
5582388|NCT00959231|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5582389|NCT00959218|Dronabinol|dronabinol
5582390|NCT00959218|(-)trans-delta9-tetrahydrocannabinol|(-)trans-delta9-tetrahydrocannabinol
5582391|NCT00959218|central neuropathic pain|central neuropathic pain
5582392|NCT00959218|multiple sclerosis|multiple sclerosis
5582393|NCT00959218|analgesic|analgesic
5582394|NCT00959218|Central neuropathic pain related to multiple sclerosis|central neuropathic pain related to multiple sclerosis
5582395|NCT00959179|CHF|chf
5582396|NCT00959166|Acute hepatitis C|acute hepatitis c
5582397|NCT00959166|HIV|hiv
5582398|NCT00959166|Neurocognitive function|neurocognitive function
5582399|NCT00959166|Neuroinflammation|neuroinflammation
5582400|NCT00959153|Fragmenting of kidney stones|fragmenting of kidney stones
5582401|NCT00959153|extracorporeal shockwave lithotripsy|extracorporeal shockwave lithotripsy
5582402|NCT00959140|Allo PBSC|allo pbsc
5582403|NCT00959140|HSCT|hsct
5582404|NCT00959140|Bone Marrow Transplant|bone marrow transplant
5582405|NCT00959140|Allogeneic Bone Marrow Transplant|allogeneic bone marrow transplant
5582406|NCT00959140|Matched Related Donor Transplant|matched related donor transplant
5582407|NCT00959140|MRD HSCT|mrd hsct
5582408|NCT00959127|Colorectal Adenocarcinoma|colorectal adenocarcinoma
5582409|NCT00959127|Colon Cancer|colon cancer
5582410|NCT00959127|Rectal Cancer|rectal cancer
5582411|NCT00959114|Celiac Disease|celiac disease
5582412|NCT00959114|Coeliac Disease|coeliac disease
5582413|NCT00959114|Celiac Sprue|celiac sprue
5582414|NCT00959114|Keliakia|keliakia
5576514|NCT00981851|COPD|copd
5582415|NCT00959075|Thiamin supplementation|thiamin supplementation
5582416|NCT00959075|Thiamin deficiency|thiamin deficiency
5582417|NCT00959075|Heart failure|heart failure
5582418|NCT00959075|Improve heart function|improve heart function
5582419|NCT00959075|Vitamin B1 supplementation|vitamin b1 supplementation
5582420|NCT00959062|Pilot Study|pilot study
5582421|NCT00959062|Randomized Controlled Trial|randomized controlled trial
5582422|NCT00959062|Critically Ill|critically ill
5582423|NCT00959062|Child|child
5582424|NCT00959062|Pediatric|pediatric
5582425|NCT00959062|Clonidine|clonidine
5582426|NCT00959062|Sedation|sedation
5582427|NCT00959023|stage I prostate cancer|stage i prostate cancer
5582428|NCT00959023|stage IIB prostate cancer|stage iib prostate cancer
5582429|NCT00959023|stage IIA prostate cancer|stage iia prostate cancer
5582430|NCT00959023|stage III prostate cancer|stage iii prostate cancer
5582431|NCT00959023|stage IV prostate cancer|stage iv prostate cancer
5582432|NCT00959023|recurrent prostate cancer|recurrent prostate cancer
5582433|NCT00959010|Omega 3|omega 3
5582434|NCT00959010|Cystic Fibrosis|cystic fibrosis
5582435|NCT00959010|Inflammatory markers|inflammatory markers
5582436|NCT00958997|diabetes|diabetes
5582437|NCT00958997|islet|islet
5582438|NCT00958997|pancreas|pancreas
5582439|NCT00958997|beta cell mass|beta cell mass
5582440|NCT00958997|PET imaging|pet imaging
5582442|NCT00958997|arginine stimulus test|arginine stimulus test
5582443|NCT00958984|pediatric|pediatric
5582444|NCT00958984|solid organ transplant|solid organ transplant
5582445|NCT00958984|hemoglobin|hemoglobin
5582446|NCT00958971|Breast cancer|breast cancer
5582447|NCT00958971|HER2 negative|her2 negative
5582448|NCT00958971|FGFR1|fgfr1
5582449|NCT00958958|Acute Coronary Syndrome|acute coronary syndrome
5582450|NCT00958958|randomized cluster trial|randomized cluster trial
5582451|NCT00958958|quality improvement|quality improvement
5582452|NCT00958945|Postoperative Hematocrit|postoperative hematocrit
5582453|NCT00958945|Postoperative Hemoglobin|postoperative hemoglobin
5582454|NCT00958919|breathlessness intensity|breathlessness intensity
5582455|NCT00958919|breathlessness unpleasantness|breathlessness unpleasantness
5582456|NCT00958919|endorphins|endorphins
5582457|NCT00958919|resistive breathing loads|resistive breathing loads
5582458|NCT00958906|Infliximab|infliximab
5582459|NCT00958906|Uveitis|uveitis
5582460|NCT00958906|Macular Edema|macular edema
5582461|NCT00958906|Intraocular Inflammation|intraocular inflammation
5582462|NCT00958893|Uterine fibroids|uterine fibroids
5582463|NCT00958867|Resistance exercise training|resistance exercise training
5582464|NCT00958867|aerobic exercise training|aerobic exercise training
5582465|NCT00958854|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5582466|NCT00958841|Rare tumors of neuroendocrine origin|rare tumors of neuroendocrine origin
5582467|NCT00958841|NETs of the pancreatic|nets of the pancreatic
5582468|NCT00958841|Pituitary NETs|pituitary nets
5582469|NCT00958841|EAS Tumors|eas tumors
5582470|NCT00958841|Nelson's Syndrome|nelson's syndrome
5582471|NCT00958841|Pancreatic neoplasm|pancreatic neoplasm
5582472|NCT00958841|pituitary neoplasm|pituitary neoplasm
5582473|NCT00958841|Nelson Syndrome|nelson syndrome
5582474|NCT00958841|ectopic ACTH syndrome|ectopic acth syndrome
5582475|NCT00958841|pasireotide LAR|pasireotide lar
5582476|NCT00958841|PNETs|pnets
5582477|NCT00958841|PiNETS|pinets
5582478|NCT00958815|vascular imaging|vascular imaging
5582479|NCT00958815|diabetes|diabetes
5582480|NCT00958815|rupture prone plaques|rupture prone plaques
5582482|NCT00958815|treatment experienced|treatment experienced
5582483|NCT00958802|tissue engineering|tissue engineering
5582484|NCT00958776|Influenza|influenza
5582485|NCT00958776|Hospitalized|hospitalized
5582486|NCT00958776|Antiviral|antiviral
5582487|NCT00958776|Flu|flu
5582488|NCT00958763|HCV|hcv
5582489|NCT00958763|Alcohol|alcohol
5582490|NCT00958763|Methadone Maintained|methadone maintained
5582491|NCT00958750|Androgenetic alopecia|androgenetic alopecia
5582492|NCT00958750|female pattern hair loss|female pattern hair loss
5582493|NCT00958737|stage III colon cancer|stage iii colon cancer
5582494|NCT00958737|adenocarcinoma of the colon|adenocarcinoma of the colon
5582495|NCT00958724|HKI-272|hki-272
5582496|NCT00958724|Vinorelbine|vinorelbine
5582497|NCT00958724|Combination|combination
5582498|NCT00958724|Solid Tumor|solid tumor
5582499|NCT00958724|Neratinib|neratinib
5582500|NCT00958724|Nerlynx|nerlynx
5582501|NCT00958724|PB-272|pb-272
5582502|NCT00958685|ginger extract|ginger extract
5582503|NCT00958685|ARDS|ards
5582504|NCT00958685|enteral feeding|enteral feeding
5582505|NCT00958685|mechanical ventilation|mechanical ventilation
5582506|NCT00958685|ICU|icu
5582507|NCT00958646|OMT|omt
5582508|NCT00958646|biomarker|biomarker
5582509|NCT00958646|Manipulation, osteopathic|manipulation, osteopathic
5582510|NCT00958633|Bipolar I disorder|bipolar i disorder
5582511|NCT00958633|Depression|depression
5582512|NCT00958633|Antidepressant|antidepressant
5582513|NCT00958620|Chronic Achilles Tendinopathy|chronic achilles tendinopathy
5582514|NCT00958607|Caregivers|caregivers
5582515|NCT00958607|Stroke|stroke
5582516|NCT00958607|Social support|social support
5582517|NCT00958607|Phase specific care|phase specific care
5582518|NCT00958581|antifibrinolytics|antifibrinolytics
5582520|NCT00958542|scoliosis|scoliosis
5582522|NCT00958529|fiber|fiber
5582523|NCT00958529|inulin|inulin
5582524|NCT00958529|gastrointestinal tolerance|gastrointestinal tolerance
5582525|NCT00958516|volunteers|volunteers
5582526|NCT00958503|safety|safety
5582527|NCT00958503|biomarker|biomarker
5582528|NCT00958503|thiamphenicol|thiamphenicol
5582529|NCT00958503|EAAT2|eaat2
5582530|NCT00958477|Safety|safety
5582531|NCT00958477|tolerability|tolerability
5582532|NCT00958477|pharmacokinetics|pharmacokinetics
5582533|NCT00958477|pharmacodynamics of EMD 525797|pharmacodynamics of emd 525797
5582534|NCT00958477|prostate cancer patients|prostate cancer patients
5582535|NCT00958464|MRI|mri
5582536|NCT00958464|Perthes'disease|perthes'disease
5582537|NCT00958464|hip|hip
5582538|NCT00958464|cartilage|cartilage
5582539|NCT00958451|Calcium|calcium
5582540|NCT00958451|Vitamin D deficiency|vitamin d deficiency
5582541|NCT00958451|Chronic Kidney disease|chronic kidney disease
5582542|NCT00958438|Intercritical Gout|intercritical gout
5582543|NCT00958438|Metabolism, Inborn Errors|metabolism, inborn errors
5582544|NCT00958438|Allopurinol|allopurinol
5582545|NCT00958438|Metabolic Diseases|metabolic diseases
5582546|NCT00958438|Genetic Diseases, Inborn|genetic diseases, inborn
5582547|NCT00958438|Musculoskeletal Diseases|musculoskeletal diseases
5582549|NCT00958438|Arthritis|arthritis
5582550|NCT00958438|Rheumatic Diseases|rheumatic diseases
5582551|NCT00958438|Metabolic disorder|metabolic disorder
5582552|NCT00958438|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5582553|NCT00958438|Gout|gout
5582554|NCT00958412|Endometriosis|endometriosis
5582555|NCT00958412|Pelvic pain|pelvic pain
5582556|NCT00958412|Oral progesterone blocker|oral progesterone blocker
5582557|NCT00958399|satiety|satiety
5582558|NCT00958399|fiber|fiber
5582559|NCT00958399|food intake|food intake
5582560|NCT00958399|gut hormones|gut hormones
5582561|NCT00958399|visual analog scales|visual analog scales
5582562|NCT00958399|microflora|microflora
5582563|NCT00958386|colorectal cancer|colorectal cancer
5582564|NCT00958386|Panitumumab|panitumumab
5582565|NCT00958386|irinotecan|irinotecan
5582566|NCT00958373|Scoliosis|scoliosis
5582567|NCT00958373|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5582568|NCT00958373|spine curve|spine curve
5582569|NCT00958373|pediatric|pediatric
5582570|NCT00958373|mental health|mental health
5582571|NCT00958373|screening|screening
5582572|NCT00958360|vision, low|vision, low
5582573|NCT00958334|Uterine fibroids|uterine fibroids
5582574|NCT00958321|adenocarcinoma of the lung|adenocarcinoma of the lung
5582575|NCT00958321|large cell lung cancer|large cell lung cancer
5582576|NCT00958321|squamous cell lung cancer|squamous cell lung cancer
5006025|NCT03958903|Amygdala electrophysiology|amygdala electrophysiology
5582577|NCT00958321|malignant pleural effusion|malignant pleural effusion
5582578|NCT00958321|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5582579|NCT00958321|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5582580|NCT00958321|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5582581|NCT00958321|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5582582|NCT00958321|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5582583|NCT00958321|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5582584|NCT00958308|Probiotic|probiotic
5582585|NCT00958308|Antibiotic-Associated Diarrhea (AAD) Prevention|antibiotic-associated diarrhea (aad) prevention
5582586|NCT00958308|Clostridium Difficile-Associated Diarrhea (CDAD)Prevention|clostridium difficile-associated diarrhea (cdad)prevention
5582587|NCT00958295|urinary tract infection|urinary tract infection
5582588|NCT00958295|cystitis|cystitis
5582589|NCT00958282|cocaine|cocaine
5582590|NCT00958282|treatment|treatment
5582591|NCT00958282|lisdexamfetamine|lisdexamfetamine
5582592|NCT00958282|dependence|dependence
5582593|NCT00958282|addiction|addiction
5582594|NCT00958282|crack|crack
5582595|NCT00958269|diabetes|diabetes
5582596|NCT00958269|DPP4 inhibitor|dpp4 inhibitor
5582597|NCT00958269|dutogliptin|dutogliptin
5582598|NCT00958269|PHX1149|phx1149
5582599|NCT00958256|Mantle Cell Lymphoma|mantle cell lymphoma
5582600|NCT00958256|Lymphoma|lymphoma
5582601|NCT00958256|Bortezomib|bortezomib
5582602|NCT00958256|Velcade|velcade
5582603|NCT00958256|Rituximab|rituximab
5582604|NCT00958256|Rituxan|rituxan
5582605|NCT00958256|Cyclophosphamide|cyclophosphamide
5582606|NCT00958256|Cytoxan|cytoxan
5582607|NCT00958256|Neosar|neosar
5582608|NCT00958256|Mesna|mesna
5582609|NCT00958256|Mesnex|mesnex
5582610|NCT00958256|G-CSF|g-csf
5582611|NCT00958256|Filgrastim|filgrastim
5582612|NCT00958256|Neupogen|neupogen
5582613|NCT00958230|endarterectomy|endarterectomy
5582614|NCT00958230|dCell|dcell
5582615|NCT00958230|Tissue Regenix Ltd|tissue regenix ltd
5582616|NCT00958230|TRL|trl
5582617|NCT00958230|Vascular Patch|vascular patch
5582618|NCT00958230|Treatment|treatment
5582619|NCT00958217|Depressive symptoms|depressive symptoms
5576727|NCT00981045|IDA|ida
5582621|NCT00958217|Posttraumatic stress disorders|posttraumatic stress disorders
5582622|NCT00958217|Psychotherapy|psychotherapy
5582623|NCT00958204|Depression|depression
5582624|NCT00958204|rating scales|rating scales
5582625|NCT00958204|RCT|rct
5582626|NCT00958204|combination treatment|combination treatment
5582627|NCT00958204|light therapy|light therapy
5582628|NCT00958204|negative ion therapy|negative ion therapy
5582629|NCT00958204|fluoxetine|fluoxetine
5582630|NCT00958204|antidepressants|antidepressants
5582631|NCT00958165|Treatment of PAF using EAS-AC|treatment of paf using eas-ac
5582632|NCT00958152|VX-950|vx-950
5582633|NCT00958152|VX-222|vx-222
5582634|NCT00958152|STAT-C|stat-c
5582635|NCT00958139|Lyme disease|lyme disease
5582636|NCT00958139|tick|tick
5582637|NCT00958100|raltegravir switch toxicity|raltegravir switch toxicity
5582638|NCT00958100|treatment experienced|treatment experienced
5582639|NCT00958061|CVD|cvd
5582640|NCT00958048|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5582641|NCT00958048|hypoventilation|hypoventilation
5582642|NCT00957996|influenza|influenza
5582643|NCT00957996|hospitalized|hospitalized
5582644|NCT00957996|flu|flu
5582646|NCT00957970|Stress shielding|stress shielding
5582647|NCT00957970|Bone mineral density|bone mineral density
5582648|NCT00957970|stemless femoral component|stemless femoral component
5582649|NCT00957944|Rotigotine|rotigotine
5582650|NCT00957944|Neupro®|neupro®
5582651|NCT00957918|levodopa-induced dyskinesia|levodopa-induced dyskinesia
5582652|NCT00957918|Parkinson's disease|parkinson's disease
5582653|NCT00957918|parkinsonian|parkinsonian
5582654|NCT00957918|levodopa-induced dyskinesias in Parkinson's disease|levodopa-induced dyskinesias in parkinson's disease
5582655|NCT00957892|Healthy Infants|healthy infants
5582656|NCT00957892|Satiation|satiation
5582658|NCT00957892|Intake Regulation|intake regulation
5582659|NCT00957892|Infant Feeding|infant feeding
5582660|NCT00957892|Infant Formula Feeding|infant formula feeding
5582661|NCT00957879|Vitamin D|vitamin d
5582662|NCT00957879|FGF23|fgf23
5582663|NCT00957879|FGF-23|fgf-23
5582664|NCT00957879|Phosphate|phosphate
5582665|NCT00957866|The number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results|the number of cases in the database thus far (4,477) is clearly sufficient to achieve meaningful results
5582666|NCT00957853|Head and Neck Cancer|head and neck cancer
5582667|NCT00957853|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5582668|NCT00957853|HNSCC|hnscc
5582669|NCT00957853|Cetuximab|cetuximab
5582670|NCT00957853|IMC-A12|imc-a12
5582671|NCT00957853|Tumor|tumor
5582672|NCT00957853|Biomarkers|biomarkers
5582673|NCT00957853|Phospho-AKT|phospho-akt
5582674|NCT00957853|Surgical resection|surgical resection
5582675|NCT00957840|Omaya reservoirs|omaya reservoirs
5582676|NCT00957840|cerebral oxygenation|cerebral oxygenation
5582677|NCT00957840|VP shunt|vp shunt
5582679|NCT00957840|post hemorrhagic ventricular dilation (PVHD)|post hemorrhagic ventricular dilation (pvhd)
5582680|NCT00957814|nutritional education|nutritional education
5582681|NCT00957814|diet adherence|diet adherence
5582682|NCT00957814|nutritional knowledge|nutritional knowledge
5582683|NCT00957814|life quality|life quality
5582684|NCT00957814|nutritional status|nutritional status
5582685|NCT00957814|impact of nutritional orientations by a systematic education program applied to outpatients with HF, in comparison to patients in a conventional treatment.|impact of nutritional orientations by a systematic education program applied to outpatients with hf, in comparison to patients in a conventional treatment.
5582686|NCT00957801|Sarcopenia|sarcopenia
5582687|NCT00957801|Aging muscle|aging muscle
5582688|NCT00957801|Androgen|androgen
5582689|NCT00957801|Cytokines|cytokines
5582690|NCT00957801|Muscle metabolism|muscle metabolism
5582691|NCT00957788|tinnitus|tinnitus
5582692|NCT00957788|acouphenes|acouphenes
5582693|NCT00957788|ear|ear
5582694|NCT00957788|ringing|ringing
5582695|NCT00957788|buzzing|buzzing
5582696|NCT00957788|roaring|roaring
5582697|NCT00957788|hissing|hissing
5582698|NCT00957788|clicking|clicking
5582699|NCT00957775|Substance Abuse Treatment|substance abuse treatment
5582700|NCT00957775|Adolescents|adolescents
5582701|NCT00957775|Substance-Related Disorders|substance-related disorders
5582702|NCT00957775|Alcohol-Related Disorders|alcohol-related disorders
5582703|NCT00957775|Marijuana Abuse|marijuana abuse
5582704|NCT00957762|Body Composition|body composition
5582705|NCT00957762|Glucose Tolerance|glucose tolerance
5582706|NCT00957762|Insulin Sensitivity|insulin sensitivity
5582707|NCT00957762|Metabolic Syndrome|metabolic syndrome
5582708|NCT00957736|graft versus host disease|graft versus host disease
5582709|NCT00957736|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5582710|NCT00957736|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5582711|NCT00957736|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5582712|NCT00957736|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5685413|NCT00556192|Cyclophosphamide|cyclophosphamide
5582713|NCT00957736|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5582714|NCT00957736|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5582715|NCT00957736|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5582716|NCT00957736|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5582717|NCT00957736|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5582718|NCT00957736|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5582719|NCT00957736|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5582720|NCT00957736|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5582721|NCT00957736|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5582722|NCT00957736|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5582723|NCT00957736|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5582724|NCT00957736|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5582725|NCT00957736|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5582726|NCT00957736|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5582727|NCT00957736|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5582728|NCT00957736|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5582729|NCT00957736|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5582730|NCT00957736|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5582731|NCT00957736|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5582732|NCT00957736|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5582733|NCT00957736|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5582734|NCT00957736|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5582735|NCT00957736|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5582736|NCT00957736|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5582737|NCT00957736|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5582738|NCT00957736|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5582739|NCT00957736|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5582740|NCT00957736|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5582741|NCT00957736|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5582742|NCT00957736|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5582743|NCT00957736|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5582744|NCT00957736|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5582745|NCT00957736|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5582746|NCT00957736|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5582747|NCT00957736|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5582748|NCT00957736|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5582749|NCT00957736|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5582750|NCT00957736|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5582751|NCT00957736|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5582752|NCT00957736|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5582753|NCT00957736|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5582754|NCT00957736|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5582755|NCT00957736|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5582980|NCT00956969|emotional expression|emotional expression
5582756|NCT00957736|noncontiguous (NC) stage II adult Burkitt lymphoma|noncontiguous (nc) stage ii adult burkitt lymphoma
5582757|NCT00957736|NC stage II adult diffuse large cell lymphoma|nc stage ii adult diffuse large cell lymphoma
5582758|NCT00957736|NC stage II adult diffuse mixed cell lymphoma|nc stage ii adult diffuse mixed cell lymphoma
5582759|NCT00957736|NC stage II adult diffuse small cleaved cell lymphoma|nc stage ii adult diffuse small cleaved cell lymphoma
5582760|NCT00957736|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
5582761|NCT00957736|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
5582762|NCT00957736|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
5582763|NCT00957736|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
5582764|NCT00957736|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
5582765|NCT00957736|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
5582766|NCT00957736|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
5582767|NCT00957736|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
5582768|NCT00957736|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5582769|NCT00957736|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5582770|NCT00957736|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5582771|NCT00957736|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5582772|NCT00957736|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5582773|NCT00957736|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5582775|NCT00957736|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5582776|NCT00957736|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5582777|NCT00957736|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5582778|NCT00957736|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5582779|NCT00957736|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5582780|NCT00957736|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5582781|NCT00957736|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5582782|NCT00957736|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5582783|NCT00957736|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5582784|NCT00957736|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5582785|NCT00957736|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5582786|NCT00957736|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5582787|NCT00957736|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5582788|NCT00957736|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5582789|NCT00957736|refractory hairy cell leukemia|refractory hairy cell leukemia
5582790|NCT00957736|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5582791|NCT00957736|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5582792|NCT00957736|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5582793|NCT00957736|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5582794|NCT00957736|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5582795|NCT00957736|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5582796|NCT00957736|primary myelofibrosis|primary myelofibrosis
5582797|NCT00957736|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5582798|NCT00957736|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5582799|NCT00957736|disseminated neuroblastoma|disseminated neuroblastoma
5582800|NCT00957736|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5582801|NCT00957736|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5582802|NCT00957736|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5582803|NCT00957736|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5582804|NCT00957736|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5582805|NCT00957736|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5582806|NCT00957736|recurrent neuroblastoma|recurrent neuroblastoma
5582807|NCT00957736|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5582808|NCT00957736|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5582809|NCT00957736|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5582810|NCT00957736|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5582811|NCT00957736|stage I multiple myeloma|stage i multiple myeloma
5582812|NCT00957736|stage II multiple myeloma|stage ii multiple myeloma
5582813|NCT00957736|stage III multiple myeloma|stage iii multiple myeloma
5582814|NCT00957736|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5582815|NCT00957736|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5582816|NCT00957736|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5582817|NCT00957736|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5582818|NCT00957736|stage IIIA breast cancer|stage iiia breast cancer
5582819|NCT00957736|stage IIIB breast cancer|stage iiib breast cancer
5582820|NCT00957736|stage IIIC breast cancer|stage iiic breast cancer
5582821|NCT00957736|stage IV breast cancer|stage iv breast cancer
5582822|NCT00957736|refractory multiple myeloma|refractory multiple myeloma
5582823|NCT00957710|progressive aphasia|progressive aphasia
5582824|NCT00957710|semantic dementia|semantic dementia
5582826|NCT00957710|treatment|treatment
5582827|NCT00957710|errorless learning|errorless learning
5582828|NCT00957697|Central Neuropathic Pain|central neuropathic pain
5582829|NCT00957697|Central Post-Stroke Pain|central post-stroke pain
5582830|NCT00957697|Stroke|stroke
5582831|NCT00957697|Pain|pain
5582832|NCT00957684|refractory|refractory
5582833|NCT00957684|partial|partial
5582834|NCT00957684|epilepsy|epilepsy
5582835|NCT00957671|TBI|tbi
5582836|NCT00957671|Traumatic Brain injury|traumatic brain injury
5582837|NCT00957671|Growth hormone deficiency|growth hormone deficiency
5582838|NCT00957671|Anterior pituitary hormone|anterior pituitary hormone
5582839|NCT00957671|Recombinant human growth Hormone|recombinant human growth hormone
5582840|NCT00957671|Genotropin|genotropin
5582841|NCT00957658|Osteoarthritis|osteoarthritis
5582842|NCT00957645|Central post-stroke pain|central post-stroke pain
5582843|NCT00957645|post-stroke pain|post-stroke pain
5582844|NCT00957645|shoulder pain|shoulder pain
5582845|NCT00957619|pentoxyfilline|pentoxyfilline
5582846|NCT00957619|liver regeneration|liver regeneration
5582847|NCT00957619|major liver resection|major liver resection
5582848|NCT00957619|reduction of the I/R injury|reduction of the i/r injury
5582849|NCT00957606|Prostate cancer|prostate cancer
5582850|NCT00957606|androgen deprivation therapy|androgen deprivation therapy
5582851|NCT00957606|osteoporosis|osteoporosis
5582852|NCT00957593|Induction of labor in term pregnancies|induction of labor in term pregnancies
5582853|NCT00957593|Term pregnancy|term pregnancy
5582854|NCT00957593|Cesarean delivery|cesarean delivery
5582855|NCT00957580|MEK Inhibitor|mek inhibitor
5582856|NCT00957580|Pimasertib|pimasertib
5582857|NCT00957580|Acute Myeloid Leukemia|acute myeloid leukemia
5582858|NCT00957580|Hematological Malignancies|hematological malignancies
5582859|NCT00957580|Elderly Patients|elderly patients
5582860|NCT00957580|Phase II|phase ii
5582861|NCT00957541|NYHA Class III or IV|nyha class iii or iv
5582862|NCT00957541|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5582863|NCT00957541|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5582864|NCT00957528|Low Normal Testosterone|low normal testosterone
5582865|NCT00957528|Male|male
5582866|NCT00957528|Aging|aging
5582867|NCT00957489|Orthodontic treatment of Class II division 1 malocclusion|orthodontic treatment of class ii division 1 malocclusion
5582868|NCT00957476|Pregnancy|pregnancy
5582869|NCT00957476|Metabolic Diseases|metabolic diseases
5582870|NCT00957476|Obesity|obesity
5582871|NCT00957476|Fetal adiposity|fetal adiposity
5582872|NCT00957476|Omega-3|omega-3
5582873|NCT00957476|Inflammation|inflammation
5582874|NCT00957476|Insulin Resistance|insulin resistance
5582876|NCT00957450|cervix cancer|cervix cancer
5582877|NCT00957450|intra-pelvic organ motion|intra-pelvic organ motion
5582878|NCT00957450|cervical cancer and CBCT|cervical cancer and cbct
5582880|NCT00957437|healthy volunteer|healthy volunteer
5582881|NCT00957437|male|male
5582882|NCT00957437|pharmacokinetics|pharmacokinetics
5582883|NCT00957437|AZD1305|azd1305
5582884|NCT00957424|tobacco use disorder|tobacco use disorder
5582885|NCT00957424|bladder cancer|bladder cancer
5582886|NCT00957424|cervical cancer|cervical cancer
5582887|NCT00957424|esophageal cancer|esophageal cancer
5582888|NCT00957424|gastric cancer|gastric cancer
5582889|NCT00957424|renal cell carcinoma|renal cell carcinoma
5582890|NCT00957424|adult primary liver cancer|adult primary liver cancer
5582891|NCT00957424|non-small cell lung cancer|non-small cell lung cancer
5582892|NCT00957424|small cell lung cancer|small cell lung cancer
5582893|NCT00957424|pancreatic cancer|pancreatic cancer
5582894|NCT00957424|hypopharyngeal cancer|hypopharyngeal cancer
5582895|NCT00957424|laryngeal cancer|laryngeal cancer
5582896|NCT00957424|lip and oral cavity cancer|lip and oral cavity cancer
5582897|NCT00957424|nasopharyngeal cancer|nasopharyngeal cancer
5582898|NCT00957424|oropharyngeal cancer|oropharyngeal cancer
5582899|NCT00957424|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5582900|NCT00957424|adult acute myeloid leukemia|adult acute myeloid leukemia
5582901|NCT00957411|stage IB cervical cancer|stage ib cervical cancer
5582902|NCT00957411|stage IIA cervical cancer|stage iia cervical cancer
5582903|NCT00957411|stage IIB cervical cancer|stage iib cervical cancer
5582904|NCT00957411|stage III cervical cancer|stage iii cervical cancer
5582905|NCT00957411|cervical adenocarcinoma|cervical adenocarcinoma
5582906|NCT00957411|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5582907|NCT00957398|Irritable Bowel Syndrome|irritable bowel syndrome
5582908|NCT00957398|Irritable Bowel Syndrome subgroups|irritable bowel syndrome subgroups
5582910|NCT00957385|Leukemia|leukemia
5582911|NCT00957385|Remission|remission
5582912|NCT00957372|epilepsy|epilepsy
5582913|NCT00957359|Cancer|cancer
5582914|NCT00957359|Anxiety|anxiety
5582915|NCT00957359|Depression|depression
5582916|NCT00957359|Hallucinogens|hallucinogens
5582917|NCT00957346|Pregnancy termination|pregnancy termination
5582918|NCT00957346|abortion|abortion
5582919|NCT00957346|medical abortion|medical abortion
5582920|NCT00957346|2nd trimester|2nd trimester
5582921|NCT00957346|mifepristone|mifepristone
5582922|NCT00957346|misoprostol|misoprostol
5582923|NCT00957333|ketamine|ketamine
5582924|NCT00957333|bladder dysfunction|bladder dysfunction
5582925|NCT00957333|bladder mucosa|bladder mucosa
5582926|NCT00957333|mechanisms|mechanisms
5582927|NCT00957320|leukemia|leukemia
5582928|NCT00957320|cancer|cancer
5582929|NCT00957320|oncology|oncology
5582930|NCT00957320|sirolimus|sirolimus
5582932|NCT00957281|Asthma|asthma
5582933|NCT00957281|Systemic inflammation|systemic inflammation
5582934|NCT00957281|Oxidative stress|oxidative stress
5582935|NCT00957281|Cardiovascular morbidity|cardiovascular morbidity
5582936|NCT00957281|Airway inflammation|airway inflammation
5582937|NCT00957268|Type 2 diabetes mellitus|type 2 diabetes mellitus
5582938|NCT00957268|Non-insulin dependent diabetes mellitus|non-insulin dependent diabetes mellitus
5582939|NCT00957268|Drug therapy|drug therapy
5582940|NCT00957268|Pediatrics|pediatrics
5577089|NCT00979615|VMR|vmr
5582941|NCT00957255|rotator cuff tear|rotator cuff tear
5582942|NCT00957255|rotator cuff repair|rotator cuff repair
5759517|NCT00285662|SP|sp
5582944|NCT00957242|Warfarin|warfarin
5582945|NCT00957216|adult onset ataxia|adult onset ataxia
5582946|NCT00957203|Parkinson's disease|parkinson's disease
5582947|NCT00957203|levodopa|levodopa
5582948|NCT00957203|end of dose wearing off|end of dose wearing off
5582949|NCT00957203|OFF time|off time
5582950|NCT00957190|Ocular Hypertension|ocular hypertension
5582951|NCT00957190|Open Angle Glaucoma|open angle glaucoma
5582952|NCT00957164|Chronic pain|chronic pain
5582953|NCT00957164|PTSD|ptsd
5582954|NCT00957151|chronic pancreatitis|chronic pancreatitis
5582955|NCT00957151|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5582956|NCT00957151|enzyme therapy|enzyme therapy
5582957|NCT00957151|patients with chronic pancreatitis and exocrine pancreatic insufficiency|patients with chronic pancreatitis and exocrine pancreatic insufficiency
5582958|NCT00957151|taking enzyme replacement therapy|taking enzyme replacement therapy
5582959|NCT00957125|Localized primary breast cancer|localized primary breast cancer
5582960|NCT00957125|Inflammatory breast cancer|inflammatory breast cancer
5582961|NCT00957112|anxiety disorder|anxiety disorder
5582962|NCT00957112|depression|depression
5582963|NCT00957112|fatigue|fatigue
5582964|NCT00957112|stage IA breast cancer|stage ia breast cancer
5582965|NCT00957112|stage IB breast cancer|stage ib breast cancer
5582966|NCT00957112|stage II breast cancer|stage ii breast cancer
5582967|NCT00957112|stage IIIA breast cancer|stage iiia breast cancer
5582968|NCT00957086|Phase III Adjuvant Concurrent Chemo-RT +/- nimotuzumab|phase iii adjuvant concurrent chemo-rt +/- nimotuzumab
5582969|NCT00957073|Heart Failure|heart failure
5582970|NCT00957073|Diastolic dysfunction|diastolic dysfunction
5582971|NCT00957047|refractory|refractory
5582972|NCT00957047|partial|partial
5582973|NCT00957047|epilepsy|epilepsy
5582974|NCT00957021|Knee|knee
5582975|NCT00956982|Hepatitis C Virus Pegylated Interferon Ribavirin Older|hepatitis c virus pegylated interferon ribavirin older
5582976|NCT00956969|headaches|headaches
5582977|NCT00956969|stress management|stress management
5582978|NCT00956969|assertiveness training|assertiveness training
5582979|NCT00956969|relaxation training|relaxation training
5582981|NCT00956956|An investigator and subject blinded (sponsor open)|an investigator and subject blinded (sponsor open)
5582982|NCT00956956|multiple dose|multiple dose
5582983|NCT00956956|dose escalation design with PF 04455242 and matching placebo.|dose escalation design with pf 04455242 and matching placebo.
5582984|NCT00956943|nicotine dependence|nicotine dependence
5582985|NCT00956943|nicotine replacement therapy|nicotine replacement therapy
5582986|NCT00956943|transdermal nicotine|transdermal nicotine
5582987|NCT00956943|nicotine metabolism|nicotine metabolism
5582988|NCT00956943|high dose|high dose
5582989|NCT00956930|advanced adult primary liver cancer|advanced adult primary liver cancer
5582990|NCT00956930|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5582991|NCT00956930|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5582992|NCT00956930|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5582993|NCT00956904|Prostate Cancer|prostate cancer
5582994|NCT00956904|Prostatectomy|prostatectomy
5582995|NCT00956904|Transrectal Ultrasound|transrectal ultrasound
5582996|NCT00956904|Tandem RALP|tandem ralp
5582997|NCT00956891|short-term effects|short-term effects
5582998|NCT00956891|long-term follow-up|long-term follow-up
5582999|NCT00956891|liver failure patients|liver failure patients
5583000|NCT00956891|autologous MSCs transplantation|autologous mscs transplantation
5583001|NCT00956878|Cancer|cancer
5583002|NCT00956878|Pain|pain
5583003|NCT00956878|SNP|snp
5583004|NCT00956865|Glaucoma|glaucoma
5583005|NCT00956865|Intervention|intervention
5583006|NCT00956865|Follow up|follow up
5583007|NCT00956839|Tropical calcific pancreatitis|tropical calcific pancreatitis
5583008|NCT00956839|Tropical chronic pancreatitis|tropical chronic pancreatitis
5583009|NCT00956839|Chronic pancreatitis|chronic pancreatitis
5583010|NCT00956839|Vitamin D|vitamin d
5583011|NCT00956839|Vitamin D deficiency|vitamin d deficiency
5583012|NCT00956839|Cholecalciferol|cholecalciferol
5583013|NCT00956839|Intramuscular vitamin D3|intramuscular vitamin d3
5583014|NCT00956826|electrode vacuum delivery|electrode vacuum delivery
5583015|NCT00956813|menopausal symptoms|menopausal symptoms
5583016|NCT00956813|hot flashes|hot flashes
5583017|NCT00956813|breast cancer|breast cancer
5583018|NCT00956813|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5583019|NCT00956787|Myelodysplastic Syndrome|myelodysplastic syndrome
5583020|NCT00956774|HSG|hsg
5583021|NCT00956774|Cannula|cannula
5583022|NCT00956774|HSG procedure|hsg procedure
5583023|NCT00956774|infertility evaluation|infertility evaluation
5583024|NCT00956761|Influenza vaccine|influenza vaccine
5583025|NCT00956748|chronic suppurative otitis media with persistent otorrhea|chronic suppurative otitis media with persistent otorrhea
5583026|NCT00956735|Cardiovascular Disease|cardiovascular disease
5583027|NCT00956735|Type II Diabetes|type ii diabetes
5583028|NCT00956735|Nutrition|nutrition
5583029|NCT00956735|Pistachios|pistachios
5862981|NCT00001430|Continuous Infusion|continuous infusion
5583036|NCT00956657|Patient Participation|patient participation
5583037|NCT00956631|Spinal Stenosis|spinal stenosis
5583038|NCT00956631|Lumbar Spinal Stenosis|lumbar spinal stenosis
5583039|NCT00956605|EEG-biofeedback|eeg-biofeedback
5583040|NCT00956605|neurofeedback|neurofeedback
5583041|NCT00956605|computer attention training systems|computer attention training systems
5583042|NCT00956605|ADHD|adhd
5583043|NCT00956605|ADD|add
5583044|NCT00956605|child|child
5583045|NCT00956605|children|children
5583046|NCT00956592|Video laryngoscopy|video laryngoscopy
5583047|NCT00956592|Intubation success|intubation success
5583048|NCT00956592|Difficult airway|difficult airway
5583049|NCT00956592|CMAC laryngoscope|cmac laryngoscope
5583050|NCT00956579|autism|autism
5583051|NCT00956579|autistic|autistic
5583052|NCT00956579|sensory|sensory
5583053|NCT00956579|MEG|meg
5583054|NCT00956579|connectivity|connectivity
5583055|NCT00956579|brain|brain
5583056|NCT00956579|MRI|mri
5583057|NCT00956579|language|language
5583058|NCT00956579|developmental|developmental
5583059|NCT00956579|neurodevelopmental|neurodevelopmental
5583060|NCT00956579|aspergers|aspergers
5583061|NCT00956579|asperger's|asperger's
5583062|NCT00956579|coherence|coherence
5583063|NCT00956553|HPV|hpv
5583064|NCT00956553|Human Papilloma Virus|human papilloma virus
5583065|NCT00956553|Cervical cancer vaccine|cervical cancer vaccine
5583066|NCT00956540|Tracheostomy|tracheostomy
5583067|NCT00956540|decannulation|decannulation
5583068|NCT00956540|weaning|weaning
5583069|NCT00956540|Tracheostomy Weaning|tracheostomy weaning
5583070|NCT00956527|Adolescent|adolescent
5583071|NCT00956527|Substance Use|substance use
5583072|NCT00956527|Early Intervention|early intervention
5583073|NCT00956527|Martial Arts|martial arts
5583074|NCT00956527|Karate|karate
5583075|NCT00956514|depression|depression
5583076|NCT00956514|major depressive disorder|major depressive disorder
5583077|NCT00956514|transcranial magnetic stimulation|transcranial magnetic stimulation
5583078|NCT00956514|TMS|tms
5583079|NCT00956514|EEG|eeg
5583080|NCT00956514|electroencephalography|electroencephalography
5583081|NCT00956514|Major Depression,|major depression,
5583082|NCT00956501|fall|fall
5583083|NCT00956501|balance|balance
5583084|NCT00956488|Exercise for Amyotrophic lateral sclerosis|exercise for amyotrophic lateral sclerosis
5583085|NCT00956475|anxiety disorder|anxiety disorder
5583086|NCT00956475|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5583087|NCT00956475|fatigue|fatigue
5583088|NCT00956475|pain|pain
5583089|NCT00956475|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5583090|NCT00956475|cancer survivor|cancer survivor
5583091|NCT00956475|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5583092|NCT00956475|acute undifferentiated leukemia|acute undifferentiated leukemia
5583093|NCT00956475|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5583094|NCT00956475|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5583095|NCT00956475|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5583096|NCT00956475|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5583097|NCT00956475|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5583098|NCT00956475|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5583099|NCT00956475|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5583100|NCT00956475|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5583101|NCT00956475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5583102|NCT00956475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5583103|NCT00956475|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5583104|NCT00956475|mast cell leukemia|mast cell leukemia
5583105|NCT00956475|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5583106|NCT00956475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5577282|NCT00978835|Diabetes|diabetes
5583107|NCT00956475|prolymphocytic leukemia|prolymphocytic leukemia
5583108|NCT00956475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5583109|NCT00956475|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5583110|NCT00956475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5583111|NCT00956475|refractory hairy cell leukemia|refractory hairy cell leukemia
5583112|NCT00956475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5583113|NCT00956475|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5583114|NCT00956475|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5583115|NCT00956475|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5583116|NCT00956475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5583117|NCT00956475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5583118|NCT00956475|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5583119|NCT00956475|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5583120|NCT00956475|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5583121|NCT00956475|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5583122|NCT00956475|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5583123|NCT00956475|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5583124|NCT00956475|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5583125|NCT00956475|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5583126|NCT00956475|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5583127|NCT00956475|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5583128|NCT00956475|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5583129|NCT00956475|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5583130|NCT00956475|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5583131|NCT00956475|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5583132|NCT00956475|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5583133|NCT00956475|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5583134|NCT00956475|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5583135|NCT00956475|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5583136|NCT00956475|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5583145|NCT00956475|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5583147|NCT00956475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5583148|NCT00956475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5583149|NCT00956475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5583150|NCT00956475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5583151|NCT00956475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5583152|NCT00956475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5583153|NCT00956475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5583154|NCT00956475|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5583155|NCT00956475|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5583156|NCT00956475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5583157|NCT00956475|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5583158|NCT00956475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5583159|NCT00956475|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5583160|NCT00956475|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5583161|NCT00956475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5583162|NCT00956475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5583163|NCT00956475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5583164|NCT00956475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5583165|NCT00956475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5583166|NCT00956475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5583167|NCT00956475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5583168|NCT00956475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5583169|NCT00956475|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5583170|NCT00956475|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5583171|NCT00956475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5583172|NCT00956475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5583173|NCT00956475|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5583174|NCT00956475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5583175|NCT00956475|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5583176|NCT00956475|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5583177|NCT00956475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5672111|NCT00612989|Temodar|temodar
5583178|NCT00956475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5862982|NCT00001430|Peripheral Stem Cells|peripheral stem cells
5583179|NCT00956475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5583180|NCT00956475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5583181|NCT00956475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5583182|NCT00956475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5583183|NCT00956475|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5583184|NCT00956475|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5583185|NCT00956475|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5583186|NCT00956475|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5583187|NCT00956475|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5583188|NCT00956475|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5583189|NCT00956475|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5583190|NCT00956475|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5583191|NCT00956475|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5583192|NCT00956475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5583193|NCT00956475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5583194|NCT00956475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5583195|NCT00956475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5583196|NCT00956475|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5583197|NCT00956475|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5583198|NCT00956475|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5583199|NCT00956475|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5583200|NCT00956475|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5583201|NCT00956475|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5583202|NCT00956475|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5583203|NCT00956475|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5583204|NCT00956475|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5583205|NCT00956475|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5583206|NCT00956475|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5583207|NCT00956475|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5583208|NCT00956475|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5583209|NCT00956475|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5583210|NCT00956475|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5583211|NCT00956475|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5583212|NCT00956475|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5583213|NCT00956475|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5583214|NCT00956475|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5680336|NCT00578175|Varicella Vaccine|varicella vaccine
5583215|NCT00956475|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5583216|NCT00956475|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5583217|NCT00956475|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5583218|NCT00956475|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5583219|NCT00956475|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5583220|NCT00956475|intraocular lymphoma|intraocular lymphoma
5583221|NCT00956475|primary central nervous system lymphoma|primary central nervous system lymphoma
5583222|NCT00956475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5583223|NCT00956475|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5583224|NCT00956475|small intestine lymphoma|small intestine lymphoma
5583225|NCT00956462|intraocular pressure|intraocular pressure
5583226|NCT00956462|Ahmed valve|ahmed valve
5583227|NCT00956462|NSAIDS|nsaids
5583228|NCT00956462|steroids|steroids
5583230|NCT00956449|influenza|influenza
5583231|NCT00956449|seasonal influenza|seasonal influenza
5583232|NCT00956449|influenza vaccine antigen|influenza vaccine antigen
5583233|NCT00956449|immunogenicity|immunogenicity
5583234|NCT00956449|safety|safety
5583235|NCT00956449|tolerability|tolerability
5583236|NCT00956449|antibody response|antibody response
5583237|NCT00956449|intra muscular|intra muscular
5583238|NCT00956449|elderly|elderly
5583239|NCT00956449|non-elderly|non-elderly
5583240|NCT00956436|Liver Cancer|liver cancer
5583241|NCT00956436|Hepatocellular Carcinoma|hepatocellular carcinoma
5583242|NCT00956436|Sorafenib|sorafenib
5583243|NCT00956436|HCC|hcc
5583244|NCT00956436|BIIB022|biib022
5583245|NCT00956436|Open-Label|open-label
5583246|NCT00956436|IGF-1R|igf-1r
5583247|NCT00956436|Nexavar|nexavar
5583248|NCT00956423|obstructive sleep apnea|obstructive sleep apnea
5583249|NCT00956423|exercise training|exercise training
5583250|NCT00956423|aerobic exercise|aerobic exercise
5583251|NCT00956423|resistance exercise|resistance exercise
5583252|NCT00956410|Active immunization|active immunization
5583253|NCT00956410|Alzheimer disease|alzheimer disease
5583254|NCT00956410|Antibody|antibody
5583255|NCT00956410|Central Nervous System Diseases|central nervous system diseases
5583256|NCT00956410|Neurodegenerative diseases|neurodegenerative diseases
5583257|NCT00956410|Vaccine|vaccine
5583258|NCT00956397|Functional Dyspepsia|functional dyspepsia
5583259|NCT00956397|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5583260|NCT00956397|chronic abdominal discomfort|chronic abdominal discomfort
5583261|NCT00956384|Breast reconstruction|breast reconstruction
5583262|NCT00956384|Early stage|early stage
5583263|NCT00956384|Skin-saving mastectomy|skin-saving mastectomy
5583264|NCT00956384|Prophylactic mastectomy|prophylactic mastectomy
5583265|NCT00956384|Acellular dermal matrix|acellular dermal matrix
5583266|NCT00956384|BRCA Mutation Carriers|brca mutation carriers
5583267|NCT00956371|ONO-7746|ono-7746
5583268|NCT00956371|Healthy adult subjects|healthy adult subjects
5583269|NCT00956358|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5565643|NCT01024361|Preterm infants|preterm infants
5583270|NCT00956332|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
5583271|NCT00956332|Peripheral vascular disease (PVD)|peripheral vascular disease (pvd)
5583272|NCT00956332|Critical limb ischemia (CLI)|critical limb ischemia (cli)
5583273|NCT00956332|Cell therapy|cell therapy
5583274|NCT00956332|Gene therapy|gene therapy
5583275|NCT00956332|Endothelial cells|endothelial cells
5583276|NCT00956332|Smooth muscle cells|smooth muscle cells
5583277|NCT00956332|Angiogenesis|angiogenesis
5583278|NCT00956332|Arteriogenesis|arteriogenesis
5583279|NCT00956332|amputation|amputation
5583280|NCT00956332|diabetic foot|diabetic foot
5583281|NCT00956319|Insomnia|insomnia
5583282|NCT00956319|Zolpidem|zolpidem
5583283|NCT00956319|Estazolam|estazolam
5583284|NCT00956306|Udenafil,DA-8159,hepatic impairment,healthy volunteers|udenafil,da-8159,hepatic impairment,healthy volunteers
5583285|NCT00956280|The frequency and type of KRAS mutation in a sample of the Brazilian population with advanced NSCLC|the frequency and type of kras mutation in a sample of the brazilian population with advanced nsclc
5583286|NCT00956280|KRAS mutation in population with advanced NSCLC|kras mutation in population with advanced nsclc
5583287|NCT00956267|Polycystic ovary syndrome|polycystic ovary syndrome
5583288|NCT00956267|clomiphene resistance|clomiphene resistance
5583289|NCT00956267|letrozole|letrozole
5583290|NCT00956267|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5583291|NCT00956254|mucositis|mucositis
5583292|NCT00956254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5583293|NCT00956254|pain|pain
5583294|NCT00956241|rectal cancer|rectal cancer
5583295|NCT00956241|colonic pouch|colonic pouch
5583296|NCT00956241|side-to-end anastomosis|side-to-end anastomosis
5583297|NCT00956241|preoperative radiotherapy|preoperative radiotherapy
5583298|NCT00956215|post operative|post operative
5583299|NCT00956215|obese|obese
5583300|NCT00956202|Influenza|influenza
5583301|NCT00956202|Pandemic Flu|pandemic flu
5583302|NCT00956202|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5583303|NCT00956202|Inactivated split-virion vaccine|inactivated split-virion vaccine
5583304|NCT00956202|Adjuvant|adjuvant
5583305|NCT00956189|Antipsychotic Agents|antipsychotic agents
5583306|NCT00956189|Metabolic Syndrome X|metabolic syndrome x
5583307|NCT00956189|Identification|identification
5583308|NCT00956189|Prediction|prediction
5583309|NCT00956176|Cidofovir|cidofovir
5583310|NCT00956176|Vistide|vistide
5583311|NCT00956176|Adenovirus|adenovirus
5583312|NCT00956176|BK virus infections|bk virus infections
5583313|NCT00956176|HSCT|hsct
5583314|NCT00956176|Hemorrhagic Cystitis|hemorrhagic cystitis
5583315|NCT00956176|Foley catheter|foley catheter
5583316|NCT00956176|Viral infection|viral infection
5583317|NCT00956176|Bladder instillation|bladder instillation
5583318|NCT00956176|Intravesical|intravesical
5583319|NCT00956176|Transurethral catheter|transurethral catheter
5583320|NCT00956176|Transplantation|transplantation
5583321|NCT00956150|Chronic Multisymptom Complex|chronic multisymptom complex
5583322|NCT00956150|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5583323|NCT00956150|Gulf War Syndrome|gulf war syndrome
5583324|NCT00956150|Chronic Multisymptom Illness Complex|chronic multisymptom illness complex
5583325|NCT00956137|spinal anesthesia|spinal anesthesia
5583326|NCT00956137|ultrasound|ultrasound
5583327|NCT00956137|palpation|palpation
5583328|NCT00956137|knee|knee
5583330|NCT00956137|surgery|surgery
5583331|NCT00956137|intervertebral space|intervertebral space
5583332|NCT00956111|Novel Influenza A/H1N1 Vaccine|novel influenza a/h1n1 vaccine
5583333|NCT00956111|Immunogenictiy|immunogenictiy
5583334|NCT00956111|Safety|safety
5583336|NCT00956072|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5583337|NCT00956059|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5583338|NCT00956059|prednisone|prednisone
5583339|NCT00956059|mycophenolate mofetil|mycophenolate mofetil
5583340|NCT00956059|FK506|fk506
5583341|NCT00956046|Influenza|influenza
5583342|NCT00956046|Pandemic Flu|pandemic flu
5583343|NCT00956046|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5583344|NCT00956046|Swine-origin Influenza Virus|swine-origin influenza virus
5583345|NCT00956046|Infants|infants
5583346|NCT00956033|Cancer|cancer
5583347|NCT00956033|Peripheral Neuropathy|peripheral neuropathy
5583348|NCT00956033|Bortezomib|bortezomib
5583349|NCT00956020|platelet rich plasma|platelet rich plasma
5583350|NCT00956020|fibrin matrix|fibrin matrix
5583351|NCT00956020|dermal filler|dermal filler
5583352|NCT00956007|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5583353|NCT00956007|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5583354|NCT00956007|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5583355|NCT00956007|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5583356|NCT00956007|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5583357|NCT00956007|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5583358|NCT00956007|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5583359|NCT00956007|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5583360|NCT00956007|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5583361|NCT00956007|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5583362|NCT00956007|tongue cancer|tongue cancer
5583363|NCT00955968|HIV Infection|hiv infection
5583364|NCT00955968|HAART|haart
5583365|NCT00955968|Maternal Health|maternal health
5583366|NCT00955955|Depression|depression
5583367|NCT00955955|Medical food|medical food
5583368|NCT00955942|radiation toxicity|radiation toxicity
5583369|NCT00955942|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5583370|NCT00955942|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5583371|NCT00955942|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5583372|NCT00955942|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5583374|NCT00955929|PLACEBO|placebo
5583375|NCT00955929|SILDENAFIL CITRATE|sildenafil citrate
5583376|NCT00955929|TRIMIX|trimix
5583377|NCT00955929|Bimix|bimix
5583378|NCT00955929|Viagra|viagra
5583379|NCT00955929|09-005|09-005
5583380|NCT00955929|Erectile Dysfunction following Bilateral Nerve-Sparing|erectile dysfunction following bilateral nerve-sparing
5583381|NCT00955916|relapsed|relapsed
5583382|NCT00955916|refractory|refractory
5583383|NCT00955916|acute|acute
5583384|NCT00955916|myeloid|myeloid
5583387|NCT00955916|blast crisis|blast crisis
5583388|NCT00955903|glucose|glucose
5583389|NCT00955903|insulin|insulin
5583390|NCT00955903|lipids|lipids
5583391|NCT00955903|C-reactive protein|c-reactive protein
5583392|NCT00955903|adiponectin|adiponectin
5583393|NCT00955903|leptin|leptin
5583394|NCT00955903|TNF alpha|tnf alpha
5583395|NCT00955903|IL-6|il-6
5583396|NCT00955903|Quality of Life|quality of life
5583397|NCT00955903|functional status|functional status
5680337|NCT00578175|Children|children
5568357|NCT01013246|Video games|video games
5583398|NCT00955890|cardioprotection|cardioprotection
5583399|NCT00955890|anthracycline chemotherapy|anthracycline chemotherapy
5583400|NCT00955890|breast cancer|breast cancer
5583401|NCT00955877|extended-release epidural morphine|extended-release epidural morphine
5583402|NCT00955877|DepoDur|depodur
5583403|NCT00955877|Spastic Cerebral Palsy|spastic cerebral palsy
5583404|NCT00955864|Cervix|cervix
5583405|NCT00955864|Colposcope|colposcope
5583406|NCT00955864|Polarized Light|polarized light
5583407|NCT00955864|Cervix Structure|cervix structure
5583408|NCT00955864|Collagen|collagen
5583409|NCT00955864|HV|hv
5583410|NCT00955864|Healthy Volunteer|healthy volunteer
5583411|NCT00955864|Healthy Women|healthy women
5583412|NCT00955825|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5583413|NCT00955812|OPB-31121|opb-31121
5583414|NCT00955812|Advanced Solid Tumor|advanced solid tumor
5583415|NCT00955812|STAT3|stat3
5583416|NCT00955812|IL-6-induced STAT3 phosphorylation|il-6-induced stat3 phosphorylation
5583417|NCT00955799|Subjective, Tinnitus|subjective, tinnitus
5583418|NCT00955786|Solid Tumors|solid tumors
5583419|NCT00955786|Lymphoma|lymphoma
5583420|NCT00955786|G-Quadruplex|g-quadruplex
5583421|NCT00955773|GSK1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, KRAS-mutant|gsk1120212, everolimus, solid tumors, pancreatic cancer, non-small lung cancer, kras-mutant
5583422|NCT00955773|cancer|cancer
5583423|NCT00955760|Healthy subjects|healthy subjects
5583424|NCT00955734|wrist|wrist
5583425|NCT00955734|fracture|fracture
5583426|NCT00955734|motion|motion
5583427|NCT00955734|surgery|surgery
5583428|NCT00955721|Cholangiocarcinoma|cholangiocarcinoma
5583429|NCT00955721|Biliary Tract Cancer|biliary tract cancer
5583430|NCT00955721|Gallbladder Cancer|gallbladder cancer
5583431|NCT00955695|adenocarcinoma of the lung|adenocarcinoma of the lung
5583432|NCT00955695|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5862983|NCT00001430|MDR|mdr
5583433|NCT00955695|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5583434|NCT00955695|large cell lung cancer|large cell lung cancer
5583435|NCT00955695|squamous cell lung cancer|squamous cell lung cancer
5583436|NCT00955695|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5583437|NCT00955695|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5583438|NCT00955682|Meningococcal vaccine GSK134612|meningococcal vaccine gsk134612
5583439|NCT00955669|mesenchymal stem cells|mesenchymal stem cells
5583441|NCT00955656|Characteristics of medical practices|characteristics of medical practices
5583442|NCT00955656|Practitioners providing care to children with asthma|practitioners providing care to children with asthma
5583443|NCT00955656|Medically underserved and impoverished Arkansas Delta region|medically underserved and impoverished arkansas delta region
5585970|NCT00946647|AML|aml
5798739|NCT00111215|Platelet Disorder|platelet disorder
5583444|NCT00955656|Characteristics of medical practices and practitioners|characteristics of medical practices and practitioners
5583445|NCT00955656|Disadvantaged populations|disadvantaged populations
5583447|NCT00955643|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5583448|NCT00955630|Histoplasmosis|histoplasmosis
5583449|NCT00955630|Lucentis|lucentis
5583450|NCT00955630|Ranibizumab|ranibizumab
5583452|NCT00955617|Dotarem|dotarem
5583453|NCT00955617|Gadovist|gadovist
5583454|NCT00955617|Peripheral arterial disease|peripheral arterial disease
5583455|NCT00955617|MRA|mra
5583456|NCT00955604|Parkinson's Disease|parkinson's disease
5583457|NCT00955604|Serotonin Toxicity|serotonin toxicity
5583458|NCT00955604|Rasagiline|rasagiline
5583459|NCT00955604|Antidepressants|antidepressants
5583460|NCT00955604|Chart Review|chart review
5583461|NCT00955604|Retrospective|retrospective
5583462|NCT00955591|human papilloma virus infection|human papilloma virus infection
5583463|NCT00955591|anal cancer|anal cancer
5583464|NCT00955591|HIV infection|hiv infection
5583465|NCT00955552|osteoarthritis (OA)|osteoarthritis (oa)
5583466|NCT00955552|knee|knee
5583467|NCT00955539|Heart Failure|heart failure
5583468|NCT00955539|Cardiac resynchronization therapy|cardiac resynchronization therapy
5583469|NCT00955539|Optimization|optimization
5583470|NCT00955539|Viability|viability
5583471|NCT00955539|Mechanical dyssynchrony|mechanical dyssynchrony
5583472|NCT00955526|Parkinson's disease|parkinson's disease
5583473|NCT00955526|levodopa|levodopa
5583474|NCT00955526|end of dose wearing off|end of dose wearing off
5583475|NCT00955526|OFF time|off time
5583476|NCT00955513|Ankle sprain|ankle sprain
5583477|NCT00955513|soft tissue injury|soft tissue injury
5583478|NCT00955500|Hepatic encephalopathy|hepatic encephalopathy
5583479|NCT00955500|Cirrhosis|cirrhosis
5583480|NCT00955500|Proteins of the diet|proteins of the diet
5583481|NCT00955500|Branched-chain amino acids|branched-chain amino acids
5583482|NCT00955487|Premature Newborns|premature newborns
5583483|NCT00955487|Inhaled Nitric Oxide|inhaled nitric oxide
5583484|NCT00955448|Anterior pelvic organ prolapse|anterior pelvic organ prolapse
5583485|NCT00955448|Surgical repair|surgical repair
5583486|NCT00955448|Pelvic floor surgery|pelvic floor surgery
5583487|NCT00955448|Randomized clinical trial|randomized clinical trial
5568452|NCT01012778|Yoga|yoga
5583488|NCT00955435|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5583489|NCT00955435|stage I prostate cancer|stage i prostate cancer
5583490|NCT00955435|stage IIB prostate cancer|stage iib prostate cancer
5583491|NCT00955435|stage IIA prostate cancer|stage iia prostate cancer
5583492|NCT00955435|stage III prostate cancer|stage iii prostate cancer
5583493|NCT00955422|Diagnosis|diagnosis
5583494|NCT00955422|Alzheimer's Disease|alzheimer's disease
5583495|NCT00955422|Memory Disorder|memory disorder
5583496|NCT00955422|Dementia|dementia
5583497|NCT00955422|Alzheimer Disease|alzheimer disease
5583498|NCT00955422|Memory Loss|memory loss
5583499|NCT00955396|sodium channel blocker|sodium channel blocker
5583500|NCT00955396|ambulatory blood pressure|ambulatory blood pressure
5583501|NCT00955383|Japanese|japanese
5583502|NCT00955370|Uncertainty|uncertainty
5583503|NCT00955370|Undiagnosed|undiagnosed
5583504|NCT00955370|Rare Diseases|rare diseases
5583506|NCT00955370|Multiple Abnormalities|multiple abnormalities
5583507|NCT00955357|Epilepsy Treatment|epilepsy treatment
5583508|NCT00955357|Anti-epileptic drugs|anti-epileptic drugs
5583509|NCT00955357|Seizures|seizures
5583510|NCT00955357|Vimpat|vimpat
5583511|NCT00955344|colorectal cancer screening|colorectal cancer screening
5583512|NCT00955344|American Board of Internal Medicine Maintenance of Certification program|american board of internal medicine maintenance of certification program
5583513|NCT00955344|Currently enrolled in or plan to enroll in the American Board of Internal Medicine Maintenance of Certification program|currently enrolled in or plan to enroll in the american board of internal medicine maintenance of certification program
5583514|NCT00955305|Non-Small Cell Lung Cancer|non-small cell lung cancer
5583515|NCT00955305|cixutumumab|cixutumumab
5583516|NCT00955292|Solid Tumors|solid tumors
5583517|NCT00955292|Lymphoma|lymphoma
5583518|NCT00955292|G-Quadruplex|g-quadruplex
5583519|NCT00955279|Ustekinumab|ustekinumab
5583520|NCT00955279|CNTO 1275|cnto 1275
5583521|NCT00955279|Stelara|stelara
5583522|NCT00955279|Golimumab|golimumab
5583523|NCT00955279|CNTO 148|cnto 148
5583525|NCT00955279|Sarcoidosis|sarcoidosis
5583526|NCT00955279|Sarcoid|sarcoid
5583527|NCT00955279|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5583528|NCT00955279|Skin Sarcoidosis|skin sarcoidosis
5583529|NCT00955266|Separation|separation
5583530|NCT00955266|Cardiopulmonary bypass|cardiopulmonary bypass
5583531|NCT00955266|Calcium chloride|calcium chloride
5583532|NCT00955253|Neglect|neglect
5583533|NCT00955253|Attention|attention
5583534|NCT00955253|Vigilance|vigilance
5583535|NCT00955253|Stroke|stroke
5583536|NCT00955253|Hemineglect|hemineglect
5583537|NCT00955253|Unilateral Neglect|unilateral neglect
5583538|NCT00955253|Spatial Neglect|spatial neglect
5583539|NCT00955240|stage II anal cancer|stage ii anal cancer
5583540|NCT00955240|stage IIIA anal cancer|stage iiia anal cancer
5583541|NCT00955240|stage IIIB anal cancer|stage iiib anal cancer
5583542|NCT00955240|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5583543|NCT00955227|Omega-3 Fatty acid|omega-3 fatty acid
5583544|NCT00955227|ALA (alpha linolenic acid)|ala (alpha linolenic acid)
5583545|NCT00955227|Ezetimibe|ezetimibe
5583546|NCT00955227|Flaxseed oil capsules|flaxseed oil capsules
5583547|NCT00955214|TAXUS Liberté|taxus liberté
5565937|NCT01023256|GM-CSF|gm-csf
5583548|NCT00955214|Small coronary artery disease|small coronary artery disease
5583549|NCT00955214|Paclitaxel-eluting stent|paclitaxel-eluting stent
5583550|NCT00955201|diabetes mellitus|diabetes mellitus
5583551|NCT00955201|diabetic neuropathies|diabetic neuropathies
5583552|NCT00955201|Aerobic Exercise|aerobic exercise
5583553|NCT00955201|Exercise Therapy|exercise therapy
5583554|NCT00955201|electromyography|electromyography
5583555|NCT00955201|United States Veterans|united states veterans
5583556|NCT00955188|colon cancer|colon cancer
5583557|NCT00955188|rectal cancer|rectal cancer
5583558|NCT00955175|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5583559|NCT00955175|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5583560|NCT00955175|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5583561|NCT00955175|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5583562|NCT00955162|Substance Abuse, Intravenous|substance abuse, intravenous
5583563|NCT00955162|Buprenorphine|buprenorphine
5583564|NCT00955149|Primary sclerosing cholangitis|primary sclerosing cholangitis
5583565|NCT00955149|Trisomy 7|trisomy 7
5583566|NCT00955149|Cholangiocarcinoma|cholangiocarcinoma
5583567|NCT00955149|Chemoprevention|chemoprevention
5583568|NCT00955149|Erlotinib|erlotinib
5583569|NCT00955136|ST elevated myocardial infarction|st elevated myocardial infarction
5583570|NCT00955136|Acute coronary syndrome|acute coronary syndrome
5583571|NCT00955136|MRX 801|mrx 801
5583572|NCT00955136|Echocardiography|echocardiography
5583573|NCT00955123|Inflammation|inflammation
5583574|NCT00955123|Urea synthesis|urea synthesis
5583575|NCT00955123|Catabolism|catabolism
5583576|NCT00955123|Nitrogen balance|nitrogen balance
5583577|NCT00955110|Opioid|opioid
5583578|NCT00955110|Recreational|recreational
5583579|NCT00955110|Oxymorphone|oxymorphone
5583580|NCT00955110|Oxycodone|oxycodone
5583581|NCT00955110|Extended Release|extended release
5583582|NCT00955110|Healthy NonDependent Recreational Opioid Users|healthy nondependent recreational opioid users
5583583|NCT00955097|Definity|definity
5583584|NCT00955097|liver tumors|liver tumors
5583585|NCT00955097|intra operative contrast|intra operative contrast
5583586|NCT00955097|liver cancer|liver cancer
5583587|NCT00955097|hepatic tumors|hepatic tumors
5583588|NCT00955097|identify liver tumors|identify liver tumors
5583589|NCT00955097|surgery liver tumors|surgery liver tumors
5583590|NCT00955097|Patients with known hepatic tumors|patients with known hepatic tumors
5583591|NCT00955071|exercise|exercise
5583592|NCT00955071|physical activity|physical activity
5583593|NCT00955071|diet|diet
5583594|NCT00955071|metabolic risk|metabolic risk
5583595|NCT00955071|visceral fat|visceral fat
5583596|NCT00955071|Insulin Resistance|insulin resistance
5583597|NCT00955058|PSA|psa
5583598|NCT00955058|PCO|pco
5583599|NCT00955058|PCOS|pcos
5583600|NCT00955045|long-term tolerability and safety|long-term tolerability and safety
5583601|NCT00955045|istradefylline treatment|istradefylline treatment
5583602|NCT00955045|levodopa/carbidopa|levodopa/carbidopa
5583603|NCT00955032|Parkinson's disease|parkinson's disease
5583604|NCT00955032|Apathy|apathy
5583605|NCT00955032|rTMS|rtms
5583606|NCT00955032|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5583607|NCT00955032|Depression|depression
5583608|NCT00955019|Barrett's|barrett's
5583609|NCT00955019|Esophagus|esophagus
5583610|NCT00955019|Reflux|reflux
5583611|NCT00955019|dysplasia|dysplasia
5583612|NCT00955019|adenocarcinoma|adenocarcinoma
5583613|NCT00955006|HIV Seronegativity|hiv seronegativity
5583614|NCT00955006|HIV Preventive Vaccine|hiv preventive vaccine
5583615|NCT00954993|Hepatitis C Virus (HCV)|hepatitis c virus (hcv)
5583616|NCT00954993|Vaniprevir|vaniprevir
5583617|NCT00954993|MK-7009|mk-7009
5583618|NCT00954980|Varicose Veins|varicose veins
5583619|NCT00954980|Superficial Thrombophlebitis|superficial thrombophlebitis
5583620|NCT00954980|Deep Vein Thrombosis|deep vein thrombosis
5583621|NCT00954980|Ulceration|ulceration
5583622|NCT00954980|leg pain|leg pain
5583623|NCT00954980|leg swelling|leg swelling
5583624|NCT00954967|Diabetes Mellitus|diabetes mellitus
5583625|NCT00954967|Smoking Cessation|smoking cessation
5583626|NCT00954967|Primary Health Care|primary health care
5583627|NCT00954967|Motivational Interview|motivational interview
5583628|NCT00954954|Arthroplasty|arthroplasty
5583629|NCT00954954|Replacement|replacement
5583630|NCT00954954|Knee|knee
5583631|NCT00954954|Range of Motion|range of motion
5583632|NCT00954941|Hematologic Disorder|hematologic disorder
5583633|NCT00954941|Acute myelogenous leukemia|acute myelogenous leukemia
5583635|NCT00954941|High-risk myelodysplastic syndrome|high-risk myelodysplastic syndrome
5583636|NCT00954941|HR-MDS|hr-mds
5583637|NCT00954941|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5583638|NCT00954941|CML|cml
5583639|NCT00954941|Ondansetron|ondansetron
5583640|NCT00954941|Zofran|zofran
5583641|NCT00954941|Aprepitant|aprepitant
5583642|NCT00954941|Emend|emend
5583643|NCT00954941|L 754030|l 754030
5583644|NCT00954941|MK 869|mk 869
5583645|NCT00954941|Emesis|emesis
5583646|NCT00954941|Nausea|nausea
5583647|NCT00954941|Vomiting|vomiting
5583648|NCT00954928|hand|hand
5583649|NCT00954928|wrist|wrist
5583650|NCT00954928|anticoagulation|anticoagulation
5583651|NCT00954928|surgery|surgery
5583652|NCT00954928|patients on anticoagulant medication|patients on anticoagulant medication
5583653|NCT00954915|chronic plaque psoriasis|chronic plaque psoriasis
5583654|NCT00954915|psoriatic arthritis|psoriatic arthritis
5583655|NCT00954902|Spice|spice
5583656|NCT00954902|responses to stress|responses to stress
5583657|NCT00954902|Inflammatory|inflammatory
5583658|NCT00954837|Thyroid cancer|thyroid cancer
5583659|NCT00954837|thyroid FNA|thyroid fna
5583660|NCT00954837|repeat FNA|repeat fna
5583661|NCT00954837|thyroid screening|thyroid screening
5583662|NCT00954837|thyroid ultrasonography|thyroid ultrasonography
5583663|NCT00954837|FNA screening|fna screening
5583664|NCT00954811|pregnancy|pregnancy
5583665|NCT00954798|Influenza|influenza
5583666|NCT00954798|Pandemic Flu|pandemic flu
5583667|NCT00954798|Swine-origin Influenza|swine-origin influenza
5583668|NCT00954798|Inactivated split-virion vaccine|inactivated split-virion vaccine
5583669|NCT00954798|Adjuvant|adjuvant
5583670|NCT00954798|Adult|adult
5583671|NCT00954785|ankle|ankle
5583672|NCT00954785|ligament|ligament
5583673|NCT00954785|sprain|sprain
5583674|NCT00954785|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5583675|NCT00954785|treatment|treatment
5583676|NCT00954785|Acute ankle ligament sprain|acute ankle ligament sprain
5583677|NCT00954772|Staged versus Simultaneous Bilateral DBS|staged versus simultaneous bilateral dbs
5583678|NCT00954759|Infantile colic|infantile colic
5583679|NCT00954759|Chiropractic|chiropractic
5583680|NCT00954759|Manipulation|manipulation
5583681|NCT00954759|Randomized controlled trial|randomized controlled trial
5583682|NCT00954746|Advanced Dupuytren's Disease|advanced dupuytren's disease
5568633|NCT01011972|Phase 1|phase 1
5583683|NCT00954746|Muscular Diseases|muscular diseases
5583684|NCT00954746|Musculoskeletal Diseases|musculoskeletal diseases
5583685|NCT00954746|Contracture Joint Diseases|contracture joint diseases
5583686|NCT00954746|Connective Tissue Diseases|connective tissue diseases
5583687|NCT00954746|Dupuytren's Contracture|dupuytren's contracture
5583688|NCT00954733|Hysteroscopic surgery|hysteroscopic surgery
5583689|NCT00954733|Hypoventilation|hypoventilation
5583690|NCT00954733|Co2|co2
5583691|NCT00954733|Transcutaneous Co2 Monitor|transcutaneous co2 monitor
5583692|NCT00954720|AML|aml
5583693|NCT00954720|ALL|all
5583694|NCT00954720|MDS|mds
5583695|NCT00954720|iron overload|iron overload
5583696|NCT00954707|Atherosclerosis|atherosclerosis
5583697|NCT00954681|Cannabis|cannabis
5583698|NCT00954681|quetiapine|quetiapine
5583699|NCT00954668|Non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5583700|NCT00954668|angiography|angiography
5583701|NCT00954668|percutaneous coronary intervention|percutaneous coronary intervention
5583702|NCT00954668|timing|timing
5583703|NCT00954655|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5583704|NCT00954642|Solid Tumor|solid tumor
5583705|NCT00954642|Locally Advanced Solid Tumor|locally advanced solid tumor
5583706|NCT00954642|Avastin|avastin
5583707|NCT00954629|Osteoarthritis|osteoarthritis
5583708|NCT00954629|Pain|pain
5583709|NCT00954629|Knee|knee
5583710|NCT00954616|Inappropriate Medications Associated|inappropriate medications associated
5583711|NCT00954616|Alzheimer's disease|alzheimer's disease
5583712|NCT00954603|delirium rating scale|delirium rating scale
5583713|NCT00954603|clinical global improvement|clinical global improvement
5583714|NCT00954603|extrapyramidal side effect|extrapyramidal side effect
5583715|NCT00954577|obesity|obesity
5583716|NCT00954577|diabetes|diabetes
5583717|NCT00954577|exercise|exercise
5583718|NCT00954577|education|education
5583719|NCT00954577|child|child
5583720|NCT00954564|arthralgia|arthralgia
5583721|NCT00954564|stage I breast cancer|stage i breast cancer
5583722|NCT00954564|stage II breast cancer|stage ii breast cancer
5583723|NCT00954564|stage IIIA breast cancer|stage iiia breast cancer
5583724|NCT00954525|Pancreatic Cancer|pancreatic cancer
5583725|NCT00954512|Antibodies, neoplasm|antibodies, neoplasm
5583726|NCT00954499|tactile stimulation|tactile stimulation
5583728|NCT00954499|immunization|immunization
5583729|NCT00954499|infant|infant
5583730|NCT00954460|VPRIV|vpriv
5583731|NCT00954460|Enzyme Replacement Therapy|enzyme replacement therapy
5583732|NCT00954460|Gaucher disease|gaucher disease
5583733|NCT00954460|glucocerebrosidase|glucocerebrosidase
5583734|NCT00954460|beta-glucocerebrosidase|beta-glucocerebrosidase
5583735|NCT00954460|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5583736|NCT00954460|glucosylceramidase|glucosylceramidase
5583737|NCT00954460|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5583738|NCT00954460|gene activation|gene activation
5583740|NCT00954395|vitamin K antagonists, D-dimer,|vitamin k antagonists, d-dimer,
5798740|NCT00111202|Genetic counseling|genetic counseling
5583741|NCT00954395|deep vein thrombosis, pulmonary embolism,|deep vein thrombosis, pulmonary embolism,
5583742|NCT00954382|Down syndrome|down syndrome
5583743|NCT00954382|IQ|iq
5583744|NCT00954382|mental age|mental age
5566148|NCT01022320|OSA|osa
5583745|NCT00954382|neuropsychological function|neuropsychological function
5583746|NCT00954369|Alzheimer's disease|alzheimer's disease
5583747|NCT00954369|AD|ad
5583748|NCT00954369|W372|w372
5583749|NCT00954369|W372000|w372000
5583750|NCT00954369|[F-18]W372|[f-18]w372
5583751|NCT00954369|exploratory|exploratory
5583752|NCT00954369|imaging|imaging
5583753|NCT00954356|Pain following 3rd molar/wisdom tooth extraction|pain following 3rd molar/wisdom tooth extraction
5583754|NCT00954343|Foot Ulcers|foot ulcers
5583755|NCT00954343|Extracorporeal Shockwave|extracorporeal shockwave
5583756|NCT00954343|Chronic wound|chronic wound
5583757|NCT00954330|rct, intervention, surgery, lateral ligament injury of the ankle|rct, intervention, surgery, lateral ligament injury of the ankle
5583758|NCT00954330|REturn to pre-injury level|return to pre-injury level
5583759|NCT00954317|epidural|epidural
5583760|NCT00954317|labour analgesia|labour analgesia
5583761|NCT00954304|Pgp inhibitor|pgp inhibitor
5583762|NCT00954304|P-glycoprotein inhibitor|p-glycoprotein inhibitor
5583763|NCT00954291|antinauseant and antiemetic|antinauseant and antiemetic
5583764|NCT00954278|non small cell lung cancer|non small cell lung cancer
5583765|NCT00954278|phase 1|phase 1
5583766|NCT00954278|sorafenib|sorafenib
5583767|NCT00954278|intrapatient dose escalation|intrapatient dose escalation
5583768|NCT00954265|pregnancy occurence|pregnancy occurence
5583769|NCT00954265|OHSS|ohss
5583770|NCT00954161|First aid|first aid
5583771|NCT00954161|Helping behaviour|helping behaviour
5583772|NCT00954161|Health education|health education
5583773|NCT00954161|Myocardial infarction|myocardial infarction
5583774|NCT00954161|Emergencies|emergencies
5583775|NCT00954148|cancer|cancer
5583776|NCT00954148|colorectal|colorectal
5583777|NCT00954148|head/neck|head/neck
5583778|NCT00954148|lung|lung
5583780|NCT00954135|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide|neoadjuvant therapy, sorafenib, letrozolo, cyclophosphamide
5583781|NCT00954122|Acute schizophrenia|acute schizophrenia
5583782|NCT00954109|Insulin Resistance|insulin resistance
5583783|NCT00954109|Type 2 Diabetes|type 2 diabetes
5583784|NCT00954070|gastroesophageal reflux disease|gastroesophageal reflux disease
5583785|NCT00954057|TED|ted
5583786|NCT00954044|randomized clinical trial|randomized clinical trial
5583787|NCT00954044|prostate cancer|prostate cancer
5583788|NCT00954044|partnered exercise|partnered exercise
5583789|NCT00954005|relapsed indolent lymphoma|relapsed indolent lymphoma
5583790|NCT00954005|gemcitabine|gemcitabine
5583791|NCT00954005|oxaliplatin|oxaliplatin
5583792|NCT00954005|rituximab|rituximab
5583793|NCT00953992|acute kidney disease|acute kidney disease
5583794|NCT00953992|prognosis|prognosis
5583795|NCT00953992|oxidative stress|oxidative stress
5583796|NCT00953992|inflammation|inflammation
5583797|NCT00953992|gene polymorphism|gene polymorphism
5583798|NCT00953979|ankylosing spondylitis|ankylosing spondylitis
5583799|NCT00953979|treatment|treatment
5583800|NCT00953979|Sulfasalazine|sulfasalazine
5583801|NCT00953979|kunxian capsule|kunxian capsule
5583802|NCT00953914|pyridostigmine|pyridostigmine
5583803|NCT00953914|autonomic modulation|autonomic modulation
5583804|NCT00953914|diabetes mellitus|diabetes mellitus
5583805|NCT00953914|heart rate variability|heart rate variability
5583806|NCT00953888|Healthy volunteer|healthy volunteer
5583807|NCT00953888|Single ascending dose|single ascending dose
5583808|NCT00953888|Safety|safety
5583809|NCT00953888|Tolerability|tolerability
5583810|NCT00953888|Healthy volunteer study|healthy volunteer study
5583811|NCT00953862|ADHD|adhd
5583812|NCT00953862|Substance Use Disorder|substance use disorder
5583813|NCT00953862|Residential Treatment Facility|residential treatment facility
5583814|NCT00953849|Calcitriol|calcitriol
5583815|NCT00953849|Celecoxib|celecoxib
5583816|NCT00953849|Immunotherapy|immunotherapy
5583817|NCT00953836|kinetics|kinetics
5583818|NCT00953836|alkylresorcinol metabolites|alkylresorcinol metabolites
5583819|NCT00953836|rye fiber|rye fiber
5583820|NCT00953823|Thiamin supplementation|thiamin supplementation
5583821|NCT00953823|Thiamin deficiency|thiamin deficiency
5583822|NCT00953823|Heart failure|heart failure
5583823|NCT00953823|Heart function|heart function
5583824|NCT00953823|Vitamin B1 supplementation|vitamin b1 supplementation
5583825|NCT00953810|heart failure|heart failure
5583827|NCT00953810|non-pharmacological management|non-pharmacological management
5583828|NCT00953810|prognosis|prognosis
5583829|NCT00953797|Resistant Hypertension|resistant hypertension
5583830|NCT00953797|Endothelial dysfunction|endothelial dysfunction
5583831|NCT00953797|Enhanced External Counterpulsation|enhanced external counterpulsation
5583832|NCT00953784|surgery|surgery
5583833|NCT00953784|wound infections|wound infections
5583834|NCT00953784|colorectal|colorectal
5583836|NCT00953771|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5798741|NCT00111202|Genetic counselling|genetic counselling
5798742|NCT00111202|Genetics|genetics
5798743|NCT00111202|Schizophrenia|schizophrenia
5583837|NCT00953758|Chronic Myeloid Leukemia Myelofibrosis Myelodysplastic Syndrome Acute myeloid Leukemia Hedgehog inhibitor|chronic myeloid leukemia myelofibrosis myelodysplastic syndrome acute myeloid leukemia hedgehog inhibitor
5583839|NCT00953745|Neuroimaging|neuroimaging
5583840|NCT00953745|Aripiprazole|aripiprazole
5566247|NCT01021956|AMD|amd
5583841|NCT00953745|Mood disorder|mood disorder
5583842|NCT00953745|PET Scan|pet scan
5583843|NCT00953745|fMRI|fmri
5583844|NCT00953732|Peplin|peplin
5583845|NCT00953732|Actinic keratosis|actinic keratosis
5583846|NCT00953732|PEP005|pep005
5583847|NCT00953719|Hip arthroplasty|hip arthroplasty
5583848|NCT00953719|Acetabular cup|acetabular cup
5583849|NCT00953719|Ceramic-on-polyethylene|ceramic-on-polyethylene
5583850|NCT00953706|Fibrosis|fibrosis
5583851|NCT00953706|Pancreatic Diseases|pancreatic diseases
5583852|NCT00953706|Digestive System Diseases|digestive system diseases
5583853|NCT00953706|Lung Diseases|lung diseases
5583854|NCT00953706|Respiratory Tract Diseases|respiratory tract diseases
5583855|NCT00953706|Genetic Diseases, Inborn|genetic diseases, inborn
5583856|NCT00953706|Infant, Newborn, Diseases|infant, newborn, diseases
5583857|NCT00953706|Pathologic Processes|pathologic processes
5583858|NCT00953693|Induced pluripotent stem cells|induced pluripotent stem cells
5583859|NCT00953693|Hepatic disorders|hepatic disorders
5583860|NCT00953693|Eye disorders|eye disorders
5583861|NCT00953693|Blood groups|blood groups
5583862|NCT00953654|Generalized Anxiety Disorder|generalized anxiety disorder
5583863|NCT00953654|Exercise Training|exercise training
5585903|NCT00946933|exercise|exercise
5583864|NCT00953654|Strength Training|strength training
5583865|NCT00953654|Mental Health|mental health
5583866|NCT00953641|Vaginal Misoprostol|vaginal misoprostol
5583867|NCT00953641|Cervical ripening|cervical ripening
5583868|NCT00953641|Endometrial biopsy|endometrial biopsy
5583869|NCT00953628|endometrium|endometrium
5583870|NCT00953628|histology|histology
5583871|NCT00953628|pregnancy|pregnancy
5583872|NCT00953615|PSC|psc
5583873|NCT00953615|Thalidomide|thalidomide
5583874|NCT00953589|treatment naive|treatment naive
5583875|NCT00953576|castration resistant prostate cancer|castration resistant prostate cancer
5583876|NCT00953576|KHAD|khad
5583877|NCT00953563|Venous Leg Ulcers|venous leg ulcers
5583878|NCT00953537|stage IV breast cancer|stage iv breast cancer
5583879|NCT00953524|Influenza|influenza
5583880|NCT00953524|Pandemic Flu|pandemic flu
5583881|NCT00953524|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5583882|NCT00953524|Adult|adult
5583883|NCT00953511|esophagus|esophagus
5583884|NCT00953511|chemoradiation|chemoradiation
5583885|NCT00953511|excision repair cross-complementing gene|excision repair cross-complementing gene
5583886|NCT00953511|polymorphism|polymorphism
5583887|NCT00953511|response prediction|response prediction
5583888|NCT00953498|diabetes|diabetes
5583889|NCT00953498|glitazones|glitazones
5583890|NCT00953498|HDL|hdl
5583891|NCT00953485|Sjogren's Syndrome|sjogren's syndrome
5583892|NCT00953485|Mesenchymal Stem Cells|mesenchymal stem cells
5583893|NCT00953485|Transplantation|transplantation
5583894|NCT00953472|hypertension treatment|hypertension treatment
5583895|NCT00953459|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5583896|NCT00953459|recurrent small cell lung cancer|recurrent small cell lung cancer
5583897|NCT00953446|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5583898|NCT00953446|ASL MRI|asl mri
5583899|NCT00953446|sunitinib|sunitinib
5583900|NCT00953446|AMG386|amg386
5583901|NCT00953433|Intratracheal|intratracheal
5583902|NCT00953420|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5583903|NCT00953420|Carboplatin|carboplatin
5583904|NCT00953420|Docetaxel|docetaxel
5583905|NCT00953420|Epstein-Barr Virus|epstein-barr virus
5583906|NCT00953420|T Lymphocytes|t lymphocytes
5583907|NCT00953420|EBV-CTLs|ebv-ctls
5583908|NCT00953394|octreotide LAR|octreotide lar
5583909|NCT00953394|neuroendocrine carcinoma|neuroendocrine carcinoma
5583910|NCT00953394|metronomic 5fluorouracil|metronomic 5fluorouracil
5583911|NCT00953381|Ilaprazole|ilaprazole
5583912|NCT00953381|Proton pump inhibitor|proton pump inhibitor
5583913|NCT00953381|Duodenal ulcer|duodenal ulcer
5583914|NCT00953381|Acid suppression|acid suppression
5583915|NCT00953381|Randomized trial|randomized trial
5583916|NCT00953368|remote ischemic preconditioning|remote ischemic preconditioning
5583917|NCT00953368|cognitive function|cognitive function
5583918|NCT00953368|off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
5583919|NCT00953342|AEROBIC EXERCISE|aerobic exercise
5583920|NCT00953342|ASTHMA CONTROL|asthma control
5583921|NCT00953342|ASTHMA QUALITY OF LIFE|asthma quality of life
5583922|NCT00953342|INFLAMMATION|inflammation
5583923|NCT00953342|TREATMENT|treatment
5583924|NCT00953303|heart failure|heart failure
5583925|NCT00953303|prednisone|prednisone
5583926|NCT00953303|cardiovascular mortality|cardiovascular mortality
5583927|NCT00953303|renal function|renal function
5583928|NCT00953290|Cellulite|cellulite
5583929|NCT00953290|Adipose tissue|adipose tissue
5583930|NCT00953290|Circumference|circumference
5583931|NCT00953290|Reduction|reduction
5583933|NCT00953277|Nerve Repair|nerve repair
5583934|NCT00953277|Erectile Function|erectile function
5583935|NCT00953277|Prostate Cancer|prostate cancer
5583936|NCT00953277|Robot Assisted Laparoscopic Prostatectomy|robot assisted laparoscopic prostatectomy
5566334|NCT01021592|EORTC QLQ C30|eortc qlq c30
5566335|NCT01021592|EQ 5D|eq 5d
5583938|NCT00953251|high sensitive troponin T; non-STEMI; early detection.|high sensitive troponin t; non-stemi; early detection.
5583939|NCT00953251|To detect non-STEMI in a cohort of patients with acute coronary syndrome|to detect non-stemi in a cohort of patients with acute coronary syndrome
5583940|NCT00953225|prostate cancer|prostate cancer
5583941|NCT00953225|vitamin D|vitamin d
5583942|NCT00953212|atrial fibrillation|atrial fibrillation
5583943|NCT00953212|cardiac surgery|cardiac surgery
5583944|NCT00953212|open heart surgery|open heart surgery
5583945|NCT00953199|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5583946|NCT00953199|ERCP|ercp
5583947|NCT00953199|pancreatitis|pancreatitis
5583948|NCT00953199|lidocaine|lidocaine
5583949|NCT00953199|post-ERCP pancreatitis|post-ercp pancreatitis
5583950|NCT00953186|Diabetes|diabetes
5583951|NCT00953186|Foot ulcer|foot ulcer
5583952|NCT00953186|Neuropathy|neuropathy
5583953|NCT00953186|Ischemia|ischemia
5583954|NCT00953160|Cellulite|cellulite
5583955|NCT00953160|Adipose tissue|adipose tissue
5583956|NCT00953160|Circumference|circumference
5583957|NCT00953160|Reduction|reduction
5583958|NCT00953160|Thigh|thigh
5583959|NCT00953160|Abdomen|abdomen
5583960|NCT00953160|Flank|flank
5583961|NCT00953134|periconceptional|periconceptional
5583962|NCT00953134|iron|iron
5583963|NCT00953134|folic acid|folic acid
5583964|NCT00953134|supplementation|supplementation
5583965|NCT00953121|irinotecan|irinotecan
5583966|NCT00953121|carboplatin|carboplatin
5583967|NCT00953121|bevacizumab|bevacizumab
5583969|NCT00953095|Autism Spectrum Disorder|autism spectrum disorder
5583970|NCT00953095|treatment|treatment
5583971|NCT00953095|joint attention|joint attention
5583972|NCT00953095|communication|communication
5583973|NCT00953095|language|language
5583974|NCT00953043|lubiprostone|lubiprostone
5583975|NCT00953043|colon|colon
5583976|NCT00953043|motility|motility
5583977|NCT00953043|sensation|sensation
5583978|NCT00953017|Efficacy of bowel cleansing|efficacy of bowel cleansing
5583979|NCT00953017|Patient tolerability|patient tolerability
5583980|NCT00953017|Amitiza|amitiza
5583981|NCT00953017|Dulcolax|dulcolax
5583982|NCT00953017|Miralax|miralax
5583983|NCT00953017|Colonoscopy preparation|colonoscopy preparation
5583984|NCT00953017|Bowel preparation|bowel preparation
5583985|NCT00953017|Screening colonoscopy|screening colonoscopy
5583986|NCT00953004|dietary fiber|dietary fiber
5583987|NCT00953004|obesity|obesity
5583988|NCT00953004|apparent energy digestibility|apparent energy digestibility
5583989|NCT00952978|Ilaprazole|ilaprazole
5583990|NCT00952978|Proton pump inhibitor|proton pump inhibitor
5583991|NCT00952978|Duodenal ulcer|duodenal ulcer
5583992|NCT00952978|Acid suppression|acid suppression
5583993|NCT00952978|Randomized trial|randomized trial
5583994|NCT00952965|BP|bp
5583995|NCT00952939|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5583996|NCT00952939|iris melanoma|iris melanoma
5583997|NCT00952939|intraocular melanoma|intraocular melanoma
5583998|NCT00952939|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5583999|NCT00952926|Watchful Waiting|watchful waiting
5584000|NCT00952926|Rectal cancer|rectal cancer
5584001|NCT00952926|Observation|observation
5584002|NCT00952926|Avoid operation|avoid operation
5584003|NCT00952900|TMJMD|tmjmd
5584004|NCT00952900|Acute Pain|acute pain
5584005|NCT00952900|RDC/TMD|rdc/tmd
5584006|NCT00952900|Community Treatment Clinics|community treatment clinics
5584007|NCT00952900|RCT|rct
5584008|NCT00952900|Evidence-Based Outcomes|evidence-based outcomes
5584009|NCT00952900|Short- and long-term follow-up|short- and long-term follow-up
5584010|NCT00952900|Biopsychosocial|biopsychosocial
5584011|NCT00952900|Assessment and Treatment|assessment and treatment
5584012|NCT00952900|Ability to read and write English|ability to read and write english
5584013|NCT00952900|6 months' or less duration of TMD|6 months' or less duration of tmd
5672112|NCT00612989|Temozolomide|temozolomide
5584014|NCT00952900|No other pain-related conditions|no other pain-related conditions
5584015|NCT00952874|anal cancer|anal cancer
5584016|NCT00952874|Molecular biology|molecular biology
5584017|NCT00952874|HIV status|hiv status
5584018|NCT00952874|HPV infection|hpv infection
5584019|NCT00952874|Microsatellite instability|microsatellite instability
5584020|NCT00952874|Biopsy proven Squamous Cell carcinoma of the Anus|biopsy proven squamous cell carcinoma of the anus
5584021|NCT00952874|Squamous Cell carcinoma of the Anus|squamous cell carcinoma of the anus
5584022|NCT00952861|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5584023|NCT00952861|Infection|infection
5584024|NCT00952861|Antibiotics|antibiotics
5584025|NCT00952848|pain|pain
5584026|NCT00952848|neurotoxicity|neurotoxicity
5584027|NCT00952848|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5584028|NCT00952848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5584029|NCT00952848|peripheral neuropathy|peripheral neuropathy
5584030|NCT00952835|Asthma|asthma
5584031|NCT00952835|rhinitis|rhinitis
5584032|NCT00952835|EIB|eib
5584033|NCT00952835|Exhaled Nitric oxide|exhaled nitric oxide
5584034|NCT00952835|lung function|lung function
5584035|NCT00952835|vitamin d|vitamin d
5584036|NCT00952796|intra-abdominal infection|intra-abdominal infection
5584037|NCT00952796|moxifloxacin|moxifloxacin
5584038|NCT00952796|ampicillin/sulbactam|ampicillin/sulbactam
5584039|NCT00952783|Peplin|peplin
5584040|NCT00952783|Actinic keratosis|actinic keratosis
5584041|NCT00952783|PEP005|pep005
5584042|NCT00952770|Coronary artery disease|coronary artery disease
5584043|NCT00952770|Coronary intervention|coronary intervention
5584044|NCT00952770|intima-media thickness|intima-media thickness
5584045|NCT00952757|APS-related hyperprolactinaemia|aps-related hyperprolactinaemia
5584046|NCT00952757|Quetiapine|quetiapine
5584047|NCT00952757|Schizophrenia|schizophrenia
5584048|NCT00952757|Bipolar|bipolar
5584049|NCT00952744|acute myocardial infarction|acute myocardial infarction
5584050|NCT00952744|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5584051|NCT00952744|STEMI|stemi
5584052|NCT00952744|non-ST-segment elevation myocardial infarction|non-st-segment elevation myocardial infarction
5584053|NCT00952744|NSTEMI|nstemi
5584054|NCT00952744|unstable angina|unstable angina
5584055|NCT00952744|unstable angina pectoris|unstable angina pectoris
5584056|NCT00952744|UA|ua
5584057|NCT00952744|UAP|uap
5584058|NCT00952692|breast cancer|breast cancer
5584059|NCT00952692|HER2|her2
5584060|NCT00952692|Lapatinib|lapatinib
5584061|NCT00952692|dHER2 ASCI|dher2 asci
5584063|NCT00952692|refractory to trastuzumab|refractory to trastuzumab
5584064|NCT00952679|The investigators evaluated the new method by comparing lymph nodes defined by CT and traditional ways.|the investigators evaluated the new method by comparing lymph nodes defined by ct and traditional ways.
5584066|NCT00952666|Transrectal Ultrasound Imaging of Prostate|transrectal ultrasound imaging of prostate
5584067|NCT00952666|Neurovascular Bundles|neurovascular bundles
5584068|NCT00952666|Robot Assisted Laparoscopic Radical Prostatectomy|robot assisted laparoscopic radical prostatectomy
5584069|NCT00952653|depression|depression
5584070|NCT00952640|vitamin A|vitamin a
5584071|NCT00952640|post-partum|post-partum
5584072|NCT00952640|infant|infant
5584073|NCT00952640|acute phase response|acute phase response
5584074|NCT00952627|Cardiac fibrosis|cardiac fibrosis
5584075|NCT00952627|Diastolic dysfunction|diastolic dysfunction
5584076|NCT00952627|Hypertension|hypertension
5584077|NCT00952614|retinal vein occlusion|retinal vein occlusion
5584078|NCT00952614|sustained drug delivery implant|sustained drug delivery implant
5584079|NCT00952614|steroid|steroid
5584080|NCT00952614|macular edema|macular edema
5584081|NCT00952601|Tourette|tourette
5584082|NCT00952601|Atkins|atkins
5584083|NCT00952601|Ketosis|ketosis
5584084|NCT00952601|Tic|tic
5584087|NCT00952575|Prevention of foeto-maternal allo-immunisation|prevention of foeto-maternal allo-immunisation
5584088|NCT00952562|vitamin d|vitamin d
5584089|NCT00952562|calcium|calcium
5584090|NCT00952562|blood pressure|blood pressure
5584091|NCT00952536|Randomised controlled trial|randomised controlled trial
5584092|NCT00952536|Double blind fully masked|double blind fully masked
5584093|NCT00952536|Dietary supplement|dietary supplement
5584094|NCT00952523|acne|acne
5584095|NCT00952523|irritation|irritation
5584096|NCT00952523|objective sensory methods|objective sensory methods
5584097|NCT00952510|Range of motion, articular|range of motion, articular
5584098|NCT00952510|Cervical spine|cervical spine
5584099|NCT00952497|Gastric Cancer|gastric cancer
5584100|NCT00952497|Gastro-Esophageal Cancer|gastro-esophageal cancer
5584101|NCT00952497|GE-Junction|ge-junction
5584102|NCT00952497|Advanced Gastric Cancer|advanced gastric cancer
5584103|NCT00952484|Hypophosphatasia|hypophosphatasia
5584104|NCT00952484|HPP|hpp
5584105|NCT00952484|Bone Disease|bone disease
5584106|NCT00952484|Soft Bones|soft bones
5584107|NCT00952484|Low Alkaline Phosphatase|low alkaline phosphatase
5584108|NCT00952484|genetic metabolic disorder|genetic metabolic disorder
5584109|NCT00952484|alkaline phosphatase|alkaline phosphatase
5584110|NCT00952484|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5584111|NCT00952484|rickets|rickets
5584112|NCT00952484|osteomalacia|osteomalacia
5584113|NCT00952471|Asthma|asthma
5584114|NCT00952471|Children|children
5584115|NCT00952471|CPOE|cpoe
5584116|NCT00952471|Decision Support|decision support
5584117|NCT00952471|Framing|framing
5584118|NCT00952471|Heuristic|heuristic
5584119|NCT00952471|Order Sets|order sets
5584120|NCT00952458|Safety|safety
5584121|NCT00952458|Midazolam and propofol sedation|midazolam and propofol sedation
5584122|NCT00952458|ERCP|ercp
5584123|NCT00952458|Bispectral Index monitoring|bispectral index monitoring
5584124|NCT00952432|Carpal Tunnel Syndrome|carpal tunnel syndrome
5584125|NCT00952432|Multiple Excitability Test|multiple excitability test
5584126|NCT00952432|Nerve Conduction Study|nerve conduction study
5584127|NCT00952432|QtracW|qtracw
5584128|NCT00952432|carbamazepine|carbamazepine
5584129|NCT00952432|Acupuncture|acupuncture
5584130|NCT00952419|Influenza|influenza
5584131|NCT00952419|Pandemic Flu|pandemic flu
5584132|NCT00952419|Swine-origin A/H1N1 Influenza|swine-origin a/h1n1 influenza
5584133|NCT00952419|Children|children
5584134|NCT00952406|Pelvic Floor Disorders|pelvic floor disorders
5584135|NCT00952406|Sexual Function|sexual function
5584136|NCT00952406|Incontinence|incontinence
5584137|NCT00952406|Pelvic Organ Prolapse|pelvic organ prolapse
5584138|NCT00952393|receptors nicotinic|receptors nicotinic
5584139|NCT00952380|VTE|vte
5584140|NCT00952354|Down syndrome|down syndrome
5584141|NCT00952354|MLU|mlu
5584142|NCT00952354|language development|language development
5584143|NCT00952354|language assessment|language assessment
5584144|NCT00952341|CINV|cinv
5584145|NCT00952328|breastfeeding outcomes|breastfeeding outcomes
5584146|NCT00952328|breastfeeding self-efficacy|breastfeeding self-efficacy
5584147|NCT00952328|infant weight loss|infant weight loss
5584148|NCT00952315|kidney stones|kidney stones
5584149|NCT00952315|intracorporeal lithotriptors|intracorporeal lithotriptors
5584150|NCT00952315|kidney stone removal|kidney stone removal
5584151|NCT00952302|Hypoxia|hypoxia
5584152|NCT00952302|Iron|iron
5584153|NCT00952302|Hypoxia-Inducible Factor 1|hypoxia-inducible factor 1
5584154|NCT00952302|Chronic mountain sickness|chronic mountain sickness
5584155|NCT00952289|Myelofibrosis|myelofibrosis
5584156|NCT00952289|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5584157|NCT00952289|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5586005|NCT00946452|Control|control
5584158|NCT00952276|Influenza Pandemic Flu Swine-origin A/H1N1 Influenza Adults|influenza pandemic flu swine-origin a/h1n1 influenza adults
5584159|NCT00952263|Hepatitis C|hepatitis c
5584160|NCT00952263|Phase I|phase i
5584161|NCT00952263|Infusion|infusion
5584162|NCT00952263|Pharmacokinetics|pharmacokinetics
5584163|NCT00952263|MBL-HCV1|mbl-hcv1
5584164|NCT00952263|Monoclonal antibody|monoclonal antibody
5584165|NCT00952263|Safety Assessment|safety assessment
5584166|NCT00952250|quality improvement|quality improvement
5584580|NCT00951509|driving assessments|driving assessments
5584167|NCT00952237|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5584169|NCT00952237|GM-CSF|gm-csf
5584170|NCT00952224|myocardial salvage|myocardial salvage
5584171|NCT00952224|cardiovascular magnetic resonance|cardiovascular magnetic resonance
5584172|NCT00952224|magnetic resonance imaging|magnetic resonance imaging
5584173|NCT00952224|myocardial infarction|myocardial infarction
5584174|NCT00952224|prognosis|prognosis
5584175|NCT00952211|stroke|stroke
5584176|NCT00952211|obstructive sleep apnea|obstructive sleep apnea
5584177|NCT00952211|fatigue|fatigue
5584178|NCT00952211|quality of life|quality of life
5584179|NCT00952185|viral infection|viral infection
5584180|NCT00952185|aplastic anemia|aplastic anemia
5584181|NCT00952185|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5584182|NCT00952185|acute undifferentiated leukemia|acute undifferentiated leukemia
5584183|NCT00952185|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5584184|NCT00952185|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5584185|NCT00952185|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5584186|NCT00952185|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5584187|NCT00952185|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5584188|NCT00952185|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5584189|NCT00952185|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5584190|NCT00952185|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5584191|NCT00952185|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5584192|NCT00952185|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5584193|NCT00952185|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5584194|NCT00952185|mast cell leukemia|mast cell leukemia
5584195|NCT00952185|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5584196|NCT00952185|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5672113|NCT00612989|O6-BG|o6-bg
5584197|NCT00952185|prolymphocytic leukemia|prolymphocytic leukemia
5584198|NCT00952185|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5584199|NCT00952185|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5584200|NCT00952185|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5584201|NCT00952185|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5584202|NCT00952185|refractory hairy cell leukemia|refractory hairy cell leukemia
5584203|NCT00952185|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5584204|NCT00952185|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5584205|NCT00952185|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5584206|NCT00952185|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5584207|NCT00952185|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5584208|NCT00952185|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5584209|NCT00952185|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5584215|NCT00952185|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5584216|NCT00952185|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5584217|NCT00952185|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5584218|NCT00952185|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5584219|NCT00952185|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5584220|NCT00952185|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5584221|NCT00952185|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5584222|NCT00952185|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5584223|NCT00952185|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5584224|NCT00952185|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5584225|NCT00952185|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5584226|NCT00952185|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5584227|NCT00952185|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5584228|NCT00952185|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5584469|NCT00951626|therapy-related toxicity|therapy-related toxicity
5584229|NCT00952185|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5584230|NCT00952185|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5584231|NCT00952185|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5584232|NCT00952185|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5584233|NCT00952185|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5584234|NCT00952185|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5584235|NCT00952185|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5584236|NCT00952185|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5584237|NCT00952185|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5584238|NCT00952185|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5584239|NCT00952185|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5584240|NCT00952185|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5584241|NCT00952185|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5584242|NCT00952185|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5584243|NCT00952185|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5584244|NCT00952185|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5584245|NCT00952185|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5584246|NCT00952185|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5584247|NCT00952185|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5584248|NCT00952185|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5584249|NCT00952185|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5584250|NCT00952185|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5584251|NCT00952185|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5584252|NCT00952185|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5584253|NCT00952185|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5584254|NCT00952185|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5584255|NCT00952185|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5672114|NCT00612989|O6-Benzylguanine|o6-benzylguanine
5584256|NCT00952185|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5584257|NCT00952185|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5584258|NCT00952185|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5584259|NCT00952185|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5584260|NCT00952185|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5584261|NCT00952185|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5584262|NCT00952185|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5584263|NCT00952185|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5586743|NCT00943904|urinary leakage associated with urinary urgency|urinary leakage associated with urinary urgency
5584264|NCT00952185|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5584265|NCT00952185|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5584266|NCT00952185|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5584267|NCT00952185|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5584268|NCT00952185|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5584269|NCT00952185|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5584270|NCT00952185|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5584271|NCT00952185|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5584272|NCT00952185|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5566707|NCT01020006|Pharmacyclics|pharmacyclics
5584273|NCT00952185|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5584274|NCT00952185|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5584275|NCT00952185|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5584276|NCT00952185|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5584277|NCT00952185|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5584278|NCT00952185|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5584279|NCT00952185|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5584280|NCT00952185|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5584281|NCT00952185|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5584282|NCT00952185|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5584283|NCT00952185|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5584284|NCT00952185|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5584285|NCT00952185|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5584286|NCT00952185|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5584287|NCT00952185|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5584288|NCT00952185|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5584289|NCT00952185|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5584290|NCT00952185|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5584291|NCT00952185|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5584292|NCT00952185|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5584293|NCT00952185|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5584294|NCT00952185|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5584295|NCT00952185|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5584296|NCT00952185|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5584297|NCT00952185|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5584298|NCT00952185|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5584299|NCT00952185|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5584300|NCT00952185|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5584301|NCT00952185|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5584302|NCT00952185|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5584303|NCT00952185|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5584304|NCT00952185|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5584305|NCT00952185|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5584306|NCT00952185|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5584307|NCT00952185|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5584308|NCT00952185|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5584309|NCT00952185|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5584310|NCT00952185|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5584311|NCT00952185|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5584312|NCT00952185|intraocular lymphoma|intraocular lymphoma
5584313|NCT00952185|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5584314|NCT00952185|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5584315|NCT00952185|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5584316|NCT00952185|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5584317|NCT00952185|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5584318|NCT00952185|primary myelofibrosis|primary myelofibrosis
5584319|NCT00952185|essential thrombocythemia|essential thrombocythemia
5584320|NCT00952185|polycythemia vera|polycythemia vera
5584321|NCT00952185|extramedullary plasmacytoma|extramedullary plasmacytoma
5584322|NCT00952185|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5584323|NCT00952185|stage I multiple myeloma|stage i multiple myeloma
5584324|NCT00952185|stage II multiple myeloma|stage ii multiple myeloma
5584325|NCT00952185|stage III multiple myeloma|stage iii multiple myeloma
5584326|NCT00952185|primary systemic amyloidosis|primary systemic amyloidosis
5584327|NCT00952185|refractory multiple myeloma|refractory multiple myeloma
5584328|NCT00952185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5584329|NCT00952185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5584330|NCT00952185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5584331|NCT00952185|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5584332|NCT00952172|Stair stepping training|stair stepping training
5584334|NCT00952172|cardiopulmonary fitness|cardiopulmonary fitness
5584335|NCT00952172|sleep disturbance|sleep disturbance
5584337|NCT00952159|tramadol|tramadol
5584339|NCT00952159|O-demethyl-tramadol|o-demethyl-tramadol
5584340|NCT00952159|poor metabolizer|poor metabolizer
5584341|NCT00952159|genotyping|genotyping
5584342|NCT00952159|phenotyping|phenotyping
5584343|NCT00952146|NOTES|notes
5584344|NCT00952146|Transgastric|transgastric
5584345|NCT00952146|Appendectomy|appendectomy
5584346|NCT00952146|Safety|safety
5584347|NCT00952146|Feasibility|feasibility
5584348|NCT00952133|PONV|ponv
5584349|NCT00952133|Outpatient surgery|outpatient surgery
5584350|NCT00952133|Laparoscopic abdominal surgery|laparoscopic abdominal surgery
5584351|NCT00952133|Laparoscopic gynecologic surgery|laparoscopic gynecologic surgery
5584352|NCT00952120|Wound healing|wound healing
5584353|NCT00952120|Negative pressure wound therapy|negative pressure wound therapy
5584354|NCT00952120|Skin graft|skin graft
5584355|NCT00952107|breast cancer|breast cancer
5584356|NCT00952107|breast reconstructive surgery|breast reconstructive surgery
5584357|NCT00952107|flap assessment|flap assessment
5584358|NCT00952094|Healthy volunteer|healthy volunteer
5584359|NCT00952081|Hypertension|hypertension
5584360|NCT00952081|Neurosurgery|neurosurgery
5584361|NCT00952081|bloodpressure control|bloodpressure control
5584362|NCT00952081|brain tumor resection|brain tumor resection
5584363|NCT00952081|epilepsy focus resection|epilepsy focus resection
5584364|NCT00952068|Back Pain|back pain
5584365|NCT00952055|neopterin|neopterin
5584366|NCT00952055|macrophage|macrophage
5584367|NCT00952055|inflammation|inflammation
5584468|NCT00951626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5584368|NCT00952042|Tendinopathy, Achilles, Eccentric training, Heavy slow resistance training|tendinopathy, achilles, eccentric training, heavy slow resistance training
5584369|NCT00952029|stage IV colon cancer|stage iv colon cancer
5584370|NCT00952029|stage IV rectal cancer|stage iv rectal cancer
5584371|NCT00952016|colorectal cancer|colorectal cancer
5584372|NCT00952016|MSH2|msh2
5584373|NCT00952016|metastatic|metastatic
5584374|NCT00952003|Avastin|avastin
5584375|NCT00952003|Campto|campto
5584376|NCT00952003|Oxaliplatin|oxaliplatin
5584377|NCT00952003|Taxotere|taxotere
5584378|NCT00951977|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5584379|NCT00951977|Transplantation|transplantation
5584380|NCT00951977|Living Kidney Donation|living kidney donation
5584381|NCT00951977|Kidney Transplant|kidney transplant
5584382|NCT00951938|Trinity Evolution|trinity evolution
5584383|NCT00951938|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5584384|NCT00951938|Allograft|allograft
5584385|NCT00951925|diagnostic bone marrow biopsies|diagnostic bone marrow biopsies
5584386|NCT00951925|bone marrow harvesting for autologous BMT|bone marrow harvesting for autologous bmt
5584387|NCT00951912|genistein|genistein
5584388|NCT00951912|daidzein|daidzein
5584389|NCT00951912|impaired glucose regulation|impaired glucose regulation
5584390|NCT00951912|glucose metabolism|glucose metabolism
5584391|NCT00951912|lipids metabolism|lipids metabolism
5584392|NCT00951912|inflammation|inflammation
5584393|NCT00951912|women|women
5584394|NCT00951899|Incretins|incretins
5584395|NCT00951899|colesevelam|colesevelam
5584396|NCT00951899|hepatobiliary circulation|hepatobiliary circulation
5584397|NCT00951886|Ataxia Teleangiectasia|ataxia teleangiectasia
5584398|NCT00951886|Spirometry|spirometry
5584399|NCT00951886|Respiratory rare diseases|respiratory rare diseases
5584400|NCT00951860|Fullterm Birth|fullterm birth
5584401|NCT00951860|Neonate|neonate
5584402|NCT00951860|Prematurity|prematurity
5584403|NCT00951860|Neurodevelopment|neurodevelopment
5584404|NCT00951860|Autonomic Nervous System activity|autonomic nervous system activity
5584405|NCT00951847|Oxcarbazepine oral suspension fed study|oxcarbazepine oral suspension fed study
5584406|NCT00951834|Alzheimer´s Disease|alzheimer´s disease
5584407|NCT00951834|Epigallocatechin-Gallate|epigallocatechin-gallate
5584408|NCT00951834|Neuroprotection|neuroprotection
5584409|NCT00951834|ADAS-COG|adas-cog
5584410|NCT00951834|early stage of Alzheimer's Disease|early stage of alzheimer's disease
5584411|NCT00951821|Suicidal Ideation|suicidal ideation
5584412|NCT00951821|Suicide Attempts|suicide attempts
5584413|NCT00951808|Anemia, Sickle Cell|anemia, sickle cell
5584414|NCT00951808|Acute Chest Syndrome|acute chest syndrome
5584415|NCT00951808|Secretory phospholipase A2(sPLA2)|secretory phospholipase a2(spla2)
5584417|NCT00951795|AIDS|aids
5584418|NCT00951795|CD4|cd4
5584419|NCT00951782|COPD|copd
5584421|NCT00951756|Microbiome composition|microbiome composition
5584423|NCT00951743|AIDS|aids
5584424|NCT00951743|HIV|hiv
5584425|NCT00951743|mDAPTA|mdapta
5584426|NCT00951730|Down Syndrome|down syndrome
5584428|NCT00951730|Children|children
5584429|NCT00951730|Sleep apnea|sleep apnea
5584430|NCT00951730|Sleep hypopnea|sleep hypopnea
5584431|NCT00951730|Polysomnography|polysomnography
5584432|NCT00951717|Postpartum Depressive Symptoms|postpartum depressive symptoms
5584433|NCT00951717|Physical Symptoms|physical symptoms
5584434|NCT00951717|Emotional Symptoms|emotional symptoms
5584435|NCT00951717|Infant Colic|infant colic
5584436|NCT00951717|Social Support|social support
5584437|NCT00951717|Breastfeeding|breastfeeding
5584438|NCT00951704|CPR|cpr
5584439|NCT00951704|Tissue Perfusion|tissue perfusion
5584440|NCT00951704|invasive arterial pressure|invasive arterial pressure
5584441|NCT00951704|exhaled carbon dioxide|exhaled carbon dioxide
5584442|NCT00951704|Quality of life|quality of life
5584443|NCT00951704|Quality of chest compressions|quality of chest compressions
5584444|NCT00951704|Epidemiology of sudden cardiac arrest(OHCA)|epidemiology of sudden cardiac arrest(ohca)
5584445|NCT00951691|Elderly|elderly
5584446|NCT00951691|Acute Medical Rehabilitation|acute medical rehabilitation
5584447|NCT00951678|ultrasound|ultrasound
5584448|NCT00951678|femoral vein|femoral vein
5584449|NCT00951678|internal jugular vein|internal jugular vein
5584450|NCT00951665|Trastuzumab DM1 (T-DM1)|trastuzumab dm1 (t-dm1)
5584451|NCT00951665|Trastuzumab emtansine|trastuzumab emtansine
5584452|NCT00951665|Armed Herceptin|armed herceptin
5584453|NCT00951665|HER2|her2
5584454|NCT00951665|HER2+|her2+
5584455|NCT00951665|HER2 Positive Breast Cancer|her2 positive breast cancer
5584456|NCT00951652|CBT|cbt
5584457|NCT00951652|GAD|gad
5584458|NCT00951652|Interpersonal Therapy|interpersonal therapy
5584459|NCT00951652|Emotion-Focused Therapy|emotion-focused therapy
5584460|NCT00951639|Cassia|cassia
5584461|NCT00951639|Cinnamon|cinnamon
5584462|NCT00951639|Blood Glucose|blood glucose
5584463|NCT00951639|Endurance exercise|endurance exercise
5584464|NCT00951639|Acute exercise|acute exercise
5584465|NCT00951639|Overweight|overweight
5584466|NCT00951639|Obesity|obesity
5584467|NCT00951639|Women|women
5584470|NCT00951626|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5584471|NCT00951626|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5584472|NCT00951626|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5584473|NCT00951626|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5584474|NCT00951626|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5584475|NCT00951626|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5584476|NCT00951626|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5584477|NCT00951626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5584478|NCT00951626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5584479|NCT00951626|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5584480|NCT00951626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5584481|NCT00951626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5584482|NCT00951626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5585079|NCT00949598|stage IA breast cancer|stage ia breast cancer
5584483|NCT00951626|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5584484|NCT00951626|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5584485|NCT00951626|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5584486|NCT00951626|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5584487|NCT00951626|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5584488|NCT00951626|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5584489|NCT00951626|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5584490|NCT00951626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5584491|NCT00951626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5584492|NCT00951626|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5584493|NCT00951626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5584494|NCT00951626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5584495|NCT00951626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5584496|NCT00951626|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5584497|NCT00951626|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5584498|NCT00951626|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5584499|NCT00951626|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5584500|NCT00951626|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5584501|NCT00951626|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5584502|NCT00951626|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5584503|NCT00951626|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5584504|NCT00951626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5584505|NCT00951626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5584506|NCT00951626|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5584507|NCT00951626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5584508|NCT00951626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5584509|NCT00951626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5584510|NCT00951626|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5584511|NCT00951626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5584512|NCT00951626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5567017|NCT01019122|cerebral palsy|cerebral palsy
5584513|NCT00951626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5584514|NCT00951626|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5584515|NCT00951626|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5584516|NCT00951626|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5584517|NCT00951626|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5584518|NCT00951626|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5584519|NCT00951626|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5584520|NCT00951626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5584521|NCT00951626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5584522|NCT00951626|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5584523|NCT00951626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5584524|NCT00951626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5584525|NCT00951626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5584526|NCT00951626|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5584527|NCT00951626|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5584528|NCT00951626|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5584529|NCT00951626|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5586546|NCT00944736|Probiotic|probiotic
5584530|NCT00951626|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5584531|NCT00951626|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5584532|NCT00951626|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5584533|NCT00951626|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5584534|NCT00951626|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5584535|NCT00951626|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5584536|NCT00951626|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5584537|NCT00951626|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5584538|NCT00951626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5584539|NCT00951626|refractory hairy cell leukemia|refractory hairy cell leukemia
5584540|NCT00951626|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5584541|NCT00951626|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5584542|NCT00951626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5584543|NCT00951626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5584544|NCT00951626|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5584545|NCT00951626|primary myelofibrosis|primary myelofibrosis
5584546|NCT00951626|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5584547|NCT00951626|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5584548|NCT00951626|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5584549|NCT00951626|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5584550|NCT00951626|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5584551|NCT00951626|refractory multiple myeloma|refractory multiple myeloma
5584552|NCT00951613|small cell lung cancer|small cell lung cancer
5584553|NCT00951613|carcinoma, lung|carcinoma, lung
5672115|NCT00612989|Recurrent GBM|recurrent gbm
5584554|NCT00951613|Sensitive-relapsed or refractory-relapsed small cell lung cancer|sensitive-relapsed or refractory-relapsed small cell lung cancer
5584555|NCT00951600|Oxcarbazepine oral suspension fasting study|oxcarbazepine oral suspension fasting study
5584556|NCT00951587|Colonic Diseases|colonic diseases
5584557|NCT00951574|thromboembolism|thromboembolism
5584559|NCT00951574|chemotherapy|chemotherapy
5584560|NCT00951574|low-molecular-weight-heparin|low-molecular-weight-heparin
5584561|NCT00951574|nadroparin|nadroparin
5584562|NCT00951561|Dysmenorrhea|dysmenorrhea
5584563|NCT00951548|Probiotics|probiotics
5584564|NCT00951548|VSL#3|vsl#3
5584565|NCT00951548|Double-blind|double-blind
5584566|NCT00951548|Placebo controlled|placebo controlled
5584567|NCT00951535|stage I prostate cancer|stage i prostate cancer
5584568|NCT00951535|stage IIB prostate cancer|stage iib prostate cancer
5584569|NCT00951535|stage IIA prostate cancer|stage iia prostate cancer
5584570|NCT00951535|stage III prostate cancer|stage iii prostate cancer
5584571|NCT00951522|Cystic Fibrosis|cystic fibrosis
5584573|NCT00951522|Mucociliary Clearance|mucociliary clearance
5584574|NCT00951522|Epithelial Sodium Channel Inhibitor|epithelial sodium channel inhibitor
5584575|NCT00951522|ENaC Inhibitor|enac inhibitor
5584576|NCT00951522|Airway Hydration|airway hydration
5584577|NCT00951522|Amiloride|amiloride
5584578|NCT00951509|Electric power wheelchair driving|electric power wheelchair driving
5584579|NCT00951509|rehabilitation|rehabilitation
5584581|NCT00951483|Cardiovascular Biomarkers|cardiovascular biomarkers
5584582|NCT00951483|Depression|depression
5584583|NCT00951483|Quetiapine|quetiapine
5584584|NCT00951470|Head and neck lymphedema|head and neck lymphedema
5584585|NCT00951470|Complete Decongestive Therapy|complete decongestive therapy
5584586|NCT00951470|CDT|cdt
5584587|NCT00951470|Oral cavity cancer|oral cavity cancer
5584588|NCT00951470|Oropharyngeal cancer|oropharyngeal cancer
5584589|NCT00951457|CLL|cll
5584590|NCT00951457|pretreated|pretreated
5584591|NCT00951457|immune therapy|immune therapy
5584592|NCT00951457|dose escalation|dose escalation
5584593|NCT00951457|maintenance therapy|maintenance therapy
5584594|NCT00951457|Bendamustine|bendamustine
5584595|NCT00951457|Alemtuzumab|alemtuzumab
5584596|NCT00951444|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5584597|NCT00951444|squamous cell lung cancer|squamous cell lung cancer
5584598|NCT00951444|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5584599|NCT00951444|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5584600|NCT00951444|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5584601|NCT00951431|Functional dyspepsia|functional dyspepsia
5584602|NCT00951431|PPI|ppi
5584603|NCT00951431|postprandial fullness|postprandial fullness
5584604|NCT00951431|delayed gastric emptying|delayed gastric emptying
5584605|NCT00951418|clozapine|clozapine
5584606|NCT00951418|schizophrenia|schizophrenia
5584607|NCT00951418|cognition|cognition
5584608|NCT00951418|t-wave morphology|t-wave morphology
5584609|NCT00951392|Insulin sensitivity|insulin sensitivity
5584610|NCT00951392|aging|aging
5584611|NCT00951392|lipid metabolism|lipid metabolism
5680338|NCT00578175|Humans|humans
5584612|NCT00951392|hyperinsulinemic clamp|hyperinsulinemic clamp
5584613|NCT00951392|gene expression|gene expression
5584614|NCT00951392|sirtuins|sirtuins
5584615|NCT00951366|premature birth|premature birth
5584616|NCT00951366|neonatal respiratory distress|neonatal respiratory distress
5584617|NCT00951366|chronic lung disease|chronic lung disease
5584618|NCT00951366|epidemiologicfactors|epidemiologicfactors
5584619|NCT00951366|genetic factors|genetic factors
5584620|NCT00951353|Transplantation|transplantation
5584621|NCT00951353|Kidney Failure|kidney failure
5584622|NCT00951353|End Stage Renal Disease|end stage renal disease
5584623|NCT00951353|Pediatric|pediatric
5584624|NCT00951340|CBT|cbt
5584625|NCT00951340|Emotional-Focused Therapy|emotional-focused therapy
5584626|NCT00951340|Interpersonal Therapy|interpersonal therapy
5584627|NCT00951327|Primary sclerosing cholangitis|primary sclerosing cholangitis
5584628|NCT00951314|Genetic Polymorphisms|genetic polymorphisms
5584629|NCT00951314|Metabotropic Glutamate Receptors|metabotropic glutamate receptors
5584630|NCT00951314|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5584631|NCT00951314|Cocaine Dependence|cocaine dependence
5584632|NCT00951314|Cue-Induced Craving|cue-induced craving
5584633|NCT00951314|Drug Abuse|drug abuse
5584634|NCT00951288|AMD|amd
5584635|NCT00951288|Retinal Function|retinal function
5584636|NCT00951288|Neuroprotection|neuroprotection
5584637|NCT00951262|life review|life review
5584638|NCT00951262|quality of life|quality of life
5584639|NCT00951262|advanced cancer patients|advanced cancer patients
5584640|NCT00951249|MSM|msm
5584641|NCT00951249|HIV infections|hiv infections
5584642|NCT00951249|HIV Seronegativity|hiv seronegativity
5584643|NCT00951236|Trigger Finger|trigger finger
5584644|NCT00951236|Trigger Thumb|trigger thumb
5584645|NCT00951210|Peripheral Artery Disease|peripheral artery disease
5584646|NCT00951210|Peripheral Vascular Disease|peripheral vascular disease
5584647|NCT00951210|Critical limb ischemia|critical limb ischemia
5584648|NCT00951210|PAD|pad
5584649|NCT00951210|CLI|cli
5584650|NCT00951197|dementia|dementia
5584651|NCT00951197|Alzheimer's Disease|alzheimer's disease
5584652|NCT00951197|diagnostic|diagnostic
5584653|NCT00951197|biomarkers|biomarkers
5584654|NCT00951197|neuroimaging|neuroimaging
5584656|NCT00951197|MRI|mri
5584657|NCT00951197|mild cognitive impairment|mild cognitive impairment
5584658|NCT00951184|depression|depression
5685414|NCT00556166|Enterra therapy|enterra therapy
5584659|NCT00951184|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5584660|NCT00951158|Conjugated Linoleic Acid|conjugated linoleic acid
5584661|NCT00951158|Clarinol|clarinol
5584662|NCT00951158|S14 Expression|s14 expression
5584663|NCT00951132|Inflammation|inflammation
5584664|NCT00951132|Atherosclerosis|atherosclerosis
5584665|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5584666|NCT00951119|type 2 diabetes|type 2 diabetes
5584667|NCT00951119|hypertension|hypertension
5584668|NCT00951119|treatment|treatment
5584669|NCT00951119|non-medical|non-medical
5584671|NCT00951106|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5584672|NCT00951106|Drug resistance|drug resistance
5584674|NCT00951093|Gastric bypass|gastric bypass
5584675|NCT00951080|ulcer|ulcer
5584676|NCT00951080|venous|venous
5584677|NCT00951080|diabetic|diabetic
5584678|NCT00951080|wounds and injuries|wounds and injuries
5584679|NCT00951067|Lymphedema|lymphedema
5584680|NCT00951067|Breast Cancer|breast cancer
5584681|NCT00951067|Upper Extremity|upper extremity
5584682|NCT00951067|Arm|arm
5584683|NCT00951054|breast cancer|breast cancer
5584684|NCT00951054|triple negative|triple negative
5584685|NCT00951054|ER-negative|er-negative
5584686|NCT00951054|PR-negative|pr-negative
5584687|NCT00951054|HER2-negative|her2-negative
5584688|NCT00951054|ER-, PR-, HER2- (Triple Negative) breast cancer|er-, pr-, her2- (triple negative) breast cancer
5584689|NCT00951041|influenza infection|influenza infection
5584690|NCT00951041|GSK Bio's influenza vaccine GSK2340272A|gsk bio's influenza vaccine gsk2340272a
5584691|NCT00951028|Adherence|adherence
5584692|NCT00951015|GSK1349572|gsk1349572
5584693|NCT00951015|emtricitabine|emtricitabine
5584694|NCT00951015|tenofovir|tenofovir
5584695|NCT00951015|efavirenz|efavirenz
5584696|NCT00951015|abacavir|abacavir
5584697|NCT00951015|antiretroviral therapy naive|antiretroviral therapy naive
5584698|NCT00951015|dose selection|dose selection
5584699|NCT00951015|HIV-1 Infection|hiv-1 infection
5584700|NCT00951015|integrase inhibitor|integrase inhibitor
5584701|NCT00951015|HIV infection|hiv infection
5584702|NCT00951015|once daily|once daily
5584703|NCT00951015|lamivudine|lamivudine
5584704|NCT00951002|anal fistula|anal fistula
5584705|NCT00951002|acellular dermal matrix|acellular dermal matrix
5584706|NCT00951002|treatment|treatment
5584707|NCT00951002|postoperative complications|postoperative complications
5584708|NCT00951002|recurrence|recurrence
5584709|NCT00950989|Autoimmune Diseases|autoimmune diseases
5584710|NCT00950989|Musculoskeletal Diseases|musculoskeletal diseases
5584711|NCT00950989|Joint Diseases|joint diseases
5584712|NCT00950989|Arthritis|arthritis
5584713|NCT00950989|Connective Tissue Diseases|connective tissue diseases
5584714|NCT00950989|Arthritis, Rheumatoid|arthritis, rheumatoid
5584715|NCT00950989|Rheumatic Diseases|rheumatic diseases
5586547|NCT00944736|Zonulin|zonulin
5584716|NCT00950963|Diabetes, Nurse phone intervention, lipid control|diabetes, nurse phone intervention, lipid control
5584717|NCT00950950|Amgen|amgen
5584718|NCT00950950|Postmenopausal|postmenopausal
5584719|NCT00950950|Bone Density|bone density
5584720|NCT00950924|Hyperopia|hyperopia
5584721|NCT00950924|Refractive Error|refractive error
5584722|NCT00950924|Ocular Biometrics|ocular biometrics
5584723|NCT00950924|Axial Length|axial length
5584724|NCT00950924|Contact Lenses|contact lenses
5584725|NCT00950924|Bifocal Contact Lenses|bifocal contact lenses
5584726|NCT00950911|Bone metastases|bone metastases
5584727|NCT00950911|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5584728|NCT00950911|Multiple myeloma|multiple myeloma
5584729|NCT00950911|Denosumab|denosumab
5584730|NCT00950911|Breast cancer|breast cancer
5584731|NCT00950911|20050103|20050103
5584732|NCT00950911|20050136|20050136
5584733|NCT00950911|20050244|20050244
5584734|NCT00950911|Advanced cancer|advanced cancer
5584735|NCT00950911|Tumor|tumor
5584736|NCT00950911|Prostate cancer|prostate cancer
5584737|NCT00950911|Zoledronic acid|zoledronic acid
5584738|NCT00950898|coffee|coffee
5584739|NCT00950898|caffeine|caffeine
5584740|NCT00950898|glucose metabolism|glucose metabolism
5584741|NCT00950898|insulin sensitivity|insulin sensitivity
5584742|NCT00950898|diabetes|diabetes
5584743|NCT00950885|sleep|sleep
5584744|NCT00950885|alertness|alertness
5584745|NCT00950885|performance|performance
5584746|NCT00950885|vigilance|vigilance
5584747|NCT00950885|circadian|circadian
5584748|NCT00950859|treatment experienced|treatment experienced
5584749|NCT00950859|HIV Infection|hiv infection
5584750|NCT00950859|raltegravir resistance|raltegravir resistance
5584751|NCT00950859|GSK1349572|gsk1349572
5584752|NCT00950859|optimized background regimen|optimized background regimen
5584753|NCT00950859|integrase inhibitor|integrase inhibitor
5584754|NCT00950846|Congenital Pediatric Disorders|congenital pediatric disorders
5584755|NCT00950846|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5584756|NCT00950846|Congenital Abnormalities|congenital abnormalities
5584757|NCT00950846|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5584759|NCT00950846|Cytoxan|cytoxan
5584760|NCT00950846|Cyclophosphamide|cyclophosphamide
5584761|NCT00950846|Fludarabine|fludarabine
5584762|NCT00950833|Catch-up vaccination|catch-up vaccination
5584763|NCT00950833|Pneumococcal vaccine|pneumococcal vaccine
5584764|NCT00950833|Immune memory|immune memory
5584765|NCT00950833|Nasopharyngeal carriage|nasopharyngeal carriage
5584766|NCT00950833|Immunogenicity|immunogenicity
5584767|NCT00950833|Pneumococcal disease|pneumococcal disease
5584768|NCT00950833|Safety|safety
5584770|NCT00950820|Phase-II-Study|phase-ii-study
5584771|NCT00950820|Randomized|randomized
5584772|NCT00950820|Metastatic|metastatic
5584773|NCT00950820|Colorectal|colorectal
5584775|NCT00950820|Panitumumab|panitumumab
5584776|NCT00950820|Vectibix®|vectibix®
5584777|NCT00950820|second-line-treatment|second-line-treatment
5584778|NCT00950820|KRAS|kras
5584779|NCT00950807|Dose ranging|dose ranging
5584780|NCT00950807|Chronic Bronchitis|chronic bronchitis
5584781|NCT00950807|Long-acting muscarinic antagonist|long-acting muscarinic antagonist
5584782|NCT00950807|cross-over|cross-over
5584783|NCT00950807|COPD|copd
5584784|NCT00950807|Emphysema|emphysema
5584785|NCT00950807|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5584786|NCT00950807|anticholinergic|anticholinergic
5584787|NCT00950794|Long acting beta2-agonist|long acting beta2-agonist
5584788|NCT00950781|Menopause|menopause
5584789|NCT00950781|Cortisol|cortisol
5584790|NCT00950781|ACTH|acth
5584791|NCT00950768|Myeloma|myeloma
5584792|NCT00950768|Melphalan|melphalan
5584793|NCT00950768|Autologous transplantation|autologous transplantation
5584794|NCT00950729|car driving simulator|car driving simulator
5584795|NCT00950729|orthopedic leg immobilisation|orthopedic leg immobilisation
5584796|NCT00950729|braking time|braking time
5584797|NCT00950729|braking force|braking force
5584798|NCT00950716|type II diabetes|type ii diabetes
5584799|NCT00950716|peer support|peer support
5584800|NCT00950716|empowerment|empowerment
5584801|NCT00950703|Assessing the perceptions of Canadian Primary care physicians towards global Cardiovascular risk assessment.|assessing the perceptions of canadian primary care physicians towards global cardiovascular risk assessment.
5584802|NCT00950690|observational safety study|observational safety study
5584803|NCT00950677|Diabetes|diabetes
5584804|NCT00950677|pramlintide|pramlintide
5584805|NCT00950677|Symlin|symlin
5584806|NCT00950677|exenatide|exenatide
5584807|NCT00950677|byetta|byetta
5584808|NCT00950677|glucagon|glucagon
5584809|NCT00950677|gastric emptying|gastric emptying
5584810|NCT00950664|cervical dystonia|cervical dystonia
5584811|NCT00950664|botulinum toxin|botulinum toxin
5584812|NCT00950638|AMD|amd
5584813|NCT00950625|intraperitoneal analgesia|intraperitoneal analgesia
5584814|NCT00950625|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5584815|NCT00950625|lignocaine|lignocaine
5584816|NCT00950625|bupevacaine|bupevacaine
5584817|NCT00950612|Tuberculosis vaccine|tuberculosis vaccine
5584818|NCT00950586|Drug interaction|drug interaction
5584819|NCT00950586|Saftey|saftey
5584820|NCT00950586|Pharmacokinetics|pharmacokinetics
5584821|NCT00950586|Cognition|cognition
5584822|NCT00950573|cardiovascular disease|cardiovascular disease
5584823|NCT00950573|endstage renal disease|endstage renal disease
5584824|NCT00950547|Blood Transfusion|blood transfusion
5584825|NCT00950547|Cell Saver|cell saver
5584826|NCT00950547|Cardiac Surgery|cardiac surgery
5584827|NCT00950547|Evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery in reducing blood transfusions.|evaluate the efficacy of cell salvage cardiopat routinely used in cardiac surgery in reducing blood transfusions.
5584828|NCT00950521|Stroke|stroke
5584829|NCT00950521|Stem Cell|stem cell
5584830|NCT00950521|Cell Therapy|cell therapy
5584831|NCT00950521|CD34 Stem cell|cd34 stem cell
5584832|NCT00950521|Peripheral blood Stem cell|peripheral blood stem cell
5584833|NCT00950495|Parallel design|parallel design
5584834|NCT00950495|Oral appliance|oral appliance
5584835|NCT00950495|Mandibular advancement device|mandibular advancement device
5584836|NCT00950495|Continuous positive airway pressure|continuous positive airway pressure
5584837|NCT00950495|Placebo|placebo
5584838|NCT00950495|Therapy|therapy
5584839|NCT00950495|Side-effects|side-effects
5584840|NCT00950495|Compliance|compliance
5584841|NCT00950482|Menopause|menopause
5584842|NCT00950482|Acupuncture|acupuncture
5584843|NCT00950482|Hotflash|hotflash
5584844|NCT00950469|high sensitive troponin T; cardiac necrosis; early detection; myoglobin; h-FABP|high sensitive troponin t; cardiac necrosis; early detection; myoglobin; h-fabp
5671237|NCT00616590|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5671320|NCT00616551|Acromegaly|acromegaly
5584845|NCT00950469|early identification and risk stratification of patients with suspicious acute coronary syndrome|early identification and risk stratification of patients with suspicious acute coronary syndrome
5584846|NCT00950443|Upper airway obstruction|upper airway obstruction
5584847|NCT00950443|child|child
5584848|NCT00950443|acoustic reflection method|acoustic reflection method
5584850|NCT00950443|work of breathing|work of breathing
5584851|NCT00950443|sleep study|sleep study
5584852|NCT00950443|CT scan|ct scan
5584853|NCT00950430|Imaging|imaging
5584855|NCT00950430|PiB|pib
5584856|NCT00950430|FDG|fdg
5584857|NCT00950430|MCI|mci
5584858|NCT00950430|Dementia|dementia
5584859|NCT00950430|Alzheimer's Disease|alzheimer's disease
5584860|NCT00950430|Brain Amyloid|brain amyloid
5584861|NCT00950417|nimotuzumab esophageal chemo-radiotherapy|nimotuzumab esophageal chemo-radiotherapy
5584862|NCT00950404|Bioavailability Pharmacokinetic Formulation|bioavailability pharmacokinetic formulation
5584863|NCT00950391|peripheral nerve injury|peripheral nerve injury
5584864|NCT00950391|peripheral nerve surgery|peripheral nerve surgery
5579180|NCT00971711|IBS|ibs
5584865|NCT00950391|nerve repair|nerve repair
5584866|NCT00950391|nerve graft|nerve graft
5584867|NCT00950378|edema|edema
5584868|NCT00950378|blood supply|blood supply
5584869|NCT00950378|lower legs|lower legs
5584870|NCT00950378|venous stasis|venous stasis
5584871|NCT00950365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5584872|NCT00950365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5584873|NCT00950365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5584874|NCT00950365|progressive or recurrent stage III or stage IV non-small cell lung cancer|progressive or recurrent stage iii or stage iv non-small cell lung cancer
5584875|NCT00950352|methamphetamine|methamphetamine
5584876|NCT00950352|Citicoline|citicoline
5584877|NCT00950352|CDP-Choline|cdp-choline
5584878|NCT00950352|Neuroimaging|neuroimaging
5584880|NCT00950352|Brain|brain
5584881|NCT00950352|MRS|mrs
5584882|NCT00950352|DTI|dti
5584883|NCT00950339|GI bleeding|gi bleeding
5584884|NCT00950339|clopidogrel|clopidogrel
5584885|NCT00950339|aspirin|aspirin
5584886|NCT00950339|prevention|prevention
5584887|NCT00950339|angiography|angiography
5584888|NCT00950326|osteoarthritis|osteoarthritis
5584889|NCT00950326|hydrotherapy|hydrotherapy
5584890|NCT00950326|affusion|affusion
5584891|NCT00950326|conventional physiotherapy|conventional physiotherapy
5584892|NCT00950326|comparison|comparison
5584893|NCT00950313|Diabetes|diabetes
5584894|NCT00950313|Screening|screening
5584895|NCT00950313|Risk|risk
5584896|NCT00950313|Self assessment|self assessment
5584897|NCT00950287|apnea-bradycardias|apnea-bradycardias
5584898|NCT00950287|preterm infants|preterm infants
5584899|NCT00950274|Cell therapy|cell therapy
5584900|NCT00950274|Bone marrow|bone marrow
5584901|NCT00950274|CD133|cd133
5584902|NCT00950274|Bypass surgery|bypass surgery
5584903|NCT00950274|Stem cells|stem cells
5584904|NCT00950274|Myocardial infarction|myocardial infarction
5584905|NCT00950274|Myocardial ischemia|myocardial ischemia
5680339|NCT00578175|Mumps|mumps
5006027|NCT03958903|Temporal lobe epilepsy|temporal lobe epilepsy
5584906|NCT00950261|Cervical neoplasms|cervical neoplasms
5584907|NCT00950261|Cisplatin|cisplatin
5584908|NCT00950261|Concurrent Chemoradiation|concurrent chemoradiation
5584909|NCT00950248|Idebenone|idebenone
5584910|NCT00950248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5584911|NCT00950248|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5584912|NCT00950248|Mitochondrial Enhancer|mitochondrial enhancer
5584913|NCT00950248|Multiple Sclerosis|multiple sclerosis
5584915|NCT00950248|Primary Progressive Multiple Sclerosis|primary progressive multiple sclerosis
5584916|NCT00950235|obese|obese
5584917|NCT00950235|pregnant|pregnant
5584918|NCT00950235|large for gestational age|large for gestational age
5584919|NCT00950235|large for gestational age baby|large for gestational age baby
5584920|NCT00950222|Intensive care unit|intensive care unit
5584921|NCT00950222|Ventilator associated pneumonia|ventilator associated pneumonia
5584922|NCT00950222|Gram negative bacilli infection|gram negative bacilli infection
5584923|NCT00950222|Empirical antibiotic therapy|empirical antibiotic therapy
5584924|NCT00950222|Pharmacokinetic / pharmacodynamic|pharmacokinetic / pharmacodynamic
5584925|NCT00950222|Imipenem|imipenem
5584926|NCT00950222|Amikacin|amikacin
5584927|NCT00950222|Gram negative bacilli|gram negative bacilli
5584928|NCT00950209|type 2 diabetic patients in the fed state|type 2 diabetic patients in the fed state
5584929|NCT00950183|cryotherapy|cryotherapy
5584930|NCT00950183|postoperative pain|postoperative pain
5584931|NCT00950183|Iceman|iceman
5584932|NCT00950183|primary first metatarsal osteotomy (PMO)|primary first metatarsal osteotomy (pmo)
5584933|NCT00950183|lateral ankle ligament reconstruction (LAR)|lateral ankle ligament reconstruction (lar)
5584934|NCT00950170|ReFacto AF|refacto af
5584935|NCT00950170|factor VIII|factor viii
5584936|NCT00950170|inhibitors|inhibitors
5584937|NCT00950170|antibodies|antibodies
5584938|NCT00950144|pain|pain
5584939|NCT00950144|depression|depression
5584940|NCT00950144|fatigue|fatigue
5584941|NCT00950144|stage III colon cancer|stage iii colon cancer
5762159|NCT00275158|cGMP|cgmp
5584942|NCT00950144|stage IV colon cancer|stage iv colon cancer
5584943|NCT00950144|recurrent colon cancer|recurrent colon cancer
5584944|NCT00950144|stage III rectal cancer|stage iii rectal cancer
5584945|NCT00950144|stage IV rectal cancer|stage iv rectal cancer
5584946|NCT00950144|recurrent rectal cancer|recurrent rectal cancer
5584947|NCT00950144|stage III pancreatic cancer|stage iii pancreatic cancer
5584948|NCT00950144|stage IV pancreatic cancer|stage iv pancreatic cancer
5584949|NCT00950144|recurrent pancreatic cancer|recurrent pancreatic cancer
5584950|NCT00950144|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5584951|NCT00950144|advanced adult primary liver cancer|advanced adult primary liver cancer
5584952|NCT00950144|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5584953|NCT00950144|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5584954|NCT00950118|Congenital Diaphragmatic Hernia (CDH)|congenital diaphragmatic hernia (cdh)
5584955|NCT00950118|Genes|genes
5584956|NCT00950118|Genetic|genetic
5584960|NCT00950118|RNAseq|rnaseq
5584961|NCT00950105|CPSI2364|cpsi2364
5584962|NCT00950105|Semapimod|semapimod
5584965|NCT00950105|Safety|safety
5584966|NCT00950105|Tolerability|tolerability
5584967|NCT00950105|Pharmacokinetics|pharmacokinetics
5584968|NCT00950092|AF|af
5584969|NCT00950092|atrial fibrillation|atrial fibrillation
5584970|NCT00950092|ablation|ablation
5584971|NCT00950092|surgical ablation|surgical ablation
5584972|NCT00950092|afib|afib
5584973|NCT00950092|coagulation|coagulation
5584974|NCT00950092|RF|rf
5584975|NCT00950092|epicardial|epicardial
5584976|NCT00950092|Arrhythmias|arrhythmias
5584977|NCT00950079|sodium bicarbonate|sodium bicarbonate
5584978|NCT00950079|diabetes mellitus|diabetes mellitus
5584979|NCT00950079|coronary angiography or intervention|coronary angiography or intervention
5584980|NCT00950040|At-risk drinking|at-risk drinking
5584981|NCT00950040|Type 2 diabetes|type 2 diabetes
5584982|NCT00950040|Treatment adherence|treatment adherence
5584983|NCT00950040|At-risk drinking among Type 2 diabetic patients|at-risk drinking among type 2 diabetic patients
5584984|NCT00950014|Numeracy|numeracy
5584985|NCT00949988|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5584986|NCT00949988|CLL|cll
5584987|NCT00949988|Dasatinib|dasatinib
5584988|NCT00949988|Rituximab|rituximab
5584989|NCT00949988|Relapsed|relapsed
5584990|NCT00949988|Refractory|refractory
5584991|NCT00949975|Chronic|chronic
5584992|NCT00949975|Obstructive|obstructive
5584993|NCT00949975|Pulmonary|pulmonary
5584994|NCT00949975|Lung|lung
5584995|NCT00949975|Respiratory disease|respiratory disease
5584996|NCT00949975|Efficacy|efficacy
5584997|NCT00949975|Safety and tolerability|safety and tolerability
5584998|NCT00949975|Placebo-controlled|placebo-controlled
5584999|NCT00949975|Pharmacokinetics|pharmacokinetics
5585000|NCT00949975|COPD|copd
5585001|NCT00949962|stage I prostate cancer|stage i prostate cancer
5585002|NCT00949962|stage IIB prostate cancer|stage iib prostate cancer
5585003|NCT00949962|stage IIA prostate cancer|stage iia prostate cancer
5585004|NCT00949962|stage III prostate cancer|stage iii prostate cancer
5585005|NCT00949936|Spine surgery|spine surgery
5585006|NCT00949923|Postmenopausal women|postmenopausal women
5585007|NCT00949923|Suspicious for breast ca|suspicious for breast ca
5585008|NCT00949897|Adult Acquired Flatfoot|adult acquired flatfoot
5585009|NCT00949897|Biofoam Porous Metal Implant|biofoam porous metal implant
5585010|NCT00949897|Allograft Bone Wedge|allograft bone wedge
5585011|NCT00949871|stage I breast cancer|stage i breast cancer
5585012|NCT00949871|stage II breast cancer|stage ii breast cancer
5585013|NCT00949871|stage IIIA breast cancer|stage iiia breast cancer
5585014|NCT00949871|stage IIIB breast cancer|stage iiib breast cancer
5585015|NCT00949871|stage IIIC breast cancer|stage iiic breast cancer
5585016|NCT00949871|stage IV breast cancer|stage iv breast cancer
5585017|NCT00949871|cancer survivor|cancer survivor
5585018|NCT00949858|Sleep Disorders|sleep disorders
5585019|NCT00949858|Obstructive Sleep Apnea|obstructive sleep apnea
5585020|NCT00949858|Restless Leg Syndrome|restless leg syndrome
5585021|NCT00949858|Insomnia|insomnia
5585022|NCT00949858|Actigraphy|actigraphy
5585023|NCT00949845|Effect of Inflammatory challenge on depressed mood|effect of inflammatory challenge on depressed mood
5585024|NCT00949845|Effect of inflammatory challenge on social pain|effect of inflammatory challenge on social pain
5585025|NCT00949832|rickets|rickets
5585026|NCT00949832|calcium|calcium
5585027|NCT00949832|vitamin D|vitamin d
5585028|NCT00949832|nutrition|nutrition
5585029|NCT00949832|child|child
5585034|NCT00949806|Botulinum toxin|botulinum toxin
5585035|NCT00949793|Pathology|pathology
5585036|NCT00949793|Microscopy, Confocal|microscopy, confocal
5585037|NCT00949793|Microscopy, Fluorescence|microscopy, fluorescence
5585038|NCT00949793|Intraoperative Procedures|intraoperative procedures
5585040|NCT00949780|Chloral Hydrate|chloral hydrate
5585041|NCT00949780|Sedation|sedation
5585042|NCT00949780|Children|children
5585043|NCT00949754|honeybee venom|honeybee venom
5585044|NCT00949754|osteoarthritis|osteoarthritis
5585046|NCT00949754|knees|knees
5585047|NCT00949728|Pterygium|pterygium
5585048|NCT00949728|Autologous Transplantation|autologous transplantation
5585049|NCT00949728|Conjunctiva|conjunctiva
5585050|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive
5585051|NCT00949728|Recurrence|recurrence
5585052|NCT00949715|Pacemaker|pacemaker
5585053|NCT00949715|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
5585054|NCT00949715|AV Conduction Disturbance|av conduction disturbance
5585055|NCT00949715|Selective Site Pacing|selective site pacing
5585056|NCT00949689|adolescence|adolescence
5585057|NCT00949689|insomnia|insomnia
5585063|NCT00949663|Xenin-25|xenin-25
5585064|NCT00949663|GIP|gip
5585065|NCT00949663|Insulin|insulin
5585066|NCT00949637|obesity prevention|obesity prevention
5585067|NCT00949637|girl scouts|girl scouts
5585068|NCT00949637|physical activity|physical activity
5585069|NCT00949637|family meals|family meals
5585070|NCT00949637|fruits and vegetables|fruits and vegetables
5585071|NCT00949637|health promotion|health promotion
5585073|NCT00949624|VEGFr inhibition;|vegfr inhibition;
5585074|NCT00949624|targeted therapy|targeted therapy
5585075|NCT00949611|Decision Aid|decision aid
5585076|NCT00949611|Shared Decision Making|shared decision making
5585077|NCT00949611|Shared Medical Decision Making|shared medical decision making
5585078|NCT00949598|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5585080|NCT00949598|stage IB breast cancer|stage ib breast cancer
5585081|NCT00949598|stage II breast cancer|stage ii breast cancer
5585082|NCT00949598|stage IIIA breast cancer|stage iiia breast cancer
5585083|NCT00949585|randomized, controlled feeding study;|randomized, controlled feeding study;
5585084|NCT00949585|crossover design|crossover design
5585085|NCT00949585|potassium intake|potassium intake
5585086|NCT00949572|mucosal immunity|mucosal immunity
5585087|NCT00949572|immunization|immunization
5585088|NCT00949572|sublingual|sublingual
5585089|NCT00949520|patients|patients
5585090|NCT00949520|functional evaluation|functional evaluation
5585091|NCT00949520|known coronary artery lesion|known coronary artery lesion
5585092|NCT00949494|knee osteoarthritis, synvisc, hyaluronan, dGEMRIC,cartilage|knee osteoarthritis, synvisc, hyaluronan, dgemric,cartilage
5585093|NCT00949481|postpartum|postpartum
5585094|NCT00949481|family planning|family planning
5585095|NCT00949481|job aid|job aid
5585096|NCT00949481|immunization|immunization
5585097|NCT00949481|pregnancy test|pregnancy test
5585098|NCT00949468|Keratitis|keratitis
5585099|NCT00949455|stage IV bladder cancer|stage iv bladder cancer
5585100|NCT00949455|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5585101|NCT00949429|postoperative pain|postoperative pain
5585102|NCT00949429|cardiac surgery|cardiac surgery
5585103|NCT00949429|risk factors|risk factors
5585104|NCT00949416|genetic|genetic
5585105|NCT00949403|Non-Alcoholic Fatty Liver disease|non-alcoholic fatty liver disease
5585106|NCT00949390|Advanced Cancer|advanced cancer
5585107|NCT00949390|Advanced Malignancy|advanced malignancy
5585108|NCT00949390|Complementary and Alternative Medicine|complementary and alternative medicine
5585109|NCT00949390|CAM|cam
5585110|NCT00949390|Investigational Cancer Therapeutics|investigational cancer therapeutics
5585111|NCT00949390|Phase I Clinical Trials|phase i clinical trials
5585112|NCT00949377|Constipation|constipation
5585113|NCT00949377|opioid|opioid
5585114|NCT00949364|Myeloproliferative Neoplasms|myeloproliferative neoplasms
5585115|NCT00949364|Pomalidomide|pomalidomide
5585116|NCT00949364|Fibrotic Stage|fibrotic stage
5585117|NCT00949364|Patients with Myeloproliferative Neoplasms in Fibrotic Stage|patients with myeloproliferative neoplasms in fibrotic stage
5585118|NCT00949351|ACEI, ARB, DN, aliskiren, proteinuria|acei, arb, dn, aliskiren, proteinuria
5585119|NCT00949338|stage I prostate cancer|stage i prostate cancer
5585120|NCT00949338|stage IIB prostate cancer|stage iib prostate cancer
5585121|NCT00949338|stage IIA prostate cancer|stage iia prostate cancer
5585122|NCT00949338|stage III prostate cancer|stage iii prostate cancer
5585123|NCT00949338|stage IV prostate cancer|stage iv prostate cancer
5585124|NCT00949338|recurrent prostate cancer|recurrent prostate cancer
5585125|NCT00949325|osteosarcoma|osteosarcoma
5585126|NCT00949325|soft tissue sarcoma|soft tissue sarcoma
5585127|NCT00949325|rhabdomyosarcoma|rhabdomyosarcoma
5585128|NCT00949325|leiomyosarcoma|leiomyosarcoma
5585129|NCT00949325|Ewing's sarcoma|ewing's sarcoma
5585130|NCT00949325|chondrosarcoma|chondrosarcoma
5585131|NCT00949325|liposarcoma|liposarcoma
5585132|NCT00949325|malignant fibrous histiocytoma|malignant fibrous histiocytoma
5585133|NCT00949325|malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
5585134|NCT00949325|pleiomorphic sarcoma|pleiomorphic sarcoma
5585135|NCT00949325|spindle cell sarcoma|spindle cell sarcoma
5585136|NCT00949325|synovial sarcoma|synovial sarcoma
5585137|NCT00949325|cancer stem cell|cancer stem cell
5585138|NCT00949312|stage II colon cancer|stage ii colon cancer
5585139|NCT00949286|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5585140|NCT00949273|cylindrical abdominoperineal resection|cylindrical abdominoperineal resection
5585141|NCT00949273|rectal cancer|rectal cancer
5585142|NCT00949273|acellular dermal matrix|acellular dermal matrix
5585143|NCT00949273|pelvic reconstruction|pelvic reconstruction
5585144|NCT00949273|circumferential resection margin|circumferential resection margin
5585145|NCT00949273|overall survival|overall survival
5585146|NCT00949260|PIH|pih
5585147|NCT00949260|pregnancy induced hypertension|pregnancy induced hypertension
5585148|NCT00949260|pregnancy|pregnancy
5585149|NCT00949260|bioimpedance|bioimpedance
5585150|NCT00949260|noninvasive monitoring|noninvasive monitoring
5585151|NCT00949260|Cardiac Output|cardiac output
5585152|NCT00949260|Blood Pressure|blood pressure
5585153|NCT00949247|stage I breast cancer|stage i breast cancer
5585154|NCT00949247|stage II breast cancer|stage ii breast cancer
5585155|NCT00949247|stage IIIA breast cancer|stage iiia breast cancer
5585156|NCT00949247|stage IIIB breast cancer|stage iiib breast cancer
5585157|NCT00949247|stage IIIC breast cancer|stage iiic breast cancer
5585158|NCT00949247|HER2-positive breast cancer|her2-positive breast cancer
5585159|NCT00949234|post exposure prophylaxis|post exposure prophylaxis
5585160|NCT00949234|biomedical prevention|biomedical prevention
5585162|NCT00949221|Type 1 diabetes|type 1 diabetes
5585163|NCT00949221|Paediatric|paediatric
5585164|NCT00949221|Real Time Continuous Glucose Monitoring|real time continuous glucose monitoring
5585165|NCT00949221|Glycemic control|glycemic control
5585166|NCT00949221|Therapeutic education|therapeutic education
5585167|NCT00949208|Healthy people|healthy people
5585168|NCT00949195|COPD|copd
5585169|NCT00949195|healthy patients|healthy patients
5585170|NCT00949195|PAP|pap
5585171|NCT00949195|CPX|cpx
5585172|NCT00949195|SSE|sse
5585173|NCT00949195|hsCRP|hscrp
5585174|NCT00949195|FMD|fmd
5585175|NCT00949182|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5585176|NCT00949182|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5585177|NCT00949169|Atherosclerosis|atherosclerosis
5585178|NCT00949169|Carotid IMT|carotid imt
5585179|NCT00949169|Multidetector CT|multidetector ct
5585180|NCT00949169|Type 2 diabetes|type 2 diabetes
5585181|NCT00949156|Craniopharyngiomas|craniopharyngiomas
5585182|NCT00949156|Classification|classification
5585183|NCT00949156|Membranous structure|membranous structure
5585184|NCT00949156|Pituitary stalk|pituitary stalk
5585185|NCT00949156|Obesity|obesity
5585186|NCT00949156|panhypopituitarism|panhypopituitarism
5585187|NCT00949143|wheelchair user|wheelchair user
5585188|NCT00949117|malnutrition|malnutrition
5585189|NCT00949117|weight changes|weight changes
5585190|NCT00949117|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5585191|NCT00949117|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5585192|NCT00949117|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5570322|NCT01005264|diabetic foot|diabetic foot
5585193|NCT00949117|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5585194|NCT00949117|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5585195|NCT00949117|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5585196|NCT00949117|other myeloid malignancies|other myeloid malignancies
5585197|NCT00949117|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5586834|NCT00943449|Sorafenib|sorafenib
5585198|NCT00949117|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5585199|NCT00949117|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5585200|NCT00949117|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5585201|NCT00949117|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5585202|NCT00949117|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5585203|NCT00949117|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5585204|NCT00949117|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5585205|NCT00949117|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5585206|NCT00949117|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5585207|NCT00949117|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5585208|NCT00949117|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5585209|NCT00949117|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5585210|NCT00949117|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5585211|NCT00949117|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5585212|NCT00949117|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5585213|NCT00949117|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5585214|NCT00949117|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5585215|NCT00949117|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5585216|NCT00949117|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5585217|NCT00949117|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5585218|NCT00949117|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5585219|NCT00949117|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5585220|NCT00949117|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5585221|NCT00949117|childhood Burkitt lymphoma|childhood burkitt lymphoma
5585222|NCT00949117|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5585223|NCT00949117|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5585224|NCT00949117|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5585225|NCT00949117|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5585226|NCT00949117|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5585227|NCT00949117|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5585228|NCT00949117|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5585229|NCT00949117|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5585230|NCT00949117|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5585231|NCT00949117|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5585233|NCT00949104|pain|pain
5585234|NCT00949104|neonate|neonate
5585235|NCT00949104|preterm|preterm
5585236|NCT00949104|orogastric tube|orogastric tube
5585237|NCT00949091|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5585238|NCT00949091|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5585239|NCT00949091|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5585240|NCT00949091|Drug Therapy|drug therapy
5585241|NCT00949078|peanut|peanut
5585242|NCT00949078|allergy|allergy
5585243|NCT00949065|complex regional pain syndrome|complex regional pain syndrome
5585244|NCT00949065|sympathetic reflex dystrophy|sympathetic reflex dystrophy
5585245|NCT00949065|intravenous immunoglobulins|intravenous immunoglobulins
5585246|NCT00949065|autoimmune disease|autoimmune disease
5585247|NCT00949052|cancer survivor|cancer survivor
5585248|NCT00949052|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5585249|NCT00949052|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5585250|NCT00949052|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5585251|NCT00949052|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5585252|NCT00949052|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5585253|NCT00949052|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5585254|NCT00949052|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5585255|NCT00949052|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5585256|NCT00949052|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5743411|NCT00345176|lutein|lutein
5585257|NCT00949052|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5585258|NCT00949052|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5585259|NCT00949052|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5585260|NCT00949052|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5585261|NCT00949052|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5585262|NCT00949052|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5585263|NCT00949052|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5585264|NCT00949052|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5585265|NCT00949052|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5585266|NCT00949052|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5585267|NCT00949052|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5585268|NCT00949052|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5585269|NCT00949052|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5585270|NCT00949052|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5585271|NCT00949052|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5585272|NCT00949052|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5585273|NCT00949052|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5585274|NCT00949052|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5585275|NCT00949052|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5585276|NCT00949052|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5585277|NCT00949052|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5585278|NCT00949052|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5585279|NCT00949052|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5585280|NCT00949052|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5585281|NCT00949052|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5585282|NCT00949052|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5585283|NCT00949052|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5585284|NCT00949052|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5585285|NCT00949052|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5585286|NCT00949052|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5585287|NCT00949052|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5585288|NCT00949052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5585289|NCT00949052|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5585290|NCT00949052|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5585291|NCT00949052|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5585292|NCT00949052|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5585392|NCT00948961|esophageal cancer|esophageal cancer
5585293|NCT00949052|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5585294|NCT00949052|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5585295|NCT00949052|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5585296|NCT00949052|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5585297|NCT00949052|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5585298|NCT00949052|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5585299|NCT00949052|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5585300|NCT00949052|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5585301|NCT00949052|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5585302|NCT00949052|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5567832|NCT01015391|T2|t2
5585303|NCT00949052|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5585304|NCT00949052|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5585305|NCT00949052|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5585306|NCT00949052|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5585307|NCT00949052|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5585308|NCT00949052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5585309|NCT00949052|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5585310|NCT00949052|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5585311|NCT00949052|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5585312|NCT00949052|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5585313|NCT00949052|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5585314|NCT00949052|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5585315|NCT00949052|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5585316|NCT00949052|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5585317|NCT00949052|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5585318|NCT00949052|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5585319|NCT00949052|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5585320|NCT00949052|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5585321|NCT00949052|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5585322|NCT00949052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5585323|NCT00949052|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5585324|NCT00949052|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5585325|NCT00949052|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5585326|NCT00949052|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5585327|NCT00949052|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5585328|NCT00949052|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5585329|NCT00949052|refractory hairy cell leukemia|refractory hairy cell leukemia
5585330|NCT00949052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5585331|NCT00949052|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5585332|NCT00949052|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5585333|NCT00949052|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5585334|NCT00949052|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5585335|NCT00949052|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5585336|NCT00949052|primary myelofibrosis|primary myelofibrosis
5585337|NCT00949052|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5585338|NCT00949052|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5585339|NCT00949052|disseminated neuroblastoma|disseminated neuroblastoma
5585340|NCT00949052|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5585341|NCT00949052|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5585342|NCT00949052|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5685415|NCT00556166|Gastric Simulation System|gastric simulation system
5585343|NCT00949052|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5585344|NCT00949052|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5585345|NCT00949052|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5585346|NCT00949052|recurrent neuroblastoma|recurrent neuroblastoma
5585347|NCT00949052|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5585348|NCT00949052|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5585349|NCT00949052|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5585350|NCT00949052|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5585351|NCT00949052|stage I multiple myeloma|stage i multiple myeloma
5585352|NCT00949052|stage II multiple myeloma|stage ii multiple myeloma
5585353|NCT00949052|stage III multiple myeloma|stage iii multiple myeloma
5585354|NCT00949052|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5585355|NCT00949052|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5585356|NCT00949052|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5585357|NCT00949052|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5585358|NCT00949052|stage IIIA breast cancer|stage iiia breast cancer
5585359|NCT00949052|stage IIIB breast cancer|stage iiib breast cancer
5585360|NCT00949052|stage IIIC breast cancer|stage iiic breast cancer
5585361|NCT00949052|stage IV breast cancer|stage iv breast cancer
5585362|NCT00949052|refractory multiple myeloma|refractory multiple myeloma
5585363|NCT00949026|Brain Cancer|brain cancer
5585364|NCT00949026|Brain Neoplasms, Malignant|brain neoplasms, malignant
5585365|NCT00949013|stage IA breast cancer|stage ia breast cancer
5585366|NCT00949013|stage IB breast cancer|stage ib breast cancer
5585367|NCT00949013|stage II breast cancer|stage ii breast cancer
5585368|NCT00949013|stage IIIA breast cancer|stage iiia breast cancer
5585369|NCT00949013|stage IIIB breast cancer|stage iiib breast cancer
5585370|NCT00949013|stage IIIC breast cancer|stage iiic breast cancer
5585371|NCT00948987|aspirin resistance|aspirin resistance
5585372|NCT00948987|cardiovascular risk|cardiovascular risk
5585373|NCT00948987|prostaglandins|prostaglandins
5585374|NCT00948987|platelet inhibition|platelet inhibition
5585375|NCT00948974|social anxiety|social anxiety
5585376|NCT00948974|treatment|treatment
5585377|NCT00948974|Cognitive Behavioral Therapy|cognitive behavioral therapy
5585378|NCT00948974|Acceptance and Commitment Therapy|acceptance and commitment therapy
5585379|NCT00948974|Cognitive Therapy|cognitive therapy
5585381|NCT00948961|cancer vaccine|cancer vaccine
5585382|NCT00948961|immunotherapy|immunotherapy
5585383|NCT00948961|breast cancer|breast cancer
5585384|NCT00948961|ovarian cancer|ovarian cancer
5585385|NCT00948961|non-small cell lung cancer|non-small cell lung cancer
5585388|NCT00948961|melanoma|melanoma
5585389|NCT00948961|Resiquimod|resiquimod
5585390|NCT00948961|Poly-ICLC|poly-iclc
5585391|NCT00948961|Hiltonol|hiltonol
5585393|NCT00948961|bladder cancer|bladder cancer
5585394|NCT00948961|chondrosarcoma|chondrosarcoma
5585395|NCT00948961|adenocarcinoma|adenocarcinoma
5585396|NCT00948935|Biliary Cancer|biliary cancer
5585397|NCT00948935|Cholangiocarcinoma|cholangiocarcinoma
5585398|NCT00948935|Panitumumab|panitumumab
5585399|NCT00948922|multiple myeloma|multiple myeloma
5585400|NCT00948922|myeloma|myeloma
5585401|NCT00948922|myeloma proteins|myeloma proteins
5585402|NCT00948922|autologous|autologous
5585403|NCT00948922|allogeneic|allogeneic
5585404|NCT00948922|G-CSR|g-csr
5585405|NCT00948922|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5585406|NCT00948922|stem cell transplant|stem cell transplant
5585407|NCT00948922|stem cell|stem cell
5585408|NCT00948922|stem cell mobilization|stem cell mobilization
5585409|NCT00948896|Chemoprevention|chemoprevention
5585410|NCT00948896|Uganda|uganda
5585411|NCT00948896|Malaria|malaria
5585412|NCT00948896|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5585413|NCT00948896|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5585414|NCT00948896|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5585415|NCT00948883|organ transplant|organ transplant
5585416|NCT00948883|cancer|cancer
5585417|NCT00948883|biobank|biobank
5585418|NCT00948883|immunosuppressive drugs|immunosuppressive drugs
5585419|NCT00948883|lymphoma|lymphoma
5585420|NCT00948870|alternative medicine|alternative medicine
5585421|NCT00948857|DHEA|dhea
5585422|NCT00948857|POF|pof
5585423|NCT00948857|Pregnancy|pregnancy
5585424|NCT00948857|Ovarian Failure|ovarian failure
5585425|NCT00948857|Otherwise Unexplained infertility|otherwise unexplained infertility
5585426|NCT00948857|Ovarian aging|ovarian aging
5585427|NCT00948844|falls|falls
5585428|NCT00948844|Missteps|missteps
5585429|NCT00948831|biologics|biologics
5585430|NCT00948831|fusion rates|fusion rates
5585431|NCT00948831|lumbar fusion|lumbar fusion
5585432|NCT00948831|ALIF|alif
5585433|NCT00948818|Irritable Bowel Syndrome|irritable bowel syndrome
5585434|NCT00948818|Constipation|constipation
5585435|NCT00948818|Linaclotide|linaclotide
5585436|NCT00948805|corpus luteum rescue|corpus luteum rescue
5585437|NCT00948805|Gonadotropin Releasing Hormone (GnRH agonist)|gonadotropin releasing hormone (gnrh agonist)
5585438|NCT00948805|human Chorionic Gonadotropin (hCG)|human chorionic gonadotropin (hcg)
5585439|NCT00948805|infertility|infertility
5585440|NCT00948805|pregnancy rate|pregnancy rate
5585441|NCT00948792|platelets|platelets
5585442|NCT00948792|transfusion|transfusion
5585443|NCT00948792|thrombocytopenia|thrombocytopenia
5585444|NCT00948779|Patient education|patient education
5585445|NCT00948779|Antibiotic|antibiotic
5585446|NCT00948779|Child|child
5585447|NCT00948779|Respiratory tract infection|respiratory tract infection
5585448|NCT00948779|Patient satisfaction|patient satisfaction
5585449|NCT00948779|Parental knowledge|parental knowledge
5585451|NCT00948766|Alzheimer's disease|alzheimer's disease
5585452|NCT00948766|dementia|dementia
5585453|NCT00948766|Alzheimer's type|alzheimer's type
5585454|NCT00948753|Graft-versus-host disease|graft-versus-host disease
5585455|NCT00948753|GVHD|gvhd
5585456|NCT00948753|Maraviroc|maraviroc
5585457|NCT00948753|non-myeloablative allogeneic stem-cell transplantation|non-myeloablative allogeneic stem-cell transplantation
5585458|NCT00948753|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5585461|NCT00948701|Exercise|exercise
5585462|NCT00948701|Physical activity|physical activity
5585463|NCT00948701|Community volunteers|community volunteers
5585464|NCT00948701|Peer mentors|peer mentors
5585465|NCT00948701|Peer coaches|peer coaches
5585466|NCT00948701|Social support|social support
5585468|NCT00948675|Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology|advanced non-small cell lung cancer of nonsquamous histology
5585469|NCT00948675|Advanced Lung Cancer|advanced lung cancer
5585470|NCT00948675|Non-Small Cell Lung Cancer|non-small cell lung cancer
5585471|NCT00948675|Lung Cancer|lung cancer
5585472|NCT00948662|Safety|safety
5585473|NCT00948662|tolerability|tolerability
5585474|NCT00948662|ascending single doses|ascending single doses
5585475|NCT00948662|healthy subjects|healthy subjects
5585476|NCT00948649|Varenicline, Working memory|varenicline, working memory
5585477|NCT00948623|COPD|copd
5585478|NCT00948623|physical activity|physical activity
5585479|NCT00948623|pulmonary rehabilitation|pulmonary rehabilitation
5585480|NCT00948623|counseling|counseling
5585481|NCT00948610|Rheumatoid Arthritis|rheumatoid arthritis
5585482|NCT00948597|propofol|propofol
5585483|NCT00948597|elective surgical procedure|elective surgical procedure
5585484|NCT00948597|Obese subjects|obese subjects
5585485|NCT00948584|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5585486|NCT00948584|Insulin dose titration system|insulin dose titration system
5585487|NCT00948571|Vital capacity, FEV1, airway resistance|vital capacity, fev1, airway resistance
5585488|NCT00948571|perioperative changes in lung function|perioperative changes in lung function
5585489|NCT00948558|citrate anticoagulation|citrate anticoagulation
5585490|NCT00948558|pharmacokinetic|pharmacokinetic
5585491|NCT00948558|critically ill|critically ill
5585492|NCT00948558|acute kidney failure|acute kidney failure
5585493|NCT00948545|Autonomic nervous system|autonomic nervous system
5585494|NCT00948545|Bariatric surgery|bariatric surgery
5585495|NCT00948545|Observational study for individuals having bariatric surgery|observational study for individuals having bariatric surgery
5585496|NCT00948532|degenerative disc disease|degenerative disc disease
5585497|NCT00948532|lumbar spine|lumbar spine
5585499|NCT00948532|Degenerative conditions|degenerative conditions
5585500|NCT00948519|Rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, ICG, indocyanine green|rhinosinusitis, sinusitis, chronic, nasal polyps, phototherapy, laser,laser therapy, antibiotic, safety laser, icg, indocyanine green
5585598|NCT00948116|Diabetes mellitus|diabetes mellitus
5585501|NCT00948519|Chronic Rhinosinusitis with or without nasal polyposis|chronic rhinosinusitis with or without nasal polyposis
5585502|NCT00948493|diabetes|diabetes
5585503|NCT00948493|insulin therapy|insulin therapy
5585504|NCT00948480|autologous tumor cell vaccine|autologous tumor cell vaccine
5585505|NCT00948480|metastatic melanoma|metastatic melanoma
5585506|NCT00948480|sargramostim (GM-CSF)|sargramostim (gm-csf)
5585507|NCT00948467|Advanced nonhematologic malignancies|advanced nonhematologic malignancies
5585508|NCT00948467|Advanced metastatic melanoma|advanced metastatic melanoma
5585509|NCT00948467|BRAF gene|braf gene
5585510|NCT00948454|smoking|smoking
5585511|NCT00948441|intestinal insufficiency|intestinal insufficiency
5585512|NCT00948441|central venous catheter|central venous catheter
5585513|NCT00948441|Catheter-Related Infections|catheter-related infections
5585515|NCT00948441|ethanol|ethanol
5585516|NCT00948428|actinic keratoses|actinic keratoses
5585517|NCT00948428|imiquimod|imiquimod
5585518|NCT00948428|therapeutic equivalence|therapeutic equivalence
5585519|NCT00948428|bioequivalence|bioequivalence
5585520|NCT00948415|Obesity|obesity
5585521|NCT00948415|Weight loss|weight loss
5585522|NCT00948415|Internet|internet
5585523|NCT00948402|PED/PEA-15 protein|ped/pea-15 protein
5585524|NCT00948402|PCOS|pcos
5585525|NCT00948402|IR|ir
5585526|NCT00948402|metformin|metformin
5585527|NCT00948402|OCP|ocp
5585528|NCT00948402|Oral Contraceptive|oral contraceptive
5585529|NCT00948376|Natural history|natural history
5585530|NCT00948376|IFT80|ift80
5585531|NCT00948376|short ribs|short ribs
5585532|NCT00948376|multivisceral involvement|multivisceral involvement
5585533|NCT00948363|Kiwi fruits|kiwi fruits
5585534|NCT00948363|Blood pressure|blood pressure
5585535|NCT00948363|Endothelial function|endothelial function
5585536|NCT00948363|Antioxidant capacity|antioxidant capacity
5585537|NCT00948350|cervical instability|cervical instability
5585538|NCT00948350|awake intubation|awake intubation
5585539|NCT00948350|laryngeal anesthesia|laryngeal anesthesia
5585540|NCT00948324|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,|ype 2 diabetes mellitus, continuous subcutaneous insulin infusion,
5585541|NCT00948324|α-lipoic acid ,rosiglitazone ,metformin，therapy|α-lipoic acid ,rosiglitazone ,metformin，therapy
5585542|NCT00948298|cardiovascular disease|cardiovascular disease
5585543|NCT00948298|vitamin D|vitamin d
5585544|NCT00948298|african american|african american
5585545|NCT00948298|low vitamin D levels|low vitamin d levels
5585546|NCT00948285|breast cancer|breast cancer
5579991|NCT00968396|Melphalan|melphalan
5585549|NCT00948272|Rabies virus|rabies virus
5585550|NCT00948272|Purified Vero Rabies Vaccine|purified vero rabies vaccine
5585551|NCT00948272|Serum Free|serum free
5585552|NCT00948259|safety|safety
5585553|NCT00948259|GSK inhibitor|gsk inhibitor
5585554|NCT00948259|Alzheimer|alzheimer
5585555|NCT00948233|Tobacco|tobacco
5585556|NCT00948233|Smoking Cessation|smoking cessation
5585557|NCT00948233|Prevention|prevention
5585558|NCT00948233|Smokeless tobacco|smokeless tobacco
5585559|NCT00948233|Habit|habit
5585560|NCT00948220|HCV|hcv
5585561|NCT00948220|hepatitis C virus|hepatitis c virus
5585562|NCT00948220|CHC|chc
5585563|NCT00948220|chronic hepatitis c|chronic hepatitis c
5585564|NCT00948220|interferon|interferon
5585565|NCT00948220|ribavirin|ribavirin
5585566|NCT00948220|DEXA|dexa
5585567|NCT00948220|BMD|bmd
5585568|NCT00948220|bone mineral density|bone mineral density
5585569|NCT00948220|osteoporosis|osteoporosis
5585570|NCT00948220|osteopenia|osteopenia
5585571|NCT00948220|osteodystrophy|osteodystrophy
5585572|NCT00948220|osteodensitometry|osteodensitometry
5585573|NCT00948220|Bone Density|bone density
5585574|NCT00948220|Hepatitis, Viral, Human|hepatitis, viral, human
5585575|NCT00948220|Anti-Infective Agents|anti-infective agents
5585576|NCT00948220|peginterferon alfa-2a|peginterferon alfa-2a
5585577|NCT00948207|Metastatic Cancer|metastatic cancer
5585578|NCT00948207|Recurrent Cancer|recurrent cancer
5585579|NCT00948207|Distributed Hematological Cancer|distributed hematological cancer
5585580|NCT00948207|Advanced Cancer|advanced cancer
5585581|NCT00948207|Terminal Cancer|terminal cancer
5585582|NCT00948207|Stage III Cancer|stage iii cancer
5585583|NCT00948207|Stage IV Cancer|stage iv cancer
5585584|NCT00948194|Extended Donor Criteria|extended donor criteria
5585585|NCT00948181|Epinephrine, Norepinephrine, normetanephrine|epinephrine, norepinephrine, normetanephrine
5585586|NCT00948181|Catecholamine concentrations during surgery|catecholamine concentrations during surgery
5585587|NCT00948168|T2DM|t2dm
5585588|NCT00948168|exenatide|exenatide
5585589|NCT00948168|HbA1c|hba1c
5585590|NCT00948168|weight|weight
5585591|NCT00948168|waist circumference|waist circumference
5585592|NCT00948168|insulin sensitivity|insulin sensitivity
5585593|NCT00948168|beta-cell function|beta-cell function
5585594|NCT00948155|smoking|smoking
5585595|NCT00948155|nicotine|nicotine
5585596|NCT00948155|varenicline|varenicline
5585597|NCT00948142|Acute Bacterial Skin and Skin Struction Infections; Bacterial Skin Diseases; Staphylococcal Skin Infections; MRSA|acute bacterial skin and skin struction infections; bacterial skin diseases; staphylococcal skin infections; mrsa
5585902|NCT00946933|dyspnea|dyspnea
5585613|NCT00948077|tuberculosis|tuberculosis
5585614|NCT00948077|pharmacokinetic|pharmacokinetic
5585615|NCT00948077|first-line drugs|first-line drugs
5585634|NCT00948038|Inflammation|inflammation
5585635|NCT00948038|Oxidative stress|oxidative stress
5585636|NCT00948025|Peripheral Nerve Repair|peripheral nerve repair
5585637|NCT00948025|Conduit|conduit
5585638|NCT00948025|AVANCE|avance
5585639|NCT00948025|Neuroma Resection|neuroma resection
5585640|NCT00948025|Nerve Gap Repair|nerve gap repair
5585641|NCT00948025|Digital Nerve Repair|digital nerve repair
5585642|NCT00948012|Sickle Cell Anemia|sickle cell anemia
5585643|NCT00948012|Pulmonary Hypertension|pulmonary hypertension
5585644|NCT00948012|Exercise echocardiography|exercise echocardiography
5585645|NCT00948012|Echocardiography|echocardiography
5585646|NCT00947973|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5585647|NCT00947973|ADHD|adhd
5585648|NCT00947973|School Based|school based
5585649|NCT00947973|Intervention|intervention
5585650|NCT00947973|Psychosocial|psychosocial
5585651|NCT00947973|Academic Intervention|academic intervention
5585652|NCT00947973|Behavioral|behavioral
5585653|NCT00947960|Adult Polyglucosan Body Disease (APBD)|adult polyglucosan body disease (apbd)
5585654|NCT00947960|Glycogen Brancher Enzyme (GBE1) Deficiency|glycogen brancher enzyme (gbe1) deficiency
5585655|NCT00947947|condom use|condom use
5585656|NCT00947947|HIV prevention|hiv prevention
5585657|NCT00947947|African American|african american
5585658|NCT00947947|Behavioral intervention|behavioral intervention
5585659|NCT00947947|HIV Seronegativity|hiv seronegativity
5585660|NCT00947934|Alzheimer disease,hypothalamus,Deep Brain Stimulation|alzheimer disease,hypothalamus,deep brain stimulation
5585661|NCT00947921|Functional MItral regurgitation|functional mitral regurgitation
5585662|NCT00947908|Hymenoptera venom allergy|hymenoptera venom allergy
5585663|NCT00947908|Dendritic cells (DC)|dendritic cells (dc)
5585665|NCT00947895|Acthar gel|acthar gel
5585666|NCT00947895|adrenocorticotropin|adrenocorticotropin
5585667|NCT00947895|methylprednisolone|methylprednisolone
5585668|NCT00947895|solumedrol|solumedrol
5585669|NCT00947895|MS|ms
5585670|NCT00947895|multiple|multiple
5585671|NCT00947895|sclerosis|sclerosis
5585672|NCT00947895|relapse|relapse
5585673|NCT00947895|exacerbation|exacerbation
5585674|NCT00947895|sub-responsive|sub-responsive
5585675|NCT00947895|IV|iv
5585676|NCT00947856|Antibodies, Monoclonal|antibodies, monoclonal
5585677|NCT00947856|Antibody-Drug Conjugate|antibody-drug conjugate
5585678|NCT00947856|Antigens, CD30|antigens, cd30
5585679|NCT00947856|Drug Therapy|drug therapy
5585680|NCT00947856|Hematologic Diseases|hematologic diseases
5585681|NCT00947856|Immunotherapy|immunotherapy
5585682|NCT00947856|Monomethylauristatin E|monomethylauristatin e
5585684|NCT00947843|CHD equivalents|chd equivalents
5585685|NCT00947830|CML|cml
5585686|NCT00947830|intracellular imatinib level|intracellular imatinib level
5585687|NCT00947830|OCT-1|oct-1
5585688|NCT00947804|Acute Coronary Artery Syndrome Risk Stratification Score|acute coronary artery syndrome risk stratification score
5585689|NCT00947791|Bipolar Disorder|bipolar disorder
5585690|NCT00947791|Depression|depression
5585691|NCT00947791|Treatment-Resistant|treatment-resistant
5585692|NCT00947791|ketamine|ketamine
5585693|NCT00947791|antidepressant|antidepressant
5585694|NCT00947791|glutamate|glutamate
5585695|NCT00947765|Tennis Elbow|tennis elbow
5585696|NCT00947765|Epicondylitis, Lateral Humeral|epicondylitis, lateral humeral
5585697|NCT00947752|Multiple Sclerosis|multiple sclerosis
5585698|NCT00947752|Relapsing Remitting Multiple Sclerosis (RRMS)|relapsing remitting multiple sclerosis (rrms)
5585699|NCT00947752|Glatiramer Acetate (GA)|glatiramer acetate (ga)
5585700|NCT00947739|CZ|cz
5585701|NCT00947739|Stehlin|stehlin
5585702|NCT00947739|Lymphomas|lymphomas
5585703|NCT00947713|Human chorionic gonadotropin|human chorionic gonadotropin
5585704|NCT00947713|Clomiphene citrate|clomiphene citrate
5585705|NCT00947713|chronic anovulation|chronic anovulation
5585706|NCT00947713|Polycystic Ovary Syndrome|polycystic ovary syndrome
5585707|NCT00947713|Follicolugenesis|follicolugenesis
5585708|NCT00947700|Infants|infants
5585709|NCT00947700|Risk markers|risk markers
5585710|NCT00947700|ERP|erp
5585711|NCT00947700|Parent child interaction|parent child interaction
5585712|NCT00947700|Promoting First Relations|promoting first relations
5585713|NCT00947700|Social Communication|social communication
5585714|NCT00947687|influenza|influenza
5585715|NCT00947687|healthy subject|healthy subject
5585716|NCT00947687|virus inoculation|virus inoculation
5585717|NCT00947687|symptom scores|symptom scores
5585718|NCT00947687|viral shedding|viral shedding
5585719|NCT00947687|bioaerosol output|bioaerosol output
5585720|NCT00947674|Cellsorba EX|cellsorba ex
5585721|NCT00947661|glaucoma latanoprost|glaucoma latanoprost
5585722|NCT00947648|acute myelogenous leukemia|acute myelogenous leukemia
5585723|NCT00947648|AML|aml
5585724|NCT00947648|myelodysplastic syndrome|myelodysplastic syndrome
5585725|NCT00947648|MDS|mds
5585726|NCT00947648|Neutropenia|neutropenia
5585727|NCT00947648|raw fruits and vegetables|raw fruits and vegetables
5585728|NCT00947635|Type 1 diabetes|type 1 diabetes
5585729|NCT00947635|Transplants|transplants
5585730|NCT00947635|Immunosuppression|immunosuppression
5585731|NCT00947635|Hyperlipidemia|hyperlipidemia
5585732|NCT00947635|Nutrition Therapy|nutrition therapy
5585733|NCT00947622|Fibromyalgia|fibromyalgia
5585734|NCT00947622|Neuromodulation|neuromodulation
5585735|NCT00947622|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5585736|NCT00947622|Occipital|occipital
5585737|NCT00947609|Latent tuberculosis|latent tuberculosis
5585738|NCT00947609|HIV|hiv
5585739|NCT00947609|Children|children
5585740|NCT00947609|Interferon gamma release assays|interferon gamma release assays
5585741|NCT00947609|Thailand|thailand
5585742|NCT00947609|QuantiFERON TB Gold In-tube|quantiferon tb gold in-tube
5585743|NCT00947609|T-Spot.TB|t-spot.tb
5585744|NCT00947596|Atropine|atropine
5585745|NCT00947596|Aerosol|aerosol
5585746|NCT00947596|Inhaler|inhaler
5585747|NCT00947596|Dry Powder|dry powder
5585748|NCT00947583|fusion rates|fusion rates
5585749|NCT00947583|TLIF|tlif
5585750|NCT00947583|Osteocel Plus|osteocel plus
5585751|NCT00947583|biologics|biologics
5585752|NCT00947583|lumbar fusion|lumbar fusion
5585753|NCT00947570|Cognitive Behavioral Therapy|cognitive behavioral therapy
5585754|NCT00947570|Functional Brain Imaging|functional brain imaging
5585755|NCT00947570|Psychotherapy|psychotherapy
5585756|NCT00947570|Treatment|treatment
5585757|NCT00947570|Brain Imaging|brain imaging
5585758|NCT00947544|Urea Cycle Disorder|urea cycle disorder
5585760|NCT00947544|GT4P|gt4p
5585761|NCT00947544|Buphenyl|buphenyl
5585762|NCT00947544|hyperammonemia|hyperammonemia
5585763|NCT00947544|sodium phenylbutyrate|sodium phenylbutyrate
5585764|NCT00947518|chlorhexidine|chlorhexidine
5585765|NCT00947518|preterm|preterm
5585766|NCT00947518|newborn|newborn
5585767|NCT00947518|skin condition|skin condition
5585768|NCT00947518|temperature|temperature
5585769|NCT00947518|skin flora|skin flora
5585770|NCT00947505|Androgenetic alopecia|androgenetic alopecia
5585771|NCT00947505|Hair loss|hair loss
5585772|NCT00947505|Male Pattern baldness|male pattern baldness
5585773|NCT00947492|Rheumatoid Arthritis patients|rheumatoid arthritis patients
5585774|NCT00947492|treated with new immunosuppressive drugs : Orencia* (abatacept) and RoActemra* (tocilizumab).|treated with new immunosuppressive drugs : orencia* (abatacept) and roactemra* (tocilizumab).
5580222|NCT00967525|AML|aml
5585775|NCT00947479|obstructive sleep apnea|obstructive sleep apnea
5585776|NCT00947479|pulse-wave velocity,|pulse-wave velocity,
5585777|NCT00947479|acute kidney injury|acute kidney injury
5585778|NCT00947479|biomarkers of acute kidney injury|biomarkers of acute kidney injury
5585779|NCT00947466|Buprenorphine transdermal patch (BTDS)|buprenorphine transdermal patch (btds)
5585780|NCT00947466|Moderate to severe mouth pain|moderate to severe mouth pain
5585781|NCT00947466|Chemotherapy induced mucositis|chemotherapy induced mucositis
5585782|NCT00947466|Pharmacokinetic|pharmacokinetic
5585783|NCT00947453|asthma|asthma
5585784|NCT00947453|montelukast|montelukast
5585785|NCT00947440|Phase 1|phase 1
5585786|NCT00947440|Bioavailability|bioavailability
5585787|NCT00947427|type 1 diabetes|type 1 diabetes
5585788|NCT00947427|newly diagnosed T1D|newly diagnosed t1d
5585790|NCT00947427|canakinumab|canakinumab
5585791|NCT00947427|anti IL-1|anti il-1
5585792|NCT00947414|cellulite; shockwave; microcirculation; skin|cellulite; shockwave; microcirculation; skin
5585793|NCT00947401|Surgery, elective|surgery, elective
5585794|NCT00947401|Fluids|fluids
5585795|NCT00947401|Post Anesthesia Care Unit|post anesthesia care unit
5585796|NCT00947401|PACU|pacu
5585797|NCT00947401|Fluid management|fluid management
5585798|NCT00947388|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5585799|NCT00947388|Bendamustine|bendamustine
5585800|NCT00947388|Alemtuzumab|alemtuzumab
5585801|NCT00947388|Phase I|phase i
5585803|NCT00947375|schizophrenia|schizophrenia
5585804|NCT00947375|lamictal TM|lamictal tm
5585805|NCT00947375|haloperidol decanoate|haloperidol decanoate
5585806|NCT00947323|simvastatin|simvastatin
5585807|NCT00947323|endothelial dysfunction|endothelial dysfunction
5585808|NCT00947323|erectile dysfunction|erectile dysfunction
5585809|NCT00947310|Inappropriate therapy|inappropriate therapy
5585810|NCT00947310|ICD therapy|icd therapy
5585811|NCT00947310|Primary prevention|primary prevention
5585812|NCT00947297|Urea Cycle Disorder|urea cycle disorder
5585813|NCT00947297|UCD|ucd
5585814|NCT00947297|hyperammonemia|hyperammonemia
5585815|NCT00947297|Buphenyl|buphenyl
5585816|NCT00947297|Sodium Phenylbutyrate|sodium phenylbutyrate
5585817|NCT00947271|STD|std
5585818|NCT00947271|STI|sti
5585819|NCT00947271|Sexual Behavior|sexual behavior
5585820|NCT00947271|Prevention|prevention
5585821|NCT00947271|HIV seronegativity|hiv seronegativity
5585822|NCT00947258|Muscle Strength|muscle strength
5585823|NCT00947258|Torque|torque
5585824|NCT00947258|Muscle Stretching Exercises|muscle stretching exercises
5585825|NCT00947258|Range of Motion|range of motion
5585826|NCT00947232|major depressive disorder|major depressive disorder
5585827|NCT00947232|physical activity|physical activity
5585828|NCT00947232|aging with physical disability|aging with physical disability
5585829|NCT00947232|motivational interviewing|motivational interviewing
5585830|NCT00947219|Androgenetic Alopecia|androgenetic alopecia
5585831|NCT00947219|Hair Loss|hair loss
5585832|NCT00947219|Male Pattern Baldness|male pattern baldness
5585833|NCT00947206|Chinese Americans|chinese americans
5585834|NCT00947206|lay health worker outreach|lay health worker outreach
5585835|NCT00947206|colorectal cancer screening|colorectal cancer screening
5585836|NCT00947193|Hemophilia A|hemophilia a
5585837|NCT00947193|Hemophilia B|hemophilia b
5585838|NCT00947193|Factor VIII|factor viii
5585839|NCT00947193|Factor IX|factor ix
5585840|NCT00947193|FVIII|fviii
5585841|NCT00947193|FIX|fix
5585842|NCT00947193|Nonsense mutation|nonsense mutation
5585843|NCT00947193|Premature stop codon|premature stop codon
5585844|NCT00947193|HA|ha
5585845|NCT00947193|HB|hb
5585846|NCT00947193|PTC124|ptc124
5585847|NCT00947193|Ataluren|ataluren
5585848|NCT00947180|Biofeedback|biofeedback
5585849|NCT00947180|Pelvic floor|pelvic floor
5585850|NCT00947180|Levator ani syndrome|levator ani syndrome
5585851|NCT00947180|Chronic proctalgia|chronic proctalgia
5585852|NCT00947180|Electrogalvanic stimulation|electrogalvanic stimulation
5585853|NCT00947180|Massage|massage
5585854|NCT00947154|trichotillomania|trichotillomania
5585855|NCT00947154|aripiprazole|aripiprazole
5585856|NCT00947154|treatment|treatment
5585857|NCT00947141|Optimising treatment of cytomegalovirus infection|optimising treatment of cytomegalovirus infection
5585858|NCT00947128|Antiemetic|antiemetic
5585859|NCT00947115|Cervical cancer|cervical cancer
5585860|NCT00947115|HPV vaccine|hpv vaccine
5585861|NCT00947102|pancreatic tubular adenocarcinoma|pancreatic tubular adenocarcinoma
5585862|NCT00947102|gemcitabine|gemcitabine
5585863|NCT00947102|gene expression|gene expression
5585864|NCT00947102|immunological status|immunological status
5585865|NCT00947102|serological status|serological status
5585866|NCT00947102|pancreatic tubular adenocarcinoma adjuvant setting|pancreatic tubular adenocarcinoma adjuvant setting
5585868|NCT00947089|SSI (Surgical site infections)|ssi (surgical site infections)
5585869|NCT00947076|Antidepressant|antidepressant
5585870|NCT00947063|Antihistamine|antihistamine
5585871|NCT00947050|CAD|cad
5585872|NCT00947050|prompt physical exercise|prompt physical exercise
5585873|NCT00947050|collateral function|collateral function
5585874|NCT00947011|Healthy volunteers|healthy volunteers
5585875|NCT00947011|GLP-1|glp-1
5585876|NCT00947011|Januvia|januvia
5585877|NCT00947011|Sitagliptin|sitagliptin
5585878|NCT00946998|Chronic Kidney Disease|chronic kidney disease
5585879|NCT00946998|Depression|depression
5585880|NCT00946998|Antidepressants|antidepressants
5585881|NCT00946998|randomized controlled trial|randomized controlled trial
5585882|NCT00946998|treatment|treatment
5585883|NCT00946998|Sertraline|sertraline
5585884|NCT00946985|Schizophrenia|schizophrenia
5585885|NCT00946985|Risperidone|risperidone
5585886|NCT00946985|Risperdal|risperdal
5585887|NCT00946985|Paliperidone Palmitate|paliperidone palmitate
5585888|NCT00946985|Invega Sustenna|invega sustenna
5585889|NCT00946972|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5585890|NCT00946959|cardiac surgery|cardiac surgery
5585891|NCT00946959|angioplasty|angioplasty
5585892|NCT00946959|cognitive decline|cognitive decline
5585893|NCT00946946|Randomized|randomized
5585894|NCT00946946|Crohn's Disease|crohn's disease
5585895|NCT00946946|Prevention|prevention
5585896|NCT00946946|Azathioprine|azathioprine
5585897|NCT00946946|mesalazine|mesalazine
5585898|NCT00946946|mesalamine|mesalamine
5585900|NCT00946933|acid-base balance|acid-base balance
5585901|NCT00946933|ventilatory control|ventilatory control
5585904|NCT00946933|modified rebreathing procedure|modified rebreathing procedure
5585905|NCT00946933|Normal|normal
5585906|NCT00946933|older|older
5585907|NCT00946907|acute pericarditis|acute pericarditis
5585908|NCT00946907|treatment|treatment
5585909|NCT00946907|recurrence|recurrence
5585910|NCT00946894|Total thyroidectomy|total thyroidectomy
5585911|NCT00946894|Subtotal thyroidectomy|subtotal thyroidectomy
5585912|NCT00946894|Dunhill operation|dunhill operation
5585913|NCT00946894|Recurrent nodular goiter|recurrent nodular goiter
5585914|NCT00946894|Completion thyroidectomy|completion thyroidectomy
5585915|NCT00946894|Recurrent laryngeal nerve palsy|recurrent laryngeal nerve palsy
5585916|NCT00946894|Hypoparathyroidism following thyroidectomy|hypoparathyroidism following thyroidectomy
5585917|NCT00946894|Recurrent goiter|recurrent goiter
5585918|NCT00946881|Prostatic disease|prostatic disease
5585919|NCT00946881|genital neoplasm, male|genital neoplasm, male
5585920|NCT00946881|Urogenital neoplasm|urogenital neoplasm
5585921|NCT00946881|Genital disease|genital disease
5585922|NCT00946881|male|male
5585923|NCT00946881|Male urogenital disease|male urogenital disease
5585924|NCT00946881|Neoplasms|neoplasms
5585925|NCT00946881|Neoplasm by site|neoplasm by site
5585926|NCT00946881|prostatic neoplasm|prostatic neoplasm
5585927|NCT00946881|Carcinoma|carcinoma
5585928|NCT00946868|intermittent claudication|intermittent claudication
5585929|NCT00946868|metabolic syndrome|metabolic syndrome
5585930|NCT00946855|soccer|soccer
5585931|NCT00946855|laboratory|laboratory
5585932|NCT00946855|reference|reference
5585933|NCT00946855|exercise|exercise
5585934|NCT00946855|variability|variability
5585935|NCT00946855|season|season
5585936|NCT00946855|elite athletes|elite athletes
5585937|NCT00946855|Define reference blood parameters in elite athletes|define reference blood parameters in elite athletes
5585938|NCT00946842|Healthy|healthy
5585939|NCT00946842|Bioavailability|bioavailability
5585940|NCT00946842|Relative bioavailability|relative bioavailability
5585941|NCT00946842|TMC207|tmc207
5585942|NCT00946842|Fed condition|fed condition
5585943|NCT00946842|Fasted condition|fasted condition
5585944|NCT00946803|Pain|pain
5585945|NCT00946803|Fatigue|fatigue
5585946|NCT00946803|Sleep|sleep
5585947|NCT00946803|Cancer|cancer
5585948|NCT00946803|Complementary therapies|complementary therapies
5585949|NCT00946790|Immunosuppressant and Antirheumatic|immunosuppressant and antirheumatic
5585950|NCT00946777|Dry Eye Signs|dry eye signs
5585951|NCT00946777|barrier function|barrier function
5585952|NCT00946764|Antidepressant|antidepressant
5585953|NCT00946751|Anticonvulsant|anticonvulsant
5585954|NCT00946738|Raynaud's phenomenon|raynaud's phenomenon
5585955|NCT00946738|biofeedback|biofeedback
5585956|NCT00946738|deep oscillation|deep oscillation
5585957|NCT00946738|systemic sclerosis|systemic sclerosis
5585958|NCT00946738|physiotherapy|physiotherapy
5585959|NCT00946725|Angina (Chest Pain)|angina (chest pain)
5585960|NCT00946725|Hypertension|hypertension
5585961|NCT00946660|Contingency Management|contingency management
5585962|NCT00946660|Drug Self-Administration|drug self-administration
5585963|NCT00946647|Myelodysplastic Syndromes|myelodysplastic syndromes
5585964|NCT00946647|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5585965|NCT00946647|Acute Myeloid Leukemia|acute myeloid leukemia
5585966|NCT00946647|hypomethylating therapy|hypomethylating therapy
5588591|NCT00936442|Early Breast Cancer|early breast cancer
5585967|NCT00946647|deacetylase inhibitor|deacetylase inhibitor
5585969|NCT00946647|CMML|cmml
5585971|NCT00946608|Antihistamine|antihistamine
5585972|NCT00946595|Undetectable|undetectable
5585973|NCT00946595|HIV infections|hiv infections
5585974|NCT00946595|Monotherapy|monotherapy
5585975|NCT00946595|Lopinavir/ritonavir|lopinavir/ritonavir
5585976|NCT00946595|Protease inhibitor|protease inhibitor
5585977|NCT00946595|Treatment experienced|treatment experienced
5585978|NCT00946582|parenting management program|parenting management program
5585979|NCT00946582|ADHD|adhd
5585980|NCT00946569|Asthma|asthma
5585981|NCT00946569|Persistent asthma|persistent asthma
5585982|NCT00946569|Adults with persistent asthma|adults with persistent asthma
5585984|NCT00946569|JNJ-39758979|jnj-39758979
5585985|NCT00946569|Placebo|placebo
5585986|NCT00946556|herpes simplex virus type 2|herpes simplex virus type 2
5585988|NCT00946556|genital immunology|genital immunology
5585989|NCT00946556|CD4+ T cell|cd4+ t cell
5585990|NCT00946556|valacyclovir|valacyclovir
5585991|NCT00946556|HIV seronegativity|hiv seronegativity
5585992|NCT00946543|stage IIB prostate cancer|stage iib prostate cancer
5585993|NCT00946543|stage IIA prostate cancer|stage iia prostate cancer
5585994|NCT00946543|stage III prostate cancer|stage iii prostate cancer
5585995|NCT00946543|stage IV prostate cancer|stage iv prostate cancer
5585996|NCT00946491|Typical Antipsychotic|typical antipsychotic
5585997|NCT00946478|atopic dermatitis|atopic dermatitis
5585998|NCT00946478|elidel|elidel
5585999|NCT00946478|pimecrolimus|pimecrolimus
5586000|NCT00946478|CASM981|casm981
5586001|NCT00946478|immunity|immunity
5586002|NCT00946478|cathelicidin|cathelicidin
5586003|NCT00946478|antimicrobial peptide|antimicrobial peptide
5586004|NCT00946478|eczema|eczema
5586006|NCT00946452|Satisfaction|satisfaction
5744432|NCT00341484|HIV|hiv
5571204|NCT01001663|CAG|cag
5586007|NCT00946439|training exercise gait|training exercise gait
5586008|NCT00946413|CBT, Depressed and suicidal adolescents|cbt, depressed and suicidal adolescents
5586009|NCT00946400|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5586010|NCT00946400|HIT|hit
5586011|NCT00946400|4Ts|4ts
5586012|NCT00946400|Chong scale|chong scale
5586013|NCT00946400|interobserver variability|interobserver variability
5586014|NCT00946387|Antiemetic|antiemetic
5586015|NCT00946374|Mantle-Cell-Lymphoma|mantle-cell-lymphoma
5586016|NCT00946374|MCL|mcl
5586017|NCT00946374|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
5586018|NCT00946374|NHL|nhl
5586019|NCT00946374|Immunochemotherapy|immunochemotherapy
5586020|NCT00946374|R-CHOP|r-chop
5586021|NCT00946374|CHOP|chop
5586022|NCT00946374|High-dose chemotherapy|high-dose chemotherapy
5586023|NCT00946374|BEAM|beam
5586024|NCT00946374|HD-BEAM|hd-beam
5586025|NCT00946374|Autologous stem cell transplantation|autologous stem cell transplantation
5586026|NCT00946374|Reduced conditioning regimen|reduced conditioning regimen
5586027|NCT00946374|Unrelated donor|unrelated donor
5586028|NCT00946374|Sibling donor|sibling donor
5586029|NCT00946374|Total Body Irradiation|total body irradiation
5586030|NCT00946374|TBI|tbi
5586031|NCT00946374|Allogenic stem cell transplantation|allogenic stem cell transplantation
5586032|NCT00946374|ABSCT|absct
5586033|NCT00946374|ASCT|asct
5586034|NCT00946374|Fludarabine+TBI|fludarabine+tbi
5586035|NCT00946348|Dronabinol|dronabinol
5586036|NCT00946348|Schizophrenia|schizophrenia
5586037|NCT00946348|Dual Diagnosis|dual diagnosis
5586038|NCT00946348|Substance Abuse|substance abuse
5586039|NCT00946348|Cannabis Use Disorder|cannabis use disorder
5586040|NCT00946322|post-traumatic stress disorder|post-traumatic stress disorder
5586041|NCT00946322|alcohol-related disorders|alcohol-related disorders
5586042|NCT00946322|substance use disorders|substance use disorders
5586043|NCT00946322|couple therapy|couple therapy
5586044|NCT00946296|Graves Disease|graves disease
5586045|NCT00946283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5586046|NCT00946283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5586047|NCT00946283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5586048|NCT00946283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5586049|NCT00946283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5586050|NCT00946283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5586051|NCT00946283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5586052|NCT00946283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5586053|NCT00946283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5586054|NCT00946283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5586055|NCT00946283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5586056|NCT00946283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5586057|NCT00946283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5586058|NCT00946283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5586059|NCT00946283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5586060|NCT00946283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5586061|NCT00946283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5586062|NCT00946283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5586063|NCT00946283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5586064|NCT00946283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5586065|NCT00946283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5586066|NCT00946283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5586067|NCT00946283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5586068|NCT00946283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5586069|NCT00946283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5586070|NCT00946283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5586071|NCT00946283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5586072|NCT00946283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5586073|NCT00946283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5586074|NCT00946283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5586075|NCT00946283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5586076|NCT00946283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5586077|NCT00946283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5586078|NCT00946283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5586079|NCT00946283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5568608|NCT01012076|parent-child|parent-child
5586080|NCT00946283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5586081|NCT00946283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5586082|NCT00946283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5586083|NCT00946283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5586084|NCT00946283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5586085|NCT00946283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5586086|NCT00946283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5586087|NCT00946283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5586088|NCT00946283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5586089|NCT00946283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5586090|NCT00946283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5586091|NCT00946283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5586092|NCT00946283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5586093|NCT00946283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5586094|NCT00946283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5586095|NCT00946283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5586096|NCT00946283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5586097|NCT00946283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5586098|NCT00946283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5586099|NCT00946283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5586100|NCT00946283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5586101|NCT00946283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5586102|NCT00946283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5586103|NCT00946283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5586104|NCT00946283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5586105|NCT00946283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5586106|NCT00946283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5586107|NCT00946283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5586108|NCT00946283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5586109|NCT00946283|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5586110|NCT00946283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5586111|NCT00946283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5586112|NCT00946283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5586113|NCT00946283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5586114|NCT00946283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5586115|NCT00946283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5586236|NCT00945919|titration|titration
5586116|NCT00946283|refractory hairy cell leukemia|refractory hairy cell leukemia
5586117|NCT00946283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5586118|NCT00946283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5586119|NCT00946283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5798744|NCT00111189|Schizophrenia|schizophrenia
5586120|NCT00946283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5586121|NCT00946283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5586122|NCT00946283|primary myelofibrosis|primary myelofibrosis
5586123|NCT00946283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5586124|NCT00946283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5586125|NCT00946283|disseminated neuroblastoma|disseminated neuroblastoma
5862984|NCT00001426|Ovarian Cancer|ovarian cancer
5586127|NCT00946283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5586128|NCT00946283|recurrent neuroblastoma|recurrent neuroblastoma
5586129|NCT00946283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5586130|NCT00946283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5586131|NCT00946283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5586132|NCT00946283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5586133|NCT00946283|stage II multiple myeloma|stage ii multiple myeloma
5586134|NCT00946283|stage III multiple myeloma|stage iii multiple myeloma
5586135|NCT00946283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5586136|NCT00946283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5586137|NCT00946283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5586138|NCT00946283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5568731|NCT01011465|Oxytocin|oxytocin
5586139|NCT00946283|stage IIIA breast cancer|stage iiia breast cancer
5586140|NCT00946283|stage IIIB breast cancer|stage iiib breast cancer
5586141|NCT00946283|stage IIIC breast cancer|stage iiic breast cancer
5586142|NCT00946283|stage IV breast cancer|stage iv breast cancer
5586143|NCT00946283|refractory multiple myeloma|refractory multiple myeloma
5586145|NCT00946270|Pomalidomide|pomalidomide
5586146|NCT00946270|polycythemia vera|polycythemia vera
5586147|NCT00946270|essential thrombocythemia myelofibrosis|essential thrombocythemia myelofibrosis
5586148|NCT00946257|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5586149|NCT00946244|Early intervention|early intervention
5586150|NCT00946244|Mother-child interaction|mother-child interaction
5586151|NCT00946244|Neurodevelopment|neurodevelopment
5586152|NCT00946244|Parenting|parenting
5586153|NCT00946244|Prematurity|prematurity
5586154|NCT00946244|Preschool age|preschool age
5586155|NCT00946231|Heart Failure|heart failure
5586157|NCT00946231|B-type natriuretic peptide|b-type natriuretic peptide
5586158|NCT00946231|home testing|home testing
5586159|NCT00946205|rectal prolapse|rectal prolapse
5586160|NCT00946205|laparoscopic rectopexy|laparoscopic rectopexy
5586161|NCT00946205|obstructed defecation|obstructed defecation
5586162|NCT00946192|Amenorrhea|amenorrhea
5586163|NCT00946192|Adolescent|adolescent
5586164|NCT00946192|Endurance|endurance
5586165|NCT00946192|Athletes|athletes
5586166|NCT00946192|Females|females
5586167|NCT00946192|Osteopenia|osteopenia
5586168|NCT00946192|Osteoporosis|osteoporosis
5586169|NCT00946192|Estrogen|estrogen
5586170|NCT00946179|Influenza|influenza
5586171|NCT00946179|Influenza virus vaccine|influenza virus vaccine
5586172|NCT00946179|Split virion|split virion
5586173|NCT00946166|pneumonia|pneumonia
5586174|NCT00946166|statins|statins
5586175|NCT00946166|cytokines|cytokines
5586176|NCT00946153|Carcinoma|carcinoma
5586177|NCT00946153|Hepatocellular|hepatocellular
5586178|NCT00946140|Ovary|ovary
5586179|NCT00946140|MRI|mri
5586180|NCT00946140|08-132|08-132
5586181|NCT00946127|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5586182|NCT00946127|Communicating Hydrocephalus|communicating hydrocephalus
5586183|NCT00946127|Gait disorder|gait disorder
5586184|NCT00946127|Cognition|cognition
5586185|NCT00946127|Shunt|shunt
5586186|NCT00946127|Endoscopic Third Ventriculostomy.|endoscopic third ventriculostomy.
5586187|NCT00946101|randomized, double-blind, placebo-controlled|randomized, double-blind, placebo-controlled
5586188|NCT00946062|low vision|low vision
5586189|NCT00946062|ophthalmology|ophthalmology
5586190|NCT00946062|randomised controlled trial|randomised controlled trial
5586191|NCT00946062|mobility|mobility
5586192|NCT00946062|orientation|orientation
5586193|NCT00946062|cane|cane
5586194|NCT00946062|aged|aged
5685416|NCT00556153|brain tumors, children|brain tumors, children
5586195|NCT00946049|Checking clinical antibacterial effect of Vicryl Plus compared to conventional Vicryl in intraoral surgery|checking clinical antibacterial effect of vicryl plus compared to conventional vicryl in intraoral surgery
5586196|NCT00946049|Bacteria|bacteria
5586197|NCT00946023|lymphoma|lymphoma
5586198|NCT00946023|non hodgkin lymphoma|non hodgkin lymphoma
5586199|NCT00946023|allogeneic|allogeneic
5586200|NCT00946023|bone marrow transplantation|bone marrow transplantation
5586201|NCT00946023|nonmyeloablative|nonmyeloablative
5586202|NCT00946023|cyclophosphamide|cyclophosphamide
5586203|NCT00946023|rituximab|rituximab
5586204|NCT00946010|Hepatitis B|hepatitis b
5586205|NCT00946010|Hepatitis C|hepatitis c
5586206|NCT00946010|genotype|genotype
5586207|NCT00946010|DNA level|dna level
5586208|NCT00946010|RNA level|rna level
5586209|NCT00946010|Taiwan|taiwan
5586210|NCT00945997|misoprostol|misoprostol
5586211|NCT00945997|mifepristone|mifepristone
5586212|NCT00945997|medical abortion|medical abortion
5586213|NCT00945997|randomised controlled trial|randomised controlled trial
5586214|NCT00945984|Localized renal cell carcinoma|localized renal cell carcinoma
5586215|NCT00945971|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5586216|NCT00945971|Catecholamine|catecholamine
5586217|NCT00945971|Children|children
5586218|NCT00945971|Physical Activity|physical activity
5586219|NCT00945958|Glaucoma|glaucoma
5586220|NCT00945958|Ocular hypertension|ocular hypertension
5586221|NCT00945945|Osteoarthritis, Knee|osteoarthritis, knee
5586222|NCT00945945|Pain|pain
5586223|NCT00945932|asthma|asthma
5586224|NCT00945932|GW870086X|gw870086x
5586225|NCT00945932|Efficacy|efficacy
5586226|NCT00945932|FEV1|fev1
5586227|NCT00945932|repeat-dose|repeat-dose
5586228|NCT00945919|Oral morphine|oral morphine
5586229|NCT00945919|oxycodone|oxycodone
5586230|NCT00945919|OPANA|opana
5586231|NCT00945919|Oxymorphone|oxymorphone
5586232|NCT00945919|pain|pain
5586233|NCT00945919|nociceptive|nociceptive
5586234|NCT00945919|neuropathic|neuropathic
5586235|NCT00945919|rotation|rotation
5586237|NCT00945919|mixed origin non-cancer pain|mixed origin non-cancer pain
5586238|NCT00945906|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
5586239|NCT00945906|Factor XIII|factor xiii
5586241|NCT00945880|Hepatitis C|hepatitis c
5571474|NCT01000506|Placebo|placebo
5586242|NCT00945880|Hepatitis|hepatitis
5586243|NCT00945867|flecainide|flecainide
5586244|NCT00945867|pharmacogenetics|pharmacogenetics
5586245|NCT00945854|wholegrain cereals|wholegrain cereals
5586246|NCT00945854|glycemic index|glycemic index
5586247|NCT00945854|metabolic syndrome|metabolic syndrome
5586248|NCT00945854|insulin sensitivity|insulin sensitivity
5586249|NCT00945841|influenza vaccine|influenza vaccine
5586250|NCT00945841|vaccine|vaccine
5586251|NCT00945828|pediatric cancer, neurocognitive outcomes for pediatric cancer|pediatric cancer, neurocognitive outcomes for pediatric cancer
5586252|NCT00945828|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5586835|NCT00943449|HDAC|hdac
5586253|NCT00945828|central nervous system tumors|central nervous system tumors
5586254|NCT00945828|lymphoma|lymphoma
5586255|NCT00945815|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5586256|NCT00945815|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5586257|NCT00945815|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5586258|NCT00945815|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5586259|NCT00945789|Asphyxia neonatorum|asphyxia neonatorum
5586260|NCT00945789|Infants|infants
5586261|NCT00945789|EEG|eeg
5586262|NCT00945789|Brain MRI|brain mri
5586263|NCT00945789|Nitric oxide|nitric oxide
5586264|NCT00945776|OSA|osa
5586265|NCT00945776|CPAP|cpap
5586266|NCT00945763|Dental Pain|dental pain
5586267|NCT00945737|hypercholesterolemia|hypercholesterolemia
5586268|NCT00945737|cholesterol|cholesterol
5586269|NCT00945737|soy|soy
5586270|NCT00945711|dual diagnosis|dual diagnosis
5586271|NCT00945698|Stunting|stunting
5586272|NCT00945698|Growth failure|growth failure
5586273|NCT00945698|Malnutrition|malnutrition
5586274|NCT00945698|Lipid based nutrient supplement|lipid based nutrient supplement
5586275|NCT00945698|LNS|lns
5586276|NCT00945698|Prevention|prevention
5586277|NCT00945698|Malawi|malawi
5586278|NCT00945698|Sub-Saharan Africa|sub-saharan africa
5586279|NCT00945698|Dietary supplementation|dietary supplementation
5586280|NCT00945698|Efficacy|efficacy
5586281|NCT00945685|Skin Aging|skin aging
5586282|NCT00945685|Skin Wrinkling|skin wrinkling
5586283|NCT00945672|Alzheimer's disease amyloid imaging antibody|alzheimer's disease amyloid imaging antibody
5586284|NCT00945633|Obesity|obesity
5586285|NCT00945633|unhealthy weight gain|unhealthy weight gain
5586286|NCT00945620|Trans-abdominis block|trans-abdominis block
5586287|NCT00945620|post-cesarean|post-cesarean
5586288|NCT00945607|Complementary Medicine|complementary medicine
5586289|NCT00945607|Alternative Medicine|alternative medicine
5586290|NCT00945607|Breast Cancer|breast cancer
5586291|NCT00945594|flexible cystoscopy|flexible cystoscopy
5586292|NCT00945594|rigid cystoscopy|rigid cystoscopy
5586293|NCT00945594|bladder|bladder
5586294|NCT00945594|outcome assessment|outcome assessment
5586295|NCT00945594|pain measurement|pain measurement
5586296|NCT00945581|Healthy Elderly volunteers|healthy elderly volunteers
5586297|NCT00945568|QOL|qol
5586298|NCT00945568|liver|liver
5586299|NCT00945555|Antibacterials|antibacterials
5586300|NCT00945555|Classification of antibacterial agent|classification of antibacterial agent
5586301|NCT00945555|Febrile neutropenia|febrile neutropenia
5586302|NCT00945555|Turkey|turkey
5586303|NCT00945542|Trauma|trauma
5586304|NCT00945542|Coagulopathy|coagulopathy
5586305|NCT00945542|Transfusion|transfusion
5586306|NCT00945542|Plasma|plasma
5586307|NCT00945542|Massive Transfusion|massive transfusion
5586308|NCT00945529|Fontan|fontan
5586309|NCT00945516|Metal stent|metal stent
5586310|NCT00945516|Bile duct stricture|bile duct stricture
5586311|NCT00945516|Stent migration|stent migration
5586312|NCT00945516|Feasibility|feasibility
5586313|NCT00945516|Safety|safety
5586314|NCT00945516|Removability|removability
5586315|NCT00945503|Glycine Tranporter|glycine tranporter
5586316|NCT00945503|MRI|mri
5586317|NCT00945503|PET|pet
5586318|NCT00945490|Benign prostatic hyperplasia|benign prostatic hyperplasia
5586319|NCT00945490|BPH|bph
5586320|NCT00945490|Enlarged prostate|enlarged prostate
5586321|NCT00945451|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5586322|NCT00945451|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5586323|NCT00945451|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5586324|NCT00945438|Influenza|influenza
5586325|NCT00945438|Influenza virus vaccine|influenza virus vaccine
5586326|NCT00945438|Split virion|split virion
5586327|NCT00945438|Intradermal|intradermal
5586328|NCT00945425|Phase I|phase i
5586329|NCT00945425|Volunteer|volunteer
5586330|NCT00945412|microdebrider tonsillotomy|microdebrider tonsillotomy
5586331|NCT00945412|Post-tonsillectomy hemorrhage|post-tonsillectomy hemorrhage
5586332|NCT00945386|children|children
5586333|NCT00945386|critically ill|critically ill
5586334|NCT00945386|furosemide|furosemide
5586335|NCT00945386|acoustic emission|acoustic emission
5586336|NCT00945373|rosacea|rosacea
5586337|NCT00945373|telangiectasias|telangiectasias
5586338|NCT00945373|topical treatment|topical treatment
5571573|NCT01000077|Routine Surgery|routine surgery
5586339|NCT00945373|pulsed dye laser|pulsed dye laser
5586340|NCT00945360|Leiomyoma|leiomyoma
5586341|NCT00945360|perimenopause|perimenopause
5586342|NCT00945360|aromatase inhibitor|aromatase inhibitor
5586343|NCT00945347|Cystic fibrosis|cystic fibrosis
5586344|NCT00945347|miglustat|miglustat
5586345|NCT00945347|nasal instillation|nasal instillation
5586346|NCT00945347|nasal potential difference|nasal potential difference
5586347|NCT00945334|Constipation predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5586348|NCT00945308|Primary PCI|primary pci
5586349|NCT00945308|Acute myocardial infarction|acute myocardial infarction
5586350|NCT00945308|Myocardial blush|myocardial blush
5586351|NCT00945308|Primary coronary intervention in acute myocardial infarction|primary coronary intervention in acute myocardial infarction
5586836|NCT00943449|4SC-201|4sc-201
5586352|NCT00945308|focusing on the effect of the study drug on the immediate TIMI|focusing on the effect of the study drug on the immediate timi
5586353|NCT00945308|flow at the infarct related artery and on the myocardial|flow at the infarct related artery and on the myocardial
5586354|NCT00945308|perfusion evaluated by the TIMI myocardial perfusion grade or|perfusion evaluated by the timi myocardial perfusion grade or
5586356|NCT00945295|Cerebrovascular Accident/Rehabilitation|cerebrovascular accident/rehabilitation
5586357|NCT00945295|Muscle Spasticity|muscle spasticity
5586358|NCT00945295|Botulinum Neurotoxin Type A|botulinum neurotoxin type a
5586359|NCT00945295|Post-stroke focal upper limb spasticity|post-stroke focal upper limb spasticity
5586360|NCT00945282|IDX12899|idx12899
5586361|NCT00945282|adaptive|adaptive
5586362|NCT00945282|monotherapy|monotherapy
5586363|NCT00945282|pharmacokinetics|pharmacokinetics
5586364|NCT00945282|Treatment-naive|treatment-naive
5586365|NCT00945282|HIV-1|hiv-1
5586366|NCT00945282|GSK2248761|gsk2248761
5586367|NCT00945282|NNRTI|nnrti
5586368|NCT00945282|HIV Infections|hiv infections
5586369|NCT00945282|treatment naive|treatment naive
5586370|NCT00945256|metabolism|metabolism
5586371|NCT00945256|exercise|exercise
5586372|NCT00945256|sodium nitroprusside|sodium nitroprusside
5586373|NCT00945243|SCDD|scdd
5586374|NCT00945230|Neurosurgical outcome|neurosurgical outcome
5586375|NCT00945230|Actigraphy|actigraphy
5586376|NCT00945230|Treatment Response Measurement|treatment response measurement
5586377|NCT00945217|Atherogenic dyslipidemia|atherogenic dyslipidemia
5586378|NCT00945217|Non-HDL-C|non-hdl-c
5586379|NCT00945217|Postmenopausal women|postmenopausal women
5586380|NCT00945217|SAH gene family|sah gene family
5586381|NCT00945204|type 2 diabetes|type 2 diabetes
5586382|NCT00945204|intermediate care|intermediate care
5586383|NCT00945204|primary care|primary care
5586384|NCT00945204|randomised controlled trial|randomised controlled trial
5586386|NCT00945191|cancer|cancer
5586387|NCT00945191|metastatic|metastatic
5586388|NCT00945191|locally|locally
5586389|NCT00945191|advanced|advanced
5586390|NCT00945191|chemotherapy|chemotherapy
5586391|NCT00945191|neoplasm|neoplasm
5586392|NCT00945178|Safety|safety
5586393|NCT00945178|Tolerability|tolerability
5586394|NCT00945178|Healthy|healthy
5586395|NCT00945178|Pharmacokinetics|pharmacokinetics
5586396|NCT00945165|Continuous Glucose Monitoring System|continuous glucose monitoring system
5586397|NCT00945165|Exercise|exercise
5586398|NCT00945152|Elimination of MRSA in open wounds|elimination of mrsa in open wounds
5586399|NCT00945152|MRSA infected open wounds|mrsa infected open wounds
5586400|NCT00945126|Allogeneic stem cell transplantation in pediatric patients|allogeneic stem cell transplantation in pediatric patients
5586401|NCT00945126|CD3/CD19 depleted stem cells|cd3/cd19 depleted stem cells
5586402|NCT00945126|malignant and non-malignant high risk diseases|malignant and non-malignant high risk diseases
5586403|NCT00945113|pilot|pilot
5586404|NCT00945113|stammer|stammer
5586405|NCT00945113|stutter|stutter
5586406|NCT00945113|children|children
5586407|NCT00945113|randomised controlled trial|randomised controlled trial
5586408|NCT00945113|RCT|rct
5586409|NCT00945113|Speech and Language Therapy|speech and language therapy
5586410|NCT00945113|Stuttering|stuttering
5586411|NCT00945100|Amblyopia|amblyopia
5586412|NCT00945100|patching|patching
5586413|NCT00945100|occlusion|occlusion
5586414|NCT00945087|bacteriophage|bacteriophage
5586415|NCT00945087|bacteriophage preparation|bacteriophage preparation
5586416|NCT00945087|bacterial infection|bacterial infection
5586417|NCT00945087|antibiotic-resistant infection|antibiotic-resistant infection
5586418|NCT00945087|multidrug-resistant bacteria|multidrug-resistant bacteria
5586420|NCT00945074|Acupuncture|acupuncture
5586421|NCT00945074|Moxibustion|moxibustion
5586422|NCT00945074|Traditional Chinese Medicine|traditional chinese medicine
5586423|NCT00945074|Complementary Medicine|complementary medicine
5586424|NCT00945074|Irritable Bowel Syndrome|irritable bowel syndrome
5586425|NCT00945074|IBS|ibs
5586426|NCT00945061|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5586427|NCT00945061|recurrent breast cancer|recurrent breast cancer
5586428|NCT00945061|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5680340|NCT00578175|Immunogenicity|immunogenicity
5745135|NCT00339456|HIV|hiv
5586429|NCT00945061|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5586430|NCT00945061|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5586431|NCT00945061|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5586432|NCT00945061|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5586433|NCT00945061|male breast cancer|male breast cancer
5586434|NCT00945022|General Surgery|general surgery
5586435|NCT00944996|PACAP (Pituitary Adenylate Cyclase Activating Polypeptide)|pacap (pituitary adenylate cyclase activating polypeptide)
5586436|NCT00944996|Major Depression|major depression
5586437|NCT00944996|Receptors|receptors
5586438|NCT00944996|Gene polymorphism|gene polymorphism
5586439|NCT00944996|PACAP signaling system|pacap signaling system
5586440|NCT00944996|Etiology of major depression|etiology of major depression
5586441|NCT00944996|Mechanism of antidepressants action|mechanism of antidepressants action
5586442|NCT00944996|PACAP receptors gene polymorphism|pacap receptors gene polymorphism
5586443|NCT00944996|Pathogenesis of major depression|pathogenesis of major depression
5586444|NCT00944996|Responsiveness to the antidepressant drugs|responsiveness to the antidepressant drugs
5586445|NCT00944983|Hypertension|hypertension
5586446|NCT00944983|Hypotension|hypotension
5586447|NCT00944983|Clinical Validation|clinical validation
5586448|NCT00944983|Blood Pressure Accuracy|blood pressure accuracy
5586449|NCT00944983|ISO 81600 Standard|iso 81600 standard
5586450|NCT00944983|British Hypertension Society|british hypertension society
5586451|NCT00944983|European Society of Hypertension|european society of hypertension
5586452|NCT00944983|International Protocol|international protocol
5586453|NCT00944970|Coronary artery disease|coronary artery disease
5586454|NCT00944970|Angina|angina
5586455|NCT00944970|Anginal symptoms|anginal symptoms
5586456|NCT00944970|Ischemic heart disease|ischemic heart disease
5586457|NCT00944970|Ischemia|ischemia
5586458|NCT00944970|Single photon emission computed tomography|single photon emission computed tomography
5586459|NCT00944970|Pharmacologic stress|pharmacologic stress
5586460|NCT00944970|Myocardial perfusion imaging|myocardial perfusion imaging
5586461|NCT00944970|Suspected coronary artery disease|suspected coronary artery disease
5586462|NCT00944970|known coronary artery disease|known coronary artery disease
5586463|NCT00944970|typical or atypical anginal symptoms|typical or atypical anginal symptoms
5586464|NCT00944957|Raltegravir|raltegravir
5586465|NCT00944957|efavirenz|efavirenz
5586466|NCT00944957|anxiety|anxiety
5586467|NCT00944957|depression|depression
5586468|NCT00944957|sleep quality|sleep quality
5586469|NCT00944957|HIV|hiv
5586470|NCT00944957|NNRTI|nnrti
5586471|NCT00944957|Tritherapy|tritherapy
5586472|NCT00944957|compliance|compliance
5586473|NCT00944957|stocrin|stocrin
5586474|NCT00944957|treatment experienced|treatment experienced
5586475|NCT00944944|CORPUS UTERI,|corpus uteri,
5586476|NCT00944944|ENDOMETRIUM|endometrium
5586477|NCT00944944|FALLOPIAN TUBE|fallopian tube
5586479|NCT00944944|VAGINA|vagina
5586480|NCT00944944|Lymphedema|lymphedema
5586481|NCT00944944|Questionnaire|questionnaire
5586482|NCT00944944|Quality of Life|quality of life
5586483|NCT00944944|09-077|09-077
5586484|NCT00944944|Fallopian Tubes|fallopian tubes
5586485|NCT00944931|Cerebral Cortex|cerebral cortex
5586486|NCT00944931|Cognition|cognition
5586487|NCT00944931|Motor Cortex|motor cortex
5586488|NCT00944931|Cognitive Enhancement|cognitive enhancement
5586489|NCT00944931|Prefrontal Cortex|prefrontal cortex
5586490|NCT00944931|Healthy Volunteer|healthy volunteer
5586491|NCT00944918|Breast Cancer|breast cancer
5586493|NCT00944879|vaccine|vaccine
5586494|NCT00944879|prevention|prevention
5586495|NCT00944879|HPV|hpv
5586496|NCT00944879|adolescents|adolescents
5586497|NCT00944853|zinc supplement|zinc supplement
5586498|NCT00944853|prevention|prevention
5586499|NCT00944853|zinc deficiency|zinc deficiency
5586500|NCT00944853|plasma zinc concentration|plasma zinc concentration
5586501|NCT00944840|Intermittent Preventive Treatment|intermittent preventive treatment
5586502|NCT00944840|Home based management of malaria|home based management of malaria
5586503|NCT00944827|Green Tea Extract|green tea extract
5586505|NCT00944827|Statin|statin
5586506|NCT00944827|atorvastatin|atorvastatin
5586507|NCT00944827|body composition|body composition
5586508|NCT00944827|visceral fat|visceral fat
5586509|NCT00944827|steatosis|steatosis
5586510|NCT00944827|oxidative stress|oxidative stress
5586511|NCT00944827|quality of life|quality of life
5586512|NCT00944827|OGTT|ogtt
5586513|NCT00944827|OGIS|ogis
5586514|NCT00944827|ISI matsuda|isi matsuda
5586515|NCT00944814|Lipid-based nutrient supplement|lipid-based nutrient supplement
5586516|NCT00944814|Prevention of malnutrition|prevention of malnutrition
5586517|NCT00944814|Prevention of micronutrient deficiencies|prevention of micronutrient deficiencies
5586518|NCT00944814|Zinc|zinc
5586519|NCT00944801|glioblastoma|glioblastoma
5586520|NCT00944801|first-line|first-line
5586521|NCT00944801|clinical trial|clinical trial
5586522|NCT00944801|PEG-liposomal doxorubicin|peg-liposomal doxorubicin
5586523|NCT00944801|temozolomide|temozolomide
5586524|NCT00944801|radiotherapy|radiotherapy
5586525|NCT00944801|phase 1|phase 1
5586526|NCT00944801|phase 2|phase 2
5586527|NCT00944788|physical activity|physical activity
5586528|NCT00944788|aging|aging
5586529|NCT00944788|inpatients|inpatients
5586530|NCT00944788|quality of life|quality of life
5586531|NCT00944788|depression|depression
5586532|NCT00944775|Exercise|exercise
5586533|NCT00944775|Dialysis|dialysis
5586534|NCT00944775|Non-invasive cardiac measures|non-invasive cardiac measures
5586535|NCT00944775|Exercise trained patients|exercise trained patients
5586536|NCT00944775|Controls|controls
5586537|NCT00944762|Stroke|stroke
5586538|NCT00944749|H- ATG|h- atg
5586539|NCT00944749|Anti -Thymocyte Globulin|anti -thymocyte globulin
5586540|NCT00944749|Lymphocyte Immune Globulin|lymphocyte immune globulin
5586541|NCT00944749|Aplastic Anemia|aplastic anemia
5586542|NCT00944736|Crohn's Disease|crohn's disease
5586543|NCT00944736|Pediatric|pediatric
5586544|NCT00944736|VSL#3|vsl#3
5586545|NCT00944736|Permeability|permeability
5586548|NCT00944723|zinc fortification|zinc fortification
5586549|NCT00944723|zinc supplementation|zinc supplementation
5586550|NCT00944723|plasma zinc concentration|plasma zinc concentration
5586551|NCT00944710|Amblyopia|amblyopia
5586552|NCT00944710|atropine|atropine
5586553|NCT00944710|Plano lens|plano lens
5586554|NCT00944684|Chronic hepatitis C|chronic hepatitis c
5586555|NCT00944684|Antiviral treatment|antiviral treatment
5586556|NCT00944684|Ribavirin|ribavirin
5586557|NCT00944684|Sustained virological response|sustained virological response
5586558|NCT00944684|Hemolytic anemia|hemolytic anemia
5586559|NCT00944684|Erythropoetin|erythropoetin
5586560|NCT00944658|Ankylosing spondylitis|ankylosing spondylitis
5586561|NCT00944658|Imaging|imaging
5586562|NCT00944580|MAGE-A1|mage-a1
5586563|NCT00944580|MAGE-A3|mage-a3
5586564|NCT00944580|NY-ESO-1|ny-eso-1
5586565|NCT00944580|antigen|antigen
5586566|NCT00944580|vaccine|vaccine
5586567|NCT00944580|dendritic cells|dendritic cells
5586568|NCT00944580|immunohistochemistry|immunohistochemistry
5586569|NCT00944580|immunology|immunology
5586570|NCT00944567|Primary Mediastinal B-Cell Lymphoma|primary mediastinal b-cell lymphoma
5586571|NCT00944567|Positron emission tomography|positron emission tomography
5586572|NCT00944554|Relapse|relapse
5586573|NCT00944554|Smoking Cessation|smoking cessation
5586574|NCT00944554|Substance Abuse|substance abuse
5586575|NCT00944541|maraviroc|maraviroc
5586576|NCT00944541|immune restoration|immune restoration
5586577|NCT00944541|treatment intensification|treatment intensification
5586578|NCT00944528|Cancer of Breast|cancer of breast
5586579|NCT00944528|Cancer of the Breast|cancer of the breast
5586580|NCT00944528|Neoplasms, Breast|neoplasms, breast
5586581|NCT00944528|Single dose radiation|single dose radiation
5586582|NCT00944528|Radiotherapy|radiotherapy
5586583|NCT00944528|Preoperative|preoperative
5586584|NCT00944515|sinusitis|sinusitis
5586585|NCT00944515|azithromycin|azithromycin
5586586|NCT00944502|Neuralgy|neuralgy
5586587|NCT00944502|Dexamethasone|dexamethasone
5586588|NCT00944502|Complex Vitamins|complex vitamins
5586589|NCT00944502|Injection|injection
5586590|NCT00944502|Symptoms of neuralgy of various origins|symptoms of neuralgy of various origins
5586591|NCT00944489|Hypertension|hypertension
5586592|NCT00944489|Health-Related Quality of Life Adherence to the antihypertension treatment|health-related quality of life adherence to the antihypertension treatment
5586593|NCT00944489|Ambulatory Patients|ambulatory patients
5586594|NCT00944489|MINICHAL score|minichal score
5586595|NCT00944489|Treatment Adherence Scale (MMAS)|treatment adherence scale (mmas)
5586596|NCT00944489|Quality of life|quality of life
5586597|NCT00944489|Adherence to treatment|adherence to treatment
5586598|NCT00944476|Sarcoma|sarcoma
5586599|NCT00944476|soft tissue|soft tissue
5586601|NCT00944476|Questionnaire|questionnaire
5586602|NCT00944476|09-078|09-078
5586603|NCT00944463|advanced pancreatic cancer|advanced pancreatic cancer
5586604|NCT00944463|gemcitabine|gemcitabine
5586605|NCT00944463|simvastatin|simvastatin
5586606|NCT00944463|placebo|placebo
5586607|NCT00944437|Ventilation, Mechanical|ventilation, mechanical
5586608|NCT00944437|Positive-Pressure Respiration|positive-pressure respiration
5586609|NCT00944437|Continuous Positive Airway Pressure|continuous positive airway pressure
5586610|NCT00944424|Vitamin D in patients with metastatic breast cancer|vitamin d in patients with metastatic breast cancer
5586611|NCT00944398|Zinc fortification|zinc fortification
5586612|NCT00944398|Plasma zinc concentration|plasma zinc concentration
5586613|NCT00944398|Assessment of zinc status|assessment of zinc status
5586615|NCT00944372|somatostatin receptor|somatostatin receptor
5586616|NCT00944359|zinc supplementation|zinc supplementation
5586617|NCT00944359|diarrhea management|diarrhea management
5586618|NCT00944359|zinc deficiency|zinc deficiency
5586619|NCT00944359|malaria|malaria
5586620|NCT00944333|second generation DES|second generation des
5586621|NCT00944333|clopidogrel|clopidogrel
5680341|NCT00578175|Safety|safety
5586622|NCT00944333|dual platelet therapy|dual platelet therapy
5586623|NCT00944333|patients with documented silent ischemia|patients with documented silent ischemia
5586624|NCT00944333|unstable angina pectoris (Braunwald Classification)|unstable angina pectoris (braunwald classification)
5586625|NCT00944333|Diagnosis of angina pectoris (CCS)|diagnosis of angina pectoris (ccs)
5586627|NCT00944307|antiretroviral|antiretroviral
5586628|NCT00944307|drug interaction|drug interaction
5586629|NCT00944307|human immunodeficiency virus|human immunodeficiency virus
5586630|NCT00944294|Coronary artery disease|coronary artery disease
5586631|NCT00944294|Angina|angina
5586632|NCT00944294|Anginal symptoms|anginal symptoms
5586633|NCT00944294|Ischemic heart disease|ischemic heart disease
5586634|NCT00944294|Ischemia|ischemia
5586635|NCT00944294|Single photon emission computed tomography|single photon emission computed tomography
5586636|NCT00944294|Pharmacologic stress|pharmacologic stress
5586637|NCT00944294|Myocardial perfusion imaging|myocardial perfusion imaging
5586638|NCT00944294|typical or atypical anginal symptoms|typical or atypical anginal symptoms
5586639|NCT00944294|Suspected coronary artery disease|suspected coronary artery disease
5586640|NCT00944294|known coronary artery disease|known coronary artery disease
5586641|NCT00944281|point-of-use fortification|point-of-use fortification
5586642|NCT00944281|zinc supplement|zinc supplement
5586643|NCT00944281|lipid-based nutrient supplement|lipid-based nutrient supplement
5586644|NCT00944281|zinc deficiency|zinc deficiency
5586645|NCT00944281|micronutrient deficiency|micronutrient deficiency
5586646|NCT00944281|anemia|anemia
5586647|NCT00944268|Passiflora, Crataegus and Salix|passiflora, crataegus and salix
5586648|NCT00944268|Mild and Moderate anxiety|mild and moderate anxiety
5586649|NCT00944268|Tablet|tablet
5586650|NCT00944268|To evaluate the efficacy and tolerability of the combination|to evaluate the efficacy and tolerability of the combination
5586651|NCT00944229|Heart Failure|heart failure
5586652|NCT00944229|omega 3|omega 3
5586653|NCT00944229|lovaza|lovaza
5586654|NCT00944229|VO2 max|vo2 max
5586655|NCT00944216|keratosis pilaris|keratosis pilaris
5586656|NCT00944203|jellyfish|jellyfish
5586657|NCT00944203|jellyfish venom|jellyfish venom
5586658|NCT00944203|jellyfish dermatitis|jellyfish dermatitis
5586659|NCT00944203|jellyfish stings|jellyfish stings
5586660|NCT00944203|Ipomea pes-caprae|ipomea pes-caprae
5586661|NCT00944190|pain|pain
5586662|NCT00944190|fatigue|fatigue
5586663|NCT00944190|depression|depression
5586664|NCT00944190|cognitive difficulties|cognitive difficulties
5586665|NCT00944190|self-management|self-management
5586666|NCT00944151|pain|pain
5586667|NCT00944151|UCSD|ucsd
5586668|NCT00944151|catheter|catheter
5586669|NCT00944151|nerve block|nerve block
5586670|NCT00944151|hernia|hernia
5586671|NCT00944151|post-surgery pain|post-surgery pain
5586672|NCT00944151|abdominal pain|abdominal pain
5586673|NCT00944151|pelvic pain|pelvic pain
5586674|NCT00944151|Transversus abdominal plane|transversus abdominal plane
5586675|NCT00944151|Hernia Repair|hernia repair
5586676|NCT00944151|Transversus Abdominal Plane Block|transversus abdominal plane block
5586677|NCT00944138|Obesity|obesity
5586678|NCT00944138|meditation|meditation
5586679|NCT00944138|chronic kidney disease|chronic kidney disease
5586680|NCT00944112|Intensive care|intensive care
5586681|NCT00944112|Blood Transfusion|blood transfusion
5586682|NCT00944112|Anemia|anemia
5586683|NCT00944099|intervention studies|intervention studies
5586684|NCT00944099|feeding behavior|feeding behavior
5586685|NCT00944099|eating frequency|eating frequency
5586686|NCT00944099|weight loss|weight loss
5586687|NCT00944099|dietary intake|dietary intake
5586688|NCT00944086|Recruitment|recruitment
5586689|NCT00944086|Oxygen Concentration|oxygen concentration
5586690|NCT00944086|pneumoperitoneum|pneumoperitoneum
5586691|NCT00944086|laparoscopy|laparoscopy
5586692|NCT00944073|H1N1, influenza A viruses, vaccine, infants, children|h1n1, influenza a viruses, vaccine, infants, children
5586693|NCT00944047|invasive breast cancer|invasive breast cancer
5586694|NCT00944047|HER2|her2
5586695|NCT00944047|primary breast cancer|primary breast cancer
5586696|NCT00944047|neo-adjuvant therapy|neo-adjuvant therapy
5586697|NCT00944047|Trastuzumab|trastuzumab
5586698|NCT00944047|Nab-paclitaxel|nab-paclitaxel
5586699|NCT00944034|Meningococcal meningitis|meningococcal meningitis
5586700|NCT00944034|prevention|prevention
5586701|NCT00944034|vaccination|vaccination
5586703|NCT00944021|Early Bactericidal Activity|early bactericidal activity
5586704|NCT00944021|EBA|eba
5586705|NCT00944021|Pulmonary Tuberculosis|pulmonary tuberculosis
5586706|NCT00944021|PA-824|pa-824
5586707|NCT00944021|pretomanid|pretomanid
5586708|NCT00944008|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5586709|NCT00944008|Depocyte®|depocyte®
5586710|NCT00944008|Neuromeningeal relapse|neuromeningeal relapse
5586711|NCT00944008|Between 16 and 30 years old|between 16 and 30 years old
5586712|NCT00944008|Standard risk|standard risk
5586713|NCT00943995|End Stage Kidney Disease|end stage kidney disease
5586714|NCT00943995|Kidney Failure|kidney failure
5586715|NCT00943995|Short stature|short stature
5586716|NCT00943995|Growth Hormone therapy|growth hormone therapy
5586717|NCT00943982|Cystoid Macular Edema|cystoid macular edema
5571953|NCT00998647|ROTEM|rotem
5586718|NCT00943982|Intermediate Uveitis|intermediate uveitis
5586719|NCT00943982|Uveitis|uveitis
5586720|NCT00943982|OCT|oct
5586721|NCT00943982|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5586722|NCT00943969|obesity|obesity
5586723|NCT00943969|gastric bypass|gastric bypass
5586724|NCT00943969|morphine|morphine
5586725|NCT00943969|pharmacokinetic|pharmacokinetic
5586726|NCT00943969|absorption|absorption
5586727|NCT00943956|stage III prostate cancer|stage iii prostate cancer
5586728|NCT00943956|stage IV prostate cancer|stage iv prostate cancer
5586729|NCT00943943|acute myelogenous leukemia|acute myelogenous leukemia
5586730|NCT00943943|AML|aml
5586731|NCT00943943|Leukemia|leukemia
5586732|NCT00943943|myeloid leukemias|myeloid leukemias
5586733|NCT00943943|mutated fms-like tyrosine kinase receptor-3|mutated fms-like tyrosine kinase receptor-3
5586734|NCT00943943|FLT3 Mutations|flt3 mutations
5586735|NCT00943943|G-CSF|g-csf
5586736|NCT00943943|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5586737|NCT00943943|Filgrastim|filgrastim
5586738|NCT00943943|Neupogen|neupogen
5586739|NCT00943943|Plerixafor|plerixafor
5586740|NCT00943943|Mobozil|mobozil
5586741|NCT00943943|Sorafenib|sorafenib
5586742|NCT00943943|BAY 43-9006|bay 43-9006
5586837|NCT00943449|Phase II|phase ii
5586747|NCT00943865|metabolic syndrome|metabolic syndrome
5586748|NCT00943865|lifestyle|lifestyle
5586749|NCT00943865|exercise|exercise
5586750|NCT00943865|endothelial dysfunction|endothelial dysfunction
5586751|NCT00943865|insulin sensitivity|insulin sensitivity
5586753|NCT00943839|stage IV renal cell cancer|stage iv renal cell cancer
5586754|NCT00943813|communication|communication
5586755|NCT00943813|survey|survey
5586756|NCT00943813|video|video
5586757|NCT00943813|09-043|09-043
5586758|NCT00943800|Appropriate candidate for transplantation|appropriate candidate for transplantation
5586759|NCT00943800|An HLA-identical related or unrelated donor cannot be identified within an appropriate time frame.|an hla-identical related or unrelated donor cannot be identified within an appropriate time frame.
5586760|NCT00943774|Physiology|physiology
5586761|NCT00943774|Phenotype|phenotype
5586762|NCT00943774|Genetics|genetics
5586763|NCT00943774|Genomics|genomics
5586764|NCT00943774|Stress|stress
5586765|NCT00943774|Baroreflex|baroreflex
5586766|NCT00943774|Blood Pressure|blood pressure
5586767|NCT00943774|Arterial stiffness|arterial stiffness
5586768|NCT00943761|hepatitis C|hepatitis c
5671238|NCT00616590|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5586769|NCT00943735|Overactive Bladder Incontinence Adherence Behavioral interventions|overactive bladder incontinence adherence behavioral interventions
5586770|NCT00943709|hyperglycemia|hyperglycemia
5586771|NCT00943709|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5685417|NCT00556127|Large B-cell Lymphoma|large b-cell lymphoma
5586772|NCT00943709|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5586773|NCT00943709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5586774|NCT00943709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5586775|NCT00943709|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5586776|NCT00943709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5586777|NCT00943709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5586778|NCT00943709|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5586779|NCT00943709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5586780|NCT00943670|MBC|mbc
5586781|NCT00943670|TDM1|tdm1
5586782|NCT00943670|Armed Herceptin|armed herceptin
5586783|NCT00943670|Herceptin|herceptin
5586784|NCT00943670|Trastuzumab emtansine|trastuzumab emtansine
5586785|NCT00943644|MBI|mbi
5586786|NCT00943644|Breast|breast
5586787|NCT00943644|Breast Cancer|breast cancer
5586788|NCT00943631|H1N1, influenza A viruses, vaccine, elderly|h1n1, influenza a viruses, vaccine, elderly
5586789|NCT00943618|Smoking Cessation|smoking cessation
5586790|NCT00943618|Nicotine Withdrawal|nicotine withdrawal
5586791|NCT00943618|Smoking Reduction|smoking reduction
5586792|NCT00943618|Varenicline|varenicline
5586793|NCT00943618|Chantix|chantix
5586794|NCT00943618|Bupropion|bupropion
5586795|NCT00943618|Zyban|zyban
5586796|NCT00943605|Mastectomy|mastectomy
5586797|NCT00943605|PlasmaBlade|plasmablade
5586798|NCT00943605|Electrosurgery|electrosurgery
5586799|NCT00943605|PEAK Surgical|peak surgical
5586800|NCT00943605|Medtronic Advanced Energy|medtronic advanced energy
5586801|NCT00943605|Medtronic|medtronic
5586802|NCT00943592|Melphalan|melphalan
5586803|NCT00943592|Alemtuzumab|alemtuzumab
5586804|NCT00943592|Clofarabine|clofarabine
5586805|NCT00943579|autism|autism
5586806|NCT00943579|autistic disorder|autistic disorder
5586807|NCT00943579|tetrahydrobiopterin|tetrahydrobiopterin
5586808|NCT00943579|sapropterin|sapropterin
5586809|NCT00943579|treatment|treatment
5586810|NCT00943566|Pain|pain
5586811|NCT00943566|Cancer|cancer
5586812|NCT00943566|Morphine|morphine
5586814|NCT00943540|pharmacokinetics|pharmacokinetics
5586815|NCT00943540|single dose|single dose
5586816|NCT00943540|raltegravir|raltegravir
5586817|NCT00943540|Treatment experienced|treatment experienced
5586818|NCT00943527|Breast|breast
5586819|NCT00943527|Menstrual Cycle|menstrual cycle
5586820|NCT00943527|Breast Cancer|breast cancer
5586821|NCT00943527|Hormone|hormone
5586822|NCT00943527|MBI|mbi
5586823|NCT00943527|Molecular Breast Imaging|molecular breast imaging
5586824|NCT00943527|Breast Imaging|breast imaging
5586831|NCT00943488|influenza A viruses, H1N1, elderly|influenza a viruses, h1n1, elderly
5586832|NCT00943475|DPNB, pain, hemodynamics effects, circumcision|dpnb, pain, hemodynamics effects, circumcision
5586833|NCT00943449|Hepatocellular Carcinoma|hepatocellular carcinoma
5586838|NCT00943449|Resminostat|resminostat
5586839|NCT00943436|Exercise|exercise
5586840|NCT00943436|Sedentary|sedentary
5586841|NCT00943436|Energy Expenditure|energy expenditure
5586842|NCT00943436|Energy Balance|energy balance
5586843|NCT00943436|Macronutrient Intake|macronutrient intake
5586844|NCT00943436|Energy and Macronutrient intake|energy and macronutrient intake
5586845|NCT00943436|Exercise and Energy Balance|exercise and energy balance
5586846|NCT00943423|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5586847|NCT00943423|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5586848|NCT00943410|HER2-positive breast cancer|her2-positive breast cancer
5586849|NCT00943410|inflammatory breast cancer|inflammatory breast cancer
5586850|NCT00943410|recurrent breast cancer|recurrent breast cancer
5586974|NCT00942903|voice prosthesis|voice prosthesis
5586851|NCT00943410|stage IIIA breast cancer|stage iiia breast cancer
5586852|NCT00943410|stage IIIB breast cancer|stage iiib breast cancer
5586853|NCT00943410|stage IIIC breast cancer|stage iiic breast cancer
5586854|NCT00943410|stage IV breast cancer|stage iv breast cancer
5586855|NCT00943358|influenza|influenza
5586856|NCT00943358|immunogenicity|immunogenicity
5586857|NCT00943358|vaccine|vaccine
5586859|NCT00943345|gastrointestinal|gastrointestinal
5586860|NCT00943345|permeability|permeability
5586861|NCT00943345|indometacin|indometacin
5586862|NCT00943345|indomethacin|indomethacin
5586863|NCT00943345|coeliac|coeliac
5586864|NCT00943332|Orthopedic Procedures|orthopedic procedures
5586865|NCT00943332|Fracture Fixation, Internal|fracture fixation, internal
5586866|NCT00943332|Fracture Fixation, External|fracture fixation, external
5586867|NCT00943332|femur fracture|femur fracture
5586868|NCT00943332|pediatrics|pediatrics
5586869|NCT00943319|Cancers of the blood|cancers of the blood
5586870|NCT00943306|Homozygous|homozygous
5586871|NCT00943306|Familial|familial
5586872|NCT00943306|Hypercholesterolemia|hypercholesterolemia
5586873|NCT00943306|MTP|mtp
5586874|NCT00943306|Apheresis|apheresis
5586875|NCT00943306|lomitapide|lomitapide
5586876|NCT00943306|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
5586877|NCT00943293|GVHD|gvhd
5586878|NCT00943280|probability of patient participation in each of the Groups 1, 2 and 3.|probability of patient participation in each of the groups 1, 2 and 3.
5586879|NCT00943280|Identification of factors predicting poor participation in screening for Barrett's esophagus.|identification of factors predicting poor participation in screening for barrett's esophagus.
5586880|NCT00943267|Activated Protein C|activated protein c
5586881|NCT00943267|Lipopolysaccharides|lipopolysaccharides
5586882|NCT00943267|Inflammation, Pulmonary|inflammation, pulmonary
5586883|NCT00943254|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
5586884|NCT00943241|Breast|breast
5586885|NCT00943241|Breast Cancer|breast cancer
5586886|NCT00943241|MBI|mbi
5586887|NCT00943241|Molecular Breast Imaging|molecular breast imaging
5586888|NCT00943241|Molecular Imaging|molecular imaging
5586889|NCT00943228|Renal transplantation|renal transplantation
5586890|NCT00943228|Adequate exposure|adequate exposure
5586891|NCT00943228|Acute rejection|acute rejection
5586892|NCT00943228|mycophenolate mofetil|mycophenolate mofetil
5586893|NCT00943228|immunosuppression|immunosuppression
5586894|NCT00943215|CALERIE II Follow-up|calerie ii follow-up
5586895|NCT00943202|H1N1, influenza A viruses, TIV, vaccine, infants, children|h1n1, influenza a viruses, tiv, vaccine, infants, children
5586896|NCT00943189|Fetal anomalies scan at the time of NT study|fetal anomalies scan at the time of nt study
5586897|NCT00943176|Fatigue|fatigue
5586898|NCT00943163|cyclorotation|cyclorotation
5586899|NCT00943163|pupil|pupil
5586900|NCT00943163|laser refractive surgery|laser refractive surgery
5586901|NCT00943150|Abdominoplasty|abdominoplasty
5586902|NCT00943150|PlasmaBlade|plasmablade
5586904|NCT00943150|PEAK Surgical|peak surgical
5586905|NCT00943150|Medtronic Advanced Energy|medtronic advanced energy
5586906|NCT00943150|Medtronic|medtronic
5586907|NCT00943111|Gaucher disease,|gaucher disease,
5586908|NCT00943111|Genz-112638,|genz-112638,
5586909|NCT00943111|beta-glucosidase,|beta-glucosidase,
5586910|NCT00943111|acid ß-glucosidase,|acid ß-glucosidase,
5586911|NCT00943111|glucocerebrosidase,|glucocerebrosidase,
5586912|NCT00943111|glucosylceramide,|glucosylceramide,
5586913|NCT00943111|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
5586914|NCT00943111|substrate reduction therapy|substrate reduction therapy
5586915|NCT00943085|Early Signs of Bipolar Disorder|early signs of bipolar disorder
5586917|NCT00943085|Adolescence|adolescence
5586918|NCT00943085|Childhood|childhood
5586919|NCT00943072|Macular edema|macular edema
5586920|NCT00943072|Retinal vein occlusion|retinal vein occlusion
5586921|NCT00943072|CRVO|crvo
5586922|NCT00943072|VEGF Trap-Eye|vegf trap-eye
5586923|NCT00943072|best-corrected visual acuity|best-corrected visual acuity
5586924|NCT00943072|Regeneron|regeneron
5586925|NCT00943072|COPERNICUS|copernicus
5586926|NCT00943059|Mitochondrial function|mitochondrial function
5586927|NCT00943059|Diabetes|diabetes
5586928|NCT00943059|Cardiomyopathy|cardiomyopathy
5586929|NCT00943059|insulin resistance|insulin resistance
5586930|NCT00943059|lipid lowering|lipid lowering
5586931|NCT00943059|triglycerides|triglycerides
5586932|NCT00943059|Acipimox|acipimox
5586933|NCT00943046|leads|leads
5586934|NCT00943046|pacemaker|pacemaker
5586935|NCT00943046|efficacy|efficacy
5586936|NCT00943046|safety|safety
5586937|NCT00943033|MBCT|mbct
5586938|NCT00943033|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5586939|NCT00943033|Mindfulness|mindfulness
5586940|NCT00943033|Meditation|meditation
5586941|NCT00943033|Relapse Prevention|relapse prevention
5586942|NCT00943033|Recurrent Depression|recurrent depression
5586943|NCT00943033|Depression|depression
5586944|NCT00943033|Major Depressive Disorder|major depressive disorder
5586945|NCT00943020|Dietary supplement|dietary supplement
5586946|NCT00943020|Carbohydrate loading|carbohydrate loading
5586947|NCT00943020|Healthy volunteers|healthy volunteers
5586948|NCT00943020|Anaesthesia|anaesthesia
5586949|NCT00943020|Surgery|surgery
5586950|NCT00943020|Glutamine|glutamine
5586951|NCT00942994|Hypertension|hypertension
5586952|NCT00942994|Aliskiren|aliskiren
5586953|NCT00942994|Amlodipine|amlodipine
5586954|NCT00942994|HCTZ|hctz
5586955|NCT00942994|Systolic blood pressure|systolic blood pressure
5586956|NCT00942994|Diastolic blood pressure|diastolic blood pressure
5586957|NCT00942994|Stage II|stage ii
5586958|NCT00942994|Combination|combination
5586959|NCT00942981|PET Study|pet study
5586960|NCT00942981|(18F) Fallypride|(18f) fallypride
5586961|NCT00942981|(11C)NNC-112|(11c)nnc-112
5586962|NCT00942981|D-1 Receptors|d-1 receptors
5586963|NCT00942981|Schizophrenia|schizophrenia
5586964|NCT00942981|Schizoaffective Disorder|schizoaffective disorder
5586965|NCT00942981|Healthy Volunteer|healthy volunteer
5586966|NCT00942981|HV|hv
5586967|NCT00942929|anorexia nervosa|anorexia nervosa
5586968|NCT00942929|adolescents|adolescents
5586969|NCT00942929|lung function tests|lung function tests
5586970|NCT00942929|refeeding|refeeding
5586971|NCT00942916|Make sure the difference of the serum inflammatory marker between the two groups|make sure the difference of the serum inflammatory marker between the two groups
5586972|NCT00942903|HME|hme
5586973|NCT00942903|Provox|provox
5586975|NCT00942903|laryngectomy|laryngectomy
5586976|NCT00942890|Case Management|case management
5586977|NCT00942890|Amputation|amputation
5586978|NCT00942890|Muscle strength|muscle strength
5586979|NCT00942890|phantom limb pain|phantom limb pain
5586980|NCT00942877|VEGF|vegf
5586981|NCT00942877|Antiangiogenesis|antiangiogenesis
5586982|NCT00942877|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5586983|NCT00942877|Advanced Cancer|advanced cancer
5586984|NCT00942851|Dystonia|dystonia
5586985|NCT00942851|Blepharospasm|blepharospasm
5586986|NCT00942851|Botulinum Toxin|botulinum toxin
5586987|NCT00942851|Treatment|treatment
5586988|NCT00942851|Clinical Trial|clinical trial
5586989|NCT00942851|Focal Dystonia|focal dystonia
5586990|NCT00942838|Recurrent Ovarian Carcinoma|recurrent ovarian carcinoma
5586991|NCT00942838|Cancer|cancer
5586992|NCT00942825|NSCL|nscl
5586993|NCT00942825|non-squamous non small cell lung cancer|non-squamous non small cell lung cancer
5586994|NCT00942825|Lung Cancer|lung cancer
5586995|NCT00942825|Lung|lung
5586996|NCT00942825|non-squamous|non-squamous
5586997|NCT00942825|metastatic|metastatic
5586998|NCT00942825|pleural effusion|pleural effusion
5586999|NCT00942825|Stage IIIb|stage iiib
5587000|NCT00942825|Stage IV|stage iv
5587001|NCT00942825|NSCLC|nsclc
5587002|NCT00942812|Children|children
5587003|NCT00942812|Recovery|recovery
5587004|NCT00942812|Diarrhea Pack|diarrhea pack
5587005|NCT00942812|Social Marketing|social marketing
5587006|NCT00942799|Genz-644282|genz-644282
5587007|NCT00942799|Topoisomerase I inhibitors|topoisomerase i inhibitors
5587009|NCT00942799|solid tumors|solid tumors
5587010|NCT00942799|dose-escalation|dose-escalation
5587011|NCT00942799|pharmacokinetic (PK)|pharmacokinetic (pk)
5587012|NCT00942799|MTD (Maximum Tolerated Dose)|mtd (maximum tolerated dose)
5587013|NCT00942799|oncology|oncology
5587014|NCT00942799|cancer|cancer
5587015|NCT00942786|natriuretic peptides|natriuretic peptides
5581399|NCT00963261|melanoma|melanoma
5587017|NCT00942773|Healthy volunteer|healthy volunteer
5587018|NCT00942747|temsirolimus, primary CNS lymphoma, PCNSL, salvage treatment|temsirolimus, primary cns lymphoma, pcnsl, salvage treatment
5587019|NCT00942734|Head and Neck|head and neck
5587020|NCT00942734|Squamous Cell Carcinoma|squamous cell carcinoma
5587021|NCT00942734|RAD001|rad001
5587022|NCT00942734|Erlotinib|erlotinib
5587023|NCT00942734|Everolimus|everolimus
5587024|NCT00942734|OSI-774|osi-774
5587025|NCT00942734|Tarceva|tarceva
5587026|NCT00942721|Web-based Intervention|web-based intervention
5587027|NCT00942721|CBT Treatment|cbt treatment
5587028|NCT00942708|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5587029|NCT00942708|Pulmonary Hypertension|pulmonary hypertension
5587030|NCT00942695|pistachio|pistachio
5587031|NCT00942695|nuts|nuts
5587032|NCT00942695|energy value|energy value
5587033|NCT00942695|cardiovascular disease|cardiovascular disease
5587034|NCT00942695|phytonutrient|phytonutrient
5587035|NCT00942695|gene expression|gene expression
5587036|NCT00942695|energy value of pistachio nuts|energy value of pistachio nuts
5587037|NCT00942682|sorafenib|sorafenib
5587038|NCT00942682|RAD001|rad001
5587039|NCT00942669|Sleep Apnea Syndrome|sleep apnea syndrome
5587041|NCT00942669|SleepStrip OTC|sleepstrip otc
5587042|NCT00942656|trans fatty acids|trans fatty acids
5587043|NCT00942656|ruminant|ruminant
5587044|NCT00942656|cardiovascular disease|cardiovascular disease
5587045|NCT00942630|percutaneous|percutaneous
5587046|NCT00942630|transhepatic|transhepatic
5587047|NCT00942630|biliary|biliary
5587048|NCT00942630|drainage|drainage
5587049|NCT00942630|cholangioscopy|cholangioscopy
5587050|NCT00942617|platelet aggregation|platelet aggregation
5587051|NCT00942617|granule secretion|granule secretion
5587052|NCT00942617|thromboxane production|thromboxane production
5587053|NCT00942617|cyclooxygenase-1|cyclooxygenase-1
5587054|NCT00942617|ATP release|atp release
5587055|NCT00942617|aspirin resistance|aspirin resistance
5587056|NCT00942617|platelet activation|platelet activation
5587057|NCT00942617|flow cytometry|flow cytometry
5587058|NCT00942617|Platelet aggregation in healthy volunteers|platelet aggregation in healthy volunteers
5587059|NCT00942604|Peplin|peplin
5587060|NCT00942604|Actinic keratosis|actinic keratosis
5587061|NCT00942604|PEP005|pep005
5587062|NCT00942591|multiple sclerosis|multiple sclerosis
5587063|NCT00942591|interferon beta|interferon beta
5587064|NCT00942591|atorvastatin|atorvastatin
5587065|NCT00942578|Dual Antiangiogenic Combination Therapy for mCRPC|dual antiangiogenic combination therapy for mcrpc
5587066|NCT00942578|Efficacy and Toxicity Profile|efficacy and toxicity profile
5587067|NCT00942578|Single Stage Phase 2 With Early Stopping, Run In Phase For Toxicity|single stage phase 2 with early stopping, run in phase for toxicity
5587068|NCT00942578|Correlative Measurements|correlative measurements
5587069|NCT00942578|Overall Survival Assessment|overall survival assessment
5587070|NCT00942578|Metastatic Prostate Cancer|metastatic prostate cancer
5587071|NCT00942578|Prostate Cancer|prostate cancer
5587072|NCT00942565|Open gynecological surgery|open gynecological surgery
5587073|NCT00942539|Neonates|neonates
5587074|NCT00942526|esophageal cancer|esophageal cancer
5587075|NCT00942526|anastomotic leakage|anastomotic leakage
5587076|NCT00942526|Prevention of anastomotic leakage after esophageal surgery|prevention of anastomotic leakage after esophageal surgery
5587077|NCT00942513|substrate absorption|substrate absorption
5587078|NCT00942513|substrate oxidation|substrate oxidation
5587079|NCT00942513|glucose regulation|glucose regulation
5587080|NCT00942513|whey protein|whey protein
5587081|NCT00942513|soy protein|soy protein
5587082|NCT00942513|sucrose|sucrose
5587083|NCT00942513|fructose|fructose
5587084|NCT00942513|lactose|lactose
5587085|NCT00942500|Post-conditioning|post-conditioning
5587086|NCT00942500|ST-elevation myocardial infarction|st-elevation myocardial infarction
5587087|NCT00942500|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5587088|NCT00942487|arterial hypertension|arterial hypertension
5587089|NCT00942474|The focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement|the focus of the study is to assess the ability of the nerve access tool to facilitate nerve lead placement
5587090|NCT00942461|a-defensins|a-defensins
5587091|NCT00942461|TLRs|tlrs
5587092|NCT00942461|Inflammatory Cytokines|inflammatory cytokines
5587094|NCT00942461|No metastases|no metastases
5587095|NCT00942461|No other obvious inflammation|no other obvious inflammation
5587096|NCT00942461|No chronic diseases|no chronic diseases
5587097|NCT00942435|YM150|ym150
5587098|NCT00942435|Bleeding|bleeding
5587100|NCT00942435|FXa inhibitor|fxa inhibitor
5587101|NCT00942435|Deep Vein Thrombosis|deep vein thrombosis
5587102|NCT00942435|Venous thromboembolism|venous thromboembolism
5587103|NCT00942422|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5587104|NCT00942422|smoldering multiple myeloma|smoldering multiple myeloma
5587105|NCT00942396|Mammography|mammography
5587106|NCT00942383|liver tumor|liver tumor
5587107|NCT00942383|liver tumors|liver tumors
5587108|NCT00942383|liver cancer|liver cancer
5587109|NCT00942383|hepatocellular carcinoma|hepatocellular carcinoma
5587110|NCT00942383|metastatic colorectal cancer|metastatic colorectal cancer
5587111|NCT00942383|metastatic cancer to the liver|metastatic cancer to the liver
5587113|NCT00942383|metastatic neuroendocrine cancer|metastatic neuroendocrine cancer
5587114|NCT00942383|liver|liver
5587115|NCT00942383|liver surgery|liver surgery
5587116|NCT00942383|radiofrequency ablation|radiofrequency ablation
5587117|NCT00942383|microwave ablation|microwave ablation
5587118|NCT00942370|mechanography|mechanography
5587119|NCT00942370|electromyography|electromyography
5587120|NCT00942370|effort cough|effort cough
5587121|NCT00942344|Amlodipine|amlodipine
5587122|NCT00942344|Losartan|losartan
5587123|NCT00942344|Hypertension|hypertension
5587124|NCT00942318|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5587125|NCT00942318|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5587126|NCT00942318|Insulin external pump|insulin external pump
5587127|NCT00942318|Multiple daily injections|multiple daily injections
5587128|NCT00942318|Basal-bolus regimen|basal-bolus regimen
5587129|NCT00942318|Education|education
5587130|NCT00942305|Allogeneic stem cell transplant|allogeneic stem cell transplant
5587131|NCT00942305|CMV seropositive (R+)|cmv seropositive (r+)
5587132|NCT00942305|transplant|transplant
5587133|NCT00942305|Allogeneic stem cell transplant recipients who were CMV seropositive (R+) at the time of transplant will be eligible for enrollment|allogeneic stem cell transplant recipients who were cmv seropositive (r+) at the time of transplant will be eligible for enrollment
5587134|NCT00942292|Hepatic|hepatic
5587135|NCT00942292|colorectal|colorectal
5587136|NCT00942292|metastases|metastases
5587137|NCT00942292|TPN|tpn
5587138|NCT00942292|Fish oil|fish oil
5587139|NCT00942253|RLS|rls
5587140|NCT00942253|Muscle|muscle
5587141|NCT00942253|Dialysis|dialysis
5587142|NCT00942253|exercise|exercise
5587143|NCT00942253|dopamine agonist|dopamine agonist
5587144|NCT00942253|Sleep|sleep
5587145|NCT00942227|Sciatica|sciatica
5587146|NCT00942227|Radiculopathy|radiculopathy
5587147|NCT00942227|Physical therapy modalities|physical therapy modalities
5587148|NCT00942227|Rehabilitation|rehabilitation
5587149|NCT00942214|Multiple sclerosis|multiple sclerosis
5587150|NCT00942214|natalizumab|natalizumab
5587151|NCT00942214|pharmacogenomics|pharmacogenomics
5587152|NCT00942201|Asthma|asthma
5587153|NCT00942201|Dexamethasone|dexamethasone
5587154|NCT00942201|Emergency Department|emergency department
5587155|NCT00942188|Diabetes|diabetes
5587156|NCT00942188|Type 2 Diabetes|type 2 diabetes
5587157|NCT00942175|Pharmacology|pharmacology
5587158|NCT00942175|Stomach Ulcer|stomach ulcer
5587159|NCT00942175|Esophagitis, Peptic|esophagitis, peptic
5587160|NCT00942175|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5587161|NCT00942175|Platelet function|platelet function
5587162|NCT00942175|PPI|ppi
5587163|NCT00942175|clopidogrel|clopidogrel
5587164|NCT00942175|Pharmacokinetics and Pharmacodynamics|pharmacokinetics and pharmacodynamics
5587165|NCT00942162|ASCI|asci
5587166|NCT00942162|Melanoma|melanoma
5587167|NCT00942162|Immunotherapeutic|immunotherapeutic
5587168|NCT00942162|Tumor antigen|tumor antigen
5587169|NCT00942162|PREDICT|predict
5587170|NCT00942149|Infants|infants
5587171|NCT00942149|Daptomycin|daptomycin
5587172|NCT00942136|HIV|hiv
5587173|NCT00942136|GSK1349572|gsk1349572
5587174|NCT00942136|omeprazole|omeprazole
5587175|NCT00942136|Prilosec|prilosec
5587176|NCT00942136|supratherapeutic dose|supratherapeutic dose
5587177|NCT00942136|pharmacokinetics|pharmacokinetics
5587178|NCT00942136|drug interaction|drug interaction
5587179|NCT00942136|HIV Infections|hiv infections
5587180|NCT00942110|Postprandial glucose, lipid metabolism|postprandial glucose, lipid metabolism
5587181|NCT00942110|humoral factors|humoral factors
5587182|NCT00942097|Homeopathy|homeopathy
5587183|NCT00942097|overweight|overweight
5587184|NCT00942097|obesity|obesity
5587185|NCT00942097|mental disorder|mental disorder
5587186|NCT00942097|pregnancy|pregnancy
5587187|NCT00942097|Overweight pregnant women with suspicious mental disorder|overweight pregnant women with suspicious mental disorder
5587188|NCT00942084|HSV|hsv
5587189|NCT00942084|Acyclovir|acyclovir
5587190|NCT00942084|Pharmacokinetics|pharmacokinetics
5587191|NCT00942084|Neonate|neonate
5587192|NCT00942084|Premature|premature
5587193|NCT00942084|Sepsis|sepsis
5587194|NCT00942071|Influenza|influenza
5587195|NCT00942071|Vaccine|vaccine
5587196|NCT00942058|biological markers|biological markers
5587197|NCT00942058|CA9 protein|ca9 protein
5587198|NCT00942058|metastatic conventional renal cell cancer|metastatic conventional renal cell cancer
5587199|NCT00942058|kidney cancer|kidney cancer
5587200|NCT00942045|cervical spine|cervical spine
5587201|NCT00942045|ACDF|acdf
5587202|NCT00942045|biologics|biologics
5587203|NCT00942045|fusion rates|fusion rates
5587204|NCT00942019|BMI|bmi
5587205|NCT00942019|obesity|obesity
5587206|NCT00942019|CO|co
5587207|NCT00942019|tobacco smoking|tobacco smoking
5587208|NCT00942019|adolescents|adolescents
5587209|NCT00942006|Lyme neuroborreliosis|lyme neuroborreliosis
5587210|NCT00942006|Lyme borreliosis|lyme borreliosis
5587211|NCT00942006|erythema migrans|erythema migrans
5587212|NCT00942006|doxycycline treatment|doxycycline treatment
5587213|NCT00942006|ceftriaxone treatment|ceftriaxone treatment
5587214|NCT00942006|outcome|outcome
5587215|NCT00942006|subjective symptoms|subjective symptoms
5587216|NCT00941980|biologics|biologics
5587217|NCT00941980|fusion rates|fusion rates
5587218|NCT00941980|PLIF|plif
5587219|NCT00941980|lumbar fusion|lumbar fusion
5587220|NCT00941967|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5587221|NCT00941967|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5587222|NCT00941967|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5587223|NCT00941967|advanced adult primary liver cancer|advanced adult primary liver cancer
5587224|NCT00941954|Physical activity|physical activity
5587225|NCT00941954|Diabetes|diabetes
5587226|NCT00941954|Prevention|prevention
5587227|NCT00941954|Pedometer|pedometer
5587228|NCT00941954|Walking|walking
5587229|NCT00941954|Structured education|structured education
5587230|NCT00941954|Randomized|randomized
5587231|NCT00941954|Risk score|risk score
5587232|NCT00941954|Impaired glucose regulation|impaired glucose regulation
5587233|NCT00941941|Inguinal|inguinal
5587234|NCT00941941|Hernia|hernia
5587235|NCT00941941|Hernia-repair|hernia-repair
5587236|NCT00941941|Non-mesh|non-mesh
5587237|NCT00941941|Mesh|mesh
5587238|NCT00941941|Desarda|desarda
5587239|NCT00941941|Lichtenstein|lichtenstein
5587240|NCT00941928|Blood And Marrow Transplantation|blood and marrow transplantation
5587241|NCT00941928|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
5587242|NCT00941928|ALL|all
5587243|NCT00941928|Leukemia|leukemia
5587244|NCT00941928|Pediatrics|pediatrics
5587245|NCT00941928|Haploidentical NK cells|haploidentical nk cells
5587246|NCT00941928|Cyclophosphamide|cyclophosphamide
5587247|NCT00941928|Cytoxan|cytoxan
5587248|NCT00941928|Neosar|neosar
5587249|NCT00941928|Epratuzumab|epratuzumab
5587250|NCT00941928|Fludarabine|fludarabine
5587251|NCT00941928|Fludarabine Phosphate|fludarabine phosphate
5587252|NCT00941928|Fludara|fludara
5587253|NCT00941928|Interleukin-2|interleukin-2
5587254|NCT00941928|IL-2|il-2
5587255|NCT00941928|Proleukin|proleukin
5587256|NCT00941928|Low-dose interleukin|low-dose interleukin
5587257|NCT00941928|Mesna|mesna
5587258|NCT00941928|Mesnex|mesnex
5587259|NCT00941928|Natural Killer Cells|natural killer cells
5587260|NCT00941928|NK Cells Transplant|nk cells transplant
5587261|NCT00941915|CaP|cap
5587262|NCT00941915|SBRT|sbrt
5587263|NCT00941915|Prostate|prostate
5587264|NCT00941915|ExacTrac|exactrac
5587265|NCT00941915|Calypso|calypso
5587266|NCT00941915|IMRT|imrt
5587268|NCT00941915|Cancer of Prostate|cancer of prostate
5587269|NCT00941915|Prostatic Neoplasms|prostatic neoplasms
5587270|NCT00941902|human asialoglycoprotein receptor (ASGPR)|human asialoglycoprotein receptor (asgpr)
5587271|NCT00941902|hepatocytes|hepatocytes
5587272|NCT00941902|bariatric surgery|bariatric surgery
5587273|NCT00941889|HIV|hiv
5587274|NCT00941889|HPV|hpv
5587275|NCT00941889|Anal condylomata|anal condylomata
5587276|NCT00941889|Vaccine|vaccine
5587277|NCT00941889|HIV positive patients|hiv positive patients
5587278|NCT00941889|Anal condylomata or anal warts|anal condylomata or anal warts
5587279|NCT00941876|AE|ae
5587280|NCT00941876|adverse event|adverse event
5587281|NCT00941876|AIDS|aids
5587282|NCT00941876|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5587283|NCT00941876|ALT (SGPT)|alt (sgpt)
5587284|NCT00941876|alanine aminotransferase|alanine aminotransferase
5587285|NCT00941876|ART|art
5587286|NCT00941876|antiretroviral therapy|antiretroviral therapy
5587287|NCT00941876|AST (SGOT)|ast (sgot)
5587288|NCT00941876|aspartate aminotransferase|aspartate aminotransferase
5587289|NCT00941876|DCF|dcf
5587290|NCT00941876|data collection forms|data collection forms
5587291|NCT00941876|DMC|dmc
5587292|NCT00941876|Data Monitoring Committee|data monitoring committee
5587293|NCT00941876|FDA|fda
5587294|NCT00941876|(U.S.) Food and Drug Administration|(u.s.) food and drug administration
5587295|NCT00941876|GCP|gcp
5587296|NCT00941876|Good Clinical Practice guidelines|good clinical practice guidelines
5587297|NCT00941876|HB sAg|hb sag
5587298|NCT00941876|Hepatitis B surface antigen|hepatitis b surface antigen
5587299|NCT00941876|ICH|ich
5587300|NCT00941876|International Conference of Harmonisation|international conference of harmonisation
5587301|NCT00941876|IND|ind
5587302|NCT00941876|Investigational New Drug Application|investigational new drug application
5587303|NCT00941876|IRB|irb
5587304|NCT00941876|Institutional Review Board|institutional review board
5587305|NCT00941876|IU|iu
5587306|NCT00941876|International units|international units
5587307|NCT00941876|mg|mg
5587308|NCT00941876|milligram(s)|milligram(s)
5587309|NCT00941876|mm3|mm3
5587310|NCT00941876|cubic millimeter(s)|cubic millimeter(s)
5587311|NCT00941876|PCR|pcr
5587312|NCT00941876|polymerase chain reaction|polymerase chain reaction
5587313|NCT00941876|SAE|sae
5587314|NCT00941876|serious adverse event|serious adverse event
5587315|NCT00941876|µg|µg
5587316|NCT00941876|microgram|microgram
5587318|NCT00941876|upper limit of the normal range|upper limit of the normal range
5587319|NCT00941876|WB|wb
5587320|NCT00941876|Western Blot|western blot
5680342|NCT00578175|Measles|measles
5680343|NCT00578175|Combined Vaccine|combined vaccine
5587321|NCT00941876|To inform the Ministry of Health strategy for integrating FP and HIV/AIDS Care and Treatment Services in Tanzania|to inform the ministry of health strategy for integrating fp and hiv/aids care and treatment services in tanzania
5587322|NCT00941876|HIV seronegativity|hiv seronegativity
5587323|NCT00941863|Sorafenib|sorafenib
5587324|NCT00941863|Advanced Solid Tumors|advanced solid tumors
5587325|NCT00941863|Maximum tolerated dose|maximum tolerated dose
5587326|NCT00941863|Carboplatin and paclitaxel chemotherapy combination|carboplatin and paclitaxel chemotherapy combination
5587327|NCT00941850|Cardiac resynchronizton therapy|cardiac resynchronizton therapy
5587328|NCT00941850|CRT|crt
5587329|NCT00941850|Heart failure|heart failure
5587330|NCT00941850|Dyssynchrony|dyssynchrony
5587331|NCT00941850|Echocardiography|echocardiography
5587332|NCT00941850|Pacemakers|pacemakers
5587333|NCT00941850|Nonresponders|nonresponders
5587334|NCT00941837|Palm olein|palm olein
5587335|NCT00941837|homocsyteine|homocsyteine
5587336|NCT00941837|Cholesterol|cholesterol
5587337|NCT00941837|lipoproteins|lipoproteins
5587338|NCT00941837|Interleukins|interleukins
5587339|NCT00941837|CRP|crp
5587340|NCT00941837|Blood Pressure|blood pressure
5587341|NCT00941837|Total homocystein|total homocystein
5587342|NCT00941837|Serum lipid profile|serum lipid profile
5587343|NCT00941837|Serum apolipoproteins|serum apolipoproteins
5587344|NCT00941837|Inflammatory markers|inflammatory markers
5587345|NCT00941824|pharmacokinetic|pharmacokinetic
5587346|NCT00941824|mycophénolate acid|mycophénolate acid
5587347|NCT00941824|kidney transplantation|kidney transplantation
5587348|NCT00941798|Asthma|asthma
5587349|NCT00941798|LABA|laba
5587350|NCT00941798|Safety|safety
5587351|NCT00941785|Malaria|malaria
5587352|NCT00941785|Intermittent Preventive Treatment|intermittent preventive treatment
5587353|NCT00941785|IPTc|iptc
5587354|NCT00941785|sIPTc|siptc
5587355|NCT00941785|Burkina Faso|burkina faso
5587356|NCT00941772|Nasogastric tube verification with ultrasonography|nasogastric tube verification with ultrasonography
5587357|NCT00941772|ultrasonography|ultrasonography
5587358|NCT00941759|Breast|breast
5587359|NCT00941759|Blood and tissue collection|blood and tissue collection
5587360|NCT00941759|Epidemiologic|epidemiologic
5587361|NCT00941759|Questionnaire|questionnaire
5587362|NCT00941759|TBCRC (Translational Breast Cancer Research Consortium)|tbcrc (translational breast cancer research consortium)
5587363|NCT00941759|09-056|09-056
5587364|NCT00941733|BTK|btk
5587365|NCT00941733|CLI|cli
5587366|NCT00941733|PTA|pta
5587367|NCT00941720|stage I multiple myeloma|stage i multiple myeloma
5587368|NCT00941720|stage II multiple myeloma|stage ii multiple myeloma
5587369|NCT00941720|stage III multiple myeloma|stage iii multiple myeloma
5587370|NCT00941707|Rheumatoid Arthritis|rheumatoid arthritis
5587371|NCT00941707|JNJ-38518168|jnj-38518168
5587372|NCT00941694|asthma|asthma
5587373|NCT00941694|aged|aged
5587374|NCT00941694|self care|self care
5587375|NCT00941681|omecamtiv mecarbil|omecamtiv mecarbil
5587376|NCT00941655|Gastric Carcinoma|gastric carcinoma
5587377|NCT00941655|Chemotherapy|chemotherapy
5587378|NCT00941655|Liver Tumors|liver tumors
5587379|NCT00941655|Peritoneal Tumors|peritoneal tumors
5587380|NCT00941655|Metastatic Gastric Cancer|metastatic gastric cancer
5587381|NCT00941655|Stomach Cancer|stomach cancer
5587382|NCT00941655|Gastric Cancer|gastric cancer
5587383|NCT00941642|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5587384|NCT00941642|Lovaza|lovaza
5587385|NCT00941642|Steatosis|steatosis
5587386|NCT00941642|Non-Alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5587387|NCT00941629|PTSD|ptsd
5587388|NCT00941629|Telemedicine|telemedicine
5587389|NCT00941629|Clinical Trial|clinical trial
5587390|NCT00941629|Psychotherapy|psychotherapy
5587391|NCT00941616|Von Willebrand Disease|von willebrand disease
5587392|NCT00941590|tick borne encephalitis|tick borne encephalitis
5587393|NCT00941590|clinical outcome|clinical outcome
5587394|NCT00941590|postencephalitic symptoms|postencephalitic symptoms
5587395|NCT00941577|Hypersensitivity|hypersensitivity
5587396|NCT00941577|Lung Diseases, Obstructive|lung diseases, obstructive
5587397|NCT00941577|Immune System Diseases|immune system diseases
5587398|NCT00941577|Respiratory Tract Diseases|respiratory tract diseases
5587399|NCT00941577|Bronchial Diseases|bronchial diseases
5587400|NCT00941577|Lung Diseases|lung diseases
5587401|NCT00941577|Hypersensitivity, Immediate|hypersensitivity, immediate
5587402|NCT00941577|Asthma|asthma
5587403|NCT00941577|Respiratory Hypersensitivity|respiratory hypersensitivity
5587404|NCT00941551|Thyroid lobectomy,|thyroid lobectomy,
5587405|NCT00941551|prophylactic levothyroxine treatment,|prophylactic levothyroxine treatment,
5587406|NCT00941551|recurrent nodular goiter,|recurrent nodular goiter,
5587407|NCT00941551|iodine deficiency,|iodine deficiency,
5587408|NCT00941551|long-term follow-up,|long-term follow-up,
5587409|NCT00941551|completion thyroidectomy|completion thyroidectomy
5587411|NCT00941538|screening|screening
5587412|NCT00941538|biomarker|biomarker
5587413|NCT00941538|early detection|early detection
5680344|NCT00578162|Cancer|cancer
5746317|NCT00334529|Flu|flu
5572639|NCT00996177|Pain|pain
5587414|NCT00941538|epidemiological survey|epidemiological survey
5587415|NCT00941525|Central corneal thickness|central corneal thickness
5587416|NCT00941525|24hour fluctuation of intraocular pressure|24hour fluctuation of intraocular pressure
5587417|NCT00941525|Open angle glaucoma|open angle glaucoma
5587418|NCT00941525|Ocular hypertension|ocular hypertension
5587419|NCT00941512|Colposcopy|colposcopy
5587420|NCT00941499|Advanced Cancers|advanced cancers
5587421|NCT00941499|Liver|liver
5587422|NCT00941499|Oxaliplatin|oxaliplatin
5587423|NCT00941499|Eloxatin|eloxatin
5587424|NCT00941499|Bevacizumab|bevacizumab
5587425|NCT00941499|Avastin|avastin
5587426|NCT00941499|Anit-VEGF monoclonal antibody|anit-vegf monoclonal antibody
5587427|NCT00941499|rhuMAb-VEGF|rhumab-vegf
5587428|NCT00941499|5-fluorouracil|5-fluorouracil
5587429|NCT00941499|5-FU|5-fu
5587430|NCT00941499|Adrucil|adrucil
5587431|NCT00941499|Efudex|efudex
5587432|NCT00941499|Leucovorin|leucovorin
5587433|NCT00941499|Citrovorum|citrovorum
5587434|NCT00941499|Wellcovorin|wellcovorin
5587435|NCT00941499|Cetuximab|cetuximab
5587436|NCT00941499|C225|c225
5587437|NCT00941499|Erbitux|erbitux
5587438|NCT00941499|IMC-C225|imc-c225
5587439|NCT00941473|Epidural Injection|epidural injection
5587440|NCT00941473|Bone Density|bone density
5587441|NCT00941460|progressive or recurrent glioblastoma|progressive or recurrent glioblastoma
5587442|NCT00941460|temozolomide|temozolomide
5587443|NCT00941460|dose intensification|dose intensification
5587444|NCT00941460|comparison of two dosing regimens|comparison of two dosing regimens
5587445|NCT00941447|Type 2 Diabetes|type 2 diabetes
5587446|NCT00941447|Obesity|obesity
5587447|NCT00941447|Self-Regulation|self-regulation
5587448|NCT00941447|Self-Efficacy|self-efficacy
5587449|NCT00941434|RUTF|rutf
5587450|NCT00941434|SAM|sam
5587451|NCT00941434|Nutributter|nutributter
5587452|NCT00941382|sibutramine|sibutramine
5587453|NCT00941382|metformin|metformin
5587454|NCT00941382|obesity|obesity
5587455|NCT00941356|MRSA nasal colonisation|mrsa nasal colonisation
5587456|NCT00941356|Probiotics|probiotics
5587457|NCT00941330|Breast, Male|breast, male
5587458|NCT00941330|Breast, Female|breast, female
5587459|NCT00941317|onychomycosis|onychomycosis
5587460|NCT00941317|micro-drilling|micro-drilling
5587461|NCT00941291|idiopathic macular hole|idiopathic macular hole
5587462|NCT00941291|cataract|cataract
5587463|NCT00941291|edema|edema
5587464|NCT00941291|Reopening|reopening
5587465|NCT00941265|treatment of anomia|treatment of anomia
5587466|NCT00941265|levodopa|levodopa
5587467|NCT00941265|"patient with aphasia hospitalised at the Service de neurorehabilitation with presence of anomia"|"patient with aphasia hospitalised at the service de neurorehabilitation with presence of anomia"
5587468|NCT00941239|Metformin ER|metformin er
5685418|NCT00556127|Rituximab|rituximab
5587469|NCT00941239|Pharmacokinetics|pharmacokinetics
5587470|NCT00941239|Tolerability|tolerability
5587471|NCT00941239|Healthy volunteers|healthy volunteers
5587472|NCT00941226|Cerebral Palsy|cerebral palsy
5587473|NCT00941226|Caregivers|caregivers
5587474|NCT00941226|Quality of Life|quality of life
5587475|NCT00941213|fractures of vertebral bodies Th10-L2|fractures of vertebral bodies th10-l2
5587476|NCT00941213|(AO A1 with kyphosis, A2.3, B or C-type)|(ao a1 with kyphosis, a2.3, b or c-type)
5587477|NCT00941187|pulmonary embolism|pulmonary embolism
5587478|NCT00941187|pulmonary capillary blood volume|pulmonary capillary blood volume
5587479|NCT00941187|double diffusion NO/CO method|double diffusion no/co method
5587480|NCT00941174|(13C5) Calcium Leucovorin|(13c5) calcium leucovorin
5587481|NCT00941174|Folate absorption across the large intestine|folate absorption across the large intestine
5587482|NCT00941174|Folate Bioavailability|folate bioavailability
5587483|NCT00941122|MRSA, VRE|mrsa, vre
5587485|NCT00941096|Glaucoma|glaucoma
5587486|NCT00941096|Ocular Hypertension|ocular hypertension
5587487|NCT00941096|Lumigan|lumigan
5587488|NCT00941096|Ganfort|ganfort
5587489|NCT00941083|Simplification from protease inhibitors to raltegravir|simplification from protease inhibitors to raltegravir
5587490|NCT00941083|Treatment Experienced|treatment experienced
5587491|NCT00941083|HIV-1 Infections|hiv-1 infections
5587492|NCT00941044|non-invasive ventilation|non-invasive ventilation
5587493|NCT00941044|diaphragm|diaphragm
5587494|NCT00941044|electrical activity|electrical activity
5587495|NCT00941044|neurally adjusted ventilatory assist|neurally adjusted ventilatory assist
5587496|NCT00941044|volunteers|volunteers
5587497|NCT00941031|Moderate to severe chronic plaque-type psoriasis|moderate to severe chronic plaque-type psoriasis
5587498|NCT00941031|AIN457|ain457
5587499|NCT00941031|dermatology|dermatology
5587500|NCT00941018|Resolvins|resolvins
5587501|NCT00941018|RvE1|rve1
5587502|NCT00941018|Healthy volunteers|healthy volunteers
5587503|NCT00940979|Integuseal microbial sealant|integuseal microbial sealant
5587504|NCT00940979|Infection prophylaxis|infection prophylaxis
5587505|NCT00940979|Postoperative wound infection|postoperative wound infection
5587506|NCT00940979|Arterial bypass surgery|arterial bypass surgery
5587507|NCT00940966|ADA diet|ada diet
5587508|NCT00940966|low carbohydrate diet|low carbohydrate diet
5587509|NCT00940966|Metabolic syndrome|metabolic syndrome
5587510|NCT00940927|Albuterol|albuterol
5587511|NCT00940927|Forced expiratory volume in one second|forced expiratory volume in one second
5587512|NCT00940927|Dose at fifty percent of maximum effect|dose at fifty percent of maximum effect
5587513|NCT00940927|Maximum effective dose|maximum effective dose
5587514|NCT00940927|Metered dose inhaler|metered dose inhaler
5587515|NCT00940927|Nebulizer|nebulizer
5587516|NCT00940914|Parkinson's disease|parkinson's disease
5587517|NCT00940914|pain|pain
5587518|NCT00940914|dopamine transporters imaging|dopamine transporters imaging
5587519|NCT00940901|priapism|priapism
5587520|NCT00940901|sickle cell disease|sickle cell disease
5587521|NCT00940901|sildenafil|sildenafil
5587522|NCT00940901|phosphodiesterase type 5 inhibitor|phosphodiesterase type 5 inhibitor
5587524|NCT00940888|CRTD|crtd
5587525|NCT00940888|Heart Failure|heart failure
5587526|NCT00940888|DF4|df4
5587527|NCT00940862|psoriasis|psoriasis
5587528|NCT00940862|vascular inflammation|vascular inflammation
5587529|NCT00940862|coronary atherosclerosis|coronary atherosclerosis
5587530|NCT00940836|Anti-cold|anti-cold
5587531|NCT00940836|Cold preparation|cold preparation
5587532|NCT00940836|RCT|rct
5587533|NCT00940823|Glaucoma Drainage Device|glaucoma drainage device
5587534|NCT00940823|Aqueous Shunt Implant|aqueous shunt implant
5587535|NCT00940823|Ahmed Valve|ahmed valve
5587536|NCT00940823|Baerveldt Tube|baerveldt tube
5587537|NCT00940823|Refractory Glaucoma|refractory glaucoma
5587538|NCT00940797|diabetes|diabetes
5587539|NCT00940797|Type 2|type 2
5587540|NCT00940797|monotherapy|monotherapy
5587541|NCT00940797|antidiabetics|antidiabetics
5587542|NCT00940797|metformin|metformin
5587543|NCT00940771|HIV|hiv
5587544|NCT00940771|Lipids|lipids
5587545|NCT00940771|Atazanavir|atazanavir
5587546|NCT00940771|Pediatric|pediatric
5587547|NCT00940771|treatment experienced|treatment experienced
5587548|NCT00940745|HICH|hich
5587549|NCT00940745|Suction drainages|suction drainages
5587550|NCT00940745|TTAC|ttac
5587551|NCT00940732|Help-seeking|help-seeking
5587552|NCT00940732|Mental Health|mental health
5587553|NCT00940732|Athletes|athletes
5587554|NCT00940719|Multiple Sclerosis|multiple sclerosis
5587555|NCT00940719|Regulatory T cell function|regulatory t cell function
5587556|NCT00940719|Vitamin D|vitamin d
5587557|NCT00940719|Vitamin D3|vitamin d3
5587558|NCT00940719|25-hydroxyvitamin D|25-hydroxyvitamin d
5587559|NCT00940706|Cerebral Palsy|cerebral palsy
5587560|NCT00940706|Activity monitoring|activity monitoring
5587561|NCT00940706|Treadmill|treadmill
5587562|NCT00940706|Group training|group training
5587563|NCT00940706|Physical active life style|physical active life style
5587564|NCT00940693|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5587566|NCT00940693|Adult|adult
5587567|NCT00940693|ADDH|addh
5587568|NCT00940693|ADHD|adhd
5587569|NCT00940680|Amlodipine|amlodipine
5587570|NCT00940680|Losartan|losartan
5587571|NCT00940680|hypertension|hypertension
5587572|NCT00940667|Amlodipine|amlodipine
5587573|NCT00940667|Losartan|losartan
5587574|NCT00940667|hypertension|hypertension
5587575|NCT00940654|Fever|fever
5587576|NCT00940654|Antipyretic|antipyretic
5587577|NCT00940654|Infection|infection
5587578|NCT00940654|Mortality|mortality
5587579|NCT00940654|Cooling|cooling
5587580|NCT00940654|Non steroid anti inflammatory drugs|non steroid anti inflammatory drugs
5587581|NCT00940654|Acetaminophen|acetaminophen
5587582|NCT00940654|Steroid|steroid
5587583|NCT00940654|ICU|icu
5587584|NCT00940654|Intensive care|intensive care
5587585|NCT00940654|Critically ill|critically ill
5587586|NCT00940641|Healthy Volunteer|healthy volunteer
5587587|NCT00940615|traumatic brain injury|traumatic brain injury
5587588|NCT00940615|aerobic exercise|aerobic exercise
5587589|NCT00940615|Diffusion Tensor Imaging|diffusion tensor imaging
5587590|NCT00940615|Neuropsychology|neuropsychology
5587591|NCT00940615|Rehabilitation|rehabilitation
5587592|NCT00940602|TELESTO|telesto
5587593|NCT00940602|MDS Study|mds study
5587594|NCT00940602|Myelodysplastic Syndromes|myelodysplastic syndromes
5587595|NCT00940602|Myelodysplastic Syndromes (low-int-1 risk)|myelodysplastic syndromes (low-int-1 risk)
5587596|NCT00940589|Alzheimer's Disease|alzheimer's disease
5587597|NCT00940589|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5587598|NCT00940589|cognitive function|cognitive function
5587599|NCT00940589|Circadin|circadin
5587600|NCT00940589|Sleep disturbances|sleep disturbances
5587601|NCT00940576|mare's milk, Crohn's disease, ulcerative colitis, clinical|mare's milk, crohn's disease, ulcerative colitis, clinical
5587602|NCT00940563|GIST|gist
5587603|NCT00940563|imatinib|imatinib
5587604|NCT00940563|advanced GIST|advanced gist
5587605|NCT00940537|Obese|obese
5587607|NCT00940537|hepatic triglyceride content|hepatic triglyceride content
5587608|NCT00940537|MR spectroscopy|mr spectroscopy
5587609|NCT00940524|Leukemia|leukemia
5587614|NCT00940524|CYTARABINE (ARA-C)|cytarabine (ara-c)
5680345|NCT00578162|Survivors|survivors
5587617|NCT00940524|DEXAMETHASONE|dexamethasone
5587618|NCT00940524|DOXORUBICIN/ADRIAMYCIN|doxorubicin/adriamycin
5587619|NCT00940524|ETOPOSIDE (VP-16)|etoposide (vp-16)
5587620|NCT00940524|MERCAPTOPURINE|mercaptopurine
5587621|NCT00940524|METHOTREXATE|methotrexate
5587622|NCT00940524|MITOXANTRONE|mitoxantrone
5587623|NCT00940524|PEGASPERGASE|pegaspergase
5587624|NCT00940524|VINCRISTINE|vincristine
5587625|NCT00940511|All conditions faced by disabled Medicaid recipients|all conditions faced by disabled medicaid recipients
5587626|NCT00940498|Phase 1|phase 1
5587627|NCT00940498|Dose Finding|dose finding
5587628|NCT00940498|Solid Tumors|solid tumors
5587629|NCT00940498|Tumors|tumors
5587630|NCT00940498|PF-05212384|pf-05212384
5587631|NCT00940472|type 2 diabetes|type 2 diabetes
5587632|NCT00940472|monotherapy|monotherapy
5587633|NCT00940472|antidiabetics|antidiabetics
5587634|NCT00940472|metformin|metformin
5587635|NCT00940459|contact lenses|contact lenses
5587636|NCT00940459|conjunctival staining|conjunctival staining
5587637|NCT00940459|contact lens wear|contact lens wear
5587638|NCT00940446|Insorb staples|insorb staples
5587639|NCT00940446|Metal Staples|metal staples
5587640|NCT00940433|Minimally invasive|minimally invasive
5587641|NCT00940433|Inguinal hernia|inguinal hernia
5587642|NCT00940433|Pro-peritoneal repair|pro-peritoneal repair
5587643|NCT00940407|dry AMD|dry amd
5587644|NCT00940407|light treatment|light treatment
5587645|NCT00940407|ARMD|armd
5587646|NCT00940407|photobiomodulation|photobiomodulation
5587647|NCT00940407|macular|macular
5587648|NCT00940407|eye disease|eye disease
5587649|NCT00940407|ageing eye disease|ageing eye disease
5587650|NCT00940394|mutual support group|mutual support group
5587651|NCT00940394|psychoeducation group|psychoeducation group
5587652|NCT00940394|family caregivers|family caregivers
5587653|NCT00940394|schizophrenia|schizophrenia
5587654|NCT00940381|Advanced Malignancies|advanced malignancies
5587655|NCT00940381|Sirolimus|sirolimus
5587656|NCT00940381|Rapamune|rapamune
5587657|NCT00940381|Cetuximab|cetuximab
5587658|NCT00940381|C225|c225
5587659|NCT00940381|Erbitux|erbitux
5587660|NCT00940381|IMC-225|imc-225
5587661|NCT00940368|Nausea|nausea
5587662|NCT00940368|Vomiting|vomiting
5587663|NCT00940368|Chemotherapy|chemotherapy
5587664|NCT00940355|COPD|copd
5587665|NCT00940355|Health Status|health status
5587666|NCT00940355|Intervention|intervention
5587667|NCT00940355|Secondary prevention|secondary prevention
5587668|NCT00940355|patient-tailored treatment|patient-tailored treatment
5587669|NCT00940342|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5587670|NCT00940342|Rituximab|rituximab
5587671|NCT00940342|Leukemia|leukemia
5587672|NCT00940342|Sargramostim|sargramostim
5587673|NCT00940342|GM-CSF|gm-csf
5587674|NCT00940329|Drug interactions|drug interactions
5587675|NCT00940329|Pharmacodynamic interactions|pharmacodynamic interactions
5685419|NCT00556127|ASCT|asct
5587676|NCT00940329|Pharmacokinetic interactions|pharmacokinetic interactions
5587677|NCT00940329|Formoterol|formoterol
5587678|NCT00940329|Healthy subjects|healthy subjects
5587679|NCT00940329|Phase I study|phase i study
5587680|NCT00940329|Roflumilast|roflumilast
5587681|NCT00940316|recurrent colon cancer|recurrent colon cancer
5587682|NCT00940316|stage IV colon cancer|stage iv colon cancer
5587683|NCT00940316|recurrent rectal cancer|recurrent rectal cancer
5587684|NCT00940316|stage IV rectal cancer|stage iv rectal cancer
5587685|NCT00940290|practice guideline as topic|practice guideline as topic
5587686|NCT00940290|decision making|decision making
5587687|NCT00940290|evidence based medicine|evidence based medicine
5587688|NCT00940277|women couples counseling groups support intervention marriage|women couples counseling groups support intervention marriage
5587689|NCT00940264|symptomatic cholecystolithiasis|symptomatic cholecystolithiasis
5587690|NCT00940251|Ayurvedic formulation|ayurvedic formulation
5587691|NCT00940251|type 2 diabetes mellitus|type 2 diabetes mellitus
5587692|NCT00940251|secondary failure to oral hypoglycemic agents|secondary failure to oral hypoglycemic agents
5587693|NCT00940251|antidiabetic|antidiabetic
5587694|NCT00940225|Breast Cancer|breast cancer
5587695|NCT00940225|Melanoma|melanoma
5587696|NCT00940225|Stomach or Gastroesophageal Junction Carcinoma|stomach or gastroesophageal junction carcinoma
5587697|NCT00940225|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5587698|NCT00940225|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5587699|NCT00940225|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5587700|NCT00940225|Ovarian Cancer|ovarian cancer
5587701|NCT00940225|Pancreatic Cancer|pancreatic cancer
5587702|NCT00940225|Prostate Cancer|prostate cancer
5590266|NCT00929617|exercise|exercise
5587704|NCT00940212|tolerability|tolerability
5587705|NCT00940212|healthy|healthy
5587706|NCT00940212|pharmacokinetics|pharmacokinetics
5587707|NCT00940199|Breast cancer, sentinel lymph node mapping, biopsy|breast cancer, sentinel lymph node mapping, biopsy
5587708|NCT00940173|xenotransplantation|xenotransplantation
5587709|NCT00940173|type I diabetes|type i diabetes
5587710|NCT00940173|porcine islets|porcine islets
5587712|NCT00940134|obesity|obesity
5587713|NCT00940134|energy expenditure|energy expenditure
5587714|NCT00940134|incretins|incretins
5587715|NCT00940134|appetite regulation|appetite regulation
5587716|NCT00940134|GLP-1|glp-1
5587717|NCT00940134|PYY|pyy
5587718|NCT00940134|ad libitum energy intake|ad libitum energy intake
5587719|NCT00940121|oral administration|oral administration
5587720|NCT00940121|YM178|ym178
5587721|NCT00940121|IV infusion|iv infusion
5587722|NCT00940121|pharmacokinetics|pharmacokinetics
5587723|NCT00940121|mirabegron|mirabegron
5587724|NCT00940121|Healthy volunteer subjects|healthy volunteer subjects
5587725|NCT00940095|Subarachnoid|subarachnoid
5587726|NCT00940095|Aneurysmal|aneurysmal
5587727|NCT00940095|surgical clipping|surgical clipping
5587728|NCT00940095|PIVLAZ|pivlaz
5587729|NCT00940095|vasospasm|vasospasm
5587730|NCT00940095|cerebral vasospasm|cerebral vasospasm
5587731|NCT00940095|clazosentan|clazosentan
5587732|NCT00940095|Actelion|actelion
5587733|NCT00940095|Hemorrhage|hemorrhage
5587734|NCT00940082|Diabetes;|diabetes;
5587735|NCT00940082|Echocardiography;|echocardiography;
5587736|NCT00940082|High-sensitive C-reactive protein;|high-sensitive c-reactive protein;
5587737|NCT00940082|homocysteine;|homocysteine;
5587744|NCT00940056|Atrial fibrillation|atrial fibrillation
5587745|NCT00940056|Ablation|ablation
5587746|NCT00940056|Thoracoscopy|thoracoscopy
5587747|NCT00940056|Atrial function|atrial function
5587748|NCT00940043|bedside test|bedside test
5587749|NCT00940043|interleukins|interleukins
5587750|NCT00940043|inflammation|inflammation
5587751|NCT00940043|vaginal secretions|vaginal secretions
5587752|NCT00940030|Mechanical Bowel Preparation (MBP)|mechanical bowel preparation (mbp)
5587753|NCT00940030|enema|enema
5587754|NCT00940017|PK|pk
5587755|NCT00940017|fungal infection|fungal infection
5587756|NCT00940004|dendritic cell vaccination|dendritic cell vaccination
5587757|NCT00940004|melanoma|melanoma
5587758|NCT00940004|toll like receptor ligands|toll like receptor ligands
5587759|NCT00940004|vaccines|vaccines
5587760|NCT00939991|GBM|gbm
5587761|NCT00939965|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5587762|NCT00939965|recurrent neuroblastoma|recurrent neuroblastoma
5587763|NCT00939965|stage 4S neuroblastoma|stage 4s neuroblastoma
5587764|NCT00939952|ertapenem|ertapenem
5587765|NCT00939952|CAPD|capd
5587766|NCT00939952|dialysis|dialysis
5587767|NCT00939913|contrast nephropathy|contrast nephropathy
5587768|NCT00939913|intravenous n-acetlycysteine|intravenous n-acetlycysteine
5587769|NCT00939900|avascular necrosis of femoral head|avascular necrosis of femoral head
5587771|NCT00939900|collapse|collapse
5587772|NCT00939874|HIV+|hiv+
5587773|NCT00939874|Raltegravir|raltegravir
5587774|NCT00939874|Tenofovir|tenofovir
5587775|NCT00939874|osteopenia|osteopenia
5587776|NCT00939874|osteoporosis|osteoporosis
5587777|NCT00939874|bone markers|bone markers
5587778|NCT00939874|treatment experienced|treatment experienced
5587779|NCT00939861|colorectal endometriosis, laparoscopy, laparotomy|colorectal endometriosis, laparoscopy, laparotomy
5587780|NCT00939861|gynecologic and digestive symptoms|gynecologic and digestive symptoms
5587781|NCT00939861|quality of life (SF-36 questionnaire)|quality of life (sf-36 questionnaire)
5587782|NCT00939861|morbidity|morbidity
5587783|NCT00939861|fertility|fertility
5587784|NCT00939848|Disease-Free Survival|disease-free survival
5587785|NCT00939757|Healthy volunteer subjects|healthy volunteer subjects
5587786|NCT00939757|pharmacokinetics|pharmacokinetics
5587788|NCT00939757|mirabegron|mirabegron
5587789|NCT00939757|food|food
5587790|NCT00939744|contractile activity|contractile activity
5587791|NCT00939744|eicosanoids|eicosanoids
5587792|NCT00939744|pregnant women|pregnant women
5587793|NCT00939744|obstetrics complications|obstetrics complications
5587794|NCT00939731|bioavailability, capsule, tablet, healthy volunteer|bioavailability, capsule, tablet, healthy volunteer
5587795|NCT00939718|depression;vitamin B12;randomized control trial|depression;vitamin b12;randomized control trial
5587796|NCT00939679|obesity|obesity
5587797|NCT00939679|bariatric surgery|bariatric surgery
5587798|NCT00939679|energy expenditure|energy expenditure
5587799|NCT00939679|incretins|incretins
5587800|NCT00939679|appetite regulation|appetite regulation
5587801|NCT00939679|body composition|body composition
5587802|NCT00939679|GLP-1|glp-1
5587803|NCT00939666|Rectal cancer|rectal cancer
5587804|NCT00939666|Chemoradiation|chemoradiation
5587805|NCT00939666|Response|response
5587806|NCT00939666|Wait-and-see policy|wait-and-see policy
5587807|NCT00939666|Transanal endoscopic microsurgery|transanal endoscopic microsurgery
5587814|NCT00939640|Diet|diet
5587815|NCT00939640|Sodium|sodium
5587816|NCT00939640|Hypertension|hypertension
5587817|NCT00939640|Potassium|potassium
5587819|NCT00939640|congestive heart failure|congestive heart failure
5587820|NCT00939640|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5587821|NCT00939640|Heart failure with preserved systolic function|heart failure with preserved systolic function
5587822|NCT00939601|Obstructive Sleep Apnea|obstructive sleep apnea
5587825|NCT00939601|CPAP|cpap
5587826|NCT00939601|Cognition|cognition
5587827|NCT00939588|Aliskiren,|aliskiren,
5587828|NCT00939588|hypertension,|hypertension,
5587829|NCT00939588|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5587830|NCT00939575|preeclampsia, metabolomics, blood, urine|preeclampsia, metabolomics, blood, urine
5587831|NCT00939562|Bioequivalence|bioequivalence
5587832|NCT00939549|High dose cyclophosphamide|high dose cyclophosphamide
5587833|NCT00939523|recurrent nonfunctioning adenoma|recurrent nonfunctioning adenoma
5587834|NCT00939523|prolactinomas|prolactinomas
5587835|NCT00939523|resistant pituitary tumors|resistant pituitary tumors
5587930|NCT00939094|Neuropathic|neuropathic
5587836|NCT00939523|aggressive pituitary tumors|aggressive pituitary tumors
5587837|NCT00939523|malignant pituitary adenomas|malignant pituitary adenomas
5587838|NCT00939510|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5587839|NCT00939510|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5587840|NCT00939510|recurrent prostate cancer|recurrent prostate cancer
5587841|NCT00939510|stage IV prostate cancer|stage iv prostate cancer
5587842|NCT00939432|incontinence|incontinence
5587843|NCT00939432|urinary|urinary
5587844|NCT00939432|taboo|taboo
5587845|NCT00939432|shame|shame
5587846|NCT00939432|embarrassment|embarrassment
5587847|NCT00939432|treatment|treatment
5587848|NCT00939432|depression|depression
5587849|NCT00939432|cancer|cancer
5587850|NCT00939419|Tuberculosis care|tuberculosis care
5587851|NCT00939419|community tuberculosis care|community tuberculosis care
5587852|NCT00939419|Health facility based tuberculosis care|health facility based tuberculosis care
5587853|NCT00939380|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5587854|NCT00939380|bone marrow transplant|bone marrow transplant
5587855|NCT00939380|children|children
5587856|NCT00939380|parents|parents
5587857|NCT00939380|counseling|counseling
5587858|NCT00939380|depression|depression
5587859|NCT00939354|Asthma in subjects over the age of 65|asthma in subjects over the age of 65
5587860|NCT00939341|Symbicort SMART|symbicort smart
5587861|NCT00939328|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5587862|NCT00939328|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5587863|NCT00939315|Glioma, diagnosis|glioma, diagnosis
5587864|NCT00939315|Imaging|imaging
5587865|NCT00939315|Positron emission tomography|positron emission tomography
5587866|NCT00939315|Magnetic resonance imaging|magnetic resonance imaging
5587867|NCT00939315|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5587868|NCT00939289|Continuous glucose monitoring|continuous glucose monitoring
5587869|NCT00939276|cataract surgery|cataract surgery
5587870|NCT00939276|macular edema|macular edema
5587871|NCT00939276|prevention|prevention
5587872|NCT00939263|deglutition disorders|deglutition disorders
5587873|NCT00939263|esophageal diseases|esophageal diseases
5587874|NCT00939263|eosinophilia|eosinophilia
5587875|NCT00939250|Diabetes|diabetes
5587876|NCT00939250|Depression|depression
5587877|NCT00939250|Disease Self Management|disease self management
5587878|NCT00939250|Measurement Based Care|measurement based care
5587879|NCT00939237|Coronary heart disease|coronary heart disease
5587880|NCT00939237|Carotid intima-media thickness|carotid intima-media thickness
5587881|NCT00939237|Biomarkers|biomarkers
5587882|NCT00939224|Near-infrared spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5587883|NCT00939224|Regional oxygen saturation|regional oxygen saturation
5587884|NCT00939224|Pediatrics|pediatrics
5587885|NCT00939224|Cardiac catheterization|cardiac catheterization
5587886|NCT00939224|Congenital heart disease|congenital heart disease
5587887|NCT00939211|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5587888|NCT00939211|efficacy|efficacy
5587889|NCT00939211|safety|safety
5587890|NCT00939211|inhalation|inhalation
5587891|NCT00939211|long-acting muscarinic receptor antagonist (LAMA)|long-acting muscarinic receptor antagonist (lama)
5587892|NCT00939198|Hookworm|hookworm
5587893|NCT00939198|Allergy|allergy
5587894|NCT00939198|Vaccine|vaccine
5587895|NCT00939198|Skin Test|skin test
5587896|NCT00939198|Immediate-type hypersensitivity to Na-ASP-2 hookworm antigen|immediate-type hypersensitivity to na-asp-2 hookworm antigen
5587897|NCT00939185|Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections|compliance and safety study in children with upper and lower respiratory tract infections
5587898|NCT00939172|Advanced Refractory Solid Malignancies|advanced refractory solid malignancies
5587899|NCT00939172|Solid tumor|solid tumor
5587900|NCT00939172|Lymphoma|lymphoma
5587901|NCT00939172|TTP607|ttp607
5587902|NCT00939159|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
5587903|NCT00939159|MDS|mds
5587904|NCT00939159|Cancer|cancer
5587905|NCT00939159|LBH589|lbh589
5587906|NCT00939146|self management|self management
5587907|NCT00939146|quality of life|quality of life
5587908|NCT00939146|end of life|end of life
5587909|NCT00939133|acne|acne
5587910|NCT00939133|tretinoin|tretinoin
5587911|NCT00939133|isotretinoin|isotretinoin
5587912|NCT00939133|recurrence|recurrence
5587913|NCT00939133|Retin A micro|retin a micro
5582247|NCT00959842|Lovaza|lovaza
5587914|NCT00939120|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5587916|NCT00939120|tolterodine ER|tolterodine er
5587917|NCT00939107|low back pain|low back pain
5587918|NCT00939107|Intervertebral disc|intervertebral disc
5587919|NCT00939107|McKenzie|mckenzie
5587920|NCT00939107|Physical Therapy|physical therapy
5587921|NCT00939107|Spinal manipulation|spinal manipulation
5587922|NCT00939107|Chiropractics|chiropractics
5587923|NCT00939107|Patient education|patient education
5587924|NCT00939107|Exercise therapy|exercise therapy
5587925|NCT00939107|Random allocation|random allocation
5587926|NCT00939094|Pain, Mechanical Hypersensitivity|pain, mechanical hypersensitivity
5587927|NCT00939094|Allodynia|allodynia
5587928|NCT00939094|Efficacy|efficacy
5587929|NCT00939094|analgesia|analgesia
5587931|NCT00939081|Obesity|obesity
5587932|NCT00939081|Women's health|women's health
5587933|NCT00939081|Minority health|minority health
5587934|NCT00939081|Obesity prevention|obesity prevention
5587935|NCT00939068|Chronic hepatitis B, Telbivudine, Intrauterine transmission|chronic hepatitis b, telbivudine, intrauterine transmission
5587936|NCT00939029|tobacco use|tobacco use
5587937|NCT00939029|smokeless tobacco|smokeless tobacco
5587938|NCT00939029|chewing tobacco|chewing tobacco
5587939|NCT00939029|snuff|snuff
5587940|NCT00939029|nicotine replacement|nicotine replacement
5587941|NCT00939029|tobacco dependence|tobacco dependence
5587942|NCT00939029|tobacco cessation|tobacco cessation
5587943|NCT00939029|tobacco abstinence|tobacco abstinence
5587944|NCT00939016|Dietary Assessment|dietary assessment
5587945|NCT00939016|24-hour dietary recall|24-hour dietary recall
5587946|NCT00939016|Dietary Restraint|dietary restraint
5587947|NCT00939016|Social Desirability|social desirability
5587948|NCT00939016|Portion estimation|portion estimation
5587949|NCT00939016|Underreporting|underreporting
5587950|NCT00938977|Obesity Hypoventilation syndrome|obesity hypoventilation syndrome
5587951|NCT00938977|cytokines|cytokines
5587952|NCT00938977|Adipokines|adipokines
5587953|NCT00938977|continuous positive airway pressure|continuous positive airway pressure
5587954|NCT00938977|bilevel support ventilation|bilevel support ventilation
5587955|NCT00938977|Response to continuous positive airway pressure|response to continuous positive airway pressure
5587956|NCT00938964|Cognition|cognition
5587957|NCT00938951|Dry Eye|dry eye
5587958|NCT00938951|Visual Performance|visual performance
5587959|NCT00938938|risk communication|risk communication
5587961|NCT00938938|Mass media|mass media
5587962|NCT00938925|aggressive debridement|aggressive debridement
5587963|NCT00938925|nail lacquer|nail lacquer
5587964|NCT00938925|onychomycosis|onychomycosis
5587965|NCT00938925|podiatry|podiatry
5587966|NCT00938925|chiropody|chiropody
5587967|NCT00938925|podiatry care|podiatry care
5587968|NCT00938912|Lacosamide (VIMPAT)|lacosamide (vimpat)
5587969|NCT00938899|TMC435350-TiDP16-C101|tmc435350-tidp16-c101
5587970|NCT00938899|TMC435350-C101|tmc435350-c101
5587971|NCT00938899|TMC435350|tmc435350
5587972|NCT00938899|HCV|hcv
5587973|NCT00938873|MBCT|mbct
5587974|NCT00938873|identity|identity
5587975|NCT00938873|depression|depression
5587976|NCT00938873|recurrent|recurrent
5587977|NCT00938873|homework|homework
5587978|NCT00938860|Hepatitis C|hepatitis c
5587979|NCT00938860|liver transplantation|liver transplantation
5587980|NCT00938860|anti-viral therapy|anti-viral therapy
5587981|NCT00938847|left ventricular dysfunction|left ventricular dysfunction
5587982|NCT00938847|myocardial infarction|myocardial infarction
5587983|NCT00938847|left ventricular dysfunction (LVDF) after acute myocardial infarction|left ventricular dysfunction (lvdf) after acute myocardial infarction
5587984|NCT00938808|Osteoarthritis|osteoarthritis
5587985|NCT00938808|Obesity|obesity
5587986|NCT00938808|Weight loss|weight loss
5587987|NCT00938808|Dietary instruction|dietary instruction
5587988|NCT00938808|Formula diet|formula diet
5587989|NCT00938808|Attention|attention
5587990|NCT00938795|liver disease|liver disease
5587991|NCT00938795|uncertainty|uncertainty
5587992|NCT00938795|self management|self management
5587993|NCT00938769|cancer|cancer
5587994|NCT00938769|caregiver|caregiver
5587995|NCT00938769|symptom|symptom
5587996|NCT00938769|self management|self management
5587997|NCT00938756|leptomeningeal metastases|leptomeningeal metastases
5587998|NCT00938756|male breast cancer|male breast cancer
5587999|NCT00938756|stage IV breast cancer|stage iv breast cancer
5588000|NCT00938756|tumors metastatic to brain|tumors metastatic to brain
5588001|NCT00938756|adult meningioma|adult meningioma
5588002|NCT00938743|ADHD|adhd
5588003|NCT00938743|adults|adults
5588004|NCT00938743|driving performance|driving performance
5588005|NCT00938743|atomoxetine|atomoxetine
5588006|NCT00938730|Nonvalvular Atrial Fibrillation (NVAF)|nonvalvular atrial fibrillation (nvaf)
5588007|NCT00938730|Factor Xa Inhibitor|factor xa inhibitor
5588008|NCT00938730|Stroke|stroke
5588009|NCT00938730|Thromboembolism|thromboembolism
5588010|NCT00938730|Transient Ischemic attack|transient ischemic attack
5588011|NCT00938730|Anticoagulants|anticoagulants
5588012|NCT00938730|Prevention|prevention
5588013|NCT00938730|YM150|ym150
5747048|NCT00331318|HV|hv
5573239|NCT00994019|HPV|hpv
5588014|NCT00938730|Warfarin|warfarin
5588015|NCT00938717|IBS|ibs
5588016|NCT00938691|Scar|scar
5588017|NCT00938691|Appearance|appearance
5588018|NCT00938691|Spread|spread
5588019|NCT00938678|Healthy volunteers|healthy volunteers
5588020|NCT00938665|Alzheimer|alzheimer
5588021|NCT00938665|Memory disorder|memory disorder
5588022|NCT00938665|dementia|dementia
5588023|NCT00938665|cognitive behavioral decline|cognitive behavioral decline
5588024|NCT00938665|vascular dementia|vascular dementia
5588025|NCT00938665|front temporal dementia|front temporal dementia
5588026|NCT00938652|triple negative breast cancer|triple negative breast cancer
5588027|NCT00938652|metastatic breast cancer|metastatic breast cancer
5588028|NCT00938652|Triple negative metastatic breast cancer|triple negative metastatic breast cancer
5588029|NCT00938626|refractory multiple myeloma|refractory multiple myeloma
5588030|NCT00938626|stage I multiple myeloma|stage i multiple myeloma
5588031|NCT00938626|stage II multiple myeloma|stage ii multiple myeloma
5588032|NCT00938626|stage III multiple myeloma|stage iii multiple myeloma
5588033|NCT00938613|SAR|sar
5588034|NCT00938600|pharmacokinetics|pharmacokinetics
5588035|NCT00938600|safety|safety
5588036|NCT00938587|Rheumatoid Arthritis Glucocorticoids Prednisone|rheumatoid arthritis glucocorticoids prednisone
5588037|NCT00938561|Chronic Kidney Disease|chronic kidney disease
5588038|NCT00938561|Glomerular Filtration Rate|glomerular filtration rate
5588039|NCT00938561|Kidney function|kidney function
5588040|NCT00938561|Markers|markers
5588041|NCT00938548|mastectomy|mastectomy
5588042|NCT00938548|pain, postoperative|pain, postoperative
5588043|NCT00938548|pregabalin|pregabalin
5588044|NCT00938535|Obesity|obesity
5588045|NCT00938535|Women's health|women's health
5588046|NCT00938535|Minority health|minority health
5588047|NCT00938535|Obesity prevention|obesity prevention
5588048|NCT00938522|Cilostazol loading|cilostazol loading
5588049|NCT00938522|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5588050|NCT00938509|IBUPROFEN|ibuprofen
5588051|NCT00938509|CHILDREN|children
5588052|NCT00938509|FEVER|fever
5588053|NCT00938483|infant formula|infant formula
5588054|NCT00938483|cow's milk allergy|cow's milk allergy
5588055|NCT00938470|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5588056|NCT00938470|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5588057|NCT00938470|stage IIIA gastric cancer|stage iiia gastric cancer
5588058|NCT00938470|stage IIIB gastric cancer|stage iiib gastric cancer
5588059|NCT00938470|stage IIIC gastric cancer|stage iiic gastric cancer
5588060|NCT00938470|stage IIIA esophageal cancer|stage iiia esophageal cancer
5588061|NCT00938470|stage IIIB esophageal cancer|stage iiib esophageal cancer
5588062|NCT00938470|stage IIIC esophageal cancer|stage iiic esophageal cancer
5588063|NCT00938457|protocol specific|protocol specific
5588064|NCT00938444|Patients with moderate to severe RA|patients with moderate to severe ra
5588065|NCT00938431|Lacosamide|lacosamide
5588066|NCT00938431|Vimpat|vimpat
5588067|NCT00938431|Children|children
5588068|NCT00938431|Epilepsy|epilepsy
5588069|NCT00938431|Seizures|seizures
5588070|NCT00938431|Anti-epileptic|anti-epileptic
5588071|NCT00938405|type 1 diabetes mellitus|type 1 diabetes mellitus
5588072|NCT00938405|colesevelam|colesevelam
5588073|NCT00938405|LDL|ldl
5588074|NCT00938405|cholesterol|cholesterol
5588075|NCT00938405|A1c|a1c
5588076|NCT00938405|target range glucose values|target range glucose values
5588077|NCT00938392|influenza infection|influenza infection
5588078|NCT00938392|GSK Bio's influenza vaccine GSK2186877A|gsk bio's influenza vaccine gsk2186877a
5588079|NCT00938379|mosquito|mosquito
5588080|NCT00938379|repellent|repellent
5588081|NCT00938379|vector control|vector control
5588082|NCT00938379|malaria|malaria
5588083|NCT00938353|Moderate croup (Westley score 3-8)|moderate croup (westley score 3-8)
5588084|NCT00938340|Cardiovascular Disease|cardiovascular disease
5588085|NCT00938327|Gastroenteritis|gastroenteritis
5588086|NCT00938301|healthy volunteer, first in human, safety and tolerability|healthy volunteer, first in human, safety and tolerability
5588087|NCT00938288|Antithrombin|antithrombin
5588088|NCT00938288|Thrombosis|thrombosis
5588089|NCT00938288|Pharmacokinetics|pharmacokinetics
5588090|NCT00938288|Hereditary Antithrombin Deficiency|hereditary antithrombin deficiency
5588091|NCT00938288|Congenital Antithrombin Deficiency|congenital antithrombin deficiency
5588092|NCT00938249|Moderately Elevated Serum Triglyceride|moderately elevated serum triglyceride
5588093|NCT00938236|lung transplant|lung transplant
5588094|NCT00938236|lung transplant recipient|lung transplant recipient
5588095|NCT00938236|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5588096|NCT00938236|bronchiolitis obliterans|bronchiolitis obliterans
5588097|NCT00938236|single lung transplant|single lung transplant
5588098|NCT00938236|double lung transplant|double lung transplant
5588099|NCT00938236|heart-lung transplant|heart-lung transplant
5588100|NCT00938236|Aerosol|aerosol
5588101|NCT00938223|melanoma|melanoma
5588102|NCT00938223|peptide|peptide
5588103|NCT00938223|vaccine|vaccine
5588104|NCT00938223|adjuvant|adjuvant
5588105|NCT00938223|advanced|advanced
5588106|NCT00938210|Colonic surgery|colonic surgery
5588107|NCT00938210|Postoperative care|postoperative care
5588108|NCT00938210|Fatigue|fatigue
5588109|NCT00938210|Physical function|physical function
5588110|NCT00938210|Quality of life|quality of life
5588112|NCT00938197|Drug interaction|drug interaction
5588113|NCT00938184|tolerance|tolerance
5588114|NCT00938184|single dose|single dose
5588115|NCT00938184|paroxetine|paroxetine
5588116|NCT00938184|controlled-release tablet|controlled-release tablet
5588117|NCT00938184|safety|safety
5588118|NCT00938184|pharmacokinetics|pharmacokinetics
5588119|NCT00938184|Japanese healthy male subjects|japanese healthy male subjects
5588120|NCT00938171|Cytokine|cytokine
5588121|NCT00938171|Anesthesia|anesthesia
5588122|NCT00938171|Local anesthesia|local anesthesia
5588123|NCT00938171|surgery|surgery
5588124|NCT00938171|breast cancer|breast cancer
5588125|NCT00938158|albiglutide|albiglutide
5588126|NCT00938158|hemodialysis|hemodialysis
5588127|NCT00938158|pharmacokinetics|pharmacokinetics
5588128|NCT00938158|renal|renal
5588129|NCT00938145|recurrent bladder cancer|recurrent bladder cancer
5588130|NCT00938145|stage II bladder cancer|stage ii bladder cancer
5588131|NCT00938145|stage III bladder cancer|stage iii bladder cancer
5588132|NCT00938145|stage IV bladder cancer|stage iv bladder cancer
5588133|NCT00938132|fimasartan|fimasartan
5588134|NCT00938132|drug interaction|drug interaction
5588135|NCT00938119|Cardiovascular disease|cardiovascular disease
5588136|NCT00938119|Diabetes|diabetes
5588137|NCT00938106|Intra-uterine Brachytherapy|intra-uterine brachytherapy
5588138|NCT00938106|cervix cancer|cervix cancer
5588139|NCT00938106|Patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.|patients suitable for intra-uterine brachytherapy for invasive carcinoma of the cervix.
5588140|NCT00938067|Injuries, Trauma|injuries, trauma
5588141|NCT00938054|Outcome|outcome
5588142|NCT00938054|Autism|autism
5588143|NCT00938054|Pervasive Developmental Disorder|pervasive developmental disorder
5588144|NCT00938028|microbiome|microbiome
5588145|NCT00938028|metabolome|metabolome
5588146|NCT00938028|stool|stool
5588147|NCT00938028|fecal samples|fecal samples
5588148|NCT00938028|handling|handling
5588149|NCT00938028|toddler|toddler
5588150|NCT00938015|postmarketing surveillance|postmarketing surveillance
5588151|NCT00938015|Enbrel|enbrel
5588152|NCT00938015|psoriatic arthritis|psoriatic arthritis
5588153|NCT00937989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5588154|NCT00937989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5588155|NCT00937989|male breast cancer|male breast cancer
5588156|NCT00937989|stage I breast cancer|stage i breast cancer
5588157|NCT00937989|stage II breast cancer|stage ii breast cancer
5588158|NCT00937989|stage IIIA breast cancer|stage iiia breast cancer
5588159|NCT00937989|stage IIIB breast cancer|stage iiib breast cancer
5588160|NCT00937989|stage IIIC breast cancer|stage iiic breast cancer
5685420|NCT00556114|eye exam|eye exam
5588161|NCT00937976|Hemodialysis and peritoneal dialysis|hemodialysis and peritoneal dialysis
5588162|NCT00937963|cholesterol|cholesterol
5588163|NCT00937963|cardiovascular|cardiovascular
5588164|NCT00937963|CVD|cvd
5588165|NCT00937963|Triglycerides|triglycerides
5588166|NCT00937963|Heart|heart
5588167|NCT00937950|HPV|hpv
5588168|NCT00937950|Papillomavirus|papillomavirus
5588169|NCT00937950|Human papillomavirus|human papillomavirus
5588170|NCT00937950|Cervical cancer|cervical cancer
5588171|NCT00937950|HPV vaccine|hpv vaccine
5588172|NCT00937924|EUS|eus
5588173|NCT00937924|ERCP|ercp
5588174|NCT00937924|Sedation Level|sedation level
5588175|NCT00937924|Adverse Symptoms|adverse symptoms
5588176|NCT00937924|Recovery time|recovery time
5588177|NCT00937911|YM150|ym150
5588178|NCT00937911|Bleeding|bleeding
5588179|NCT00937911|Anticoagulant|anticoagulant
5588180|NCT00937911|Venous thromboembolism|venous thromboembolism
5588181|NCT00937911|FXa inhibitor|fxa inhibitor
5588182|NCT00937898|lean beef|lean beef
5588183|NCT00937898|cholesterol|cholesterol
5588184|NCT00937898|lipids|lipids
5588185|NCT00937898|diet intervention|diet intervention
5588186|NCT00937885|Reminiscence|reminiscence
5588187|NCT00937885|Nursing home staff|nursing home staff
5588188|NCT00937885|Nursing home residents|nursing home residents
5588189|NCT00937885|Elderly|elderly
5588190|NCT00937846|Cognitive impairment|cognitive impairment
5588191|NCT00937846|Schizophrenia|schizophrenia
5588192|NCT00937846|Alzheimer's Disease|alzheimer's disease
5588193|NCT00937846|PET|pet
5588194|NCT00937833|prostate cancer|prostate cancer
5588195|NCT00937833|prostatectomy|prostatectomy
5588196|NCT00937833|incontinence|incontinence
5588197|NCT00937820|YM150|ym150
5588198|NCT00937820|Bleeding|bleeding
5588199|NCT00937820|VTE|vte
5588200|NCT00937820|FXa inhibitor|fxa inhibitor
5588201|NCT00937820|Venous thromboembolism|venous thromboembolism
5588202|NCT00937807|hemodynamic stability|hemodynamic stability
5588203|NCT00937807|xenon|xenon
5588204|NCT00937807|carotid surgery|carotid surgery
5588205|NCT00937807|general anesthesia|general anesthesia
5588206|NCT00937781|stage III melanoma|stage iii melanoma
5588207|NCT00937781|recurrent melanoma|recurrent melanoma
5588208|NCT00937755|schizophrenia|schizophrenia
5588209|NCT00937755|antipsychotics|antipsychotics
5588210|NCT00937755|glucose homeostasis|glucose homeostasis
5588211|NCT00937755|metabolic disturbance|metabolic disturbance
5588212|NCT00937742|cardiovascular disease|cardiovascular disease
5588214|NCT00937742|Tomato|tomato
5588215|NCT00937729|uncompliant patients with virological failure|uncompliant patients with virological failure
5588216|NCT00937729|Treatment experienced|treatment experienced
5588217|NCT00937716|schizophrenia|schizophrenia
5588218|NCT00937716|treatment response|treatment response
5588219|NCT00937716|risperidone|risperidone
5588220|NCT00937716|functional magnetic resonance|functional magnetic resonance
5588221|NCT00937716|functional magnetic spectroscopy|functional magnetic spectroscopy
5588222|NCT00937690|melanoma|melanoma
5588223|NCT00937690|cutaneous|cutaneous
5588224|NCT00937690|imaging|imaging
5588225|NCT00937677|Tysabri|tysabri
5588226|NCT00937677|VWMTR|vwmtr
5588227|NCT00937664|Phase I|phase i
5588228|NCT00937664|cancer|cancer
5588229|NCT00937664|solid tumors|solid tumors
5588230|NCT00937664|advanced solid malignancies|advanced solid malignancies
5588231|NCT00937664|dose escalation|dose escalation
5588232|NCT00937664|combination treatment|combination treatment
5588233|NCT00937664|CHK inhibitor|chk inhibitor
5588234|NCT00937664|Japanese|japanese
5588235|NCT00937651|Fimasartan|fimasartan
5588236|NCT00937651|Essential Hypertension|essential hypertension
5588237|NCT00937638|Metabolic syndrome|metabolic syndrome
5588238|NCT00937638|Lean Beef|lean beef
5588239|NCT00937638|CVD|cvd
5588240|NCT00937612|Head and Neck Neoplasms|head and neck neoplasms
5588241|NCT00937612|Chemotherapy|chemotherapy
5588242|NCT00937612|Radiotherapy, Adjuvant|radiotherapy, adjuvant
5588243|NCT00937612|Surgery|surgery
5588244|NCT00937599|obese|obese
5588245|NCT00937599|brazil nuts|brazil nuts
5588246|NCT00937599|oxidative stress|oxidative stress
5588247|NCT00937599|microcirculatory|microcirculatory
5588248|NCT00937599|metabolic profile|metabolic profile
5588249|NCT00937586|Metastatic Prostate Cancer|metastatic prostate cancer
5588250|NCT00937586|Prostate Cancer Risk Assessment|prostate cancer risk assessment
5588251|NCT00937573|stents|stents
5588252|NCT00937573|mortality|mortality
5588253|NCT00937573|revascularization|revascularization
5588254|NCT00937573|stent thrombosis|stent thrombosis
5588255|NCT00937573|Drug-Eluting Stents|drug-eluting stents
5588256|NCT00937547|cervical cancer|cervical cancer
5588257|NCT00937547|Human Papillomavirus Infection|human papillomavirus infection
5588259|NCT00937534|healthy elderly and young male volunteer|healthy elderly and young male volunteer
5588260|NCT00937534|pharmacokinetic|pharmacokinetic
5588261|NCT00937521|Immunogenicity|immunogenicity
5588262|NCT00937521|Meningitis|meningitis
5588263|NCT00937521|Antibody|antibody
5588264|NCT00937521|Infants|infants
5588265|NCT00937508|smoking|smoking
5588266|NCT00937508|quitting|quitting
5588267|NCT00937508|varenicline|varenicline
5588268|NCT00937508|preoperative|preoperative
5588269|NCT00937508|long term abstinence|long term abstinence
5588270|NCT00937469|Social skills training for children with ADHD|social skills training for children with adhd
5588271|NCT00937469|Children with ADHD|children with adhd
5588272|NCT00937456|Esophagus|esophagus
5588273|NCT00937456|Cancer|cancer
5588274|NCT00937456|Surgery|surgery
5588275|NCT00937456|Laparoscopy|laparoscopy
5588276|NCT00937456|Randomized trial|randomized trial
5588277|NCT00937456|Esophageal cancer deemed to be resectable|esophageal cancer deemed to be resectable
5588278|NCT00937443|Physical Activity|physical activity
5588279|NCT00937443|Cardiac Heart Failure|cardiac heart failure
5588280|NCT00937443|Exercise Regimen|exercise regimen
5588281|NCT00937443|Cardioreparative Factors|cardioreparative factors
5588282|NCT00937430|Pelvic organ prolapse|pelvic organ prolapse
5588283|NCT00937430|Bowel preparation|bowel preparation
5588284|NCT00937417|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5588285|NCT00937417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5588286|NCT00937417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5588287|NCT00937417|stage IV breast cancer|stage iv breast cancer
5588288|NCT00937417|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5588289|NCT00937417|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5588290|NCT00937417|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5588291|NCT00937417|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5588292|NCT00937417|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5588293|NCT00937417|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5588294|NCT00937417|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5588295|NCT00937417|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5588296|NCT00937417|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5588297|NCT00937417|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5798745|NCT00111189|Paliperidone palmitate|paliperidone palmitate
5588298|NCT00937417|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5582657|NCT00957892|Satiety|satiety
5588299|NCT00937417|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5588300|NCT00937417|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5588301|NCT00937417|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5588302|NCT00937417|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5588303|NCT00937417|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5588304|NCT00937417|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5588305|NCT00937417|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5588306|NCT00937417|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5588307|NCT00937417|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5588308|NCT00937417|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5588309|NCT00937417|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5588310|NCT00937417|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5588311|NCT00937417|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5588312|NCT00937417|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5588313|NCT00937417|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5588314|NCT00937417|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5588315|NCT00937417|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5588316|NCT00937417|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5588317|NCT00937417|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5588318|NCT00937417|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5588319|NCT00937417|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5588320|NCT00937417|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5588321|NCT00937417|recurrent salivary gland cancer|recurrent salivary gland cancer
5588322|NCT00937417|stage IV salivary gland cancer|stage iv salivary gland cancer
5588323|NCT00937417|anaplastic thyroid cancer|anaplastic thyroid cancer
5685421|NCT00556114|Retina|retina
5588324|NCT00937417|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5588325|NCT00937417|insular thyroid cancer|insular thyroid cancer
5588326|NCT00937417|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5588327|NCT00937417|recurrent thyroid cancer|recurrent thyroid cancer
5588328|NCT00937417|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5588329|NCT00937417|recurrent prostate cancer|recurrent prostate cancer
5588330|NCT00937417|hormone-resistant prostate cancer|hormone-resistant prostate cancer
5588331|NCT00937417|recurrent breast cancer|recurrent breast cancer
5588332|NCT00937417|stage IV prostate cancer|stage iv prostate cancer
5588333|NCT00937417|male breast cancer|male breast cancer
5588335|NCT00937391|MRI agents|mri agents
5588336|NCT00937391|Magnevist|magnevist
5588337|NCT00937365|Pregnancy|pregnancy
5588338|NCT00937365|Pain|pain
5588339|NCT00937365|Low back pain|low back pain
5588340|NCT00937365|Pubic symphysis pain|pubic symphysis pain
5588341|NCT00937365|CAM|cam
5588342|NCT00937365|Complementary & Alternative Medicine|complementary & alternative medicine
5588343|NCT00937365|Exercise|exercise
5588344|NCT00937365|Chiropractic|chiropractic
5588345|NCT00937365|Spinal manipulation|spinal manipulation
5588346|NCT00937365|Adjustments|adjustments
5588347|NCT00937365|Neuroemotional technique|neuroemotional technique
5588348|NCT00937365|Mind body|mind body
5588349|NCT00937365|Mind body therapy|mind body therapy
5588350|NCT00937365|Attachment|attachment
5588351|NCT00937365|Maternal Fetal relationship|maternal fetal relationship
5588352|NCT00937365|Intrauterine attachment|intrauterine attachment
5588353|NCT00937365|Heart rate variability|heart rate variability
5588354|NCT00937365|VAS|vas
5588355|NCT00937365|Visual analog scale|visual analog scale
5588356|NCT00937365|Roland Morris Disability Index|roland morris disability index
5588357|NCT00937352|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5588358|NCT00937339|cerebrovascular accident|cerebrovascular accident
5588359|NCT00937339|bone|bone
5588360|NCT00937339|muscle|muscle
5588361|NCT00937339|vibration|vibration
5588362|NCT00937287|HPV|hpv
5588363|NCT00937287|African American|african american
5588364|NCT00937287|Rural|rural
5588365|NCT00937274|ETEC EPEC diarrhoea|etec epec diarrhoea
5588366|NCT00937274|phage therapy|phage therapy
5588367|NCT00937274|ORS|ors
5573500|NCT00993486|TH9402|th9402
5588368|NCT00937248|Cone Beam CT in rectal cancer patients|cone beam ct in rectal cancer patients
5588369|NCT00937248|Immobilizing rectal cancer patients|immobilizing rectal cancer patients
5798746|NCT00111189|R092670|r092670
5588370|NCT00937248|Image guided radiotherapy in rectal cancer patients|image guided radiotherapy in rectal cancer patients
5588371|NCT00937235|Smoking Cessation|smoking cessation
5588373|NCT00937235|Behavior Therapy|behavior therapy
5588374|NCT00937235|Varenicline|varenicline
5588375|NCT00937222|diabetes|diabetes
5588376|NCT00937222|cholesterol|cholesterol
5588377|NCT00937222|peanuts|peanuts
5588378|NCT00937222|peanut butter|peanut butter
5588379|NCT00937222|dietary intervention|dietary intervention
5588380|NCT00937222|HDL cholesterol|hdl cholesterol
5588381|NCT00937183|dendritic cell vaccine|dendritic cell vaccine
5588382|NCT00937183|tumor cell lysate|tumor cell lysate
5588383|NCT00937183|lymphoma|lymphoma
5588384|NCT00937170|Total Knee Replacement|total knee replacement
5588385|NCT00937170|Gender Specific Design|gender specific design
5588386|NCT00937157|Inflammation|inflammation
5588387|NCT00937157|Multiple Sclerosis|multiple sclerosis
5588388|NCT00937157|Glatiramer Acetate|glatiramer acetate
5588389|NCT00937157|Gd enhancing lesions|gd enhancing lesions
5588390|NCT00937157|1.5T protocol|1.5t protocol
5588391|NCT00937157|3T protocol|3t protocol
5588392|NCT00937157|Magnetization transfer imaging (MTI)|magnetization transfer imaging (mti)
5589375|NCT00933452|HAN|han
5588393|NCT00937157|Lesion activity analysis|lesion activity analysis
5588394|NCT00937157|Copaxone|copaxone
5588395|NCT00937144|endothelial function|endothelial function
5588396|NCT00937144|endothelial progenitor stem cells|endothelial progenitor stem cells
5588397|NCT00937118|laparotomy|laparotomy
5588398|NCT00937118|duodenal injury|duodenal injury
5588399|NCT00937118|pancreatic injury|pancreatic injury
5588400|NCT00937118|trauma|trauma
5588401|NCT00937092|Heart Failure|heart failure
5588402|NCT00937092|Dopamine|dopamine
5588403|NCT00937092|Furosemide|furosemide
5588404|NCT00937092|Worsening Renal Function|worsening renal function
5588405|NCT00937092|Hypokalemia|hypokalemia
5588406|NCT00937092|Outcomes|outcomes
5588407|NCT00937092|Prognosis|prognosis
5588408|NCT00937079|Glucagon-like peptide-1 receptor targeting|glucagon-like peptide-1 receptor targeting
5588409|NCT00937079|Insulinoma imaging|insulinoma imaging
5588410|NCT00937079|Exendin-4|exendin-4
5588411|NCT00937079|molecular imaging|molecular imaging
5588412|NCT00937066|Cost-effectiveness analysis|cost-effectiveness analysis
5588413|NCT00937066|Symbicort|symbicort
5588414|NCT00937053|Neutropenia|neutropenia
5588415|NCT00937053|Transfusions|transfusions
5588416|NCT00937053|Hemoglobin|hemoglobin
5588417|NCT00937053|Bone marrow transplant|bone marrow transplant
5588418|NCT00937053|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5588419|NCT00937040|Osmotic Release Oral System (OROS®) Extended Release Methylphenidate HCl|osmotic release oral system (oros®) extended release methylphenidate hcl
5588420|NCT00937040|CONCERTA® (OROS MPH)|concerta® (oros mph)
5588421|NCT00937027|Antifolate|antifolate
5588422|NCT00937027|Psoriasis|psoriasis
5588423|NCT00937027|Antiinflammatory drug|antiinflammatory drug
5588424|NCT00937027|Autoimmune disease|autoimmune disease
5588425|NCT00937027|Treatment|treatment
5588426|NCT00937014|infant formula|infant formula
5588427|NCT00937014|growth|growth
5588428|NCT00937014|weight|weight
5588429|NCT00937001|myopathy|myopathy
5588430|NCT00937001|respiratory failure|respiratory failure
5588431|NCT00937001|cognitive impairment|cognitive impairment
5588432|NCT00937001|delirium|delirium
5588433|NCT00936988|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5588434|NCT00936988|cinacalcet|cinacalcet
5588435|NCT00936962|Meningococcal C vaccine|meningococcal c vaccine
5588436|NCT00936962|Meningitis study|meningitis study
5588437|NCT00936962|Canadian vaccine schedule|canadian vaccine schedule
5588438|NCT00936962|Prevention of Meningococcal C disease|prevention of meningococcal c disease
5588439|NCT00936949|total hip arthroplasty|total hip arthroplasty
5588440|NCT00936949|posterolateral|posterolateral
5588441|NCT00936949|modified lateral|modified lateral
5588442|NCT00936936|Testis|testis
5588443|NCT00936936|Relapsed Testicular Cancer|relapsed testicular cancer
5588444|NCT00936936|Bevacizumab|bevacizumab
5588445|NCT00936936|Avastin|avastin
5588446|NCT00936936|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5588447|NCT00936936|rhuMAb-VEGF|rhumab-vegf
5588448|NCT00936936|Carboplatin|carboplatin
5588449|NCT00936936|Paraplatin|paraplatin
5588450|NCT00936936|Docetaxel|docetaxel
5588451|NCT00936936|Taxotere|taxotere
5588452|NCT00936936|Etoposide|etoposide
5588453|NCT00936936|VePesid|vepesid
5588454|NCT00936936|Gemcitabine|gemcitabine
5588455|NCT00936936|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5588456|NCT00936936|Gemzar|gemzar
5588457|NCT00936936|Ifosfamide|ifosfamide
5588458|NCT00936936|Ifex|ifex
5588459|NCT00936936|Melphalan|melphalan
5588460|NCT00936936|Alkeran|alkeran
5588461|NCT00936923|CAPD|capd
5588462|NCT00936923|Diuretics|diuretics
5747709|NCT00328640|CVA|cva
5588463|NCT00936923|Residual Renal Function|residual renal function
5588464|NCT00936923|furosemide|furosemide
5588465|NCT00936910|central line fungal infections|central line fungal infections
5588466|NCT00936910|antifungal lock therapy|antifungal lock therapy
5588467|NCT00936910|Ambisome lock therapy|ambisome lock therapy
5588468|NCT00936884|Opioid Induced Constipation|opioid induced constipation
5588469|NCT00936871|lersivirine QT QTc ECG HIV NNRTI|lersivirine qt qtc ecg hiv nnrti
5588470|NCT00936858|radioiodine refractory thyroid cancer|radioiodine refractory thyroid cancer
5588472|NCT00936832|stage IV rectal cancer|stage iv rectal cancer
5588473|NCT00936832|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5588474|NCT00936832|liver metastases|liver metastases
5588475|NCT00936832|lung metastases|lung metastases
5588476|NCT00936819|Stent|stent
5588477|NCT00936819|endothelial progenitor cells|endothelial progenitor cells
5588478|NCT00936819|nitric oxide|nitric oxide
5588479|NCT00936819|myocardial infarction|myocardial infarction
5588481|NCT00936806|Intracranial tumor patients|intracranial tumor patients
5588482|NCT00936793|Drug Interaction|drug interaction
5588483|NCT00936793|Asthma|asthma
5588485|NCT00936793|Beclomethasone|beclomethasone
5588486|NCT00936793|Protease Inhibitors|protease inhibitors
5588487|NCT00936793|HV|hv
5588488|NCT00936793|Healthy Volunteer|healthy volunteer
5588489|NCT00936793|HIV Infections|hiv infections
5588490|NCT00936780|Coronary Artery Disease|coronary artery disease
5588491|NCT00936780|Restenosis|restenosis
5588492|NCT00936780|Stent thrombosis|stent thrombosis
5588493|NCT00936780|Coronary stents|coronary stents
5588494|NCT00936780|Angioplasty|angioplasty
5588495|NCT00936780|Drug Eluting Stents (DES)|drug eluting stents (des)
5588496|NCT00936767|falciparum malaria|falciparum malaria
5588497|NCT00936767|artemisone|artemisone
5588498|NCT00936767|artesunate|artesunate
5588499|NCT00936767|resistance|resistance
5588500|NCT00936754|Glycemic index|glycemic index
5588501|NCT00936754|Reduction of glycemic index of ingested foods|reduction of glycemic index of ingested foods
5588502|NCT00936741|Cushing's Disease|cushing's disease
5588503|NCT00936741|Cushing's Syndrome|cushing's syndrome
5588504|NCT00936741|Cushings|cushings
5588505|NCT00936741|Pituitary|pituitary
5588506|NCT00936741|ACTH|acth
5588507|NCT00936741|Adrenocorticotropic hormone|adrenocorticotropic hormone
5588508|NCT00936741|Ectopic|ectopic
5588509|NCT00936741|Adrenal adenoma|adrenal adenoma
5588510|NCT00936741|Adrenal carcinoma|adrenal carcinoma
5588511|NCT00936741|Adrenal autonomy|adrenal autonomy
5588512|NCT00936741|Cortisol|cortisol
5588513|NCT00936741|Hypercortisolemia|hypercortisolemia
5588514|NCT00936741|Cushingoid|cushingoid
5588515|NCT00936741|Moon facies|moon facies
5588516|NCT00936741|Dorsocervical fat|dorsocervical fat
5588517|NCT00936741|Plethora|plethora
5588518|NCT00936741|Hirsutism|hirsutism
5588519|NCT00936741|Violaceous striae|violaceous striae
5588520|NCT00936741|Hormone|hormone
5588521|NCT00936741|Contraceptive|contraceptive
5588522|NCT00936741|Endocrine|endocrine
5588523|NCT00936741|Cushing Syndrome|cushing syndrome
5588524|NCT00936741|Ectopic ACTH Secretion|ectopic acth secretion
5588525|NCT00936715|prevention of chronic hepatitis B recurrence|prevention of chronic hepatitis b recurrence
5588526|NCT00936715|post orthotopic liver transplant|post orthotopic liver transplant
5588527|NCT00936715|prevention of chronic hepatitis B recurrence in patients who have undergone orthotopic liver transplant|prevention of chronic hepatitis b recurrence in patients who have undergone orthotopic liver transplant
5588528|NCT00936702|Newly Diagnosed Carcinoma of Unknown Primary Origin|newly diagnosed carcinoma of unknown primary origin
5588529|NCT00936702|Squamous Cell Carcinoma of Unknown Primary Origin|squamous cell carcinoma of unknown primary origin
5588530|NCT00936702|Undifferentiated Carcinoma of Unknown Primary|undifferentiated carcinoma of unknown primary
5588531|NCT00936702|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5588532|NCT00936689|Hepatocellular carcinoma;|hepatocellular carcinoma;
5588533|NCT00936689|Chemoembolization;|chemoembolization;
5588534|NCT00936689|DC-Beads.|dc-beads.
5588535|NCT00936676|parkinson's|parkinson's
5588536|NCT00936676|long-term effects|long-term effects
5588537|NCT00936676|adagio|adagio
5588538|NCT00936676|rasagiline|rasagiline
5588539|NCT00936676|delayed start|delayed start
5588540|NCT00936663|Diabetes|diabetes
5588541|NCT00936663|Kidney Transplant|kidney transplant
5588542|NCT00936663|Sitagliptin|sitagliptin
5588543|NCT00936650|Hyperparathyroidism, Primary|hyperparathyroidism, primary
5588544|NCT00936650|cinacalcet|cinacalcet
5588545|NCT00936624|Persistent asthma|persistent asthma
5588546|NCT00936611|LBH589|lbh589
5588548|NCT00936611|panobinostat|panobinostat
5588549|NCT00936611|relapsed|relapsed
5588550|NCT00936611|waldenstrom|waldenstrom
5588551|NCT00936611|macroglobulinemia|macroglobulinemia
5588552|NCT00936598|Sleep|sleep
5588553|NCT00936598|Endometrial Neoplasms|endometrial neoplasms
5588554|NCT00936598|Pain|pain
5588555|NCT00936585|Crohn's Disease|crohn's disease
5588556|NCT00936585|Infusion|infusion
5588557|NCT00936585|Anti IL-17 Monoclonal Antibody|anti il-17 monoclonal antibody
5588558|NCT00936585|Placebo|placebo
5588559|NCT00936585|Crohn Disease|crohn disease
5588560|NCT00936585|Inflammatory Bowel Disease|inflammatory bowel disease
5588561|NCT00936572|Probiotics|probiotics
5588562|NCT00936572|La1|la1
5588563|NCT00936572|BB536|bb536
5588564|NCT00936572|Colorectal surgery|colorectal surgery
5588565|NCT00936572|Intestinal immunity|intestinal immunity
5588566|NCT00936572|Dendritic cells|dendritic cells
5588568|NCT00936572|Microbiota|microbiota
5588569|NCT00936559|rotator cuff tear repair|rotator cuff tear repair
5588570|NCT00936559|open surgical technique|open surgical technique
5588571|NCT00936559|safety|safety
5588572|NCT00936520|Diabetic Macular Edema|diabetic macular edema
5588573|NCT00936520|DME|dme
5588574|NCT00936520|Pars Plana Vitrectomy|pars plana vitrectomy
5588575|NCT00936520|Ocular Inflammation|ocular inflammation
5588576|NCT00936507|energy density|energy density
5588577|NCT00936507|portion size|portion size
5588578|NCT00936507|child feeding|child feeding
5588579|NCT00936494|obstructive sleep apnea|obstructive sleep apnea
5588580|NCT00936494|sleep related breathing disorder|sleep related breathing disorder
5588581|NCT00936494|snoring|snoring
5588582|NCT00936494|disturbed sleeping|disturbed sleeping
5588583|NCT00936494|open mouth breathing|open mouth breathing
5588584|NCT00936494|upper airway resistance syndrome|upper airway resistance syndrome
5588585|NCT00936481|OSA|osa
5588586|NCT00936468|Elderly influenza vaccine|elderly influenza vaccine
5588587|NCT00936455|telemedicine|telemedicine
5588588|NCT00936455|telephone|telephone
5588589|NCT00936455|outcomes|outcomes
5588590|NCT00936442|Compliance|compliance
5588593|NCT00936429|Dengue hemorrhagic fever|dengue hemorrhagic fever
5588594|NCT00936429|Dengue shock syndrome|dengue shock syndrome
5588595|NCT00936429|Vaccine|vaccine
5588596|NCT00936429|Hawaii Biotech|hawaii biotech
5588597|NCT00936416|Glomerular Filtration Rate|glomerular filtration rate
5588598|NCT00936416|Renal Blood Flow|renal blood flow
5588599|NCT00936416|MRI|mri
5588600|NCT00936416|Inulin|inulin
5588601|NCT00936416|Para-Aminohippuric Acid|para-aminohippuric acid
5588602|NCT00936390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5588603|NCT00936390|stage IIB prostate cancer|stage iib prostate cancer
5588604|NCT00936390|stage IIA prostate cancer|stage iia prostate cancer
5588605|NCT00936351|schizophrenia|schizophrenia
5588606|NCT00936351|intervention studies|intervention studies
5588607|NCT00936351|mindfulness meditation|mindfulness meditation
5588608|NCT00936351|vocational rehabilitation|vocational rehabilitation
5588609|NCT00936351|schizoaffective disorder|schizoaffective disorder
5588610|NCT00936351|psychotic disorders|psychotic disorders
5672116|NCT00612989|Progressive GBM|progressive gbm
5588611|NCT00936338|anterior disc displacement without reduction of temporomandibular disorders|anterior disc displacement without reduction of temporomandibular disorders
5588614|NCT00936299|Adolescents|adolescents
5588615|NCT00936299|Substance Use Disorder|substance use disorder
5588616|NCT00936299|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5588617|NCT00936299|Cognitive Behavioral Therapy|cognitive behavioral therapy
5588618|NCT00936286|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5588619|NCT00936286|Respiratory Muscle Training|respiratory muscle training
5588620|NCT00936286|Normocapnic Hyperpnea|normocapnic hyperpnea
5588621|NCT00936286|SpiroTiger|spirotiger
5588622|NCT00936286|Polysomnography|polysomnography
5588623|NCT00936273|Sleep apnea syndrome|sleep apnea syndrome
5588625|NCT00936273|double loop gain|double loop gain
5588626|NCT00936273|DLI|dli
5588627|NCT00936273|double loop index|double loop index
5588628|NCT00936273|periodic breathing|periodic breathing
5588629|NCT00936273|polysomnography|polysomnography
5588630|NCT00936260|osteoporosis|osteoporosis
5588631|NCT00936260|postmenopausal|postmenopausal
5588632|NCT00936260|alendronate|alendronate
5588633|NCT00936234|CAD|cad
5588634|NCT00936234|diabetes|diabetes
5588635|NCT00936234|SDF-1|sdf-1
5588636|NCT00936234|endothelial function|endothelial function
5588637|NCT00936221|BRAF mutation positive|braf mutation positive
5588638|NCT00936221|advanced melanoma|advanced melanoma
5588639|NCT00936221|Advanced cutaneous melanoma|advanced cutaneous melanoma
5588640|NCT00936221|Unknown primary melanoma|unknown primary melanoma
5588641|NCT00936195|HIV|hiv
5588642|NCT00936195|pregnancy|pregnancy
5588643|NCT00936195|breastfeeding|breastfeeding
5588644|NCT00936195|PMTCT|pmtct
5588645|NCT00936195|ARV treatment|arv treatment
5588646|NCT00936195|treatment naive|treatment naive
5588647|NCT00936169|Patients with at least one complex lesion suitable for implantation of a drug-eluting stent|patients with at least one complex lesion suitable for implantation of a drug-eluting stent
5588648|NCT00936143|Spondylitis, Ankylosing|spondylitis, ankylosing
5588649|NCT00936143|infliximab|infliximab
5588650|NCT00936143|Antibodies, Monoclonal|antibodies, monoclonal
5588651|NCT00936130|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
5588652|NCT00936130|Sleeve gastrectomy (SGx) surgery|sleeve gastrectomy (sgx) surgery
5588653|NCT00936130|Gastric banding (GBx) surgery|gastric banding (gbx) surgery
5573775|NCT00992368|Breast|breast
5588654|NCT00936130|Low calorie diet program|low calorie diet program
5588655|NCT00936117|Cancer of the Blood|cancer of the blood
5588656|NCT00936117|Cancer of Bone Marrow|cancer of bone marrow
5588657|NCT00936117|Acute Leukemia|acute leukemia
5588658|NCT00936117|AML|aml
5588659|NCT00936117|Fungal infection|fungal infection
5588660|NCT00936117|Prophylaxis|prophylaxis
5588661|NCT00936117|Posaconazole|posaconazole
5588662|NCT00936117|SCH 56592|sch 56592
5588663|NCT00936117|Noxafil|noxafil
5588664|NCT00936117|Chemotherapy|chemotherapy
5588665|NCT00936104|pancreas|pancreas
5588666|NCT00936104|cancer|cancer
5588667|NCT00936104|stem cell|stem cell
5588668|NCT00936091|intestinal parasitic infections|intestinal parasitic infections
5588669|NCT00936091|malnutrition|malnutrition
5588670|NCT00936091|Anemia|anemia
5588671|NCT00936078|kidney transplantation|kidney transplantation
5588672|NCT00936078|cohort study|cohort study
5588673|NCT00936078|qualitative research|qualitative research
5588674|NCT00936078|health services research|health services research
5588675|NCT00936078|hypertension|hypertension
5588676|NCT00936065|Etanercept|etanercept
5588677|NCT00936065|Acitretin|acitretin
5588678|NCT00936065|Psoriasis|psoriasis
5588679|NCT00936052|glioblastomas|glioblastomas
5588680|NCT00936052|GBM|gbm
5588681|NCT00936052|gliosarcoma|gliosarcoma
5588682|NCT00936052|blastoma|blastoma
5588683|NCT00936052|sarcoma|sarcoma
5588684|NCT00936013|novel influenza A(H1N1)|novel influenza a(h1n1)
5588685|NCT00936013|chinese medicinal herbs|chinese medicinal herbs
5588686|NCT00936000|alcohol abuse|alcohol abuse
5589376|NCT00933452|BDNF|bdnf
5588687|NCT00936000|alveolar capillary permeability|alveolar capillary permeability
5588688|NCT00935987|Primary Myelofibrosis|primary myelofibrosis
5588689|NCT00935987|Post-Polycythemia Vera|post-polycythemia vera
5588690|NCT00935987|Post-Essential Thrombocythemia|post-essential thrombocythemia
5588691|NCT00935987|CYT387|cyt387
5588692|NCT00935961|CISPLATIN|cisplatin
5588693|NCT00935961|RAD001|rad001
5588694|NCT00935961|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5588695|NCT00935961|09-028|09-028
5588696|NCT00935961|Squamous Cell Carcinoma|squamous cell carcinoma
5588697|NCT00935961|Local-Regional Advanced Head and Neck|local-regional advanced head and neck
5588698|NCT00935948|hemorrhoids|hemorrhoids
5588699|NCT00935948|hemorrhoidal disease|hemorrhoidal disease
5588700|NCT00935948|water smartweed|water smartweed
5588701|NCT00935948|hamamelis|hamamelis
5588702|NCT00935948|RCT|rct
5588703|NCT00935935|Treatment experienced|treatment experienced
5588704|NCT00935922|Flaxseed|flaxseed
5588705|NCT00935922|Weight loss|weight loss
5588706|NCT00935922|Heart health|heart health
5588707|NCT00935922|Diabetes|diabetes
5588708|NCT00935909|IV cannulation|iv cannulation
5588709|NCT00935896|Ventilator-associated lung injury|ventilator-associated lung injury
5588710|NCT00935896|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5588711|NCT00935896|Interleukin-8|interleukin-8
5588712|NCT00935896|Mechanical ventilation|mechanical ventilation
5588713|NCT00935896|Low tidal volume ventilation|low tidal volume ventilation
5588714|NCT00935896|Normal lungs|normal lungs
5588715|NCT00935883|Age Related macular Degeneration|age related macular degeneration
5588716|NCT00935883|Macular Degeneration|macular degeneration
5588717|NCT00935883|Drusen|drusen
5588718|NCT00935883|Geographic atrophy|geographic atrophy
5588719|NCT00935883|Eculizumab|eculizumab
5588720|NCT00935883|Soliris|soliris
5588721|NCT00935857|Balloon Enteroscopy|balloon enteroscopy
5588722|NCT00935857|Looping|looping
5588723|NCT00935844|Advanced solid tumors|advanced solid tumors
5588724|NCT00935844|Lymphoma|lymphoma
5588725|NCT00935831|Tolerability|tolerability
5588726|NCT00935831|Safety|safety
5588727|NCT00935831|Pharmacokinetics|pharmacokinetics
5588728|NCT00935831|Pharmacodynamics|pharmacodynamics
5588729|NCT00935818|smoking|smoking
5588730|NCT00935818|nicotine|nicotine
5588731|NCT00935818|tobacco|tobacco
5588732|NCT00935818|dependence|dependence
5588733|NCT00935818|cessation|cessation
5588734|NCT00935818|abstinence|abstinence
5588735|NCT00935805|Diabetes Mellitus|diabetes mellitus
5588736|NCT00935805|Arterial Hypertension|arterial hypertension
5588737|NCT00935805|Treatment|treatment
5588738|NCT00935805|Primary Care|primary care
5588739|NCT00935792|hematopoietic cancer|hematopoietic cancer
5588740|NCT00935792|lymphoid cancer|lymphoid cancer
5588741|NCT00935779|Stomach Neoplasms|stomach neoplasms
5588742|NCT00935779|Peritoneum|peritoneum
5588743|NCT00935766|Latinos Using Cardio Health Actions to Reduce Risk|latinos using cardio health actions to reduce risk
5588744|NCT00935766|Omega three Fatty Acids|omega three fatty acids
5588745|NCT00935766|Vascular Function and Inflammation|vascular function and inflammation
5588746|NCT00935753|Lesch-Nyhan Disease|lesch-nyhan disease
5588747|NCT00935753|self-mutilating behavior|self-mutilating behavior
5588748|NCT00935740|thromboembolic disease|thromboembolic disease
5588749|NCT00935740|thromboplastin|thromboplastin
5588750|NCT00935740|hypercoagulability|hypercoagulability
5588751|NCT00935740|congestive heart failure|congestive heart failure
5588752|NCT00935727|renal transplant|renal transplant
5588753|NCT00935727|ultrasound|ultrasound
5588754|NCT00935727|elastography|elastography
5588755|NCT00935714|Arm|arm
5588756|NCT00935714|Lymphedema|lymphedema
5588757|NCT00935714|Breast Cancer|breast cancer
5588758|NCT00935714|Exercise|exercise
5588759|NCT00935714|Breast Cancer related Lymphedema|breast cancer related lymphedema
5588760|NCT00935701|Autism Spectrum Disorder|autism spectrum disorder
5588761|NCT00935701|Acupressure|acupressure
5588762|NCT00935701|Acupuncture|acupuncture
5588763|NCT00935688|malaria|malaria
5588764|NCT00935688|rapid diagnostic tests|rapid diagnostic tests
5588765|NCT00935688|afghanistan|afghanistan
5588766|NCT00935688|Non-specific fever|non-specific fever
5862985|NCT00001426|Initial Therapy|initial therapy
5862986|NCT00001426|Paclitaxel|paclitaxel
5588781|NCT00935610|Body composition|body composition
5588782|NCT00935610|Inflammatory cytokine levels|inflammatory cytokine levels
5588783|NCT00935610|Cognitive functions|cognitive functions
5588784|NCT00935610|Cysteine-rich whey protein isolate|cysteine-rich whey protein isolate
5588785|NCT00935610|Immunocal|immunocal
5588786|NCT00935610|Resistance training|resistance training
5588787|NCT00935610|Improved muscle function|improved muscle function
5588788|NCT00935610|Improved quality of life|improved quality of life
5588789|NCT00935610|Aging processes|aging processes
5588790|NCT00935610|Quality of life|quality of life
5588791|NCT00935597|Relapsed Non-Hodgkin's Lymphoma|relapsed non-hodgkin's lymphoma
5588792|NCT00935597|Hodgkin's Disease|hodgkin's disease
5588793|NCT00935597|Multiple Myeloma|multiple myeloma
5588794|NCT00935597|Chronic Lymphocytic Lymphoma|chronic lymphocytic lymphoma
5588795|NCT00935597|Relapsed Non-Hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)|relapsed non-hodgkin's lymphoma (excluding follicular lymphoma and marginal zone lymphoma)
5588796|NCT00935584|Communication|communication
5588797|NCT00935584|Doctor-patient relations|doctor-patient relations
5588798|NCT00935584|medical informatics|medical informatics
5588799|NCT00935584|patient-centered care|patient-centered care
5588800|NCT00935584|medical records systems, computerized|medical records systems, computerized
5588801|NCT00935558|dendritic cell|dendritic cell
5588802|NCT00935558|cancer vaccine|cancer vaccine
5588803|NCT00935558|breast cancer|breast cancer
5588804|NCT00935558|aromatase inhibitor|aromatase inhibitor
5588805|NCT00935558|Zadaxin|zadaxin
5588806|NCT00935545|Brain Tumors|brain tumors
5588807|NCT00935545|High Grade|high grade
5588809|NCT00935532|diabetes; exenatide once weekly; Byetta; glargine; Lantus; Amylin; Lilly|diabetes; exenatide once weekly; byetta; glargine; lantus; amylin; lilly
5588810|NCT00935519|total hip arthroplasty, ceramic, survival|total hip arthroplasty, ceramic, survival
5588811|NCT00935493|guanfacine|guanfacine
5588812|NCT00935493|aging|aging
5588813|NCT00935493|cognitive aging|cognitive aging
5588814|NCT00935493|prefrontal cognitive function|prefrontal cognitive function
5588815|NCT00935493|executive function|executive function
5588816|NCT00935493|prefrontal cortex|prefrontal cortex
5588817|NCT00935480|HIV|hiv
5588818|NCT00935480|INTEGRASE INHIBITOR|integrase inhibitor
5588819|NCT00935480|Inhibitor on the lymphoid reservoir|inhibitor on the lymphoid reservoir
5588820|NCT00935480|Residual HIV replication|residual hiv replication
5588821|NCT00935480|treatment experienced|treatment experienced
5588822|NCT00935454|hepatocyte matrix implantation|hepatocyte matrix implantation
5588823|NCT00935454|endstage liver disease|endstage liver disease
5588825|NCT00935454|impaired liver parenchyma|impaired liver parenchyma
5588826|NCT00935454|improvement of liver function|improvement of liver function
5588827|NCT00935441|Diabetes mellitus|diabetes mellitus
5588828|NCT00935441|chronic care|chronic care
5588829|NCT00935441|case management|case management
5588830|NCT00935441|telemedicine|telemedicine
5588831|NCT00935428|Equestrian injury|equestrian injury
5588832|NCT00935428|Horse injury|horse injury
5588833|NCT00935428|Trauma|trauma
5588834|NCT00935415|asthma|asthma
5588835|NCT00935415|exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5588836|NCT00935415|montelukast|montelukast
5588837|NCT00935415|clinical protection|clinical protection
5588838|NCT00935415|children|children
5588839|NCT00935415|time effect|time effect
5588840|NCT00935402|Energy balance|energy balance
5588841|NCT00935402|Weight management|weight management
5588842|NCT00935402|Food intake|food intake
5588843|NCT00935402|Energy expenditure|energy expenditure
5588844|NCT00935376|Sleep Management|sleep management
5588845|NCT00935376|Awareness Training Programs|awareness training programs
5588846|NCT00935376|Mindfulness Meditation|mindfulness meditation
5588847|NCT00935376|Mind Body Bridging|mind body bridging
5588848|NCT00935363|glyburide|glyburide
5588849|NCT00935363|pharmacokinetics|pharmacokinetics
5588850|NCT00935363|pharmacodynamics|pharmacodynamics
5588851|NCT00935363|drug interaction|drug interaction
5588852|NCT00935363|Healthy Volunteers|healthy volunteers
5588854|NCT00935350|fibre|fibre
5588855|NCT00935350|polysaccharide|polysaccharide
5588856|NCT00935350|blood glucose|blood glucose
5588857|NCT00935350|postprandial|postprandial
5588858|NCT00935337|Sleep problems|sleep problems
5588859|NCT00935337|Awareness training program|awareness training program
5588860|NCT00935337|Mind body bridging|mind body bridging
5588861|NCT00935324|allo-SCT, GvHD, CK18-F|allo-sct, gvhd, ck18-f
5588862|NCT00935298|Renal Transplantation|renal transplantation
5588864|NCT00935298|CYP3A5|cyp3a5
5588865|NCT00935298|Genotyping|genotyping
5588866|NCT00935285|Ventilator-associated pneumonia (VAP)|ventilator-associated pneumonia (vap)
5588867|NCT00935285|Intensive care unit (ICU)|intensive care unit (icu)
5588868|NCT00935285|Toll-like receptors|toll-like receptors
5588869|NCT00935259|Hypercholesterolemia, Dyslipidemia, simvastatin, Zocor|hypercholesterolemia, dyslipidemia, simvastatin, zocor
5588870|NCT00935246|Genomic devices|genomic devices
5588871|NCT00935246|Prediction of Escitalopram Response|prediction of escitalopram response
5588872|NCT00935246|Depressed Patients|depressed patients
5588873|NCT00935233|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5588874|NCT00935207|Pain|pain
5588875|NCT00935207|Pediatric Pain|pediatric pain
5588876|NCT00935207|Pain Diary|pain diary
5588877|NCT00935207|Pediatric Pain Measurement|pediatric pain measurement
5588878|NCT00935207|Pain Measurement|pain measurement
5588879|NCT00935194|Novel Influenza A(H1N1)|novel influenza a(h1n1)
5588880|NCT00935194|Oseltamivir|oseltamivir
5588881|NCT00935194|Chinese Medicinal Herbs|chinese medicinal herbs
5588883|NCT00935181|diaphragm|diaphragm
5588884|NCT00935181|muscle|muscle
5588885|NCT00935181|stretching|stretching
5588886|NCT00935181|exercises|exercises
5588887|NCT00935181|dyspnea|dyspnea
5588888|NCT00935181|respiratory muscle stretching|respiratory muscle stretching
5588889|NCT00935181|pulmonary rehabilitation|pulmonary rehabilitation
5588890|NCT00935181|exercise training|exercise training
5588891|NCT00935181|improved exercise capacity, dyspnea, quality of life|improved exercise capacity, dyspnea, quality of life
5588892|NCT00935168|Intensive Care|intensive care
5588893|NCT00935168|Fluid Resuscitation|fluid resuscitation
5588894|NCT00935168|Saline|saline
5588895|NCT00935168|Hydroxy-ethyl starch|hydroxy-ethyl starch
5588896|NCT00935155|exercise therapy|exercise therapy
5588897|NCT00935155|Knee arthroplasty|knee arthroplasty
5588898|NCT00935155|Acupuncture Analgesia|acupuncture analgesia
5588899|NCT00935155|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5588900|NCT00935155|rehabilitation|rehabilitation
5672117|NCT00612989|Brain tumor|brain tumor
5588901|NCT00935142|stage IV cancer with no treatment options|stage iv cancer with no treatment options
5588903|NCT00935129|Treatment satisfaction|treatment satisfaction
5588904|NCT00935129|OmniPod|omnipod
5588905|NCT00935129|Insulin pump|insulin pump
5588906|NCT00935129|diabetes|diabetes
5588907|NCT00935103|Addiction|addiction
5588908|NCT00935103|Psychoeducation|psychoeducation
5588909|NCT00935103|Risk reduction behaviour|risk reduction behaviour
5588910|NCT00935103|Drop in center (DIC)|drop in center (dic)
5588911|NCT00935090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5588912|NCT00935090|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5588913|NCT00935090|acute undifferentiated leukemia|acute undifferentiated leukemia
5588914|NCT00935090|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5588915|NCT00935090|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5588916|NCT00935090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5588917|NCT00935090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5588918|NCT00935090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5588919|NCT00935090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5588920|NCT00935090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5588921|NCT00935090|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5588922|NCT00935090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5588923|NCT00935090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5588924|NCT00935090|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5588925|NCT00935090|mast cell leukemia|mast cell leukemia
5588926|NCT00935090|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5588927|NCT00935090|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5588928|NCT00935090|prolymphocytic leukemia|prolymphocytic leukemia
5588929|NCT00935090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5583373|NCT00955929|Penis|penis
5588930|NCT00935090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5588931|NCT00935090|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5588932|NCT00935090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5588933|NCT00935090|refractory hairy cell leukemia|refractory hairy cell leukemia
5588934|NCT00935090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5588935|NCT00935090|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5588936|NCT00935090|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5588937|NCT00935090|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5588938|NCT00935090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5588941|NCT00935090|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5588942|NCT00935090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5588943|NCT00935090|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5588944|NCT00935090|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5588945|NCT00935090|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5588946|NCT00935090|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5588947|NCT00935090|untreated hairy cell leukemia|untreated hairy cell leukemia
5588948|NCT00935090|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5588949|NCT00935090|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5588950|NCT00935090|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5588951|NCT00935090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5588952|NCT00935090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5588953|NCT00935090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5588954|NCT00935090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5588955|NCT00935090|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5588956|NCT00935090|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5588957|NCT00935090|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5588958|NCT00935090|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5588959|NCT00935090|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5588960|NCT00935090|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5588961|NCT00935090|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5588962|NCT00935090|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5588963|NCT00935090|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5588964|NCT00935090|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5588965|NCT00935090|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5588966|NCT00935090|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5588967|NCT00935090|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5588968|NCT00935090|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5588969|NCT00935090|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5588970|NCT00935090|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5588971|NCT00935090|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5588972|NCT00935090|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5588973|NCT00935090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5588974|NCT00935090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5588975|NCT00935090|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5588976|NCT00935090|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5588977|NCT00935090|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5588978|NCT00935090|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5588979|NCT00935090|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5588980|NCT00935090|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5588981|NCT00935090|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5588982|NCT00935090|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5588983|NCT00935090|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5588984|NCT00935090|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5588985|NCT00935090|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5588986|NCT00935090|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5588987|NCT00935090|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5588988|NCT00935090|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5588989|NCT00935090|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5588990|NCT00935090|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5588991|NCT00935090|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5588992|NCT00935090|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5588993|NCT00935090|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5588994|NCT00935090|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5588995|NCT00935090|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5588996|NCT00935090|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5591628|NCT00924248|Liver MRI|liver mri
5591629|NCT00924209|Neoadjuvant|neoadjuvant
5588997|NCT00935090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5588998|NCT00935090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5588999|NCT00935090|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5589000|NCT00935090|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5589001|NCT00935090|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5589002|NCT00935090|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5589003|NCT00935090|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5589004|NCT00935090|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5589005|NCT00935090|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5589006|NCT00935090|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5589007|NCT00935090|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5589008|NCT00935090|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5589009|NCT00935090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5589010|NCT00935090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5589011|NCT00935090|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5589012|NCT00935090|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5589013|NCT00935090|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5589014|NCT00935090|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5589015|NCT00935090|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5589016|NCT00935090|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5589017|NCT00935090|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5589018|NCT00935090|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5589019|NCT00935090|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5589020|NCT00935090|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5589021|NCT00935090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5589022|NCT00935090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5589023|NCT00935090|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5589024|NCT00935090|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5589025|NCT00935090|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5589026|NCT00935090|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5589027|NCT00935090|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5589028|NCT00935090|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5589029|NCT00935090|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5589030|NCT00935090|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5589031|NCT00935090|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5589032|NCT00935090|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5589033|NCT00935090|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5589034|NCT00935090|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5589035|NCT00935090|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5589036|NCT00935090|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5589037|NCT00935090|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5589038|NCT00935090|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5589039|NCT00935090|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5589040|NCT00935090|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5589041|NCT00935090|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5589042|NCT00935090|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5589043|NCT00935090|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5589044|NCT00935090|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5589045|NCT00935090|intraocular lymphoma|intraocular lymphoma
5589046|NCT00935090|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5589047|NCT00935090|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5589048|NCT00935090|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5589049|NCT00935090|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5589050|NCT00935090|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5583385|NCT00955916|AML|aml
5589053|NCT00935090|polycythemia vera|polycythemia vera
5589054|NCT00935090|extramedullary plasmacytoma|extramedullary plasmacytoma
5589055|NCT00935090|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5589056|NCT00935090|stage I multiple myeloma|stage i multiple myeloma
5589057|NCT00935090|stage II multiple myeloma|stage ii multiple myeloma
5589058|NCT00935090|stage III multiple myeloma|stage iii multiple myeloma
5589062|NCT00935090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5589063|NCT00935090|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5589064|NCT00935090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5589066|NCT00935077|Pharmacist Physician Collaborative Management of Hypertension|pharmacist physician collaborative management of hypertension
5589067|NCT00935064|Diabetes|diabetes
5589068|NCT00935051|type 1 diabetes|type 1 diabetes
5589069|NCT00935051|type 2 diabetes|type 2 diabetes
5589070|NCT00935051|Diabetic foot ulcer|diabetic foot ulcer
5589071|NCT00935025|Phase I|phase i
5589072|NCT00935025|Japanese healthy volunteer|japanese healthy volunteer
5589073|NCT00935025|AZD1305|azd1305
5589074|NCT00935025|Japanese and Caucasian|japanese and caucasian
5589075|NCT00934986|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5589076|NCT00934986|NK Cells|nk cells
5589077|NCT00934973|irritable bowel syndrome|irritable bowel syndrome
5589078|NCT00934973|treatment|treatment
5589079|NCT00934960|vision|vision
5589080|NCT00934960|Intraocular lenses|intraocular lenses
5589081|NCT00934947|Burns|burns
5589082|NCT00934947|Pain|pain
5589083|NCT00934934|Candida|candida
5589084|NCT00934934|ventilator associated pneumonia|ventilator associated pneumonia
5589085|NCT00934934|respiratory tract infection|respiratory tract infection
5589086|NCT00934934|antifungal|antifungal
5589087|NCT00934934|biomarker|biomarker
5589088|NCT00934921|Bioequivalence|bioequivalence
5589089|NCT00934908|Zyprexa®|zyprexa®
5589090|NCT00934908|Green Tea|green tea
5589091|NCT00934908|ALL|all
5589092|NCT00934895|stage IIIA breast cancer|stage iiia breast cancer
5589093|NCT00934895|stage IIIB breast cancer|stage iiib breast cancer
5589094|NCT00934895|stage IIIC breast cancer|stage iiic breast cancer
5589095|NCT00934895|stage IV breast cancer|stage iv breast cancer
5589096|NCT00934895|HER2-negative breast cancer|her2-negative breast cancer
5589097|NCT00934895|recurrent breast cancer|recurrent breast cancer
5589098|NCT00934882|Colorectal cancer|colorectal cancer
5589099|NCT00934882|Targeted therapy|targeted therapy
5589100|NCT00934882|Multi-kinase inhibitor|multi-kinase inhibitor
5589101|NCT00934882|FOLFOX|folfox
5589102|NCT00934882|FOLFIRI|folfiri
5589103|NCT00934843|Cardiopulmonary Bypass (CPB)|cardiopulmonary bypass (cpb)
5589104|NCT00934843|System Inflammatory Response|system inflammatory response
5589105|NCT00934843|Low Cardiac Output Syndrome (LCOS) in Neonates|low cardiac output syndrome (lcos) in neonates
5589106|NCT00934843|Methylprednisolone|methylprednisolone
5589107|NCT00934843|Cardiopulmonary Bypass (CPB) in Neonates|cardiopulmonary bypass (cpb) in neonates
5589108|NCT00934843|Glucocorticoid Use in Neonatal Cardiac Surgery|glucocorticoid use in neonatal cardiac surgery
5589109|NCT00934843|Steroid|steroid
5589110|NCT00934830|Antibiotic|antibiotic
5589111|NCT00934830|Ultrasound|ultrasound
5589112|NCT00934830|Efficacy|efficacy
5589113|NCT00934830|Treatment|treatment
5589114|NCT00934817|Volunteer|volunteer
5589115|NCT00934804|refractive surgery|refractive surgery
5589116|NCT00934791|Kidney Transplant|kidney transplant
5589117|NCT00934791|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5589118|NCT00934791|Polycystic liver disease|polycystic liver disease
5589119|NCT00934778|Confocal microscopy|confocal microscopy
5589120|NCT00934778|Endocytoscopy|endocytoscopy
5589121|NCT00934778|Diffuse lung disease|diffuse lung disease
5589122|NCT00934778|Minimally invasive|minimally invasive
5589123|NCT00934778|Lung cancer and dysplasia|lung cancer and dysplasia
5589124|NCT00934765|overweight, obesity, male, fertility|overweight, obesity, male, fertility
5589125|NCT00934752|de novo stenotic lesions|de novo stenotic lesions
5589126|NCT00934739|High-Risk Oral Cavity Cancer,|high-risk oral cavity cancer,
5589127|NCT00934739|Anti-Angiogenesis|anti-angiogenesis
5589128|NCT00934726|Quality of Life|quality of life
5589129|NCT00934726|Patient satisfaction|patient satisfaction
5589130|NCT00934726|Schizophrenia|schizophrenia
5589131|NCT00934726|Investigate quality of life in schizophrenia|investigate quality of life in schizophrenia
5589132|NCT00934713|montelukast, very young children, lung function tests|montelukast, very young children, lung function tests
5589133|NCT00934700|perinatal asphyxia|perinatal asphyxia
5589134|NCT00934700|encephalopathy|encephalopathy
5589135|NCT00934700|neuroprotection|neuroprotection
5589136|NCT00934687|depression|depression
5589137|NCT00934687|depressive|depressive
5589138|NCT00934687|botulinum|botulinum
5589139|NCT00934687|botox|botox
5589140|NCT00934674|Healthy Subjects|healthy subjects
5748677|NCT00324753|cancer|cancer
5589141|NCT00934661|hip resurfacing|hip resurfacing
5589142|NCT00934661|hip arthroplasty|hip arthroplasty
5591831|NCT00923611|Fimasartan|fimasartan
5589151|NCT00934622|ReSTOR|restor
5589152|NCT00934622|Aspheric IOL|aspheric iol
5589153|NCT00934622|Cataract|cataract
5589154|NCT00934609|Exercise|exercise
5589155|NCT00934609|heart failure|heart failure
5589156|NCT00934609|dilated cardiomyopathy|dilated cardiomyopathy
5589157|NCT00934609|Endurance training|endurance training
5589158|NCT00934596|Cardiac de-airing|cardiac de-airing
5589159|NCT00934596|CO2 insufflation|co2 insufflation
5589160|NCT00934596|Air emboli|air emboli
5589161|NCT00934596|Trans cranial doppler|trans cranial doppler
5589162|NCT00934596|Intraoperative echocardiography|intraoperative echocardiography
5589163|NCT00934583|Bulimia Nervosa|bulimia nervosa
5589164|NCT00934583|Binge Eating|binge eating
5589165|NCT00934583|Binge-Eating Disorder|binge-eating disorder
5589166|NCT00934570|Obesity|obesity
5589167|NCT00934570|Metformin|metformin
5589168|NCT00934570|Physical activity|physical activity
5589169|NCT00934570|Cardiovascular health|cardiovascular health
5589170|NCT00934544|Myelofibrosis|myelofibrosis
5589171|NCT00934544|Post-Polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5589172|NCT00934544|Post-Essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5589173|NCT00934531|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5589174|NCT00934531|Falls|falls
5589175|NCT00934531|donepezil|donepezil
5589176|NCT00934531|gait variability|gait variability
5589177|NCT00934518|Squamous cell carcinoma, Head and Neck cancer|squamous cell carcinoma, head and neck cancer
5589178|NCT00934505|Positron-Emission Tomography|positron-emission tomography
5589179|NCT00934505|PET Scan|pet scan
5589180|NCT00934505|FDG|fdg
5589181|NCT00934505|oesophageal cancer|oesophageal cancer
5589182|NCT00934505|chemo-Radiation Oncology|chemo-radiation oncology
5589183|NCT00934505|SUV|suv
5589184|NCT00934492|Malnutrition|malnutrition
5589185|NCT00934492|Wasting|wasting
5589186|NCT00934492|Kwashiorkor|kwashiorkor
5589187|NCT00934492|Immune deficiency|immune deficiency
5589188|NCT00934492|Infection|infection
5589189|NCT00934492|Prophylaxis|prophylaxis
5589190|NCT00934492|Mortality|mortality
5589191|NCT00934492|Kenya|kenya
5589192|NCT00934479|Chronic Constipation|chronic constipation
5672118|NCT00612989|Malignant glioma|malignant glioma
5589193|NCT00934479|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5589194|NCT00934479|Intestinal Microecology|intestinal microecology
5589195|NCT00934453|Healthy adult volunteers|healthy adult volunteers
5589196|NCT00934453|Lactobacillus rhamnosus GG|lactobacillus rhamnosus gg
5589197|NCT00934453|probiotic|probiotic
5589198|NCT00934453|dietary supplement|dietary supplement
5589199|NCT00934453|safety|safety
5589200|NCT00934453|Safety Assessment|safety assessment
5589201|NCT00934440|kidney cancer|kidney cancer
5589202|NCT00934440|renal cell|renal cell
5589203|NCT00934427|Raynaud's|raynaud's
5589204|NCT00934427|scleroderma|scleroderma
5589205|NCT00934427|nitroglycerin|nitroglycerin
5589206|NCT00934427|MQX-503|mqx-503
5589207|NCT00934427|treatment|treatment
5589208|NCT00934401|FLT|flt
5589209|NCT00934401|fluorolabeled thymidine|fluorolabeled thymidine
5589210|NCT00934401|breast cancer|breast cancer
5589211|NCT00934401|Positron-Emission Mammography|positron-emission mammography
5589212|NCT00934388|Sportsmans groin, Gilmores groin|sportsmans groin, gilmores groin
5589213|NCT00934375|Mild Cognitive Impairment|mild cognitive impairment
5589214|NCT00934349|Comoro Island|comoro island
5589215|NCT00934349|vit B1 intake|vit b1 intake
5589216|NCT00934349|Thiamine status|thiamine status
5589217|NCT00934349|Genetic factor|genetic factor
5589218|NCT00934323|volunteer|volunteer
5589219|NCT00934310|Patient Safety|patient safety
5589220|NCT00934310|Team work|team work
5589221|NCT00934310|Communication|communication
5589222|NCT00934310|Ambulatory surgical patients|ambulatory surgical patients
5685422|NCT00556101|Magnetic resonance|magnetic resonance
5589223|NCT00934297|MRI visible breast lesions that are occult under ultrasound|mri visible breast lesions that are occult under ultrasound
5589224|NCT00934284|sciatic neuropathy|sciatic neuropathy
5589225|NCT00934284|physical therapy|physical therapy
5589226|NCT00934284|spinal injections|spinal injections
5589227|NCT00934271|acromegaly|acromegaly
5589228|NCT00934271|irradiation|irradiation
5589229|NCT00934271|remission|remission
5589230|NCT00934271|pituitary function|pituitary function
5589232|NCT00934258|rosuvastatin|rosuvastatin
5589233|NCT00934258|fenofibrate|fenofibrate
5589234|NCT00934258|Cardiovascular (CV) diseases|cardiovascular (cv) diseases
5589235|NCT00934258|dyslipidemia|dyslipidemia
5589236|NCT00934258|metabolic syndrome|metabolic syndrome
5589237|NCT00934258|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes|identify genetic determinants of the wide range of interindividual variability in phenotypic and clinical response to the lipid-lowering drug classes
5589238|NCT00934258|identify genetic susceptibility to drug-related side effects.|identify genetic susceptibility to drug-related side effects.
5589239|NCT00934245|Influenza|influenza
5589240|NCT00934245|India|india
5589241|NCT00934245|Children|children
5589242|NCT00934245|Trivalent Influenza Vaccine (TIV)|trivalent influenza vaccine (tiv)
5589243|NCT00934245|Inactivated poliovirus vaccine (IPV)|inactivated poliovirus vaccine (ipv)
5589244|NCT00934245|Direct vaccine effectiveness|direct vaccine effectiveness
5589245|NCT00934245|Indirect vaccine effectiveness|indirect vaccine effectiveness
5589246|NCT00934232|cancer|cancer
5589247|NCT00934232|myeloma|myeloma
5589248|NCT00934219|hypertriglyceridemia|hypertriglyceridemia
5589249|NCT00934219|triglycerides|triglycerides
5589250|NCT00934219|familial hypertriglyceridemia|familial hypertriglyceridemia
5589251|NCT00934206|Exercise|exercise
5589252|NCT00934206|healthy subjects|healthy subjects
5589253|NCT00934180|Bioequivalence|bioequivalence
5589254|NCT00934154|multiple myeloma|multiple myeloma
5589255|NCT00934154|thalidomide|thalidomide
5589256|NCT00934154|melphalan|melphalan
5589257|NCT00934154|prednisolone|prednisolone
5589258|NCT00934154|newly diagnosed|newly diagnosed
5589259|NCT00934154|elderly|elderly
5589260|NCT00934154|not eligible for transplantation|not eligible for transplantation
5589261|NCT00934141|Organizational change|organizational change
5589262|NCT00934141|process improvement|process improvement
5589263|NCT00934141|addiction treatment|addiction treatment
5589264|NCT00934141|cost effectiveness study|cost effectiveness study
5589265|NCT00934128|Advanced Cancer|advanced cancer
5589266|NCT00934128|Persistent Dyspnea|persistent dyspnea
5589267|NCT00934128|Shortness of breath|shortness of breath
5589268|NCT00934128|Specialized breathing devices|specialized breathing devices
5589269|NCT00934128|Bilevel positive airway pressure device|bilevel positive airway pressure device
5589270|NCT00934128|BIPAP|bipap
5589271|NCT00934128|High flow oxygen delivery device|high flow oxygen delivery device
5589272|NCT00934128|VapoTherm|vapotherm
5589273|NCT00934128|Edmonton Symptom Assessment Scale|edmonton symptom assessment scale
5589274|NCT00934128|ESAS|esas
5589275|NCT00934115|To define the incidence, categories of infections by organ systems, etiologic agents and risk|to define the incidence, categories of infections by organ systems, etiologic agents and risk
5589276|NCT00934037|Coronary Artery Disease|coronary artery disease
5589277|NCT00934037|Computed Tomography|computed tomography
5589278|NCT00934037|Myoperfusion|myoperfusion
5589279|NCT00934037|Angiography|angiography
5589280|NCT00934037|SPECT|spect
5589281|NCT00934024|nicotine dependence|nicotine dependence
5589282|NCT00934024|tobacco|tobacco
5589283|NCT00934024|smoking|smoking
5589284|NCT00934011|C-reactive protein|c-reactive protein
5589285|NCT00934011|procalcitonin|procalcitonin
5589286|NCT00934011|sepsis|sepsis
5589287|NCT00934011|antibiotic therapy|antibiotic therapy
5589288|NCT00933998|DPN|dpn
5589289|NCT00933959|Sleep problems|sleep problems
5589290|NCT00933959|Awareness training program|awareness training program
5589291|NCT00933959|Mind body bridging|mind body bridging
5589292|NCT00933920|Aliskiren,|aliskiren,
5589293|NCT00933920|hypertension,|hypertension,
5589294|NCT00933920|renin-angiotensin-aldosterone system,|renin-angiotensin-aldosterone system,
5589295|NCT00933920|pharmacokinetics,|pharmacokinetics,
5589296|NCT00933920|pharmacodynamics|pharmacodynamics
5589297|NCT00933894|VX-950-TiDP24-C133|vx-950-tidp24-c133
5589298|NCT00933894|VX-950-C133|vx-950-c133
5589299|NCT00933894|VX950|vx950
5589300|NCT00933894|HCV|hcv
5589301|NCT00933894|telaprevir|telaprevir
5589302|NCT00933894|escitalopram|escitalopram
5589303|NCT00933881|GDM|gdm
5589304|NCT00933868|A stroke that occurred three months to four years ago|a stroke that occurred three months to four years ago
5589305|NCT00933855|Training Workshop|training workshop
5589306|NCT00933855|Communication|communication
5589307|NCT00933855|Questionnaires|questionnaires
5589308|NCT00933855|Multiple Diseases|multiple diseases
5589309|NCT00933829|absorbable sutures|absorbable sutures
5589310|NCT00933829|non-absorbable sutures|non-absorbable sutures
5589311|NCT00933829|wound management|wound management
5589312|NCT00933816|sorafenib|sorafenib
5589313|NCT00933816|intraarterial infusion chemotherapy|intraarterial infusion chemotherapy
5589314|NCT00933816|Low dose FP|low dose fp
5589315|NCT00933816|cisplatin|cisplatin
5589316|NCT00933816|fluorouracil|fluorouracil
5589317|NCT00933790|TB|tb
5589318|NCT00933790|HIV|hiv
5589319|NCT00933790|ARR|arr
5589320|NCT00933790|Short course chemotherapy|short course chemotherapy
5589321|NCT00933790|Drug resistance|drug resistance
5589322|NCT00933751|central venous oxygen saturation|central venous oxygen saturation
5589323|NCT00933751|oxygen transport|oxygen transport
5589324|NCT00933751|physiologic monitoring|physiologic monitoring
5589325|NCT00933751|tissue oxygenation|tissue oxygenation
5589326|NCT00933751|Patients before high risk abdominal surgery|patients before high risk abdominal surgery
5589327|NCT00933738|Patients needing OAT (Oral Anticoagulation Therapy)|patients needing oat (oral anticoagulation therapy)
5589328|NCT00933725|menopausal syndrome|menopausal syndrome
5589329|NCT00933725|TCM intervention|tcm intervention
5589330|NCT00933673|NK/T cell lymphoma|nk/t cell lymphoma
5589332|NCT00933673|L-asparaginase|l-asparaginase
5589333|NCT00933660|Education|education
5589334|NCT00933660|Retention|retention
5589335|NCT00933660|Retrieval|retrieval
5589336|NCT00933647|Camellia sinensis|camellia sinensis
5589337|NCT00933647|Ilex paraguariensis|ilex paraguariensis
5589338|NCT00933647|Green tea|green tea
5589339|NCT00933647|Yerba mate tea|yerba mate tea
5589340|NCT00933647|Maté|maté
5589341|NCT00933647|Dyslipidemia|dyslipidemia
5862987|NCT00001426|Cisplatin|cisplatin
5589342|NCT00933647|Inflammation|inflammation
5589343|NCT00933647|Obesity|obesity
5589344|NCT00933634|atrial fibrillation|atrial fibrillation
5589345|NCT00933634|electrical cardioversion|electrical cardioversion
5589346|NCT00933634|pharmacological cardioversion|pharmacological cardioversion
5589347|NCT00933608|subjective memory complaints|subjective memory complaints
5589348|NCT00933608|cognitively healthy|cognitively healthy
5589349|NCT00933608|family history|family history
5589350|NCT00933608|AD|ad
5589351|NCT00933595|HIV|hiv
5589352|NCT00933595|Lung|lung
5589353|NCT00933582|Osteoarthritis, Knee|osteoarthritis, knee
5589354|NCT00933582|Knee Pain|knee pain
5589355|NCT00933582|Pain Measurement|pain measurement
5589356|NCT00933582|Naproxen|naproxen
5589357|NCT00933582|Placebo|placebo
5589358|NCT00933582|Treatment Outcome|treatment outcome
5589359|NCT00933556|infection|infection
5589360|NCT00933556|probiotics|probiotics
5589361|NCT00933543|Acne Vulgaris|acne vulgaris
5589362|NCT00933543|Moderate to severe|moderate to severe
5589363|NCT00933517|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy|breast cancer, neoadjuvant therapies, chemotherapy, targeted therapy
5589364|NCT00933491|healthy|healthy
5589365|NCT00933478|Patulous Eustachian Tube Dysfunction|patulous eustachian tube dysfunction
5589366|NCT00933465|Fecal incontinence|fecal incontinence
5589367|NCT00933452|duloxetine|duloxetine
5589368|NCT00933452|pharmacokinetics|pharmacokinetics
5589369|NCT00933452|antidepressant|antidepressant
5589370|NCT00933452|antidepressive agents|antidepressive agents
5589371|NCT00933452|depression|depression
5589372|NCT00933452|psychotropic drugs|psychotropic drugs
5589373|NCT00933452|safety|safety
5589374|NCT00933452|Chinese|chinese
5589377|NCT00933439|Depression|depression
5589378|NCT00933439|Major Depressive Disorder|major depressive disorder
5589379|NCT00933439|Cognitive Function|cognitive function
5589380|NCT00933439|Psychosocial Function|psychosocial function
5589381|NCT00933426|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5589382|NCT00933426|CRPC|crpc
5589383|NCT00933426|Prostate|prostate
5589384|NCT00933426|Lenalidomide|lenalidomide
5589385|NCT00933426|Revlimid|revlimid
5589386|NCT00933426|CC-5103|cc-5103
5589387|NCT00933426|Paclitaxel|paclitaxel
5589388|NCT00933426|Taxol|taxol
5589389|NCT00933426|Taxanes|taxanes
5574615|NCT00989040|NPZ|npz
5589390|NCT00933400|Computed Tomography|computed tomography
5589392|NCT00933400|Cardiac CT|cardiac ct
5589393|NCT00933400|CT|ct
5589394|NCT00933400|Cardiac CTA|cardiac cta
5589395|NCT00933400|Chest Pain|chest pain
5589396|NCT00933400|Heart Attack|heart attack
5589397|NCT00933400|Emergency Department|emergency department
5589398|NCT00933400|Myocardial Infarction|myocardial infarction
5589399|NCT00933400|Cost Effectiveness|cost effectiveness
5589400|NCT00933400|Acute Coronary Event|acute coronary event
5589401|NCT00933400|Heart Imaging|heart imaging
5589402|NCT00933387|oral squamous cell carcinoma|oral squamous cell carcinoma
5589403|NCT00933387|neoadjuvant bio-chemotherapy|neoadjuvant bio-chemotherapy
5589404|NCT00933387|concurrent bio-radiotherapy|concurrent bio-radiotherapy
5589405|NCT00933387|biomarker|biomarker
5589406|NCT00933374|bladder cancer|bladder cancer
5589407|NCT00933374|RAD001|rad001
5589408|NCT00933374|Paclitaxel|paclitaxel
5589409|NCT00933361|Adult|adult
5589410|NCT00933348|ulcer|ulcer
5589411|NCT00933348|venous|venous
5589412|NCT00933348|pressure|pressure
5589413|NCT00933348|wound|wound
5589414|NCT00933348|treatment|treatment
5589415|NCT00933322|ruminant|ruminant
5589416|NCT00933322|industrial|industrial
5589417|NCT00933322|endothelial function|endothelial function
5589418|NCT00933322|flow-mediated dilation|flow-mediated dilation
5589419|NCT00933322|blood lipids|blood lipids
5589420|NCT00933322|nutrition|nutrition
5589421|NCT00933322|trans fatty acids|trans fatty acids
5589422|NCT00933322|coronary disease|coronary disease
5589423|NCT00933322|endothelial function of the brachial artery|endothelial function of the brachial artery
5589424|NCT00933322|inflammation|inflammation
5589425|NCT00933322|insulin resistancy|insulin resistancy
5589426|NCT00933322|coagulation|coagulation
5589427|NCT00933309|Breast|breast
5589428|NCT00933309|Obese|obese
5589429|NCT00933309|Obesity Treatment|obesity treatment
5589430|NCT00933309|Exemestane|exemestane
5589431|NCT00933309|Aromasin|aromasin
5589432|NCT00933309|Metformin and Rosiglitazone|metformin and rosiglitazone
5589433|NCT00933309|Avandamet|avandamet
5589434|NCT00933309|Postmenopausal|postmenopausal
5589435|NCT00933309|Hormone-sensitive|hormone-sensitive
5589436|NCT00933309|Hormone-receptive-positive breast cancer|hormone-receptive-positive breast cancer
5589437|NCT00933296|Schnitzler syndrome|schnitzler syndrome
5589438|NCT00933296|Waldentsröm's disease|waldentsröm's disease
5589439|NCT00933296|anakinra|anakinra
5589440|NCT00933283|Healthy participants|healthy participants
5589441|NCT00933283|Pharmacokinetics|pharmacokinetics
5589442|NCT00933283|Pharmacodynamic|pharmacodynamic
5589443|NCT00933283|Potential interaction|potential interaction
5589444|NCT00933283|VX-950-TiDP24-C135|vx-950-tidp24-c135
5589445|NCT00933283|VX-950|vx-950
5589446|NCT00933283|Methadone|methadone
5589447|NCT00933283|Telaprevir|telaprevir
5589449|NCT00933270|Superficial Femoral Artery or SFA|superficial femoral artery or sfa
5589450|NCT00933244|Vitamin D|vitamin d
5589451|NCT00933244|Cholecalciferol|cholecalciferol
5589452|NCT00933244|Parathyroid Hormone|parathyroid hormone
5589453|NCT00933244|Calcium Absorption|calcium absorption
5589454|NCT00933244|Bone Mineral Density|bone mineral density
5589455|NCT00933244|Muscle Function|muscle function
5589456|NCT00933231|Tacrolimus|tacrolimus
5589457|NCT00933231|Kidney Transplantation|kidney transplantation
5589458|NCT00933231|Advagraf|advagraf
5589459|NCT00933231|Immunosuppression|immunosuppression
5589460|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5589461|NCT00933179|Prevention of pregnancy|prevention of pregnancy
5589462|NCT00933153|Elderly|elderly
5589463|NCT00933153|Malnutrition|malnutrition
5589464|NCT00933153|Oral Nutrition Supplement|oral nutrition supplement
5589465|NCT00933153|Meals on Wheels|meals on wheels
5589466|NCT00933140|HIV|hiv
5589467|NCT00933140|women|women
5589468|NCT00933140|anal cytology|anal cytology
5589469|NCT00933127|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5589470|NCT00933127|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5589471|NCT00933127|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5589472|NCT00933127|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5589473|NCT00933127|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5589474|NCT00933127|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5590161|NCT00930046|pediatric|pediatric
5589475|NCT00933127|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5589476|NCT00933127|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5589477|NCT00933127|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5589478|NCT00933127|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5589479|NCT00933127|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5672119|NCT00612989|Neulasta|neulasta
5589480|NCT00933127|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5589481|NCT00933114|DCE MRI|dce mri
5589482|NCT00933114|PET|pet
5589483|NCT00933114|Perfusion|perfusion
5589484|NCT00933114|Permeability|permeability
5589485|NCT00933114|Cancer of the head and neck|cancer of the head and neck
5589486|NCT00933114|Head, Neck neoplasms|head, neck neoplasms
5589487|NCT00933088|adolescent coping strategies|adolescent coping strategies
5589488|NCT00933088|stress response|stress response
5589489|NCT00933088|breast cancer|breast cancer
5589490|NCT00933049|Efficacy|efficacy
5589491|NCT00933049|children|children
5589492|NCT00933049|pneumonia|pneumonia
5589493|NCT00933049|cotrimoxazole|cotrimoxazole
5589494|NCT00933049|amoxicillin|amoxicillin
5589495|NCT00933036|Osteoporosis|osteoporosis
5589496|NCT00933036|VCF|vcf
5589497|NCT00933036|PVA|pva
5589498|NCT00933036|Vertebroplasty|vertebroplasty
5589499|NCT00933036|Kyphoplasty|kyphoplasty
5589500|NCT00933036|Vertebral fracture|vertebral fracture
5589501|NCT00933036|Pathologic fracture|pathologic fracture
5589502|NCT00933036|Vertebral augmentation|vertebral augmentation
5589503|NCT00933010|metabolic syndrome|metabolic syndrome
5589504|NCT00933010|lipids|lipids
5589505|NCT00933010|waist circumference|waist circumference
5589506|NCT00933010|HDL|hdl
5589507|NCT00933010|hypertension|hypertension
5589508|NCT00932997|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5589509|NCT00932997|stage I breast cancer|stage i breast cancer
5589510|NCT00932997|stage II breast cancer|stage ii breast cancer
5589511|NCT00932997|stage IIIA breast cancer|stage iiia breast cancer
5589512|NCT00932997|cancer survivor|cancer survivor
5589513|NCT00932958|Myocardial Infarction|myocardial infarction
5589514|NCT00932919|Agoraphobia|agoraphobia
5589515|NCT00932919|Cognitive therapy|cognitive therapy
5589516|NCT00932919|Thought field therapy|thought field therapy
5589517|NCT00932919|Psychotherapy research|psychotherapy research
5589518|NCT00932906|Education|education
5589519|NCT00932906|Retention|retention
5589520|NCT00932906|Retrieval|retrieval
5589521|NCT00932906|Self training|self training
5589522|NCT00932893|Lung Neoplasms ALK gene crizotinib|lung neoplasms alk gene crizotinib
5589523|NCT00932867|Arterial Hypertension|arterial hypertension
5589524|NCT00932854|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5589526|NCT00932854|Bronchoscopy|bronchoscopy
5589527|NCT00932854|Sarcoidosis|sarcoidosis
5589528|NCT00932828|Peanut allergy|peanut allergy
5589529|NCT00932802|Non-Interventional|non-interventional
5589530|NCT00932802|Observational|observational
5589532|NCT00932802|Moxifloxacin|moxifloxacin
5589533|NCT00932802|MXF|mxf
5589534|NCT00932802|Avelox|avelox
5589535|NCT00932802|AECB|aecb
5574751|NCT00988377|blood glucose|blood glucose
5589536|NCT00932750|Body composition|body composition
5589537|NCT00932750|Weight loss|weight loss
5589538|NCT00932750|Weight management|weight management
5589539|NCT00932750|Beverages|beverages
5589542|NCT00932724|Colorectal|colorectal
5589543|NCT00932724|Cancer|cancer
5589544|NCT00932724|refractory|refractory
5589545|NCT00932724|Phase II|phase ii
5589546|NCT00932724|randomised|randomised
5589547|NCT00932724|double-blind|double-blind
5589548|NCT00932724|controlled|controlled
5589549|NCT00932724|multicenter|multicenter
5589550|NCT00932724|CY-503|cy-503
5589551|NCT00932724|Cytavis|cytavis
5589552|NCT00932711|COPD|copd
5589553|NCT00932698|Relapsed multiple myeloma|relapsed multiple myeloma
5589554|NCT00932698|Refractory multiple myeloma|refractory multiple myeloma
5589555|NCT00932698|Ixazomib Proteasome inhibitor|ixazomib proteasome inhibitor
5589556|NCT00932685|pediatric emergence agitation and pain|pediatric emergence agitation and pain
5589557|NCT00932672|Prostate Cancer|prostate cancer
5589558|NCT00932672|Atkins|atkins
5589559|NCT00932659|End-Stage Renal Disease|end-stage renal disease
5589560|NCT00932659|Hemodialysis|hemodialysis
5589561|NCT00932659|Cardiac Arrhythmias|cardiac arrhythmias
5589562|NCT00932633|neonatal brain injury|neonatal brain injury
5589563|NCT00932633|congenital heart disease|congenital heart disease
5589564|NCT00932633|magnetic resonance imaging|magnetic resonance imaging
5589565|NCT00932633|cardiopulmonary bypass|cardiopulmonary bypass
5589566|NCT00932633|neurodevelopmental outcome|neurodevelopmental outcome
5589567|NCT00932620|hypercholesterolemia|hypercholesterolemia
5589568|NCT00932620|statins|statins
5589569|NCT00932620|simvastatin|simvastatin
5589570|NCT00932620|ezetimibe|ezetimibe
5589571|NCT00932620|LDL particles|ldl particles
5589572|NCT00932607|seasonal|seasonal
5589573|NCT00932607|rhinitis|rhinitis
5589574|NCT00932607|rhinoconjunctivitis|rhinoconjunctivitis
5589575|NCT00932607|birch pollen|birch pollen
5589576|NCT00932607|immunotherapy|immunotherapy
5589577|NCT00932607|sublingual|sublingual
5589578|NCT00932594|Create the New Serial Treatment of TMD|create the new serial treatment of tmd
5589579|NCT00932594|Promote the Classification of Biodynamics in the TMD|promote the classification of biodynamics in the tmd
5589580|NCT00932594|Evaluate the Effect of Adjusting TMJ Treatment|evaluate the effect of adjusting tmj treatment
5589581|NCT00932594|Establish the New Standard of the TMJ Treatment|establish the new standard of the tmj treatment
5589582|NCT00932594|Invent New Device to Measure Pressure without Trauma|invent new device to measure pressure without trauma
5589583|NCT00932581|Parkinson's Disease|parkinson's disease
5589584|NCT00932581|Movement Disorders|movement disorders
5589585|NCT00932581|Unified Parkinson's Disease Rating Scale|unified parkinson's disease rating scale
5589586|NCT00932581|Short Parkinson's Evaluation Scale|short parkinson's evaluation scale
5589587|NCT00932581|Scales for Outcomes in Parkinson's Disease|scales for outcomes in parkinson's disease
5589588|NCT00932581|Motor Evaluation|motor evaluation
5589589|NCT00932581|Schwab and England activities of daily living|schwab and england activities of daily living
5589590|NCT00932581|Bradykinesia|bradykinesia
5589591|NCT00932581|psychometrics|psychometrics
5589592|NCT00932581|order effects|order effects
5589593|NCT00932581|hoehn yahr aging|hoehn yahr aging
5589594|NCT00932581|assessments|assessments
5589595|NCT00932555|Octocog alfa|octocog alfa
5589596|NCT00932555|Hemophilia A|hemophilia a
5589597|NCT00932542|Hemorrhoidectomy|hemorrhoidectomy
5589598|NCT00932529|Antipsychotic drugs|antipsychotic drugs
5589599|NCT00932529|Treatment effectiveness|treatment effectiveness
5589600|NCT00932529|Randomized controlled trial|randomized controlled trial
5589601|NCT00932516|South Beach Diet™|south beach diet™
5589602|NCT00932516|overweight|overweight
5589603|NCT00932516|obesity|obesity
5589604|NCT00932516|satiety|satiety
5589605|NCT00932516|weight loss|weight loss
5589606|NCT00932503|Vicryl plus|vicryl plus
5589607|NCT00932503|wound infection|wound infection
5589608|NCT00932503|coated suture material|coated suture material
5589609|NCT00932503|open abdominal surgery|open abdominal surgery
5589610|NCT00932503|transverse laparotomy|transverse laparotomy
5589611|NCT00932451|Lung Neoplasms ALK gene Crizotinib|lung neoplasms alk gene crizotinib
5589612|NCT00932438|colon cancer|colon cancer
5589613|NCT00932438|liver metastases|liver metastases
5589614|NCT00932425|Stroke|stroke
5589615|NCT00932425|Cryptogenic|cryptogenic
5589616|NCT00932425|Cardioembolic|cardioembolic
5589617|NCT00932425|Atrial Fibrillation|atrial fibrillation
5589618|NCT00932412|Younger Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML).|younger patients with newly-diagnosed acute myeloid leukemia (aml).
5589619|NCT00932386|Lower extremity surgery with tourniquet use|lower extremity surgery with tourniquet use
5589620|NCT00932373|HER2-positive breast cancer|her2-positive breast cancer
5589622|NCT00932373|Trastuzumab emtansine|trastuzumab emtansine
5589623|NCT00932373|Herceptin|herceptin
5589624|NCT00932373|T-DM1|t-dm1
5589625|NCT00932360|Fibromyalgia|fibromyalgia
5589626|NCT00932360|Transcutaneous Electrical Nerve Stimulation (TENS)|transcutaneous electrical nerve stimulation (tens)
5589627|NCT00932347|Camellia sinensis|camellia sinensis
5589628|NCT00932347|volatile sulfur compounds|volatile sulfur compounds
5589629|NCT00932334|kidney|kidney
5589630|NCT00932334|transplant|transplant
5589631|NCT00932334|donation|donation
5589632|NCT00932321|Contraception|contraception
5589633|NCT00932295|tobacco|tobacco
5589634|NCT00932295|cigarette|cigarette
5589635|NCT00932295|nicotine|nicotine
5589636|NCT00932282|Peanut|peanut
5589637|NCT00932282|Allergy|allergy
5589638|NCT00932282|Hypersensitivity|hypersensitivity
5589639|NCT00932269|Diphtheria|diphtheria
5589640|NCT00932269|Tetanus|tetanus
5589641|NCT00932269|Pertussis|pertussis
5589642|NCT00932269|Polio|polio
5589643|NCT00932269|Haemophilus influenzae type B|haemophilus influenzae type b
5589644|NCT00932269|Hib|hib
5589645|NCT00932269|Measles|measles
5589646|NCT00932269|Mumps|mumps
5589647|NCT00932269|Rubella|rubella
5589648|NCT00932269|Hepatitis B|hepatitis b
5589649|NCT00932269|Vaccine|vaccine
5589650|NCT00932269|Vaccination|vaccination
5589651|NCT00932269|Immunity|immunity
5589652|NCT00932269|Vaccination program|vaccination program
5589653|NCT00932269|Sweden|sweden
5589654|NCT00932269|ELISA|elisa
5589655|NCT00932256|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5589656|NCT00932243|bacteremia|bacteremia
5589657|NCT00932243|sepsis|sepsis
5589658|NCT00932243|Toll-Like-Receptors (TLRs)|toll-like-receptors (tlrs)
5589659|NCT00932204|obsessive-compulsive disorder|obsessive-compulsive disorder
5589660|NCT00932204|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5589661|NCT00932204|right dorsolateral prefrontal cortex|right dorsolateral prefrontal cortex
5589662|NCT00932204|supplementary motor area (SMA)|supplementary motor area (sma)
5589663|NCT00932191|Cataract|cataract
5589664|NCT00932191|Corneal endothelial cell loss|corneal endothelial cell loss
5589665|NCT00932191|Ultrasound power|ultrasound power
5589666|NCT00932191|Corneal endothelium|corneal endothelium
5589667|NCT00932178|Anxiety|anxiety
5589668|NCT00932178|Worry|worry
5589669|NCT00932178|nervousness|nervousness
5589670|NCT00932178|Older Adult|older adult
5590162|NCT00930046|children|children
5589671|NCT00932152|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5589672|NCT00932152|postmenopausal|postmenopausal
5589673|NCT00932152|bevacizumab|bevacizumab
5589674|NCT00932152|fulvestrant|fulvestrant
5589675|NCT00932152|anastrozole|anastrozole
5589676|NCT00932139|Hypertension|hypertension
5589677|NCT00932139|blood pressure|blood pressure
5589678|NCT00932139|arrhythmias|arrhythmias
5589679|NCT00932139|mild to moderate hypertension|mild to moderate hypertension
5589680|NCT00932126|Phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study|phase 1 dose escalation dose finding pharmacokinetic and pharmacodynamic study
5589681|NCT00932113|tumor necrosis factor (TNF) inhibitor|tumor necrosis factor (tnf) inhibitor
5589682|NCT00932113|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
5589683|NCT00932113|Methotrexate|methotrexate
5589684|NCT00932113|treatment|treatment
5589685|NCT00932113|mechanism|mechanism
5589686|NCT00932113|psoriasis|psoriasis
5589687|NCT00932100|ACS|acs
5589688|NCT00932100|Acute Coronary Syndrome|acute coronary syndrome
5589689|NCT00932100|Catheterization|catheterization
5589690|NCT00932087|Platelet function|platelet function
5589691|NCT00932087|diabetes|diabetes
5589692|NCT00932087|metabolic syndrome|metabolic syndrome
5589693|NCT00932074|Atopic Dermatitis|atopic dermatitis
5589694|NCT00932061|Fibromyalgia|fibromyalgia
5589695|NCT00932061|Healthy controls|healthy controls
5589696|NCT00932061|Acupuncture|acupuncture
5589697|NCT00932061|Sham Acupuncture|sham acupuncture
5589698|NCT00932061|fMRI|fmri
5589699|NCT00932061|Biological marker|biological marker
5589700|NCT00932048|Diabetes Mellitus|diabetes mellitus
5589701|NCT00932048|Statins|statins
5589702|NCT00932048|PET|pet
5589703|NCT00932035|breast cancer|breast cancer
5589704|NCT00932035|axillary mapping|axillary mapping
5589705|NCT00932035|lymphedema|lymphedema
5589706|NCT00932009|Human papillomavirus infection|human papillomavirus infection
5589707|NCT00932009|Tanzanian men|tanzanian men
5589708|NCT00932009|Prevalence|prevalence
5589709|NCT00931996|schizophrenia|schizophrenia
5589710|NCT00931996|antipsychotic|antipsychotic
5589711|NCT00931996|risperidone|risperidone
5589712|NCT00931983|Incomplete spinal cord injuries|incomplete spinal cord injuries
5589713|NCT00931983|Walking|walking
5589714|NCT00931983|Treadmill|treadmill
5589715|NCT00931983|Training|training
5589716|NCT00931970|Hemodialysis|hemodialysis
5589717|NCT00931970|Peritoneal dialysis|peritoneal dialysis
5589718|NCT00931970|Mortality|mortality
5589719|NCT00931970|Prospective cohort|prospective cohort
5589720|NCT00931970|Clinical study|clinical study
5589721|NCT00931957|Etanercept|etanercept
5589722|NCT00931957|Behcet's syndrome|behcet's syndrome
5589723|NCT00931957|Behcet's Disease|behcet's disease
5589724|NCT00931957|Ocular Lesions|ocular lesions
5589725|NCT00931957|Uveitis|uveitis
5589726|NCT00931957|Retinal Vasculitis|retinal vasculitis
5589728|NCT00931944|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5589729|NCT00931944|Lou Gehrig|lou gehrig
5574950|NCT00987649|HE4|he4
5589730|NCT00931944|Lou Gehrig's|lou gehrig's
5589731|NCT00931944|Lou Gehrig's disease|lou gehrig's disease
5589732|NCT00931944|Motor Neuron Disease|motor neuron disease
5589733|NCT00931944|Nervous System Diseases|nervous system diseases
5589734|NCT00931944|KNS-760704|kns-760704
5589735|NCT00931944|RTPB|rtpb
5589736|NCT00931905|This study included workers exposed to lead.|this study included workers exposed to lead.
5589737|NCT00931892|celiac disease|celiac disease
5589738|NCT00931892|gluten challenge|gluten challenge
5589739|NCT00931866|diclofenac|diclofenac
5589740|NCT00931866|acute pain|acute pain
5589742|NCT00931866|patch|patch
5589743|NCT00931866|Acute Pain due to Mild to Moderate Soft Tissue Injury|acute pain due to mild to moderate soft tissue injury
5589744|NCT00931840|EZN-2208 (PEG-SN38)|ezn-2208 (peg-sn38)
5589745|NCT00931827|Contraception|contraception
5589746|NCT00931814|Depression|depression
5589747|NCT00931814|physical function|physical function
5589748|NCT00931814|Quality of life|quality of life
5589749|NCT00931801|AIDS|aids
5589750|NCT00931801|HIV|hiv
5589751|NCT00931801|Atazanavir|atazanavir
5589752|NCT00931801|Raltegravir|raltegravir
5589753|NCT00931801|Tenofovir|tenofovir
5589754|NCT00931801|protease inhibitors|protease inhibitors
5589755|NCT00931788|Management of hypertension and cholesterol|management of hypertension and cholesterol
5589756|NCT00931788|stroke|stroke
5589757|NCT00931788|TIA|tia
5589758|NCT00931775|Major depressive disorder, citalopram, pindolol, HDRS|major depressive disorder, citalopram, pindolol, hdrs
5589759|NCT00931762|Bone marrow|bone marrow
5589760|NCT00931762|Myelofibrosis|myelofibrosis
5589761|NCT00931762|JAK2mutation|jak2mutation
5589762|NCT00931762|Post-Polycythemia Vera|post-polycythemia vera
5589763|NCT00931762|Post-Essential Thrombocytopenia|post-essential thrombocytopenia
5589764|NCT00931749|ultrasound therapy|ultrasound therapy
5589765|NCT00931749|knee cartilage thickness|knee cartilage thickness
5589766|NCT00931749|knee cartilage volume|knee cartilage volume
5589767|NCT00931749|mild knee osteoarthritis|mild knee osteoarthritis
5589768|NCT00931749|moderate knee osteoarthritis|moderate knee osteoarthritis
5589769|NCT00931736|Tuberculosis|tuberculosis
5589770|NCT00931723|Acute Mania|acute mania
5589771|NCT00931723|Mania, Adults|mania, adults
5589772|NCT00931723|Seroquel|seroquel
5589773|NCT00931723|Acute Mania in Adult Patients|acute mania in adult patients
5589774|NCT00931710|Hypertension|hypertension
5589775|NCT00931710|combination therapy|combination therapy
5589776|NCT00931710|valsartan|valsartan
5589777|NCT00931710|cardiovascular diseases|cardiovascular diseases
5589778|NCT00931697|Mefloquine|mefloquine
5589779|NCT00931697|Malaria|malaria
5589780|NCT00931697|(+) Mefloquine|(+) mefloquine
5589781|NCT00931697|Pharmacokinetics|pharmacokinetics
5589782|NCT00931671|Physical fitness|physical fitness
5589783|NCT00931671|Cerebral circulation|cerebral circulation
5589784|NCT00931671|Walking|walking
5589785|NCT00931645|Chronic lymphocytic leukemia,|chronic lymphocytic leukemia,
5589786|NCT00931645|autologous stem cell transplantation|autologous stem cell transplantation
5589787|NCT00931632|Bronchopulmonary Dysplasia, BPD|bronchopulmonary dysplasia, bpd
5589788|NCT00931619|Fluorine-18 Fluorodeoxyglucose|fluorine-18 fluorodeoxyglucose
5589789|NCT00931619|Epilepsy|epilepsy
5589790|NCT00931619|Epileptic Focus|epileptic focus
5589791|NCT00931619|Temporal Lobe Epilepsy|temporal lobe epilepsy
5589792|NCT00931619|Depression|depression
5589793|NCT00931619|Major Depressive Disorder|major depressive disorder
5589794|NCT00931619|Healthy Volunteer|healthy volunteer
5589795|NCT00931619|HV|hv
5589796|NCT00931606|anemia|anemia
5589797|NCT00931606|metastatic|metastatic
5589798|NCT00931606|breast|breast
5589799|NCT00931606|cancer|cancer
5589800|NCT00931593|Transient lower esophageal sphincter relaxation|transient lower esophageal sphincter relaxation
5589801|NCT00931593|high resolution manometry|high resolution manometry
5589802|NCT00931593|dentsleeve probe|dentsleeve probe
5589803|NCT00931593|healthy volunteers|healthy volunteers
5589804|NCT00931580|Vitamin D|vitamin d
5589805|NCT00931580|Adolescent|adolescent
5589806|NCT00931580|African American|african american
5589808|NCT00931541|Safety|safety
5589809|NCT00931541|Tolerability|tolerability
5589810|NCT00931541|Healthy|healthy
5589811|NCT00931528|sexual dysfunction|sexual dysfunction
5589812|NCT00931528|stage IIB prostate cancer|stage iib prostate cancer
5589813|NCT00931528|stage IIA prostate cancer|stage iia prostate cancer
5589814|NCT00931528|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5589815|NCT00931515|DDD|ddd
5589816|NCT00931502|Stent thrombosis|stent thrombosis
5589817|NCT00931502|Acute Coronary Syndrome|acute coronary syndrome
5589818|NCT00931502|ACS|acs
5589819|NCT00931502|Stenting|stenting
5589820|NCT00931502|Interventional Cardiology|interventional cardiology
5589821|NCT00931502|Cardiology|cardiology
5589822|NCT00931502|Cardiovascular Research|cardiovascular research
5589823|NCT00931502|Registry|registry
5589824|NCT00931489|Age Related Macular Degeneration|age related macular degeneration
5589825|NCT00931489|Lucentis|lucentis
5589826|NCT00931489|Ranibizumab|ranibizumab
5589827|NCT00931489|Antibodies|antibodies
5589828|NCT00931489|Retinal and RPE Autoimmunity|retinal and rpe autoimmunity
5589829|NCT00931463|second line therapy|second line therapy
5589830|NCT00931463|combination antiretroviral therapy|combination antiretroviral therapy
5589831|NCT00931463|first-line failure|first-line failure
5589832|NCT00931463|AIDS|aids
5589833|NCT00931463|treatment experienced|treatment experienced
5589834|NCT00931450|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5589842|NCT00931437|Bio-availability|bio-availability
5589843|NCT00931424|Primary Chronic Venous Insufficiency|primary chronic venous insufficiency
5589844|NCT00931424|surgery|surgery
5589845|NCT00931424|reconstruction|reconstruction
5589846|NCT00931424|valve|valve
5589847|NCT00931411|Atopic Dermatitis|atopic dermatitis
5589848|NCT00931411|Vitamin B3|vitamin b3
5589849|NCT00931372|Insulin release|insulin release
5589850|NCT00931372|Diabetes mellitus type 2|diabetes mellitus type 2
5589851|NCT00931372|GLP-1 agonist|glp-1 agonist
5589852|NCT00931359|axillary|axillary
5589853|NCT00931359|hyperhidrosis|hyperhidrosis
5589854|NCT00931359|primary focal|primary focal
5589855|NCT00931346|HIV|hiv
5589856|NCT00931346|Human Immunodeficiency Virus|human immunodeficiency virus
5589857|NCT00931333|Vertebroplasty|vertebroplasty
5589858|NCT00931333|spine|spine
5589859|NCT00931333|vertebra height|vertebra height
5589860|NCT00931333|adverse events|adverse events
5589861|NCT00931333|calcium phosphate bone cement|calcium phosphate bone cement
5589862|NCT00931320|Ratio improvement|ratio improvement
5589863|NCT00931320|LDL-C|ldl-c
5589864|NCT00931320|HDL-C|hdl-c
5589865|NCT00931320|Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement|ratio of low density lipoprotein cholesterol to high density lipoprotein cholesterol improvement
5589866|NCT00931320|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
5590163|NCT00930046|continuous|continuous
5589867|NCT00931281|Multiple Ascending Doses|multiple ascending doses
5768508|NCT00250185|HV|hv
5589868|NCT00931268|Lipoatrophy|lipoatrophy
5589869|NCT00931268|Buttock treatment|buttock treatment
5589870|NCT00931255|kidney transplant|kidney transplant
5589871|NCT00931255|tacrolimus|tacrolimus
5589872|NCT00931255|sirolimus|sirolimus
5589873|NCT00931255|delayed graft function|delayed graft function
5589874|NCT00931255|Graft survival|graft survival
5589875|NCT00931255|Acute rejection|acute rejection
5589876|NCT00931255|Chronic allograft nephropathy|chronic allograft nephropathy
5589877|NCT00931242|eczema|eczema
5589878|NCT00931242|dermatitis|dermatitis
5589879|NCT00931242|TNF blockade|tnf blockade
5589880|NCT00931242|PDE4 inhibitor|pde4 inhibitor
5589881|NCT00931242|T cell inhibitor|t cell inhibitor
5589882|NCT00931229|hepatitis B reactivation|hepatitis b reactivation
5589883|NCT00931216|PMTCT|pmtct
5589884|NCT00931216|Vertical transmission of HIV|vertical transmission of hiv
5589885|NCT00931216|Pregnant women|pregnant women
5589886|NCT00931216|Infant HIV testing|infant hiv testing
5589887|NCT00931216|Kenya|kenya
5589888|NCT00931216|AIDS|aids
5589889|NCT00931164|phase I/II study|phase i/ii study
5589890|NCT00931164|effects of sodium oxybate|effects of sodium oxybate
5589891|NCT00931164|cohort of 6 children and young adults|cohort of 6 children and young adults
5589892|NCT00931164|AHC|ahc
5589893|NCT00931138|Acute Myeloid Leukemia in adults|acute myeloid leukemia in adults
5589894|NCT00931138|Newly-diagnosed untreated AML|newly-diagnosed untreated aml
5589895|NCT00931138|Patient aged 50 to 70 years|patient aged 50 to 70 years
5589896|NCT00931125|Severe proliferative diabetic retinopathy|severe proliferative diabetic retinopathy
5589897|NCT00931112|Peripheral Arterial Disease|peripheral arterial disease
5589898|NCT00931112|Walking ability|walking ability
5589899|NCT00931112|Quality of life|quality of life
5589900|NCT00931112|Exercise training|exercise training
5589901|NCT00931099|pregnancy|pregnancy
5589902|NCT00931099|sleep disordered breathing|sleep disordered breathing
5589903|NCT00931099|obstructive sleep apnea|obstructive sleep apnea
5589904|NCT00931086|Rheumatoid Arthritis|rheumatoid arthritis
5589906|NCT00931073|Drug Interactions|drug interactions
5589907|NCT00931073|pharmacokinetics|pharmacokinetics
5589908|NCT00931073|CYP2D6|cyp2d6
5589909|NCT00931073|CYP2C19|cyp2c19
5589910|NCT00931073|ketoconazole|ketoconazole
5589911|NCT00931073|omeprazole|omeprazole
5589912|NCT00931060|Ammonia|ammonia
5589913|NCT00931060|Citric acid cycle|citric acid cycle
5589914|NCT00931060|Branched Chain Amino Acids|branched chain amino acids
5589915|NCT00931034|South Beach Diet™|south beach diet™
5589916|NCT00931034|overweight|overweight
5589918|NCT00931034|satiety|satiety
5589919|NCT00931034|weight loss|weight loss
5589920|NCT00931034|diabetes|diabetes
5589921|NCT00931008|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
5589922|NCT00930982|Ciprofloxacin|ciprofloxacin
5589924|NCT00930982|Bronchiectasis|bronchiectasis
5589925|NCT00930969|Cardiac Ischemia|cardiac ischemia
5589926|NCT00930969|ST segment elevated Myocardial Infarction (STEMI)|st segment elevated myocardial infarction (stemi)
5589927|NCT00930969|Non-ST Segment elevated Myocardial Infarction (NSTEMI)|non-st segment elevated myocardial infarction (nstemi)
5589928|NCT00930969|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5589929|NCT00930969|Cardiac Electrogram (EGM)|cardiac electrogram (egm)
5589930|NCT00930969|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5589931|NCT00930956|Diabetes|diabetes
5589932|NCT00930956|Obesity|obesity
5589933|NCT00930956|Hyperglycemia|hyperglycemia
5589934|NCT00930956|Dietary Fiber|dietary fiber
5589935|NCT00930956|Wheat|wheat
5589936|NCT00930956|Grain|grain
5589937|NCT00930943|opioid tolerant|opioid tolerant
5589938|NCT00930943|chronic pain|chronic pain
5589939|NCT00930930|triple-negative breast cancer|triple-negative breast cancer
5589940|NCT00930930|stage II breast cancer|stage ii breast cancer
5589941|NCT00930930|stage IIIA breast cancer|stage iiia breast cancer
5589942|NCT00930930|stage IIIB breast cancer|stage iiib breast cancer
5589943|NCT00930930|stage IIIC breast cancer|stage iiic breast cancer
5589944|NCT00930930|male breast cancer|male breast cancer
5589945|NCT00930917|delivery room, polyethylene cap, preterm infant, temperature|delivery room, polyethylene cap, preterm infant, temperature
5589946|NCT00930891|Extensive-Disease Small-Cell Lung Cancer|extensive-disease small-cell lung cancer
5589947|NCT00930878|registry|registry
5589948|NCT00930878|drug eluting coronary stent system|drug eluting coronary stent system
5589949|NCT00930878|observational|observational
5589950|NCT00930878|prospective|prospective
5589951|NCT00930878|open-label|open-label
5589952|NCT00930852|Migraine|migraine
5589953|NCT00930852|Children|children
5589954|NCT00930852|Primary headache disorders|primary headache disorders
5589955|NCT00930852|Appetite|appetite
5589956|NCT00930852|Obesity|obesity
5589957|NCT00930852|Feeding Behavior|feeding behavior
5589958|NCT00930839|Niacin|niacin
5589959|NCT00930839|Prostaglandin D2|prostaglandin d2
5589960|NCT00930839|Flushing|flushing
5589961|NCT00930839|Nicotinic acid stimulated release of prostaglandin D2|nicotinic acid stimulated release of prostaglandin d2
5589962|NCT00930826|The effect of bronchial asthma on school performance|the effect of bronchial asthma on school performance
5589963|NCT00930813|Drug coated balloon|drug coated balloon
5589964|NCT00930813|SFA disease|sfa disease
5589965|NCT00930813|Femoropopliteal disease|femoropopliteal disease
5589966|NCT00930813|Angioplasty|angioplasty
5589967|NCT00930813|PAD|pad
5589968|NCT00930813|Paclitaxel|paclitaxel
5589969|NCT00930813|Tubulin modulators|tubulin modulators
5589970|NCT00930813|Antineoplastic Agents|antineoplastic agents
5589971|NCT00930813|Mitosis Modulators|mitosis modulators
5589972|NCT00930813|Balloon angioplasty|balloon angioplasty
5589973|NCT00930813|Local drug delivery|local drug delivery
5589974|NCT00930813|Restenosis|restenosis
5572649|NCT00996138|Adult|adult
5589975|NCT00930813|Drug-coated balloon|drug-coated balloon
5589976|NCT00930800|Exercise capacity|exercise capacity
5589977|NCT00930800|Physical activity|physical activity
5589978|NCT00930800|Quality of life|quality of life
5589979|NCT00930787|hernia repair, surgical mesh, co-morbidities|hernia repair, surgical mesh, co-morbidities
5589980|NCT00930774|traumatic brain injury|traumatic brain injury
5589981|NCT00930774|rehabilitation|rehabilitation
5589982|NCT00930774|auditory processing disorder|auditory processing disorder
5589983|NCT00930761|breast feeding|breast feeding
5589984|NCT00930761|music therapy|music therapy
5589985|NCT00930761|maternal welfare|maternal welfare
5589986|NCT00930761|infant, newborn|infant, newborn
5589987|NCT00930722|Quinapril non-interventional/observational study safety|quinapril non-interventional/observational study safety
5589988|NCT00930709|Botulinum Toxin Type A|botulinum toxin type a
5589989|NCT00930709|Exercise|exercise
5589990|NCT00930709|Randomized Controlled Trial|randomized controlled trial
5589991|NCT00930709|Muscle Stretching Exercises|muscle stretching exercises
5589992|NCT00930709|Strength Training|strength training
5589993|NCT00930709|Treatment Outcome|treatment outcome
5589994|NCT00930696|endometriosis|endometriosis
5589995|NCT00930696|abdominal lavage|abdominal lavage
5589996|NCT00930696|bowel perforation|bowel perforation
5589997|NCT00930696|discoid resection|discoid resection
5589998|NCT00930696|laparoscopy|laparoscopy
5589999|NCT00930670|ranitidine|ranitidine
5590000|NCT00930670|pantoprazole|pantoprazole
5590001|NCT00930670|esomeprazole|esomeprazole
5590002|NCT00930670|omeprazole|omeprazole
5590003|NCT00930670|atorvastatin|atorvastatin
5592738|NCT00920283|PCI|pci
5590005|NCT00930670|statin|statin
5590006|NCT00930670|clopidogrel resistance|clopidogrel resistance
5590007|NCT00930670|antiplatelet therapy|antiplatelet therapy
5590008|NCT00930670|coronary artery disease|coronary artery disease
5590009|NCT00930670|percutaneous coronary intervention|percutaneous coronary intervention
5590012|NCT00930670|proton pump inhibitors|proton pump inhibitors
5590013|NCT00930670|drug interactions|drug interactions
5590014|NCT00930670|drug resistance|drug resistance
5590015|NCT00930670|genetic polymorphism|genetic polymorphism
5590016|NCT00930657|Panic Disorder|panic disorder
5590017|NCT00930657|Separation Anxiety|separation anxiety
5590018|NCT00930657|Familial|familial
5590019|NCT00930657|Risk|risk
5590020|NCT00930657|Respiratory Physiology|respiratory physiology
5590021|NCT00930644|short bowel syndrome|short bowel syndrome
5590022|NCT00930644|parenteral nutrition|parenteral nutrition
5590023|NCT00930644|PN|pn
5590024|NCT00930644|HPN|hpn
5590025|NCT00930644|TPN|tpn
5590026|NCT00930644|SBS|sbs
5590027|NCT00930631|CAD|cad
5590028|NCT00930631|Pharmacokinetics|pharmacokinetics
5590029|NCT00930631|BMS747158|bms747158
5590030|NCT00930618|Prolonged pregnancy|prolonged pregnancy
5590031|NCT00930618|Nulliparity|nulliparity
5590032|NCT00930618|Cervical ripening|cervical ripening
5590033|NCT00930618|Induced labor|induced labor
5590034|NCT00930618|Cesarean section|cesarean section
5590035|NCT00930592|Psoriasis|psoriasis
5590036|NCT00930592|Metabolic Syndrome|metabolic syndrome
5590037|NCT00930592|Cardiovascular Risk|cardiovascular risk
5590038|NCT00930566|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5590039|NCT00930566|Extracorporeal Photopheresis|extracorporeal photopheresis
5590040|NCT00930553|Multiple Sclerosis|multiple sclerosis
5590041|NCT00930501|chemotherapy|chemotherapy
5590042|NCT00930501|cancer|cancer
5590043|NCT00930501|AMH|amh
5590044|NCT00930501|gonadotoxicity|gonadotoxicity
5590045|NCT00930501|ovarian reserve|ovarian reserve
5590046|NCT00930501|patients exposed to chemotherapy|patients exposed to chemotherapy
5590047|NCT00930488|Moxifloxacin|moxifloxacin
5590048|NCT00930488|MXF|mxf
5590049|NCT00930488|Avelox|avelox
5590050|NCT00930488|Sinusitis|sinusitis
5590051|NCT00930488|Acute bacterial sinusitis, ABS|acute bacterial sinusitis, abs
5590052|NCT00930462|colonoscopy|colonoscopy
5590053|NCT00930462|cap|cap
5590054|NCT00930462|hood|hood
5590055|NCT00930462|cecal intubation time|cecal intubation time
5590056|NCT00930462|polyp detection rate|polyp detection rate
5590057|NCT00930462|performance|performance
5590058|NCT00930449|Pediatrics|pediatrics
5672120|NCT00612989|Pegfilgrastim|pegfilgrastim
5590059|NCT00930449|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5590060|NCT00930449|Learning Disorder|learning disorder
5590061|NCT00930449|Computerized Working Memory Training Program|computerized working memory training program
5590062|NCT00930436|chronic kidney disease|chronic kidney disease
5590063|NCT00930410|pancreas neoplasms|pancreas neoplasms
5590064|NCT00930410|bile duct diseases|bile duct diseases
5590065|NCT00930410|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5590066|NCT00930410|ERCP|ercp
5590067|NCT00930397|Pre-eclampsia|pre-eclampsia
5590068|NCT00930397|UTERO-placental unit vascularization|utero-placental unit vascularization
5590069|NCT00930397|Hypertension, pregnancy- induced|hypertension, pregnancy- induced
5590070|NCT00930397|IUGR|iugr
5590071|NCT00930397|Screening|screening
5590072|NCT00930397|3D Doppler Ultrasound|3d doppler ultrasound
5590073|NCT00930384|psoriasis|psoriasis
5590074|NCT00930384|fatty liver|fatty liver
5590075|NCT00930384|metabolic syndrome|metabolic syndrome
5590076|NCT00930371|fatty liver|fatty liver
5590077|NCT00930371|insulin resistance|insulin resistance
5590078|NCT00930371|diet|diet
5590079|NCT00930371|inflammation|inflammation
5590080|NCT00930371|oxidative stress|oxidative stress
5590081|NCT00930358|Sedation|sedation
5590082|NCT00930358|Colonoscopy|colonoscopy
5590083|NCT00930358|General anesthesia|general anesthesia
5590084|NCT00930345|Renal cell carcinoma|renal cell carcinoma
5590085|NCT00930345|Antiangiogenics|antiangiogenics
5590086|NCT00930345|Biomarkers|biomarkers
5590087|NCT00930345|Imagery|imagery
5590088|NCT00930332|sleep disorders|sleep disorders
5590089|NCT00930332|nausea and vomiting|nausea and vomiting
5590090|NCT00930332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5590091|NCT00930332|pain|pain
5590092|NCT00930306|Chronic Pain|chronic pain
5590093|NCT00930306|AZD2066|azd2066
5590094|NCT00930293|Interpersonal Psychotherapy|interpersonal psychotherapy
5590095|NCT00930280|stroke|stroke
5590096|NCT00930280|brain attack|brain attack
5590097|NCT00930280|hemorrhagic stroke|hemorrhagic stroke
5590098|NCT00930280|risk factors|risk factors
5590099|NCT00930267|fever|fever
5590100|NCT00930267|children|children
5590101|NCT00930267|cancer|cancer
5590102|NCT00930267|leukemia|leukemia
5590103|NCT00930267|stem cell transplantation|stem cell transplantation
5798747|NCT00111189|antipsychotic|antipsychotic
5590104|NCT00930267|infections in pediatric cancer patients presenting with fever during or following chemotherapy.|infections in pediatric cancer patients presenting with fever during or following chemotherapy.
5590106|NCT00930254|peripheral catheterization|peripheral catheterization
5590107|NCT00930254|ultrasonics|ultrasonics
5590108|NCT00930254|intravenous infusions|intravenous infusions
5590109|NCT00930241|Lung Transplantation|lung transplantation
5590110|NCT00930241|Tacrolimus|tacrolimus
5590111|NCT00930241|Deterioration of graft function|deterioration of graft function
5590112|NCT00930228|Luteinizing hormone|luteinizing hormone
5590113|NCT00930228|Testosterone|testosterone
5590114|NCT00930215|Healthy volunteer|healthy volunteer
5590115|NCT00930215|Japanese males|japanese males
5590117|NCT00930215|Bioequivalence study|bioequivalence study
5590118|NCT00930202|Traumatic Brain Injury|traumatic brain injury
5590119|NCT00930202|Conivaptan|conivaptan
5590120|NCT00930202|Vaprisol|vaprisol
5590121|NCT00930202|Sodium|sodium
5590122|NCT00930189|age related macular degeneration|age related macular degeneration
5590123|NCT00930163|Adult Asthma|adult asthma
5590124|NCT00930150|Schizoaffective Disorder|schizoaffective disorder
5590125|NCT00930137|Cardiovascular disease|cardiovascular disease
5590126|NCT00930137|Trans fatty acids|trans fatty acids
5590127|NCT00930137|Ruminant|ruminant
5590128|NCT00930137|Blood lipids|blood lipids
5590129|NCT00930137|Lipoproteins|lipoproteins
5590130|NCT00930137|Women|women
5590131|NCT00930124|cleft lip and palate|cleft lip and palate
5590132|NCT00930124|distraction osteogenesis|distraction osteogenesis
5590133|NCT00930124|conventional orthognathic surgery|conventional orthognathic surgery
5590134|NCT00930124|stability|stability
5590135|NCT00930124|morbidity|morbidity
5590136|NCT00930124|soft tissue changes|soft tissue changes
5590137|NCT00930124|psychological adjustment|psychological adjustment
5590138|NCT00930124|speech changes|speech changes
5590139|NCT00930124|velopharyngeal function|velopharyngeal function
5590140|NCT00930111|inpatient|inpatient
5590141|NCT00930111|hospitalists|hospitalists
5590142|NCT00930111|residency|residency
5590143|NCT00930111|job satisfaction|job satisfaction
5590144|NCT00930111|burnout, professional|burnout, professional
5590145|NCT00930111|professional practice|professional practice
5590146|NCT00930111|medical education|medical education
5590147|NCT00930098|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5590148|NCT00930098|clolar|clolar
5590149|NCT00930098|evoltra|evoltra
5590150|NCT00930098|clofarabine|clofarabine
5590151|NCT00930098|refractory/relapsed acute leukemia|refractory/relapsed acute leukemia
5590152|NCT00930098|pediatric acute leukemia|pediatric acute leukemia
5590153|NCT00930085|sepsis|sepsis
5590154|NCT00930085|septic shock|septic shock
5590155|NCT00930059|Alzheimer's disease|alzheimer's disease
5590156|NCT00930059|PF-04447943|pf-04447943
5590157|NCT00930059|efficacy|efficacy
5590158|NCT00930059|safety|safety
5590159|NCT00930059|plasma concentrations|plasma concentrations
5590160|NCT00930046|ropivacaine|ropivacaine
5590164|NCT00930046|wound|wound
5590165|NCT00930046|catheter|catheter
5590166|NCT00930046|infusion|infusion
5590167|NCT00930046|pyeloplasty|pyeloplasty
5590168|NCT00930033|Nephrectomy,|nephrectomy,
5590169|NCT00930033|metastatic renal cell carcinoma,|metastatic renal cell carcinoma,
5590170|NCT00930033|sunitinib|sunitinib
5590171|NCT00930020|ischemic stroke recovery|ischemic stroke recovery
5590172|NCT00930020|minocycline|minocycline
5590173|NCT00930020|neuroprotection|neuroprotection
5590174|NCT00930020|acute stroke|acute stroke
5590175|NCT00930007|Luteinizing hormone|luteinizing hormone
5590176|NCT00930007|Puberty|puberty
5590177|NCT00929994|cardiac rehab|cardiac rehab
5590178|NCT00929981|Contact Dermatitis|contact dermatitis
5590179|NCT00929981|Allergic Dermatitis|allergic dermatitis
5590180|NCT00929968|Allergic rhinitis,|allergic rhinitis,
5590181|NCT00929968|atopic patients,|atopic patients,
5590182|NCT00929968|seasonal allergy,|seasonal allergy,
5590183|NCT00929968|ragweed allergy|ragweed allergy
5590184|NCT00929955|Anti inflammatory|anti inflammatory
5590185|NCT00929955|Schizophrenia|schizophrenia
5590186|NCT00929955|Simvastatin|simvastatin
5590187|NCT00929955|ondansetron|ondansetron
5590188|NCT00929942|lung transplantation|lung transplantation
5590189|NCT00929942|bronchial stenosis|bronchial stenosis
5590190|NCT00929942|biodegradable stent|biodegradable stent
5590191|NCT00929929|Aging|aging
5590192|NCT00929929|Functionality|functionality
5590193|NCT00929929|Sarcopenia|sarcopenia
5590194|NCT00929929|Leucine|leucine
5590195|NCT00929929|Progressive resistance exercise|progressive resistance exercise
5590196|NCT00929916|colonoscopy|colonoscopy
5590197|NCT00929916|MoviPrep|moviprep
5590198|NCT00929890|Obesity|obesity
5590199|NCT00929890|Exercise|exercise
5590200|NCT00929890|Diet|diet
5590201|NCT00929890|Lifestyle|lifestyle
5590202|NCT00929890|Vascular reactivity|vascular reactivity
5590203|NCT00929890|Body composition|body composition
5590204|NCT00929890|Lipids|lipids
5590205|NCT00929890|Glucose|glucose
5590206|NCT00929890|Insulin resistance|insulin resistance
5590207|NCT00929838|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5590208|NCT00929838|Diabetes Mellitus, Adult-Onset|diabetes mellitus, adult-onset
5680346|NCT00578149|chemoradiotherapy|chemoradiotherapy
5590209|NCT00929838|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5590210|NCT00929838|African Americans|african americans
5590211|NCT00929838|Blacks|blacks
5590212|NCT00929838|Randomized Controlled Trial|randomized controlled trial
5590213|NCT00929838|Controlled Clinical Trial|controlled clinical trial
5590214|NCT00929838|Behavioral Research|behavioral research
5590215|NCT00929838|Behavioral Medicine|behavioral medicine
5590216|NCT00929825|Salivary stimulation|salivary stimulation
5590217|NCT00929825|Transplantation of hematopoietic stem cells|transplantation of hematopoietic stem cells
5590218|NCT00929825|Hyperboloid|hyperboloid
5590219|NCT00929825|Transcutaneous Electrical Stimulation|transcutaneous electrical stimulation
5590220|NCT00929812|obesity|obesity
5590221|NCT00929812|food intake|food intake
5590222|NCT00929812|glucagon|glucagon
5590223|NCT00929812|ghrelin|ghrelin
5590224|NCT00929812|glucose|glucose
5590225|NCT00929812|insulin|insulin
5590226|NCT00929786|Plasma levels isoniazid rifampicin pyrazinamide|plasma levels isoniazid rifampicin pyrazinamide
5590227|NCT00929760|Chronic Kidney disease|chronic kidney disease
5590228|NCT00929760|Nephrologists|nephrologists
5590229|NCT00929760|Primary Care|primary care
5590230|NCT00929760|Death|death
5590231|NCT00929760|Renal Replacement Therapy|renal replacement therapy
5590232|NCT00929760|Specialised renal care|specialised renal care
5590233|NCT00929747|Cataract|cataract
5590234|NCT00929747|Toric|toric
5590235|NCT00929747|IOL|iol
5590236|NCT00929747|AcrySof, LRI|acrysof, lri
5590237|NCT00929734|Inflammation|inflammation
5590238|NCT00929734|Atherosclerosis|atherosclerosis
5590239|NCT00929734|Hydroxymethylglutaryl-coenzyme A Reductase Inhibitors|hydroxymethylglutaryl-coenzyme a reductase inhibitors
5590240|NCT00929721|CAP|cap
5590241|NCT00929708|COPD|copd
5590242|NCT00929708|Efficacy|efficacy
5590243|NCT00929708|Safety|safety
5590244|NCT00929708|Inhalation|inhalation
5590245|NCT00929682|Labor|labor
5590246|NCT00929682|Epidural analgesia|epidural analgesia
5590247|NCT00929682|Local anesthetics|local anesthetics
5590248|NCT00929682|Levobupivacaine|levobupivacaine
5590249|NCT00929682|Opiates|opiates
5590250|NCT00929682|Patient-controlled|patient-controlled
5590251|NCT00929682|Active spontaneous labor requiring epidural analgesia|active spontaneous labor requiring epidural analgesia
5590252|NCT00929669|pituitary tumor|pituitary tumor
5590253|NCT00929669|endocrine|endocrine
5590254|NCT00929656|Rehabilitation|rehabilitation
5590255|NCT00929656|Neurophysiology|neurophysiology
5590256|NCT00929656|Upper Extremity|upper extremity
5590257|NCT00929643|health care costs|health care costs
5590258|NCT00929643|Intra-Abdominal Infection|intra-abdominal infection
5590259|NCT00929630|fibrin glue|fibrin glue
5590260|NCT00929630|transsphincteric anal fistulas|transsphincteric anal fistulas
5590262|NCT00929630|incontinence|incontinence
5590263|NCT00929630|prospective randomised trial|prospective randomised trial
5590264|NCT00929617|breast cancer|breast cancer
5590265|NCT00929617|physical activity|physical activity
5590271|NCT00929604|Zambia|zambia
5590272|NCT00929604|viral load|viral load
5590273|NCT00929604|antiretroviral therapy|antiretroviral therapy
5590274|NCT00929604|cluster randomization|cluster randomization
5590275|NCT00929604|ART monitoring|art monitoring
5590276|NCT00929604|treatment failure|treatment failure
5590277|NCT00929604|randomized clinical trial|randomized clinical trial
5590278|NCT00929604|treatment naive|treatment naive
5590279|NCT00929591|stage II breast cancer|stage ii breast cancer
5590280|NCT00929591|stage IIIA breast cancer|stage iiia breast cancer
5590281|NCT00929578|Psoriasis|psoriasis
5590282|NCT00929578|T-lymphocytes|t-lymphocytes
5590283|NCT00929578|Fluphenazine|fluphenazine
5590284|NCT00929565|hemoptysis|hemoptysis
5590285|NCT00929552|Blood pressure|blood pressure
5590286|NCT00929552|Insulin sensitivity|insulin sensitivity
5590287|NCT00929552|Blood lipid profile|blood lipid profile
5590288|NCT00929539|Diabetes|diabetes
5590289|NCT00929526|HPV vaccine|hpv vaccine
5590290|NCT00929526|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5590291|NCT00929526|including new onset of autoimmune disease [NOAD])|including new onset of autoimmune disease [noad])
5590292|NCT00929526|new onset of chronic disease (NOCD)|new onset of chronic disease (nocd)
5590293|NCT00929526|medically significant condition (MSC)|medically significant condition (msc)
5590294|NCT00929487|contact lens wear|contact lens wear
5590295|NCT00929487|contact lens solution|contact lens solution
5590296|NCT00929487|corneal staining|corneal staining
5590297|NCT00929461|omega-3 fatty acids|omega-3 fatty acids
5590298|NCT00929461|lactate|lactate
5590299|NCT00929461|surgery|surgery
5590300|NCT00929461|gastric cancer|gastric cancer
5590301|NCT00929461|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.|address the effect of postoperative administration of omega-3 fatty acids on cellular hypoperfusion associated with major gastric surgery.
5590302|NCT00929448|Traumatic brain injury|traumatic brain injury
5590303|NCT00929435|MRSA|mrsa
5590304|NCT00929435|Contact isolation|contact isolation
5590305|NCT00929435|Incidence|incidence
5590306|NCT00929422|spinal cord injury|spinal cord injury
5590308|NCT00929422|cerebral function|cerebral function
5590309|NCT00929422|cortical reorganization|cortical reorganization
5590310|NCT00929409|Postpartum anemia, iron-deficiency|postpartum anemia, iron-deficiency
5590311|NCT00929396|Tuberculosis|tuberculosis
5590312|NCT00929396|Vaccine|vaccine
5590313|NCT00929396|Ag85B|ag85b
5590314|NCT00929396|ESAT-6|esat-6
5590315|NCT00929396|IC31|ic31
5590316|NCT00929383|Intracranial Atherosclerosis|intracranial atherosclerosis
5590317|NCT00929383|Stenosis|stenosis
5590318|NCT00929383|ICAD|icad
5590319|NCT00929383|atherosclerotic lesions|atherosclerotic lesions
5590320|NCT00929383|stenting|stenting
5590321|NCT00929370|Schizophrenia|schizophrenia
5590322|NCT00929370|GSK1018921|gsk1018921
5590323|NCT00929370|GlyT-1 inhibitor|glyt-1 inhibitor
5590324|NCT00929370|Healthy Volunteers|healthy volunteers
5590326|NCT00929370|Patient|patient
5590327|NCT00929370|Midazolam|midazolam
5590328|NCT00929344|Alcohol|alcohol
5590329|NCT00929344|Alcohol treatment|alcohol treatment
5590330|NCT00929344|Alcoholism|alcoholism
5590331|NCT00929344|Alcohol Abuse|alcohol abuse
5590332|NCT00929344|Alcohol Dependence|alcohol dependence
5590333|NCT00929331|Influenza|influenza
5590334|NCT00929331|Fluviral®|fluviral®
5590335|NCT00929305|chronic pain|chronic pain
5590336|NCT00929305|neck|neck
5590337|NCT00929305|shoulder|shoulder
5590338|NCT00929305|musculoskeletal origin|musculoskeletal origin
5590339|NCT00929292|Infant formula|infant formula
5590340|NCT00929292|Alpha-lactalbumin|alpha-lactalbumin
5590341|NCT00929292|Protein composition|protein composition
5590342|NCT00929292|Colic|colic
5590343|NCT00929292|Probiotics|probiotics
5590344|NCT00929279|Acute coronary syndrome|acute coronary syndrome
5590345|NCT00929279|Abciximab|abciximab
5590346|NCT00929279|Bolus|bolus
5590347|NCT00929279|Infusion|infusion
5590348|NCT00929279|platelet inhibition|platelet inhibition
5590349|NCT00929279|Non ST segment elevation acute coronary syndrome|non st segment elevation acute coronary syndrome
5590350|NCT00929266|peripheral stem cells (PSC) donors|peripheral stem cells (psc) donors
5590351|NCT00929266|cultured red blood cells|cultured red blood cells
5590352|NCT00929266|In vivo half life|in vivo half life
5590353|NCT00929253|Opioid Dependence|opioid dependence
5590354|NCT00929253|Opiates|opiates
5590355|NCT00929253|Hydrocodone|hydrocodone
5590356|NCT00929253|Oxycodone|oxycodone
5590357|NCT00929253|Oxycontin|oxycontin
5590358|NCT00929253|Narcotic Abuse|narcotic abuse
5590363|NCT00929214|Breast Cancer|breast cancer
5590364|NCT00929214|Metastasized|metastasized
5590365|NCT00929214|Limited bone-only metastasis|limited bone-only metastasis
5590366|NCT00929214|Local Therapy|local therapy
5590367|NCT00929214|Radiation|radiation
5590368|NCT00929214|Radiation Therapy|radiation therapy
5590369|NCT00929214|RT|rt
5590370|NCT00929214|Surgery|surgery
5590371|NCT00929214|Standard Therapy|standard therapy
5590372|NCT00929214|Chemotherapy|chemotherapy
5590373|NCT00929214|Endocrine Therapy|endocrine therapy
5590374|NCT00929188|Moderate to severe chronic, cancer-related pain related to an active cancer|moderate to severe chronic, cancer-related pain related to an active cancer
5590375|NCT00929188|Cancer-related pain|cancer-related pain
5590376|NCT00929188|Moderate to severe chronic pain|moderate to severe chronic pain
5590377|NCT00929188|JNJ-42160443|jnj-42160443
5590378|NCT00929175|Hypertension|hypertension
5590379|NCT00929175|Resistant Hypertension|resistant hypertension
5590380|NCT00929175|Sleep apnea syndrome|sleep apnea syndrome
5590381|NCT00929175|Treatment|treatment
5590382|NCT00929162|ovarian|ovarian
5590383|NCT00929162|cancer|cancer
5590384|NCT00929162|chemotherapy|chemotherapy
5590385|NCT00929162|sensitive|sensitive
5590386|NCT00929162|ZD4054|zd4054
5590387|NCT00929136|Endotoxin|endotoxin
5590388|NCT00929136|Insulin resistance|insulin resistance
5590389|NCT00929136|Lipolysis|lipolysis
5590390|NCT00929136|Proteolysis|proteolysis
5590391|NCT00929136|Intracellular Insulin Signaling|intracellular insulin signaling
5590392|NCT00929136|Regional effects of inflammation/endotoxin|regional effects of inflammation/endotoxin
5590393|NCT00929123|manual therapy|manual therapy
5590394|NCT00929123|carpal tunnel syndrome|carpal tunnel syndrome
5590395|NCT00929123|central sensitization|central sensitization
5590396|NCT00929110|COPD|copd
5590398|NCT00929110|glycopyrronium bromide|glycopyrronium bromide
5590399|NCT00929097|Colorectal Neoplasms, (Hereditary Nonpolyposis)|colorectal neoplasms, (hereditary nonpolyposis)
5590400|NCT00929097|Guideline|guideline
5590401|NCT00929097|Health Plan Implementation|health plan implementation
5590402|NCT00929097|Decision Support Techniques|decision support techniques
5590403|NCT00929097|Risk assessment|risk assessment
5590404|NCT00929097|Familial colorectal cancer risk|familial colorectal cancer risk
5590405|NCT00929097|Risk assessment tool|risk assessment tool
5590406|NCT00929084|Race Disparities|race disparities
5590407|NCT00929084|Breast Cancer|breast cancer
5590408|NCT00929084|Quality of Life|quality of life
5590409|NCT00929084|Treatment Adherence|treatment adherence
5590410|NCT00929071|wrinkles|wrinkles
5590411|NCT00929071|dermal filler|dermal filler
5590412|NCT00929071|collagen|collagen
5680347|NCT00578149|Lung cancer|lung cancer
5590413|NCT00929071|soft tissue augmentation|soft tissue augmentation
5590414|NCT00929071|lidocaine|lidocaine
5590415|NCT00929071|aesthetic|aesthetic
5590416|NCT00929045|Growth Hormone replacement|growth hormone replacement
5590417|NCT00929045|subject 8 to 21|subject 8 to 21
5590418|NCT00929045|moderate to severe traumatic brain injury|moderate to severe traumatic brain injury
5590419|NCT00929045|growth hormone deficient|growth hormone deficient
5590420|NCT00929032|Liver Transplantation|liver transplantation
5590421|NCT00929032|Immunosystem of the Liver|immunosystem of the liver
5590422|NCT00929032|Marginal and Non-marginal grafts|marginal and non-marginal grafts
5590423|NCT00929019|uveal melanoma|uveal melanoma
5590425|NCT00929019|high risk|high risk
5590426|NCT00929019|immunotherapy|immunotherapy
5590427|NCT00929019|adjuvant|adjuvant
5590428|NCT00929019|high risk genetic profile|high risk genetic profile
5590429|NCT00929019|loss of chromosome 3|loss of chromosome 3
5590430|NCT00929006|hyperandrogenemia|hyperandrogenemia
5590431|NCT00929006|pubertal|pubertal
5590432|NCT00929006|polycystic ovary syndrome|polycystic ovary syndrome
5590433|NCT00928993|actigraphy|actigraphy
5590434|NCT00928993|polysomnography|polysomnography
5590435|NCT00928993|pediatrics|pediatrics
5590436|NCT00928993|sleep|sleep
5590437|NCT00928993|To validate Actigraphy against polysomnography|to validate actigraphy against polysomnography
5590438|NCT00928980|Recurrent Major Depressive Disorder|recurrent major depressive disorder
5590439|NCT00928980|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5590440|NCT00928980|Cost-effectiveness|cost-effectiveness
5590441|NCT00928980|Antidepressant medication|antidepressant medication
5590442|NCT00928980|Randomized Controlled Trial|randomized controlled trial
5590443|NCT00928967|Multiple Sclerosis|multiple sclerosis
5590444|NCT00928967|Quality of life|quality of life
5590445|NCT00928954|gabapentin|gabapentin
5590446|NCT00928954|memantine|memantine
5590447|NCT00928954|nystagmus|nystagmus
5590448|NCT00928954|Drug treatment|drug treatment
5590449|NCT00928941|PTSD|ptsd
5590450|NCT00928941|rehabilitation|rehabilitation
5590451|NCT00928928|Lipid peroxidation|lipid peroxidation
5590452|NCT00928928|Protein peroxidation|protein peroxidation
5590453|NCT00928928|DNA peroxidation|dna peroxidation
5590454|NCT00928928|RNA peroxidation|rna peroxidation
5590455|NCT00928928|Cytokines|cytokines
5590456|NCT00928928|hsCRP|hscrp
5590457|NCT00928928|Oxidative stress markers|oxidative stress markers
5590458|NCT00928928|Open surgery|open surgery
5590459|NCT00928928|Laparoscopic surgery|laparoscopic surgery
5590460|NCT00928915|Intracranial Hemorrhages|intracranial hemorrhages
5590461|NCT00928915|Vitamin-K antagonist|vitamin-k antagonist
5590462|NCT00928915|Hemostatic treatment|hemostatic treatment
5590463|NCT00928915|Prothrombin complex|prothrombin complex
5590464|NCT00928915|Fresh frozen plasma|fresh frozen plasma
5590465|NCT00928915|Intracranial Hemorrhages related to vitamin-K antagonist|intracranial hemorrhages related to vitamin-k antagonist
5590466|NCT00928902|melanoma|melanoma
5590468|NCT00928902|peptides|peptides
5590469|NCT00928902|adjuvant|adjuvant
5590470|NCT00928902|immunogenicity|immunogenicity
5590471|NCT00928902|stage IIB, stage III or resected stage IV|stage iib, stage iii or resected stage iv
5590472|NCT00928889|diabetes mellitus, type 2|diabetes mellitus, type 2
5590473|NCT00928889|nateglinide|nateglinide
5590474|NCT00928889|acarbose|acarbose
5590475|NCT00928889|hyperglycemia|hyperglycemia
5590476|NCT00928889|dyslipidemias|dyslipidemias
5590477|NCT00928889|C-reactive protein|c-reactive protein
5590478|NCT00928876|anakinra|anakinra
5573105|NCT00994487|Bottle Feeding|bottle feeding
5590479|NCT00928876|Diabetes mellitus, type 2|diabetes mellitus, type 2
5590480|NCT00928876|Insulin resistance|insulin resistance
5590481|NCT00928876|Interleukin-1beta|interleukin-1beta
5590482|NCT00928863|haemorrhagia postpartum|haemorrhagia postpartum
5590483|NCT00928863|implementation guidelines|implementation guidelines
5590484|NCT00928863|maternal morbidity|maternal morbidity
5590485|NCT00928863|management of obstetrics and trauma|management of obstetrics and trauma
5590486|NCT00928850|Prostate|prostate
5590487|NCT00928850|Radical Prostatectomy|radical prostatectomy
5590488|NCT00928850|urethral irrigation|urethral irrigation
5590489|NCT00928850|fascial suturing|fascial suturing
5590490|NCT00928850|09-051|09-051
5590491|NCT00928811|Simulect|simulect
5590492|NCT00928811|de novo kidney transplant subjects|de novo kidney transplant subjects
5590493|NCT00928811|calcineurin inhibitors|calcineurin inhibitors
5590494|NCT00928811|Prograf|prograf
5590495|NCT00928785|Tetanus Vaccine|tetanus vaccine
5590496|NCT00928785|Tdap-IPV vaccine|tdap-ipv vaccine
5590497|NCT00928772|Cranial Electro Stimulation|cranial electro stimulation
5590498|NCT00928772|First Eye Cataract Surgery|first eye cataract surgery
5590499|NCT00928772|Preoperative sedation|preoperative sedation
5590500|NCT00928772|Perioperative sedation|perioperative sedation
5590501|NCT00928759|Obesity|obesity
5590502|NCT00928759|Polycystic Ovary Syndrome|polycystic ovary syndrome
5590503|NCT00928733|Permeability|permeability
5590504|NCT00928733|tight junctions|tight junctions
5590505|NCT00928733|cytokines|cytokines
5590506|NCT00928733|inflammatory bowel diseases|inflammatory bowel diseases
5798748|NCT00111189|recurrence prevention|recurrence prevention
5590507|NCT00928733|The effect of alcohol on the intestinal permeability may have major consequences on health.|the effect of alcohol on the intestinal permeability may have major consequences on health.
5590508|NCT00928733|It's generally accepted that an increased intestinal permeability in alcoholic subjects lead|it's generally accepted that an increased intestinal permeability in alcoholic subjects lead
5590509|NCT00928733|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.|to translocation of bacterial endotoxins from the gut lumen into the portal vein and then to the liver.
5590510|NCT00928733|In the liver, endotoxins trigger the immune system and activate the resident macrophages, Kupffer cells.|in the liver, endotoxins trigger the immune system and activate the resident macrophages, kupffer cells.
5590511|NCT00928733|Activation of Kupffer cells leads to production of chemokines (IL-8) and|activation of kupffer cells leads to production of chemokines (il-8) and
5590512|NCT00928733|proinflammatory cytokines (IL-1, TNFα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.|proinflammatory cytokines (il-1, tnfα),resulting in hepatocytes damage, inflammation, fibrosis and finally cirrhosis.
5590513|NCT00928720|fibromyalgia|fibromyalgia
5590515|NCT00928720|sleep disturbance|sleep disturbance
5590516|NCT00928720|fatigue|fatigue
5590517|NCT00928720|depression|depression
5590518|NCT00928720|functional magnetic resonance imaging|functional magnetic resonance imaging
5590519|NCT00928707|Polycythemia Vera|polycythemia vera
5590520|NCT00928707|GIVINOSTAT|givinostat
5590521|NCT00928707|ITF2357|itf2357
5590522|NCT00928655|apnea|apnea
5590523|NCT00928655|sleep|sleep
5590524|NCT00928655|altitude|altitude
5590525|NCT00928655|hypoxia|hypoxia
5590526|NCT00928655|treatment|treatment
5590527|NCT00928655|CPAP|cpap
5590528|NCT00928642|ovarian|ovarian
5590529|NCT00928642|cancer|cancer
5590530|NCT00928642|peritoneal|peritoneal
5590531|NCT00928642|endometrioid|endometrioid
5590532|NCT00928642|mucinous|mucinous
5590533|NCT00928642|serous|serous
5590534|NCT00928642|clear cell|clear cell
5590535|NCT00928629|Peripheral Arterial Disease|peripheral arterial disease
5590536|NCT00928629|Cardiovascular Disease|cardiovascular disease
5590537|NCT00928629|Vascular Disease|vascular disease
5590538|NCT00928616|hyperlipidemia|hyperlipidemia
5590539|NCT00928616|plant sterols|plant sterols
5590540|NCT00928616|monocytes|monocytes
5590541|NCT00928603|prostate cancer|prostate cancer
5590542|NCT00928603|therapy|therapy
5590543|NCT00928590|open-angle glaucoma|open-angle glaucoma
5590544|NCT00928590|ocular hypertension|ocular hypertension
5590545|NCT00928590|pseudoexfoliation|pseudoexfoliation
5590546|NCT00928590|pigment dispersion|pigment dispersion
5590547|NCT00928577|Smallpox|smallpox
5590548|NCT00928577|Smallpox Vaccine|smallpox vaccine
5590549|NCT00928577|Vaccinia virus|vaccinia virus
5590550|NCT00928577|Military|military
5769264|NCT00247559|ageing|ageing
5590551|NCT00928564|Pelvic floor muscle spasm|pelvic floor muscle spasm
5590552|NCT00928564|Pelvic pain|pelvic pain
5590553|NCT00928564|physical therapy|physical therapy
5590554|NCT00928564|pudendal block|pudendal block
5590555|NCT00928538|Female Contraception|female contraception
5590556|NCT00928538|Home Visits|home visits
5590557|NCT00928538|CONTRACEPTIVE AGENTS|contraceptive agents
5590558|NCT00928538|CONTRACEPTIVE DEVICES|contraceptive devices
5590559|NCT00928525|PDGFr alpha|pdgfr alpha
5590560|NCT00928525|PDGFr beta|pdgfr beta
5590561|NCT00928525|KIT|kit
5590562|NCT00928512|Rheumatoid Arthritis, RA, ACR, inflammatory joints|rheumatoid arthritis, ra, acr, inflammatory joints
5590563|NCT00928499|urge/frequency|urge/frequency
5590564|NCT00928499|urge incontinence|urge incontinence
5590565|NCT00928499|Interstim|interstim
5590566|NCT00928499|after success Interstim planning IPG placement|after success interstim planning ipg placement
5590567|NCT00928460|Electrocardiogram|electrocardiogram
5590568|NCT00928460|Electrocardiography|electrocardiography
5590569|NCT00928460|Perioperative care|perioperative care
5590570|NCT00928460|Preoperative care|preoperative care
5590571|NCT00928460|Preanesthesia Evaluation|preanesthesia evaluation
5590572|NCT00928460|Acute Coronary Syndrome|acute coronary syndrome
5590573|NCT00928460|Postoperative Myocardial Infarction|postoperative myocardial infarction
5590574|NCT00928460|Myocardial ischaemia|myocardial ischaemia
5685423|NCT00556101|whole body|whole body
5590575|NCT00928460|Postoperative Cardiac Death|postoperative cardiac death
5590576|NCT00928460|Intraoperative complications|intraoperative complications
5590577|NCT00928460|Postoperative complications|postoperative complications
5590578|NCT00928460|Cost-effectiveness analysis|cost-effectiveness analysis
5590579|NCT00928447|rHuPH20|rhuph20
5590580|NCT00928447|Recombinant Human hyaluronidase|recombinant human hyaluronidase
5590581|NCT00928421|Varicose Veins|varicose veins
5590582|NCT00928395|Urgent PC|urgent pc
5590583|NCT00928395|Overactive Bladder|overactive bladder
5590584|NCT00928395|SUmiT Trial|sumit trial
5590585|NCT00928395|Overactive Urinary Bladder|overactive urinary bladder
5590586|NCT00928382|Spinal Cord|spinal cord
5590587|NCT00928382|Healthy Volunteer|healthy volunteer
5590588|NCT00928382|Metastasis|metastasis
5590589|NCT00928382|Samples|samples
5590590|NCT00928382|Spinal Cord Vertebrae|spinal cord vertebrae
5590591|NCT00928382|Cancer|cancer
5590592|NCT00928382|HV|hv
5590593|NCT00928356|Coronary Artery Disease|coronary artery disease
5590594|NCT00928356|Robotic Coronary Artery Bypass Surgery|robotic coronary artery bypass surgery
5590595|NCT00928356|Percutaneous Coronary Intervention|percutaneous coronary intervention
5590596|NCT00928356|Hybrid Coronary Revascularization|hybrid coronary revascularization
5590597|NCT00928343|Safety|safety
5590598|NCT00928343|Tolerability|tolerability
5590599|NCT00928343|Pharmacokinetics|pharmacokinetics
5590600|NCT00928330|TDM-1|tdm-1
5590601|NCT00928330|HER2|her2
5590602|NCT00928330|HER2+|her2+
5590603|NCT00928330|HER2+ Breast Cancer|her2+ breast cancer
5590604|NCT00928330|HER-2|her-2
5590605|NCT00928330|MBC|mbc
5590606|NCT00928330|Trastuzumab emtansine|trastuzumab emtansine
5584769|NCT00950820|Open-label|open-label
5590608|NCT00928304|Down Syndrome|down syndrome
5590609|NCT00928291|procalcitonin|procalcitonin
5590610|NCT00928291|neutropenia|neutropenia
5590611|NCT00928291|febrile neutropenia|febrile neutropenia
5590612|NCT00928291|antibiotic therapy|antibiotic therapy
5590613|NCT00928291|neutropenic patients|neutropenic patients
5590614|NCT00928265|intracranial|intracranial
5590615|NCT00928265|stenting|stenting
5590616|NCT00928265|endovascular treatment|endovascular treatment
5590617|NCT00928265|stent-assisted coiling|stent-assisted coiling
5590618|NCT00928265|cerebrovascular disease|cerebrovascular disease
5590619|NCT00928252|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5590620|NCT00928252|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5590621|NCT00928239|vaginal vault prolapse|vaginal vault prolapse
5590622|NCT00928239|laparoscopic sacropexy|laparoscopic sacropexy
5590623|NCT00928213|Preeclampsia|preeclampsia
5590624|NCT00928213|IUGR|iugr
5590626|NCT00928213|PP13|pp13
5590627|NCT00928213|Doppler|doppler
5590628|NCT00928213|placenta|placenta
5590629|NCT00928213|PTD|ptd
5590630|NCT00928213|Preterm delivery|preterm delivery
5590631|NCT00928200|Relapsed|relapsed
5590632|NCT00928200|Allergy|allergy
5590633|NCT00928200|Erwinia|erwinia
5590634|NCT00928200|Acute|acute
5590635|NCT00928200|Lymphoblastic|lymphoblastic
5590636|NCT00928200|Leukemia|leukemia
5590637|NCT00928187|HIV|hiv
5590638|NCT00928187|Second line treatment|second line treatment
5590639|NCT00928187|WHO recommendations|who recommendations
5590640|NCT00928187|Africa|africa
5590641|NCT00928187|Treatment strategies|treatment strategies
5590642|NCT00928187|treatment experienced|treatment experienced
5590643|NCT00928174|Androgen insensitive prostate cancer|androgen insensitive prostate cancer
5590644|NCT00928161|Reflux Disease|reflux disease
5590645|NCT00928161|Acid-reflux|acid-reflux
5590646|NCT00928161|Head and Neck Cancer|head and neck cancer
5590647|NCT00928161|HNC|hnc
5590648|NCT00928161|Radiation Therapy|radiation therapy
5590649|NCT00928161|Mucositis|mucositis
5590650|NCT00928161|Radiation-induced xerostomia|radiation-induced xerostomia
5590652|NCT00928161|Dry Mouth|dry mouth
5590653|NCT00928161|Heartburn|heartburn
5590654|NCT00928161|Dexlansoprazole|dexlansoprazole
5590655|NCT00928161|Prevacid|prevacid
5590656|NCT00928161|Prevacid Solu-Tab|prevacid solu-tab
5590657|NCT00928161|GERD|gerd
5590658|NCT00928109|eating disorders|eating disorders
5590659|NCT00928109|couples therapy|couples therapy
5590660|NCT00928096|Lymphoma|lymphoma
5590661|NCT00928096|Radiotherapy|radiotherapy
5590662|NCT00928096|Positron-Emission Tomography|positron-emission tomography
5590663|NCT00928096|CT scan|ct scan
5590664|NCT00928083|Phase I|phase i
5590665|NCT00928083|Safety and tolerability|safety and tolerability
5590666|NCT00928083|Pharmacokinetic|pharmacokinetic
5590667|NCT00928083|synthetic peroxide|synthetic peroxide
5590668|NCT00928083|trioxolane|trioxolane
5590669|NCT00928083|treatment of erythrocytic stages of malaria|treatment of erythrocytic stages of malaria
5590670|NCT00928070|Urgency Urinary Incontinence OAB|urgency urinary incontinence oab
5590671|NCT00928057|Pen Needle|pen needle
5590672|NCT00928057|Diabetes|diabetes
5590673|NCT00928057|Insulin|insulin
5590674|NCT00928057|Glycemic|glycemic
5590675|NCT00928057|Pain|pain
5590676|NCT00928057|Fructosamine|fructosamine
5590677|NCT00928057|Leakage|leakage
5590678|NCT00928057|Hypoglycemia|hypoglycemia
5590679|NCT00928057|Hyperglycemia|hyperglycemia
5590680|NCT00928018|allogeneic stem cell transplant|allogeneic stem cell transplant
5590681|NCT00928018|reduced intensity conditioning|reduced intensity conditioning
5590682|NCT00928018|graft versus host disease|graft versus host disease
5590683|NCT00928018|GVHD|gvhd
5590684|NCT00928018|RIC transplantation|ric transplantation
5590685|NCT00928005|Weight loss diet|weight loss diet
5590686|NCT00928005|Exercise training|exercise training
5590687|NCT00928005|Type 2 diabetes|type 2 diabetes
5590688|NCT00928005|Prediabetes|prediabetes
5590689|NCT00928005|Cardiovascular health|cardiovascular health
5590690|NCT00927966|RAD001|rad001
5590691|NCT00927966|CP-751,871|cp-751,871
5590692|NCT00927966|advanced sarcoma|advanced sarcoma
5590693|NCT00927966|advanced malignant solid tumor|advanced malignant solid tumor
5590694|NCT00927953|West Nile virus|west nile virus
5590695|NCT00927953|WNV|wnv
5590696|NCT00927953|Encephalitis|encephalitis
5590697|NCT00927953|Meningitis|meningitis
5590698|NCT00927953|Acute Flaccid Paralysis|acute flaccid paralysis
5590700|NCT00927953|WNND|wnnd
5590701|NCT00927953|West Nile Fever|west nile fever
5590702|NCT00927953|WNF|wnf
5590703|NCT00927940|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5590704|NCT00927940|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5590705|NCT00927940|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5590706|NCT00927940|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5590707|NCT00927940|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5590708|NCT00927940|STENT THROMBOSIS|stent thrombosis
5584879|NCT00950352|MRI|mri
5590712|NCT00927901|asthma|asthma
5590713|NCT00927901|indacaterol salts (acetate, maleate, and xinafoate)|indacaterol salts (acetate, maleate, and xinafoate)
5590714|NCT00927901|orally inhaled indacaterol salts|orally inhaled indacaterol salts
5590715|NCT00927901|persistent asthma|persistent asthma
5590716|NCT00927862|warfarin metabolism|warfarin metabolism
5590717|NCT00927862|CYP2C9|cyp2c9
5590718|NCT00927862|genotyping|genotyping
5590719|NCT00927862|VKORC1|vkorc1
5590720|NCT00927862|anticoagulation|anticoagulation
5590721|NCT00927862|atrial fibrillation|atrial fibrillation
5590722|NCT00927862|deep vein thrombosis|deep vein thrombosis
5590723|NCT00927862|pulmonary embolism|pulmonary embolism
5590724|NCT00927862|Patients initiating warfarin for thromboembolic conditions|patients initiating warfarin for thromboembolic conditions
5590725|NCT00927849|anal hypertonia|anal hypertonia
5590726|NCT00927849|sphincterotomy|sphincterotomy
5590727|NCT00927849|incontinence|incontinence
5590728|NCT00927849|manometry|manometry
5590729|NCT00927810|Gout|gout
5590730|NCT00927810|Gouty arthritis|gouty arthritis
5590731|NCT00927810|Gout flares|gout flares
5590732|NCT00927810|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5590733|NCT00927797|immunochemotherapy|immunochemotherapy
5590734|NCT00927797|Pentostatin|pentostatin
5590735|NCT00927797|Cyclophosphamide|cyclophosphamide
5590736|NCT00927797|Rituximab|rituximab
5590737|NCT00927797|Maintenance|maintenance
5590738|NCT00927797|indolent B-NHL|indolent b-nhl
5590739|NCT00927797|B-CLL|b-cll
5590740|NCT00927797|B-NHL|b-nhl
5590741|NCT00927784|Mesenchymal Precursor Cells|mesenchymal precursor cells
5590742|NCT00927784|Left Ventricular Assist Device|left ventricular assist device
5590743|NCT00927784|LVAD|lvad
5590744|NCT00927784|Congestive Heart Failure|congestive heart failure
5590745|NCT00927784|Stem Cells|stem cells
5590746|NCT00927771|melanosis|melanosis
5590747|NCT00927771|melasma|melasma
5590748|NCT00927771|azelaic acid|azelaic acid
5590749|NCT00927771|hydroquinone|hydroquinone
5590750|NCT00927745|Respiration Artificial|respiration artificial
5590751|NCT00927745|Positive-Pressure Respiration|positive-pressure respiration
5590752|NCT00927745|Critical Care|critical care
5590753|NCT00927745|Intensive Care Units|intensive care units
5590754|NCT00927732|Brugada|brugada
5590755|NCT00927732|hydroquinidine|hydroquinidine
5590756|NCT00927732|ventricular arrhythmia|ventricular arrhythmia
5590757|NCT00927732|patients with Brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator|patients with brugada syndrome, high cardiac arrhythmic risk and implanted with an implantable cardioverter defibrillator
5590758|NCT00927719|Smallpox|smallpox
5590759|NCT00927719|Smallpox Vaccine|smallpox vaccine
5590760|NCT00927719|Vaccinia virus|vaccinia virus
5590761|NCT00927719|Military|military
5590762|NCT00927706|Assistive Technology|assistive technology
5590763|NCT00927706|Mobility Limitation|mobility limitation
5590764|NCT00927706|Physical Disability|physical disability
5590765|NCT00927706|Caregiver|caregiver
5590766|NCT00927706|Participation|participation
5590767|NCT00927693|Atherosclerosis|atherosclerosis
5590768|NCT00927693|Coronary Artery Disease|coronary artery disease
5590769|NCT00927693|Cardiac Risk Factors|cardiac risk factors
5590770|NCT00927693|Coronary Calcium Scan|coronary calcium scan
5590771|NCT00927693|Prevention|prevention
5590772|NCT00927680|Colorectal Cancer|colorectal cancer
5590773|NCT00927680|Familial Colorectal Cancer|familial colorectal cancer
5590774|NCT00927680|Genetics|genetics
5590775|NCT00927680|Hispanics|hispanics
5590776|NCT00927680|Lynch Syndrome|lynch syndrome
5590777|NCT00927667|Hemophilia A|hemophilia a
5590778|NCT00927667|Joint Status|joint status
5590779|NCT00927667|Bleeds|bleeds
5590780|NCT00927667|Magnetic Resonce Imaging|magnetic resonce imaging
5590781|NCT00927654|Iloprost|iloprost
5590782|NCT00927654|pulmonary hypertension|pulmonary hypertension
5590783|NCT00927654|cardio pulmonary morbidity|cardio pulmonary morbidity
5590784|NCT00927654|high risk cardiac surgical patients|high risk cardiac surgical patients
5590785|NCT00927641|Ankle Sprain|ankle sprain
5590786|NCT00927628|vitrectomy|vitrectomy
5590787|NCT00927628|macular hole|macular hole
5590788|NCT00927628|ILM peeling|ilm peeling
5590789|NCT00927615|myocardial infarction|myocardial infarction
5590790|NCT00927615|glycoprotein IIb/IIIa|glycoprotein iib/iiia
5590791|NCT00927615|percutaneous coronary intervention|percutaneous coronary intervention
5590792|NCT00927615|thrombus aspiration|thrombus aspiration
5590794|NCT00927602|renal failure|renal failure
5590795|NCT00927602|medical patient|medical patient
5590796|NCT00927602|venous thromboembolism|venous thromboembolism
5590797|NCT00927602|prophylaxis|prophylaxis
5590798|NCT00927602|fondaparinux|fondaparinux
5590799|NCT00927589|HER2+ Metastatic Cancer|her2+ metastatic cancer
5590800|NCT00927589|HER2+ Locally Advanced Inoperable Cancer|her2+ locally advanced inoperable cancer
5590801|NCT00927589|HER2+ Solid Malignancy|her2+ solid malignancy
5590808|NCT00927563|Gambling|gambling
5590809|NCT00927563|Addiction|addiction
5590810|NCT00927550|resistant depression|resistant depression
5590811|NCT00927550|lithium|lithium
5590813|NCT00927550|lithium therapy|lithium therapy
5590814|NCT00927550|standard therapy|standard therapy
5590815|NCT00927537|Hypertension|hypertension
5590816|NCT00927524|Insulin analogs|insulin analogs
5590817|NCT00927524|diabetes|diabetes
5590818|NCT00927511|metastatic hormone-responsive breast cancer menopausal women|metastatic hormone-responsive breast cancer menopausal women
5590819|NCT00927498|Acute myeloid Leukemia|acute myeloid leukemia
5590820|NCT00927498|patient aged 50 to 70 years|patient aged 50 to 70 years
5590821|NCT00927485|Familial Adenomatous Polyposis (FAP)|familial adenomatous polyposis (fap)
5590822|NCT00927485|Curcumin|curcumin
5590823|NCT00927485|Colorectal polyps|colorectal polyps
5590824|NCT00927485|Duodenal polyps|duodenal polyps
5590825|NCT00927472|Head Lice|head lice
5590826|NCT00927459|cholesterol|cholesterol
5590827|NCT00927459|coronary artery disease|coronary artery disease
5590828|NCT00927446|esophageal cancer|esophageal cancer
5590829|NCT00927446|head and neck cancer|head and neck cancer
5590830|NCT00927446|narrow band imaging|narrow band imaging
5590831|NCT00927446|endoscopy|endoscopy
5590832|NCT00927446|screening|screening
5590833|NCT00927433|Fatigue|fatigue
5590834|NCT00927433|Cancer|cancer
5590835|NCT00927433|Radiation therapy|radiation therapy
5590836|NCT00927433|Chemotherapy|chemotherapy
5590837|NCT00927433|Hormones|hormones
5590838|NCT00927433|Surgery|surgery
5590839|NCT00927433|Breast cancer|breast cancer
5590840|NCT00927420|Bipolar disorder|bipolar disorder
5590841|NCT00927420|adherence|adherence
5590842|NCT00927420|treatment|treatment
5590843|NCT00927420|real life practice|real life practice
5590844|NCT00927407|Head Lice|head lice
5590845|NCT00927394|Hypertension, Type II Diabetes, Aliskiren, Valsartan,|hypertension, type ii diabetes, aliskiren, valsartan,
5590944|NCT00926939|Voucher reinforcement|voucher reinforcement
5590846|NCT00927394|Systolic blood pressure, Diastolic blood pressure,|systolic blood pressure, diastolic blood pressure,
5590847|NCT00927394|Stage II, Combination|stage ii, combination
5590848|NCT00927368|TKA|tka
5590849|NCT00927368|total knee replacement|total knee replacement
5590850|NCT00927355|pioglitazone|pioglitazone
5590851|NCT00927355|human bone marrow stem cells|human bone marrow stem cells
5590852|NCT00927355|adipocytes|adipocytes
5590853|NCT00927355|osteoblasts|osteoblasts
5590854|NCT00927355|bone mineral density|bone mineral density
5590855|NCT00927355|adiponectin|adiponectin
5590856|NCT00927355|leptin|leptin
5590857|NCT00927355|CTX|ctx
5590858|NCT00927355|P1NP|p1np
5590859|NCT00927355|Osteocalcin|osteocalcin
5590860|NCT00927342|Air leak|air leak
5590861|NCT00927342|Thoracic Surgery|thoracic surgery
5590862|NCT00927342|Sealants|sealants
5590863|NCT00927329|Dermatophagoides|dermatophagoides
5590864|NCT00927329|farinae|farinae
5590865|NCT00927329|allergen|allergen
5590866|NCT00927329|dust|dust
5590867|NCT00927329|allergic|allergic
5590868|NCT00927329|mite|mite
5590869|NCT00927329|allergy|allergy
5590870|NCT00927316|Report of Urinary Tract Infection episode|report of urinary tract infection episode
5590871|NCT00927303|retinal thickness|retinal thickness
5590872|NCT00927303|threshold algorithm|threshold algorithm
5590873|NCT00927303|optical coherence tomography|optical coherence tomography
5590995|NCT00926692|B1 Cells|b1 cells
5590874|NCT00927290|hepatitis C; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response|hepatitis c; insulin resistance; glitazones; pioglitazone; steatosis; viral kinetics; antiviral response
5590875|NCT00927264|tobacco smoke exposure smoking|tobacco smoke exposure smoking
5590876|NCT00927251|heart failure|heart failure
5590877|NCT00927251|cardiac pacing|cardiac pacing
5685424|NCT00556101|angiography|angiography
5590878|NCT00927251|cardiac resynchronization therapy|cardiac resynchronization therapy
5590879|NCT00927251|left ventricular lead|left ventricular lead
5590880|NCT00927238|Single Level|single level
5590881|NCT00927238|Lumbar Disc Disease|lumbar disc disease
5590883|NCT00927199|High-Oleic Canola Oil|high-oleic canola oil
5590884|NCT00927199|Flaxseed Oil|flaxseed oil
5590885|NCT00927199|Monounsaturated Fatty Acids|monounsaturated fatty acids
5590886|NCT00927199|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5590888|NCT00927199|Cardiovascular|cardiovascular
5590889|NCT00927199|Hypercholesterolemia|hypercholesterolemia
5590891|NCT00927199|Inflammation|inflammation
5590892|NCT00927199|Metabolism|metabolism
5590893|NCT00927186|osteoporosis|osteoporosis
5590894|NCT00927186|teriparatide|teriparatide
5590895|NCT00927186|zoledronic acid|zoledronic acid
5590896|NCT00927186|histomorphometry|histomorphometry
5590897|NCT00927186|bone biopsy|bone biopsy
5590898|NCT00927186|postmenopausal|postmenopausal
5590899|NCT00927173|TMS|tms
5590900|NCT00927173|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5590901|NCT00927173|MDD|mdd
5590902|NCT00927173|Major Depressive Disorder|major depressive disorder
5590903|NCT00927160|Mobile Acute Care of the Elderly Unit|mobile acute care of the elderly unit
5590904|NCT00927160|Geriatric Models of Care|geriatric models of care
5590905|NCT00927147|head and neck cancer|head and neck cancer
5590906|NCT00927147|boron neutron capture therapy|boron neutron capture therapy
5590907|NCT00927147|cetuximab|cetuximab
5590908|NCT00927147|epidermal growth factor receptor|epidermal growth factor receptor
5590909|NCT00927147|safety|safety
5590910|NCT00927147|efficacy|efficacy
5590911|NCT00927147|survival|survival
5590912|NCT00927134|Chronic Granulomatous Disease in children (=or< 18 years)|chronic granulomatous disease in children (=or< 18 years)
5590913|NCT00927108|Adult Progenitor Stem cells|adult progenitor stem cells
5590914|NCT00927108|Alzheimer's disease|alzheimer's disease
5590915|NCT00927108|Parkinson's disease|parkinson's disease
5590916|NCT00927108|Multiple sclerosis|multiple sclerosis
5590917|NCT00927095|PMDD|pmdd
5590918|NCT00927095|Oral contraceptives|oral contraceptives
5590919|NCT00927095|steroid hormones|steroid hormones
5590920|NCT00927095|neurosteroids|neurosteroids
5590921|NCT00927069|Adalimumab|adalimumab
5590922|NCT00927030|Autism|autism
5590923|NCT00927030|children|children
5590924|NCT00927030|sleep|sleep
5590925|NCT00927030|insomnia|insomnia
5590926|NCT00927017|Healthy volunteers|healthy volunteers
5590927|NCT00927004|mechanical hyperalgesia|mechanical hyperalgesia
5590928|NCT00927004|cold hyperalgesia|cold hyperalgesia
5590929|NCT00927004|chronic pain|chronic pain
5590930|NCT00926978|Thyroid|thyroid
5590931|NCT00926978|I-124|i-124
5590932|NCT00926965|tardive dyskinesia|tardive dyskinesia
5590933|NCT00926965|neurocognitive function|neurocognitive function
5590934|NCT00926952|Actinic keratoses|actinic keratoses
5590935|NCT00926952|actinic keratosis|actinic keratosis
5590936|NCT00926952|methylamonolevulinate|methylamonolevulinate
5590937|NCT00926952|photodynamic therapy|photodynamic therapy
5590938|NCT00926952|without occlusion|without occlusion
5590939|NCT00926952|short incubation|short incubation
5590940|NCT00926939|Cigarette|cigarette
5590941|NCT00926939|Nicotine|nicotine
5590942|NCT00926939|Smoking|smoking
5590943|NCT00926939|Contingency Management|contingency management
5590945|NCT00926939|Smoking Abstinence|smoking abstinence
5590946|NCT00926939|Internet-based treatment|internet-based treatment
5590947|NCT00926926|Healthy volunteer|healthy volunteer
5590948|NCT00926913|Macular Degeneration|macular degeneration
5590949|NCT00926900|Alcoholism|alcoholism
5590950|NCT00926900|D-cycloserine|d-cycloserine
5590951|NCT00926900|extinction|extinction
5590952|NCT00926900|cue-exposure|cue-exposure
5590953|NCT00926874|ischaemic stroke|ischaemic stroke
5590954|NCT00926874|acute coronary syndrome|acute coronary syndrome
5590955|NCT00926874|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5590956|NCT00926874|brachial endothelial function|brachial endothelial function
5590957|NCT00926874|blood pressure|blood pressure
5590958|NCT00926874|aortic stiffness|aortic stiffness
5590959|NCT00926861|age-related macular degeneration|age-related macular degeneration
5590960|NCT00926861|detachment of the posterior hyaloid|detachment of the posterior hyaloid
5590961|NCT00926861|AMD|amd
5590962|NCT00926848|coronary heart disease|coronary heart disease
5573508|NCT00993447|Dengue virus|dengue virus
5590963|NCT00926848|cardiac rehabilitation|cardiac rehabilitation
5590964|NCT00926848|lifestyle change|lifestyle change
5590965|NCT00926848|coronary artery bypass graft|coronary artery bypass graft
5590966|NCT00926848|social support|social support
5590967|NCT00926848|social cognitive learning theory|social cognitive learning theory
5590968|NCT00926809|endoscopic mucosal resection|endoscopic mucosal resection
5590969|NCT00926809|iatrogenic|iatrogenic
5590970|NCT00926796|gonorrhea, gonococcal infections, Neisseria gonorrhoeae|gonorrhea, gonococcal infections, neisseria gonorrhoeae
5590971|NCT00926783|paroxysmal|paroxysmal
5590972|NCT00926783|persistent|persistent
5590973|NCT00926783|targeted|targeted
5590974|NCT00926783|generalized|generalized
5590975|NCT00926783|CFAE|cfae
5590976|NCT00926757|lymphoma|lymphoma
5590977|NCT00926757|CD20|cd20
5590978|NCT00926757|Hepatitis B virus|hepatitis b virus
5590979|NCT00926757|reactivation|reactivation
5590980|NCT00926757|Rituximab|rituximab
5590981|NCT00926744|physical activity|physical activity
5590982|NCT00926744|nutrition|nutrition
5590983|NCT00926744|cardiovascular diseases|cardiovascular diseases
5750961|NCT00316264|RSV|rsv
5590984|NCT00926744|musculo-skeletal problems|musculo-skeletal problems
5590985|NCT00926731|Acute Myeloid Leukaemia (AML)|acute myeloid leukaemia (aml)
5590986|NCT00926718|BIS monitor|bis monitor
5590987|NCT00926718|rocuronium|rocuronium
5590988|NCT00926718|The effect of the neuromuscular blocking drug rocuronium on the response of the Composite Variability Index to laryngoscopy|the effect of the neuromuscular blocking drug rocuronium on the response of the composite variability index to laryngoscopy
5590990|NCT00926705|Fentanyl|fentanyl
5590991|NCT00926705|Pain|pain
5590992|NCT00926705|Pediatrics|pediatrics
5590993|NCT00926692|B-cells|b-cells
5590996|NCT00926692|Healthy Controls|healthy controls
5590997|NCT00926666|Ageing|ageing
5590998|NCT00926666|Pain|pain
5590999|NCT00926666|Pharmacology|pharmacology
5591000|NCT00926666|Imaging|imaging
5591001|NCT00926666|Anaesthesiology|anaesthesiology
5591002|NCT00926666|Musculoskeletal disease|musculoskeletal disease
5591003|NCT00926653|Geriatric Depression|geriatric depression
5591004|NCT00926640|Solid Tumors|solid tumors
5591005|NCT00926640|Histone deacetylase inhibitors|histone deacetylase inhibitors
5591006|NCT00926640|EP &amp; Belinostat|ep &amp; belinostat
5591007|NCT00926640|Phase I|phase i
5591008|NCT00926640|SCLC|sclc
5591009|NCT00926640|Small Cell Lung Cancer|small cell lung cancer
5591010|NCT00926627|endothelin receptor antagonist|endothelin receptor antagonist
5591011|NCT00926627|bosentan|bosentan
5591012|NCT00926614|GT1|gt1
5591013|NCT00926614|HCV|hcv
5591014|NCT00926614|non responder|non responder
5591015|NCT00926614|relapser|relapser
5591016|NCT00926588|Pain|pain
5591017|NCT00926588|Telecare|telecare
5591018|NCT00926588|Collaborative care|collaborative care
5591019|NCT00926575|BDP|bdp
5591020|NCT00926575|orBec|orbec
5591021|NCT00926575|GVHD|gvhd
5591022|NCT00926575|beclomethasone dipropionate|beclomethasone dipropionate
5591023|NCT00926575|bone marrow transplant|bone marrow transplant
5591024|NCT00926575|hematopoietic cell transplant|hematopoietic cell transplant
5591025|NCT00926575|HCT|hct
5591026|NCT00926575|stem cell transplant|stem cell transplant
5591027|NCT00926575|marrow transplant|marrow transplant
5591028|NCT00926575|SCT|sct
5591029|NCT00926575|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
5591030|NCT00926562|Contrast Induced Nephropathy|contrast induced nephropathy
5591031|NCT00926562|CIN|cin
5591032|NCT00926562|Cardiac Catheterization|cardiac catheterization
5591033|NCT00926549|spectral domain-OCT|spectral domain-oct
5591034|NCT00926549|macular thickness|macular thickness
5591035|NCT00926549|myopia|myopia
5591036|NCT00926549|hypermetropia|hypermetropia
5591037|NCT00926549|normal|normal
5591038|NCT00926523|Pulmonary Hypertension|pulmonary hypertension
5591039|NCT00926523|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5591040|NCT00926523|Interstitial Lung Disease|interstitial lung disease
5591041|NCT00926523|MIF|mif
5591042|NCT00926497|antibiotic therapy|antibiotic therapy
5591043|NCT00926497|early-onset sepsis|early-onset sepsis
5591044|NCT00926497|interventions study|interventions study
5591045|NCT00926497|procalcitonin|procalcitonin
5591046|NCT00926497|term and near-term neonates|term and near-term neonates
5591047|NCT00926484|Dentin hypersensitivity|dentin hypersensitivity
5591048|NCT00926484|Tooth Mousse|tooth mousse
5591049|NCT00926484|fluoride varnish|fluoride varnish
5591050|NCT00926471|Autism|autism
5591051|NCT00926471|Anxiety|anxiety
5591052|NCT00926471|Autism Spectrum Disorders with Comorbid Anxiety|autism spectrum disorders with comorbid anxiety
5591053|NCT00926458|stress echocardiography|stress echocardiography
5591054|NCT00926458|coronary angiography|coronary angiography
5591055|NCT00926458|coronary artery disease|coronary artery disease
5591056|NCT00926445|Pain behavior|pain behavior
5591057|NCT00926432|Balance|balance
5591058|NCT00926432|Spine disorders|spine disorders
5591059|NCT00926432|equilibrium|equilibrium
5591060|NCT00926419|Varicella|varicella
5591061|NCT00926419|Hepatitis A|hepatitis a
5591062|NCT00926419|Vaccine|vaccine
5591063|NCT00926419|Injector|injector
5591064|NCT00926419|Fractional dose|fractional dose
5591065|NCT00926419|Intradermal|intradermal
5591066|NCT00926419|Children|children
5591067|NCT00926406|Environmental lead exposure, maintenance hemodialysis; blood lead levels, EDTA chelating agents, malnutrition, anemia, inflammation, mortality.|environmental lead exposure, maintenance hemodialysis; blood lead levels, edta chelating agents, malnutrition, anemia, inflammation, mortality.
5591068|NCT00926406|To determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.|to determine whether lead chelation therapy improves the anemia, malnutrition, inflammation, morbidity or mortality in hemodialysis patients.
5591069|NCT00926393|inpatient|inpatient
5591070|NCT00926393|bipolar depression|bipolar depression
5591071|NCT00926393|quetiapine|quetiapine
5591072|NCT00926393|Seroquel IR|seroquel ir
5591073|NCT00926393|Seroquel XR|seroquel xr
5591074|NCT00926393|safety|safety
5591075|NCT00926393|tolerability|tolerability
5591076|NCT00926380|osteoporosis|osteoporosis
5591077|NCT00926380|postmenopausal|postmenopausal
5591078|NCT00926380|denosumab|denosumab
5591079|NCT00926380|teriparatide|teriparatide
5591080|NCT00926380|Forteo®|forteo®
5591081|NCT00926380|DXA|dxa
5591082|NCT00926380|Bone Mineral Density|bone mineral density
5591083|NCT00926380|pQCT|pqct
5591084|NCT00926367|Acne|acne
5591085|NCT00926341|Metabolic syndrome|metabolic syndrome
5591087|NCT00926341|Thiazolidinediones|thiazolidinediones
5591088|NCT00926341|Angiotensin receptor blockers|angiotensin receptor blockers
5591089|NCT00926328|Gingivitis and Plaque|gingivitis and plaque
5591090|NCT00926315|Breast Neoplasms|breast neoplasms
5591091|NCT00926315|Calcitriol|calcitriol
5591092|NCT00926315|Postmenopausal|postmenopausal
5591093|NCT00926315|Cell Proliferation|cell proliferation
5591094|NCT00926315|Gene Expression Profiling|gene expression profiling
5591095|NCT00926302|The bioequivalence of Levetiracetam vs. Keppra|the bioequivalence of levetiracetam vs. keppra
5591096|NCT00926302|volunteer|volunteer
5591097|NCT00926276|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5591098|NCT00926276|Bronchopulmonary Dysplasia (BPD)|bronchopulmonary dysplasia (bpd)
5591099|NCT00926276|Fundoplication|fundoplication
5591100|NCT00926263|Pharmacokinetics|pharmacokinetics
5591101|NCT00926263|Pharmacodynamics|pharmacodynamics
5591102|NCT00926263|QTc interval prolongation|qtc interval prolongation
5591103|NCT00926250|Sarcopenia|sarcopenia
5591104|NCT00926237|Tinnitus|tinnitus
5591105|NCT00926237|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5591106|NCT00926237|TMS|tms
5591107|NCT00926237|rTMS|rtms
5591108|NCT00926224|Adult patients with chronic liver disease scheduled for a liver biopsy and a BMI superior or equal to 28 kg/m²|adult patients with chronic liver disease scheduled for a liver biopsy and a bmi superior or equal to 28 kg/m²
5591109|NCT00926198|Upper airway infections|upper airway infections
5591110|NCT00926198|pharyngotonsillitis|pharyngotonsillitis
5591111|NCT00926198|GABHS|gabhs
5591112|NCT00926185|Dry Eye|dry eye
5591113|NCT00926185|ophthalmic delivery|ophthalmic delivery
5591114|NCT00926172|Magnetic resonance angiography|magnetic resonance angiography
5591115|NCT00926172|Intracranial aneurysm|intracranial aneurysm
5591116|NCT00926172|cerebral aneurysm|cerebral aneurysm
5591117|NCT00926172|unruptured aneurysm|unruptured aneurysm
5591118|NCT00926172|Epidemiology|epidemiology
5591119|NCT00926172|Magnetic Resonance Imaging|magnetic resonance imaging
5591120|NCT00926159|Cardiomyopathies|cardiomyopathies
5591121|NCT00926146|Hepatitis B and C|hepatitis b and c
5591123|NCT00926146|nurse case management|nurse case management
5591124|NCT00926146|HIV seronegativity|hiv seronegativity
5591125|NCT00926120|Chronic Hepatitis C|chronic hepatitis c
5591126|NCT00926081|Peripheral Artery Disease|peripheral artery disease
5591127|NCT00926081|Quality of Life|quality of life
5591128|NCT00926081|Outcome|outcome
5591129|NCT00926081|Endothelial Progenitor Cells|endothelial progenitor cells
5591130|NCT00926081|Microcirculation|microcirculation
5591131|NCT00926068|Diabetes Mellitus|diabetes mellitus
5591132|NCT00926068|Foot Ulcer|foot ulcer
5591133|NCT00926068|DFU|dfu
5591134|NCT00926068|Wound healing|wound healing
5591135|NCT00926055|high risk patients in atherosclerosis|high risk patients in atherosclerosis
5591136|NCT00926042|Healthy|healthy
5591137|NCT00926042|volunteer|volunteer
5591138|NCT00926042|Healthy controls|healthy controls
5591139|NCT00926042|Normal controls|normal controls
5591140|NCT00926016|Hepatitis C|hepatitis c
5591141|NCT00926003|HIV|hiv
5591142|NCT00926003|Children|children
5591143|NCT00926003|Africa|africa
5591144|NCT00926003|Neuropsychology|neuropsychology
5591145|NCT00926003|cognitive rehabilitation|cognitive rehabilitation
5591146|NCT00926003|computers|computers
5591147|NCT00925990|HCV|hcv
5591148|NCT00925990|interferon-naive|interferon-naive
5591149|NCT00925977|treatment satisfaction|treatment satisfaction
5591150|NCT00925977|insulin Glargine|insulin glargine
5591151|NCT00925977|insulin Apidra|insulin apidra
5591152|NCT00925977|NPH insulin|nph insulin
5591153|NCT00925951|Persistent Non-specific Low Back Pain|persistent non-specific low back pain
5591154|NCT00925951|wet cupping|wet cupping
5591155|NCT00925951|cupping|cupping
5591156|NCT00925951|Numerical Rating Scale|numerical rating scale
5591157|NCT00925938|Hysteroscopy|hysteroscopy
5591158|NCT00925938|Cervical priming|cervical priming
5591159|NCT00925938|Cervical dilatation|cervical dilatation
5591160|NCT00925938|Misoprostol|misoprostol
5591161|NCT00925938|Endoscopy, uterine|endoscopy, uterine
5591162|NCT00925925|Low birth weight|low birth weight
5591163|NCT00925925|small for gestational age|small for gestational age
5591164|NCT00925925|B-cell function|b-cell function
5591165|NCT00925925|epigenetics|epigenetics
5591166|NCT00925925|B1a|b1a
5591167|NCT00925925|B1b|b1b
5591169|NCT00925925|CD5|cd5
5591170|NCT00925912|Hemorrhoidectomy|hemorrhoidectomy
5591171|NCT00925912|perianal block|perianal block
5591172|NCT00925912|local anesthesia|local anesthesia
5591173|NCT00925912|spinal anesthesia|spinal anesthesia
5591174|NCT00925899|Melatonin|melatonin
5591175|NCT00925899|Palliative care|palliative care
5591176|NCT00925899|Advanced cancer|advanced cancer
5591177|NCT00925899|Symptoms|symptoms
5591178|NCT00925899|Quality of life|quality of life
5591179|NCT00925899|Randomized controlled trial|randomized controlled trial
5591180|NCT00925886|Astigmatism|astigmatism
5591181|NCT00925886|Cataract|cataract
5591182|NCT00925873|Fludarabine|fludarabine
5591183|NCT00925873|AML|aml
5591184|NCT00925873|elderly patients|elderly patients
5591185|NCT00925847|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5591187|NCT00925847|Survival|survival
5591188|NCT00925834|Coronary angiography|coronary angiography
5591189|NCT00925834|Placebo effect|placebo effect
5591190|NCT00925834|Suggestion|suggestion
5591191|NCT00925821|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5591192|NCT00925821|Lenalidomide|lenalidomide
5591193|NCT00925821|IMiD|imid
5591194|NCT00925808|Unsuspected Venous Thromboembolism|unsuspected venous thromboembolism
5591195|NCT00925808|VTE|vte
5591196|NCT00925808|Routine Computed Tomography|routine computed tomography
5591197|NCT00925808|CT Scans|ct scans
5591198|NCT00925795|HIV|hiv
5591199|NCT00925795|atherosclerosis|atherosclerosis
5591200|NCT00925795|extra virgin olive oil|extra virgin olive oil
5591201|NCT00925795|Alternative therapies|alternative therapies
5591202|NCT00925795|Treatment experienced+|treatment experienced+
5591203|NCT00925782|autologous stem cell transplantation|autologous stem cell transplantation
5591204|NCT00925756|HIV|hiv
5591205|NCT00925756|low CD4 recovery|low cd4 recovery
5591206|NCT00925756|Low CD4 recovery despite HIV control|low cd4 recovery despite hiv control
5591207|NCT00925756|Treatment experienced|treatment experienced
5591208|NCT00925743|Phase 1|phase 1
5591209|NCT00925743|XRP6258|xrp6258
5591210|NCT00925743|cisplatin|cisplatin
5591211|NCT00925743|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5591212|NCT00925730|Atopic dermatitis|atopic dermatitis
5591213|NCT00925730|AD|ad
5591214|NCT00925730|pimecrolimus|pimecrolimus
5591215|NCT00925730|blood|blood
5591216|NCT00925730|absorption|absorption
5591217|NCT00925730|systemic|systemic
5591218|NCT00925717|ADA recommendation|ada recommendation
5591219|NCT00925665|Intubation|intubation
5591220|NCT00925665|Glidescope|glidescope
5591221|NCT00925665|Macintosh|macintosh
5591222|NCT00925665|Abscess|abscess
5591223|NCT00925665|Difficult intubations in patients with odontogenic abscesses|difficult intubations in patients with odontogenic abscesses
5591224|NCT00925652|CM|cm
5591225|NCT00925652|bevacizumab|bevacizumab
5591226|NCT00925652|cyclophosphamide|cyclophosphamide
5591227|NCT00925652|methotrexate|methotrexate
5591228|NCT00925652|exercise intervention|exercise intervention
5591229|NCT00925652|diet intervention|diet intervention
5591230|NCT00925639|phytoestrogen|phytoestrogen
5591231|NCT00925639|coagulation|coagulation
5591232|NCT00925639|menopause|menopause
5591233|NCT00925639|ddimer|ddimer
5591234|NCT00925639|antithrombin|antithrombin
5591235|NCT00925639|hypercoagulation|hypercoagulation
5591236|NCT00925613|Exchanging double lumen tube with laryngeal mask Proseal|exchanging double lumen tube with laryngeal mask proseal
5591237|NCT00925613|Exchange double lumen tube with tracheal tube|exchange double lumen tube with tracheal tube
5591238|NCT00925613|Exchange double lumen tube before emergence decrease cough|exchange double lumen tube before emergence decrease cough
5591429|NCT00925054|PKU|pku
5591239|NCT00925613|thoracoscopy and postoperative respiratory complications|thoracoscopy and postoperative respiratory complications
5591240|NCT00925613|thoracostomy and postoperative respiratory complications|thoracostomy and postoperative respiratory complications
5591241|NCT00925613|postoperative cough|postoperative cough
5591242|NCT00925613|postoperative respiratory complications|postoperative respiratory complications
5591243|NCT00925613|laryngeal mask and postoperative respiratory complications|laryngeal mask and postoperative respiratory complications
5591244|NCT00925600|Lens Opacification|lens opacification
5591245|NCT00925600|Bone Loss|bone loss
5591246|NCT00925600|Androgen Deprivation Therapy|androgen deprivation therapy
5591247|NCT00925600|Non-metastatic prostate cancer|non-metastatic prostate cancer
5591249|NCT00925587|Anemia|anemia
5591250|NCT00925587|correction|correction
5591251|NCT00925587|darbepoetin alfa|darbepoetin alfa
5591252|NCT00925574|CNTO 1959|cnto 1959
5591253|NCT00925574|Healthy Volunteers|healthy volunteers
5591254|NCT00925574|Psoriasis|psoriasis
5591255|NCT00925561|Coronary Artery Calcification|coronary artery calcification
5591256|NCT00925548|Phase III trial|phase iii trial
5591257|NCT00925548|randomized|randomized
5591258|NCT00925548|cancer vaccine|cancer vaccine
5591259|NCT00925548|MUC1|muc1
5591260|NCT00925548|BLP25|blp25
5591261|NCT00925548|advanced breast cancer|advanced breast cancer
5591262|NCT00925548|postmenopausal breast cancer|postmenopausal breast cancer
5591263|NCT00925548|immunotherapy of breast cancer|immunotherapy of breast cancer
5591264|NCT00925548|Inoperable locally advanced, recurrent, or metastatic endocrine-sensitive Breast Cancer|inoperable locally advanced, recurrent, or metastatic endocrine-sensitive breast cancer
5591265|NCT00925535|Pharmacokinetics HIV Tuberculosis Lersivirine UK-453|pharmacokinetics hiv tuberculosis lersivirine uk-453
5591266|NCT00925535|061 Rifabutin|061 rifabutin
5591267|NCT00925535|HIV Infections|hiv infections
5591268|NCT00925509|upper digestive tract cancer|upper digestive tract cancer
5591269|NCT00925509|implants|implants
5591270|NCT00925509|implants insertion|implants insertion
5591271|NCT00925509|radio-surgical guidance|radio-surgical guidance
5591272|NCT00925509|accuracy of implants insertion|accuracy of implants insertion
5591273|NCT00925509|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.|cranial/facial radiotherapy or brachytherapy and/or microvascular fibula transfer.
5591274|NCT00925509|Bone volume sufficient to support an implant|bone volume sufficient to support an implant
5591275|NCT00925496|Omarthrosis shoulder joint|omarthrosis shoulder joint
5591276|NCT00925483|left ventricular mass|left ventricular mass
5591277|NCT00925483|cardiac MRI|cardiac mri
5591278|NCT00925483|long dialysis|long dialysis
5591279|NCT00925483|daily dialysis|daily dialysis
5591280|NCT00925470|Target organs impairment|target organs impairment
5591281|NCT00925470|High blood pressure|high blood pressure
5862988|NCT00001426|Cyclophosphamide|cyclophosphamide
5862989|NCT00001420|Lymphocytes|lymphocytes
5591282|NCT00925470|Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease|evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
5591284|NCT00925457|Sudden cardiac death|sudden cardiac death
5591285|NCT00925457|Domperidone|domperidone
5591286|NCT00925457|Case-control study|case-control study
5591287|NCT00925457|Saskatchewan residents|saskatchewan residents
5591288|NCT00925457|Observational Study|observational study
5591289|NCT00925444|Absorbable implants|absorbable implants
5591291|NCT00925444|Alginates|alginates
5591292|NCT00925444|Pneumonectomy/methods|pneumonectomy/methods
5591293|NCT00925444|Pneumonectomy/instrumentation|pneumonectomy/instrumentation
5591294|NCT00925444|Surgical Stapling|surgical stapling
5591295|NCT00925444|Thoracic surgery|thoracic surgery
5591296|NCT00925444|Tissue Adhesives|tissue adhesives
5591297|NCT00925444|Prospective studies|prospective studies
5591298|NCT00925418|Neoplasm|neoplasm
5591299|NCT00925418|breast Neoplasm|breast neoplasm
5591300|NCT00925418|docetaxel|docetaxel
5591301|NCT00925418|Glove|glove
5591302|NCT00925405|Breast Cancer|breast cancer
5591303|NCT00925405|Hodgkin's lymphoma|hodgkin's lymphoma
5591304|NCT00925405|Mantle-field Irradiation|mantle-field irradiation
5591305|NCT00925405|Mammogram|mammogram
5591306|NCT00925405|Magnetic resonance imaging|magnetic resonance imaging
5591307|NCT00925405|MRI Breast Cancer Screening|mri breast cancer screening
5591308|NCT00925392|doripenem|doripenem
5591309|NCT00925392|epithelial lining fluid|epithelial lining fluid
5591310|NCT00925392|alveolar macrophages|alveolar macrophages
5591311|NCT00925392|pharmacokinetics|pharmacokinetics
5591312|NCT00925392|Healthy adult subjects|healthy adult subjects
5591313|NCT00925366|Shoulder|shoulder
5591315|NCT00925366|MR arthrography|mr arthrography
5591316|NCT00925366|CT arthrography|ct arthrography
5591317|NCT00925366|Rotator cuff tear|rotator cuff tear
5591318|NCT00925366|Arthroscopy|arthroscopy
5591319|NCT00925353|lidocaine|lidocaine
5591320|NCT00925353|pre-medication|pre-medication
5591321|NCT00925353|mammography|mammography
5591322|NCT00925353|pain|pain
5591323|NCT00925353|safety|safety
5591324|NCT00925340|Alcohol|alcohol
5591325|NCT00925340|Substance Abuse|substance abuse
5591326|NCT00925340|Adolescent|adolescent
5591327|NCT00925340|Family functioning|family functioning
5591328|NCT00925314|Stage III Melanoma|stage iii melanoma
5591329|NCT00925314|Melanoma|melanoma
5591330|NCT00925314|TLI|tli
5591331|NCT00925314|Transgenic Lymphocyte Immunization|transgenic lymphocyte immunization
5591332|NCT00925314|CB-10-01-02|cb-10-01-02
5591333|NCT00925301|Amicus Therapeutics|amicus therapeutics
5591334|NCT00925301|AT1001|at1001
5591335|NCT00925301|Migalastat|migalastat
5591336|NCT00925301|Pharmacokinetics|pharmacokinetics
5591337|NCT00925301|Substrate|substrate
5591338|NCT00925301|Galafold|galafold
5591339|NCT00925288|Female sex worker|female sex worker
5591340|NCT00925288|Peru|peru
5591341|NCT00925288|Cervical infection|cervical infection
5591342|NCT00925288|Cervical abnormality|cervical abnormality
5591343|NCT00925288|Serum antibody|serum antibody
5591344|NCT00925288|Vaccine acceptance|vaccine acceptance
5591345|NCT00925288|Alternative schedule|alternative schedule
5591346|NCT00925288|Viral infections|viral infections
5591347|NCT00925288|Human papillomavirus vaccine|human papillomavirus vaccine
5591348|NCT00925288|Human papillomavirus (HPV)|human papillomavirus (hpv)
5591349|NCT00925288|non inferiority|non inferiority
5591350|NCT00925275|Solid tumors|solid tumors
5591351|NCT00925275|Refractory|refractory
5591352|NCT00925275|Relapsed|relapsed
5591353|NCT00925275|Radiation|radiation
5591354|NCT00925275|Dosimetry|dosimetry
5591355|NCT00925275|Radiopharmaceutical|radiopharmaceutical
5591356|NCT00925275|Biodistribution|biodistribution
5591357|NCT00925275|Pharmacokinetics|pharmacokinetics
5591358|NCT00925275|Cancer|cancer
5591359|NCT00925275|Phase I|phase i
5591360|NCT00925262|mental health|mental health
5591361|NCT00925262|randomized controlled trial|randomized controlled trial
5591362|NCT00925262|torture|torture
5591363|NCT00925249|rheumatoid arthritis|rheumatoid arthritis
5591364|NCT00925249|RA|ra
5591365|NCT00925249|TB|tb
5591366|NCT00925249|tuberculosis|tuberculosis
5591367|NCT00925249|anti-TNF therapy|anti-tnf therapy
5591368|NCT00925249|biologic therapy|biologic therapy
5591370|NCT00925249|IGRA|igra
5591371|NCT00925249|Newly diagnosed rheumatoid arthritis (RA) in the Tricare system|newly diagnosed rheumatoid arthritis (ra) in the tricare system
5591372|NCT00925236|MYH9 gene|myh9 gene
5591377|NCT00925236|MYH9 Related Disorders|myh9 related disorders
5591379|NCT00925223|BDNf|bdnf
5591380|NCT00925223|visceral hypersensitivity|visceral hypersensitivity
5591381|NCT00925210|Endobronchial ultrasound|endobronchial ultrasound
5591382|NCT00925210|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
5591383|NCT00925210|Bronchoscopy|bronchoscopy
5591384|NCT00925210|Ultrasonography|ultrasonography
5591385|NCT00925197|anticoagulation|anticoagulation
5591386|NCT00925197|fluindione|fluindione
5591387|NCT00925197|patient self-testing|patient self-testing
5591388|NCT00925197|coaguchek|coaguchek
5591389|NCT00925197|inratio|inratio
5591390|NCT00925197|Post operative antivitamin K therapy|post operative antivitamin k therapy
5591391|NCT00925184|questionnaire, medical education, medical students.|questionnaire, medical education, medical students.
5591392|NCT00925171|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5591393|NCT00925171|Pulmonary rehabilitation|pulmonary rehabilitation
5591394|NCT00925171|Chronic Respiratory Questionnaire|chronic respiratory questionnaire
5591395|NCT00925158|Rhytidoplasty|rhytidoplasty
5591396|NCT00925158|Video-Assisted Surgery|video-assisted surgery
5591397|NCT00925158|Surgical instruments|surgical instruments
5591398|NCT00925158|Dissection|dissection
5591399|NCT00925158|Innovative therapies|innovative therapies
5591400|NCT00925158|Face|face
5591401|NCT00925158|Aging|aging
5591402|NCT00925158|Premature aging|premature aging
5591403|NCT00925158|Rejuvenation|rejuvenation
5591404|NCT00925132|Metastatic|metastatic
5591405|NCT00925132|Melanoma|melanoma
5591406|NCT00925132|Epigenetic|epigenetic
5591407|NCT00925132|Temozolomide|temozolomide
5591408|NCT00925132|Decitabine|decitabine
5591409|NCT00925132|Panobinostat|panobinostat
5591410|NCT00925132|LBH589|lbh589
5591411|NCT00925119|Diabetes|diabetes
5591412|NCT00925119|Atenolol|atenolol
5591413|NCT00925119|Genetic|genetic
5591414|NCT00925106|Bioavailability, pharmacokinetics, celecoxib|bioavailability, pharmacokinetics, celecoxib
5591415|NCT00925093|vancomycin|vancomycin
5591416|NCT00925093|teicoplanin|teicoplanin
5591417|NCT00925093|linezolid|linezolid
5591418|NCT00925093|intravenous|intravenous
5591419|NCT00925093|cerebrospinal fluid|cerebrospinal fluid
5770312|NCT00243789|Genetic|genetic
5591420|NCT00925093|CSF|csf
5591421|NCT00925093|pharmacokinetics|pharmacokinetics
5591422|NCT00925093|penetration|penetration
5591423|NCT00925093|blood-brain barrier|blood-brain barrier
5591424|NCT00925093|Pharmacokinetics of three antibiotics in relation to cerebrospinal fluid|pharmacokinetics of three antibiotics in relation to cerebrospinal fluid
5591425|NCT00925067|Inguinal hernia|inguinal hernia
5591426|NCT00925067|Laparoscopic repair|laparoscopic repair
5591427|NCT00925067|Prostheses|prostheses
5591428|NCT00925067|Male fertility|male fertility
5591430|NCT00925054|PEG PAL|peg pal
5591431|NCT00925054|BioMarin|biomarin
5591432|NCT00924989|Adrenocortical carcinoma|adrenocortical carcinoma
5591433|NCT00924989|OSI-906|osi-906
5591434|NCT00924989|ACC|acc
5591435|NCT00924989|GALACCTIC|galacctic
5591436|NCT00924989|Insulin-like growth factor-1 receptor (IGF-1R)|insulin-like growth factor-1 receptor (igf-1r)
5591437|NCT00924963|Pain of venipuncture or IV insertion|pain of venipuncture or iv insertion
5591438|NCT00924950|Psoriasis|psoriasis
5591439|NCT00924950|Plaque psoriasis, with bilateral symmetrical lesions.|plaque psoriasis, with bilateral symmetrical lesions.
5591440|NCT00924950|A diagnosis of stable plaque-type psoriasis vulgaris|a diagnosis of stable plaque-type psoriasis vulgaris
5591441|NCT00924950|with at least one pair of symmetric lesions on either|with at least one pair of symmetric lesions on either
5591442|NCT00924950|the trunk, arms, or legs that would serve as target lesions.|the trunk, arms, or legs that would serve as target lesions.
5591443|NCT00924937|Cardiovascular events|cardiovascular events
5591444|NCT00924937|Blood pressure|blood pressure
5591445|NCT00924937|Incidence of Cancer|incidence of cancer
5591446|NCT00924937|Cognitive decline|cognitive decline
5591447|NCT00924937|Mediterranean Diet|mediterranean diet
5591448|NCT00924937|Secondary Prevention|secondary prevention
5591449|NCT00924937|Low fat diet|low fat diet
5591450|NCT00924924|health promotion|health promotion
5591451|NCT00924924|prevention|prevention
5591452|NCT00924924|worksite wellness|worksite wellness
5591453|NCT00924924|behavior change|behavior change
5591454|NCT00924924|healthy volunteers|healthy volunteers
5591455|NCT00924911|GSK1322322, relative bioavailability, single dose, food effect, H2 blocker, healthy subjects, open label, PIB, tablet|gsk1322322, relative bioavailability, single dose, food effect, h2 blocker, healthy subjects, open label, pib, tablet
5591456|NCT00924898|Acute HIV|acute hiv
5591457|NCT00924898|HIV|hiv
5591458|NCT00924898|Acute Infections|acute infections
5591459|NCT00924898|Acute Infection|acute infection
5591460|NCT00924885|Reproductive Medicine|reproductive medicine
5591461|NCT00924885|Fertilization in Vitro|fertilization in vitro
5591462|NCT00924885|Oocyte retrieval|oocyte retrieval
5591463|NCT00924885|Local anaesthesia|local anaesthesia
5591464|NCT00924885|Aspiration needle|aspiration needle
5591465|NCT00924872|stroke|stroke
5591466|NCT00924872|power wheelchair skills|power wheelchair skills
5591467|NCT00924872|training|training
5591468|NCT00924872|safety|safety
5591469|NCT00924859|cerebral venous thrombosis|cerebral venous thrombosis
5591470|NCT00924859|stroke|stroke
5591471|NCT00924859|coagulation|coagulation
5591472|NCT00924846|high frequency oscillatory ventilation|high frequency oscillatory ventilation
5591473|NCT00924846|respiratory failure|respiratory failure
5591474|NCT00924846|children|children
5591475|NCT00924846|inhaled nitric oxide|inhaled nitric oxide
5591476|NCT00924833|hypoxia|hypoxia
5591477|NCT00924833|autonomic nervous system|autonomic nervous system
5591478|NCT00924833|blood pressure|blood pressure
5591479|NCT00924833|heart rate|heart rate
5591480|NCT00924833|exercise|exercise
5591482|NCT00924833|receptors, adrenergic, beta.|receptors, adrenergic, beta.
5591483|NCT00924820|Neoplastic Meningitis|neoplastic meningitis
5591485|NCT00924820|Advanced Cancers|advanced cancers
5591486|NCT00924820|Brain Cancer|brain cancer
5591487|NCT00924820|Advanced Cancer|advanced cancer
5591488|NCT00924820|Brain Diseases|brain diseases
5591489|NCT00924820|Central Nervous System Disorders|central nervous system disorders
5591490|NCT00924820|CNS|cns
5591491|NCT00924820|Bevacizumab|bevacizumab
5591492|NCT00924820|Avastin|avastin
5591493|NCT00924820|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5591494|NCT00924820|rhuMAb-VEGF|rhumab-vegf
5591495|NCT00924820|Spinal Cord|spinal cord
5591496|NCT00924820|meninges|meninges
5591497|NCT00924820|cerebrospinal fluid|cerebrospinal fluid
5591498|NCT00924820|CSF|csf
5591499|NCT00924807|Prostate Cancer|prostate cancer
5591500|NCT00924807|Combined Androgen Blockade|combined androgen blockade
5591501|NCT00924807|Radiotherapy|radiotherapy
5591502|NCT00924807|Sorafenib|sorafenib
5591503|NCT00924781|Anemia associated with chronic kidney disease (CKD)|anemia associated with chronic kidney disease (ckd)
5591504|NCT00924781|Hemodialysis|hemodialysis
5591505|NCT00924768|Otherwise healthy current cigarette smokers|otherwise healthy current cigarette smokers
5591506|NCT00924768|current cigarette smokers|current cigarette smokers
5591507|NCT00924755|Surgical mesh|surgical mesh
5591508|NCT00924742|The PK of Tapimycin|the pk of tapimycin
5591509|NCT00924742|volunteer|volunteer
5591510|NCT00924690|Colon|colon
5591511|NCT00924690|Cancer|cancer
5770531|NCT00242879|RTV|rtv
5591512|NCT00924690|Screening|screening
5591513|NCT00924690|Prevention|prevention
5591514|NCT00924690|Information|information
5591515|NCT00924677|genicular nerve|genicular nerve
5591516|NCT00924677|osteoarthritis|osteoarthritis
5591517|NCT00924677|knee|knee
5591518|NCT00924677|neurotomy|neurotomy
5591519|NCT00924664|low back pain monoclonal antibody nerve growth factor|low back pain monoclonal antibody nerve growth factor
5591520|NCT00924651|fatigue|fatigue
5591521|NCT00924651|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5591522|NCT00924638|atrial fibrillation|atrial fibrillation
5591523|NCT00924638|cryptogenic stroke|cryptogenic stroke
5591524|NCT00924638|continuous monitoring|continuous monitoring
5591525|NCT00924638|implantable loop recorder|implantable loop recorder
5591526|NCT00924638|insertable cardiac monitor|insertable cardiac monitor
5591527|NCT00924612|Primary hypogonadism|primary hypogonadism
5591528|NCT00924612|Secondary hypogonadism|secondary hypogonadism
5591529|NCT00924599|Recurring Gestational Diabetes|recurring gestational diabetes
5591530|NCT00924599|Prevention|prevention
5591531|NCT00924573|Glimepiride|glimepiride
5591532|NCT00924573|Metformin|metformin
5591533|NCT00924573|Combination Drug Therapy|combination drug therapy
5591534|NCT00924560|Adolescents|adolescents
5591535|NCT00924560|Bone Mineral Density|bone mineral density
5591536|NCT00924560|Oral Contraceptive|oral contraceptive
5591537|NCT00924547|Cystic Fibrosis|cystic fibrosis
5591538|NCT00924547|Docosahexanoic Acid|docosahexanoic acid
5591540|NCT00924547|isoprostanes|isoprostanes
5591541|NCT00924547|fatty acid|fatty acid
5591542|NCT00924534|type 2 diabetes|type 2 diabetes
5591543|NCT00924534|interventional|interventional
5591544|NCT00924534|placebo|placebo
5591545|NCT00924534|controlled|controlled
5591546|NCT00924534|PK|pk
5591547|NCT00924534|PD|pd
5591548|NCT00924534|safety|safety
5591549|NCT00924521|grains|grains
5591550|NCT00924521|fiber|fiber
5591551|NCT00924521|metabolic syndrome|metabolic syndrome
5591552|NCT00924521|insulin|insulin
5591553|NCT00924508|eczema|eczema
5591554|NCT00924508|at least 3 patches of eczema|at least 3 patches of eczema
5591555|NCT00924495|low back pain|low back pain
5591556|NCT00924495|motor control|motor control
5591557|NCT00924495|cortical regulation|cortical regulation
5591558|NCT00924495|transcranial magnetic stimulation|transcranial magnetic stimulation
5591559|NCT00924482|cardiac output|cardiac output
5591560|NCT00924482|ECOM|ecom
5591561|NCT00924482|Endotracheal Cardiac Output Monitor|endotracheal cardiac output monitor
5591577|NCT00924443|clofarabine|clofarabine
5591578|NCT00924443|untreated acute leukemia|untreated acute leukemia
5591579|NCT00924443|adult acute leukemia|adult acute leukemia
5591580|NCT00924430|Interaction SLV337 and simvastatin|interaction slv337 and simvastatin
5591581|NCT00924430|Type 2 diabetes mellitus|type 2 diabetes mellitus
5591582|NCT00924417|Pain associated with peripheral intravenous line placement|pain associated with peripheral intravenous line placement
5591583|NCT00924404|Xylitol vs. Saline|xylitol vs. saline
5591584|NCT00924404|nasal washes|nasal washes
5591585|NCT00924404|sinusitis|sinusitis
5591586|NCT00924391|cholesterol|cholesterol
5591587|NCT00924391|plant sterols|plant sterols
5591588|NCT00924391|cholesterol absorption|cholesterol absorption
5591589|NCT00924365|Children|children
5591590|NCT00924365|AIDS|aids
5591591|NCT00924365|Toxicity|toxicity
5591592|NCT00924365|Development|development
5591593|NCT00924365|Puberty|puberty
5591595|NCT00924365|Pediatrics|pediatrics
5591596|NCT00924365|HIV Infections|hiv infections
5591598|NCT00924339|soy protein|soy protein
5591599|NCT00924339|familial hypercholesterolaemia|familial hypercholesterolaemia
5591600|NCT00924339|children and adolescents|children and adolescents
5591601|NCT00924339|isoflavones|isoflavones
5591602|NCT00924339|FH|fh
5591603|NCT00924326|B Cell Malignancies|b cell malignancies
5591604|NCT00924326|T Cell Persistence|t cell persistence
5591605|NCT00924326|Immunotherapy|immunotherapy
5591606|NCT00924326|Cell Transfer|cell transfer
5591607|NCT00924326|Leukemia|leukemia
5591608|NCT00924326|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5591609|NCT00924326|CLL|cll
5591610|NCT00924326|Lymphoma|lymphoma
5591611|NCT00924313|Prostate Cancer|prostate cancer
5591612|NCT00924313|MRI|mri
5591613|NCT00924313|C-11 Acetate|c-11 acetate
5591614|NCT00924313|PET|pet
5591615|NCT00924300|feasibility of MEG in pediatric populations|feasibility of meg in pediatric populations
5591616|NCT00924287|Metastatic Cancer|metastatic cancer
5591617|NCT00924287|Tumor Regression|tumor regression
5591618|NCT00924287|Immunotherapy|immunotherapy
5591619|NCT00924287|Safety|safety
5591620|NCT00924287|Cancer|cancer
5591621|NCT00924261|hip|hip
5591622|NCT00924261|gait|gait
5591623|NCT00924261|walking|walking
5591624|NCT00924261|falls|falls
5591625|NCT00924261|stretching|stretching
5591626|NCT00924261|Flexibility|flexibility
5591627|NCT00924261|Aged|aged
5591632|NCT00924209|Gemcitabine|gemcitabine
5591633|NCT00924209|Bevacizumab|bevacizumab
5591634|NCT00924209|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591635|NCT00924209|NSCLC|nsclc
5591644|NCT00924183|Depression|depression
5591645|NCT00924183|Symptom scales|symptom scales
5591646|NCT00924183|Symptom measures|symptom measures
5591647|NCT00924183|Vancouver Semi-Structured Interview for Depression|vancouver semi-structured interview for depression
5591648|NCT00924183|V-SID|v-sid
5591649|NCT00924183|VSID|vsid
5591650|NCT00924183|treatment-as-usual|treatment-as-usual
5591651|NCT00924183|treatment as usual|treatment as usual
5591652|NCT00924183|open-label|open-label
5591653|NCT00924183|open label|open label
5591654|NCT00924183|Major Depressive Episode|major depressive episode
5591655|NCT00924183|MDE|mde
5591656|NCT00924170|Immunotoxin|immunotoxin
5591657|NCT00924170|CD25|cd25
5591658|NCT00924170|Immunogenicity|immunogenicity
5591659|NCT00924170|Neutralization|neutralization
5591660|NCT00924170|Neutralizing Antibodies|neutralizing antibodies
5591661|NCT00924170|Adult T-Cell Leukemia|adult t-cell leukemia
5591662|NCT00924170|Leukemia|leukemia
5591663|NCT00924170|ATL|atl
5591664|NCT00924131|Late Effects|late effects
5591665|NCT00924131|Radiation|radiation
5591666|NCT00924131|Chemotherapy|chemotherapy
5591667|NCT00924131|Hodgkin's Disease|hodgkin's disease
5591668|NCT00924131|Lymphoma|lymphoma
5591669|NCT00924131|Hodgkin Disease|hodgkin disease
5591670|NCT00924118|Acute myocardial infarction|acute myocardial infarction
5591671|NCT00924118|Reperfusion injury|reperfusion injury
5591672|NCT00924118|Nitric oxide|nitric oxide
5591673|NCT00924092|Immunotherapy|immunotherapy
5591674|NCT00924092|Lung Cancer|lung cancer
5591675|NCT00924092|Colorectal Cancer|colorectal cancer
5591676|NCT00924092|Head and Neck Cancer|head and neck cancer
5591677|NCT00924092|Prostate|prostate
5591678|NCT00924092|Breast Cancer|breast cancer
5591679|NCT00924079|Analysis of plasma concentration of nalbuphine|analysis of plasma concentration of nalbuphine
5591680|NCT00924066|Ixabepilone|ixabepilone
5591681|NCT00924066|BMS-247550|bms-247550
5591682|NCT00924066|Ixempra|ixempra
5591684|NCT00924066|Epothilone|epothilone
5591685|NCT00924053|Diabetes Mellitus Type 2|diabetes mellitus type 2
5591686|NCT00924040|BL22 in HCL after Immunotoxin|bl22 in hcl after immunotoxin
5591687|NCT00924040|Hairy Cell Leukemia|hairy cell leukemia
5591688|NCT00924040|Leukemia|leukemia
5591694|NCT00924014|heart failure|heart failure
5591695|NCT00924001|Clinical Response|clinical response
5591696|NCT00924001|Immunotherapy|immunotherapy
5591697|NCT00924001|Cancer|cancer
5591698|NCT00924001|Cytokines|cytokines
5591699|NCT00924001|Adoptive Cell Therapy|adoptive cell therapy
5591700|NCT00924001|Melanoma|melanoma
5591701|NCT00924001|Metastatic Melanoma|metastatic melanoma
5591702|NCT00923988|Secondhand smoke|secondhand smoke
5591703|NCT00923988|passive smoking|passive smoking
5591704|NCT00923988|platelet function|platelet function
5591705|NCT00923988|endothelial function|endothelial function
5591706|NCT00923962|Basic science|basic science
5591707|NCT00923962|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5591708|NCT00923962|Glucagon like peptid-1|glucagon like peptid-1
5591709|NCT00923962|Coronary Bloodflow|coronary bloodflow
5591710|NCT00923962|Metabolite uptake|metabolite uptake
5591711|NCT00923949|NSCLC Stage Ia-IIb|nsclc stage ia-iib
5591712|NCT00923949|Resectable NSCLC|resectable nsclc
5591713|NCT00923949|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591714|NCT00923949|NSCLC|nsclc
5591715|NCT00923936|Kaposi's Sarcoma|kaposi's sarcoma
5591716|NCT00923936|HIV|hiv
5591717|NCT00923936|Doxil|doxil
5591721|NCT00923923|PTSD|ptsd
5591722|NCT00923923|alcohol dependence|alcohol dependence
5591723|NCT00923923|drinking|drinking
5591724|NCT00923923|craving|craving
5591725|NCT00923910|WT1 Peptide Dendritic Cell Vaccine|wt1 peptide dendritic cell vaccine
5591726|NCT00923910|Hematologic Malignancies|hematologic malignancies
5591727|NCT00923910|Relapse After Allogeneic Stem Cell Transplantation|relapse after allogeneic stem cell transplantation
5591728|NCT00923910|Donor Lymphocyte Infusions|donor lymphocyte infusions
5591729|NCT00923910|WT1-Positive|wt1-positive
5591730|NCT00923910|Dendritic Cell Vaccine|dendritic cell vaccine
5591731|NCT00923910|Tumor Immunotherapy|tumor immunotherapy
5591732|NCT00923910|Allogeneic Adoptive Immunotherapy|allogeneic adoptive immunotherapy
5591733|NCT00923910|Hodgkins Lymphoma|hodgkins lymphoma
5591734|NCT00923910|Leukemia|leukemia
5591735|NCT00923910|Acute Myelogenous Leukemia|acute myelogenous leukemia
5591736|NCT00923910|AML|aml
5591737|NCT00923910|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5591738|NCT00923910|ALL|all
5591739|NCT00923910|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5591740|NCT00923910|CML|cml
5591741|NCT00923910|Myelodysplasia Syndrome|myelodysplasia syndrome
5591742|NCT00923910|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5591743|NCT00923897|Hepatocellular Carcinoma|hepatocellular carcinoma
5591744|NCT00923897|Hepatic Metastasis|hepatic metastasis
5591745|NCT00923897|Palliative Radiation Therapy|palliative radiation therapy
5591746|NCT00923897|Locally advanced HCC and Hepatic Metastasis|locally advanced hcc and hepatic metastasis
5591747|NCT00923884|NSCLC|nsclc
5591748|NCT00923884|Genotype|genotype
5591749|NCT00923884|SCLC|sclc
5591750|NCT00923884|Lung Cancer|lung cancer
5591751|NCT00923884|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591752|NCT00923884|Small Cell Lung Cancer|small cell lung cancer
5591753|NCT00923871|CBCT|cbct
5591754|NCT00923871|Breast Cancer|breast cancer
5591755|NCT00923858|Rotator Cuff|rotator cuff
5591756|NCT00923858|Ultrasound|ultrasound
5591757|NCT00923858|Pain|pain
5591758|NCT00923858|Tear Progression|tear progression
5591759|NCT00923845|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5591760|NCT00923845|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5591761|NCT00923845|Th2 Cells|th2 cells
5591762|NCT00923845|Sirolimus|sirolimus
5591763|NCT00923845|Pentostatin|pentostatin
5591764|NCT00923845|Kidney Cancer|kidney cancer
5591765|NCT00923845|Renal Cell Carcinoma|renal cell carcinoma
5591766|NCT00923845|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5591767|NCT00923832|Fungal Infections|fungal infections
5591769|NCT00923832|Cell Wall Derived Biomarkers|cell wall derived biomarkers
5591770|NCT00923832|EORTC/MSG Definitions|eortc/msg definitions
5591771|NCT00923832|Molecular Assays|molecular assays
5591772|NCT00923832|Lung Fungal Infection|lung fungal infection
5591773|NCT00923832|Invasive Pulmonary Fungal Infection|invasive pulmonary fungal infection
5591774|NCT00923832|Invasive Pulmonary Aspegillosis|invasive pulmonary aspegillosis
5591775|NCT00923832|Invasive Pulmonary Zycomycosis|invasive pulmonary zycomycosis
5591776|NCT00923819|Adolescents|adolescents
5591777|NCT00923819|Gastric Bypass|gastric bypass
5591778|NCT00923819|Quality of Life|quality of life
5591779|NCT00923819|Mental Health|mental health
5591780|NCT00923819|Lifestyle|lifestyle
5591781|NCT00923806|Metastatic Cancer|metastatic cancer
5591782|NCT00923806|Tumor Regression|tumor regression
5591783|NCT00923806|Safety|safety
5591784|NCT00923806|Immunotherapy|immunotherapy
5591785|NCT00923793|skull defects|skull defects
5591786|NCT00923793|Hydroxylapatite implant|hydroxylapatite implant
5591787|NCT00923793|Titanium implant|titanium implant
5591788|NCT00923793|calotte defects without the possibility to be covered with the missing own bone|calotte defects without the possibility to be covered with the missing own bone
5574303|NCT00990249|ALL|all
5591789|NCT00923780|Tissue Acquisition|tissue acquisition
5591790|NCT00923780|Gene Expression|gene expression
5591791|NCT00923780|Class Predictor Model|class predictor model
5591792|NCT00923780|Endocrine Tumor|endocrine tumor
5591793|NCT00923741|Lung Cancer|lung cancer
5591794|NCT00923741|Immunity|immunity
5591795|NCT00923741|Clinical Response|clinical response
5591796|NCT00923741|Cytokines|cytokines
5591797|NCT00923741|Elispot Assay|elispot assay
5591798|NCT00923741|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591800|NCT00923728|AVN - 944|avn - 944
5591801|NCT00923728|Phase I|phase i
5591802|NCT00923728|Adult Solid Tumors|adult solid tumors
5591803|NCT00923728|Cancer|cancer
5591804|NCT00923728|Solid Tumor|solid tumor
5591805|NCT00923676|Hyperlipidemia|hyperlipidemia
5591806|NCT00923676|LDL-cholesterol|ldl-cholesterol
5591807|NCT00923676|HDL-cholesterol|hdl-cholesterol
5591808|NCT00923676|triglycerides|triglycerides
5591809|NCT00923676|IIEF|iief
5591810|NCT00923676|FSFI|fsfi
5591811|NCT00923676|Male and female sexual dysfunctions|male and female sexual dysfunctions
5591812|NCT00923663|MALT lymphoma|malt lymphoma
5585867|NCT00947089|ORC (oxidized regenerated cellulose)|orc (oxidized regenerated cellulose)
5591813|NCT00923663|Advanced or Helicobacter pylori-refractory MALT lymphoma|advanced or helicobacter pylori-refractory malt lymphoma
5591814|NCT00923650|Informed Consent|informed consent
5591815|NCT00923650|Pediatric Phase I Clinical Trials|pediatric phase i clinical trials
5591817|NCT00923650|Questionnaires|questionnaires
5591818|NCT00923650|Osteosarcoma|osteosarcoma
5591819|NCT00923650|Ewing's Sarcoma|ewing's sarcoma
5591820|NCT00923650|Neuroblastoma|neuroblastoma
5591821|NCT00923650|Brain Tumors|brain tumors
5591822|NCT00923650|Leukemia|leukemia
5591823|NCT00923637|Non small cell lung cancer|non small cell lung cancer
5591824|NCT00923637|video assisted thoracic surgery|video assisted thoracic surgery
5591825|NCT00923637|Adjuvant chemotherapy|adjuvant chemotherapy
5591826|NCT00923637|Pemetrexed|pemetrexed
5591827|NCT00923637|Oxaliplatin|oxaliplatin
5591833|NCT00923598|Bilateral|bilateral
5591834|NCT00923598|Cleveland Clinic|cleveland clinic
5591835|NCT00923598|UCSD|ucsd
5591836|NCT00923598|Catheter|catheter
5591837|NCT00923598|Nerve block|nerve block
5591838|NCT00923598|Postoperative pain|postoperative pain
5591839|NCT00923598|Femoral Catheter|femoral catheter
5591840|NCT00923598|Bilateral Total Knee Arthroplasty|bilateral total knee arthroplasty
5591841|NCT00923598|Bilateral Femoral Catheter|bilateral femoral catheter
5591842|NCT00923572|Oral contraceptive|oral contraceptive
5591843|NCT00923533|Fimasartan|fimasartan
5591844|NCT00923533|Drug interaction|drug interaction
5591845|NCT00923520|Solid Tumors|solid tumors
5591846|NCT00923520|Phase I|phase i
5591847|NCT00923520|Lymphoma|lymphoma
5591848|NCT00923520|Dimethane Sulfonate (DMS612, NSC 281612)|dimethane sulfonate (dms612, nsc 281612)
5591849|NCT00923520|Cancer|cancer
5591850|NCT00923520|Solid Tumor|solid tumor
5591851|NCT00923520|Renal Cell Cancer|renal cell cancer
5591852|NCT00923520|Kidney Cancer|kidney cancer
5591853|NCT00923520|Breast Cancer|breast cancer
5591854|NCT00923520|Colon Cancer|colon cancer
5591855|NCT00923520|Lung Disease|lung disease
5591856|NCT00923520|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5591857|NCT00923520|NHL|nhl
5591858|NCT00923507|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5591859|NCT00923507|Monoclonal B Cell Lymphocytosis|monoclonal b cell lymphocytosis
5591860|NCT00923507|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5591861|NCT00923507|Leukemia|leukemia
5591862|NCT00923507|Lymphoma|lymphoma
5591863|NCT00923494|Anesthesia|anesthesia
5591864|NCT00923481|Multi-Kinase Inhibitor|multi-kinase inhibitor
5591865|NCT00923481|Neoplasms|neoplasms
5591866|NCT00923481|Advanced Cancer|advanced cancer
5591867|NCT00923481|Kidney Cancer|kidney cancer
5591868|NCT00923481|Liver Cancer|liver cancer
5591869|NCT00923481|Pheochromocytoma|pheochromocytoma
5591870|NCT00923481|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591871|NCT00923481|Colorectal Cancer|colorectal cancer
5591872|NCT00923481|Head and Neck Cancer|head and neck cancer
5591873|NCT00923468|Pharmacokinetics|pharmacokinetics
5591874|NCT00923468|Phase I Trials|phase i trials
5591875|NCT00923468|Children|children
5591876|NCT00923468|Relaspsed Solid Tumors|relaspsed solid tumors
5591877|NCT00923468|Relapsed Leukemia|relapsed leukemia
5591878|NCT00923468|Relapsed Brain Tumors|relapsed brain tumors
5591884|NCT00923429|Manual therapy|manual therapy
5591885|NCT00923429|Low back pain|low back pain
5591886|NCT00923429|Pain|pain
5591887|NCT00923429|Return to work|return to work
5591888|NCT00923416|Intra-Prostate Markers|intra-prostate markers
5591889|NCT00923416|Transrectal Ultrasound|transrectal ultrasound
5591890|NCT00923416|Prostate Cancer Patients|prostate cancer patients
5591891|NCT00923403|plant sterols|plant sterols
5591892|NCT00923403|diet|diet
5591894|NCT00923403|cholesterol|cholesterol
5591895|NCT00923390|Renal Cancer|renal cancer
5591896|NCT00923390|Immunotherapy|immunotherapy
5591897|NCT00923390|Clinical Response|clinical response
5591898|NCT00923390|Toxicity|toxicity
5591899|NCT00923390|Gene Therapy|gene therapy
5591900|NCT00923390|Kidney Cancer|kidney cancer
5591901|NCT00923377|Breast Cancer|breast cancer
5591902|NCT00923377|Breast Cancer Prevention|breast cancer prevention
5591903|NCT00923377|High Risk|high risk
5591904|NCT00923377|Breast Stem Cells|breast stem cells
5591905|NCT00923377|Mammographic Density|mammographic density
5591906|NCT00923377|Breast Cancer Risk|breast cancer risk
5591907|NCT00923364|GATA2|gata2
5591908|NCT00923364|Transplant|transplant
5591909|NCT00923364|Immunodeficiency|immunodeficiency
5591910|NCT00923364|Myelodysplasia|myelodysplasia
5591911|NCT00923364|MonoMAC|monomac
5591912|NCT00923351|Vaccine|vaccine
5591913|NCT00923351|Immunotherapy|immunotherapy
5591914|NCT00923351|Cancer|cancer
5591915|NCT00923351|Chemotherapy|chemotherapy
5591916|NCT00923351|Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine|tumor lysate/klh pulsed dendritic cell vaccine
5591917|NCT00923351|Neuroblastoma|neuroblastoma
5591918|NCT00923351|Autologous Lymphocyte Infusion|autologous lymphocyte infusion
5591919|NCT00923351|Ewing's Sarcoma|ewing's sarcoma
5591920|NCT00923351|Rhabdomyosarcoma|rhabdomyosarcoma
5591921|NCT00923338|fistula|fistula
5862990|NCT00001420|Cytokines|cytokines
5591923|NCT00923325|Biomarker Analysis|biomarker analysis
5591924|NCT00923325|Sarcomas|sarcomas
5591925|NCT00923325|Ewing's Sarcoma|ewing's sarcoma
5591926|NCT00923325|Osteosarcoma|osteosarcoma
5591927|NCT00923325|Rhabdomyosarcoma|rhabdomyosarcoma
5591928|NCT00923325|Synovial Sarcoma|synovial sarcoma
5591937|NCT00923273|mTOR Inhibitor|mtor inhibitor
5591938|NCT00923273|NSCLC|nsclc
5591939|NCT00923273|Lung Cancer|lung cancer
5591940|NCT00923260|Omentectomy|omentectomy
5591941|NCT00923260|metabolic syndrome|metabolic syndrome
5591942|NCT00923260|acute phase reactants|acute phase reactants
5591943|NCT00923247|Vandetanib|vandetanib
5591944|NCT00923247|Bortezomib|bortezomib
5591945|NCT00923247|Medullary Thyroid|medullary thyroid
5591946|NCT00923247|Proteasome Inhibitor|proteasome inhibitor
5591947|NCT00923247|Cancer|cancer
5591948|NCT00923247|Solid Tumor|solid tumor
5591949|NCT00923247|Thyroid Cancer|thyroid cancer
5591950|NCT00923247|Medullary Thyroid Cancer|medullary thyroid cancer
5591951|NCT00923234|monosomy 5|monosomy 5
5591952|NCT00923234|del5q|del5q
5591953|NCT00923234|lenalidomide|lenalidomide
5591954|NCT00923234|azacitidine|azacitidine
5591955|NCT00923221|Blood|blood
5591956|NCT00923221|Prostate Cancer|prostate cancer
5591957|NCT00923221|Genotyping|genotyping
5591958|NCT00923195|Metastatic Melanoma|metastatic melanoma
5591959|NCT00923195|Tumor Regression|tumor regression
5591960|NCT00923195|Safety|safety
5591961|NCT00923195|Immunotherapy|immunotherapy
5591962|NCT00923182|Relapsed or Refractory Chronic Lymphocytic Leukemia,|relapsed or refractory chronic lymphocytic leukemia,
5591964|NCT00923169|Renal Cell|renal cell
5591965|NCT00923169|Melanoma|melanoma
5591966|NCT00923169|Monoclonal Antibodies|monoclonal antibodies
5591967|NCT00923169|Phase I|phase i
5591968|NCT00923169|TGF-B|tgf-b
5591969|NCT00923156|Heart failure|heart failure
5591970|NCT00923156|Systolic|systolic
5591971|NCT00923156|Aliskiren|aliskiren
5591972|NCT00923156|Ramipril|ramipril
5591973|NCT00923156|Angiotensin II|angiotensin ii
5591974|NCT00923156|Ang II|ang ii
5591975|NCT00923156|Plasma Renin Activity|plasma renin activity
5591977|NCT00923156|Plasma Renin Concentration|plasma renin concentration
5591978|NCT00923156|PR,|pr,
5591979|NCT00923156|brain natriuretic peptide|brain natriuretic peptide
5591980|NCT00923156|BNP|bnp
5591981|NCT00923156|urinary aldosterone|urinary aldosterone
5591982|NCT00923156|Escape|escape
5591983|NCT00923156|Pharmacokinetic|pharmacokinetic
5591984|NCT00923156|PK|pk
5591985|NCT00923130|Renal Cell Carcinoma|renal cell carcinoma
5591987|NCT00923130|Ixabepilone|ixabepilone
5591988|NCT00923130|Phase II|phase ii
5591989|NCT00923117|Glioblastoma|glioblastoma
5591990|NCT00923117|Chemotherapy|chemotherapy
5591991|NCT00923117|Anti-Angiogenesis|anti-angiogenesis
5591992|NCT00923117|Radiation|radiation
5591993|NCT00923117|Brain Tumor|brain tumor
5591994|NCT00923117|Malignant Glioma|malignant glioma
5591995|NCT00923117|Glioblastoma Multiforme|glioblastoma multiforme
5591996|NCT00923104|Radiation|radiation
5591997|NCT00923104|Blister|blister
5591998|NCT00923104|Healthy Volunteer|healthy volunteer
5591999|NCT00923104|Samples|samples
5592000|NCT00923104|Prostate Cancer|prostate cancer
5592001|NCT00923104|Breast Cancer|breast cancer
5592002|NCT00923104|HV|hv
5592003|NCT00923091|triple combination|triple combination
5592004|NCT00923091|parallel group|parallel group
5592005|NCT00923091|dual combination|dual combination
5592006|NCT00923078|schizophrenia|schizophrenia
5592007|NCT00923078|cognitive remediation|cognitive remediation
5592008|NCT00923078|rehabilitation|rehabilitation
5592009|NCT00923078|electrophysiology|electrophysiology
5592010|NCT00923078|neuropsychology|neuropsychology
5592014|NCT00923052|Cancer Stem Cells|cancer stem cells
5592015|NCT00923052|Biomarkers|biomarkers
5592017|NCT00923052|Solid Organ Cancers|solid organ cancers
5592018|NCT00923052|Natural History|natural history
5592019|NCT00923052|Cancer|cancer
5592020|NCT00923052|Solid Organ Cancer|solid organ cancer
5592021|NCT00923052|Liver Cancer|liver cancer
5592022|NCT00923052|Colorectal Cancer|colorectal cancer
5592023|NCT00923052|Breast Cancer|breast cancer
5592024|NCT00923052|Gastric Cancer|gastric cancer
5592025|NCT00923052|Pancreatic Ductal Cancer|pancreatic ductal cancer
5592026|NCT00923039|The early origin of cardiovascular disease|the early origin of cardiovascular disease
5592034|NCT00923013|Hairy Cell Leukemia|hairy cell leukemia
5592035|NCT00923013|Cladribine|cladribine
5592036|NCT00923013|Rituximab|rituximab
5592037|NCT00923013|Minimal Residual Disease|minimal residual disease
5592038|NCT00923013|Leukemia|leukemia
5592039|NCT00923000|Herb Drug|herb drug
5592040|NCT00923000|volunteers|volunteers
5592041|NCT00922987|lyrica pregabalin epilepsy partial seizures|lyrica pregabalin epilepsy partial seizures
5592042|NCT00922974|spinal bone metastases|spinal bone metastases
5592043|NCT00922974|pain|pain
5592044|NCT00922961|brachytherapy, late cutaneous toxicity|brachytherapy, late cutaneous toxicity
5592045|NCT00922948|Radiofrequency ablation|radiofrequency ablation
5592046|NCT00922948|Cryosurgery|cryosurgery
5592047|NCT00922948|Renal cancers|renal cancers
5592049|NCT00922896|Cisplatin|cisplatin
5592050|NCT00922896|Erlotinib|erlotinib
5592051|NCT00922883|Promacta|promacta
5592053|NCT00922883|Aplastic Anemia|aplastic anemia
5592054|NCT00922883|Thrombocytopenia|thrombocytopenia
5592055|NCT00922857|Respiratory Insufficiency|respiratory insufficiency
5592056|NCT00922857|Muscular Atrophy|muscular atrophy
5592057|NCT00922857|Respiratory rehabilitation|respiratory rehabilitation
5592058|NCT00922844|hypotension|hypotension
5592059|NCT00922844|low blood pressure|low blood pressure
5592060|NCT00922844|vasopressor need|vasopressor need
5592061|NCT00922831|Cognition, Affective MS symptoms|cognition, affective ms symptoms
5592062|NCT00922818|Perineal|perineal
5592063|NCT00922818|Prostatectomy|prostatectomy
5592064|NCT00922818|Nerve|nerve
5592065|NCT00922818|Anatomic|anatomic
5592066|NCT00922818|Surgery|surgery
5592067|NCT00922818|Neoplasms, Prostatic|neoplasms, prostatic
5592068|NCT00922818|Prostate Cancer|prostate cancer
5592069|NCT00922818|Prostate Neoplasms|prostate neoplasms
5592070|NCT00922818|Prostatic Cancer|prostatic cancer
5592071|NCT00922818|Prostate|prostate
5592072|NCT00922818|Cancer|cancer
5592073|NCT00922818|Recurrent|recurrent
5592074|NCT00922805|Pediatrics, short bowel syndrome, soluble fiber|pediatrics, short bowel syndrome, soluble fiber
5592075|NCT00922766|dalteparin non-ST segment elevated acute coronary syndromes|dalteparin non-st segment elevated acute coronary syndromes
5592076|NCT00922753|Preoxygenation|preoxygenation
5592077|NCT00922753|Inspiratory|inspiratory
5592078|NCT00922753|Support|support
5592079|NCT00922753|Healthy|healthy
5592080|NCT00922753|EndtidalO2|endtidalo2
5592081|NCT00922740|Nocturia|nocturia
5592082|NCT00922740|Pharmacokinetics|pharmacokinetics
5592083|NCT00922740|Pharmacodynamics|pharmacodynamics
5592084|NCT00922740|Water-loading|water-loading
5592085|NCT00922740|Elderly|elderly
5592086|NCT00922740|Males|males
5592087|NCT00922727|L. reuteri|l. reuteri
5592088|NCT00922727|Cytokines|cytokines
5592089|NCT00922727|Toll like receptors|toll like receptors
5592090|NCT00922727|Healthy Adults|healthy adults
5592091|NCT00922727|Probiotics|probiotics
5592092|NCT00922714|Glutamine|glutamine
5592093|NCT00922714|ICU patients|icu patients
5592094|NCT00922714|Critically ill|critically ill
5592095|NCT00922714|Nutrition|nutrition
5592096|NCT00922701|Peritoneal dialysis|peritoneal dialysis
5592097|NCT00922701|L-carnitine|l-carnitine
5592098|NCT00922688|Dipeptide Alanyl-Glutamine|dipeptide alanyl-glutamine
5592099|NCT00922688|Insulin sensitivity|insulin sensitivity
5592100|NCT00922688|Intracellular signaling|intracellular signaling
5592101|NCT00922688|Antioxidant/oxidant parameters|antioxidant/oxidant parameters
5592102|NCT00922688|Lipolysis|lipolysis
5592103|NCT00922688|Inflammatory response in the liver|inflammatory response in the liver
5592104|NCT00922675|ST-elevation myocardial infarction|st-elevation myocardial infarction
5592105|NCT00922662|coronary artery disease|coronary artery disease
5592106|NCT00922662|chest pain|chest pain
5592107|NCT00922662|CCTA|ccta
5592108|NCT00922623|Nasolabial folds|nasolabial folds
5592109|NCT00922597|Continuous infusion|continuous infusion
5592110|NCT00922597|Surgery|surgery
5592111|NCT00922597|Severe haemophilia A|severe haemophilia a
5592112|NCT00922584|non-small cell lung cancer|non-small cell lung cancer
5592113|NCT00922584|Sorafenib|sorafenib
5592114|NCT00922584|targeted therapy|targeted therapy
5592115|NCT00922571|Cataract|cataract
5592116|NCT00922571|Femtosecond laser|femtosecond laser
5592117|NCT00922558|tetra-axiametric posturography|tetra-axiametric posturography
5592118|NCT00922558|postural control|postural control
5592119|NCT00922558|tetrax|tetrax
5592121|NCT00922545|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5752379|NCT00310804|Flu|flu
5592122|NCT00922545|Quality of life|quality of life
5592123|NCT00922545|Primary health care|primary health care
5592124|NCT00922532|Hypoxic Respiratory Failure (HRF), Pulmonary Hypertension|hypoxic respiratory failure (hrf), pulmonary hypertension
5592125|NCT00922519|Positron Emission Tomography|positron emission tomography
5592126|NCT00922519|Sodium 18F-Fluoride|sodium 18f-fluoride
5592127|NCT00922519|99mTc-MDP|99mtc-mdp
5592128|NCT00922519|Bone Scan|bone scan
5592129|NCT00922506|Overactive bladder|overactive bladder
5592130|NCT00922506|Benign prostate hyperplasia|benign prostate hyperplasia
5592131|NCT00922506|Doxazosin|doxazosin
5592132|NCT00922506|Tolterodine|tolterodine
5592133|NCT00922493|weaning|weaning
5592134|NCT00922493|inspiratory muscle training|inspiratory muscle training
5592337|NCT00921700|Ibuprofen|ibuprofen
5592135|NCT00922493|maximum inspiratory pressure (MIP)|maximum inspiratory pressure (mip)
5592136|NCT00922493|index of Tobin (IT)|index of tobin (it)
5592137|NCT00922493|intubated|intubated
5592138|NCT00922493|intensive care unit|intensive care unit
5592139|NCT00922493|elderly|elderly
5592140|NCT00922480|Hypertension|hypertension
5592141|NCT00922480|Losartan|losartan
5592142|NCT00922454|patients will be matched based on AAA neck length and neck and iliac angulation|patients will be matched based on aaa neck length and neck and iliac angulation
5592143|NCT00922441|Fimasartan|fimasartan
5586144|NCT00946270|CC-4047|cc-4047
5592145|NCT00922441|24hour ABPM|24hour abpm
5592146|NCT00922441|Population PK|population pk
5592147|NCT00922428|rheumatism|rheumatism
5592148|NCT00922428|arthralgia|arthralgia
5592149|NCT00922428|myalgia|myalgia
5592150|NCT00922428|lumbago|lumbago
5592151|NCT00922428|homoeopathy|homoeopathy
5592152|NCT00922428|injection|injection
5592153|NCT00922428|PASCOE-Agil HOM Injektopas|pascoe-agil hom injektopas
5592154|NCT00922428|efficacy|efficacy
5592155|NCT00922428|tolerability|tolerability
5592156|NCT00922428|acceptance|acceptance
5592157|NCT00922428|safety|safety
5592158|NCT00922415|Crohn's disease|crohn's disease
5592159|NCT00922415|calprotectin|calprotectin
5592160|NCT00922402|Acute|acute
5592161|NCT00922402|heart failure|heart failure
5592162|NCT00922402|hyperglycemia|hyperglycemia
5592163|NCT00922402|Acute heart failure with high levels of glycemia|acute heart failure with high levels of glycemia
5592164|NCT00922389|Diabetes Complications|diabetes complications
5592165|NCT00922389|Lower limb ischemia|lower limb ischemia
5592166|NCT00922389|Adult stem cells|adult stem cells
5592167|NCT00922389|peripheral blood stem cells|peripheral blood stem cells
5592168|NCT00922376|Diabetes|diabetes
5592169|NCT00922376|self- management|self- management
5592170|NCT00922376|glycemic control|glycemic control
5592171|NCT00922376|telehealth|telehealth
5592172|NCT00922376|mhealth|mhealth
5592173|NCT00922363|safety|safety
5592174|NCT00922363|vaccine|vaccine
5592175|NCT00922363|tuberculosis|tuberculosis
5592176|NCT00922363|CAF01|caf01
5592177|NCT00922363|Ag85B-ESAT-6|ag85b-esat-6
5592178|NCT00922363|prevention|prevention
5592179|NCT00922350|asthma|asthma
5592180|NCT00922350|heliox|heliox
5592181|NCT00922350|bronchodilators|bronchodilators
5592182|NCT00922350|posture|posture
5592183|NCT00922337|distal embolization|distal embolization
5592184|NCT00922337|thrombotic lesions|thrombotic lesions
5592185|NCT00922337|AMI|ami
5592186|NCT00922337|ACS|acs
5592187|NCT00922337|SVG|svg
5592188|NCT00922324|Healthy volunteers|healthy volunteers
5592189|NCT00922311|Proteinuria|proteinuria
5592190|NCT00922285|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5592191|NCT00922285|health status unknown|health status unknown
5592192|NCT00922272|Schizophrenia|schizophrenia
5592193|NCT00922259|Flu|flu
5592194|NCT00922259|Influenza|influenza
5592195|NCT00922259|Vaccine|vaccine
5592196|NCT00922259|Prevention|prevention
5592197|NCT00922246|overuse injuries|overuse injuries
5592198|NCT00922246|conscript|conscript
5592199|NCT00922246|prevention|prevention
5592200|NCT00922233|Contraception|contraception
5592205|NCT00922194|Type 2 diabetes|type 2 diabetes
5592206|NCT00922194|Obesity|obesity
5592207|NCT00922194|Extended Release Metformin|extended release metformin
5592208|NCT00922181|malignancy|malignancy
5592209|NCT00922181|liver|liver
5592210|NCT00922181|microwave|microwave
5592211|NCT00922181|surgery|surgery
5592212|NCT00922168|Sleep|sleep
5592213|NCT00922168|apnea|apnea
5592214|NCT00922168|obstructive|obstructive
5592215|NCT00922168|central|central
5592216|NCT00922155|endobronchial ultrasound|endobronchial ultrasound
5592217|NCT00922155|guide sheath|guide sheath
5592218|NCT00922155|peripheral pulmonary lesions|peripheral pulmonary lesions
5592219|NCT00922129|Sirolimus|sirolimus
5592220|NCT00922129|Calcineurin inhibitor|calcineurin inhibitor
5592221|NCT00922129|prostate cancer|prostate cancer
5592222|NCT00922103|Colitis, Ulcerative|colitis, ulcerative
5592223|NCT00922103|Ileo Neo Rectal Anastomosis|ileo neo rectal anastomosis
5592224|NCT00922103|Ileal Pouch Anal Anastomosis|ileal pouch anal anastomosis
5592225|NCT00922103|Quality of Life|quality of life
5592227|NCT00922103|reconstructive surgery|reconstructive surgery
5592228|NCT00922103|surgery|surgery
5592229|NCT00922090|Schizophrenia|schizophrenia
5592230|NCT00922090|Seroquel XR|seroquel xr
5592231|NCT00922090|CGI-CB|cgi-cb
5592232|NCT00922090|SWN-K|swn-k
5592233|NCT00922051|COPD|copd
5592234|NCT00922051|FEV1|fev1
5592235|NCT00922051|beta endorphin|beta endorphin
5592236|NCT00922051|TENS|tens
5592237|NCT00922051|acupuncture|acupuncture
5592238|NCT00922025|NSCLC|nsclc
5592239|NCT00922025|Male|male
5592240|NCT00922025|Smoking Pattern|smoking pattern
5592241|NCT00922025|Efficacy|efficacy
5592338|NCT00921700|Pain|pain
5592242|NCT00922012|Electromagnetic Stimulation Therapy|electromagnetic stimulation therapy
5592243|NCT00922012|Chronic Prostatitis|chronic prostatitis
5592244|NCT00922012|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
5592245|NCT00921999|Chickenpox|chickenpox
5592246|NCT00921999|Shingles|shingles
5592247|NCT00921999|Varicella|varicella
5592248|NCT00921999|Zoster|zoster
5592249|NCT00921999|Vaccine|vaccine
5592250|NCT00921986|genetics|genetics
5592251|NCT00921986|biorepository|biorepository
5592252|NCT00921986|cardiac death|cardiac death
5592253|NCT00921986|atrial fibrillation|atrial fibrillation
5592254|NCT00921986|ventricular fibrillation|ventricular fibrillation
5592255|NCT00921986|ventricular tachycardia|ventricular tachycardia
5592256|NCT00921986|supraventricular tachycardias|supraventricular tachycardias
5592257|NCT00921986|premature ventricular complexes|premature ventricular complexes
5592258|NCT00921986|premature atrial complexes|premature atrial complexes
5592259|NCT00921986|atrioventricular and intraventricular blocks|atrioventricular and intraventricular blocks
5592260|NCT00921986|sinus node dysfunction|sinus node dysfunction
5592262|NCT00921986|vasovagal reactivity|vasovagal reactivity
5592263|NCT00921986|postural orthostatic tachycardia syndrome|postural orthostatic tachycardia syndrome
5592264|NCT00921973|influenza|influenza
5592265|NCT00921973|universal influenza vaccine|universal influenza vaccine
5592266|NCT00921960|Left ventricular dysfunction|left ventricular dysfunction
5592267|NCT00921960|Left ventricular systolic dysfunction|left ventricular systolic dysfunction
5592268|NCT00921960|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5592269|NCT00921960|Myocardial Infarction|myocardial infarction
5592270|NCT00921960|Hypertension|hypertension
5592271|NCT00921960|Diabetes|diabetes
5592272|NCT00921960|Obesity|obesity
5592273|NCT00921960|Dyslipidaemia|dyslipidaemia
5592274|NCT00921960|Heart Failure|heart failure
5592275|NCT00921960|Prevention|prevention
5592276|NCT00921960|Screening|screening
5592277|NCT00921960|Cardiovascular Risk Factors|cardiovascular risk factors
5592278|NCT00921960|Echocardiography|echocardiography
5592279|NCT00921960|Natriuretic Peptides|natriuretic peptides
5592280|NCT00921947|influenza vaccine|influenza vaccine
5592281|NCT00921947|M2e|m2e
5592282|NCT00921947|Universal influenza vaccine|universal influenza vaccine
5592283|NCT00921934|Herpes|herpes
5592284|NCT00921934|Shingles|shingles
5592285|NCT00921934|virus disease|virus disease
5592286|NCT00921934|vitamin C|vitamin c
5592287|NCT00921934|ascorbic acid|ascorbic acid
5592288|NCT00921934|antioxidant|antioxidant
5592289|NCT00921934|oxidative stress|oxidative stress
5592290|NCT00921908|total hip arthroplasty|total hip arthroplasty
5592291|NCT00921895|Pink Eye,|pink eye,
5592292|NCT00921895|Viral conjunctivitis|viral conjunctivitis
5592293|NCT00921895|Adenoviral conjunctivitis|adenoviral conjunctivitis
5592294|NCT00921895|Keratoconjunctivitis|keratoconjunctivitis
5592295|NCT00921882|Type 2 diabetes|type 2 diabetes
5592296|NCT00921882|Post-partum screening|post-partum screening
5592304|NCT00921830|pharmacokinetics|pharmacokinetics
5592305|NCT00921830|suppository|suppository
5592306|NCT00921817|healthy children|healthy children
5592307|NCT00921804|Schizophrenia|schizophrenia
5592308|NCT00921804|Hallucinations|hallucinations
5592309|NCT00921804|Paranoia|paranoia
5592310|NCT00921804|Inpatient schizophrenia clinical trial|inpatient schizophrenia clinical trial
5592311|NCT00921791|Hypertension|hypertension
5592312|NCT00921791|Blood pressure|blood pressure
5592313|NCT00921791|Home Blood Pressure Monitoring|home blood pressure monitoring
5592314|NCT00921791|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5592315|NCT00921791|Pharmaceutical care|pharmaceutical care
5592316|NCT00921778|Laparoscopic supracervical hysterectomy|laparoscopic supracervical hysterectomy
5592317|NCT00921778|Vaginal bleeding|vaginal bleeding
5592318|NCT00921778|Patient satisfaction|patient satisfaction
5592319|NCT00921778|vaginal bleeding after laparoscopic hysterectomy|vaginal bleeding after laparoscopic hysterectomy
5592321|NCT00921765|Naloxone|naloxone
5592322|NCT00921765|Ketamine|ketamine
5592323|NCT00921765|Third Molar|third molar
5592324|NCT00921765|Surgery|surgery
5592325|NCT00921752|Lipid therapy|lipid therapy
5592326|NCT00921752|high CV risk|high cv risk
5592327|NCT00921752|lipid goal attainment|lipid goal attainment
5592328|NCT00921752|High cardiovascular risk patients|high cardiovascular risk patients
5592329|NCT00921739|Non small cell lung cancer|non small cell lung cancer
5592330|NCT00921739|Small cell lung cancer|small cell lung cancer
5592331|NCT00921739|Thymoma unresectable|thymoma unresectable
5592332|NCT00921739|Thymic carcinoma unresectable|thymic carcinoma unresectable
5592333|NCT00921726|Drug Interaction|drug interaction
5592334|NCT00921713|Early cancer care|early cancer care
5592336|NCT00921700|Acetaminophen|acetaminophen
5592339|NCT00921700|Postoperative pain|postoperative pain
5592340|NCT00921700|third molar|third molar
5592341|NCT00921674|therapeutic equivalency|therapeutic equivalency
5592342|NCT00921674|pharmacokinetics|pharmacokinetics
5592343|NCT00921674|food|food
5592344|NCT00921674|Healthy Volunteers|healthy volunteers
5592345|NCT00921661|oxaliplatin|oxaliplatin
5592346|NCT00921661|5-FU|5-fu
5592347|NCT00921661|Folinic Acid|folinic acid
5592349|NCT00921648|general paresis|general paresis
5592350|NCT00921648|MRI|mri
5592351|NCT00921648|neurosyphilis|neurosyphilis
5592352|NCT00921635|Haemoglobin|haemoglobin
5592353|NCT00921622|Blood pressure|blood pressure
5592354|NCT00921622|Vitamin C|vitamin c
5592355|NCT00921622|Vitamin D|vitamin d
5592356|NCT00921609|Acromegaly|acromegaly
5592357|NCT00921609|OGTT|ogtt
5592358|NCT00921609|post-op|post-op
5592359|NCT00921596|Surgical Procedures, Cardiac|surgical procedures, cardiac
5592360|NCT00921596|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5592361|NCT00921596|Thoracoscopes|thoracoscopes
5592362|NCT00921596|Cardiopulmonary Bypass|cardiopulmonary bypass
5862991|NCT00001420|Apoptosis|apoptosis
5592364|NCT00921583|success rate|success rate
5592366|NCT00921570|FMD|fmd
5592367|NCT00921570|PTX3|ptx3
5592368|NCT00921570|Valsartan|valsartan
5592369|NCT00921570|Amlodipine|amlodipine
5592370|NCT00921570|Renin Angiotensin System|renin angiotensin system
5592371|NCT00921557|Bone mineral density|bone mineral density
5592372|NCT00921544|ROP|rop
5592373|NCT00921544|sucrose|sucrose
5592374|NCT00921544|pain|pain
5592375|NCT00921531|Hepatocellular carcinoma|hepatocellular carcinoma
5592376|NCT00921531|thalidomide|thalidomide
5592378|NCT00921531|Child-Pugh Class A or B|child-pugh class a or b
5592379|NCT00921518|Cardiac surgery|cardiac surgery
5592380|NCT00921518|Sodium bicarbonate|sodium bicarbonate
5592381|NCT00921518|Acute kidney injury|acute kidney injury
5592382|NCT00921518|Saline|saline
5592383|NCT00921505|Acetaminophen|acetaminophen
5592384|NCT00921505|Ibuprofen|ibuprofen
5592385|NCT00921505|Platelets|platelets
5592386|NCT00921505|Leukocytes|leukocytes
5592387|NCT00921505|Oxygen species|oxygen species
5592388|NCT00921505|Humans|humans
5592389|NCT00921505|Blood Platelets|blood platelets
5592390|NCT00921505|Reactive Oxygen Species|reactive oxygen species
5592391|NCT00921505|Platelet Activation|platelet activation
5592392|NCT00921492|Luteinizing hormone|luteinizing hormone
5592393|NCT00921492|Cortisol|cortisol
5595049|NCT00910806|TMC207|tmc207
5592394|NCT00921492|HPA axis|hpa axis
5592395|NCT00921492|HPO axis|hpo axis
5592396|NCT00921492|Ovulation|ovulation
5592397|NCT00921492|Heart rate variability|heart rate variability
5592398|NCT00921492|Psychological distress and quality of life|psychological distress and quality of life
5592399|NCT00921479|third molar|third molar
5592400|NCT00921479|quality of life|quality of life
5592401|NCT00921479|postoperative swelling|postoperative swelling
5592402|NCT00921479|postoperative pain|postoperative pain
5592403|NCT00921479|Surgical Procedures, Operative|surgical procedures, operative
5592404|NCT00921479|Postoperative Period|postoperative period
5592405|NCT00921466|Evaluate the clinical content of the e-SSRS-IVR|evaluate the clinical content of the e-ssrs-ivr
5592406|NCT00921453|Internet|internet
5592407|NCT00921453|Information supply|information supply
5592408|NCT00921453|Tailoring|tailoring
5592409|NCT00921453|Patient empowerment|patient empowerment
5592410|NCT00921453|Headaches|headaches
5592411|NCT00921453|Meta-search|meta-search
5592412|NCT00921453|Consumer Health Information|consumer health information
5592413|NCT00921453|Information Services|information services
5592414|NCT00921453|Information Storage and Retrieval|information storage and retrieval
5592415|NCT00921453|Information Systems|information systems
5592416|NCT00921440|coronary artery|coronary artery
5592417|NCT00921440|stenosis|stenosis
5592418|NCT00921427|Hemianopia|hemianopia
5592419|NCT00921427|Rehabilitation|rehabilitation
5592420|NCT00921427|Transcranial direct current stimulation|transcranial direct current stimulation
5592421|NCT00921427|Visual field|visual field
5592422|NCT00921414|Mantle cell lymphoma|mantle cell lymphoma
5592423|NCT00921414|R DHAP|r dhap
5592424|NCT00921414|ASCT|asct
5592425|NCT00921414|Rituximab Maintenance|rituximab maintenance
5592426|NCT00921388|Smoking Cessation|smoking cessation
5592427|NCT00921388|Exercise|exercise
5592428|NCT00921388|Postmenopausal women|postmenopausal women
5592429|NCT00921388|CHANTIX|chantix
5592430|NCT00921388|varenicline|varenicline
5592431|NCT00921362|Schizophrenia|schizophrenia
5592432|NCT00921349|Prophylaxis|prophylaxis
5592433|NCT00921349|ligation|ligation
5592434|NCT00921349|beta blockers|beta blockers
5592435|NCT00921349|First bleeding rate|first bleeding rate
5592436|NCT00921336|subjects with advanced Solid tumor who have not responded to standard therapy or for whom no standard therapy is available|subjects with advanced solid tumor who have not responded to standard therapy or for whom no standard therapy is available
5592437|NCT00921323|Obesity|obesity
5592438|NCT00921323|Physical activity|physical activity
5592439|NCT00921323|pedometers|pedometers
5592440|NCT00921323|children|children
5592541|NCT00920972|Non-malignant|non-malignant
5592441|NCT00921310|Temsirolimus and pemetrexed for recurrent or refractory NSCLC|temsirolimus and pemetrexed for recurrent or refractory nsclc
5592442|NCT00921297|Alzheimer's Disease|alzheimer's disease
5592443|NCT00921297|vision impairment|vision impairment
5592444|NCT00921297|cataract|cataract
5592445|NCT00921297|quality of life|quality of life
5592446|NCT00921297|retinal nerve fiber layer|retinal nerve fiber layer
5592447|NCT00921271|Compartment syndrome|compartment syndrome
5592448|NCT00921258|latent prostate cancer|latent prostate cancer
5592449|NCT00921258|Patient with latent prostate cancer|patient with latent prostate cancer
5592450|NCT00921258|PSA ≤ 10 ng/ml|psa ≤ 10 ng/ml
5592451|NCT00921258|Clinical stage T1c or T2a|clinical stage t1c or t2a
5592452|NCT00921258|Patient who accept just be control|patient who accept just be control
5592453|NCT00921245|Overactive Bladder|overactive bladder
5592454|NCT00921232|Life-ending patient|life-ending patient
5592455|NCT00921232|caregiver|caregiver
5592456|NCT00921219|therapeutic equivalency|therapeutic equivalency
5592457|NCT00921219|pharmacokinetics|pharmacokinetics
5592458|NCT00921219|food|food
5592461|NCT00921206|influenza vaccine|influenza vaccine
5592462|NCT00921206|universal influenza vaccine|universal influenza vaccine
5592463|NCT00921206|Matrix 2e protein|matrix 2e protein
5592464|NCT00921206|M2e|m2e
5592465|NCT00921206|Immune response|immune response
5592466|NCT00921193|Prostate|prostate
5592467|NCT00921193|fiducials|fiducials
5592468|NCT00921193|radiation Therapy|radiation therapy
5592469|NCT00921193|Tracking|tracking
5592470|NCT00921193|Localization|localization
5592471|NCT00921180|Hepatitis B, chronic|hepatitis b, chronic
5592472|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a
5592473|NCT00921180|Entecavir|entecavir
5592474|NCT00921167|Glioblastoma|glioblastoma
5592475|NCT00921167|Astrocytoma|astrocytoma
5592476|NCT00921167|Chemotherapy|chemotherapy
5592477|NCT00921154|therapeutic equivalency|therapeutic equivalency
5592478|NCT00921154|pharmacokinetics|pharmacokinetics
5592479|NCT00921154|fasting|fasting
5592480|NCT00921154|Healthy Volunteers|healthy volunteers
5592481|NCT00921141|Implantable central venous access ports, cancer|implantable central venous access ports, cancer
5592482|NCT00921128|Muscimol|muscimol
5592483|NCT00921128|Convection-Enhanced Delivery|convection-enhanced delivery
5592484|NCT00921128|Parkinson's Disease|parkinson's disease
5592485|NCT00921128|Deep Brain Stimulation|deep brain stimulation
5592486|NCT00921128|Parkinson Disease|parkinson disease
5592487|NCT00921128|PD|pd
5592488|NCT00921115|hormone receptor positive|hormone receptor positive
5592489|NCT00921115|invasive breast cancer|invasive breast cancer
5592490|NCT00921115|endocrine therapy|endocrine therapy
5592491|NCT00921115|Anastrazole|anastrazole
5592492|NCT00921115|Fulvestrant|fulvestrant
5592493|NCT00921115|breast tumors|breast tumors
5592494|NCT00921115|postmenopausal|postmenopausal
5592495|NCT00921102|Atropine|atropine
5592496|NCT00921102|Morphine|morphine
5592497|NCT00921102|Analgesics, Opioid|analgesics, opioid
5592498|NCT00921102|Antiemetics|antiemetics
5592499|NCT00921089|Atherosclerosis|atherosclerosis
5592500|NCT00921089|Cardiovascular disease|cardiovascular disease
5592501|NCT00921089|Hemodialysis|hemodialysis
5592502|NCT00921089|Inflammation|inflammation
5592503|NCT00921089|Vascular calcification|vascular calcification
5592504|NCT00921050|subclinical hypothyroidism|subclinical hypothyroidism
5592505|NCT00921050|elderly|elderly
5592506|NCT00921050|mild cognitive impairment|mild cognitive impairment
5592507|NCT00921050|neuropsychological test|neuropsychological test
5592508|NCT00921050|NEUROPSI|neuropsi
5592509|NCT00921037|Neurofibromatosis Type 1|neurofibromatosis type 1
5592510|NCT00921037|Morbus Recklinghausen|morbus recklinghausen
5592511|NCT00921037|cutaneous neurofibromas|cutaneous neurofibromas
5592512|NCT00921037|Erbium-YAG-Laser|erbium-yag-laser
5592513|NCT00921037|Vaporisation|vaporisation
5592514|NCT00921037|Thermal Necrosis|thermal necrosis
5592515|NCT00921024|Complicated Urinary Tract Infection|complicated urinary tract infection
5592516|NCT00921024|Pyelonephritis|pyelonephritis
5592517|NCT00921024|Antimicrobial|antimicrobial
5592518|NCT00921024|Cephalosporin|cephalosporin
5592519|NCT00921024|Intravenous|intravenous
5592520|NCT00921011|hypertension|hypertension
5592521|NCT00921011|diabetes|diabetes
5592522|NCT00921011|smoking|smoking
5592523|NCT00921011|hyperlipidemia|hyperlipidemia
5592524|NCT00921011|atherosclerosis risk|atherosclerosis risk
5592525|NCT00920998|Z-338|z-338
5592526|NCT00920998|YM443|ym443
5592527|NCT00920998|healthy volunteers|healthy volunteers
5592528|NCT00920985|Pregnancy prevention|pregnancy prevention
5592529|NCT00920985|Female contraception|female contraception
5592530|NCT00920985|Patch|patch
5592531|NCT00920972|Bone marrow|bone marrow
5592532|NCT00920972|Transplant|transplant
5592533|NCT00920972|Transplantation|transplantation
5592534|NCT00920972|Hematopoietic|hematopoietic
5592535|NCT00920972|Umbilical cord|umbilical cord
5592536|NCT00920972|Related|related
5592537|NCT00920972|Unrelated|unrelated
5592538|NCT00920972|Reduced|reduced
5592539|NCT00920972|Non-myeloablative|non-myeloablative
5592540|NCT00920972|Nonmyeloablative|nonmyeloablative
5592542|NCT00920972|Nonmalignant|nonmalignant
5592543|NCT00920946|Huntington|huntington
5592544|NCT00920946|Dimebon|dimebon
5592546|NCT00920946|Huntingtin|huntingtin
5592547|NCT00920933|Ozone challenge|ozone challenge
5592548|NCT00920933|airway neutrophilia|airway neutrophilia
5592549|NCT00920933|induced sputum|induced sputum
5592550|NCT00920933|Healthy volunteers|healthy volunteers
5592551|NCT00920920|3D-4D MRI-based Brachytherapy|3d-4d mri-based brachytherapy
5592552|NCT00920920|Cervical Cancer|cervical cancer
5771673|NCT00237575|bladder|bladder
5592553|NCT00920920|Multicenter Clinical Study|multicenter clinical study
5592554|NCT00920920|Locally advanced cervical cancer|locally advanced cervical cancer
5592555|NCT00920881|Continuous glucose monitoring|continuous glucose monitoring
5592556|NCT00920881|Accuracy|accuracy
5592557|NCT00920881|Continuous glucose-error grid analysis|continuous glucose-error grid analysis
5592558|NCT00920868|Phase I|phase i
5592559|NCT00920868|Solid Tumor|solid tumor
5592562|NCT00920868|Sprycel|sprycel
5592563|NCT00920868|Bevacizumab|bevacizumab
5592564|NCT00920868|Avastin|avastin
5592565|NCT00920868|Oxaliplatin|oxaliplatin
5592566|NCT00920868|Eloxatin|eloxatin
5592567|NCT00920868|Capecitabine|capecitabine
5592568|NCT00920868|Xeloda|xeloda
5592569|NCT00920868|Duke|duke
5592570|NCT00920868|Any Solid Tumor (Phase I)|any solid tumor (phase i)
5592571|NCT00920868|Metastatic Colorectal Cancer (Expanded Cohort)|metastatic colorectal cancer (expanded cohort)
5592572|NCT00920842|metabolic syndrome|metabolic syndrome
5592573|NCT00920842|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5592574|NCT00920842|cardiovascular complications|cardiovascular complications
5592575|NCT00920842|cancer survivor|cancer survivor
5592576|NCT00920842|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5592577|NCT00920842|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5592578|NCT00920842|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5592579|NCT00920842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5592580|NCT00920842|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5592581|NCT00920842|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5592582|NCT00920842|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5592583|NCT00920842|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5592589|NCT00920816|Axitinib in First & Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in first & second line treatment of patients with metastatic renal cell cancer
5592591|NCT00920777|Fukuda criteria|fukuda criteria
5592592|NCT00920777|Mental functioning|mental functioning
5592593|NCT00920777|Physical functioning|physical functioning
5592594|NCT00920764|CKD Stages 3&4|ckd stages 3&4
5592595|NCT00920764|Endothelin antagonist|endothelin antagonist
5592596|NCT00920764|Proteinuria|proteinuria
5592597|NCT00920751|water infusion|water infusion
5592598|NCT00920751|air insufflation|air insufflation
5592599|NCT00920751|colonoscopy|colonoscopy
5592600|NCT00920751|colorectal cancer screening|colorectal cancer screening
5592601|NCT00920738|metabolic syndrome|metabolic syndrome
5592602|NCT00920738|cancer survivor|cancer survivor
5592603|NCT00920738|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5592604|NCT00920738|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5592605|NCT00920738|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5592606|NCT00920738|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5592607|NCT00920738|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5592608|NCT00920738|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5592609|NCT00920738|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5592610|NCT00920738|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5592611|NCT00920738|childhood brain stem glioma|childhood brain stem glioma
5592612|NCT00920738|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5592613|NCT00920738|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5592614|NCT00920738|childhood choroid plexus tumor|childhood choroid plexus tumor
5592615|NCT00920738|childhood craniopharyngioma|childhood craniopharyngioma
5592616|NCT00920738|childhood embryonal tumor|childhood embryonal tumor
5592617|NCT00920738|childhood ependymoma|childhood ependymoma
5592618|NCT00920738|childhood oligodendroglioma|childhood oligodendroglioma
5592619|NCT00920738|childhood pineal parenchymal tumor|childhood pineal parenchymal tumor
5592620|NCT00920738|childhood mixed glioma|childhood mixed glioma
5685425|NCT00556101|questionnaire|questionnaire
5592621|NCT00920738|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
5592622|NCT00920738|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5592624|NCT00920712|chronic atrophic gastritis|chronic atrophic gastritis
5592625|NCT00920712|Traditional Chinese Medicine|traditional chinese medicine
5592626|NCT00920686|Migraine|migraine
5592627|NCT00920686|aura|aura
5592628|NCT00920673|child|child
5592629|NCT00920647|enlarged adenoids|enlarged adenoids
5592630|NCT00920647|hunters syndrome|hunters syndrome
5592631|NCT00920647|enzyme replacement therapy|enzyme replacement therapy
5592632|NCT00920647|hunter's syndrome|hunter's syndrome
5592633|NCT00920647|mps society|mps society
5592634|NCT00920647|Mucopolysaccharidosis (mps) 2|mucopolysaccharidosis (mps) 2
5592635|NCT00920647|mps diagnosis|mps diagnosis
5592636|NCT00920647|hunter disease|hunter disease
5592637|NCT00920647|iduronate 2 sulfatase|iduronate 2 sulfatase
5592638|NCT00920647|idursulfase|idursulfase
5592639|NCT00920647|hunters disease|hunters disease
5592640|NCT00920647|hunter's syndrome treatment|hunter's syndrome treatment
5592641|NCT00920647|mucopolysaccharides|mucopolysaccharides
5592642|NCT00920647|hunter syndrome treatment|hunter syndrome treatment
5592643|NCT00920647|Mucopolysaccharidosis (mps) ii|mucopolysaccharidosis (mps) ii
5592644|NCT00920647|elaprase|elaprase
5592645|NCT00920647|hunter syndrome therapy|hunter syndrome therapy
5592646|NCT00920647|lysosomal storage disease|lysosomal storage disease
5592647|NCT00920647|hunter's disease|hunter's disease
5592648|NCT00920647|Mucopolysaccharidosis(MPS) II|mucopolysaccharidosis(mps) ii
5592649|NCT00920647|Mucopolysaccharidosis(MPS)2|mucopolysaccharidosis(mps)2
5592650|NCT00920647|hunter's disease treatment|hunter's disease treatment
5592651|NCT00920647|lysosomal storage disorder|lysosomal storage disorder
5592652|NCT00920647|chronic ear infection|chronic ear infection
5592653|NCT00920647|mps symptoms|mps symptoms
5592654|NCT00920647|iduronate sulfatase|iduronate sulfatase
5592655|NCT00920647|ert treatment|ert treatment
5592658|NCT00920621|Randomized Control Trial|randomized control trial
5592659|NCT00920608|AZD9056|azd9056
5592660|NCT00920608|Pharmacokinetics|pharmacokinetics
5592661|NCT00920608|interaction|interaction
5592662|NCT00920608|Methotrexate|methotrexate
5592663|NCT00920608|Rheumatoid Arthritis|rheumatoid arthritis
5592664|NCT00920595|Cancer|cancer
5592665|NCT00920582|Teplizumab|teplizumab
5592666|NCT00920582|Protege|protege
5592667|NCT00920582|Protege Encore|protege encore
5592668|NCT00920582|MGA031|mga031
5595325|NCT00909870|chronic wound|chronic wound
5592669|NCT00920582|Monoclonal antibody|monoclonal antibody
5592670|NCT00920582|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5592672|NCT00920582|MacroGenics|macrogenics
5592673|NCT00920582|Recent Onset Diabetes|recent onset diabetes
5592674|NCT00920582|hOKT3γ1 (Ala-Ala)|hokt3γ1 (ala-ala)
5592675|NCT00920582|Encore|encore
5592676|NCT00920569|cardiac output|cardiac output
5592677|NCT00920569|recirculation|recirculation
5592678|NCT00920569|oxygenator blood volume|oxygenator blood volume
5592679|NCT00920569|venoarterial extracorporeal membrane oxygenation|venoarterial extracorporeal membrane oxygenation
5592680|NCT00920569|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
5592681|NCT00920530|Screening|screening
5592682|NCT00920530|real time PCR|real time pcr
5592683|NCT00920530|Streptococcus agalactiae|streptococcus agalactiae
5592684|NCT00920530|Pregnant women|pregnant women
5592685|NCT00920504|Mesh: patient education as topic|mesh: patient education as topic
5592686|NCT00920504|Mesh: neoplasms|mesh: neoplasms
5592687|NCT00920504|Mesh: medication therapy management|mesh: medication therapy management
5592688|NCT00920504|pain self management|pain self management
5592689|NCT00920504|symptom management|symptom management
5592690|NCT00920504|education of patients with pain from neoplasm metastases|education of patients with pain from neoplasm metastases
5592691|NCT00920491|Chief complaint|chief complaint
5592692|NCT00920491|non-specific symptoms|non-specific symptoms
5592693|NCT00920491|general weakness / general deterioration|general weakness / general deterioration
5592694|NCT00920491|risk assessment in ED patients with non-specific symptoms|risk assessment in ed patients with non-specific symptoms
5592695|NCT00920478|Rheumatoid arthritis|rheumatoid arthritis
5592696|NCT00920478|Musculoskeletal Ultrasound|musculoskeletal ultrasound
5592697|NCT00920478|Synovitis|synovitis
5592698|NCT00920478|DMARD|dmard
5592699|NCT00920478|Etanercept|etanercept
5592700|NCT00920478|Biomarkers|biomarkers
5592701|NCT00920478|Undifferentiated Inflammatory Polyarthritis|undifferentiated inflammatory polyarthritis
5592702|NCT00920452|implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5592703|NCT00920452|defibrillation leads, cardiac resynchronization therapy (CRT)|defibrillation leads, cardiac resynchronization therapy (crt)
5592704|NCT00920439|Poliomyelitis Vaccines|poliomyelitis vaccines
5592705|NCT00920439|IPV|ipv
5592706|NCT00920426|HIV|hiv
5753071|NCT00308009|Surgery|surgery
5592707|NCT00920426|naive|naive
5592708|NCT00920426|Phase II|phase ii
5592709|NCT00920426|integrase inhibitor|integrase inhibitor
5592710|NCT00920426|GSK1265744|gsk1265744
5685426|NCT00556088|LBH589|lbh589
5592711|NCT00920426|newly diagnosed|newly diagnosed
5592712|NCT00920426|pharmacokinetics|pharmacokinetics
5592713|NCT00920426|AIDS|aids
5592714|NCT00920426|integrase|integrase
5592715|NCT00920426|HIV Infections|hiv infections
5592716|NCT00920426|Treatment naive|treatment naive
5592717|NCT00920387|Anxiety|anxiety
5592718|NCT00920387|quality of life|quality of life
5592719|NCT00920387|psychotherapy|psychotherapy
5592720|NCT00920387|potentially fatal illness|potentially fatal illness
5592721|NCT00920387|lysergic acid diethylamide|lysergic acid diethylamide
5592722|NCT00920374|Influenza|influenza
5592723|NCT00920348|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5592724|NCT00920348|COPD|copd
5592725|NCT00920348|Cohort study|cohort study
5592726|NCT00920348|prospective longitudinal study|prospective longitudinal study
5592727|NCT00920348|tissue bank|tissue bank
5592728|NCT00920335|Adult intracranial ependymoma|adult intracranial ependymoma
5592729|NCT00920322|Depression|depression
5592730|NCT00920322|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5592731|NCT00920309|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5592732|NCT00920309|rapamycin|rapamycin
5592733|NCT00920309|ADPKD|adpkd
5592734|NCT00920296|drug interaction|drug interaction
5592735|NCT00920296|integrase inhibitor|integrase inhibitor
5592736|NCT00920283|Stents|stents
5592737|NCT00920283|Bare Metal Stents|bare metal stents
5592739|NCT00920283|Coronary Artery Disease|coronary artery disease
5592740|NCT00920283|Coronary Artery Stenosis|coronary artery stenosis
5592741|NCT00920283|Stent Thrombosis|stent thrombosis
5592742|NCT00920283|Vascular Disease|vascular disease
5592743|NCT00920283|Myocardial Ischemia|myocardial ischemia
5592744|NCT00920270|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5592745|NCT00920270|Gram Negative Bacteria|gram negative bacteria
5592746|NCT00920257|oncology|oncology
5592747|NCT00920257|breast cancer|breast cancer
5592748|NCT00920257|AKT inhibitor|akt inhibitor
5592749|NCT00920257|first time in human|first time in human
5592750|NCT00920257|lymphoma|lymphoma
5592751|NCT00920257|endometrial cancer|endometrial cancer
5592752|NCT00920257|GSK2141795|gsk2141795
5592753|NCT00920257|solid tumors|solid tumors
5592754|NCT00920244|Resuscitation|resuscitation
5592755|NCT00920244|Cardiac arrest|cardiac arrest
5592756|NCT00920244|State-transitions|state-transitions
5592758|NCT00920218|Vaccine|vaccine
5592759|NCT00920218|Safety|safety
5592760|NCT00920218|Herpes Zoster|herpes zoster
5592761|NCT00920218|Immunogenicity|immunogenicity
5592762|NCT00920218|Stem cell transplantation|stem cell transplantation
5592763|NCT00920205|MPC-3100|mpc-3100
5592764|NCT00920205|HSP90 inhibitor|hsp90 inhibitor
5592765|NCT00920205|oral drug|oral drug
5592767|NCT00920192|c-MET|c-met
5592768|NCT00920192|VEGFR2|vegfr2
5592769|NCT00920192|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5592770|NCT00920179|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland|dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland
5592771|NCT00920166|Infant formula|infant formula
5592772|NCT00920166|Alpha-lactalbumin|alpha-lactalbumin
5592773|NCT00920166|Symbiotic|symbiotic
5592774|NCT00920166|Allergy|allergy
5592775|NCT00920166|Gastrointestinal tolerance|gastrointestinal tolerance
5592776|NCT00920166|Bacterial colonization|bacterial colonization
5592777|NCT00920166|Faecal IgA analysis|faecal iga analysis
5592778|NCT00920153|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5592779|NCT00920153|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5592780|NCT00920153|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5592781|NCT00920153|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5592782|NCT00920140|Oncology, GSK1120212, MEK inhibitor, hematological malignancies, AML|oncology, gsk1120212, mek inhibitor, hematological malignancies, aml
5592783|NCT00920140|CMML|cmml
5592784|NCT00920140|MDS|mds
5592785|NCT00920127|AKL1|akl1
5592786|NCT00920127|COPD|copd
5592787|NCT00920101|atherosclerotic plaques|atherosclerotic plaques
5592788|NCT00920101|hypercholesterolemia|hypercholesterolemia
5592789|NCT00920101|HMG-CoA reductase inhibitor|hmg-coa reductase inhibitor
5592790|NCT00920101|statin|statin
5592791|NCT00920101|lipid-lowering therapy|lipid-lowering therapy
5592792|NCT00920088|probes|probes
5592793|NCT00920088|NNRTI|nnrti
5592794|NCT00920088|drug interaction|drug interaction
5592795|NCT00920088|protease inhitibor|protease inhitibor
5592796|NCT00920075|Juvenile Osteoporosis|juvenile osteoporosis
5592797|NCT00920075|Bone Mineral Density|bone mineral density
5592798|NCT00920075|Fosamax|fosamax
5592799|NCT00920075|Dual Energy X-Ray Absorptiometry|dual energy x-ray absorptiometry
5592800|NCT00920075|Fracture|fracture
5592801|NCT00920062|recirculation|recirculation
5592802|NCT00920062|ultrasound dilution|ultrasound dilution
5680348|NCT00578136|Rectus Sheath|rectus sheath
5592803|NCT00920062|venovenous extracorporeal membrane oxygenation|venovenous extracorporeal membrane oxygenation
5592804|NCT00920049|Driving|driving
5592805|NCT00920049|Injury|injury
5592806|NCT00920049|Prevention|prevention
5592807|NCT00920049|Intervention|intervention
5592808|NCT00920049|Parents|parents
5592809|NCT00920036|PTSD|ptsd
5592810|NCT00920036|Combat|combat
5592811|NCT00920036|Biofeedback|biofeedback
5592812|NCT00920036|Psychophysiology|psychophysiology
5592813|NCT00920023|SPIO MRI|spio mri
5592814|NCT00920023|Feridex|feridex
5592815|NCT00920010|non-small cell lung cancer|non-small cell lung cancer
5592816|NCT00920010|small cell lung cancer|small cell lung cancer
5592817|NCT00919997|human papilloma virus infection|human papilloma virus infection
5592818|NCT00919997|HIV infection|hiv infection
5592819|NCT00919997|HIV Infections|hiv infections
5592820|NCT00919984|OVARIAN NEOPLASMS|ovarian neoplasms
5592821|NCT00919984|ADJUVANT CHEMOTHERAPY|adjuvant chemotherapy
5592822|NCT00919984|INTRAPERITONEAL CHEMOTHERAPY|intraperitoneal chemotherapy
5592823|NCT00919971|Bi spectral Index|bi spectral index
5592824|NCT00919971|Sedation depth monitoring|sedation depth monitoring
5592825|NCT00919971|Out of hospital ventilated patients|out of hospital ventilated patients
5592826|NCT00919958|Peripheral Artery Disease|peripheral artery disease
5592827|NCT00919958|Peripheral Vascular Disease|peripheral vascular disease
5592828|NCT00919958|Critical limb ischemia|critical limb ischemia
5592829|NCT00919945|Neonates|neonates
5592830|NCT00919945|Congenital Heart Disease|congenital heart disease
5592831|NCT00919945|Postoperative Feeding|postoperative feeding
5592832|NCT00919945|Splanchnic Blood Flow|splanchnic blood flow
5592833|NCT00919932|Depression|depression
5592834|NCT00919932|CBT|cbt
5592835|NCT00919932|Texting|texting
5592836|NCT00919932|SMS|sms
5592837|NCT00919919|menopause|menopause
5592838|NCT00919919|Endometrial Thickness|endometrial thickness
5586813|NCT00943553|AML|aml
5592840|NCT00919906|haptic|haptic
5592841|NCT00919906|rehabilitation|rehabilitation
5592842|NCT00919906|fine-motor skill|fine-motor skill
5592843|NCT00919906|handwriting|handwriting
5592844|NCT00919893|chronic prostatitis symptom index|chronic prostatitis symptom index
5592845|NCT00919893|male|male
5592846|NCT00919893|inflammatory|inflammatory
5592847|NCT00919893|CP-CPPS|cp-cpps
5592848|NCT00919893|Cernilton|cernilton
5592849|NCT00919893|pelvic pain|pelvic pain
5592850|NCT00919893|symptoms|symptoms
5592851|NCT00919867|Normal, healthy volunteers (for this Phase 1 study)|normal, healthy volunteers (for this phase 1 study)
5592852|NCT00919854|Human immunodeficiency virus 1|human immunodeficiency virus 1
5592853|NCT00919854|HIV-1|hiv-1
5592854|NCT00919854|Darunavir|darunavir
5592855|NCT00919854|Ritonavir|ritonavir
5592856|NCT00919854|Norvir|norvir
5592857|NCT00919841|postpartum|postpartum
5592858|NCT00919841|involution|involution
5592859|NCT00919841|three-dimension sonography|three-dimension sonography
5592860|NCT00919841|size of the uterus|size of the uterus
5592861|NCT00919815|Leprosy|leprosy
5592862|NCT00919815|Type 1 Reactions|type 1 reactions
5592863|NCT00919815|Prednisolone|prednisolone
5592865|NCT00919802|Interstitial cystitis (IC)|interstitial cystitis (ic)
5592866|NCT00919802|Oxytocin|oxytocin
5592867|NCT00919802|Bladder|bladder
5592868|NCT00919802|Void|void
5592869|NCT00919776|Leprosy|leprosy
5592870|NCT00919776|ENL|enl
5592871|NCT00919776|Erythema Nodosum Leprosum|erythema nodosum leprosum
5592872|NCT00919776|Prednisolone|prednisolone
5592873|NCT00919776|Ciclosporin|ciclosporin
5592874|NCT00919763|Atopic Dermatitis|atopic dermatitis
5592875|NCT00919737|NPC-08|npc-08
5592876|NCT00919737|carmustine|carmustine
5592877|NCT00919737|nitrosourea|nitrosourea
5592878|NCT00919737|safety|safety
5592879|NCT00919724|AIDS|aids
5592880|NCT00919724|Endothelial Function|endothelial function
5592881|NCT00919724|Inflammation|inflammation
5592882|NCT00919724|Immune Activation|immune activation
5592883|NCT00919724|treatment naive|treatment naive
5592884|NCT00919711|Menopausal Osteoporosis|menopausal osteoporosis
5592885|NCT00919698|Hypnotics and Sedatives|hypnotics and sedatives
5592886|NCT00919698|Respiration, Artificial|respiration, artificial
5592887|NCT00919698|Ventilators, Mechanical|ventilators, mechanical
5592888|NCT00919698|Critical care|critical care
5592889|NCT00919698|Intensive care|intensive care
5592890|NCT00919672|Irritable bowel syndrome|irritable bowel syndrome
5592891|NCT00919672|Sacral nerve stimulation|sacral nerve stimulation
5592892|NCT00919672|Motility|motility
5592893|NCT00919672|Pain perception|pain perception
5592894|NCT00919672|GSRS-IBS|gsrs-ibs
5592895|NCT00919672|IBS-IS|ibs-is
5592896|NCT00919659|parenteral nutrition|parenteral nutrition
5592897|NCT00919659|cancer cachexia|cancer cachexia
5592898|NCT00919659|pancreatic cancer|pancreatic cancer
5592899|NCT00919633|hepatitis C|hepatitis c
5592900|NCT00919633|HCV|hcv
5592901|NCT00919633|genotype|genotype
5592902|NCT00919633|sustained virological response|sustained virological response
5592903|NCT00919633|rapid virological response|rapid virological response
5592904|NCT00919633|interferon|interferon
5592905|NCT00919620|Psychotic disorders|psychotic disorders
5578061|NCT00975845|ACL|acl
5592906|NCT00919620|Psychoses|psychoses
5592907|NCT00919607|quetiapine fumarate(SEROQUEL) extended-release(XR) China PK Study|quetiapine fumarate(seroquel) extended-release(xr) china pk study
5685427|NCT00556088|Phase I|phase i
5592908|NCT00919607|pharmacokinetics parameters|pharmacokinetics parameters
5592909|NCT00919594|Interpersonal Psychotherapy|interpersonal psychotherapy
5592910|NCT00919594|Depression|depression
5592911|NCT00919594|Mothers|mothers
5592912|NCT00919581|Spinal cord injury|spinal cord injury
5592913|NCT00919555|ALS Treatment|als treatment
5592914|NCT00919555|Tretinoin|tretinoin
5592915|NCT00919555|Pioglitazone HCL|pioglitazone hcl
5592916|NCT00919555|Actos|actos
5592917|NCT00919555|Tau levels|tau levels
5592918|NCT00919555|ALS|als
5592919|NCT00919542|Leprosy|leprosy
5592920|NCT00919542|ENL|enl
5592921|NCT00919542|Erythema Nodosum Leprosum|erythema nodosum leprosum
5592922|NCT00919542|Prednisolone|prednisolone
5592923|NCT00919542|Ciclosporin|ciclosporin
5592924|NCT00919516|Bone marrow transplantation|bone marrow transplantation
5592926|NCT00919516|Neoangiogenesis|neoangiogenesis
5592927|NCT00919516|Peripheral arterial disease|peripheral arterial disease
5592928|NCT00919516|Stem cell therapy|stem cell therapy
5592929|NCT00919503|nonmalignant diseases|nonmalignant diseases
5592930|NCT00919503|nonmalignant inherited disorders|nonmalignant inherited disorders
5592931|NCT00919503|primary immunodeficiency diseases|primary immunodeficiency diseases
5592932|NCT00919503|primary immune deficiency disorders|primary immune deficiency disorders
5592933|NCT00919503|chronic granulomatous|chronic granulomatous
5592935|NCT00919503|IPEX syndrome|ipex syndrome
5592936|NCT00919503|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5592937|NCT00919503|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
5592938|NCT00919503|bone marrow failure syndromes|bone marrow failure syndromes
5592939|NCT00919503|Shwachman Diamond Syndrome|shwachman diamond syndrome
5592940|NCT00919503|Dyskeratosis Congenita|dyskeratosis congenita
5592942|NCT00919503|inborn errors of metabolism|inborn errors of metabolism
5592943|NCT00919503|metabolic diseases|metabolic diseases
5592944|NCT00919503|hemoglobinopathies|hemoglobinopathies
5592945|NCT00919503|sickle cell disease|sickle cell disease
5592946|NCT00919503|thalassemia|thalassemia
5592947|NCT00919503|reduced intensity transplantation|reduced intensity transplantation
5592948|NCT00919503|hematopoietic cell transplantation|hematopoietic cell transplantation
5592949|NCT00919503|bone marrow transplantation|bone marrow transplantation
5592950|NCT00919503|umbilical cord blood transplantation|umbilical cord blood transplantation
5592951|NCT00919490|Healthy Volunteers|healthy volunteers
5592952|NCT00919477|Prostate cancer|prostate cancer
5592953|NCT00919477|Casodex|casodex
5592954|NCT00919477|Monotherapy|monotherapy
5592955|NCT00919464|Compartment pressure|compartment pressure
5592956|NCT00919464|compartment syndrome|compartment syndrome
5592957|NCT00919464|femur fracture|femur fracture
5592958|NCT00919451|Leprosy|leprosy
5592959|NCT00919451|Type 1 Reaction|type 1 reaction
5592960|NCT00919451|Prednisolone|prednisolone
5592961|NCT00919451|Ciclosporin|ciclosporin
5592962|NCT00919425|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5592963|NCT00919425|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5592964|NCT00919425|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5592965|NCT00919425|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5592966|NCT00919425|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5592967|NCT00919425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5592968|NCT00919425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5592969|NCT00919425|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5592970|NCT00919425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5592971|NCT00919425|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5592972|NCT00919425|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5592973|NCT00919425|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5592974|NCT00919425|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5592975|NCT00919425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5592976|NCT00919425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5592977|NCT00919425|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5592978|NCT00919425|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5592979|NCT00919425|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5592980|NCT00919425|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5592981|NCT00919425|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5592982|NCT00919425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5592983|NCT00919425|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5592984|NCT00919425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5753433|NCT00306605|fathers|fathers
5592985|NCT00919425|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5592986|NCT00919425|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5685428|NCT00556088|Solid Tumors|solid tumors
5685429|NCT00556088|Paclitaxel|paclitaxel
5592987|NCT00919425|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5592988|NCT00919425|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5592989|NCT00919425|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5592990|NCT00919425|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5592991|NCT00919425|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5592992|NCT00919425|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5592993|NCT00919425|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5592994|NCT00919425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5592995|NCT00919425|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5592996|NCT00919425|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5592997|NCT00919425|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5592998|NCT00919425|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5592999|NCT00919425|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5593000|NCT00919412|Non Invasive Biomarkers Preterm Delivery|non invasive biomarkers preterm delivery
5593002|NCT00919399|locally advanced|locally advanced
5593003|NCT00919399|Menopausal patient|menopausal patient
5593004|NCT00919399|aromasin|aromasin
5593005|NCT00919399|tamoxifen|tamoxifen
5593006|NCT00919399|efficacy|efficacy
5593007|NCT00919386|Ureteric Measurement|ureteric measurement
5593008|NCT00919373|Catheter Ablation|catheter ablation
5593009|NCT00919373|Defibrillators, Implantable|defibrillators, implantable
5593010|NCT00919347|Cardiovascular Autonomic Neuropathy|cardiovascular autonomic neuropathy
5593011|NCT00919347|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5593012|NCT00919347|Autonomic Dysfunction|autonomic dysfunction
5593013|NCT00919334|Myopia progression|myopia progression
5593014|NCT00919334|Myopia control|myopia control
5593015|NCT00919334|Simultaneous vision|simultaneous vision
5593016|NCT00919334|Myopic defocus|myopic defocus
5593017|NCT00919321|CLL|cll
5593018|NCT00919321|PPV|ppv
5593019|NCT00919321|PCV|pcv
5593020|NCT00919308|Simulation|simulation
5593021|NCT00919308|Invasive procedures|invasive procedures
5593022|NCT00919295|Fibromyalgia syndrome|fibromyalgia syndrome
5593023|NCT00919295|mirtazapine|mirtazapine
5593024|NCT00919295|randomized controlled trial|randomized controlled trial
5593025|NCT00919295|pilot study|pilot study
5593026|NCT00919282|pancreatic cancer|pancreatic cancer
5593027|NCT00919282|gemcitabine|gemcitabine
5593028|NCT00919282|combination|combination
5593029|NCT00919243|prednisone|prednisone
5593030|NCT00919243|allopurinol|allopurinol
5593031|NCT00919243|heart failure|heart failure
5593032|NCT00919243|hyperuricemia|hyperuricemia
5593033|NCT00919230|Hip fracture|hip fracture
5593034|NCT00919230|iron therapy|iron therapy
5593035|NCT00919230|anaemia|anaemia
5593036|NCT00919217|Multiple Sclerosis|multiple sclerosis
5593037|NCT00919217|MS|ms
5593038|NCT00919217|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5593039|NCT00919217|RR-MS|rr-ms
5593040|NCT00919217|Women|women
5593041|NCT00919204|AG-013736, axitinib, pharmacokinetics, healthy, Chinese|ag-013736, axitinib, pharmacokinetics, healthy, chinese
5593042|NCT00919191|acne|acne
5593043|NCT00919191|irritation|irritation
5593044|NCT00919191|objective sensory methods|objective sensory methods
5593045|NCT00919178|Dengue virus|dengue virus
5593046|NCT00919178|Vaccine|vaccine
5593047|NCT00919178|DEN4|den4
5593048|NCT00919178|Dengue|dengue
5593049|NCT00919165|carotid stenting|carotid stenting
5593050|NCT00919165|cognitive function|cognitive function
5593051|NCT00919165|pre and post stent|pre and post stent
5593052|NCT00919165|severe carotid artery stenosis|severe carotid artery stenosis
5593053|NCT00919152|stress ulcer prophylaxis|stress ulcer prophylaxis
5593054|NCT00919152|intensive care|intensive care
5593055|NCT00919152|Critically ill|critically ill
5593056|NCT00919152|proton pump inhibitors|proton pump inhibitors
5593057|NCT00919152|pharmacoeconomics|pharmacoeconomics
5593058|NCT00919139|multiple myeloma|multiple myeloma
5593059|NCT00919139|Waldenström macroglobulinemia|waldenström macroglobulinemia
5593060|NCT00919139|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5593061|NCT00919139|primary systemic amyloidosis|primary systemic amyloidosis
5593062|NCT00919126|Xenon in Anaesthesia|xenon in anaesthesia
5593063|NCT00919113|Bladder Pain|bladder pain
5593064|NCT00919113|GAG replacement therapy|gag replacement therapy
5593065|NCT00919113|IC/PBS|ic/pbs
5593066|NCT00919100|pediatric|pediatric
5593067|NCT00919100|venipuncture|venipuncture
5593068|NCT00919100|pain|pain
5593069|NCT00919100|vibration|vibration
5593070|NCT00919100|vapocoolant|vapocoolant
5680349|NCT00578136|Local infiltration|local infiltration
5680350|NCT00578136|Pain Control|pain control
5685430|NCT00556088|Carboplatin|carboplatin
5685431|NCT00556088|Bevacizumab|bevacizumab
5593071|NCT00919074|Patients undergoing endoscopic retrograde cholangiopancreatography for the first time|patients undergoing endoscopic retrograde cholangiopancreatography for the first time
5593072|NCT00919074|Particular focus on patients who meet predefined criteria for a difficult bile duct cannulation|particular focus on patients who meet predefined criteria for a difficult bile duct cannulation
5593073|NCT00919061|GALL BLADDER|gall bladder
5593074|NCT00919061|BILE DUCTS|bile ducts
5593075|NCT00919061|BAY 43-9006|bay 43-9006
5593076|NCT00919061|SORAFENIB|sorafenib
5593077|NCT00919061|CISPLATIN|cisplatin
5593078|NCT00919061|GEMCITABINE|gemcitabine
5593079|NCT00919061|09-029|09-029
5593080|NCT00919035|prostate cancer|prostate cancer
5593081|NCT00919035|androgen-independent prostate cancer (AIPC) Prostate Cancer|androgen-independent prostate cancer (aipc) prostate cancer
5593082|NCT00919022|Inoperable Prostate Cancer|inoperable prostate cancer
5593083|NCT00919022|Erectile Dysfunction|erectile dysfunction
5593084|NCT00919009|TACE|tace
5593085|NCT00919009|Sorafenib|sorafenib
5593086|NCT00918996|Cesarean Section|cesarean section
5593087|NCT00918996|Bladder Flap|bladder flap
5593088|NCT00918996|Operating time|operating time
5593089|NCT00918983|Benign prostatic hyperplasia|benign prostatic hyperplasia
5593091|NCT00918983|Enlarged prostate|enlarged prostate
5593092|NCT00918970|autonomous nervous system|autonomous nervous system
5593093|NCT00918970|brain death|brain death
5593094|NCT00918970|organs transplantation|organs transplantation
5593095|NCT00918957|Tobramycin Inhalation Powder|tobramycin inhalation powder
5593096|NCT00918957|Cystic fibrosis|cystic fibrosis
5593097|NCT00918957|Lung diseases|lung diseases
5593098|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents
5593099|NCT00918957|Treatment of infections with P. aeruginosa in cystic fibrosis subjects|treatment of infections with p. aeruginosa in cystic fibrosis subjects
5593100|NCT00918944|clinical decision support tool|clinical decision support tool
5593101|NCT00918944|electronic health record|electronic health record
5593102|NCT00918944|control tool|control tool
5593103|NCT00918944|spirometry|spirometry
5593104|NCT00918944|quality of life survey|quality of life survey
5593105|NCT00918944|provider survey|provider survey
5593106|NCT00918931|Leukemia|leukemia
5593107|NCT00918931|Systemic Mastocytosis|systemic mastocytosis
5593109|NCT00918931|Obatoclax mesylate|obatoclax mesylate
5593110|NCT00918931|GX15-070MS|gx15-070ms
5593111|NCT00918918|Alcohol Consumption|alcohol consumption
5593112|NCT00918918|High Density Lipoprotein (HDL)|high density lipoprotein (hdl)
5593113|NCT00918918|lipopolysaccharides (LPS)|lipopolysaccharides (lps)
5593114|NCT00918918|Apolipoproteins|apolipoproteins
5593115|NCT00918918|Inflammation|inflammation
5593116|NCT00918905|pervasive healthcare|pervasive healthcare
5593117|NCT00918905|telecare|telecare
5593118|NCT00918905|telemedicine|telemedicine
5593119|NCT00918905|COPD|copd
5593120|NCT00918892|breast cancer|breast cancer
5593121|NCT00918892|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5593122|NCT00918892|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5593123|NCT00918892|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5593124|NCT00918892|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5593125|NCT00918892|triple-negative breast cancer|triple-negative breast cancer
5593126|NCT00918892|HER2-negative breast cancer|her2-negative breast cancer
5593127|NCT00918892|HER2-positive breast cancer|her2-positive breast cancer
5593128|NCT00918879|DPP-4 inhibitors|dpp-4 inhibitors
5593130|NCT00918879|Incretins|incretins
5593131|NCT00918866|Phase 4|phase 4
5593132|NCT00918866|DEFINITY®|definity®
5593133|NCT00918866|hemodynamics|hemodynamics
5593134|NCT00918866|pulmonary artery pressure|pulmonary artery pressure
5593135|NCT00918853|pancreas|pancreas
5593136|NCT00918853|adenocarcinoma|adenocarcinoma
5593137|NCT00918840|HIV|hiv
5593138|NCT00918840|Vaccine|vaccine
5593139|NCT00918840|Immune Therapy|immune therapy
5593140|NCT00918840|DermaVir|dermavir
5593141|NCT00918840|Treatment experienced|treatment experienced
5593142|NCT00918827|adenocarcinoma of the colon|adenocarcinoma of the colon
5593143|NCT00918827|stage III colon cancer|stage iii colon cancer
5593144|NCT00918801|T1DM|t1dm
5593145|NCT00918801|MRI|mri
5593146|NCT00918788|breast cancer|breast cancer
5593147|NCT00918762|perioperative/postoperative complications|perioperative/postoperative complications
5593148|NCT00918762|precancerous condition|precancerous condition
5593149|NCT00918762|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5593150|NCT00918762|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5593151|NCT00918762|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5593152|NCT00918762|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5593153|NCT00918762|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5593154|NCT00918762|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5593155|NCT00918762|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5593156|NCT00918762|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5680351|NCT00578123|Prostate|prostate
5593157|NCT00918762|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5593158|NCT00918762|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5593159|NCT00918762|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5593160|NCT00918762|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5593161|NCT00918762|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5593162|NCT00918762|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5593163|NCT00918762|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5593164|NCT00918762|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5593165|NCT00918762|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5593166|NCT00918762|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5593167|NCT00918762|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5593168|NCT00918762|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5593169|NCT00918762|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5593170|NCT00918736|Ankle joint|ankle joint
5593171|NCT00918736|Balance|balance
5593172|NCT00918736|Hyaluronic acid|hyaluronic acid
5593173|NCT00918736|Osteoarthritis|osteoarthritis
5593174|NCT00918710|Squamous cell carcinoma of Oropharynx|squamous cell carcinoma of oropharynx
5593175|NCT00918710|Human papillomavirus.|human papillomavirus.
5593176|NCT00918710|Biological prognostic markers.|biological prognostic markers.
5593177|NCT00918697|photorefractive keratectomy|photorefractive keratectomy
5593178|NCT00918697|PRK|prk
5593179|NCT00918697|alcohol-assisted debridement|alcohol-assisted debridement
5593180|NCT00918697|mechanical debridement|mechanical debridement
5593181|NCT00918697|confocal scan|confocal scan
5593182|NCT00918697|confocal microscopy|confocal microscopy
5593183|NCT00918684|Depression|depression
5593184|NCT00918671|Headache|headache
5593185|NCT00918671|Medication overuse|medication overuse
5593186|NCT00918671|chronic|chronic
5593187|NCT00918671|relapse|relapse
5593188|NCT00918658|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5593189|NCT00918658|chronic myelogenous leukemia|chronic myelogenous leukemia
5593190|NCT00918658|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5593191|NCT00918658|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5593192|NCT00918658|adult acute myeloid leukemia|adult acute myeloid leukemia
5593193|NCT00918658|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5593194|NCT00918658|multiple myeloma|multiple myeloma
5593195|NCT00918645|stage IV prostate cancer|stage iv prostate cancer
5593196|NCT00918645|recurrent prostate cancer|recurrent prostate cancer
5593197|NCT00918645|bone metastases|bone metastases
5593198|NCT00918632|food-effect pharmacokinetics AG-013736 food fasting|food-effect pharmacokinetics ag-013736 food fasting
5593199|NCT00918619|randomized,|randomized,
5593200|NCT00918619|controlled,|controlled,
5593201|NCT00918619|haemostatic agents,|haemostatic agents,
5593202|NCT00918619|Sangustop,|sangustop,
5593203|NCT00918619|Tachosil,|tachosil,
5593204|NCT00918619|liver resection,|liver resection,
5593205|NCT00918619|haemostasis|haemostasis
5593206|NCT00918593|Metastases|metastases
5593207|NCT00918593|Cutaneous|cutaneous
5593208|NCT00918593|Ulcerating|ulcerating
5593210|NCT00918593|ulcerating metastases|ulcerating metastases
5593211|NCT00918567|ADHD|adhd
5593212|NCT00918567|impact of atomoxetine with and and without behavior therapy at school and home|impact of atomoxetine with and and without behavior therapy at school and home
5593213|NCT00918554|Sarcoid-associated uveitis|sarcoid-associated uveitis
5593214|NCT00918554|Macular oedema|macular oedema
5593215|NCT00918554|Methotrexate|methotrexate
5593216|NCT00918554|Conventional corticosteroids sparing agent.|conventional corticosteroids sparing agent.
5593217|NCT00918541|atherosclerotic disease|atherosclerotic disease
5593218|NCT00918541|progression|progression
5593219|NCT00918541|natural progression of atherosclerotic disease|natural progression of atherosclerotic disease
5593220|NCT00918541|natural history of atherosclerosis at the level of the carotid artery as evaluated by MRI|natural history of atherosclerosis at the level of the carotid artery as evaluated by mri
5593221|NCT00918528|Urethral stricture|urethral stricture
5593222|NCT00918528|Mitomycin C|mitomycin c
5593223|NCT00918528|Internal Urethrotomy|internal urethrotomy
5593224|NCT00918515|Sedation|sedation
5593225|NCT00918515|Anaesthesia|anaesthesia
5593226|NCT00918515|Safety|safety
5593227|NCT00918515|tolerability|tolerability
5593228|NCT00918515|pharmacokinetics|pharmacokinetics
5593229|NCT00918515|pharmacodynamics|pharmacodynamics
5593230|NCT00918515|healthy male volunteers|healthy male volunteers
5593231|NCT00918489|soft tissue sarcoma|soft tissue sarcoma
5593232|NCT00918489|metastatic|metastatic
5593233|NCT00918489|vorinostat|vorinostat
5593234|NCT00918463|lymphoma|lymphoma
5593235|NCT00918463|diffuse|diffuse
5593236|NCT00918463|refractory|refractory
5593237|NCT00918437|uvulopalatoplasty|uvulopalatoplasty
5593238|NCT00918437|postoperative pain|postoperative pain
5593239|NCT00918437|quality of life|quality of life
5593240|NCT00918411|diarrhea|diarrhea
5593242|NCT00918411|Colonic diseases|colonic diseases
5593244|NCT00918385|hormone resistant prostate cancer|hormone resistant prostate cancer
5593245|NCT00918385|castration resistant prostate cancer|castration resistant prostate cancer
5593246|NCT00918385|hormone refractory prostate cancer|hormone refractory prostate cancer
5593247|NCT00918385|metastatic prostate cancer|metastatic prostate cancer
5593248|NCT00918385|hormonal therapy|hormonal therapy
5593249|NCT00918385|antiandrogen therapy|antiandrogen therapy
5593250|NCT00918385|androgen receptor|androgen receptor
5593251|NCT00918385|nilutamide|nilutamide
5593252|NCT00918385|dasatinib|dasatinib
5593253|NCT00918385|genomics|genomics
5593254|NCT00918385|genomic signature|genomic signature
5593255|NCT00918385|genomic predictor|genomic predictor
5593256|NCT00918385|genomic analysis|genomic analysis
5593257|NCT00918385|genomic expression profile|genomic expression profile
5593258|NCT00918372|MSCTA|mscta
5593259|NCT00918372|Marathon runners|marathon runners
5593260|NCT00918346|Ocular hypertension|ocular hypertension
5593261|NCT00918320|Temozolomide|temozolomide
5593262|NCT00918320|Topotecan|topotecan
5593263|NCT00918320|paediatric solid tumours|paediatric solid tumours
5593264|NCT00918320|Miscellaneous other solid tumours|miscellaneous other solid tumours
5593265|NCT00918307|Tobacco Dependence|tobacco dependence
5593266|NCT00918307|HIV infection|hiv infection
5593267|NCT00918307|varenicline|varenicline
5593268|NCT00918294|CRT|crt
5593269|NCT00918294|heart failure|heart failure
5593270|NCT00918294|optimization|optimization
5593271|NCT00918294|Timing cycle optimization methods|timing cycle optimization methods
5593272|NCT00918268|Influenza vaccine|influenza vaccine
5593273|NCT00918255|Hidradenitis Suppurativa|hidradenitis suppurativa
5593274|NCT00918255|Adalimumab|adalimumab
5593275|NCT00918255|Nodule|nodule
5593276|NCT00918255|Abscess|abscess
5593277|NCT00918255|Fistula|fistula
5593278|NCT00918255|Physicians Global Assessment|physicians global assessment
5593279|NCT00918255|Hurley Stage|hurley stage
5593280|NCT00918255|Sartorius Scale|sartorius scale
5593281|NCT00918242|Coronary Heart Disease|coronary heart disease
5593282|NCT00918242|computed tomography|computed tomography
5593283|NCT00918242|prevalence of coronary artery disease|prevalence of coronary artery disease
5593284|NCT00918229|Prostate|prostate
5593285|NCT00918229|cancer|cancer
5593286|NCT00918229|radiation|radiation
5593287|NCT00918229|biodegradable implantable balloon|biodegradable implantable balloon
5593288|NCT00918229|intrarectal balloon|intrarectal balloon
5593289|NCT00918216|breast cancer|breast cancer
5593290|NCT00918203|Lung neoplasms|lung neoplasms
5593291|NCT00918203|IMC-3G3|imc-3g3
5593292|NCT00918203|carboplatin|carboplatin
5593293|NCT00918203|paclitaxel|paclitaxel
5593294|NCT00918203|PDGFr|pdgfr
5593295|NCT00918190|Postoperative nausea and vomiting|postoperative nausea and vomiting
5593296|NCT00918190|Pediatric|pediatric
5593297|NCT00918190|Strabismus|strabismus
5593298|NCT00918190|Late onset postoperative nausea and vomiting|late onset postoperative nausea and vomiting
5593299|NCT00918112|Parkinson's Disease|parkinson's disease
5593300|NCT00918099|Mesh|mesh
5593301|NCT00918099|vaginal prolapse|vaginal prolapse
5593302|NCT00918099|Recurrence rate|recurrence rate
5593303|NCT00918086|Vitamin D|vitamin d
5593304|NCT00918086|Tuberculosis|tuberculosis
5593305|NCT00918073|HIV infected smokers|hiv infected smokers
5593307|NCT00918034|BPH|bph
5593308|NCT00918034|LUTS|luts
5593309|NCT00918034|talaporfin sodium|talaporfin sodium
5593310|NCT00918008|URINARY BLADDER|urinary bladder
5593311|NCT00918008|Bladder|bladder
5593312|NCT00918008|Blood sample|blood sample
5593313|NCT00918008|Lymph Nodes|lymph nodes
5593314|NCT00917995|parastomal hernia|parastomal hernia
5593315|NCT00917995|prophylactic mesh|prophylactic mesh
5593316|NCT00917995|colostomy|colostomy
5593317|NCT00917995|hernia|hernia
5593318|NCT00917956|Lithium|lithium
5593319|NCT00917956|IBM|ibm
5593320|NCT00917956|InclusionIBM|inclusionibm
5593321|NCT00917956|Myositis|myositis
5593322|NCT00917943|smoking|smoking
5593323|NCT00917943|pregnancy|pregnancy
5593324|NCT00917943|counseling|counseling
5593325|NCT00917943|prevention|prevention
5593326|NCT00917943|tailored intervention|tailored intervention
5593327|NCT00917943|postpartum|postpartum
5593328|NCT00917943|women|women
5593329|NCT00917943|cessation|cessation
5593330|NCT00917930|exercise training|exercise training
5593331|NCT00917930|functional recovery|functional recovery
5593332|NCT00917930|heart diseases|heart diseases
5593333|NCT00917930|altered glucose metabolism early after an acute cardiac event|altered glucose metabolism early after an acute cardiac event
5593458|NCT00917358|Hepatitis C|hepatitis c
5593334|NCT00917930|non diabetes CAD patients|non diabetes cad patients
5593335|NCT00917930|glycometabolic state|glycometabolic state
5593336|NCT00917917|Metabolic syndrome|metabolic syndrome
5593337|NCT00917917|exercise training|exercise training
5593338|NCT00917917|abdominal fat mass|abdominal fat mass
5593339|NCT00917917|endothelial function|endothelial function
5593340|NCT00917917|diastolic function|diastolic function
5680352|NCT00578123|Cancer|cancer
5593341|NCT00917904|HIV Infections|hiv infections
5593342|NCT00917904|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5593344|NCT00917904|HIV seronegativity|hiv seronegativity
5593345|NCT00917891|HIV Infections|hiv infections
5593346|NCT00917891|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5593347|NCT00917891|Healthy|healthy
5593348|NCT00917891|HIV seronegativity|hiv seronegativity
5593349|NCT00917878|Milk|milk
5593350|NCT00917878|Postprandial hyperlipidemia|postprandial hyperlipidemia
5593351|NCT00917878|Postprandial inflammation|postprandial inflammation
5593352|NCT00917878|Overweight|overweight
5593353|NCT00917852|aorta|aorta
5593354|NCT00917852|trauma|trauma
5593355|NCT00917852|transection|transection
5593356|NCT00917839|neuroprotection|neuroprotection
5593357|NCT00917839|multiple sclerosis|multiple sclerosis
5593358|NCT00917839|brain atrophy|brain atrophy
5593359|NCT00917839|mr-spectroscopy|mr-spectroscopy
5593361|NCT00917813|monoclonal antibody|monoclonal antibody
5593362|NCT00917813|KD-247|kd-247
5593363|NCT00917813|treatment naive|treatment naive
5593364|NCT00917800|angiography|angiography
5593365|NCT00917800|exercise testing|exercise testing
5593366|NCT00917800|high frequency ECG|high frequency ecg
5593966|NCT00915356|AZD1305|azd1305
5593367|NCT00917800|coronary artery disease|coronary artery disease
5593368|NCT00917787|Asthma|asthma
5593369|NCT00917774|gender specific knee|gender specific knee
5593370|NCT00917774|osteoarthritis|osteoarthritis
5593371|NCT00917774|total knee arthroplasty|total knee arthroplasty
5593372|NCT00917761|Hepatitis B, chronic|hepatitis b, chronic
5593373|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a
5593374|NCT00917761|Entecavir|entecavir
5593375|NCT00917735|Green tea|green tea
5593376|NCT00917735|Breast cancer|breast cancer
5593377|NCT00917735|Prevention|prevention
5593378|NCT00917735|COMT genotype|comt genotype
5593379|NCT00917735|EGCG (Epigallocatechin gallate)|egcg (epigallocatechin gallate)
5593380|NCT00917735|Mammographic density|mammographic density
5593381|NCT00917735|Reproductive hormones|reproductive hormones
5593382|NCT00917735|IGF axis proteins|igf axis proteins
5593383|NCT00917735|Oxidative stress|oxidative stress
5593384|NCT00917722|Parkinson's Disease|parkinson's disease
5593385|NCT00917722|STN DBS|stn dbs
5593386|NCT00917722|Deep Brain Stimulation|deep brain stimulation
5593387|NCT00917709|dementia with Lewy bodies|dementia with lewy bodies
5593388|NCT00917709|imaging|imaging
5593389|NCT00917709|acetylcholine|acetylcholine
5593390|NCT00917709|dopamine|dopamine
5593391|NCT00917709|IBVM|ibvm
5593392|NCT00917709|DATSCAN|datscan
5593393|NCT00917670|trabecular meshwork|trabecular meshwork
5593394|NCT00917670|electron microscopy|electron microscopy
5593395|NCT00917657|photorefractive keratectomy|photorefractive keratectomy
5593396|NCT00917657|hyperopia|hyperopia
5593397|NCT00917657|radial keratotomy|radial keratotomy
5593398|NCT00917657|refractive surgery|refractive surgery
5593399|NCT00917644|Bioqeuivalence, Pharmacokinetics, Atorvastatin|bioqeuivalence, pharmacokinetics, atorvastatin
5593400|NCT00917631|Co-bedding|co-bedding
5593401|NCT00917631|Procedural pain|procedural pain
5593402|NCT00917631|Twin|twin
5593403|NCT00917631|Comfort|comfort
5593404|NCT00917631|RCT|rct
5593405|NCT00917618|osteoarthritis|osteoarthritis
5593406|NCT00917618|knee|knee
5593407|NCT00917618|exercise|exercise
5593408|NCT00917618|cycling|cycling
5593409|NCT00917592|Diverticulitis|diverticulitis
5593410|NCT00917579|Bioequivalence, pharmacokinetics, atorvastatin|bioequivalence, pharmacokinetics, atorvastatin
5593412|NCT00917566|Pediatric|pediatric
5593413|NCT00917553|diabetic retinopathy|diabetic retinopathy
5593414|NCT00917553|diabetes|diabetes
5593415|NCT00917553|diabetic eye studies|diabetic eye studies
5593416|NCT00917527|Subjects with family history of coronary heart disease|subjects with family history of coronary heart disease
5593417|NCT00917514|Dosing Tool|dosing tool
5593418|NCT00917514|Compliance|compliance
5593419|NCT00917514|User Friendly|user friendly
5593420|NCT00917514|Crohn's Disease|crohn's disease
5593421|NCT00917514|Ulcerative Colitis|ulcerative colitis
5593422|NCT00917501|Mania|mania
5593423|NCT00917501|Adolescents at risk for Mania|adolescents at risk for mania
5593424|NCT00917488|Allergen extract Standardization|allergen extract standardization
5593425|NCT00917475|preterm infants|preterm infants
5593426|NCT00917462|ESOPHAGUS|esophagus
5593427|NCT00917462|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
5593428|NCT00917462|09-016|09-016
5593429|NCT00917462|Nexavar®.|nexavar®.
5593430|NCT00917449|Metabolic Syndrome|metabolic syndrome
5593431|NCT00917449|Impaired glucose tolerance|impaired glucose tolerance
5593432|NCT00917449|Type 2 diabetes mellitus|type 2 diabetes mellitus
5593433|NCT00917449|Endothelial dysfunction|endothelial dysfunction
5593434|NCT00917449|L-arginine|l-arginine
5593435|NCT00917449|Insulin resistance|insulin resistance
5593436|NCT00917423|Anorexia Nervosa|anorexia nervosa
5593437|NCT00917423|Exercise|exercise
5593438|NCT00917423|Physical Activity|physical activity
5593439|NCT00917397|Traumatized refugee|traumatized refugee
5593440|NCT00917397|treatment|treatment
5593441|NCT00917397|antidepressants|antidepressants
5593442|NCT00917397|psychotherapy|psychotherapy
5593443|NCT00917397|PTSD in traumatized refugees|ptsd in traumatized refugees
5593445|NCT00917384|Monoclonal antibody (MAb)|monoclonal antibody (mab)
5593446|NCT00917384|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5593447|NCT00917384|Human vascular endothelial growth factor receptor-2 (VEGFR-2)|human vascular endothelial growth factor receptor-2 (vegfr-2)
5593448|NCT00917384|Platinum resistant|platinum resistant
5593449|NCT00917384|platinum refractory|platinum refractory
5593450|NCT00917384|Gastric|gastric
5593451|NCT00917384|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5593452|NCT00917384|metastatic|metastatic
5593453|NCT00917384|Angiogenesis|angiogenesis
5593454|NCT00917371|adults with attention-deficit hyperactivity disorder|adults with attention-deficit hyperactivity disorder
5593455|NCT00917371|atomoxetine|atomoxetine
5593456|NCT00917371|neuropsychological functioning|neuropsychological functioning
5593457|NCT00917371|brain imaging studies|brain imaging studies
5593459|NCT00917358|Dialysis|dialysis
5593460|NCT00917358|Interferon|interferon
5593461|NCT00917345|ARC|arc
5593462|NCT00917345|PRA|pra
5593463|NCT00917345|primary aldosteronism|primary aldosteronism
5593464|NCT00917345|captopril test|captopril test
5593465|NCT00917345|aldosterone-renin ratio|aldosterone-renin ratio
5593466|NCT00917345|Primary aldosteronism (PA) than PRA and establish thresholds for the diagnosis using ARC.|primary aldosteronism (pa) than pra and establish thresholds for the diagnosis using arc.
5593467|NCT00917332|pain|pain
5593468|NCT00917332|childbirth|childbirth
5593469|NCT00917332|relaxation|relaxation
5593470|NCT00917332|guided imagery|guided imagery
5593471|NCT00917332|VAS|vas
5593472|NCT00917332|epidural|epidural
5593473|NCT00917306|Peplin|peplin
5593474|NCT00917306|Actinic keratosis|actinic keratosis
5593475|NCT00917306|PEP005|pep005
5593476|NCT00917293|Tardive Dyskinesia|tardive dyskinesia
5593477|NCT00917293|Schizophrenia|schizophrenia
5593478|NCT00917293|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5593479|NCT00917280|Parkinson's Disease|parkinson's disease
5593480|NCT00917267|diabetes|diabetes
5593481|NCT00917267|exenatide|exenatide
5593482|NCT00917267|once weekly|once weekly
5593483|NCT00917267|Byetta|byetta
5593490|NCT00917254|Anticoagulant|anticoagulant
5593491|NCT00917254|FXa inhibitor|fxa inhibitor
5593492|NCT00917241|Graves' disease|graves' disease
5593493|NCT00917241|dexamethasone|dexamethasone
5593494|NCT00917241|relapse|relapse
5593495|NCT00917241|methimazole|methimazole
5593496|NCT00917215|Asthma|asthma
5593497|NCT00917215|Acupuncture|acupuncture
5593498|NCT00917215|Pulmonary function|pulmonary function
5593499|NCT00917215|Quality of life|quality of life
5593500|NCT00917189|VCFS|vcfs
5593501|NCT00917189|Chromosome 22q Deletion Syndrome|chromosome 22q deletion syndrome
5593502|NCT00917189|Learning Disorders|learning disorders
5593503|NCT00917163|coronary artery disease|coronary artery disease
5593504|NCT00917163|restenosis|restenosis
5593505|NCT00917163|stent thrombosis|stent thrombosis
5593506|NCT00917163|coronary stents|coronary stents
5593507|NCT00917163|angioplasty|angioplasty
5593508|NCT00917163|drug eluting stents|drug eluting stents
5593509|NCT00917150|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5593511|NCT00917150|emphysema|emphysema
5593512|NCT00917137|Lung cancer|lung cancer
5593513|NCT00917137|Lung nodule|lung nodule
5593514|NCT00917137|Transbronchial needle aspiration|transbronchial needle aspiration
5593515|NCT00917137|Transbronchial lung biopsy|transbronchial lung biopsy
5593516|NCT00917137|Bronchoscopy|bronchoscopy
5593517|NCT00917124|cerebral oximetry|cerebral oximetry
5593518|NCT00917124|NIRS|nirs
5593519|NCT00917124|INVOS|invos
5593520|NCT00917111|Randomized|randomized
5593521|NCT00917111|Double-Blind|double-blind
5593522|NCT00917111|Multi-Center|multi-center
5593523|NCT00917111|Placebo-Controlled|placebo-controlled
5593524|NCT00917111|Phase II|phase ii
5593525|NCT00917111|Nasal Carbon Dioxide|nasal carbon dioxide
5593526|NCT00917111|Carbon Dioxide|carbon dioxide
5593527|NCT00917111|Efficacy|efficacy
5593528|NCT00917111|Safety|safety
5593529|NCT00917111|Total Nasal Symptom Score|total nasal symptom score
5593530|NCT00917098|Behavior Therapy|behavior therapy
5593531|NCT00917098|Supportive Counseling|supportive counseling
5593532|NCT00917098|Child|child
5593533|NCT00917098|Adolescent|adolescent
5593534|NCT00917098|Hair Pulling|hair pulling
5593536|NCT00917085|Preterm infant|preterm infant
5593537|NCT00917085|Skin-to-skin contact|skin-to-skin contact
5593538|NCT00917085|kangaroo care|kangaroo care
5593539|NCT00917085|temperature|temperature
5593540|NCT00917085|behavioral state|behavioral state
5593541|NCT00917072|Clinical Handoff|clinical handoff
5593542|NCT00917072|Medical Education|medical education
5593543|NCT00917072|Simulation|simulation
5593544|NCT00917072|Residency and Internship|residency and internship
5593545|NCT00917059|Major Depressive Disorder|major depressive disorder
5593548|NCT00917046|All-cause heart failure patients|all-cause heart failure patients
5593549|NCT00917046|coronary artery disease etiology|coronary artery disease etiology
5593550|NCT00917046|dilated cardiomyopathy etiology|dilated cardiomyopathy etiology
5593551|NCT00917020|Randomized|randomized
5593552|NCT00917020|Double-Blind|double-blind
5593553|NCT00917020|Multi-Center|multi-center
5593554|NCT00917020|Phase II|phase ii
5593555|NCT00917020|Nasal Carbon Dioxide|nasal carbon dioxide
5593556|NCT00917020|Carbon Dioxide|carbon dioxide
5593557|NCT00917020|Efficacy|efficacy
5593558|NCT00917020|Safety|safety
5593559|NCT00917020|Total Nasal Symptom Score|total nasal symptom score
5593560|NCT00917007|ABO incompatibility|abo incompatibility
5593561|NCT00917007|hemolysis|hemolysis
5593562|NCT00917007|jaundice|jaundice
5593563|NCT00917007|hyperbilirubinemia|hyperbilirubinemia
5593564|NCT00917007|newborn|newborn
5593565|NCT00916994|Rotator Cuff Tear|rotator cuff tear
5593566|NCT00916981|pseudarthrosis|pseudarthrosis
5593567|NCT00916981|Treatment|treatment
5593568|NCT00916981|osteoblast grafting|osteoblast grafting
5593569|NCT00916981|cell therapy|cell therapy
5593570|NCT00916981|nonunion|nonunion
5593571|NCT00916968|Gender specific|gender specific
5593572|NCT00916968|cruciate retaining|cruciate retaining
5593573|NCT00916968|total knee arthroplasty|total knee arthroplasty
5593574|NCT00916968|Bilateral Osteoarthritis of the knee joint|bilateral osteoarthritis of the knee joint
5593575|NCT00916955|22q11.2 deletion syndrome|22q11.2 deletion syndrome
5593576|NCT00916955|velo-cardio-facial syndrome|velo-cardio-facial syndrome
5593577|NCT00916955|congenital anomalies|congenital anomalies
5593578|NCT00916955|mental illness|mental illness
5593579|NCT00916955|congenital heart disease|congenital heart disease
5593580|NCT00916942|Tolerability study|tolerability study
5593581|NCT00916916|Acromegaly|acromegaly
5593582|NCT00916916|Lanreotide|lanreotide
5593583|NCT00916903|Talus|talus
5593584|NCT00916903|Neuroserpin|neuroserpin
5593585|NCT00916903|mental retardation|mental retardation
5593586|NCT00916903|epilepsy|epilepsy
5593588|NCT00916903|XLMR|xlmr
5593589|NCT00916890|Opioid pharmacogenetics|opioid pharmacogenetics
5593590|NCT00916890|Opioid pharmacokinetic|opioid pharmacokinetic
5593591|NCT00916890|Long-term opioid treatment|long-term opioid treatment
5593592|NCT00916890|Cancer pain|cancer pain
5593593|NCT00916877|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5593594|NCT00916877|Her-2-positive met breast cancer|her-2-positive met breast cancer
5593595|NCT00916851|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5593596|NCT00916851|autism spectrum disorders|autism spectrum disorders
5593597|NCT00916851|normally developing children and adolescents|normally developing children and adolescents
5593598|NCT00916851|cognitive functions|cognitive functions
5593599|NCT00916851|emotion/behaviors|emotion/behaviors
5593600|NCT00916851|brain imaging|brain imaging
5593601|NCT00916851|genotypes|genotypes
5593602|NCT00916838|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
5593604|NCT00916825|breast cancer|breast cancer
5593605|NCT00916825|quality of life|quality of life
5593606|NCT00916825|children of somatically ill parents|children of somatically ill parents
5593607|NCT00916825|psychological adaptation|psychological adaptation
5593608|NCT00916812|Difficult intubation|difficult intubation
5593609|NCT00916812|Hyomental distance|hyomental distance
5593610|NCT00916812|Obstetric|obstetric
5593611|NCT00916812|Mallampati classification|mallampati classification
5593612|NCT00916812|Thyromental distance|thyromental distance
5593613|NCT00916812|Sternomental distance|sternomental distance
5593614|NCT00916799|telehealth|telehealth
5593615|NCT00916799|oximetry|oximetry
5593617|NCT00916786|Attention-deficit/hyperactivity disorder|attention-deficit/hyperactivity disorder
5593618|NCT00916786|pharmacogenetics|pharmacogenetics
5593619|NCT00916786|molecular genetics|molecular genetics
5593620|NCT00916786|medication response|medication response
5593621|NCT00916773|Obstructive sleep apnea|obstructive sleep apnea
5593622|NCT00916773|Airway inflammation|airway inflammation
5593623|NCT00916773|Exercise-induced bronchoconstriction|exercise-induced bronchoconstriction
5593624|NCT00916773|Continuous positive airway pressure|continuous positive airway pressure
5593625|NCT00916760|allergic, rhinoconjunctivitis, Immunotherapy|allergic, rhinoconjunctivitis, immunotherapy
5593626|NCT00916747|Progeria|progeria
5593627|NCT00916734|McKenzie|mckenzie
5593628|NCT00916734|thrust manipulation|thrust manipulation
5593629|NCT00916734|clinical prediction rule|clinical prediction rule
5593630|NCT00916721|Smoking cessation|smoking cessation
5593631|NCT00916721|propranolol|propranolol
5593632|NCT00916721|memory reconsolidation blockade|memory reconsolidation blockade
5593633|NCT00916721|craving|craving
5593634|NCT00916708|endometrial cancer|endometrial cancer
5593635|NCT00916708|follow up|follow up
5593636|NCT00916708|relapse|relapse
5593637|NCT00916695|Stents|stents
5593638|NCT00916695|Angioplasty|angioplasty
5593639|NCT00916695|Coronary Artery Disease|coronary artery disease
5593640|NCT00916695|Bifurcation Coronary Lesions|bifurcation coronary lesions
5593641|NCT00916669|SCLC|sclc
5593642|NCT00916669|enoxaparin sodium|enoxaparin sodium
5593643|NCT00916669|cisplatin|cisplatin
5593644|NCT00916669|etoposide|etoposide
5593645|NCT00916656|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
5593646|NCT00916643|Hypercholesterolemia|hypercholesterolemia
5593647|NCT00916643|FH|fh
5593648|NCT00916643|LDL-C|ldl-c
5593649|NCT00916643|CHD|chd
5593650|NCT00916630|recurrent|recurrent
5593651|NCT00916630|alimta|alimta
5593652|NCT00916630|pemetrexed|pemetrexed
5593653|NCT00916630|CNS lymphoma|cns lymphoma
5593654|NCT00916630|Primary CNS lymphoma|primary cns lymphoma
5593655|NCT00916630|Metastatic lymphoma to brain|metastatic lymphoma to brain
5593656|NCT00916617|open-label|open-label
5593657|NCT00916617|safety|safety
5593658|NCT00916617|antibody|antibody
5593659|NCT00916604|AZD1656|azd1656
5593660|NCT00916604|Safety|safety
5593661|NCT00916604|Pharmacokinetics|pharmacokinetics
5593662|NCT00916604|Pharmacodynamic|pharmacodynamic
5593663|NCT00916604|Multiple ascending doses|multiple ascending doses
5593664|NCT00916604|Japanese|japanese
5593665|NCT00916604|T2DM|t2dm
5593666|NCT00916591|gastroesophageal reflux|gastroesophageal reflux
5593667|NCT00916591|respiratory aspiration|respiratory aspiration
5593668|NCT00916578|Advanced Inflammatory Breast Cancer|advanced inflammatory breast cancer
5593669|NCT00916578|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
5593670|NCT00916578|Capecitabine|capecitabine
5593671|NCT00916578|Xeloda|xeloda
5593672|NCT00916578|Concomitant Radiation|concomitant radiation
5593673|NCT00916578|Radiation Therapy|radiation therapy
5593674|NCT00916578|Radiotherapy|radiotherapy
5593675|NCT00916578|Women|women
5593676|NCT00916565|optimize nutritional content of infant formula|optimize nutritional content of infant formula
5593677|NCT00916565|Infant|infant
5593678|NCT00916552|Erythropoietin|erythropoietin
5593679|NCT00916552|Epo|epo
5593680|NCT00916552|depression|depression
5593681|NCT00916552|bipolar disorder|bipolar disorder
5593682|NCT00916552|cognition|cognition
5593684|NCT00916552|antidepressant|antidepressant
5593685|NCT00916526|Chronic cough|chronic cough
5593686|NCT00916526|Inhaled corticosteroid treatment|inhaled corticosteroid treatment
5593687|NCT00916526|Bronchial provocation test with mannitol|bronchial provocation test with mannitol
5593688|NCT00916526|Methacholine|methacholine
5593689|NCT00916513|Diabetes|diabetes
5593690|NCT00916513|Treatment Satisfaction|treatment satisfaction
5593691|NCT00916513|Quality of Life|quality of life
5593692|NCT00916513|HbA1c levels and goals|hba1c levels and goals
5593693|NCT00916513|Healthcare resources consumption|healthcare resources consumption
5593694|NCT00916500|CERVICAL CANCER, CONCURRENT CHEMORADIATION, CISPLATIN|cervical cancer, concurrent chemoradiation, cisplatin
5593695|NCT00916461|First episode psychosis|first episode psychosis
5593696|NCT00916461|Schizophrenia|schizophrenia
5593697|NCT00916461|Minocycline|minocycline
5593698|NCT00916461|neuroprotection|neuroprotection
5593699|NCT00916461|First episode non affective psychosis|first episode non affective psychosis
5593700|NCT00916461|With in first five years of illness|with in first five years of illness
5593701|NCT00916448|Endotoxin|endotoxin
5593702|NCT00916448|Bilirubin|bilirubin
5593703|NCT00916448|Inflammation|inflammation
5593709|NCT00916435|Cardiac Arrest|cardiac arrest
5593710|NCT00916435|Cardiomyopathy|cardiomyopathy
5593711|NCT00916435|Heart Failure|heart failure
5593712|NCT00916422|Immunotherapy|immunotherapy
5593713|NCT00916422|Allergoid|allergoid
5593714|NCT00916422|Depigmented|depigmented
5593715|NCT00916422|Polymerized|polymerized
5593716|NCT00916422|Allergen-extract|allergen-extract
5593717|NCT00916422|Rhinoconjunctivitis|rhinoconjunctivitis
5593718|NCT00916409|Glioblastoma Multiforme|glioblastoma multiforme
5593719|NCT00916409|Glioblastoma|glioblastoma
5593720|NCT00916409|GBM|gbm
5593721|NCT00916409|Brain tumor|brain tumor
5593722|NCT00916409|Treatment|treatment
5593723|NCT00916409|Minimal toxicity|minimal toxicity
5593724|NCT00916409|Newly Diagnosed|newly diagnosed
5593725|NCT00916409|TTFields|ttfields
5593726|NCT00916409|Tumor Treating Fields|tumor treating fields
5593727|NCT00916409|NovoCure|novocure
5593728|NCT00916383|Skin Irritation|skin irritation
5593729|NCT00916383|Donepezil Transdermal Patch System|donepezil transdermal patch system
5593730|NCT00916383|Elderly|elderly
5593731|NCT00916383|Alzheimer's subjects|alzheimer's subjects
5593732|NCT00916383|Skin Irritation in elderly Alzheimer's subjects|skin irritation in elderly alzheimer's subjects
5593733|NCT00916370|drug eluting stents|drug eluting stents
5593734|NCT00916370|stents|stents
5593735|NCT00916370|Angioplasty|angioplasty
5593736|NCT00916370|myocardial ischemia|myocardial ischemia
5593737|NCT00916370|coronary artery stenosis|coronary artery stenosis
5593738|NCT00916370|Coronary Disease|coronary disease
5593739|NCT00916370|Coronary Artery Disease|coronary artery disease
5593740|NCT00916370|Coronary Restenosis|coronary restenosis
5593741|NCT00916370|Long lesion|long lesion
5593742|NCT00916357|recombinant human hyaluronidase PH20 (rHuPH20)|recombinant human hyaluronidase ph20 (rhuph20)
5593743|NCT00916357|Insulin lispro|insulin lispro
5593744|NCT00916357|Regular human insulin|regular human insulin
5685432|NCT00556088|Dose escalation|dose escalation
5593745|NCT00916331|total knee replacement arthroplasty|total knee replacement arthroplasty
5593746|NCT00916331|subcutaneous indwelling|subcutaneous indwelling
5593747|NCT00916331|blood loss|blood loss
5593748|NCT00916331|complications|complications
5593749|NCT00916331|functional status|functional status
5593750|NCT00916305|deafness noise tinnitus hearingloss|deafness noise tinnitus hearingloss
5593751|NCT00916292|Diabetes|diabetes
5593752|NCT00916292|dermal ulcers|dermal ulcers
5593753|NCT00916279|Bare Metal In-Stent Restenosis|bare metal in-stent restenosis
5593754|NCT00916279|Paclitaxel Coated Balloon Catheter|paclitaxel coated balloon catheter
5593755|NCT00916279|Drug Coated Balloon|drug coated balloon
5593756|NCT00916279|Coronary Artery Disease|coronary artery disease
5593757|NCT00916266|Seizure frequency|seizure frequency
5593758|NCT00916266|Hippocampal volume|hippocampal volume
5593759|NCT00916266|Adverse effects|adverse effects
5593760|NCT00916253|Sleep|sleep
5593761|NCT00916253|real driving|real driving
5593762|NCT00916253|simulated driving|simulated driving
5593764|NCT00916240|Adolescents|adolescents
5593765|NCT00916240|African American|african american
5593766|NCT00916227|Low or Intermediate-1 Risk Myelodysplastic Syndrome|low or intermediate-1 risk myelodysplastic syndrome
5593767|NCT00916201|schizophrenia|schizophrenia
5593768|NCT00916188|Black Tea|black tea
5593769|NCT00916188|Oxidative Stress|oxidative stress
5593770|NCT00916188|Blood Lipids|blood lipids
5593771|NCT00916188|Insulin Sensitivity|insulin sensitivity
5593772|NCT00916175|hyperglycemia|hyperglycemia
5593773|NCT00916175|overweight|overweight
5593774|NCT00916175|functional food|functional food
5593775|NCT00916175|aloe vera|aloe vera
5593776|NCT00916175|cnidoscolus chayamansa|cnidoscolus chayamansa
5593777|NCT00916162|aromatase inhibitor|aromatase inhibitor
5593778|NCT00916149|Epilepsy|epilepsy
5593779|NCT00916149|Cognition|cognition
5593780|NCT00916149|Lamictal|lamictal
5593781|NCT00916149|Lamotrigine|lamotrigine
5593782|NCT00916149|Keppra|keppra
5593783|NCT00916149|Levetiracetam|levetiracetam
5593784|NCT00916136|Pre-operative Traction|pre-operative traction
5593785|NCT00916136|Traction|traction
5593786|NCT00916136|Proximal Femur Fracture|proximal femur fracture
5593787|NCT00916136|Femoral Fractures|femoral fractures
5593788|NCT00916136|Femoral Fracture|femoral fracture
5593789|NCT00916136|Skeletal Traction|skeletal traction
5593790|NCT00916136|Cutaneous Traction|cutaneous traction
5593791|NCT00916123|castrate-resistant prostate cancer|castrate-resistant prostate cancer
5593792|NCT00916123|CRPC|crpc
5593793|NCT00916110|healthy subjects|healthy subjects
5593794|NCT00916071|Bulimia Nervosa|bulimia nervosa
5593795|NCT00916071|Eating Disorder NOS|eating disorder nos
5593796|NCT00916071|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5593797|NCT00916071|ADHD|adhd
5593798|NCT00916058|Multiple Myeloma|multiple myeloma
5593799|NCT00916058|Autologous Stem Cell Transplant|autologous stem cell transplant
5593800|NCT00916058|ASCT|asct
5593801|NCT00916058|MM|mm
5593802|NCT00916019|gene expression|gene expression
5593803|NCT00916019|skeletal muscle|skeletal muscle
5593804|NCT00916019|Healthy men|healthy men
5593805|NCT00916006|Peplin|peplin
5593806|NCT00916006|Actinic keratosis|actinic keratosis
5593807|NCT00916006|PEP005|pep005
5593808|NCT00915980|Meal-test|meal-test
5593809|NCT00915980|reduced OGTT|reduced ogtt
5593810|NCT00915980|gastric bypass surgery and glucose metabolism|gastric bypass surgery and glucose metabolism
5593811|NCT00915980|Glucose metabolism before and after gastric bypass|glucose metabolism before and after gastric bypass
5593812|NCT00915980|Different OGTT|different ogtt
5593813|NCT00915980|New meal- test|new meal- test
5593814|NCT00915967|Infection|infection
5593815|NCT00915967|Vancomycin|vancomycin
5593816|NCT00915967|Neurosurgery|neurosurgery
5593817|NCT00915967|Stimulator|stimulator
5593818|NCT00915967|Pump|pump
5593819|NCT00915967|Deep Brain Stimulation|deep brain stimulation
5593820|NCT00915967|Intrathecal Pump|intrathecal pump
5593821|NCT00915954|Acromegaly|acromegaly
5593822|NCT00915954|Type 2 diabetes mellitus|type 2 diabetes mellitus
5593823|NCT00915954|recombinant human Insulin like growth factor 1 (IGF1)|recombinant human insulin like growth factor 1 (igf1)
5593824|NCT00915954|oral glucose tolerance test|oral glucose tolerance test
5593825|NCT00915915|Female contraception|female contraception
5593826|NCT00915915|Ovulation inhibition|ovulation inhibition
5593827|NCT00915889|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5593828|NCT00915889|stage IA cervical cancer|stage ia cervical cancer
5593829|NCT00915889|stage IB cervical cancer|stage ib cervical cancer
5593830|NCT00915889|stage IIA cervical cancer|stage iia cervical cancer
5593831|NCT00915889|stage IIB cervical cancer|stage iib cervical cancer
5593832|NCT00915889|stage III cervical cancer|stage iii cervical cancer
5593833|NCT00915889|cancer survivor|cancer survivor
5593834|NCT00915876|chronic kidney disease|chronic kidney disease
5593835|NCT00915876|Vitamin D|vitamin d
5593836|NCT00915863|pancreaticoduodenectomy|pancreaticoduodenectomy
5593837|NCT00915863|pancreatic fistula|pancreatic fistula
5593838|NCT00915863|reconstruction|reconstruction
5593839|NCT00915863|isolated Roux-en-Y|isolated roux-en-y
5593840|NCT00915837|DME|dme
5593841|NCT00915824|Drug therapy|drug therapy
5593842|NCT00915824|Prescribing|prescribing
5593843|NCT00915824|Appropriateness|appropriateness
5593844|NCT00915824|Randomized controlled trial|randomized controlled trial
5593845|NCT00915824|STOPP/START criteria|stopp/start criteria
5672121|NCT00612976|treatment of COPD|treatment of copd
5593846|NCT00915824|Appropriateness of prescribing in older patients|appropriateness of prescribing in older patients
5593847|NCT00915824|Prescription Drugs|prescription drugs
5593848|NCT00915811|Myelodysplastic Syndromes|myelodysplastic syndromes
5593849|NCT00915811|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5593850|NCT00915811|Haematopoietic stem cell transplantation|haematopoietic stem cell transplantation
5593851|NCT00915811|Fludarabine|fludarabine
5593852|NCT00915811|Busulphan|busulphan
5593853|NCT00915811|Thymoglobuline|thymoglobuline
5593854|NCT00915759|ProKera|prokera
5593855|NCT00915759|Amniotic membrane|amniotic membrane
5593856|NCT00915759|Photorefractive Keratectomy|photorefractive keratectomy
5593857|NCT00915759|PRK|prk
5593858|NCT00915759|time to re-epithelialization|time to re-epithelialization
5593859|NCT00915746|Phase I|phase i
5593860|NCT00915746|ketoconazole|ketoconazole
5593861|NCT00915746|CYP3A4 inhibitor|cyp3a4 inhibitor
5593862|NCT00915746|drug interaction|drug interaction
5593863|NCT00915746|metabolism|metabolism
5593864|NCT00915746|Healthly Volunteer|healthly volunteer
5593865|NCT00915746|JNJ-31001074|jnj-31001074
5593866|NCT00915733|acute myocardial infarction|acute myocardial infarction
5593867|NCT00915733|inhibition of platelet aggregation|inhibition of platelet aggregation
5593868|NCT00915733|triple antiplatelet therapy|triple antiplatelet therapy
5593869|NCT00915733|high maintenance-dose clopidogrel.|high maintenance-dose clopidogrel.
5593870|NCT00915733|CYP2C19 polymorphism|cyp2c19 polymorphism
5593871|NCT00915733|High posttreatment platelet reactivity|high posttreatment platelet reactivity
5593872|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5593873|NCT00915733|CYP2C19, human|cyp2c19, human
5593874|NCT00915720|Atrial Fibrillation|atrial fibrillation
5593875|NCT00915720|Surgical Ablation|surgical ablation
5593876|NCT00915720|Implanted loop recorder|implanted loop recorder
5593877|NCT00915720|Atrial Fibrillation Ablation|atrial fibrillation ablation
5593879|NCT00915707|diabetes, risk|diabetes, risk
5593880|NCT00915707|obesity, diabetes risk related to sleep|obesity, diabetes risk related to sleep
5593881|NCT00915694|adult giant cell glioblastoma|adult giant cell glioblastoma
5593882|NCT00915694|adult gliosarcoma|adult gliosarcoma
5593883|NCT00915694|adult glioblastoma|adult glioblastoma
5593884|NCT00915681|amatoxin|amatoxin
5593885|NCT00915681|amanita|amanita
5593886|NCT00915681|mushroom poisoning|mushroom poisoning
5593887|NCT00915681|hepatic failure|hepatic failure
5593888|NCT00915681|milk thistle|milk thistle
5593889|NCT00915681|Silibinin|silibinin
5593890|NCT00915681|Legalon|legalon
5593891|NCT00915668|Healthy women|healthy women
5593892|NCT00915668|Non-childbearing potential|non-childbearing potential
5593893|NCT00915668|Drug-drug interaction|drug-drug interaction
5593894|NCT00915668|Oral contraceptive|oral contraceptive
5593895|NCT00915668|OC|oc
5593896|NCT00915668|Ovral-L|ovral-l
5593897|NCT00915668|ethinyl estradiol|ethinyl estradiol
5593898|NCT00915668|EE|ee
5593899|NCT00915668|levonorgestrel|levonorgestrel
5593900|NCT00915668|JNJ-31001074|jnj-31001074
5593901|NCT00915655|HIV Infections|hiv infections
5593902|NCT00915655|TMC114-TiDP29-C230|tmc114-tidp29-c230
5593903|NCT00915655|TMC114-C230|tmc114-c230
5593904|NCT00915655|TMC114|tmc114
5593905|NCT00915655|HIV-1|hiv-1
5593906|NCT00915655|Darunavir|darunavir
5593907|NCT00915655|Ritonavir|ritonavir
5593908|NCT00915655|NRTI|nrti
5593909|NCT00915655|Treatment Naive|treatment naive
5593910|NCT00915642|Obesity|obesity
5593911|NCT00915642|Weight loss rate|weight loss rate
5593912|NCT00915642|Sleep|sleep
5593913|NCT00915642|Vigil|vigil
5593914|NCT00915642|Metabolism|metabolism
5593915|NCT00915642|Actigraphy|actigraphy
5593916|NCT00915642|Normal|normal
5593917|NCT00915603|Metastatic Breast Cancer|metastatic breast cancer
5593918|NCT00915603|Paclitaxel|paclitaxel
5593919|NCT00915603|Bevacizumab|bevacizumab
5593920|NCT00915603|Everolimus|everolimus
5593921|NCT00915577|Multiple Sclerosis|multiple sclerosis
5593922|NCT00915577|interferon beta-1a|interferon beta-1a
5593923|NCT00915577|Avonex|avonex
5593924|NCT00915577|liquid Avonex|liquid avonex
5593925|NCT00915564|Hepatitis C|hepatitis c
5593926|NCT00915564|HCV|hcv
5593927|NCT00915564|Hepatitis C Virus|hepatitis c virus
5593928|NCT00915564|HCV negative|hcv negative
5593929|NCT00915564|Protease inhibitor|protease inhibitor
5593930|NCT00915564|Methadone|methadone
5593931|NCT00915564|TMC435|tmc435
5593932|NCT00915551|Peplin|peplin
5593933|NCT00915551|Actinic keratosis|actinic keratosis
5593934|NCT00915551|PEP005|pep005
5593935|NCT00915538|Asthma|asthma
5593936|NCT00915538|Formoterol|formoterol
5593937|NCT00915538|LABA|laba
5593938|NCT00915538|Symbicort|symbicort
5593939|NCT00915538|Aerochamber|aerochamber
5593940|NCT00915512|Schizophrenia|schizophrenia
5593941|NCT00915512|Paliperidone|paliperidone
5593942|NCT00915512|Invega|invega
5593943|NCT00915486|Diabetic|diabetic
5593944|NCT00915486|ulcer|ulcer
5593945|NCT00915486|topical|topical
5593946|NCT00915486|PDGF|pdgf
5593947|NCT00915486|GSoC|gsoc
5593948|NCT00915460|Multiple Sclerosis|multiple sclerosis
5593949|NCT00915460|Avonex|avonex
5593950|NCT00915460|Interferon beta-1a|interferon beta-1a
5593951|NCT00915460|patients at high risk to develop multiple sclerosis|patients at high risk to develop multiple sclerosis
5593952|NCT00915447|Cat Allergic Rhinitis|cat allergic rhinitis
5593953|NCT00915434|Healthy volunteer|healthy volunteer
5593954|NCT00915434|Phase I|phase i
5593955|NCT00915434|Non-childbearing potential|non-childbearing potential
5593956|NCT00915434|JNJ-31001074|jnj-31001074
5593957|NCT00915434|Food|food
5593958|NCT00915434|Pharmacokinetics|pharmacokinetics
5593959|NCT00915421|cardiac arrest|cardiac arrest
5593960|NCT00915421|therapeutic hypothermia|therapeutic hypothermia
5593961|NCT00915421|Postresuscitative disease|postresuscitative disease
5593962|NCT00915408|Multiple Myeloma|multiple myeloma
5593963|NCT00915408|Cyclophosphamide|cyclophosphamide
5593964|NCT00915408|Dexamethasone|dexamethasone
5593965|NCT00915408|Lenalidomide|lenalidomide
5593967|NCT00915356|intravenous cardioversion of Atrial Fibrillation|intravenous cardioversion of atrial fibrillation
5593968|NCT00915343|Adrenal insufficiency|adrenal insufficiency
5593969|NCT00915343|Primary adrenal insufficiency|primary adrenal insufficiency
5593970|NCT00915343|Addison's disease|addison's disease
5593971|NCT00915343|Hydrocortisone|hydrocortisone
5593972|NCT00915343|Modified release|modified release
5593973|NCT00915330|Transbronchial needle aspiration|transbronchial needle aspiration
5593974|NCT00915330|Bronchoscopy|bronchoscopy
5593975|NCT00915330|Rapid on-site cytopathologic evaluation|rapid on-site cytopathologic evaluation
5593976|NCT00915330|Mediastinal lymphadenopathy|mediastinal lymphadenopathy
5593977|NCT00915330|Hilar Lymphadenopathy|hilar lymphadenopathy
5593978|NCT00915304|Clinical Decision Support System|clinical decision support system
5593979|NCT00915304|Automatic reminder|automatic reminder
5593980|NCT00915304|Primary care|primary care
5593981|NCT00915304|Evidence-Based Medicine|evidence-based medicine
5593982|NCT00915291|medical education|medical education
5593983|NCT00915291|clinical decisionmaking|clinical decisionmaking
5593984|NCT00915291|pharmaceutical marketing|pharmaceutical marketing
5593985|NCT00915278|Neoplasms|neoplasms
5593986|NCT00915278|monoclonal antibody|monoclonal antibody
5593987|NCT00915278|PF-04605412|pf-04605412
5593988|NCT00915278|advanced metastatic solid tumors|advanced metastatic solid tumors
5593989|NCT00915265|Epidural analgesia|epidural analgesia
5593990|NCT00915265|Continuous preperitoneal analgesia|continuous preperitoneal analgesia
5593991|NCT00915265|Surgery|surgery
5593992|NCT00915265|Open colorectal surgery|open colorectal surgery
5593993|NCT00915265|Fast-track surgery|fast-track surgery
5593994|NCT00915265|ERAS|eras
5593995|NCT00915252|Acute Myeloid Leukemia|acute myeloid leukemia
5593997|NCT00915252|elderly|elderly
5593998|NCT00915252|demethylating agent|demethylating agent
5593999|NCT00915252|flt3|flt3
5594000|NCT00915252|AML|aml
5594001|NCT00915239|volunteers|volunteers
5594002|NCT00915226|Optic disk|optic disk
5594003|NCT00915226|Regional blood flow|regional blood flow
5594004|NCT00915226|Autoregulation|autoregulation
5594005|NCT00915213|E. Coli|e. coli
5594006|NCT00915213|Prostate Biopsy|prostate biopsy
5594007|NCT00915200|Diabetic Nephropathies|diabetic nephropathies
5594008|NCT00915200|Proteinuria|proteinuria
5594009|NCT00915200|Renal Insufficiency, Chronic|renal insufficiency, chronic
5594010|NCT00915200|Monocytes|monocytes
5594011|NCT00915200|Oxidative stress|oxidative stress
5594012|NCT00915200|Inflammation|inflammation
5594013|NCT00915200|Antioxidants|antioxidants
5594014|NCT00915200|Glutathione|glutathione
5594015|NCT00915200|Silymarin|silymarin
5594016|NCT00915200|Acetylcysteine|acetylcysteine
5594017|NCT00915200|Dietary Supplements|dietary supplements
5594018|NCT00915200|Complementary Therapies|complementary therapies
5594019|NCT00915187|Vaccination, influenza prevention|vaccination, influenza prevention
5594020|NCT00915174|drug-drug interaction study|drug-drug interaction study
5594021|NCT00915161|ventilation|ventilation
5594022|NCT00915161|oxygenation|oxygenation
5594023|NCT00915148|Prolonged labor|prolonged labor
5594024|NCT00915148|Ultrasound|ultrasound
5594025|NCT00915148|Caeserian section|caeserian section
5594026|NCT00915135|Insomnia|insomnia
5594027|NCT00915135|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5594028|NCT00915135|Drug Therapy|drug therapy
5594029|NCT00915122|IMRT treatment for Prostate cancer patients|imrt treatment for prostate cancer patients
5594030|NCT00915122|Radiation treatment for prostate cancer|radiation treatment for prostate cancer
5594031|NCT00915122|cancer of the prostate|cancer of the prostate
5594032|NCT00915122|Patients with high risk adenocarcinoma of the prostate|patients with high risk adenocarcinoma of the prostate
5594033|NCT00915109|amputees|amputees
5594034|NCT00915109|lower limb|lower limb
5594036|NCT00915096|PET|pet
5594037|NCT00915096|GELA|gela
5594038|NCT00915070|BQ-123|bq-123
5594039|NCT00915070|Optic Nerve Head Blood Flow|optic nerve head blood flow
5594040|NCT00915070|Intraocular Pressure|intraocular pressure
5594041|NCT00915070|Regional Blood Flow|regional blood flow
5594042|NCT00915070|Ocular Physiology|ocular physiology
5594043|NCT00915070|Optic Disk|optic disk
5594044|NCT00915044|IBD|ibd
5672286|NCT00612469|vancomycin|vancomycin
5594045|NCT00915031|Robotic prostatectomy|robotic prostatectomy
5594046|NCT00915031|Hypothermia|hypothermia
5594048|NCT00915018|ErbB-2 positive advanced breast cancer|erbb-2 positive advanced breast cancer
5594049|NCT00915018|HKI-272|hki-272
5594050|NCT00915018|Neratinib|neratinib
5594051|NCT00915018|Nerlynx|nerlynx
5594052|NCT00915018|HER2|her2
5594053|NCT00915018|PB-272|pb-272
5594054|NCT00915018|metastatic breast cancer|metastatic breast cancer
5594055|NCT00915005|Locally-advanced non-small-cell lung carcinoma|locally-advanced non-small-cell lung carcinoma
5594056|NCT00915005|NSCLC|nsclc
5594057|NCT00915005|Lung Cancer|lung cancer
5594058|NCT00915005|Image-Guided Adaptive Conformal Photon|image-guided adaptive conformal photon
5594059|NCT00915005|Proton Therapy|proton therapy
5594060|NCT00915005|Chemotherapy|chemotherapy
5594061|NCT00915005|Treatment Related Pneumonitis|treatment related pneumonitis
5594062|NCT00914992|optic disk|optic disk
5594153|NCT00914654|Formoterol|formoterol
5594063|NCT00914992|regional blood flow|regional blood flow
5594064|NCT00914992|autoregulation|autoregulation
5594065|NCT00914979|Angiosculpt|angiosculpt
5594066|NCT00914979|Bifurcation Lesion|bifurcation lesion
5594067|NCT00914979|Side branch|side branch
5594068|NCT00914979|IVUS|ivus
5594069|NCT00914953|social isolation|social isolation
5594070|NCT00914953|cooperative behavior|cooperative behavior
5594071|NCT00914953|depression|depression
5594072|NCT00914953|loneliness|loneliness
5594073|NCT00914953|happiness|happiness
5594074|NCT00914953|empathy|empathy
5594075|NCT00914940|graft versus host disease|graft versus host disease
5594076|NCT00914940|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5594077|NCT00914940|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5594078|NCT00914940|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5594079|NCT00914940|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5594080|NCT00914940|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5594081|NCT00914940|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5594082|NCT00914940|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5594083|NCT00914940|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5594084|NCT00914940|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5594085|NCT00914940|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5596729|NCT00904293|genotype-guided therapy|genotype-guided therapy
5594086|NCT00914940|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5594087|NCT00914940|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5594088|NCT00914940|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5594089|NCT00914940|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5594090|NCT00914940|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5594091|NCT00914940|refractory anemia with excess blasts|refractory anemia with excess blasts
5594092|NCT00914940|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5594093|NCT00914940|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5594094|NCT00914927|Thrombocytopenia|thrombocytopenia
5594095|NCT00914927|chronic liver disease|chronic liver disease
5594096|NCT00914901|Asthma|asthma
5594097|NCT00914901|Doping|doping
5594098|NCT00914901|Salmeterol|salmeterol
5594099|NCT00914901|Beta-agonist|beta-agonist
5594100|NCT00914901|Urine concentrations|urine concentrations
5594101|NCT00914888|children|children
5594102|NCT00914888|pediatry|pediatry
5594103|NCT00914888|pneumonia|pneumonia
5594104|NCT00914888|intra-abdominal|intra-abdominal
5594105|NCT00914888|infection|infection
5594106|NCT00914875|kidney function tests|kidney function tests
5594107|NCT00914875|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
5594108|NCT00914875|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5594109|NCT00914875|adult|adult
5594110|NCT00914862|Sleep Initiation and Maintenance Disorders|sleep initiation and maintenance disorders
5594111|NCT00914862|Drug Therapy|drug therapy
5594112|NCT00914836|shoulder|shoulder
5594113|NCT00914836|subacromion|subacromion
5594114|NCT00914836|corticosteroid|corticosteroid
5594115|NCT00914836|bursitis|bursitis
5594116|NCT00914836|tendinitis|tendinitis
5594117|NCT00914836|calcific tendonitis|calcific tendonitis
5594118|NCT00914836|subacromial bursitis|subacromial bursitis
5594119|NCT00914836|rotator cuff tendinitis|rotator cuff tendinitis
5680353|NCT00578123|Quality of Life|quality of life
5594120|NCT00914810|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5594121|NCT00914810|Vitamin D|vitamin d
5594122|NCT00914810|Cholecalciferol|cholecalciferol
5594123|NCT00914810|Skeletal muscle|skeletal muscle
5594124|NCT00914797|Asthma|asthma
5594125|NCT00914797|Doping|doping
5594126|NCT00914797|Beta agonist|beta agonist
5594127|NCT00914797|Terbutaline|terbutaline
5594128|NCT00914797|Pharmacokinetics|pharmacokinetics
5594129|NCT00914784|TRALI|trali
5594130|NCT00914784|Transfusion|transfusion
5594131|NCT00914784|dyspnea|dyspnea
5594132|NCT00914784|pulmonary infiltrates|pulmonary infiltrates
5594133|NCT00914771|Pandemic Influenza|pandemic influenza
5594134|NCT00914771|H5N1|h5n1
5594135|NCT00914771|Adults and Elderly|adults and elderly
5594136|NCT00914771|antigen dose|antigen dose
5594137|NCT00914758|multiple sclerosis|multiple sclerosis
5594138|NCT00914758|cognition|cognition
5594139|NCT00914758|cognitive functioning|cognitive functioning
5594140|NCT00914758|Campath|campath
5594141|NCT00914758|Rebif|rebif
5594142|NCT00914758|alemtuzumab|alemtuzumab
5594143|NCT00914758|interferon|interferon
5594144|NCT00914732|IMVAMUNE®, smallpox, vaccine|imvamune®, smallpox, vaccine
5594145|NCT00914719|sexual risk behavior among adolescents|sexual risk behavior among adolescents
5594146|NCT00914719|alcohol and drug use among adolescents|alcohol and drug use among adolescents
5594147|NCT00914706|Diabetes|diabetes
5594148|NCT00914693|Fertility control|fertility control
5594149|NCT00914693|Contraception|contraception
5594150|NCT00914667|Overactive Bladder Urgency Frequency|overactive bladder urgency frequency
5594151|NCT00914654|Asthma|asthma
5594152|NCT00914654|Doping|doping
5594157|NCT00914628|high risk acute leukemia|high risk acute leukemia
5594158|NCT00914628|HSV-TK|hsv-tk
5594159|NCT00914628|Haploidentical HCT|haploidentical hct
5594160|NCT00914628|GvHD|gvhd
5594162|NCT00914628|Immunoreconstitution|immunoreconstitution
5594163|NCT00914615|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5594164|NCT00914615|Liver Metastasis from colorectal cancer|liver metastasis from colorectal cancer
5594165|NCT00914615|Patients with Liver Metastasis|patients with liver metastasis
5594166|NCT00914576|Endotoxin, Escherichia Coli|endotoxin, escherichia coli
5594167|NCT00914576|Retina|retina
5594168|NCT00914576|Regional Blood Flow|regional blood flow
5594169|NCT00914563|Burned shock|burned shock
5594170|NCT00914563|Volume resuscitative patterns|volume resuscitative patterns
5594171|NCT00914563|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
5594172|NCT00914550|Pneumonia|pneumonia
5594173|NCT00914550|Lung Infiltrates|lung infiltrates
5594174|NCT00914550|Antibiotic discontinuation|antibiotic discontinuation
5594175|NCT00914550|De-escalation therapy|de-escalation therapy
5594182|NCT00914524|Chronic Glomerulonephritis|chronic glomerulonephritis
5594183|NCT00914524|Diabetic Nephropathy|diabetic nephropathy
5594184|NCT00914524|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5594185|NCT00914524|Urinary Protein|urinary protein
5594187|NCT00914511|Sperm|sperm
5594188|NCT00914511|Avanafil|avanafil
5594189|NCT00914511|Pharmacokinetics|pharmacokinetics
5594190|NCT00914511|Elderly|elderly
5594191|NCT00914498|Xylocaine|xylocaine
5594192|NCT00914498|Casarean section|casarean section
5594193|NCT00914498|Post operative pain|post operative pain
5594194|NCT00914498|Scar quality|scar quality
5594195|NCT00914472|Preventing the thrombi formation|preventing the thrombi formation
5594196|NCT00914459|hemophilia A|hemophilia a
5594197|NCT00914446|Steatohepatitis|steatohepatitis
5594198|NCT00914433|COPD|copd
5594200|NCT00914420|Reendothelialisation|reendothelialisation
5594201|NCT00914420|Intrepide|intrepide
5594202|NCT00914420|Trapidil|trapidil
5594203|NCT00914420|Taxus|taxus
5594204|NCT00914407|Ocular physiology|ocular physiology
5594205|NCT00914394|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5594206|NCT00914394|Optic Nerve Head Blood Flow|optic nerve head blood flow
5594207|NCT00914394|Intraocular Pressure|intraocular pressure
5594208|NCT00914394|Regional Blood Flow|regional blood flow
5594209|NCT00914394|Ocular Physiology|ocular physiology
5594210|NCT00914394|Optic Disk|optic disk
5594211|NCT00914381|Community reinforcement approach|community reinforcement approach
5594212|NCT00914381|Contingency management|contingency management
5594213|NCT00914381|12-step facilitation counseling|12-step facilitation counseling
5594214|NCT00914381|Cocaine dependence|cocaine dependence
5594215|NCT00914381|Women|women
5594216|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5594217|NCT00914368|Aspirin|aspirin
5594218|NCT00914368|Clopidogrel|clopidogrel
5594219|NCT00914368|Pathologic Processes|pathologic processes
5594220|NCT00914368|Disease|disease
5594221|NCT00914368|Therapeutic Uses|therapeutic uses
5594222|NCT00914368|Syndrome|syndrome
5594223|NCT00914368|Hematologic Agents|hematologic agents
5594224|NCT00914368|Cardiovascular Diseases|cardiovascular diseases
5594225|NCT00914368|Pharmacologic Actions|pharmacologic actions
5594226|NCT00914355|Hepatocellular Carcinoma|hepatocellular carcinoma
5594227|NCT00914355|Stereotactic Body Radiation|stereotactic body radiation
5594228|NCT00914355|Unresectable liver cancer|unresectable liver cancer
5594229|NCT00914355|Patients with Hepatocellular Carcinoma|patients with hepatocellular carcinoma
5594230|NCT00914342|Gerd|gerd
5594231|NCT00914342|GerdQ questionnaire|gerdq questionnaire
5594232|NCT00914342|work productivity|work productivity
5594233|NCT00914342|Greece|greece
5594234|NCT00914329|stress provoked|stress provoked
5594235|NCT00914329|healthy volunteers|healthy volunteers
5594236|NCT00914329|gelsemium|gelsemium
5594237|NCT00914329|homeopathy|homeopathy
5594238|NCT00914316|Lower leg claudication|lower leg claudication
5594239|NCT00914316|Poor circulation of the leg muscles|poor circulation of the leg muscles
5594240|NCT00914316|Cramping or discomfort in the lower legs|cramping or discomfort in the lower legs
5594241|NCT00914316|Lower leg pain|lower leg pain
5594242|NCT00914316|PAD (Peripheral arterial disease)|pad (peripheral arterial disease)
5594244|NCT00914303|tolerability|tolerability
5594245|NCT00914303|healthy|healthy
5594246|NCT00914303|Healthy volunteer study|healthy volunteer study
5594247|NCT00914277|Rho-kinase inhibitor|rho-kinase inhibitor
5594248|NCT00914277|male impotence|male impotence
5594249|NCT00914264|chronic obstructive airway disease|chronic obstructive airway disease
5594443|NCT00913315|tolterodine|tolterodine
5594250|NCT00914264|obstructive sleep apnea|obstructive sleep apnea
5594251|NCT00914264|continuous positive airway pressure|continuous positive airway pressure
5594252|NCT00914251|endothelial|endothelial
5594253|NCT00914251|metabolic syndrome|metabolic syndrome
5594254|NCT00914251|hesperidin|hesperidin
5594255|NCT00914238|Randomized clinical trial|randomized clinical trial
5594256|NCT00914238|first episode psychosis of schizophrenia and schizotypal disorder|first episode psychosis of schizophrenia and schizotypal disorder
5594257|NCT00914238|rehabilitation|rehabilitation
5594258|NCT00914238|psychosocial|psychosocial
5594259|NCT00914238|health service research|health service research
5594260|NCT00914238|schizotypal Disorder|schizotypal disorder
5594261|NCT00914225|Human immunodeficiency virus|human immunodeficiency virus
5594262|NCT00914225|malaria|malaria
5594263|NCT00914225|plasmodium falciparum|plasmodium falciparum
5594264|NCT00914225|diarrhea|diarrhea
5594265|NCT00914225|helminth|helminth
5594267|NCT00914225|Treatment naive|treatment naive
5594268|NCT00914199|PCI|pci
5594269|NCT00914199|Bifurcation lesion|bifurcation lesion
5594270|NCT00914186|Atopic Dermatitis|atopic dermatitis
5594271|NCT00914186|Pruritus|pruritus
5594272|NCT00914160|Anti-inflammatory|anti-inflammatory
5588334|NCT00937404|IPV|ipv
5594273|NCT00914147|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5594274|NCT00914134|Parkinson's disease|parkinson's disease
5594275|NCT00914134|Autonomic nervous system|autonomic nervous system
5594276|NCT00914134|Levodopa infusion|levodopa infusion
5594277|NCT00914108|Preterm Infants|preterm infants
5594278|NCT00914108|Developmental Care|developmental care
5594279|NCT00914108|NIDCAP|nidcap
5594280|NCT00914108|Intrauterine Growth Restriction|intrauterine growth restriction
5594281|NCT00914108|APIB|apib
5594282|NCT00914108|EEG|eeg
5594283|NCT00914108|Neurobehavior|neurobehavior
5594284|NCT00914095|Parkinson's disease|parkinson's disease
5594285|NCT00914095|Freezing of Gait|freezing of gait
5594286|NCT00914095|Methylphenidate|methylphenidate
5594287|NCT00914095|Dopamine transporter inhibitor|dopamine transporter inhibitor
5594289|NCT00914082|Self hypnosis|self hypnosis
5594290|NCT00914082|Hypnosis|hypnosis
5594291|NCT00914082|mental training|mental training
5594292|NCT00914082|antenatal training|antenatal training
5594293|NCT00914082|pregnancy|pregnancy
5594294|NCT00914082|pain control|pain control
5594295|NCT00914082|Childbirth|childbirth
5594296|NCT00914082|Analgesia|analgesia
5594297|NCT00914043|fatigue|fatigue
5594298|NCT00914043|HER2-negative breast cancer|her2-negative breast cancer
5594299|NCT00914043|stage II breast cancer|stage ii breast cancer
5594300|NCT00914043|stage IIIA breast cancer|stage iiia breast cancer
5594301|NCT00914043|stage IIIB breast cancer|stage iiib breast cancer
5594302|NCT00914030|Visual perception|visual perception
5594303|NCT00914030|Local/global processing|local/global processing
5594304|NCT00914030|Attention|attention
5594305|NCT00914030|Visual priming|visual priming
5594306|NCT00914030|Collinearity|collinearity
5594307|NCT00914030|Grouping|grouping
5594308|NCT00914017|Breast Cancer|breast cancer
5594309|NCT00914017|Breast Cancer Prevention|breast cancer prevention
5594310|NCT00914017|Mammographic Density|mammographic density
5594311|NCT00914017|Breast Density|breast density
5594312|NCT00914017|Breast Cancer Biomarkers|breast cancer biomarkers
5594313|NCT00914004|Antidepressant|antidepressant
5594314|NCT00913991|Nitric Oxide|nitric oxide
5594315|NCT00913978|Normothermia|normothermia
5594316|NCT00913978|Colorectal Surgery|colorectal surgery
5594317|NCT00913978|Bair Huggers|bair huggers
5594318|NCT00913978|VitaHeat|vitaheat
5594319|NCT00913952|Antidepressant|antidepressant
5594320|NCT00913939|Prostate Cancer|prostate cancer
5594321|NCT00913939|HDR Brachytherapy|hdr brachytherapy
5594322|NCT00913939|Prostate Brachytherapy|prostate brachytherapy
5594323|NCT00913926|Climacteric symptoms|climacteric symptoms
5594324|NCT00913913|Renal Cell Carcinoma|renal cell carcinoma
5594325|NCT00913900|Arterial Occlusive Diseases|arterial occlusive diseases
5594326|NCT00913900|Vascular Disease|vascular disease
5594327|NCT00913887|Anti-Inflammatory|anti-inflammatory
5594328|NCT00913861|endoscopy|endoscopy
5594329|NCT00913861|comfort|comfort
5594330|NCT00913861|non-pharmacological|non-pharmacological
5594331|NCT00913848|Treatment of Epilepsy and Bipolar Disorder|treatment of epilepsy and bipolar disorder
5594332|NCT00913835|Liposomal Doxorubicin|liposomal doxorubicin
5594333|NCT00913835|IMC-3G3|imc-3g3
5594334|NCT00913835|3G3|3g3
5594335|NCT00913835|Platinum resistant|platinum resistant
5594336|NCT00913835|Platinum refractory|platinum refractory
5594337|NCT00913835|Ovary|ovary
5594338|NCT00913835|Neoplasm|neoplasm
5594339|NCT00913835|PDGFr|pdgfr
5594340|NCT00913822|Antidepressant|antidepressant
5594341|NCT00913809|Antidepressant|antidepressant
5594342|NCT00913796|Renal transplantation|renal transplantation
5594343|NCT00913796|Metabolic acidosis|metabolic acidosis
5594344|NCT00913796|Physical capacity|physical capacity
5594345|NCT00913796|Bone histology|bone histology
5594346|NCT00913796|Bone histomorphometry|bone histomorphometry
5594347|NCT00913796|Parathyroid function|parathyroid function
5594444|NCT00913302|Ankylosing Spondylitis|ankylosing spondylitis
5594359|NCT00913731|Psychotic symptom assessments|psychotic symptom assessments
5594360|NCT00913731|Observational assessments of patients with acute psychotic symptoms|observational assessments of patients with acute psychotic symptoms
5594361|NCT00913705|NATCH|natch
5594362|NCT00913705|LUNG|lung
5594363|NCT00913705|OPERABLE NSCLC|operable nsclc
5594364|NCT00913705|SURGERY PLUS ADJUVANT THERAPY|surgery plus adjuvant therapy
5594365|NCT00913705|SURGERY PLUS NEOADJUVANT THERAPY|surgery plus neoadjuvant therapy
5594366|NCT00913692|Glutamine|glutamine
5594367|NCT00913692|Herpes Labialis|herpes labialis
5594368|NCT00913692|Herpes Simplex Virus|herpes simplex virus
5594369|NCT00913692|Cold Sore|cold sore
5594370|NCT00913679|osteonecrosis|osteonecrosis
5594371|NCT00913679|femoral neck fracture|femoral neck fracture
5594372|NCT00913679|implant fixation|implant fixation
5594373|NCT00913679|implant failure|implant failure
5594374|NCT00913679|periprosthetic bone mineral density|periprosthetic bone mineral density
5594375|NCT00913679|gait function|gait function
5594376|NCT00913679|gait analysis|gait analysis
5594377|NCT00913679|patient recovery|patient recovery
5594378|NCT00913666|Multiple Sclerosis|multiple sclerosis
5594379|NCT00913653|Heart failure|heart failure
5594380|NCT00913653|LCZ696|lcz696
5594381|NCT00913640|Prospective Memory Performance|prospective memory performance
5594382|NCT00913640|Prospective Memory Outcome|prospective memory outcome
5594383|NCT00913640|Parkinson's Disease|parkinson's disease
5594384|NCT00913627|Extended-release|extended-release
5594385|NCT00913627|ibuprofen|ibuprofen
5594386|NCT00913614|insomnia pediatric safety|insomnia pediatric safety
5594387|NCT00913601|Idiopathic Fecal Incontinence|idiopathic fecal incontinence
5594388|NCT00913601|Fecal Incontinence|fecal incontinence
5594389|NCT00913601|Sacral Nerve Stimulation|sacral nerve stimulation
5594390|NCT00913601|Sacral Nerve Neuromodulation|sacral nerve neuromodulation
5594391|NCT00913575|neuromuscular training|neuromuscular training
5594392|NCT00913575|preoperative exercise|preoperative exercise
5594393|NCT00913575|physiotherapy|physiotherapy
5594394|NCT00913575|total knee replacement|total knee replacement
5594395|NCT00913575|knee osteoarthritis|knee osteoarthritis
5594396|NCT00913562|Ocular Physiology|ocular physiology
5594397|NCT00913562|Regional Blood Flow|regional blood flow
5594398|NCT00913549|Antihistamine|antihistamine
5594399|NCT00913536|Bladder Cancer|bladder cancer
5594400|NCT00913536|Cone Beam CT|cone beam ct
5594401|NCT00913536|On-line image guidance|on-line image guidance
5594402|NCT00913536|Radiation therapy in bladder cancer patients|radiation therapy in bladder cancer patients
5594403|NCT00913523|tampons|tampons
5594404|NCT00913523|Glycerol Monolaurate|glycerol monolaurate
5594405|NCT00913523|vaginal microflora|vaginal microflora
5594406|NCT00913523|microbes|microbes
5594407|NCT00913523|Vaginal Tampon|vaginal tampon
5594408|NCT00913497|Type 1 diabetes mellitus in children|type 1 diabetes mellitus in children
5594409|NCT00913497|insulin glulisine|insulin glulisine
5594410|NCT00913497|insulin aspart|insulin aspart
5594411|NCT00913497|post prandial|post prandial
5594412|NCT00913484|Disulfiram|disulfiram
5594413|NCT00913484|Buprenorphine|buprenorphine
5594414|NCT00913484|Cocaine dependence|cocaine dependence
5594415|NCT00913484|Opioid dependence|opioid dependence
5594416|NCT00913484|Dopamine-Beta-Hydroxylase|dopamine-beta-hydroxylase
5594417|NCT00913471|Spinal cord injury|spinal cord injury
5594418|NCT00913471|SCI|sci
5594419|NCT00913471|Neuropathic pain|neuropathic pain
5594420|NCT00913471|Pain|pain
5594421|NCT00913445|Appendicitis|appendicitis
5594422|NCT00913445|appendicectomy|appendicectomy
5594423|NCT00913445|stitches|stitches
5594424|NCT00913445|wound healing|wound healing
5594425|NCT00913445|cosmetic results|cosmetic results
5594426|NCT00913432|rheumatoid arthritis|rheumatoid arthritis
5594427|NCT00913432|methotrexate|methotrexate
5594428|NCT00913432|DMARD|dmard
5594429|NCT00913432|c-kit inhibitor|c-kit inhibitor
5594430|NCT00913419|Antidepressant|antidepressant
5594431|NCT00913406|Effect of lutein fortification growth healthy term infants|effect of lutein fortification growth healthy term infants
5594432|NCT00913367|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5594433|NCT00913354|infertility|infertility
5594435|NCT00913354|acupuncture|acupuncture
5594436|NCT00913328|Asthma|asthma
5594437|NCT00913328|Airway responsiveness|airway responsiveness
5594438|NCT00913328|Dose-response plateau|dose-response plateau
5594439|NCT00913328|Montelukast|montelukast
5594440|NCT00913328|Add-on to inhaled corticosteroids|add-on to inhaled corticosteroids
5594441|NCT00913315|prostatitis|prostatitis
5594442|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5594445|NCT00913302|Education|education
5594446|NCT00913302|Physical fitness|physical fitness
5594447|NCT00913289|Liver Cirrhosis|liver cirrhosis
5594448|NCT00913263|Prostate cancer|prostate cancer
5594449|NCT00913250|Multiple Sclerosis|multiple sclerosis
5594450|NCT00913250|Interferon beta-1a|interferon beta-1a
5594451|NCT00913237|Antidepressant|antidepressant
5594452|NCT00913224|Anti-inflammatory|anti-inflammatory
5594453|NCT00913198|Pancreas|pancreas
5594454|NCT00913198|Advanced adenocarcinoma|advanced adenocarcinoma
5594455|NCT00913198|CP-4126|cp-4126
5594456|NCT00913185|Acne|acne
5594457|NCT00913172|TB|tb
5594458|NCT00913172|cost|cost
5594459|NCT00913172|HEWs|hews
5594460|NCT00913172|Cost-effectiveness|cost-effectiveness
5594461|NCT00913172|treatment success rate|treatment success rate
5594462|NCT00913159|Renal stones|renal stones
5594463|NCT00913159|lithotripsy|lithotripsy
5594464|NCT00913159|stone free rate|stone free rate
5594465|NCT00913146|Management of fever|management of fever
5594466|NCT00913146|Malaria|malaria
5594467|NCT00913146|Malaria rapid diagnostic test|malaria rapid diagnostic test
5594468|NCT00913146|Clinical trial|clinical trial
5594469|NCT00913133|Anticoagulation|anticoagulation
5594470|NCT00913133|Prophylaxis|prophylaxis
5594471|NCT00913133|Desirudin|desirudin
5594472|NCT00913133|Direct thrombin inhibitor|direct thrombin inhibitor
5576881|NCT00980382|Stomach Neoplasms|stomach neoplasms
5594473|NCT00913133|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5594474|NCT00913120|YM150|ym150
5594475|NCT00913120|FXa inhibitor|fxa inhibitor
5594476|NCT00913120|Thrombosis|thrombosis
5594477|NCT00913120|Anticoagulant|anticoagulant
5594478|NCT00913120|Venous thromboembolism|venous thromboembolism
5594479|NCT00913120|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
5594480|NCT00913107|Trigeminal Neuralgia|trigeminal neuralgia
5594481|NCT00913107|Lamotrigine|lamotrigine
5594482|NCT00913107|Carbamazepine|carbamazepine
5594483|NCT00913107|Lamictal®|lamictal®
5594485|NCT00913094|Hypertension|hypertension
5594487|NCT00913081|pharmacology|pharmacology
5594488|NCT00913081|metabolism|metabolism
5594489|NCT00913081|lipid|lipid
5594490|NCT00913068|radical prostatectomy|radical prostatectomy
5594491|NCT00913055|S-LAR|s-lar
5594492|NCT00913055|Octreotide|octreotide
5594493|NCT00913055|Implant|implant
5594494|NCT00913042|Febrile neutropenia|febrile neutropenia
5594495|NCT00913042|Blood culture|blood culture
5594496|NCT00913042|Bacteremia|bacteremia
5594497|NCT00913042|Bacterial DNA testing|bacterial dna testing
5594498|NCT00913029|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
5594499|NCT00913029|OAG|oag
5594500|NCT00913029|glaucoma|glaucoma
5594501|NCT00913016|hormonal therapy(letrozole)|hormonal therapy(letrozole)
5594502|NCT00913016|postmenopausal breast cancer|postmenopausal breast cancer
5594503|NCT00913016|quality of life|quality of life
5594504|NCT00913003|Lidocaine|lidocaine
5594505|NCT00913003|Mastectomy|mastectomy
5594506|NCT00913003|Pain|pain
5594507|NCT00912990|Pediatric|pediatric
5594508|NCT00912977|Parkinsons disease|parkinsons disease
5594509|NCT00912977|dyskinesia|dyskinesia
5594510|NCT00912977|measurement|measurement
5594511|NCT00912964|Urgency|urgency
5594512|NCT00912964|YM178|ym178
5594513|NCT00912964|Urinary incontinence|urinary incontinence
5594514|NCT00912964|Mirabegron|mirabegron
5594515|NCT00912964|Micturition|micturition
5594516|NCT00912964|Frequency|frequency
5594517|NCT00912964|Urinary urgency incontinence|urinary urgency incontinence
5594518|NCT00912964|Overactive Bladder|overactive bladder
5594519|NCT00912938|metastatic breast cancer|metastatic breast cancer
5594520|NCT00912938|bone remodeling markers|bone remodeling markers
5594521|NCT00912938|zoledronic acid|zoledronic acid
5594522|NCT00912912|Genitourinary|genitourinary
5594523|NCT00912912|Testis|testis
5594524|NCT00912912|Refractory Germ Cell Tumors|refractory germ cell tumors
5594525|NCT00912912|Advanced germ cell tumors|advanced germ cell tumors
5594526|NCT00912912|GCTs|gcts
5594527|NCT00912912|Sunitinib Malate|sunitinib malate
5594528|NCT00912912|Sutent|sutent
5594529|NCT00912912|SU011248|su011248
5594530|NCT00912899|Refractory Multiple Myeloma|refractory multiple myeloma
5594531|NCT00912899|CB3304|cb3304
5594532|NCT00912899|Noscapine HCl|noscapine hcl
5594533|NCT00912899|Multiple Myeloma|multiple myeloma
5594534|NCT00912886|alzheimer|alzheimer
5594535|NCT00912886|memory|memory
5594536|NCT00912886|neurosteroids|neurosteroids
5594537|NCT00912873|pain|pain
5594538|NCT00912873|catheter|catheter
5594539|NCT00912873|nerve block|nerve block
5594540|NCT00912873|UCSD|ucsd
5594541|NCT00912873|range of motion|range of motion
5594542|NCT00912873|hip surgery|hip surgery
5594543|NCT00912873|psoas compartment|psoas compartment
5594544|NCT00912860|multiple sclerosis|multiple sclerosis
5594545|NCT00912860|interferon beta-1a|interferon beta-1a
5594547|NCT00912847|HBV carriers|hbv carriers
5594548|NCT00912834|hematuria|hematuria
5594549|NCT00912834|urinary tract infection|urinary tract infection
5594550|NCT00912821|Renal Replacement Therapy|renal replacement therapy
5594648|NCT00912457|donepezil|donepezil
5594551|NCT00912821|Peritoneal dialysis|peritoneal dialysis
5594552|NCT00912808|parkinsons disease|parkinsons disease
5594554|NCT00912795|Smoking Cessation|smoking cessation
5594555|NCT00912795|technology|technology
5594556|NCT00912795|developing countries|developing countries
5594557|NCT00912782|ESRD|esrd
5594558|NCT00912782|Vitamin D|vitamin d
5594559|NCT00912782|Arteriovenous Fistulae|arteriovenous fistulae
5594560|NCT00912782|Dialysis Vascular Access|dialysis vascular access
5594561|NCT00912769|Total knee replacement|total knee replacement
5594562|NCT00912769|Subvastus|subvastus
5594563|NCT00912769|Midvastus|midvastus
5594564|NCT00912769|Isokinetic|isokinetic
5594565|NCT00912769|Quadriceps|quadriceps
5594566|NCT00912756|endovascular therapy|endovascular therapy
5594567|NCT00912756|restenosis|restenosis
5594568|NCT00912756|cilostazol|cilostazol
5594569|NCT00912756|femoropopliteal artery lesions|femoropopliteal artery lesions
5594570|NCT00912756|Chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area|chronic arteriosclerosis obliterans afflicting the femoropopliteal artery area
5594571|NCT00912743|Colorectal cancer|colorectal cancer
5594572|NCT00912743|Olaparib|olaparib
5594573|NCT00912743|MSI status|msi status
5594574|NCT00912743|Stage IV|stage iv
5594575|NCT00912743|Measurable Colorectal Cancer|measurable colorectal cancer
5594576|NCT00912743|Stratified by MSI Status|stratified by msi status
5594577|NCT00912730|melanoma|melanoma
5594578|NCT00912730|imaging|imaging
5594579|NCT00912730|sentinel node|sentinel node
5594580|NCT00912730|biopsy|biopsy
5594581|NCT00912704|Hemodialysis patients|hemodialysis patients
5594582|NCT00912704|Kidney|kidney
5594583|NCT00912704|Physician attitudes|physician attitudes
5594584|NCT00912704|Family wishes|family wishes
5594585|NCT00912704|30 numbers require maximum|30 numbers require maximum
5594586|NCT00912691|Autism|autism
5594587|NCT00912678|Kidney transplantation|kidney transplantation
5594588|NCT00912678|Old for old kidney transplantation|old for old kidney transplantation
5594589|NCT00912678|European senior program|european senior program
5594590|NCT00912678|Calcineurin inhibitor free immunosuppression|calcineurin inhibitor free immunosuppression
5594591|NCT00912665|Optic Nerve Head Blood Flow|optic nerve head blood flow
5594592|NCT00912665|Intraocular Pressure|intraocular pressure
5594593|NCT00912665|Regional Blood Flow|regional blood flow
5594594|NCT00912665|Ocular Physiology|ocular physiology
5594595|NCT00912665|Optic Disk|optic disk
5594596|NCT00912652|obesity|obesity
5594597|NCT00912652|rural health|rural health
5594598|NCT00912652|exercise|exercise
5594599|NCT00912639|recurrent breast cancer|recurrent breast cancer
5594600|NCT00912639|Genexol-PM|genexol-pm
5594601|NCT00912626|siblings|siblings
5594602|NCT00912626|family|family
5594603|NCT00912626|child behavior|child behavior
5594604|NCT00912626|critical illness|critical illness
5594605|NCT00912626|social support|social support
5594606|NCT00912613|Critical illness|critical illness
5594607|NCT00912613|ICU Diaries|icu diaries
5594608|NCT00912613|Post Traumatic Stress Disorder|post traumatic stress disorder
5594609|NCT00912613|Incidence|incidence
5594610|NCT00912600|Intensive Care Units|intensive care units
5594611|NCT00912600|Triage|triage
5594612|NCT00912600|Aged, 80 and over|aged, 80 and over
5594613|NCT00912600|Death|death
5594614|NCT00912600|Activities of Daily Living|activities of daily living
5594615|NCT00912600|Health Services Research|health services research
5594616|NCT00912600|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5594617|NCT00912574|Melanoma|melanoma
5594618|NCT00912574|adjuvant|adjuvant
5594619|NCT00912574|dendritic cells|dendritic cells
5594620|NCT00912574|vaccine|vaccine
5594621|NCT00912561|chronic brain ischaemia|chronic brain ischaemia
5594622|NCT00912561|stroke prevention|stroke prevention
5594623|NCT00912561|exercise|exercise
5594624|NCT00912561|physical training|physical training
5594625|NCT00912561|Chronic, extra- or intracranial stenoses of brain supplying arteries|chronic, extra- or intracranial stenoses of brain supplying arteries
5594626|NCT00912548|premenopause|premenopause
5594627|NCT00912548|ovarian function suppression|ovarian function suppression
5594628|NCT00912548|tamoxifen|tamoxifen
5594629|NCT00912535|Primary Anxiety Disorders|primary anxiety disorders
5685433|NCT00556075|Endometriosis|endometriosis
5594630|NCT00912535|Mood Disorders with Comorbid Anxiety Symptoms|mood disorders with comorbid anxiety symptoms
5594631|NCT00912522|reward|reward
5594633|NCT00912522|cognition|cognition
5594635|NCT00912522|Perception|perception
5594636|NCT00912522|Decision making|decision making
5594637|NCT00912509|infectious keratitis|infectious keratitis
5594638|NCT00912509|cross linking|cross linking
5594639|NCT00912509|corneal ulcer|corneal ulcer
5594640|NCT00912509|corneal infection|corneal infection
5594641|NCT00912509|collagen cross linking|collagen cross linking
5594642|NCT00912496|Influenza, H5N1, vaccine, avian influenza|influenza, h5n1, vaccine, avian influenza
5594644|NCT00912470|genetic vascular risc factors|genetic vascular risc factors
5594645|NCT00912470|ocular blood flow|ocular blood flow
5594646|NCT00912470|progressive glaucoma|progressive glaucoma
5594647|NCT00912457|sleep apnea|sleep apnea
5594649|NCT00912457|pharmacological|pharmacological
5594650|NCT00912457|cholinergic|cholinergic
5594651|NCT00912444|Breast Neoplasms|breast neoplasms
5594652|NCT00912444|Neoadjuvant|neoadjuvant
5594653|NCT00912444|Chemotherapy|chemotherapy
5594654|NCT00912444|Docetaxel|docetaxel
5594655|NCT00912444|Cyclophosphamide|cyclophosphamide
5594656|NCT00912444|Anthracycline|anthracycline
5594657|NCT00912431|Healthy Volunteers|healthy volunteers
5594658|NCT00912418|melanoma|melanoma
5594659|NCT00912418|vaccine|vaccine
5594660|NCT00912418|IL2 low dose|il2 low dose
5594661|NCT00912405|Patients diagnosed with Chronic Sinusitis undergoing functional endoscopic surgery (FESS)|patients diagnosed with chronic sinusitis undergoing functional endoscopic surgery (fess)
5594662|NCT00912366|VATS|vats
5594663|NCT00912366|Lung cancer|lung cancer
5594664|NCT00912366|NSCLC|nsclc
5594665|NCT00912353|Phase I|phase i
5594666|NCT00912353|Japanese healthy volunteer|japanese healthy volunteer
5594667|NCT00912353|AZD7268|azd7268
5594668|NCT00912340|Breast Cancer|breast cancer
5594669|NCT00912327|Colorectal|colorectal
5594670|NCT00912327|KRAS mutation|kras mutation
5594671|NCT00912327|Stage IV|stage iv
5594672|NCT00912327|Imprime PGG|imprime pgg
5594673|NCT00912327|Cetuximab|cetuximab
5594674|NCT00912327|Immunotherapy|immunotherapy
5594675|NCT00912314|OAB|oab
5594676|NCT00912314|overactive bladder|overactive bladder
5594677|NCT00912314|ptns|ptns
5577068|NCT00979693|spirituality|spirituality
5594678|NCT00912314|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5594679|NCT00912314|percutaneous tibial nerve stimulation|percutaneous tibial nerve stimulation
5594680|NCT00912301|chenodeoxycholate, IBS, transit, colon, constipation|chenodeoxycholate, ibs, transit, colon, constipation
5594681|NCT00912288|Alzheimer disease moderate-to-severe memantine safety and efficacy|alzheimer disease moderate-to-severe memantine safety and efficacy
5594682|NCT00912262|Analgesics|analgesics
5594683|NCT00912262|Capsaicin|capsaicin
5594684|NCT00912249|Horticulture Therapy|horticulture therapy
5594685|NCT00912249|Psychiatric Rehabilitation|psychiatric rehabilitation
5594686|NCT00912249|Nature-assisted psychotherapy|nature-assisted psychotherapy
5594687|NCT00912249|Day Care|day care
5594688|NCT00912236|Obesity|obesity
5594689|NCT00912236|HDL|hdl
5594690|NCT00912236|HDL functionality|hdl functionality
5594691|NCT00912223|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5594692|NCT00912223|Hematopoietic Stem Cell Transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5594693|NCT00912223|Non-Myeloablative Transplant (NST)|non-myeloablative transplant (nst)
5594694|NCT00912184|Kidney failure, acute|kidney failure, acute
5594695|NCT00912184|Shock|shock
5594696|NCT00912184|Toxins, biological|toxins, biological
5594697|NCT00912184|Hemofiltration|hemofiltration
5594698|NCT00912184|High cut off/super high flux membranes|high cut off/super high flux membranes
5594699|NCT00912171|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5594700|NCT00912171|snoring|snoring
5594701|NCT00912171|adenotonsillar hypertrophy|adenotonsillar hypertrophy
5594702|NCT00912171|polysomnography|polysomnography
5594703|NCT00912171|intranasal steroids|intranasal steroids
5594704|NCT00912171|Anti-leukotrienes|anti-leukotrienes
5594705|NCT00912158|CPE|cpe
5594706|NCT00912158|CPAP|cpap
5594707|NCT00912158|BiPAP|bipap
5594708|NCT00912158|non invasive mechanical ventilation|non invasive mechanical ventilation
5594709|NCT00912132|Fetal Growth|fetal growth
5594710|NCT00912132|Pregnancy|pregnancy
5594711|NCT00912119|craniofacial surgery|craniofacial surgery
5594712|NCT00912119|pharmacokinetics|pharmacokinetics
5594713|NCT00912119|cranial vault abnormalities|cranial vault abnormalities
5594714|NCT00912119|homologous blood products|homologous blood products
5594715|NCT00912119|wide scalp dissections|wide scalp dissections
5594716|NCT00912119|transfusion requirements|transfusion requirements
5594717|NCT00912106|osteoarthritis|osteoarthritis
5594718|NCT00912106|HA|ha
5594719|NCT00912106|synovial fluid|synovial fluid
5594720|NCT00912106|lubrication|lubrication
5594721|NCT00912093|HAE|hae
5594722|NCT00912093|Type I HAE|type i hae
5594723|NCT00912093|Type II HAE|type ii hae
5594724|NCT00912080|genomic signature|genomic signature
5594725|NCT00912080|lymph nodes|lymph nodes
5594726|NCT00912080|no metastases|no metastases
5594727|NCT00912054|OAG|oag
5594728|NCT00912054|OH|oh
5594729|NCT00912041|Brain computer interface|brain computer interface
5594730|NCT00912041|Assistive device|assistive device
5594731|NCT00912041|Environmental control|environmental control
5594732|NCT00912041|Communication device|communication device
5594733|NCT00912041|quadriplegia|quadriplegia
5594734|NCT00912041|tetraplegia|tetraplegia
5594735|NCT00911989|Obesity|obesity
5594736|NCT00911989|Weight Loss|weight loss
5594737|NCT00911976|Coronary artery bypass|coronary artery bypass
5594738|NCT00911976|Stents|stents
5594739|NCT00911976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5594740|NCT00911976|Coronary Restenosis|coronary restenosis
5594741|NCT00911976|Everolimus|everolimus
5594742|NCT00911976|Saphenous vein grafts|saphenous vein grafts
5594743|NCT00911963|VX-222|vx-222
5594744|NCT00911937|incontinence OAB urgency nocturia|incontinence oab urgency nocturia
5594745|NCT00911924|primary open angle glaucoma (POAG)|primary open angle glaucoma (poag)
5594746|NCT00911924|OAG|oag
5594747|NCT00911924|glaucoma|glaucoma
5594748|NCT00911911|Breast cancer|breast cancer
5594749|NCT00911911|Neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5594750|NCT00911911|Proteomic|proteomic
5594751|NCT00911911|Histological response|histological response
5594752|NCT00911898|Her2 amplified solid tumors|her2 amplified solid tumors
5594753|NCT00911898|Breast Cancer|breast cancer
5594754|NCT00911898|Her3/ErbB3|her3/erbb3
5594755|NCT00911898|Bispecific Antibody|bispecific antibody
5594756|NCT00911885|Weight|weight
5594757|NCT00911885|Diet|diet
5594758|NCT00911885|Lipids|lipids
5594759|NCT00911872|wrinkles|wrinkles
5594760|NCT00911872|dermal filler|dermal filler
5594761|NCT00911872|collagen|collagen
5594762|NCT00911872|soft tissue augmentation|soft tissue augmentation
5594763|NCT00911872|aesthetic|aesthetic
5594764|NCT00911859|Multiple Myeloma|multiple myeloma
5594765|NCT00911859|CNTO328|cnto328
5594766|NCT00911859|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5594767|NCT00911859|Monoclonal antibody|monoclonal antibody
5594768|NCT00911859|Anti-IL-6 monoclonal antibody|anti-il-6 monoclonal antibody
5594769|NCT00911859|Bortezomib|bortezomib
5594770|NCT00911859|Velcade|velcade
5594771|NCT00911859|Melphalan|melphalan
5594772|NCT00911859|Prednisone|prednisone
5594773|NCT00911846|opioid dependence substitution buprenorphine methadone|opioid dependence substitution buprenorphine methadone
5594774|NCT00911846|"substitution"|"substitution"
5594775|NCT00911833|Trust|trust
5594776|NCT00911807|Clinical Trial, Phase II|clinical trial, phase ii
5594777|NCT00911807|Randomized Controlled Trial|randomized controlled trial
5594778|NCT00911807|Multicenter Study|multicenter study
5594779|NCT00911807|Cerebrolysin|cerebrolysin
5594780|NCT00911807|Donepezil|donepezil
5594781|NCT00911794|Dyspnea|dyspnea
5594782|NCT00911794|Written Disclosure Therapy|written disclosure therapy
5594783|NCT00911794|COPD|copd
5594784|NCT00911794|Pulmonary Fibrosis|pulmonary fibrosis
5594785|NCT00911794|Chronic Lung Diseases|chronic lung diseases
5594787|NCT00911781|Infantile hemangioma|infantile hemangioma
5594788|NCT00911768|Xerostomia|xerostomia
5594789|NCT00911768|Panax ginseng(Korean Red Ginseng)|panax ginseng(korean red ginseng)
5594790|NCT00911768|Visual Analogue Scale|visual analogue scale
5594791|NCT00911768|Salivary Flow Rates|salivary flow rates
5594792|NCT00911755|Laryngoscopy|laryngoscopy
5594793|NCT00911755|Glidescope|glidescope
5594794|NCT00911729|paraganglioma|paraganglioma
5594795|NCT00911729|pheochromocytoma|pheochromocytoma
5594796|NCT00911716|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5594797|NCT00911716|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5594798|NCT00911716|HER2-negative breast cancer|her2-negative breast cancer
5594799|NCT00911716|stage IA breast cancer|stage ia breast cancer
5594800|NCT00911716|stage IB breast cancer|stage ib breast cancer
5594801|NCT00911716|stage II breast cancer|stage ii breast cancer
5594802|NCT00911716|stage IIIA breast cancer|stage iiia breast cancer
5594803|NCT00911716|male breast cancer|male breast cancer
5594804|NCT00911690|Dementia|dementia
5594805|NCT00911690|Alzheimers Disease|alzheimers disease
5594806|NCT00911690|Cognitive Disorders|cognitive disorders
5594807|NCT00911690|Tissue Banking|tissue banking
5594808|NCT00911677|Delirium (MeSH Unique ID D003693)|delirium (mesh unique id d003693)
5594809|NCT00911677|Cognition Disorders (MeSH Unique ID D003072)|cognition disorders (mesh unique id d003072)
5594810|NCT00911677|Postoperative Complications (MeSH Unique ID D011183)|postoperative complications (mesh unique id d011183)
5594811|NCT00911677|Apolipoproteins E (MeSH Unique ID D001057)|apolipoproteins e (mesh unique id d001057)
5594812|NCT00911664|Vitamin D|vitamin d
5594813|NCT00911664|HIV-Infected children|hiv-infected children
5594814|NCT00911664|CD4 count|cd4 count
5594815|NCT00911651|COPD|copd
5594816|NCT00911651|salbutamol|salbutamol
5594817|NCT00911651|ipratropium bromide|ipratropium bromide
5594818|NCT00911651|computational fluid dynamics|computational fluid dynamics
5594819|NCT00911651|functional imaging|functional imaging
5594820|NCT00911651|central and peripheral airways|central and peripheral airways
5594821|NCT00911638|Patient decision aids|patient decision aids
5594822|NCT00911638|Patient preferences|patient preferences
5594823|NCT00911638|Osteoarthritis|osteoarthritis
5594825|NCT00911638|Waiting times|waiting times
5594826|NCT00911625|glargine|glargine
5594827|NCT00911625|glulisine|glulisine
5594828|NCT00911625|type 2 diabetes|type 2 diabetes
5594829|NCT00911625|renal insufficiency|renal insufficiency
5594830|NCT00911612|bile acid|bile acid
5594831|NCT00911612|malabsorption|malabsorption
5594832|NCT00911612|permeability|permeability
5594833|NCT00911612|diarrhea|diarrhea
5594835|NCT00911612|stool|stool
5594836|NCT00911599|Individuals undergoing unilateral total hip replacement.|individuals undergoing unilateral total hip replacement.
5594837|NCT00911573|pediatry|pediatry
5594838|NCT00911573|children|children
5594839|NCT00911573|skin|skin
5594840|NCT00911573|bacteria|bacteria
5594841|NCT00911573|MRSA|mrsa
5594842|NCT00911560|BETA-D-GLUCAN|beta-d-glucan
5594843|NCT00911560|OPT-821|opt-821
5594844|NCT00911560|GD2-KLH|gd2-klh
5594845|NCT00911560|GD3-KLH|gd3-klh
5594846|NCT00911560|QS 21|qs 21
5594847|NCT00911560|Vaccine|vaccine
5594848|NCT00911560|05-075|05-075
5594849|NCT00911547|chronic asthma|chronic asthma
5594850|NCT00911534|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5594851|NCT00911534|GERD|gerd
5594852|NCT00911521|human papillomavirus|human papillomavirus
5594853|NCT00911521|vaccine|vaccine
5594854|NCT00911521|lupus|lupus
5594855|NCT00911508|Atrial Fibrillation|atrial fibrillation
5594856|NCT00911508|Left Atrial Ablation|left atrial ablation
5594857|NCT00911508|Pulmonary Vein Isolation|pulmonary vein isolation
5594858|NCT00911508|Catheter Ablation|catheter ablation
5594859|NCT00911508|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5594860|NCT00911495|Sickle Cell Disease|sickle cell disease
5594861|NCT00911482|Type 2 Diabetes|type 2 diabetes
5594862|NCT00911482|Dyslipidemia|dyslipidemia
5594863|NCT00911482|FFA|ffa
5594864|NCT00911482|Triglycerides|triglycerides
5594865|NCT00911482|Tracers|tracers
5594866|NCT00911469|Knee osteoarthritis|knee osteoarthritis
5594867|NCT00911469|fibroblast growth factor 18|fibroblast growth factor 18
5594868|NCT00911430|Staphylococcus Aureus (S. Areus)|staphylococcus aureus (s. areus)
5594869|NCT00911430|Recurrent Staphylococcal Infection|recurrent staphylococcal infection
5594870|NCT00911430|Atopic Dermatitis|atopic dermatitis
5594871|NCT00911430|Immunodeficiency|immunodeficiency
5594872|NCT00911430|Community Associated Staphylococcal Infection|community associated staphylococcal infection
5594873|NCT00911430|Staphylococcal Infection|staphylococcal infection
5594874|NCT00911430|Invasive Staphylococcal Infection|invasive staphylococcal infection
5594875|NCT00911430|Staph Infection|staph infection
5594876|NCT00911417|peripheral arterial disease|peripheral arterial disease
5594877|NCT00911417|peripheral vascular disease|peripheral vascular disease
5594878|NCT00911404|Gestational diabetes|gestational diabetes
5594879|NCT00911404|Carbohydrate|carbohydrate
5594880|NCT00911404|Diet|diet
5594881|NCT00911404|Insulin|insulin
5594886|NCT00911391|Perioperative Care|perioperative care
5594887|NCT00911378|weaning|weaning
5594888|NCT00911378|mechanical ventilation|mechanical ventilation
5594889|NCT00911365|voluntary participants|voluntary participants
5594890|NCT00911365|75 years old or less|75 years old or less
5594891|NCT00911352|Cryotherapy|cryotherapy
5594892|NCT00911352|Hand toxicity|hand toxicity
5594893|NCT00911352|Nail toxicity|nail toxicity
5594894|NCT00911352|Infection control|infection control
5594895|NCT00911326|HNSCC|hnscc
5594896|NCT00911313|Polycystic ovary syndrome|polycystic ovary syndrome
5594897|NCT00911313|clomiphene resistance|clomiphene resistance
5594898|NCT00911313|letrozole|letrozole
5594899|NCT00911300|Cardioversion, Electric|cardioversion, electric
5594900|NCT00911300|Pathological Conditions, Sings and Symptoms|pathological conditions, sings and symptoms
5594901|NCT00911300|Cardiovascular Diseases|cardiovascular diseases
5594902|NCT00911300|Heart Diseases|heart diseases
5594903|NCT00911300|Atrial Fibrillation|atrial fibrillation
5594904|NCT00911300|Arrhythmias, Cardiac|arrhythmias, cardiac
5594905|NCT00911300|Pathologic Processes|pathologic processes
5594906|NCT00911300|Anticoagulants|anticoagulants
5594907|NCT00911287|Chronic pain|chronic pain
5594908|NCT00911287|Extended Release|extended release
5594909|NCT00911287|Long-Acting Opioid|long-acting opioid
5594910|NCT00911287|Opioid|opioid
5594911|NCT00911287|Opioid-Naive|opioid-naive
5594912|NCT00911287|Oxymorphone|oxymorphone
5594913|NCT00911274|Bioequivalence|bioequivalence
5594914|NCT00911274|Healthy Subjects|healthy subjects
5594915|NCT00911261|Cancer Pain|cancer pain
5594916|NCT00911261|Neuropathic Pain|neuropathic pain
5594917|NCT00911261|Extended Release|extended release
5594918|NCT00911261|Long-Acting Opioid|long-acting opioid
5594919|NCT00911261|Oxymorphone|oxymorphone
5594920|NCT00911248|Angiogenesis|angiogenesis
5594921|NCT00911248|Neurofibromatosis|neurofibromatosis
5594922|NCT00911248|Post-transcriptional control|post-transcriptional control
5594923|NCT00911248|PTC299|ptc299
5594924|NCT00911248|VEGF|vegf
5579988|NCT00968396|PBPC|pbpc
5685434|NCT00556075|Pelvic pain|pelvic pain
5685435|NCT00556075|Oral progesterone blocker|oral progesterone blocker
5594925|NCT00911235|The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects|the effect of fluconazole on pharmacokinetics of fesoterodine in healthy subjects
5594926|NCT00911222|antiemetic therapy|antiemetic therapy
5594928|NCT00911222|vomiting|vomiting
5594929|NCT00911222|nausea|nausea
5594930|NCT00911222|moderately and highly emetogenic chemotherapy|moderately and highly emetogenic chemotherapy
5594931|NCT00911222|cisplatin|cisplatin
5594932|NCT00911222|carboplatin|carboplatin
5594933|NCT00911222|oxaliplatin|oxaliplatin
5594934|NCT00911222|anthracycline|anthracycline
5594935|NCT00911222|cyclophosphamid|cyclophosphamid
5594936|NCT00911209|Heart Disease|heart disease
5594937|NCT00911209|Obesity|obesity
5594938|NCT00911196|Prognosis|prognosis
5594939|NCT00911196|Markers|markers
5594940|NCT00911196|Expression analysis|expression analysis
5594941|NCT00911196|Hepatocellular carcinoma|hepatocellular carcinoma
5594942|NCT00911183|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5595133|NCT00910481|High Risk|high risk
5594945|NCT00911183|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5594946|NCT00911170|adenocarcinoma of the colon or rectum|adenocarcinoma of the colon or rectum
5594947|NCT00911170|febrile neutropenia|febrile neutropenia
5594948|NCT00911170|Bevacizumab|bevacizumab
5594949|NCT00911170|Avastin|avastin
5594950|NCT00911170|5-fluorouracil, Oxaliplatin, Leucovorin (FOLFOX)|5-fluorouracil, oxaliplatin, leucovorin (folfox)
5594951|NCT00911170|5-fluorouracil, Irinotecan, Leucovorin (FOLFIRI)|5-fluorouracil, irinotecan, leucovorin (folfiri)
5594952|NCT00911157|Pulmonary thromboembolism|pulmonary thromboembolism
5594953|NCT00911157|contrast-enhanced MDCT|contrast-enhanced mdct
5594954|NCT00911157|Deep Vein Thrombosis|deep vein thrombosis
5594955|NCT00911157|Fondaparinux sodium|fondaparinux sodium
5594956|NCT00911144|Safety|safety
5594957|NCT00911144|Pneumococcal vaccine|pneumococcal vaccine
5594958|NCT00911144|Immunogenicity|immunogenicity
5594959|NCT00911144|Pneumococcal disease|pneumococcal disease
5594960|NCT00911144|Booster vaccination|booster vaccination
5594961|NCT00911131|Small grade esophageal varices|small grade esophageal varices
5594962|NCT00911131|capsule endoscopy|capsule endoscopy
5594963|NCT00911131|PillCam ESO|pillcam eso
5594964|NCT00911131|abdominal binder|abdominal binder
5594965|NCT00911118|prostate|prostate
5594966|NCT00911118|radiation|radiation
5594967|NCT00911118|09-035|09-035
5594968|NCT00911105|Multiple Myeloma|multiple myeloma
5594969|NCT00911105|Non-interventional study|non-interventional study
5594970|NCT00911105|Lenalidomide|lenalidomide
5594971|NCT00911105|Dexamethasone|dexamethasone
5594972|NCT00911105|Observational|observational
5594973|NCT00911105|Time to progression|time to progression
5594974|NCT00911105|Clinical routine|clinical routine
5594975|NCT00911105|Germany|germany
5594976|NCT00911105|Plasmacytoma|plasmacytoma
5594977|NCT00911092|Oesophageal cancer|oesophageal cancer
5594978|NCT00911092|exclusive concomitant radiochemotherapy|exclusive concomitant radiochemotherapy
5594979|NCT00911079|Stage III, IV cervical cancer|stage iii, iv cervical cancer
5594980|NCT00911079|Rising prostate specific antigen (PSA) after local therapy|rising prostate specific antigen (psa) after local therapy
5594981|NCT00911053|melatonin|melatonin
5594983|NCT00911053|blindness|blindness
5594984|NCT00911053|blind individuals|blind individuals
5594985|NCT00911027|Prostate|prostate
5594986|NCT00911027|Cancer|cancer
5594987|NCT00911027|Biopsy|biopsy
5594988|NCT00911027|Guided|guided
5594989|NCT00911027|Contrast|contrast
5594990|NCT00911027|Enhanced|enhanced
5594991|NCT00911027|SonoVue|sonovue
5594992|NCT00911027|Suspicion of prostate cancer|suspicion of prostate cancer
5594995|NCT00911001|Replacement|replacement
5594996|NCT00911001|Knee|knee
5594997|NCT00910988|healthy|healthy
5594998|NCT00910988|sedentary|sedentary
5594999|NCT00910988|men|men
5595000|NCT00910988|acute effects of antipsychotic|acute effects of antipsychotic
5595001|NCT00910988|blood sugar|blood sugar
5595002|NCT00910988|insulin sensitivity|insulin sensitivity
5595003|NCT00910975|Hepatitis C virus|hepatitis c virus
5595004|NCT00910975|Real-time PCR|real-time pcr
5595005|NCT00910975|Treatment|treatment
5595006|NCT00910962|NSTEMI, acute coronary syndrome, p38 MAPK inhibitor, GW856553, percutaneous coronary intervention|nstemi, acute coronary syndrome, p38 mapk inhibitor, gw856553, percutaneous coronary intervention
5595007|NCT00910949|persistent pain|persistent pain
5595008|NCT00910949|neuropathic pain|neuropathic pain
5595009|NCT00910949|Thoracotomy|thoracotomy
5595010|NCT00910949|Chronic Pain|chronic pain
5595011|NCT00910936|HIV|hiv
5595012|NCT00910936|Exercise|exercise
5595013|NCT00910936|Inflammation|inflammation
5595014|NCT00910936|Quality of life|quality of life
5595015|NCT00910936|Lipodystrophia|lipodystrophia
5595016|NCT00910923|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5595017|NCT00910897|Newly Diagnosed|newly diagnosed
5595018|NCT00910897|multiple myeloma|multiple myeloma
5595019|NCT00910897|induction|induction
5595020|NCT00910897|Thalidomide|thalidomide
5595021|NCT00910884|stage I breast cancer|stage i breast cancer
5595022|NCT00910884|stage II breast cancer|stage ii breast cancer
5595023|NCT00910884|stage III breast cancer|stage iii breast cancer
5595024|NCT00910884|stage IV breast cancer|stage iv breast cancer
5595025|NCT00910884|hormonal cancers|hormonal cancers
5595026|NCT00910884|skin cancers|skin cancers
5595027|NCT00910871|Tuberculosis|tuberculosis
5595028|NCT00910871|TMC207-TiDP13-C209|tmc207-tidp13-c209
5595029|NCT00910871|TMC207-C209|tmc207-c209
5595030|NCT00910871|TMC207|tmc207
5595032|NCT00910871|MDR-TB|mdr-tb
5595033|NCT00910832|Dyschesia treatment|dyschesia treatment
5595034|NCT00910832|Rehabilitation|rehabilitation
5595035|NCT00910832|Dyschesia|dyschesia
5595056|NCT00910793|Asthma|asthma
5595057|NCT00910793|Formoterol|formoterol
5595058|NCT00910793|Beclomethasone Dipropionate|beclomethasone dipropionate
5595059|NCT00910793|Computational Fluid Dynamics|computational fluid dynamics
5595060|NCT00910793|Functional Imaging|functional imaging
5595061|NCT00910793|Central and Peripheral Airways|central and peripheral airways
5595062|NCT00910754|Prostate neoplasms|prostate neoplasms
5595063|NCT00910754|Metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5595064|NCT00910754|Abiraterone acetate|abiraterone acetate
5595065|NCT00910754|CB7630|cb7630
5595066|NCT00910741|pancreatic cancer|pancreatic cancer
5595067|NCT00910741|Gemcitabine|gemcitabine
5595068|NCT00910728|Primary Myelofibrosis (PMF)|primary myelofibrosis (pmf)
5595069|NCT00910728|Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)|post-polycythaemia vera/essential thrombocythaemia myelofibrosis (post-pv/et mf)
5595070|NCT00910728|Myeloproliferative diseases|myeloproliferative diseases
5595071|NCT00910728|Phase I|phase i
5595072|NCT00910728|Phase II|phase ii
5595073|NCT00910728|Bone marrow|bone marrow
5595074|NCT00910715|erythema migrans|erythema migrans
5595075|NCT00910715|Lyme borreliosis|lyme borreliosis
5595076|NCT00910715|doxycycline treatment|doxycycline treatment
5595077|NCT00910715|outcome|outcome
5595078|NCT00910715|subjective symptoms|subjective symptoms
5595079|NCT00910702|retinal detachment, vitreous body substitute|retinal detachment, vitreous body substitute
5595080|NCT00910689|Migraine Headache|migraine headache
5595081|NCT00910689|Preventive Therapy|preventive therapy
5595082|NCT00910689|Beta Blocker Medication|beta blocker medication
5595083|NCT00910689|Behavior Therapy|behavior therapy
5595084|NCT00910689|Clinical Trial|clinical trial
5595085|NCT00910676|EGF-R inhibitors|egf-r inhibitors
5595086|NCT00910663|Bioequivalence|bioequivalence
5595087|NCT00910663|Healthy Subjects|healthy subjects
5595090|NCT00910637|Pregnancy prevention|pregnancy prevention
5595091|NCT00910637|Female contraception|female contraception
5595092|NCT00910637|Patch|patch
5595093|NCT00910611|pediatric|pediatric
5595094|NCT00910611|immunization|immunization
5595095|NCT00910611|pain|pain
5595096|NCT00910611|analgesia|analgesia
5595097|NCT00910611|Immunization pain|immunization pain
5767446|NCT00254280|RCT|rct
5595101|NCT00910598|Optical Coherence Tomography|optical coherence tomography
5595103|NCT00910585|asthma|asthma
5595104|NCT00910572|Yttrium-90|yttrium-90
5595105|NCT00910572|Radiation|radiation
5595106|NCT00910572|Radioembolization|radioembolization
5595107|NCT00910572|Hepatoma|hepatoma
5595108|NCT00910572|BCLC classification|bclc classification
5595109|NCT00910572|Hepatic loco-regional treatments|hepatic loco-regional treatments
5595110|NCT00910572|Yttrium|yttrium
5595111|NCT00910572|Microspheres|microspheres
5595112|NCT00910559|Autism Spectrum Disorder|autism spectrum disorder
5595113|NCT00910559|Autism|autism
5595114|NCT00910559|Asperger Syndrome|asperger syndrome
5595115|NCT00910559|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
5595116|NCT00910546|Lung Cancer|lung cancer
5595117|NCT00910546|Stereotactic radiotherapy|stereotactic radiotherapy
5595118|NCT00910546|Image guidance|image guidance
5595119|NCT00910546|breathing adaption|breathing adaption
5595120|NCT00910546|tumor motion|tumor motion
5595121|NCT00910546|implanted marker|implanted marker
5595122|NCT00910533|Lyme neuroborreliosis|lyme neuroborreliosis
5595123|NCT00910507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5595124|NCT00910507|Exercise|exercise
5595125|NCT00910507|Counseling|counseling
5595126|NCT00910507|Behavior|behavior
5595127|NCT00910494|Rectal neoplasm C04.588.274.476.411.307.790|rectal neoplasm c04.588.274.476.411.307.790
5595128|NCT00910494|Intraoperative Radiotherapy|intraoperative radiotherapy
5595129|NCT00910481|Coronary Artery Disease|coronary artery disease
5595130|NCT00910481|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5595131|NCT00910481|Intraaortic Balloon Pumping|intraaortic balloon pumping
5595132|NCT00910481|Left Ventricular Dysfunction|left ventricular dysfunction
5595134|NCT00910455|Phase 1|phase 1
5595135|NCT00910455|Safety|safety
5595136|NCT00910455|Tolerability|tolerability
5595137|NCT00910455|Pharmacokinetics|pharmacokinetics
5595138|NCT00910429|Chronic thromboembolic Hypertension|chronic thromboembolic hypertension
5595140|NCT00910429|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
5595141|NCT00910429|sGC|sgc
5595142|NCT00910416|Anesthesia|anesthesia
5595143|NCT00910416|Monitoring, Intraoperative|monitoring, intraoperative
5595144|NCT00910416|Electroencephalography/*drug effects|electroencephalography/*drug effects
5595145|NCT00910403|Presbyopia|presbyopia
5595146|NCT00910403|LASIK|lasik
5595147|NCT00910403|Hyperopes|hyperopes
5595148|NCT00910390|IVF|ivf
5595149|NCT00910390|embryo cryopreservation|embryo cryopreservation
5595150|NCT00910390|vitrification|vitrification
5595151|NCT00910390|Human Embryo|human embryo
5595152|NCT00910390|Embryonic development|embryonic development
5595153|NCT00910390|Pregnancy rate|pregnancy rate
5595154|NCT00910377|breastfeeding|breastfeeding
5595155|NCT00910377|exclusive breastfeeding|exclusive breastfeeding
5595156|NCT00910377|lactation counseling|lactation counseling
5595157|NCT00910377|teenagers|teenagers
5595158|NCT00910377|complementary food|complementary food
5595159|NCT00910377|adolescent|adolescent
5595160|NCT00910377|caregivers|caregivers
5595161|NCT00910364|Lower extremity DVT|lower extremity dvt
5595162|NCT00910364|Clot|clot
5595163|NCT00910364|leg clot|leg clot
5595164|NCT00910364|Deep vein thrombosis|deep vein thrombosis
5595165|NCT00910364|Thrombosis|thrombosis
5595166|NCT00910364|Warfarin|warfarin
5595167|NCT00910351|Cystic Fibrosis|cystic fibrosis
5595168|NCT00910351|Pharmacokinetics|pharmacokinetics
5595169|NCT00910351|Pediatrics|pediatrics
5595170|NCT00910351|Inhalation|inhalation
5595171|NCT00910351|Sputum|sputum
5595172|NCT00910338|Pelvic Floor Muscle Training|pelvic floor muscle training
5595173|NCT00910338|Extracorporeal Biofeedback|extracorporeal biofeedback
5595174|NCT00910325|Female|female
5595175|NCT00910325|Cholelithiasis|cholelithiasis
5595176|NCT00910325|Natural Orifice Surgery|natural orifice surgery
5595177|NCT00910325|Laparoscopic- Assisted|laparoscopic- assisted
5595178|NCT00910325|Transvaginal|transvaginal
5595179|NCT00910299|Clopidogrel|clopidogrel
5595180|NCT00910299|VerifyNow|verifynow
5595181|NCT00910299|PRU Measurements|pru measurements
5595182|NCT00910299|Drug Eluting Stents (DES)|drug eluting stents (des)
5595183|NCT00910299|Heart Disease|heart disease
5595184|NCT00910299|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5595185|NCT00910299|P2Y12|p2y12
5595186|NCT00910299|Platelets|platelets
5595187|NCT00910299|Platelet Reactivity|platelet reactivity
5595188|NCT00910286|Pressure support ventilation|pressure support ventilation
5595189|NCT00910286|cycling off criteria|cycling off criteria
5595190|NCT00910286|expiratory trigger|expiratory trigger
5589065|NCT00935077|Hypertension|hypertension
5595198|NCT00910247|Monotherapy|monotherapy
5595199|NCT00910247|Epilepsy with simple or complete partial onset seizures|epilepsy with simple or complete partial onset seizures
5595200|NCT00910234|Periventricular leukomalacia (PVL)|periventricular leukomalacia (pvl)
5595201|NCT00910234|Erythropoietin (EPO)|erythropoietin (epo)
5595202|NCT00910234|Retinopathy of prematurity (ROP)|retinopathy of prematurity (rop)
5595203|NCT00910234|Hypoxia-ischemia|hypoxia-ischemia
5595204|NCT00910221|Cardiac surgery|cardiac surgery
5595205|NCT00910221|Cardiopulmonary bypass|cardiopulmonary bypass
5595206|NCT00910221|Oxidative stress|oxidative stress
5595207|NCT00910221|Acute renal dysfunction|acute renal dysfunction
5595208|NCT00910221|Atorvastatin|atorvastatin
5595210|NCT00910208|Analgesia|analgesia
5595211|NCT00910208|Analgesia, Patient-controlled|analgesia, patient-controlled
5595212|NCT00910208|Emergency Medicine|emergency medicine
5595213|NCT00910195|Obstructive sleep apnea|obstructive sleep apnea
5595214|NCT00910195|CPAP|cpap
5595215|NCT00910195|Bi-Level|bi-level
5595216|NCT00910182|Splenic rupture|splenic rupture
5595217|NCT00910182|abdominal injuries|abdominal injuries
5595218|NCT00910182|Surgery|surgery
5595219|NCT00910182|Angiography|angiography
5595220|NCT00910182|Embolisation|embolisation
5595221|NCT00910182|Computed tomography|computed tomography
5595222|NCT00910182|Classification|classification
5595223|NCT00910169|Anorexia nervosa|anorexia nervosa
5595224|NCT00910169|treatment|treatment
5595225|NCT00910169|inpatient|inpatient
5595226|NCT00910169|efficacy|efficacy
5595227|NCT00910169|outcome|outcome
5595228|NCT00910143|Rectal cancer|rectal cancer
5595229|NCT00910143|Colorectal Surgery|colorectal surgery
5595230|NCT00910143|Surgery|surgery
5595231|NCT00910143|Local neoplasm recurrence|local neoplasm recurrence
5595232|NCT00910143|survival|survival
5595233|NCT00910143|Follow-up Study|follow-up study
5595234|NCT00910130|Retinol Binding Protein 4|retinol binding protein 4
5595235|NCT00910130|Insulin Resistance|insulin resistance
5595236|NCT00910130|Diabetes|diabetes
5595237|NCT00910130|End Stage Renal Disease|end stage renal disease
5595238|NCT00910130|Dialysis|dialysis
5595239|NCT00910130|Nutrition|nutrition
5595240|NCT00910117|HNSCC|hnscc
5595241|NCT00910117|induction chemotherapy|induction chemotherapy
5595242|NCT00910117|nimotuzumab|nimotuzumab
5595244|NCT00910104|Omegaven|omegaven
5595245|NCT00910104|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5595246|NCT00910104|Cholestasis|cholestasis
5595247|NCT00910104|Short Bowel Syndrome|short bowel syndrome
5595248|NCT00910091|Endometrial cancer|endometrial cancer
5595249|NCT00910091|Antitumour efficacy in women with advanced endometrial cancer|antitumour efficacy in women with advanced endometrial cancer
5595250|NCT00910078|Total kappa and lambda ratio|total kappa and lambda ratio
5685436|NCT00556049|mRCC|mrcc
5595251|NCT00910078|Stem cell transplantation|stem cell transplantation
5595252|NCT00910078|Serum immunofixation|serum immunofixation
5595253|NCT00910065|Acute Coronary Syndrome|acute coronary syndrome
5595254|NCT00910065|ACS|acs
5595255|NCT00910065|Aspirin|aspirin
5595256|NCT00910052|randomised|randomised
5595257|NCT00910052|controlled|controlled
5595258|NCT00910052|double blinded|double blinded
5595259|NCT00910039|cognitive/functional effects|cognitive/functional effects
5595260|NCT00910039|tumors metastatic to brain|tumors metastatic to brain
5595261|NCT00910039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5595262|NCT00910026|EBC and mechanical ventilation|ebc and mechanical ventilation
5595263|NCT00910026|low tidal volume ventilation|low tidal volume ventilation
5595264|NCT00910026|high tidal volume ventilation|high tidal volume ventilation
5595265|NCT00910026|inflammatory and oxidative stress EBC biomarkers|inflammatory and oxidative stress ebc biomarkers
5595266|NCT00910026|Ventilator induced lung injury|ventilator induced lung injury
5595267|NCT00910013|TKR|tkr
5595268|NCT00910013|Femoral block|femoral block
5595269|NCT00910013|Ropivacaïne|ropivacaïne
5595270|NCT00910013|intra-articular ropivacaïne|intra-articular ropivacaïne
5595271|NCT00910013|post-operative analgesia|post-operative analgesia
5595272|NCT00910000|carboplatin|carboplatin
5595273|NCT00910000|gemcitabine|gemcitabine
5595274|NCT00910000|vorinostat|vorinostat
5595275|NCT00909987|rectum|rectum
5595276|NCT00909987|intermediate risk cancer rectum|intermediate risk cancer rectum
5595277|NCT00909987|neoadjuvant|neoadjuvant
5595278|NCT00909974|multiple micronutrients|multiple micronutrients
5595279|NCT00909974|energy deficiency|energy deficiency
5595280|NCT00909961|Osteoporosis|osteoporosis
5595281|NCT00909961|Bone Mineral Density|bone mineral density
5595283|NCT00909948|Related stem cell transplant,|related stem cell transplant,
5595284|NCT00909948|TBI,|tbi,
5595285|NCT00909948|Mismatched stem cell transplant|mismatched stem cell transplant
5595286|NCT00909948|Fludarabine|fludarabine
5595287|NCT00909948|Non-myeloablative|non-myeloablative
5595288|NCT00909948|Lymphoma|lymphoma
5595289|NCT00909948|Multiple myeloma|multiple myeloma
5595290|NCT00909935|To determine pharmacokinetics of dexmedetomidine in children|to determine pharmacokinetics of dexmedetomidine in children
5595291|NCT00909922|Amputation|amputation
5595292|NCT00909922|Amputees|amputees
5595293|NCT00909922|Artificial Limbs|artificial limbs
5595294|NCT00909922|Leg Length Inequality|leg length inequality
5595295|NCT00909922|Lower Extremity|lower extremity
5595296|NCT00909922|Pelvis|pelvis
5595297|NCT00909922|Posture|posture
5595298|NCT00909922|Prostheses|prostheses
5595299|NCT00909922|Range of Motion|range of motion
5595300|NCT00909922|Trunk Muscles|trunk muscles
5595301|NCT00909909|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5595302|NCT00909909|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5595303|NCT00909909|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5595306|NCT00909909|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5595307|NCT00909909|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5595309|NCT00909909|stage II breast cancer|stage ii breast cancer
5595310|NCT00909909|stage IIIA breast cancer|stage iiia breast cancer
5595311|NCT00909896|endometrial|endometrial
5595312|NCT00909896|pain|pain
5595313|NCT00909883|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5595314|NCT00909883|Foot (Tiptoe) dystonia|foot (tiptoe) dystonia
5595315|NCT00909883|Botulinum Toxin|botulinum toxin
5595316|NCT00909883|Muscles : Flexor digitorum longus/ Flexor digitorum brevis/ quadratus plantae|muscles : flexor digitorum longus/ flexor digitorum brevis/ quadratus plantae
5595317|NCT00909870|Venous leg ulcer|venous leg ulcer
5595318|NCT00909870|randomized trial|randomized trial
5595319|NCT00909870|clinical trial|clinical trial
5595320|NCT00909870|Dermagraft|dermagraft
5595321|NCT00909870|compression therapy|compression therapy
5595322|NCT00909870|surgical debridement|surgical debridement
5595323|NCT00909870|venous stasis|venous stasis
5595324|NCT00909870|chronic ulcer|chronic ulcer
5595329|NCT00909831|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5595331|NCT00909805|suture|suture
5595332|NCT00909805|children|children
5595333|NCT00909779|Chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5595334|NCT00909779|respiratory|respiratory
5595335|NCT00909779|long-acting beta agonist (LABA)|long-acting beta agonist (laba)
5595336|NCT00909753|Bioequivalence|bioequivalence
5595337|NCT00909753|Healthy Subjects|healthy subjects
5595338|NCT00909740|Solid Tumor|solid tumor
5595339|NCT00909740|Cancer|cancer
5595340|NCT00909727|Fibrosis|fibrosis
5595341|NCT00909727|Pancreatic Diseases|pancreatic diseases
5595342|NCT00909727|Digestive System Diseases|digestive system diseases
5595343|NCT00909727|Lung Diseases|lung diseases
5595344|NCT00909727|Respiratory Tract Diseases|respiratory tract diseases
5595345|NCT00909727|Genetic Diseases, Inborn|genetic diseases, inborn
5595346|NCT00909727|Infant, Newborn, Diseases|infant, newborn, diseases
5595347|NCT00909727|Pathologic Processes|pathologic processes
5595353|NCT00909701|Dietary supplement|dietary supplement
5595354|NCT00909701|healthy volunteers|healthy volunteers
5595355|NCT00909701|Anaesthesia for surgery|anaesthesia for surgery
5595356|NCT00909688|Healthy Subjects|healthy subjects
5595357|NCT00909662|cognitive/functional effects|cognitive/functional effects
5595358|NCT00909662|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5595359|NCT00909662|fatigue|fatigue
5595360|NCT00909662|stage I breast cancer|stage i breast cancer
5595361|NCT00909662|stage II breast cancer|stage ii breast cancer
5595362|NCT00909662|stage IIIA breast cancer|stage iiia breast cancer
5595363|NCT00909662|stage IIIB breast cancer|stage iiib breast cancer
5595364|NCT00909662|stage IIIC breast cancer|stage iiic breast cancer
5595365|NCT00909649|fibrin glue|fibrin glue
5595366|NCT00909649|seroma|seroma
5595367|NCT00909649|mastectomy|mastectomy
5595368|NCT00909636|multiple ascending doses (MAD)|multiple ascending doses (mad)
5595369|NCT00909610|Bioequivalence|bioequivalence
5595370|NCT00909610|Healthy Subjects|healthy subjects
5595371|NCT00909584|Hematology|hematology
5595372|NCT00909584|Neutropenia|neutropenia
5595373|NCT00909584|SCN|scn
5595374|NCT00909584|Severe Chronic Neutropenia|severe chronic neutropenia
5595375|NCT00909584|Idiopathic|idiopathic
5595376|NCT00909584|Telintra|telintra
5595377|NCT00909584|ezatiostat hydrochloride|ezatiostat hydrochloride
5595378|NCT00909584|ezatiostat|ezatiostat
5595379|NCT00909584|TLK199|tlk199
5595380|NCT00909584|Glutathione|glutathione
5595381|NCT00909584|Glutathione analog|glutathione analog
5595382|NCT00909584|Glutathione Transferase|glutathione transferase
5589231|NCT00934258|genes|genes
5595383|NCT00909584|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5595384|NCT00909584|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5595386|NCT00909584|Apoptosis|apoptosis
5595387|NCT00909584|Differentiation|differentiation
5595388|NCT00909584|Enzyme inhibitor|enzyme inhibitor
5595389|NCT00909571|FK506E|fk506e
5595390|NCT00909571|MR4|mr4
5595391|NCT00909571|Prograf|prograf
5595392|NCT00909571|Tacrolimus|tacrolimus
5595393|NCT00909571|Living Liver Transplantation|living liver transplantation
5595394|NCT00909558|metastatic malignancies|metastatic malignancies
5595395|NCT00909558|tumor markers|tumor markers
5595396|NCT00909558|chemotherapy|chemotherapy
5595397|NCT00909558|cancer|cancer
5595398|NCT00909558|breast cancer|breast cancer
5595399|NCT00909558|glioma|glioma
5595400|NCT00909558|hepatocellular cancer|hepatocellular cancer
5595401|NCT00909558|squamous cell lung cancer|squamous cell lung cancer
5595402|NCT00909558|pancreatic cancer|pancreatic cancer
5595403|NCT00909558|colon cancer|colon cancer
5595404|NCT00909558|prostate cancer|prostate cancer
5595405|NCT00909545|Early Parkinson disease|early parkinson disease
5595406|NCT00909532|Fibrosis|fibrosis
5595407|NCT00909532|Pancreatic Diseases|pancreatic diseases
5595408|NCT00909532|Lung Diseases|lung diseases
5595409|NCT00909532|Respiratory Tract Diseases|respiratory tract diseases
5595410|NCT00909532|Genetic Diseases, Inborn|genetic diseases, inborn
5595411|NCT00909532|Infant, Newborn, Diseases|infant, newborn, diseases
5595412|NCT00909532|Pathologic Processes|pathologic processes
5595413|NCT00909493|Improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management|improvement of patient care as measured by self-rated health and improve physician satisfaction with chronic pain management
5595414|NCT00909454|Vitamin D deficiency|vitamin d deficiency
5595415|NCT00909454|Adolescents|adolescents
5595416|NCT00909454|African Americans|african americans
5595417|NCT00909454|Overweight|overweight
5595419|NCT00909441|Breast Cancer|breast cancer
5595420|NCT00909441|Node Positive Breast Cancer|node positive breast cancer
5595421|NCT00909441|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5595422|NCT00909441|Breast Surgery|breast surgery
5595423|NCT00909441|Axillary Lymph Node Dissection|axillary lymph node dissection
5595424|NCT00909441|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5595425|NCT00909428|Bladder|bladder
5595426|NCT00909428|Urinary Urgency|urinary urgency
5595427|NCT00909428|Solifenacin|solifenacin
5595428|NCT00909428|Vesicare(R)|vesicare(r)
5595429|NCT00909415|patients with anorectal malformation|patients with anorectal malformation
5595430|NCT00909376|Pregnancy|pregnancy
5595431|NCT00909376|Ultrasonography|ultrasonography
5595432|NCT00909376|outcome|outcome
5595433|NCT00909376|adverse|adverse
5595434|NCT00909350|Barrett's esophagus|barrett's esophagus
5595436|NCT00909350|esophageal adenocarcinoma|esophageal adenocarcinoma
5595437|NCT00909350|Micro-RNA|micro-rna
5595438|NCT00909350|miR expression|mir expression
5595439|NCT00909324|Post LASIK dry eye|post lasik dry eye
5595440|NCT00909324|Pre LASIK dry eye|pre lasik dry eye
5595441|NCT00909324|Hypromellose|hypromellose
5595442|NCT00909311|Food effect|food effect
5595443|NCT00909298|Left ventricular assist devices|left ventricular assist devices
5595444|NCT00909298|Cardiac Disease|cardiac disease
5595445|NCT00909298|Heart Failure|heart failure
5595446|NCT00909298|Anticoagulant for Left Ventricular Assist Devices|anticoagulant for left ventricular assist devices
5595447|NCT00909285|Alzheimer|alzheimer
5595449|NCT00909285|cognitive training|cognitive training
5595450|NCT00909272|ultrasound|ultrasound
5595451|NCT00909272|diagnostic|diagnostic
5595452|NCT00909272|lumbar|lumbar
5595453|NCT00909272|median branch|median branch
5595455|NCT00909272|Lumbar facet joint pain|lumbar facet joint pain
5595456|NCT00909259|Sleep Disordered Breathing|sleep disordered breathing
5595457|NCT00909259|Periodic Breathing|periodic breathing
5595458|NCT00909259|Cheyne-Stokes Respiration|cheyne-stokes respiration
5595459|NCT00909259|Sleep Apnea|sleep apnea
5595460|NCT00909233|Erectile dysfunction,|erectile dysfunction,
5595461|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5595462|NCT00909220|Major Depressive Disorder, EEG, Negativity bias|major depressive disorder, eeg, negativity bias
5595463|NCT00909207|Advanced Cancers|advanced cancers
5595464|NCT00909207|Hematologic Disorders|hematologic disorders
5595465|NCT00909207|Solid Tumors|solid tumors
5595466|NCT00909207|Cognitive Interview|cognitive interview
5595467|NCT00909207|Patient-Reported Outcomes|patient-reported outcomes
5595468|NCT00909207|PRO|pro
5595469|NCT00909207|Common Terminology Criteria for Adverse Events|common terminology criteria for adverse events
5595470|NCT00909207|CTCAE|ctcae
5595471|NCT00909207|PRO-CTCAE|pro-ctcae
5595472|NCT00909207|Cancer Symptoms|cancer symptoms
5595473|NCT00909207|Interview|interview
5595474|NCT00909194|Juvenile Primary Fibromyalgia|juvenile primary fibromyalgia
5595475|NCT00909194|Adolescents|adolescents
5595476|NCT00909194|Psychiatry|psychiatry
5595477|NCT00909168|Induction chemotherapy|induction chemotherapy
5595478|NCT00909168|Fludarabine|fludarabine
5595479|NCT00909168|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5595480|NCT00909155|Major Depressive Disorder|major depressive disorder
5595481|NCT00909142|Breast cancer|breast cancer
5595482|NCT00909142|Prostate cancer|prostate cancer
5595483|NCT00909142|Multiple myeloma|multiple myeloma
5595484|NCT00909129|HIV-1|hiv-1
5595485|NCT00909129|Chronic hepatitis C|chronic hepatitis c
5595486|NCT00909129|Immune activation|immune activation
5595487|NCT00909129|HCV kinetics|hcv kinetics
5595488|NCT00909129|IP-10|ip-10
5595490|NCT00909116|chronic constipation|chronic constipation
5595491|NCT00909116|internal rectal prolapse|internal rectal prolapse
5595492|NCT00909116|rectocele|rectocele
5595493|NCT00909116|Stapled Transanal Rectal Resection|stapled transanal rectal resection
5595494|NCT00909116|Contour Transtar|contour transtar
5595495|NCT00909116|STARR|starr
5595496|NCT00909103|Endoscopic Ultrasound Elastography|endoscopic ultrasound elastography
5595497|NCT00909103|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5595498|NCT00909103|Chronic Pancreatitis|chronic pancreatitis
5598000|NCT00900159|MWT|mwt
5595499|NCT00909090|macular pigment|macular pigment
5595500|NCT00909090|glare disability|glare disability
5595502|NCT00909090|photostress|photostress
5595503|NCT00909077|ITP-Rituximab-dexamethasone|itp-rituximab-dexamethasone
5595504|NCT00909051|Diabetes Mellitus|diabetes mellitus
5595505|NCT00909012|phenylketonuria|phenylketonuria
5595506|NCT00909012|docosahexaenoic acid|docosahexaenoic acid
5595507|NCT00909012|visually evoked potential|visually evoked potential
5595508|NCT00909012|choice-reaction time|choice-reaction time
5595509|NCT00908999|anosognosia fMRI amnestic MCI Alzheimer|anosognosia fmri amnestic mci alzheimer
5595510|NCT00908999|anosognosia in AD and MCI|anosognosia in ad and mci
5595511|NCT00908986|Lupus Membranous Nephritis|lupus membranous nephritis
5595512|NCT00908973|Obesity|obesity
5595513|NCT00908973|Gastric bypass|gastric bypass
5595514|NCT00908973|Gut hormone|gut hormone
5595515|NCT00908973|Intestinal transit time|intestinal transit time
5595516|NCT00908960|enoxaparin|enoxaparin
5595517|NCT00908947|SFA|sfa
5595518|NCT00908947|Stent|stent
5595519|NCT00908947|Popliteal|popliteal
5595520|NCT00908947|infrainguinal|infrainguinal
5595521|NCT00908947|LifeStent|lifestent
5595522|NCT00908947|Peripheral|peripheral
5595523|NCT00908947|Arterial|arterial
5595524|NCT00908934|Relative Bioavailability|relative bioavailability
5595525|NCT00908934|AZD9056|azd9056
5595526|NCT00908908|Advanced Solid Tumors|advanced solid tumors
5595527|NCT00908908|Failure of Multiple Prior Chemotherapy Regimens|failure of multiple prior chemotherapy regimens
5595528|NCT00908895|Radius fractures|radius fractures
5595529|NCT00908895|Radio-radial fixator|radio-radial fixator
5595530|NCT00908895|Percutaneous pinning|percutaneous pinning
5595531|NCT00908895|Grip strength|grip strength
5595532|NCT00908882|Nursing Care|nursing care
5595533|NCT00908882|Veterans|veterans
5580586|NCT00965978|Food Effect|food effect
5595534|NCT00908869|advanced neoplasm|advanced neoplasm
5595535|NCT00908869|adult advanced neoplasm|adult advanced neoplasm
5595536|NCT00908856|stroke cell therapy repair autologous|stroke cell therapy repair autologous
5595537|NCT00908843|Contrast nephropathy|contrast nephropathy
5595538|NCT00908843|Renal failure|renal failure
5595539|NCT00908817|postoperative sore throat|postoperative sore throat
5595540|NCT00908817|tracheal intubation|tracheal intubation
5595541|NCT00908817|lubrication|lubrication
5595542|NCT00908817|triamcinolone|triamcinolone
5595543|NCT00908804|acute appendicitis|acute appendicitis
5595544|NCT00908791|Conjugated Linoleic Acid|conjugated linoleic acid
5595545|NCT00908791|Proof of Principle|proof of principle
5595546|NCT00908791|Lipogenic Pathway|lipogenic pathway
5595547|NCT00908791|Clarinol|clarinol
5595548|NCT00908778|Diabetic Retinopathy|diabetic retinopathy
5595549|NCT00908765|Exercise Training COPD|exercise training copd
5595550|NCT00908752|HCC|hcc
5595551|NCT00908739|stage I renal cell cancer|stage i renal cell cancer
5595552|NCT00908739|stage III renal cell cancer|stage iii renal cell cancer
5595553|NCT00908739|recurrent renal cell cancer|recurrent renal cell cancer
5595554|NCT00908739|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5595555|NCT00908739|childhood renal cell carcinoma|childhood renal cell carcinoma
5595556|NCT00908713|Severe CAP|severe cap
5595557|NCT00908713|Adjuvant therapy|adjuvant therapy
5595558|NCT00908713|Glucocorticoids|glucocorticoids
5595559|NCT00908713|CAP Fine V with C-reactive protein >= 15 mg/100 mL|cap fine v with c-reactive protein >= 15 mg/100 ml
5595560|NCT00908700|Atrial fibrillation|atrial fibrillation
5595561|NCT00908700|Stroke|stroke
5595562|NCT00908700|left atrial appendage|left atrial appendage
5595563|NCT00908700|Re-exploration for bleeding|re-exploration for bleeding
5595564|NCT00908661|Parastomal, hernia|parastomal, hernia
5595565|NCT00908648|screening colonoscopy|screening colonoscopy
5595566|NCT00908648|narrow band imaging|narrow band imaging
5595567|NCT00908635|sepsis|sepsis
5595568|NCT00908635|organ failure|organ failure
5595569|NCT00908622|Percutaneous implantation of autologous myoblasts|percutaneous implantation of autologous myoblasts
5595570|NCT00908609|Breast Cancer Diagnosis|breast cancer diagnosis
5595571|NCT00908609|Optical Imaging|optical imaging
5595572|NCT00908609|Ultrasound Imaging|ultrasound imaging
5595573|NCT00908609|Monitoring Neoadjuvant Chemotherapy Response|monitoring neoadjuvant chemotherapy response
5595574|NCT00908596|Nephrogenic Systemic Fibrosis (NSF)|nephrogenic systemic fibrosis (nsf)
5595575|NCT00908596|Primovist / Eovist|primovist / eovist
5595576|NCT00908583|Alloantibody|alloantibody
5595577|NCT00908583|Desensitization|desensitization
5595578|NCT00908583|Kidney Transplantation|kidney transplantation
5595580|NCT00908583|Plasma Cells|plasma cells
5595581|NCT00908583|Translational Research/Science|translational research/science
5595582|NCT00908570|estrogen|estrogen
5595583|NCT00908570|estriol|estriol
5595584|NCT00908570|cream|cream
5595585|NCT00908570|vagina|vagina
5595586|NCT00908570|infection prevention|infection prevention
5595587|NCT00908557|Lexicosyntactic readability improvement|lexicosyntactic readability improvement
5595588|NCT00908557|phase II/III trials|phase ii/iii trials
5595589|NCT00908557|ethic|ethic
5595590|NCT00908557|Informed consent|informed consent
5595591|NCT00908544|HIV-infection|hiv-infection
5595592|NCT00908544|Primary HIV-infection|primary hiv-infection
5595593|NCT00908544|Proviral DNA|proviral dna
5595594|NCT00908544|Eradication|eradication
5595595|NCT00908544|Multi drug class HAART|multi drug class haart
5595596|NCT00908531|Breast neoplasms|breast neoplasms
5595597|NCT00908531|Randomised trial|randomised trial
5595598|NCT00908531|Aromatase Inhibitors|aromatase inhibitors
5595599|NCT00908531|Preoperative care|preoperative care
5595600|NCT00908531|Age 60 or older|age 60 or older
5595601|NCT00908531|Hormone receptor positive tumor|hormone receptor positive tumor
5595602|NCT00908531|Tumor lager than 2 cm|tumor lager than 2 cm
5595603|NCT00908531|No distant metastasis|no distant metastasis
5595604|NCT00908518|Cognitive dysfunction|cognitive dysfunction
5595605|NCT00908518|Cardiac morbidity|cardiac morbidity
5595606|NCT00908518|anesthesia|anesthesia
5595607|NCT00908505|Cystic fibrosis|cystic fibrosis
5595608|NCT00908505|physiotherapy|physiotherapy
5595609|NCT00908505|pulmonary function test|pulmonary function test
5595610|NCT00908492|Randomized control trial|randomized control trial
5595611|NCT00908492|Dementia caregivers|dementia caregivers
5595900|NCT00907257|irritation|irritation
5595612|NCT00908492|Occupational Therapy|occupational therapy
5595613|NCT00908492|Caregivers|caregivers
5595614|NCT00908479|Exercise|exercise
5595615|NCT00908479|Rehabilitation|rehabilitation
5595616|NCT00908479|leg function|leg function
5595617|NCT00908479|in patient|in patient
5595618|NCT00908479|RCT|rct
5595619|NCT00908466|Non-infectious|non-infectious
5595620|NCT00908466|Uveitis|uveitis
5595621|NCT00908466|Panuveitis|panuveitis
5595622|NCT00908453|NPC-06|npc-06
5595623|NCT00908453|fosphenytoin|fosphenytoin
5595624|NCT00908453|phenytoin|phenytoin
5595625|NCT00908453|pharmacokinetics|pharmacokinetics
5595626|NCT00908453|safety|safety
5595627|NCT00908440|Decision Aid|decision aid
5595628|NCT00908440|Posttraumatic Stress Disorder|posttraumatic stress disorder
5595629|NCT00908440|evidence-based treatments|evidence-based treatments
5595630|NCT00908427|benign prostatic hyperplasia|benign prostatic hyperplasia
5595632|NCT00908427|transurethral resection of prostate|transurethral resection of prostate
5595633|NCT00908427|urinary bladder neck obstruction|urinary bladder neck obstruction
5595634|NCT00908414|PEPI-TiDP23-C104|pepi-tidp23-c104
5595635|NCT00908414|PEPI-C104|pepi-c104
5595636|NCT00908414|PEPI|pepi
5595637|NCT00908414|TMC589337|tmc589337
5595638|NCT00908414|TMC589354|tmc589354
5595639|NCT00908414|TMC310911|tmc310911
5595640|NCT00908414|Healthy Volunteers|healthy volunteers
5595641|NCT00908401|breastmilk|breastmilk
5595642|NCT00908401|oral sucrose|oral sucrose
5595643|NCT00908401|analgesia|analgesia
5595644|NCT00908401|preterm neonates|preterm neonates
5595645|NCT00908401|Neonates|neonates
5595646|NCT00908388|Acute, Complicated Type B Dissection|acute, complicated type b dissection
5595647|NCT00908375|Pregabalin|pregabalin
5595648|NCT00908375|Radicular pain|radicular pain
5595649|NCT00908375|Failed back surgery|failed back surgery
5595650|NCT00908375|Of greater than 3 months duration|of greater than 3 months duration
5595651|NCT00908362|Dendritic cells|dendritic cells
5595652|NCT00908362|Airway|airway
5595653|NCT00908362|Smoker|smoker
5595654|NCT00908362|COPD|copd
5595655|NCT00908336|Adenocarcinoma|adenocarcinoma
5595656|NCT00908336|Carcinoma, Non-Small Cell|carcinoma, non-small cell
5595657|NCT00908336|Lung Neoplasms|lung neoplasms
5595658|NCT00908336|Docetaxel|docetaxel
5595659|NCT00908336|Erlotinib|erlotinib
5595660|NCT00908336|Chemotherapy|chemotherapy
5595661|NCT00908323|HIV Seronegativity|hiv seronegativity
5595662|NCT00908323|HIV Preventive Vaccine|hiv preventive vaccine
5595663|NCT00908310|CKD - Chronic Kidney Disease|ckd - chronic kidney disease
5595664|NCT00908310|GBCA - Gadolinium-based contrast agent|gbca - gadolinium-based contrast agent
5595665|NCT00908310|GFR - Glomerular Filtration Rate|gfr - glomerular filtration rate
5595666|NCT00908310|MRI - Magnetic Resonance Imaging|mri - magnetic resonance imaging
5595667|NCT00908310|NSF - Nephrogenic Systemic Fibrosis|nsf - nephrogenic systemic fibrosis
5595668|NCT00908310|Known or suspected CKD with an eGFR greater than or equal to 30mL & less than 60 mL/min/1.73m2 as measured within 30 days prior to the OMNISCAN.|known or suspected ckd with an egfr greater than or equal to 30ml & less than 60 ml/min/1.73m2 as measured within 30 days prior to the omniscan.
5595669|NCT00908297|Cardiovascular disease|cardiovascular disease
5595670|NCT00908297|End stage renal disease|end stage renal disease
5595671|NCT00908297|Atherosclerosis|atherosclerosis
5595672|NCT00908297|Oxidative stress|oxidative stress
5595673|NCT00908297|Antioxidants|antioxidants
5595674|NCT00908284|AIDS|aids
5595675|NCT00908284|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5595676|NCT00908284|Human Immunodeficiency Virus|human immunodeficiency virus
5595677|NCT00908284|Exercise Physiology|exercise physiology
5595678|NCT00908284|Endothelial Dysfunction|endothelial dysfunction
5595679|NCT00908245|Preconditioning|preconditioning
5595680|NCT00908245|Hepatectomy|hepatectomy
5595681|NCT00908245|Clamping|clamping
5595682|NCT00908232|multiple myeloma|multiple myeloma
5595683|NCT00908232|bortezomib|bortezomib
5595684|NCT00908232|hematology|hematology
5595685|NCT00908232|bone marrow cancer|bone marrow cancer
5595686|NCT00908232|immunoglobulin|immunoglobulin
5595687|NCT00908232|refractory|refractory
5595688|NCT00908232|progression|progression
5595689|NCT00908232|dexamethasone|dexamethasone
5595690|NCT00908232|lenalidomide|lenalidomide
5595691|NCT00908232|cyclophosphamide|cyclophosphamide
5595692|NCT00908219|malignant ascites|malignant ascites
5595693|NCT00908219|bevacizumab|bevacizumab
5578102|NCT00975689|NPC|npc
5595694|NCT00908219|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5595695|NCT00908219|paracentesis|paracentesis
5595696|NCT00908206|Alcoholism|alcoholism
5595697|NCT00908206|Craving|craving
5595698|NCT00908206|Dependence|dependence
5595699|NCT00908206|Alcohol|alcohol
5595700|NCT00908193|Treatment of abdominal ruptured|treatment of abdominal ruptured
5595701|NCT00908193|Digestive system disease|digestive system disease
5595702|NCT00908193|Coelioscopy|coelioscopy
5595703|NCT00908193|Assistance robotics|assistance robotics
5595704|NCT00908193|Medical device|medical device
5595705|NCT00908193|DA VINCI Robot|da vinci robot
5595706|NCT00908193|Pain patient|pain patient
5595707|NCT00908193|Morphine consumption|morphine consumption
5595708|NCT00908193|Comparative Randomized study|comparative randomized study
5595709|NCT00908193|patient over 18 years|patient over 18 years
5595710|NCT00908193|with ruptured abdominal|with ruptured abdominal
5595711|NCT00908193|with an indication of treatment of ruptured|with an indication of treatment of ruptured
5595712|NCT00908180|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5595713|NCT00908167|sorafenib|sorafenib
5595714|NCT00908167|cytarabine|cytarabine
5595715|NCT00908167|clofarabine|clofarabine
5595716|NCT00908167|acute myeloid leukemia|acute myeloid leukemia
5595717|NCT00908167|acute promyelocytic leukemia|acute promyelocytic leukemia
5595718|NCT00908167|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5595719|NCT00908154|sodium channel blocker|sodium channel blocker
5595720|NCT00908154|bipolar disorder|bipolar disorder
5595721|NCT00908154|repeat dose|repeat dose
5595722|NCT00908141|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5595723|NCT00908141|recurrent prostate cancer|recurrent prostate cancer
5595724|NCT00908128|Bioequivalence|bioequivalence
5595725|NCT00908128|Healthy Subjects|healthy subjects
5595726|NCT00908102|low back pain|low back pain
5595727|NCT00908102|recurrent|recurrent
5595728|NCT00908102|subacute|subacute
5595729|NCT00908102|secondary prevention|secondary prevention
5595730|NCT00908102|primary care|primary care
5595731|NCT00908102|occupational health|occupational health
5595732|NCT00908102|back book|back book
5595733|NCT00908102|rehabilitation|rehabilitation
5595734|NCT00908089|rheumatoid arthritis|rheumatoid arthritis
5595735|NCT00908089|methotrexate|methotrexate
5595736|NCT00908089|sulfasalazine|sulfasalazine
5595737|NCT00908089|hydroxychloroquine|hydroxychloroquine
5595738|NCT00908089|infliximab|infliximab
5595739|NCT00908076|constipation|constipation
5595740|NCT00908076|Parkinson's disease|parkinson's disease
5595742|NCT00908063|Traumatic Brain Injury|traumatic brain injury
5595743|NCT00908050|bruxism, botulinum toxin, sleep study|bruxism, botulinum toxin, sleep study
5595744|NCT00908037|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5595745|NCT00908037|thrombocytopenia|thrombocytopenia
5595746|NCT00908037|pharmacodynamics|pharmacodynamics
5595747|NCT00908037|ITP|itp
5595748|NCT00908037|eltrombopag|eltrombopag
5595749|NCT00908037|pharmacokinetics|pharmacokinetics
5595750|NCT00908037|chronic ITP|chronic itp
5595751|NCT00908037|pediatrics|pediatrics
5595752|NCT00908011|Hypercholesterolemia|hypercholesterolemia
5595753|NCT00908011|HIV|hiv
5595754|NCT00908011|Ezetimibe|ezetimibe
5595755|NCT00908011|Statin|statin
5595756|NCT00908011|Apolipoprotein B100/Apolipoprotein A1 ratio|apolipoprotein b100/apolipoprotein a1 ratio
5595757|NCT00907998|Coronary heart disease|coronary heart disease
5595758|NCT00907998|APL180|apl180
5595759|NCT00907985|Healthy Volunteer|healthy volunteer
5595760|NCT00907985|Resting motor threshold (rMT)|resting motor threshold (rmt)
5595761|NCT00907985|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5595762|NCT00907972|Parkinson's Disease|parkinson's disease
5595763|NCT00907972|Parkinson Disease|parkinson disease
5595764|NCT00907972|PD|pd
5595765|NCT00907972|Movement Disorder|movement disorder
5595766|NCT00907946|Renal stones|renal stones
5595767|NCT00907907|Bioequivalence|bioequivalence
5595769|NCT00907894|Chronic hepatitis B,|chronic hepatitis b,
5595770|NCT00907894|telbivudine,|telbivudine,
5595771|NCT00907894|pharmacokinetics,|pharmacokinetics,
5595772|NCT00907894|safety,|safety,
5595773|NCT00907894|tolerability,|tolerability,
5595774|NCT00907894|pediatric|pediatric
5595775|NCT00907868|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5595776|NCT00907855|Ischemic Heart Disease|ischemic heart disease
5595777|NCT00907855|Duke Activity Status Index|duke activity status index
5595778|NCT00907855|Stress Myocardial Perfusion Imaging|stress myocardial perfusion imaging
5595779|NCT00907842|stoma|stoma
5595780|NCT00907829|stroke|stroke
5595781|NCT00907829|fingertip force|fingertip force
5595782|NCT00907829|muscle coordination|muscle coordination
5595783|NCT00907816|this study does not look at patient conditions|this study does not look at patient conditions
5595784|NCT00907803|Orthopoxvirus|orthopoxvirus
5595785|NCT00907803|Smallpox|smallpox
5595786|NCT00907803|This is a safety study only|this is a safety study only
5595787|NCT00907803|ST-246 is being studied for treatment of Orthopoxviruses|st-246 is being studied for treatment of orthopoxviruses
5595788|NCT00907790|Irritable Bowel Syndrome|irritable bowel syndrome
5595789|NCT00907790|Cognitive Therapy|cognitive therapy
5595790|NCT00907790|Abdominal Pain|abdominal pain
5595791|NCT00907790|Quality of Life|quality of life
5595792|NCT00907777|Haemophilus influenzae|haemophilus influenzae
5595793|NCT00907777|Streptococcus pneumoniae|streptococcus pneumoniae
5595794|NCT00907777|safety|safety
5595795|NCT00907777|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5595796|NCT00907777|immunogenicity|immunogenicity
5595797|NCT00907725|medical abortion|medical abortion
5595798|NCT00907725|serum BhCG follow-up|serum bhcg follow-up
5595799|NCT00907725|ultrasonographic follow-up|ultrasonographic follow-up
5595800|NCT00907725|follow-up methods|follow-up methods
5595801|NCT00907712|amputation|amputation
5595802|NCT00907712|vascular|vascular
5595803|NCT00907712|below knee|below knee
5595804|NCT00907712|above knee|above knee
5595805|NCT00907712|cardiovascular|cardiovascular
5595806|NCT00907712|echo|echo
5595807|NCT00907712|cardiovascular assessment|cardiovascular assessment
5595808|NCT00907699|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5595809|NCT00907699|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5595810|NCT00907699|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5595811|NCT00907686|Transfusion Transmitted Cytomegalovirus (TT-CMV)|transfusion transmitted cytomegalovirus (tt-cmv)
5595812|NCT00907686|Low birthweight infants (LBWIs)|low birthweight infants (lbwis)
5595813|NCT00907686|Leukoreduction and filter failure|leukoreduction and filter failure
5680354|NCT00578123|Questionaires|questionaires
5595814|NCT00907686|CMV Seronegative blood products|cmv seronegative blood products
5595815|NCT00907660|Obesity|obesity
5595816|NCT00907660|Weight loss|weight loss
5595817|NCT00907660|Meal replacements|meal replacements
5595818|NCT00907660|Health services research|health services research
5595819|NCT00907634|cervix|cervix
5595820|NCT00907634|cervical|cervical
5595821|NCT00907634|radiation|radiation
5595822|NCT00907621|Infant Colic|infant colic
5595823|NCT00907621|Acupuncture|acupuncture
5595824|NCT00907621|General Practice|general practice
5595825|NCT00907595|Huntington's chorea|huntington's chorea
5595826|NCT00907595|Huntington's Disease|huntington's disease
5595827|NCT00907595|Parkinson's Disease|parkinson's disease
5595828|NCT00907595|Parkinsonism|parkinsonism
5595829|NCT00907595|Dementia|dementia
5595830|NCT00907595|Dementia with Lewy Bodies|dementia with lewy bodies
5595831|NCT00907595|Actigraphy|actigraphy
5595832|NCT00907595|Circadian dysregulation|circadian dysregulation
5595833|NCT00907595|Sleep Disorders|sleep disorders
5595834|NCT00907595|Circadian rhythm|circadian rhythm
5595835|NCT00907582|PCR negative|pcr negative
5595836|NCT00907569|Small cell lung cancer|small cell lung cancer
5595837|NCT00907569|radiotherapy dose escalation|radiotherapy dose escalation
5595838|NCT00907543|esophageal carcinoma|esophageal carcinoma
5595839|NCT00907543|chemotherapy|chemotherapy
5595840|NCT00907543|radiation|radiation
5595842|NCT00907543|randomized clinical trial|randomized clinical trial
5595843|NCT00907543|Clinical Trial|clinical trial
5595844|NCT00907543|Radiotherapy|radiotherapy
5595845|NCT00907491|Cough|cough
5595846|NCT00907491|Wheeze Rate|wheeze rate
5595847|NCT00907491|Respiratory Function Tests|respiratory function tests
5595848|NCT00907478|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5595849|NCT00907478|Idiopathic Thrombocytopenia Purpura|idiopathic thrombocytopenia purpura
5595850|NCT00907478|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5595851|NCT00907478|Immune Thrombocytopenia|immune thrombocytopenia
5595853|NCT00907452|Pharmacogenomics|pharmacogenomics
5595854|NCT00907452|prediction response|prediction response
5595855|NCT00907452|prediction adverse event|prediction adverse event
5595856|NCT00907439|Diastole, physiopathology|diastole, physiopathology
5595857|NCT00907439|coronary artery disease|coronary artery disease
5595858|NCT00907439|volatile anesthetic|volatile anesthetic
5595859|NCT00907439|sevoflurane|sevoflurane
5595860|NCT00907426|eyelashes|eyelashes
5595861|NCT00907413|cancer|cancer
5595862|NCT00907413|bile duct|bile duct
5595863|NCT00907400|Phase 1|phase 1
5595864|NCT00907400|Healthy Volunteer|healthy volunteer
5595865|NCT00907400|Healthy Volunteer Study|healthy volunteer study
5595866|NCT00907387|Lateral Canthal Lines|lateral canthal lines
5595867|NCT00907387|Crow's Feet|crow's feet
5595868|NCT00907387|Facial Wrinkles|facial wrinkles
5595869|NCT00907374|Microalbuminuria|microalbuminuria
5595870|NCT00907374|Carotid intima media thickness|carotid intima media thickness
5595871|NCT00907374|Endothelial dysfunction|endothelial dysfunction
5595872|NCT00907374|Renin angiotensin system|renin angiotensin system
5595873|NCT00907374|Diabetic nephropathy|diabetic nephropathy
5595874|NCT00907361|pacemaker|pacemaker
5595875|NCT00907361|ICD|icd
5595876|NCT00907361|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5595877|NCT00907361|MRI|mri
5595878|NCT00907361|Magnetic Resonance Imaging|magnetic resonance imaging
5595879|NCT00907348|NHL|nhl
5595880|NCT00907348|Non Hodgkin Lymphoma|non hodgkin lymphoma
5595881|NCT00907348|Follicular Lymphoma|follicular lymphoma
5595882|NCT00907335|acne|acne
5595883|NCT00907335|irritation|irritation
5595884|NCT00907335|objective sensory methods|objective sensory methods
5578282|NCT00974961|Levobupivacaine|levobupivacaine
5595885|NCT00907322|oral, single ascending doses; CYP2D6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics|oral, single ascending doses; cyp2d6 metabolizer status; healthy subjects; safety, tolerability, pharmacokinetics
5595886|NCT00907309|alcohol abuse|alcohol abuse
5595887|NCT00907309|marijuana abuse|marijuana abuse
5595888|NCT00907309|drug abuse|drug abuse
5595889|NCT00907309|tobacco use|tobacco use
5595890|NCT00907309|tobacco dependence|tobacco dependence
5595891|NCT00907296|Fracture Healing|fracture healing
5595892|NCT00907296|Tibial Diaphyseal Fracture|tibial diaphyseal fracture
5595893|NCT00907283|NBIA|nbia
5595894|NCT00907283|Iron overload AND brain|iron overload and brain
5595895|NCT00907283|Iron chelation AND neurodegeneration|iron chelation and neurodegeneration
5595896|NCT00907283|Brain iron Overload|brain iron overload
5595897|NCT00907283|Neurodegeneration|neurodegeneration
5595898|NCT00907283|Brain iron Accumulation|brain iron accumulation
5595899|NCT00907257|acne|acne
5595901|NCT00907257|objective sensory methods|objective sensory methods
5595902|NCT00907218|ADHD|adhd
5595903|NCT00907218|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5595904|NCT00907218|ADHD medication|adhd medication
5595905|NCT00907218|Chantix|chantix
5595906|NCT00907218|varenicline|varenicline
5595907|NCT00907218|smoking|smoking
5595908|NCT00907218|smoking cessation|smoking cessation
5595909|NCT00907218|quit smoking|quit smoking
5595910|NCT00907205|Advanced Solid Tumors|advanced solid tumors
5595911|NCT00907205|Metastatic Solid Tumors|metastatic solid tumors
5595912|NCT00907205|PI3K|pi3k
5595913|NCT00907205|PI3K Inhibitors|pi3k inhibitors
5595914|NCT00907205|PI3 Kinase Inhibitors|pi3 kinase inhibitors
5595915|NCT00907205|mTORC inhibitor|mtorc inhibitor
5595916|NCT00907205|mTORC1 inhibitor|mtorc1 inhibitor
5595917|NCT00907205|mTORC2 inhibitor|mtorc2 inhibitor
5595918|NCT00907205|vascular targeted|vascular targeted
5595919|NCT00907205|conjugate|conjugate
5595920|NCT00907192|Cancer|cancer
5595921|NCT00907192|Opioid analgesic prescriptions|opioid analgesic prescriptions
5595922|NCT00907192|Narcotic pain drugs|narcotic pain drugs
5595923|NCT00907192|Self-report|self-report
5595924|NCT00907192|Questionnaire|questionnaire
5595925|NCT00907192|Interview|interview
5595926|NCT00907192|Actual use|actual use
5595927|NCT00907192|Doctor-prescribed use|doctor-prescribed use
5595928|NCT00907192|Frequency of deviation|frequency of deviation
5595929|NCT00907166|Cornerstone Pharmaceuticals, Inc.|cornerstone pharmaceuticals, inc.
5595930|NCT00907166|CPI-613|cpi-613
5595931|NCT00907166|Altered Energy Metabolism Directed Compound|altered energy metabolism directed compound
5595932|NCT00907166|Phase I|phase i
5595933|NCT00907166|Phase II|phase ii
5595934|NCT00907166|Cancer|cancer
5595935|NCT00907166|Carcinoma of the Pancreas|carcinoma of the pancreas
5595936|NCT00907166|Pancreatic Cancer|pancreatic cancer
5595937|NCT00907166|Pancreatic Carcinoma|pancreatic carcinoma
5595938|NCT00907153|Polycystic Ovary Syndrome|polycystic ovary syndrome
5595939|NCT00907153|Vitamin D|vitamin d
5595940|NCT00907153|Insulin resistance|insulin resistance
5595941|NCT00907153|Inflammation|inflammation
5595942|NCT00907140|Cervical Cancer|cervical cancer
5595943|NCT00907140|Positron Emission Tomography|positron emission tomography
5595944|NCT00907140|Fluorodeoxyglucose|fluorodeoxyglucose
5595945|NCT00907127|Metabolic|metabolic
5595946|NCT00907127|Syndrome|syndrome
5595947|NCT00907127|CAN|can
5595948|NCT00907114|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5595949|NCT00907114|macular edema|macular edema
5595950|NCT00907114|panphotocoagulation|panphotocoagulation
5595951|NCT00907114|topic ketorolac|topic ketorolac
5595952|NCT00907114|efficacy|efficacy
5595953|NCT00907114|treatment|treatment
5595954|NCT00907088|Iron depletion|iron depletion
5595955|NCT00907088|Children|children
5595956|NCT00907088|Educational intervention|educational intervention
5595957|NCT00907088|Office-based|office-based
5595958|NCT00907075|diabetes|diabetes
5595959|NCT00907075|nutrition|nutrition
5595960|NCT00907075|diet|diet
5595962|NCT00907062|vitiligo|vitiligo
5595963|NCT00907062|leucoderma|leucoderma
5595964|NCT00907049|quality of sleep|quality of sleep
5595965|NCT00907049|neck pain|neck pain
5595966|NCT00907049|disability|disability
5595967|NCT00907049|catastrophizing|catastrophizing
5595968|NCT00907049|depression|depression
5595969|NCT00907036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5595970|NCT00907023|solid organ transplant|solid organ transplant
5595971|NCT00907023|hospital discharge|hospital discharge
5595972|NCT00907010|Ageing|ageing
5595973|NCT00907010|Sarcopenia|sarcopenia
5595974|NCT00907010|Muscular contraction|muscular contraction
5595975|NCT00906997|Colorectal cancer|colorectal cancer
5595976|NCT00906997|Screening|screening
5595977|NCT00906997|Prevention|prevention
5595978|NCT00906997|Fecal occult blood test|fecal occult blood test
5595979|NCT00906997|Colonoscopy|colonoscopy
5595980|NCT00906997|Colorectal neoplasm|colorectal neoplasm
5595981|NCT00906997|Randomized clinical trial|randomized clinical trial
5595982|NCT00906984|Hepatocellular carcinoma|hepatocellular carcinoma
5595983|NCT00906984|Liver cancer|liver cancer
5595984|NCT00906984|Primary liver cancer|primary liver cancer
5595985|NCT00906984|Unresectable liver cancer|unresectable liver cancer
5595986|NCT00906984|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5595987|NCT00906984|TheraSphere|therasphere
5595988|NCT00906971|Physical Therapy|physical therapy
5595989|NCT00906971|Chronic Functional Constipation|chronic functional constipation
5595990|NCT00906971|Children|children
5595991|NCT00906945|stem cell mobilization|stem cell mobilization
5595992|NCT00906945|chemosensitization|chemosensitization
5595993|NCT00906945|CXCR4|cxcr4
5595994|NCT00906945|SDF-1|sdf-1
5595995|NCT00906945|CXCL-12|cxcl-12
5595996|NCT00906932|Fiberoptic intubation|fiberoptic intubation
5595997|NCT00906932|direct laryngoscopy|direct laryngoscopy
5595998|NCT00906932|Trachview|trachview
5595999|NCT00906932|Comparison of a fiberoptic intubating videoscope to direct laryngoscopy.|comparison of a fiberoptic intubating videoscope to direct laryngoscopy.
5596000|NCT00906919|self-efficacy|self-efficacy
5596001|NCT00906919|health behavior|health behavior
5596002|NCT00906919|patient education|patient education
5596003|NCT00906919|health education|health education
5596004|NCT00906893|[18F]-FMISO uptake|[18f]-fmiso uptake
5596005|NCT00906893|Glioblastoma|glioblastoma
5596007|NCT00906893|tumours|tumours
5596008|NCT00906880|Human African Trypanosomiasis|human african trypanosomiasis
5596010|NCT00906880|sleeping sickness|sleeping sickness
5680355|NCT00578123|04-094|04-094
5596011|NCT00906880|combination treatment|combination treatment
5596012|NCT00906880|nifurtimox|nifurtimox
5596013|NCT00906880|eflornithine|eflornithine
5596014|NCT00906880|Human African Trypanosomiasis in the meningo-encephalitic phase (stage 2 HAT)|human african trypanosomiasis in the meningo-encephalitic phase (stage 2 hat)
5596015|NCT00906867|Vocal cord dysfunction|vocal cord dysfunction
5596016|NCT00906867|Laryngoscopy|laryngoscopy
5596017|NCT00906867|Methacholine challenge|methacholine challenge
5596018|NCT00906867|Pulmonary function testing|pulmonary function testing
5596019|NCT00906854|urinary incontinence|urinary incontinence
5596020|NCT00906854|physical exercise|physical exercise
5596021|NCT00906841|Disseminated diffuse large B-cell lymphoma|disseminated diffuse large b-cell lymphoma
5596022|NCT00906841|first line treatment|first line treatment
5596023|NCT00906841|R CHOP|r chop
5596024|NCT00906841|90Y-DOTA-hLL2|90y-dota-hll2
5596025|NCT00906841|Patients older than 60 years|patients older than 60 years
5596026|NCT00906828|Levodopa/carbidopa infusion|levodopa/carbidopa infusion
5596027|NCT00906828|entacapone|entacapone
5596028|NCT00906828|tolcapone|tolcapone
5596029|NCT00906828|efficacy|efficacy
5596030|NCT00906828|pharmacokinetic|pharmacokinetic
5596031|NCT00906828|pharmacodynamics|pharmacodynamics
5596032|NCT00906802|pancreaticoduodenectomy|pancreaticoduodenectomy
5596033|NCT00906802|reconstruction|reconstruction
5596034|NCT00906789|Lung Cancer|lung cancer
5596035|NCT00906789|Chest Radiograph|chest radiograph
5596036|NCT00906789|Computer-aided Detection|computer-aided detection
5596037|NCT00906789|Image processing|image processing
5596038|NCT00906763|Parkinson's disease|parkinson's disease
5596039|NCT00906763|Neurodegenerative Disorders|neurodegenerative disorders
5596040|NCT00906763|Biogenic amines|biogenic amines
5596041|NCT00906763|Chocolate|chocolate
5596042|NCT00906763|Cocoa|cocoa
5596043|NCT00906750|FLuMIST|flumist
5596044|NCT00906750|Inactivated influenza vaccine|inactivated influenza vaccine
5596045|NCT00906750|Study of FluMist versus inactivated influenza vaccine in children with cancer|study of flumist versus inactivated influenza vaccine in children with cancer
5596046|NCT00906737|Multiple Sclerosis|multiple sclerosis
5596047|NCT00906737|Gait|gait
5596048|NCT00906737|foot-drop|foot-drop
5596049|NCT00906737|Ankle-Bot|ankle-bot
5596050|NCT00906737|Physical Therapy|physical therapy
5596051|NCT00906737|Gait Abnormalities|gait abnormalities
5596052|NCT00906711|Aging|aging
5596053|NCT00906711|Postural Balance|postural balance
5596054|NCT00906685|CRVO|crvo
5596055|NCT00906685|anti-VEGF|anti-vegf
5596056|NCT00906685|Macular edema|macular edema
5589917|NCT00931034|obesity|obesity
5596057|NCT00906672|Dermal substitute Integra®|dermal substitute integra®
5596059|NCT00906672|graft|graft
5596060|NCT00906672|traumatic wound|traumatic wound
5596061|NCT00906672|medico economic costs|medico economic costs
5596062|NCT00906672|esthetical and functional scar results|esthetical and functional scar results
5596063|NCT00906659|center point thickness|center point thickness
5596064|NCT00906659|diabetic retinopathy|diabetic retinopathy
5596065|NCT00906659|diabetic macular edema|diabetic macular edema
5596066|NCT00906659|macular volume|macular volume
5596067|NCT00906659|visual capacity|visual capacity
5596068|NCT00906659|visual function|visual function
5596069|NCT00906646|cardiac|cardiac
5596070|NCT00906646|surgery|surgery
5596071|NCT00906646|metabolic|metabolic
5596072|NCT00906646|supplements|supplements
5596073|NCT00906646|antioxidant|antioxidant
5596074|NCT00906633|antifungal therapies|antifungal therapies
5596075|NCT00906620|Data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality|data on student's healthy and at-risk lifestyles and their relation with health measured by well-being, depression and suicidality
5596076|NCT00906607|Urinary Incontinence|urinary incontinence
5596077|NCT00906581|Depression|depression
5596078|NCT00906568|Cystic fibrosis|cystic fibrosis
5596079|NCT00906568|Sensitization to Aspergillus|sensitization to aspergillus
5596080|NCT00906568|Bronchial allergen challenge|bronchial allergen challenge
5596081|NCT00906568|Induced Sputum|induced sputum
5596082|NCT00906568|Bronchial inflammation|bronchial inflammation
5596083|NCT00906568|Small airways disease (SAD)|small airways disease (sad)
5596084|NCT00906542|acute stroke|acute stroke
5596085|NCT00906542|ischemic stroke|ischemic stroke
5596086|NCT00906542|pneumonia|pneumonia
5596087|NCT00906542|chest infection|chest infection
5596088|NCT00906542|brain lesion|brain lesion
5596089|NCT00906542|lesion topology|lesion topology
5596090|NCT00906542|dysphagia|dysphagia
5596091|NCT00906542|sympathetic activation|sympathetic activation
5596092|NCT00906542|immunosuppression|immunosuppression
5596093|NCT00906529|Type 2 Diabetes|type 2 diabetes
5596094|NCT00906529|Inpatient|inpatient
5596095|NCT00906529|Length of Stay|length of stay
5596096|NCT00906529|Blood Glucose Control|blood glucose control
5596097|NCT00906516|Recurrent Glioblastoma multiforme (GBM)|recurrent glioblastoma multiforme (gbm)
5596098|NCT00906516|Recurrent Brain Tumor|recurrent brain tumor
5596099|NCT00906516|Recurrent Brain Disease|recurrent brain disease
5596101|NCT00906516|Avastin|avastin
5596102|NCT00906516|Bevacizumab|bevacizumab
5581145|NCT00963989|mRS|mrs
5596103|NCT00906503|pulmonary nodule|pulmonary nodule
5596104|NCT00906490|Glucose Monitoring|glucose monitoring
5596105|NCT00906490|Accurate Blood Glucose Monitoring in critical care setting|accurate blood glucose monitoring in critical care setting
5596106|NCT00906451|myocardial infarction|myocardial infarction
5596107|NCT00906451|inflammation|inflammation
5596108|NCT00906451|endothelial dysfunction|endothelial dysfunction
5596109|NCT00906425|Dental Implant|dental implant
5596110|NCT00906412|Essential Tremor|essential tremor
5596111|NCT00906399|interferon|interferon
5596112|NCT00906399|injectable|injectable
5596115|NCT00906399|PEGylated|pegylated
5596116|NCT00906399|Interferon beta-1a|interferon beta-1a
5596117|NCT00906399|relapsing|relapsing
5596118|NCT00906399|PEG|peg
5596119|NCT00906399|multiple sclerosis|multiple sclerosis
5596120|NCT00906399|subcutaneous|subcutaneous
5596121|NCT00906386|Varenicline|varenicline
5596122|NCT00906373|Hepatocellular Carcinoma|hepatocellular carcinoma
5596123|NCT00906373|Liver Neoplasms|liver neoplasms
5596124|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal
5596125|NCT00906347|Labor augmentation|labor augmentation
5596126|NCT00906347|Oral misoprostol|oral misoprostol
5596127|NCT00906334|Myelodysplastic Syndrome|myelodysplastic syndrome
5596128|NCT00906334|Trisomy 8|trisomy 8
5596129|NCT00906334|Intermediate-2 Risk Group|intermediate-2 risk group
5596130|NCT00906334|High-Risk Group|high-risk group
5596131|NCT00906334|azacitidine|azacitidine
5596132|NCT00906334|azacytidine|azacytidine
5596133|NCT00906334|Vidaza|vidaza
5596134|NCT00906334|decitabine|decitabine
5596135|NCT00906334|Dacogen|dacogen
5596136|NCT00906321|Web-Based Decision Support|web-based decision support
5596137|NCT00906321|Breast Cancer Risk|breast cancer risk
5596138|NCT00906295|Hemoglobin|hemoglobin
5596139|NCT00906295|Ambulation|ambulation
5596140|NCT00906282|neoadjuvant NSCLC|neoadjuvant nsclc
5596141|NCT00906282|NSCLC|nsclc
5596142|NCT00906282|pemetrexed|pemetrexed
5596143|NCT00906269|impotence|impotence
5596144|NCT00906269|prostatic neoplasms|prostatic neoplasms
5596145|NCT00906269|hyperbaric oxygenation|hyperbaric oxygenation
5596146|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5596147|NCT00906256|Hepatitis C|hepatitis c
5596148|NCT00906256|Pharmacokinetics|pharmacokinetics
5596149|NCT00906256|AZD7295|azd7295
5596150|NCT00906256|Healthy volunteers|healthy volunteers
5596151|NCT00906217|colonoscopy|colonoscopy
5596152|NCT00906217|preparation|preparation
5596153|NCT00906217|safety|safety
5596154|NCT00906217|elderly|elderly
5596155|NCT00906204|Renal transplantation|renal transplantation
5596156|NCT00906204|Kidney transplantation|kidney transplantation
5596158|NCT00906178|technology|technology
5596159|NCT00906178|adolescent|adolescent
5596160|NCT00906178|developing countries|developing countries
5596161|NCT00906152|quality of sleep|quality of sleep
5596162|NCT00906152|low back pain|low back pain
5596163|NCT00906152|disability|disability
5596164|NCT00906152|catastrophizing|catastrophizing
5596165|NCT00906152|depression|depression
5596166|NCT00906139|Propofol|propofol
5596167|NCT00906139|Midazolam|midazolam
5596168|NCT00906139|Cirrhosis|cirrhosis
5596169|NCT00906139|Gastrointestinal endoscopy|gastrointestinal endoscopy
5596170|NCT00906139|Complications|complications
5596171|NCT00906139|Sedation|sedation
5596172|NCT00906126|oral misoprostol|oral misoprostol
5596173|NCT00906126|labor augmentation|labor augmentation
5596174|NCT00906126|arrest of dilation|arrest of dilation
5596175|NCT00906126|nulliparous|nulliparous
5596176|NCT00906113|Retinoblastoma|retinoblastoma
5596177|NCT00906100|Biventricular ICD|biventricular icd
5596178|NCT00906100|AV delay|av delay
5596179|NCT00906087|Myocilin gene|myocilin gene
5596180|NCT00906087|Glaucoma|glaucoma
5596181|NCT00906087|dorzolamide and timolol combination eyedrop|dorzolamide and timolol combination eyedrop
5596183|NCT00906074|Surgical Site Infection|surgical site infection
5596184|NCT00906074|Abdominal Surgery|abdominal surgery
5596185|NCT00906061|Carcinoma, Small Cell|carcinoma, small cell
5596186|NCT00906061|Lung Neoplasms|lung neoplasms
5596187|NCT00906061|Docetaxel|docetaxel
5596188|NCT00906061|Gemcitabine|gemcitabine
5596189|NCT00906061|ECOG 2|ecog 2
5596190|NCT00906035|Peripheral Arterial Disease|peripheral arterial disease
5596191|NCT00906035|PAD|pad
5596192|NCT00906035|Claudication|claudication
5596193|NCT00906035|Peripheral Vascular Disease|peripheral vascular disease
5596194|NCT00906022|Below the Knee|below the knee
5596195|NCT00906022|Infrapopliteal arteries|infrapopliteal arteries
5596196|NCT00906022|nitinol|nitinol
5596197|NCT00906022|limb ischemia|limb ischemia
5596198|NCT00906022|claudication|claudication
5596199|NCT00906022|self-expanding stent|self-expanding stent
5596200|NCT00906022|duplex|duplex
5596201|NCT00906022|angiography|angiography
5596202|NCT00905983|Carcinoma, Non-Small-Cell|carcinoma, non-small-cell
5596203|NCT00905983|Elderly patients|elderly patients
5596204|NCT00905983|Docetaxel|docetaxel
5596205|NCT00905983|Gemcitabine|gemcitabine
5596206|NCT00905957|transversus abdominis plane block|transversus abdominis plane block
5596208|NCT00905944|Left ventricular failure|left ventricular failure
5596209|NCT00905944|chronic heart failure|chronic heart failure
5596210|NCT00905944|Pacemaker|pacemaker
5596211|NCT00905944|Resynchronisation therapy|resynchronisation therapy
5596212|NCT00905944|Exercise|exercise
5596213|NCT00905944|Endurance exercise|endurance exercise
5596214|NCT00905931|Aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
5596215|NCT00905931|Cerebral vasospasm|cerebral vasospasm
5596216|NCT00905931|impaired cerebral autoregulation|impaired cerebral autoregulation
5596217|NCT00905931|transient hyperaemic response test|transient hyperaemic response test
5596218|NCT00905931|delayed ischaemic neurological deficits|delayed ischaemic neurological deficits
5596219|NCT00905918|colon cancer|colon cancer
5596220|NCT00905918|rectal cancer|rectal cancer
5596221|NCT00905905|myocardial infarction|myocardial infarction
5596222|NCT00905905|systemic inflammatory activity|systemic inflammatory activity
5596223|NCT00905905|endothelial function|endothelial function
5596224|NCT00905892|overfeeding|overfeeding
5596225|NCT00905892|stable isotopes|stable isotopes
5596226|NCT00905892|lipoprotein metabolism|lipoprotein metabolism
5596227|NCT00905892|lipid oxidation|lipid oxidation
5596228|NCT00905892|fat distribution|fat distribution
5596229|NCT00905892|gene expression|gene expression
5596230|NCT00905892|endotoxemia|endotoxemia
5596231|NCT00905892|mass spectrometry/gas chromatography|mass spectrometry/gas chromatography
5596232|NCT00905879|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5596233|NCT00905879|Observational study|observational study
5596234|NCT00905879|Gadobutrol|gadobutrol
5596235|NCT00905866|Quality of life|quality of life
5596236|NCT00905866|Hyperparathyroidism|hyperparathyroidism
5596237|NCT00905853|Ventricular Tachycardia|ventricular tachycardia
5596238|NCT00905853|Catheter Ablation|catheter ablation
5596239|NCT00905853|ICD therapy|icd therapy
5596240|NCT00905853|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5596241|NCT00905853|Ischemic Heart Disease|ischemic heart disease
5596242|NCT00905827|suicide|suicide
5596243|NCT00905827|assessment|assessment
5596244|NCT00905827|management|management
5596245|NCT00905827|Provider Training|provider training
5596246|NCT00905827|health services|health services
5596247|NCT00905814|Bioequivalence|bioequivalence
5596248|NCT00905801|Non small cell lung cancer|non small cell lung cancer
5596249|NCT00905801|NSCLC|nsclc
5596250|NCT00905801|CTP|ctp
5596251|NCT00905801|Perfusion|perfusion
5596252|NCT00905801|Imaging|imaging
5596253|NCT00905788|Embryo transfer|embryo transfer
5596254|NCT00905788|IVF/ICSI|ivf/icsi
5596255|NCT00905788|Embryo expulsion|embryo expulsion
5596256|NCT00905775|Isoflurane;|isoflurane;
5596257|NCT00905775|Propofol|propofol
5596258|NCT00905775|Renal functions tests|renal functions tests
5596259|NCT00905775|Cardiovascular tests|cardiovascular tests
5596260|NCT00905775|revascularization surgery of the myocardium|revascularization surgery of the myocardium
5596261|NCT00905775|extracorporeal circulation|extracorporeal circulation
5596262|NCT00905762|pharmacokinetics|pharmacokinetics
5596263|NCT00905736|tendon|tendon
5596264|NCT00905736|healing|healing
5596265|NCT00905736|microcurrent|microcurrent
5596266|NCT00905736|chronic tennis elbow|chronic tennis elbow
5596267|NCT00905723|climacterium|climacterium
5596268|NCT00905723|sexual life|sexual life
5596269|NCT00905723|isoflavone|isoflavone
5596270|NCT00905723|estrogen|estrogen
5596271|NCT00905723|McCoy's sexual questionnaire|mccoy's sexual questionnaire
5596272|NCT00905723|Kupperman index|kupperman index
5596273|NCT00905710|colorectal adenomas|colorectal adenomas
5596274|NCT00905710|colorectal cancer|colorectal cancer
5596275|NCT00905710|Lynch syndrome|lynch syndrome
5596276|NCT00905710|chromoendoscopy|chromoendoscopy
5596277|NCT00905697|Living donor lung transplantation|living donor lung transplantation
5596278|NCT00905697|Health-related quality of life|health-related quality of life
5596279|NCT00905697|Prognosis|prognosis
5596280|NCT00905697|Patient reported outcome|patient reported outcome
5596281|NCT00905684|Compliance|compliance
5596282|NCT00905684|Hormonal Contraception|hormonal contraception
5596283|NCT00905671|Lipid Core Plaque|lipid core plaque
5596285|NCT00905671|Bifurcation|bifurcation
5596286|NCT00905671|Stenosis|stenosis
5596287|NCT00905671|Lesion|lesion
5596288|NCT00905671|Angioplasty|angioplasty
5596289|NCT00905658|stage IVA cervical cancer|stage iva cervical cancer
5596290|NCT00905658|stage IVB cervical cancer|stage ivb cervical cancer
5596291|NCT00905658|fallopian tube cancer|fallopian tube cancer
5596292|NCT00905658|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5596293|NCT00905658|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5596294|NCT00905658|ovarian sarcoma|ovarian sarcoma
5596295|NCT00905658|ovarian stromal cancer|ovarian stromal cancer
5596296|NCT00905658|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5596297|NCT00905658|stage IV uterine sarcoma|stage iv uterine sarcoma
5596298|NCT00905658|stage IVA vaginal cancer|stage iva vaginal cancer
5596299|NCT00905658|stage IVB vaginal cancer|stage ivb vaginal cancer
5596300|NCT00905658|stage IV vulvar cancer|stage iv vulvar cancer
5596302|NCT00905645|Breast Reconstruction|breast reconstruction
5596303|NCT00905645|Breast Revision|breast revision
5596304|NCT00905645|Silicone breast implants|silicone breast implants
5596305|NCT00905606|Bioequivalence|bioequivalence
5596306|NCT00905606|Healthy Subjects|healthy subjects
5596307|NCT00905593|chronic myeloid leukemia,|chronic myeloid leukemia,
5596308|NCT00905593|blast crisis,|blast crisis,
5596309|NCT00905593|accelerated phase,|accelerated phase,
5596310|NCT00905593|nilotinib,|nilotinib,
5596311|NCT00905593|imatinib,|imatinib,
5596312|NCT00905593|resistant,|resistant,
5596313|NCT00905593|intolerant,|intolerant,
5596314|NCT00905593|chronic phase|chronic phase
5596315|NCT00905580|thyroidectomy|thyroidectomy
5596316|NCT00905580|pain, postoperative|pain, postoperative
5596317|NCT00905580|pregabalin|pregabalin
5596318|NCT00905567|Bioequivalence|bioequivalence
5596319|NCT00905567|Healthy Subjects|healthy subjects
5596320|NCT00905554|sedation|sedation
5596321|NCT00905554|warm water|warm water
5596322|NCT00905528|type 2 diabetes mellitus|type 2 diabetes mellitus
5596323|NCT00905528|endothelial function|endothelial function
5596324|NCT00905528|renal hemodynamics|renal hemodynamics
5596325|NCT00905515|Kidney Transplantation|kidney transplantation
5596326|NCT00905515|Immunosuppressive Agents|immunosuppressive agents
5596327|NCT00905502|Obesity|obesity
5596328|NCT00905502|fluid management|fluid management
5596329|NCT00905502|postoperative complications|postoperative complications
5596330|NCT00905502|bariatric surgery|bariatric surgery
5596331|NCT00905502|hemostasis|hemostasis
5596332|NCT00905476|NPPV|nppv
5596333|NCT00905476|Prognosis|prognosis
5596334|NCT00905476|Health-related quality of life|health-related quality of life
5596335|NCT00905476|Patient reported outcomes|patient reported outcomes
5596336|NCT00905463|Lung transplant candidates|lung transplant candidates
5596337|NCT00905463|Health-related quality of life|health-related quality of life
5596338|NCT00905463|patient reported outcome|patient reported outcome
5596339|NCT00905463|Prognosis|prognosis
5596340|NCT00905450|Surgery|surgery
5596341|NCT00905437|perioperative|perioperative
5596342|NCT00905437|pregabalin|pregabalin
5596343|NCT00905437|total hip replacement|total hip replacement
5596344|NCT00905437|post-operative pain|post-operative pain
5596345|NCT00905411|Overweight|overweight
5596346|NCT00905411|blood pressure|blood pressure
5596347|NCT00905411|DASH diet|dash diet
5596348|NCT00905411|Pacific|pacific
5596349|NCT00905411|children|children
5596350|NCT00905398|Leukemia|leukemia
5596351|NCT00905398|Lymphoblastic|lymphoblastic
5596352|NCT00905398|Acute|acute
5596353|NCT00905398|Philadelphia|philadelphia
5596354|NCT00905398|BCR-ABL|bcr-abl
5596355|NCT00905398|Nilotinib|nilotinib
5596356|NCT00905398|Treatment|treatment
5862992|NCT00001420|Psoriasis|psoriasis
5596357|NCT00905385|nontypeable Haemophilus influenzae, NTHi|nontypeable haemophilus influenzae, nthi
5596358|NCT00905346|Bioequivalence|bioequivalence
5596359|NCT00905346|Healthy Subjects|healthy subjects
5596360|NCT00905333|pharmacokinetics|pharmacokinetics
5596362|NCT00905333|felodipine|felodipine
5596363|NCT00905333|test formulations|test formulations
5596364|NCT00905333|Atacand®|atacand®
5596365|NCT00905333|Splendil®|splendil®
5596366|NCT00905333|healthy volunteers|healthy volunteers
5596367|NCT00905333|blood samples|blood samples
5596368|NCT00905333|after meal intake interaction|after meal intake interaction
5596369|NCT00905333|Kinetic interaction amongst test formulations of Candesartan and Felodipine and the brands Atacand® and Splendil® in healthy volunteers after a fasting period.|kinetic interaction amongst test formulations of candesartan and felodipine and the brands atacand® and splendil® in healthy volunteers after a fasting period.
5596370|NCT00905320|Hernia repair|hernia repair
5596371|NCT00905307|Schizophrenia|schizophrenia
5596372|NCT00905307|Relapsed|relapsed
5596373|NCT00905281|Metastatic breast cancer|metastatic breast cancer
5596374|NCT00905281|Supportive care|supportive care
5596375|NCT00905281|Third or fourth line of chemotherapy|third or fourth line of chemotherapy
5596377|NCT00905281|Treatment preferences|treatment preferences
5596378|NCT00905268|FRDA|frda
5596379|NCT00905268|idebenone|idebenone
5596380|NCT00905268|FRDA disease|frda disease
5596381|NCT00905255|hyperglycemia|hyperglycemia
5596382|NCT00905255|GLP-1|glp-1
5596383|NCT00905242|Kidney Transplantation|kidney transplantation
5596384|NCT00905242|Gastrointestinal Agents|gastrointestinal agents
5596385|NCT00905229|hip fracture|hip fracture
5596386|NCT00905229|warfarin|warfarin
5596387|NCT00905229|vitamin k|vitamin k
5596388|NCT00905229|Phytonadione|phytonadione
5596389|NCT00905229|INR level|inr level
5596390|NCT00905216|heparin|heparin
5596391|NCT00905203|Postmenopausal women|postmenopausal women
5596392|NCT00905203|Diabetes|diabetes
5596393|NCT00905203|Skin microcirculation|skin microcirculation
5596394|NCT00905203|Exercise capacity|exercise capacity
5596395|NCT00905203|Skeletal muscle oxygenation|skeletal muscle oxygenation
5596396|NCT00905203|Dose-response relationship|dose-response relationship
5596397|NCT00905203|postmenopausal diabetic women|postmenopausal diabetic women
5596398|NCT00905177|Atrial Fibrillation|atrial fibrillation
5596399|NCT00905177|deep vein thrombosis|deep vein thrombosis
5596400|NCT00905177|anticoagulation|anticoagulation
5596401|NCT00905177|warfarin|warfarin
5596402|NCT00905177|coumadin|coumadin
5596403|NCT00905164|Bioequivalence|bioequivalence
5596404|NCT00905164|Healthy Subjects|healthy subjects
5596405|NCT00905151|HIV positive|hiv positive
5596407|NCT00905151|antiretroviral|antiretroviral
5596408|NCT00905151|Kidney disease|kidney disease
5596409|NCT00905151|Antiretroviral Therapy|antiretroviral therapy
5596410|NCT00905138|Safety|safety
5596411|NCT00905138|Tolerability|tolerability
5596412|NCT00905138|Pharmacokinetics|pharmacokinetics
5685437|NCT00556049|sunitinib|sunitinib
5685438|NCT00556049|gemcitabine|gemcitabine
5596413|NCT00905125|influenza, trivalent, vaccine, pregnant women|influenza, trivalent, vaccine, pregnant women
5596414|NCT00905112|Pregnancy|pregnancy
5596415|NCT00905112|Pain|pain
5596416|NCT00905112|Musculoskeletal manipulations|musculoskeletal manipulations
5596417|NCT00905112|Exercise|exercise
5596418|NCT00905086|cognitive/functional effects|cognitive/functional effects
5596419|NCT00905086|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5596420|NCT00905086|stage I breast cancer|stage i breast cancer
5596421|NCT00905086|stage II breast cancer|stage ii breast cancer
5596422|NCT00905086|stage IIIA breast cancer|stage iiia breast cancer
5596423|NCT00905086|stage IIIB breast cancer|stage iiib breast cancer
5596424|NCT00905086|stage IIIC breast cancer|stage iiic breast cancer
5596425|NCT00905086|stage I colon cancer|stage i colon cancer
5596426|NCT00905086|stage II colon cancer|stage ii colon cancer
5596427|NCT00905086|stage III colon cancer|stage iii colon cancer
5596428|NCT00905086|stage I rectal cancer|stage i rectal cancer
5596429|NCT00905086|stage II rectal cancer|stage ii rectal cancer
5596430|NCT00905086|stage III rectal cancer|stage iii rectal cancer
5596431|NCT00905086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5596432|NCT00905086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5596433|NCT00905086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5596434|NCT00905086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5596435|NCT00905086|stage I prostate cancer|stage i prostate cancer
5596436|NCT00905086|stage II prostate cancer|stage ii prostate cancer
5596437|NCT00905086|stage III prostate cancer|stage iii prostate cancer
5596438|NCT00905086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5596439|NCT00905086|limited stage small cell lung cancer|limited stage small cell lung cancer
5596440|NCT00905073|type 1 diabetes mellitus|type 1 diabetes mellitus
5596441|NCT00905073|cyclosporin|cyclosporin
5596442|NCT00905073|methotrexate|methotrexate
5596443|NCT00905073|renal function|renal function
5596444|NCT00905060|Newly Diagnosed Glioblastoma Multiforme, vaccine|newly diagnosed glioblastoma multiforme, vaccine
5596445|NCT00905047|colo-rectal cancer|colo-rectal cancer
5596446|NCT00905047|advanced|advanced
5596447|NCT00905047|metastatic|metastatic
5596448|NCT00905047|locally advanced or metastatic colo-rectal cancer|locally advanced or metastatic colo-rectal cancer
5596449|NCT00905034|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5596451|NCT00905034|Leukemia|leukemia
5596452|NCT00905034|Methotrexate|methotrexate
5596453|NCT00905034|Vincristine|vincristine
5596454|NCT00905034|PEG-l-asparaginase|peg-l-asparaginase
5596455|NCT00905034|PEG asparaginase|peg asparaginase
5596456|NCT00905034|Pegaspargase|pegaspargase
5596457|NCT00905034|Oncaspar|oncaspar
5596458|NCT00905034|Polyethylene Glycol Conjugated Lasparaginase-H|polyethylene glycol conjugated lasparaginase-h
5596459|NCT00905034|Dexamethasone|dexamethasone
5596460|NCT00905034|Decadron|decadron
5596461|NCT00905034|Rituximab|rituximab
5596462|NCT00905034|Rituxan|rituxan
5596463|NCT00905021|Breast Cancer|breast cancer
5596464|NCT00905021|Metastatic|metastatic
5596465|NCT00905021|Hormone Receptor Positive|hormone receptor positive
5596466|NCT00905008|drug-eluting stent|drug-eluting stent
5596467|NCT00905008|bare-metal stent|bare-metal stent
5596468|NCT00905008|long-term safety|long-term safety
5596469|NCT00905008|mortality|mortality
5596470|NCT00905008|stent thrombosis|stent thrombosis
5596471|NCT00905008|Angioplasty|angioplasty
5596472|NCT00905008|Transluminal|transluminal
5596473|NCT00905008|Percutaneous Coronary|percutaneous coronary
5596474|NCT00904995|Leukemia|leukemia
5596475|NCT00904995|Cancer of the blood|cancer of the blood
5596476|NCT00904995|Cancer of the bone marrow|cancer of the bone marrow
5596477|NCT00904995|Hematologic malignancy|hematologic malignancy
5596478|NCT00904995|Invasive fungal infection|invasive fungal infection
5596479|NCT00904995|Voriconazole|voriconazole
5596480|NCT00904995|Vfend|vfend
5596481|NCT00904995|antifungal prophylaxis|antifungal prophylaxis
5596482|NCT00904982|warfarin|warfarin
5596483|NCT00904982|coumadin|coumadin
5596484|NCT00904982|adherence|adherence
5596486|NCT00904969|Urinary Incontinence, Stress|urinary incontinence, stress
5596491|NCT00904969|Radical prostatectomy|radical prostatectomy
5596492|NCT00904969|Open prostatectomy|open prostatectomy
5596493|NCT00904969|Post-suprapubic prostatectomy|post-suprapubic prostatectomy
5596494|NCT00904956|Latent Tuberculosis Infection|latent tuberculosis infection
5596495|NCT00904956|High Resolution Scanners|high resolution scanners
5596496|NCT00904956|Dynamic Hypothesis of Latent Tuberculosis Infection|dynamic hypothesis of latent tuberculosis infection
5596498|NCT00904943|Healthy Subjects|healthy subjects
5596499|NCT00904930|Tooth mobility assessment|tooth mobility assessment
5596500|NCT00904930|Splinting|splinting
5596501|NCT00904930|Splint Rigidity|splint rigidity
5596502|NCT00904917|African American Mothers|african american mothers
5596503|NCT00904917|Children|children
5596504|NCT00904917|African American Families|african american families
5596505|NCT00904917|Parental Depression|parental depression
5596506|NCT00904917|Preventive Intervention|preventive intervention
5596507|NCT00904891|Adolescents|adolescents
5596508|NCT00904891|Prevention|prevention
5596509|NCT00904891|Bibliotherapy|bibliotherapy
5596510|NCT00904878|pregnant IBD patients|pregnant ibd patients
5596511|NCT00904865|Single port access|single port access
5596512|NCT00904865|Laparoscopy|laparoscopy
5596513|NCT00904865|cholecystectomy|cholecystectomy
5596514|NCT00904865|cholangiography|cholangiography
5596515|NCT00904865|cosmesis|cosmesis
5596516|NCT00904826|NMO|nmo
5596517|NCT00904826|Devic's disease|devic's disease
5596518|NCT00904826|Neuromyelitis optica|neuromyelitis optica
5596519|NCT00904826|NMO-IgG|nmo-igg
5596520|NCT00904826|Aquaporin-4 antibody|aquaporin-4 antibody
5596521|NCT00904826|Eculizumab|eculizumab
5596522|NCT00904826|Complement|complement
5596523|NCT00904813|Rectal cancer|rectal cancer
5596524|NCT00904813|Preoperative radiotherapy|preoperative radiotherapy
5596525|NCT00904813|Timing of Surgery|timing of surgery
5596526|NCT00904813|Prognosis|prognosis
5596527|NCT00904800|Phase I|phase i
5596528|NCT00904800|Healthy volunteers|healthy volunteers
5596529|NCT00904787|Leukemia|leukemia
5596530|NCT00904787|Hematologic neoplasms|hematologic neoplasms
5596531|NCT00904774|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5596532|NCT00904774|neonates|neonates
5596533|NCT00904774|lung development|lung development
5596534|NCT00904774|prematurity|prematurity
5596535|NCT00904761|diabetes mellitus|diabetes mellitus
5596536|NCT00904761|autonomic neuropathy|autonomic neuropathy
5596537|NCT00904761|exercise training|exercise training
5596538|NCT00904761|exercise capacity|exercise capacity
5596539|NCT00904761|heart rate variability|heart rate variability
5596540|NCT00904748|Sildenafil|sildenafil
5596541|NCT00904748|Bio-equivalence|bio-equivalence
5596542|NCT00904735|adult grade I meningioma|adult grade i meningioma
5596543|NCT00904735|adult grade II meningioma|adult grade ii meningioma
5596544|NCT00904735|adult anaplastic meningioma|adult anaplastic meningioma
5596545|NCT00904735|adult papillary meningioma|adult papillary meningioma
5596546|NCT00904735|recurrent adult brain tumor|recurrent adult brain tumor
5596547|NCT00904722|Follicular lymphoma|follicular lymphoma
5596548|NCT00904722|Immunotherapy|immunotherapy
5596549|NCT00904722|CT-011|ct-011
5596550|NCT00904722|Monoclonal Antibody CT-011|monoclonal antibody ct-011
5596551|NCT00904722|Rituximab|rituximab
5596553|NCT00904696|Irritable bowel syndrome|irritable bowel syndrome
5596554|NCT00904696|probiotics|probiotics
5596555|NCT00904670|Hyperactivity Attention Deficit Disorder|hyperactivity attention deficit disorder
5596556|NCT00904670|ADHD|adhd
5596557|NCT00904670|Pediatric Patients|pediatric patients
5596558|NCT00904670|Quillivant|quillivant
5596559|NCT00904670|methylphenidate|methylphenidate
5596560|NCT00904657|pharmacokinetic/pharmacodynamic modeling|pharmacokinetic/pharmacodynamic modeling
5596561|NCT00904657|biomarkers (growth factors) as a possible tool of drug effect|biomarkers (growth factors) as a possible tool of drug effect
5596562|NCT00904644|HIV|hiv
5596563|NCT00904644|antiretroviral treatment|antiretroviral treatment
5596564|NCT00904644|Swiss HIV Cohort Study|swiss hiv cohort study
5596565|NCT00904644|drug resistance|drug resistance
5596566|NCT00904644|integrase inhibitor|integrase inhibitor
5596567|NCT00904644|Treatment|treatment
5596568|NCT00904618|Suburethral slings|suburethral slings
5596569|NCT00904618|Urethra|urethra
5596570|NCT00904618|Urinary incontinence|urinary incontinence
5596571|NCT00904618|Urinary stress incontinence|urinary stress incontinence
5596572|NCT00904592|diabetic retinopathy|diabetic retinopathy
5596573|NCT00904592|traditional chinese medicine|traditional chinese medicine
5596580|NCT00904566|microarray|microarray
5596581|NCT00904566|gene expression profiling|gene expression profiling
5596582|NCT00904566|MammaPrint|mammaprint
5596583|NCT00904566|breast cancer|breast cancer
5596584|NCT00904553|Brain|brain
5596585|NCT00904553|metastases|metastases
5596586|NCT00904527|Relaxation (Schultz)|relaxation (schultz)
5596587|NCT00904527|Migraine|migraine
5596588|NCT00904527|antipain center|antipain center
5596589|NCT00904514|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5596590|NCT00904514|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5596591|NCT00904514|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5596592|NCT00904514|Waldenström macroglobulinemia|waldenström macroglobulinemia
5596593|NCT00904514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5596594|NCT00904514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5596595|NCT00904514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5596596|NCT00904514|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5596597|NCT00904514|refractory hairy cell leukemia|refractory hairy cell leukemia
5596598|NCT00904514|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5596599|NCT00904514|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5596600|NCT00904514|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5596601|NCT00904514|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5596602|NCT00904514|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5685439|NCT00556036|healthy|healthy
5596603|NCT00904514|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5596604|NCT00904514|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5596605|NCT00904514|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5596606|NCT00904514|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5596607|NCT00904514|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5596608|NCT00904514|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5596609|NCT00904514|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5596610|NCT00904514|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5596611|NCT00904514|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5596612|NCT00904514|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5596614|NCT00904514|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5596615|NCT00904514|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5596616|NCT00904514|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5596617|NCT00904514|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5596618|NCT00904514|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5596619|NCT00904514|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5596620|NCT00904514|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5596621|NCT00904514|stage IV colon cancer|stage iv colon cancer
5596622|NCT00904514|stage IV breast cancer|stage iv breast cancer
5596623|NCT00904514|recurrent breast cancer|recurrent breast cancer
5596624|NCT00904514|stage IV gastric cancer|stage iv gastric cancer
5596625|NCT00904514|recurrent gastric cancer|recurrent gastric cancer
5596626|NCT00904514|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5596627|NCT00904514|recurrent pancreatic cancer|recurrent pancreatic cancer
5596628|NCT00904514|recurrent colon cancer|recurrent colon cancer
5596629|NCT00904514|stage IV esophageal cancer|stage iv esophageal cancer
5596630|NCT00904514|recurrent esophageal cancer|recurrent esophageal cancer
5596631|NCT00904514|recurrent bladder cancer|recurrent bladder cancer
5596632|NCT00904514|stage IV bladder cancer|stage iv bladder cancer
5596633|NCT00904514|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5596634|NCT00904514|epithelial mesothelioma|epithelial mesothelioma
5596635|NCT00904514|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5596636|NCT00904514|recurrent salivary gland cancer|recurrent salivary gland cancer
5596637|NCT00904514|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5596638|NCT00904514|stage III cervical cancer|stage iii cervical cancer
5596639|NCT00904514|recurrent cervical cancer|recurrent cervical cancer
5596640|NCT00904514|stage IVB cervical cancer|stage ivb cervical cancer
5596641|NCT00904514|stage IVA cervical cancer|stage iva cervical cancer
5596642|NCT00904514|squamous cell lung cancer|squamous cell lung cancer
5596643|NCT00904514|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5596644|NCT00904514|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5596645|NCT00904514|advanced malignant mesothelioma|advanced malignant mesothelioma
5596646|NCT00904514|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5596647|NCT00904514|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5596648|NCT00904514|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5596649|NCT00904514|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5596650|NCT00904514|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5596651|NCT00904514|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5596652|NCT00904514|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5596763|NCT00904124|eating behaviour|eating behaviour
5596653|NCT00904514|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5672287|NCT00612469|chlorhexidine|chlorhexidine
5596654|NCT00904514|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5596655|NCT00904514|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5596656|NCT00904514|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5596657|NCT00904514|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5596658|NCT00904514|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5596659|NCT00904514|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5596660|NCT00904514|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5596661|NCT00904514|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5596662|NCT00904514|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5596663|NCT00904514|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5596664|NCT00904514|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5596665|NCT00904514|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5596666|NCT00904514|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5596667|NCT00904514|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5596668|NCT00904514|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5596669|NCT00904514|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5596670|NCT00904514|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5596671|NCT00904514|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5596672|NCT00904514|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5596673|NCT00904514|fallopian tube cancer|fallopian tube cancer
5596674|NCT00904514|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5596675|NCT00904514|ovarian carcinosarcoma|ovarian carcinosarcoma
5596676|NCT00904514|Brenner tumor|brenner tumor
5596677|NCT00904514|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5596678|NCT00904514|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5596679|NCT00904514|stage III salivary gland cancer|stage iii salivary gland cancer
5596680|NCT00904514|stage IV salivary gland cancer|stage iv salivary gland cancer
5596681|NCT00904514|stage II pancreatic cancer|stage ii pancreatic cancer
5596682|NCT00904514|stage III pancreatic cancer|stage iii pancreatic cancer
5596683|NCT00904514|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5596684|NCT00904514|stage IV pancreatic cancer|stage iv pancreatic cancer
5596685|NCT00904514|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5596686|NCT00904514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5596687|NCT00904514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5596688|NCT00904514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5596689|NCT00904514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5596690|NCT00904514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5596691|NCT00904501|Limb ischemia|limb ischemia
5596692|NCT00904501|Cell Therapy|cell therapy
5596693|NCT00904488|Acute Decompensated Heart Failure|acute decompensated heart failure
5596695|NCT00904436|Tetraplegia|tetraplegia
5596698|NCT00904410|adenocarcinoma|adenocarcinoma
5596699|NCT00904410|breast|breast
5596700|NCT00904384|HIV+|hiv+
5596701|NCT00904384|COPD|copd
5596702|NCT00904384|emphysema|emphysema
5596703|NCT00904358|internal jugular vein|internal jugular vein
5596704|NCT00904358|cross sectional area|cross sectional area
5596705|NCT00904358|ultrasound|ultrasound
5596706|NCT00904358|central venous pressure|central venous pressure
5596707|NCT00904345|SCC Head and Neck Cancer|scc head and neck cancer
5596708|NCT00904332|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5596709|NCT00904332|Electroencephalogram (EEG)|electroencephalogram (eeg)
5596710|NCT00904332|Motor Learning|motor learning
5596711|NCT00904332|Health Volunteer|health volunteer
5596713|NCT00904319|osteoarthritis|osteoarthritis
5596714|NCT00904319|knee pain|knee pain
5596715|NCT00904319|power training|power training
5596716|NCT00904319|rehabilitation|rehabilitation
5596717|NCT00904306|binge eating|binge eating
5596718|NCT00904306|chromium|chromium
5596719|NCT00904306|mood|mood
5596720|NCT00904306|glucose|glucose
5596721|NCT00904306|appetite|appetite
5596722|NCT00904293|warfarin|warfarin
5596723|NCT00904293|CYP2C9|cyp2c9
5596724|NCT00904293|VKOR|vkor
5596725|NCT00904293|Coumadin|coumadin
5596726|NCT00904293|pharmacogenetics|pharmacogenetics
5596727|NCT00904293|pharmacogenomics|pharmacogenomics
5596728|NCT00904293|anticoagulation|anticoagulation
5596835|NCT00903682|efavirenz|efavirenz
5596730|NCT00904254|cerebrovascular disorders|cerebrovascular disorders
5596731|NCT00904254|symptomatic carotid artery stenosis|symptomatic carotid artery stenosis
5596732|NCT00904254|asymptomatic carotid artery stenosis|asymptomatic carotid artery stenosis
5596733|NCT00904254|monoclonal antibody|monoclonal antibody
5596734|NCT00904254|diagnostics|diagnostics
5596735|NCT00904254|molecular target|molecular target
5596736|NCT00904254|immunoglobulin Fab fragments|immunoglobulin fab fragments
5596737|NCT00904254|physiological effects of drugs|physiological effects of drugs
5596738|NCT00904254|Tc99m-pertechnetate|tc99m-pertechnetate
5596739|NCT00904254|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
5596740|NCT00904254|Antibodies, Monoclonal|antibodies, monoclonal
5596741|NCT00904254|Antibodies|antibodies
5596742|NCT00904228|hypothermia|hypothermia
5596743|NCT00904228|euthermia|euthermia
5596744|NCT00904228|hyperthermia|hyperthermia
5596745|NCT00904228|mortality|mortality
5596746|NCT00904228|morbidity|morbidity
5596748|NCT00904228|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5596749|NCT00904228|intraventricular hemorrhage|intraventricular hemorrhage
5596750|NCT00904228|ventilator days|ventilator days
5596751|NCT00904150|menstruation|menstruation
5596752|NCT00904150|migraine|migraine
5596753|NCT00904150|menstrual migraine|menstrual migraine
5596754|NCT00904150|genetics|genetics
5596755|NCT00904137|Supracondylar fracture|supracondylar fracture
5596756|NCT00904137|humerus|humerus
5596757|NCT00904137|elbow|elbow
5596758|NCT00904124|Dietary fiber|dietary fiber
5596759|NCT00904124|guar gum|guar gum
5596760|NCT00904124|alginate|alginate
5596761|NCT00904124|cellulose|cellulose
5596762|NCT00904124|food intake|food intake
5596764|NCT00904098|migraine|migraine
5596765|NCT00904072|CDSS|cdss
5596766|NCT00904072|prescribing error|prescribing error
5596767|NCT00904072|prescribing errors influenced by CDSS|prescribing errors influenced by cdss
5596768|NCT00904072|CPOE|cpoe
5596769|NCT00904046|Uric acid|uric acid
5596770|NCT00904046|Nephrolithiasis|nephrolithiasis
5596771|NCT00904007|Educational Technology|educational technology
5596772|NCT00904007|Hypertension|hypertension
5596773|NCT00904007|Education, Professional|education, professional
5596775|NCT00903968|refractory|refractory
5596776|NCT00903968|relapsed|relapsed
5596777|NCT00903968|bortezomib|bortezomib
5596778|NCT00903968|AMD3100|amd3100
5596779|NCT00903968|plerixafor|plerixafor
5596780|NCT00903955|Mucus|mucus
5596781|NCT00903955|COPD|copd
5596782|NCT00903955|Chronic Bronchitis|chronic bronchitis
5596783|NCT00903916|antipsychotic|antipsychotic
5596784|NCT00903916|ghrelin|ghrelin
5596786|NCT00903916|appetite|appetite
5596787|NCT00903916|weight gain|weight gain
5596788|NCT00903903|active synovitis|active synovitis
5596789|NCT00903838|Parkinson's disease|parkinson's disease
5596790|NCT00903825|femoral artery puncture|femoral artery puncture
5596791|NCT00903825|local anesthesia|local anesthesia
5596792|NCT00903825|ultrasound guided|ultrasound guided
5596793|NCT00903799|Drug-refractory gastroparesis|drug-refractory gastroparesis
5596794|NCT00903799|diabetes mellitus induced gastroparesis|diabetes mellitus induced gastroparesis
5596795|NCT00903799|Gastric electrical stimulation|gastric electrical stimulation
5596796|NCT00903799|Long-term multicenter study|long-term multicenter study
5596797|NCT00903786|Seizure|seizure
5596798|NCT00903786|epilepsy|epilepsy
5596799|NCT00903773|VX-950-TiDP24-C132|vx-950-tidp24-c132
5596800|NCT00903773|VX-950-C132|vx-950-c132
5596801|NCT00903773|VX-950|vx-950
5596802|NCT00903773|HCV|hcv
5590699|NCT00927953|Monoclonal Antibody|monoclonal antibody
5596804|NCT00903760|MDS|mds
5596805|NCT00903760|Leukemia|leukemia
5596806|NCT00903760|Decitabine|decitabine
5596807|NCT00903760|clofarabine|clofarabine
5596808|NCT00903760|Dacogen®|dacogen®
5596809|NCT00903760|Clolar®|clolar®
5596810|NCT00903747|Prucalopride|prucalopride
5596811|NCT00903747|safety study|safety study
5596812|NCT00903734|Metastatic Cancer|metastatic cancer
5596813|NCT00903734|Histology-independent|histology-independent
5596814|NCT00903734|EGFR Mutation|egfr mutation
5596815|NCT00903734|EGFR inhibitor-sensitive mutation|egfr inhibitor-sensitive mutation
5596816|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride
5596817|NCT00903734|Tarceva|tarceva
5596818|NCT00903734|OSI-774|osi-774
5596819|NCT00903734|Cetuximab|cetuximab
5596820|NCT00903734|Bortezomib|bortezomib
5596821|NCT00903734|Dasatinib|dasatinib
5596822|NCT00903708|Advanced Cancers|advanced cancers
5596823|NCT00903708|LY2275796|ly2275796
5596824|NCT00903708|Eukaryotic initiation factor 4E|eukaryotic initiation factor 4e
5596825|NCT00903708|eIF-4E|eif-4e
5596826|NCT00903695|Memory XL|memory xl
5596827|NCT00903695|Mild Cognitive Impairment|mild cognitive impairment
5596828|NCT00903695|cognitive status|cognitive status
5596829|NCT00903682|HIV|hiv
5596830|NCT00903682|Intelence|intelence
5596831|NCT00903682|etravirine|etravirine
5596832|NCT00903682|ETR|etr
5596833|NCT00903682|TMC125|tmc125
5596834|NCT00903682|Sustiva|sustiva
5596836|NCT00903682|EFV|efv
5596837|NCT00903682|Non-nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5596838|NCT00903682|NNRTI|nnrti
5596839|NCT00903682|treatment-naive|treatment-naive
5596840|NCT00903669|Facial paralysis|facial paralysis
5596841|NCT00903669|Muscle tonus|muscle tonus
5596842|NCT00903669|Rehabilitation|rehabilitation
5596843|NCT00903669|Myofunctional|myofunctional
5596844|NCT00903669|Stomatognathic system|stomatognathic system
5596845|NCT00903656|metastatic breast cancer|metastatic breast cancer
5596846|NCT00903656|Her2|her2
5596847|NCT00903656|Lapatinib|lapatinib
5596848|NCT00903656|Caelyx|caelyx
5596849|NCT00903656|cardiotoxic|cardiotoxic
5596850|NCT00903643|Painful Bladder Syndrome|painful bladder syndrome
5596851|NCT00903643|Urinary Bladder|urinary bladder
5596852|NCT00903630|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5596853|NCT00903630|fallopian tube cancer|fallopian tube cancer
5596854|NCT00903630|peritoneal cavity cancer|peritoneal cavity cancer
5596855|NCT00903617|lipids|lipids
5596856|NCT00903617|HM74A|hm74a
5596857|NCT00903604|Cardiac surgery|cardiac surgery
5596858|NCT00903604|coronary artery bypass grafting|coronary artery bypass grafting
5596859|NCT00903604|valve surgery|valve surgery
5685440|NCT00556036|overweight|overweight
5685441|NCT00556036|obese|obese
5596860|NCT00903604|aortic root or ascending aortic aneurysm repair surgery|aortic root or ascending aortic aneurysm repair surgery
5596861|NCT00903604|Acute kidney injury|acute kidney injury
5596863|NCT00903591|cancer|cancer
5596864|NCT00903591|09-040|09-040
5596865|NCT00903591|blood sample|blood sample
5596866|NCT00903591|saliva sample|saliva sample
5596867|NCT00903591|WECARE|wecare
5596868|NCT00903591|GWA|gwa
5596869|NCT00903578|FGF-23|fgf-23
5596870|NCT00903578|vitamin D|vitamin d
5596871|NCT00903578|phosphate|phosphate
5596872|NCT00903578|allograft dysfunction|allograft dysfunction
5596873|NCT00903578|mortality|mortality
5596874|NCT00903565|genomic profiling|genomic profiling
5596875|NCT00903565|gene expression|gene expression
5596876|NCT00903565|ColoPrint|coloprint
5596877|NCT00903565|adenocarcinoma colon|adenocarcinoma colon
5596878|NCT00903565|recurrence risk assessment|recurrence risk assessment
5596879|NCT00903565|prospective|prospective
5596880|NCT00903539|Peripherally Inserted Central Catheter|peripherally inserted central catheter
5596881|NCT00903539|Central Venous Catheter|central venous catheter
5596882|NCT00903539|Intravenous Catheter|intravenous catheter
5596883|NCT00903539|StatLock|statlock
5596884|NCT00903539|Patients indicated to have an intravenous catheter placed|patients indicated to have an intravenous catheter placed
5596885|NCT00903526|fungal susceptibility|fungal susceptibility
5596886|NCT00903474|anxiety disorder|anxiety disorder
5596887|NCT00903474|depression|depression
5596888|NCT00903474|cognitive/functional effects|cognitive/functional effects
5596889|NCT00903474|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5596890|NCT00903474|cancer survivor|cancer survivor
5596891|NCT00903474|breast cancer|breast cancer
5596892|NCT00903448|Normal Healthy Subject Population|normal healthy subject population
5596893|NCT00903435|Cystitis|cystitis
5596894|NCT00903435|Urinary|urinary
5596895|NCT00903435|Bladder|bladder
5596896|NCT00903422|Advanced Myelodysplastic Syndrome|advanced myelodysplastic syndrome
5596897|NCT00903422|Thrombocytopenia|thrombocytopenia
5596898|NCT00903422|sAML/MDS|saml/mds
5596899|NCT00903422|Eltrombopag|eltrombopag
5596900|NCT00903422|TPO-R agonist|tpo-r agonist
5596901|NCT00903422|de novo AML|de novo aml
5596902|NCT00903422|Thrombopoietin|thrombopoietin
5596903|NCT00903422|MDS|mds
5596904|NCT00903422|Thrombopoietin receptor agonist|thrombopoietin receptor agonist
5596905|NCT00903422|secondary Acute Myeloid Leukemia after MDS|secondary acute myeloid leukemia after mds
5596906|NCT00903422|Platelets|platelets
5596907|NCT00903409|High triglycerides|high triglycerides
5596908|NCT00903409|Lovaza|lovaza
5596909|NCT00903409|simvastatin|simvastatin
5596910|NCT00903409|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5596911|NCT00903396|nausea and vomiting|nausea and vomiting
5596912|NCT00903396|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
5596913|NCT00903396|anal cancer|anal cancer
5596914|NCT00903396|carcinoma of the appendix|carcinoma of the appendix
5596915|NCT00903396|colon cancer|colon cancer
5596916|NCT00903396|rectal cancer|rectal cancer
5596917|NCT00903396|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5596918|NCT00903396|gallbladder cancer|gallbladder cancer
5596919|NCT00903396|gastric cancer|gastric cancer
5596920|NCT00903396|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5596921|NCT00903396|pancreatic cancer|pancreatic cancer
5596922|NCT00903396|small intestine cancer|small intestine cancer
5596923|NCT00903396|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5596924|NCT00903370|Mitral Valve Regurgitation|mitral valve regurgitation
5596925|NCT00903370|Mitral Valve Surgery|mitral valve surgery
5596926|NCT00903370|Mitral Valve Disease|mitral valve disease
5596927|NCT00903370|Ablation, Catheter|ablation, catheter
5596937|NCT00903318|Generational sex ratio trends|generational sex ratio trends
5596938|NCT00903318|Mexican American|mexican american
5596939|NCT00903318|Baytown|baytown
5596940|NCT00903318|Rio Grande Valley|rio grande valley
5596941|NCT00903318|Hidalgo County|hidalgo county
5596942|NCT00903318|Texas|texas
5596943|NCT00903305|pain|pain
5596944|NCT00903305|fatigue|fatigue
5596945|NCT00903305|nausea and vomiting|nausea and vomiting
5596946|NCT00903305|stage I breast cancer|stage i breast cancer
5596947|NCT00903305|stage II breast cancer|stage ii breast cancer
5596948|NCT00903305|stage IIIA breast cancer|stage iiia breast cancer
5596949|NCT00903305|stage IIIB breast cancer|stage iiib breast cancer
5596950|NCT00903305|stage IIIC breast cancer|stage iiic breast cancer
5596952|NCT00903292|NSCLC|nsclc
5596953|NCT00903292|EGFR mutation rate|egfr mutation rate
5596954|NCT00903279|MRSA colonization|mrsa colonization
5596955|NCT00903279|Orthopedic Surgery|orthopedic surgery
5596956|NCT00903279|Altabax|altabax
5596957|NCT00903279|Placebo|placebo
5596958|NCT00903266|Aphasia|aphasia
5596959|NCT00903266|Speech Impairment|speech impairment
5596960|NCT00903266|Stroke|stroke
5596961|NCT00903266|Cerebrovascular Accident|cerebrovascular accident
5596962|NCT00903266|Cerebral Infarction|cerebral infarction
5596963|NCT00903266|Brain Ischemia|brain ischemia
5596964|NCT00903266|Brain Infarction|brain infarction
5596965|NCT00903266|Cerebrovascular Disorder|cerebrovascular disorder
5596966|NCT00903227|Asthma|asthma
5596967|NCT00903227|Allergic rhinitis|allergic rhinitis
5596968|NCT00903227|fluticasone|fluticasone
5596969|NCT00903227|methacholine|methacholine
5596970|NCT00903214|stage I breast cancer|stage i breast cancer
5596971|NCT00903214|stage II breast cancer|stage ii breast cancer
5596972|NCT00903214|stage IIIA breast cancer|stage iiia breast cancer
5596973|NCT00903201|cystic fibrosis|cystic fibrosis
5596974|NCT00903188|Renal Transplantation|renal transplantation
5596975|NCT00903188|graft function|graft function
5596976|NCT00903188|cardiovascular events|cardiovascular events
5596977|NCT00903188|malignancy|malignancy
5596978|NCT00903188|cyclosporin|cyclosporin
5596979|NCT00903188|steroids|steroids
5596980|NCT00903188|mycophenolate|mycophenolate
5596981|NCT00903188|everolimus|everolimus
5596982|NCT00903188|renal biopsies|renal biopsies
5596983|NCT00903188|pharmacokinetics|pharmacokinetics
5596984|NCT00903175|RAD001|rad001
5596985|NCT00903175|everolimus|everolimus
5596986|NCT00903175|sunitinib|sunitinib
5596987|NCT00903175|renal cell carcinoma|renal cell carcinoma
5596988|NCT00903175|kidney cancer|kidney cancer
5596989|NCT00903175|metastatic renal cell cancer|metastatic renal cell cancer
5596990|NCT00903175|advanced kidney cancer|advanced kidney cancer
5596991|NCT00903162|hormone-receptor positive|hormone-receptor positive
5596992|NCT00903162|tamoxifen|tamoxifen
5596993|NCT00903162|letrozole|letrozole
5596994|NCT00903162|zoledronic acid|zoledronic acid
5596995|NCT00903162|leuprolide|leuprolide
5596996|NCT00903149|Premature babies|premature babies
5596997|NCT00903149|Social interaction|social interaction
5596998|NCT00903149|Psychoeducative intervention|psychoeducative intervention
5596999|NCT00903149|Mother Infant Transaction Program|mother infant transaction program
5597000|NCT00903149|Three years follow-up|three years follow-up
5597001|NCT00903149|Late preterm|late preterm
5597002|NCT00903149|Cognitive development|cognitive development
5597003|NCT00903149|Social development|social development
5597004|NCT00903149|Emotional development|emotional development
5597005|NCT00903149|Motor development|motor development
5597006|NCT00903149|Children born preterm and their parents|children born preterm and their parents
5597007|NCT00903136|Barrett esophagus|barrett esophagus
5597008|NCT00903136|esophageal cancer|esophageal cancer
5597009|NCT00903136|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5597010|NCT00903084|Pharmacokinetics in Hair|pharmacokinetics in hair
5597012|NCT00903084|Pharmacokinetics|pharmacokinetics
5597013|NCT00903084|Concentrations|concentrations
5597015|NCT00903071|Hypertension|hypertension
5597016|NCT00903071|Primary Care|primary care
5597017|NCT00903071|Physician Learning|physician learning
5597018|NCT00903045|Overactive bladder|overactive bladder
5597020|NCT00903032|compliance/adherence|compliance/adherence
5597021|NCT00903019|Homebound|homebound
5597022|NCT00903019|Older Adults|older adults
5597023|NCT00903019|Disability|disability
5597024|NCT00903019|Videoconferencing|videoconferencing
5597025|NCT00903006|Breast|breast
5597026|NCT00903006|Hormone receptor-positive metastatic breast cancer|hormone receptor-positive metastatic breast cancer
5597027|NCT00903006|Fulvestrant|fulvestrant
5597028|NCT00903006|Faslodex|faslodex
5597030|NCT00903006|Dasatinib|dasatinib
5597031|NCT00903006|BMS-354825|bms-354825
5597032|NCT00903006|Sprycel|sprycel
5597033|NCT00903006|Adjuvant hormonal therapy|adjuvant hormonal therapy
5597035|NCT00902993|NNR|nnr
5597036|NCT00902993|to investigate safety and tolerability in a multiple ascending dose study in Healthy subjects|to investigate safety and tolerability in a multiple ascending dose study in healthy subjects
5597037|NCT00902993|AZD1446|azd1446
5597038|NCT00902980|Kidney transplantation|kidney transplantation
5597039|NCT00902980|Tacrolimus|tacrolimus
5597040|NCT00902980|Immunosuppression|immunosuppression
5597041|NCT00902967|Postoperative pain|postoperative pain
5597042|NCT00902967|atorvastatin|atorvastatin
5597043|NCT00902967|analgesic|analgesic
5597044|NCT00902967|antiinflammatory|antiinflammatory
5597045|NCT00902954|Disease free survival|disease free survival
5597046|NCT00902954|Distant disease free survival|distant disease free survival
5597047|NCT00902954|Toxicity|toxicity
5597048|NCT00902954|Overall survival|overall survival
5597049|NCT00902941|Parkinson´s disease|parkinson´s disease
5597050|NCT00902941|olfaction|olfaction
5597051|NCT00902941|rasagiline|rasagiline
5597052|NCT00902941|smell testing|smell testing
5597053|NCT00902928|Elective hip replacement surgery|elective hip replacement surgery
5597054|NCT00902928|Factor Xa|factor xa
5597055|NCT00902928|Venous Thromboembolism|venous thromboembolism
5597056|NCT00902928|Thrombosis|thrombosis
5597057|NCT00902928|Anticoagulants|anticoagulants
5597058|NCT00902928|Prevention|prevention
5597059|NCT00902928|YM150|ym150
5597060|NCT00902915|multiple myeloma renal insufficiency|multiple myeloma renal insufficiency
5597061|NCT00902902|Hepatocellular carcinoma|hepatocellular carcinoma
5597062|NCT00902889|Globus pallidus|globus pallidus
5597063|NCT00902889|Huntington's Disease|huntington's disease
5597064|NCT00902889|Deep Brain Stimulation|deep brain stimulation
5597065|NCT00902889|Movement Disorders|movement disorders
5597066|NCT00902876|root coverage|root coverage
5597067|NCT00902876|gingival recession|gingival recession
5597068|NCT00902876|keratinized gingiva|keratinized gingiva
5597069|NCT00902863|chronic pain|chronic pain
5597070|NCT00902863|mindfulness|mindfulness
5597071|NCT00902863|yoga|yoga
5597072|NCT00902863|quality of life|quality of life
5597073|NCT00902863|stress|stress
5597074|NCT00902837|randomised|randomised
5597075|NCT00902837|double-blind|double-blind
5597076|NCT00902837|double-dummy|double-dummy
5597077|NCT00902837|parallel-group|parallel-group
5597078|NCT00902837|non-inferiority|non-inferiority
5597079|NCT00902837|pain locomotor function|pain locomotor function
5597080|NCT00902837|improvement in symptoms of constipation|improvement in symptoms of constipation
5597081|NCT00902837|moderate to severe pain due to osteoarthritis (OA)|moderate to severe pain due to osteoarthritis (oa)
5597082|NCT00902837|OXN PR|oxn pr
5597083|NCT00902837|OxyPR|oxypr
5597084|NCT00902837|Moderate to severe chronic nonmalignant OA|moderate to severe chronic nonmalignant oa
5597085|NCT00902824|HIV|hiv
5597086|NCT00902811|uncomplicated falciparum malaria|uncomplicated falciparum malaria
5597087|NCT00902811|artemisinin combination therapy|artemisinin combination therapy
5597088|NCT00902798|Autism|autism
5597089|NCT00902798|Autism Spectrum Disorders|autism spectrum disorders
5597090|NCT00902798|Asperger's Syndrome|asperger's syndrome
5597091|NCT00902798|Pervasive Developmental Disorder|pervasive developmental disorder
5597092|NCT00902798|Cognition|cognition
5597093|NCT00902798|Social Cognition|social cognition
5597094|NCT00902798|Psychosocial Treatment|psychosocial treatment
5597095|NCT00902798|Cognitive Enhancement Therapy|cognitive enhancement therapy
5597096|NCT00902798|Enriched Supportive Therapy|enriched supportive therapy
5597097|NCT00902798|Therapy|therapy
5597098|NCT00902798|Psychotherapy|psychotherapy
5597099|NCT00902785|exploratory|exploratory
5597100|NCT00902785|observational|observational
5597101|NCT00902785|non-interventional study age-related macular degeneration (AMD) choroidal neovascularization (CNV)|non-interventional study age-related macular degeneration (amd) choroidal neovascularization (cnv)
5597102|NCT00902772|Recreational CNS depressant|recreational cns depressant
5597103|NCT00902772|Abuse liability|abuse liability
5597104|NCT00902772|Abuse potential|abuse potential
5597105|NCT00902772|Healthy Recreational CNS Depressant Users|healthy recreational cns depressant users
5597106|NCT00902759|Surgery|surgery
5597107|NCT00902759|Chemotherapy|chemotherapy
5597109|NCT00902759|Pancreatic cancer|pancreatic cancer
5597110|NCT00902759|Fatigue|fatigue
5597111|NCT00902733|pain|pain
5597112|NCT00902733|fatigue|fatigue
5597113|NCT00902733|nausea and vomiting|nausea and vomiting
5597114|NCT00902733|recurrent pancreatic cancer|recurrent pancreatic cancer
5597156|NCT00902551|DNA cytometry|dna cytometry
5597157|NCT00902551|Cytology|cytology
5597158|NCT00902551|Diagnosis accuracy|diagnosis accuracy
5597159|NCT00902538|Add on treatment|add on treatment
5597160|NCT00902538|essential hypertension|essential hypertension
5597161|NCT00902525|two sequential doses of 90Y-Ibritumomab Tiuxetan|two sequential doses of 90y-ibritumomab tiuxetan
5597162|NCT00902499|functional magnetic resonance imaging|functional magnetic resonance imaging
5597163|NCT00902486|Rheumatoid arthritis|rheumatoid arthritis
5597164|NCT00902473|Topiramate fed study|topiramate fed study
5597165|NCT00902460|drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents|drug interactions cyp3a4 cyp3a5 midazolam anti-rheumatic agents
5597166|NCT00902447|Human Blood Cell Disorders|human blood cell disorders
5599201|NCT00898612|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5597167|NCT00902447|lymphoid, myeloid and erythroid proliferative disease|lymphoid, myeloid and erythroid proliferative disease
5597168|NCT00902434|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5597169|NCT00902421|Overactive bladder|overactive bladder
5597170|NCT00902421|SSRI|ssri
5597171|NCT00902421|Antimuscarinics|antimuscarinics
5597172|NCT00902395|Preschool children|preschool children
5597173|NCT00902382|Infertility|infertility
5597174|NCT00902382|Ovulation stimulation|ovulation stimulation
5597175|NCT00902382|Pregnancy|pregnancy
5597176|NCT00902369|AK106-001616|ak106-001616
5597177|NCT00902356|Amgen|amgen
5597178|NCT00902356|Phase 1|phase 1
5597179|NCT00902356|First in Human|first in human
5597180|NCT00902356|Postmenopausal|postmenopausal
5597181|NCT00902343|Liver|liver
5597182|NCT00902343|Cancer|cancer
5597183|NCT00902343|Primary|primary
5597184|NCT00902343|Metastatic|metastatic
5597185|NCT00902343|transfusions|transfusions
5597186|NCT00902343|08-158|08-158
5597187|NCT00902330|depression|depression
5597188|NCT00902330|anxiety disorder|anxiety disorder
5597189|NCT00902330|fatigue|fatigue
5597190|NCT00902330|pain|pain
5597191|NCT00902330|sleep disorders|sleep disorders
5597192|NCT00902330|stage IA breast cancer|stage ia breast cancer
5597193|NCT00902330|stage IB breast cancer|stage ib breast cancer
5597194|NCT00902330|stage II breast cancer|stage ii breast cancer
5597195|NCT00902330|stage IIIA breast cancer|stage iiia breast cancer
5597196|NCT00902304|Hypertension|hypertension
5597197|NCT00902304|valsartan|valsartan
5597198|NCT00902291|Clinical Trial, Phase II|clinical trial, phase ii
5597199|NCT00902291|Combination Drug Therapy|combination drug therapy
5597200|NCT00902291|Gemcitabine|gemcitabine
5597201|NCT00902291|AGS-1C4D4|ags-1c4d4
5597202|NCT00902291|Pancreatic Cancer|pancreatic cancer
5597203|NCT00902278|influenzavirus A|influenzavirus a
5597204|NCT00902278|influenzavirus B|influenzavirus b
5597205|NCT00902278|human influenza|human influenza
5597206|NCT00902278|T lymphocytes|t lymphocytes
5597207|NCT00902278|influenza vaccines|influenza vaccines
5597208|NCT00902226|Social Anxiety Disorder|social anxiety disorder
5597210|NCT00902226|Antidepressant|antidepressant
5597211|NCT00902226|Anxiolytic|anxiolytic
5597212|NCT00902200|Glaucoma|glaucoma
5597213|NCT00902200|Intraocular pressure|intraocular pressure
5597214|NCT00902187|Bioequivalence|bioequivalence
5597215|NCT00902174|Pulmonary arterial hypertension|pulmonary arterial hypertension
5597216|NCT00902174|Imatinib|imatinib
5597217|NCT00902174|6MWD|6mwd
5597218|NCT00902174|Borg scale|borg scale
5597219|NCT00902174|Pulmonary hypertension|pulmonary hypertension
5597220|NCT00902148|Surgery|surgery
5597221|NCT00902148|Colectomy|colectomy
5597222|NCT00902148|Proctocolectomy|proctocolectomy
5597223|NCT00902148|Adhesions|adhesions
5597224|NCT00902135|Multiple Sclerosis|multiple sclerosis
5597225|NCT00902135|Interferon beta-1b|interferon beta-1b
5597226|NCT00902122|p53 gene|p53 gene
5597227|NCT00902122|thyroid|thyroid
5597228|NCT00902122|gene therapy|gene therapy
5597229|NCT00902122|malignant tumors|malignant tumors
5597230|NCT00902109|visual field|visual field
5597231|NCT00902109|perimetry|perimetry
5597232|NCT00902109|progression|progression
5597233|NCT00902109|POAG|poag
5597234|NCT00902109|glaucoma|glaucoma
5597235|NCT00902096|cord blood|cord blood
5597237|NCT00902096|prenatal|prenatal
5597238|NCT00902096|predictor|predictor
5597239|NCT00902083|p53 gene|p53 gene
5597240|NCT00902083|Oral and Maxillofacial|oral and maxillofacial
5597241|NCT00902083|gene therapy|gene therapy
5597242|NCT00902083|malignant tumors|malignant tumors
5597243|NCT00902044|Refractory Sarcoma|refractory sarcoma
5597244|NCT00902044|Metastatic Sarcoma|metastatic sarcoma
5597245|NCT00902044|Sarcoma|sarcoma
5597246|NCT00902044|HER2-positive|her2-positive
5597247|NCT00902044|Gene Therapy|gene therapy
5597248|NCT00902044|HER2-specific T cells|her2-specific t cells
5597250|NCT00902031|Constipation|constipation
5597251|NCT00902031|Colace|colace
5597252|NCT00902031|Palliative Care|palliative care
5597253|NCT00902031|Sennoside|sennoside
5597254|NCT00902031|Senokot|senokot
5597255|NCT00902031|Terminally Ill|terminally ill
5597256|NCT00902031|Stool|stool
5597257|NCT00902031|Randomized Trial|randomized trial
5597258|NCT00902018|ITP|itp
5597259|NCT00902005|Endothelial dysfunction|endothelial dysfunction
5597260|NCT00902005|Bone and cartilage markers|bone and cartilage markers
5597261|NCT00902005|Inflammatory disease activity|inflammatory disease activity
5597262|NCT00902005|Rheumatoid arthritis|rheumatoid arthritis
5597263|NCT00902005|Psoriatic arthritis|psoriatic arthritis
5597264|NCT00902005|Ankylosing Spondylitis|ankylosing spondylitis
5597265|NCT00901992|type 2 diabetes|type 2 diabetes
5597266|NCT00901992|education|education
5597267|NCT00901992|self-management|self-management
5597268|NCT00901992|insulin therapy|insulin therapy
5597269|NCT00901979|Type 2 Diabetes|type 2 diabetes
5597270|NCT00901966|Melanoma|melanoma
5597271|NCT00901966|Sun Exposure History|sun exposure history
5597272|NCT00901966|Agricultural Health Study|agricultural health study
5597273|NCT00901966|Sun Exposure|sun exposure
5597274|NCT00901953|migraine|migraine
5597275|NCT00901953|migrainous vertigo|migrainous vertigo
5597276|NCT00901953|vestibular evoked myogenic potentials|vestibular evoked myogenic potentials
5597277|NCT00901953|vestibular function test|vestibular function test
5597278|NCT00901953|vestibular disorders|vestibular disorders
5597279|NCT00901927|Lymphoma|lymphoma
5597280|NCT00901927|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5597281|NCT00901927|Untreated High Risk Follicular Lymphoma|untreated high risk follicular lymphoma
5597282|NCT00901927|Bendamustine hydrochloride|bendamustine hydrochloride
5579575|NCT00969982|misoprostol|misoprostol
5597283|NCT00901927|Bendamustine HCI|bendamustine hci
5597284|NCT00901927|Bendamustine|bendamustine
5597285|NCT00901927|CEP-18083|cep-18083
5597286|NCT00901927|SDX-105|sdx-105
5597287|NCT00901927|Treanda|treanda
5597288|NCT00901927|Mitoxantrone|mitoxantrone
5597289|NCT00901927|Novantrone|novantrone
5597290|NCT00901927|Rituximab|rituximab
5597291|NCT00901927|Rituxan|rituxan
5597292|NCT00901914|Hypersensitivity|hypersensitivity
5597293|NCT00901914|Allergy|allergy
5597294|NCT00901914|Birch, allergy, Sublingual Immunotherapy|birch, allergy, sublingual immunotherapy
5597295|NCT00901901|Sorafenib (Nexavar)|sorafenib (nexavar)
5597296|NCT00901901|Erlotinib (Tarceva)|erlotinib (tarceva)
5597297|NCT00901901|First Line|first line
5597298|NCT00901901|HCC|hcc
5597299|NCT00901888|Renin Angiotensin System|renin angiotensin system
5597300|NCT00901875|Buprenorphine|buprenorphine
5597301|NCT00901875|Naloxone|naloxone
5597302|NCT00901875|Suboxone|suboxone
5597303|NCT00901862|Migraine|migraine
5597304|NCT00901862|therapy|therapy
5597305|NCT00901862|magnetic therapy|magnetic therapy
5597306|NCT00901862|prophylaxis|prophylaxis
5597307|NCT00901862|prevention|prevention
5597308|NCT00901836|Sarcoma|sarcoma
5597309|NCT00901810|Length Determination|length determination
5597310|NCT00901810|Working Length|working length
5597311|NCT00901810|Electronic Apex Locator|electronic apex locator
5597312|NCT00901810|Root Canal Therapy|root canal therapy
5597313|NCT00901810|Endodontics|endodontics
5597314|NCT00901797|ABD|abd
5597315|NCT00901797|ABDuction|abduction
5597316|NCT00901797|ABR|abr
5597317|NCT00901797|Arthroscopic Bankart Repair|arthroscopic bankart repair
5597318|NCT00901797|ACJ|acj
5597319|NCT00901797|AcromioClavicular Joint|acromioclavicular joint
5597320|NCT00901797|AD|ad
5597321|NCT00901797|Anterior Drawer|anterior drawer
5597322|NCT00901797|ARIC|aric
5597323|NCT00901797|Arthroscopic Rotator Interval Closure|arthroscopic rotator interval closure
5597324|NCT00901797|BL|bl
5597325|NCT00901797|Bankart Lesion|bankart lesion
5597326|NCT00901797|CHL|chl
5597327|NCT00901797|CoracoHumeral Ligament|coracohumeral ligament
5597328|NCT00901797|ER|er
5597329|NCT00901797|External Rotation|external rotation
5597330|NCT00901797|FF|ff
5597331|NCT00901797|Forward Flexion|forward flexion
5597332|NCT00901797|GHJ|ghj
5597333|NCT00901797|GlenoHumeral Joint|glenohumeral joint
5597334|NCT00901797|HSL|hsl
5597335|NCT00901797|HillSacs Lesion|hillsacs lesion
5597336|NCT00901797|IR|ir
5597337|NCT00901797|Internal Rotation|internal rotation
5597338|NCT00901797|ISP|isp
5597339|NCT00901797|InfraSPinatus|infraspinatus
5597340|NCT00901797|PD|pd
5597341|NCT00901797|Posterior Drawer|posterior drawer
5597342|NCT00901797|RI|ri
5597343|NCT00901797|Rotator Interval|rotator interval
5597344|NCT00901797|ROM|rom
5597345|NCT00901797|Range Of Motion|range of motion
5597346|NCT00901797|SGHL|sghl
5597347|NCT00901797|Superior GlenoHumeral Ligament|superior glenohumeral ligament
5597348|NCT00901797|SSC|ssc
5597349|NCT00901797|SubSCapularis|subscapularis
5597350|NCT00901797|SSP|ssp
5597351|NCT00901797|SupraSPinatus|supraspinatus
5597352|NCT00901784|Topiramate fasting study|topiramate fasting study
5597353|NCT00901771|Sleep|sleep
5597354|NCT00901771|Sleep Apnea, Obstructive|sleep apnea, obstructive
5597355|NCT00901771|OSA|osa
5597356|NCT00901771|OSAH|osah
5597357|NCT00901745|Renin angiotensin system|renin angiotensin system
5597358|NCT00901745|Apelin|apelin
5597359|NCT00901745|Vasodilatation|vasodilatation
5597360|NCT00901745|Heart disease|heart disease
5597361|NCT00901745|Vascular biology|vascular biology
5597362|NCT00901732|Caphosol|caphosol
5597363|NCT00901732|Oral Mucositis|oral mucositis
5597364|NCT00901732|Eusa Pharma|eusa pharma
5597365|NCT00901732|Moffitt Cancer Center|moffitt cancer center
5597366|NCT00901719|Renin angiotensin system|renin angiotensin system
5597367|NCT00901719|Apelin|apelin
5597368|NCT00901719|Cardiac output|cardiac output
5597369|NCT00901719|Vasodilatation|vasodilatation
5597370|NCT00901706|Self-Neglect|self-neglect
5597371|NCT00901706|Comprehensive Geriatric Assessment (CGA)|comprehensive geriatric assessment (cga)
5597372|NCT00901706|Geriatric Syndromes|geriatric syndromes
5597373|NCT00901706|Quality of Life|quality of life
5597374|NCT00901706|Basic Activities of Daily Living|basic activities of daily living
5597375|NCT00901706|Instrumental Activities of Daily Living|instrumental activities of daily living
5597376|NCT00901693|pink eye|pink eye
5597377|NCT00901693|eye infection|eye infection
5597378|NCT00901693|conjunctivitis|conjunctivitis
5597379|NCT00901680|Tissue Bank|tissue bank
5597380|NCT00901654|Vaccination|vaccination
5597381|NCT00901654|Diarrhea|diarrhea
5597382|NCT00901654|Traveler's Diarrhea|traveler's diarrhea
5597383|NCT00901654|ETEC|etec
5597384|NCT00901654|Enterotoxigenic E. coli|enterotoxigenic e. coli
5597385|NCT00901641|cognitive training|cognitive training
5597386|NCT00901641|insomnia|insomnia
5597387|NCT00901628|periarticular multimodal drug injection|periarticular multimodal drug injection
5597388|NCT00901615|lymphoma|lymphoma
5597389|NCT00901615|lenalidomide|lenalidomide
5597390|NCT00901615|gela|gela
5597391|NCT00901602|streptococcus pneumoniae|streptococcus pneumoniae
5597392|NCT00901602|pneumococcus|pneumococcus
5597393|NCT00901602|pneumonia|pneumonia
5597394|NCT00901602|meningitis|meningitis
5597395|NCT00901602|serotypes|serotypes
5597396|NCT00901602|bacteremia|bacteremia
5597397|NCT00901602|sepsis|sepsis
5597398|NCT00901589|n-3 PUFAs|n-3 pufas
5597399|NCT00901589|menopause|menopause
5597400|NCT00901589|adipose tissue|adipose tissue
5597401|NCT00901589|estrogens|estrogens
5597402|NCT00901589|Incorporation of fishoil in pre- and postmenopausal women|incorporation of fishoil in pre- and postmenopausal women
5597403|NCT00901589|Marine n-3 PUFAs influence on female hormones in blood|marine n-3 pufas influence on female hormones in blood
5597404|NCT00901576|Healthy volunteers|healthy volunteers
5597405|NCT00901563|Gap Junctions|gap junctions
5597406|NCT00901563|Rotigaptide|rotigaptide
5597407|NCT00901563|Ischaemia reperfusion|ischaemia reperfusion
5597408|NCT00901563|t-PA|t-pa
5597409|NCT00901563|Fibrinolysis|fibrinolysis
5597410|NCT00901563|Endothelial function|endothelial function
5597411|NCT00901563|Venous occlusion plethysmography|venous occlusion plethysmography
5597413|NCT00901550|anti-TNF|anti-tnf
5597414|NCT00901550|Early RA|early ra
5597415|NCT00901537|Non-small Cell Lung Cancer|non-small cell lung cancer
5597416|NCT00901537|Head and Neck Cancer|head and neck cancer
5597417|NCT00901537|Azacitidine|azacitidine
5597418|NCT00901537|Vidaza|vidaza
5597419|NCT00901537|Cisplatin|cisplatin
5597420|NCT00901524|HCV Genotype 1, 4|hcv genotype 1, 4
5597421|NCT00901524|Virological response|virological response
5597422|NCT00901524|Ribavirin|ribavirin
5597423|NCT00901524|PegPegIFN- alpha 2a|pegpegifn- alpha 2a
5597424|NCT00901524|Viral Hepatitis (HCV)|viral hepatitis (hcv)
5597425|NCT00901511|Whole lung lavage|whole lung lavage
5597426|NCT00901511|Pulmonary surfactant|pulmonary surfactant
5597427|NCT00901511|GM-CSF|gm-csf
5597428|NCT00901511|Autoantibodies anti GM-CSF|autoantibodies anti gm-csf
5597429|NCT00901485|Respiratory insufficiency|respiratory insufficiency
5597430|NCT00901485|Hypercapnia|hypercapnia
5597431|NCT00901485|Hypoventilation|hypoventilation
5597432|NCT00901485|Sleep|sleep
5597433|NCT00901485|Polysomnography|polysomnography
5597434|NCT00901485|Hypoxia|hypoxia
5597435|NCT00901485|Titration|titration
5597436|NCT00901485|Non Invasive Ventilation|non invasive ventilation
5597437|NCT00901472|Type 2 diabetes,|type 2 diabetes,
5597438|NCT00901472|obstructive sleep apnea|obstructive sleep apnea
5597439|NCT00901459|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5597440|NCT00901459|Cigarette Smoker|cigarette smoker
5597441|NCT00901459|Cigarette Dependence|cigarette dependence
5597442|NCT00901459|To block cue-elicited craving in dependent cigarette smokers|to block cue-elicited craving in dependent cigarette smokers
5597443|NCT00901433|Asthma|asthma
5597444|NCT00901433|Wheeze Rate|wheeze rate
5597445|NCT00901433|Respiratory Function Tests|respiratory function tests
5597446|NCT00901420|Prostate|prostate
5597447|NCT00901420|Urodynamic Evaluation|urodynamic evaluation
5597448|NCT00901420|Prostatectomy|prostatectomy
5597449|NCT00901420|Salvage prostatectomy|salvage prostatectomy
5597450|NCT00901420|Bladder compliance|bladder compliance
5597451|NCT00901420|Radiation Therapy|radiation therapy
5597452|NCT00901420|External beam radiation therapy|external beam radiation therapy
5597453|NCT00901420|Quality-of-life|quality-of-life
5597460|NCT00901394|vitamin B12|vitamin b12
5597461|NCT00901394|folate|folate
5597462|NCT00901394|No specific diseases targeted|no specific diseases targeted
5597463|NCT00901381|Ischemic stroke|ischemic stroke
5597464|NCT00901381|Stem cells|stem cells
5597465|NCT00901381|Colony-stimulating factors|colony-stimulating factors
5597466|NCT00901381|Filgrastim|filgrastim
5597467|NCT00901381|Randomized controlled trial|randomized controlled trial
5597468|NCT00901355|Blood pressure|blood pressure
5597469|NCT00901355|Arterial stiffness|arterial stiffness
5597470|NCT00901355|Morbidity|morbidity
5597471|NCT00901355|Mortality|mortality
5597472|NCT00901355|Elderly|elderly
5597473|NCT00901342|Androgen independent prostate cancer (AIPC)|androgen independent prostate cancer (aipc)
5597474|NCT00901342|CRPC|crpc
5597475|NCT00901342|prostate cancer|prostate cancer
5597476|NCT00901342|prostate|prostate
5597477|NCT00901342|immune therapy|immune therapy
5597478|NCT00901342|immunotherapy|immunotherapy
5597479|NCT00901342|vaccine|vaccine
5597481|NCT00901342|antigen-presenting cells|antigen-presenting cells
5597482|NCT00901342|antigen presenting cells|antigen presenting cells
5597483|NCT00901342|cancer vaccine|cancer vaccine
5597484|NCT00901342|prostate specific antigen (PSA)|prostate specific antigen (psa)
5597485|NCT00901342|prostatic adenocarcinoma|prostatic adenocarcinoma
5597486|NCT00901329|TKA|tka
5597487|NCT00901329|functional outcome|functional outcome
5597488|NCT00901329|pain|pain
5597489|NCT00901329|ROM|rom
5597490|NCT00901329|gait|gait
5597491|NCT00901316|Skin and Soft Tissue Infections|skin and soft tissue infections
5597492|NCT00901316|Abscesses|abscesses
5597493|NCT00901316|Boils|boils
5597494|NCT00901316|Clorox Baths|clorox baths
5597495|NCT00901316|Colonization|colonization
5597496|NCT00901316|Staph|staph
5597497|NCT00901316|MRSA|mrsa
5597498|NCT00901316|MSSA|mssa
5597499|NCT00901316|Recurrent Infections|recurrent infections
5597500|NCT00901316|Prevention CA-SA Infections|prevention ca-sa infections
5597501|NCT00901316|Community-Acquired Staphylococcus in Children|community-acquired staphylococcus in children
5597502|NCT00901290|oral contraceptive|oral contraceptive
5597503|NCT00901277|Post MI|post mi
5597504|NCT00901264|Chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment|chemosensitivity, chemotherapy, all cancers, personalized chemotherapy, personalized cancer treatment
5597505|NCT00901264|Cancer Patients for whom chemotherapy is planned.|cancer patients for whom chemotherapy is planned.
5597506|NCT00901251|OABSS|oabss
5597507|NCT00901238|retinoblastoma|retinoblastoma
5597508|NCT00901238|intra-arterial chemotherapy|intra-arterial chemotherapy
5597509|NCT00901238|chemosurgery|chemosurgery
5597510|NCT00901238|melphalan|melphalan
5597511|NCT00901238|topotecan|topotecan
5597512|NCT00901225|NHL|nhl
5597513|NCT00901212|Heart Failure|heart failure
5597514|NCT00901212|resynchronisation|resynchronisation
5597515|NCT00901212|ICD|icd
5597516|NCT00901199|Thalassemia|thalassemia
5597517|NCT00901199|Chelation|chelation
5597518|NCT00901199|Iron Overload|iron overload
5597519|NCT00901199|Thalassemia patients with Iron overload|thalassemia patients with iron overload
5597520|NCT00901186|Diabetic Macular Edema|diabetic macular edema
5597521|NCT00901186|Ranibizumab|ranibizumab
5597522|NCT00901186|Laser Treatment|laser treatment
5597523|NCT00901186|Visual impairment|visual impairment
5597524|NCT00901173|Case-Control Study|case-control study
5672288|NCT00612469|sodium fluoride|sodium fluoride
5597525|NCT00901173|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5597526|NCT00901173|Risk Factors|risk factors
5597527|NCT00901160|thromboelastography|thromboelastography
5597528|NCT00901160|post-operative complications|post-operative complications
5597529|NCT00901160|anti-platelet agents|anti-platelet agents
5597530|NCT00901160|prospective|prospective
5597531|NCT00901160|pilot|pilot
5597532|NCT00901160|patients taking anti-platelet agents|patients taking anti-platelet agents
5597533|NCT00901147|t-cell lymphoma|t-cell lymphoma
5597534|NCT00901147|peripheral t-cell lymphoma|peripheral t-cell lymphoma
5597535|NCT00901147|nk/t-cell lymphoma, nasal type|nk/t-cell lymphoma, nasal type
5597536|NCT00901147|bortezomib|bortezomib
5597537|NCT00901147|velcade|velcade
5597538|NCT00901147|panobinostat|panobinostat
5597539|NCT00901147|LBH589b|lbh589b
5597540|NCT00901147|histone deacetylase inhibitor|histone deacetylase inhibitor
5597541|NCT00901147|proteasome inhibitor|proteasome inhibitor
5597542|NCT00901134|therapeutic hypothermia after cardiac arrest|therapeutic hypothermia after cardiac arrest
5597543|NCT00901121|maxillary sinus lift|maxillary sinus lift
5597544|NCT00901121|Histomorphometric evaluation|histomorphometric evaluation
5597545|NCT00901121|bone graft|bone graft
5597546|NCT00901121|bone augmentation|bone augmentation
5597547|NCT00901108|open angle glaucoma|open angle glaucoma
5597548|NCT00901108|trabectome|trabectome
5597549|NCT00901108|trabeculectomy|trabeculectomy
5597550|NCT00901108|cataract|cataract
5597551|NCT00901082|chronic pain|chronic pain
5597553|NCT00901082|intervention|intervention
5597554|NCT00901082|information|information
5597555|NCT00901082|relaxation|relaxation
5597556|NCT00901056|ED|ed
5597557|NCT00901056|Erectile Dysfunction|erectile dysfunction
5597558|NCT00901056|Erectile dysfunction treated with PDE-5 inhibitors|erectile dysfunction treated with pde-5 inhibitors
5597559|NCT00901030|platelet function|platelet function
5597560|NCT00901030|perioperative complications|perioperative complications
5597561|NCT00901030|thromboelastography|thromboelastography
5597562|NCT00901030|coronary stents|coronary stents
5597563|NCT00901030|non-cardiac surgery|non-cardiac surgery
5597564|NCT00901004|Minimal Change|minimal change
5597565|NCT00901004|GERD|gerd
5597566|NCT00901004|GERDQ|gerdq
5597567|NCT00900991|Pandemic Influenza A Vaccine|pandemic influenza a vaccine
5597568|NCT00900991|Immunogenictiy|immunogenictiy
5597569|NCT00900991|Safety|safety
5597570|NCT00900978|Streptococcus pneumoniae|streptococcus pneumoniae
5597571|NCT00900978|carriage|carriage
5597572|NCT00900978|Resistance|resistance
5597573|NCT00900978|Serotype|serotype
5597574|NCT00900978|vaccination|vaccination
5597575|NCT00900978|Colonization of S. pneumoniae|colonization of s. pneumoniae
5597576|NCT00900965|irritable bowel syndrome|irritable bowel syndrome
5597578|NCT00900965|fMRI|fmri
5597579|NCT00900965|acupuncture|acupuncture
5597580|NCT00900965|functional|functional
5597581|NCT00900965|brain|brain
5597582|NCT00900900|Cigarette Smokers|cigarette smokers
5597583|NCT00900900|DHEA|dhea
5597584|NCT00900900|dehydroepiandrosterone|dehydroepiandrosterone
5597585|NCT00900900|pregnenolone|pregnenolone
5597586|NCT00900900|Nicotine withdrawal symptoms|nicotine withdrawal symptoms
5597587|NCT00900887|diabetic retinopathy|diabetic retinopathy
5597588|NCT00900887|clinically significant macular edema|clinically significant macular edema
5597589|NCT00900887|selective photocoagulation|selective photocoagulation
5597590|NCT00900887|topic ketorolac|topic ketorolac
5597591|NCT00900887|topic nepafenac|topic nepafenac
5597592|NCT00900887|efficacy|efficacy
5597593|NCT00900887|treatment|treatment
5597594|NCT00900874|Formoterol|formoterol
5597595|NCT00900874|Rapid bronchodilation|rapid bronchodilation
5597596|NCT00900861|asthma control level|asthma control level
5597597|NCT00900861|visual analogue scale|visual analogue scale
5597598|NCT00900848|Posterior tibial artery bypass|posterior tibial artery bypass
5597599|NCT00900848|Iliofemoral artery injury|iliofemoral artery injury
5597600|NCT00900848|Shock|shock
5597601|NCT00900848|Reconstruction|reconstruction
5597602|NCT00900835|fatigue|fatigue
5597603|NCT00900835|pain|pain
5597604|NCT00900835|recurrent breast cancer|recurrent breast cancer
5597605|NCT00900835|stage I breast cancer|stage i breast cancer
5597606|NCT00900835|stage II breast cancer|stage ii breast cancer
5597607|NCT00900835|stage IIIA breast cancer|stage iiia breast cancer
5597608|NCT00900835|stage IIIB breast cancer|stage iiib breast cancer
5597609|NCT00900835|stage IIIC breast cancer|stage iiic breast cancer
5597610|NCT00900835|stage IV breast cancer|stage iv breast cancer
5597611|NCT00900835|recurrent prostate cancer|recurrent prostate cancer
5597612|NCT00900835|stage I prostate cancer|stage i prostate cancer
5597613|NCT00900835|stage II prostate cancer|stage ii prostate cancer
5597614|NCT00900835|stage III prostate cancer|stage iii prostate cancer
5597615|NCT00900835|stage IV prostate cancer|stage iv prostate cancer
5597616|NCT00900835|recurrent colon cancer|recurrent colon cancer
5597617|NCT00900835|stage I colon cancer|stage i colon cancer
5597618|NCT00900835|stage II colon cancer|stage ii colon cancer
5597619|NCT00900835|stage III colon cancer|stage iii colon cancer
5597620|NCT00900835|stage IV colon cancer|stage iv colon cancer
5597621|NCT00900835|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5597622|NCT00900835|limited stage small cell lung cancer|limited stage small cell lung cancer
5597623|NCT00900835|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5597624|NCT00900835|recurrent small cell lung cancer|recurrent small cell lung cancer
5597625|NCT00900835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5597626|NCT00900835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5597627|NCT00900835|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5597924|NCT00900302|stage IV melanoma|stage iv melanoma
5597628|NCT00900835|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5597629|NCT00900835|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5597630|NCT00900822|bone grafting|bone grafting
5597631|NCT00900822|sinus elevation|sinus elevation
5597632|NCT00900822|sinus augmentation|sinus augmentation
5597633|NCT00900809|Acute Myeloid Leukemia|acute myeloid leukemia
5597634|NCT00900809|Neukoplast™|neukoplast™
5597635|NCT00900809|NK-92|nk-92
5597636|NCT00900809|Refractory|refractory
5597637|NCT00900809|Refractory or Relapsed Acute Myeloid Leukemia|refractory or relapsed acute myeloid leukemia
5597638|NCT00900796|Ankylosing spondylitis;predictive factors|ankylosing spondylitis;predictive factors
5597655|NCT00900731|beta 2 agonist|beta 2 agonist
5597656|NCT00900731|tiotropium|tiotropium
5597657|NCT00900692|Excessive pronation|excessive pronation
5597659|NCT00900692|Forearm|forearm
5597660|NCT00900692|Excessive pronation following CVA|excessive pronation following cva
5597661|NCT00900679|transitional care planning|transitional care planning
5597662|NCT00900679|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5597663|NCT00900679|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5597664|NCT00900679|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5597665|NCT00900679|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5597666|NCT00900666|Stiff knee gait|stiff knee gait
5597667|NCT00900666|Gait analysis|gait analysis
5597668|NCT00900666|Traumatic Brain Injury|traumatic brain injury
5597669|NCT00900666|Acquired Brain Injury|acquired brain injury
5597670|NCT00900653|urinary tract infections|urinary tract infections
5597671|NCT00900653|postmenopause|postmenopause
5597672|NCT00900653|lactobacillus|lactobacillus
5597674|NCT00900627|Cancer|cancer
5597675|NCT00900627|Tumour|tumour
5597676|NCT00900627|Breast cancer|breast cancer
5597677|NCT00900627|Metastatic|metastatic
5597678|NCT00900627|Secondary|secondary
5597679|NCT00900614|Hematologic malignancy|hematologic malignancy
5597680|NCT00900614|Prostate carcinoma|prostate carcinoma
5597681|NCT00900614|Hematologic cancer|hematologic cancer
5597682|NCT00900614|Prostate cancer|prostate cancer
5597683|NCT00900601|Sacroiliac pain|sacroiliac pain
5597684|NCT00900601|Sacroiliac instability|sacroiliac instability
5597685|NCT00900601|Pelvic girdle pain|pelvic girdle pain
5597686|NCT00900601|Sacroiliac arthrodesis|sacroiliac arthrodesis
5597687|NCT00900601|Arthrodesis|arthrodesis
5597688|NCT00900601|Surgery|surgery
5597689|NCT00900588|immunogenictiy|immunogenictiy
5597690|NCT00900588|safety|safety
5597691|NCT00900588|pandemic influenza A vaccine|pandemic influenza a vaccine
5597692|NCT00900575|cervical cancer|cervical cancer
5597693|NCT00900575|LEEP|leep
5597694|NCT00900575|colposcopy|colposcopy
5597695|NCT00900575|Pap smear|pap smear
5597696|NCT00900562|Zalypsis|zalypsis
5597697|NCT00900562|Cancer|cancer
5597698|NCT00900562|Endometrial|endometrial
5597699|NCT00900562|Uterine Cervical|uterine cervical
5597700|NCT00900562|PharmaMar|pharmamar
5597701|NCT00900549|Heart failure|heart failure
5597702|NCT00900549|Cardiac resynchronization therapy|cardiac resynchronization therapy
5597703|NCT00900549|ICD|icd
5597704|NCT00900536|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5597705|NCT00900536|stage I renal cell cancer|stage i renal cell cancer
5597706|NCT00900536|stage II renal cell cancer|stage ii renal cell cancer
5597707|NCT00900536|stage III renal cell cancer|stage iii renal cell cancer
5597708|NCT00900536|stage IV renal cell cancer|stage iv renal cell cancer
5597709|NCT00900536|papillary renal cell carcinoma|papillary renal cell carcinoma
5597710|NCT00900523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5685442|NCT00556036|anorexia nervosa|anorexia nervosa
5597711|NCT00900523|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5597712|NCT00900523|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5597713|NCT00900523|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5597714|NCT00900523|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5597715|NCT00900510|subcutaneous abscess|subcutaneous abscess
5597716|NCT00900510|Incision and drainage|incision and drainage
5597717|NCT00900510|Methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5597718|NCT00900497|granulocytes|granulocytes
5597719|NCT00900497|Graft-vs-Host-Disease|graft-vs-host-disease
5597720|NCT00900484|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5597721|NCT00900484|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5597722|NCT00900484|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5597723|NCT00900484|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5597724|NCT00900484|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5597725|NCT00900484|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5597726|NCT00900484|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5597727|NCT00900484|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5597728|NCT00900484|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5597729|NCT00900484|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5597730|NCT00900484|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5597731|NCT00900484|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5597732|NCT00900484|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5597733|NCT00900484|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5597734|NCT00900484|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5597735|NCT00900484|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5597736|NCT00900484|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5597737|NCT00900484|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5597738|NCT00900484|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5597739|NCT00900484|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5597740|NCT00900484|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5597741|NCT00900484|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5597742|NCT00900484|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5597743|NCT00900484|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5597744|NCT00900484|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5597745|NCT00900484|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5597746|NCT00900484|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5597747|NCT00900484|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5597748|NCT00900471|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5597749|NCT00900471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5597750|NCT00900458|preeclampsia|preeclampsia
5597751|NCT00900458|low vs high plasma volume|low vs high plasma volume
5597752|NCT00900432|recurrent colon cancer|recurrent colon cancer
5597753|NCT00900432|stage I colon cancer|stage i colon cancer
5597754|NCT00900432|stage II colon cancer|stage ii colon cancer
5597755|NCT00900432|stage III colon cancer|stage iii colon cancer
5597756|NCT00900432|stage IV colon cancer|stage iv colon cancer
5597757|NCT00900419|non-small cell lung cancer|non-small cell lung cancer
5597758|NCT00900419|small cell lung cancer|small cell lung cancer
5597759|NCT00900419|squamous lung dysplasia|squamous lung dysplasia
5597760|NCT00900419|hypopharyngeal cancer|hypopharyngeal cancer
5597761|NCT00900419|laryngeal cancer|laryngeal cancer
5597762|NCT00900419|lip and oral cavity cancer|lip and oral cavity cancer
5597763|NCT00900419|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5597764|NCT00900419|nasopharyngeal cancer|nasopharyngeal cancer
5597765|NCT00900419|oropharyngeal cancer|oropharyngeal cancer
5597766|NCT00900419|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5597767|NCT00900419|salivary gland cancer|salivary gland cancer
5597768|NCT00900419|esophageal cancer|esophageal cancer
5597769|NCT00900419|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5597770|NCT00900419|tongue cancer|tongue cancer
5597771|NCT00900380|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5597772|NCT00900380|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5597773|NCT00900380|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5597774|NCT00900380|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5597775|NCT00900380|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5597776|NCT00900380|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5597777|NCT00900380|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5597778|NCT00900380|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5597779|NCT00900380|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5597780|NCT00900380|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5597781|NCT00900380|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5597782|NCT00900380|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5597783|NCT00900380|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5597784|NCT00900380|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5597785|NCT00900380|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5597786|NCT00900367|breast cancer|breast cancer
5862993|NCT00001420|Genetics|genetics
5597787|NCT00900354|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5597788|NCT00900341|adult soft tissue sarcoma|adult soft tissue sarcoma
5597789|NCT00900341|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5597790|NCT00900328|adenocarcinoma of the lung|adenocarcinoma of the lung
5597791|NCT00900328|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5597792|NCT00900328|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5597793|NCT00900328|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5597794|NCT00900328|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5597795|NCT00900328|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5597796|NCT00900328|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5597797|NCT00900328|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5597798|NCT00900302|male breast cancer|male breast cancer
5597799|NCT00900302|recurrent breast cancer|recurrent breast cancer
5597800|NCT00900302|stage IA breast cancer|stage ia breast cancer
5597801|NCT00900302|stage IB breast cancer|stage ib breast cancer
5597802|NCT00900302|stage II breast cancer|stage ii breast cancer
5597803|NCT00900302|stage IIIA breast cancer|stage iiia breast cancer
5597804|NCT00900302|stage IIIB breast cancer|stage iiib breast cancer
5597805|NCT00900302|stage IIIC breast cancer|stage iiic breast cancer
5597806|NCT00900302|stage IV breast cancer|stage iv breast cancer
5597807|NCT00900302|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5597808|NCT00900302|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5597809|NCT00900302|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5597810|NCT00900302|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5597811|NCT00900302|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5597812|NCT00900302|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5597813|NCT00900302|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5597814|NCT00900302|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5597815|NCT00900302|squamous cell lung cancer|squamous cell lung cancer
5597816|NCT00900302|vaginal squamous cell carcinoma|vaginal squamous cell carcinoma
5597817|NCT00900302|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5597818|NCT00900302|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5597819|NCT00900302|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5597820|NCT00900302|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5597821|NCT00900302|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5597822|NCT00900302|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5597823|NCT00900302|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5597824|NCT00900302|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5597825|NCT00900302|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5597826|NCT00900302|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5597827|NCT00900302|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5597828|NCT00900302|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5597829|NCT00900302|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5597830|NCT00900302|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5597831|NCT00900302|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5580202|NCT00967616|rectum|rectum
5597832|NCT00900302|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5597833|NCT00900302|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5597834|NCT00900302|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5597835|NCT00900302|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5597836|NCT00900302|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5597837|NCT00900302|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5597838|NCT00900302|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5671586|NCT00615381|Intracranial Aneurysm, Unruptured|intracranial aneurysm, unruptured
5597839|NCT00900302|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5597840|NCT00900302|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5597841|NCT00900302|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5597842|NCT00900302|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5597843|NCT00900302|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5597844|NCT00900302|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5597845|NCT00900302|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5597846|NCT00900302|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5597847|NCT00900302|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5597848|NCT00900302|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5597849|NCT00900302|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5597850|NCT00900302|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5597851|NCT00900302|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5597852|NCT00900302|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5597853|NCT00900302|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5597854|NCT00900302|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5597855|NCT00900302|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5597856|NCT00900302|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5597857|NCT00900302|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5597858|NCT00900302|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5597859|NCT00900302|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5597860|NCT00900302|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5597861|NCT00900302|stage I salivary gland cancer|stage i salivary gland cancer
5597862|NCT00900302|stage II salivary gland cancer|stage ii salivary gland cancer
5597863|NCT00900302|stage III salivary gland cancer|stage iii salivary gland cancer
5597864|NCT00900302|stage IV salivary gland cancer|stage iv salivary gland cancer
5597865|NCT00900302|recurrent salivary gland cancer|recurrent salivary gland cancer
5597866|NCT00900302|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5597867|NCT00900302|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5597868|NCT00900302|penile squamous cell carcinoma|penile squamous cell carcinoma
5597869|NCT00900302|recurrent anal cancer|recurrent anal cancer
5597870|NCT00900302|stage I anal cancer|stage i anal cancer
5597871|NCT00900302|stage II anal cancer|stage ii anal cancer
5597872|NCT00900302|stage IIIA anal cancer|stage iiia anal cancer
5597873|NCT00900302|stage IIIB anal cancer|stage iiib anal cancer
5597875|NCT00900302|recurrent bladder cancer|recurrent bladder cancer
5597876|NCT00900302|stage I bladder cancer|stage i bladder cancer
5597877|NCT00900302|stage II bladder cancer|stage ii bladder cancer
5597878|NCT00900302|stage III bladder cancer|stage iii bladder cancer
5597879|NCT00900302|stage IV bladder cancer|stage iv bladder cancer
5597880|NCT00900302|recurrent esophageal cancer|recurrent esophageal cancer
5597881|NCT00900302|stage I esophageal cancer|stage i esophageal cancer
5597882|NCT00900302|stage II esophageal cancer|stage ii esophageal cancer
5597883|NCT00900302|stage III esophageal cancer|stage iii esophageal cancer
5597884|NCT00900302|stage IV esophageal cancer|stage iv esophageal cancer
5597885|NCT00900302|localized gallbladder cancer|localized gallbladder cancer
5597886|NCT00900302|recurrent gallbladder cancer|recurrent gallbladder cancer
5597887|NCT00900302|unresectable gallbladder cancer|unresectable gallbladder cancer
5597888|NCT00900302|recurrent vulvar cancer|recurrent vulvar cancer
5597889|NCT00900302|stage I vulvar cancer|stage i vulvar cancer
5597890|NCT00900302|stage II vulvar cancer|stage ii vulvar cancer
5597891|NCT00900302|stage III vulvar cancer|stage iii vulvar cancer
5597892|NCT00900302|stage IV vulvar cancer|stage iv vulvar cancer
5597893|NCT00900302|recurrent cervical cancer|recurrent cervical cancer
5597894|NCT00900302|stage IA cervical cancer|stage ia cervical cancer
5597895|NCT00900302|stage IB cervical cancer|stage ib cervical cancer
5597896|NCT00900302|stage IIA cervical cancer|stage iia cervical cancer
5597897|NCT00900302|stage IIB cervical cancer|stage iib cervical cancer
5597898|NCT00900302|stage III cervical cancer|stage iii cervical cancer
5597899|NCT00900302|stage IVA cervical cancer|stage iva cervical cancer
5597900|NCT00900302|stage IVB cervical cancer|stage ivb cervical cancer
5597901|NCT00900302|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5597902|NCT00900302|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5685443|NCT00556036|weight|weight
5597903|NCT00900302|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5597904|NCT00900302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5597905|NCT00900302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5597906|NCT00900302|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5597907|NCT00900302|recurrent skin cancer|recurrent skin cancer
5597908|NCT00900302|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5597909|NCT00900302|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5597910|NCT00900302|recurrent penile cancer|recurrent penile cancer
5597911|NCT00900302|stage I penile cancer|stage i penile cancer
5597912|NCT00900302|stage II penile cancer|stage ii penile cancer
5597913|NCT00900302|stage III penile cancer|stage iii penile cancer
5597914|NCT00900302|stage IV penile cancer|stage iv penile cancer
5597916|NCT00900302|stage IA melanoma|stage ia melanoma
5597917|NCT00900302|stage IB melanoma|stage ib melanoma
5597918|NCT00900302|stage IIA melanoma|stage iia melanoma
5597919|NCT00900302|stage IIB melanoma|stage iib melanoma
5597920|NCT00900302|stage IIC melanoma|stage iic melanoma
5597921|NCT00900302|stage IIIA melanoma|stage iiia melanoma
5597922|NCT00900302|stage IIIB melanoma|stage iiib melanoma
5597923|NCT00900302|stage IIIC melanoma|stage iiic melanoma
5597928|NCT00900289|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5597929|NCT00900289|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5597930|NCT00900289|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5597931|NCT00900289|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5597932|NCT00900289|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5597933|NCT00900276|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5597934|NCT00900276|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5597935|NCT00900276|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5597936|NCT00900276|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5597937|NCT00900276|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5597938|NCT00900276|stage I renal cell cancer|stage i renal cell cancer
5597939|NCT00900276|stage II renal cell cancer|stage ii renal cell cancer
5597940|NCT00900276|recurrent renal cell cancer|recurrent renal cell cancer
5597941|NCT00900276|recurrent bladder cancer|recurrent bladder cancer
5597942|NCT00900276|stage I bladder cancer|stage i bladder cancer
5597943|NCT00900276|stage II bladder cancer|stage ii bladder cancer
5597944|NCT00900276|stage III bladder cancer|stage iii bladder cancer
5597945|NCT00900276|stage IV bladder cancer|stage iv bladder cancer
5597946|NCT00900276|anterior urethral cancer|anterior urethral cancer
5597947|NCT00900276|posterior urethral cancer|posterior urethral cancer
5597948|NCT00900276|recurrent urethral cancer|recurrent urethral cancer
5597949|NCT00900276|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5597950|NCT00900263|stage I multiple myeloma|stage i multiple myeloma
5597951|NCT00900263|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5597952|NCT00900263|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5597953|NCT00900237|Partial|partial
5597954|NCT00900237|Epilepsy|epilepsy
5597955|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate
5597956|NCT00900237|Pharmacokinetics|pharmacokinetics
5597957|NCT00900237|Tolerability|tolerability
5597958|NCT00900224|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5597959|NCT00900224|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5597960|NCT00900224|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5597961|NCT00900224|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5597962|NCT00900224|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5597963|NCT00900224|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5597964|NCT00900224|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5597965|NCT00900224|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5597966|NCT00900211|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5597967|NCT00900211|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5597968|NCT00900211|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5597969|NCT00900211|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5597970|NCT00900211|adult synovial sarcoma|adult synovial sarcoma
5597971|NCT00900211|adult angiosarcoma|adult angiosarcoma
5597972|NCT00900211|adult epithelioid sarcoma|adult epithelioid sarcoma
5597973|NCT00900211|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5597974|NCT00900211|adult leiomyosarcoma|adult leiomyosarcoma
5597975|NCT00900211|adult liposarcoma|adult liposarcoma
5597976|NCT00900211|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5685444|NCT00556036|cortisol|cortisol
5597977|NCT00900211|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5597978|NCT00900211|adult malignant mesenchymoma|adult malignant mesenchymoma
5597979|NCT00900211|adult fibrosarcoma|adult fibrosarcoma
5597980|NCT00900211|adult neurofibrosarcoma|adult neurofibrosarcoma
5597986|NCT00900185|recurrent prostate cancer|recurrent prostate cancer
5597987|NCT00900185|stage I prostate cancer|stage i prostate cancer
5597988|NCT00900185|stage IIB prostate cancer|stage iib prostate cancer
5597989|NCT00900185|stage IIA prostate cancer|stage iia prostate cancer
5597990|NCT00900185|stage III prostate cancer|stage iii prostate cancer
5597991|NCT00900185|stage IV prostate cancer|stage iv prostate cancer
5597992|NCT00900172|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5597993|NCT00900172|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5597994|NCT00900172|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5591986|NCT00923130|Bevacizumab|bevacizumab
5597995|NCT00900172|adenocarcinoma of the lung|adenocarcinoma of the lung
5597996|NCT00900172|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5597997|NCT00900159|Shift-work|shift-work
5598001|NCT00900159|shiftworkers|shiftworkers
5598002|NCT00900146|type 2 diabetes|type 2 diabetes
5598003|NCT00900146|canakinumab|canakinumab
5598004|NCT00900133|stage I breast cancer|stage i breast cancer
5598005|NCT00900133|stage II breast cancer|stage ii breast cancer
5598006|NCT00900133|stage IIIA breast cancer|stage iiia breast cancer
5598007|NCT00900133|stage IIIB breast cancer|stage iiib breast cancer
5598008|NCT00900133|stage IIIC breast cancer|stage iiic breast cancer
5598009|NCT00900120|aplastic anemia|aplastic anemia
5598010|NCT00900120|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5598011|NCT00900120|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598012|NCT00900120|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5598013|NCT00900120|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5598014|NCT00900120|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5598015|NCT00900120|acute undifferentiated leukemia|acute undifferentiated leukemia
5598016|NCT00900120|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5598017|NCT00900120|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5598018|NCT00900120|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598019|NCT00900120|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598020|NCT00900120|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5598021|NCT00900120|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5598022|NCT00900120|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598023|NCT00900120|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5598024|NCT00900120|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5598025|NCT00900120|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5598026|NCT00900120|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5598027|NCT00900120|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5598028|NCT00900120|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5598029|NCT00900120|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5598030|NCT00900120|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5598031|NCT00900120|mast cell leukemia|mast cell leukemia
5598032|NCT00900120|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5598033|NCT00900120|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5598034|NCT00900120|prolymphocytic leukemia|prolymphocytic leukemia
5598035|NCT00900120|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5598036|NCT00900120|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5598037|NCT00900120|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5598038|NCT00900120|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5598039|NCT00900120|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5598040|NCT00900120|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5598041|NCT00900120|refractory hairy cell leukemia|refractory hairy cell leukemia
5598042|NCT00900120|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5580484|NCT00966472|Erlotinib|erlotinib
5598043|NCT00900120|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598044|NCT00900120|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5598045|NCT00900120|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5598046|NCT00900120|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5598047|NCT00900120|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5598048|NCT00900120|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5598049|NCT00900120|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5685445|NCT00556036|hormone|hormone
5598050|NCT00900120|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5598051|NCT00900120|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5598052|NCT00900120|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5598053|NCT00900120|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5598054|NCT00900120|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5598055|NCT00900120|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5598056|NCT00900120|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5598057|NCT00900120|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5598058|NCT00900120|untreated hairy cell leukemia|untreated hairy cell leukemia
5598059|NCT00900120|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5598060|NCT00900120|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5598061|NCT00900120|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5598064|NCT00900120|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5598065|NCT00900120|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5598066|NCT00900120|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5598068|NCT00900120|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5598069|NCT00900120|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5598070|NCT00900120|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5598071|NCT00900120|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5598072|NCT00900120|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5598073|NCT00900120|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5598074|NCT00900120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5598075|NCT00900120|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5598076|NCT00900120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5598077|NCT00900120|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5598078|NCT00900120|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5598079|NCT00900120|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5598080|NCT00900120|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5598081|NCT00900120|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5598082|NCT00900120|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5598083|NCT00900120|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5598084|NCT00900120|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5598085|NCT00900120|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5598086|NCT00900120|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5598087|NCT00900120|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5598088|NCT00900120|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5598089|NCT00900120|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5598090|NCT00900120|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5598091|NCT00900120|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5598092|NCT00900120|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5598093|NCT00900120|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5598094|NCT00900120|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5598095|NCT00900120|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5598096|NCT00900120|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5598097|NCT00900120|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5598098|NCT00900120|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5598099|NCT00900120|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5598100|NCT00900120|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5598101|NCT00900120|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5598102|NCT00900120|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5598103|NCT00900120|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5598104|NCT00900120|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5598105|NCT00900120|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5598106|NCT00900120|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5598107|NCT00900120|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5598108|NCT00900120|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5598109|NCT00900120|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5598110|NCT00900120|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5598111|NCT00900120|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5598112|NCT00900120|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5598113|NCT00900120|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5598114|NCT00900120|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5598115|NCT00900120|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5598116|NCT00900120|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5598117|NCT00900120|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5598118|NCT00900120|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5598119|NCT00900120|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5598120|NCT00900120|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5598125|NCT00900120|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5600517|NCT00895765|Melamine|melamine
5598126|NCT00900120|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5598127|NCT00900120|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5598128|NCT00900120|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5598129|NCT00900120|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5598130|NCT00900120|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5598131|NCT00900120|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5598132|NCT00900120|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5598133|NCT00900120|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5598134|NCT00900120|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5598135|NCT00900120|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5598136|NCT00900120|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5598137|NCT00900120|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5598904|NCT00899132|pancreatic cancer|pancreatic cancer
5598138|NCT00900120|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5598139|NCT00900120|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5598140|NCT00900120|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5598141|NCT00900120|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5598142|NCT00900120|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5598143|NCT00900120|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5598144|NCT00900120|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5598145|NCT00900120|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5598146|NCT00900120|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5598147|NCT00900120|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5598148|NCT00900120|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5598149|NCT00900120|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5598150|NCT00900120|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5598151|NCT00900120|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5598152|NCT00900120|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5598153|NCT00900120|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5598154|NCT00900120|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5598155|NCT00900120|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5598156|NCT00900120|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5598157|NCT00900120|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5598158|NCT00900120|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5598159|NCT00900120|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5598160|NCT00900120|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5598161|NCT00900120|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5580678|NCT00965536|Bipolar Disorder|bipolar disorder
5580694|NCT00965497|ALS|als
5598162|NCT00900120|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5598163|NCT00900120|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5598164|NCT00900120|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5598165|NCT00900120|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5598166|NCT00900120|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5598167|NCT00900120|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5598168|NCT00900120|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5598169|NCT00900120|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5598170|NCT00900120|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5598171|NCT00900120|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5598172|NCT00900120|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5598173|NCT00900120|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5598174|NCT00900120|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5598175|NCT00900120|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5598176|NCT00900120|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5598177|NCT00900120|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5598178|NCT00900120|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5598179|NCT00900120|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5598180|NCT00900120|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5598181|NCT00900120|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5598182|NCT00900120|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5598183|NCT00900120|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5598184|NCT00900120|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5598185|NCT00900120|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5598186|NCT00900120|Burkitt lymphoma|burkitt lymphoma
5598849|NCT00899301|stage IA breast cancer|stage ia breast cancer
5598187|NCT00900120|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5598188|NCT00900120|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5598189|NCT00900120|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5598190|NCT00900120|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5598191|NCT00900120|intraocular lymphoma|intraocular lymphoma
5598192|NCT00900120|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5598193|NCT00900120|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5598194|NCT00900120|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5598195|NCT00900120|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5598196|NCT00900120|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5598197|NCT00900120|primary myelofibrosis|primary myelofibrosis
5598198|NCT00900120|essential thrombocythemia|essential thrombocythemia
5598199|NCT00900120|polycythemia vera|polycythemia vera
5598200|NCT00900120|extramedullary plasmacytoma|extramedullary plasmacytoma
5598201|NCT00900120|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5598202|NCT00900120|stage I multiple myeloma|stage i multiple myeloma
5598203|NCT00900120|stage II multiple myeloma|stage ii multiple myeloma
5598204|NCT00900120|stage III multiple myeloma|stage iii multiple myeloma
5598205|NCT00900120|primary systemic amyloidosis|primary systemic amyloidosis
5598206|NCT00900120|refractory multiple myeloma|refractory multiple myeloma
5598207|NCT00900120|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5598208|NCT00900120|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5598209|NCT00900120|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5598210|NCT00900120|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5598211|NCT00900120|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5598212|NCT00900120|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5598213|NCT00900120|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5598214|NCT00900120|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5598216|NCT00900094|stage II breast cancer|stage ii breast cancer
5598217|NCT00900094|stage IIIA breast cancer|stage iiia breast cancer
5598218|NCT00900094|stage IIIB breast cancer|stage iiib breast cancer
5598219|NCT00900094|stage IV breast cancer|stage iv breast cancer
5598220|NCT00900094|adenocarcinoma of the colon|adenocarcinoma of the colon
5598221|NCT00900094|stage I colon cancer|stage i colon cancer
5598222|NCT00900094|stage II colon cancer|stage ii colon cancer
5598223|NCT00900094|stage III colon cancer|stage iii colon cancer
5598224|NCT00900094|stage IV colon cancer|stage iv colon cancer
5598225|NCT00900094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5598226|NCT00900094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5598227|NCT00900094|stage I esophageal cancer|stage i esophageal cancer
5598228|NCT00900094|stage II esophageal cancer|stage ii esophageal cancer
5598229|NCT00900094|stage III esophageal cancer|stage iii esophageal cancer
5598230|NCT00900094|stage IV esophageal cancer|stage iv esophageal cancer
5598231|NCT00900094|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5598232|NCT00900094|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5598233|NCT00900094|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5598234|NCT00900094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5598235|NCT00900094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5598236|NCT00900094|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5598237|NCT00900094|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5598238|NCT00900094|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5598239|NCT00900094|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5598240|NCT00900094|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5598241|NCT00900094|advanced adult primary liver cancer|advanced adult primary liver cancer
5862994|NCT00001420|Psoriatic Arthritis|psoriatic arthritis
5598242|NCT00900094|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5598243|NCT00900094|stage II pancreatic cancer|stage ii pancreatic cancer
5598244|NCT00900094|stage III pancreatic cancer|stage iii pancreatic cancer
5598245|NCT00900094|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5598246|NCT00900094|stage IIIC breast cancer|stage iiic breast cancer
5598247|NCT00900094|stage IV pancreatic cancer|stage iv pancreatic cancer
5598248|NCT00900094|recurrent breast cancer|recurrent breast cancer
5598249|NCT00900094|recurrent colon cancer|recurrent colon cancer
5598250|NCT00900094|recurrent esophageal cancer|recurrent esophageal cancer
5598251|NCT00900094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5598252|NCT00900094|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5598253|NCT00900094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5598254|NCT00900094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5598255|NCT00900094|recurrent small cell lung cancer|recurrent small cell lung cancer
5598256|NCT00900081|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5598257|NCT00900081|stage IA cervical cancer|stage ia cervical cancer
5598258|NCT00900081|stage 0 cervical cancer|stage 0 cervical cancer
5598259|NCT00900081|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5598260|NCT00900081|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5598261|NCT00900081|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5598262|NCT00900068|nausea and vomiting|nausea and vomiting
5598263|NCT00900068|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5598264|NCT00900068|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5598265|NCT00900068|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5598266|NCT00900068|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5598267|NCT00900068|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5598268|NCT00900068|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5598269|NCT00900068|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5598270|NCT00900068|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5598271|NCT00900068|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5598272|NCT00900068|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5598273|NCT00900068|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5598274|NCT00900068|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5598275|NCT00900068|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5598276|NCT00900068|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5598277|NCT00900068|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5598278|NCT00900068|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5598279|NCT00900068|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5598280|NCT00900068|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5598281|NCT00900068|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5598282|NCT00900068|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5598283|NCT00900068|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5598284|NCT00900068|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5598285|NCT00900068|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5598286|NCT00900068|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5598287|NCT00900068|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5798749|NCT00111176|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5598288|NCT00900068|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5598289|NCT00900068|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5598290|NCT00900068|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5598291|NCT00900068|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5598292|NCT00900068|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5598293|NCT00900068|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5598294|NCT00900068|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5598295|NCT00900068|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5598296|NCT00900068|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5598297|NCT00900068|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5598298|NCT00900068|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5598299|NCT00900068|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5671588|NCT00615381|Insulin|insulin
5598300|NCT00900068|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5598301|NCT00900068|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5598302|NCT00900068|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5598303|NCT00900068|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5598304|NCT00900068|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5598305|NCT00900068|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5598306|NCT00900068|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5598309|NCT00900068|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5598310|NCT00900068|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5598311|NCT00900068|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5598312|NCT00900068|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5598313|NCT00900068|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5598314|NCT00900068|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5598315|NCT00900068|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5598316|NCT00900068|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5598317|NCT00900068|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5598318|NCT00900068|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5598319|NCT00900068|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5598320|NCT00900068|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5598321|NCT00900068|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5598322|NCT00900068|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598323|NCT00900068|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598324|NCT00900068|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5598325|NCT00900068|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5599726|NCT00897819|stage IV colon cancer|stage iv colon cancer
5598326|NCT00900068|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598327|NCT00900068|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5598328|NCT00900068|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5598329|NCT00900068|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5598330|NCT00900068|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5598331|NCT00900068|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5598332|NCT00900068|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5598333|NCT00900068|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5598334|NCT00900068|refractory hairy cell leukemia|refractory hairy cell leukemia
5598335|NCT00900068|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5598336|NCT00900068|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598337|NCT00900068|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5598338|NCT00900068|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5598339|NCT00900068|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5598340|NCT00900068|primary myelofibrosis|primary myelofibrosis
5598341|NCT00900068|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5598342|NCT00900068|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5598343|NCT00900068|disseminated neuroblastoma|disseminated neuroblastoma
5598344|NCT00900068|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5598345|NCT00900068|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5598346|NCT00900068|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5598347|NCT00900068|recurrent neuroblastoma|recurrent neuroblastoma
5598348|NCT00900068|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5598349|NCT00900068|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5598350|NCT00900068|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5598351|NCT00900068|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5598352|NCT00900068|stage I multiple myeloma|stage i multiple myeloma
5598353|NCT00900068|stage II multiple myeloma|stage ii multiple myeloma
5598354|NCT00900068|stage III multiple myeloma|stage iii multiple myeloma
5598355|NCT00900068|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5598356|NCT00900068|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5598357|NCT00900068|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5598358|NCT00900068|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5598359|NCT00900068|stage IIIA breast cancer|stage iiia breast cancer
5598360|NCT00900068|stage IIIB breast cancer|stage iiib breast cancer
5598361|NCT00900068|stage IIIC breast cancer|stage iiic breast cancer
5598362|NCT00900068|stage IV breast cancer|stage iv breast cancer
5598363|NCT00900068|refractory multiple myeloma|refractory multiple myeloma
5598364|NCT00900055|Fanconi anemia|fanconi anemia
5592585|NCT00920829|Alcoholism|alcoholism
5598366|NCT00900055|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5598367|NCT00900055|myelodysplastic/myeloproliferative neoplasms|myelodysplastic/myeloproliferative neoplasms
5598368|NCT00900042|stage IV renal cell cancer|stage iv renal cell cancer
5598369|NCT00900029|Venous Leg Ulcer|venous leg ulcer
5598370|NCT00900029|Venous Stasis Ulcer|venous stasis ulcer
5598373|NCT00900029|Leg Ulcer|leg ulcer
5598374|NCT00900029|Leg Wound|leg wound
5598375|NCT00900016|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5598376|NCT00900016|recurrent pancreatic cancer|recurrent pancreatic cancer
5598377|NCT00900016|stage I pancreatic cancer|stage i pancreatic cancer
5598378|NCT00900016|stage II pancreatic cancer|stage ii pancreatic cancer
5598379|NCT00900003|stage I pancreatic cancer|stage i pancreatic cancer
5598380|NCT00900003|stage II pancreatic cancer|stage ii pancreatic cancer
5598381|NCT00900003|stage III pancreatic cancer|stage iii pancreatic cancer
5598382|NCT00900003|stage IV pancreatic cancer|stage iv pancreatic cancer
5598383|NCT00899977|refractory hypertension|refractory hypertension
5598384|NCT00899977|hypertension|hypertension
5598385|NCT00899951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598386|NCT00899951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5598387|NCT00899951|acute undifferentiated leukemia|acute undifferentiated leukemia
5598388|NCT00899951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5598389|NCT00899951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5598390|NCT00899951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598391|NCT00899951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598392|NCT00899951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5598393|NCT00899951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5598394|NCT00899951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598395|NCT00899951|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5598396|NCT00899951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5598397|NCT00899951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5598398|NCT00899951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5598399|NCT00899951|mast cell leukemia|mast cell leukemia
5598400|NCT00899951|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5598401|NCT00899951|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5598402|NCT00899951|prolymphocytic leukemia|prolymphocytic leukemia
5598403|NCT00899951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5598404|NCT00899951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5598405|NCT00899951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5598406|NCT00899951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5598407|NCT00899951|refractory hairy cell leukemia|refractory hairy cell leukemia
5598408|NCT00899951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5598409|NCT00899951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598410|NCT00899951|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5598411|NCT00899951|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5598412|NCT00899951|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5598413|NCT00899951|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5598414|NCT00899951|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5598415|NCT00899951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5598416|NCT00899951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5598417|NCT00899951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5598418|NCT00899951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5598419|NCT00899951|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5598420|NCT00899951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5598421|NCT00899951|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5598422|NCT00899951|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5598423|NCT00899951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5598424|NCT00899951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5598425|NCT00899951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5598426|NCT00899951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5598427|NCT00899951|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5598428|NCT00899951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5598429|NCT00899951|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5598430|NCT00899951|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5598431|NCT00899951|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5598432|NCT00899951|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5598433|NCT00899951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5598434|NCT00899951|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5598435|NCT00899951|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5598436|NCT00899951|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5598437|NCT00899951|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5598438|NCT00899951|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5598439|NCT00899951|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5598440|NCT00899951|Waldenström macroglobulinemia|waldenström macroglobulinemia
5598441|NCT00899951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5598442|NCT00899951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5598443|NCT00899951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5598444|NCT00899951|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5598445|NCT00899951|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5598446|NCT00899951|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5598447|NCT00899951|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5598448|NCT00899951|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5598449|NCT00899951|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5598450|NCT00899951|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5598451|NCT00899951|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5598452|NCT00899951|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5598453|NCT00899951|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5598454|NCT00899951|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5598455|NCT00899951|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5598456|NCT00899951|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5598457|NCT00899951|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5598458|NCT00899951|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5598459|NCT00899951|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5598460|NCT00899951|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5598461|NCT00899951|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5598462|NCT00899951|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5598463|NCT00899951|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5598464|NCT00899951|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5598465|NCT00899951|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5598466|NCT00899951|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5598467|NCT00899951|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5598468|NCT00899951|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5598469|NCT00899951|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5598470|NCT00899951|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5598471|NCT00899951|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5598472|NCT00899951|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5598473|NCT00899951|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5598474|NCT00899951|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5598475|NCT00899951|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5598479|NCT00899951|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5598480|NCT00899951|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5598481|NCT00899951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5598482|NCT00899951|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5598483|NCT00899951|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5598484|NCT00899951|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5598485|NCT00899951|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5598486|NCT00899951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5598487|NCT00899951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5598488|NCT00899951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5598489|NCT00899951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5598490|NCT00899951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5598491|NCT00899951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5592766|NCT00920205|cancer|cancer
5598493|NCT00899951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5598494|NCT00899951|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5685446|NCT00556036|bone density|bone density
5685447|NCT00556036|bone|bone
5598495|NCT00899951|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5598496|NCT00899951|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5598497|NCT00899951|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5598498|NCT00899951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5598499|NCT00899951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5598500|NCT00899951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5598501|NCT00899951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5598502|NCT00899951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5598503|NCT00899951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5598504|NCT00899951|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5598505|NCT00899951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5598506|NCT00899951|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5598507|NCT00899951|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5598508|NCT00899951|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5598509|NCT00899951|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5598510|NCT00899951|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5598511|NCT00899951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5598512|NCT00899951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5598851|NCT00899301|stage II breast cancer|stage ii breast cancer
5598513|NCT00899951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5598514|NCT00899951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5598515|NCT00899951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5598516|NCT00899951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5598517|NCT00899951|intraocular lymphoma|intraocular lymphoma
5598518|NCT00899951|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5598519|NCT00899951|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5598520|NCT00899951|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5598521|NCT00899951|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5598522|NCT00899951|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5598523|NCT00899951|primary myelofibrosis|primary myelofibrosis
5598524|NCT00899951|essential thrombocythemia|essential thrombocythemia
5583727|NCT00954499|pain|pain
5598525|NCT00899951|polycythemia vera|polycythemia vera
5598526|NCT00899951|extramedullary plasmacytoma|extramedullary plasmacytoma
5598527|NCT00899951|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5598528|NCT00899951|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5598529|NCT00899951|stage I multiple myeloma|stage i multiple myeloma
5598530|NCT00899951|stage II multiple myeloma|stage ii multiple myeloma
5598531|NCT00899951|stage III multiple myeloma|stage iii multiple myeloma
5598532|NCT00899951|primary systemic amyloidosis|primary systemic amyloidosis
5598533|NCT00899951|refractory multiple myeloma|refractory multiple myeloma
5598534|NCT00899951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5600323|NCT00896662|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5598535|NCT00899951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5598536|NCT00899951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5598537|NCT00899951|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5598539|NCT00899912|stage IIB prostate cancer|stage iib prostate cancer
5598540|NCT00899912|stage IIA prostate cancer|stage iia prostate cancer
5598541|NCT00899912|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5598542|NCT00899899|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5598543|NCT00899899|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5598544|NCT00899899|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5598545|NCT00899899|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5598546|NCT00899873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5598547|NCT00899860|recurrent renal cell cancer|recurrent renal cell cancer
5598548|NCT00899860|stage I renal cell cancer|stage i renal cell cancer
5598549|NCT00899860|stage II renal cell cancer|stage ii renal cell cancer
5598550|NCT00899860|stage III renal cell cancer|stage iii renal cell cancer
5598551|NCT00899860|stage IV renal cell cancer|stage iv renal cell cancer
5598552|NCT00899834|adult brain stem glioma|adult brain stem glioma
5598553|NCT00899834|childhood brain stem glioma|childhood brain stem glioma
5598554|NCT00899821|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5598555|NCT00899821|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5598556|NCT00899821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5598557|NCT00899821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5598558|NCT00899821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5598560|NCT00899821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5598561|NCT00899821|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5598562|NCT00899821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5598563|NCT00899821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5598564|NCT00899821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5598565|NCT00899821|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5598566|NCT00899821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5598567|NCT00899821|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5598568|NCT00899821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5598569|NCT00899821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5598570|NCT00899821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5598571|NCT00899821|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5598572|NCT00899821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5598573|NCT00899821|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5598574|NCT00899821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5598575|NCT00899821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5598576|NCT00899821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5598577|NCT00899821|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5598578|NCT00899821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5598579|NCT00899821|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5598580|NCT00899821|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5598581|NCT00899821|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5598582|NCT00899821|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5598583|NCT00899821|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5598584|NCT00899821|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5598585|NCT00899821|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5598587|NCT00899821|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5598588|NCT00899821|stage I salivary gland cancer|stage i salivary gland cancer
5598589|NCT00899821|stage II salivary gland cancer|stage ii salivary gland cancer
5598590|NCT00899821|stage III salivary gland cancer|stage iii salivary gland cancer
5598591|NCT00899821|stage IV salivary gland cancer|stage iv salivary gland cancer
5598592|NCT00899808|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598593|NCT00899808|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5598594|NCT00899808|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5598595|NCT00899795|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598596|NCT00899795|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598597|NCT00899795|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5598598|NCT00899795|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5598599|NCT00899795|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598600|NCT00899795|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5598601|NCT00899795|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5598602|NCT00899795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5598603|NCT00899795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598604|NCT00899795|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5598605|NCT00899795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5598606|NCT00899795|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5598607|NCT00899769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5598608|NCT00899769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5598609|NCT00899769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5598610|NCT00899769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5598611|NCT00899769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5598612|NCT00899769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5598613|NCT00899769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5598614|NCT00899769|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5598615|NCT00899769|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5598616|NCT00899769|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5598617|NCT00899769|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5598618|NCT00899769|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5598619|NCT00899769|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5598620|NCT00899769|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5598621|NCT00899769|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5598622|NCT00899769|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5598623|NCT00899769|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5598624|NCT00899769|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5598625|NCT00899769|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5598626|NCT00899769|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5598627|NCT00899769|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5598628|NCT00899769|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5598629|NCT00899769|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5598630|NCT00899769|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5598631|NCT00899769|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5598632|NCT00899769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5598633|NCT00899769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5598634|NCT00899769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5598635|NCT00899769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5598636|NCT00899769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5598637|NCT00899769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5598638|NCT00899769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5598639|NCT00899769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5598640|NCT00899769|recurrent salivary gland cancer|recurrent salivary gland cancer
5598641|NCT00899769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5598642|NCT00899769|stage I salivary gland cancer|stage i salivary gland cancer
5598643|NCT00899769|stage II salivary gland cancer|stage ii salivary gland cancer
5598644|NCT00899769|stage III salivary gland cancer|stage iii salivary gland cancer
5598645|NCT00899769|stage IV salivary gland cancer|stage iv salivary gland cancer
5598652|NCT00899743|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5598653|NCT00899743|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5598654|NCT00899743|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5598655|NCT00899743|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5598656|NCT00899743|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5598657|NCT00899743|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5598658|NCT00899743|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5598659|NCT00899743|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598660|NCT00899743|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5598661|NCT00899743|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598662|NCT00899743|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598663|NCT00899743|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5598664|NCT00899717|Temporomandibular Joint Disorders (TMD)|temporomandibular joint disorders (tmd)
5581368|NCT00963326|tongue cancer|tongue cancer
5598667|NCT00899717|Craniomandibular dysfunction syndrome|craniomandibular dysfunction syndrome
5598668|NCT00899717|Axiography|axiography
5598669|NCT00899717|Gnatography|gnatography
5598670|NCT00899717|Preferred chewing side|preferred chewing side
5598671|NCT00899717|Occlusal adjustment|occlusal adjustment
5598673|NCT00899717|Handedness|handedness
5598674|NCT00899717|Bruxism|bruxism
5598676|NCT00899717|Costen's Syndrome|costen's syndrome
5598677|NCT00899717|Myofascial pain|myofascial pain
5598678|NCT00899717|TMD treatment|tmd treatment
5598679|NCT00899717|Pain|pain
5598680|NCT00899704|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5598681|NCT00899704|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5598682|NCT00899704|tongue cancer|tongue cancer
5598683|NCT00899691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598684|NCT00899678|Certolizumab Pegol|certolizumab pegol
5598685|NCT00899678|Cimzia ®|cimzia ®
5598686|NCT00899678|Crohn's Disease|crohn's disease
5598687|NCT00899665|stage IV prostate cancer|stage iv prostate cancer
5598688|NCT00899665|bone metastases|bone metastases
5598689|NCT00899665|anemia|anemia
5598690|NCT00899665|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5598691|NCT00899665|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5598692|NCT00899665|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5598693|NCT00899665|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5598694|NCT00899652|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5598695|NCT00899652|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5598696|NCT00899652|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5598697|NCT00899652|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598698|NCT00899652|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5600518|NCT00895765|Calculus|calculus
5598699|NCT00899652|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5598700|NCT00899652|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5598701|NCT00899652|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5598702|NCT00899639|stage I breast cancer|stage i breast cancer
5598703|NCT00899639|stage II breast cancer|stage ii breast cancer
5598704|NCT00899639|stage IIIA breast cancer|stage iiia breast cancer
5598705|NCT00899639|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5598706|NCT00899639|male breast cancer|male breast cancer
5598707|NCT00899626|colon cancer|colon cancer
5598708|NCT00899626|esophageal cancer|esophageal cancer
5598709|NCT00899626|gastric cancer|gastric cancer
5598711|NCT00899626|adenomatous polyp|adenomatous polyp
5598712|NCT00899613|localized malignant mesothelioma|localized malignant mesothelioma
5598713|NCT00899613|lung metastases|lung metastases
5598714|NCT00899613|malignant pleural effusion|malignant pleural effusion
5598715|NCT00899600|chronic pain|chronic pain
5598716|NCT00899600|back surgery|back surgery
5598717|NCT00899600|opioid dependent|opioid dependent
5598718|NCT00899600|NMDA receptor antagonism|nmda receptor antagonism
5598719|NCT00899600|Ketamine|ketamine
5598720|NCT00899600|Central sensitization|central sensitization
5598721|NCT00899574|toll-like receptor|toll-like receptor
5598722|NCT00899574|toll-like receptor agonist|toll-like receptor agonist
5598723|NCT00899574|recurrent breast cancer|recurrent breast cancer
5598724|NCT00899574|breast cancer metastasized to skin and/or chestwall|breast cancer metastasized to skin and/or chestwall
5598725|NCT00899574|immunomodulator|immunomodulator
5598726|NCT00899561|Chronic rhinosinusitis|chronic rhinosinusitis
5598727|NCT00899561|Computed tomography|computed tomography
5598728|NCT00899561|Histology|histology
5598729|NCT00899561|Middle turbinate|middle turbinate
5598730|NCT00899561|Morphometry|morphometry
5598731|NCT00899561|osteomyelitis|osteomyelitis
5598732|NCT00899561|polyps|polyps
5598733|NCT00899548|stage IV breast cancer|stage iv breast cancer
5598734|NCT00899548|recurrent breast cancer|recurrent breast cancer
5598735|NCT00899535|adenocarcinoma of the lung|adenocarcinoma of the lung
5598736|NCT00899535|large cell lung cancer|large cell lung cancer
5598737|NCT00899535|squamous cell lung cancer|squamous cell lung cancer
5598738|NCT00899535|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5598739|NCT00899535|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5598740|NCT00899522|Fanconi anemia|fanconi anemia
5598741|NCT00899522|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598742|NCT00899522|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5598743|NCT00899509|stage II breast cancer|stage ii breast cancer
5598744|NCT00899509|stage IIIA breast cancer|stage iiia breast cancer
5598745|NCT00899496|stage IV bladder cancer|stage iv bladder cancer
5598746|NCT00899496|stage IV colon cancer|stage iv colon cancer
5598747|NCT00899496|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5598748|NCT00899496|stage IV pancreatic cancer|stage iv pancreatic cancer
5581512|NCT00962832|SLE|sle
5598749|NCT00899496|stage IV rectal cancer|stage iv rectal cancer
5598750|NCT00899496|stage IV renal cell cancer|stage iv renal cell cancer
5598751|NCT00899496|stage IV melanoma|stage iv melanoma
5598752|NCT00899496|stage III multiple myeloma|stage iii multiple myeloma
5598753|NCT00899496|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5598754|NCT00899496|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5598755|NCT00899496|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5598757|NCT00899496|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5598758|NCT00899496|stage IV prostate cancer|stage iv prostate cancer
5598759|NCT00899496|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5598760|NCT00899496|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5598761|NCT00899496|metastatic osteosarcoma|metastatic osteosarcoma
5598762|NCT00899496|stage IV uterine sarcoma|stage iv uterine sarcoma
5598763|NCT00899496|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5598764|NCT00899496|ovarian sarcoma|ovarian sarcoma
5598765|NCT00899496|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5598766|NCT00899496|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5598767|NCT00899496|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5598768|NCT00899496|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5598769|NCT00899496|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5598770|NCT00899496|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5598771|NCT00899496|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5598772|NCT00899496|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5598773|NCT00899496|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5598774|NCT00899496|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5598775|NCT00899496|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5598852|NCT00899301|stage IIIA breast cancer|stage iiia breast cancer
5598776|NCT00899496|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5598777|NCT00899496|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5598778|NCT00899496|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5598779|NCT00899496|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5598780|NCT00899496|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5598781|NCT00899496|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5598782|NCT00899496|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5598783|NCT00899496|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5598784|NCT00899496|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5598785|NCT00899496|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5598786|NCT00899496|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5598787|NCT00899496|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5598788|NCT00899496|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5598789|NCT00899496|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5598790|NCT00899496|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5598791|NCT00899496|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5598792|NCT00899496|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5598793|NCT00899496|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5598794|NCT00899496|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5598795|NCT00899496|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5598796|NCT00899496|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5598797|NCT00899496|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5598798|NCT00899496|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5598799|NCT00899496|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5598800|NCT00899496|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5598801|NCT00899496|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5598802|NCT00899496|intraocular lymphoma|intraocular lymphoma
5598803|NCT00899457|squamous cell lung cancer|squamous cell lung cancer
5598804|NCT00899457|non-small cell lung cancer|non-small cell lung cancer
5598805|NCT00899457|small cell lung cancer|small cell lung cancer
5598806|NCT00899457|healthy, no evidence of disease|healthy, no evidence of disease
5598807|NCT00899431|Nonmyeloablative Stem Cell Transplantation|nonmyeloablative stem cell transplantation
5598808|NCT00899431|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5598810|NCT00899431|Immunomanipulation|immunomanipulation
5598811|NCT00899431|Fludarabine|fludarabine
5598812|NCT00899431|Lenalidomide|lenalidomide
5598813|NCT00899431|Rituximab|rituximab
5598814|NCT00899431|Thymoglobulin|thymoglobulin
5598815|NCT00899431|Stem Cell Transplantation|stem cell transplantation
5598816|NCT00899418|recurrent breast cancer|recurrent breast cancer
5598817|NCT00899418|stage IV breast cancer|stage iv breast cancer
5598818|NCT00899405|lung cancer|lung cancer
5598819|NCT00899392|consent|consent
5598820|NCT00899392|Anxiety|anxiety
5598821|NCT00899392|Satisfaction|satisfaction
5598822|NCT00899392|Efficiency|efficiency
5598823|NCT00899392|Questions|questions
5685448|NCT00556036|osteopenia|osteopenia
5598824|NCT00899392|Attainment of Informed Consent (Consent-20)|attainment of informed consent (consent-20)
5598825|NCT00899392|Procedural State Anxiety (STAI)|procedural state anxiety (stai)
5598826|NCT00899392|Subject Satisfaction (mGHAA-9)|subject satisfaction (mghaa-9)
5598827|NCT00899392|Duration in Endoscopy Suite|duration in endoscopy suite
5598828|NCT00899392|Number of questions asked|number of questions asked
5598829|NCT00899366|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5598830|NCT00899366|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5598831|NCT00899366|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5598832|NCT00899366|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5598833|NCT00899366|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5598834|NCT00899366|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5598835|NCT00899366|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5598836|NCT00899366|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5598837|NCT00899353|ES-CLL|es-cll
5598838|NCT00899353|MGUS|mgus
5598839|NCT00899353|SMM|smm
5598840|NCT00899353|Early Stage - Chronic Lymphocytic Leukemia|early stage - chronic lymphocytic leukemia
5598841|NCT00899340|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5598842|NCT00899340|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5598843|NCT00899340|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5598844|NCT00899340|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5598845|NCT00899340|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5598846|NCT00899327|myelodysplastic syndromes|myelodysplastic syndromes
5598847|NCT00899327|acute myeloid leukemia|acute myeloid leukemia
5598848|NCT00899301|breast cancer|breast cancer
5598853|NCT00899301|stage IIIB breast cancer|stage iiib breast cancer
5598854|NCT00899301|stage IIIC breast cancer|stage iiic breast cancer
5598855|NCT00899301|stage IV breast cancer|stage iv breast cancer
5598856|NCT00899288|osteoporosis|osteoporosis
5598857|NCT00899288|stage I breast cancer|stage i breast cancer
5598858|NCT00899288|stage II breast cancer|stage ii breast cancer
5598859|NCT00899288|stage IIIA breast cancer|stage iiia breast cancer
5598860|NCT00899262|lung cancer|lung cancer
5598861|NCT00899262|tobacco use disorder|tobacco use disorder
5598862|NCT00899210|liver metastases|liver metastases
5598863|NCT00899210|adenocarcinoma of the colon|adenocarcinoma of the colon
5598864|NCT00899210|stage IV colon cancer|stage iv colon cancer
5598865|NCT00899210|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5598866|NCT00899210|stage IV rectal cancer|stage iv rectal cancer
5598867|NCT00899210|recurrent colon cancer|recurrent colon cancer
5598868|NCT00899210|recurrent rectal cancer|recurrent rectal cancer
5598869|NCT00899197|stage I breast cancer|stage i breast cancer
5598870|NCT00899197|stage II breast cancer|stage ii breast cancer
5598871|NCT00899197|stage IIIA breast cancer|stage iiia breast cancer
5598872|NCT00899197|stage IIIB breast cancer|stage iiib breast cancer
5598873|NCT00899184|recurrent prostate cancer|recurrent prostate cancer
5598874|NCT00899184|stage IV prostate cancer|stage iv prostate cancer
5598875|NCT00899184|stage I prostate cancer|stage i prostate cancer
5598876|NCT00899184|stage IIB prostate cancer|stage iib prostate cancer
5598877|NCT00899184|stage IIA prostate cancer|stage iia prostate cancer
5598878|NCT00899184|stage III prostate cancer|stage iii prostate cancer
5598879|NCT00899171|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5598880|NCT00899171|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5598881|NCT00899171|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5598882|NCT00899171|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5598883|NCT00899171|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5598884|NCT00899171|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5598885|NCT00899171|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5598886|NCT00899171|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5598887|NCT00899171|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5598888|NCT00899171|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5598889|NCT00899171|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5598890|NCT00899171|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5598891|NCT00899171|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5598892|NCT00899171|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5598893|NCT00899171|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5598894|NCT00899171|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5598895|NCT00899171|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5598896|NCT00899158|recurrent pancreatic cancer|recurrent pancreatic cancer
5598897|NCT00899158|stage I pancreatic cancer|stage i pancreatic cancer
5598898|NCT00899158|stage II pancreatic cancer|stage ii pancreatic cancer
5598899|NCT00899158|stage III pancreatic cancer|stage iii pancreatic cancer
5598900|NCT00899158|stage IV pancreatic cancer|stage iv pancreatic cancer
5598903|NCT00899132|small intestine cancer|small intestine cancer
5598905|NCT00899132|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5598906|NCT00899132|testicular teratoma|testicular teratoma
5598907|NCT00899119|Waldenström macroglobulinemia|waldenström macroglobulinemia
5598908|NCT00899080|stage I multiple myeloma|stage i multiple myeloma
5598909|NCT00899080|stage II multiple myeloma|stage ii multiple myeloma
5598910|NCT00899080|stage III multiple myeloma|stage iii multiple myeloma
5598911|NCT00899041|Prosthesis|prosthesis
5598912|NCT00899028|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5598913|NCT00899028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5598914|NCT00899028|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5598915|NCT00899028|limited stage small cell lung cancer|limited stage small cell lung cancer
5598916|NCT00899028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5598917|NCT00899028|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5598918|NCT00899028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5598919|NCT00899028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5598920|NCT00899015|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5598921|NCT00899015|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5598922|NCT00899015|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5598923|NCT00899015|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5598924|NCT00899015|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5598925|NCT00899015|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5598926|NCT00899015|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5598927|NCT00899015|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5598928|NCT00899015|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5598929|NCT00899002|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5598930|NCT00899002|childhood liver cancer|childhood liver cancer
5598931|NCT00899002|adult primary liver cancer|adult primary liver cancer
5598932|NCT00899002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5598934|NCT00898976|stage II breast cancer|stage ii breast cancer
5598935|NCT00898976|stage IV breast cancer|stage iv breast cancer
5598936|NCT00898976|stage IIIA breast cancer|stage iiia breast cancer
5598937|NCT00898976|breast cancer in situ|breast cancer in situ
5598938|NCT00898976|recurrent breast cancer|recurrent breast cancer
5598939|NCT00898976|stage IIIB breast cancer|stage iiib breast cancer
5598940|NCT00898976|inflammatory breast cancer|inflammatory breast cancer
5598941|NCT00898976|stage IIIC breast cancer|stage iiic breast cancer
5598942|NCT00898963|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5598943|NCT00898963|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5598944|NCT00898963|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5598945|NCT00898963|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5598946|NCT00898963|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5598947|NCT00898963|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5598948|NCT00898950|diabetes|diabetes
5598950|NCT00898950|oxidative stress|oxidative stress
5598951|NCT00898950|insulin resistance|insulin resistance
5598952|NCT00898950|endothelial function|endothelial function
5598953|NCT00898950|inflammation|inflammation
5598954|NCT00898950|photoplethysmography|photoplethysmography
5598955|NCT00898950|dysglycaemia|dysglycaemia
5598956|NCT00898937|breast cancer|breast cancer
5598957|NCT00898924|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5598958|NCT00898924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5598959|NCT00898911|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5598960|NCT00898911|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5598961|NCT00898911|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5598962|NCT00898911|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5598963|NCT00898911|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5598964|NCT00898911|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5598965|NCT00898911|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5598966|NCT00898911|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5598967|NCT00898911|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5598968|NCT00898911|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5598969|NCT00898911|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5593411|NCT00917566|Airtraq|airtraq
5598970|NCT00898911|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5598971|NCT00898911|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5598972|NCT00898911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5598973|NCT00898911|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5598974|NCT00898911|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5598975|NCT00898911|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5598976|NCT00898911|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5598977|NCT00898911|recurrent salivary gland cancer|recurrent salivary gland cancer
5598978|NCT00898911|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5598979|NCT00898911|stage IV salivary gland cancer|stage iv salivary gland cancer
5598980|NCT00898898|stage IA breast cancer|stage ia breast cancer
5598981|NCT00898898|stage IB breast cancer|stage ib breast cancer
5598982|NCT00898898|stage II breast cancer|stage ii breast cancer
5598983|NCT00898898|stage IIIA breast cancer|stage iiia breast cancer
5598984|NCT00898898|HER2-positive breast cancer|her2-positive breast cancer
5598985|NCT00898885|oral manifestations|oral manifestations
5598986|NCT00898885|bone marrow transplantation|bone marrow transplantation
5598987|NCT00898885|adverse effects|adverse effects
5598988|NCT00898872|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5598989|NCT00898872|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5598990|NCT00898872|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5598991|NCT00898872|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5598992|NCT00898872|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5598993|NCT00898872|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5598994|NCT00898872|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5598995|NCT00898872|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5598996|NCT00898872|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5598997|NCT00898872|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5598998|NCT00898872|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5598999|NCT00898872|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5599000|NCT00898872|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5599001|NCT00898872|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5599002|NCT00898872|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5599003|NCT00898872|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5599004|NCT00898872|Waldenström macroglobulinemia|waldenström macroglobulinemia
5599005|NCT00898872|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5599006|NCT00898872|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5599007|NCT00898872|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5599008|NCT00898872|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5599009|NCT00898872|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5599010|NCT00898872|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5599011|NCT00898872|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5599012|NCT00898872|childhood Burkitt lymphoma|childhood burkitt lymphoma
5599013|NCT00898872|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5599015|NCT00898859|epithelial|epithelial
5599016|NCT00898859|COPD|copd
5599017|NCT00898846|stage II colon cancer|stage ii colon cancer
5599018|NCT00898846|stage II rectal cancer|stage ii rectal cancer
5599019|NCT00898846|adenocarcinoma of the colon|adenocarcinoma of the colon
5599020|NCT00898846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5599021|NCT00898833|recurrent prostate cancer|recurrent prostate cancer
5599022|NCT00898833|stage III prostate cancer|stage iii prostate cancer
5599023|NCT00898833|stage IV prostate cancer|stage iv prostate cancer
5599024|NCT00898833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5599025|NCT00898820|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5599026|NCT00898820|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5599027|NCT00898820|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5599028|NCT00898807|neuropsychiatric symptoms|neuropsychiatric symptoms
5599029|NCT00898807|aggression|aggression
5599030|NCT00898807|mood lability|mood lability
5599031|NCT00898794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5599032|NCT00898794|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5599033|NCT00898781|male breast cancer|male breast cancer
5599034|NCT00898781|stage IV breast cancer|stage iv breast cancer
5599035|NCT00898781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5599036|NCT00898781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5599037|NCT00898781|stage IV pancreatic cancer|stage iv pancreatic cancer
5599040|NCT00898768|Lynch syndrome|lynch syndrome
5599041|NCT00898768|HNPCC|hnpcc
5599042|NCT00898768|Capsule endoscopy|capsule endoscopy
5599043|NCT00898768|Small bowel cancer|small bowel cancer
5599044|NCT00898768|Double balloon endoscopy|double balloon endoscopy
5599045|NCT00898742|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5599046|NCT00898742|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5599047|NCT00898742|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5599048|NCT00898742|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5599049|NCT00898742|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5599050|NCT00898742|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5599051|NCT00898742|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5599052|NCT00898742|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5599053|NCT00898742|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5599054|NCT00898742|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5599055|NCT00898742|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5599056|NCT00898742|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5599057|NCT00898742|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5599058|NCT00898742|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5599059|NCT00898742|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5599060|NCT00898742|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599061|NCT00898742|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5599068|NCT00898690|stage II breast cancer|stage ii breast cancer
5599069|NCT00898690|stage IIIA breast cancer|stage iiia breast cancer
5599070|NCT00898690|stage IIIB breast cancer|stage iiib breast cancer
5599071|NCT00898690|stage IIIC breast cancer|stage iiic breast cancer
5599073|NCT00898690|recurrent breast cancer|recurrent breast cancer
5599074|NCT00898664|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5599075|NCT00898664|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5599076|NCT00898664|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5599077|NCT00898664|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5599078|NCT00898664|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5599079|NCT00898664|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5599080|NCT00898664|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5599081|NCT00898664|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5599082|NCT00898664|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5599083|NCT00898664|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5599084|NCT00898664|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5599085|NCT00898664|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5599086|NCT00898664|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5599087|NCT00898664|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5599088|NCT00898664|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5599089|NCT00898664|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5599090|NCT00898664|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5599091|NCT00898664|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5599092|NCT00898664|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5599093|NCT00898664|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5599094|NCT00898664|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5599905|NCT00897767|mast cell leukemia|mast cell leukemia
5599095|NCT00898664|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5599096|NCT00898664|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5599097|NCT00898664|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5599098|NCT00898664|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5599099|NCT00898664|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5599102|NCT00898664|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5599103|NCT00898664|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599104|NCT00898664|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599105|NCT00898664|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5599106|NCT00898664|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5599107|NCT00898664|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5599108|NCT00898664|stage I salivary gland cancer|stage i salivary gland cancer
5599109|NCT00898664|stage II salivary gland cancer|stage ii salivary gland cancer
5599110|NCT00898664|stage III salivary gland cancer|stage iii salivary gland cancer
5599111|NCT00898664|stage IV salivary gland cancer|stage iv salivary gland cancer
5599112|NCT00898664|recurrent salivary gland cancer|recurrent salivary gland cancer
5599227|NCT00898612|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5599228|NCT00898612|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5599229|NCT00898612|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5599230|NCT00898612|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5599231|NCT00898612|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5599232|NCT00898612|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5599233|NCT00898612|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5599234|NCT00898612|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5599235|NCT00898612|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5599236|NCT00898612|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5599237|NCT00898612|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5599238|NCT00898612|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5599239|NCT00898612|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5599240|NCT00898612|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5599241|NCT00898612|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5599242|NCT00898612|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5599243|NCT00898612|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5599244|NCT00898612|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5599245|NCT00898612|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5599246|NCT00898612|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5599247|NCT00898612|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5599248|NCT00898612|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5599249|NCT00898612|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5599250|NCT00898612|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5599251|NCT00898612|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5599252|NCT00898612|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5599253|NCT00898612|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5599254|NCT00898612|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5599255|NCT00898612|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5599256|NCT00898612|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5599257|NCT00898612|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5599258|NCT00898612|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5599259|NCT00898612|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5599260|NCT00898612|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5599261|NCT00898612|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5599263|NCT00898612|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5599264|NCT00898612|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5599265|NCT00898612|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5599266|NCT00898612|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5599267|NCT00898612|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5599268|NCT00898612|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5599269|NCT00898612|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5599270|NCT00898612|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5599271|NCT00898612|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5582024|NCT00960739|stage 4S neuroblastoma|stage 4s neuroblastoma
5599272|NCT00898612|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5599274|NCT00898612|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5599275|NCT00898612|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5599276|NCT00898612|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5599277|NCT00898612|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5599278|NCT00898612|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5599279|NCT00898612|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5599280|NCT00898612|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5599281|NCT00898612|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5599282|NCT00898612|refractory hairy cell leukemia|refractory hairy cell leukemia
5599283|NCT00898612|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5599284|NCT00898612|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5599285|NCT00898612|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5599286|NCT00898612|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5599287|NCT00898612|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5599288|NCT00898612|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5599289|NCT00898612|primary myelofibrosis|primary myelofibrosis
5599290|NCT00898612|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5599291|NCT00898612|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5599292|NCT00898612|disseminated neuroblastoma|disseminated neuroblastoma
5599293|NCT00898612|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5599294|NCT00898612|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5599295|NCT00898612|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5599296|NCT00898612|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5599297|NCT00898612|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5599298|NCT00898612|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5599300|NCT00898612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5599301|NCT00898612|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5599302|NCT00898612|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5599303|NCT00898612|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5599304|NCT00898612|stage I multiple myeloma|stage i multiple myeloma
5599305|NCT00898612|stage II multiple myeloma|stage ii multiple myeloma
5599306|NCT00898612|stage III multiple myeloma|stage iii multiple myeloma
5599307|NCT00898612|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5599308|NCT00898612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5599309|NCT00898612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5671590|NCT00615368|Type 1 diabetes|type 1 diabetes
5599310|NCT00898612|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5599311|NCT00898612|stage IIIA breast cancer|stage iiia breast cancer
5599312|NCT00898612|stage IIIB breast cancer|stage iiib breast cancer
5599313|NCT00898612|stage IIIC breast cancer|stage iiic breast cancer
5599314|NCT00898612|stage IV breast cancer|stage iv breast cancer
5599315|NCT00898612|refractory multiple myeloma|refractory multiple myeloma
5599316|NCT00898573|breast cancer|breast cancer
5599318|NCT00898560|Epilepsy|epilepsy
5599319|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate
5599320|NCT00898560|Combined oral contraceptive|combined oral contraceptive
5599321|NCT00898560|Pharmacokinetics|pharmacokinetics
5599322|NCT00898560|Tolerability|tolerability
5599323|NCT00898547|advanced malignant mesothelioma|advanced malignant mesothelioma
5599324|NCT00898547|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5599325|NCT00898547|epithelial mesothelioma|epithelial mesothelioma
5599326|NCT00898547|sarcomatous mesothelioma|sarcomatous mesothelioma
5599327|NCT00898534|Pediatrics|pediatrics
5599328|NCT00898534|Hemoglobin A1c|hemoglobin a1c
5599329|NCT00898534|Point of Care testing|point of care testing
5599330|NCT00898508|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5599331|NCT00898508|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5599332|NCT00898508|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5599333|NCT00898508|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5599334|NCT00898508|stage I breast cancer|stage i breast cancer
5599335|NCT00898508|stage II breast cancer|stage ii breast cancer
5599336|NCT00898508|stage IIIA breast cancer|stage iiia breast cancer
5599337|NCT00898508|stage IIIB breast cancer|stage iiib breast cancer
5599338|NCT00898508|stage IIIC breast cancer|stage iiic breast cancer
5599340|NCT00898495|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5599341|NCT00898495|stage II esophageal cancer|stage ii esophageal cancer
5599342|NCT00898495|stage III esophageal cancer|stage iii esophageal cancer
5599343|NCT00898495|stage IV esophageal cancer|stage iv esophageal cancer
5599344|NCT00898495|stage I esophageal cancer|stage i esophageal cancer
5599345|NCT00898482|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5599346|NCT00898482|recurrent pancreatic cancer|recurrent pancreatic cancer
5599347|NCT00898482|stage I pancreatic cancer|stage i pancreatic cancer
5599348|NCT00898482|stage II pancreatic cancer|stage ii pancreatic cancer
5599349|NCT00898482|stage III pancreatic cancer|stage iii pancreatic cancer
5599350|NCT00898482|stage IV pancreatic cancer|stage iv pancreatic cancer
5599351|NCT00898469|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5599352|NCT00898456|adult acute myeloid leukemia|adult acute myeloid leukemia
5599353|NCT00898456|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5599354|NCT00898456|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5599355|NCT00898456|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5599356|NCT00898456|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5599357|NCT00898456|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5599358|NCT00898456|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5599359|NCT00898456|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5599360|NCT00898456|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5599724|NCT00897819|stage III colon cancer|stage iii colon cancer
5599361|NCT00898456|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5599362|NCT00898456|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5599363|NCT00898456|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5599364|NCT00898456|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5599365|NCT00898456|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5599366|NCT00898456|adult acute basophilic leukemia|adult acute basophilic leukemia
5599367|NCT00898456|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5584655|NCT00951197|PET|pet
5599368|NCT00898430|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5599369|NCT00898430|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5599370|NCT00898430|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5599371|NCT00898430|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5599372|NCT00898430|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5599373|NCT00898430|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5599374|NCT00898430|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5599375|NCT00898430|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5599376|NCT00898430|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5599377|NCT00898430|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5599378|NCT00898430|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5599379|NCT00898430|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5599380|NCT00898430|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5599381|NCT00898430|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5599382|NCT00898430|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5599383|NCT00898430|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599384|NCT00898430|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599385|NCT00898430|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5599386|NCT00898430|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5599387|NCT00898430|stage III salivary gland cancer|stage iii salivary gland cancer
5599388|NCT00898430|stage IV salivary gland cancer|stage iv salivary gland cancer
5599389|NCT00898417|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5599390|NCT00898417|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5599391|NCT00898417|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5599392|NCT00898417|adenocarcinoma of the lung|adenocarcinoma of the lung
5599393|NCT00898417|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5599394|NCT00898378|healthy, no evidence of disease|healthy, no evidence of disease
5599395|NCT00898378|stage I colon cancer|stage i colon cancer
5599396|NCT00898378|stage II colon cancer|stage ii colon cancer
5599397|NCT00898378|stage III colon cancer|stage iii colon cancer
5599398|NCT00898378|stage IV colon cancer|stage iv colon cancer
5599399|NCT00898378|stage I rectal cancer|stage i rectal cancer
5599401|NCT00898378|stage III rectal cancer|stage iii rectal cancer
5599402|NCT00898378|stage IV rectal cancer|stage iv rectal cancer
5599403|NCT00898378|recurrent rectal cancer|recurrent rectal cancer
5599404|NCT00898378|recurrent colon cancer|recurrent colon cancer
5599405|NCT00898378|adenomatous polyp|adenomatous polyp
5599406|NCT00898352|stage III vulvar cancer|stage iii vulvar cancer
5599407|NCT00898352|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5599408|NCT00898326|stage I prostate cancer|stage i prostate cancer
5599409|NCT00898326|stage IIB prostate cancer|stage iib prostate cancer
5599410|NCT00898326|stage IIA prostate cancer|stage iia prostate cancer
5599411|NCT00898313|lung cancer|lung cancer
5599412|NCT00898300|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5599413|NCT00898300|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5599414|NCT00898300|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5599415|NCT00898300|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5599416|NCT00898300|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5599417|NCT00898300|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5599418|NCT00898300|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5599419|NCT00898300|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5599420|NCT00898300|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5599421|NCT00898300|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5599422|NCT00898300|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5599423|NCT00898300|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5599424|NCT00898300|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5599425|NCT00898300|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5599426|NCT00898300|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5599427|NCT00898300|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5599428|NCT00898300|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5599429|NCT00898300|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5599430|NCT00898300|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5599431|NCT00898300|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5599432|NCT00898300|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5599433|NCT00898300|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5599434|NCT00898300|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5599435|NCT00898300|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5599436|NCT00898300|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5599437|NCT00898300|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5599438|NCT00898300|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5671591|NCT00615368|Hypoglycaemia|hypoglycaemia
5599439|NCT00898300|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5599440|NCT00898300|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5599441|NCT00898300|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5599442|NCT00898300|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5599443|NCT00898300|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5599444|NCT00898300|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5599445|NCT00898300|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5599446|NCT00898300|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5599447|NCT00898300|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5599448|NCT00898300|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5599449|NCT00898300|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5599450|NCT00898300|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5599451|NCT00898300|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5599452|NCT00898300|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5599453|NCT00898300|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5599454|NCT00898300|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5599455|NCT00898300|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5599456|NCT00898300|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5599457|NCT00898300|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5599458|NCT00898300|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5599459|NCT00898300|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5599460|NCT00898300|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599461|NCT00898300|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599462|NCT00898300|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599463|NCT00898300|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599464|NCT00898300|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599465|NCT00898300|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5599466|NCT00898300|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5599467|NCT00898300|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5599468|NCT00898300|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5599469|NCT00898300|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5599470|NCT00898300|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5599471|NCT00898300|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5599472|NCT00898300|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5599473|NCT00898300|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5599474|NCT00898300|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599475|NCT00898300|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599476|NCT00898300|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5599477|NCT00898300|stage I salivary gland cancer|stage i salivary gland cancer
5599478|NCT00898300|stage II salivary gland cancer|stage ii salivary gland cancer
5599479|NCT00898300|stage III salivary gland cancer|stage iii salivary gland cancer
5798751|NCT00111176|minimally invasive|minimally invasive
5599480|NCT00898300|stage IV salivary gland cancer|stage iv salivary gland cancer
5599481|NCT00898300|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5599482|NCT00898300|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5599483|NCT00898300|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5599484|NCT00898300|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5599485|NCT00898300|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5599486|NCT00898300|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5671592|NCT00615368|Cognitive function|cognitive function
5599487|NCT00898300|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5599488|NCT00898300|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5599489|NCT00898300|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599490|NCT00898300|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5599491|NCT00898300|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5599492|NCT00898300|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5599493|NCT00898300|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5599494|NCT00898300|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5599495|NCT00898300|recurrent salivary gland cancer|recurrent salivary gland cancer
5599496|NCT00898300|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5599497|NCT00898300|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5599498|NCT00898300|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5599499|NCT00898287|Locally advanced or metastatic adenocarcinoma of pancreas|locally advanced or metastatic adenocarcinoma of pancreas
5599500|NCT00898274|prostate cancer|prostate cancer
5599501|NCT00898274|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5599502|NCT00898261|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5599504|NCT00898222|healthy volunteers|healthy volunteers
5599506|NCT00898222|Normal healthy subjects|normal healthy subjects
5599507|NCT00898209|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5599508|NCT00898209|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5599509|NCT00898209|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5599510|NCT00898209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5599511|NCT00898209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5599512|NCT00898183|stage III melanoma|stage iii melanoma
5599513|NCT00898183|stage IV melanoma|stage iv melanoma
5599514|NCT00898183|recurrent melanoma|recurrent melanoma
5599516|NCT00898170|hypertension|hypertension
5599517|NCT00898170|erythropoetin|erythropoetin
5599518|NCT00898170|blood pressure|blood pressure
5599519|NCT00898170|erythropoetin level|erythropoetin level
5599520|NCT00898157|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5599521|NCT00898157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5599522|NCT00898157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5599523|NCT00898157|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5599524|NCT00898157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5599525|NCT00898157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5599526|NCT00898144|cervical cancer|cervical cancer
5599527|NCT00898144|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5599528|NCT00898144|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5599529|NCT00898144|cervical adenocarcinoma|cervical adenocarcinoma
5599530|NCT00898144|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5599531|NCT00898131|breast cancer|breast cancer
5599532|NCT00898118|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5599533|NCT00898118|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5599534|NCT00898118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5599535|NCT00898118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5599536|NCT00898092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5599725|NCT00897819|stage III rectal cancer|stage iii rectal cancer
5599537|NCT00898092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5599538|NCT00898092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5599539|NCT00898092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5599540|NCT00898092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5599541|NCT00898092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5599542|NCT00898092|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5599543|NCT00898092|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5599544|NCT00898092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5599545|NCT00898092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5599546|NCT00898092|adult acute basophilic leukemia|adult acute basophilic leukemia
5599547|NCT00898092|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5599548|NCT00898066|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5599549|NCT00898066|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5599550|NCT00898066|primary systemic amyloidosis|primary systemic amyloidosis
5599551|NCT00898066|stage I multiple myeloma|stage i multiple myeloma
5599552|NCT00898066|stage II multiple myeloma|stage ii multiple myeloma
5599553|NCT00898066|stage III multiple myeloma|stage iii multiple myeloma
5599554|NCT00898040|stage I multiple myeloma|stage i multiple myeloma
5599555|NCT00898040|stage II multiple myeloma|stage ii multiple myeloma
5599556|NCT00898040|stage III multiple myeloma|stage iii multiple myeloma
5599557|NCT00898040|refractory multiple myeloma|refractory multiple myeloma
5599558|NCT00898027|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5599559|NCT00898014|stage IV breast cancer|stage iv breast cancer
5599560|NCT00897988|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5599561|NCT00897988|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5599562|NCT00897988|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5599563|NCT00897988|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5599564|NCT00897988|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599565|NCT00897975|statin associated myalgias|statin associated myalgias
5599566|NCT00897975|hyperlipidemia|hyperlipidemia
5599567|NCT00897975|red yeast rice|red yeast rice
5599568|NCT00897975|phytosterols|phytosterols
5599569|NCT00897975|therapeutic lifestyle changes|therapeutic lifestyle changes
5599570|NCT00897975|compliance|compliance
5599571|NCT00897962|stage IV breast cancer|stage iv breast cancer
5599572|NCT00897936|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5599573|NCT00897936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5599574|NCT00897936|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5599575|NCT00897936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5599576|NCT00897936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5599577|NCT00897936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5599578|NCT00897936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5599579|NCT00897936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5599580|NCT00897923|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5599581|NCT00897923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5599582|NCT00897923|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5599583|NCT00897923|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5599584|NCT00897923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5599586|NCT00897923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5599587|NCT00897923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5599588|NCT00897923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5599589|NCT00897923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5599590|NCT00897923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5599591|NCT00897923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5599592|NCT00897923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5599593|NCT00897923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5599594|NCT00897923|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5599595|NCT00897923|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5599596|NCT00897923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5599597|NCT00897923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5599598|NCT00897923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5599599|NCT00897923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5599600|NCT00897923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5599601|NCT00897923|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5599602|NCT00897923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5599603|NCT00897923|small intestine lymphoma|small intestine lymphoma
5599604|NCT00897923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5599605|NCT00897923|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5599606|NCT00897923|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5599607|NCT00897923|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5599608|NCT00897923|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5599609|NCT00897923|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5599610|NCT00897923|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5599611|NCT00897923|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5599612|NCT00897923|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5599613|NCT00897923|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5599614|NCT00897923|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5599615|NCT00897923|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5599616|NCT00897923|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5599617|NCT00897923|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5599618|NCT00897923|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5599619|NCT00897923|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5599620|NCT00897923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5599621|NCT00897923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5599622|NCT00897923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5599623|NCT00897923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5599624|NCT00897923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5599625|NCT00897923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5599626|NCT00897923|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5599627|NCT00897923|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5599628|NCT00897923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5599629|NCT00897923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5599630|NCT00897923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5599631|NCT00897923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5599632|NCT00897923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5599633|NCT00897923|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5599634|NCT00897923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5599635|NCT00897923|Waldenström macroglobulinemia|waldenström macroglobulinemia
5599636|NCT00897923|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5599637|NCT00897923|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5599638|NCT00897923|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5599639|NCT00897923|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5599640|NCT00897923|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5599641|NCT00897923|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5599642|NCT00897923|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5599643|NCT00897923|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5599644|NCT00897923|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5599645|NCT00897923|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5582620|NCT00958217|Substance-related disorders|substance-related disorders
5599646|NCT00897923|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5599647|NCT00897923|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5599648|NCT00897923|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5599649|NCT00897923|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5599650|NCT00897923|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5599651|NCT00897923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5599652|NCT00897923|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5599653|NCT00897923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5599654|NCT00897923|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5599655|NCT00897923|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5599656|NCT00897923|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5599657|NCT00897923|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5599658|NCT00897923|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5599659|NCT00897923|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5599660|NCT00897923|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5599661|NCT00897923|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5599662|NCT00897923|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5599663|NCT00897923|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5599664|NCT00897923|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5599665|NCT00897923|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5599666|NCT00897923|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5599667|NCT00897923|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5599668|NCT00897923|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5599669|NCT00897923|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5599670|NCT00897923|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5599671|NCT00897923|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5599672|NCT00897923|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5599673|NCT00897923|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5599674|NCT00897923|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5599675|NCT00897923|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5599676|NCT00897923|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5599677|NCT00897923|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5599678|NCT00897923|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5599679|NCT00897923|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5599680|NCT00897923|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5599681|NCT00897910|stage I multiple myeloma|stage i multiple myeloma
5599682|NCT00897910|stage II multiple myeloma|stage ii multiple myeloma
5599683|NCT00897910|stage III multiple myeloma|stage iii multiple myeloma
5599684|NCT00897910|refractory multiple myeloma|refractory multiple myeloma
5599687|NCT00897897|HIFU|hifu
5599688|NCT00897897|Ablation|ablation
5599689|NCT00897897|High Intensity Focused Ultrasound|high intensity focused ultrasound
5599690|NCT00897884|breast cancer|breast cancer
5599691|NCT00897884|metformin|metformin
5599692|NCT00897884|breast surgery|breast surgery
5599693|NCT00897871|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5599694|NCT00897858|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5599695|NCT00897858|childhood choroid plexus tumor|childhood choroid plexus tumor
5599696|NCT00897858|childhood grade I meningioma|childhood grade i meningioma
5599697|NCT00897858|childhood grade II meningioma|childhood grade ii meningioma
5599698|NCT00897858|childhood grade III meningioma|childhood grade iii meningioma
5599699|NCT00897858|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5599700|NCT00897858|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5599701|NCT00897858|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5599702|NCT00897858|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5599703|NCT00897858|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5599704|NCT00897858|childhood craniopharyngioma|childhood craniopharyngioma
5599705|NCT00897858|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5599706|NCT00897858|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5599707|NCT00897858|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5599708|NCT00897858|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5599709|NCT00897858|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5599710|NCT00897858|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5599711|NCT00897858|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5599712|NCT00897858|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5599713|NCT00897858|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5599714|NCT00897858|childhood central nervous system germinoma|childhood central nervous system germinoma
5599715|NCT00897858|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5599716|NCT00897858|childhood central nervous system teratoma|childhood central nervous system teratoma
5599717|NCT00897858|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5599718|NCT00897845|stage II breast cancer|stage ii breast cancer
5599719|NCT00897845|stage IIIA breast cancer|stage iiia breast cancer
5599720|NCT00897845|stage IIIB breast cancer|stage iiib breast cancer
5599721|NCT00897832|pancreatic cancer|pancreatic cancer
5599722|NCT00897819|recurrent colon cancer|recurrent colon cancer
5599723|NCT00897819|recurrent rectal cancer|recurrent rectal cancer
5599728|NCT00897819|adenocarcinoma of the colon|adenocarcinoma of the colon
5599729|NCT00897819|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5599730|NCT00897806|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5599731|NCT00897806|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5599732|NCT00897806|peritoneal cavity cancer|peritoneal cavity cancer
5599733|NCT00897793|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5599734|NCT00897793|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5599735|NCT00897793|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5599736|NCT00897793|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5599737|NCT00897793|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5798752|NCT00111176|endovascular|endovascular
5599738|NCT00897793|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5599739|NCT00897793|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5599740|NCT00897793|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5599741|NCT00897793|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5599742|NCT00897793|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5599743|NCT00897793|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5599744|NCT00897793|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5599745|NCT00897793|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5599746|NCT00897793|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5599747|NCT00897793|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5599748|NCT00897793|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5599749|NCT00897793|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5599750|NCT00897793|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5599751|NCT00897793|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5599752|NCT00897793|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5599753|NCT00897793|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5599754|NCT00897793|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5599755|NCT00897793|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5599756|NCT00897793|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5685449|NCT00556036|osteoporosis|osteoporosis
5599757|NCT00897793|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5599758|NCT00897793|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5599760|NCT00897793|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5599761|NCT00897793|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5599762|NCT00897793|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5599763|NCT00897793|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5599764|NCT00897793|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5599765|NCT00897793|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5599766|NCT00897793|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5599767|NCT00897793|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5672109|NCT00612989|Gliosarcoma|gliosarcoma
5599768|NCT00897793|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5599769|NCT00897793|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5599770|NCT00897793|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5599771|NCT00897793|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5599772|NCT00897793|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5599773|NCT00897793|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5599774|NCT00897793|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5599775|NCT00897793|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5599776|NCT00897793|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5599777|NCT00897793|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5599778|NCT00897793|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5599779|NCT00897793|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5599780|NCT00897793|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5599781|NCT00897793|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5599782|NCT00897793|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5599783|NCT00897793|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5599784|NCT00897793|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5599785|NCT00897793|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5599786|NCT00897793|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5599787|NCT00897793|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5599788|NCT00897793|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5599789|NCT00897793|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5599790|NCT00897793|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5599791|NCT00897793|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5599792|NCT00897793|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5601504|NCT00891787|Probiotics|probiotics
5904083|NCT00071786|Bipolar Mood Disorder|bipolar mood disorder
5599793|NCT00897793|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5599794|NCT00897793|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5599795|NCT00897793|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599796|NCT00897793|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599797|NCT00897793|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5599798|NCT00897793|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5599799|NCT00897793|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5599800|NCT00897793|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599801|NCT00897793|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5599802|NCT00897793|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5599803|NCT00897793|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5599804|NCT00897793|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599805|NCT00897793|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5599806|NCT00897793|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5599807|NCT00897793|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599808|NCT00897793|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600528|NCT00895713|liver transplantation|liver transplantation
5599809|NCT00897793|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5862995|NCT00001418|Sympathetic Nervous System|sympathetic nervous system
5599810|NCT00897793|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5599811|NCT00897793|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5599812|NCT00897793|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5599813|NCT00897793|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5599814|NCT00897793|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5599815|NCT00897793|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5599816|NCT00897793|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5599817|NCT00897793|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5599818|NCT00897793|recurrent salivary gland cancer|recurrent salivary gland cancer
5599819|NCT00897793|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5599820|NCT00897793|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5599821|NCT00897793|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5599822|NCT00897793|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5599823|NCT00897793|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5599824|NCT00897793|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5599825|NCT00897793|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5599826|NCT00897793|stage I salivary gland cancer|stage i salivary gland cancer
5599827|NCT00897793|stage II salivary gland cancer|stage ii salivary gland cancer
5599828|NCT00897793|stage III salivary gland cancer|stage iii salivary gland cancer
5599829|NCT00897793|stage IV salivary gland cancer|stage iv salivary gland cancer
5599830|NCT00897793|limited stage small cell lung cancer|limited stage small cell lung cancer
5599831|NCT00897793|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5599832|NCT00897793|recurrent small cell lung cancer|recurrent small cell lung cancer
5599833|NCT00897793|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5599834|NCT00897793|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5599835|NCT00897793|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5599836|NCT00897793|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5599837|NCT00897793|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5599838|NCT00897793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5599839|NCT00897793|male breast cancer|male breast cancer
5599840|NCT00897793|recurrent breast cancer|recurrent breast cancer
5599841|NCT00897793|stage I breast cancer|stage i breast cancer
5599842|NCT00897793|stage II breast cancer|stage ii breast cancer
5599843|NCT00897793|stage IIIA breast cancer|stage iiia breast cancer
5599844|NCT00897793|stage IIIB breast cancer|stage iiib breast cancer
5904084|NCT00071786|Migraine|migraine
5904085|NCT00071786|Behavior Genetics|behavior genetics
5782356|NCT00182897|coping|coping
5599845|NCT00897793|stage IIIC breast cancer|stage iiic breast cancer
5599846|NCT00897793|stage IV breast cancer|stage iv breast cancer
5599847|NCT00897793|recurrent colon cancer|recurrent colon cancer
5599848|NCT00897793|stage I colon cancer|stage i colon cancer
5599849|NCT00897793|stage II colon cancer|stage ii colon cancer
5599850|NCT00897793|stage III colon cancer|stage iii colon cancer
5599851|NCT00897793|stage IV colon cancer|stage iv colon cancer
5599852|NCT00897793|recurrent rectal cancer|recurrent rectal cancer
5599853|NCT00897793|stage I rectal cancer|stage i rectal cancer
5599854|NCT00897793|stage II rectal cancer|stage ii rectal cancer
5599855|NCT00897793|stage III rectal cancer|stage iii rectal cancer
5599856|NCT00897793|stage IV rectal cancer|stage iv rectal cancer
5599857|NCT00897793|recurrent prostate cancer|recurrent prostate cancer
5599858|NCT00897793|stage I prostate cancer|stage i prostate cancer
5599859|NCT00897793|stage II prostate cancer|stage ii prostate cancer
5599860|NCT00897793|stage III prostate cancer|stage iii prostate cancer
5599861|NCT00897793|stage IV prostate cancer|stage iv prostate cancer
5599862|NCT00897780|Headache|headache
5599863|NCT00897780|Pediatric|pediatric
5599864|NCT00897780|Virtual Reality|virtual reality
5599865|NCT00897780|Biofeedback|biofeedback
5599866|NCT00897767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5685450|NCT00556036|amenorrhea|amenorrhea
5599867|NCT00897767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5599868|NCT00897767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5599869|NCT00897767|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5599870|NCT00897767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5599871|NCT00897767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5599872|NCT00897767|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5599873|NCT00897767|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5599874|NCT00897767|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5599875|NCT00897767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5599876|NCT00897767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5599877|NCT00897767|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5599878|NCT00897767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5599879|NCT00897767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5599880|NCT00897767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5599881|NCT00897767|refractory hairy cell leukemia|refractory hairy cell leukemia
5599882|NCT00897767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5599883|NCT00897767|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5599884|NCT00897767|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5599885|NCT00897767|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5599886|NCT00897767|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5599887|NCT00897767|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5599888|NCT00897767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5599889|NCT00897767|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5599890|NCT00897767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5599891|NCT00897767|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5599892|NCT00897767|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5599893|NCT00897767|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5599894|NCT00897767|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5599895|NCT00897767|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5599896|NCT00897767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5762840|NCT00272519|HIV|hiv
5599897|NCT00897767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5599898|NCT00897767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5599899|NCT00897767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5599900|NCT00897767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5599901|NCT00897767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5599902|NCT00897767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5599903|NCT00897767|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5599904|NCT00897767|acute undifferentiated leukemia|acute undifferentiated leukemia
5599906|NCT00897767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5599907|NCT00897767|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5599908|NCT00897767|prolymphocytic leukemia|prolymphocytic leukemia
5599909|NCT00897767|untreated hairy cell leukemia|untreated hairy cell leukemia
5599910|NCT00897754|adenocarcinoma of the colon|adenocarcinoma of the colon
5599911|NCT00897754|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5904086|NCT00071786|Genetic Epidemiology|genetic epidemiology
5904087|NCT00071786|Family Study|family study
5599912|NCT00897754|recurrent rectal cancer|recurrent rectal cancer
5599913|NCT00897754|stage III rectal cancer|stage iii rectal cancer
5599914|NCT00897754|stage IV rectal cancer|stage iv rectal cancer
5599915|NCT00897754|recurrent colon cancer|recurrent colon cancer
5599916|NCT00897754|stage III colon cancer|stage iii colon cancer
5599917|NCT00897754|stage IV colon cancer|stage iv colon cancer
5599918|NCT00897741|recurrent pancreatic cancer|recurrent pancreatic cancer
5599919|NCT00897741|stage IV pancreatic cancer|stage iv pancreatic cancer
5599920|NCT00897728|stage IA breast cancer|stage ia breast cancer
5599921|NCT00897728|stage IB breast cancer|stage ib breast cancer
5599922|NCT00897728|stage II breast cancer|stage ii breast cancer
5599923|NCT00897728|stage IIIA breast cancer|stage iiia breast cancer
5599924|NCT00897728|stage IIIB breast cancer|stage iiib breast cancer
5599925|NCT00897728|stage IIIC breast cancer|stage iiic breast cancer
5599926|NCT00897728|HER2-positive breast cancer|her2-positive breast cancer
5599927|NCT00897728|triple-negative breast cancer|triple-negative breast cancer
5599928|NCT00897728|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5599930|NCT00897715|inflammation|inflammation
5599931|NCT00897715|CVD|cvd
5599932|NCT00897702|recurrent breast cancer|recurrent breast cancer
5599933|NCT00897702|male breast cancer|male breast cancer
5685451|NCT00556036|menses|menses
5599934|NCT00897702|stage IV breast cancer|stage iv breast cancer
5599935|NCT00897676|Hyperinsulinism|hyperinsulinism
5599936|NCT00897676|Hypoglycemia|hypoglycemia
5599937|NCT00897676|KATP channel|katp channel
5599938|NCT00897663|adult giant cell glioblastoma|adult giant cell glioblastoma
5599939|NCT00897663|adult gliosarcoma|adult gliosarcoma
5599940|NCT00897663|adult glioblastoma|adult glioblastoma
5599941|NCT00897650|lung cancer|lung cancer
5599942|NCT00897624|metastatic intraocular melanoma|metastatic intraocular melanoma
5599943|NCT00897624|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5599944|NCT00897624|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5583031|NCT00956696|Epilepsy|epilepsy
5599945|NCT00897611|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5599946|NCT00897611|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5599947|NCT00897611|adult giant cell glioblastoma|adult giant cell glioblastoma
5599948|NCT00897611|recurrent adult brain tumor|recurrent adult brain tumor
5599950|NCT00897611|adult gliosarcoma|adult gliosarcoma
5599951|NCT00897559|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5599952|NCT00897546|recurrent melanoma|recurrent melanoma
5599953|NCT00897546|stage IV melanoma|stage iv melanoma
5599954|NCT00897546|stage IA melanoma|stage ia melanoma
5599955|NCT00897546|stage IB melanoma|stage ib melanoma
5599956|NCT00897546|stage IIA melanoma|stage iia melanoma
5599957|NCT00897546|stage IIB melanoma|stage iib melanoma
5599958|NCT00897546|stage IIC melanoma|stage iic melanoma
5599959|NCT00897546|stage IIIA melanoma|stage iiia melanoma
5599960|NCT00897546|stage IIIB melanoma|stage iiib melanoma
5599961|NCT00897546|stage IIIC melanoma|stage iiic melanoma
5599962|NCT00897533|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5599963|NCT00897533|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5599964|NCT00897533|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5599965|NCT00897533|adenocarcinoma of the lung|adenocarcinoma of the lung
5599966|NCT00897533|squamous cell lung cancer|squamous cell lung cancer
5599967|NCT00897533|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5599968|NCT00897520|stage II melanoma|stage ii melanoma
5599969|NCT00897520|stage III melanoma|stage iii melanoma
5599970|NCT00897520|stage IV melanoma|stage iv melanoma
5599971|NCT00897507|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5599972|NCT00897507|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5585514|NCT00948441|pediatrics|pediatrics
5599973|NCT00897494|stage I pancreatic cancer|stage i pancreatic cancer
5599974|NCT00897494|stage II pancreatic cancer|stage ii pancreatic cancer
5599975|NCT00897494|stage III pancreatic cancer|stage iii pancreatic cancer
5599976|NCT00897494|stage IV pancreatic cancer|stage iv pancreatic cancer
5599977|NCT00897481|stage IV melanoma|stage iv melanoma
5599978|NCT00897481|recurrent melanoma|recurrent melanoma
5599979|NCT00897481|stage IA melanoma|stage ia melanoma
5599980|NCT00897481|stage IB melanoma|stage ib melanoma
5599981|NCT00897481|stage IIA melanoma|stage iia melanoma
5599982|NCT00897481|stage IIB melanoma|stage iib melanoma
5599983|NCT00897481|stage IIC melanoma|stage iic melanoma
5599984|NCT00897481|stage IIIA melanoma|stage iiia melanoma
5599985|NCT00897481|stage IIIB melanoma|stage iiib melanoma
5599986|NCT00897481|stage IIIC melanoma|stage iiic melanoma
5599987|NCT00897468|breast cancer|breast cancer
5599988|NCT00897455|breast cancer|breast cancer
5599989|NCT00897455|BRCA1 mutation carrier|brca1 mutation carrier
5599990|NCT00897455|BRCA2 mutation carrier|brca2 mutation carrier
5599991|NCT00897429|stage IIA colon cancer|stage iia colon cancer
5599992|NCT00897429|stage IIB colon cancer|stage iib colon cancer
5599993|NCT00897429|stage IIC colon cancer|stage iic colon cancer
5599994|NCT00897416|breast cancer|breast cancer
5599995|NCT00897416|stage I breast cancer|stage i breast cancer
5599996|NCT00897416|stage II breast cancer|stage ii breast cancer
5599997|NCT00897416|stage IIIA breast cancer|stage iiia breast cancer
5599998|NCT00897416|stage IIIB breast cancer|stage iiib breast cancer
5599999|NCT00897416|stage IIIC breast cancer|stage iiic breast cancer
5600000|NCT00897416|stage IV breast cancer|stage iv breast cancer
5600001|NCT00897403|colon cancer|colon cancer
5600002|NCT00897403|health status unknown|health status unknown
5600003|NCT00897364|non-small cell lung cancer|non-small cell lung cancer
5600004|NCT00897364|small cell lung cancer|small cell lung cancer
5600005|NCT00897364|squamous lung dysplasia|squamous lung dysplasia
5600006|NCT00897351|recurrent prostate cancer|recurrent prostate cancer
5600007|NCT00897338|stage IV breast cancer|stage iv breast cancer
5600008|NCT00897312|stage IV melanoma|stage iv melanoma
5600009|NCT00897312|hepatitis C infection|hepatitis c infection
5600010|NCT00897312|melanoma (skin)|melanoma (skin)
5600011|NCT00897312|precancerous/nonmalignant condition|precancerous/nonmalignant condition
5600012|NCT00897299|estrogen receptor|estrogen receptor
5600013|NCT00897299|HER-2|her-2
5600015|NCT00897299|stage II breast cancer|stage ii breast cancer
5600016|NCT00897299|stage IIIA breast cancer|stage iiia breast cancer
5600017|NCT00897299|stage IIIB breast cancer|stage iiib breast cancer
5600018|NCT00897286|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5600019|NCT00897286|childhood choroid plexus tumor|childhood choroid plexus tumor
5600020|NCT00897286|childhood medulloblastoma|childhood medulloblastoma
5600021|NCT00897286|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5600022|NCT00897286|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5600023|NCT00897286|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5600024|NCT00897286|recurrent childhood ependymoma|recurrent childhood ependymoma
5600025|NCT00897286|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5600026|NCT00897286|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5600027|NCT00897286|gliomas|gliomas
5600028|NCT00897273|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5600029|NCT00897273|oropharyngeal cancer|oropharyngeal cancer
5863009|NCT00001417|Spinal Angiography|spinal angiography
5600033|NCT00897273|human papilloma virus infection|human papilloma virus infection
5600034|NCT00897260|Unrelated Umbilical Cord Blood Transplant|unrelated umbilical cord blood transplant
5600035|NCT00897260|Multiple cord blood|multiple cord blood
5600036|NCT00897247|malignant mesothelioma|malignant mesothelioma
5600037|NCT00897247|pulmonary complications|pulmonary complications
5600038|NCT00897234|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5600039|NCT00897234|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5600040|NCT00897234|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5600041|NCT00897234|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5600042|NCT00897234|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5600043|NCT00897234|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5600044|NCT00897221|Friedreich's ataxia|friedreich's ataxia
5600045|NCT00897208|breast cancer|breast cancer
5600046|NCT00897208|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5600047|NCT00897208|breast cancer in situ|breast cancer in situ
5600048|NCT00897208|stage IA breast cancer|stage ia breast cancer
5600049|NCT00897208|stage IB breast cancer|stage ib breast cancer
5600050|NCT00897208|stage II breast cancer|stage ii breast cancer
5600051|NCT00897182|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5600052|NCT00897182|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5600053|NCT00897182|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5600054|NCT00897182|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5600055|NCT00897182|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5600056|NCT00897182|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5600057|NCT00897182|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5600058|NCT00897182|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5600059|NCT00897182|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5600060|NCT00897182|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5600061|NCT00897143|non-small cell lung cancer|non-small cell lung cancer
5600062|NCT00897143|malignant pleural effusion|malignant pleural effusion
5600063|NCT00897143|small cell lung cancer|small cell lung cancer
5600064|NCT00897130|low-risk (IPSS 0-INT1) MDS according to WHO classification|low-risk (ipss 0-int1) mds according to who classification
5600065|NCT00897117|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5600066|NCT00897117|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5600067|NCT00897091|stage II breast cancer|stage ii breast cancer
5600068|NCT00897091|stage IIIA breast cancer|stage iiia breast cancer
5600069|NCT00897078|cancer survivor|cancer survivor
5600070|NCT00897078|healthy, no evidence of disease|healthy, no evidence of disease
5600071|NCT00897078|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5600072|NCT00897078|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5600073|NCT00897065|stage IA breast cancer|stage ia breast cancer
5600074|NCT00897065|stage IB breast cancer|stage ib breast cancer
5600075|NCT00897065|stage II breast cancer|stage ii breast cancer
5600076|NCT00897065|stage IIIA breast cancer|stage iiia breast cancer
5600077|NCT00897065|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5600078|NCT00897065|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5600079|NCT00897052|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5600409|NCT00896285|Pleural malignancy|pleural malignancy
5600080|NCT00897052|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5600081|NCT00897052|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5600082|NCT00897052|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5600083|NCT00897052|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5600084|NCT00897052|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5600085|NCT00897052|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5685452|NCT00556036|irregular|irregular
5600086|NCT00897052|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5600087|NCT00897052|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5600088|NCT00897052|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5600089|NCT00897052|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5600090|NCT00897052|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5600091|NCT00897039|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5600092|NCT00897039|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5600093|NCT00897039|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5600094|NCT00897039|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5600095|NCT00897039|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5600096|NCT00897039|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5600097|NCT00897039|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5600098|NCT00897039|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5600099|NCT00897039|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5600100|NCT00897039|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5600101|NCT00897039|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5600102|NCT00897039|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5600103|NCT00897039|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5600104|NCT00897039|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5600105|NCT00897039|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5600106|NCT00897039|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5600107|NCT00897039|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5600108|NCT00897039|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5600109|NCT00897039|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5600110|NCT00897039|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5600111|NCT00897039|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5600112|NCT00897039|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5600113|NCT00897039|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5600529|NCT00895713|Protective levels|protective levels
5600114|NCT00897039|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5600115|NCT00897039|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5600116|NCT00897039|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5600117|NCT00897039|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5600118|NCT00897039|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5600119|NCT00897039|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5600120|NCT00897039|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5600121|NCT00897039|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5600122|NCT00897039|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5600123|NCT00897039|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5600124|NCT00897039|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5600125|NCT00897039|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5600126|NCT00897026|stage II breast cancer|stage ii breast cancer
5600127|NCT00897026|stage IIIA breast cancer|stage iiia breast cancer
5600128|NCT00896987|Epilepsy|epilepsy
5600129|NCT00896987|lamotrigine|lamotrigine
5600130|NCT00896987|cognitive function|cognitive function
5600131|NCT00896948|head and neck cancer|head and neck cancer
5600132|NCT00896935|cancer|cancer
5671593|NCT00615368|Erythropoietin|erythropoietin
5798753|NCT00111176|rupture|rupture
5798754|NCT00111176|back pain|back pain
5600133|NCT00896922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5600134|NCT00896922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5600135|NCT00896922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5600136|NCT00896922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5600137|NCT00896922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5600138|NCT00896922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5600139|NCT00896922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5600140|NCT00896922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5600141|NCT00896922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5600142|NCT00896922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5600143|NCT00896922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5600144|NCT00896922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5600145|NCT00896909|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5600146|NCT00896909|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5600147|NCT00896909|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5600148|NCT00896896|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5600149|NCT00896896|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5600150|NCT00896896|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5600151|NCT00896896|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5600152|NCT00896896|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5600153|NCT00896896|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5600154|NCT00896896|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5600155|NCT00896896|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5863010|NCT00001417|Intratumoral Pressure|intratumoral pressure
5600156|NCT00896896|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5600157|NCT00896896|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5600158|NCT00896896|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5600159|NCT00896896|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5600160|NCT00896896|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5600161|NCT00896896|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5600162|NCT00896896|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5600163|NCT00896896|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5600164|NCT00896896|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5600165|NCT00896896|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5600166|NCT00896896|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5600167|NCT00896896|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5600168|NCT00896896|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5600169|NCT00896896|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5600170|NCT00896896|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5600171|NCT00896896|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5600172|NCT00896896|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5600173|NCT00896896|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5600174|NCT00896896|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5600175|NCT00896896|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5600176|NCT00896896|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5600177|NCT00896896|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5600178|NCT00896896|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5600179|NCT00896896|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5600180|NCT00896896|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5600181|NCT00896896|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5600182|NCT00896896|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5600183|NCT00896896|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5600184|NCT00896896|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5600185|NCT00896896|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5600186|NCT00896896|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5600187|NCT00896896|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5600188|NCT00896896|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5600189|NCT00896896|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5600190|NCT00896896|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5600191|NCT00896896|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5600192|NCT00896896|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5600193|NCT00896896|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5600194|NCT00896896|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5600195|NCT00896896|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5600196|NCT00896896|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5600197|NCT00896896|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5600198|NCT00896896|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5600199|NCT00896896|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5600200|NCT00896896|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5600201|NCT00896896|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5600202|NCT00896896|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5600203|NCT00896896|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5600204|NCT00896896|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5600205|NCT00896896|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5600206|NCT00896896|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5600207|NCT00896896|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5600208|NCT00896896|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5583386|NCT00955916|CML|cml
5600211|NCT00896896|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5600212|NCT00896896|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5600213|NCT00896896|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600214|NCT00896896|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5600215|NCT00896896|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5600216|NCT00896896|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5600217|NCT00896896|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600218|NCT00896896|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5600219|NCT00896896|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5680438|NCT00577798|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5600220|NCT00896896|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5600221|NCT00896896|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600222|NCT00896896|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5600223|NCT00896896|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5600224|NCT00896896|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5600225|NCT00896896|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600226|NCT00896896|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5600227|NCT00896896|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5600228|NCT00896896|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5600229|NCT00896896|stage I salivary gland cancer|stage i salivary gland cancer
5600230|NCT00896896|stage II salivary gland cancer|stage ii salivary gland cancer
5600231|NCT00896896|stage III salivary gland cancer|stage iii salivary gland cancer
5600232|NCT00896896|stage IV salivary gland cancer|stage iv salivary gland cancer
5600233|NCT00896896|recurrent salivary gland cancer|recurrent salivary gland cancer
5600234|NCT00896896|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5600235|NCT00896896|recurrent colon cancer|recurrent colon cancer
5671594|NCT00615355|vitiligo|vitiligo
5600236|NCT00896896|stage IV colon cancer|stage iv colon cancer
5600237|NCT00896896|recurrent rectal cancer|recurrent rectal cancer
5600238|NCT00896896|stage IV rectal cancer|stage iv rectal cancer
5600239|NCT00896896|adenocarcinoma of the colon|adenocarcinoma of the colon
5600240|NCT00896883|turbinate|turbinate
5600242|NCT00896883|sinus surgery|sinus surgery
5600243|NCT00896883|Turbinates|turbinates
5600244|NCT00896857|breast cancer|breast cancer
5600245|NCT00896857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5600246|NCT00896844|emotional disclosure|emotional disclosure
5600247|NCT00896844|expressive writing|expressive writing
5600248|NCT00896844|students|students
5600249|NCT00896831|minimal hepatic encephalopathy|minimal hepatic encephalopathy
5600250|NCT00896831|L-ornithine-L-aspartate|l-ornithine-l-aspartate
5600251|NCT00896831|psychometric test|psychometric test
5600252|NCT00896831|critical flicker frequency|critical flicker frequency
5600253|NCT00896831|quality of life|quality of life
5600254|NCT00896831|Treatment|treatment
5600255|NCT00896831|Health-related quality of life|health-related quality of life
5600256|NCT00896818|breast cancer|breast cancer
5600257|NCT00896792|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5600258|NCT00896792|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5600259|NCT00896766|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5600411|NCT00896285|pleurodesis|pleurodesis
5600260|NCT00896766|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5600261|NCT00896753|stage IV colon cancer|stage iv colon cancer
5600262|NCT00896753|liver metastases|liver metastases
5600263|NCT00896753|lung metastases|lung metastases
5600264|NCT00896753|recurrent colon cancer|recurrent colon cancer
5600265|NCT00896740|Fanconi anemia|fanconi anemia
5600267|NCT00896727|stage IB breast cancer|stage ib breast cancer
5600268|NCT00896727|stage II breast cancer|stage ii breast cancer
5600269|NCT00896727|stage IIIA breast cancer|stage iiia breast cancer
5600270|NCT00896701|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5600271|NCT00896701|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5600272|NCT00896701|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5600273|NCT00896701|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5600274|NCT00896701|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5600275|NCT00896701|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5600276|NCT00896701|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5600277|NCT00896688|cervical branch block|cervical branch block
5600278|NCT00896688|fluoroscopic guidance|fluoroscopic guidance
5600279|NCT00896688|ultrasound guidance|ultrasound guidance
5600280|NCT00896675|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5600281|NCT00896675|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5600282|NCT00896675|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5600283|NCT00896675|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5600284|NCT00896675|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5600285|NCT00896675|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5600286|NCT00896675|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5600287|NCT00896675|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5600288|NCT00896675|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5600289|NCT00896675|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5600290|NCT00896675|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5600291|NCT00896675|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5600292|NCT00896675|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5600293|NCT00896675|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5600294|NCT00896675|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5600295|NCT00896675|stage IV salivary gland cancer|stage iv salivary gland cancer
5600296|NCT00896675|recurrent salivary gland cancer|recurrent salivary gland cancer
5600297|NCT00896662|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5600298|NCT00896662|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5600299|NCT00896662|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5600300|NCT00896662|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5600301|NCT00896662|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5600302|NCT00896662|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5600303|NCT00896662|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5600304|NCT00896662|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5600305|NCT00896662|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5600306|NCT00896662|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5600307|NCT00896662|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5600308|NCT00896662|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5600309|NCT00896662|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5600310|NCT00896662|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5600311|NCT00896662|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5600312|NCT00896662|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5600313|NCT00896662|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5600314|NCT00896662|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5600315|NCT00896662|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5600316|NCT00896662|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5600317|NCT00896662|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5600318|NCT00896662|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5600319|NCT00896662|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5600320|NCT00896662|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5685453|NCT00556036|stress|stress
5600321|NCT00896662|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5600326|NCT00896636|breast cancer|breast cancer
5600327|NCT00896636|healthy, no evidence of disease|healthy, no evidence of disease
5600328|NCT00896623|stage I breast cancer|stage i breast cancer
5600329|NCT00896623|stage II breast cancer|stage ii breast cancer
5595418|NCT00909454|Obesity|obesity
5600337|NCT00896584|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5600339|NCT00896584|Pre-flight evaluation|pre-flight evaluation
5600340|NCT00896584|Hypobaria|hypobaria
5600341|NCT00896584|COPD|copd
5600342|NCT00896584|Pulseoximetry|pulseoximetry
5600343|NCT00896584|Air travel|air travel
5600344|NCT00896584|Exercise desaturation|exercise desaturation
5600345|NCT00896571|Fertility control|fertility control
5600346|NCT00896571|Contraception|contraception
5583524|NCT00955279|Simponi|simponi
5600347|NCT00896558|GSK1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind|gsk1322322, repeat dose, healthy subjects, elderly, drug-drug interaction, probe, midazolam, double-blind
5600348|NCT00896519|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5600349|NCT00896519|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5600350|NCT00896519|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5600351|NCT00896519|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5600352|NCT00896519|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5600353|NCT00896519|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5600354|NCT00896480|ASCI (Antigen-Specific Cancer Immunotherapeutic)|asci (antigen-specific cancer immunotherapeutic)
5600355|NCT00896480|MAGE-A3|mage-a3
5600356|NCT00896480|Malignant melanoma|malignant melanoma
5600357|NCT00896480|Cancer immunotherapeutic|cancer immunotherapeutic
5600358|NCT00896467|anxiety disorder|anxiety disorder
5600359|NCT00896467|depression|depression
5600360|NCT00896467|stage IV breast cancer|stage iv breast cancer
5600361|NCT00896467|stage IV renal cell cancer|stage iv renal cell cancer
5600362|NCT00896467|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5600363|NCT00896467|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5600365|NCT00896467|stage IV anal cancer|stage iv anal cancer
5600366|NCT00896467|stage IV pancreatic cancer|stage iv pancreatic cancer
5600367|NCT00896467|stage IV esophageal cancer|stage iv esophageal cancer
5600368|NCT00896467|advanced adult primary liver cancer|advanced adult primary liver cancer
5600369|NCT00896467|unresectable gallbladder cancer|unresectable gallbladder cancer
5600370|NCT00896467|small intestine cancer|small intestine cancer
5600371|NCT00896454|hypercalcemia|hypercalcemia
5600372|NCT00896454|calcium|calcium
5600373|NCT00896454|bisphosphonates|bisphosphonates
5600374|NCT00896454|denosumab|denosumab
5600375|NCT00896454|amgen|amgen
5600376|NCT00896454|malignancy|malignancy
5600377|NCT00896454|20070315|20070315
5600378|NCT00896454|HMC|hmc
5600379|NCT00896454|oncology|oncology
5600380|NCT00896454|hematology|hematology
5600381|NCT00896428|Asthma|asthma
5600382|NCT00896428|gallopamil|gallopamil
5600383|NCT00896428|airway remodelling|airway remodelling
5600384|NCT00896428|smooth muscle|smooth muscle
5600385|NCT00896415|on two models of CT scanner acquire CT images of the abdomen pelvis and midthigh in 20 Postmenopausal female volunteers|on two models of ct scanner acquire ct images of the abdomen pelvis and midthigh in 20 postmenopausal female volunteers
5600386|NCT00896402|chloraprep|chloraprep
5600387|NCT00896402|betadine|betadine
5600388|NCT00896402|colonization|colonization
5600389|NCT00896402|femoral catheter|femoral catheter
5600390|NCT00896389|hypertension|hypertension
5600391|NCT00896389|hydrochlorothiazide|hydrochlorothiazide
5600392|NCT00896389|HCTZ|hctz
5600393|NCT00896389|Salt sensitivity|salt sensitivity
5600394|NCT00896389|Hydrochlorothiazide induced hyperglycemia|hydrochlorothiazide induced hyperglycemia
5600395|NCT00896376|stage IV breast cancer|stage iv breast cancer
5600396|NCT00896376|HER2-positive breast cancer|her2-positive breast cancer
5600398|NCT00896363|Severe Depression|severe depression
5600399|NCT00896363|Efficacy|efficacy
5600400|NCT00896363|Major Depressive Disorder|major depressive disorder
5600401|NCT00896363|Major Depressive Episode|major depressive episode
5600402|NCT00896337|iliac artery stenosis|iliac artery stenosis
5600403|NCT00896337|claudication|claudication
5600404|NCT00896337|atherosclerotic iliac disease|atherosclerotic iliac disease
5600405|NCT00896337|peripheral vascular disease|peripheral vascular disease
5600406|NCT00896324|Quality of life|quality of life
5600407|NCT00896298|Lipodystrophy|lipodystrophy
5600408|NCT00896298|Insulin secretory response|insulin secretory response
5600414|NCT00896285|cancer pain management|cancer pain management
5600415|NCT00896272|Klinefelter Syndrome|klinefelter syndrome
5600416|NCT00896272|47,XXY|47,xxy
5600418|NCT00896259|Unilateral total hip arthroplasty|unilateral total hip arthroplasty
5600419|NCT00896233|Staging of liver fibrosis prior to clinical trials for treatment of Hepatitis C Virus|staging of liver fibrosis prior to clinical trials for treatment of hepatitis c virus
5600420|NCT00896220|chronic critical illness|chronic critical illness
5600421|NCT00896220|mechanical ventilation|mechanical ventilation
5600422|NCT00896220|outcomes|outcomes
5600423|NCT00896220|weakness|weakness
5600424|NCT00896220|quality of life|quality of life
5600425|NCT00896220|Critically Ill patients and their family caregiver|critically ill patients and their family caregiver
5600426|NCT00896194|Overweight|overweight
5600427|NCT00896194|Obesity|obesity
5600428|NCT00896194|Self-Efficacy|self-efficacy
5600429|NCT00896194|Treatment Adherence|treatment adherence
5600430|NCT00896168|Arthritis, Rheumatoid|arthritis, rheumatoid
5600431|NCT00896168|Infliximab|infliximab
5600432|NCT00896168|Methotrexate|methotrexate
5600433|NCT00896155|Breast cancer|breast cancer
5600434|NCT00896155|Pulmonary fibrosis|pulmonary fibrosis
5600435|NCT00896155|tamoxifen|tamoxifen
5600436|NCT00896155|radiotherapy|radiotherapy
5600437|NCT00896142|ischemic cardiomyopathy|ischemic cardiomyopathy
5600438|NCT00896142|cardiac resynchronization therapy|cardiac resynchronization therapy
5600439|NCT00896142|LV structure and function|lv structure and function
5600440|NCT00896129|Health Outcomes Research|health outcomes research
5600441|NCT00896129|CML|cml
5600442|NCT00896077|healthy subjects|healthy subjects
5600443|NCT00896064|Pneumococcal vaccine|pneumococcal vaccine
5600444|NCT00896064|Streptococcus pneumoniae|streptococcus pneumoniae
5600445|NCT00896064|Young adults|young adults
5600446|NCT00896051|HIV Infections|hiv infections
5600447|NCT00896051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5600448|NCT00896051|TMC125-TiDP2-C238|tmc125-tidp2-c238
5600449|NCT00896051|TMC125-C238|tmc125-c238
5600450|NCT00896051|Etravirine|etravirine
5600451|NCT00896051|Intelence|intelence
5600452|NCT00896051|HIV|hiv
5600453|NCT00896051|HIV-1|hiv-1
5600454|NCT00896051|Pharmacokinetics|pharmacokinetics
5600455|NCT00896038|Alcohol Dependence|alcohol dependence
5600456|NCT00896038|Alcohol Treatment|alcohol treatment
5600457|NCT00896038|Alcoholics|alcoholics
5600458|NCT00896038|Alcoholism|alcoholism
5600459|NCT00896038|Posttraumatic Stress Disorder|posttraumatic stress disorder
5600460|NCT00896038|PTSD|ptsd
5600461|NCT00896025|Liver disease|liver disease
5600462|NCT00896012|Kidney Transplant|kidney transplant
5600463|NCT00896012|Immunosuppression drugs|immunosuppression drugs
5600464|NCT00896012|Rapamune|rapamune
5600465|NCT00896012|tacrolimus|tacrolimus
5600466|NCT00896012|calcineurin inhibitor|calcineurin inhibitor
5600467|NCT00896012|Kidney Biopsy, Needle|kidney biopsy, needle
5600468|NCT00895986|Diabetes|diabetes
5600469|NCT00895986|Education|education
5600470|NCT00895960|Brain|brain
5600471|NCT00895960|CNS Disease|cns disease
5600472|NCT00895960|CNS|cns
5600473|NCT00895960|Intracranial Supratentorial GBM|intracranial supratentorial gbm
5600474|NCT00895960|Gliosarcoma|gliosarcoma
5600475|NCT00895960|GS|gs
5600476|NCT00895960|Glioblastoma|glioblastoma
5600477|NCT00895960|GBM|gbm
5600478|NCT00895960|Dasatinib|dasatinib
5600479|NCT00895960|Sprycel|sprycel
5600480|NCT00895960|Temozolomide|temozolomide
5600481|NCT00895960|TMZ|tmz
5600482|NCT00895960|Temodar|temodar
5600483|NCT00895960|Radiation Therapy|radiation therapy
5600484|NCT00895960|Radiotherapy|radiotherapy
5600485|NCT00895960|RT|rt
5600486|NCT00895947|Prophylaxis|prophylaxis
5600487|NCT00895947|Treatment|treatment
5600488|NCT00895947|Symptoms|symptoms
5600489|NCT00895947|Winter Colds and Flu|winter colds and flu
5600490|NCT00895921|Insulin Resistance|insulin resistance
5600491|NCT00895921|Antipsychotic Medications|antipsychotic medications
5600492|NCT00895908|ADHD|adhd
5600493|NCT00895908|Psychosocial Intervention|psychosocial intervention
5600494|NCT00895908|Social Skills Training|social skills training
5600495|NCT00895869|Screening|screening
5600496|NCT00895869|Retinopathy|retinopathy
5600497|NCT00895869|Prematurity|prematurity
5600498|NCT00895869|Pain|pain
5600499|NCT00895856|Physiotherapy|physiotherapy
5600500|NCT00895856|Aged|aged
5600501|NCT00895856|Functionality|functionality
5600502|NCT00895856|Physiotherapic assistance|physiotherapic assistance
5600503|NCT00895856|Functional capacity|functional capacity
5600504|NCT00895843|Third molar|third molar
5600505|NCT00895817|Eosinophilic esophagitis|eosinophilic esophagitis
5600506|NCT00895817|acid reflux|acid reflux
5600507|NCT00895804|MDMA|mdma
5600508|NCT00895804|beta adrenergic|beta adrenergic
5600509|NCT00895804|Ecstasy|ecstasy
5600510|NCT00895791|coronary bifurcation|coronary bifurcation
5600511|NCT00895791|stent implantation|stent implantation
5600513|NCT00895791|Optical Coherence Tomography|optical coherence tomography
5600514|NCT00895778|Neuromuscular blockade|neuromuscular blockade
5600515|NCT00895778|post-operative pain|post-operative pain
5600516|NCT00895778|post-operative pulmonary function|post-operative pulmonary function
5600521|NCT00895739|aplastic anemia|aplastic anemia
5600522|NCT00895726|cachexia|cachexia
5600523|NCT00895726|neoplasms|neoplasms
5600524|NCT00895713|Hepatitis B|hepatitis b
5600525|NCT00895713|HBV|hbv
5600526|NCT00895713|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
5600527|NCT00895713|Immunoglobulins|immunoglobulins
5600530|NCT00895713|Recurrence|recurrence
5600531|NCT00895713|Intramuscular|intramuscular
5600533|NCT00895700|ICD concerns|icd concerns
5600534|NCT00895700|Quality of life|quality of life
5600535|NCT00895687|Metastatic Cancer|metastatic cancer
5600536|NCT00895687|Bortezomib|bortezomib
5600537|NCT00895687|Velcade|velcade
5600538|NCT00895687|Erlotinib|erlotinib
5600539|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride
5600540|NCT00895687|Tarceva|tarceva
5600541|NCT00895687|EGFR|egfr
5600542|NCT00895687|EGFR mutations|egfr mutations
5600543|NCT00895674|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5600545|NCT00895648|Meso|meso
5600546|NCT00895648|mesothelioma|mesothelioma
5600547|NCT00895648|pleura|pleura
5600548|NCT00895648|pleural|pleural
5600549|NCT00895635|Claudication|claudication
5600550|NCT00895635|Peripheral Arterial Disease|peripheral arterial disease
5600551|NCT00895635|Exercise Rehabilitation|exercise rehabilitation
5600552|NCT00895635|Cardiovascular Function|cardiovascular function
5600553|NCT00895622|adult grade I meningioma|adult grade i meningioma
5600554|NCT00895622|adult grade II meningioma|adult grade ii meningioma
5600555|NCT00895622|adult grade III meningioma|adult grade iii meningioma
5600556|NCT00895622|adult anaplastic meningioma|adult anaplastic meningioma
5600557|NCT00895622|adult papillary meningioma|adult papillary meningioma
5600558|NCT00895622|recurrent adult brain tumor|recurrent adult brain tumor
5600559|NCT00895609|Residual neuromuscular block|residual neuromuscular block
5600560|NCT00895609|post-operative residual curarization|post-operative residual curarization
5600561|NCT00895609|PORC|porc
5600562|NCT00895609|sugammadex|sugammadex
5600563|NCT00895609|neostigmine|neostigmine
5600564|NCT00895609|Shallow neuromuscular block (TOF-ratio of 0.5)|shallow neuromuscular block (tof-ratio of 0.5)
5600565|NCT00895596|Chronic hepatitis B|chronic hepatitis b
5600566|NCT00895596|Lamivudine resistant|lamivudine resistant
5600567|NCT00895596|YMDD mutant type|ymdd mutant type
5600568|NCT00895583|renal transplant|renal transplant
5600569|NCT00895583|immunosuppression|immunosuppression
5600570|NCT00895583|sirolimus/rapamune|sirolimus/rapamune
5600571|NCT00895583|planned transition|planned transition
5600572|NCT00895570|sleep restriction|sleep restriction
5600573|NCT00895570|glucose metabolism|glucose metabolism
5600574|NCT00895570|modafinil|modafinil
5600575|NCT00895570|euglycemic clamp|euglycemic clamp
5600576|NCT00895570|insulin sensitivity|insulin sensitivity
5600577|NCT00895570|insulin release|insulin release
5600578|NCT00895557|varenicline|varenicline
5600579|NCT00895557|cocaine|cocaine
5600580|NCT00895557|brain imaging|brain imaging
5600581|NCT00895531|Knee Replacement, Total|knee replacement, total
5600582|NCT00895531|Morphine|morphine
5600583|NCT00895518|PTSD|ptsd
5600584|NCT00895505|DVT|dvt
5600585|NCT00895505|Venous thromboembolism|venous thromboembolism
5600586|NCT00895505|D-Dimer|d-dimer
5600587|NCT00895505|thrombophilia|thrombophilia
5600588|NCT00895505|secondary prophylaxis|secondary prophylaxis
5600589|NCT00895505|secondary prophylaxis using oral anticoagulant treatment (OAT)|secondary prophylaxis using oral anticoagulant treatment (oat)
5600590|NCT00895505|higher risk of recurrence in patients showing increased levels|higher risk of recurrence in patients showing increased levels
5600591|NCT00895505|of D-Dimer after withdrawal of OAT|of d-dimer after withdrawal of oat
5600592|NCT00895505|D-Dimer-based treatment|d-dimer-based treatment
5600593|NCT00895492|diarrhea|diarrhea
5600594|NCT00895492|rotavirus|rotavirus
5600595|NCT00895492|genotype|genotype
5600596|NCT00895492|VP4|vp4
5600597|NCT00895492|VP7|vp7
5600598|NCT00895479|End Stage Renal Disease|end stage renal disease
5600599|NCT00895479|ESRD|esrd
5600600|NCT00895479|Hemodialysis|hemodialysis
5600601|NCT00895479|Access Graft|access graft
5600602|NCT00895466|prostatic diseases|prostatic diseases
5600603|NCT00895466|neoplasms|neoplasms
5600604|NCT00895466|prostatic neoplasms|prostatic neoplasms
5603081|NCT00886249|Eye|eye
5600605|NCT00895466|hormones|hormones
5600606|NCT00895466|androgen antagonists|androgen antagonists
5600607|NCT00895466|vaccines|vaccines
5600608|NCT00895466|peptide vaccines|peptide vaccines
5600609|NCT00895466|adjuvants, immunological|adjuvants, immunological
5600610|NCT00895453|recurrent vulvovaginal candidiasis|recurrent vulvovaginal candidiasis
5600611|NCT00895453|itraconazole|itraconazole
5600612|NCT00895453|classic homeopathy|classic homeopathy
5600613|NCT00895440|Diabetes|diabetes
5600614|NCT00895440|Diabetic neuropathy|diabetic neuropathy
5600615|NCT00895440|neuropad|neuropad
5600616|NCT00895440|Painless peripheral diabetic neuropathy|painless peripheral diabetic neuropathy
5600617|NCT00895440|Painful peripheral diabetic neuropathy|painful peripheral diabetic neuropathy
5600618|NCT00895440|Autonomic peripheral neuropathy|autonomic peripheral neuropathy
5600619|NCT00895440|Charcot neuroarthropathy|charcot neuroarthropathy
5600620|NCT00895427|Coronary artery calcification|coronary artery calcification
5600628|NCT00895401|Malnutrition|malnutrition
5600629|NCT00895401|Hemodialysis|hemodialysis
5600630|NCT00895401|Nepro with Carb Steady|nepro with carb steady
5600631|NCT00895388|Urinary function|urinary function
5600632|NCT00895388|Anal function|anal function
5600633|NCT00895375|Dermatology|dermatology
5600634|NCT00895375|Skin|skin
5600635|NCT00895375|Psoriasis|psoriasis
5600636|NCT00895375|Sleep|sleep
5600637|NCT00895375|Wake Forest|wake forest
5600638|NCT00895375|Insomnia|insomnia
5600639|NCT00895362|Advanced Cancer|advanced cancer
5600640|NCT00895362|EGFR mutation|egfr mutation
5600641|NCT00895362|Erlotinib|erlotinib
5600642|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride
5600643|NCT00895362|Tarceva|tarceva
5600644|NCT00895362|OSI-774|osi-774
5600645|NCT00895362|Cetuximab|cetuximab
5600646|NCT00895362|C225|c225
5600647|NCT00895362|Erbitux|erbitux
5600648|NCT00895362|IMC-C225|imc-c225
5600649|NCT00895349|Positron Emission Tomography (PET)|positron emission tomography (pet)
5600650|NCT00895349|Diagnostic Intervention|diagnostic intervention
5600651|NCT00895349|Locally Advanced Cervical Cancer|locally advanced cervical cancer
5600652|NCT00895336|Pediatric Ulcerative Colitis|pediatric ulcerative colitis
5600653|NCT00895323|stage I colon cancer|stage i colon cancer
5600654|NCT00895323|stage II colon cancer|stage ii colon cancer
5600655|NCT00895323|stage III colon cancer|stage iii colon cancer
5600656|NCT00895323|stage IV colon cancer|stage iv colon cancer
5600657|NCT00895323|stage I rectal cancer|stage i rectal cancer
5600658|NCT00895323|stage II rectal cancer|stage ii rectal cancer
5600659|NCT00895323|stage III rectal cancer|stage iii rectal cancer
5600660|NCT00895323|stage IV rectal cancer|stage iv rectal cancer
5600661|NCT00895323|recurrent colon cancer|recurrent colon cancer
5600662|NCT00895323|recurrent rectal cancer|recurrent rectal cancer
5600663|NCT00895310|PSA|psa
5600664|NCT00895310|Ketoconazole|ketoconazole
5600665|NCT00895310|Prostate Cancer|prostate cancer
5600666|NCT00895310|Hormone Refractory|hormone refractory
5600667|NCT00895310|Chemotherapy Regimen|chemotherapy regimen
5600668|NCT00895297|Relapsing after allogeneic transplantation|relapsing after allogeneic transplantation
5600669|NCT00895297|Dasatinib|dasatinib
5600670|NCT00895297|Sprycel|sprycel
5600671|NCT00895297|Philadelphia Chromosomes|philadelphia chromosomes
5586385|NCT00945191|ovarian|ovarian
5600672|NCT00895284|robotic|robotic
5600673|NCT00895284|laparoscopic surgical procedures|laparoscopic surgical procedures
5600682|NCT00895258|Schizoaffective Disorder|schizoaffective disorder
5600683|NCT00895258|Major Depressive Disorder|major depressive disorder
5600684|NCT00895258|Supported Employment|supported employment
5600685|NCT00895258|Work|work
5600686|NCT00895258|Rehabilitation|rehabilitation
5600687|NCT00895258|Severe Mental Illness|severe mental illness
5600688|NCT00895258|Cognitive Training|cognitive training
5600689|NCT00895258|Cognitive Rehabilitation|cognitive rehabilitation
5600690|NCT00895258|Cognitive Remediation|cognitive remediation
5600691|NCT00895219|Hyperventilation|hyperventilation
5600692|NCT00895219|Dysfunctional breathing|dysfunctional breathing
5600693|NCT00895219|Physiotherapy|physiotherapy
5600694|NCT00895219|Musculoskeletal techniques|musculoskeletal techniques
5600695|NCT00895193|Niacin|niacin
5600696|NCT00895193|Hypercholesterolemia|hypercholesterolemia
5600697|NCT00895193|Flushing|flushing
5600698|NCT00895180|recurrent adult brain tumor|recurrent adult brain tumor
5600699|NCT00895180|adult glioblastoma|adult glioblastoma
5600700|NCT00895180|adult giant cell glioblastoma|adult giant cell glioblastoma
5600701|NCT00895180|adult gliosarcoma|adult gliosarcoma
5600702|NCT00895167|Heme Oxygenase|heme oxygenase
5600703|NCT00895167|Genetic Polymorphism|genetic polymorphism
5600704|NCT00895167|Healthy Subjects|healthy subjects
5600705|NCT00895154|Sickle Cell Disease|sickle cell disease
5600706|NCT00895154|Sickle Cell|sickle cell
5600707|NCT00895154|Memory|memory
5600708|NCT00895154|Learning|learning
5600709|NCT00895154|Achievement|achievement
5600710|NCT00895141|Saturated fat|saturated fat
5600711|NCT00895141|LDL size|ldl size
5600712|NCT00895141|Large LDL|large ldl
5600713|NCT00895141|Large HDL|large hdl
5600714|NCT00895128|Advanced Cancer|advanced cancer
5600715|NCT00895128|EGFR mutations|egfr mutations
5600716|NCT00895128|Dasatinib|dasatinib
5600717|NCT00895128|Sprycel|sprycel
5600718|NCT00895128|Erlotinib|erlotinib
5602026|NCT00890227|kyphosis|kyphosis
5600719|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride
5600720|NCT00895128|Tarceva|tarceva
5600721|NCT00895115|prostate cancer|prostate cancer
5600722|NCT00895102|Bioavailability (BA)|bioavailability (ba)
5600723|NCT00895102|Single Ascending Dose (SAD)|single ascending dose (sad)
5600724|NCT00895089|liver abscess|liver abscess
5600725|NCT00895089|moxifloxacin|moxifloxacin
5600726|NCT00895089|ceftriaxone|ceftriaxone
5600727|NCT00895089|treatment|treatment
5600728|NCT00895063|Spasmodic Dysphonia|spasmodic dysphonia
5600729|NCT00895063|Botulinum Toxin|botulinum toxin
5600730|NCT00895063|Vocal Exercise|vocal exercise
5600731|NCT00895024|Caregiver|caregiver
5600732|NCT00895024|Questionnaire|questionnaire
5600733|NCT00895024|Home Hospice Care|home hospice care
5600734|NCT00895024|Family Evaluation of Hospice Care|family evaluation of hospice care
5600735|NCT00895024|FEHC|fehc
5600736|NCT00895024|The Texas Revised Inventory of Grief|the texas revised inventory of grief
5600737|NCT00895024|TRIG|trig
5600738|NCT00895024|Cross-ethnic differences|cross-ethnic differences
5600739|NCT00895024|Parenteral Hydration|parenteral hydration
5600740|NCT00895024|Grief|grief
5600741|NCT00895011|Erectile Dysfunction|erectile dysfunction
5600742|NCT00895011|E.D.|e.d.
5600743|NCT00894998|heparin cardiac surgery|heparin cardiac surgery
5600744|NCT00894985|heparin cardiac surgery|heparin cardiac surgery
5600745|NCT00894959|heparin cardiac surgery|heparin cardiac surgery
5600746|NCT00894946|recurrent IVF implantation failure|recurrent ivf implantation failure
5600747|NCT00894933|Prostate Cancer|prostate cancer
5600748|NCT00894933|Radical Prostatectomy|radical prostatectomy
5600749|NCT00894933|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
5600750|NCT00894920|biotin|biotin
5600751|NCT00894920|deficiency|deficiency
5600752|NCT00894920|pregnancy|pregnancy
5600753|NCT00894920|lymphocyte propionyl-CoA carboxylase|lymphocyte propionyl-coa carboxylase
5600754|NCT00894907|Severe pancreatitis|severe pancreatitis
5600755|NCT00894907|acute pancreatitis|acute pancreatitis
5600756|NCT00894907|haemodynamic monitoring|haemodynamic monitoring
5600757|NCT00894907|PiCCO|picco
5600758|NCT00894894|MP470|mp470
5600759|NCT00894894|MP-470|mp-470
5600760|NCT00894894|SuperGen|supergen
5600761|NCT00894894|Tyrosine|tyrosine
5600762|NCT00894894|Kinase|kinase
5600763|NCT00894894|Inhibitor|inhibitor
5600764|NCT00894894|Solid Malignancies|solid malignancies
5600765|NCT00894894|Oncology|oncology
5600766|NCT00894881|colonoscopy|colonoscopy
5600767|NCT00894881|Healthy individuals before colonoscopy|healthy individuals before colonoscopy
5600768|NCT00894868|Congestive Heart Failure|congestive heart failure
5600769|NCT00894868|CHF, vildagliptin|chf, vildagliptin
5600770|NCT00894868|metabolic disease|metabolic disease
5600771|NCT00894868|cardiovascular disease|cardiovascular disease
5600772|NCT00894868|T2DM|t2dm
5600773|NCT00894855|skin cancer prevention|skin cancer prevention
5600774|NCT00894855|SHADE|shade
5600775|NCT00894855|Beach|beach
5600776|NCT00894842|Schizophrenia|schizophrenia
5600777|NCT00894842|Pregnenolone|pregnenolone
5600778|NCT00894842|Neurocognition|neurocognition
5600779|NCT00894829|heparin cardiac surgery|heparin cardiac surgery
5600780|NCT00894816|Prevention|prevention
5600781|NCT00894816|Probiotics|probiotics
5600782|NCT00894816|Eczema|eczema
5600783|NCT00894816|Allergy|allergy
5600784|NCT00894816|Asthma|asthma
5600785|NCT00894816|Obesity|obesity
5600786|NCT00894816|Caries|caries
5600787|NCT00894816|Gut microbiota|gut microbiota
5600788|NCT00894803|acute ischemic stroke|acute ischemic stroke
5600789|NCT00894803|stroke|stroke
5600790|NCT00894803|rt-PA, thrombolytic|rt-pa, thrombolytic
5600791|NCT00894803|t-PA|t-pa
5600792|NCT00894803|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5600793|NCT00894803|Activase|activase
5600794|NCT00894803|eptifibatide|eptifibatide
5600795|NCT00894803|Integrilin|integrilin
5600796|NCT00894803|fibrinolytic agents|fibrinolytic agents
5600797|NCT00894803|clot dissolving|clot dissolving
5600798|NCT00894803|blood clot|blood clot
5600799|NCT00894790|Treatment of the acute pain due to cervical|treatment of the acute pain due to cervical
5600800|NCT00894790|sprain|sprain
5600801|NCT00894790|Celecoxib|celecoxib
5600802|NCT00894790|NSAID|nsaid
5600803|NCT00894790|Diclofenac|diclofenac
5600804|NCT00894777|Psoriasis|psoriasis
5600805|NCT00894764|Childhood|childhood
5600806|NCT00894764|Pneumonia|pneumonia
5600807|NCT00894764|Pneumococcal|pneumococcal
5600808|NCT00894764|pneumococcus|pneumococcus
5600809|NCT00894764|Carriage|carriage
5600810|NCT00894751|dexmedetomidine and propofol for MRI|dexmedetomidine and propofol for mri
5600811|NCT00894751|quality of care between two anesthetic agents for MRI|quality of care between two anesthetic agents for mri
5600812|NCT00894738|pediatric|pediatric
5600813|NCT00894738|mental illness|mental illness
5600814|NCT00894738|antipsychotic|antipsychotic
5600815|NCT00894738|cardiometabolic risk|cardiometabolic risk
5600816|NCT00894738|Antipsychotic agents|antipsychotic agents
5600817|NCT00894738|Mental disorders diagnosed in childhood|mental disorders diagnosed in childhood
5600819|NCT00894712|Radiation Therapy|radiation therapy
5600820|NCT00894699|procedural sedation|procedural sedation
5600821|NCT00894673|heparin cardiac surgery|heparin cardiac surgery
5600822|NCT00894660|Bioequivalence, Healthy Volunteers|bioequivalence, healthy volunteers
5600823|NCT00894647|actinic keratosis|actinic keratosis
5600824|NCT00894647|skin disease|skin disease
5600826|NCT00894621|Respiration, artificial|respiration, artificial
5600827|NCT00894621|Norepinephrine|norepinephrine
5600828|NCT00894608|letrozole|letrozole
5600829|NCT00894608|ovarian stimulation|ovarian stimulation
5600830|NCT00894608|PCOS|pcos
5600831|NCT00894608|IVF-ET|ivf-et
5600832|NCT00894595|Incidence of ACL injury|incidence of acl injury
5600833|NCT00894595|Risk factors for ACL injury|risk factors for acl injury
5600834|NCT00894595|Prevention of ACL injury or any acute knee injury|prevention of acl injury or any acute knee injury
5600835|NCT00894582|massive ventral hernia|massive ventral hernia
5600836|NCT00894582|abdominal volume|abdominal volume
5600837|NCT00894582|pulmonary function|pulmonary function
5600838|NCT00894582|components separation|components separation
5600839|NCT00894582|abdominal compartments syndrome|abdominal compartments syndrome
5600840|NCT00894569|carcinoma of unknown primary|carcinoma of unknown primary
5600841|NCT00894569|cancer of unknown primary|cancer of unknown primary
5600842|NCT00894569|CUP|cup
5600843|NCT00894569|carboplatin|carboplatin
5600844|NCT00894569|paclitaxel|paclitaxel
5600845|NCT00894569|cetuximab|cetuximab
5600846|NCT00894556|Treatment of acute migraine with or without aura in adults|treatment of acute migraine with or without aura in adults
5600847|NCT00894543|Hot flashes|hot flashes
5600848|NCT00894543|Menopause|menopause
5600849|NCT00894543|Vasomotor symptoms|vasomotor symptoms
5600850|NCT00894504|Metastatic Breast Cancer|metastatic breast cancer
5600851|NCT00894504|Triple Negative|triple negative
5600852|NCT00894504|Panitumumab|panitumumab
5600853|NCT00894504|Vectibix|vectibix
5600854|NCT00894504|Gemcitabine|gemcitabine
5600856|NCT00894504|Carboplatin|carboplatin
5600857|NCT00894491|alternative medicine|alternative medicine
5600858|NCT00894491|complementary medicine|complementary medicine
5600859|NCT00894491|acupuncture|acupuncture
5600860|NCT00894491|Chinese herbals|chinese herbals
5600861|NCT00894478|MRI-Negative|mri-negative
5600862|NCT00894478|Diffusion tensor imaging|diffusion tensor imaging
5600863|NCT00894478|Localization-related epilepsy|localization-related epilepsy
5600864|NCT00894478|Partial Epilepsy|partial epilepsy
5600865|NCT00894478|Children|children
5600866|NCT00894465|Midazolam|midazolam
5600867|NCT00894465|VCUG|vcug
5600868|NCT00894465|Anxiety|anxiety
5600869|NCT00894452|Methadone|methadone
5600870|NCT00894452|CYP|cyp
5600871|NCT00894452|OPRM1|oprm1
5600872|NCT00894452|MDR1|mdr1
5600873|NCT00894452|COMT|comt
5600874|NCT00894452|Midazolam challenge|midazolam challenge
5600875|NCT00894426|COPD|copd
5600876|NCT00894426|Symptom|symptom
5600877|NCT00894426|Morning activity|morning activity
5600878|NCT00894426|Questionnaire|questionnaire
5600879|NCT00894400|AF|af
5600880|NCT00894400|catheter ablation|catheter ablation
5600881|NCT00894400|fractionated electrogram|fractionated electrogram
5600882|NCT00894400|complex fractionated atrial electrogram (CFAE)|complex fractionated atrial electrogram (cfae)
5600883|NCT00894387|elevated BNP|elevated bnp
5600884|NCT00894387|reduced LVEF|reduced lvef
5600885|NCT00894387|Acute Heart Failure|acute heart failure
5600886|NCT00894387|Cardiovascular death|cardiovascular death
5600887|NCT00894387|CHF|chf
5600888|NCT00894387|hospitalization|hospitalization
5600889|NCT00894387|morbi-mortality trial|morbi-mortality trial
5600890|NCT00894387|outcome study|outcome study
5600891|NCT00894387|endpoint driven|endpoint driven
5600892|NCT00894387|plasma renin activity|plasma renin activity
5600893|NCT00894387|renin angiotensin|renin angiotensin
5600894|NCT00894387|aldosterone system|aldosterone system
5600895|NCT00894387|direct renin inhibitors|direct renin inhibitors
5600896|NCT00894387|BNP|bnp
5600897|NCT00894387|KCCQ|kccq
5600898|NCT00894387|eGFR|egfr
5600899|NCT00894374|Bio-equivalence, Healthy Volunteers|bio-equivalence, healthy volunteers
5600900|NCT00894361|knee arthritis|knee arthritis
5600901|NCT00894361|total knee arthroplasty|total knee arthroplasty
5600902|NCT00894361|total knee replacement|total knee replacement
5600903|NCT00894361|mobile bearing design|mobile bearing design
5600904|NCT00894361|all-polyethylene tibia|all-polyethylene tibia
5600905|NCT00894348|ERCP|ercp
5600906|NCT00894348|Positive Biliary Brush Cytology|positive biliary brush cytology
5600907|NCT00894335|retroperitoneoscopic adrenalectomy|retroperitoneoscopic adrenalectomy
5600908|NCT00894335|intraoperative arterial-alveolar Carbon dioxide Difference|intraoperative arterial-alveolar carbon dioxide difference
5600909|NCT00894322|diabetes|diabetes
5600910|NCT00894322|exenatide once weekly|exenatide once weekly
5783991|NCT00175188|RSA|rsa
5600911|NCT00894322|Byetta|byetta
5600912|NCT00894322|Amylin|amylin
5600913|NCT00894322|Lilly|lilly
5600914|NCT00894296|MEG|meg
5600915|NCT00894296|schizophrenia|schizophrenia
5600916|NCT00894296|negative symptoms|negative symptoms
5600917|NCT00894283|DVT|dvt
5600918|NCT00894283|PE|pe
5600919|NCT00894283|MRV|mrv
5600920|NCT00894283|bariatric surgery|bariatric surgery
5600921|NCT00894270|Diabetes|diabetes
5600924|NCT00894257|HCV infected pregnant women|hcv infected pregnant women
5600925|NCT00894244|None- Normal healthy upper arm skin will be used.|none- normal healthy upper arm skin will be used.
5600926|NCT00894205|neuropsychological function|neuropsychological function
5600927|NCT00894205|cognitive function|cognitive function
5600928|NCT00894205|exercise|exercise
5600929|NCT00894205|older adult|older adult
5600930|NCT00894192|This study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.|this study tests functional ability of patients with refractive error or normal vision while using different types of eyeglasses.
5600931|NCT00894179|coronary artery disease|coronary artery disease
5600932|NCT00894179|stress echocardiography|stress echocardiography
5600933|NCT00894179|regadenoson|regadenoson
5600934|NCT00894179|atropine|atropine
5600935|NCT00894179|coronary angiogram|coronary angiogram
5600936|NCT00894166|Smoking Cessation|smoking cessation
5600937|NCT00894166|Chantix|chantix
5600938|NCT00894166|varenicline|varenicline
5600939|NCT00894166|Nicotine Replacement Therapy|nicotine replacement therapy
5600940|NCT00894166|Nicotine Patches|nicotine patches
5600941|NCT00894166|Zyban|zyban
5600942|NCT00894166|bupropion|bupropion
5600943|NCT00894166|Quit Smoking|quit smoking
5600944|NCT00894153|p53 gene|p53 gene
5600945|NCT00894153|head and neck malignent tumors|head and neck malignent tumors
5600946|NCT00894153|gene therapy|gene therapy
5600947|NCT00894140|Hip|hip
5600948|NCT00894140|Cementless|cementless
5600949|NCT00894140|Conservative|conservative
5600950|NCT00894127|Lung Cancer|lung cancer
5600951|NCT00894127|Porphyrin|porphyrin
5600952|NCT00894127|Fluorescence|fluorescence
5600953|NCT00894127|Diagnostic|diagnostic
5600954|NCT00894127|Sputum Cytology|sputum cytology
5600955|NCT00894127|Early Detection|early detection
5600958|NCT00894075|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5600960|NCT00894075|osteomalacia|osteomalacia
5600961|NCT00894036|esbl children Switzerland|esbl children switzerland
5600962|NCT00894036|Colonization|colonization
5600963|NCT00894036|ESBL-producing gram-negative bacilli|esbl-producing gram-negative bacilli
5600964|NCT00894036|Infection|infection
5600965|NCT00894023|Patients with AMI|patients with ami
5600966|NCT00894010|Photosensitive epilepsy|photosensitive epilepsy
5600967|NCT00894010|Photosensitivity|photosensitivity
5600968|NCT00894010|Seizures|seizures
5600969|NCT00894010|Epilepsy|epilepsy
5600970|NCT00893997|myelodysplastic syndrome|myelodysplastic syndrome
5600971|NCT00893997|MDS|mds
5600972|NCT00893997|PR1 Peptide Vaccine|pr1 peptide vaccine
5600973|NCT00893984|Intolerance|intolerance
5600974|NCT00893984|Beta blocker|beta blocker
5600975|NCT00893971|Healthy Volunteers|healthy volunteers
5600976|NCT00893932|SIRS leptin outcome sepsis|sirs leptin outcome sepsis
5600977|NCT00893906|influenza|influenza
5600978|NCT00893906|influenza vaccine|influenza vaccine
5600979|NCT00893906|vaccine effectiveness|vaccine effectiveness
5600980|NCT00893906|cluster randomized|cluster randomized
5600981|NCT00893906|Africa|africa
5600982|NCT00893893|Obesity|obesity
5600983|NCT00893893|Lipid metabolism|lipid metabolism
5600984|NCT00893893|VLDL|vldl
5600985|NCT00893880|Tinea Pedis|tinea pedis
5600986|NCT00893880|Athletes Foot|athletes foot
5600987|NCT00893880|Nitric Oxide|nitric oxide
5600988|NCT00893867|acute ischemic stroke|acute ischemic stroke
5600989|NCT00893867|neuroprotective agent|neuroprotective agent
5600990|NCT00893841|bipolar|bipolar
5600991|NCT00893841|bipolar depression|bipolar depression
5600992|NCT00893841|bipolar disorder|bipolar disorder
5600993|NCT00893841|depression|depression
5600994|NCT00893841|quetiapine|quetiapine
5600995|NCT00893841|pramipexole|pramipexole
5600996|NCT00893841|Seroquel XR|seroquel xr
5600997|NCT00893841|Mirapex|mirapex
5600998|NCT00893815|HIV|hiv
5600999|NCT00893815|Neurocognitive function|neurocognitive function
5601000|NCT00893802|periodontal disease|periodontal disease
5601001|NCT00893802|pregnancy|pregnancy
5601002|NCT00893802|periodontal treatment|periodontal treatment
5601003|NCT00893763|Nosocomial (Hospital-Acquired) Infections|nosocomial (hospital-acquired) infections
5601004|NCT00893763|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5601005|NCT00893763|Mechanical ventilation|mechanical ventilation
5601006|NCT00893763|Endotracheal intubation|endotracheal intubation
5601007|NCT00893750|Vulnerable Youths in Northern Uganda|vulnerable youths in northern uganda
5601008|NCT00893750|Formerly Abducted Children|formerly abducted children
5601009|NCT00893750|Reintegration and Reconciliation|reintegration and reconciliation
5601010|NCT00893750|Trauma Treatment|trauma treatment
5601011|NCT00893750|Narrative Exposure Therapy|narrative exposure therapy
5601012|NCT00893750|Reconciliation|reconciliation
5601013|NCT00893750|Revenge Feelings|revenge feelings
5601015|NCT00893737|Headache, Migraine|headache, migraine
5601016|NCT00893724|DME|dme
5601017|NCT00893724|NAMD|namd
5601018|NCT00893724|Oxidative damage|oxidative damage
5601019|NCT00893724|Nutritional supplements/vitamins|nutritional supplements/vitamins
5601020|NCT00893724|DNA repair|dna repair
5601021|NCT00893724|NAMD/wet AMD|namd/wet amd
5601022|NCT00893711|infantile colic|infantile colic
5601023|NCT00893711|lactobacillus|lactobacillus
5601024|NCT00893711|gut microflora|gut microflora
5601025|NCT00893711|FISH|fish
5601026|NCT00893711|toll like receptor|toll like receptor
5601027|NCT00893711|T reg|t reg
5601028|NCT00893711|messenger RNA|messenger rna
5601029|NCT00893711|CC‑chemokine receptor 7|cc‑chemokine receptor 7
5601030|NCT00893711|interleukin 10|interleukin 10
5601031|NCT00893685|Telemedicine|telemedicine
5601032|NCT00893672|Radiography, Thoracic|radiography, thoracic
5601033|NCT00893672|Intensive Care Units|intensive care units
5601034|NCT00893672|Ventilation, mechanical|ventilation, mechanical
5601035|NCT00893672|Matched-Pair Analysis|matched-pair analysis
5601036|NCT00893659|Beta-glucan|beta-glucan
5601037|NCT00893659|faecal microflora|faecal microflora
5601038|NCT00893659|polypectomized|polypectomized
5601039|NCT00893659|Precancerous Nonmalignant Condition|precancerous nonmalignant condition
5601040|NCT00893646|abdominal obesity|abdominal obesity
5601041|NCT00893646|weight reduction|weight reduction
5601042|NCT00893646|diet|diet
5601043|NCT00893646|exercise training|exercise training
5601044|NCT00893646|lifestyle activity|lifestyle activity
5601045|NCT00893646|health-related fitness|health-related fitness
5601046|NCT00893646|walking|walking
5601047|NCT00893646|actigraphy|actigraphy
5601048|NCT00893646|lifestyle modification|lifestyle modification
5601049|NCT00893646|sleep|sleep
5601050|NCT00893646|sleep hygiene|sleep hygiene
5601051|NCT00893646|alertness|alertness
5601052|NCT00893646|daytime sleepiness|daytime sleepiness
5596114|NCT00906399|SC|sc
5601054|NCT00893646|counselling|counselling
5601055|NCT00893646|health education|health education
5601056|NCT00893646|truck drivers|truck drivers
5601057|NCT00893646|bus drivers|bus drivers
5601058|NCT00893646|randomized controlled trial|randomized controlled trial
5601059|NCT00893633|neuromuscular diseases|neuromuscular diseases
5601060|NCT00893633|critical illness|critical illness
5601061|NCT00893633|mechanical ventilation|mechanical ventilation
5601062|NCT00893633|phrenic nerve|phrenic nerve
5601063|NCT00893633|nerve conduction studies|nerve conduction studies
5601064|NCT00893620|iliac aneurysm|iliac aneurysm
5601065|NCT00893620|endovascular repair|endovascular repair
5601066|NCT00893594|migraine|migraine
5601067|NCT00893594|migraine with aura|migraine with aura
5601068|NCT00893594|headache|headache
5601069|NCT00893581|mania|mania
5601070|NCT00893581|adolescent|adolescent
5601071|NCT00893581|bipolar|bipolar
5601072|NCT00893568|Post traumatic stress disorder PTSD|post traumatic stress disorder ptsd
5601073|NCT00893555|Invasive fungal infection|invasive fungal infection
5601074|NCT00893555|hematological malignancy|hematological malignancy
5601075|NCT00893555|voriconazole|voriconazole
5601076|NCT00893555|therapeutic drug monitoring|therapeutic drug monitoring
5601077|NCT00893529|overweight|overweight
5601078|NCT00893529|children|children
5601079|NCT00893529|intervention|intervention
5601080|NCT00893529|sugar-sweetened beverages|sugar-sweetened beverages
5601081|NCT00893516|non cutaneous peripheral t-cell lymphoma with nodal involvement|non cutaneous peripheral t-cell lymphoma with nodal involvement
5601082|NCT00893477|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5601083|NCT00893477|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5601084|NCT00893477|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5601085|NCT00893477|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5601086|NCT00893477|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5601087|NCT00893477|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5601088|NCT00893477|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5601089|NCT00893477|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5601090|NCT00893477|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5601091|NCT00893451|renal disease|renal disease
5601092|NCT00893451|renal impairment|renal impairment
5601093|NCT00893451|chronic kidney disease stage 3-4|chronic kidney disease stage 3-4
5601094|NCT00893451|25(OH) vitamin D|25(oh) vitamin d
5601095|NCT00893451|cholecalciferol|cholecalciferol
5601096|NCT00893451|vitamin D deficiency|vitamin d deficiency
5601097|NCT00893451|insulin resistance|insulin resistance
5601098|NCT00893451|insulin-glucose clamp|insulin-glucose clamp
5601099|NCT00893451|non-diabetic|non-diabetic
5601100|NCT00893438|Chronic Fatigue Syndrome (CFS)|chronic fatigue syndrome (cfs)
5601101|NCT00893438|Adolescence|adolescence
5601102|NCT00893438|Cognitive behaviour therapy (CBT)|cognitive behaviour therapy (cbt)
5601103|NCT00893438|Web-based|web-based
5601104|NCT00893438|Internet|internet
5601105|NCT00893438|Efficacy|efficacy
5601106|NCT00893425|CD95|cd95
5601107|NCT00893425|ADMA|adma
5601108|NCT00893425|proteinuria|proteinuria
5601109|NCT00893425|diabetic nephropathy|diabetic nephropathy
5601110|NCT00893425|CD95 and ADMA levels|cd95 and adma levels
5601111|NCT00893412|HSG|hsg
5601112|NCT00893412|analgesia|analgesia
5601113|NCT00893412|tramadol|tramadol
5601114|NCT00893412|metal cannula|metal cannula
5601115|NCT00893412|balloon catheter|balloon catheter
5601116|NCT00893399|adult patients|adult patients
5601117|NCT00893399|NPM1 mutation|npm1 mutation
5601118|NCT00893386|Extraction|extraction
5601119|NCT00893386|Removal|removal
5601120|NCT00893386|Lead|lead
5601121|NCT00893386|Heart Failure|heart failure
5601122|NCT00893373|AML|aml
5601123|NCT00893373|sorafenib|sorafenib
5601124|NCT00893360|Adult Stem cells|adult stem cells
5601125|NCT00893360|Cardiosphere derived stem cells|cardiosphere derived stem cells
5601126|NCT00893360|Myocardial infarction|myocardial infarction
5601127|NCT00893347|Mild traumatic brain injury|mild traumatic brain injury
5601128|NCT00893347|Concussion|concussion
5601129|NCT00893347|Post-Concussion Syndrome|post-concussion syndrome
5601130|NCT00893347|Cognitive-Behavioural Therapy|cognitive-behavioural therapy
5601131|NCT00893334|Duchenne and Becker muscular dystrophy|duchenne and becker muscular dystrophy
5601132|NCT00893334|muscular dystrophy|muscular dystrophy
5685454|NCT00556036|depression|depression
5601133|NCT00893295|colon cancer|colon cancer
5601134|NCT00893295|rectal cancer|rectal cancer
5601135|NCT00893282|renal|renal
5601136|NCT00893282|calculi|calculi
5601137|NCT00893282|kidney|kidney
5601138|NCT00893282|stones|stones
5601139|NCT00893269|marijuana|marijuana
5601140|NCT00893269|cannabis|cannabis
5601141|NCT00893269|dependence|dependence
5601142|NCT00893269|withdrawal|withdrawal
5601143|NCT00893256|schizophrenia|schizophrenia
5601144|NCT00893256|risperidone|risperidone
5601145|NCT00893256|citalopram|citalopram
5601146|NCT00893256|secondary negative symptoms|secondary negative symptoms
5601147|NCT00893230|atopic dermatitis|atopic dermatitis
5601150|NCT00893178|eNOS Polymorphism|enos polymorphism
5601151|NCT00893178|TNF alpha polymorphism|tnf alpha polymorphism
5601152|NCT00893178|pulmonary pressure|pulmonary pressure
5601153|NCT00893178|polymorphism of vasoactive substances|polymorphism of vasoactive substances
5601154|NCT00893165|inflammation|inflammation
5601155|NCT00893165|cardiovascular disease|cardiovascular disease
5601156|NCT00893139|Dry Eye|dry eye
5601157|NCT00893126|psoriasis|psoriasis
5601158|NCT00893126|coronary arteriosclerosis|coronary arteriosclerosis
5601159|NCT00893126|coronary events|coronary events
5601160|NCT00893126|rheumatoid arthritis|rheumatoid arthritis
5601161|NCT00893126|arthritis|arthritis
5601162|NCT00893087|Ventilatory care, children, intensive care, asynchrony, triggering|ventilatory care, children, intensive care, asynchrony, triggering
5601163|NCT00893087|Children needing ventilatory care|children needing ventilatory care
5601164|NCT00893074|withdrawal|withdrawal
5601165|NCT00893074|acute effects|acute effects
5601166|NCT00893074|cognitive performance|cognitive performance
5601167|NCT00893074|Marijuana Use|marijuana use
5601168|NCT00893074|Marijuana Abstinence|marijuana abstinence
5601169|NCT00893061|stage IA breast cancer|stage ia breast cancer
5601170|NCT00893061|stage IB breast cancer|stage ib breast cancer
5601171|NCT00893061|stage II breast cancer|stage ii breast cancer
5601172|NCT00893061|stage IIIA breast cancer|stage iiia breast cancer
5601173|NCT00893061|stage IIIB breast cancer|stage iiib breast cancer
5601174|NCT00893061|stage IIIC breast cancer|stage iiic breast cancer
5601175|NCT00893061|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5601176|NCT00893061|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5601177|NCT00893048|prednisone|prednisone
5601178|NCT00893048|cellulitis|cellulitis
5601179|NCT00893048|erysipelas|erysipelas
5601180|NCT00893048|steroids|steroids
5601181|NCT00893048|oral|oral
5601182|NCT00893035|Radiotherapy|radiotherapy
5601183|NCT00893035|Late side effects|late side effects
5601184|NCT00893035|Predictive assay|predictive assay
5601185|NCT00893009|Forced expiratory volume in one second|forced expiratory volume in one second
5601186|NCT00893009|Inspiratory capacity|inspiratory capacity
5601187|NCT00893009|endurance time|endurance time
5601188|NCT00893009|residual volume|residual volume
5601189|NCT00892996|Intrathecal morphine|intrathecal morphine
5601190|NCT00892996|Cesarean section|cesarean section
5601191|NCT00892996|Nausea and vomiting|nausea and vomiting
5601192|NCT00892996|Prevention|prevention
5601193|NCT00892983|Obesity|obesity
5601194|NCT00892983|Sleep|sleep
5601195|NCT00892983|Physical activity|physical activity
5601196|NCT00892983|Breast feeding|breast feeding
5601197|NCT00892983|Depression|depression
5601198|NCT00892957|Vascular Surgery|vascular surgery
5601199|NCT00892957|Arterio-arterial bypasses|arterio-arterial bypasses
5601200|NCT00892957|Arterio-venous (AV) shunts|arterio-venous (av) shunts
5601201|NCT00892944|Positron Emission Tomography|positron emission tomography
5601202|NCT00892944|Phase 1|phase 1
5601203|NCT00892944|Healthy volunteers|healthy volunteers
5601204|NCT00892944|AZD2516|azd2516
5601205|NCT00892931|Glioblastoma|glioblastoma
5601207|NCT00892931|Recurrence|recurrence
5601208|NCT00892918|pterygium|pterygium
5601209|NCT00892918|gatifloxacin|gatifloxacin
5601210|NCT00892918|moxifloxacin|moxifloxacin
5601211|NCT00892918|corneal epithelial defect|corneal epithelial defect
5601212|NCT00892905|coagulation|coagulation
5601213|NCT00892905|INR|inr
5601214|NCT00892905|aPTT|aptt
5602128|NCT00889863|arthritis|arthritis
5601215|NCT00892905|point of care|point of care
5601216|NCT00892905|laboratory|laboratory
5601218|NCT00892905|surgery|surgery
5601219|NCT00892892|sympatholytic treatment|sympatholytic treatment
5601220|NCT00892892|sympathetic nerve activity|sympathetic nerve activity
5601221|NCT00892853|calcification|calcification
5601222|NCT00892853|osteoporosis|osteoporosis
5601223|NCT00892827|Rituximab|rituximab
5601224|NCT00892827|Mabthera|mabthera
5601225|NCT00892827|FFP|ffp
5601226|NCT00892827|Fresh Frozen Plasma|fresh frozen plasma
5601227|NCT00892827|CLL|cll
5601228|NCT00892827|Complement|complement
5601229|NCT00892827|Response|response
5601230|NCT00892827|Overall response rate of FFP+Rituximab combined therapy|overall response rate of ffp+rituximab combined therapy
5685455|NCT00556036|exercise|exercise
5685456|NCT00556036|diet|diet
5601231|NCT00892827|Analysis of complement activation pathways prior to, during and|analysis of complement activation pathways prior to, during and
5601232|NCT00892827|after the study treatment.|after the study treatment.
5601233|NCT00892827|Time to disease progression|time to disease progression
5601234|NCT00892827|Time to re-treatment (See Appendix I).|time to re-treatment (see appendix i).
5601235|NCT00892827|Safety of the combination treatment of FFP and RTX.|safety of the combination treatment of ffp and rtx.
5601236|NCT00892801|tumors metastatic to brain|tumors metastatic to brain
5601237|NCT00892801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5601238|NCT00892801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5601239|NCT00892788|Overweight|overweight
5601240|NCT00892788|Obesity|obesity
5601241|NCT00892788|Contingency Management|contingency management
5601243|NCT00892775|Rubella|rubella
5601244|NCT00892775|Mumps|mumps
5601245|NCT00892775|Varicella|varicella
5601246|NCT00892775|Combined measles-mumps-rubella-varicella vaccine|combined measles-mumps-rubella-varicella vaccine
5601247|NCT00892775|Pediatric immunization|pediatric immunization
5601248|NCT00892775|Measles|measles
5601249|NCT00892762|Open Angle Glaucoma|open angle glaucoma
5601250|NCT00892762|Ocular hypertension|ocular hypertension
5601252|NCT00892762|OH|oh
5601253|NCT00892749|hyperphosphatemia|hyperphosphatemia
5601254|NCT00892749|hemodialysis|hemodialysis
5601255|NCT00892749|CKD|ckd
5601256|NCT00892749|ASP1585|asp1585
5601257|NCT00892723|AZX100|azx100
5601258|NCT00892723|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5601259|NCT00892723|POSAS|posas
5601260|NCT00892723|Visual Analog Scale|visual analog scale
5601261|NCT00892723|VAS|vas
5601262|NCT00892723|Keloid|keloid
5601263|NCT00892723|Scarring|scarring
5601264|NCT00892723|Scar reduction|scar reduction
5601265|NCT00892723|Scar prevention|scar prevention
5601266|NCT00892710|Non small cell lung cancer|non small cell lung cancer
5601268|NCT00892710|Pemetrexed|pemetrexed
5601269|NCT00892710|Bevacizumab|bevacizumab
5601270|NCT00892710|Avastin|avastin
5601271|NCT00892710|Carboplatin|carboplatin
5601272|NCT00892710|Stage IIIB/IV|stage iiib/iv
5601273|NCT00892697|hepatitis C|hepatitis c
5601274|NCT00892697|FNA|fna
5601275|NCT00892697|intrahepatic|intrahepatic
5601276|NCT00892684|Randomized|randomized
5601277|NCT00892684|Placebo controlled|placebo controlled
5601278|NCT00892684|Double blind|double blind
5601279|NCT00892684|Omega-3 fatty acids|omega-3 fatty acids
5601280|NCT00892684|Pregnancy|pregnancy
5601281|NCT00892684|Childhood allergy|childhood allergy
5601282|NCT00892684|Cytokines|cytokines
5601283|NCT00892684|Eicosanoids|eicosanoids
5601284|NCT00892684|Polyunsaturated fatty acids|polyunsaturated fatty acids
5601285|NCT00892671|Perceived effectiveness|perceived effectiveness
5601286|NCT00892658|Sorafenib|sorafenib
5601287|NCT00892658|Hepatocellular carcinoma|hepatocellular carcinoma
5601288|NCT00892632|Biliary Strictures|biliary strictures
5601289|NCT00892632|Cholangiocarcinoma|cholangiocarcinoma
5601291|NCT00892619|Epiretinal Membrane|epiretinal membrane
5601292|NCT00892619|Vitreomacular traction|vitreomacular traction
5601293|NCT00892619|MVR blade|mvr blade
5601294|NCT00892619|Tano brush|tano brush
5601295|NCT00892619|ILM forceps|ilm forceps
5601296|NCT00892619|surgical technique|surgical technique
5601297|NCT00892606|Surgery, Orthopedic|surgery, orthopedic
5601298|NCT00892606|Pain, Postoperative|pain, postoperative
5601299|NCT00892593|colon|colon
5601300|NCT00892593|neoplasia|neoplasia
5601302|NCT00892593|adenoma|adenoma
5601303|NCT00892593|FIT|fit
5601304|NCT00892593|cancer|cancer
5601305|NCT00892580|fragile X syndrome|fragile x syndrome
5601306|NCT00892580|biomarkers|biomarkers
5601307|NCT00892567|breast cancer|breast cancer
5601308|NCT00892567|peptide vaccine|peptide vaccine
5601309|NCT00892567|immunotherapy|immunotherapy
5601310|NCT00892554|Phenylketonurias|phenylketonurias
5601311|NCT00892554|Docosahexaenoic Acids|docosahexaenoic acids
5601312|NCT00892554|Neuropsychological Tests|neuropsychological tests
5601314|NCT00892554|Adolescent|adolescent
5601315|NCT00892554|Adult|adult
5601316|NCT00892541|Schizophrenia|schizophrenia
5601317|NCT00892541|Mood disorders|mood disorders
5601318|NCT00892541|Antipsychotic drugs|antipsychotic drugs
5601319|NCT00892541|Renal secretion|renal secretion
5601320|NCT00892541|ER OROS paliperidone|er oros paliperidone
5601321|NCT00892515|breast cancer|breast cancer
5601322|NCT00892515|healthy, no evidence of disease|healthy, no evidence of disease
5601323|NCT00892502|haematology|haematology
5601324|NCT00892502|haematological|haematological
5601325|NCT00892502|hematology|hematology
5601326|NCT00892502|hematological|hematological
5601327|NCT00892502|malignancy|malignancy
5601328|NCT00892502|lymphoma|lymphoma
5601329|NCT00892502|myeloma|myeloma
5601330|NCT00892502|leukemia|leukemia
5601331|NCT00892502|blood diseases|blood diseases
5601332|NCT00892502|malignant|malignant
5601333|NCT00892502|bismuth|bismuth
5685457|NCT00556023|interventional|interventional
5601334|NCT00892489|Schizophrenia, Mood disorders, Antipsychotics|schizophrenia, mood disorders, antipsychotics
5601335|NCT00892489|ER OROS Paliperidone|er oros paliperidone
5601336|NCT00892476|myopia|myopia
5601337|NCT00892476|calcium supplementation|calcium supplementation
5601338|NCT00892476|prematurity|prematurity
5601339|NCT00892463|Major Depressive Disorder|major depressive disorder
5601340|NCT00892463|Seroquel XR|seroquel xr
5601341|NCT00892463|Quetiapine|quetiapine
5601342|NCT00892450|Overactive bladder symptoms|overactive bladder symptoms
5601343|NCT00892450|Parkinson's disease|parkinson's disease
5601344|NCT00892450|darifenacin|darifenacin
5601345|NCT00892450|oxybutynin|oxybutynin
5601346|NCT00892450|cognition|cognition
5601347|NCT00892437|HIV|hiv
5601348|NCT00892437|HIV-1|hiv-1
5601349|NCT00892437|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
5601350|NCT00892424|Liver metastasis|liver metastasis
5601351|NCT00892424|sorafenib|sorafenib
5601352|NCT00892424|Liver metastasis from cancer|liver metastasis from cancer
5601353|NCT00892411|Neuroplasticity|neuroplasticity
5601354|NCT00892411|Prognosis|prognosis
5601355|NCT00892398|Trabeculectomy|trabeculectomy
5601356|NCT00892398|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5601357|NCT00892398|Wound Healing|wound healing
5601358|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors
5601359|NCT00892385|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5601360|NCT00892372|body weight|body weight
5601361|NCT00892372|glycohemoglobin|glycohemoglobin
5601362|NCT00892359|pharmacokinetics|pharmacokinetics
5601363|NCT00892359|renal replacement therapy|renal replacement therapy
5601364|NCT00892359|hemofiltration|hemofiltration
5601365|NCT00892359|anidulafungin|anidulafungin
5601366|NCT00892346|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5601367|NCT00892346|maintenance|maintenance
5601368|NCT00892333|Repair of a large hernia with SurgiMend 3.0, a biologic mesh|repair of a large hernia with surgimend 3.0, a biologic mesh
5601369|NCT00892320|Schizophrenia, mood stabilizers, antipsychotics|schizophrenia, mood stabilizers, antipsychotics
5601370|NCT00892320|ER OROS paliperidone|er oros paliperidone
5601371|NCT00892307|Diagnostic Imaging|diagnostic imaging
5601372|NCT00892307|Dual Source Multidetector Computed Tomography|dual source multidetector computed tomography
5601373|NCT00892307|Computed Tomography|computed tomography
5601375|NCT00892307|Single Photon Emission Computed Tomography|single photon emission computed tomography
5601376|NCT00892307|SPECT|spect
5601377|NCT00892307|Myocardial Perfusion|myocardial perfusion
5601378|NCT00892307|Atherosclerosis|atherosclerosis
5601379|NCT00892268|menopausal symptoms|menopausal symptoms
5601380|NCT00892268|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5601381|NCT00892268|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5601382|NCT00892268|breast cancer|breast cancer
5601383|NCT00892268|pain|pain
5601384|NCT00892255|Liver cancer|liver cancer
5601385|NCT00892255|Tumors|tumors
5601386|NCT00892242|Neoadjuvant zoledronic acid in resectable pancreas cancer|neoadjuvant zoledronic acid in resectable pancreas cancer
5601387|NCT00892229|First trimester missed abortion|first trimester missed abortion
5601388|NCT00892229|Misoprostol|misoprostol
5601389|NCT00892229|buccal|buccal
5601390|NCT00892229|vaginal|vaginal
5601391|NCT00892229|cervical ripening|cervical ripening
5601392|NCT00892229|first trimester|first trimester
5601393|NCT00892229|missed abortion|missed abortion
5601394|NCT00892216|PONV|ponv
5601395|NCT00892216|NUSS procedure|nuss procedure
5601396|NCT00892216|Acupressure|acupressure
5601397|NCT00892216|Pectus Excavatum|pectus excavatum
5601398|NCT00892203|Migraine|migraine
5601399|NCT00892203|Headache|headache
5601400|NCT00892190|AML|aml
5601401|NCT00892190|Dasatinib|dasatinib
5601402|NCT00892190|all trans retinoic acid|all trans retinoic acid
5601403|NCT00892190|relapsed AML|relapsed aml
5601404|NCT00892190|refractory AML|refractory aml
5601405|NCT00892190|Relapsed/Refractory Acute myelogenous leukemia|relapsed/refractory acute myelogenous leukemia
5603861|NCT00882999|MS|ms
5601406|NCT00892190|Elderly subjects (age 65 or older) with acute myelogenous leukemia|elderly subjects (age 65 or older) with acute myelogenous leukemia
5601407|NCT00892190|Myelodysplastic Syndrome|myelodysplastic syndrome
5601408|NCT00892190|MDS|mds
5601409|NCT00892177|adult giant cell glioblastoma|adult giant cell glioblastoma
5601410|NCT00892177|adult glioblastoma|adult glioblastoma
5601411|NCT00892177|adult gliosarcoma|adult gliosarcoma
5601412|NCT00892177|adult mixed glioma|adult mixed glioma
5602301|NCT00889369|duloxetine|duloxetine
5601413|NCT00892177|recurrent adult brain tumor|recurrent adult brain tumor
5601414|NCT00892177|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5601415|NCT00892177|adult oligodendroglioma|adult oligodendroglioma
5601416|NCT00892177|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5601417|NCT00892164|thyroid surgery|thyroid surgery
5601418|NCT00892164|total thyroidectomy|total thyroidectomy
5601419|NCT00892164|harmonic scalpel|harmonic scalpel
5601420|NCT00892164|electrothermal bipolar vessel sealer|electrothermal bipolar vessel sealer
5601421|NCT00892164|hemostatic device|hemostatic device
5601422|NCT00892138|mindfulness training|mindfulness training
5601423|NCT00892138|medical students|medical students
5601424|NCT00892138|psychology students|psychology students
5601425|NCT00892138|stress management|stress management
5601426|NCT00892138|personal development|personal development
5601427|NCT00892138|stress|stress
5601428|NCT00892125|Schizophrenia|schizophrenia
5601429|NCT00892125|Bipolar I disorder|bipolar i disorder
5601430|NCT00892125|mood disorders|mood disorders
5601431|NCT00892125|antipsychotic drugs|antipsychotic drugs
5601432|NCT00892125|enzyme inducer|enzyme inducer
5601433|NCT00892125|Paliperidone ER|paliperidone er
5601434|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5601435|NCT00892112|Cardiomyopathies|cardiomyopathies
5601436|NCT00892112|Parvo B19, Human|parvo b19, human
5601437|NCT00892099|end stage renal disease|end stage renal disease
5601438|NCT00892099|hemodialysis|hemodialysis
5601439|NCT00892086|geriatric syndrome|geriatric syndrome
5601440|NCT00892086|immobility|immobility
5601441|NCT00892073|Craniopharyngioma surgery|craniopharyngioma surgery
5601442|NCT00892073|Hypothalamic Obesity|hypothalamic obesity
5601443|NCT00892073|Children|children
5601444|NCT00892073|Combined Diazoxide and Metformin|combined diazoxide and metformin
5601445|NCT00892047|Depression|depression
5601446|NCT00892047|Aripiprazole|aripiprazole
5601447|NCT00892047|Venlafaxine|venlafaxine
5601448|NCT00892047|Partial Remission|partial remission
5601449|NCT00892047|Augmentation strategy|augmentation strategy
5601450|NCT00892047|Treatment resistance|treatment resistance
5601452|NCT00892047|Late-life|late-life
5601453|NCT00892008|pregabalin|pregabalin
5601454|NCT00892008|neuropathic pain|neuropathic pain
5601455|NCT00892008|safety|safety
5601456|NCT00891995|Type 1 Diabetes|type 1 diabetes
5601457|NCT00891995|Closed Loop Therapy|closed loop therapy
5601458|NCT00891995|Continuous Glucose Monitor|continuous glucose monitor
5601459|NCT00891982|Acne Vulgaris|acne vulgaris
5601460|NCT00891969|stage I breast cancer|stage i breast cancer
5601461|NCT00891969|stage II breast cancer|stage ii breast cancer
5601462|NCT00891969|stage IIIA breast cancer|stage iiia breast cancer
5601463|NCT00891956|Rett Syndrome|rett syndrome
5601464|NCT00891943|Obesity|obesity
5601465|NCT00891943|Overweight|overweight
5601466|NCT00891943|Randomised controlled trial|randomised controlled trial
5601467|NCT00891943|Primary Care|primary care
5601468|NCT00891943|Weight|weight
5601469|NCT00891943|Cardiovascular Risk|cardiovascular risk
5601470|NCT00891943|Diabetes|diabetes
5601471|NCT00891943|Quality of life|quality of life
5601472|NCT00891930|wild-type KRAS|wild-type kras
5601473|NCT00891930|panitumumab|panitumumab
5601474|NCT00891930|biomarker|biomarker
5601475|NCT00891930|mechanisms of acquired resistance|mechanisms of acquired resistance
5601476|NCT00891930|metastatic colorectal cancer|metastatic colorectal cancer
5601477|NCT00891917|Down syndrome|down syndrome
5601478|NCT00891917|coenzyme Q10|coenzyme q10
5601479|NCT00891917|language function|language function
5601480|NCT00891917|behavior|behavior
5601481|NCT00891904|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5601482|NCT00891904|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5601483|NCT00891904|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5601484|NCT00891904|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5601485|NCT00891904|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5671595|NCT00615355|narrow-band UVB|narrow-band uvb
5671596|NCT00615355|ReCell|recell
5601486|NCT00891904|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5601487|NCT00891891|spina bifida, psychosocial adjustment, adolescence, emerging adulthood|spina bifida, psychosocial adjustment, adolescence, emerging adulthood
5601488|NCT00891878|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5601489|NCT00891878|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5601490|NCT00891878|recurrent esophageal cancer|recurrent esophageal cancer
5601491|NCT00891878|stage IV esophageal cancer|stage iv esophageal cancer
5601492|NCT00891878|stage III esophageal cancer|stage iii esophageal cancer
5601493|NCT00891865|lung transplant|lung transplant
5601495|NCT00891865|OB|ob
5601496|NCT00891865|Respiratory Viral Infection (RVI)|respiratory viral infection (rvi)
5601497|NCT00891865|Lung disease|lung disease
5601498|NCT00891826|Bipolar disorders|bipolar disorders
5601499|NCT00891826|Omega-3 fatty acids|omega-3 fatty acids
5601500|NCT00891826|Heart rate|heart rate
5601501|NCT00891800|Cancer|cancer
5601502|NCT00891800|Breast|breast
5601503|NCT00891800|Liver|liver
5601505|NCT00891787|Isoagglutinins|isoagglutinins
5601506|NCT00891787|Anti-A|anti-a
5601507|NCT00891787|Anti-B|anti-b
5601508|NCT00891787|Hemolysis|hemolysis
5601509|NCT00891787|Healthy Volunteer|healthy volunteer
5601510|NCT00891787|HV|hv
5601511|NCT00891761|cisplatin|cisplatin
5601512|NCT00891761|nausea|nausea
5601513|NCT00891761|vomiting|vomiting
5601514|NCT00891761|cancer|cancer
5601515|NCT00891761|lung cancer|lung cancer
5601516|NCT00891735|Lucentis|lucentis
5601518|NCT00891735|Age-related macular degeneration|age-related macular degeneration
5601519|NCT00891735|Subfoveal neovascular age-related macular degeneration|subfoveal neovascular age-related macular degeneration
5601520|NCT00891735|Wet AMD|wet amd
5601521|NCT00891735|Macular degeneration|macular degeneration
5601522|NCT00891735|Ranibizumab|ranibizumab
5601523|NCT00891722|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5601524|NCT00891722|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5601525|NCT00891722|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5601526|NCT00891722|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5601527|NCT00891722|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5601528|NCT00891722|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5601529|NCT00891722|childhood oligodendroglioma|childhood oligodendroglioma
5863011|NCT00001417|Vertebral Hemangioma|vertebral hemangioma
5601530|NCT00891722|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5601531|NCT00891722|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5601532|NCT00891722|childhood mixed glioma|childhood mixed glioma
5601533|NCT00891696|Sarcopenia|sarcopenia
5601534|NCT00891696|Aging|aging
5601535|NCT00891696|Metabolism|metabolism
5601536|NCT00891696|Muscle|muscle
5601537|NCT00891696|mTOR|mtor
5601538|NCT00891696|Essential Amino Acids|essential amino acids
5601539|NCT00891696|Exercise|exercise
5601540|NCT00891696|Rapamycin|rapamycin
5601541|NCT00891683|Diabetic|diabetic
5601542|NCT00891683|peripheral|peripheral
5601543|NCT00891683|neuropathy|neuropathy
5601544|NCT00891683|pain|pain
5601545|NCT00891683|hyperalgesia|hyperalgesia
5601546|NCT00891683|allodynia|allodynia
5601547|NCT00891670|CYP2C19 polymorphism|cyp2c19 polymorphism
5601548|NCT00891670|platelet|platelet
5601549|NCT00891670|Adjunctive cilostazol|adjunctive cilostazol
5587267|NCT00941915|Radiation|radiation
5601550|NCT00891670|high maintenance dose clopidogrel|high maintenance dose clopidogrel
5601551|NCT00891670|P2Y12 Reaction Unit|p2y12 reaction unit
5601552|NCT00891657|Adhesion|adhesion
5601553|NCT00891657|Fibroid|fibroid
5601554|NCT00891657|Myoma|myoma
5601555|NCT00891657|Leiomyoma|leiomyoma
5601556|NCT00891657|Myomectomy|myomectomy
5601557|NCT00891644|HIV|hiv
5601558|NCT00891644|Care-seeking|care-seeking
5601559|NCT00891631|tobacco|tobacco
5601560|NCT00891631|alcohol|alcohol
5601561|NCT00891631|marijuana|marijuana
5601562|NCT00891631|drug use|drug use
5601563|NCT00891631|seat-belt|seat-belt
5601564|NCT00891631|weapons|weapons
5601565|NCT00891631|depression|depression
5601566|NCT00891631|suicidality|suicidality
5601567|NCT00891631|sexual risk behaviors|sexual risk behaviors
5601568|NCT00891618|Lymphoma|lymphoma
5601569|NCT00891618|Myeloma|myeloma
5601570|NCT00891618|Multiple Myeloma|multiple myeloma
5601571|NCT00891618|MM|mm
5601572|NCT00891618|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5601573|NCT00891618|NHL|nhl
5601574|NCT00891618|Acupuncture|acupuncture
5601575|NCT00891618|Treatment-induced Peripheral Neuropathy|treatment-induced peripheral neuropathy
5601576|NCT00891618|Thalidomide|thalidomide
5601577|NCT00891618|Bortezomib|bortezomib
5601578|NCT00891618|Neuropathy|neuropathy
5601579|NCT00891618|Peripheral Neuropathy|peripheral neuropathy
5601580|NCT00891605|Paclitaxel|paclitaxel
5601581|NCT00891605|Solid Tumors|solid tumors
5601582|NCT00891592|AML|aml
5601583|NCT00891592|MDS|mds
5601584|NCT00891592|ALL|all
5601585|NCT00891592|NHL|nhl
5601586|NCT00891592|Multiple Myeloma|multiple myeloma
5601587|NCT00891592|Hodgkin's|hodgkin's
5601588|NCT00891579|NSCLC|nsclc
5601589|NCT00891579|EGFR|egfr
5601590|NCT00891579|Pemetrexed|pemetrexed
5601591|NCT00891579|Gefitinib|gefitinib
5601592|NCT00891579|without EGFR mutations|without egfr mutations
5601593|NCT00891566|medium to large tear|medium to large tear
5601594|NCT00891566|rotator cuff tear|rotator cuff tear
5601595|NCT00891566|arthroscopic repair|arthroscopic repair
5601596|NCT00891566|repair integrity|repair integrity
5601597|NCT00891566|immobilization|immobilization
5601598|NCT00891553|bone mineral density|bone mineral density
5601599|NCT00891553|calcium-sensing receptor antagonist|calcium-sensing receptor antagonist
5601600|NCT00891553|ronacaleret|ronacaleret
5601601|NCT00891553|postmenopausal osteoporosis|postmenopausal osteoporosis
5601602|NCT00891527|Pulmonary Vein Stenosis,|pulmonary vein stenosis,
5601603|NCT00891527|Avastin and Gleevec,|avastin and gleevec,
5601604|NCT00891527|Targeting VEGF and PDGF|targeting vegf and pdgf
5601605|NCT00891514|Exercise|exercise
5601606|NCT00891514|Inflammation|inflammation
5601607|NCT00891514|Insulin Sensitivity|insulin sensitivity
5601608|NCT00891501|autologous bone marrow mesenchymal stem cells|autologous bone marrow mesenchymal stem cells
5601609|NCT00891501|cartilage repair|cartilage repair
5601610|NCT00891501|osteoarthritis|osteoarthritis
5601611|NCT00891501|osteochondral defects|osteochondral defects
5601612|NCT00891488|VO2 max|vo2 max
5601613|NCT00891488|stress|stress
5601614|NCT00891488|cortisol|cortisol
5601615|NCT00891488|fitness|fitness
5601616|NCT00891475|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5601617|NCT00891475|radiofrequency ablation|radiofrequency ablation
5601618|NCT00891462|COPD|copd
5601619|NCT00891462|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5601620|NCT00891462|Chronic Bronchitis|chronic bronchitis
5601621|NCT00891462|Emphysema|emphysema
5601622|NCT00891462|Airflow Obstruction, Chronic|airflow obstruction, chronic
5601623|NCT00891462|Chronic Airflow Obstruction|chronic airflow obstruction
5601624|NCT00891462|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5601625|NCT00891462|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5601626|NCT00891449|space flight simulation study|space flight simulation study
5601627|NCT00891449|medical research study|medical research study
5601628|NCT00891449|bed rest|bed rest
5601629|NCT00891449|microgravity|microgravity
5601630|NCT00891449|weightlessness|weightlessness
5863012|NCT00001417|Spinal Metastasis|spinal metastasis
5601631|NCT00891449|The effects of long duration microgravity on humans|the effects of long duration microgravity on humans
5601632|NCT00891423|Meropenem|meropenem
5601633|NCT00891423|extended infusion|extended infusion
5601634|NCT00891423|prolonged infusion|prolonged infusion
5601635|NCT00891423|Time above MIC|time above mic
5601636|NCT00891397|CPRS|cprs
5601637|NCT00891397|stellate ganglion block|stellate ganglion block
5601638|NCT00891397|pregabalin|pregabalin
5601639|NCT00891397|pain|pain
5601640|NCT00891397|Type I|type i
5601641|NCT00891384|Multiple Myeloma|multiple myeloma
5601642|NCT00891384|maintenance therapy|maintenance therapy
5601643|NCT00891384|lenalidomide|lenalidomide
5601644|NCT00891371|symptomatic treatment of patients with refractory diarrhea|symptomatic treatment of patients with refractory diarrhea
5601645|NCT00891358|Adolescent Medicine Trials Network for HIV/AIDS Interventions|adolescent medicine trials network for hiv/aids interventions
5601646|NCT00891358|Human Immunodeficiency Virus|human immunodeficiency virus
5601647|NCT00891358|HIV seronegativity|hiv seronegativity
5584673|NCT00951093|GERD|gerd
5601648|NCT00891345|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5601649|NCT00891345|Immunotherapy|immunotherapy
5601650|NCT00891319|hand|hand
5601651|NCT00891319|stroke|stroke
5601652|NCT00891319|hemiplegia|hemiplegia
5601653|NCT00891319|electrical stimulation|electrical stimulation
5601654|NCT00891319|recovery|recovery
5601655|NCT00891306|LPLD, Lipoprotein Lipase Deficiency|lpld, lipoprotein lipase deficiency
5601656|NCT00891306|Chylomicronemia|chylomicronemia
5601657|NCT00891306|Gene therapy|gene therapy
5601659|NCT00891306|Lipoprotein Lipase|lipoprotein lipase
5601660|NCT00891306|Alipogene tiparvovec|alipogene tiparvovec
5601661|NCT00891306|AMT-011|amt-011
5601662|NCT00891293|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5601663|NCT00891293|Very high triglycerides|very high triglycerides
5601664|NCT00891293|Lovaza|lovaza
5601665|NCT00891293|fenofibrate|fenofibrate
5601666|NCT00891280|Inflammatory breast cancer|inflammatory breast cancer
5601667|NCT00891280|Castleman's Disease|castleman's disease
5601668|NCT00891280|Multiple Myeloma|multiple myeloma
5601669|NCT00891280|Breast cancer|breast cancer
5601670|NCT00891280|Solid tumors|solid tumors
5601671|NCT00891280|CK2 inhibitor|ck2 inhibitor
5601672|NCT00891267|Inflammatory markers|inflammatory markers
5601673|NCT00891267|Vascular protection|vascular protection
5601674|NCT00891267|OM Effect|om effect
5601675|NCT00891267|Metabolic syndrome|metabolic syndrome
5601676|NCT00891267|Hypertension|hypertension
5601677|NCT00891254|Incisional hernia|incisional hernia
5601678|NCT00891254|Intraperitoneal mesh repair|intraperitoneal mesh repair
5601679|NCT00891254|On-lay repair|on-lay repair
5601680|NCT00891254|Prosthetic mesh|prosthetic mesh
5784998|NCT00169767|BPH|bph
5601681|NCT00891254|First repair (no recurrent hernia will be included)|first repair (no recurrent hernia will be included)
5601682|NCT00891254|Recurrence|recurrence
5601683|NCT00891254|Complications|complications
5601684|NCT00891241|Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry|heart failure, pet imaging, implantable cardioverter-defibrillator, dosimetry
5601685|NCT00891228|Contraception|contraception
5601686|NCT00891228|Male Contraception|male contraception
5601687|NCT00891228|Suppression of Sperm Production|suppression of sperm production
5601688|NCT00891202|Gaucher,|gaucher,
5601689|NCT00891202|beta-glucosidase,|beta-glucosidase,
5601690|NCT00891202|acid ß-glucosidase,|acid ß-glucosidase,
5601691|NCT00891202|glucocerebrosidase,|glucocerebrosidase,
5601692|NCT00891202|glucosylceramide,|glucosylceramide,
5601693|NCT00891202|D-glucosyl-N-acylsphingosine glucohydrolase,|d-glucosyl-n-acylsphingosine glucohydrolase,
5601694|NCT00891202|substrate reduction therapy|substrate reduction therapy
5601695|NCT00891189|Circadian Rhythm|circadian rhythm
5601696|NCT00891176|Conjugate vaccines|conjugate vaccines
5601697|NCT00891176|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5601698|NCT00891176|Antibody persistence|antibody persistence
5601699|NCT00891176|Pneumococcal vaccine|pneumococcal vaccine
5601700|NCT00891176|Haemophilus Influenzae type b vaccine|haemophilus influenzae type b vaccine
5601701|NCT00891163|Topical anesthesia|topical anesthesia
5601703|NCT00891137|adult acute myeloid leukemia 11q23 (MLL) abnormalities|adult acute myeloid leukemia 11q23 (mll) abnormalities
5601704|NCT00891137|adult acute myeloid leukemia inv(16)(p13;q22)|adult acute myeloid leukemia inv(16)(p13;q22)
5601705|NCT00891137|adult acute myeloid leukemia t(15;17)(q22;q12)|adult acute myeloid leukemia t(15;17)(q22;q12)
5601706|NCT00891137|adult acute myeloid leukemia t(16;16)(p13;q22)|adult acute myeloid leukemia t(16;16)(p13;q22)
5601707|NCT00891137|adult acute myeloid leukemia t(8;21)(q22;q22)|adult acute myeloid leukemia t(8;21)(q22;q22)
5601708|NCT00891137|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5601709|NCT00891137|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5601710|NCT00891137|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5601711|NCT00891137|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5601712|NCT00891137|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5601713|NCT00891137|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5596785|NCT00903916|PYY|pyy
5601715|NCT00891137|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5601716|NCT00891137|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5601717|NCT00891137|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5601718|NCT00891137|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5601719|NCT00891137|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
5601720|NCT00891137|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
5601721|NCT00891137|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5601722|NCT00891137|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5601723|NCT00891137|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5601724|NCT00891137|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5601725|NCT00891137|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5601726|NCT00891137|noncontiguous stage II adult immunoblastic|noncontiguous stage ii adult immunoblastic
5601727|NCT00891137|contiguous stage II adult immunoblastic|contiguous stage ii adult immunoblastic
5601728|NCT00891137|large cell lymphoma|large cell lymphoma
5601729|NCT00891137|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5601730|NCT00891137|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5601731|NCT00891137|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5601732|NCT00891137|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5601733|NCT00891137|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5601734|NCT00891137|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5601735|NCT00891137|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5601736|NCT00891137|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5601737|NCT00891137|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5601738|NCT00891137|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5601739|NCT00891137|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5601740|NCT00891137|refractory multiple myeloma|refractory multiple myeloma
5601741|NCT00891137|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5601742|NCT00891137|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5601743|NCT00891137|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5601744|NCT00891137|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5601745|NCT00891137|stage I multiple myeloma|stage i multiple myeloma
5601746|NCT00891137|stage II multiple myeloma|stage ii multiple myeloma
5601747|NCT00891137|stage III multiple myeloma|stage iii multiple myeloma
5601748|NCT00891137|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5601749|NCT00891137|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5601750|NCT00891137|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5601751|NCT00891137|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5601752|NCT00891137|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5601867|NCT00890851|Men health|men health
5601753|NCT00891137|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5601754|NCT00891137|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5601755|NCT00891137|refractory anemia with excess blasts|refractory anemia with excess blasts
5601757|NCT00891137|prolymphocytic leukemia|prolymphocytic leukemia
5601758|NCT00891137|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5601759|NCT00891137|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5601760|NCT00891137|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5601761|NCT00891137|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5601762|NCT00891137|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5685458|NCT00556023|dose-finding|dose-finding
5601763|NCT00891137|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5602302|NCT00889369|menopause|menopause
5601764|NCT00891137|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5601765|NCT00891137|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5601766|NCT00891137|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5601767|NCT00891137|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5601768|NCT00891137|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5601769|NCT00891137|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5601770|NCT00891137|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5601771|NCT00891137|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5601772|NCT00891137|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5601773|NCT00891137|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5601774|NCT00891137|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5601775|NCT00891137|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5601782|NCT00891137|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5601783|NCT00891137|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5601784|NCT00891137|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5601785|NCT00891137|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5601786|NCT00891137|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5601787|NCT00891137|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5601788|NCT00891137|Burkitt lymphoma|burkitt lymphoma
5601789|NCT00891124|Hypertension|hypertension
5601791|NCT00891124|Hyperlipidemia|hyperlipidemia
5601792|NCT00891124|Glycemia|glycemia
5601793|NCT00891124|ADA 2008 guideline|ada 2008 guideline
5601794|NCT00891124|Patient Consultation|patient consultation
5601795|NCT00891111|Health Risk Assessment|health risk assessment
5601796|NCT00891111|Incentives|incentives
5601797|NCT00891111|Preventative Healthcare|preventative healthcare
5601798|NCT00891111|Encouraging Health Risk Assessments|encouraging health risk assessments
5601799|NCT00891085|ventilation|ventilation
5601800|NCT00891085|ards|ards
5601802|NCT00891085|trauma|trauma
5601803|NCT00891085|Trauma Patients with ISS > 25|trauma patients with iss > 25
5601804|NCT00891059|Cognitive Impairment|cognitive impairment
5601805|NCT00891059|Diskus Inhaler|diskus inhaler
5601806|NCT00891059|Nursing Home|nursing home
5601807|NCT00891046|Flare|flare
5601808|NCT00891046|arthritis|arthritis
5601809|NCT00891046|IL-1beta antagonist|il-1beta antagonist
5601810|NCT00891046|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5601811|NCT00891046|CHAQ|chaq
5601812|NCT00891046|steroids|steroids
5601813|NCT00891046|ACR pediatric response|acr pediatric response
5601814|NCT00891046|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
5601815|NCT00891033|cancer|cancer
5601816|NCT00891007|Measles|measles
5601817|NCT00891007|Virus Disease|virus disease
5601818|NCT00891007|Paediatric Diseases|paediatric diseases
5601819|NCT00891007|Paramyoxyviridae|paramyoxyviridae
5601821|NCT00890994|Molecular Breast Imaging|molecular breast imaging
5601822|NCT00890994|Breast Cancer|breast cancer
5601823|NCT00890994|DCIS|dcis
5601824|NCT00890994|Breast|breast
5601825|NCT00890994|Calcifications|calcifications
5601826|NCT00890994|Microcalcifications|microcalcifications
5601827|NCT00890968|hand dermatitis|hand dermatitis
5601828|NCT00890968|hand eczema|hand eczema
5601829|NCT00890968|triamcinolone acetonide|triamcinolone acetonide
5601830|NCT00890955|Solid tumors|solid tumors
5601831|NCT00890942|pruritus|pruritus
5601832|NCT00890942|intrathecal morphine|intrathecal morphine
5601834|NCT00890929|Acute myeloblastic leukemia|acute myeloblastic leukemia
5601835|NCT00890929|AML|aml
5601836|NCT00890916|spinal cord injury|spinal cord injury
5601837|NCT00890916|neuroprosthesis|neuroprosthesis
5601838|NCT00890916|functional electrical stimulation|functional electrical stimulation
5601839|NCT00890916|quadriplegia|quadriplegia
5601840|NCT00890903|NSCLC|nsclc
5601841|NCT00890903|non small cell lung carcinoma|non small cell lung carcinoma
5601842|NCT00890903|metastatic breast cancer|metastatic breast cancer
5601843|NCT00890903|MBC|mbc
5601844|NCT00890903|advanced breast cancer|advanced breast cancer
5601845|NCT00890903|Navelbine|navelbine
5601846|NCT00890903|Navelbine-ORAL|navelbine-oral
5601847|NCT00890903|Vinorelbine|vinorelbine
5601848|NCT00890903|Vinorelbine-ORAL|vinorelbine-oral
5601849|NCT00890903|daily routine|daily routine
5602027|NCT00890227|Surgical treatment|surgical treatment
5601850|NCT00890903|concomitant antiemetic therapy|concomitant antiemetic therapy
5601851|NCT00890903|patient compliance|patient compliance
5601852|NCT00890903|germany|germany
5601853|NCT00890903|non-interventional study|non-interventional study
5601854|NCT00890903|oral anti cancer therapy|oral anti cancer therapy
5601855|NCT00890903|quality of life|quality of life
5601856|NCT00890877|asthma|asthma
5601857|NCT00890877|treatment|treatment
5601858|NCT00890877|placebo|placebo
5601859|NCT00890877|efficacy|efficacy
5601860|NCT00890877|safety|safety
5601861|NCT00890864|Breast screening|breast screening
5601863|NCT00890864|Routine screening programme|routine screening programme
5601864|NCT00890851|Radiofrequency|radiofrequency
5601865|NCT00890851|Mini invasin surgery|mini invasin surgery
5601866|NCT00890851|Outpatient treatment|outpatient treatment
5601868|NCT00890838|IVFO|ivfo
5601869|NCT00890838|Inflammation|inflammation
5601870|NCT00890838|Valvular surgery|valvular surgery
5601871|NCT00890838|Inflammatory status|inflammatory status
5601872|NCT00890838|Infectious complications|infectious complications
5601873|NCT00890825|Non small cell lung cancer (NSCLC)|non small cell lung cancer (nsclc)
5601874|NCT00890825|KRAS mutation|kras mutation
5601875|NCT00890812|Acute Ischemic Stroke|acute ischemic stroke
5601876|NCT00890799|transcatheter closure|transcatheter closure
5601877|NCT00890799|ventricular septal defects|ventricular septal defects
5601878|NCT00890760|Malaria|malaria
5601879|NCT00890760|Vaccine|vaccine
5601880|NCT00890747|HIV Infections|hiv infections
5601881|NCT00890747|treatment experienced|treatment experienced
5601882|NCT00890721|Hemorrhoid|hemorrhoid
5601883|NCT00890721|Hemorrhoidectomy|hemorrhoidectomy
5601884|NCT00890721|Postoperative pain|postoperative pain
5601885|NCT00890721|Analgesia|analgesia
5601886|NCT00890695|supplementary feeding|supplementary feeding
5601887|NCT00890695|moderate malnutrition|moderate malnutrition
5601888|NCT00890695|acute infection|acute infection
5601889|NCT00890695|developing country|developing country
5601890|NCT00890695|children|children
5601891|NCT00890682|Bunion|bunion
5601892|NCT00890682|Bunionectomy|bunionectomy
5601893|NCT00890682|Osteotomy|osteotomy
5601894|NCT00890669|treadmill training|treadmill training
5601895|NCT00890669|body load|body load
5601896|NCT00890669|quality of life|quality of life
5601897|NCT00890669|Parkinson's disease|parkinson's disease
5601898|NCT00890669|Motor Symptoms|motor symptoms
5601899|NCT00890656|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5601901|NCT00890656|Leukemia|leukemia
5601902|NCT00890656|Hyper-CVAD|hyper-cvad
5601903|NCT00890643|Stress disorders, post-traumatic|stress disorders, post-traumatic
5601904|NCT00890643|Combat Disorders|combat disorders
5601905|NCT00890643|prazosin|prazosin
5601906|NCT00890643|cognition|cognition
5601907|NCT00890643|neurophysiology|neurophysiology
5601908|NCT00890617|lung metastases|lung metastases
5601909|NCT00890617|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5601910|NCT00890591|hypertension|hypertension
5601911|NCT00890591|angiotensin II type 1 receptor blocker|angiotensin ii type 1 receptor blocker
5601912|NCT00890591|olmesartan|olmesartan
5601913|NCT00890578|Histoacryl|histoacryl
5601914|NCT00890578|closure of surgical incisions|closure of surgical incisions
5601915|NCT00890565|Electrocardiogram|electrocardiogram
5601916|NCT00890565|Effect on electrocardiogram|effect on electrocardiogram
5601917|NCT00890565|Granisetron|granisetron
5601918|NCT00890565|Moxifloxacin|moxifloxacin
5601919|NCT00890565|Pharmacokinetic profile|pharmacokinetic profile
5601920|NCT00890565|Sancuso® patch|sancuso® patch
5601921|NCT00890565|Transdermal|transdermal
5601922|NCT00890526|Tinnitus Retraining Therapy (TRT)|tinnitus retraining therapy (trt)
5601923|NCT00890474|Breech presentation at 34 to 36 weeks of gestation|breech presentation at 34 to 36 weeks of gestation
5601924|NCT00890461|ECG|ecg
5601925|NCT00890461|ICD|icd
5601926|NCT00890448|Alanine Transaminase elevation|alanine transaminase elevation
5601927|NCT00890448|Genetic Markers|genetic markers
5601928|NCT00890448|DNA Markers|dna markers
5601929|NCT00890435|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5601930|NCT00890435|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5601931|NCT00890435|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5601932|NCT00890435|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5601933|NCT00890435|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5601934|NCT00890435|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5601935|NCT00890435|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5601936|NCT00890435|recurrent childhood ependymoma|recurrent childhood ependymoma
5601937|NCT00890435|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5601938|NCT00890435|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5601939|NCT00890435|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5601940|NCT00890435|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5601941|NCT00890435|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5601942|NCT00890435|childhood choroid plexus tumor|childhood choroid plexus tumor
5601943|NCT00890435|childhood craniopharyngioma|childhood craniopharyngioma
5601944|NCT00890435|childhood ependymoblastoma|childhood ependymoblastoma
5601945|NCT00890435|childhood medulloepithelioma|childhood medulloepithelioma
5601946|NCT00890435|childhood meningioma|childhood meningioma
5601947|NCT00890435|childhood mixed glioma|childhood mixed glioma
5601948|NCT00890435|childhood oligodendroglioma|childhood oligodendroglioma
5601949|NCT00890435|adult astrocytic tumors|adult astrocytic tumors
5597019|NCT00903045|Propiverin|propiverin
5601978|NCT00890435|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5601979|NCT00890435|refractory hairy cell leukemia|refractory hairy cell leukemia
5601980|NCT00890435|prolymphocytic leukemia|prolymphocytic leukemia
5601981|NCT00890422|encephalitis|encephalitis
5601982|NCT00890422|FSME|fsme
5601983|NCT00890422|central european encephalitis|central european encephalitis
5601984|NCT00890409|hypothermia|hypothermia
5601985|NCT00890409|neonate|neonate
5601986|NCT00890409|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5601987|NCT00890409|efficacy|efficacy
5601988|NCT00890409|safety|safety
5601989|NCT00890396|Sickle Cell Anemia|sickle cell anemia
5601990|NCT00890396|Hydroxyurea|hydroxyurea
5601991|NCT00890383|trauma resuscitation|trauma resuscitation
5601992|NCT00890383|abdominal hypertension|abdominal hypertension
5601993|NCT00890383|abdominal compartment syndrome|abdominal compartment syndrome
5601995|NCT00890370|Airway clearance|airway clearance
5601996|NCT00890344|PeaPod|peapod
5601998|NCT00890344|Anthropometry|anthropometry
5601999|NCT00890344|Body Composition|body composition
5602000|NCT00890344|Fat Mass|fat mass
5602001|NCT00890344|Total Body Water|total body water
5602002|NCT00890344|Neonatology|neonatology
5602003|NCT00890305|Metastatic colorectal cancer|metastatic colorectal cancer
5602004|NCT00890305|FOLFOX chemotherapy|folfox chemotherapy
5602005|NCT00890292|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5602006|NCT00890292|ADHD|adhd
5602007|NCT00890292|JNJ-31001074|jnj-31001074
5602008|NCT00890279|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5602009|NCT00890279|Hypertension|hypertension
5602010|NCT00890279|Angiotensin-II Receptor Blocker|angiotensin-ii receptor blocker
5602011|NCT00890279|Calcium Channel Blocker|calcium channel blocker
5602012|NCT00890279|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5602013|NCT00890279|Kidney Volume|kidney volume
5602014|NCT00890279|eGFR|egfr
5602015|NCT00890266|keratoconus|keratoconus
5602016|NCT00890266|collagen cross-linking|collagen cross-linking
5602017|NCT00890266|riboflavin|riboflavin
5602018|NCT00890266|UV light|uv light
5602019|NCT00890253|Renal impairment|renal impairment
5602020|NCT00890253|Liver transplantation|liver transplantation
5602021|NCT00890253|Chronic Renal Insufficiency|chronic renal insufficiency
5602022|NCT00890240|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5602023|NCT00890240|ADHD|adhd
5602024|NCT00890240|JNJ-31001074|jnj-31001074
5602025|NCT00890227|scoliosis|scoliosis
5602028|NCT00890214|Anticoagulation|anticoagulation
5602029|NCT00890214|Prostacyclin|prostacyclin
5602030|NCT00890214|Heparin|heparin
5602031|NCT00890214|Renal Replacement Therapy|renal replacement therapy
5602032|NCT00890214|Kidney failure acute|kidney failure acute
5602033|NCT00890214|Platelet aggregation|platelet aggregation
5602034|NCT00890201|Pancreaticobiliary reflux|pancreaticobiliary reflux
5602035|NCT00890201|Normal pancreaticobiliary junction|normal pancreaticobiliary junction
5602036|NCT00890201|Gallstones|gallstones
5602037|NCT00890201|Cholelithiasis|cholelithiasis
5602038|NCT00890201|Cholecystectomy|cholecystectomy
5602039|NCT00890188|THALIDOMIDE|thalidomide
5602040|NCT00890188|UFUR|ufur
5602041|NCT00890188|Colorectal cancer|colorectal cancer
5602042|NCT00890188|Oxaliplatin|oxaliplatin
5602043|NCT00890175|Asthma, Staccato loxapine|asthma, staccato loxapine
5602044|NCT00890162|Omalizumab|omalizumab
5602045|NCT00890162|Idiopathic Anaphylaxis|idiopathic anaphylaxis
5602046|NCT00890162|Serum Tryptase|serum tryptase
5602047|NCT00890162|Placebo-Controlled|placebo-controlled
5602048|NCT00890162|Adult|adult
5602049|NCT00890162|Anaphylaxis|anaphylaxis
5602050|NCT00890162|Allergic Reaction|allergic reaction
5602051|NCT00890149|alcohol abuse|alcohol abuse
5602052|NCT00890149|binge drinking|binge drinking
5602053|NCT00890149|severe drinking|severe drinking
5602054|NCT00890149|alcoholism|alcoholism
5602055|NCT00890149|heavy drinking|heavy drinking
5602056|NCT00890136|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5602057|NCT00890123|Omega 3 Fatty Acids|omega 3 fatty acids
5602058|NCT00890123|Inflammation|inflammation
5602059|NCT00890123|Hip Surgery|hip surgery
5602060|NCT00890123|Inflammatory status|inflammatory status
5602061|NCT00890123|Infectious complications|infectious complications
5602062|NCT00890110|Renal cell cancer|renal cell cancer
5602063|NCT00890110|sunitinib|sunitinib
5602064|NCT00890110|autologous vaccine|autologous vaccine
5602065|NCT00890110|metastatic RCC|metastatic rcc
5602066|NCT00890097|Geographic Atrophy|geographic atrophy
5602067|NCT00890097|GA|ga
5602068|NCT00890097|Age-Related Macular Degeneration|age-related macular degeneration
5602069|NCT00890097|AMD|amd
5602070|NCT00890071|Fluid responsiveness|fluid responsiveness
5602072|NCT00890071|Cardiac output|cardiac output
5602073|NCT00890058|Arthritis|arthritis
5602074|NCT00890058|Synovitis|synovitis
5602075|NCT00890058|Aromatase Inhibitor|aromatase inhibitor
5602076|NCT00890058|Arthralgia Syndrome|arthralgia syndrome
5602077|NCT00890045|Vascular access hemodialysis|vascular access hemodialysis
5602078|NCT00890045|ePTFE graft|eptfe graft
5602079|NCT00890045|Graft-eligible|graft-eligible
5602080|NCT00890045|Long-term vascular access for hemodialysis|long-term vascular access for hemodialysis
5602081|NCT00890032|adult giant cell glioblastoma|adult giant cell glioblastoma
5602082|NCT00890032|adult glioblastoma|adult glioblastoma
5602083|NCT00890032|adult gliosarcoma|adult gliosarcoma
5602084|NCT00890032|adult astrocytoma|adult astrocytoma
5602085|NCT00890032|recurrent adult brain tumor|recurrent adult brain tumor
5602086|NCT00890006|Prostate cancer|prostate cancer
5602087|NCT00890006|Magnetic resonance imaging|magnetic resonance imaging
5602088|NCT00889993|Food intake|food intake
5602089|NCT00889993|Gut hormones|gut hormones
5602090|NCT00889993|Fiber|fiber
5602091|NCT00889993|Visual analog scales|visual analog scales
5602092|NCT00889967|Pseudomonas aeruginosa|pseudomonas aeruginosa
5602093|NCT00889967|antimicrobial|antimicrobial
5602094|NCT00889967|inhalation|inhalation
5602095|NCT00889967|ciprofloxacin|ciprofloxacin
5602096|NCT00889967|Non-Cystic Fibrosis Bronchiectasis|non-cystic fibrosis bronchiectasis
5602097|NCT00889954|EBV+|ebv+
5602098|NCT00889954|Her2|her2
5602099|NCT00889954|TGFBeta|tgfbeta
5602100|NCT00889954|EBV positive|ebv positive
5602101|NCT00889954|HER 2 positive malignancy|her 2 positive malignancy
5602102|NCT00889954|cytotoxic T lymphocytes|cytotoxic t lymphocytes
5602103|NCT00889928|gallbladder disease|gallbladder disease
5602104|NCT00889928|cholecystectomy|cholecystectomy
5602105|NCT00889928|gallbladder disease indicated for cholecystectomy|gallbladder disease indicated for cholecystectomy
5602106|NCT00889915|ADHD|adhd
5602107|NCT00889915|Methylphenidate|methylphenidate
5602108|NCT00889915|Amphetamine|amphetamine
5602109|NCT00889902|Molecular Markers|molecular markers
5602110|NCT00889902|Cervical Cancer|cervical cancer
5602111|NCT00889902|Screening|screening
5602112|NCT00889902|Makov|makov
5602113|NCT00889889|Influenza|influenza
5602114|NCT00889889|Phase II|phase ii
5602115|NCT00889889|Placebo-controlled|placebo-controlled
5602116|NCT00889876|Obesity|obesity
5602117|NCT00889876|Adolescents|adolescents
5602118|NCT00889876|Nocturnal blood pressure reduction|nocturnal blood pressure reduction
5602119|NCT00889876|Insulin metabolism|insulin metabolism
5602120|NCT00889876|Cardiovascular structure and function|cardiovascular structure and function
5602121|NCT00889876|Treatment|treatment
5602122|NCT00889876|Exercise|exercise
5602123|NCT00889876|Metformin|metformin
5602124|NCT00889876|Insulin|insulin
5602125|NCT00889876|Blood glucose|blood glucose
5602126|NCT00889876|Impaired nocturnal blood pressure reduction|impaired nocturnal blood pressure reduction
5602127|NCT00889863|Flare|flare
5602129|NCT00889863|IL-1beta antagonist|il-1beta antagonist
5602130|NCT00889863|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5602131|NCT00889863|Juvenile rheumatoid|juvenile rheumatoid
5602132|NCT00889850|Healthy|healthy
5602133|NCT00889850|Bioavailability|bioavailability
5602134|NCT00889850|Bioequivalence|bioequivalence
5602135|NCT00889850|Esomeprazole|esomeprazole
5602136|NCT00889850|Bioavailability, Therapeutical Indication Not Studied|bioavailability, therapeutical indication not studied
5602137|NCT00889837|Staccato Loxapine|staccato loxapine
5602138|NCT00889837|COPD|copd
5602139|NCT00889837|pulmonary safety|pulmonary safety
5602140|NCT00889824|Chronic imbalance|chronic imbalance
5602141|NCT00889824|vestibular disorders|vestibular disorders
5602142|NCT00889824|balance prosthesis|balance prosthesis
5602143|NCT00889811|OPCAB|opcab
5602144|NCT00889811|RIPC|ripc
5602145|NCT00889798|Malignant lymphatic disease|malignant lymphatic disease
5602146|NCT00889798|therapy-reality|therapy-reality
5602147|NCT00889798|observation|observation
5602148|NCT00889798|registry|registry
5602149|NCT00889798|therapy sequences|therapy sequences
5602151|NCT00889798|CLL|cll
5602152|NCT00889798|Germany|germany
5602153|NCT00889798|lenalidomide|lenalidomide
5602154|NCT00889798|alemtuzumab|alemtuzumab
5602155|NCT00889798|rituximab|rituximab
5602156|NCT00889798|bendamustin|bendamustin
5602157|NCT00889798|thalidomide|thalidomide
5602158|NCT00889798|bortezomib|bortezomib
5587960|NCT00938938|medical reporting|medical reporting
5602159|NCT00889798|ibritumomab-tiuxetan|ibritumomab-tiuxetan
5602160|NCT00889798|G-CSF (Granulocyte-Colony Stimulating Factor)|g-csf (granulocyte-colony stimulating factor)
5602161|NCT00889798|chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
5602162|NCT00889798|follicular lymphoma|follicular lymphoma
5602163|NCT00889798|gastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|gastric malt lymphoma (mucosa associated lymphoid tissue)
5602164|NCT00889798|nongastric MALT lymphoma (Mucosa Associated Lymphoid Tissue)|nongastric malt lymphoma (mucosa associated lymphoid tissue)
5602165|NCT00889798|nodal marginal zone lymphoma|nodal marginal zone lymphoma
5602166|NCT00889798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5602167|NCT00889798|mantle cell lymphoma|mantle cell lymphoma
5602168|NCT00889798|diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5602170|NCT00889785|Type 2 Diabetes|type 2 diabetes
5602171|NCT00889785|Behavioral Research|behavioral research
5602172|NCT00889772|Respiratory distress, adult|respiratory distress, adult
5602173|NCT00889772|risk|risk
5602174|NCT00889772|emergency room|emergency room
5602175|NCT00889772|high risk surgery|high risk surgery
5602176|NCT00889772|sepsis|sepsis
5602177|NCT00889772|trauma|trauma
5602178|NCT00889772|aspiration|aspiration
5602179|NCT00889772|pneumonia|pneumonia
5602180|NCT00889759|Tuberculosis|tuberculosis
5602181|NCT00889759|Outbreaks|outbreaks
5602182|NCT00889720|smoking cessation|smoking cessation
5602183|NCT00889720|varenicline|varenicline
5602184|NCT00889720|elective surgery|elective surgery
5602185|NCT00889720|wound infections|wound infections
5602186|NCT00889720|post-operative complications|post-operative complications
5602187|NCT00889707|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5602188|NCT00889707|BPH|bph
5602189|NCT00889707|Enlarged Prostate|enlarged prostate
5602191|NCT00889668|GlucoTrack|glucotrack
5602192|NCT00889668|Self glucose monitoring|self glucose monitoring
5602193|NCT00889655|efficacy of bowel cleansing|efficacy of bowel cleansing
5602194|NCT00889655|patient tolerability|patient tolerability
5602195|NCT00889655|Golytely|golytely
5602196|NCT00889655|MiraLax|miralax
5602197|NCT00889655|colonoscopy preparation|colonoscopy preparation
5602198|NCT00889655|bowel preparation|bowel preparation
5602199|NCT00889655|screening colonoscopy|screening colonoscopy
5602200|NCT00889629|kidney transplantation|kidney transplantation
5602201|NCT00889629|kidney transplant recipients|kidney transplant recipients
5602202|NCT00889616|Malaria|malaria
5602203|NCT00889616|Asexual Blood Stafe|asexual blood stafe
5602204|NCT00889616|Plasmodium Falciparum|plasmodium falciparum
5602205|NCT00889616|Immunogenicity|immunogenicity
5602206|NCT00889616|Safety|safety
5602207|NCT00889616|Vaccine|vaccine
5602209|NCT00889603|non-interventional study|non-interventional study
5602210|NCT00889603|Alzheimer's Disease|alzheimer's disease
5602211|NCT00889603|Vascular Dementia|vascular dementia
5602212|NCT00889603|efficacy|efficacy
5602213|NCT00889603|tolerability|tolerability
5602214|NCT00889603|safety.|safety.
5602215|NCT00889590|GCT|gct
5602216|NCT00889590|Bisfosfonates|bisfosfonates
5602217|NCT00889564|Vascular access for hemodialysis|vascular access for hemodialysis
5602218|NCT00889564|Catheter dependent patients|catheter dependent patients
5602219|NCT00889564|Access challenged patients|access challenged patients
5602220|NCT00889564|Bacteremia|bacteremia
5602221|NCT00889564|HeRO Vascular Access Device|hero vascular access device
5602222|NCT00889538|Autism|autism
5602223|NCT00889538|Severe Behavior Disorder|severe behavior disorder
5602224|NCT00889538|Glutathione|glutathione
5602225|NCT00889538|Antioxidants|antioxidants
5602226|NCT00889525|Cabergoline|cabergoline
5602227|NCT00889486|gastroparesis|gastroparesis
5602228|NCT00889486|diabetes mellitus|diabetes mellitus
5602229|NCT00889486|delayed gastric emptying|delayed gastric emptying
5602230|NCT00889473|larazotide acetate|larazotide acetate
5602231|NCT00889473|gluten|gluten
5602232|NCT00889460|rBet v 1|rbet v 1
5602233|NCT00889460|Birch pollen allergy|birch pollen allergy
5602234|NCT00889460|Sublingual Immunotherapy|sublingual immunotherapy
5602235|NCT00889447|Chronic Obstructive Pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5602236|NCT00889434|Cystic fibrosis|cystic fibrosis
5602237|NCT00889434|splicing mutations|splicing mutations
5602238|NCT00889434|molecular therapy|molecular therapy
5602239|NCT00889434|EGCG|egcg
5602240|NCT00889434|Tocotrienol|tocotrienol
5602241|NCT00889434|Splicing-mutation-mediated Cystic Fibrosis|splicing-mutation-mediated cystic fibrosis
5602242|NCT00889421|uveitis|uveitis
5602243|NCT00889421|apremilast|apremilast
5602244|NCT00889408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5602245|NCT00889408|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5602246|NCT00889408|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5602247|NCT00889408|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5602248|NCT00889408|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5602249|NCT00889408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5602250|NCT00889408|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5602251|NCT00889408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5602252|NCT00889408|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5602253|NCT00889408|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5602254|NCT00889408|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5602255|NCT00889408|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5602256|NCT00889408|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5602257|NCT00889408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5602258|NCT00889408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5602259|NCT00889408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5602260|NCT00889408|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5602261|NCT00889408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5602262|NCT00889408|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5602263|NCT00889408|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5602264|NCT00889408|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5602265|NCT00889408|Waldenström macroglobulinemia|waldenström macroglobulinemia
5602266|NCT00889408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5602267|NCT00889408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5602268|NCT00889408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5602269|NCT00889408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5602270|NCT00889408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5602271|NCT00889408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5602272|NCT00889408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5602273|NCT00889408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5602274|NCT00889408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5602275|NCT00889408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5602276|NCT00889408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5602277|NCT00889408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5602278|NCT00889408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5602279|NCT00889408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5602280|NCT00889408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5602281|NCT00889408|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5602282|NCT00889408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5602283|NCT00889408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5602284|NCT00889408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5602285|NCT00889408|childhood Burkitt lymphoma|childhood burkitt lymphoma
5602286|NCT00889408|intraocular lymphoma|intraocular lymphoma
5602287|NCT00889408|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5602288|NCT00889408|prolymphocytic leukemia|prolymphocytic leukemia
5602289|NCT00889395|MISC|misc
5602290|NCT00889395|caregivers|caregivers
5602291|NCT00889395|children|children
5602292|NCT00889395|psychosocial gains|psychosocial gains
5602293|NCT00889395|cognitive benefits|cognitive benefits
5602294|NCT00889382|Ovarian|ovarian
5602295|NCT00889382|IGF-1R|igf-1r
5602296|NCT00889382|Paclitaxel|paclitaxel
5602297|NCT00889382|Ovarian Cancer|ovarian cancer
5602298|NCT00889382|OSI-906|osi-906
5602299|NCT00889382|Solid Tumors|solid tumors
5602300|NCT00889369|depression|depression
5602303|NCT00889369|imaging|imaging
5602304|NCT00889369|FMRI|fmri
5602305|NCT00889369|Menopausal staging|menopausal staging
5602306|NCT00889369|vasomotor symptoms|vasomotor symptoms
5602307|NCT00889343|Second-line therapy of metastatic colorectal cancer|second-line therapy of metastatic colorectal cancer
5602308|NCT00889343|Sorafenib|sorafenib
5602309|NCT00889343|Colorectal Neoplasms|colorectal neoplasms
5602310|NCT00889343|palliative therapy|palliative therapy
5602311|NCT00889343|after progression of firstline therapy with an Oxaliplatin- or Irinotecan based Fluoropyrimidine containing regimen ± bevacizumab|after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab
5602312|NCT00889304|HTO, high tibial osteotomy, open wedge, medial arthritis|hto, high tibial osteotomy, open wedge, medial arthritis
5602313|NCT00889291|End stage renal disease|end stage renal disease
5602314|NCT00889291|Bacteremia|bacteremia
5602315|NCT00889291|HeRO Vascular Access Device|hero vascular access device
5602316|NCT00889291|Access challenged|access challenged
5602317|NCT00889291|Catheter dependent|catheter dependent
5680356|NCT00578110|glaucoma VEP detection device diagnosis vision|glaucoma vep detection device diagnosis vision
5680357|NCT00578071|esophageal cancer|esophageal cancer
5602318|NCT00889291|End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population|end stage renal disease requiring vascular access. see hero device instructions for use for appropriate patient population
5602319|NCT00889278|Lymphoma|lymphoma
5602320|NCT00889278|Autologous Peripheral Blood Stem Cell Transplant|autologous peripheral blood stem cell transplant
5602322|NCT00889278|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5602323|NCT00889265|Alveolar Bone Augmentation|alveolar bone augmentation
5602324|NCT00889265|Implant Surgery|implant surgery
5602325|NCT00889265|Guided Bone Regeneration (GBR)|guided bone regeneration (gbr)
5602326|NCT00889265|Guided Tissue Regeneration (GTR)|guided tissue regeneration (gtr)
5602327|NCT00889265|Bone Graft|bone graft
5602328|NCT00889265|Periodontal Surgery|periodontal surgery
5602329|NCT00889239|ceramic|ceramic
5602330|NCT00889239|wear rate|wear rate
5602331|NCT00889239|opposing enamel|opposing enamel
5602332|NCT00889226|pitavastatin|pitavastatin
5602334|NCT00889226|ESPRIT|esprit
5602335|NCT00889226|Pitavastatin and Atorvastatin|pitavastatin and atorvastatin
5602336|NCT00889226|Adiponectin|adiponectin
5602337|NCT00889226|fasting insulin|fasting insulin
5602338|NCT00889226|hs-CRP|hs-crp
5602339|NCT00889226|baPWV|bapwv
5602340|NCT00889213|pancreatectomy|pancreatectomy
5602341|NCT00889213|fistula|fistula
5602342|NCT00889213|fibrin glue|fibrin glue
5602343|NCT00889213|falciform patch|falciform patch
5602344|NCT00889213|surgery|surgery
5602345|NCT00889213|complications|complications
5602346|NCT00889187|radiation therapy|radiation therapy
5602347|NCT00889187|capecitabine|capecitabine
5602348|NCT00889174|Genetic Disorders of the White Matter|genetic disorders of the white matter
5602349|NCT00889174|Leukodystrophies|leukodystrophies
5602350|NCT00889174|Myelin|myelin
5602351|NCT00889174|White Matter Disorder|white matter disorder
5602352|NCT00889174|Genetic Disorder|genetic disorder
5602353|NCT00889161|Crohn's disease|crohn's disease
5602354|NCT00889161|ulcerative colitis|ulcerative colitis
5602357|NCT00889161|inflammatory bowel disease|inflammatory bowel disease
5602359|NCT00889148|arthroplasty|arthroplasty
5602360|NCT00889148|postoperative pain|postoperative pain
5602361|NCT00889148|gabapentin|gabapentin
5602362|NCT00889122|Obesity|obesity
5602363|NCT00889122|Exergames|exergames
5602364|NCT00889122|Videogames|videogames
5602365|NCT00889122|Prevention|prevention
5602366|NCT00889122|Family|family
5602367|NCT00889122|Dance Dance Revolution|dance dance revolution
5602368|NCT00889122|Pedometer|pedometer
5602369|NCT00889096|memory|memory
5602370|NCT00889096|heart rate|heart rate
5602371|NCT00889096|skin conductance|skin conductance
5602372|NCT00889096|α-amylase|α-amylase
5602373|NCT00889096|propranolol|propranolol
5602374|NCT00889096|tolerability|tolerability
5602375|NCT00889083|Sepsis|sepsis
5602376|NCT00889083|Peritonitis|peritonitis
5602377|NCT00889083|Mitochondria|mitochondria
5602379|NCT00889057|osteosarcoma|osteosarcoma
5602380|NCT00889057|sorafenib|sorafenib
5602381|NCT00889057|target therapy|target therapy
5602382|NCT00889031|CLL|cll
5602383|NCT00889018|intraocular retinoblastoma|intraocular retinoblastoma
5602384|NCT00889018|chemotherapy|chemotherapy
5602385|NCT00889005|Post-traumatic Stress Disorder|post-traumatic stress disorder
5602386|NCT00889005|Acute Stress Disorder|acute stress disorder
5602387|NCT00889005|Cognitive behavioral therapy|cognitive behavioral therapy
5602388|NCT00889005|Secondary Prevention|secondary prevention
5602389|NCT00889005|Anxiety disorders|anxiety disorders
5602390|NCT00889005|Service Delivery|service delivery
5602391|NCT00888992|Smoking|smoking
5602392|NCT00888992|Cessation|cessation
5602393|NCT00888992|Quitline|quitline
5602394|NCT00888992|Counseling|counseling
5602395|NCT00888979|Smoking Cessation during Pregnancy|smoking cessation during pregnancy
5602396|NCT00888979|Nicotrol Inhaler|nicotrol inhaler
5602397|NCT00888966|heart arrest|heart arrest
5602398|NCT00888966|oxidative stress|oxidative stress
5602399|NCT00888966|lactic acid|lactic acid
5602400|NCT00888966|outcome|outcome
5602401|NCT00888953|Falls|falls
5602402|NCT00888953|Nursing Homes|nursing homes
5602403|NCT00888953|Elderly|elderly
5602404|NCT00888953|Prevention|prevention
5602405|NCT00888953|Spain|spain
5602406|NCT00888953|Cluster Randomized Clinical Trial|cluster randomized clinical trial
5602407|NCT00888927|T-Cell Lymphoma|t-cell lymphoma
5602408|NCT00888927|PTCL|ptcl
5602409|NCT00888927|CTCL|ctcl
5602410|NCT00888914|Lateral Canthal Lines|lateral canthal lines
5602411|NCT00888914|Crow's Feet|crow's feet
5602412|NCT00888914|Facial Wrinkles|facial wrinkles
5602413|NCT00888901|ITP|itp
5602414|NCT00888901|eltrombopag|eltrombopag
5602415|NCT00888901|platelet function|platelet function
5602416|NCT00888901|thrombocytopenia|thrombocytopenia
5602417|NCT00888901|Platelet function in patients with cAITP on eltrombopag|platelet function in patients with caitp on eltrombopag
5602418|NCT00888888|Acute appendicitis|acute appendicitis
5602419|NCT00888888|Colonic diverticulitis|colonic diverticulitis
5602420|NCT00888888|Colonic tumors|colonic tumors
5602421|NCT00888888|Colonic resections|colonic resections
5602422|NCT00888875|i-gel|i-gel
5602423|NCT00888875|Fastrach|fastrach
5602424|NCT00888875|intubation|intubation
5602425|NCT00888875|fiberoptic|fiberoptic
5602426|NCT00888875|difficult airway|difficult airway
5602427|NCT00888875|Patients undergoing elective surgery requiring tracheal intubation|patients undergoing elective surgery requiring tracheal intubation
5602428|NCT00888875|Presenting at least one sign of difficult intubation|presenting at least one sign of difficult intubation
5602429|NCT00888862|depression|depression
5602430|NCT00888862|desvenlafaxine|desvenlafaxine
5602431|NCT00888862|menopause|menopause
5602432|NCT00888862|imaging|imaging
5602433|NCT00888862|FMRI|fmri
5602434|NCT00888849|Stapling|stapling
5602435|NCT00888849|hand sutured anastamosis|hand sutured anastamosis
5602436|NCT00888849|colorectal disease|colorectal disease
5602437|NCT00888836|bariatric surgery|bariatric surgery
5602438|NCT00888836|GBP|gbp
5602439|NCT00888836|BPD|bpd
5602440|NCT00888836|type 2 diabetes|type 2 diabetes
5602441|NCT00888823|Fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
5602442|NCT00888823|Medically inoperable|medically inoperable
5602443|NCT00888823|Image-guided radiotherapy|image-guided radiotherapy
5602444|NCT00888810|ovarian - cancer - relapse - topotecan - lapatinib|ovarian - cancer - relapse - topotecan - lapatinib
5602445|NCT00888771|Colorectal cancer|colorectal cancer
5602446|NCT00888771|polyps|polyps
5602447|NCT00888771|colonoscopy|colonoscopy
5602448|NCT00888771|advanced imaging|advanced imaging
5602449|NCT00888758|Stents|stents
5602450|NCT00888745|RA|ra
5602451|NCT00888732|Diabetes|diabetes
5602452|NCT00888680|Migraine|migraine
5602453|NCT00888680|Headaches|headaches
5602454|NCT00888680|Migraine headaches|migraine headaches
5602455|NCT00888680|Head pain|head pain
5602456|NCT00888667|ICD patients with PVCs and EGM recordings|icd patients with pvcs and egm recordings
5597577|NCT00900965|IBS|ibs
5602457|NCT00888654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5602458|NCT00888654|stage I prostate cancer|stage i prostate cancer
5602459|NCT00888654|stage II prostate cancer|stage ii prostate cancer
5602460|NCT00888628|Type I diabetes|type i diabetes
5602461|NCT00888628|Islet after Kidney Transplant|islet after kidney transplant
5602462|NCT00888628|Islet transplantation|islet transplantation
5602464|NCT00888589|Molecular Breast Imaging|molecular breast imaging
5602466|NCT00888589|Breast Cancer|breast cancer
5602467|NCT00888589|Molecular Imaging|molecular imaging
5602468|NCT00888563|Fatigue|fatigue
5602469|NCT00888563|Depression|depression
5602470|NCT00888563|Healthy Volunteer|healthy volunteer
5602471|NCT00888563|HV|hv
5602472|NCT00888537|Decision aid|decision aid
5602473|NCT00888537|Heart attack|heart attack
5602474|NCT00888537|myocardial infarction|myocardial infarction
5602475|NCT00888524|head out water immersion,|head out water immersion,
5602476|NCT00888524|high intensity exercise,|high intensity exercise,
5602477|NCT00888524|evidence-based physiotherapy;|evidence-based physiotherapy;
5602478|NCT00888524|aquatics;|aquatics;
5602479|NCT00888524|hydrotherapy|hydrotherapy
5602480|NCT00888524|aquatics therapy|aquatics therapy
5602481|NCT00888524|exercise therapy|exercise therapy
5602482|NCT00888511|Lung cancer|lung cancer
5602483|NCT00888511|Non-small cell lung cancer|non-small cell lung cancer
5602484|NCT00888511|Tarceva|tarceva
5602485|NCT00888511|Radiotherapy|radiotherapy
5602486|NCT00888511|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
5602487|NCT00888498|Sprains and Strains|sprains and strains
5602488|NCT00888498|Ankle|ankle
5602489|NCT00888498|Manual Therapies|manual therapies
5602490|NCT00888498|Outcome Studies|outcome studies
5602491|NCT00888472|Extracorporeal leukocytapheresis|extracorporeal leukocytapheresis
5602492|NCT00888459|tobacco|tobacco
5602493|NCT00888459|chew|chew
5602494|NCT00888459|nrt|nrt
5602495|NCT00888459|nicotine lozenges|nicotine lozenges
5602496|NCT00888459|self-help|self-help
5602497|NCT00888446|HIV|hiv
5602498|NCT00888446|HIV seronegativity|hiv seronegativity
5602499|NCT00888446|preventative vaccine|preventative vaccine
5602500|NCT00888433|hypertension|hypertension
5602501|NCT00888433|renal denervation|renal denervation
5602502|NCT00888433|sympathetic nervous system|sympathetic nervous system
5602503|NCT00888433|RDN|rdn
5602504|NCT00888420|Chronic Pain|chronic pain
5602505|NCT00888407|Asian American Health|asian american health
5602506|NCT00888407|Cancer|cancer
5602507|NCT00888407|Hepatitis|hepatitis
5602508|NCT00888407|Hepatitis B|hepatitis b
5602509|NCT00888407|Liver Cancer|liver cancer
5602510|NCT00888394|chiropody|chiropody
5602511|NCT00888394|podiatry|podiatry
5602512|NCT00888394|insoles|insoles
5602513|NCT00888394|foot orthesis|foot orthesis
5602514|NCT00888342|Pulmonary Disease|pulmonary disease
5602515|NCT00888342|Chronic Obstructive|chronic obstructive
5602516|NCT00888342|Hypercapnia|hypercapnia
5602517|NCT00888342|Hypoxemia|hypoxemia
5680358|NCT00578032|head|head
5602518|NCT00888342|Arrhythmias, Cardiac|arrhythmias, cardiac
5602519|NCT00888342|Polysomnography|polysomnography
5602520|NCT00888342|Capnography|capnography
5602521|NCT00888342|Electrocardiography, Holter|electrocardiography, holter
5602522|NCT00888329|Elective hysterectomy|elective hysterectomy
5602523|NCT00888316|iron overload|iron overload
5602524|NCT00888290|metabolic acidosis|metabolic acidosis
5602525|NCT00888290|chronic kidney disease|chronic kidney disease
5602526|NCT00888290|Estimated GFR 15-45|estimated gfr 15-45
5602527|NCT00888264|Antipsychotics|antipsychotics
5602528|NCT00888264|Bipolar Disorder|bipolar disorder
5602529|NCT00888264|Depressive episodes|depressive episodes
5602530|NCT00888264|Bipolar I or II Disorders|bipolar i or ii disorders
5602531|NCT00888251|Obesity|obesity
5602532|NCT00888251|Meal replacement|meal replacement
5602533|NCT00888251|Obesity treatment|obesity treatment
5602534|NCT00888251|Weight management|weight management
5602535|NCT00888225|Tennis elbow|tennis elbow
5602536|NCT00888225|Epicondylitis|epicondylitis
5602537|NCT00888225|Pain|pain
5602538|NCT00888225|Muscle strength|muscle strength
5602539|NCT00888225|Quality of life|quality of life
5602540|NCT00888225|RCT|rct
5602541|NCT00888225|Tendinitis|tendinitis
5602542|NCT00888225|Chronic tennis elbow|chronic tennis elbow
5602543|NCT00888199|amputation|amputation
5602544|NCT00888199|amputee|amputee
5602545|NCT00888199|prosthetic|prosthetic
5602546|NCT00888199|foot|foot
5602547|NCT00888199|prosthesis|prosthesis
5602548|NCT00888199|Tensegrity|tensegrity
5602549|NCT00888199|Prosthetics|prosthetics
5602550|NCT00888199|K3 Promoter|k3 promoter
5602551|NCT00888186|Dyskinesias|dyskinesias
5602552|NCT00888186|Duodenal levodopa infusion|duodenal levodopa infusion
5602553|NCT00888186|Dose optimization|dose optimization
5602554|NCT00888186|Pharmacokinetics|pharmacokinetics
5602555|NCT00888186|Pharmacodynamics|pharmacodynamics
5602556|NCT00888147|Tube feeding|tube feeding
5602557|NCT00888147|Fiber|fiber
5602558|NCT00888147|Constipation|constipation
5602559|NCT00888095|deep brain stimulation|deep brain stimulation
5602560|NCT00888095|caudal Zona incerta|caudal zona incerta
5602561|NCT00888095|Nucleus subthalamicus|nucleus subthalamicus
5602562|NCT00888095|Parkinson's disease|parkinson's disease
5602563|NCT00888095|randomized|randomized
5602564|NCT00888095|blinded|blinded
5602565|NCT00888095|Movement disorder|movement disorder
5602566|NCT00888082|adjuvant chemotherapy|adjuvant chemotherapy
5602567|NCT00888082|breast cancer|breast cancer
5602568|NCT00888082|goserelin acetate|goserelin acetate
5602569|NCT00888082|ovarian function|ovarian function
5602570|NCT00888082|Chemotherapy|chemotherapy
5602571|NCT00888082|Primary invasive breast cancer|primary invasive breast cancer
5602572|NCT00888069|Parathyroid Diseases|parathyroid diseases
5602573|NCT00888069|Renal Insufficiency|renal insufficiency
5602574|NCT00888069|Kidney Failure, Chronic|kidney failure, chronic
5602575|NCT00888069|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5602576|NCT00888069|Vitamin D|vitamin d
5602577|NCT00888069|Hyperparathyroidism|hyperparathyroidism
5602578|NCT00888069|Renal Insufficiency, Chronic|renal insufficiency, chronic
5602579|NCT00888069|Kidney Diseases|kidney diseases
5602580|NCT00888069|Kidney Failure|kidney failure
5602581|NCT00888043|solid tumors|solid tumors
5602582|NCT00888043|avastin|avastin
5602583|NCT00888043|Phase I|phase i
5602584|NCT00888043|combination therapy|combination therapy
5602585|NCT00888043|bevacizumab|bevacizumab
5602586|NCT00888030|p-cresol|p-cresol
5602587|NCT00888030|indoxyl sulfate|indoxyl sulfate
5602588|NCT00888030|chronic kidney disease|chronic kidney disease
5602590|NCT00888017|bone density|bone density
5602591|NCT00888017|proton pump inhibitors|proton pump inhibitors
5602592|NCT00888017|premature infants|premature infants
5602593|NCT00888004|Parkinson's|parkinson's
5602594|NCT00888004|L-dopa|l-dopa
5602595|NCT00888004|dyskinesia|dyskinesia
5602596|NCT00887991|Randomised trial|randomised trial
5602597|NCT00887991|breast pumps|breast pumps
5602598|NCT00887991|efficacy|efficacy
5602599|NCT00887991|preterm|preterm
5602600|NCT00887991|Mothers of preterm infants who plan to express milk for their infants.|mothers of preterm infants who plan to express milk for their infants.
5602601|NCT00887965|Low Bone Mass|low bone mass
5602602|NCT00887965|Low Bone Mineral Density|low bone mineral density
5602603|NCT00887965|Osteoporosis|osteoporosis
5602604|NCT00887965|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5602605|NCT00887965|Bone Biopsy|bone biopsy
5602606|NCT00887965|Transiliac Crest Bone Histology|transiliac crest bone histology
5602607|NCT00887965|Histomorphometry|histomorphometry
5602608|NCT00887952|Deep caries lesion|deep caries lesion
5602609|NCT00887952|dentine caries removal|dentine caries removal
5602610|NCT00887952|dental restoration|dental restoration
5602611|NCT00887952|stepwise excavation|stepwise excavation
5602612|NCT00887939|Hives|hives
5602613|NCT00887939|Inflammasome|inflammasome
5602614|NCT00887939|Mast Cell|mast cell
5602615|NCT00887939|Urticaria|urticaria
5602616|NCT00887926|AML|aml
5602617|NCT00887926|Leukemia|leukemia
5602618|NCT00887926|Acute Myeloid Leukemia|acute myeloid leukemia
5602619|NCT00887926|Antibodies, Monoclonal|antibodies, monoclonal
5588480|NCT00936819|MRI|mri
5602620|NCT00887900|lamellar keratoplasty|lamellar keratoplasty
5602621|NCT00887900|keratoconus|keratoconus
5602622|NCT00887900|penetrated keratoplasty|penetrated keratoplasty
5602623|NCT00887900|Visual acuity|visual acuity
5602624|NCT00887887|liver surgery|liver surgery
5602625|NCT00887887|gene polymorphisms|gene polymorphisms
5602626|NCT00887887|innate immune response|innate immune response
5602627|NCT00887887|infectious complications|infectious complications
5602628|NCT00887887|post-resectional liver failure|post-resectional liver failure
5602629|NCT00887887|mortality|mortality
5602630|NCT00887861|epilepsy|epilepsy
5602631|NCT00887861|seizure|seizure
5602632|NCT00887861|monotherapy trials|monotherapy trials
5602633|NCT00887861|partial seizure|partial seizure
5602634|NCT00887861|Partial seizures and undergoing evaluation for epilepsy surgery|partial seizures and undergoing evaluation for epilepsy surgery
5602635|NCT00887848|Child|child
5602636|NCT00887848|Robotic-assisted treadmill training|robotic-assisted treadmill training
5602637|NCT00887848|Rehabilitation|rehabilitation
5602638|NCT00887835|PERPOS fusion|perpos fusion
5602639|NCT00887809|Bevacizumab (avastin)|bevacizumab (avastin)
5602640|NCT00887809|Gemcitabine|gemcitabine
5602641|NCT00887809|Taxotere (docetaxel)|taxotere (docetaxel)
5602642|NCT00887809|09-015|09-015
5602643|NCT00887809|Soft tissue|soft tissue
5602644|NCT00887783|Induction chemotherapy|induction chemotherapy
5602645|NCT00887783|Non-small cell lung cancer|non-small cell lung cancer
5602646|NCT00887783|Randomized phase II study|randomized phase ii study
5602647|NCT00887783|Navelbine Oral (R)|navelbine oral (r)
5602648|NCT00887783|3D-conformal radiotherapy|3d-conformal radiotherapy
5602649|NCT00887783|Chemo-radiotherapy|chemo-radiotherapy
5602650|NCT00887783|Local-regionally advanced non-small cell lung cancer|local-regionally advanced non-small cell lung cancer
5602651|NCT00887770|QTcF|qtcf
5602652|NCT00887770|Crossover|crossover
5602653|NCT00887770|ICH E14|ich e14
5602654|NCT00887770|QT/QTc prolongation|qt/qtc prolongation
5602655|NCT00887770|Moxifloxacin|moxifloxacin
5602656|NCT00887770|QT/QTc Interval|qt/qtc interval
5602657|NCT00887744|Degenerative Lumbar Spinal Stenosis|degenerative lumbar spinal stenosis
5602658|NCT00887744|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5602659|NCT00887744|Interpinous Device|interpinous device
5602661|NCT00887731|closed loop oxygen controller|closed loop oxygen controller
5602662|NCT00887731|premature infants|premature infants
5602663|NCT00887731|oxygen exposure|oxygen exposure
5602664|NCT00887718|PET scan and Hodgkin's Lymphoma|pet scan and hodgkin's lymphoma
5602665|NCT00887718|PET scan and Non Hodgkin's Lymphoma|pet scan and non hodgkin's lymphoma
5602666|NCT00887718|PET scan|pet scan
5602667|NCT00887705|COPD|copd
5602668|NCT00887705|Pulmonary Rehabilitation|pulmonary rehabilitation
5602669|NCT00887705|ADL-Training|adl-training
5602670|NCT00887705|COPD Rehabilitation|copd rehabilitation
5602671|NCT00887679|Escitalopram|escitalopram
5602672|NCT00887679|Anxiety Disorder|anxiety disorder
5602673|NCT00887679|HIV and AIDS|hiv and aids
5602674|NCT00887679|treatment experienced|treatment experienced
5602675|NCT00887640|metastatic|metastatic
5602676|NCT00887640|Temsirolimus|temsirolimus
5602677|NCT00887640|prostate|prostate
5602679|NCT00887627|Pharmacokinetics|pharmacokinetics
5602680|NCT00887627|Protein Binding|protein binding
5602681|NCT00887627|Conivaptan|conivaptan
5602682|NCT00887627|Vaprisol|vaprisol
5602683|NCT00887627|Kidney Diseases|kidney diseases
5602684|NCT00887614|mindfulness|mindfulness
5602685|NCT00887614|meditation|meditation
5602686|NCT00887614|stress|stress
5602687|NCT00887614|rumination|rumination
5602688|NCT00887614|emotion regulation|emotion regulation
5602689|NCT00887614|sleep quality|sleep quality
5585683|NCT00947843|CHD|chd
5602690|NCT00887614|spirituality|spirituality
5602691|NCT00887614|quality of life|quality of life
5602692|NCT00887588|Chronic heart failure|chronic heart failure
5602693|NCT00887588|preserved ejection fraction|preserved ejection fraction
5602694|NCT00887588|cardiovascular disease|cardiovascular disease
5602695|NCT00887588|NT-proBNP|nt-probnp
5602696|NCT00887588|biomarkers|biomarkers
5602697|NCT00887588|Heart failure with preserved left-ventricular ejection|heart failure with preserved left-ventricular ejection
5602698|NCT00887588|fraction|fraction
5602699|NCT00887575|Breast Cancer|breast cancer
5602700|NCT00887575|Triple-Negative|triple-negative
5602701|NCT00887575|Paclitaxel|paclitaxel
5602702|NCT00887575|Carboplatin|carboplatin
5602703|NCT00887575|Sunitinib|sunitinib
5602704|NCT00887575|Sutent|sutent
5602705|NCT00887575|Neoadjuvant|neoadjuvant
5602706|NCT00887536|National Surgical Adjuvant Breast and Bowel Project (NSABP)|national surgical adjuvant breast and bowel project (nsabp)
5602707|NCT00887536|Taxotere|taxotere
5602708|NCT00887536|Docetaxel|docetaxel
5602709|NCT00887536|Doxorubicin|doxorubicin
5602710|NCT00887536|Cyclophosphamide|cyclophosphamide
5602711|NCT00887536|Bevacizumab|bevacizumab
5602712|NCT00887536|Breast Neoplasms|breast neoplasms
5602713|NCT00887536|Adenocarcinoma|adenocarcinoma
5602714|NCT00887536|Breast Diseases|breast diseases
5602715|NCT00887536|Carcinoma|carcinoma
5602716|NCT00887536|HER2 negative|her2 negative
5602717|NCT00887536|Node negative|node negative
5602718|NCT00887536|High risk node positive|high risk node positive
5602719|NCT00887536|Adjuvant Therapy|adjuvant therapy
5602720|NCT00887510|Metabolic Syndrome|metabolic syndrome
5602721|NCT00887510|High Blood Pressure|high blood pressure
5602722|NCT00887510|Abdominal Obesity|abdominal obesity
5602723|NCT00887510|Impaired Glucose Tolerance|impaired glucose tolerance
5602725|NCT00887484|Acne Vulgaris|acne vulgaris
5602726|NCT00887471|Sleep-disordered breathing|sleep-disordered breathing
5602727|NCT00887471|Obstructive sleep apnea|obstructive sleep apnea
5602728|NCT00887471|Polysomnography|polysomnography
5602729|NCT00887471|Tonsillectomy|tonsillectomy
5685459|NCT00555997|Major Depressive Disorder|major depressive disorder
5602730|NCT00887471|Microdebrider assisted partial intracapsular tonsillectomy|microdebrider assisted partial intracapsular tonsillectomy
5602731|NCT00887458|metastatic prostate cancer|metastatic prostate cancer
5602732|NCT00887458|castration resistant prostate cancer|castration resistant prostate cancer
5602733|NCT00887458|rising PSA|rising psa
5602734|NCT00887445|First in Man|first in man
5602735|NCT00887445|SLV341|slv341
5602736|NCT00887445|diabetes|diabetes
5602737|NCT00887419|chronic back pain|chronic back pain
5602738|NCT00887419|spinal cord stimulator implant|spinal cord stimulator implant
5602739|NCT00887406|first time in human study|first time in human study
5602740|NCT00887406|COPD|copd
5602741|NCT00887406|long-acting bronchodilator|long-acting bronchodilator
5602742|NCT00887393|morbid obesity|morbid obesity
5602743|NCT00887393|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5602744|NCT00887393|bariatric surgery|bariatric surgery
5602745|NCT00887393|low fat diet|low fat diet
5602746|NCT00887393|low carbohydrate diet|low carbohydrate diet
5602747|NCT00887380|Breast Cancer|breast cancer
5602748|NCT00887380|Timing of Radiotherapy|timing of radiotherapy
5602749|NCT00887380|Local control|local control
5602750|NCT00887367|Healthy volunteers|healthy volunteers
5602751|NCT00887367|Substance dependence|substance dependence
5602752|NCT00887367|Alcohol dependence|alcohol dependence
5786480|NCT00162864|asthma|asthma
5602753|NCT00887354|Low bone mass|low bone mass
5602754|NCT00887354|Recent pertrochanteric hip fracture|recent pertrochanteric hip fracture
5602755|NCT00887328|ischemic stroke|ischemic stroke
5602757|NCT00887328|magnetic resonance imaging|magnetic resonance imaging
5602759|NCT00887328|diffusion imaging|diffusion imaging
5602760|NCT00887328|DWI|dwi
5602761|NCT00887328|perfusion imaging|perfusion imaging
5602762|NCT00887328|PWI|pwi
5602763|NCT00887328|thrombolysis|thrombolysis
5602764|NCT00887328|alteplase|alteplase
5602765|NCT00887328|tPA|tpa
5602766|NCT00887328|EPITHET|epithet
5602767|NCT00887315|NSCLC|nsclc
5602768|NCT00887315|Metastatic Stage IV NSCLC|metastatic stage iv nsclc
5602769|NCT00887315|Limited Volume Stage IV Non-small Cell Lung Cancer|limited volume stage iv non-small cell lung cancer
5602770|NCT00887276|Ampicillin|ampicillin
5602771|NCT00887276|Amoxicillin|amoxicillin
5602772|NCT00887276|Moxifloxacin|moxifloxacin
5602773|NCT00887276|Community-Acquired Pneumonia|community-acquired pneumonia
5602774|NCT00887237|Heart failure|heart failure
5602775|NCT00887237|Cardiac resynchronization|cardiac resynchronization
5602776|NCT00887237|Triple site ventricular pacing|triple site ventricular pacing
5602777|NCT00887224|Major Depressive Disorder|major depressive disorder
5602779|NCT00887211|coronary artery disease|coronary artery disease
5602780|NCT00887198|Prostate cancer|prostate cancer
5602781|NCT00887198|Abiraterone acetate|abiraterone acetate
5602782|NCT00887198|CB7630|cb7630
5602783|NCT00887198|CRPC|crpc
5602784|NCT00887198|Metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5602785|NCT00887198|hormone refractory prostate cancer|hormone refractory prostate cancer
5602786|NCT00887185|Surgical Simulation|surgical simulation
5602787|NCT00887185|Surgical skills training|surgical skills training
5602788|NCT00887185|Temporal bone surgery|temporal bone surgery
5602789|NCT00887185|Computer simulation|computer simulation
5602790|NCT00887172|Acute upper respiratory tract infections|acute upper respiratory tract infections
5602791|NCT00887146|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5602792|NCT00887146|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5602793|NCT00887146|adult mixed glioma|adult mixed glioma
5602794|NCT00887120|Second line treatment|second line treatment
5602795|NCT00887120|therapeutic drug monitoring|therapeutic drug monitoring
5602796|NCT00887120|Asia|asia
5602797|NCT00887120|LPV|lpv
5602798|NCT00887120|children|children
5602799|NCT00887120|pharmacokinetic|pharmacokinetic
5603051|NCT00886379|Mongolia|mongolia
5602800|NCT00887120|To study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in Protease inhibitor (PI)- naive HIV-1 infected Thai patients.|to study the pharmacokinetics of low-dose and standard dose, lopinavir/ritonavir in protease inhibitor (pi)- naive hiv-1 infected thai patients.
5602801|NCT00887120|To study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in PI naive HIV-1 infected Thai patients.|to study clinical and immunological efficacy after 48-weeks of lopinavir/ritonavir-based antiretroviral therapy in pi naive hiv-1 infected thai patients.
5602802|NCT00887094|Diabetes mellitus|diabetes mellitus
5602803|NCT00887094|Exercise|exercise
5602804|NCT00887094|Endurance|endurance
5602805|NCT00887094|Resistance|resistance
5602806|NCT00887094|Continuous glucose monitoring system|continuous glucose monitoring system
5602807|NCT00887081|antiviral treatment in hemoglobinopathies|antiviral treatment in hemoglobinopathies
5602808|NCT00887081|management of chronic viral hepatitis C infection|management of chronic viral hepatitis c infection
5602809|NCT00887081|antiviral treatment|antiviral treatment
5602810|NCT00887068|Leukemia|leukemia
5602811|NCT00887068|Acute myelogenous leukemia|acute myelogenous leukemia
5602812|NCT00887068|AML|aml
5602813|NCT00887068|Myelodysplastic syndrome|myelodysplastic syndrome
5602814|NCT00887068|MDS|mds
5602815|NCT00887068|Remission|remission
5602816|NCT00887068|Allogeneic stem cell transplant|allogeneic stem cell transplant
5602817|NCT00887068|Allotx|allotx
5602818|NCT00887068|Azacitidine|azacitidine
5602819|NCT00887068|5-Azacitidine|5-azacitidine
5602820|NCT00887068|5-aza|5-aza
5602821|NCT00887068|Vidaza|vidaza
5602822|NCT00887068|5-AZC|5-azc
5602823|NCT00887068|AZA-CR|aza-cr
5602824|NCT00887068|Ladakamycin|ladakamycin
5602825|NCT00887068|NSC-102816|nsc-102816
5602826|NCT00887042|Acute myeloid leukemia|acute myeloid leukemia
5602827|NCT00887042|Cord blood transplantation|cord blood transplantation
5602828|NCT00887042|Pediatric|pediatric
5602829|NCT00887029|Topical prostaglandin analogue|topical prostaglandin analogue
5602830|NCT00887029|glaucoma|glaucoma
5602831|NCT00887029|POAG|poag
5602832|NCT00887029|OHT|oht
5602833|NCT00887029|OAG|oag
5602834|NCT00887029|ocular hypertension|ocular hypertension
5602835|NCT00887029|fixed combination protaglandin analogue therapy|fixed combination protaglandin analogue therapy
5602836|NCT00887029|DuoTrav|duotrav
5602837|NCT00887029|timolol|timolol
5602838|NCT00887029|travoprost|travoprost
5602839|NCT00887029|24 hour post dose|24 hour post dose
5602840|NCT00887029|IOP|iop
5602841|NCT00887029|dosing preference|dosing preference
5602842|NCT00887003|epidural|epidural
5602843|NCT00887003|volume|volume
5602844|NCT00887003|dose|dose
5602845|NCT00887003|pain relief|pain relief
5602846|NCT00887003|steroid|steroid
5602847|NCT00886990|single- and double-boosted PI|single- and double-boosted pi
5602849|NCT00886990|NNRTI failure|nnrti failure
5602850|NCT00886990|HIV-infected children|hiv-infected children
5602851|NCT00886990|Compare virological efficacy and safety of single- or double-boosted PI regimens as second line therapy in children with NNRTI-based treatment failure|compare virological efficacy and safety of single- or double-boosted pi regimens as second line therapy in children with nnrti-based treatment failure
5602852|NCT00886990|treatment experienced|treatment experienced
5602853|NCT00886977|ALS|als
5602854|NCT00886964|HBV vaccine|hbv vaccine
5602855|NCT00886964|HIV children|hiv children
5602856|NCT00886964|immune recovery|immune recovery
5602857|NCT00886964|HBV antibody|hbv antibody
5602858|NCT00886964|Intradermal|intradermal
5602859|NCT00886964|Intramuscular|intramuscular
5602860|NCT00886964|antibody response after HBV vaccine|antibody response after hbv vaccine
5602861|NCT00886964|treatment experienced|treatment experienced
5602862|NCT00886938|tinnitus|tinnitus
5602863|NCT00886925|Hepatic encephalopathy|hepatic encephalopathy
5602864|NCT00886925|Cirrhosis|cirrhosis
5602865|NCT00886925|Albumin|albumin
5602866|NCT00886912|mountain sickness|mountain sickness
5602867|NCT00886899|CTO|cto
5602868|NCT00886899|chronic total occlusion|chronic total occlusion
5602869|NCT00886899|CAD|cad
5602870|NCT00886899|coronary artery disease|coronary artery disease
5602871|NCT00886899|interventional cardiology|interventional cardiology
5602872|NCT00886899|revascularization|revascularization
5602873|NCT00886899|recanalization|recanalization
5602874|NCT00886886|MDMA|mdma
5602875|NCT00886886|norepinephrine|norepinephrine
5602876|NCT00886886|Ecstasy|ecstasy
5602877|NCT00886886|stimulant|stimulant
5585899|NCT00946946|TPMT|tpmt
5602878|NCT00886873|Uterine fibroids|uterine fibroids
5602879|NCT00886873|Mifepristone|mifepristone
5602880|NCT00886873|Antiprogestins|antiprogestins
5602881|NCT00886860|Efficacy|efficacy
5602882|NCT00886860|Cervical ripening/Labor induction|cervical ripening/labor induction
5602883|NCT00886860|Titrated oral misoprostol/Conventional oral misoprostol|titrated oral misoprostol/conventional oral misoprostol
5602884|NCT00886860|Term pregnancy|term pregnancy
5602885|NCT00886847|Lung|lung
5602886|NCT00886847|Lymphadenopathy|lymphadenopathy
5602887|NCT00886847|Enlarged hilar or/and mediastinal lymph adenopathy|enlarged hilar or/and mediastinal lymph adenopathy
5602888|NCT00886847|Benign|benign
5602889|NCT00886847|Malignant|malignant
5602890|NCT00886847|Mediastinal lymph nodes|mediastinal lymph nodes
5602891|NCT00886847|Hilar lymph nodes|hilar lymph nodes
5603054|NCT00886353|ACE2|ace2
5602892|NCT00886847|Fine Needle Aspiration|fine needle aspiration
5602893|NCT00886847|FNA|fna
5602894|NCT00886847|Fine Needle Capillary Sampling|fine needle capillary sampling
5602895|NCT00886847|FNC|fnc
5602896|NCT00886847|Endobronchial Ultrasound-Guided Biopsy|endobronchial ultrasound-guided biopsy
5602897|NCT00886847|EBUS|ebus
5602898|NCT00886847|Tissue Sample|tissue sample
5602899|NCT00886847|Suction|suction
5602900|NCT00886834|IUD insertion|iud insertion
5602901|NCT00886834|Nulliparous women|nulliparous women
5602902|NCT00886834|Contraception|contraception
5602903|NCT00886834|Family Planning|family planning
5602904|NCT00886834|IUD insertion in nulliparous women|iud insertion in nulliparous women
5602905|NCT00886821|Phase 1 Type 2 diabetes CVX-096 diabetes mellitus|phase 1 type 2 diabetes cvx-096 diabetes mellitus
5602906|NCT00886821|adult-onset diabetes mellitus|adult-onset diabetes mellitus
5602907|NCT00886821|non-insulin dependent|non-insulin dependent
5602908|NCT00886808|DME, Diabetic Retinopathy, Diabetic Macular Edema|dme, diabetic retinopathy, diabetic macular edema
5602909|NCT00886795|hives|hives
5602910|NCT00886795|rash|rash
5602911|NCT00886795|pruritis|pruritis
5602912|NCT00886782|Advanced and/or Metastatic solid cancers|advanced and/or metastatic solid cancers
5602913|NCT00886769|Flare|flare
5602914|NCT00886769|arthritis|arthritis
5602915|NCT00886769|IL-1beta antagonist|il-1beta antagonist
5602916|NCT00886769|systemic juvenile idiopathic arthritis|systemic juvenile idiopathic arthritis
5602917|NCT00886769|Juvenile Rheumatoid|juvenile rheumatoid
5602918|NCT00886769|Systemic juvenile idiopathic arthritis with active flare|systemic juvenile idiopathic arthritis with active flare
5602919|NCT00886756|Phase I|phase i
5602920|NCT00886756|Japanese healthy volunteer|japanese healthy volunteer
5602921|NCT00886756|AZD8529|azd8529
5602922|NCT00886730|Depressive disorder|depressive disorder
5602923|NCT00886730|Primary care|primary care
5602924|NCT00886730|Internet|internet
5602925|NCT00886730|Social support|social support
5602926|NCT00886730|Feasibility|feasibility
5602927|NCT00886717|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5602928|NCT00886717|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5602929|NCT00886717|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5602930|NCT00886717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5602931|NCT00886717|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5602932|NCT00886717|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5602933|NCT00886717|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5602934|NCT00886717|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5602935|NCT00886704|Omega-3 fatty acids|omega-3 fatty acids
5602936|NCT00886704|dietary supplementation|dietary supplementation
5602938|NCT00886678|Non-Small Cell Lung Cancer|non-small cell lung cancer
5602939|NCT00886678|pemetrexed|pemetrexed
5602940|NCT00886678|radiation|radiation
5602941|NCT00886665|Diabetic Neuropathy|diabetic neuropathy
5602942|NCT00886665|Nerve Conduction Studies|nerve conduction studies
5602943|NCT00886665|Clinical Trial|clinical trial
5602944|NCT00886652|Scoliosis|scoliosis
5602945|NCT00886652|Muscle Strength|muscle strength
5602946|NCT00886652|Respiratory function tests|respiratory function tests
5602947|NCT00886652|Exercise therapy|exercise therapy
5602948|NCT00886639|COPD III/IV|copd iii/iv
5602949|NCT00886639|Oxygen Supply|oxygen supply
5602950|NCT00886639|Six-Minute-Walking-Test|six-minute-walking-test
5602951|NCT00886639|Oxygen Responder|oxygen responder
5602952|NCT00886626|Obesity|obesity
5602953|NCT00886626|Impaired Glucose Tolerance|impaired glucose tolerance
5602954|NCT00886626|Children|children
5602955|NCT00886587|eczema|eczema
5602956|NCT00886574|Cilostazol versus Aspirin|cilostazol versus aspirin
5602957|NCT00886574|Anti-PLT drug|anti-plt drug
5602958|NCT00886574|Primary Prevention of Atherosclerotic Events|primary prevention of atherosclerotic events
5602959|NCT00886574|Type 2 DM|type 2 dm
5602960|NCT00886574|Intima media thickness (IMT)|intima media thickness (imt)
5602961|NCT00886561|HIV prevention, female sex workers|hiv prevention, female sex workers
5602962|NCT00886561|HIV seronegativity|hiv seronegativity
5602963|NCT00886535|breast cancer|breast cancer
5602964|NCT00886535|hot flashes|hot flashes
5602965|NCT00886535|tamoxifen|tamoxifen
5602966|NCT00886522|Anti-thymocyte globulin Fresenius|anti-thymocyte globulin fresenius
5602967|NCT00886522|Busulfan|busulfan
5602968|NCT00886522|Cord blood|cord blood
5602969|NCT00886522|Cyclophosphamide|cyclophosphamide
5602970|NCT00886522|Fludarabine|fludarabine
5602971|NCT00886522|Human Leucocyte Antigen|human leucocyte antigen
5602972|NCT00886522|Hematopoietic Stem Cell|hematopoietic stem cell
5602973|NCT00886522|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5602974|NCT00886522|Graft-versus-Host-Disease|graft-versus-host-disease
5602975|NCT00886522|Graft-versus-Host-Disease prophylaxis|graft-versus-host-disease prophylaxis
5602976|NCT00886522|Intrabone infusion|intrabone infusion
5602977|NCT00886522|Thiotepa|thiotepa
5602978|NCT00886509|Coronary Artery Disease|coronary artery disease
5602979|NCT00886509|Stable|stable
5602980|NCT00886509|Coronary Collaterals|coronary collaterals
5602981|NCT00886509|Therapeutic Collateral Promotion (TCP)|therapeutic collateral promotion (tcp)
5603052|NCT00886366|Type II Diabetes|type ii diabetes
5603053|NCT00886353|RAS|ras
5602982|NCT00886496|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5602983|NCT00886496|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5602984|NCT00886496|neutropenia|neutropenia
5602985|NCT00886496|infection|infection
5602986|NCT00886496|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5602987|NCT00886496|stage I and II childhood small noncleaved cell lymphoma|stage i and ii childhood small noncleaved cell lymphoma
5602988|NCT00886496|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5602989|NCT00886496|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5602990|NCT00886496|stage III and IV childhood small noncleaved cell lymphoma|stage iii and iv childhood small noncleaved cell lymphoma
5602991|NCT00886496|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5602992|NCT00886496|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5685460|NCT00555997|Major Depression|major depression
5602993|NCT00886496|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5602994|NCT00886496|stage I and II childhood lymphoblastic lymphoma|stage i and ii childhood lymphoblastic lymphoma
5602995|NCT00886496|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5602996|NCT00886496|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5602997|NCT00886496|stage III and IV childhood lymphoblastic lymphoma|stage iii and iv childhood lymphoblastic lymphoma
5602998|NCT00886496|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5602999|NCT00886496|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5603000|NCT00886496|childhood Burkitt lymphoma|childhood burkitt lymphoma
5603001|NCT00886496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5603002|NCT00886496|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5603003|NCT00886496|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5603004|NCT00886496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5603005|NCT00886496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5603006|NCT00886496|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5603007|NCT00886496|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5603008|NCT00886496|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5603009|NCT00886496|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5603010|NCT00886496|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5603011|NCT00886496|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5603012|NCT00886496|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5603013|NCT00886496|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5603014|NCT00886496|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5603015|NCT00886496|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5603016|NCT00886496|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5603017|NCT00886496|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5603018|NCT00886496|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5603019|NCT00886496|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5603020|NCT00886496|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5603021|NCT00886496|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5603022|NCT00886496|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5603028|NCT00886470|pain|pain
5603029|NCT00886470|scarring|scarring
5603030|NCT00886470|vascularity|vascularity
5603031|NCT00886457|Biopsy proven cancer, which is metastatic or unresectable|biopsy proven cancer, which is metastatic or unresectable
5603033|NCT00886431|embryo cryopreservation|embryo cryopreservation
5603034|NCT00886431|vitrification|vitrification
5603035|NCT00886431|slow cooling|slow cooling
5603036|NCT00886431|slow freezing|slow freezing
5603037|NCT00886431|surplus embryos|surplus embryos
5603038|NCT00886431|Human Reproduction|human reproduction
5603039|NCT00886405|Nitroglycerin|nitroglycerin
5763757|NCT00269048|CHD|chd
5603040|NCT00886405|Locally advanced non small-cell lung cancer|locally advanced non small-cell lung cancer
5603041|NCT00886405|Vascular endothelial growth factor|vascular endothelial growth factor
5603042|NCT00886405|Hypoxia Inducible Factor|hypoxia inducible factor
5603043|NCT00886405|Clinical stage IIIA and/or IIIB (without pleural effusion)|clinical stage iiia and/or iiib (without pleural effusion)
5603044|NCT00886392|Clinically Significant Macular Edema|clinically significant macular edema
5603045|NCT00886392|Diabetic Macular Edema|diabetic macular edema
5603046|NCT00886392|Optical Coherence Tomography|optical coherence tomography
5603047|NCT00886392|Diabetic Retinopathy|diabetic retinopathy
5603048|NCT00886392|Severity|severity
5603049|NCT00886379|vitamin d|vitamin d
5603050|NCT00886379|children|children
5603055|NCT00886353|Cardiovascular|cardiovascular
5603056|NCT00886353|Pulmonary|pulmonary
5603057|NCT00886353|Angiotensin II|angiotensin ii
5603058|NCT00886353|Angiotensin 1-7|angiotensin 1-7
5603059|NCT00886340|diabetes prevention, primary care|diabetes prevention, primary care
5603060|NCT00886327|Colonic capsule endoscopy|colonic capsule endoscopy
5603061|NCT00886327|Crohn's disease|crohn's disease
5603062|NCT00886327|Capsule endoscopy|capsule endoscopy
5603063|NCT00886314|children|children
5603064|NCT00886314|surgery|surgery
5588902|NCT00935142|non-curative|non-curative
5603065|NCT00886314|anxiety|anxiety
5603066|NCT00886301|overweight|overweight
5603067|NCT00886301|obesity|obesity
5603068|NCT00886301|steatohepatitis|steatohepatitis
5603069|NCT00886301|ectopic fat|ectopic fat
5603070|NCT00886275|Postoperative sedation in intensive care|postoperative sedation in intensive care
5603071|NCT00886262|liver transplantation|liver transplantation
5603072|NCT00886262|vasopressin|vasopressin
5603073|NCT00886262|renal function|renal function
5603074|NCT00886262|hypotension|hypotension
5603075|NCT00886262|creatinine|creatinine
5603076|NCT00886262|urine output|urine output
5603077|NCT00886262|diuretics|diuretics
5603078|NCT00886262|vasopressors|vasopressors
5603079|NCT00886262|hemodynamic stability|hemodynamic stability
5603082|NCT00886249|Cataract|cataract
5603083|NCT00886236|Gastric Bypass|gastric bypass
5603084|NCT00886236|Gabapentin|gabapentin
5603085|NCT00886236|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5603086|NCT00886236|Analgesics, Opioids|analgesics, opioids
5603087|NCT00886236|Sleep Apnea, Obstructive|sleep apnea, obstructive
5603088|NCT00886236|Respiratory Depression|respiratory depression
5603089|NCT00886236|Oximetry|oximetry
5603090|NCT00886223|vaginal vault prolapse repair|vaginal vault prolapse repair
5603091|NCT00886223|robot-assisted laparoscopic sacropexy|robot-assisted laparoscopic sacropexy
5603092|NCT00886223|robot-assisted laparoscopic sacrocolpopexy|robot-assisted laparoscopic sacrocolpopexy
5603093|NCT00886223|robotic laparoscopic sacropexy|robotic laparoscopic sacropexy
5603094|NCT00886210|drain|drain
5603095|NCT00886210|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5603096|NCT00886210|pneumoperitonum|pneumoperitonum
5603097|NCT00886197|reflux|reflux
5603098|NCT00886197|GERD|gerd
5603099|NCT00886184|Hypothermia|hypothermia
5603100|NCT00886184|Cardiac arrest|cardiac arrest
5603101|NCT00886184|Biomarkers|biomarkers
5603102|NCT00886184|Pre hospital cardiac arrest|pre hospital cardiac arrest
5603103|NCT00886171|social skills|social skills
5603104|NCT00886171|physical activity|physical activity
5603105|NCT00886171|peer relationships|peer relationships
5603106|NCT00886171|childhood obesity|childhood obesity
5603107|NCT00886171|changes in physical activity|changes in physical activity
5603108|NCT00886171|changes in social involvement|changes in social involvement
5603109|NCT00886158|Organ Transplants|organ transplants
5603110|NCT00886145|Spinal Cord Injuries|spinal cord injuries
5603111|NCT00886145|Mechanical Stimulation|mechanical stimulation
5603112|NCT00886145|Vibration Plate|vibration plate
5603113|NCT00886132|Phase 2 Study|phase 2 study
5603114|NCT00886132|Sunitinib|sunitinib
5603115|NCT00886132|Recurrent|recurrent
5603116|NCT00886132|Metastatic|metastatic
5603122|NCT00886106|Hyperalgesia|hyperalgesia
5603123|NCT00886093|pharmacokinetics, single dose, crossover, fed vs fasted state|pharmacokinetics, single dose, crossover, fed vs fasted state
5603124|NCT00886080|Atrial fibrillation|atrial fibrillation
5603125|NCT00886080|Health related Quality of Life|health related quality of life
5603126|NCT00886080|Add-on surgery|add-on surgery
5603127|NCT00886080|Ablation|ablation
5603128|NCT00886080|Randomised controlled trial|randomised controlled trial
5603129|NCT00886080|SF-36|sf-36
5603130|NCT00886080|EuroQoL|euroqol
5603131|NCT00886080|MFI-20|mfi-20
5603132|NCT00886067|AZD1446|azd1446
5603133|NCT00886067|PET examination|pet examination
5603134|NCT00886054|Transcranial Doppler|transcranial doppler
5603135|NCT00886054|Transcranial color-coded duplex sonography|transcranial color-coded duplex sonography
5603136|NCT00886054|Neurocritical patients|neurocritical patients
5603137|NCT00886041|laparoscopy|laparoscopy
5603138|NCT00886041|unexplained infertility|unexplained infertility
5603139|NCT00886028|Malignant pleural mesothelioma|malignant pleural mesothelioma
5603140|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin
5603141|NCT00886028|Progression free survival|progression free survival
5603142|NCT00886028|Patients who received LD 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles|patients who received ld 60mg/m2 plus cisplatin 80 mg/m2 every 4 weeks for 6 cycles
5603143|NCT00886028|Patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of MPM|patients with epithelial, sarcomatoid or biphasic histological confirmed diagnosis of mpm
5603144|NCT00886015|Trachoma|trachoma
5603145|NCT00886015|trichiasis|trichiasis
5603146|NCT00886015|bilamellar tarsal rotation procedure|bilamellar tarsal rotation procedure
5603147|NCT00886002|Healthy volunteers|healthy volunteers
5603148|NCT00885989|SLV338|slv338
5603149|NCT00885989|phase I|phase i
5603150|NCT00885989|healthy volunteers|healthy volunteers
5603151|NCT00885950|colorectal liver metastases|colorectal liver metastases
5603152|NCT00885950|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5603153|NCT00885950|oxaliplatin|oxaliplatin
5603154|NCT00885950|sinusoidal obstruction syndrome|sinusoidal obstruction syndrome
5603155|NCT00885950|anticoagulants|anticoagulants
5603156|NCT00885937|Dexpanthenol|dexpanthenol
5603157|NCT00885937|Safety,|safety,
5603158|NCT00885937|New formulation|new formulation
5603159|NCT00885937|Topical administration|topical administration
5603160|NCT00885924|postoperative Hemorrhage|postoperative hemorrhage
5603161|NCT00885924|Hemorrhage|hemorrhage
5603162|NCT00885924|Vasopressin|vasopressin
5603163|NCT00885924|Blood Loss, Surgical|blood loss, surgical
5603164|NCT00885911|Intubating laryngeal airway|intubating laryngeal airway
5603165|NCT00885911|pediatric|pediatric
5603166|NCT00885911|observational study|observational study
5603167|NCT00885898|Respiratory Insufficiency|respiratory insufficiency
5603168|NCT00885898|Respiratory Failure|respiratory failure
5603169|NCT00885885|Colorectal Cancer|colorectal cancer
5603170|NCT00885885|Panitumumab|panitumumab
5603171|NCT00885885|FOLFOX-4|folfox-4
5603172|NCT00885885|FOLFIRI|folfiri
5603173|NCT00885846|Qigong|qigong
5603174|NCT00885846|Breathing management|breathing management
5603175|NCT00885846|Glucose|glucose
5603176|NCT00885833|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5603177|NCT00885833|HSCT|hsct
5603178|NCT00885820|Kidney Transplantation|kidney transplantation
5603179|NCT00885820|Tacrolimus|tacrolimus
5603180|NCT00885820|Immunosuppression|immunosuppression
5603181|NCT00885820|Graft Survival|graft survival
5603182|NCT00885807|ADHD|adhd
5603183|NCT00885807|WFIRS|wfirs
5603184|NCT00885807|WSR|wsr
5603185|NCT00885794|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
5603186|NCT00885794|Focal Laser|focal laser
5603187|NCT00885794|GRID-Laser|grid-laser
5603188|NCT00885794|Ranibizumab|ranibizumab
5603189|NCT00885794|Lucentis|lucentis
5603190|NCT00885794|Microperimetry|microperimetry
5603191|NCT00885794|High-Definition OCT|high-definition oct
5603192|NCT00885794|Randomized|randomized
5603193|NCT00885794|Observer-Blinded|observer-blinded
5671597|NCT00615355|transplantation|transplantation
5671598|NCT00615355|laser|laser
5603194|NCT00885794|Ineffective Treatment with Focal Laser or GRID-Laser|ineffective treatment with focal laser or grid-laser
5603195|NCT00885768|RAS(renal Artery Stenosis)|ras(renal artery stenosis)
5603196|NCT00885768|Atherosclerosis|atherosclerosis
5603197|NCT00885768|angiography|angiography
5603198|NCT00885742|Hereditary Factor XIII deficiency|hereditary factor xiii deficiency
5603199|NCT00885742|Factor XIII|factor xiii
5603200|NCT00885729|Cartilage defect|cartilage defect
5603201|NCT00885729|chondrocytes|chondrocytes
5603202|NCT00885729|mesenchymal stem cells (MSC)|mesenchymal stem cells (msc)
5603203|NCT00885729|femoral condyle|femoral condyle
5603204|NCT00885729|knee|knee
5603205|NCT00885703|CM|cm
5603206|NCT00885703|HIV|hiv
5603207|NCT00885703|Meningitis|meningitis
5603208|NCT00885690|Schizophrenia|schizophrenia
5603209|NCT00885690|Antipsychotic|antipsychotic
5603210|NCT00885690|Cognition|cognition
5603211|NCT00885664|HIV|hiv
5603212|NCT00885664|immune reconstitution|immune reconstitution
5603213|NCT00885664|treatment naive|treatment naive
5603214|NCT00885651|SNP|snp
5603215|NCT00885651|catecholamines|catecholamines
5603216|NCT00885651|metoprolole|metoprolole
5603217|NCT00885651|healthy subjects|healthy subjects
5603218|NCT00885651|physiological stress|physiological stress
5603219|NCT00885638|GLP-1|glp-1
5603220|NCT00885638|Insulin secretion|insulin secretion
5603221|NCT00885638|Macronutrients|macronutrients
5603222|NCT00885625|invasive pneumococcal disease|invasive pneumococcal disease
5603223|NCT00885625|pneumococcal conjugated vaccine|pneumococcal conjugated vaccine
5603224|NCT00885612|CHD-Risk|chd-risk
5603225|NCT00885612|Breast Cancer|breast cancer
5603226|NCT00885612|Aromatase Inhibitors|aromatase inhibitors
5603227|NCT00885612|postmenopausal early breast cancer|postmenopausal early breast cancer
5603228|NCT00885599|gingivitis|gingivitis
5603229|NCT00885599|natural remedy|natural remedy
5603230|NCT00885599|inflammation|inflammation
5603231|NCT00885599|C-reactive protein|c-reactive protein
5603232|NCT00885599|mouthwash|mouthwash
5603233|NCT00885586|herpes zoster|herpes zoster
5603234|NCT00885586|neuropathic pain|neuropathic pain
5603235|NCT00885586|acupuncture|acupuncture
5603236|NCT00885586|randomised controlled trial|randomised controlled trial
5603237|NCT00885586|acute herpes zoster|acute herpes zoster
5603238|NCT00885573|sleep apnea|sleep apnea
5603239|NCT00885573|pharyngeal sensitivity|pharyngeal sensitivity
5603240|NCT00885573|pharyngeal dilator reflex|pharyngeal dilator reflex
5603241|NCT00885573|diagnosis algorithm|diagnosis algorithm
5603242|NCT00885573|patients with suspected sleep apnea syndrome|patients with suspected sleep apnea syndrome
5603243|NCT00885560|ADHD|adhd
5603244|NCT00885560|SNAP 25|snap 25
5603245|NCT00885560|amphetamine|amphetamine
5603246|NCT00885560|methylphenidate|methylphenidate
5603247|NCT00885534|skin cancer|skin cancer
5603248|NCT00885534|CISPLATIN|cisplatin
5603249|NCT00885534|TEMOZOLOMIDE|temozolomide
5603250|NCT00885534|VINBLASTINE|vinblastine
5603251|NCT00885534|09-017|09-017
5603252|NCT00885508|MDS|mds
5603254|NCT00885508|deletion 5q|deletion 5q
5603255|NCT00885508|Documented diagnosis of MDS, or CMML|documented diagnosis of mds, or cmml
5603256|NCT00885508|with WBC < 13,000/mm3 that meets IPSS criteria for intermediate-2|with wbc < 13,000/mm3 that meets ipss criteria for intermediate-2
5603257|NCT00885508|or high-risk disease, or AML with an associated del 5q[31]|or high-risk disease, or aml with an associated del 5q[31]
5603258|NCT00885508|(the deleted chromosomal region must include 5q[31]),|(the deleted chromosomal region must include 5q[31]),
5680359|NCT00578032|neck|neck
5603259|NCT00885508|with or without additional cytogenetic abnormalities|with or without additional cytogenetic abnormalities
5603260|NCT00885495|HIV|hiv
5603261|NCT00885495|dyslipidemia|dyslipidemia
5603262|NCT00885495|statins|statins
5603263|NCT00885495|protease inhibitors|protease inhibitors
5603264|NCT00885482|HIV/AIDS|hiv/aids
5603265|NCT00885482|HAART|haart
5603266|NCT00885482|Simplification|simplification
5603267|NCT00885482|Atazanavir|atazanavir
5603268|NCT00885482|Lamivudine|lamivudine
5603269|NCT00885482|treatment experienced|treatment experienced
5603270|NCT00885469|known Barrett's Esophagus|known barrett's esophagus
5603271|NCT00885469|Suspected Barrett's Esophagus|suspected barrett's esophagus
5603272|NCT00885469|chronic GERD|chronic gerd
5603273|NCT00885469|known Barrett's Esophagus or chronic GERD|known barrett's esophagus or chronic gerd
5603274|NCT00885456|stroke|stroke
5603275|NCT00885456|secondary prevention|secondary prevention
5603276|NCT00885456|vascular risk|vascular risk
5603277|NCT00885456|behavioral change|behavioral change
5603278|NCT00885456|exercise|exercise
5603279|NCT00885456|lifestyle modification|lifestyle modification
5603280|NCT00885443|propofol|propofol
5603281|NCT00885443|sevoflurane|sevoflurane
5603282|NCT00885443|pediatric|pediatric
5603283|NCT00885443|emergence delirium|emergence delirium
5603284|NCT00885443|Induction of sedation|induction of sedation
5603285|NCT00885430|colonoscopy|colonoscopy
5603286|NCT00885430|preparation|preparation
5603287|NCT00885417|Helicobacter pylori|helicobacter pylori
5603288|NCT00885417|sequential therapy|sequential therapy
5603289|NCT00885417|levofloxacin|levofloxacin
5603290|NCT00885417|clarithromycin|clarithromycin
5603291|NCT00885417|rescue|rescue
5603292|NCT00885417|salvage|salvage
5603293|NCT00885417|treatment failure|treatment failure
5603294|NCT00885417|For those who fail from one standard eradication therapy for H. pylori infection|for those who fail from one standard eradication therapy for h. pylori infection
5603295|NCT00885404|chloride|chloride
5603296|NCT00885404|acidosis|acidosis
5603297|NCT00885391|Atrial Fibrillation|atrial fibrillation
5603298|NCT00885391|Cardioversion|cardioversion
5603299|NCT00885391|Direct Current Cardioversion|direct current cardioversion
5603300|NCT00885391|QT Interval|qt interval
5603301|NCT00885365|cystic fibrosis|cystic fibrosis
5603302|NCT00885365|P. aeruginosa|p. aeruginosa
5603303|NCT00885365|tobramycin|tobramycin
5603304|NCT00885339|Colonic Diseases|colonic diseases
5603305|NCT00885326|recurrent neuroblastoma|recurrent neuroblastoma
5603307|NCT00885313|NASH|nash
5603308|NCT00885313|fibrosis|fibrosis
5603310|NCT00885287|HIV/AIDS|hiv/aids
5603311|NCT00885287|drug interactions|drug interactions
5603312|NCT00885287|antimalarial drug efficacy|antimalarial drug efficacy
5603313|NCT00885287|antiretrovirals|antiretrovirals
5603314|NCT00885287|pharmacovigilance|pharmacovigilance
5603315|NCT00885287|Tanzania|tanzania
5603316|NCT00885261|chronic pain and metabolic syndrome|chronic pain and metabolic syndrome
5603317|NCT00885248|pancreatic cancer|pancreatic cancer
5603318|NCT00885248|integrated PET-CT|integrated pet-ct
5603319|NCT00885235|Bowel Diseases|bowel diseases
5603320|NCT00885222|Parkinson's disease|parkinson's disease
5603321|NCT00885222|Major depressive disorder|major depressive disorder
5603322|NCT00885222|Deep brain stimulation|deep brain stimulation
5603323|NCT00885209|Colonic Diseases|colonic diseases
5603324|NCT00885196|Psoriasis|psoriasis
5603325|NCT00885196|plaque psoriasis|plaque psoriasis
5603326|NCT00885196|inflammatory skin disease|inflammatory skin disease
5603327|NCT00885196|scaly patches|scaly patches
5603328|NCT00885196|AEB071|aeb071
5603329|NCT00885183|breast cancer|breast cancer
5603330|NCT00885183|chemotherapy|chemotherapy
5603331|NCT00885183|adjuvant therapy|adjuvant therapy
5603332|NCT00885183|acupuncture|acupuncture
5603333|NCT00885183|fatigue|fatigue
5603334|NCT00885183|Early stage breast cancer patients|early stage breast cancer patients
5603335|NCT00885157|Poliomyelitis|poliomyelitis
5603336|NCT00885157|intradermal|intradermal
5603337|NCT00885144|Stunting|stunting
5603338|NCT00885144|Growth failure|growth failure
5603339|NCT00885144|Malnutrition|malnutrition
5603340|NCT00885144|Lipid based nutrient supplement|lipid based nutrient supplement
5603342|NCT00885144|Prevention|prevention
5603343|NCT00885144|Malawi|malawi
5603344|NCT00885144|Sub-Saharan Africa|sub-saharan africa
5603345|NCT00885144|Dietary supplementation|dietary supplementation
5603346|NCT00885131|Reward Processing|reward processing
5603347|NCT00885131|Motor Cortex|motor cortex
5603348|NCT00885131|HV|hv
5603349|NCT00885131|Healthy Volunteer|healthy volunteer
5603350|NCT00885105|Fluzone® vaccine|fluzone® vaccine
5603351|NCT00885105|Influenza|influenza
5603352|NCT00885092|Contact lenses|contact lenses
5603353|NCT00885092|Disinfecting solutions|disinfecting solutions
5603354|NCT00885066|stage III pancreatic cancer|stage iii pancreatic cancer
5603355|NCT00885066|stage IV pancreatic cancer|stage iv pancreatic cancer
5603356|NCT00885066|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5603357|NCT00885066|recurrent pancreatic cancer|recurrent pancreatic cancer
5603358|NCT00885053|Inflammation|inflammation
5603359|NCT00885053|Fatty acids, Omega 3|fatty acids, omega 3
5603360|NCT00885053|Leukotrienes|leukotrienes
5603361|NCT00885053|Adiponectin|adiponectin
5603362|NCT00885053|Adipose tissue|adipose tissue
5603363|NCT00885053|RNA, Messenger|rna, messenger
5603364|NCT00885040|Neurofeedback|neurofeedback
5603365|NCT00885040|Tourette Syndrome|tourette syndrome
5603366|NCT00885040|Healthy Volunteer|healthy volunteer
5603367|NCT00885040|Movement Disorder|movement disorder
5603368|NCT00885040|Brain Activity|brain activity
5603370|NCT00885040|HV|hv
5603371|NCT00885014|Depressive disorder|depressive disorder
5603372|NCT00885014|Behavior therapy|behavior therapy
5603373|NCT00885014|Workplace|workplace
5603374|NCT00885014|Subthreshold depression|subthreshold depression
5603375|NCT00884988|ankle fracture|ankle fracture
5603376|NCT00884988|edema|edema
5603377|NCT00884988|surgical repair|surgical repair
5603378|NCT00884988|homeopathy|homeopathy
5603379|NCT00884988|lymphomyosot|lymphomyosot
5603380|NCT00884975|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5603381|NCT00884975|exacerbations|exacerbations
5603382|NCT00884975|quality of life|quality of life
5603383|NCT00884975|emphysema|emphysema
5603384|NCT00884962|emphysema|emphysema
5603385|NCT00884962|aeris|aeris
5603386|NCT00884962|PLVR|plvr
5603387|NCT00884962|BLVR|blvr
5603388|NCT00884962|germany|germany
5603389|NCT00884962|treatment|treatment
5603390|NCT00884962|device|device
5603391|NCT00884962|breathing|breathing
5603392|NCT00884949|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5603393|NCT00884949|MPS IV Type A|mps iv type a
5603394|NCT00884949|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5603395|NCT00884949|MPS IVA|mps iva
5603396|NCT00884949|Morquio A Syndrome|morquio a syndrome
5603397|NCT00884949|Lysosomal Storage Disorder|lysosomal storage disorder
5603399|NCT00884949|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5603400|NCT00884949|N-acetylgalactosamine-6-sulfate sulfatase|n-acetylgalactosamine-6-sulfate sulfatase
5603401|NCT00884949|galactose-6-sulfatase|galactose-6-sulfatase
5603402|NCT00884949|GALNS|galns
5603403|NCT00884949|enzyme replacement therapy|enzyme replacement therapy
5603404|NCT00884949|ERT|ert
5603405|NCT00884936|Skin|skin
5603406|NCT00884936|Aging|aging
5603407|NCT00884936|Dermogenomics|dermogenomics
5603408|NCT00884936|Genetic|genetic
5603409|NCT00884936|Biomarker|biomarker
5603410|NCT00884936|Dermatology|dermatology
5603411|NCT00884910|laryngectomy|laryngectomy
5603412|NCT00884910|Provox Vega|provox vega
5603414|NCT00884897|Social Cognition|social cognition
5603415|NCT00884897|Schizophrenia|schizophrenia
5603416|NCT00884897|Oxytocin|oxytocin
5603417|NCT00884884|Alcohol dependence|alcohol dependence
5603418|NCT00884884|alcohol abuse|alcohol abuse
5603419|NCT00884884|topiramate|topiramate
5603420|NCT00884884|aripiprazole|aripiprazole
5603421|NCT00884871|pelvic floor disorders|pelvic floor disorders
5603422|NCT00884871|weight loss|weight loss
5603423|NCT00884858|HIV-1|hiv-1
5603425|NCT00884858|INR|inr
5603426|NCT00884858|HIV-1 infection|hiv-1 infection
5603427|NCT00884858|extreme immunological compromission|extreme immunological compromission
5603428|NCT00884858|treatment experienced|treatment experienced
5603429|NCT00884845|PM2734|pm2734
5603430|NCT00884845|Tumors|tumors
5603431|NCT00884845|PharmaMar|pharmamar
5603432|NCT00884845|Erlotinib|erlotinib
5603433|NCT00884845|Tarceva|tarceva
5603434|NCT00884832|fecal incontinence|fecal incontinence
5603435|NCT00884832|stool leakage|stool leakage
5603436|NCT00884832|incontinence|incontinence
5603438|NCT00884832|Urge predominant fecal incontinence|urge predominant fecal incontinence
5603439|NCT00884819|polycystic ovary syndrome|polycystic ovary syndrome
5603440|NCT00884819|hepatic adiposity|hepatic adiposity
5603441|NCT00884819|diabetes|diabetes
5603442|NCT00884819|hormones|hormones
5603443|NCT00884819|cardiovascular disease|cardiovascular disease
5603444|NCT00884806|Contact lenses|contact lenses
5603445|NCT00884806|Disinfecting solutions|disinfecting solutions
5603446|NCT00884793|HIV|hiv
5586419|NCT00945087|MRSA|mrsa
5603447|NCT00884793|persistence|persistence
5603448|NCT00884793|reservoirs|reservoirs
5603449|NCT00884793|residual replication|residual replication
5603450|NCT00884793|gut|gut
5603451|NCT00884793|gut-associated lymphoid tissue|gut-associated lymphoid tissue
5603452|NCT00884793|treatment experienced|treatment experienced
5603453|NCT00884780|Electronic Diary|electronic diary
5603454|NCT00884780|Body Map|body map
5603455|NCT00884780|Electronic Measure of Pediatric Pain|electronic measure of pediatric pain
5603456|NCT00884767|neurotoxicity|neurotoxicity
5603457|NCT00884767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5603458|NCT00884767|recurrent colon cancer|recurrent colon cancer
5603459|NCT00884767|stage I colon cancer|stage i colon cancer
5603460|NCT00884767|stage II colon cancer|stage ii colon cancer
5603461|NCT00884767|stage III colon cancer|stage iii colon cancer
5603462|NCT00884767|stage IV colon cancer|stage iv colon cancer
5603463|NCT00884767|recurrent rectal cancer|recurrent rectal cancer
5680360|NCT00578032|cancer|cancer
5603464|NCT00884767|stage I rectal cancer|stage i rectal cancer
5603465|NCT00884767|stage II rectal cancer|stage ii rectal cancer
5603466|NCT00884767|stage III rectal cancer|stage iii rectal cancer
5603467|NCT00884767|stage IV rectal cancer|stage iv rectal cancer
5603468|NCT00884728|Scabies|scabies
5603469|NCT00884728|Impetigo|impetigo
5603470|NCT00884728|Pyoderma|pyoderma
5603471|NCT00884728|Streptococcal infections|streptococcal infections
5603472|NCT00884702|Sleep|sleep
5603473|NCT00884702|14C-Leucine|14c-leucine
5603474|NCT00884702|Cerebral Protein Synthesis|cerebral protein synthesis
5603475|NCT00884702|Memory|memory
5603476|NCT00884702|Positron Emission Tomography (PET)|positron emission tomography (pet)
5603477|NCT00884702|HV|hv
5603478|NCT00884702|Healthy Volunteer|healthy volunteer
5603479|NCT00884689|Symbicort SMART|symbicort smart
5603480|NCT00884689|Free Combination GCS/LABA treatment|free combination gcs/laba treatment
5603481|NCT00884676|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5603482|NCT00884650|Pain|pain
5603483|NCT00884650|Pain management|pain management
5603484|NCT00884650|Cerebral Palsy|cerebral palsy
5603485|NCT00884637|HMP|hmp
5603486|NCT00884637|CNV|cnv
5603487|NCT00884637|AMD|amd
5603488|NCT00884637|PHP|php
5603489|NCT00884637|HPHP|hphp
5603490|NCT00884637|foresee home|foresee home
5603491|NCT00884624|Bowel Diseases|bowel diseases
5603492|NCT00884598|adult tumors metastatic to brain|adult tumors metastatic to brain
5603493|NCT00884598|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5603494|NCT00884598|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5787377|NCT00158821|HIV|hiv
5603495|NCT00884559|Leadership|leadership
5603496|NCT00884559|Team building|team building
5603497|NCT00884559|Resuscitation|resuscitation
5603498|NCT00884533|QTc|qtc
5603499|NCT00884533|pharmacokinetics|pharmacokinetics
5603500|NCT00884533|rosiglitazone XR|rosiglitazone xr
5603501|NCT00884533|cardiac conduction|cardiac conduction
5603502|NCT00884533|healthy volunteers|healthy volunteers
5603503|NCT00884520|[F-18]VM4-037|[f-18]vm4-037
5603504|NCT00884520|VM4-037|vm4-037
5603505|NCT00884520|hypoxia|hypoxia
5603506|NCT00884520|CA-IX|ca-ix
5603507|NCT00884520|CAIX|caix
5603508|NCT00884520|carbonic anhydrase IX|carbonic anhydrase ix
5603509|NCT00884520|hypoxia marker|hypoxia marker
5603510|NCT00884520|lung cancer|lung cancer
5603511|NCT00884520|renal carcinoma|renal carcinoma
5603513|NCT00884520|hepatic carcinoma|hepatic carcinoma
5603514|NCT00884520|head and neck cancer|head and neck cancer
5598371|NCT00900029|VLU|vlu
5603515|NCT00884520|advanced stage lung cancer|advanced stage lung cancer
5603517|NCT00884494|Obesity|obesity
5603518|NCT00884494|Insulin resistance|insulin resistance
5603519|NCT00884494|Ghrelin|ghrelin
5603520|NCT00884468|Anxiety and depression in patients with psoriatic arthritis|anxiety and depression in patients with psoriatic arthritis
5603521|NCT00884455|tissue banking, research|tissue banking, research
5603522|NCT00884442|Healthy|healthy
5603523|NCT00884442|Bioavailability|bioavailability
5603524|NCT00884442|Nifedipine|nifedipine
5603525|NCT00884429|Chest physiotherapy|chest physiotherapy
5603526|NCT00884416|high grade glioma|high grade glioma
5603527|NCT00884416|glioblastoma|glioblastoma
5603528|NCT00884416|gliosarcoma|gliosarcoma
5603529|NCT00884416|anaplastic astrocytoma|anaplastic astrocytoma
5603530|NCT00884416|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5603531|NCT00884416|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5603532|NCT00884416|phase I|phase i
5603533|NCT00884416|first line treatment|first line treatment
5603534|NCT00884416|sorafenib|sorafenib
5603535|NCT00884416|temozolomide|temozolomide
5603536|NCT00884416|radiation therapy|radiation therapy
5603537|NCT00884416|safety|safety
5603538|NCT00884416|tolerability|tolerability
5603539|NCT00884416|protein kinase inhibitors|protein kinase inhibitors
5603540|NCT00884403|abortion|abortion
5603541|NCT00884403|pregnancy dating|pregnancy dating
5603542|NCT00884403|gestational age|gestational age
5603543|NCT00884403|ultrasound|ultrasound
5603544|NCT00884390|Hemophilia A|hemophilia a
5603545|NCT00884364|Lymphoma|lymphoma
5603546|NCT00884364|Leukemia|leukemia
5603547|NCT00884364|Multiple myeloma|multiple myeloma
5603548|NCT00884364|Hodgkin´s disease|hodgkin´s disease
5603549|NCT00884364|Exercise|exercise
5603550|NCT00884364|Sport|sport
5603551|NCT00884364|Fatigue|fatigue
5603552|NCT00884364|Hematological neoplastic diseases|hematological neoplastic diseases
5603553|NCT00884351|Epilepsy|epilepsy
5603554|NCT00884351|MEG|meg
5603555|NCT00884351|Seizures|seizures
5603556|NCT00884338|Fatigue|fatigue
5603557|NCT00884338|Cancer|cancer
5603558|NCT00884338|Cognitive impairment|cognitive impairment
5603559|NCT00884338|Exercise|exercise
5603560|NCT00884338|Sport|sport
5603561|NCT00884338|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5603562|NCT00884338|High-dose chemotherapy|high-dose chemotherapy
5603563|NCT00884325|Itching|itching
5603564|NCT00884325|Atopic Dermatitis|atopic dermatitis
5603565|NCT00884312|Multiple myeloma|multiple myeloma
5603566|NCT00884312|proteasome|proteasome
5603567|NCT00884312|Hematological|hematological
5603568|NCT00884312|carfilzomib|carfilzomib
5603569|NCT00884312|PR-171|pr-171
5603570|NCT00884299|Lung function|lung function
5603571|NCT00884299|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5603572|NCT00884299|Antioxidants|antioxidants
5603573|NCT00884286|Aplidin|aplidin
5603574|NCT00884286|Aggressive Non Hodgkin Lymphoma|aggressive non hodgkin lymphoma
5603575|NCT00884286|Leukemia-Lymphoma, Adult T-Cell and B-cell|leukemia-lymphoma, adult t-cell and b-cell
5603576|NCT00884260|Contraception|contraception
5603577|NCT00884260|Intrauterine contraception system|intrauterine contraception system
5603578|NCT00884247|GERD|gerd
5603579|NCT00884247|Quality of life|quality of life
5603580|NCT00884247|Structured treatment|structured treatment
5603581|NCT00884234|Lateral Canthal Lines|lateral canthal lines
5603582|NCT00884234|Crow's Feet|crow's feet
5603583|NCT00884234|Facial Wrinkles|facial wrinkles
5603584|NCT00884234|Lateral Canthal Area|lateral canthal area
5603585|NCT00884195|Obesity|obesity
5603586|NCT00884182|Influenza|influenza
5603587|NCT00884182|Orthomyxoviruses|orthomyxoviruses
5603588|NCT00884182|Split Virion Pandemic Influenza Vaccine|split virion pandemic influenza vaccine
5603589|NCT00884182|A/H5N1|a/h5n1
5603590|NCT00884143|tamoxifen|tamoxifen
5603591|NCT00884143|arimidex|arimidex
5603592|NCT00884143|adjuvant hormonal therapies|adjuvant hormonal therapies
5603593|NCT00884143|breast cancer|breast cancer
5603594|NCT00884143|post-menopausal|post-menopausal
5603595|NCT00884143|Adjuvant hormonal therapy in patients post menopausal with breast cancer|adjuvant hormonal therapy in patients post menopausal with breast cancer
5603596|NCT00884130|Laparoscopy|laparoscopy
5603597|NCT00884130|Colorectal surgery|colorectal surgery
5603598|NCT00884130|Quality of life|quality of life
5603599|NCT00884130|economic analysis|economic analysis
5603600|NCT00884130|Patients undergoing laparoscopic colorectal surgery|patients undergoing laparoscopic colorectal surgery
5603601|NCT00884104|Solifenacin|solifenacin
5603602|NCT00884104|Tamsulosin|tamsulosin
5603604|NCT00884091|Chinese|chinese
5603605|NCT00884091|Glucagon-like peptide 1|glucagon-like peptide 1
5603606|NCT00884091|Glucagon|glucagon
5603607|NCT00884091|Insulin|insulin
5603608|NCT00884091|Mixed meals|mixed meals
5603609|NCT00884091|Healthy Adults|healthy adults
5606218|NCT00873444|Hip|hip
5603610|NCT00884078|Self harm in south asian women|self harm in south asian women
5603611|NCT00884078|depression|depression
5603612|NCT00884078|suicidal ideations|suicidal ideations
5603613|NCT00884078|problem solving training|problem solving training
5603621|NCT00884039|intraocular pressure|intraocular pressure
5603623|NCT00884026|Cesarean delivery|cesarean delivery
5603624|NCT00884026|hypotension|hypotension
5603625|NCT00884026|Augmentation Index|augmentation index
5603626|NCT00884026|Pulse Wave analysis|pulse wave analysis
5603627|NCT00884026|spinal anesthesia|spinal anesthesia
5603628|NCT00884026|Hypotension following spinal anesthesia for cesarean delivery|hypotension following spinal anesthesia for cesarean delivery
5603629|NCT00884013|Pay for Quality|pay for quality
5603630|NCT00884013|Provider|provider
5603631|NCT00884013|Clinical Decision Support|clinical decision support
5603632|NCT00884013|Quality Reporting|quality reporting
5603633|NCT00884013|Quality Measurement|quality measurement
5603634|NCT00883974|preterm bith|preterm bith
5603635|NCT00883974|neurodevelopment|neurodevelopment
5603636|NCT00883974|sensitivity training|sensitivity training
5603637|NCT00883974|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5603638|NCT00883974|Infant neurodevelopment following preterm birth|infant neurodevelopment following preterm birth
5603639|NCT00883961|High-dose chemotherapy|high-dose chemotherapy
5603640|NCT00883961|Hematological neoplasties|hematological neoplasties
5603641|NCT00883961|Fatigue|fatigue
5603642|NCT00883961|Cancer|cancer
5603643|NCT00883961|Exercise|exercise
5603644|NCT00883961|Sport|sport
5603645|NCT00883961|Hematologic neoplastic disorders|hematologic neoplastic disorders
5603646|NCT00883948|Acute Lung Injury|acute lung injury
5603647|NCT00883948|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5603648|NCT00883948|Feeding|feeding
5603649|NCT00883948|Critical Care|critical care
5603650|NCT00883948|Ventilator|ventilator
5603651|NCT00883935|GSK1349572|gsk1349572
5603652|NCT00883935|Atazanavir|atazanavir
5603653|NCT00883935|Ritonavir|ritonavir
5603654|NCT00883935|Reyataz|reyataz
5603655|NCT00883935|Norvir|norvir
5603656|NCT00883935|healthy|healthy
5603657|NCT00883935|pharmacokinetic|pharmacokinetic
5603658|NCT00883909|Prostate Cancer|prostate cancer
5603659|NCT00883909|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5603660|NCT00883896|Rheumatoid Arthritis|rheumatoid arthritis
5603662|NCT00883896|Methotrexate|methotrexate
5603663|NCT00883896|Interleukin-22|interleukin-22
5603664|NCT00883883|Antibiotic|antibiotic
5603665|NCT00883870|mesenchymal stem cells|mesenchymal stem cells
5603666|NCT00883870|critical limb ischemia|critical limb ischemia
5603667|NCT00883844|Hepatitis B|hepatitis b
5603668|NCT00883844|sustained response|sustained response
5603669|NCT00883844|peginterferon|peginterferon
5603670|NCT00883844|nucleos(t)ide analogues|nucleos(t)ide analogues
5603671|NCT00883831|Acupuncture|acupuncture
5603672|NCT00883831|Hemodialysis|hemodialysis
5603673|NCT00883831|Symptom|symptom
5603674|NCT00883831|end stage renal disease|end stage renal disease
5603675|NCT00883831|chronic kidney disease|chronic kidney disease
5603676|NCT00883831|supportive care|supportive care
5603677|NCT00883818|Overactive bladder|overactive bladder
5603678|NCT00883818|Mycoplasma|mycoplasma
5603679|NCT00883805|Metal Ion Concentration|metal ion concentration
5603680|NCT00883805|Osteolysis|osteolysis
5603681|NCT00883766|Polycystic Ovary Syndrome|polycystic ovary syndrome
5603682|NCT00883766|GnRH Antagonist|gnrh antagonist
5603683|NCT00883766|Long Agonist Protocol|long agonist protocol
5603684|NCT00883766|OHSS|ohss
5603813|NCT00883233|Acne|acne
5603685|NCT00883740|Fibromyalgia sleep maintenance disturbance pregabalin|fibromyalgia sleep maintenance disturbance pregabalin
5603686|NCT00883727|mesenchymal stem cells|mesenchymal stem cells
5603687|NCT00883727|myocardial infarction|myocardial infarction
5603688|NCT00883714|Exercise|exercise
5603689|NCT00883714|sport|sport
5603690|NCT00883714|Allogeneic blood stem cell transplantation|allogeneic blood stem cell transplantation
5603691|NCT00883714|Blood stem cell transplantation|blood stem cell transplantation
5603692|NCT00883714|Fatigue|fatigue
5603693|NCT00883714|Cancer|cancer
5603694|NCT00883714|Physical performance|physical performance
5603695|NCT00883714|Mood|mood
5603696|NCT00883714|Complications|complications
5603697|NCT00883701|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5603698|NCT00883701|exacerbations|exacerbations
5603699|NCT00883701|perforin|perforin
5603700|NCT00883701|granzymes|granzymes
5603701|NCT00883688|Brain Tumor|brain tumor
5603702|NCT00883688|Recurrent Ependymoma|recurrent ependymoma
5603703|NCT00883688|Refractory Ependymoma|refractory ependymoma
5603704|NCT00883688|Intracranial ependymoma|intracranial ependymoma
5603705|NCT00883688|Ependymoblastoma|ependymoblastoma
5603706|NCT00883688|Subependymoma|subependymoma
5603707|NCT00883688|Myxopapillary|myxopapillary
5603708|NCT00883688|Clear cell|clear cell
5603709|NCT00883688|Anaplastic|anaplastic
5603710|NCT00883688|Bevacizumab|bevacizumab
5603711|NCT00883688|Avastin|avastin
5603712|NCT00883688|Anti-VEGF Monoclonal Antibody|anti-vegf monoclonal antibody
5603713|NCT00883688|rhuMAb-VEGF|rhumab-vegf
5603714|NCT00883688|Lapatinib|lapatinib
5603715|NCT00883688|Tykerb|tykerb
5603716|NCT00883688|GW572016|gw572016
5603717|NCT00883675|Lung cancer|lung cancer
5603718|NCT00883675|Adjuvant therapy|adjuvant therapy
5603719|NCT00883649|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5603720|NCT00883649|Dry Eyes|dry eyes
5603721|NCT00883649|Post-menopausal|post-menopausal
5603722|NCT00883636|Podocyte Protein|podocyte protein
5603723|NCT00883636|Podocyte Mutation|podocyte mutation
5603724|NCT00883623|AL-Amyloidosis|al-amyloidosis
5603725|NCT00883623|Lenalidomide|lenalidomide
5603726|NCT00883610|QT Interval|qt interval
5603727|NCT00883610|Dual Chamber Pacemaker|dual chamber pacemaker
5603728|NCT00883610|Atrial Fibrillation|atrial fibrillation
5603729|NCT00883584|Proof of Concept|proof of concept
5603730|NCT00883584|Inflammatory Markers|inflammatory markers
5603731|NCT00883584|Lung Function|lung function
5603732|NCT00883584|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5603733|NCT00883584|COPD|copd
5603734|NCT00883571|anal stenosis|anal stenosis
5603735|NCT00883571|flaps|flaps
5603736|NCT00883571|anoplasty|anoplasty
5603737|NCT00883558|recombinant human hyaluronidase (rHuPH20)|recombinant human hyaluronidase (rhuph20)
5603738|NCT00883558|Insulin lispro|insulin lispro
5603739|NCT00883558|regular human insulin|regular human insulin
5603740|NCT00883545|Adherence to screening colonoscopy in women|adherence to screening colonoscopy in women
5603741|NCT00883532|Preterm infant|preterm infant
5603742|NCT00883532|Respiratory distress syndrome|respiratory distress syndrome
5603743|NCT00883532|chronic lung disease|chronic lung disease
5603744|NCT00883532|budesonide|budesonide
5603745|NCT00883532|surfactant|surfactant
5603746|NCT00883493|Acute bipolar depression|acute bipolar depression
5603747|NCT00883493|Lithium carbonate|lithium carbonate
5603748|NCT00883493|quetiapine fumarate|quetiapine fumarate
5603749|NCT00883493|MADRS|madrs
5603750|NCT00883480|NSCLC|nsclc
5603751|NCT00883467|Ischemic Preconditioning|ischemic preconditioning
5603752|NCT00883467|functional MRI|functional mri
5603753|NCT00883467|BOLD|bold
5603754|NCT00883467|Reperfusion|reperfusion
5603755|NCT00883454|hepatocellular carcinoma|hepatocellular carcinoma
5603756|NCT00883454|liver tumor|liver tumor
5603757|NCT00883454|cirrhosis|cirrhosis
5603758|NCT00883454|liver resection|liver resection
5603759|NCT00883454|tumor staging|tumor staging
5603760|NCT00883454|liver disease staging|liver disease staging
5603761|NCT00883441|IMPLEMENTATION RESEARCH|implementation research
5603763|NCT00883441|VECTOR CONTROL|vector control
5603764|NCT00883428|low back pain|low back pain
5603765|NCT00883428|pelvic pain|pelvic pain
5603766|NCT00883428|pregnancy|pregnancy
5603767|NCT00883415|metabolism|metabolism
5603768|NCT00883415|myocardium|myocardium
5603769|NCT00883415|chronic kidney disease|chronic kidney disease
5603770|NCT00883402|Carotid stenosis|carotid stenosis
5603772|NCT00883402|CAS|cas
5603773|NCT00883402|Stenting|stenting
5603774|NCT00883389|patient safety|patient safety
5603775|NCT00883389|chronic kidney disease|chronic kidney disease
5603776|NCT00883389|med-alert|med-alert
5603777|NCT00883376|Classification of Stanford for Snoring|classification of stanford for snoring
5603778|NCT00883376|OSAS|osas
5603779|NCT00883376|Apnea-Hipopnea Index|apnea-hipopnea index
5603780|NCT00883363|precondition|precondition
5603781|NCT00883363|ruptured abdominal aortic aneurysm|ruptured abdominal aortic aneurysm
5685461|NCT00555997|Depression|depression
5603782|NCT00883363|myocardial infarction|myocardial infarction
5603783|NCT00883350|Body weight changes|body weight changes
5603784|NCT00883350|Overweight|overweight
5603785|NCT00883350|Obesity|obesity
5603786|NCT00883337|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5603788|NCT00883324|fetal fibronectin|fetal fibronectin
5603789|NCT00883324|non-speculum|non-speculum
5603790|NCT00883324|risk of preterm delivery|risk of preterm delivery
5603791|NCT00883311|Efficacy|efficacy
5603792|NCT00883298|temozolomide|temozolomide
5603793|NCT00883298|bevacizumab|bevacizumab
5603794|NCT00883298|Temodar|temodar
5603795|NCT00883298|Avastin|avastin
5603796|NCT00883298|glioblastoma multiforme|glioblastoma multiforme
5603797|NCT00883298|gliosarcoma|gliosarcoma
5603798|NCT00883298|glioma|glioma
5603799|NCT00883298|GBM|gbm
5603800|NCT00883298|brain tumor|brain tumor
5603801|NCT00883272|Menopause|menopause
5603802|NCT00883272|Thrombophilia|thrombophilia
5603803|NCT00883272|factor V Leiden|factor v leiden
5603804|NCT00883272|Estrogen Replacement Therapy|estrogen replacement therapy
5603805|NCT00883272|Hypercoagulability|hypercoagulability
5603806|NCT00883272|Venous Thrombosis|venous thrombosis
5603807|NCT00883259|High-risk patients|high-risk patients
5603808|NCT00883259|Metformin|metformin
5603810|NCT00883259|Pregnancy complications|pregnancy complications
5603811|NCT00883259|Previous gestational DM|previous gestational dm
5603814|NCT00883220|self management|self management
5603815|NCT00883220|chronic condition|chronic condition
5603816|NCT00883220|urinary catheter|urinary catheter
5603817|NCT00883207|Depression|depression
5603818|NCT00883207|family therapy|family therapy
5603819|NCT00883207|dialogical processes|dialogical processes
5603820|NCT00883207|Developing couple therapy for depression|developing couple therapy for depression
5603821|NCT00883194|Experimental Pain Model|experimental pain model
5603822|NCT00883155|Antidepressant|antidepressant
5603823|NCT00883142|Lokomat|lokomat
5603824|NCT00883142|Suspended walking|suspended walking
5603825|NCT00883142|Body Weight Supported|body weight supported
5603826|NCT00883142|Treadmill Training|treadmill training
5603827|NCT00883129|Systemic Sclerosis|systemic sclerosis
5603828|NCT00883129|Mycophenolate Mofetil|mycophenolate mofetil
5603829|NCT00883129|Cyclophosphamide|cyclophosphamide
5603830|NCT00883129|High Resolution Computerized Tomography|high resolution computerized tomography
5603831|NCT00883129|Pulmonary Function|pulmonary function
5603832|NCT00883129|Dyspnea|dyspnea
5603833|NCT00883129|Health Related Quality of Life|health related quality of life
5603834|NCT00883103|female urethral catheterization|female urethral catheterization
5603835|NCT00883103|Lidocaine|lidocaine
5603836|NCT00883103|lubricant|lubricant
5603837|NCT00883103|Q-tip test|q-tip test
5603838|NCT00883103|Q tip test|q tip test
5603839|NCT00883103|K-Y jelly|k-y jelly
5603840|NCT00883103|pain perception|pain perception
5603841|NCT00883103|straight catheterization|straight catheterization
5603842|NCT00883090|Factor XIII|factor xiii
5603843|NCT00883077|permeability|permeability
5603844|NCT00883077|inflammatory bowel disease|inflammatory bowel disease
5603845|NCT00883077|confocal laser endomicroscopy|confocal laser endomicroscopy
5603846|NCT00883077|irritable bowel syndrome|irritable bowel syndrome
5603847|NCT00883051|COL-144|col-144
5603848|NCT00883051|acute treatment|acute treatment
5603849|NCT00883051|migraine|migraine
5603850|NCT00883038|insulin resistance|insulin resistance
5603851|NCT00883038|vegetarian diet|vegetarian diet
5603852|NCT00883025|Friedman Classification|friedman classification
5603853|NCT00883025|Apnea-Hypopnea Index|apnea-hypopnea index
5603854|NCT00883025|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5603855|NCT00883012|Viral-confirmed|viral-confirmed
5603856|NCT00882999|Relapsing|relapsing
5603857|NCT00882999|Remitting|remitting
5603858|NCT00882999|Multiple Sclerosis|multiple sclerosis
5603859|NCT00882999|Multiple|multiple
5603860|NCT00882999|Sclerosis|sclerosis
5603862|NCT00882999|LY2127399|ly2127399
5603863|NCT00882986|insulin resistance|insulin resistance
5603864|NCT00882960|pre-hospital|pre-hospital
5603865|NCT00882960|intra-nasal fentanyl|intra-nasal fentanyl
5603866|NCT00882960|patients requiring analgesia|patients requiring analgesia
5603867|NCT00882947|Primary Pulmonary Hypertension (PPH)|primary pulmonary hypertension (pph)
5603868|NCT00882934|Placebo|placebo
5603869|NCT00882934|Placebo Effect|placebo effect
5603870|NCT00882934|Sexual Dysfunction|sexual dysfunction
5603871|NCT00882934|Erectile Dysfunction|erectile dysfunction
5603872|NCT00882934|Clinical Trial|clinical trial
5603873|NCT00882921|MPS 2|mps 2
5603874|NCT00882921|MPSII|mpsii
5603875|NCT00882921|hunter's disease treatment|hunter's disease treatment
5603876|NCT00882921|enzyme replacement therapy|enzyme replacement therapy
5603877|NCT00882921|hunter's disease|hunter's disease
5603878|NCT00882921|iduronate 2 sulfatase|iduronate 2 sulfatase
5603879|NCT00882921|mps diagnosis|mps diagnosis
5603880|NCT00882921|mps symptoms|mps symptoms
5603881|NCT00882921|iduronate sulfatase|iduronate sulfatase
5603882|NCT00882921|MPS II treatment|mps ii treatment
5603883|NCT00882921|chronic ear infection|chronic ear infection
5603884|NCT00882921|hunters syndrome|hunters syndrome
5603885|NCT00882921|mps ii therapy|mps ii therapy
5603886|NCT00882921|MPS2|mps2
5603887|NCT00882921|hunter's syndrome|hunter's syndrome
5603888|NCT00882921|Hunter syndrome|hunter syndrome
5603889|NCT00882921|elaprase|elaprase
5603890|NCT00882921|lysosomal storage disease|lysosomal storage disease
5603891|NCT00882921|hunter syndrome therapy|hunter syndrome therapy
5603892|NCT00882921|mps society|mps society
5603893|NCT00882921|hunter syndrome treatment|hunter syndrome treatment
5603894|NCT00882921|hunter's syndrome treatment|hunter's syndrome treatment
5603895|NCT00882921|mucopolysaccharides|mucopolysaccharides
5603896|NCT00882921|mps ii|mps ii
5603897|NCT00882921|idursulfase|idursulfase
5603898|NCT00882921|hunters disease|hunters disease
5603899|NCT00882921|enlarged adenoids|enlarged adenoids
5603900|NCT00882921|ert treatment|ert treatment
5603901|NCT00882921|hunter disease|hunter disease
5603902|NCT00882921|lysosomal storage disorder|lysosomal storage disorder
5603903|NCT00882908|Hepatitis C|hepatitis c
5603904|NCT00882908|TMC435|tmc435
5603905|NCT00882908|Peginterferon alpha-2a|peginterferon alpha-2a
5603906|NCT00882908|PegIFNalpha-2a|pegifnalpha-2a
5603907|NCT00882908|RBV|rbv
5603908|NCT00882908|Ribavirin|ribavirin
5603909|NCT00882908|Placebo|placebo
5603910|NCT00882895|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5603919|NCT00882869|sorafenib|sorafenib
5603920|NCT00882856|Clozapine|clozapine
5603921|NCT00882856|Sinustachycardia|sinustachycardia
5603922|NCT00882856|Heartrate variability|heartrate variability
5603923|NCT00882856|Cardiomyopathy|cardiomyopathy
5603924|NCT00882843|Vibrating plate|vibrating plate
5603925|NCT00882843|Mechanical Stimulation|mechanical stimulation
5603926|NCT00882843|Osteoporosis|osteoporosis
5603927|NCT00882830|ICU|icu
5603928|NCT00882830|myopathy|myopathy
5603929|NCT00882830|neuropathy|neuropathy
5603930|NCT00882830|EMS|ems
5603931|NCT00882830|critical illness polyneuromyopathy|critical illness polyneuromyopathy
5603932|NCT00882830|NIRS|nirs
5603933|NCT00882830|muscle biopsy|muscle biopsy
5603934|NCT00882830|microdialysis|microdialysis
5603935|NCT00882830|CIPNM|cipnm
5603936|NCT00882817|ILD|ild
5603937|NCT00882804|hemin, heme oxygenase, humans, HO-1|hemin, heme oxygenase, humans, ho-1
5603938|NCT00882791|Skin Cancer|skin cancer
5603939|NCT00882791|Basal Cell|basal cell
5603940|NCT00882791|Mohs surgery|mohs surgery
5603941|NCT00882765|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5603942|NCT00882765|stage I pancreatic cancer|stage i pancreatic cancer
5603943|NCT00882765|stage II pancreatic cancer|stage ii pancreatic cancer
5603944|NCT00882765|stage III pancreatic cancer|stage iii pancreatic cancer
5603945|NCT00882752|Ulcerative Colitis (UC)|ulcerative colitis (uc)
5603946|NCT00882739|angiography|angiography
5603947|NCT00882739|percutaneous coronary intervention|percutaneous coronary intervention
5603948|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5603949|NCT00882739|Platelet Function Tests|platelet function tests
5603950|NCT00882726|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5603951|NCT00882726|CNTO 3649|cnto 3649
5603952|NCT00882726|safety|safety
5603953|NCT00882726|Phase I|phase i
5603954|NCT00882726|healthy adults|healthy adults
5603955|NCT00882726|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5603956|NCT00882700|Antibiotic|antibiotic
5603957|NCT00882661|Neck Pain|neck pain
5603958|NCT00882661|Arm Pain|arm pain
5603959|NCT00882648|Drug dependence during pregnancy|drug dependence during pregnancy
5603960|NCT00882635|STEMI|stemi
5603961|NCT00882635|acute coronary syndromes|acute coronary syndromes
5603962|NCT00882635|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5603963|NCT00882622|Ischemic Preconditioning|ischemic preconditioning
5603964|NCT00882622|Cardiac Surgery|cardiac surgery
5603965|NCT00882609|bone metastasis|bone metastasis
5603966|NCT00882609|bone metastases|bone metastases
5603967|NCT00882609|Sodium Fluoride|sodium fluoride
5603968|NCT00882609|F18 Fluoride|f18 fluoride
5603969|NCT00882609|bone scan|bone scan
5603970|NCT00882596|Contura|contura
5603971|NCT00882596|Cancer|cancer
5603972|NCT00882596|Accelerated|accelerated
5603973|NCT00882596|Partial|partial
5603974|NCT00882596|Breast|breast
5603975|NCT00882596|Irradiation|irradiation
5603976|NCT00882583|HNSCC|hnscc
5603977|NCT00882583|Dasatinib|dasatinib
5603978|NCT00882583|Cetuximab|cetuximab
5603979|NCT00882583|Cisplatin|cisplatin
5603980|NCT00882570|Antibiotic|antibiotic
5603981|NCT00882557|End-stage renal disease|end-stage renal disease
5603982|NCT00882557|hemodialysis|hemodialysis
5603983|NCT00882557|chronic renal failure|chronic renal failure
5603984|NCT00882544|hydronephrosis|hydronephrosis
5603985|NCT00882544|robotic pyeloplasty|robotic pyeloplasty
5603986|NCT00882544|pediatric pyeloplasty|pediatric pyeloplasty
5603987|NCT00882518|Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)|quetiapine fumarate (seroquel) extended-release (xr)
5603988|NCT00882518|qualified PANSS assessment|qualified panss assessment
5603989|NCT00882492|Cardiac|cardiac
5603990|NCT00882492|Surgery|surgery
5603991|NCT00882492|Glycemia|glycemia
5603992|NCT00882466|erythropoietin|erythropoietin
5603993|NCT00882453|Physical Activity|physical activity
5603994|NCT00882453|Fatigue|fatigue
5603995|NCT00882453|RRMS|rrms
5603996|NCT00882453|CIS|cis
5603997|NCT00882427|algorithm|algorithm
5603998|NCT00882427|tight glycemic control|tight glycemic control
5603999|NCT00882427|glucose control|glucose control
5604000|NCT00882427|intensive care|intensive care
5604001|NCT00882427|insulin|insulin
5604002|NCT00882427|ICU|icu
5604003|NCT00882414|ferric carboxymaltose|ferric carboxymaltose
5604004|NCT00882414|platelet|platelet
5604006|NCT00882414|ferritin|ferritin
5604007|NCT00882414|hemoglobin|hemoglobin
5604008|NCT00882414|transferrin|transferrin
5604009|NCT00882388|celecoxib|celecoxib
5604010|NCT00882388|platelet|platelet
5604011|NCT00882388|thrombosis|thrombosis
5604012|NCT00882388|Volunteers|volunteers
5604013|NCT00882375|Smoking Cessation|smoking cessation
5604014|NCT00882336|Cardiovascular risk management|cardiovascular risk management
5604016|NCT00882336|Hypertension|hypertension
5604017|NCT00882336|Diabetes|diabetes
5604019|NCT00882310|Pancreatic cancer|pancreatic cancer
5604020|NCT00882310|Gemzar|gemzar
5604021|NCT00882310|Taxotere|taxotere
5604022|NCT00882310|Xeloda|xeloda
5604023|NCT00882310|GTX|gtx
5604024|NCT00882297|Ultrasoundography|ultrasoundography
5604025|NCT00882297|catheterization|catheterization
5604026|NCT00882297|central venous subclavian vein methods|central venous subclavian vein methods
5604027|NCT00882284|NICHD Neonatal Research Network|nichd neonatal research network
5604028|NCT00882284|Blood Pressure Management|blood pressure management
5604029|NCT00882271|Fibromyalgia|fibromyalgia
5604030|NCT00882271|Acupuncture|acupuncture
5604031|NCT00882271|Pain|pain
5604032|NCT00882258|Uterine fibroids|uterine fibroids
5604033|NCT00882232|prostate|prostate
5604034|NCT00882232|cancer|cancer
5604035|NCT00882232|cross-linked|cross-linked
5604036|NCT00882232|hyaluronan|hyaluronan
5604037|NCT00882232|gel|gel
5604038|NCT00882232|Hylaform|hylaform
5604039|NCT00882232|rectal|rectal
5604040|NCT00882232|toxicity|toxicity
5604041|NCT00882219|Drug eluting stent|drug eluting stent
5604042|NCT00882219|Stents|stents
5604043|NCT00882219|Angioplasty|angioplasty
5604044|NCT00882219|Chronic coronary occlusion|chronic coronary occlusion
5604045|NCT00882219|Stent thrombosis|stent thrombosis
5604046|NCT00882219|Vascular disease|vascular disease
5604047|NCT00882219|Myocardial ischemia|myocardial ischemia
5604048|NCT00882219|Coronary artery stenosis|coronary artery stenosis
5604049|NCT00882219|Coronary Disease|coronary disease
5604050|NCT00882219|Coronary Artery Disease|coronary artery disease
5604051|NCT00882219|Coronary Restenosis|coronary restenosis
5604052|NCT00882206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5604053|NCT00882206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5604054|NCT00882206|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5604055|NCT00882206|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5604056|NCT00882193|Chronic hepatitis C|chronic hepatitis c
5604057|NCT00882193|Genotype 1|genotype 1
5604058|NCT00882193|Nonresponder|nonresponder
5604059|NCT00882193|Relapser|relapser
5604060|NCT00882193|Betaine|betaine
5604061|NCT00882193|Antiviral therapy|antiviral therapy
5604062|NCT00882180|Liver|liver
5604063|NCT00882180|Solid Tumors|solid tumors
5680361|NCT00578032|reconstruction|reconstruction
5604064|NCT00882180|Advanced Solid Tumors with Liver Involvement|advanced solid tumors with liver involvement
5604065|NCT00882154|Antibiotic|antibiotic
5604066|NCT00882141|Exercise|exercise
5604067|NCT00882141|Obesity|obesity
5604068|NCT00882141|Insulin Sensitivity|insulin sensitivity
5604069|NCT00882128|Asthma seasonal respiratory symptoms|asthma seasonal respiratory symptoms
5604070|NCT00882128|Asthmatic patients with increase of respiratory symptoms|asthmatic patients with increase of respiratory symptoms
5604071|NCT00882115|DEP|dep
5604072|NCT00882115|Broccoli Sprout Extract|broccoli sprout extract
5604073|NCT00882115|Allergies|allergies
5604074|NCT00882102|Acute Myelogenous Leukemia|acute myelogenous leukemia
5604075|NCT00882102|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5604076|NCT00882102|AML|aml
5604077|NCT00882102|MDS|mds
5604078|NCT00882102|Leukemia|leukemia
5604079|NCT00882102|Decitabine|decitabine
5604080|NCT00882102|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5604081|NCT00882102|Dacogen|dacogen
5604082|NCT00882102|Mylotarg|mylotarg
5604083|NCT00882089|Contura|contura
5604084|NCT00882089|Cancer|cancer
5604085|NCT00882089|Accelerated|accelerated
5604086|NCT00882089|Partial|partial
5604087|NCT00882089|Breast|breast
5604088|NCT00882089|Irradiation|irradiation
5604089|NCT00882076|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5604090|NCT00882076|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5604091|NCT00882063|Multiple Myeloma|multiple myeloma
5604092|NCT00882037|Methamphetamine Dependence|methamphetamine dependence
5604093|NCT00882037|Substance Abuse Treatment|substance abuse treatment
5604094|NCT00882037|Rural and Urban|rural and urban
5604095|NCT00882037|Latino and Non-Latino|latino and non-latino
5604096|NCT00882024|Rheumatoid arthritis|rheumatoid arthritis
5604097|NCT00882011|T-lymphoblastic lymphoma|t-lymphoblastic lymphoma
5604098|NCT00882011|Intensive chemo/radiotherapy|intensive chemo/radiotherapy
5604099|NCT00882011|Intensive chemotherapy|intensive chemotherapy
5604100|NCT00882011|Transplant|transplant
5604101|NCT00882011|Adult patients|adult patients
5598710|NCT00899626|pancreatic cancer|pancreatic cancer
5863013|NCT00001417|Absolute Ethanol|absolute ethanol
5604102|NCT00881998|Evaluate early functional outcomes of two anterior approaches to total hip arthroplasty|evaluate early functional outcomes of two anterior approaches to total hip arthroplasty
5604104|NCT00881985|resistant hypertension|resistant hypertension
5604105|NCT00881985|refractory hypertension|refractory hypertension
5604106|NCT00881985|continuous positive airway pressure|continuous positive airway pressure
5604107|NCT00881985|blood pressure control|blood pressure control
5604108|NCT00881959|exposed Root Surface or Tooth|exposed root surface or tooth
5604109|NCT00881959|Tooth Sensitivity Miller Class I|tooth sensitivity miller class i
5604111|NCT00881959|Gingival Margin|gingival margin
5604112|NCT00881946|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5604113|NCT00881946|aggressive lymphoma|aggressive lymphoma
5604114|NCT00881946|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5604115|NCT00881946|Hodgkin's lymphoma|hodgkin's lymphoma
5604116|NCT00881946|chronic myelogenous leukemia|chronic myelogenous leukemia
5604117|NCT00881946|multiple myeloma|multiple myeloma
5604118|NCT00881946|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5604119|NCT00881946|acute myeloid leukemia|acute myeloid leukemia
5604120|NCT00881933|Fludarabine, Cyclophosphamide, TBI, severe aplastic anemia,|fludarabine, cyclophosphamide, tbi, severe aplastic anemia,
5604121|NCT00881933|cord blood transplantation, pediatric|cord blood transplantation, pediatric
5604122|NCT00881920|Lymphocytic|lymphocytic
5604123|NCT00881920|Leukemia|leukemia
5604125|NCT00881920|Non-Hodgkin|non-hodgkin
5604126|NCT00881920|Multiple Myeloma|multiple myeloma
5604127|NCT00881920|Lymphoma|lymphoma
5604128|NCT00881907|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
5604129|NCT00881907|Immature Permanent Tooth With a Diagnosis of Pulpal Necrosis|immature permanent tooth with a diagnosis of pulpal necrosis
5604130|NCT00881894|Rotigotine|rotigotine
5604131|NCT00881894|Neupro®|neupro®
5604132|NCT00881894|Transdermal Patch|transdermal patch
5604133|NCT00881855|Antibiotics|antibiotics
5604134|NCT00881842|Influenza|influenza
5604135|NCT00881842|Vaccine|vaccine
5604136|NCT00881842|CHMP criteria|chmp criteria
5604137|NCT00881829|Pulse Oximetry|pulse oximetry
5604138|NCT00881829|Temperature|temperature
5604139|NCT00881829|Respiratory Rate|respiratory rate
5604140|NCT00881829|Respiratory Gases|respiratory gases
5604141|NCT00881829|This study determine the measurement accuracy of the physiological parameters|this study determine the measurement accuracy of the physiological parameters
5604142|NCT00881816|Liposomal Paclitaxel|liposomal paclitaxel
5604143|NCT00881816|Capecitabine|capecitabine
5604144|NCT00881816|Maximum tolerated dose|maximum tolerated dose
5604145|NCT00881816|Dose limiting toxicity|dose limiting toxicity
5604146|NCT00881803|Spinal Cord Injuries|spinal cord injuries
5604147|NCT00881803|Ascorbic Acid|ascorbic acid
5604148|NCT00881803|Vitamin C|vitamin c
5604149|NCT00881803|Iron|iron
5604150|NCT00881803|Dietary Supplements|dietary supplements
5604151|NCT00881777|Heart Failure|heart failure
5604152|NCT00881777|Cardiomyopathy|cardiomyopathy
5604153|NCT00881777|Ventricular Dysfunction|ventricular dysfunction
5604154|NCT00881777|Heart Disease|heart disease
5604155|NCT00881764|Anesthesia|anesthesia
5604156|NCT00881764|New York|new york
5604157|NCT00881764|Columbia|columbia
5604158|NCT00881764|Children|children
5604159|NCT00881764|Neurodevelopment|neurodevelopment
5604160|NCT00881764|Child development|child development
5604161|NCT00881764|Pediatric|pediatric
5604162|NCT00881751|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5604163|NCT00881751|advanced adult primary liver cancer|advanced adult primary liver cancer
5604164|NCT00881751|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5604165|NCT00881738|Antibiotic|antibiotic
5604166|NCT00881725|Metformin|metformin
5604167|NCT00881725|Prostate Cancer|prostate cancer
5604168|NCT00881725|Radical Prostatectomy|radical prostatectomy
5604169|NCT00881725|Neoadjuvant Intervention|neoadjuvant intervention
5604170|NCT00881725|PTEN/AKT Pathway|pten/akt pathway
5604171|NCT00881725|Tumour Expression|tumour expression
5604172|NCT00881725|Ki67 Expression|ki67 expression
5604173|NCT00881712|Non-small cell lung Cancer|non-small cell lung cancer
5604174|NCT00881712|Proton Radiation|proton radiation
5604175|NCT00881712|Stage III|stage iii
5604176|NCT00881699|HIV Information|hiv information
5604177|NCT00881699|HIV Prevention|hiv prevention
5604178|NCT00881699|Severe Mental Illness|severe mental illness
5604179|NCT00881699|HIV seronegativity|hiv seronegativity
5604180|NCT00881686|Ischemic Preconditioning, Myocardial|ischemic preconditioning, myocardial
5604181|NCT00881686|Adenosine|adenosine
5604182|NCT00881673|Conjunctivitis|conjunctivitis
5604183|NCT00881660|Fetal Tracheal Occlusion|fetal tracheal occlusion
5604184|NCT00881660|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5604185|NCT00881660|FETO plug-unplug|feto plug-unplug
5604186|NCT00881660|Goldvalve balloon|goldvalve balloon
5604187|NCT00881660|Severe Congenital Diaphragmatic Hernia|severe congenital diaphragmatic hernia
5604188|NCT00881660|Extremely Severe Congenital Diaphragmatic Hernia|extremely severe congenital diaphragmatic hernia
5604189|NCT00881660|Goldbal balloon|goldbal balloon
5604191|NCT00881647|PTSD|ptsd
5604193|NCT00881647|Insomnia|insomnia
5604194|NCT00881647|CBT|cbt
5604195|NCT00881621|Pancreas cancer|pancreas cancer
5604196|NCT00881621|lapatinib|lapatinib
5604197|NCT00881621|capecitabine|capecitabine
5604198|NCT00881608|Menstruation|menstruation
5604199|NCT00881595|Sarcomas|sarcomas
5604200|NCT00881595|High-Risk Soft Tissue Sarcomas|high-risk soft tissue sarcomas
5604201|NCT00881582|Hepatitis c|hepatitis c
5604202|NCT00881582|Renal transplantation|renal transplantation
5604203|NCT00881582|Pegylated interferon|pegylated interferon
5604204|NCT00881556|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5604205|NCT00881556|AlloSCT|allosct
5604206|NCT00881556|RDEB|rdeb
5604207|NCT00881556|recessive dystrophic epidermolysis bullosa|recessive dystrophic epidermolysis bullosa
5604208|NCT00881543|Sitagliptin|sitagliptin
5604209|NCT00881543|Diets|diets
5604210|NCT00881543|Diabetes type 2|diabetes type 2
5604211|NCT00881543|Näive patients|näive patients
5604212|NCT00881517|human cytomegalovirus|human cytomegalovirus
5604213|NCT00881517|immune globulin|immune globulin
5604214|NCT00881517|congenital infection|congenital infection
5604215|NCT00881517|prevention|prevention
5604216|NCT00881517|pregnancy|pregnancy
5604217|NCT00881504|Biliary|biliary
5604218|NCT00881504|Oxaliplatin|oxaliplatin
5604219|NCT00881504|Bevacizumab|bevacizumab
5604220|NCT00881491|Regeneration (revascularization) of dental pulp|regeneration (revascularization) of dental pulp
5604221|NCT00881491|Immature permanent tooth with a diagnosis of|immature permanent tooth with a diagnosis of
5604222|NCT00881478|Obesity|obesity
5604223|NCT00881478|Children|children
5604224|NCT00881478|Dyslipidemia|dyslipidemia
5604225|NCT00881478|Hypertension|hypertension
5604226|NCT00881465|Obsessive compulsive disorder|obsessive compulsive disorder
5604227|NCT00881452|Autism|autism
5604228|NCT00881439|Heart failure|heart failure
5604229|NCT00881439|Renal Failure|renal failure
5604230|NCT00881439|Cardiorenal Syndrome|cardiorenal syndrome
5604231|NCT00881439|Renin inhibition|renin inhibition
5604232|NCT00881439|Aliskiren|aliskiren
5604233|NCT00881426|Antibiotic|antibiotic
5604234|NCT00881413|Peptic ulcer bleeding|peptic ulcer bleeding
5604235|NCT00881413|Proton pump inhibitor|proton pump inhibitor
5604236|NCT00881413|Esomeprazole|esomeprazole
5604237|NCT00881413|Pantoprazole|pantoprazole
5604238|NCT00881413|Recurrent bleeding|recurrent bleeding
5604239|NCT00881413|bleeding|bleeding
5604240|NCT00881400|Antibiotic|antibiotic
5604241|NCT00881387|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5604242|NCT00881387|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5604243|NCT00881387|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5604244|NCT00881387|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5604245|NCT00881387|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5604246|NCT00881361|stage II breast cancer|stage ii breast cancer
5604247|NCT00881361|stage IIIA breast cancer|stage iiia breast cancer
5604248|NCT00881361|stage IIIB breast cancer|stage iiib breast cancer
5604250|NCT00881335|pulmonary disease|pulmonary disease
5604251|NCT00881335|flutter|flutter
5604252|NCT00881335|sputum|sputum
5604253|NCT00881335|physical therapy techniques|physical therapy techniques
5604254|NCT00881296|Elder Patients|elder patients
5604255|NCT00881296|Non-Small Cell Lung Cancer|non-small cell lung cancer
5604256|NCT00881296|Previously Untreated|previously untreated
5604257|NCT00881296|Advanced|advanced
5604258|NCT00881283|Cushing's disease|cushing's disease
5604259|NCT00881257|Peripheral Vascular Disease|peripheral vascular disease
5604260|NCT00881257|Peripheral Artery Disease|peripheral artery disease
5604261|NCT00881257|Radiofrequency|radiofrequency
5604262|NCT00881218|myocardial ischemia, perfusion imaging, cardiac MRI|myocardial ischemia, perfusion imaging, cardiac mri
5604263|NCT00881205|Multiple Sclerosis|multiple sclerosis
5604264|NCT00881205|Cognition|cognition
5604265|NCT00881205|Rivastigmine|rivastigmine
5604266|NCT00881205|Patch|patch
5604267|NCT00881192|CABG|cabg
5604268|NCT00881192|coronary surgery|coronary surgery
5604269|NCT00881192|intra-aortic balloon pump|intra-aortic balloon pump
5604270|NCT00881192|CABG operation|cabg operation
5604271|NCT00881179|Antibiotic|antibiotic
5604272|NCT00881166|MP-470|mp-470
5604273|NCT00881166|Multi-targeted Tyrosine Kinase Inhibitor|multi-targeted tyrosine kinase inhibitor
5604274|NCT00881166|Malignant disease|malignant disease
5604275|NCT00881153|Antibiotic|antibiotic
5604276|NCT00881140|oral mifepristone|oral mifepristone
5604277|NCT00881140|vaginal tablets|vaginal tablets
5604278|NCT00881114|Head and neck cancer|head and neck cancer
5604279|NCT00881114|pharmacogenetics|pharmacogenetics
5604280|NCT00881114|chemoradiotherapy|chemoradiotherapy
5604281|NCT00881101|Liposomal Paclitaxel|liposomal paclitaxel
5604282|NCT00881101|Maximum tolerated dose|maximum tolerated dose
5604283|NCT00881101|Dose limiting toxicity|dose limiting toxicity
5604284|NCT00881088|Deep vein trombosis|deep vein trombosis
5604285|NCT00881088|Profylaxis|profylaxis
5604286|NCT00881088|Below knee plaster cast|below knee plaster cast
5604287|NCT00881088|Ankle fracture|ankle fracture
5604289|NCT00881075|Heart diseases|heart diseases
5604290|NCT00881075|myocardial infarction|myocardial infarction
5604291|NCT00881075|contrast agents|contrast agents
5604292|NCT00881075|manganese|manganese
5604293|NCT00881062|ABSORPTION|absorption
5604294|NCT00881062|METABOLISM|metabolism
5604295|NCT00881062|EXCRETION|excretion
5798756|NCT00111176|endovascular aneurysm repair|endovascular aneurysm repair
5798757|NCT00111176|aortic aneurysm|aortic aneurysm
5604296|NCT00881049|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase|metastatic acral or mucosal melanoma with c-kit mutation or copy number increase
5604297|NCT00881036|Hepatitis B|hepatitis b
5604298|NCT00881010|Breast Cancer|breast cancer
5604299|NCT00881010|Pain Intervention|pain intervention
5604300|NCT00881010|Underserved minority patients|underserved minority patients
5604301|NCT00881010|African American|african american
5604302|NCT00881010|Hispanic|hispanic
5604303|NCT00881010|Automated Telephone System for measuring symptoms|automated telephone system for measuring symptoms
5604304|NCT00881010|Interactive voice response|interactive voice response
5604306|NCT00880997|Cocaine Dependence|cocaine dependence
5604307|NCT00880997|Substance Related Disorders|substance related disorders
5604308|NCT00880984|Colon Anastomosis|colon anastomosis
5604309|NCT00880984|Rectum Anastomosis|rectum anastomosis
5604310|NCT00880984|Intestine|intestine
5604311|NCT00880984|Colorectal Surgery|colorectal surgery
5604312|NCT00880984|Colorectal Anastomosis|colorectal anastomosis
5604313|NCT00880971|Lung|lung
5604314|NCT00880971|Carcinoma|carcinoma
5604315|NCT00880971|radiotherapy|radiotherapy
5604316|NCT00880971|Surgery|surgery
5604317|NCT00880945|FBS|fbs
5604318|NCT00880945|coin lesions|coin lesions
5604319|NCT00880945|ENB|enb
5604320|NCT00880945|ROSE|rose
5604321|NCT00880932|warfarin|warfarin
5604322|NCT00880932|NSAID|nsaid
5604323|NCT00880932|The condition is the concomitant prescription of|the condition is the concomitant prescription of
5604324|NCT00880919|Borderline Personality Disorder|borderline personality disorder
5604325|NCT00880919|BPD|bpd
5604326|NCT00880919|Seroquel|seroquel
5604327|NCT00880919|Seroquel XR|seroquel xr
5604328|NCT00880919|quetiapine|quetiapine
5604329|NCT00880919|quetiapine extended-release|quetiapine extended-release
5604330|NCT00880906|eosinophilic esophagitis|eosinophilic esophagitis
5604331|NCT00880906|esophageal food impaction|esophageal food impaction
5604332|NCT00880906|dysphagia|dysphagia
5604333|NCT00880893|Dengue virus|dengue virus
5604334|NCT00880893|Dengue fever|dengue fever
5604335|NCT00880893|Dengue Hemorrhagic fever|dengue hemorrhagic fever
5604336|NCT00880893|Dengue diseases|dengue diseases
5604337|NCT00880893|Sanofi Pasteur's CYD Dengue Vaccine|sanofi pasteur's cyd dengue vaccine
5604338|NCT00880880|urinary incontinence|urinary incontinence
5604339|NCT00880880|fecal incontinence|fecal incontinence
5604340|NCT00880880|communication|communication
5604341|NCT00880867|Low Grade Recurrent B and T Cell Lymphoma|low grade recurrent b and t cell lymphoma
5604342|NCT00880854|bladder cancer|bladder cancer
5604343|NCT00880854|BCG-resistant localized transitional cell of the bladder|bcg-resistant localized transitional cell of the bladder
5604344|NCT00880841|healthy normals, phase 1|healthy normals, phase 1
5604442|NCT00880373|Morphine|morphine
5604345|NCT00880841|phase 1a study for healthy normals|phase 1a study for healthy normals
5604346|NCT00880828|Cervical Radiculopathy|cervical radiculopathy
5604347|NCT00880828|Radicular Pain|radicular pain
5604348|NCT00880828|Acute neck pain|acute neck pain
5604349|NCT00880828|Cervicobrachial pain|cervicobrachial pain
5604350|NCT00880828|Far-infrared ray|far-infrared ray
5604351|NCT00880828|FIR|fir
5604352|NCT00880828|Cervical collar|cervical collar
5604353|NCT00880828|Cervical device|cervical device
5604354|NCT00880828|FIR Device|fir device
5604355|NCT00880802|Acute Coronary Syndromes|acute coronary syndromes
5604356|NCT00880802|Non ST-Segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
5604357|NCT00880802|ST-Segment Elevation Myocardial Infarction|st-segment elevation myocardial infarction
5604358|NCT00880802|Unstable Angina|unstable angina
5604359|NCT00880789|Cord Blood Transplant|cord blood transplant
5604360|NCT00880789|cytomegalovirus|cytomegalovirus
5604361|NCT00880789|CMV|cmv
5604362|NCT00880789|Adenovirus|adenovirus
5604363|NCT00880789|ADV|adv
5604364|NCT00880750|End stage Renal disease|end stage renal disease
5604365|NCT00880724|COPD|copd
5604366|NCT00880724|Emphysema|emphysema
5604367|NCT00880724|Bronchoscopic Treatment|bronchoscopic treatment
5604368|NCT00880724|Interventional Bronchoscopy|interventional bronchoscopy
5604370|NCT00880711|Faslodex|faslodex
5788489|NCT00153621|HIV|hiv
5604371|NCT00880711|Advanced Breast Cancer|advanced breast cancer
5604372|NCT00880711|Real life data|real life data
5604373|NCT00880711|Collect real life data in clinical practice across Austria|collect real life data in clinical practice across austria
5604374|NCT00880698|Rotavirus|rotavirus
5604375|NCT00880698|Rotavirus vaccine|rotavirus vaccine
5604376|NCT00880685|Compulsive Stealing|compulsive stealing
5604377|NCT00880685|Compulsive Shoplifting|compulsive shoplifting
5604378|NCT00880672|prostate, dutasteride|prostate, dutasteride
5604380|NCT00880672|hypoxia inducible factor|hypoxia inducible factor
5604381|NCT00880659|Influenza|influenza
5604382|NCT00880659|secondary transmission|secondary transmission
5604383|NCT00880659|handwashing|handwashing
5604385|NCT00880633|periampullary neoplasms|periampullary neoplasms
5604386|NCT00880620|Parkinson's disease|parkinson's disease
5604387|NCT00880607|Pain|pain
5604388|NCT00880607|Pediatric|pediatric
5604389|NCT00880607|Spinal Fusion|spinal fusion
5604390|NCT00880607|pain management|pain management
5604391|NCT00880555|Magnetic Resonance Imaging|magnetic resonance imaging
5604392|NCT00880555|Alzheimer disease|alzheimer disease
5604393|NCT00880555|Mild cognitive impairment|mild cognitive impairment
5604394|NCT00880555|Continuous arterial spin labeling|continuous arterial spin labeling
5604395|NCT00880555|Semantic memory|semantic memory
5604396|NCT00880542|localized osteosarcoma|localized osteosarcoma
5604397|NCT00880542|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5604398|NCT00880542|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5604399|NCT00880529|rib fractures|rib fractures
5604401|NCT00880529|ON-Q|on-q
5604402|NCT00880529|analgesia|analgesia
5604403|NCT00880503|Multidrug Resistance Molecular Target Analysis|multidrug resistance molecular target analysis
5604404|NCT00880490|COPD|copd
5604405|NCT00880464|autologous vaccination|autologous vaccination
5604406|NCT00880464|GM-CSF|gm-csf
5604407|NCT00880464|adenoviral mediated gene transfer|adenoviral mediated gene transfer
5604408|NCT00880464|Stage IV breast cancer|stage iv breast cancer
5604409|NCT00880451|Children and Adolescents|children and adolescents
5604410|NCT00880451|Aging|aging
5604411|NCT00880451|Brain Imaging|brain imaging
5604412|NCT00880451|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5604413|NCT00880412|safety|safety
5604414|NCT00880412|efficacy|efficacy
5604415|NCT00880412|Alzheimer's disease|alzheimer's disease
5604416|NCT00880412|treatment|treatment
5604417|NCT00880412|phase II|phase ii
5604418|NCT00880412|study|study
5604419|NCT00880412|cholinesterase inhibitor|cholinesterase inhibitor
5604420|NCT00880399|depression|depression
5604421|NCT00880399|QIDS-SR|qids-sr
5604422|NCT00880399|HAMD-17|hamd-17
5604423|NCT00880399|orvepitant|orvepitant
5604424|NCT00880399|MDD|mdd
5604425|NCT00880399|neurokinin-1 antagonist|neurokinin-1 antagonist
5604426|NCT00880399|double-blind|double-blind
5604427|NCT00880399|Phase II|phase ii
5604428|NCT00880399|randomized|randomized
5604429|NCT00880399|efficacy|efficacy
5604430|NCT00880399|placebo|placebo
5604431|NCT00880399|safety|safety
5604432|NCT00880386|dyspnea|dyspnea
5604554|NCT00880048|NK-1 antagonist|nk-1 antagonist
5604433|NCT00880386|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5604434|NCT00880386|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5604435|NCT00880386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5604436|NCT00880386|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5604437|NCT00880386|pulmonary complications|pulmonary complications
5604438|NCT00880386|radiation fibrosis|radiation fibrosis
5604439|NCT00880373|Sickle Cell Disease|sickle cell disease
5604440|NCT00880373|Pain|pain
5604441|NCT00880373|Ibuprofen|ibuprofen
5604443|NCT00880373|Diamorphine|diamorphine
5604444|NCT00880373|Patient Controlled Analgesia|patient controlled analgesia
5604445|NCT00880360|Epithelial Ovarian Cancer|epithelial ovarian cancer
5604446|NCT00880360|FIGO (International Fed of Gyn and Ob)Stage III or Stage IV|figo (international fed of gyn and ob)stage iii or stage iv
5604447|NCT00880360|Extraovarian Peritoneal Cancer|extraovarian peritoneal cancer
5604448|NCT00880360|Fallopian Tube Carcinoma Failing|fallopian tube carcinoma failing
5604449|NCT00880347|Alzheimer's disease|alzheimer's disease
5604450|NCT00880347|Other dementia|other dementia
5604451|NCT00880347|Vascular dementia|vascular dementia
5604452|NCT00880347|Mixed dementia|mixed dementia
5604453|NCT00880347|Parkinson's Disease dementia|parkinson's disease dementia
5604454|NCT00880347|Lewy bodies dementia|lewy bodies dementia
5604455|NCT00880347|Frontotemporal dementia|frontotemporal dementia
5604456|NCT00880347|Blood signature|blood signature
5604457|NCT00880347|Diagnosis|diagnosis
5604458|NCT00880347|SpliceArray (tm)|splicearray (tm)
5604459|NCT00880347|Alzheimer's Disease and other non-AD dementia|alzheimer's disease and other non-ad dementia
5604461|NCT00880334|Zactima|zactima
5604462|NCT00880334|docetaxel|docetaxel
5604463|NCT00880334|ZD6474|zd6474
5604464|NCT00880334|taxotere|taxotere
5604465|NCT00880321|first time in human|first time in human
5604466|NCT00880321|BRAF inhibitor|braf inhibitor
5604467|NCT00880321|dose escalation|dose escalation
5604468|NCT00880308|Advanced tumors|advanced tumors
5604469|NCT00880308|hedgehog|hedgehog
5604470|NCT00880308|smoothened inhibitor|smoothened inhibitor
5604471|NCT00880269|Acute myeloid leukemia|acute myeloid leukemia
5604472|NCT00880269|AML|aml
5604473|NCT00880269|relapsed acute myeloid leukemia|relapsed acute myeloid leukemia
5604474|NCT00880269|refractory AML|refractory aml
5604475|NCT00880269|refractory de novo AML|refractory de novo aml
5604477|NCT00880269|secondary AML|secondary aml
5604478|NCT00880269|AML following myelodysplastic syndrome (MDS)|aml following myelodysplastic syndrome (mds)
5604479|NCT00880269|AML following antecedent hematological disorder (AHD)|aml following antecedent hematological disorder (ahd)
5604480|NCT00880269|AML resistant to therapy|aml resistant to therapy
5604481|NCT00880256|irritable bowel|irritable bowel
5604482|NCT00880256|mindfulness|mindfulness
5604483|NCT00880256|stress|stress
5604484|NCT00880256|meditation|meditation
5604485|NCT00880243|Acute myeloid leukemia|acute myeloid leukemia
5604486|NCT00880243|Priming|priming
5604487|NCT00880243|GM-CSF|gm-csf
5604488|NCT00880243|Timed-sequential chemotherapy|timed-sequential chemotherapy
5604489|NCT00880243|Prognosis|prognosis
5604490|NCT00880230|Iliac Artery Stenting|iliac artery stenting
5604491|NCT00880230|Peripheral Artery Disease|peripheral artery disease
5604492|NCT00880217|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5604493|NCT00880217|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5604494|NCT00880217|Adult ADHD|adult adhd
5604495|NCT00880217|JNJ-31001074|jnj-31001074
5604496|NCT00880204|Cluster Randomized Trial|cluster randomized trial
5604497|NCT00880204|ESS-EMCH|ess-emch
5604498|NCT00880204|Neonatal|neonatal
5604499|NCT00880204|Maternal|maternal
5604500|NCT00880204|Life threatening emergency event|life threatening emergency event
5604501|NCT00880191|nausea and vomiting|nausea and vomiting
5604502|NCT00880191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5604503|NCT00880178|Simvastatin|simvastatin
5604504|NCT00880178|Niacin|niacin
5604505|NCT00880178|Vascular Disease|vascular disease
5604506|NCT00880178|Magnetic Resonance Imaging|magnetic resonance imaging
5604507|NCT00880178|High Density Lipoprotein|high density lipoprotein
5604508|NCT00880178|Oxidation|oxidation
5604509|NCT00880178|Proteomics|proteomics
5604510|NCT00880178|Stroke|stroke
5604511|NCT00880178|Cerebrovascular Accident|cerebrovascular accident
5604512|NCT00880165|Polysomnogram|polysomnogram
5604513|NCT00880165|Continuous positive airway pressure|continuous positive airway pressure
5604514|NCT00880152|stress|stress
5604515|NCT00880152|mindfulness|mindfulness
5604516|NCT00880152|trauma|trauma
5604517|NCT00880139|Diabetes mellitus, type 1|diabetes mellitus, type 1
5604518|NCT00880139|Inflammation|inflammation
5604519|NCT00880139|Cytokines|cytokines
5604520|NCT00880139|Vascular reactivity|vascular reactivity
5604521|NCT00880126|Individualized Implementation|individualized implementation
5604522|NCT00880126|Community Development Teams|community development teams
5604523|NCT00880113|CT-perfusion|ct-perfusion
5604524|NCT00880113|CT-angiography|ct-angiography
5604525|NCT00880100|Steatorrhea|steatorrhea
5604526|NCT00880100|Malabsorption of fat|malabsorption of fat
5604527|NCT00880100|Pancreatic enzymes|pancreatic enzymes
5604528|NCT00880100|Abdominal pain|abdominal pain
5604529|NCT00880100|Greasy stools|greasy stools
5604530|NCT00880087|Cardiac Arrest|cardiac arrest
5604531|NCT00880087|Cardiopulmonary Arrest|cardiopulmonary arrest
5604532|NCT00880087|Pediatric Cardiac Arrest|pediatric cardiac arrest
5604533|NCT00880087|VABS|vabs
5604534|NCT00880087|Vineland Adaptive Behavior Scale|vineland adaptive behavior scale
5604535|NCT00880087|POPC/PCPC|popc/pcpc
5604536|NCT00880087|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5604537|NCT00880074|Advanced Cancers|advanced cancers
5604538|NCT00880074|FLT-PET|flt-pet
5604539|NCT00880074|Positron Emission Tomography|positron emission tomography
5604540|NCT00880074|PET|pet
5604541|NCT00880074|[18F] fluorothymidine|[18f] fluorothymidine
5604542|NCT00880074|[F-18]-fluoro-L-thymidine|[f-18]-fluoro-l-thymidine
5604543|NCT00880074|FLT|flt
5604544|NCT00880061|Diffuse Infiltrating Pontine Glioma|diffuse infiltrating pontine glioma
5587523|NCT00940888|ICD|icd
5604545|NCT00880061|Supratentorial High Grade Glioma|supratentorial high grade glioma
5604546|NCT00880061|Convection-Enhanced Delivery|convection-enhanced delivery
5604547|NCT00880061|Pediatric Brain Tumor|pediatric brain tumor
5604548|NCT00880061|Brain Tumor|brain tumor
5604549|NCT00880061|Glioma|glioma
5604550|NCT00880048|depression|depression
5604551|NCT00880048|safety|safety
5604552|NCT00880048|HAMD|hamd
5604553|NCT00880048|QIDS-SR|qids-sr
5604555|NCT00880048|efficacy|efficacy
5604556|NCT00880048|orvepitant|orvepitant
5604557|NCT00880048|placebo|placebo
5604558|NCT00880048|MDD|mdd
5604559|NCT00880048|video-rating|video-rating
5604560|NCT00880035|sedative drug|sedative drug
5604561|NCT00880035|stress|stress
5604562|NCT00880035|music|music
5604563|NCT00880035|mechanical ventilation|mechanical ventilation
5604564|NCT00880035|IL-6|il-6
5604565|NCT00880035|cortisol|cortisol
5604566|NCT00880035|prolactin|prolactin
5604567|NCT00880035|CRP|crp
5604568|NCT00880035|copeptin|copeptin
5604569|NCT00880022|compression|compression
5604570|NCT00880022|Flexitouch|flexitouch
5604571|NCT00880022|breast cancer|breast cancer
5604572|NCT00880022|lymphedema|lymphedema
5604573|NCT00879996|Opiate Addiction|opiate addiction
5604574|NCT00879996|Narcotic Addiction|narcotic addiction
5604575|NCT00879996|Drug Addiction|drug addiction
5604576|NCT00879996|Pain|pain
5604577|NCT00879983|azithromycin, pharmacokinetics|azithromycin, pharmacokinetics
5604578|NCT00879970|Cardiovascular Outcomes|cardiovascular outcomes
5604579|NCT00879957|Infant, Premature|infant, premature
5604580|NCT00879957|Infant|infant
5604581|NCT00879957|Central venous catheterization|central venous catheterization
5604582|NCT00879957|Anticoagulants|anticoagulants
5604583|NCT00879944|Psoriasis|psoriasis
5604584|NCT00879944|Obesity|obesity
5604586|NCT00879944|Atopic Dermatitis|atopic dermatitis
5604587|NCT00879918|Cigarette Smoking in African Americans|cigarette smoking in african americans
5604588|NCT00879905|Phase I|phase i
5604589|NCT00879905|Adults|adults
5604590|NCT00879905|HSP990|hsp990
5604591|NCT00879905|Advanced Solid Tumors|advanced solid tumors
5604592|NCT00879905|Hsp90 inhibitor|hsp90 inhibitor
5604593|NCT00879905|Cancer|cancer
5604594|NCT00879892|xenon|xenon
5604595|NCT00879892|hypothermia|hypothermia
5604596|NCT00879892|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5604597|NCT00879879|precancerous condition|precancerous condition
5604598|NCT00879866|NSCLC|nsclc
5604599|NCT00879866|immunocytokine|immunocytokine
5604600|NCT00879866|radiation|radiation
5604601|NCT00879866|interleukin-2|interleukin-2
5604602|NCT00879866|immunotherapy|immunotherapy
5604603|NCT00879866|maintenance therapy|maintenance therapy
5604604|NCT00879853|PTSD|ptsd
5604605|NCT00879853|Depression|depression
5604606|NCT00879853|Anger|anger
5604607|NCT00879853|Domestic Violence|domestic violence
5604608|NCT00879853|Refugee|refugee
5604609|NCT00879853|Asylum Seeker|asylum seeker
5604610|NCT00879853|Community Therapist|community therapist
5604611|NCT00879853|Paraprofessional Therapists|paraprofessional therapists
5604612|NCT00879840|Screening|screening
5604613|NCT00879840|Modalities|modalities
5604614|NCT00879840|Gynecological Cancers|gynecological cancers
5604615|NCT00879801|prevention of diabetes|prevention of diabetes
5604616|NCT00879801|susceptibility genes|susceptibility genes
5604617|NCT00879801|type 2 diabetes|type 2 diabetes
5604618|NCT00879801|insulin resistance|insulin resistance
5604619|NCT00879801|beta-cell funtion|beta-cell funtion
5604620|NCT00879788|Ramipril fed condition|ramipril fed condition
5604621|NCT00879775|Pain|pain
5604622|NCT00879775|Cancer patients|cancer patients
5604623|NCT00879775|Caffeine|caffeine
5604624|NCT00879775|Adjuvant analgesics|adjuvant analgesics
5604625|NCT00879775|Sedation|sedation
5604626|NCT00879775|Confusion|confusion
5604627|NCT00879775|Quality of life|quality of life
5604628|NCT00879775|Fatigue|fatigue
5604629|NCT00879762|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
5604630|NCT00879736|Doctor-patient communication|doctor-patient communication
5604631|NCT00879736|Encounters|encounters
5604632|NCT00879736|Patient education training|patient education training
5604633|NCT00879723|post-burn recovery|post-burn recovery
5604634|NCT00879723|oxidative stress|oxidative stress
5604635|NCT00879723|micronutrient protocol|micronutrient protocol
5604636|NCT00879710|Diabetes Mellitus|diabetes mellitus
5604637|NCT00879710|Hypercholesterolemia|hypercholesterolemia
5604638|NCT00879710|Simvastatin|simvastatin
5604639|NCT00879710|Ezetimibe.|ezetimibe.
5604640|NCT00879697|peripheral arterial disease|peripheral arterial disease
5604641|NCT00879697|exercise|exercise
5604642|NCT00879697|resistance training|resistance training
5604643|NCT00879697|cardiac rehabilitation|cardiac rehabilitation
5604644|NCT00879684|Phase 1|phase 1
5604645|NCT00879684|Tumors|tumors
5604646|NCT00879684|CVX-060|cvx-060
5604647|NCT00879671|lutein|lutein
5604648|NCT00879671|nonexudative AMD|nonexudative amd
5604649|NCT00879671|MPOD|mpod
5604650|NCT00879671|Supplementary Concepts|supplementary concepts
5604651|NCT00879658|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5604652|NCT00879658|Relapsing-Remitting|relapsing-remitting
5604653|NCT00879658|Demyelinating Autoimmune Diseases|demyelinating autoimmune diseases
5604654|NCT00879658|Disseminated sclerosis|disseminated sclerosis
5604655|NCT00879658|Encephalomyelitis disseminate|encephalomyelitis disseminate
5604656|NCT00879658|Inflammatory disease|inflammatory disease
5604657|NCT00879658|Demyelination|demyelination
5604658|NCT00879658|Auto-inflammatory disease|auto-inflammatory disease
5604659|NCT00879658|Devic's disease|devic's disease
5604660|NCT00879658|Balo concentric sclerosis|balo concentric sclerosis
5604661|NCT00879658|Schilder's diffuse sclerosis|schilder's diffuse sclerosis
5604662|NCT00879645|Renal Impairment|renal impairment
5604663|NCT00879645|Renal Disease|renal disease
5604664|NCT00879645|Sodium Sulfide|sodium sulfide
5604665|NCT00879606|Sepsis|sepsis
5604666|NCT00879606|Acute Lung Injury|acute lung injury
5604667|NCT00879606|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5604668|NCT00879606|ALI/ARDS|ali/ards
5604669|NCT00879606|Lung Disease|lung disease
5604670|NCT00879580|aneurysm|aneurysm
5604671|NCT00879580|stent|stent
5604672|NCT00879580|intracranial aneurysm|intracranial aneurysm
5604673|NCT00879580|Ruptured Intracranial Aneurysm|ruptured intracranial aneurysm
5604674|NCT00879554|Phase 1|phase 1
5604675|NCT00879554|Solid Tumors|solid tumors
5604676|NCT00879554|CVX-045|cvx-045
5604678|NCT00879528|Hodgkin's Lymphoma|hodgkin's lymphoma
5604679|NCT00879528|stem cell reinfusion|stem cell reinfusion
5604680|NCT00879515|Fragile X Premutation|fragile x premutation
5604681|NCT00879515|Fragile X Syndrome|fragile x syndrome
5604682|NCT00879515|Down Syndrome|down syndrome
5604683|NCT00879502|Fragile X Premutation|fragile x premutation
5604684|NCT00879502|FMR1|fmr1
5604685|NCT00879502|Premutation|premutation
5604686|NCT00879502|Fragile X|fragile x
5604687|NCT00879502|Brain Function|brain function
5798758|NCT00111176|thoracic|thoracic
5604688|NCT00879489|Stage IV histologically proven breast cancer|stage iv histologically proven breast cancer
5604689|NCT00879476|Bioequivalence ramipril fasting condition|bioequivalence ramipril fasting condition
5604690|NCT00879463|Blood transfusion in cardiac operations under CPB|blood transfusion in cardiac operations under cpb
5604691|NCT00879463|Infrared spectrophotoscopy|infrared spectrophotoscopy
5604692|NCT00879450|Congenital muscular torticollis|congenital muscular torticollis
5604693|NCT00879437|brain tumor|brain tumor
5604694|NCT00879437|bevacizumab|bevacizumab
5604695|NCT00879437|valproic acid|valproic acid
5604696|NCT00879437|radiation therapy|radiation therapy
5604697|NCT00879424|vitamin D|vitamin d
5604698|NCT00879424|atopic dermatitis|atopic dermatitis
5604699|NCT00879424|eczema|eczema
5604700|NCT00879424|winter|winter
5604701|NCT00879385|KRAS wild-type|kras wild-type
5604702|NCT00879385|Colon|colon
5604703|NCT00879385|Cancer|cancer
5604704|NCT00879385|colorectal|colorectal
5604705|NCT00879385|metastatic colorectal|metastatic colorectal
5604706|NCT00879385|advanced colorectal|advanced colorectal
5604707|NCT00879372|Bipolar Disorder|bipolar disorder
5604708|NCT00879372|cognitive impairment|cognitive impairment
5604709|NCT00879372|depression|depression
5604710|NCT00879346|Healthy Volunteers|healthy volunteers
5604711|NCT00879346|ADME|adme
5604712|NCT00879346|Healthy male volunteers|healthy male volunteers
5604713|NCT00879333|Gastric cancer,|gastric cancer,
5604714|NCT00879333|advanced gastric cancer,|advanced gastric cancer,
5604715|NCT00879333|stomach neoplasm,|stomach neoplasm,
5604716|NCT00879333|stomach disease,|stomach disease,
5604717|NCT00879333|adenocarcinoma of stomach,|adenocarcinoma of stomach,
5604718|NCT00879333|GI neoplasm|gi neoplasm
5604719|NCT00879320|ADHD|adhd
5604720|NCT00879320|health|health
5604721|NCT00879320|healthy lifestyle|healthy lifestyle
5604722|NCT00879294|Perforated appendicitis|perforated appendicitis
5604723|NCT00879294|Ruptured appendicitis|ruptured appendicitis
5604724|NCT00879294|Acute appendicitis with perforation|acute appendicitis with perforation
5604725|NCT00879281|COPD|copd
5604726|NCT00879281|emphysema|emphysema
5604727|NCT00879281|chronic bronchitis|chronic bronchitis
5604728|NCT00879268|Liver Transplantation|liver transplantation
5604729|NCT00879268|Organ Preservation|organ preservation
5604730|NCT00879268|Liver Preservation|liver preservation
5604731|NCT00879268|Machine Perfusion|machine perfusion
5604732|NCT00879268|Vasosol|vasosol
5604733|NCT00879268|Machine Preservation|machine preservation
5604734|NCT00879255|cognitive processing therapy|cognitive processing therapy
5604735|NCT00879255|combat|combat
5604736|NCT00879255|veterans|veterans
5604737|NCT00879255|PTSD|ptsd
5604738|NCT00879255|Telemental Health|telemental health
5604739|NCT00879255|Videoteleconference|videoteleconference
5604740|NCT00879255|outcome|outcome
5604741|NCT00879255|Rural|rural
5604742|NCT00879255|Remote|remote
5604744|NCT00879255|VTC|vtc
5604745|NCT00879242|Thalassemia|thalassemia
5604746|NCT00879242|cardiac MRI T2*|cardiac mri t2*
5604747|NCT00879229|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5604748|NCT00879229|Pulmonary Hypertension|pulmonary hypertension
5604749|NCT00879229|PH|ph
5604750|NCT00879229|IPF|ipf
5604751|NCT00879229|Ambrisentan|ambrisentan
5604752|NCT00879229|ERA|era
5604753|NCT00879229|Endothelin Receptor Antagonist|endothelin receptor antagonist
5604754|NCT00879229|Cardiovascular|cardiovascular
5604755|NCT00879216|Nocturia|nocturia
5604756|NCT00879216|Hyptotension|hyptotension
5604757|NCT00879216|Elderly|elderly
5604758|NCT00879216|Males|males
5604759|NCT00879203|Type 1 Diabetes Mellitis|type 1 diabetes mellitis
5604760|NCT00879203|Youth|youth
5604761|NCT00879203|Hypoglycemia|hypoglycemia
5604762|NCT00879203|Hyperglycemia|hyperglycemia
5604763|NCT00879203|Cognition|cognition
5604764|NCT00879203|Memory|memory
5604765|NCT00879203|Brain Growth & Development|brain growth & development
5604766|NCT00879203|Magnetic Resonance Imaging|magnetic resonance imaging
5604768|NCT00879177|varenicline|varenicline
5604769|NCT00879177|behavioral therapy|behavioral therapy
5604770|NCT00879177|ABPM|abpm
5604771|NCT00879177|hypertension|hypertension
5604772|NCT00879164|hot flashes|hot flashes
5604773|NCT00879125|Gastric by-pass on patients with T2DM|gastric by-pass on patients with t2dm
5604774|NCT00879112|Hyperlipidemia|hyperlipidemia
5604775|NCT00879099|Interaction|interaction
5604776|NCT00879099|healthy volunteers|healthy volunteers
5604777|NCT00879099|Interaction study for healthy volunteers|interaction study for healthy volunteers
5604778|NCT00879086|Breast Cancer|breast cancer
5604779|NCT00879086|Oncology|oncology
5604780|NCT00879073|Brain and Nervous System|brain and nervous system
5604781|NCT00879060|Fibrosis|fibrosis
5604782|NCT00879060|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5604783|NCT00879060|MRI|mri
5604784|NCT00879060|To evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in Hypertrophic cardiomyopathy|to evaluate the efficacy of spironolactone in decreasing myocardial fibrosis in hypertrophic cardiomyopathy
5604785|NCT00879047|HIV|hiv
5604786|NCT00879047|Hepatitis C|hepatitis c
5604787|NCT00879034|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5604788|NCT00879034|HGPS|hgps
5604793|NCT00879034|Zoledronic Acid|zoledronic acid
5604794|NCT00879034|Pravastatin|pravastatin
5604795|NCT00879021|The outcome is to prevent Central Neuropathic Pain|the outcome is to prevent central neuropathic pain
5604796|NCT00879021|participants will have suffered spinal cord trauma|participants will have suffered spinal cord trauma
5604797|NCT00879008|Disease Exacerbation|disease exacerbation
5604798|NCT00879008|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
5604799|NCT00879008|AECB|aecb
5604800|NCT00879008|Avelox|avelox
5604801|NCT00879008|Bronchitis|bronchitis
5604802|NCT00878995|stage IIB cervical cancer|stage iib cervical cancer
5604803|NCT00878995|stage III cervical cancer|stage iii cervical cancer
5604804|NCT00878995|recurrent cervical cancer|recurrent cervical cancer
5604805|NCT00878995|cachexia|cachexia
5604806|NCT00878995|advanced head/neck carcinoma|advanced head/neck carcinoma
5604807|NCT00878995|recurrent head/neck carcinoma|recurrent head/neck carcinoma
5604808|NCT00878969|Hemodialysis|hemodialysis
5604809|NCT00878969|fibrinolysis|fibrinolysis
5604810|NCT00878969|oxidative stress|oxidative stress
5604811|NCT00878969|systemic inflammatory reaction|systemic inflammatory reaction
5604812|NCT00878969|endothelial dysfunction|endothelial dysfunction
5604813|NCT00878969|carotid intima media thickness (IMT|carotid intima media thickness (imt
5604814|NCT00878969|angiotensin receptor blockade|angiotensin receptor blockade
5604815|NCT00878969|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
5604816|NCT00878956|Cardiac surgery|cardiac surgery
5604817|NCT00878956|Cardiopulmonary bypass|cardiopulmonary bypass
5604818|NCT00878956|Oxidative stress|oxidative stress
5604819|NCT00878956|Acute renal dysfunction|acute renal dysfunction
5604820|NCT00878956|Sodium bicarbonate|sodium bicarbonate
5604821|NCT00878943|Open label access|open label access
5604822|NCT00878943|sildenafil|sildenafil
5604823|NCT00878943|pulmonary arterial hypertension|pulmonary arterial hypertension
5604824|NCT00878930|Breast cancer|breast cancer
5604825|NCT00878930|Fulvestrant|fulvestrant
5604826|NCT00878930|Faslodex|faslodex
5604827|NCT00878930|Acceptability|acceptability
5604828|NCT00878930|Compliance|compliance
5604829|NCT00878930|Efficacy|efficacy
5604830|NCT00878917|Equivalence Study|equivalence study
5604831|NCT00878917|Eye Drops Solution|eye drops solution
5604832|NCT00878917|Dorzolamide|dorzolamide
5604833|NCT00878917|Open Angle Glaucoma|open angle glaucoma
5604834|NCT00878917|Ocular Hypertension|ocular hypertension
5604835|NCT00878904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5604836|NCT00878891|Microdialysis|microdialysis
5604837|NCT00878891|realtime|realtime
5604838|NCT00878891|glucose sensor|glucose sensor
5604839|NCT00878891|coronary artery bypass|coronary artery bypass
5604840|NCT00878878|Pulmonary artery systolic pressure (PASP)|pulmonary artery systolic pressure (pasp)
5604841|NCT00878878|Pulmonary Vascular Resistance (PVR)|pulmonary vascular resistance (pvr)
5604842|NCT00878878|Right Heart Catheterization|right heart catheterization
5604843|NCT00878878|Pulmonary hemodynamics|pulmonary hemodynamics
5604844|NCT00878865|Alprazolam|alprazolam
5604845|NCT00878865|bioequivalence|bioequivalence
5604846|NCT00878839|Cataract|cataract
5604847|NCT00878839|Toric IOL|toric iol
5604848|NCT00878839|Corneal Aberration|corneal aberration
5604849|NCT00878839|Astigmatism|astigmatism
5604851|NCT00878813|Copeptin|copeptin
5604852|NCT00878813|Vasopressin|vasopressin
5604853|NCT00878813|Stroke|stroke
5604854|NCT00878813|Transient ischemic attack|transient ischemic attack
5604855|NCT00878813|Thrombolytic therapy|thrombolytic therapy
5604856|NCT00878813|Prognosis|prognosis
5604857|NCT00878813|Complications|complications
5604858|NCT00878800|Phase I/II trial|phase i/ii trial
5604859|NCT00878800|Solid tumors|solid tumors
5789107|NCT00149838|Brain|brain
5604860|NCT00878800|Soft tissue sarcoma|soft tissue sarcoma
5604861|NCT00878800|PXD101|pxd101
5604862|NCT00878800|Doxorubicin|doxorubicin
5604863|NCT00878774|Ragweed allergy|ragweed allergy
5604864|NCT00878774|Immunotherapy|immunotherapy
5604865|NCT00878774|Rhinoconjunctivitis|rhinoconjunctivitis
5604866|NCT00878774|Toleromune Ragweed|toleromune ragweed
5604867|NCT00878761|Renal transplant|renal transplant
5604868|NCT00878761|Interstitial fibrosis and tubular atrophy|interstitial fibrosis and tubular atrophy
5604869|NCT00878761|Chronic allograft dysfunction|chronic allograft dysfunction
5604870|NCT00878761|Chronic allograft nephropathy|chronic allograft nephropathy
5604871|NCT00878761|kidney transplant|kidney transplant
5604872|NCT00878735|Meditation|meditation
5604873|NCT00878735|Mindfulness|mindfulness
5604874|NCT00878735|fMRI|fmri
5604875|NCT00878735|cancer|cancer
5604877|NCT00878735|anxiety|anxiety
5604878|NCT00878735|depression|depression
5604879|NCT00878735|attention|attention
5604880|NCT00878735|Neuroscience|neuroscience
5604881|NCT00878735|Neuroimaging|neuroimaging
5604883|NCT00878735|Healthy volunteers (regular meditators and non-meditators)|healthy volunteers (regular meditators and non-meditators)
5604884|NCT00878722|Acute Myeloid Leukemia|acute myeloid leukemia
5604885|NCT00878722|PXD101|pxd101
5604886|NCT00878722|Belinostat|belinostat
5604887|NCT00878722|Idarubicin|idarubicin
5604888|NCT00878709|HER-2/erbB-2 positive breast cancer|her-2/erbb-2 positive breast cancer
5604889|NCT00878709|breast cancer|breast cancer
5604890|NCT00878709|adjuvant therapy|adjuvant therapy
5604891|NCT00878709|neratinib|neratinib
5604892|NCT00878709|HKI-272|hki-272
5604893|NCT00878709|Nerlynx|nerlynx
5604894|NCT00878709|PB-272|pb-272
5604895|NCT00878657|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5604896|NCT00878657|stage III pancreatic cancer|stage iii pancreatic cancer
5604897|NCT00878644|Cardiac Arrest|cardiac arrest
5604898|NCT00878644|Cardiopulmonary Arrest|cardiopulmonary arrest
5604899|NCT00878644|Pediatric Cardiac Arrest|pediatric cardiac arrest
5604900|NCT00878644|VABS|vabs
5604901|NCT00878644|Vineland Adaptive Behavior Survey|vineland adaptive behavior survey
5604902|NCT00878644|POPC/PCPC|popc/pcpc
5604903|NCT00878644|hypoxic-ichemic encephalopathy|hypoxic-ichemic encephalopathy
5604904|NCT00878631|emergency medical services|emergency medical services
5604905|NCT00878631|traumatic brain injury|traumatic brain injury
5604906|NCT00878631|hypertonic saline with dextran|hypertonic saline with dextran
5604907|NCT00878631|fluid resuscitation|fluid resuscitation
5604908|NCT00878618|Healthy volunteers|healthy volunteers
5604909|NCT00878605|Diabetes|diabetes
5604910|NCT00878605|Cyclo-Z|cyclo-z
5604911|NCT00878592|Post liver transplant|post liver transplant
5604912|NCT00878592|weight reduction classes|weight reduction classes
5604913|NCT00878592|obesity|obesity
5604914|NCT00878592|weight management|weight management
5604915|NCT00878592|dietary and lifestyle modification|dietary and lifestyle modification
5604916|NCT00878579|back pain|back pain
5604917|NCT00878579|Spine|spine
5604918|NCT00878579|Spinal|spinal
5604919|NCT00878579|Lower back pain|lower back pain
5604920|NCT00878579|Lumbar|lumbar
5604921|NCT00878579|Lumbar Pain|lumbar pain
5604923|NCT00878579|Degenerative Disc Disease|degenerative disc disease
5604924|NCT00878566|hypertension|hypertension
5604925|NCT00878566|pharmacists|pharmacists
5604926|NCT00878566|rural health|rural health
5604927|NCT00878566|prescribing|prescribing
5604928|NCT00878553|insomnia|insomnia
5604929|NCT00878553|middle of the night|middle of the night
5604930|NCT00878553|sleep maintenance|sleep maintenance
5604931|NCT00878540|mirtazapine|mirtazapine
5604932|NCT00878540|metabolism|metabolism
5604934|NCT00878540|Healthy males|healthy males
5604935|NCT00878527|Heart Failure|heart failure
5604936|NCT00878527|Partial Circulatory Assist|partial circulatory assist
5604937|NCT00878527|NYHA Class IIIb|nyha class iiib
5604938|NCT00878527|NYHA Class IV|nyha class iv
5604939|NCT00878527|Ventricular Assist Device|ventricular assist device
5604940|NCT00878527|VAD|vad
5604941|NCT00878514|Alprazolam|alprazolam
5604942|NCT00878514|Bioequivalence|bioequivalence
5604943|NCT00878501|Phase II|phase ii
5604944|NCT00878501|Pain|pain
5604945|NCT00878475|Quantitative Capnometry|quantitative capnometry
5604946|NCT00878475|N-Terminal Pro-Brain Natriuretic Peptide|n-terminal pro-brain natriuretic peptide
5604947|NCT00878475|Acute Heart Failure|acute heart failure
5604948|NCT00878475|Diagnostic Accuracy|diagnostic accuracy
5604949|NCT00878436|histone deacetylase inhibitor|histone deacetylase inhibitor
5604950|NCT00878436|hormone therapy|hormone therapy
5604951|NCT00878436|androgen-independent|androgen-independent
5604952|NCT00878436|PSA|psa
5604953|NCT00878436|androgen receptor|androgen receptor
5604954|NCT00878423|HSP90|hsp90
5604955|NCT00878423|Metastatic solid tumor including lymphoma which are|metastatic solid tumor including lymphoma which are
5604956|NCT00878423|refractory to standard therapy|refractory to standard therapy
5604957|NCT00878397|malaria|malaria
5604958|NCT00878397|long lasting insecticide nets|long lasting insecticide nets
5604960|NCT00878397|schools|schools
5604961|NCT00878384|Atrial Fibrillation|atrial fibrillation
5604962|NCT00878384|Heart Failure|heart failure
5604963|NCT00878384|Heart Rate Control|heart rate control
5604964|NCT00878384|Catheter Ablation|catheter ablation
5604965|NCT00878371|morphine|morphine
5604966|NCT00878371|blood brain barrier|blood brain barrier
5604967|NCT00878371|surgery induced peripheral inflammatory response|surgery induced peripheral inflammatory response
5604968|NCT00878358|Osteoarthritis|osteoarthritis
5604969|NCT00878358|Total knee replacement|total knee replacement
5604970|NCT00878345|Pediatric sedation|pediatric sedation
5604971|NCT00878345|Pentobarbital|pentobarbital
5604972|NCT00878345|Dexmedetomidine|dexmedetomidine
5604973|NCT00878345|Procedural sedation in children|procedural sedation in children
5604974|NCT00878332|edentulous|edentulous
5604975|NCT00878332|fixed dental rehabilitation|fixed dental rehabilitation
5604976|NCT00878332|insufficient bone height|insufficient bone height
5798759|NCT00111163|malaria|malaria
5798760|NCT00111163|anemia|anemia
5604979|NCT00878332|The recipient bone with insufficient bone height for dental implant insertion.|the recipient bone with insufficient bone height for dental implant insertion.
5604982|NCT00878319|diaphyseal (mid-shaft)|diaphyseal (mid-shaft)
5604983|NCT00878319|fracture|fracture
5604984|NCT00878319|operative|operative
5604985|NCT00878319|non-operative|non-operative
5604986|NCT00878306|Treatment of drug dependency with HIV medications|treatment of drug dependency with hiv medications
5604987|NCT00878306|HIV|hiv
5604988|NCT00878293|analgesic|analgesic
5604989|NCT00878293|diabetes mellitus|diabetes mellitus
5604990|NCT00878293|chronic neuropathic pain|chronic neuropathic pain
5604991|NCT00878293|painful polyneuropathy caused by diabetes mellitus type I or II|painful polyneuropathy caused by diabetes mellitus type i or ii
5604992|NCT00878267|Cancer|cancer
5604993|NCT00878267|Computer Program|computer program
5604994|NCT00878267|Palliative Care|palliative care
5604995|NCT00878267|Patient-Reported Outcomes|patient-reported outcomes
5604996|NCT00878267|PRO|pro
5604997|NCT00878267|Palliative and Hospice Care Practice|palliative and hospice care practice
5604998|NCT00878267|Electronic Health Record|electronic health record
5604999|NCT00878267|EHR|ehr
5605000|NCT00878267|Interview|interview
5605001|NCT00878254|Mantle Cell Lymphoma|mantle cell lymphoma
5605002|NCT00878254|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5605003|NCT00878254|MCL|mcl
5605004|NCT00878254|NHL|nhl
5605005|NCT00878241|Colon Anastomosis|colon anastomosis
5605006|NCT00878241|Rectum Anastomosis|rectum anastomosis
5605007|NCT00878241|Intestine|intestine
5605008|NCT00878241|Colorectal Surgery|colorectal surgery
5605009|NCT00878241|Colorectal Anastomosis|colorectal anastomosis
5605010|NCT00878215|Image Guided Liver Surgery|image guided liver surgery
5605011|NCT00878189|Phase 1 dose escalation study in advanced solid tumor malignancy and leukemia|phase 1 dose escalation study in advanced solid tumor malignancy and leukemia
5605012|NCT00878176|sacral neuromodulation therapy|sacral neuromodulation therapy
5605013|NCT00878176|urinary retention|urinary retention
5605014|NCT00878176|screening|screening
5605015|NCT00878176|non obstructive urinary retention|non obstructive urinary retention
5605016|NCT00878150|traumatic brain injury|traumatic brain injury
5605017|NCT00878150|TBI|tbi
5605018|NCT00878150|head injury|head injury
5605019|NCT00878150|brain injury|brain injury
5605020|NCT00878150|depression|depression
5605021|NCT00878150|major depressive disorder|major depressive disorder
5605022|NCT00878150|cognitive behavioral therapy|cognitive behavioral therapy
5605023|NCT00878150|CBT|cbt
5605024|NCT00878150|counseling|counseling
5605025|NCT00878124|Poor ovarian response|poor ovarian response
5605026|NCT00878124|Chromosomal aberrations|chromosomal aberrations
5605027|NCT00878124|poor pregnancy outcome|poor pregnancy outcome
5605028|NCT00878124|Late maternal age|late maternal age
5605029|NCT00878111|NGR-hTNF|ngr-htnf
5605030|NCT00878111|Solid tumours|solid tumours
5605031|NCT00878111|High doses|high doses
5605033|NCT00878098|Malaria|malaria
5605034|NCT00878098|Pregnancy Outcome|pregnancy outcome
5605356|NCT00876928|diabetes|diabetes
5605035|NCT00878098|Spontaneous Abortion|spontaneous abortion
5605036|NCT00878098|HIV|hiv
5605037|NCT00878098|Pregnancy|pregnancy
5605038|NCT00878085|Robot Therapy|robot therapy
5605039|NCT00878085|Upper Limb|upper limb
5605040|NCT00878085|Stroke|stroke
5605041|NCT00878085|Rehabilitation|rehabilitation
5605042|NCT00878085|fMRI|fmri
5605043|NCT00878085|DTI|dti
5605044|NCT00878072|Herpes labialis|herpes labialis
5605045|NCT00878072|cold sores|cold sores
5605046|NCT00878072|herpes simplex type 1|herpes simplex type 1
5605047|NCT00878046|Hip|hip
5605048|NCT00878046|Cementless|cementless
5605049|NCT00878046|Conservative|conservative
5605050|NCT00878007|Anaemia|anaemia
5605051|NCT00878007|Malaria|malaria
5605052|NCT00878007|Literacy|literacy
5605053|NCT00878007|Kenya|kenya
5605054|NCT00877994|Disordered Eating|disordered eating
5605055|NCT00877994|Parenting|parenting
5605056|NCT00877994|Mothers|mothers
5605057|NCT00877981|hyperparathyroidism|hyperparathyroidism
5605058|NCT00877981|surgery|surgery
5605059|NCT00877981|minimal invasive|minimal invasive
5605060|NCT00877981|videoassited|videoassited
5605061|NCT00877968|Pea flour|pea flour
5605062|NCT00877968|Glycemic response|glycemic response
5605063|NCT00877968|Diabetes|diabetes
5605065|NCT00877968|Functional food|functional food
5605066|NCT00877968|Diabetes control and prevention|diabetes control and prevention
5605067|NCT00877955|bioequivalence|bioequivalence
5605068|NCT00877955|pharmacokinetic|pharmacokinetic
5605069|NCT00877955|alprazolam|alprazolam
5605070|NCT00877955|sublingual|sublingual
5605071|NCT00877903|Acute myocardial infarction|acute myocardial infarction
5607693|NCT00867724|polyp|polyp
5605079|NCT00877890|diabetes|diabetes
5605080|NCT00877890|exenatide once weekly|exenatide once weekly
5605081|NCT00877890|Byetta|byetta
5605082|NCT00877890|Amylin|amylin
5605083|NCT00877890|Lilly|lilly
5605084|NCT00877890|Bydureon|bydureon
5605085|NCT00877877|HPV vaccine|hpv vaccine
5605086|NCT00877877|cervical cancer|cervical cancer
5605087|NCT00877864|diabetes|diabetes
5605088|NCT00877864|exercise|exercise
5605089|NCT00877864|printed materials|printed materials
5605090|NCT00877851|Diet|diet
5605091|NCT00877851|Physical activity|physical activity
5605092|NCT00877851|Self management|self management
5605093|NCT00877851|Goal setting|goal setting
5605094|NCT00877838|Headache|headache
5605095|NCT00877838|Migraine|migraine
5605096|NCT00877838|Aura|aura
5605097|NCT00877838|Acute|acute
5605098|NCT00877838|Attack|attack
5605099|NCT00877838|Clinical|clinical
5605100|NCT00877838|Trial|trial
5605101|NCT00877838|Intervention|intervention
5605102|NCT00877838|Nitrogen Oxide|nitrogen oxide
5605104|NCT00877838|nNOS|nnos
5605105|NCT00877838|Triptan|triptan
5605106|NCT00877838|5HT|5ht
5605107|NCT00877838|Serotonin|serotonin
5605108|NCT00877825|Diet Therapy|diet therapy
5605109|NCT00877812|Vitamin B6|vitamin b6
5605110|NCT00877812|Vitamin B6 deficiency|vitamin b6 deficiency
5605111|NCT00877812|Amino acids|amino acids
5605112|NCT00877812|pyridoxine|pyridoxine
5605113|NCT00877799|pain|pain
5605114|NCT00877799|acute pain|acute pain
5605115|NCT00877799|visceral pain|visceral pain
5605116|NCT00877799|kappa agonist|kappa agonist
5605117|NCT00877799|opioid analgesics|opioid analgesics
5605118|NCT00877799|peripheral nervous system agents|peripheral nervous system agents
5605119|NCT00877799|physiological effects of drugs|physiological effects of drugs
5605120|NCT00877799|surgery|surgery
5605121|NCT00877799|hysterectomy|hysterectomy
5605122|NCT00877799|post-operative|post-operative
5605123|NCT00877799|post-operative complications|post-operative complications
5605124|NCT00877773|Advanced cancer|advanced cancer
5605125|NCT00877773|Advanced Cancer with genetic mutation|advanced cancer with genetic mutation
5605126|NCT00877773|Phosphoinositides 3-kinase|phosphoinositides 3-kinase
5605127|NCT00877773|PI3K|pi3k
5605128|NCT00877773|PIK3 mutations|pik3 mutations
5605129|NCT00877773|Temsirolimus|temsirolimus
5605130|NCT00877773|CCI-779|cci-779
5605131|NCT00877773|Torisel|torisel
5605132|NCT00877773|mTOR inhibitor|mtor inhibitor
5605133|NCT00877760|Hepatitis B Entecavir pegylated interferon a-2a|hepatitis b entecavir pegylated interferon a-2a
5605134|NCT00877747|PET|pet
5605135|NCT00877734|alcohol dependence|alcohol dependence
5605136|NCT00877734|baclofen|baclofen
5605137|NCT00877734|pharmacotherapy|pharmacotherapy
5605138|NCT00877734|women|women
5605139|NCT00877721|Postural Control|postural control
5605140|NCT00877721|Gait|gait
5605141|NCT00877721|Falls|falls
5605142|NCT00877721|Elderly|elderly
5605143|NCT00877721|Old adults (65 years old and older) with low risk of falls|old adults (65 years old and older) with low risk of falls
5605144|NCT00877708|E. Coli|e. coli
5605145|NCT00877708|isolates|isolates
5605147|NCT00877695|HIV Seronegativity|hiv seronegativity
5605148|NCT00877695|prevention|prevention
5605149|NCT00877695|Hispanic|hispanic
5605150|NCT00877695|Latino|latino
5605151|NCT00877695|MSM|msm
5605152|NCT00877695|men|men
5605153|NCT00877682|Prostate Cancer|prostate cancer
5605154|NCT00877682|Prostate Tumor|prostate tumor
5605155|NCT00877682|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5605156|NCT00877682|PCA|pca
5605157|NCT00877682|Regional Prostate Cryoablation|regional prostate cryoablation
5605158|NCT00877682|Cryotherapy|cryotherapy
5605159|NCT00877682|Cryoablation|cryoablation
5605160|NCT00877682|Health Related Quality of Life|health related quality of life
5605161|NCT00877682|HRQOL|hrqol
5605162|NCT00877617|Quality of Life|quality of life
5605163|NCT00877617|QOL|qol
5605164|NCT00877617|Questionnaire|questionnaire
5605165|NCT00877617|High Risk localized Prostate Cancer|high risk localized prostate cancer
5605166|NCT00877617|HRLPC|hrlpc
5605167|NCT00877617|Neoadjuvant Investigational Therapy|neoadjuvant investigational therapy
5605168|NCT00877617|Radical Prostatectomy|radical prostatectomy
5605169|NCT00877604|ALS|als
5605170|NCT00877604|Therapy|therapy
5588111|NCT00938197|Fimasartan|fimasartan
5605171|NCT00877604|Tauroursodeoxycholic acid|tauroursodeoxycholic acid
5605172|NCT00877604|TUDCA|tudca
5605173|NCT00877604|antioxidant|antioxidant
5605174|NCT00877604|antiapoptotic drug|antiapoptotic drug
5605175|NCT00877604|neuroprotective drug|neuroprotective drug
5605176|NCT00877591|Interaction of Buprenorphine with HIV and TB Medications|interaction of buprenorphine with hiv and tb medications
5605177|NCT00877578|elderly patient|elderly patient
5605178|NCT00877578|malnutrition|malnutrition
5605179|NCT00877578|new nutritional support|new nutritional support
5605180|NCT00877578|micronutrients|micronutrients
5605181|NCT00877578|elderly patient malnutrition|elderly patient malnutrition
5605183|NCT00877565|Left ventricular systolic function|left ventricular systolic function
5605184|NCT00877552|Schizophrenia|schizophrenia
5605185|NCT00877552|brain development|brain development
5605187|NCT00877539|Asthma Allergen Challenge|asthma allergen challenge
5605188|NCT00877513|Smoking|smoking
5605189|NCT00877513|Insulin resistance|insulin resistance
5605190|NCT00877513|Metabolic syndrome|metabolic syndrome
5605191|NCT00877513|Body fat distribution|body fat distribution
5605192|NCT00877513|Cigarette smoking|cigarette smoking
5605193|NCT00877487|ADHD|adhd
5605194|NCT00877474|PM01183|pm01183
5605195|NCT00877474|Solid tumors|solid tumors
5605196|NCT00877474|PharmaMar USA|pharmamar usa
5605197|NCT00877448|INFLUENZA|influenza
5605198|NCT00877448|VACCINE|vaccine
5605199|NCT00877448|UNIVERSAL|universal
5605200|NCT00877448|SAFETY|safety
5605201|NCT00877422|vitamin deficiency|vitamin deficiency
5605202|NCT00877409|Acnase|acnase
5605203|NCT00877409|Acne Vulgaris|acne vulgaris
5605204|NCT00877409|Safety|safety
5605205|NCT00877409|Efficacy|efficacy
5605206|NCT00877383|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5605207|NCT00877383|COPD|copd
5605208|NCT00877383|indacaterol|indacaterol
5605209|NCT00877383|tiotropium|tiotropium
5605210|NCT00877383|bronchodilation|bronchodilation
5605211|NCT00877370|ertapenem|ertapenem
5605212|NCT00877370|continuous hemodialysis|continuous hemodialysis
5605213|NCT00877370|pharmacokinetics|pharmacokinetics
5605214|NCT00877357|Vaccine|vaccine
5605215|NCT00877357|Prevention|prevention
5605216|NCT00877357|Diphtheria|diphtheria
5605217|NCT00877357|Tetanus|tetanus
5605218|NCT00877357|Pertussis|pertussis
5605219|NCT00877357|Hepatitis B|hepatitis b
5605220|NCT00877357|Haemophilus influenzae type b|haemophilus influenzae type b
5605221|NCT00877357|Lot Consistency|lot consistency
5605222|NCT00877357|Long Term Immunogenicity|long term immunogenicity
5605223|NCT00877357|Reactogenicity|reactogenicity
5605224|NCT00877357|Healthy infants|healthy infants
5605225|NCT00877344|Pregnancy|pregnancy
5605226|NCT00877344|IUC|iuc
5605227|NCT00877344|abortion|abortion
5605228|NCT00877344|contraception|contraception
5605229|NCT00877331|Drug Abuse|drug abuse
5605230|NCT00877331|Drug Addiction|drug addiction
5605231|NCT00877331|Drug Dependence|drug dependence
5605232|NCT00877331|Drug Usage|drug usage
5605233|NCT00877331|Drug Use Disorders|drug use disorders
5605234|NCT00877331|Substance Abuse|substance abuse
5605235|NCT00877331|Substance Addiction|substance addiction
5605236|NCT00877331|Substance Dependence|substance dependence
5605237|NCT00877331|Substance Use Disorders|substance use disorders
5605238|NCT00877305|Ischemic Preconditioning|ischemic preconditioning
5605239|NCT00877305|Cognitive function|cognitive function
5605240|NCT00877292|Down Syndrome|down syndrome
5605241|NCT00877292|trisomy 21|trisomy 21
5605242|NCT00877292|prenatal testing|prenatal testing
5605243|NCT00877292|pregnant women|pregnant women
5605244|NCT00877279|Facial wrinkles|facial wrinkles
5605245|NCT00877279|Nasolabial folds|nasolabial folds
5605246|NCT00877266|catheter|catheter
5605247|NCT00877266|ultrasound guidance|ultrasound guidance
5605248|NCT00877266|nerve stimulation|nerve stimulation
5605249|NCT00877266|electrical stimulation|electrical stimulation
5605250|NCT00877266|nerve block|nerve block
5605251|NCT00877266|UCSD|ucsd
5605252|NCT00877266|timed placement|timed placement
5605253|NCT00877266|surgery|surgery
5605254|NCT00877266|Catheter Placement Time|catheter placement time
5605255|NCT00877227|CVA|cva
5605256|NCT00877227|stroke|stroke
5605257|NCT00877227|newborns|newborns
5605258|NCT00877227|homocysteine|homocysteine
5605259|NCT00877227|folinic acid|folinic acid
5605260|NCT00877214|Bendamustine|bendamustine
5605261|NCT00877214|Rituximab|rituximab
5605262|NCT00877214|Significance of maintenance therapy|significance of maintenance therapy
5605263|NCT00877214|Efficacy and safety|efficacy and safety
5605264|NCT00877201|Accommodation|accommodation
5605265|NCT00877201|visual display terminal (VDT)|visual display terminal (vdt)
5605266|NCT00877201|antioxidant|antioxidant
5605267|NCT00877188|breast cancer|breast cancer
5605268|NCT00877188|exercise|exercise
5605269|NCT00877188|upper extremity function|upper extremity function
5605270|NCT00877188|quality of life|quality of life
5605271|NCT00877175|preterm infants|preterm infants
5605272|NCT00877175|mydriasis|mydriasis
5605273|NCT00877175|pupil dilation|pupil dilation
5605274|NCT00877162|Cognitive and behavioural intervention|cognitive and behavioural intervention
5605275|NCT00877162|trial|trial
5605276|NCT00877162|group|group
5605277|NCT00877162|Behavioral sleep problems|behavioral sleep problems
5605278|NCT00877149|Chronic HBV|chronic hbv
5605279|NCT00877136|Liver tumors|liver tumors
5605280|NCT00877136|Liver cancer|liver cancer
5685462|NCT00555997|Geodon|geodon
5605281|NCT00877136|Adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5605282|NCT00877136|HCC|hcc
5605283|NCT00877136|Hepatoma|hepatoma
5605284|NCT00877136|Neoplasms|neoplasms
5605285|NCT00877123|fasting glucose|fasting glucose
5605286|NCT00877123|obesity|obesity
5605287|NCT00877123|arab women|arab women
5605288|NCT00877123|interleukin|interleukin
5605289|NCT00877123|diabetes|diabetes
5605290|NCT00877123|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
5605291|NCT00877110|BETA-D-GLUCAN|beta-d-glucan
5605292|NCT00877110|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5605293|NCT00877110|MAB 131 I - 3F8|mab 131 i - 3f8
5605294|NCT00877110|TOPOTECAN|topotecan
5605295|NCT00877110|VINCRISTINE|vincristine
5605296|NCT00877110|Neuroblastoma|neuroblastoma
5605297|NCT00877110|09-011|09-011
5605298|NCT00877097|osteoporosis|osteoporosis
5605299|NCT00877097|Bone mineral density|bone mineral density
5605300|NCT00877097|clodronate|clodronate
5605302|NCT00877097|postmenopausal|postmenopausal
5605303|NCT00877084|exacerbation|exacerbation
5605305|NCT00877084|Resistance training|resistance training
5605306|NCT00877084|Muscle force|muscle force
5605307|NCT00877058|Frailty|frailty
5605308|NCT00877058|health promotion|health promotion
5605309|NCT00877058|prevention|prevention
5605310|NCT00877058|self management|self management
5605311|NCT00877058|intervention|intervention
5605312|NCT00877045|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5605313|NCT00877045|GIST|gist
5605314|NCT00877045|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5605315|NCT00877045|Imatinib|imatinib
5605316|NCT00877045|Gleevec|gleevec
5605317|NCT00877045|Suntinib|suntinib
5605318|NCT00877045|Sutent|sutent
5605319|NCT00877032|Phase 1|phase 1
5605320|NCT00877032|Dry Age Related Macular Degeneration|dry age related macular degeneration
5605321|NCT00877032|RN6G|rn6g
5605322|NCT00877019|sonic brushes|sonic brushes
5605323|NCT00877019|time effectiveness|time effectiveness
5605324|NCT00877019|brush head design|brush head design
5605325|NCT00877019|ADA-toothbrush|ada-toothbrush
5605326|NCT00877019|professional brushing|professional brushing
5605327|NCT00877019|time dependence|time dependence
5605328|NCT00877019|efficacy|efficacy
5605329|NCT00877019|toothbrush|toothbrush
5605330|NCT00876980|Obstructive sleep apnea|obstructive sleep apnea
5605331|NCT00876980|Type II diabetes mellitus|type ii diabetes mellitus
5605332|NCT00876980|Randomized controlled trial|randomized controlled trial
5605333|NCT00876967|anesthesiology|anesthesiology
5605334|NCT00876967|randomized|randomized
5605335|NCT00876967|laryngoscope|laryngoscope
5605336|NCT00876967|intubation|intubation
5605337|NCT00876967|laryngeal exposition|laryngeal exposition
5605338|NCT00876967|laryngoscope blades|laryngoscope blades
5605339|NCT00876967|plastic single use blade|plastic single use blade
5605340|NCT00876967|metallic single use blade|metallic single use blade
5605341|NCT00876967|metallic reusable blade|metallic reusable blade
5605342|NCT00876967|success to intubation at first attempt|success to intubation at first attempt
5605343|NCT00876967|Cormack and lehanne modify grade|cormack and lehanne modify grade
5605344|NCT00876941|Drug|drug
5605345|NCT00876941|Drug Use|drug use
5605346|NCT00876941|Screening|screening
5605347|NCT00876941|Brief Intervention|brief intervention
5605348|NCT00876941|Primary Care|primary care
5605349|NCT00876941|Utilization|utilization
5605350|NCT00876928|pre-diabetes|pre-diabetes
5605351|NCT00876928|minorities|minorities
5605352|NCT00876928|oral glucose tolerance test|oral glucose tolerance test
5605353|NCT00876928|disposition index|disposition index
5605354|NCT00876928|insulin secretion|insulin secretion
5605355|NCT00876928|insulin sensitivity|insulin sensitivity
5605357|NCT00876915|prevention of VTE and PE in high risk cancer patients|prevention of vte and pe in high risk cancer patients
5605358|NCT00876902|liver transplantation|liver transplantation
5605359|NCT00876902|cadaveric liver transplantation|cadaveric liver transplantation
5605360|NCT00876902|ischemic reperfusion injury|ischemic reperfusion injury
5605361|NCT00876902|primary non-function|primary non-function
5605362|NCT00876902|delayed non-Function|delayed non-function
5605363|NCT00876902|poor early graft function|poor early graft function
5605364|NCT00876902|YSPSL|yspsl
5605365|NCT00876902|recombinant PSGL-Ig|recombinant psgl-ig
5605366|NCT00876889|spinal cord injury|spinal cord injury
5605367|NCT00876889|riluzole|riluzole
5605368|NCT00876889|pharmacokinetics|pharmacokinetics
5605369|NCT00876889|Acute Traumatic Spinal Cord Injury|acute traumatic spinal cord injury
5605370|NCT00876876|hypervolemic hyponatremia|hypervolemic hyponatremia
5605371|NCT00876876|serum sodium|serum sodium
5605372|NCT00876876|fluid overload|fluid overload
5605373|NCT00876876|heartfailure|heartfailure
5605374|NCT00876876|acute heart failure|acute heart failure
5605375|NCT00876876|vasopressin antagonist|vasopressin antagonist
5605376|NCT00876863|Alzheimer's disease|alzheimer's disease
5605377|NCT00876863|Dementia|dementia
5605378|NCT00876863|Memory loss|memory loss
5605379|NCT00876863|Cognitive impairment|cognitive impairment
5605380|NCT00876863|Nerve growth factor|nerve growth factor
5605382|NCT00876863|Neurotrophic factors|neurotrophic factors
5605383|NCT00876863|Gene therapy|gene therapy
5605384|NCT00876850|cSSI|cssi
5605385|NCT00876850|Abscess|abscess
5605386|NCT00876850|Would|would
5605387|NCT00876850|Cellulitis|cellulitis
5605388|NCT00876850|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5605389|NCT00876824|Black Fever|black fever
5605390|NCT00876824|Kala-Azar|kala-azar
5605391|NCT00876824|Amphotericin B lipid emulsion|amphotericin b lipid emulsion
5605392|NCT00876824|Liposomal Amphotericin B|liposomal amphotericin b
5605393|NCT00876811|raspberry|raspberry
5605394|NCT00876811|fruit|fruit
5605395|NCT00876811|antioxidants|antioxidants
5605396|NCT00876811|polyphenols|polyphenols
5605397|NCT00876811|oxidative stress|oxidative stress
5605398|NCT00876811|dietary intervention|dietary intervention
5605399|NCT00876798|Euvolemic Hyponatremia|euvolemic hyponatremia
5605400|NCT00876798|SIADH|siadh
5605402|NCT00876785|Rye bread satiety breakfast|rye bread satiety breakfast
5605403|NCT00876772|ALS|als
5605404|NCT00876772|olanazapine|olanazapine
5605405|NCT00876772|Loss of Apptetite|loss of apptetite
5605406|NCT00876772|Appetite Loss|appetite loss
5605407|NCT00876772|Malnutrition|malnutrition
5605408|NCT00876772|Cachexia|cachexia
5605409|NCT00876772|Zyprexa|zyprexa
5605410|NCT00876759|cerebral metastases|cerebral metastases
5605411|NCT00876746|Pain|pain
5605412|NCT00876746|surgery|surgery
5605413|NCT00876746|catheter|catheter
5605414|NCT00876746|nerve block|nerve block
5605415|NCT00876746|supraclavicular|supraclavicular
5605416|NCT00876746|infraclavicular|infraclavicular
5605417|NCT00876746|UCSD|ucsd
5605418|NCT00876746|moderate-to-severe pain|moderate-to-severe pain
5605419|NCT00876746|Supraclavicular catheter|supraclavicular catheter
5605420|NCT00876746|Infraclavicular catheter|infraclavicular catheter
5605421|NCT00876720|Tinnitus|tinnitus
5605422|NCT00876720|chronic subjective tinnitus|chronic subjective tinnitus
5605423|NCT00876720|transcranial magnetic stimulation|transcranial magnetic stimulation
5605424|NCT00876720|sensation disorders|sensation disorders
5605425|NCT00876720|hearing disorders|hearing disorders
5605426|NCT00876707|wavefront|wavefront
5605427|NCT00876707|multifocal IOL|multifocal iol
5605428|NCT00876707|modulation transfer function|modulation transfer function
5605429|NCT00876707|intraocular lenses|intraocular lenses
5605430|NCT00876707|wavefront data|wavefront data
5605431|NCT00876707|Visual performance|visual performance
5605432|NCT00876694|COPD, Chronic Obstructive Pulmonary Disease, Indacaterol, long acting β2-agonist|copd, chronic obstructive pulmonary disease, indacaterol, long acting β2-agonist
5605433|NCT00876681|Catheter|catheter
5605434|NCT00876681|Ultrasound-guidance|ultrasound-guidance
5605435|NCT00876681|Nerve Stimulation|nerve stimulation
5605436|NCT00876681|Electrical stimulation|electrical stimulation
5605437|NCT00876681|nerve block|nerve block
5605438|NCT00876681|UCSD|ucsd
5605439|NCT00876681|Orthopedic surgery|orthopedic surgery
5605440|NCT00876681|Foot/ankle pain|foot/ankle pain
5605441|NCT00876681|Foot/ankle numbness|foot/ankle numbness
5605442|NCT00876681|Popliteal-Sciatic Catheters|popliteal-sciatic catheters
5605443|NCT00876668|Peripheral Vascular diseases|peripheral vascular diseases
5605444|NCT00876668|Microcirculation|microcirculation
5605445|NCT00876668|fluorescence angiography|fluorescence angiography
5605446|NCT00876642|Radiation dermatitis|radiation dermatitis
5605447|NCT00876642|best supportive care|best supportive care
5605448|NCT00876642|Aloe vera gel|aloe vera gel
5605449|NCT00876642|phase III study was to assess the effectiveness of aloe vera and vitamin E.|phase iii study was to assess the effectiveness of aloe vera and vitamin e.
5605450|NCT00876629|MR Elastography|mr elastography
5605451|NCT00876629|kidney|kidney
5605452|NCT00876629|fibrosis|fibrosis
5605551|NCT00876226|Citalopram|citalopram
5605453|NCT00876616|lupus nephritis;multi-target therapy; MMF; FK506|lupus nephritis;multi-target therapy; mmf; fk506
5605454|NCT00876603|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5605455|NCT00876603|anterior decompression and fusion|anterior decompression and fusion
5605456|NCT00876603|cervical laminoplasty|cervical laminoplasty
5671699|NCT00614744|Perinatal asphyxia|perinatal asphyxia
5605457|NCT00876577|Acute Exacerbations of Chronic Bronchitis|acute exacerbations of chronic bronchitis
5605458|NCT00876577|Avelox|avelox
5605459|NCT00876577|Bronchitis|bronchitis
5605460|NCT00876564|Triage precision|triage precision
5605461|NCT00876551|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5605462|NCT00876551|Endoscopic/endoluminal V.A.C. therapy|endoscopic/endoluminal v.a.c. therapy
5605463|NCT00876551|Esophagectomy|esophagectomy
5605464|NCT00876551|Anastomotic leakage|anastomotic leakage
5605465|NCT00876551|Anastomosis, Surgical|anastomosis, surgical
5605466|NCT00876538|Chemotherapy Induced Peripheral Neuropathy|chemotherapy induced peripheral neuropathy
5605467|NCT00876538|TR019622|tr019622
5605468|NCT00876538|Trophos|trophos
5605469|NCT00876525|Heart diseases.|heart diseases.
5605470|NCT00876525|Aortic valve diseases.|aortic valve diseases.
5605471|NCT00876525|Aortic valve insufficiency.|aortic valve insufficiency.
5605472|NCT00876525|Aortic valve stenosis.|aortic valve stenosis.
5685463|NCT00555997|Ziprasidone|ziprasidone
5605473|NCT00876512|thienopyridine resistance|thienopyridine resistance
5605474|NCT00876512|stable effort angina|stable effort angina
5605475|NCT00876512|platelet activation|platelet activation
5605477|NCT00876512|von Willebrand Factor|von willebrand factor
5605478|NCT00876499|Primary Brain Tumor|primary brain tumor
5605479|NCT00876499|PBT|pbt
5605480|NCT00876499|Brain Cancer|brain cancer
5605481|NCT00876499|Primary glioma|primary glioma
5605482|NCT00876499|Astrocytoma|astrocytoma
5605483|NCT00876499|Oligodendroglioma|oligodendroglioma
5605484|NCT00876499|Oligo-astrocytoma|oligo-astrocytoma
5605485|NCT00876499|Ependymoma|ependymoma
5605486|NCT00876499|Anaplastic astrocytoma|anaplastic astrocytoma
5605487|NCT00876499|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5605488|NCT00876499|Anaplastic oligo-astrocytoma|anaplastic oligo-astrocytoma
5605489|NCT00876499|Anaplastic ependymoma|anaplastic ependymoma
5605490|NCT00876499|Fatigue|fatigue
5605491|NCT00876499|Cytokines|cytokines
5605492|NCT00876499|Questionnaires|questionnaires
5605494|NCT00876499|Sleep Disturbance|sleep disturbance
5605495|NCT00876499|Radiation Therapy|radiation therapy
5605497|NCT00876473|Acute Respiratory Failure|acute respiratory failure
5605498|NCT00876434|Sirolimus|sirolimus
5605499|NCT00876434|Anterior Uveitis|anterior uveitis
5605500|NCT00876434|Autoimmune Disease|autoimmune disease
5605501|NCT00876434|Uveitis|uveitis
5605502|NCT00876421|ONO-8539|ono-8539
5605503|NCT00876421|Overactive bladder|overactive bladder
5605504|NCT00876421|OAB|oab
5605505|NCT00876408|RT-PCR molecular profiling assay|rt-pcr molecular profiling assay
5605506|NCT00876408|Molecular Profiling-Real Time Polymerase Chain Reaction|molecular profiling-real time polymerase chain reaction
5605507|NCT00876408|Unknown Primary|unknown primary
5605508|NCT00876408|UPC|upc
5605509|NCT00876408|CUP|cup
5605510|NCT00876395|Breast Cancer|breast cancer
5605511|NCT00876395|HER2+|her2+
5605512|NCT00876395|mTOR|mtor
5605513|NCT00876395|everolimus|everolimus
5605514|NCT00876395|RAD001|rad001
5605515|NCT00876395|first line|first line
5605516|NCT00876395|metastatic|metastatic
5605517|NCT00876395|locally advanced|locally advanced
5605518|NCT00876395|Trastuzumab|trastuzumab
5605519|NCT00876395|Paclitaxel|paclitaxel
5605520|NCT00876395|First Line Therapy|first line therapy
5605521|NCT00876395|HER2 Positive|her2 positive
5605522|NCT00876395|Metastatic Breast Cancer|metastatic breast cancer
5605523|NCT00876382|advanced renal cell carcinoma|advanced renal cell carcinoma
5605524|NCT00876382|renal cancer|renal cancer
5605525|NCT00876382|renal cell|renal cell
5605526|NCT00876382|Sorafenib|sorafenib
5605527|NCT00876382|Nexavar|nexavar
5605528|NCT00876382|Bevacizumab|bevacizumab
5605529|NCT00876382|Avastin|avastin
5605530|NCT00876382|Sunitinib|sunitinib
5605531|NCT00876382|Sutent|sutent
5605532|NCT00876369|urticaria|urticaria
5605533|NCT00876369|angioedema|angioedema
5605534|NCT00876369|vitamin D|vitamin d
5605535|NCT00876369|allergy|allergy
5605536|NCT00876356|Asthma|asthma
5605537|NCT00876356|Conjugated Linoleic Acid (CLA)|conjugated linoleic acid (cla)
5605538|NCT00876356|dietary supplement|dietary supplement
5605539|NCT00876330|Clinical Decision Support Systems|clinical decision support systems
5605540|NCT00876330|Hyperlipidemia|hyperlipidemia
5605541|NCT00876330|Hypertension|hypertension
5605542|NCT00876317|Tenosynovitis|tenosynovitis
5605543|NCT00876317|Bursitis|bursitis
5605544|NCT00876304|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
5605545|NCT00876278|Cataract|cataract
5605546|NCT00876278|Intraocular Lens (IOL)|intraocular lens (iol)
5605547|NCT00876278|Mesotest II|mesotest ii
5605548|NCT00876278|Evaluation of usability of Mesotest II for assessment of night driving capacity of pseudo-phakic patients|evaluation of usability of mesotest ii for assessment of night driving capacity of pseudo-phakic patients
5605549|NCT00876265|Facial wrinkles|facial wrinkles
5605550|NCT00876265|Nasolabial fold|nasolabial fold
5605552|NCT00876226|Pharmacokinetics|pharmacokinetics
5605553|NCT00876226|Short Bowel Syndrome|short bowel syndrome
5605554|NCT00876213|Amylin|amylin
5605555|NCT00876213|GLP-1|glp-1
5789990|NCT00146224|anemia|anemia
5605556|NCT00876213|gastric emptying|gastric emptying
5605557|NCT00876213|appetite and food intake|appetite and food intake
5605558|NCT00876200|Williams Beuren syndrome|williams beuren syndrome
5605559|NCT00876200|Cardiovascular abnormalities|cardiovascular abnormalities
5605560|NCT00876200|Cardiovascular structure|cardiovascular structure
5605561|NCT00876187|randomized controlled trial|randomized controlled trial
5605562|NCT00876187|monoclonal antibody|monoclonal antibody
5605563|NCT00876187|nerve growth factor|nerve growth factor
5605564|NCT00876187|naproxen|naproxen
5605565|NCT00876174|Chronic hepatitis C|chronic hepatitis c
5605566|NCT00876174|Genotype 1|genotype 1
5605567|NCT00876161|Healthy Adults|healthy adults
5605568|NCT00876148|Incidence of hepatitis B after allografting|incidence of hepatitis b after allografting
5605569|NCT00876148|Risk of hepatitis B reactivation|risk of hepatitis b reactivation
5605570|NCT00876148|Lamivudine prophylaxis|lamivudine prophylaxis
5588471|NCT00936858|RAD001|rad001
5605572|NCT00876122|Metastatic Solid Tumors|metastatic solid tumors
5605573|NCT00876122|PI3K Inhibitors|pi3k inhibitors
5605574|NCT00876122|PI3K|pi3k
5605575|NCT00876109|Metastatic Solid Tumors|metastatic solid tumors
5605576|NCT00876109|PI3K|pi3k
5605577|NCT00876109|PI3K Inhibitors|pi3k inhibitors
5605578|NCT00876096|Diagnosis, Differential|diagnosis, differential
5605579|NCT00876083|Drug utilization review|drug utilization review
5605580|NCT00876070|Metastatic Breast Cancer|metastatic breast cancer
5605581|NCT00876070|Breast Cancer|breast cancer
5605582|NCT00876070|MBC|mbc
5605583|NCT00876070|Abraxane|abraxane
5605584|NCT00876070|Paclitaxel|paclitaxel
5605585|NCT00876070|Taxol|taxol
5605586|NCT00876070|Docetaxel|docetaxel
5605587|NCT00876070|Taxotere|taxotere
5605588|NCT00876057|psychological well-being|psychological well-being
5605589|NCT00876057|recovery|recovery
5605590|NCT00876057|time in hospital|time in hospital
5605591|NCT00876057|sick-leave|sick-leave
5605592|NCT00876057|complications|complications
5782286|NCT00183118|HIV|hiv
5605594|NCT00876031|pediatric soft tissue sarcoma|pediatric soft tissue sarcoma
5605595|NCT00876031|rhabdomyosarcoma|rhabdomyosarcoma
5605596|NCT00876031|extraosseous Ewing family tumours|extraosseous ewing family tumours
5605597|NCT00876031|synovial sarcoma|synovial sarcoma
5605598|NCT00876031|undifferentiated sarcoma|undifferentiated sarcoma
5605599|NCT00876018|physical performance|physical performance
5605600|NCT00876018|micronutrients|micronutrients
5605601|NCT00876018|physical fitness|physical fitness
5605602|NCT00876018|healthy children|healthy children
5605603|NCT00876005|Wound infection|wound infection
5605604|NCT00875979|MBC|mbc
5605605|NCT00875979|Breast Cancer|breast cancer
5605606|NCT00875979|HER2+|her2+
5605607|NCT00875979|HER2+ breast cancer|her2+ breast cancer
5605608|NCT00875979|HER2 positive breast cancer|her2 positive breast cancer
5605609|NCT00875979|herceptin|herceptin
5605610|NCT00875979|Trastuzumab emtansine|trastuzumab emtansine
5605611|NCT00875953|squamous cell carcinoma|squamous cell carcinoma
5605612|NCT00875953|head and neck cancer|head and neck cancer
5605613|NCT00875953|neck dissection|neck dissection
5605614|NCT00875927|Halitosis|halitosis
5605615|NCT00875914|AV-node reentry tachycardia|av-node reentry tachycardia
5605616|NCT00875914|radiofrequency ablation|radiofrequency ablation
5605617|NCT00875914|magnetic navigation system|magnetic navigation system
5605618|NCT00875901|Lung Cancer|lung cancer
5605619|NCT00875901|Stage I Non-Small Cell Lung Cancer|stage i non-small cell lung cancer
5605620|NCT00875901|Proton Radiation|proton radiation
5605621|NCT00875901|HypoIGRT|hypoigrt
5605622|NCT00875875|Diarrhea, travelers|diarrhea, travelers
5605623|NCT00875875|Acute travelers' diarrhea|acute travelers' diarrhea
5605624|NCT00875862|UCSD|ucsd
5605625|NCT00875862|pain|pain
5605626|NCT00875862|quality-of-life|quality-of-life
5605627|NCT00875862|range-of-motion|range-of-motion
5605628|NCT00875862|interscalene catheter|interscalene catheter
5605629|NCT00875862|nerve block|nerve block
5605630|NCT00875862|shoulder|shoulder
5605631|NCT00875862|Shoulder Manipulation|shoulder manipulation
5605632|NCT00875849|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5605633|NCT00875849|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5605634|NCT00875849|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5680362|NCT00578032|quality of life|quality of life
5680363|NCT00578032|07-150|07-150
5605635|NCT00875849|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5605636|NCT00875849|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5605637|NCT00875849|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5605638|NCT00875849|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5605639|NCT00875849|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5605640|NCT00875849|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5605641|NCT00875849|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5606309|NCT00873041|Thalassemia|thalassemia
5605642|NCT00875849|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5605643|NCT00875849|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5605644|NCT00875849|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5605645|NCT00875849|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5605646|NCT00875849|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5605647|NCT00875849|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5605648|NCT00875849|tongue cancer|tongue cancer
5605649|NCT00875836|Marijuana|marijuana
5605650|NCT00875836|Buspirone|buspirone
5605651|NCT00875836|Contingency management|contingency management
5605652|NCT00875836|Motivational enhancement therapy|motivational enhancement therapy
5605653|NCT00875823|PH|ph
5605654|NCT00875823|Primary Hyperoxaluria|primary hyperoxaluria
5605656|NCT00875823|Type II|type ii
5605657|NCT00875823|NonI-NonII|noni-nonii
5605658|NCT00875823|Kidney stones|kidney stones
5605659|NCT00875823|oxalate|oxalate
5605660|NCT00875823|oxalosis|oxalosis
5605661|NCT00875797|enteral|enteral
5605662|NCT00875797|parenteral|parenteral
5605663|NCT00875797|glutamine|glutamine
5605664|NCT00875797|intestinal permeability|intestinal permeability
5605665|NCT00875797|infection|infection
5605666|NCT00875784|Sumatriptan exposure|sumatriptan exposure
5605667|NCT00875771|metastatic colorectal cancer|metastatic colorectal cancer
5605668|NCT00875771|BEVACIZUMAB|bevacizumab
5605669|NCT00875771|CAPECITABINE|capecitabine
5605670|NCT00875771|IRINOTECAN|irinotecan
5605671|NCT00875758|preterm infants|preterm infants
5605672|NCT00875758|IVH|ivh
5605673|NCT00875758|germinal matrix|germinal matrix
5605674|NCT00875758|intraventricular hemorrhage|intraventricular hemorrhage
5605675|NCT00875758|hydrocephalus|hydrocephalus
5605676|NCT00875732|Resynchronization|resynchronization
5605677|NCT00875732|Device|device
5605680|NCT00875732|Cardiac Resynchronization|cardiac resynchronization
5605681|NCT00875719|COPD patients with respiratory failure|copd patients with respiratory failure
5605682|NCT00875706|Nursing Homes|nursing homes
5605683|NCT00875706|Implementation of innovative programs|implementation of innovative programs
5605684|NCT00875706|Nursing staff|nursing staff
5605685|NCT00875706|Nurses' aides|nurses' aides
5605686|NCT00875706|Educational models|educational models
5605687|NCT00875693|AML|aml
5605688|NCT00875693|leukemia|leukemia
5605689|NCT00875693|MDS|mds
5605690|NCT00875667|Mantle Cell Lymphoma|mantle cell lymphoma
5605691|NCT00875667|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5605692|NCT00875667|Refractory Mantle Cell Lymphoma|refractory mantle cell lymphoma
5605693|NCT00875667|Lymphoma|lymphoma
5605694|NCT00875667|MCL|mcl
5605695|NCT00875654|Cell therapy|cell therapy
5605696|NCT00875654|Stroke|stroke
5605697|NCT00875654|Neuronal Plasticity|neuronal plasticity
5605698|NCT00875654|Recovery|recovery
5605699|NCT00875654|Mesenchymal Stem Cells|mesenchymal stem cells
5605700|NCT00875654|Transplantation|transplantation
5605701|NCT00875628|Japanese Healthy volunteers HCV pharmacokinetics PF-00868554 filibuvir|japanese healthy volunteers hcv pharmacokinetics pf-00868554 filibuvir
5605702|NCT00875615|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5605703|NCT00875615|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5605704|NCT00875615|advanced adult primary liver cancer|advanced adult primary liver cancer
5605705|NCT00875602|All hospitalized patients in a general Med/ Surg unit|all hospitalized patients in a general med/ surg unit
5605706|NCT00875589|Traumatic Brain Injury|traumatic brain injury
5605707|NCT00875589|Eye movement recording|eye movement recording
5605708|NCT00875576|social influences|social influences
5605709|NCT00875576|meals|meals
5605710|NCT00875576|obesity|obesity
5605711|NCT00875576|amount of food consumed|amount of food consumed
5605712|NCT00875550|Intubated and mechanically ventilated PICU subjects|intubated and mechanically ventilated picu subjects
5605713|NCT00875537|Burning mouth syndrome|burning mouth syndrome
5605714|NCT00875537|neuropathy|neuropathy
5605715|NCT00875537|inflammation|inflammation
5605716|NCT00875537|tongue mucosa|tongue mucosa
5605717|NCT00875537|tongue innervation|tongue innervation
5605718|NCT00875537|dysgeusia|dysgeusia
5605719|NCT00875524|Dengue virus|dengue virus
5605720|NCT00875524|Dengue fever|dengue fever
5605721|NCT00875524|Dengue hemorrhagic fever|dengue hemorrhagic fever
5605722|NCT00875524|Dengue diseases|dengue diseases
5605723|NCT00875524|Dengue vaccine|dengue vaccine
5605724|NCT00875511|peer rejection|peer rejection
5605725|NCT00875511|obesity|obesity
5605726|NCT00875511|amount of food chosen|amount of food chosen
5605727|NCT00875511|amount of social time chosen|amount of social time chosen
5605728|NCT00875498|iTBS|itbs
5605729|NCT00875498|Negative Symptoms|negative symptoms
5605730|NCT00875485|Monovalent Hepatitis A|monovalent hepatitis a
5605731|NCT00875485|hepatitis B vaccine|hepatitis b vaccine
5605732|NCT00875485|Belgium and Czech Republic|belgium and czech republic
5605733|NCT00875472|social influences|social influences
5605738|NCT00875420|hot flashes|hot flashes
5605739|NCT00875420|hot flushes|hot flushes
5605740|NCT00875420|vasomotor symptoms|vasomotor symptoms
5605741|NCT00875420|postmenopausal|postmenopausal
5605742|NCT00875381|Melanocytes|melanocytes
5605743|NCT00875368|HIV-1|hiv-1
5605744|NCT00875368|HAART|haart
5605745|NCT00875368|CD4 cell|cd4 cell
5605746|NCT00875368|Immunologic non-responders|immunologic non-responders
5605747|NCT00875368|Immunology|immunology
5605748|NCT00875368|treatment experienced|treatment experienced
5605749|NCT00875355|tumors metastatic to brain|tumors metastatic to brain
5605750|NCT00875355|stage IV breast cancer|stage iv breast cancer
5605758|NCT00875329|Brain Injury|brain injury
5605759|NCT00875316|Parkinson's disease|parkinson's disease
5605760|NCT00875316|Phase I|phase i
5608403|NCT00865163|PCI|pci
5605761|NCT00875303|Parents' plans to discipline their children|parents' plans to discipline their children
5605762|NCT00875290|Diabetes Mellitus, Type I|diabetes mellitus, type i
5605763|NCT00875290|Children|children
5605764|NCT00875290|Insulin pump therapy|insulin pump therapy
5605765|NCT00875290|Continuous glucose monitor|continuous glucose monitor
5605766|NCT00875264|CEP-11981|cep-11981
5605767|NCT00875264|TIE-2|tie-2
5605768|NCT00875264|VEGF-R|vegf-r
5605769|NCT00875251|body composition|body composition
5605770|NCT00875251|preterm infant|preterm infant
5605771|NCT00875251|anthropometry|anthropometry
5605772|NCT00875238|cardiac toxicity|cardiac toxicity
5605773|NCT00875238|cardiovascular complications|cardiovascular complications
5605774|NCT00875238|stage I breast cancer|stage i breast cancer
5605775|NCT00875238|stage II breast cancer|stage ii breast cancer
5605776|NCT00875238|stage IIIA breast cancer|stage iiia breast cancer
5605777|NCT00875238|stage IIIB breast cancer|stage iiib breast cancer
5605778|NCT00875238|stage IIIC breast cancer|stage iiic breast cancer
5605779|NCT00875225|Hypertension|hypertension
5605780|NCT00875225|Adherence to medications|adherence to medications
5605781|NCT00875212|Calcium glycerophosphate|calcium glycerophosphate
5605782|NCT00875212|Fluoride|fluoride
5605783|NCT00875212|Dentifrice|dentifrice
5605784|NCT00875212|Biofilm|biofilm
5605785|NCT00875212|Dental caries|dental caries
5605786|NCT00875199|Overweight|overweight
5605787|NCT00875199|Obesity|obesity
5605788|NCT00875199|Contingency Management|contingency management
5605789|NCT00875186|bariatric surgery|bariatric surgery
5605790|NCT00875186|co-morbidities|co-morbidities
5605791|NCT00875186|aerobic physical exercise|aerobic physical exercise
5605792|NCT00875173|Selenium|selenium
5605793|NCT00875173|Chagas disease|chagas disease
5605794|NCT00875173|Chagasic cardiopathy|chagasic cardiopathy
5605795|NCT00875147|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5605796|NCT00875147|bevacizumab|bevacizumab
5605797|NCT00875121|Food reinforcement|food reinforcement
5605798|NCT00875121|social reinforcers|social reinforcers
5605799|NCT00875121|overweight|overweight
5605800|NCT00875121|children|children
5605801|NCT00875095|sperm DNA integrity|sperm dna integrity
5605802|NCT00875095|Toluidine blue staining|toluidine blue staining
5605803|NCT00875082|Asthma|asthma
5605804|NCT00875082|Children|children
5605805|NCT00875082|Remodelling|remodelling
5605806|NCT00875082|Metalloproteinases|metalloproteinases
5605807|NCT00875082|Montelukast|montelukast
5605808|NCT00875069|Nosocomial infection|nosocomial infection
5605809|NCT00875069|Catheterization|catheterization
5605810|NCT00875069|Central Venous Ethanol|central venous ethanol
5605811|NCT00875069|lock solution|lock solution
5605812|NCT00875069|intensive care units|intensive care units
5605813|NCT00875069|Renal replacement therapy in ICU|renal replacement therapy in icu
5605814|NCT00875043|ischemic optic neuropathy|ischemic optic neuropathy
5605815|NCT00875043|cortical blindness|cortical blindness
5605816|NCT00875030|Bioequivalence study-artesunate sachets-arsuamoon tablet|bioequivalence study-artesunate sachets-arsuamoon tablet
5605817|NCT00875004|anemia|anemia
5605818|NCT00875004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5605819|NCT00874991|Cardiac deformation|cardiac deformation
5605820|NCT00874991|Cardiopulmonary bypass|cardiopulmonary bypass
5605822|NCT00874991|Cardiac Surgery|cardiac surgery
5605823|NCT00874991|Left ventricular function|left ventricular function
5605824|NCT00874991|Pulmonary Artery catheter|pulmonary artery catheter
5605825|NCT00874991|Tissue Doppler|tissue doppler
5605826|NCT00874991|Left ventricular function in cardiac surgery|left ventricular function in cardiac surgery
5605827|NCT00874978|Lenalidomide|lenalidomide
5605828|NCT00874978|myelodysplastic syndromes|myelodysplastic syndromes
5606692|NCT00871650|Brain|brain
5605833|NCT00874965|Anabolism/catabolism pathway|anabolism/catabolism pathway
5605834|NCT00874952|Metabolic syndrome|metabolic syndrome
5605835|NCT00874952|Lipids|lipids
5605836|NCT00874952|Waist Circumference|waist circumference
5605838|NCT00874952|hypertension|hypertension
5605839|NCT00874926|Octocog alfa|octocog alfa
5605840|NCT00874926|Haemophilia A|haemophilia a
5605841|NCT00874913|blood flow|blood flow
5605842|NCT00874913|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5605843|NCT00874913|normal tension glaucoma|normal tension glaucoma
5605844|NCT00874874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5605845|NCT00874874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5605846|NCT00874874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5605847|NCT00874874|adult angiosarcoma|adult angiosarcoma
5605848|NCT00874861|cancer|cancer
5605849|NCT00874861|brain|brain
5605850|NCT00874861|tumor|tumor
5605851|NCT00874861|vaccine|vaccine
5605852|NCT00874848|Imprime PGG|imprime pgg
5605853|NCT00874848|NSCLC|nsclc
5605854|NCT00874848|Cetuximab|cetuximab
5605855|NCT00874835|Endothelial Keratoplasty|endothelial keratoplasty
5605856|NCT00874835|EK|ek
5605857|NCT00874835|Descemet Stripping Endothelial Keratoplasty|descemet stripping endothelial keratoplasty
5605858|NCT00874835|Corneal Transplantation|corneal transplantation
5605859|NCT00874835|Keratoplasty|keratoplasty
5605860|NCT00874835|DSEK|dsek
5605861|NCT00874835|DSAEK|dsaek
5605862|NCT00874809|insulin pump|insulin pump
5605863|NCT00874809|DM Type 2|dm type 2
5605864|NCT00874809|CGMS|cgms
5605865|NCT00874809|basal rate|basal rate
5605866|NCT00874796|apoptosis|apoptosis
5605867|NCT00874796|liver inflammation|liver inflammation
5605868|NCT00874796|hepatitis C|hepatitis c
5605869|NCT00874783|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5605870|NCT00874783|Familial Dysautonomia|familial dysautonomia
5605871|NCT00874783|Parkinson's Disease|parkinson's disease
5605872|NCT00874783|Alzheimer's Disease|alzheimer's disease
5605873|NCT00874783|Age Related Macular Degeneration|age related macular degeneration
5605874|NCT00874783|Retinitis Pigmentosa|retinitis pigmentosa
5605875|NCT00874783|Huntington's Disease|huntington's disease
5605876|NCT00874783|Machado - Joseph Disease|machado - joseph disease
5605877|NCT00874783|SMA - Spinal Muscular Atrophy|sma - spinal muscular atrophy
5605878|NCT00874783|Ataxia Telangiectasia|ataxia telangiectasia
5605879|NCT00874770|Antivirals|antivirals
5605880|NCT00874757|Statins, anti-inflammatory|statins, anti-inflammatory
5605881|NCT00874757|Healthy subjects study|healthy subjects study
5605882|NCT00874744|Diabetic macular edema|diabetic macular edema
5605883|NCT00874744|intravitreal injection|intravitreal injection
5605884|NCT00874744|Pharmacological treatment|pharmacological treatment
5605885|NCT00874718|repetitive strain injury|repetitive strain injury
5605886|NCT00874718|quality of life|quality of life
5605887|NCT00874718|functional capacity|functional capacity
5605888|NCT00874718|workers|workers
5605889|NCT00874692|tap water temperature|tap water temperature
5605890|NCT00874692|social housing|social housing
5605891|NCT00874692|scald reduction|scald reduction
5605892|NCT00874692|Temperature (degrees Celsius) of hot tap water at point of delivery.|temperature (degrees celsius) of hot tap water at point of delivery.
5605893|NCT00874666|garlic|garlic
5605894|NCT00874666|allicin|allicin
5605895|NCT00874666|allyl methyl sulfide|allyl methyl sulfide
5605896|NCT00874666|healthy persons|healthy persons
5605897|NCT00874640|Drug utilization review|drug utilization review
5605898|NCT00874627|children > 5 years old|children > 5 years old
5605899|NCT00874627|IgE-mediated|ige-mediated
5605900|NCT00874627|cow milk allergy|cow milk allergy
5605901|NCT00874627|IgE-mediated cow milk allergy persisting after 5 years|ige-mediated cow milk allergy persisting after 5 years
5605908|NCT00874601|acute ischemic stroke|acute ischemic stroke
5605909|NCT00874601|blood pressure|blood pressure
5605910|NCT00874601|valsartan|valsartan
5605911|NCT00874601|death|death
5605912|NCT00874601|dependancy|dependancy
5605913|NCT00874575|HMB|hmb
5605914|NCT00874575|Vitamin D|vitamin d
5605915|NCT00874575|Older Adults|older adults
5605916|NCT00874562|rapamycin|rapamycin
5605917|NCT00874562|corticosteroid|corticosteroid
5605918|NCT00874562|ALL|all
5605919|NCT00874549|Meningococcal Vaccine|meningococcal vaccine
5605920|NCT00874549|Menactra®|menactra®
5605921|NCT00874549|Menomune®|menomune®
5605922|NCT00874536|ADHD|adhd
5605923|NCT00874536|methylphenidate|methylphenidate
5605924|NCT00874536|omega-3|omega-3
5605925|NCT00874523|raltegravir|raltegravir
5605926|NCT00874523|atazanavir|atazanavir
5605927|NCT00874523|HIV infections|hiv infections
5606693|NCT00871650|Imaging|imaging
5605928|NCT00874523|pharmacokinetics|pharmacokinetics
5605929|NCT00874523|antiretroviral agents|antiretroviral agents
5605930|NCT00874523|treatment experienced|treatment experienced
5605931|NCT00874510|sleep deprivation|sleep deprivation
5605932|NCT00874510|fatigue|fatigue
5605933|NCT00874458|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5605934|NCT00874432|cardiovascular disease|cardiovascular disease
5605935|NCT00874432|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5605936|NCT00874432|chronic kidney disease|chronic kidney disease
5605937|NCT00874432|cardiovascular disease in elderly patients with CKD|cardiovascular disease in elderly patients with ckd
5605938|NCT00874419|EGFR mutation|egfr mutation
5605939|NCT00874419|EGFR-TKI|egfr-tki
5605940|NCT00874419|Chemotherapy|chemotherapy
5605941|NCT00874406|colorectal cancer|colorectal cancer
5605942|NCT00874406|liver metastasis|liver metastasis
5605943|NCT00874406|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5605944|NCT00874393|NICHD Neonatal Research Network|nichd neonatal research network
5605945|NCT00874393|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5605946|NCT00874393|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5605947|NCT00874393|Prematurity|prematurity
5605948|NCT00874393|Blood Pressure Management|blood pressure management
5605949|NCT00874393|Dopamine|dopamine
5605950|NCT00874393|Hydrocortisone|hydrocortisone
5605951|NCT00874380|Fiber|fiber
5605952|NCT00874380|Dialysis|dialysis
5605953|NCT00874380|Renal Replacement Therapy|renal replacement therapy
5605954|NCT00874380|Food Frequency Questionnaire|food frequency questionnaire
5605956|NCT00874380|Dietary counseling|dietary counseling
5605957|NCT00874367|NICHD Neonatal Research Network|nichd neonatal research network
5605958|NCT00874367|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5605959|NCT00874367|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5605960|NCT00874367|Prematurity|prematurity
5605961|NCT00874367|Early Onset Sepsis|early onset sepsis
5605962|NCT00874354|Myocardial Infarction|myocardial infarction
5605963|NCT00874354|Heart Attack|heart attack
5605964|NCT00874354|Infarct|infarct
5605965|NCT00874354|Stem Cells|stem cells
5605966|NCT00874354|Bone Marrow Derived Mononuclear Cells|bone marrow derived mononuclear cells
5605968|NCT00874354|Congestive Heart Failure|congestive heart failure
5605969|NCT00874354|Stent|stent
5605971|NCT00874354|Percutaneous Coronary Intervention|percutaneous coronary intervention
5605972|NCT00874341|Fruit|fruit
5605973|NCT00874341|Vegetables|vegetables
5605974|NCT00874341|Intervention|intervention
5605975|NCT00874341|Insulin resistance|insulin resistance
5605976|NCT00874341|Cardiovascular disease risk|cardiovascular disease risk
5605977|NCT00874341|Dose response|dose response
5605978|NCT00874341|High risk of cardiovascular disease|high risk of cardiovascular disease
5605979|NCT00874328|Non small cell lung cancer|non small cell lung cancer
5605980|NCT00874328|Irinotecan plus Cisplatin plus S-1|irinotecan plus cisplatin plus s-1
5605981|NCT00874328|Phase I/II trial|phase i/ii trial
5605982|NCT00874315|recurrent or refractory neuroblastoma|recurrent or refractory neuroblastoma
5605984|NCT00874289|NGAL|ngal
5605985|NCT00874289|Heart failure|heart failure
5605986|NCT00874276|DCA|dca
5605987|NCT00874276|Dichloroacetate|dichloroacetate
5605988|NCT00874276|Trichloroacetate|trichloroacetate
5605989|NCT00874263|Probe-based imaging of GI pre-malignant or malignant lesions|probe-based imaging of gi pre-malignant or malignant lesions
5605990|NCT00874237|Staccato loxapine|staccato loxapine
5605991|NCT00874237|QT/QTc|qt/qtc
5605992|NCT00874237|healthy volunteers|healthy volunteers
5605993|NCT00874237|Thorough QT/QTc study|thorough qt/qtc study
5605994|NCT00874237|ADASUVE|adasuve
5605995|NCT00874237|inhaled loxapine|inhaled loxapine
5605996|NCT00874224|Colorectal cancer liver metastasis|colorectal cancer liver metastasis
5605997|NCT00874224|Benign liver disease|benign liver disease
5605998|NCT00874211|bone metastases|bone metastases
5605999|NCT00874211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5606000|NCT00874211|refractory multiple myeloma|refractory multiple myeloma
5606001|NCT00874211|stage I multiple myeloma|stage i multiple myeloma
5606002|NCT00874211|stage II multiple myeloma|stage ii multiple myeloma
5606003|NCT00874211|stage III multiple myeloma|stage iii multiple myeloma
5606004|NCT00874211|male breast cancer|male breast cancer
5606005|NCT00874211|recurrent breast cancer|recurrent breast cancer
5606006|NCT00874211|stage IA breast cancer|stage ia breast cancer
5606007|NCT00874211|stage IB breast cancer|stage ib breast cancer
5606008|NCT00874211|stage II breast cancer|stage ii breast cancer
5606009|NCT00874211|stage IIIA breast cancer|stage iiia breast cancer
5606010|NCT00874211|stage IIIB breast cancer|stage iiib breast cancer
5606011|NCT00874211|stage IIIC breast cancer|stage iiic breast cancer
5606012|NCT00874211|stage IV breast cancer|stage iv breast cancer
5606013|NCT00874211|recurrent prostate cancer|recurrent prostate cancer
5606014|NCT00874211|stage I prostate cancer|stage i prostate cancer
5606015|NCT00874211|stage IIB prostate cancer|stage iib prostate cancer
5606016|NCT00874211|stage IIA prostate cancer|stage iia prostate cancer
5606017|NCT00874211|stage III prostate cancer|stage iii prostate cancer
5606018|NCT00874211|stage IV prostate cancer|stage iv prostate cancer
5606019|NCT00874211|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5606020|NCT00874211|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5606021|NCT00874211|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5606022|NCT00874211|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5606023|NCT00874211|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5606024|NCT00874211|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5606025|NCT00874211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5606026|NCT00874211|limited stage small cell lung cancer|limited stage small cell lung cancer
5606027|NCT00874211|recurrent small cell lung cancer|recurrent small cell lung cancer
5606028|NCT00874198|normal pressure hydrocephalus|normal pressure hydrocephalus
5606029|NCT00874198|cerebrospinal fluid dynamic test|cerebrospinal fluid dynamic test
5606030|NCT00874198|cerebrospinal fluid outflow resistance|cerebrospinal fluid outflow resistance
5606031|NCT00874198|cerebrospinal compliance|cerebrospinal compliance
5606033|NCT00874198|shunt surgery|shunt surgery
5606034|NCT00874198|normal pressure hydrocephalus guidelines|normal pressure hydrocephalus guidelines
5606035|NCT00874198|biomarkers|biomarkers
5606036|NCT00874198|shunt surgery selection|shunt surgery selection
5606037|NCT00874198|Outcome measures|outcome measures
5606038|NCT00874198|Outcomes assessment|outcomes assessment
5606039|NCT00874198|Outcome and process assessment|outcome and process assessment
5606040|NCT00874185|satisfaction|satisfaction
5591539|NCT00924547|DHA|dha
5606042|NCT00874172|Sickle Cell|sickle cell
5606043|NCT00874172|Analgesic|analgesic
5606044|NCT00874172|Pain|pain
5606045|NCT00874172|Emergency treatment|emergency treatment
5606046|NCT00874172|Quality of life|quality of life
5606047|NCT00874107|NSCLC|nsclc
5606048|NCT00874107|Phase 2|phase 2
5606049|NCT00874107|Randomized|randomized
5606050|NCT00874107|Efficacy|efficacy
5606051|NCT00874107|Safety|safety
5606052|NCT00874107|Imprime PGG|imprime pgg
5606053|NCT00874107|Bevacizumab|bevacizumab
5606054|NCT00874094|nasolabial folds|nasolabial folds
5606055|NCT00874094|platelet rich plasma|platelet rich plasma
5606056|NCT00874094|fibrin matrix|fibrin matrix
5606057|NCT00874094|facial rhytids|facial rhytids
5606058|NCT00874094|dermal filler|dermal filler
5606059|NCT00874068|term infants|term infants
5606060|NCT00874068|preterm infants|preterm infants
5606061|NCT00874068|bone strength|bone strength
5606062|NCT00874068|Speed of sound (SOS)|speed of sound (sos)
5606063|NCT00874068|Ultrasound|ultrasound
5606064|NCT00874055|social influence|social influence
5606065|NCT00874055|friends|friends
5606066|NCT00874055|eating behavior|eating behavior
5606067|NCT00874055|childhood overweight|childhood overweight
5606068|NCT00874042|dose escalation|dose escalation
5606069|NCT00874042|safety|safety
5606070|NCT00874042|tolerability|tolerability
5606071|NCT00874042|tumor|tumor
5606073|NCT00874029|Uterine Fibroids|uterine fibroids
5606074|NCT00874029|Myomas|myomas
5606075|NCT00874016|intubation|intubation
5606077|NCT00874016|pediatric|pediatric
5606078|NCT00874016|airway|airway
5606079|NCT00874003|alcohol dependence|alcohol dependence
5606080|NCT00874003|anti-depressant|anti-depressant
5606081|NCT00874003|5-HT|5-ht
5606082|NCT00874003|NE|ne
5606083|NCT00873990|fissure sealant|fissure sealant
5606084|NCT00873990|self etch|self etch
5606085|NCT00873990|total etch|total etch
5606086|NCT00873977|Adherence|adherence
5606087|NCT00873977|Continuous Positive Airway Pressure|continuous positive airway pressure
5606088|NCT00873964|Metabolic Syndrome|metabolic syndrome
5606089|NCT00873964|Obesity|obesity
5606090|NCT00873964|Elderly|elderly
5606091|NCT00873964|Insulin Resistance|insulin resistance
5606092|NCT00873938|Artesunate-Amodiaquine|artesunate-amodiaquine
5606093|NCT00873938|Compliance|compliance
5606094|NCT00873938|Malaria|malaria
5606095|NCT00873925|Type 1 Diabetes|type 1 diabetes
5606096|NCT00873912|influenza|influenza
5606097|NCT00873912|FluMist|flumist
5606098|NCT00873899|Heart Failure|heart failure
5606099|NCT00873899|Implantable defibrillator|implantable defibrillator
5606100|NCT00873899|Remote Monitoring|remote monitoring
5606101|NCT00873873|Asthma Progression|asthma progression
5606102|NCT00873873|Airway Wall Thickness|airway wall thickness
5606103|NCT00873873|Corticosteroid Resistance|corticosteroid resistance
5606104|NCT00873873|Biomarkers|biomarkers
5606105|NCT00873873|Pulmonary Physiology|pulmonary physiology
5606106|NCT00873860|CAT-354|cat-354
5606107|NCT00873860|Tralokinumab|tralokinumab
5606108|NCT00873860|Asthma|asthma
5606109|NCT00873847|NICHD Neonatal Research Network|nichd neonatal research network
5606110|NCT00873847|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5606111|NCT00873847|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5606112|NCT00873847|Prematurity|prematurity
5606113|NCT00873847|Amplitude-integrated Electroencephalography (aEEG)|amplitude-integrated electroencephalography (aeeg)
5606114|NCT00873834|autism|autism
5606115|NCT00873834|fluoxetine|fluoxetine
5606116|NCT00873834|Comparative|comparative
5606117|NCT00873834|double blind|double blind
5606118|NCT00873834|placebo|placebo
5606119|NCT00873834|controlled trial|controlled trial
5606120|NCT00873834|anatomy-functional imaging|anatomy-functional imaging
5606121|NCT00873834|children|children
5606122|NCT00873834|DSM-IV-R criteria for autism and CARS score (of 30 or above)|dsm-iv-r criteria for autism and cars score (of 30 or above)
5606123|NCT00873808|breast cancer|breast cancer
5606124|NCT00873795|efficacy|efficacy
5606125|NCT00873795|tolerability|tolerability
5606126|NCT00873795|combination of aripiprazole and SSRI(sertraline)|combination of aripiprazole and ssri(sertraline)
5606127|NCT00873782|Limb Perfusion|limb perfusion
5606128|NCT00873782|Gene Therapy|gene therapy
5606129|NCT00873769|Staccato Loxapine|staccato loxapine
5606130|NCT00873769|pharmacokinetics|pharmacokinetics
5606131|NCT00873769|smokers|smokers
5606132|NCT00873769|non-smokers|non-smokers
5606133|NCT00873756|CRC|crc
5606134|NCT00873756|Colon Cancer|colon cancer
5606135|NCT00873756|Avastin|avastin
5606136|NCT00873756|Apo2L/TRAIL|apo2l/trail
5606137|NCT00873743|lower pain intensity with combination drug after cesarian section in first 48h postoperatively|lower pain intensity with combination drug after cesarian section in first 48h postoperatively
5606138|NCT00873730|Effect of etanercept in subjects with ankylosing spondylitis|effect of etanercept in subjects with ankylosing spondylitis
5606139|NCT00873717|elderly|elderly
5606140|NCT00873717|long-term facilities|long-term facilities
5606141|NCT00873717|nutritional status|nutritional status
5606142|NCT00873691|Patients indicated for an ICD/ CRT-D|patients indicated for an icd/ crt-d
5606143|NCT00873678|Molar tooth|molar tooth
5606144|NCT00873678|AHI1 gene|ahi1 gene
5606145|NCT00873678|CEP290 gene|cep290 gene
5606146|NCT00873678|ciliopathies|ciliopathies
5606147|NCT00873652|Hepatitis B vaccine|hepatitis b vaccine
5606148|NCT00873652|Booster dose|booster dose
5606149|NCT00873652|Persistence|persistence
5606150|NCT00873652|Immune response|immune response
5606151|NCT00873652|Healthy children|healthy children
5606152|NCT00873626|Urinary tract infection|urinary tract infection
5606153|NCT00873626|treatment duration|treatment duration
5606154|NCT00873626|acute pyelonephritis|acute pyelonephritis
5606155|NCT00873626|good use of antibiotics|good use of antibiotics
5606156|NCT00873600|cognitive/functional effects|cognitive/functional effects
5606157|NCT00873600|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5606158|NCT00873600|stage I breast cancer|stage i breast cancer
5606159|NCT00873600|stage II breast cancer|stage ii breast cancer
5606160|NCT00873600|stage IIIA breast cancer|stage iiia breast cancer
5606161|NCT00873600|stage IIIB breast cancer|stage iiib breast cancer
5606162|NCT00873600|stage IIIC breast cancer|stage iiic breast cancer
5606163|NCT00873600|adenocarcinoma of the colon|adenocarcinoma of the colon
5606164|NCT00873600|stage I colon cancer|stage i colon cancer
5606165|NCT00873600|stage II colon cancer|stage ii colon cancer
5606166|NCT00873600|stage III colon cancer|stage iii colon cancer
5606167|NCT00873587|Thoracotomy|thoracotomy
5606168|NCT00873587|Inspiration|inspiration
5606169|NCT00873587|Expiration|expiration
5606170|NCT00873587|Chest Tube|chest tube
5606171|NCT00873587|pneumothorax|pneumothorax
5606172|NCT00873587|Method of chest tube removal|method of chest tube removal
5606173|NCT00873574|Familial myeloproliferative disorders|familial myeloproliferative disorders
5606174|NCT00873574|JAK-STAT|jak-stat
5606176|NCT00873574|JAK2|jak2
5606177|NCT00873561|diabetes|diabetes
5606178|NCT00873561|type 1|type 1
5606179|NCT00873561|adult|adult
5606180|NCT00873561|adolescent|adolescent
5606181|NCT00873561|new onset|new onset
5606182|NCT00873535|Nicotine|nicotine
5606183|NCT00873535|Nicotine dependence|nicotine dependence
5606184|NCT00873535|Smoking cessation|smoking cessation
5606185|NCT00873535|Alcohol|alcohol
5606186|NCT00873535|Alcohol dependence|alcohol dependence
5606187|NCT00873535|Alcohol cessation|alcohol cessation
5606188|NCT00873535|Treatment|treatment
5606189|NCT00873535|Smoking|smoking
5606190|NCT00873535|Cigarette|cigarette
5606191|NCT00873535|Heavy drinkers|heavy drinkers
5606192|NCT00873535|Social drinkers|social drinkers
5606193|NCT00873535|Co-morbidity of alcohol and nicotine dependence|co-morbidity of alcohol and nicotine dependence
5606194|NCT00873535|Nicotine receptor|nicotine receptor
5606195|NCT00873535|Nicotinic receptor|nicotinic receptor
5606196|NCT00873535|Nicotinic acetycholine receptor|nicotinic acetycholine receptor
5606197|NCT00873535|Alpha-4-beta-2 nicotinic acetycholine receptor|alpha-4-beta-2 nicotinic acetycholine receptor
5606198|NCT00873535|Cholinergic receptor|cholinergic receptor
5606199|NCT00873535|Dopamine|dopamine
5606200|NCT00873535|Craving|craving
5606201|NCT00873535|Diary|diary
5606202|NCT00873535|Cue induced|cue induced
5606203|NCT00873535|Pharmacotherapy|pharmacotherapy
5606204|NCT00873535|Varenicline|varenicline
5606205|NCT00873535|Chantix|chantix
5606206|NCT00873535|Champix|champix
5606207|NCT00873522|pneumonia|pneumonia
5606208|NCT00873509|Autism|autism
5606209|NCT00873496|Sjögren's Syndrome|sjögren's syndrome
5606210|NCT00873496|hyposalivation|hyposalivation
5606211|NCT00873496|mouth dryness|mouth dryness
5606212|NCT00873496|complications|complications
5606213|NCT00873483|Pregnancy prevention|pregnancy prevention
5606214|NCT00873483|female contraception|female contraception
5606215|NCT00873483|patch|patch
5606216|NCT00873457|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5606217|NCT00873457|Leukemia|leukemia
5606219|NCT00873444|Cementless|cementless
5606220|NCT00873444|Ceramic-on-Metal|ceramic-on-metal
5606221|NCT00873444|Metal-on-Metal|metal-on-metal
5606222|NCT00873431|Prevention of pneumococcal infections|prevention of pneumococcal infections
5606223|NCT00873418|Heart Failure|heart failure
5606224|NCT00873418|Intervention|intervention
5606225|NCT00873418|Cognitive Behavior Therapy|cognitive behavior therapy
5606226|NCT00873418|Quality of Life|quality of life
5606227|NCT00873405|Type 2 diabetes mellitus|type 2 diabetes mellitus
5606228|NCT00873405|Metabolic control|metabolic control
5606229|NCT00873405|Bariatric Surgery|bariatric surgery
5606230|NCT00873405|Weight Loss|weight loss
5606231|NCT00873405|Sleeve gastrectomy|sleeve gastrectomy
5606232|NCT00873405|BMI reduction|bmi reduction
5606233|NCT00873405|Waist circumference reduction|waist circumference reduction
5606234|NCT00873405|Percentage of excess BMI loss|percentage of excess bmi loss
5606235|NCT00873405|Glucose homeostasis|glucose homeostasis
5606236|NCT00873392|Parkinson's disease|parkinson's disease
5606237|NCT00873392|Motor fluctuation|motor fluctuation
5606238|NCT00873392|Nicotine|nicotine
5606239|NCT00873392|Drug treatment|drug treatment
5606240|NCT00873392|neuroprotection|neuroprotection
5606241|NCT00873366|stage I breast cancer|stage i breast cancer
5606242|NCT00873366|stage II breast cancer|stage ii breast cancer
5606243|NCT00873366|stage IIIA breast cancer|stage iiia breast cancer
5606244|NCT00873366|stage IIIB breast cancer|stage iiib breast cancer
5606245|NCT00873366|stage IIIC breast cancer|stage iiic breast cancer
5606246|NCT00873353|Metastatic Adenocarcinoma of the Pancreas|metastatic adenocarcinoma of the pancreas
5606247|NCT00873340|MS|ms
5606248|NCT00873340|Multiple Sclerosis|multiple sclerosis
5606249|NCT00873340|Betaferon|betaferon
5606250|NCT00873340|Colombia|colombia
5606264|NCT00873275|adenocarcinoma of the colon|adenocarcinoma of the colon
5606265|NCT00873275|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5606267|NCT00873262|Hormones|hormones
5606268|NCT00873262|Skin tests|skin tests
5606269|NCT00873262|Desensitization|desensitization
5606270|NCT00873262|Allergen Immunotherapy|allergen immunotherapy
5606271|NCT00873249|Schizophrenia|schizophrenia
5606272|NCT00873249|Therapeutic adherence|therapeutic adherence
5606273|NCT00873249|Short message system|short message system
5606274|NCT00873249|Mobile phone|mobile phone
5606275|NCT00873236|stage III renal cell cancer|stage iii renal cell cancer
5606276|NCT00873236|stage IV renal cell cancer|stage iv renal cell cancer
5606277|NCT00873210|renal cell carcinoma|renal cell carcinoma
5606278|NCT00873210|sunitinib malate|sunitinib malate
5606279|NCT00873197|Co-administration of transdermal and intravenous granisetron|co-administration of transdermal and intravenous granisetron
5606280|NCT00873197|Granisetron|granisetron
5606281|NCT00873197|Healthy subjects|healthy subjects
5606282|NCT00873197|Intravenous|intravenous
5606283|NCT00873197|Pharmacokinetic profile|pharmacokinetic profile
5606284|NCT00873197|Sancuso® patch|sancuso® patch
5606286|NCT00873197|Pharmacokinetics|pharmacokinetics
5606287|NCT00873184|massage therapy in patients with brain tumors|massage therapy in patients with brain tumors
5606288|NCT00873171|Osteopathic Manipulation|osteopathic manipulation
5606289|NCT00873158|Adhesive Capsulitis|adhesive capsulitis
5606290|NCT00873158|ROM|rom
5606291|NCT00873158|Dynasplint|dynasplint
5606292|NCT00873145|Survival|survival
5606293|NCT00873145|Function|function
5606294|NCT00873145|Infection|infection
5606295|NCT00873145|Revision|revision
5606296|NCT00873145|Loosening|loosening
5606297|NCT00873119|Belinostat|belinostat
5606298|NCT00873119|PXD101|pxd101
5606299|NCT00873119|Carboplatin|carboplatin
5606300|NCT00873119|Paclitaxel|paclitaxel
5606301|NCT00873119|CUP|cup
5606302|NCT00873119|Carcinoma of unknown primary|carcinoma of unknown primary
5606303|NCT00873119|Occult primary|occult primary
5606304|NCT00873080|reliability|reliability
5606305|NCT00873080|photogrammetry|photogrammetry
5606306|NCT00873067|Atrial fibrillation|atrial fibrillation
5606307|NCT00873067|Complex fractionated electrograms|complex fractionated electrograms
5606308|NCT00873067|CFAE|cfae
5606310|NCT00873041|thalassemia intermedia|thalassemia intermedia
5606311|NCT00873041|alpha-thalassemia|alpha-thalassemia
5606312|NCT00873041|beta-thalassemia|beta-thalassemia
5606313|NCT00873041|deferasirox|deferasirox
5606314|NCT00873041|iron overload|iron overload
5606315|NCT00873041|non-transfusion dependent|non-transfusion dependent
5606316|NCT00873028|Physical therapy|physical therapy
5606317|NCT00873028|Inspiratory muscles|inspiratory muscles
5606318|NCT00873028|Exercise|exercise
5606319|NCT00873015|Cerebral aneurysm|cerebral aneurysm
5606320|NCT00873015|Subarachnoid hemorrhage|subarachnoid hemorrhage
5606321|NCT00873015|Nitrite|nitrite
5606322|NCT00873002|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5606323|NCT00873002|advanced adult primary liver cancer|advanced adult primary liver cancer
5606324|NCT00873002|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5606325|NCT00873002|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5606326|NCT00872989|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5606327|NCT00872989|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5606328|NCT00872989|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5609001|NCT00862550|HNC|hnc
5606329|NCT00872963|malaria vaccine|malaria vaccine
5606331|NCT00872950|LEMS|lems
5606332|NCT00872950|CMS|cms
5606333|NCT00872950|3,4 DIAMINOPYRIDINE|3,4 diaminopyridine
5606334|NCT00872950|3,4 DAP|3,4 dap
5606335|NCT00872924|Bioequivalence|bioequivalence
5606336|NCT00872911|Sarcopenia|sarcopenia
5606337|NCT00872911|nutrition|nutrition
5606338|NCT00872911|aging|aging
5606339|NCT00872911|metabolism|metabolism
5606340|NCT00872911|exercise|exercise
5606341|NCT00872898|autism|autism
5606342|NCT00872898|memantine|memantine
5606343|NCT00872898|pediatric|pediatric
5606344|NCT00872898|Forest Laboratories|forest laboratories
5606345|NCT00872898|Autism in pediatric patients|autism in pediatric patients
5606346|NCT00872885|analgesic|analgesic
5606347|NCT00872885|bunionectomy|bunionectomy
5606348|NCT00872885|surgery|surgery
5606349|NCT00872885|post operative pain|post operative pain
5606350|NCT00872885|single Hallux valgus repair|single hallux valgus repair
5606351|NCT00872872|NVP|nvp
5606352|NCT00872872|PMTCT|pmtct
5606353|NCT00872872|pregnancy|pregnancy
5606354|NCT00872872|resistance|resistance
5606355|NCT00872859|Breast Cancer|breast cancer
5606356|NCT00872859|Cancer of Breast|cancer of breast
5606357|NCT00872859|Reconstructive Surgery|reconstructive surgery
5606358|NCT00872846|Body weight|body weight
5606359|NCT00872846|Signs and symptoms|signs and symptoms
5606360|NCT00872846|Obesity|obesity
5606361|NCT00872846|Metabolic disease|metabolic disease
5606362|NCT00872846|Diabetes mellitus type 2|diabetes mellitus type 2
5606363|NCT00872846|Diabetes mellitus|diabetes mellitus
5606364|NCT00872846|Nutrition disorder|nutrition disorder
5606365|NCT00872846|Endocrine system diseases|endocrine system diseases
5606367|NCT00872846|Overnutrition|overnutrition
5606368|NCT00872846|Glucose metabolic disorder|glucose metabolic disorder
5606369|NCT00872833|Transfusion-Dependant Thalassemia|transfusion-dependant thalassemia
5606370|NCT00872833|Pain|pain
5606371|NCT00872833|Mild Pain|mild pain
5606372|NCT00872820|Social Anxiety|social anxiety
5606373|NCT00872820|Social Anxiety Treatment|social anxiety treatment
5606374|NCT00872820|Cognitive Therapy|cognitive therapy
5606375|NCT00872820|Mindfulness|mindfulness
5606376|NCT00872820|Social Phobia|social phobia
5606377|NCT00872820|Social Phobia Treatment|social phobia treatment
5606378|NCT00872807|childhood|childhood
5606379|NCT00872807|therapy|therapy
5606380|NCT00872807|life style|life style
5606381|NCT00872807|motor activity|motor activity
5606382|NCT00872807|obesity|obesity
5606383|NCT00872807|overweight|overweight
5606384|NCT00872807|body mass index|body mass index
5606385|NCT00872807|treatment|treatment
5606386|NCT00872794|Hip|hip
5606387|NCT00872794|Conservative|conservative
5606389|NCT00872794|Resurfacing|resurfacing
5606390|NCT00872781|Bioequivalence fixed dose combination of Quinapril HCl 20 mg and Hydrochlorothiazide 25 mg tablets|bioequivalence fixed dose combination of quinapril hcl 20 mg and hydrochlorothiazide 25 mg tablets
5606391|NCT00872742|Impulse Control Disorders|impulse control disorders
5606392|NCT00872742|Behavior Therapy|behavior therapy
5606393|NCT00872742|Acceptance|acceptance
5606394|NCT00872742|Habit Reversal|habit reversal
5606395|NCT00872729|cystinosis|cystinosis
5606396|NCT00872729|cysteamine|cysteamine
5606397|NCT00872729|inheritable disease|inheritable disease
5606398|NCT00872729|orphan disease|orphan disease
5606399|NCT00872729|CTNS protein, human|ctns protein, human
5606400|NCT00872729|nephropathic cystinosis|nephropathic cystinosis
5606401|NCT00872716|specific phobia|specific phobia
5606402|NCT00872716|simple phobia|simple phobia
5606403|NCT00872716|anxiety disorder|anxiety disorder
5606405|NCT00872703|Prenatal Diagnosis|prenatal diagnosis
5606406|NCT00872703|Ultrasound|ultrasound
5606407|NCT00872703|MRI|mri
5606408|NCT00872690|Multiple Trauma|multiple trauma
5606409|NCT00872690|Blast Injuries|blast injuries
5606410|NCT00872690|Brain Injuries|brain injuries
5606411|NCT00872690|Rehabilitation, Vocational|rehabilitation, vocational
5606412|NCT00872690|Consumer participation|consumer participation
5606413|NCT00872677|weight changes|weight changes
5606414|NCT00872677|obesity|obesity
5606415|NCT00872677|stage I breast cancer|stage i breast cancer
5606416|NCT00872677|stage II breast cancer|stage ii breast cancer
5606417|NCT00872677|stage IIIA breast cancer|stage iiia breast cancer
5606418|NCT00872664|ROP|rop
5606419|NCT00872664|anti-oxidants|anti-oxidants
5606420|NCT00872664|carotenoids|carotenoids
5606421|NCT00872651|Glaucoma|glaucoma
5791107|NCT00140244|leptin|leptin
5606422|NCT00872651|intraocular pressure|intraocular pressure
5606423|NCT00872651|travoprost/timolol|travoprost/timolol
5606424|NCT00872651|timolol|timolol
5606425|NCT00872638|wound edge eversion|wound edge eversion
5606426|NCT00872638|cosmetic outcomes|cosmetic outcomes
5606427|NCT00872638|surgical incisions|surgical incisions
5606428|NCT00872625|stage IA breast cancer|stage ia breast cancer
5606429|NCT00872625|stage IB breast cancer|stage ib breast cancer
5606430|NCT00872625|stage II breast cancer|stage ii breast cancer
5606431|NCT00872625|stage IIIA breast cancer|stage iiia breast cancer
5606432|NCT00872625|stage IIIB breast cancer|stage iiib breast cancer
5606433|NCT00872625|stage IIIC breast cancer|stage iiic breast cancer
5606435|NCT00872612|Sarcoidosis|sarcoidosis
5606436|NCT00872612|Diagnosis|diagnosis
5606437|NCT00872612|Non-caseating granulomas|non-caseating granulomas
5606438|NCT00872612|BAL|bal
5606439|NCT00872612|EUS-FNA|eus-fna
5606440|NCT00872612|EBUS-TBNA|ebus-tbna
5606441|NCT00872612|TBLB|tblb
5606442|NCT00872599|Hypertension|hypertension
5606443|NCT00872599|Phenotyping|phenotyping
5606444|NCT00872599|High Salt intake|high salt intake
5606445|NCT00872599|frequently sampled IV glucose tolerance test(FSIVGTT)|frequently sampled iv glucose tolerance test(fsivgtt)
5606446|NCT00872599|fenofibrate|fenofibrate
5606447|NCT00872599|epoxyeicosatrienoic acids|epoxyeicosatrienoic acids
5606448|NCT00872599|hydroxyeicosatetraenoic acids|hydroxyeicosatetraenoic acids
5606449|NCT00872599|dihydroxyeicosatrienoic acid|dihydroxyeicosatrienoic acid
5606450|NCT00872599|PPAR Alpha Agonist|ppar alpha agonist
5606451|NCT00872599|CYP Monooxygenase Activity|cyp monooxygenase activity
5606452|NCT00872573|Hip|hip
5606453|NCT00872573|Cemented|cemented
5606454|NCT00872547|Hip|hip
5606455|NCT00872547|Resurfacing|resurfacing
5606456|NCT00872547|Metal-on-Metal|metal-on-metal
5606457|NCT00872547|Large Heads|large heads
5606458|NCT00872547|XL Head|xl head
5606459|NCT00872547|ASR - osteoarthritis (primary)|asr - osteoarthritis (primary)
5606460|NCT00872534|To evaluate the acute gastrointestinal safety of PL-2100.|to evaluate the acute gastrointestinal safety of pl-2100.
5606461|NCT00872521|Multiple Myeloma|multiple myeloma
5606462|NCT00872521|transplant eligible|transplant eligible
5606463|NCT00872521|doxorubicin|doxorubicin
5606464|NCT00872521|dexamethasone|dexamethasone
5606465|NCT00872521|bortezomib|bortezomib
5606466|NCT00872521|bortezomib resistance|bortezomib resistance
5606467|NCT00872521|PAD induction|pad induction
5606468|NCT00872521|PIMMS Trial|pimms trial
5606469|NCT00872495|Urothelial Cancer|urothelial cancer
5606470|NCT00872495|Cancer|cancer
5606471|NCT00872495|Bladder Neoplasms|bladder neoplasms
5606472|NCT00872495|Urinary Bladder Cancer|urinary bladder cancer
5606473|NCT00872482|non-small cell lung cancer|non-small cell lung cancer
5606474|NCT00872482|NSCLC|nsclc
5606475|NCT00872482|Brain metastases|brain metastases
5606476|NCT00872482|nimotuzumab|nimotuzumab
5606477|NCT00872482|TheraCIM|theracim
5606478|NCT00872482|h-R3|h-r3
5606479|NCT00872482|Radiation|radiation
5606480|NCT00872469|Postpartum haemorrhage|postpartum haemorrhage
5606481|NCT00872469|randomised controlled trial|randomised controlled trial
5606482|NCT00872469|tranexamic acid|tranexamic acid
5606483|NCT00872469|antifibrinolytic|antifibrinolytic
5606484|NCT00872456|Diabetes Mellitus|diabetes mellitus
5606485|NCT00872456|Cardiovascular Disease|cardiovascular disease
5606488|NCT00872430|RCT|rct
5606489|NCT00872430|phytotherapy|phytotherapy
5606490|NCT00872417|HIV/AIDS|hiv/aids
5606491|NCT00872417|antiretroviral therapy|antiretroviral therapy
5606492|NCT00872417|immune reconstitution|immune reconstitution
5606493|NCT00872404|CP-751,871|cp-751,871
5606494|NCT00872404|squamous cell carcinoma|squamous cell carcinoma
5606495|NCT00872404|recurrent or metastatic|recurrent or metastatic
5606496|NCT00872404|after 1st line chemotherapy|after 1st line chemotherapy
5606497|NCT00872378|Morbid Obesity|morbid obesity
5606498|NCT00872378|LAP Band|lap band
5606499|NCT00872378|Adjustable Gastric Band|adjustable gastric band
5606500|NCT00872378|Exenatide|exenatide
5606501|NCT00872378|Byetta|byetta
5606502|NCT00872378|Weight Loss|weight loss
5606503|NCT00872378|Bariatric Surgery|bariatric surgery
5606504|NCT00872365|Pregnancy|pregnancy
5606505|NCT00872365|Exercise|exercise
5606506|NCT00872365|Nutrition|nutrition
5606507|NCT00872365|Micronutrients|micronutrients
5606508|NCT00872365|non-transmissible chronic diseases|non-transmissible chronic diseases
5606509|NCT00872365|Endothelium|endothelium
5606510|NCT00872352|Multiple Myeloma|multiple myeloma
5606511|NCT00872352|Bortezomib|bortezomib
5606512|NCT00872352|Peripheral Neuropathy|peripheral neuropathy
5606513|NCT00872352|evaluation|evaluation
5606514|NCT00872352|evaluation of electrophysiological changes related to the dose and time of bortezomib administration|evaluation of electrophysiological changes related to the dose and time of bortezomib administration
5606515|NCT00872352|investigation of correlation between the incidence of BIPN and the subtype of myeloma|investigation of correlation between the incidence of bipn and the subtype of myeloma
5791267|NCT00139217|iNO|ino
5606516|NCT00872339|Transfusion-Dependent Thalassemia|transfusion-dependent thalassemia
5680364|NCT00578019|Comparative|comparative
5606517|NCT00872339|Non-Transfusion-Dependent Thalassemia|non-transfusion-dependent thalassemia
5606518|NCT00872326|Diabetes Complications|diabetes complications
5606519|NCT00872326|Lower limb ischemia|lower limb ischemia
5606520|NCT00872326|Adult stem cells|adult stem cells
5606522|NCT00872313|Psychology|psychology
5606523|NCT00872313|Postpartum Psychology|postpartum psychology
5606524|NCT00872287|minimally invasive surgery|minimally invasive surgery
5606525|NCT00872287|scarless cholecystectomy|scarless cholecystectomy
5606526|NCT00872287|new techniques in laparoscopy|new techniques in laparoscopy
5606527|NCT00872287|invisible scar|invisible scar
5606528|NCT00872287|single port access|single port access
5606529|NCT00872287|abdominal pain|abdominal pain
5606530|NCT00872287|shoulder pain|shoulder pain
5606531|NCT00872274|Bioequivalence|bioequivalence
5606532|NCT00872261|Clinical Trials as Topic|clinical trials as topic
5606533|NCT00872261|Adolescent Psychology|adolescent psychology
5606534|NCT00872261|Patient Acceptance of Health Care|patient acceptance of health care
5606535|NCT00872261|HIV Risk Behaviors|hiv risk behaviors
5606536|NCT00872261|Adolescents|adolescents
5606537|NCT00872261|Clinical Trial Recruitment|clinical trial recruitment
5606538|NCT00872261|Microbicide Acceptability|microbicide acceptability
5606539|NCT00872261|Ethics|ethics
5606540|NCT00872261|Mixed Methods|mixed methods
5606542|NCT00872248|Restless leg syndrome|restless leg syndrome
5606543|NCT00872248|Spinal anesthesia|spinal anesthesia
5606544|NCT00872248|Epidural anesthesia|epidural anesthesia
5606545|NCT00872248|Neuraxial block|neuraxial block
5606546|NCT00872235|Bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets|bioequivalence fixed-dose combination of quinapril 20 mg and hydrochlorothiazide 25 mg tablets
5606547|NCT00872222|Hip|hip
5606548|NCT00872222|Cementless|cementless
5606549|NCT00872222|Ceramic-on-Ceramic|ceramic-on-ceramic
5606550|NCT00872209|swimmer's ear|swimmer's ear
5606551|NCT00872209|ear drops|ear drops
5606552|NCT00872209|ear foam|ear foam
5606553|NCT00872209|otic foam|otic foam
5606554|NCT00872209|ear infection|ear infection
5606555|NCT00872209|ear pain|ear pain
5606556|NCT00872209|ear inflammation|ear inflammation
5606557|NCT00872183|Motor Learning|motor learning
5606558|NCT00872183|Mirror Neurons|mirror neurons
5606559|NCT00872183|Healthy Volunteer|healthy volunteer
5606560|NCT00872183|HV|hv
5606561|NCT00872170|Pulmonary Hypertension|pulmonary hypertension
5606562|NCT00872157|Castrate-Resistant Prostate Cancer|castrate-resistant prostate cancer
5606563|NCT00872157|Prostate|prostate
5606564|NCT00872157|High-Volume Osseous Metastases|high-volume osseous metastases
5606565|NCT00872157|BMTP-11|bmtp-11
5606566|NCT00872157|Prostate State Antigen|prostate state antigen
5606567|NCT00872157|PSA|psa
5606568|NCT00872131|Anxiety|anxiety
5606569|NCT00872131|Social Phobia|social phobia
5606570|NCT00872131|Generalized Social Anxiety Disorder|generalized social anxiety disorder
5606571|NCT00872118|alcohol consumption|alcohol consumption
5606572|NCT00872118|social anxiety|social anxiety
5606573|NCT00872118|brief intervention|brief intervention
5606574|NCT00872118|motivational interviewing|motivational interviewing
5606575|NCT00872118|cognitive behavioral|cognitive behavioral
5606576|NCT00872105|clavicle|clavicle
5606577|NCT00872105|fractures|fractures
5606578|NCT00872105|distal|distal
5606579|NCT00872092|small bowel|small bowel
5606580|NCT00872092|bacterial overgrowth|bacterial overgrowth
5606581|NCT00872079|warfarin|warfarin
5606582|NCT00872079|pharmacokinetics|pharmacokinetics
5606583|NCT00872079|pharmacodynamics|pharmacodynamics
5606585|NCT00872066|Bone Cement|bone cement
5606586|NCT00872053|robot|robot
5606587|NCT00872053|treadmill|treadmill
5606588|NCT00872053|foot drop|foot drop
5606589|NCT00872053|rehabilitation|rehabilitation
5606590|NCT00872053|gait|gait
5606591|NCT00872040|Sexual function|sexual function
5606592|NCT00872040|Pelvic floor disorders|pelvic floor disorders
5606593|NCT00872040|Delivery mode|delivery mode
5606594|NCT00872027|Critical Illness|critical illness
5606595|NCT00872027|Intensive Care Unit|intensive care unit
5606596|NCT00872027|Acute Respiratory Failure|acute respiratory failure
5606597|NCT00872027|Prolonged Mechanical Ventilation|prolonged mechanical ventilation
5606598|NCT00871975|LUTS|luts
5606599|NCT00871975|OAB|oab
5606600|NCT00871962|long-term oxygen therapy|long-term oxygen therapy
5606601|NCT00871962|COPD patients on necessity of long-term oxygen therapy|copd patients on necessity of long-term oxygen therapy
5606602|NCT00871949|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
5606603|NCT00871923|Non-small cell lung cancer|non-small cell lung cancer
5606604|NCT00871923|NSCLC|nsclc
5606605|NCT00871923|Brain Metastases|brain metastases
5606606|NCT00871923|Brain Cancer|brain cancer
5606607|NCT00871923|Lung Cancer|lung cancer
5606608|NCT00871923|Tarceva|tarceva
5606609|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride
5606610|NCT00871923|OSI-774|osi-774
5606611|NCT00871923|Radiation Therapy|radiation therapy
5606612|NCT00871923|Whole Brain Radiation Therapy|whole brain radiation therapy
5606613|NCT00871923|WBRT|wbrt
5606614|NCT00871897|Neuropsychology|neuropsychology
5606615|NCT00871897|Cardiac Rehabilitation|cardiac rehabilitation
5606616|NCT00871884|Post Concussion Syndrome|post concussion syndrome
5606617|NCT00871884|Cognitive Behavioral Therapy|cognitive behavioral therapy
5606618|NCT00871884|Anxiety Sensitivity|anxiety sensitivity
5606619|NCT00871884|Mild Head Injury|mild head injury
5606620|NCT00871884|Psychotherapy|psychotherapy
5606621|NCT00871884|Chronic Post Concussion Symptoms|chronic post concussion symptoms
5606622|NCT00871858|stage II breast cancer|stage ii breast cancer
5606626|NCT00871858|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5606628|NCT00871845|hepatitis C|hepatitis c
5606629|NCT00871845|insulin resistance|insulin resistance
5606630|NCT00871845|metabolic syndrome|metabolic syndrome
5606631|NCT00871832|hyperglycemia|hyperglycemia
5606632|NCT00871832|HgA1c|hga1c
5606633|NCT00871832|mortality|mortality
5606634|NCT00871819|Spinal Cord Stimulation|spinal cord stimulation
5606635|NCT00871806|Pharmacokinetics|pharmacokinetics
5606636|NCT00871806|eletriptan|eletriptan
5606637|NCT00871806|bioavailability|bioavailability
5606638|NCT00871806|oral disintegrating tablet|oral disintegrating tablet
5606639|NCT00871780|TYSABRI naive|tysabri naive
5606640|NCT00871780|Relapsing-remitting multiple sclerosis (RRMS)|relapsing-remitting multiple sclerosis (rrms)
5606641|NCT00871767|AZD5672|azd5672
5606642|NCT00871767|relative bioavailability|relative bioavailability
5606643|NCT00871767|rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5606644|NCT00871754|Bladder Cancer|bladder cancer
5606645|NCT00871754|Cancer, bladder|cancer, bladder
5606646|NCT00871754|Urinary Bladder Cancer|urinary bladder cancer
5606647|NCT00871741|Combined vaccine|combined vaccine
5606648|NCT00871741|Primary vaccination|primary vaccination
5606649|NCT00871728|Onychomycosis, Toe|onychomycosis, toe
5606650|NCT00871728|Itraconazole|itraconazole
5606651|NCT00871728|Sporanox|sporanox
5606652|NCT00871715|stroke|stroke
5606653|NCT00871715|hemiparesis|hemiparesis
5606654|NCT00871715|physical therapy|physical therapy
5606655|NCT00871715|occupational therapy|occupational therapy
5606656|NCT00871715|neurorehabilitation|neurorehabilitation
5606657|NCT00871715|patient focused|patient focused
5606658|NCT00871715|motor learning|motor learning
5606659|NCT00871715|motor control|motor control
5606660|NCT00871715|skill acquisition|skill acquisition
5606661|NCT00871715|skill training|skill training
5606662|NCT00871715|motor recovery|motor recovery
5606663|NCT00871715|task oriented training|task oriented training
5606664|NCT00871715|task specific training|task specific training
5606665|NCT00871715|arm function|arm function
5606666|NCT00871715|hand function|hand function
5606667|NCT00871715|upper extremity|upper extremity
5606668|NCT00871715|arm therapy|arm therapy
5606669|NCT00871715|physical rehabilitation|physical rehabilitation
5606670|NCT00871715|arm rehabilitation|arm rehabilitation
5606671|NCT00871715|motor function|motor function
5606672|NCT00871702|Leukemia|leukemia
5606673|NCT00871702|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5606674|NCT00871702|Hodgkin Disease|hodgkin disease
5606675|NCT00871702|Myelodysplastic Syndromes|myelodysplastic syndromes
5606676|NCT00871702|Multiple Myeloma|multiple myeloma
5606677|NCT00871689|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5863014|NCT00001417|Spinal Tumor|spinal tumor
5863015|NCT00001417|Vertebral Tumor|vertebral tumor
5606678|NCT00871689|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5606679|NCT00871689|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5606680|NCT00871689|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5606681|NCT00871689|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5606682|NCT00871689|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5606684|NCT00871689|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5606685|NCT00871689|childhood acute myeloid leukemia with 11q23 (MLL) abnormalities|childhood acute myeloid leukemia with 11q23 (mll) abnormalities
5606686|NCT00871689|childhood acute myeloid leukemia with inv(16)(p13;q22)|childhood acute myeloid leukemia with inv(16)(p13;q22)
5606687|NCT00871689|childhood acute myeloid leukemia with t(15;17)(q22;q12)|childhood acute myeloid leukemia with t(15;17)(q22;q12)
5606688|NCT00871689|childhood acute myeloid leukemia with t(16;16)(p13;q22)|childhood acute myeloid leukemia with t(16;16)(p13;q22)
5606689|NCT00871689|childhood acute myeloid leukemia with t(8;21)(q22;q22)|childhood acute myeloid leukemia with t(8;21)(q22;q22)
5606690|NCT00871650|Post Traumatic Stress Disorder|post traumatic stress disorder
5606691|NCT00871650|PTSD|ptsd
5606695|NCT00871650|Neural|neural
5606696|NCT00871650|Sleep|sleep
5606697|NCT00871650|REM Sleep|rem sleep
5606698|NCT00871637|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5606699|NCT00871637|Airway macrophages|airway macrophages
5606700|NCT00871637|Sputum milieu|sputum milieu
5606701|NCT00871637|Airway inflammation|airway inflammation
5606702|NCT00871637|Occupational diseases|occupational diseases
5606703|NCT00871611|Hereditary|hereditary
5606704|NCT00871611|Anderson-Fabry|anderson-fabry
5606705|NCT00871611|prevalence|prevalence
5606706|NCT00871611|heart|heart
5606707|NCT00871611|hypertrophy|hypertrophy
5606708|NCT00871611|urine|urine
5606709|NCT00871611|globotriaosylceramide|globotriaosylceramide
5606710|NCT00871611|isoforms|isoforms
5606711|NCT00871611|α - Galactosidase|α - galactosidase
5606712|NCT00871598|plaque psoriasis|plaque psoriasis
5606713|NCT00871598|BTT1023|btt1023
5606714|NCT00871598|safety|safety
5606715|NCT00871598|pharmacokinetics|pharmacokinetics
5606716|NCT00871585|bicalutamide|bicalutamide
5606718|NCT00871585|advanced prostate cancer|advanced prostate cancer
5606719|NCT00871572|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5606720|NCT00871533|Biochemical Marker|biochemical marker
5606721|NCT00871533|Biochemical Markers|biochemical markers
5606722|NCT00871533|Biologic Marker|biologic marker
5606723|NCT00871533|Biologic Markers|biologic markers
5606724|NCT00871533|Biomarkers|biomarkers
5606725|NCT00871533|Clinical Marker|clinical marker
5606726|NCT00871533|Clinical Markers|clinical markers
5606727|NCT00871533|Immune Marker|immune marker
5606728|NCT00871533|Immune Markers|immune markers
5606729|NCT00871533|Immunologic Marker|immunologic marker
5606730|NCT00871533|Immunologic Markers|immunologic markers
5606731|NCT00871533|Laboratory Marker|laboratory marker
5606732|NCT00871533|Laboratory Markers|laboratory markers
5606733|NCT00871533|Marker, Biochemical|marker, biochemical
5606734|NCT00871533|Marker, Biological|marker, biological
5606735|NCT00871533|Marker, Clinical|marker, clinical
5606736|NCT00871533|Marker, Immunologic|marker, immunologic
5606737|NCT00871533|Marker, Laboratory|marker, laboratory
5606738|NCT00871533|Marker, Serum|marker, serum
5606739|NCT00871533|Marker, Surrogate|marker, surrogate
5606740|NCT00871533|Markers, Biochemical|markers, biochemical
5606741|NCT00871533|Markers, Biological|markers, biological
5606742|NCT00871533|Markers, Clinical|markers, clinical
5606743|NCT00871533|Markers, Immunologic|markers, immunologic
5606744|NCT00871533|Markers, Laboratory|markers, laboratory
5606745|NCT00871533|Markers, Serum|markers, serum
5606746|NCT00871533|Markers, Surrogate|markers, surrogate
5606747|NCT00871533|Markers, Viral|markers, viral
5606748|NCT00871533|Serum Marker|serum marker
5606749|NCT00871533|Serum Markers|serum markers
5606750|NCT00871533|Surrogate End Point|surrogate end point
5606751|NCT00871533|Surrogate End Points|surrogate end points
5606752|NCT00871533|Surrogate Endpoint|surrogate endpoint
5606753|NCT00871533|Surrogate Endpoints|surrogate endpoints
5606754|NCT00871533|Surrogate Marker|surrogate marker
5606755|NCT00871533|Surrogate Markers|surrogate markers
5606756|NCT00871533|Viral Marker|viral marker
5606757|NCT00871533|Viral Markers|viral markers
5606758|NCT00871520|Palliative Care|palliative care
5606759|NCT00871520|Predictive Value of Tests|predictive value of tests
5606760|NCT00871520|Prospective Studies|prospective studies
5606761|NCT00871520|Survival Analysis|survival analysis
5606762|NCT00871520|Survival prediction|survival prediction
5606763|NCT00871507|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5606764|NCT00871455|Spinal Cord Injury|spinal cord injury
5606765|NCT00871455|Baclofen|baclofen
5606766|NCT00871455|Growth Hormone, Pituitary|growth hormone, pituitary
5606767|NCT00871455|Insulin-Like Growth Factor I|insulin-like growth factor i
5606768|NCT00871442|PCEA|pcea
5606769|NCT00871442|labor and delivery|labor and delivery
5606771|NCT00871442|epidural|epidural
5606772|NCT00871442|anesthesia|anesthesia
5606773|NCT00871442|pregnant women|pregnant women
5606774|NCT00871429|skin toxicity|skin toxicity
5606775|NCT00871429|cancer patients|cancer patients
5606776|NCT00871429|adverse effects|adverse effects
5606777|NCT00871403|GW786034|gw786034
5606778|NCT00871403|pazopanib|pazopanib
5606779|NCT00871403|pemetrexed|pemetrexed
5606780|NCT00871403|cisplatin|cisplatin
5606781|NCT00871403|non-small cell lung cancer|non-small cell lung cancer
5606782|NCT00871403|NSCLC|nsclc
5606783|NCT00871390|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5606784|NCT00871390|Permanent/Persistent Atrial Fibrillation|permanent/persistent atrial fibrillation
5606785|NCT00871377|epilepsy|epilepsy
5606786|NCT00871377|cardiac risk factors|cardiac risk factors
5606787|NCT00871377|memory|memory
5606788|NCT00871377|cognition|cognition
5606789|NCT00871377|n-3 fatty acids|n-3 fatty acids
5606790|NCT00871377|fish oil|fish oil
5606792|NCT00871377|DHA|dha
5606793|NCT00871377|seizures|seizures
5606794|NCT00871364|Bioequivalence|bioequivalence
5606795|NCT00871364|venlafaxine|venlafaxine
5606796|NCT00871364|Healthy subjects|healthy subjects
5606797|NCT00871338|combined|combined
5606798|NCT00871338|Vaccines|vaccines
5606799|NCT00871325|Gastric emptying|gastric emptying
5606800|NCT00871325|Small bowel transit|small bowel transit
5606801|NCT00871325|Colonic transit|colonic transit
5606802|NCT00871325|Whole gut transit|whole gut transit
5606803|NCT00871325|Postoperative Ileus|postoperative ileus
5606804|NCT00871312|diabetes|diabetes
5606805|NCT00871312|diabetic|diabetic
5606806|NCT00871312|wound|wound
5606807|NCT00871312|ulcer|ulcer
5606808|NCT00871312|lower extremity|lower extremity
5606809|NCT00871312|foot|foot
5606810|NCT00871312|oxygen|oxygen
5606811|NCT00871312|hyperbaric|hyperbaric
5606812|NCT00871312|topical wound oxygen|topical wound oxygen
5606813|NCT00871299|Treatment-resistant depression, meditation, mindfulness|treatment-resistant depression, meditation, mindfulness
5606814|NCT00871286|Chronic rhinosinusitis|chronic rhinosinusitis
5606816|NCT00871286|CRS|crs
5606817|NCT00871273|capecitabine|capecitabine
5606818|NCT00871273|total gastrectomy|total gastrectomy
5606819|NCT00871273|pharmacokinetic|pharmacokinetic
5606820|NCT00871260|Coronary Disease|coronary disease
5606821|NCT00871260|Stress Testing|stress testing
5606822|NCT00871260|Lexiscan (regadenoson)|lexiscan (regadenoson)
5606823|NCT00871260|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5606824|NCT00871247|Bioequivalence|bioequivalence
5606825|NCT00871247|finasteride|finasteride
5606826|NCT00871247|Healthy subjects|healthy subjects
5606827|NCT00871234|HIV|hiv
5606828|NCT00871234|Endothelial function|endothelial function
5606829|NCT00871234|Etravirine|etravirine
5606830|NCT00871208|Atopic Dermatitis|atopic dermatitis
5606831|NCT00871208|pruritus|pruritus
5606832|NCT00871208|quality of life|quality of life
5606833|NCT00871195|Rhesus D|rhesus d
5606834|NCT00871195|RHD|rhd
5606835|NCT00871195|genotype|genotype
5606836|NCT00871195|phenotype|phenotype
5606837|NCT00871195|neonatal|neonatal
5606838|NCT00871195|noninvasive|noninvasive
5606839|NCT00871195|fetal|fetal
5606840|NCT00871195|MassARRAY|massarray
5606841|NCT00871195|DNA|dna
5606842|NCT00871182|COPD|copd
5606843|NCT00871182|obstructive lung diseases|obstructive lung diseases
5606844|NCT00871182|Tiotropium|tiotropium
5606845|NCT00871169|Irinotecan|irinotecan
5606846|NCT00871169|Oxaliplatin|oxaliplatin
5606847|NCT00871169|Cetuximab|cetuximab
5606848|NCT00871169|Advanced or metastatic pancreatic cancer|advanced or metastatic pancreatic cancer
5606849|NCT00871156|Drug-Drug Interaction|drug-drug interaction
5606850|NCT00871143|CBT|cbt
5606851|NCT00871143|BDD|bdd
5606852|NCT00871130|Thyroid gland|thyroid gland
5606853|NCT00871130|bariatric surgery|bariatric surgery
5606854|NCT00871130|weight loss|weight loss
5606855|NCT00871130|thyroid hormones|thyroid hormones
5606856|NCT00871130|adult|adult
5606857|NCT00871130|morbid obesity|morbid obesity
5606858|NCT00871130|cohort|cohort
5606859|NCT00871117|Co-administration|co-administration
5606860|NCT00871117|Immunization|immunization
5606861|NCT00871117|Preschool|preschool
5606862|NCT00871117|Booster|booster
5606863|NCT00871104|Infective endocarditis|infective endocarditis
5606864|NCT00871091|CAD/CAM|cad/cam
5606865|NCT00871091|orthodontics|orthodontics
5606866|NCT00871091|fixed appliance|fixed appliance
5606867|NCT00871091|tooth movement|tooth movement
5606868|NCT00871065|Cerebral Vasospasm|cerebral vasospasm
5606869|NCT00871065|Vasospasm|vasospasm
5606870|NCT00871065|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5606871|NCT00871065|Sildenafil citrate|sildenafil citrate
5606872|NCT00871065|Aneurysm|aneurysm
5606873|NCT00871065|Intracranial aneurysm|intracranial aneurysm
5606874|NCT00871052|Polymorphic light eruption|polymorphic light eruption
5606875|NCT00871052|UV radiation|uv radiation
5606876|NCT00871052|Vitamin D|vitamin d
5606877|NCT00871052|Immune suppression|immune suppression
5606878|NCT00871052|Prevention|prevention
5606879|NCT00871039|Alcoholism|alcoholism
5606880|NCT00871039|Mechanical ventilation|mechanical ventilation
5606881|NCT00871026|CAD/CAM|cad/cam
5606882|NCT00871026|orthodontics|orthodontics
5606883|NCT00871026|fixed appliance|fixed appliance
5606884|NCT00871026|tooth movement|tooth movement
5606885|NCT00871026|Adverse Effects|adverse effects
5606886|NCT00871026|Time Factors|time factors
5606887|NCT00871026|Treatment Outcome|treatment outcome
5606888|NCT00871013|This study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma|this study is being done in an attempt to improve the remission rate and the survival time for participants with high-risk myeloma
5606889|NCT00871000|Boostrix Polio|boostrix polio
5606890|NCT00871000|dTpa-IPV|dtpa-ipv
5606891|NCT00870987|Malaria|malaria
5606892|NCT00870987|Vaccine|vaccine
5606893|NCT00870974|Parkinson|parkinson
5606894|NCT00870974|Huntington's|huntington's
5606895|NCT00870974|Fragile X|fragile x
5606896|NCT00870974|Autistic Spectrum|autistic spectrum
5606897|NCT00870974|Alzheimer's|alzheimer's
5606898|NCT00870974|MCI|mci
5606899|NCT00870961|colon cancer|colon cancer
5606900|NCT00870961|rectal cancer|rectal cancer
5606901|NCT00870961|adenomatous polyp|adenomatous polyp
5606902|NCT00870948|Open Label|open label
5606903|NCT00870948|Healthy Volunteers|healthy volunteers
5606904|NCT00870935|Balloon catheter|balloon catheter
5606905|NCT00870935|Cervical vacuum cup|cervical vacuum cup
5606906|NCT00870935|Hysterosalpingography|hysterosalpingography
5606907|NCT00870935|Infertility|infertility
5606908|NCT00870935|Pain|pain
5606909|NCT00870935|Fallopian Tube Patency Tests|fallopian tube patency tests
5606910|NCT00870935|Female Infertility|female infertility
5606911|NCT00870896|capsaicin|capsaicin
5606912|NCT00870896|COPD|copd
5606913|NCT00870896|COPD with chronic bronchitis|copd with chronic bronchitis
5606914|NCT00870870|Tumors|tumors
5606915|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal
5606916|NCT00870870|Stage IIIb Metastatic Non-Small Cell Lung Cancer|stage iiib metastatic non-small cell lung cancer
5606917|NCT00870870|Stage IV Metastatic Non-Small Cell Lung Cancer|stage iv metastatic non-small cell lung cancer
5606918|NCT00870857|Lungs|lungs
5606919|NCT00870857|antiretrovirals|antiretrovirals
5606920|NCT00870857|HIV|hiv
5606921|NCT00870857|COPD|copd
5606922|NCT00870844|Acute ischemic stroke|acute ischemic stroke
5606923|NCT00870844|Erythropoietin|erythropoietin
5606924|NCT00870844|Carbamylated|carbamylated
5606925|NCT00870844|Neuroprotection|neuroprotection
5606926|NCT00870831|diabetes|diabetes
5606927|NCT00870818|Teplizumab|teplizumab
5606928|NCT00870818|Protege|protege
5606929|NCT00870818|MGA031|mga031
5606930|NCT00870818|Monoclonal antibody|monoclonal antibody
5606931|NCT00870818|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5606932|NCT00870818|T1DM|t1dm
5606933|NCT00870818|MacroGenics|macrogenics
5606934|NCT00870792|HIV|hiv
5606935|NCT00870792|antiretroviral therapy|antiretroviral therapy
5606936|NCT00870792|medication adherence|medication adherence
5606937|NCT00870792|Treatment Experienced|treatment experienced
5606938|NCT00870779|Fluorescence|fluorescence
5606939|NCT00870779|Brain Tumor|brain tumor
5606940|NCT00870779|Malignant Glioma|malignant glioma
5606941|NCT00870779|Pituitary Tumor|pituitary tumor
5606942|NCT00870779|Skull Base Tumor|skull base tumor
5606943|NCT00870779|Brain Lesions|brain lesions
5606944|NCT00870779|Brain Metastases|brain metastases
5606945|NCT00870779|Meningioma|meningioma
5606946|NCT00870753|Eating disorders|eating disorders
5606947|NCT00870753|yoga|yoga
5606948|NCT00870753|body awareness|body awareness
5606949|NCT00870753|depression|depression
5606950|NCT00870753|anxiety|anxiety
5606951|NCT00870740|MS|ms
5606952|NCT00870740|Multiple Sclerosis|multiple sclerosis
5606953|NCT00870727|PDD NOS|pdd nos
5606954|NCT00870714|Prostate Cancer|prostate cancer
5606955|NCT00870714|Neoadjuvant|neoadjuvant
5606956|NCT00870701|sarcoma|sarcoma
5606957|NCT00870701|soft tissue|soft tissue
5606958|NCT00870701|members|members
5606959|NCT00870701|radiotherapy|radiotherapy
5606960|NCT00870701|absence of radiotherapy|absence of radiotherapy
5606961|NCT00870688|valproate|valproate
5606962|NCT00870688|epilepsy|epilepsy
5606963|NCT00870688|compliance|compliance
5606964|NCT00870688|sustained released minitablet|sustained released minitablet
5606965|NCT00870688|Orfiril long|orfiril long
5606966|NCT00870675|Ventriculomegaly|ventriculomegaly
5606967|NCT00870675|ultrasound|ultrasound
5606968|NCT00870675|MRI|mri
5606969|NCT00870675|fetus|fetus
5606970|NCT00870649|Schistosomiasis vaccine|schistosomiasis vaccine
5606971|NCT00870649|therapeutic vaccine|therapeutic vaccine
5606972|NCT00870649|Bilhvax|bilhvax
5606973|NCT00870636|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
5606974|NCT00870636|Safety|safety
5606975|NCT00870636|ROP|rop
5606976|NCT00870636|Bevacizumab|bevacizumab
5606977|NCT00870636|Avastin|avastin
5606978|NCT00870610|jugular venous oxygen saturation|jugular venous oxygen saturation
5606979|NCT00870610|hypothermia|hypothermia
5606980|NCT00870597|Floaters|floaters
5606981|NCT00870597|multifocal IOL|multifocal iol
5606982|NCT00870597|visual complaints|visual complaints
5606984|NCT00870584|Asthma; asthma management; asthma impairment ; Xolair ; omalizumab|asthma; asthma management; asthma impairment ; xolair ; omalizumab
5606985|NCT00870571|Bioequivalence|bioequivalence
5606986|NCT00870571|amlodipine besylate|amlodipine besylate
5606987|NCT00870571|amlodipine|amlodipine
5606988|NCT00870571|Healthy subjects|healthy subjects
5606989|NCT00870558|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5606990|NCT00870558|advanced adult primary liver cancer|advanced adult primary liver cancer
5606991|NCT00870558|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5606992|NCT00870558|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5606993|NCT00870545|spouses|spouses
5606994|NCT00870545|social support|social support
5606995|NCT00870545|reintegration|reintegration
5606996|NCT00870545|families|families
5606997|NCT00870545|military|military
5606998|NCT00870545|post deployment|post deployment
5606999|NCT00870545|OEF/OIF|oef/oif
5607000|NCT00870532|Phase I|phase i
5607001|NCT00870532|Combination|combination
5607002|NCT00870532|Anti-angiogenic|anti-angiogenic
5607003|NCT00870532|Sorafenib|sorafenib
5607004|NCT00870532|Metronomic oral vinorelbine|metronomic oral vinorelbine
5607005|NCT00870519|Alzheimer disease|alzheimer disease
5607006|NCT00870506|Randomized Controlled Trial|randomized controlled trial
5791836|NCT00136591|relapse|relapse
5607007|NCT00870506|Healthcare Disparities|healthcare disparities
5607008|NCT00870493|proteinuria|proteinuria
5607009|NCT00870493|renal failure|renal failure
5607010|NCT00870493|glomerulonephritis|glomerulonephritis
5607011|NCT00870480|Bioequivalence|bioequivalence
5607012|NCT00870480|finasteride|finasteride
5607013|NCT00870480|Healthy subjects|healthy subjects
5607014|NCT00870467|Rheumatoid Arthritis|rheumatoid arthritis
5607015|NCT00870454|Diabetic neuropathies|diabetic neuropathies
5607016|NCT00870454|Diabetic neuropathy, painful|diabetic neuropathy, painful
5607018|NCT00870454|Neurotherapeutic agents|neurotherapeutic agents
5607019|NCT00870441|ASP2151|asp2151
5607020|NCT00870441|Valacyclovir|valacyclovir
5607021|NCT00870441|Healthy Volunteers|healthy volunteers
5607022|NCT00870428|Preeclampsia|preeclampsia
5607023|NCT00870428|proteinuria|proteinuria
5607024|NCT00870415|stage IA breast cancer|stage ia breast cancer
5607025|NCT00870415|stage IB breast cancer|stage ib breast cancer
5607026|NCT00870415|stage II breast cancer|stage ii breast cancer
5607027|NCT00870415|stage IIIA breast cancer|stage iiia breast cancer
5607028|NCT00870415|stage IIIC breast cancer|stage iiic breast cancer
5607029|NCT00870415|ductal breast carcinoma|ductal breast carcinoma
5607030|NCT00870415|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5607031|NCT00870402|aldosterone|aldosterone
5607032|NCT00870402|albuminuria|albuminuria
5607033|NCT00870402|diastolic disfunction|diastolic disfunction
5607034|NCT00870402|hyperkalemia|hyperkalemia
5607035|NCT00870376|lower urinary tract symptoms|lower urinary tract symptoms
5607036|NCT00870376|biomarkers|biomarkers
5607037|NCT00870376|urodynamic studies|urodynamic studies
5607038|NCT00870363|HIV|hiv
5607039|NCT00870363|HIV positive|hiv positive
5607040|NCT00870363|Gastrointestinal Associated Lymphoid Tissue (GALT)|gastrointestinal associated lymphoid tissue (galt)
5607041|NCT00870363|GALT Immune Reconstruction|galt immune reconstruction
5607042|NCT00870363|treatment naive|treatment naive
5607043|NCT00870350|immunogenicity|immunogenicity
5607044|NCT00870350|safety|safety
5607045|NCT00870350|tetanus|tetanus
5607046|NCT00870350|diphtheria|diphtheria
5607047|NCT00870350|acellular|acellular
5607048|NCT00870350|pertussis|pertussis
5607049|NCT00870350|vaccine|vaccine
5607050|NCT00870350|booster|booster
5607051|NCT00870350|adverse event|adverse event
5607052|NCT00870350|adverse reaction|adverse reaction
5607053|NCT00870350|DT1aP|dt1ap
5607054|NCT00870350|DT5ap|dt5ap
5607055|NCT00870350|FHA|fha
5607056|NCT00870350|fimbriae|fimbriae
5607057|NCT00870350|pertactin|pertactin
5607058|NCT00870350|SMI|smi
5607059|NCT00870350|Smittskyddsinstitutet|smittskyddsinstitutet
5607060|NCT00870350|Immune response and safety profile to a Tdap booster|immune response and safety profile to a tdap booster
5607061|NCT00870337|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5607062|NCT00870337|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5607063|NCT00870337|endometrial adenocarcinoma|endometrial adenocarcinoma
5607065|NCT00870324|Tachyarrhythmias|tachyarrhythmias
5607066|NCT00870324|Atrial Fibrillation|atrial fibrillation
5607067|NCT00870324|Patients who meets current ICD or CRT-D implant indications|patients who meets current icd or crt-d implant indications
5607068|NCT00870311|Lithium|lithium
5607069|NCT00870311|Neuroprotection|neuroprotection
5607070|NCT00870311|Neurotrophic|neurotrophic
5607071|NCT00870311|bcl2|bcl2
5607072|NCT00870311|gsk3|gsk3
5607073|NCT00870311|pkc|pkc
5607074|NCT00870311|MRI|mri
5607075|NCT00870311|myoinositol|myoinositol
5607076|NCT00870311|MRS|mrs
5607077|NCT00870311|Alzheimers Disease|alzheimers disease
5607078|NCT00870298|drug orders|drug orders
5607079|NCT00870285|Psoriasis|psoriasis
5607080|NCT00870285|Biologic|biologic
5607081|NCT00870285|Ustekinumab|ustekinumab
5607083|NCT00870285|phototherapy|phototherapy
5607084|NCT00870285|half-side comparison|half-side comparison
5607085|NCT00870272|Medical Abortion|medical abortion
5607086|NCT00870272|Mifepristone|mifepristone
5607087|NCT00870272|Misoprostol|misoprostol
5607088|NCT00870272|Sublingual administration|sublingual administration
5607089|NCT00870272|Buccal administration|buccal administration
5607090|NCT00870259|Weight loss|weight loss
5607091|NCT00870259|Weight maintenance|weight maintenance
5607093|NCT00870246|pulmonary emphysema|pulmonary emphysema
5607094|NCT00870233|Gynecologic cancers|gynecologic cancers
5607095|NCT00870233|Quality of Life|quality of life
5607096|NCT00870233|08-155|08-155
5607097|NCT00870233|Surgery|surgery
5607098|NCT00870220|Turner's Syndrome|turner's syndrome
5607099|NCT00870207|Feasibility of implementing TSSC in worksite environment|feasibility of implementing tssc in worksite environment
5607100|NCT00870194|diabetes|diabetes
5607101|NCT00870194|exenatide|exenatide
5607102|NCT00870194|Byetta|byetta
5607103|NCT00870194|sitagliptin|sitagliptin
5607104|NCT00870194|Januvia|januvia
5607105|NCT00870194|Amylin|amylin
5607106|NCT00870194|Lilly|lilly
5607201|NCT00869765|Depression|depression
5607107|NCT00870168|stage IV breast cancer|stage iv breast cancer
5607108|NCT00870168|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5607109|NCT00870168|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5607110|NCT00870142|Bioequivalence|bioequivalence
5607111|NCT00870142|amlodipine besylate|amlodipine besylate
5607112|NCT00870142|amlodipine|amlodipine
5607113|NCT00870142|Healthy subjects|healthy subjects
5607114|NCT00870129|brain tumor|brain tumor
5607115|NCT00870129|radiation|radiation
5607117|NCT00870129|09-009|09-009
5607118|NCT00870116|SBRT|sbrt
5607120|NCT00870116|non-metastatic|non-metastatic
5607121|NCT00870116|non-small-cell lung cancer|non-small-cell lung cancer
5607122|NCT00870116|conformational radiotherapy|conformational radiotherapy
5607123|NCT00870116|non-operated non-metastatic non-small-cell lung cancer|non-operated non-metastatic non-small-cell lung cancer
5607124|NCT00870103|Cataract|cataract
5607125|NCT00870077|Intrahepatic fat|intrahepatic fat
5607126|NCT00870077|obesity|obesity
5607127|NCT00870077|body fat|body fat
5607128|NCT00870077|impaired glucose tolerance|impaired glucose tolerance
5607129|NCT00870064|Surgical Procedures, Operative|surgical procedures, operative
5607130|NCT00870064|Fractures, Open|fractures, open
5607131|NCT00870064|Fracture Fixation|fracture fixation
5607132|NCT00870051|Endurant|endurant
5607133|NCT00870051|Stent Graft|stent graft
5607134|NCT00870051|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5607135|NCT00870038|PCI|pci
5607136|NCT00870038|stent|stent
5607137|NCT00870038|drug eluting stent|drug eluting stent
5607138|NCT00870038|reendothelialization|reendothelialization
5607139|NCT00870038|restenosis|restenosis
5607140|NCT00870038|Percutaneous Coronary Angioplasty|percutaneous coronary angioplasty
5607141|NCT00870025|androgens|androgens
5607142|NCT00870025|hCG|hcg
5607143|NCT00870025|low response|low response
5607144|NCT00870025|IVF|ivf
5607145|NCT00870025|Ovarian response in women with previous low response|ovarian response in women with previous low response
5607146|NCT00869999|rituximab|rituximab
5607147|NCT00869999|everolimus|everolimus
5607148|NCT00869999|DLBCL|dlbcl
5607149|NCT00869999|mTOR|mtor
5607150|NCT00869973|aprepitant|aprepitant
5607151|NCT00869973|delayed emesis|delayed emesis
5607152|NCT00869973|cyclophosphamide plus anthracyclines|cyclophosphamide plus anthracyclines
5607153|NCT00869973|breast cancer|breast cancer
5607154|NCT00869973|antiemetic|antiemetic
5607155|NCT00869960|Healthy Volunteers|healthy volunteers
5607156|NCT00869947|Unilateral below the knee amputation|unilateral below the knee amputation
5607157|NCT00869934|Insomnia|insomnia
5607158|NCT00869934|Sleep disorders|sleep disorders
5607159|NCT00869934|Treatment|treatment
5607160|NCT00869934|Sleep disturbances|sleep disturbances
5607161|NCT00869895|Advanced solid tumors|advanced solid tumors
5607162|NCT00869882|Spondylolisthesis|spondylolisthesis
5607163|NCT00869882|degeneration|degeneration
5607164|NCT00869882|spinal fusion|spinal fusion
5607165|NCT00869869|Heart Failure|heart failure
5607166|NCT00869869|Sleep Disorders|sleep disorders
5607167|NCT00869869|Melatonin|melatonin
5607168|NCT00869869|Antioxidants|antioxidants
5607169|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5607170|NCT00869869|Nervous System Diseases|nervous system diseases
5607171|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs
5607172|NCT00869869|Vascular Diseases|vascular diseases
5607173|NCT00869869|Central Nervous System Depressants|central nervous system depressants
5607174|NCT00869869|Protective Agents|protective agents
5607175|NCT00869869|Pharmacologic Actions|pharmacologic actions
5607176|NCT00869869|Signs and Symptoms|signs and symptoms
5607177|NCT00869869|Mental Disorders|mental disorders
5607178|NCT00869869|Therapeutic Uses|therapeutic uses
5607179|NCT00869869|Neurologic Manifestations|neurologic manifestations
5607180|NCT00869869|Cardiovascular Diseases|cardiovascular diseases
5607181|NCT00869869|Central Nervous System Agents|central nervous system agents
5607182|NCT00869856|Treatment associated with CRI|treatment associated with cri
5607183|NCT00869843|Metastatic colorectal cancer|metastatic colorectal cancer
5607185|NCT00869830|constipation|constipation
5607186|NCT00869830|Parkinson's disease|parkinson's disease
5607187|NCT00869817|Alzheimer's disease|alzheimer's disease
5607188|NCT00869817|antecedent biomarkers|antecedent biomarkers
5607189|NCT00869817|Amyloid Precursor Protein (APP) mutation|amyloid precursor protein (app) mutation
5607190|NCT00869817|presenilin I (PS1) mutation|presenilin i (ps1) mutation
5607191|NCT00869817|presenilin 2 (PS2) mutation|presenilin 2 (ps2) mutation
5607192|NCT00869817|Autosomal Dominant Alzheimer's Disease|autosomal dominant alzheimer's disease
5607193|NCT00869804|breast cancer|breast cancer
5607194|NCT00869804|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5607195|NCT00869804|exercise|exercise
5607196|NCT00869791|Parkinson's|parkinson's
5607197|NCT00869778|Chronic Hepatitis B|chronic hepatitis b
5607198|NCT00869778|HBeAg positive|hbeag positive
5607199|NCT00869778|Therapeutic HBV Vaccine|therapeutic hbv vaccine
5607200|NCT00869778|HBV-specific Cytotoxic T Lymphocyte|hbv-specific cytotoxic t lymphocyte
5607202|NCT00869765|Treatment|treatment
5607203|NCT00869765|Transcranial direct current stimulation|transcranial direct current stimulation
5607204|NCT00869765|D-cycloserine|d-cycloserine
5607205|NCT00869752|combined type small cell lung cancer|combined type small cell lung cancer
5607206|NCT00869752|fusiform type small cell lung cancer|fusiform type small cell lung cancer
5607207|NCT00869752|polygonal type small cell lung cancer|polygonal type small cell lung cancer
5607208|NCT00869752|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
5607209|NCT00869752|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5607210|NCT00869739|cancer survivor|cancer survivor
5607211|NCT00869739|depression|depression
5607212|NCT00869739|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5607213|NCT00869739|male erectile disorder|male erectile disorder
5607214|NCT00869739|urinary complications|urinary complications
5607215|NCT00869739|gastrointestinal complications|gastrointestinal complications
5607216|NCT00869739|stage I prostate cancer|stage i prostate cancer
5607217|NCT00869739|stage IIB prostate cancer|stage iib prostate cancer
5607218|NCT00869739|stage IIA prostate cancer|stage iia prostate cancer
5607219|NCT00869739|stage III prostate cancer|stage iii prostate cancer
5607220|NCT00869713|Hemorrhagic Fever|hemorrhagic fever
5607221|NCT00869713|Viral Infections|viral infections
5607222|NCT00869713|Neurologic diseases|neurologic diseases
5607223|NCT00869713|Arbovirus Infections|arbovirus infections
5607224|NCT00869713|RVF|rvf
5607225|NCT00869700|HIV|hiv
5607226|NCT00869700|Malaria|malaria
5607227|NCT00869700|Pharmacokinetics|pharmacokinetics
5607228|NCT00869700|Treatment Experienced|treatment experienced
5607229|NCT00869674|GeneSearch|genesearch
5607230|NCT00869674|Breast cancer|breast cancer
5607231|NCT00869648|Airway|airway
5607232|NCT00869648|Anaesthesia|anaesthesia
5607233|NCT00869648|Resuscitation|resuscitation
5607234|NCT00869648|Ventilation|ventilation
5607235|NCT00869635|Cholangiocarcinoma|cholangiocarcinoma
5607236|NCT00869635|Photodynamic therapy|photodynamic therapy
5607237|NCT00869635|S-1|s-1
5607238|NCT00869622|osteoporosis|osteoporosis
5607239|NCT00869622|bone mineral density|bone mineral density
5607240|NCT00869622|fracture|fracture
5607241|NCT00869622|antiepileptic drug|antiepileptic drug
5607242|NCT00869622|seizure|seizure
5607243|NCT00869622|Prevention of bone loss|prevention of bone loss
5607244|NCT00869622|Prevention of osteoporosis|prevention of osteoporosis
5607245|NCT00869622|Prevention of Fractures|prevention of fractures
5607246|NCT00869609|Diabetes Prevention|diabetes prevention
5607247|NCT00869609|CVD Risk Reduction|cvd risk reduction
5607248|NCT00869609|Lifestyle Intervention|lifestyle intervention
5607249|NCT00869596|Sputum inflammatory biomarkers|sputum inflammatory biomarkers
5607250|NCT00869583|Women|women
5607251|NCT00869583|Physical Activity|physical activity
5607252|NCT00869583|Hispanic|hispanic
5607253|NCT00869583|Overweight|overweight
5685464|NCT00555984|Intracranial tumors|intracranial tumors
5607254|NCT00869570|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5607255|NCT00869570|stage II rectal cancer|stage ii rectal cancer
5607256|NCT00869570|stage III rectal cancer|stage iii rectal cancer
5607258|NCT00869557|HIV-1|hiv-1
5607259|NCT00869557|Antiretroviral Treatment-Naive|antiretroviral treatment-naive
5607260|NCT00869557|treatment naive|treatment naive
5607261|NCT00869544|HIV|hiv
5607262|NCT00869544|smoker|smoker
5607263|NCT00869544|emphysema|emphysema
5607264|NCT00869544|antiretrovirals|antiretrovirals
5607265|NCT00869544|COPD|copd
5607266|NCT00869531|Obesity|obesity
5607267|NCT00869531|wholegrain|wholegrain
5607268|NCT00869531|wheat|wheat
5607269|NCT00869531|cardiovascular disease|cardiovascular disease
5607270|NCT00869518|Staphylococcus aureus|staphylococcus aureus
5607271|NCT00869518|colonization|colonization
5607272|NCT00869518|eradication|eradication
5607273|NCT00869518|HIV|hiv
5607274|NCT00869518|rifabutin|rifabutin
5607275|NCT00869505|To evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (OCD)|to evaluate the effectiveness of memantine as an augmenting agent for standard intensive residential treatment of severe obsessive-compulsive disorder (ocd)
5607277|NCT00869492|Nadifloxacin|nadifloxacin
5607278|NCT00869492|benzoyl peroxide|benzoyl peroxide
5607279|NCT00869479|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
5607280|NCT00869479|Screening|screening
5607281|NCT00869466|weight changes|weight changes
5607282|NCT00869466|stage IA breast cancer|stage ia breast cancer
5607283|NCT00869466|stage IB breast cancer|stage ib breast cancer
5607284|NCT00869466|stage II breast cancer|stage ii breast cancer
5607285|NCT00869466|stage IIIA breast cancer|stage iiia breast cancer
5607286|NCT00869466|stage IIIB breast cancer|stage iiib breast cancer
5607287|NCT00869466|stage IIIC breast cancer|stage iiic breast cancer
5607288|NCT00869453|Gut hormone|gut hormone
5607289|NCT00869453|hyperglycaemic clamp|hyperglycaemic clamp
5607290|NCT00869453|glucose turnver|glucose turnver
5607291|NCT00869440|CNS 7056|cns 7056
5607292|NCT00869440|Procedural Sedation|procedural sedation
5607293|NCT00869440|Sedation|sedation
5607294|NCT00869440|Endoscopy|endoscopy
5607296|NCT00869427|Spinal cord injury|spinal cord injury
5607297|NCT00869427|Prevention|prevention
5607298|NCT00869427|Vitamin C|vitamin c
5607299|NCT00869414|hypoglycemia|hypoglycemia
5607300|NCT00869414|type 1 diabetes|type 1 diabetes
5607301|NCT00869414|split dosing insulin glargine|split dosing insulin glargine
5607302|NCT00869414|continuous glucose monitoring|continuous glucose monitoring
5607303|NCT00869401|adult giant cell glioblastoma|adult giant cell glioblastoma
5607304|NCT00869401|adult glioblastoma|adult glioblastoma
5607305|NCT00869401|adult gliosarcoma|adult gliosarcoma
5607306|NCT00869388|malignant|malignant
5607307|NCT00869388|resistant|resistant
5607308|NCT00869388|solid tumor|solid tumor
5607309|NCT00869375|acute or critical limb ischemia with angiographic thrombus|acute or critical limb ischemia with angiographic thrombus
5607310|NCT00869349|Rheumatoid Arthritis|rheumatoid arthritis
5607312|NCT00869349|psychosocial|psychosocial
5607313|NCT00869349|social support|social support
5607314|NCT00869336|Tinea Pedis|tinea pedis
5607315|NCT00869336|Athlete's Foot|athlete's foot
5607316|NCT00869323|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5607317|NCT00869310|aprepitant|aprepitant
5607318|NCT00869310|delayed emesis|delayed emesis
5607319|NCT00869310|cisplatin|cisplatin
5607320|NCT00869310|antiemetic|antiemetic
5607321|NCT00869284|High-dose chemotherapy|high-dose chemotherapy
5607322|NCT00869284|aggressive NHL|aggressive nhl
5607323|NCT00869284|high-risk|high-risk
5607324|NCT00869284|PBSC|pbsc
5607325|NCT00869271|liver metastasis|liver metastasis
5607326|NCT00869271|colorectal cancer|colorectal cancer
5607327|NCT00869258|Pancreatic cancer|pancreatic cancer
5607328|NCT00869258|Gemcitabine|gemcitabine
5607329|NCT00869258|Docetaxel|docetaxel
5607330|NCT00869258|Capecitabine|capecitabine
5607331|NCT00869245|ACS|acs
5607332|NCT00869245|Acute Coronary Syndrome|acute coronary syndrome
5607333|NCT00869245|Chest pain|chest pain
5607334|NCT00869245|Cardiac MRI|cardiac mri
5607335|NCT00869245|CMR|cmr
5607336|NCT00869245|Risk Stratification|risk stratification
5607337|NCT00869245|Emergency Department|emergency department
5607338|NCT00869232|Multiple Myeloma|multiple myeloma
5607339|NCT00869219|Pain|pain
5607340|NCT00869219|Pain after eyedrops|pain after eyedrops
5607341|NCT00869206|pain|pain
5607342|NCT00869206|Prostate Adenocarcinoma|prostate adenocarcinoma
5607343|NCT00869206|urinary complications|urinary complications
5607344|NCT00869206|stage IV breast cancer|stage iv breast cancer
5607345|NCT00869206|Recurrent Breast Carcinoma|recurrent breast carcinoma
5607346|NCT00869206|stage IV prostate cancer|stage iv prostate cancer
5607347|NCT00869206|recurrent prostate cancer|recurrent prostate cancer
5607348|NCT00869206|Recurrent Prostate Carcinoma|recurrent prostate carcinoma
5607349|NCT00869206|stage I multiple myeloma|stage i multiple myeloma
5607350|NCT00869206|stage II multiple myeloma|stage ii multiple myeloma
5607351|NCT00869206|Refractory Plasma Cell Myeloma|refractory plasma cell myeloma
5607352|NCT00869206|bone metastases|bone metastases
5607353|NCT00869193|Blood pressure|blood pressure
5607354|NCT00869193|Grape seed|grape seed
5607355|NCT00869180|diclofenac|diclofenac
5607356|NCT00869180|ankle sprain|ankle sprain
5607357|NCT00869180|acute pain|acute pain
5607358|NCT00869180|topical|topical
5607359|NCT00869180|patch|patch
5607360|NCT00869180|Acute Pain due to Mild to Moderate Ankle Sprain|acute pain due to mild to moderate ankle sprain
5607361|NCT00869154|Mild TBI|mild tbi
5607362|NCT00869154|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5607363|NCT00869154|Traumatic Brain Injury|traumatic brain injury
5607364|NCT00869154|Injury, Brain, Traumatic|injury, brain, traumatic
5607365|NCT00869154|Injuries, Acute Brain|injuries, acute brain
5607366|NCT00869154|Brain Injuries, Traumatic|brain injuries, traumatic
5607367|NCT00869154|Acute Brain Injuries|acute brain injuries
5607368|NCT00869141|Glaucoma tube shunt procedure|glaucoma tube shunt procedure
5607369|NCT00869128|melatonin|melatonin
5607370|NCT00869128|insomnia|insomnia
5607371|NCT00869128|diabetes|diabetes
5607372|NCT00869128|sleep|sleep
5607373|NCT00869115|Digoxin|digoxin
5607374|NCT00869115|Inotropes|inotropes
5607375|NCT00869115|Lusitropic agents|lusitropic agents
5607376|NCT00869115|Istaroxime|istaroxime
5607377|NCT00869115|Debio 0614|debio 0614
5607379|NCT00869102|IFG|ifg
5607380|NCT00869089|PN|pn
5607381|NCT00869076|Diabetes Mellitus|diabetes mellitus
5607382|NCT00869076|Pharmacist|pharmacist
5607383|NCT00869063|wrist|wrist
5607384|NCT00869063|sprain|sprain
5607385|NCT00869063|strain|strain
5607386|NCT00869063|contusion|contusion
5607387|NCT00869063|diclofenac|diclofenac
5607388|NCT00869063|patch|patch
5607389|NCT00869063|acute pain|acute pain
5607390|NCT00869063|acute pain due to mild to moderate wrist sprain, strain or contusion|acute pain due to mild to moderate wrist sprain, strain or contusion
5607391|NCT00869050|Pancreatic cancer|pancreatic cancer
5607392|NCT00869050|Neuroendocrine tumors|neuroendocrine tumors
5607393|NCT00869050|Carcinoid tumors|carcinoid tumors
5607394|NCT00869050|Pheochromocytomas|pheochromocytomas
5607395|NCT00869050|Gastrinomas|gastrinomas
5607396|NCT00869050|Zollinger-Ellison syndrome|zollinger-ellison syndrome
5607397|NCT00869050|MEN Type I/II|men type i/ii
5607398|NCT00869050|Somatostatinomas|somatostatinomas
5607399|NCT00869050|VIPomas|vipomas
5607400|NCT00869050|Merkel cell tumors|merkel cell tumors
5607401|NCT00869050|medullary thyroid carcinoma|medullary thyroid carcinoma
5607402|NCT00869037|Randomized controlled study|randomized controlled study
5607403|NCT00869037|Total knee arthroplasty|total knee arthroplasty
5607404|NCT00869037|Post operative pain|post operative pain
5607405|NCT00869037|Continuous Femoral Nerve Block|continuous femoral nerve block
5607406|NCT00869037|Posterior Capsular injection|posterior capsular injection
5607407|NCT00869037|Periarticular injection|periarticular injection
5607409|NCT00869024|Left ventricular assist device|left ventricular assist device
5607410|NCT00869024|Stem cells|stem cells
5607411|NCT00869011|Cancer|cancer
5607412|NCT00869011|renal cell carcinoma|renal cell carcinoma
5607413|NCT00869011|fatigue|fatigue
5607414|NCT00869011|exercise|exercise
5607415|NCT00868998|Biliary Cancer|biliary cancer
5607416|NCT00868972|Renal Artery Obstruction|renal artery obstruction
5607417|NCT00868972|renovascular hypertension|renovascular hypertension
5607418|NCT00868972|stent|stent
5607419|NCT00868972|Kidney Failure|kidney failure
5607420|NCT00868972|embolic protection|embolic protection
5607422|NCT00868959|Depression|depression
5607423|NCT00868959|Lurasidone|lurasidone
5607424|NCT00868959|Latuda|latuda
5607425|NCT00868946|Ribavirin|ribavirin
5607426|NCT00868946|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
5607427|NCT00868946|Dobrava Virus|dobrava virus
5607428|NCT00868946|Puumala Virus|puumala virus
5607429|NCT00868881|Hypertension|hypertension
5607430|NCT00868881|Therapeutic diagnostic attitude|therapeutic diagnostic attitude
5607431|NCT00868881|Blood pressure|blood pressure
5607432|NCT00868868|Pedometer|pedometer
5607433|NCT00868868|Prostate|prostate
5607434|NCT00868868|Cancer|cancer
5607435|NCT00868868|Hormonotherapy|hormonotherapy
5607436|NCT00868868|Exercise|exercise
5607437|NCT00868855|Coronary Artery Disease|coronary artery disease
5607438|NCT00868842|Penicillin|penicillin
5607439|NCT00868842|Allergy|allergy
5607440|NCT00868842|Prevention|prevention
5607441|NCT00868842|Anaphylaxis|anaphylaxis
5607442|NCT00868842|Clinically proven history of penicillin allergy|clinically proven history of penicillin allergy
5607443|NCT00868842|preventing anaphylaxis|preventing anaphylaxis
5607444|NCT00868829|Stent|stent
5607445|NCT00868829|FireBird2|firebird2
5607446|NCT00868829|Coronary Heart Disease|coronary heart disease
5607447|NCT00868816|oxaliplatine|oxaliplatine
5607448|NCT00868816|colorectal cancer|colorectal cancer
5607449|NCT00868816|chemotherapy|chemotherapy
5607450|NCT00868803|prostate cancer|prostate cancer
5607451|NCT00868777|Implant site development|implant site development
5607452|NCT00868777|Bone grafting|bone grafting
5607453|NCT00868777|Dental implants|dental implants
5607454|NCT00868764|Effect of age|effect of age
5607455|NCT00868764|Effect of body fat|effect of body fat
5607456|NCT00868764|Granisetron|granisetron
5607457|NCT00868764|Pharmacokinetic profile|pharmacokinetic profile
5607458|NCT00868764|Sancuso® patch|sancuso® patch
5607459|NCT00868764|Transdermal|transdermal
5607460|NCT00868751|Antibodies, Monoclonal|antibodies, monoclonal
5607461|NCT00868751|Interleukin 6|interleukin 6
5607462|NCT00868738|Calcium|calcium
5607463|NCT00868738|Vitamin D|vitamin d
5607464|NCT00868738|Magnesium|magnesium
5607465|NCT00868738|Zinc|zinc
5607466|NCT00868725|oral cavity|oral cavity
5607467|NCT00868725|carcinoma|carcinoma
5607468|NCT00868725|thermal imaging|thermal imaging
5607469|NCT00868712|coronary calcification|coronary calcification
5607470|NCT00868712|vitamin K dependent proteins|vitamin k dependent proteins
5607471|NCT00868712|warfarin|warfarin
5607472|NCT00868699|Bipolar I, Depression|bipolar i, depression
5607473|NCT00868673|Role of Fructose in overweight and obesity|role of fructose in overweight and obesity
5607474|NCT00868673|Fructose and metabolic syndrome|fructose and metabolic syndrome
5607476|NCT00868673|Effects of fructose in blood pressure and hypertension|effects of fructose in blood pressure and hypertension
5607477|NCT00868673|Somatometry changes observed in fructose diets|somatometry changes observed in fructose diets
5607478|NCT00868673|Fructose induced overweight and obesity|fructose induced overweight and obesity
5607479|NCT00868673|Fructose induced metabolic syndrome|fructose induced metabolic syndrome
5607480|NCT00868673|Fructose induced hyperuricemia|fructose induced hyperuricemia
5607481|NCT00868608|Refractory Indolent NHL|refractory indolent nhl
5607482|NCT00868608|lymphoma|lymphoma
5607483|NCT00868582|Patients with proven or suspected cancer referred for NaF-18 PET to identify bone metastasis|patients with proven or suspected cancer referred for naf-18 pet to identify bone metastasis
5607484|NCT00868569|liver metastasis|liver metastasis
5607485|NCT00868569|colorectal cancer|colorectal cancer
5607486|NCT00868569|oxaliplatine|oxaliplatine
5607487|NCT00868569|transartery chemotherapy|transartery chemotherapy
5607488|NCT00868569|embolision|embolision
5607489|NCT00868569|Unresectable Liver Metastasis of Colorectal Cancer|unresectable liver metastasis of colorectal cancer
5607490|NCT00868556|fMRI scans|fmri scans
5607491|NCT00868556|episodic migraine sufferers|episodic migraine sufferers
5607492|NCT00868556|chronic migraine sufferers|chronic migraine sufferers
5607496|NCT00868543|superobese|superobese
5607497|NCT00868530|On-demand treatment; Hemostatic Efficacy Assessments; Factor VIII recovery; Factor VIII Inhibitor; Chinese|on-demand treatment; hemostatic efficacy assessments; factor viii recovery; factor viii inhibitor; chinese
5607498|NCT00868517|Veterans|veterans
5607499|NCT00868517|Operation Iraqi Freedom|operation iraqi freedom
5607500|NCT00868517|Operation Enduring Freedom|operation enduring freedom
5607501|NCT00868517|Combat Disorders|combat disorders
5607502|NCT00868517|Acupuncture|acupuncture
5607503|NCT00868517|Complementary Therapies|complementary therapies
5607504|NCT00868504|GI tract|gi tract
5607505|NCT00868504|Tumors|tumors
5607506|NCT00868504|Temperatures|temperatures
5607507|NCT00868491|head and neck cancer|head and neck cancer
5607508|NCT00868491|inoperable|inoperable
5607509|NCT00868491|induction chemotherapy|induction chemotherapy
5607510|NCT00868491|concomitant radiochemotherapy|concomitant radiochemotherapy
5607511|NCT00868491|biological agent|biological agent
5607512|NCT00868491|efficacy|efficacy
5607513|NCT00868491|toxicity|toxicity
5607514|NCT00868478|humanized monoclonal antibody|humanized monoclonal antibody
5607515|NCT00868452|Bipolar I|bipolar i
5607516|NCT00868452|Latuda|latuda
5607517|NCT00868452|Lurasidone|lurasidone
5607519|NCT00868439|Heart failure|heart failure
5607520|NCT00868439|hyperkalemia|hyperkalemia
5607521|NCT00868439|chronic kidney disease|chronic kidney disease
5607522|NCT00868439|prevention of hyperkalemia in heart failure participants|prevention of hyperkalemia in heart failure participants
5607523|NCT00868426|Healthy volunteer study|healthy volunteer study
5607524|NCT00868400|Preoperative care|preoperative care
5607525|NCT00868400|colorectal surgery|colorectal surgery
5607526|NCT00868400|carbohydrate|carbohydrate
5607527|NCT00868400|fasting|fasting
5607528|NCT00868387|weight reduction|weight reduction
5607529|NCT00868387|low-carbohydrate|low-carbohydrate
5607530|NCT00868387|body fat|body fat
5607531|NCT00868387|telemedicine|telemedicine
5607532|NCT00868387|cardiovascular risk markers|cardiovascular risk markers
5607533|NCT00868361|Mass Balance|mass balance
5607534|NCT00868361|Talampanel|talampanel
5607535|NCT00868361|Pharmacokinetics|pharmacokinetics
5607536|NCT00868361|Metabolism|metabolism
5607537|NCT00868361|Metabolites|metabolites
5607538|NCT00868361|Healthy Volunteers|healthy volunteers
5607539|NCT00868348|Total Knee Arthroplasty|total knee arthroplasty
5607540|NCT00868335|Cervical degenerative disc disease|cervical degenerative disc disease
5607541|NCT00868335|Anterior cervical discectomy|anterior cervical discectomy
5607542|NCT00868335|Cervical disc prosthesis|cervical disc prosthesis
5607543|NCT00868335|Activ-C|activ-c
5607544|NCT00868335|Mobility|mobility
5607545|NCT00868335|Movement|movement
5607546|NCT00868309|Snake Bite|snake bite
5607547|NCT00868309|Venom and antivenom kinetics|venom and antivenom kinetics
5607548|NCT00868296|Safety|safety
5607549|NCT00868257|AIDS|aids
5607550|NCT00868257|Adherence to Antiretroviral Therapy|adherence to antiretroviral therapy
5607551|NCT00868257|Pediatric|pediatric
5607552|NCT00868257|Resource Limited Setting|resource limited setting
5607553|NCT00868257|Treatment experienced|treatment experienced
5607554|NCT00868244|facial patterns|facial patterns
5607555|NCT00868244|bruxism|bruxism
5607556|NCT00868244|masticatory muscles|masticatory muscles
5607557|NCT00868231|COPD|copd
5607558|NCT00868231|Antimuscarinic|antimuscarinic
5607559|NCT00868218|Influenza A|influenza a
5607560|NCT00868218|pandemic|pandemic
5607561|NCT00868218|vaccine|vaccine
5607562|NCT00868218|immunogenicity|immunogenicity
5607563|NCT00868218|Virus|virus
5607564|NCT00868218|H5N1|h5n1
5607565|NCT00868205|oxidative stress|oxidative stress
5607566|NCT00868205|Comet assay|comet assay
5607567|NCT00868205|antioxidants|antioxidants
5607568|NCT00868179|Thrombosis|thrombosis
5601494|NCT00891865|BOS|bos
5607569|NCT00868179|total knee replacement|total knee replacement
5607573|NCT00868127|Hyperlipidemia|hyperlipidemia
5607574|NCT00868127|Drug Therapy|drug therapy
5607575|NCT00868127|Dyslipidemia|dyslipidemia
5607576|NCT00868114|Inoperable pancreatic cancer|inoperable pancreatic cancer
5607577|NCT00868114|Dendritic Cell Vaccine|dendritic cell vaccine
5607578|NCT00868114|Locally advanced or low volume metatstatic pancreatic cancer|locally advanced or low volume metatstatic pancreatic cancer
5607579|NCT00868101|ischemic|ischemic
5607580|NCT00868101|preconditioning|preconditioning
5607581|NCT00868101|congenital heart disease|congenital heart disease
5607582|NCT00868088|AC|ac
5607583|NCT00868088|SCC|scc
5607584|NCT00868088|SCC-is|scc-is
5607585|NCT00868088|PDT|pdt
5607586|NCT00868088|Mohs|mohs
5607587|NCT00868075|Physiotherapy|physiotherapy
5607588|NCT00868075|Rehabilitation|rehabilitation
5607589|NCT00868075|Bronchiectasis|bronchiectasis
5607689|NCT00867737|Asthma|asthma
5607690|NCT00867737|Forced Oscillation|forced oscillation
5607691|NCT00867737|Impulse Oscillometry|impulse oscillometry
5671700|NCT00614731|Keyhole Limpet Hemocyanin|keyhole limpet hemocyanin
5680365|NCT00578019|Supracondylar Femur Fracture|supracondylar femur fracture
5680366|NCT00578019|Intramedullary nailing|intramedullary nailing
5607590|NCT00868062|The responses of patients to 1L infusions of Gelofusine (succinylated gelatine 40g/L) and Voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.|the responses of patients to 1l infusions of gelofusine (succinylated gelatine 40g/l) and voluven (6% hydroxyethyl starch in 0.9% saline) intraoperatively.
5607591|NCT00868049|chewing|chewing
5607592|NCT00868049|deglutition|deglutition
5607593|NCT00868049|orofacial motricity|orofacial motricity
5607594|NCT00868049|obesity|obesity
5607595|NCT00868036|urticaria|urticaria
5607596|NCT00868036|hives|hives
5607597|NCT00868036|dermatitis|dermatitis
5607598|NCT00868036|rash|rash
5607599|NCT00868036|contact dermatitis|contact dermatitis
5607600|NCT00868036|contact|contact
5607601|NCT00868036|contact sensitization|contact sensitization
5607602|NCT00868036|allergy|allergy
5607603|NCT00868036|allergen|allergen
5607604|NCT00868036|patch testing|patch testing
5607605|NCT00868036|IgG|igg
5607606|NCT00868036|delayed-hypersensitivity reaction|delayed-hypersensitivity reaction
5607607|NCT00868036|hypersensitivity|hypersensitivity
5607608|NCT00868010|stroke|stroke
5607609|NCT00868010|donepezil|donepezil
5607610|NCT00868010|recovery|recovery
5607611|NCT00867997|Noncarious Cervical Lesions|noncarious cervical lesions
5607612|NCT00867997|Hypersensitivity|hypersensitivity
5607613|NCT00867997|Teeth|teeth
5607614|NCT00867997|Dentistry|dentistry
5607615|NCT00867997|Practice-based research network|practice-based research network
5607616|NCT00867984|CRT, resynchronization,|crt, resynchronization,
5607617|NCT00867958|Colon Anastomosis|colon anastomosis
5607618|NCT00867958|Rectum Anastomosis|rectum anastomosis
5607619|NCT00867958|Intestine|intestine
5607620|NCT00867958|Colorectal Surgery|colorectal surgery
5607621|NCT00867958|Colorectal Anastomosis|colorectal anastomosis
5607622|NCT00867932|Alexion|alexion
5607623|NCT00867932|Eculizumab|eculizumab
5607624|NCT00867932|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5607625|NCT00867932|PNH|pnh
5607626|NCT00867932|Soliris|soliris
5607627|NCT00867906|Cat allergy|cat allergy
5607628|NCT00867906|Immunotherapy|immunotherapy
5607629|NCT00867906|Cat-PAD|cat-pad
5607630|NCT00867880|To evaluate the Pharmacokinetic Profile of IVIb|to evaluate the pharmacokinetic profile of ivib
5607631|NCT00867867|Iron deficiency anemia|iron deficiency anemia
5607632|NCT00867867|Helicobacter pylori|helicobacter pylori
5607633|NCT00867867|Iron absorption|iron absorption
5607634|NCT00867867|Iron fortification|iron fortification
5607635|NCT00867867|ferrous sulphate|ferrous sulphate
5607636|NCT00867867|ferrous fumarate|ferrous fumarate
5607637|NCT00867854|de-intensification|de-intensification
5607638|NCT00867854|HAART|haart
5607639|NCT00867854|monotherapy|monotherapy
5701818|NCT00495651|Early Intervention|early intervention
5607640|NCT00867854|persistent low-level viremia (LLV)|persistent low-level viremia (llv)
5607641|NCT00867854|treatment experienced|treatment experienced
5607642|NCT00867841|pneumonia, community-acquired|pneumonia, community-acquired
5607643|NCT00867841|polymerase chain reaction|polymerase chain reaction
5607644|NCT00867841|pneumococcus|pneumococcus
5607645|NCT00867841|mycoplasma|mycoplasma
5607646|NCT00867841|chlamydophila|chlamydophila
5607647|NCT00867841|anti-bacterial agents|anti-bacterial agents
5607648|NCT00867828|Decline of global cognitive function|decline of global cognitive function
5607649|NCT00867828|Neuropsychological Test Battery (NTB)|neuropsychological test battery (ntb)
5607650|NCT00867828|Early stage Alzheimer's disease|early stage alzheimer's disease
5607651|NCT00867815|Non-arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5607652|NCT00867815|NAION|naion
5607653|NCT00867815|PDE5 inhibitors|pde5 inhibitors
5607654|NCT00867815|vardenafil|vardenafil
5607655|NCT00867815|Levitra|levitra
5607656|NCT00867815|sildenafil|sildenafil
5607657|NCT00867815|Viagra|viagra
5607658|NCT00867815|Tadalafil|tadalafil
5607659|NCT00867815|Cialis|cialis
5607660|NCT00867815|acute vision loss|acute vision loss
5607661|NCT00867815|vision loss|vision loss
5607662|NCT00867815|blurred vision|blurred vision
5607663|NCT00867815|optic neuropathy|optic neuropathy
5607664|NCT00867815|erectile dysfunction.|erectile dysfunction.
5607665|NCT00867802|MICAS|micas
5607666|NCT00867802|MBSR|mbsr
5607667|NCT00867789|abscess|abscess
5607668|NCT00867789|outcomes|outcomes
5607669|NCT00867789|antibiotics|antibiotics
5607670|NCT00867789|incision and drainage|incision and drainage
5607671|NCT00867789|skin abscess|skin abscess
5607672|NCT00867776|Depression|depression
5607673|NCT00867776|African Americans|african americans
5607674|NCT00867776|Exercise|exercise
5607675|NCT00867776|Culturally tailored intervention|culturally tailored intervention
5607676|NCT00867776|Health disparities|health disparities
5607677|NCT00867763|Polycystic ovaries,|polycystic ovaries,
5607678|NCT00867763|Tubal occlusion|tubal occlusion
5607679|NCT00867763|Unexplained infertility|unexplained infertility
5607680|NCT00867763|Low ovarian reserve|low ovarian reserve
5607681|NCT00867763|Male factor infertility|male factor infertility
5607682|NCT00867750|HCC|hcc
5607683|NCT00867750|RE|re
5607684|NCT00867750|Yttrium-90|yttrium-90
5607685|NCT00867750|SIR-Spheres microspheres|sir-spheres microspheres
5607686|NCT00867750|TACE|tace
5607687|NCT00867750|Radioembolisation|radioembolisation
5607688|NCT00867750|Transarterial Chemoembolisation|transarterial chemoembolisation
5607696|NCT00867698|HE|he
5607697|NCT00867698|MHE|mhe
5607698|NCT00867698|Cognitive impairment|cognitive impairment
5607699|NCT00867698|Cognitive dysfunction|cognitive dysfunction
5607700|NCT00867698|Liver Disease|liver disease
5607701|NCT00867698|Cirrhosis|cirrhosis
5607702|NCT00867685|Healthy Volunteers|healthy volunteers
5607703|NCT00867672|Acute Myeloid Leukemia|acute myeloid leukemia
5607704|NCT00867672|Low-dose Decitabine|low-dose decitabine
5607705|NCT00867672|Valproic acid|valproic acid
5607706|NCT00867672|All-trans retinoic acid|all-trans retinoic acid
5607707|NCT00867672|Older Patients|older patients
5607708|NCT00867659|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5607709|NCT00867659|cetrotide acetate|cetrotide acetate
5607710|NCT00867659|GnRH antagonist|gnrh antagonist
5607711|NCT00867659|oocyte donors|oocyte donors
5607712|NCT00867646|PT|pt
5607713|NCT00867646|DVT|dvt
5607714|NCT00867633|urothelial carinoma|urothelial carinoma
5607715|NCT00867633|aristolochic acid|aristolochic acid
5607716|NCT00867633|DNA|dna
5607717|NCT00867633|adduct|adduct
5607718|NCT00867607|Contact dermatitis|contact dermatitis
5607719|NCT00867607|Eczema|eczema
5607720|NCT00867581|middle cerebral artery|middle cerebral artery
5607721|NCT00867581|infarction|infarction
5607722|NCT00867581|chronic stage|chronic stage
5607723|NCT00867581|hippocampal volume|hippocampal volume
5607724|NCT00867581|MRI|mri
5607725|NCT00867581|MRS|mrs
5607726|NCT00867581|neuropsychologic assessment|neuropsychologic assessment
5607727|NCT00867568|Relapsed Neuroblastoma|relapsed neuroblastoma
5607728|NCT00867568|Refractory Neuroblastoma|refractory neuroblastoma
5607729|NCT00867568|Relapsed Medulloblastoma|relapsed medulloblastoma
5607730|NCT00867568|Refractory Medulloblastoma|refractory medulloblastoma
5607731|NCT00867542|past IUGR|past iugr
5607732|NCT00867542|ECC|ecc
5607733|NCT00867542|oral findings in children with past IUGR|oral findings in children with past iugr
5607734|NCT00867503|ovarian cancer|ovarian cancer
5607735|NCT00867503|bendamustine|bendamustine
5607736|NCT00867490|Hypertension|hypertension
5607737|NCT00867490|aliskiren|aliskiren
5607738|NCT00867490|cardiovascular diseases|cardiovascular diseases
5607739|NCT00867477|Cancer of esophagus|cancer of esophagus
5607740|NCT00867477|Gastrointestine|gastrointestine
5607741|NCT00867477|esophagus cancer|esophagus cancer
5607742|NCT00867477|Positron emission tomography|positron emission tomography
5607743|NCT00867477|PET scan|pet scan
5607744|NCT00867477|Nitric oxide|nitric oxide
5607745|NCT00867477|NO|no
5607746|NCT00867477|NO Breathing Test|no breathing test
5607747|NCT00867477|Respiratory symptoms questionnaire|respiratory symptoms questionnaire
5607754|NCT00867451|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5607755|NCT00867438|ulcerative colitis|ulcerative colitis
5607756|NCT00867438|Left-sided, mild to moderate ulcerative colitis|left-sided, mild to moderate ulcerative colitis
5607757|NCT00867425|Diabetes|diabetes
5607758|NCT00867425|Internet|internet
5607759|NCT00867425|Obesity|obesity
5607760|NCT00867425|Obesity with high cardiovascular risks|obesity with high cardiovascular risks
5607761|NCT00867412|NSCLC|nsclc
5607762|NCT00867412|PET/CT|pet/ct
5607763|NCT00867412|Surgery|surgery
5607764|NCT00867412|FDG|fdg
5607765|NCT00867412|staging|staging
5607766|NCT00867373|Obesity|obesity
5607767|NCT00867373|Weight perceptions|weight perceptions
5607768|NCT00867347|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5607769|NCT00867347|stage II bladder cancer|stage ii bladder cancer
5607770|NCT00867347|stage III bladder cancer|stage iii bladder cancer
5607771|NCT00867334|colorectal neoplasm|colorectal neoplasm
5607772|NCT00867334|colorectal cancer|colorectal cancer
5607773|NCT00867334|imatinib mesylate|imatinib mesylate
5607774|NCT00867334|Gleevec|gleevec
5607775|NCT00867334|Physiological Effects of Drugs|physiological effects of drugs
5607776|NCT00867334|panitumumab|panitumumab
5607777|NCT00867334|Vectibix|vectibix
5607778|NCT00867334|c-kit receptor|c-kit receptor
5607780|NCT00867334|Platelet-Derived Growth Factor alpha|platelet-derived growth factor alpha
5607781|NCT00867321|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5607782|NCT00867321|advanced adult primary liver cancer|advanced adult primary liver cancer
5607783|NCT00867321|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5607784|NCT00867321|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5607786|NCT00867308|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5607787|NCT00867308|MDS)|mds)
5607788|NCT00867308|5q31.1 deletions|5q31.1 deletions
5607789|NCT00867295|implantable catheters|implantable catheters
5607795|NCT00867295|totally implantable venous access device|totally implantable venous access device
5607802|NCT00867256|arthritis|arthritis
5607803|NCT00867243|Hepatitis C virus|hepatitis c virus
5607804|NCT00867243|HCV|hcv
5607805|NCT00867243|Hepatitis C (and cirrhosis)|hepatitis c (and cirrhosis)
5607806|NCT00867243|Liver cirrhosis not due to HCV infection|liver cirrhosis not due to hcv infection
5607807|NCT00867230|Myelodysplastic Syndrome|myelodysplastic syndrome
5671701|NCT00614731|KLH|klh
5607808|NCT00867230|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5607809|NCT00867230|Acute Myeloid Leukemia|acute myeloid leukemia
5607810|NCT00867230|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5607811|NCT00867230|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5607812|NCT00867230|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5607813|NCT00867230|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5607814|NCT00867230|FTS|fts
5607815|NCT00867230|S-Trans, Trans-Farnesylthiosalicylic Acid|s-trans, trans-farnesylthiosalicylic acid
5607816|NCT00867204|ERCP|ercp
5607817|NCT00867204|Study focus was to compare the performance of the ERCP short-wire device versus the Long-wire device.|study focus was to compare the performance of the ercp short-wire device versus the long-wire device.
5798761|NCT00111163|Plasmodium falciparum|plasmodium falciparum
5607818|NCT00867165|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5607819|NCT00867165|nonfamilial hypercholesterolemia|nonfamilial hypercholesterolemia
5607820|NCT00867152|ritonavir|ritonavir
5607821|NCT00867152|GSK1349572|gsk1349572
5607822|NCT00867152|integrase|integrase
5607823|NCT00867152|lopinavir|lopinavir
5607824|NCT00867152|darunavir|darunavir
5607825|NCT00867152|etravirine|etravirine
5607826|NCT00867139|Influenza|influenza
5607827|NCT00867139|Immunocompromised|immunocompromised
5607828|NCT00867139|Antiviral|antiviral
5607829|NCT00867126|stage IV pancreatic cancer|stage iv pancreatic cancer
5607830|NCT00867126|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5607831|NCT00867126|recurrent pancreatic cancer|recurrent pancreatic cancer
5607832|NCT00867113|Imatinib|imatinib
5607833|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors
5607834|NCT00867113|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5607835|NCT00867113|Digestive System Diseases|digestive system diseases
5607836|NCT00867113|Digestive System Neoplasms|digestive system neoplasms
5607837|NCT00867113|Gastrointestinal Diseases|gastrointestinal diseases
5607838|NCT00867113|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5607839|NCT00867113|Adjuvant|adjuvant
5607840|NCT00867113|PERSIST|persist
5607841|NCT00867113|PERSIS-5|persis-5
5607842|NCT00867087|Diffuse large b-cell lymphoma|diffuse large b-cell lymphoma
5607843|NCT00867087|inotuzumab ozogamicin|inotuzumab ozogamicin
5607844|NCT00867087|autologous stem cell transplant|autologous stem cell transplant
5607845|NCT00867061|Myelodysplastic|myelodysplastic
5607846|NCT00867061|IPSS Intermediate 1|ipss intermediate 1
5607847|NCT00867061|IPSS Intermediate 2|ipss intermediate 2
5607848|NCT00867061|IPSS High risk|ipss high risk
5607849|NCT00867048|highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5607850|NCT00867048|CD4 Count|cd4 count
5607851|NCT00867048|Early Intervention|early intervention
5607852|NCT00867048|HIV|hiv
5607853|NCT00867048|HIV Infection|hiv infection
5607854|NCT00867048|HIV Infections|hiv infections
5607855|NCT00867048|treatment naive|treatment naive
5590625|NCT00928213|GH|gh
5607856|NCT00867022|Inflammatory factors|inflammatory factors
5607857|NCT00867022|Coagulation factors|coagulation factors
5607858|NCT00867022|Sympathetic activity|sympathetic activity
5607859|NCT00866996|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5607860|NCT00866996|Methylphenidate|methylphenidate
5607861|NCT00866996|Atomoxetine|atomoxetine
5607862|NCT00866996|Concerta|concerta
5607863|NCT00866983|Open label|open label
5607864|NCT00866983|sildenafil|sildenafil
5607865|NCT00866983|PAH|pah
5607866|NCT00866983|Brazil|brazil
5607867|NCT00866970|Lung Cancer|lung cancer
5607868|NCT00866970|Fatigue|fatigue
5607869|NCT00866970|Cachexia|cachexia
5607870|NCT00866944|Colorectal carcinoma|colorectal carcinoma
5607871|NCT00866944|Liver metastases (only)|liver metastases (only)
5607872|NCT00866944|R0 resection|r0 resection
5607873|NCT00866944|R0 resection of liver metastases from colorectal cancer|r0 resection of liver metastases from colorectal cancer
5607874|NCT00866905|Breast Cancer|breast cancer
5607875|NCT00866905|Ixabepilone|ixabepilone
5607876|NCT00866905|Ixempra|ixempra
5607879|NCT00866905|Neoadjuvant Therapy|neoadjuvant therapy
5607880|NCT00866879|Sirolimus|sirolimus
5607881|NCT00866879|Rapamune|rapamune
5607882|NCT00866879|Immunosuppression|immunosuppression
5607883|NCT00866879|Renal allograft function|renal allograft function
5607884|NCT00866879|Lymphocytes function|lymphocytes function
5607885|NCT00866853|TMC435350|tmc435350
5607886|NCT00866853|HCV|hcv
5607887|NCT00866853|Hepatitis C|hepatitis c
5607888|NCT00866853|TMC435|tmc435
5607889|NCT00866853|protease inhibitor|protease inhibitor
5607890|NCT00866853|CYP|cyp
5607891|NCT00866853|Cooperstown 5+1 cocktail|cooperstown 5+1 cocktail
5607892|NCT00866840|stage III melanoma|stage iii melanoma
5607893|NCT00866840|stage IV melanoma|stage iv melanoma
5607894|NCT00866840|recurrent melanoma|recurrent melanoma
5607895|NCT00866827|Airway|airway
5607896|NCT00866827|Hemangiomas|hemangiomas
5607897|NCT00866827|Venous Malformations|venous malformations
5607898|NCT00866827|Lymphatic Malformations|lymphatic malformations
5607899|NCT00866814|hernia|hernia
5607900|NCT00866814|open|open
5607901|NCT00866801|coronary blood flow|coronary blood flow
5607902|NCT00866801|coronary flow reserve|coronary flow reserve
5607903|NCT00866801|cardiac sympathetic innervation|cardiac sympathetic innervation
5607904|NCT00866801|general anesthesia|general anesthesia
5607905|NCT00866801|thoracic epidural|thoracic epidural
5607906|NCT00866801|autonomic dysfunction|autonomic dysfunction
5607907|NCT00866801|autonomic neuropathy|autonomic neuropathy
5607908|NCT00866788|Xolair|xolair
5607909|NCT00866788|CIU|ciu
5607910|NCT00866775|Seizure|seizure
5607911|NCT00866775|Epilepsy|epilepsy
5607912|NCT00866775|Anticonvulsant|anticonvulsant
5607913|NCT00866775|Historical Control|historical control
5607914|NCT00866775|Monotherapy|monotherapy
5607915|NCT00866762|Polycythaemia Vera|polycythaemia vera
5607916|NCT00866762|Polycythemia Vera|polycythemia vera
5607917|NCT00866762|Essential Thrombocythaemia|essential thrombocythaemia
5607918|NCT00866762|Essential Thrombocythemia|essential thrombocythemia
5607919|NCT00866762|HDAC-inhibitor|hdac-inhibitor
5607920|NCT00866762|Haematology|haematology
5607921|NCT00866762|Hematology|hematology
5607922|NCT00866762|Haematological disorder|haematological disorder
5607923|NCT00866762|Haematological disease|haematological disease
5607924|NCT00866762|Hematological disorder|hematological disorder
5607925|NCT00866762|Hematological disease|hematological disease
5607926|NCT00866749|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5607927|NCT00866749|acute lymphoblastic lymphoma|acute lymphoblastic lymphoma
5607928|NCT00866749|Leukemia|leukemia
5607929|NCT00866749|ALL|all
5607930|NCT00866749|6-Thioguanine|6-thioguanine
5607931|NCT00866749|Cyclophosphamide|cyclophosphamide
5607932|NCT00866749|Cytarabine|cytarabine
5607933|NCT00866749|Daunorubicin|daunorubicin
5607934|NCT00866749|Doxorubicin|doxorubicin
5607935|NCT00866749|Methotrexate|methotrexate
5607936|NCT00866749|PEG-L-Asparaginase|peg-l-asparaginase
5607937|NCT00866749|Vincristine|vincristine
5607938|NCT00866749|Intrathecal Methotrexate|intrathecal methotrexate
5607939|NCT00866749|Mercaptopurine|mercaptopurine
5607940|NCT00866736|chronic myeloid leukemia|chronic myeloid leukemia
5607941|NCT00866736|dasatinib|dasatinib
5607942|NCT00866736|chronic phase myeloid leukemia|chronic phase myeloid leukemia
5607943|NCT00866723|Avastin|avastin
5607944|NCT00866723|bevacizumab|bevacizumab
5607945|NCT00866697|fallopian tube cancer|fallopian tube cancer
5607946|NCT00866697|pazopanib|pazopanib
5607947|NCT00866697|anti-angiogenesis|anti-angiogenesis
5607948|NCT00866697|ovarian cancer|ovarian cancer
5607949|NCT00866697|primary peritoneal cancer|primary peritoneal cancer
5607950|NCT00866697|tyrosine kinase inhibitors|tyrosine kinase inhibitors
5607951|NCT00866697|gynecologic cancer|gynecologic cancer
5607952|NCT00866684|renal transplant-patients with high-risk for skin cancer|renal transplant-patients with high-risk for skin cancer
5607954|NCT00866671|Safety|safety
5607955|NCT00866671|Post Authorisation Safety Study|post authorisation safety study
5607956|NCT00866671|T-LBL|t-lbl
5607957|NCT00866671|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5607958|NCT00866671|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5607959|NCT00866658|hyperglycemia|hyperglycemia
5607960|NCT00866658|GLP-1|glp-1
5607961|NCT00866658|sulfonylurea|sulfonylurea
5607962|NCT00866658|insulin|insulin
5607963|NCT00866645|Agitation|agitation
5607964|NCT00866645|Schizophrenia|schizophrenia
5607965|NCT00866645|Randomized|randomized
5607966|NCT00866645|Blind|blind
5607967|NCT00866645|Parallel|parallel
5607968|NCT00866645|Intramuscular Haloperidol|intramuscular haloperidol
5607969|NCT00866645|Controlled|controlled
5607970|NCT00866645|Multicenter|multicenter
5607971|NCT00866645|Clinical Trial|clinical trial
5607972|NCT00866645|Efficacy|efficacy
5607973|NCT00866645|Safety|safety
5607974|NCT00866645|Intramuscular Levosulpiride|intramuscular levosulpiride
5607975|NCT00866645|Chinese|chinese
5607976|NCT00866645|PANSS-EC|panss-ec
5607977|NCT00866645|ACES|aces
5607978|NCT00866645|CGI|cgi
5607979|NCT00866645|BPRS|bprs
5607980|NCT00866645|PANSS|panss
5607981|NCT00866645|RSESE|rsese
5607982|NCT00866645|BAS|bas
5607983|NCT00866632|Depression|depression
5607984|NCT00866632|Anxiety|anxiety
5607985|NCT00866632|Brain Injury|brain injury
5607986|NCT00866632|Cognitive Therapy|cognitive therapy
5608184|NCT00866034|ICSI|icsi
5607987|NCT00866632|Coping Skills|coping skills
5607988|NCT00866606|On-demand treatment|on-demand treatment
5607989|NCT00866606|Hemostatic efficacy|hemostatic efficacy
5607990|NCT00866606|Factor IX activity|factor ix activity
5607991|NCT00866606|Factor IX recovery|factor ix recovery
5607992|NCT00866606|Factor IX inhibitor|factor ix inhibitor
5607993|NCT00866606|Chinese|chinese
5607994|NCT00866593|major depressive disorder(MDD)|major depressive disorder(mdd)
5607995|NCT00866593|depression|depression
5607996|NCT00866593|antidepressant|antidepressant
5607997|NCT00866593|escitalpram oxalate|escitalpram oxalate
5607998|NCT00866593|generic|generic
5608000|NCT00866593|Lexapro|lexapro
5608001|NCT00866593|efficacy|efficacy
5608002|NCT00866593|safety|safety
5608003|NCT00866593|multicenter|multicenter
5608004|NCT00866593|double-blind|double-blind
5608005|NCT00866593|randomized|randomized
5608006|NCT00866593|chinese|chinese
5608007|NCT00866593|HAMD|hamd
5608008|NCT00866593|MADRS|madrs
5608009|NCT00866593|HAMA|hama
5608010|NCT00866593|VAS-PI|vas-pi
5608012|NCT00866593|CGI|cgi
5608013|NCT00866580|Pandemic influenza|pandemic influenza
5608014|NCT00866567|prematurity|prematurity
5608015|NCT00866567|VLBW|vlbw
5608016|NCT00866567|sepsis|sepsis
5608017|NCT00866567|innate immunity|innate immunity
5608018|NCT00866554|Prostate|prostate
5608019|NCT00866554|Brachytherapy|brachytherapy
5608020|NCT00866554|Cytoreduction|cytoreduction
5608021|NCT00866554|Sexual function|sexual function
5608022|NCT00866554|Toxicity|toxicity
5608023|NCT00866541|resistance|resistance
5798762|NCT00111163|infants|infants
5608025|NCT00866541|pressure support ventilation|pressure support ventilation
5608027|NCT00866541|assistant breathing|assistant breathing
5608028|NCT00866541|breathing comfort and objective breathing data|breathing comfort and objective breathing data
5608029|NCT00866528|paclitaxel|paclitaxel
5608030|NCT00866528|NSCLC|nsclc
5608031|NCT00866528|pazopanib|pazopanib
5608032|NCT00866528|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5608033|NCT00866528|non-small cell lung cancer|non-small cell lung cancer
5608034|NCT00866528|Advanced Solid Tumor|advanced solid tumor
5608035|NCT00866528|GW786034|gw786034
5608036|NCT00866528|Metastatic Non-Small Cell Lung Cancer|metastatic non-small cell lung cancer
5608037|NCT00866515|Healthy volunteer|healthy volunteer
5608038|NCT00866515|pharmacodynamics|pharmacodynamics
5608039|NCT00866515|Ketoconazole|ketoconazole
5608040|NCT00866515|Drug Interaction|drug interaction
5608041|NCT00866515|pharmacokinetcs|pharmacokinetcs
5608042|NCT00866515|GW642444M|gw642444m
5608043|NCT00866515|pharmacokinetics|pharmacokinetics
5608044|NCT00866502|Parkinson|parkinson
5608045|NCT00866502|Safety|safety
5608046|NCT00866502|PDGF|pdgf
5608047|NCT00866502|Intracerebroventricular|intracerebroventricular
5608048|NCT00866502|Infusion|infusion
5608049|NCT00866502|Device|device
5608050|NCT00866489|Experimental|experimental
5608051|NCT00866476|Shigella|shigella
5608052|NCT00866476|Vaccine|vaccine
5608053|NCT00866476|Mucosal immunity|mucosal immunity
5608054|NCT00866463|Sildenafil, Pharmacokinetics, Healthy Volunteer|sildenafil, pharmacokinetics, healthy volunteer
5608055|NCT00866437|PMS|pms
5608056|NCT00866437|Hormones|hormones
5608057|NCT00866437|Skin tests|skin tests
5608058|NCT00866437|Allergen Immunotherapy|allergen immunotherapy
5608059|NCT00866424|trigeminal neuralgia|trigeminal neuralgia
5608060|NCT00866424|pain|pain
5608061|NCT00866424|HBO|hbo
5608062|NCT00866424|VAS|vas
5608063|NCT00866424|MGPQ|mgpq
5608064|NCT00866411|cranial electrotherapy stimulation|cranial electrotherapy stimulation
5608065|NCT00866411|anxiety|anxiety
5608066|NCT00866411|depression|depression
5608067|NCT00866411|pain|pain
5608068|NCT00866411|sleep disturbance|sleep disturbance
5608069|NCT00866411|combat exposure|combat exposure
5608070|NCT00866411|post traumatic stress|post traumatic stress
5608071|NCT00866411|health status|health status
5608072|NCT00866411|medication use|medication use
5608073|NCT00866411|soldiers|soldiers
5608074|NCT00866398|coronary heart disease|coronary heart disease
5608075|NCT00866398|chd|chd
5608076|NCT00866398|stent|stent
5608077|NCT00866385|Healthy Volunteer|healthy volunteer
5608078|NCT00866385|AZD8566|azd8566
5608079|NCT00866385|Food Effect|food effect
5608080|NCT00866385|Microtracer|microtracer
5608081|NCT00866346|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5608082|NCT00866346|CML|cml
5608083|NCT00866346|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
5608084|NCT00866346|Bone Marrow Transplant|bone marrow transplant
5608085|NCT00866346|PR1-Specific Cytotoxic T-Lymphocyte Infusion|pr1-specific cytotoxic t-lymphocyte infusion
5608086|NCT00866333|Hodgkin's Lymphoma|hodgkin's lymphoma
5608087|NCT00866333|Relapsed Hodgkin's Lymphoma|relapsed hodgkin's lymphoma
5608088|NCT00866333|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
5608089|NCT00866320|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5608090|NCT00866320|recurrent renal cell cancer|recurrent renal cell cancer
5608091|NCT00866320|stage IV renal cell cancer|stage iv renal cell cancer
5608092|NCT00866294|Immediate-release formulation of paroxetine (paroxetine IR)|immediate-release formulation of paroxetine (paroxetine ir)
5608093|NCT00866294|HAM-D (17 items)|ham-d (17 items)
5608094|NCT00866294|Controlled-release formulation of paroxetine (paroxetine CR)|controlled-release formulation of paroxetine (paroxetine cr)
5608095|NCT00866281|Acute Myeloid Leukemia|acute myeloid leukemia
5608096|NCT00866281|AML|aml
5608097|NCT00866281|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5608098|NCT00866281|ALL|all
5608099|NCT00866281|midostaurin|midostaurin
5608100|NCT00866281|PKC412|pkc412
5608101|NCT00866281|Pediatric relapsed or refractory FLT3 positive Acute Myeloid Leukemia|pediatric relapsed or refractory flt3 positive acute myeloid leukemia
5671702|NCT00614731|atopic dermatitis|atopic dermatitis
5608102|NCT00866281|Pediatric relapsed or refractory Mixed-lineage leukemia gene rearranged Acute Lymphoblastic leukemia|pediatric relapsed or refractory mixed-lineage leukemia gene rearranged acute lymphoblastic leukemia
5608103|NCT00866268|Blood loss|blood loss
5608104|NCT00866268|Total knee arthroplasty|total knee arthroplasty
5608105|NCT00866268|Adults|adults
5608106|NCT00866268|Drain|drain
5608107|NCT00866268|Drainage system|drainage system
5608108|NCT00866255|endotracheal tube|endotracheal tube
5608109|NCT00866255|endotracheal pressure|endotracheal pressure
5608110|NCT00866255|airway pressure|airway pressure
5608111|NCT00866255|pressure drop|pressure drop
5608112|NCT00866255|calculation|calculation
5608113|NCT00866255|continuous calculation|continuous calculation
5608114|NCT00866242|Shigella|shigella
5608117|NCT00866190|Mycobacterium tuberculosis, SQ109|mycobacterium tuberculosis, sq109
5608118|NCT00866164|back pain|back pain
5608119|NCT00866164|intractable pain|intractable pain
5608120|NCT00866164|implantable infusion pump|implantable infusion pump
5608121|NCT00866164|morphine|morphine
5608122|NCT00866151|genetic biomarker|genetic biomarker
5608123|NCT00866151|biomarker|biomarker
5608124|NCT00866151|molecular diagnostics|molecular diagnostics
5608125|NCT00866151|genes|genes
5608126|NCT00866151|genetics|genetics
5608127|NCT00866151|overweight management|overweight management
5608128|NCT00866151|weight management|weight management
5608129|NCT00866151|weight reduction|weight reduction
5608130|NCT00866151|SNPs|snps
5608131|NCT00866151|single nucleotide polymorphisms|single nucleotide polymorphisms
5608132|NCT00866138|multiple myeloma|multiple myeloma
5608133|NCT00866138|t(4/14)|t(4/14)
5608134|NCT00866138|relapsing|relapsing
5608135|NCT00866138|refractory|refractory
5608136|NCT00866125|Polymyositis|polymyositis
5608137|NCT00866125|Dermatomyositis|dermatomyositis
5608138|NCT00866125|Grip force|grip force
5608139|NCT00866125|Quality of life|quality of life
5608140|NCT00866125|Activity performance|activity performance
5608141|NCT00866112|Wheelchair use|wheelchair use
5608142|NCT00866112|Spinal cord injury|spinal cord injury
5608143|NCT00866112|Multiple sclerosis|multiple sclerosis
5608144|NCT00866112|Muscular dystrophy|muscular dystrophy
5608145|NCT00866112|Cerebral palsy|cerebral palsy
5608146|NCT00866112|Spina bifida|spina bifida
5608147|NCT00866112|Amputation|amputation
5608148|NCT00866112|Arthritis|arthritis
5608149|NCT00866112|Stroke|stroke
5608150|NCT00866099|Dementia|dementia
5608151|NCT00866099|primary care|primary care
5608152|NCT00866099|early diagnosis|early diagnosis
5608153|NCT00866099|psychosocial interventions|psychosocial interventions
5608154|NCT00866099|cholinesterase inhibitors|cholinesterase inhibitors
5608155|NCT00866086|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5608156|NCT00866086|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5608157|NCT00866086|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5608158|NCT00866086|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5608159|NCT00866086|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5608160|NCT00866086|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5608161|NCT00866086|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5608162|NCT00866086|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5608163|NCT00866086|limited stage small cell lung cancer|limited stage small cell lung cancer
5608164|NCT00866086|recurrent small cell lung cancer|recurrent small cell lung cancer
5608166|NCT00866073|Acute myeloid leukemia|acute myeloid leukemia
5608167|NCT00866073|Decitabine|decitabine
5608168|NCT00866060|donepezil|donepezil
5608169|NCT00866060|memantine|memantine
5608170|NCT00866060|moderately severe Alzheimer's disease|moderately severe alzheimer's disease
5608171|NCT00866060|severe Alzheimer's disease|severe alzheimer's disease
5608172|NCT00866047|Antigens, CD30|antigens, cd30
5608173|NCT00866047|Antibody-Drug Conjugate|antibody-drug conjugate
5608174|NCT00866047|Antibodies, Monoclonal|antibodies, monoclonal
5608175|NCT00866047|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5608176|NCT00866047|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5608177|NCT00866047|monomethyl auristatin E|monomethyl auristatin e
5608178|NCT00866047|Drug Therapy|drug therapy
5608179|NCT00866047|Immunotherapy|immunotherapy
5608180|NCT00866047|Hematologic Diseases|hematologic diseases
5608181|NCT00866047|Lymphoma|lymphoma
5608182|NCT00866034|Cetrotide|cetrotide
5608185|NCT00866034|Treatment protocol|treatment protocol
5608186|NCT00866021|HIV infection|hiv infection
5608187|NCT00866021|HCV infection|hcv infection
5608188|NCT00866021|treatment experienced|treatment experienced
5608190|NCT00866008|In vitro implantation|in vitro implantation
5608191|NCT00866008|Preimplantation genetic screening|preimplantation genetic screening
5608192|NCT00866008|Aneuploidy|aneuploidy
5608193|NCT00865995|pepsin|pepsin
5608194|NCT00865995|aspiration|aspiration
5608195|NCT00865995|GE reflux|ge reflux
5608196|NCT00865982|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus|adenocarcinoma of the stomach, gastro-esophageal junction or distal esophagus
5608197|NCT00865982|gastric cancer|gastric cancer
5608198|NCT00865982|esophageal cancer|esophageal cancer
5608199|NCT00865982|gastro-esophageal junction|gastro-esophageal junction
5608200|NCT00865982|docetaxel|docetaxel
5608201|NCT00865982|capecitabine|capecitabine
5608202|NCT00865982|cisplatin|cisplatin
5608203|NCT00865982|perioperative chemotherapy|perioperative chemotherapy
5608204|NCT00865969|Belinostat|belinostat
5608205|NCT00865969|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5608206|NCT00865969|PXD101|pxd101
5608207|NCT00865969|PTCL|ptcl
5608208|NCT00865969|HDAC inhibitor|hdac inhibitor
5610849|NCT00854542|Depression|depression
5608209|NCT00865969|histone deacetylase inhibitor|histone deacetylase inhibitor
5608210|NCT00865956|disease management|disease management
5608211|NCT00865956|substance use disorders|substance use disorders
5608212|NCT00865956|behavioral incentives|behavioral incentives
5608213|NCT00865943|Bioequivalence|bioequivalence
5608214|NCT00865943|Citalopram|citalopram
5608215|NCT00865943|Healthy subjects|healthy subjects
5608216|NCT00865917|POTS|pots
5608217|NCT00865904|∆F508|∆f508
5608218|NCT00865904|F508del|f508del
5608219|NCT00865904|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
5608220|NCT00865904|CFTR|cftr
5608221|NCT00865904|Pancreatic diseases|pancreatic diseases
5608222|NCT00865904|Lung diseases|lung diseases
5608223|NCT00865904|Genetic disease, inborn|genetic disease, inborn
5608224|NCT00865904|Infant, newborn, diseases|infant, newborn, diseases
5608225|NCT00865891|Bioequivalence|bioequivalence
5608226|NCT00865891|Nifedipine|nifedipine
5608227|NCT00865891|Healthy subjects|healthy subjects
5608228|NCT00865878|Actinic Keratoses|actinic keratoses
5608229|NCT00865878|Skin Neoplasms|skin neoplasms
5608230|NCT00865878|Photodynamic Therapy|photodynamic therapy
5608231|NCT00865878|Transplants|transplants
5608232|NCT00865865|Knee|knee
5608233|NCT00865865|Computer|computer
5608234|NCT00865865|Gap|gap
5608235|NCT00865865|Soft tissue|soft tissue
5608236|NCT00865865|Balancing|balancing
5608237|NCT00865865|Replacement|replacement
5608238|NCT00865865|Arthroplasty|arthroplasty
5608239|NCT00865852|Bioequivalence|bioequivalence
5608240|NCT00865852|Metformin|metformin
5608241|NCT00865852|Healthy subjects|healthy subjects
5608242|NCT00865839|Bioequivalence|bioequivalence
5608243|NCT00865839|Metformin|metformin
5608244|NCT00865839|Healthy subjects|healthy subjects
5608245|NCT00865826|Pulmonary Tuberculosis|pulmonary tuberculosis
5608246|NCT00865826|Myobacterium Infections|myobacterium infections
5608247|NCT00865813|Punch biopsy,|punch biopsy,
5608248|NCT00865813|periocular|periocular
5608249|NCT00865813|tumors.|tumors.
5608250|NCT00865774|Trauma|trauma
5608251|NCT00865774|Alcohol|alcohol
5608252|NCT00865774|Brief Intervention|brief intervention
5608253|NCT00865761|Bioequivalence|bioequivalence
5608254|NCT00865761|Alprazolam|alprazolam
5608255|NCT00865761|Healthy subjects|healthy subjects
5608256|NCT00865748|Bioequivalence|bioequivalence
5608257|NCT00865748|Metformin|metformin
5608258|NCT00865748|Healthy subjects|healthy subjects
5608259|NCT00865722|Remote Postconditioning|remote postconditioning
5608260|NCT00865722|Myocardial reperfusion Injury|myocardial reperfusion injury
5608261|NCT00865722|Myocardial Infarction|myocardial infarction
5608262|NCT00865722|Primary PCI|primary pci
5608263|NCT00865709|Colorectal Cancer|colorectal cancer
5608264|NCT00865709|Metastasis|metastasis
5608265|NCT00865709|Stage IV|stage iv
5608266|NCT00865709|Liver Metastasis|liver metastasis
5608267|NCT00865696|Bioequivalence|bioequivalence
5608268|NCT00865696|Mirtazapine|mirtazapine
5608269|NCT00865696|Healthy subjects|healthy subjects
5608270|NCT00865683|Gestational Diabetes|gestational diabetes
5608271|NCT00865683|Pregnancy|pregnancy
5608272|NCT00865683|Docosahexaenoic Acid|docosahexaenoic acid
5608273|NCT00865683|DHA|dha
5608274|NCT00865683|Maternal-Fetal Exchange|maternal-fetal exchange
5608275|NCT00865657|Bioequivalence|bioequivalence
5608276|NCT00865657|Alprazolam|alprazolam
5608277|NCT00865657|Healthy subjects|healthy subjects
5608278|NCT00865644|imiquimod 5% cream|imiquimod 5% cream
5608279|NCT00865631|Bioequivalence|bioequivalence
5608280|NCT00865631|Gabapentin|gabapentin
5608282|NCT00865605|bioequivalence|bioequivalence
5608283|NCT00865605|Vasoconstriction|vasoconstriction
5608284|NCT00865605|Halobetasol|halobetasol
5608285|NCT00865605|Healthy subjects|healthy subjects
5608286|NCT00865592|diabetes|diabetes
5608287|NCT00865592|DPP4 inhibitor|dpp4 inhibitor
5608289|NCT00865592|PHX1149|phx1149
5608290|NCT00865579|MAO inhibitors|mao inhibitors
5608291|NCT00865579|motor fluctuations|motor fluctuations
5608292|NCT00865579|dyskinesia|dyskinesia
5608293|NCT00865579|Parkinson's Disease|parkinson's disease
5608294|NCT00865566|HIV Seronegativity|hiv seronegativity
5608295|NCT00865566|HIV Preventive Vaccine|hiv preventive vaccine
5608296|NCT00865566|HIV Treatment Vaccine|hiv treatment vaccine
5608297|NCT00865566|Adenovirus|adenovirus
5608298|NCT00865553|tobacco use disorder|tobacco use disorder
5608299|NCT00865540|cataract|cataract
5608300|NCT00865540|pupillary dilation|pupillary dilation
5608301|NCT00865540|anti-inflammatory|anti-inflammatory
5608302|NCT00865540|therapeutic use|therapeutic use
5608303|NCT00865527|Colorectal cancer|colorectal cancer
5608304|NCT00865527|Colon cancer|colon cancer
5608305|NCT00865527|Adenomatous polyps|adenomatous polyps
5608306|NCT00865527|Screening|screening
5608307|NCT00865527|Fecal occult blood test|fecal occult blood test
5608308|NCT00865527|Computed tomographic colonography|computed tomographic colonography
5608309|NCT00865527|Colonoscopy|colonoscopy
5608310|NCT00865514|dichloroacetate|dichloroacetate
5608311|NCT00865514|tyrosine|tyrosine
5608312|NCT00865514|maleylacetoacetate|maleylacetoacetate
5608313|NCT00865514|trichloroethylene|trichloroethylene
5608314|NCT00865514|leucine|leucine
5608315|NCT00865514|haplotype|haplotype
5608316|NCT00865501|primary hypertension|primary hypertension
5608317|NCT00865501|aldosterone|aldosterone
5608318|NCT00865501|left ventricular hypertrophy|left ventricular hypertrophy
5608319|NCT00865475|HIV infection|hiv infection
5608320|NCT00865475|Treatment Experienced|treatment experienced
5608321|NCT00865462|Bioequivalence|bioequivalence
5608322|NCT00865462|Bupropion|bupropion
5608323|NCT00865462|Healthy subjects|healthy subjects
5608324|NCT00865449|spironolactone|spironolactone
5608325|NCT00865449|peritoneal fibrosis|peritoneal fibrosis
5608326|NCT00865449|peritoneal dialysis|peritoneal dialysis
5608327|NCT00865436|Bioequivalence|bioequivalence
5608328|NCT00865436|Metformin|metformin
5608329|NCT00865436|Glyburide|glyburide
5608330|NCT00865436|Healthy subjects|healthy subjects
5608331|NCT00865423|Bioequivalence|bioequivalence
5608332|NCT00865423|Gabapentin|gabapentin
5608333|NCT00865423|Healthy subjects|healthy subjects
5608334|NCT00865410|Bioequivalence|bioequivalence
5608335|NCT00865410|Bupropion|bupropion
5608336|NCT00865410|Healthy subjects|healthy subjects
5608337|NCT00865384|Bioequivalence|bioequivalence
5608338|NCT00865384|Mirtazapine|mirtazapine
5608339|NCT00865384|Healthy subjects|healthy subjects
5608340|NCT00865371|Bioequivalence|bioequivalence
5608341|NCT00865371|Bupropion|bupropion
5608342|NCT00865371|Healthy subjects|healthy subjects
5608343|NCT00865358|yoga|yoga
5608344|NCT00865358|complementary alternative medicine|complementary alternative medicine
5608345|NCT00865358|low back pain|low back pain
5608346|NCT00865358|minority health|minority health
5608347|NCT00865358|health care disparities|health care disparities
5608348|NCT00865358|community health centers|community health centers
5608349|NCT00865345|blood sugar|blood sugar
5608350|NCT00865345|glucose|glucose
5608351|NCT00865345|sensor|sensor
5608352|NCT00865332|PET|pet
5608353|NCT00865332|fMRI|fmri
5608354|NCT00865332|D-Amphetamine|d-amphetamine
5608355|NCT00865332|Cocaine Addiction|cocaine addiction
5608357|NCT00865319|Non Small Cell Lung Cancer|non small cell lung cancer
5608358|NCT00865319|Spect CT Imaging|spect ct imaging
5608359|NCT00865319|PET CT Imaging as Comparator|pet ct imaging as comparator
5608360|NCT00865306|Cognitive behavioral therapy|cognitive behavioral therapy
5608361|NCT00865306|Anxiety|anxiety
5608362|NCT00865306|Preschoolers|preschoolers
5608363|NCT00865306|Young Children|young children
5608364|NCT00865306|Parents|parents
5608365|NCT00865306|At-risk|at-risk
5608366|NCT00865306|Behavioral Inhibition|behavioral inhibition
5608367|NCT00865293|Obesity|obesity
5608368|NCT00865293|expiratory flow limitation|expiratory flow limitation
5608369|NCT00865293|EFL|efl
5608370|NCT00865293|posture|posture
5608371|NCT00865293|small airways obstruction|small airways obstruction
5608372|NCT00865293|FOT|fot
5608373|NCT00865280|CSSI|cssi
5608374|NCT00865280|Abscess|abscess
5608375|NCT00865280|Wound|wound
5608376|NCT00865280|Cellulitis|cellulitis
5608377|NCT00865280|Complicated Skin and Skin Structure Infections (cSSSI)|complicated skin and skin structure infections (csssi)
5608378|NCT00865267|Vasoconstriction|vasoconstriction
5608379|NCT00865267|Halobetasol|halobetasol
5608380|NCT00865267|Healthy adult subjects|healthy adult subjects
5608381|NCT00865254|Nicotine Dependence|nicotine dependence
5608382|NCT00865254|Smoking|smoking
5608383|NCT00865254|Smoking Cessation|smoking cessation
5608384|NCT00865254|Contingency Management|contingency management
5608385|NCT00865241|Bioequivalence|bioequivalence
5608386|NCT00865241|Metformin|metformin
5608387|NCT00865241|Glyburide|glyburide
5608388|NCT00865241|Healthy subjects|healthy subjects
5608389|NCT00865228|Hyperlipidemia|hyperlipidemia
5608390|NCT00865228|Dyslipidemia|dyslipidemia
5608391|NCT00865228|High Cholesterol|high cholesterol
5608392|NCT00865228|Drug Therapy|drug therapy
5608393|NCT00865215|Bioequivalence|bioequivalence
5608394|NCT00865215|Propranolol|propranolol
5608395|NCT00865215|Healthy subjects|healthy subjects
5608396|NCT00865202|delirium|delirium
5608397|NCT00865202|surgery|surgery
5608398|NCT00865202|operation|operation
5608399|NCT00865202|geriatric|geriatric
5594047|NCT00915031|Potency|potency
5608400|NCT00865202|complication|complication
5608401|NCT00865163|Percutaneous Coronary Intervention|percutaneous coronary intervention
5608402|NCT00865163|anticoagulation|anticoagulation
5608404|NCT00865150|Prematurity|prematurity
5608405|NCT00865150|Neonatal screening|neonatal screening
5608406|NCT00865150|Parenteral nutrition|parenteral nutrition
5608407|NCT00865150|Amino acids|amino acids
5608408|NCT00865150|Acylcarnitine|acylcarnitine
5608409|NCT00865137|Kidney Transplantation|kidney transplantation
5608410|NCT00865137|Pharmacokinetics|pharmacokinetics
5608411|NCT00865137|Tacrolimus modified release|tacrolimus modified release
5608412|NCT00865137|FK506E|fk506e
5608413|NCT00865111|Bioequivalence|bioequivalence
5608414|NCT00865111|Bupropion|bupropion
5608415|NCT00865111|Healthy subjects|healthy subjects
5608416|NCT00865098|Newly diagnosed locally advanced squamous cell carcinoma of the head and neck (SCCHN)|newly diagnosed locally advanced squamous cell carcinoma of the head and neck (scchn)
5608417|NCT00865085|Bioequivalence|bioequivalence
5608418|NCT00865085|Citalopram|citalopram
5608419|NCT00865085|Healthy subjects|healthy subjects
5608420|NCT00865072|Bioequivalence|bioequivalence
5608421|NCT00865072|Metformin|metformin
5608422|NCT00865072|Healthy subjects|healthy subjects
5608423|NCT00865059|Bioequivalence|bioequivalence
5608424|NCT00865059|Gabapentin|gabapentin
5608425|NCT00865059|Healthy subjects|healthy subjects
5608426|NCT00865046|acupuncture|acupuncture
5608427|NCT00865020|Hypertension|hypertension
5608428|NCT00865020|ABPM|abpm
5608429|NCT00865020|systolic blood pressure|systolic blood pressure
5608430|NCT00865020|diastolic blood pressure|diastolic blood pressure
5608431|NCT00865020|cardiovascular disease|cardiovascular disease
5608432|NCT00865020|aliskiren|aliskiren
5608433|NCT00865020|telmisartan|telmisartan
5608434|NCT00865007|Lipodystrophy|lipodystrophy
5608435|NCT00865007|treatment experienced|treatment experienced
5608436|NCT00864994|COPD|copd
5608437|NCT00864994|Inflammation|inflammation
5608438|NCT00864994|Smoking|smoking
5608439|NCT00864994|Multiorgan pathology|multiorgan pathology
5608440|NCT00864994|Extra pulmonary manifestations|extra pulmonary manifestations
5608441|NCT00864968|Bioequivalence|bioequivalence
5608442|NCT00864968|Nabumetone|nabumetone
5608443|NCT00864968|Healthy subjects|healthy subjects
5608444|NCT00864955|UV-A irradiation|uv-a irradiation
5608445|NCT00864955|Cyclobutane-Pyrimidine Dimer|cyclobutane-pyrimidine dimer
5608446|NCT00864955|Oxidative lesions|oxidative lesions
5608447|NCT00864955|cutaneous phototype|cutaneous phototype
5608448|NCT00864955|UV-B irradiation|uv-b irradiation
5608449|NCT00864955|DNA damages|dna damages
5608450|NCT00864942|CLL|cll
5608451|NCT00864942|NHL|nhl
5608452|NCT00864942|lymphoma|lymphoma
5608453|NCT00864929|Non-interventional study|non-interventional study
5608454|NCT00864929|Vietnam|vietnam
5608455|NCT00864929|inappropriate treatment|inappropriate treatment
5608456|NCT00864929|nosocomial infection|nosocomial infection
5608457|NCT00864916|Endothelial Function|endothelial function
5608458|NCT00864916|Pentoxifylline|pentoxifylline
5608459|NCT00864916|Antiretroviral Therapy|antiretroviral therapy
5608460|NCT00864916|Inflammation|inflammation
5608461|NCT00864903|enterovirus|enterovirus
5608462|NCT00864903|aseptic meningitis|aseptic meningitis
5608463|NCT00864903|real time PCR|real time pcr
5608464|NCT00864903|diagnostics|diagnostics
5608465|NCT00864890|Bioequivalence|bioequivalence
5608466|NCT00864890|Citalopram|citalopram
5608467|NCT00864890|Healthy subjects|healthy subjects
5608468|NCT00864877|retrospective|retrospective
5608469|NCT00864877|comparison|comparison
5608470|NCT00864877|biodegradable|biodegradable
5608471|NCT00864877|implant|implant
5608472|NCT00864877|ankle fracture|ankle fracture
5608473|NCT00864864|sunitinib|sunitinib
5608474|NCT00864838|intraocular pressure|intraocular pressure
5608475|NCT00864838|bevacizumab|bevacizumab
5608476|NCT00864838|acetazolamide|acetazolamide
5608477|NCT00864838|brimonidine|brimonidine
5608478|NCT00864838|anterior chamber paracentesis|anterior chamber paracentesis
5608479|NCT00864825|Schizophrenia|schizophrenia
5608480|NCT00864825|Allopurinol|allopurinol
5608481|NCT00864825|Add-on-treatment|add-on-treatment
5608482|NCT00864799|Abortion|abortion
5608483|NCT00864799|Misoprostol|misoprostol
5608484|NCT00864799|Mifepristone|mifepristone
5608485|NCT00864799|Pregnancy|pregnancy
5608486|NCT00864799|Fetus|fetus
5608487|NCT00864786|Multiple dose safety and pharmacokinetics study|multiple dose safety and pharmacokinetics study
5608489|NCT00864760|Gabapentin|gabapentin
5608490|NCT00864760|Healthy subjects|healthy subjects
5608491|NCT00864747|Bioequivalence|bioequivalence
5608492|NCT00864747|Propranolol|propranolol
5608493|NCT00864747|Healthy subjects|healthy subjects
5608494|NCT00864734|Bioequivalence|bioequivalence
5608495|NCT00864734|Metformin|metformin
5608496|NCT00864734|Glyburide|glyburide
5608497|NCT00864734|Healthy subjects|healthy subjects
5608498|NCT00864721|Untreated NSCLC in patients > 70|untreated nsclc in patients > 70
5608499|NCT00864708|Functional Electrical Stimulation|functional electrical stimulation
5608500|NCT00864695|Anesthesia|anesthesia
5608501|NCT00864695|Ethics|ethics
5608502|NCT00864695|Trends|trends
5608503|NCT00864695|Manpower|manpower
5608504|NCT00864695|Perioperative care|perioperative care
5608505|NCT00864682|propofol|propofol
5608506|NCT00864682|lidocaine|lidocaine
5608507|NCT00864682|injection pain|injection pain
5608508|NCT00864669|Bioequivalence|bioequivalence
5608509|NCT00864669|Metformin|metformin
5608510|NCT00864669|Healthy subjects|healthy subjects
5608511|NCT00864656|adrenergic alpha-agonists|adrenergic alpha-agonists
5608512|NCT00864656|phenylephrine|phenylephrine
5608513|NCT00864656|drug effects|drug effects
5608514|NCT00864656|diagnostic use|diagnostic use
5608515|NCT00864643|Hyperlipidemia|hyperlipidemia
5608516|NCT00864643|Drug Therapy|drug therapy
5608517|NCT00864643|Dyslipidemia|dyslipidemia
5608518|NCT00864617|Bioequivalence|bioequivalence
5608519|NCT00864617|Nifedipine|nifedipine
5608520|NCT00864617|Healthy subjects|healthy subjects
5608521|NCT00864604|Bioequivalence|bioequivalence
5608522|NCT00864604|Nabumetone|nabumetone
5608534|NCT00864552|Recombinant Factor VIII|recombinant factor viii
5608535|NCT00864539|vitamin D fortification|vitamin d fortification
5608537|NCT00864539|orange juice|orange juice
5608538|NCT00864539|supplement|supplement
5608539|NCT00864539|efficacy|efficacy
5608540|NCT00864526|Bioequivalence|bioequivalence
5608541|NCT00864526|Oxycodone|oxycodone
5608542|NCT00864526|Ibuprofen|ibuprofen
5608543|NCT00864526|Healthy subjects|healthy subjects
5608544|NCT00864513|pancreas|pancreas
5608545|NCT00864513|metastatic|metastatic
5608546|NCT00864513|recurrent|recurrent
5608547|NCT00864500|Bio-Equivalence|bio-equivalence
5608548|NCT00864500|Vasoconstriction|vasoconstriction
5608549|NCT00864500|Clobetasol|clobetasol
5608550|NCT00864500|Healthy adult females|healthy adult females
5608551|NCT00864461|Down syndrome|down syndrome
5608552|NCT00864461|Metabolic syndrome X|metabolic syndrome x
5608553|NCT00864461|Insulin resistance|insulin resistance
5608554|NCT00864448|Bioequivalence|bioequivalence
5608555|NCT00864448|Ramipril|ramipril
5608556|NCT00864448|Healthy subjects|healthy subjects
5608557|NCT00864435|Bioequivalence|bioequivalence
5608558|NCT00864435|Carvedilol|carvedilol
5608559|NCT00864435|Healthy subjects|healthy subjects
5608560|NCT00864422|low back pain|low back pain
5608561|NCT00864422|motor training|motor training
5608562|NCT00864422|motor cortex|motor cortex
5608563|NCT00864422|brain plasticity|brain plasticity
5608564|NCT00864409|postoperative pain|postoperative pain
5608565|NCT00864409|total hip arthroplasty|total hip arthroplasty
5608566|NCT00864396|Laryngopharyngeal reflux|laryngopharyngeal reflux
5608567|NCT00864396|Gastroesophageal reflux disease|gastroesophageal reflux disease
5608568|NCT00864396|GERD|gerd
5608569|NCT00864370|Psychiatry|psychiatry
5608570|NCT00864370|Pregnancy|pregnancy
5608571|NCT00864370|Bipolar Disorder|bipolar disorder
5608572|NCT00864357|Bioequivalence|bioequivalence
5608573|NCT00864357|Oxycodone|oxycodone
5608574|NCT00864357|Ibuprofen|ibuprofen
5608575|NCT00864357|Healthy subjects|healthy subjects
5608576|NCT00864344|Bioequivalence|bioequivalence
5608577|NCT00864344|Sertralin|sertralin
5608578|NCT00864344|Healthy subjectse|healthy subjectse
5608579|NCT00864331|lung cancer|lung cancer
5608580|NCT00864331|nonsmall cell lung cancer|nonsmall cell lung cancer
5608581|NCT00864331|radiation therapy|radiation therapy
5608582|NCT00864331|chemotherapy|chemotherapy
5608583|NCT00864331|Locally advanced and metastatic nonsmall cell lung cancer|locally advanced and metastatic nonsmall cell lung cancer
5608584|NCT00864318|refractory|refractory
5608585|NCT00864318|germ cell tumors|germ cell tumors
5608586|NCT00864318|relapse|relapse
5608587|NCT00864318|bad prognosis|bad prognosis
5608588|NCT00864318|Refractory germ cell tumors with relapse and bad prognosis|refractory germ cell tumors with relapse and bad prognosis
5608589|NCT00864305|Bioequivalence|bioequivalence
5608590|NCT00864305|Gabapentin|gabapentin
5608591|NCT00864305|Healthy subjects|healthy subjects
5608592|NCT00864279|Bioequivalence|bioequivalence
5608593|NCT00864279|Cetirizine|cetirizine
5608594|NCT00864279|Healthy subjects|healthy subjects
5608595|NCT00864266|Non small cell lung carcinoma|non small cell lung carcinoma
5608596|NCT00864266|Chemotherapy|chemotherapy
5608597|NCT00864266|Response prediction|response prediction
5608598|NCT00864253|Melanoma|melanoma
5608599|NCT00864253|Malignant|malignant
5608600|NCT00864253|Abraxane|abraxane
5608601|NCT00864253|ABI-007|abi-007
5608602|NCT00864253|Dacarbazine|dacarbazine
5608603|NCT00864253|Dtic-Dome|dtic-dome
5608604|NCT00864240|Vasoconstriction|vasoconstriction
5608605|NCT00864240|Clobetasol|clobetasol
5608606|NCT00864240|Healthy adult females|healthy adult females
5608607|NCT00864227|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5608608|NCT00864227|Acute Myelogenous Leukemia|acute myelogenous leukemia
5608609|NCT00864227|Mantel-Cell Lymphoma|mantel-cell lymphoma
5608610|NCT00864227|Hematopoietic Transplant|hematopoietic transplant
5594243|NCT00914303|Safety|safety
5608611|NCT00864227|Umbilical Cord Blood (UCB)|umbilical cord blood (ucb)
5611232|NCT00853021|stage IV renal cell cancer|stage iv renal cell cancer
5608612|NCT00864227|Non-Myeloablative Transplant|non-myeloablative transplant
5608613|NCT00864214|bioidentical hormone|bioidentical hormone
5608614|NCT00864214|menopause|menopause
5608615|NCT00864214|estrogen|estrogen
5608616|NCT00864214|progesterone|progesterone
5608617|NCT00864188|skin health|skin health
5608618|NCT00864188|probiotics|probiotics
5608619|NCT00864188|dairy|dairy
5608620|NCT00864188|oral|oral
5608621|NCT00864162|Bioequivalence|bioequivalence
5608622|NCT00864162|Ramipril|ramipril
5608623|NCT00864162|Healthy subjects|healthy subjects
5608624|NCT00864149|Bioequivalence|bioequivalence
5608625|NCT00864149|Carvedilol|carvedilol
5608626|NCT00864149|Healthy subjects|healthy subjects
5608627|NCT00864123|Obsessive-compulsive disorder|obsessive-compulsive disorder
5608628|NCT00864110|Non small cell lung cancer|non small cell lung cancer
5608629|NCT00864110|SPECT CT imaging|spect ct imaging
5608630|NCT00864110|Pharmacokinetic|pharmacokinetic
5608631|NCT00864110|Radiation Dosimetry|radiation dosimetry
5608632|NCT00864110|PET CT comparison|pet ct comparison
5608633|NCT00864097|Arthritis monoclonal antibody nerve growth factor (NGF) anti-NGF tanezumab PF-04383119 RN-624 OA|arthritis monoclonal antibody nerve growth factor (ngf) anti-ngf tanezumab pf-04383119 rn-624 oa
5608634|NCT00864071|Bioequivalence|bioequivalence
5608635|NCT00864071|Griseofulvin|griseofulvin
5608636|NCT00864071|Healthy subjects|healthy subjects
5608637|NCT00864058|Bioequivalence|bioequivalence
5608638|NCT00864058|Gabapentin|gabapentin
5608639|NCT00864058|Healthy subjects|healthy subjects
5608640|NCT00864032|Soft tissue sarcoma of the extremity and body wall|soft tissue sarcoma of the extremity and body wall
5608641|NCT00864019|Bioequivalence|bioequivalence
5608642|NCT00864019|Sertraline|sertraline
5608643|NCT00864019|Healthy subjects|healthy subjects
5608644|NCT00863980|angiotensin|angiotensin
5608645|NCT00863980|receptor|receptor
5608646|NCT00863980|vulnerable plaque|vulnerable plaque
5608647|NCT00863980|coronary artery|coronary artery
5608648|NCT00863967|physical examination|physical examination
5608649|NCT00863967|diagnostic techniques and procedures|diagnostic techniques and procedures
5608650|NCT00863967|diagnosis|diagnosis
5608651|NCT00863967|immunologic tests|immunologic tests
5608652|NCT00863967|diagnostic tests|diagnostic tests
5608653|NCT00863967|causality|causality
5608654|NCT00863967|genetic test|genetic test
5608655|NCT00863967|biomarker|biomarker
5608656|NCT00863941|Bioequivalence|bioequivalence
5608657|NCT00863941|Bupropion|bupropion
5608658|NCT00863941|Healthy subjects|healthy subjects
5608659|NCT00863915|Bioequivalence|bioequivalence
5608660|NCT00863915|Ramipril|ramipril
5608661|NCT00863915|Healthy subjects|healthy subjects
5608662|NCT00863902|Bioequivalence|bioequivalence
5608663|NCT00863902|Cetirizine|cetirizine
5608664|NCT00863902|Healthy subjects|healthy subjects
5701819|NCT00495651|Naive patients|naive patients
5608665|NCT00863876|wavefront measurements of the entire eye|wavefront measurements of the entire eye
5608666|NCT00863863|Bioequivalence|bioequivalence
5608667|NCT00863863|Griseofulvin|griseofulvin
5608668|NCT00863863|Healthy subjects|healthy subjects
5608669|NCT00863837|Acute variceal bleeding|acute variceal bleeding
5608670|NCT00863837|banding ligation|banding ligation
5608671|NCT00863837|vasoconstrictor|vasoconstrictor
5608672|NCT00863837|proton pump inhibitor|proton pump inhibitor
5608673|NCT00863824|NNAL|nnal
5608674|NCT00863824|Cotinine|cotinine
5608675|NCT00863824|Second hand smoke|second hand smoke
5608676|NCT00863824|NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.|nnal is a known lung carcinogen. so, we are studying an agent that can potentially cause lung cancer.
5608677|NCT00863811|POAG|poag
5608679|NCT00863811|Forskolin|forskolin
5608680|NCT00863811|beta-blockers|beta-blockers
5608681|NCT00863811|prostaglandins|prostaglandins
5608682|NCT00863798|Major Depressive Disorder|major depressive disorder
5608683|NCT00863785|Acute Alcoholic Hepatitis|acute alcoholic hepatitis
5608684|NCT00863785|Cirrhosis|cirrhosis
5608685|NCT00863785|Alcohol|alcohol
5608686|NCT00863785|Alcoholic Liver disease|alcoholic liver disease
5608687|NCT00863759|intra-ocular lenses|intra-ocular lenses
5608688|NCT00863759|comparative study|comparative study
5608689|NCT00863759|Ocular aberrations|ocular aberrations
5608690|NCT00863759|Contrast Sensitivity|contrast sensitivity
5608691|NCT00863746|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5608692|NCT00863746|Sorafenib|sorafenib
5608693|NCT00863707|regadenoson|regadenoson
5608694|NCT00863707|chronic kidney disease stage III|chronic kidney disease stage iii
5608790|NCT00863356|HemCon® Nasal Plugs|hemcon® nasal plugs
5608695|NCT00863707|chronic kidney disease stage IV|chronic kidney disease stage iv
5608696|NCT00863707|renal impairment|renal impairment
5608697|NCT00863707|coronary artery disease|coronary artery disease
5608698|NCT00863694|cystic fibrosis|cystic fibrosis
5608699|NCT00863694|calprotectin|calprotectin
5608700|NCT00863694|elastase|elastase
5608701|NCT00863681|Pulmonary arterial hypertension|pulmonary arterial hypertension
5608703|NCT00863681|Stimulator|stimulator
5608704|NCT00863668|Infection|infection
5608705|NCT00863668|HIV 1|hiv 1
5608706|NCT00863668|HIV|hiv
5608707|NCT00863668|treatment naive|treatment naive
5608708|NCT00863655|Breast Cancer|breast cancer
5798763|NCT00111163|prevention|prevention
5608712|NCT00863655|mTOR|mtor
5608713|NCT00863655|everolimus|everolimus
5608714|NCT00863655|refractory|refractory
5608715|NCT00863655|NSAI|nsai
5608716|NCT00863642|Early cholecystectomy|early cholecystectomy
5608717|NCT00863642|gallstone pancreatitis|gallstone pancreatitis
5608718|NCT00863629|myocardial infarction|myocardial infarction
5608719|NCT00863629|oxidative stress|oxidative stress
5608720|NCT00863629|stem cells|stem cells
5608721|NCT00863629|glycemic control|glycemic control
5608722|NCT00863616|COPD|copd
5608723|NCT00863616|Mucus hypersecretion|mucus hypersecretion
5608724|NCT00863616|HRQL|hrql
5608725|NCT00863616|ESWT|eswt
5608726|NCT00863616|HFCWO|hfcwo
5608727|NCT00863603|Supplemental oxygen|supplemental oxygen
5608728|NCT00863603|Intimal hyperplasia|intimal hyperplasia
5608729|NCT00863603|Graft patency|graft patency
5608730|NCT00863577|Healthy volunteers|healthy volunteers
5608731|NCT00863564|Postprandial Period|postprandial period
5608732|NCT00863564|Postprandial Lipaemia|postprandial lipaemia
5608733|NCT00863564|Incretins|incretins
5608734|NCT00863564|Subclinical Inflammation|subclinical inflammation
5608735|NCT00863564|Obesity|obesity
5608736|NCT00863564|Atherosclerosis|atherosclerosis
5608737|NCT00863564|Triglyceride|triglyceride
5608738|NCT00863564|Lipoproteins|lipoproteins
5608739|NCT00863564|Postprandial inflammation|postprandial inflammation
5608740|NCT00863538|Spinocerebellar degeneration|spinocerebellar degeneration
5608741|NCT00863538|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5608743|NCT00863512|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5608744|NCT00863512|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5608745|NCT00863512|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5608746|NCT00863512|adenocarcinoma of the lung|adenocarcinoma of the lung
5608747|NCT00863512|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5608748|NCT00863512|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5608749|NCT00863512|large cell lung cancer|large cell lung cancer
5608750|NCT00863512|squamous cell lung cancer|squamous cell lung cancer
5608751|NCT00863499|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5608752|NCT00863499|Attention Deficit Disorder|attention deficit disorder
5608753|NCT00863499|ADHD|adhd
5608754|NCT00863499|ADD|add
5608755|NCT00863499|iSPOT|ispot
5608756|NCT00863473|Proximal Humerus Fracture in elderly|proximal humerus fracture in elderly
5608757|NCT00863421|Sleep disordered breathing|sleep disordered breathing
5608758|NCT00863421|Prevalence|prevalence
5608759|NCT00863421|Chronic heart failure|chronic heart failure
5608760|NCT00863421|Incidence|incidence
5608761|NCT00863421|Sleep apnea|sleep apnea
5608762|NCT00863421|Cheyne-Stokes-Breathing|cheyne-stokes-breathing
5608763|NCT00863408|Mosquito|mosquito
5608764|NCT00863408|Human Landing Collection|human landing collection
5608766|NCT00863395|pruritis|pruritis
5608767|NCT00863395|itch|itch
5608768|NCT00863395|CTCL|ctcl
5608769|NCT00863382|atrial fibrillation|atrial fibrillation
5608770|NCT00863369|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5608771|NCT00863369|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5608772|NCT00863369|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5591481|NCT00924833|heart failure|heart failure
5608773|NCT00863369|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5608774|NCT00863369|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5608775|NCT00863369|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5608776|NCT00863369|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5608777|NCT00863369|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5608778|NCT00863369|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5608779|NCT00863369|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5608780|NCT00863356|Epistaxis|epistaxis
5608781|NCT00863356|Chitosan|chitosan
5608782|NCT00863356|Hemostatic|hemostatic
5608783|NCT00863356|Nose bleed|nose bleed
5608784|NCT00863356|Nasal bleeding|nasal bleeding
5608785|NCT00863356|Nasal pack|nasal pack
5608786|NCT00863356|Sealant|sealant
5608787|NCT00863356|ChitoFlex®|chitoflex®
5608788|NCT00863356|HemCon|hemcon
5608789|NCT00863356|HemCon® ChitoFlex Surgical Dressing|hemcon® chitoflex surgical dressing
5608791|NCT00863356|Biocompatible dressing|biocompatible dressing
5608792|NCT00863343|Influenza infections|influenza infections
5608793|NCT00863343|Orthomyxoviridae infections|orthomyxoviridae infections
5608795|NCT00863330|recurrent melanoma|recurrent melanoma
5608796|NCT00863317|Bronchiolitis|bronchiolitis
5608797|NCT00863317|montelukast|montelukast
5608798|NCT00863317|leukotriene inhibitor|leukotriene inhibitor
5611428|NCT00852306|slow freeze|slow freeze
5608799|NCT00863304|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth factor OA pain arthritis|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth factor oa pain arthritis
5608803|NCT00863265|Phytosterols|phytosterols
5608804|NCT00863265|Ezetimibe|ezetimibe
5608805|NCT00863265|Cholesterol Excretion|cholesterol excretion
5608806|NCT00863265|Cholesterol Absorption|cholesterol absorption
5608808|NCT00863265|Mass Spectrometry|mass spectrometry
5608809|NCT00863265|Deuterium|deuterium
5608810|NCT00863252|proteinuria|proteinuria
5608811|NCT00863252|creatinine|creatinine
5608812|NCT00863252|kidney survival|kidney survival
5608813|NCT00863252|ESRD|esrd
5608814|NCT00863239|treatment naive|treatment naive
5608815|NCT00863239|genotype 1|genotype 1
5608816|NCT00863226|Quality of Life issues in Parkinson's disease|quality of life issues in parkinson's disease
5608817|NCT00863213|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5608818|NCT00863213|Atrial fibrillation|atrial fibrillation
5608819|NCT00863213|Antiarrhythmic Drugs|antiarrhythmic drugs
5608820|NCT00863200|Depression|depression
5608821|NCT00863200|Cancer|cancer
5608822|NCT00863200|African Americans|african americans
5608823|NCT00863200|Latinos|latinos
5608824|NCT00863200|Hispanics|hispanics
5608825|NCT00863200|Interactive voice response|interactive voice response
5608826|NCT00863200|IVR|ivr
5608827|NCT00863200|Behavioral Intervention|behavioral intervention
5608828|NCT00863174|Multiple myeloma|multiple myeloma
5608829|NCT00863174|Bio-equivalence|bio-equivalence
5608830|NCT00863161|Safety|safety
5608831|NCT00863161|tolerability|tolerability
5608832|NCT00863161|exposure|exposure
5608833|NCT00863161|healthy|healthy
5608834|NCT00863161|renally impaired subjects|renally impaired subjects
5608835|NCT00863148|MDS|mds
5608836|NCT00863148|AML|aml
5608837|NCT00863148|ALL|all
5608838|NCT00863148|RIC|ric
5608839|NCT00863148|clofarabine|clofarabine
5608840|NCT00863148|allo-HSCT|allo-hsct
5608841|NCT00863148|high-risk MDS/AML|high-risk mds/aml
5608842|NCT00863135|obstructive sleep apnea|obstructive sleep apnea
5608843|NCT00863135|refractory arterial hypertension|refractory arterial hypertension
5608844|NCT00863135|continuous positive airways pressure|continuous positive airways pressure
5608845|NCT00863122|Lapatinib|lapatinib
5608846|NCT00863122|Tykerb|tykerb
5608847|NCT00863122|EGFR inhibitor|egfr inhibitor
5608848|NCT00863122|ErbB2 inhibitor|erbb2 inhibitor
5608849|NCT00863122|Pharmacokinetics|pharmacokinetics
5608850|NCT00863096|HPV|hpv
5608851|NCT00863096|acceptability|acceptability
5608852|NCT00863083|pediatric obesity|pediatric obesity
5608853|NCT00863083|pediatric overweight|pediatric overweight
5608854|NCT00863083|multi-family group weight management intervention|multi-family group weight management intervention
5608855|NCT00863083|financial rewards|financial rewards
5608856|NCT00863070|Bladder exstrophy|bladder exstrophy
5608857|NCT00863070|Abnormal gait|abnormal gait
5608858|NCT00863070|anatomy|anatomy
5608859|NCT00863070|urinary bladder disease|urinary bladder disease
5608860|NCT00863070|urogenital abnormalities|urogenital abnormalities
5608861|NCT00863057|HIV Infections|hiv infections
5608862|NCT00863057|Neuropathy|neuropathy
5608863|NCT00863057|Pain|pain
5608864|NCT00863044|off pump coronary bypass|off pump coronary bypass
5608865|NCT00863044|high frequency ventilation|high frequency ventilation
5608866|NCT00863044|cerebral oxygen saturation|cerebral oxygen saturation
5608867|NCT00863044|vasopressors used|vasopressors used
5608868|NCT00863044|right and left ventricular function|right and left ventricular function
5608869|NCT00863044|arterial blood pressure|arterial blood pressure
5608870|NCT00863044|heart rate|heart rate
5608871|NCT00863031|mental health|mental health
5608872|NCT00863031|problem-solving therapy|problem-solving therapy
5608873|NCT00863031|elderly|elderly
5608874|NCT00863031|health-related quality of life|health-related quality of life
5608875|NCT00863031|primary care|primary care
5608876|NCT00863031|Chinese|chinese
5608877|NCT00863018|Corneal endothelial cell|corneal endothelial cell
5608878|NCT00863018|Specular microscopy|specular microscopy
5608879|NCT00863018|Glaucoma implant surgery|glaucoma implant surgery
5608880|NCT00863018|Ahmed glaucoma valve|ahmed glaucoma valve
5608881|NCT00863018|Trabeculectomy|trabeculectomy
5608882|NCT00862992|schizophrenia|schizophrenia
5608883|NCT00862992|antipsychotics|antipsychotics
5608884|NCT00862992|dopamine D3/D2 antagonist|dopamine d3/d2 antagonist
5608885|NCT00862979|Heart Transplantation|heart transplantation
5608886|NCT00862979|Cardiac Transplantation|cardiac transplantation
5608887|NCT00862979|CNI-sparing|cni-sparing
5608888|NCT00862979|renal function|renal function
5608889|NCT00862979|CNI|cni
5608890|NCT00862979|Cyclosporine A|cyclosporine a
5608891|NCT00862979|Everolimus|everolimus
5608892|NCT00862979|mycophenolic acid|mycophenolic acid
5608893|NCT00862953|low carbohydrate|low carbohydrate
5608895|NCT00862940|Memantine|memantine
5611559|NCT00851799|ART|art
5608897|NCT00862940|MRI|mri
5608898|NCT00862940|Brain atrophy|brain atrophy
5608899|NCT00862927|Smoking Cessation|smoking cessation
5608900|NCT00862927|Cigarette Smoking|cigarette smoking
5594546|NCT00912860|avonex|avonex
5608901|NCT00862927|Tobacco Smoking|tobacco smoking
5608902|NCT00862927|Cue Reactivity|cue reactivity
5608903|NCT00862927|Virtual Reality|virtual reality
5608904|NCT00862927|VR|vr
5608905|NCT00862927|Contextual Cues|contextual cues
5608906|NCT00862927|Explicit Smoking Cues|explicit smoking cues
5608907|NCT00862927|Craving|craving
5608908|NCT00862927|Physiological Arousal|physiological arousal
5608909|NCT00862927|Nicotine Dependence|nicotine dependence
5608910|NCT00862927|Breath Sample|breath sample
5608911|NCT00862927|Saliva Test|saliva test
5608912|NCT00862927|Questionnaire|questionnaire
5608913|NCT00862914|Skin|skin
5608914|NCT00862914|MicroRNA|microrna
5608915|NCT00862914|miRNA|mirna
5608916|NCT00862914|Dicer|dicer
5608917|NCT00862914|Malignant Melanoma|malignant melanoma
5608918|NCT00862901|cancer|cancer
5608919|NCT00862901|skin metastases|skin metastases
5608920|NCT00862901|chest wall progression of breast cancer|chest wall progression of breast cancer
5608921|NCT00862901|malignant melanoma|malignant melanoma
5608922|NCT00862901|photodynamic therapy|photodynamic therapy
5608923|NCT00862901|photophrin|photophrin
5608924|NCT00862901|satellite and in-transit metastases of malignant melanoma|satellite and in-transit metastases of malignant melanoma
5608925|NCT00862901|skin cancer|skin cancer
5608926|NCT00862875|Insulin initiation|insulin initiation
5608927|NCT00862875|oral therapy failure|oral therapy failure
5608928|NCT00862862|infection|infection
5608929|NCT00862862|staphylococcus aureus|staphylococcus aureus
5608930|NCT00862862|vancomycin|vancomycin
5608931|NCT00862862|pharmacodynammics|pharmacodynammics
5608932|NCT00862849|rHuPH20|rhuph20
5608933|NCT00862849|Recombinant Human Hyaluronidase|recombinant human hyaluronidase
5608934|NCT00862849|Insulin Lispro|insulin lispro
5608935|NCT00862849|Regular Human Insulin|regular human insulin
5608936|NCT00862836|ZD6474|zd6474
5608937|NCT00862836|Vandetanib|vandetanib
5608938|NCT00862836|Zactima|zactima
5608939|NCT00862836|Ovarian Cancer|ovarian cancer
5608940|NCT00862836|Phase I|phase i
5608941|NCT00862836|Phase II|phase ii
5608942|NCT00862836|Randomized|randomized
5608943|NCT00862836|Safety|safety
5608944|NCT00862823|Healthy Volunteers|healthy volunteers
5608945|NCT00862810|Human papillomavirus|human papillomavirus
5608946|NCT00862810|Cervical cancer|cervical cancer
5608947|NCT00862810|Genital warts|genital warts
5608948|NCT00862810|Vaccine|vaccine
5608949|NCT00862810|Immunogenicity|immunogenicity
5608950|NCT00862797|endotracheal tube|endotracheal tube
5608951|NCT00862797|swallowing|swallowing
5608952|NCT00862797|aspiration|aspiration
5608953|NCT00862797|cuff pressure|cuff pressure
5608954|NCT00862797|pneumonia|pneumonia
5608955|NCT00862784|Colorectal carcinoma|colorectal carcinoma
5608956|NCT00862784|CRC|crc
5608957|NCT00862784|Colon Cancer|colon cancer
5608958|NCT00862758|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5608959|NCT00862732|active suicidal ideation|active suicidal ideation
5608960|NCT00862732|cognitive behavioural therapy|cognitive behavioural therapy
5608961|NCT00862732|Sri Lanka|sri lanka
5608963|NCT00862706|Chronic HBV|chronic hbv
5608964|NCT00862693|Immunoglobulin A|immunoglobulin a
5608965|NCT00862693|Antibodies|antibodies
5608966|NCT00862693|treatment|treatment
5608967|NCT00862667|Pharmacokinetics|pharmacokinetics
5608968|NCT00862641|regadenoson|regadenoson
5608969|NCT00862641|CVT 3146|cvt 3146
5608970|NCT00862641|asthma|asthma
5608971|NCT00862641|coronary artery disease|coronary artery disease
5608972|NCT00862641|pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5608973|NCT00862615|Ageing|ageing
5608974|NCT00862615|Inflammation|inflammation
5608975|NCT00862615|Muscle protein synthesis|muscle protein synthesis
5608976|NCT00862615|Osteopenia|osteopenia
5608977|NCT00862615|Sarcopenia|sarcopenia
5608978|NCT00862602|GDM|gdm
5608979|NCT00862602|gestational diabetes|gestational diabetes
5608980|NCT00862602|pregnancy|pregnancy
5608981|NCT00862602|diabetes|diabetes
5608982|NCT00862602|walking|walking
5608983|NCT00862602|exercise|exercise
5608984|NCT00862602|pedometer|pedometer
5608985|NCT00862602|online|online
5608986|NCT00862589|glucagon|glucagon
5608987|NCT00862589|GLP-1|glp-1
5608988|NCT00862589|hyperglycemia|hyperglycemia
5608989|NCT00862576|Burning Mouth Syndrome|burning mouth syndrome
5608990|NCT00862576|Sleep|sleep
5608991|NCT00862576|Neuropathic pain|neuropathic pain
5608992|NCT00862576|Glossodynia|glossodynia
5608993|NCT00862576|Chronic pain|chronic pain
5608994|NCT00862576|Orofacial pain|orofacial pain
5608995|NCT00862563|Alcoholism|alcoholism
5608996|NCT00862563|Alcohol Dependence|alcohol dependence
5794228|NCT00127504|Therapy|therapy
5609013|NCT00862498|Written Emotional Disclosure|written emotional disclosure
5609015|NCT00862498|Narrative Writing|narrative writing
5609016|NCT00862498|Motor Vehicle Accident|motor vehicle accident
5609017|NCT00862472|open-angle glaucoma|open-angle glaucoma
5609019|NCT00862472|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
5609020|NCT00862459|Contrast Agents|contrast agents
5609021|NCT00862446|Parenteral nutrition associate liver disease|parenteral nutrition associate liver disease
5609022|NCT00862446|TPN cholestasis|tpn cholestasis
5609023|NCT00862446|TPN Associated Liver Disease|tpn associated liver disease
5609036|NCT00862420|Platelet aggregation inhibitors|platelet aggregation inhibitors
5609037|NCT00862420|Peripheral arterial disease (PAD)|peripheral arterial disease (pad)
5609042|NCT00862381|shock|shock
5609043|NCT00862381|Tracheal Intubation|tracheal intubation
5609044|NCT00862381|reanimation|reanimation
5609045|NCT00862381|suprarenal insufficiency|suprarenal insufficiency
5609046|NCT00862381|Etomidate|etomidate
5609047|NCT00862381|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5609048|NCT00862381|hydrocortisone|hydrocortisone
5609049|NCT00862368|Motivational Interviewing|motivational interviewing
5609050|NCT00862368|Pediatric Asthma|pediatric asthma
5609051|NCT00862368|Smoking Cessation|smoking cessation
5609052|NCT00862368|Environmental Tobacco Smoke|environmental tobacco smoke
5609053|NCT00862368|Second hand smoke|second hand smoke
5609054|NCT00862368|Biomarker|biomarker
5609055|NCT00862368|Asthma|asthma
5609056|NCT00862368|Asthma Education|asthma education
5609057|NCT00862368|Family Intervention|family intervention
5609058|NCT00862368|Smoking|smoking
5609059|NCT00862368|Nicotine Patch|nicotine patch
5609060|NCT00862368|Parents|parents
5609061|NCT00862368|Caregivers|caregivers
5609062|NCT00862368|Child Wellness|child wellness
5609063|NCT00862355|Carcinoma|carcinoma
5609064|NCT00862355|Ovary|ovary
5609065|NCT00862355|Carcinoma Ovary|carcinoma ovary
5609066|NCT00862342|colorectal cancer|colorectal cancer
5609067|NCT00862342|Bevacizumab|bevacizumab
5609068|NCT00862329|Healthy subjects|healthy subjects
5609069|NCT00862316|Eligible for Unicompartmental Knee Arthritis|eligible for unicompartmental knee arthritis
5609070|NCT00862303|autologous cytokine induced killer cells|autologous cytokine induced killer cells
5609071|NCT00862303|dendritic cell|dendritic cell
5609072|NCT00862303|vaccine|vaccine
5609073|NCT00862303|renal cell carcinoma|renal cell carcinoma
5609074|NCT00862290|sepsis|sepsis
5609075|NCT00862290|microRNA|microrna
5609076|NCT00862277|Menactra®|menactra®
5609077|NCT00862277|Menomune®|menomune®
5609078|NCT00862277|Meningitis|meningitis
5609079|NCT00862277|Meningococcal Infections|meningococcal infections
5609080|NCT00862251|cardiovascular disorder|cardiovascular disorder
5609081|NCT00862225|rhinomanometry|rhinomanometry
5609082|NCT00862225|mode of action|mode of action
5609083|NCT00862225|grass pollen|grass pollen
5609084|NCT00862212|anxiety|anxiety
5609085|NCT00862212|social anxiety|social anxiety
5609086|NCT00862212|social anxiety disorder|social anxiety disorder
5609087|NCT00862212|coping behaviors|coping behaviors
5609088|NCT00862212|alcohol abuse|alcohol abuse
5609089|NCT00862186|Neoplasms|neoplasms
5609090|NCT00862186|Fatigue|fatigue
5609091|NCT00862186|Self Care|self care
5609092|NCT00862173|Gene-expression profile|gene-expression profile
5609093|NCT00862173|Central nervous system metastasis|central nervous system metastasis
5609094|NCT00862173|Non-small-cell lung cancer|non-small-cell lung cancer
5609095|NCT00862160|coronary artery bypass surgery|coronary artery bypass surgery
5609096|NCT00862160|cardiopulmonary bypass|cardiopulmonary bypass
5609097|NCT00862160|heart lung machine|heart lung machine
5609098|NCT00862160|acute cerebrovascular event|acute cerebrovascular event
5609099|NCT00862160|intracranial embolism|intracranial embolism
5609100|NCT00862160|embolism, air|embolism, air
5609101|NCT00862160|outcome assessment (health care)|outcome assessment (health care)
5609102|NCT00862160|neuropsychological tests|neuropsychological tests
5609103|NCT00862160|magnetic resonance imaging|magnetic resonance imaging
5591816|NCT00923650|Assent|assent
5609104|NCT00862160|saccadic eye movement test|saccadic eye movement test
5609105|NCT00862147|Child psychosocial Functioning|child psychosocial functioning
5609106|NCT00862108|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5609107|NCT00862108|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5609108|NCT00862108|SLC6A2 protein, human|slc6a2 protein, human
5609109|NCT00862108|ADRA2A protein, human|adra2a protein, human
5609110|NCT00862056|asymptomatic|asymptomatic
5609111|NCT00862056|coronary artery disease|coronary artery disease
5609112|NCT00862043|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5609113|NCT00862043|Valvular Heart Disease|valvular heart disease
5609114|NCT00862043|Phosphodiesterase-Inhibitors|phosphodiesterase-inhibitors
5609115|NCT00862043|Sildenafil|sildenafil
5609116|NCT00862043|Outcomes Research|outcomes research
5609117|NCT00862030|Palliative radiotherapy|palliative radiotherapy
5609118|NCT00862030|Treatment planning|treatment planning
5609119|NCT00862030|Non-small cell lung cancer|non-small cell lung cancer
5609120|NCT00862017|Physiology|physiology
5609121|NCT00862004|video-assisted thoracoscopic surgery (VATS)|video-assisted thoracoscopic surgery (vats)
5609122|NCT00862004|systematic node dissection (SND)|systematic node dissection (snd)
5609123|NCT00862004|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5609124|NCT00861991|medical communication|medical communication
5609126|NCT00861991|medical education|medical education
5609127|NCT00861991|standardized patients|standardized patients
5609128|NCT00861991|"enhancing patient satisfaction"|"enhancing patient satisfaction"
5609129|NCT00861978|mild to moderate depression with atypical features according to DSM-IV|mild to moderate depression with atypical features according to dsm-iv
5609130|NCT00861965|Leukemia|leukemia
5609131|NCT00861965|Lymphoma|lymphoma
5609132|NCT00861965|Multiple Myeloma|multiple myeloma
5609133|NCT00861952|Diabetic peripheral neuropathies|diabetic peripheral neuropathies
5609134|NCT00861952|Neuralgia|neuralgia
5609135|NCT00861952|Complementary medicine|complementary medicine
5609136|NCT00861952|Analgesia|analgesia
5609137|NCT00861926|Maintenance and Reliever Treatments|maintenance and reliever treatments
5609138|NCT00861887|Clostridium difficile|clostridium difficile
5609139|NCT00861887|colitis|colitis
5609140|NCT00861887|recurrence|recurrence
5609141|NCT00861887|relapse|relapse
5609142|NCT00861887|Vancomycin|vancomycin
5609143|NCT00861861|Pitavastatin|pitavastatin
5609144|NCT00861861|Atorvastatin|atorvastatin
5609146|NCT00861861|HDL-C|hdl-c
5609147|NCT00861861|Adiponectin|adiponectin
5609148|NCT00861822|Anemia|anemia
5609149|NCT00861822|Cardiac surgery|cardiac surgery
5609150|NCT00861822|RBC transfusion|rbc transfusion
5609151|NCT00861822|Acute Kidney Injury|acute kidney injury
5609152|NCT00861822|Cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
5609153|NCT00861809|single dose|single dose
5609154|NCT00861809|gut motility|gut motility
5609155|NCT00861809|Type I Diabetes Mellitus patients|type i diabetes mellitus patients
5609156|NCT00861809|tolerability|tolerability
5609157|NCT00861809|phase II|phase ii
5609158|NCT00861809|13C octanoic acid breath test|13c octanoic acid breath test
5609159|NCT00861809|pharmacodynamics|pharmacodynamics
5609160|NCT00861809|gastric emtpying|gastric emtpying
5609161|NCT00861809|pharmacokinetics|pharmacokinetics
5609162|NCT00861783|oxaliplatin|oxaliplatin
5609163|NCT00861783|diaminocyclohexane oxalatoplatinum|diaminocyclohexane oxalatoplatinum
5609164|NCT00861783|oxalatoplatin|oxalatoplatin
5609165|NCT00861783|oxalatoplatinum|oxalatoplatinum
5609166|NCT00861783|Eloxatin|eloxatin
5609167|NCT00861770|Congestive Heart Failure|congestive heart failure
5609168|NCT00861770|Ultrafiltration|ultrafiltration
5609169|NCT00861770|Blood Volume Measurement|blood volume measurement
5609170|NCT00861744|Measles, Mumps, Rubella, Varicella Vaccine|measles, mumps, rubella, varicella vaccine
5609171|NCT00861744|Children|children
5609172|NCT00861744|Immunogenicity|immunogenicity
5609173|NCT00861744|Safety|safety
5609174|NCT00861744|Humans|humans
5609175|NCT00861744|Combined Vaccine|combined vaccine
5609176|NCT00861744|Vaccines|vaccines
5609177|NCT00861731|chronic renal failure|chronic renal failure
5609178|NCT00861731|proteinuria|proteinuria
5609179|NCT00861731|apolipoprotein|apolipoprotein
5609180|NCT00861731|c reactive protein|c reactive protein
5609181|NCT00861718|Phase 1|phase 1
5609182|NCT00861718|Healthy Volunteer|healthy volunteer
5609183|NCT00861692|Argatroban|argatroban
5609184|NCT00861692|heparin induced thrombocytopenia (HIT)|heparin induced thrombocytopenia (hit)
5609185|NCT00861692|direct thrombin inhibitor (DTI)|direct thrombin inhibitor (dti)
5609186|NCT00861679|HSCT|hsct
5609187|NCT00861679|ALL|all
5609188|NCT00861679|GvHD|gvhd
5609189|NCT00861666|Forgiveness|forgiveness
5609190|NCT00861666|Writing|writing
5609191|NCT00861666|PTSD|ptsd
5609192|NCT00861666|OEF|oef
5609193|NCT00861666|OIF|oif
5609194|NCT00861666|Veterans|veterans
5609195|NCT00861653|Atherosclerosis|atherosclerosis
5609196|NCT00861653|Subjects diagnosed with atherosclerosis|subjects diagnosed with atherosclerosis
5609197|NCT00861640|rabeprazole|rabeprazole
5609198|NCT00861640|omeprazole|omeprazole
5609199|NCT00861640|upper gastrointestinal bleeding|upper gastrointestinal bleeding
5609200|NCT00861627|REOLYSIN|reolysin
5609201|NCT00861627|reovirus|reovirus
5609202|NCT00861627|non-small cell lung cancer|non-small cell lung cancer
5609203|NCT00861627|carcinoma|carcinoma
5609204|NCT00861627|oncolytics virus|oncolytics virus
5609205|NCT00861627|chemotherapy|chemotherapy
5609206|NCT00861627|paclitaxel|paclitaxel
5609207|NCT00861627|carboplatin|carboplatin
5609208|NCT00861588|complementary & alternative medicine|complementary & alternative medicine
5609209|NCT00861588|randomized control trial|randomized control trial
5609210|NCT00861588|uroflowmetry|uroflowmetry
5609211|NCT00861588|quality of life|quality of life
5609212|NCT00861588|benign prostate hyperplasia|benign prostate hyperplasia
5609213|NCT00861575|Cardiovascular|cardiovascular
5609214|NCT00861562|constipation|constipation
5609215|NCT00861562|hemorrhoids|hemorrhoids
5609216|NCT00861562|water smartweed|water smartweed
5609217|NCT00861562|RCT|rct
5609218|NCT00861549|Bioavailability|bioavailability
5609219|NCT00861549|Pharmacokinetics|pharmacokinetics
5609220|NCT00861549|Safety Evaluation|safety evaluation
5609221|NCT00861536|risk factors|risk factors
5609222|NCT00861536|immunology|immunology
5609230|NCT00861510|Prolymphocytic Lymphoma (PLL)|prolymphocytic lymphoma (pll)
5609231|NCT00861510|Hairy Cell Leukemia (HCL)|hairy cell leukemia (hcl)
5609232|NCT00861510|Mantle Cell Lymphoma|mantle cell lymphoma
5609234|NCT00861510|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5609235|NCT00861510|CLL|cll
5609236|NCT00861510|Multiple Myeloma|multiple myeloma
5609237|NCT00861510|MM|mm
5609238|NCT00861497|Open-label|open-label
5609239|NCT00861497|Flexible-dose|flexible-dose
5609240|NCT00861497|Extension|extension
5609241|NCT00861497|Safety study|safety study
5609242|NCT00861471|hormone refractory prostate cancer|hormone refractory prostate cancer
5609243|NCT00861471|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5609244|NCT00861471|Gleevec|gleevec
5609245|NCT00861471|PSA|psa
5609246|NCT00861471|prostate specific antigen|prostate specific antigen
5609247|NCT00861471|growth factor receptor inhibitor|growth factor receptor inhibitor
5609248|NCT00861471|androgen independent|androgen independent
5609249|NCT00861445|Lacosamide, Vimpat®|lacosamide, vimpat®
5609250|NCT00861432|Life quality|life quality
5609251|NCT00861432|questionnaire|questionnaire
5609252|NCT00861432|tumor patients|tumor patients
5609253|NCT00861419|AMG 386|amg 386
5609254|NCT00861419|AMG 706|amg 706
5609255|NCT00861419|Bevacizumab|bevacizumab
5609256|NCT00861419|Sorafenib|sorafenib
5609257|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors
5609258|NCT00861419|Combination Therapy|combination therapy
5609259|NCT00861419|Peptibody|peptibody
5609260|NCT00861419|Sunitinib|sunitinib
5609261|NCT00861406|Melanoma|melanoma
5609262|NCT00861406|Stage II melanoma|stage ii melanoma
5609263|NCT00861406|Pegylated Interferon-alfa 2b|pegylated interferon-alfa 2b
5609264|NCT00861406|PEG Interferon alfa-2b|peg interferon alfa-2b
5609265|NCT00861406|PEG Intron|peg intron
5609266|NCT00861406|Melanoma Peptide Vaccine|melanoma peptide vaccine
5609267|NCT00861406|GP100 Vaccine|gp100 vaccine
5609268|NCT00861406|gp100|gp100
5609269|NCT00861406|peptide vaccine|peptide vaccine
5609270|NCT00861406|Leukapheresis|leukapheresis
5609271|NCT00861406|Immune-cell response|immune-cell response
5609272|NCT00861380|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5609273|NCT00861380|Invasive disease|invasive disease
5609274|NCT00861380|Respiratory tract infections|respiratory tract infections
5609275|NCT00861380|Haemophilus influenzae|haemophilus influenzae
5609276|NCT00861380|Streptococcus pneumoniae|streptococcus pneumoniae
5609277|NCT00861380|Acute otitis media|acute otitis media
5609278|NCT00861380|Pneumonia|pneumonia
5609279|NCT00861367|aspirin|aspirin
5609280|NCT00861367|blood loss|blood loss
5609281|NCT00861367|transurethral surgery|transurethral surgery
5609282|NCT00861354|atrial fibrillation|atrial fibrillation
5609283|NCT00861354|home blood pressure monitoring|home blood pressure monitoring
5609284|NCT00861341|Pioglitazone|pioglitazone
5609285|NCT00861341|Thiazolidinediones|thiazolidinediones
5609286|NCT00861341|Platelet Function|platelet function
5609287|NCT00861341|Platelet aggregation|platelet aggregation
5609288|NCT00861341|Diabetic|diabetic
5609289|NCT00861341|Aspirin.|aspirin.
5609291|NCT00861328|maximum tolerated dose|maximum tolerated dose
5609292|NCT00861328|oxaliplatin|oxaliplatin
5609293|NCT00861328|irinotecan|irinotecan
5609294|NCT00861328|ON 01910.Na|on 01910.na
5609295|NCT00861315|Pneumonia|pneumonia
5609296|NCT00861315|Nebulization|nebulization
5609297|NCT00861315|Amikacin|amikacin
5609298|NCT00861276|Smoking Cessation|smoking cessation
5609299|NCT00861276|Nicotine|nicotine
5609300|NCT00861276|Administration and dosage|administration and dosage
5609301|NCT00861276|Randomized Controlled Trial|randomized controlled trial
5609302|NCT00861250|Bortezomib plus dexamethasone induction therapy|bortezomib plus dexamethasone induction therapy
5609303|NCT00861250|Autologous stem cell transplantation|autologous stem cell transplantation
5609304|NCT00861250|Molecular remission|molecular remission
5609305|NCT00861237|Nux vomica|nux vomica
5609306|NCT00861237|homeopathy|homeopathy
5609307|NCT00861237|heart lung machine|heart lung machine
5609308|NCT00861237|heart surgery|heart surgery
5609309|NCT00861237|postoperatively studied|postoperatively studied
5609310|NCT00861211|asthma|asthma
5609311|NCT00861211|inflammation|inflammation
5609312|NCT00861211|bronchoconstriction|bronchoconstriction
5609313|NCT00861211|allergen challenge|allergen challenge
5609314|NCT00861211|KCa3.1|kca3.1
5609315|NCT00861185|bronchospasm|bronchospasm
5609316|NCT00861185|exercise asthma|exercise asthma
5609324|NCT00861172|Physiopathology|physiopathology
5609325|NCT00861172|Physiopathology of active lesions formation in Multiple Sclerosis using multimodal MR sequences|physiopathology of active lesions formation in multiple sclerosis using multimodal mr sequences
5609326|NCT00861159|RLIP76 Auto Antibodies|rlip76 auto antibodies
5609327|NCT00861146|nicotine dependence|nicotine dependence
5609328|NCT00861146|tobacco dependence|tobacco dependence
5609329|NCT00861146|smoking cessation|smoking cessation
5609330|NCT00861146|alcoholism|alcoholism
5609331|NCT00861146|self-efficacy|self-efficacy
5609332|NCT00861146|relapse|relapse
5609333|NCT00861133|cardiac monitor|cardiac monitor
5609334|NCT00861133|loop recorder|loop recorder
5609335|NCT00861133|stroke|stroke
5609337|NCT00861133|Implantable Loop Recorder|implantable loop recorder
5609338|NCT00861133|cryptogenic|cryptogenic
5609339|NCT00861133|ILR|ilr
5609340|NCT00861120|Ovarian cancer|ovarian cancer
5609341|NCT00861120|KRAS wildtype|kras wildtype
5609342|NCT00861120|Platinum resistant|platinum resistant
5609343|NCT00861107|Colorectal cancer|colorectal cancer
5609344|NCT00861107|Breast Cancer|breast cancer
5609345|NCT00861107|Melanoma|melanoma
5609346|NCT00861107|GI cancer|gi cancer
5609347|NCT00861107|Prostate cancer|prostate cancer
5609348|NCT00861107|Kidney cancer|kidney cancer
5609349|NCT00861107|Lung cancer|lung cancer
5609350|NCT00861107|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation|all types metastatic cancer where at least one tumor lesion is accessable for percutaneous cryoablation
5609351|NCT00861094|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5609352|NCT00861094|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5609353|NCT00861094|stage IIA esophageal cancer|stage iia esophageal cancer
5609354|NCT00861094|stage IIB esophageal cancer|stage iib esophageal cancer
5609355|NCT00861094|stage IIIA esophageal cancer|stage iiia esophageal cancer
5609356|NCT00861094|stage IIIB esophageal cancer|stage iiib esophageal cancer
5609357|NCT00861094|stage IIIC esophageal cancer|stage iiic esophageal cancer
5609358|NCT00861094|stage IV esophageal cancer|stage iv esophageal cancer
5609359|NCT00861081|Group Clinics|group clinics
5609360|NCT00861081|Self Management|self management
5609361|NCT00861068|Lacosamide, Vimpat®|lacosamide, vimpat®
5609362|NCT00861042|Lacosamide, Vimpat®|lacosamide, vimpat®
5609363|NCT00861029|GW786034, pazopanib, moxifloxacin, ECG intervals and morphology, QTc, Holter monitor, pharmacokinetics, safety, cancer|gw786034, pazopanib, moxifloxacin, ecg intervals and morphology, qtc, holter monitor, pharmacokinetics, safety, cancer
5609364|NCT00861016|Post marketing study|post marketing study
5609365|NCT00861003|schizophrenia|schizophrenia
5609366|NCT00861003|adherence|adherence
5609367|NCT00860977|HIV|hiv
5609368|NCT00860977|Herpes simplex virus type II|herpes simplex virus type ii
5609369|NCT00860977|Genital herpes|genital herpes
5609370|NCT00860977|Treatment Naive|treatment naive
5609371|NCT00860964|estradiol valerate|estradiol valerate
5609372|NCT00860964|Medroxyprogesterone|medroxyprogesterone
5609373|NCT00860964|menopause|menopause
5609374|NCT00860964|Lipid|lipid
5609375|NCT00860964|Bone mineral density|bone mineral density
5609376|NCT00860964|Body Composition|body composition
5609377|NCT00860951|Normal|normal
5609378|NCT00860938|Inhaled corticosteroids|inhaled corticosteroids
5609379|NCT00860938|COPD|copd
5609380|NCT00860938|mannitol|mannitol
5609381|NCT00860925|Randomized Controlled Trial|randomized controlled trial
5609382|NCT00860925|Blinded|blinded
5609383|NCT00860925|Clonidine|clonidine
5609388|NCT00860912|Cystocele|cystocele
5609389|NCT00860912|Prolapse|prolapse
5609390|NCT00860899|clonidine|clonidine
5609391|NCT00860899|levobupivacaine|levobupivacaine
5609392|NCT00860899|preoperative analgesia|preoperative analgesia
5609393|NCT00860899|postoperative pain|postoperative pain
5609394|NCT00860899|systemic inflammatory stress response|systemic inflammatory stress response
5609395|NCT00860899|epidural analgesia|epidural analgesia
5609396|NCT00860899|Anesthetics, Local|anesthetics, local
5609403|NCT00860860|radioimmunotherapy|radioimmunotherapy
5609404|NCT00860860|pretargeting|pretargeting
5609405|NCT00860860|bispecific antibody|bispecific antibody
5609406|NCT00860860|lutetium 177|lutetium 177
5609407|NCT00860860|phase I clinical trial|phase i clinical trial
5609408|NCT00860847|Progression of Atherosclerosis|progression of atherosclerosis
5609409|NCT00860847|Aged garlic extract|aged garlic extract
5609410|NCT00860847|Biomarkers of inflammation|biomarkers of inflammation
5609411|NCT00860847|Coronary Plaque Volume and coronary Stenosis|coronary plaque volume and coronary stenosis
5609412|NCT00860847|Vascular function|vascular function
5609413|NCT00860834|Consumer Participation|consumer participation
5609414|NCT00860834|Telephone Coaching Program|telephone coaching program
5609415|NCT00860821|Healthy subjects|healthy subjects
5609416|NCT00860821|LPS|lps
5609417|NCT00860821|Effect|effect
5609418|NCT00860821|Intranasally|intranasally
5609419|NCT00860808|tinnitus|tinnitus
5609420|NCT00860795|Echinacea|echinacea
5609421|NCT00860795|prevention|prevention
5609422|NCT00860795|immune modulation|immune modulation
5609423|NCT00860782|Sickle Cell Disease|sickle cell disease
5609424|NCT00860782|Educational Outcomes|educational outcomes
5609425|NCT00860782|Neurodevelopmental Functioning|neurodevelopmental functioning
5609426|NCT00860756|sleep|sleep
5609427|NCT00860756|disturbance|disturbance
5609428|NCT00860756|deployment|deployment
5609429|NCT00860756|intervention|intervention
5609430|NCT00860756|actigraph|actigraph
5609431|NCT00860743|intermittent hypoxia|intermittent hypoxia
5609432|NCT00860743|ventilatory long-term facilitation|ventilatory long-term facilitation
5609433|NCT00860743|autonomic nervous system plasticity|autonomic nervous system plasticity
5609434|NCT00860730|Aortic valve replacement|aortic valve replacement
5609435|NCT00860730|Aortic stenosis|aortic stenosis
5609436|NCT00860730|Biological valve|biological valve
5609437|NCT00860730|Sutureless valve|sutureless valve
5609438|NCT00860730|Stented valve|stented valve
5609439|NCT00860730|Aortic Valve Disease|aortic valve disease
5609440|NCT00860717|Leprosy|leprosy
5609441|NCT00860717|Ulcers|ulcers
5609442|NCT00860717|Laser|laser
5609443|NCT00860704|goal directed fluid therapy|goal directed fluid therapy
5609444|NCT00860704|lean patients|lean patients
5609445|NCT00860704|obese patients|obese patients
5609446|NCT00860704|crystalloids|crystalloids
5609447|NCT00860704|Esophageal Doppler|esophageal doppler
5609448|NCT00860704|tissue oxygenation|tissue oxygenation
5609449|NCT00860704|Fluid management during surgery|fluid management during surgery
5609450|NCT00860704|Fluid management|fluid management
5609451|NCT00860691|Curative surgical resection|curative surgical resection
5609452|NCT00860691|Laparoscopic technique|laparoscopic technique
5609453|NCT00860665|colorectal cancer|colorectal cancer
5609454|NCT00860665|prevention|prevention
5609455|NCT00860665|colonoscopy|colonoscopy
5609456|NCT00860665|screening|screening
5609457|NCT00860665|quality assessment|quality assessment
5609458|NCT00860665|colorectal cancer prevention|colorectal cancer prevention
5609459|NCT00860652|Oncology|oncology
5609460|NCT00860652|Prostate Cancer|prostate cancer
5609461|NCT00860652|Radiotherapy|radiotherapy
5609462|NCT00860652|Radical Prostatectomy|radical prostatectomy
5609463|NCT00860652|Prior Radical Prostatectomy (RP)|prior radical prostatectomy (rp)
5609464|NCT00860652|Histological Confirmation of adenocarcinoma of the prostate|histological confirmation of adenocarcinoma of the prostate
5609465|NCT00860652|Positive margins and/or extraprostatic extension (EPE)|positive margins and/or extraprostatic extension (epe)
5609466|NCT00860639|AML|aml
5609467|NCT00860639|gemtuzumab ozogamycin|gemtuzumab ozogamycin
5609468|NCT00860613|gestational diabetes|gestational diabetes
5609469|NCT00860613|medical nutrition therapy program|medical nutrition therapy program
5609470|NCT00860613|glucose monitoring|glucose monitoring
5609471|NCT00860613|metabolic control|metabolic control
5609472|NCT00860613|nutritional status|nutritional status
5609473|NCT00860613|cost effectiveness|cost effectiveness
5609474|NCT00860600|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
5609475|NCT00860600|Platelet Response|platelet response
5609476|NCT00860600|PG2 Treatment|pg2 treatment
5609477|NCT00860600|Quality of Life|quality of life
5609478|NCT00860600|Fatigue|fatigue
5609479|NCT00860600|WHO Bleeding score|who bleeding score
5609480|NCT00860587|Antibiotic resistance|antibiotic resistance
5609481|NCT00860587|Antibiotic treatment|antibiotic treatment
5609482|NCT00860561|Efficacy profile|efficacy profile
5609483|NCT00860561|Safety profile|safety profile
5609484|NCT00860561|Faslodex|faslodex
5609485|NCT00860522|relapsed leukemia|relapsed leukemia
5609486|NCT00860522|refractory leukemia|refractory leukemia
5609487|NCT00860509|phytosterols|phytosterols
5609488|NCT00860509|cholesterol excretion|cholesterol excretion
5609489|NCT00860509|cholesterol absorption|cholesterol absorption
5609491|NCT00860509|mass spectrometry|mass spectrometry
5609492|NCT00860509|deuterium|deuterium
5609493|NCT00860496|Immunosuppression, JAK3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability|immunosuppression, jak3 inhibitor, calcineurin inhibitors, tacrolimus, cyclosporine, pharmacokinetics, safety, tolerability
5609494|NCT00860483|Comparison of experienced and novice laparoscopic surgeons|comparison of experienced and novice laparoscopic surgeons
5609495|NCT00860470|micronutrients|micronutrients
5609496|NCT00860470|deficiency|deficiency
5609497|NCT00860470|pregnancy|pregnancy
5609498|NCT00860470|birth outcomes|birth outcomes
5609499|NCT00860470|infant mortality|infant mortality
5609500|NCT00860470|neonatal mortality|neonatal mortality
5609501|NCT00860470|malnutrition|malnutrition
5609502|NCT00860470|antenatal|antenatal
5609503|NCT00860457|Leukemia|leukemia
5609504|NCT00860444|Primary Care|primary care
5609505|NCT00860444|Diet|diet
5609506|NCT00860444|Physical Activity|physical activity
5609507|NCT00860418|asthma|asthma
5609508|NCT00860418|feedback|feedback
5609509|NCT00860418|anti-inflammatory|anti-inflammatory
5609511|NCT00860366|Acute ischemic stroke|acute ischemic stroke
5609512|NCT00860366|thrombolysis|thrombolysis
5609513|NCT00860366|alteplase|alteplase
5609514|NCT00860366|uric acid|uric acid
5609515|NCT00860366|neuroprotection|neuroprotection
5609516|NCT00860366|oxidative stress|oxidative stress
5609517|NCT00860353|Healthy Volunteer|healthy volunteer
5609518|NCT00860353|Single Ascending Dose|single ascending dose
5609520|NCT00860353|Tolerability|tolerability
5609521|NCT00860353|AZD2551|azd2551
5609522|NCT00860353|Healthy Volunteer Study|healthy volunteer study
5609523|NCT00860340|Congestive Heart Failure|congestive heart failure
5609524|NCT00860340|Hemodynamics|hemodynamics
5609525|NCT00860340|Echocardiographs|echocardiographs
5609526|NCT00860327|Pediatric Heart Disease|pediatric heart disease
5609527|NCT00860327|Congenital Heart Disease|congenital heart disease
5609528|NCT00860327|Congenital Heart Defects|congenital heart defects
5609529|NCT00860327|Developmental Biology|developmental biology
5609530|NCT00860327|Contractile Function|contractile function
5609531|NCT00860314|external electrical cardioversion|external electrical cardioversion
5609532|NCT00860314|typical atrial flutter|typical atrial flutter
5609533|NCT00860314|electrode position|electrode position
5609534|NCT00860314|antero-lateral|antero-lateral
5609535|NCT00860314|antero-posterior|antero-posterior
5609536|NCT00860314|biphasic cardioversion|biphasic cardioversion
5609537|NCT00860314|step-up protocol|step-up protocol
5609538|NCT00860301|infantile colic|infantile colic
5609539|NCT00860288|Type 2 Diabetes|type 2 diabetes
5609540|NCT00860288|vildagliptin|vildagliptin
5609541|NCT00860249|education|education
5609542|NCT00860249|preventive service|preventive service
5609543|NCT00860249|screening|screening
5609544|NCT00860249|Colorectal Cancer Screening|colorectal cancer screening
5609545|NCT00860249|Prevention & Control|prevention & control
5609546|NCT00860236|CFS|cfs
5609547|NCT00860236|Giardia|giardia
5609548|NCT00860236|Fatigue|fatigue
5609549|NCT00860236|Cognitive behavioural therapy|cognitive behavioural therapy
5609550|NCT00860236|CBT|cbt
5609551|NCT00860236|Chronic fatigue syndrome|chronic fatigue syndrome
5609552|NCT00860223|Healthy Subjects|healthy subjects
5609553|NCT00860197|Coffee|coffee
5609554|NCT00860197|Elderly|elderly
5609555|NCT00860197|Immune response|immune response
5609556|NCT00860197|Inflammatory status|inflammatory status
5609557|NCT00860184|carotid artery|carotid artery
5609558|NCT00860184|atherosclerosis|atherosclerosis
5609559|NCT00860184|stroke|stroke
5609560|NCT00860184|transient ischemic attack|transient ischemic attack
5609561|NCT00860184|MRI|mri
5609562|NCT00860184|software|software
5609563|NCT00860184|risk|risk
5609564|NCT00860145|epilepsy|epilepsy
5609565|NCT00860145|radiosurgery|radiosurgery
5609566|NCT00860145|temporal lobectomy|temporal lobectomy
5609567|NCT00860132|hip fracture elderly orthogeriatric|hip fracture elderly orthogeriatric
5609568|NCT00860132|cost effectiveness of hip fracture patients|cost effectiveness of hip fracture patients
5609569|NCT00860119|Bioequivalence, Pharmacokinetics, Alprazolam, Sublingual|bioequivalence, pharmacokinetics, alprazolam, sublingual
5609570|NCT00860106|VTE|vte
5609571|NCT00860106|VKA treatment|vka treatment
5609572|NCT00860106|VKA treatment cessation|vka treatment cessation
5609573|NCT00860093|Kidney Calculi|kidney calculi
5609574|NCT00860093|Urolithiasis|urolithiasis
5609575|NCT00860093|Lithotripsy|lithotripsy
5609576|NCT00860093|potassium compounds|potassium compounds
5609577|NCT00860093|magnesium compounds|magnesium compounds
5609578|NCT00860080|post-surgery adhesion formation|post-surgery adhesion formation
5609579|NCT00860067|influenza, FluMist, adults, vaccine|influenza, flumist, adults, vaccine
5609580|NCT00860054|phytosterols|phytosterols
5609581|NCT00860054|cholesterol excretion|cholesterol excretion
5609582|NCT00860054|cholesterol absorption|cholesterol absorption
5609583|NCT00860054|diet|diet
5609584|NCT00860054|mass spectrometry|mass spectrometry
5609586|NCT00860041|pain|pain
5609587|NCT00860041|neurotoxicity|neurotoxicity
5609588|NCT00860041|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5609589|NCT00860041|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5609590|NCT00860028|Smoking cessation|smoking cessation
5609591|NCT00860028|Smoking|smoking
5609592|NCT00860028|Tobacco|tobacco
5609593|NCT00860028|Varenicline|varenicline
5609594|NCT00860028|Alcohol|alcohol
5609595|NCT00860002|myomectomy|myomectomy
5609596|NCT00860002|uterine artery occlusion|uterine artery occlusion
5609597|NCT00860002|uterine vessel occlusion|uterine vessel occlusion
5609598|NCT00860002|fibroids|fibroids
5609599|NCT00860002|leiomyomas|leiomyomas
5609600|NCT00860002|Surgical technique, patient suffering and outcomes|surgical technique, patient suffering and outcomes
5609601|NCT00859989|breast cancer|breast cancer
5609602|NCT00859989|weight changes|weight changes
5609603|NCT00859989|obesity|obesity
5609604|NCT00859976|BoneMaster|bonemaster
5609605|NCT00859976|Total Hip Replacement|total hip replacement
5609606|NCT00859976|Bone Density|bone density
5609607|NCT00859976|Patients suitable for Total Hip Replacement|patients suitable for total hip replacement
5603341|NCT00885144|LNS|lns
5609608|NCT00859963|Press fit tibial tray|press fit tibial tray
5609609|NCT00859950|Sleep Apnea|sleep apnea
5609610|NCT00859950|Vascular Occlusion|vascular occlusion
5592365|NCT00921570|TWEAK|tweak
5609611|NCT00859950|Nocturnal Polysomnography|nocturnal polysomnography
5609612|NCT00859950|Continuous Positive Airway Pressure|continuous positive airway pressure
5609613|NCT00859911|micronutrients|micronutrients
5609614|NCT00859898|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5609615|NCT00859898|Diabetes Mellitus|diabetes mellitus
5609616|NCT00859898|Endocrine System Diseases|endocrine system diseases
5609620|NCT00859898|Dapagliflozin|dapagliflozin
5609621|NCT00859898|Hypoglycemic Agents|hypoglycemic agents
5609622|NCT00859898|Pharmacologic Actions|pharmacologic actions
5609623|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs
5609624|NCT00859885|patent foramen ovale|patent foramen ovale
5609625|NCT00859885|ischemic stroke|ischemic stroke
5609626|NCT00859885|transient ischemic attack|transient ischemic attack
5609627|NCT00859885|secondary prevention|secondary prevention
5609628|NCT00859885|medical treatment|medical treatment
5609629|NCT00859885|percutaneous device closure|percutaneous device closure
5609630|NCT00859872|acute psychotic agitation|acute psychotic agitation
5609631|NCT00859872|schizophrenia|schizophrenia
5609632|NCT00859872|risperidone oral solution|risperidone oral solution
5609633|NCT00859872|clonazepam|clonazepam
5609634|NCT00859872|haloperidol|haloperidol
5609635|NCT00859846|Arterial line|arterial line
5609636|NCT00859846|Ultrasound|ultrasound
5609637|NCT00859846|Anesthesia|anesthesia
5609638|NCT00859846|Pediatric|pediatric
5609639|NCT00859833|adenosine|adenosine
5609640|NCT00859833|regadenoson|regadenoson
5609641|NCT00859833|adenosine receptor subtypes|adenosine receptor subtypes
5609642|NCT00859807|Amodiaquine suspension|amodiaquine suspension
5609643|NCT00859807|Flavoquine tablets|flavoquine tablets
5609644|NCT00859807|Bioequivalence study|bioequivalence study
5609645|NCT00859794|Epilepsy|epilepsy
5609646|NCT00859794|fMRI|fmri
5609647|NCT00859794|Electrophysiology|electrophysiology
5609648|NCT00859794|Cortical Mapping|cortical mapping
5609649|NCT00859794|Neurosurgery|neurosurgery
5609651|NCT00859768|Cancer|cancer
5609653|NCT00859729|Vaccine|vaccine
5609654|NCT00859729|Electroporation|electroporation
5609655|NCT00859729|xenogenic|xenogenic
5609656|NCT00859729|PSA|psa
5609657|NCT00859716|Vaccination|vaccination
5609658|NCT00859716|Diarrhea|diarrhea
5609659|NCT00859716|Traveler's Diarrhea|traveler's diarrhea
5609660|NCT00859716|Campylobacter jejuni|campylobacter jejuni
5609661|NCT00859716|C. jejuni|c. jejuni
5609662|NCT00859716|Campylobacter|campylobacter
5609663|NCT00859716|Campy|campy
5609664|NCT00859703|Aromatase inhibitor treatment|aromatase inhibitor treatment
5609665|NCT00859703|osteoporosis|osteoporosis
5609666|NCT00859703|breast cancer|breast cancer
5609667|NCT00859703|bisphosphonates|bisphosphonates
5609668|NCT00859690|Obstructive Sleep Apnea|obstructive sleep apnea
5609669|NCT00859690|Thrombosis|thrombosis
5609670|NCT00859690|Adenosine Deaminase|adenosine deaminase
5609671|NCT00859690|Sleep Disorder|sleep disorder
5609672|NCT00859677|HIV|hiv
5609673|NCT00859677|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5609674|NCT00859677|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
5609675|NCT00859651|breast cancer chemoprevention|breast cancer chemoprevention
5609676|NCT00859651|vitamin D|vitamin d
5609677|NCT00859651|breast density|breast density
5609678|NCT00859625|colonoscopy|colonoscopy
5609679|NCT00859625|adenoma detection rate|adenoma detection rate
5609680|NCT00859599|Monochromatic Phototherapy|monochromatic phototherapy
5609681|NCT00859599|Diabetic Foot Ulcers|diabetic foot ulcers
5609682|NCT00859599|Wound healing|wound healing
5609683|NCT00859599|Bacterial colonisation|bacterial colonisation
5609684|NCT00859586|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5609685|NCT00859586|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5609686|NCT00859586|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5609687|NCT00859586|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5609688|NCT00859586|Acute Myelogenous Leukemia|acute myelogenous leukemia
5609690|NCT00859586|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5609691|NCT00859586|ALL|all
5609692|NCT00859586|Myelodysplastic Syndrome|myelodysplastic syndrome
5609693|NCT00859586|MDS|mds
5609694|NCT00859560|Breast cancer|breast cancer
5609695|NCT00859560|post-menopausal women|post-menopausal women
5609696|NCT00859560|Arimidex|arimidex
5609697|NCT00859560|bone fracture|bone fracture
5609698|NCT00859534|Solar Urticaria|solar urticaria
5609699|NCT00859521|Bioequivalence|bioequivalence
5609700|NCT00859521|Healthy Subjects|healthy subjects
5609701|NCT00859508|dura repair following cranial surgery|dura repair following cranial surgery
5609702|NCT00859482|natalizumab|natalizumab
5609703|NCT00859482|multiple sclerosis|multiple sclerosis
5609704|NCT00859469|Mesothelioma|mesothelioma
5609705|NCT00859430|Bioequivalence|bioequivalence
5795081|NCT00124228|Sepsis|sepsis
5609706|NCT00859430|Healthy Subjects|healthy subjects
5609707|NCT00859417|correction of anterior prolapse|correction of anterior prolapse
5609710|NCT00859404|Mild to moderate persistent asthma|mild to moderate persistent asthma
5609713|NCT00859378|Hip endoprosthesis|hip endoprosthesis
5592460|NCT00921206|influenza|influenza
5609714|NCT00859378|Hip fracture|hip fracture
5609715|NCT00859378|Femoral fracture|femoral fracture
5609716|NCT00859378|Bone cement|bone cement
5609717|NCT00859378|Non-cemented|non-cemented
5609718|NCT00859365|back pain|back pain
5609719|NCT00859365|neck pain|neck pain
5609720|NCT00859365|anxiety|anxiety
5609721|NCT00859365|range of motion|range of motion
5609722|NCT00859339|TCC|tcc
5609723|NCT00859300|myocardial infarction|myocardial infarction
5609724|NCT00859300|ventricular fibrillation|ventricular fibrillation
5609725|NCT00859300|sudden death|sudden death
5609726|NCT00859300|polymorphism|polymorphism
5609727|NCT00859287|Reflux esophagitis|reflux esophagitis
5609728|NCT00859287|Omepral®|omepral®
5609729|NCT00859287|QOLRAD|qolrad
5609730|NCT00859235|Percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5609731|NCT00859235|peristomal wound infection|peristomal wound infection
5609732|NCT00859235|antibiotic mouth wash solution|antibiotic mouth wash solution
5609733|NCT00859235|prophylaxis prior Percutaneous endoscopic gastrostomy (PEG)|prophylaxis prior percutaneous endoscopic gastrostomy (peg)
5609734|NCT00859222|LBH589|lbh589
5609735|NCT00859222|bevacizumab|bevacizumab
5609736|NCT00859222|Avastin|avastin
5609737|NCT00859222|Panobinostat|panobinostat
5609738|NCT00859209|HVF|hvf
5609739|NCT00859209|Premature infants|premature infants
5609740|NCT00859209|ETCO2|etco2
5609741|NCT00859196|Wound healing|wound healing
5609742|NCT00859196|Cell proliferation|cell proliferation
5609743|NCT00859196|Gene expression|gene expression
5609744|NCT00859183|in-stent restenosis|in-stent restenosis
5609745|NCT00859183|stents|stents
5609746|NCT00859183|sirolimus|sirolimus
5609747|NCT00859170|kidney stones|kidney stones
5609748|NCT00859170|ureter|ureter
5609749|NCT00859170|laser lithotripsy|laser lithotripsy
5609750|NCT00859157|perioperative/postoperative complications|perioperative/postoperative complications
5609751|NCT00859157|pain|pain
5609752|NCT00859157|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5609753|NCT00859157|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5609754|NCT00859157|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5609755|NCT00859157|stage IA breast cancer|stage ia breast cancer
5609756|NCT00859157|stage IB breast cancer|stage ib breast cancer
5609757|NCT00859157|stage II breast cancer|stage ii breast cancer
5609758|NCT00859157|stage IIIA breast cancer|stage iiia breast cancer
5609759|NCT00859157|stage IIIB breast cancer|stage iiib breast cancer
5609760|NCT00859144|HIV Prevention|hiv prevention
5609761|NCT00859144|Youth|youth
5609762|NCT00859144|Adolescent|adolescent
5609763|NCT00859144|Community Collaboration|community collaboration
5609764|NCT00859144|Community Mentorship|community mentorship
5609765|NCT00859144|Minority|minority
5609766|NCT00859144|Urban|urban
5609767|NCT00859144|Sexual Risk Behaviors|sexual risk behaviors
5609768|NCT00859144|HIV seronegativity|hiv seronegativity
5609769|NCT00859079|diabetes mellitus type 2, GLP-1, insulin infusion|diabetes mellitus type 2, glp-1, insulin infusion
5609770|NCT00859040|recurrent intracranial meningioma(s)|recurrent intracranial meningioma(s)
5609771|NCT00859040|progressive intracranial meningioma(s)|progressive intracranial meningioma(s)
5609772|NCT00859027|Non-metastatic|non-metastatic
5609773|NCT00858975|renal tumor|renal tumor
5609774|NCT00858975|cryotherapy|cryotherapy
5609775|NCT00858975|cytokine|cytokine
5609776|NCT00858962|HIV|hiv
5609777|NCT00858962|Pharmacokinetics|pharmacokinetics
5609778|NCT00858962|Pharmacodynamics|pharmacodynamics
5609779|NCT00858962|Buprenorphine|buprenorphine
5609780|NCT00858962|Raltegravir|raltegravir
5609781|NCT00858962|HIV seronegativity|hiv seronegativity
5609782|NCT00858962|Interaction|interaction
5609783|NCT00858949|Outpatient surgery|outpatient surgery
5609784|NCT00858949|Postoperative nausea and vomiting|postoperative nausea and vomiting
5609785|NCT00858949|Costs|costs
5609786|NCT00858949|Observational|observational
5609787|NCT00858936|CABG(coronary artery bypass graft)|cabg(coronary artery bypass graft)
5609788|NCT00858936|Ischemia|ischemia
5609789|NCT00858936|Heart surgery|heart surgery
5609790|NCT00858936|Heart damage|heart damage
5609791|NCT00858923|Extracorporeal Photophoresis|extracorporeal photophoresis
5609792|NCT00858923|immuno-therapy|immuno-therapy
5609793|NCT00858923|treatment naive|treatment naive
5609794|NCT00858910|Motor imagery|motor imagery
5609795|NCT00858910|Motor skill|motor skill
5609796|NCT00858910|Performance improvement|performance improvement
5609797|NCT00858897|Glutathione|glutathione
5609798|NCT00858884|Systemic lupus erythematosus|systemic lupus erythematosus
5609799|NCT00858884|Libman-Sacks endocarditis|libman-sacks endocarditis
5609800|NCT00858884|Stroke|stroke
5609801|NCT00858884|Transient ischemic attack|transient ischemic attack
5609802|NCT00858884|Neuropsychiatric systemic lupus erythematosus|neuropsychiatric systemic lupus erythematosus
5609803|NCT00858884|Transesophageal echocardiography|transesophageal echocardiography
5609804|NCT00858884|Magnetic resonance imaging|magnetic resonance imaging
5609806|NCT00858845|Skeletal Myopathy|skeletal myopathy
5609807|NCT00858845|Sympathetic Nerve Activity|sympathetic nerve activity
5609808|NCT00858819|Osteoporosis|osteoporosis
5609809|NCT00858819|Fractures|fractures
5609810|NCT00858819|Bone Mineral Density|bone mineral density
5609811|NCT00858819|Quantitative Computed Tomography|quantitative computed tomography
5609814|NCT00858793|Lymphoma|lymphoma
5609815|NCT00858793|Stem Cell Transplantation|stem cell transplantation
5609816|NCT00858793|gene-modified Stem Cells|gene-modified stem cells
5609817|NCT00858793|treatment experienced|treatment experienced
5609818|NCT00858767|vitamin K2|vitamin k2
5609819|NCT00858767|absorption|absorption
5609820|NCT00858767|efficacy|efficacy
5609821|NCT00858754|opioid induced constipation|opioid induced constipation
5609822|NCT00858754|Cancer patients|cancer patients
5609823|NCT00858754|methylnaltrexone|methylnaltrexone
5609824|NCT00858741|bone metastases from any histological subtype.|bone metastases from any histological subtype.
5609825|NCT00858728|Natural killer cell cytotoxicity|natural killer cell cytotoxicity
5609826|NCT00858728|Antibody response|antibody response
5609827|NCT00858728|Tetanus toxoid vaccination|tetanus toxoid vaccination
5609828|NCT00858728|Pneumovax II vaccination|pneumovax ii vaccination
5609829|NCT00858728|Total serum immunoglobulins|total serum immunoglobulins
5609830|NCT00858728|IgG subclasses|igg subclasses
5609831|NCT00858715|Clopidogrel|clopidogrel
5609832|NCT00858715|Aspirin|aspirin
5609833|NCT00858715|Antithrombotic therapy|antithrombotic therapy
5609834|NCT00858715|Platelet function testing|platelet function testing
5609835|NCT00858702|Essential hypertension|essential hypertension
5609836|NCT00858702|Combination therapy|combination therapy
5609837|NCT00858689|Clinical Drug Trial|clinical drug trial
5609838|NCT00858676|acarbose|acarbose
5609839|NCT00858676|diabetes mellitus|diabetes mellitus
5609840|NCT00858676|impaired glucose tolerance|impaired glucose tolerance
5609841|NCT00858676|coronary artery disease|coronary artery disease
5609842|NCT00858663|RAD001(Everolimus)|rad001(everolimus)
5609843|NCT00858663|Cisplatin|cisplatin
5609844|NCT00858663|08-138|08-138
5609845|NCT00858650|registry|registry
5609846|NCT00858650|natural history|natural history
5609847|NCT00858637|Chronic Kidney Disease|chronic kidney disease
5609848|NCT00858637|Dialysis|dialysis
5609849|NCT00858637|Dyslipidemia|dyslipidemia
5609850|NCT00858637|Bile acid sequestrant|bile acid sequestrant
5609851|NCT00858624|Cough|cough
5609852|NCT00858624|Cough reflex|cough reflex
5609853|NCT00858624|NMDA receptor|nmda receptor
5609854|NCT00858624|central sensitisation|central sensitisation
5609855|NCT00858611|Influenza|influenza
5609856|NCT00858611|Healthy|healthy
5609857|NCT00858611|Immunity|immunity
5609858|NCT00858611|Preventive|preventive
5609859|NCT00858611|Flu|flu
5609860|NCT00858611|Healthy Volunteer|healthy volunteer
5609861|NCT00858611|HV|hv
5609862|NCT00858598|Total Knee Arthroplasty|total knee arthroplasty
5609863|NCT00858598|Revision|revision
5609864|NCT00858598|Tibial|tibial
5609865|NCT00858598|Void|void
5609866|NCT00858598|Bone Filler|bone filler
5609867|NCT00858585|Bone metastasis, SNP concordance|bone metastasis, snp concordance
5609868|NCT00858572|Synta|synta
5609869|NCT00858572|STA-9090|sta-9090
5609870|NCT00858572|AML|aml
5609871|NCT00858572|CML|cml
5609872|NCT00858572|MDS|mds
5609873|NCT00858572|myeloproliferative disorder|myeloproliferative disorder
5609874|NCT00858572|hematologic malignancy|hematologic malignancy
5609875|NCT00858572|ganetespib|ganetespib
5609876|NCT00858559|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5609877|NCT00858559|Remote monitoring|remote monitoring
5609878|NCT00858559|Follow-up|follow-up
5609879|NCT00858533|early intervention|early intervention
5609880|NCT00858533|sickness absence|sickness absence
5609881|NCT00858533|return to work|return to work
5609882|NCT00858533|primary care|primary care
5609884|NCT00858520|Lung cancer|lung cancer
5609885|NCT00858520|genes|genes
5609887|NCT00858494|upper respiratory tract infection|upper respiratory tract infection
5609888|NCT00858494|children|children
5609889|NCT00858494|homeopathic|homeopathic
5609890|NCT00858481|Pediculosis capitis|pediculosis capitis
5609891|NCT00858481|Head Lice|head lice
5609892|NCT00858468|Influenza|influenza
5609893|NCT00858468|Influenza vaccine|influenza vaccine
5609894|NCT00858455|Healthy Volunteers|healthy volunteers
5609895|NCT00858455|Drug interation, Pharmacokinetics|drug interation, pharmacokinetics
5609896|NCT00858442|Burn sequelae|burn sequelae
5609897|NCT00858442|PRP|prp
5609898|NCT00858442|Children|children
5609899|NCT00858429|advanced adult primary liver cancer|advanced adult primary liver cancer
5609900|NCT00858429|liver metastases|liver metastases
5795359|NCT00122941|HIV|hiv
5609901|NCT00858429|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5609902|NCT00858403|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5609903|NCT00858377|Amgen|amgen
5775461|NCT00220441|IGT|igt
5609905|NCT00858377|First in Human|first in human
5609906|NCT00858377|Advanced Solid Tumors|advanced solid tumors
5609907|NCT00858377|Clinical Trial|clinical trial
5609908|NCT00858377|Aurora kinase inhibitor|aurora kinase inhibitor
5609917|NCT00858364|malignant pleural effusion|malignant pleural effusion
5609918|NCT00858364|metastatic lung cancer|metastatic lung cancer
5609921|NCT00858364|lung cancer|lung cancer
5609922|NCT00858364|pleural effusion|pleural effusion
5609923|NCT00858364|Stage IIIB lung cancer|stage iiib lung cancer
5609924|NCT00858364|Stage IV lung cancer|stage iv lung cancer
5609925|NCT00858351|Diabetes|diabetes
5609926|NCT00858351|Neuropathy|neuropathy
5609927|NCT00858351|Peripheral|peripheral
5609928|NCT00858351|Painful|painful
5609929|NCT00858351|Thermal|thermal
5609930|NCT00858351|Temperature|temperature
5609931|NCT00858351|Biofeedback|biofeedback
5609932|NCT00858351|Relaxation|relaxation
5609933|NCT00858351|Diabetic|diabetic
5609934|NCT00858338|stomach cancer|stomach cancer
5609935|NCT00858338|gastroesophageal junction cancer|gastroesophageal junction cancer
5609936|NCT00858338|GEJ cancer|gej cancer
5609937|NCT00858338|intraperitoneal|intraperitoneal
5609938|NCT00858338|adjuvant chemoradiation therapy|adjuvant chemoradiation therapy
5609939|NCT00858338|resection of advanced stomach cancer|resection of advanced stomach cancer
5609940|NCT00858338|locally advanced stomach cancer|locally advanced stomach cancer
5609941|NCT00858325|Cubicin|cubicin
5609942|NCT00858325|PK|pk
5609943|NCT00858325|China Registration|china registration
5609944|NCT00858325|Pharmacokinetics|pharmacokinetics
5609945|NCT00858312|dairy foods|dairy foods
5609946|NCT00858312|weight loss|weight loss
5609947|NCT00858312|fat loss|fat loss
5609948|NCT00858312|metabolic regulation|metabolic regulation
5609949|NCT00858299|proteinuria|proteinuria
5609950|NCT00858299|chronic kidney disease|chronic kidney disease
5609951|NCT00858299|renin-angiotensin system|renin-angiotensin system
5609952|NCT00858299|angiotensinogen|angiotensinogen
5609953|NCT00858273|Glutathione|glutathione
5609954|NCT00858260|Klotho|klotho
5609955|NCT00858260|calcium|calcium
5609956|NCT00858260|phosphate|phosphate
5609957|NCT00858260|parathormone|parathormone
5609958|NCT00858260|survival|survival
5609959|NCT00858260|dialysis|dialysis
5609960|NCT00858260|Adult patients undergoing maintenance dialysis since at leat three months|adult patients undergoing maintenance dialysis since at leat three months
5609961|NCT00858247|vitamin D|vitamin d
5609962|NCT00858247|Obesity|obesity
5609963|NCT00858247|Insulin sensitivity|insulin sensitivity
5609964|NCT00858247|Adolescent Obesity|adolescent obesity
5609965|NCT00858221|obesity|obesity
5609966|NCT00858221|genes|genes
5609967|NCT00858221|polymorphisms|polymorphisms
5609968|NCT00858221|weight loss|weight loss
5609969|NCT00858221|haplotype|haplotype
5609970|NCT00858221|diplotype|diplotype
5609971|NCT00858208|efficacy and safety of Macugen in routine clinical practice|efficacy and safety of macugen in routine clinical practice
5609972|NCT00858195|Anti-inflammatory|anti-inflammatory
5609973|NCT00858182|L-Carnitine|l-carnitine
5609974|NCT00858182|Xylitol|xylitol
5609975|NCT00858182|Peritoneal Dialysis|peritoneal dialysis
5609976|NCT00858169|three-dimensional power Doppler ultrasonography|three-dimensional power doppler ultrasonography
5609977|NCT00858169|wrist|wrist
5609978|NCT00858169|knee|knee
5609979|NCT00858169|rheumatoid arthritis|rheumatoid arthritis
5609980|NCT00858156|Pharmacokinetics|pharmacokinetics
5609981|NCT00858143|Open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study|open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study
5609982|NCT00858130|Veinoplus|veinoplus
5609983|NCT00858130|post thrombotic syndrome|post thrombotic syndrome
5609984|NCT00858130|deep vein thrombosis|deep vein thrombosis
5609985|NCT00858130|electrical muscle stimulator|electrical muscle stimulator
5609986|NCT00858130|Venous stasis syndrome|venous stasis syndrome
5609987|NCT00858130|venous insufficiency syndrome|venous insufficiency syndrome
5609988|NCT00858130|Postphlebitic syndrome|postphlebitic syndrome
5609989|NCT00858130|history of deep vein thrombosis|history of deep vein thrombosis
5609990|NCT00858117|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5609991|NCT00858117|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5609992|NCT00858117|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5609993|NCT00858117|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5609994|NCT00858117|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5610003|NCT00858065|Adolescent alcohol and other drug use|adolescent alcohol and other drug use
5610005|NCT00858065|Family-based|family-based
5610006|NCT00858065|Prevention|prevention
5610007|NCT00858052|breast implants|breast implants
5610008|NCT00858052|saline|saline
5610009|NCT00858026|weaning|weaning
5610010|NCT00858026|breastfeeding|breastfeeding
5610011|NCT00858026|infant formula|infant formula
5610012|NCT00858026|fermented formula|fermented formula
5610013|NCT00858013|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5610014|NCT00858013|Nateglinide|nateglinide
5863016|NCT00001414|Behavior Genetics|behavior genetics
5610015|NCT00858013|Pancreatic beta cell function|pancreatic beta cell function
5610017|NCT00858000|expression analysis|expression analysis
5610018|NCT00857987|IRA, Guaifenesin, Etaphedrine, Doxilamine|ira, guaifenesin, etaphedrine, doxilamine
5610019|NCT00857974|Physical Activity|physical activity
5610020|NCT00857974|Renal Transplant Candidate|renal transplant candidate
5610021|NCT00857974|Physical Function|physical function
5610022|NCT00857974|Body Composition|body composition
5610023|NCT00857948|head lice|head lice
5592757|NCT00920244|Markov|markov
5610024|NCT00857948|Pediculus humanus capitis|pediculus humanus capitis
5610025|NCT00857948|ivermectin|ivermectin
5610026|NCT00857935|Pediculosis Capitis|pediculosis capitis
5610027|NCT00857935|Head Lice|head lice
5610028|NCT00857922|Neurological|neurological
5610029|NCT00857922|Neurosurgical|neurosurgical
5610030|NCT00857896|Study of fesoterodine in pediatric overactive bladder patients|study of fesoterodine in pediatric overactive bladder patients
5610031|NCT00857883|Obesity|obesity
5610032|NCT00857883|Food Effect|food effect
5610033|NCT00857883|Pharmacokinetics|pharmacokinetics
5610034|NCT00857883|First-Time-In-Humans|first-time-in-humans
5610035|NCT00857883|Pharmacodynamics|pharmacodynamics
5610036|NCT00857883|Healthy Volunteers|healthy volunteers
5610037|NCT00857857|asthma|asthma
5610038|NCT00857857|late phase response|late phase response
5610039|NCT00857857|allergen|allergen
5610040|NCT00857857|challenge|challenge
5610041|NCT00857857|GW870086X|gw870086x
5610042|NCT00857844|Chronic Nephrotoxicity|chronic nephrotoxicity
5610043|NCT00857844|Kidney dysfunction post liver transplant|kidney dysfunction post liver transplant
5610044|NCT00857844|Urinary biomarkers of chronic nephrotoxicity from CI|urinary biomarkers of chronic nephrotoxicity from ci
5610045|NCT00857831|spinal cord injury|spinal cord injury
5610046|NCT00857831|Vitamin D deficiency|vitamin d deficiency
5610047|NCT00857831|Functional Electrical Stimulation|functional electrical stimulation
5610048|NCT00857805|Transarterial chemoembolization|transarterial chemoembolization
5610049|NCT00857805|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5610050|NCT00857805|Proton Beam Radiotherapy|proton beam radiotherapy
5610051|NCT00857792|Coronary Disease|coronary disease
5610052|NCT00857792|Cardiac CT Imaging|cardiac ct imaging
5610053|NCT00857792|Stress Testing|stress testing
5610054|NCT00857792|Lexiscan (regadenoson)|lexiscan (regadenoson)
5610055|NCT00857779|allergen immunotherapy|allergen immunotherapy
5610056|NCT00857779|allergy to grass pollen|allergy to grass pollen
5610057|NCT00857766|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5610058|NCT00857766|arterial stiffness|arterial stiffness
5610059|NCT00857766|Computed Tomography|computed tomography
5610060|NCT00857766|pulse wave velocity|pulse wave velocity
5610061|NCT00857766|Pulse wave analysis|pulse wave analysis
5610062|NCT00857727|Dexmedetomidine|dexmedetomidine
5610268|NCT00857038|Doxycycline|doxycycline
5610063|NCT00857727|Emergence Delirium|emergence delirium
5610064|NCT00857727|Agitation|agitation
5610065|NCT00857727|Pediatric|pediatric
5610066|NCT00857727|Anesthesia|anesthesia
5610067|NCT00857714|DCIS|dcis
5610068|NCT00857714|breast|breast
5610069|NCT00857701|total knee arthroplasty|total knee arthroplasty
5610070|NCT00857701|Dynamic Splinting|dynamic splinting
5610071|NCT00857701|Knee extension|knee extension
5610072|NCT00857701|knee|knee
5610073|NCT00857701|Reduced knee flexion after total knee arthroscopy|reduced knee flexion after total knee arthroscopy
5610074|NCT00857688|aphtous|aphtous
5610075|NCT00857688|bismuth|bismuth
5610076|NCT00857688|procain|procain
5610077|NCT00857688|neomycin|neomycin
5610078|NCT00857688|Efficacy of the Association in Treatment of Aphtous|efficacy of the association in treatment of aphtous
5610079|NCT00857675|HBV DNA suppression|hbv dna suppression
5610080|NCT00857675|ALT normalisation|alt normalisation
5610081|NCT00857675|Viral resistance|viral resistance
5610082|NCT00857675|HBeAg seroconversion|hbeag seroconversion
5610083|NCT00857662|US Multicenter|us multicenter
5610084|NCT00857662|Randomized|randomized
5610085|NCT00857662|Onyx|onyx
5610086|NCT00857662|Brain Arteriovenous Malformation (BAVMs)|brain arteriovenous malformation (bavms)
5610087|NCT00857649|Alzheimer's Disease|alzheimer's disease
5610088|NCT00857636|Ethnic minority women|ethnic minority women
5610089|NCT00857636|Cancer screening|cancer screening
5610090|NCT00857636|Health literacy|health literacy
5610091|NCT00857636|Behavioral intervention|behavioral intervention
5610092|NCT00857636|Breast Cancer screening|breast cancer screening
5610093|NCT00857636|Cervical Cancer screening|cervical cancer screening
5610095|NCT00857623|Diabetic Neuropathy|diabetic neuropathy
5610097|NCT00857623|Analgesia|analgesia
5610098|NCT00857623|Efficacy|efficacy
5610100|NCT00857610|Photoaged skin|photoaged skin
5610102|NCT00857610|Topical retinoids|topical retinoids
5610103|NCT00857597|GERD|gerd
5610104|NCT00857597|endoscopic|endoscopic
5610105|NCT00857597|fundoplication|fundoplication
5610106|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors
5610107|NCT00857597|heartburn|heartburn
5610108|NCT00857597|anti-reflux surgery|anti-reflux surgery
5610109|NCT00857584|Bipolar disorder|bipolar disorder
5775756|NCT00218712|HIV|hiv
5610110|NCT00857584|Bipolar depression|bipolar depression
5603812|NCT00883246|PAD|pad
5610111|NCT00857584|quetiapine|quetiapine
5610112|NCT00857584|sertraline|sertraline
5610113|NCT00857571|Dose Response Bioavailability Study|dose response bioavailability study
5610114|NCT00857532|amyloid burden|amyloid burden
5610115|NCT00857532|Parkinson's disease|parkinson's disease
5610116|NCT00857532|florbetapir PET|florbetapir pet
5610117|NCT00857532|amyloid PET imaging|amyloid pet imaging
5610118|NCT00857519|retinoblastoma|retinoblastoma
5610119|NCT00857519|Intraarterial|intraarterial
5610120|NCT00857519|Chemotherapy|chemotherapy
5610121|NCT00857519|Melphalan|melphalan
5610122|NCT00857519|Carboplatin|carboplatin
5610123|NCT00857506|Cognitive outcome|cognitive outcome
5610124|NCT00857506|18F-AV-45 PET scan|18f-av-45 pet scan
5610125|NCT00857506|Amyloid PET scan|amyloid pet scan
5610126|NCT00857506|Florbetapir F 18 amyloid PET scan|florbetapir f 18 amyloid pet scan
5610127|NCT00857506|Normal cognition|normal cognition
5610128|NCT00857506|Change in cognitive status in relation to brain amyloid on PET|change in cognitive status in relation to brain amyloid on pet
5610129|NCT00857415|florbetapir F 18 PET|florbetapir f 18 pet
5610130|NCT00857415|amyloid imaging|amyloid imaging
5610131|NCT00857415|Amyloid pathology in the brain|amyloid pathology in the brain
5610132|NCT00857402|Arginine|arginine
5610133|NCT00857402|Nitric oxide|nitric oxide
5610134|NCT00857402|Peanuts|peanuts
5610135|NCT00857402|Sedimentation rate|sedimentation rate
5610136|NCT00857389|Cancer|cancer
5610137|NCT00857389|Blood And Marrow Transplantation|blood and marrow transplantation
5610138|NCT00857389|Stem Cell|stem cell
5610139|NCT00857389|Leukemia|leukemia
5610140|NCT00857389|Lymphoma|lymphoma
5610141|NCT00857389|Pediatrics|pediatrics
5610142|NCT00857389|Bone marrow|bone marrow
5610143|NCT00857389|Lymph node system|lymph node system
5610144|NCT00857389|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5610145|NCT00857389|ASCT|asct
5610146|NCT00857389|Busulfan|busulfan
5610147|NCT00857389|Busulfex|busulfex
5610148|NCT00857389|Myleran|myleran
5610149|NCT00857389|Clofarabine|clofarabine
5610150|NCT00857389|Clofarex|clofarex
5610151|NCT00857389|Clolar|clolar
5610152|NCT00857389|Thiotepa|thiotepa
5610153|NCT00857389|Antithymocyte globulin|antithymocyte globulin
5610154|NCT00857389|ATG|atg
5610155|NCT00857389|Thymoglobulin|thymoglobulin
5610156|NCT00857389|G-CSF|g-csf
5610157|NCT00857389|Filgrastim|filgrastim
5610158|NCT00857389|Neupogen|neupogen
5610159|NCT00857389|Cyclophosphamide|cyclophosphamide
5610160|NCT00857389|Cytoxan|cytoxan
5610161|NCT00857389|Neosar|neosar
5610162|NCT00857389|Mesna|mesna
5610163|NCT00857389|Mesnex|mesnex
5610164|NCT00857389|Tacrolimus|tacrolimus
5610165|NCT00857389|Prograf|prograf
5610166|NCT00857389|Methotrexate|methotrexate
5610457|NCT00856232|Headache|headache
5610167|NCT00857376|Heart disease risk factors|heart disease risk factors
5610168|NCT00857376|Risk factor management|risk factor management
5610169|NCT00857376|Pre-Diabetes|pre-diabetes
5610170|NCT00857376|Hypertension|hypertension
5610172|NCT00857376|glucose intolerance|glucose intolerance
5610173|NCT00857376|high cholesterol|high cholesterol
5610174|NCT00857376|abdominal obesity|abdominal obesity
5610175|NCT00857376|enlarged waist|enlarged waist
5610176|NCT00857363|capsule|capsule
5610177|NCT00857363|constipation|constipation
5610178|NCT00857363|whole gut transit|whole gut transit
5610179|NCT00857363|colonic transit|colonic transit
5610180|NCT00857363|gastric emptying|gastric emptying
5610181|NCT00857363|small bowel transit|small bowel transit
5610182|NCT00857350|HIV|hiv
5610183|NCT00857350|resistance|resistance
5610184|NCT00857350|opioid dependence|opioid dependence
5610185|NCT00857324|Refractory or relapsed patients|refractory or relapsed patients
5610186|NCT00857324|dose-finding|dose-finding
5610187|NCT00857324|Vorinostat|vorinostat
5610188|NCT00857298|HIV|hiv
5610189|NCT00857298|Metabolic Syndrome|metabolic syndrome
5610190|NCT00857298|Obesity|obesity
5610191|NCT00857298|Treatment Experienced|treatment experienced
5610192|NCT00857272|colonoscopy|colonoscopy
5610193|NCT00857272|bowel preparation|bowel preparation
5610195|NCT00857259|macular degeneration|macular degeneration
5610196|NCT00857259|Everolimus|everolimus
5610197|NCT00857259|Lucentis|lucentis
5610198|NCT00857259|Ranibizumab|ranibizumab
5610199|NCT00857259|Choroidal Neo-Vascular (CNV) age-onset macular degeneration|choroidal neo-vascular (cnv) age-onset macular degeneration
5610200|NCT00857259|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5610201|NCT00857246|stomach cancer|stomach cancer
5610202|NCT00857246|biologics|biologics
5610203|NCT00857246|antibody|antibody
5610204|NCT00857246|chemotherapy|chemotherapy
5610205|NCT00857246|chemoradiation|chemoradiation
5610206|NCT00857246|adjuvant therapy|adjuvant therapy
5610207|NCT00857246|neoadjuvant therapy|neoadjuvant therapy
5610208|NCT00857246|epidermal growth factor receptor|epidermal growth factor receptor
5610209|NCT00857246|combination therapy|combination therapy
5610210|NCT00857233|Alzheimer's Disease|alzheimer's disease
5610211|NCT00857220|Hypnotic|hypnotic
5610212|NCT00857220|Eszopiclone|eszopiclone
5610213|NCT00857220|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5610214|NCT00857220|Insomnia|insomnia
5610216|NCT00857220|Adolescent|adolescent
5610217|NCT00857207|Cognitive Therapy|cognitive therapy
5610218|NCT00857207|Outcomes Assessment|outcomes assessment
5610219|NCT00857194|Coronary Heart Disease|coronary heart disease
5610220|NCT00857194|spinal cord injury|spinal cord injury
5610221|NCT00857194|risk factor|risk factor
5610222|NCT00857194|postprandial lipemia|postprandial lipemia
5610223|NCT00857181|Liver Cirrhosis|liver cirrhosis
5610224|NCT00857181|Infection|infection
5610225|NCT00857181|Inflammation|inflammation
5610226|NCT00857181|Cytokines|cytokines
5610227|NCT00857155|Coronary Artery Disease|coronary artery disease
5610228|NCT00857155|CABG|cabg
5610229|NCT00857155|Clopidogrel|clopidogrel
5610230|NCT00857155|Aspirin|aspirin
5610231|NCT00857155|Point of Care devices|point of care devices
5610232|NCT00857129|"normal birth"|"normal birth"
5610233|NCT00857129|"birth outcome"|"birth outcome"
5610234|NCT00857129|"low risk birth"|"low risk birth"
5610235|NCT00857129|"low risk units"|"low risk units"
5610236|NCT00857129|If type of birth care unit have effect on birth outcome|if type of birth care unit have effect on birth outcome
5610237|NCT00857129|Apgar score|apgar score
5610238|NCT00857129|breast feeding frequency|breast feeding frequency
5610239|NCT00857129|patient satisfaction|patient satisfaction
5610240|NCT00857116|Deworming|deworming
5610241|NCT00857116|Tuberculosis|tuberculosis
5610242|NCT00857116|TB-score|tb-score
5610243|NCT00857116|Albendazole|albendazole
5610244|NCT00857116|Helminths|helminths
5610245|NCT00857103|computer support|computer support
5610246|NCT00857103|patient-provider communication|patient-provider communication
5610247|NCT00857103|patient-centered care|patient-centered care
5610248|NCT00857103|cancer|cancer
5610249|NCT00857090|Urinary Calculi|urinary calculi
5610250|NCT00857090|Urinary Stones|urinary stones
5610251|NCT00857090|Urinary Tract Stones|urinary tract stones
5610252|NCT00857090|Renal Calculi|renal calculi
5610253|NCT00857090|Kidney Stones|kidney stones
5610254|NCT00857090|Calculi|calculi
5610255|NCT00857090|Urolithotomy|urolithotomy
5610256|NCT00857090|Ureteroscopy|ureteroscopy
5610257|NCT00857077|incidence of anaemia|incidence of anaemia
5610258|NCT00857064|Schizophrenia|schizophrenia
5610259|NCT00857064|antipsychotics|antipsychotics
5610260|NCT00857064|social functioning|social functioning
5610261|NCT00857064|subjective well being|subjective well being
5610262|NCT00857064|Patients suffering from Schizophrenia|patients suffering from schizophrenia
5610263|NCT00857051|Stress|stress
5610264|NCT00857038|COPD|copd
5610265|NCT00857038|Inflammation|inflammation
5610266|NCT00857038|Neutrophilic|neutrophilic
5610267|NCT00857038|Myeloperoxidase|myeloperoxidase
5610269|NCT00857025|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5610270|NCT00857025|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5610271|NCT00857025|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5610272|NCT00857025|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5610273|NCT00857012|Primary early MCa|primary early mca
5610274|NCT00857012|Arimidex|arimidex
5610275|NCT00856999|Glabellar lines of moderate severity at maximum frown|glabellar lines of moderate severity at maximum frown
5610276|NCT00856973|Hypnotic|hypnotic
5610277|NCT00856973|Eszopiclone|eszopiclone
5610278|NCT00856973|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5610279|NCT00856973|Insomnia|insomnia
5610280|NCT00856973|Children|children
5610281|NCT00856973|Adolescent|adolescent
5610282|NCT00856973|Polysomnography|polysomnography
5610283|NCT00856973|Actigraphy|actigraphy
5610284|NCT00856947|wheeze|wheeze
5610285|NCT00856947|infections|infections
5610286|NCT00856947|allergy|allergy
5610287|NCT00856947|eczema|eczema
5610288|NCT00856947|vitamin D|vitamin d
5610289|NCT00856934|Skin graft donor site healing|skin graft donor site healing
5610290|NCT00856934|skin|skin
5610291|NCT00856934|wound|wound
5610292|NCT00856934|platelet concentrate|platelet concentrate
5610293|NCT00856934|keratinocytes|keratinocytes
5610294|NCT00856934|burns|burns
5610295|NCT00856921|Relationship between achalasia and AAAS gene|relationship between achalasia and aaas gene
5610296|NCT00856908|Type II Diabetes|type ii diabetes
5610297|NCT00856895|Improved Life Quality|improved life quality
5610298|NCT00856856|Bioabsorbable|bioabsorbable
5610299|NCT00856856|Coronary Stent|coronary stent
5610300|NCT00856856|Everolimus|everolimus
5610301|NCT00856856|Drug eluting stents|drug eluting stents
5610302|NCT00856856|Stents|stents
5610303|NCT00856856|Angioplasty|angioplasty
5610304|NCT00856856|Coronary artery disease (CAD)|coronary artery disease (cad)
5610305|NCT00856856|Total coronary occlusion|total coronary occlusion
5610306|NCT00856856|Coronary artery restenosis|coronary artery restenosis
5610307|NCT00856856|Stent thrombosis|stent thrombosis
5610308|NCT00856856|Vascular disease|vascular disease
5610309|NCT00856856|Myocardial ischemia|myocardial ischemia
5610310|NCT00856856|Coronary artery stenosis|coronary artery stenosis
5610311|NCT00856843|colonoscopy|colonoscopy
5610312|NCT00856843|bowel preparation|bowel preparation
5610313|NCT00856830|Small cell lung cancer|small cell lung cancer
5610315|NCT00856830|Bendamustine|bendamustine
5610316|NCT00856830|Irinotecan|irinotecan
5610317|NCT00856830|Etoposide|etoposide
5610318|NCT00856830|Carboplatin|carboplatin
5610319|NCT00856804|Thalidomide|thalidomide
5610320|NCT00856804|Hepatitis C|hepatitis c
5610321|NCT00856804|Interferon resistance|interferon resistance
5610322|NCT00856804|Immunomodulators|immunomodulators
5610324|NCT00856791|Cancer|cancer
5610325|NCT00856791|Cisplatin|cisplatin
5610326|NCT00856791|Carboplatin|carboplatin
5610327|NCT00856778|Male sling|male sling
5610328|NCT00856778|stress urinary incontinence|stress urinary incontinence
5610329|NCT00856778|urinary incontinence|urinary incontinence
5610330|NCT00856739|obesity|obesity
5610331|NCT00856739|arthritis|arthritis
5610332|NCT00856700|GLP-1|glp-1
5610333|NCT00856700|Endothelial Function|endothelial function
5610334|NCT00856700|Metabolic Syndrome|metabolic syndrome
5610335|NCT00856687|Asthma Allergen Challenge|asthma allergen challenge
5610336|NCT00856674|IgA nephropathy|iga nephropathy
5610337|NCT00856674|chemokine fusion protein|chemokine fusion protein
5610338|NCT00856674|leukocyte population modulator|leukocyte population modulator
5610339|NCT00856674|phase-1|phase-1
5610340|NCT00856661|Acute ischemic stroke|acute ischemic stroke
5610341|NCT00856661|Angiography|angiography
5610342|NCT00856661|Desmoteplase|desmoteplase
5610343|NCT00856661|Thrombolytic|thrombolytic
5610344|NCT00856622|open-angle glaucoma ocular hypertension glaucoma|open-angle glaucoma ocular hypertension glaucoma
5610345|NCT00856609|Weight Loss|weight loss
5610346|NCT00856609|Byetta (Exenatide)|byetta (exenatide)
5610347|NCT00856609|Energy Expenditure|energy expenditure
5610348|NCT00856609|Food Intake|food intake
5610349|NCT00856609|Obesity|obesity
5610350|NCT00856596|Tinea pedis|tinea pedis
5610351|NCT00856596|Fungus|fungus
5610352|NCT00856596|Pruritus|pruritus
5610353|NCT00856596|Dermatophyte|dermatophyte
5610354|NCT00856596|Athlete's foot|athlete's foot
5610355|NCT00856596|Dermatomycosis|dermatomycosis
5610356|NCT00856596|Skin manifestation|skin manifestation
5610357|NCT00856596|Infectious skin disease|infectious skin disease
5610358|NCT00856596|Foot diseases|foot diseases
5610359|NCT00856570|YM178|ym178
5610360|NCT00856570|Mirabegron|mirabegron
5610362|NCT00856570|Phase I|phase i
5610363|NCT00856570|Warfarin|warfarin
5610364|NCT00856570|Pharmacokinetics|pharmacokinetics
5610365|NCT00856557|Patients with complex psychosocial needs|patients with complex psychosocial needs
5610366|NCT00856544|Arthritis|arthritis
5610367|NCT00856544|Rheumatoid|rheumatoid
5610368|NCT00856544|Antirheumatic Agents|antirheumatic agents
5610369|NCT00856544|Clinical Trial|clinical trial
5610370|NCT00856531|Möbius syndrome|möbius syndrome
5610371|NCT00856531|Language|language
5610372|NCT00856531|Speech, Language and Hearing Sciences|speech, language and hearing sciences
5610373|NCT00856518|Multiple Sclerosis|multiple sclerosis
5610374|NCT00856518|Parkinson's disease|parkinson's disease
5610375|NCT00856518|Dysphagia|dysphagia
5610376|NCT00856505|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5610377|NCT00856505|Drug Therapy, Combination|drug therapy, combination
5610378|NCT00856505|Immunosuppression|immunosuppression
5610379|NCT00856492|inflammatory breast cancer|inflammatory breast cancer
5610380|NCT00856492|stage II breast cancer|stage ii breast cancer
5610381|NCT00856492|stage IIIA breast cancer|stage iiia breast cancer
5610382|NCT00856492|stage IIIB breast cancer|stage iiib breast cancer
5610383|NCT00856492|HER2-negative breast cancer|her2-negative breast cancer
5610384|NCT00856492|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5610385|NCT00856492|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5671703|NCT00614731|IgG antibodies|igg antibodies
5610386|NCT00856492|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5610387|NCT00856492|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5610388|NCT00856492|stage IIIC breast cancer|stage iiic breast cancer
5610390|NCT00856479|cost analysis|cost analysis
5610391|NCT00856479|Non union diaphyseal fracture|non union diaphyseal fracture
5610392|NCT00856479|The efficacy of Infuse BMP 2 in Non union diaphyseal fractures. Also the cost analysis with the amount of time spent in hospital post op.|the efficacy of infuse bmp 2 in non union diaphyseal fractures. also the cost analysis with the amount of time spent in hospital post op.
5610393|NCT00856453|fatigue|fatigue
5610394|NCT00856453|depression|depression
5610395|NCT00856453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5610396|NCT00856453|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5610397|NCT00856453|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5610398|NCT00856453|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5610399|NCT00856453|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5610400|NCT00856453|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5610401|NCT00856453|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5610402|NCT00856453|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5610403|NCT00856453|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5610404|NCT00856453|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5610406|NCT00856427|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5610407|NCT00856427|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5610408|NCT00856427|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5610409|NCT00856427|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5610410|NCT00856427|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5610411|NCT00856427|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5610412|NCT00856401|hypoparathyroidism|hypoparathyroidism
5610413|NCT00856401|hypopara|hypopara
5610415|NCT00856401|parathyroid hormone|parathyroid hormone
5610416|NCT00856401|CL-11-040|cl-11-040
5610417|NCT00856401|CL1-11 Study|cl1-11 study
5610418|NCT00856401|NPSP 558|npsp 558
5610419|NCT00856401|RELAY|relay
5610420|NCT00856401|RACE|race
5610421|NCT00856401|REPLACE|replace
5610422|NCT00856401|HEXT|hext
5610423|NCT00856401|c10-007|c10-007
5610424|NCT00856401|c10-008|c10-008
5610425|NCT00856401|NPSP558|npsp558
5610426|NCT00856401|Columbia study|columbia study
5610427|NCT00856401|Columbia studies|columbia studies
5610428|NCT00856401|HPTH|hpth
5610429|NCT00856401|PTH1-84|pth1-84
5610430|NCT00856375|colorectal cancer|colorectal cancer
5610431|NCT00856375|Colorectal cancer, second line|colorectal cancer, second line
5610432|NCT00856362|Healthy Subjects|healthy subjects
5610433|NCT00856349|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5610434|NCT00856349|Cardiac Resynchronization Therapy-Defibrillator (CRT-D)|cardiac resynchronization therapy-defibrillator (crt-d)
5610435|NCT00856349|Lead Integrity Alert (LIA)|lead integrity alert (lia)
5610436|NCT00856349|Therapy Programming Report (TPR)|therapy programming report (tpr)
5610437|NCT00856323|Methamphetamine|methamphetamine
5610438|NCT00856323|HIV|hiv
5610439|NCT00856323|Post-exposure prophylaxis|post-exposure prophylaxis
5610440|NCT00856323|HIV seronegativity|hiv seronegativity
5610441|NCT00856310|Healthy volunteers|healthy volunteers
5610442|NCT00856297|Meningococcal|meningococcal
5610443|NCT00856297|ACWY|acwy
5610444|NCT00856297|Conjugate Vaccine|conjugate vaccine
5610445|NCT00856297|Meningitis|meningitis
5610446|NCT00856297|Adolescents|adolescents
5610447|NCT00856297|Persistence|persistence
5610448|NCT00856284|Diabetes Mellitus|diabetes mellitus
5610449|NCT00856284|Drug Therapy|drug therapy
5610450|NCT00856284|Hyperinsulinism|hyperinsulinism
5610451|NCT00856284|Hyperglycemia|hyperglycemia
5610452|NCT00856284|Glucose Intolerance|glucose intolerance
5610453|NCT00856258|Multiple dose in healthy volunteers|multiple dose in healthy volunteers
5610454|NCT00856245|non-Hodgkins|non-hodgkins
5610455|NCT00856245|lymphoma|lymphoma
5610456|NCT00856245|stem cell transplant|stem cell transplant
5610458|NCT00856232|Cephalgia|cephalgia
5610459|NCT00856232|Migraine|migraine
5610460|NCT00856219|Immune System|immune system
5610461|NCT00856206|Metabolism, Inborn Errors|metabolism, inborn errors
5610462|NCT00856206|Allopurinol|allopurinol
5610463|NCT00856206|Metabolic Disease|metabolic disease
5610464|NCT00856206|Genetic Diseases, Inborn|genetic diseases, inborn
5610465|NCT00856206|Musculoskeletal Diseases|musculoskeletal diseases
5610466|NCT00856206|Joint Diseases|joint diseases
5610467|NCT00856206|Arthritis|arthritis
5610468|NCT00856206|Rheumatic Diseases|rheumatic diseases
5610469|NCT00856206|Metabolic disorder|metabolic disorder
5610470|NCT00856206|Purine Pyrimidine Metabolism, Inborn Errors|purine pyrimidine metabolism, inborn errors
5610471|NCT00856206|Gout|gout
5610472|NCT00856206|Intercritical Gout|intercritical gout
5610473|NCT00856193|COPD|copd
5610474|NCT00856193|Bronchodilator|bronchodilator
5610475|NCT00856180|avastin|avastin
5610476|NCT00856180|bevacizumab|bevacizumab
5610477|NCT00856180|cyclophosphamide|cyclophosphamide
5610478|NCT00856180|cytoxan|cytoxan
5610479|NCT00856180|mullerian malignancies|mullerian malignancies
5610480|NCT00856167|temporomandibular dysfunction|temporomandibular dysfunction
5610481|NCT00856167|TMD|tmd
5610482|NCT00856167|TMJ|tmj
5610483|NCT00856167|Traditional Chinese Medicine|traditional chinese medicine
5610484|NCT00856167|TCM|tcm
5610485|NCT00856154|HIV-1|hiv-1
5610486|NCT00856154|HLA-A2|hla-a2
5610487|NCT00856154|Therapeutic|therapeutic
5610488|NCT00856154|Vaccine|vaccine
5610489|NCT00856154|treatment vaccine|treatment vaccine
5610490|NCT00856154|treatment naive|treatment naive
5610491|NCT00856141|IOP measurement|iop measurement
5610492|NCT00856141|IOP fluctuation|iop fluctuation
5798765|NCT00111163|efficacy|efficacy
5610493|NCT00856141|in-vivo IOP measuring device|in-vivo iop measuring device
5610494|NCT00856141|intraocular pressure measurement|intraocular pressure measurement
5610495|NCT00856115|stage I colon cancer|stage i colon cancer
5596100|NCT00906516|Neuradiab|neuradiab
5610496|NCT00856115|stage II colon cancer|stage ii colon cancer
5610497|NCT00856115|stage III colon cancer|stage iii colon cancer
5610498|NCT00856115|stage IV colon cancer|stage iv colon cancer
5610499|NCT00856115|stage I rectal cancer|stage i rectal cancer
5610500|NCT00856115|stage II rectal cancer|stage ii rectal cancer
5610501|NCT00856115|stage III rectal cancer|stage iii rectal cancer
5610503|NCT00856076|Venous thromboembolism|venous thromboembolism
5610504|NCT00856076|Intrauterine fetal death|intrauterine fetal death
5610505|NCT00856076|Risk factor|risk factor
5610506|NCT00856076|Thrombophilia|thrombophilia
5610507|NCT00856076|Venous thromboembolism (in pregnancy)|venous thromboembolism (in pregnancy)
5610508|NCT00856063|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5610509|NCT00856063|Atomoxetine|atomoxetine
5610510|NCT00856063|Electrodermal Response|electrodermal response
5610511|NCT00856063|Impulsivity|impulsivity
5610512|NCT00856063|Preschool Children|preschool children
5610513|NCT00856050|estrogen receptor positive|estrogen receptor positive
5610514|NCT00856050|progesterone receptor positive|progesterone receptor positive
5610515|NCT00856050|letrozole|letrozole
5610516|NCT00855998|Thymidine Kinase 1|thymidine kinase 1
5610517|NCT00855998|BRCA1 and BRCA2 mutations|brca1 and brca2 mutations
5610518|NCT00855998|hereditary breast/ovarian cancer|hereditary breast/ovarian cancer
5610519|NCT00855985|Pancreatic anastomosis|pancreatic anastomosis
5610520|NCT00855985|Whipple operation|whipple operation
5610521|NCT00855959|Asthma|asthma
5610522|NCT00855959|Pulmicort Respules|pulmicort respules
5610523|NCT00855946|tumor response|tumor response
5610524|NCT00855946|rectal adenocarcinoma|rectal adenocarcinoma
5610525|NCT00855946|preoperative radiochemotherapy|preoperative radiochemotherapy
5610526|NCT00855946|Proteomic analysis|proteomic analysis
5610527|NCT00855946|MALDI-TOF-TOF|maldi-tof-tof
5610528|NCT00855946|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy|rectal adenocarcinoma, tumor response after preoperative radiochemotherapy
5610529|NCT00855920|Metabolism, Inborn Errors|metabolism, inborn errors
5610530|NCT00855920|Allopurinol|allopurinol
5610531|NCT00855920|Metabolic Diseases|metabolic diseases
5610532|NCT00855920|Genetic Diseases, Inborn|genetic diseases, inborn
5610533|NCT00855920|Musculoskeletal Diseases|musculoskeletal diseases
5610534|NCT00855920|Joint Diseases|joint diseases
5610535|NCT00855920|Arthritis|arthritis
5610536|NCT00855920|Rheumatic Diseases|rheumatic diseases
5610537|NCT00855920|Metabolic disorder|metabolic disorder
5610538|NCT00855920|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5610539|NCT00855920|Gout|gout
5610540|NCT00855920|Flare|flare
5610542|NCT00855907|inflammatory bowel disease|inflammatory bowel disease
5610543|NCT00855907|fatty liver|fatty liver
5610544|NCT00855894|Tarceva|tarceva
5610545|NCT00855894|NSCLC|nsclc
5610546|NCT00855881|adjuvant chemotherapy for head and neck cancer|adjuvant chemotherapy for head and neck cancer
5610547|NCT00855868|Amyloid imaging|amyloid imaging
5610548|NCT00855868|Positron Emission Tomography|positron emission tomography
5610549|NCT00855868|18F-AV-45|18f-av-45
5610550|NCT00855868|florbetapir F 18|florbetapir f 18
5610551|NCT00855868|Diagnostic imaging|diagnostic imaging
5610552|NCT00855855|Diphtheria|diphtheria
5610553|NCT00855855|Tetanus|tetanus
5610554|NCT00855855|Pertussis|pertussis
5610555|NCT00855855|Poliovirus types 1-3|poliovirus types 1-3
5610556|NCT00855855|Haemophilus influenzae type b|haemophilus influenzae type b
5610557|NCT00855855|Pentacel®|pentacel®
5610558|NCT00855842|second trimester abortion|second trimester abortion
5610559|NCT00855842|labor induction abortion|labor induction abortion
5610560|NCT00855842|second trimester medical abortion|second trimester medical abortion
5610561|NCT00855842|pregnancy|pregnancy
5610562|NCT00855803|spinal cord metastases|spinal cord metastases
5610563|NCT00855803|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5610564|NCT00855803|pain|pain
5610565|NCT00855790|evaluate the effectiveness of one bite polypectomy with the RJ3 biopsy forcep versus the RJ4 biopsy forcep|evaluate the effectiveness of one bite polypectomy with the rj3 biopsy forcep versus the rj4 biopsy forcep
5610566|NCT00855777|third molar extraction|third molar extraction
5610567|NCT00855777|etoricoxib|etoricoxib
5610568|NCT00855777|ibuprofen|ibuprofen
5610569|NCT00855777|analgesic efficacy|analgesic efficacy
5610570|NCT00855777|pain|pain
5610571|NCT00855738|epilepsy antiepileptic biotherapy|epilepsy antiepileptic biotherapy
5610572|NCT00855725|Epilepsy|epilepsy
5610573|NCT00855725|Depression|depression
5610574|NCT00855725|Neurology|neurology
5610575|NCT00855725|fMRI|fmri
5610576|NCT00855725|Healthy Controls|healthy controls
5610577|NCT00855712|Heart Failure|heart failure
5610578|NCT00855712|Transplant|transplant
5610579|NCT00855712|Warm Perfusion|warm perfusion
5610580|NCT00855712|Organ Care|organ care
5610581|NCT00855712|Resting Mode|resting mode
5610582|NCT00855699|Alcohol detoxification|alcohol detoxification
5610583|NCT00855686|Memantine|memantine
5610584|NCT00855686|Cognition|cognition
5610585|NCT00855686|Parkinson's Disease Dementia|parkinson's disease dementia
5610586|NCT00855686|Dementia With Lewy Bodies|dementia with lewy bodies
5610587|NCT00855673|Claudication|claudication
5610588|NCT00855673|Peripheral Arterial Disease|peripheral arterial disease
5610589|NCT00855673|Intermittent Compression|intermittent compression
5610590|NCT00855673|Mechanical Compression|mechanical compression
5610591|NCT00855673|Flowmedic|flowmedic
5610592|NCT00855660|Bone Metabolism|bone metabolism
5610593|NCT00855634|Pancreatic cancer|pancreatic cancer
5610594|NCT00855634|metastasis|metastasis
5610595|NCT00855634|venous infiltration|venous infiltration
5610596|NCT00855634|Pancreatic cancer with minimal metastatic disease or venous infiltration|pancreatic cancer with minimal metastatic disease or venous infiltration
5610597|NCT00855621|deep brain stimulation|deep brain stimulation
5610598|NCT00855621|subthalamic nucleus|subthalamic nucleus
5610599|NCT00855608|choroidal neovascularization|choroidal neovascularization
5610600|NCT00855608|diabetic retinopathy|diabetic retinopathy
5610602|NCT00855608|refractory cases of uveitis|refractory cases of uveitis
5610603|NCT00855595|Rosacea|rosacea
5610604|NCT00855582|Erectile Dysfunction|erectile dysfunction
5610605|NCT00855582|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5610606|NCT00855569|allografting|allografting
5610607|NCT00855530|Depression|depression
5610608|NCT00855504|preeclampsia|preeclampsia
5610609|NCT00855504|periodontitis|periodontitis
5610610|NCT00855504|cytokines|cytokines
5610612|NCT00855491|POCO|poco
5610613|NCT00855465|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5610614|NCT00855465|PH|ph
5610615|NCT00855465|soluble Guanylate Cyclase Stimulator|soluble guanylate cyclase stimulator
5610616|NCT00855465|sGC|sgc
5610617|NCT00855452|GVL|gvl
5610618|NCT00855452|rIL-2(LAK)|ril-2(lak)
5610619|NCT00855452|GVHD|gvhd
5610620|NCT00855452|MST|mst
5610621|NCT00855452|alloCT|alloct
5610622|NCT00855452|alloBMT|allobmt
5610623|NCT00855439|Diabetes|diabetes
5610624|NCT00855439|Neuropathy|neuropathy
5610625|NCT00855439|Glucose|glucose
5610626|NCT00855439|Control|control
5610627|NCT00855439|Peripheral|peripheral
5610628|NCT00855439|Autonomic|autonomic
5610629|NCT00855413|Acute HIV|acute hiv
5610630|NCT00855413|HIV|hiv
5610631|NCT00855413|Treatment Naive|treatment naive
5610632|NCT00855413|Acute Infections|acute infections
5610633|NCT00855400|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5610634|NCT00855400|Bone marrow|bone marrow
5610635|NCT00855400|Stem cells|stem cells
5610636|NCT00855400|Autologous|autologous
5610637|NCT00855400|Safety|safety
5610638|NCT00855387|Clinical outcome (complications), in-hospital costs|clinical outcome (complications), in-hospital costs
5610639|NCT00855387|The influence and impact of postoperative complications on in-hospital costs|the influence and impact of postoperative complications on in-hospital costs
5610640|NCT00855361|Gastroesophageal Reflux|gastroesophageal reflux
5610641|NCT00855361|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
5610642|NCT00855361|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
5610643|NCT00855361|Endoscopy|endoscopy
5610644|NCT00855361|Pediatrics|pediatrics
5610645|NCT00855361|GERD|gerd
5610646|NCT00855361|Rabeprazole, Rabeprazole sodium|rabeprazole, rabeprazole sodium
5610647|NCT00855361|AcipHex|aciphex
5610648|NCT00855348|colorectal cancer|colorectal cancer
5610649|NCT00855348|early detection|early detection
5610650|NCT00855348|methylation, biomarker|methylation, biomarker
5610651|NCT00855335|HIV-1|hiv-1
5610652|NCT00855335|HIV|hiv
5610653|NCT00855335|Pregnancy|pregnancy
5610654|NCT00855335|Postpartum|postpartum
5610655|NCT00855335|Human immunodeficiency virus|human immunodeficiency virus
5610656|NCT00855335|PREZISTA|prezista
5610657|NCT00855335|INTELENCE|intelence
5610658|NCT00855335|NORVIR|norvir
5610659|NCT00855335|TMC114|tmc114
5610660|NCT00855335|TMC125|tmc125
5610661|NCT00855335|darunavir|darunavir
5610662|NCT00855335|ritonavir|ritonavir
5610663|NCT00855335|etravirine|etravirine
5610664|NCT00855335|rilpivirine|rilpivirine
5610665|NCT00855335|TMC278|tmc278
5610666|NCT00855335|Cobicistat|cobicistat
5610667|NCT00855335|treatment experienced|treatment experienced
5610668|NCT00855322|Arthritis, Rheumatoid|arthritis, rheumatoid
5610669|NCT00855322|Exercise|exercise
5610670|NCT00855322|Biological Therapy|biological therapy
5610671|NCT00855309|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5610672|NCT00855309|renal toxicity|renal toxicity
5610673|NCT00855309|infection|infection
5610674|NCT00855309|neutropenia|neutropenia
5610675|NCT00855270|PTSD|ptsd
5610676|NCT00855257|Acid nicotinique|acid nicotinique
5610677|NCT00855257|FLOW MEDIATED DILATATION (FMD)|flow mediated dilatation (fmd)
5610678|NCT00855257|HDL-C< 0.4 G/L|hdl-c< 0.4 g/l
5610679|NCT00855244|Bone marrow transplantation|bone marrow transplantation
5610680|NCT00855231|Acute coronary syndrome|acute coronary syndrome
5610681|NCT00855231|Coronary artery disease|coronary artery disease
5610682|NCT00855231|cardiac imaging|cardiac imaging
5610683|NCT00855231|computed tomography|computed tomography
5610684|NCT00855218|Sorafenib|sorafenib
5610685|NCT00855218|TACE|tace
5610686|NCT00855218|DC bead|dc bead
5610688|NCT00855205|pulmonary sarcoidosis|pulmonary sarcoidosis
5610689|NCT00855192|anxiety|anxiety
5610690|NCT00855192|depression|depression
5610691|NCT00855192|pregnancy|pregnancy
5610692|NCT00855192|antenatal|antenatal
5610693|NCT00855192|prenatal|prenatal
5610694|NCT00855192|mindfulness-based therapy|mindfulness-based therapy
5610695|NCT00855192|interpersonal therapy|interpersonal therapy
5610696|NCT00855192|support groups|support groups
5604400|NCT00880529|ventilator|ventilator
5610697|NCT00855166|Dapagliflozin|dapagliflozin
5610698|NCT00855166|Metformin|metformin
5610699|NCT00855166|Type 2 diabetes|type 2 diabetes
5610700|NCT00855166|body weight|body weight
5610701|NCT00855153|PTSD|ptsd
5610702|NCT00855153|burns|burns
5610703|NCT00855153|virtual reality exposure|virtual reality exposure
5610704|NCT00855153|D-Cycloserine|d-cycloserine
5610705|NCT00855153|Combat related psychological trauma in burned servicemembers|combat related psychological trauma in burned servicemembers
5610706|NCT00855140|Insomnia|insomnia
5610707|NCT00855140|Primary insomnia|primary insomnia
5610708|NCT00855140|Insomnia disorder|insomnia disorder
5610709|NCT00855140|Acupuncture|acupuncture
5610710|NCT00855127|Biological Markers|biological markers
5610711|NCT00855127|Renal Replacement Therapy|renal replacement therapy
5610712|NCT00855127|Mortality|mortality
5610713|NCT00855114|stage II breast cancer|stage ii breast cancer
5610714|NCT00855114|stage III breast cancer|stage iii breast cancer
5610715|NCT00855114|stage IIIA breast cancer|stage iiia breast cancer
5610716|NCT00855101|Pharmacokinetics and safety of voriconazole intravenous oral adults|pharmacokinetics and safety of voriconazole intravenous oral adults
5610717|NCT00855088|HIV seronegativity|hiv seronegativity
5610718|NCT00855075|Sedation|sedation
5610719|NCT00855075|Analgesia|analgesia
5610720|NCT00855075|Mechanical ventilation|mechanical ventilation
5610721|NCT00855075|Cerebral State Monitor|cerebral state monitor
5610722|NCT00855075|Cerebral State Index|cerebral state index
5610723|NCT00855062|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5610724|NCT00855062|HIV associated cognitive impairment|hiv associated cognitive impairment
5610725|NCT00855062|HIV dementia|hiv dementia
5610726|NCT00855062|Uganda|uganda
5610727|NCT00855062|Acquired immune deficiency syndrome (AIDS)|acquired immune deficiency syndrome (aids)
5610728|NCT00855062|Treatment Naive|treatment naive
5610729|NCT00855049|Pharmacokinetics|pharmacokinetics
5610730|NCT00855049|Acetaminophen|acetaminophen
5610731|NCT00855049|Intranasal|intranasal
5610732|NCT00855049|Absorption|absorption
5610733|NCT00855036|blunt renal injury|blunt renal injury
5610734|NCT00855036|kidney laceration|kidney laceration
5610735|NCT00855023|anterior cruciate ligament|anterior cruciate ligament
5610736|NCT00855023|Knee Joint|knee joint
5610737|NCT00855010|Pioglitazone|pioglitazone
5610738|NCT00855010|prediabetes|prediabetes
5610739|NCT00855010|diabetes|diabetes
5610740|NCT00855010|obesity|obesity
5610741|NCT00855010|Pancreatic fat|pancreatic fat
5610742|NCT00854997|Obstructive sleep apnea; myocardial infarction|obstructive sleep apnea; myocardial infarction
5610743|NCT00854984|Depression|depression
5610744|NCT00854984|diabetes|diabetes
5610745|NCT00854984|Coronary heart disease|coronary heart disease
5610746|NCT00854984|CBT|cbt
5610747|NCT00854984|Cognitive behavioural therapy|cognitive behavioural therapy
5610748|NCT00854971|NKCell|nkcell
5610749|NCT00854971|FOLFOX-4|folfox-4
5610750|NCT00854971|advanced or unresectable colorectal cancer|advanced or unresectable colorectal cancer
5610751|NCT00854958|Oral|oral
5610755|NCT00854958|Pollen|pollen
5610756|NCT00854945|Myelodysplastic Syndrome|myelodysplastic syndrome
5610757|NCT00854945|Refractory Cytopenia|refractory cytopenia
5610758|NCT00854945|Refractory Anemia|refractory anemia
5610759|NCT00854945|Dysplasia|dysplasia
5610760|NCT00854945|Acute Myeloid Leukemia|acute myeloid leukemia
5610761|NCT00854932|procalcitonin|procalcitonin
5610762|NCT00854932|sepsis|sepsis
5610763|NCT00854932|newborn|newborn
5610764|NCT00854932|intervention study|intervention study
5610765|NCT00854919|obsessive-compulsive disorder|obsessive-compulsive disorder
5610766|NCT00854919|augmentation treatment|augmentation treatment
5796444|NCT00118911|ADD|add
5610767|NCT00854919|SSRI-refractory|ssri-refractory
5610768|NCT00854906|dry eye|dry eye
5610769|NCT00854906|keratometer|keratometer
5610770|NCT00854906|fluorescein|fluorescein
5610771|NCT00854893|stroke|stroke
5610772|NCT00854893|aphasia|aphasia
5610773|NCT00854893|aging|aging
5610774|NCT00854893|language learning|language learning
5610775|NCT00854880|Erosive Gastritis|erosive gastritis
5610776|NCT00854867|Solid tumour neoplastic meningitis|solid tumour neoplastic meningitis
5610777|NCT00854867|STNM|stnm
5610778|NCT00854867|leptomeningeal metastases|leptomeningeal metastases
5610779|NCT00854867|DepoCyte|depocyte
5610780|NCT00854867|WBRT|wbrt
5610781|NCT00854867|Whole Brain Radiotherapy|whole brain radiotherapy
5610782|NCT00854867|Liposomal cytarabine intrathecal|liposomal cytarabine intrathecal
5680439|NCT00577798|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5610783|NCT00854867|Solid Tumour Neoplastic Meningitis with or without brain metastasis|solid tumour neoplastic meningitis with or without brain metastasis
5610785|NCT00854854|FOLFOX-4|folfox-4
5610786|NCT00854854|gastric cancer|gastric cancer
5610791|NCT00854828|Symptomatic 40-80 y/o w/lumbar Cobb of 30 degrees|symptomatic 40-80 y/o w/lumbar cobb of 30 degrees
5610792|NCT00854828|All Participants must be reasonable surgical candidate at enrollment|all participants must be reasonable surgical candidate at enrollment
5610793|NCT00854815|Perforated appendicitis|perforated appendicitis
5610794|NCT00854815|laparoscopic appendectomy|laparoscopic appendectomy
5610795|NCT00854815|children|children
5610796|NCT00854815|irrigation|irrigation
5610797|NCT00854802|Hepatitis|hepatitis
5610800|NCT00854776|aspirin|aspirin
5610801|NCT00854776|clopidogrel|clopidogrel
5610802|NCT00854776|proton pump inhibitor|proton pump inhibitor
5610803|NCT00854776|peptic ulcer|peptic ulcer
5610804|NCT00854776|ulcer complications|ulcer complications
5610805|NCT00854750|Multiple Sclerosis, hx of unilateral ON, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome|multiple sclerosis, hx of unilateral on, evidence of thermal sensitivity, and no evidence of an ocular motor syndrome
5593484|NCT00917267|Amylin|amylin
5593485|NCT00917267|Lilly|lilly
5593486|NCT00917254|YM150|ym150
5610806|NCT00854750|Multiple Sclerosis, no evidence of ON, and evidence of thermal sensitivity|multiple sclerosis, no evidence of on, and evidence of thermal sensitivity
5610807|NCT00854750|Healthy age/gender matched controls|healthy age/gender matched controls
5610808|NCT00854737|bipolar disorder|bipolar disorder
5610809|NCT00854737|bipolar depression|bipolar depression
5610810|NCT00854737|bipolar mania|bipolar mania
5610811|NCT00854737|manic depression|manic depression
5610812|NCT00854737|depression|depression
5610813|NCT00854737|mania|mania
5610814|NCT00854737|hypomania|hypomania
5610815|NCT00854711|ST elevated Myocardical infraction|st elevated myocardical infraction
5610816|NCT00854698|THE LEFT VENTRICULAR REMODELING AFTER MECHANICAL AORTIC VALVE REPLACEMENT|the left ventricular remodeling after mechanical aortic valve replacement
5610817|NCT00854698|exercise training|exercise training
5610818|NCT00854672|Sarcoidosis|sarcoidosis
5610819|NCT00854672|muscle strength|muscle strength
5610820|NCT00854672|exercise intolerance|exercise intolerance
5610822|NCT00854646|ON 01910.Na|on 01910.na
5610823|NCT00854646|refractory|refractory
5610824|NCT00854646|leukemia|leukemia
5610825|NCT00854646|myelodysplastic|myelodysplastic
5610826|NCT00854646|cell cycle|cell cycle
5610827|NCT00854633|Pre-term infants|pre-term infants
5610828|NCT00854633|Pre-term infants 750 to 1500 grams|pre-term infants 750 to 1500 grams
5610829|NCT00854594|Diabetes|diabetes
5610830|NCT00854594|Telemedicine|telemedicine
5610831|NCT00854594|Shared Medical Appointments|shared medical appointments
5610832|NCT00854581|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5610833|NCT00854581|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5610834|NCT00854581|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5610835|NCT00854581|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5610836|NCT00854581|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5610837|NCT00854581|HTLV-1 infection|htlv-1 infection
5610838|NCT00854568|B-cell lymphoma|b-cell lymphoma
5610839|NCT00854568|CHOP|chop
5610840|NCT00854568|CEOP|ceop
5610841|NCT00854568|Cardiotoxicity|cardiotoxicity
5610946|NCT00854126|NHL|nhl
5610847|NCT00854542|Culturally Sensitive Collaborative Treatment|culturally sensitive collaborative treatment
5610848|NCT00854542|Chinese Americans|chinese americans
5610850|NCT00854529|bevacizumab|bevacizumab
5610851|NCT00854529|subconjunctival injection|subconjunctival injection
5610852|NCT00854529|trabeculectomy|trabeculectomy
5610853|NCT00854529|bleb|bleb
5610854|NCT00854529|mitomycin c|mitomycin c
5610855|NCT00854516|compression therapy|compression therapy
5610856|NCT00854516|3M|3m
5610857|NCT00854503|Statins administration in diabetic dyslipidemia|statins administration in diabetic dyslipidemia
5610858|NCT00854477|capecitabine|capecitabine
5610859|NCT00854477|Post whipples|post whipples
5796569|NCT00118534|PTSD|ptsd
5610860|NCT00854477|pancreatico-duodenectomy|pancreatico-duodenectomy
5610861|NCT00854477|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5610862|NCT00854477|pharmacokinetic|pharmacokinetic
5610863|NCT00854464|Arsenic Methylation Capability|arsenic methylation capability
5610864|NCT00854464|Arsenic Methylation Enzymes|arsenic methylation enzymes
5610865|NCT00854464|Cigarette Metabolites|cigarette metabolites
5610866|NCT00854464|Cigarette Metabolic Enzymes|cigarette metabolic enzymes
5610867|NCT00854464|DNA Repair Enzymes|dna repair enzymes
5610869|NCT00854464|Urothelial Carcinoma|urothelial carcinoma
5610870|NCT00854451|Helicobacter pylori|helicobacter pylori
5610871|NCT00854451|CYP2C19 genotype|cyp2c19 genotype
5610872|NCT00854451|intragastric pH|intragastric ph
5610873|NCT00854451|dual therapy|dual therapy
5610874|NCT00854451|antibiotic resistance|antibiotic resistance
5613461|NCT00844129|scoliosis|scoliosis
5596485|NCT00904982|mechanical heart valves|mechanical heart valves
5610875|NCT00854438|anticholinergic drugs|anticholinergic drugs
5610876|NCT00854438|adverse events|adverse events
5610878|NCT00854438|clinical pharmacist|clinical pharmacist
5610879|NCT00854438|Evaluate the clinical effects of reducing anticholinergic in elderly|evaluate the clinical effects of reducing anticholinergic in elderly
5610880|NCT00854412|Obesity|obesity
5610881|NCT00854412|Weight loss|weight loss
5610882|NCT00854412|Very low-calorie diet|very low-calorie diet
5610883|NCT00854412|Mannose-binding lectin|mannose-binding lectin
5610884|NCT00854412|Insulin resistance|insulin resistance
5610885|NCT00854386|fluid management|fluid management
5610886|NCT00854386|VATS|vats
5610887|NCT00854386|ALI|ali
5610888|NCT00854386|ARDS|ards
5610889|NCT00854373|Infertility|infertility
5610892|NCT00854360|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5610893|NCT00854360|Hayfever|hayfever
5610894|NCT00854347|hyperglycemia|hyperglycemia
5610895|NCT00854347|diabetes|diabetes
5610896|NCT00854347|intensive care|intensive care
5610897|NCT00854347|prevalence|prevalence
5610898|NCT00854334|Sleep|sleep
5610899|NCT00854334|Overweight|overweight
5610900|NCT00854334|Physical activity|physical activity
5610901|NCT00854334|Appetite|appetite
5610902|NCT00854334|NEAT|neat
5610903|NCT00854321|rheumatoid arthritis|rheumatoid arthritis
5610904|NCT00854321|rituximab|rituximab
5610905|NCT00854321|therapy|therapy
5610906|NCT00854308|Tarceva|tarceva
5610907|NCT00854308|Lung Cancer|lung cancer
5610908|NCT00854308|NSCLC|nsclc
5610909|NCT00854295|arthritis|arthritis
5610910|NCT00854295|osteoarthritis|osteoarthritis
5610911|NCT00854295|degenerative knee disease|degenerative knee disease
5610912|NCT00854295|avascular necrosis|avascular necrosis
5610913|NCT00854295|total knee replacement|total knee replacement
5610914|NCT00854295|TKA|tka
5610915|NCT00854256|glaucoma|glaucoma
5610916|NCT00854230|HIV|hiv
5610917|NCT00854230|alcohol|alcohol
5610918|NCT00854230|naltrexone|naltrexone
5610919|NCT00854230|Treatment Experienced|treatment experienced
5610920|NCT00854204|Innovation-TiFP4-C101|innovation-tifp4-c101
5610921|NCT00854204|Innovation-C101|innovation-c101
5610922|NCT00854204|Innovation|innovation
5610923|NCT00854204|TMC114/TMC41629|tmc114/tmc41629
5610924|NCT00854204|controlled-release coformulations|controlled-release coformulations
5610925|NCT00854204|immediate-release coformulation|immediate-release coformulation
5610926|NCT00854204|Pharmacokinetics|pharmacokinetics
5610927|NCT00854191|mechanical simulator|mechanical simulator
5610928|NCT00854191|ERCP|ercp
5610929|NCT00854191|training|training
5610930|NCT00854178|isoflurane|isoflurane
5610931|NCT00854178|propofol|propofol
5610932|NCT00854178|genotoxicity|genotoxicity
5610933|NCT00854178|gene expression|gene expression
5610934|NCT00854178|cytokines|cytokines
5610935|NCT00854178|apoptosis|apoptosis
5610936|NCT00854165|lung transplantation|lung transplantation
5610937|NCT00854165|respiratory failure|respiratory failure
5610938|NCT00854165|ECMO|ecmo
5610939|NCT00854165|Lung transplants in respiratory failure patients|lung transplants in respiratory failure patients
5610940|NCT00854152|NHL|nhl
5610941|NCT00854152|Tumors|tumors
5610942|NCT00854152|Carcinogenic Tumors|carcinogenic tumors
5610943|NCT00854139|Multiple myeloma|multiple myeloma
5610944|NCT00854139|Renal failure|renal failure
5610945|NCT00854139|Kidney transplant|kidney transplant
5610947|NCT00854126|Solid Tumors|solid tumors
5610948|NCT00854126|Carcinogenic Tumors|carcinogenic tumors
5610949|NCT00854113|Diabetes Mellitus Type 2|diabetes mellitus type 2
5610950|NCT00854100|Adjunctive|adjunctive
5610951|NCT00854100|Depression|depression
5610952|NCT00854100|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5610953|NCT00854087|Hepatitis C Virus|hepatitis c virus
5610954|NCT00854087|HCV|hcv
5610955|NCT00854087|Herbal treatment|herbal treatment
5610956|NCT00854087|Herbs|herbs
5610957|NCT00854087|San Diego|san diego
5610958|NCT00854087|Non responder|non responder
5610959|NCT00854087|Relapser|relapser
5610960|NCT00854087|Treatment failure|treatment failure
5610961|NCT00854087|Antifibrotic|antifibrotic
5610962|NCT00854087|Anti-fibrotic|anti-fibrotic
5610963|NCT00854087|Fibrosis|fibrosis
5610964|NCT00854087|Failure of previous Interferon based therapy|failure of previous interferon based therapy
5610965|NCT00854087|Refuse Interferon based therapy|refuse interferon based therapy
5610966|NCT00854087|Intolerance to Interferon|intolerance to interferon
5610967|NCT00854087|Male or female 18-70 years of age|male or female 18-70 years of age
5610968|NCT00854074|Post-operative Paralytic Ileus|post-operative paralytic ileus
5610969|NCT00854074|Neuromodulation|neuromodulation
5610970|NCT00854074|Neurostimulation|neurostimulation
5610971|NCT00854074|Extended loss of functional bowel motility|extended loss of functional bowel motility
5610972|NCT00854048|Pediatric|pediatric
5610973|NCT00854048|Oxygen Saturation|oxygen saturation
5610974|NCT00854048|Cardiopulmonary bypass|cardiopulmonary bypass
5610975|NCT00854035|MK-0431/ONO-5435|mk-0431/ono-5435
5610976|NCT00854035|Type 2 diabetes mellitus|type 2 diabetes mellitus
5610977|NCT00854009|Healthy Subjects|healthy subjects
5610978|NCT00853983|Healthy Volunteers|healthy volunteers
5610980|NCT00853970|Pain and Inflammation as a function of cataract surgery|pain and inflammation as a function of cataract surgery
5610981|NCT00853957|Hypertension|hypertension
5610982|NCT00853957|African Americans|african americans
5610983|NCT00853957|Aliskiren|aliskiren
5610984|NCT00853957|Amlodipine|amlodipine
5610985|NCT00853957|Systolic blood pressure|systolic blood pressure
5610986|NCT00853957|Diastolic blood pressure|diastolic blood pressure
5610987|NCT00853957|Stage II|stage ii
5610988|NCT00853957|Combination|combination
5610989|NCT00853944|islet transplantation|islet transplantation
5604743|NCT00879255|CPT|cpt
5610993|NCT00853931|metastatic colorectal cancer|metastatic colorectal cancer
5610994|NCT00853931|KRAS wild type metastatic colorectal cancer with no prior exposure to EGFR inhibitors|kras wild type metastatic colorectal cancer with no prior exposure to egfr inhibitors
5610996|NCT00853918|Mail survey|mail survey
5610997|NCT00853918|Response rate|response rate
5610998|NCT00853905|open angle glaucoma (POAG)|open angle glaucoma (poag)
5610999|NCT00853905|angle closure glaucoma (PACG)|angle closure glaucoma (pacg)
5611000|NCT00853905|pigmentary glaucoma|pigmentary glaucoma
5611001|NCT00853905|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
5611002|NCT00853905|neovascular glaucoma|neovascular glaucoma
5611003|NCT00853905|traumatic glaucoma|traumatic glaucoma
5611004|NCT00853892|Healthy Subjects|healthy subjects
5611005|NCT00853892|Bioequivalence|bioequivalence
5611006|NCT00853866|stroke|stroke
5611007|NCT00853866|reboxetine|reboxetine
5611008|NCT00853866|noradrenaline|noradrenaline
5611009|NCT00853866|motor cortex|motor cortex
5611010|NCT00853866|transcranial direct current stimulation|transcranial direct current stimulation
5611011|NCT00853866|motor function|motor function
5611012|NCT00853866|rehabilitation|rehabilitation
5611013|NCT00853866|Jebsen Taylor test|jebsen taylor test
5611014|NCT00853853|Hemorrhoidectomy|hemorrhoidectomy
5611015|NCT00853853|Hemorrhoids|hemorrhoids
5611016|NCT00853840|pharmacodynamics. maraviroc, vardenafil, blood pressure|pharmacodynamics. maraviroc, vardenafil, blood pressure
5611017|NCT00853827|CAD|cad
5611018|NCT00853827|coronary artery disease|coronary artery disease
5611019|NCT00853827|coronary atherosclerosis|coronary atherosclerosis
5611020|NCT00853827|coronary angiography|coronary angiography
5611021|NCT00853827|IVUS|ivus
5611022|NCT00853827|intravascular ultrasound|intravascular ultrasound
5611023|NCT00853827|plasma renin activity|plasma renin activity
5611024|NCT00853827|renin angiotensin aldosterone system,|renin angiotensin aldosterone system,
5611025|NCT00853827|direct renin inhibitors|direct renin inhibitors
5611026|NCT00853827|coronary atheroma|coronary atheroma
5611027|NCT00853814|adolescence|adolescence
5611028|NCT00853814|obesity|obesity
5611029|NCT00853814|physical activity|physical activity
5611030|NCT00853814|built environment|built environment
5611031|NCT00853814|neighborhood environment|neighborhood environment
5611032|NCT00853814|children|children
5611033|NCT00853814|youth|youth
5611034|NCT00853814|increasing physical activity|increasing physical activity
5611035|NCT00853814|changing dietary intake|changing dietary intake
5611036|NCT00853814|reducing zBMI|reducing zbmi
5611037|NCT00853801|Pre-Diabetes|pre-diabetes
5611038|NCT00853801|Metabolic Syndrome|metabolic syndrome
5611039|NCT00853801|Type 2 Diabetes|type 2 diabetes
5611040|NCT00853801|Diabetes Prevention|diabetes prevention
5611041|NCT00853801|Lifestyle Modification|lifestyle modification
5611042|NCT00853801|Diet Therapy|diet therapy
5611043|NCT00853801|Provider Education|provider education
5611044|NCT00853788|systemic sclerosis|systemic sclerosis
5611045|NCT00853788|biomarkers|biomarkers
5611046|NCT00853788|microarray|microarray
5611047|NCT00853775|heart disease|heart disease
5611048|NCT00853775|cardiovascular disease|cardiovascular disease
5611049|NCT00853775|lipoproteins|lipoproteins
5611050|NCT00853775|lipoprotein(a)|lipoprotein(a)
5611051|NCT00853775|Lp(a)|lp(a)
5611052|NCT00853775|apolipoprotein(a)|apolipoprotein(a)
5611053|NCT00853775|apo(a)|apo(a)
5611054|NCT00853775|fats|fats
5611055|NCT00853775|proteins|proteins
5611056|NCT00853775|metabolism|metabolism
5611057|NCT00853749|Immune response|immune response
5611058|NCT00853749|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5611059|NCT00853749|polysaccharide|polysaccharide
5611060|NCT00853736|Healthy Subjects|healthy subjects
5611061|NCT00853736|Bioequivalence|bioequivalence
5611062|NCT00853723|osteoporosis|osteoporosis
5611063|NCT00853723|post-menopausal|post-menopausal
5611064|NCT00853723|bone anabolic agents|bone anabolic agents
5611065|NCT00853710|Prostate-Specific Antigen|prostate-specific antigen
5611066|NCT00853710|Prostate Cancer|prostate cancer
5596694|NCT00904488|Diuretics|diuretics
5611068|NCT00853710|Assay|assay
5611069|NCT00853697|Prostate|prostate
5611070|NCT00853697|DUTASTERIDE|dutasteride
5611071|NCT00853697|TESTOSTERONE|testosterone
5611072|NCT00853697|09-008|09-008
5611073|NCT00853697|Consortium Protocol LOI# c09-028|consortium protocol loi# c09-028
5611074|NCT00853684|Advanced Colorectal Cancer|advanced colorectal cancer
5611076|NCT00853684|Capecitabine|capecitabine
5611077|NCT00853684|Endostar|endostar
5611078|NCT00853684|efficacy|efficacy
5611079|NCT00853671|Coronary Artery Disease|coronary artery disease
5611080|NCT00853671|Multidetector Computed Tomography|multidetector computed tomography
5611081|NCT00853671|Myocardial Perfusion Imaging|myocardial perfusion imaging
5611082|NCT00853658|Chronic Heart Failure|chronic heart failure
5604790|NCT00879034|FTI|fti
5611084|NCT00853658|CHF hospitalization|chf hospitalization
5611085|NCT00853658|morbi-mortality trial|morbi-mortality trial
5611086|NCT00853658|outcome study|outcome study
5611087|NCT00853658|endpoint driven|endpoint driven
5611088|NCT00853658|plasma renin activity|plasma renin activity
5611089|NCT00853658|renin angiotensin aldosterone system|renin angiotensin aldosterone system
5611090|NCT00853658|direct renin inhibitors|direct renin inhibitors
5611091|NCT00853658|BNP|bnp
5611092|NCT00853658|KCCQ|kccq
5611093|NCT00853658|eGFR|egfr
5611094|NCT00853658|(NYHA class II to IV) with elevated|(nyha class ii to iv) with elevated
5611095|NCT00853658|BNP and reduced LVEF|bnp and reduced lvef
5611096|NCT00853632|Mitral valve|mitral valve
5611097|NCT00853632|pericardial bioprostheses|pericardial bioprostheses
5611098|NCT00853632|PERIMOUNT|perimount
5611099|NCT00853632|bovine pericardial leaflets|bovine pericardial leaflets
5611100|NCT00853632|mitral valve replacement|mitral valve replacement
5611101|NCT00853632|mitral valve regurgitation|mitral valve regurgitation
5611102|NCT00853632|Heart valve disease|heart valve disease
5611103|NCT00853619|clinical decision support|clinical decision support
5611104|NCT00853619|knowledge management|knowledge management
5611105|NCT00853619|knowledge representation|knowledge representation
5611106|NCT00853619|clinical guidelines|clinical guidelines
5611107|NCT00853619|coronary artery disease|coronary artery disease
5611108|NCT00853619|myocardial ischemia|myocardial ischemia
5611109|NCT00853619|diabetes mellitus|diabetes mellitus
5611110|NCT00853619|hypertension|hypertension
5611111|NCT00853606|ED|ed
5611112|NCT00853606|Erectile Dysfunction|erectile dysfunction
5611113|NCT00853606|Dysfunction|dysfunction
5611114|NCT00853606|Erectile|erectile
5611115|NCT00853593|heart failure|heart failure
5611116|NCT00853593|cardiac pacing|cardiac pacing
5611117|NCT00853593|cardiac resynchronization therapy|cardiac resynchronization therapy
5611118|NCT00853593|left ventricular lead|left ventricular lead
5611119|NCT00853580|Neurofibromatosis Type 1, Neurocognitive, Phase II|neurofibromatosis type 1, neurocognitive, phase ii
5611120|NCT00853567|Uterine Fibroids|uterine fibroids
5611121|NCT00853554|Healthy Subjects|healthy subjects
5611122|NCT00853554|Bioequivalence|bioequivalence
5611123|NCT00853541|renal impairment|renal impairment
5611124|NCT00853541|heart failure|heart failure
5611125|NCT00853541|hyperphosphatemia|hyperphosphatemia
5611126|NCT00853541|coronary artery calcification|coronary artery calcification
5611127|NCT00853528|spinal cord metastases|spinal cord metastases
5611128|NCT00853502|anorexia nervosa|anorexia nervosa
5611129|NCT00853502|testosterone|testosterone
5611130|NCT00853502|disordered eating|disordered eating
5611131|NCT00853502|hypogonadism|hypogonadism
5611132|NCT00853502|bone|bone
5611133|NCT00853489|Open tibia fractures|open tibia fractures
5611134|NCT00853489|rhBMP-2|rhbmp-2
5611135|NCT00853489|critical size defects|critical size defects
5611136|NCT00853489|bone grafting|bone grafting
5611137|NCT00853463|Pulmonary Embolism|pulmonary embolism
5611138|NCT00853463|Deep Vein Thrombosis|deep vein thrombosis
5611139|NCT00853463|Prophylaxis|prophylaxis
5611140|NCT00853463|Venous thromboembolism|venous thromboembolism
5611141|NCT00853463|Prevention|prevention
5611142|NCT00853463|Medical patients|medical patients
5611143|NCT00853450|Antiplatelet|antiplatelet
5611144|NCT00853437|Comparison of CO by new method to clinician's estimate and implied CO from the measurement of arteriovenous oxygen content difference.|comparison of co by new method to clinician's estimate and implied co from the measurement of arteriovenous oxygen content difference.
5611145|NCT00853424|diabetic retinopathy|diabetic retinopathy
5611146|NCT00853424|diabetic macular edema|diabetic macular edema
5611147|NCT00853424|type 1 diabetes|type 1 diabetes
5611148|NCT00853424|intensive medical therapy|intensive medical therapy
5611149|NCT00853424|islet cell transplantation|islet cell transplantation
5611150|NCT00853424|visual acuity|visual acuity
5611151|NCT00853424|diabetic eye disease|diabetic eye disease
5611152|NCT00853411|Moderate to severe asthma|moderate to severe asthma
5611153|NCT00853398|Primary Osteoarthritis of the knee.|primary osteoarthritis of the knee.
5611154|NCT00853385|oral DMARD|oral dmard
5611155|NCT00853385|JAK inhibitor|jak inhibitor
5611156|NCT00853385|clinical trial|clinical trial
5611157|NCT00853346|Depression|depression
5611158|NCT00853346|Parkinson's Disease|parkinson's disease
5611159|NCT00853346|Major Depression|major depression
5611160|NCT00853346|Cognitive Behavioral Therapy|cognitive behavioral therapy
5611161|NCT00853333|Pain|pain
5611162|NCT00853333|Propofol|propofol
5611163|NCT00853333|Dexmedetomidine|dexmedetomidine
5611164|NCT00853333|Midazolam|midazolam
5611165|NCT00853333|Effects of sedation on pain perception.|effects of sedation on pain perception.
5611167|NCT00853320|Bioequivalence|bioequivalence
5611168|NCT00853307|Drug therapy|drug therapy
5611169|NCT00853294|Healthy Subjects|healthy subjects
5611170|NCT00853294|Bioequivalence|bioequivalence
5611171|NCT00853281|Forest malaria prevention|forest malaria prevention
5611172|NCT00853281|Long-lasting insecticidal hammocks|long-lasting insecticidal hammocks
5611173|NCT00853281|Cluster randomized trial|cluster randomized trial
5611174|NCT00853281|Central Vietnam|central vietnam
5611180|NCT00853242|Phosphate|phosphate
5611181|NCT00853242|Hyperphosphatemia|hyperphosphatemia
5611182|NCT00853229|vulvodynia|vulvodynia
5611183|NCT00853229|vulvar vestibulitis|vulvar vestibulitis
5611184|NCT00853229|chronic vulvar pain|chronic vulvar pain
5611185|NCT00853229|generalized vulvodynia|generalized vulvodynia
5611186|NCT00853229|localized vulvodynia|localized vulvodynia
5611187|NCT00853216|Healthy Subjects|healthy subjects
5611188|NCT00853216|Bioequivalence|bioequivalence
5611189|NCT00853203|Colorectal Cancer|colorectal cancer
5611190|NCT00853203|Rectal Cancer|rectal cancer
5611191|NCT00853203|Psychosocial|psychosocial
5611192|NCT00853203|Expressive Disclosure|expressive disclosure
5611193|NCT00853203|Questionnaires|questionnaires
5611194|NCT00853203|Quality of life|quality of life
5611196|NCT00853203|Electronically Activated Recorder|electronically activated recorder
5611197|NCT00853203|EAR|ear
5611198|NCT00853190|Healthy Subjects|healthy subjects
5611199|NCT00853177|Oocyte retrieval|oocyte retrieval
5611200|NCT00853177|pain|pain
5611201|NCT00853177|surgery|surgery
5611202|NCT00853177|anaesthesiology|anaesthesiology
5611203|NCT00853177|Assisted Reproductive Technologies|assisted reproductive technologies
5611204|NCT00853164|prostate cancer|prostate cancer
5611205|NCT00853164|aerobic exercise|aerobic exercise
5611206|NCT00853164|resistance training|resistance training
5611207|NCT00853138|cognitive-behavioral therapy|cognitive-behavioral therapy
5611208|NCT00853138|chronic pain|chronic pain
5611209|NCT00853138|randomized controlled trial|randomized controlled trial
5611210|NCT00853138|pediatrics|pediatrics
5611211|NCT00853125|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5611212|NCT00853125|stage IV renal cell cancer|stage iv renal cell cancer
5611213|NCT00853112|PAH pulmonary hypertension pulmonary arterial hypertension|pah pulmonary hypertension pulmonary arterial hypertension
5611214|NCT00853099|Ulcerative Colitis|ulcerative colitis
5611215|NCT00853073|failing blebs|failing blebs
5611216|NCT00853073|failing express shunt|failing express shunt
5611217|NCT00853073|avastin|avastin
5611218|NCT00853073|bevacizumab|bevacizumab
5611219|NCT00853073|glaucoma|glaucoma
5611220|NCT00853073|prior trabeculectomy|prior trabeculectomy
5611221|NCT00853073|Express shunt placed under a scleral flap|express shunt placed under a scleral flap
5611222|NCT00853073|subsequent filtration failure|subsequent filtration failure
5611223|NCT00853060|energy expenditure|energy expenditure
5611224|NCT00853060|mechanical ventilation|mechanical ventilation
5611225|NCT00853060|weaning|weaning
5611226|NCT00853060|pressure support ventilation|pressure support ventilation
5611227|NCT00853060|T-tube|t-tube
5611228|NCT00853034|gastrointestinal effects|gastrointestinal effects
5611229|NCT00853034|prebiotic|prebiotic
5611230|NCT00853021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5611231|NCT00853021|recurrent renal cell cancer|recurrent renal cell cancer
5611243|NCT00852982|Risk factors|risk factors
5611244|NCT00852982|Primary health care|primary health care
5611245|NCT00852969|Chronic Kidney Disease|chronic kidney disease
5611246|NCT00852969|Niacin|niacin
5611247|NCT00852969|HDL|hdl
5611248|NCT00852969|Endothelial Function|endothelial function
5611249|NCT00852956|Betahistine|betahistine
5611250|NCT00852956|Olanzapine|olanzapine
5611251|NCT00852956|Safety of co-administration of Betahistien and Olanzapine|safety of co-administration of betahistien and olanzapine
5611257|NCT00852930|lymphedema|lymphedema
5611258|NCT00852930|quality of life|quality of life
5611259|NCT00852930|breast cancer|breast cancer
5611260|NCT00852930|symptoms|symptoms
5611261|NCT00852930|lymphedema in breast cancer survivors|lymphedema in breast cancer survivors
5611262|NCT00852917|Pain due to Osteoarthritis of the Knee|pain due to osteoarthritis of the knee
5611269|NCT00852891|weaning|weaning
5611270|NCT00852891|echocardiogram|echocardiogram
5611271|NCT00852891|diastolic dysfunction|diastolic dysfunction
5611272|NCT00852891|Mechanical ventilation|mechanical ventilation
5611273|NCT00852878|Recurrent Abdominal Pain|recurrent abdominal pain
5611274|NCT00852878|Biofeedback|biofeedback
5611275|NCT00852878|Heart Rate Variability|heart rate variability
5611276|NCT00852865|Inflammation|inflammation
5611277|NCT00852865|Pain|pain
5611278|NCT00852852|ESRA-C 2|esra-c 2
5611279|NCT00852852|computerized assessment|computerized assessment
5611281|NCT00852839|Sjogren's syndrome|sjogren's syndrome
5611283|NCT00852826|axillary seroma|axillary seroma
5611284|NCT00852826|axillary lymphadenectomy|axillary lymphadenectomy
5611285|NCT00852826|morbidity|morbidity
5611286|NCT00852826|morbidity postlymphadenectomy|morbidity postlymphadenectomy
5611287|NCT00852826|Lymphadenectomy|lymphadenectomy
5611288|NCT00852813|tolerance|tolerance
5611289|NCT00852813|prebiotic|prebiotic
5611296|NCT00852787|digibind|digibind
5611297|NCT00852787|digoxin immune fab|digoxin immune fab
5611298|NCT00852787|end-stage-renal-disease|end-stage-renal-disease
5611299|NCT00852787|marinobufagenin|marinobufagenin
5611300|NCT00852761|Psoriasis|psoriasis
5611301|NCT00852748|headache|headache
5611302|NCT00852735|Cardiovascular diseases|cardiovascular diseases
5611303|NCT00852735|Rapeseed oil|rapeseed oil
5611304|NCT00852735|Micronutriments|micronutriments
5611305|NCT00852735|HDL cholesterol|hdl cholesterol
5611306|NCT00852735|Oxidative stress|oxidative stress
5611307|NCT00852735|Tocopherols|tocopherols
5611308|NCT00852735|Sterols|sterols
5611309|NCT00852735|Prevention of cardiovascular diseases|prevention of cardiovascular diseases
5611310|NCT00852722|Multiple sclerosis|multiple sclerosis
5611311|NCT00852722|Diet|diet
5611312|NCT00852709|Myelodysplastic syndrome that has transformed to AML (AML/MDS)|myelodysplastic syndrome that has transformed to aml (aml/mds)
5611313|NCT00852709|Treatment-related AML|treatment-related aml
5611314|NCT00852709|AML evolving from myeloproliferative disorders (MPD)|aml evolving from myeloproliferative disorders (mpd)
5611315|NCT00852709|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5611316|NCT00852709|Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy|acute promyelocytic leukemia (apl) refractory to arsenic therapy or retinoic acid therapy
5611317|NCT00852709|Relapsed and/or refractory acute leukemia with progressive disease since last therapy|relapsed and/or refractory acute leukemia with progressive disease since last therapy
5611318|NCT00852709|Chronic myelogenous leukemia (CML) in accelerated phase or blast crisis refractory to imatinib|chronic myelogenous leukemia (cml) in accelerated phase or blast crisis refractory to imatinib
5611319|NCT00852709|High-risk MPD including myelofibrosis, chronic myelomonocytic leukemia (CMML, and relapsed or refractory juvenile myelomonocytic leukemia (JMML).|high-risk mpd including myelofibrosis, chronic myelomonocytic leukemia (cmml, and relapsed or refractory juvenile myelomonocytic leukemia (jmml).
5611320|NCT00852696|Overactive Bladder|overactive bladder
5611321|NCT00852696|Incontinence|incontinence
5611322|NCT00852696|Solifenacin|solifenacin
5611323|NCT00852696|Women|women
5611324|NCT00852696|Postoperative|postoperative
5611325|NCT00852657|Rotator cuff tear|rotator cuff tear
5611326|NCT00852657|surgical repair|surgical repair
5611327|NCT00852657|Physiotherapy|physiotherapy
5611328|NCT00852657|Treatment benefit|treatment benefit
5611329|NCT00852657|Surgery|surgery
5611330|NCT00852644|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5611331|NCT00852644|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5611332|NCT00852631|Quetiapine efficacy in schizophrenia|quetiapine efficacy in schizophrenia
5611333|NCT00852618|HIV Integrase Inhibitors|hiv integrase inhibitors
5611334|NCT00852618|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
5611335|NCT00852618|Treatment Naive|treatment naive
5611336|NCT00852618|Viral Load|viral load
5611337|NCT00852605|Acute Lung Injury after allogeneic transplantation|acute lung injury after allogeneic transplantation
5611338|NCT00852592|Bipolar Disorder Depression Midday Light Therapy|bipolar disorder depression midday light therapy
5611339|NCT00852592|Bipolar Disorder Type I or II|bipolar disorder type i or ii
5611340|NCT00852579|Asthma|asthma
5611341|NCT00852579|Smoker|smoker
5611342|NCT00852579|Macrolide|macrolide
5611343|NCT00852566|Chronic myeloid leukemia|chronic myeloid leukemia
5611344|NCT00852566|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5611345|NCT00852566|stem cell|stem cell
5611346|NCT00852566|Philadelphia chromosome|philadelphia chromosome
5611347|NCT00852566|dasatinib|dasatinib
5611348|NCT00852553|intestinal|intestinal
5611349|NCT00852553|smooth|smooth
5611350|NCT00852553|muscle|muscle
5611351|NCT00852553|GI|gi
5611352|NCT00852553|motility|motility
5611353|NCT00852540|impetigo|impetigo
5611354|NCT00852540|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5611355|NCT00852540|linezolid|linezolid
5611356|NCT00852540|secondarily-infected traumatic lesion|secondarily-infected traumatic lesion
5611357|NCT00852540|uncomplicated skin infection|uncomplicated skin infection
5611358|NCT00852540|retapamulin|retapamulin
5611359|NCT00852527|Traumatic Brain Injury|traumatic brain injury
5611360|NCT00852527|Screening|screening
5611361|NCT00852527|Diagnosis|diagnosis
5611362|NCT00852527|Rehabilitation Outcome|rehabilitation outcome
5611363|NCT00852514|Bioimpedance|bioimpedance
5611364|NCT00852514|ultrafiltration|ultrafiltration
5611365|NCT00852514|blood pressure|blood pressure
5611366|NCT00852514|pulse pressure|pulse pressure
5613935|NCT00842218|Gait|gait
5611367|NCT00852501|Non-functioning pituitary adenoma|non-functioning pituitary adenoma
5611369|NCT00852501|Hormonal receptors|hormonal receptors
5611370|NCT00852475|MUFA|mufa
5611371|NCT00852475|PUFA|pufa
5611372|NCT00852475|MOVE! program|move! program
5611374|NCT00852462|Symptom Assessment and Management Intervention Program|symptom assessment and management intervention program
5611375|NCT00852449|Intraoperative fluid|intraoperative fluid
5611376|NCT00852449|Monitoring|monitoring
5611377|NCT00852449|Oesophageal Doppler|oesophageal doppler
5611378|NCT00852449|Abdominal surgery|abdominal surgery
5611379|NCT00852449|major abdominal surgery|major abdominal surgery
5611380|NCT00852436|neuropathic pain|neuropathic pain
5611381|NCT00852436|orofacial pain|orofacial pain
5611382|NCT00852436|clinical trials|clinical trials
5611383|NCT00852436|pregabalin|pregabalin
5611384|NCT00852436|randomized controlled trial|randomized controlled trial
5611385|NCT00852423|Malaria in pregnancy|malaria in pregnancy
5611386|NCT00852423|Sub-saharan Africa|sub-saharan africa
5611387|NCT00852423|Treatment|treatment
5611388|NCT00852423|Artemisinin containing Therapy|artemisinin containing therapy
5611389|NCT00852423|Efficacy|efficacy
5611390|NCT00852423|Safety|safety
5611391|NCT00852410|Endoscopic sinus surgery|endoscopic sinus surgery
5611392|NCT00852384|Anesthesia induction|anesthesia induction
5611393|NCT00852384|Obese patients|obese patients
5611394|NCT00852384|Noninvasive ventilation|noninvasive ventilation
5611395|NCT00852384|Alveolar recruitment|alveolar recruitment
5611396|NCT00852371|Malaria|malaria
5611397|NCT00852371|Intermittent preventive treatment|intermittent preventive treatment
5611398|NCT00852371|Efficacy|efficacy
5611399|NCT00852371|Safety|safety
5611400|NCT00852371|Tolerability|tolerability
5611401|NCT00852371|Schoolchildren|schoolchildren
5611402|NCT00852371|Uganda|uganda
5611403|NCT00852358|mucopolysaccharidosis|mucopolysaccharidosis
5611404|NCT00852358|Hurler-Scheie|hurler-scheie
5611405|NCT00852358|Scheie|scheie
5611406|NCT00852358|laronidase|laronidase
5611407|NCT00852358|cognitive decline|cognitive decline
5611408|NCT00852358|central nervous system|central nervous system
5611409|NCT00852358|enzyme replacement therapy|enzyme replacement therapy
5611410|NCT00852358|intrathecal|intrathecal
5611411|NCT00852358|LA Biomed|la biomed
5611412|NCT00852345|multibacillary leprosy|multibacillary leprosy
5611413|NCT00852345|leprosy|leprosy
5611414|NCT00852345|clofazamine|clofazamine
5611415|NCT00852332|male breast cancer|male breast cancer
5611416|NCT00852332|stage IIIB breast cancer|stage iiib breast cancer
5611417|NCT00852332|stage IIIC breast cancer|stage iiic breast cancer
5611420|NCT00852332|stage IIIA breast cancer|stage iiia breast cancer
5611421|NCT00852332|HER2-negative breast cancer|her2-negative breast cancer
5611422|NCT00852319|Interpregnancy Care|interpregnancy care
5611423|NCT00852319|Preconceptual Care|preconceptual care
5611424|NCT00852319|Premature Birth|premature birth
5611425|NCT00852319|Preterm Delivery|preterm delivery
5611426|NCT00852306|oocyte freezing|oocyte freezing
5611427|NCT00852306|vitrification|vitrification
5611429|NCT00852306|fertility preservation|fertility preservation
5611430|NCT00852293|liver disease|liver disease
5611431|NCT00852293|Chitinase 3 like-1 protein|chitinase 3 like-1 protein
5611432|NCT00852280|scars|scars
5611433|NCT00852280|late effect of burn|late effect of burn
5611434|NCT00852280|burn|burn
5611435|NCT00852280|pulsed-dye laser|pulsed-dye laser
5611436|NCT00852267|cholesterol|cholesterol
5611437|NCT00852267|diet|diet
5611438|NCT00852267|protein|protein
5611439|NCT00852267|carbohydrate|carbohydrate
5611440|NCT00852267|saturated fat|saturated fat
5611441|NCT00852267|LDL subclass|ldl subclass
5611442|NCT00852267|healthy volunteers|healthy volunteers
5611443|NCT00852254|Cardiac Index|cardiac index
5611444|NCT00852254|Ultrasound Dilution|ultrasound dilution
5611445|NCT00852254|Accuracy of ultrasound dilution cardiac index.|accuracy of ultrasound dilution cardiac index.
5611446|NCT00852228|colorectal cancer|colorectal cancer
5611447|NCT00852228|unresectable metastases|unresectable metastases
5611448|NCT00852228|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5611449|NCT00852228|liver metastases|liver metastases
5611450|NCT00852228|chronotherapy|chronotherapy
5611451|NCT00852228|cetuximab|cetuximab
5611452|NCT00852228|irinotecan|irinotecan
5611453|NCT00852228|oxaliplatin|oxaliplatin
5611454|NCT00852228|5-fluorouracil|5-fluorouracil
5611455|NCT00852228|hepatic artery infusion|hepatic artery infusion
5611456|NCT00852228|Unresectable hepatic lesions|unresectable hepatic lesions
5611457|NCT00852228|1 to 3 prior chemotherapy regimens|1 to 3 prior chemotherapy regimens
5611458|NCT00852215|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5611459|NCT00852215|Paclitaxel-eluting stent|paclitaxel-eluting stent
5611460|NCT00852215|Vision stent|vision stent
5611461|NCT00852202|bipolar|bipolar
5611462|NCT00852202|depression|depression
5611463|NCT00852189|Cancer|cancer
5611464|NCT00852189|Phase 1|phase 1
5611465|NCT00852189|EC0489|ec0489
5611466|NCT00852189|EC20|ec20
5611467|NCT00852189|Refractory|refractory
5611468|NCT00852189|Metastatic|metastatic
5611469|NCT00852189|Experimental|experimental
5605182|NCT00877565|LVF|lvf
5611470|NCT00852176|Coronary brachytherapy|coronary brachytherapy
5611471|NCT00852176|Coronary restenosis|coronary restenosis
5611472|NCT00852176|Coronary in stent restenosis|coronary in stent restenosis
5611473|NCT00852163|conditioning, preparative|conditioning, preparative
5611474|NCT00852163|clofarabine; transplant|clofarabine; transplant
5611475|NCT00852163|Busulfan|busulfan
5611476|NCT00852163|leukemia|leukemia
5611477|NCT00852163|myelodysplastic syndrome|myelodysplastic syndrome
5611478|NCT00852150|gastritis|gastritis
5611479|NCT00852150|duodenitis|duodenitis
5611480|NCT00852150|inter-rater reliability|inter-rater reliability
5611481|NCT00852150|intra-rater reliablity|intra-rater reliablity
5611482|NCT00852150|gastroscopy|gastroscopy
5611483|NCT00852150|duodenoscopy|duodenoscopy
5611485|NCT00852137|PEP005|pep005
5611486|NCT00852137|Actinic Keratosis|actinic keratosis
5611487|NCT00852124|Asthma|asthma
5611488|NCT00852124|Probiotic|probiotic
5611489|NCT00852124|VSL#3|vsl#3
5611494|NCT00852098|Fundoplication|fundoplication
5611495|NCT00852098|gastroesophageal reflux|gastroesophageal reflux
5611496|NCT00852098|gastric vessels|gastric vessels
5611497|NCT00852098|surgery|surgery
5611498|NCT00852085|Counseling|counseling
5611499|NCT00852085|Crime|crime
5611500|NCT00852085|Adolescent|adolescent
5611501|NCT00852072|common bile duct stones|common bile duct stones
5611502|NCT00852072|mechanical lithotripsy|mechanical lithotripsy
5611503|NCT00852072|balloon sphincteroplasty|balloon sphincteroplasty
5611504|NCT00852072|single-operator cholangioscopy-guided laser lithotripy|single-operator cholangioscopy-guided laser lithotripy
5611505|NCT00852059|ADHD|adhd
5611506|NCT00852059|children|children
5611507|NCT00852059|adolescents|adolescents
5611508|NCT00852059|methylphenidate|methylphenidate
5611509|NCT00852059|adherence|adherence
5611510|NCT00852059|immediate release|immediate release
5611511|NCT00852059|extended release|extended release
5611512|NCT00852059|efficacy|efficacy
5611513|NCT00852046|Mechanical ventilation|mechanical ventilation
5611514|NCT00852033|alcoholism|alcoholism
5611515|NCT00852033|alcohol abuse|alcohol abuse
5611516|NCT00852033|prevention|prevention
5611517|NCT00852033|behavior modification|behavior modification
5611518|NCT00852033|parent offspring interaction|parent offspring interaction
5611519|NCT00852033|university student|university student
5611522|NCT00852007|prostate cancer|prostate cancer
5611523|NCT00852007|dendritic cells|dendritic cells
5611524|NCT00852007|MUC-1|muc-1
5611525|NCT00852007|immune therapy|immune therapy
5611526|NCT00851994|Patients having surgery|patients having surgery
5611527|NCT00851981|Alcohol Liver Disease|alcohol liver disease
5611528|NCT00851968|hepatectomy|hepatectomy
5611529|NCT00851968|Selective HepaticVascular Clamping|selective hepaticvascular clamping
5611530|NCT00851942|Volunteer|volunteer
5611531|NCT00851942|Hypoadrenalism|hypoadrenalism
5611532|NCT00851942|Hypopituitarism|hypopituitarism
5611533|NCT00851942|Healthy volunteers|healthy volunteers
5611534|NCT00851929|sarcoidosis|sarcoidosis
5611535|NCT00851929|pulmonary hypertension|pulmonary hypertension
5611536|NCT00851929|dyspnea|dyspnea
5611537|NCT00851929|sarcoidosis associated pulmonary hypertension|sarcoidosis associated pulmonary hypertension
5611538|NCT00851877|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5611539|NCT00851877|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5611540|NCT00851877|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5611541|NCT00851877|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5611542|NCT00851877|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5611543|NCT00851877|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5611544|NCT00851877|tongue cancer|tongue cancer
5611545|NCT00851864|anticoagulation|anticoagulation
5611546|NCT00851864|pregnancy|pregnancy
5611547|NCT00851851|Surgical patients|surgical patients
5611548|NCT00851838|Peritoneal dialysis|peritoneal dialysis
5611549|NCT00851838|L-carnitine|l-carnitine
5797416|NCT00115648|HIV|hiv
5611550|NCT00851838|ESRD|esrd
5611551|NCT00851825|autonomic modulation|autonomic modulation
5611552|NCT00851825|heart rate|heart rate
5611553|NCT00851825|pressure support ventilation|pressure support ventilation
5611554|NCT00851825|T-tube|t-tube
5611555|NCT00851825|Mechanical ventilation|mechanical ventilation
5611560|NCT00851799|Antiretroviral therapy|antiretroviral therapy
5611561|NCT00851799|Treatment naive|treatment naive
5611562|NCT00851799|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5611563|NCT00851786|Herpes Zoster Vaccine|herpes zoster vaccine
5611564|NCT00851786|Herpes Zoster Virus|herpes zoster virus
5611565|NCT00851786|HIV|hiv
5611566|NCT00851721|Hemophilia A|hemophilia a
5611567|NCT00851721|Factor VIII Inhibitor|factor viii inhibitor
5611568|NCT00851721|Factor IX Inhibitor|factor ix inhibitor
5611569|NCT00851721|Hemophilia B|hemophilia b
5611570|NCT00851708|kidney|kidney
5611571|NCT00851708|deceased kidney transplant|deceased kidney transplant
5611572|NCT00851708|oxidative stress|oxidative stress
5611573|NCT00851708|renal function measurements|renal function measurements
5611574|NCT00851695|Lung Function Decline|lung function decline
5611575|NCT00851695|Lung Function|lung function
5611578|NCT00851695|Vitamin D|vitamin d
5611579|NCT00851682|Prostate Cancer|prostate cancer
5611580|NCT00851682|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
5611581|NCT00851682|Non-invasive Prostate Cancer Detection|non-invasive prostate cancer detection
5611582|NCT00851669|depression|depression
5611583|NCT00851669|alcohol dependence|alcohol dependence
5611584|NCT00851669|women|women
5611585|NCT00851669|psychotherapy|psychotherapy
5611586|NCT00851669|men|men
5611587|NCT00851630|HIV|hiv
5611588|NCT00851630|Tuberculosis|tuberculosis
5611589|NCT00851630|Treatment Naive|treatment naive
5611590|NCT00851617|Mechanical ventilator weaning|mechanical ventilator weaning
5611591|NCT00851617|Respiratory Muscle Training|respiratory muscle training
5611592|NCT00851617|Ventilator dependent|ventilator dependent
5611593|NCT00851604|ProGRP|progrp
5611594|NCT00851604|CgA|cga
5611595|NCT00851604|NSE|nse
5611596|NCT00851604|TUM2-PK|tum2-pk
5611597|NCT00851604|Neuroendocrine Tumors|neuroendocrine tumors
5611598|NCT00851591|fenugreek|fenugreek
5611599|NCT00851591|galactogogue|galactogogue
5611600|NCT00851591|breastmilk|breastmilk
5611601|NCT00851591|Trigonella foenum-graecum|trigonella foenum-graecum
5611602|NCT00851591|Bird's Foot|bird's foot
5611603|NCT00851591|Greek Clover|greek clover
5611604|NCT00851591|Greek Hay|greek hay
5611605|NCT00851591|Hu Lu Ba|hu lu ba
5611606|NCT00851591|Trigonella|trigonella
5611607|NCT00851578|AF|af
5611608|NCT00851578|atrial fibrillation|atrial fibrillation
5611609|NCT00851578|LAA occlusion|laa occlusion
5611610|NCT00851552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5611611|NCT00851552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5611612|NCT00851552|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5611613|NCT00851539|HIV|hiv
5611614|NCT00851539|Teenagers|teenagers
5611615|NCT00851539|Adolescent|adolescent
5611616|NCT00851539|HIV Testing|hiv testing
5611617|NCT00851539|HIV Seronegativity|hiv seronegativity
5611618|NCT00851526|Coronary bifurcation lesion|coronary bifurcation lesion
5611619|NCT00851526|Drug-eluting stent|drug-eluting stent
5611620|NCT00851513|Pudendal neuralgia|pudendal neuralgia
5611621|NCT00851513|pudendal nerve|pudendal nerve
5611622|NCT00851513|Alcock's canal syndrome|alcock's canal syndrome
5611623|NCT00851513|Canal syndrome|canal syndrome
5611624|NCT00851513|neuropathic pain|neuropathic pain
5611625|NCT00851513|infiltration|infiltration
5611626|NCT00851513|randomized protocol|randomized protocol
5611627|NCT00851513|pain scales|pain scales
5611628|NCT00851500|atherosclerosis|atherosclerosis
5611629|NCT00851500|carotid artery disease|carotid artery disease
5611631|NCT00851487|LRTI|lrti
5611632|NCT00851474|COstatus(R)|costatus(r)
5611633|NCT00851474|Ultrasound Dilution|ultrasound dilution
5611634|NCT00851474|Cardiac Output|cardiac output
5611635|NCT00851474|Blood Volumes|blood volumes
5611636|NCT00851474|Comparison of COstatus(R) cardiac output with other methods|comparison of costatus(r) cardiac output with other methods
5611637|NCT00851461|Spinobulbar muscular atrophy|spinobulbar muscular atrophy
5611638|NCT00851461|Kennedy's disease|kennedy's disease
5611639|NCT00851461|Goserelin|goserelin
5611640|NCT00851461|Electrophysiologic study|electrophysiologic study
5611641|NCT00851461|Inclusion body|inclusion body
5611642|NCT00851435|Pneumonia|pneumonia
5611643|NCT00851435|Nosocomial pneumonia|nosocomial pneumonia
5611644|NCT00851435|Pseudomonas aeruginosa|pseudomonas aeruginosa
5611645|NCT00851435|Monoclonal antibody|monoclonal antibody
5611646|NCT00851435|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5611647|NCT00851422|Ultrasound Dilution|ultrasound dilution
5611648|NCT00851422|Cardiac Output|cardiac output
5611649|NCT00851422|Validation of measured ultrasound dilution cardiac output|validation of measured ultrasound dilution cardiac output
5611650|NCT00851396|Vitamin D deficiency|vitamin d deficiency
5611651|NCT00851396|Insulin resistance|insulin resistance
5611652|NCT00851396|Glucose- Insulin dynamics|glucose- insulin dynamics
5611653|NCT00851396|Obese adolescents|obese adolescents
5611655|NCT00851383|Human Immunodeficiency Virus|human immunodeficiency virus
5611656|NCT00851383|HIV Seronegativity|hiv seronegativity
5611657|NCT00851383|Preventive Vaccine|preventive vaccine
5611658|NCT00851370|COPD|copd
5611659|NCT00851370|Exacerbation|exacerbation
5611660|NCT00851357|Nicotine Replacement Therapy|nicotine replacement therapy
5611661|NCT00851357|Nicotine Patch|nicotine patch
5611662|NCT00851357|Smoking cessation|smoking cessation
5611663|NCT00851357|Telephone|telephone
5611664|NCT00851357|Tobacco cessation|tobacco cessation
5611665|NCT00851357|Counseling|counseling
5611666|NCT00851357|Nicotine|nicotine
5611667|NCT00851357|Self-Help|self-help
5611668|NCT00851357|Smoking abstinence|smoking abstinence
5611669|NCT00851357|Tobacco Use Disorder|tobacco use disorder
5611670|NCT00851344|Proof-of-Concept|proof-of-concept
5611671|NCT00851344|Allergic Rhinitis|allergic rhinitis
5611672|NCT00851331|Benign childhood epilepsy|benign childhood epilepsy
5611675|NCT00851318|Cimzia|cimzia
5611676|NCT00851305|Stomach|stomach
5611678|NCT00851305|neoplasms|neoplasms
5611679|NCT00851292|prostate cancer|prostate cancer
5611681|NCT00851292|TRUS|trus
5611682|NCT00851292|diagnosis|diagnosis
5611683|NCT00851279|arrhythmia|arrhythmia
5611684|NCT00851279|ventricular tachycardia|ventricular tachycardia
5611685|NCT00851279|ablation|ablation
5611686|NCT00851279|mapping|mapping
5611687|NCT00851279|electrophysiology|electrophysiology
5611688|NCT00851253|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5611689|NCT00851253|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5611690|NCT00851253|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5611691|NCT00851253|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5611692|NCT00851253|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5611693|NCT00851253|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5611694|NCT00851253|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5611695|NCT00851253|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5611696|NCT00851253|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5611697|NCT00851253|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5611698|NCT00851253|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5611699|NCT00851253|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5611700|NCT00851253|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5611701|NCT00851253|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5611702|NCT00851253|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5611881|NCT00850759|road-crossing|road-crossing
5611703|NCT00851253|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5611704|NCT00851253|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5611705|NCT00851253|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5611706|NCT00851253|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5611707|NCT00851253|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5611708|NCT00851253|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5611709|NCT00851253|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5611710|NCT00851253|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5611711|NCT00851253|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5611712|NCT00851253|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5611713|NCT00851253|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5611714|NCT00851253|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5611715|NCT00851253|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5611716|NCT00851253|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5611717|NCT00851253|recurrent salivary gland cancer|recurrent salivary gland cancer
5611718|NCT00851253|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5611719|NCT00851253|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5611720|NCT00851253|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5611721|NCT00851253|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5611722|NCT00851253|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5611723|NCT00851253|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5611724|NCT00851253|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5611725|NCT00851253|stage II salivary gland cancer|stage ii salivary gland cancer
5611726|NCT00851253|stage III salivary gland cancer|stage iii salivary gland cancer
5611727|NCT00851253|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5611728|NCT00851253|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5611729|NCT00851253|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5611730|NCT00851253|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5611731|NCT00851253|stage IV salivary gland cancer|stage iv salivary gland cancer
5611732|NCT00851253|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5611733|NCT00851253|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5611734|NCT00851253|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5611735|NCT00851253|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5611736|NCT00851253|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5611737|NCT00851240|rheumatoid arthritis|rheumatoid arthritis
5611739|NCT00851227|Pharmacokinetics|pharmacokinetics
5611741|NCT00851227|Conivaptan|conivaptan
5611742|NCT00851227|Vaprisol|vaprisol
5611743|NCT00851227|Liver Disease|liver disease
5611744|NCT00851214|Non-invasive hemodynamic monitoring|non-invasive hemodynamic monitoring
5611745|NCT00851214|Emergency Department patients|emergency department patients
5611746|NCT00851214|trauma with an ISS>15|trauma with an iss>15
5611747|NCT00851214|Non-invasive continuous hemodynamic monitoring|non-invasive continuous hemodynamic monitoring
5611748|NCT00851201|children|children
5611749|NCT00851201|obesity|obesity
5611750|NCT00851201|weight loss|weight loss
5611751|NCT00851201|prevention|prevention
5611752|NCT00851201|diabetes risk|diabetes risk
5611753|NCT00851201|cardiometabolic|cardiometabolic
5611754|NCT00851162|Bone defect|bone defect
5611755|NCT00851162|Benign bone lesions|benign bone lesions
5611756|NCT00851162|Stem cells|stem cells
5611757|NCT00851149|aorta|aorta
5611758|NCT00851149|disease|disease
5611759|NCT00851149|abdominal|abdominal
5611760|NCT00851149|surgery|surgery
5611761|NCT00851149|Osteoarthritis, Hip|osteoarthritis, hip
5611762|NCT00851149|replacement|replacement
5611763|NCT00851149|blood|blood
5611764|NCT00851149|autolog|autolog
5611765|NCT00851149|transfusion|transfusion
5611766|NCT00851149|cytokines|cytokines
5611768|NCT00851136|Colon cancer|colon cancer
5611769|NCT00851136|Avastin|avastin
5611770|NCT00851136|APM4566g|apm4566g
5611771|NCT00851123|Stroke|stroke
5611772|NCT00851123|arm paresis|arm paresis
5611773|NCT00851123|mCIMT|mcimt
5611774|NCT00851123|bimanual training|bimanual training
5611775|NCT00851123|rehabilitation|rehabilitation
5611776|NCT00851110|high dose|high dose
5611777|NCT00851110|breast cancer|breast cancer
5611778|NCT00851110|adjuvant|adjuvant
5611779|NCT00851084|Angiogenesis|angiogenesis
5611780|NCT00851084|Colon cancer|colon cancer
5611781|NCT00851084|Rectal cancer|rectal cancer
5611782|NCT00851084|Oxaliplatin|oxaliplatin
5611783|NCT00851071|Anxiety|anxiety
5611882|NCT00850759|children|children
5611784|NCT00851071|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5611785|NCT00851071|Defibrillators, Implantable|defibrillators, implantable
5611786|NCT00851058|Behavioral research|behavioral research
5611787|NCT00851058|Motivational counseling|motivational counseling
5611788|NCT00851058|Group Counseling|group counseling
5611789|NCT00851058|Motivational Interviewing|motivational interviewing
5611790|NCT00851058|Vicarious Learning|vicarious learning
5611791|NCT00851058|Risky alcohol use|risky alcohol use
5611792|NCT00851058|Recidivism|recidivism
5611793|NCT00851058|Motor Vehicles|motor vehicles
5611794|NCT00851058|Crime|crime
5611795|NCT00851032|Advanced Cancer|advanced cancer
5594484|NCT00913107|Tegretol®|tegretol®
5611796|NCT00851032|Initiative for Molecular Profiling in Advanced Cancer Therapy|initiative for molecular profiling in advanced cancer therapy
5611797|NCT00851032|IMPACT|impact
5611798|NCT00851032|Molecular Profile-Based Study|molecular profile-based study
5611799|NCT00851032|Investigational Cancer Therapeutics Program|investigational cancer therapeutics program
5611800|NCT00851032|Molecular profiling|molecular profiling
5611801|NCT00851032|Phase I Therapies|phase i therapies
5611802|NCT00851032|Tissue Bank|tissue bank
5611803|NCT00851019|Exercise|exercise
5611804|NCT00851019|Video game|video game
5611805|NCT00851019|Type 2 diabetes|type 2 diabetes
5611806|NCT00851019|Dance|dance
5611807|NCT00851006|Depression|depression
5611808|NCT00851006|Females|females
5611809|NCT00851006|Adolescents|adolescents
5611810|NCT00850993|Hemolysis|hemolysis
5611811|NCT00850941|Registry|registry
5611812|NCT00850941|Research Database|research database
5611813|NCT00850941|Prostate cancer|prostate cancer
5611814|NCT00850941|Casodex|casodex
5611815|NCT00850941|Flutamide|flutamide
5611816|NCT00850941|Goserelin Acetate|goserelin acetate
5611817|NCT00850941|Leuprolide Acetate|leuprolide acetate
5611818|NCT00850941|Radiation|radiation
5611819|NCT00850941|PSA|psa
5611820|NCT00850941|Post-prostatectomy|post-prostatectomy
5611821|NCT00850941|Radiation Therapy|radiation therapy
5611822|NCT00850941|Prostate Specific Antigen|prostate specific antigen
5611823|NCT00850941|Adenocarcinoma|adenocarcinoma
5611824|NCT00850941|Radical Prostatectomy|radical prostatectomy
5611825|NCT00850941|Bicalutamide|bicalutamide
5611826|NCT00850941|Zoladex|zoladex
5611827|NCT00850941|Lupron Depot|lupron depot
5611828|NCT00850941|Tissue banking|tissue banking
5611829|NCT00850941|Hormones|hormones
5611830|NCT00850928|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5611831|NCT00850928|MCI|mci
5611832|NCT00850928|Mild Cognitive Impairment|mild cognitive impairment
5611833|NCT00850928|Aβ40|aβ40
5611834|NCT00850928|Aβ42|aβ42
5611835|NCT00850928|Apolipoprotein E|apolipoprotein e
5611836|NCT00850928|Inflammatory Markers|inflammatory markers
5611837|NCT00850928|Apolipoprotein E Profile|apolipoprotein e profile
5611838|NCT00850928|Serum Beta Amyloid Profile|serum beta amyloid profile
5611839|NCT00850928|Inflammatory Markers Profile|inflammatory markers profile
5611841|NCT00850915|community IPT|community ipt
5611842|NCT00850915|isoniazid adverse events|isoniazid adverse events
5611843|NCT00850915|tuberculosis incidence|tuberculosis incidence
5611845|NCT00850902|Humidity|humidity
5611846|NCT00850902|BPD|bpd
5611847|NCT00850889|Aesthetic correction of nasolabial folds|aesthetic correction of nasolabial folds
5611848|NCT00850863|COPD|copd
5611849|NCT00850863|Inflammation|inflammation
5611850|NCT00850863|Smoking|smoking
5611851|NCT00850863|Susceptibility|susceptibility
5611852|NCT00850850|PACU|pacu
5611853|NCT00850850|Physostigmine|physostigmine
5611854|NCT00850850|Recovery|recovery
5611855|NCT00850850|Postanesthesia Nursing|postanesthesia nursing
5611856|NCT00850850|Wakefulness|wakefulness
5611857|NCT00850850|General anesthesia|general anesthesia
5611858|NCT00850850|General Anesthetics|general anesthetics
5611859|NCT00850850|Postoperative Period|postoperative period
5611860|NCT00850837|Microbicide|microbicide
5611861|NCT00850837|HIV Seronegativity|hiv seronegativity
5611862|NCT00850824|T2DM|t2dm
5611863|NCT00850811|Peplin|peplin
5611864|NCT00850811|PEP005|pep005
5611865|NCT00850798|Type 2 diabetes|type 2 diabetes
5611866|NCT00850798|Elder patients|elder patients
5611867|NCT00850798|Glycemic control|glycemic control
5611868|NCT00850798|Men or women aged ≥80 years at time of randomization. There is no upper age limit.|men or women aged ≥80 years at time of randomization. there is no upper age limit.
5611869|NCT00850798|Be able to walk by themselves|be able to walk by themselves
5611870|NCT00850798|They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.|they had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
5611871|NCT00850772|Enteral nutrition|enteral nutrition
5611872|NCT00850772|Ovarian cancer|ovarian cancer
5611873|NCT00850772|Peritoneal cancer|peritoneal cancer
5611874|NCT00850772|Fallopian tube cancer|fallopian tube cancer
5611875|NCT00850772|Malnutrition|malnutrition
5611876|NCT00850772|Surgery|surgery
5611877|NCT00850772|Gynecological Cancer|gynecological cancer
5611878|NCT00850772|Suspected advanced epithelial ovarian cancer|suspected advanced epithelial ovarian cancer
5611879|NCT00850759|pedestrian safety|pedestrian safety
5611880|NCT00850759|street-crossing ability|street-crossing ability
5611883|NCT00850759|injury prevention|injury prevention
5611884|NCT00850746|QT interval|qt interval
5611885|NCT00850746|Cardiac Repolarization|cardiac repolarization
5611886|NCT00850746|Cardiac Conduction|cardiac conduction
5611887|NCT00850746|Healthy Subjects|healthy subjects
5611888|NCT00850746|YM443 (Z-338, acotiamide hydrochloride)|ym443 (z-338, acotiamide hydrochloride)
5611889|NCT00850746|Evaluation of QT Interval|evaluation of qt interval
5611890|NCT00850720|Biological Response Modifiers|biological response modifiers
5611891|NCT00850720|Bypass Surgery|bypass surgery
5611892|NCT00850720|Cardiology|cardiology
5611893|NCT00850720|Congenital Heart Disease|congenital heart disease
5611894|NCT00850720|Endocrinology|endocrinology
5611895|NCT00850720|Hormone Dysfunction|hormone dysfunction
5611896|NCT00850720|Hormones|hormones
5611897|NCT00850720|Neuroendocrinology|neuroendocrinology
5611898|NCT00850720|Pediatric Surgery|pediatric surgery
5611899|NCT00850707|AVF|avf
5611900|NCT00850707|AVG|avg
5611901|NCT00850707|TCC|tcc
5611902|NCT00850707|inflammation|inflammation
5611903|NCT00850707|monocite senescence|monocite senescence
5611904|NCT00850694|Vitamin D deficiency|vitamin d deficiency
5611905|NCT00850694|Obesity|obesity
5611906|NCT00850694|Insulin resistance|insulin resistance
5611907|NCT00850694|Glucose tolerance|glucose tolerance
5611908|NCT00850681|Peplin|peplin
5611909|NCT00850681|PEP005|pep005
5611910|NCT00850668|Food Allergy|food allergy
5611911|NCT00850668|Peanut Allergy|peanut allergy
5611912|NCT00850642|Sputum cell counts|sputum cell counts
5611913|NCT00850642|Neutrophils|neutrophils
5611914|NCT00850642|Severe Asthma|severe asthma
5611915|NCT00850642|ICS|ics
5611916|NCT00850642|Inhaled corticosteroids|inhaled corticosteroids
5611917|NCT00850629|weight regain|weight regain
5611918|NCT00850629|endocrine counterregulation|endocrine counterregulation
5611919|NCT00850616|HIV|hiv
5611920|NCT00850616|HIV Seronegativity|hiv seronegativity
5611921|NCT00850616|Preventive Vaccine|preventive vaccine
5611922|NCT00850603|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
5611923|NCT00850603|Meningococcal Infections|meningococcal infections
5611924|NCT00850603|Meningitis|meningitis
5611925|NCT00850564|growth hormone releasing hormone|growth hormone releasing hormone
5611926|NCT00850551|Early Intervention|early intervention
5611927|NCT00850551|Pulmonary Exacerbation|pulmonary exacerbation
5611929|NCT00850551|Lung Function|lung function
5611930|NCT00850551|Spirometry|spirometry
5611931|NCT00850551|Phillips Telemonitor|phillips telemonitor
5611932|NCT00850551|Home Spirometry|home spirometry
5611933|NCT00850551|PiKo-6|piko-6
5611934|NCT00850551|Home Monitoring|home monitoring
5611935|NCT00850538|Bone Marrow Lesion|bone marrow lesion
5611936|NCT00850538|BML|bml
5611937|NCT00850538|Arthroplasty|arthroplasty
5611938|NCT00850538|Replacement|replacement
5611939|NCT00850538|Knee|knee
5611940|NCT00850538|Discarded tissue|discarded tissue
5611941|NCT00850486|women|women
5611942|NCT00850486|ischemic heart disease|ischemic heart disease
5611943|NCT00850486|high frequency ECG|high frequency ecg
5605655|NCT00875823|Type I|type i
5611944|NCT00850486|exercise stress testing|exercise stress testing
5611945|NCT00850486|signal processing|signal processing
5611946|NCT00850486|ischemic heart disease in women|ischemic heart disease in women
5611948|NCT00850473|CT|ct
5611949|NCT00850473|Heart Attack|heart attack
5611950|NCT00850473|Coronary Artery disease|coronary artery disease
5611951|NCT00850473|Cardiac Catheterization|cardiac catheterization
5611952|NCT00850447|Posttraumatic stress disorder|posttraumatic stress disorder
5611953|NCT00850447|Cognition|cognition
5611954|NCT00850447|Neuropsychological Tests|neuropsychological tests
5611955|NCT00850421|migraine headache|migraine headache
5611956|NCT00850421|Botulinum Toxin Type A|botulinum toxin type a
5611957|NCT00850421|BOTOX|botox
5611958|NCT00850421|BTX-A|btx-a
5611959|NCT00850408|Stroke|stroke
5611960|NCT00850408|rTMS|rtms
5611961|NCT00850408|TMS|tms
5611962|NCT00850408|Rehabilitation|rehabilitation
5611963|NCT00850408|Upper Extremity|upper extremity
5611964|NCT00850395|HIV-1|hiv-1
5611965|NCT00850395|non-interventional|non-interventional
5611966|NCT00850395|CCR-5 tropic virus|ccr-5 tropic virus
5611967|NCT00850395|therapy experienced patients|therapy experienced patients
5611968|NCT00850382|CBF AML|cbf aml
5611969|NCT00850382|Dasatinib|dasatinib
5611970|NCT00850382|Core Binding Factor (CBF)|core binding factor (cbf)
5611971|NCT00850369|Pulmonary hypertension|pulmonary hypertension
5611972|NCT00850369|Sickle cell disease|sickle cell disease
5611973|NCT00850356|Bariatric Surgery|bariatric surgery
5611974|NCT00850356|Body Weight|body weight
5611975|NCT00850356|Health care costs|health care costs
5611976|NCT00850356|Obesity|obesity
5611977|NCT00850356|Obesity Complications|obesity complications
5611978|NCT00850356|Prolonged wait times|prolonged wait times
5611979|NCT00850356|Quality of Life|quality of life
5611980|NCT00850343|Rheumatoid Arthritis|rheumatoid arthritis
5611981|NCT00850343|Certolizumab Pegol|certolizumab pegol
5611982|NCT00850343|Cimzia|cimzia
5611983|NCT00850330|Drug interactions|drug interactions
5611984|NCT00850330|Drug interaction software|drug interaction software
5611985|NCT00850330|Older patients|older patients
5611986|NCT00850330|Hospitalization|hospitalization
5611988|NCT00850291|Partial duodenopancreatectomy using electrosurgical vessel sealing device|partial duodenopancreatectomy using electrosurgical vessel sealing device
5611989|NCT00850278|Brain tumor|brain tumor
5611990|NCT00850278|[18F]FLT|[18f]flt
5611991|NCT00850278|[11C]MET|[11c]met
5611992|NCT00850278|TEP-imaging|tep-imaging
5611993|NCT00850278|tumor cell proliferation|tumor cell proliferation
5611994|NCT00850265|Asthma|asthma
5611995|NCT00850265|Formoterol|formoterol
5611996|NCT00850265|Beclomethasone|beclomethasone
5611997|NCT00850265|Extrafine formulation|extrafine formulation
5611998|NCT00850265|Spacer|spacer
5611999|NCT00850265|Moderate|moderate
5612000|NCT00850265|Severe|severe
5612001|NCT00850265|Stable|stable
5612002|NCT00850252|Lifeline|lifeline
5612003|NCT00850252|Tissue engineered blood vessel|tissue engineered blood vessel
5612004|NCT00850252|A-V shunt|a-v shunt
5612005|NCT00850239|diabetes|diabetes
5612006|NCT00850239|DPP4 inhibitor|dpp4 inhibitor
5612007|NCT00850239|dutogliptin|dutogliptin
5612008|NCT00850226|test anxiety|test anxiety
5612009|NCT00850200|Hodgkin Lymphoma, Proton Radiation|hodgkin lymphoma, proton radiation
5612010|NCT00850187|Knee cartilage diseases|knee cartilage diseases
5612011|NCT00850174|Bioequivalence|bioequivalence
5612012|NCT00850174|Healthy Subjects|healthy subjects
5612013|NCT00850161|Type 1 Diabetes|type 1 diabetes
5612014|NCT00850161|Nasal Insulin|nasal insulin
5612015|NCT00850161|Insulin Deficiency|insulin deficiency
5612016|NCT00850161|Insulin-Dependent|insulin-dependent
5612017|NCT00850148|Anwar|anwar
5612018|NCT00850148|Melles|melles
5612019|NCT00850148|Keratoconus|keratoconus
5612020|NCT00850096|Phase 2 Study for novel insulin delivery of type 2 diabetes|phase 2 study for novel insulin delivery of type 2 diabetes
5612021|NCT00850083|Fever|fever
5612022|NCT00850083|Children|children
5612023|NCT00850070|autism|autism
5612025|NCT00850044|SAD|sad
5612026|NCT00850031|Presbyopia|presbyopia
5612027|NCT00850031|Accommodation|accommodation
5612028|NCT00850031|Near visual acuity|near visual acuity
5612029|NCT00850031|LASIK|lasik
5612030|NCT00850018|Sickle Cell Disease|sickle cell disease
5612031|NCT00850018|Sickle Cell Anemia|sickle cell anemia
5612032|NCT00850018|Hemoglobin SS|hemoglobin ss
5612033|NCT00850018|Hemoglobin SB0|hemoglobin sb0
5612034|NCT00850005|neuropathic pain|neuropathic pain
5612035|NCT00850005|resistant|resistant
5612036|NCT00850005|neuroinflammation|neuroinflammation
5612037|NCT00850005|neuroinflammatory markers|neuroinflammatory markers
5612038|NCT00850005|Neuropathic pain that has not responded to standard therapy|neuropathic pain that has not responded to standard therapy
5612039|NCT00849992|Actinic cheilitis|actinic cheilitis
5612040|NCT00849992|Imiquimod 5%|imiquimod 5%
5612041|NCT00849992|Photodynamic therapy|photodynamic therapy
5612042|NCT00849979|Colorectal|colorectal
5612043|NCT00849979|Gastric|gastric
5612044|NCT00849979|Gastrointestinal|gastrointestinal
5612045|NCT00849979|GI|gi
5612046|NCT00849979|Liver|liver
5612047|NCT00849979|Pancreas|pancreas
5612048|NCT00849979|Gastrointestinal Cancers|gastrointestinal cancers
5612049|NCT00849979|Gastro-Intestinal Chemotherapy|gastro-intestinal chemotherapy
5612050|NCT00849979|M.D. Anderson Symptom Inventory|m.d. anderson symptom inventory
5612051|NCT00849979|MDASI-GI|mdasi-gi
5612052|NCT00849979|Medical Oncology|medical oncology
5612053|NCT00849966|Celebrex|celebrex
5612054|NCT00849966|celecoxib|celecoxib
5612055|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5612056|NCT00849966|Anti-Inflammatory Agents Non-Steroidal|anti-inflammatory agents non-steroidal
5612057|NCT00849966|Adverse drug events|adverse drug events
5612058|NCT00849966|quality of life|quality of life
5612059|NCT00849966|Pain Postoperative|pain postoperative
5612060|NCT00849966|Tonsillectomy|tonsillectomy
5612061|NCT00849966|Adenotonsillectomy|adenotonsillectomy
5612062|NCT00849966|Otologic Surgical Procedures|otologic surgical procedures
5612063|NCT00849940|Spectroscopy|spectroscopy
5612064|NCT00849940|Near infrared|near infrared
5612065|NCT00849940|Oximetry|oximetry
5612066|NCT00849940|Hypoxemia|hypoxemia
5612067|NCT00849940|Tissue oxygenation|tissue oxygenation
5612068|NCT00849940|Pediatric|pediatric
5612069|NCT00849927|shoulder instability|shoulder instability
5612070|NCT00849927|labral lesions|labral lesions
5612071|NCT00849927|arthroscopic labral repair|arthroscopic labral repair
5612072|NCT00849927|SLAP|slap
5612073|NCT00849927|triple labrum|triple labrum
5612074|NCT00849927|circumferential labrum|circumferential labrum
5612075|NCT00849927|Pan-labral lesion|pan-labral lesion
5612076|NCT00849888|Thymus Transplantation|thymus transplantation
5612077|NCT00849888|DiGeorge Anomaly|digeorge anomaly
5612078|NCT00849888|Athymia|athymia
5612079|NCT00849888|Low T cell numbers|low t cell numbers
5612080|NCT00849888|Immunoreconstitution|immunoreconstitution
5612081|NCT00849888|Immunodeficiency|immunodeficiency
5612082|NCT00849875|ASCI|asci
5612083|NCT00849875|Dacarbazine|dacarbazine
5612084|NCT00849875|Cancer immunotherapeutic|cancer immunotherapeutic
5612085|NCT00849875|MAGE-A3|mage-a3
5612086|NCT00849875|Malignant melanoma|malignant melanoma
5612087|NCT00849862|Bioequivalence|bioequivalence
5612088|NCT00849862|Healthy Subjects|healthy subjects
5612089|NCT00849849|postgestational diabetes|postgestational diabetes
5612090|NCT00849849|diabetes mellitus|diabetes mellitus
5612091|NCT00849849|OGTT|ogtt
5612092|NCT00849849|insulin sensitivity|insulin sensitivity
5612093|NCT00849849|insulin secretion|insulin secretion
5612094|NCT00849823|African American|african american
5612095|NCT00849823|Men|men
5612096|NCT00849823|Condoms|condoms
5612097|NCT00849823|Randomization|randomization
5612098|NCT00849823|Brief Intervention|brief intervention
5612099|NCT00849823|HIV|hiv
5612100|NCT00849823|HIV Seronegativity|hiv seronegativity
5612101|NCT00849810|Hypertension|hypertension
5612102|NCT00849810|Beta-blockers|beta-blockers
5612103|NCT00849810|Ambulatory blood pressure|ambulatory blood pressure
5612104|NCT00849810|Basal metabolic rate|basal metabolic rate
5612105|NCT00849810|Quality of life|quality of life
5612106|NCT00849797|Bioequivalence|bioequivalence
5612107|NCT00849797|Healthy Subjects|healthy subjects
5612108|NCT00849771|Displaced Scapula Fracture|displaced scapula fracture
5612109|NCT00849771|Scapula Fracture|scapula fracture
5612110|NCT00849771|Extraarticular Scapula Fractures|extraarticular scapula fractures
5612111|NCT00849771|Clavicle|clavicle
5612112|NCT00849758|breast cancer|breast cancer
5612113|NCT00849758|elderly|elderly
5612114|NCT00849758|biomarker|biomarker
5612115|NCT00849745|severe autoimmune diseases|severe autoimmune diseases
5612116|NCT00849745|allogeneic stem cell transplant|allogeneic stem cell transplant
5612117|NCT00849732|HIV Seronegativity|hiv seronegativity
5612118|NCT00849732|Preventive Vaccine|preventive vaccine
5612119|NCT00849719|visual analog scale|visual analog scale
5612120|NCT00849719|patient controlled analgesia|patient controlled analgesia
5612121|NCT00849719|post operative pain|post operative pain
5612122|NCT00849719|rescue drug|rescue drug
5612123|NCT00849706|sleep deprivation|sleep deprivation
5612124|NCT00849706|workload|workload
5612125|NCT00849706|increased workload|increased workload
5612126|NCT00849680|HIV Seronegativity|hiv seronegativity
5612127|NCT00849680|Preventive Vaccine|preventive vaccine
5612128|NCT00849667|ovarian cancer|ovarian cancer
5612129|NCT00849667|relapsed ovarian cancer|relapsed ovarian cancer
5612130|NCT00849667|Platinum-sensitive Ovarian Cancer|platinum-sensitive ovarian cancer
5612131|NCT00849654|PCI-32765|pci-32765
5612132|NCT00849654|Lymphoma|lymphoma
5612133|NCT00849654|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5612134|NCT00849654|Lymphoma, B-Cell|lymphoma, b-cell
5612135|NCT00849654|Burkitt Lymphoma|burkitt lymphoma
5612136|NCT00849654|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5612137|NCT00849654|Lymphoma, B-Cell, Diffuse|lymphoma, b-cell, diffuse
5612138|NCT00849654|Lymphoma, Follicular|lymphoma, follicular
5612139|NCT00849654|Lymphoma, Mantle Cell|lymphoma, mantle cell
5612140|NCT00849654|Leukemia, Lymphoid|leukemia, lymphoid
5612141|NCT00849654|Leukemia, B-Cell|leukemia, b-cell
5612147|NCT00849641|near infrared spectroscopy|near infrared spectroscopy
5612148|NCT00849628|Aged|aged
5612149|NCT00849628|Polypharmacy|polypharmacy
5612150|NCT00849628|Adverse effects|adverse effects
5612152|NCT00849589|Screening|screening
5612153|NCT00849589|Brief intervention|brief intervention
5612154|NCT00849589|Underage drinking|underage drinking
5612155|NCT00849563|predictive genomics|predictive genomics
5612156|NCT00849563|personalized medicine|personalized medicine
5612157|NCT00849563|personal genomics|personal genomics
5612158|NCT00849563|genetic knowledge|genetic knowledge
5612159|NCT00849563|genetic attitudes|genetic attitudes
5612160|NCT00849563|prevention|prevention
5612161|NCT00849563|health outcomes|health outcomes
5612162|NCT00849563|behavioral|behavioral
5612163|NCT00849550|Advanced Solid Tumors|advanced solid tumors
5612164|NCT00849550|Cancer|cancer
5612165|NCT00849550|Capecitabine|capecitabine
5612166|NCT00849550|XELOX|xelox
5612167|NCT00849550|Neoplasms|neoplasms
5612168|NCT00849550|Oxaliplatin|oxaliplatin
5612169|NCT00849550|Bevacizumab|bevacizumab
5612170|NCT00849550|RAD001|rad001
5612171|NCT00849537|Triamcinolon|triamcinolon
5612172|NCT00849537|Cataract|cataract
5612173|NCT00849537|Diabetic retinopathy|diabetic retinopathy
5612174|NCT00849537|non-proliferative retinopathy|non-proliferative retinopathy
5612175|NCT00849511|Migraine prevention|migraine prevention
5612176|NCT00849511|Crossover|crossover
5612177|NCT00849511|Melatonin|melatonin
5612178|NCT00849485|Bioequivalence|bioequivalence
5612179|NCT00849485|Healthy Subjects|healthy subjects
5612180|NCT00849472|Neoadjuvant Breast Cancer|neoadjuvant breast cancer
5612181|NCT00849472|Pazopanib (GW786034)|pazopanib (gw786034)
5612182|NCT00849472|NSABP Foundation, Inc.|nsabp foundation, inc.
5612183|NCT00849472|cyclophosphamide|cyclophosphamide
5612184|NCT00849472|Paclitaxel|paclitaxel
5612185|NCT00849472|Doxorubicin|doxorubicin
5612186|NCT00849459|recurrent breast cancer|recurrent breast cancer
5612283|NCT00849004|keloid|keloid
5612187|NCT00849459|stage IV breast cancer|stage iv breast cancer
5612188|NCT00849433|Inflammation|inflammation
5612189|NCT00849433|epithelial|epithelial
5612190|NCT00849433|integrity|integrity
5612191|NCT00849433|ECIS|ecis
5612192|NCT00849394|bevacizumab|bevacizumab
5612193|NCT00849394|proteinuria|proteinuria
5612195|NCT00849381|HPV vaccine|hpv vaccine
5612196|NCT00849381|papillomavirus|papillomavirus
5612197|NCT00849381|cervical cancer|cervical cancer
5612198|NCT00849381|human papillomavirus|human papillomavirus
5612199|NCT00849329|lapatinib (GW572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, Phase 1|lapatinib (gw572016), subject, pharmacokinetic, esomeprazole, proton-pump inhibitor, drug interaction, phase 1
5612200|NCT00849303|stroke|stroke
5612201|NCT00849303|rehabilitation|rehabilitation
5612202|NCT00849303|gait|gait
5612203|NCT00849303|timing|timing
5594882|NCT00911391|Doppler|doppler
5612204|NCT00849303|transcranial magnetic stimulation|transcranial magnetic stimulation
5612205|NCT00849277|Respiratory Tract Infections|respiratory tract infections
5612206|NCT00849277|Influenza, Human|influenza, human
5612207|NCT00849277|Probiotics|probiotics
5612208|NCT00849264|hepatocellular carcinoma|hepatocellular carcinoma
5612209|NCT00849264|portal vein tumor thrombus|portal vein tumor thrombus
5612210|NCT00849264|surgical comprehensive treatment|surgical comprehensive treatment
5612211|NCT00849212|Seizures|seizures
5612212|NCT00849212|epilepsy|epilepsy
5612213|NCT00849199|screening|screening
5612214|NCT00849199|early detection|early detection
5612215|NCT00849199|prevention|prevention
5612216|NCT00849199|cancer|cancer
5612217|NCT00849199|high risk|high risk
5612218|NCT00849199|ovarian cancer|ovarian cancer
5612219|NCT00849199|breast cancer|breast cancer
5612220|NCT00849186|stage I renal cell cancer|stage i renal cell cancer
5612221|NCT00849186|stage II renal cell cancer|stage ii renal cell cancer
5612222|NCT00849186|stage III renal cell cancer|stage iii renal cell cancer
5612223|NCT00849186|stage IV renal cell cancer|stage iv renal cell cancer
5612224|NCT00849173|Endometriosis|endometriosis
5612225|NCT00849173|Infertility|infertility
5612226|NCT00849173|Tubal Ligation|tubal ligation
5612227|NCT00849173|Chronic Pelvic Pain|chronic pelvic pain
5612228|NCT00849173|Quality of Life|quality of life
5612229|NCT00849160|Treatment Experienced|treatment experienced
5612230|NCT00849147|Acute Lymphoblastic Leukemia/Lymphoma|acute lymphoblastic leukemia/lymphoma
5612231|NCT00849147|Acute Myelogenous Leukemia|acute myelogenous leukemia
5612232|NCT00849147|Mantel-Cell Lymphoma|mantel-cell lymphoma
5612233|NCT00849147|Hematopoietic Transplant|hematopoietic transplant
5612234|NCT00849147|Haplo-Identical Transplant|haplo-identical transplant
5612235|NCT00849147|Non-Myeloablative Transplant|non-myeloablative transplant
5612236|NCT00849134|First-Time-in-Human|first-time-in-human
5612237|NCT00849134|Tolerability|tolerability
5612238|NCT00849134|Pharmacodynamics|pharmacodynamics
5612239|NCT00849134|Safety|safety
5612240|NCT00849134|Food Effect|food effect
5612241|NCT00849134|Pharmacokinetics|pharmacokinetics
5612242|NCT00849134|Healthy Volunteers|healthy volunteers
5612243|NCT00849121|Vaccine|vaccine
5612244|NCT00849121|pTVG-HP|ptvg-hp
5612245|NCT00849121|Prostate Cancer|prostate cancer
5612246|NCT00849121|Castrate Resistant|castrate resistant
5612247|NCT00849108|Myocardial Perfusion|myocardial perfusion
5612248|NCT00849108|PET imaging|pet imaging
5612249|NCT00849108|SPECT imaging|spect imaging
5612250|NCT00849108|Coronary artery disease|coronary artery disease
5612251|NCT00849108|Subjects that are male and nonpregnant female patients|subjects that are male and nonpregnant female patients
5612252|NCT00849108|presenting with reversible ischemia as characterized by a|presenting with reversible ischemia as characterized by a
5612253|NCT00849108|rest/stress SPECT imaging study using|rest/stress spect imaging study using
5612254|NCT00849108|Technetium(99mTc)-labeled tracers|technetium(99mtc)-labeled tracers
5612255|NCT00849095|Adult|adult
5612256|NCT00849095|Asthma|asthma
5612257|NCT00849095|Bronchodilator Agents|bronchodilator agents
5612258|NCT00849095|Budesonide|budesonide
5612259|NCT00849095|Double-Blind Method|double-blind method
5612260|NCT00849095|Drug Therapy, Combination|drug therapy, combination
5612261|NCT00849095|Ethanolamines|ethanolamines
5612262|NCT00849095|Female|female
5612263|NCT00849095|Forced Expiratory Volume|forced expiratory volume
5612264|NCT00849095|Humans|humans
5612265|NCT00849095|Male|male
5612266|NCT00849095|Terbutaline|terbutaline
5612267|NCT00849082|stage IIB prostate cancer|stage iib prostate cancer
5612268|NCT00849082|stage IIA prostate cancer|stage iia prostate cancer
5612269|NCT00849082|stage III prostate cancer|stage iii prostate cancer
5612270|NCT00849082|stage IV prostate cancer|stage iv prostate cancer
5612271|NCT00849069|Streptococcus pneumoniae|streptococcus pneumoniae
5612272|NCT00849069|Vaccine|vaccine
5612273|NCT00849069|Non-typable Haemophilus influenza|non-typable haemophilus influenza
5612274|NCT00849069|Adults and Elderly Adults|adults and elderly adults
5612275|NCT00849056|diabetes|diabetes
5612276|NCT00849043|obstructive sleep apnea hypopnea|obstructive sleep apnea hypopnea
5612278|NCT00849043|OSAH|osah
5612279|NCT00849017|placebo|placebo
5612280|NCT00849017|albiglutide|albiglutide
5612281|NCT00849017|monotherapy|monotherapy
5612282|NCT00849017|diabetes|diabetes
5612286|NCT00849004|paper tape|paper tape
5612287|NCT00849004|steri-strip|steri-strip
5612288|NCT00848991|precedex|precedex
5612289|NCT00848991|propofol|propofol
5612290|NCT00848978|Functional capacity|functional capacity
5612291|NCT00848978|Quality of life|quality of life
5612292|NCT00848978|Depression|depression
5612294|NCT00848978|Body composition|body composition
5612295|NCT00848978|Physical activity|physical activity
5612296|NCT00848965|fluticasone propionate|fluticasone propionate
5612297|NCT00848965|Vienna Challenge Chamber|vienna challenge chamber
5612298|NCT00848965|glucocorticosteroids|glucocorticosteroids
5612299|NCT00848965|allergic rhinitis|allergic rhinitis
5612300|NCT00848939|systemic sclerosis|systemic sclerosis
5612301|NCT00848939|scleroderma|scleroderma
5612302|NCT00848939|pharmacokinetics|pharmacokinetics
5612303|NCT00848939|treprostinil diethanolamine|treprostinil diethanolamine
5612304|NCT00848926|Antigens, CD30|antigens, cd30
5612305|NCT00848926|Antibody-Drug Conjugate|antibody-drug conjugate
5612306|NCT00848926|Antibodies, Monoclonal|antibodies, monoclonal
5612307|NCT00848926|Disease, Hodgkin|disease, hodgkin
5612308|NCT00848926|Hematologic Diseases|hematologic diseases
5612309|NCT00848926|Lymphoma|lymphoma
5612310|NCT00848926|monomethylauristatin E|monomethylauristatin e
5612311|NCT00848926|Drug Therapy|drug therapy
5612312|NCT00848926|Immunotherapy|immunotherapy
5612313|NCT00848913|strength deficit|strength deficit
5612314|NCT00848913|physical function|physical function
5798402|NCT00112515|fatigue|fatigue
5612315|NCT00848887|Influenza|influenza
5612317|NCT00848887|Vaccine|vaccine
5612318|NCT00848887|Adjuvant|adjuvant
5612319|NCT00848861|propofol sedation|propofol sedation
5612320|NCT00848861|colonoscopy|colonoscopy
5612321|NCT00848861|recovery time|recovery time
5612322|NCT00848861|recovery time after sedation for colonoscopy|recovery time after sedation for colonoscopy
5612323|NCT00848848|Influenza|influenza
5612324|NCT00848848|Flu|flu
5612325|NCT00848848|Vaccine|vaccine
5612326|NCT00848848|Intradermal|intradermal
5612327|NCT00848848|Adjuvant|adjuvant
5612328|NCT00848835|defibrillator|defibrillator
5612329|NCT00848822|Pediatrics|pediatrics
5612330|NCT00848822|Sleep|sleep
5612331|NCT00848822|Glucose regulation|glucose regulation
5612332|NCT00848822|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5612333|NCT00848809|Acute kidney injury|acute kidney injury
5612334|NCT00848809|Vancomycin therapy|vancomycin therapy
5612335|NCT00848809|Slow-low efficiency daily dialysis|slow-low efficiency daily dialysis
5612336|NCT00848809|Intermittent Hemodialysis|intermittent hemodialysis
5612337|NCT00848809|Kidney|kidney
5612340|NCT00848796|Heparin Leo|heparin leo
5612341|NCT00848796|Hepalean|hepalean
5612342|NCT00848796|CPB Cardiopuilmonary Bypass|cpb cardiopuilmonary bypass
5612343|NCT00848796|CABG Coronary Artery Bypass Grafting|cabg coronary artery bypass grafting
5612344|NCT00848796|Anticoagulation efficacy|anticoagulation efficacy
5612345|NCT00848783|gastric cancer|gastric cancer
5612346|NCT00848783|gastroesophageal junction|gastroesophageal junction
5612347|NCT00848783|stomach cancer|stomach cancer
5612348|NCT00848783|intraperitoneal infusion|intraperitoneal infusion
5612350|NCT00848783|irinotecan|irinotecan
5612351|NCT00848783|cisplatin|cisplatin
5612352|NCT00848783|floxuridine|floxuridine
5612353|NCT00848770|Stroke, Acute|stroke, acute
5612356|NCT00848757|Lifestyle Intervention|lifestyle intervention
5612357|NCT00848744|Acne|acne
5612358|NCT00848731|pulmonary hypertension|pulmonary hypertension
5612359|NCT00848731|venous thromboembolism|venous thromboembolism
5612360|NCT00848718|Tumors, cancer|tumors, cancer
5612361|NCT00848705|type 1 diabetes, adolescent, self-management|type 1 diabetes, adolescent, self-management
5612362|NCT00848692|Chronic Fatigue Syndrome|chronic fatigue syndrome
5612363|NCT00848692|CFS|cfs
5612364|NCT00848692|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5612365|NCT00848692|Rituximab|rituximab
5612366|NCT00848692|B-lymphocyte depletion|b-lymphocyte depletion
5612367|NCT00848692|B-cell depletion|b-cell depletion
5612368|NCT00848679|Pre-eclampsia|pre-eclampsia
5612369|NCT00848679|Pregnancy|pregnancy
5612370|NCT00848679|Uteroplacental blood flow|uteroplacental blood flow
5612371|NCT00848679|Epidural|epidural
5612372|NCT00848679|Anesthesia|anesthesia
5612376|NCT00848601|SGI-1776|sgi-1776
5612377|NCT00848601|PIM|pim
5612378|NCT00848601|Hormone & Docetaxel refractory Prostate Cancer|hormone & docetaxel refractory prostate cancer
5612379|NCT00848601|Refractory non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5612380|NCT00848588|agonal breathing|agonal breathing
5612381|NCT00848588|cardiac arrest|cardiac arrest
5612382|NCT00848588|9-1-1 call taker|9-1-1 call taker
5612383|NCT00848588|survey|survey
5612384|NCT00848562|sudden cardiac death|sudden cardiac death
5612385|NCT00848549|Epilepsy|epilepsy
5612386|NCT00848549|Monotherapy|monotherapy
5612387|NCT00848536|OAG|oag
5612388|NCT00848536|OHT|oht
5612389|NCT00848523|LBH859|lbh859
5612390|NCT00848523|Panobinostat|panobinostat
5612391|NCT00848523|GBM|gbm
5612392|NCT00848523|Glioma|glioma
5612393|NCT00848523|Glioblastoma|glioblastoma
5612394|NCT00848523|Astrocytoma|astrocytoma
5612395|NCT00848523|oligodendroglioma|oligodendroglioma
5612396|NCT00848523|oligoastrocytoma|oligoastrocytoma
5612397|NCT00848523|gliosarcoma|gliosarcoma
5612398|NCT00848523|anaplastic|anaplastic
5612399|NCT00848497|hormone replacement therapy|hormone replacement therapy
5612400|NCT00848497|radical prostatectomy|radical prostatectomy
5612401|NCT00848497|erectile dysfunctions|erectile dysfunctions
5612402|NCT00848497|scheduled for removal of prostate gland|scheduled for removal of prostate gland
5612403|NCT00848471|Indirect calorimeter|indirect calorimeter
5612404|NCT00848471|Validation|validation
5612405|NCT00848471|Energy expenditure|energy expenditure
5612406|NCT00848471|Healthy volunteers|healthy volunteers
5612407|NCT00848458|Azelaic Acid|azelaic acid
5612408|NCT00848458|Iontophoresis|iontophoresis
5612409|NCT00848432|Schizophrenia|schizophrenia
5612410|NCT00848432|Risperidone|risperidone
5612411|NCT00848432|Maintenance treatment|maintenance treatment
5612412|NCT00848432|Relapse|relapse
5612413|NCT00848419|Epidural|epidural
5612414|NCT00848419|Analgesia|analgesia
5612415|NCT00848419|Methadone|methadone
5612416|NCT00848419|Morphine|morphine
5612417|NCT00848419|Pharmacokinetic-pharmacodynamic|pharmacokinetic-pharmacodynamic
5612418|NCT00848419|Experimental pain - analgesic response|experimental pain - analgesic response
5612419|NCT00848406|bronchial|bronchial
5612420|NCT00848406|COPD|copd
5612421|NCT00848406|Asthma|asthma
5612422|NCT00848406|sputum|sputum
5612423|NCT00848406|biopsies|biopsies
5612424|NCT00848393|pediatric cardiac surgery|pediatric cardiac surgery
5612425|NCT00848393|stress response|stress response
5612426|NCT00848393|early extubation|early extubation
5612427|NCT00848393|Dexmedetomidine|dexmedetomidine
5612428|NCT00848393|TOF|tof
5612429|NCT00848393|VSD|vsd
5612430|NCT00848393|AVSD|avsd
5612431|NCT00848380|Hypertension|hypertension
5612432|NCT00848380|hyperlipidemia|hyperlipidemia
5612433|NCT00848354|enbrel|enbrel
5612434|NCT00848354|moderate arthritis|moderate arthritis
5612435|NCT00848354|severe arthritis|severe arthritis
5612436|NCT00848354|rheumatoid arthritis|rheumatoid arthritis
5612437|NCT00848328|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5612438|NCT00848328|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5612439|NCT00848328|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5612440|NCT00848328|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5612441|NCT00848315|cognitive behavioral intervention|cognitive behavioral intervention
5612442|NCT00848315|low literate/illiterate Hispanic patients|low literate/illiterate hispanic patients
5612443|NCT00848302|peripheral vascular disease|peripheral vascular disease
5612444|NCT00848302|endothelial dysfunction|endothelial dysfunction
5612445|NCT00848302|intravascular ultrasound|intravascular ultrasound
5612446|NCT00848302|L-Arginine|l-arginine
5612447|NCT00848289|Bladder cancer|bladder cancer
5612448|NCT00848289|Genetic susceptibility|genetic susceptibility
5612449|NCT00848289|Increased Risk|increased risk
5612450|NCT00848276|PCSK9|pcsk9
5612451|NCT00848276|Lipoprotein metabolism|lipoprotein metabolism
5612452|NCT00848276|testosterone|testosterone
5612453|NCT00848276|estradiol|estradiol
5612472|NCT00848211|THYMON|thymon
5612473|NCT00848211|Treatment Naive|treatment naive
5612474|NCT00848198|Dry Eye Disease|dry eye disease
5612475|NCT00848198|Dry Eye Syndrome|dry eye syndrome
5612476|NCT00848198|Dry Eye|dry eye
5612477|NCT00848185|VEGF|vegf
5612478|NCT00848185|Trigger|trigger
5612479|NCT00848185|OHSS|ohss
5612480|NCT00848172|Essential Tremor|essential tremor
5612481|NCT00848172|Octanol|octanol
5612482|NCT00848172|Octanoic Acid|octanoic acid
5612483|NCT00848172|Ethanol|ethanol
5612484|NCT00848172|Accelerometry|accelerometry
5612485|NCT00848159|Osteoporosis|osteoporosis
5612486|NCT00848159|kyphosis|kyphosis
5612487|NCT00848159|photogrammetry|photogrammetry
5612488|NCT00848107|systemic sclerosis|systemic sclerosis
5612489|NCT00848107|scleroderma|scleroderma
5612490|NCT00848107|digital ulcers|digital ulcers
5612491|NCT00848107|vasculopathy|vasculopathy
5612492|NCT00848094|hepatocellular carcinoma|hepatocellular carcinoma
5612493|NCT00848094|radiation therapy|radiation therapy
5612494|NCT00848094|3-dimensional conformal radiation therapy (3-DCRT)|3-dimensional conformal radiation therapy (3-dcrt)
5612495|NCT00848094|intensity modulated radiation therapy (IMRT)|intensity modulated radiation therapy (imrt)
5612496|NCT00848094|active breathing control|active breathing control
5612497|NCT00848081|Prostate|prostate
5612498|NCT00848081|BPH|bph
5612499|NCT00848081|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5612500|NCT00848081|BPH-LUTS|bph-luts
5612501|NCT00848081|LUTS|luts
5612502|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors
5612503|NCT00848081|tadalafil|tadalafil
5612504|NCT00848081|alpha blockers|alpha blockers
5612505|NCT00848068|lipid layer thickness|lipid layer thickness
5612506|NCT00848042|cancer|cancer
5612507|NCT00848042|head and neck|head and neck
5612508|NCT00848042|laser|laser
5612509|NCT00848042|ablation|ablation
5612510|NCT00848029|Influenza vaccine|influenza vaccine
5612511|NCT00848003|Probiotics|probiotics
5612512|NCT00848003|BB-12|bb-12
5612513|NCT00848003|Yogurt|yogurt
5612514|NCT00848003|Antibiotics|antibiotics
5612515|NCT00847990|Down syndrome|down syndrome
5612516|NCT00847990|aneuploidy|aneuploidy
5612517|NCT00847990|chromosome abnormality|chromosome abnormality
5612518|NCT00847990|amniocentesis|amniocentesis
5612519|NCT00847990|chorionic villus sampling|chorionic villus sampling
5612520|NCT00847990|Laboratory Developed Test (LDT)|laboratory developed test (ldt)
5612521|NCT00847977|Acute head trauma|acute head trauma
5612522|NCT00847964|Heart Failure|heart failure
5612523|NCT00847951|renal|renal
5612524|NCT00847951|neonates|neonates
5612525|NCT00847938|neostigmine|neostigmine
5612526|NCT00847938|neuromuscular blocking agent|neuromuscular blocking agent
5612527|NCT00847938|train of four|train of four
5612528|NCT00847938|anesthesia|anesthesia
5612529|NCT00847912|NMSC|nmsc
5612530|NCT00847912|nonmelanoma skin cancer|nonmelanoma skin cancer
5612531|NCT00847912|topical 5-FU 5% cream|topical 5-fu 5% cream
5612532|NCT00847912|Neoplasms|neoplasms
5612533|NCT00847912|Antineoplastic Agents|antineoplastic agents
5612534|NCT00847912|Therapeutic Uses|therapeutic uses
5612535|NCT00847912|Dermatologic Agents|dermatologic agents
5612536|NCT00847912|Neoplasms by Site|neoplasms by site
5612537|NCT00847912|carcinoma, basal cell|carcinoma, basal cell
5612538|NCT00847912|carcinoma, squamous cell|carcinoma, squamous cell
5612539|NCT00847899|hypertension|hypertension
5612540|NCT00847899|impaired glucose tolerance|impaired glucose tolerance
5612542|NCT00847899|pre-diabetes|pre-diabetes
5612544|NCT00847873|domestic violence|domestic violence
5612545|NCT00847873|alcohol abuse|alcohol abuse
5612546|NCT00847873|alcohol dependence|alcohol dependence
5612547|NCT00847873|drug abuse|drug abuse
5612548|NCT00847873|drug dependence|drug dependence
5612549|NCT00847873|addiction|addiction
5612550|NCT00847860|cognition|cognition
5612552|NCT00847847|Motor neuron|motor neuron
5612553|NCT00847847|Pathophysiology|pathophysiology
5612554|NCT00847847|Neuromuscular junction|neuromuscular junction
5612555|NCT00847847|Neuromuscular transmission|neuromuscular transmission
5612556|NCT00847847|Microelectrodes|microelectrodes
5612557|NCT00847808|Esophageal Reflux|esophageal reflux
5612558|NCT00847808|Gastro-Esophageal Reflux|gastro-esophageal reflux
5612559|NCT00847808|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5612561|NCT00847808|Regurgitation, Gastric|regurgitation, gastric
5612562|NCT00847808|Heartburn|heartburn
5612563|NCT00847808|Drug Therapy|drug therapy
5612564|NCT00847769|Ankle Sprain|ankle sprain
5612565|NCT00847756|Otitis media|otitis media
5612566|NCT00847756|demography|demography
5612567|NCT00847756|Streptococcus pneumoniae|streptococcus pneumoniae
5612568|NCT00847756|Haemophilus influenzae|haemophilus influenzae
5612569|NCT00847756|Moraxella catarrhalis|moraxella catarrhalis
5612570|NCT00847756|rhinovirus|rhinovirus
5612571|NCT00847756|children, 0-5 years of age|children, 0-5 years of age
5612572|NCT00847756|diagnosed rAOM, COME or CSOM by an otorhinolaryngologist|diagnosed raom, come or csom by an otorhinolaryngologist
5612573|NCT00847756|primary and secondary hospital Nijmegen, the Netherlands|primary and secondary hospital nijmegen, the netherlands
5612574|NCT00847743|oxidative stress|oxidative stress
5612576|NCT00847743|ischemia-reperfusion|ischemia-reperfusion
5612577|NCT00847730|Ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the ActiVAC therapy|ease of dressing application, dressing conformability and ease of dressing removal on diabetic foot ulcers using the activac therapy
5612578|NCT00847717|Oral|oral
5612579|NCT00847717|cancer|cancer
5612580|NCT00847717|surgery|surgery
5612581|NCT00847717|neck dissection|neck dissection
5612582|NCT00847717|spinal accessory nerve|spinal accessory nerve
5612583|NCT00847704|Stroke|stroke
5612584|NCT00847704|Rehabilitation|rehabilitation
5612585|NCT00847704|Robotics|robotics
5612586|NCT00847691|economic evaluation|economic evaluation
5612587|NCT00847691|diagnostics|diagnostics
5612588|NCT00847691|sarcoma|sarcoma
5612589|NCT00847678|Cryptococcal Meningitis|cryptococcal meningitis
5612590|NCT00847665|Pressure ulcers|pressure ulcers
5612591|NCT00847665|Repositioning|repositioning
5612592|NCT00847665|Prevention|prevention
5612593|NCT00847665|Mechanical Ventilation|mechanical ventilation
5612594|NCT00847665|Critical care|critical care
5612595|NCT00847639|Multiple Myeloma|multiple myeloma
5612596|NCT00847639|lenalidomide|lenalidomide
5612597|NCT00847639|Revlimid|revlimid
5612598|NCT00847639|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5612599|NCT00847626|Hypertensive|hypertensive
5612600|NCT00847626|Blood Pressure, High|blood pressure, high
5612601|NCT00847626|Vascular Disease|vascular disease
5612602|NCT00847626|Cardiovascular Disease|cardiovascular disease
5612603|NCT00847626|Drug Therapy|drug therapy
5612604|NCT00847613|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays|double-blind placebo-controlled investigational drug oral therapy safety and efficacy hand and feet x-rays
5612605|NCT00847600|Schizophrenia|schizophrenia
5612606|NCT00847600|Neurosteroids|neurosteroids
5612607|NCT00847600|Pregnenolone|pregnenolone
5612608|NCT00847600|Augmentation|augmentation
5612609|NCT00847587|Contraceptive|contraceptive
5612610|NCT00847587|Implant|implant
5612611|NCT00847587|Postpartum period|postpartum period
5612612|NCT00847587|etonogestrel-releasing|etonogestrel-releasing
5612613|NCT00847587|lactogenesis|lactogenesis
5612614|NCT00847587|Breastfeeding|breastfeeding
5612615|NCT00847574|Weight loss|weight loss
5612616|NCT00847574|Weight maintenance|weight maintenance
5612617|NCT00847574|Weight management|weight management
5612618|NCT00847574|Cardiovascular disease risk|cardiovascular disease risk
5612619|NCT00847574|Dietary Guidelines|dietary guidelines
5612620|NCT00847574|Diet and exercise|diet and exercise
5612621|NCT00847574|Prevention|prevention
5612623|NCT00847548|intimate partner violence|intimate partner violence
5612624|NCT00847548|domestic violence|domestic violence
5612625|NCT00847548|substance abuse|substance abuse
5612626|NCT00847548|alcohol abuse|alcohol abuse
5612628|NCT00847548|addiction|addiction
5612629|NCT00847522|melanoma|melanoma
5612630|NCT00847522|skin cancer|skin cancer
5612631|NCT00847522|lymph node|lymph node
5612632|NCT00847522|sentinel lymph node|sentinel lymph node
5612633|NCT00847522|malignant melanoma|malignant melanoma
5612634|NCT00847522|mapping|mapping
5612639|NCT00847509|radiation|radiation
5612640|NCT00847509|chemoradiation|chemoradiation
5612641|NCT00847509|FLT|flt
5612642|NCT00847509|[F-18]FLT|[f-18]flt
5612643|NCT00847509|FDG|fdg
5612645|NCT00847496|Partial Thickness burn|partial thickness burn
5612646|NCT00847496|Biological Dressing|biological dressing
5612647|NCT00847483|glaucoma|glaucoma
5612648|NCT00847483|ocular hypertension|ocular hypertension
5612649|NCT00847483|latanoprost|latanoprost
5612650|NCT00847483|travoprost|travoprost
5612651|NCT00847483|bimatoprost|bimatoprost
5612652|NCT00847470|Dental caries|dental caries
5612653|NCT00847470|Assessments|assessments
5612654|NCT00847470|dental materials|dental materials
5612655|NCT00847457|Exercise|exercise
5612656|NCT00847457|Stretching|stretching
5612657|NCT00847457|Adolescents|adolescents
5612658|NCT00847431|Subthalamic Nucleus|subthalamic nucleus
5612659|NCT00847431|Deep Brain Stimulation|deep brain stimulation
5612660|NCT00847431|Depression|depression
5612661|NCT00847431|Anxiety|anxiety
5612662|NCT00847431|Parkinson's Disease|parkinson's disease
5612663|NCT00847418|pharmacokinetics|pharmacokinetics
5612664|NCT00847418|ketamine|ketamine
5612665|NCT00847418|Anesthetics, Dissociative|anesthetics, dissociative
5612666|NCT00847405|Bioequivalence|bioequivalence
5612667|NCT00847405|Healthy Subjects|healthy subjects
5612668|NCT00847392|Urethral catheterization|urethral catheterization
5612669|NCT00847392|Emergency Department|emergency department
5612670|NCT00847392|Ultrasound|ultrasound
5612671|NCT00847392|Urinary tract infection|urinary tract infection
5612672|NCT00847392|Pediatric|pediatric
5612673|NCT00847379|Duchenne muscular dystrophy|duchenne muscular dystrophy
5612674|NCT00847379|Becker muscular dystrophy|becker muscular dystrophy
5612675|NCT00847379|Nonsense mutation|nonsense mutation
5612676|NCT00847379|Premature stop codon|premature stop codon
5612677|NCT00847379|DMD|dmd
5612678|NCT00847379|BMD|bmd
5612679|NCT00847379|Ataluren|ataluren
5612680|NCT00847379|PTC124|ptc124
5612681|NCT00847366|Perifosine|perifosine
5612682|NCT00847353|high frequency ECG|high frequency ecg
5612683|NCT00847353|normal values|normal values
5612684|NCT00847353|asymptomatic|asymptomatic
5612685|NCT00847353|obese|obese
5612686|NCT00847340|Genital warts|genital warts
5612687|NCT00847340|HPV typing|hpv typing
5612688|NCT00847340|HPV infections|hpv infections
5612689|NCT00847340|Condyloma Acuminata|condyloma acuminata
5612690|NCT00847327|Type 1 Diabetes|type 1 diabetes
5612691|NCT00847327|Parenting|parenting
5612692|NCT00847327|Young Children|young children
5612693|NCT00847314|Hypogonadism|hypogonadism
5612694|NCT00847314|Abdominal obesity|abdominal obesity
5612695|NCT00847314|Physical exercise|physical exercise
5612696|NCT00847314|Testosterone|testosterone
5612697|NCT00847288|Heart Failure|heart failure
5612698|NCT00847288|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5612699|NCT00847288|Cardiac Resynchronization Therapy with Defibrillator (CRT D)|cardiac resynchronization therapy with defibrillator (crt d)
5612700|NCT00847288|OptiVol®|optivol®
5612701|NCT00847275|Elderly patients|elderly patients
5612702|NCT00847275|renal insufficiency|renal insufficiency
5612703|NCT00847275|gerontologic evaluation|gerontologic evaluation
5612704|NCT00847262|Hypertension|hypertension
5612705|NCT00847262|Abdominal obesity|abdominal obesity
5612706|NCT00847262|Diabetes|diabetes
5612707|NCT00847262|Treatment|treatment
5612708|NCT00847249|safety|safety
5612709|NCT00847249|tolerability|tolerability
5612710|NCT00847249|healthy|healthy
5612711|NCT00847249|inhalation|inhalation
5612712|NCT00847249|Healthy males|healthy males
5612713|NCT00847236|Polymyalgia Rheumatica|polymyalgia rheumatica
5612714|NCT00847236|Rheumatoid Arthritis|rheumatoid arthritis
5612715|NCT00847236|Rheumatic Disease|rheumatic disease
5612716|NCT00847236|PMR|pmr
5612717|NCT00847223|Mantle cell lymphoma|mantle cell lymphoma
5612718|NCT00847223|Lymphoma|lymphoma
5612719|NCT00847223|relapsed, refractory or progressive MCL|relapsed, refractory or progressive mcl
5612720|NCT00847223|Mantle cell lymphoma (relapsed, refractory or progressive)|mantle cell lymphoma (relapsed, refractory or progressive)
5612721|NCT00847210|Esophageal Reflux|esophageal reflux
5612722|NCT00847210|Gastro-Esophageal Reflux|gastro-esophageal reflux
5595385|NCT00909584|GSTp1-1 inhibitor|gstp1-1 inhibitor
5612723|NCT00847210|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5612724|NCT00847210|GERD|gerd
5612725|NCT00847210|Regurgitation, Gastric|regurgitation, gastric
5612726|NCT00847210|Heartburn|heartburn
5612727|NCT00847210|Drug Therapy|drug therapy
5612728|NCT00847210|Adolescent|adolescent
5612729|NCT00847184|nasal intubation|nasal intubation
5612730|NCT00847184|Aitraq|aitraq
5612731|NCT00847184|difficult intubation|difficult intubation
5612732|NCT00847171|male breast cancer|male breast cancer
5612733|NCT00847171|stage II breast cancer|stage ii breast cancer
5612734|NCT00847171|stage IIIA breast cancer|stage iiia breast cancer
5612735|NCT00847171|stage IIIB breast cancer|stage iiib breast cancer
5612736|NCT00847171|stage IIIC breast cancer|stage iiic breast cancer
5612737|NCT00847171|stage IV breast cancer|stage iv breast cancer
5612738|NCT00847171|HER2-positive breast cancer|her2-positive breast cancer
5612739|NCT00847158|POAG|poag
5612740|NCT00847158|Combination glaucoma & cataract procedure|combination glaucoma & cataract procedure
5612741|NCT00847158|trabecular micro-bypass stent|trabecular micro-bypass stent
5612743|NCT00847145|toddler|toddler
5612744|NCT00847145|Meningococcal disease|meningococcal disease
5612745|NCT00847145|prevention|prevention
5612746|NCT00847145|vaccination|vaccination
5612747|NCT00847132|Collaborative Care|collaborative care
5612748|NCT00847119|rectum|rectum
5612749|NCT00847119|adenocarcinoma|adenocarcinoma
5612750|NCT00847119|neoadjuvant|neoadjuvant
5612751|NCT00847119|bevacizumab|bevacizumab
5612752|NCT00847119|capecitabine|capecitabine
5612753|NCT00847119|radiotherapy|radiotherapy
5612754|NCT00847119|locally|locally
5612755|NCT00847119|advanced|advanced
5612756|NCT00847119|resectable|resectable
5612757|NCT00847119|resectable locally advanced adenocarcinoma of the rectum|resectable locally advanced adenocarcinoma of the rectum
5612758|NCT00847119|xeberecto|xeberecto
5612759|NCT00847106|Dendritic Cells|dendritic cells
5612760|NCT00847106|Regulatory T cells|regulatory t cells
5612761|NCT00847106|CD25|cd25
5612762|NCT00847106|Melanoma|melanoma
5612763|NCT00847106|Immunotherapy|immunotherapy
5612764|NCT00847106|Daclizumab|daclizumab
5612765|NCT00847106|Stage IV Melanoma|stage iv melanoma
5612766|NCT00847080|Reactive hypoglycemia|reactive hypoglycemia
5612767|NCT00847080|Sitagliptin|sitagliptin
5612768|NCT00847080|Glucagon-Like Peptide 1|glucagon-like peptide 1
5612769|NCT00847080|Incretins|incretins
5612770|NCT00847080|Prediabetes|prediabetes
5612771|NCT00847054|Solid Tumor|solid tumor
5612772|NCT00847054|Endosialin|endosialin
5612773|NCT00847028|Newborn|newborn
5612774|NCT00847028|Pain|pain
5612775|NCT00847028|glucose solution|glucose solution
5612776|NCT00847028|venipuncture|venipuncture
5612777|NCT00847028|non-pharmacologic pain relief.|non-pharmacologic pain relief.
5612780|NCT00847015|CISPLATIN|cisplatin
5612781|NCT00847015|GEMCITABINE|gemcitabine
5612782|NCT00847015|SU011248 (Sunitinib Malate)|su011248 (sunitinib malate)
5612783|NCT00847015|08-159|08-159
5612784|NCT00847002|Flexitouch system|flexitouch system
5612785|NCT00847002|FarrowWrap|farrowwrap
5612786|NCT00847002|venous stasis ulcer|venous stasis ulcer
5612787|NCT00846989|glaucoma,|glaucoma,
5612788|NCT00846989|primary open-angle glaucoma (POAG),|primary open-angle glaucoma (poag),
5612789|NCT00846989|ocular hypertension (OH),|ocular hypertension (oh),
5612791|NCT00846976|Safety|safety
5612792|NCT00846963|parenteral nutrition associated cholestasis in neonates|parenteral nutrition associated cholestasis in neonates
5612793|NCT00846963|parenteral nutrition induced cholestasis in preterms|parenteral nutrition induced cholestasis in preterms
5612794|NCT00846963|Bile duct obstruction|bile duct obstruction
5612795|NCT00846963|biliary stasis|biliary stasis
5612796|NCT00846950|H1-antagonist|h1-antagonist
5612797|NCT00846950|Event Related Potentials|event related potentials
5612798|NCT00846950|Memory|memory
5612799|NCT00846950|Information processing|information processing
5612800|NCT00846950|The effects of an H1 antagonist (dexchlorpheniramine) on human cognition|the effects of an h1 antagonist (dexchlorpheniramine) on human cognition
5612801|NCT00846937|Cholesterol|cholesterol
5612802|NCT00846937|Plant stanolester|plant stanolester
5612803|NCT00846937|Beverage|beverage
5612804|NCT00846937|Ileostoma|ileostoma
5612805|NCT00846937|Serum cholesterol level|serum cholesterol level
5612806|NCT00846937|serum LDL-cholesterol level|serum ldl-cholesterol level
5612807|NCT00846937|Intestinal cholesterol absorption efficiency|intestinal cholesterol absorption efficiency
5612808|NCT00846924|Stroke|stroke
5612809|NCT00846924|Transient Ischemic Attack|transient ischemic attack
5612810|NCT00846924|Atrial fibrillation|atrial fibrillation
5612811|NCT00846924|Atrial flutter|atrial flutter
5612812|NCT00846911|Acute Exacerbation of Chronic Bronchitis (AECB) patients|acute exacerbation of chronic bronchitis (aecb) patients
5612813|NCT00846898|blood sugar|blood sugar
5612814|NCT00846898|cholesterol|cholesterol
5612815|NCT00846898|cinnamon|cinnamon
5612816|NCT00846898|HbA1c|hba1c
5612817|NCT00846885|Bioequivalence|bioequivalence
5612818|NCT00846885|Healthy Subjects|healthy subjects
5612819|NCT00846872|GHRP-3|ghrp-3
5612820|NCT00846872|Insulin Resistance|insulin resistance
5612821|NCT00846872|Markers of inflammation|markers of inflammation
5612822|NCT00846872|Endothelial Dysfunction|endothelial dysfunction
5612823|NCT00846872|Flow Mediated Dilation|flow mediated dilation
5612824|NCT00846872|GH/IGF-1 axis|gh/igf-1 axis
5612825|NCT00846872|Post menopausal|post menopausal
5612826|NCT00846859|alcohol dependence|alcohol dependence
5612827|NCT00846859|nicotine dependence|nicotine dependence
5612828|NCT00846859|alcohol abuse|alcohol abuse
5612830|NCT00846859|Champix|champix
5612831|NCT00846859|Chantix|chantix
5612833|NCT00846859|drinking|drinking
5612834|NCT00846859|snuffing|snuffing
5612835|NCT00846859|diary|diary
5612836|NCT00846859|phosphatidyl ethanol|phosphatidyl ethanol
5612837|NCT00846859|PEth|peth
5612838|NCT00846833|Melanoma, Experimental|melanoma, experimental
5612839|NCT00846755|Thyroid|thyroid
5612840|NCT00846755|Pregnancy|pregnancy
5612842|NCT00846716|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5612843|NCT00846716|Diabetic Nephropathy|diabetic nephropathy
5612844|NCT00846716|Diabetic Retinopathy|diabetic retinopathy
5612845|NCT00846716|pioglitazone|pioglitazone
5612851|NCT00846690|dental anesthesia|dental anesthesia
5612852|NCT00846677|Healthy|healthy
5612853|NCT00846677|Infants|infants
5612854|NCT00846677|Vitamin D|vitamin d
5612855|NCT00846651|spinal anesthesia|spinal anesthesia
5612856|NCT00846651|cesarean section|cesarean section
5612857|NCT00846638|Risk drinking|risk drinking
5612858|NCT00846638|Women|women
5612859|NCT00846638|Medical problems|medical problems
5612860|NCT00846625|Biomedical research|biomedical research
5612861|NCT00846625|Macular Edema|macular edema
5612862|NCT00846625|Uveitis|uveitis
5612863|NCT00846625|Ranibizumab|ranibizumab
5612864|NCT00846625|Steroids|steroids
5612865|NCT00846612|refractory|refractory
5612866|NCT00846612|avastin|avastin
5612867|NCT00846612|doxil|doxil
5612868|NCT00846612|relapsed|relapsed
5612869|NCT00846612|ovarian cancer|ovarian cancer
5612870|NCT00846612|platinum-resistant|platinum-resistant
5612871|NCT00846599|brachial artery ultrasound|brachial artery ultrasound
5612872|NCT00846599|brachial artery reactivity|brachial artery reactivity
5612873|NCT00846599|HIV|hiv
5612874|NCT00846599|human immunodeficiency virus|human immunodeficiency virus
5612875|NCT00846599|cardiovascular risk|cardiovascular risk
5612876|NCT00846599|omega three|omega three
5612877|NCT00846599|saturated fat|saturated fat
5612878|NCT00846599|sustiva|sustiva
5612879|NCT00846599|atripla|atripla
5612880|NCT00846599|kaletra|kaletra
5612881|NCT00846599|treatment naive|treatment naive
5612882|NCT00846586|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5612883|NCT00846586|COPD|copd
5612884|NCT00846586|indacaterol|indacaterol
5612885|NCT00846586|tiotropium|tiotropium
5612886|NCT00846586|bronchodilation|bronchodilation
5612887|NCT00846573|Helium|helium
5612888|NCT00846573|MRI|mri
5612889|NCT00846573|Hyperpolarized Helium|hyperpolarized helium
5613088|NCT00845806|fMRI|fmri
5612890|NCT00846573|Hyperpolarized Noble Gas|hyperpolarized noble gas
5612891|NCT00846547|Autism|autism
5612892|NCT00846547|Autism Spectrum Disorders|autism spectrum disorders
5612893|NCT00846547|irritability|irritability
5612894|NCT00846547|aberrant behavior|aberrant behavior
5612895|NCT00846534|Oxidative stress markers|oxidative stress markers
5612896|NCT00846534|Cardiac surgery|cardiac surgery
5612897|NCT00846534|Atrial Fibrillation|atrial fibrillation
5612898|NCT00846521|Pediatric Obesity|pediatric obesity
5612899|NCT00846521|Insulin Resistance|insulin resistance
5612900|NCT00846521|Glucose Tolerance|glucose tolerance
5612901|NCT00846521|Adolescents|adolescents
5612902|NCT00846521|Acarbose|acarbose
5612903|NCT00846521|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
5612904|NCT00846521|Endothelial Dysfunction|endothelial dysfunction
5612905|NCT00846508|cervical cancer|cervical cancer
5612906|NCT00846508|Cisplatin|cisplatin
5612907|NCT00846508|chemoradiation|chemoradiation
5612908|NCT00846495|Migraine|migraine
5612909|NCT00846495|Migraine prevention|migraine prevention
5612910|NCT00846495|Prodrome|prodrome
5612911|NCT00846495|Premonitory phase|premonitory phase
5612912|NCT00846495|Preemptive therapy|preemptive therapy
5612913|NCT00846482|Colorectal cancer|colorectal cancer
5612914|NCT00846482|Oxaliplatin|oxaliplatin
5612915|NCT00846482|ERCC-1|ercc-1
5612916|NCT00846456|Tumor setm cell|tumor setm cell
5612917|NCT00846443|non-small cell lung cancer|non-small cell lung cancer
5612918|NCT00846430|Neurofibromas|neurofibromas
5612919|NCT00846430|Neurofibromatosis 1|neurofibromatosis 1
5612920|NCT00846430|Celecoxib|celecoxib
5612921|NCT00846430|Celebrex|celebrex
5612922|NCT00846430|Peg-Interferon alpha-2b|peg-interferon alpha-2b
5612923|NCT00846430|PEG-Intron|peg-intron
5612924|NCT00846430|Temozolomide|temozolomide
5612925|NCT00846430|Temodar|temodar
5612926|NCT00846430|Vincristine Sulfate|vincristine sulfate
5612927|NCT00846430|Oncovin|oncovin
5612928|NCT00846417|myocardial infarction|myocardial infarction
5612929|NCT00846417|heart failure|heart failure
5612930|NCT00846417|arrhythmia|arrhythmia
5612931|NCT00846404|heart failure|heart failure
5612932|NCT00846404|cardiomyopathy|cardiomyopathy
5612933|NCT00846404|diastolic dysfunction|diastolic dysfunction
5595579|NCT00908583|Nephrology|nephrology
5612934|NCT00846378|ST segment elevation myocardial infarction (STEMI)|st segment elevation myocardial infarction (stemi)
5612935|NCT00846378|timed balloon inflations|timed balloon inflations
5612936|NCT00846378|post conditioning|post conditioning
5612937|NCT00846365|Essential Hypertension|essential hypertension
5612938|NCT00846365|Hypertensive|hypertensive
5612939|NCT00846365|Blood Pressure, High|blood pressure, high
5612940|NCT00846365|Vascular Disease|vascular disease
5612941|NCT00846365|Cardiovascular Disease|cardiovascular disease
5612942|NCT00846365|Drug Therapy|drug therapy
5612944|NCT00846352|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5612945|NCT00846352|Bronchoscopy|bronchoscopy
5612946|NCT00846339|Smoking cessation|smoking cessation
5612947|NCT00846339|Bupropion|bupropion
5612948|NCT00846326|allergic rhinitis|allergic rhinitis
5612949|NCT00846326|rhinitis medicamentosa|rhinitis medicamentosa
5612950|NCT00846326|imidazolines|imidazolines
5612951|NCT00846326|corticosteroid|corticosteroid
5612952|NCT00846313|Dietary intake|dietary intake
5612953|NCT00846313|Dietary counseling|dietary counseling
5612954|NCT00846313|Weight loss|weight loss
5612955|NCT00846313|Body composition|body composition
5612956|NCT00846313|Resting energy expenditure|resting energy expenditure
5612957|NCT00846313|Quality of life|quality of life
5612958|NCT00846300|Patient compliance|patient compliance
5612959|NCT00846300|Hispanics|hispanics
5612960|NCT00846300|Health Behavior|health behavior
5612961|NCT00846300|Family Physicians|family physicians
5612962|NCT00846300|Primary Healthcare|primary healthcare
5612964|NCT00846287|aformoterol|aformoterol
5612966|NCT00846287|Hyperpolarized helium|hyperpolarized helium
5612967|NCT00846287|Hyperpolarized Noble Gas|hyperpolarized noble gas
5612969|NCT00846274|Healthy Male subjects|healthy male subjects
5612970|NCT00846261|infected|infected
5612971|NCT00846261|Ilizarov|ilizarov
5612972|NCT00846248|diabetes|diabetes
5612973|NCT00846248|insulin resistance|insulin resistance
5612974|NCT00846248|chromium|chromium
5612975|NCT00846248|healthy volunteers|healthy volunteers
5612976|NCT00846235|Dermatitis|dermatitis
5612977|NCT00846235|Atopic|atopic
5612978|NCT00846235|Moisturising cream|moisturising cream
5612979|NCT00846235|Skin|skin
5612980|NCT00846209|prescription drug|prescription drug
5612981|NCT00846209|warnings|warnings
5612982|NCT00846209|health literacy|health literacy
5612983|NCT00846209|enhanced language|enhanced language
5612984|NCT00846183|local injury|local injury
5612985|NCT00846183|implantation rate|implantation rate
5612986|NCT00846183|endometrial receptivity|endometrial receptivity
5612988|NCT00846170|Irritable bowel syndrome probiotics|irritable bowel syndrome probiotics
5612989|NCT00846157|natural killer cell|natural killer cell
5613089|NCT00845806|Arabic|arabic
5612990|NCT00846157|DLBCL (Diffuse Large B Cell Lymphoma)|dlbcl (diffuse large b cell lymphoma)
5612991|NCT00846144|Glucose stimulated insulin secretion|glucose stimulated insulin secretion
5612992|NCT00846144|copper|copper
5612993|NCT00846144|cytokines|cytokines
5612994|NCT00846144|diabetes|diabetes
5612995|NCT00846144|Reduction in insulin secretion|reduction in insulin secretion
5612996|NCT00846131|Subjects with primary hepatocellular carcinoma, intended for liver transplantation.|subjects with primary hepatocellular carcinoma, intended for liver transplantation.
5612997|NCT00846118|Pitavastatin|pitavastatin
5612998|NCT00846118|Hemodialysis|hemodialysis
5612999|NCT00846118|Mortality|mortality
5613000|NCT00846118|Cardiovascular disease|cardiovascular disease
5613001|NCT00846105|methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5613002|NCT00846105|MRSA|mrsa
5613003|NCT00846105|cross-infection|cross-infection
5613004|NCT00846105|staphylococcal infection|staphylococcal infection
5613005|NCT00846105|infection control|infection control
5613006|NCT00846092|Diabetic Retinopathy|diabetic retinopathy
5613007|NCT00846092|Diabetic Macular Edema|diabetic macular edema
5613008|NCT00846092|NIR|nir
5613009|NCT00846092|Near-infrared Light Therapy|near-infrared light therapy
5613010|NCT00846079|coronary artery disease|coronary artery disease
5613011|NCT00846079|stress testing|stress testing
5613012|NCT00846066|educational research,|educational research,
5613013|NCT00846066|instructional methods,|instructional methods,
5613014|NCT00846066|Hands on training,|hands on training,
5613015|NCT00846066|Web based training,|web based training,
5613016|NCT00846066|pediatric residents|pediatric residents
5613017|NCT00846066|preventive oral health,|preventive oral health,
5613018|NCT00846066|dental caries,|dental caries,
5613019|NCT00846066|Instructional strategies in Preventive Oral health|instructional strategies in preventive oral health
5613020|NCT00846066|Web-based training on Preventive Oral Health|web-based training on preventive oral health
5613021|NCT00846066|Hands on Training on Preventive Oral Health|hands on training on preventive oral health
5613022|NCT00846040|Obesity|obesity
5613023|NCT00846040|Weight Loss|weight loss
5613024|NCT00846040|Carbohydrate|carbohydrate
5613025|NCT00846040|Fat|fat
5613026|NCT00846040|Macronutrient Balance|macronutrient balance
5613027|NCT00846040|Healthy Volunteer|healthy volunteer
5613028|NCT00846014|asthma|asthma
5613029|NCT00846014|exacerbation|exacerbation
5613030|NCT00846014|Helium|helium
5613031|NCT00846014|MRI|mri
5613032|NCT00846014|Lung imaging|lung imaging
5613033|NCT00846001|Resynchronization Therapy|resynchronization therapy
5613034|NCT00845988|Bipolar disorder|bipolar disorder
5613035|NCT00845988|metabolic complication|metabolic complication
5613036|NCT00845988|Aripiprazole|aripiprazole
5613037|NCT00845988|Weight gain|weight gain
5613038|NCT00845988|Clinical Trial|clinical trial
5613040|NCT00845988|Metabolic syndrome|metabolic syndrome
5613041|NCT00845988|Psychopharmacology|psychopharmacology
5613042|NCT00845988|Open Label|open label
5613043|NCT00845962|bupivacaine|bupivacaine
5613044|NCT00845962|chloroprocaine|chloroprocaine
5613045|NCT00845962|spinal|spinal
5613046|NCT00845962|anesthesia|anesthesia
5613047|NCT00845962|elective surgery|elective surgery
5613048|NCT00845962|ambulatory surgery|ambulatory surgery
5613049|NCT00845949|chemokines synovium|chemokines synovium
5613050|NCT00845936|Atypical antipsychotics|atypical antipsychotics
5613051|NCT00845936|Weight|weight
5613052|NCT00845936|adolecsents|adolecsents
5613053|NCT00845936|pediatric|pediatric
5613054|NCT00845936|Metformin|metformin
5613055|NCT00845923|Postherpetic neuralgia of at least 6 months|postherpetic neuralgia of at least 6 months
5613056|NCT00845897|Diabetes mellitus|diabetes mellitus
5613057|NCT00845897|plantar ulcers|plantar ulcers
5613058|NCT00845897|peripheral neuropathy|peripheral neuropathy
5613059|NCT00845884|Gastric|gastric
5613060|NCT00845884|Cancer|cancer
5613061|NCT00845884|Advanced|advanced
5613062|NCT00845884|Docetaxel|docetaxel
5613063|NCT00845884|Cisplatin|cisplatin
5613064|NCT00845884|Capecitabine|capecitabine
5613065|NCT00845884|Bevacizumab|bevacizumab
5613066|NCT00845871|Exjade|exjade
5613067|NCT00845871|deferasirox|deferasirox
5613068|NCT00845871|palatability|palatability
5613069|NCT00845871|tolerability|tolerability
5613070|NCT00845871|food|food
5613071|NCT00845871|iron overload|iron overload
5613072|NCT00845871|Serum Iron overload due to transfusions|serum iron overload due to transfusions
5613073|NCT00845858|Gastroparesis|gastroparesis
5613074|NCT00845858|Diabetic Gastroparesis|diabetic gastroparesis
5613075|NCT00845858|Diabetes|diabetes
5613076|NCT00845858|Diabetes Mellitus|diabetes mellitus
5613077|NCT00845858|Delayed Gastric Emptying|delayed gastric emptying
5613078|NCT00845845|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5613079|NCT00845845|Omega-3 fatty acids|omega-3 fatty acids
5613080|NCT00845845|MRI|mri
5613081|NCT00845845|NASH|nash
5613083|NCT00845819|intensive chemotherapy|intensive chemotherapy
5613084|NCT00845819|stem cell transplantation|stem cell transplantation
5613085|NCT00845819|epidermal growth factor|epidermal growth factor
5613086|NCT00845806|Diacritics|diacritics
5613087|NCT00845806|Neuronal Processing|neuronal processing
5613090|NCT00845793|Type 2 diabetes|type 2 diabetes
5613091|NCT00845793|Nutrition|nutrition
5613092|NCT00845793|Lifestyle modifications|lifestyle modifications
5613093|NCT00845780|persistent atrial fibrillation|persistent atrial fibrillation
5613094|NCT00845780|amiodarone|amiodarone
5613095|NCT00845780|late recurrence atrial fibrillation|late recurrence atrial fibrillation
5613096|NCT00845780|adverse events|adverse events
5613097|NCT00845767|Nitric Oxide|nitric oxide
5613098|NCT00845767|Nitric Oxide Synthase|nitric oxide synthase
5613099|NCT00845767|Air Pollution|air pollution
5613100|NCT00845767|Endothelial Dysfunction|endothelial dysfunction
5613101|NCT00845767|Diesel Exhaust|diesel exhaust
5613102|NCT00845754|Post-operative febrile morbidity|post-operative febrile morbidity
5613103|NCT00845754|Post-operative pain management|post-operative pain management
5613104|NCT00845728|Indacaterol|indacaterol
5613105|NCT00845728|Tiotropium|tiotropium
5613106|NCT00845728|COPD|copd
5613107|NCT00845715|rotator cuff|rotator cuff
5613108|NCT00845715|rehabilitation|rehabilitation
5613109|NCT00845715|range of motion|range of motion
5613110|NCT00845702|Renal artery stenosis|renal artery stenosis
5613111|NCT00845702|Contrast agent|contrast agent
5613112|NCT00845702|MRA|mra
5613113|NCT00845689|liver surgery|liver surgery
5613114|NCT00845676|Hepatitis C virus|hepatitis c virus
5613115|NCT00845676|Acute hepatitis C infection|acute hepatitis c infection
5613116|NCT00845676|HIV|hiv
5613117|NCT00845676|HCV|hcv
5613118|NCT00845663|certolizumab pegol|certolizumab pegol
5613119|NCT00845663|Cimzia|cimzia
5613120|NCT00845663|bioequivalence|bioequivalence
5613121|NCT00845663|Comparison Bioequivalence Study|comparison bioequivalence study
5613122|NCT00845650|Anthrax|anthrax
5613123|NCT00845650|Human Anthrax Immune Globulin Intravenous|human anthrax immune globulin intravenous
5613124|NCT00845650|Safety|safety
5613125|NCT00845650|Pharmacokinetics|pharmacokinetics
5613126|NCT00845637|eggplant|eggplant
5613127|NCT00845637|dyslipidemia|dyslipidemia
5613128|NCT00845637|postprandial lipemia|postprandial lipemia
5613129|NCT00845624|oxygen saturation|oxygen saturation
5779620|NCT00199329|PCA|pca
5613130|NCT00845624|retinopathy of prematurity|retinopathy of prematurity
5613131|NCT00845624|long term outcomes|long term outcomes
5613132|NCT00845624|hypoxia|hypoxia
5613133|NCT00845624|hyperoxia|hyperoxia
5613134|NCT00845611|peptide vaccine|peptide vaccine
5613135|NCT00845611|URLC10|urlc10
5613136|NCT00845598|Allergic Rhinitis|allergic rhinitis
5613137|NCT00845585|arterial reconstruction|arterial reconstruction
5613138|NCT00845585|bypass|bypass
5613139|NCT00845585|below knee|below knee
5613140|NCT00845585|PZFE|pzfe
5613141|NCT00845585|Ovine graft|ovine graft
5613142|NCT00845585|Omniflow II|omniflow ii
5613143|NCT00845585|graft patency|graft patency
5613144|NCT00845572|Schizophrenia|schizophrenia
5613145|NCT00845572|Schizoaffective|schizoaffective
5613146|NCT00845572|Risperdal Consta|risperdal consta
5613147|NCT00845572|Medication Adherence|medication adherence
5613148|NCT00845572|Antipsychotic|antipsychotic
5613149|NCT00845559|Childhood Obesity|childhood obesity
5613150|NCT00845559|Insulin resistance|insulin resistance
5613151|NCT00845559|Impaired Glucose Tolerance|impaired glucose tolerance
5613152|NCT00845559|Cardiovascular Disease|cardiovascular disease
5613153|NCT00845559|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5613154|NCT00845559|Continuous Glucose Monitoring (CGMS)|continuous glucose monitoring (cgms)
5613155|NCT00845559|Exenatide|exenatide
5613156|NCT00845559|Oral Glucose Tolerance Test|oral glucose tolerance test
5613157|NCT00845546|Bioequivalence 10 mg Loratadine 240 mg Pseudoephedrine Sulfate Extended Release Tablets|bioequivalence 10 mg loratadine 240 mg pseudoephedrine sulfate extended release tablets
5613158|NCT00845507|weight gain|weight gain
5613159|NCT00845494|Medication history|medication history
5613160|NCT00845494|medication errors|medication errors
5613161|NCT00845494|Reduction of admission medication history errors|reduction of admission medication history errors
5613162|NCT00845468|coronary flow reserve|coronary flow reserve
5613163|NCT00845468|diabetes mellitus|diabetes mellitus
5613164|NCT00845468|acute myocardial infarction|acute myocardial infarction
5613165|NCT00845468|transthoracic echocardiography|transthoracic echocardiography
5613166|NCT00845442|Bilateral vocal cord paralyses|bilateral vocal cord paralyses
5613167|NCT00845442|Implanted laryngeal stimulator|implanted laryngeal stimulator
5613168|NCT00845442|vocal cord opening|vocal cord opening
5613169|NCT00845442|pulmonary function tests|pulmonary function tests
5613170|NCT00845429|Influenza|influenza
5613171|NCT00845429|Orthomyxoviruses|orthomyxoviruses
5613172|NCT00845429|Split-virion inactivated influenza vaccine|split-virion inactivated influenza vaccine
5613173|NCT00845429|cell-based vaccine|cell-based vaccine
5613174|NCT00845429|Adults|adults
5613175|NCT00845416|TREC|trec
5613176|NCT00845416|T cell|t cell
5613177|NCT00845416|Primary Immunodeficiency|primary immunodeficiency
5613179|NCT00845416|Navajo|navajo
5613180|NCT00845416|SCID|scid
5613181|NCT00845403|Hepatitis B carrier|hepatitis b carrier
5613182|NCT00845377|Depression|depression
5613183|NCT00845377|Aging|aging
5613184|NCT00845377|Psychological well-being|psychological well-being
5613185|NCT00845377|Psychosocial intervention|psychosocial intervention
5613186|NCT00845364|Perhexiline|perhexiline
5613379|NCT00844493|vaccine|vaccine
5613187|NCT00845364|Coronary artery bypass|coronary artery bypass
5613188|NCT00845364|Myocardial reperfusion injury|myocardial reperfusion injury
5613189|NCT00845364|Cardiac output, low|cardiac output, low
5613190|NCT00845364|Troponin|troponin
5613191|NCT00845351|Cushing's|cushing's
5613192|NCT00845338|Darifenacin|darifenacin
5613193|NCT00845338|Multiple Sclerosis|multiple sclerosis
5613194|NCT00845338|Open Label Study|open label study
5613195|NCT00845325|Carpal tunnel release|carpal tunnel release
5613196|NCT00845325|Rehabilitation|rehabilitation
5613197|NCT00845325|Early motion|early motion
5613199|NCT00845312|Mortality|mortality
5613200|NCT00845299|glaucoma|glaucoma
5613201|NCT00845299|ocular hypertension|ocular hypertension
5613202|NCT00845286|exercise, myocardial dysfunction, endothelial dysfunction,|exercise, myocardial dysfunction, endothelial dysfunction,
5613203|NCT00845286|polymorphism|polymorphism
5613204|NCT00845273|Subfoveal choroidal neovascularization secondary to age-related macular degeneration|subfoveal choroidal neovascularization secondary to age-related macular degeneration
5613205|NCT00845247|Case Management|case management
5613206|NCT00845234|behavioral intervention|behavioral intervention
5613207|NCT00845234|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5613208|NCT00845234|psychosocial education|psychosocial education
5613209|NCT00845234|anxiety|anxiety
5613210|NCT00845234|depression|depression
5613211|NCT00845208|Network Support|network support
5613212|NCT00845208|AA|aa
5613213|NCT00845208|Contingency Management|contingency management
5613214|NCT00845195|Rhinitis|rhinitis
5613215|NCT00845195|Allergy|allergy
5613216|NCT00845195|Nasal Spray|nasal spray
5613217|NCT00845195|Antihistamine|antihistamine
5613218|NCT00845195|Intranasal Corticosteroid|intranasal corticosteroid
5613219|NCT00845182|Type 2 diabetes pathogenesis, thiazolidinediones|type 2 diabetes pathogenesis, thiazolidinediones
5613220|NCT00845182|impaired glucose tolerance|impaired glucose tolerance
5613221|NCT00845182|Incretins|incretins
5613222|NCT00845182|Insulin secretion|insulin secretion
5613223|NCT00845169|Air Pollution|air pollution
5613224|NCT00845169|Nitric Oxide|nitric oxide
5613225|NCT00845169|Nitric Oxide Synthase|nitric oxide synthase
5613226|NCT00845169|Diesel exhaust|diesel exhaust
5613227|NCT00845169|endothelial dysfunction|endothelial dysfunction
5613228|NCT00845156|Diabetes|diabetes
5613229|NCT00845156|Insulin resistance|insulin resistance
5613230|NCT00845156|healthy controls|healthy controls
5613231|NCT00845156|anti oxidants|anti oxidants
5613232|NCT00845143|Non-small cell lung cancer|non-small cell lung cancer
5613234|NCT00845143|lung function|lung function
5613235|NCT00845130|Diabetes|diabetes
5613236|NCT00845130|MR imaging|mr imaging
5613237|NCT00845130|Vitamin C|vitamin c
5613238|NCT00845117|Aniridia,|aniridia,
5613239|NCT00845117|Steven Johnsons Syndrome,|steven johnsons syndrome,
5613240|NCT00845117|Ocular burns,|ocular burns,
5613241|NCT00845117|Pterygium|pterygium
5613242|NCT00845091|Parasympathetic activity|parasympathetic activity
5613243|NCT00845091|Exercise|exercise
5613244|NCT00845091|Education|education
5613245|NCT00845091|Arrhythmias|arrhythmias
5613246|NCT00845091|Defibrillators, Implantable|defibrillators, implantable
5613247|NCT00845078|Breast|breast
5613248|NCT00845078|Radiotherapy|radiotherapy
5613249|NCT00845078|Esthetics|esthetics
5613250|NCT00845078|Treatment Outcome|treatment outcome
5613251|NCT00845078|Reconstructive Surgical Procedures|reconstructive surgical procedures
5613252|NCT00845052|Housestaff|housestaff
5613253|NCT00845052|Patient Safety|patient safety
5613254|NCT00845052|Patient Care|patient care
5613255|NCT00845052|Focus of Study: To assess safety climate amongst housestaff|focus of study: to assess safety climate amongst housestaff
5613256|NCT00845039|Tumors|tumors
5613257|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal
5613258|NCT00845039|Colorectal Neoplasms|colorectal neoplasms
5613259|NCT00845039|Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum|metastatic k-ras wild-type carcinoma of the colon or rectum
5613260|NCT00845013|HIV infection|hiv infection
5613261|NCT00845013|pulmonary hypertension|pulmonary hypertension
5613262|NCT00845013|endothelial function|endothelial function
5613263|NCT00845013|antiretroviral medication|antiretroviral medication
5613264|NCT00845013|Treatment Experienced|treatment experienced
5613265|NCT00844987|PDGF|pdgf
5613267|NCT00844987|VEGF|vegf
5613268|NCT00844987|ACS|acs
5613269|NCT00844987|markers of myocardial injury|markers of myocardial injury
5613270|NCT00844987|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5613271|NCT00844987|Hepatocyte Growth Factor|hepatocyte growth factor
5613272|NCT00844987|Platelet Derived Growth Factor|platelet derived growth factor
5613274|NCT00844961|IBS|ibs
5613275|NCT00844961|CBT|cbt
5613276|NCT00844961|Internet treatment|internet treatment
5613277|NCT00844961|Cognitive behavior therapy|cognitive behavior therapy
5613278|NCT00844948|Depression|depression
5613279|NCT00844935|Heart rate variability, mechanical ventilation, weaning,|heart rate variability, mechanical ventilation, weaning,
5613280|NCT00844935|spontaneous breathing trial|spontaneous breathing trial
5613281|NCT00844909|CNTO 136|cnto 136
5613282|NCT00844909|safety|safety
5613283|NCT00844909|pharmacokinetics|pharmacokinetics
5613284|NCT00844909|healthy Japanese|healthy japanese
5613285|NCT00844909|healthy Caucasian|healthy caucasian
5613286|NCT00844909|Phase I|phase i
5613287|NCT00844909|antibody|antibody
5613288|NCT00844909|male.|male.
5613289|NCT00844896|Pathological stress & PTSD in preschool children & parents|pathological stress & ptsd in preschool children & parents
5613290|NCT00844896|Child and parent resilience after burn trauma|child and parent resilience after burn trauma
5613291|NCT00844883|primary liver cancer|primary liver cancer
5613292|NCT00844883|sorafenib|sorafenib
5613293|NCT00844883|Nexavar|nexavar
5613294|NCT00844883|doxorubicin|doxorubicin
5613295|NCT00844883|drug eluting beads|drug eluting beads
5613296|NCT00844883|transarterial chemoembolization|transarterial chemoembolization
5613297|NCT00844870|rehabilitation, reaching, stroke|rehabilitation, reaching, stroke
5613298|NCT00844857|Bipolar I Depression|bipolar i depression
5613299|NCT00844844|aHUS|ahus
5613300|NCT00844831|Constipation|constipation
5613301|NCT00844831|small intestinal bacterial overgrowth|small intestinal bacterial overgrowth
5613302|NCT00844831|stool bacteria|stool bacteria
5613303|NCT00844818|smoking cessation|smoking cessation
5613304|NCT00844818|parents|parents
5613305|NCT00844792|Male Urogenital Diseases|male urogenital diseases
5613306|NCT00844792|Antioxidants|antioxidants
5613307|NCT00844792|Vitamin E|vitamin e
5613308|NCT00844792|Vitamin D|vitamin d
5613309|NCT00844792|Lycopene|lycopene
5613310|NCT00844792|Selenium|selenium
5613311|NCT00844779|Metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression|metabolic syndrome- hepatic steatosis- steatohepatitis - gene expression
5613312|NCT00844779|Non alcoholic fatty liver disease (NFALD)|non alcoholic fatty liver disease (nfald)
5613313|NCT00844766|Lactose intolerance|lactose intolerance
5613315|NCT00844766|Home-screening test|home-screening test
5613316|NCT00844766|Validate|validate
5613317|NCT00844753|Autism|autism
5613318|NCT00844753|PDD NOS|pdd nos
5613319|NCT00844753|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5613320|NCT00844753|Parent Management Training|parent management training
5613321|NCT00844740|Familial hypophosphatemic rickets|familial hypophosphatemic rickets
5613322|NCT00844740|Cinacalcet|cinacalcet
5613323|NCT00844740|hyperparathyroidism|hyperparathyroidism
5613324|NCT00844714|endothelial function|endothelial function
5613325|NCT00844714|rheumatoid arthritis|rheumatoid arthritis
5613326|NCT00844714|cardiovascular risk|cardiovascular risk
5613327|NCT00844714|rituxan therapy|rituxan therapy
5613328|NCT00844701|nicotine|nicotine
5613329|NCT00844701|addiction|addiction
5613330|NCT00844701|fMRI|fmri
5613331|NCT00844701|neuroimaging|neuroimaging
5613333|NCT00844701|craving|craving
5613334|NCT00844688|Hepatocellular Carcinoma|hepatocellular carcinoma
5613335|NCT00844688|Sorafenib|sorafenib
5613336|NCT00844688|Gemcitabine|gemcitabine
5613337|NCT00844675|endoscopic mucosal resection|endoscopic mucosal resection
5613338|NCT00844675|Proton Pump Inhibitor|proton pump inhibitor
5613339|NCT00844675|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5613340|NCT00844675|rabeprazole|rabeprazole
5613341|NCT00844662|Hyperphosphataemia|hyperphosphataemia
5613342|NCT00844662|phosphate binder|phosphate binder
5613343|NCT00844636|Needlestick injuries|needlestick injuries
5613344|NCT00844636|Glove perforations|glove perforations
5613345|NCT00844636|Blunt Needles|blunt needles
5613346|NCT00844636|Glove perforations of surgeons, assistants|glove perforations of surgeons, assistants
5613347|NCT00844636|Needlestick injuries of same|needlestick injuries of same
5613348|NCT00844623|primary liver cancer, hepatoma|primary liver cancer, hepatoma
5613349|NCT00844584|Atrial fibrillation|atrial fibrillation
5613350|NCT00844584|radiofrequency|radiofrequency
5613351|NCT00844584|totally thoracoscope|totally thoracoscope
5613352|NCT00844584|epicardial|epicardial
5613353|NCT00844571|child abuse and neglect|child abuse and neglect
5613354|NCT00844571|child maltreatment|child maltreatment
5613355|NCT00844571|non accidental injury|non accidental injury
5613356|NCT00844571|training|training
5613357|NCT00844571|educational program|educational program
5613358|NCT00844558|osteoarthritis|osteoarthritis
5613359|NCT00844558|knee pain|knee pain
5613360|NCT00844558|gait training|gait training
5613361|NCT00844558|power training|power training
5613362|NCT00844558|rehabilitation|rehabilitation
5613363|NCT00844558|physical therapy|physical therapy
5613364|NCT00844545|aHUS|ahus
5613365|NCT00844532|Atherosclerosis|atherosclerosis
5613366|NCT00844532|Peripheral artery disease|peripheral artery disease
5613367|NCT00844532|Peripheral vascular disease|peripheral vascular disease
5613369|NCT00844532|Claudication|claudication
5613370|NCT00844532|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5613371|NCT00844532|Stent|stent
5613372|NCT00844532|PAOD|paod
5613373|NCT00844532|PVD|pvd
5613374|NCT00844519|Treatment Experienced|treatment experienced
5613375|NCT00844519|CCR5 receptor|ccr5 receptor
5613376|NCT00844519|maraviroc|maraviroc
5613377|NCT00844506|Ovarian cancer patients with recurrent disease|ovarian cancer patients with recurrent disease
5613378|NCT00844493|diarrhea|diarrhea
5613380|NCT00844493|enterotoxigenic E coli|enterotoxigenic e coli
5613381|NCT00844493|colonization factor antigen|colonization factor antigen
5613382|NCT00844493|volunteer study|volunteer study
5613383|NCT00844480|spinal cord injury|spinal cord injury
5613384|NCT00844480|osteoporosis|osteoporosis
5613385|NCT00844480|bone loss|bone loss
5613386|NCT00844480|zoledronic acid|zoledronic acid
5613387|NCT00844480|bisphosphonate|bisphosphonate
5613388|NCT00844467|Risk factors|risk factors
5613389|NCT00844467|Case fatality|case fatality
5613390|NCT00844467|disease burden|disease burden
5613391|NCT00844467|Resistance|resistance
5613392|NCT00844467|Benefits of pneumococcal vaccination|benefits of pneumococcal vaccination
5613393|NCT00844454|hepatocellular carcinoma|hepatocellular carcinoma
5613395|NCT00844454|RF ablation|rf ablation
5613396|NCT00844454|tumor ablation|tumor ablation
5613397|NCT00844441|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5613398|NCT00844441|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5613399|NCT00844441|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5613400|NCT00844441|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5613401|NCT00844441|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5613402|NCT00844441|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5613403|NCT00844441|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5613404|NCT00844441|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5613405|NCT00844441|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5613406|NCT00844441|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5613407|NCT00844441|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5613408|NCT00844441|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5613409|NCT00844441|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5613410|NCT00844441|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5613411|NCT00844441|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5613412|NCT00844441|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5613413|NCT00844441|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5613415|NCT00844441|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5613416|NCT00844441|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5596058|NCT00906672|Flap|flap
5613417|NCT00844441|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5613419|NCT00844402|Atherosclerosis|atherosclerosis
5613421|NCT00844402|Vascular function|vascular function
5613422|NCT00844389|Open Angle Glaucoma|open angle glaucoma
5613423|NCT00844389|Biophotomodulation|biophotomodulation
5613424|NCT00844389|Near to Infrared light stimulation|near to infrared light stimulation
5613425|NCT00844389|Neuroprotection|neuroprotection
5613426|NCT00844376|Cardiovascular Diseases|cardiovascular diseases
5613427|NCT00844350|Oxytocin|oxytocin
5613428|NCT00844350|Letrozole|letrozole
5613429|NCT00844350|Induction of ovulation|induction of ovulation
5613430|NCT00844337|antibiotic regimens|antibiotic regimens
5613431|NCT00844337|sepsis|sepsis
5613432|NCT00844337|young infants|young infants
5613433|NCT00844337|Bangladeshi|bangladeshi
5613434|NCT00844337|outpatient treatment|outpatient treatment
5613435|NCT00844337|Suspected sepsis in young infants|suspected sepsis in young infants
5613436|NCT00844324|Candesartan|candesartan
5613437|NCT00844324|Bioequivalence|bioequivalence
5613439|NCT00844311|human chorionic gonadotropin|human chorionic gonadotropin
5613440|NCT00844298|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5613441|NCT00844298|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5613444|NCT00844272|Opiate Dependence|opiate dependence
5613445|NCT00844272|Chronic Hepatitis C|chronic hepatitis c
5613446|NCT00844259|Down syndrome|down syndrome
5613447|NCT00844259|Pragmatics|pragmatics
5613448|NCT00844259|Language Development|language development
5613449|NCT00844246|Developmental delays|developmental delays
5613450|NCT00844246|Early intervention services|early intervention services
5613451|NCT00844220|Suspected coronary artery disease|suspected coronary artery disease
5613452|NCT00844207|Bioavailability|bioavailability
5613453|NCT00844155|Prevention or treatment of influenza in ventilated patients|prevention or treatment of influenza in ventilated patients
5613454|NCT00844142|ankylosing spondylitis|ankylosing spondylitis
5613455|NCT00844142|axial spondyloarthritis|axial spondyloarthritis
5613456|NCT00844142|magnetic resonance imaging|magnetic resonance imaging
5613457|NCT00844142|etanercept|etanercept
5613458|NCT00844142|sulfasalazine|sulfasalazine
5613459|NCT00844129|neurofibromatosis type 1|neurofibromatosis type 1
5613460|NCT00844129|spinal abnormalities|spinal abnormalities
5613465|NCT00844103|Volunteer|volunteer
5613466|NCT00844103|Safety|safety
5613467|NCT00844103|Tolerability|tolerability
5613468|NCT00844103|AZD8566|azd8566
5613469|NCT00844090|Apathy|apathy
5613470|NCT00844090|Diabetes|diabetes
5613471|NCT00844090|Self-care behaviors|self-care behaviors
5613472|NCT00844077|Barrett's Intestinal Metaplasia|barrett's intestinal metaplasia
5613473|NCT00844064|Pancreatic cancer|pancreatic cancer
5613474|NCT00844064|Metastatic melanoma|metastatic melanoma
5613475|NCT00844064|Advanced tumor|advanced tumor
5613476|NCT00844064|Targeted therapy|targeted therapy
5613477|NCT00844064|Antisense|antisense
5613478|NCT00844064|Transforming Growth Factor beta 2|transforming growth factor beta 2
5613479|NCT00844064|Dose escalation|dose escalation
5613480|NCT00844051|Influenza|influenza
5613481|NCT00844051|influenza vaccination|influenza vaccination
5613482|NCT00844051|school-based vaccination|school-based vaccination
5613483|NCT00844038|Steven-Johnson syndrome|steven-johnson syndrome
5613484|NCT00844038|erythema multiform|erythema multiform
5613485|NCT00844038|autoimmune disease|autoimmune disease
5613486|NCT00844025|Adverse drug reaction|adverse drug reaction
5613487|NCT00844025|Inappropriate medication|inappropriate medication
5613488|NCT00844025|Pharmacist|pharmacist
5613489|NCT00844025|Pharmaceutical care|pharmaceutical care
5613490|NCT00843986|hyponatremia|hyponatremia
5613491|NCT00843986|euvolemic hyponatremia|euvolemic hyponatremia
5613492|NCT00843986|hypervolemic hyponatremia|hypervolemic hyponatremia
5613493|NCT00843986|acute decompensated heart failure|acute decompensated heart failure
5613494|NCT00843986|conivaptan|conivaptan
5613495|NCT00843986|Vaprisol|vaprisol
5613496|NCT00843973|Iliac Crest Bone Graft|iliac crest bone graft
5613497|NCT00843973|Reamer Irrigator Aspirator|reamer irrigator aspirator
5613498|NCT00843934|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5613499|NCT00843934|Trans arterial chemoembolization|trans arterial chemoembolization
5613500|NCT00843934|Epirubicin|epirubicin
5613501|NCT00843934|Cisplatin|cisplatin
5613503|NCT00843908|Stress incontinence|stress incontinence
5613504|NCT00843908|Surgical Treatments|surgical treatments
5613505|NCT00843908|Minislings|minislings
5613506|NCT00843895|Laboratory based study|laboratory based study
5613507|NCT00843895|antibiotic susceptibilty|antibiotic susceptibilty
5613508|NCT00843895|invasive strains|invasive strains
5613509|NCT00843856|Glomerulonephritis|glomerulonephritis
5613510|NCT00843843|Circadian Rhythms|circadian rhythms
5613511|NCT00843817|cystic fibrosis|cystic fibrosis
5613512|NCT00843804|nosocomial infection|nosocomial infection
5613513|NCT00843804|bloodstream infection|bloodstream infection
5613514|NCT00843804|central venous catheter|central venous catheter
5613515|NCT00843804|invasive Aspergillosis|invasive aspergillosis
5613516|NCT00843804|Clostridium difficile associated disease|clostridium difficile associated disease
5613517|NCT00843791|obesity|obesity
5613518|NCT00843778|Rheumatoid Arthritis|rheumatoid arthritis
5613519|NCT00843778|Moderate to Low Disease Activity|moderate to low disease activity
5613521|NCT00843765|Stroke|stroke
5613522|NCT00843765|Traditional Chinese Medicine|traditional chinese medicine
5613523|NCT00843765|Rehabilitation|rehabilitation
5613524|NCT00843739|Breathing|breathing
5613525|NCT00843739|Cough|cough
5613526|NCT00843739|Speech|speech
5613527|NCT00843739|Swallow|swallow
5613528|NCT00843739|Parkinson's disease|parkinson's disease
5613532|NCT00843713|endothelium|endothelium
5613533|NCT00843713|inflammation|inflammation
5613534|NCT00843713|Treatment Experienced|treatment experienced
5613535|NCT00843687|Schizophrenia|schizophrenia
5613536|NCT00843687|Risperidone|risperidone
5613537|NCT00843687|Long-acting injectable|long-acting injectable
5613538|NCT00843687|Intramuscular injection|intramuscular injection
5613539|NCT00843687|Pharmacokinetics|pharmacokinetics
5613540|NCT00843661|Treatment Experienced|treatment experienced
5613541|NCT00843648|antibody immune profile|antibody immune profile
5613542|NCT00843648|preterm|preterm
5613543|NCT00843648|c-section|c-section
5613544|NCT00843648|breastfeeding|breastfeeding
5613545|NCT00843635|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5613546|NCT00843635|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5613547|NCT00843635|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5613548|NCT00843635|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5613549|NCT00843635|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5613550|NCT00843635|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5613551|NCT00843635|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5613552|NCT00843635|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5613553|NCT00843635|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5613554|NCT00843635|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5613555|NCT00843635|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5613556|NCT00843635|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5613557|NCT00843622|Smoking|smoking
5613558|NCT00843622|Smoking cessation|smoking cessation
5613559|NCT00843622|Smokeless tobacco|smokeless tobacco
5613560|NCT00843622|Snus|snus
5613561|NCT00843609|diabetes mellitus, type 1|diabetes mellitus, type 1
5613562|NCT00843609|hypoglycemia|hypoglycemia
5613563|NCT00843609|continuous glucose monitoring|continuous glucose monitoring
5613564|NCT00843609|HbA1c|hba1c
5613565|NCT00843609|glycemic variability|glycemic variability
5613566|NCT00843596|cardiac surgery requiring ECC|cardiac surgery requiring ecc
5613567|NCT00843583|prevalence|prevalence
5613568|NCT00843583|obstructive sleep apnea|obstructive sleep apnea
5613569|NCT00843583|resistant hypertension|resistant hypertension
5613570|NCT00843570|IVF|ivf
5613571|NCT00843570|Frozen Embryo Replacement|frozen embryo replacement
5613572|NCT00843557|critical illness|critical illness
5613573|NCT00843557|intensive care|intensive care
5613574|NCT00843557|nosocomial infection|nosocomial infection
5613575|NCT00843531|neuroendocrine|neuroendocrine
5613576|NCT00843531|islet cell|islet cell
5613577|NCT00843531|carcinoid|carcinoid
5613578|NCT00843531|pancreatic neuroendocrine|pancreatic neuroendocrine
5613579|NCT00843531|paraganglioma|paraganglioma
5613580|NCT00843531|pheochromocytoma|pheochromocytoma
5613582|NCT00843531|everolimus|everolimus
5613583|NCT00843531|erlotinib|erlotinib
5613584|NCT00843531|Tarceva|tarceva
5613585|NCT00843518|Agitation and Aggression|agitation and aggression
5613586|NCT00843505|Smoking Cessation|smoking cessation
5613587|NCT00843505|Motivational Interviewing|motivational interviewing
5613588|NCT00843505|Quitline|quitline
5613589|NCT00843505|Telemedicine|telemedicine
5613590|NCT00843505|Stop Smoking Medication|stop smoking medication
5613591|NCT00843492|deep vein thrombosis|deep vein thrombosis
5613592|NCT00843492|immobilization|immobilization
5613593|NCT00843492|nadroparin|nadroparin
5613594|NCT00843492|isolated lower-extremity injuries distal to the knee|isolated lower-extremity injuries distal to the knee
5613595|NCT00843492|plaster cast|plaster cast
5613596|NCT00843492|non-surgical leg injury|non-surgical leg injury
5613597|NCT00843492|venous thromboembolism|venous thromboembolism
5613598|NCT00843492|bleeding events|bleeding events
5613599|NCT00843492|fondaparinux|fondaparinux
5613600|NCT00843479|diabetes mellitus, type 2|diabetes mellitus, type 2
5613606|NCT00843479|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5613607|NCT00843479|insulin|insulin
5613608|NCT00843479|glucagon|glucagon
5613609|NCT00843479|ghrelin|ghrelin
5613610|NCT00843466|Hand dermatitis|hand dermatitis
5613611|NCT00843453|vitamin B12 deficiency|vitamin b12 deficiency
5613612|NCT00843453|cyanocobalamin deficiency|cyanocobalamin deficiency
5613613|NCT00843453|proton pump inhibitors|proton pump inhibitors
5613614|NCT00843453|omeprazole|omeprazole
5613615|NCT00843440|Antiangiogenic therapies|antiangiogenic therapies
5613617|NCT00843440|Hemorrhagic Hereditary Telangiectasia (HHT) with severe liver involvement|hemorrhagic hereditary telangiectasia (hht) with severe liver involvement
5613618|NCT00843427|aphasia|aphasia
5613619|NCT00843427|stroke|stroke
5613620|NCT00843427|functional magnetic resonance imaging|functional magnetic resonance imaging
5613621|NCT00843427|fMRI|fmri
5613622|NCT00843427|language recovery after stroke|language recovery after stroke
5613623|NCT00843427|constraint-induced aphasia therapy|constraint-induced aphasia therapy
5613624|NCT00843427|CIAT|ciat
5613625|NCT00843414|Emphysema|emphysema
5613626|NCT00843414|Sarcoidosis|sarcoidosis
5613627|NCT00843414|Interstitial Pulmonary Fibrosis|interstitial pulmonary fibrosis
5613628|NCT00843401|Low oxygen saturation|low oxygen saturation
5613629|NCT00843401|Anticipated need for pulse oximetry monitoring|anticipated need for pulse oximetry monitoring
5613630|NCT00843401|Arterial line in place as indicated per patient's clinical management needs|arterial line in place as indicated per patient's clinical management needs
5613631|NCT00843401|Availability to analyze arterial blood saturation by Co-Oximeter or|availability to analyze arterial blood saturation by co-oximeter or
5613632|NCT00843401|Blood Gas Analyzer|blood gas analyzer
5613633|NCT00843349|Phosphorus|phosphorus
5613634|NCT00843349|Fibroblast Growth Factor-23|fibroblast growth factor-23
5613635|NCT00843349|Kidney Disease|kidney disease
5613636|NCT00843336|fertility monitoring|fertility monitoring
5613637|NCT00843336|contraception|contraception
5613638|NCT00843310|multiple myeloma|multiple myeloma
5613639|NCT00843310|frontline treatment|frontline treatment
5613640|NCT00843310|first-line treatment|first-line treatment
5613643|NCT00843297|Outcome, neurological|outcome, neurological
5613644|NCT00843297|Coolgard|coolgard
5613645|NCT00843297|ArcticSun|arcticsun
5613646|NCT00843284|neuropathic, pain, pregabalin, Lyrica|neuropathic, pain, pregabalin, lyrica
5613647|NCT00843271|COPD MESA LUNG BIOMARKERS|copd mesa lung biomarkers
5613648|NCT00843258|therapy|therapy
5613649|NCT00843258|ultrasound|ultrasound
5613650|NCT00843258|mild dysplasia|mild dysplasia
5613651|NCT00843245|Heart Failure|heart failure
5613652|NCT00843245|Electric bioimpedance|electric bioimpedance
5613653|NCT00843245|Body composition|body composition
5613654|NCT00843245|Diagnosis|diagnosis
5613655|NCT00843245|monitoring|monitoring
5613656|NCT00843245|Prognosis|prognosis
5613657|NCT00843245|Total body water|total body water
5613658|NCT00843232|diabetes mellitus, type 2|diabetes mellitus, type 2
5613659|NCT00843232|Insulin resistance|insulin resistance
5613660|NCT00843232|Aging|aging
5613661|NCT00843232|Incretins|incretins
5613662|NCT00843232|DPP-IV protein, human|dpp-iv protein, human
5613663|NCT00843232|Glucagon-Like Peptide 1|glucagon-like peptide 1
5613664|NCT00843232|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5613665|NCT00843232|insulin|insulin
5613666|NCT00843232|glucagon|glucagon
5613667|NCT00843232|ghrelin|ghrelin
5613668|NCT00843219|Lung|lung
5613669|NCT00843219|Lung Cancer|lung cancer
5613670|NCT00843219|Non-small cell Lung Cancer|non-small cell lung cancer
5613671|NCT00843219|NSCLC|nsclc
5613672|NCT00843219|Motion Correction|motion correction
5613673|NCT00843219|PET/CT Scan|pet/ct scan
5613674|NCT00843219|PET|pet
5613675|NCT00843219|Positron Emission Tomography|positron emission tomography
5613676|NCT00843219|CT|ct
5613677|NCT00843219|Computed Tomography|computed tomography
5613678|NCT00843219|Amplitude Gating|amplitude gating
5613679|NCT00843193|Asthma|asthma
5613680|NCT00843193|Asthma control questionnaire|asthma control questionnaire
5613681|NCT00843180|Bone Marrow Transplant|bone marrow transplant
5613682|NCT00843180|Massage|massage
5613683|NCT00843180|Pediatric Oncology|pediatric oncology
5613684|NCT00843180|children undergoing bone marrow transplantation|children undergoing bone marrow transplantation
5613685|NCT00843167|mammography|mammography
5613686|NCT00843167|biopsy|biopsy
5613687|NCT00843167|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5613688|NCT00843167|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5613689|NCT00843154|Natriuretic Peptide, Brain|natriuretic peptide, brain
5613690|NCT00843154|Biological Markers|biological markers
5616259|NCT00832507|PH|ph
5613694|NCT00843154|Heart Decompensation|heart decompensation
5613695|NCT00843154|Drug Therapy|drug therapy
5613696|NCT00843141|ADHD|adhd
5613697|NCT00843141|Executive functions|executive functions
5613698|NCT00843141|Quality of life|quality of life
5613699|NCT00843115|Alzheimer's Disease, naturalistic study|alzheimer's disease, naturalistic study
5613700|NCT00843102|atherosclerosis|atherosclerosis
5613701|NCT00843102|pulmonary hypertension|pulmonary hypertension
5613702|NCT00843089|coronary artery disease|coronary artery disease
5613703|NCT00843089|CABG|cabg
5613704|NCT00843063|pantoprazole|pantoprazole
5613705|NCT00843063|famotidine|famotidine
5613706|NCT00843063|aspirin|aspirin
5613707|NCT00843063|dyspepsia|dyspepsia
5613708|NCT00843063|gastrointestinal bleeding|gastrointestinal bleeding
5613709|NCT00843063|peptic ulcer / erosion|peptic ulcer / erosion
5613710|NCT00843050|CKD inhibitor|ckd inhibitor
5613711|NCT00843050|Mantle Cell Lymphoma|mantle cell lymphoma
5613712|NCT00843037|PARAGANGLIOMA|paraganglioma
5613713|NCT00843037|PHEOCHROMOCYTOMA|pheochromocytoma
5613714|NCT00843037|SUNITINIB|sunitinib
5613715|NCT00843037|PHASE II|phase ii
5613716|NCT00843037|Metastatic or locally advanced malignant paraganglioma|metastatic or locally advanced malignant paraganglioma
5613717|NCT00843037|Metastatic or locally advanced malignant pheochromocytoma|metastatic or locally advanced malignant pheochromocytoma
5613718|NCT00843024|Migraine with or without aura|migraine with or without aura
5613719|NCT00843024|Migraine efficacy|migraine efficacy
5613720|NCT00843024|Migraine|migraine
5613721|NCT00843024|Migraine headache|migraine headache
5613722|NCT00843024|Adolescent migraine|adolescent migraine
5613723|NCT00843024|TREXIMET|treximet
5613724|NCT00843024|Sumatriptan succinate|sumatriptan succinate
5613725|NCT00843024|Naproxen sodium|naproxen sodium
5613726|NCT00843024|Migraine, acute|migraine, acute
5613727|NCT00843011|formulation|formulation
5613728|NCT00843011|safety and tolerability|safety and tolerability
5613729|NCT00843011|pharmacokinetics|pharmacokinetics
5613730|NCT00843011|NK1 antagonist|nk1 antagonist
5613731|NCT00843011|effect of food|effect of food
5613732|NCT00842998|breast cancer|breast cancer
5613733|NCT00842998|HER2|her2
5613734|NCT00842998|Trastuzumab|trastuzumab
5613735|NCT00842998|Lapatinib|lapatinib
5613736|NCT00842998|HER2 gene-amplification|her2 gene-amplification
5613737|NCT00842985|Cannabis Abuse|cannabis abuse
5613738|NCT00842985|Cannabis Dependence|cannabis dependence
5613739|NCT00842985|Cannabis-Related Disorder|cannabis-related disorder
5613740|NCT00842985|Marijuana Dependence|marijuana dependence
5613741|NCT00842985|Marihuana Abuse|marihuana abuse
5613742|NCT00842959|Improvement of adjustment accuracy of intraocular lenses and imaging quality|improvement of adjustment accuracy of intraocular lenses and imaging quality
5613743|NCT00842933|Septic shock|septic shock
5613744|NCT00842933|Acute adrenal insufficiency|acute adrenal insufficiency
5613745|NCT00842920|amnestic MCI|amnestic mci
5613746|NCT00842907|Brazil|brazil
5613747|NCT00842907|isotretinoin|isotretinoin
5613748|NCT00842907|photodamage|photodamage
5613749|NCT00842907|photoaging|photoaging
5613750|NCT00842881|Healingstone|healingstone
5613751|NCT00842868|atherosclerosis|atherosclerosis
5613752|NCT00842868|contrast induced nephropathy|contrast induced nephropathy
5613753|NCT00842868|renal impairment|renal impairment
5613754|NCT00842868|catheterization|catheterization
5613755|NCT00842855|GERD|gerd
5613756|NCT00842855|PPI|ppi
5613757|NCT00842855|partial responders|partial responders
5613758|NCT00842842|surgical fixation devices|surgical fixation devices
5613759|NCT00842842|postoperative pain|postoperative pain
5613760|NCT00842842|ventral hernia|ventral hernia
5613761|NCT00842842|fibrin tissue adhesive|fibrin tissue adhesive
5613762|NCT00842842|laparoscopy|laparoscopy
5613763|NCT00842842|quality of life|quality of life
5613764|NCT00842842|fatigue|fatigue
5613765|NCT00842829|Breakthrough Cancer Pain|breakthrough cancer pain
5613766|NCT00842816|Dementia|dementia
5613767|NCT00842816|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5613768|NCT00842816|Cognitive impairment|cognitive impairment
5613769|NCT00842803|Liver|liver
5613770|NCT00842803|transplant|transplant
5613771|NCT00842803|albumin|albumin
5613772|NCT00842803|outcome|outcome
5613773|NCT00842803|Liver transplant recipients canadian transplant status 1 or 2|liver transplant recipients canadian transplant status 1 or 2
5613774|NCT00842790|Carcinoma, Renal Cell [C04.557.470.200.025.390]|carcinoma, renal cell [c04.557.470.200.025.390]
5613775|NCT00842790|Angiogenesis Inhibitors [D27.505.954.248.025]|angiogenesis inhibitors [d27.505.954.248.025]
5613776|NCT00842790|Tomography Scanners, X-Ray Computed [E07.913]|tomography scanners, x-ray computed [e07.913]
5613777|NCT00842790|Magnetic Resonance Imaging [E01.370.350.825.500]|magnetic resonance imaging [e01.370.350.825.500]
5613778|NCT00842790|Diffusion Magnetic Resonance Imaging [E01.370.350.825.500.150]|diffusion magnetic resonance imaging [e01.370.350.825.500.150]
5613779|NCT00842790|Perfusion [E05.680]|perfusion [e05.680]
5613780|NCT00842777|Childhood obesity|childhood obesity
5613781|NCT00842777|Quality of life|quality of life
5613782|NCT00842777|Self-esteem|self-esteem
5613784|NCT00842777|parental group treatment|parental group treatment
5613785|NCT00842777|Body image|body image
5613786|NCT00842764|eyelid fat pads|eyelid fat pads
5613787|NCT00842751|5α-reductase|5α-reductase
5613788|NCT00842751|androgen|androgen
5613789|NCT00842751|dihydrotestosterone (DHT)|dihydrotestosterone (dht)
5613790|NCT00842751|drug delivery|drug delivery
5613791|NCT00842751|oestradiol|oestradiol
5613792|NCT00842738|Screening|screening
5613793|NCT00842738|Cervical cancer|cervical cancer
5613794|NCT00842738|Cervical dysplasia|cervical dysplasia
5613795|NCT00842738|Adverse psychosocial effects|adverse psychosocial effects
5613796|NCT00842738|Alternative treatment|alternative treatment
5613797|NCT00842712|First-line treatment for subjects with advanced NSCLC,|first-line treatment for subjects with advanced nsclc,
5613798|NCT00842712|integrin receptor antagonist, EGFR chimerized monoclonal antibody, chemotherapy|integrin receptor antagonist, egfr chimerized monoclonal antibody, chemotherapy
5613799|NCT00842712|safety run-in + randomization part, MTD, PFS, Overall survival time, best overall response|safety run-in + randomization part, mtd, pfs, overall survival time, best overall response
5613800|NCT00842686|rectal cancer|rectal cancer
5613801|NCT00842686|capecitabine|capecitabine
5613803|NCT00842686|radiotherapy|radiotherapy
5613804|NCT00842673|Dementia|dementia
5613805|NCT00842673|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5613806|NCT00842673|Cognitive impairment|cognitive impairment
5613807|NCT00842660|Cervical cancer|cervical cancer
5613808|NCT00842660|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5613809|NCT00842660|gemcitabine|gemcitabine
5613810|NCT00842647|Sensitivity|sensitivity
5613811|NCT00842647|specificity|specificity
5613812|NCT00842647|positive rate|positive rate
5613813|NCT00842647|negative rate|negative rate
5613814|NCT00842634|HIV|hiv
5613815|NCT00842634|Treatment Experienced|treatment experienced
5613816|NCT00842621|Sickle Cell Disease, Hemolytic Anemia|sickle cell disease, hemolytic anemia
5613817|NCT00842621|Hemolysis|hemolysis
5613818|NCT00842608|confusion|confusion
5613819|NCT00842608|dementia|dementia
5613820|NCT00842595|relapsed aggressive B-cell lymphoma|relapsed aggressive b-cell lymphoma
5613821|NCT00842595|Chemotherapy|chemotherapy
5613822|NCT00842582|Ovarian cancer|ovarian cancer
5613823|NCT00842582|chemotherapy|chemotherapy
5613824|NCT00842582|azacitidine|azacitidine
5613825|NCT00842569|obesity|obesity
5613826|NCT00842569|cognitive process|cognitive process
5613827|NCT00842569|reward|reward
5613828|NCT00842569|P300|p300
5613829|NCT00842569|ERP|erp
5613830|NCT00842569|Event-related potential during oddball paradigm|event-related potential during oddball paradigm
5613831|NCT00842569|brain electrophysiological patterns|brain electrophysiological patterns
5613832|NCT00842569|externalizing factor|externalizing factor
5613833|NCT00842543|Nutrition|nutrition
5613834|NCT00842543|Oxidative Stress|oxidative stress
5613835|NCT00842543|Insulin Resistance|insulin resistance
5613836|NCT00842543|Whole Food Supplement|whole food supplement
5613837|NCT00842543|Pediatric|pediatric
5613838|NCT00842543|Retinoids|retinoids
5613839|NCT00842543|Antioxidants|antioxidants
5613840|NCT00842543|Dietary Supplements|dietary supplements
5613841|NCT00842530|Dengue virus|dengue virus
5613842|NCT00842530|Dengue fever|dengue fever
5613843|NCT00842530|Dengue hemorrhagic fever|dengue hemorrhagic fever
5613844|NCT00842530|Dengue diseases|dengue diseases
5613845|NCT00842530|Dengue vaccine|dengue vaccine
5613846|NCT00842517|Cocaine Dependence|cocaine dependence
5613847|NCT00842517|Cocaine Abuse|cocaine abuse
5613848|NCT00842517|Substance Abuse|substance abuse
5613849|NCT00842517|Contingency Management|contingency management
5613850|NCT00842517|Drug Treatment|drug treatment
5613851|NCT00842504|Anti-fungal|anti-fungal
5613852|NCT00842504|Immunocompromised|immunocompromised
5613853|NCT00842504|Pharmacokinetic|pharmacokinetic
5613854|NCT00842504|Prophylaxis|prophylaxis
5613855|NCT00842504|Pharmacokinetics|pharmacokinetics
5613856|NCT00842465|Breast diseases,|breast diseases,
5613857|NCT00842465|human mutation,|human mutation,
5613858|NCT00842465|prolactin receptor;|prolactin receptor;
5613859|NCT00842465|breast cancer|breast cancer
5613860|NCT00842452|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5613861|NCT00842452|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5613862|NCT00842452|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5613863|NCT00842452|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5613864|NCT00842452|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5613865|NCT00842452|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5613866|NCT00842452|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5613867|NCT00842452|stage III endometrial carcinoma|stage iii endometrial carcinoma
5613868|NCT00842452|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5613869|NCT00842452|recurrent uterine sarcoma|recurrent uterine sarcoma
5613870|NCT00842452|stage III uterine sarcoma|stage iii uterine sarcoma
5613871|NCT00842452|stage IV uterine sarcoma|stage iv uterine sarcoma
5613872|NCT00842452|recurrent vaginal cancer|recurrent vaginal cancer
5613875|NCT00842452|stage IVB vaginal cancer|stage ivb vaginal cancer
5613876|NCT00842452|recurrent vulvar cancer|recurrent vulvar cancer
5613877|NCT00842452|stage III vulvar cancer|stage iii vulvar cancer
5613878|NCT00842452|stage IV vulvar cancer|stage iv vulvar cancer
5613879|NCT00842452|recurrent cervical cancer|recurrent cervical cancer
5613880|NCT00842452|stage III cervical cancer|stage iii cervical cancer
5613881|NCT00842452|stage IVA cervical cancer|stage iva cervical cancer
5613882|NCT00842452|stage IVB cervical cancer|stage ivb cervical cancer
5613883|NCT00842452|fallopian tube cancer|fallopian tube cancer
5613884|NCT00842452|ovarian sarcoma|ovarian sarcoma
5613885|NCT00842452|ovarian stromal cancer|ovarian stromal cancer
5613886|NCT00842439|aggression|aggression
5613887|NCT00842439|Prevention and treatment of youth aggression|prevention and treatment of youth aggression
5613888|NCT00842426|Diabetes|diabetes
5613889|NCT00842426|Cardiovascular disease|cardiovascular disease
5613890|NCT00842426|Metabolic syndrome|metabolic syndrome
5613891|NCT00842426|Cardiometabolic|cardiometabolic
5613892|NCT00842413|Prefrontal cortex|prefrontal cortex
5613893|NCT00842413|visual consciousness|visual consciousness
5613894|NCT00842413|focal lesions|focal lesions
5613895|NCT00842413|action perception|action perception
5613897|NCT00842387|gastroesophageal reflux disease|gastroesophageal reflux disease
5613899|NCT00842387|regurgitation|regurgitation
5613900|NCT00842387|acid control|acid control
5613902|NCT00842387|antiacid|antiacid
5613903|NCT00842387|primary care|primary care
5613904|NCT00842387|esophagitis|esophagitis
5613905|NCT00842348|Lanreotide|lanreotide
5613906|NCT00842348|Somatuline|somatuline
5613907|NCT00842348|Neuroendocrine tumour|neuroendocrine tumour
5613908|NCT00842348|NET|net
5613909|NCT00842335|solid tumors|solid tumors
5613910|NCT00842335|angiogenesis inhibitor|angiogenesis inhibitor
5613911|NCT00842335|dose escalation|dose escalation
5613912|NCT00842335|maximum tolerated dose|maximum tolerated dose
5613913|NCT00842335|JI-101|ji-101
5613914|NCT00842322|chronic kidney disease|chronic kidney disease
5613915|NCT00842322|transplantation|transplantation
5613916|NCT00842322|kidney function|kidney function
5613917|NCT00842322|fluid intake|fluid intake
5613918|NCT00842322|osmolarity|osmolarity
5613919|NCT00842296|GSV|gsv
5613920|NCT00842296|RadioFrequency|radiofrequency
5613921|NCT00842283|dermatologic diseases|dermatologic diseases
5613922|NCT00842270|severe asthma|severe asthma
5613923|NCT00842270|corticosteroids dependent|corticosteroids dependent
5613924|NCT00842270|asthma exacerbation|asthma exacerbation
5613925|NCT00842270|weaning|weaning
5613926|NCT00842270|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5613927|NCT00842270|severe persistent corticosteroid dependent asthma|severe persistent corticosteroid dependent asthma
5613928|NCT00842257|panitumumab|panitumumab
5613929|NCT00842257|cetuximab|cetuximab
5613930|NCT00842257|KRAS wild-type|kras wild-type
5613931|NCT00842231|Corneal astigmatism|corneal astigmatism
5613932|NCT00842231|post-cataract surgery|post-cataract surgery
5613933|NCT00842231|visual performance|visual performance
5613934|NCT00842231|Corneal astigmatism 0.5-0.75 Diopter|corneal astigmatism 0.5-0.75 diopter
5613936|NCT00842218|scoliosis|scoliosis
5613937|NCT00842218|energy|energy
5613938|NCT00842218|mechanics|mechanics
5613939|NCT00842205|hepatitis C|hepatitis c
5613940|NCT00842205|NASH|nash
5613941|NCT00842205|Hem Oxygenase|hem oxygenase
5613942|NCT00842205|Gene polymorphism|gene polymorphism
5613943|NCT00842179|Perclose|perclose
5613944|NCT00842153|Psoriasis|psoriasis
5613945|NCT00842153|Plaque Type Psoriasis|plaque type psoriasis
5613946|NCT00842140|Polycystic ovary syndrome|polycystic ovary syndrome
5613947|NCT00842140|Oral Contraceptives, Hormonal|oral contraceptives, hormonal
5613948|NCT00842140|Cardiovascular Disease|cardiovascular disease
5613949|NCT00842140|Endothelium|endothelium
5613950|NCT00842127|Methylphenidate|methylphenidate
5613951|NCT00842127|ADHD|adhd
5613952|NCT00842127|Multidrug resistance(MDR)polymorphism|multidrug resistance(mdr)polymorphism
5613953|NCT00842127|OROS methylphenidate|oros methylphenidate
5613954|NCT00842114|Intermediate-high FLIPI score|intermediate-high flipi score
5613955|NCT00842114|Follicular Lymphoma|follicular lymphoma
5613956|NCT00842114|Progression free survival|progression free survival
5613957|NCT00842101|Intramedullary nails|intramedullary nails
5613958|NCT00842101|Compartmental syndrome|compartmental syndrome
5613959|NCT00842101|Fractures|fractures
5613960|NCT00842075|type 1 diabetes|type 1 diabetes
5613961|NCT00842075|adolescents|adolescents
5613962|NCT00842075|post prandial glucose|post prandial glucose
5613963|NCT00842049|Subarachnoid haemorrhage|subarachnoid haemorrhage
5613964|NCT00842049|Aneurysm|aneurysm
5613965|NCT00842049|Cerebrospinal fluid drainage|cerebrospinal fluid drainage
5613966|NCT00842036|Family Therapy|family therapy
5613967|NCT00842036|Relationship Dysfunction|relationship dysfunction
5613968|NCT00842036|Family Dysfunction|family dysfunction
5613969|NCT00842036|Family Relations|family relations
5613970|NCT00842036|Stimulant Dependence|stimulant dependence
5613971|NCT00842036|Opiate Dependence|opiate dependence
5613972|NCT00842036|Alcohol Dependence|alcohol dependence
5613973|NCT00842036|Behavior Therapy|behavior therapy
5613974|NCT00842036|Drug Treatment|drug treatment
5613975|NCT00842036|Substance Abuse|substance abuse
5613976|NCT00842036|Drug Addiction|drug addiction
5613977|NCT00842023|Natriuretic peptides|natriuretic peptides
5613979|NCT00842023|Heart Failure|heart failure
5613980|NCT00842023|Nitoglycerin|nitoglycerin
5613981|NCT00842023|Biomarkers|biomarkers
5613982|NCT00842010|Diabetes|diabetes
5613983|NCT00842010|Inpatient|inpatient
5613984|NCT00842010|Hospital|hospital
5613985|NCT00842010|Hyperglycemia|hyperglycemia
5613986|NCT00841984|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5613987|NCT00841984|neurological diseases|neurological diseases
5613988|NCT00841984|metabolic|metabolic
5613989|NCT00841984|inborn errors of metabolism|inborn errors of metabolism
5613990|NCT00841984|Complex neurological diseases of unknown cause|complex neurological diseases of unknown cause
5613991|NCT00841945|Diffuse B larg cell lymphoma|diffuse b larg cell lymphoma
5613992|NCT00841945|Chemotherapy|chemotherapy
5613993|NCT00841945|Radiotherapy|radiotherapy
5613994|NCT00841932|Fractional Flow Reserve|fractional flow reserve
5613995|NCT00841932|Without anticoagulation|without anticoagulation
5613996|NCT00841919|Diabetes|diabetes
5613997|NCT00841919|Inpatient|inpatient
5614000|NCT00841893|Thermogenesis|thermogenesis
5614001|NCT00841893|Meal-induced thermogenesis|meal-induced thermogenesis
5614002|NCT00841893|Energy expenditure|energy expenditure
5614003|NCT00841893|Fat oxidation|fat oxidation
5614004|NCT00841893|Carbohydrate oxidation|carbohydrate oxidation
5614005|NCT00841893|Bioactive ingredient|bioactive ingredient
5614006|NCT00841893|Spice|spice
5614007|NCT00841867|Impaired Glucose Tolerance|impaired glucose tolerance
5614008|NCT00841867|Diabetes|diabetes
5614009|NCT00841854|Helicobacter pylori|helicobacter pylori
5614010|NCT00841854|Bismuth|bismuth
5614011|NCT00841854|Salvage treatment|salvage treatment
5614012|NCT00841854|Metronidazole|metronidazole
5614013|NCT00841841|Analgesia|analgesia
5614014|NCT00841841|molar third|molar third
5614015|NCT00841841|acetaminophen|acetaminophen
5614016|NCT00841841|dipyrone|dipyrone
5614017|NCT00841828|HER2-positive breast cancer|her2-positive breast cancer
5614018|NCT00841828|Lapatinib|lapatinib
5614019|NCT00841828|Neoadjuvant|neoadjuvant
5614020|NCT00841828|Trastuzumab|trastuzumab
5614021|NCT00841828|Biomarkers|biomarkers
5614022|NCT00841815|Bioequivalence|bioequivalence
5614023|NCT00841815|Healthy Subjects|healthy subjects
5614024|NCT00841802|Chronic sinusitis|chronic sinusitis
5614025|NCT00841802|Chronic rhinosinusitis|chronic rhinosinusitis
5614026|NCT00841802|Nasal polyps|nasal polyps
5614027|NCT00841789|Etanercept|etanercept
5614028|NCT00841776|Acne Vulgaris|acne vulgaris
5614029|NCT00841776|Acne|acne
5614030|NCT00841763|virus|virus
5614031|NCT00841763|pandemic influenza|pandemic influenza
5614032|NCT00841763|vaccine|vaccine
5614033|NCT00841750|Chest Tubes|chest tubes
5614034|NCT00841750|Thoracic Surgery, Video-Assisted|thoracic surgery, video-assisted
5614035|NCT00841750|Lung Diseases, Interstitial|lung diseases, interstitial
5614036|NCT00841750|Pulmonary Nodule, Solitary|pulmonary nodule, solitary
5614037|NCT00841737|Depressive Disorders;|depressive disorders;
5614038|NCT00841737|Primary Health Care;|primary health care;
5614039|NCT00841737|Nurses;|nurses;
5614040|NCT00841737|Health education.|health education.
5614041|NCT00841724|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5614042|NCT00841724|Reduced-intensity conditioning|reduced-intensity conditioning
5614043|NCT00841724|Reduced-toxicity conditioning|reduced-toxicity conditioning
5614044|NCT00841724|Hematological malignancies|hematological malignancies
5614045|NCT00841724|IV Busulfan|iv busulfan
5614046|NCT00841711|HIV|hiv
5614047|NCT00841711|AIDS|aids
5614048|NCT00841711|Buprenorphine|buprenorphine
5614049|NCT00841711|Intensive Case Management|intensive case management
5614050|NCT00841711|Money Management|money management
5614051|NCT00841711|Rapid Testing|rapid testing
5614052|NCT00841711|Substance Abuse|substance abuse
5614053|NCT00841711|Opioid Dependance|opioid dependance
5614054|NCT00841711|Inmate Population|inmate population
5614055|NCT00841698|Bioequivalence|bioequivalence
5614056|NCT00841698|Healthy Subjects|healthy subjects
5614057|NCT00841672|Hypertension|hypertension
5614058|NCT00841672|systolic blood pressure|systolic blood pressure
5614059|NCT00841672|cardiovascular disease|cardiovascular disease
5614060|NCT00841672|aliskiren|aliskiren
5614061|NCT00841672|amlodipine|amlodipine
5614062|NCT00841659|Bioequivalence|bioequivalence
5614063|NCT00841659|Healthy Subjects|healthy subjects
5614064|NCT00841646|Influenza vaccine|influenza vaccine
5614065|NCT00841633|subarachnoid hemorrhage|subarachnoid hemorrhage
5614066|NCT00841633|ischemia|ischemia
5614067|NCT00841633|vasospasm|vasospasm
5614068|NCT00841633|CT|ct
5614069|NCT00841633|perfusion|perfusion
5614070|NCT00841633|induced hypertension|induced hypertension
5614071|NCT00841633|delayed cerebral ischemia|delayed cerebral ischemia
5614072|NCT00841620|Symptoms|symptoms
5614073|NCT00841620|Postoperative pain|postoperative pain
5614074|NCT00841620|Postoperative complications|postoperative complications
5614075|NCT00841620|Milligan|milligan
5614076|NCT00841620|Anopxy|anopxy
5614077|NCT00841607|whipple|whipple
5614078|NCT00841607|pancreas|pancreas
5614079|NCT00841607|reconstruction|reconstruction
5614080|NCT00841607|leak|leak
5614081|NCT00841607|fistula|fistula
5614082|NCT00841594|healthy volunteers|healthy volunteers
5614083|NCT00841581|Age Related Macular Degeneration|age related macular degeneration
5614084|NCT00841581|Pigment Epithelial Detachment|pigment epithelial detachment
5614085|NCT00841581|Intravitreal Detachment|intravitreal detachment
5614086|NCT00841581|Anti-VEGF|anti-vegf
5614087|NCT00841568|ADPKD|adpkd
5614088|NCT00841568|Tolvaptan|tolvaptan
5614089|NCT00841555|adult giant cell glioblastoma|adult giant cell glioblastoma
5614090|NCT00841555|adult gliosarcoma|adult gliosarcoma
5614091|NCT00841555|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5614092|NCT00841555|adult glioblastoma|adult glioblastoma
5614093|NCT00841555|GBM/AA|gbm/aa
5614094|NCT00841542|Bioequivalence|bioequivalence
5614095|NCT00841542|Healthy Subjects|healthy subjects
5614096|NCT00841529|left atrial appendage|left atrial appendage
5614098|NCT00841529|atrial fibrillation|atrial fibrillation
5614099|NCT00841529|AF|af
5614100|NCT00841516|Specific immunotherapy|specific immunotherapy
5614101|NCT00841516|SIT|sit
5614102|NCT00841516|SCIT|scit
5614103|NCT00841516|recombinant|recombinant
5614104|NCT00841516|Type 1 - Allergy|type 1 - allergy
5614105|NCT00841503|functional food study|functional food study
5614106|NCT00841490|Helicobacter pylori|helicobacter pylori
5614107|NCT00841490|Oral Health|oral health
5596696|NCT00904436|Breathing Patterns|breathing patterns
5614108|NCT00841490|Intellectually & Developmentally Disabled|intellectually & developmentally disabled
5614109|NCT00841477|druguser,HB vaccine adherence, HBV, HCV, HIV incidence|druguser,hb vaccine adherence, hbv, hcv, hiv incidence
5614110|NCT00841464|Parkinson's disease|parkinson's disease
5614111|NCT00841464|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5614112|NCT00841451|Atrial Fibrillation|atrial fibrillation
5614113|NCT00841451|Persistent|persistent
5614114|NCT00841451|Paroxysmal|paroxysmal
5614115|NCT00841451|Pulmonary Vein isolation|pulmonary vein isolation
5614116|NCT00841451|Omega three fatty acids|omega three fatty acids
5614117|NCT00841451|Fish Oils|fish oils
5614118|NCT00841438|Angioplasty|angioplasty
5614119|NCT00841438|Transluminal|transluminal
5614120|NCT00841438|Percutaneous Coronary|percutaneous coronary
5614121|NCT00841412|Usual Care Control Group|usual care control group
5614122|NCT00841399|Breast cancer|breast cancer
5614123|NCT00841386|Cornea|cornea
5614124|NCT00841386|Keratoconus|keratoconus
5614125|NCT00841386|Ectasia|ectasia
5614126|NCT00841386|Riboflavin|riboflavin
5614127|NCT00841386|Collagen cross-linking|collagen cross-linking
5614233|NCT00840996|Epidural Anesthetic|epidural anesthetic
5614128|NCT00841373|Retinal ischemia: Iris/Angle Neovascularization|retinal ischemia: iris/angle neovascularization
5614129|NCT00841360|Social network|social network
5614130|NCT00841360|Asymptomatic HIV|asymptomatic hiv
5614131|NCT00841347|Obesity|obesity
5614132|NCT00841347|Glucose metabolism disorders|glucose metabolism disorders
5614133|NCT00841347|Appetite regulation|appetite regulation
5614134|NCT00841347|Sleep|sleep
5614135|NCT00841347|Adolescent|adolescent
5614136|NCT00841347|Randomized controlled trials|randomized controlled trials
5614137|NCT00841334|Adolescent|adolescent
5614138|NCT00841334|Overweight|overweight
5614139|NCT00841334|Obesity|obesity
5614140|NCT00841334|Weight loss|weight loss
5614141|NCT00841334|Nutrition|nutrition
5614142|NCT00841334|Physical activity|physical activity
5614143|NCT00841334|Community-based participatory research|community-based participatory research
5614144|NCT00841334|School-based|school-based
5614145|NCT00841334|Primary Care|primary care
5614146|NCT00841334|Motivational interviewing|motivational interviewing
5614147|NCT00841321|Ginkgo biloba|ginkgo biloba
5614148|NCT00841321|Multiple Sclerosis|multiple sclerosis
5614149|NCT00841321|Cognition|cognition
5614150|NCT00841321|Neuropsychological Tests|neuropsychological tests
5614151|NCT00841321|Neurobehavioral Manifestations|neurobehavioral manifestations
5614152|NCT00841321|Quality of life|quality of life
5614153|NCT00841321|Randomized Controlled Trials|randomized controlled trials
5614154|NCT00841321|Placebos|placebos
5614155|NCT00841321|Double-Blind Method|double-blind method
5614156|NCT00841282|Colorectal cancer screening|colorectal cancer screening
5614157|NCT00841282|Optical colonoscopy|optical colonoscopy
5614158|NCT00841282|Water method|water method
5614159|NCT00841282|Sedation|sedation
5614160|NCT00841269|Bipolar Manic Depression|bipolar manic depression
5614161|NCT00841256|specific immunotherapy|specific immunotherapy
5614163|NCT00841256|SLIT|slit
5614164|NCT00841256|sublingual|sublingual
5614165|NCT00841243|Hepatitis C|hepatitis c
5614166|NCT00841243|Antiviral therapy|antiviral therapy
5614167|NCT00841243|weight loss|weight loss
5614169|NCT00841243|dietary advise|dietary advise
5614170|NCT00841230|Tinnitus|tinnitus
5614171|NCT00841217|Drug treatment|drug treatment
5614172|NCT00841191|Resistant to anti-EGFR|resistant to anti-egfr
5614173|NCT00841191|Interleukin-6|interleukin-6
5614174|NCT00841191|Neoplasms by Histologic Type|neoplasms by histologic type
5614175|NCT00841191|Immunologic Factors|immunologic factors
5614176|NCT00841191|Mol Physiological Effects of Drugs|mol physiological effects of drugs
5614177|NCT00841191|KRAS protein, human|kras protein, human
5614179|NCT00841178|Randomised controlled trial|randomised controlled trial
5614180|NCT00841178|Venous insufficiency|venous insufficiency
5614181|NCT00841178|Varicose veins|varicose veins
5614182|NCT00841178|Quality of Life|quality of life
5614183|NCT00841178|Clinical effectiveness|clinical effectiveness
5614184|NCT00841178|Cost effectiveness|cost effectiveness
5614185|NCT00841165|Carbon Monoxide Toxicity|carbon monoxide toxicity
5614186|NCT00841165|Carbon|carbon
5614187|NCT00841165|Monoxide|monoxide
5614188|NCT00841165|Poisoning|poisoning
5614189|NCT00841165|Toxicity|toxicity
5614190|NCT00841165|Treatment|treatment
5614191|NCT00841165|CPAP|cpap
5614192|NCT00841165|Hyperbaric|hyperbaric
5614193|NCT00841165|Oxygen|oxygen
5614194|NCT00841152|Bone tumors|bone tumors
5614195|NCT00841152|Surgery|surgery
5614196|NCT00841152|Bone graft substitutes|bone graft substitutes
5614197|NCT00841152|Bioactive glass|bioactive glass
5614198|NCT00841152|Bioceramics|bioceramics
5614199|NCT00841152|Bone autograft|bone autograft
5614200|NCT00841152|Bone allograft|bone allograft
5614203|NCT00841139|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5614204|NCT00841139|cardiac energetics|cardiac energetics
5614205|NCT00841126|Hyperphosphatemia|hyperphosphatemia
5614206|NCT00841126|Phosphate binder|phosphate binder
5614207|NCT00841113|Prostate cancer|prostate cancer
5614208|NCT00841113|Advanced|advanced
5614209|NCT00841113|Metastatic|metastatic
5614210|NCT00841100|PKU|pku
5614211|NCT00841100|Kuvan|kuvan
5614212|NCT00841100|BH4|bh4
5614213|NCT00841100|tetrahydrobiopterin|tetrahydrobiopterin
5614214|NCT00841074|Pneumonia|pneumonia
5614215|NCT00841074|Elderly|elderly
5614216|NCT00841074|Chlorhexidine|chlorhexidine
5614217|NCT00841074|Respiratory pathogens|respiratory pathogens
5614218|NCT00841048|Safety and tolerability|safety and tolerability
5614219|NCT00841035|Pancreatic|pancreatic
5614220|NCT00841035|Cancer|cancer
5614221|NCT00841035|Assay|assay
5614222|NCT00841035|Biomarkers|biomarkers
5614223|NCT00841022|anxiety|anxiety
5614224|NCT00841022|anaesthesia|anaesthesia
5614225|NCT00841022|child|child
5614227|NCT00841022|Elective surgery|elective surgery
5614228|NCT00841009|gastric bypass|gastric bypass
5614229|NCT00841009|obesity|obesity
5614230|NCT00840996|Spine Surgery|spine surgery
5614231|NCT00840996|Intraocular pressure|intraocular pressure
5614232|NCT00840996|Lidocaine|lidocaine
5614234|NCT00840983|delayed cord clamping|delayed cord clamping
5614235|NCT00840983|very low birthweight infant|very low birthweight infant
5614236|NCT00840983|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5614237|NCT00840983|intraventricular hemorrhage|intraventricular hemorrhage
5614238|NCT00840983|motor function|motor function
5614239|NCT00840944|gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
5614240|NCT00840944|growth hormone|growth hormone
5614241|NCT00840944|final height|final height
5614242|NCT00840944|bone density|bone density
5614243|NCT00840944|puberty|puberty
5614244|NCT00840931|Myeloid|myeloid
5614245|NCT00840931|Monocytic|monocytic
5614246|NCT00840931|Immunotherapy|immunotherapy
5614247|NCT00840931|Vaccine|vaccine
5614248|NCT00840931|MDS|mds
5614249|NCT00840931|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
5614250|NCT00840918|Cardiac surgery|cardiac surgery
5614251|NCT00840918|Lidocaine|lidocaine
5614252|NCT00840918|Quality of life|quality of life
5614253|NCT00840905|HPV|hpv
5614254|NCT00840879|Bioequivalence|bioequivalence
5614255|NCT00840879|Healthy Subjects|healthy subjects
5614256|NCT00840866|Bioequivalence|bioequivalence
5614257|NCT00840866|Healthy Subjects|healthy subjects
5614258|NCT00840853|Stem cell transplant|stem cell transplant
5614259|NCT00840853|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5614260|NCT00840853|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5614261|NCT00840853|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5614262|NCT00840853|Cytotoxic T lymphocytes|cytotoxic t lymphocytes
5614264|NCT00840853|CD-19|cd-19
5614265|NCT00840853|chimeric receptor|chimeric receptor
5614266|NCT00840840|Bioequivalence|bioequivalence
5614267|NCT00840840|Healthy Subjects|healthy subjects
5614268|NCT00840827|stage (IPSS low and INT-1)|stage (ipss low and int-1)
5614269|NCT00840827|RBC transfusion-dependent|rbc transfusion-dependent
5614270|NCT00840827|non-del 5q MDS|non-del 5q mds
5614271|NCT00840814|lymphedema|lymphedema
5614272|NCT00840814|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5614273|NCT00840814|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5614274|NCT00840814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5614275|NCT00840814|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5614276|NCT00840814|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5614277|NCT00840814|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5614278|NCT00840814|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5614279|NCT00840814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5614280|NCT00840814|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5614281|NCT00840814|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5614282|NCT00840814|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5614283|NCT00840814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5614284|NCT00840814|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5614285|NCT00840814|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5614286|NCT00840814|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5614287|NCT00840814|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5614288|NCT00840814|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5608026|NCT00866541|volunteers|volunteers
5614290|NCT00840814|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5614291|NCT00840814|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5614292|NCT00840814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5614293|NCT00840814|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5614294|NCT00840814|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5614295|NCT00840814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5614296|NCT00840814|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5614297|NCT00840814|stage I salivary gland cancer|stage i salivary gland cancer
5614298|NCT00840814|stage II salivary gland cancer|stage ii salivary gland cancer
5614299|NCT00840814|stage III salivary gland cancer|stage iii salivary gland cancer
5614301|NCT00840788|tissue adhesive|tissue adhesive
5614302|NCT00840788|mediolateral episiotomy|mediolateral episiotomy
5614303|NCT00840788|perineal repair|perineal repair
5614304|NCT00840788|labor and delivery|labor and delivery
5614305|NCT00840788|repair|repair
5614306|NCT00840775|Stent|stent
5614307|NCT00840775|interventional cardiology|interventional cardiology
5614309|NCT00840775|symptomatic ischemic heart disease|symptomatic ischemic heart disease
5614310|NCT00840762|HIV-1|hiv-1
5614312|NCT00840762|HIV Genotypic testing|hiv genotypic testing
5614313|NCT00840762|resistance|resistance
5614314|NCT00840749|STARS|stars
5614315|NCT00840749|Early Stage Non Small Cell Lung Cancer|early stage non small cell lung cancer
5614316|NCT00840749|NSCLC|nsclc
5614317|NCT00840749|CyberKnife|cyberknife
5614318|NCT00840749|Surgery|surgery
5614319|NCT00840749|Accuray|accuray
5614321|NCT00840736|LAGB|lagb
5614322|NCT00840736|long term results|long term results
5614323|NCT00840736|Weight loss|weight loss
5614324|NCT00840736|Complications|complications
5614325|NCT00840736|Reoperations|reoperations
5614326|NCT00840736|Conversion|conversion
5614327|NCT00840723|Healthy smokers|healthy smokers
5614328|NCT00840723|Current cigarette smokers|current cigarette smokers
5614329|NCT00840723|No lung disease|no lung disease
5614330|NCT00840710|women in active labor|women in active labor
5614331|NCT00840697|low back pain|low back pain
5614332|NCT00840697|neck pain|neck pain
5614333|NCT00840697|return to work|return to work
5614334|NCT00840697|exercises|exercises
5614335|NCT00840697|cognitive intervention|cognitive intervention
5614336|NCT00840684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5614337|NCT00840684|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5614338|NCT00840671|Cerebrolysin|cerebrolysin
5614339|NCT00840671|Alteplase|alteplase
5614340|NCT00840671|Ischemic Stroke|ischemic stroke
5614341|NCT00840671|Modified Rankin Scale|modified rankin scale
5614342|NCT00840671|NIH Stroke Scale|nih stroke scale
5614343|NCT00840671|Barthel Index|barthel index
5614344|NCT00840671|Glasgow Outcome Score|glasgow outcome score
5614346|NCT00840658|Injection drug users|injection drug users
5614347|NCT00840658|Female sex workers|female sex workers
5614349|NCT00840658|HIV Seronegativity|hiv seronegativity
5614350|NCT00840645|YM178|ym178
5614351|NCT00840645|Urinary Bladder, Overactive|urinary bladder, overactive
5614352|NCT00840645|Mirabegron|mirabegron
5614353|NCT00840632|Bioequivalence|bioequivalence
5614354|NCT00840632|Healthy Subjects|healthy subjects
5614355|NCT00840606|Bioequivalence|bioequivalence
5614356|NCT00840606|Healthy Subjects|healthy subjects
5614357|NCT00840593|Acromioclavicular Joint|acromioclavicular joint
5614358|NCT00840593|Dislocation|dislocation
5614359|NCT00840593|Trials, Randomized Clinical|trials, randomized clinical
5614360|NCT00840593|Surgical Procedures, Operative|surgical procedures, operative
5614361|NCT00840580|Cataract, Cornea, Vigamox, Cravit|cataract, cornea, vigamox, cravit
5614362|NCT00840567|Stem cells|stem cells
5614363|NCT00840554|Fatigue|fatigue
5614364|NCT00840554|Cancer-related fatigue|cancer-related fatigue
5614365|NCT00840554|High grade glioma|high grade glioma
5614366|NCT00840554|Quality of life|quality of life
5614367|NCT00840554|Exercise|exercise
5614368|NCT00840554|Physical Therapy|physical therapy
5614370|NCT00840554|QOL|qol
5614371|NCT00840528|ozone|ozone
5614372|NCT00840502|malaria|malaria
5614373|NCT00840502|ultrasound|ultrasound
5614374|NCT00840502|pregnancy|pregnancy
5614375|NCT00840502|Pregnant women (infected with malaria and without)|pregnant women (infected with malaria and without)
5614376|NCT00840476|Bioequivalence|bioequivalence
5614377|NCT00840476|Healthy Subjects|healthy subjects
5614378|NCT00840463|Pulmonary Hypertension|pulmonary hypertension
5614379|NCT00840463|Diastolic Heart Failure|diastolic heart failure
5614380|NCT00840450|ovarian cancer|ovarian cancer
5614381|NCT00840450|recurrent|recurrent
5614382|NCT00840450|Gleevec|gleevec
5614383|NCT00840450|Paclitaxel|paclitaxel
5614384|NCT00840450|Taxane|taxane
5614385|NCT00840450|mullerian|mullerian
5614386|NCT00840437|angina|angina
5614387|NCT00840437|health related quality of life|health related quality of life
5614388|NCT00840411|Bioequivalence|bioequivalence
5614389|NCT00840411|Healthy Subjects|healthy subjects
5614390|NCT00840398|Bioequivalence|bioequivalence
5614391|NCT00840398|Healthy Subjects|healthy subjects
5614392|NCT00840385|Peripheral T-cell lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
5614393|NCT00840385|Fludarabine|fludarabine
5614394|NCT00840372|Blunt needles|blunt needles
5614395|NCT00840372|Semi-blunt needles|semi-blunt needles
5614396|NCT00840372|Buttonhole cannulation method|buttonhole cannulation method
5614397|NCT00840359|Cutaneous leishmaniasis|cutaneous leishmaniasis
5614398|NCT00840359|Photodynamic therapy|photodynamic therapy
5614399|NCT00840346|Acute Myeloblastic Leukaemia (AML)|acute myeloblastic leukaemia (aml)
5614400|NCT00840346|Panobinostat|panobinostat
5614401|NCT00840320|Safety|safety
5614402|NCT00840320|tolerability|tolerability
5614403|NCT00840307|Obesity|obesity
5614404|NCT00840307|Type 2 Diabetes|type 2 diabetes
5614405|NCT00840307|Gastric Banding|gastric banding
5614406|NCT00840294|Men with Elevated PSA|men with elevated psa
5614407|NCT00840281|Bioequivalence|bioequivalence
5614408|NCT00840281|Healthy Subjects|healthy subjects
5614409|NCT00840268|OSDI|osdi
5614410|NCT00840268|corneal staining|corneal staining
5614412|NCT00840268|Dry Eye Signs and Symptoms in Dry Eye Patients|dry eye signs and symptoms in dry eye patients
5614505|NCT00839722|leiomyomas|leiomyomas
5614413|NCT00840255|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
5614414|NCT00840229|adhesive capsulitis|adhesive capsulitis
5614415|NCT00840229|corticosteroids|corticosteroids
5614416|NCT00840229|injection|injection
5614417|NCT00840229|pain|pain
5614418|NCT00840216|Bioequivalence|bioequivalence
5614419|NCT00840216|Healthy Subjects|healthy subjects
5614420|NCT00840203|Bioequivalence|bioequivalence
5614421|NCT00840203|Healthy Subjects|healthy subjects
5614422|NCT00840177|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5614423|NCT00840177|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5614424|NCT00840177|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5614425|NCT00840177|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5671704|NCT00614731|scarification|scarification
5614426|NCT00840177|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5614427|NCT00840177|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5614428|NCT00840164|small-fiber sensory neuropathy|small-fiber sensory neuropathy
5614429|NCT00840164|nerve pathology|nerve pathology
5614430|NCT00840164|vasculature pathology|vasculature pathology
5614431|NCT00840164|amputation|amputation
5614432|NCT00840164|diabetic foot wound|diabetic foot wound
5614433|NCT00840164|sensory neuropathy|sensory neuropathy
5614434|NCT00840164|below knee amputation|below knee amputation
5614435|NCT00840151|Substance Abuse|substance abuse
5614436|NCT00840151|Contingency Management|contingency management
5614437|NCT00840125|NSCLC|nsclc
5614438|NCT00840125|ERLOTINIB|erlotinib
5614439|NCT00840125|DOCETAXEL|docetaxel
5614440|NCT00840125|first line treatment|first line treatment
5614441|NCT00840125|Stage IIIB /IV|stage iiib /iv
5614442|NCT00840125|not previously treated|not previously treated
5614443|NCT00840125|ECOG PS 2 or age over 65|ecog ps 2 or age over 65
5614444|NCT00840112|Long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD)|long-chain 3-hydroxyacyl coa dehydrogenase (lchad)
5614445|NCT00840112|Mitochondrial trifunctional protein (TFP)|mitochondrial trifunctional protein (tfp)
5614446|NCT00840112|LCHAD/TFP deficiency with peripheral neuropathy|lchad/tfp deficiency with peripheral neuropathy
5614447|NCT00840099|Bioequivalence|bioequivalence
5614448|NCT00840099|Healthy Subjects|healthy subjects
5614449|NCT00840073|Bioequivalence|bioequivalence
5614450|NCT00840073|Healthy Subjects|healthy subjects
5614451|NCT00840047|Pediatric brain tumor|pediatric brain tumor
5614452|NCT00840047|Pediatric solid tumor|pediatric solid tumor
5614453|NCT00840047|Pediatric solid neoplasms|pediatric solid neoplasms
5614454|NCT00840008|peptic ulcer bleeding|peptic ulcer bleeding
5614455|NCT00840008|upper GI hemorrhage|upper gi hemorrhage
5614456|NCT00840008|adherence to guidelines|adherence to guidelines
5614457|NCT00840008|knowledge transfer|knowledge transfer
5614458|NCT00839995|To determine the efficacy of ROTEM on assessing coagulation profiles.|to determine the efficacy of rotem on assessing coagulation profiles.
5614459|NCT00839969|overactive bladder syndrome|overactive bladder syndrome
5614461|NCT00839969|pressure flow studies|pressure flow studies
5614462|NCT00839969|urethral dilatation|urethral dilatation
5614463|NCT00839943|ozone|ozone
5614464|NCT00839943|clean air|clean air
5614465|NCT00839930|Bioequivalence|bioequivalence
5614466|NCT00839930|Healthy Subjects|healthy subjects
5614467|NCT00839917|Measles|measles
5614468|NCT00839917|Mumps|mumps
5614469|NCT00839917|Rubella|rubella
5614470|NCT00839917|Varicella|varicella
5614471|NCT00839904|children|children
5614472|NCT00839904|cancer|cancer
5614473|NCT00839904|exercise|exercise
5614474|NCT00839904|fitness|fitness
5614475|NCT00839904|body composition|body composition
5614476|NCT00839891|TQT, QTc|tqt, qtc
5614477|NCT00839865|Evidence-based evaluation|evidence-based evaluation
5614478|NCT00839865|Multi-center randomized controlled clinical trials|multi-center randomized controlled clinical trials
5614479|NCT00839865|Traditional Chinese Medicine|traditional chinese medicine
5614480|NCT00839865|therapy|therapy
5614481|NCT00839865|diabetic foot ulcer|diabetic foot ulcer
5614482|NCT00839865|clinical trails|clinical trails
5614483|NCT00839839|infertility|infertility
5614484|NCT00839839|egg freezing|egg freezing
5614485|NCT00839839|fertility preservation|fertility preservation
5597108|NCT00902759|Radiation Therapy|radiation therapy
5614486|NCT00839826|Prevention of Thromboembolism after total hip replacement|prevention of thromboembolism after total hip replacement
5614487|NCT00839813|Yoga|yoga
5614488|NCT00839813|Posttraumatic Stress Disorder|posttraumatic stress disorder
5614489|NCT00839813|PTSD|ptsd
5614490|NCT00839813|women's health|women's health
5614491|NCT00839800|Asthma|asthma
5614492|NCT00839800|Symbicort Turbuhaler|symbicort turbuhaler
5614493|NCT00839774|Peas|peas
5614494|NCT00839774|Cardiovascular|cardiovascular
5614495|NCT00839774|Diabetes|diabetes
5614496|NCT00839774|Insulin|insulin
5614497|NCT00839774|Insulin resistance|insulin resistance
5614498|NCT00839774|Abdominal fat|abdominal fat
5614499|NCT00839748|asthma|asthma
5614500|NCT00839748|registry for future asthmatic studies|registry for future asthmatic studies
5614501|NCT00839748|questionnaires|questionnaires
5614502|NCT00839748|lung function tests|lung function tests
5614503|NCT00839735|COPD|copd
5614504|NCT00839722|Uterine embolization|uterine embolization
5614506|NCT00839722|fertility|fertility
5614507|NCT00839722|myomectomies|myomectomies
5614508|NCT00839709|liver disease|liver disease
5614509|NCT00839709|liver transplantation|liver transplantation
5614510|NCT00839709|depletion immunosuppression|depletion immunosuppression
5614511|NCT00839709|non-depletion immunosuppression|non-depletion immunosuppression
5614512|NCT00839696|Breast|breast
5614513|NCT00839696|Estrogens|estrogens
5614514|NCT00839696|Mammography|mammography
5614515|NCT00839670|1- Constraint induced therapy|1- constraint induced therapy
5614516|NCT00839670|2- Stroke|2- stroke
5614517|NCT00839670|3- Upper limb|3- upper limb
5614518|NCT00839670|4- Rehabilitation|4- rehabilitation
5614519|NCT00839670|5- Motor training|5- motor training
5614520|NCT00839670|1- First time clinical ischemic or hemorrhagic stroke|1- first time clinical ischemic or hemorrhagic stroke
5614521|NCT00839670|2- At least 10° of active wrist extension|2- at least 10° of active wrist extension
5614522|NCT00839670|3- At least 10° of thumb abduction/ extension|3- at least 10° of thumb abduction/ extension
5614523|NCT00839670|4- At least 10° of extension in at least 2 additional digits|4- at least 10° of extension in at least 2 additional digits
5614524|NCT00839670|3- Adequate balance while wearing the restraint.|3- adequate balance while wearing the restraint.
5614525|NCT00839657|Embolism|embolism
5614526|NCT00839657|Thrombosis|thrombosis
5614527|NCT00839644|cystic fibrosis|cystic fibrosis
5614528|NCT00839644|Chest Wall Oscillation|chest wall oscillation
5614529|NCT00839644|drainage, postural|drainage, postural
5614530|NCT00839644|Medication Adherence|medication adherence
5614531|NCT00839644|patient dropouts|patient dropouts
5614532|NCT00839631|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.|subjects with advanced solid tumors refractory to standard therapy or for whom no effective therapy is available.
5614533|NCT00839605|Thoracic surgery one lung ventilation|thoracic surgery one lung ventilation
5614534|NCT00839605|airway reconstruction|airway reconstruction
5614535|NCT00839592|Insomnia|insomnia
5614536|NCT00839592|Acupuncture|acupuncture
5614537|NCT00839592|Electroacupuncture|electroacupuncture
5614538|NCT00839592|Randomized Clinical Trial|randomized clinical trial
5614539|NCT00839592|Traditional Chinese Medicine|traditional chinese medicine
5614540|NCT00839579|slightly overweight|slightly overweight
5614541|NCT00839579|males 35-45 years|males 35-45 years
5614542|NCT00839566|Atrial Fibrillation|atrial fibrillation
5614543|NCT00839566|Heart Failure|heart failure
5614544|NCT00839540|candidemia|candidemia
5614545|NCT00839540|echinocandin|echinocandin
5614546|NCT00839540|micafungin|micafungin
5614547|NCT00839540|caspofungin|caspofungin
5614548|NCT00839527|diabetes|diabetes
5614549|NCT00839514|Parkinson's disease|parkinson's disease
5614550|NCT00839514|Trichloroethylene|trichloroethylene
5614551|NCT00839488|pantoprazole|pantoprazole
5614552|NCT00839488|famotidine|famotidine
5614553|NCT00839488|stomach ulcer|stomach ulcer
5614554|NCT00839488|digestive system surgical procedure|digestive system surgical procedure
5614555|NCT00839475|colposcopy|colposcopy
5614556|NCT00839475|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5614557|NCT00839475|cervical cancer|cervical cancer
5614558|NCT00839475|cervical precancer|cervical precancer
5614559|NCT00839462|Thermal Erythema|thermal erythema
5614560|NCT00839462|Dexpanthenol|dexpanthenol
5614561|NCT00839462|Erythema|erythema
5614562|NCT00839462|Efficacy|efficacy
5614563|NCT00839449|subarachnoid hemorrhage|subarachnoid hemorrhage
5614564|NCT00839449|cerebral vasospasm|cerebral vasospasm
5614565|NCT00839449|eicosapentaenoic acid|eicosapentaenoic acid
5614566|NCT00839436|Idiopathic CD4+ T-Lymphocytopenia|idiopathic cd4+ t-lymphocytopenia
5614568|NCT00839436|Clinical Trial|clinical trial
5614569|NCT00839436|T-Lymphocytes|t-lymphocytes
5614570|NCT00839436|Idiopathic CD4 Lymphocytopenia (ICL)|idiopathic cd4 lymphocytopenia (icl)
5614572|NCT00839423|Major depressive disorder|major depressive disorder
5614573|NCT00839423|Placebo-controlled|placebo-controlled
5614574|NCT00839423|Active reference|active reference
5614575|NCT00839423|Multicenter study|multicenter study
5614576|NCT00839423|Randomised study|randomised study
5614577|NCT00839423|Acute treatment|acute treatment
5614578|NCT00839410|skin cancer|skin cancer
5614579|NCT00839410|melanoma|melanoma
5614580|NCT00839410|sentinel lymph node biopsy|sentinel lymph node biopsy
5614581|NCT00839410|bio bank|bio bank
5614582|NCT00839410|genetic polymorphism|genetic polymorphism
5614583|NCT00839410|prospective cohort|prospective cohort
5614584|NCT00839410|cohort|cohort
5614585|NCT00839410|sentinel lymph nodes|sentinel lymph nodes
5614586|NCT00839410|tissue samples|tissue samples
5614587|NCT00839371|bispectral analysis|bispectral analysis
5614588|NCT00839371|bronchoscopy|bronchoscopy
5614590|NCT00839371|propofol|propofol
5614591|NCT00839371|recovery|recovery
5614592|NCT00839371|sedation|sedation
5614593|NCT00839358|cirrhosis|cirrhosis
5614594|NCT00839358|renal failure|renal failure
5614595|NCT00839358|midodrine|midodrine
5614596|NCT00839358|albumine|albumine
5614597|NCT00839345|platelet|platelet
5614598|NCT00839345|clopidogrel|clopidogrel
5614599|NCT00839345|VerifyNow|verifynow
5614600|NCT00839345|ticlopidine|ticlopidine
5614601|NCT00839345|thrombosis|thrombosis
5614602|NCT00839332|Pancreas|pancreas
5614603|NCT00839332|metastatic cancer|metastatic cancer
5614604|NCT00839332|advanced cancer|advanced cancer
5614605|NCT00839332|Pancreatic cancer|pancreatic cancer
5614606|NCT00839319|hCG|hcg
5614607|NCT00839319|testosterone|testosterone
5614608|NCT00839319|Acyline|acyline
5614609|NCT00839319|Intratesticular hormone|intratesticular hormone
5614610|NCT00839306|Gastroesophageal|gastroesophageal
5614611|NCT00839306|Reflux|reflux
5614612|NCT00839306|Disease|disease
5614613|NCT00839306|GERD|gerd
5614614|NCT00839293|Bioavailability|bioavailability
5614615|NCT00839280|Dry skin|dry skin
5614616|NCT00839280|Dexpanthenol|dexpanthenol
5614617|NCT00839280|Moisturizing effect|moisturizing effect
5614618|NCT00839267|platelet|platelet
5614619|NCT00839267|VASP|vasp
5614620|NCT00839267|clopidogrel|clopidogrel
5614621|NCT00839267|cardiogenic shock|cardiogenic shock
5614622|NCT00839267|myocardial infarction|myocardial infarction
5614623|NCT00839267|percutaneous coronary intervention|percutaneous coronary intervention
5614624|NCT00839254|Streptococcus pneumoniae|streptococcus pneumoniae
5614625|NCT00839254|acute otitis media|acute otitis media
5614626|NCT00839254|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5614627|NCT00839254|nasopharyngeal carriage|nasopharyngeal carriage
5614628|NCT00839254|Haemophilus influenzae|haemophilus influenzae
5614629|NCT00839254|immunogenicity|immunogenicity
5614630|NCT00839254|invasive disease|invasive disease
5614631|NCT00839228|diastolic dysfunction|diastolic dysfunction
5614632|NCT00839228|cardiac energetics|cardiac energetics
5614633|NCT00839228|perhexiline|perhexiline
5614634|NCT00839228|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5614635|NCT00839202|factor VIII|factor viii
5614636|NCT00839202|hemophilia A|hemophilia a
5614637|NCT00839202|assay|assay
5614638|NCT00839189|CCRE|ccre
5614639|NCT00839189|endotoxin|endotoxin
5614642|NCT00839189|allergies|allergies
5614643|NCT00839189|allergic rhinitis|allergic rhinitis
5614644|NCT00839176|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5614645|NCT00839176|Serdaxin|serdaxin
5614647|NCT00839163|Embolism and Thrombosis|embolism and thrombosis
5614648|NCT00839163|Pulmonary embolism|pulmonary embolism
5614649|NCT00839163|Embolism|embolism
5614650|NCT00839163|Thrombosis|thrombosis
5614651|NCT00839150|Diabetic retinopathy|diabetic retinopathy
5614652|NCT00839150|Color vision|color vision
5614653|NCT00839150|Contrast sensitivity|contrast sensitivity
5614654|NCT00839150|Electroretinogram|electroretinogram
5614655|NCT00839150|Flicker-induced vasodilatation|flicker-induced vasodilatation
5614656|NCT00839150|Dynamic Vessel Analyzer|dynamic vessel analyzer
5614657|NCT00839137|asthma|asthma
5614658|NCT00839137|exercise therapy|exercise therapy
5614659|NCT00839124|normal volunteer|normal volunteer
5614660|NCT00839124|healthy control volunteer|healthy control volunteer
5614661|NCT00839124|healthy subjects|healthy subjects
5614662|NCT00839124|asthma|asthma
5614663|NCT00839124|allergy|allergy
5614664|NCT00839124|allergic asthma|allergic asthma
5614665|NCT00839111|Progression free survival|progression free survival
5614666|NCT00839111|Toxicity|toxicity
5614667|NCT00839111|Response rate|response rate
5614668|NCT00839111|overall survival|overall survival
5614669|NCT00839098|power wheelchairs|power wheelchairs
5614670|NCT00839098|assistive technology|assistive technology
5614671|NCT00839098|rehabilitation|rehabilitation
5614672|NCT00839085|CABG|cabg
5614673|NCT00839085|on pump|on pump
5614686|NCT00839046|Indoor Particulate Matter|indoor particulate matter
5614687|NCT00839033|Cough assisted device|cough assisted device
5614688|NCT00839033|Neuromuscular disease|neuromuscular disease
5614689|NCT00839033|Respiratory exacerbation|respiratory exacerbation
5614690|NCT00839033|Invasive ventilation,|invasive ventilation,
5614691|NCT00839033|Chest physiotherapy|chest physiotherapy
5614692|NCT00839033|Congenital myopathies|congenital myopathies
5614693|NCT00839020|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5614694|NCT00839020|Range of Motion|range of motion
5614695|NCT00839020|Articular Arthroplasty, Replacement, Knee|articular arthroplasty, replacement, knee
5614696|NCT00839007|ADHF|adhf
5614697|NCT00839007|AHF|ahf
5614698|NCT00839007|HF|hf
5614699|NCT00838994|Insomnia|insomnia
5614700|NCT00838994|Depression|depression
5614701|NCT00838994|Electroacupuncture|electroacupuncture
5614702|NCT00838994|Acupuncture|acupuncture
5614703|NCT00838994|Randomized Clinical Trial|randomized clinical trial
5614704|NCT00838994|Traditional Chinese Medicine|traditional chinese medicine
5614705|NCT00838981|Treatment for addiction|treatment for addiction
5614706|NCT00838981|Methadone given for opioid dependence|methadone given for opioid dependence
5614707|NCT00838981|Cocaine|cocaine
5614708|NCT00838981|Opiates|opiates
5614709|NCT00838968|hepatocellular carcinoma|hepatocellular carcinoma
5614710|NCT00838968|interferon-alpha|interferon-alpha
5614711|NCT00838968|p48|p48
5614712|NCT00838955|Hodgkin's lymphoma|hodgkin's lymphoma
5614713|NCT00838955|relapsed Hodgkin's lymphoma|relapsed hodgkin's lymphoma
5614714|NCT00838955|refractory Hodgkin's lymphoma|refractory hodgkin's lymphoma
5801308|NCT00102752|Solid|solid
5614715|NCT00838955|Temsirolimus|temsirolimus
5614716|NCT00838942|Eyes disease and dementia.|eyes disease and dementia.
5614717|NCT00838942|Cataract surgery in the patient with dementia.|cataract surgery in the patient with dementia.
5614718|NCT00838942|Visual hallucinations|visual hallucinations
5614719|NCT00838942|Visual acuity,|visual acuity,
5614720|NCT00838942|Specific eye pathologies in Alzheimer's disease.|specific eye pathologies in alzheimer's disease.
5614721|NCT00838942|Improvement of behaviour,|improvement of behaviour,
5614722|NCT00838942|Improvement of autonomy|improvement of autonomy
5614723|NCT00838942|Improvement of mood|improvement of mood
5614724|NCT00838942|Cataract extraction in Alzheimer disease patient|cataract extraction in alzheimer disease patient
5614725|NCT00838929|brain metastases|brain metastases
5614726|NCT00838929|radiation|radiation
5614727|NCT00838929|vorinostat|vorinostat
5614728|NCT00838929|lung cancer|lung cancer
5614729|NCT00838929|breast cancer|breast cancer
5614730|NCT00838916|diabetes|diabetes
5614731|NCT00838903|diabetes|diabetes
5614732|NCT00838877|Alzheimer's Disease|alzheimer's disease
5614733|NCT00838877|PET|pet
5614734|NCT00838877|Phase 1|phase 1
5614735|NCT00838877|Positron Emission Tomography|positron emission tomography
5614736|NCT00838864|variceal bleeding|variceal bleeding
5614737|NCT00838864|antibiotic prophylaxis|antibiotic prophylaxis
5614738|NCT00838864|ceftrioxone|ceftrioxone
5614739|NCT00838851|endotoxin|endotoxin
5614740|NCT00838851|CCRE|ccre
5614742|NCT00838838|Testosterone replacement therapy|testosterone replacement therapy
5614743|NCT00838838|Hypogonadism|hypogonadism
5614744|NCT00838838|Osteoporosis|osteoporosis
5614745|NCT00838838|Immobilisation|immobilisation
5614746|NCT00838838|Paraplegia|paraplegia
5614747|NCT00838838|Testosterone|testosterone
5614748|NCT00838825|diabetes|diabetes
5614749|NCT00838825|chronic care management|chronic care management
5614750|NCT00838825|resource utilization|resource utilization
5614751|NCT00838825|outcome|outcome
5614752|NCT00838825|glycohemoglobin|glycohemoglobin
5614753|NCT00838825|hospitalization|hospitalization
5614754|NCT00838812|clindamycin|clindamycin
5614755|NCT00838812|tretinoin|tretinoin
5614756|NCT00838812|acne vulgaris|acne vulgaris
5614757|NCT00838812|Acne vulgaris mild to moderate|acne vulgaris mild to moderate
5614758|NCT00838799|diabetic|diabetic
5614759|NCT00838799|peripheral|peripheral
5614763|NCT00838799|diabetes|diabetes
5614764|NCT00838760|PEPI-TiDP23-C103|pepi-tidp23-c103
5614765|NCT00838760|PEPI-C103|pepi-c103
5614766|NCT00838760|PEPI|pepi
5614767|NCT00838760|TMC558445|tmc558445
5614768|NCT00838760|TMC310911|tmc310911
5614769|NCT00838760|Darunavir, Healthy volunteers|darunavir, healthy volunteers
5614770|NCT00838760|Pharmacokinetics|pharmacokinetics
5614771|NCT00838760|HIV Infections|hiv infections
5614772|NCT00838747|folate receptor|folate receptor
5614773|NCT00838747|blood samples|blood samples
5614774|NCT00838747|ovarian cancer|ovarian cancer
5614775|NCT00838747|development of measure of folate receptor in blood samples|development of measure of folate receptor in blood samples
5614776|NCT00838747|possible selection of patients for treatment with FR targeted agents|possible selection of patients for treatment with fr targeted agents
5614777|NCT00838734|CORNEAL TOPOGRAPHY|corneal topography
5614778|NCT00838734|KERATOPLASTY|keratoplasty
5614779|NCT00838721|Open Angle Glaucoma|open angle glaucoma
5614780|NCT00838721|Ocular Hypertension|ocular hypertension
5614781|NCT00838721|Laser Trabeculoplasty|laser trabeculoplasty
5614782|NCT00838695|Hand vein sensitivity|hand vein sensitivity
5614783|NCT00838695|phenylephrine|phenylephrine
5614784|NCT00838695|nitroglycerin|nitroglycerin
5614785|NCT00838682|peptic ulcer bleeding|peptic ulcer bleeding
5614786|NCT00838682|rabeprazole|rabeprazole
5614787|NCT00838682|proton pump inhibitor|proton pump inhibitor
5614788|NCT00838669|Schizophrenia|schizophrenia
5614789|NCT00838669|Mood disorders|mood disorders
5614790|NCT00838669|Antipsychotic drugs|antipsychotic drugs
5597455|NCT00901407|depression|depression
5614791|NCT00838669|Extended release OROS paliperidone|extended release oros paliperidone
5614792|NCT00838656|ovarian carcinosarcoma|ovarian carcinosarcoma
5614793|NCT00838656|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5614794|NCT00838656|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5614795|NCT00838656|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5614796|NCT00838656|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5614797|NCT00838656|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5614892|NCT00838357|Lymphoma|lymphoma
5614801|NCT00838656|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5614802|NCT00838656|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5614803|NCT00838656|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5614804|NCT00838656|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5614805|NCT00838643|allogeneic transplantation|allogeneic transplantation
5614806|NCT00838643|Invasive aspergillosis|invasive aspergillosis
5801448|NCT00102336|ITP|itp
5614807|NCT00838630|Bioequivalence|bioequivalence
5614808|NCT00838630|Healthy Subjects|healthy subjects
5614809|NCT00838617|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5614810|NCT00838617|Ultrasonography|ultrasonography
5614811|NCT00838617|Atrophy|atrophy
5614812|NCT00838591|MN-221|mn-221
5614813|NCT00838591|Asthma|asthma
5614814|NCT00838591|Acute|acute
5614815|NCT00838591|Exacerbation|exacerbation
5614816|NCT00838578|KRN330|krn330
5614817|NCT00838578|Colorectal Cancer|colorectal cancer
5614818|NCT00838578|Antimetabolites|antimetabolites
5614819|NCT00838578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic
5614820|NCT00838578|Digestive System Neoplasms|digestive system neoplasms
5614821|NCT00838578|Immunologic Factors|immunologic factors
5614822|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5614823|NCT00838578|Antineoplastic Agents|antineoplastic agents
5614824|NCT00838578|Gastrointestinal Diseases|gastrointestinal diseases
5614825|NCT00838578|Physiological Effects of Drugs|physiological effects of drugs
5614826|NCT00838578|Colonic Diseases|colonic diseases
5614827|NCT00838578|Irinotecan|irinotecan
5614828|NCT00838578|Enzyme Inhibitors|enzyme inhibitors
5614829|NCT00838578|Intestinal Diseases|intestinal diseases
5614830|NCT00838578|Immunosuppressive Agents|immunosuppressive agents
5614832|NCT00838578|Pharmacologic Actions|pharmacologic actions
5614833|NCT00838578|Intestinal Neoplasms|intestinal neoplasms
5614834|NCT00838578|Neoplasms by Site|neoplasms by site
5614835|NCT00838578|Digestive System Diseases|digestive system diseases
5614836|NCT00838578|Therapeutic Uses|therapeutic uses
5614837|NCT00838578|Fluorouracil|fluorouracil
5614838|NCT00838578|Neoplasms|neoplasms
5614839|NCT00838578|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5614840|NCT00838578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5614841|NCT00838578|Colorectal Neoplasms|colorectal neoplasms
5614842|NCT00838565|Safety and tolerability Pharmacokinetics Pharmacodynamics PF-04236921|safety and tolerability pharmacokinetics pharmacodynamics pf-04236921
5614843|NCT00838552|asthma inflammation bronchoscopy|asthma inflammation bronchoscopy
5614844|NCT00838539|Neratinib|neratinib
5614845|NCT00838539|solid tumors|solid tumors
5614847|NCT00838539|dose finding study|dose finding study
5614848|NCT00838539|HKI-272|hki-272
5614849|NCT00838539|Nerlynx|nerlynx
5614850|NCT00838539|Temsirolimus|temsirolimus
5614851|NCT00838539|PB-272|pb-272
5614858|NCT00838500|Leg ulcer|leg ulcer
5614859|NCT00838500|balneology|balneology
5614860|NCT00838500|hydrotherapy|hydrotherapy
5614861|NCT00838500|Modified Rutherford score|modified rutherford score
5614862|NCT00838500|Euroquol EQ 5d scale|euroquol eq 5d scale
5614863|NCT00838500|CIVIQ2 scale|civiq2 scale
5614864|NCT00838500|Visual analogic Scale|visual analogic scale
5614865|NCT00838500|SPA treatment|spa treatment
5614866|NCT00838487|chondroitin|chondroitin
5614867|NCT00838487|glucosamine|glucosamine
5614868|NCT00838487|osteoarthritis|osteoarthritis
5614869|NCT00838474|metabolic rate|metabolic rate
5614870|NCT00838474|music|music
5614871|NCT00838474|preterm infants|preterm infants
5614872|NCT00838474|energy expenditure|energy expenditure
5614873|NCT00838474|NIDCA|nidca
5614874|NCT00838448|exercise|exercise
5614875|NCT00838448|cannabis use|cannabis use
5614876|NCT00838448|visual cues|visual cues
5614884|NCT00838383|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-CPB|multi-center, placebo-controlled, randomized study of sitaxsentan administered to subjects post-cross-clamp release and 12 hours post-cpb
5614885|NCT00838370|Pharmacogenetics|pharmacogenetics
5614886|NCT00838370|cost-benefit analysis|cost-benefit analysis
5614887|NCT00838370|toxicity|toxicity
5614888|NCT00838370|antineoplastic drugs|antineoplastic drugs
5614889|NCT00838370|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5614890|NCT00838357|Mobilisation stem cells|mobilisation stem cells
5614891|NCT00838357|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
5614893|NCT00838357|Multiple Myeloma|multiple myeloma
5614894|NCT00838344|medication adherence|medication adherence
5614895|NCT00838344|medication persistence|medication persistence
5597552|NCT00901082|anxiety|anxiety
5614896|NCT00838344|pharmacist interventions|pharmacist interventions
5614897|NCT00838344|diabetes|diabetes
5614898|NCT00838344|persistence|persistence
5614899|NCT00838344|adherence|adherence
5614900|NCT00838331|Blood Transfusions|blood transfusions
5614901|NCT00838318|Colorectal CancerScreening|colorectal cancerscreening
5614902|NCT00838318|CRC|crc
5614903|NCT00838318|Hispanic|hispanic
5614904|NCT00838318|CRC Patients|crc patients
5614905|NCT00838318|First-Degree Relatives|first-degree relatives
5614906|NCT00838318|FDRs|fdrs
5614907|NCT00838318|Interviews|interviews
5614908|NCT00838318|Colorectal cancer screening|colorectal cancer screening
5614910|NCT00838318|Key Informants|key informants
5614911|NCT00838305|MDMA|mdma
5614912|NCT00838305|citalopram|citalopram
5614913|NCT00838305|serotonin|serotonin
5614914|NCT00838305|psychedelic|psychedelic
5614915|NCT00838292|food supplementation|food supplementation
5614916|NCT00838292|HIV|hiv
5614917|NCT00838292|malnutrition|malnutrition
5614918|NCT00838279|Bioequivalence|bioequivalence
5614919|NCT00838279|Healthy Subjects|healthy subjects
5614920|NCT00838266|mouthrinse|mouthrinse
5614921|NCT00838266|grape seed extract|grape seed extract
5614922|NCT00838266|fluor|fluor
5614923|NCT00838266|plaque index|plaque index
5614924|NCT00838253|Acute Heart Failure|acute heart failure
5614925|NCT00838253|Inotropes|inotropes
5614926|NCT00838253|Lusitropic agents|lusitropic agents
5614927|NCT00838253|Istaroxime|istaroxime
5614928|NCT00838253|Debio 0614|debio 0614
5614929|NCT00838240|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5614930|NCT00838240|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5617513|NCT00827476|ovary|ovary
5798766|NCT00111163|antimalarials|antimalarials
5614931|NCT00838240|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5614932|NCT00838240|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5614933|NCT00838240|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5614934|NCT00838240|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5614935|NCT00838240|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5614936|NCT00838240|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5614937|NCT00838240|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5614938|NCT00838240|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5614939|NCT00838240|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5614940|NCT00838240|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5614941|NCT00838240|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5614942|NCT00838240|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5608710|NCT00863655|ER+|er+
5614945|NCT00838227|Schizophrenia|schizophrenia
5614946|NCT00838227|Cognition|cognition
5614947|NCT00838227|Obesity|obesity
5614948|NCT00838227|Sedation|sedation
5614949|NCT00838201|Androgen deprivation therapy for non-metastatic prostate cancer|androgen deprivation therapy for non-metastatic prostate cancer
5614950|NCT00838188|Metabolic rate|metabolic rate
5614951|NCT00838188|indirect calorimetry|indirect calorimetry
5614952|NCT00838188|oral feeding|oral feeding
5614953|NCT00838175|Peripheral Venous Catheterization|peripheral venous catheterization
5614954|NCT00838162|Human immunodeficiency virus type 1|human immunodeficiency virus type 1
5614955|NCT00838162|HIV-1|hiv-1
5614956|NCT00838162|HIV-1 treatment-naive|hiv-1 treatment-naive
5614957|NCT00838162|TMC310911|tmc310911
5614958|NCT00838162|Protease inhibitor|protease inhibitor
5614959|NCT00838162|Ritonavir|ritonavir
5614960|NCT00838162|Antiviral Activity|antiviral activity
5614961|NCT00838162|HIV Infections|hiv infections
5614962|NCT00838162|Treatment Naive|treatment naive
5614963|NCT00838136|Bioequivalence|bioequivalence
5614964|NCT00838136|Healthy Subjects|healthy subjects
5614965|NCT00838110|Alzheimer's Disease|alzheimer's disease
5614966|NCT00838110|Dimebon|dimebon
5614967|NCT00838110|Safety|safety
5614968|NCT00838110|Tolerability|tolerability
5614969|NCT00838097|CKD|ckd
5614970|NCT00838097|Paediatric|paediatric
5614971|NCT00838097|Darbepoetin Alfa|darbepoetin alfa
5614972|NCT00838071|Hepatitis B|hepatitis b
5614973|NCT00838071|HBV|hbv
5614974|NCT00838071|Anti-hepatitis B antibodies|anti-hepatitis b antibodies
5614975|NCT00838071|Immunoglobulins|immunoglobulins
5614976|NCT00838071|liver transplantation|liver transplantation
5614977|NCT00838071|Protective levels|protective levels
5614978|NCT00838071|Recurrence|recurrence
5614979|NCT00838071|Intravenous|intravenous
5614980|NCT00838058|pharmacology formulation normal healthy volunteers food effect|pharmacology formulation normal healthy volunteers food effect
5614981|NCT00838032|acute schizophrenic patients|acute schizophrenic patients
5614982|NCT00838006|post-traumatic stress disorder|post-traumatic stress disorder
5614983|NCT00838006|post-deployment|post-deployment
5614986|NCT00837993|Advanced Stage Serous Carcinoma of the Ovary|advanced stage serous carcinoma of the ovary
5614987|NCT00837993|serous ovarian carcinoma|serous ovarian carcinoma
5614988|NCT00837993|Ovary|ovary
5614989|NCT00837993|GOG Protocol 158|gog protocol 158
5614990|NCT00837993|Survival Analysis|survival analysis
5614991|NCT00837993|Pathology Slides|pathology slides
5614992|NCT00837993|Two-tier Grading System|two-tier grading system
5614993|NCT00837993|Ancillary Study|ancillary study
5614994|NCT00837980|head and neck cancer|head and neck cancer
5614995|NCT00837980|DW MRI|dw mri
5614996|NCT00837980|PET|pet
5614997|NCT00837980|DCE MRI|dce mri
5614998|NCT00837980|functional imaging|functional imaging
5615000|NCT00837967|Asthma|asthma
5615001|NCT00837967|Symbicort Turbuhaler|symbicort turbuhaler
5615003|NCT00837954|Suture Hole Bleeding|suture hole bleeding
5615004|NCT00837954|Hemostasis|hemostasis
5615005|NCT00837928|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5615006|NCT00837928|tumors metastatic to brain|tumors metastatic to brain
5615007|NCT00837915|Bioequivaelnce Loratadine 10mg /Pseudoephedrine Sulfate 240 mg Extended Release Tablets|bioequivaelnce loratadine 10mg /pseudoephedrine sulfate 240 mg extended release tablets
5615008|NCT00837902|Atenolol|atenolol
5615009|NCT00837902|Exercise|exercise
5615010|NCT00837902|Genotype|genotype
5615011|NCT00837902|Healthy volunteers|healthy volunteers
5615012|NCT00837889|cognition|cognition
5615013|NCT00837889|decompensation|decompensation
5615014|NCT00837889|heart failure|heart failure
5615015|NCT00837889|recompensation|recompensation
5615016|NCT00837876|recurrent pancreatic cancer|recurrent pancreatic cancer
5615017|NCT00837876|stage III pancreatic cancer|stage iii pancreatic cancer
5615018|NCT00837876|stage IV pancreatic cancer|stage iv pancreatic cancer
5615019|NCT00837876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5615020|NCT00837850|total hip arthroplasty|total hip arthroplasty
5615021|NCT00837850|Charnley stem|charnley stem
5615022|NCT00837850|RSA|rsa
5615023|NCT00837850|non-inflammatory arthritis|non-inflammatory arthritis
5615024|NCT00837837|pharmacokinetics|pharmacokinetics
5615025|NCT00837837|children|children
5615026|NCT00837837|adolescents|adolescents
5615027|NCT00837837|antihistamine|antihistamine
5615028|NCT00837824|Fabry Disease patients with Severe Renal Disease|fabry disease patients with severe renal disease
5615029|NCT00837811|Arthritis|arthritis
5615030|NCT00837772|Alignment|alignment
5615031|NCT00837759|Type I Diabetes|type i diabetes
5615032|NCT00837759|Preserve Beta Cell Function|preserve beta cell function
5615033|NCT00837759|Sitagliptin|sitagliptin
5615034|NCT00837759|Lansoprazole|lansoprazole
5615035|NCT00837759|GAD65 (Diamyd)|gad65 (diamyd)
5615036|NCT00837759|Diabetes|diabetes
5615037|NCT00837759|Type 1 Diabetes|type 1 diabetes
5615038|NCT00837759|T1DM|t1dm
5615040|NCT00837733|IVF/ICSI|ivf/icsi
5615041|NCT00837733|Pregnancy outcome|pregnancy outcome
5615042|NCT00837733|Recurrent implantation failure|recurrent implantation failure
5615043|NCT00837720|hypertension|hypertension
5615044|NCT00837720|blood pressure|blood pressure
5615045|NCT00837720|Atacand®|atacand®
5615046|NCT00837720|candesartan|candesartan
5615047|NCT00837707|aripiprazole|aripiprazole
5615048|NCT00837707|Tardive Dyskinesia|tardive dyskinesia
5615049|NCT00837694|BMI|bmi
5615050|NCT00837694|obesity|obesity
5615051|NCT00837694|sensitization|sensitization
5615052|NCT00837694|food reinforcement|food reinforcement
5615053|NCT00837694|snack food|snack food
5615054|NCT00837694|Portion size of daily snacks|portion size of daily snacks
5615055|NCT00837694|Weight status|weight status
5615056|NCT00837681|Bone Marrow Transplant|bone marrow transplant
5615057|NCT00837681|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5615058|NCT00837668|sarcoidosis|sarcoidosis
5615059|NCT00837668|stromal gene expression|stromal gene expression
5615060|NCT00837668|pulmonary sarcoidosis|pulmonary sarcoidosis
5615061|NCT00837668|bronchoscopy|bronchoscopy
5615062|NCT00837655|Chronic kidney disease|chronic kidney disease
5615063|NCT00837655|End-stage renal disease|end-stage renal disease
5615064|NCT00837655|phosphate binder|phosphate binder
5615065|NCT00837655|insulin resistance|insulin resistance
5615066|NCT00837655|glucose intolerance|glucose intolerance
5615067|NCT00837655|sevelamer|sevelamer
5615317|NCT00836641|preschool asthma|preschool asthma
5615069|NCT00837629|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5615070|NCT00837629|COPD|copd
5615071|NCT00837629|Symbicort Turbuhaler|symbicort turbuhaler
5615072|NCT00837616|Turner Syndrome|turner syndrome
5615073|NCT00837616|Hypogonadism|hypogonadism
5615074|NCT00837616|GH|gh
5615075|NCT00837616|Estrogen|estrogen
5615076|NCT00837616|Estrogen Patches|estrogen patches
5615077|NCT00837616|IGF-I|igf-i
5615078|NCT00837616|Body Composition|body composition
5615079|NCT00837616|Protein Metabolism|protein metabolism
5615080|NCT00837616|Lipid Oxidation|lipid oxidation
5615081|NCT00837616|Estradiol assay by LCMSMS|estradiol assay by lcmsms
5615082|NCT00837616|Recombinant Cell Bioassay|recombinant cell bioassay
5615083|NCT00837603|tga|tga
5615084|NCT00837603|atrial switch|atrial switch
5615085|NCT00837603|training|training
5615086|NCT00837590|Vascular function|vascular function
5615087|NCT00837590|Glucose tolerance|glucose tolerance
5615088|NCT00837590|Obesity|obesity
5615089|NCT00837590|Pre-diabetes|pre-diabetes
5615090|NCT00837564|chronic depression|chronic depression
5615091|NCT00837564|CBASP|cbasp
5615092|NCT00837564|Escitalopram|escitalopram
5615093|NCT00837564|depression|depression
5615094|NCT00837564|trauma|trauma
5615095|NCT00837551|Non-steroid|non-steroid
5615096|NCT00837551|Small molecule|small molecule
5615097|NCT00837551|Topical cream|topical cream
5615098|NCT00837551|Inflammatory disease|inflammatory disease
5615099|NCT00837551|Skin|skin
5615100|NCT00837538|Spinal sagittal range of motion|spinal sagittal range of motion
5615101|NCT00837538|Intersegmental range of motion|intersegmental range of motion
5615102|NCT00837538|Spinal Mouse|spinal mouse
5615103|NCT00837512|microneedle continuous subcutaneous insulin infusion|microneedle continuous subcutaneous insulin infusion
5615104|NCT00837499|Breast|breast
5615105|NCT00837499|Breast Cancer|breast cancer
5615106|NCT00837499|Risk Factors|risk factors
5615107|NCT00837499|Mexican Women|mexican women
5615108|NCT00837499|Mexican-American Women|mexican-american women
5615109|NCT00837499|African-American Women|african-american women
5615110|NCT00837499|Epidemiological|epidemiological
5615111|NCT00837499|Questionnaire|questionnaire
5615112|NCT00837499|Survey|survey
5615113|NCT00837499|Interview|interview
5615114|NCT00837486|Treatment Resistant Depression|treatment resistant depression
5615115|NCT00837486|Treatment Refractory Depression|treatment refractory depression
5615116|NCT00837486|Deep Brain Stimulation|deep brain stimulation
5615117|NCT00837486|Depression|depression
5615118|NCT00837473|Bone Void Filler|bone void filler
5615119|NCT00837473|Iliac Crest Bone Void Filler|iliac crest bone void filler
5615120|NCT00837473|Back Surgery and Autograft Bone|back surgery and autograft bone
5615121|NCT00837473|Autograft Bone|autograft bone
5615122|NCT00837473|Allograft Bone|allograft bone
5615124|NCT00837460|Rehabilitation|rehabilitation
5615125|NCT00837434|tumor necrosis factor (TNF) blockade|tumor necrosis factor (tnf) blockade
5615126|NCT00837434|inflammatory autoimmune disorder|inflammatory autoimmune disorder
5615127|NCT00837421|sepsis|sepsis
5615128|NCT00837421|registry|registry
5615129|NCT00837408|GWAS|gwas
5615130|NCT00837395|premenstrual increase in asthma symptoms|premenstrual increase in asthma symptoms
5615131|NCT00837369|Stress echocardiography|stress echocardiography
5615132|NCT00837369|SPECT|spect
5615133|NCT00837369|Myocardial perfusion imaging|myocardial perfusion imaging
5615134|NCT00837343|Bipolar disorder|bipolar disorder
5615135|NCT00837330|polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5615136|NCT00837330|choroidal neovascularization|choroidal neovascularization
5615137|NCT00837330|ranibizumab|ranibizumab
5615138|NCT00837330|Lucentis|lucentis
5615140|NCT00837317|Laser-Doppler|laser-doppler
5615141|NCT00837317|Olive Oil|olive oil
5615142|NCT00837317|Sunflower Oil|sunflower oil
5615143|NCT00837317|Dimethylpolysiloxane|dimethylpolysiloxane
5615144|NCT00837317|Postprandial|postprandial
5615145|NCT00837317|Inflammation|inflammation
5615146|NCT00837317|Oxidative Stress|oxidative stress
5615147|NCT00837291|osteoarthritis|osteoarthritis
5615148|NCT00837291|knee|knee
5615149|NCT00837291|CF101|cf101
5615150|NCT00837278|IVF|ivf
5615151|NCT00837278|angiogenic factors|angiogenic factors
5615152|NCT00837278|cytokines|cytokines
5615153|NCT00837265|Breast Cancer Supportive Care Neutropenia|breast cancer supportive care neutropenia
5615154|NCT00837252|Central Serous Chorioretinopathy|central serous chorioretinopathy
5615155|NCT00837252|Finasteride|finasteride
5615156|NCT00837252|Proscar|proscar
5615157|NCT00837252|Retinal Eye Disease|retinal eye disease
5615158|NCT00837239|HuaChanSu|huachansu
5615159|NCT00837239|HCS|hcs
5615160|NCT00837239|Gastrointestinal|gastrointestinal
5615161|NCT00837239|Gastrointestinal Disease|gastrointestinal disease
5615162|NCT00837239|Metastases|metastases
5615163|NCT00837239|Cancer|cancer
5615164|NCT00837239|Pancreatic cancer|pancreatic cancer
5615165|NCT00837239|Placebo|placebo
5615166|NCT00837239|Gemcitabine|gemcitabine
5615167|NCT00837239|Gemcitabine Hydrocholoride|gemcitabine hydrocholoride
5615168|NCT00837239|Gemzar|gemzar
5615169|NCT00837239|Fudan UniversityCancer Hospital|fudan universitycancer hospital
5615170|NCT00837213|Acne|acne
5615171|NCT00837200|lymphoma|lymphoma
5615172|NCT00837200|myeloma|myeloma
5615173|NCT00837187|dexmedetomidine|dexmedetomidine
5615174|NCT00837187|intranasal|intranasal
5615175|NCT00837187|pharmacokinetics|pharmacokinetics
5615176|NCT00837187|pharmacodynamics|pharmacodynamics
5615177|NCT00837174|non-Hodgkin Lymphoma|non-hodgkin lymphoma
5615178|NCT00837174|aggressive lymphoma|aggressive lymphoma
5615179|NCT00837174|indolent lymphoma|indolent lymphoma
5615180|NCT00837174|B cell lymphoma|b cell lymphoma
5615181|NCT00837174|T cell lymphoma|t cell lymphoma
5615182|NCT00837174|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5615183|NCT00837174|anaplastic large B cell lymphoma|anaplastic large b cell lymphoma
5615185|NCT00837174|Burkitt's lymphoma|burkitt's lymphoma
5615186|NCT00837174|transformed follicular center cell lymphoma|transformed follicular center cell lymphoma
5615187|NCT00837174|transformed marginal zone lymphoma|transformed marginal zone lymphoma
5615188|NCT00837174|transformed small lymphocytic lymphoma|transformed small lymphocytic lymphoma
5615189|NCT00837174|grade 3 follicular center cell lymphoma|grade 3 follicular center cell lymphoma
5615190|NCT00837174|blastic form marginal zone lymphoma|blastic form marginal zone lymphoma
5615191|NCT00837174|transformed cutaneous T cell lymphoma|transformed cutaneous t cell lymphoma
5615192|NCT00837174|mycosis fungoides stage IV|mycosis fungoides stage iv
5615446|NCT00836173|DEXAMETHASONE|dexamethasone
5615193|NCT00837174|angioimmunoblastic lymphadenopathy-like T-cell lymphoma|angioimmunoblastic lymphadenopathy-like t-cell lymphoma
5615194|NCT00837174|nasal NK/T cell lymphoma|nasal nk/t cell lymphoma
5615195|NCT00837174|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5615196|NCT00837174|small lymphocytic lymphoma|small lymphocytic lymphoma
5615197|NCT00837174|lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5615198|NCT00837174|follicular center cell lymphoma grade 1|follicular center cell lymphoma grade 1
5615199|NCT00837174|follicular center cell lymphoma grade 2|follicular center cell lymphoma grade 2
5615200|NCT00837174|mantle cell lymphoma|mantle cell lymphoma
5615201|NCT00837174|marginal zone lymphoma|marginal zone lymphoma
5615202|NCT00837174|mycosis fungoides|mycosis fungoides
5615203|NCT00837161|High Intensity Focused Ultrasound Ablation|high intensity focused ultrasound ablation
5615204|NCT00837161|Uterine Fibroids|uterine fibroids
5615205|NCT00837161|Leiomyomata|leiomyomata
5615206|NCT00837161|Non-Invasive Treatment of Uterine Fibroids|non-invasive treatment of uterine fibroids
5615207|NCT00837161|MRI-Guided|mri-guided
5615208|NCT00837161|Fibroids|fibroids
5615209|NCT00837161|Uterine Leiomyomata|uterine leiomyomata
5615210|NCT00837148|Sarcoma|sarcoma
5615211|NCT00837148|Bone|bone
5615212|NCT00837148|BAY 43-9006 (SORAFENIB)|bay 43-9006 (sorafenib)
5615213|NCT00837148|DACARBAZINE|dacarbazine
5615214|NCT00837148|08-068|08-068
5615215|NCT00837135|Pancreatic Cancer|pancreatic cancer
5615221|NCT00837083|Crestor|crestor
5615222|NCT00837070|Zygapophyseal|zygapophyseal
5615223|NCT00837070|joint|joint
5615224|NCT00837070|cyst|cyst
5615225|NCT00837070|Fluoroscopy|fluoroscopy
5615226|NCT00837070|guided|guided
5615227|NCT00837070|percutaneous|percutaneous
5615228|NCT00837070|Lumbar|lumbar
5615229|NCT00837031|Pancreatic|pancreatic
5615230|NCT00837031|Pancreatic Cancer|pancreatic cancer
5615231|NCT00837031|Lenalidomide|lenalidomide
5615232|NCT00837031|Revlimid|revlimid
5615233|NCT00837031|Gemcitabine|gemcitabine
5615234|NCT00837018|OSAS|osas
5615235|NCT00837018|exercise|exercise
5615236|NCT00837018|metabolic|metabolic
5615237|NCT00837018|cardio-vascular|cardio-vascular
5615238|NCT00837005|dobutamine stress|dobutamine stress
5615239|NCT00837005|inducible ischemia|inducible ischemia
5615241|NCT00836992|anal cancer|anal cancer
5615242|NCT00836992|colon cancer|colon cancer
5615243|NCT00836992|rectal cancer|rectal cancer
5615244|NCT00836992|esophageal cancer|esophageal cancer
5615245|NCT00836992|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5615246|NCT00836992|gallbladder cancer|gallbladder cancer
5615247|NCT00836992|gastric cancer|gastric cancer
5615248|NCT00836992|adult primary liver cancer|adult primary liver cancer
5615249|NCT00836992|pancreatic cancer|pancreatic cancer
5615250|NCT00836992|small intestine cancer|small intestine cancer
5615251|NCT00836992|non-small cell lung cancer|non-small cell lung cancer
5615252|NCT00836992|small cell lung cancer|small cell lung cancer
5615253|NCT00836992|head and neck cancer|head and neck cancer
5615254|NCT00836979|Urinary Incontinence|urinary incontinence
5615255|NCT00836979|Incontinence|incontinence
5615256|NCT00836979|bladder problems|bladder problems
5615257|NCT00836979|bladder dysfunction|bladder dysfunction
5615258|NCT00836953|Influenza|influenza
5615259|NCT00836953|Fluzone®|fluzone®
5615260|NCT00836953|Children|children
5615261|NCT00836940|Type 2 diabetes mellitus|type 2 diabetes mellitus
5615262|NCT00836940|GRC 8200|grc 8200
5615263|NCT00836914|Allergic Rhinitis|allergic rhinitis
5615264|NCT00836914|Allergy|allergy
5615265|NCT00836914|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5615266|NCT00836901|Bioequivalence|bioequivalence
5615267|NCT00836901|Healthy Subjects|healthy subjects
5615268|NCT00836888|ONO-4538|ono-4538
5615269|NCT00836888|MDX-1106|mdx-1106
5615270|NCT00836888|solid tumors|solid tumors
5615271|NCT00836875|Pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized|pediatrics voriconazole invasive fungal infection invasive aspergillosis immunocompromized
5615272|NCT00836862|Hemodialysis|hemodialysis
5615273|NCT00836862|Vascular access|vascular access
5615274|NCT00836862|Arteriovenous fistula|arteriovenous fistula
5591976|NCT00923156|PRA|pra
5615279|NCT00836823|Patient-reported most bothersome symptom|patient-reported most bothersome symptom
5615280|NCT00836823|Patient-reported symptom-specific goal achievement|patient-reported symptom-specific goal achievement
5615281|NCT00836823|Medical treatment|medical treatment
5615282|NCT00836810|Circadian variations of cytokines in PMR|circadian variations of cytokines in pmr
5615283|NCT00836810|effect of TRT Prednisone in cytokines|effect of trt prednisone in cytokines
5615284|NCT00836797|Alveolar Bone Loss|alveolar bone loss
5615285|NCT00836797|Alveolar ridge|alveolar ridge
5615286|NCT00836797|Alveolar Process|alveolar process
5615287|NCT00836784|Old tooth brush|old tooth brush
5615288|NCT00836784|Plaque removal|plaque removal
5615289|NCT00836771|Infant formula|infant formula
5615290|NCT00836771|Probiotic microorganisms|probiotic microorganisms
5615291|NCT00836771|prebiotic|prebiotic
5615292|NCT00836745|Advanced renal cell Cancer|advanced renal cell cancer
5615293|NCT00836745|Non interventional study|non interventional study
5615294|NCT00836745|Renal Cancer|renal cancer
5615295|NCT00836745|Sutent|sutent
5615296|NCT00836745|Metastatic|metastatic
5615297|NCT00836745|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5615298|NCT00836732|celle therapy|celle therapy
5615299|NCT00836732|cell culture|cell culture
5615300|NCT00836732|mesenchymal stem cells|mesenchymal stem cells
5615301|NCT00836719|Multiple sclerosis|multiple sclerosis
5615302|NCT00836719|safety|safety
5615303|NCT00836719|open label|open label
5615304|NCT00836719|Polyphenon E|polyphenon e
5615305|NCT00836719|EGCG|egcg
5615307|NCT00836719|N-acetyl-aspartate|n-acetyl-aspartate
5615309|NCT00836706|Bioequivalence|bioequivalence
5615310|NCT00836706|Healthy Subjects|healthy subjects
5615311|NCT00836693|Erectile Dysfunction|erectile dysfunction
5615312|NCT00836667|Bioequivalence|bioequivalence
5615313|NCT00836667|Healthy Subjects|healthy subjects
5615314|NCT00836654|EpCAM positive tumor|epcam positive tumor
5615315|NCT00836654|malignant ascites|malignant ascites
5615316|NCT00836654|intraperitoneal|intraperitoneal
5615318|NCT00836641|sequential pneumococcal immunization|sequential pneumococcal immunization
5615319|NCT00836641|immunogenicity|immunogenicity
5615320|NCT00836641|safety|safety
5615321|NCT00836589|Long-term safety and reliability of ICD leads|long-term safety and reliability of icd leads
5615322|NCT00836576|Bioequivalence|bioequivalence
5615323|NCT00836576|Healthy Subjects|healthy subjects
5615324|NCT00836563|Hemodialysis|hemodialysis
5615325|NCT00836563|Arteriovenous Graft|arteriovenous graft
5615326|NCT00836550|HIV|hiv
5615327|NCT00836550|HIV knowledge measure|hiv knowledge measure
5615328|NCT00836550|Teen HIV testing|teen hiv testing
5615329|NCT00836550|HIV Seronegativity|hiv seronegativity
5615330|NCT00836537|Bioequivalence|bioequivalence
5615331|NCT00836537|Healthy Subjects|healthy subjects
5615332|NCT00836524|IUGR|iugr
5615333|NCT00836524|Preeclampsia|preeclampsia
5615334|NCT00836524|ultrasound|ultrasound
5615335|NCT00836524|YKL-40|ykl-40
5615336|NCT00836472|Bioequivalence|bioequivalence
5615337|NCT00836472|Healthy Subjects|healthy subjects
5615338|NCT00836459|Humans|humans
5615339|NCT00836459|Middle Aged|middle aged
5615340|NCT00836459|Behavior Therapy|behavior therapy
5615341|NCT00836459|Directive Counseling|directive counseling
5615342|NCT00836459|Health Behavior|health behavior
5615343|NCT00836459|Interview, Psychological|interview, psychological
5615345|NCT00836459|Exercise|exercise
5615346|NCT00836459|Physical Fitness|physical fitness
5615347|NCT00836459|Self Efficacy|self efficacy
5615348|NCT00836459|Life Style|life style
5615349|NCT00836459|Health Promotion|health promotion
5615350|NCT00836459|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5615351|NCT00836459|Body Mass Index|body mass index
5615352|NCT00836459|Monitoring, Ambulatory|monitoring, ambulatory
5615353|NCT00836459|Walking|walking
5615354|NCT00836446|school-aged|school-aged
5615355|NCT00836446|children|children
5615356|NCT00836446|obesity|obesity
5615357|NCT00836446|cardiovascular risk|cardiovascular risk
5615358|NCT00836446|physical activity|physical activity
5615359|NCT00836433|staff education|staff education
5615360|NCT00836433|complexity science|complexity science
5615361|NCT00836433|social constructivist theory|social constructivist theory
5615362|NCT00836420|ammonia|ammonia
5615363|NCT00836420|acute liver failure|acute liver failure
5615364|NCT00836420|brain edema|brain edema
5615365|NCT00836420|oxidative metabolism|oxidative metabolism
5615366|NCT00836420|intracranial pressure|intracranial pressure
5615372|NCT00836394|arthritis|arthritis
5615373|NCT00836394|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5615374|NCT00836394|pediatric|pediatric
5615375|NCT00836394|intervention|intervention
5615376|NCT00836394|vibration therapy|vibration therapy
5615377|NCT00836394|JIA|jia
5615378|NCT00836381|Overactive bladder|overactive bladder
5615379|NCT00836381|Antimuscarinics|antimuscarinics
5615380|NCT00836381|Patient-reported goal achievement|patient-reported goal achievement
5615381|NCT00836368|Asthma|asthma
5615382|NCT00836368|Asthmatic|asthmatic
5615383|NCT00836368|Allergy|allergy
5615384|NCT00836368|Allergic|allergic
5615385|NCT00836368|Gamma-tocopherol|gamma-tocopherol
5615386|NCT00836368|Vitamin|vitamin
5615387|NCT00836368|Vitamin E|vitamin e
5615388|NCT00836355|stroke|stroke
5615389|NCT00836355|magnetic resonance imaging|magnetic resonance imaging
5615390|NCT00836355|enoxaparin|enoxaparin
5615391|NCT00836355|minocycline|minocycline
5615392|NCT00836355|NIH stroke scale|nih stroke scale
5615393|NCT00836355|modified Rankin scale|modified rankin scale
5615394|NCT00836355|neuroprotection|neuroprotection
5615395|NCT00836342|Non-melanoma skin cancer|non-melanoma skin cancer
5615396|NCT00836342|Basal cell carcinoma|basal cell carcinoma
5615397|NCT00836342|Squamous cell carcinoma|squamous cell carcinoma
5615398|NCT00836329|Neurologic|neurologic
5615399|NCT00836329|Diabetes|diabetes
5615400|NCT00836329|Cardiac Surgery|cardiac surgery
5615401|NCT00836329|Stroke|stroke
5615402|NCT00836316|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5615403|NCT00836290|risk reduction|risk reduction
5615404|NCT00836290|HIV prevention|hiv prevention
5615405|NCT00836290|HIV education|hiv education
5615406|NCT00836290|HIV Seronegativity|hiv seronegativity
5615407|NCT00836277|Panitumumab|panitumumab
5615408|NCT00836277|Irinotecan|irinotecan
5615409|NCT00836277|Esophageal Adenocarcinoma|esophageal adenocarcinoma
5615410|NCT00836277|Phase II|phase ii
5615411|NCT00836264|Morphine|morphine
5615412|NCT00836264|Phenotype|phenotype
5615413|NCT00836264|Genotype|genotype
5615414|NCT00836264|Tonsillectomy|tonsillectomy
5615415|NCT00836264|Adenoidectomy|adenoidectomy
5615416|NCT00836264|Opioid Receptors|opioid receptors
5615417|NCT00836264|Genome-Wide Association|genome-wide association
5615418|NCT00836264|Pharmacokinetics|pharmacokinetics
5615419|NCT00836251|energy expenditure|energy expenditure
5615420|NCT00836251|schizophrenia|schizophrenia
5615421|NCT00836238|Prostate Cancer|prostate cancer
5615422|NCT00836238|Neural Functioning Assessment|neural functioning assessment
5615423|NCT00836238|Physical Assessment|physical assessment
5615424|NCT00836238|Questionnaire|questionnaire
5615425|NCT00836238|Objective Measures of Functional Status|objective measures of functional status
5615426|NCT00836238|Physical Function|physical function
5615427|NCT00836238|Symptom Assessment Interview|symptom assessment interview
5615429|NCT00836225|diabetes|diabetes
5615430|NCT00836225|SGLT2 inhibitor|sglt2 inhibitor
5615432|NCT00836212|Adjusting Antiretroviral Therapy|adjusting antiretroviral therapy
5615433|NCT00836212|Dosage using Therapeutic Drug Monitoring|dosage using therapeutic drug monitoring
5615434|NCT00836212|Swiss HIV Cohort Study|swiss hiv cohort study
5615435|NCT00836212|HIV Geneva|hiv geneva
5615436|NCT00836212|lopinavir|lopinavir
5615437|NCT00836212|efavirenz|efavirenz
5615438|NCT00836212|Treatment Experienced|treatment experienced
5615439|NCT00836199|smoking cessation|smoking cessation
5615440|NCT00836199|NicVAX|nicvax
5615441|NCT00836199|smoking vaccine|smoking vaccine
5615442|NCT00836199|smoking abstinence|smoking abstinence
5615443|NCT00836199|smoking|smoking
5615444|NCT00836199|tobacco cessation|tobacco cessation
5615445|NCT00836173|CARBOPLATIN|carboplatin
5615447|NCT00836173|DIFFUSE LARGE B-CELL LYMPHOMA|diffuse large b-cell lymphoma
5615448|NCT00836173|ETOPOSIDE|etoposide
5615449|NCT00836173|GALLIUM NITRATE|gallium nitrate
5615450|NCT00836173|IFOSFAMIDE|ifosfamide
5615451|NCT00836173|PHASE II|phase ii
5615452|NCT00836173|RELAPSED OR REFRACTORY|relapsed or refractory
5615453|NCT00836173|RITUXIMAB|rituximab
5615454|NCT00836160|EGFR-TKI therapy|egfr-tki therapy
5615456|NCT00836160|Efficacy|efficacy
5615457|NCT00836134|pain relief after umbilical hernia repair|pain relief after umbilical hernia repair
5615458|NCT00836134|morphine consumption|morphine consumption
5615459|NCT00836134|plasma bupivacaine levels|plasma bupivacaine levels
5615460|NCT00836121|Teratoma|teratoma
5615461|NCT00836121|Mediastinum|mediastinum
5615462|NCT00836108|Lung Diseases, Obstructive|lung diseases, obstructive
5615463|NCT00836108|Breathing Exercises|breathing exercises
5615464|NCT00836108|Exercise Tolerance|exercise tolerance
5615466|NCT00836108|Arm Exercise|arm exercise
5615467|NCT00836095|laryngeal mask, proseal|laryngeal mask, proseal
5615468|NCT00836082|Healthy volunteers|healthy volunteers
5615469|NCT00836069|Generalized Anxiety Disorder|generalized anxiety disorder
5615470|NCT00836056|Bioequivalence|bioequivalence
5615471|NCT00836056|Healthy Subjects|healthy subjects
5615472|NCT00836043|CLL|cll
5615473|NCT00836043|alemtuzumab|alemtuzumab
5615474|NCT00836004|Bioequivalence|bioequivalence
5615475|NCT00836004|Healthy Subjects|healthy subjects
5615476|NCT00835991|Bioequivalence|bioequivalence
5615477|NCT00835991|Healthy Subjects|healthy subjects
5615573|NCT00835562|elderly|elderly
5615674|NCT00835107|Antipsychotic|antipsychotic
5615478|NCT00835978|axitinib or AG-013736 dose titration (increase) renal cell carcinoma|axitinib or ag-013736 dose titration (increase) renal cell carcinoma
5615479|NCT00835978|kidney cancer|kidney cancer
5615480|NCT00835965|Laparoscopic|laparoscopic
5615481|NCT00835965|Surgery|surgery
5615482|NCT00835965|Postoperative|postoperative
5615483|NCT00835965|Nausea|nausea
5615484|NCT00835965|Vomiting|vomiting
5615485|NCT00835965|Aprepitant|aprepitant
5615486|NCT00835965|Dexamethasone|dexamethasone
5615487|NCT00835965|Postoperative Nausea, Postoperative Vomiting|postoperative nausea, postoperative vomiting
5615488|NCT00835939|Achilles|achilles
5615489|NCT00835939|Tendinopathy|tendinopathy
5615490|NCT00835939|Sclerotherapy|sclerotherapy
5615491|NCT00835939|Neovascularisation|neovascularisation
5615492|NCT00835939|sports medicine|sports medicine
5615493|NCT00835939|interventional radiology|interventional radiology
5615494|NCT00835926|Influenza|influenza
5615495|NCT00835926|Fluzone®|fluzone®
5615496|NCT00835913|Autonomic nervous system|autonomic nervous system
5615497|NCT00835913|Sepsis shock|sepsis shock
5615498|NCT00835913|severe sepsis|severe sepsis
5615499|NCT00835913|sinusal change|sinusal change
5615500|NCT00835913|Myocardiac fixing|myocardiac fixing
5615501|NCT00835913|NTproBNP|ntprobnp
5615502|NCT00835913|Patient in intensive care unit with sepsis shock or severe|patient in intensive care unit with sepsis shock or severe
5615503|NCT00835913|Sepsis|sepsis
5615504|NCT00835900|smoking cessation|smoking cessation
5615505|NCT00835900|varenicline|varenicline
5615506|NCT00835900|smoking cessation treatment|smoking cessation treatment
5615507|NCT00835874|probiotic|probiotic
5615508|NCT00835874|preterm|preterm
5615509|NCT00835874|lactation|lactation
5615510|NCT00835874|breast feeding|breast feeding
5615511|NCT00835874|necrotizing enterocolitis|necrotizing enterocolitis
5615512|NCT00835874|sepsis|sepsis
5615513|NCT00835874|bacterial cultures|bacterial cultures
5615514|NCT00835874|lactating mother|lactating mother
5615515|NCT00835874|breast feeding of at least 50% of enteric feeding volume|breast feeding of at least 50% of enteric feeding volume
5615516|NCT00835874|Infant, very low birth weight|infant, very low birth weight
5615517|NCT00835861|Non Insulin Dependent Diabetes|non insulin dependent diabetes
5615518|NCT00835861|Pregnancy|pregnancy
5615519|NCT00835848|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5615520|NCT00835848|Primary PCI|primary pci
5615521|NCT00835848|Postconditioning|postconditioning
5615522|NCT00835835|Multiple Sclerosis|multiple sclerosis
5615524|NCT00835835|falls|falls
5615525|NCT00835835|lokomat|lokomat
5615526|NCT00835835|body-weight support treadmill training|body-weight support treadmill training
5615527|NCT00835822|Chronic Venous Insufficiency, Venocur Triplex®|chronic venous insufficiency, venocur triplex®
5615528|NCT00835809|Acute respiratory insufficiency respiratory|acute respiratory insufficiency respiratory
5615529|NCT00835809|Biomarkers|biomarkers
5615530|NCT00835809|Emergency|emergency
5615531|NCT00835809|Intensive care unit|intensive care unit
5615532|NCT00835809|Prospective|prospective
5615533|NCT00835809|Patient hospitalize in emergency or in intensive care unit|patient hospitalize in emergency or in intensive care unit
5615534|NCT00835809|for acute respiratory insufficiency|for acute respiratory insufficiency
5615535|NCT00835796|Bioequivalence|bioequivalence
5615536|NCT00835796|Healthy Subjects|healthy subjects
5615537|NCT00835770|relapsing|relapsing
5615538|NCT00835770|multiple sclerosis|multiple sclerosis
5615539|NCT00835770|remitting|remitting
5615540|NCT00835770|oral|oral
5615541|NCT00835744|ovulation induction|ovulation induction
5615542|NCT00835744|clomiphene citrate|clomiphene citrate
5615543|NCT00835744|gonadotropins|gonadotropins
5615544|NCT00835731|induced abortion|induced abortion
5615545|NCT00835731|misoprostol|misoprostol
5615546|NCT00835731|cervical ripening|cervical ripening
5615547|NCT00835731|second trimester abortion|second trimester abortion
5615548|NCT00835731|Dilapan-S|dilapan-s
5615549|NCT00835705|Bioequivalence|bioequivalence
5615550|NCT00835705|Healthy Subjects|healthy subjects
5615551|NCT00835692|Bioequivalence|bioequivalence
5615552|NCT00835692|Healthy Subjects|healthy subjects
5615553|NCT00835666|Bioequivalence|bioequivalence
5615554|NCT00835666|Healthy Subjects|healthy subjects
5615555|NCT00835640|Bioequivalence|bioequivalence
5615556|NCT00835640|Healthy Subjects|healthy subjects
5615557|NCT00835627|Treatment|treatment
5615558|NCT00835627|Cognitive Behavior Therapy|cognitive behavior therapy
5615559|NCT00835627|pharmacotherapy|pharmacotherapy
5615560|NCT00835627|psychogenic nonepileptic seizures|psychogenic nonepileptic seizures
5615561|NCT00835627|pseudoseizures|pseudoseizures
5615562|NCT00835627|dissociative seizures|dissociative seizures
5615563|NCT00835627|conversion disorder|conversion disorder
5615564|NCT00835614|Bioequivalence|bioequivalence
5615565|NCT00835614|Healthy Subjects|healthy subjects
5615566|NCT00835588|Bioequivalence|bioequivalence
5615567|NCT00835588|Healthy Subjects|healthy subjects
5615568|NCT00835575|Bioequivalence|bioequivalence
5615569|NCT00835575|Healthy Subjects|healthy subjects
5615570|NCT00835562|Shoulder fractures|shoulder fractures
5615571|NCT00835562|Proximal humeral fractures|proximal humeral fractures
5615572|NCT00835562|Randomised clinical trial|randomised clinical trial
5615574|NCT00835562|Displaced four-part fractures of the proximal humerus|displaced four-part fractures of the proximal humerus
5615575|NCT00835549|Bioequivalence|bioequivalence
5615576|NCT00835549|Healthy Subjects|healthy subjects
5615577|NCT00835536|Bioequivalence|bioequivalence
5615578|NCT00835536|Healthy Subjects|healthy subjects
5615579|NCT00835523|frozen-thawed embryo replacement|frozen-thawed embryo replacement
5615580|NCT00835523|GnRH agonist|gnrh agonist
5615581|NCT00835523|GnRH antagonist|gnrh antagonist
5615582|NCT00835523|ovarian hyperstimulation|ovarian hyperstimulation
5615583|NCT00835510|Tinea pedis|tinea pedis
5615584|NCT00835497|Bioequivalence|bioequivalence
5615585|NCT00835497|Healthy Subjects|healthy subjects
5615586|NCT00835484|Bioequivalence|bioequivalence
5615587|NCT00835484|Healthy Subjects|healthy subjects
5615588|NCT00835471|Lung cancer|lung cancer
5615589|NCT00835471|non-small-cell|non-small-cell
5615590|NCT00835471|erlotinib|erlotinib
5615591|NCT00835471|chemotherapy|chemotherapy
5615592|NCT00835458|gastric fistula|gastric fistula
5615593|NCT00835458|perforation|perforation
5615594|NCT00835458|endoscopy|endoscopy
5615595|NCT00835458|closure|closure
5615596|NCT00835458|endolumenal|endolumenal
5615597|NCT00835432|Lateral augmentation|lateral augmentation
5615598|NCT00835432|GBR|gbr
5615599|NCT00835432|BoneCeramic|boneceramic
5615600|NCT00835432|collagen membrane|collagen membrane
5615601|NCT00835432|histomorphometry|histomorphometry
5615602|NCT00835432|morphometry|morphometry
5615603|NCT00835432|reentry|reentry
5615604|NCT00835432|biopsy|biopsy
5615605|NCT00835419|metastatic malignant melanoma with cyclin D1 positivity|metastatic malignant melanoma with cyclin d1 positivity
5615607|NCT00835406|Healthy Subjects|healthy subjects
5615608|NCT00835393|Bioequivalence|bioequivalence
5615609|NCT00835393|Healthy Subjects|healthy subjects
5615610|NCT00835367|Bioequivalence|bioequivalence
5615611|NCT00835367|Healthy Subjects|healthy subjects
5615612|NCT00835354|Bioequivalence|bioequivalence
5615613|NCT00835354|Healthy Subjects|healthy subjects
5615614|NCT00835341|oral epithelial dysplasia|oral epithelial dysplasia
5615615|NCT00835341|p16 methylation|p16 methylation
5615616|NCT00835341|prognosis|prognosis
5615617|NCT00835341|malignant transformation|malignant transformation
5615618|NCT00835341|oral squamous cell carcinoma|oral squamous cell carcinoma
5615619|NCT00835328|hyperinsulinism|hyperinsulinism
5615620|NCT00835328|hypoglycemia|hypoglycemia
5615621|NCT00835328|ATP- sensitive potassium channel (KATP)|atp- sensitive potassium channel (katp)
5615622|NCT00835315|interdigital psoriasis (psoriasis alba)|interdigital psoriasis (psoriasis alba)
5615624|NCT00835302|Thoracic|thoracic
5615625|NCT00835302|Manipulation|manipulation
5615626|NCT00835302|Mobilization|mobilization
5615627|NCT00835302|Clinical prediction rule|clinical prediction rule
5615628|NCT00835302|Shoulder pain.|shoulder pain.
5615629|NCT00835289|Clinical Trials, Randomized|clinical trials, randomized
5615630|NCT00835276|Bioequivalence|bioequivalence
5615631|NCT00835276|Healthy Subjects|healthy subjects
5615632|NCT00835263|Bioequivalence|bioequivalence
5615633|NCT00835263|Healthy Subjects|healthy subjects
5615634|NCT00835250|Transvaginal cholecystectomy|transvaginal cholecystectomy
5615635|NCT00835250|NOTES|notes
5615636|NCT00835250|Minilaparoscopy|minilaparoscopy
5615637|NCT00835250|Endoscopic surgery|endoscopic surgery
5615638|NCT00835250|Cholecystectomy|cholecystectomy
5615639|NCT00835250|Surgical translumenal endoscopic surgery|surgical translumenal endoscopic surgery
5615640|NCT00835250|Transvaginal translumenal endoscopic surgery|transvaginal translumenal endoscopic surgery
5615641|NCT00835237|Boostrix®|boostrix®
5615642|NCT00835237|adults|adults
5615643|NCT00835224|Spinal Cord Injury|spinal cord injury
5615644|NCT00835224|Orthostatic Hypotension|orthostatic hypotension
5615645|NCT00835224|Blood Pressure|blood pressure
5615646|NCT00835224|Midodrine Hydrochloride|midodrine hydrochloride
5615647|NCT00835224|L-NAME|l-name
5615648|NCT00835211|Bioequivalence|bioequivalence
5615649|NCT00835211|Healthy Subjects|healthy subjects
5615650|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal
5615651|NCT00835185|Colorectal Neoplasms|colorectal neoplasms
5615652|NCT00835172|Bioequivalence|bioequivalence
5615653|NCT00835172|Healthy Subjects|healthy subjects
5615654|NCT00835159|Postoperative Delirium|postoperative delirium
5615655|NCT00835159|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5615656|NCT00835159|Rivastigmine|rivastigmine
5615657|NCT00835159|Exelon|exelon
5615658|NCT00835159|Memory impairment|memory impairment
5615659|NCT00835159|Delirium|delirium
5615660|NCT00835159|Cognitive function|cognitive function
5615661|NCT00835146|Bioequivalence|bioequivalence
5615662|NCT00835146|Healthy Subjects|healthy subjects
5615663|NCT00835133|family|family
5615664|NCT00835133|history|history
5615665|NCT00835133|pancreas|pancreas
5615666|NCT00835133|cancer|cancer
5615667|NCT00835133|melanoma|melanoma
5615668|NCT00835133|genetic|genetic
5615669|NCT00835107|Bipolar Depression|bipolar depression
5615670|NCT00835107|Sleep|sleep
5615671|NCT00835107|Polysomnograph|polysomnograph
5615672|NCT00835107|Slow Wave Sleep|slow wave sleep
5615673|NCT00835107|Ziprasidone|ziprasidone
5615675|NCT00835107|Placebo|placebo
5615676|NCT00835081|Bioequivalence|bioequivalence
5615677|NCT00835081|Healthy Subjects|healthy subjects
5615678|NCT00835068|Hemophilia B|hemophilia b
5615679|NCT00835068|observational|observational
5615680|NCT00835068|post marketing study|post marketing study
5615681|NCT00835055|rectal cancer with neoadjuvant treatment|rectal cancer with neoadjuvant treatment
5615682|NCT00835055|standardized clinical tests|standardized clinical tests
5615683|NCT00835055|tumor markers on tumor tissue|tumor markers on tumor tissue
5615684|NCT00835042|Bioequivalence|bioequivalence
5615685|NCT00835042|Healthy Subjects|healthy subjects
5615686|NCT00835029|oral|oral
5615687|NCT00835029|candida|candida
5615688|NCT00835029|denture|denture
5615689|NCT00835029|clotrimazole|clotrimazole
5615690|NCT00835029|slow releases|slow releases
5615691|NCT00835016|Early psychosocial stimulation, RCT, Depressed mother|early psychosocial stimulation, rct, depressed mother
5615692|NCT00835003|Neonatal admission|neonatal admission
5615693|NCT00835003|Elective Caesarean Section|elective caesarean section
5615694|NCT00835003|Timing|timing
5615695|NCT00835003|Choice behavior|choice behavior
5615696|NCT00835003|Intraoperative complications|intraoperative complications
5615697|NCT00835003|Postoperative complications|postoperative complications
5615698|NCT00834990|Bioequivalence|bioequivalence
5615699|NCT00834990|Healthy Subjects|healthy subjects
5615700|NCT00834977|Bioequivalence|bioequivalence
5615701|NCT00834977|Healthy Subjects|healthy subjects
5615702|NCT00834964|Bioequivalence|bioequivalence
5615703|NCT00834964|Healthy Subjects|healthy subjects
5615704|NCT00834951|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5615705|NCT00834951|Elderly patients|elderly patients
5615706|NCT00834951|Low dose total body irradiation|low dose total body irradiation
5615707|NCT00834951|RCHOP14|rchop14
5615708|NCT00834938|diabetes mellitus, type 2|diabetes mellitus, type 2
5615709|NCT00834938|Insulin resistance|insulin resistance
5615710|NCT00834938|bariatric surgery|bariatric surgery
5615711|NCT00834938|Glucagon-Like Peptide 1|glucagon-like peptide 1
5615712|NCT00834938|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5615713|NCT00834938|insulin|insulin
5615714|NCT00834938|glucagon|glucagon
5615715|NCT00834938|ghrelin|ghrelin
5615716|NCT00834938|adiponectin|adiponectin
5615717|NCT00834938|Cytokines|cytokines
5615718|NCT00834938|gastric bypass|gastric bypass
5615719|NCT00834938|Obesity|obesity
5615720|NCT00834925|atrial fibrillation with rapid ventricular response|atrial fibrillation with rapid ventricular response
5615721|NCT00834912|Healthy Subjects|healthy subjects
5615722|NCT00834899|Sickle cell disease|sickle cell disease
5615723|NCT00834899|Pain crisis|pain crisis
5615724|NCT00834899|Acute pain episode|acute pain episode
5615725|NCT00834899|Eptifibatide|eptifibatide
5615726|NCT00834899|Antiplatelet therapy|antiplatelet therapy
5615728|NCT00834899|Treatment|treatment
5615729|NCT00834873|Bioequivalence|bioequivalence
5615730|NCT00834873|Healthy Subjects|healthy subjects
5615731|NCT00834860|chronic hepatitis C|chronic hepatitis c
5615732|NCT00834860|sustained virological response|sustained virological response
5615733|NCT00834860|peginterferon|peginterferon
5615734|NCT00834860|ribavirin|ribavirin
5615735|NCT00834860|neoplasm|neoplasm
5615736|NCT00834847|Bioequivalence|bioequivalence
5615737|NCT00834847|Healthy Subjects|healthy subjects
5615738|NCT00834834|Suicidal and Self-Injurious Behavior|suicidal and self-injurious behavior
5615739|NCT00834821|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5615740|NCT00834821|ADHD, Predominantly Inattentive Type|adhd, predominantly inattentive type
5615741|NCT00834821|Inattention|inattention
5615742|NCT00834821|Psychosocial Intervention|psychosocial intervention
5615743|NCT00834821|Behavioral Intervention|behavioral intervention
5615744|NCT00834808|Healthy volunteers|healthy volunteers
5615745|NCT00834795|Bioequivalence|bioequivalence
5615750|NCT00834756|Healthy Subjects|healthy subjects
5615751|NCT00834743|Bioequivalence|bioequivalence
5615752|NCT00834743|Healthy Subjects|healthy subjects
5615753|NCT00834717|Bioequivalence|bioequivalence
5615754|NCT00834717|Healthy Subjects|healthy subjects
5615756|NCT00834704|PEGylated recombinant human hyaluronidase|pegylated recombinant human hyaluronidase
5615757|NCT00834704|Metastatic or locally advanced solid tumor|metastatic or locally advanced solid tumor
5615758|NCT00834691|Inflammation|inflammation
5615759|NCT00834691|Oxidative stress|oxidative stress
5615760|NCT00834691|Estimated glomerular filtration rate|estimated glomerular filtration rate
5615761|NCT00834678|male breast cancer|male breast cancer
5615762|NCT00834678|recurrent breast cancer|recurrent breast cancer
5615763|NCT00834678|stage IIIB breast cancer|stage iiib breast cancer
5615764|NCT00834678|stage IIIC breast cancer|stage iiic breast cancer
5615765|NCT00834678|stage IV breast cancer|stage iv breast cancer
5615766|NCT00834678|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5615767|NCT00834678|HER2-negative breast cancer|her2-negative breast cancer
5615768|NCT00834678|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5615769|NCT00834678|triple-negative breast cancer|triple-negative breast cancer
5615770|NCT00834652|Metabolic Diseases|metabolic diseases
5615771|NCT00834652|Depressive Disorder, Major|depressive disorder, major
5615772|NCT00834652|Depressive Disorder|depressive disorder
5615773|NCT00834652|Glucose Metabolism Disorders|glucose metabolism disorders
5615774|NCT00834652|Depression Recurrence|depression recurrence
5615775|NCT00834639|Bioequivalence|bioequivalence
5615776|NCT00834639|Healthy Subjects|healthy subjects
5615777|NCT00834626|Ileal Interposition|ileal interposition
5615778|NCT00834626|Sleeve Gastrectomy|sleeve gastrectomy
5615779|NCT00834626|Type-2 Diabetes|type-2 diabetes
5615780|NCT00834613|Bioequivalence|bioequivalence
5615781|NCT00834613|Healthy Subjects|healthy subjects
5615782|NCT00834587|Bioequivalence|bioequivalence
5615783|NCT00834587|Healthy Subjects|healthy subjects
5615784|NCT00834574|Bioequivalence|bioequivalence
5615785|NCT00834574|Healthy Subjects|healthy subjects
5615786|NCT00834561|Bioequivalence|bioequivalence
5615787|NCT00834561|Healthy Subjects|healthy subjects
5615788|NCT00834548|Magnetic resonance|magnetic resonance
5615789|NCT00834548|whole body|whole body
5615790|NCT00834548|angiography|angiography
5615791|NCT00834548|hybrid protocol|hybrid protocol
5615793|NCT00834535|Bioequivalence|bioequivalence
5615794|NCT00834535|Healthy Subjects|healthy subjects
5615795|NCT00834522|Bioequivalence|bioequivalence
5615796|NCT00834522|Healthy Subjects|healthy subjects
5615798|NCT00834483|Efficacy|efficacy
5615799|NCT00834483|Cost-savings|cost-savings
5615800|NCT00834483|Cosmesis|cosmesis
5615801|NCT00834483|Safety and efficacy of wound closure|safety and efficacy of wound closure
5615802|NCT00834483|Cost-savings potential|cost-savings potential
5615803|NCT00834483|Cosmesis of the wound/scar|cosmesis of the wound/scar
5615804|NCT00834457|AIDS-related Kaposi's sarcoma|aids-related kaposi's sarcoma
5615805|NCT00834457|antiretroviral therapy|antiretroviral therapy
5615806|NCT00834444|Bioequivalence|bioequivalence
5615807|NCT00834444|Healthy Subjects|healthy subjects
5615808|NCT00834431|Bioequivalence|bioequivalence
5615809|NCT00834431|Healthy Subjects|healthy subjects
5615810|NCT00834418|Bioequivalence|bioequivalence
5615811|NCT00834418|Healthy Subjects|healthy subjects
5615813|NCT00834405|Healthy Subjects|healthy subjects
5615814|NCT00834379|Bioequivalence|bioequivalence
5615815|NCT00834379|Healthy Subjects|healthy subjects
5615816|NCT00834366|Healthy volunteers|healthy volunteers
5615818|NCT00834340|Healthy Subjects|healthy subjects
5615819|NCT00834327|Restless Legs Syndrome|restless legs syndrome
5615820|NCT00834301|End Stage Renal Disease|end stage renal disease
5615821|NCT00834301|Inflammation|inflammation
5615822|NCT00834288|Healthy subjects|healthy subjects
5615823|NCT00834288|Pharmacokinetics|pharmacokinetics
5615824|NCT00834288|Bioavailability|bioavailability
5615825|NCT00834275|Bioequivalence|bioequivalence
5615826|NCT00834275|Healthy Subjects|healthy subjects
5615827|NCT00834249|Bioequivalence|bioequivalence
5615828|NCT00834249|Healthy Subjects|healthy subjects
5615829|NCT00834236|gastric cancer|gastric cancer
5615830|NCT00834236|proteomics|proteomics
5615831|NCT00834236|gastric juice|gastric juice
5615832|NCT00834223|refractory chronic forms of open angle glaucoma (OAG)|refractory chronic forms of open angle glaucoma (oag)
5615833|NCT00834223|OAG|oag
5615834|NCT00834223|glaucoma|glaucoma
5615835|NCT00834197|Bioequivalence|bioequivalence
5615836|NCT00834197|Healthy Subjects|healthy subjects
5615837|NCT00834184|nikkomycin Z|nikkomycin z
5615838|NCT00834184|evaluate safety, tolerance and pharmacokinetics of nikkomycin Z|evaluate safety, tolerance and pharmacokinetics of nikkomycin z
5615839|NCT00834158|Hepatocellular Carcinoma|hepatocellular carcinoma
5615840|NCT00834158|Hepatitis B|hepatitis b
5615841|NCT00834158|Transarterial chemoembolization (TACE)|transarterial chemoembolization (tace)
5615842|NCT00834158|Portal vein embolization (PVE)|portal vein embolization (pve)
5615843|NCT00834158|Surgical resection|surgical resection
5615844|NCT00834158|Disease-free survival|disease-free survival
5615845|NCT00834158|Overall survival|overall survival
5615847|NCT00834145|Right heart failure|right heart failure
5615848|NCT00834145|Cor pulmonale|cor pulmonale
5615849|NCT00834145|Pump|pump
5615850|NCT00834145|Leg compression|leg compression
5615851|NCT00834132|Bioequivalence|bioequivalence
5615852|NCT00834132|Healthy Subjects|healthy subjects
5615853|NCT00834106|HPV 6/11/16/18 Infection|hpv 6/11/16/18 infection
5615854|NCT00834093|Epstein-Barr Virus|epstein-barr virus
5615855|NCT00834093|NPC|npc
5615856|NCT00834093|EBV|ebv
5615857|NCT00834093|immunotherapy|immunotherapy
5615858|NCT00834080|opioid dependence|opioid dependence
5615859|NCT00834080|VIVITROL|vivitrol
5615860|NCT00834080|opioid-related disorders|opioid-related disorders
5615861|NCT00834067|Bioequivalence|bioequivalence
5615862|NCT00834067|Healthy Subjects|healthy subjects
5615863|NCT00834041|aliskiren|aliskiren
5615864|NCT00834041|pediatric|pediatric
5615865|NCT00834041|hypertension|hypertension
5615866|NCT00834041|pharmacokinetics (PK)|pharmacokinetics (pk)
5615867|NCT00834041|pharmacodynamics (PD)|pharmacodynamics (pd)
5615868|NCT00834041|plasma renin activity|plasma renin activity
5615869|NCT00834041|mini-tablet formulation|mini-tablet formulation
5615870|NCT00834028|hepatocellular carcinoma|hepatocellular carcinoma
5615871|NCT00834028|vascular endothelial growth factor|vascular endothelial growth factor
5615872|NCT00834028|angiopoietin|angiopoietin
5615873|NCT00834028|cathepsin|cathepsin
5615874|NCT00834015|spinal fusion|spinal fusion
5615875|NCT00834015|pain|pain
5615876|NCT00834015|disability|disability
5615877|NCT00834015|muscle strength|muscle strength
5615878|NCT00834015|mobility|mobility
5615879|NCT00834015|quality of life|quality of life
5615880|NCT00834015|lumbar|lumbar
5615881|NCT00834015|isthmic or degenerative spondylolisthesis|isthmic or degenerative spondylolisthesis
5615882|NCT00834002|AML in remission|aml in remission
5615883|NCT00833950|Tinnitus|tinnitus
5615884|NCT00833950|Phase Out|phase out
5615885|NCT00833937|Bioequivalence|bioequivalence
5615886|NCT00833937|Healthy Subjects|healthy subjects
5615887|NCT00833924|Low Profile|low profile
5615888|NCT00833924|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5615889|NCT00833924|Endovascular|endovascular
5615890|NCT00833911|Moderate to severe symptomatic osteoarthritis of the knee|moderate to severe symptomatic osteoarthritis of the knee
5615891|NCT00833898|depression|depression
5615892|NCT00833898|stress|stress
5615893|NCT00833898|caregiving|caregiving
5615894|NCT00833898|anxiety|anxiety
5615895|NCT00833898|psychoeducation intervention|psychoeducation intervention
5615896|NCT00833898|psycho-oncology|psycho-oncology
5615897|NCT00833885|Non pharmaceutical measures|non pharmaceutical measures
5615898|NCT00833859|stereotactic radiosurgery|stereotactic radiosurgery
5615899|NCT00833859|borderline resectable pancreatic cancer|borderline resectable pancreatic cancer
5615900|NCT00833859|gastrointestinal|gastrointestinal
5615901|NCT00833859|pancreas|pancreas
5615902|NCT00833846|Mitochondria in Platelets|mitochondria in platelets
5615903|NCT00833846|Mitochondria in Diabetes|mitochondria in diabetes
5615904|NCT00833846|Insulin Resistance and Mitochondria|insulin resistance and mitochondria
5615905|NCT00833846|Diabetes|diabetes
5615906|NCT00833846|Insulin Resistance|insulin resistance
5615907|NCT00833820|ALS|als
5615908|NCT00833820|transcranial brain stimulation|transcranial brain stimulation
5615909|NCT00833807|Melanoma|melanoma
5615910|NCT00833807|Metastatic Melanoma to the Liver|metastatic melanoma to the liver
5615911|NCT00833807|Liver metastasis|liver metastasis
5615912|NCT00833807|Nab-paclitaxel|nab-paclitaxel
5615913|NCT00833807|Abraxane|abraxane
5615914|NCT00833807|Paclitaxel (protein-bound)|paclitaxel (protein-bound)
5615915|NCT00833807|intraarterial intrahepatic administration|intraarterial intrahepatic administration
5615916|NCT00833807|Hepatic Artery|hepatic artery
5615917|NCT00833807|Hepatic Arterial Infusion|hepatic arterial infusion
5615918|NCT00833807|Hepatic Administration|hepatic administration
5615919|NCT00833781|HIV vaccine|hiv vaccine
5615920|NCT00833781|Dendritic cells|dendritic cells
5615921|NCT00833781|treatment experienced|treatment experienced
5615922|NCT00833755|Pain|pain
5615923|NCT00833755|Chronic pain|chronic pain
5615924|NCT00833755|Opioid induced hyperalgesia|opioid induced hyperalgesia
5615925|NCT00833755|Opioid therapy|opioid therapy
5615926|NCT00833742|somatization|somatization
5615927|NCT00833742|psychosomatic|psychosomatic
5615928|NCT00833742|short-term|short-term
5615929|NCT00833742|dynamic|dynamic
5615930|NCT00833742|psychotherapy|psychotherapy
5615931|NCT00833729|psoriasis|psoriasis
5615932|NCT00833729|etanercept|etanercept
5615933|NCT00833729|adalimumab|adalimumab
5615934|NCT00833729|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5615935|NCT00833703|cyanotic congenital heart disease|cyanotic congenital heart disease
5615936|NCT00833703|shunt palliation|shunt palliation
5615939|NCT00833690|Parkinson's disease|parkinson's disease
5615940|NCT00833690|Parkinson disease|parkinson disease
5615941|NCT00833690|PD|pd
5615942|NCT00833690|inosine|inosine
5615943|NCT00833690|urate|urate
5615944|NCT00833690|uric acid|uric acid
5615945|NCT00833690|cerebrospinal fluid|cerebrospinal fluid
5615946|NCT00833677|Coping skills|coping skills
5615947|NCT00833677|Chinese|chinese
5615948|NCT00833677|Immigrant|immigrant
5615949|NCT00833677|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5615950|NCT00833677|Family research|family research
5615951|NCT00833664|Bioequivalence|bioequivalence
5615952|NCT00833664|Healthy Subjects|healthy subjects
5615953|NCT00833651|Transplant|transplant
5615954|NCT00833651|Immunology|immunology
5615955|NCT00833651|Immunosuppression|immunosuppression
5615956|NCT00833638|Erectile Dysfunction|erectile dysfunction
5615957|NCT00833625|Gastrointestinal|gastrointestinal
5615958|NCT00833625|Esophagus|esophagus
5615959|NCT00833625|Cancer of the esophagus|cancer of the esophagus
5615960|NCT00833625|Biopsy|biopsy
5615961|NCT00833625|EGD|egd
5615962|NCT00833625|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5615963|NCT00833625|PET/CT|pet/ct
5615964|NCT00833625|Positive Emission Tomography/Computerized Tomography|positive emission tomography/computerized tomography
5615965|NCT00833625|Esophageal Cancer|esophageal cancer
5615966|NCT00833625|Chemoradiation|chemoradiation
5615967|NCT00833625|Chemotherapy|chemotherapy
5615968|NCT00833625|Radiation Therapy|radiation therapy
5615969|NCT00833612|IABC|iabc
5615970|NCT00833612|AMI|ami
5615971|NCT00833599|Lymphedema|lymphedema
5615972|NCT00833599|Genetic|genetic
5615973|NCT00833599|Lymphatic Disorder|lymphatic disorder
5615974|NCT00833599|Lipedema|lipedema
5615975|NCT00833599|Vascular Malformation|vascular malformation
5615976|NCT00833599|Vascular Anomaly|vascular anomaly
5615977|NCT00833599|Dercum Disease|dercum disease
5615978|NCT00833586|Bioequivalence|bioequivalence
5615979|NCT00833586|Healthy Subjects|healthy subjects
5615980|NCT00833573|GERD digestive expression|gerd digestive expression
5615981|NCT00833573|ages|ages
5615982|NCT00833560|Multiple Myeloma|multiple myeloma
5615983|NCT00833560|Untreated multiple myeloma|untreated multiple myeloma
5615984|NCT00833560|Bortezomib|bortezomib
5615985|NCT00833560|VELCADE|velcade
5615986|NCT00833560|Cyclophosphamide|cyclophosphamide
5615987|NCT00833560|Dexamethasone|dexamethasone
5615988|NCT00833560|Chemotherapy|chemotherapy
5615989|NCT00833560|Remission therapy|remission therapy
5615990|NCT00833560|Induction therapy|induction therapy
5615991|NCT00833560|Stem Cell Transplantation|stem cell transplantation
5615992|NCT00833547|sleep|sleep
5615993|NCT00833547|schizophrenia|schizophrenia
5615994|NCT00833547|procedural learning|procedural learning
5615995|NCT00833547|motor skill|motor skill
5615996|NCT00833534|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5615997|NCT00833534|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5615998|NCT00833534|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5615999|NCT00833534|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5616000|NCT00833534|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5616001|NCT00833534|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5616002|NCT00833534|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5616003|NCT00833534|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5616004|NCT00833534|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5616005|NCT00833521|Bioequivalence|bioequivalence
5616006|NCT00833521|Healthy Subjects|healthy subjects
5616007|NCT00833508|Exercise capacity|exercise capacity
5616008|NCT00833508|Chemoradiotherapy|chemoradiotherapy
5616009|NCT00833508|Colorectal cancer|colorectal cancer
5616010|NCT00833469|women|women
5616011|NCT00833469|postpartum depression|postpartum depression
5616012|NCT00833469|anxiety|anxiety
5616013|NCT00833456|schizophrenia|schizophrenia
5616014|NCT00833456|Seroquel SR|seroquel sr
5616015|NCT00833456|atypical antipsychotics|atypical antipsychotics
5616016|NCT00833456|assessment of functioning|assessment of functioning
5616017|NCT00833456|GAF scale|gaf scale
5616018|NCT00833443|Methamphetamine|methamphetamine
5616019|NCT00833443|Addiction|addiction
5616020|NCT00833443|Pharmacogenomics|pharmacogenomics
5616021|NCT00833443|Amphetamine|amphetamine
5616022|NCT00833443|Bupropion|bupropion
5616023|NCT00833443|Meth|meth
5616024|NCT00833443|Crank|crank
5616025|NCT00833443|Crystal|crystal
5616027|NCT00833430|Femoral Head Collapse|femoral head collapse
5616028|NCT00833417|BCC|bcc
5616029|NCT00833417|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5616030|NCT00833417|Hedgehog|hedgehog
5616031|NCT00833417|Basal Cell Cancer|basal cell cancer
5616032|NCT00833404|Smoking|smoking
5616033|NCT00833404|Smoking Cessation|smoking cessation
5616034|NCT00833404|Quit Smoking|quit smoking
5616035|NCT00833404|Stop Smoking|stop smoking
5616044|NCT00833391|pharmacokinetics|pharmacokinetics
5616045|NCT00833378|Drug interaction, SB-497115 (eltrombopag), Kaletra (Lopinavir, Ritonavir),thrombocytopenia, pharmacokinetics|drug interaction, sb-497115 (eltrombopag), kaletra (lopinavir, ritonavir),thrombocytopenia, pharmacokinetics
5616046|NCT00833365|premature infants|premature infants
5616048|NCT00833365|ibuprofen|ibuprofen
5616049|NCT00833313|Atrial fibrillation|atrial fibrillation
5616050|NCT00833313|Gene expression|gene expression
5616051|NCT00833313|Genetic|genetic
5616052|NCT00833300|Delirium|delirium
5616053|NCT00833300|Agitation|agitation
5616054|NCT00833300|Intensive Care|intensive care
5616055|NCT00833300|Critical Care|critical care
5616056|NCT00833300|Antipsychotics|antipsychotics
5616057|NCT00833300|Olanzapine|olanzapine
5616058|NCT00833300|Haloperidol|haloperidol
5616059|NCT00833287|immunoregulatory|immunoregulatory
5616060|NCT00833287|dysfunction|dysfunction
5616061|NCT00833287|obesity|obesity
5616062|NCT00833261|recurrent hypopharynx Cancer|recurrent hypopharynx cancer
5616063|NCT00833261|recurrent larynx Cancer|recurrent larynx cancer
5616064|NCT00833261|recurrent verrucous carcinoma|recurrent verrucous carcinoma
5616065|NCT00833261|squamous cell carcinoma|squamous cell carcinoma
5616066|NCT00833261|recurrent oral cavity cancer|recurrent oral cavity cancer
5616067|NCT00833261|recurrent metastatic occult primary cancer|recurrent metastatic occult primary cancer
5616068|NCT00833261|recurrent oropharynx cacner|recurrent oropharynx cacner
5616069|NCT00833261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5616070|NCT00833261|tongue cancer|tongue cancer
5616071|NCT00833222|premature birth|premature birth
5616072|NCT00833209|Orbitofrontal cortex|orbitofrontal cortex
5598372|NCT00900029|VSU|vsu
5616073|NCT00833209|Medication Overuse Headache|medication overuse headache
5616074|NCT00833209|Chronic headache|chronic headache
5616075|NCT00833209|withdrawal|withdrawal
5616076|NCT00833170|pediatric inflammatory bowel disease|pediatric inflammatory bowel disease
5616077|NCT00833170|multiple site study|multiple site study
5616078|NCT00833157|Knee Osteoarthritis|knee osteoarthritis
5616079|NCT00833157|exercise|exercise
5616080|NCT00833157|strength training|strength training
5616081|NCT00833157|Glucosamine|glucosamine
5616082|NCT00833157|Dietary supplement|dietary supplement
5616083|NCT00833157|Ibuprofen|ibuprofen
5616084|NCT00833157|NSAID|nsaid
5616085|NCT00833144|heart failure|heart failure
5616086|NCT00833144|dyspnea|dyspnea
5616087|NCT00833144|ultrasound|ultrasound
5616088|NCT00833131|Rectal cancer|rectal cancer
5616089|NCT00833131|Preoperative radiotherapy and consolidating chemotherapy|preoperative radiotherapy and consolidating chemotherapy
5616090|NCT00833118|Surgery|surgery
5616091|NCT00833118|General Anesthesia|general anesthesia
5616092|NCT00833118|Intubation|intubation
5616093|NCT00833105|Incomplete Spinal Cord Injury|incomplete spinal cord injury
5616094|NCT00833105|Rehabilitation|rehabilitation
5616095|NCT00833105|Upper Extremity|upper extremity
5616096|NCT00833105|AMES device|ames device
5616097|NCT00833105|Incomplete SCI|incomplete sci
5616098|NCT00833105|Quadriplegia|quadriplegia
5616099|NCT00833092|magnesium|magnesium
5616100|NCT00833092|Nutritional Requirements|nutritional requirements
5616101|NCT00833092|Sleep|sleep
5616102|NCT00833079|Atopic Dermatitis|atopic dermatitis
5616103|NCT00833066|hay fever|hay fever
5616104|NCT00833066|grass pollen allergy|grass pollen allergy
5616105|NCT00833040|Cancer breakthrough pain|cancer breakthrough pain
5798767|NCT00111150|HIV incidence|hiv incidence
5616106|NCT00833001|Anterior vaginal prolapse (medial, lateral,apical cystocele)|anterior vaginal prolapse (medial, lateral,apical cystocele)
5616107|NCT00833001|Posterior vaginal prolapse (rectocele and/or enterocele)|posterior vaginal prolapse (rectocele and/or enterocele)
5616108|NCT00833001|Vault prolapse (enterocele, uterine/vaginal vault prolapse)|vault prolapse (enterocele, uterine/vaginal vault prolapse)
5616109|NCT00832988|pacing thresholds|pacing thresholds
5616111|NCT00832988|impedance|impedance
5616112|NCT00832962|Rhesus D|rhesus d
5616113|NCT00832962|Anti-D allo-immunization|anti-d allo-immunization
5616114|NCT00832962|Fetal RHD genotyping|fetal rhd genotyping
5616115|NCT00832962|anti-D immunoglobulins|anti-d immunoglobulins
5616116|NCT00832962|anti-D prophylaxis|anti-d prophylaxis
5616117|NCT00832949|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5616118|NCT00832949|Peer support|peer support
5616120|NCT00832949|Self-management|self-management
5616121|NCT00832949|Patient education|patient education
5616122|NCT00832923|parental empowerment|parental empowerment
5616123|NCT00832923|parent self-efficacy|parent self-efficacy
5616124|NCT00832910|Body image|body image
5616125|NCT00832910|Rheumatoid Arthritis|rheumatoid arthritis
5616126|NCT00832897|Keratoconus|keratoconus
5616127|NCT00832897|riboflavin|riboflavin
5616128|NCT00832897|cornea|cornea
5616129|NCT00832897|crosslinking|crosslinking
5616130|NCT00832884|partial|partial
5616131|NCT00832884|onset|onset
5616132|NCT00832884|epilepsy|epilepsy
5616133|NCT00832884|pediatric|pediatric
5616134|NCT00832884|lacosamide|lacosamide
5616135|NCT00832884|partial onset epilepsy|partial onset epilepsy
5616136|NCT00832884|vimpat|vimpat
5616137|NCT00832871|Mifepristone|mifepristone
5616138|NCT00832871|RU-486|ru-486
5616139|NCT00832871|Compassionate Use|compassionate use
5616140|NCT00832871|Antiprogesterone|antiprogesterone
5616141|NCT00832845|Late-life schizophrenia (LLS)|late-life schizophrenia (lls)
5616142|NCT00832845|Cognitive Behavioural Social Skills Training (CBSST)|cognitive behavioural social skills training (cbsst)
5616143|NCT00832845|Randomized|randomized
5616144|NCT00832832|Glaucoma|glaucoma
5616145|NCT00832832|Eye drop|eye drop
5616146|NCT00832832|Intraocular pressure|intraocular pressure
5616147|NCT00832832|Eyelid closure|eyelid closure
5616148|NCT00832819|Cancer|cancer
5616149|NCT00832819|Lung Cancer|lung cancer
5616150|NCT00832806|smoking|smoking
5616151|NCT00832806|Champix|champix
5616152|NCT00832806|Integrated Voice Response technology|integrated voice response technology
5616153|NCT00832793|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5616154|NCT00832793|Peer support|peer support
5616155|NCT00832793|Early inflammatory arthritis|early inflammatory arthritis
5616156|NCT00832793|Self-management|self-management
5616157|NCT00832793|Patient education|patient education
5616158|NCT00832780|Lung cancer|lung cancer
5616159|NCT00832780|radiation therapy|radiation therapy
5616160|NCT00832780|SBRT|sbrt
5616161|NCT00832780|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5616162|NCT00832780|Tomotherapy|tomotherapy
5616163|NCT00832780|other solid tumors|other solid tumors
5616164|NCT00832767|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5616165|NCT00832767|Single Incision Laparoscopic Surgery|single incision laparoscopic surgery
5616166|NCT00832767|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5616167|NCT00832754|malaria|malaria
5616168|NCT00832754|rapid diagnostic test|rapid diagnostic test
5616169|NCT00832754|artemisinin|artemisinin
5616170|NCT00832754|Ghana|ghana
5616171|NCT00832741|GLP-1|glp-1
5616172|NCT00832741|Type 1 diabetes|type 1 diabetes
5616173|NCT00832741|Glycemic control|glycemic control
5616174|NCT00832741|Incretin hormone|incretin hormone
5616175|NCT00832715|Lung|lung
5616176|NCT00832715|Lung Cancer|lung cancer
5616177|NCT00832715|NSCLC|nsclc
5616178|NCT00832715|Non Small Cell Lung Cancer|non small cell lung cancer
5616179|NCT00832715|Squamous Cell|squamous cell
5616180|NCT00832715|Adenocarcinoma|adenocarcinoma
5616181|NCT00832715|Large Cell|large cell
5616182|NCT00832715|Endobronchial Ultrasound Transbronchial Needle Aspiration|endobronchial ultrasound transbronchial needle aspiration
5616183|NCT00832715|Mediastinal lymph node negative disease|mediastinal lymph node negative disease
5616184|NCT00832715|Mediastinal Nodal Metastasis|mediastinal nodal metastasis
5616185|NCT00832715|EBUS-FNA|ebus-fna
5616186|NCT00832715|Endobronchial Ultrasound Fine Needle Aspiration|endobronchial ultrasound fine needle aspiration
5616187|NCT00832715|EBUS guided needle mediastinal lymph node biopsy|ebus guided needle mediastinal lymph node biopsy
5616188|NCT00832715|Biopsy|biopsy
5616189|NCT00832715|PET scan|pet scan
5616190|NCT00832715|Positron Emission Tomography|positron emission tomography
5616191|NCT00832715|CT Scans|ct scans
5616192|NCT00832715|Computed Tomography Scans|computed tomography scans
5616193|NCT00832715|Lymph node|lymph node
5616194|NCT00832715|Mediastinoscopy|mediastinoscopy
5616195|NCT00832715|Bronchoscope|bronchoscope
5616198|NCT00832702|Coronary Vascular Dysfunction|coronary vascular dysfunction
5616199|NCT00832689|toxicity|toxicity
5616200|NCT00832676|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5616201|NCT00832676|Peer support|peer support
5616202|NCT00832676|Early inflammatory arthritis|early inflammatory arthritis
5616203|NCT00832676|Self-management|self-management
5616204|NCT00832676|Patient education|patient education
5616205|NCT00832663|Muscle regeneration|muscle regeneration
5616206|NCT00832663|Satellite cells|satellite cells
5616207|NCT00832663|electrical stimulation|electrical stimulation
5616208|NCT00832663|eccentric contractions|eccentric contractions
5616209|NCT00832663|myogenic precursor cells|myogenic precursor cells
5616210|NCT00832650|Healthy; Fesoterodine; Solifenacin|healthy; fesoterodine; solifenacin
5616211|NCT00832637|Liver|liver
5616212|NCT00832637|Gallbladder|gallbladder
5616213|NCT00832637|Bile duct|bile duct
5616214|NCT00832637|Gemzar|gemzar
5616217|NCT00832637|erlotinib|erlotinib
5616218|NCT00832637|Gem-ox|gem-ox
5616219|NCT00832611|Lung Disease|lung disease
5616220|NCT00832611|Chronic Airflow Obstruction|chronic airflow obstruction
5616221|NCT00832611|Chronic Bronchitis|chronic bronchitis
5616222|NCT00832611|Chronic Emphysema|chronic emphysema
5616223|NCT00832598|18F-FACBC|18f-facbc
5616224|NCT00832598|PET scan imaging|pet scan imaging
5616225|NCT00832598|08-142|08-142
5616226|NCT00832585|Atopic|atopic
5616227|NCT00832585|Dermatitis|dermatitis
5616228|NCT00832585|chronic|chronic
5616229|NCT00832585|skin|skin
5616230|NCT00832572|Coronary Artery Disease|coronary artery disease
5616231|NCT00832572|Pain|pain
5616232|NCT00832572|Peripheral Neuropathy|peripheral neuropathy
5616233|NCT00832572|Polyneuropathy|polyneuropathy
5616234|NCT00832559|CAVATAK|cavatak
5616235|NCT00832559|Coxsackievirus A21|coxsackievirus a21
5616236|NCT00832559|CVA21|cva21
5616237|NCT00832559|Oncolytic virotherapy|oncolytic virotherapy
5616238|NCT00832533|Vitamin D|vitamin d
5616239|NCT00832533|Serum 25-Hydroxyvitamin D|serum 25-hydroxyvitamin d
5616240|NCT00832533|UV exposure|uv exposure
5616241|NCT00832533|Ultraviolet Light Exposure|ultraviolet light exposure
5616242|NCT00832533|Skin Melanoma Advanced|skin melanoma advanced
5616243|NCT00832520|Advanced cancer|advanced cancer
5616244|NCT00832520|weight loss|weight loss
5616245|NCT00832520|Remeron|remeron
5616246|NCT00832520|body weight|body weight
5616247|NCT00832507|PAH|pah
5616248|NCT00832507|pulmonary hypertension|pulmonary hypertension
5616249|NCT00832507|cicletanine|cicletanine
5616250|NCT00832507|cicletanine HCL|cicletanine hcl
5616251|NCT00832507|cardiovascular|cardiovascular
5616252|NCT00832507|endothelin receptor antagonist|endothelin receptor antagonist
5616253|NCT00832507|ERA|era
5616254|NCT00832507|monotherapy|monotherapy
5616255|NCT00832507|combination therapy|combination therapy
5616256|NCT00832507|phosphodiesterase type-5 inhibitor|phosphodiesterase type-5 inhibitor
5616257|NCT00832507|PDE5i|pde5i
5616264|NCT00832468|ear acupressure|ear acupressure
5616265|NCT00832442|Beta blocker|beta blocker
5616266|NCT00832442|Heart Failure|heart failure
5616267|NCT00832442|Meta analysis|meta analysis
5616268|NCT00832442|Individual patient data|individual patient data
5616269|NCT00832429|Sebaceous Gland Carcinoma of the Eyelid|sebaceous gland carcinoma of the eyelid
5616270|NCT00832429|Eyelid Sebaceous Gland Carcinoma|eyelid sebaceous gland carcinoma
5616271|NCT00832429|Cancer of the eyelid|cancer of the eyelid
5616272|NCT00832429|Eye Cancer|eye cancer
5616273|NCT00832429|Tumors of the Eye|tumors of the eye
5616274|NCT00832429|Sentinel Lymph Node Localization and Biopsy|sentinel lymph node localization and biopsy
5616275|NCT00832429|SLN|sln
5616276|NCT00832429|Metastatic Disease|metastatic disease
5616277|NCT00832429|Metastatic Cancer of the Eyelid|metastatic cancer of the eyelid
5616278|NCT00832429|Lymphatic Mapping|lymphatic mapping
5616279|NCT00832429|SLN Mapping/Biopsy|sln mapping/biopsy
5616280|NCT00832429|SLN Biopsy Procedure|sln biopsy procedure
5616281|NCT00832429|SLN Biopsy|sln biopsy
5616282|NCT00832429|Lymph Nodes|lymph nodes
5616283|NCT00832429|Tc99m-Sulfur Colloid|tc99m-sulfur colloid
5616284|NCT00832429|Single Photon Emission Computed Tomography|single photon emission computed tomography
5616285|NCT00832429|Computed Tomography|computed tomography
5616286|NCT00832429|SPECT/CT|spect/ct
5616287|NCT00832403|atrophic rhinitis|atrophic rhinitis
5616288|NCT00832403|implants|implants
5616289|NCT00832403|Polytetrafluoroethylene|polytetrafluoroethylene
5616290|NCT00832364|Psoriasis|psoriasis
5616291|NCT00832364|Moderate to Severe Plaque Psoriasis|moderate to severe plaque psoriasis
5616292|NCT00832351|Stroke|stroke
5616293|NCT00832351|Brain infarction|brain infarction
5616294|NCT00832351|Intracerebral hemorrhage|intracerebral hemorrhage
5616295|NCT00832351|Early Mobilisation|early mobilisation
5616296|NCT00832338|Breast cancer|breast cancer
5616297|NCT00832338|Tumors, Breast|tumors, breast
5616298|NCT00832338|Cancer of the breast|cancer of the breast
5616299|NCT00832325|Childhood Survivor|childhood survivor
5616300|NCT00832325|survivors|survivors
5616301|NCT00832325|Young Adult Cancer Survivors|young adult cancer survivors
5616302|NCT00832325|Childhood cancers|childhood cancers
5616304|NCT00832312|Osteoarthritis|osteoarthritis
5616305|NCT00832312|Knee|knee
5616306|NCT00832312|Pain management|pain management
5616307|NCT00832312|Ozone therapy|ozone therapy
5616308|NCT00832312|Intraarticular injection|intraarticular injection
5616309|NCT00832286|genomic techniques,intestinal microbiome|genomic techniques,intestinal microbiome
5616310|NCT00832273|Expanded access to ELAD® in patients with liver failure|expanded access to elad® in patients with liver failure
5616311|NCT00832247|Hepatitis C|hepatitis c
5616312|NCT00832247|Cirrhosis|cirrhosis
5616313|NCT00832247|Stem cell|stem cell
5616314|NCT00832234|Morbus Waldenstrom|morbus waldenstrom
5616315|NCT00832234|Waldenstroms Macroglobulinemia|waldenstroms macroglobulinemia
5616316|NCT00832234|Therapy|therapy
5616317|NCT00832234|Rituximab|rituximab
5616318|NCT00832234|Dexamethasone|dexamethasone
5616319|NCT00832234|Bortezomib|bortezomib
5616320|NCT00832221|PET|pet
5616321|NCT00832221|Phase 1|phase 1
5616322|NCT00832221|Depression|depression
5616323|NCT00832221|SEROQUEL|seroquel
5616324|NCT00832221|Positron Emission Tomography|positron emission tomography
5616325|NCT00832221|Drug profile comparison|drug profile comparison
5616326|NCT00832195|running|running
5616327|NCT00832195|injury|injury
5616328|NCT00832195|pronation|pronation
5616329|NCT00832195|footwear.|footwear.
5616330|NCT00832169|Pain|pain
5616336|NCT00832143|neonatal illness|neonatal illness
5616337|NCT00832143|qualified care seeking|qualified care seeking
5616338|NCT00832143|Behaviour change|behaviour change
5616339|NCT00832143|Urban slums|urban slums
5616340|NCT00832143|India|india
5616341|NCT00832143|Neonatal morbidity|neonatal morbidity
5616342|NCT00832143|Care seeking for neonatal illnesses|care seeking for neonatal illnesses
5616343|NCT00832143|Qualified medical care seeking|qualified medical care seeking
5616344|NCT00832143|Integrated management of neonatal and childhood illnesses (IMNCI)|integrated management of neonatal and childhood illnesses (imnci)
5616345|NCT00832117|Lung Cancer (NSCLC)|lung cancer (nsclc)
5616346|NCT00832091|Venous Stasis Ulcers|venous stasis ulcers
5616347|NCT00832091|venous insufficiency|venous insufficiency
5616348|NCT00832091|leg ulcers|leg ulcers
5616349|NCT00832091|Thymosin Beta 4|thymosin beta 4
5616350|NCT00832091|Laminin-5|laminin-5
5616351|NCT00832065|Sleep Apnea Syndrome|sleep apnea syndrome
5616352|NCT00832065|Sleep Apnea|sleep apnea
5616353|NCT00832065|CPAP|cpap
5616354|NCT00832065|Low testosterone|low testosterone
5616355|NCT00832065|Sexual Dysfunction|sexual dysfunction
5616358|NCT00832039|adjunctive therapy|adjunctive therapy
5616359|NCT00832039|sodium-selenite|sodium-selenite
5616360|NCT00832039|procalcitonin|procalcitonin
5616361|NCT00832026|sleep apnea|sleep apnea
5616363|NCT00832026|sleep apnea treatment|sleep apnea treatment
5616364|NCT00832026|TNI|tni
5616365|NCT00832026|Trans nasal insufflation|trans nasal insufflation
5616366|NCT00832026|Open CPAP|open cpap
5616367|NCT00832013|Propofol|propofol
5616368|NCT00832013|sedation|sedation
5616369|NCT00832013|pediatric|pediatric
5616370|NCT00832013|Induction of sedation|induction of sedation
5616371|NCT00831987|Fluzone®|fluzone®
5616372|NCT00831987|Influenza|influenza
5616373|NCT00831987|Adults|adults
5616374|NCT00831974|mastocytosis|mastocytosis
5616375|NCT00831974|indolent|indolent
5616376|NCT00831974|handicap|handicap
5616377|NCT00831974|wild-type|wild-type
5616378|NCT00831974|systemic|systemic
5616379|NCT00831974|not D816V mutated|not d816v mutated
5616380|NCT00831961|Antibiotic resistance, Conjunctival flora, Intravitreal injections|antibiotic resistance, conjunctival flora, intravitreal injections
5616381|NCT00831935|Acoustic properties of voice in depression|acoustic properties of voice in depression
5616382|NCT00831922|Rheumatoid Arthritis|rheumatoid arthritis
5616383|NCT00831922|DMARD failure|dmard failure
5616384|NCT00831922|ACR|acr
5616385|NCT00831909|Lung Cancer|lung cancer
5616386|NCT00831909|NSCLC management|nsclc management
5616387|NCT00831909|NSCLC use of health care resources|nsclc use of health care resources
5616388|NCT00831883|Adolescent|adolescent
5616389|NCT00831883|Adolescent behavior|adolescent behavior
5616390|NCT00831883|Health behavior|health behavior
5616391|NCT00831883|Sexual Behavior|sexual behavior
5616392|NCT00831883|Incarceration|incarceration
5616393|NCT00831883|Behavioral Intervention|behavioral intervention
5616394|NCT00831883|Risk Reduction Behavior|risk reduction behavior
5616395|NCT00831870|EndoSure Sensor|endosure sensor
5616396|NCT00831870|s2 Sensor|s2 sensor
5616397|NCT00831870|abdominal aortic aneurysm|abdominal aortic aneurysm
5616398|NCT00831831|perinatal|perinatal
5616399|NCT00831831|intimate partner violence|intimate partner violence
5616400|NCT00831831|randomized controlled trial|randomized controlled trial
5616401|NCT00831831|preterm|preterm
5616402|NCT00831831|hemorrhage|hemorrhage
5616403|NCT00831831|safety|safety
5616404|NCT00831818|breastfeeding|breastfeeding
5616405|NCT00831818|ghrelin|ghrelin
5616406|NCT00831818|PYY|pyy
5616407|NCT00831818|appetite-regulation|appetite-regulation
5616408|NCT00831805|geriatrics|geriatrics
5616409|NCT00831805|psycho-cognitive troubles|psycho-cognitive troubles
5616410|NCT00831805|elderly|elderly
5616411|NCT00831805|mobile unit|mobile unit
5616412|NCT00831805|elderly patients|elderly patients
5616413|NCT00831792|Prostate Cancer|prostate cancer
5616414|NCT00831792|Advanced Prostate Cancer|advanced prostate cancer
5616415|NCT00831792|Castrate Resistant Prostate Cancer|castrate resistant prostate cancer
5616416|NCT00831792|Prostate Specific Antigen|prostate specific antigen
5616417|NCT00831792|PSA|psa
5616418|NCT00831792|Castration-Resistant Prostate Cancer Patients|castration-resistant prostate cancer patients
5616419|NCT00831792|TK1258|tk1258
5616420|NCT00831792|CHIR-258|chir-258
5616424|NCT00831753|Diphtheria|diphtheria
5616425|NCT00831753|Tetanus|tetanus
5616426|NCT00831753|Pertussis|pertussis
5616427|NCT00831753|whooping cough|whooping cough
5616428|NCT00831753|Haemophilus influenzae type b|haemophilus influenzae type b
5616429|NCT00831753|Hepatitis B|hepatitis b
5616430|NCT00831753|Poliomyelitis|poliomyelitis
5616431|NCT00831740|Stroke|stroke
5616432|NCT00831740|Communication|communication
5616433|NCT00831740|Speech and Language Therapy|speech and language therapy
5616434|NCT00831727|expressive writing|expressive writing
5616435|NCT00831727|trauma|trauma
5616436|NCT00831727|intervention|intervention
5616437|NCT00831727|posttraumatic stress|posttraumatic stress
5616438|NCT00831714|Prophylaxis of Venous Thromboembolism|prophylaxis of venous thromboembolism
5616439|NCT00831701|Adrenergic alpha antagonists|adrenergic alpha antagonists
5616440|NCT00831701|drug therapy|drug therapy
5616441|NCT00831701|tamsulosin|tamsulosin
5616442|NCT00831701|ureter|ureter
5616443|NCT00831688|Meniere|meniere
5616444|NCT00831688|vertigo|vertigo
5616445|NCT00831688|overpressure treatment|overpressure treatment
5616446|NCT00831688|caloric irrigation|caloric irrigation
5616447|NCT00831688|hearing levels|hearing levels
5616448|NCT00831688|vertigo severity|vertigo severity
5616449|NCT00831688|functional disability scale|functional disability scale
5616450|NCT00831675|Influenza|influenza
5616451|NCT00831675|Fluzone® vaccine|fluzone® vaccine
5616452|NCT00831675|Infants|infants
5616453|NCT00831675|Toddlers|toddlers
5616454|NCT00831636|CP-4055|cp-4055
5616455|NCT00831636|Cancer|cancer
5616456|NCT00831636|Metastatic|metastatic
5616457|NCT00831636|Solid tumors|solid tumors
5616458|NCT00831636|advanced ovarian cancer|advanced ovarian cancer
5616459|NCT00831636|stage III and IV ovarian cancer|stage iii and iv ovarian cancer
5616460|NCT00831636|advanced epithelian ovarian cancer|advanced epithelian ovarian cancer
5616461|NCT00831623|hypofractionation|hypofractionation
5616462|NCT00831623|proton beam radiation|proton beam radiation
5616463|NCT00831610|bariatric surgery|bariatric surgery
5616464|NCT00831610|plastic surgery|plastic surgery
5616465|NCT00831610|abdominal wall|abdominal wall
5616466|NCT00831610|skin|skin
5616467|NCT00831610|sensation|sensation
5616468|NCT00831610|abdominoplasty|abdominoplasty
5616469|NCT00831597|Lymphoma|lymphoma
5616470|NCT00831597|B-Cell|b-cell
5616471|NCT00831571|oxaliplatin|oxaliplatin
5616472|NCT00831571|hypersensitivity|hypersensitivity
5616473|NCT00831532|Dimebon Hepatic Impairment|dimebon hepatic impairment
5616474|NCT00831506|digoxin dimebon drug-drug interaction study|digoxin dimebon drug-drug interaction study
5616475|NCT00831493|Pancreas|pancreas
5616476|NCT00831493|Pancreatic Cancer|pancreatic cancer
5616477|NCT00831493|Locally Advanced Pancreatic Cancer|locally advanced pancreatic cancer
5616478|NCT00831493|LAPC|lapc
5616479|NCT00831493|Non-Metastatic|non-metastatic
5616480|NCT00831493|Unresectable|unresectable
5616481|NCT00831493|Vorinostat|vorinostat
5616482|NCT00831493|XRT|xrt
5616483|NCT00831493|RT|rt
5616484|NCT00831493|Radiation Therapy|radiation therapy
5616485|NCT00831493|SAHA|saha
5616486|NCT00831493|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5616487|NCT00831493|MSK-390|msk-390
5616488|NCT00831480|Renal cell carcinoma|renal cell carcinoma
5616489|NCT00831480|Everolimus|everolimus
5616490|NCT00831480|Neoadjuvant|neoadjuvant
5616491|NCT00831480|advanced kidney cancer|advanced kidney cancer
5616492|NCT00831467|Hormonal refractory prostate cancer|hormonal refractory prostate cancer
5616493|NCT00831467|RNA vaccine|rna vaccine
5616494|NCT00831441|NOS|nos
5616495|NCT00831428|asthma|asthma
5616496|NCT00831428|rhinitis|rhinitis
5616497|NCT00831428|swimmers|swimmers
5616498|NCT00831428|mannitol|mannitol
5616499|NCT00831415|Open-label Long-term extension study|open-label long-term extension study
5616500|NCT00831402|woman|woman
5616501|NCT00831376|Asthma|asthma
5616502|NCT00831376|Genotype|genotype
5616503|NCT00831376|Beta2adrenoreceptor|beta2adrenoreceptor
5616504|NCT00831376|Levosalbutamol|levosalbutamol
5616505|NCT00831363|gait analysis|gait analysis
5616506|NCT00831363|minimal invasive approach|minimal invasive approach
5616507|NCT00831363|transgluteal approach|transgluteal approach
5616509|NCT00831350|RVO|rvo
5616510|NCT00831350|PVD|pvd
5616511|NCT00831337|VSL3|vsl3
5616512|NCT00831337|Probiotics|probiotics
5616513|NCT00831337|Gut microbiota|gut microbiota
5616514|NCT00831337|Cytokines|cytokines
5616515|NCT00831337|Portal hypertension|portal hypertension
5616516|NCT00831337|Chemokines|chemokines
5616517|NCT00831337|Liver cirrhosis|liver cirrhosis
5616518|NCT00831311|Diphtheria|diphtheria
5616519|NCT00831311|Tetanus|tetanus
5616520|NCT00831311|Pertussis|pertussis
5616521|NCT00831311|Whooping cough|whooping cough
5616522|NCT00831311|Hepatitis B|hepatitis b
5616523|NCT00831311|Poliomyelitis|poliomyelitis
5616524|NCT00831311|Haemophilus influenzae type b|haemophilus influenzae type b
5616525|NCT00831298|alzheimer disease|alzheimer disease
5616526|NCT00831298|sleep disturbance|sleep disturbance
5616527|NCT00831298|apathy|apathy
5616528|NCT00831298|memory loss|memory loss
5616529|NCT00831285|Healthy volunteers|healthy volunteers
5616530|NCT00831259|stroke|stroke
5616531|NCT00831259|PFO|pfo
5616532|NCT00831259|embolism|embolism
5616533|NCT00831246|Ileus,|ileus,
5616534|NCT00831246|Gynecologic surgery,|gynecologic surgery,
5616535|NCT00831246|Post-operative,|post-operative,
5616536|NCT00831246|Flatus|flatus
5616537|NCT00831220|COPD|copd
5616538|NCT00831220|exacerbations|exacerbations
5616539|NCT00831220|EPCs|epcs
5616540|NCT00831220|Erythropoietin|erythropoietin
5616541|NCT00831220|C-RP|c-rp
5616542|NCT00831220|COPD and endothelial dysfunction|copd and endothelial dysfunction
5616543|NCT00831207|B-2 microglobulin|b-2 microglobulin
5616544|NCT00831207|Serum cytokines|serum cytokines
5616545|NCT00831207|HIV-1|hiv-1
5616546|NCT00831207|Resistance|resistance
5616547|NCT00831207|HAART|haart
5616548|NCT00831207|Therapeutic failure|therapeutic failure
5616549|NCT00831207|Genotyping.|genotyping.
5616550|NCT00831194|Type 2 Diabetes|type 2 diabetes
5616551|NCT00831194|Obesity|obesity
5616552|NCT00831194|Weight loss|weight loss
5616553|NCT00831194|PDA|pda
5616554|NCT00831194|Stress|stress
5616555|NCT00831194|Dietary lapse|dietary lapse
5616556|NCT00831194|salivary alpha amylase|salivary alpha amylase
5616557|NCT00831181|stage II rectal cancer|stage ii rectal cancer
5616558|NCT00831181|stage III rectal cancer|stage iii rectal cancer
5616559|NCT00831181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5616560|NCT00831168|neonatal|neonatal
5616561|NCT00831168|premature babies|premature babies
5616562|NCT00831168|healthcare research|healthcare research
5616563|NCT00831168|Babies born before 27 weeks gestation|babies born before 27 weeks gestation
5616564|NCT00831155|smoking|smoking
5616565|NCT00831155|nicotine patches|nicotine patches
5616571|NCT00831116|LipiScan|lipiscan
5616572|NCT00831116|lipid core|lipid core
5616573|NCT00831116|percutaneous coronary intervention|percutaneous coronary intervention
5616574|NCT00831116|myocardial infarction|myocardial infarction
5616575|NCT00831116|NIRS|nirs
5616576|NCT00831116|intravascular imaging|intravascular imaging
5616577|NCT00831103|EPB348|epb348
5616578|NCT00831103|Valomaciclovir Stearate|valomaciclovir stearate
5616579|NCT00831103|Valacyclovir|valacyclovir
5616580|NCT00831103|Herpes Zoster|herpes zoster
5616581|NCT00831103|Shingles|shingles
5616582|NCT00831077|Healthy volunteers|healthy volunteers
5616583|NCT00831064|bowel preparation quality|bowel preparation quality
5616584|NCT00831064|colonoscopy|colonoscopy
5616585|NCT00831051|Bunionectomy|bunionectomy
5616586|NCT00831038|pulmonary function tests|pulmonary function tests
5616587|NCT00831038|infants|infants
5616588|NCT00831038|chronic lung disease|chronic lung disease
5616589|NCT00831038|dysphagia|dysphagia
5616590|NCT00831038|chronic aspiration|chronic aspiration
5616591|NCT00831025|Immunotherapy|immunotherapy
5616592|NCT00831025|Allergoid|allergoid
5616593|NCT00831025|Depigmented|depigmented
5616594|NCT00831025|Polymerized|polymerized
5616595|NCT00831025|Allergen-extract|allergen-extract
5616596|NCT00831025|Rhinoconjunctivitis|rhinoconjunctivitis
5616597|NCT00831012|Dengue Vaccine|dengue vaccine
5616598|NCT00831012|Dengue Virus|dengue virus
5616599|NCT00831012|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5616600|NCT00831012|Dengue Shock Syndrome|dengue shock syndrome
5616601|NCT00830999|fat metabolism|fat metabolism
5616602|NCT00830999|exercise|exercise
5616603|NCT00830999|liver|liver
5616604|NCT00830999|lipoproteins|lipoproteins
5616605|NCT00830999|triglycerides|triglycerides
5616606|NCT00830986|Mental Cognition Change|mental cognition change
5616607|NCT00830986|Fat Embolism|fat embolism
5616608|NCT00830986|Bone Marrow Debris Emboli|bone marrow debris emboli
5616609|NCT00830986|Computer Assisted Total Knee Arthroplasty|computer assisted total knee arthroplasty
5616610|NCT00830986|Conventional Instrumented Total Knee Arthroplasty|conventional instrumented total knee arthroplasty
5616611|NCT00830973|Estrogen Antagonists|estrogen antagonists
5616612|NCT00830973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5616613|NCT00830973|Hormone Antagonists|hormone antagonists
5616614|NCT00830973|Hormones|hormones
5616615|NCT00830973|Hormone Substitutes|hormone substitutes
5616616|NCT00830973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
5616617|NCT00830973|Estrogen Receptor Modulators|estrogen receptor modulators
5616618|NCT00830973|Neoplasms|neoplasms
5616619|NCT00830973|Neoplasms by Site|neoplasms by site
5616620|NCT00830947|Orthodontic|orthodontic
5616621|NCT00830947|Extraction|extraction
5616622|NCT00830947|Device|device
5616623|NCT00830947|Space Closure|space closure
5616624|NCT00830947|Orthodontic malocclusion|orthodontic malocclusion
5616625|NCT00830934|pelvic girdle pain|pelvic girdle pain
5616626|NCT00830934|symphysio pubic dysfunction|symphysio pubic dysfunction
5616627|NCT00830934|group care|group care
5616628|NCT00830934|individual care|individual care
5616629|NCT00830921|Histocytologically proven thoracic malignancy|histocytologically proven thoracic malignancy
5616630|NCT00830908|seborrheic dermatitis|seborrheic dermatitis
5616631|NCT00830895|Renal cell carcinoma|renal cell carcinoma
5616632|NCT00830895|Non-clear cell|non-clear cell
5616633|NCT00830895|RAD001|rad001
5616634|NCT00830895|Metastatic, non-clear cell, renal cell carcinoma|metastatic, non-clear cell, renal cell carcinoma
5616635|NCT00830882|asthma|asthma
5616636|NCT00830882|levosalbutamol|levosalbutamol
5616637|NCT00830882|genotype|genotype
5616638|NCT00830882|bronchoprotection|bronchoprotection
5616639|NCT00830869|Drug therapy|drug therapy
5616640|NCT00830856|Cryptococcal Meningitis|cryptococcal meningitis
5616641|NCT00830856|HIV|hiv
5616642|NCT00830856|Fluconazole|fluconazole
5616643|NCT00830856|Antiretroviral therapy|antiretroviral therapy
5616644|NCT00830856|Africa|africa
5616645|NCT00830856|treatment naive|treatment naive
5616646|NCT00830843|SAH|sah
5616647|NCT00830843|sedation|sedation
5616648|NCT00830843|anesthesia|anesthesia
5616649|NCT00830817|Topical cream application|topical cream application
5616650|NCT00830817|Mild to moderate psoriasis|mild to moderate psoriasis
5616651|NCT00830804|Treatment Naive|treatment naive
5616652|NCT00830778|pancreas|pancreas
5616653|NCT00830778|surgery|surgery
5616654|NCT00830778|cancer|cancer
5616655|NCT00830778|pancreaticoduodenectomy (PD)|pancreaticoduodenectomy (pd)
5616656|NCT00830778|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)|peri-ampullary tumours (ampulla, duodenum, distal bile duct, and miscellaneous tumours)
5616657|NCT00830778|pancreatic tumors|pancreatic tumors
5616658|NCT00830778|peri-ampullary tumors|peri-ampullary tumors
5616659|NCT00830752|alexithymia|alexithymia
5616660|NCT00830739|Smoking Cessation|smoking cessation
5616661|NCT00830739|Dopamine|dopamine
5616662|NCT00830739|Cognitive Control|cognitive control
5616756|NCT00830401|myoma|myoma
5616663|NCT00830739|Reward Processing|reward processing
5616664|NCT00830739|Varenicline|varenicline
5616665|NCT00830726|Aquaporin|aquaporin
5616666|NCT00830726|Epithelial Sodium Channels|epithelial sodium channels
5616667|NCT00830726|Heart Failure|heart failure
5616668|NCT00830726|Valvular heart disease|valvular heart disease
5616669|NCT00830726|Ischemic heart disease|ischemic heart disease
5616670|NCT00830713|vitiligo|vitiligo
5616671|NCT00830713|skin transplantation|skin transplantation
5616672|NCT00830713|non-cultured|non-cultured
5616673|NCT00830713|melanocyte|melanocyte
5616674|NCT00830713|surgery|surgery
5616675|NCT00830700|ADHD|adhd
5616676|NCT00830700|telemental health|telemental health
5616677|NCT00830700|TMH|tmh
5616678|NCT00830700|telepsychiatry|telepsychiatry
5616679|NCT00830700|rural mental health services for children|rural mental health services for children
5616680|NCT00830687|subcapital femoral fractures|subcapital femoral fractures
5616681|NCT00830687|transcervical femoral fractures|transcervical femoral fractures
5616682|NCT00830687|TARGON FN|targon fn
5616683|NCT00830674|XLH|xlh
5616684|NCT00830661|transsphincteric anal fistula|transsphincteric anal fistula
5616685|NCT00830661|cryptoglandular origin|cryptoglandular origin
5616686|NCT00830661|anal fistula repair|anal fistula repair
5616687|NCT00830661|Ligation of Intersphincteric Fistula Track (LIFT) procedure|ligation of intersphincteric fistula track (lift) procedure
5616688|NCT00830661|anal fistula plug (Plug)|anal fistula plug (plug)
5616689|NCT00830661|surgical repair|surgical repair
5616690|NCT00830648|varicella-zoster virus|varicella-zoster virus
5616691|NCT00830648|varicella|varicella
5616692|NCT00830635|long-term effects of cancer treatment|long-term effects of cancer treatment
5616693|NCT00830635|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5616694|NCT00830635|depression|depression
5616695|NCT00830635|stage IA breast cancer|stage ia breast cancer
5616696|NCT00830635|stage IB breast cancer|stage ib breast cancer
5616697|NCT00830635|stage II breast cancer|stage ii breast cancer
5616698|NCT00830635|stage I prostate cancer|stage i prostate cancer
5616699|NCT00830635|stage II prostate cancer|stage ii prostate cancer
5616700|NCT00830622|HIV/AIDS|hiv/aids
5616701|NCT00830622|Adherence|adherence
5616702|NCT00830622|Antiretroviral Therapy, ART, ARV|antiretroviral therapy, art, arv
5616703|NCT00830622|Mobile phone, cell phone, telephone|mobile phone, cell phone, telephone
5616704|NCT00830622|Text message, SMS|text message, sms
5616705|NCT00830622|Telemedicine|telemedicine
5616706|NCT00830622|Africa|africa
5616707|NCT00830622|Resource-limited setting|resource-limited setting
5616708|NCT00830622|Counseling, support|counseling, support
5616709|NCT00830622|treatment experienced|treatment experienced
5616710|NCT00830609|Chronic Hepatitis C|chronic hepatitis c
5616711|NCT00830609|Genotype 3|genotype 3
5616712|NCT00830609|High viral load|high viral load
5616713|NCT00830570|CYP2C9|cyp2c9
5616714|NCT00830570|VKORC1|vkorc1
5616715|NCT00830570|polymorphism|polymorphism
5616716|NCT00830570|warfarin|warfarin
5616717|NCT00830570|Coumadin|coumadin
5616718|NCT00830557|recurrent pancreatic cancer|recurrent pancreatic cancer
5616719|NCT00830557|stage I pancreatic cancer|stage i pancreatic cancer
5616720|NCT00830557|stage II pancreatic cancer|stage ii pancreatic cancer
5616721|NCT00830557|stage III pancreatic cancer|stage iii pancreatic cancer
5616722|NCT00830557|stage IV pancreatic cancer|stage iv pancreatic cancer
5616723|NCT00830557|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5616724|NCT00830557|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
5616725|NCT00830557|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
5616726|NCT00830557|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
5616727|NCT00830557|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
5616728|NCT00830544|neoadjuvant chemotherapy breast cancer|neoadjuvant chemotherapy breast cancer
5616729|NCT00830544|Breast cancer patients with tumors over one cm|breast cancer patients with tumors over one cm
5616730|NCT00830531|Hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5616731|NCT00830531|Neonatal stroke|neonatal stroke
5616732|NCT00830531|Intracranial hemorrhage|intracranial hemorrhage
5616733|NCT00830531|Perinatal asphyxia|perinatal asphyxia
5616734|NCT00830531|Neonatal Seizures|neonatal seizures
5616735|NCT00830518|Drug therapy|drug therapy
5616736|NCT00830505|fluticasone|fluticasone
5616737|NCT00830505|salmeterol|salmeterol
5616738|NCT00830505|bronchoprotection|bronchoprotection
5616739|NCT00830492|clomiphene citrate|clomiphene citrate
5616740|NCT00830492|GnRH agonist|gnrh agonist
5616741|NCT00830492|GnRH antagonist|gnrh antagonist
5616742|NCT00830492|in vitro fertilization|in vitro fertilization
5616743|NCT00830492|clinical pregnancy|clinical pregnancy
5616744|NCT00830492|pregnancy|pregnancy
5616745|NCT00830466|port wine stain|port wine stain
5616746|NCT00830453|Brain injury with sequelae from stroke, anoxia, or trauma|brain injury with sequelae from stroke, anoxia, or trauma
5616747|NCT00830427|asthma bronchial diseases|asthma bronchial diseases
5616748|NCT00830414|Bioequivalence|bioequivalence
5616749|NCT00830414|Healthy Subjects|healthy subjects
5616750|NCT00830401|intra-uterine abnormalities|intra-uterine abnormalities
5616751|NCT00830401|intracavitary pathology|intracavitary pathology
5616752|NCT00830401|hysteroscopy|hysteroscopy
5616754|NCT00830401|ICSI|icsi
5616755|NCT00830401|polyp|polyp
5616757|NCT00830401|adhesion|adhesion
5616758|NCT00830401|septum|septum
5616759|NCT00830401|endometritis|endometritis
5616760|NCT00830388|tinea versicolor|tinea versicolor
5616761|NCT00830388|ketoconazole|ketoconazole
5616762|NCT00830375|Buying|buying
5616763|NCT00830375|Shopping|shopping
5616764|NCT00830375|Impulse Control|impulse control
5616765|NCT00830362|cocaine|cocaine
5616766|NCT00830362|cocaine-dependent|cocaine-dependent
5616767|NCT00830362|propranolol|propranolol
5616768|NCT00830362|craving|craving
5616769|NCT00830362|beta-blockade|beta-blockade
5616770|NCT00830362|cue exposure|cue exposure
5616771|NCT00830362|drug|drug
5616772|NCT00830362|addiction|addiction
5616773|NCT00830362|memory|memory
5616774|NCT00830362|addictive behavior|addictive behavior
5616775|NCT00830349|Bioequivalence|bioequivalence
5616776|NCT00830349|Healthy Subjects|healthy subjects
5616777|NCT00830336|Bioequivalence|bioequivalence
5616778|NCT00830336|Healthy Subjects|healthy subjects
5616779|NCT00830310|Patient Non-Adherence|patient non-adherence
5616780|NCT00830310|Patient Non-Compliance|patient non-compliance
5616781|NCT00830310|Patient Nonadherence|patient nonadherence
5616782|NCT00830310|Patient Noncompliance|patient noncompliance
5616783|NCT00830310|Patient Refusal of Treatment|patient refusal of treatment
5616784|NCT00830310|Refusal of Treatment|refusal of treatment
5616785|NCT00830310|Treatment Refusal|treatment refusal
5616786|NCT00830297|TIP|tip
5616787|NCT00830297|NODAT|nodat
5616788|NCT00830297|hyperglycemia|hyperglycemia
5616789|NCT00830297|long-acting insulin|long-acting insulin
5616790|NCT00830297|post-transplant hyperglycemia|post-transplant hyperglycemia
5616791|NCT00830284|Pediatric Acute Respiratory Distress Syndrome (ARDS)|pediatric acute respiratory distress syndrome (ards)
5616792|NCT00830284|Pediatric Acute Lung Injury (ALI)|pediatric acute lung injury (ali)
5616793|NCT00830271|surgical site infection|surgical site infection
5616794|NCT00830271|wound complications|wound complications
5616796|NCT00830271|antiseptic|antiseptic
5616797|NCT00830271|wound closure|wound closure
5616798|NCT00830258|Bioequivalence|bioequivalence
5616799|NCT00830258|Healthy Subjects|healthy subjects
5616800|NCT00830245|EGFR mutation|egfr mutation
5616801|NCT00830245|Erlotinib|erlotinib
5616803|NCT00830245|leptomeningeal carcinomatosis in EGFR mutation positive non-small cell lung cancer|leptomeningeal carcinomatosis in egfr mutation positive non-small cell lung cancer
5616804|NCT00830232|Stroke|stroke
5616805|NCT00830232|Carotid stenosis|carotid stenosis
5616806|NCT00830232|stents|stents
5616807|NCT00830219|Bioequivalence|bioequivalence
5616808|NCT00830219|Healthy Subjects|healthy subjects
5616809|NCT00830206|Bioequivalence|bioequivalence
5616810|NCT00830206|Healthy Subjects|healthy subjects
5616811|NCT00830193|N-acetylcysteine|n-acetylcysteine
5616812|NCT00830193|prevention|prevention
5616813|NCT00830193|contrast-induced nephropathy|contrast-induced nephropathy
5616814|NCT00830193|critically ill adults|critically ill adults
5616815|NCT00830180|Cancer pain|cancer pain
5616817|NCT00830180|open-label extension|open-label extension
5616818|NCT00830154|stutter|stutter
5616819|NCT00830154|stuttering|stuttering
5616820|NCT00830154|Adults with a history of stuttering|adults with a history of stuttering
5616821|NCT00830141|Ghrelin|ghrelin
5616822|NCT00830141|obesity|obesity
5616823|NCT00830141|idiopathic short stature (ISS)|idiopathic short stature (iss)
5616824|NCT00830115|PPI therapy|ppi therapy
5616825|NCT00830115|Pantoprazole|pantoprazole
5616826|NCT00830115|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
5616827|NCT00830115|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5616828|NCT00830102|Mild to Moderate Asthma|mild to moderate asthma
5616829|NCT00830089|Transversus abdominis plane block|transversus abdominis plane block
5616830|NCT00830089|Laparoscopic colorectal surgery|laparoscopic colorectal surgery
5616831|NCT00830089|Analgesia|analgesia
5616832|NCT00830063|monoclonal antibody|monoclonal antibody
5616833|NCT00830063|RN624|rn624
5616834|NCT00830063|PF-04383119|pf-04383119
5616835|NCT00830063|nerve growth factor|nerve growth factor
5616836|NCT00830063|anti-nerve growth factor|anti-nerve growth factor
5616839|NCT00830050|fMRI functional magnetic resonance imaging Pain|fmri functional magnetic resonance imaging pain
5616840|NCT00830037|anemia|anemia
5616841|NCT00830037|iron|iron
5616842|NCT00830037|kidney disease|kidney disease
5616843|NCT00830037|progression|progression
5616844|NCT00830037|glomerular filtration rate|glomerular filtration rate
5616845|NCT00830024|Bioequivalence|bioequivalence
5616846|NCT00830024|Healthy Subjects|healthy subjects
5616847|NCT00830011|diabetes|diabetes
5616848|NCT00830011|neuropathy|neuropathy
5616849|NCT00830011|chronic pain|chronic pain
5616850|NCT00830011|Cognitive behavioral therapy|cognitive behavioral therapy
5616851|NCT00829998|Bioequivalence|bioequivalence
5616852|NCT00829998|Healthy Subjects|healthy subjects
5616853|NCT00829985|Rhinitis, Allergic, Perennial|rhinitis, allergic, perennial
5616854|NCT00829985|Rhinitis, Allergic, Seasonal|rhinitis, allergic, seasonal
5616855|NCT00829985|Immunotherapy|immunotherapy
5616857|NCT00829985|Nasal Allergies|nasal allergies
5616858|NCT00829985|Hypersensitivity|hypersensitivity
5616859|NCT00829959|Ovary, Cancer|ovary, cancer
5616860|NCT00829959|Ovarian Cancer|ovarian cancer
5616861|NCT00829959|Breast Cancer|breast cancer
5616862|NCT00829959|Hereditary Breast and Ovarian Cancer Syndrome|hereditary breast and ovarian cancer syndrome
5616863|NCT00829959|HBOC|hboc
5616864|NCT00829959|Genetic testing|genetic testing
5616865|NCT00829959|Pregnancy|pregnancy
5616866|NCT00829959|Fertility|fertility
5616867|NCT00829959|Prenatal diagnostic testing|prenatal diagnostic testing
5616868|NCT00829946|Strength training|strength training
5616869|NCT00829946|Anorexia|anorexia
5616870|NCT00829946|Girls|girls
5616871|NCT00829946|Quality of life|quality of life
5616872|NCT00829946|Functional mobility|functional mobility
5616873|NCT00829933|Atrial fibrillation|atrial fibrillation
5616874|NCT00829933|Factor Xa inhibition|factor xa inhibition
5616875|NCT00829920|Bladder cancer|bladder cancer
5616876|NCT00829907|Healthy volunteer study|healthy volunteer study
5616877|NCT00829894|Bioequivalence|bioequivalence
5616878|NCT00829894|Healthy Subjects|healthy subjects
5616879|NCT00829881|Attention|attention
5616880|NCT00829868|Bioequivalence|bioequivalence
5616881|NCT00829868|Healthy Subjects|healthy subjects
5616882|NCT00829855|pulmonary edema|pulmonary edema
5616883|NCT00829855|hypertension|hypertension
5616884|NCT00829855|echocardiography|echocardiography
5616885|NCT00829842|chlorexidine|chlorexidine
5616886|NCT00829842|ventilator-associated pneumonia|ventilator-associated pneumonia
5616887|NCT00829842|nosocomial pneumonia|nosocomial pneumonia
5616888|NCT00829842|heart surgery|heart surgery
5616889|NCT00829842|oral hygiene|oral hygiene
5616890|NCT00829829|Metabolism, Inborn Errors|metabolism, inborn errors
5616891|NCT00829829|Allopurinol|allopurinol
5616892|NCT00829829|Metabolic Diseases|metabolic diseases
5616893|NCT00829829|Genetic Diseases, Inborn|genetic diseases, inborn
5616894|NCT00829829|Musculoskeletal Diseases|musculoskeletal diseases
5616895|NCT00829829|Joint Diseases|joint diseases
5616896|NCT00829829|Arthritis|arthritis
5616897|NCT00829829|Rheumatic Diseases|rheumatic diseases
5616898|NCT00829829|Metabolic disorder|metabolic disorder
5616899|NCT00829829|Purine-Pyrimidine Metabolism, Inborn Errors|purine-pyrimidine metabolism, inborn errors
5616901|NCT00829816|Alzheimers disease|alzheimers disease
5616902|NCT00829816|donepezil|donepezil
5616903|NCT00829816|memantine|memantine
5616904|NCT00829803|To acquire developmental data to prospectively support SNAP|to acquire developmental data to prospectively support snap
5601301|NCT00892593|polyp|polyp
5616905|NCT00829803|II index ranges at the studied anesthetic states.|ii index ranges at the studied anesthetic states.
5616906|NCT00829790|Bioequivalence|bioequivalence
5616907|NCT00829790|Healthy Subjects|healthy subjects
5616908|NCT00829777|Naloxone|naloxone
5616909|NCT00829777|6β-Naltrexol|6β-naltrexol
5616910|NCT00829777|Opioid-dependent|opioid-dependent
5616911|NCT00829777|Pharmacokinetics|pharmacokinetics
5616912|NCT00829777|peripheral effects of withdrawal|peripheral effects of withdrawal
5616913|NCT00829777|central effects of withdrawal|central effects of withdrawal
5616914|NCT00829764|Bioequivalence|bioequivalence
5616915|NCT00829764|Healthy Subjects|healthy subjects
5616916|NCT00829751|staining|staining
5616917|NCT00829751|toxicity|toxicity
5616918|NCT00829751|fluorometry|fluorometry
5616919|NCT00829751|dye diffusion|dye diffusion
5616920|NCT00829751|anterior chamber|anterior chamber
5616922|NCT00829738|pantoprazole|pantoprazole
5616923|NCT00829738|GERD (Erosive Gastroesophageal Reflux Disease)|gerd (erosive gastroesophageal reflux disease)
5616924|NCT00829725|subcapital femoral fractures|subcapital femoral fractures
5616925|NCT00829725|transcervical femoral fractures|transcervical femoral fractures
5616926|NCT00829725|TARGON FN|targon fn
5616927|NCT00829712|Bioequivalence|bioequivalence
5616928|NCT00829712|Healthy Subjects|healthy subjects
5616929|NCT00829699|endothelial function|endothelial function
5616930|NCT00829699|fibrinolytic balance|fibrinolytic balance
5616931|NCT00829686|abscess|abscess
5616932|NCT00829686|cellulitis|cellulitis
5616933|NCT00829686|antibiotics|antibiotics
5616934|NCT00829686|MRSA|mrsa
5616935|NCT00829673|Bioequivalence|bioequivalence
5616939|NCT00829647|dasatinib|dasatinib
5616940|NCT00829647|lenalidomide|lenalidomide
5616942|NCT00829647|revlimid|revlimid
5616943|NCT00829647|CLL relapsed or refractory to fludarabine|cll relapsed or refractory to fludarabine
5616944|NCT00829634|methamphetamine|methamphetamine
5616945|NCT00829634|inpatient|inpatient
5616946|NCT00829634|d-MA|d-ma
5616947|NCT00829634|l-MA|l-ma
5616948|NCT00829634|APRL|aprl
5616949|NCT00829634|San Francisco|san francisco
5616950|NCT00829634|metabolism|metabolism
5616951|NCT00829634|Metabolism of methamphetamine|metabolism of methamphetamine
5616952|NCT00829621|BMP-2|bmp-2
5616953|NCT00829621|Incisional Vacuum Assisted Closure (IVAC)|incisional vacuum assisted closure (ivac)
5616954|NCT00829608|RRP|rrp
5616955|NCT00829608|Recurrent Respiratory Papillomatosis|recurrent respiratory papillomatosis
5616956|NCT00829608|HPV vaccine|hpv vaccine
5616958|NCT00829595|inflammatory bowel disease|inflammatory bowel disease
5616959|NCT00829595|Crohn disease|crohn disease
5616960|NCT00829595|ulcerative colitis|ulcerative colitis
5616961|NCT00829595|immunosuppression|immunosuppression
5616962|NCT00829595|anti tumor necrosis alpha|anti tumor necrosis alpha
5616963|NCT00829595|pneumovax|pneumovax
5616964|NCT00829595|pneumococcal vaccine|pneumococcal vaccine
5616965|NCT00829569|Intralipid|intralipid
5616966|NCT00829569|Omegaven|omegaven
5616967|NCT00829569|fish oil|fish oil
5616968|NCT00829569|hyperinsulinemic isoglycemic clamps|hyperinsulinemic isoglycemic clamps
5616969|NCT00829569|C-peptide glucagon test|c-peptide glucagon test
5616970|NCT00829569|indirect calorimetry|indirect calorimetry
5616971|NCT00829569|F2-isoprostanes|f2-isoprostanes
5616972|NCT00829543|Spodyloarthropathy|spodyloarthropathy
5616973|NCT00829543|Guide-free sacroiliac injection|guide-free sacroiliac injection
5616974|NCT00829530|Bioequivalence|bioequivalence
5616975|NCT00829530|Healthy Subjects|healthy subjects
5616976|NCT00829517|Contraception|contraception
5616977|NCT00829517|sexually transmitted diseases|sexually transmitted diseases
5616978|NCT00829504|Bioequivalence|bioequivalence
5616979|NCT00829504|Healthy Subjects|healthy subjects
5616980|NCT00829491|Cardiovascular Disease Prevention|cardiovascular disease prevention
5616981|NCT00829491|Behavior change|behavior change
5616982|NCT00829491|Risk Reduction|risk reduction
5616983|NCT00829478|Atrial fibrillation|atrial fibrillation
5616984|NCT00829478|Cerebrovascular accident|cerebrovascular accident
5616985|NCT00829478|Anticoagulation|anticoagulation
5616986|NCT00829478|Decision-making|decision-making
5616987|NCT00829452|Bioequivalence|bioequivalence
5616988|NCT00829452|Healthy Subjects|healthy subjects
5616989|NCT00829439|Angelman syndrome|angelman syndrome
5616990|NCT00829439|Levodopa|levodopa
5616991|NCT00829439|Carbidopa|carbidopa
5616993|NCT00829426|Bioequivalence|bioequivalence
5616994|NCT00829426|Healthy Subjects|healthy subjects
5616995|NCT00829400|Neuropsychology|neuropsychology
5616996|NCT00829400|Cognitive Remediation|cognitive remediation
5616997|NCT00829400|Vocational Rehabilitation|vocational rehabilitation
5616998|NCT00829400|Schizophrenia|schizophrenia
5616999|NCT00829400|Severe and persistent mental illness|severe and persistent mental illness
5617000|NCT00829400|Chronic and disabling mental illness|chronic and disabling mental illness
5617001|NCT00829387|Diabetes|diabetes
5617002|NCT00829387|Pain|pain
5617003|NCT00829387|Neuropathic Pain|neuropathic pain
5617004|NCT00829374|Alzheimer's disease|alzheimer's disease
5617005|NCT00829374|clinical trial|clinical trial
5617006|NCT00829374|mitochondria|mitochondria
5617007|NCT00829374|memory loss|memory loss
5617008|NCT00829374|neurodegenerative disease|neurodegenerative disease
5617009|NCT00829374|dementia|dementia
5617010|NCT00829374|investigational drug|investigational drug
5617011|NCT00829361|Telemedicine|telemedicine
5617012|NCT00829361|Acute stroke|acute stroke
5617013|NCT00829361|Rural|rural
5617014|NCT00829361|thrombosis|thrombosis
5617015|NCT00829361|consultation|consultation
5617016|NCT00829361|Stroke|stroke
5617017|NCT00829361|Cerebral Infarction|cerebral infarction
5617018|NCT00829361|Vascular diseases|vascular diseases
5617019|NCT00829361|brain ischemia|brain ischemia
5617020|NCT00829361|brain infarction|brain infarction
5617021|NCT00829361|brain diseases|brain diseases
5617022|NCT00829361|cerebrovascular disorders|cerebrovascular disorders
5617023|NCT00829348|Compliance|compliance
5617025|NCT00829348|Pharmacotherapy|pharmacotherapy
5617026|NCT00829348|Statins|statins
5617027|NCT00829335|Intraoperative ultrasound|intraoperative ultrasound
5617028|NCT00829335|Segmentectomy|segmentectomy
5617030|NCT00829309|Bioequivalence|bioequivalence
5617031|NCT00829309|Healthy Subjects|healthy subjects
5617032|NCT00829296|diabetes|diabetes
5617033|NCT00829296|hypertension|hypertension
5617034|NCT00829296|aortic impedance|aortic impedance
5617035|NCT00829283|Experimental|experimental
5610787|NCT00854841|CML|cml
5617037|NCT00829244|Infertility|infertility
5617038|NCT00829244|Assisted reproductive technology|assisted reproductive technology
5617039|NCT00829231|Liver disease|liver disease
5617040|NCT00829218|Irritable Bowel Syndrome|irritable bowel syndrome
5617041|NCT00829218|Fibromyalgia|fibromyalgia
5617042|NCT00829218|Glutamate|glutamate
5617043|NCT00829218|Diet|diet
5617044|NCT00829218|Food additives|food additives
5617045|NCT00829205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5617046|NCT00829192|Actinic keratoses (AK)|actinic keratoses (ak)
5617047|NCT00829192|Squamous cell carcinomas (SCC)|squamous cell carcinomas (scc)
5617048|NCT00829192|CUV1647|cuv1647
5617049|NCT00829192|Afamelanotide|afamelanotide
5617050|NCT00829192|Clinuvel|clinuvel
5617051|NCT00829192|Photoprotection|photoprotection
5617052|NCT00829192|Organ transplant|organ transplant
5617053|NCT00829179|Asthma|asthma
5617054|NCT00829153|Fistula patency|fistula patency
5617055|NCT00829127|volunteers|volunteers
5617057|NCT00829114|AIDS|aids
5617058|NCT00829114|ALT|alt
5617059|NCT00829114|ART|art
5617060|NCT00829114|AST|ast
5617061|NCT00829114|DCF|dcf
5617062|NCT00829114|DMC|dmc
5617063|NCT00829114|FDA|fda
5617064|NCT00829114|GCP|gcp
5617065|NCT00829114|HB sAg|hb sag
5617066|NCT00829114|ICH|ich
5617067|NCT00829114|IND|ind
5617068|NCT00829114|IRB|irb
5617069|NCT00829114|IU|iu
5617070|NCT00829114|mg|mg
5617071|NCT00829114|mm3|mm3
5617072|NCT00829114|PCR|pcr
5617073|NCT00829114|SAE|sae
5617074|NCT00829114|ULN|uln
5617075|NCT00829114|WB|wb
5617076|NCT00829114|COC|coc
5617077|NCT00829114|Combined Oral Contraceptives|combined oral contraceptives
5617078|NCT00829101|unilateral cleft lip and palate|unilateral cleft lip and palate
5617079|NCT00829101|primary palatal surgery|primary palatal surgery
5617080|NCT00829101|articulation|articulation
5617081|NCT00829101|phonology|phonology
5617082|NCT00829101|one stage palatal repair|one stage palatal repair
5617083|NCT00829101|two stage palatal repair|two stage palatal repair
5617084|NCT00829088|Mass balance|mass balance
5617085|NCT00829088|AZD2066|azd2066
5617086|NCT00829088|Pain|pain
5617087|NCT00829088|Pain conditions|pain conditions
5617088|NCT00829062|Type 1 diabetes|type 1 diabetes
5617089|NCT00829062|Insulin pump|insulin pump
5617090|NCT00829062|Glycemic variability|glycemic variability
5617091|NCT00829036|Rehabilitation|rehabilitation
5617092|NCT00829036|Sensory Aid|sensory aid
5617093|NCT00829023|Positive aerobic or anaerobic cultures|positive aerobic or anaerobic cultures
5617094|NCT00829010|Human Immunodeficiency Virus|human immunodeficiency virus
5617095|NCT00829010|Booster vaccination|booster vaccination
5617096|NCT00829010|Safety|safety
5617097|NCT00829010|Primary vaccination|primary vaccination
5617098|NCT00829010|Pneumococcal vaccine|pneumococcal vaccine
5617099|NCT00829010|Immunogenicity|immunogenicity
5617100|NCT00829010|Pneumococcal disease|pneumococcal disease
5617101|NCT00828997|rheumatoid arthritis|rheumatoid arthritis
5617102|NCT00828997|spondylarthropathy|spondylarthropathy
5617103|NCT00828997|immunological response following vaccination with Prevenar|immunological response following vaccination with prevenar
5617104|NCT00828971|Complicated skin and skin structure infections|complicated skin and skin structure infections
5617105|NCT00828971|cSSSI|csssi
5617106|NCT00828958|schizophrenia|schizophrenia
5617107|NCT00828958|Risperidone|risperidone
5617108|NCT00828958|Long acting injectable|long acting injectable
5617109|NCT00828958|Intradeltoidal injection|intradeltoidal injection
5617110|NCT00828919|VEGFR inhibitor|vegfr inhibitor
5617111|NCT00828919|angi-angiogenic|angi-angiogenic
5617112|NCT00828919|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5617113|NCT00828906|Glaucoma|glaucoma
5617114|NCT00828906|IOP|iop
5617115|NCT00828906|DuoTrav|duotrav
5617116|NCT00828893|drain under scanner|drain under scanner
5617117|NCT00828867|healthy subjects|healthy subjects
5617118|NCT00828867|FTIH, single dose, food effect, healthy subjects, double-blind|ftih, single dose, food effect, healthy subjects, double-blind
5617119|NCT00828854|breast cancer|breast cancer
5617120|NCT00828854|estrogen receptor postive|estrogen receptor postive
5617121|NCT00828828|Influenza Vaccine|influenza vaccine
5617122|NCT00828828|Sarcoidosis|sarcoidosis
5617123|NCT00828828|Antibody|antibody
5617124|NCT00828815|HIV-negative|hiv-negative
5617125|NCT00828815|buprenorphine/nalaxone|buprenorphine/nalaxone
5617126|NCT00828815|norbuprenorphine|norbuprenorphine
5617127|NCT00828815|opioid-dependent|opioid-dependent
5617128|NCT00828815|TMC125-TiDP2-C188|tmc125-tidp2-c188
5617129|NCT00828815|TMC125-C188|tmc125-c188
5617130|NCT00828815|TMC125|tmc125
5617131|NCT00828815|HIV Infections|hiv infections
5617132|NCT00828802|Myelodysplastic Syndromes|myelodysplastic syndromes
5617133|NCT00828802|MDS|mds
5617134|NCT00828789|Hepatitis C|hepatitis c
5617135|NCT00828789|HCV|hcv
5617136|NCT00828789|HIV|hiv
5617137|NCT00828789|AIDS|aids
5617138|NCT00828789|Telaprevir|telaprevir
5617139|NCT00828789|Efavirenz|efavirenz
5617140|NCT00828789|Tenofovir disproxil fumarate|tenofovir disproxil fumarate
5617142|NCT00828789|VX-950-C134|vx-950-c134
5617143|NCT00828789|VX-950-TiDP24-C134|vx-950-tidp24-c134
5617144|NCT00828789|HIV Infections|hiv infections
5617145|NCT00828776|TTPa|ttpa
5617146|NCT00828776|Anti-Xa|anti-xa
5617147|NCT00828776|Adverse Reactions|adverse reactions
5617148|NCT00828763|healthy volunteer|healthy volunteer
5617149|NCT00828763|radiolabelled|radiolabelled
5617150|NCT00828750|eltrombopag|eltrombopag
5617151|NCT00828750|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5617152|NCT00828750|ITP|itp
5617153|NCT00828750|blood platelet|blood platelet
5617154|NCT00828711|Misoprostol vaginal insert|misoprostol vaginal insert
5617155|NCT00828711|Induction of labor|induction of labor
5617156|NCT00828711|Cervical ripening|cervical ripening
5617157|NCT00828711|Rate of cesarean section|rate of cesarean section
5617158|NCT00828698|Death, sudden|death, sudden
5617159|NCT00828698|All cause mortality|all cause mortality
5617160|NCT00828685|Return to Work|return to work
5617161|NCT00828685|CRPP|crpp
5617162|NCT00828685|ORIF|orif
5617163|NCT00828685|Distal Radius|distal radius
5617164|NCT00828672|bevacizumab|bevacizumab
5617165|NCT00828672|capecitabine|capecitabine
5617166|NCT00828672|radiation therapy|radiation therapy
5617167|NCT00828672|oxaliplatin|oxaliplatin
5617168|NCT00828672|multimodality treatments|multimodality treatments
5617169|NCT00828672|TME (total mesorectal excision)|tme (total mesorectal excision)
5617170|NCT00828672|Axe Beam|axe beam
5617171|NCT00828672|rectal cancer|rectal cancer
5617172|NCT00828672|neoadjuvant|neoadjuvant
5617173|NCT00828672|pathological complete response|pathological complete response
5617174|NCT00828672|postoperative complications|postoperative complications
5617175|NCT00828659|Abuse potential|abuse potential
5617176|NCT00828646|Healthy Subjects|healthy subjects
5617177|NCT00828633|stage I prostate cancer|stage i prostate cancer
5617178|NCT00828633|stage II prostate cancer|stage ii prostate cancer
5617179|NCT00828607|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5617180|NCT00828607|Liver tumors|liver tumors
5617181|NCT00828607|Hepatocellular carcinoma|hepatocellular carcinoma
5617182|NCT00828607|Hemangioma|hemangioma
5617183|NCT00828607|Focal Nodular Hyperplasia|focal nodular hyperplasia
5617184|NCT00828607|Hepatic metastases|hepatic metastases
5617185|NCT00828594|Hepatocellular carcinoma|hepatocellular carcinoma
5617186|NCT00828594|dose-finding study|dose-finding study
5617187|NCT00828594|randomized trial|randomized trial
5617188|NCT00828594|medical treatment|medical treatment
5617189|NCT00828594|RAD001|rad001
5617190|NCT00828594|sorafenib|sorafenib
5617191|NCT00828594|Advanced hepatocellular cancer (HCC)|advanced hepatocellular cancer (hcc)
5617192|NCT00828568|Actinic Keratosis|actinic keratosis
5617193|NCT00828555|HPV vaccine|hpv vaccine
5617194|NCT00828555|Tdap vaccine|tdap vaccine
5617195|NCT00828542|Adverse Effects|adverse effects
5617196|NCT00828542|Etonogestrel|etonogestrel
5617197|NCT00828542|Postpartum period|postpartum period
5617198|NCT00828542|Contraception|contraception
5617199|NCT00828542|Hemostasis|hemostasis
5617200|NCT00828542|Metabolism|metabolism
5617201|NCT00828529|TMC207-TiDP13-C110|tmc207-tidp13-c110
5617202|NCT00828529|TMC207-C110|tmc207-c110
5617203|NCT00828529|TMC207|tmc207
5617204|NCT00828529|Drug-drug interaction|drug-drug interaction
5617205|NCT00828529|Tuberculosis|tuberculosis
5617206|NCT00828529|HIV|hiv
5617207|NCT00828529|Kaletra|kaletra
5617208|NCT00828529|Lopinavir|lopinavir
5617209|NCT00828529|Ritonavir|ritonavir
5617210|NCT00828529|Open-label|open-label
5617211|NCT00828529|HIV Infections|hiv infections
5617212|NCT00828516|lymphedema|lymphedema
5617213|NCT00828516|male breast cancer|male breast cancer
5617214|NCT00828516|stage IA breast cancer|stage ia breast cancer
5617215|NCT00828516|stage IB breast cancer|stage ib breast cancer
5617216|NCT00828516|stage II breast cancer|stage ii breast cancer
5617217|NCT00828516|recurrent breast cancer|recurrent breast cancer
5617218|NCT00828516|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5617219|NCT00828516|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5617220|NCT00828516|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5617221|NCT00828516|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5617222|NCT00828516|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5617223|NCT00828516|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5617224|NCT00828516|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5617225|NCT00828516|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5617226|NCT00828516|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5617227|NCT00828516|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5617228|NCT00828516|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5617229|NCT00828516|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5617230|NCT00828516|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5617231|NCT00828516|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5617232|NCT00828516|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5617233|NCT00828516|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5617234|NCT00828516|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5617235|NCT00828516|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5617236|NCT00828516|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5617237|NCT00828516|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5617238|NCT00828516|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5617239|NCT00828516|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5617240|NCT00828516|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5617241|NCT00828516|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5617242|NCT00828516|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5617243|NCT00828516|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5617244|NCT00828516|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5617245|NCT00828516|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5617246|NCT00828516|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5617247|NCT00828516|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5617248|NCT00828516|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5617249|NCT00828516|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5617250|NCT00828516|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5617251|NCT00828516|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5617252|NCT00828516|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5617253|NCT00828516|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5617254|NCT00828516|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5672289|NCT00612469|mutans streptococci|mutans streptococci
5617255|NCT00828516|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5617256|NCT00828516|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5617257|NCT00828516|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5617258|NCT00828516|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5617259|NCT00828516|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5617260|NCT00828516|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5617261|NCT00828516|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5617262|NCT00828516|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5617263|NCT00828516|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5617264|NCT00828516|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5617265|NCT00828516|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5617266|NCT00828516|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5617267|NCT00828516|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5617268|NCT00828516|recurrent salivary gland cancer|recurrent salivary gland cancer
5617269|NCT00828516|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5617270|NCT00828516|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5617271|NCT00828516|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5617272|NCT00828516|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5617273|NCT00828516|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5617274|NCT00828516|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5617275|NCT00828516|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5617276|NCT00828516|stage I salivary gland cancer|stage i salivary gland cancer
5617277|NCT00828516|stage II salivary gland cancer|stage ii salivary gland cancer
5617278|NCT00828516|tongue cancer|tongue cancer
5617279|NCT00828503|Certi-CMV|certi-cmv
5617280|NCT00828503|immunosuppressive switch (to Certican)|immunosuppressive switch (to certican)
5617281|NCT00828503|renal transplant|renal transplant
5617282|NCT00828490|Fraud and Abuse|fraud and abuse
5617283|NCT00828490|opioids|opioids
5617284|NCT00828464|Dermatosis, Dermatitis, Dry skin, Irritated skin|dermatosis, dermatitis, dry skin, irritated skin
5617288|NCT00828451|growth factors|growth factors
5617289|NCT00828451|metabolism|metabolism
5617290|NCT00828425|Diabetes Mellitus|diabetes mellitus
5617291|NCT00828425|retinopathy|retinopathy
5617292|NCT00828425|Management of diabetic patients with retinopathy|management of diabetic patients with retinopathy
5617293|NCT00828399|Radiotherapy|radiotherapy
5617294|NCT00828399|Diarrhoea|diarrhoea
5617295|NCT00828399|Glutamine|glutamine
5617296|NCT00828399|Oxydative stress|oxydative stress
5617297|NCT00828399|Calprotectin|calprotectin
5617298|NCT00828399|Citrulline|citrulline
5617299|NCT00828386|Nasopharyngeal cancers|nasopharyngeal cancers
5617300|NCT00828386|induction chemotherapy|induction chemotherapy
5617301|NCT00828386|radiochemotherapy|radiochemotherapy
5617302|NCT00828360|Heart Failure|heart failure
5617303|NCT00828360|CRT|crt
5617304|NCT00828360|Dobutamine echocardiography|dobutamine echocardiography
5617305|NCT00828334|transcatheter occlusion of patent ductus arteriosus|transcatheter occlusion of patent ductus arteriosus
5617306|NCT00828321|Bioequivalency|bioequivalency
5617307|NCT00828321|Healthy Volunteers|healthy volunteers
5617308|NCT00828308|localized|localized
5617310|NCT00828308|prostate cancer|prostate cancer
5617311|NCT00828308|neoadjuvant treatment|neoadjuvant treatment
5617312|NCT00828295|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5617313|NCT00828295|palonosetron|palonosetron
5617314|NCT00828295|pediatric|pediatric
5617315|NCT00828282|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5617316|NCT00828282|Simvastatin|simvastatin
5617318|NCT00828269|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5617319|NCT00828256|arthroscopic repair|arthroscopic repair
5617320|NCT00828256|rotator cuff|rotator cuff
5617321|NCT00828256|tears|tears
5617322|NCT00828256|shoulder|shoulder
5617323|NCT00828256|chronic tear of rotator cuff|chronic tear of rotator cuff
5617324|NCT00828243|Pulmonary surfactants|pulmonary surfactants
5617325|NCT00828243|Pulmonary surfactant associated protein B|pulmonary surfactant associated protein b
5617326|NCT00828243|Pulmonary surfactant associated protein C|pulmonary surfactant associated protein c
5617327|NCT00828243|ATP-binding cassette protein sub member family A3|atp-binding cassette protein sub member family a3
5617328|NCT00828230|budesonide|budesonide
5617329|NCT00828230|placebo|placebo
5617330|NCT00828230|acute radiation proctitis|acute radiation proctitis
5617331|NCT00828230|late radiation proctitis|late radiation proctitis
5617332|NCT00828230|Prevention of acute radiation proctitis|prevention of acute radiation proctitis
5617333|NCT00828230|Prevention of late radiation proctitis|prevention of late radiation proctitis
5617334|NCT00828217|adapted physical activity|adapted physical activity
5617335|NCT00828217|hospital|hospital
5617336|NCT00828217|health-related quality of life|health-related quality of life
5617337|NCT00828217|satisfaction with care|satisfaction with care
5617338|NCT00828217|child|child
5617339|NCT00828217|adolescent|adolescent
5617340|NCT00828217|randomized controlled trial|randomized controlled trial
5617341|NCT00828217|physical activity|physical activity
5617342|NCT00828217|quality of life|quality of life
5617343|NCT00828191|Luteal support in IVF|luteal support in ivf
5617345|NCT00828178|atherosclerosis|atherosclerosis
5617346|NCT00828178|omega-3|omega-3
5617347|NCT00828126|Metastatic Melanoma|metastatic melanoma
5617348|NCT00828126|AJCC Stage III Melanoma|ajcc stage iii melanoma
5617349|NCT00828126|AJCC stage IV Melanoma|ajcc stage iv melanoma
5617350|NCT00828126|PET-CT|pet-ct
5617351|NCT00828126|Positron Emission Tomography-Computed Tomography|positron emission tomography-computed tomography
5617352|NCT00828126|Contrast-enhanced Computed Tomography Scan|contrast-enhanced computed tomography scan
5617354|NCT00828126|Conventional Imaging|conventional imaging
5617355|NCT00828126|False Positive Rate|false positive rate
5617356|NCT00828126|Fluorodeoxyglucose|fluorodeoxyglucose
5617357|NCT00828126|FDG|fdg
5617358|NCT00828126|Surgery|surgery
5617359|NCT00828113|smoking|smoking
5617360|NCT00828113|relapse|relapse
5617361|NCT00828113|withdrawal|withdrawal
5617362|NCT00828087|acute myocardial infarction|acute myocardial infarction
5617363|NCT00828087|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5617364|NCT00828087|drug-eluting stent|drug-eluting stent
5617365|NCT00828074|stage IV breast cancer|stage iv breast cancer
5617366|NCT00828074|recurrent breast cancer|recurrent breast cancer
5617367|NCT00828035|robotics|robotics
5617368|NCT00828035|laparoscopy|laparoscopy
5617369|NCT00828035|surgery|surgery
5617370|NCT00828035|computer assisted|computer assisted
5617371|NCT00828022|measles-positive NSCLC|measles-positive nsclc
5617372|NCT00828022|measles vaccine|measles vaccine
5617373|NCT00828022|consolidation|consolidation
5617374|NCT00828022|Stage 3B with pleural effusion or stage 4 non-small cell lung cancer in remission|stage 3b with pleural effusion or stage 4 non-small cell lung cancer in remission
5617375|NCT00828009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5617376|NCT00828009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5617377|NCT00828009|adenocarcinoma of the lung|adenocarcinoma of the lung
5617379|NCT00827996|abcesses|abcesses
5617380|NCT00827983|Luteal Phase Support in IVF patients|luteal phase support in ivf patients
5617381|NCT00827970|mass screening|mass screening
5617382|NCT00827957|Hypothermia|hypothermia
5617383|NCT00827957|Internal cooling|internal cooling
5617384|NCT00827957|External cooling|external cooling
5617385|NCT00827957|Cardiac arrest|cardiac arrest
5617386|NCT00827944|Uncomplicated primary inguinal hernias|uncomplicated primary inguinal hernias
5617387|NCT00827931|tranexamic acid|tranexamic acid
5617388|NCT00827931|major abdominal surgery|major abdominal surgery
5617389|NCT00827931|blood loss|blood loss
5617390|NCT00827918|Acute Exacerbation of Schizophrenia|acute exacerbation of schizophrenia
5617391|NCT00827905|Non-Contact|non-contact
5617392|NCT00827905|Radar|radar
5617393|NCT00827905|Respiratory|respiratory
5617394|NCT00827905|Respiration|respiration
5617395|NCT00827905|Breathing|breathing
5617396|NCT00827905|Rate|rate
5617397|NCT00827905|Frequency|frequency
5617398|NCT00827905|Respiratory Mechanics|respiratory mechanics
5617399|NCT00827905|Respiratory Rate Measurement|respiratory rate measurement
5617400|NCT00827892|Intracerebral Hemorrhage|intracerebral hemorrhage
5617401|NCT00827892|Treatment|treatment
5617402|NCT00827892|MRI|mri
5617403|NCT00827879|Intimate partner aggression|intimate partner aggression
5617404|NCT00827879|Couples intervention|couples intervention
5617405|NCT00827879|PTSD|ptsd
5617406|NCT00827879|Veterans|veterans
5617407|NCT00827879|Prevention|prevention
5617408|NCT00827879|Violence Prevention|violence prevention
5617409|NCT00827879|Prevention of pertetration of intimate partner aggression.|prevention of pertetration of intimate partner aggression.
5617410|NCT00827866|Tobacco quitline|tobacco quitline
5617411|NCT00827866|Childhood cancer survivors|childhood cancer survivors
5617412|NCT00827866|Adult-onset cancer survivors|adult-onset cancer survivors
5617413|NCT00827853|Diabetes|diabetes
5617414|NCT00827853|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5617415|NCT00827853|Superficial Femoral Artery (SFA)|superficial femoral artery (sfa)
5617416|NCT00827853|Cryoplasty|cryoplasty
5617417|NCT00827853|Restenosis|restenosis
5617418|NCT00827827|Stroke|stroke
5617419|NCT00827827|Exercise|exercise
5617420|NCT00827827|Strength Training|strength training
5617421|NCT00827827|Skeletal Muscle|skeletal muscle
5617422|NCT00827827|Insulin Sensitivity|insulin sensitivity
5617423|NCT00827801|Cancer|cancer
5617424|NCT00827801|Heart Failure|heart failure
5617426|NCT00827801|Cancer and Concurrent Heart Failure|cancer and concurrent heart failure
5617427|NCT00827801|MDASI-HF Symptom Management Program|mdasi-hf symptom management program
5617428|NCT00827801|MDASI-HF|mdasi-hf
5617429|NCT00827801|MDASI-HF questionnaire|mdasi-hf questionnaire
5617430|NCT00827801|M. D. Anderson Symptom Inventory - Heart Failure|m. d. anderson symptom inventory - heart failure
5617431|NCT00827801|Questionnaire|questionnaire
5617432|NCT00827801|Symptom Management Gap|symptom management gap
5617433|NCT00827788|contrast media|contrast media
5617434|NCT00827788|angiography|angiography
5617435|NCT00827788|percutaneous coronary intervention|percutaneous coronary intervention
5617436|NCT00827775|Hypertension|hypertension
5617437|NCT00827775|Hemodialysis|hemodialysis
5617438|NCT00827762|phenylketonuria|phenylketonuria
5617439|NCT00827762|Kuvan|kuvan
5617440|NCT00827762|sapropterin|sapropterin
5617441|NCT00827762|behavior|behavior
5617442|NCT00827762|cognition|cognition
5617443|NCT00827762|executive abilities|executive abilities
5617444|NCT00827762|attention|attention
5617445|NCT00827749|swallowing disorders|swallowing disorders
5617446|NCT00827749|geriatrics|geriatrics
5617447|NCT00827736|anal fissure|anal fissure
5617448|NCT00827736|fissura ani|fissura ani
5617449|NCT00827736|botox|botox
5617451|NCT00827736|Nitric oxide donor|nitric oxide donor
5617452|NCT00827723|Hepatic functional reserve|hepatic functional reserve
5617453|NCT00827723|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5617454|NCT00827723|Indocyanine Green retention rate at 15 minutes (ICG-R15')|indocyanine green retention rate at 15 minutes (icg-r15')
5617455|NCT00827723|Portal Pressure (PP)|portal pressure (pp)
5617456|NCT00827723|Hepatic Portal Venous Gradient (HPVG)|hepatic portal venous gradient (hpvg)
5617457|NCT00827723|Alcoholic and Viral Cirrhosis|alcoholic and viral cirrhosis
5617458|NCT00827723|Makuuchi criteria|makuuchi criteria
5617459|NCT00827723|Barcelona Clinic of Liver Cancer (BCLC)|barcelona clinic of liver cancer (bclc)
5617460|NCT00827723|Hepatic resection|hepatic resection
5617461|NCT00827710|diabetes|diabetes
5617462|NCT00827710|registry|registry
5617463|NCT00827710|computer|computer
5617464|NCT00827710|self management|self management
5617465|NCT00827697|Gonorrhea|gonorrhea
5617466|NCT00827697|Chlamydia|chlamydia
5617467|NCT00827697|Rectal|rectal
5617468|NCT00827684|KRAS mutation|kras mutation
5617469|NCT00827658|anesthesia, local|anesthesia, local
5617470|NCT00827658|ulnar nerve|ulnar nerve
5617471|NCT00827658|hand|hand
5617472|NCT00827658|surgery, plastic|surgery, plastic
5617473|NCT00827658|blinded|blinded
5617474|NCT00827658|randomized|randomized
5617475|NCT00827658|prospective|prospective
5617477|NCT00827658|volar wrist block|volar wrist block
5617478|NCT00827658|hypothenar palm block|hypothenar palm block
5617479|NCT00827658|hand surgery|hand surgery
5617480|NCT00827632|Ovarian Suppression|ovarian suppression
5617481|NCT00827632|Oral Contraceptives|oral contraceptives
5617482|NCT00827632|Obese and Normal BMI|obese and normal bmi
5617483|NCT00827619|Peripheral Arterial Disease|peripheral arterial disease
5617484|NCT00827606|pediatric heterozygous familial hypercholesterolemia|pediatric heterozygous familial hypercholesterolemia
5617486|NCT00827580|patients with breast or colon cancer receiving capecitabine|patients with breast or colon cancer receiving capecitabine
5617487|NCT00827567|Breast cancer|breast cancer
5617488|NCT00827567|metastatic breast|metastatic breast
5617489|NCT00827567|triple negative|triple negative
5617490|NCT00827567|ER/PR negative|er/pr negative
5617491|NCT00827567|Her2 Neu negative|her2 neu negative
5617492|NCT00827554|Liver Neoplasms|liver neoplasms
5617493|NCT00827554|Liver Diseases|liver diseases
5617494|NCT00827554|Digestive System Diseases|digestive system diseases
5617495|NCT00827554|Digestive System Neoplasms|digestive system neoplasms
5617496|NCT00827554|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5617497|NCT00827554|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5617498|NCT00827554|Adenocarcinoma|adenocarcinoma
5617499|NCT00827554|Hepatocellular carcinoma|hepatocellular carcinoma
5617500|NCT00827554|Neoplasms|neoplasms
5617501|NCT00827554|Transarterial chemoembolization|transarterial chemoembolization
5617502|NCT00827554|Nadroparin|nadroparin
5617503|NCT00827554|low-molecular-weight heparin|low-molecular-weight heparin
5617504|NCT00827554|chemoembolization|chemoembolization
5617505|NCT00827541|tigecycline|tigecycline
5617506|NCT00827541|complicated intra-abdominal infections (cIAI)|complicated intra-abdominal infections (ciai)
5617507|NCT00827541|complicated skin and soft tissue infections (cSSTI).|complicated skin and soft tissue infections (cssti).
5617508|NCT00827528|Pelvic Organ Prolapse|pelvic organ prolapse
5617509|NCT00827528|Surgical Treatment|surgical treatment
5617510|NCT00827515|Relative Bioavailability Effect of food|relative bioavailability effect of food
5617511|NCT00827502|TRULIMAX (AZITHROMYCIN ) NON-INTERVENTIONAL STUDY|trulimax (azithromycin ) non-interventional study
5617512|NCT00827489|schizophrenia|schizophrenia
5617515|NCT00827476|transplantaion|transplantaion
5617516|NCT00827476|ovarian failure|ovarian failure
5617517|NCT00827463|aneamia|aneamia
5617518|NCT00827463|aneamia during the maternity|aneamia during the maternity
5617519|NCT00827450|hepatic steatosis|hepatic steatosis
5617520|NCT00827450|coffee|coffee
5617521|NCT00827450|fructose|fructose
5617522|NCT00827450|lipids|lipids
5617523|NCT00827424|physical activity (PA)|physical activity (pa)
5617524|NCT00827424|obesity|obesity
5617525|NCT00827424|life style modification|life style modification
5617526|NCT00827424|physical activity|physical activity
5617527|NCT00827424|diet|diet
5617528|NCT00827424|BMI reduction|bmi reduction
5617529|NCT00827424|clinical and metabolic measure|clinical and metabolic measure
5617530|NCT00827424|health expenditure|health expenditure
5617531|NCT00827424|improvement of patient readiness for lifestyle change|improvement of patient readiness for lifestyle change
5617532|NCT00827411|Drug Eluting Stent|drug eluting stent
5617533|NCT00827411|Percutaneous coronary intervention|percutaneous coronary intervention
5617534|NCT00827411|Oral antiplatelet therapy|oral antiplatelet therapy
5617535|NCT00827411|Clopidogrel/Aspirin|clopidogrel/aspirin
5617536|NCT00827411|Acute Coronary Syndrome|acute coronary syndrome
5617537|NCT00827398|MSC|msc
5617538|NCT00827398|GVHD|gvhd
5617539|NCT00827398|Adults|adults
5617540|NCT00827398|Children|children
5617541|NCT00827398|steroid refractory acute GVHD occurring after allogeneic stem cell transplantation|steroid refractory acute gvhd occurring after allogeneic stem cell transplantation
5617542|NCT00827359|everolimus|everolimus
5617543|NCT00827333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5617544|NCT00827333|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5617545|NCT00827333|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5617546|NCT00827333|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5617547|NCT00827333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5617548|NCT00827333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5617549|NCT00827307|breast carcinoma; goserelin; Mammographic density|breast carcinoma; goserelin; mammographic density
5617550|NCT00827294|Phantom limb pain|phantom limb pain
5617551|NCT00827294|Mirror therapy|mirror therapy
5617552|NCT00827294|amputation|amputation
5617553|NCT00827294|Limb loss|limb loss
5617555|NCT00827281|DCS|dcs
5617556|NCT00827281|CBT|cbt
5617557|NCT00827281|smoking|smoking
5617558|NCT00827281|tobacco|tobacco
5617559|NCT00827268|Dyslexia|dyslexia
5617560|NCT00827268|Reading|reading
5617561|NCT00827268|Aphasia|aphasia
5617562|NCT00827268|Stroke|stroke
5617563|NCT00827242|Signs and Symptoms|signs and symptoms
5617564|NCT00827242|Prostatic Hyperplasia|prostatic hyperplasia
5617565|NCT00827242|Hyperplasia|hyperplasia
5617566|NCT00827242|Genital Diseases, Male|genital diseases, male
5617567|NCT00827242|Prostatic Diseases|prostatic diseases
5617569|NCT00827229|Active labor|active labor
5617570|NCT00827229|Term pregnancy|term pregnancy
5617571|NCT00827229|Vertex presentation|vertex presentation
5617572|NCT00827229|Single fetus|single fetus
5617573|NCT00827216|Gastric emptying|gastric emptying
5617574|NCT00827216|emergency anesthesia|emergency anesthesia
5617575|NCT00827216|intravenous erythromycin|intravenous erythromycin
5617576|NCT00827203|cancer|cancer
5617577|NCT00827203|metastatic|metastatic
5617578|NCT00827203|Elesclomol Sodium|elesclomol sodium
5617579|NCT00827203|tumor|tumor
5617580|NCT00827203|Advanced solid tumors that are metastatic and unresectable|advanced solid tumors that are metastatic and unresectable
5617581|NCT00827190|Acute Ischemic Stroke|acute ischemic stroke
5617582|NCT00827177|dose escalation|dose escalation
5617583|NCT00827177|safety|safety
5617584|NCT00827177|tolerability|tolerability
5617585|NCT00827177|tumor|tumor
5617586|NCT00827177|PK|pk
5617587|NCT00827177|hepatocellular carcinoma|hepatocellular carcinoma
5617588|NCT00827177|renal cell carcinoma|renal cell carcinoma
5617589|NCT00827177|melanoma|melanoma
5617590|NCT00827177|non-small cell lung cancer|non-small cell lung cancer
5617591|NCT00827177|breast cancer|breast cancer
5617592|NCT00827164|head and neck cancer|head and neck cancer
5617593|NCT00827164|resistance training|resistance training
5617594|NCT00827164|nutrition counseling|nutrition counseling
5617595|NCT00827164|radiation therapy|radiation therapy
5617596|NCT00827164|pharyngeal or laryngeal cancer|pharyngeal or laryngeal cancer
5617597|NCT00827151|amenorrhea|amenorrhea
5617598|NCT00827151|athletes|athletes
5617599|NCT00827151|bone loss|bone loss
5617600|NCT00827151|eumenorrhea|eumenorrhea
5617601|NCT00827125|active stage|active stage
5617602|NCT00827125|labor|labor
5617603|NCT00827125|progression|progression
5617604|NCT00827125|pregnant woman during active phases of labor|pregnant woman during active phases of labor
5617605|NCT00827112|CCR5-tropic HIV-1 virus|ccr5-tropic hiv-1 virus
5617606|NCT00827099|accelerated phase cml|accelerated phase cml
5617607|NCT00827099|adult ALL in remission|adult all in remission
5617608|NCT00827099|adult AML in remission|adult aml in remission
5617609|NCT00827099|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5617610|NCT00827099|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
5617611|NCT00827099|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5617612|NCT00827099|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5617613|NCT00827099|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5617614|NCT00827099|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5617615|NCT00827099|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5617616|NCT00827099|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5617617|NCT00827099|prolymphocytic leukemia|prolymphocytic leukemia
5617618|NCT00827099|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5617619|NCT00827099|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5617620|NCT00827099|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5617621|NCT00827099|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5617622|NCT00827099|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5781726|NCT00186810|Anemia|anemia
5617623|NCT00827099|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5617624|NCT00827099|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5617625|NCT00827099|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5617626|NCT00827099|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5617627|NCT00827099|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5617628|NCT00827099|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5617629|NCT00827099|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5617630|NCT00827099|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5617631|NCT00827099|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5617632|NCT00827099|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5617633|NCT00827099|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5617634|NCT00827099|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5617635|NCT00827099|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5617636|NCT00827099|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5617637|NCT00827099|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5617638|NCT00827099|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5617639|NCT00827099|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5617640|NCT00827099|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5617760|NCT00826566|caffeine|caffeine
5617641|NCT00827099|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5617642|NCT00827099|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5617643|NCT00827099|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5617644|NCT00827099|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5617645|NCT00827099|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5617646|NCT00827099|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5617647|NCT00827099|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5617648|NCT00827099|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5617649|NCT00827099|stage I multiple myeloma|stage i multiple myeloma
5617650|NCT00827099|stage II multiple myeloma|stage ii multiple myeloma
5617651|NCT00827099|stage III multiple myeloma|stage iii multiple myeloma
5617652|NCT00827099|refractory multiple myeloma|refractory multiple myeloma
5617653|NCT00827099|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5617654|NCT00827099|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5617655|NCT00827099|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5617656|NCT00827086|influencing factors (smoking, nutrition, education)|influencing factors (smoking, nutrition, education)
5617657|NCT00827060|primary care|primary care
5617658|NCT00827060|procalcitonin|procalcitonin
5617659|NCT00827060|acute respiratory tract infection|acute respiratory tract infection
5617660|NCT00827047|hepatocellular carcinoma|hepatocellular carcinoma
5617661|NCT00827047|Surgical resection|surgical resection
5617662|NCT00827047|total hemihepatic vascular exclusion|total hemihepatic vascular exclusion
5617663|NCT00827047|occlusion|occlusion
5617664|NCT00827047|bleeding|bleeding
5617665|NCT00827047|overall survival|overall survival
5617666|NCT00827034|Dimebon Warfarin Drug-Drug Interaction|dimebon warfarin drug-drug interaction
5617667|NCT00826995|patient Education|patient education
5617668|NCT00826995|dermatology Patient Education|dermatology patient education
5617669|NCT00826995|melanoma|melanoma
5617670|NCT00826995|melanoma education|melanoma education
5617671|NCT00826995|malignant melanoma|malignant melanoma
5617672|NCT00826995|melanoma detection|melanoma detection
5617674|NCT00826969|Ciclesonide|ciclesonide
5617675|NCT00826943|Allergic Rhinitis|allergic rhinitis
5617676|NCT00826930|High Grade Glioma|high grade glioma
5617677|NCT00826930|Brain Tumor|brain tumor
5617678|NCT00826930|Solid Tumor|solid tumor
5617679|NCT00826930|Partial Debulking|partial debulking
5617680|NCT00826930|Tumor Resection|tumor resection
5617681|NCT00826930|Tumor Tissue Hypoxia|tumor tissue hypoxia
5617682|NCT00826930|Radiation Sensitizer|radiation sensitizer
5617683|NCT00826930|Cancerous Tumor|cancerous tumor
5671239|NCT00616590|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5617684|NCT00826917|3D, 2D, ultrasound, volumetry, multiplanar, VOCALTM, XI VOCALTM, fetal, gestational sac, placenta|3d, 2d, ultrasound, volumetry, multiplanar, vocaltm, xi vocaltm, fetal, gestational sac, placenta
5617685|NCT00826904|Fetal programming|fetal programming
5617686|NCT00826904|Fetal macrosomia|fetal macrosomia
5617687|NCT00826904|Fetal health|fetal health
5617688|NCT00826904|Gestational diabetes|gestational diabetes
5617689|NCT00826904|Maternal health|maternal health
5617690|NCT00826904|Maternal obesity|maternal obesity
5617691|NCT00826878|tivozanib|tivozanib
5617693|NCT00826839|In vitro fertilization|in vitro fertilization
5617694|NCT00826839|Poor responder patients|poor responder patients
5617695|NCT00826839|Randomized clinical trial|randomized clinical trial
5617696|NCT00826839|Estrogen patch|estrogen patch
5617697|NCT00826839|Gonadotropin-releasing hormone antagonist|gonadotropin-releasing hormone antagonist
5617698|NCT00826839|Oral contraceptive pill|oral contraceptive pill
5617699|NCT00826839|Microdose lupron|microdose lupron
5617700|NCT00826826|Atrial fibrillation|atrial fibrillation
5617701|NCT00826826|Amiodarone|amiodarone
5617702|NCT00826826|Arrhythmias, Cardiac|arrhythmias, cardiac
5617703|NCT00826826|Catheter ablation|catheter ablation
5617704|NCT00826813|Dysphagia|dysphagia
5617705|NCT00826813|esophageal cancer|esophageal cancer
5617706|NCT00826813|stent|stent
5617707|NCT00826813|brachytherapy|brachytherapy
5617708|NCT00826800|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5617709|NCT00826800|FLUOROURACIL|fluorouracil
5617710|NCT00826800|LEUCOVORIN|leucovorin
5617711|NCT00826800|OXALIPLATIN|oxaliplatin
5617712|NCT00826800|Chemotherapy|chemotherapy
5617713|NCT00826774|Body Weight|body weight
5617714|NCT00826774|Overweight|overweight
5617715|NCT00826774|Hypertension|hypertension
5617716|NCT00826774|Hyperglycemia|hyperglycemia
5617717|NCT00826748|COPD|copd
5617718|NCT00826748|inhaled steroids|inhaled steroids
5617719|NCT00826748|gene expression|gene expression
5617720|NCT00826748|smoker's lungs|smoker's lungs
5617721|NCT00826735|third stage of labor|third stage of labor
5617722|NCT00826735|bleeding|bleeding
5617723|NCT00826735|guided imagery|guided imagery
5617725|NCT00826696|preeclampsia|preeclampsia
5617726|NCT00826683|Non-small cell lung cancer|non-small cell lung cancer
5617727|NCT00826683|Endothelial cell progenitor|endothelial cell progenitor
5617728|NCT00826683|Angiogenesis|angiogenesis
5617729|NCT00826683|Vascular endothelial cell growth factor|vascular endothelial cell growth factor
5617730|NCT00826683|Healthy control|healthy control
5617731|NCT00826683|COPD patients|copd patients
5617732|NCT00826683|NSCLC patients|nsclc patients
5617733|NCT00826670|Antibiotic resistance|antibiotic resistance
5617734|NCT00826670|ESBL carriage|esbl carriage
5617735|NCT00826657|B12 deficiency|b12 deficiency
5617737|NCT00826657|homocystein|homocystein
5617738|NCT00826657|vitamin B12 supplementation intervention|vitamin b12 supplementation intervention
5617739|NCT00826644|Small cell lung cancer|small cell lung cancer
5617740|NCT00826644|Camptothecin|camptothecin
5617741|NCT00826644|Response rate|response rate
5617742|NCT00826631|weight|weight
5617743|NCT00826631|metabolism|metabolism
5617744|NCT00826631|cholesterol|cholesterol
5617745|NCT00826631|insulin|insulin
5617746|NCT00826618|Uveitis|uveitis
5617747|NCT00826618|Cystoid Macular Edema|cystoid macular edema
5617748|NCT00826605|Weight loss, urobilinogen|weight loss, urobilinogen
5617749|NCT00826592|patient education|patient education
5617750|NCT00826592|dermatology patient education|dermatology patient education
5617751|NCT00826592|atopic dermatitis|atopic dermatitis
5617752|NCT00826592|atopic dermatitis education|atopic dermatitis education
5617753|NCT00826592|atopic eczema|atopic eczema
5617754|NCT00826592|infantile eczema|infantile eczema
5617755|NCT00826592|hand eczema|hand eczema
5617756|NCT00826579|Sentinel lymph node|sentinel lymph node
5617757|NCT00826579|Lymph node analysis|lymph node analysis
5617758|NCT00826579|Bone marrow analysis|bone marrow analysis
5617759|NCT00826566|COPD|copd
5617761|NCT00826566|chronic systemic inflammation|chronic systemic inflammation
5617762|NCT00826566|oxidative stress|oxidative stress
5617763|NCT00826566|supplementation|supplementation
5617764|NCT00826566|stable COPD GOLD stage II with CRP levels ≥ 3 mg/l|stable copd gold stage ii with crp levels ≥ 3 mg/l
5617765|NCT00826553|sedative|sedative
5617766|NCT00826553|GABA|gaba
5617767|NCT00826553|alpha 2 agonist|alpha 2 agonist
5617768|NCT00826553|propofol|propofol
5617769|NCT00826553|midazolam|midazolam
5617770|NCT00826553|lorazepam|lorazepam
5617771|NCT00826553|dexmedetomidine|dexmedetomidine
5617772|NCT00826553|sleep|sleep
5617773|NCT00826553|electroencephalogram|electroencephalogram
5617774|NCT00826553|polysomnogram|polysomnogram
5617775|NCT00826553|ICU|icu
5617776|NCT00826514|Chronic Prostatis|chronic prostatis
5617777|NCT00826488|Breast Cancer|breast cancer
5617778|NCT00826488|Mammography|mammography
5617779|NCT00826488|Benign masses|benign masses
5617780|NCT00826488|Breast Lump|breast lump
5617781|NCT00826488|Breast Biopsy|breast biopsy
5617782|NCT00826488|Breast Mass|breast mass
5617783|NCT00826475|Migraine|migraine
5617784|NCT00826475|Headache|headache
5617785|NCT00826462|Randomised|randomised
5617786|NCT00826462|Placebo-controlled|placebo-controlled
5617787|NCT00826462|double blind|double blind
5617788|NCT00826462|Intervention study|intervention study
5617789|NCT00826462|Primary health care|primary health care
5617790|NCT00826449|Advanced Solid Tumors|advanced solid tumors
5617791|NCT00826449|Advanced Cancer|advanced cancer
5617792|NCT00826449|Non-Small Cell Lung Cancer|non-small cell lung cancer
5617793|NCT00826449|NSCLC|nsclc
5617794|NCT00826449|Solid Tumor Malignancy|solid tumor malignancy
5617795|NCT00826449|Dasatinib|dasatinib
5617796|NCT00826449|BMS-354825|bms-354825
5617797|NCT00826449|Sprycel®|sprycel®
5617798|NCT00826449|Erlotinib|erlotinib
5617799|NCT00826449|Erlotinib hydrochloride|erlotinib hydrochloride
5617800|NCT00826449|Tarceva|tarceva
5617801|NCT00826449|OSI-774|osi-774
5617802|NCT00826423|treatment with Triple antibiotic therapy|treatment with triple antibiotic therapy
5617803|NCT00826410|Laparotomy|laparotomy
5617804|NCT00826410|Surgical site infection|surgical site infection
5617805|NCT00826410|Drainage|drainage
5617806|NCT00826397|Aromatase Inhibitors|aromatase inhibitors
5617807|NCT00826397|Joint Pain|joint pain
5617808|NCT00826397|Symptoms Control|symptoms control
5617809|NCT00826397|Acupuncture|acupuncture
5617810|NCT00826384|hepatocellular carcinoma|hepatocellular carcinoma
5617811|NCT00826384|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5617812|NCT00826384|overall survival|overall survival
5617813|NCT00826371|AMD|amd
5617814|NCT00826371|Ranibizumab|ranibizumab
5617815|NCT00826358|Adverse events|adverse events
5617816|NCT00826358|Pharmacokinetic|pharmacokinetic
5617817|NCT00826345|Peripheral Neuropathy|peripheral neuropathy
5617818|NCT00826345|Neuropathy|neuropathy
5617819|NCT00826345|HIV|hiv
5617820|NCT00826345|AIDS|aids
5617821|NCT00826345|DSP|dsp
5617822|NCT00826345|alternative therapies|alternative therapies
5617823|NCT00826332|ultrasound|ultrasound
5617824|NCT00826332|IVF|ivf
5617825|NCT00826332|Embryo transfer|embryo transfer
5617826|NCT00826332|Pregnancy rate|pregnancy rate
5617827|NCT00826332|female patient undergoing IVF|female patient undergoing ivf
5617828|NCT00826319|Chronic Kidney Disease|chronic kidney disease
5617829|NCT00826319|Renal Insufficiency|renal insufficiency
5617830|NCT00826319|Biomarkers|biomarkers
5617831|NCT00826319|Observational|observational
5617832|NCT00826306|patient education|patient education
5617833|NCT00826306|dermatology patient education|dermatology patient education
5617834|NCT00826306|sunscreen|sunscreen
5617835|NCT00826306|sunscreen education|sunscreen education
5617836|NCT00826306|skin cancer|skin cancer
5617837|NCT00826280|pharmacologic stress|pharmacologic stress
5617838|NCT00826280|ischemia|ischemia
5617839|NCT00826280|coronary artery disease (CAD)|coronary artery disease (cad)
5617841|NCT00826254|Bone Mineral Density|bone mineral density
5617842|NCT00826254|undercarboxylated osteocalcin|undercarboxylated osteocalcin
5617843|NCT00826241|Brain Tumor|brain tumor
5617844|NCT00826241|Central Nervous System|central nervous system
5617845|NCT00826241|CNS|cns
5617846|NCT00826241|Spinal Cord Tumor|spinal cord tumor
5617847|NCT00826241|Anaplastic Ependymoma|anaplastic ependymoma
5617848|NCT00826241|Supratentorial Ependymoma|supratentorial ependymoma
5617849|NCT00826241|Infratentorial Ependymoma|infratentorial ependymoma
5617850|NCT00826241|Spinal Cord Ependymoma|spinal cord ependymoma
5617851|NCT00826241|Lapatinib|lapatinib
5617852|NCT00826241|GW572016|gw572016
5617853|NCT00826241|Temozolomide|temozolomide
5617854|NCT00826241|Temodar|temodar
5617855|NCT00826215|mechanical|mechanical
5617856|NCT00826215|neck pain|neck pain
5617857|NCT00826215|chronic|chronic
5617858|NCT00826215|acupuncture|acupuncture
5617859|NCT00826215|chronic mechanical neck pain|chronic mechanical neck pain
5617860|NCT00826202|schizophrenia|schizophrenia
5617861|NCT00826202|d-serine|d-serine
5617862|NCT00826202|prodrome|prodrome
5617863|NCT00826189|Probiotics|probiotics
5617864|NCT00826189|Asthma|asthma
5617865|NCT00826189|Allergic Rhinitis|allergic rhinitis
5617866|NCT00826150|ovarian cancer|ovarian cancer
5617867|NCT00826150|H19 gene|h19 gene
5617868|NCT00826150|plasmid|plasmid
5617872|NCT00826124|low back pain|low back pain
5617873|NCT00826124|radiculopathy|radiculopathy
5617874|NCT00826124|sciatica|sciatica
5617875|NCT00826111|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5617876|NCT00826111|Glutamate|glutamate
5617877|NCT00826111|Glutamine|glutamine
5617879|NCT00826111|Lexapro|lexapro
5617880|NCT00826111|Lunesta|lunesta
5617881|NCT00826111|Escitalopram|escitalopram
5617882|NCT00826111|Eszopiclone|eszopiclone
5617883|NCT00826098|Total knee replacement|total knee replacement
5617884|NCT00826098|Platelet Rich Plasma|platelet rich plasma
5617885|NCT00826098|PRP|prp
5617886|NCT00826098|Biologic|biologic
5617887|NCT00826098|Randomized|randomized
5617888|NCT00826085|Breast Cancer|breast cancer
5617889|NCT00826085|Recurrent Chest Wall Cancer|recurrent chest wall cancer
5617890|NCT00826085|Loco-regional Recurrent Breast Cancer|loco-regional recurrent breast cancer
5672290|NCT00612456|angiogenesis|angiogenesis
5617891|NCT00826085|Breast Cancer Recurrence at the Chest Wall|breast cancer recurrence at the chest wall
5617892|NCT00826072|Single Nucleotide Polymorphism|single nucleotide polymorphism
5617893|NCT00826072|cardiopulmonary bypass|cardiopulmonary bypass
5617894|NCT00826072|cardiac surgery|cardiac surgery
5617899|NCT00826046|GVHD|gvhd
5617900|NCT00826046|Prochymal|prochymal
5617901|NCT00826046|Graft vs Host Disease|graft vs host disease
5617902|NCT00826033|Fluorine-18-α-methyltyrosine|fluorine-18-α-methyltyrosine
5617903|NCT00826033|Positron emission tomography|positron emission tomography
5617904|NCT00826033|Lung cancer|lung cancer
5617905|NCT00826033|chemotherapy|chemotherapy
5617906|NCT00826033|monitoring|monitoring
5617907|NCT00826020|PN|pn
5617908|NCT00826020|parenteral nutrition|parenteral nutrition
5617909|NCT00826020|fat emulsions|fat emulsions
5617910|NCT00826020|omega-6 fatty acid|omega-6 fatty acid
5617911|NCT00826020|liver disease|liver disease
5617912|NCT00826020|fatty acid deficiency|fatty acid deficiency
5600923|NCT00894270|Needle|needle
5617913|NCT00826007|perioperative hypoglycemia diabetes surgery|perioperative hypoglycemia diabetes surgery
5617914|NCT00826007|surgery|surgery
5617915|NCT00825994|menopause|menopause
5617916|NCT00825994|perimenopause|perimenopause
5617917|NCT00825994|postmenopause|postmenopause
5617918|NCT00825994|depression|depression
5617919|NCT00825994|mood|mood
5617920|NCT00825994|sleep|sleep
5617921|NCT00825994|hot flashes|hot flashes
5617922|NCT00825968|Electrophysiological|electrophysiological
5617923|NCT00825968|Heart Disease|heart disease
5617924|NCT00825968|Cardiology|cardiology
5617925|NCT00825968|Atrial Fibrillation|atrial fibrillation
5617926|NCT00825968|Risk Factors|risk factors
5617927|NCT00825968|Follow-up|follow-up
5617928|NCT00825968|Outcomes|outcomes
5617929|NCT00825942|Asteroid hyalosis|asteroid hyalosis
5617930|NCT00825942|Opthalmic Study|opthalmic study
5617931|NCT00825929|pharmacokinetics|pharmacokinetics
5617932|NCT00825929|pregnancy|pregnancy
5617933|NCT00825929|antiretrovirals|antiretrovirals
5617934|NCT00825929|neonates|neonates
5617935|NCT00825929|HIV|hiv
5617936|NCT00825929|treatment experienced|treatment experienced
5617937|NCT00825916|AZX100|azx100
5617938|NCT00825916|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5617939|NCT00825916|POSAS|posas
5617940|NCT00825916|Visual Analog Scale|visual analog scale
5617941|NCT00825916|VAS|vas
5617942|NCT00825916|Keloid|keloid
5617943|NCT00825916|Scarring|scarring
5617944|NCT00825916|Scar reduction|scar reduction
5617945|NCT00825916|Scar prevention|scar prevention
5617946|NCT00825903|aquatic exercise|aquatic exercise
5617947|NCT00825903|asthma|asthma
5617948|NCT00825890|high cup disc ratio|high cup disc ratio
5611738|NCT00851240|safety|safety
5617950|NCT00825877|Hepatitis C|hepatitis c
5617951|NCT00825877|Sustained Virological Response|sustained virological response
5617952|NCT00825877|HALT-C|halt-c
5617953|NCT00825877|Peginterferon and Ribavirin|peginterferon and ribavirin
5617954|NCT00825877|HCV RNA|hcv rna
5617955|NCT00825838|Body weight|body weight
5617956|NCT00825838|Body composition|body composition
5617957|NCT00825838|Resting metabolic rate and fat oxidation in men|resting metabolic rate and fat oxidation in men
5617958|NCT00825838|class I obese|class i obese
5617959|NCT00825825|Citalopram|citalopram
5617960|NCT00825825|Escitalopram|escitalopram
5617961|NCT00825825|Celexa|celexa
5617962|NCT00825825|Lexapro|lexapro
5617963|NCT00825825|fMRI|fmri
5617964|NCT00825825|antidepressant|antidepressant
5617965|NCT00825825|healthy volunteers|healthy volunteers
5617966|NCT00825799|biomarker|biomarker
5617967|NCT00825799|depression|depression
5617968|NCT00825799|blood test|blood test
5617969|NCT00825786|surgery for arm hand or elbow|surgery for arm hand or elbow
5617970|NCT00825786|mepivacaine|mepivacaine
5617971|NCT00825786|ropivacaine|ropivacaine
5617972|NCT00825786|hand surgery|hand surgery
5617973|NCT00825786|elbow surgery|elbow surgery
5617974|NCT00825786|forearm surgery|forearm surgery
5617975|NCT00825773|TVF|tvf
5617976|NCT00825773|TLF|tlf
5617977|NCT00825773|MACE|mace
5617978|NCT00825773|Ischemia-driven Target Vessel Failure (TVF) at 12 months.|ischemia-driven target vessel failure (tvf) at 12 months.
5617979|NCT00825773|Ischemia-driven Target Lesion Failure (TLF) at 12 months defined as a|ischemia-driven target lesion failure (tlf) at 12 months defined as a
5617980|NCT00825773|composite of cardiac death that can not be clearly attributed to a vessel|composite of cardiac death that can not be clearly attributed to a vessel
5617981|NCT00825773|other than the target vessel, target vessel MI (Q and Non-Q wave) and|other than the target vessel, target vessel mi (q and non-q wave) and
5617982|NCT00825773|ischemia-driven TLR.|ischemia-driven tlr.
5617983|NCT00825773|Rates of stent thrombosis, defined (per ARC definition) as definite or probable|rates of stent thrombosis, defined (per arc definition) as definite or probable
5617984|NCT00825773|and categorized as early, late or very late.|and categorized as early, late or very late.
5617985|NCT00825773|Major Adverse Cardiac Events (MACE) defined as cardiac death, target|major adverse cardiac events (mace) defined as cardiac death, target
5617986|NCT00825773|vessel MI (Q and Non-Q wave), or target lesion revascularization (TLR) at 30|vessel mi (q and non-q wave), or target lesion revascularization (tlr) at 30
5617987|NCT00825773|days, 6 months, 12 months and 2 to 5 years annually.|days, 6 months, 12 months and 2 to 5 years annually.
5617988|NCT00825760|Antimicrobial Photodynamic Therapy|antimicrobial photodynamic therapy
5617989|NCT00825760|Photodynamic Therapy|photodynamic therapy
5617990|NCT00825760|PDT|pdt
5617991|NCT00825760|Red light|red light
5617992|NCT00825760|Visible light|visible light
5617993|NCT00825760|Antimicrobial|antimicrobial
5617994|NCT00825760|Antibacterial|antibacterial
5617995|NCT00825760|Wound healing|wound healing
5617996|NCT00825760|Wound management|wound management
5617997|NCT00825760|Leg ulcer|leg ulcer
5617998|NCT00825760|Chronic venous leg ulcer|chronic venous leg ulcer
5617999|NCT00825760|Chronic wound|chronic wound
5618000|NCT00825760|Wound therapy|wound therapy
5618001|NCT00825760|Antimicrobial therapy|antimicrobial therapy
5618002|NCT00825747|Cataract|cataract
5618003|NCT00825747|Cataract surgery|cataract surgery
5618004|NCT00825747|intraocular lens|intraocular lens
5618005|NCT00825747|Aspheric lens|aspheric lens
5618006|NCT00825734|Metastatic Breast Cancer|metastatic breast cancer
5618007|NCT00825734|Sorafenib|sorafenib
5618008|NCT00825734|Nexavar|nexavar
5618009|NCT00825734|Ixabepilone|ixabepilone
5618010|NCT00825734|Ixempra|ixempra
5618011|NCT00825721|Cataract Study|cataract study
5618012|NCT00825721|Ophthalmic Study|ophthalmic study
5618013|NCT00825721|Agerelated cataract|agerelated cataract
5618014|NCT00825721|Nuclear Cataract|nuclear cataract
5618015|NCT00825721|Low grade nuclear cataracts|low grade nuclear cataracts
5618016|NCT00825708|ADHD|adhd
5618017|NCT00825682|Breast cancer|breast cancer
5618018|NCT00825682|Radiation therapy|radiation therapy
5618019|NCT00825682|Reflexology|reflexology
5618020|NCT00825682|Fatigue|fatigue
5618021|NCT00825682|Quality of life|quality of life
5618022|NCT00825682|Sleep disturbance|sleep disturbance
5618023|NCT00825669|hepatocellular carcinoma|hepatocellular carcinoma
5618024|NCT00825669|Portal vein tumor thrombus|portal vein tumor thrombus
5618025|NCT00825669|laser ablation|laser ablation
5618026|NCT00825656|Allergic Rhinitis|allergic rhinitis
5618027|NCT00825656|Capsaicin|capsaicin
5618028|NCT00825656|Homeopathic|homeopathic
5618029|NCT00825656|Sinol|sinol
5618030|NCT00825656|Sinol-M|sinol-m
5618032|NCT00825630|UBT|ubt
5618033|NCT00825630|PPI|ppi
5618034|NCT00825617|TS|ts
5618035|NCT00825617|HRT|hrt
5618036|NCT00825617|Liver function tests|liver function tests
5618037|NCT00825604|stable coronary artery disease|stable coronary artery disease
5618038|NCT00825604|quality of life|quality of life
5618039|NCT00825604|target achievement|target achievement
5618040|NCT00825604|physical training|physical training
5618041|NCT00825604|percutaneous coronary intervention|percutaneous coronary intervention
5618042|NCT00825591|optic nerve hypoplasia|optic nerve hypoplasia
5618043|NCT00825591|septo-optic dysplasia|septo-optic dysplasia
5618044|NCT00825591|melatonin|melatonin
5618045|NCT00825591|circadian rhythm|circadian rhythm
5618046|NCT00825578|intrabronchial valve|intrabronchial valve
5618047|NCT00825578|heterogeneous emphysema|heterogeneous emphysema
5618048|NCT00825578|non-upper lobe|non-upper lobe
5618049|NCT00825565|Epidermolysis bullosa|epidermolysis bullosa
5618050|NCT00825552|Risperidone|risperidone
5618051|NCT00825552|Severe mood dysregulation|severe mood dysregulation
5618052|NCT00825552|bipolar|bipolar
5618053|NCT00825552|children|children
5618054|NCT00825539|Schizophrenia|schizophrenia
5618055|NCT00825539|Manic depression|manic depression
5618056|NCT00825539|anxiety|anxiety
5618057|NCT00825526|Mindfulness Based Stress Reduction (MBSR)|mindfulness based stress reduction (mbsr)
5618058|NCT00825526|Stress Reduction|stress reduction
5618059|NCT00825526|hypertension|hypertension
5618060|NCT00825526|high blood pressure|high blood pressure
5618061|NCT00825526|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5618062|NCT00825500|Migraine headache|migraine headache
5618063|NCT00825500|Loxapine|loxapine
5618064|NCT00825500|Staccato|staccato
5618066|NCT00825487|hematologic|hematologic
5618067|NCT00825487|malignancy|malignancy
5618068|NCT00825487|multiple|multiple
5618069|NCT00825487|myeloma|myeloma
5618070|NCT00825487|malignant|malignant
5618071|NCT00825487|lymphoma|lymphoma
5618072|NCT00825487|chronic|chronic
5618073|NCT00825487|lymphocytic|lymphocytic
5618074|NCT00825487|leukemia|leukemia
5618075|NCT00825487|acute|acute
5618076|NCT00825487|myelogenous|myelogenous
5618077|NCT00825487|promyelocytic|promyelocytic
5618078|NCT00825487|dose escalation|dose escalation
5618079|NCT00825487|safety|safety
5618080|NCT00825487|tolerability|tolerability
5618081|NCT00825487|pharmacodynamics|pharmacodynamics
5618082|NCT00825487|tumor|tumor
5618083|NCT00825487|PK|pk
5618084|NCT00825474|small hepatocellular carcinoma|small hepatocellular carcinoma
5618085|NCT00825474|partial hepatectomy|partial hepatectomy
5618086|NCT00825474|TACE plus PEI|tace plus pei
5618087|NCT00825461|Anorexia Nervosa|anorexia nervosa
5618088|NCT00825448|alcohol addiction|alcohol addiction
5618089|NCT00825435|Coronary CT angiogram|coronary ct angiogram
5618090|NCT00825435|Cardiac imaging|cardiac imaging
5618091|NCT00825435|Cost analysis|cost analysis
5618092|NCT00825435|acute chest pain|acute chest pain
5618093|NCT00825435|risk stratification|risk stratification
5618094|NCT00825435|cumulative costs over 90-days of providing treatment services|cumulative costs over 90-days of providing treatment services
5618095|NCT00825422|Posterior lumbar arthrodesis|posterior lumbar arthrodesis
5618096|NCT00825422|Degenerative spine|degenerative spine
5618097|NCT00825422|Postoperative analgesia|postoperative analgesia
5618098|NCT00825422|Local anesthesic|local anesthesic
5618099|NCT00825422|Continuous wound infusion catheter|continuous wound infusion catheter
5618100|NCT00825422|Pain|pain
5618101|NCT00825422|lumbar vertebrae|lumbar vertebrae
5618102|NCT00825422|Spinal fusion|spinal fusion
5618103|NCT00825383|Diabetes|diabetes
5618104|NCT00825383|lipids|lipids
5618105|NCT00825383|fiber|fiber
5618106|NCT00825370|Hydromorphone|hydromorphone
5618107|NCT00825370|acute pain|acute pain
5618108|NCT00825370|Protocolized|protocolized
5618109|NCT00825370|Efficacy|efficacy
5618110|NCT00825370|Safety|safety
5618111|NCT00825357|biological markers|biological markers
5618112|NCT00825357|sepsis|sepsis
5618113|NCT00825357|acute lung injury|acute lung injury
5618114|NCT00825344|postoperative pain|postoperative pain
5618115|NCT00825344|inguinal hernia|inguinal hernia
5618116|NCT00825344|chronic postsurgical pain|chronic postsurgical pain
5618117|NCT00825344|cytokine|cytokine
5618118|NCT00825344|preemptive analgesia|preemptive analgesia
5618119|NCT00825344|patients with inguinal hernia scheduled for surgery|patients with inguinal hernia scheduled for surgery
5618120|NCT00825331|guide wire|guide wire
5618121|NCT00825331|cardiac catheterization|cardiac catheterization
5618122|NCT00825331|ultrasound-guided examination of the access site|ultrasound-guided examination of the access site
5618123|NCT00825331|graduated scheme|graduated scheme
5618124|NCT00825331|elective and non elective cardiac catheterization|elective and non elective cardiac catheterization
5618125|NCT00825318|End-stage renal disease|end-stage renal disease
5618126|NCT00825318|Chronic kidney disease|chronic kidney disease
5618127|NCT00825318|Hemodialysis|hemodialysis
5618128|NCT00825305|vaccine|vaccine
5618129|NCT00825305|prevention|prevention
5618130|NCT00825305|rabies|rabies
5618131|NCT00825305|Rabies disease|rabies disease
5618132|NCT00825292|colon polyps, colon adenomas|colon polyps, colon adenomas
5618133|NCT00825279|Biodegradable polymer|biodegradable polymer
5618134|NCT00825279|Drug Eluting Stent|drug eluting stent
5618135|NCT00825279|In stent restenosis|in stent restenosis
5618136|NCT00825279|stent thrombosis|stent thrombosis
5618137|NCT00825279|Bare Metal Stent|bare metal stent
5618138|NCT00825266|pulmonary hypertension & insulin resistance|pulmonary hypertension & insulin resistance
5618139|NCT00825240|Colorectal Cancer|colorectal cancer
5618140|NCT00825240|Cancer Survivorship Study|cancer survivorship study
5618141|NCT00825240|Questionnaires|questionnaires
5618142|NCT00825240|Survivorship|survivorship
5618143|NCT00825240|Survivor Health|survivor health
5618144|NCT00825240|Health Promotion|health promotion
5618145|NCT00825240|Behavior Changes|behavior changes
5618146|NCT00825240|Computer-assisted intervention program|computer-assisted intervention program
5618148|NCT00825227|Fatigue|fatigue
5618149|NCT00825227|Taxanes|taxanes
5618150|NCT00825201|peritoneal carcinomatosis|peritoneal carcinomatosis
5618151|NCT00825201|peritoneal cavity cancer|peritoneal cavity cancer
5618152|NCT00825201|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5618153|NCT00825201|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5618154|NCT00825201|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5618155|NCT00825175|Down syndrome|down syndrome
5618156|NCT00825175|Gait|gait
5618157|NCT00825175|Motor Development|motor development
5618158|NCT00825175|Orthoses|orthoses
5618159|NCT00825136|Panic Disorder|panic disorder
5618160|NCT00825136|Temperature Biofeedback|temperature biofeedback
5618161|NCT00825136|Internet|internet
5618162|NCT00825123|healthy individuals|healthy individuals
5618163|NCT00825110|colorectal|colorectal
5618164|NCT00825110|cancer|cancer
5618165|NCT00825110|gene expression|gene expression
5618166|NCT00825110|biomarker|biomarker
5618167|NCT00825110|genomic mismatch repair|genomic mismatch repair
5618168|NCT00825097|Spastic equinovarus foot|spastic equinovarus foot
5618169|NCT00825097|Stroke|stroke
5618170|NCT00825097|Tibial neurotomy|tibial neurotomy
5618171|NCT00825097|Botulinum toxin type A|botulinum toxin type a
5618172|NCT00825097|Selective tibial neurotomy|selective tibial neurotomy
5618173|NCT00825084|Dimebon, Japanese and Western population, pharmacokinetics|dimebon, japanese and western population, pharmacokinetics
5618174|NCT00825071|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5618175|NCT00825071|Ondansetron|ondansetron
5618176|NCT00825071|Dexamethasone|dexamethasone
5618177|NCT00825058|Depression|depression
5618178|NCT00825045|dopamine|dopamine
5618180|NCT00825045|D3|d3
5618181|NCT00825045|caudate|caudate
5618182|NCT00825045|putamen|putamen
5618183|NCT00825045|globus pallidus|globus pallidus
5618184|NCT00825045|antipsychotic|antipsychotic
5618185|NCT00825045|risperidone|risperidone
5618186|NCT00825045|geriatric|geriatric
5618187|NCT00825045|Brief Psychiatric Rating Scale|brief psychiatric rating scale
5618188|NCT00825045|PET|pet
5618189|NCT00825045|radiotracer|radiotracer
5618190|NCT00825045|[11C]-(+)-PHNO|[11c]-(+)-phno
5618191|NCT00825045|[11C]-raclopride|[11c]-raclopride
5618192|NCT00825032|Pulmonary disease, chronic obstructive|pulmonary disease, chronic obstructive
5618193|NCT00825032|Upper extremity|upper extremity
5618194|NCT00825032|Exercise therapy|exercise therapy
5618195|NCT00825019|Depression|depression
5618196|NCT00825006|Cardiac resynchronization therapy|cardiac resynchronization therapy
5618197|NCT00825006|Anodal stimulation|anodal stimulation
5618198|NCT00824993|Blood Cancer|blood cancer
5618199|NCT00824993|Calcium|calcium
5618200|NCT00824993|Vitamin D|vitamin d
5786209|NCT00164229|control|control
5618201|NCT00824993|Ibandronate|ibandronate
5618202|NCT00824993|Boniva|boniva
5618203|NCT00824993|Hematological Malignancies|hematological malignancies
5618204|NCT00824993|Bone Marrow Transplantation|bone marrow transplantation
5618205|NCT00824993|BMT|bmt
5618206|NCT00824993|Osteoporosis|osteoporosis
5618207|NCT00824993|Bone Loss|bone loss
5618208|NCT00824993|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5618209|NCT00824954|0 to 30 years|0 to 30 years
5618210|NCT00824954|Refractory Acute GVHD|refractory acute gvhd
5618211|NCT00824941|Abdominal Pain|abdominal pain
5618212|NCT00824941|Women's Health and Disease|women's health and disease
5618213|NCT00824941|Inflammation|inflammation
5618214|NCT00824941|Symptoms|symptoms
5618216|NCT00824941|Chronic Abdominal Pain|chronic abdominal pain
5618217|NCT00824928|Prostate Cancer|prostate cancer
5618218|NCT00824928|Recurrent Prostate Cancer|recurrent prostate cancer
5618219|NCT00824928|Prostate Cancer Recurrence|prostate cancer recurrence
5618220|NCT00824928|Radiation Failure|radiation failure
5618221|NCT00824928|Salvage Cryotherapy|salvage cryotherapy
5618222|NCT00824915|Lead Integrity Algorithm|lead integrity algorithm
5618223|NCT00824902|Prostate Cancer|prostate cancer
5618224|NCT00824902|Prostate|prostate
5618225|NCT00824902|Radical Prostatectomy|radical prostatectomy
5618226|NCT00824902|Tissue Elastography|tissue elastography
5618227|NCT00824902|Tissue Elastography Imaging|tissue elastography imaging
5618228|NCT00824902|Software Program Measuring Prostate Elasticity|software program measuring prostate elasticity
5618229|NCT00824902|Elasticity/Tissue Strain-Hardening Imaging|elasticity/tissue strain-hardening imaging
5618230|NCT00824902|Ultrasound|ultrasound
5618231|NCT00824876|Mammae cancer patients|mammae cancer patients
5618232|NCT00824863|pityrosporum folliculitis|pityrosporum folliculitis
5618233|NCT00824863|ketoconazole 2% foam|ketoconazole 2% foam
5618234|NCT00824850|Single site|single site
5618235|NCT00824850|single dose|single dose
5618236|NCT00824850|Participated in Wyeth D118-P8|participated in wyeth d118-p8
5618237|NCT00824837|beta 2 microglobulin|beta 2 microglobulin
5618238|NCT00824837|haemodialysis|haemodialysis
5618244|NCT00824811|Prostate Cancer|prostate cancer
5618245|NCT00824811|Non-small cell lung cancer|non-small cell lung cancer
5618246|NCT00824811|Bladder Cancer|bladder cancer
5618247|NCT00824811|Esophageal Cancer|esophageal cancer
5618248|NCT00824811|Head and Neck Cancer|head and neck cancer
5618250|NCT00824811|Small Cell Lung Cancer|small cell lung cancer
5618251|NCT00824811|SCLC|sclc
5618252|NCT00824811|Ovarian Cancer|ovarian cancer
5618253|NCT00824811|Stomach Cancer|stomach cancer
5618254|NCT00824811|Canalicular Stenosis|canalicular stenosis
5618255|NCT00824811|Excessive tearing|excessive tearing
5618256|NCT00824811|Eye inflammation|eye inflammation
5618257|NCT00824811|Cyclosporine Ophthalmic Emulsion 0.05%|cyclosporine ophthalmic emulsion 0.05%
5618258|NCT00824811|Docetaxel|docetaxel
5618259|NCT00824811|Taxotere|taxotere
5618260|NCT00824811|Restasis®|restasis®
5618261|NCT00824811|Cyclosporine|cyclosporine
5618262|NCT00824811|Cyclosporine eye drops|cyclosporine eye drops
5618263|NCT00824811|FML Forte®|fml forte®
5618264|NCT00824811|Fluorometholone 0.25% ophthalmic suspension|fluorometholone 0.25% ophthalmic suspension
5618265|NCT00824811|Fluorometholone eye drops|fluorometholone eye drops
5618266|NCT00824811|Fluorometholone|fluorometholone
5618267|NCT00824811|Refresh Endura™|refresh endura™
5618268|NCT00824811|Lubricant eye drops|lubricant eye drops
5618269|NCT00824811|Eye drops|eye drops
5618270|NCT00824798|gait|gait
5618271|NCT00824798|haemophilia|haemophilia
5618272|NCT00824798|arthropathy|arthropathy
5618273|NCT00824785|epirubicin|epirubicin
5618274|NCT00824785|oxaliplatin|oxaliplatin
5618275|NCT00824785|capecitabine|capecitabine
5618276|NCT00824785|panitumumab|panitumumab
5618277|NCT00824772|pharmacogenetics|pharmacogenetics
5618278|NCT00824759|Healthy subjects|healthy subjects
5618279|NCT00824759|CABG|cabg
5618280|NCT00824759|Patients undergoing coronary artery bypass graft under cardiopulmonary bypass|patients undergoing coronary artery bypass graft under cardiopulmonary bypass
5618281|NCT00824746|Gefitinib|gefitinib
5618282|NCT00824746|Recurrence|recurrence
5618283|NCT00824746|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5618284|NCT00824733|recurrent breast cancer|recurrent breast cancer
5618285|NCT00824733|stage IV breast cancer|stage iv breast cancer
5672291|NCT00612456|pazopanib,|pazopanib,
5618286|NCT00824733|stage IIIA breast cancer|stage iiia breast cancer
5618287|NCT00824733|stage IIIB breast cancer|stage iiib breast cancer
5618288|NCT00824733|stage IIIC breast cancer|stage iiic breast cancer
5618289|NCT00824733|HER2-positive breast cancer|her2-positive breast cancer
5618290|NCT00824733|male breast cancer|male breast cancer
5618291|NCT00824707|primary liver cancer|primary liver cancer
5618292|NCT00824707|hepatitis B virus|hepatitis b virus
5618294|NCT00824694|Glucose|glucose
5618295|NCT00824694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5618296|NCT00824694|HbA1c|hba1c
5618297|NCT00824681|Psychological adjustment of family|psychological adjustment of family
5618298|NCT00824681|family of patients|family of patients
5618299|NCT00824681|children of patients|children of patients
5618300|NCT00824681|intensive care unit|intensive care unit
5618301|NCT00824681|burn|burn
5618302|NCT00824681|music therapy|music therapy
5618303|NCT00824681|music|music
5618304|NCT00824681|music program|music program
5618305|NCT00824681|anxiety|anxiety
5618306|NCT00824681|coping|coping
5618307|NCT00824681|adjustment|adjustment
5618308|NCT00824681|psychological stressor|psychological stressor
5618309|NCT00824681|emotional stressor|emotional stressor
5618310|NCT00824655|Healthy Subjects|healthy subjects
5618311|NCT00824655|Vaccines|vaccines
5618312|NCT00824655|Pneumococcal|pneumococcal
5618313|NCT00824642|Asthma|asthma
5618314|NCT00824642|Exercise training|exercise training
5618315|NCT00824642|TENS|tens
5618316|NCT00824642|Acupuncture|acupuncture
5618317|NCT00824642|FEV1|fev1
5618318|NCT00824629|Embryo transfer|embryo transfer
5618319|NCT00824629|IVF|ivf
5618320|NCT00824629|Ultrasound embryo transfer|ultrasound embryo transfer
5618321|NCT00824590|Dimebon|dimebon
5618322|NCT00824590|renal impairment|renal impairment
5618323|NCT00824590|pharmacokinetics|pharmacokinetics
5618324|NCT00824577|heart rate variability|heart rate variability
5618325|NCT00824577|autonomic function|autonomic function
5618326|NCT00824577|heart function|heart function
5618327|NCT00824564|Tranexamic Acid|tranexamic acid
5618328|NCT00824564|Blood Loss|blood loss
5618329|NCT00824564|Long Bone Fracture Surgery|long bone fracture surgery
5618330|NCT00824551|Acute Thermal Burns|acute thermal burns
5618331|NCT00824551|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5618332|NCT00824551|Burns conversion|burns conversion
5618333|NCT00824538|stage IA breast cancer|stage ia breast cancer
5618334|NCT00824538|stage IB breast cancer|stage ib breast cancer
5618335|NCT00824538|stage II breast cancer|stage ii breast cancer
5618336|NCT00824538|stage IIIA breast cancer|stage iiia breast cancer
5618337|NCT00824538|stage IIIB breast cancer|stage iiib breast cancer
5618338|NCT00824538|stage IIIC breast cancer|stage iiic breast cancer
5618339|NCT00824486|child|child
5618340|NCT00824486|injury prevention|injury prevention
5618341|NCT00824460|Hemodialysis|hemodialysis
5618342|NCT00824447|randomised|randomised
5618343|NCT00824447|double-blind|double-blind
5618344|NCT00824447|placebo-controlled|placebo-controlled
5618345|NCT00824447|long-term efficacy and safety|long-term efficacy and safety
5618346|NCT00824447|Oralgen® Grass Pollen|oralgen® grass pollen
5618347|NCT00824447|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5618348|NCT00824447|Allergy|allergy
5618349|NCT00824447|Rhinoconjunctivitis|rhinoconjunctivitis
5618350|NCT00824447|Immunotherapy|immunotherapy
5618351|NCT00824447|Grass pollen extract|grass pollen extract
5618352|NCT00824434|Atherosclerosis|atherosclerosis
5618353|NCT00824434|Coronary Artery Disease|coronary artery disease
5618354|NCT00824421|HIV-1. Treatment Naive|hiv-1. treatment naive
5618355|NCT00824421|HIV Infections|hiv infections
5618356|NCT00824421|treatment naive|treatment naive
5618357|NCT00824395|diabetes|diabetes
5618358|NCT00824395|type 1|type 1
5618359|NCT00824395|type 2|type 2
5618360|NCT00824395|metabolic syndrome|metabolic syndrome
5618361|NCT00824395|mitochondria|mitochondria
5618362|NCT00824369|HIV-1|hiv-1
5618363|NCT00824369|Rollover|rollover
5618364|NCT00824369|Safety.|safety.
5618365|NCT00824369|HIV Infections|hiv infections
5618366|NCT00824369|treatment experienced|treatment experienced
5618367|NCT00824356|Allergic Rhinitis|allergic rhinitis
5618368|NCT00824356|Proof-of-Concept|proof-of-concept
5618369|NCT00824330|Aging|aging
5618370|NCT00824330|Type 2 diabetes|type 2 diabetes
5618371|NCT00824330|exercise|exercise
5618372|NCT00824330|walking|walking
5618373|NCT00824330|glucose metabolism|glucose metabolism
5618374|NCT00824330|arterial baroreceptors|arterial baroreceptors
5618375|NCT00824330|heart rate variability|heart rate variability
5618376|NCT00824330|cerebral autoregulation|cerebral autoregulation
5618377|NCT00824330|tilt table study|tilt table study
5618378|NCT00824330|transcranial Doppler|transcranial doppler
5618379|NCT00824330|autonomic nervous system|autonomic nervous system
5618380|NCT00824304|cognitive performance|cognitive performance
5618381|NCT00824304|growth|growth
5618382|NCT00824304|iron|iron
5618383|NCT00824304|zinc|zinc
5618384|NCT00824291|Major Depressive Disorder|major depressive disorder
5618385|NCT00824278|Pediatrics|pediatrics
5618386|NCT00824278|Distresss Screening|distresss screening
5618387|NCT00824278|Cancer|cancer
5618388|NCT00824278|Neurofibromatosis|neurofibromatosis
5618390|NCT00824278|Pediatric Cancer|pediatric cancer
5618391|NCT00824278|Distress Screening|distress screening
5618392|NCT00824265|Relapsed|relapsed
5618393|NCT00824265|Oncology|oncology
5618394|NCT00824265|Safety|safety
5618395|NCT00824265|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5618396|NCT00824265|Ofatumumab|ofatumumab
5618397|NCT00824265|Efficacy|efficacy
5618398|NCT00824252|Head And Neck Cancer|head and neck cancer
5618400|NCT00824252|Radiation Therapy|radiation therapy
5618401|NCT00824252|Spousal Support|spousal support
5618402|NCT00824252|Emotional Disclosure|emotional disclosure
5618403|NCT00824252|Observational|observational
5618404|NCT00824252|Social Constraints|social constraints
5618405|NCT00824252|Questionnaires|questionnaires
5618406|NCT00824252|Videotaped Interview|videotaped interview
5618407|NCT00824252|Quality of Life|quality of life
5618408|NCT00824239|critical care|critical care
5618409|NCT00824239|sedation|sedation
5618410|NCT00824239|Mechanically ventilated patients|mechanically ventilated patients
5618411|NCT00824226|primary hypoparathyroidism|primary hypoparathyroidism
5618412|NCT00824226|secondary hypoparathyroidism|secondary hypoparathyroidism
5618413|NCT00824226|magnesium|magnesium
5618414|NCT00824213|Whole Body SPECT imaging|whole body spect imaging
5618415|NCT00824200|Sleep|sleep
5618416|NCT00824200|Quality of life|quality of life
5618417|NCT00824200|nocturia|nocturia
5618418|NCT00824187|Premenstrual Dysphoric Disorder ( PMDD)|premenstrual dysphoric disorder ( pmdd)
5618419|NCT00824187|Oral contraceptive|oral contraceptive
5618420|NCT00824174|Questionnaire|questionnaire
5618421|NCT00824174|Head and Neck Cancer|head and neck cancer
5618422|NCT00824174|Skin Cancer|skin cancer
5618423|NCT00824174|Body Image|body image
5618424|NCT00824174|Surgical Treatment|surgical treatment
5618425|NCT00824174|Oral Cavity Cancer|oral cavity cancer
5618426|NCT00824174|Cutaneous Cancer|cutaneous cancer
5618427|NCT00824148|Real-time glucose monitoring system|real-time glucose monitoring system
5618428|NCT00824148|HbA1c|hba1c
5618429|NCT00824148|Quality of life|quality of life
5618430|NCT00824148|Hypoglycemia|hypoglycemia
5618431|NCT00824135|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
5618432|NCT00824135|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5618433|NCT00824135|Maximal Tolerated Dose|maximal tolerated dose
5618434|NCT00824135|Clofarabine|clofarabine
5618436|NCT00824135|Apheresis|apheresis
5618437|NCT00824109|Aneurysmal disease of the abdominal aorta|aneurysmal disease of the abdominal aorta
5618438|NCT00824109|Occlusive disease of the abdominal aorta|occlusive disease of the abdominal aorta
5618439|NCT00824096|endotracheal intubation|endotracheal intubation
5618440|NCT00824096|cuff-leak test|cuff-leak test
5618441|NCT00824096|post-extubation stridor|post-extubation stridor
5618442|NCT00824096|bronchoscopy|bronchoscopy
5618443|NCT00824096|corticosteroids|corticosteroids
5618444|NCT00824096|Cuff-leak volume less than 24%|cuff-leak volume less than 24%
5618445|NCT00824083|bone tumors|bone tumors
5618446|NCT00824083|long-term function|long-term function
5618447|NCT00824083|daily activity|daily activity
5618448|NCT00824083|late sequelae|late sequelae
5618449|NCT00824070|Bioavailability|bioavailability
5618451|NCT00824044|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5618452|NCT00824044|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5618453|NCT00824044|Escitalopram|escitalopram
5618454|NCT00824044|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5618455|NCT00824031|schizophrenia|schizophrenia
5618456|NCT00824031|medical mental care|medical mental care
5618457|NCT00824031|caregiver|caregiver
5618458|NCT00824031|Sapin|sapin
5618459|NCT00824005|Congestive Heart Failure|congestive heart failure
5618460|NCT00824005|Regional Wall Motion|regional wall motion
5618461|NCT00824005|Perfusion Defects|perfusion defects
5618462|NCT00823979|HIV-1 NNRTI Treatment Experienced|hiv-1 nnrti treatment experienced
5618463|NCT00823979|may have Protease inhibitor experience|may have protease inhibitor experience
5618464|NCT00823953|diabetes type 2|diabetes type 2
5618465|NCT00823940|FTIH|ftih
5618466|NCT00823940|Glucagon|glucagon
5618467|NCT00823940|Safety|safety
5618468|NCT00823940|GSK1362885|gsk1362885
5618469|NCT00823940|Pharmacokinetics|pharmacokinetics
5618470|NCT00823940|Tolerability|tolerability
5618471|NCT00823940|Pharmacodynamics|pharmacodynamics
5618472|NCT00823927|lung damage|lung damage
5618473|NCT00823927|cigarette smoking|cigarette smoking
5618474|NCT00823927|HIV-seropositive|hiv-seropositive
5618475|NCT00823927|emphysema|emphysema
5618476|NCT00823914|Psoriasis|psoriasis
5618477|NCT00823914|Quality of Life|quality of life
5618478|NCT00823901|rosacea|rosacea
5618479|NCT00823901|clindamycin|clindamycin
5618480|NCT00823901|tretinoin|tretinoin
5618481|NCT00823901|clinical study|clinical study
5618482|NCT00823901|treatment|treatment
5618483|NCT00823888|Knee Osteoarthritis|knee osteoarthritis
5618484|NCT00823888|pneumatic bracing|pneumatic bracing
5618485|NCT00823862|HCV|hcv
5618486|NCT00823862|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5618487|NCT00823862|TLR9 (toll-like receptor 9)|tlr9 (toll-like receptor 9)
5618488|NCT00823862|interferon (IFN)|interferon (ifn)
5618489|NCT00823862|ribavirin|ribavirin
5618490|NCT00823849|type 2 diabetes mellitus, with Arteriosclerosis obliterans|type 2 diabetes mellitus, with arteriosclerosis obliterans
5618491|NCT00823836|Ropinirole, advanced Parkinson's disease, L-dopa adjunctive therapy|ropinirole, advanced parkinson's disease, l-dopa adjunctive therapy
5618492|NCT00823823|Casting techniques|casting techniques
5618493|NCT00823823|Bivalved cast|bivalved cast
5618494|NCT00823823|Circumferential cast|circumferential cast
5618495|NCT00823823|Displaced distal radius fracture|displaced distal radius fracture
5618496|NCT00823823|Children|children
5618497|NCT00823810|Colorectal cancer|colorectal cancer
5618498|NCT00823810|Response to treatment|response to treatment
5618499|NCT00823810|FDG PET/CT|fdg pet/ct
5618500|NCT00823784|hemorrhoids|hemorrhoids
5618501|NCT00823784|stapler|stapler
5618502|NCT00823784|Doppler|doppler
5618503|NCT00823784|artery ligation|artery ligation
5618504|NCT00823784|outcome|outcome
5618505|NCT00823784|recurrence|recurrence
5618506|NCT00823758|Acetaminophen|acetaminophen
5618507|NCT00823758|Liver|liver
5618508|NCT00823758|Centers for Education and Research on Therapeutics|centers for education and research on therapeutics
5618509|NCT00823758|CERTS|certs
5618510|NCT00823758|Over-the-counter Acetaminophen|over-the-counter acetaminophen
5618512|NCT00823758|Self-administration|self-administration
5618513|NCT00823758|Parental administration|parental administration
5618514|NCT00823758|Houston|houston
5618515|NCT00823758|Texas|texas
5618516|NCT00823758|Liver toxicity|liver toxicity
5618517|NCT00823758|Qualitative study|qualitative study
5618518|NCT00823758|Pharmacists|pharmacists
5618519|NCT00823758|Adolescents|adolescents
5618520|NCT00823758|Primary care physicians|primary care physicians
5618521|NCT00823758|Family Practitioners|family practitioners
5618522|NCT00823758|General Internist|general internist
5618523|NCT00823732|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5618524|NCT00823732|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5618529|NCT00823719|efficacy|efficacy
5618530|NCT00823719|safety|safety
5618531|NCT00823719|DHAP|dhap
5618532|NCT00823719|ofatumumab|ofatumumab
5618533|NCT00823719|refractory|refractory
5618534|NCT00823719|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5618535|NCT00823719|Diffuse Large B Cell Lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
5618537|NCT00823719|ICE|ice
5618538|NCT00823719|Transformed follicular lymphoma|transformed follicular lymphoma
5618539|NCT00823706|chronic angle closure hyperopia|chronic angle closure hyperopia
5618540|NCT00823667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5618541|NCT00823667|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5618542|NCT00823667|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5618543|NCT00823654|Breast|breast
5618544|NCT00823654|Questionaires|questionaires
5618545|NCT00823654|Blood draw|blood draw
5618546|NCT00823654|BRCA1|brca1
5618547|NCT00823654|BRCA2|brca2
5618548|NCT00823654|08-156|08-156
5618549|NCT00823641|HAM/TSP|ham/tsp
5618550|NCT00823641|HTLV-I|htlv-i
5618551|NCT00823602|GnRH antagonist|gnrh antagonist
5618552|NCT00823602|GnRH agonist|gnrh agonist
5618553|NCT00823602|pregnancy rate|pregnancy rate
5618554|NCT00823602|Ovarian stimulation|ovarian stimulation
5618555|NCT00823589|ELDERLY POPULATION|elderly population
5618556|NCT00823576|Arthodeses rachis lombar|arthodeses rachis lombar
5618557|NCT00823576|Spinal Surgery|spinal surgery
5618558|NCT00823550|Chronic hepatitis B|chronic hepatitis b
5618559|NCT00823550|Advanced fibrosis|advanced fibrosis
5618560|NCT00823550|Lamivudine|lamivudine
5618561|NCT00823550|Entecavir|entecavir
5618562|NCT00823524|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5618563|NCT00823524|acute undifferentiated leukemia|acute undifferentiated leukemia
5618564|NCT00823524|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5618565|NCT00823524|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5618566|NCT00823524|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5618567|NCT00823524|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5618568|NCT00823524|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5618569|NCT00823524|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5618570|NCT00823524|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5618571|NCT00823524|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5618572|NCT00823524|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5618573|NCT00823524|mast cell leukemia|mast cell leukemia
5618574|NCT00823524|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5618575|NCT00823524|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5618576|NCT00823524|prolymphocytic leukemia|prolymphocytic leukemia
5618577|NCT00823524|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5618578|NCT00823524|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5618579|NCT00823524|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5618580|NCT00823524|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5618581|NCT00823524|refractory hairy cell leukemia|refractory hairy cell leukemia
5618582|NCT00823524|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5618583|NCT00823524|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5618584|NCT00823524|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5618585|NCT00823524|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5618586|NCT00823524|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5618587|NCT00823524|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5618588|NCT00823524|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5618589|NCT00823524|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5618590|NCT00823524|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5618591|NCT00823524|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5618592|NCT00823524|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5618593|NCT00823524|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5600410|NCT00896285|pleural effusion|pleural effusion
5618594|NCT00823524|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5618595|NCT00823524|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5618596|NCT00823524|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5621071|NCT00814879|AIDS|aids
5618597|NCT00823524|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5618598|NCT00823524|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5618599|NCT00823524|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5618600|NCT00823524|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5618601|NCT00823524|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5618602|NCT00823524|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5618603|NCT00823524|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5618604|NCT00823524|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5863017|NCT00001414|Normal Personality|normal personality
5618606|NCT00823524|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5618607|NCT00823524|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5618608|NCT00823524|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5618609|NCT00823524|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5618610|NCT00823524|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5618611|NCT00823524|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5618612|NCT00823524|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5618613|NCT00823524|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5618614|NCT00823524|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5618615|NCT00823524|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5618616|NCT00823524|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5618617|NCT00823524|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5618618|NCT00823524|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5618619|NCT00823524|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5618620|NCT00823524|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5618621|NCT00823524|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5618622|NCT00823524|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5618623|NCT00823524|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5618624|NCT00823524|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5618625|NCT00823524|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5618626|NCT00823524|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5618627|NCT00823524|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5618628|NCT00823524|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5618629|NCT00823524|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5618630|NCT00823524|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5618631|NCT00823524|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5618632|NCT00823524|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5618633|NCT00823524|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5618634|NCT00823524|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5618635|NCT00823524|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5618636|NCT00823524|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5672486|NCT00611715|recurrent breast cancer|recurrent breast cancer
5618637|NCT00823524|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5618638|NCT00823524|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5618639|NCT00823524|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5618640|NCT00823524|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5618641|NCT00823524|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5618642|NCT00823524|intraocular lymphoma|intraocular lymphoma
5618643|NCT00823524|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5618644|NCT00823524|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5618645|NCT00823524|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5618646|NCT00823524|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5618647|NCT00823524|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5618648|NCT00823524|primary myelofibrosis|primary myelofibrosis
5618649|NCT00823524|essential thrombocythemia|essential thrombocythemia
5618650|NCT00823524|polycythemia vera|polycythemia vera
5618651|NCT00823524|extramedullary plasmacytoma|extramedullary plasmacytoma
5618652|NCT00823524|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5618653|NCT00823524|stage II multiple myeloma|stage ii multiple myeloma
5618654|NCT00823524|stage III multiple myeloma|stage iii multiple myeloma
5618655|NCT00823524|primary systemic amyloidosis|primary systemic amyloidosis
5618656|NCT00823524|refractory multiple myeloma|refractory multiple myeloma
5618657|NCT00823524|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5618658|NCT00823524|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5618659|NCT00823524|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5618660|NCT00823524|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5618661|NCT00823524|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5618662|NCT00823524|Waldenström macroglobulinemia|waldenström macroglobulinemia
5618663|NCT00823524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5618665|NCT00823511|Human Papillomavirus Infection|human papillomavirus infection
5618666|NCT00823511|Cervix Uteri|cervix uteri
5618667|NCT00823511|Cancer Control|cancer control
5618668|NCT00823511|Risk Assessment, Detection & Intervention|risk assessment, detection & intervention
5618669|NCT00823511|Sexually Transmitted|sexually transmitted
5618670|NCT00823511|Neoplasia|neoplasia
5618676|NCT00823498|African American Youth|african american youth
5618677|NCT00823498|Public Housing|public housing
5618678|NCT00823498|Physical Activity|physical activity
5618679|NCT00823498|Focus Groups|focus groups
5618680|NCT00823498|Housing Developments|housing developments
5618681|NCT00823498|Houston Public Housing|houston public housing
5618682|NCT00823498|Photovoice Project|photovoice project
5618683|NCT00823498|Prevention|prevention
5618684|NCT00823472|embryonic structures|embryonic structures
5618685|NCT00823472|sperm injections, intracytoplasmic|sperm injections, intracytoplasmic
5618686|NCT00823472|IVF|ivf
5618687|NCT00823472|GnRH antagonist|gnrh antagonist
5618688|NCT00823472|ovarian stimulation|ovarian stimulation
5618689|NCT00823472|cycle day 2 versus cycle day 5|cycle day 2 versus cycle day 5
5618690|NCT00823433|Penicillin|penicillin
5618691|NCT00823433|Group B Streptococcus|group b streptococcus
5618692|NCT00823433|Pregnancy|pregnancy
5618693|NCT00823433|Labor|labor
5618694|NCT00823420|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
5618695|NCT00823420|aneuploidy|aneuploidy
5618696|NCT00823420|in-vitro maturation of oocytes|in-vitro maturation of oocytes
5618697|NCT00823407|MDA|mda
5618698|NCT00823407|MDMA|mdma
5618699|NCT00823407|Ecstasy|ecstasy
5618700|NCT00823407|entactogen|entactogen
5618701|NCT00823407|pharmacokinetics|pharmacokinetics
5618702|NCT00823407|pharmacodynamics|pharmacodynamics
5618804|NCT00823004|controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5618703|NCT00823407|Pharmacokinetics and pharmacodynamics of MDA studies in healthy volunteers|pharmacokinetics and pharmacodynamics of mda studies in healthy volunteers
5618704|NCT00823394|African American|african american
5618705|NCT00823394|Adults|adults
5618706|NCT00823394|African American Cancer Prevention Project|african american cancer prevention project
5618707|NCT00823394|Health Disparities|health disparities
5618708|NCT00823394|Questionnaire|questionnaire
5618709|NCT00823394|Body Measurements|body measurements
5618710|NCT00823394|Self-help|self-help
5618711|NCT00823394|Cancer Rates|cancer rates
5618712|NCT00823394|Prevention|prevention
5618713|NCT00823381|obesity|obesity
5618714|NCT00823381|metabolic syndrome|metabolic syndrome
5618715|NCT00823381|diabetes|diabetes
5618716|NCT00823381|aging|aging
5618717|NCT00823381|calorie restriction|calorie restriction
5618718|NCT00823381|resveratrol|resveratrol
5618719|NCT00823381|antioxidant|antioxidant
5618720|NCT00823368|fragile X syndrome|fragile x syndrome
5618721|NCT00823368|biomarkers|biomarkers
5618722|NCT00823342|HBe, Hepatitis, Vireda (TENOFOVIR, CLEVUDINE), HBV, HBe Ag negative|hbe, hepatitis, vireda (tenofovir, clevudine), hbv, hbe ag negative
5618723|NCT00823329|measurement of energy expenditure of physical activity|measurement of energy expenditure of physical activity
5618724|NCT00823329|analysis of body composition and hydration status|analysis of body composition and hydration status
5618725|NCT00823316|Mesenchymal Stem Cells|mesenchymal stem cells
5618726|NCT00823316|Allogeneic Transplantation|allogeneic transplantation
5618727|NCT00823316|Engraftment|engraftment
5618728|NCT00823316|GvHD|gvhd
5618729|NCT00823316|Childhood|childhood
5618730|NCT00823316|unrelated HSCT|unrelated hsct
5618731|NCT00823303|PTH|pth
5618732|NCT00823303|Active Vitamin D|active vitamin d
5618733|NCT00823303|hypercalcemia|hypercalcemia
5618734|NCT00823303|Chronic Kidney Disease|chronic kidney disease
5618735|NCT00823290|HCC|hcc
5618736|NCT00823290|sorafenib|sorafenib
5618737|NCT00823290|HDAC|hdac
5618738|NCT00823290|LBH589|lbh589
5618739|NCT00823290|Panobinostat|panobinostat
5618740|NCT00823264|Anticonvulsants|anticonvulsants
5618741|NCT00823264|Toxicology|toxicology
5618742|NCT00823264|multidose charcoal|multidose charcoal
5618743|NCT00823264|phenytoin|phenytoin
5618744|NCT00823225|Diabetes|diabetes
5618745|NCT00823225|urokinase|urokinase
5618746|NCT00823225|ulcer healing|ulcer healing
5618747|NCT00823225|major amputation|major amputation
5618748|NCT00823225|survival|survival
5618749|NCT00823212|drug-eluting stents|drug-eluting stents
5618750|NCT00823212|DES|des
5618751|NCT00823212|atherosclerotic|atherosclerotic
5618752|NCT00823186|cervical carcinoma|cervical carcinoma
5618753|NCT00823186|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5618754|NCT00823173|Uveitis|uveitis
5618755|NCT00823173|TNF-alpha|tnf-alpha
5618756|NCT00823173|Topical|topical
5618757|NCT00823173|ESBA105|esba105
5618758|NCT00823173|scFv antibody fragment|scfv antibody fragment
5618759|NCT00823173|ocular inflammation|ocular inflammation
5618760|NCT00823160|Pericardial window|pericardial window
5618761|NCT00823160|Sternotomy|sternotomy
5618762|NCT00823160|Haemopericardium|haemopericardium
5618763|NCT00823147|Pain|pain
5618764|NCT00823147|Systemic Inflammation|systemic inflammation
5618765|NCT00823147|Pain Catastrophizing|pain catastrophizing
5618766|NCT00823121|Fresh embryo transfer|fresh embryo transfer
5618767|NCT00823121|frozen- thawed embryo transfer|frozen- thawed embryo transfer
5618768|NCT00823121|vitrification|vitrification
5618769|NCT00823121|endometrial receptivity|endometrial receptivity
5618770|NCT00823121|implantation rate|implantation rate
5618771|NCT00823121|pregnancy|pregnancy
5618772|NCT00823121|ART|art
5618773|NCT00823108|GIK, septic shock, sepsis|gik, septic shock, sepsis
5618774|NCT00823095|chronic cutaneous ulcers|chronic cutaneous ulcers
5618775|NCT00823095|Nitric Oxide|nitric oxide
5618776|NCT00823095|topically applied|topically applied
5618777|NCT00823095|Biofilm|biofilm
5618778|NCT00823095|Colonized chronic non-healing ulcers|colonized chronic non-healing ulcers
5618779|NCT00823082|antithrombin|antithrombin
5618780|NCT00823082|ATIII|atiii
5618781|NCT00823082|acquired deficiency|acquired deficiency
5618782|NCT00823082|anticoagulants|anticoagulants
5618783|NCT00823082|cardiopulmonary bypass|cardiopulmonary bypass
5618784|NCT00823082|surgery|surgery
5618785|NCT00823082|complications|complications
5618786|NCT00823082|postoperative outcomes|postoperative outcomes
5618787|NCT00823069|Correction of Nasolabial Folds|correction of nasolabial folds
5618788|NCT00823056|Probiotics|probiotics
5618789|NCT00823056|Infections|infections
5618790|NCT00823056|Children|children
5618791|NCT00823030|Interstitial Cystitis|interstitial cystitis
5618792|NCT00823030|Intravesical Lidocaine|intravesical lidocaine
5618793|NCT00823017|ICU environment|icu environment
5618794|NCT00823017|Auditory stimulation|auditory stimulation
5618795|NCT00823017|Properties of relaxation music|properties of relaxation music
5618796|NCT00823017|music|music
5618797|NCT00823017|music therapy|music therapy
5618798|NCT00823017|pain|pain
5618799|NCT00823017|anxiety|anxiety
5618800|NCT00823017|cortisol|cortisol
5618801|NCT00823017|IgA|iga
5618802|NCT00823017|biomarkers|biomarkers
5618803|NCT00823017|relaxation music|relaxation music
5618805|NCT00823004|pregnancy rate|pregnancy rate
5618806|NCT00823004|Poor responders|poor responders
5618807|NCT00823004|GnRH antagonist|gnrh antagonist
5618808|NCT00823004|GnRH agonist|gnrh agonist
5618809|NCT00823004|letrozole|letrozole
5618810|NCT00823004|in vitro fertilization|in vitro fertilization
5618811|NCT00822991|Sonazoid|sonazoid
5618812|NCT00822991|Early detection|early detection
5618813|NCT00822991|Hepatocellular carcinoma|hepatocellular carcinoma
5618814|NCT00822991|Liver cirrhosis|liver cirrhosis
5618815|NCT00822978|healthy|healthy
5618816|NCT00822978|volunteers|volunteers
5618817|NCT00822978|subjects|subjects
5618818|NCT00822965|Pacemakers|pacemakers
5618819|NCT00822965|PM|pm
5618820|NCT00822965|Implantable cardioverter-defibrillators|implantable cardioverter-defibrillators
5618821|NCT00822965|ICD|icd
5618822|NCT00822965|Implantable pulse generators|implantable pulse generators
5618823|NCT00822965|Educational Interventions|educational interventions
5618824|NCT00822913|Botulinum A toxin|botulinum a toxin
5618825|NCT00822913|Parkinson's disease|parkinson's disease
5618826|NCT00822900|Trauma|trauma
5618827|NCT00822900|Brain Injury|brain injury
5618828|NCT00822887|malignant|malignant
5618829|NCT00822887|gliomas|gliomas
5618830|NCT00822874|PCOS and normal ovulatory patients|pcos and normal ovulatory patients
5618831|NCT00822874|aneuploidy|aneuploidy
5618832|NCT00822874|in-vitro maturation of oocytes|in-vitro maturation of oocytes
5618833|NCT00822848|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5618834|NCT00822848|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5618835|NCT00822822|Questionnaire|questionnaire
5618836|NCT00822822|Electronic Health History|electronic health history
5618837|NCT00822809|Cancer|cancer
5618838|NCT00822809|Neoplasms|neoplasms
5618839|NCT00822809|Carcinoma|carcinoma
5618840|NCT00822809|Malignant Ascites|malignant ascites
5618841|NCT00822809|Drug therapy|drug therapy
5618842|NCT00822809|Antineoplastic Protocols|antineoplastic protocols
5618843|NCT00822809|Immunotherapy|immunotherapy
5618844|NCT00822809|Phase III|phase iii
5618845|NCT00822809|trifunctional antibody|trifunctional antibody
5618846|NCT00822809|monoclonal antibody|monoclonal antibody
5618847|NCT00822809|EpCAM|epcam
5618848|NCT00822796|Hypothermia|hypothermia
5618849|NCT00822796|Severe burns|severe burns
5618850|NCT00822796|Warming catheter|warming catheter
5618851|NCT00822796|Thermogard™|thermogard™
5618852|NCT00822796|Coagulopathy|coagulopathy
5600338|NCT00896584|Hypoxemia|hypoxemia
5618853|NCT00822783|Serum IgE levels|serum ige levels
5618854|NCT00822783|inflammatory cells in the skin|inflammatory cells in the skin
5618855|NCT00822783|inflammatory cells in the blood|inflammatory cells in the blood
5618856|NCT00822783|IgE|ige
5618857|NCT00822783|IgE depletion|ige depletion
5618858|NCT00822783|atopic dermatitis|atopic dermatitis
5618859|NCT00822783|atopic eczema|atopic eczema
5618860|NCT00822783|Omalizumab|omalizumab
5618861|NCT00822770|Blood Stem Cell Transplantation|blood stem cell transplantation
5618862|NCT00822770|Bone Marrow Transplantation|bone marrow transplantation
5618863|NCT00822770|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5618864|NCT00822770|Stem Cell Transplantation|stem cell transplantation
5863018|NCT00001414|Intelligence|intelligence
5618865|NCT00822770|Allogeneic Hematopoietic Transplantation|allogeneic hematopoietic transplantation
5618867|NCT00822770|Acute Myeloid Leukemia|acute myeloid leukemia
5618868|NCT00822770|AML|aml
5618869|NCT00822770|Myelodysplastic syndrome|myelodysplastic syndrome
5618870|NCT00822770|MDS|mds
5618871|NCT00822770|Chronic Myeloid Leukemia|chronic myeloid leukemia
5618872|NCT00822770|CML|cml
5618873|NCT00822770|Graft Versus Host Disease|graft versus host disease
5618874|NCT00822770|GVHD|gvhd
5618875|NCT00822770|ATG|atg
5618876|NCT00822770|Busulfan|busulfan
5618877|NCT00822770|Busulfex™|busulfex™
5618878|NCT00822770|Myleran®|myleran®
5618879|NCT00822770|Filgrastim|filgrastim
5618880|NCT00822770|Neupogen|neupogen
5618881|NCT00822770|Fludarabine|fludarabine
5618882|NCT00822770|Fludarabine Phosphate|fludarabine phosphate
5618883|NCT00822770|Fludara™|fludara™
5618884|NCT00822770|G-CSF|g-csf
5618885|NCT00822770|Plerixafor|plerixafor
5618886|NCT00822770|Antithymocyte globulin|antithymocyte globulin
5618887|NCT00822770|Thymoglobulin|thymoglobulin
5618888|NCT00822757|study in healthy subjects|study in healthy subjects
5618889|NCT00822744|Depression|depression
5618890|NCT00822744|Major Depressive Episode|major depressive episode
5618891|NCT00822744|Antidepressant|antidepressant
5618892|NCT00822731|Lymphoma|lymphoma
5618893|NCT00822731|prognosis|prognosis
5618894|NCT00822731|morbidity|morbidity
5618895|NCT00822718|obestatin|obestatin
5618896|NCT00822718|ghrelin|ghrelin
5618897|NCT00822718|stomach cancer|stomach cancer
5618898|NCT00822718|distal gastrectomy|distal gastrectomy
5618899|NCT00822705|Appetite, energy consumption, gastrointestinal hormones|appetite, energy consumption, gastrointestinal hormones
5618900|NCT00822692|Abscess|abscess
5618901|NCT00822692|Cellulitis|cellulitis
5618902|NCT00822692|Antibiotics|antibiotics
5618903|NCT00822692|MRSA|mrsa
5618904|NCT00822679|Acute Coronary Syndrome|acute coronary syndrome
5618905|NCT00822679|cytokines|cytokines
5618906|NCT00822679|pro-coagulant mediators|pro-coagulant mediators
5618907|NCT00822679|sleep disorders|sleep disorders
5618908|NCT00822666|Platelet aggregation|platelet aggregation
5618909|NCT00822666|Platelet|platelet
5618910|NCT00822666|Thrombosis|thrombosis
5618911|NCT00822666|Clopidogrel|clopidogrel
5618912|NCT00822653|hemodialysis treatment|hemodialysis treatment
5618913|NCT00822653|pump stimulation|pump stimulation
5618914|NCT00822653|reduce hypotensive episodes|reduce hypotensive episodes
5618915|NCT00822640|Prosthesis Design|prosthesis design
5618916|NCT00822640|Range of Motion, Articular|range of motion, articular
5618917|NCT00822640|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5618918|NCT00822627|Influenza|influenza
5618919|NCT00822627|vaccination|vaccination
5618920|NCT00822627|Emergency Department|emergency department
5618921|NCT00822614|Pain|pain
5618922|NCT00822601|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5618923|NCT00822601|Supplementary Motor Area|supplementary motor area
5618924|NCT00822601|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5618925|NCT00822601|Sham rTMS|sham rtms
5618926|NCT00822601|Placebo-controlled|placebo-controlled
5618928|NCT00822601|Double-blind|double-blind
5618929|NCT00822601|fMRI|fmri
5618930|NCT00822601|DSM-IV Obsessive-Compulsive Disorder|dsm-iv obsessive-compulsive disorder
5618931|NCT00822575|mosquito bites|mosquito bites
5618932|NCT00822575|itching|itching
5618933|NCT00822562|hepatocellular carcinoma|hepatocellular carcinoma
5618934|NCT00822562|surgery|surgery
5618935|NCT00822549|Morphine titration|morphine titration
5618936|NCT00822549|Sub acute pain|sub acute pain
5618937|NCT00822549|Major orthopaedic surgery|major orthopaedic surgery
5618938|NCT00822549|Pharmacokinetics|pharmacokinetics
5618939|NCT00822549|Pharmacodynamics|pharmacodynamics
5618940|NCT00822549|Genetic polymorphism|genetic polymorphism
5618941|NCT00822549|PACU|pacu
5618942|NCT00822549|Patients undergoing major scheduled orthopaedic surgery|patients undergoing major scheduled orthopaedic surgery
5618943|NCT00822536|Drug-eluting stent|drug-eluting stent
5618944|NCT00822536|Clopidogrel|clopidogrel
5618945|NCT00822536|Stent thrombosis|stent thrombosis
5618946|NCT00822536|Myocardial infarction|myocardial infarction
5618947|NCT00822510|Psychosocial Intervention|psychosocial intervention
5618948|NCT00822510|Men with Prostate Cancer & Partners|men with prostate cancer & partners
5618949|NCT00822497|music therapy|music therapy
5618950|NCT00822497|pain|pain
5618951|NCT00822497|anxiety|anxiety
5618952|NCT00822497|muscle tension|muscle tension
5618953|NCT00822471|Diabetes|diabetes
5618954|NCT00822471|Self-Management Education|self-management education
5618955|NCT00822471|Library|library
5618956|NCT00822471|Emergency Department Visits|emergency department visits
5618957|NCT00822471|African American|african american
5618958|NCT00822471|CVD prevention|cvd prevention
5618960|NCT00822471|Uncontrolled diabetes|uncontrolled diabetes
5618961|NCT00822445|Biomarker|biomarker
5618962|NCT00822445|S100 protein|s100 protein
5618963|NCT00822445|Traumatic brain injury|traumatic brain injury
5618964|NCT00822445|Craniocerebral tomodensitometry|craniocerebral tomodensitometry
5618966|NCT00822432|biomarkers|biomarkers
5618967|NCT00822432|ABC transporters|abc transporters
5618968|NCT00822432|MRP2|mrp2
5618969|NCT00822432|MTX pharmacokinetics|mtx pharmacokinetics
5618970|NCT00822419|sternotomy pain|sternotomy pain
5618971|NCT00822406|allergy|allergy
5618972|NCT00822406|rhinitis|rhinitis
5618973|NCT00822406|homeopathy|homeopathy
5618974|NCT00822406|double-blind|double-blind
5618975|NCT00822393|Treosulfan|treosulfan
5618976|NCT00822393|Busulfan|busulfan
5618977|NCT00822393|Conditioning|conditioning
5618978|NCT00822393|Allogeneic|allogeneic
5618979|NCT00822393|Transplantation|transplantation
5618980|NCT00822380|Anemia|anemia
5618981|NCT00822380|Iron|iron
5618982|NCT00822380|Children|children
5618983|NCT00822380|Micronutrients|micronutrients
5618984|NCT00822354|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
5618985|NCT00822328|Probiotics|probiotics
5618986|NCT00822328|Lactobacillus|lactobacillus
5618987|NCT00822328|Intestine|intestine
5618988|NCT00822328|Flora|flora
5618990|NCT00822315|Tuberculosis|tuberculosis
5618991|NCT00822315|Pharmacokinetics|pharmacokinetics
5618992|NCT00822315|Raltegravir|raltegravir
5618993|NCT00822315|France|france
5618994|NCT00822315|Brazil|brazil
5618995|NCT00822315|treatment naive|treatment naive
5618996|NCT00822302|atherosclerosis|atherosclerosis
5618997|NCT00822302|stroke|stroke
5618998|NCT00822302|ischaemia|ischaemia
5618999|NCT00822289|radioactive iodine|radioactive iodine
5619000|NCT00822289|Helicobacter pylori|helicobacter pylori
5619001|NCT00822289|Thyroid diseases|thyroid diseases
5619002|NCT00822289|CagA|caga
5619003|NCT00822276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5619004|NCT00822276|MRSA|mrsa
5619005|NCT00822276|Methicillin-sensitive Staphylococcus aureus|methicillin-sensitive staphylococcus aureus
5619006|NCT00822276|MSSA|mssa
5619007|NCT00822276|Atopic Dermatitis|atopic dermatitis
5619303|NCT00821015|LA ablation|la ablation
5619008|NCT00822276|Eczema Herpeticum|eczema herpeticum
5619009|NCT00822263|mild traumatic brain injury|mild traumatic brain injury
5619010|NCT00822263|anti-oxidant|anti-oxidant
5619011|NCT00822263|early treatment|early treatment
5619012|NCT00822224|acute pain|acute pain
5619013|NCT00822224|MEOPA|meopa
5619014|NCT00822224|Dementia|dementia
5619015|NCT00822211|Diabetes Mellitus|diabetes mellitus
5619016|NCT00822211|HbA1c reduction|hba1c reduction
5619017|NCT00822211|vildagliptin|vildagliptin
5619018|NCT00822211|add-on to metformin|add-on to metformin
5619019|NCT00822211|Chinese patients|chinese patients
5619020|NCT00822198|peripheral neuropathy|peripheral neuropathy
5619021|NCT00822198|diabetes|diabetes
5619022|NCT00822198|plantar vibration|plantar vibration
5619023|NCT00822172|Peripheral Vascular Disease|peripheral vascular disease
5619024|NCT00822172|Peripheral Arterial Disease|peripheral arterial disease
5619025|NCT00822172|Intermittent Claudication|intermittent claudication
5619026|NCT00822172|Peak Walking Time|peak walking time
5619027|NCT00822172|Claudication Onset Time|claudication onset time
5619028|NCT00822172|Cilostazol|cilostazol
5619029|NCT00822172|Carnitine|carnitine
5619030|NCT00822159|Fixation failure|fixation failure
5619031|NCT00822159|Bone strength|bone strength
5619032|NCT00822159|DensiProbe|densiprobe
5619033|NCT00822146|CRT|crt
5619034|NCT00822133|ketamine|ketamine
5619035|NCT00822133|preemption|preemption
5619036|NCT00822133|postoperative|postoperative
5619037|NCT00822133|pain|pain
5619038|NCT00822133|safety|safety
5619039|NCT00822120|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5619040|NCT00822120|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5619041|NCT00822120|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5619042|NCT00822120|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5619043|NCT00822120|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5619044|NCT00822120|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5619045|NCT00822120|HIV infection|hiv infection
5619046|NCT00822107|Hypokalemia|hypokalemia
5619047|NCT00822107|Bartter Syndrome|bartter syndrome
5619048|NCT00822107|Salt Wasting|salt wasting
5619049|NCT00822094|Acute|acute
5619050|NCT00822094|Myeloid|myeloid
5619051|NCT00822094|Leukemia|leukemia
5619052|NCT00822094|Adult|adult
5619053|NCT00822094|First|first
5619054|NCT00822094|Relapse|relapse
5619055|NCT00822094|AML|aml
5600544|NCT00895661|rituximab|rituximab
5619056|NCT00822094|Acute Myelogenous leukemia|acute myelogenous leukemia
5619057|NCT00822094|Leukemia, Myeloid|leukemia, myeloid
5619058|NCT00822094|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5619059|NCT00822094|Acute myelocytic leukemia|acute myelocytic leukemia
5619061|NCT00822068|aphasia|aphasia
5619062|NCT00822068|rehabilitation|rehabilitation
5619063|NCT00822068|transcranial direct current stimulation|transcranial direct current stimulation
5619064|NCT00822068|intensive training|intensive training
5619065|NCT00822068|chronic aphasia after stroke|chronic aphasia after stroke
5619066|NCT00822042|Lipodystrophy|lipodystrophy
5619067|NCT00822042|Adipokines|adipokines
5619068|NCT00822042|Glucocorticoids|glucocorticoids
5619069|NCT00822042|Patients with glucocorticoids|patients with glucocorticoids
5619070|NCT00822016|Best Supportive Care|best supportive care
5619071|NCT00822016|Protocol of Standard Practice|protocol of standard practice
5619072|NCT00822016|Carcinoma of the Lung|carcinoma of the lung
5619073|NCT00822003|GLP-1|glp-1
5619074|NCT00822003|insulin|insulin
5619075|NCT00822003|glucose|glucose
5619076|NCT00821990|Failed after previous chemotherapy|failed after previous chemotherapy
5619077|NCT00821977|Type 2 Diabetes|type 2 diabetes
5619078|NCT00821977|Vildagliptin|vildagliptin
5619079|NCT00821964|Breast Cancer|breast cancer
5619080|NCT00821964|Stage IV|stage iv
5619081|NCT00821964|cream|cream
5619082|NCT00821964|topical|topical
5619083|NCT00821938|Narrow QRS|narrow qrs
5619085|NCT00821925|osteoporosis|osteoporosis
5619086|NCT00821899|diabetes type 1|diabetes type 1
5619087|NCT00821899|bone marrow transplantation|bone marrow transplantation
5619088|NCT00821886|Breast Cancer|breast cancer
5619089|NCT00821886|Neoadjuvant|neoadjuvant
5619090|NCT00821886|Ixabepilone|ixabepilone
5619091|NCT00821886|Carboplatin|carboplatin
5619092|NCT00821886|Trastuzumab|trastuzumab
5619093|NCT00821873|Cartilage injury|cartilage injury
5619094|NCT00821873|OATS|oats
5619095|NCT00821873|Knee injury|knee injury
5619096|NCT00821873|allograft|allograft
5619097|NCT00821873|autograft|autograft
5619098|NCT00821860|epithelial mesothelioma|epithelial mesothelioma
5619099|NCT00821860|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5619100|NCT00821860|sarcomatous mesothelioma|sarcomatous mesothelioma
5619101|NCT00821860|malignant pleural effusion|malignant pleural effusion
5619102|NCT00821860|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5619103|NCT00821860|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5619104|NCT00821860|stage II malignant mesothelioma|stage ii malignant mesothelioma
5619105|NCT00821860|stage III malignant mesothelioma|stage iii malignant mesothelioma
5619106|NCT00821860|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5619108|NCT00821847|glomerular filtration rate|glomerular filtration rate
5619109|NCT00821847|cockcroft|cockcroft
5619110|NCT00821847|MDRD formula|mdrd formula
5619111|NCT00821847|creatinine|creatinine
5619112|NCT00821847|cystatin C|cystatin c
5619113|NCT00821847|isotopic clearance|isotopic clearance
5619114|NCT00821847|EDTA-51Cr|edta-51cr
5619115|NCT00821847|DEXA scan|dexa scan
5619116|NCT00821834|Old Myocardial infarction|old myocardial infarction
5619117|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5619118|NCT00821834|Angioplasty|angioplasty
5619119|NCT00821834|Transluminal|transluminal
5619120|NCT00821834|Percutaneous Coronary|percutaneous coronary
5619121|NCT00821834|Stents|stents
5619122|NCT00821795|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5619123|NCT00821795|insulin|insulin
5619125|NCT00821782|Bacteria|bacteria
5619126|NCT00821782|Oral flora bacteria|oral flora bacteria
5619127|NCT00821782|Resistance|resistance
5619128|NCT00821756|Suicidal behaviour|suicidal behaviour
5619129|NCT00821756|Attempted suicide|attempted suicide
5619130|NCT00821756|Self harm|self harm
5619131|NCT00821756|Suicide|suicide
5619132|NCT00821756|Health system contacts|health system contacts
5619133|NCT00821756|Contacts with health system|contacts with health system
5619134|NCT00821730|Mixed methods research (qualitative and quantitative)|mixed methods research (qualitative and quantitative)
5619135|NCT00821730|Peer support|peer support
5619136|NCT00821730|Early inflammatory arthritis|early inflammatory arthritis
5619137|NCT00821730|Self-management|self-management
5619138|NCT00821730|Patient education|patient education
5619139|NCT00821717|Chronic Heart Failure|chronic heart failure
5619140|NCT00821717|Iron deficiency|iron deficiency
5619141|NCT00821717|Iron deficiency anaemia|iron deficiency anaemia
5619142|NCT00821717|Anaemia|anaemia
5619143|NCT00821717|Heart disease|heart disease
5619144|NCT00821691|cerebral infarction|cerebral infarction
5619145|NCT00821678|telemedicine|telemedicine
5619146|NCT00821678|rural|rural
5619147|NCT00821678|veterans|veterans
5619148|NCT00821678|care management|care management
5619149|NCT00821678|psychotherapy|psychotherapy
5619150|NCT00821665|Type 2 diabetes|type 2 diabetes
5619151|NCT00821665|Glycemic control|glycemic control
5619152|NCT00821665|(postprandial) Hyperglycemia|(postprandial) hyperglycemia
5619153|NCT00821665|Sucrose|sucrose
5619154|NCT00821652|Tumor|tumor
5619155|NCT00821652|NY-ESO-1 expression|ny-eso-1 expression
5619156|NCT00821652|Tumors that often express NY-ESO-1.|tumors that often express ny-eso-1.
5619157|NCT00821626|Influenza|influenza
5619158|NCT00821626|Rapid flu test|rapid flu test
5619159|NCT00821626|Returning travelers with fever|returning travelers with fever
5619164|NCT00821587|Hepatitis C Post Liver Transplant|hepatitis c post liver transplant
5619165|NCT00821574|Hypertension, dyslipidemia|hypertension, dyslipidemia
5619167|NCT00821561|cornea|cornea
5619168|NCT00821561|defect|defect
5619169|NCT00821561|Nexagon|nexagon
5619170|NCT00821561|Coda|coda
5619171|NCT00821548|facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
5619172|NCT00821548|electrostimulation|electrostimulation
5619173|NCT00821548|training|training
5619174|NCT00821535|pharmacokinetics, Japanese, healthy volunteer, maraviroc|pharmacokinetics, japanese, healthy volunteer, maraviroc
5619175|NCT00821522|Acute Kidney Insufficiency|acute kidney insufficiency
5619176|NCT00821522|Acute Renal Insufficiency|acute renal insufficiency
5619177|NCT00821522|Acute Kidney Injury|acute kidney injury
5619178|NCT00821522|Cardiac Surgical Procedures|cardiac surgical procedures
5619179|NCT00821522|Ischemic Preconditioning|ischemic preconditioning
5619180|NCT00821509|virus infection|virus infection
5619181|NCT00821509|hygiene|hygiene
5619182|NCT00821509|transmission|transmission
5619183|NCT00821509|intervention|intervention
5619184|NCT00821496|Multiple dose administration|multiple dose administration
5619185|NCT00821496|Oral Contraceptives|oral contraceptives
5619190|NCT00821457|existing scars the are two to six months old|existing scars the are two to six months old
5619191|NCT00821444|schizophrenia, pharmacokinetics, bioavailability, food effect|schizophrenia, pharmacokinetics, bioavailability, food effect
5619192|NCT00821405|Number : 250~300 patients|number : 250~300 patients
5619193|NCT00821405|Correlation between PET, glucose loading and peritoneal thickness/calcification|correlation between pet, glucose loading and peritoneal thickness/calcification
5619194|NCT00821379|PCOS|pcos
5619195|NCT00821379|Polycystic Ovary Syndrome|polycystic ovary syndrome
5619196|NCT00821379|Pregnancy Complications|pregnancy complications
5619197|NCT00821379|Gestational Diabetes|gestational diabetes
5619198|NCT00821379|Pre eclampsia|pre eclampsia
5619199|NCT00821379|Prediction Model|prediction model
5619200|NCT00821379|Pre conceptional|pre conceptional
5619201|NCT00821366|HIV/AIDS|hiv/aids
5619202|NCT00821366|Food security|food security
5619803|NCT00819078|cessation|cessation
5619203|NCT00821366|treatment experienced|treatment experienced
5619204|NCT00821353|Atrial fibrillation|atrial fibrillation
5619205|NCT00821353|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5619206|NCT00821353|RF ablation|rf ablation
5619207|NCT00821353|Antiarrhythmic drugs|antiarrhythmic drugs
5619208|NCT00821340|Leber congenital amaurosis|leber congenital amaurosis
5619210|NCT00821340|RPE65|rpe65
5619211|NCT00821340|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
5619212|NCT00821340|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
5619213|NCT00821301|Multiple myeloma|multiple myeloma
5619214|NCT00821288|cancer survivorship|cancer survivorship
5619215|NCT00821288|survivorship prescription|survivorship prescription
5619216|NCT00821288|cancer related anxiety|cancer related anxiety
5619217|NCT00821275|Uterine Artery Embolization|uterine artery embolization
5619219|NCT00821275|myomectomy|myomectomy
5619220|NCT00821275|hysterectomy|hysterectomy
5619221|NCT00821275|pregnancy|pregnancy
5619222|NCT00821275|complication|complication
5619223|NCT00821275|ovarian function|ovarian function
5619224|NCT00821275|quality of life|quality of life
5619225|NCT00821262|Sevoflurane|sevoflurane
5619226|NCT00821262|Anesthesia|anesthesia
5619227|NCT00821262|Troponin|troponin
5619228|NCT00821262|Myocardial Preconditioning|myocardial preconditioning
5619229|NCT00821262|Surgery, Cardiac|surgery, cardiac
5619230|NCT00821262|Stents|stents
5619231|NCT00821262|Non-cardiac Surgery|non-cardiac surgery
5619232|NCT00821262|Surgery|surgery
5619233|NCT00821249|plasma cell dyscrasia|plasma cell dyscrasia
5619234|NCT00821249|plasmacytoma|plasmacytoma
5619235|NCT00821249|kinesin spindle protein|kinesin spindle protein
5619236|NCT00821249|anti-mitotic|anti-mitotic
5619237|NCT00821236|Myopia|myopia
5619238|NCT00821236|LASIK|lasik
5619239|NCT00821236|Astigmatism|astigmatism
5619240|NCT00821236|Laser Vision Correction|laser vision correction
5619241|NCT00821236|Excimer Laser|excimer laser
5619242|NCT00821223|phacoemulsification|phacoemulsification
5619243|NCT00821223|manual small incision cataract surgery|manual small incision cataract surgery
5619244|NCT00821223|visual acuity|visual acuity
5619245|NCT00821223|contrast sensitivity|contrast sensitivity
5619246|NCT00821223|quality of vision|quality of vision
5619247|NCT00821210|Obstructive sleep apnea|obstructive sleep apnea
5619248|NCT00821210|myocardial infarction|myocardial infarction
5619249|NCT00821197|obesity|obesity
5619250|NCT00821197|laparoscopy|laparoscopy
5619251|NCT00821197|bariatric|bariatric
5619252|NCT00821197|super obesity|super obesity
5619253|NCT00821184|urinary incontinence|urinary incontinence
5619254|NCT00821184|overactive bladder|overactive bladder
5619255|NCT00821184|urinary frequency|urinary frequency
5619256|NCT00821145|abdominal aortic aneurysms|abdominal aortic aneurysms
5619258|NCT00821132|ALS|als
5619259|NCT00821132|ALS/FTD|als/ftd
5619260|NCT00821132|SALS|sals
5619261|NCT00821132|MND|mnd
5619262|NCT00821132|PLS|pls
5619263|NCT00821119|non invasive ventilation|non invasive ventilation
5619264|NCT00821119|mechanical ventilation|mechanical ventilation
5619265|NCT00821119|pulmonary morbidity|pulmonary morbidity
5619266|NCT00821119|preterm infant|preterm infant
5619267|NCT00821119|Respiratory distress syndrome|respiratory distress syndrome
5619268|NCT00821119|nasal intermittent positive pressure|nasal intermittent positive pressure
5619269|NCT00821119|nasal continuous positive pressure|nasal continuous positive pressure
5613178|NCT00845416|PID|pid
5619270|NCT00821119|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5619271|NCT00821106|Coronary angiography|coronary angiography
5619272|NCT00821106|percutaneous coronary intervention|percutaneous coronary intervention
5619273|NCT00821106|Transradial approach|transradial approach
5619274|NCT00821093|respiratory|respiratory
5619276|NCT00821093|breathlessness|breathlessness
5619277|NCT00821093|COPD|copd
5619278|NCT00821093|indacaterol|indacaterol
5619279|NCT00821093|long-acting β2-agonist|long-acting β2-agonist
5619280|NCT00821080|vandetanib|vandetanib
5619281|NCT00821080|sirolimus|sirolimus
5619282|NCT00821080|recurrent glioblastoma|recurrent glioblastoma
5619283|NCT00019539|adult solid tumor|adult solid tumor
5619284|NCT00019539|body system/site cancer|body system/site cancer
5619285|NCT00019539|cancer|cancer
5619286|NCT00019539|kidney tumor|kidney tumor
5619287|NCT00019539|kidney/urinary cancer|kidney/urinary cancer
5619288|NCT00019539|recurrent renal cell cancer|recurrent renal cell cancer
5619289|NCT00019539|renal cell cancer|renal cell cancer
5619290|NCT00019539|solid tumor|solid tumor
5619291|NCT00019539|stage IV renal cell cancer|stage iv renal cell cancer
5619292|NCT00019539|stage, renal cell cancer|stage, renal cell cancer
5619293|NCT00821054|Phase I Food Effect|phase i food effect
5619294|NCT00821041|insomnia|insomnia
5619295|NCT00821041|online systems|online systems
5619296|NCT00821028|atherosclerosis|atherosclerosis
5619297|NCT00821028|angioplasty|angioplasty
5619298|NCT00821028|peripheral arterial disease|peripheral arterial disease
5619299|NCT00821015|cryoablation|cryoablation
5619300|NCT00821015|recurring arrhythmia|recurring arrhythmia
5619301|NCT00821015|stroke|stroke
5619302|NCT00821015|RF ablation|rf ablation
5619304|NCT00821015|nodal ablation|nodal ablation
5619305|NCT00821015|catheter ablation|catheter ablation
5619306|NCT00821002|Glaucoma|glaucoma
5619307|NCT00820989|Healthy Immune System|healthy immune system
5619308|NCT00820976|G-CSF|g-csf
5619309|NCT00820976|AML|aml
5619310|NCT00820976|survival|survival
5619311|NCT00820963|adult giant cell glioblastoma|adult giant cell glioblastoma
5619312|NCT00820963|adult glioblastoma|adult glioblastoma
5619313|NCT00820963|adult gliosarcoma|adult gliosarcoma
5619314|NCT00820924|HER-2|her-2
5619315|NCT00820924|Circulating Tumour Cell (CTC)|circulating tumour cell (ctc)
5619316|NCT00820924|EGFR|egfr
5619317|NCT00820924|Lapatinib (GW572016)|lapatinib (gw572016)
5619318|NCT00820924|Breast Cancer|breast cancer
5619319|NCT00820911|Kidney transplant|kidney transplant
5619320|NCT00820911|AEB071|aeb071
5619321|NCT00820872|male breast cancer|male breast cancer
5619322|NCT00820872|stage I breast cancer|stage i breast cancer
5619323|NCT00820872|stage II breast cancer|stage ii breast cancer
5619324|NCT00820872|stage IIIA breast cancer|stage iiia breast cancer
5619325|NCT00820872|stage IIIB breast cancer|stage iiib breast cancer
5619326|NCT00820859|Cognition disorder|cognition disorder
5619327|NCT00820859|nursing home residents|nursing home residents
5619328|NCT00820859|agitation|agitation
5619329|NCT00820859|behavior disorder|behavior disorder
5619330|NCT00820846|HIV Seronegativity|hiv seronegativity
5619331|NCT00820846|HIV Preventive Vaccine|hiv preventive vaccine
5619332|NCT00820833|infant formula|infant formula
5619333|NCT00820833|obesity|obesity
5619334|NCT00820833|growth|growth
5619335|NCT00820820|Atopic Dermatitis|atopic dermatitis
5619336|NCT00820820|immunosuppression|immunosuppression
5619337|NCT00820820|Measles vaccine|measles vaccine
5619338|NCT00820820|T lymphocytes|t lymphocytes
5619339|NCT00820820|Atopic Dermatitis in adults|atopic dermatitis in adults
5619340|NCT00820807|dietary fiber|dietary fiber
5619341|NCT00820807|fiber|fiber
5619342|NCT00820807|insulin sensitivity|insulin sensitivity
5619343|NCT00820807|insulin resistance|insulin resistance
5619344|NCT00820807|glucose metabolism|glucose metabolism
5619345|NCT00820794|Drug-drug interaction, lithium, PD 0332334, pharmacokinetics|drug-drug interaction, lithium, pd 0332334, pharmacokinetics
5619346|NCT00820781|bleeding gastric varices|bleeding gastric varices
5619347|NCT00820781|cirrhosis of the liver|cirrhosis of the liver
5619348|NCT00820781|portacaval shunt|portacaval shunt
5619349|NCT00820781|endoscopic variceal sclerotherapy|endoscopic variceal sclerotherapy
5619350|NCT00820781|endoscopic variceal ligation|endoscopic variceal ligation
5619351|NCT00820781|Bleeding gastric varices due to cirrhosis of the liver|bleeding gastric varices due to cirrhosis of the liver
5619352|NCT00820742|A5751025|a5751025
5619353|NCT00820729|interstitial lung disease|interstitial lung disease
5619354|NCT00820729|pulmonary hypertension|pulmonary hypertension
5619356|NCT00820729|NT-pro-BNP|nt-pro-bnp
5619357|NCT00820729|von Willebrand factor|von willebrand factor
5619358|NCT00820729|D-dimer|d-dimer
5619359|NCT00820729|Exhaled NO|exhaled no
5619360|NCT00820729|Troponin-t|troponin-t
5619361|NCT00820716|Asthma|asthma
5619362|NCT00820716|Asthmatic subjects|asthmatic subjects
5619363|NCT00820716|Exercise training|exercise training
5619364|NCT00820716|Constant load|constant load
5619365|NCT00820716|Alternate load|alternate load
5619366|NCT00820703|Nexagon|nexagon
5619367|NCT00820703|CoDa|coda
5619368|NCT00820703|ulcer|ulcer
5619369|NCT00820703|diabetic|diabetic
5619370|NCT00820703|foot|foot
5619371|NCT00820690|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5619372|NCT00820690|advanced breast cancer|advanced breast cancer
5619373|NCT00820690|microarray|microarray
5619374|NCT00820690|correlation analysis|correlation analysis
5619375|NCT00820690|oncoplastic surgery|oncoplastic surgery
5619376|NCT00820651|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5619377|NCT00820651|Insulinresistance|insulinresistance
5619378|NCT00820651|Diet and exercise|diet and exercise
5619379|NCT00820651|Nutritional supplement|nutritional supplement
5619380|NCT00820651|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5619381|NCT00820651|Lifestyle modifications|lifestyle modifications
5619382|NCT00820638|neurorobotics|neurorobotics
5619383|NCT00820638|occupational therapy|occupational therapy
5619384|NCT00820599|Sapien Valve|sapien valve
5619385|NCT00820599|Cardiovascular Diseases|cardiovascular diseases
5619386|NCT00820599|Valvular Heart Disease|valvular heart disease
5619387|NCT00820599|Aortic Stenosis|aortic stenosis
5619388|NCT00820599|Heart Valve Therapy|heart valve therapy
5619389|NCT00820599|Transfemoral|transfemoral
5619390|NCT00820599|Transcatheter|transcatheter
5619391|NCT00820586|Intramyocardial|intramyocardial
5619392|NCT00820586|Autologous|autologous
5619393|NCT00820586|Bone|bone
5619394|NCT00820586|Marrow|marrow
5619395|NCT00820586|Randomized|randomized
5619396|NCT00820586|Percutaneous|percutaneous
5619397|NCT00820586|CD34+|cd34+
5619398|NCT00820586|Refractory|refractory
5619399|NCT00820586|Angina|angina
5619400|NCT00820586|Pectoris.|pectoris.
5619401|NCT00820573|Diabetes|diabetes
5619402|NCT00820547|inflammatory breast cancer|inflammatory breast cancer
5619804|NCT00819078|depression|depression
5619403|NCT00820547|stage IIIA breast cancer|stage iiia breast cancer
5619404|NCT00820547|stage IIIB breast cancer|stage iiib breast cancer
5619405|NCT00820547|stage IIIC breast cancer|stage iiic breast cancer
5619406|NCT00820547|male breast cancer|male breast cancer
5619407|NCT00820547|HER2-negative breast cancer|her2-negative breast cancer
5619408|NCT00820534|cold sore|cold sore
5619409|NCT00820508|Haematological disease|haematological disease
5619410|NCT00820508|Lymphoid malignancy|lymphoid malignancy
5619411|NCT00820508|Histone deacetylase inhibitor|histone deacetylase inhibitor
5619412|NCT00820508|dose escalation|dose escalation
5619413|NCT00820495|Smokeless tobacco|smokeless tobacco
5619414|NCT00820495|Chewing Tobacco|chewing tobacco
5619415|NCT00820495|Internet|internet
5619416|NCT00820495|Adolescent|adolescent
5619417|NCT00820469|Rituximab|rituximab
5619418|NCT00820469|Plasma exchange|plasma exchange
5619419|NCT00820469|Autoimmune diseases|autoimmune diseases
5619420|NCT00820456|colorectal cancer|colorectal cancer
5619421|NCT00820456|colorectal neoplasm|colorectal neoplasm
5619422|NCT00820456|colorectal neoplasms|colorectal neoplasms
5619423|NCT00820456|metastasis|metastasis
5619424|NCT00820456|metastases|metastases
5619425|NCT00820456|liver|liver
5619426|NCT00820456|hepatic metastasis|hepatic metastasis
5619427|NCT00820456|liver metastasis|liver metastasis
5619428|NCT00820456|perfusion imaging|perfusion imaging
5619429|NCT00820456|MRI|mri
5619430|NCT00820456|magnetic resonance imaging|magnetic resonance imaging
5619431|NCT00820456|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5619432|NCT00820456|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
5619433|NCT00820430|osteoarthritis|osteoarthritis
5619434|NCT00820430|knee|knee
5619435|NCT00820430|magnetic resonance imaging|magnetic resonance imaging
5619436|NCT00820430|knee cartilage|knee cartilage
5619437|NCT00820430|reproducibility|reproducibility
5619438|NCT00820417|cetuximab|cetuximab
5619439|NCT00820417|monoclonal|monoclonal
5619440|NCT00820417|antibody|antibody
5619441|NCT00820417|epidermal|epidermal
5619442|NCT00820417|growth|growth
5619443|NCT00820417|factor|factor
5619444|NCT00820417|receptor|receptor
5619445|NCT00820417|EGFR|egfr
5619446|NCT00820417|Gefitinib|gefitinib
5619447|NCT00820417|tyrosine|tyrosine
5619448|NCT00820417|kinase|kinase
5619449|NCT00820417|inhibitor|inhibitor
5619450|NCT00820417|advanced|advanced
5619451|NCT00820417|cancer|cancer
5619452|NCT00820391|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5619453|NCT00820378|Aortic dimension|aortic dimension
5619454|NCT00820378|Atherosclerosis|atherosclerosis
5619456|NCT00820378|Risk factors|risk factors
5619457|NCT00820365|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5619458|NCT00820365|Crohn's Disease|crohn's disease
5619459|NCT00820365|Ulcerative Colitis|ulcerative colitis
5619460|NCT00820365|SC12267|sc12267
5619461|NCT00820365|4SC-101|4sc-101
5619462|NCT00820365|Phase II|phase ii
5619463|NCT00820352|HFNEF|hfnef
5619464|NCT00820352|HFPEF|hfpef
5619465|NCT00820352|Secondary Pulmonary Hypertension|secondary pulmonary hypertension
5619466|NCT00820352|Endothelin Receptor Blockade|endothelin receptor blockade
5619467|NCT00820339|hepatocellular carcinoma|hepatocellular carcinoma
5619468|NCT00820339|hepatic vein|hepatic vein
5619469|NCT00820339|Surgical resection|surgical resection
5619470|NCT00820339|occlusion|occlusion
5619471|NCT00820339|time to recurrence|time to recurrence
5863019|NCT00001414|Siblings|siblings
5619474|NCT00820313|Biomarkers of Cardiovascular Disease|biomarkers of cardiovascular disease
5619475|NCT00820313|Health Related Quality of Life|health related quality of life
5619476|NCT00820313|Diabetes|diabetes
5619477|NCT00820313|Diet|diet
5619478|NCT00820287|Testicular cancer|testicular cancer
5619479|NCT00820287|incidence|incidence
5619480|NCT00820287|young men|young men
5619481|NCT00820261|Genotypes|genotypes
5619482|NCT00820261|Epidemiology|epidemiology
5619483|NCT00820261|Diarrhea|diarrhea
5619484|NCT00820248|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5619485|NCT00820248|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5619486|NCT00820248|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5619487|NCT00820248|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5619488|NCT00820248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5619489|NCT00820248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5619490|NCT00820248|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5619491|NCT00820248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5619492|NCT00820248|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5619493|NCT00820248|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5619494|NCT00820248|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5620238|NCT00817765|boosting|boosting
5619495|NCT00820248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5619496|NCT00820222|ErbB2|erbb2
5619497|NCT00820222|HERCEPTIN|herceptin
5619498|NCT00820222|XELODA|xeloda
5619499|NCT00820222|ErbB1|erbb1
5619500|NCT00820222|TYKERB|tykerb
5619501|NCT00820222|metastatic breast cancer|metastatic breast cancer
5619502|NCT00820222|trastuzumab|trastuzumab
5619503|NCT00820222|breast cancer|breast cancer
5619504|NCT00820222|capecitabine|capecitabine
5619505|NCT00820222|lapatinib|lapatinib
5619506|NCT00820222|brain metastases|brain metastases
5619508|NCT00820222|TYVERB|tyverb
5619509|NCT00820196|Venous ulcer|venous ulcer
5619510|NCT00820196|Nexagon|nexagon
5619511|NCT00820196|CoDa|coda
5619512|NCT00820183|Hypertension|hypertension
5619513|NCT00820183|Intervention|intervention
5619514|NCT00820183|Primary Care|primary care
5619515|NCT00820183|Quality improvement|quality improvement
5619516|NCT00820170|Breast|breast
5619517|NCT00820170|Cancer|cancer
5619518|NCT00820170|DASATINIB|dasatinib
5619519|NCT00820170|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5619521|NCT00820157|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5619522|NCT00820157|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5619523|NCT00820157|Cytoreductive|cytoreductive
5619524|NCT00820144|immune response|immune response
5619525|NCT00820144|b-subunit of cholera toxin|b-subunit of cholera toxin
5619526|NCT00820144|mucosal way|mucosal way
5619527|NCT00820144|healthy volonteers|healthy volonteers
5619528|NCT00820144|vaccine|vaccine
5619529|NCT00820118|ANTIRETROVIRAL THERAPY|antiretroviral therapy
5619530|NCT00820118|STRUCTURED TREATMENT INTERRUPTIONS|structured treatment interruptions
5619531|NCT00820118|treatment naive|treatment naive
5619532|NCT00820105|Migraine|migraine
5619533|NCT00820105|Aura|aura
5619534|NCT00820105|Migraine headache|migraine headache
5619535|NCT00820092|Xerecept|xerecept
5619536|NCT00820092|Pharmacokinetics|pharmacokinetics
5619537|NCT00820092|Japanese versus Caucasians|japanese versus caucasians
5619538|NCT00820079|Gastroesophageal reflux|gastroesophageal reflux
5619539|NCT00820079|Heartburn|heartburn
5619540|NCT00820079|Regurgitation|regurgitation
5619541|NCT00820053|hepatocellular carcinoma|hepatocellular carcinoma
5619542|NCT00820053|adjuvant therapy|adjuvant therapy
5619543|NCT00820053|TACE|tace
5619544|NCT00820053|time to recurrence|time to recurrence
5619545|NCT00820053|overall survival|overall survival
5619546|NCT00820014|ESBA105|esba105
5622019|NCT00811421|HIV|hiv
5619547|NCT00820014|scFv antibody fragment|scfv antibody fragment
5619549|NCT00820014|pharmacokinetics|pharmacokinetics
5619550|NCT00820014|biodistribution|biodistribution
5619551|NCT00820014|Irvine-Gass syndrome|irvine-gass syndrome
5619552|NCT00820001|Cognitive Behavioral Therapy|cognitive behavioral therapy
5619553|NCT00820001|Multimodal Treatment|multimodal treatment
5619554|NCT00820001|Physiological Parameters|physiological parameters
5619555|NCT00820001|Hormone Concentration in pubertal development|hormone concentration in pubertal development
5619556|NCT00820001|Treatment as usual comparison|treatment as usual comparison
5619557|NCT00819988|Postoperative|postoperative
5619558|NCT00819988|Perioperative|perioperative
5619559|NCT00819988|Orthopedic surgery|orthopedic surgery
5619560|NCT00819988|Vascular surgery|vascular surgery
5619561|NCT00819988|Gabapentinoid|gabapentinoid
5619563|NCT00819975|Whey|whey
5619564|NCT00819975|postprandial|postprandial
5619565|NCT00819975|Triglyceride|triglyceride
5619566|NCT00819975|Free fatty acids|free fatty acids
5619567|NCT00819975|Retinyl palmitate|retinyl palmitate
5619568|NCT00819975|Incretins|incretins
5619569|NCT00819975|Type 2 Diabetes|type 2 diabetes
5619570|NCT00819949|Robot|robot
5619571|NCT00819949|Treadmill|treadmill
5619572|NCT00819949|Rehabilitation|rehabilitation
5619573|NCT00819949|Freezing of gait|freezing of gait
5619574|NCT00819936|abdominal aorta surgery|abdominal aorta surgery
5619575|NCT00819936|Physical Training|physical training
5619576|NCT00819936|backward walking|backward walking
5619577|NCT00819936|physiotherapy|physiotherapy
5619578|NCT00819923|Titanium|titanium
5619579|NCT00819923|everolimus|everolimus
5619580|NCT00819923|drug eluting stent|drug eluting stent
5619581|NCT00819923|stent thrombosis|stent thrombosis
5619582|NCT00819923|restenosis|restenosis
5619583|NCT00819923|percutaneous coronary intervention|percutaneous coronary intervention
5619584|NCT00819923|acute coronary syndrome|acute coronary syndrome
5619585|NCT00819910|Type 4 hyperlipidemia|type 4 hyperlipidemia
5619586|NCT00819910|Rosiglitazone|rosiglitazone
5619587|NCT00819910|Fenofibrate|fenofibrate
5619588|NCT00819897|MS|ms
5619589|NCT00819897|CIS|cis
5619590|NCT00819897|IFN|ifn
5619591|NCT00819897|MRI|mri
5619592|NCT00819897|OCT|oct
5619593|NCT00819897|QOL|qol
5619594|NCT00819884|Type II Diabetes|type ii diabetes
5619595|NCT00819884|24 hour glucose profile|24 hour glucose profile
5619596|NCT00819858|weight loss|weight loss
5619597|NCT00819858|weight gain|weight gain
5619598|NCT00819858|malnutrition|malnutrition
5619599|NCT00819858|convalescence|convalescence
5619600|NCT00819858|malaria|malaria
5619601|NCT00819858|RUTF|rutf
5619602|NCT00819858|RUF|ruf
5619603|NCT00819858|supplementation|supplementation
5619604|NCT00819858|nutrition|nutrition
5619605|NCT00819845|Duchenne|duchenne
5619606|NCT00819845|Becker muscular dystrophy|becker muscular dystrophy
5619607|NCT00819845|cardioprotective therapy|cardioprotective therapy
5619608|NCT00819845|cardiac magnetic resonance|cardiac magnetic resonance
5619609|NCT00819845|ultrasound tissue characterization|ultrasound tissue characterization
5619610|NCT00819832|vertebral compression fractures|vertebral compression fractures
5619612|NCT00819832|Spinal|spinal
5619613|NCT00819832|Broken spinal bones|broken spinal bones
5619614|NCT00819832|Kyphoplasty|kyphoplasty
5619615|NCT00819832|vertebroplasty|vertebroplasty
5619616|NCT00819832|Cavity SpineWand|cavity spinewand
5619617|NCT00819832|Circulating Tumor Cell Burden|circulating tumor cell burden
5619618|NCT00819832|CTCB|ctcb
5619619|NCT00819832|Spine pain|spine pain
5619620|NCT00819832|Coblation|coblation
5619621|NCT00819832|plasma radiofrequency ablation|plasma radiofrequency ablation
5619622|NCT00819832|Plasma-mediated ablation technology|plasma-mediated ablation technology
5619623|NCT00819832|precise molecular dissociation (ablation) process|precise molecular dissociation (ablation) process
5619624|NCT00819832|medical cement|medical cement
5619625|NCT00819793|Cardiac Dysfunction|cardiac dysfunction
5619626|NCT00819793|Failure-to-wean from CPB|failure-to-wean from cpb
5619627|NCT00819793|CentriMag|centrimag
5619628|NCT00819793|Levitronix|levitronix
5619629|NCT00819793|Thoratec Corporation|thoratec corporation
5619630|NCT00819780|Colon Cancer|colon cancer
5619631|NCT00819780|Colorectal Cancer|colorectal cancer
5619632|NCT00819780|Rectal Cancer|rectal cancer
5619633|NCT00819780|Panitumumab|panitumumab
5619634|NCT00819780|Vectibix|vectibix
5619635|NCT00819780|modified FOLFOX 6|modified folfox 6
5619636|NCT00819780|mFOLFOX 6|mfolfox 6
5619637|NCT00819780|FOLFOX|folfox
5619638|NCT00819780|Bevacizumab|bevacizumab
5619639|NCT00819780|Avastin|avastin
5619640|NCT00819780|First-Line|first-line
5619641|NCT00819780|metastatic|metastatic
5619642|NCT00819767|hypertension|hypertension
5619643|NCT00819767|systolic blood pressure|systolic blood pressure
5619644|NCT00819767|exercise test|exercise test
5619645|NCT00819767|cardiovascular disease|cardiovascular disease
5619646|NCT00819767|aliskiren|aliskiren
5619647|NCT00819767|valsartan|valsartan
5619648|NCT00819715|Preterm infants|preterm infants
5622104|NCT00811200|uveal|uveal
5619649|NCT00819715|small for gestational age|small for gestational age
5619650|NCT00819715|electrogastrography|electrogastrography
5619651|NCT00819702|child abuse prevention|child abuse prevention
5619652|NCT00819702|primary care|primary care
5619653|NCT00819702|professional education in primary care|professional education in primary care
5619654|NCT00819650|hepatocellular carcinoma|hepatocellular carcinoma
5619655|NCT00819650|adjuvant therapy|adjuvant therapy
5619656|NCT00819650|Licartin|licartin
5619657|NCT00819650|time to recurrence|time to recurrence
5619658|NCT00819650|overall survival|overall survival
5619659|NCT00819637|Acute asthma|acute asthma
5619660|NCT00819637|Arformoterol|arformoterol
5619661|NCT00819637|Long acting beta agonists|long acting beta agonists
5619662|NCT00819624|fibromyalgia methodology pain sleep fatigue|fibromyalgia methodology pain sleep fatigue
5619663|NCT00819611|Attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
5613531|NCT00843713|HIV|hiv
5619669|NCT00819585|Gout|gout
5619670|NCT00819585|Chronic gout|chronic gout
5619671|NCT00819585|Gouty arthritis|gouty arthritis
5619672|NCT00819585|Gout flares|gout flares
5619673|NCT00819572|Osteoarthritis|osteoarthritis
5619674|NCT00819572|TNF-alpha|tnf-alpha
5619675|NCT00819572|DLX105|dlx105
5619676|NCT00819572|scFv antibody fragment|scfv antibody fragment
5619677|NCT00819572|pain|pain
5619678|NCT00819572|fragment|fragment
5619679|NCT00819572|antibody fragment|antibody fragment
5619680|NCT00819559|Rectal neoplasm|rectal neoplasm
5619681|NCT00819559|Clinical stage|clinical stage
5619682|NCT00819559|T3N0|t3n0
5619683|NCT00819559|Preoperative chemoradiotherapy|preoperative chemoradiotherapy
5619684|NCT00819559|Laparoscopic|laparoscopic
5619685|NCT00819559|Open resection|open resection
5619688|NCT00819520|pediculosis capitis|pediculosis capitis
5619689|NCT00819520|pediculus|pediculus
5619690|NCT00819507|Skin barrier|skin barrier
5619691|NCT00819507|Atopic Dermatitis|atopic dermatitis
5619692|NCT00819507|Corticosteroid|corticosteroid
5619693|NCT00819507|Effects on skin severity and barrier function|effects on skin severity and barrier function
5619694|NCT00819494|Contrast media skin test|contrast media skin test
5619695|NCT00819494|Skin test|skin test
5619696|NCT00819494|hypersensitivity|hypersensitivity
5619697|NCT00819494|contrast media|contrast media
5619698|NCT00819481|Total knee replacement|total knee replacement
5619699|NCT00819455|Diabetes|diabetes
5619700|NCT00819455|Prevention of Diabetes|prevention of diabetes
5619701|NCT00819455|Lifestyle Modification|lifestyle modification
5619702|NCT00819455|Text messages|text messages
5619703|NCT00819442|heart failure|heart failure
5619704|NCT00819442|desmin|desmin
5619705|NCT00819442|ubiquitin|ubiquitin
5619706|NCT00819429|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5619707|NCT00819429|Conduct Disorder|conduct disorder
5619708|NCT00819429|Oppositional Defiant Disorder|oppositional defiant disorder
5619709|NCT00819429|Omega 3 Supplements|omega 3 supplements
5619710|NCT00819429|Social Skills Training|social skills training
5619711|NCT00819429|Dietary Intake|dietary intake
5619712|NCT00819429|Aggression|aggression
5619713|NCT00819429|Nutrition|nutrition
5619714|NCT00819429|Disruptive Behaviors Disorder|disruptive behaviors disorder
5619715|NCT00819416|randomized controlled trial|randomized controlled trial
5619716|NCT00819416|clinical trial|clinical trial
5619717|NCT00819403|triglycerides|triglycerides
5619718|NCT00819403|hypertension|hypertension
5619720|NCT00819403|obesity|obesity
5619721|NCT00819377|Valvular surgery|valvular surgery
5619722|NCT00819377|pulmonary artery pressure|pulmonary artery pressure
5619723|NCT00819364|Autism|autism
5619724|NCT00819364|early intervention|early intervention
5619725|NCT00819364|BCRI model|bcri model
5619726|NCT00819351|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5619727|NCT00819351|child|child
5619728|NCT00819351|PEG-Asparaginase|peg-asparaginase
5619730|NCT00819351|efficacy|efficacy
5619731|NCT00819351|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5619732|NCT00819338|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5619733|NCT00819338|Polyunsaturated fatty acids|polyunsaturated fatty acids
5619734|NCT00819338|Omega-3|omega-3
5619735|NCT00819325|diabetes|diabetes
5619736|NCT00819325|stents|stents
5619737|NCT00819325|restenosis|restenosis
5619738|NCT00819325|thiazolidinediones|thiazolidinediones
5619739|NCT00819325|coronary atherosclerosis|coronary atherosclerosis
5619740|NCT00819312|Contraceptives,|contraceptives,
5619741|NCT00819312|Oral Hormonal;|oral hormonal;
5619742|NCT00819312|Contraceptive Methods;|contraceptive methods;
5619743|NCT00819312|Female|female
5619744|NCT00819299|Presbyopia|presbyopia
5619745|NCT00819299|accommodation|accommodation
5619746|NCT00819299|near visual acuity|near visual acuity
5619747|NCT00819299|LASIK|lasik
5619748|NCT00819286|open heart surgery|open heart surgery
5619749|NCT00819273|hsCRP|hscrp
5619750|NCT00819260|Mammaplasty|mammaplasty
5619751|NCT00819260|Electrocoagulation|electrocoagulation
5619752|NCT00819260|Breast|breast
5619753|NCT00819234|Leptin|leptin
5619754|NCT00819234|Pramlintide|pramlintide
5619755|NCT00819234|Obese|obese
5619756|NCT00819234|Symlin|symlin
5619757|NCT00819234|Amylin|amylin
5619758|NCT00819221|advanced tumors|advanced tumors
5619759|NCT00819221|solid tumors|solid tumors
5619760|NCT00819221|dose escalation|dose escalation
5619761|NCT00819221|combination|combination
5619762|NCT00819221|AZD2281|azd2281
5619763|NCT00819221|liposomal doxorubicin|liposomal doxorubicin
5619764|NCT00819221|pharmacology|pharmacology
5619765|NCT00819221|phase I|phase i
5619766|NCT00819221|multicenter|multicenter
5619770|NCT00819208|anxiety disorder|anxiety disorder
5619771|NCT00819208|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5619772|NCT00819208|cognitive/functional effects|cognitive/functional effects
5619773|NCT00819208|stage II colon cancer|stage ii colon cancer
5619774|NCT00819208|stage III colon cancer|stage iii colon cancer
5619775|NCT00819208|adenocarcinoma of the colon|adenocarcinoma of the colon
5619776|NCT00819195|relapsing-remitting|relapsing-remitting
5619777|NCT00819195|multiple sclerosis|multiple sclerosis
5619778|NCT00819195|Copaxone|copaxone
5619779|NCT00819195|glatiramer acetate|glatiramer acetate
5619781|NCT00819182|Menopause|menopause
5619782|NCT00819182|Breast Cancer|breast cancer
5619783|NCT00819182|Hot Flash|hot flash
5619784|NCT00819182|Night Sweats|night sweats
5619785|NCT00819169|AMG 655|amg 655
5619786|NCT00819169|AMG 479|amg 479
5619787|NCT00819169|Apoptosis|apoptosis
5619788|NCT00819169|Monoclonal Antibody|monoclonal antibody
5619789|NCT00819169|Tumor Necrosis Factor|tumor necrosis factor
5619790|NCT00819169|Insulin-like Growth Factor|insulin-like growth factor
5619791|NCT00819143|Tissue Procurement|tissue procurement
5619792|NCT00819143|Sample Collection|sample collection
5619793|NCT00819143|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5619794|NCT00819143|Laboratory Research|laboratory research
5619795|NCT00819117|Epicardial leads|epicardial leads
5619796|NCT00819117|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5619797|NCT00819104|Primary hypertension|primary hypertension
5619798|NCT00819104|Metoprolol XL|metoprolol xl
5619799|NCT00819104|Amlodipine|amlodipine
5619800|NCT00819078|adolescent|adolescent
5619801|NCT00819078|bupropion|bupropion
5619802|NCT00819078|smoking|smoking
5619805|NCT00819065|Botulinum toxin A|botulinum toxin a
5619806|NCT00819065|Spasticity|spasticity
5619807|NCT00819065|Randomized Clinical Trial|randomized clinical trial
5619808|NCT00819000|Specialty Pharmacy|specialty pharmacy
5619809|NCT00819000|Therapy Management|therapy management
5619810|NCT00819000|Medication Compliance|medication compliance
5619811|NCT00819000|Medication Adherence|medication adherence
5619812|NCT00819000|Medication Persistence|medication persistence
5619813|NCT00819000|Health Outcomes|health outcomes
5619814|NCT00818987|Operative|operative
5619815|NCT00818987|Non operative|non operative
5619816|NCT00818961|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5619817|NCT00818961|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5619818|NCT00818961|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5619819|NCT00818961|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5619820|NCT00818961|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5619821|NCT00818961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5619822|NCT00818961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5619823|NCT00818961|prolymphocytic leukemia|prolymphocytic leukemia
5619824|NCT00818961|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5619825|NCT00818961|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5619826|NCT00818961|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5619827|NCT00818961|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5619828|NCT00818961|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5619829|NCT00818961|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5619830|NCT00818961|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5619831|NCT00818961|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5619832|NCT00818961|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5619833|NCT00818961|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5619834|NCT00818961|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5619835|NCT00818961|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5619836|NCT00818961|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5619837|NCT00818961|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5619838|NCT00818961|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5619839|NCT00818961|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5619840|NCT00818961|recurrent cutaneous T-cell NHL|recurrent cutaneous t-cell nhl
5619841|NCT00818961|stage I cutaneous T-cell NHL|stage i cutaneous t-cell nhl
5619842|NCT00818961|stage II cutaneous T-cell NHL|stage ii cutaneous t-cell nhl
5619843|NCT00818961|stage III cutaneous T-cell NHL|stage iii cutaneous t-cell nhl
5619844|NCT00818961|stage IV cutaneous T-cell NHL|stage iv cutaneous t-cell nhl
5619845|NCT00818961|extranodal marginal zone B-cell lymphoma of mucosal tissue|extranodal marginal zone b-cell lymphoma of mucosal tissue
5619846|NCT00818961|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5619847|NCT00818961|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5613691|NCT00843154|Biomarkers|biomarkers
5619848|NCT00818961|contiguous st II adult diffuse large cell lymphoma|contiguous st ii adult diffuse large cell lymphoma
5601374|NCT00892307|CT|ct
5619849|NCT00818961|contiguous st II adult diffuse mixed cell lymphoma|contiguous st ii adult diffuse mixed cell lymphoma
5619850|NCT00818961|contiguous st II adult diffuse sm cleaved cell lymphoma|contiguous st ii adult diffuse sm cleaved cell lymphoma
5619851|NCT00818961|contiguous st II grade 1 follicular lymphoma|contiguous st ii grade 1 follicular lymphoma
5619852|NCT00818961|contiguous st II grade 2 follicular lymphoma|contiguous st ii grade 2 follicular lymphoma
5619853|NCT00818961|contiguous st II grade 3 follicular lymphoma|contiguous st ii grade 3 follicular lymphoma
5619854|NCT00818961|contiguous st II mantle cell lymphoma|contiguous st ii mantle cell lymphoma
5619855|NCT00818961|contiguous st II marginal zone lymphoma|contiguous st ii marginal zone lymphoma
5619856|NCT00818961|contiguous st II small lymphocytic lymphoma|contiguous st ii small lymphocytic lymphoma
5619857|NCT00818961|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5619858|NCT00818961|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5619859|NCT00818961|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5619860|NCT00818961|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5619861|NCT00818961|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5619862|NCT00818961|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5619863|NCT00818961|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5619864|NCT00818961|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5619865|NCT00818961|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5619866|NCT00818961|noncontiguous st II adult diffuse large cell lymphoma|noncontiguous st ii adult diffuse large cell lymphoma
5619867|NCT00818961|noncontiguous st II adult diffuse mixed cell lymphoma|noncontiguous st ii adult diffuse mixed cell lymphoma
5619868|NCT00818961|noncontiguous st II adult diffuse sm cleaved cell lymphoma|noncontiguous st ii adult diffuse sm cleaved cell lymphoma
5619869|NCT00818961|noncontiguous st II grade 1 follicular lymphoma|noncontiguous st ii grade 1 follicular lymphoma
5619870|NCT00818961|noncontiguous st II grade 2 follicular lymphoma|noncontiguous st ii grade 2 follicular lymphoma
5619871|NCT00818961|noncontiguous st II grade 3 follicular lymphoma|noncontiguous st ii grade 3 follicular lymphoma
5619872|NCT00818961|noncontiguous st II mantle cell lymphoma|noncontiguous st ii mantle cell lymphoma
5619873|NCT00818961|noncontiguous st II marginal zone lymphoma|noncontiguous st ii marginal zone lymphoma
5619874|NCT00818961|noncontiguous st II small lymphocytic lymphoma|noncontiguous st ii small lymphocytic lymphoma
5619875|NCT00818961|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5619876|NCT00818961|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5619877|NCT00818961|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5619878|NCT00818961|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5619879|NCT00818961|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5619880|NCT00818961|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5619881|NCT00818961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5619882|NCT00818961|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5619883|NCT00818961|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5619884|NCT00818961|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5619885|NCT00818961|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5619886|NCT00818961|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5619887|NCT00818961|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5619888|NCT00818961|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5619889|NCT00818961|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5619890|NCT00818961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5619891|NCT00818961|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5619892|NCT00818961|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5619893|NCT00818961|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5619894|NCT00818961|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5619895|NCT00818961|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5619896|NCT00818961|recurrent adult gr III lymphomatoid granulomatosis|recurrent adult gr iii lymphomatoid granulomatosis
5619897|NCT00818961|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5619898|NCT00818961|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5619899|NCT00818961|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5619900|NCT00818961|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5619901|NCT00818961|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5619902|NCT00818961|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5619904|NCT00818961|previously treated MDS|previously treated mds
5619905|NCT00818961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5619906|NCT00818961|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5619907|NCT00818961|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5619910|NCT00818909|Dry eye|dry eye
5619911|NCT00818909|Systane|systane
5619912|NCT00818909|Moderate to severe dry eye|moderate to severe dry eye
5619915|NCT00818896|post-partum thyroid dysfunction|post-partum thyroid dysfunction
5619916|NCT00818896|permanent hypothyroidism|permanent hypothyroidism
5619918|NCT00818883|Hypertensive|hypertensive
5619919|NCT00818883|Blood Pressure, High|blood pressure, high
5619920|NCT00818883|Vascular Disease|vascular disease
5619921|NCT00818883|Cardiovascular Disease|cardiovascular disease
5619922|NCT00818883|Drug Therapy|drug therapy
5619923|NCT00818870|Gastroesophageal Reflux|gastroesophageal reflux
5619925|NCT00818870|Nocturnal GERD|nocturnal gerd
5619926|NCT00818870|Heartburn|heartburn
5619927|NCT00818870|Nighttime Heartburn|nighttime heartburn
5619928|NCT00818870|Nocturnal Heartburn|nocturnal heartburn
5619929|NCT00818857|cancer screening|cancer screening
5619930|NCT00818857|screening disparities|screening disparities
5619931|NCT00818857|underserved populations|underserved populations
5619932|NCT00818844|Nepafenac|nepafenac
5619933|NCT00818844|vitrectomy surgery|vitrectomy surgery
5619934|NCT00818844|Epiretinal membrane surgery|epiretinal membrane surgery
5619935|NCT00818831|Advanced, refractory solid tumors|advanced, refractory solid tumors
5619936|NCT00818818|Leishmaniasis|leishmaniasis
5619937|NCT00818818|Cutaneous leishmaniasis|cutaneous leishmaniasis
5619938|NCT00818818|Leishmania braziliensis|leishmania braziliensis
5619939|NCT00818818|Pentavalent antimonial|pentavalent antimonial
5619940|NCT00818818|Glucantime|glucantime
5619941|NCT00818805|conjunctivitis|conjunctivitis
5619942|NCT00818792|Percutaneous coronary intervention|percutaneous coronary intervention
5619943|NCT00818792|Drug-eluting stent|drug-eluting stent
5619944|NCT00818792|Chronic kidney disease|chronic kidney disease
5619945|NCT00818792|Restenosis|restenosis
5619946|NCT00818779|diabetes|diabetes
5619947|NCT00818779|heart disease|heart disease
5619948|NCT00818779|atherosclerosis|atherosclerosis
5619949|NCT00818766|Thoracic Surgery|thoracic surgery
5619950|NCT00818766|Antibiotic Prophylaxis|antibiotic prophylaxis
5619951|NCT00818766|Chest Tube|chest tube
5619953|NCT00818727|SSRI|ssri
5619954|NCT00818727|newborn infants|newborn infants
5619955|NCT00818714|IIIA, selected IIIB|iiia, selected iiib
5619956|NCT00818714|(T1N2-3M0, T2N2-3M0, T3N1-3M0)|(t1n2-3m0, t2n2-3m0, t3n1-3m0)
5619957|NCT00818701|Congestive Heart Failure|congestive heart failure
5619958|NCT00818701|Congestive Heart Failure with a NYHF Class 2-3|congestive heart failure with a nyhf class 2-3
5619959|NCT00818701|Ejection Fraction of 35 or less|ejection fraction of 35 or less
5619960|NCT00818688|Superficial thrombophlebitis (ST)|superficial thrombophlebitis (st)
5619961|NCT00818688|Deep-vein thrombosis|deep-vein thrombosis
5619962|NCT00818688|Symptomatic pulmonary embolism|symptomatic pulmonary embolism
5619963|NCT00818688|Symptomatic Superficial Thrombophlebitis of the lower limbs|symptomatic superficial thrombophlebitis of the lower limbs
5619964|NCT00818662|Alzheimer´s|alzheimer´s
5619965|NCT00818662|Dementia|dementia
5619966|NCT00818662|Dementia of Alzheimer Type|dementia of alzheimer type
5619967|NCT00818662|Immunoglobulins|immunoglobulins
5619968|NCT00818662|Gammaglobulins|gammaglobulins
5619969|NCT00818662|Immune Globulin Intravenous (IGIV)|immune globulin intravenous (igiv)
5619970|NCT00818662|Intravenous Immune Globulin (IVIG)|intravenous immune globulin (ivig)
5619971|NCT00818662|Antibodies|antibodies
5619972|NCT00818662|Amyloid|amyloid
5619973|NCT00818662|Immunotherapy|immunotherapy
5619974|NCT00818649|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5619975|NCT00818649|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5619976|NCT00818649|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5619977|NCT00818649|refractory anemia with excess blasts|refractory anemia with excess blasts
5619978|NCT00818649|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5619979|NCT00818649|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5619980|NCT00818649|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5619981|NCT00818649|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5619982|NCT00818649|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5619983|NCT00818649|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5619984|NCT00818649|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5619985|NCT00818649|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5619986|NCT00818649|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5619987|NCT00818649|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5619988|NCT00818649|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5619989|NCT00818649|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5619990|NCT00818649|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5619991|NCT00818649|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5619992|NCT00818649|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5619993|NCT00818636|expressive writing|expressive writing
5619994|NCT00818636|ruminating|ruminating
5619995|NCT00818636|ruminative thinking|ruminative thinking
5619996|NCT00818636|experiential avoidance|experiential avoidance
5619997|NCT00818636|depression|depression
5619998|NCT00818636|alcohol|alcohol
5619999|NCT00818636|drinking|drinking
5620000|NCT00818636|emotional processing|emotional processing
5620001|NCT00818610|Community-acquired infections|community-acquired infections
5620002|NCT00818610|Pneumonia|pneumonia
5620003|NCT00818610|Clinical Stability|clinical stability
5620004|NCT00818610|Antibiotics|antibiotics
5620005|NCT00818610|Combination therapy|combination therapy
5620006|NCT00818610|Atypical bacteria|atypical bacteria
5620007|NCT00818597|septic shock|septic shock
5620008|NCT00818597|immunoparalysis|immunoparalysis
5620009|NCT00818597|extracorporeal|extracorporeal
5620010|NCT00818597|granulocyte bioreactor|granulocyte bioreactor
5620011|NCT00818597|plasmapheresis|plasmapheresis
5620012|NCT00818584|Micafungin|micafungin
5620013|NCT00818584|Candida|candida
5620014|NCT00818584|Neonates|neonates
5620015|NCT00818584|Mycamine|mycamine
5620016|NCT00818584|FK463|fk463
5620017|NCT00818571|Renal impairment|renal impairment
5620018|NCT00818571|Diabetes|diabetes
5620019|NCT00818571|vildagliptin|vildagliptin
5620020|NCT00818571|Galvus|galvus
5620021|NCT00818571|Eucreas|eucreas
5620022|NCT00818558|non small cell lung cancer|non small cell lung cancer
5620023|NCT00818545|aging|aging
5620024|NCT00818545|barrier function|barrier function
5620025|NCT00818545|transcriptomic|transcriptomic
5620026|NCT00818532|Corneal astigmatism|corneal astigmatism
5620027|NCT00818532|Low diopter|low diopter
5620028|NCT00818532|Corneal measurement|corneal measurement
5620029|NCT00818532|Corneal astigmatism < 1 Diopter|corneal astigmatism < 1 diopter
5620030|NCT00818519|Moderate Acne Vulgaris|moderate acne vulgaris
5620031|NCT00818519|Oral contraceptive|oral contraceptive
5620032|NCT00818519|Female|female
5620033|NCT00818506|Depression|depression
5620034|NCT00818506|Major depressive disorder|major depressive disorder
5620035|NCT00818506|Coronary artery disease|coronary artery disease
5620036|NCT00818506|White Matter Hyperintensities|white matter hyperintensities
5620037|NCT00818506|White Matter Lesions|white matter lesions
5620038|NCT00818506|Coronary artery calcification|coronary artery calcification
5620039|NCT00818493|total knee arthroplasty|total knee arthroplasty
5620040|NCT00818493|total hip arthroplasty|total hip arthroplasty
5620041|NCT00818480|prostate cancer|prostate cancer
5620042|NCT00818480|melanoma|melanoma
5620043|NCT00818480|lymphoma|lymphoma
5620044|NCT00818480|YM155|ym155
5620045|NCT00818467|Skin tone|skin tone
5620046|NCT00818467|Vitamin D|vitamin d
5620047|NCT00818441|lung cancer adenocarcinoma HER2|lung cancer adenocarcinoma her2
5620048|NCT00818428|Phonological Awareness|phonological awareness
5620049|NCT00818428|Speech Articulation Disorder|speech articulation disorder
5620050|NCT00818428|Development Articulation Disorder|development articulation disorder
5620051|NCT00818428|Phonological Impairment|phonological impairment
5620052|NCT00818428|Dyslexia|dyslexia
5620053|NCT00818428|Speech Therapy|speech therapy
5620054|NCT00818428|School Transition|school transition
5620055|NCT00818402|Quality of life|quality of life
5620056|NCT00818402|symptoms|symptoms
5620057|NCT00818389|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5620058|NCT00818389|ALS|als
5620059|NCT00818389|Lou Gehrig's disease|lou gehrig's disease
5620060|NCT00818389|riluzole|riluzole
5620061|NCT00818389|lithium|lithium
5620062|NCT00818389|neurodegeneration|neurodegeneration
5620063|NCT00818376|Chlorhexidine|chlorhexidine
5620064|NCT00818376|adverse effects|adverse effects
5620065|NCT00818376|staining|staining
5620066|NCT00818376|dental calculus|dental calculus
5620067|NCT00818376|dental plaque|dental plaque
5620068|NCT00818363|Postoperative pain|postoperative pain
5620069|NCT00818363|shoulder surgery|shoulder surgery
5620070|NCT00818363|opioid|opioid
5620071|NCT00818311|Light emitting diode|light emitting diode
5620072|NCT00818311|tolerance|tolerance
5620073|NCT00818311|photomodulation|photomodulation
5620074|NCT00818298|schizophrenia|schizophrenia
5620075|NCT00818298|schizoaffective disorder|schizoaffective disorder
5620076|NCT00818298|PET Scan|pet scan
5620077|NCT00818298|ziprasidone|ziprasidone
5620078|NCT00818298|dopamine|dopamine
5620079|NCT00818298|D2|d2
5620080|NCT00818298|receptor|receptor
5620081|NCT00818298|antagonist|antagonist
5620082|NCT00818298|occupancy|occupancy
5620083|NCT00818298|dissociation|dissociation
5620084|NCT00818298|affinity|affinity
5620085|NCT00818298|constant|constant
5620086|NCT00818298|Ki|ki
5620087|NCT00818298|ligand|ligand
5620089|NCT00818298|half-life|half-life
5620090|NCT00818298|striatal|striatal
5620091|NCT00818298|plasma dynamics|plasma dynamics
5620092|NCT00818298|central dynamics|central dynamics
5620093|NCT00818298|plasma drug level|plasma drug level
5620094|NCT00818298|compliance|compliance
5620095|NCT00818298|antipsychotic|antipsychotic
5620096|NCT00818298|pharmacotherapy|pharmacotherapy
5620097|NCT00818298|twice daily dosing|twice daily dosing
5620098|NCT00818298|BID dosing|bid dosing
5620099|NCT00818298|once daily dosing|once daily dosing
5620100|NCT00818298|od dosing|od dosing
5620101|NCT00818298|qd dosing|qd dosing
5620102|NCT00818298|dosing schedule|dosing schedule
5620103|NCT00818233|dynamic contour tonometry|dynamic contour tonometry
5620104|NCT00818233|variability|variability
5620105|NCT00818233|pulse amplitude|pulse amplitude
5620106|NCT00818233|Ocular pulse amplitude|ocular pulse amplitude
5620107|NCT00818220|intraventricular hemorrhage|intraventricular hemorrhage
5620108|NCT00818220|sepsis|sepsis
5620109|NCT00818220|motor function|motor function
5620110|NCT00818220|motor functioning at 7 months corrected age|motor functioning at 7 months corrected age
5620111|NCT00818220|cytokines in cord blood and at 6 and 20 hours of age|cytokines in cord blood and at 6 and 20 hours of age
5620112|NCT00818220|stem cells in cord blood and at 20 hours of age|stem cells in cord blood and at 20 hours of age
5620113|NCT00818207|Smoking cessation|smoking cessation
5620114|NCT00818207|quit rates|quit rates
5620115|NCT00818207|reimbursement|reimbursement
5620116|NCT00818207|drug coverage|drug coverage
5620117|NCT00818207|effectiveness|effectiveness
5620118|NCT00818207|cost-effectiveness|cost-effectiveness
5620119|NCT00818207|health policy|health policy
5620120|NCT00818207|drug utilization|drug utilization
5620121|NCT00818207|adherence|adherence
5620122|NCT00818207|urine cotinine.|urine cotinine.
5620123|NCT00818194|Tacrolimus|tacrolimus
5620124|NCT00818194|cyclosporine A|cyclosporine a
5620125|NCT00818194|renal plasma flow|renal plasma flow
5620126|NCT00818194|glomerular filtration rate|glomerular filtration rate
5620127|NCT00818194|human|human
5620128|NCT00818194|pharmacodynamics|pharmacodynamics
5620129|NCT00818194|pharmacokinetics|pharmacokinetics
5620130|NCT00818194|Pharmacodynamics of tacrolimus|pharmacodynamics of tacrolimus
5620131|NCT00818181|Type I - Allergy, rhinoconjunctivitis|type i - allergy, rhinoconjunctivitis
5620132|NCT00818129|Phase I|phase i
5620133|NCT00818129|Japan|japan
5620134|NCT00818129|Japanese|japanese
5620135|NCT00818129|oral solution|oral solution
5620136|NCT00818116|Cataract|cataract
5620137|NCT00818116|visual acuity|visual acuity
5620138|NCT00818116|AcrySof ReSTOR Aspheric Intraoculare Lens|acrysof restor aspheric intraoculare lens
5620139|NCT00818116|Bilateral cataract|bilateral cataract
5620239|NCT00817765|drug-drug interaction|drug-drug interaction
5620140|NCT00818103|Multiple Sclerosis,Genetics,Pathogenesis,Pathology,Therapy|multiple sclerosis,genetics,pathogenesis,pathology,therapy
5620141|NCT00818090|thymic epithelial tumor|thymic epithelial tumor
5620142|NCT00818090|paclitaxel|paclitaxel
5620143|NCT00818090|cisplatin|cisplatin
5620144|NCT00818090|thymic carcinoma|thymic carcinoma
5620145|NCT00818090|invasive thymoma|invasive thymoma
5620146|NCT00818051|stage IA breast cancer|stage ia breast cancer
5620147|NCT00818051|stage IB breast cancer|stage ib breast cancer
5620148|NCT00818051|stage II breast cancer|stage ii breast cancer
5620149|NCT00818051|stage IIIA breast cancer|stage iiia breast cancer
5620150|NCT00818038|RRMS|rrms
5620151|NCT00818038|Relapsing Remitting|relapsing remitting
5620152|NCT00818038|MS|ms
5620153|NCT00818025|Transplantation|transplantation
5620154|NCT00818025|Self-care agency|self-care agency
5620155|NCT00818025|Self-care behaviors|self-care behaviors
5620156|NCT00818025|Hand-held device|hand-held device
5620157|NCT00818012|atrial fibrillation|atrial fibrillation
5620158|NCT00818012|atrial electromechanical interval|atrial electromechanical interval
5620159|NCT00818012|direct current cardioversion|direct current cardioversion
5620160|NCT00818012|pulse wave velocity|pulse wave velocity
5620161|NCT00817999|Platelet Aggregation Inhibition|platelet aggregation inhibition
5620162|NCT00817986|Acute back pain in the lumbar region|acute back pain in the lumbar region
5620163|NCT00817973|Whey protein|whey protein
5620164|NCT00817973|gluten|gluten
5620165|NCT00817973|casein|casein
5620166|NCT00817973|cod protein|cod protein
5620167|NCT00817973|GLP-1|glp-1
5620168|NCT00817973|postprandial|postprandial
5620169|NCT00817973|triglyceride|triglyceride
5620170|NCT00817973|free fatty acids|free fatty acids
5620171|NCT00817973|chylomicrons|chylomicrons
5620172|NCT00817973|retinyl palmitate|retinyl palmitate
5620173|NCT00817973|type 2 diabetes|type 2 diabetes
5620174|NCT00817973|GIP|gip
5620175|NCT00817973|Postprandial incretins|postprandial incretins
5620176|NCT00817960|Dual tasking|dual tasking
5620177|NCT00817960|Postural Control|postural control
5620178|NCT00817960|Methylphenidate (Ritalin)|methylphenidate (ritalin)
5620179|NCT00817960|old adults|old adults
5620180|NCT00817947|Airway clearance|airway clearance
5620181|NCT00817947|Cystic fibrosis|cystic fibrosis
5620182|NCT00817947|High frequency chest wall oscillation|high frequency chest wall oscillation
5620183|NCT00817934|Efficacy|efficacy
5620184|NCT00817934|patient's tolerance|patient's tolerance
5620185|NCT00817934|patient's safety|patient's safety
5620186|NCT00817921|premature renal function|premature renal function
5620188|NCT00817921|blood pressure|blood pressure
5620189|NCT00817921|Renal function|renal function
5620190|NCT00817908|liver transplant|liver transplant
5620191|NCT00817908|lung transplant|lung transplant
5620192|NCT00817908|kidney transplant|kidney transplant
5620193|NCT00817908|heart transplant|heart transplant
5620194|NCT00817908|CMV CMI|cmv cmi
5620195|NCT00817908|Transplant|transplant
5620196|NCT00817895|hepatocellular carcinoma|hepatocellular carcinoma
5620198|NCT00817895|intraoperative chemotherapy|intraoperative chemotherapy
5620199|NCT00817882|vocational|vocational
5620200|NCT00817882|rehabilitation|rehabilitation
5620201|NCT00817882|work|work
5620202|NCT00817882|ability|ability
5620203|NCT00817882|low back pain|low back pain
5620204|NCT00817869|Floors and Floorcoverings|floors and floorcoverings
5620205|NCT00817869|Health Services for the Aged|health services for the aged
5620206|NCT00817869|Fractures, bone|fractures, bone
5620207|NCT00817869|Delirium, Dementia, Amnestic, Cognitive Disorders|delirium, dementia, amnestic, cognitive disorders
5620208|NCT00817869|Frail Elderly|frail elderly
5620209|NCT00817869|Aged, 80 and over|aged, 80 and over
5620210|NCT00817843|Postprandial hypertriglyceridemia|postprandial hypertriglyceridemia
5620211|NCT00817843|Metabolic syndrome|metabolic syndrome
5620212|NCT00817843|Endothelial function|endothelial function
5620213|NCT00817843|Flow mediated dilatation|flow mediated dilatation
5620214|NCT00817843|EndoPAT|endopat
5620215|NCT00817843|Simvastatin|simvastatin
5620216|NCT00817843|Ezetimibe|ezetimibe
5620217|NCT00817830|Coronaropathy|coronaropathy
5620218|NCT00817830|lodenafil carbonate|lodenafil carbonate
5620219|NCT00817830|Erectile dysfunction|erectile dysfunction
5620220|NCT00817830|Treatment|treatment
5620221|NCT00817830|QT interval|qt interval
5620222|NCT00817830|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5620223|NCT00817830|Cardiac arrhythmia|cardiac arrhythmia
5620224|NCT00817830|Effort testPhosphodiesterase 5 inhibitors|effort testphosphodiesterase 5 inhibitors
5620225|NCT00817830|Cardiovascular test|cardiovascular test
5620226|NCT00817804|noninvasive ventilation|noninvasive ventilation
5620227|NCT00817791|CABG|cabg
5620228|NCT00817791|hyperbaric oxygen|hyperbaric oxygen
5620229|NCT00817791|preconditioning|preconditioning
5620230|NCT00817791|S100B|s100b
5620231|NCT00817791|NSE|nse
5620232|NCT00817791|Troponin I|troponin i
5620233|NCT00817791|CABG surgery|cabg surgery
5620234|NCT00817791|neuroprotection|neuroprotection
5620235|NCT00817778|Type II Diabetes|type ii diabetes
5620236|NCT00817765|interaction|interaction
5620237|NCT00817765|pharmacokinetics|pharmacokinetics
5620240|NCT00817765|safety|safety
5620241|NCT00817752|stress|stress
5620242|NCT00817752|inflammation|inflammation
5620243|NCT00817752|natural remedy|natural remedy
5620244|NCT00817752|cytokines|cytokines
5620245|NCT00817752|interleukin|interleukin
5620246|NCT00817752|inflammatory conditions|inflammatory conditions
5620247|NCT00817752|auto-immune disorders|auto-immune disorders
5620248|NCT00817739|Drug therapy|drug therapy
5620249|NCT00817726|Rapid Eye Movement Sleep Behavior Disorder|rapid eye movement sleep behavior disorder
5620250|NCT00817726|Parkinson's Disease|parkinson's disease
5620251|NCT00817726|Parkinsonian Syndromes|parkinsonian syndromes
5620252|NCT00817726|Atypical Parkinson's|atypical parkinson's
5620254|NCT00817726|PD|pd
5620255|NCT00817726|fMRI|fmri
5620256|NCT00817726|PSP|psp
5620257|NCT00817726|MSA|msa
5620258|NCT00817713|Human Immunodeficiency Virus|human immunodeficiency virus
5620259|NCT00817713|Helminthiasis|helminthiasis
5620260|NCT00817713|treatment naive|treatment naive
5620261|NCT00817713|co-infection|co-infection
5620262|NCT00817713|immune modulation|immune modulation
5620263|NCT00817700|Sleep|sleep
5620264|NCT00817700|young adults|young adults
5620265|NCT00817700|middle-age adults|middle-age adults
5620266|NCT00817700|older adults|older adults
5620267|NCT00817674|CKD|ckd
5620268|NCT00817674|Kidney Disease|kidney disease
5620269|NCT00817674|poor sleep|poor sleep
5620270|NCT00817674|CKD progression|ckd progression
5620271|NCT00817661|vitamin A|vitamin a
5620272|NCT00817661|influenza vaccine|influenza vaccine
5620273|NCT00817661|passive immunity|passive immunity
5620274|NCT00817661|pregnant mothers|pregnant mothers
5620275|NCT00817661|vitamin A suplementation|vitamin a suplementation
5620276|NCT00817661|Influenza vaccination|influenza vaccination
5620277|NCT00817661|Infant immune responses|infant immune responses
5620278|NCT00817648|schizophrenia|schizophrenia
5620279|NCT00817648|antipsychotics|antipsychotics
5620280|NCT00817648|quetiapine|quetiapine
5620281|NCT00817648|risperidone|risperidone
5620282|NCT00817648|efficacy|efficacy
5620283|NCT00817648|safety|safety
5620284|NCT00817648|multicenter|multicenter
5620285|NCT00817648|rater-blind|rater-blind
5620286|NCT00817648|randomized|randomized
5620287|NCT00817648|chinese|chinese
5620288|NCT00817648|han|han
5620289|NCT00817635|Blood Pressure|blood pressure
5620290|NCT00817635|Hypertension|hypertension
5620291|NCT00817635|Resistant Hypertension|resistant hypertension
5620292|NCT00817622|diabetes mellitus type 2|diabetes mellitus type 2
5620293|NCT00817622|EPA|epa
5620294|NCT00817622|leptin|leptin
5620295|NCT00817622|adiponectin|adiponectin
5620296|NCT00817609|Angongniuhuang Pill|angongniuhuang pill
5620297|NCT00817609|consciousness level of patients who suffered from a stroke|consciousness level of patients who suffered from a stroke
5620298|NCT00817583|Phase 2 Clinical Trial|phase 2 clinical trial
5620299|NCT00817583|NPC|npc
5614168|NCT00841243|dietary support|dietary support
5620301|NCT00817583|concurrent chemoradiation|concurrent chemoradiation
5620302|NCT00817570|Trans Femoral Amputees Balance Reactions|trans femoral amputees balance reactions
5620303|NCT00817557|Contact lenses|contact lenses
5620304|NCT00817557|Loteprednol|loteprednol
5620305|NCT00817557|Effect on CL dryness|effect on cl dryness
5620306|NCT00817544|3098004|3098004
5620307|NCT00817544|Healthy volunteers|healthy volunteers
5620308|NCT00817531|Breast Cancer|breast cancer
5620309|NCT00817505|Type I diabetes|type i diabetes
5620310|NCT00817505|bioavailability|bioavailability
5620311|NCT00817492|Sleep|sleep
5620312|NCT00817492|CKD|ckd
5620313|NCT00817492|kidney|kidney
5620314|NCT00817492|PSG|psg
5620315|NCT00817492|polysomnography|polysomnography
5620316|NCT00817492|Decreased sleep time|decreased sleep time
5620317|NCT00817492|Decreased sleep quality|decreased sleep quality
5620318|NCT00817479|Subject has intraabdominal disease either proven or strongly|subject has intraabdominal disease either proven or strongly
5620319|NCT00817479|suspected to be ovarian or primary peritoneal cancer|suspected to be ovarian or primary peritoneal cancer
5620320|NCT00817466|bronchiolitis|bronchiolitis
5620321|NCT00817466|infants|infants
5620322|NCT00817466|racemic adrenaline|racemic adrenaline
5620323|NCT00817466|inhalations|inhalations
5620324|NCT00817466|treatment|treatment
5620325|NCT00817453|Parkinson's Disease|parkinson's disease
5620326|NCT00817440|growth hormone insulin signaltransduction signalpathways|growth hormone insulin signaltransduction signalpathways
5620327|NCT00817440|growth hormone and insulin signalpathways|growth hormone and insulin signalpathways
5620328|NCT00817427|Chronic Kidney Disease|chronic kidney disease
5620329|NCT00817427|Poor sleep|poor sleep
5620330|NCT00817427|CKD|ckd
5620331|NCT00817427|Kidney Failure|kidney failure
5620332|NCT00817414|Blood Pressure|blood pressure
5620333|NCT00817414|Hypertension|hypertension
5620334|NCT00817414|Cortisol|cortisol
5620335|NCT00817401|asphyxia|asphyxia
5620336|NCT00817401|hypothermia|hypothermia
5620337|NCT00817401|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5620338|NCT00817401|neonates|neonates
5620339|NCT00817388|Interstitial cystitis|interstitial cystitis
5620340|NCT00817388|pelvic pain|pelvic pain
5620341|NCT00817375|Pharmacogenomics|pharmacogenomics
5620342|NCT00817375|Prediction of Antidepressant Response|prediction of antidepressant response
5620343|NCT00817375|Depressed Patients|depressed patients
5620344|NCT00817362|Breast Cancer|breast cancer
5620345|NCT00817362|Advanced Breast Cancer|advanced breast cancer
5620346|NCT00817362|Metastatic Breast Cancer|metastatic breast cancer
5620347|NCT00817362|HER2 Positive Breast Cancer|her2 positive breast cancer
5620348|NCT00817362|Cancer of the breast|cancer of the breast
5620349|NCT00817362|Trastuzumab|trastuzumab
5620350|NCT00817362|Herceptin|herceptin
5620351|NCT00817349|Angio-Seal|angio-seal
5620352|NCT00817349|Peripheral vascular disease|peripheral vascular disease
5620353|NCT00817349|Vascular closure device|vascular closure device
5620354|NCT00817349|Arterial closure|arterial closure
5620355|NCT00817349|Coronary artery disease|coronary artery disease
5620356|NCT00817349|Arterial hemostasis|arterial hemostasis
5620357|NCT00817349|Coronary cardiac catheterization|coronary cardiac catheterization
5620358|NCT00817349|Percutaneous coronary intervention|percutaneous coronary intervention
5620359|NCT00817349|Interventional catheterization|interventional catheterization
5620360|NCT00817349|Diagnostic catheterization|diagnostic catheterization
5620361|NCT00817349|Common femoral artery|common femoral artery
5620362|NCT00817349|Manual compression|manual compression
5620363|NCT00817349|Vascular intervention|vascular intervention
5620364|NCT00817349|Angiogram|angiogram
5620365|NCT00817349|Coronary intervention|coronary intervention
5620366|NCT00817349|Coronary angioplasty|coronary angioplasty
5620367|NCT00817349|Angiography|angiography
5620368|NCT00817349|Arteriotomy|arteriotomy
5620369|NCT00817349|Vascular access|vascular access
5620370|NCT00817336|biomarker|biomarker
5620372|NCT00817336|schizophrenia|schizophrenia
5620373|NCT00817336|NMDA|nmda
5620374|NCT00817336|D-serine|d-serine
5620375|NCT00817323|bipolar depression|bipolar depression
5620376|NCT00817323|atypical antipsychotic|atypical antipsychotic
5620377|NCT00817323|remission|remission
5620378|NCT00817323|depletion|depletion
5620379|NCT00817323|mood|mood
5620380|NCT00817297|noninvasive ventilation|noninvasive ventilation
5620381|NCT00817284|Newly diagnosed patients with glioblastoma multiforme.|newly diagnosed patients with glioblastoma multiforme.
5620382|NCT00817284|Performance status 0-2.|performance status 0-2.
5620383|NCT00817271|Type II Diabetes|type ii diabetes
5620384|NCT00817271|Counter-regulatory response|counter-regulatory response
5620385|NCT00817271|Hypoglycemia|hypoglycemia
5620386|NCT00817258|Phase 2 Clinical Trial|phase 2 clinical trial
5620388|NCT00817258|radiation therapy|radiation therapy
5620389|NCT00817258|chemotherapy|chemotherapy
5620390|NCT00817245|CSR|csr
5620391|NCT00817245|Helicobacter pylori|helicobacter pylori
5620392|NCT00817232|tennis elbow|tennis elbow
5620393|NCT00817232|microcurrent|microcurrent
5620394|NCT00817232|tissue healing|tissue healing
5620395|NCT00817206|kidney transplantation|kidney transplantation
5601862|NCT00890864|Mammogram|mammogram
5620396|NCT00817206|renal transplantation|renal transplantation
5620397|NCT00817206|maintenance immunosuppression|maintenance immunosuppression
5620399|NCT00817206|Prevention of acute allograft rejection|prevention of acute allograft rejection
5620400|NCT00817193|Clinical trial|clinical trial
5620401|NCT00817193|Short Physical Performance Battery|short physical performance battery
5620402|NCT00817193|Disability|disability
5620403|NCT00817193|Senior Housing|senior housing
5620405|NCT00817180|physiotherapy|physiotherapy
5620406|NCT00817180|airway clearance techniques|airway clearance techniques
5620407|NCT00817180|Positive Expiratory Pressure Technique|positive expiratory pressure technique
5620408|NCT00817180|high frequency Chest Wall Oscillation|high frequency chest wall oscillation
5620409|NCT00817180|vest|vest
5620410|NCT00817167|Known or suspected lung disease|known or suspected lung disease
5620411|NCT00817167|Candidates for non-emergency bronchoscopy|candidates for non-emergency bronchoscopy
5620412|NCT00817154|Older persons with SMI|older persons with smi
5620413|NCT00817128|Complex Regional Pain Syndrome Type I|complex regional pain syndrome type i
5620414|NCT00817128|Sympathetic Reflex Dystrophy|sympathetic reflex dystrophy
5620415|NCT00817128|Pain Exposure Physical Therapy|pain exposure physical therapy
5620416|NCT00817128|Pharmacological treatment|pharmacological treatment
5620417|NCT00817128|Functional recovery|functional recovery
5620418|NCT00817115|Region-of-Interest Imaging|region-of-interest imaging
5620419|NCT00817115|X-ray Fovea Imaging|x-ray fovea imaging
5620420|NCT00817115|Cardiovascular Diseases|cardiovascular diseases
5620421|NCT00817115|Radiation Dosage|radiation dosage
5620422|NCT00817115|Radiographic Image Enhancement|radiographic image enhancement
5620423|NCT00817115|Radiography, Interventional|radiography, interventional
5620424|NCT00817102|coronary artery stenoses|coronary artery stenoses
5620425|NCT00817063|retinoid treatment|retinoid treatment
5620426|NCT00817063|fingertip dermatitis|fingertip dermatitis
5620427|NCT00817063|hyperkeratotic hand eczema|hyperkeratotic hand eczema
5620428|NCT00817063|vesicular hand eczema|vesicular hand eczema
5620429|NCT00817063|pompholyx|pompholyx
5620430|NCT00817037|Chronic kidney disease|chronic kidney disease
5620431|NCT00817037|Proteinuria|proteinuria
5620432|NCT00817037|Blood pressure|blood pressure
5620433|NCT00817037|Arterial stiffness|arterial stiffness
5620434|NCT00817037|Endothelin antagonist|endothelin antagonist
5620435|NCT00817037|Sitaxsentan|sitaxsentan
5620436|NCT00817024|Coronary Heart Disease|coronary heart disease
5620437|NCT00817024|PCI|pci
5620438|NCT00817024|Traditional Chinese Medicine|traditional chinese medicine
5620439|NCT00817024|Quality of Life|quality of life
5620440|NCT00817011|depression|depression
5620441|NCT00817011|pharmacogenomics|pharmacogenomics
5620442|NCT00817011|antidepressant response|antidepressant response
5620443|NCT00817011|biological markers|biological markers
5620444|NCT00817011|clinical variables|clinical variables
5620445|NCT00816998|Radius fractures|radius fractures
5620446|NCT00816985|Female|female
5620447|NCT00816985|Lymphedema|lymphedema
5620448|NCT00816959|Lymphocytic Predominant Hodgkin's Lymphoma|lymphocytic predominant hodgkin's lymphoma
5620449|NCT00816959|Late, widespread and recurrent LPHD|late, widespread and recurrent lphd
5620450|NCT00816946|malnutrition|malnutrition
5620451|NCT00816946|growth|growth
5620452|NCT00816933|pain|pain
5620453|NCT00816933|operative times|operative times
5620454|NCT00816933|complication|complication
5620455|NCT00816933|time to return for normal life|time to return for normal life
5620456|NCT00816933|pain using VAS score|pain using vas score
5620457|NCT00816920|distal DVT|distal dvt
5620458|NCT00816920|calf DVT|calf dvt
5620459|NCT00816920|DVT diagnosis|dvt diagnosis
5620460|NCT00816920|management of patients with suspected leg DVT|management of patients with suspected leg dvt
5620461|NCT00816907|Schizoaffective Disorder|schizoaffective disorder
5620462|NCT00816894|schizophrenia|schizophrenia
5620463|NCT00816894|treatment resistance|treatment resistance
5620464|NCT00816894|D-serine|d-serine
5620465|NCT00816894|Olanzapine|olanzapine
5620466|NCT00816894|treatment refractory schizophrenia|treatment refractory schizophrenia
5620467|NCT00816881|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5620468|NCT00816881|flutter|flutter
5620469|NCT00816881|airway clearance|airway clearance
5620470|NCT00816881|sputum|sputum
5620471|NCT00816881|Physical Therapy Techniques|physical therapy techniques
5620472|NCT00816868|stage IIIB/IV adenocarcinoma non-small cell lung cancer|stage iiib/iv adenocarcinoma non-small cell lung cancer
5620473|NCT00816855|Phase 2 Clinical Trial|phase 2 clinical trial
5620475|NCT00816855|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5620476|NCT00816855|concurrent chemoradiation|concurrent chemoradiation
5620477|NCT00816842|citrulline|citrulline
5620478|NCT00816842|malabsorption|malabsorption
5620480|NCT00816842|enteropathy|enteropathy
5620481|NCT00816829|Dyslipidemia|dyslipidemia
5620482|NCT00816829|Sleep Apnea Syndromes|sleep apnea syndromes
5620483|NCT00816829|Fenofibrate|fenofibrate
5620484|NCT00816829|Obese|obese
5620485|NCT00816829|Overweight or obese patients|overweight or obese patients
5620486|NCT00816816|Phase 2 Clinical Trial|phase 2 clinical trial
5620488|NCT00816816|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5620489|NCT00816816|concurrent chemoradiation|concurrent chemoradiation
5620490|NCT00816803|Spinal cord injury|spinal cord injury
5620491|NCT00816790|Septic shock|septic shock
5620492|NCT00816790|Acute Renal Failure|acute renal failure
5620493|NCT00816790|Antimicrobial|antimicrobial
5620494|NCT00816790|Drug Dosing|drug dosing
5620495|NCT00816790|Feasibility Study|feasibility study
5620496|NCT00816777|Cancer|cancer
5620497|NCT00816777|Carcinoma|carcinoma
5620498|NCT00816777|Colon Cancer|colon cancer
5620499|NCT00816777|Colorectal Cancer|colorectal cancer
5620500|NCT00816777|Gastric Cancer|gastric cancer
5620501|NCT00816777|Gastrointestinal Cancer|gastrointestinal cancer
5620502|NCT00816777|Metastases|metastases
5620503|NCT00816777|Metastatic Cancer|metastatic cancer
5620504|NCT00816777|Metastatic Colorectal Cancer|metastatic colorectal cancer
5620505|NCT00816777|Oncology|oncology
5620506|NCT00816777|Rectal Cancer|rectal cancer
5620507|NCT00816764|clinical trial, phase 1|clinical trial, phase 1
5620508|NCT00816764|carcinoma|carcinoma
5620509|NCT00816764|pharmacokinetics|pharmacokinetics
5620510|NCT00816764|safety|safety
5620511|NCT00816764|ovarian|ovarian
5620512|NCT00816751|Local anesthesia|local anesthesia
5620513|NCT00816751|Paracervical|paracervical
5620514|NCT00816751|Intracervical|intracervical
5620515|NCT00816751|Abortion|abortion
5620516|NCT00816751|Pain|pain
5620517|NCT00816751|Local anesthesia for elective first trimester abortion|local anesthesia for elective first trimester abortion
5620518|NCT00816738|Nd: YAG laser|nd: yag laser
5620519|NCT00816738|recurrent corneal erosions|recurrent corneal erosions
5620520|NCT00816738|trauma|trauma
5620521|NCT00816738|anterior stromal puncture|anterior stromal puncture
5620522|NCT00816725|Postnatal Depression|postnatal depression
5620523|NCT00816725|Cognitive Behavioral Therapy|cognitive behavioral therapy
5620524|NCT00816725|Mood Management|mood management
5620525|NCT00816725|Self-help|self-help
5620526|NCT00816725|Internet|internet
5620527|NCT00816712|Males with low-normal serum total testosterone levels.|males with low-normal serum total testosterone levels.
5620528|NCT00816699|Anxiety|anxiety
5620529|NCT00816699|preprint anesthetic risk information|preprint anesthetic risk information
5620530|NCT00816686|clinical trial, phase 1|clinical trial, phase 1
5621361|NCT00813722|adherence|adherence
5620531|NCT00816686|carcinoma, advanced renal cell|carcinoma, advanced renal cell
5620532|NCT00816686|kidney|kidney
5620533|NCT00816686|pharmacokinetics|pharmacokinetics
5620534|NCT00816686|safety|safety
5620535|NCT00816686|AGS-16M18|ags-16m18
5620536|NCT00816673|Insomnia|insomnia
5620537|NCT00816673|Primary insomnia|primary insomnia
5620538|NCT00816673|sleep latency|sleep latency
5620539|NCT00816673|non restorative sleep|non restorative sleep
5620540|NCT00816673|sleep quality|sleep quality
5620541|NCT00816673|Double-Blind|double-blind
5620542|NCT00816673|Placebo Controlled|placebo controlled
5620543|NCT00816673|Parallel-Group|parallel-group
5620544|NCT00816673|Sleep Laboratory Study|sleep laboratory study
5620545|NCT00816647|Patella|patella
5620546|NCT00816647|Dislocation|dislocation
5604959|NCT00878397|anaemia|anaemia
5620547|NCT00816647|Knee|knee
5620548|NCT00816647|Medial Patellofemoral Ligament|medial patellofemoral ligament
5620549|NCT00816634|First line chemotherapy|first line chemotherapy
5620550|NCT00816634|Advanced or recurrent esophageal squamous cell carcinoma|advanced or recurrent esophageal squamous cell carcinoma
5620551|NCT00816621|Internationally Adopted Children|internationally adopted children
5620552|NCT00816621|Adoption|adoption
5620553|NCT00816621|Attachment|attachment
5620554|NCT00816621|Inattention|inattention
5620555|NCT00816621|Prevention|prevention
5620556|NCT00816608|diabetes|diabetes
5620557|NCT00816608|prediabetes|prediabetes
5620558|NCT00816608|impaired fasting glucose (IFG)|impaired fasting glucose (ifg)
5620559|NCT00816608|impaired glucose tolerance (IGT)|impaired glucose tolerance (igt)
5620560|NCT00816608|body weight|body weight
5620561|NCT00816595|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5620562|NCT00816595|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5620563|NCT00816595|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5620564|NCT00816595|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5620565|NCT00816595|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5620566|NCT00816595|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5620567|NCT00816595|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5620568|NCT00816595|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5620569|NCT00816595|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5620570|NCT00816595|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5620571|NCT00816595|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5620572|NCT00816582|Post-menopausal hormone receptor positive recurrent/metastatic breast cancer.|post-menopausal hormone receptor positive recurrent/metastatic breast cancer.
5620574|NCT00816582|Recurrent or metastatic|recurrent or metastatic
5620575|NCT00816569|Orthokeratology|orthokeratology
5620576|NCT00816569|Keratoconus|keratoconus
5620577|NCT00816530|breast|breast
5620578|NCT00816530|breast cancer|breast cancer
5620579|NCT00816530|breast screening|breast screening
5620580|NCT00816530|breast cancer screening|breast cancer screening
5620581|NCT00816530|ultrasound|ultrasound
5620582|NCT00816530|ultrasonography|ultrasonography
5620583|NCT00816530|mammogram|mammogram
5620584|NCT00816530|mammography|mammography
5620585|NCT00816530|breast density|breast density
5620586|NCT00816530|dense breasts|dense breasts
5620587|NCT00816530|early detection|early detection
5620588|NCT00816530|somo v|somo v
5620589|NCT00816530|somo•v|somo•v
5620590|NCT00816530|U-Systems|u-systems
5620591|NCT00816530|Automated Breast Ultrasound|automated breast ultrasound
5620592|NCT00816530|Ultrasonography, Mammary|ultrasonography, mammary
5620593|NCT00816530|Breast Neoplasms|breast neoplasms
5620594|NCT00816530|Breast Density > 50% (BI-RADS III & IV)|breast density > 50% (bi-rads iii & iv)
5620595|NCT00816517|Psoriasis|psoriasis
5620596|NCT00816517|Botulinum toxin|botulinum toxin
5620597|NCT00816504|FSGS|fsgs
5620598|NCT00816504|Permeability factor|permeability factor
5620599|NCT00816504|Galactose|galactose
5620600|NCT00816504|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
5620601|NCT00816491|patient with long-standing UC|patient with long-standing uc
5620602|NCT00816478|FSGS|fsgs
5620603|NCT00816478|Permeability factor|permeability factor
5620604|NCT00816478|Galactose|galactose
5620605|NCT00816478|Primary FSGS, resistant to immunosuppressive medication|primary fsgs, resistant to immunosuppressive medication
5620606|NCT00816465|Hoodia gordoni|hoodia gordoni
5620607|NCT00816465|NASH|nash
5620608|NCT00816465|NAFLD|nafld
5620609|NCT00816452|Osteoporosis|osteoporosis
5620610|NCT00816452|Prostate Cancer|prostate cancer
5620611|NCT00816452|Osteoporosis in male with Prostate Cancer|osteoporosis in male with prostate cancer
5620612|NCT00816439|Positron Emission Tomography|positron emission tomography
5620613|NCT00816439|Brain Imaging|brain imaging
5620614|NCT00816439|Alcoholism|alcoholism
5620615|NCT00816426|Tuberculosis|tuberculosis
5620616|NCT00816426|Lesions|lesions
5620617|NCT00816426|Pharmacokinetics|pharmacokinetics
5620618|NCT00816426|Maldistribution|maldistribution
5620619|NCT00816426|Histopathology|histopathology
5620620|NCT00816413|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5620683|NCT00816413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5620621|NCT00816413|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5620622|NCT00816413|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5672487|NCT00611715|stage IV breast cancer|stage iv breast cancer
5620623|NCT00816413|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5620624|NCT00816413|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5620625|NCT00816413|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5620626|NCT00816413|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5605072|NCT00877903|AMI|ami
5620627|NCT00816413|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5620628|NCT00816413|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5620629|NCT00816413|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5620630|NCT00816413|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5620631|NCT00816413|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5620632|NCT00816413|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5620633|NCT00816413|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5620634|NCT00816413|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5620635|NCT00816413|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5620636|NCT00816413|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5620637|NCT00816413|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5620638|NCT00816413|essential thrombocythemia|essential thrombocythemia
5620639|NCT00816413|polycythemia vera|polycythemia vera
5620640|NCT00816413|primary myelofibrosis|primary myelofibrosis
5620641|NCT00816413|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5620642|NCT00816413|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5620643|NCT00816413|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5620644|NCT00816413|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5620645|NCT00816413|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5620646|NCT00816413|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5620647|NCT00816413|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5620648|NCT00816413|aplastic anemia|aplastic anemia
5620649|NCT00816413|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5620650|NCT00816413|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5701820|NCT00495638|6-Minute Walk|6-minute walk
5620651|NCT00816413|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5620652|NCT00816413|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5620653|NCT00816413|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5620654|NCT00816413|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5620655|NCT00816413|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5620657|NCT00816413|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5620658|NCT00816413|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5620659|NCT00816413|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5620660|NCT00816413|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5620661|NCT00816413|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5620662|NCT00816413|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5620663|NCT00816413|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5620664|NCT00816413|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5620665|NCT00816413|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5620666|NCT00816413|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5620667|NCT00816413|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5620668|NCT00816413|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5620669|NCT00816413|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5620789|NCT00816036|Veterans Administration|veterans administration
5620670|NCT00816413|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5620671|NCT00816413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5620672|NCT00816413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5620673|NCT00816413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5620674|NCT00816413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5620675|NCT00816413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5620676|NCT00816413|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5620677|NCT00816413|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5620678|NCT00816413|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5620679|NCT00816413|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5620680|NCT00816413|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5620681|NCT00816413|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5620682|NCT00816413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5620780|NCT00816049|child|child
5620684|NCT00816413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5620685|NCT00816413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5620686|NCT00816374|cutaneous malignant melanoma|cutaneous malignant melanoma
5620688|NCT00816374|total cutaneous examination|total cutaneous examination
5620689|NCT00816374|TCE|tce
5620690|NCT00816374|skin self-examination|skin self-examination
5620692|NCT00816374|first degree relatives|first degree relatives
5620693|NCT00816374|FDR|fdr
5620694|NCT00816374|skin cancer protection|skin cancer protection
5620695|NCT00816374|skin cancer screening|skin cancer screening
5620696|NCT00816348|Cholestasis|cholestasis
5620697|NCT00816348|Parenteral Nutrition Associated Liver Disease|parenteral nutrition associated liver disease
5620698|NCT00816335|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5620699|NCT00816309|physiotherapy|physiotherapy
5620700|NCT00816309|bronchiectasis|bronchiectasis
5620701|NCT00816296|NAFLD|nafld
5620702|NCT00816296|Obesity|obesity
5620703|NCT00816296|Microbiome|microbiome
5620704|NCT00816283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5620705|NCT00816283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5620706|NCT00816283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5620707|NCT00816283|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5620708|NCT00816283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5620709|NCT00816283|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5620710|NCT00816270|Blepharoptosis|blepharoptosis
5620711|NCT00816270|Dermatochalasis|dermatochalasis
5620712|NCT00816270|octyl 2-cyanoacrylate|octyl 2-cyanoacrylate
5620713|NCT00816270|Suture Techniques|suture techniques
5620714|NCT00816270|Tissue Adhesive|tissue adhesive
5620715|NCT00816257|lung tissue repository|lung tissue repository
5620716|NCT00816244|Breast cancer|breast cancer
5620717|NCT00816244|Postmenopausal|postmenopausal
5620718|NCT00816244|Neo-adjuvant|neo-adjuvant
5620719|NCT00816244|Tumor proliferation|tumor proliferation
5620720|NCT00816244|Statin|statin
5620721|NCT00816244|Atorvastatin|atorvastatin
5620723|NCT00816244|Translational research|translational research
5620724|NCT00816244|Cell cycle regulators|cell cycle regulators
5620725|NCT00816244|Gene expression|gene expression
5620726|NCT00816244|Genomic profiling|genomic profiling
5620727|NCT00816244|Apoptosis|apoptosis
5620728|NCT00816244|Window-of-opportunity|window-of-opportunity
5614640|NCT00839189|LPS|lps
5620729|NCT00816231|Prevention Intervention|prevention intervention
5620731|NCT00816231|Tobacco|tobacco
5620732|NCT00816231|Nicotine|nicotine
5620733|NCT00816231|Craving|craving
5620734|NCT00816231|Cue Reactivity|cue reactivity
5620735|NCT00816231|Cross Cue Reactions|cross cue reactions
5620736|NCT00816192|FA|fa
5620737|NCT00816192|Atrial fibrillation|atrial fibrillation
5620738|NCT00816192|Catheter|catheter
5620739|NCT00816192|Ablation|ablation
5620740|NCT00816192|RF|rf
5620741|NCT00816179|Pancreatic head mass|pancreatic head mass
5620742|NCT00816179|Pancreatic cancer|pancreatic cancer
5620743|NCT00816179|NOTES|notes
5620744|NCT00816179|Endoscopic peritoneoscopy|endoscopic peritoneoscopy
5620745|NCT00816179|Whipple|whipple
5620746|NCT00816179|palliative gastrojejunostomy|palliative gastrojejunostomy
5620747|NCT00816166|Ischemic stroke|ischemic stroke
5620748|NCT00816166|Transient Ischemic Attack|transient ischemic attack
5620749|NCT00816166|Intracranial Stenting|intracranial stenting
5620750|NCT00816153|Pleth variability Index|pleth variability index
5620751|NCT00816153|Fluid management|fluid management
5620752|NCT00816153|Fluid management during surgery|fluid management during surgery
5620753|NCT00816140|Helicobacter pylori|helicobacter pylori
5620754|NCT00816140|levofloxacin|levofloxacin
5620755|NCT00816140|clarithromycin|clarithromycin
5620756|NCT00816140|ERADICATION RATE|eradication rate
5620757|NCT00816127|liver cirrhosis|liver cirrhosis
5620758|NCT00816127|coagulopathy|coagulopathy
5620759|NCT00816127|desmopressin|desmopressin
5620760|NCT00816127|blood transfusion|blood transfusion
5620761|NCT00816114|Imatinib|imatinib
5620762|NCT00816114|Gleevec|gleevec
5620763|NCT00816114|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5620764|NCT00816114|CML|cml
5620765|NCT00816101|Curettage and electrodesiccation|curettage and electrodesiccation
5620766|NCT00816101|acute wounds|acute wounds
5620767|NCT00816101|partial thickness wounds|partial thickness wounds
5620768|NCT00816088|chemotherapy|chemotherapy
5620769|NCT00816088|Stem cell transplantation|stem cell transplantation
5620770|NCT00816075|distilled water|distilled water
5620771|NCT00816075|recurrent|recurrent
5620772|NCT00816075|bladder|bladder
5620773|NCT00816075|mitomycin|mitomycin
5620774|NCT00816062|Aortic Aneurysm|aortic aneurysm
5620775|NCT00816062|Aneurysm|aneurysm
5620776|NCT00816062|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5620777|NCT00816062|Talent|talent
5620778|NCT00816062|Medtronic|medtronic
5620779|NCT00816049|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5620781|NCT00816049|6-mercaptopurine|6-mercaptopurine
5620782|NCT00816049|minimal residual disease|minimal residual disease
5620783|NCT00816049|efficacy|efficacy
5620784|NCT00816049|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5620785|NCT00816036|Smoking Cessation|smoking cessation
5620786|NCT00816036|Practice Guidelines|practice guidelines
5620787|NCT00816036|Inpatient|inpatient
5620788|NCT00816036|Effectiveness Trial|effectiveness trial
5620790|NCT00816036|Relapse prevention|relapse prevention
5620791|NCT00816010|drug compliance|drug compliance
5620792|NCT00816010|lifestyle modification|lifestyle modification
5620793|NCT00815997|radial artery|radial artery
5620794|NCT00815997|transradial intervention|transradial intervention
5620795|NCT00815997|stent|stent
5620796|NCT00815984|Asthma|asthma
5620797|NCT00815984|Allergic Rhinitis|allergic rhinitis
5620798|NCT00815984|Atopic Dermatitis|atopic dermatitis
5620799|NCT00815984|Children|children
5620800|NCT00815984|lung function|lung function
5620801|NCT00815984|skin prick tests|skin prick tests
5620802|NCT00815984|FeNO|feno
5620803|NCT00815971|EGFR mutations|egfr mutations
5620804|NCT00815971|EGFR inhibitor|egfr inhibitor
5620805|NCT00815971|erlotinib|erlotinib
5620806|NCT00815958|knee replacement surgery|knee replacement surgery
5620807|NCT00815958|Reamer-Irrigator-Aspirator|reamer-irrigator-aspirator
5620808|NCT00815958|femoral reaming|femoral reaming
5620809|NCT00815958|fat embolism|fat embolism
5620810|NCT00815945|leiomyosarcoma|leiomyosarcoma
5620811|NCT00815945|carcinosarcoma|carcinosarcoma
5620812|NCT00815945|mixed epithelial mesenchymal tumor|mixed epithelial mesenchymal tumor
5620813|NCT00815945|endometrial stroma sarcomas|endometrial stroma sarcomas
5620814|NCT00815945|Müllerian mixed tumors|müllerian mixed tumors
5620815|NCT00815945|carcinosarcoma of the uterus|carcinosarcoma of the uterus
5620816|NCT00815945|mesenchymal tumors of the ovary or uterus|mesenchymal tumors of the ovary or uterus
5620817|NCT00815945|mixed epithelial mesenchymal tumors of the ovary or uterus|mixed epithelial mesenchymal tumors of the ovary or uterus
5620818|NCT00815919|cGVHD|cgvhd
5620819|NCT00815919|Velcade|velcade
5620820|NCT00815919|bortezomib|bortezomib
5620821|NCT00815893|Dexmedetomidine|dexmedetomidine
5620822|NCT00815893|Fiberoptic nasal intubation|fiberoptic nasal intubation
5620824|NCT00815880|Heart Failure|heart failure
5620825|NCT00815880|Device|device
5620826|NCT00815880|Implantable|implantable
5620827|NCT00815880|Active|active
5620828|NCT00815880|Class III and Class IV|class iii and class iv
5620829|NCT00815880|Counterpulsation|counterpulsation
5620830|NCT00815867|kidney failure|kidney failure
5614741|NCT00838851|LPS|lps
5620831|NCT00815867|kidney transplant|kidney transplant
5620833|NCT00815867|haemoglobin|haemoglobin
5620834|NCT00815867|epoetin|epoetin
5620835|NCT00815854|Antipsychotic|antipsychotic
5620836|NCT00815854|Metabolic Syndrome|metabolic syndrome
5620837|NCT00815854|Insulin Resistance|insulin resistance
5620838|NCT00815854|Endothelial Function|endothelial function
5620839|NCT00815841|Determine the effect of MPH on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults|determine the effect of mph on a diagnostic continuous performance task that assesses attention and on a decision making test in young healthy adults
5620840|NCT00815828|Gestational Diabetes|gestational diabetes
5620841|NCT00815828|Resistance Exercise|resistance exercise
5620842|NCT00815828|Pregnancy|pregnancy
5620843|NCT00815828|Insulin|insulin
5620844|NCT00815815|Anorexia Nervosa|anorexia nervosa
5620845|NCT00815802|Children in day care centers|children in day care centers
5620846|NCT00815802|cytomegalovirus excretion|cytomegalovirus excretion
5620847|NCT00815776|Temporomandibular disorders|temporomandibular disorders
5620848|NCT00815763|randomized trial|randomized trial
5620849|NCT00815763|ischemic stroke|ischemic stroke
5620850|NCT00815763|Ginsenoside-Rd|ginsenoside-rd
5620851|NCT00815750|Prostate Cancer|prostate cancer
5620852|NCT00815737|Lung Infection After Cerebral Hemorrhage|lung infection after cerebral hemorrhage
5620853|NCT00815737|Prevention of Pneumonia|prevention of pneumonia
5620854|NCT00815737|Rhubarb|rhubarb
5620855|NCT00815724|Daily Inhaled Corticosteroids|daily inhaled corticosteroids
5620856|NCT00815724|Distributed Learning|distributed learning
5620857|NCT00815724|E-learning|e-learning
5620859|NCT00815698|pain|pain
5620860|NCT00815685|n-3 fatty acids|n-3 fatty acids
5620861|NCT00815685|nutritional treatment|nutritional treatment
5620862|NCT00815685|molecular pathogenesis|molecular pathogenesis
5620863|NCT00815672|Exercise|exercise
5620864|NCT00815672|Prostate cancer|prostate cancer
5620865|NCT00815672|Fatigue|fatigue
5620866|NCT00815659|plasma lipid profile|plasma lipid profile
5620867|NCT00815659|metabolic syndrome|metabolic syndrome
5620868|NCT00815646|Immersion pulmonary edema|immersion pulmonary edema
5620869|NCT00815646|Diving|diving
5620870|NCT00815646|Swimming|swimming
5620871|NCT00815646|Pulmonary edema|pulmonary edema
5620872|NCT00815646|Cold water immersion|cold water immersion
5620873|NCT00815633|PRP|prp
5620874|NCT00815633|Pityriasis Rubra Pilaris|pityriasis rubra pilaris
5620875|NCT00815633|Amevive|amevive
5620876|NCT00815633|Alefacept|alefacept
5620877|NCT00815633|Biologic|biologic
5620878|NCT00815633|Immunosuppressant|immunosuppressant
5620879|NCT00815633|Severe skin disease|severe skin disease
5620880|NCT00815620|neuroendocrine tumors|neuroendocrine tumors
5620881|NCT00815620|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5620882|NCT00815620|selective internal radiotherapy|selective internal radiotherapy
5620883|NCT00815620|surgery|surgery
5620884|NCT00815620|radio-frequency ablation|radio-frequency ablation
5620885|NCT00815620|peptide-receptor radiotherapy|peptide-receptor radiotherapy
5620886|NCT00815620|progression-free survival|progression-free survival
5620887|NCT00815620|quality of life|quality of life
5620888|NCT00815620|overall survival|overall survival
5620889|NCT00815620|weight|weight
5620890|NCT00815620|time of hospitalization|time of hospitalization
5620891|NCT00815607|melanoma|melanoma
5620892|NCT00815607|biologic|biologic
5620893|NCT00815607|immunotherapy|immunotherapy
5620894|NCT00815607|cancer|cancer
5620895|NCT00815594|bleb|bleb
5620896|NCT00815594|vascular change|vascular change
5620897|NCT00815594|bevacizumab|bevacizumab
5620898|NCT00815594|trabeculectomy|trabeculectomy
5620899|NCT00815594|Bleb vascularity associated with increased scarring activity|bleb vascularity associated with increased scarring activity
5620900|NCT00815594|Conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery|conjunctival scarring finally leads to the obstruction of the fistula tract created by the filtering surgery
5620901|NCT00815594|the recombinant human anti-VEGF antibody could inhibit angiogenesis of conjunctiva.|the recombinant human anti-vegf antibody could inhibit angiogenesis of conjunctiva.
5620902|NCT00815581|children between 1 to 10 years old|children between 1 to 10 years old
5620903|NCT00815581|amblyopy|amblyopy
5620904|NCT00815568|fludarabine|fludarabine
5620905|NCT00815568|busulfan|busulfan
5620906|NCT00815568|total body irradiation|total body irradiation
5620907|NCT00815568|conditioning regimen|conditioning regimen
5620908|NCT00815555|receptor positive breast cancer|receptor positive breast cancer
5620909|NCT00815555|Tamoxifen treatment|tamoxifen treatment
5620910|NCT00815555|CYP2D6 status|cyp2d6 status
5620911|NCT00815555|relapse|relapse
5620912|NCT00815529|Acupuncture|acupuncture
5620913|NCT00815529|Chronic low back pain|chronic low back pain
5620914|NCT00815529|Qualitative study|qualitative study
5620915|NCT00815516|candidiasis|candidiasis
5620916|NCT00815516|candida|candida
5620917|NCT00815516|Neonate|neonate
5620918|NCT00815516|candidemia|candidemia
5620919|NCT00815516|Micafungin|micafungin
5620920|NCT00815516|Mycamine|mycamine
5620921|NCT00815516|amphotericin B deoxycholate|amphotericin b deoxycholate
5620922|NCT00815503|Anesthetics|anesthetics
5614846|NCT00838539|phase 1|phase 1
5620924|NCT00815503|Periacetabular osteotomy|periacetabular osteotomy
5620925|NCT00815490|Spectroscopy, near infrared|spectroscopy, near infrared
5620926|NCT00815490|Oximetry|oximetry
5620927|NCT00815490|Hypoxemia|hypoxemia
5620928|NCT00815490|Tissue oxygenation|tissue oxygenation
5620929|NCT00815464|Chronic Hepatitis B|chronic hepatitis b
5620930|NCT00815464|Liquid Acupuncture(Herb Acupoint Injection)|liquid acupuncture(herb acupoint injection)
5620931|NCT00815464|Therapeutics|therapeutics
5620932|NCT00815464|Herbalist|herbalist
5620933|NCT00815464|Acupoint|acupoint
5620934|NCT00815438|Transvaginal|transvaginal
5620935|NCT00815438|Cholecystectomy|cholecystectomy
5620936|NCT00815438|NOTES|notes
5620937|NCT00815438|Endoscopic|endoscopic
5620938|NCT00815425|African American|african american
5620939|NCT00815386|mitral valve|mitral valve
5620940|NCT00815386|heart failure|heart failure
5620941|NCT00815386|mitral regurgitation|mitral regurgitation
5620942|NCT00815386|annuloplasty|annuloplasty
5620943|NCT00815386|coronary sinus|coronary sinus
5620944|NCT00815373|Ocular Blood flow|ocular blood flow
5620945|NCT00815373|Ocular hypertension|ocular hypertension
5620946|NCT00815373|POAG|poag
5620947|NCT00815373|Ocular hemodynamics|ocular hemodynamics
5620948|NCT00815373|Xalacom|xalacom
5620949|NCT00815373|Cosopt|cosopt
5620950|NCT00815360|diabetic macular edema|diabetic macular edema
5620951|NCT00815347|Asthma|asthma
5620952|NCT00815334|vesicoureteral reflux|vesicoureteral reflux
5620953|NCT00815334|low compliant bladder|low compliant bladder
5620954|NCT00815321|chronic myeloid leukemia|chronic myeloid leukemia
5620955|NCT00815321|autologous cytokine induced killer cells|autologous cytokine induced killer cells
5620956|NCT00815321|Chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors|chronic myeloid leukemia in blast crisis treated with chemotherapy or kinase inhibitors
5620957|NCT00815321|Chronic myeloid leukemia with mutation resistant to kinase inhibitors|chronic myeloid leukemia with mutation resistant to kinase inhibitors
5620958|NCT00815321|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease|chronic myeloid leukemia with good response to kinase inhibitor and stable persistence of residual disease
5620959|NCT00815308|Therapeutic|therapeutic
5620960|NCT00815308|Drug Therapy, combination|drug therapy, combination
5620961|NCT00815308|Radiotherapy|radiotherapy
5620962|NCT00815295|squamous cell cancer, head and neck|squamous cell cancer, head and neck
5620963|NCT00815269|Inhalant anesthetic|inhalant anesthetic
5620964|NCT00815269|Vasodilation|vasodilation
5620965|NCT00815269|General anesthesia|general anesthesia
5620966|NCT00815269|Ultrasonography|ultrasonography
5620967|NCT00815256|Cornea degeneration|cornea degeneration
5620968|NCT00815256|keratoconus|keratoconus
5620969|NCT00815256|collagen cross linking|collagen cross linking
5620971|NCT00815256|Riboflavin|riboflavin
5620972|NCT00815243|fracture|fracture
5620973|NCT00815243|coxarthrosis|coxarthrosis
5620974|NCT00815243|complication|complication
5620975|NCT00815243|congenital abnormalities|congenital abnormalities
5620977|NCT00815243|joint|joint
5620978|NCT00815243|telemedicine|telemedicine
5620979|NCT00815243|transportation|transportation
5620980|NCT00815243|decision making|decision making
5620981|NCT00815243|outcomes|outcomes
5620982|NCT00815230|radiation injury|radiation injury
5620983|NCT00815230|computed tomography|computed tomography
5620984|NCT00815230|reactive oxygen species|reactive oxygen species
5620985|NCT00815230|free radicals|free radicals
5620986|NCT00815217|Lipoaspirate|lipoaspirate
5620987|NCT00815217|Diabetes Mellitus|diabetes mellitus
5620988|NCT00815217|Mesenchymal Stem cells|mesenchymal stem cells
5620989|NCT00815217|Fat grafts|fat grafts
5620990|NCT00815217|venous stasis|venous stasis
5620991|NCT00815204|PTSD|ptsd
5620992|NCT00815204|HPA axis|hpa axis
5620993|NCT00815204|Pituitary volume|pituitary volume
5620994|NCT00815191|temperature|temperature
5620995|NCT00815191|surgery|surgery
5620996|NCT00815191|heating device|heating device
5620997|NCT00815178|inspiratory muscle weakness|inspiratory muscle weakness
5620998|NCT00815178|autonomic modulation|autonomic modulation
5620999|NCT00815178|diabetes mellitus|diabetes mellitus
5621000|NCT00815178|heart rate variability|heart rate variability
5621001|NCT00815178|functional capacity|functional capacity
5621002|NCT00815165|cytomegalovirus, CMV, cell-mediated immunity, children, sub-study|cytomegalovirus, cmv, cell-mediated immunity, children, sub-study
5621003|NCT00815152|high grade glioma|high grade glioma
5621004|NCT00815152|Coping skills intervention|coping skills intervention
5621005|NCT00815152|caregivers|caregivers
5621006|NCT00815139|Coronary artery disease, stent|coronary artery disease, stent
5621007|NCT00815113|Gastric cancer|gastric cancer
5621008|NCT00815113|screening|screening
5621009|NCT00815113|high-risk|high-risk
5621010|NCT00815113|relatives|relatives
5621011|NCT00815113|gastroscopy|gastroscopy
5621012|NCT00815100|Ivabradine|ivabradine
5621013|NCT00815100|Acute coronary syndrome.|acute coronary syndrome.
5621014|NCT00815100|Inflammation|inflammation
5621015|NCT00815100|C-reactive protein|c-reactive protein
5621016|NCT00815100|Atherosclerosis|atherosclerosis
5621017|NCT00815087|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5621018|NCT00815087|functional electrical stimulation|functional electrical stimulation
5621019|NCT00815074|Military Women|military women
5621020|NCT00815074|Women's Health|women's health
5621021|NCT00815074|Genitourinary Symptoms|genitourinary symptoms
5621022|NCT00815074|Illness Behaviors|illness behaviors
5621023|NCT00815074|To determine how women manage genitourinary symptoms while deployed.|to determine how women manage genitourinary symptoms while deployed.
5621024|NCT00815061|prevalence|prevalence
5621025|NCT00815061|Incidence|incidence
5621026|NCT00815061|crohn's disease|crohn's disease
5621027|NCT00815061|ulcerative colitis|ulcerative colitis
5621028|NCT00815061|Epidemiology|epidemiology
5621029|NCT00815048|Remifentanil|remifentanil
5621030|NCT00815048|Endotracheal intubation|endotracheal intubation
5621031|NCT00815048|Premedication|premedication
5621032|NCT00815048|Sedation|sedation
5621033|NCT00815048|Endotracheal Intubation in Neonates|endotracheal intubation in neonates
5621034|NCT00815035|Peanut Allergy|peanut allergy
5621035|NCT00815022|Temperature|temperature
5621036|NCT00815022|Spinal anesthesia|spinal anesthesia
5621037|NCT00815022|Cesarean section|cesarean section
5621038|NCT00815022|Cephalad sensory blockade|cephalad sensory blockade
5621039|NCT00815022|Regional anesthesia|regional anesthesia
5621040|NCT00815009|NAFLD|nafld
5621041|NCT00815009|NASH|nash
5621042|NCT00814983|myeloablative|myeloablative
5621043|NCT00814983|stem cell|stem cell
5621044|NCT00814983|naive T-cell depleted|naive t-cell depleted
5621045|NCT00814983|allogeneic|allogeneic
5621046|NCT00814970|PAD|pad
5621047|NCT00814970|peripheral arterial disease|peripheral arterial disease
5621048|NCT00814970|stent|stent
5621049|NCT00814970|SFA|sfa
5621050|NCT00814970|PPA|ppa
5621051|NCT00814957|positron emission tomography|positron emission tomography
5621052|NCT00814957|addiction|addiction
5621053|NCT00814944|dry eye|dry eye
5621054|NCT00814944|sirolimus|sirolimus
5621055|NCT00814944|rapamycin|rapamycin
5621056|NCT00814918|acne vulgaris|acne vulgaris
5621057|NCT00814918|acne|acne
5621058|NCT00814918|dermatalogy|dermatalogy
5621059|NCT00814905|chorioamnionitis|chorioamnionitis
5621060|NCT00814905|antibiotics|antibiotics
5621061|NCT00814905|cesarean|cesarean
5621062|NCT00814905|vaginal delivery|vaginal delivery
5621063|NCT00814892|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5621064|NCT00814892|recurrent prostate cancer|recurrent prostate cancer
5621065|NCT00814892|stage I prostate cancer|stage i prostate cancer
5621066|NCT00814892|stage IIB prostate cancer|stage iib prostate cancer
5621067|NCT00814892|stage IIA prostate cancer|stage iia prostate cancer
5621068|NCT00814892|stage III prostate cancer|stage iii prostate cancer
5622189|NCT00810875|cord blood|cord blood
5621073|NCT00814879|Antiretroviral|antiretroviral
5621074|NCT00814879|Antiviral Agents|antiviral agents
5621075|NCT00814879|Atazanavir|atazanavir
5621076|NCT00814879|Human Immunodeficiency Virus|human immunodeficiency virus
5621077|NCT00814879|HIV|hiv
5621078|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors
5621079|NCT00814879|NRTI|nrti
5621080|NCT00814879|Nucleoside Reverse Transcriptase Inhibitors|nucleoside reverse transcriptase inhibitors
5621081|NCT00814879|Raltegravir|raltegravir
5621082|NCT00814879|Resistance|resistance
5621083|NCT00814879|treatment experienced|treatment experienced
5621084|NCT00814866|Rheumatoid arthritis|rheumatoid arthritis
5621085|NCT00814866|arthritis|arthritis
5621086|NCT00814866|osteoclasts|osteoclasts
5621087|NCT00814866|bone|bone
5621088|NCT00814853|Extubation|extubation
5621089|NCT00814853|testing|testing
5621090|NCT00814853|ventilator weaning|ventilator weaning
5621091|NCT00814853|Pediatric extubation|pediatric extubation
5621092|NCT00814840|Heart failure|heart failure
5621093|NCT00814840|Dyssynchrony|dyssynchrony
5621094|NCT00814840|Cardiac resynchronization|cardiac resynchronization
5621095|NCT00814840|Triple-site pacing|triple-site pacing
5621101|NCT00814801|Alzheimer's Disease|alzheimer's disease
5621102|NCT00814801|Cognitive dysfunction|cognitive dysfunction
5621103|NCT00814801|Dementia|dementia
5621104|NCT00814801|Galantamine|galantamine
5621105|NCT00814801|R113675|r113675
5621106|NCT00814788|stage IV prostate cancer|stage iv prostate cancer
5621107|NCT00814788|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5621108|NCT00814788|recurrent prostate cancer|recurrent prostate cancer
5621109|NCT00814775|Laryngeal mask|laryngeal mask
5621110|NCT00814775|Difficult intubation|difficult intubation
5621111|NCT00814762|immunogenicity|immunogenicity
5621112|NCT00814762|HIV|hiv
5621113|NCT00814762|reactogenicity|reactogenicity
5621114|NCT00814762|safety|safety
5621115|NCT00814762|vaccine|vaccine
5621116|NCT00814762|HIV Infections|hiv infections
5621117|NCT00814749|stress urinary incontinence|stress urinary incontinence
5621118|NCT00814749|urodynamics|urodynamics
5621119|NCT00814749|randomized clinical trial|randomized clinical trial
5621120|NCT00814749|surgery|surgery
5621121|NCT00814710|Pneumococcal disease|pneumococcal disease
5621122|NCT00814710|Pneumococcal vaccine|pneumococcal vaccine
5621123|NCT00814710|Safety|safety
5621124|NCT00814710|Primary vaccination|primary vaccination
5621125|NCT00814710|Immunogenicity|immunogenicity
5621126|NCT00814697|Alzheimer|alzheimer
5621127|NCT00814697|Language|language
5621129|NCT00814697|TMS|tms
5621130|NCT00814697|rTMS|rtms
5621131|NCT00814671|Tuberculosis|tuberculosis
5621132|NCT00814671|Pharmacokinetics|pharmacokinetics
5621133|NCT00814658|Dementia|dementia
5621134|NCT00814658|Mixed Dementia|mixed dementia
5621135|NCT00814658|Galantamine|galantamine
5621136|NCT00814658|Reminyl ER|reminyl er
5621137|NCT00814658|Nimodipine|nimodipine
5621138|NCT00814632|vulvodynia|vulvodynia
5621139|NCT00814632|pelvic pain|pelvic pain
5621140|NCT00814632|vulvar pain|vulvar pain
5621141|NCT00814619|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5621142|NCT00814619|stage III rectal cancer|stage iii rectal cancer
5621143|NCT00814619|stage II rectal cancer|stage ii rectal cancer
5621144|NCT00814606|genotype 1 hepatitis C|genotype 1 hepatitis c
5621145|NCT00814606|hepatitis C|hepatitis c
5621146|NCT00814606|HCV|hcv
5621147|NCT00814606|liver|liver
5621148|NCT00814593|adult giant cell glioblastoma|adult giant cell glioblastoma
5621149|NCT00814593|adult gliosarcoma|adult gliosarcoma
5621150|NCT00814593|adult glioblastoma|adult glioblastoma
5621151|NCT00814580|analgesia|analgesia
5621152|NCT00814580|postoperative pain|postoperative pain
5621153|NCT00814580|opioid|opioid
5621154|NCT00814580|rotator cuff repair|rotator cuff repair
5621155|NCT00814580|labral tear repair|labral tear repair
5621156|NCT00814580|Bankart procedure|bankart procedure
5621157|NCT00814580|oxycodone|oxycodone
5621158|NCT00814580|tapentadol|tapentadol
5621159|NCT00814580|arthroscopic shoulder surgery|arthroscopic shoulder surgery
5621160|NCT00814567|recurrent breast cancer|recurrent breast cancer
5621161|NCT00814567|stage IA breast cancer|stage ia breast cancer
5621162|NCT00814567|stage II breast cancer|stage ii breast cancer
5621163|NCT00814567|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5621164|NCT00814567|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5621166|NCT00814554|nutrition|nutrition
5621167|NCT00814554|cluster randomized trial|cluster randomized trial
5621168|NCT00814554|high school|high school
5621169|NCT00814554|primary prevention|primary prevention
5621170|NCT00814541|refractory multiple myeloma|refractory multiple myeloma
5621171|NCT00814541|stage I multiple myeloma|stage i multiple myeloma
5621172|NCT00814541|stage II multiple myeloma|stage ii multiple myeloma
5621173|NCT00814541|stage III multiple myeloma|stage iii multiple myeloma
5621174|NCT00814528|actinic keratosis|actinic keratosis
5621175|NCT00814528|skin lesions|skin lesions
5621176|NCT00814528|5-ALA|5-ala
5621177|NCT00814528|AK|ak
5621178|NCT00814528|Blu-Light|blu-light
5621179|NCT00814515|Moderate|moderate
5621180|NCT00814515|Severe|severe
5621181|NCT00814515|Dry|dry
5621182|NCT00814515|Eye|eye
5621183|NCT00814515|Ciclosporin|ciclosporin
5621184|NCT00814515|Cyclosporine|cyclosporine
5621185|NCT00814502|Alzheimer disease|alzheimer disease
5621186|NCT00814502|Dementia, vascular|dementia, vascular
5621187|NCT00814502|Actigraphy|actigraphy
5621188|NCT00814502|Circadian dysregulation|circadian dysregulation
5621189|NCT00814502|Sleep Disorders|sleep disorders
5621190|NCT00814502|Circadian rhythm|circadian rhythm
5621191|NCT00814489|Non-typable Haemophilus influenzae|non-typable haemophilus influenzae
5621192|NCT00814489|protein vaccine|protein vaccine
5621193|NCT00814489|Streptococcus pneumoniae|streptococcus pneumoniae
5621194|NCT00814489|young adults|young adults
5621195|NCT00814476|Medtronic CareLink|medtronic carelink
5621196|NCT00814476|therapy management|therapy management
5621197|NCT00814476|diabetes|diabetes
5621198|NCT00814476|insulin pump|insulin pump
5621199|NCT00814476|Blood glucose monitor|blood glucose monitor
5621200|NCT00814463|tumors metastatic to brain|tumors metastatic to brain
5621201|NCT00814463|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5621202|NCT00814450|Biopsy|biopsy
5621203|NCT00814450|Fine needle aspiration|fine needle aspiration
5621204|NCT00814424|EtCO2|etco2
5621205|NCT00814424|supplemental oxygen delivery|supplemental oxygen delivery
5621206|NCT00814424|ERCP|ercp
5621207|NCT00814411|contraception|contraception
5621208|NCT00814411|noninferiority|noninferiority
5621209|NCT00814411|intention|intention
5621210|NCT00814411|family planning counseling|family planning counseling
5621211|NCT00814411|post abortion care|post abortion care
5621212|NCT00814411|Family planning intention among women with unmet need|family planning intention among women with unmet need
5621213|NCT00814398|Infertility|infertility
5621214|NCT00814398|IVF|ivf
5621215|NCT00814398|SET|set
5621216|NCT00814398|DET|det
5621217|NCT00814398|Blastocyst|blastocyst
5621218|NCT00814359|mucositis|mucositis
5621219|NCT00814359|radiation|radiation
5621220|NCT00814359|magic mouthwash|magic mouthwash
5621221|NCT00814359|sucralfate|sucralfate
5621222|NCT00814359|benzydamine|benzydamine
5621223|NCT00814359|diphenhydramine|diphenhydramine
5621224|NCT00814359|dexamethasone|dexamethasone
5621225|NCT00814359|nystatin|nystatin
5621226|NCT00814346|Mild Alzheimer's disease (AD) patients|mild alzheimer's disease (ad) patients
5621227|NCT00814346|Memory complaint patients with cognitive impairment (MC)|memory complaint patients with cognitive impairment (mc)
5621232|NCT00814281|particulate air pollution|particulate air pollution
5621233|NCT00814281|leukotriene|leukotriene
5621234|NCT00814281|asthma|asthma
5621235|NCT00814281|montelukast|montelukast
5621236|NCT00814281|vascular endothelial dysfunction|vascular endothelial dysfunction
5621237|NCT00814281|nitric oxide(NO)endothelin (ET) system|nitric oxide(no)endothelin (et) system
5621238|NCT00814255|Primary FSGS|primary fsgs
5621239|NCT00814255|Steroid Resistant|steroid resistant
5621240|NCT00814255|Rosiglitazone|rosiglitazone
5621241|NCT00814255|Adalimumab|adalimumab
5621242|NCT00814255|Resistant primary FSGS|resistant primary fsgs
5621243|NCT00814255|GALACTOSE|galactose
5621244|NCT00814242|Hepatocellular Carcinoma|hepatocellular carcinoma
5621245|NCT00814242|Adjacent to Major Blood Vessels|adjacent to major blood vessels
5621246|NCT00814242|Surgical resection|surgical resection
5621247|NCT00814242|Ppercutaneous radiationfrequency ablation|ppercutaneous radiationfrequency ablation
5621248|NCT00814242|Time to recurrence|time to recurrence
5621249|NCT00814242|Disease-free survival|disease-free survival
5621250|NCT00814242|Overall survival|overall survival
5621251|NCT00814229|influenza|influenza
5621252|NCT00814229|H9N2|h9n2
5621253|NCT00814229|vaccine|vaccine
5621254|NCT00814216|Efficacy|efficacy
5621255|NCT00814216|safety|safety
5621256|NCT00814216|QAV680|qav680
5621257|NCT00814216|pharmacokinetics|pharmacokinetics
5621258|NCT00814216|corticosteroid|corticosteroid
5621259|NCT00814216|asthma|asthma
5621260|NCT00814203|COPD|copd
5621261|NCT00814190|Type 2 Diabetes|type 2 diabetes
5621262|NCT00814190|Internet Therapeutic Intervention|internet therapeutic intervention
5621263|NCT00814177|warfarin|warfarin
5621264|NCT00814177|dosing|dosing
5621265|NCT00814177|prothrombin time|prothrombin time
5621266|NCT00814177|Heart valve prosthesis|heart valve prosthesis
5621267|NCT00814164|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5621268|NCT00814164|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5621359|NCT00813735|Major Depression|major depression
5621269|NCT00814164|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5621270|NCT00814164|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5621271|NCT00814164|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5621272|NCT00814164|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5621273|NCT00814164|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5671240|NCT00616590|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5621274|NCT00814164|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5621275|NCT00814164|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5621276|NCT00814164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5621277|NCT00814164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5621278|NCT00814164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5621279|NCT00814164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5602758|NCT00887328|MRI|mri
5621280|NCT00814164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5621281|NCT00814164|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5621282|NCT00814151|Blood culture|blood culture
5621283|NCT00814151|Staphylococcus aureus|staphylococcus aureus
5621284|NCT00814151|Bacteremia|bacteremia
5621285|NCT00814151|MRSA|mrsa
5621286|NCT00814151|MSSA|mssa
5621287|NCT00814151|MicroPhage|microphage
5621288|NCT00814138|myasthenia gravis|myasthenia gravis
5621289|NCT00814125|Endometrial|endometrial
5621290|NCT00814125|Endometrial histological findings|endometrial histological findings
5621291|NCT00814099|Acute Respiratory Failure|acute respiratory failure
5621292|NCT00814099|Acute Lung Injury|acute lung injury
5621293|NCT00814073|Mastocytosis with handicap|mastocytosis with handicap
5621294|NCT00814073|Mastocytosis|mastocytosis
5621295|NCT00814073|Mast cell|mast cell
5621296|NCT00814073|Mast cell infiltration|mast cell infiltration
5621297|NCT00814073|Skin|skin
5621298|NCT00814073|Bone marrow|bone marrow
5621299|NCT00814073|Pruritus|pruritus
5621300|NCT00814073|Flushes|flushes
5621301|NCT00814073|c-kit|c-kit
5621302|NCT00814073|c-kit mutation|c-kit mutation
5621303|NCT00814073|Wild Type|wild type
5621304|NCT00814073|Mutation Asp-816-Val(D816V)|mutation asp-816-val(d816v)
5621305|NCT00814073|Indolent systemic mastocytosis|indolent systemic mastocytosis
5621306|NCT00814073|smoldering systemic mastocytosis|smoldering systemic mastocytosis
5621307|NCT00814047|ultrasonography|ultrasonography
5621311|NCT00814021|recurrent renal cell cancer|recurrent renal cell cancer
5621312|NCT00814021|stage IV renal cell cancer|stage iv renal cell cancer
5621313|NCT00814021|tumors metastatic to brain|tumors metastatic to brain
5621317|NCT00813969|Multiple Sclerosis|multiple sclerosis
5621318|NCT00813956|triple negative breast cancer|triple negative breast cancer
5621319|NCT00813943|Newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
5621320|NCT00813943|Cilengitide|cilengitide
5621321|NCT00813943|Temozolomide|temozolomide
5621322|NCT00813943|Radiotherapy|radiotherapy
5621323|NCT00813930|Diabetes|diabetes
5621324|NCT00813930|Lifestyle Intervention|lifestyle intervention
5621325|NCT00813930|Cardiovascular risk reduction|cardiovascular risk reduction
5621326|NCT00813891|ranibizumab|ranibizumab
5621327|NCT00813891|verteporfin|verteporfin
5621328|NCT00813878|breast cancer|breast cancer
5621329|NCT00813878|breast cancer in situ|breast cancer in situ
5621330|NCT00813865|Amicus Therapeutics|amicus therapeutics
5621331|NCT00813865|AT2101|at2101
5621332|NCT00813865|afegostat tartrate|afegostat tartrate
5621333|NCT00813865|isofagomine tartrate|isofagomine tartrate
5621334|NCT00813852|obstructive sleep apnea|obstructive sleep apnea
5621335|NCT00813852|skeletal muscle|skeletal muscle
5621336|NCT00813852|magnetic stimulation|magnetic stimulation
5621337|NCT00813852|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5621338|NCT00813852|inflammatory markers|inflammatory markers
5621339|NCT00813852|exercise|exercise
5621340|NCT00813839|SmartCare|smartcare
5621341|NCT00813839|Spontaneous Breathing Trials|spontaneous breathing trials
5621342|NCT00813839|Mechanical Ventilation|mechanical ventilation
5621343|NCT00813839|Weaning|weaning
5621344|NCT00813839|Patients requiring prolonged mechanical ventilation (>72 hours)|patients requiring prolonged mechanical ventilation (>72 hours)
5621345|NCT00813826|PHN|phn
5621346|NCT00813826|Pain after Shingles|pain after shingles
5621347|NCT00813800|Smoking|smoking
5621348|NCT00813800|Bipolar Disorder|bipolar disorder
5621349|NCT00813800|Depression|depression
5621350|NCT00813787|Magnetic Resonance Imaging|magnetic resonance imaging
5621351|NCT00813787|Glioma|glioma
5621352|NCT00813774|Cimzia|cimzia
5621353|NCT00813774|certolizumab pegol|certolizumab pegol
5621354|NCT00813774|Bioavailability|bioavailability
5621355|NCT00813774|Healthy volunteers|healthy volunteers
5621356|NCT00813748|Asthma|asthma
5621357|NCT00813748|Anaphylaxis|anaphylaxis
5621358|NCT00813735|Insomnia|insomnia
5621360|NCT00813735|Geriatric|geriatric
5621362|NCT00813722|blood pressure|blood pressure
5621363|NCT00813722|hypertension|hypertension
5621364|NCT00813722|compliance|compliance
5621365|NCT00813722|atenolol|atenolol
5621366|NCT00813722|hydrochlorothiazide|hydrochlorothiazide
5621367|NCT00813722|amlodipine|amlodipine
5621368|NCT00813722|losartan|losartan
5672488|NCT00611702|ELISPOT|elispot
5621369|NCT00813709|Interferon 1-beta|interferon 1-beta
5621370|NCT00813709|Clinical Definite Multiple Sclerosis|clinical definite multiple sclerosis
5621371|NCT00813696|chemotherapy|chemotherapy
5621372|NCT00813696|advanced cancer|advanced cancer
5621373|NCT00813696|inoperable|inoperable
5621374|NCT00813696|Stage II, III, IV|stage ii, iii, iv
5621375|NCT00813683|Acupuncture, moxybustion,|acupuncture, moxybustion,
5621376|NCT00813683|Cephalic version,|cephalic version,
5621377|NCT00813683|Breech presentation|breech presentation
5621378|NCT00813631|Malignant fungating wound|malignant fungating wound
5621379|NCT00813631|Head and neck|head and neck
5621380|NCT00813631|Ionic silver-releasing dressing|ionic silver-releasing dressing
5621381|NCT00813631|Wound care|wound care
5621382|NCT00813631|RCT|rct
5621383|NCT00813618|Acute GvHD of at least Grade II severity|acute gvhd of at least grade ii severity
5621384|NCT00813605|AMG 655|amg 655
5621385|NCT00813605|AMG 479|amg 479
5621386|NCT00813605|Colon Cancer|colon cancer
5621387|NCT00813605|Rectal Cancer|rectal cancer
5621388|NCT00813605|Monoclonal Antibody|monoclonal antibody
5621389|NCT00813605|Clinical Trial|clinical trial
5621390|NCT00813605|Colorectal Cancer|colorectal cancer
5621391|NCT00813605|metastatic colorectal cancer|metastatic colorectal cancer
5621392|NCT00813605|metastatic cancer|metastatic cancer
5621393|NCT00813605|antibody-2nd line|antibody-2nd line
5621394|NCT00813605|KRAS|kras
5621395|NCT00813605|adenocarcinoma|adenocarcinoma
5621396|NCT00813592|meningioma|meningioma
5621397|NCT00813592|brain|brain
5621398|NCT00813579|assess the safety of living kidney donation|assess the safety of living kidney donation
5621399|NCT00813566|cancer|cancer
5621400|NCT00813566|imaging|imaging
5621401|NCT00813566|PET scanning|pet scanning
5621402|NCT00813553|physical fitness|physical fitness
5621403|NCT00813553|exercise|exercise
5621404|NCT00813553|amino acid|amino acid
5621405|NCT00813540|Colonic Neoplasms|colonic neoplasms
5621406|NCT00813540|Aerobic Exercise|aerobic exercise
5621407|NCT00813540|Weight Lifting|weight lifting
5621408|NCT00813540|Body Composition|body composition
5621409|NCT00813527|Drug Therapy|drug therapy
5621410|NCT00813527|Lipid Metabolism Disorders|lipid metabolism disorders
5621411|NCT00813527|Hyperlipidemias|hyperlipidemias
5621412|NCT00813527|Hypercholesterolemia|hypercholesterolemia
5621413|NCT00813527|Hypertriglyceridemia|hypertriglyceridemia
5621415|NCT00813514|VEGF genotyping|vegf genotyping
5621417|NCT00813514|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5621418|NCT00813501|graft versus host disease|graft versus host disease
5621419|NCT00813501|infection|infection
5621420|NCT00813501|therapy-related toxicity|therapy-related toxicity
5621421|NCT00813501|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5621422|NCT00813501|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5621423|NCT00813501|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5621424|NCT00813501|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5621425|NCT00813501|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5621426|NCT00813501|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5621427|NCT00813501|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5621428|NCT00813501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5621429|NCT00813501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5621430|NCT00813501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5621431|NCT00813501|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5621432|NCT00813501|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5621433|NCT00813501|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5621434|NCT00813501|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5621435|NCT00813501|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5621436|NCT00813501|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5621437|NCT00813501|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5621438|NCT00813501|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5621439|NCT00813501|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5621440|NCT00813501|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5621441|NCT00813501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5621442|NCT00813501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5621443|NCT00813501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5621444|NCT00813501|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5621445|NCT00813501|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5621446|NCT00813501|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5621508|NCT00813501|refractory multiple myeloma|refractory multiple myeloma
5621447|NCT00813501|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5621448|NCT00813501|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5621449|NCT00813501|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5605967|NCT00874354|CHF|chf
5621450|NCT00813501|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5621451|NCT00813501|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5621452|NCT00813501|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5621453|NCT00813501|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5621454|NCT00813501|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5621455|NCT00813501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5621456|NCT00813501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5621457|NCT00813501|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5621458|NCT00813501|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5621459|NCT00813501|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5621460|NCT00813501|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5602937|NCT00886704|atherosclerosis|atherosclerosis
5621461|NCT00813501|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5621462|NCT00813501|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5621463|NCT00813501|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5621464|NCT00813501|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5621465|NCT00813501|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5621466|NCT00813501|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5621467|NCT00813501|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5621468|NCT00813501|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5621469|NCT00813501|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5621470|NCT00813501|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5621471|NCT00813501|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5621472|NCT00813501|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5621473|NCT00813501|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5701821|NCT00495638|Chuvash Polycythemia|chuvash polycythemia
5621474|NCT00813501|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5621475|NCT00813501|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5621476|NCT00813501|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5621477|NCT00813501|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5621478|NCT00813501|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5621479|NCT00813501|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5621480|NCT00813501|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5621481|NCT00813501|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5621482|NCT00813501|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5621483|NCT00813501|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5621484|NCT00813501|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5621485|NCT00813501|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5621486|NCT00813501|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5621487|NCT00813501|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5621488|NCT00813501|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5621489|NCT00813501|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5621490|NCT00813501|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5621491|NCT00813501|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5621492|NCT00813501|refractory hairy cell leukemia|refractory hairy cell leukemia
5621493|NCT00813501|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5621494|NCT00813501|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5621495|NCT00813501|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5621496|NCT00813501|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5621497|NCT00813501|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5621498|NCT00813501|primary myelofibrosis|primary myelofibrosis
5621499|NCT00813501|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5621500|NCT00813501|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5621501|NCT00813501|disseminated neuroblastoma|disseminated neuroblastoma
5621502|NCT00813501|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5621503|NCT00813501|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5621504|NCT00813501|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5621505|NCT00813501|stage I multiple myeloma|stage i multiple myeloma
5621506|NCT00813501|stage II multiple myeloma|stage ii multiple myeloma
5621507|NCT00813501|stage III multiple myeloma|stage iii multiple myeloma
5622834|NCT00808470|Tinnitus|tinnitus
5621509|NCT00813488|Breakthrough Pain|breakthrough pain
5621510|NCT00813488|Opioid-tolerant|opioid-tolerant
5621511|NCT00813488|Chronic Pain|chronic pain
5621512|NCT00813475|cardio vascular outcome|cardio vascular outcome
5621513|NCT00813449|Endostar|endostar
5621514|NCT00813449|advanced melanoma|advanced melanoma
5621515|NCT00813449|combined chemotherapy|combined chemotherapy
5621517|NCT00813436|Theory of Mind|theory of mind
5621518|NCT00813436|Simulation|simulation
5621519|NCT00813436|Empathy|empathy
5621520|NCT00813436|Oxytocin|oxytocin
5621521|NCT00813436|Schizophrenia|schizophrenia
5621522|NCT00813384|Cancer|cancer
5621523|NCT00813384|Solid Tumors|solid tumors
5621524|NCT00813384|Phase 1|phase 1
5621525|NCT00813384|C-met inhibitor|c-met inhibitor
5621526|NCT00813384|Clinical Trial|clinical trial
5621527|NCT00813371|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5621528|NCT00813371|acute lung injury|acute lung injury
5621529|NCT00813371|Airway Pressure Release Ventilation|airway pressure release ventilation
5621530|NCT00813371|ARDSnet|ardsnet
5621531|NCT00813371|Bi-level|bi-level
5621532|NCT00813371|respiratory failure|respiratory failure
5621533|NCT00813371|trauma|trauma
5621534|NCT00813371|APRV|aprv
5621535|NCT00813358|Endovascular Aneurysm Repair|endovascular aneurysm repair
5621536|NCT00813358|Aortic Aneurysm|aortic aneurysm
5621537|NCT00813358|Thoracic|thoracic
5621538|NCT00813345|anesthesia propofol ambulatory rhythm|anesthesia propofol ambulatory rhythm
5621539|NCT00813332|Endostar|endostar
5621540|NCT00813332|NSCLC|nsclc
5621541|NCT00813332|Docetaxel|docetaxel
5621542|NCT00813332|Combined therapy|combined therapy
5621543|NCT00813332|second-line chemotherapy|second-line chemotherapy
5621544|NCT00813319|GARDASIL|gardasil
5621545|NCT00813319|HPV|hpv
5621546|NCT00813319|Vaccination|vaccination
5621547|NCT00813306|GERD|gerd
5621548|NCT00813306|TLESR|tlesr
5621549|NCT00813306|reflux|reflux
5621550|NCT00813293|Hepatocellular Cancer|hepatocellular cancer
5621551|NCT00813293|HCC|hcc
5621552|NCT00813293|Liver Cancer|liver cancer
5621553|NCT00813293|radiofrequency ablation|radiofrequency ablation
5621555|NCT00813293|sorafenib|sorafenib
5621556|NCT00813293|nexavaar|nexavaar
5621557|NCT00813293|liver directed therapy|liver directed therapy
5621558|NCT00813293|interventional radiology|interventional radiology
5621559|NCT00813267|Mesenchymal Stem Cells|mesenchymal stem cells
5621560|NCT00813267|Osteonecrosis of the Femoral Head|osteonecrosis of the femoral head
5621561|NCT00813254|Platinum-Resistant Ovarian Cancer|platinum-resistant ovarian cancer
5621562|NCT00813254|Platinum-based chemotherapy|platinum-based chemotherapy
5621564|NCT00813254|Ovary|ovary
5621565|NCT00813254|Epithelial ovarian cancer|epithelial ovarian cancer
5621566|NCT00813254|Quality of Life|quality of life
5621567|NCT00813254|Cost Utility Analysis|cost utility analysis
5621568|NCT00813254|Sexual functioning|sexual functioning
5621569|NCT00813254|Questionnaire|questionnaire
5621570|NCT00813254|Caregiver|caregiver
5621571|NCT00813241|Ankylosing spondylitis,Rheumatoid Arthritis,Adenomatous Polyposis Coli,Osteoarthritis,Dysmenorrhoea,pharmacokinetic study|ankylosing spondylitis,rheumatoid arthritis,adenomatous polyposis coli,osteoarthritis,dysmenorrhoea,pharmacokinetic study
5621572|NCT00813228|Immune Function|immune function
5621573|NCT00813228|DDP-4|ddp-4
5621574|NCT00813228|Sitagliptin|sitagliptin
5621575|NCT00813228|GLP-1|glp-1
5621576|NCT00813228|TGF Beta|tgf beta
5621577|NCT00813215|Type 2 diabetes mellitus|type 2 diabetes mellitus
5621578|NCT00813215|Postprandial dysmetabolism|postprandial dysmetabolism
5621579|NCT00813215|Postprandial inflammation|postprandial inflammation
5621580|NCT00813215|Relatives|relatives
5621581|NCT00813215|Meal challenge|meal challenge
5621582|NCT00813202|Nesiritide|nesiritide
5621583|NCT00813202|Natrecor|natrecor
5621584|NCT00813202|Quanke|quanke
5621585|NCT00813202|Acute Decompensated Heart Failure|acute decompensated heart failure
5621586|NCT00813189|glucocorticoid therapy|glucocorticoid therapy
5621587|NCT00813189|muscle function|muscle function
5621588|NCT00813189|growth hormone treatment|growth hormone treatment
5621589|NCT00813176|Obesity|obesity
5621590|NCT00813176|One-Lung Ventilation|one-lung ventilation
5621591|NCT00813176|Anesthesia|anesthesia
5621592|NCT00813176|Thoracic|thoracic
5621593|NCT00813176|One-lung ventilation in the morbidly obese patient|one-lung ventilation in the morbidly obese patient
5621594|NCT00813163|Phase II study|phase ii study
5621595|NCT00813163|Second line|second line
5621596|NCT00813163|Pancreatic cancer|pancreatic cancer
5621597|NCT00813163|Metastatic|metastatic
5621598|NCT00813150|Multiple myeloma|multiple myeloma
5621599|NCT00813150|Bortezomib|bortezomib
5621600|NCT00813150|Dexamethasone|dexamethasone
5621601|NCT00813150|Cyclophosphamide|cyclophosphamide
5621602|NCT00813150|Oncology|oncology
5621603|NCT00813137|Colorectal Cancer|colorectal cancer
5621604|NCT00813137|chemotherapy|chemotherapy
5621605|NCT00813137|recombinant human endostatin|recombinant human endostatin
5621606|NCT00813124|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5621608|NCT00813124|Donor stem cell transplant|donor stem cell transplant
5621609|NCT00813124|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5621610|NCT00813124|Stem cell transplant|stem cell transplant
5621611|NCT00813124|ATG|atg
5621612|NCT00813124|Antithymocyte globulin|antithymocyte globulin
5621613|NCT00813124|Vidaza|vidaza
5621614|NCT00813124|Azacitidine|azacitidine
5621615|NCT00813124|5-Azacitidine|5-azacitidine
5621616|NCT00813124|5-Aza|5-aza
5621617|NCT00813124|5-AZC|5-azc
5621618|NCT00813124|Ladakamycin|ladakamycin
5621619|NCT00813124|NSC-102816|nsc-102816
5621620|NCT00813124|allotx|allotx
5621621|NCT00813124|Busulfan|busulfan
5621622|NCT00813124|Busulfex|busulfex
5621623|NCT00813124|Myleran|myleran
5621624|NCT00813124|Fludarabine|fludarabine
5621625|NCT00813124|Fludarabine Phosphate|fludarabine phosphate
5621626|NCT00813124|Tacrolimus|tacrolimus
5621627|NCT00813124|Methotrexate|methotrexate
5621628|NCT00813124|Azacitidine maintenance therapy|azacitidine maintenance therapy
5621629|NCT00813124|molecular remission|molecular remission
5621630|NCT00813124|HLA compatible donor|hla compatible donor
5621631|NCT00813124|Engraftment|engraftment
5621632|NCT00813124|Chimerism|chimerism
5621633|NCT00813124|Graft vs host disease|graft vs host disease
5621634|NCT00813124|GVHD|gvhd
5621635|NCT00813111|Postsurgical pain|postsurgical pain
5621636|NCT00813111|Analgesia|analgesia
5621637|NCT00813111|Breast augmentation|breast augmentation
5621638|NCT00813085|Diabetes|diabetes
5621639|NCT00813085|Computerized clinical decision support|computerized clinical decision support
5621640|NCT00813085|shared care|shared care
5621641|NCT00813085|patient self-monitoring|patient self-monitoring
5621642|NCT00813085|quality of care|quality of care
5621643|NCT00813085|complex interventions|complex interventions
5621644|NCT00813085|composite outcomes|composite outcomes
5621645|NCT00813072|Gastric Cancer|gastric cancer
5621646|NCT00813072|Stomach Cancer|stomach cancer
5621647|NCT00813072|Gastroesophageal|gastroesophageal
5621648|NCT00813072|Gastroesophageal Junction|gastroesophageal junction
5621649|NCT00813072|Esophageal Cancer|esophageal cancer
5621650|NCT00813072|phase II|phase ii
5621651|NCT00813072|PEP02|pep02
5621652|NCT00813072|randomization|randomization
5621653|NCT00813072|randomisation|randomisation
5621654|NCT00813072|adenocarcinoma|adenocarcinoma
5621655|NCT00813072|locally advanced|locally advanced
5621656|NCT00813072|metastatic|metastatic
5621657|NCT00813072|simon's two|simon's two
5621658|NCT00813059|NAION|naion
5621659|NCT00813059|bevacizumab|bevacizumab
5615623|NCT00835302|Cervical|cervical
5621660|NCT00813033|create a patient decision aid for endoscopy|create a patient decision aid for endoscopy
5621661|NCT00813033|evaluate efficacy of a patient decision aid for endoscopy|evaluate efficacy of a patient decision aid for endoscopy
5621662|NCT00813007|Cervical Cancer|cervical cancer
5621664|NCT00813007|Questionnaire|questionnaire
5621665|NCT00813007|Adenocarcinoma of uterine cervix|adenocarcinoma of uterine cervix
5621666|NCT00813007|Squamous cell carcinoma of uterine cervix|squamous cell carcinoma of uterine cervix
5621667|NCT00813007|Adenosquamous carcinoma of uterine cervix|adenosquamous carcinoma of uterine cervix
5621668|NCT00813007|Abdominal radical trachelectomy|abdominal radical trachelectomy
5621669|NCT00813007|Trachelectomy|trachelectomy
5621670|NCT00813007|Quality of life|quality of life
5621671|NCT00813007|Sexual functioning|sexual functioning
5621672|NCT00812994|Depression|depression
5621673|NCT00812994|BDNF|bdnf
5621674|NCT00812994|neurotrophic factor|neurotrophic factor
5621675|NCT00812994|neurosetroid|neurosetroid
5621676|NCT00812994|allopregnanolone|allopregnanolone
5621677|NCT00812981|Pandemic influenza|pandemic influenza
5621678|NCT00812968|Myelodysplastic Syndromes|myelodysplastic syndromes
5621679|NCT00812968|Lenalidomide|lenalidomide
5621680|NCT00812955|Dyslipidemia|dyslipidemia
5621681|NCT00812955|Hypercholesterolemia|hypercholesterolemia
5621682|NCT00812955|Hypertriglyceridemia|hypertriglyceridemia
5621683|NCT00812942|average-risk subjects for|average-risk subjects for
5621684|NCT00812929|Asthma, Exercise Induced Asthma, Exercise Induced Bronchospasm|asthma, exercise induced asthma, exercise induced bronchospasm
5621685|NCT00812916|Persistent or longstanding persistent atrial fibrillation|persistent or longstanding persistent atrial fibrillation
5621686|NCT00812903|Neck|neck
5621687|NCT00812903|Pain|pain
5621688|NCT00812903|Exercise|exercise
5621689|NCT00812903|Pilots|pilots
5621690|NCT00812903|Crew|crew
5621691|NCT00812877|pulp capping|pulp capping
5621692|NCT00812877|MTA|mta
5621693|NCT00812877|CaOH|caoh
5621694|NCT00812877|Mineral Trioxide Aggregate|mineral trioxide aggregate
5621695|NCT00812877|Calcium Hydroxide|calcium hydroxide
5621696|NCT00812864|Capecitabine|capecitabine
5621697|NCT00812864|pharmacocinetics|pharmacocinetics
5621698|NCT00812864|Breast metastatic cancer|breast metastatic cancer
5621699|NCT00812864|colorectal metastatic cancer|colorectal metastatic cancer
5621700|NCT00812864|Elderly patients|elderly patients
5621701|NCT00812851|ALS|als
5621702|NCT00812851|cramps|cramps
5621703|NCT00812851|THC|thc
5621704|NCT00812851|Dronabinol|dronabinol
5621705|NCT00812825|Safety Tolerability Pharmacokinetics/pharmacodynamics|safety tolerability pharmacokinetics/pharmacodynamics
5621706|NCT00812812|paroxetine|paroxetine
5621900|NCT00811954|Treatment inexperienced|treatment inexperienced
5672490|NCT00611702|Luminex|luminex
5621707|NCT00812812|selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5621708|NCT00812812|CDRS-R|cdrs-r
5621709|NCT00812812|children and adolescents|children and adolescents
5621710|NCT00812799|randomised|randomised
5621711|NCT00812799|double-blind|double-blind
5621712|NCT00812799|placebo-controlled|placebo-controlled
5621713|NCT00812799|efficacy and safety|efficacy and safety
5621714|NCT00812799|Oralgen® Grass Pollen|oralgen® grass pollen
5621715|NCT00812799|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5621716|NCT00812799|allergy|allergy
5621717|NCT00812799|rhinoconjunctivitis|rhinoconjunctivitis
5621718|NCT00812799|immunotherapy|immunotherapy
5621719|NCT00812799|grass pollen extract|grass pollen extract
5621720|NCT00812786|heart transplantation|heart transplantation
5621721|NCT00812786|immunosuppressive drugs|immunosuppressive drugs
5621722|NCT00812786|individual dose adjustment|individual dose adjustment
5621723|NCT00812786|harmacokinetics|harmacokinetics
5621724|NCT00812786|modelling|modelling
5621725|NCT00812773|GSK2190915|gsk2190915
5621726|NCT00812773|Repeat|repeat
5621727|NCT00812773|Oral|oral
5621728|NCT00812773|Dose|dose
5621729|NCT00812773|Challenge|challenge
5621730|NCT00812773|Asthma|asthma
5621731|NCT00812773|Allergen|allergen
5621732|NCT00812760|Electroretinography|electroretinography
5621733|NCT00812760|levodopa|levodopa
5621734|NCT00812747|surgical wound infection|surgical wound infection
5621735|NCT00812747|risk factor|risk factor
5621736|NCT00812734|Neuropathic pain|neuropathic pain
5621737|NCT00812734|chronic pain|chronic pain
5621738|NCT00812734|postoperative|postoperative
5621739|NCT00812734|surgery|surgery
5621740|NCT00812734|anesthesiology|anesthesiology
5621741|NCT00812734|Scheduled surgery|scheduled surgery
5621742|NCT00812721|higher order aberrations|higher order aberrations
5621743|NCT00812721|tear blur|tear blur
5621744|NCT00812708|aniridia|aniridia
5621745|NCT00812708|Morcher iris diaphragms|morcher iris diaphragms
5621746|NCT00812708|modified capsule tension ring|modified capsule tension ring
5621747|NCT00812708|artificial iris|artificial iris
5621748|NCT00812708|iris reconstruction lens|iris reconstruction lens
5621749|NCT00812708|glare sensitivity|glare sensitivity
5621751|NCT00812695|Obstructive sleep apnea|obstructive sleep apnea
5621752|NCT00812695|Refractory hypertension|refractory hypertension
5621753|NCT00812695|Heart remodeling|heart remodeling
5621755|NCT00812695|CPAP|cpap
5621756|NCT00812682|SYMBICORT AMD|symbicort amd
5621757|NCT00812669|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5621758|NCT00812669|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5621759|NCT00812669|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5621760|NCT00812669|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5621761|NCT00812669|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5621762|NCT00812669|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5621763|NCT00812643|pharmacokinetics|pharmacokinetics
5621764|NCT00812630|male hormonal contraception|male hormonal contraception
5621765|NCT00812630|Blood pressure, sperm concentration|blood pressure, sperm concentration
5621766|NCT00812578|Type 2 diabetes|type 2 diabetes
5621767|NCT00812578|Vitamin D insufficiency|vitamin d insufficiency
5621768|NCT00812578|Insulin secretion|insulin secretion
5621769|NCT00812578|Insulin sensitivity|insulin sensitivity
5621770|NCT00812578|Pulsatility|pulsatility
5621771|NCT00812539|Diabetes|diabetes
5621772|NCT00812539|Blood glucose monitoring|blood glucose monitoring
5621773|NCT00812539|Internet|internet
5621774|NCT00812526|Choroid|choroid
5621775|NCT00812526|Regional blood flow|regional blood flow
5621776|NCT00812526|Autoregulation|autoregulation
5621777|NCT00812526|Laser Doppler flowmetry|laser doppler flowmetry
5621778|NCT00812513|rhPDGF-BB|rhpdgf-bb
5621779|NCT00812513|Platelet derived growth factor|platelet derived growth factor
5621780|NCT00812513|Burns|burns
5621781|NCT00812513|Thermal burns|thermal burns
5621782|NCT00812513|Electric burns|electric burns
5621783|NCT00812500|assess the effect of age on the EAR and RDA for protein|assess the effect of age on the ear and rda for protein
5621784|NCT00812487|congestive heart failure|congestive heart failure
5621785|NCT00812487|diabetes mellitus|diabetes mellitus
5621786|NCT00812487|hyperglycemia|hyperglycemia
5621787|NCT00812474|cerebral blood flow|cerebral blood flow
5621788|NCT00812461|Pharmacologic Actions|pharmacologic actions
5621789|NCT00812461|Alcohol-Related Disorders|alcohol-related disorders
5621790|NCT00812461|Alcoholism|alcoholism
5621791|NCT00812461|Mental Disorders|mental disorders
5621792|NCT00812461|Central Nervous System Agents|central nervous system agents
5621793|NCT00812448|prophylaxis|prophylaxis
5621794|NCT00812448|influenza infection|influenza infection
5621795|NCT00812448|catechins|catechins
5621796|NCT00812448|prophylaxis of influenza infection|prophylaxis of influenza infection
5621797|NCT00812435|STEMI|stemi
5621798|NCT00812435|Patients|patients
5621799|NCT00812435|male or female|male or female
5621800|NCT00812435|greater than 18 years of age|greater than 18 years of age
5621801|NCT00812435|presenting with ST elevation myocardial infarction|presenting with st elevation myocardial infarction
5621802|NCT00812422|Fever due to acute upper respiratory tract infection|fever due to acute upper respiratory tract infection
5621803|NCT00812409|Measuring markers of metabolic syndrome in overweight and obese adults.|measuring markers of metabolic syndrome in overweight and obese adults.
5621804|NCT00812396|Biomarkers of muscle anabolism|biomarkers of muscle anabolism
5621805|NCT00812370|DVT|dvt
5621806|NCT00812370|Deep Venous Thrombosis|deep venous thrombosis
5621807|NCT00812370|UNBLOCK|unblock
5621808|NCT00812370|Bivalirudin|bivalirudin
5621809|NCT00812370|Angiomax|angiomax
5621810|NCT00812357|Symbicort Turbuhaler|symbicort turbuhaler
5621811|NCT00812357|asthma|asthma
5621812|NCT00812357|cohort study|cohort study
5621813|NCT00812357|France|france
5621814|NCT00812344|pharmacokinetics|pharmacokinetics
5621815|NCT00812331|Hepatitis C|hepatitis c
5621816|NCT00812331|TMC435|tmc435
5621817|NCT00812318|HIV infected subjects|hiv infected subjects
5621818|NCT00812318|Healthy volunteer|healthy volunteer
5621819|NCT00812318|GSK1265744.|gsk1265744.
5621820|NCT00812292|TMC278|tmc278
5621821|NCT00812292|TMC278-C145|tmc278-c145
5621822|NCT00812292|TMC278-TiDP38-C145|tmc278-tidp38-c145
5621823|NCT00812292|concept pediatric formulations of TMC278|concept pediatric formulations of tmc278
5621824|NCT00812292|HIV Infections|hiv infections
5621825|NCT00812279|Smokers with acceptable health conditions|smokers with acceptable health conditions
5621826|NCT00812266|SCLC|sclc
5621827|NCT00812266|Extensive disease|extensive disease
5621828|NCT00812266|topotecan|topotecan
5621829|NCT00812253|Heart failure|heart failure
5621830|NCT00812253|Hyperglycemia|hyperglycemia
5621831|NCT00812253|Hospital|hospital
5621832|NCT00812253|Diabetes Mellitus|diabetes mellitus
5621833|NCT00812240|Gastro-Intestinal Stromal Tumor|gastro-intestinal stromal tumor
5621834|NCT00812240|GIST|gist
5621835|NCT00812240|metastatic|metastatic
5621836|NCT00812240|non resectable locally advanced|non resectable locally advanced
5621837|NCT00812227|Depression|depression
5621838|NCT00812227|Psychotherapy|psychotherapy
5621839|NCT00812227|Neuroimaging|neuroimaging
5621840|NCT00812227|Subjects with Major Depressive Disorder (MDD)|subjects with major depressive disorder (mdd)
5621843|NCT00812214|eszopiclone|eszopiclone
5621844|NCT00812214|insomnia in migraineurs|insomnia in migraineurs
5621845|NCT00812201|Heart failure|heart failure
5621846|NCT00812201|auto threshold|auto threshold
5621848|NCT00812201|CRT-P or CRT-D recipients, threshold measurements|crt-p or crt-d recipients, threshold measurements
5621849|NCT00812188|Morphea|morphea
5621850|NCT00812188|Plaque morphea|plaque morphea
5621851|NCT00812188|Localized Scleroderma|localized scleroderma
5621852|NCT00812175|Hepatocellular Carcinoma|hepatocellular carcinoma
5621853|NCT00812175|HCC|hcc
5621854|NCT00812175|Sorafenib|sorafenib
5621855|NCT00812149|Type-2 Deiodinase|type-2 deiodinase
5621856|NCT00812149|Genetic Polymorphism|genetic polymorphism
5621857|NCT00812149|Triiodothyronine (T3)|triiodothyronine (t3)
5621858|NCT00812149|Thyrotropin Releasing Hormone (TRH) Test|thyrotropin releasing hormone (trh) test
5621859|NCT00812136|Using Parent Mentors to Improve Asthma Care for Urban Minority Children|using parent mentors to improve asthma care for urban minority children
5621860|NCT00812123|kidney transplantation|kidney transplantation
5621861|NCT00812123|calcineurin inhibitor free|calcineurin inhibitor free
5621862|NCT00812123|protocol biopsy|protocol biopsy
5621863|NCT00812123|Cyclosporin A|cyclosporin a
5621864|NCT00812123|Sirolimus|sirolimus
5621865|NCT00812110|Influenza prevention|influenza prevention
5621866|NCT00812097|Breast Augmentation|breast augmentation
5621867|NCT00812097|Breast Reconstruction|breast reconstruction
5621868|NCT00812097|Breast Revision|breast revision
5621869|NCT00812097|Silicone gel|silicone gel
5621870|NCT00812097|Contour Profile Gel|contour profile gel
5621871|NCT00812097|Siltex®|siltex®
5621872|NCT00812084|Quality of life|quality of life
5621873|NCT00812084|health resources|health resources
5621874|NCT00812084|costs|costs
5621875|NCT00812084|community-acquired pneumonia|community-acquired pneumonia
5621876|NCT00812071|volunteers|volunteers
5621877|NCT00812058|Bipolar Depression|bipolar depression
5621878|NCT00812058|Bipolar Disease|bipolar disease
5621879|NCT00812058|Bipolar Disorder|bipolar disorder
5621880|NCT00812058|Bipolar|bipolar
5621881|NCT00812058|Manic Depression|manic depression
5621882|NCT00812058|Manic Depressive Disorder|manic depressive disorder
5621883|NCT00812045|Induced sputum|induced sputum
5621884|NCT00812045|cystic fibrosis|cystic fibrosis
5621885|NCT00812045|biomarker|biomarker
5621886|NCT00812045|CYBER|cyber
5621887|NCT00812032|NIDDM|niddm
5621888|NCT00812032|Aspirin|aspirin
5621889|NCT00812032|platelet inhibition|platelet inhibition
5621890|NCT00812032|Aspirin treatment|aspirin treatment
5621891|NCT00812019|H5N1 Influenza|h5n1 influenza
5621892|NCT00812019|Pandemic Flu|pandemic flu
5621893|NCT00812019|MF59 Adjuvant|mf59 adjuvant
5621894|NCT00812019|Cell Culture-Derived|cell culture-derived
5621896|NCT00812019|Immunogenicity|immunogenicity
5621897|NCT00812019|Vaccination|vaccination
5621898|NCT00812019|H5N1 influenza pandemic|h5n1 influenza pandemic
5621899|NCT00811954|Treatment naive|treatment naive
5621901|NCT00811941|Pharmacologic Actions|pharmacologic actions
5621902|NCT00811941|Alcohol-Related Disorders|alcohol-related disorders
5621903|NCT00811941|Alcoholism|alcoholism
5621904|NCT00811941|Mental Disorders|mental disorders
5621905|NCT00811941|Central Nervous System Agents|central nervous system agents
5621906|NCT00811928|high-risk leukopenic patients|high-risk leukopenic patients
5621907|NCT00811915|Sirolimus|sirolimus
5621908|NCT00811915|Tacrolimus|tacrolimus
5621909|NCT00811915|Kidney transplantation|kidney transplantation
5621910|NCT00811915|Kidney Transplant Recipients|kidney transplant recipients
5621911|NCT00811902|Multiple sclerosis|multiple sclerosis
5621912|NCT00811876|Prostate cancer|prostate cancer
5621913|NCT00811863|Nephrogenic Systemic Fibrosis|nephrogenic systemic fibrosis
5621914|NCT00811863|Renal Insufficiency|renal insufficiency
5621915|NCT00811863|Gadoversetamide|gadoversetamide
5621916|NCT00811863|OptiMARK|optimark
5621917|NCT00811863|Magnetic Resonance Imaging|magnetic resonance imaging
5621918|NCT00811837|Sunburn|sunburn
5621919|NCT00811837|Remifentanil|remifentanil
5621920|NCT00811837|Hyperalgesia|hyperalgesia
5621921|NCT00811824|Weight loss|weight loss
5621922|NCT00811824|Physical activity|physical activity
5621923|NCT00811824|Dietary change|dietary change
5621924|NCT00811811|Hypertension|hypertension
5621925|NCT00811811|Biofeedback|biofeedback
5621926|NCT00811811|Relaxation training|relaxation training
5621927|NCT00811798|Hong Kong|hong kong
5621928|NCT00811798|Human papillomavirus|human papillomavirus
5621929|NCT00811798|Safety|safety
5621930|NCT00811785|Copper Deficiency|copper deficiency
5621931|NCT00811785|Menkes Disease|menkes disease
5621932|NCT00811785|Neurodegeneration|neurodegeneration
5621933|NCT00811785|Occipital Horn Syndrome|occipital horn syndrome
5621934|NCT00811785|Copper|copper
5621935|NCT00811772|Randomized controlled trial|randomized controlled trial
5621936|NCT00811772|Bare metal stent|bare metal stent
5621937|NCT00811772|Drug eluting stent|drug eluting stent
5621938|NCT00811759|stage IV melanoma|stage iv melanoma
5621939|NCT00811759|stage III melanoma|stage iii melanoma
5621940|NCT00811759|recurrent melanoma|recurrent melanoma
5621941|NCT00811746|obstructive sleep apnea|obstructive sleep apnea
5621942|NCT00811746|eszopiclone|eszopiclone
5621943|NCT00811746|ramelteon|ramelteon
5621944|NCT00811746|polysomnography|polysomnography
5621945|NCT00811733|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5621946|NCT00811733|Ofatumumab|ofatumumab
5621947|NCT00811720|Alcohol-Related Disorders|alcohol-related disorders
5621948|NCT00811720|Alcoholism|alcoholism
5621949|NCT00811720|Mental Disorders|mental disorders
5621950|NCT00811720|Central Nervous System Agents|central nervous system agents
5621951|NCT00811707|ultrasound image|ultrasound image
5621952|NCT00811707|epidural space|epidural space
5621953|NCT00811694|glaucoma|glaucoma
5621954|NCT00811694|ficker stimulation|ficker stimulation
5621955|NCT00811694|ocular blood flow|ocular blood flow
5621956|NCT00811681|Friedreich's ataxia|friedreich's ataxia
5621957|NCT00811681|Pioglitazone|pioglitazone
5621958|NCT00811668|Sleep Apnea Syndromes|sleep apnea syndromes
5621959|NCT00811668|heart diseases|heart diseases
5621960|NCT00811655|tumors metastatic to brain|tumors metastatic to brain
5621961|NCT00811655|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5621962|NCT00811642|refractory or first line medication intolerable invasive fungal infection|refractory or first line medication intolerable invasive fungal infection
5621963|NCT00811629|Receptor for advanced glycation end products (RAGE)|receptor for advanced glycation end products (rage)
5621964|NCT00811629|Soluble RAGE (sRAGE)|soluble rage (srage)
5621965|NCT00811629|Acute Lung Injury (ALI)|acute lung injury (ali)
5621966|NCT00811629|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5621967|NCT00811629|Severe sepsis|severe sepsis
5621968|NCT00811629|Septic shock|septic shock
5621969|NCT00811629|Alveolar epithelium|alveolar epithelium
5621970|NCT00811629|Mechanical ventilation|mechanical ventilation
5621971|NCT00811629|Intensive Care Unit (ICU)|intensive care unit (icu)
5621972|NCT00811616|Coronary artery disease|coronary artery disease
5621973|NCT00811616|Supralimus-Core™|supralimus-core™
5621974|NCT00811616|de novo native coronary artery lesion|de novo native coronary artery lesion
5621975|NCT00811603|Antibiotic|antibiotic
5621976|NCT00811603|Prophylaxis|prophylaxis
5621977|NCT00811603|Cesarean|cesarean
5621978|NCT00811603|Infection|infection
5621979|NCT00811603|Antibiotic prophylaxis|antibiotic prophylaxis
5621980|NCT00811590|Cancer|cancer
5621981|NCT00811590|Polyps|polyps
5621982|NCT00811577|AZX100|azx100
5621983|NCT00811577|Patient and Observer Scar Assessment Scale|patient and observer scar assessment scale
5621984|NCT00811577|POSAS|posas
5621985|NCT00811577|Visual Analog Scale|visual analog scale
5621987|NCT00811577|Trocar|trocar
5621988|NCT00811577|Scarring|scarring
5621989|NCT00811577|Scar reduction|scar reduction
5621990|NCT00811577|Scar prevention|scar prevention
5621991|NCT00811551|Heart Failure|heart failure
5621992|NCT00811551|Impedance Monitoring|impedance monitoring
5621993|NCT00811551|Wedge Pressure|wedge pressure
5621994|NCT00811538|ischemic stroke|ischemic stroke
5621995|NCT00811538|endovascular treatment|endovascular treatment
5621996|NCT00811538|Thrombolysis|thrombolysis
5621997|NCT00811538|outcome|outcome
5621998|NCT00811525|Breast Augmentation|breast augmentation
5621999|NCT00811525|Breast Reconstruction|breast reconstruction
5622000|NCT00811525|Breast Revision|breast revision
5622001|NCT00811525|Silicone gel|silicone gel
5622002|NCT00811525|Contour Profile Gel|contour profile gel
5622003|NCT00811525|Siltex|siltex
5622004|NCT00811512|retina|retina
5622005|NCT00811512|fold|fold
5622006|NCT00811512|fovea|fovea
5622007|NCT00811473|Bipolar Depression|bipolar depression
5622008|NCT00811473|Depression|depression
5622009|NCT00811473|Children|children
5622010|NCT00811473|Adolescents|adolescents
5622011|NCT00811473|Seroquel|seroquel
5622012|NCT00811473|Bipolar Depression in Children and Adolescents|bipolar depression in children and adolescents
5622013|NCT00811434|encephalopathy|encephalopathy
5622014|NCT00811434|pediatric liver disease|pediatric liver disease
5622015|NCT00811434|pediatric cirrhosis|pediatric cirrhosis
5622016|NCT00811434|serum ammonia levels|serum ammonia levels
5622017|NCT00811421|Malaria|malaria
5622018|NCT00811421|Pregnancy|pregnancy
5622020|NCT00811421|Prevention|prevention
5622021|NCT00811421|Malaria prevention|malaria prevention
5622022|NCT00811408|human papilloma virus infection|human papilloma virus infection
5622023|NCT00811408|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5622024|NCT00811408|cervical adenocarcinoma|cervical adenocarcinoma
5622025|NCT00811408|stage IB cervical cancer|stage ib cervical cancer
5622026|NCT00811408|stage II cervical cancer|stage ii cervical cancer
5622027|NCT00811408|stage III cervical cancer|stage iii cervical cancer
5622028|NCT00811408|stage IVA cervical cancer|stage iva cervical cancer
5622029|NCT00811382|CRT|crt
5622030|NCT00811382|therapy of AF|therapy of af
5622031|NCT00811382|telecardiology|telecardiology
5622032|NCT00811382|home monitoring|home monitoring
5622033|NCT00811382|cardiovascular hospitalization|cardiovascular hospitalization
5622034|NCT00811382|cardiovascular mortality|cardiovascular mortality
5622035|NCT00811369|Breast Cancer|breast cancer
5622036|NCT00811369|Bone Metastases|bone metastases
5622037|NCT00811369|Telopeptide|telopeptide
5622038|NCT00811369|Zactima|zactima
5622039|NCT00811369|Fulvestrant|fulvestrant
5622040|NCT00811356|Food Effect|food effect
5622041|NCT00811356|Drug-Drug Interaction|drug-drug interaction
5622042|NCT00811356|Antimalarial|antimalarial
5622043|NCT00811356|First Time In Human|first time in human
5622044|NCT00811356|Single Dose|single dose
5622045|NCT00811356|Repeat Dose|repeat dose
5622046|NCT00811343|anti TNF Therapy|anti tnf therapy
5622047|NCT00811343|Tuberculosis|tuberculosis
5622048|NCT00811343|Tuberculin test|tuberculin test
5622050|NCT00811343|T-SPOT.TB|t-spot.tb
5622051|NCT00811343|Need anti TNF Therapy|need anti tnf therapy
5622052|NCT00811330|Left ventricular hypertrophy|left ventricular hypertrophy
5622053|NCT00811330|Aortic valve stenosis|aortic valve stenosis
5622054|NCT00811330|Aortic valve replacement|aortic valve replacement
5622055|NCT00811330|Cardiopulmonary bypass|cardiopulmonary bypass
5622056|NCT00811330|Statins|statins
5622057|NCT00811330|Myocardial preconditioning|myocardial preconditioning
5622058|NCT00811330|Left ventricular reverse remodeling|left ventricular reverse remodeling
5622059|NCT00811317|diabetes|diabetes
5622060|NCT00811317|glucose|glucose
5622061|NCT00811317|hyperglycemia|hyperglycemia
5622062|NCT00811317|hypoglycemia|hypoglycemia
5622063|NCT00811317|insulin|insulin
5622064|NCT00811317|glucagon|glucagon
5622065|NCT00811317|counter-regulation|counter-regulation
5622066|NCT00811317|closed-loop|closed-loop
5622067|NCT00811317|feedback|feedback
5622068|NCT00811317|control|control
5622069|NCT00811317|dual-infusion|dual-infusion
5622070|NCT00811317|subcutaneous|subcutaneous
5622071|NCT00811317|automated|automated
5622072|NCT00811317|artificial pancreas|artificial pancreas
5622073|NCT00811317|intensive insulin therapy|intensive insulin therapy
5622074|NCT00811304|ultrasound|ultrasound
5622075|NCT00811304|labor epidural|labor epidural
5622076|NCT00811304|failed epidural|failed epidural
5622077|NCT00811304|outcome|outcome
5622078|NCT00811304|Epidural insertion under realtime ultrasound guidance|epidural insertion under realtime ultrasound guidance
5622079|NCT00811291|B-vitamins|b-vitamins
5622080|NCT00811291|Folic-Acid|folic-acid
5622081|NCT00811291|kindergarten kids|kindergarten kids
5622082|NCT00811291|cognitive tests|cognitive tests
5622083|NCT00811291|Healthy kids|healthy kids
5622084|NCT00811291|second part low urine vitamine-B-metabolites|second part low urine vitamine-b-metabolites
5622085|NCT00811278|inhaled corticosteroids|inhaled corticosteroids
5622086|NCT00811265|ExAblate MRgFUS|exablate mrgfus
5622087|NCT00811265|Focused ultrasound|focused ultrasound
5622088|NCT00811265|Magnetic resonance imaging|magnetic resonance imaging
5622089|NCT00811265|Prostate cancer|prostate cancer
5622090|NCT00811265|Radical prostatectomy candidate|radical prostatectomy candidate
5622091|NCT00811252|Depression|depression
5622092|NCT00811252|Elderly|elderly
5622093|NCT00811252|Acute treatment|acute treatment
5622094|NCT00811239|antivenom|antivenom
5622095|NCT00811239|snake bite|snake bite
5622096|NCT00811239|Bungarus multicinctus|bungarus multicinctus
5622097|NCT00811239|Vietnam|vietnam
5622098|NCT00811226|Hypertension Stage I|hypertension stage i
5622099|NCT00811226|Hypertension Stage II|hypertension stage ii
5622100|NCT00811200|radiation|radiation
5622101|NCT00811200|retinopathy|retinopathy
5622102|NCT00811200|maculopathy|maculopathy
5622103|NCT00811200|choroidopathy|choroidopathy
5622105|NCT00811200|melanoma|melanoma
5622106|NCT00811200|lucentis|lucentis
5622107|NCT00811200|ranibizumab|ranibizumab
5622108|NCT00811200|kenalog|kenalog
5622109|NCT00811200|triamcinolone acetonide|triamcinolone acetonide
5622110|NCT00811200|radiation retinopathy after irradiation of uveal melanoma|radiation retinopathy after irradiation of uveal melanoma
5622111|NCT00811200|radiation maculopathy after irradiation of uveal melanoma|radiation maculopathy after irradiation of uveal melanoma
5603614|NCT00884065|Physiotherapy|physiotherapy
5603619|NCT00884039|cornea|cornea
5622112|NCT00811200|radiation choroidopathy after irradiation of uveal melanoma|radiation choroidopathy after irradiation of uveal melanoma
5622113|NCT00811187|Hysteroscopy|hysteroscopy
5622114|NCT00811187|Pain medication|pain medication
5622115|NCT00811187|Lidocaine|lidocaine
5622116|NCT00811187|Office Procedures|office procedures
5622117|NCT00811161|Remodeling|remodeling
5622118|NCT00811161|Airgent|airgent
5622119|NCT00811161|Hyaluronic acid|hyaluronic acid
5622120|NCT00811161|Collagen formation|collagen formation
5622121|NCT00811148|Brain Neoplasms|brain neoplasms
5622122|NCT00811148|Central Nervous System Diseases|central nervous system diseases
5622123|NCT00811148|Central Nervous System Neoplasms|central nervous system neoplasms
5622124|NCT00811148|Brain Diseases|brain diseases
5622125|NCT00811148|Nervous System Neoplasms|nervous system neoplasms
5622126|NCT00811122|Alzheimer's disease|alzheimer's disease
5622128|NCT00811122|Frontotemporal dementia|frontotemporal dementia
5622129|NCT00811122|FTD|ftd
5622130|NCT00811109|Acute Kidney Injury|acute kidney injury
5622131|NCT00811109|Critical care|critical care
5622132|NCT00811109|Hypotension|hypotension
5622133|NCT00811109|Renal replacement therapy|renal replacement therapy
5622134|NCT00811109|Efficacy|efficacy
5622135|NCT00811109|Tolerance|tolerance
5622136|NCT00811109|Outcome|outcome
5622137|NCT00811096|Malaria, Vivax/*drug therapy|malaria, vivax/*drug therapy
5622138|NCT00811096|Tinidazole/pharmacology/*therapeutic use|tinidazole/pharmacology/*therapeutic use
5622140|NCT00811096|Plasmodium vivax/*drug effects|plasmodium vivax/*drug effects
5622141|NCT00811083|autism|autism
5622142|NCT00811083|toxic metals|toxic metals
5622143|NCT00811083|DMSA|dmsa
5622144|NCT00811083|dimercaptosuccinic acid|dimercaptosuccinic acid
5622145|NCT00811083|chelation|chelation
5616110|NCT00832988|sensing|sensing
5622146|NCT00811070|CML. Chronic myelocytic leukemia. Philadelphia Chromosome. Japanese. SKI-606. Bosutinib. Imatinib resistant. Imatinib intolerant|cml. chronic myelocytic leukemia. philadelphia chromosome. japanese. ski-606. bosutinib. imatinib resistant. imatinib intolerant
5622147|NCT00811057|Preterm Labor in Pregnancy|preterm labor in pregnancy
5622148|NCT00811044|diabetes|diabetes
5622149|NCT00811044|genetics|genetics
5622150|NCT00811044|oral glucose tolerance testing|oral glucose tolerance testing
5622151|NCT00811044|family history of diabetes|family history of diabetes
5622152|NCT00811044|gestational diabetes|gestational diabetes
5622153|NCT00811031|Prostate|prostate
5622154|NCT00811031|prostate gland|prostate gland
5622155|NCT00811031|prostate cancer markers|prostate cancer markers
5622156|NCT00811031|Taxotere®|taxotere®
5622157|NCT00811031|Docetaxel|docetaxel
5622158|NCT00811031|Prednisone|prednisone
5622159|NCT00811031|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5622160|NCT00811031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5622161|NCT00811018|Open-label study|open-label study
5622162|NCT00811005|acitretin|acitretin
5622163|NCT00811005|fumaric acid ester|fumaric acid ester
5622164|NCT00811005|pustular palmoplantar psoriasis|pustular palmoplantar psoriasis
5622165|NCT00811005|PUVA|puva
5622166|NCT00810992|dietary, behavior|dietary, behavior
5622167|NCT00810992|IDF criteria|idf criteria
5622168|NCT00810992|coronary artery disease|coronary artery disease
5622169|NCT00810992|Traditional Tibetan Medicine|traditional tibetan medicine
5622170|NCT00810992|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the International Diabetes Federation (IDF)|coronary artery disease in patients, who have an increased cardiovascular risk profile according to the criteria by the international diabetes federation (idf)
5622171|NCT00810940|TBI|tbi
5622172|NCT00810940|closed head injury|closed head injury
5622173|NCT00810940|severe head trauma|severe head trauma
5622174|NCT00810940|traumatic brain injury|traumatic brain injury
5622175|NCT00810914|Patient controlled epidural anesthesia|patient controlled epidural anesthesia
5622176|NCT00810914|Pain control in labor|pain control in labor
5622177|NCT00810901|ethnic minority adolescents|ethnic minority adolescents
5622178|NCT00810901|designated organ donor|designated organ donor
5622179|NCT00810888|intracerebral hemorrhage|intracerebral hemorrhage
5622180|NCT00810888|ICH|ich
5622181|NCT00810888|computed tomography angiography|computed tomography angiography
5622182|NCT00810888|CTA|cta
5622183|NCT00810888|recombinant activated factor seven|recombinant activated factor seven
5622184|NCT00810888|rFVIIa|rfviia
5622185|NCT00810888|NovoSeven|novoseven
5622186|NCT00810888|recombinant activated factor VII|recombinant activated factor vii
5622187|NCT00810875|pregnancy|pregnancy
5622188|NCT00810875|immunity|immunity
5622190|NCT00810875|influenza vaccines|influenza vaccines
5672491|NCT00611702|Genomics|genomics
5622191|NCT00810875|disease transmission, vertical|disease transmission, vertical
5622192|NCT00810862|African American children|african american children
5622193|NCT00810849|Tuberculosis, pericardium|tuberculosis, pericardium
5622195|NCT00810823|gastric bypass|gastric bypass
5622196|NCT00810823|type 2 diabetes and gastric bypass|type 2 diabetes and gastric bypass
5622197|NCT00810810|Blood Component Transfusion|blood component transfusion
5622198|NCT00810810|Leukoreduction|leukoreduction
5622199|NCT00810810|HLA antibody|hla antibody
5622200|NCT00810810|Immunosuppression|immunosuppression
5622201|NCT00810797|recurrent breast cancer|recurrent breast cancer
5622202|NCT00810797|stage IV breast cancer|stage iv breast cancer
5622203|NCT00810784|Venous Thromboembolism|venous thromboembolism
5622204|NCT00810784|Prevention|prevention
5622205|NCT00810784|Quality Improvement|quality improvement
5622206|NCT00810784|Education|education
5622207|NCT00810784|Compliance with VTE prophylaxis|compliance with vte prophylaxis
5622208|NCT00810771|Hospitals, Veterans|hospitals, veterans
5622209|NCT00810771|Mass Screening/utilization|mass screening/utilization
5622210|NCT00810771|Patient Preference|patient preference
5622211|NCT00810771|Prevention & Control|prevention & control
5622212|NCT00810771|Epidemiology|epidemiology
5622213|NCT00810758|HCV|hcv
5622214|NCT00810758|Toll-like receptor 7|toll-like receptor 7
5622215|NCT00810758|Multiple oral dose escalation study of PF-04878691|multiple oral dose escalation study of pf-04878691
5622216|NCT00810745|ODS|ods
5622217|NCT00810745|stapled transanal rectal resection|stapled transanal rectal resection
5622218|NCT00810732|This study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.|this study is being conducted to evaluate sitaxsentan dosing in subjects with chronic kidney disease.
5622220|NCT00810719|recurrent pancreatic cancer|recurrent pancreatic cancer
5622221|NCT00810719|stage IV pancreatic cancer|stage iv pancreatic cancer
5622222|NCT00810706|Breast Cancer|breast cancer
5622223|NCT00810706|Aromatase inhibitors|aromatase inhibitors
5622224|NCT00810706|Exemestane|exemestane
5622225|NCT00810706|Tamoxifen|tamoxifen
5622226|NCT00810706|Lipids|lipids
5622227|NCT00810693|Pulmonary arterial hypertension|pulmonary arterial hypertension
5622229|NCT00810693|Stimulator|stimulator
5622230|NCT00810680|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5622231|NCT00810680|relapsed|relapsed
5622232|NCT00810680|refractory|refractory
5622233|NCT00810680|valproic acid|valproic acid
5622235|NCT00810667|Schizophrenia|schizophrenia
5622236|NCT00810667|Cognition|cognition
5622237|NCT00810667|BACS|bacs
5622238|NCT00810667|Risperidone|risperidone
5622239|NCT00810667|Augmentation therapy|augmentation therapy
5622240|NCT00810667|Add-on therapy|add-on therapy
5622241|NCT00810667|Lu AE58054|lu ae58054
5622242|NCT00810654|Celiac disease|celiac disease
5622243|NCT00810654|Coeliac disease|coeliac disease
5622244|NCT00810654|treatment|treatment
5622245|NCT00810654|AN-PEP|an-pep
5622246|NCT00810654|prolyl endoprotease|prolyl endoprotease
5622247|NCT00810654|gluten|gluten
5622248|NCT00810641|BPPV(benign paroxysmal positional vertigo)|bppv(benign paroxysmal positional vertigo)
5622249|NCT00810641|HC-BPPV(BPPV involving the horizontal semicircular canal)|hc-bppv(bppv involving the horizontal semicircular canal)
5622250|NCT00810641|Nystagmus|nystagmus
5622251|NCT00810641|Treatment outcome|treatment outcome
5622252|NCT00810641|Horizontal Canal Benign Paroxysmal Positional Vertigo|horizontal canal benign paroxysmal positional vertigo
5622253|NCT00810628|Parkinson's disease|parkinson's disease
5622254|NCT00810628|depression|depression
5622255|NCT00810628|Parkinson's disease with mild to moderate depression.|parkinson's disease with mild to moderate depression.
5622256|NCT00810615|chronic TBI|chronic tbi
5622257|NCT00810615|cognitive function|cognitive function
5622258|NCT00810615|PTSD|ptsd
5622259|NCT00810615|HBO|hbo
5622260|NCT00810615|hyperbaric|hyperbaric
5622261|NCT00810615|oxygen|oxygen
5622262|NCT00810615|chronic brain injury|chronic brain injury
5622263|NCT00810576|Relapsed T-Cell Non-Hodgkin's Lymphoma|relapsed t-cell non-hodgkin's lymphoma
5622264|NCT00810576|Refractory T-Cell Non-Hodgkin's Lymphoma|refractory t-cell non-hodgkin's lymphoma
5622265|NCT00810576|NHL|nhl
5622266|NCT00810576|T-cell NHL|t-cell nhl
5622267|NCT00810576|vorinostat|vorinostat
5622268|NCT00810576|SAHA|saha
5622269|NCT00810576|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5622270|NCT00810576|MSK-390|msk-390
5622271|NCT00810576|Zolinza|zolinza
5622272|NCT00810576|Bortezomib|bortezomib
5622273|NCT00810576|Velcade|velcade
5622274|NCT00810576|LDP-341|ldp-341
5622275|NCT00810576|MLN341|mln341
5622277|NCT00810576|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
5622278|NCT00810576|CD 30 + anaplastic large cell lymphoma|cd 30 + anaplastic large cell lymphoma
5622279|NCT00810576|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5622280|NCT00810576|Angiocentric/nasal type T/NK-cell lymphoma|angiocentric/nasal type t/nk-cell lymphoma
5622281|NCT00810576|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
5622282|NCT00810576|Hepatosplenic gamma delta T-cell lymphoma|hepatosplenic gamma delta t-cell lymphoma
5622376|NCT00810173|behavior change|behavior change
5809712|NCT00085865|PET|pet
5622283|NCT00810576|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
5622284|NCT00810576|Transformed Mycosis fungoides|transformed mycosis fungoides
5622285|NCT00810563|pain|pain
5622286|NCT00810563|tubal ligation|tubal ligation
5622287|NCT00810563|bupivacaine|bupivacaine
5622288|NCT00810563|laparoscopy|laparoscopy
5622289|NCT00810524|Chronic hepatitis B|chronic hepatitis b
5622290|NCT00810524|antiviral treatment|antiviral treatment
5622291|NCT00810524|long term prognosis|long term prognosis
5622292|NCT00810485|Gastroesophageal reflux|gastroesophageal reflux
5622293|NCT00810485|Proton pump inhibitor|proton pump inhibitor
5622294|NCT00810485|Heartburn|heartburn
5622295|NCT00810485|Regurgitation|regurgitation
5622296|NCT00810472|Penetrating keratoplasty|penetrating keratoplasty
5622297|NCT00810472|HLA matching|hla matching
5622298|NCT00810472|Corneal diseases that require penetrating keratoplasty|corneal diseases that require penetrating keratoplasty
5622299|NCT00810420|Hypoglycemia|hypoglycemia
5622300|NCT00810420|EEG|eeg
5622301|NCT00810420|type 1 diabetes|type 1 diabetes
5622302|NCT00810420|neuroglycopenia|neuroglycopenia
5622303|NCT00810420|Hypoglycemia is a potential dangerous condition|hypoglycemia is a potential dangerous condition
5622304|NCT00810420|EEG is changed during hypoglycemia|eeg is changed during hypoglycemia
5622305|NCT00810420|A hypoglycemia alarm based on EEG-measures may prevent development of severe hypoglycemia|a hypoglycemia alarm based on eeg-measures may prevent development of severe hypoglycemia
5622306|NCT00810394|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5622307|NCT00810381|Nitrovasodilators|nitrovasodilators
5622308|NCT00810381|ONH blood flow|onh blood flow
5622309|NCT00810381|Choroidal blood flow|choroidal blood flow
5622310|NCT00810381|Nitroglycerin|nitroglycerin
5622311|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate
5622312|NCT00810381|Sodium nitroprusside|sodium nitroprusside
5622313|NCT00810381|Laser-Doppler Flowmetry|laser-doppler flowmetry
5622314|NCT00810381|Regional Blood Flow|regional blood flow
5622315|NCT00810368|Carnosine|carnosine
5622316|NCT00810368|antioxidant|antioxidant
5622317|NCT00810368|Persian Gulf War|persian gulf war
5622318|NCT00810368|Gulf War Syndrome|gulf war syndrome
5622320|NCT00810368|Gulf War Illness|gulf war illness
5622321|NCT00810368|Exercise|exercise
5622322|NCT00810368|Chronic Fatigue|chronic fatigue
5622323|NCT00810368|Fibromyalgia|fibromyalgia
5622324|NCT00810368|Veterans|veterans
5622325|NCT00810368|Irritable Bowel Syndrome|irritable bowel syndrome
5622327|NCT00810368|Neuropathy|neuropathy
5622328|NCT00810368|Multiple Chemical Sensitivity|multiple chemical sensitivity
5622329|NCT00810355|Schizophrenia Spectrum Disorders|schizophrenia spectrum disorders
5622330|NCT00810355|Cognitive Behavior Therapy|cognitive behavior therapy
5622332|NCT00810342|physical activity standard|physical activity standard
5622333|NCT00810342|exercise|exercise
5622334|NCT00810329|CFS,FM,CSF,Proteomics,Pain,Fatigue,GWI,IBS,IC,MCS.|cfs,fm,csf,proteomics,pain,fatigue,gwi,ibs,ic,mcs.
5622335|NCT00810316|Alprazolam|alprazolam
5622336|NCT00810316|Alprazolam extended release|alprazolam extended release
5622337|NCT00810316|Clonazepam|clonazepam
5622338|NCT00810316|Pharmacokinetics|pharmacokinetics
5622339|NCT00810316|Mexican population|mexican population
5622340|NCT00810316|Healthy|healthy
5622341|NCT00810290|Metabolic syndrome|metabolic syndrome
5622342|NCT00810290|Latino health|latino health
5622343|NCT00810290|Community participatory research|community participatory research
5622344|NCT00810290|Translational Research|translational research
5622345|NCT00810264|Long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients|long-term safety and reliability of a bipolar left ventricular lead on congestive heart failure patients
5622346|NCT00810251|rib fracture|rib fracture
5622347|NCT00810251|flail chest|flail chest
5622348|NCT00810251|plate|plate
5622349|NCT00810251|chest trauma|chest trauma
5622350|NCT00810251|osteosynthesis|osteosynthesis
5622351|NCT00810251|mechanical ventilation|mechanical ventilation
5622352|NCT00810251|respirator|respirator
5622353|NCT00810238|Heart failure|heart failure
5622354|NCT00810238|Cell therapy|cell therapy
5622355|NCT00810225|CNDP1|cndp1
5622356|NCT00810225|carnosine dipeptidase 1|carnosine dipeptidase 1
5622357|NCT00810225|Persian Gulf War|persian gulf war
5622358|NCT00810225|Gulf War Syndrome|gulf war syndrome
5622359|NCT00810225|GWI|gwi
5622360|NCT00810225|Gulf War Illness|gulf war illness
5622361|NCT00810225|Exercise|exercise
5622362|NCT00810225|Chronic Fatigue|chronic fatigue
5622363|NCT00810225|Fibromyalgia|fibromyalgia
5622364|NCT00810225|Veterans|veterans
5622365|NCT00810225|Irritable Bowel Syndrome|irritable bowel syndrome
5622366|NCT00810225|Migraine headaches|migraine headaches
5622367|NCT00810225|Neuropathy|neuropathy
5622368|NCT00810225|Multiple Chemical Sensitivity|multiple chemical sensitivity
5622369|NCT00810212|Degenerative disc disease|degenerative disc disease
5622370|NCT00810212|Spondylolisthesis|spondylolisthesis
5622371|NCT00810212|Spinal stenosis|spinal stenosis
5622372|NCT00810212|Stem cell|stem cell
5622373|NCT00810212|Spinal Fusion|spinal fusion
5622374|NCT00810173|type 2 diabetes|type 2 diabetes
5622375|NCT00810173|physical activity|physical activity
5622377|NCT00810173|profile personality|profile personality
5622378|NCT00810173|phone call support|phone call support
5622379|NCT00810160|probiotic|probiotic
5622380|NCT00810160|prebiotic|prebiotic
5622381|NCT00810160|oligosaccharides|oligosaccharides
5622382|NCT00810160|GOS|gos
5622383|NCT00810160|galacto oligosaccharides|galacto oligosaccharides
5622384|NCT00810160|Bifidobacterium infantis|bifidobacterium infantis
5622385|NCT00810160|Bifidobacterium animalis|bifidobacterium animalis
5622386|NCT00810134|Superficial femoral artery occlusion (TASC II B or C)|superficial femoral artery occlusion (tasc ii b or c)
5622387|NCT00810108|HIV/AIDS|hiv/aids
5622388|NCT00810108|pediatrics|pediatrics
5622389|NCT00810108|resource-limited settings|resource-limited settings
5622390|NCT00810108|lopinavir|lopinavir
5622391|NCT00810108|ritonavir|ritonavir
5622392|NCT00810108|Kaletra®|kaletra®
5622393|NCT00810108|antiretroviral treatment|antiretroviral treatment
5622394|NCT00810108|crushed tablets|crushed tablets
5622395|NCT00810108|treatment experienced|treatment experienced
5622396|NCT00810095|Cerebral Infarction|cerebral infarction
5622397|NCT00810095|Stroke|stroke
5622398|NCT00810095|Vascular Diseases|vascular diseases
5622399|NCT00810095|Central Nervous System Diseases|central nervous system diseases
5622400|NCT00810095|Penumbra|penumbra
5622401|NCT00810095|Functional Outcome|functional outcome
5622402|NCT00810095|Aphasia|aphasia
5622403|NCT00810095|Hemiplegia|hemiplegia
5622404|NCT00810095|Left sided weakness|left sided weakness
5622405|NCT00810095|Right Sided weakness|right sided weakness
5622406|NCT00810069|Major Depressive Disorder|major depressive disorder
5622407|NCT00810069|MDD|mdd
5622408|NCT00810069|Depression|depression
5622411|NCT00810056|Mentoring|mentoring
5622412|NCT00810056|Skills groups|skills groups
5622413|NCT00810056|Assessment|assessment
5622414|NCT00810030|ferric carboxymaltose|ferric carboxymaltose
5622415|NCT00810030|iron sucrose|iron sucrose
5622416|NCT00810030|Iron-Deficiency Anemia|iron-deficiency anemia
5622417|NCT00810030|Crohn's Disease|crohn's disease
5622418|NCT00810030|Ulcerative Colitis|ulcerative colitis
5622419|NCT00810030|Ferritin|ferritin
5622420|NCT00810030|Transferrin|transferrin
5622421|NCT00810017|Her2 Positive|her2 positive
5622422|NCT00810017|Breast Cancer|breast cancer
5622423|NCT00810017|Metastatic|metastatic
5622424|NCT00809991|Prostate Cancer|prostate cancer
5622425|NCT00809965|Rivaroxaban|rivaroxaban
5622426|NCT00809965|Acute Coronary Syndrome|acute coronary syndrome
5622428|NCT00809965|Aspirin|aspirin
5622429|NCT00809965|Thienopyridine|thienopyridine
5622430|NCT00809965|Unstable Angina|unstable angina
5622431|NCT00809965|Myocardial Infarction|myocardial infarction
5622432|NCT00809965|Anticoagulation|anticoagulation
5622433|NCT00809965|Clopidogrel (Plavix)|clopidogrel (plavix)
5622434|NCT00809939|preterm delivery|preterm delivery
5622435|NCT00809939|short cervical length|short cervical length
5622436|NCT00809939|progesterone|progesterone
5622437|NCT00809926|Hypertension, aliskiren and valsartan|hypertension, aliskiren and valsartan
5622438|NCT00809913|Urinary Tract Infection|urinary tract infection
5622439|NCT00809913|Fever|fever
5622440|NCT00809913|Acute Pyelonephritis|acute pyelonephritis
5622441|NCT00809913|Treatment duration|treatment duration
5622442|NCT00809913|Febrile Urinary Tract Infection Treatment Duration|febrile urinary tract infection treatment duration
5622443|NCT00809887|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter|catheter fungal infections, antimicrobial lock therapy, micafungin, central venous catheter
5622444|NCT00809874|Postprandial Period|postprandial period
5622445|NCT00809874|Postprandial Lipaemia|postprandial lipaemia
5622446|NCT00809874|Incretins|incretins
5622447|NCT00809874|Subclinical Inflammation|subclinical inflammation
5622448|NCT00809874|Obesity|obesity
5622449|NCT00809874|Atherosclerosis|atherosclerosis
5622450|NCT00809874|Triglyceride|triglyceride
5622451|NCT00809874|Lipoproteins|lipoproteins
5622452|NCT00809835|Cocaine|cocaine
5622453|NCT00809835|Methadone|methadone
5622455|NCT00809822|IVIG in pemphigoid|ivig in pemphigoid
5622456|NCT00809822|Patients with bullous pemphigoid unresponsive to corticosteroids|patients with bullous pemphigoid unresponsive to corticosteroids
5622457|NCT00809809|Cold sores|cold sores
5622458|NCT00809809|Zinc|zinc
5622459|NCT00809809|HSL|hsl
5622460|NCT00809809|Herpes simple labialis|herpes simple labialis
5622461|NCT00809783|Tanezumab OA arthritis|tanezumab oa arthritis
5622463|NCT00809770|drug abuse|drug abuse
5622464|NCT00809770|schizophrenia|schizophrenia
5622465|NCT00809770|bipolar disorder|bipolar disorder
5622466|NCT00809770|major depressive disorder|major depressive disorder
5622467|NCT00809770|contingency management|contingency management
5622468|NCT00809770|psychosocial treatment|psychosocial treatment
5622469|NCT00809757|Asthma|asthma
5622470|NCT00809731|Schizophrenia remission status by 8-item PANSS|schizophrenia remission status by 8-item panss
5622471|NCT00809718|Raltegravir|raltegravir
5622472|NCT00809718|Pharmacokinetics|pharmacokinetics
5622473|NCT00809718|Rifapentine|rifapentine
5622474|NCT00809718|Drug Kinetics|drug kinetics
5622475|NCT00809692|histamine biotransformation|histamine biotransformation
5622476|NCT00809692|laser Doppler flowimetry|laser doppler flowimetry
5622477|NCT00809692|pediatric pharmacology|pediatric pharmacology
5622478|NCT00809679|Postherpetic neuralgia|postherpetic neuralgia
5622479|NCT00809679|Varicella Zoster|varicella zoster
5622480|NCT00809679|Shingles|shingles
5622481|NCT00809679|Neuropathic pain|neuropathic pain
5622482|NCT00809679|Analgesia|analgesia
5622483|NCT00809679|Pain|pain
5622484|NCT00809666|pregnancy|pregnancy
5622485|NCT00809666|hypertension|hypertension
5622486|NCT00809666|mercury sphygmomanometry|mercury sphygmomanometry
5622487|NCT00809666|blood pressure|blood pressure
5622488|NCT00809666|automated blood pressure|automated blood pressure
5622489|NCT00809666|pre eclampsia|pre eclampsia
5622490|NCT00809666|Hypertension in pregnancy|hypertension in pregnancy
5622491|NCT00809653|Air pollution|air pollution
5622492|NCT00809653|Face mask|face mask
5622493|NCT00809653|Myocardial ischaemia|myocardial ischaemia
5622494|NCT00809653|Heart rate variability|heart rate variability
5622495|NCT00809653|Angina pectoris|angina pectoris
5622496|NCT00809653|Coronary heart disease|coronary heart disease
5622497|NCT00809640|low back pain|low back pain
5622498|NCT00809640|prevention|prevention
5622499|NCT00809640|schoolchildren|schoolchildren
5622500|NCT00809640|education campaign|education campaign
5622501|NCT00809627|headache|headache
5622502|NCT00809627|caffeine|caffeine
5622503|NCT00809627|pain|pain
5622504|NCT00809614|Psoriatic arthritis|psoriatic arthritis
5622505|NCT00809614|IgG1K monoclonal antibody|igg1k monoclonal antibody
5622506|NCT00809614|Interleukin -17A neutralizing|interleukin -17a neutralizing
5622507|NCT00809588|vaccination|vaccination
5622508|NCT00809588|GM-CSF|gm-csf
5622509|NCT00809588|autologous|autologous
5622510|NCT00809588|irradiated|irradiated
5622511|NCT00809575|adult|adult
5622512|NCT00809575|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5622513|NCT00809575|Quality of life|quality of life
5622514|NCT00809575|Patient reported outcomes|patient reported outcomes
5622515|NCT00809549|Stroke|stroke
5622516|NCT00809549|GCSF|gcsf
5622517|NCT00809549|Hematopoeitic|hematopoeitic
5622518|NCT00809549|Neupogen|neupogen
5622519|NCT00809549|Filgrastim|filgrastim
5622520|NCT00809536|metformin, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|metformin, pd 0332334, organic cation transporter, oct2, pharmacokinetics
5622521|NCT00809523|SAD|sad
5622522|NCT00809523|winter depression|winter depression
5622523|NCT00809497|PLC for treatment of peripheral arterial diseases|plc for treatment of peripheral arterial diseases
5622524|NCT00809484|Arimidex|arimidex
5622525|NCT00809484|Bone Mineral density|bone mineral density
5622526|NCT00809484|Bisphosphonates|bisphosphonates
5622527|NCT00809484|Aromatase Inhibitors|aromatase inhibitors
5622528|NCT00809471|ED|ed
5622529|NCT00809471|Erectile Dysfunction|erectile dysfunction
5622530|NCT00809471|Dysfunction|dysfunction
5622531|NCT00809471|Diabetic|diabetic
5622532|NCT00809471|Erectile|erectile
5622533|NCT00809458|Vitamin E|vitamin e
5622534|NCT00809458|Prostate Cancer|prostate cancer
5622535|NCT00809458|Alpha-tocopherol (α-tocopherol)|alpha-tocopherol (α-tocopherol)
5622536|NCT00809432|Air pollution|air pollution
5622537|NCT00809432|Heart rate|heart rate
5622538|NCT00809432|Heart rate variability|heart rate variability
5622539|NCT00809432|Blood pressure|blood pressure
5622540|NCT00809432|Face mask|face mask
5622541|NCT00809419|Brachytherapy|brachytherapy
5622542|NCT00809419|EpiRad|epirad
5622543|NCT00809419|Macular Degeneration|macular degeneration
5622544|NCT00809419|Ranibizumab|ranibizumab
5622545|NCT00809393|Antifibrinolytic|antifibrinolytic
5622546|NCT00809393|Tranexamic acid|tranexamic acid
5622547|NCT00809393|Cardiopulmonary bypass|cardiopulmonary bypass
5622548|NCT00809393|Transfusion|transfusion
5622549|NCT00809393|Hemorrhage|hemorrhage
5622550|NCT00809380|Conscious sedation|conscious sedation
5622551|NCT00809380|Parental presence|parental presence
5622552|NCT00809380|Invasive procedure|invasive procedure
5622553|NCT00809380|Children|children
5622554|NCT00809380|Anxiety|anxiety
5622555|NCT00809367|MDS|mds
5622556|NCT00809367|AML|aml
5622557|NCT00809367|banking study|banking study
5622558|NCT00809354|monoclonal antibody|monoclonal antibody
5622559|NCT00809354|nerve growth factor (NGF)|nerve growth factor (ngf)
5622560|NCT00809354|anti-NGF|anti-ngf
5622561|NCT00809354|tanezumab|tanezumab
5622562|NCT00809354|PF-04383119|pf-04383119
5622563|NCT00809354|RN624|rn624
5622564|NCT00809354|osteoarthritis (OA)|osteoarthritis (oa)
5622565|NCT00809341|B-Cell|b-cell
5622566|NCT00809341|non-Hodgkin's|non-hodgkin's
5622567|NCT00809341|Lymphoma|lymphoma
5622568|NCT00809315|Child abuse and neglect|child abuse and neglect
5622569|NCT00809315|Out-of-home care|out-of-home care
5622570|NCT00809315|Mentoring|mentoring
5622571|NCT00809315|Skills groups|skills groups
5622572|NCT00809315|Assessment|assessment
5672492|NCT00611689|Refractory Malignancy|refractory malignancy
5622573|NCT00809315|Functioning as a result of maltreatment and placement in out-of-home care|functioning as a result of maltreatment and placement in out-of-home care
5622574|NCT00809289|Thorough QT/QTc study|thorough qt/qtc study
5622575|NCT00809276|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5622576|NCT00809276|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5622577|NCT00809276|Acute Leukemia|acute leukemia
5622578|NCT00809276|Refractory or Relapsed AML|refractory or relapsed aml
5622579|NCT00809276|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5622580|NCT00809276|Chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5622581|NCT00809276|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5622582|NCT00809276|Hodgkin's Lymphoma|hodgkin's lymphoma
5622583|NCT00809276|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5622584|NCT00809276|Philadelphia-negative myeloproliferative disorder|philadelphia-negative myeloproliferative disorder
5622585|NCT00809276|Hematologic Malignancies|hematologic malignancies
5622586|NCT00809276|Transplantation|transplantation
5622587|NCT00809276|Busulfan|busulfan
5622588|NCT00809276|Fludarabine|fludarabine
5622590|NCT00809276|Bone Marrow|bone marrow
5622591|NCT00809276|Allogeneic|allogeneic
5622592|NCT00809276|Related donor|related donor
5622593|NCT00809276|unrelated donor|unrelated donor
5622594|NCT00809263|homeopathy|homeopathy
5622595|NCT00809263|homeopathic drug proving|homeopathic drug proving
5622596|NCT00809263|Document symptoms associated with administration of a homeopathic remedy.|document symptoms associated with administration of a homeopathic remedy.
5622597|NCT00809250|vaccination|vaccination
5622598|NCT00809250|AML|aml
5622599|NCT00809250|CMML|cmml
5622600|NCT00809250|MDS-RAEB|mds-raeb
5622603|NCT00809237|Hydroxychloroquine|hydroxychloroquine
5622604|NCT00809224|ALS|als
5622605|NCT00809224|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5622606|NCT00809224|brain-computer interface|brain-computer interface
5622607|NCT00809224|functional magnetic resonance imaging|functional magnetic resonance imaging
5622608|NCT00809224|radiology|radiology
5622609|NCT00809224|fMRI|fmri
5622610|NCT00809211|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5622611|NCT00809211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5622612|NCT00809198|Sodium Hyaluronate, Kynex, Carboxymethylcellulose sodium|sodium hyaluronate, kynex, carboxymethylcellulose sodium
5622613|NCT00809198|Refresh Plus|refresh plus
5622614|NCT00809198|Dry Eye|dry eye
5622615|NCT00809198|Cornea Staining|cornea staining
5622616|NCT00809198|TBUT|tbut
5622617|NCT00809185|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5622618|NCT00809185|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5622619|NCT00809185|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5622620|NCT00809172|Atopic-dermatitis|atopic-dermatitis
5622621|NCT00809172|scorad|scorad
5622622|NCT00809172|methotrexate|methotrexate
5622623|NCT00809172|ciclosporin|ciclosporin
5622624|NCT00809159|ankylosing spondylitis|ankylosing spondylitis
5622625|NCT00809146|Status Epilepticus|status epilepticus
5622626|NCT00809146|Emergency Medical Services|emergency medical services
5622627|NCT00809146|Anticonvulsants|anticonvulsants
5622628|NCT00809146|Drug Administration Routes|drug administration routes
5622629|NCT00809146|Seizures|seizures
5622630|NCT00809120|Electrostimulation|electrostimulation
5622631|NCT00809120|COPD|copd
5622632|NCT00809120|Tolerance|tolerance
5622633|NCT00809120|Muscle fatigue|muscle fatigue
5622634|NCT00809120|Cardio-respiratory response|cardio-respiratory response
5622635|NCT00809107|natural cycle|natural cycle
5622636|NCT00809107|FET|fet
5622637|NCT00809107|spontaneous LH pic|spontaneous lh pic
5622638|NCT00809107|HCG|hcg
5622639|NCT00809081|periampullar carcinoma|periampullar carcinoma
5622640|NCT00809081|Pancreaticoduodenectomy|pancreaticoduodenectomy
5622641|NCT00809081|Enteral feeding|enteral feeding
5622642|NCT00809081|Total Parenteral Support|total parenteral support
5622643|NCT00809068|Menopause|menopause
5622644|NCT00809068|menopausal symptoms|menopausal symptoms
5622645|NCT00809068|tibolone|tibolone
5622646|NCT00809068|HDL-C|hdl-c
5622647|NCT00809068|fenofibrate|fenofibrate
5622648|NCT00809042|Hydroxyurea|hydroxyurea
5622649|NCT00809042|magnesium chloride|magnesium chloride
5622650|NCT00809042|L-carnitine|l-carnitine
5622651|NCT00809042|β-thalassemia intermedia|β-thalassemia intermedia
5622653|NCT00809029|OBESITY|obesity
5622654|NCT00809029|HSL|hsl
5622655|NCT00809029|LPL|lpl
5622656|NCT00809029|ADIPOCYTOKINES|adipocytokines
5622657|NCT00809029|BARIATRIC SURGERY|bariatric surgery
5622658|NCT00809016|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5622659|NCT00809016|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5622660|NCT00809016|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5622661|NCT00809016|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5622662|NCT00809016|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5622663|NCT00809016|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5622664|NCT00809016|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5622665|NCT00809016|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5622737|NCT00808873|follow up study|follow up study
5622666|NCT00809016|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5622667|NCT00809016|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5622668|NCT00809016|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5622669|NCT00809016|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5622670|NCT00809016|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5622671|NCT00809016|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5622672|NCT00809016|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5622673|NCT00809016|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5622674|NCT00809016|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5622675|NCT00809016|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5622676|NCT00809016|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5622677|NCT00809016|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5622678|NCT00809016|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5622679|NCT00809016|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5622680|NCT00809016|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5622681|NCT00809016|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5622682|NCT00809016|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5622683|NCT00809016|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5622684|NCT00809016|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5622685|NCT00809016|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5622686|NCT00809016|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5622687|NCT00809016|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5622688|NCT00809016|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5622689|NCT00809016|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5863985|NCT00001147|Monoamine Oxidase|monoamine oxidase
5622690|NCT00809016|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5622691|NCT00809016|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5622692|NCT00809016|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5622693|NCT00809016|recurrent salivary gland cancer|recurrent salivary gland cancer
5622694|NCT00809016|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5622695|NCT00809016|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5622696|NCT00809016|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5622697|NCT00809016|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5622698|NCT00809016|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5622699|NCT00809016|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5622700|NCT00809016|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5622701|NCT00809016|stage III salivary gland cancer|stage iii salivary gland cancer
5622702|NCT00809016|stage IV salivary gland cancer|stage iv salivary gland cancer
5622703|NCT00809003|Non dry eyed(normals)|non dry eyed(normals)
5622704|NCT00808990|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5622705|NCT00808990|Non Alcoholic SteatoHepatitis|non alcoholic steatohepatitis
5622706|NCT00808990|Small bowel bacterial overgrowth|small bowel bacterial overgrowth
5622707|NCT00808990|Probiotics|probiotics
5622708|NCT00808990|Patients with Non Alcoholic Fatty Liver Disease|patients with non alcoholic fatty liver disease
5622710|NCT00808964|anticoagulant|anticoagulant
5622711|NCT00808964|Off-Pump CABG|off-pump cabg
5622712|NCT00808951|Uncomplicated malaria|uncomplicated malaria
5622713|NCT00808951|P falciparum|p falciparum
5622714|NCT00808951|Children|children
5622715|NCT00808951|National treatment protocol|national treatment protocol
5622716|NCT00808951|Burkina Faso|burkina faso
5622717|NCT00808951|Artemether-lumefantrine|artemether-lumefantrine
5622718|NCT00808951|Artesunate-amodiaquine|artesunate-amodiaquine
5622719|NCT00808951|In vivo efficacy|in vivo efficacy
5622720|NCT00808951|In vitro efficacy|in vitro efficacy
5622721|NCT00808925|acclimation|acclimation
5622723|NCT00808925|cytokines|cytokines
5622724|NCT00808925|stress|stress
5622725|NCT00808925|inflammation|inflammation
5622726|NCT00808912|phosphodiesterase|phosphodiesterase
5622727|NCT00808912|sildenafil|sildenafil
5622728|NCT00808912|pulmonary hypertension|pulmonary hypertension
5622729|NCT00808912|exercise performance|exercise performance
5622730|NCT00808912|air pollution|air pollution
5622731|NCT00808899|Neuroblastoma|neuroblastoma
5622732|NCT00808886|cataract|cataract
5622733|NCT00808886|locs3|locs3
5622734|NCT00808886|pentacam|pentacam
5622735|NCT00808873|attempted suicide|attempted suicide
5622736|NCT00808873|socio-educational intervention|socio-educational intervention
5622738|NCT00808860|Herbal medicine|herbal medicine
5622739|NCT00808860|Type 2 diabetes|type 2 diabetes
5622740|NCT00808860|Gynostemma pentaphyllum Tea|gynostemma pentaphyllum tea
5622741|NCT00808860|Insulin sensitivity|insulin sensitivity
5622742|NCT00808860|add-on|add-on
5622743|NCT00808808|FluMist, TIV, vaccination rates|flumist, tiv, vaccination rates
5622744|NCT00808795|Acute kidney injury|acute kidney injury
5622745|NCT00808795|contrast-induced nephropathy|contrast-induced nephropathy
5622746|NCT00808795|Chronic kidney disease|chronic kidney disease
5622747|NCT00808795|Diabetes mellitus|diabetes mellitus
5622748|NCT00808795|N-acetylcysteine|n-acetylcysteine
5622749|NCT00808782|Pervasive Developmental Disorders|pervasive developmental disorders
5622750|NCT00808782|Asperger Syndrome|asperger syndrome
5622751|NCT00808782|Autism|autism
5622752|NCT00808756|Carbohydrates|carbohydrates
5622753|NCT00808756|Infant|infant
5622754|NCT00808756|Intestine|intestine
5622755|NCT00808756|Faeces|faeces
5622756|NCT00808756|Growth|growth
5622757|NCT00808756|Diet|diet
5622758|NCT00808743|Familial adenomatous polyposis|familial adenomatous polyposis
5622759|NCT00808743|Adenomatous Polyposis Coli|adenomatous polyposis coli
5622760|NCT00808743|Digestive System Neoplasms|digestive system neoplasms
5622761|NCT00808743|Gastrointestinal Disease|gastrointestinal disease
5622762|NCT00808743|Intestinal disease|intestinal disease
5622763|NCT00808743|Intestinal neoplasms|intestinal neoplasms
5622764|NCT00808743|Gastrointestinal neoplasms|gastrointestinal neoplasms
5622765|NCT00808743|Polyps|polyps
5622766|NCT00808743|Adenoma|adenoma
5622767|NCT00808743|Adenomatous Polyps|adenomatous polyps
5622768|NCT00808743|Neoplastic Syndromes, Hereditary|neoplastic syndromes, hereditary
5622769|NCT00808743|Digestive System Diseases|digestive system diseases
5622770|NCT00808743|Genetic Diseases, Inborn|genetic diseases, inborn
5622778|NCT00808717|Coronary Angioplasty|coronary angioplasty
5622779|NCT00808717|Myocardial infarction, Angioplasty, Transluminal, Percutaneous Coronary|myocardial infarction, angioplasty, transluminal, percutaneous coronary
5622781|NCT00808704|erythropoietin|erythropoietin
5622782|NCT00808704|neonates|neonates
5622783|NCT00808678|Adverse Events|adverse events
5622784|NCT00808665|Lumbar Fusion|lumbar fusion
5622785|NCT00808665|Inflammation|inflammation
5622786|NCT00808665|Dexmedetomidine|dexmedetomidine
5622787|NCT00808665|Length of Hospital Stay|length of hospital stay
5622789|NCT00808665|Anti-inflammatory|anti-inflammatory
5622790|NCT00808665|GPCR|gpcr
5622791|NCT00808665|Cytokine|cytokine
5622792|NCT00808665|Immune Response|immune response
5622793|NCT00808639|pegfilgrastim|pegfilgrastim
5622794|NCT00808639|MVAC|mvac
5622795|NCT00808600|lung transplantation|lung transplantation
5622796|NCT00808600|heart-lung transplantation|heart-lung transplantation
5622797|NCT00808600|rehabilitation|rehabilitation
5622798|NCT00808600|resource-activating training|resource-activating training
5622799|NCT00808600|anaerobic exercise training|anaerobic exercise training
5622800|NCT00808587|Genomic Scan|genomic scan
5622801|NCT00808587|Personalized Medicine|personalized medicine
5622802|NCT00808587|Gene testing|gene testing
5622803|NCT00808574|Obstructive sleep apnea|obstructive sleep apnea
5622804|NCT00808574|Internet|internet
5622805|NCT00808574|Screening|screening
5622806|NCT00808574|Health belief model|health belief model
5622807|NCT00808548|stress|stress
5622808|NCT00808548|carer's experiences|carer's experiences
5622809|NCT00808548|Prader-willi syndrome|prader-willi syndrome
5622810|NCT00808548|personal experiences|personal experiences
5622811|NCT00808535|Endothelial dysfunction|endothelial dysfunction
5622812|NCT00808535|Cardiac Perfusion MRI|cardiac perfusion mri
5622813|NCT00808535|Vasomotor Stress|vasomotor stress
5622814|NCT00808535|Cold Pressor Test|cold pressor test
5622815|NCT00808535|Adenosine Stress|adenosine stress
5622816|NCT00808522|Breast Cancer|breast cancer
5622817|NCT00808522|Chemoprevention|chemoprevention
5622818|NCT00808522|Tamoxifen|tamoxifen
5622819|NCT00808522|Breast density|breast density
5622821|NCT00808509|adalimumab,Remission,drug discontinuation|adalimumab,remission,drug discontinuation
5622822|NCT00808496|Magnetic resonance imaging|magnetic resonance imaging
5622823|NCT00808496|Radiography|radiography
5622824|NCT00808496|Randomized controlled trial|randomized controlled trial
5622825|NCT00808496|Antirheumatic agents|antirheumatic agents
5622826|NCT00808483|total hip arthroplasty|total hip arthroplasty
5622827|NCT00808483|physical functioning|physical functioning
5622828|NCT00808483|training program|training program
5622829|NCT00808483|self-efficacy|self-efficacy
5622830|NCT00808483|exercise therapy|exercise therapy
5622831|NCT00808483|walking|walking
5622832|NCT00808470|Noise|noise
5622833|NCT00808470|Hearing Loss|hearing loss
5622835|NCT00808470|Antioxidant|antioxidant
5622836|NCT00808470|Vasodilator|vasodilator
5622837|NCT00808470|Beta-Carotene|beta-carotene
5622838|NCT00808470|Vitamin C|vitamin c
5622839|NCT00808470|Vitamin E|vitamin e
5622840|NCT00808470|Magnesium|magnesium
5622841|NCT00808457|chest ultrasound|chest ultrasound
5622842|NCT00808457|pneumonia|pneumonia
5622843|NCT00808457|X-ray|x-ray
5622845|NCT00808457|Sensitivity and specificity of chest ultrasound in diagnosing pneumonia|sensitivity and specificity of chest ultrasound in diagnosing pneumonia
5622846|NCT00808444|Pneumococcal vaccine|pneumococcal vaccine
5622847|NCT00808444|Immunogenicity|immunogenicity
5622848|NCT00808444|Primary vaccination|primary vaccination
5622849|NCT00808444|Safety|safety
5622850|NCT00808444|Pneumococcal disease|pneumococcal disease
5622851|NCT00808431|Obesity|obesity
5622852|NCT00808431|Diabetes|diabetes
5622853|NCT00808431|Physical Activity|physical activity
5622854|NCT00808431|Child Feeding|child feeding
5622855|NCT00808431|Growth Trajectories|growth trajectories
5622856|NCT00808431|Family based|family based
5622857|NCT00808418|prostate|prostate
5622858|NCT00808418|cancer|cancer
5625361|NCT00798330|Cancer|cancer
5622859|NCT00808418|metastatic|metastatic
5622860|NCT00808418|castration|castration
5622861|NCT00808418|refractory|refractory
5622862|NCT00808418|elesclomol|elesclomol
5622863|NCT00808418|sodium|sodium
5622864|NCT00808418|docetaxel|docetaxel
5622865|NCT00808418|prednisone|prednisone
5622866|NCT00808405|herpes simplex virus|herpes simplex virus
5622867|NCT00808405|acyclovir|acyclovir
5622870|NCT00808405|Africa|africa
5622871|NCT00808392|vaccine|vaccine
5622872|NCT00808392|prevention|prevention
5622873|NCT00808392|haemophilus influenzae type b|haemophilus influenzae type b
5622874|NCT00808392|children|children
5622875|NCT00808379|Unresectable rectal cancers|unresectable rectal cancers
5622877|NCT00808327|Cesarean section|cesarean section
5622878|NCT00808327|Spinal|spinal
5622879|NCT00808314|Lexiscan(TM)|lexiscan(tm)
5622880|NCT00808314|Dipyridamole|dipyridamole
5622881|NCT00808314|Myocardial Perfusion|myocardial perfusion
5622882|NCT00808314|Positron Emission Computed Tomography|positron emission computed tomography
5622883|NCT00808301|Coeliac disease|coeliac disease
5622884|NCT00808301|Oat|oat
5622885|NCT00808288|COPD Respiratory Long acting beta agonist|copd respiratory long acting beta agonist
5622886|NCT00808275|dietary calcium|dietary calcium
5622887|NCT00808275|weight loss|weight loss
5622888|NCT00808262|anti-TNFa|anti-tnfa
5622889|NCT00808262|immunization|immunization
5622890|NCT00808262|kinoid|kinoid
5622892|NCT00808249|Generalized Anxiety Disorder|generalized anxiety disorder
5622894|NCT00808249|Anxiety|anxiety
5622895|NCT00808236|Cardiac Arrest|cardiac arrest
5622896|NCT00808236|Pre-hospital|pre-hospital
5622897|NCT00808236|Mild hypothermia|mild hypothermia
5622898|NCT00808236|Resuscitation|resuscitation
5622899|NCT00808223|alefacept|alefacept
5622900|NCT00808223|adolescent|adolescent
5622901|NCT00808223|psoriasis|psoriasis
5622902|NCT00808210|RA|ra
5622903|NCT00808210|Arthritis|arthritis
5622904|NCT00808197|AMD|amd
5622905|NCT00808197|choroidal blood flow|choroidal blood flow
5622906|NCT00808197|fellow eye in patients with unilateral choroidal neovascularisation|fellow eye in patients with unilateral choroidal neovascularisation
5622907|NCT00808184|Histologically or cytologically proven solid tumour for which CPT-11 given by the Folfiri regimen|histologically or cytologically proven solid tumour for which cpt-11 given by the folfiri regimen
5622908|NCT00808171|lumbar punction|lumbar punction
5622909|NCT00808171|myelogram|myelogram
5622910|NCT00808171|pain assessment|pain assessment
5622911|NCT00808171|nitrous oxide and EMLA|nitrous oxide and emla
5622912|NCT00808171|Leukemia and non Hodgkin lymphoma|leukemia and non hodgkin lymphoma
5622913|NCT00808145|Treatment of advanced liver cancer|treatment of advanced liver cancer
5622914|NCT00808132|Postmenopausal Women|postmenopausal women
5622915|NCT00808132|Bazedoxifene/Conjugated Estrogens|bazedoxifene/conjugated estrogens
5622916|NCT00808106|Oculocutaneous Albinism|oculocutaneous albinism
5622917|NCT00808093|Food Effect|food effect
5622918|NCT00808093|GSK256073F|gsk256073f
5622919|NCT00808093|TRIS Salt|tris salt
5622921|NCT00808054|Pain|pain
5622922|NCT00808054|preterm neonate|preterm neonate
5622923|NCT00808054|pain assessment|pain assessment
5622924|NCT00808054|EMLA|emla
5622925|NCT00808054|oral glucose|oral glucose
5622926|NCT00808041|Neoadjuvant Treatment|neoadjuvant treatment
5622927|NCT00808041|Therapy Response|therapy response
5622928|NCT00808041|Breast Computed Tomography|breast computed tomography
5622929|NCT00808015|Observational non-interventional trial|observational non-interventional trial
5622930|NCT00808002|Maraviroc|maraviroc
5622931|NCT00808002|CCR5 antagonists|ccr5 antagonists
5622932|NCT00808002|Primary HIV Infection|primary hiv infection
5622933|NCT00808002|HIV-1 reservoir|hiv-1 reservoir
5622934|NCT00808002|eradication|eradication
5622935|NCT00808002|treatment naive|treatment naive
5622936|NCT00807976|Diabetes mellitus|diabetes mellitus
5622937|NCT00807976|Elderly|elderly
5622938|NCT00807976|Orthostatic hypotension|orthostatic hypotension
5622939|NCT00807963|Pharmacokinetics|pharmacokinetics
5622940|NCT00807963|rHuPH20|rhuph20
5622941|NCT00807937|Generalized Anxiety Disorder|generalized anxiety disorder
5622942|NCT00807937|GAD|gad
5622943|NCT00807937|Anxiety|anxiety
5622944|NCT00807924|Fibroadenomas|fibroadenomas
5622945|NCT00807924|Papillomas|papillomas
5622946|NCT00807924|Breast|breast
5622947|NCT00807924|Minimally invasive|minimally invasive
5622948|NCT00807924|Interstitial laser therapy|interstitial laser therapy
5622949|NCT00807924|Laser ablation|laser ablation
5622950|NCT00807924|Benign|benign
5622951|NCT00807924|Non-cancerous|non-cancerous
5622952|NCT00807924|Breast lesion|breast lesion
5622953|NCT00807924|Breast tumor|breast tumor
5622954|NCT00807911|rectal cancer|rectal cancer
5622955|NCT00807911|adjuvant chemotherapy|adjuvant chemotherapy
5622956|NCT00807911|FOLFOX|folfox
5622957|NCT00807898|Gardasil|gardasil
5622958|NCT00807898|HPV vaccine|hpv vaccine
5622959|NCT00807898|decision making|decision making
5622960|NCT00807898|mother|mother
5622961|NCT00807898|daughter|daughter
5622962|NCT00807885|dehydration|dehydration
5622963|NCT00807885|fluid therapy|fluid therapy
5622964|NCT00807885|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5622965|NCT00807885|hyaluronidase|hyaluronidase
5622966|NCT00807885|hypodermoclysis|hypodermoclysis
5622967|NCT00807885|clysis|clysis
5622968|NCT00807885|subcutaneous hydration|subcutaneous hydration
5622969|NCT00807885|subcutaneous rehydration|subcutaneous rehydration
5622970|NCT00807885|hyaluronan|hyaluronan
5622972|NCT00807872|Radioimmunoimaging|radioimmunoimaging
5622973|NCT00807872|AL Amyloidosis|al amyloidosis
5622974|NCT00807872|PET/CT|pet/ct
5622975|NCT00807859|AMG 386|amg 386
5622976|NCT00807859|Paclitaxel|paclitaxel
5622977|NCT00807859|Trastuzumab|trastuzumab
5622978|NCT00807859|Capecitabine|capecitabine
5622979|NCT00807859|Lapatinib|lapatinib
5622980|NCT00807859|HER2-positive|her2-positive
5622981|NCT00807859|metastatic breast cancer|metastatic breast cancer
5622982|NCT00807859|locally recurrent breast cancer|locally recurrent breast cancer
5622983|NCT00807859|Taxol|taxol
5622984|NCT00807859|Herceptin|herceptin
5622985|NCT00807859|Xeloda|xeloda
5622986|NCT00807859|Tykerb|tykerb
5622987|NCT00807859|anti-angiogenic therapy|anti-angiogenic therapy
5622988|NCT00807846|Juvenile Arthritis; Juvenile Rheumatoid Arthritis;Blood Pressure;Juvenile Idiopathic Arthritis|juvenile arthritis; juvenile rheumatoid arthritis;blood pressure;juvenile idiopathic arthritis
5622989|NCT00807833|SAH|sah
5622990|NCT00807833|TBI|tbi
5622991|NCT00807820|Prostate Cancer|prostate cancer
5622992|NCT00807807|Plasma Homocysteine Concentration|plasma homocysteine concentration
5622993|NCT00807807|Folate|folate
5622994|NCT00807807|Homocysteine|homocysteine
5622995|NCT00807807|Supplements|supplements
5622996|NCT00807807|Folic Acid|folic acid
5622997|NCT00807755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5622998|NCT00807755|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5622999|NCT00807755|recurrent small cell lung cancer|recurrent small cell lung cancer
5623000|NCT00807742|Contingency management for smoking for substance abusers|contingency management for smoking for substance abusers
5623001|NCT00807742|Contingency reinforcement for smoking abstinence|contingency reinforcement for smoking abstinence
5623002|NCT00807742|Contingency Management|contingency management
5623003|NCT00807742|Noncontingent Reinforcement|noncontingent reinforcement
5623004|NCT00807729|Laparoscopy|laparoscopy
5623005|NCT00807729|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5623006|NCT00807729|Sphincterotomy|sphincterotomy
5623007|NCT00807729|Common bile duct stones|common bile duct stones
5623008|NCT00807729|Laparoscoopic common bile duct exploration|laparoscoopic common bile duct exploration
5623009|NCT00807729|Cost efficiency|cost efficiency
5623010|NCT00807729|Examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones|examination of efficacy, safety, cost of intervention for patients with choleclithiasis and likely common bile duct stones
5623011|NCT00807716|physiotherapy|physiotherapy
5623012|NCT00807716|functional outcome|functional outcome
5623013|NCT00807716|activity level|activity level
5623014|NCT00807716|self efficacy|self efficacy
5623015|NCT00807716|task oriented exercises|task oriented exercises
5623016|NCT00807703|Parkinson|parkinson
5623017|NCT00807703|deep brain stimulation (DBS)|deep brain stimulation (dbs)
5623018|NCT00807703|subthalamic nucleus (STN)|subthalamic nucleus (stn)
5623019|NCT00807703|Parkinson patients|parkinson patients
5623020|NCT00807690|vitiligo|vitiligo
5623021|NCT00807690|tacrolimus ointment 0.1%|tacrolimus ointment 0.1%
5623022|NCT00807690|narrowband UVB (TL01)|narrowband uvb (tl01)
5623023|NCT00807677|Chronic myelogenous leukemia (CML) in chronic phase, accelerated phase, or blast crisis|chronic myelogenous leukemia (cml) in chronic phase, accelerated phase, or blast crisis
5623024|NCT00807677|Intermediate or high risk myelodysplastic syndrome|intermediate or high risk myelodysplastic syndrome
5623025|NCT00807677|Philadelphia chromosome-negative CML (including blast phase)|philadelphia chromosome-negative cml (including blast phase)
5623026|NCT00807677|All subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia|all subtypes of myeloid metaplasia with myelofibrosis; advanced polycythemia
5623027|NCT00807651|Diabetes Mellitus|diabetes mellitus
5623028|NCT00807651|Stem cells|stem cells
5623029|NCT00807651|Autologous stem cell transplantation|autologous stem cell transplantation
5623030|NCT00807651|Autoimmune diseases|autoimmune diseases
5623031|NCT00807625|HIV/AIDS|hiv/aids
5623032|NCT00807625|Contraception|contraception
5623033|NCT00807625|Birth control|birth control
5623034|NCT00807625|CD4+|cd4+
5623035|NCT00807625|Viral Load|viral load
5623036|NCT00807625|T-cell activation|t-cell activation
5623037|NCT00807625|B-cell activation|b-cell activation
5623038|NCT00807625|Hormonal|hormonal
5623039|NCT00807625|Intrauterine device|intrauterine device
5623040|NCT00807625|Depo Provera|depo provera
5623041|NCT00807625|Women|women
5623042|NCT00807625|IUCD|iucd
5623043|NCT00807625|treatment naive|treatment naive
5623044|NCT00807612|AMG 479|amg 479
5623045|NCT00807612|IGF-1R|igf-1r
5604585|NCT00879944|BMI|bmi
5623046|NCT00807612|Apoptosis|apoptosis
5623047|NCT00807612|Monoclonal Antibody|monoclonal antibody
5623048|NCT00807612|Advanced Squamous Non-Small Cell Lung Cancer|advanced squamous non-small cell lung cancer
5623049|NCT00807612|antibody 1st-line|antibody 1st-line
5623050|NCT00807599|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5623051|NCT00807599|DEXAMETHASONE|dexamethasone
5623052|NCT00807599|G-CSF|g-csf
5623053|NCT00807599|Lenalidomide|lenalidomide
5623054|NCT00807599|MELPHALAN|melphalan
5623055|NCT00807599|PEG-FILGRASTIM (NEULASTA)|peg-filgrastim (neulasta)
5623056|NCT00807599|08-121|08-121
5623057|NCT00807586|Atrial Fibrillation|atrial fibrillation
5623058|NCT00807586|Corticosteroid|corticosteroid
5623059|NCT00807586|Radiofrequency catheter ablation for atrial fibrillation|radiofrequency catheter ablation for atrial fibrillation
5623060|NCT00807573|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5623061|NCT00807573|PEMETREXED (ALTIMA)|pemetrexed (altima)
5623062|NCT00807573|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5623063|NCT00807573|08-109|08-109
5623064|NCT00807560|Overweight|overweight
5623065|NCT00807560|Obesity|obesity
5623066|NCT00807560|Adolescents|adolescents
5623067|NCT00807560|Family Therapy|family therapy
5623068|NCT00807534|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5623069|NCT00807534|Exercise|exercise
5623070|NCT00807534|3-min constant rate stepping test|3-min constant rate stepping test
5623071|NCT00807534|3-min constant rate walking test|3-min constant rate walking test
5623072|NCT00807534|Bronchodilation|bronchodilation
5623073|NCT00807534|Ipratropium bromide|ipratropium bromide
5623074|NCT00807495|MLN8237|mln8237
5623075|NCT00807495|Alisertib|alisertib
5623076|NCT00807495|Drug therapy|drug therapy
5623078|NCT00807482|Mucociliary Clearance|mucociliary clearance
5623079|NCT00807482|Genetic Mutation|genetic mutation
5623080|NCT00807469|COPD|copd
5623081|NCT00807469|smoking|smoking
5623082|NCT00807469|susceptibility|susceptibility
5623083|NCT00807469|inflammation|inflammation
5623084|NCT00807469|genetic|genetic
5623085|NCT00807443|HIV-1|hiv-1
5623086|NCT00807443|integrase inhibitor (raltegravir)|integrase inhibitor (raltegravir)
5623087|NCT00807443|the cell reservoir of HIV-1|the cell reservoir of hiv-1
5623088|NCT00807443|treatment experienced|treatment experienced
5623089|NCT00807430|Bruxism|bruxism
5623091|NCT00807430|Biofeedback|biofeedback
5623092|NCT00807404|ductal intraepithelial neoplasia|ductal intraepithelial neoplasia
5623093|NCT00807391|lung cancer|lung cancer
5623094|NCT00807391|transbronchial biopsy|transbronchial biopsy
5623095|NCT00807391|transbronchial catheter aspiration|transbronchial catheter aspiration
5623096|NCT00807391|transbronchial needle aspiration|transbronchial needle aspiration
5623097|NCT00807391|peripheral pulmonary lesion|peripheral pulmonary lesion
5623098|NCT00807391|bronchoscopy|bronchoscopy
5623099|NCT00807378|CNS viral infection|cns viral infection
5623101|NCT00807378|HYBRIDIZATION|hybridization
5623102|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone
5623103|NCT00807365|Growth Hormone Insufficiency|growth hormone insufficiency
5623104|NCT00807365|Aging|aging
5623105|NCT00807365|Growth Hormone|growth hormone
5623106|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs
5623107|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5623108|NCT00807365|Hormones|hormones
5623109|NCT00807352|Triage|triage
5623110|NCT00807352|Pediatrics|pediatrics
5623111|NCT00807352|Emergency Department|emergency department
5623112|NCT00807339|CyberKnife|cyberknife
5623113|NCT00807326|Antidiarrheals|antidiarrheals
5623114|NCT00807313|Oligometastatic disease|oligometastatic disease
5623115|NCT00807313|Colorectal cancer|colorectal cancer
5623116|NCT00807313|Stereotactic body radiotherapy|stereotactic body radiotherapy
5623117|NCT00807313|Tomotherapy|tomotherapy
5623118|NCT00807313|Metabolic response|metabolic response
5623119|NCT00807313|Stage IV|stage iv
5623120|NCT00807300|percutaneous treatment|percutaneous treatment
5623121|NCT00807287|jejunal tube placement|jejunal tube placement
5623122|NCT00807274|Adult congenital heart disease|adult congenital heart disease
5623123|NCT00807274|Heart failure|heart failure
5623124|NCT00807274|Renal failure|renal failure
5623125|NCT00807274|Proteinuria|proteinuria
5623126|NCT00807235|Lucinactant|lucinactant
5623127|NCT00807235|Nasal continuous positive airway pressure (nCPAP)|nasal continuous positive airway pressure (ncpap)
5623128|NCT00807235|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
5623129|NCT00807235|Pediatric|pediatric
5623130|NCT00807235|Premature|premature
5623132|NCT00807222|Vyvanse|vyvanse
5623133|NCT00807222|lisdexamfetamine dimesylate|lisdexamfetamine dimesylate
5623134|NCT00807222|LDX|ldx
5623135|NCT00807222|sleep|sleep
5623136|NCT00807209|Pain|pain
5623137|NCT00807209|postoperative|postoperative
5623138|NCT00807209|thoracotomy|thoracotomy
5623139|NCT00807196|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5623140|NCT00807196|Zevalin|zevalin
5623141|NCT00807196|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5623142|NCT00807170|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5623143|NCT00807170|Whole Brain Radiotherapy|whole brain radiotherapy
5623144|NCT00807170|metastasis|metastasis
5623145|NCT00807157|PROBIOSTICK®|probiostick®
5623146|NCT00807157|Probiotic|probiotic
5623147|NCT00807157|Anxiety|anxiety
5623148|NCT00807157|Daily stress|daily stress
5623149|NCT00807144|Kidney transplant|kidney transplant
5623150|NCT00807144|Rejection|rejection
5623151|NCT00807144|Adherence|adherence
5623152|NCT00807144|Quality of life|quality of life
5623153|NCT00807131|pharmacy care|pharmacy care
5623154|NCT00807131|hypertension|hypertension
5623155|NCT00807131|primary care|primary care
5623156|NCT00807131|adherence|adherence
5623157|NCT00807118|bioequivalence, food effect|bioequivalence, food effect
5623158|NCT00807105|MOOD EVALUATION|mood evaluation
5623159|NCT00807079|recurrent cervical cancer|recurrent cervical cancer
5623160|NCT00807079|stage IVB cervical cancer|stage ivb cervical cancer
5623161|NCT00807079|stage IVA cervical cancer|stage iva cervical cancer
5623162|NCT00807079|cervical adenocarcinoma|cervical adenocarcinoma
5623163|NCT00807079|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5623164|NCT00807079|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5623165|NCT00807066|QUALITY OF LIFE|quality of life
5623166|NCT00807053|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5623167|NCT00807053|Ciclesonide|ciclesonide
5623169|NCT00807040|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5623170|NCT00807040|Mitral Valve Disease|mitral valve disease
5623171|NCT00807040|Severe Mitral Regurgitation|severe mitral regurgitation
5623172|NCT00807027|Glioblastoma|glioblastoma
5623173|NCT00807027|Newly diagnosed Glioblastoma|newly diagnosed glioblastoma
5623174|NCT00807014|Differin|differin
5623175|NCT00807014|quality of life|quality of life
5623176|NCT00807014|Acne|acne
5623177|NCT00807014|Duac|duac
5623178|NCT00807014|Acne Vulgaris|acne vulgaris
5623179|NCT00807001|Hepatitis C, HCV, treatment-naive|hepatitis c, hcv, treatment-naive
5623180|NCT00806988|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5623181|NCT00806988|Mitral Valve Regurgitation|mitral valve regurgitation
5623182|NCT00806910|Heart Failure|heart failure
5623183|NCT00806910|conivaptan|conivaptan
5623184|NCT00806910|Diuresis|diuresis
5623185|NCT00806884|Cystic Fibrosis|cystic fibrosis
5623186|NCT00806884|Musculoskeletal Physiotherapy|musculoskeletal physiotherapy
5623187|NCT00806884|Manual therapy|manual therapy
5623188|NCT00806884|Posture|posture
5623189|NCT00806884|Pain|pain
5623190|NCT00806845|HIV|hiv
5623191|NCT00806845|B-lymphocyte|b-lymphocyte
5623192|NCT00806832|Medical clowns|medical clowns
5623193|NCT00806832|Cataract surgery|cataract surgery
5623194|NCT00806832|Blood pressure|blood pressure
5623195|NCT00806832|Heart rate|heart rate
5623196|NCT00806806|pain management|pain management
5623197|NCT00806806|postoperative|postoperative
5623198|NCT00806780|gallstones|gallstones
5623199|NCT00806780|cholangiography|cholangiography
5623200|NCT00806767|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5623201|NCT00806767|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5623294|NCT00806741|Intraocular Pressure|intraocular pressure
5623202|NCT00806767|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5623203|NCT00806767|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5623204|NCT00806767|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5623205|NCT00806767|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5623206|NCT00806767|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5623207|NCT00806767|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5623208|NCT00806767|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5623209|NCT00806767|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5623210|NCT00806767|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5623211|NCT00806767|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5623212|NCT00806767|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5623213|NCT00806767|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5623214|NCT00806767|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5623366|NCT00806455|occurs in cystic fibrosis|occurs in cystic fibrosis
5623215|NCT00806767|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5623216|NCT00806767|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5623217|NCT00806767|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5623218|NCT00806767|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5623219|NCT00806767|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5623220|NCT00806767|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5623221|NCT00806767|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5623222|NCT00806767|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5623223|NCT00806767|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5623224|NCT00806767|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5623225|NCT00806767|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5623226|NCT00806767|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5623227|NCT00806767|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5623228|NCT00806767|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5623229|NCT00806767|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5623230|NCT00806767|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5623231|NCT00806767|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5623232|NCT00806767|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5623233|NCT00806767|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5623234|NCT00806767|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5623235|NCT00806767|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5623236|NCT00806767|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5623237|NCT00806767|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5623238|NCT00806767|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5623239|NCT00806767|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5623240|NCT00806767|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5623241|NCT00806767|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5623242|NCT00806767|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5623243|NCT00806767|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5623244|NCT00806767|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5623245|NCT00806767|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5863986|NCT00001147|Phenosulfotransferase|phenosulfotransferase
5623246|NCT00806767|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5623247|NCT00806767|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5623248|NCT00806767|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5623249|NCT00806767|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5623250|NCT00806767|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5623251|NCT00806767|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5623252|NCT00806767|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5623253|NCT00806767|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5623254|NCT00806767|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5623255|NCT00806767|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5623256|NCT00806767|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5623257|NCT00806767|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5623258|NCT00806767|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5623259|NCT00806767|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5623260|NCT00806767|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5623261|NCT00806767|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5623262|NCT00806767|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5623263|NCT00806767|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5623264|NCT00806767|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5623265|NCT00806767|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5623266|NCT00806767|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5623267|NCT00806767|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5623268|NCT00806767|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5623269|NCT00806767|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5623270|NCT00806767|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5623271|NCT00806767|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5623272|NCT00806767|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5623273|NCT00806767|refractory hairy cell leukemia|refractory hairy cell leukemia
5623274|NCT00806767|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5623275|NCT00806767|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5623276|NCT00806767|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5623277|NCT00806767|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5623278|NCT00806767|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5623279|NCT00806767|primary myelofibrosis|primary myelofibrosis
5623280|NCT00806767|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5623281|NCT00806767|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5623282|NCT00806767|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5623283|NCT00806767|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5623284|NCT00806767|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5604876|NCT00878735|stress|stress
5623285|NCT00806767|stage I multiple myeloma|stage i multiple myeloma
5623286|NCT00806767|stage II multiple myeloma|stage ii multiple myeloma
5623287|NCT00806767|stage III multiple myeloma|stage iii multiple myeloma
5623288|NCT00806767|refractory multiple myeloma|refractory multiple myeloma
5623289|NCT00806754|Perennial Allergic Rhinitis|perennial allergic rhinitis
5623292|NCT00806741|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5623293|NCT00806741|Optic Nerve Head blood flow|optic nerve head blood flow
5623295|NCT00806741|Regional blood flow|regional blood flow
5623296|NCT00806741|Ocular Physiology|ocular physiology
5623299|NCT00806715|Iron overload|iron overload
5623300|NCT00806715|Stem cell transplant|stem cell transplant
5623301|NCT00806715|Pediatrics|pediatrics
5623302|NCT00806715|Pediatric Stem cell transplant|pediatric stem cell transplant
5623303|NCT00806689|heart rhythm surveillance|heart rhythm surveillance
5623304|NCT00806689|follow-up|follow-up
5623305|NCT00806689|atrial fibrillation success|atrial fibrillation success
5623306|NCT00806676|chronic kidney disease|chronic kidney disease
5623307|NCT00806676|children|children
5623308|NCT00806676|dialysis|dialysis
5623309|NCT00806676|kidney transplant|kidney transplant
5623310|NCT00806676|human papilloma virus|human papilloma virus
5623311|NCT00806676|Gardasil|gardasil
5623312|NCT00806676|Chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.|chronic kidney disease (non-dialysis, dialysis, and kidney transplant) secondary to any cause.
5623313|NCT00806663|mCRC|mcrc
5623314|NCT00806663|colorectal cancer|colorectal cancer
5623315|NCT00806663|FOLFIRI|folfiri
5623316|NCT00806663|sunitinib|sunitinib
5623317|NCT00806663|DCE-MRI|dce-mri
5623318|NCT00806663|DCE-USI|dce-usi
5623319|NCT00806650|stage I renal cell cancer|stage i renal cell cancer
5623320|NCT00806650|stage II renal cell cancer|stage ii renal cell cancer
5623321|NCT00806650|stage III renal cell cancer|stage iii renal cell cancer
5623322|NCT00806650|stage IV renal cell cancer|stage iv renal cell cancer
5623323|NCT00806637|Vessel sealing system|vessel sealing system
5623325|NCT00806637|UPPP|uppp
5623326|NCT00806637|uvulopalatal flap|uvulopalatal flap
5623327|NCT00806637|bleeding|bleeding
5623328|NCT00806637|operative time|operative time
5623329|NCT00806637|adverse effects|adverse effects
5623330|NCT00806611|pancreatic cancer|pancreatic cancer
5623331|NCT00806611|periampullary cancer|periampullary cancer
5623332|NCT00806611|resectable|resectable
5623333|NCT00806611|unresectable|unresectable
5623334|NCT00806611|celiac plexus neurolysis|celiac plexus neurolysis
5623335|NCT00806611|surgery|surgery
5623336|NCT00806598|Myelodysplastic Syndrome|myelodysplastic syndrome
5623337|NCT00806598|Aplastic Anemia|aplastic anemia
5623338|NCT00806598|Thymoglobulin|thymoglobulin
5623339|NCT00806598|Cyclosporine|cyclosporine
5623340|NCT00806598|Methylprednisolone|methylprednisolone
5623341|NCT00806598|G-CSF|g-csf
5623342|NCT00806572|Diabetes, juvenile diabetes, teplizumab|diabetes, juvenile diabetes, teplizumab
5623343|NCT00806559|effects clinical space|effects clinical space
5623344|NCT00806559|follow-up appointments|follow-up appointments
5623345|NCT00806520|Continuous Glucose Monitoring|continuous glucose monitoring
5623346|NCT00806520|Exenatide Once Weekly or|exenatide once weekly or
5623347|NCT00806520|Januvia or|januvia or
5623348|NCT00806520|Actos|actos
5623349|NCT00806507|Tissue Doppler Imaging|tissue doppler imaging
5623350|NCT00806507|B-type natriuretic peptide|b-type natriuretic peptide
5623351|NCT00806507|Advia Centaur immunoassay system|advia centaur immunoassay system
5623352|NCT00806507|GE Vivid ultrasound machine|ge vivid ultrasound machine
5623353|NCT00806507|Roche 2010 system|roche 2010 system
5623354|NCT00806507|Echocardiography|echocardiography
5623355|NCT00806507|Herceptin|herceptin
5623356|NCT00806494|Fesoterodine|fesoterodine
5623357|NCT00806494|Open Label|open label
5623358|NCT00806494|Flexible Dose|flexible dose
5623359|NCT00806494|OAB|oab
5623360|NCT00806481|Phosphate|phosphate
5623361|NCT00806468|nycturia|nycturia
5623362|NCT00806468|Parkinson syndrome|parkinson syndrome
5623363|NCT00806468|desmopressin|desmopressin
5623364|NCT00806468|Nocturnal polyuria in patients with Parkinson syndrome|nocturnal polyuria in patients with parkinson syndrome
5623365|NCT00806455|to determine how often exercise-induced bronchospasm|to determine how often exercise-induced bronchospasm
5623367|NCT00806455|Exercise-induced bronchospasm in cystic fibrosis|exercise-induced bronchospasm in cystic fibrosis
5623368|NCT00806442|Asthma|asthma
5623369|NCT00806442|Fatty acids|fatty acids
5623370|NCT00806442|Leukotrienes|leukotrienes
5623371|NCT00806442|Diet|diet
5623372|NCT00806429|appendicitis|appendicitis
5623373|NCT00806429|surgery|surgery
5623374|NCT00806429|laparoscopy|laparoscopy
5623375|NCT00806429|natural orifice transluminal surgery|natural orifice transluminal surgery
5623376|NCT00806403|thrombolysis|thrombolysis
5623377|NCT00806403|primary PCI|primary pci
5623378|NCT00806403|abciximab|abciximab
5623379|NCT00806403|ST-segment resolution|st-segment resolution
5623380|NCT00806403|TIMI flow|timi flow
5623381|NCT00806390|ejection fraction|ejection fraction
5623382|NCT00806390|anthracyclines|anthracyclines
5623383|NCT00806390|beta-adrenergic blockade|beta-adrenergic blockade
5623384|NCT00806390|Patients receiving anthracyclines|patients receiving anthracyclines
5623385|NCT00806377|Electromagnetic field|electromagnetic field
5623386|NCT00806377|Oversensing|oversensing
5623388|NCT00806364|Skin|skin
5623390|NCT00806364|Allergy|allergy
5623391|NCT00806364|Healthy Volunteer|healthy volunteer
5623392|NCT00806364|Non-atopic|non-atopic
5623393|NCT00806351|Candidiasis; Invasive Candidiasis; Candida; Candidemia; Fungal Infection; Neutropenia|candidiasis; invasive candidiasis; candida; candidemia; fungal infection; neutropenia
5623394|NCT00806325|Severe Sepsis|severe sepsis
5623395|NCT00806325|Acute Myeloid Leukemia|acute myeloid leukemia
5623396|NCT00806325|Sepsis in patients being treated for Acute Myeloid Leukemia|sepsis in patients being treated for acute myeloid leukemia
5623397|NCT00806312|MiRNA|mirna
5623398|NCT00806312|pulmonary arterial hypertension|pulmonary arterial hypertension
5623399|NCT00806273|debridement|debridement
5623400|NCT00806273|root canal|root canal
5623401|NCT00806260|Overweight|overweight
5623402|NCT00806260|Obesity|obesity
5623403|NCT00806260|coordination|coordination
5623404|NCT00806260|psychomotor|psychomotor
5623405|NCT00806247|Tapentadol|tapentadol
5623406|NCT00806247|Bunionectomy|bunionectomy
5623407|NCT00806247|Analgesia|analgesia
5623408|NCT00806247|Acute pain|acute pain
5623409|NCT00806247|Postsurgical pain|postsurgical pain
5623410|NCT00806234|Weight Gain|weight gain
5623411|NCT00806234|Obesity|obesity
5623412|NCT00806234|IMPACT|impact
5623413|NCT00806234|Antipsychotic Treatment|antipsychotic treatment
5623414|NCT00806234|Excessive Weight Gain Associated With Antipsychotic Treatment|excessive weight gain associated with antipsychotic treatment
5623415|NCT00806234|Hybrid Efficacy/Effectiveness Design|hybrid efficacy/effectiveness design
5623417|NCT00806234|Improving Metabolic Parameters|improving metabolic parameters
5623418|NCT00806234|Aripiprazole|aripiprazole
5623419|NCT00806234|Metformin|metformin
5623420|NCT00806234|Risperdal|risperdal
5623421|NCT00806234|Seroquel|seroquel
5623422|NCT00806234|Quetiapine|quetiapine
5623423|NCT00806234|Olanzapine|olanzapine
5623424|NCT00806234|Zyprexa|zyprexa
5623425|NCT00806234|Geodon|geodon
5623426|NCT00806234|Risperidone|risperidone
5623427|NCT00806234|Abilify|abilify
5623428|NCT00806234|Trilafon|trilafon
5623429|NCT00806234|Perphenazine|perphenazine
5623430|NCT00806234|Glucophage|glucophage
5623431|NCT00806234|Paliperidone|paliperidone
5623432|NCT00806234|Olanzapine/fluoxetine|olanzapine/fluoxetine
5623433|NCT00806221|Atopic Dermatitis|atopic dermatitis
5623434|NCT00806221|Prevention|prevention
5623435|NCT00806221|Skin Barrier|skin barrier
5623436|NCT00806195|vaccine|vaccine
5623437|NCT00806195|infants|infants
5623438|NCT00806195|healthy|healthy
5623439|NCT00806195|meningitis|meningitis
5623440|NCT00806195|meningococcal|meningococcal
5623441|NCT00806182|paraneoplastic|paraneoplastic
5623442|NCT00806182|neuroblastoma|neuroblastoma
5623443|NCT00806182|Kinsbourne syndrome|kinsbourne syndrome
5623444|NCT00806182|autoimmune disease|autoimmune disease
5623445|NCT00806182|immunotherapy|immunotherapy
5623446|NCT00806182|ataxia|ataxia
5623447|NCT00806169|combined therapy|combined therapy
5623448|NCT00806169|DRP|drp
5623449|NCT00806169|efficacy|efficacy
5623450|NCT00806169|safety|safety
5623451|NCT00806169|sustainability|sustainability
5623452|NCT00806169|macular edema due to DRP|macular edema due to drp
5623453|NCT00806143|Depression|depression
5623454|NCT00806143|TMS|tms
5623455|NCT00806117|Cervical cancer|cervical cancer
5623456|NCT00806117|Concurrent chemoradiation|concurrent chemoradiation
5623457|NCT00806117|Randomized controlled clinical trials|randomized controlled clinical trials
5623458|NCT00806091|AM proteomes will be compared between smokers with and without COPD|am proteomes will be compared between smokers with and without copd
5623459|NCT00806078|Healthy|healthy
5623460|NCT00806078|Bioequivalence|bioequivalence
5623461|NCT00806078|Pharmacokinetics|pharmacokinetics
5623462|NCT00806039|Kidney Failure, Acute|kidney failure, acute
5623463|NCT00806039|Renal Insufficiency, Acute|renal insufficiency, acute
5623464|NCT00806039|Kidney Failure|kidney failure
5623465|NCT00806039|Renal Insufficiency|renal insufficiency
5623466|NCT00806026|RLS|rls
5623467|NCT00806013|genotype|genotype
5623468|NCT00806000|Prevalence of Exercised induced asthma in athletes|prevalence of exercised induced asthma in athletes
5623469|NCT00805974|diapasom|diapasom
5623470|NCT00805974|sleep quality|sleep quality
5623471|NCT00805974|type I diabete|type i diabete
5623472|NCT00805974|blood pressure|blood pressure
5623473|NCT00805974|plasma glucose|plasma glucose
5623474|NCT00805974|daytime and nighttime variations|daytime and nighttime variations
5623475|NCT00805961|Glioblastoma Multiforme|glioblastoma multiforme
5623476|NCT00805961|Radiation Therapy|radiation therapy
5623477|NCT00805961|Temozolomide|temozolomide
5623478|NCT00805961|Bevacizumab|bevacizumab
5623479|NCT00805961|Everolimus|everolimus
5623480|NCT00805948|thoracic aneurysm|thoracic aneurysm
5623481|NCT00805948|thoracic aortic aneurysms|thoracic aortic aneurysms
5623482|NCT00805948|Thoracic Endovascular Aneurysm Repair (TEVAR)|thoracic endovascular aneurysm repair (tevar)
5623483|NCT00805948|Talent Thoracic Stent Graft|talent thoracic stent graft
5623484|NCT00805935|pre-menopausal women|pre-menopausal women
5623485|NCT00805935|PCOS|pcos
5623486|NCT00805935|polycystic ovarian syndrome|polycystic ovarian syndrome
5623488|NCT00805935|IVF|ivf
5623489|NCT00805935|in vitro fertilization|in vitro fertilization
5623490|NCT00805883|Prostate Neoplasm|prostate neoplasm
5623491|NCT00805883|Localized|localized
5623492|NCT00805883|Photothermal|photothermal
5623493|NCT00805883|Radical Prostatectomy|radical prostatectomy
5623494|NCT00805844|Spine|spine
5623495|NCT00805844|Motor Evoked Potentials|motor evoked potentials
5623496|NCT00805831|sutureless vascular bypass|sutureless vascular bypass
5623497|NCT00805805|Copper|copper
5623498|NCT00805805|ceruloplasmin|ceruloplasmin
5623499|NCT00805805|tetrathiomolybdate|tetrathiomolybdate
5623500|NCT00805792|Ischemic stroke|ischemic stroke
5623501|NCT00805792|treatment|treatment
5623502|NCT00805792|recovery|recovery
5623503|NCT00805792|donepezil|donepezil
5623504|NCT00805792|Aricept|aricept
5623505|NCT00805779|Overactive Bladder|overactive bladder
5623506|NCT00805779|Overactive Urinary Bladder|overactive urinary bladder
5623507|NCT00805779|Bladder, Overactive|bladder, overactive
5623508|NCT00805779|Overactive Detrusor|overactive detrusor
5623509|NCT00805779|Detrusor, Overactive|detrusor, overactive
5623510|NCT00805779|Overactive Detrusor Function|overactive detrusor function
5623511|NCT00805779|Detrusor Function, Overactive|detrusor function, overactive
5623512|NCT00805766|Infliximab|infliximab
5623513|NCT00805766|REMICADE|remicade
5623514|NCT00805766|Crohn's disease|crohn's disease
5617554|NCT00827294|treatment|treatment
5863020|NCT00001414|Sixteen Personality Factor Questionnaire|sixteen personality factor questionnaire
5623515|NCT00805740|Candidiasis; Invasive Candidiasis; Deep Tissue Candidiasis; Candida; Candidemia; Fungal Infection|candidiasis; invasive candidiasis; deep tissue candidiasis; candida; candidemia; fungal infection
5623516|NCT00805714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5623517|NCT00805701|prostate|prostate
5623518|NCT00805701|cancer|cancer
5623519|NCT00805701|avodart|avodart
5623520|NCT00805701|dutasteride|dutasteride
5623521|NCT00805701|mitcheson|mitcheson
5623522|NCT00805688|Questionnaire|questionnaire
5623523|NCT00805688|Pancreas|pancreas
5623524|NCT00805688|Pancreatic Cancer|pancreatic cancer
5623525|NCT00805688|Metastatic Disease|metastatic disease
5623526|NCT00805688|symptom outcomes|symptom outcomes
5623527|NCT00805688|Biomarkers|biomarkers
5623528|NCT00805688|Pedometer|pedometer
5623529|NCT00805688|MDASI-GI symptom assessment|mdasi-gi symptom assessment
5623530|NCT00805688|interactive voice response telephone system|interactive voice response telephone system
5623531|NCT00805688|IVRS|ivrs
5623532|NCT00805675|Chronic HBV|chronic hbv
5623533|NCT00805675|Asian adult subjects with chronic HBV, in immune tolerant phase, and positive for hepatitis B e antigen (HBeAg)|asian adult subjects with chronic hbv, in immune tolerant phase, and positive for hepatitis b e antigen (hbeag)
5623534|NCT00805662|IUI|iui
5623535|NCT00805662|oxytocin|oxytocin
5623536|NCT00805649|ARMD|armd
5623538|NCT00805649|efficacy|efficacy
5623539|NCT00805649|safety|safety
5623540|NCT00805636|cell death|cell death
5623541|NCT00805636|PET imaging|pet imaging
5623542|NCT00805636|brain metastases|brain metastases
5623543|NCT00805636|stereotactic radiosurgery|stereotactic radiosurgery
5623544|NCT00805623|sucrose|sucrose
5623545|NCT00805623|sucking|sucking
5623546|NCT00805623|pain relief|pain relief
5623547|NCT00805623|infant|infant
5623548|NCT00805623|require venous puncture|require venous puncture
5623549|NCT00805610|Liver Failure|liver failure
5623550|NCT00805610|Hepatocyte Transplantation|hepatocyte transplantation
5623551|NCT00805610|Liver Transplantation|liver transplantation
5623552|NCT00805597|breast cancer|breast cancer
5623553|NCT00805597|mastectomy|mastectomy
5623554|NCT00805597|one to three positive nodes|one to three positive nodes
5623555|NCT00805597|radiotherapy|radiotherapy
5623556|NCT00805571|Rejection|rejection
5623557|NCT00805571|Infection|infection
5623558|NCT00805571|Side effect of immunosuppressive drug (nephrotoxicity)|side effect of immunosuppressive drug (nephrotoxicity)
5623559|NCT00805558|Chronic Periodontitis|chronic periodontitis
5623560|NCT00805558|antibiotics|antibiotics
5623561|NCT00805532|PTSD|ptsd
5623562|NCT00805532|depression|depression
5623563|NCT00805532|behavior therapy|behavior therapy
5623564|NCT00805532|veterans|veterans
5623565|NCT00805532|behavioral activation|behavioral activation
5623566|NCT00805532|usual care|usual care
5623567|NCT00805519|Osteoarthritis of the Knee|osteoarthritis of the knee
5623568|NCT00805519|Glucosamine Chondroitin sulfate|glucosamine chondroitin sulfate
5623569|NCT00805519|Prednisolone|prednisolone
5623570|NCT00805519|Chloroquine|chloroquine
5623571|NCT00805506|continuous glucose monitoring accuracy|continuous glucose monitoring accuracy
5623572|NCT00805493|Mania|mania
5623573|NCT00805493|Bipolar|bipolar
5623574|NCT00805493|Bipolar Disorder|bipolar disorder
5623575|NCT00805493|Bipolar Manic-Depressive Illness|bipolar manic-depressive illness
5623576|NCT00805493|Bipolar Mood Disorder|bipolar mood disorder
5623577|NCT00805480|Plaque|plaque
5623578|NCT00805480|psoriasis|psoriasis
5623579|NCT00805480|inflammatory skin disease|inflammatory skin disease
5623580|NCT00805480|skin condition, thickening|skin condition, thickening
5623581|NCT00805480|flaking|flaking
5623582|NCT00805480|scaly patches|scaly patches
5623591|NCT00805389|Adjuvant Systems|adjuvant systems
5623592|NCT00805389|Hepatitis B|hepatitis b
5623594|NCT00805376|Brain Cancer|brain cancer
5623595|NCT00805376|Central Nervous System Diseases|central nervous system diseases
5623596|NCT00805376|CNS|cns
5623597|NCT00805376|Conditionally Replication-Competent Adenovirus|conditionally replication-competent adenovirus
5623598|NCT00805376|Delta-24-RGD|delta-24-rgd
5623599|NCT00805376|DNX-2401|dnx-2401
5623600|NCT00805376|Recurrent Malignant Gliomas|recurrent malignant gliomas
5623601|NCT00805376|malignant brain tumor|malignant brain tumor
5623602|NCT00805350|Insomnia|insomnia
5623603|NCT00805350|Sleep Maintenance|sleep maintenance
5623604|NCT00805350|Polysomnography|polysomnography
5623605|NCT00805337|Cancer amplitude-modulated electromagnetic fields|cancer amplitude-modulated electromagnetic fields
5623606|NCT00805311|Internal Carotid Artery Stenosis|internal carotid artery stenosis
5623607|NCT00805311|Carotid Endarterectomy|carotid endarterectomy
5623608|NCT00805311|Stroke|stroke
5623609|NCT00805311|Cerebrovascular|cerebrovascular
5623610|NCT00805311|Atherosclerosis|atherosclerosis
5623611|NCT00805298|third molar|third molar
5623612|NCT00805298|postoperative pain|postoperative pain
5623613|NCT00805298|thermography|thermography
5623614|NCT00805298|postoperative inflammation|postoperative inflammation
5623615|NCT00805298|methylprednisolone|methylprednisolone
5623616|NCT00805298|local anaesthetic|local anaesthetic
5623617|NCT00805298|postoperative pain after removal of lower third molars|postoperative pain after removal of lower third molars
5623618|NCT00805298|inflammation after removal of lower third molars|inflammation after removal of lower third molars
5623620|NCT00805285|Ulcerative Colitis|ulcerative colitis
5623622|NCT00805285|Corticosteroids|corticosteroids
5623623|NCT00805272|HIV|hiv
5623624|NCT00805272|tuberculosis|tuberculosis
5623625|NCT00805272|IGRA|igra
5623626|NCT00805272|diagnosis|diagnosis
5623627|NCT00805272|treatment naive|treatment naive
5623628|NCT00805259|cognitive function|cognitive function
5623629|NCT00805259|elderly|elderly
5623630|NCT00805259|technology|technology
5623631|NCT00805259|financial incentives|financial incentives
5623632|NCT00805259|General maintenance of cognitive function|general maintenance of cognitive function
5623633|NCT00805246|Pulmonary embolism|pulmonary embolism
5623634|NCT00805246|PE|pe
5623635|NCT00805246|CT|ct
5623636|NCT00805246|Biomarker|biomarker
5623637|NCT00805246|Prognosis|prognosis
5623638|NCT00805246|Risk Prediction|risk prediction
5623639|NCT00805233|Neovascular|neovascular
5623640|NCT00805233|AMD|amd
5623641|NCT00805233|Treatment|treatment
5623642|NCT00805233|Lucentis|lucentis
5623643|NCT00805233|Bromfenac|bromfenac
5623644|NCT00805220|frail elderly walking capacity walk training Nordic Walking|frail elderly walking capacity walk training nordic walking
5623645|NCT00805207|sleep apnea|sleep apnea
5623646|NCT00805207|obese|obese
5623647|NCT00805207|Very-low density lipoprotein (VLDL) metabolism|very-low density lipoprotein (vldl) metabolism
5623648|NCT00805207|isotope tracer|isotope tracer
5623649|NCT00805207|women|women
5623650|NCT00805155|Bioequivalence|bioequivalence
5623651|NCT00805155|Mometasone Furoate|mometasone furoate
5623652|NCT00805142|Pain|pain
5623653|NCT00805142|Cancer|cancer
5623654|NCT00805142|Tapentadol|tapentadol
5623655|NCT00805129|URETER|ureter
5623656|NCT00805129|URINARY BLADDER|urinary bladder
5623657|NCT00805129|RAD001|rad001
5623658|NCT00805129|Everolimus|everolimus
5623659|NCT00805129|Urothelium|urothelium
5623660|NCT00805129|08-123|08-123
5623661|NCT00805103|Brain Metastases|brain metastases
5623662|NCT00805103|Stereotactic radiosurgery (SRS)|stereotactic radiosurgery (srs)
5623663|NCT00805103|Hypofractionated stereotactic radiotherapy (HSRT)|hypofractionated stereotactic radiotherapy (hsrt)
5623765|NCT00804687|Allergy|allergy
5623664|NCT00805103|Recurrent Brain Metastases|recurrent brain metastases
5623665|NCT00805090|Renal|renal
5623666|NCT00805090|Hepatic|hepatic
5623667|NCT00805090|Healthy|healthy
5623668|NCT00805077|interoperative care|interoperative care
5623669|NCT00805077|Tidal volume|tidal volume
5623670|NCT00805077|Postoperative complications|postoperative complications
5623671|NCT00805077|Pneumonectomy|pneumonectomy
5623672|NCT00805077|Lobectomy|lobectomy
5623673|NCT00805077|Mechanical ventilation|mechanical ventilation
5623674|NCT00805051|Aortic stenosis|aortic stenosis
5623675|NCT00805051|aortic valve replacement|aortic valve replacement
5623676|NCT00805051|von Willebrand disease|von willebrand disease
5623677|NCT00805051|blood loss|blood loss
5623678|NCT00805012|S-1|s-1
5623679|NCT00805012|docetaxel|docetaxel
5623680|NCT00805012|head and neck cancer|head and neck cancer
5623681|NCT00805012|Recurrent or metastatic head and neck squamous cell carcinoma|recurrent or metastatic head and neck squamous cell carcinoma
5623682|NCT00804999|confocal microscopy|confocal microscopy
5623683|NCT00804999|contact lens wear|contact lens wear
5623684|NCT00804999|contact lens solutions|contact lens solutions
5623685|NCT00804999|sodium fluorescein|sodium fluorescein
5623686|NCT00804973|Migraine|migraine
5623687|NCT00804973|Headache|headache
5623688|NCT00804960|Cost of Infertility Treatment|cost of infertility treatment
5623689|NCT00804960|Ovulation Induction|ovulation induction
5605301|NCT00877097|HRT|hrt
5623690|NCT00804960|Letrozole|letrozole
5623691|NCT00804960|In Vitro Fertilization|in vitro fertilization
5623692|NCT00804947|Autologous transplantation|autologous transplantation
5623693|NCT00804947|Multiple Myeloma|multiple myeloma
5623694|NCT00804947|Intravenous Busulfan|intravenous busulfan
5623695|NCT00804921|bevacizumab|bevacizumab
5623696|NCT00804921|intra-ocular pressure|intra-ocular pressure
5623697|NCT00804921|acetazolamide|acetazolamide
5623698|NCT00804921|anterior chamber paracentesis|anterior chamber paracentesis
5623699|NCT00804921|brimonidine|brimonidine
5623700|NCT00804921|macular edema secondary to diabetic retinopathy or macular degeneration|macular edema secondary to diabetic retinopathy or macular degeneration
5623701|NCT00804908|Temozolomide|temozolomide
5623702|NCT00804908|Skin cancer|skin cancer
5623703|NCT00804908|Melanoma|melanoma
5623704|NCT00804908|Metastatic Melanoma|metastatic melanoma
5623705|NCT00804908|ABT-888|abt-888
5623707|NCT00804895|cluster headache|cluster headache
5623708|NCT00804895|greater occipital nerve block|greater occipital nerve block
5623709|NCT00804895|cortivazol|cortivazol
5623710|NCT00804882|Metabolic syndrome|metabolic syndrome
5623711|NCT00804882|Heart failure|heart failure
5623712|NCT00804882|Mexican Americans|mexican americans
5623713|NCT00804882|Ethnic differences|ethnic differences
5623714|NCT00804882|Echocardiography|echocardiography
5623715|NCT00804830|adjuvant|adjuvant
5623716|NCT00804830|Anaplastic thyroid cancer|anaplastic thyroid cancer
5623717|NCT00804817|self management|self management
5623718|NCT00804817|adherence|adherence
5623719|NCT00804817|activity enhancement|activity enhancement
5623720|NCT00804817|oral mucositis prevention|oral mucositis prevention
5623721|NCT00804817|and mal nutrition prevention|and mal nutrition prevention
5623722|NCT00804817|cancer|cancer
5623723|NCT00804817|hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5623724|NCT00804817|loss of activity|loss of activity
5623725|NCT00804804|Sleep|sleep
5623726|NCT00804804|aging|aging
5623727|NCT00804804|cognitives processes|cognitives processes
5623728|NCT00804804|constant routine|constant routine
5623729|NCT00804791|dry eye|dry eye
5623730|NCT00804791|autofluorescence|autofluorescence
5623731|NCT00804791|residence time|residence time
5623733|NCT00804778|CABG|cabg
5623734|NCT00804778|CO|co
5623735|NCT00804778|CI|ci
5623736|NCT00804778|thermodilution|thermodilution
5623737|NCT00804778|USCOM|uscom
5623738|NCT00804765|Prevention|prevention
5623739|NCT00804765|child obesity|child obesity
5623740|NCT00804765|pregnancy|pregnancy
5623741|NCT00804765|overweight women|overweight women
5623742|NCT00804765|obese women|obese women
5623743|NCT00804752|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5623744|NCT00804739|Major Depression|major depression
5623745|NCT00804739|Postpartum Depression|postpartum depression
5623746|NCT00804739|Perinatal Depression|perinatal depression
5623747|NCT00804739|Treatment Feasibility|treatment feasibility
5623748|NCT00804739|Treatment Engagement|treatment engagement
5623749|NCT00804739|Treatment Adherence|treatment adherence
5623750|NCT00804739|Postpartum|postpartum
5623751|NCT00804739|Interpersonal Psychotherapy|interpersonal psychotherapy
5623752|NCT00804739|IPT|ipt
5623753|NCT00804739|Sertraline|sertraline
5623754|NCT00804739|Zoloft|zoloft
5623755|NCT00804726|Cataract extraction|cataract extraction
5623756|NCT00804726|Phacoemulsification|phacoemulsification
5623757|NCT00804713|TB|tb
5623758|NCT00804713|tuberculosis diagnosis|tuberculosis diagnosis
5623759|NCT00804713|TB screening|tb screening
5623760|NCT00804700|synchronous|synchronous
5623761|NCT00804700|exercise|exercise
5623762|NCT00804700|music|music
5623763|NCT00804700|heartbeat|heartbeat
5623764|NCT00804700|tunes|tunes
5623766|NCT00804687|Rhinitis|rhinitis
5623767|NCT00804687|Allergic Rhinitis|allergic rhinitis
5623768|NCT00804687|JNJ-39220675|jnj-39220675
5623769|NCT00804687|Pseudoephedrine|pseudoephedrine
5623770|NCT00804674|bupivacain|bupivacain
5623771|NCT00804674|breast|breast
5623772|NCT00804674|reconstruction|reconstruction
5623773|NCT00804674|diep|diep
5623774|NCT00804674|pain|pain
5623775|NCT00804674|postoperative|postoperative
5623776|NCT00804674|catheter|catheter
5623778|NCT00804661|sleep|sleep
5623779|NCT00804661|nocturnal hypoventilation|nocturnal hypoventilation
5623780|NCT00804661|sleep quality|sleep quality
5623781|NCT00804661|lung function|lung function
5623782|NCT00804622|HBeAg positive compensated chronic hepatitis B|hbeag positive compensated chronic hepatitis b
5623783|NCT00804583|Cystic Fibrosis|cystic fibrosis
5623784|NCT00804583|Liver Disease|liver disease
5623785|NCT00804583|Genetic Modifiers|genetic modifiers
5623786|NCT00804557|Male Urinary Disorders|male urinary disorders
5623787|NCT00804557|Urinary catheterization|urinary catheterization
5623788|NCT00804557|Urinary retention|urinary retention
5623789|NCT00804544|Integrated SPECT/CT|integrated spect/ct
5623791|NCT00804544|Chemosensitivity|chemosensitivity
5623792|NCT00804531|Low back pain|low back pain
5623793|NCT00804531|steroid injection|steroid injection
5623794|NCT00804531|inter-vertebral disc|inter-vertebral disc
5623795|NCT00804531|randomized trial|randomized trial
5623796|NCT00804531|Lack of efficacy of usual recommended treatments|lack of efficacy of usual recommended treatments
5623797|NCT00804531|More than 40 on the pain numeric scale (0-100)|more than 40 on the pain numeric scale (0-100)
5623798|NCT00804531|Inflammatory discopathy (MODIC I) on MRI|inflammatory discopathy (modic i) on mri
5623799|NCT00804518|Aging|aging
5623800|NCT00804518|Diastolic dysfunction|diastolic dysfunction
5623801|NCT00804518|Systolic function|systolic function
5623802|NCT00804518|Exercise|exercise
5623803|NCT00804518|Echocardiography|echocardiography
5623804|NCT00804518|tissue Doppler imaging|tissue doppler imaging
5623805|NCT00804518|Cardiac function|cardiac function
5623806|NCT00804505|Substantial equivalence to control device|substantial equivalence to control device
5623807|NCT00804492|To organize a multidisciplinary team for integrated falls prevention|to organize a multidisciplinary team for integrated falls prevention
5623808|NCT00804492|To draft a guideline for falls prevention in the elderly|to draft a guideline for falls prevention in the elderly
5623809|NCT00804492|To set up a multidisciplinary fall clinic|to set up a multidisciplinary fall clinic
5623810|NCT00804492|To set up a falls prevention classroom|to set up a falls prevention classroom
5623811|NCT00804492|To enhance cooperate between hospitals and primary care units for falls prevention|to enhance cooperate between hospitals and primary care units for falls prevention
5623812|NCT00804466|Human Papillomavirus|human papillomavirus
5623813|NCT00804466|Cervical Cancer|cervical cancer
5623815|NCT00804453|Chronic Kidney Failure|chronic kidney failure
5623816|NCT00804453|Hemodialysis|hemodialysis
5623817|NCT00804453|Biocompatibility|biocompatibility
5623818|NCT00804440|bioequivalency|bioequivalency
5623819|NCT00804440|ibuprofen|ibuprofen
5623820|NCT00804427|Fish oil|fish oil
5623821|NCT00804427|Triglycerides|triglycerides
5623822|NCT00804427|Low-density Lipoprotein (LDL) cholesterol|low-density lipoprotein (ldl) cholesterol
5623823|NCT00804427|Low-density Lipoprotein (LDL) subclass|low-density lipoprotein (ldl) subclass
5623824|NCT00804427|Low-density Lipoprotein (LDL) particle size|low-density lipoprotein (ldl) particle size
5623825|NCT00804427|Low-density Lipoprotein (LDL) phenotype|low-density lipoprotein (ldl) phenotype
5623826|NCT00804414|Diabetes|diabetes
5623827|NCT00804414|Diabetic ulcer|diabetic ulcer
5623828|NCT00804414|Chronic ulcer|chronic ulcer
5623829|NCT00804414|SBG|sbg
5623830|NCT00804401|bioequivalency|bioequivalency
5623831|NCT00804401|Naproxen|naproxen
5623832|NCT00804388|Vitamine E|vitamine e
5623833|NCT00804388|E-poly|e-poly
5623835|NCT00804388|Degenerative joint disease|degenerative joint disease
5623836|NCT00804375|stump pain|stump pain
5623837|NCT00804349|Heart Decompensation|heart decompensation
5623838|NCT00804349|Heart Failure, Congestive|heart failure, congestive
5623839|NCT00804349|Heart Failure, Left-Sided|heart failure, left-sided
5623840|NCT00804349|Heart Failure, Right-Sided|heart failure, right-sided
5623841|NCT00804349|Apnea, Sleep|apnea, sleep
5623842|NCT00804349|Sleep Apnea, Mixed Central and Obstructive|sleep apnea, mixed central and obstructive
5623843|NCT00804349|Sleep Hypopnea|sleep hypopnea
5623844|NCT00804349|Sleep-Disordered Breathing|sleep-disordered breathing
5623845|NCT00804336|pasireotide|pasireotide
5623846|NCT00804336|SOM230|som230
5623847|NCT00804336|RAD001|rad001
5623848|NCT00804310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5623849|NCT00804297|Hypoglycemia|hypoglycemia
5623850|NCT00804297|Diabetes Mellitus|diabetes mellitus
5623851|NCT00804297|Octreotide|octreotide
5623852|NCT00804284|DAPTACEL®|daptacel®
5623853|NCT00804284|PENTACEL®|pentacel®
5623854|NCT00804284|Diphtheria|diphtheria
5623855|NCT00804284|Tetanus|tetanus
5623856|NCT00804284|Pertussis|pertussis
5623857|NCT00804284|Haemophilus influenzae type b|haemophilus influenzae type b
5623860|NCT00804258|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5623861|NCT00804258|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5623862|NCT00804258|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5623863|NCT00804258|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5623864|NCT00804258|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5623865|NCT00804258|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5623866|NCT00804258|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5623867|NCT00804258|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5623868|NCT00804245|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5623869|NCT00804245|stage I prostate cancer|stage i prostate cancer
5623870|NCT00804245|stage II prostate cancer|stage ii prostate cancer
5623871|NCT00804245|stage III prostate cancer|stage iii prostate cancer
5623872|NCT00804245|stage IV prostate cancer|stage iv prostate cancer
5623873|NCT00804232|Diabetes type1; children|diabetes type1; children
5623874|NCT00804219|low responsiveness after vaccination|low responsiveness after vaccination
5701822|NCT00495638|Echocardiogram|echocardiogram
5623875|NCT00804206|Intravitreal injection of Bevacizumab|intravitreal injection of bevacizumab
5623876|NCT00804206|Visual acuity|visual acuity
5623877|NCT00804206|central retinal thickness|central retinal thickness
5623878|NCT00804206|color studies, Farnsworth-Munsell|color studies, farnsworth-munsell
5623879|NCT00804206|electroretinogram studies|electroretinogram studies
5605493|NCT00876499|Actigraphy|actigraphy
5623881|NCT00804193|Ciclopirox Olamine|ciclopirox olamine
5623882|NCT00804180|anxiety|anxiety
5623883|NCT00804180|injection|injection
5623884|NCT00804180|needle|needle
5623885|NCT00804180|pediatric|pediatric
5623886|NCT00804180|youth|youth
5623887|NCT00804180|children|children
5623888|NCT00804180|adolescents|adolescents
5623889|NCT00804180|cognitive behavioral|cognitive behavioral
5623890|NCT00804180|behavioral|behavioral
5623891|NCT00804180|exposure|exposure
5623892|NCT00804180|group|group
5623893|NCT00804180|treatment|treatment
5623894|NCT00804180|chronic illness|chronic illness
5623895|NCT00804180|adherence|adherence
5623896|NCT00804167|Hypertensive patients aged of 75 years and older|hypertensive patients aged of 75 years and older
5623897|NCT00804167|renal damage|renal damage
5623898|NCT00804167|Clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage|clinical characteristics of hypertensive patients aged of 75 years and older seen in general practitioner consultation according to their renal damage
5623903|NCT00804141|treatment for opioid-induced constipation|treatment for opioid-induced constipation
5623904|NCT00804128|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5623905|NCT00804115|Exfoliation Syndrome|exfoliation syndrome
5623906|NCT00804115|Latanoprost|latanoprost
5623907|NCT00804115|Timolol|timolol
5623908|NCT00804115|Pilocarpine|pilocarpine
5623909|NCT00804102|Retinitis pigmentosa|retinitis pigmentosa
5623910|NCT00804102|Macula off|macula off
5623911|NCT00804102|Primary open angle Glaucoma|primary open angle glaucoma
5623912|NCT00804102|Hereditary Macular Degeneration|hereditary macular degeneration
5623913|NCT00804102|Treated Retina detachment|treated retina detachment
5623914|NCT00804102|Retinal Artery Occlusion|retinal artery occlusion
5623916|NCT00804102|Non-Arthritic-Anterior-Ischemic Optic-Neuropathy|non-arthritic-anterior-ischemic optic-neuropathy
5623917|NCT00804102|Hereditary autosomal dominant Optic atrophy|hereditary autosomal dominant optic atrophy
5623918|NCT00804102|dry Age-related Macular Degeneration|dry age-related macular degeneration
5623919|NCT00804102|Ischemic Macula edema|ischemic macula edema
5623920|NCT00804089|Low Back Pain, Chronic|low back pain, chronic
5623921|NCT00804089|Acupuncture|acupuncture
5623922|NCT00804089|Dry Needling|dry needling
5623923|NCT00804089|Acupressure|acupressure
5623924|NCT00804089|Acupuncture Points|acupuncture points
5623925|NCT00804089|Trigger Points, Myofascial|trigger points, myofascial
5623926|NCT00804076|gene therapy|gene therapy
5623927|NCT00804076|replication defective HSV vector|replication defective hsv vector
5623928|NCT00804076|pain|pain
5623929|NCT00804076|enkephalin|enkephalin
5623930|NCT00804076|intradermal|intradermal
5623931|NCT00804063|glaucoma|glaucoma
5623932|NCT00804063|citrate|citrate
5623933|NCT00804050|Myelodysplastic Syndromes|myelodysplastic syndromes
5623934|NCT00804050|Erythropoietin|erythropoietin
5623935|NCT00804050|Acid 13-Cis-Retinoic|acid 13-cis-retinoic
5623936|NCT00804050|Dihydroxyvitamin D3|dihydroxyvitamin d3
5623937|NCT00804050|low or intermediate-1 IPSS|low or intermediate-1 ipss
5623938|NCT00804050|MDS low risk|mds low risk
5623939|NCT00804037|Snoring and Mild Apnea|snoring and mild apnea
5623940|NCT00804024|Heart Diseases. Vascular Diseases.|heart diseases. vascular diseases.
5623941|NCT00804011|Snakebite|snakebite
5623942|NCT00804011|Weaning|weaning
5623943|NCT00804011|Mechanical ventilation|mechanical ventilation
5623944|NCT00803985|Inguinal hernia|inguinal hernia
5623945|NCT00803985|TEP|tep
5623946|NCT00803985|Lichtenstein|lichtenstein
5623947|NCT00803985|Mesh|mesh
5623948|NCT00803985|Randomized|randomized
5623949|NCT00803985|Chronic pain|chronic pain
5623950|NCT00803985|Sexual dysfunction|sexual dysfunction
5623951|NCT00803972|Humalog|humalog
5623952|NCT00803972|Humulin R|humulin r
5623953|NCT00803972|rHuPH20|rhuph20
5623954|NCT00803972|Hylenex|hylenex
5623955|NCT00803959|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
5623956|NCT00803946|bioequivalency|bioequivalency
5623957|NCT00803946|ibuprofen|ibuprofen
5623958|NCT00803933|first stage|first stage
5623959|NCT00803933|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
5623960|NCT00803933|T. b. gambiense|t. b. gambiense
5623961|NCT00803933|sleeping sickness|sleeping sickness
5623962|NCT00803933|First stage T. b. gambiense sleeping sickness|first stage t. b. gambiense sleeping sickness
5623963|NCT00803920|exenatide twice daily or once weekly|exenatide twice daily or once weekly
5623964|NCT00803920|continuous glucose monitoring|continuous glucose monitoring
5623965|NCT00803907|immunomodulator|immunomodulator
5623966|NCT00803907|Carcinoma, Basal Cell|carcinoma, basal cell
5623967|NCT00803894|Biomarkers of Notch inhibition|biomarkers of notch inhibition
5623969|NCT00803855|pharmacokinetics|pharmacokinetics
5623970|NCT00803855|safety|safety
5623971|NCT00803855|healthy volunteers|healthy volunteers
5623972|NCT00803855|food interaction|food interaction
5623973|NCT00803855|AZD1446|azd1446
5623975|NCT00803842|rash|rash
5623976|NCT00803842|supportive care|supportive care
5623977|NCT00803816|endogoneous|endogoneous
5623978|NCT00803816|posterior|posterior
5623979|NCT00803816|intermediate|intermediate
5623980|NCT00803803|Pilocarpine|pilocarpine
5623981|NCT00803803|POAG|poag
5623982|NCT00803803|IOP|iop
5623983|NCT00803803|Concentration|concentration
5623984|NCT00803803|Frequency|frequency
5623985|NCT00803803|Primary open-angle glaucoma|primary open-angle glaucoma
5623986|NCT00803803|Primary open-angle glaucoma suspect|primary open-angle glaucoma suspect
5623987|NCT00803764|bioequivalency|bioequivalency
5623988|NCT00803764|naproxen|naproxen
5623989|NCT00803751|Laryngoscopy [E04.580.373]|laryngoscopy [e04.580.373]
5623990|NCT00803738|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5623991|NCT00803738|Terconazole|terconazole
5623992|NCT00803725|spinal anesthesia|spinal anesthesia
5623993|NCT00803725|mepivacaine|mepivacaine
5623994|NCT00803725|fentanyl|fentanyl
5623995|NCT00803725|duration of anesthesia|duration of anesthesia
5623996|NCT00803725|knee arthroscopy|knee arthroscopy
5623997|NCT00803725|regional anesthesia|regional anesthesia
5623998|NCT00803725|Spinal anesthesia for knee arthroscopy|spinal anesthesia for knee arthroscopy
5623999|NCT00803699|selenium|selenium
5624000|NCT00803673|Healthy volunteers|healthy volunteers
5624001|NCT00803673|New formulation|new formulation
5624002|NCT00803660|hypertension|hypertension
5624003|NCT00803660|BP|bp
5624004|NCT00803660|diabetes|diabetes
5624005|NCT00803660|anti-hypertensive treatment|anti-hypertensive treatment
5624006|NCT00803660|ACE-I|ace-i
5624007|NCT00803660|ARB|arb
5624008|NCT00803647|NSABP|nsabp
5624009|NCT00803647|Cetuximab|cetuximab
5624011|NCT00803647|Oxaliplatin|oxaliplatin
5624012|NCT00803647|Leucovorin|leucovorin
5624013|NCT00803647|5-FU|5-fu
5624014|NCT00803647|colorectal cancer|colorectal cancer
5624015|NCT00803647|KRAS wild type|kras wild type
5624016|NCT00803647|metastatic colorectal cancer|metastatic colorectal cancer
5624017|NCT00803647|Erbitux|erbitux
5624018|NCT00803647|Eloxatin|eloxatin
5624019|NCT00803647|Liver resection|liver resection
5624020|NCT00803647|Liver ablation|liver ablation
5624021|NCT00803647|Metastasectomy|metastasectomy
5624022|NCT00803634|Hypertension|hypertension
5624023|NCT00803634|Antihypertensive Agent|antihypertensive agent
5624024|NCT00803634|Calcium Channel Blocker|calcium channel blocker
5624025|NCT00803608|Plantar|plantar
5624026|NCT00803608|Ulcer|ulcer
5624027|NCT00803608|Diabetes|diabetes
5624028|NCT00803595|Influenza|influenza
5624029|NCT00803595|Neuraminidase inhibitor|neuraminidase inhibitor
5624030|NCT00803569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5624031|NCT00803569|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5624032|NCT00803569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5624033|NCT00803569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5624034|NCT00803569|fallopian tube cancer|fallopian tube cancer
5624035|NCT00803569|peritoneal cavity cancer|peritoneal cavity cancer
5624036|NCT00803543|HSV-2|hsv-2
5624037|NCT00803543|Herpes Simplex|herpes simplex
5624038|NCT00803543|HSV Type 2|hsv type 2
5624039|NCT00803543|HIV|hiv
5624040|NCT00803543|HIV/HSV|hiv/hsv
5624041|NCT00803543|treatment experienced|treatment experienced
5624042|NCT00803530|myelodysplastic syndromes|myelodysplastic syndromes
5624043|NCT00803530|arsenic trioxide|arsenic trioxide
5624044|NCT00803530|ascorbic acid|ascorbic acid
5624045|NCT00803517|chronic central serous chorioretinopathy|chronic central serous chorioretinopathy
5624046|NCT00803517|multifocal electroretinogram|multifocal electroretinogram
5624326|NCT00802295|Aneuploidy|aneuploidy
5624047|NCT00803517|central retinal function after treatment in chronic serous chorioretinopathy|central retinal function after treatment in chronic serous chorioretinopathy
5624048|NCT00803504|optic disc morphology|optic disc morphology
5624049|NCT00803504|ocular blood flow|ocular blood flow
5624050|NCT00803504|retina|retina
5624051|NCT00803504|ocular physiology|ocular physiology
5624052|NCT00803491|Rheumatic diseases|rheumatic diseases
5624053|NCT00803491|Problem based learning|problem based learning
5624054|NCT00803491|Health-related quality of life|health-related quality of life
5624055|NCT00803491|Empowerment|empowerment
5624056|NCT00803491|Self-care|self-care
5624057|NCT00803478|IntraLase LASIK for primary myopia|intralase lasik for primary myopia
5624058|NCT00803465|Bioequivalence|bioequivalence
5624059|NCT00803465|Fluticasone Propionate|fluticasone propionate
5624060|NCT00803452|Meibomian gland dysfunction|meibomian gland dysfunction
5624061|NCT00803452|Lid margin disease|lid margin disease
5624062|NCT00803452|doxycycline|doxycycline
5624063|NCT00803452|azithromycin|azithromycin
5624064|NCT00803452|essential fatty acid|essential fatty acid
5624065|NCT00803439|Bioequivalence|bioequivalence
5624066|NCT00803439|Clobetasol Propionate|clobetasol propionate
5624067|NCT00803426|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5624068|NCT00803426|nerve block|nerve block
5624069|NCT00803426|popliteal fossa|popliteal fossa
5624070|NCT00803426|sciatic nerve|sciatic nerve
5624071|NCT00803426|common peroneal nerve|common peroneal nerve
5624072|NCT00803426|tibial nerve|tibial nerve
5624073|NCT00803426|onset time|onset time
5624074|NCT00803426|ankle surgery|ankle surgery
5624075|NCT00803426|foot surgery|foot surgery
5624076|NCT00803413|Chronic low back pain|chronic low back pain
5624077|NCT00803413|Back School|back school
5624078|NCT00803413|Walking|walking
5624079|NCT00803413|Physical activity|physical activity
5624080|NCT00803400|Panic disorder|panic disorder
5624081|NCT00803400|Exercise|exercise
5624082|NCT00803400|Alprazolam|alprazolam
5624083|NCT00803400|Aerobic|aerobic
5624084|NCT00803387|ocular dryness|ocular dryness
5624085|NCT00803387|ocular irritation|ocular irritation
5624086|NCT00803387|open-angle glaucoma|open-angle glaucoma
5624087|NCT00803387|ocular hypertension|ocular hypertension
5624088|NCT00803387|TravatanZ|travatanz
5624089|NCT00803387|Xalatan|xalatan
5624090|NCT00803361|anxiety|anxiety
5624091|NCT00803348|continuous femoral nerve blockade|continuous femoral nerve blockade
5624092|NCT00803348|knee arthroplasty|knee arthroplasty
5624093|NCT00803348|knee replacement|knee replacement
5624094|NCT00803348|regional anesthesia|regional anesthesia
5624095|NCT00803348|readiness to discharge|readiness to discharge
5624096|NCT00803348|Femoral nerve blockade for total knee arthroplasty|femoral nerve blockade for total knee arthroplasty
5624097|NCT00803335|pelvic organ prolapse|pelvic organ prolapse
5624098|NCT00803335|vaginal atrophy|vaginal atrophy
5624099|NCT00803335|atrophic vaginitis|atrophic vaginitis
5624100|NCT00803335|postmenopausal|postmenopausal
5624101|NCT00803335|posthysterectomy|posthysterectomy
5624102|NCT00803335|vaginal health|vaginal health
5624103|NCT00803335|vaginal cytology|vaginal cytology
5624104|NCT00803335|vaginal maturity index|vaginal maturity index
5618147|NCT00825227|Cancer|cancer
5624105|NCT00803335|vaginal histology|vaginal histology
5624106|NCT00803335|quality of life questionnaires|quality of life questionnaires
5624108|NCT00803322|community|community
5624109|NCT00803322|community health workers|community health workers
5624110|NCT00803322|Ethiopia|ethiopia
5624111|NCT00803322|identify suspects of pulmonary tuberculosis|identify suspects of pulmonary tuberculosis
5624112|NCT00803322|collect sputum specimen for examination|collect sputum specimen for examination
5624113|NCT00803322|treat smear positive cases in the community|treat smear positive cases in the community
5624114|NCT00803309|Chronic HCV-genotype 2/3|chronic hcv-genotype 2/3
5624115|NCT00803309|Efficacy of treatment extension|efficacy of treatment extension
5624116|NCT00803309|PegIntron|pegintron
5624117|NCT00803309|pegylated interferon alpha-2b|pegylated interferon alpha-2b
5624118|NCT00803309|Rebetol|rebetol
5624119|NCT00803309|ribavirin|ribavirin
5624120|NCT00803283|Pain|pain
5608807|NCT00863265|Diet|diet
5624121|NCT00803283|Hydromorphone hydrochloride OROS|hydromorphone hydrochloride oros
5624122|NCT00803283|Morphine|morphine
5624123|NCT00803270|Stress urinary incontinence, Mixed, Urge|stress urinary incontinence, mixed, urge
5624124|NCT00803257|Carpal Tunnel Syndrome|carpal tunnel syndrome
5624125|NCT00803257|Splint|splint
5624126|NCT00803257|Hand exercises|hand exercises
5624127|NCT00803244|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5624128|NCT00803218|Bioequivalence|bioequivalence
5624129|NCT00803218|Fluticasone Propionate|fluticasone propionate
5624130|NCT00803205|Cystic fibrosis|cystic fibrosis
5624131|NCT00803205|Nonsense mutation|nonsense mutation
5624132|NCT00803205|Premature stop codon|premature stop codon
5624133|NCT00803205|PTC124|ptc124
5624134|NCT00803205|Ataluren|ataluren
5624135|NCT00803192|bioavailability|bioavailability
5624136|NCT00803192|famotidine|famotidine
5624137|NCT00803179|CF|cf
5624138|NCT00803166|Bioequivalence|bioequivalence
5624139|NCT00803166|Halobetasol Propionate|halobetasol propionate
5624140|NCT00803153|Panretinal photocoagulation|panretinal photocoagulation
5624141|NCT00803153|Bruch rupture|bruch rupture
5624517|NCT00801502|Omega-3|omega-3
5624142|NCT00803153|Choroidal detachment|choroidal detachment
5624143|NCT00803153|complication rates|complication rates
5624144|NCT00803140|scarring|scarring
5624145|NCT00803127|vaginal infection, color appearance|vaginal infection, color appearance
5624146|NCT00803114|Postpartum perineal pain|postpartum perineal pain
5624147|NCT00803114|Epidural morphine|epidural morphine
5624148|NCT00803114|Randomised clinical trial|randomised clinical trial
5624149|NCT00803101|Anticoagulant reversal|anticoagulant reversal
5624150|NCT00803101|Prothrombin Complex Concentrate|prothrombin complex concentrate
5624151|NCT00803101|Coagulopathy|coagulopathy
5624152|NCT00803101|Coumarin derivatives|coumarin derivatives
5624153|NCT00803101|Emergency surgery|emergency surgery
5624156|NCT00803101|Reversal of coagulopathy induced by coumarin derivatives|reversal of coagulopathy induced by coumarin derivatives
5624158|NCT00803049|Multiple Sclerosis|multiple sclerosis
5624159|NCT00803049|Oral treatment|oral treatment
5624160|NCT00803036|spreading cortical depression|spreading cortical depression
5624161|NCT00803036|electroencephalography|electroencephalography
5624162|NCT00803036|traumatic brain injury|traumatic brain injury
5624163|NCT00803036|intensive care|intensive care
5624164|NCT00803036|vascular hypotension|vascular hypotension
5624165|NCT00803036|intracranial hypertension|intracranial hypertension
5624166|NCT00803010|Acute Graft Versus Host Disease (aGVHD)|acute graft versus host disease (agvhd)
5624167|NCT00803010|GVHD|gvhd
5624168|NCT00803010|graft-versus-host disease|graft-versus-host disease
5624169|NCT00803010|tacrolimus|tacrolimus
5624170|NCT00803010|sirolimus|sirolimus
5624171|NCT00803010|methotrexate|methotrexate
5624172|NCT00803010|combination therapy|combination therapy
5605821|NCT00874991|TEE|tee
5624173|NCT00803010|GVHD prophylaxis|gvhd prophylaxis
5624174|NCT00802971|Reactive hypoglycaemia|reactive hypoglycaemia
5624175|NCT00802971|Fiber|fiber
5624176|NCT00802971|Prevalence|prevalence
5624177|NCT00802971|Randomised controlled trial|randomised controlled trial
5624178|NCT00802971|Idiopathic reactive hypoglycemia|idiopathic reactive hypoglycemia
5624179|NCT00802958|Bioequivalence|bioequivalence
5624180|NCT00802958|Halobetasol Propionate|halobetasol propionate
5624181|NCT00802932|breast cancer|breast cancer
5624182|NCT00802932|female|female
5624183|NCT00802932|metallic markers|metallic markers
5624184|NCT00802932|image guided radiation therapy|image guided radiation therapy
5624185|NCT00802932|IGRT|igrt
5624186|NCT00802919|schizophrenia|schizophrenia
5624187|NCT00802919|smoking|smoking
5624188|NCT00802919|nicotine|nicotine
5624189|NCT00802919|cognitive deficits|cognitive deficits
5624190|NCT00802919|nicotinic receptors|nicotinic receptors
5624191|NCT00802919|Cognitive Deficits in Schizophrenia|cognitive deficits in schizophrenia
5624192|NCT00802906|micropulselaserphotocoagulation|micropulselaserphotocoagulation
5624193|NCT00802906|bevacizumab|bevacizumab
5624194|NCT00802906|CSC|csc
5624195|NCT00802893|Isolated Systolic Hypertension with Endothelial Dysfunction|isolated systolic hypertension with endothelial dysfunction
5624196|NCT00802867|DAPTACEL®|daptacel®
5624197|NCT00802867|PENTACEL™|pentacel™
5624198|NCT00802867|Diphtheria|diphtheria
5624199|NCT00802867|Tetanus|tetanus
5624200|NCT00802867|Pertussis|pertussis
5624201|NCT00802867|Haemophilus influenzae type b|haemophilus influenzae type b
5624202|NCT00802854|anidulafungin|anidulafungin
5624203|NCT00802854|safety|safety
5624204|NCT00802854|efficacy|efficacy
5624205|NCT00802841|Chronic|chronic
5624206|NCT00802841|Myelogenous|myelogenous
5624207|NCT00802841|Leukemia|leukemia
5624208|NCT00802841|CML|cml
5624209|NCT00802841|Chronic Phase|chronic phase
5624210|NCT00802841|Suboptimal Response|suboptimal response
5624211|NCT00802828|bioavailability|bioavailability
5624212|NCT00802828|famotidine|famotidine
5624213|NCT00802763|VAGINAL INFECTION|vaginal infection
5624214|NCT00802763|COLOR APPEARANCE|color appearance
5624215|NCT00802763|ELEVATED Ph|elevated ph
5624216|NCT00802737|Maintenance|maintenance
5624217|NCT00802737|Retreatment|retreatment
5624218|NCT00802737|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5624219|NCT00802737|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5624220|NCT00802737|Ofatumumab|ofatumumab
5624221|NCT00802724|low back pain|low back pain
5624222|NCT00802724|classification|classification
5624224|NCT00802711|stage IA breast cancer|stage ia breast cancer
5624225|NCT00802711|stage IB breast cancer|stage ib breast cancer
5624226|NCT00802711|stage II breast cancer|stage ii breast cancer
5624227|NCT00802711|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5624228|NCT00802698|Biphasic waveform|biphasic waveform
5624229|NCT00802698|Central retinal artery occlusion|central retinal artery occlusion
5672493|NCT00611689|Solid Tumors|solid tumors
5624230|NCT00802698|To describe the effect of Transcorneal Electrical Stimulation (TES) with a non conventional biphasic bipolar waveform|to describe the effect of transcorneal electrical stimulation (tes) with a non conventional biphasic bipolar waveform
5624231|NCT00802698|in central retinal artery occlusion|in central retinal artery occlusion
5624232|NCT00802685|Patent ductus arteriosus|patent ductus arteriosus
5624233|NCT00802685|Respiratory outcome|respiratory outcome
5624234|NCT00802672|Tinea Pedis|tinea pedis
5624235|NCT00802672|Ciclopirox Olamine|ciclopirox olamine
5624236|NCT00802646|first-time mother|first-time mother
5624237|NCT00802646|epidural request|epidural request
5624238|NCT00802646|vaginal childbirth|vaginal childbirth
5624239|NCT00802633|Tissue sealing device|tissue sealing device
5624240|NCT00802633|Articulating stapling device|articulating stapling device
5624241|NCT00802633|Radical cystectomy|radical cystectomy
5624242|NCT00802620|Amniotic membrane|amniotic membrane
5624243|NCT00802620|Conjunctival autograft|conjunctival autograft
5626825|NCT00791791|Surgical Stress|surgical stress
5624244|NCT00802620|Recurrent pterygia|recurrent pterygia
5624245|NCT00802620|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia|compare amniotic membrane associated with conjunctival autograft versus conjunctival autograft alone in the treatment of recurrent pterygia
5624246|NCT00802607|Bone Diseases|bone diseases
5624247|NCT00802607|Connective Tissue Diseases|connective tissue diseases
5624248|NCT00802594|first stage|first stage
5624249|NCT00802594|T.b. gambiense|t.b. gambiense
5624250|NCT00802594|sleeping sickness|sleeping sickness
5624251|NCT00802594|Patients with first stage T.b. gambiense sleeping sickness|patients with first stage t.b. gambiense sleeping sickness
5624252|NCT00802581|sciatic nerve block|sciatic nerve block
5624253|NCT00802581|local anesthetic|local anesthetic
5624254|NCT00802581|lidocaine|lidocaine
5624255|NCT00802581|ankle surgery|ankle surgery
5624256|NCT00802581|foot surgery|foot surgery
5624257|NCT00802581|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5624258|NCT00802581|circumferential spread|circumferential spread
5624259|NCT00802581|anesthetic infiltration|anesthetic infiltration
5624260|NCT00802568|stage I multiple myeloma|stage i multiple myeloma
5624261|NCT00802568|stage II multiple myeloma|stage ii multiple myeloma
5624262|NCT00802568|stage III multiple myeloma|stage iii multiple myeloma
5624263|NCT00802568|refractory multiple myeloma|refractory multiple myeloma
5624264|NCT00802568|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma
5624266|NCT00802555|Cirrhotic Patients with Hepatocellular Carcinoma|cirrhotic patients with hepatocellular carcinoma
5624267|NCT00802542|Hypertension|hypertension
5624268|NCT00802542|blood pressure|blood pressure
5624269|NCT00802542|Atacand|atacand
5624270|NCT00802529|Meniere's disease|meniere's disease
5624271|NCT00802529|transtympanic steroids|transtympanic steroids
5624272|NCT00802529|Randomised controlled trial|randomised controlled trial
5624273|NCT00802503|Critically ill|critically ill
5624274|NCT00802503|nutrition|nutrition
5624275|NCT00802503|randomised controlled clinical trial|randomised controlled clinical trial
5624276|NCT00802503|human|human
5624277|NCT00802503|adult|adult
5624278|NCT00802503|Supplemental parenteral nutrition|supplemental parenteral nutrition
5624279|NCT00802490|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5624280|NCT00802490|Electroencephalogram biofeedback|electroencephalogram biofeedback
5624281|NCT00802490|Inattention|inattention
5624282|NCT00802490|Brain-Computer Interface System|brain-computer interface system
5624283|NCT00802477|mastectomy|mastectomy
5624284|NCT00802477|seroma|seroma
5624285|NCT00802477|lymph node dissection|lymph node dissection
5624286|NCT00802464|Cytokine|cytokine
5624287|NCT00802464|Vaccine|vaccine
5624288|NCT00802464|Herpes Zoster (HZ)|herpes zoster (hz)
5624289|NCT00802464|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
5624290|NCT00802464|Antibody response|antibody response
5624291|NCT00802464|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5624293|NCT00802451|Bioavailability|bioavailability
5624294|NCT00802451|Mesalamine|mesalamine
5624295|NCT00802438|asthma|asthma
5624296|NCT00802438|allergic inflammation|allergic inflammation
5624297|NCT00802438|interleukin-5|interleukin-5
5624298|NCT00802425|Sudden hearing loss|sudden hearing loss
5624299|NCT00802425|Sudden deafness|sudden deafness
5624300|NCT00802425|Acoustic trauma|acoustic trauma
5624301|NCT00802425|Noise trauma|noise trauma
5624302|NCT00802412|tobacco use disorders|tobacco use disorders
5624304|NCT00802399|Cornea|cornea
5624305|NCT00802399|Dry eye|dry eye
5624306|NCT00802399|lacrimal punctual occlusion|lacrimal punctual occlusion
5624307|NCT00802399|lacrimal film|lacrimal film
5624308|NCT00802399|ocular surface|ocular surface
5624309|NCT00802386|BACTERIAL VAGINOSIS|bacterial vaginosis
5624310|NCT00802386|IUD INSERTION|iud insertion
5624311|NCT00802373|Overactive Bladder|overactive bladder
5624312|NCT00802360|Healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring IVF|healthy, pre-menopausal women, age 18-42 with a history of infertility and requiring ivf
5624313|NCT00802347|Delayed Graft Function|delayed graft function
5624314|NCT00802347|Kidney Transplant|kidney transplant
5624315|NCT00802347|Renal Transplant|renal transplant
5672494|NCT00611689|PTK787|ptk787
5624316|NCT00802347|small interfering ribonucleic acid (siRNA)|small interfering ribonucleic acid (sirna)
5624317|NCT00802334|generic lopinavir/ritonavir|generic lopinavir/ritonavir
5624318|NCT00802334|therapeutic drug monitoring|therapeutic drug monitoring
5624319|NCT00802334|safety and efficacy|safety and efficacy
5624320|NCT00802321|steroid 5AReductase|steroid 5areductase
5624321|NCT00802321|genetic polymorphism|genetic polymorphism
5624322|NCT00802321|GABA receptor|gaba receptor
5624323|NCT00802295|Ovarian|ovarian
5624324|NCT00802295|hyperstimulation|hyperstimulation
5624325|NCT00802295|Embryo|embryo
5624327|NCT00802295|Ovarian hyperstimulation and Embryo Aneuploidy Rates|ovarian hyperstimulation and embryo aneuploidy rates
5624328|NCT00802282|healthy volunteers|healthy volunteers
5624329|NCT00802282|spirituality|spirituality
5624330|NCT00802282|psilocybin|psilocybin
5624331|NCT00802282|meditation|meditation
5624332|NCT00802269|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5624333|NCT00802269|Laser photocoagulation|laser photocoagulation
5624334|NCT00802269|Pain|pain
5624335|NCT00802256|pulpotomy|pulpotomy
5624336|NCT00802256|primary molar teeth|primary molar teeth
5624337|NCT00802256|MTA|mta
5624338|NCT00802256|NEC|nec
5624339|NCT00802256|CEM|cem
5624340|NCT00802256|Primary Molar Teeth Which Require Pulpotomy Treatment|primary molar teeth which require pulpotomy treatment
5624341|NCT00802243|Bullous pemphigoid|bullous pemphigoid
5624342|NCT00802243|leflunomide|leflunomide
5624343|NCT00802243|corticosteroid treatment reduction|corticosteroid treatment reduction
5701823|NCT00495638|Sickle Cell Anemia|sickle cell anemia
5685465|NCT00555984|Inflammatory markers|inflammatory markers
5624344|NCT00802243|Patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.|patients are screened by: the physicians in different departments of the hospital, the liberal dermatologists and the general practicioners.
5624345|NCT00802243|Phase I: Patients will be referred to the investigators of Dupuytren Hospital Dermatology Department.|phase i: patients will be referred to the investigators of dupuytren hospital dermatology department.
5624346|NCT00802243|Phase II: Patients will be referred to the investigators of Purpan (Toulouse), Haut Leveque (Pessac) and Dupuytren (Limoges) Hospitals.|phase ii: patients will be referred to the investigators of purpan (toulouse), haut leveque (pessac) and dupuytren (limoges) hospitals.
5624349|NCT00802217|Tolerability|tolerability
5624350|NCT00802217|Healthy Volunteers|healthy volunteers
5624351|NCT00802204|Obesity|obesity
5624352|NCT00802204|Insulin Resistance|insulin resistance
5624353|NCT00802204|Neuroendocrine regulation|neuroendocrine regulation
5624354|NCT00802204|Eating behaviors|eating behaviors
5624355|NCT00802204|Dopamine signaling|dopamine signaling
5624356|NCT00802165|Asymptomatic normals|asymptomatic normals
5624357|NCT00802152|Diabetes|diabetes
5624358|NCT00802152|Hypertension|hypertension
5624359|NCT00802139|iron deficiency anemia|iron deficiency anemia
5624360|NCT00802139|pregnant women with iron deficiency anemia|pregnant women with iron deficiency anemia
5624361|NCT00802113|Autologous Stem Cell Transplant|autologous stem cell transplant
5624362|NCT00802113|Cord Blood Transplant|cord blood transplant
5624363|NCT00802113|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5624364|NCT00802113|Relapsed Lymphoma|relapsed lymphoma
5624365|NCT00802100|Schizoaffective Disorder|schizoaffective disorder
5624366|NCT00802087|Hydrocodone|hydrocodone
5624367|NCT00802087|Pharmacokinetics|pharmacokinetics
5624368|NCT00802087|Safety & Tolerability|safety & tolerability
5624369|NCT00802074|Healthy Subjects|healthy subjects
5624370|NCT00802074|Pharmacokinetics study|pharmacokinetics study
5624371|NCT00802074|Pharmacokinetics of medications|pharmacokinetics of medications
5624372|NCT00802061|progressive glaucoma despite controlled IOP|progressive glaucoma despite controlled iop
5624373|NCT00802048|Sternotomy|sternotomy
5624374|NCT00802048|Postoperative hyperalgesia|postoperative hyperalgesia
5624379|NCT00802048|Cardiac surgery|cardiac surgery
5624381|NCT00802048|Cardiac surgical procedures|cardiac surgical procedures
5624382|NCT00802035|ALK29|alk29
5624383|NCT00802035|Alcohol Dependence|alcohol dependence
5624384|NCT00802035|Pharmacokinetics|pharmacokinetics
5624385|NCT00802022|diabetic neuropathies|diabetic neuropathies
5624386|NCT00802022|electric stimulation therapy|electric stimulation therapy
5624387|NCT00802009|ultrasound-guided regional anesthesia|ultrasound-guided regional anesthesia
5624388|NCT00802009|nerve block|nerve block
5624389|NCT00802009|brachial plexus|brachial plexus
5624390|NCT00802009|mepivicaine|mepivicaine
5624391|NCT00802009|dexamethasone|dexamethasone
5624392|NCT00802009|hand wrist surgery|hand wrist surgery
5624393|NCT00802009|duration|duration
5624394|NCT00802009|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery|anesthetic duration following brachial plexus/nerve block for hand/wrist surgery
5624395|NCT00801996|prostate cancer|prostate cancer
5624396|NCT00801996|genetics|genetics
5624397|NCT00801970|Fear of childbirth|fear of childbirth
5624398|NCT00801970|Tokophobia|tokophobia
5624399|NCT00801970|Anxiety|anxiety
5624400|NCT00801970|Labor|labor
5624401|NCT00801970|Pregnancy|pregnancy
5624402|NCT00801970|Cognitive-behavioral|cognitive-behavioral
5624403|NCT00801970|Psychoanalysis|psychoanalysis
5624404|NCT00801970|Group Therapy|group therapy
5624405|NCT00801970|etiology|etiology
5624406|NCT00801957|atopic dermatitis|atopic dermatitis
5624407|NCT00801957|meningitis|meningitis
5624408|NCT00801957|vaccination|vaccination
5624409|NCT00801957|tacrolimus|tacrolimus
5624410|NCT00801957|steroids|steroids
5624411|NCT00801957|equivalence response|equivalence response
5624412|NCT00801957|meningococcal vaccine|meningococcal vaccine
5624413|NCT00801944|Overactive Bladder|overactive bladder
5624414|NCT00801931|Cord Blood Transplant|cord blood transplant
5624415|NCT00801931|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5624416|NCT00801918|lymphoma|lymphoma
5624417|NCT00801918|pediatric|pediatric
5624418|NCT00801918|adolescent|adolescent
5624419|NCT00801918|relapsed|relapsed
5624420|NCT00801918|refractory|refractory
5624421|NCT00801918|denileukin diftitox|denileukin diftitox
5624422|NCT00801918|Ontak|ontak
5624423|NCT00801905|Macular thickening|macular thickening
5624424|NCT00801905|Macular edema|macular edema
5624425|NCT00801905|Pan-retinal photocoagulation|pan-retinal photocoagulation
5624426|NCT00801905|Nepafenac|nepafenac
5624427|NCT00801905|Topical non-steroidal anti inflammatory agents|topical non-steroidal anti inflammatory agents
5624428|NCT00801892|daytime sleepiness|daytime sleepiness
5624429|NCT00801892|obstructive sleep apnea|obstructive sleep apnea
5624430|NCT00801892|type 2 diabetes mellitus|type 2 diabetes mellitus
5624431|NCT00801892|diabetes management|diabetes management
5624432|NCT00801879|mupirocin|mupirocin
5624433|NCT00801879|Staphylococcus aureus|staphylococcus aureus
5624434|NCT00801879|colonization|colonization
5624435|NCT00801879|infection|infection
5624436|NCT00801879|HIV|hiv
5624437|NCT00801866|Panretinal Photocoagulation|panretinal photocoagulation
5624438|NCT00801866|Macular Edema|macular edema
5624439|NCT00801866|Intravitreal Bevacizumab|intravitreal bevacizumab
5624440|NCT00801853|asthma|asthma
5624441|NCT00801853|allergy|allergy
5624442|NCT00801853|atopy|atopy
5624443|NCT00801853|atopic|atopic
5624444|NCT00801853|wheeze|wheeze
5624445|NCT00801827|Obesity|obesity
5624446|NCT00801827|Addiction|addiction
5624447|NCT00801827|PET imaging|pet imaging
5624448|NCT00801814|viscous|viscous
5624449|NCT00801814|fibre|fibre
5624450|NCT00801814|polysaccharide|polysaccharide
5624451|NCT00801814|blood glucose|blood glucose
5624452|NCT00801814|post prandial|post prandial
5624453|NCT00801801|Docetaxel|docetaxel
5624454|NCT00801801|Sorafenib|sorafenib
5624455|NCT00801775|calorimetry|calorimetry
5624456|NCT00801736|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5624457|NCT00801736|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5624458|NCT00801736|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5624459|NCT00801723|Ulcerative Colitis|ulcerative colitis
5624460|NCT00801697|HIV Seronegativity|hiv seronegativity
5624461|NCT00801697|HIV Preventive Vaccine|hiv preventive vaccine
5624462|NCT00801697|Adenovirus|adenovirus
5624463|NCT00801684|COPD|copd
5624464|NCT00801684|pulmonary|pulmonary
5624465|NCT00801684|inhalation|inhalation
5624466|NCT00801671|obstructive sleep apnea|obstructive sleep apnea
5624467|NCT00801671|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5624468|NCT00801671|hypertension|hypertension
5624469|NCT00801671|systemic hypertension|systemic hypertension
5618526|NCT00823719|Salvage chemotherapy|salvage chemotherapy
5624470|NCT00801671|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5624471|NCT00801658|glaucoma|glaucoma
5624472|NCT00801658|SLT|slt
5624473|NCT00801658|Laser treatment|laser treatment
5624474|NCT00801658|IOP|iop
5624475|NCT00801658|glaucoma treated with eye drops but IOP not controlled|glaucoma treated with eye drops but iop not controlled
5624476|NCT00801645|Obesity|obesity
5624477|NCT00801645|Cardiovascular disease|cardiovascular disease
5624478|NCT00801645|Endothelial function|endothelial function
5624479|NCT00801645|Blood pressure|blood pressure
5624480|NCT00801645|Exercise|exercise
5624481|NCT00801645|Physical activity|physical activity
5624482|NCT00801645|Metabolic syndrome|metabolic syndrome
5624483|NCT00801645|Children|children
5624484|NCT00801645|Pediatric|pediatric
5624485|NCT00801632|renal allograft tolerance|renal allograft tolerance
5624487|NCT00801632|kidney transplant|kidney transplant
5624488|NCT00801632|bone marrow transplant|bone marrow transplant
5624489|NCT00801632|antirejection|antirejection
5624490|NCT00801632|immunosuppression|immunosuppression
5624491|NCT00801606|Micronutrient|micronutrient
5624492|NCT00801606|Childhood Tuberculosis|childhood tuberculosis
5624493|NCT00801593|JIA|jia
5624494|NCT00801580|relapsed ALL|relapsed all
5624495|NCT00801580|refractory ALL|refractory all
5624496|NCT00801580|relapsed adult acute lymphoid leukemia|relapsed adult acute lymphoid leukemia
5624497|NCT00801567|Bipolar disorder|bipolar disorder
5624498|NCT00801567|Schizophrenia|schizophrenia
5624499|NCT00801567|Healthy volunteer|healthy volunteer
5624500|NCT00801567|Brain imaging|brain imaging
5624501|NCT00801567|Photic stimulation|photic stimulation
5624502|NCT00801554|Autism Spectrum Disorder|autism spectrum disorder
5624503|NCT00801554|ASD|asd
5624504|NCT00801554|Autism|autism
5624505|NCT00801554|Asperger's Syndrome|asperger's syndrome
5624506|NCT00801554|PDD-NOS|pdd-nos
5624507|NCT00801554|Pervasive Developmental Disorders- Not Otherwise Specified|pervasive developmental disorders- not otherwise specified
5624508|NCT00801554|Adults|adults
5624509|NCT00801554|Children|children
5624510|NCT00801541|AMD|amd
5624511|NCT00801528|ropivacaine|ropivacaine
5624512|NCT00801528|diclofenac|diclofenac
5624513|NCT00801528|local anesthetic instillation|local anesthetic instillation
5624514|NCT00801515|Compassionate|compassionate
5624515|NCT00801515|HIV|hiv
5624516|NCT00801515|CCR5|ccr5
5624518|NCT00801502|Oily fish|oily fish
5624519|NCT00801502|Antioxidant|antioxidant
5624520|NCT00801502|Selenium|selenium
5624521|NCT00801502|Atopic disease|atopic disease
5624522|NCT00801502|Pregnancy|pregnancy
5624523|NCT00801502|Nutrient status|nutrient status
5624524|NCT00801476|Breast Cancer|breast cancer
5624525|NCT00801476|Magnetic Resonance Imaging|magnetic resonance imaging
5624526|NCT00801476|Preoperative MRI|preoperative mri
5624527|NCT00801463|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5624528|NCT00801463|Prednisone|prednisone
5624529|NCT00801463|Tripterygium Wilfordii|tripterygium wilfordii
5624530|NCT00801450|diabetes|diabetes
5624531|NCT00801450|macular edema|macular edema
5624532|NCT00801450|triamcinolone|triamcinolone
5624533|NCT00801450|cataract|cataract
5624534|NCT00801450|refractory diabetic macular edema|refractory diabetic macular edema
5624535|NCT00801437|glaucoma, open-angle, non-interventional study, safety, tolerability|glaucoma, open-angle, non-interventional study, safety, tolerability
5624536|NCT00801424|abdominal surgery|abdominal surgery
5624537|NCT00801424|hypothermia|hypothermia
5624538|NCT00801424|wound dessication|wound dessication
5624539|NCT00801424|warming|warming
5624540|NCT00801411|stage II breast cancer|stage ii breast cancer
5624541|NCT00801398|Opioid tolerant|opioid tolerant
5624542|NCT00801398|Pediatric|pediatric
5624543|NCT00801398|Pain|pain
5624544|NCT00801398|Non malignant|non malignant
5624545|NCT00801398|Malignant|malignant
5624546|NCT00801385|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5624547|NCT00801385|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5624548|NCT00801385|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5624549|NCT00801372|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.|pregnant, healthy females older than 18 who signed an informed consent for the termination of the pregnancy.
5624550|NCT00801372|pregnant healthy couples older than 18 who signed an informed consent for a c-section.|pregnant healthy couples older than 18 who signed an informed consent for a c-section.
5624551|NCT00801372|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.|healthy male newborns, undergoing surgical circumcision who's parents older than 18 signed an informed consent.
5624552|NCT00801359|cataract|cataract
5624553|NCT00801359|phacoemulsification|phacoemulsification
5624554|NCT00801359|irrigation solution|irrigation solution
5624555|NCT00801359|endothelial cell density|endothelial cell density
5624556|NCT00801359|corneal thickness|corneal thickness
5624557|NCT00801346|fatigue|fatigue
5624558|NCT00801346|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5624559|NCT00801346|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5624560|NCT00801346|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5863987|NCT00001147|Sympathetic Nervous System|sympathetic nervous system
5624561|NCT00801346|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5624563|NCT00801320|tumor harvest|tumor harvest
5624564|NCT00801320|tumor collection|tumor collection
5624565|NCT00801320|tumor storage|tumor storage
5624566|NCT00801307|evaluate Inspiratory Capacity (IC) measured by spirometry|evaluate inspiratory capacity (ic) measured by spirometry
5624567|NCT00801281|Lymphoma|lymphoma
5624568|NCT00801281|Immunochemotherapy|immunochemotherapy
5624569|NCT00801281|Induction therapy|induction therapy
5624570|NCT00801281|Maintenance therapy|maintenance therapy
5624571|NCT00801281|Follicular lymphoma grade 1,2,3a|follicular lymphoma grade 1,2,3a
5624572|NCT00801281|Marginal zone lymphoma, including MALT type|marginal zone lymphoma, including malt type
5624573|NCT00801281|Small lymphocytic lymphoma (BM inv. <30%)|small lymphocytic lymphoma (bm inv. <30%)
5624574|NCT00801268|polycystic kidney disease|polycystic kidney disease
5624575|NCT00801268|tripterygium wilfordii|tripterygium wilfordii
5624576|NCT00801229|ADHD|adhd
5624577|NCT00801229|young adults|young adults
5624578|NCT00801229|driving|driving
5624579|NCT00801229|Vyvanse|vyvanse
5624580|NCT00801229|lisdexamfetamine|lisdexamfetamine
5624581|NCT00801216|B-cell lymphomas|b-cell lymphomas
5624582|NCT00801216|lymphomatous meningitis|lymphomatous meningitis
5624583|NCT00801216|liposomal cytarabine|liposomal cytarabine
5624584|NCT00801216|autologous transplant|autologous transplant
5624585|NCT00801216|CNS involvement|cns involvement
5624586|NCT00801216|Secondary CNS lymphomas|secondary cns lymphomas
5624587|NCT00801203|Stress Urinary Incontinence|stress urinary incontinence
5624588|NCT00801190|colloid|colloid
5624589|NCT00801190|CABG|cabg
5624590|NCT00801190|cardiopulmonary bypass|cardiopulmonary bypass
5624591|NCT00801190|bleeding|bleeding
5624592|NCT00801177|Tumors|tumors
5624593|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal
5624594|NCT00801164|Diabetes Type 2|diabetes type 2
5624595|NCT00801164|Periodontitis|periodontitis
5624596|NCT00801138|ropivacaine|ropivacaine
5624597|NCT00801138|bupivacaine|bupivacaine
5624598|NCT00801138|glucocorticoid|glucocorticoid
5624599|NCT00801112|Bioimpedance|bioimpedance
5624600|NCT00801112|Fluid status|fluid status
5624601|NCT00801112|Peritoneal Dialysis|peritoneal dialysis
5624602|NCT00801112|Extra-cellular fluid volume|extra-cellular fluid volume
5624603|NCT00801099|Postoperative wound infection|postoperative wound infection
5624604|NCT00801099|surgical site infection|surgical site infection
5624605|NCT00801099|antimicrobial prophylaxis|antimicrobial prophylaxis
5624606|NCT00801099|developing countries|developing countries
5624607|NCT00801099|Sub-Saharan Africa|sub-saharan africa
5624608|NCT00801099|reduction of SSI using preoperative antibiotics|reduction of ssi using preoperative antibiotics
5624609|NCT00801086|Alopecia|alopecia
5624610|NCT00801086|Hair loss|hair loss
5624612|NCT00801086|Whole brain radiotherapy|whole brain radiotherapy
5624613|NCT00801086|Radiation-induced alopecia|radiation-induced alopecia
5624614|NCT00801073|Amniotic membrane|amniotic membrane
5624615|NCT00801073|Cornea|cornea
5624616|NCT00801073|Scleral thinning|scleral thinning
5624617|NCT00801060|Fludara|fludara
5624618|NCT00801060|CD23|cd23
5624619|NCT00801060|Cyclophosphamide|cyclophosphamide
5624620|NCT00801060|Antibody|antibody
5624621|NCT00801060|Fludarabine|fludarabine
5624623|NCT00801060|Rituximab|rituximab
5624624|NCT00801060|Mabthera|mabthera
5624625|NCT00801060|Biogen Idec|biogen idec
5624626|NCT00801060|Lumiliximab|lumiliximab
5624627|NCT00801060|Rituxan|rituxan
5624628|NCT00801060|Cytoxan|cytoxan
5624629|NCT00801060|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5624630|NCT00801047|Epidural|epidural
5624631|NCT00801047|Labor|labor
5624632|NCT00801047|Remifentanil|remifentanil
5624633|NCT00801034|hypertension|hypertension
5624634|NCT00801034|potassium|potassium
5624635|NCT00801034|blood pressure|blood pressure
5624636|NCT00801021|Cystitis|cystitis
5624637|NCT00801021|Urinary Tract Infections|urinary tract infections
5624638|NCT00801008|young adult|young adult
5624639|NCT00801008|cancer|cancer
5624640|NCT00801008|exercise|exercise
5624641|NCT00801008|relaxation|relaxation
5624642|NCT00800995|ARMD|armd
5624644|NCT00800982|Obese patients (BMI>30)|obese patients (bmi>30)
5624645|NCT00800982|Patients with moderate to severe psoriasis|patients with moderate to severe psoriasis
5624646|NCT00800969|Adenocarcinoma of the stomach and esophagogastric junction|adenocarcinoma of the stomach and esophagogastric junction
5624647|NCT00800956|Radiolabel ADME study Healthy volunteers|radiolabel adme study healthy volunteers
5624648|NCT00800943|Leukemia|leukemia
5624649|NCT00800943|Chronic|chronic
5624650|NCT00800943|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5624651|NCT00800943|CAMPATH|campath
5624652|NCT00800943|Alemtuzumab|alemtuzumab
5624653|NCT00800943|MabCampath|mabcampath
5624654|NCT00800943|Subcutaneous|subcutaneous
5624655|NCT00800943|CLL|cll
5624656|NCT00800943|C-CLL|c-cll
5624657|NCT00800943|Residual|residual
5624658|NCT00800930|Shigellosis|shigellosis
5624659|NCT00800930|sodium butyrate|sodium butyrate
5624660|NCT00800930|antimicrobial peptides|antimicrobial peptides
5624661|NCT00800930|LL-37|ll-37
5624662|NCT00800930|innate immunity|innate immunity
5624663|NCT00800930|The aims are to assess efficacy of sodium butyrate enema in|the aims are to assess efficacy of sodium butyrate enema in
5624664|NCT00800930|marked improvement in clinical features|marked improvement in clinical features
5624665|NCT00800930|endoscopic findings|endoscopic findings
5624666|NCT00800930|histological features|histological features
5624667|NCT00800930|Induction of LL-37 in the rectum.|induction of ll-37 in the rectum.
5624668|NCT00800904|Asthma|asthma
5624669|NCT00800904|Inhaled corticosteroid|inhaled corticosteroid
5624670|NCT00800904|Thai patient eligibility|thai patient eligibility
5624671|NCT00800904|Persistent asthma|persistent asthma
5624672|NCT00800878|Chronic Kidney Disease|chronic kidney disease
5624673|NCT00800878|Renal insufficiency|renal insufficiency
5624674|NCT00800852|adiponectin|adiponectin
5624675|NCT00800852|adiponectin receptor|adiponectin receptor
5624676|NCT00800852|Prader-Willi syndrome|prader-willi syndrome
5624677|NCT00800839|Post-allogeneic transplantation|post-allogeneic transplantation
5624678|NCT00800839|Graft-versus-Host Disease Prophylaxis|graft-versus-host disease prophylaxis
5624679|NCT00800839|Graft-versus-Host Disease|graft-versus-host disease
5624680|NCT00800839|GVHD|gvhd
5624681|NCT00800839|Hematologic malignancies|hematologic malignancies
5624682|NCT00800839|Leukemia|leukemia
5624683|NCT00800839|Lymphoma|lymphoma
5624684|NCT00800839|Myeloma|myeloma
5624685|NCT00800839|Human Leukocyte Antigen|human leukocyte antigen
5624686|NCT00800839|HLA|hla
5624687|NCT00800839|Busulfan|busulfan
5624688|NCT00800839|Cyclophosphamide|cyclophosphamide
5624689|NCT00800839|Fludarabine|fludarabine
5624690|NCT00800839|Mesna|mesna
5624691|NCT00800839|Cytoxan®|cytoxan®
5624692|NCT00800839|Neosar®|neosar®
5624693|NCT00800839|Busulfex|busulfex
5624694|NCT00800839|Myleran®|myleran®
5624695|NCT00800839|Fludarabine Phosphate|fludarabine phosphate
5624696|NCT00800813|Prostate|prostate
5624697|NCT00800813|Erectile function|erectile function
5624698|NCT00800813|Peyronie's Plaque|peyronie's plaque
5624699|NCT00800813|08-135|08-135
5624700|NCT00800800|progression of aortic stenosis|progression of aortic stenosis
5624701|NCT00800787|Chronic hepatitis B liver disease|chronic hepatitis b liver disease
5624702|NCT00800774|LASIK|lasik
5624703|NCT00800774|safety|safety
5624704|NCT00800774|efficacy|efficacy
5624705|NCT00800774|stability|stability
5624706|NCT00800774|high anisometropia|high anisometropia
5624707|NCT00800774|patients 8 to 15 years old|patients 8 to 15 years old
5624708|NCT00800774|conventional treatments have failed|conventional treatments have failed
5624709|NCT00800722|hypervascular anomalies|hypervascular anomalies
5624710|NCT00800709|Alzheimer's Disease|alzheimer's disease
5624711|NCT00800709|tau protein|tau protein
5624712|NCT00800709|PET|pet
5624713|NCT00800709|Memantine|memantine
5624714|NCT00800696|antibiotics|antibiotics
5624715|NCT00800696|Hospitalization|hospitalization
5624716|NCT00800696|oral care|oral care
5624717|NCT00800670|tuberculosis|tuberculosis
5624718|NCT00800670|vaccine|vaccine
5624720|NCT00800657|Cardiac Resynchronization|cardiac resynchronization
5624721|NCT00800657|Dilated Cardiomyopathy|dilated cardiomyopathy
5624722|NCT00800657|Stem Cells Therapy|stem cells therapy
5624723|NCT00800657|Heart Failure|heart failure
5624724|NCT00800657|Stem Cells/Cardiac Pacing, Artificial|stem cells/cardiac pacing, artificial
5624725|NCT00800644|Cervical Cancer|cervical cancer
5624726|NCT00800644|Endometrial Cancer|endometrial cancer
5624727|NCT00800644|Vaginal Cancer|vaginal cancer
5624729|NCT00800644|Endometrial|endometrial
5624730|NCT00800644|X-ray|x-ray
5624731|NCT00800644|Computed tomography|computed tomography
5624732|NCT00800644|Magnetic resonance imaging|magnetic resonance imaging
5624733|NCT00800644|Vagina|vagina
5624734|NCT00800644|Pelvic radiation therapy|pelvic radiation therapy
5624735|NCT00800644|Bone density|bone density
5624736|NCT00800644|Bone mineral density test|bone mineral density test
5624737|NCT00800644|Pelvic fractures|pelvic fractures
5624738|NCT00800644|Gynecologic Oncology|gynecologic oncology
5624739|NCT00800644|Bone turnover|bone turnover
5624740|NCT00800592|Sildenafil, Revatio, PAH, IV, Bolus|sildenafil, revatio, pah, iv, bolus
5624741|NCT00800579|cystic fibrosis|cystic fibrosis
5624742|NCT00800579|CF|cf
5624743|NCT00800579|mucociliary clearance|mucociliary clearance
5624744|NCT00800579|amiloride|amiloride
5624745|NCT00800579|ENaC|enac
5624746|NCT00800579|ENaC Inhibitor|enac inhibitor
5624747|NCT00800579|airway hydration|airway hydration
5624748|NCT00800579|epithelial sodium channel inhibitor|epithelial sodium channel inhibitor
5624749|NCT00800566|Clofarabine|clofarabine
5624750|NCT00800566|Leukemia|leukemia
5624751|NCT00800566|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5624752|NCT00800553|sleep deprivation|sleep deprivation
5624753|NCT00800553|fMRI|fmri
5624754|NCT00800553|double blind crossover study|double blind crossover study
5624755|NCT00800540|glaucoma|glaucoma
5624756|NCT00800540|ocular perfusion pressure|ocular perfusion pressure
5624757|NCT00800540|ocular blood flow|ocular blood flow
5624758|NCT00800540|open angle glaucoma requiring more than one IOP-lowering medication|open angle glaucoma requiring more than one iop-lowering medication
5624759|NCT00800527|sternotomy|sternotomy
5624760|NCT00800527|pain|pain
5624761|NCT00800527|paresthesia|paresthesia
5624762|NCT00800527|Poststernotomy chest pain|poststernotomy chest pain
5624763|NCT00800527|Poststernotomy chest paresthesia|poststernotomy chest paresthesia
5624764|NCT00800514|perception of time, traumatic brain injury, amantadine|perception of time, traumatic brain injury, amantadine
5624765|NCT00800501|ALS|als
5624766|NCT00800501|VEGF165|vegf165
5624767|NCT00800501|Safety|safety
5624768|NCT00800501|Intracerebroventricular|intracerebroventricular
5624769|NCT00800501|Infusion|infusion
5624770|NCT00800501|Implantable|implantable
5624771|NCT00800488|Fever|fever
5624772|NCT00800488|Infant|infant
5624773|NCT00800488|Procalcitonin|procalcitonin
5624774|NCT00800488|Serious Bacterial Infection|serious bacterial infection
5624775|NCT00800475|bioavailability|bioavailability
5624776|NCT00800475|Gemfibrozil|gemfibrozil
5624777|NCT00800449|Haptoglobin|haptoglobin
5624778|NCT00800449|sepsis|sepsis
5624779|NCT00800449|premature babies|premature babies
5624780|NCT00800423|corneal edema|corneal edema
5624781|NCT00800423|postoperative corneal edema|postoperative corneal edema
5624782|NCT00800423|central corneal thickness|central corneal thickness
5624783|NCT00800423|visual acuity|visual acuity
5624784|NCT00800423|postoperative|postoperative
5624785|NCT00800423|brimonidine|brimonidine
5624786|NCT00800423|timolol|timolol
5624787|NCT00800423|cataract surgery|cataract surgery
5624788|NCT00800410|Randomized Controlled Trial|randomized controlled trial
5624789|NCT00800371|JIA|jia
5624790|NCT00800358|Secondary hyperparathyroidism|secondary hyperparathyroidism
5624791|NCT00800358|End stage renal disease|end stage renal disease
5624792|NCT00800358|Haemodialysis|haemodialysis
5624793|NCT00800358|Peritoneal dialysis|peritoneal dialysis
5624794|NCT00800358|Paricalcitol (Zemplar)|paricalcitol (zemplar)
5812424|NCT00082927|pain|pain
5624795|NCT00800358|Calcitriol|calcitriol
5624796|NCT00800345|Gynecologic tumors|gynecologic tumors
5624797|NCT00800332|Rhinoconjunctivitis due to house dust mite allergy|rhinoconjunctivitis due to house dust mite allergy
5624798|NCT00800319|Alcohol dependence|alcohol dependence
5624799|NCT00800319|Opioid antagonist|opioid antagonist
5624800|NCT00800319|RDC-0313|rdc-0313
5624801|NCT00800306|sepsis|sepsis
5624802|NCT00800306|septic shock|septic shock
5624803|NCT00800306|microcirculation|microcirculation
5624804|NCT00800306|levosimendan|levosimendan
5624805|NCT00800306|dobutamine|dobutamine
5624806|NCT00800306|inotropes|inotropes
5624807|NCT00800306|inhaled nitric oxide|inhaled nitric oxide
5624808|NCT00800293|bioequivalence|bioequivalence
5624809|NCT00800293|betamethasone dipropionate|betamethasone dipropionate
5624810|NCT00800293|Bioequivalency|bioequivalency
5798768|NCT00111150|HIV prevention|hiv prevention
5685466|NCT00555984|Craniotomy|craniotomy
5624811|NCT00800280|cimetidine, PD 0332334, organic cation transporter, OCT2, pharmacokinetics|cimetidine, pd 0332334, organic cation transporter, oct2, pharmacokinetics
5624812|NCT00800267|glaucoma|glaucoma
5624813|NCT00800267|ocular hypertension|ocular hypertension
5624814|NCT00800267|Fixed combination latanoprost-timolol|fixed combination latanoprost-timolol
5624815|NCT00800267|latanoprost|latanoprost
5624816|NCT00800267|timolol|timolol
5624817|NCT00800254|electrical stimulation|electrical stimulation
5624818|NCT00800254|total knee arthroplasty|total knee arthroplasty
5624819|NCT00800254|quadriceps|quadriceps
5624820|NCT00800254|muscle|muscle
5624821|NCT00800254|arthroscopy|arthroscopy
5624822|NCT00800241|Asthma|asthma
5624823|NCT00800241|Symbicort SMART|symbicort smart
5624824|NCT00800241|Thai patient eligibility|thai patient eligibility
5624825|NCT00800241|Persistent asthma|persistent asthma
5624826|NCT00800228|salt|salt
5624827|NCT00800228|blood pressure|blood pressure
5624828|NCT00800228|breathing|breathing
5624829|NCT00800215|Epilepsy|epilepsy
5624830|NCT00800150|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5606486|NCT00872456|Haptoglobin|haptoglobin
5606487|NCT00872430|constipation|constipation
5624831|NCT00800150|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5624832|NCT00800150|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5624833|NCT00800150|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5624834|NCT00800150|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5624835|NCT00800150|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5624836|NCT00800150|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5624837|NCT00800150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5624838|NCT00800150|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5624839|NCT00800150|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5624840|NCT00800150|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5624841|NCT00800150|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5624842|NCT00800150|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5624843|NCT00800150|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5624844|NCT00800150|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5624845|NCT00800150|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5624846|NCT00800150|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5624848|NCT00800150|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5624849|NCT00800150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5624850|NCT00800150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5624851|NCT00800150|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5624852|NCT00800150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5624853|NCT00800150|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5624854|NCT00800150|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5624855|NCT00800150|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5624856|NCT00800150|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5624857|NCT00800150|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5624858|NCT00800150|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5624859|NCT00800150|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5624860|NCT00800150|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5624861|NCT00800150|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5624862|NCT00800150|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5624863|NCT00800150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5624864|NCT00800150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5624865|NCT00800150|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5624866|NCT00800150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5624867|NCT00800150|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5624868|NCT00800150|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5624869|NCT00800150|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5624870|NCT00800150|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5624871|NCT00800150|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5624872|NCT00800150|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5624873|NCT00800150|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5624874|NCT00800150|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5624875|NCT00800150|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5624876|NCT00800150|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5625260|NCT00798720|HDAC|hdac
5624877|NCT00800150|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5624882|NCT00800150|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5624883|NCT00800150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5624884|NCT00800150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5624885|NCT00800150|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5624886|NCT00800150|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5624887|NCT00800150|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5624888|NCT00800150|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5624889|NCT00800150|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5624890|NCT00800150|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5624892|NCT00800150|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5624893|NCT00800150|primary myelofibrosis|primary myelofibrosis
5624894|NCT00800150|stage II multiple myeloma|stage ii multiple myeloma
5624895|NCT00800150|stage III multiple myeloma|stage iii multiple myeloma
5624896|NCT00800150|refractory multiple myeloma|refractory multiple myeloma
5624897|NCT00800150|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5624898|NCT00800150|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5624899|NCT00800150|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5624900|NCT00800150|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5624901|NCT00800150|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5624902|NCT00800150|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5624903|NCT00800137|coumadin|coumadin
5624904|NCT00800137|device surgery|device surgery
5624905|NCT00800137|pocket hematoma|pocket hematoma
5624906|NCT00800137|Pocket hematoma and device surgery|pocket hematoma and device surgery
5624907|NCT00800124|hip fracture|hip fracture
5624908|NCT00800124|hemiprosthesis|hemiprosthesis
5624909|NCT00800124|bone cement|bone cement
5624910|NCT00800124|clinical outcome|clinical outcome
5624911|NCT00800111|failed penetrating keratoplasty|failed penetrating keratoplasty
5624912|NCT00800085|first degree relatives of type 1 diabetes patients|first degree relatives of type 1 diabetes patients
5624913|NCT00800085|hyperglycemic clamp test|hyperglycemic clamp test
5624914|NCT00800072|to verify accurrancy of data collected by the NOWOX|to verify accurrancy of data collected by the nowox
5624915|NCT00800059|Relapse|relapse
5624916|NCT00800059|Refractory|refractory
5624917|NCT00800046|Mitral valve|mitral valve
5624918|NCT00800046|Mitral regurgitation|mitral regurgitation
5624919|NCT00800046|Functional mitral regurgitation|functional mitral regurgitation
5624921|NCT00800046|FMR|fmr
5624922|NCT00800046|Heart valve|heart valve
5624923|NCT00800046|Mitral valve insufficiency|mitral valve insufficiency
5624924|NCT00800046|Valve repair|valve repair
5624925|NCT00800046|Valve disorder|valve disorder
5624926|NCT00800046|Cardiac surgery|cardiac surgery
5624927|NCT00800033|metabolic syndrome|metabolic syndrome
5624929|NCT00800033|blood pressure|blood pressure
5624930|NCT00800033|body composition|body composition
5624931|NCT00800007|Hepatitis C, HCV, ANZ-521, Listeria|hepatitis c, hcv, anz-521, listeria
5624932|NCT00799994|glaucoma|glaucoma
5624933|NCT00799994|intraocular pressure|intraocular pressure
5624934|NCT00799994|multifocal visually evoked potentials|multifocal visually evoked potentials
5624935|NCT00799968|Thrombolytic therapy|thrombolytic therapy
5624936|NCT00799968|Urokinase|urokinase
5624937|NCT00799968|Efficacy|efficacy
5624938|NCT00799968|Safety|safety
5624939|NCT00799955|Cesarean delivery|cesarean delivery
5624940|NCT00799955|post-operative analgesia|post-operative analgesia
5624941|NCT00799955|TAP block|tap block
5624942|NCT00799955|ultrasound|ultrasound
5624943|NCT00799942|Nystagmus, congenital idiopathic|nystagmus, congenital idiopathic
5624944|NCT00799929|IVF Research Study|ivf research study
5624945|NCT00799929|Infertility Sudy|infertility sudy
5624946|NCT00799929|in vitro fertilization|in vitro fertilization
5624947|NCT00799929|Mini IVF|mini ivf
5624948|NCT00799929|Conventional IVF|conventional ivf
5624949|NCT00799916|Sepsis|sepsis
5624950|NCT00799916|Fluid resuscitation|fluid resuscitation
5624951|NCT00799916|Voluven|voluven
5624952|NCT00799916|Colloids|colloids
5624953|NCT00799916|Saline solution|saline solution
5624954|NCT00799916|Crystalloids|crystalloids
5627609|NCT00788931|LBH589|lbh589
5624955|NCT00799916|Sublingual microcirculation|sublingual microcirculation
5624956|NCT00799903|heart disease|heart disease
5624957|NCT00799903|Lp-PLA2 inhibitor|lp-pla2 inhibitor
5624958|NCT00799903|cardiovascular disease|cardiovascular disease
5624959|NCT00799903|coronary heart disease|coronary heart disease
5624960|NCT00799903|CV risk|cv risk
5624961|NCT00799903|Atherosclerosis|atherosclerosis
5624962|NCT00799890|primary or secondary chronic-progressive|primary or secondary chronic-progressive
5624963|NCT00799890|sunphenon egcg|sunphenon egcg
5624964|NCT00799890|brain atrophy|brain atrophy
5624965|NCT00799890|T2 lesions|t2 lesions
5624966|NCT00799877|Psoriasis|psoriasis
5624967|NCT00799877|Moderate Psoriasis|moderate psoriasis
5624968|NCT00799877|Severe Psoriasis|severe psoriasis
5624969|NCT00799877|Chronic Plaque Psoriasis|chronic plaque psoriasis
5624970|NCT00799877|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
5624971|NCT00799877|Registry|registry
5624972|NCT00799864|HIV Infection|hiv infection
5624973|NCT00799864|Antiretroviral|antiretroviral
5624974|NCT00799864|HIV-1|hiv-1
5624975|NCT00799864|AIDS|aids
5624976|NCT00799864|Children|children
5624977|NCT00799864|Rilpivirine (TMC278)|rilpivirine (tmc278)
5624978|NCT00799864|Pediatric|pediatric
5624979|NCT00799851|advanced liver disease|advanced liver disease
5624980|NCT00799851|esophageal varices|esophageal varices
5624981|NCT00799851|band ligation|band ligation
5624982|NCT00799851|cyanoacrylate injection|cyanoacrylate injection
5624983|NCT00799825|papillomavirus|papillomavirus
5624984|NCT00799825|HPV vaccine|hpv vaccine
5624985|NCT00799825|cervical cancer|cervical cancer
5624987|NCT00799825|human papillomavirus|human papillomavirus
5624988|NCT00799812|antimicrobial|antimicrobial
5624989|NCT00799812|antisepsis|antisepsis
5624990|NCT00799799|Nk cells infusion|nk cells infusion
5624991|NCT00799799|minimal residual disease in AML patients|minimal residual disease in aml patients
5624992|NCT00799799|trafficking of NK cells after infusion|trafficking of nk cells after infusion
5624993|NCT00799799|cytolytic effects on leukemic cells|cytolytic effects on leukemic cells
5624995|NCT00799773|Rituximab|rituximab
5624996|NCT00799773|Plasma Exchange|plasma exchange
5624997|NCT00799760|influenza A|influenza a
5624998|NCT00799760|neuraminidase inhibitor|neuraminidase inhibitor
5624999|NCT00799760|oseltamivir|oseltamivir
5625000|NCT00799760|zanamivir|zanamivir
5625001|NCT00799760|treatment outcome|treatment outcome
5625002|NCT00799760|resistance|resistance
5625003|NCT00799760|mutation|mutation
5625004|NCT00799760|combination therapy|combination therapy
5625005|NCT00799760|monotherapy|monotherapy
5625006|NCT00799760|pandemic|pandemic
5625007|NCT00799760|primary care|primary care
5625008|NCT00799760|randomized controlled trials|randomized controlled trials
5625009|NCT00799760|antiviral agent|antiviral agent
5625010|NCT00799747|safety|safety
5625011|NCT00799747|tolerability|tolerability
5625012|NCT00799747|pharmacokinetics|pharmacokinetics
5625013|NCT00799747|AZD4017Japanese|azd4017japanese
5625014|NCT00799734|hot flushes|hot flushes
5625015|NCT00799734|night sweats|night sweats
5625016|NCT00799734|menopausal symptoms|menopausal symptoms
5625017|NCT00799734|osteoporosis|osteoporosis
5625018|NCT00799734|complementary and alternative medicine|complementary and alternative medicine
5625024|NCT00799721|sFLT-1|sflt-1
5625025|NCT00799721|very low birth weight infants|very low birth weight infants
5625026|NCT00799721|retinopathy of prematurity|retinopathy of prematurity
5625027|NCT00799721|erythropoietin therapy and risk of ROP|erythropoietin therapy and risk of rop
5609813|NCT00858793|HIV|hiv
5625028|NCT00799708|Biomarkers of estrogen receptor beta activation|biomarkers of estrogen receptor beta activation
5625029|NCT00799695|diabetic retinopathy|diabetic retinopathy
5625030|NCT00799695|screening|screening
5625031|NCT00799695|annual|annual
5625032|NCT00799682|Dry Eye|dry eye
5625033|NCT00799682|Monotherapy for Ocular Hypertension, Glaucoma|monotherapy for ocular hypertension, glaucoma
5625034|NCT00799682|Ocular Hypertension|ocular hypertension
5625035|NCT00799682|Chronic Open-Angle Glaucoma|chronic open-angle glaucoma
5625036|NCT00799682|Chronic Angle-Closure Glaucoma|chronic angle-closure glaucoma
5625037|NCT00799682|Iridotomy|iridotomy
5625038|NCT00799682|Iridectomy|iridectomy
5625039|NCT00799682|Pseudo Exfoliate|pseudo exfoliate
5625040|NCT00799682|Pigmentary Glaucoma|pigmentary glaucoma
5625041|NCT00799682|Systemic Non-Glaucoma Medications|systemic non-glaucoma medications
5625042|NCT00799682|Hyperemia|hyperemia
5625043|NCT00799669|hypopharyngeal cancer|hypopharyngeal cancer
5625044|NCT00799669|laryngeal cancer|laryngeal cancer
5625045|NCT00799669|lip and oral cavity cancer|lip and oral cavity cancer
5672495|NCT00611689|ZK222584|zk222584
5625046|NCT00799669|nasopharyngeal cancer|nasopharyngeal cancer
5625047|NCT00799669|oropharyngeal cancer|oropharyngeal cancer
5625048|NCT00799669|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5625049|NCT00799669|tobacco use disorder|tobacco use disorder
5625050|NCT00799656|Diabetic neuropathy|diabetic neuropathy
5625051|NCT00799656|painful pain|painful pain
5625052|NCT00799656|postoperative|postoperative
5625053|NCT00799643|Type 2 Diabetes Mellitus (T2D)|type 2 diabetes mellitus (t2d)
5625055|NCT00799643|Obesity|obesity
5625056|NCT00799643|Metabolic Syndrome|metabolic syndrome
5625057|NCT00799643|Salicylates|salicylates
5625058|NCT00799630|energy drink|energy drink
5625059|NCT00799630|exercise|exercise
5625060|NCT00799630|BCAA|bcaa
5625061|NCT00799630|peripheral and central fatigue|peripheral and central fatigue
5625062|NCT00799617|Testosterone|testosterone
5625063|NCT00799617|Mobility disability|mobility disability
5625064|NCT00799617|Decreased libido|decreased libido
5625065|NCT00799617|Age associated memory impairment|age associated memory impairment
5625066|NCT00799617|Low vitality|low vitality
5625067|NCT00799617|Anemia|anemia
5625068|NCT00799604|Hypertension|hypertension
5625069|NCT00799604|Antihypertensive Agent|antihypertensive agent
5625070|NCT00799604|Calcium Channel Blocker|calcium channel blocker
5625071|NCT00799591|Registre MONTRAVERS|registre montravers
5625072|NCT00799578|NASH, NAFLD,nonalcoholic steatohepatitis|nash, nafld,nonalcoholic steatohepatitis
5625073|NCT00799565|Mitral Valve prolapse|mitral valve prolapse
5625075|NCT00799565|genetic study|genetic study
5625076|NCT00799565|study case-witness|study case-witness
5625077|NCT00799565|Patients with a Mitral Valve Prolapse|patients with a mitral valve prolapse
5625078|NCT00799552|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5625079|NCT00799552|Dry eye|dry eye
5625080|NCT00799552|Resolvin|resolvin
5625081|NCT00799539|Prednisone|prednisone
5625082|NCT00799539|Bortezomib|bortezomib
5625083|NCT00799539|Melphalan|melphalan
5625084|NCT00799526|Ex Vivo Conjunctival Epithelial Cell|ex vivo conjunctival epithelial cell
5625085|NCT00799526|Transplantation|transplantation
5625086|NCT00799513|Lenalidomide|lenalidomide
5625087|NCT00799513|revlimid|revlimid
5625088|NCT00799513|large B-cell lymphoma|large b-cell lymphoma
5625089|NCT00799513|relapse|relapse
5625090|NCT00799487|ADHD|adhd
5625091|NCT00799487|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5625092|NCT00799435|Diabetes|diabetes
5625093|NCT00799435|Diastolic Heart Failure|diastolic heart failure
5625094|NCT00799435|Aortic Stiffness|aortic stiffness
5625095|NCT00799435|Exenatide|exenatide
5625096|NCT00799422|Conjunctival Staining|conjunctival staining
5625097|NCT00799422|lens parameters|lens parameters
5625098|NCT00799422|lens fit|lens fit
5625099|NCT00799409|ADHD|adhd
5625100|NCT00799409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5625101|NCT00799383|Risperidone|risperidone
5625102|NCT00799383|hyperprolactinemia|hyperprolactinemia
5625103|NCT00799383|children|children
5625104|NCT00799383|adolescents|adolescents
5625105|NCT00799383|antipsychotics|antipsychotics
5625106|NCT00799383|prevention|prevention
5625107|NCT00799383|calcium|calcium
5625108|NCT00799383|vitamin D|vitamin d
5625109|NCT00799383|Risperidone-induced hyperprolactinemia|risperidone-induced hyperprolactinemia
5625110|NCT00799370|Osteotomy|osteotomy
5625111|NCT00799370|Weight bearing|weight bearing
5625112|NCT00799370|Opening wedge|opening wedge
5625114|NCT00799344|Coronary Stent|coronary stent
5625115|NCT00799331|Healthy volunteers|healthy volunteers
5625116|NCT00799279|smoking|smoking
5625117|NCT00799279|cessation|cessation
5625118|NCT00799279|family medicine|family medicine
5625119|NCT00799279|evidence-based|evidence-based
5625120|NCT00799279|knowledge translation|knowledge translation
5625121|NCT00799279|smoking cessation, primary care|smoking cessation, primary care
5625122|NCT00799266|Osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, Duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions|osteoporosis, children and adolescents, zoledronic acid, chronic inflammation, duchenne muscular dystrophy, glucocorticoids, chronic inflammatory conditions
5625123|NCT00799240|lung cancer|lung cancer
5625124|NCT00799240|stage IIIb|stage iiib
5625125|NCT00799240|pleural effusion|pleural effusion
5625126|NCT00799240|stage IV|stage iv
5625127|NCT00799240|metastatic lung cancer|metastatic lung cancer
5625128|NCT00799240|non squamous lung cancer|non squamous lung cancer
5625129|NCT00799240|IGF-1R|igf-1r
5625130|NCT00799240|Pemetrexed|pemetrexed
5625131|NCT00799240|Cisplatin|cisplatin
5625132|NCT00799214|bacterial vaginosis|bacterial vaginosis
5625133|NCT00799214|intravaginal|intravaginal
5625134|NCT00799214|boric acid|boric acid
5625135|NCT00799214|metronidazole|metronidazole
5625136|NCT00799214|placebo controlled|placebo controlled
5625137|NCT00799214|double-blind|double-blind
5625138|NCT00799214|randomized|randomized
5625139|NCT00799214|multicenter|multicenter
5625140|NCT00799214|non-inferiority|non-inferiority
5625141|NCT00799201|Enteral nutrition|enteral nutrition
5625142|NCT00799201|Constipation|constipation
5625143|NCT00799201|Gastrointestinal motility|gastrointestinal motility
5625144|NCT00799201|Naloxone|naloxone
5625145|NCT00799201|Docusate|docusate
5625146|NCT00799201|Bowel stimulant|bowel stimulant
5625147|NCT00799201|Stool softener|stool softener
5625148|NCT00799188|Cardiac Transplantation|cardiac transplantation
5625149|NCT00799188|Skin cancer|skin cancer
5625150|NCT00799188|Everolimus|everolimus
5625151|NCT00799175|Postoperative pain|postoperative pain
5625152|NCT00799175|Local infiltration analgesia|local infiltration analgesia
5625153|NCT00799175|Knee arthroplasty|knee arthroplasty
5625154|NCT00799149|Post-operative pain|post-operative pain
5625155|NCT00799149|Knee arthroscopy|knee arthroscopy
5625156|NCT00799149|Gabapentin|gabapentin
5625157|NCT00799149|Etoricoxib|etoricoxib
5625259|NCT00798720|non small cell lung cancer|non small cell lung cancer
5625158|NCT00799149|Elective ambulatory knee arthroscopy|elective ambulatory knee arthroscopy
5625159|NCT00799136|Lymphoma Large B Cell Diffuse|lymphoma large b cell diffuse
5625160|NCT00799136|Acquired Immunodeficiency|acquired immunodeficiency
5625161|NCT00799123|NT-proBNP|nt-probnp
5625162|NCT00799110|dendritic cells|dendritic cells
5625163|NCT00799110|fusion vaccines|fusion vaccines
5625164|NCT00799110|GM-CSF|gm-csf
5625165|NCT00799110|imiquimod|imiquimod
5625166|NCT00799084|symptom management|symptom management
5625167|NCT00799084|cancer|cancer
5625168|NCT00799084|chemotherapy treatment|chemotherapy treatment
5625169|NCT00799084|Behavioral Research|behavioral research
5625170|NCT00799084|Physiological Effects of Drugs|physiological effects of drugs
5625171|NCT00799084|Clinical Trial, Phase II|clinical trial, phase ii
5625172|NCT00799071|prophylaxis|prophylaxis
5625173|NCT00799071|CGD|cgd
5625174|NCT00799071|pharmacokinetics|pharmacokinetics
5625175|NCT00799058|HIV-1 infections|hiv-1 infections
5625176|NCT00799045|Migraine|migraine
5625177|NCT00799045|atrial septal defects|atrial septal defects
5625178|NCT00799045|transcatheter|transcatheter
5625179|NCT00799045|clopidogrel|clopidogrel
5625180|NCT00799032|Coronary Stent|coronary stent
5625181|NCT00799019|EPO antibody mediated PRCA|epo antibody mediated prca
5625182|NCT00799019|Erythropoiesis stimulating agents|erythropoiesis stimulating agents
5625183|NCT00799006|Single Ascending Dose Study in Overweight subjects|single ascending dose study in overweight subjects
5625184|NCT00798993|Chronic kidney failure|chronic kidney failure
5625185|NCT00798993|25 hydroxyvitamin D|25 hydroxyvitamin d
5625186|NCT00798993|falls|falls
5625187|NCT00798993|exercise|exercise
5625188|NCT00798993|quadriceps strength|quadriceps strength
5625189|NCT00798980|Mirena|mirena
5625190|NCT00798980|Nulliparous|nulliparous
5625191|NCT00798980|Intrauterine Devices|intrauterine devices
5625192|NCT00798967|SBS|sbs
5625193|NCT00798967|short bowel syndrome|short bowel syndrome
5625194|NCT00798967|TPN|tpn
5625195|NCT00798967|parenteral nutrition|parenteral nutrition
5625196|NCT00798967|PN|pn
5625197|NCT00798915|Diabetes|diabetes
5625198|NCT00798915|Blood Sugar|blood sugar
5625199|NCT00798915|Xenin-25|xenin-25
5625200|NCT00798915|GIP|gip
5625201|NCT00798915|Insulin|insulin
5625202|NCT00798902|DDD|ddd
5625203|NCT00798902|Spondylolisthesis|spondylolisthesis
5625204|NCT00798902|Spine Fusion|spine fusion
5625205|NCT00798902|Lumbar Spine|lumbar spine
5625206|NCT00798902|Bone Graft|bone graft
5625207|NCT00798889|Solid tumors|solid tumors
5625208|NCT00798863|submandibular gland|submandibular gland
5625209|NCT00798863|video assisted neck surgery|video assisted neck surgery
5625210|NCT00798850|Claudication|claudication
5625212|NCT00798850|Peripheral Vascular Disease|peripheral vascular disease
5625213|NCT00798850|Peripheral arterial disease|peripheral arterial disease
5625214|NCT00798850|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
5625215|NCT00798850|Angioplasty|angioplasty
5625216|NCT00798850|Femoral angioplasty|femoral angioplasty
5625217|NCT00798850|Superficial femoral artery|superficial femoral artery
5625218|NCT00798850|Femoral arterial disease|femoral arterial disease
5625219|NCT00798850|Exercise|exercise
5625220|NCT00798850|Supervised exercise|supervised exercise
5625221|NCT00798850|Exercise therapy|exercise therapy
5625222|NCT00798850|Exercise programme|exercise programme
5625223|NCT00798850|Infrainuginal|infrainuginal
5625224|NCT00798850|Quality of life|quality of life
5625225|NCT00798850|SF36|sf36
5625226|NCT00798850|Questionnaire|questionnaire
5625227|NCT00798850|VascuQol|vascuqol
5625228|NCT00798850|Randomised|randomised
5625229|NCT00798850|Randomised trial|randomised trial
5625230|NCT00798850|Combination therapy|combination therapy
5625231|NCT00798850|Intermittent Claudication due to Femoropopliteal Disease|intermittent claudication due to femoropopliteal disease
5625232|NCT00798837|prostate|prostate
5625233|NCT00798837|cancer|cancer
5625234|NCT00798837|IMRT|imrt
5625235|NCT00798837|radiation|radiation
5625236|NCT00798824|tube feeding|tube feeding
5625237|NCT00798824|premature infant|premature infant
5625238|NCT00798811|brain tumor|brain tumor
5625239|NCT00798811|high-dose chemotherapy|high-dose chemotherapy
5625240|NCT00798811|autologous stem cell transplantation|autologous stem cell transplantation
5625241|NCT00798811|infant|infant
5625242|NCT00798785|diabetes mellitus type 1|diabetes mellitus type 1
5625243|NCT00798785|pancreatic beta cell|pancreatic beta cell
5625244|NCT00798785|transplantation|transplantation
5625245|NCT00798772|HIV infection|hiv infection
5625246|NCT00798772|Micronutrients|micronutrients
5625247|NCT00798772|Antioxidants|antioxidants
5625248|NCT00798759|Open-angle glaucoma|open-angle glaucoma
5625249|NCT00798759|Ocular hypertension|ocular hypertension
5625250|NCT00798746|Esophageal cancer|esophageal cancer
5625251|NCT00798746|pyloric drainage|pyloric drainage
5625252|NCT00798746|pyloric drainage procedure|pyloric drainage procedure
5625253|NCT00798746|reflux|reflux
5625254|NCT00798746|reflux symptoms|reflux symptoms
5625255|NCT00798746|esophagectomy|esophagectomy
5625256|NCT00798746|Quality of Life|quality of life
5625257|NCT00798746|Health-related quality of life|health-related quality of life
5625261|NCT00798720|proteasome inhibitor|proteasome inhibitor
5625262|NCT00798707|Major Depressive Disorder|major depressive disorder
5625263|NCT00798694|glaucoma|glaucoma
5625264|NCT00798694|impression cytology|impression cytology
5625265|NCT00798694|ocular surface changes|ocular surface changes
5625266|NCT00798694|prostaglandins|prostaglandins
5625267|NCT00798681|parenteral nutrition|parenteral nutrition
5625268|NCT00798681|ready-to-use|ready-to-use
5625269|NCT00798681|customized nutrition formulation|customized nutrition formulation
5625270|NCT00798681|olive oil|olive oil
5625271|NCT00798681|soybean oil|soybean oil
5625272|NCT00798681|LCT/MCT|lct/mct
5625273|NCT00798681|Clinoleic|clinoleic
5625274|NCT00798681|oliclinomel|oliclinomel
5625275|NCT00798681|number of infections associated with TPN delivery system|number of infections associated with tpn delivery system
5625277|NCT00798681|Infection rates|infection rates
5625278|NCT00798668|Endocrine and Gastrointestinal Response to Food|endocrine and gastrointestinal response to food
5625279|NCT00798655|panitumumab|panitumumab
5625280|NCT00798655|cisplatin|cisplatin
5625281|NCT00798655|radiation|radiation
5625282|NCT00798642|Hypnotherapy|hypnotherapy
5625283|NCT00798642|Ulcerative Colitis|ulcerative colitis
5625284|NCT00798642|Inflammatory Bowel Disease|inflammatory bowel disease
5625285|NCT00798642|Gastrointestinal Diseases|gastrointestinal diseases
5625286|NCT00798642|Digestive System Diseases|digestive system diseases
5625287|NCT00798642|Intestinal Diseases|intestinal diseases
5625288|NCT00798642|Colonic Diseases|colonic diseases
5625289|NCT00798629|stage III melanoma|stage iii melanoma
5625290|NCT00798629|stage IV melanoma|stage iv melanoma
5625291|NCT00798629|recurrent melanoma|recurrent melanoma
5625292|NCT00798629|mucosal melanoma|mucosal melanoma
5625293|NCT00798616|bronchiolitis|bronchiolitis
5625294|NCT00798616|steroids|steroids
5625295|NCT00798616|corticosteroids|corticosteroids
5625296|NCT00798616|albuterol|albuterol
5625297|NCT00798616|child|child
5625298|NCT00798616|infant|infant
5625299|NCT00798616|pediatric|pediatric
5625300|NCT00798603|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5625301|NCT00798603|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5625302|NCT00798603|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5625303|NCT00798603|adenocarcinoma of the lung|adenocarcinoma of the lung
5625304|NCT00798603|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5625305|NCT00798590|Intensive insulin therapy (IIT)|intensive insulin therapy (iit)
5625306|NCT00798590|Insulin infusion|insulin infusion
5625307|NCT00798590|Tight glycemic control|tight glycemic control
5625308|NCT00798590|Intensive Care Units|intensive care units
5625310|NCT00798564|Exercise|exercise
5625311|NCT00798564|Mannitol|mannitol
5625312|NCT00798538|Buprenorphine|buprenorphine
5625313|NCT00798538|HIV|hiv
5625314|NCT00798538|Drug Abuse|drug abuse
5625315|NCT00798538|Drug Addiction|drug addiction
5625316|NCT00798538|Drug Dependence|drug dependence
5625317|NCT00798538|Drug Use Disorders|drug use disorders
5610094|NCT00857623|Pain|pain
5625318|NCT00798538|Drug Use Disorder|drug use disorder
5625319|NCT00798538|Substance Abuse|substance abuse
5625320|NCT00798538|Opiate Addiction|opiate addiction
5625321|NCT00798538|Substance-related disorders|substance-related disorders
5625322|NCT00798525|thrombocytopenia|thrombocytopenia
5625323|NCT00798525|Heparin|heparin
5625324|NCT00798525|Lepirudin|lepirudin
5625325|NCT00798525|Argatroban|argatroban
5625326|NCT00798525|critically ill patients|critically ill patients
5625327|NCT00798512|carotid artery stenting|carotid artery stenting
5625328|NCT00798512|cerebral protection|cerebral protection
5625329|NCT00798512|stroke|stroke
5625330|NCT00798512|ischemic lesion|ischemic lesion
5625331|NCT00798512|DW-MRI|dw-mri
5625332|NCT00798499|haemophilia|haemophilia
5625333|NCT00798499|patients with haemophilia|patients with haemophilia
5625334|NCT00798473|Crohn's disease|crohn's disease
5625335|NCT00798473|Osteopenia|osteopenia
5625336|NCT00798473|Osteoporosis|osteoporosis
5625337|NCT00798473|Bisphosphonates|bisphosphonates
5625338|NCT00798473|Zoledronate|zoledronate
5625339|NCT00798460|Chronic hepatitis B|chronic hepatitis b
5625340|NCT00798460|lamivudine resistance|lamivudine resistance
5625341|NCT00798460|clevudine|clevudine
5625342|NCT00798447|post OP|post op
5625343|NCT00798434|Overactive bladder syndrome|overactive bladder syndrome
5625344|NCT00798434|fesoterodine|fesoterodine
5625345|NCT00798434|elderly|elderly
5625346|NCT00798434|flexible dose regimen|flexible dose regimen
5625347|NCT00798434|urgency|urgency
5625348|NCT00798434|frequency|frequency
5625349|NCT00798434|urge urinary incontinence|urge urinary incontinence
5625350|NCT00798434|anticholinergic|anticholinergic
5625351|NCT00798434|antimuscarinic|antimuscarinic
5625353|NCT00798408|Evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly|evaluate the effects of energy-yielding fluids and solids endocrine and metabolic response to food in the elderly
5625354|NCT00798369|Acute flares|acute flares
5625355|NCT00798369|Gout|gout
5625356|NCT00798369|Anti-interleukin-1β monoclonal antibody|anti-interleukin-1β monoclonal antibody
5625357|NCT00798369|Colchicine|colchicine
5625367|NCT00798330|PICC line|picc line
5625368|NCT00798304|Meningococcal B vaccine|meningococcal b vaccine
5625369|NCT00798304|infants|infants
5625370|NCT00798304|safety|safety
5625371|NCT00798304|immunogenicity|immunogenicity
5625372|NCT00798278|Empyema|empyema
5625373|NCT00798278|Urokinase|urokinase
5625374|NCT00798278|Thoracoscopic|thoracoscopic
5625375|NCT00798278|Childhood|childhood
5685467|NCT00555984|Postoperative complications|postoperative complications
5625384|NCT00798252|metastatic, chemotherapy combination|metastatic, chemotherapy combination
5625385|NCT00798239|DDD|ddd
5625386|NCT00798239|Spondylolisthesis|spondylolisthesis
5625387|NCT00798239|Spine Fusion|spine fusion
5625388|NCT00798239|Lumbar Spine|lumbar spine
5625389|NCT00798239|Bone Graft|bone graft
5625394|NCT00798200|Cancer|cancer
5625395|NCT00798200|Oncology|oncology
5625396|NCT00798200|Rehabilitation|rehabilitation
5625397|NCT00798200|Endurance|endurance
5625398|NCT00798200|Strength|strength
5625399|NCT00798187|Prostate Cancer|prostate cancer
5625400|NCT00798187|Breast Cancer|breast cancer
5625401|NCT00798187|Behavioral Intervention|behavioral intervention
5625402|NCT00798187|Cancer Support Programs|cancer support programs
5625403|NCT00798187|Social Comparison|social comparison
5625404|NCT00798187|Heterogeneous support group|heterogeneous support group
5625405|NCT00798187|Homogeneous support group|homogeneous support group
5625406|NCT00798174|DFT|dft
5625407|NCT00798174|Congestive Heart failure (CHF)|congestive heart failure (chf)
5625408|NCT00798174|ICD|icd
5625409|NCT00798148|Neuroblastoma|neuroblastoma
5625410|NCT00798148|MIBG|mibg
5625411|NCT00798148|Autologous Peripheral Stem Cell Transplantation|autologous peripheral stem cell transplantation
5625412|NCT00798122|sex|sex
5625413|NCT00798122|acute coronary syndromes|acute coronary syndromes
5625414|NCT00798122|normal angiogram|normal angiogram
5625415|NCT00798122|no obstruction at angiography|no obstruction at angiography
5625416|NCT00798122|women|women
5625417|NCT00798109|Schizophrenia|schizophrenia
5625418|NCT00798109|Cannabis misuse comorbidity|cannabis misuse comorbidity
5625419|NCT00798109|Motivational interview|motivational interview
5625420|NCT00798109|Randomised open trial|randomised open trial
5625421|NCT00798096|T Cell Lymphoma|t cell lymphoma
5625422|NCT00798096|Lymphoma|lymphoma
5625423|NCT00798070|Lymph node positive or high risk lymph node negative breast|lymph node positive or high risk lymph node negative breast
5625424|NCT00798070|cancer|cancer
5625425|NCT00798057|Pituitary tumor|pituitary tumor
5625426|NCT00798057|Outcomes|outcomes
5625427|NCT00798057|Proton radiation|proton radiation
5625428|NCT00798044|quality improvement|quality improvement
5625429|NCT00798044|feedback|feedback
5625433|NCT00798031|posterior tooth loss|posterior tooth loss
5625434|NCT00798031|short dental implant|short dental implant
5625435|NCT00798031|Adults, 18 years of age and older|adults, 18 years of age and older
5625436|NCT00798031|Missing a minimum of two posterior teeth in their upper jaw|missing a minimum of two posterior teeth in their upper jaw
5625437|NCT00798031|Subjects in need of dental implants|subjects in need of dental implants
5625438|NCT00798031|the research study is survival and function of the implants|the research study is survival and function of the implants
5625439|NCT00798018|lidocaine|lidocaine
5625440|NCT00798018|tetracaine|tetracaine
5625441|NCT00798018|tracheal intubation|tracheal intubation
5625442|NCT00798018|pharyngitis|pharyngitis
5625443|NCT00798005|NV1FGF|nv1fgf
5625444|NCT00798005|PAOD|paod
5625445|NCT00798005|CLI|cli
5625446|NCT00797992|Bevacizumab|bevacizumab
5625447|NCT00797992|Myopia|myopia
5625448|NCT00797992|Complications|complications
5625449|NCT00797992|Neovascularization|neovascularization
5625450|NCT00797992|OCT|oct
5625451|NCT00797979|Craniotomy|craniotomy
5625452|NCT00797979|Skull fixation|skull fixation
5625453|NCT00797979|Skull Grip|skull grip
5625454|NCT00797979|Reconstructive cranial surgery|reconstructive cranial surgery
5625455|NCT00797966|OPC-34712, Major Depressive Disorder, Adjunctive Treatment|opc-34712, major depressive disorder, adjunctive treatment
5625456|NCT00797953|Angina Pectoris Treatment|angina pectoris treatment
5625457|NCT00797940|GBM|gbm
5625458|NCT00797940|Glioblastoma|glioblastoma
5625459|NCT00797940|Glioblastoma Multiforme|glioblastoma multiforme
5625460|NCT00797940|Brain Tumor|brain tumor
5625461|NCT00797940|Brain Cancer|brain cancer
5625462|NCT00797940|Glioma|glioma
5625463|NCT00797927|schizophrenia|schizophrenia
5625464|NCT00797927|quetiapine|quetiapine
5625465|NCT00797927|conventional antipsychotics|conventional antipsychotics
5625466|NCT00797927|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5625467|NCT00797914|Colonoscopy|colonoscopy
5625474|NCT00797888|HbA1c|hba1c
5625475|NCT00797888|health disparities|health disparities
5625476|NCT00797875|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion|proprioceptive neuromuscular facilitation stretching technique, total knee arthroplasty, range of motion
5625477|NCT00797862|Aliskiren|aliskiren
5625478|NCT00797862|Amlodipine|amlodipine
5625479|NCT00797862|Hypertension|hypertension
5625480|NCT00797862|SPA1000|spa1000
5625481|NCT00797862|Norvasc|norvasc
5625482|NCT00797849|phantom limb pain|phantom limb pain
5625483|NCT00797849|amputees|amputees
5625484|NCT00797849|Farabloc|farabloc
5625485|NCT00797849|Phantom limb pain in the missing limb of Veteran amputees|phantom limb pain in the missing limb of veteran amputees
5625486|NCT00797836|Occupational Diseases|occupational diseases
5625487|NCT00797836|Tuberculosis|tuberculosis
5625488|NCT00797836|Tuberculin Test|tuberculin test
5625489|NCT00797836|Immunoassay|immunoassay
5625490|NCT00797823|diabetes|diabetes
5625491|NCT00797823|pancreas|pancreas
5625492|NCT00797823|beta cell|beta cell
5625495|NCT00797823|hypoglycemia|hypoglycemia
5625496|NCT00797810|Acute lymphoblastic leukemia of the mature B-cell type|acute lymphoblastic leukemia of the mature b-cell type
5625497|NCT00797810|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
5625498|NCT00797797|fibromyalgia|fibromyalgia
5625499|NCT00797797|milnacipran|milnacipran
5625500|NCT00797797|pregabalin|pregabalin
5625501|NCT00797797|treatment|treatment
5625502|NCT00797797|Forest Research Institute|forest research institute
5625503|NCT00797771|Insulin delivery|insulin delivery
5625504|NCT00797758|Cord blood transplantation|cord blood transplantation
5625505|NCT00797758|Conditioning regimen|conditioning regimen
5625506|NCT00797758|Acute myeloid leukaemia|acute myeloid leukaemia
5625507|NCT00797758|SORROR comorbidity index|sorror comorbidity index
5625508|NCT00797758|Quality of life|quality of life
5625509|NCT00797758|Innate immunity|innate immunity
5625510|NCT00797758|Immune reconstitution post transplant|immune reconstitution post transplant
5625511|NCT00797758|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5625512|NCT00797758|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5625513|NCT00797745|genotype 1 infection|genotype 1 infection
5625514|NCT00797732|acupuncture|acupuncture
5625515|NCT00797732|dysphagia|dysphagia
5625516|NCT00797732|chemoradiation related effects|chemoradiation related effects
5625517|NCT00797732|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5625518|NCT00797732|nasopharyngeal cancer|nasopharyngeal cancer
5625519|NCT00797732|oropharynx cancer|oropharynx cancer
5625520|NCT00797732|hypopharynx cancer|hypopharynx cancer
5625521|NCT00797732|larynx cancer|larynx cancer
5625522|NCT00797719|MPM|mpm
5625523|NCT00797719|Short hemithoracic IMRT|short hemithoracic imrt
5625524|NCT00797693|First trimester|first trimester
5625525|NCT00797693|missed abortion|missed abortion
5625526|NCT00797693|misoprostol|misoprostol
5625527|NCT00797693|cervical ripening|cervical ripening
5625529|NCT00797693|vaginal|vaginal
5625530|NCT00797693|first trimester missed abortion|first trimester missed abortion
5625531|NCT00797680|Pediatric cardiac arrest|pediatric cardiac arrest
5625532|NCT00797654|Sexual Risks for HIV|sexual risks for hiv
5625533|NCT00797654|Psychosocial Sequelae Relating to Childhood Sexual Abuse|psychosocial sequelae relating to childhood sexual abuse
5625534|NCT00797641|bleeding|bleeding
5625536|NCT00797641|hemorrhage|hemorrhage
5625537|NCT00797641|gastrointestinal diseases|gastrointestinal diseases
5625538|NCT00797641|digestive system disease|digestive system disease
5625539|NCT00797641|peptic ulcer|peptic ulcer
5625540|NCT00797641|proton pump inhibitor|proton pump inhibitor
5625541|NCT00797602|Chordomas|chordomas
5625542|NCT00797602|Chondrosarcomas|chondrosarcomas
5625543|NCT00797602|Cancer|cancer
5625544|NCT00797602|Outcomes|outcomes
5625545|NCT00797602|Proton radiation|proton radiation
5625546|NCT00797589|aorta valve|aorta valve
5625547|NCT00797589|mitral valve|mitral valve
5625548|NCT00797589|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5625549|NCT00797589|perfusion|perfusion
5625550|NCT00797589|priming|priming
5625551|NCT00797576|left atrial appendage thrombi|left atrial appendage thrombi
5625552|NCT00797576|transesophageal echocardiogram|transesophageal echocardiogram
5672496|NCT00611676|osteoarthritis pain|osteoarthritis pain
5625553|NCT00797576|cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5625554|NCT00797576|atrial fibrillation|atrial fibrillation
5625555|NCT00797576|cardioversion|cardioversion
5625556|NCT00797550|posterolateral spine fusion|posterolateral spine fusion
5625557|NCT00797550|bone graft|bone graft
5625558|NCT00797537|Inflammation of bone and cartilage|inflammation of bone and cartilage
5625559|NCT00797511|Diphtheria|diphtheria
5625561|NCT00797511|Pertussis|pertussis
5625562|NCT00797511|Poliomyelitis|poliomyelitis
5625563|NCT00797498|Nasal Cavity|nasal cavity
5625564|NCT00797498|Paranasal Sinuses|paranasal sinuses
5625565|NCT00797498|Proton Radiation|proton radiation
5625566|NCT00797498|Outcomes|outcomes
5625567|NCT00797485|stage IV colon cancer|stage iv colon cancer
5625568|NCT00797485|stage IV rectal cancer|stage iv rectal cancer
5625569|NCT00797472|Hodgkin's Lymphoma|hodgkin's lymphoma
5625570|NCT00797472|R-mabHD|r-mabhd
5625571|NCT00797472|ABVD treatment|abvd treatment
5625572|NCT00797472|Hodgkin's Disease|hodgkin's disease
5625573|NCT00797459|Correction of Nasolabial Folds|correction of nasolabial folds
5625574|NCT00797446|Oropharyngeal|oropharyngeal
5625575|NCT00797446|cancer|cancer
5625576|NCT00797446|proton|proton
5625577|NCT00797446|radiation|radiation
5625578|NCT00797446|outcomes|outcomes
5625579|NCT00797433|testosterone|testosterone
5625580|NCT00797433|mechanical ventilation|mechanical ventilation
5625581|NCT00797420|fluconazole|fluconazole
5625582|NCT00797420|pharmacokinetic|pharmacokinetic
5625583|NCT00797420|candidiasis|candidiasis
5625584|NCT00797420|sepsis|sepsis
5625585|NCT00797420|pediatric|pediatric
5625586|NCT00797420|infants|infants
5625587|NCT00797420|antifungal|antifungal
5625588|NCT00797420|candidemia|candidemia
5625589|NCT00797420|fungemia|fungemia
5625590|NCT00797420|loading dose|loading dose
5625591|NCT00797407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5625592|NCT00797407|Creatine|creatine
5625593|NCT00797407|Adverse Effects|adverse effects
5625594|NCT00797407|Muscle Toxicity|muscle toxicity
5625595|NCT00797394|prostate|prostate
5625596|NCT00797394|dietary supplements|dietary supplements
5625597|NCT00797394|saw palmetto|saw palmetto
5625598|NCT00797394|canada|canada
5625599|NCT00797381|MK-0518|mk-0518
5625600|NCT00797381|HIV|hiv
5625601|NCT00797381|AIDS|aids
5625602|NCT00797381|hemophilia|hemophilia
5625603|NCT00797381|treatment experienced|treatment experienced
5625604|NCT00797368|ankle sprain|ankle sprain
5625605|NCT00797368|manual therapy|manual therapy
5625606|NCT00797368|exercise|exercise
5625607|NCT00797368|physical therapy|physical therapy
5625608|NCT00797368|Patients who have sustained an inversion ankle sprain|patients who have sustained an inversion ankle sprain
5625609|NCT00797342|rheumatoid arthritis First in human safety pharmacokinetics pharmacodynamics|rheumatoid arthritis first in human safety pharmacokinetics pharmacodynamics
5625610|NCT00797329|psychiatric patients with violent behavior|psychiatric patients with violent behavior
5625611|NCT00797316|Hypertension|hypertension
5625612|NCT00797316|Metabolic Syndrome|metabolic syndrome
5625613|NCT00797316|aliskiren|aliskiren
5625614|NCT00797316|hydrochlorothiazide|hydrochlorothiazide
5625615|NCT00797316|systolic blood pressure|systolic blood pressure
5625616|NCT00797316|diastolic blood pressure|diastolic blood pressure
5625617|NCT00797316|stage 2|stage 2
5625618|NCT00797303|bevacizumab|bevacizumab
5625619|NCT00797303|cornea|cornea
5625620|NCT00797303|neovascularization|neovascularization
5625621|NCT00797290|Nasopharynx Cancer, Proton Radiation, Outcomes|nasopharynx cancer, proton radiation, outcomes
5625622|NCT00797277|schizophrenia|schizophrenia
5625623|NCT00797277|schizoaffective disorder|schizoaffective disorder
5625624|NCT00797277|olanzapine|olanzapine
5625625|NCT00797277|haloperidol|haloperidol
5625626|NCT00797277|lorazepam|lorazepam
5625627|NCT00797277|agitation|agitation
5625628|NCT00797264|Ketamine|ketamine
5625629|NCT00797264|Morphine|morphine
5625631|NCT00797264|Hyperalgesia|hyperalgesia
5625632|NCT00797264|Nor-ketamine|nor-ketamine
5625633|NCT00797251|Colorectal liver metastasis|colorectal liver metastasis
5625634|NCT00797251|hepatocellular carcinoma|hepatocellular carcinoma
5625635|NCT00797251|liver surgery|liver surgery
5625636|NCT00797251|intraoperative ultrasound|intraoperative ultrasound
5625637|NCT00797251|finger-compression|finger-compression
5625638|NCT00797238|Gene Expression|gene expression
5625639|NCT00797238|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5625640|NCT00797238|Chemotherapy|chemotherapy
5625641|NCT00797225|bone mineral density,endometriosis,pelvic pain|bone mineral density,endometriosis,pelvic pain
5625642|NCT00797199|Breast Cancer Risk|breast cancer risk
5625643|NCT00797199|Hormone Replacement Therapy|hormone replacement therapy
5625644|NCT00797199|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5625645|NCT00797199|Optical Breast Spectroscopy|optical breast spectroscopy
5625646|NCT00797199|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5625647|NCT00797186|diabetes|diabetes
5625648|NCT00797186|dyslipidemia|dyslipidemia
5625649|NCT00797186|microvascular dysfunction|microvascular dysfunction
5625650|NCT00797186|imaging|imaging
5625651|NCT00797160|propofol|propofol
5625652|NCT00797160|midazolam|midazolam
5625653|NCT00797160|neonate|neonate
5625654|NCT00797160|tracheal intubation|tracheal intubation
5625655|NCT00797121|Cholangiocarcinoma|cholangiocarcinoma
5625656|NCT00797121|Drainage|drainage
5625657|NCT00797095|Adolescence|adolescence
5625658|NCT00797095|Obesity|obesity
5625659|NCT00797095|Substance use|substance use
5625660|NCT00797095|Prevalence|prevalence
5625661|NCT00797095|Social and Environmental Contexts|social and environmental contexts
5625662|NCT00797095|Survey|survey
5625663|NCT00797082|Diabetic|diabetic
5625664|NCT00797082|Coronary disease|coronary disease
5625665|NCT00797082|Atherosclerosis|atherosclerosis
5625666|NCT00797082|Magnetic resonance imaging|magnetic resonance imaging
5625667|NCT00797082|Myocardial Perfusion Scintigraphy|myocardial perfusion scintigraphy
5625668|NCT00797082|Coronary angiography|coronary angiography
5625669|NCT00797056|G-CSF|g-csf
5625670|NCT00797056|angiogenesis|angiogenesis
5625671|NCT00797056|endothelial progenitor cell|endothelial progenitor cell
5625672|NCT00797056|limb ischemia|limb ischemia
5625673|NCT00797056|revascularization|revascularization
5625674|NCT00797043|Carcinoma of the skin of the head and neck|carcinoma of the skin of the head and neck
5625675|NCT00797043|Proton radiation|proton radiation
5625676|NCT00797043|Outcomes|outcomes
5625677|NCT00797030|dry eye syndromes|dry eye syndromes
5625678|NCT00797030|keratoconjuntivitis sicca / drug therapy|keratoconjuntivitis sicca / drug therapy
5625679|NCT00797030|cyclosporine|cyclosporine
5625680|NCT00797030|ophthalmic solutions|ophthalmic solutions
5625681|NCT00797030|HIV seropositivity|hiv seropositivity
5625682|NCT00797017|Chronic Pain|chronic pain
5625684|NCT00797017|Spinal disorder-related pain|spinal disorder-related pain
5625685|NCT00797004|olfactory dysfunction|olfactory dysfunction
5625686|NCT00796991|Untreated Advanced Melanoma|untreated advanced melanoma
5625687|NCT00796978|stage I breast cancer|stage i breast cancer
5625688|NCT00796978|stage II breast cancer|stage ii breast cancer
5625689|NCT00796978|stage IIIA breast cancer|stage iiia breast cancer
5625690|NCT00796978|stage IIIB breast cancer|stage iiib breast cancer
5625691|NCT00796978|stage IIIC breast cancer|stage iiic breast cancer
5625692|NCT00796978|HER2-positive breast cancer|her2-positive breast cancer
5625693|NCT00796965|Phase 1|phase 1
5625694|NCT00796952|Head/ neck cancer|head/ neck cancer
5625695|NCT00796952|Swallowing|swallowing
5625696|NCT00796952|behavioral treatment|behavioral treatment
5625697|NCT00796939|Delayed Sleep Phase Syndrome|delayed sleep phase syndrome
5625698|NCT00796939|Sleep|sleep
5625699|NCT00796900|Hyperthermia|hyperthermia
5625700|NCT00796900|subarachnoidal hemorrhage|subarachnoidal hemorrhage
5625701|NCT00796900|placebo controlled|placebo controlled
5625702|NCT00796900|double blinded|double blinded
5625703|NCT00796900|Dantrolene|dantrolene
5625704|NCT00796887|Ischemic Stroke|ischemic stroke
5625705|NCT00796887|Recovery of Function|recovery of function
5625706|NCT00796887|Extended-release niacin|extended-release niacin
5625707|NCT00796874|stage I prostate cancer|stage i prostate cancer
5625708|NCT00796874|stage II prostate cancer|stage ii prostate cancer
5625709|NCT00796861|malignant ascites|malignant ascites
5625710|NCT00796835|Schizophrenia|schizophrenia
5625711|NCT00796835|Mood disorders|mood disorders
5625712|NCT00796835|Antipsychotic drugs|antipsychotic drugs
5625713|NCT00796835|ER OROS Paliperidone|er oros paliperidone
5625714|NCT00796822|Endothelial Function|endothelial function
5625715|NCT00796822|Inflammation|inflammation
5625716|NCT00796809|TNF inhibitors|tnf inhibitors
5625717|NCT00796809|Biologic agents|biologic agents
5625718|NCT00796809|coccidioidomycosis|coccidioidomycosis
5625719|NCT00796809|Rheumatoid arthritis|rheumatoid arthritis
5625720|NCT00796796|Non-small cell lung cancer|non-small cell lung cancer
5625722|NCT00796796|radiation therapy|radiation therapy
5625723|NCT00796783|Cushing's Disease|cushing's disease
5625724|NCT00796783|Cushing's Syndrome|cushing's syndrome
5625725|NCT00796783|Cushings|cushings
5625726|NCT00796783|Pituitary|pituitary
5625727|NCT00796783|ACTH|acth
5625728|NCT00796783|Adrenocorticotropic hormone|adrenocorticotropic hormone
5625729|NCT00796783|Ectopic|ectopic
5625730|NCT00796783|Adrenal adenoma|adrenal adenoma
5625731|NCT00796783|Adrenal carcinoma|adrenal carcinoma
5625732|NCT00796783|Adrenal autonomy|adrenal autonomy
5625733|NCT00796783|Cortisol|cortisol
5625734|NCT00796783|Hypercortisolemia|hypercortisolemia
5625735|NCT00796783|Cushinoid|cushinoid
5625736|NCT00796783|Moon facies|moon facies
5625737|NCT00796783|Dorsalcervical fat|dorsalcervical fat
5625738|NCT00796783|Plethora|plethora
5625739|NCT00796783|Hirsutism|hirsutism
5625740|NCT00796783|Violaceous striae|violaceous striae
5625741|NCT00796783|Hormone|hormone
5625742|NCT00796783|Contraceptive|contraceptive
5625743|NCT00796783|Endocrine|endocrine
5625744|NCT00796783|Cushing Syndrome|cushing syndrome
5625745|NCT00796783|Ectopic ACTH Secretion|ectopic acth secretion
5625746|NCT00796770|HIV|hiv
5625747|NCT00796770|Vaccine|vaccine
5625748|NCT00796770|HAART|haart
5625749|NCT00796770|HIV-1|hiv-1
5625750|NCT00796770|AIDS|aids
5625751|NCT00796770|Dendritic Cells|dendritic cells
5625752|NCT00796770|DALIA|dalia
5625753|NCT00796744|Diabetes mellitus|diabetes mellitus
5625754|NCT00796744|Diabetic neuropathy|diabetic neuropathy
5625755|NCT00796744|Peripheral vascular disease|peripheral vascular disease
5625756|NCT00796744|Infection|infection
5625757|NCT00796744|Topical application|topical application
5625758|NCT00796744|plantar foot ulcers|plantar foot ulcers
5625759|NCT00796731|B-cell lymphoma|b-cell lymphoma
5625760|NCT00796731|NHL|nhl
5625761|NCT00796692|Heparin|heparin
5625762|NCT00796692|Low molecular weight heparin|low molecular weight heparin
5625763|NCT00796692|Safety|safety
5625764|NCT00796692|Efficacy|efficacy
5625765|NCT00796692|Cost effective|cost effective
5625766|NCT00796679|paricalcitol|paricalcitol
5625767|NCT00796679|chronic kidney disease|chronic kidney disease
5625768|NCT00796679|cardiac hypertrophy|cardiac hypertrophy
5625769|NCT00796666|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
5625770|NCT00796666|Sitaxsentan|sitaxsentan
5625771|NCT00796640|Schizophrenia|schizophrenia
5625772|NCT00796640|Mood disorders|mood disorders
5625773|NCT00796640|Antipsychotic drugs|antipsychotic drugs
5625774|NCT00796640|ER Paliperidone|er paliperidone
5625775|NCT00796627|Wound Healing|wound healing
5625776|NCT00796627|Burns|burns
5625777|NCT00796627|HIF-1|hif-1
5625778|NCT00796627|CAC|cac
5625779|NCT00796614|tamsulosin|tamsulosin
5625780|NCT00796614|pediatric|pediatric
5625781|NCT00796614|neurogenic bladder|neurogenic bladder
5685468|NCT00555958|Obesity|obesity
5625782|NCT00796601|double-blind placebo-controlled maintenance of efficacy|double-blind placebo-controlled maintenance of efficacy
5625783|NCT00796588|preconditioning|preconditioning
5625784|NCT00796588|remote|remote
5625785|NCT00796575|multiple ascending dose healthy volunteers|multiple ascending dose healthy volunteers
5625786|NCT00796575|pharmacokinetics|pharmacokinetics
5625787|NCT00796575|pharmacodynamics|pharmacodynamics
5625788|NCT00796562|Leukemia|leukemia
5625789|NCT00796562|Lymphoma|lymphoma
5625790|NCT00796562|Hematologic malignancies|hematologic malignancies
5625791|NCT00796562|ALL|all
5625792|NCT00796562|AML|aml
5625793|NCT00796562|MDS|mds
5625794|NCT00796562|Transplantation|transplantation
5625795|NCT00796562|Mismatched|mismatched
5625796|NCT00796562|Haploidentical|haploidentical
5625797|NCT00796562|Busulfan|busulfan
5625798|NCT00796562|Cyclophosphamide|cyclophosphamide
5625799|NCT00796562|Cellcept|cellcept
5625800|NCT00796562|Tacrolimus|tacrolimus
5625801|NCT00796562|TBI|tbi
5625802|NCT00796562|CMMOL|cmmol
5625803|NCT00796562|CML|cml
5625804|NCT00796562|JMML|jmml
5625805|NCT00796536|Acute Pain|acute pain
5625806|NCT00796536|Low Back Pain|low back pain
5625807|NCT00796536|Back Pain|back pain
5625808|NCT00796536|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5625809|NCT00796536|Cognitive Behavioral Therapy|cognitive behavioral therapy
5625810|NCT00796536|Pain Education|pain education
5625811|NCT00796523|colic|colic
5625812|NCT00796523|crying|crying
5625813|NCT00796523|clinical trial|clinical trial
5625814|NCT00796510|endothelin receptor antagonist (ETRA)|endothelin receptor antagonist (etra)
5625815|NCT00796510|sitaxsentan|sitaxsentan
5625816|NCT00796497|Obsessive Compulsive Disorder|obsessive compulsive disorder
5625817|NCT00796497|5-ht3|5-ht3
5625818|NCT00796497|ondansetron|ondansetron
5625819|NCT00796484|Cancer|cancer
5625820|NCT00796484|Solid Tumors|solid tumors
5625821|NCT00796471|Schizophrenia|schizophrenia
5625822|NCT00796471|Mood Disorders|mood disorders
5625823|NCT00796471|Antipsychotic drugs|antipsychotic drugs
5625824|NCT00796471|Paliperidone ER|paliperidone er
5625825|NCT00796458|pain|pain
5625826|NCT00796458|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5625828|NCT00796458|stage IV prostate cancer|stage iv prostate cancer
5625829|NCT00796458|stage III prostate cancer|stage iii prostate cancer
5625830|NCT00796445|DERMA|derma
5625831|NCT00796445|Tumor antigen|tumor antigen
5625832|NCT00796445|Immunotherapeutic|immunotherapeutic
5625833|NCT00796445|Adjuvant cancer therapy|adjuvant cancer therapy
5625834|NCT00796445|Melanoma|melanoma
5625835|NCT00796445|ASCI|asci
5625836|NCT00796432|Schizophrenia|schizophrenia
5625837|NCT00796432|mood disorders|mood disorders
5625838|NCT00796432|antipsychotic drugs|antipsychotic drugs
5625839|NCT00796432|dopamine|dopamine
5625840|NCT00796432|receptor occupancy|receptor occupancy
5625841|NCT00796432|OROS paliperidone|oros paliperidone
5625842|NCT00796419|Acute lung injury (ALI)|acute lung injury (ali)
5625843|NCT00796419|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5625844|NCT00796419|Respiratory failure|respiratory failure
5625845|NCT00796367|Obesity|obesity
5625846|NCT00796354|Constipation|constipation
5625847|NCT00796354|Irritable Bowel Syndrome|irritable bowel syndrome
5625848|NCT00796341|invitro-fertilization ,embryo transfer,endometrial injury|invitro-fertilization ,embryo transfer,endometrial injury
5625849|NCT00796315|Pharmacokinetic study|pharmacokinetic study
5625850|NCT00796302|Conduct Disorder|conduct disorder
5625851|NCT00796302|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5625852|NCT00796289|anovulatory/oligoovulatory infertility|anovulatory/oligoovulatory infertility
5813503|NCT00003239|HHT|hht
5625853|NCT00796276|Schizophrenia|schizophrenia
5625854|NCT00796276|Mood disorders|mood disorders
5625855|NCT00796276|Antipsychotics|antipsychotics
5625856|NCT00796276|Pharmacokinetics|pharmacokinetics
5625857|NCT00796276|Enantiomer|enantiomer
5625858|NCT00796276|IR OROS Paliperidone|ir oros paliperidone
5625859|NCT00796276|ER OROS Paliperidone|er oros paliperidone
5625860|NCT00796263|Acute HIV infection|acute hiv infection
5625861|NCT00796263|Chronic HIV infection|chronic hiv infection
5625862|NCT00796237|stroke|stroke
5625863|NCT00796237|bone|bone
5625864|NCT00796237|gait|gait
5625865|NCT00796237|muscle|muscle
5625866|NCT00796237|vibration|vibration
5625867|NCT00796237|motor balance|motor balance
5625868|NCT00796224|azithromycin, pharmacokinetics, pediatrics|azithromycin, pharmacokinetics, pediatrics
5625869|NCT00796211|Psoriasis|psoriasis
5625870|NCT00796211|CRx-197|crx-197
5625871|NCT00796211|nortriptyline|nortriptyline
5625872|NCT00796211|loratadine|loratadine
5625873|NCT00796211|CombinatoRx|combinatorx
5625874|NCT00796211|Dermatology|dermatology
5625875|NCT00796211|Erythema|erythema
5625876|NCT00796211|Pruritus|pruritus
5625877|NCT00796198|Glaucoma|glaucoma
5625878|NCT00796198|Intraocular pressure|intraocular pressure
5625879|NCT00796198|Ocular diastolic perfusion pressure|ocular diastolic perfusion pressure
5625880|NCT00796198|Dorzolamide/timolol Fixed combination|dorzolamide/timolol fixed combination
5625881|NCT00796198|Heidelberg Retina Flowmeter|heidelberg retina flowmeter
5625883|NCT00796185|Schizoaffective Disorder|schizoaffective disorder
5625884|NCT00796185|Mood Disorders|mood disorders
5625885|NCT00796185|Antipsychotic drugs|antipsychotic drugs
5625886|NCT00796185|Paliperidone ER|paliperidone er
5625887|NCT00796172|Hypertension|hypertension
5625888|NCT00796172|High Blood Pressure|high blood pressure
5625889|NCT00796172|Blood Lipid Management|blood lipid management
5625890|NCT00796159|Efficacy; Tolerability; Safety; Essential Hypertension|efficacy; tolerability; safety; essential hypertension
5625891|NCT00796133|NES/E2|nes/e2
5625892|NCT00796133|transdermal gel delivery|transdermal gel delivery
5625893|NCT00796133|contraception|contraception
5625894|NCT00796133|ovulation|ovulation
5625895|NCT00796133|bleeding patterns|bleeding patterns
5625896|NCT00796120|Sarcomas|sarcomas
5625897|NCT00796120|Trabectedin|trabectedin
5625898|NCT00796120|Doxorubicin|doxorubicin
5625899|NCT00796120|Ifosfamide|ifosfamide
5625900|NCT00796120|YONDELIS|yondelis
5625901|NCT00796081|Schizophrenia|schizophrenia
5625902|NCT00796081|Schizoaffective disorder|schizoaffective disorder
5625903|NCT00796081|Schizophreniform disorders|schizophreniform disorders
5625904|NCT00796081|Mood disorders|mood disorders
5625905|NCT00796081|Antipshychotic drugs|antipshychotic drugs
5625906|NCT00796081|Pediatrics|pediatrics
5625907|NCT00796081|ER OROS Paliperidone, Paliperidone ER|er oros paliperidone, paliperidone er
5625908|NCT00796042|Pressure Ulcer|pressure ulcer
5625909|NCT00796042|Bed Sores|bed sores
5625910|NCT00796042|Bedsore|bedsore
5625911|NCT00796042|Decubitus Ulcer|decubitus ulcer
5625912|NCT00796042|Pressure Sore|pressure sore
5625913|NCT00796042|Best rest|best rest
5625914|NCT00796042|mobility|mobility
5625915|NCT00796042|pressure management|pressure management
5625916|NCT00796029|Schizophrenia|schizophrenia
5625917|NCT00796029|Mood disorders|mood disorders
5625918|NCT00796029|Antipsychotic drugs: 14C-paliperidone|antipsychotic drugs: 14c-paliperidone
5625919|NCT00796003|Myelodysplastic syndrome|myelodysplastic syndrome
5625920|NCT00796003|MDS|mds
5625921|NCT00796003|Decitabine|decitabine
5625922|NCT00796003|JNJ-30979754|jnj-30979754
5625924|NCT00795977|preoperative|preoperative
5625925|NCT00795977|intratumor|intratumor
5625926|NCT00795977|dendritic cells|dendritic cells
5625927|NCT00795977|pancreatic cancer|pancreatic cancer
5625928|NCT00795977|OK-432|ok-432
5625929|NCT00795964|tidal volume|tidal volume
5625930|NCT00795964|predicted body weight|predicted body weight
5625931|NCT00795964|lung function|lung function
5625932|NCT00795964|respiratory outcome|respiratory outcome
5625933|NCT00795964|Respiratory Function Tests|respiratory function tests
5625934|NCT00795964|surgery|surgery
5625935|NCT00795951|allergic|allergic
5625936|NCT00795951|contact dermatitis|contact dermatitis
5625937|NCT00795951|contact allergy|contact allergy
5625938|NCT00795951|Type IV|type iv
5625939|NCT00795951|Children|children
5625940|NCT00795951|TRUE TEST|true test
5625941|NCT00795925|propiverine|propiverine
5625942|NCT00795925|anticholinergics|anticholinergics
5625943|NCT00795925|urinary incontinence|urinary incontinence
5625944|NCT00795925|overactive bladder|overactive bladder
5625945|NCT00795925|children|children
5625946|NCT00795925|dose-finding in children aged 5-10 years|dose-finding in children aged 5-10 years
5625947|NCT00795912|Systolic heart failure|systolic heart failure
5625948|NCT00795912|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
5625949|NCT00795912|B-type natriuretic peptide|b-type natriuretic peptide
5625950|NCT00795912|Inflammation|inflammation
5625951|NCT00795912|Myocardial collagen turnover|myocardial collagen turnover
5626334|NCT00794157|COPD|copd
5625952|NCT00795899|Safety and efficacy of experimental treatment|safety and efficacy of experimental treatment
5625954|NCT00795886|Cancer|cancer
5625955|NCT00795886|Stem Cell Transplant|stem cell transplant
5625956|NCT00795873|Heart failure|heart failure
5625957|NCT00795873|cardiac resynchronization therapy|cardiac resynchronization therapy
5625958|NCT00795860|Insulin sensitivity|insulin sensitivity
5625959|NCT00795860|fat metabolism|fat metabolism
5625960|NCT00795860|inflammation|inflammation
5625961|NCT00795847|Hypertensive patients with morning hypertension|hypertensive patients with morning hypertension
5625962|NCT00795834|polyphenolics|polyphenolics
5625963|NCT00795834|flavonols|flavonols
5625964|NCT00795834|lipids|lipids
5625965|NCT00795834|endothelial function|endothelial function
5625966|NCT00795834|vascular risk factors|vascular risk factors
5625967|NCT00795808|Polycystic ovary syndrome|polycystic ovary syndrome
5625968|NCT00795808|PCOS|pcos
5625969|NCT00795808|Anovulation|anovulation
5625970|NCT00795808|Infertility|infertility
5625971|NCT00795808|Anovulatory polycystic ovary syndrome (PCOS)|anovulatory polycystic ovary syndrome (pcos)
5625972|NCT00795795|Chromosomal abnormalities in preimplantation embryos|chromosomal abnormalities in preimplantation embryos
5625973|NCT00795782|Papillary thyroid carcinoma|papillary thyroid carcinoma
5625974|NCT00795782|Lymph node dissection|lymph node dissection
5625975|NCT00795782|Lymph node metastasis|lymph node metastasis
5625976|NCT00795782|Prophylactic node dissection|prophylactic node dissection
5625977|NCT00795782|Central lymph node metastasis|central lymph node metastasis
5625979|NCT00795756|Central nervous system prophylaxis|central nervous system prophylaxis
5625980|NCT00795756|Minimal residual disease|minimal residual disease
5625981|NCT00795743|Central Venous Catheterization|central venous catheterization
5625982|NCT00795743|coagulopathy|coagulopathy
5625983|NCT00795743|thromboelastography|thromboelastography
5625984|NCT00795730|Alzheimer's Disease|alzheimer's disease
5625985|NCT00795730|schizophrenia|schizophrenia
5625986|NCT00795717|HIV|hiv
5625987|NCT00795717|cardiovascular risk|cardiovascular risk
5625988|NCT00795717|atherogenic lipid profile|atherogenic lipid profile
5625989|NCT00795717|brachial artery reactivity|brachial artery reactivity
5625990|NCT00795717|omega three fatty acids|omega three fatty acids
5625991|NCT00795704|Herbal Supplement|herbal supplement
5625992|NCT00795704|Type 2 Diabetes|type 2 diabetes
5625993|NCT00795704|Mulberry|mulberry
5625994|NCT00795704|Hemoglobin A1C|hemoglobin a1c
5625995|NCT00795691|diabetes|diabetes
5625996|NCT00795691|low-carbohydrate diet|low-carbohydrate diet
5625997|NCT00795691|weight loss|weight loss
5625998|NCT00795691|obesity|obesity
5625999|NCT00795691|dietary intervention|dietary intervention
5626000|NCT00795678|tumors metastatic to brain|tumors metastatic to brain
5626001|NCT00795678|stage IV breast cancer|stage iv breast cancer
5626002|NCT00795665|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5626003|NCT00795665|adult glioblastoma|adult glioblastoma
5626004|NCT00795665|adult gliosarcoma|adult gliosarcoma
5626005|NCT00795665|adult giant cell glioblastoma|adult giant cell glioblastoma
5626006|NCT00795665|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5626007|NCT00795665|adult mixed glioma|adult mixed glioma
5626008|NCT00795665|recurrent adult brain tumor|recurrent adult brain tumor
5626009|NCT00795652|Postpartum depression|postpartum depression
5626010|NCT00795652|Distance therapy|distance therapy
5626011|NCT00795652|depression|depression
5626012|NCT00795652|Distance Treatment|distance treatment
5626013|NCT00795652|Barriers to care|barriers to care
5626015|NCT00795639|endothelin receptor antagonist|endothelin receptor antagonist
5626016|NCT00795626|nursing education|nursing education
5626017|NCT00795626|cardiovascular risk factors|cardiovascular risk factors
5626018|NCT00795626|coronary heart disease|coronary heart disease
5626020|NCT00795574|Hidradenitis Suppurativa|hidradenitis suppurativa
5626021|NCT00795561|Hyperemesis gravidarum|hyperemesis gravidarum
5626022|NCT00795561|nausea|nausea
5626023|NCT00795561|vomiting|vomiting
5626024|NCT00795561|pregnancy|pregnancy
5626025|NCT00795561|day care|day care
5626026|NCT00795561|inpatient management|inpatient management
5626027|NCT00795561|Nausea and vomiting of pregnancy|nausea and vomiting of pregnancy
5626028|NCT00795548|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5626029|NCT00795548|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5626030|NCT00795548|Stem cell transplantation|stem cell transplantation
5626031|NCT00795548|5-Azacitidine|5-azacitidine
5626032|NCT00795548|Donor lymphocyte infusion|donor lymphocyte infusion
5626033|NCT00795548|MDS or AML relapsed after stem cell transplantation|mds or aml relapsed after stem cell transplantation
5626034|NCT00795535|Injury|injury
5626035|NCT00795496|Atopic dermatitis|atopic dermatitis
5626036|NCT00795496|Bronchial hyperreactivity|bronchial hyperreactivity
5626037|NCT00795496|Skin prick tests|skin prick tests
5626038|NCT00795496|Serum IgE|serum ige
5626039|NCT00795496|Mantoux test|mantoux test
5626040|NCT00795483|Osteoporosis|osteoporosis
5626041|NCT00795483|HIV infection|hiv infection
5626042|NCT00795483|Bisphosphonates|bisphosphonates
5626043|NCT00795483|Zoledronic acid|zoledronic acid
5626044|NCT00795470|urinary tract infection|urinary tract infection
5626045|NCT00795470|critically ill|critically ill
5626047|NCT00795470|antimicrobial|antimicrobial
5626048|NCT00795470|Catheter associated urinary tract infections|catheter associated urinary tract infections
5626050|NCT00795457|WHO Grade II Astrocytoma|who grade ii astrocytoma
5626051|NCT00795457|WHO Grade II Oligo-Astrocytoma|who grade ii oligo-astrocytoma
5626052|NCT00795444|HIV-1|hiv-1
5626053|NCT00795444|CCR5 coreceptor antagonist (Maraviroc)|ccr5 coreceptor antagonist (maraviroc)
5626054|NCT00795444|the cell reservoir of HIV-1|the cell reservoir of hiv-1
5626055|NCT00795418|Active immunization|active immunization
5626056|NCT00795418|Alzheimer's disease|alzheimer's disease
5626057|NCT00795418|Antibody|antibody
5626058|NCT00795418|Vaccine|vaccine
5626059|NCT00795418|Central Nervous System Diseases|central nervous system diseases
5626060|NCT00795418|Neurodegenerative diseases|neurodegenerative diseases
5626061|NCT00795405|sporting events|sporting events
5626062|NCT00795405|stress|stress
5626063|NCT00795405|myocardial ischemia|myocardial ischemia
5626064|NCT00795405|ST-segment depression|st-segment depression
5626065|NCT00795405|blood pressure|blood pressure
5626066|NCT00795392|Psychology|psychology
5626067|NCT00795392|Postoperative outcome|postoperative outcome
5626068|NCT00795392|Surgical Operation|surgical operation
5626069|NCT00795379|Psychotherapy|psychotherapy
5626070|NCT00795366|TBI, trauma, brain|tbi, trauma, brain
5626071|NCT00795353|plaque psoriasis|plaque psoriasis
5626072|NCT00795353|psoriasis|psoriasis
5626073|NCT00795353|alefacept|alefacept
5626075|NCT00795340|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5626076|NCT00795340|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5626077|NCT00795340|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5626078|NCT00795314|Opioids|opioids
5626079|NCT00795314|General anesthesia|general anesthesia
5626080|NCT00795301|tumor|tumor
5626081|NCT00795288|subarachnoid hemorrhage|subarachnoid hemorrhage
5626082|NCT00795288|vasospasm|vasospasm
5626083|NCT00795288|cerebral blood flow|cerebral blood flow
5626084|NCT00795288|cerebral metabolism|cerebral metabolism
5626085|NCT00795288|autoregulation|autoregulation
5626086|NCT00795288|statin|statin
5626087|NCT00795288|Vasospasm associated with Subarachnoid hemorrhage|vasospasm associated with subarachnoid hemorrhage
5626088|NCT00795275|pre-diabetes|pre-diabetes
5626089|NCT00795275|isotopes|isotopes
5626090|NCT00795275|insulin secretion|insulin secretion
5626091|NCT00795275|insulin action|insulin action
5626092|NCT00795275|GLP-1|glp-1
5626093|NCT00795275|simple obesity|simple obesity
5626094|NCT00795275|impaired fasting glucose|impaired fasting glucose
5626095|NCT00795262|brachial artery reactivity|brachial artery reactivity
5626096|NCT00795236|melatonin|melatonin
5626097|NCT00795210|HIV lipodystrophy|hiv lipodystrophy
5626098|NCT00795210|growth hormone|growth hormone
5626099|NCT00795210|growth hormone releasing hormone|growth hormone releasing hormone
5626100|NCT00795197|Gaucher Disease,|gaucher disease,
5626101|NCT00795197|acid B-glucosidase,|acid b-glucosidase,
5626102|NCT00795197|gluco cerebrosidase,|gluco cerebrosidase,
5626103|NCT00795197|glucosylceramide,|glucosylceramide,
5626104|NCT00795184|Barrett's Esophagus|barrett's esophagus
5626105|NCT00795184|EsoGastroDuodenoscopy|esogastroduodenoscopy
5626106|NCT00795184|Barrett's Carcinoma|barrett's carcinoma
5626107|NCT00795184|adenocarcinoma|adenocarcinoma
5626108|NCT00795184|Cellvizio|cellvizio
5626109|NCT00795184|endomicroscopy|endomicroscopy
5626110|NCT00795184|random biopsy|random biopsy
5607779|NCT00867334|Receptor|receptor
5626111|NCT00795145|Linezolid, QTc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose|linezolid, qtc interval, pharmacokinetics, therapeutic dose, supra-therapeutic dose
5626113|NCT00795132|Hematologic Malignancies|hematologic malignancies
5626114|NCT00795132|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5626115|NCT00795119|Near Infrared Spectroscopy|near infrared spectroscopy
5626116|NCT00795119|Diagnosis|diagnosis
5626117|NCT00795119|Children|children
5626118|NCT00795106|Capsaicin|capsaicin
5626119|NCT00795106|hydrogel|hydrogel
5626120|NCT00795106|myofascial pain syndrome|myofascial pain syndrome
5626121|NCT00795106|neck pain|neck pain
5626122|NCT00795093|GERD|gerd
5626123|NCT00795093|PPI|ppi
5626124|NCT00795093|partial responders|partial responders
5626125|NCT00795080|CVJ malformations|cvj malformations
5626126|NCT00795054|Stem cell transplantation|stem cell transplantation
5626127|NCT00795054|Financial impact|financial impact
5626128|NCT00795041|vitrification|vitrification
5626129|NCT00795041|ovarian stimulation|ovarian stimulation
5626130|NCT00795041|reproductive medicine|reproductive medicine
5626131|NCT00795028|older women|older women
5626132|NCT00795028|hip fracture|hip fracture
5626133|NCT00795028|exercise intervention|exercise intervention
5626134|NCT00795015|postoperative blood glucose control|postoperative blood glucose control
5626135|NCT00795015|IV insulin infusion|iv insulin infusion
5626136|NCT00794989|breast cancer|breast cancer
5626137|NCT00794989|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5626138|NCT00794989|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5626139|NCT00794989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5626140|NCT00794989|breast cancer prevention|breast cancer prevention
5626141|NCT00794989|high risk breast cancer|high risk breast cancer
5626143|NCT00794950|High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma|high risk non-muscle invasive lower urinary tract urothelial carcinoma
5626144|NCT00794924|probiotics|probiotics
5626146|NCT00794924|motility|motility
5626147|NCT00794924|diarrhea|diarrhea
5626148|NCT00794911|Liver Transplantation|liver transplantation
5626149|NCT00794911|Quality of Life|quality of life
5626150|NCT00794911|Chronic HCV|chronic hcv
5626151|NCT00794911|Hepatitis C Virus|hepatitis c virus
5626152|NCT00794911|Cirrhosis|cirrhosis
5626153|NCT00794911|Liver disease|liver disease
5626154|NCT00794885|hypertension|hypertension
5626155|NCT00794885|stroke|stroke
5626156|NCT00794885|cardiovascular events|cardiovascular events
5626157|NCT00794885|enalapril|enalapril
5626158|NCT00794885|folic acid|folic acid
5626159|NCT00794885|randomized controlled trial|randomized controlled trial
5626160|NCT00794885|MTHFR C677T genotype|mthfr c677t genotype
5626161|NCT00794872|Cardiovascular autonomic neuropathy|cardiovascular autonomic neuropathy
5626162|NCT00794872|Chemoreflex sensitivity|chemoreflex sensitivity
5626163|NCT00794872|Chronic kidney disease|chronic kidney disease
5626164|NCT00794872|Sudden cardiac arrest|sudden cardiac arrest
5626165|NCT00794820|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5626167|NCT00794820|Leukemia|leukemia
5626168|NCT00794820|Fludarabine phosphate|fludarabine phosphate
5626169|NCT00794820|Cyclophosphamide|cyclophosphamide
5626170|NCT00794820|Rituximab|rituximab
5626171|NCT00794820|FCR|fcr
5626172|NCT00794820|Cytoxan®|cytoxan®
5626173|NCT00794820|Neosar®|neosar®
5626174|NCT00794820|Rituxan®|rituxan®
5626175|NCT00794807|Alefacept|alefacept
5626176|NCT00794807|Skin Diseases|skin diseases
5626177|NCT00794807|Psoriasis|psoriasis
5626178|NCT00794807|Skin Diseases, Papulosquamos|skin diseases, papulosquamos
5626179|NCT00794807|Therapeutic Uses|therapeutic uses
5626180|NCT00794807|Dermatologic Agents|dermatologic agents
5626181|NCT00794781|Cancer|cancer
5626182|NCT00794781|solid tumors|solid tumors
5626183|NCT00794755|Vitamin K|vitamin k
5626184|NCT00794755|Vitamin K1 (Phytonadione)|vitamin k1 (phytonadione)
5626185|NCT00794755|Unstable INR|unstable inr
5626186|NCT00794755|VTE or Thrombosis|vte or thrombosis
5626187|NCT00794755|Warfarin|warfarin
5626188|NCT00794755|Anticoagulation Control|anticoagulation control
5626189|NCT00794755|Patients on warfarin with unstable anticoagulation control|patients on warfarin with unstable anticoagulation control
5626190|NCT00794742|Burn|burn
5626191|NCT00794742|Antimicrobial|antimicrobial
5626192|NCT00794742|Bacteria|bacteria
5626193|NCT00794742|Resistance|resistance
5626194|NCT00794742|Biofilm|biofilm
5626195|NCT00794742|Pathogen|pathogen
5626196|NCT00794729|Healthy Volunteers|healthy volunteers
5626197|NCT00794729|Consents|consents
5626198|NCT00794703|Antifungal|antifungal
5626199|NCT00794703|micafungin|micafungin
5626200|NCT00794703|itraconazole|itraconazole
5626201|NCT00794690|cimicifuga racemosa|cimicifuga racemosa
5626202|NCT00794690|liver blood flow and functions|liver blood flow and functions
5626203|NCT00794677|Hypercholesterolemia|hypercholesterolemia
5626204|NCT00794677|Oxysterol|oxysterol
5626205|NCT00794677|Ezetimibe|ezetimibe
5626206|NCT00794677|Zetia|zetia
5626207|NCT00794651|osteoarthritis|osteoarthritis
5626208|NCT00794651|testing kit|testing kit
5626209|NCT00794651|knee|knee
5620187|NCT00817921|ibuprofen|ibuprofen
5626210|NCT00794638|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5626211|NCT00794638|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5626212|NCT00794638|Mantle cell Lymphoma|mantle cell lymphoma
5626213|NCT00794638|Transformed lymphoma, transformed to diffuse large B-cell lymphoma|transformed lymphoma, transformed to diffuse large b-cell lymphoma
5626215|NCT00794625|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5626216|NCT00794625|Aggressive Behavior|aggressive behavior
5626217|NCT00794625|Oppositional Defiant Disorder|oppositional defiant disorder
5626218|NCT00794625|Conduct Disorder|conduct disorder
5626219|NCT00794586|cystic fibrosis|cystic fibrosis
5626220|NCT00794586|CF|cf
5626221|NCT00794586|inhaled antibiotic|inhaled antibiotic
5626222|NCT00794586|antipseudomonal antibiotic|antipseudomonal antibiotic
5626223|NCT00794586|tobramycin|tobramycin
5626224|NCT00794586|fosfomycin|fosfomycin
5626225|NCT00794586|lung infection|lung infection
5626226|NCT00794586|pseudomonal infection|pseudomonal infection
5626227|NCT00794586|FTI|fti
5626228|NCT00794573|Smoking Cessation|smoking cessation
5626229|NCT00794573|Cardiac Population|cardiac population
5626230|NCT00794573|Acute Coronary Syndrome|acute coronary syndrome
5626231|NCT00794573|Varenicline|varenicline
5626232|NCT00794573|Champix|champix
5626233|NCT00794560|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5626234|NCT00794560|compliance|compliance
5626235|NCT00794560|drug safety|drug safety
5626236|NCT00794560|self-administration|self-administration
5626237|NCT00794560|ambulatory Care|ambulatory care
5626244|NCT00794508|Retroviral Vector|retroviral vector
5626245|NCT00794508|ADA-deficient SCID|ada-deficient scid
5626246|NCT00794469|Resting metabolic rate|resting metabolic rate
5626247|NCT00794456|Passiflora|passiflora
5626248|NCT00794456|Crataegus|crataegus
5626249|NCT00794456|Herbal|herbal
5626250|NCT00794456|Valeriana|valeriana
5626251|NCT00794456|anxiety|anxiety
5626252|NCT00794443|ONO-5920|ono-5920
5626253|NCT00794443|YM529|ym529
5626254|NCT00794443|Bone mineral density|bone mineral density
5626255|NCT00794443|Minodronic acid|minodronic acid
5626256|NCT00794430|Safety|safety
5626257|NCT00794430|Tolerability|tolerability
5626258|NCT00794430|Efficacy|efficacy
5626259|NCT00794430|Patients|patients
5626260|NCT00794430|Diabetic peripheral neuropathic pain.|diabetic peripheral neuropathic pain.
5626261|NCT00794417|advanced cancer|advanced cancer
5626262|NCT00794417|lung cancer|lung cancer
5626263|NCT00794417|NSCLC|nsclc
5626264|NCT00794417|Non-small Cell Lung Cancer|non-small cell lung cancer
5626265|NCT00794417|aflibercept|aflibercept
5626266|NCT00794417|chemotherapy|chemotherapy
5626267|NCT00794391|Vulnerable Populations|vulnerable populations
5626268|NCT00794391|Injecting drug users|injecting drug users
5626269|NCT00794391|IDU|idu
5626270|NCT00794391|Risky injecting practices|risky injecting practices
5626271|NCT00794391|Psychotherapy, brief|psychotherapy, brief
5626272|NCT00794391|Motivational interviewing|motivational interviewing
5626273|NCT00794391|Educational activities|educational activities
5626274|NCT00794391|Clinical trial|clinical trial
5626275|NCT00794391|Risk behavior|risk behavior
5626276|NCT00794391|risk reduction behavior|risk reduction behavior
5626277|NCT00794365|Smoking; smoking cessation; Philippines; Varenicline|smoking; smoking cessation; philippines; varenicline
5626286|NCT00794339|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5626287|NCT00794339|stage IIB cervical cancer|stage iib cervical cancer
5626288|NCT00794339|stage III cervical cancer|stage iii cervical cancer
5626289|NCT00794339|stage IV cervical cancer|stage iv cervical cancer
5626290|NCT00794339|stage IVA cervical cancer|stage iva cervical cancer
5626291|NCT00794339|stage IB cervical cancer|stage ib cervical cancer
5626292|NCT00794339|stage IIA cervical cancer|stage iia cervical cancer
5626293|NCT00794326|Chronic Kidney Failure|chronic kidney failure
5626294|NCT00794326|Peritoneal Dialysis|peritoneal dialysis
5626295|NCT00794326|Low sodium solution|low sodium solution
5626296|NCT00794326|Hypertension|hypertension
5626297|NCT00794326|Total Body Water|total body water
5626298|NCT00794313|Parkinsons disease|parkinsons disease
5626299|NCT00794313|dyskinesia|dyskinesia
5626300|NCT00794313|amantadine|amantadine
5626301|NCT00794313|efficacy|efficacy
5626302|NCT00794300|reproducibility|reproducibility
5626303|NCT00794300|contrast agent|contrast agent
5626304|NCT00794300|magnetic resonance imaging|magnetic resonance imaging
5626305|NCT00794300|infarct size|infarct size
5626306|NCT00794300|myocardial salvage index|myocardial salvage index
5626307|NCT00794300|myocardial salvage assessment|myocardial salvage assessment
5626308|NCT00794274|Sarcodiosis|sarcodiosis
5626309|NCT00794274|tumor necrosis factor|tumor necrosis factor
5626310|NCT00794261|Myeloma|myeloma
5626311|NCT00794261|lymphoma|lymphoma
5626312|NCT00794261|high-dose chemotherapy|high-dose chemotherapy
5626313|NCT00794261|PSC infusion, autologous|psc infusion, autologous
5626314|NCT00794261|neutropenia|neutropenia
5626315|NCT00794261|thrombocytopenia|thrombocytopenia
5626316|NCT00794261|hospital stay|hospital stay
5626317|NCT00794261|infection|infection
5680367|NCT00578019|Less Invasive Stabilization System (LISS) Plating|less invasive stabilization system (liss) plating
5626318|NCT00794261|Autologous PSC transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy|autologous psc transplantation for patients with lymphoma or myeloma treated with high-dose chemotherapy
5626319|NCT00794222|Cellular phones|cellular phones
5626320|NCT00794222|mental health|mental health
5626321|NCT00794222|Early intervention|early intervention
5626322|NCT00794222|prevention|prevention
5626323|NCT00794222|momentary sampling|momentary sampling
5626324|NCT00794222|Adolescent|adolescent
5626325|NCT00794209|AeroLEF, fentanyl, liposome encapsulated, opioid|aerolef, fentanyl, liposome encapsulated, opioid
5626326|NCT00794196|Medication adherence|medication adherence
5626327|NCT00794196|Antidepressive agents|antidepressive agents
5626328|NCT00794196|Primary care|primary care
5626329|NCT00794196|Pharmaceutical care|pharmaceutical care
5626330|NCT00794183|heart failure|heart failure
5626332|NCT00794183|CHF|chf
5626333|NCT00794170|Treatment Compliance|treatment compliance
5626335|NCT00794157|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5626336|NCT00794157|indacaterol|indacaterol
5626337|NCT00794157|long acting β2-agonist|long acting β2-agonist
5626338|NCT00794144|Allergic Rhinitis|allergic rhinitis
5626339|NCT00794144|Pediatric|pediatric
5626340|NCT00794144|PATANASE|patanase
5626341|NCT00794131|cancer|cancer
5626342|NCT00794131|vaccinia virus|vaccinia virus
5626343|NCT00794131|vaccinia|vaccinia
5626344|NCT00794131|oncolytic|oncolytic
5626345|NCT00794131|oncolytic virus|oncolytic virus
5626346|NCT00794131|biological|biological
5626347|NCT00794131|imaging|imaging
5626349|NCT00794105|Middle ear|middle ear
5626350|NCT00794079|Healthy volunteers|healthy volunteers
5626351|NCT00794079|young adults|young adults
5626352|NCT00794079|Aged|aged
5626353|NCT00794066|PAD|pad
5626354|NCT00794066|Stroke|stroke
5626355|NCT00794066|ICH|ich
5626356|NCT00794066|prevalence|prevalence
5626357|NCT00794053|Sentinel lymph node|sentinel lymph node
5626358|NCT00794053|thyroid cancer|thyroid cancer
5626359|NCT00794053|neck dissection|neck dissection
5626360|NCT00794040|Irritability|irritability
5626361|NCT00794040|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5626362|NCT00794040|Explosive|explosive
5626363|NCT00794040|Tantrums|tantrums
5626364|NCT00794040|Bipolar Mood Disorder|bipolar mood disorder
5626365|NCT00794040|Mood Disorder|mood disorder
5626366|NCT00794040|Childhood Mood Disorder|childhood mood disorder
5626367|NCT00794040|ADHD|adhd
5626368|NCT00794027|heart failure|heart failure
5626369|NCT00794027|yoga|yoga
5626370|NCT00794027|quality of life|quality of life
5626371|NCT00794014|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5626372|NCT00794001|myocardial infarction|myocardial infarction
5626373|NCT00794001|angioplasty|angioplasty
5626374|NCT00794001|data feedback|data feedback
5626375|NCT00794001|continuous quality improvement|continuous quality improvement
5626376|NCT00794001|STEMI|stemi
5626377|NCT00794001|Feedback|feedback
5626378|NCT00794001|Quality Assurance, Health Care|quality assurance, health care
5626379|NCT00794001|Emergency service hospital|emergency service hospital
5626380|NCT00793988|vibration|vibration
5626381|NCT00793988|local anaesthesia|local anaesthesia
5626382|NCT00793988|ptosis surgery|ptosis surgery
5626383|NCT00793988|blepharoplasty|blepharoplasty
5626384|NCT00793988|Upper eyelid surgery|upper eyelid surgery
5626385|NCT00793988|dermatochalasis +/- blepharoptosis|dermatochalasis +/- blepharoptosis
5626386|NCT00793975|Tumors|tumors
5626387|NCT00793975|Antibodies, Monoclonal|antibodies, monoclonal
5626388|NCT00793962|breast cancer|breast cancer
5626389|NCT00793962|mastectomy|mastectomy
5626390|NCT00793962|radiotherapy|radiotherapy
5626391|NCT00793962|fractionation|fractionation
5626392|NCT00793936|Right Double Lumen Tube|right double lumen tube
5626393|NCT00793923|Exudative Age Related Macular Degeneration|exudative age related macular degeneration
5626394|NCT00793910|Gabapentin|gabapentin
5626396|NCT00793910|pain|pain
5626397|NCT00793897|Subjects with Advanced or Metastatic Solid Tumors or Neoplasms|subjects with advanced or metastatic solid tumors or neoplasms
5626398|NCT00793884|Diabetes|diabetes
5626399|NCT00793884|Latino population|latino population
5626400|NCT00793871|sunitinib|sunitinib
5626401|NCT00793871|Phase IV|phase iv
5626402|NCT00793871|gastrointestinal stomal tumor|gastrointestinal stomal tumor
5626403|NCT00793871|imatinib resistant or intolerant|imatinib resistant or intolerant
5626404|NCT00793871|Chinese|chinese
5626405|NCT00793845|tandem high-dose chemotherapy for high-risk neuroblastoma|tandem high-dose chemotherapy for high-risk neuroblastoma
5626406|NCT00793832|weight loss|weight loss
5626407|NCT00793819|nocturia|nocturia
5626408|NCT00793819|BPH|bph
5626409|NCT00793819|benign prostate hyperplasia|benign prostate hyperplasia
5626410|NCT00793819|nocturia in men with benign prostate hyperplasia|nocturia in men with benign prostate hyperplasia
5626411|NCT00793806|chronic kidney disease|chronic kidney disease
5626412|NCT00793780|obesity|obesity
5626413|NCT00793780|schizophrenia|schizophrenia
5626414|NCT00793780|schizoaffective disorder|schizoaffective disorder
5626415|NCT00793780|weight loss|weight loss
5626416|NCT00793767|Erythropoietin|erythropoietin
5626418|NCT00793767|insulin sensitivity|insulin sensitivity
5626419|NCT00793767|substrate metabolism|substrate metabolism
5626420|NCT00793741|Type 1 diabetes|type 1 diabetes
5626421|NCT00793741|Hypoglycemia unawareness|hypoglycemia unawareness
5626422|NCT00793741|Islet transplant|islet transplant
5626423|NCT00793728|Morbid obesity|morbid obesity
5626424|NCT00793728|High risk|high risk
5626425|NCT00793715|acute pancreatitis|acute pancreatitis
5626426|NCT00793715|abdominal compartment syndrome|abdominal compartment syndrome
5626427|NCT00793715|decompressive laparotomy|decompressive laparotomy
5626428|NCT00793715|percutaneous abdominal puncture|percutaneous abdominal puncture
5626429|NCT00793715|Mortality of patients treated in both arms|mortality of patients treated in both arms
5626430|NCT00793702|tuberculosis|tuberculosis
5626431|NCT00793702|diagnosis|diagnosis
5626432|NCT00793702|ESAT-6|esat-6
5626433|NCT00793702|CFP-10|cfp-10
5626435|NCT00793702|Skin test for the diagnosis of tuberculosis infection|skin test for the diagnosis of tuberculosis infection
5626436|NCT00793689|parathyroid|parathyroid
5626437|NCT00793689|thyroidectomy|thyroidectomy
5626438|NCT00793689|hypoparathyroidism|hypoparathyroidism
5626439|NCT00793689|Parathyroid function after total thyroidectomy|parathyroid function after total thyroidectomy
5626440|NCT00793676|GPCR expression|gpcr expression
5626441|NCT00793676|transcriptomic|transcriptomic
5626442|NCT00793676|white blood cells|white blood cells
5626443|NCT00793676|diagnostic|diagnostic
5626444|NCT00793676|Control|control
5626445|NCT00793663|Xenon|xenon
5626447|NCT00793663|Postoperative Nausea and vomiting|postoperative nausea and vomiting
5626448|NCT00793663|Depth of anaesthesia|depth of anaesthesia
5626449|NCT00793650|Cancer|cancer
5626450|NCT00793650|Multiple Myeloma|multiple myeloma
5626455|NCT00793611|Overactive Bladder|overactive bladder
5626456|NCT00793611|Hypnotherapy|hypnotherapy
5626457|NCT00793598|CMX001|cmx001
5626458|NCT00793598|Kidney transplant|kidney transplant
5626459|NCT00793598|HSCT transplant|hsct transplant
5626460|NCT00793598|BK Virus|bk virus
5626461|NCT00793598|Post kidney transplant patients with BK virus viruria > 10^4|post kidney transplant patients with bk virus viruria > 10^4
5626462|NCT00793598|Post HSCT transplant patients with BK virus viruria > 10^4|post hsct transplant patients with bk virus viruria > 10^4
5626463|NCT00793585|IgA nephropathy|iga nephropathy
5626464|NCT00793559|septic shock refractory to catecholamines|septic shock refractory to catecholamines
5626465|NCT00793546|Bosutinib|bosutinib
5626466|NCT00793546|Exemestane|exemestane
5626467|NCT00793546|postmenopausal|postmenopausal
5626468|NCT00793546|breast cancer|breast cancer
5626469|NCT00793520|fibromyalgia|fibromyalgia
5626470|NCT00793520|milnacipran|milnacipran
5626471|NCT00793520|Forest Laboratories|forest laboratories
5626472|NCT00793507|childhood caries|childhood caries
5626598|NCT00792883|Resistance|resistance
5626473|NCT00793494|Irritable bowel syndrome|irritable bowel syndrome
5626474|NCT00793494|Children|children
5626475|NCT00793494|Pediatrics|pediatrics
5626476|NCT00793494|Probiotics|probiotics
5626477|NCT00793481|Metabolic Syndrome|metabolic syndrome
5626478|NCT00793468|nicotine dependence|nicotine dependence
5626479|NCT00793468|smoking|smoking
5626480|NCT00793468|pharmacological treatment|pharmacological treatment
5626481|NCT00793468|relapse prevention|relapse prevention
5626482|NCT00793455|education|education
5626483|NCT00793455|preventive service|preventive service
5626484|NCT00793455|screening|screening
5626485|NCT00793442|sepsis|sepsis
5626486|NCT00793442|severe sepsis|severe sepsis
5626487|NCT00793442|septic shock|septic shock
5626488|NCT00793442|endothelium|endothelium
5626489|NCT00793442|microcirculation|microcirculation
5626490|NCT00793442|biomarkers|biomarkers
5626491|NCT00793429|electrocardiographic safety|electrocardiographic safety
5626492|NCT00793429|pharmacokinetics|pharmacokinetics
5626493|NCT00793416|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5626494|NCT00793416|Valve Adjustment|valve adjustment
5626495|NCT00793416|Blocked Shunt in NPH patients|blocked shunt in nph patients
5626496|NCT00793416|Diagnosis of blockage|diagnosis of blockage
5626497|NCT00793403|Observational cohort|observational cohort
5626498|NCT00793403|prospectives|prospectives
5626499|NCT00793403|multicentre|multicentre
5626500|NCT00793403|the Italian study RA patient CLARA and PRO-CLARA|the italian study ra patient clara and pro-clara
5626501|NCT00793390|Aggressive Breat Cancer|aggressive breat cancer
5626502|NCT00793364|Cholesterol, stanol-ester, mediterranean diet, cardiac risk|cholesterol, stanol-ester, mediterranean diet, cardiac risk
5626503|NCT00793351|reduced intensity stem cell transplantation for neuroblastoma|reduced intensity stem cell transplantation for neuroblastoma
5626504|NCT00793351|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue|relapsed neuroblastoma after high-dose chemotherapy and autologous stem cell rescue
5626505|NCT00793338|Heart failure|heart failure
5626506|NCT00793338|Sildenafil|sildenafil
5626507|NCT00793338|Cardiopulmonary exercise test|cardiopulmonary exercise test
5626508|NCT00793338|quality of life|quality of life
5626509|NCT00793338|6 minute walk test|6 minute walk test
5626510|NCT00793286|inguinal hernia|inguinal hernia
5626511|NCT00793286|laparoscopy|laparoscopy
5626512|NCT00793286|mesh|mesh
5626513|NCT00793234|TKR|tkr
5626515|NCT00793234|DVT|dvt
5626516|NCT00793221|Coronary stent.|coronary stent.
5626517|NCT00793221|Restenosis.|restenosis.
5626518|NCT00793221|Coronary artery disease.|coronary artery disease.
5626519|NCT00793221|Chronic total occlusion.|chronic total occlusion.
5626520|NCT00793208|Lung cancer|lung cancer
5626521|NCT00793208|non small cell|non small cell
5626522|NCT00793208|vaccine|vaccine
5626523|NCT00793208|carcinoma|carcinoma
5626524|NCT00793208|immunization|immunization
5626525|NCT00793208|autologous Tumor|autologous tumor
5626526|NCT00793208|vaccination|vaccination
5626527|NCT00793195|Neonates|neonates
5626528|NCT00793195|Short Bowel Syndrome|short bowel syndrome
5626529|NCT00793195|Intestinal Failure|intestinal failure
5626530|NCT00793195|Liver Failure|liver failure
5626531|NCT00793195|Parenteral Nutrition|parenteral nutrition
5626532|NCT00793195|Intralipid|intralipid
5626533|NCT00793195|SMOF|smof
5626534|NCT00793182|Renal|renal
5626535|NCT00793182|Kidney|kidney
5626536|NCT00793182|Contrast Induced Nephropathy|contrast induced nephropathy
5626537|NCT00793169|squamous cell carcinoma of the head or neck|squamous cell carcinoma of the head or neck
5626538|NCT00793156|uremic pruritus|uremic pruritus
5626539|NCT00793143|morbid obesity|morbid obesity
5629092|NCT00783770|Nutrition|nutrition
5626540|NCT00793143|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5626542|NCT00793143|laparoscopic gastric bypass|laparoscopic gastric bypass
5626543|NCT00793143|LGB|lgb
5626544|NCT00793143|comorbidities|comorbidities
5626545|NCT00793143|diabetes|diabetes
5626546|NCT00793143|excessive weight loss|excessive weight loss
5626547|NCT00793143|weight loss|weight loss
5626548|NCT00793130|Ulcerative|ulcerative
5626549|NCT00793130|Colitis|colitis
5626550|NCT00793130|Coltect|coltect
5626551|NCT00793130|Curcumin|curcumin
5626552|NCT00793130|Green tea|green tea
5626553|NCT00793130|Selenium|selenium
5626554|NCT00793130|inflammation|inflammation
5626555|NCT00793130|bowel|bowel
5626556|NCT00793117|chronic sinusitis|chronic sinusitis
5626557|NCT00793117|FESS|fess
5626558|NCT00793117|packing|packing
5626559|NCT00793104|allograft|allograft
5626560|NCT00793104|knee injury|knee injury
5626561|NCT00793104|cartilage injury|cartilage injury
5626562|NCT00793104|Osteochondral defects in the articular femoral cartilage|osteochondral defects in the articular femoral cartilage
5626563|NCT00793078|sepsis|sepsis
5626564|NCT00793078|arterial blood pressure|arterial blood pressure
5626565|NCT00793078|complexity|complexity
5626566|NCT00793078|variability|variability
5626567|NCT00793065|electronic health records|electronic health records
5626568|NCT00793065|health information technology|health information technology
5626569|NCT00793065|physician incentives|physician incentives
5626570|NCT00793065|quality of health care|quality of health care
5626572|NCT00793052|Edema|edema
5626573|NCT00793052|pain|pain
5626574|NCT00793013|Acute Lung Injury|acute lung injury
5626575|NCT00793013|Adult Respiratory Distress Syndrome|adult respiratory distress syndrome
5626576|NCT00793013|Airway Pressure Release Ventilation|airway pressure release ventilation
5626577|NCT00793013|Acute Kidney Injury|acute kidney injury
5626578|NCT00793013|Pressure Trial|pressure trial
5626579|NCT00793000|Safety tolerability pharmacokinetics PK first in human FIH|safety tolerability pharmacokinetics pk first in human fih
5626580|NCT00792974|Cognitive behavioral education|cognitive behavioral education
5626581|NCT00792974|COPD (Chronic Obstructive Pulmonary Disease), GOLD II-IV|copd (chronic obstructive pulmonary disease), gold ii-iv
5626582|NCT00792961|Prostate cancer|prostate cancer
5626583|NCT00792961|Robotic surgery|robotic surgery
5626584|NCT00792961|Endomicroscopy|endomicroscopy
5626585|NCT00792922|Trachoma|trachoma
5626586|NCT00792922|Azithromycin|azithromycin
5626587|NCT00792922|Mass treatment|mass treatment
5626588|NCT00792909|Pneumococcal vaccine|pneumococcal vaccine
5626589|NCT00792909|Pneumococcal disease|pneumococcal disease
5626590|NCT00792909|Safety|safety
5626591|NCT00792909|Immunogenicity|immunogenicity
5626592|NCT00792883|PICU|picu
5626593|NCT00792883|BIA|bia
5626594|NCT00792883|Phase angle|phase angle
5626595|NCT00792883|RQ|rq
5626596|NCT00792883|EEM|eem
5626597|NCT00792883|Compliance|compliance
5626599|NCT00792883|Curves|curves
5626600|NCT00792883|Polymorphisms|polymorphisms
5626601|NCT00792883|NF-kappa B|nf-kappa b
5626602|NCT00792883|Scores|scores
5626603|NCT00792883|PIM 2|pim 2
5626604|NCT00792883|PRISM I|prism i
5626605|NCT00792870|Obesity|obesity
5626606|NCT00792870|Weight loss|weight loss
5626607|NCT00792870|Internet|internet
5626608|NCT00792857|Parathyroid Diseases|parathyroid diseases
5626609|NCT00792857|Renal Insufficiency|renal insufficiency
5626610|NCT00792857|Kidney Failure, Chronic|kidney failure, chronic
5626611|NCT00792857|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5626612|NCT00792857|Vitamin D|vitamin d
5626613|NCT00792857|Hyperparathyroidism|hyperparathyroidism
5626614|NCT00792857|Renal Insufficiency, Chronic|renal insufficiency, chronic
5626615|NCT00792857|Kidney Diseases|kidney diseases
5626616|NCT00792857|Kidney Failure|kidney failure
5620573|NCT00816582|PET/CT|pet/ct
5626617|NCT00792818|Osteoarthritis, Knee, Curcumin, Multicenter, RCT|osteoarthritis, knee, curcumin, multicenter, rct
5626619|NCT00792805|indacaterol|indacaterol
5626620|NCT00792805|long-acting β2-agonist|long-acting β2-agonist
5626621|NCT00792805|adults|adults
5626622|NCT00792792|tissue transfer|tissue transfer
5626623|NCT00792779|Morbid obesity|morbid obesity
5626624|NCT00792779|General anaesthesia|general anaesthesia
5626625|NCT00792779|Propofol|propofol
5626626|NCT00792779|Sevoflurane|sevoflurane
5626627|NCT00792766|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5626628|NCT00792766|Angiolipoma|angiolipoma
5626629|NCT00792766|mTOR|mtor
5626630|NCT00792766|Everolimus|everolimus
5626631|NCT00792753|Coronary Artery Disease|coronary artery disease
5626632|NCT00792727|Pain|pain
5626633|NCT00792727|Knee|knee
5626634|NCT00792727|Arthritis|arthritis
5626635|NCT00792727|Knee pain|knee pain
5626636|NCT00792701|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5626637|NCT00792688|burn wounds|burn wounds
5626638|NCT00792688|wound healing|wound healing
5626639|NCT00792675|exercise|exercise
5626640|NCT00792675|disease activity|disease activity
5626641|NCT00792675|inflammation|inflammation
5626642|NCT00792675|resistance training|resistance training
5626643|NCT00792675|rehabilitation|rehabilitation
5626644|NCT00792662|Diabetes Mellitus|diabetes mellitus
5626645|NCT00792662|Alzheimer's Disease|alzheimer's disease
5626646|NCT00792662|Apathy|apathy
5626647|NCT00792662|Methylphenidate|methylphenidate
5626648|NCT00792662|Dementia|dementia
5626649|NCT00792636|sumatriptan and naproxen sodium|sumatriptan and naproxen sodium
5626650|NCT00792636|migraine with or without aura|migraine with or without aura
5626651|NCT00792636|naproxen sodium|naproxen sodium
5626652|NCT00792636|sumatriptan|sumatriptan
5626653|NCT00792636|blood pressure|blood pressure
5626654|NCT00792636|migraine headaches|migraine headaches
5626655|NCT00792623|Varicella|varicella
5626656|NCT00792623|VarilrixTM|varilrixtm
5626657|NCT00792610|youth|youth
5626658|NCT00792610|hepatitis B|hepatitis b
5626659|NCT00792610|vaccination|vaccination
5626660|NCT00792610|booster|booster
5626661|NCT00792610|immunity response|immunity response
5626662|NCT00792584|etravirine|etravirine
5626663|NCT00792584|efavirenz|efavirenz
5626664|NCT00792584|anxiety|anxiety
5626665|NCT00792584|depression|depression
5626666|NCT00792584|sleep quality|sleep quality
5626667|NCT00792584|HIV|hiv
5626668|NCT00792584|NNRTI|nnrti
5626669|NCT00792584|Tritherapy|tritherapy
5626670|NCT00792584|compliance|compliance
5626671|NCT00792584|stocrin|stocrin
5626672|NCT00792584|To replace efavirenz in long-term users with etravirine|to replace efavirenz in long-term users with etravirine
5626673|NCT00792584|To investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety|to investigate effect of such replacement on patient preference, sleep quality, daytime sleepiness, and anxiety
5626674|NCT00792519|alcohol use|alcohol use
5626675|NCT00792519|HIV|hiv
5626676|NCT00792519|cognitive behavioral treatment|cognitive behavioral treatment
5626677|NCT00792519|Kenya|kenya
5626678|NCT00792519|hazardous/binge drinking|hazardous/binge drinking
5626679|NCT00792519|alcohol abuse/dependence|alcohol abuse/dependence
5626680|NCT00792493|Healthy volunteer study|healthy volunteer study
5626681|NCT00792480|Obesity|obesity
5626682|NCT00792480|Pregnancy|pregnancy
5626683|NCT00792480|Exercise|exercise
5626684|NCT00792480|Nutrition|nutrition
5626685|NCT00792480|obesity in pregnancy|obesity in pregnancy
5626686|NCT00792454|Chronic kidney disease|chronic kidney disease
5626687|NCT00792454|End stage renal disease|end stage renal disease
5626688|NCT00792454|Exercise|exercise
5626689|NCT00792454|Cardiovascular disease|cardiovascular disease
5626690|NCT00792441|Specific inspiratory muscle training(SIMT)|specific inspiratory muscle training(simt)
5626691|NCT00792441|Loaded deep breathing|loaded deep breathing
5626692|NCT00792441|Weaning|weaning
5626693|NCT00792441|Mechanical ventilation|mechanical ventilation
5626694|NCT00792441|Respiratory muscle|respiratory muscle
5626695|NCT00792428|Stroke|stroke
5626696|NCT00792428|Ischemia|ischemia
5626697|NCT00792428|Infarction|infarction
5626698|NCT00792428|Cerebrovascular Disorder|cerebrovascular disorder
5626699|NCT00792428|Central Nervous System Diseases|central nervous system diseases
5626700|NCT00792428|Brain Infarction|brain infarction
5626701|NCT00792428|Brain Ischemia|brain ischemia
5626702|NCT00792428|Rehabilitation|rehabilitation
5626703|NCT00792428|Recovery|recovery
5626704|NCT00792428|Neurorehabilitation|neurorehabilitation
5626705|NCT00792428|Plasticity|plasticity
5626706|NCT00792415|Abstinence syndrome symptoms|abstinence syndrome symptoms
5626707|NCT00792415|Withdrawal symptoms|withdrawal symptoms
5626708|NCT00792415|Opioid dependence|opioid dependence
5626709|NCT00792402|chronic heart failure|chronic heart failure
5626710|NCT00792402|Computerized clinical guidelines|computerized clinical guidelines
5626711|NCT00792402|Primary care|primary care
5626712|NCT00792389|Gallstones|gallstones
5626713|NCT00792389|Gallbladder|gallbladder
5626714|NCT00792389|Cholecystectomy|cholecystectomy
5626715|NCT00792389|Gallstone disease|gallstone disease
5626716|NCT00792376|NSAID|nsaid
5626717|NCT00792376|tendon|tendon
5626718|NCT00792376|pain|pain
5626720|NCT00792376|Achilles|achilles
5626721|NCT00792363|KRAS|kras
5626722|NCT00792350|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5626723|NCT00792350|Sorafenib|sorafenib
5626724|NCT00792311|Tsui test|tsui test
5626725|NCT00792311|Epidural Analgesia|epidural analgesia
5626726|NCT00792285|Colon cancer|colon cancer
5626727|NCT00792285|Prevention|prevention
5626728|NCT00792285|Screening|screening
5626729|NCT00792285|Telephone|telephone
5626730|NCT00792272|aspirin resistance|aspirin resistance
5626731|NCT00792272|aspirin resistance in hemodialysis patients|aspirin resistance in hemodialysis patients
5626732|NCT00792246|pharmacokinetics|pharmacokinetics
5626733|NCT00792246|pediatric|pediatric
5626734|NCT00792246|bioavailability|bioavailability
5626735|NCT00792233|Poly JIA|poly jia
5626736|NCT00792233|TNF|tnf
5626737|NCT00792233|Remission|remission
5626738|NCT00792220|stroke|stroke
5626739|NCT00792220|mobile stroke unit|mobile stroke unit
5626740|NCT00792220|thrombolysis|thrombolysis
5626741|NCT00792220|stroke management|stroke management
5626742|NCT00792220|computerized tomography|computerized tomography
5626743|NCT00792194|Cystic fibrosis|cystic fibrosis
5626744|NCT00792194|Exercise training|exercise training
5626745|NCT00792194|Home training|home training
5626746|NCT00792194|Aerobic capacity|aerobic capacity
5626747|NCT00792181|The focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in Ambulance service.|the focus is the pain reduce in the first 15 minutes for patients suffering an acute myocardial infarction, treated by caregivers in ambulance service.
5626748|NCT00792155|PKD|pkd
5626749|NCT00792142|neurotoxicity|neurotoxicity
5626750|NCT00792142|stage I multiple myeloma|stage i multiple myeloma
5626751|NCT00792142|stage II multiple myeloma|stage ii multiple myeloma
5626752|NCT00792142|stage III multiple myeloma|stage iii multiple myeloma
5626753|NCT00792129|MIS|mis
5626754|NCT00792129|Minimally invasive|minimally invasive
5626755|NCT00792129|Atavi|atavi
5626756|NCT00792129|Flex Posure|flex posure
5626757|NCT00792129|retractor|retractor
5626758|NCT00792129|Patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,|patients with chronic low back and/or leg pain who are candidates for elective lumbar interbody fusion through a posterior unilateral approach,
5626759|NCT00792129|for inclusion in the study.|for inclusion in the study.
5626760|NCT00792129|If the patient meets all of the eligibility criteria,|if the patient meets all of the eligibility criteria,
5626761|NCT00792129|they will be enrolled into the study and have either the MiLIF or open procedure depending on the surgeon they present to|they will be enrolled into the study and have either the milif or open procedure depending on the surgeon they present to
5626762|NCT00792129|(i.e., what group their surgeon agreed to participate in.)|(i.e., what group their surgeon agreed to participate in.)
5626763|NCT00792090|allergy|allergy
5626764|NCT00792090|cow's milk|cow's milk
5626765|NCT00792090|sensibilisation|sensibilisation
5626766|NCT00792090|fermented milk|fermented milk
5626767|NCT00792090|infant formula|infant formula
5626768|NCT00792077|Leukemia|leukemia
5626769|NCT00792077|Lenalidomide|lenalidomide
5626770|NCT00792077|Actigraph|actigraph
5626771|NCT00792077|Sleep Test Study|sleep test study
5626772|NCT00792077|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5626773|NCT00792077|CC-5013|cc-5013
5626774|NCT00792077|Revlimid|revlimid
5626775|NCT00792064|quality of life|quality of life
5626776|NCT00792064|adverse effects|adverse effects
5626777|NCT00792051|influenza|influenza
5626778|NCT00792051|vaccination|vaccination
5626779|NCT00792051|children|children
5626780|NCT00792051|Influenza-like illness|influenza-like illness
5626781|NCT00792038|Psychological tests|psychological tests
5626782|NCT00792038|Magnetic Resonance Imaging|magnetic resonance imaging
5626783|NCT00792038|Cognitive therapy|cognitive therapy
5626784|NCT00792025|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5626785|NCT00792025|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5626786|NCT00792025|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5626787|NCT00792025|stage III bladder cancer|stage iii bladder cancer
5626788|NCT00792025|stage IV bladder cancer|stage iv bladder cancer
5626789|NCT00792025|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5626790|NCT00792025|recurrent bladder cancer|recurrent bladder cancer
5626791|NCT00792012|Glioblastoma Multiforme|glioblastoma multiforme
5626792|NCT00791999|Rheumatoid Arthritis|rheumatoid arthritis
5626793|NCT00791999|Certolizumab Pegol|certolizumab pegol
5626794|NCT00791999|Cimzia|cimzia
5626795|NCT00791986|Breathing exercise|breathing exercise
5626796|NCT00791986|blood pressure|blood pressure
5626797|NCT00791986|hypertension|hypertension
5626798|NCT00791960|Cesarean Section|cesarean section
5626799|NCT00791960|Dimenhydrinate|dimenhydrinate
5626800|NCT00791960|Gravol|gravol
5626801|NCT00791960|Antiemetics|antiemetics
5626802|NCT00791921|Rheumatoid Arthritis|rheumatoid arthritis
5626803|NCT00791921|Certolizumab Pegol|certolizumab pegol
5626804|NCT00791921|Cimzia|cimzia
5626805|NCT00791869|bupropion|bupropion
5626807|NCT00791869|pharmacokinetics|pharmacokinetics
5626808|NCT00791869|Pharmacokinetics of bupropion|pharmacokinetics of bupropion
5626809|NCT00791843|CHF|chf
5608488|NCT00864760|Bioequivalence|bioequivalence
5626810|NCT00791830|Residual renal function|residual renal function
5626811|NCT00791830|Haemodialysis|haemodialysis
5626812|NCT00791830|Applanation tonometry|applanation tonometry
5626813|NCT00791830|Cardiac output|cardiac output
5626814|NCT00791830|Quality of life|quality of life
5626815|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5626816|NCT00791817|pharmacokinetics study|pharmacokinetics study
5626817|NCT00791804|Pain|pain
5626818|NCT00791804|Post Op pain|post op pain
5626819|NCT00791804|Fentanyl|fentanyl
5626820|NCT00791804|Pain Control|pain control
5626821|NCT00791804|Surgery|surgery
5626822|NCT00791791|Anesthesia General|anesthesia general
5626826|NCT00791791|Diagnostic Techniques and Procedures|diagnostic techniques and procedures
5626827|NCT00791778|Peritoneal Neoplasma|peritoneal neoplasma
5626828|NCT00791765|Scalp|scalp
5626829|NCT00791765|Psoriasis|psoriasis
5626830|NCT00791765|Plaque Psoriasis|plaque psoriasis
5626831|NCT00791765|Skin Diseases|skin diseases
5626832|NCT00791765|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5626833|NCT00791765|etanercept|etanercept
5626834|NCT00791752|Safety and Tolerability|safety and tolerability
5626836|NCT00791739|trazodone|trazodone
5626837|NCT00791739|pregabalin|pregabalin
5626838|NCT00791739|Fibromyalgia Impact Questionnaire (FIQ)|fibromyalgia impact questionnaire (fiq)
5626839|NCT00791739|Pittsburgh Sleep Quality Inventory (PSQI)|pittsburgh sleep quality inventory (psqi)
5626840|NCT00791739|Brief Pain Inventory (BPI)|brief pain inventory (bpi)
5626841|NCT00791726|microperimetry|microperimetry
5626842|NCT00791726|macular edema|macular edema
5626844|NCT00791726|Retinal sensitivity as measured with fundus related microperimetry|retinal sensitivity as measured with fundus related microperimetry
5626845|NCT00791713|Paliperidone ER|paliperidone er
5626846|NCT00791713|Antipsychotic drugs|antipsychotic drugs
5626847|NCT00791713|Selective serotonin reuptake inhibitors|selective serotonin reuptake inhibitors
5626848|NCT00791713|Mood disorders|mood disorders
5626849|NCT00791713|Schizophrenia|schizophrenia
5626850|NCT00791700|Open label pharmacokinetic safety and efficacy in HIV-1 infected pediatrics|open label pharmacokinetic safety and efficacy in hiv-1 infected pediatrics
5626851|NCT00791687|Antioxidant enzymes|antioxidant enzymes
5626852|NCT00791687|Glutathione|glutathione
5626853|NCT00791687|Oxidative stress|oxidative stress
5626854|NCT00791687|Prematurity|prematurity
5626855|NCT00791687|Respiratory distress|respiratory distress
5626856|NCT00791687|Non enzymatic antioxidant defense system|non enzymatic antioxidant defense system
5626857|NCT00791687|Enzymatic antioxidant defense system|enzymatic antioxidant defense system
5626858|NCT00791674|Opiates|opiates
5626859|NCT00791674|sleep apnea|sleep apnea
5626860|NCT00791674|ventilatory failure|ventilatory failure
5626861|NCT00791648|aki|aki
5626862|NCT00791648|delirium|delirium
5626863|NCT00791648|statin|statin
5626864|NCT00791648|short-term|short-term
5626865|NCT00791648|cardiac|cardiac
5626866|NCT00791635|Cervical Cancer|cervical cancer
5626867|NCT00791635|Vaginal Cancer|vaginal cancer
5626868|NCT00791635|Endometrial Cancer|endometrial cancer
5626869|NCT00791635|Cervix|cervix
5626870|NCT00791635|Endometrial|endometrial
5626871|NCT00791635|Pelvic Exenteration|pelvic exenteration
5626872|NCT00791635|Pelvic Exenteration Surgery|pelvic exenteration surgery
5626873|NCT00791635|Questionnaire|questionnaire
5626874|NCT00791635|Gynecologic Cancer|gynecologic cancer
5626875|NCT00791635|Vagina|vagina
5626876|NCT00791635|Vulva|vulva
5626877|NCT00791635|Gynecologic Malignancy|gynecologic malignancy
5626878|NCT00791622|Paliperidone ER|paliperidone er
5626879|NCT00791622|Schizophernia|schizophernia
5626880|NCT00791622|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
5626881|NCT00791622|Cardiovascular|cardiovascular
5626882|NCT00791622|Schizoaffective Disorder|schizoaffective disorder
5626883|NCT00791609|cancer|cancer
5626884|NCT00791596|Ergonomic intervention|ergonomic intervention
5626885|NCT00791596|Musculoskeletal disorders|musculoskeletal disorders
5626886|NCT00791596|Low back pain|low back pain
5626887|NCT00791596|Posture|posture
5626888|NCT00791596|Video display terminal|video display terminal
5626889|NCT00791583|Emergency Medicine (EM)|emergency medicine (em)
5626890|NCT00791583|Central Venous Catheter (CVC)|central venous catheter (cvc)
5626891|NCT00791583|Maximal Barrier Precaution (MBP)|maximal barrier precaution (mbp)
5626892|NCT00791583|Precaution Technique during Central Venous Cathether Placement|precaution technique during central venous cathether placement
5626893|NCT00791544|monoclonal antibody, anti IGF1R|monoclonal antibody, anti igf1r
5626894|NCT00791531|Methotrexate|methotrexate
5626895|NCT00791531|Malaria|malaria
5626896|NCT00791518|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5626897|NCT00791518|Spirometry|spirometry
5626901|NCT00791492|FAP|fap
5626902|NCT00791492|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5626903|NCT00791492|ATTR-PN|attr-pn
5626904|NCT00791492|transthyretin|transthyretin
5626905|NCT00791492|TTR|ttr
5626906|NCT00791492|amyloid|amyloid
5626907|NCT00791492|polyneuropathy|polyneuropathy
5626908|NCT00791492|familial|familial
5626909|NCT00791492|hereditary|hereditary
5626910|NCT00791492|amyloidosis|amyloidosis
5626911|NCT00791492|FoldRx|foldrx
5626912|NCT00791479|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
5626913|NCT00791466|Iodine deficiency|iodine deficiency
5626914|NCT00791466|Pregnancy|pregnancy
5626915|NCT00791466|Thyroid function|thyroid function
5626916|NCT00791466|Infant development|infant development
5626917|NCT00791466|Growth|growth
5627113|NCT00790803|uveitis|uveitis
5626918|NCT00791453|Diabetic patients at the Clarksdale Diabetes|diabetic patients at the clarksdale diabetes
5626919|NCT00791453|and Metabolism Clinic and must be between the|and metabolism clinic and must be between the
5626920|NCT00791453|ages of 18 and 64 years of age.|ages of 18 and 64 years of age.
5626921|NCT00791440|Schizophrenia|schizophrenia
5626922|NCT00791440|Schizoaffective|schizoaffective
5626923|NCT00791440|Schizophreniform|schizophreniform
5626924|NCT00791440|Psychosis|psychosis
5626925|NCT00791440|Psychotic|psychotic
5626926|NCT00791440|Hallucinations|hallucinations
5626927|NCT00791440|Delusions|delusions
5626928|NCT00791440|Paranoia|paranoia
5626929|NCT00791440|Paranoid|paranoid
5626930|NCT00791440|Voices|voices
5626931|NCT00791440|CBT|cbt
5626932|NCT00791440|Cognitive Behavior Therapy|cognitive behavior therapy
5814569|NCT00081822|Foran|foran
5626933|NCT00791440|Cognitive Therapy|cognitive therapy
5626934|NCT00791401|Schizophrenia|schizophrenia
5626935|NCT00791401|Mood disorders|mood disorders
5626936|NCT00791401|Antipsychotic drugs|antipsychotic drugs
5626937|NCT00791401|ER OROS Paliperidone|er oros paliperidone
5626938|NCT00791388|Pharmacokinetics|pharmacokinetics
5626939|NCT00791375|young adult|young adult
5626941|NCT00791375|exercise|exercise
5626942|NCT00791375|physical activity|physical activity
5626943|NCT00791362|accreditation|accreditation
5626944|NCT00791362|cardiovascular disease|cardiovascular disease
5626945|NCT00791362|primary care|primary care
5626946|NCT00791349|Schizophrenia|schizophrenia
5626947|NCT00791349|Schizoaffective Disorder|schizoaffective disorder
5626948|NCT00791349|Mood Disorders|mood disorders
5626949|NCT00791349|Antipsychotic drugs|antipsychotic drugs
5626950|NCT00791349|Cardiovascular|cardiovascular
5626951|NCT00791349|Immediate release (IR) Paliperidone|immediate release (ir) paliperidone
5626952|NCT00791336|NSCLC|nsclc
5626953|NCT00791336|chemotherapy|chemotherapy
5626954|NCT00791336|radiation therapy|radiation therapy
5626957|NCT00791310|Medical ICU|medical icu
5626958|NCT00791310|Severe sepsis|severe sepsis
5626959|NCT00791297|CDB-2914|cdb-2914
5626960|NCT00791297|Contraceptive Vaginal Rings|contraceptive vaginal rings
5626961|NCT00791297|ovulation|ovulation
5626962|NCT00791297|endometrial changes|endometrial changes
5626963|NCT00791297|bleeding patterns|bleeding patterns
5626964|NCT00791297|normal cycling women|normal cycling women
5626965|NCT00791297|Inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women|inhibition of ovulation, endometrial changes and bleeding patterns in normal cycling women
5626966|NCT00791284|Schizophrenia|schizophrenia
5626967|NCT00791284|Mood disorders|mood disorders
5626968|NCT00791284|Antipsychotic drugs|antipsychotic drugs
5626969|NCT00791284|intermediate release (IR) Paliperidone|intermediate release (ir) paliperidone
5626970|NCT00791271|Melanoma|melanoma
5626971|NCT00791271|Malignant melanoma|malignant melanoma
5626972|NCT00791271|Unresectable|unresectable
5626973|NCT00791271|Decitabine|decitabine
5626974|NCT00791271|PEG Interferon Alpha-2b|peg interferon alpha-2b
5626975|NCT00791271|PEG Intron|peg intron
5626976|NCT00791271|5-Aza-Deoxycytidine|5-aza-deoxycytidine
5626977|NCT00791271|Dacogen|dacogen
5626978|NCT00791245|ISTO Technologies, Inc|isto technologies, inc
5626979|NCT00791245|cartilage repair|cartilage repair
5626980|NCT00791245|arthroscopy|arthroscopy
5626981|NCT00791245|361 HCT/P|361 hct/p
5626982|NCT00791245|human tissue|human tissue
5626983|NCT00791245|biologic|biologic
5626984|NCT00791245|knee|knee
5626985|NCT00791232|Extended-release paliperidone|extended-release paliperidone
5626986|NCT00791232|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
5626987|NCT00791232|ER OROS paliperidone|er oros paliperidone
5626988|NCT00791219|Onychomycosis|onychomycosis
5626989|NCT00791206|exercise|exercise
5626990|NCT00791206|ischemia|ischemia
5626991|NCT00791206|MRI|mri
5626992|NCT00791206|MRI spectroscopy|mri spectroscopy
5626993|NCT00791206|Ischemia preconditioning|ischemia preconditioning
5626994|NCT00791193|Paliperidone ER|paliperidone er
5626995|NCT00791193|Antipsychotic drugs|antipsychotic drugs
5626996|NCT00791193|Schizophrenia|schizophrenia
5626997|NCT00791193|Mood disorders|mood disorders
5626998|NCT00791180|dynamic stabilization|dynamic stabilization
5626999|NCT00791180|Dynesys|dynesys
5627000|NCT00791180|fusion success|fusion success
5680368|NCT00578006|toxicity related symptoms|toxicity related symptoms
5680369|NCT00578006|04-020|04-020
5627001|NCT00791180|Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:|immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
5863021|NCT00001414|NEO-Personality Inventory (Revised)|neo-personality inventory (revised)
5863022|NCT00001414|X-Chromosome|x-chromosome
5627002|NCT00791180|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine|acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
5627003|NCT00791180|degenerative spondylolisthesis with objective evidence of neurologic impairment|degenerative spondylolisthesis with objective evidence of neurologic impairment
5627004|NCT00791180|failed previous fusion (pseudarthrosis).|failed previous fusion (pseudarthrosis).
5627006|NCT00791167|Schizophrenia|schizophrenia
5627007|NCT00791167|Paliperidone ER|paliperidone er
5627008|NCT00791154|Extensive disease|extensive disease
5627009|NCT00791154|Extrathoracic metasasis|extrathoracic metasasis
5627112|NCT00790816|Chronic administration|chronic administration
5627010|NCT00791154|Malignant pericardial effusion|malignant pericardial effusion
5627011|NCT00791154|Malignant pleural effusion|malignant pleural effusion
5627012|NCT00791154|Contralateral hilar adenopathy|contralateral hilar adenopathy
5627013|NCT00791141|Head and Neck Cancer|head and neck cancer
5627014|NCT00791141|Radiation therapy|radiation therapy
5627015|NCT00791141|Chemotherapy|chemotherapy
5627016|NCT00791141|Chemoradiotherapy|chemoradiotherapy
5627017|NCT00791141|adjuvant cetuximab administration|adjuvant cetuximab administration
5627018|NCT00791128|Type 2 Diabetes|type 2 diabetes
5627019|NCT00791115|Prostate cancer|prostate cancer
5627020|NCT00791115|prostatectomy|prostatectomy
5627021|NCT00791115|radiotherapy|radiotherapy
5627022|NCT00791115|prostatectomy after radiotherapy|prostatectomy after radiotherapy
5627023|NCT00791089|Radiofrequency Ablation|radiofrequency ablation
5627024|NCT00791089|atrial fibrillation|atrial fibrillation
5627025|NCT00791076|Insulin pump therapy|insulin pump therapy
5627026|NCT00791076|Type 1 diabetic|type 1 diabetic
5627027|NCT00791076|Chronic pancreatitis|chronic pancreatitis
5627028|NCT00791076|Pancreatic resection|pancreatic resection
5627029|NCT00791076|Pancreatic polypeptide|pancreatic polypeptide
5627030|NCT00791063|cell death|cell death
5627031|NCT00791063|Apoptosis|apoptosis
5627032|NCT00791063|PET imaging|pet imaging
5627033|NCT00791063|brain metastases|brain metastases
5627034|NCT00791063|whole brain radiation therapy|whole brain radiation therapy
5627035|NCT00791050|Hypothermia/complications/etiology|hypothermia/complications/etiology
5627036|NCT00791050|coronary artery bypass/adverse effects|coronary artery bypass/adverse effects
5627037|NCT00791024|Analgesia Tests|analgesia tests
5627038|NCT00791024|Analog Pain Scale|analog pain scale
5627039|NCT00791024|Pain Measurement|pain measurement
5627040|NCT00791011|Lymphoma|lymphoma
5627041|NCT00791011|AMG 655|amg 655
5627042|NCT00791011|Trail receptor|trail receptor
5627043|NCT00791011|Apoptosis|apoptosis
5627044|NCT00791011|Vorinostat|vorinostat
5627045|NCT00791011|Bortezomib|bortezomib
5627046|NCT00791011|SAHA|saha
5627047|NCT00791011|Velcade|velcade
5627048|NCT00790998|onchocerciasis|onchocerciasis
5627049|NCT00790998|river blindness|river blindness
5627050|NCT00790998|onchocerca volvulus|onchocerca volvulus
5627051|NCT00790998|moxidectin|moxidectin
5627052|NCT00790998|ivermectin|ivermectin
5627053|NCT00790972|MRSA|mrsa
5627054|NCT00790972|sinofresh|sinofresh
5627055|NCT00790972|nasal spray|nasal spray
5627056|NCT00790959|Intimate Partner Violence|intimate partner violence
5627057|NCT00790959|HIV/AIDS|hiv/aids
5627058|NCT00790959|Gender|gender
5627059|NCT00790959|Prevention|prevention
5627060|NCT00790959|Community mobilisation|community mobilisation
5627061|NCT00790959|Uganda|uganda
5627062|NCT00790946|valsartan|valsartan
5627063|NCT00790946|Metabolic syndrome|metabolic syndrome
5627064|NCT00790933|Drug therapy|drug therapy
5627065|NCT00790920|Acute ischemic stroke|acute ischemic stroke
5627066|NCT00790920|Angiography|angiography
5627067|NCT00790920|Desmoteplase|desmoteplase
5627068|NCT00790920|Thrombolytic|thrombolytic
5627069|NCT00790907|Unstable angina|unstable angina
5627070|NCT00790907|Non ST elevation myocardial infarction|non st elevation myocardial infarction
5627071|NCT00790907|PCI|pci
5627072|NCT00790907|unfractionated heparin|unfractionated heparin
5627073|NCT00790907|fondaparinux|fondaparinux
5627074|NCT00790907|acute coronary syndrome|acute coronary syndrome
5627075|NCT00790881|malaria|malaria
5627076|NCT00790881|HIV|hiv
5627077|NCT00790881|AIDS|aids
5627078|NCT00790881|nevirapine|nevirapine
5627079|NCT00790881|lumefantrine|lumefantrine
5627080|NCT00790881|artemether|artemether
5627081|NCT00790881|drug interaction|drug interaction
5627082|NCT00790881|pharmacokinetics|pharmacokinetics
5627083|NCT00790868|Panic Disorder|panic disorder
5627084|NCT00790868|Anxiety|anxiety
5627085|NCT00790868|D-cycloserine|d-cycloserine
5627086|NCT00790868|DCS|dcs
5627087|NCT00790868|Cognitive Behavioral Therapy|cognitive behavioral therapy
5627088|NCT00790868|CBT|cbt
5627089|NCT00790855|Bendamustine|bendamustine
5627090|NCT00790855|Acute Leukemia|acute leukemia
5627091|NCT00790855|Leukemia|leukemia
5627092|NCT00790855|Acute myeloid leukemia|acute myeloid leukemia
5627093|NCT00790855|Myelodysplastic Syndrome|myelodysplastic syndrome
5627094|NCT00790855|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5627095|NCT00790855|Chronic myeloid leukemia|chronic myeloid leukemia
5627097|NCT00790855|ALL|all
5627098|NCT00790855|AML|aml
5627099|NCT00790855|CML|cml
5627100|NCT00790842|Refractory Multiple Myeloma|refractory multiple myeloma
5627101|NCT00790842|Relapsed Multiple Myeloma|relapsed multiple myeloma
5608794|NCT00863330|stage IV melanoma|stage iv melanoma
5627102|NCT00790842|Multiple Myeloma with Renal Dysfunction|multiple myeloma with renal dysfunction
5627103|NCT00790842|Stage I Multiple Myeloma|stage i multiple myeloma
5627104|NCT00790842|Stage II Multiple Myeloma|stage ii multiple myeloma
5627105|NCT00790842|Stage III Multiple Myeloma|stage iii multiple myeloma
5627106|NCT00790829|preemptive|preemptive
5627107|NCT00790829|Nicotine Patch|nicotine patch
5627108|NCT00790829|Open Abdominal Surgery|open abdominal surgery
5627109|NCT00790816|Cancer|cancer
5627110|NCT00790816|lapatinib|lapatinib
5627111|NCT00790816|Combination therapy|combination therapy
5627114|NCT00790803|cystoid macular edema|cystoid macular edema
5627115|NCT00790777|Paliperidone ER|paliperidone er
5627116|NCT00790777|Schizophrenia, Mood disorders, Antipsychotic drugs|schizophrenia, mood disorders, antipsychotic drugs
5627117|NCT00790751|ED|ed
5627118|NCT00790751|Erectile Dysfunction|erectile dysfunction
5627119|NCT00790751|Dysfunction|dysfunction
5627120|NCT00790751|Erectile|erectile
5627121|NCT00790738|bipolar disorder|bipolar disorder
5627122|NCT00790738|depression|depression
5627123|NCT00790738|treatment|treatment
5627124|NCT00790738|randomized controlled trial|randomized controlled trial
5627125|NCT00790699|diabetes|diabetes
5627126|NCT00790699|Symlin|symlin
5627127|NCT00790699|pramlintide acetate|pramlintide acetate
5627128|NCT00790699|insulin|insulin
5627129|NCT00790699|multiple injection port|multiple injection port
5627130|NCT00790699|I-PORT|i-port
5627131|NCT00790686|Ureteral obstruction|ureteral obstruction
5627132|NCT00790686|Urologic surgical procedure|urologic surgical procedure
5627133|NCT00790686|Stents|stents
5627134|NCT00790686|Endoscopy|endoscopy
5627135|NCT00790686|Urology|urology
5627136|NCT00790673|Hepatitis C|hepatitis c
5627137|NCT00790673|Viral hepatitis|viral hepatitis
5627138|NCT00790660|ASP1941|asp1941
5627139|NCT00790660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5627140|NCT00790647|primary systemic amyloidosis|primary systemic amyloidosis
5627141|NCT00790595|Prostatectomy|prostatectomy
5627142|NCT00790582|ALS|als
5627143|NCT00790582|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5627144|NCT00790582|Lou Gehrig's Disease|lou gehrig's disease
5627146|NCT00790582|Lithium Carbonate|lithium carbonate
5627147|NCT00790569|bladder cancer|bladder cancer
5627148|NCT00790569|cervical cancer|cervical cancer
5627149|NCT00790569|esophageal cancer|esophageal cancer
5627150|NCT00790569|gastric cancer|gastric cancer
5627151|NCT00790569|renal cell carcinoma|renal cell carcinoma
5627152|NCT00790569|adult primary liver cancer|adult primary liver cancer
5627153|NCT00790569|non-small cell lung cancer|non-small cell lung cancer
5627154|NCT00790569|small cell lung cancer|small cell lung cancer
5627155|NCT00790569|pancreatic cancer|pancreatic cancer
5627156|NCT00790569|hypopharyngeal cancer|hypopharyngeal cancer
5627157|NCT00790569|laryngeal cancer|laryngeal cancer
5627158|NCT00790569|lip and oral cavity cancer|lip and oral cavity cancer
5627159|NCT00790569|nasopharyngeal cancer|nasopharyngeal cancer
5627160|NCT00790569|oropharyngeal cancer|oropharyngeal cancer
5627161|NCT00790569|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5627162|NCT00790569|adult acute myeloid leukemia|adult acute myeloid leukemia
5627163|NCT00790569|tobacco use disorder|tobacco use disorder
5627164|NCT00790543|Crohn's Disease|crohn's disease
5627165|NCT00790543|Inflammatory Bowel Disease|inflammatory bowel disease
5627166|NCT00790530|Diabetes|diabetes
5627167|NCT00790530|Information Technology|information technology
5627168|NCT00790530|Health Plans|health plans
5627169|NCT00790517|Weight loss|weight loss
5627170|NCT00790517|Diabetes prevention|diabetes prevention
5627171|NCT00790517|Serious mental illness|serious mental illness
5627172|NCT00790517|Antipsychotic medications|antipsychotic medications
5627173|NCT00790517|Lifestyle intervention|lifestyle intervention
5627174|NCT00790517|Antipsychotic Agents|antipsychotic agents
5627175|NCT00790504|Pelvic floor|pelvic floor
5627176|NCT00790504|Transperineal ultrasound|transperineal ultrasound
5627177|NCT00790504|Multiple pregnancy|multiple pregnancy
5627178|NCT00790504|Singleton pregnancy|singleton pregnancy
5627179|NCT00790504|Female pelvic floor|female pelvic floor
5627180|NCT00790491|reduction in risk of heart disease and diabetes|reduction in risk of heart disease and diabetes
5627181|NCT00790478|Ulcerative Colitis|ulcerative colitis
5627182|NCT00790478|Melatonin|melatonin
5627183|NCT00790478|Gastrointestinal|gastrointestinal
5627184|NCT00790478|Irritable Bowel syndrome|irritable bowel syndrome
5627185|NCT00790478|Sleep|sleep
5627186|NCT00790478|Pilot Study|pilot study
5627187|NCT00790465|achalasia|achalasia
5627188|NCT00790465|lower esophageal sphincter|lower esophageal sphincter
5627189|NCT00790465|nitric oxide|nitric oxide
5627190|NCT00790465|dark chocolate|dark chocolate
5627191|NCT00790465|flavanols|flavanols
5627192|NCT00790452|Brain|brain
5627193|NCT00790452|Hematologic Disorder|hematologic disorder
5627194|NCT00790452|Venous Thromboembolism|venous thromboembolism
5627195|NCT00790452|Glioblastoma|glioblastoma
5627196|NCT00790452|Aspirin|aspirin
5627197|NCT00790452|Placebo|placebo
5627199|NCT00790452|ASA|asa
5627200|NCT00790452|DVT|dvt
5627201|NCT00790439|Insulin dependence|insulin dependence
5627202|NCT00790426|Advanced urothelial cancer|advanced urothelial cancer
5627203|NCT00790413|Radiotherapy|radiotherapy
5627204|NCT00790413|Immunotherapy|immunotherapy
5627205|NCT00790413|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5627206|NCT00790400|Angiomyolipoma|angiomyolipoma
5627207|NCT00790400|AML|aml
5627208|NCT00790400|Tuberous Sclerosis Complex|tuberous sclerosis complex
5627209|NCT00790400|TSC|tsc
5627210|NCT00790400|mTOR|mtor
5627211|NCT00790400|RAD001|rad001
5627212|NCT00790400|Mammalian Target of Rapamycin|mammalian target of rapamycin
5627213|NCT00790400|Everolimus|everolimus
5627214|NCT00790400|Afinitor|afinitor
5627215|NCT00790400|SEGA|sega
5627463|NCT00789503|osteoporosis|osteoporosis
5627216|NCT00790400|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
5627217|NCT00790400|Seizures|seizures
5627218|NCT00790400|Tuberous sclerosis complex (TSC)|tuberous sclerosis complex (tsc)
5627219|NCT00790400|Tuberous sclerosis|tuberous sclerosis
5627220|NCT00790400|benign tumors of brain|benign tumors of brain
5627221|NCT00790400|kidney|kidney
5627222|NCT00790400|heart|heart
5627223|NCT00790400|eyes|eyes
5627224|NCT00790400|lungs|lungs
5627225|NCT00790400|skinTSC1|skintsc1
5627226|NCT00790400|TSC2|tsc2
5627227|NCT00790400|hamaratin|hamaratin
5627228|NCT00790400|tuberin, tumor growth suppressors|tuberin, tumor growth suppressors
5627229|NCT00790400|gyri|gyri
5627230|NCT00790400|tubers|tubers
5627231|NCT00790400|Sporadic Lymphangioleiomyomatosis.|sporadic lymphangioleiomyomatosis.
5627232|NCT00790400|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5627233|NCT00790400|rare lung disease|rare lung disease
5627234|NCT00790387|enoxaparin|enoxaparin
5627235|NCT00790387|tirofiban|tirofiban
5627236|NCT00790387|percutaneous intervention|percutaneous intervention
5627237|NCT00790387|platelet inhibition|platelet inhibition
5627238|NCT00790387|CD40L|cd40l
5627239|NCT00790387|Mac-1|mac-1
5627240|NCT00790387|prothrombin fragment 1+2.|prothrombin fragment 1+2.
5627241|NCT00790374|Pharmacodynamic profile and safety of BN83495|pharmacodynamic profile and safety of bn83495
5627242|NCT00790361|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5627243|NCT00790361|spinal cord compression|spinal cord compression
5627244|NCT00790361|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5627245|NCT00790361|functional magnetic resonance imaging|functional magnetic resonance imaging
5627246|NCT00790361|brain plasticity|brain plasticity
5627247|NCT00790335|deep vein thrombosis|deep vein thrombosis
5627248|NCT00790335|deep venous thrombosis|deep venous thrombosis
5627249|NCT00790335|post thrombotic syndrome|post thrombotic syndrome
5627250|NCT00790335|blood clot|blood clot
5627251|NCT00790335|thrombolysis|thrombolysis
5627252|NCT00790335|tissue plasminogen activator|tissue plasminogen activator
5627253|NCT00790335|rt-PA|rt-pa
5627254|NCT00790335|Activase|activase
5627255|NCT00790335|mechanical thrombectomy|mechanical thrombectomy
5627256|NCT00790335|pharmacomechanical|pharmacomechanical
5627257|NCT00790335|ATTRACT|attract
5627258|NCT00790322|Cancer|cancer
5627259|NCT00790322|Radiation therapy|radiation therapy
5627260|NCT00790322|Radiotherapy|radiotherapy
5627261|NCT00790322|Oral Mucositis|oral mucositis
5627262|NCT00790322|SBG|sbg
5627263|NCT00790309|Obesity|obesity
5627264|NCT00790309|Diabetes|diabetes
5627265|NCT00790309|Bariatric surgery|bariatric surgery
5627266|NCT00790296|cancer fatigue|cancer fatigue
5627267|NCT00790283|Treatment of de novo lesions in native coronary arteries|treatment of de novo lesions in native coronary arteries
5627268|NCT00790270|Cervical strain|cervical strain
5627269|NCT00790270|whiplash|whiplash
5627270|NCT00790270|ibuprofen|ibuprofen
5627271|NCT00790270|cyclobenzaprine|cyclobenzaprine
5627272|NCT00790257|Diabetes|diabetes
5627273|NCT00790257|Islets transplantation|islets transplantation
5627274|NCT00790257|Encapsulation|encapsulation
5627275|NCT00790244|Soft-tissue sarcomas|soft-tissue sarcomas
5627276|NCT00790244|prognostic factors|prognostic factors
5627277|NCT00790244|adjuvant|adjuvant
5627278|NCT00790244|chemotherapy|chemotherapy
5627279|NCT00790244|radiotherapy|radiotherapy
5627280|NCT00790244|metastases-free survival|metastases-free survival
5627281|NCT00790244|toxicity|toxicity
5627282|NCT00790244|High malignancy grade|high malignancy grade
5627283|NCT00790244|High-risk for metastases|high-risk for metastases
5627284|NCT00790244|Adult|adult
5627285|NCT00790231|urinary bladder|urinary bladder
5627286|NCT00790231|thoracic epidural analgesia|thoracic epidural analgesia
5627287|NCT00790231|urodynamics|urodynamics
5627288|NCT00790231|open kidney surgery with lumbotomy|open kidney surgery with lumbotomy
5627289|NCT00790218|Hepatocellular carcinoma|hepatocellular carcinoma
5627290|NCT00790218|Hepatoma|hepatoma
5627291|NCT00790218|HCC|hcc
5627292|NCT00790192|Schizophrenia|schizophrenia
5627293|NCT00790192|SM-13496|sm-13496
5627294|NCT00790192|Latuda|latuda
5627295|NCT00790192|Lurasidone|lurasidone
5627296|NCT00790179|Continuous lumbar plexus,Femoral,hydromorphone|continuous lumbar plexus,femoral,hydromorphone
5627301|NCT00790140|body composition|body composition
5627302|NCT00790140|immunology|immunology
5627303|NCT00790114|Phase I|phase i
5627304|NCT00790088|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5627305|NCT00790088|continuous glucose monitoring|continuous glucose monitoring
5627306|NCT00790088|sensor-augmented pump therapy|sensor-augmented pump therapy
5627307|NCT00790075|agitation|agitation
5627308|NCT00790075|Episodes of agitation regardless of diagnosis|episodes of agitation regardless of diagnosis
5627309|NCT00790062|Uterine atony|uterine atony
5627310|NCT00790062|Postpartum hemorrhage|postpartum hemorrhage
5627311|NCT00790062|clinical trial|clinical trial
5627312|NCT00790062|Prophylactic oxytocin|prophylactic oxytocin
5627313|NCT00790036|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5627314|NCT00790036|DLBCL|dlbcl
5627315|NCT00790036|poor risk|poor risk
5627316|NCT00790036|R-IPI 3-5|r-ipi 3-5
5627317|NCT00790036|adjuvant therapy|adjuvant therapy
5627318|NCT00790036|after R-CHOP or R-EPOCH|after r-chop or r-epoch
5627319|NCT00790036|after R-CHOP|after r-chop
5627320|NCT00790036|B-cell lymphoma|b-cell lymphoma
5627321|NCT00790036|lymphoma|lymphoma
5627322|NCT00790036|b cells|b cells
5627323|NCT00790036|blood cancer|blood cancer
5627324|NCT00790036|lymph nodes|lymph nodes
5627325|NCT00790036|Hodgkin's|hodgkin's
5627326|NCT00790036|non-Hodgkin|non-hodgkin
5627328|NCT00790010|bevacizumab|bevacizumab
5627329|NCT00790010|ipilimumab|ipilimumab
5627330|NCT00790010|unresectable stage III melanoma|unresectable stage iii melanoma
5627331|NCT00790010|unresectable stage IV melanoma|unresectable stage iv melanoma
5627332|NCT00789997|COPD Exacerbation|copd exacerbation
5627333|NCT00789997|Etanercept|etanercept
5627334|NCT00789997|TNF alpha|tnf alpha
5627335|NCT00789997|Randomized|randomized
5627336|NCT00789984|Keratic precipitates|keratic precipitates
5627337|NCT00789971|orbital floor triamcinolone|orbital floor triamcinolone
5627338|NCT00789971|phacoemulsification|phacoemulsification
5627339|NCT00789971|post op inflammation|post op inflammation
5627341|NCT00789958|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5627342|NCT00789958|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5685469|NCT00555958|Bariatric surgery|bariatric surgery
5627343|NCT00789958|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5627344|NCT00789958|localized gallbladder cancer|localized gallbladder cancer
5627345|NCT00789958|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5627346|NCT00789958|unresectable gallbladder cancer|unresectable gallbladder cancer
5627347|NCT00789958|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5627348|NCT00789958|metastatic gallbladder cancer|metastatic gallbladder cancer
5627350|NCT00789945|continuous glucose monitoring|continuous glucose monitoring
5627351|NCT00789945|Intensive Insulin therapy|intensive insulin therapy
5627352|NCT00789919|Mild Preeclampsia|mild preeclampsia
5627353|NCT00789906|Computerized Neuropsychological Assessment|computerized neuropsychological assessment
5627354|NCT00789906|Development of Population Norms of the Computerized Neuropsychological Assessment|development of population norms of the computerized neuropsychological assessment
5627355|NCT00789893|external beam pelvic radiation|external beam pelvic radiation
5627356|NCT00789893|brachytherapy|brachytherapy
5627357|NCT00789880|Vitamin D3|vitamin d3
5627358|NCT00789880|Atopic Dermatitis|atopic dermatitis
5627359|NCT00789880|Antimicrobial Peptide Expression|antimicrobial peptide expression
5627360|NCT00789867|Single dose|single dose
5627361|NCT00789867|Pilot|pilot
5627362|NCT00789867|Safety|safety
5627363|NCT00789867|Gene expression|gene expression
5627364|NCT00789867|Tolerability|tolerability
5627365|NCT00789867|CFTR gene|cftr gene
5627366|NCT00789867|Cystic fibrosis|cystic fibrosis
5627367|NCT00789867|Non-viral|non-viral
5627368|NCT00789854|Depression|depression
5627369|NCT00789854|MDD|mdd
5627370|NCT00789854|TRD|trd
5627371|NCT00789841|Neuroendocrine tumor|neuroendocrine tumor
5627372|NCT00789841|Carcinoid syndrome|carcinoid syndrome
5627373|NCT00789841|Motility|motility
5627374|NCT00789841|Transit time|transit time
5627375|NCT00789828|SEGA|sega
5627376|NCT00789828|Tuberous Sclerosis|tuberous sclerosis
5627377|NCT00789828|Subependymal Giant Cell Astrocytoma|subependymal giant cell astrocytoma
5627378|NCT00789828|mTOR|mtor
5627379|NCT00789828|RAD001|rad001
5627380|NCT00789828|Mamalian Target Rapamycin|mamalian target rapamycin
5627381|NCT00789828|Everolimus|everolimus
5627382|NCT00789828|TSC|tsc
5627383|NCT00789815|flexible bronchoscopy|flexible bronchoscopy
5627384|NCT00789815|sedation|sedation
5627385|NCT00789815|bispectral index|bispectral index
5627386|NCT00789802|contraception|contraception
5627387|NCT00789802|progestin contraception|progestin contraception
5627388|NCT00789802|intrauterine contraception|intrauterine contraception
5627389|NCT00789802|unscheduled bleeding|unscheduled bleeding
5627390|NCT00789802|placebo|placebo
5627391|NCT00789789|Cohort|cohort
5627392|NCT00789789|HIV uninfected volunteers|hiv uninfected volunteers
5627393|NCT00789789|HIV preventive vaccine|hiv preventive vaccine
5627394|NCT00789789|Long term safety|long term safety
5627395|NCT00789763|pancreatic cancer|pancreatic cancer
5627396|NCT00789763|Pancreatic cancer locally advanced|pancreatic cancer locally advanced
5627397|NCT00789724|acute myocardial infarction|acute myocardial infarction
5627398|NCT00789698|Schizophrenia|schizophrenia
5627399|NCT00789698|SM-13496|sm-13496
5627400|NCT00789698|Latuda|latuda
5627401|NCT00789698|Lurasidone|lurasidone
5627402|NCT00789685|Open label|open label
5627403|NCT00789672|Amblyopia|amblyopia
5627404|NCT00789672|Patching|patching
5627405|NCT00789672|Levodopa|levodopa
5627406|NCT00789659|Fracture fixation, internal|fracture fixation, internal
5627407|NCT00789659|Obesity|obesity
5627408|NCT00789659|Pelvis|pelvis
5627409|NCT00789659|Negative pressure wound therapy|negative pressure wound therapy
5627410|NCT00789659|Vacuum-assisted closure|vacuum-assisted closure
5627411|NCT00789646|corneal ulcer|corneal ulcer
5627412|NCT00789646|painless|painless
5627413|NCT00789646|subconjunctival injection|subconjunctival injection
5627414|NCT00789646|antibiotics|antibiotics
5627415|NCT00789646|antifungal|antifungal
5627416|NCT00789646|lidocaine|lidocaine
5627417|NCT00789633|Pancreatic cancer|pancreatic cancer
5627418|NCT00789633|Advanced pancreatic cancer|advanced pancreatic cancer
5627419|NCT00789633|Metastatic pancreatic cancer|metastatic pancreatic cancer
5627420|NCT00789633|Gemcitabine|gemcitabine
5627421|NCT00789633|Chemo-naive|chemo-naive
5627422|NCT00789620|intravenous lidocaine|intravenous lidocaine
5627423|NCT00789620|laparoscopic urological surgery|laparoscopic urological surgery
5627424|NCT00789620|hospital stay|hospital stay
5627426|NCT00789620|fatigue|fatigue
5627427|NCT00789620|length of stay|length of stay
5627428|NCT00789607|prostate cancer|prostate cancer
5627429|NCT00789607|individualized radiotherapy|individualized radiotherapy
5627430|NCT00789607|fiducial markers|fiducial markers
5627432|NCT00789607|ultrasound|ultrasound
5627433|NCT00789607|High-Risk Localized Prostate Cancer|high-risk localized prostate cancer
5627434|NCT00789594|Monitoring|monitoring
5627435|NCT00789594|Testing|testing
5627436|NCT00789594|Medications|medications
5627437|NCT00789594|Patients receiving medications and having laboratory tests|patients receiving medications and having laboratory tests
5627438|NCT00789581|Breast Cancer|breast cancer
5627440|NCT00789581|Doxorubicin|doxorubicin
5627441|NCT00789581|Cyclophosphamide|cyclophosphamide
5627442|NCT00789581|Paclitaxel|paclitaxel
5627443|NCT00789581|Ixabepilone|ixabepilone
5627444|NCT00789581|TITAN|titan
5627445|NCT00789568|Hyperphenylalanemia due to Phenylketonuria|hyperphenylalanemia due to phenylketonuria
5627446|NCT00789555|nasal allergy|nasal allergy
5627447|NCT00789555|nasal spray|nasal spray
5627448|NCT00789555|seasonal allergy|seasonal allergy
5627449|NCT00789555|perennial allergy|perennial allergy
5627450|NCT00789542|stroke|stroke
5627451|NCT00789542|deep vein thrombosis|deep vein thrombosis
5627452|NCT00789542|doppler|doppler
5627453|NCT00789529|Contact lenses, wettability, Contact Lens Disinfectant Solutions, pre-lens tear film|contact lenses, wettability, contact lens disinfectant solutions, pre-lens tear film
5627454|NCT00789516|Coagulation markers, thalassemia disease post SCT|coagulation markers, thalassemia disease post sct
5627455|NCT00789503|dietary fortification|dietary fortification
5627456|NCT00789503|Vitamin D3|vitamin d3
5627457|NCT00789503|Osteomalacia|osteomalacia
5627458|NCT00789503|bread|bread
5627459|NCT00789503|bone mineral density|bone mineral density
5627460|NCT00789503|geriatrics|geriatrics
5627461|NCT00789503|cholecalciferol|cholecalciferol
5627462|NCT00789503|calcidiol|calcidiol
5627464|NCT00789503|dual-energy photon absorptiometry|dual-energy photon absorptiometry
5627465|NCT00789503|bread fortification|bread fortification
5627466|NCT00789490|pregnancy|pregnancy
5627467|NCT00789490|relative bioavailability|relative bioavailability
5627468|NCT00789490|iron|iron
5627469|NCT00789490|folic acid|folic acid
5627470|NCT00789490|ferric pyrophosphate|ferric pyrophosphate
5627471|NCT00789490|Study focus is to compare the relative bioavailability of SuppleFem Sprinkles to the current tradtional tablet Materna in pregnant women|study focus is to compare the relative bioavailability of supplefem sprinkles to the current tradtional tablet materna in pregnant women
5627472|NCT00789464|Urinary Tract Infection|urinary tract infection
5627473|NCT00789464|Probiotics|probiotics
5627474|NCT00789464|Dietary Supplements|dietary supplements
5627475|NCT00789464|Bacteriuria|bacteriuria
5627476|NCT00789451|Ischaemia reperfusion|ischaemia reperfusion
5627477|NCT00789451|t-PA|t-pa
5627478|NCT00789451|Fibrinolysis|fibrinolysis
5627479|NCT00789451|Endothelial function|endothelial function
5627480|NCT00789438|Analgesia|analgesia
5627481|NCT00789438|Sedation|sedation
5627482|NCT00789438|Spinal|spinal
5627483|NCT00789438|Stress|stress
5627484|NCT00789438|Surgical|surgical
5627485|NCT00789438|Surgical Stress|surgical stress
5627486|NCT00789438|Pain|pain
5627487|NCT00789425|osteoporosis|osteoporosis
5627488|NCT00789425|osteopenia|osteopenia
5627489|NCT00789425|olive extract|olive extract
5627490|NCT00789425|oleuropein|oleuropein
5627491|NCT00789412|Analgesia|analgesia
5627492|NCT00789412|Sedation|sedation
5627493|NCT00789412|Critical Illness|critical illness
5627494|NCT00789412|Intensive Care|intensive care
5627495|NCT00789399|deep vein thrombosis|deep vein thrombosis
5627496|NCT00789399|coronary artery bypass surgery|coronary artery bypass surgery
5627497|NCT00789399|Venous thromboembolism|venous thromboembolism
5627498|NCT00789386|Capsaicin|capsaicin
5627499|NCT00789386|Remifentanil|remifentanil
5627500|NCT00789386|Hyperalgesia|hyperalgesia
5627501|NCT00789360|Healthy volunteers|healthy volunteers
5627502|NCT00789347|Neuropathic pain|neuropathic pain
5627503|NCT00789347|Cortical excitability|cortical excitability
5627504|NCT00789347|Transcranial magnetic stimulation|transcranial magnetic stimulation
5627505|NCT00789347|Contact Heat evoked potential|contact heat evoked potential
5627506|NCT00789347|peripheral nerve stimulation|peripheral nerve stimulation
5627507|NCT00789347|neurotrophic factors|neurotrophic factors
5627508|NCT00789308|Insulin dependence|insulin dependence
5627509|NCT00789295|Mediterranean diet|mediterranean diet
5627510|NCT00789295|Postprandial lipids|postprandial lipids
5627511|NCT00789295|Postprandial glucose|postprandial glucose
5627512|NCT00789295|High fibre diet|high fibre diet
5627513|NCT00789295|Low- CHO diet|low- cho diet
5627514|NCT00789295|High MUFA diet|high mufa diet
5627515|NCT00789295|Dietary approach|dietary approach
5627516|NCT00789282|chronic disease|chronic disease
5627517|NCT00789282|Family Physician|family physician
5627518|NCT00789282|primary care network|primary care network
5627519|NCT00789282|practice-based model|practice-based model
5627520|NCT00789282|type 2 diabetes|type 2 diabetes
5627522|NCT00789282|sequelae|sequelae
5627523|NCT00789269|lung infection after ischemic Stroke|lung infection after ischemic stroke
5627524|NCT00789269|prevention of pneumonia|prevention of pneumonia
5627525|NCT00789269|rhubarb|rhubarb
5627526|NCT00789256|Acute Myelogenous Leukemia|acute myelogenous leukemia
5627527|NCT00789256|AML|aml
5627528|NCT00789256|Myelodysplastic Syndromes|myelodysplastic syndromes
5627529|NCT00789256|MDS|mds
5627530|NCT00789256|Melphalan|melphalan
5627531|NCT00789256|Bortezomib|bortezomib
5627532|NCT00789256|Velcade|velcade
5627533|NCT00789243|Ischaemia reperfusion|ischaemia reperfusion
5627534|NCT00789243|t-PA|t-pa
5627535|NCT00789243|Fibrinolysis|fibrinolysis
5627536|NCT00789243|Endothelial function|endothelial function
5627537|NCT00789243|Local and remote ischaemic preconditioning|local and remote ischaemic preconditioning
5627538|NCT00789230|umbilical|umbilical
5627539|NCT00789230|hernia|hernia
5627540|NCT00789230|mesh|mesh
5627541|NCT00789217|Penicillin|penicillin
5627542|NCT00789217|Beta-Lactams|beta-lactams
5627543|NCT00789217|Allergy|allergy
5627544|NCT00789217|Hypersensitivity|hypersensitivity
5627545|NCT00789204|exercise|exercise
5627546|NCT00789204|low back pain|low back pain
5627547|NCT00789204|posture|posture
5627548|NCT00789204|rehabilitation|rehabilitation
5627549|NCT00789178|memory disturbances|memory disturbances
5627550|NCT00789165|Brugada syndrome|brugada syndrome
5627551|NCT00789165|quinidine|quinidine
5627552|NCT00789165|Asymptomatic Brugada Syndrome|asymptomatic brugada syndrome
5627553|NCT00789113|lamotrigine|lamotrigine
5627554|NCT00789113|epilepsy|epilepsy
5627555|NCT00789113|metabolism|metabolism
5627556|NCT00789113|bipolar disorder|bipolar disorder
5627557|NCT00789113|bipolar depression|bipolar depression
5627558|NCT00789113|glucuronidation|glucuronidation
5627559|NCT00789100|telehealth|telehealth
5627560|NCT00789100|telemonitor|telemonitor
5627561|NCT00789100|telemedicine|telemedicine
5627562|NCT00789100|Co-morbidities|co-morbidities
5627563|NCT00789087|Pleural Effusion.|pleural effusion.
5627564|NCT00789087|Talc.|talc.
5627565|NCT00789087|Pleurodesis.|pleurodesis.
5627566|NCT00789087|Quality of Life.|quality of life.
5627567|NCT00789087|Thoracoscopy.|thoracoscopy.
5627568|NCT00789074|Smoking cessation|smoking cessation
5627569|NCT00789074|Tobacco dependence|tobacco dependence
5627570|NCT00789074|Varenicline|varenicline
5627571|NCT00789074|Preloading|preloading
5627572|NCT00789061|Acute hearing loss in patients with SLC26A4 mutations|acute hearing loss in patients with slc26a4 mutations
5627573|NCT00789048|hip|hip
5627574|NCT00789048|arthroplasty|arthroplasty
5627575|NCT00789048|radiograph|radiograph
5627576|NCT00789022|First-Psychotic-Episode (FPE)|first-psychotic-episode (fpe)
5627577|NCT00789022|Glutamatergic system|glutamatergic system
5627578|NCT00789022|Glycine|glycine
5627579|NCT00789022|D-Serine|d-serine
5627580|NCT00789022|Oxytocin|oxytocin
5627581|NCT00789022|Estrogen|estrogen
5627582|NCT00789009|Opportunistic Infections|opportunistic infections
5627583|NCT00789009|AIDS|aids
5627584|NCT00789009|HIV|hiv
5627585|NCT00788996|Tobacco Smoke Pollution/prevention and control|tobacco smoke pollution/prevention and control
5627586|NCT00788996|Parent-Child Relations|parent-child relations
5627587|NCT00788996|Environmental Tobacco Smoke (ETS)|environmental tobacco smoke (ets)
5627588|NCT00788983|Induced hypoxia|induced hypoxia
5609318|NCT00861185|KCa3.1|kca3.1
5627589|NCT00788983|Pulse oximeter|pulse oximeter
5627590|NCT00788983|Nonin Medical|nonin medical
5627591|NCT00788983|Verification of SpO2 accuracy|verification of spo2 accuracy
5627592|NCT00788970|Acupressure|acupressure
5627593|NCT00788970|Shiatsu|shiatsu
5627594|NCT00788970|Schizophrenia|schizophrenia
5627595|NCT00788957|panitumumab|panitumumab
5627596|NCT00788957|vectibix|vectibix
5627597|NCT00788957|AMG 102|amg 102
5627598|NCT00788957|AMG 479|amg 479
5627599|NCT00788957|colon cancer|colon cancer
5627600|NCT00788957|rectal cancer|rectal cancer
5627601|NCT00788957|colorectal cancer|colorectal cancer
5627602|NCT00788957|metastatic colorectal cancer|metastatic colorectal cancer
5627603|NCT00788957|EGFR inhibitor|egfr inhibitor
5627604|NCT00788957|IGF inhibitor|igf inhibitor
5627605|NCT00788957|c-MET inhibitor|c-met inhibitor
5627606|NCT00788931|Breast Cancer|breast cancer
5627607|NCT00788931|HER2 positive|her2 positive
5627608|NCT00788931|adult-female|adult-female
5627617|NCT00788918|MR spectroscopy|mr spectroscopy
5627618|NCT00788918|interferon|interferon
5627619|NCT00788918|ribavirin|ribavirin
5627620|NCT00788918|sustained virologic response, major depressive disorder|sustained virologic response, major depressive disorder
5627621|NCT00788905|Hemodialysis|hemodialysis
5627622|NCT00788892|Acute|acute
5627623|NCT00788892|Myeloid|myeloid
5627624|NCT00788892|Leukemia|leukemia
5627625|NCT00788892|elderly|elderly
5627626|NCT00788892|Newly|newly
5627627|NCT00788892|Diagnosed|diagnosed
5627628|NCT00788879|Behavioral Journalism|behavioral journalism
5627629|NCT00788879|Mexican-Americans|mexican-americans
5627630|NCT00788879|Obesity|obesity
5627631|NCT00788879|Nutrition|nutrition
5627632|NCT00788879|Physical Activity|physical activity
5627633|NCT00788879|Border Health|border health
5627634|NCT00788866|Neuroprotection|neuroprotection
5627635|NCT00788866|Antioxidants|antioxidants
5627636|NCT00788866|Neonatal brain injury|neonatal brain injury
5627637|NCT00788866|Pomegranate juice|pomegranate juice
5627638|NCT00788853|DiabCare Asia 2008, Cross-sectional survey, Glycemic control, Psychosocial well-being, Diabetic complications, Quality of life.|diabcare asia 2008, cross-sectional survey, glycemic control, psychosocial well-being, diabetic complications, quality of life.
5627639|NCT00788827|diabetes type I|diabetes type i
5627640|NCT00788827|diabetes type 2|diabetes type 2
5627641|NCT00788827|renal transplant|renal transplant
5627642|NCT00788827|stem cells|stem cells
5627643|NCT00788827|successful renal transplant|successful renal transplant
5627644|NCT00788788|Airway obstruction|airway obstruction
5627645|NCT00788788|Heliox|heliox
5627646|NCT00788788|Different Helium content|different helium content
5627647|NCT00788775|nilotinib|nilotinib
5627648|NCT00788762|glaucoma|glaucoma
5627649|NCT00788762|myocilin|myocilin
5627650|NCT00788749|chronic rhinosinusitis|chronic rhinosinusitis
5627651|NCT00788749|nasal polyps|nasal polyps
5627652|NCT00788749|oral steroid|oral steroid
5627653|NCT00788749|intranasal steroid|intranasal steroid
5627654|NCT00788749|medical polypectomy|medical polypectomy
5627655|NCT00788736|venous thromboembolism|venous thromboembolism
5627656|NCT00788736|long-term oral anticoagulant therapy|long-term oral anticoagulant therapy
5627657|NCT00788736|warfarin|warfarin
5627658|NCT00788736|bleeding risk|bleeding risk
5627659|NCT00788736|clinical prediction rule|clinical prediction rule
5627660|NCT00788736|predictors|predictors
5627661|NCT00788736|deep vein thrombosis|deep vein thrombosis
5627662|NCT00788736|pulmonary embolism|pulmonary embolism
5627663|NCT00788736|vitamin k antagonist|vitamin k antagonist
5627664|NCT00788736|side effect|side effect
5627665|NCT00788723|Severe Brain Injury|severe brain injury
5627666|NCT00788723|Excitability|excitability
5627667|NCT00788723|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5627675|NCT00788658|Obstructed constipation|obstructed constipation
5627676|NCT00788658|Quality of life|quality of life
5627677|NCT00788645|Smoking|smoking
5627678|NCT00788645|COPD|copd
5627679|NCT00788645|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5627680|NCT00788645|COPD Exacerbations|copd exacerbations
5627681|NCT00788645|Viruses and Bacteria associated with COPD exacerbations|viruses and bacteria associated with copd exacerbations
5627682|NCT00788632|Osteoporosis|osteoporosis
5627684|NCT00788632|Bisphosphonates|bisphosphonates
5627685|NCT00788632|Educational materials|educational materials
5627686|NCT00788632|Patient Stories|patient stories
5627687|NCT00788619|Infertility|infertility
5627688|NCT00788619|Assisted reproductive technology|assisted reproductive technology
5627689|NCT00788619|Nitric oxide|nitric oxide
5627690|NCT00788606|diffused large B cell lymphoma, DLBCL, R-Chop, bevacizumab|diffused large b cell lymphoma, dlbcl, r-chop, bevacizumab
5627691|NCT00788606|Diffuse large B-cell non-Hodgkin's lymphoma.|diffuse large b-cell non-hodgkin's lymphoma.
5627692|NCT00788593|Chronic Pancreatitis|chronic pancreatitis
5627693|NCT00788593|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5627694|NCT00788580|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5627695|NCT00788554|groin|groin
5627696|NCT00788554|inguinal|inguinal
5627697|NCT00788554|hernia|hernia
5627698|NCT00788554|lichtenstein|lichtenstein
5627700|NCT00788541|Open-Angle Glaucoma|open-angle glaucoma
5621554|NCT00813293|RFA|rfa
5627701|NCT00788541|Intraocular Pressure|intraocular pressure
5627702|NCT00788541|Anecortave Acetate|anecortave acetate
5627703|NCT00788528|Obesity|obesity
5627704|NCT00788515|insomnia|insomnia
5627705|NCT00788515|sleep maintenance|sleep maintenance
5627706|NCT00788489|breast cancer|breast cancer
5627707|NCT00788489|FDG-PET|fdg-pet
5627708|NCT00788489|MRI|mri
5627709|NCT00788489|chemotherapy|chemotherapy
5627710|NCT00788489|ultrasonography|ultrasonography
5627711|NCT00788476|Needs Assessment Survey|needs assessment survey
5627712|NCT00788476|Childhood Cancer Survivors|childhood cancer survivors
5627713|NCT00788476|Parents|parents
5627714|NCT00788476|Primary Caregiver|primary caregiver
5627715|NCT00788476|Survey|survey
5627716|NCT00788463|administration, intranasal|administration, intranasal
5627717|NCT00788463|aerosol|aerosol
5627718|NCT00788463|beclomethasone|beclomethasone
5627719|NCT00788463|QVAR|qvar
5627720|NCT00788463|corticosteroids|corticosteroids
5627721|NCT00788463|nasal polyps|nasal polyps
5627722|NCT00788463|rhinomanometry|rhinomanometry
5627723|NCT00788463|Rhinitis Quality of Life Questionnaire|rhinitis quality of life questionnaire
5627724|NCT00788463|Quality of Life|quality of life
5627725|NCT00788424|AS101 Psoriasis|as101 psoriasis
5627726|NCT00788385|Hydrocephalus|hydrocephalus
5627727|NCT00788385|High Pressure|high pressure
5627728|NCT00788385|Shunt Blockage|shunt blockage
5627729|NCT00788372|Chronic pain|chronic pain
5627730|NCT00788372|Fentanyl Patch|fentanyl patch
5627731|NCT00788359|cystic fibrosis|cystic fibrosis
5627732|NCT00788359|pulmonary exacerbation|pulmonary exacerbation
5627733|NCT00788359|biomarkers|biomarkers
5627734|NCT00788346|Heavily marketed medications|heavily marketed medications
5627735|NCT00788346|Prescribing|prescribing
5627771|NCT00788177|Pegaptanib|pegaptanib
5627772|NCT00788177|Macugen|macugen
5627773|NCT00788164|cervical cancer|cervical cancer
5627774|NCT00788164|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5627775|NCT00788164|therapeutic vaccine|therapeutic vaccine
5627776|NCT00788164|treatment|treatment
5627777|NCT00788164|CIN|cin
5627778|NCT00788164|HPV|hpv
5627779|NCT00788164|vaccine|vaccine
5627780|NCT00788164|Hopkins|hopkins
5627781|NCT00788164|Trimble|trimble
5627782|NCT00788151|Dengue virus|dengue virus
5627783|NCT00788151|Dengue fever|dengue fever
5627784|NCT00788151|Dengue Hemorrhagic fever|dengue hemorrhagic fever
5627785|NCT00788151|Dengue diseases|dengue diseases
5627786|NCT00788151|Dengue vaccine|dengue vaccine
5627787|NCT00788138|Cystic Fibrosis|cystic fibrosis
5627788|NCT00788138|Vitamin D|vitamin d
5627789|NCT00788138|Anti-microbial peptides|anti-microbial peptides
5627883|NCT00788060|Renal Cell Carcinoma|renal cell carcinoma
5627886|NCT00788034|Relapse prevention|relapse prevention
5627887|NCT00788034|GAD|gad
5627888|NCT00788034|Maintenance|maintenance
5627889|NCT00788034|Double-blind|double-blind
5627890|NCT00788034|Multicentre|multicentre
5627891|NCT00788021|Transplant|transplant
5627892|NCT00788021|Immunity|immunity
5627893|NCT00788021|Immunosuppression|immunosuppression
5627894|NCT00788008|spinal, joint|spinal, joint
5627895|NCT00787995|Mucopolysaccharidosis IV type A|mucopolysaccharidosis iv type a
5627896|NCT00787995|MPS IV Type A|mps iv type a
5627897|NCT00787995|Mucopolysaccharidosis IVA|mucopolysaccharidosis iva
5627898|NCT00787995|MPS IVA|mps iva
5627899|NCT00787995|Morquio A Syndrome|morquio a syndrome
5627900|NCT00787995|Lysosomal Storage Disorder|lysosomal storage disorder
5627901|NCT00787995|LSD|lsd
5627902|NCT00787995|N-acetylgalactosamine-6-sulfatase|n-acetylgalactosamine-6-sulfatase
5627903|NCT00787995|galactose-6-sulfatase|galactose-6-sulfatase
5627904|NCT00787995|GALNS|galns
5627905|NCT00787995|enzyme replacement therapy|enzyme replacement therapy
5627906|NCT00787995|ERT|ert
5627907|NCT00787982|brain|brain
5627908|NCT00787982|metastasis|metastasis
5627909|NCT00787982|neoplasm|neoplasm
5627910|NCT00787982|tumor|tumor
5627911|NCT00787982|Patients with secondary brain neoplasms|patients with secondary brain neoplasms
5627912|NCT00787982|laser therapy|laser therapy
5627913|NCT00787982|laser interstitial thermal therapy|laser interstitial thermal therapy
5627914|NCT00787969|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5627915|NCT00787969|Stage II Contiguous Mantle Cell Lymphoma|stage ii contiguous mantle cell lymphoma
5627916|NCT00787969|Stage II Non-Contiguous Mantle Cell Lymphoma|stage ii non-contiguous mantle cell lymphoma
5627917|NCT00787969|Stage III Mantle Cell Lymphoma|stage iii mantle cell lymphoma
5627918|NCT00787969|Stage IV Mantle Cell Lymphoma|stage iv mantle cell lymphoma
5627919|NCT00787943|Acne|acne
5627920|NCT00787930|BPD|bpd
5627921|NCT00787917|Cystic Fibrosis|cystic fibrosis
5627922|NCT00787917|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
5627923|NCT00787917|omalizumab|omalizumab
5627924|NCT00787917|oral corticosteroid use|oral corticosteroid use
5627925|NCT00787917|anti-immunoglobulin E|anti-immunoglobulin e
5627926|NCT00787904|Osteoporosis, T-cells|osteoporosis, t-cells
5627927|NCT00787891|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5627928|NCT00787891|Erosive Gastroesophageal Reflux Disease|erosive gastroesophageal reflux disease
5627929|NCT00787891|Ulcerative Gastroesophageal Reflux Disease|ulcerative gastroesophageal reflux disease
5627930|NCT00787891|Endoscopy|endoscopy
5627931|NCT00787891|Pediatrics|pediatrics
5627932|NCT00787891|Rabeprazole|rabeprazole
5627933|NCT00787865|Diffusion Tensor Imaging|diffusion tensor imaging
5627934|NCT00787865|DTI|dti
5627935|NCT00787865|Newborn|newborn
5627936|NCT00787865|Krabbe Disease|krabbe disease
5627937|NCT00787865|Motor Development|motor development
5627938|NCT00787865|Motor Disability|motor disability
5627939|NCT00787852|dasatinib|dasatinib
5627940|NCT00787852|radiation|radiation
5627941|NCT00787852|paclitaxel|paclitaxel
5627942|NCT00787852|carboplatin|carboplatin
5627943|NCT00787852|NSCLC|nsclc
5627944|NCT00787852|safety addition of dasatinib to chemo RT stage III NSCLC|safety addition of dasatinib to chemo rt stage iii nsclc
5627945|NCT00787839|type 2 diabetes mellitus|type 2 diabetes mellitus
5627946|NCT00787839|prediabetic state|prediabetic state
5627947|NCT00787839|mass screening|mass screening
5627948|NCT00787839|glucose tolerance test|glucose tolerance test
5627949|NCT00787826|Live Vaccine Strain (LVS)|live vaccine strain (lvs)
5627950|NCT00787813|N-acetyl cysteine (NAC)|n-acetyl cysteine (nac)
5627951|NCT00787813|Cervical cerclage|cervical cerclage
5628105|NCT00787553|tinidazole|tinidazole
5627952|NCT00787813|cervical cerclage for cervical insufficiency|cervical cerclage for cervical insufficiency
5627953|NCT00787800|Shock prevention|shock prevention
5627954|NCT00787800|Single vs. Dual Chamber|single vs. dual chamber
5627955|NCT00787800|Reduce ventricular pacing|reduce ventricular pacing
5627956|NCT00787800|Atrial Fibrillation|atrial fibrillation
5627957|NCT00787800|Remote Monitoring|remote monitoring
5627958|NCT00787800|ICD|icd
5627959|NCT00787800|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5627960|NCT00787774|HIV|hiv
5627961|NCT00787774|resistance|resistance
5627962|NCT00787774|integrase|integrase
5627963|NCT00787761|accelerated phase CML|accelerated phase cml
5627964|NCT00787761|blastic phase CML|blastic phase cml
5627965|NCT00787761|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
5627966|NCT00787761|stage I CLL|stage i cll
5627967|NCT00787761|stage II CLL|stage ii cll
5627968|NCT00787761|stage III CLL|stage iii cll
5627969|NCT00787761|stage IV CLL|stage iv cll
5627970|NCT00787761|stage I multiple myeloma|stage i multiple myeloma
5627971|NCT00787761|stage II multiple myeloma|stage ii multiple myeloma
5627972|NCT00787761|stage III multiple myeloma|stage iii multiple myeloma
5627973|NCT00787761|adult AML with 11q23 (MLL) abnormalities|adult aml with 11q23 (mll) abnormalities
5627974|NCT00787761|adult CML in remission|adult cml in remission
5627975|NCT00787761|adult ALL in remission|adult all in remission
5627976|NCT00787761|stage IV renal cell cancer|stage iv renal cell cancer
5627977|NCT00787761|de novo MDS|de novo mds
5627978|NCT00787761|previously treated MDS|previously treated mds
5627979|NCT00787761|secondary MDS|secondary mds
5627980|NCT00787761|atypical CML, BCR-ABL negative|atypical cml, bcr-abl negative
5627981|NCT00787761|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5627982|NCT00787761|MDS/myeloproliferative neoplasm, unclassifiable|mds/myeloproliferative neoplasm, unclassifiable
5627983|NCT00787761|primary myelofibrosis|primary myelofibrosis
5627984|NCT00787761|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5627985|NCT00787761|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5627986|NCT00787761|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5627987|NCT00787761|adult AML with inv(16)(p13;q22)|adult aml with inv(16)(p13;q22)
5627988|NCT00787761|adult AML with t(15;17)(q22;q12)|adult aml with t(15;17)(q22;q12)
5627989|NCT00787761|adult AML with t(16;16)(p13;q22)|adult aml with t(16;16)(p13;q22)
5627990|NCT00787761|adult AML with t(8;21)(q22;q22)|adult aml with t(8;21)(q22;q22)
5627991|NCT00787761|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5627992|NCT00787761|AML/transient myeloproliferative disorder|aml/transient myeloproliferative disorder
5627993|NCT00787761|Burkitt lymphoma|burkitt lymphoma
5627994|NCT00787761|chronic phase CML|chronic phase cml
5627995|NCT00787761|extranodal marginal zone B-cell lymphoma of mucosa tissue|extranodal marginal zone b-cell lymphoma of mucosa tissue
5627996|NCT00787761|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5627997|NCT00787761|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5627998|NCT00787761|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5627999|NCT00787761|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5628000|NCT00787761|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5628001|NCT00787761|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5628002|NCT00787761|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5628003|NCT00787761|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5628004|NCT00787761|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5628005|NCT00787761|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5628006|NCT00787761|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5628007|NCT00787761|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5628008|NCT00787761|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5628009|NCT00787761|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5628010|NCT00787761|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5628011|NCT00787761|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5628012|NCT00787761|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5628013|NCT00787761|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5628014|NCT00787761|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5628016|NCT00787761|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5628017|NCT00787761|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5628018|NCT00787761|contiguous st II adult diffuse small cleaved cell lymphoma|contiguous st ii adult diffuse small cleaved cell lymphoma
5628019|NCT00787761|noncontiguous st II diffuse small cleaved cell lymphoma|noncontiguous st ii diffuse small cleaved cell lymphoma
5628020|NCT00787761|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5628021|NCT00787761|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5628022|NCT00787761|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5628023|NCT00787761|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5628024|NCT00787761|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5628025|NCT00787761|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5628026|NCT00787761|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5628027|NCT00787761|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5628028|NCT00787761|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5628029|NCT00787761|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5628030|NCT00787761|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5628031|NCT00787761|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5628032|NCT00787761|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5628033|NCT00787761|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5628034|NCT00787761|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5628035|NCT00787761|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5628036|NCT00787761|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5628037|NCT00787761|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5628038|NCT00787761|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5798769|NCT00111137|darbepoetin alfa|darbepoetin alfa
5628043|NCT00787761|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5628044|NCT00787761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5628045|NCT00787761|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5628047|NCT00787761|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5628048|NCT00787761|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5628049|NCT00787761|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5628050|NCT00787761|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5628051|NCT00787761|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5628052|NCT00787761|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5628053|NCT00787748|Cardiovascular|cardiovascular
5628055|NCT00787748|Population|population
5628056|NCT00787748|Prevalence|prevalence
5628057|NCT00787748|Underdiagnosis|underdiagnosis
5628060|NCT00787709|Obesity prevention|obesity prevention
5628061|NCT00787709|Health promotion|health promotion
5628062|NCT00787709|School based curriculum|school based curriculum
5628063|NCT00787696|HIV prevention|hiv prevention
5628064|NCT00787696|female adolescent offenders|female adolescent offenders
5628065|NCT00787696|sexual risk reduction|sexual risk reduction
5628066|NCT00787696|alcohol and other drug abuse|alcohol and other drug abuse
5628067|NCT00787683|Patients with ventricular arrhythmias and the prevention of sudden cardiac death|patients with ventricular arrhythmias and the prevention of sudden cardiac death
5628068|NCT00787670|Obese|obese
5628069|NCT00787670|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5628070|NCT00787670|Gastric Bypass surgery|gastric bypass surgery
5628071|NCT00787670|Risk of cardiovascular diseases|risk of cardiovascular diseases
5628072|NCT00787657|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5628073|NCT00787644|Asthma|asthma
5628074|NCT00787644|Adipose Tissue|adipose tissue
5628075|NCT00787644|Asthmatics|asthmatics
5628076|NCT00787644|Pioglitazone|pioglitazone
5628077|NCT00787644|Actos|actos
5628078|NCT00787644|Obesity|obesity
5628079|NCT00787644|Exacerbation|exacerbation
5628080|NCT00787644|Fat|fat
5628081|NCT00787644|Overweight|overweight
5628082|NCT00787644|Leptin|leptin
5628083|NCT00787644|Adiponectin|adiponectin
5628084|NCT00787644|Wheezing|wheezing
5628085|NCT00787644|Vermont|vermont
5628086|NCT00787644|Pulmonary|pulmonary
5628087|NCT00787644|Lung|lung
5628088|NCT00787631|birch pollen pollen allergy|birch pollen pollen allergy
5628089|NCT00787631|oral allergy syndrome to apple|oral allergy syndrome to apple
5628090|NCT00787631|cross reactivity|cross reactivity
5628091|NCT00787631|bet v 1|bet v 1
5628092|NCT00787631|mal d 1|mal d 1
5628093|NCT00787618|Renal impairment|renal impairment
5628094|NCT00787605|Hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2|hypertension, diabetes mellitus, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, amlodipine, stage 2
5628095|NCT00787592|Burns|burns
5628096|NCT00787592|children|children
5628097|NCT00787592|collagenase|collagenase
5628098|NCT00787592|silver sulfadiazine|silver sulfadiazine
5628099|NCT00787592|Childhood burns|childhood burns
5628100|NCT00787579|Myopia, bifocal, children|myopia, bifocal, children
5628101|NCT00787566|Highly emetogenic chemotherapy induced nausea and vomiting|highly emetogenic chemotherapy induced nausea and vomiting
5628102|NCT00787553|hysterectomy|hysterectomy
5628103|NCT00787553|antibiotic prophylaxis|antibiotic prophylaxis
5628104|NCT00787553|bacterial vaginosis|bacterial vaginosis
5628113|NCT00787527|Vorinostat|vorinostat
5628114|NCT00787527|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5628115|NCT00787527|MSK-390|msk-390
5628116|NCT00787527|CHOP|chop
5628117|NCT00787527|Cyclophosphamide|cyclophosphamide
5628118|NCT00787527|Doxorubicin|doxorubicin
5628119|NCT00787527|AD|ad
5628120|NCT00787527|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5628121|NCT00787527|Cytoxan|cytoxan
5628122|NCT00787527|Neosar|neosar
5628123|NCT00787527|Vincristine|vincristine
5628124|NCT00787527|Prednisone|prednisone
5628125|NCT00787527|Untreated T-cell|untreated t-cell
5628126|NCT00787527|T-cell NHL|t-cell nhl
5628127|NCT00787527|Peripheral T-cell lymphoma|peripheral t-cell lymphoma
5628128|NCT00787527|PTCL|ptcl
5628129|NCT00787527|CD 30|cd 30
5628130|NCT00787527|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5628131|NCT00787527|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5628135|NCT00787501|Major Depressive Disorder|major depressive disorder
5628137|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5628138|NCT00787501|Cognitive Behavior Therapy|cognitive behavior therapy
5628139|NCT00787501|Cognitive Therapy|cognitive therapy
5628140|NCT00787501|antidepressant medications|antidepressant medications
5628141|NCT00787488|Ovarian|ovarian
5628142|NCT00787488|debulked|debulked
5628144|NCT00787488|Stage III|stage iii
5628145|NCT00787488|Stage IV|stage iv
5628146|NCT00787475|Diabetes|diabetes
5628147|NCT00787475|Community health worker|community health worker
5628148|NCT00787475|Community outreach|community outreach
5628149|NCT00787462|Neuropathic|neuropathic
5628150|NCT00787462|Neuropathic pain|neuropathic pain
5628151|NCT00787462|Nerve pain|nerve pain
5628153|NCT00787462|Chronic pain|chronic pain
5628154|NCT00787462|Pregabalin|pregabalin
5628155|NCT00787462|Lyrica|lyrica
5628156|NCT00787462|Small fiber neuropathy|small fiber neuropathy
5628157|NCT00787462|Neuropathy|neuropathy
5628158|NCT00787436|portal hypertension|portal hypertension
5628159|NCT00787436|Gastroesophageal|gastroesophageal
5628160|NCT00787436|Varices|varices
5628161|NCT00787436|Liver disease|liver disease
5628162|NCT00787436|cirrhosis|cirrhosis
5628169|NCT00787410|malignant mesothelioma|malignant mesothelioma
5628170|NCT00787410|IRESSA|iressa
5628171|NCT00787410|ZD1839|zd1839
5628172|NCT00787397|Sleep difficulties in pediatric anxiety disorder|sleep difficulties in pediatric anxiety disorder
5628173|NCT00787397|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
5628174|NCT00787397|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
5628175|NCT00787397|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
5628176|NCT00787397|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
5628177|NCT00787397|Social Phobia in pediatric populations|social phobia in pediatric populations
5628178|NCT00787384|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
5628179|NCT00787384|chronic eosinophilic leukaemia (CEL)|chronic eosinophilic leukaemia (cel)
5628180|NCT00787384|chronic idiopathic hypereosinophilia (CIH)|chronic idiopathic hypereosinophilia (cih)
5628181|NCT00787384|Imatinib|imatinib
5628182|NCT00787384|Response|response
5628183|NCT00787384|Timing to response|timing to response
5628184|NCT00787371|alanine transaminase|alanine transaminase
5628185|NCT00787358|osteoporosis|osteoporosis
5628186|NCT00787358|intertrochanteric|intertrochanteric
5628187|NCT00787358|hip fracture|hip fracture
5628188|NCT00787358|compression hip screw|compression hip screw
5628189|NCT00787358|surgical fixation|surgical fixation
5680370|NCT00577993|Lymphoma|lymphoma
5680371|NCT00577993|Follicular Lymphoma|follicular lymphoma
5628190|NCT00787345|precaution technique during central venous catheter placement.|precaution technique during central venous catheter placement.
5628191|NCT00787332|Suspected Heparin Induced Thrombocytopenia (HIT)|suspected heparin induced thrombocytopenia (hit)
5628192|NCT00787319|Ophthalmology|ophthalmology
5628193|NCT00787319|Age-related macular degeneration|age-related macular degeneration
5628194|NCT00787319|outpatients|outpatients
5628195|NCT00787306|chronic disease management|chronic disease management
5628196|NCT00787306|decision aids|decision aids
5628197|NCT00787306|cardiovascular risk factors|cardiovascular risk factors
5628198|NCT00787293|Heart Failure|heart failure
5628200|NCT00787293|Percutaneous|percutaneous
5628201|NCT00787293|Coronary sinus|coronary sinus
5628203|NCT00787280|overweight|overweight
5628204|NCT00787280|fMRI|fmri
5628205|NCT00787280|Diet|diet
5628206|NCT00787267|NSCLC|nsclc
5628207|NCT00787267|Lung Cancer|lung cancer
5628208|NCT00787267|Dasatinib|dasatinib
5628209|NCT00787267|Genomics|genomics
5628210|NCT00787267|Genomics analysis|genomics analysis
5628211|NCT00787267|Genomic signature|genomic signature
5628212|NCT00787254|Curling Ulcer|curling ulcer
5628213|NCT00787254|Gastric Ulcer|gastric ulcer
5628214|NCT00787254|Nonsteroid anti-inflammatory drug|nonsteroid anti-inflammatory drug
5628215|NCT00787254|Drug Therapy|drug therapy
5628216|NCT00787241|Platelets|platelets
5628217|NCT00787241|Labor|labor
5628218|NCT00787241|Preeclampsia|preeclampsia
5628219|NCT00787215|oral glucose tolerance test|oral glucose tolerance test
5628220|NCT00787215|Hong Kong Chinese|hong kong chinese
5628221|NCT00787202|treatment of ulcerative colitis; CP 690 550|treatment of ulcerative colitis; cp 690 550
5628222|NCT00787189|sensorineural hearing loss|sensorineural hearing loss
5628223|NCT00787189|tinnitus|tinnitus
5628224|NCT00787189|word recognition|word recognition
5628225|NCT00787176|Oxytocin|oxytocin
5628226|NCT00787176|Labor, Obstetric|labor, obstetric
5628227|NCT00787176|Non-reassuring fetal heart rate|non-reassuring fetal heart rate
5628228|NCT00787176|epidural|epidural
5628230|NCT00787163|oligohydramnios|oligohydramnios
5628231|NCT00787163|amnioinfusion|amnioinfusion
5628232|NCT00787163|prematurity|prematurity
5628233|NCT00787163|Early premature rupture of membranes in pregnancy|early premature rupture of membranes in pregnancy
5628234|NCT00787111|Drug: Fluoxetine|drug: fluoxetine
5628235|NCT00787098|therapeutic mobility|therapeutic mobility
5628236|NCT00787098|acute care|acute care
5628237|NCT00787098|nursing|nursing
5628238|NCT00787098|inflammatory markers|inflammatory markers
5628239|NCT00787085|Funguria|funguria
5628240|NCT00787085|Epidemiology|epidemiology
5628241|NCT00787085|Urinary Tract Infections|urinary tract infections
5628242|NCT00787059|Adenylyl Cyclase|adenylyl cyclase
5628244|NCT00787059|adenovirus|adenovirus
5628245|NCT00787059|gene therapy|gene therapy
5628246|NCT00787059|congestive heart failure|congestive heart failure
5628247|NCT00787059|intracoronary|intracoronary
5628248|NCT00787059|nitroprusside|nitroprusside
5628249|NCT00787033|Focal Adhesion Kinase; Advanced Non-Hematologic Malignancies|focal adhesion kinase; advanced non-hematologic malignancies
5628250|NCT00787020|Cerebrospinal Fluid|cerebrospinal fluid
5628251|NCT00787020|Ventriculostomy|ventriculostomy
5628252|NCT00787020|Subarachnoid hemorrhage|subarachnoid hemorrhage
5628253|NCT00787020|vasospasm|vasospasm
5628254|NCT00787020|Human Subjects|human subjects
5628255|NCT00787007|healthy volunteers|healthy volunteers
5628256|NCT00787007|pharmacokinetics|pharmacokinetics
5628257|NCT00786994|Actinic Keratoses|actinic keratoses
5628258|NCT00786968|mucopolysaccharidosis|mucopolysaccharidosis
5628259|NCT00786968|Hurler-Scheie|hurler-scheie
5628260|NCT00786968|Scheie|scheie
5628261|NCT00786968|laronidase|laronidase
5628262|NCT00786968|spinal cord compression|spinal cord compression
5628263|NCT00786968|central nervous system|central nervous system
5628264|NCT00786968|enzyme replacement therapy|enzyme replacement therapy
5628265|NCT00786968|intrathecal|intrathecal
5628266|NCT00786942|osteotomy|osteotomy
5628267|NCT00786942|knee|knee
5628268|NCT00786942|varus deformity|varus deformity
5628269|NCT00786942|bone graft|bone graft
5628270|NCT00786929|Conversion to more aggressive treatment of recurrent fluid collection|conversion to more aggressive treatment of recurrent fluid collection
5628271|NCT00786916|pain|pain
5628272|NCT00786916|propofol|propofol
5628273|NCT00786916|lidocaine|lidocaine
5628274|NCT00786916|sedation|sedation
5628275|NCT00786916|pediatric|pediatric
5628276|NCT00786890|Prediabetes (IFG, IGT)|prediabetes (ifg, igt)
5628277|NCT00786890|Hong Kong Chinese|hong kong chinese
5628278|NCT00786890|Cardiovascular risk factors|cardiovascular risk factors
5628279|NCT00786877|pneumonia|pneumonia
5628280|NCT00786864|Randomised controlled trial|randomised controlled trial
5628281|NCT00786864|low back pain|low back pain
5628282|NCT00786864|exercise|exercise
5628283|NCT00786864|children|children
5628284|NCT00786864|school-based|school-based
5628285|NCT00786864|prevalence|prevalence
5628286|NCT00786864|intensity|intensity
5628287|NCT00786851|MANTLE CELL LYMPHOMA (MCL)|mantle cell lymphoma (mcl)
5628288|NCT00786851|Lenalidomide (Len)|lenalidomide (len)
5628289|NCT00786851|Dexamethasone (Dex)|dexamethasone (dex)
5628290|NCT00786838|Solid tumor|solid tumor
5628291|NCT00786838|Advanced solid tumor|advanced solid tumor
5628292|NCT00786838|Malignant tumors|malignant tumors
5628293|NCT00786838|Sarcoma|sarcoma
5628294|NCT00786838|Breast tumor|breast tumor
5628295|NCT00786838|Ovarian tumor|ovarian tumor
5628296|NCT00786838|QT interval|qt interval
5628297|NCT00786838|Trabectedin|trabectedin
5628298|NCT00786838|Yondelis|yondelis
5628299|NCT00786838|Ecteinascidin 743|ecteinascidin 743
5628301|NCT00786825|Type 1 diabetes|type 1 diabetes
5609904|NCT00858377|Phase 1|phase 1
5628302|NCT00786825|Hypoglycemia unawareness|hypoglycemia unawareness
5628303|NCT00786812|Leukemia|leukemia
5628304|NCT00786812|adult chronic myeloid leukemia|adult chronic myeloid leukemia
5628305|NCT00786812|imatinib|imatinib
5628306|NCT00786812|nilotinib|nilotinib
5628307|NCT00786786|Any person with a spinal cord injury|any person with a spinal cord injury
5628308|NCT00786786|at least 18 years of age|at least 18 years of age
5628309|NCT00786773|GERD|gerd
5628310|NCT00786773|reflux symptom|reflux symptom
5628311|NCT00786773|heartburn|heartburn
5628312|NCT00786773|acid regurgitation|acid regurgitation
5628314|NCT00786773|H2RA|h2ra
5628315|NCT00786773|antacid|antacid
5628316|NCT00786760|HPV|hpv
5628317|NCT00786760|Papillomavirus|papillomavirus
5628318|NCT00786760|Infection|infection
5628319|NCT00786760|Sexually transmitted disease|sexually transmitted disease
5628320|NCT00786760|STD|std
5628321|NCT00786747|Computer-assisted instruction|computer-assisted instruction
5628322|NCT00786747|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
5628323|NCT00786747|Mass screening|mass screening
5628324|NCT00786747|Patient acceptance of health care|patient acceptance of health care
5628325|NCT00786747|Patient education as topic|patient education as topic
5628326|NCT00786747|Primary health care|primary health care
5628327|NCT00786747|Self-efficacy|self-efficacy
5628328|NCT00786734|pitavastatin|pitavastatin
5628329|NCT00786734|PCI|pci
5628330|NCT00786734|stable angina|stable angina
5628331|NCT00786721|Mitochondria and Metabolic Syndrome|mitochondria and metabolic syndrome
5628332|NCT00786708|renal|renal
5628333|NCT00786708|kidney|kidney
5628334|NCT00786708|lipocalin|lipocalin
5628335|NCT00786708|urine|urine
5628336|NCT00786708|biomarker|biomarker
5628337|NCT00786708|Azotemia|azotemia
5628338|NCT00786708|Renal insufficiency, chronic|renal insufficiency, chronic
5628339|NCT00786708|Renal failure, acute|renal failure, acute
5628340|NCT00786708|Hydronephrosis|hydronephrosis
5628342|NCT00786695|gastroesophageal reflux disease|gastroesophageal reflux disease
5628343|NCT00786695|diagnostic test|diagnostic test
5628344|NCT00786695|proton pump inhibitor|proton pump inhibitor
5628345|NCT00786695|esomeprazole|esomeprazole
5628346|NCT00786682|stage IV prostate cancer|stage iv prostate cancer
5628347|NCT00786682|recurrent prostate cancer|recurrent prostate cancer
5628348|NCT00786656|Navigation|navigation
5628349|NCT00786656|Coordination|coordination
5628350|NCT00786656|Cancer Care|cancer care
5628351|NCT00786656|Patient Experience|patient experience
5628352|NCT00786656|Cancer|cancer
5628353|NCT00786656|Patient Survey|patient survey
5628354|NCT00786643|Gamma Interferon|gamma interferon
5628355|NCT00786643|5-FU|5-fu
5628356|NCT00786643|LV|lv
5628357|NCT00786630|Drug treatment entry and retention|drug treatment entry and retention
5628358|NCT00786630|Drug injection frequency|drug injection frequency
5628359|NCT00786630|HIV risk behaviors|hiv risk behaviors
5628360|NCT00786630|Hepatitis C risk behaviors|hepatitis c risk behaviors
5628361|NCT00786591|Acute pancreatitis|acute pancreatitis
5628362|NCT00786591|biological markers|biological markers
5628363|NCT00786591|substance P|substance p
5628364|NCT00786591|hydrogen sulfide|hydrogen sulfide
5628365|NCT00786591|disease severity index|disease severity index
5628366|NCT00786578|training|training
5628367|NCT00786578|intramyocellular lipid|intramyocellular lipid
5628368|NCT00786578|insulin resistance|insulin resistance
5628369|NCT00786552|recurrent/advanced thyroid cancer|recurrent/advanced thyroid cancer
5628370|NCT00786552|papillary or anaplastic thyroid cancer|papillary or anaplastic thyroid cancer
5628371|NCT00786539|mitochondrial|mitochondrial
5628372|NCT00786526|Mechanical ventilation|mechanical ventilation
5628373|NCT00786526|Ventilator induced diaphragmatic dysfunction|ventilator induced diaphragmatic dysfunction
5628374|NCT00786526|Weaning|weaning
5628375|NCT00786526|Neuromuscular diseases- Respiratory function tests|neuromuscular diseases- respiratory function tests
5628376|NCT00786526|Intubated patients in intensive care unit|intubated patients in intensive care unit
5628377|NCT00786513|Cystic fibrosis|cystic fibrosis
5628378|NCT00786513|Pseudomonas aeruginosa|pseudomonas aeruginosa
5628379|NCT00786513|biofilm|biofilm
5628380|NCT00786513|antibiotic susceptibility testing|antibiotic susceptibility testing
5628381|NCT00786513|pediatrics|pediatrics
5628382|NCT00786500|Herbal medicine|herbal medicine
5628383|NCT00786500|Type 2 diabetes|type 2 diabetes
5628384|NCT00786500|Insulin sensitivity|insulin sensitivity
5628385|NCT00786500|Insulin secretion|insulin secretion
5628386|NCT00786487|insulin resistance|insulin resistance
5628387|NCT00786487|lipid metabolism|lipid metabolism
5628388|NCT00786487|lipid infusion|lipid infusion
5628389|NCT00786487|glycerol infusion|glycerol infusion
5628390|NCT00786487|skeletal muscle|skeletal muscle
5628392|NCT00786474|Bridging Anticoagulation|bridging anticoagulation
5628393|NCT00786461|silver nitrate|silver nitrate
5628394|NCT00786461|marsupialisation|marsupialisation
5628395|NCT00786448|Overactive Bladder|overactive bladder
5628396|NCT00786422|Embolism and Thrombosis|embolism and thrombosis
5628397|NCT00786422|Pulmonary Embolism|pulmonary embolism
5628398|NCT00786422|Embolism|embolism
5628399|NCT00786422|Venous Thrombosis|venous thrombosis
5628400|NCT00786422|Thrombosis|thrombosis
5628401|NCT00786422|Enzyme Inducers|enzyme inducers
5628402|NCT00786422|CYP Inducers|cyp inducers
5628403|NCT00786422|Cohort Study|cohort study
5628404|NCT00786422|Pharmacologic Actions|pharmacologic actions
5628405|NCT00786422|Respiratory Tract Diseases|respiratory tract diseases
5628406|NCT00786422|Lung Diseases|lung diseases
5628407|NCT00786422|Vascular Diseases|vascular diseases
5628408|NCT00786422|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5628409|NCT00786422|Neurologic disease|neurologic disease
5628410|NCT00786422|Additional relevant MeSH terms:|additional relevant mesh terms:
5628411|NCT00786422|Fibrin Modulating Agents|fibrin modulating agents
5628412|NCT00786422|Anticoagulants|anticoagulants
5628413|NCT00786422|Therapeutic Uses|therapeutic uses
5628414|NCT00786422|Hematologic Agents|hematologic agents
5628415|NCT00786422|Enzyme Inhibitors|enzyme inhibitors
5628416|NCT00786422|Cardiovascular Diseases|cardiovascular diseases
5628417|NCT00786422|Cardiovascular Agents|cardiovascular agents
5628418|NCT00786409|Lupus|lupus
5628420|NCT00786396|AIDS|aids
5628421|NCT00786396|substance abuse|substance abuse
5628422|NCT00786396|directly administered antiretroviral therapy|directly administered antiretroviral therapy
5628423|NCT00786396|adherence|adherence
5628424|NCT00786396|Substance Abuse and Dependency|substance abuse and dependency
5628425|NCT00786383|Phase I|phase i
5628426|NCT00786383|cancer|cancer
5628427|NCT00786383|solid tumors|solid tumors
5628428|NCT00786383|1121B|1121b
5628429|NCT00786383|VEGFR-2|vegfr-2
5628430|NCT00786383|Anti-Vascular Endothelial Growth Factor Receptor 2|anti-vascular endothelial growth factor receptor 2
5628431|NCT00786370|propofol|propofol
5628432|NCT00786370|dexmedetomidine|dexmedetomidine
5628433|NCT00786370|cataract|cataract
5628434|NCT00786370|respiratory|respiratory
5628436|NCT00786370|Cataract surgery|cataract surgery
5628437|NCT00786357|shift-work|shift-work
5628438|NCT00786357|sleep|sleep
5628439|NCT00786357|nurse|nurse
5628440|NCT00786357|relaxation|relaxation
5628441|NCT00786344|Health Promotion: Wellness Programs|health promotion: wellness programs
5628442|NCT00786344|Occupational Therapy|occupational therapy
5628443|NCT00786344|Quality of Life|quality of life
5628444|NCT00786344|Health|health
5628445|NCT00786344|Biomarkers|biomarkers
5628446|NCT00786331|second line treatment|second line treatment
5628447|NCT00786331|pemetrexed|pemetrexed
5628448|NCT00786331|carboplatin|carboplatin
5628449|NCT00786318|Psychosis|psychosis
5628450|NCT00786318|Agitation|agitation
5628451|NCT00786318|Delirium|delirium
5628452|NCT00786305|Nebulization|nebulization
5628453|NCT00786305|ceftazidime|ceftazidime
5628454|NCT00786305|amikacin|amikacin
5628455|NCT00786305|pneumonia|pneumonia
5628456|NCT00786305|Pseudomonas aeruginosa|pseudomonas aeruginosa
5628457|NCT00786305|mechanical ventilation|mechanical ventilation
5628458|NCT00786305|Ventilator-associated pneumonia|ventilator-associated pneumonia
5628459|NCT00786305|treatment|treatment
5628460|NCT00786279|atherosclerosis|atherosclerosis
5628461|NCT00786266|shift-work|shift-work
5628462|NCT00786266|sleep|sleep
5628463|NCT00786266|nurse|nurse
5628464|NCT00786266|relaxation|relaxation
5628465|NCT00786253|Erectile dysfunction|erectile dysfunction
5628466|NCT00786253|Vardenafil|vardenafil
5628467|NCT00786240|Bioequivalence|bioequivalence
5628468|NCT00786240|Therapeutic Equivalency|therapeutic equivalency
5628469|NCT00786214|Functional Dyspepsia|functional dyspepsia
5628470|NCT00786214|Acupuncture|acupuncture
5628471|NCT00786214|Traditional Chinese Medicine|traditional chinese medicine
5628472|NCT00786201|CNTO 888|cnto 888
5628473|NCT00786201|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5628475|NCT00786188|Menopause|menopause
5628476|NCT00786188|Vasomotor Symptoms|vasomotor symptoms
5628477|NCT00786188|Hot flash|hot flash
5628478|NCT00786188|Perimenopause|perimenopause
5628479|NCT00786188|Nonhormonal therapies|nonhormonal therapies
5628480|NCT00786188|Climacteric symptoms|climacteric symptoms
5628481|NCT00786188|Mesafem|mesafem
5628482|NCT00786188|Low-Dose Mesylate salt of Paroxetine (LDMP)|low-dose mesylate salt of paroxetine (ldmp)
5628483|NCT00786149|Underserved populations|underserved populations
5628484|NCT00786149|Homelessness|homelessness
5628485|NCT00786149|Nicotine replacement therapy|nicotine replacement therapy
5628486|NCT00786149|Counseling|counseling
5628487|NCT00786149|Cancer Prevention and control|cancer prevention and control
5628488|NCT00786136|diabetes mellitus|diabetes mellitus
5628489|NCT00786136|chronic kidney disease|chronic kidney disease
5628490|NCT00786136|contrast induced acute kidney injury|contrast induced acute kidney injury
5628491|NCT00786136|angiography|angiography
5628492|NCT00786123|irritable bowel syndrome|irritable bowel syndrome
5628493|NCT00786123|rectal hypersensitivity|rectal hypersensitivity
5628494|NCT00786123|probiotics|probiotics
5628495|NCT00786123|melatonin|melatonin
5628496|NCT00786123|brain-gut axis|brain-gut axis
5628497|NCT00786110|Sorafenib|sorafenib
5628498|NCT00786110|Paclitaxel|paclitaxel
5628499|NCT00786110|Disease free survival|disease free survival
5628500|NCT00786084|Hiatal hernia|hiatal hernia
5628501|NCT00786084|PEH|peh
5628502|NCT00786084|paraesophageal hernia|paraesophageal hernia
5628503|NCT00786084|synthetic mesh|synthetic mesh
5628504|NCT00786084|small intestine submucosa|small intestine submucosa
5628505|NCT00786071|Rett syndrome.|rett syndrome.
5628506|NCT00786071|Nutritional status.|nutritional status.
5628507|NCT00786071|Metabolic alterations.|metabolic alterations.
5628508|NCT00786058|refractory pancreatic cancer|refractory pancreatic cancer
5628509|NCT00786058|gemcitabine|gemcitabine
5628510|NCT00786058|phase III|phase iii
5628511|NCT00786058|second line|second line
5628512|NCT00786045|stroke|stroke
5628513|NCT00786045|rehabilitation|rehabilitation
5628514|NCT00786045|walking|walking
5628515|NCT00786032|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5628516|NCT00786032|Brain Computer Interface (BCI)|brain computer interface (bci)
5628517|NCT00786032|Lou Gehrig's disease|lou gehrig's disease
5628518|NCT00786019|Type|type
5628519|NCT00786019|2|2
5628520|NCT00786019|Diabetes|diabetes
5628521|NCT00786019|Blood|blood
5628526|NCT00786019|Intervention|intervention
5628527|NCT00786019|Vitamin|vitamin
5628528|NCT00786019|C|c
5628529|NCT00786019|Men|men
5628531|NCT00786019|Blood vessel function|blood vessel function
5628532|NCT00786006|pancreatic cancer|pancreatic cancer
5628533|NCT00786006|gemcitabine|gemcitabine
5628534|NCT00786006|oxaliplatin|oxaliplatin
5628535|NCT00786006|irinotecan|irinotecan
5628536|NCT00786006|fluorouracil|fluorouracil
5628537|NCT00786006|Failure to gemcitabine chemotherapy|failure to gemcitabine chemotherapy
5628538|NCT00785993|Egg banking, clinical outcome|egg banking, clinical outcome
5628539|NCT00785980|quinine sulfate|quinine sulfate
5628540|NCT00785980|ciprofloxacin|ciprofloxacin
5628541|NCT00785980|drug interactions|drug interactions
5628542|NCT00785980|cytochrome p450|cytochrome p450
5628544|NCT00785980|female|female
5628545|NCT00785980|adult|adult
5628546|NCT00785980|pharmacokinetics|pharmacokinetics
5628547|NCT00785967|V(D)J recombination; RAG-1/2 recombinase function|v(d)j recombination; rag-1/2 recombinase function
5628548|NCT00785954|Heart Diseases|heart diseases
5628549|NCT00785954|Myocardial Ischemia|myocardial ischemia
5628550|NCT00785954|Infarction|infarction
5628551|NCT00785954|Myocardial Infarction|myocardial infarction
5628552|NCT00785941|Tumors|tumors
5628553|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal
5628554|NCT00785928|Arthritis|arthritis
5628555|NCT00785915|AZD6765|azd6765
5628556|NCT00785915|Japanese and Caucasian Healthy Volunteers|japanese and caucasian healthy volunteers
5628557|NCT00785915|Phase I study|phase i study
5628558|NCT00785915|Single and multiple Ascending Dose|single and multiple ascending dose
5628559|NCT00785915|Japanese volunteers|japanese volunteers
5628560|NCT00785889|Colorectal cancer screening|colorectal cancer screening
5628561|NCT00785889|optical colonoscopy|optical colonoscopy
5628562|NCT00785889|water method|water method
5628563|NCT00785889|sedation|sedation
5628564|NCT00785876|Paediatric|paediatric
5628565|NCT00785876|Emergency Department|emergency department
5628566|NCT00785876|Ankle|ankle
5628567|NCT00785876|Injury|injury
5628568|NCT00785876|Low risk ankle rule|low risk ankle rule
5628569|NCT00785863|hyperalgesia|hyperalgesia
5628570|NCT00785863|remifentanil|remifentanil
5628571|NCT00785863|ketorolac|ketorolac
5628572|NCT00785863|parecoxib|parecoxib
5628573|NCT00785863|COX-1 inhibitor|cox-1 inhibitor
5628574|NCT00785863|COX-2 inhibitor|cox-2 inhibitor
5628575|NCT00785837|Hydrotherapy|hydrotherapy
5628576|NCT00785837|Perinatal Care|perinatal care
5628577|NCT00785837|Neonatology|neonatology
5628578|NCT00785824|Lactation|lactation
5628579|NCT00785824|Endocrine System Diseases|endocrine system diseases
5628580|NCT00785824|Musculoskeletal System Disease|musculoskeletal system disease
5628581|NCT00785824|Hormone|hormone
5628582|NCT00785824|Physiological Properties|physiological properties
5628583|NCT00785798|Relapsed Lymphomas|relapsed lymphomas
5628584|NCT00785798|Refractory Lymphomas|refractory lymphomas
5628585|NCT00785785|Unresectable GIST|unresectable gist
5628586|NCT00785785|metastatic GIST|metastatic gist
5628587|NCT00785785|nilotinib|nilotinib
5628588|NCT00785785|AMN107|amn107
5628589|NCT00785785|imatinib|imatinib
5628590|NCT00785785|STI571|sti571
5628591|NCT00785772|Gabapentin Pharmacokinetics|gabapentin pharmacokinetics
5628592|NCT00785759|Alzheimer's Disease|alzheimer's disease
5628593|NCT00785746|elderly, balance, core, strength|elderly, balance, core, strength
5628594|NCT00785733|asthma|asthma
5628595|NCT00785707|sensorineural hearing loss|sensorineural hearing loss
5628596|NCT00785707|cochlear implant|cochlear implant
5628597|NCT00785668|Asthma|asthma
5628598|NCT00785668|Allergy|allergy
5628599|NCT00785668|Interleukin-4|interleukin-4
5628600|NCT00785668|Interleukin-13|interleukin-13
5628601|NCT00785668|IL-4|il-4
5628602|NCT00785668|IL-13|il-13
5628603|NCT00785668|Pharmacokinetics|pharmacokinetics
5628604|NCT00785668|Safety|safety
5628605|NCT00785668|Tolerability|tolerability
5628606|NCT00785668|Aerovance|aerovance
5628607|NCT00785668|dry powder|dry powder
5628608|NCT00785629|phosphorus|phosphorus
5628609|NCT00785629|secondary hyperparathyroidism|secondary hyperparathyroidism
5628610|NCT00785629|vascular calcification|vascular calcification
5628612|NCT00785616|Adherence|adherence
5628613|NCT00785616|MEMS|mems
5628614|NCT00785603|Depression|depression
5628615|NCT00785603|pain|pain
5628616|NCT00785603|CYP2D6|cyp2d6
5628617|NCT00785603|interactions|interactions
5628618|NCT00785603|Pupillometry|pupillometry
5628619|NCT00785603|Tramadol|tramadol
5628620|NCT00785603|Paroxetine|paroxetine
5628621|NCT00785603|MR-ratio|mr-ratio
5628622|NCT00785564|T-wave memory|t-wave memory
5628623|NCT00785564|Sick Sinus Syndrome|sick sinus syndrome
5628624|NCT00785551|male|male
5628625|NCT00785551|female|female
5628626|NCT00785551|pharmacokinetics|pharmacokinetics
5628627|NCT00785551|normal and impaired renal function|normal and impaired renal function
5628628|NCT00785538|Tumors|tumors
5628629|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal
5628630|NCT00785525|Healthy Unrelated Stem Cell Donors|healthy unrelated stem cell donors
5628631|NCT00785512|nebivolol|nebivolol
5628632|NCT00785512|Bystolic®|bystolic®
5628633|NCT00785512|Hypertension|hypertension
5628634|NCT00785512|blood pressure|blood pressure
5628635|NCT00785512|withdrawal|withdrawal
5628636|NCT00785499|obesity|obesity
5628637|NCT00785499|metabolic syndrome|metabolic syndrome
5628638|NCT00785499|milk components|milk components
5628639|NCT00785499|casein|casein
5628640|NCT00785499|whey|whey
5628641|NCT00785499|children|children
5628642|NCT00785499|adolescent|adolescent
5628643|NCT00785486|midazolam|midazolam
5628644|NCT00785486|drug interactions|drug interactions
5628645|NCT00785486|cytochrome p450|cytochrome p450
5628646|NCT00785447|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5628647|NCT00785447|Respiratory Physiology|respiratory physiology
5628648|NCT00785447|Mouth to mouth ventilation|mouth to mouth ventilation
5628649|NCT00785447|Mouth to nose ventilation|mouth to nose ventilation
5628651|NCT00785434|escitalopram|escitalopram
5628652|NCT00785421|heparin|heparin
5628653|NCT00785421|LMWH|lmwh
5628654|NCT00785421|pancreatic cancer|pancreatic cancer
5628655|NCT00785408|obesity|obesity
5628656|NCT00785408|overweight|overweight
5628657|NCT00785408|weight loss|weight loss
5628658|NCT00785408|Amylin|amylin
5628659|NCT00785408|AC2307|ac2307
5628660|NCT00785382|Pain, Pregabalin, Lyrica, Breast surgery|pain, pregabalin, lyrica, breast surgery
5628661|NCT00785369|skin disorders|skin disorders
5628662|NCT00785369|skin cancer|skin cancer
5628663|NCT00785369|melanoma|melanoma
5628664|NCT00785369|lentigo maligna|lentigo maligna
5628665|NCT00785356|Uterine fibroids|uterine fibroids
5628666|NCT00785356|Anemia|anemia
5628667|NCT00785343|stroke|stroke
5628668|NCT00785343|acute|acute
5628669|NCT00785343|arm|arm
5628670|NCT00785343|robot|robot
5628671|NCT00785343|therapy|therapy
5628672|NCT00785343|arm paresis|arm paresis
5628673|NCT00785330|rituximab|rituximab
5628674|NCT00785330|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5628675|NCT00785330|diffuse large B cell lymphoma|diffuse large b cell lymphoma
5628676|NCT00785330|peripheral t cell lymphoma|peripheral t cell lymphoma
5628677|NCT00785330|graft-versus-host disease|graft-versus-host disease
5628678|NCT00785330|graft-versus-lymphoma effect|graft-versus-lymphoma effect
5628679|NCT00785330|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
5628680|NCT00785330|relapsed or primary progressive aggressive Non-Hodgkin's lymphoma|relapsed or primary progressive aggressive non-hodgkin's lymphoma
5628681|NCT00785317|Postmenopausal Hormone Replacement Therapy|postmenopausal hormone replacement therapy
5628682|NCT00785278|Wheelchair Set-Up|wheelchair set-up
5628683|NCT00785278|Shoulder Joint Forces|shoulder joint forces
5628684|NCT00785278|Manual Wheelchair Users|manual wheelchair users
5628685|NCT00785278|Paraplegia|paraplegia
5628686|NCT00785278|Upper Limb Pain|upper limb pain
5628687|NCT00785278|Secondary Injury to Spinal Cord Injury|secondary injury to spinal cord injury
5628688|NCT00785278|Biomechanics|biomechanics
5628689|NCT00785265|Live Donor Kidney Transplantation|live donor kidney transplantation
5628690|NCT00785265|LDKT|ldkt
5628691|NCT00785265|African Americans|african americans
5628692|NCT00785265|Disparity|disparity
5628693|NCT00785265|Education|education
5628694|NCT00785252|Catheters, Indwelling|catheters, indwelling
5628695|NCT00785239|Malignant Airway Disease|malignant airway disease
5628696|NCT00785239|Benign Airway Disease|benign airway disease
5613314|NCT00844766|Lactose|lactose
5628697|NCT00785239|Lung Cancer|lung cancer
5628698|NCT00785239|Emphysema|emphysema
5628699|NCT00785239|Chronic Bronchitis|chronic bronchitis
5628700|NCT00785239|COPD|copd
5628701|NCT00785239|Asthma|asthma
5628702|NCT00785239|Sarcoidosis|sarcoidosis
5628703|NCT00785239|Mesothelioma|mesothelioma
5628704|NCT00785239|CryoSpray Ablation|cryospray ablation
5628705|NCT00785239|Cryotherapy|cryotherapy
5628706|NCT00785239|Cryospray|cryospray
5628707|NCT00785239|Cryo|cryo
5628708|NCT00785213|rosiglitazone|rosiglitazone
5628709|NCT00785213|quinine sulfate|quinine sulfate
5628710|NCT00785213|drug interactions|drug interactions
5628712|NCT00785200|MRSA|mrsa
5628713|NCT00785200|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5628714|NCT00785200|Chlorhexidine|chlorhexidine
5628715|NCT00785200|Asymptomatic colonization|asymptomatic colonization
5628716|NCT00785200|Asymptomatic colonization, MRSA|asymptomatic colonization, mrsa
5628717|NCT00785200|Skin and soft tissue infections|skin and soft tissue infections
5628718|NCT00785187|UVB induced skin erythema|uvb induced skin erythema
5628719|NCT00785174|noninvasive ventilation, continuous posi|noninvasive ventilation, continuous posi
5628720|NCT00785161|Penumbra System|penumbra system
5628721|NCT00785161|Mechanical Thrombectomy|mechanical thrombectomy
5628722|NCT00785161|Ischemic Stroke|ischemic stroke
5628723|NCT00785161|Intervention|intervention
5628724|NCT00785161|Neurovascular|neurovascular
5628725|NCT00785161|Thrombus|thrombus
5628726|NCT00785161|Imaging|imaging
5628727|NCT00785161|Ischemic Penumbra|ischemic penumbra
5628728|NCT00785161|Functional Outcome|functional outcome
5628729|NCT00785135|vision, binocular|vision, binocular
5628730|NCT00785135|vision disparity|vision disparity
5628731|NCT00785135|headache|headache
5628732|NCT00785135|dizziness|dizziness
5628733|NCT00785135|anxiety|anxiety
5628734|NCT00785135|neck pain|neck pain
5628735|NCT00785135|learning disorders|learning disorders
5628736|NCT00785135|asthenopia|asthenopia
5628737|NCT00785135|motion sickness|motion sickness
5628738|NCT00785135|depth perception|depth perception
5628739|NCT00785135|gait disorder|gait disorder
5628740|NCT00785135|diplopia|diplopia
5628741|NCT00785135|photophobia|photophobia
5628742|NCT00785135|agoraphobia|agoraphobia
5628743|NCT00785135|panic disorder|panic disorder
5628745|NCT00785109|aortic valve calcification|aortic valve calcification
5628746|NCT00785109|vitamin K supplementation|vitamin k supplementation
5628747|NCT00785096|Perception, surgical complications, patients, nurses and physicians|perception, surgical complications, patients, nurses and physicians
5628748|NCT00785083|Asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume|asthma, adrenergic beta agonists, multiple sclerosis, pulmonary function tests, forced expiratory volume
5628749|NCT00785070|Perioperative|perioperative
5628750|NCT00785070|Obstructive Sleep Apnea|obstructive sleep apnea
5628751|NCT00785070|Screening|screening
5628752|NCT00785070|Home Sleep Testing|home sleep testing
5628753|NCT00785057|Hypertension|hypertension
5628754|NCT00785057|Stroke|stroke
5628755|NCT00785057|Neurology|neurology
5628756|NCT00785057|JNC7|jnc7
5628757|NCT00785057|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5628758|NCT00785057|survey|survey
5628759|NCT00785044|Heart Failure|heart failure
5628760|NCT00785044|MIBG|mibg
5628761|NCT00785044|123I-mIBG|123i-mibg
5628762|NCT00785031|risk management|risk management
5628763|NCT00785031|Self Management|self management
5628764|NCT00785031|Self-Efficacy|self-efficacy
5628765|NCT00785031|Disease management|disease management
5628766|NCT00785031|nurse practitioner|nurse practitioner
5628767|NCT00785031|internet|internet
5628768|NCT00785031|risk factors|risk factors
5628769|NCT00785031|vascular diseases|vascular diseases
5628770|NCT00785031|economic evaluation|economic evaluation
5628771|NCT00785018|Endotoxin|endotoxin
5628772|NCT00785018|C1-inhibitor|c1-inhibitor
5628773|NCT00785018|Inflammation|inflammation
5628774|NCT00785018|Sepsis|sepsis
5628775|NCT00785018|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5628776|NCT00785018|Complement activation|complement activation
5628777|NCT00785005|Diabetes|diabetes
5628778|NCT00785005|Exercise|exercise
5628779|NCT00785005|Women|women
5628780|NCT00785005|Research|research
5628781|NCT00785005|Bike|bike
5628782|NCT00785005|Type|type
5628783|NCT00785005|Control|control
5628784|NCT00785005|Healthy|healthy
5628785|NCT00784992|NLDO|nldo
5628786|NCT00784992|DCR|dcr
5628787|NCT00784992|silicone tubes|silicone tubes
5628788|NCT00784992|stent|stent
5628789|NCT00784979|Renal|renal
5628790|NCT00784979|Transplant|transplant
5628791|NCT00784979|PRA|pra
5628792|NCT00784966|Islet transplantation|islet transplantation
5628793|NCT00784966|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5628794|NCT00784966|Kidney Transplantation|kidney transplantation
5628795|NCT00784953|Symbicort SMART|symbicort smart
5628796|NCT00784953|budesonide|budesonide
5628797|NCT00784953|formoterol|formoterol
5628798|NCT00784953|ICS/LABA|ics/laba
5628799|NCT00784953|Asthma Control Questionnaire|asthma control questionnaire
5628800|NCT00784953|Not optimally controlled asthma|not optimally controlled asthma
5628801|NCT00784927|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5628802|NCT00784927|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5628803|NCT00784927|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5628804|NCT00784927|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5628805|NCT00784927|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5628806|NCT00784927|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5628989|NCT00784277|Nucynta|nucynta
5628807|NCT00784927|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5628808|NCT00784927|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5628810|NCT00784927|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5628811|NCT00784927|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5628812|NCT00784927|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5628813|NCT00784927|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5628814|NCT00784927|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5628815|NCT00784927|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5628816|NCT00784927|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5798770|NCT00111137|anemia|anemia
5798771|NCT00111137|Amgen|amgen
5628817|NCT00784927|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5628818|NCT00784927|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5628819|NCT00784927|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5628820|NCT00784927|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5628821|NCT00784927|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5628822|NCT00784927|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5628823|NCT00784927|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5628824|NCT00784927|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5628825|NCT00784914|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5628826|NCT00784914|adult diffuse astrocytoma|adult diffuse astrocytoma
5628828|NCT00784914|adult choroid plexus tumor|adult choroid plexus tumor
5628829|NCT00784914|adult brain stem glioma|adult brain stem glioma
5628830|NCT00784914|tumors metastatic to brain|tumors metastatic to brain
5628831|NCT00784914|recurrent adult brain tumor|recurrent adult brain tumor
5628832|NCT00784914|adult gliosarcoma|adult gliosarcoma
5628833|NCT00784914|adult giant cell glioblastoma|adult giant cell glioblastoma
5628834|NCT00784914|adult ependymoblastoma|adult ependymoblastoma
5628835|NCT00784914|adult medulloblastoma|adult medulloblastoma
5628836|NCT00784914|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5628837|NCT00784914|adult anaplastic ependymoma|adult anaplastic ependymoma
5628838|NCT00784914|adult ependymoma|adult ependymoma
5628839|NCT00784914|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5628840|NCT00784914|adult subependymoma|adult subependymoma
5628841|NCT00784914|adult mixed glioma|adult mixed glioma
5628842|NCT00784914|meningeal melanocytoma|meningeal melanocytoma
5628843|NCT00784914|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5628844|NCT00784914|adult grade I meningioma|adult grade i meningioma
5628845|NCT00784914|adult grade II meningioma|adult grade ii meningioma
5628846|NCT00784914|adult grade III meningioma|adult grade iii meningioma
5628847|NCT00784914|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5628848|NCT00784914|adult oligodendroglioma|adult oligodendroglioma
5628849|NCT00784914|adult pineoblastoma|adult pineoblastoma
5628850|NCT00784914|adult pineocytoma|adult pineocytoma
5628851|NCT00784901|Macular Thickness Analyzed by Optical Coherence Tomography in Retinitis Pigmemtosa|macular thickness analyzed by optical coherence tomography in retinitis pigmemtosa
5628852|NCT00784888|aromatase inhibitor|aromatase inhibitor
5628853|NCT00784888|quality of life|quality of life
5628854|NCT00784888|safety|safety
5628855|NCT00784888|postmenopausal breast cancer|postmenopausal breast cancer
5628856|NCT00784849|Breast cancer|breast cancer
5628857|NCT00784849|diagnostic|diagnostic
5628858|NCT00784849|lymph nodes|lymph nodes
5628859|NCT00784836|Multiple Sclerosis - Relapsing|multiple sclerosis - relapsing
5628860|NCT00784810|Efficacy, tolerability, moderate/severe, oxycodone/naloxone|efficacy, tolerability, moderate/severe, oxycodone/naloxone
5628861|NCT00784810|codeine/paracetamol, chronic low back pain, osteoarthritis|codeine/paracetamol, chronic low back pain, osteoarthritis
5628862|NCT00784784|antiviral drugs|antiviral drugs
5628863|NCT00784784|influenza vaccines|influenza vaccines
5628864|NCT00784771|Hypnotherapy|hypnotherapy
5628865|NCT00784771|Hypnosis|hypnosis
5628866|NCT00784771|PTSD|ptsd
5628867|NCT00784758|Asthma|asthma
5628868|NCT00784758|Lung Diseases|lung diseases
5628869|NCT00784758|Respiratory Tract Diseases|respiratory tract diseases
5628870|NCT00784745|incretin effect|incretin effect
5628871|NCT00784745|type 2 diabetes|type 2 diabetes
5628872|NCT00784745|GLP-1|glp-1
5628873|NCT00784745|GIP|gip
5628874|NCT00784745|dexamethasone|dexamethasone
5628875|NCT00784732|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5628876|NCT00784732|Environmental Exposure Chamber|environmental exposure chamber
5628877|NCT00784732|nasal lavage|nasal lavage
5628878|NCT00784719|Dry eye|dry eye
5628879|NCT00784706|stroke rehabilitation|stroke rehabilitation
5628880|NCT00784706|perceptual deficits|perceptual deficits
5628881|NCT00784706|kinematic analysis|kinematic analysis
5628882|NCT00784693|Endometriosis|endometriosis
5628883|NCT00784693|pain|pain
5628884|NCT00784693|tanezumab|tanezumab
5628885|NCT00784693|nerve growth factor|nerve growth factor
5628886|NCT00784693|questionnaires|questionnaires
5628887|NCT00784667|Colorectal neoplasm|colorectal neoplasm
5628889|NCT00784615|Phenotypes of Polycystic Ovary Syndrome|phenotypes of polycystic ovary syndrome
5628890|NCT00784615|Cardiovascular risk factors|cardiovascular risk factors
5628891|NCT00784615|Adiponectin|adiponectin
5628892|NCT00784615|C Reactive Protein|c reactive protein
5628893|NCT00784602|prolapse|prolapse
5628894|NCT00784602|pelvic organ prolapse|pelvic organ prolapse
5628895|NCT00784589|Corticothérapy|corticothérapy
5628896|NCT00784589|Rituximab|rituximab
5628897|NCT00784589|therapeutic efficacity|therapeutic efficacity
5628898|NCT00784589|therapeutic tolerance|therapeutic tolerance
5628899|NCT00784576|Delirium|delirium
5628900|NCT00784576|Cardiac Surgery|cardiac surgery
5628901|NCT00784576|Depression|depression
5628902|NCT00784576|Cognitive Impairment|cognitive impairment
5628903|NCT00784576|Diagnostic Criteria for Delirium|diagnostic criteria for delirium
5628904|NCT00784576|Memorial Delirium Assessment Scale|memorial delirium assessment scale
5628905|NCT00784576|Delirium Index|delirium index
5628906|NCT00784563|Parkinson Disease|parkinson disease
5628907|NCT00784563|Exercise/*physiology|exercise/*physiology
5628908|NCT00784563|*Physical Fitness|*physical fitness
5628909|NCT00784563|Rehabilitation|rehabilitation
5628910|NCT00784563|Cognition|cognition
5628911|NCT00784550|Spirometry|spirometry
5628912|NCT00784550|COPD|copd
5628913|NCT00784537|Hodgkin's lymphoma|hodgkin's lymphoma
5628914|NCT00784537|ABVD|abvd
5685470|NCT00555958|Excess weight loss|excess weight loss
5671705|NCT00614718|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5628915|NCT00784537|FDG-PET (18-Fluoro-deoxy-D-glucose Positron Emission Tomography)|fdg-pet (18-fluoro-deoxy-d-glucose positron emission tomography)
5628916|NCT00784537|Radiotherapy|radiotherapy
5628917|NCT00784524|stage IV breast cancer|stage iv breast cancer
5628918|NCT00784524|recurrent breast cancer|recurrent breast cancer
5628919|NCT00784524|metastatic breast cancer|metastatic breast cancer
5628920|NCT00784511|diabetes|diabetes
5628921|NCT00784511|vitamin D|vitamin d
5628922|NCT00784511|African Americans|african americans
5628923|NCT00784511|overweight|overweight
5628924|NCT00784511|insulin sensitivity|insulin sensitivity
5628925|NCT00784511|glucose control|glucose control
5628926|NCT00784498|Procedural sedation and analgesia|procedural sedation and analgesia
5628927|NCT00784498|Emergency Department|emergency department
5628928|NCT00784498|propofol versus ketamine and midazolam|propofol versus ketamine and midazolam
5628929|NCT00784498|painful orthopedic manipulations|painful orthopedic manipulations
5628931|NCT00784485|Respiratory Tract Diseases|respiratory tract diseases
5628932|NCT00784485|Lung Diseases|lung diseases
5628933|NCT00784485|Dyspnea|dyspnea
5628934|NCT00784472|PCNL|pcnl
5628935|NCT00784472|oxycodone|oxycodone
5628936|NCT00784472|morphine|morphine
5628937|NCT00784472|visceral pain|visceral pain
5628938|NCT00784459|Asthma|asthma
5628939|NCT00784459|Allergy|allergy
5628940|NCT00784446|AIO|aio
5628941|NCT00784446|colorectal cancer|colorectal cancer
5628942|NCT00784446|0205|0205
5628943|NCT00784446|Capecitabine|capecitabine
5628944|NCT00784446|Oxaliplatin|oxaliplatin
5628945|NCT00784446|Bevacizumab|bevacizumab
5628946|NCT00784446|Imatinib|imatinib
5628947|NCT00784433|alcohol diabetes CVD|alcohol diabetes cvd
5628948|NCT00784420|Drug Interaction, Pharmacokinetics|drug interaction, pharmacokinetics
5628949|NCT00784407|thyroid surgery|thyroid surgery
5628950|NCT00784407|total thyroidectomy|total thyroidectomy
5628951|NCT00784407|harmonic scalpel|harmonic scalpel
5628952|NCT00784173|Syndrome|syndrome
5628953|NCT00784173|Velocardiofacial|velocardiofacial
5628954|NCT00784173|Middle ear|middle ear
5628955|NCT00784173|Inner ear|inner ear
5628956|NCT00784173|Malformation|malformation
5628957|NCT00784381|Renal failure|renal failure
5628958|NCT00784381|Elderly|elderly
5628959|NCT00784381|Drug Therapy Computer-Assisted|drug therapy computer-assisted
5628960|NCT00784381|Quality of care|quality of care
5628961|NCT00784381|Patients With Impaired Renal Function|patients with impaired renal function
5628962|NCT00784381|Inappropriateness of target drug prescribed|inappropriateness of target drug prescribed
5628963|NCT00784368|Mycoses|mycoses
5613581|NCT00843531|RAD001|rad001
5628964|NCT00784368|Candidiasis|candidiasis
5628965|NCT00784368|Aspergillosis|aspergillosis
5628966|NCT00784368|Cryptococcosis|cryptococcosis
5628967|NCT00784368|Blastomycosis|blastomycosis
5628968|NCT00784368|Histoplasmosis|histoplasmosis
5628969|NCT00784368|Neutropenia|neutropenia
5628970|NCT00784368|Itraconazole|itraconazole
5628971|NCT00784368|JK1211|jk1211
5628972|NCT00784355|recurrence of idiopathic pancreatitis|recurrence of idiopathic pancreatitis
5628973|NCT00784355|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5628974|NCT00784355|etiology of pancreatitis|etiology of pancreatitis
5628975|NCT00784342|COPD|copd
5628976|NCT00784329|Lung Cancer|lung cancer
5628977|NCT00784329|Squamous Cell Lung Cancer|squamous cell lung cancer
5628978|NCT00784329|Bronchial carcinoma in situ|bronchial carcinoma in situ
5628979|NCT00784329|Central Airway Diseases|central airway diseases
5628980|NCT00784316|Prevention|prevention
5628992|NCT00784264|central obesity|central obesity
5628993|NCT00784264|cardiovascular disease|cardiovascular disease
5628995|NCT00784251|Leg pain|leg pain
5628996|NCT00784251|Back pain|back pain
5628997|NCT00784251|PROMIS|promis
5628998|NCT00784238|Schizophrenia|schizophrenia
5628999|NCT00784238|Paliperidone Extended-release|paliperidone extended-release
5629000|NCT00784238|Paliperidone|paliperidone
5629001|NCT00784238|R076477|r076477
5629002|NCT00784225|cataract|cataract
5610601|NCT00855608|uveitis|uveitis
5629003|NCT00784225|advanced macular degeneration|advanced macular degeneration
5629004|NCT00784212|Photosensitive Epilepsy, photic stimulation, electroencephalogram|photosensitive epilepsy, photic stimulation, electroencephalogram
5629006|NCT00784199|Depression|depression
5629007|NCT00784186|Pregnancy termination|pregnancy termination
5629008|NCT00784186|abortion|abortion
5629009|NCT00784186|medical abortion|medical abortion
5629010|NCT00784186|2nd trimester|2nd trimester
5629011|NCT00784186|mifepristone|mifepristone
5629012|NCT00784186|misoprostol|misoprostol
5629013|NCT00784147|HIV|hiv
5629014|NCT00784147|CD4|cd4
5629015|NCT00784147|experienced|experienced
5629016|NCT00784147|resistant|resistant
5629018|NCT00784147|monoclonal|monoclonal
5629019|NCT00784147|antibody|antibody
5629020|NCT00784147|infusion|infusion
5629021|NCT00784147|ibalizumab|ibalizumab
5629022|NCT00784147|TNX355|tnx355
5629023|NCT00784147|TNX-355|tnx-355
5629024|NCT00784147|TMB355|tmb355
5629025|NCT00784147|TMB-355|tmb-355
5685471|NCT00555958|Vagus nerve|vagus nerve
5629026|NCT00784134|intraventricular hemorrhage thrombolysis|intraventricular hemorrhage thrombolysis
5629027|NCT00784095|quality of life|quality of life
5629028|NCT00784082|Sickle cell disease, hydroxyurea, inflammation|sickle cell disease, hydroxyurea, inflammation
5629029|NCT00784043|Cochlear implant|cochlear implant
5629030|NCT00784043|hearing loss|hearing loss
5629031|NCT00784030|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5629032|NCT00784030|Polycystic Kidney Disease|polycystic kidney disease
5629033|NCT00784030|Water Loading|water loading
5629034|NCT00784030|Biomarkers|biomarkers
5629035|NCT00784017|Children with previously untreated acute lymphoblastic leukemia|children with previously untreated acute lymphoblastic leukemia
5629036|NCT00784004|breathing patterns,|breathing patterns,
5629037|NCT00784004|unidirectional breathing,|unidirectional breathing,
5629038|NCT00784004|mask ventilation,|mask ventilation,
5629039|NCT00784004|respiratory physiology|respiratory physiology
5629040|NCT00783991|IVF|ivf
5629041|NCT00783991|PDA|pda
5629042|NCT00783991|PC|pc
5629043|NCT00783991|CAT|cat
5629044|NCT00783991|COPD|copd
5629045|NCT00783991|MDD|mdd
5629046|NCT00783991|RA|ra
5629047|NCT00783978|Surfactant protein C|surfactant protein c
5629048|NCT00783978|Interstitial|interstitial
5629049|NCT00783978|lung|lung
5629050|NCT00783978|Children|children
5629051|NCT00783965|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5629052|NCT00783965|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5629053|NCT00783952|Mixed venous oxygen saturation|mixed venous oxygen saturation
5629054|NCT00783952|Tissue oxygenation|tissue oxygenation
5629055|NCT00783952|Near infrared spectroscopy|near infrared spectroscopy
5629056|NCT00783913|Direct Current Stimulation|direct current stimulation
5629057|NCT00783913|Rehabilitation|rehabilitation
5629058|NCT00783913|Motor Learning|motor learning
5629059|NCT00783913|Stroke|stroke
5629060|NCT00783900|Prevention|prevention
5629061|NCT00783887|Cilia|cilia
5629062|NCT00783887|Axoneme|axoneme
5629063|NCT00783887|Dynein|dynein
5629064|NCT00783887|Gene|gene
5629065|NCT00783887|Ultrastructure|ultrastructure
5629066|NCT00783887|Linkage analysis|linkage analysis
5629067|NCT00783848|CHF|chf
5629068|NCT00783835|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5629069|NCT00783835|Methylphenidate|methylphenidate
5629070|NCT00783835|Concerta|concerta
5629071|NCT00783835|CONQoL|conqol
5629072|NCT00783822|breast neoplasms|breast neoplasms
5629073|NCT00783822|genetic counseling|genetic counseling
5629074|NCT00783809|intracranial pressure|intracranial pressure
5629075|NCT00783809|intracranial hypertension|intracranial hypertension
5629076|NCT00783809|ultrasound|ultrasound
5629077|NCT00783809|emergency|emergency
5629078|NCT00783809|traumatic brain injury|traumatic brain injury
5629079|NCT00783809|ocular ultrasound|ocular ultrasound
5629080|NCT00783796|Coronary artery disease|coronary artery disease
5629081|NCT00783796|Atherosclerosis|atherosclerosis
5629082|NCT00783796|Myocardial ischemia|myocardial ischemia
5629083|NCT00783783|Psychiatric disorders|psychiatric disorders
5629084|NCT00783783|Neurodevelopmental disorders|neurodevelopmental disorders
5629085|NCT00783783|Autism|autism
5629086|NCT00783783|Risperidone|risperidone
5629087|NCT00783783|Pharmacogenetics|pharmacogenetics
5629088|NCT00783783|Pharmacokinetics|pharmacokinetics
5629089|NCT00783770|Breastfeeding|breastfeeding
5629090|NCT00783770|Infant|infant
5629091|NCT00783770|Preterm|preterm
5629097|NCT00783731|intubation|intubation
5629098|NCT00783679|Cardiac output|cardiac output
5629099|NCT00783679|Noninvasive cardiac output measurement|noninvasive cardiac output measurement
5629100|NCT00783679|Thermodilution|thermodilution
5629106|NCT00783627|Endothelium|endothelium
5629107|NCT00783627|progenitors|progenitors
5629108|NCT00783627|stem cells|stem cells
5629109|NCT00783627|sickle cell|sickle cell
5629110|NCT00783614|HIV|hiv
5629111|NCT00783614|Cardiovascular Disease|cardiovascular disease
5629112|NCT00783614|Endothelial Dysfunction|endothelial dysfunction
5629113|NCT00783601|Chronic Asthma|chronic asthma
5629114|NCT00783588|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5629116|NCT00783588|Leukemia|leukemia
5629117|NCT00783588|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5629118|NCT00783588|Leukemia, B-Cell|leukemia, b-cell
5629119|NCT00783588|Immune System Diseases|immune system diseases
5629120|NCT00783588|ISF35|isf35
5629121|NCT00783588|Ad-ISF35|ad-isf35
5629122|NCT00783588|Immunotherapy|immunotherapy
5629123|NCT00783588|Immune therapy|immune therapy
5629124|NCT00783588|Active immune therapy|active immune therapy
5629125|NCT00783575|Crohn's disease|crohn's disease
5629126|NCT00783575|Ulcerative colitis|ulcerative colitis
5629127|NCT00783575|Inflammatory bowel disease|inflammatory bowel disease
5629128|NCT00783575|NOD2,CARD 15 mutations|nod2,card 15 mutations
5629129|NCT00783562|Low back pain|low back pain
5629130|NCT00783562|Neck pain|neck pain
5629131|NCT00783562|Functional disability|functional disability
5629132|NCT00783562|Nursery school teachers|nursery school teachers
5629133|NCT00783562|Exercise program|exercise program
5629134|NCT00783562|Prevention|prevention
5629135|NCT00783549|tolerability|tolerability
5629136|NCT00783549|pharmacodynamics|pharmacodynamics
5629137|NCT00783549|pharmacokinetics|pharmacokinetics
5629138|NCT00783549|safety|safety
5629139|NCT00783536|An randomized, open label, multicenter study to compare the ef|an randomized, open label, multicenter study to compare the ef
5629140|NCT00783510|JIA|jia
5629141|NCT00783510|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5629142|NCT00783510|Juvenile Arthritis|juvenile arthritis
5629143|NCT00783510|Polyarticular JIA|polyarticular jia
5629144|NCT00783510|Polyarticular-course JIA|polyarticular-course jia
5629145|NCT00783497|High Blood Pressure|high blood pressure
5629146|NCT00783497|Stress|stress
5629147|NCT00783484|First in Human (FIH), PF-03716539, PK enhancer|first in human (fih), pf-03716539, pk enhancer
5629148|NCT00783445|Metabolic Cardiovascular Syndrome|metabolic cardiovascular syndrome
5629149|NCT00783445|Metabolic Syndrome|metabolic syndrome
5629150|NCT00783445|Obesity|obesity
5629151|NCT00783445|Hyperglycemia|hyperglycemia
5629152|NCT00783419|tubo-ovarian abscess, pelvic-inflammatory disease|tubo-ovarian abscess, pelvic-inflammatory disease
5629153|NCT00783406|COPD|copd
5629154|NCT00783380|Influenza vaccination|influenza vaccination
5629155|NCT00783380|Subunit|subunit
5629156|NCT00783380|Virosomal|virosomal
5629157|NCT00783380|HIV/AIDS|hiv/aids
5629158|NCT00783380|Renal Dialysis|renal dialysis
5629159|NCT00783380|Kidney transplantation|kidney transplantation
5629160|NCT00783380|Rheumatologic diseases|rheumatologic diseases
5629161|NCT00783380|Immunogenicity|immunogenicity
5629162|NCT00783380|Reactogenicity|reactogenicity
5629163|NCT00783367|Revlimid|revlimid
5629164|NCT00783367|Celgene brand of lenalidomide|celgene brand of lenalidomide
5629165|NCT00783367|lenalidomide|lenalidomide
5629166|NCT00783367|Rituxan|rituxan
5629167|NCT00783367|CD20 antibody, rituximab|cd20 antibody, rituximab
5629168|NCT00783367|rituximab|rituximab
5629169|NCT00783367|Follicular Lymphoma|follicular lymphoma
5629170|NCT00783367|Marginal Zone B-Cell Lymphoma|marginal zone b-cell lymphoma
5629171|NCT00783367|Lymphoma, Small Lymphocytic|lymphoma, small lymphocytic
5629172|NCT00783367|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5629173|NCT00783367|Mantle-Cell Lymphoma|mantle-cell lymphoma
5629174|NCT00783367|Antigens, CD20|antigens, cd20
5629175|NCT00783367|refractory|refractory
5629176|NCT00783367|resistantRefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen|resistantrefractory/progressive lymphoma less than 6 months from first rituximab dose of previous rituximab-containing regimen
5629177|NCT00783367|Previously treated|previously treated
5629178|NCT00783367|Treated with rituximab|treated with rituximab
5629179|NCT00783328|solid tumor|solid tumor
5629180|NCT00783315|Hypertension|hypertension
5629181|NCT00783315|Diabetes|diabetes
5629182|NCT00783315|Hypercholesterolemia|hypercholesterolemia
5629184|NCT00783302|Visipaque|visipaque
5629185|NCT00783302|CCTA|ccta
5629186|NCT00783289|Asthma|asthma
5629187|NCT00783289|Benralizumab|benralizumab
5629188|NCT00783289|MEDI-563|medi-563
5629189|NCT00783250|COPD|copd
5629190|NCT00783250|Respiratory Mechanics|respiratory mechanics
5629191|NCT00783250|Bronchodilators|bronchodilators
5629192|NCT00783250|COPD patients with poor reversibility|copd patients with poor reversibility
5629193|NCT00783185|psychotic disorders|psychotic disorders
5629194|NCT00783185|cannabis|cannabis
5629195|NCT00783185|intervention|intervention
5629196|NCT00783172|pancreas|pancreas
5629197|NCT00783172|pancreatic cancer|pancreatic cancer
5629198|NCT00783172|cancer|cancer
5629199|NCT00783172|Opioid Growth Factor|opioid growth factor
5629200|NCT00783172|OGF|ogf
5629201|NCT00783172|gemcitabine|gemcitabine
5629202|NCT00783172|chemotherapy|chemotherapy
5629203|NCT00783159|Muscle power|muscle power
5629204|NCT00783159|Frailty|frailty
5629205|NCT00783159|Exercise|exercise
5629206|NCT00783159|Vitamin D|vitamin d
5629207|NCT00783120|schizophrenia, negative symptoms, TMS, magnetic stimulation|schizophrenia, negative symptoms, tms, magnetic stimulation
5629208|NCT00783107|Gold Stage III COPD|gold stage iii copd
5629209|NCT00783081|Intermittent Claudication|intermittent claudication
5631714|NCT00772330|GDD|gdd
5629210|NCT00783081|Peripheral Arterial Disease|peripheral arterial disease
5629212|NCT00783068|GTS-21|gts-21
5629213|NCT00783068|Vagal activity|vagal activity
5629214|NCT00783068|Autonomic balance|autonomic balance
5629215|NCT00783055|Autonomy|autonomy
5629216|NCT00783055|Older people|older people
5629217|NCT00783055|Physically frail|physically frail
5629218|NCT00783055|Nursing home|nursing home
5629219|NCT00783055|Intervention study|intervention study
5629220|NCT00783042|TTDE-CFR|ttde-cfr
5629221|NCT00783042|coronary artery function|coronary artery function
5629222|NCT00783042|cardiovascular biomarkers|cardiovascular biomarkers
5629223|NCT00783042|rosuvastatin|rosuvastatin
5629225|NCT00783029|Vasodilation|vasodilation
5629226|NCT00783029|Vessel Reactivity|vessel reactivity
5629227|NCT00783029|Dynamic Vessel Analyzer|dynamic vessel analyzer
5629228|NCT00783029|Retina|retina
5629229|NCT00783016|appendicitis|appendicitis
5629230|NCT00783016|diagnosis|diagnosis
5629231|NCT00783003|Tolerability|tolerability
5629232|NCT00783003|Muscarinic Receptor Antagonist, Anticholinergic|muscarinic receptor antagonist, anticholinergic
5629233|NCT00783003|Safety|safety
5629234|NCT00783003|Anticholinergic|anticholinergic
5629235|NCT00783003|ß2 agonist|ß2 agonist
5629236|NCT00783003|Pharmacokinetics|pharmacokinetics
5629237|NCT00782990|stress urinary incontinence|stress urinary incontinence
5629238|NCT00782990|female incontinence|female incontinence
5629239|NCT00782990|surgical treatment|surgical treatment
5629240|NCT00782990|Female stress urinary incontinence|female stress urinary incontinence
5629241|NCT00782977|Apneic oxygenation|apneic oxygenation
5629242|NCT00782977|Apneic diffusion oxygenation|apneic diffusion oxygenation
5629243|NCT00782964|Depression|depression
5629244|NCT00782964|Major Depressive Disorder|major depressive disorder
5629245|NCT00782964|SSRI resistant depression|ssri resistant depression
5629246|NCT00782964|strategies in depression|strategies in depression
5629247|NCT00782925|Low back pain|low back pain
5629248|NCT00782925|recurrence|recurrence
5629249|NCT00782925|chronic low back pain|chronic low back pain
5629250|NCT00782925|educational program|educational program
5629251|NCT00782925|physical therapy|physical therapy
5629252|NCT00782925|home exercise|home exercise
5629253|NCT00782925|compliance|compliance
5629254|NCT00782912|postpartum anemia, postpartum depression|postpartum anemia, postpartum depression
5629255|NCT00782899|Schizophrenia|schizophrenia
5629256|NCT00782899|subjective well-being|subjective well-being
5629257|NCT00782899|depressive symptoms|depressive symptoms
5629258|NCT00782899|schizophrenia course|schizophrenia course
5629259|NCT00782886|Pathfinder|pathfinder
5629260|NCT00782886|Liver|liver
5629261|NCT00782886|Resection|resection
5629262|NCT00782886|Surgery|surgery
5629263|NCT00782886|To evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.|to evaluate the effectiveness of image-guided liver surgery by measuring variables before, during and following surgery.
5629264|NCT00782886|Completeness of resection and the accuracy of the resection, as determined by preoperative predicted RLV|completeness of resection and the accuracy of the resection, as determined by preoperative predicted rlv
5629265|NCT00782873|propofol|propofol
5629266|NCT00782873|sedation|sedation
5629267|NCT00782873|safety|safety
5629269|NCT00782860|Early pregnancy failure|early pregnancy failure
5629270|NCT00782860|Misoprostol|misoprostol
5629271|NCT00782860|Gestational sac volume|gestational sac volume
5629272|NCT00782847|diabetes mellitus|diabetes mellitus
5629273|NCT00782847|diabetic nephropathy|diabetic nephropathy
5629274|NCT00782847|hypertension|hypertension
5629275|NCT00782834|GIST|gist
5629276|NCT00782834|Nilotinib|nilotinib
5629277|NCT00782821|Kidney|kidney
5629278|NCT00782821|Renal|renal
5629279|NCT00782821|Rejection|rejection
5629280|NCT00782821|High risk|high risk
5629281|NCT00782821|Induction|induction
5629282|NCT00782821|Immunology|immunology
5629283|NCT00782821|Transplantation|transplantation
5629284|NCT00782821|B Cell|b cell
5629285|NCT00782821|Allograft|allograft
5629369|NCT00782392|Nutrition|nutrition
5629286|NCT00782821|Desensitization|desensitization
5629287|NCT00782808|HIV DNA in Monocytes|hiv dna in monocytes
5629288|NCT00782795|Chronic pancreatitis|chronic pancreatitis
5629289|NCT00782795|Insulin resistance|insulin resistance
5629290|NCT00782756|Radiation|radiation
5629291|NCT00782756|BEVACIZUMAB|bevacizumab
5629292|NCT00782756|AVASTIN|avastin
5629293|NCT00782756|TEMOZOLOMIDE|temozolomide
5629294|NCT00782756|newly diagnosed|newly diagnosed
5629295|NCT00782756|Glioblastoma|glioblastoma
5629296|NCT00782756|GBM|gbm
5629297|NCT00782756|malignant glioma|malignant glioma
5629298|NCT00782756|Radiotherapy|radiotherapy
5629299|NCT00782756|08-126|08-126
5629300|NCT00782743|phenprocoumon|phenprocoumon
5629301|NCT00782743|anticoagulation|anticoagulation
5629302|NCT00782743|acetylic salicylic acid|acetylic salicylic acid
5629303|NCT00782743|Need for new anticoagulation treatment|need for new anticoagulation treatment
5629304|NCT00782730|bladder volume measurement|bladder volume measurement
5629305|NCT00782730|pregnancy|pregnancy
5629306|NCT00782730|bladder function|bladder function
5629307|NCT00782730|Postvoid residual volume assessment|postvoid residual volume assessment
5629308|NCT00782730|Bladder volumes|bladder volumes
5629309|NCT00782717|diabetic retinopathy|diabetic retinopathy
5629310|NCT00782717|cystoid macular edema;|cystoid macular edema;
5629311|NCT00782704|A self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.|a self-administered questionnaire to collect data from patients, physicians and nurses about the severity of postoperative surgical complications.
5629312|NCT00782704|Based on this questionnaire we will develop the morbidity index|based on this questionnaire we will develop the morbidity index
5629313|NCT00782691|FDG-PET segmentation tools|fdg-pet segmentation tools
5629314|NCT00782691|Head-and-neck cancer|head-and-neck cancer
5629315|NCT00782691|Histological validation|histological validation
5629316|NCT00782665|postoperative|postoperative
5629317|NCT00782665|infection|infection
5629318|NCT00782665|c-section|c-section
5629319|NCT00782652|myocaridal infarction|myocaridal infarction
5629320|NCT00782652|right ventricular infarction|right ventricular infarction
5629321|NCT00782652|cardiogenic shock|cardiogenic shock
5629322|NCT00782652|RVAD|rvad
5629323|NCT00782652|Right ventricular assist device|right ventricular assist device
5629324|NCT00782652|cardiac disease|cardiac disease
5629325|NCT00782652|right ventricle|right ventricle
5629326|NCT00782652|cardiac shock|cardiac shock
5629327|NCT00782652|heart dysfunction|heart dysfunction
5629328|NCT00782626|RAD001|rad001
5629329|NCT00782613|Psoriasis|psoriasis
5629330|NCT00782613|The primary objective of this study will be to evaluate the|the primary objective of this study will be to evaluate the
5629331|NCT00782613|efficacy of topical ALT-2074 applied twice daily for 28|efficacy of topical alt-2074 applied twice daily for 28
5629332|NCT00782613|days for treatment of chronic plaque psoriasis in adult|days for treatment of chronic plaque psoriasis in adult
5629333|NCT00782613|subjects.|subjects.
5629334|NCT00782613|The secondary objective will be to evaluate the safety|the secondary objective will be to evaluate the safety
5629335|NCT00782613|of topical ALT-2074 applied twice daily for 28 days for|of topical alt-2074 applied twice daily for 28 days for
5629336|NCT00782613|treatment of chronic plaque psoriasis in adult subjects.|treatment of chronic plaque psoriasis in adult subjects.
5629337|NCT00782613|Tertiary objectives will be to provide visual documentation|tertiary objectives will be to provide visual documentation
5629338|NCT00782613|of the improvement of psoriatic plaques treated with|of the improvement of psoriatic plaques treated with
5629339|NCT00782613|ALT-2074 using digital photography, and to determine the|alt-2074 using digital photography, and to determine the
5629340|NCT00782613|extent of systemic absorption of topically applied ALT-2074|extent of systemic absorption of topically applied alt-2074
5629341|NCT00782613|based on a pharmacokinetic measurement of blood|based on a pharmacokinetic measurement of blood
5629342|NCT00782613|concentration.|concentration.
5629343|NCT00782600|Pharmacokinetics Immediate Release Oral Suspension Controlled Release Formulation|pharmacokinetics immediate release oral suspension controlled release formulation
5629344|NCT00782587|Non-Muscle-Invasive Bladder Cancer|non-muscle-invasive bladder cancer
5629345|NCT00782587|Superficial Bladder Cancer|superficial bladder cancer
5629346|NCT00782587|recombinant human hyaluronidase|recombinant human hyaluronidase
5629347|NCT00782587|rHuPH20|rhuph20
5629348|NCT00782587|Chemophase®|chemophase®
5629349|NCT00782587|Mitomycin|mitomycin
5629350|NCT00782574|Advanced solid tumours|advanced solid tumours
5629351|NCT00782574|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5629352|NCT00782574|homologous deficiency|homologous deficiency
5629354|NCT00782561|steroid resistant focal segmental glomerulosclerosis|steroid resistant focal segmental glomerulosclerosis
5629355|NCT00782561|FSGS|fsgs
5629356|NCT00782561|adolescent focal segmental glomerulosclerosis|adolescent focal segmental glomerulosclerosis
5629357|NCT00782561|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5629358|NCT00782548|KADIAN|kadian
5629359|NCT00782548|morphine|morphine
5629360|NCT00782548|Avinza|avinza
5629361|NCT00782548|30 mg|30 mg
5629362|NCT00782548|bioequivalence|bioequivalence
5629364|NCT00782483|Diagnosis|diagnosis
5629365|NCT00782483|Port Wine Stain|port wine stain
5629366|NCT00782483|PWS|pws
5629367|NCT00782405|antidepressant action|antidepressant action
5629368|NCT00782405|clinical psychopharmacology|clinical psychopharmacology
5629370|NCT00782392|Infant Formula|infant formula
5629371|NCT00782379|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5629372|NCT00782379|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5629373|NCT00782379|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5629374|NCT00782379|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5629375|NCT00782379|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5629376|NCT00782379|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5629377|NCT00782379|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5629378|NCT00782379|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5629379|NCT00782379|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5629380|NCT00782379|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5629381|NCT00782379|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5798772|NCT00111137|Chemotherapy|chemotherapy
5629382|NCT00782379|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5629383|NCT00782379|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5629384|NCT00782379|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5629385|NCT00782379|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5629386|NCT00782379|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5629387|NCT00782379|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5629388|NCT00782379|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5629389|NCT00782379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5629390|NCT00782379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5671706|NCT00614718|lead failure|lead failure
5629391|NCT00782379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5629392|NCT00782379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5629393|NCT00782379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5629394|NCT00782379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5629395|NCT00782379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5629396|NCT00782379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5629397|NCT00782379|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5629398|NCT00782379|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5629399|NCT00782379|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5629400|NCT00782379|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5629401|NCT00782379|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5629402|NCT00782379|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5629403|NCT00782379|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5629404|NCT00782379|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5629405|NCT00782379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5629406|NCT00782379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5629407|NCT00782379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5629408|NCT00782379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5629409|NCT00782379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5629410|NCT00782379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5629411|NCT00782379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5629412|NCT00782379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5629413|NCT00782379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5629414|NCT00782379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5629415|NCT00782379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5629416|NCT00782379|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5629417|NCT00782379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5629418|NCT00782379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5629419|NCT00782379|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5629420|NCT00782379|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5629421|NCT00782379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5629422|NCT00782379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5629423|NCT00782379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5629424|NCT00782379|prolymphocytic leukemia|prolymphocytic leukemia
5629426|NCT00782366|personalized medicine|personalized medicine
5629427|NCT00782366|personal genomics|personal genomics
5629428|NCT00782366|direct-to-consumer genetic testing|direct-to-consumer genetic testing
5629429|NCT00782366|genetic knowledge|genetic knowledge
5629430|NCT00782366|genetic attitudes|genetic attitudes
5629432|NCT00782340|NOH|noh
5629433|NCT00782340|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5629434|NCT00782340|Orthostatic hypotension|orthostatic hypotension
5629435|NCT00782340|PAF|paf
5629436|NCT00782340|Pure Autonomic Failure|pure autonomic failure
5629437|NCT00782340|MSA|msa
5629438|NCT00782340|Multiple System Atrophy|multiple system atrophy
5629439|NCT00782340|Neuropathy|neuropathy
5629440|NCT00782340|Autonomic Failure|autonomic failure
5629441|NCT00782340|Parkinson|parkinson
5629442|NCT00782340|Dopamine Deficiency|dopamine deficiency
5629443|NCT00782340|Dopamine|dopamine
5629444|NCT00782340|Droxidopa|droxidopa
5629445|NCT00782314|asthma|asthma
5629446|NCT00782314|SMART|smart
5629447|NCT00782314|Symbicort Turbuhaler|symbicort turbuhaler
5629448|NCT00782314|asthma control|asthma control
5629449|NCT00782301|HIV and Hepatitis co-infection|hiv and hepatitis co-infection
5629450|NCT00782288|digitoxin|digitoxin
5629451|NCT00782288|inflammatory markers|inflammatory markers
5629452|NCT00782288|cytokines|cytokines
5629453|NCT00782288|gene expression|gene expression
5629454|NCT00782275|RCC|rcc
5629455|NCT00782275|avastin|avastin
5629456|NCT00782275|temsirolimus|temsirolimus
5629457|NCT00782223|hips, spine, lower limb, digital radiograph measurements, TraumaCad, digital software|hips, spine, lower limb, digital radiograph measurements, traumacad, digital software
5629458|NCT00782223|Measurements of orthopaedic parameters on digital X-rays using particular software|measurements of orthopaedic parameters on digital x-rays using particular software
5629459|NCT00782197|osteoarthritis|osteoarthritis
5629460|NCT00782197|knee|knee
5629461|NCT00782197|PRGF|prgf
5629462|NCT00782197|autologous plasma|autologous plasma
5629463|NCT00782197|plasma preparations|plasma preparations
5629464|NCT00782197|treatment|treatment
5629465|NCT00782171|Dental implants|dental implants
5629466|NCT00782158|HIV|hiv
5629468|NCT00782158|Coinfection|coinfection
5629469|NCT00782158|Liver Fibrosis|liver fibrosis
5629470|NCT00782158|Transient Elastography|transient elastography
5629471|NCT00782145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5629472|NCT00782145|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5629473|NCT00782145|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5629474|NCT00782145|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5629475|NCT00782145|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5629476|NCT00782145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5629477|NCT00782145|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5629478|NCT00782145|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5629479|NCT00782145|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5629480|NCT00782145|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5629481|NCT00782145|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5629482|NCT00782145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5629483|NCT00782145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5629484|NCT00782145|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5629485|NCT00782145|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5629486|NCT00782145|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5629487|NCT00782145|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5629488|NCT00782145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5629489|NCT00782145|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5629490|NCT00782145|primary myelofibrosis|primary myelofibrosis
5629491|NCT00782145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5629492|NCT00782145|disseminated neuroblastoma|disseminated neuroblastoma
5629493|NCT00782145|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5629494|NCT00782145|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5680372|NCT00577993|Indolent Lymphoma|indolent lymphoma
5629495|NCT00782145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5629496|NCT00782145|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5629497|NCT00782145|recurrent neuroblastoma|recurrent neuroblastoma
5629498|NCT00782145|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5629499|NCT00782145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5629500|NCT00782132|Infertility Services, HIV, pregnancy planning|infertility services, hiv, pregnancy planning
5629501|NCT00782093|AMD|amd
5629502|NCT00782080|ADHD|adhd
5629503|NCT00782080|children|children
5629504|NCT00782080|adolescents|adolescents
5629505|NCT00782080|St. John`s Wort|st. john`s wort
5629506|NCT00782080|Valerian extract|valerian extract
5629507|NCT00782080|Safety|safety
5629508|NCT00782080|Efficacy|efficacy
5629509|NCT00782067|Aggressive systemic mastocytosis|aggressive systemic mastocytosis
5629511|NCT00782067|C-Findings|c-findings
5629512|NCT00782067|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5629513|NCT00782067|KIT mutation|kit mutation
5629514|NCT00782067|AHNMD|ahnmd
5629515|NCT00782067|Systemic|systemic
5629516|NCT00782067|Aggressive|aggressive
5629517|NCT00782054|pruritus|pruritus
5629518|NCT00782054|itch|itch
5629519|NCT00782054|burn|burn
5629520|NCT00782054|endopeptidase|endopeptidase
5629521|NCT00782054|moisturizer|moisturizer
5629522|NCT00782054|randomized controlled|randomized controlled
5629523|NCT00782028|primary care, high-risk families, maternal depression|primary care, high-risk families, maternal depression
5629524|NCT00782015|almonds|almonds
5629525|NCT00782015|heart disease|heart disease
5629526|NCT00782015|vascular reactivity|vascular reactivity
5629527|NCT00782015|inflammation|inflammation
5629528|NCT00782015|dyslipidemia|dyslipidemia
5629529|NCT00782015|oxidative stress|oxidative stress
5629530|NCT00782002|Solid Tumors|solid tumors
5629531|NCT00782002|VEGF-A|vegf-a
5629532|NCT00782002|stromal cells|stromal cells
5629533|NCT00782002|endothelial cells|endothelial cells
5629534|NCT00782002|malignant cells|malignant cells
5629535|NCT00781989|early rheumatoid arthritis|early rheumatoid arthritis
5629536|NCT00781989|biomarkers|biomarkers
5629537|NCT00781989|ultrasound|ultrasound
5629538|NCT00781963|cognitive behavior therapy|cognitive behavior therapy
5629539|NCT00781963|insomnia|insomnia
5629540|NCT00781950|PAD|pad
5629541|NCT00781950|Peripheral Arterial Disease|peripheral arterial disease
5629542|NCT00781950|Diabetes|diabetes
5629543|NCT00781950|Atherosclerosis|atherosclerosis
5629544|NCT00781950|Flax|flax
5629545|NCT00781950|Flaxseeds|flaxseeds
5629546|NCT00781950|Functional Foods|functional foods
5629547|NCT00781950|Essential Fatty Acids|essential fatty acids
5629548|NCT00781950|Winnipeg|winnipeg
5629549|NCT00781911|Islet Cell|islet cell
5629550|NCT00781911|CARCINOMA, ISLET CELL|carcinoma, islet cell
5629551|NCT00781911|Octreotide|octreotide
5629552|NCT00781911|depot octreotide acetate|depot octreotide acetate
5629553|NCT00781911|Insulin-Like Growth Factor (IGF) 1|insulin-like growth factor (igf) 1
5629554|NCT00781911|Metastatic, Carcinoid or Islet Cell|metastatic, carcinoid or islet cell
5629555|NCT00781911|Neuroendocrine Tumors|neuroendocrine tumors
5629556|NCT00781898|Depot naltrexone|depot naltrexone
5629557|NCT00781898|Parolees|parolees
5629558|NCT00781898|Opioid addiction prevention|opioid addiction prevention
5629559|NCT00781898|Medication Treatment Alternatives|medication treatment alternatives
5629560|NCT00781898|Prevention of Relapse to Opioid Addiction|prevention of relapse to opioid addiction
5629561|NCT00781872|multiple sclerosis (MS)|multiple sclerosis (ms)
5629562|NCT00781872|bone marrow stromal cells|bone marrow stromal cells
5629563|NCT00781872|stem cells|stem cells
5629564|NCT00781833|Therapeutic Electric Stimulation|therapeutic electric stimulation
5629565|NCT00781833|Functional Electric Stimulation|functional electric stimulation
5629566|NCT00781833|Implantable Stimulator|implantable stimulator
5629567|NCT00781833|Muscle Strength|muscle strength
5629568|NCT00781833|Muscle Spasticity|muscle spasticity
5629569|NCT00781820|Bifonazole|bifonazole
5629570|NCT00781820|Placebo|placebo
5629571|NCT00781820|Urea|urea
5629572|NCT00781820|Nail fungus|nail fungus
5629573|NCT00781807|Heart-Assist-Devices|heart-assist-devices
5629574|NCT00781807|Rehabilitation|rehabilitation
5629575|NCT00781807|Outcome Assessment (Health Care)|outcome assessment (health care)
5629576|NCT00781807|Exercise Capacity|exercise capacity
5629577|NCT00781807|Ergometry|ergometry
5629578|NCT00781807|Social Support|social support
5629579|NCT00781807|Quality of Life|quality of life
5629580|NCT00781807|Nutrition Assessment|nutrition assessment
5629581|NCT00781807|Nutrition Therapy|nutrition therapy
5629582|NCT00781807|Neuropsychological Tests|neuropsychological tests
5629583|NCT00781781|Myeloid and Lymphoid malignances|myeloid and lymphoid malignances
5629584|NCT00781768|Bone Marrow Transplant|bone marrow transplant
5629585|NCT00781768|Nausea|nausea
5629586|NCT00781768|Vomiting|vomiting
5629587|NCT00781768|NK-1 antagonist|nk-1 antagonist
5629588|NCT00781755|smoking cessation|smoking cessation
5629589|NCT00781755|varenicline|varenicline
5629590|NCT00781755|schizophrenia|schizophrenia
5629591|NCT00781755|serious mental illness|serious mental illness
5629592|NCT00781755|Nicotine addiction|nicotine addiction
5629593|NCT00781755|Smoking Behavior|smoking behavior
5629594|NCT00781742|Depression|depression
5629595|NCT00781742|Depressive Disorder|depressive disorder
5629596|NCT00781742|MDD|mdd
5629597|NCT00781729|Kyphosis|kyphosis
5629598|NCT00781729|Yoga|yoga
5629599|NCT00781729|Aging|aging
5629600|NCT00781729|Physical performance|physical performance
5629601|NCT00781729|Quality of Life|quality of life
5629602|NCT00781716|ST elevation myocardial infarction|st elevation myocardial infarction
5629603|NCT00781716|Drug eluting stents|drug eluting stents
5629604|NCT00781690|Chronic kidney failure|chronic kidney failure
5629605|NCT00781690|Heparin|heparin
5629606|NCT00781690|Hemodialysis|hemodialysis
5629607|NCT00781690|Biocompatibility|biocompatibility
5629731|NCT00781079|Opinion Leaders|opinion leaders
5629609|NCT00781677|Depression|depression
5629610|NCT00781677|Anxiety|anxiety
5629611|NCT00781638|Pediatric UC, Adacolumn apheresis|pediatric uc, adacolumn apheresis
5629612|NCT00781625|probiotics|probiotics
5629613|NCT00781625|QoL|qol
5629614|NCT00781625|inflammation|inflammation
5629615|NCT00781625|nutritional factors|nutritional factors
5629616|NCT00781625|prophylactic aid|prophylactic aid
5629617|NCT00781625|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
5629618|NCT00781625|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
5629619|NCT00781625|Recurrent lower UTI in women|recurrent lower uti in women
5611292|NCT00852800|albumin|albumin
5629620|NCT00781599|African american|african american
5629621|NCT00781599|smokers|smokers
5629622|NCT00781599|smoking cessation|smoking cessation
5629623|NCT00781599|African American smokers|african american smokers
5629624|NCT00781586|Energy expenditure|energy expenditure
5629625|NCT00781586|Nutritional|nutritional
5629626|NCT00781586|Weight control|weight control
5629627|NCT00781573|Drug Eluting Stent|drug eluting stent
5629628|NCT00781573|Clopidogrel|clopidogrel
5629629|NCT00781573|Optimal duration of clopidogrel post DES stent implantation|optimal duration of clopidogrel post des stent implantation
5629630|NCT00781560|Hyperlipidemia|hyperlipidemia
5629631|NCT00781560|Chinese National Adult Lipid Treatment Guideline (2007)|chinese national adult lipid treatment guideline (2007)
5629632|NCT00781560|Crestor®|crestor®
5629633|NCT00781547|growth hormone|growth hormone
5629634|NCT00781547|obesity|obesity
5629635|NCT00781547|abdominal obesity|abdominal obesity
5629636|NCT00781534|Health Supplements|health supplements
5629637|NCT00781534|Ginseng|ginseng
5629638|NCT00781534|Diabetes|diabetes
5629639|NCT00781508|heart failure, left sided|heart failure, left sided
5629640|NCT00781508|ventricular dysfunction|ventricular dysfunction
5629641|NCT00781508|diastolic dysfunction|diastolic dysfunction
5629642|NCT00781508|sildenafil|sildenafil
5629643|NCT00781495|insulin|insulin
5629644|NCT00781482|Positron Emission Tomography|positron emission tomography
5629645|NCT00781482|GABA receptor binding|gaba receptor binding
5629646|NCT00781482|Hypnotic Drugs|hypnotic drugs
5629648|NCT00781482|Zolpidem|zolpidem
5629649|NCT00781482|[11-C] Flumazenil|[11-c] flumazenil
5629650|NCT00781482|Molecular imaging of the brain|molecular imaging of the brain
5629651|NCT00781469|Rheumatoid arthritis|rheumatoid arthritis
5629652|NCT00781469|RNA|rna
5629653|NCT00781469|Synovium|synovium
5629654|NCT00781469|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
5629655|NCT00781456|Migraine headache|migraine headache
5629656|NCT00781456|menstrual|menstrual
5629657|NCT00781456|oral contraceptive|oral contraceptive
5629658|NCT00781456|Menstrually-Related Migraine Headache|menstrually-related migraine headache
5629659|NCT00781443|Asthma|asthma
5629660|NCT00781417|vitamin D|vitamin d
5629661|NCT00781417|Chronic Kidney Disease|chronic kidney disease
5629662|NCT00781417|parathyroid hormone|parathyroid hormone
5629663|NCT00781417|Chronic kidney disease Stage II and III|chronic kidney disease stage ii and iii
5629664|NCT00781404|adenosine|adenosine
5629665|NCT00781404|angioplasty|angioplasty
5629666|NCT00781404|acute myocardial infarction|acute myocardial infarction
5629667|NCT00781404|acute coronary syndrome with ST segment elevation|acute coronary syndrome with st segment elevation
5629668|NCT00781404|infarct size|infarct size
5629669|NCT00781404|rescued myocardium|rescued myocardium
5629670|NCT00781391|Systemic embolic events|systemic embolic events
5629671|NCT00781378|Thrombolytic therapy|thrombolytic therapy
5629672|NCT00781378|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5629673|NCT00781378|Efficacy|efficacy
5629674|NCT00781378|Safety|safety
5629675|NCT00781365|Hypertension|hypertension
5629676|NCT00781365|Telemonitoring|telemonitoring
5629677|NCT00781365|Pharmacy management|pharmacy management
5629678|NCT00781352|nitrous oxide|nitrous oxide
5629679|NCT00781352|cancer recurrence|cancer recurrence
5629680|NCT00781352|colorectal surgery|colorectal surgery
5629681|NCT00781339|Bacteriuria|bacteriuria
5629682|NCT00781339|Catheterized|catheterized
5629683|NCT00781339|Chronically Catheterized|chronically catheterized
5629684|NCT00781326|Depressive Disorder, Major|depressive disorder, major
5680373|NCT00577993|Fludarabine|fludarabine
5629685|NCT00781326|Cerebrovascular Disorders|cerebrovascular disorders
5629686|NCT00781326|Risk Factors|risk factors
5629687|NCT00781326|Nimodipine|nimodipine
5629688|NCT00781300|Intraocular pressure|intraocular pressure
5629689|NCT00781300|Pterygium|pterygium
5629690|NCT00781300|Surgery|surgery
5629691|NCT00781300|Steroids|steroids
5629692|NCT00781300|Glaucoma|glaucoma
5629693|NCT00781287|human immunodeficiency virus|human immunodeficiency virus
5629694|NCT00781287|raltegravir|raltegravir
5629695|NCT00781287|primary HIV infection|primary hiv infection
5629696|NCT00781287|HIV-1|hiv-1
5629697|NCT00781261|hip|hip
5629698|NCT00781261|collapse femoral head|collapse femoral head
5629699|NCT00781261|bisphosphonates|bisphosphonates
5629700|NCT00781261|osteonecrosis|osteonecrosis
5629701|NCT00781248|enteral feeding|enteral feeding
5623387|NCT00806377|Non-thoracic surgery|non-thoracic surgery
5629702|NCT00781248|Subject who requires nasogastric tube|subject who requires nasogastric tube
5629703|NCT00781209|irradiation|irradiation
5629704|NCT00781209|stereotactic radiosurgery|stereotactic radiosurgery
5629705|NCT00781209|posterior fossa|posterior fossa
5629706|NCT00781209|cerebellar metastases|cerebellar metastases
5629707|NCT00781196|phenytoin|phenytoin
5629708|NCT00781196|gum hyperplasia|gum hyperplasia
5629709|NCT00781196|phenytoin induced gingival overgrowth|phenytoin induced gingival overgrowth
5629710|NCT00781196|plaque index|plaque index
5629711|NCT00781196|gingival overgrowth grade|gingival overgrowth grade
5629713|NCT00781183|rehabilitation|rehabilitation
5629714|NCT00781183|walking|walking
5629715|NCT00781170|Multiple Myeloma|multiple myeloma
5629716|NCT00781170|Plasmocytoma|plasmocytoma
5629717|NCT00781170|Stem Cell Transplantation|stem cell transplantation
5629718|NCT00781157|Spinal induced hypotension in cesarean delivery|spinal induced hypotension in cesarean delivery
5629719|NCT00781118|Acute Myocardial Infarction (MI)|acute myocardial infarction (mi)
5629720|NCT00781118|ST Shift|st shift
5629721|NCT00781118|Coronary Occlusion|coronary occlusion
5629722|NCT00781118|Acute Coronary Syndrome|acute coronary syndrome
5629723|NCT00781105|Chronic hepatitis B|chronic hepatitis b
5629724|NCT00781105|Adult|adult
5629725|NCT00781105|HBV DNA suppression|hbv dna suppression
5629726|NCT00781105|Telbivudine|telbivudine
5629727|NCT00781092|Dry Eyes|dry eyes
5629728|NCT00781092|LASIK|lasik
5629729|NCT00781092|Laser Vision Correction|laser vision correction
5629730|NCT00781079|Organization Innovation|organization innovation
5629732|NCT00781079|Schizophrenia|schizophrenia
5798773|NCT00111124|psoriasis|psoriasis
5629733|NCT00781066|POSTPARTUM HEMORRHAGE|postpartum hemorrhage
5629734|NCT00781066|PREVENTION|prevention
5629735|NCT00781066|CORD TRACTION|cord traction
5629736|NCT00781066|THIRD STAGE LABOR|third stage labor
5629737|NCT00781053|skin fibrosis|skin fibrosis
5629738|NCT00781053|systemic scleroderma|systemic scleroderma
5629739|NCT00781053|systemic sclerosis|systemic sclerosis
5629740|NCT00781053|p144|p144
5629741|NCT00781053|orphan drug|orphan drug
5629742|NCT00781040|Severe sepsis in neutropenic haematological patients|severe sepsis in neutropenic haematological patients
5629743|NCT00781001|neuropathic pain|neuropathic pain
5629744|NCT00781001|diabetic neuropathy|diabetic neuropathy
5629745|NCT00781001|cannabis|cannabis
5629746|NCT00781001|marijuana|marijuana
5629747|NCT00780975|Aplidin|aplidin
5629748|NCT00780975|Plitidepsin|plitidepsin
5629749|NCT00780975|Prostate|prostate
5629750|NCT00780975|Cancer|cancer
5629751|NCT00780962|NAC|nac
5629752|NCT00780962|Radiocontrast Nephropathy|radiocontrast nephropathy
5629753|NCT00780962|N-Acetylcysteine|n-acetylcysteine
5629754|NCT00780962|RCN|rcn
5629755|NCT00780962|RCIN|rcin
5629756|NCT00780962|Creatinine|creatinine
5629757|NCT00780962|Computerized Tomography|computerized tomography
5629758|NCT00780962|CT|ct
5629759|NCT00780962|Emergency Department|emergency department
5629760|NCT00780962|ED|ed
5629761|NCT00780949|Crohn's Disease, inflammatory bowel disease, Peyer's patches|crohn's disease, inflammatory bowel disease, peyer's patches
5629762|NCT00780897|PREMATURE OVARIAN FAILURE (POF)|premature ovarian failure (pof)
5629763|NCT00780897|GENETIC ANALYSIS|genetic analysis
5629764|NCT00780897|PHYSIOPATHOLOGIC ANALYSIS|physiopathologic analysis
5629765|NCT00780884|acupuncture|acupuncture
5629766|NCT00780884|schizophrenia|schizophrenia
5629767|NCT00780884|insomnia|insomnia
5629768|NCT00780858|GnRH antagonist|gnrh antagonist
5629769|NCT00780858|IUI|iui
5629770|NCT00780845|Acute Kidney failure|acute kidney failure
5629771|NCT00780845|Clinical outcomes|clinical outcomes
5629772|NCT00780845|On-pump|on-pump
5629773|NCT00780845|Coronary artery bypass grafting|coronary artery bypass grafting
5629774|NCT00780845|Morbidity|morbidity
5629775|NCT00780845|Mortality|mortality
5629776|NCT00780832|overactive bladder|overactive bladder
5629777|NCT00780832|dietary caffeine|dietary caffeine
5629778|NCT00780832|anticholinergic medication|anticholinergic medication
5629779|NCT00780832|lifestyle modification|lifestyle modification
5629780|NCT00780832|incontinence|incontinence
5629781|NCT00780832|urinary frequency|urinary frequency
5629782|NCT00780806|MnB|mnb
5629783|NCT00780806|rLP2086|rlp2086
5629784|NCT00780806|blood collection|blood collection
5629785|NCT00780806|vaccination|vaccination
5629786|NCT00780793|Rheumatoid arthritis|rheumatoid arthritis
5629787|NCT00780793|Remission|remission
5629788|NCT00780793|Therapeutic strategy|therapeutic strategy
5629789|NCT00780793|DMARDs|dmards
5629790|NCT00780793|Biological agents|biological agents
5629791|NCT00780780|triamcinolone|triamcinolone
5629792|NCT00780780|nepafenac|nepafenac
5629793|NCT00780780|DME|dme
5629794|NCT00780780|edema macular|edema macular
5629795|NCT00780767|angiojet|angiojet
5629796|NCT00780767|massive pulmonary embolism|massive pulmonary embolism
5629797|NCT00780767|RHEOLYTIC THROMBECTOMY|rheolytic thrombectomy
5629798|NCT00780767|patients presenting with massive pulmonary embolism|patients presenting with massive pulmonary embolism
5629799|NCT00780754|prostate cancer|prostate cancer
5629800|NCT00780754|chemoprevention|chemoprevention
5629801|NCT00780754|dutasteride|dutasteride
5629810|NCT00780702|Relapse|relapse
5629812|NCT00780702|Ecological Momentary Assessment (EMA)|ecological momentary assessment (ema)
5629813|NCT00780702|Contingency Management|contingency management
5629814|NCT00780676|Dasatinib|dasatinib
5629815|NCT00780676|Metastatic Breast Cancer|metastatic breast cancer
5629816|NCT00780676|Sprycel|sprycel
5629817|NCT00780676|BMS-354825|bms-354825
5629818|NCT00780676|Genetic testing|genetic testing
5629819|NCT00780676|AZD6244|azd6244
5629820|NCT00780676|Selumetinib|selumetinib
5629821|NCT00780663|Neuroendocrine|neuroendocrine
5629822|NCT00780663|Carcinoid|carcinoid
5629823|NCT00780663|NET|net
5629824|NCT00780663|MEN-1|men-1
5629825|NCT00780663|Islet cell|islet cell
5629826|NCT00780637|Heart Transplant|heart transplant
5629827|NCT00780637|Endothelial Function|endothelial function
5629828|NCT00780637|Fibrinolysis|fibrinolysis
5629829|NCT00780637|Transplant recipients at baseline|transplant recipients at baseline
5629830|NCT00780624|RDS|rds
5629831|NCT00780624|Infant, newborn|infant, newborn
5629832|NCT00780624|NIPPV|nippv
5629833|NCT00780624|CPAP|cpap
5629834|NCT00780598|Acute Myeloid Leukemia|acute myeloid leukemia
5629835|NCT00780598|AML|aml
5629836|NCT00780598|Cancer|cancer
5798774|NCT00111124|arthritis|arthritis
5629837|NCT00780598|Hematological malignancies|hematological malignancies
5629838|NCT00780598|Elderly|elderly
5629839|NCT00780598|Refractory|refractory
5629840|NCT00780598|Relapsed|relapsed
5629841|NCT00780598|Blood disorder|blood disorder
5629842|NCT00780572|Safety Management|safety management
5629843|NCT00780572|Risk Management|risk management
5629844|NCT00780572|surveillance|surveillance
5629845|NCT00780572|triggers|triggers
5629846|NCT00780559|Neuropathy|neuropathy
5629847|NCT00780559|diabetes|diabetes
5629848|NCT00780546|tuberculosis|tuberculosis
5629849|NCT00780546|spatial epidemiology|spatial epidemiology
5629850|NCT00780546|geographic information system|geographic information system
5629851|NCT00780520|glutamine inflammation HSP70 sepsis|glutamine inflammation hsp70 sepsis
5629853|NCT00780481|Endothelial Function|endothelial function
5629854|NCT00780481|Fibrinolytic Balance|fibrinolytic balance
5629855|NCT00780481|Baseline|baseline
5629856|NCT00780468|Weight loss|weight loss
5629858|NCT00780468|Obesity|obesity
5629859|NCT00780455|KineSEP|kinesep
5629860|NCT00780455|Rehabilitation|rehabilitation
5629861|NCT00780455|Betaferon|betaferon
5629862|NCT00780442|substance related disorders|substance related disorders
5629863|NCT00780429|kidney|kidney
5629864|NCT00780429|transplant|transplant
5629865|NCT00780429|Mycophenolic acid|mycophenolic acid
5629866|NCT00780429|Inosine monophosphate dehydrogenase|inosine monophosphate dehydrogenase
5629867|NCT00780416|Chronic Hepatitis C|chronic hepatitis c
5629868|NCT00780416|Protease Inhibitor|protease inhibitor
5629869|NCT00780416|Telaprevir|telaprevir
5629870|NCT00780416|Peginterferon Alfa-2b|peginterferon alfa-2b
5629871|NCT00780416|Ribavirin|ribavirin
5629872|NCT00780390|RSD|rsd
5629873|NCT00780390|SCS|scs
5629874|NCT00780390|CRPS|crps
5629875|NCT00780390|Complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments|complex regional pain syndrome patients before undergoing spinal cord stimulator implant and under other treatments
5629876|NCT00780377|Heart Transplant|heart transplant
5629877|NCT00780377|Fibrinolysis|fibrinolysis
5629878|NCT00780377|Resting conditions|resting conditions
5629879|NCT00780364|stroke; sour taste; cold temperature; pharyngeal swallowing|stroke; sour taste; cold temperature; pharyngeal swallowing
5629880|NCT00780351|vancomycin, SLEDD-f|vancomycin, sledd-f
5629881|NCT00780325|Cyclooxygenase-2|cyclooxygenase-2
5629882|NCT00780325|Carbonic anhydrase|carbonic anhydrase
5629883|NCT00780325|Eicosanoids|eicosanoids
5629884|NCT00780325|Healthy volunteers|healthy volunteers
5629885|NCT00780312|radiotherapy|radiotherapy
5629886|NCT00780312|trismus|trismus
5629887|NCT00780312|physiotherapy|physiotherapy
5629888|NCT00780312|lymphoedema|lymphoedema
5629889|NCT00780312|late side effects|late side effects
5629890|NCT00780312|fibrosis|fibrosis
5629891|NCT00780312|decreased cervical range of motion|decreased cervical range of motion
5629892|NCT00780312|quality of life|quality of life
5629893|NCT00780299|Plasma epuration|plasma epuration
5629894|NCT00780299|Hemofiltration|hemofiltration
5629895|NCT00780299|Cardiac arrest|cardiac arrest
5629896|NCT00780299|Shock|shock
5629897|NCT00780299|Inflammatory mediators|inflammatory mediators
5629898|NCT00780273|subjects with edentulous mandible|subjects with edentulous mandible
5629899|NCT00780260|HIV/AIDS|hiv/aids
5629900|NCT00780260|African Americans|african americans
5629901|NCT00780260|Women|women
5629902|NCT00780260|Case Management|case management
5629903|NCT00780247|Vitamin D|vitamin d
5629904|NCT00780247|Sun|sun
5629905|NCT00780247|Latitude|latitude
5629906|NCT00780247|Vitamin D status|vitamin d status
5629907|NCT00780234|chemoprevention|chemoprevention
5629908|NCT00780234|lung cancer|lung cancer
5629909|NCT00780234|pioglitazone|pioglitazone
5629910|NCT00780221|CRP|crp
5629911|NCT00780221|coronary artery disease|coronary artery disease
5629912|NCT00780221|polymorphisms|polymorphisms
5629913|NCT00780208|Attention Deficit Hyperactivity ADHD|attention deficit hyperactivity adhd
5629914|NCT00780195|hypoglycemia|hypoglycemia
5629915|NCT00780195|African Americans|african americans
5629916|NCT00780182|Bioavailability|bioavailability
5629917|NCT00780156|Drug eluting stent|drug eluting stent
5629918|NCT00780156|Dual antiplatelet therapy|dual antiplatelet therapy
5629919|NCT00780156|bleeding|bleeding
5629920|NCT00780156|stent thrombosis|stent thrombosis
5630018|NCT00779727|increased|increased
5629921|NCT00780156|follow-up of the drug eluting stent|follow-up of the drug eluting stent
5629922|NCT00780143|Tumor|tumor
5629923|NCT00780143|Leukemia|leukemia
5629924|NCT00780143|Plitidepsin|plitidepsin
5629925|NCT00780143|Aplidin|aplidin
5629926|NCT00780117|CURRARINO syndrome|currarino syndrome
5611576|NCT00851695|Allergy|allergy
5629927|NCT00780117|Sacrococcygeal teratoma|sacrococcygeal teratoma
5629928|NCT00780117|HLXB9 (MNX1) gene|hlxb9 (mnx1) gene
5629929|NCT00780117|Alpha foeto protein|alpha foeto protein
5629930|NCT00780117|Prognosis factors|prognosis factors
5629931|NCT00780104|Advanced myeloid leukemias|advanced myeloid leukemias
5629932|NCT00780104|AML|aml
5629933|NCT00780104|Leukemia|leukemia
5629934|NCT00780104|Relapsed myeloid leukemias|relapsed myeloid leukemias
5629935|NCT00780104|Refractory myeloid leukemias|refractory myeloid leukemias
5629936|NCT00780104|MEC|mec
5629937|NCT00780104|Rapamycin|rapamycin
5629938|NCT00780104|Sirolimus|sirolimus
5629939|NCT00780091|optimization|optimization
5629940|NCT00780091|risk scale|risk scale
5629941|NCT00780091|non inferiority|non inferiority
5629942|NCT00780091|cluster randomization|cluster randomization
5629943|NCT00780091|monitoring strategies|monitoring strategies
5629944|NCT00780078|Intensive care unit|intensive care unit
5629945|NCT00780078|Extubation failure|extubation failure
5629946|NCT00780078|Physiotherapist|physiotherapist
5629947|NCT00780078|Pre-extubation bedside tests|pre-extubation bedside tests
5629948|NCT00780078|Swallowing disorders|swallowing disorders
5629949|NCT00780052|Hematologic Malignancies|hematologic malignancies
5629951|NCT00780052|c-myb AS ODN|c-myb as odn
5629952|NCT00780026|liver|liver
5629953|NCT00780026|transplant|transplant
5629954|NCT00780026|blood sugar|blood sugar
5629955|NCT00780013|Bioequivalence metformin hydrochloride|bioequivalence metformin hydrochloride
5629956|NCT00779987|Dry eye|dry eye
5629957|NCT00779987|Autologous serum|autologous serum
5629958|NCT00779987|Ocular Surface Disease Index|ocular surface disease index
5629959|NCT00779974|Total Shoulder Arthroplasty|total shoulder arthroplasty
5629960|NCT00779974|Osteoarthritis|osteoarthritis
5629961|NCT00779961|pediatric|pediatric
5629962|NCT00779961|cleft palate|cleft palate
5629963|NCT00779961|plastic surgery|plastic surgery
5629964|NCT00779961|palatoplasty|palatoplasty
5629965|NCT00779961|pharyngoplasty|pharyngoplasty
5629966|NCT00779948|Femoral Neck Fracture|femoral neck fracture
5629967|NCT00779948|Internal Fixation|internal fixation
5629968|NCT00779948|Dynamic Hip Screw|dynamic hip screw
5629969|NCT00779922|Multiple Myeloma|multiple myeloma
5629970|NCT00779922|impaired renal function|impaired renal function
5629971|NCT00779909|vitamin D|vitamin d
5629972|NCT00779909|gingivitis|gingivitis
5629973|NCT00779909|periodontal disease|periodontal disease
5629974|NCT00779909|inflammation|inflammation
5629975|NCT00779896|To evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of Stage I-IIA CTCL. Patients with Stage I-IIA disease are enrolled into the study|to evaluate therapeutic potential of tazarotene 0.1% cream for the treatment of stage i-iia ctcl. patients with stage i-iia disease are enrolled into the study
5629976|NCT00779896|Stage I-IIA disease CTCL|stage i-iia disease ctcl
5629977|NCT00779883|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5629978|NCT00779883|CLL|cll
5629979|NCT00779883|Leukemia|leukemia
5629980|NCT00779883|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5629981|NCT00779883|Leukemia, B-Cell|leukemia, b-cell
5629982|NCT00779883|Immune System Diseases|immune system diseases
5629983|NCT00779883|ISF35|isf35
5629984|NCT00779883|Ad-ISF35|ad-isf35
5629985|NCT00779883|Immunotherapy|immunotherapy
5629986|NCT00779883|Immune therapy|immune therapy
5629987|NCT00779883|Active immune therapy|active immune therapy
5629988|NCT00779870|asthma severity|asthma severity
5629989|NCT00779870|airway smooth muscle|airway smooth muscle
5629990|NCT00779870|oxidative stress|oxidative stress
5629991|NCT00779857|left atrial appendage|left atrial appendage
5629994|NCT00779857|afib|afib
5629995|NCT00779857|af|af
5629996|NCT00779857|stroke|stroke
5629997|NCT00779857|tia|tia
5629998|NCT00779844|Anesthesia|anesthesia
5629999|NCT00779844|Obesity|obesity
5630000|NCT00779831|Bioequivalence Pseudoephedrine hydrochloride 120 mg extended release tablets|bioequivalence pseudoephedrine hydrochloride 120 mg extended release tablets
5630001|NCT00779805|Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablets|bioequivalence pseudoephedrine hydrochloride 120 mg er tablets
5630002|NCT00779792|Irritant contact dermatitis|irritant contact dermatitis
5630003|NCT00779792|experimental contact dermatitis|experimental contact dermatitis
5630004|NCT00779792|treatment|treatment
5630005|NCT00779792|efficacy|efficacy
5630006|NCT00779792|topical steroids|topical steroids
5630007|NCT00779792|topical immune modulators|topical immune modulators
5630008|NCT00779792|glycerol|glycerol
5630009|NCT00779779|Gastroenteritis|gastroenteritis
5630010|NCT00779766|Human papillomavirus|human papillomavirus
5630011|NCT00779766|vaccine|vaccine
5630012|NCT00779766|cervical cancer|cervical cancer
5630013|NCT00779766|cervical infection|cervical infection
5630014|NCT00779753|Parenteral Feeding|parenteral feeding
5630015|NCT00779753|Neonate|neonate
5630016|NCT00779753|Lysine|lysine
5630017|NCT00779727|women|women
5630019|NCT00779727|risk|risk
5630020|NCT00779714|metastatic (AJCC stage IV)|metastatic (ajcc stage iv)
5630021|NCT00779714|first-line chemotherapy|first-line chemotherapy
5630022|NCT00779714|ex-vivo chemosensitivity profiling|ex-vivo chemosensitivity profiling
5630023|NCT00779714|evaluation of biomarkers|evaluation of biomarkers
5630024|NCT00779701|Hyperglycemia|hyperglycemia
5630025|NCT00779701|Glycemic control|glycemic control
5630026|NCT00779688|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5630027|NCT00779688|ERCP|ercp
5630028|NCT00779688|bile duct cancer|bile duct cancer
5630029|NCT00779688|pancreatic duct cancer|pancreatic duct cancer
5630030|NCT00779688|gall bladder|gall bladder
5630031|NCT00779688|pancreas|pancreas
5630032|NCT00779688|duodenoscope|duodenoscope
5630033|NCT00779688|Cellvizio|cellvizio
5630034|NCT00779688|endomicroscopy|endomicroscopy
5630035|NCT00779688|cholangiopancreatoscopy|cholangiopancreatoscopy
5630036|NCT00779688|Biliary Tract Neoplasms (suspected)|biliary tract neoplasms (suspected)
5630037|NCT00779688|Biliary Tract Mass (suspected)|biliary tract mass (suspected)
5630038|NCT00779688|Biliary Tract Stricture (suspected)|biliary tract stricture (suspected)
5630039|NCT00779688|Pancreatic Duct Neoplasms (suspected)|pancreatic duct neoplasms (suspected)
5630040|NCT00779688|Pancreatic Duct Mass (suspected)|pancreatic duct mass (suspected)
5630041|NCT00779688|Pancreatic Duct Stricture (suspected)|pancreatic duct stricture (suspected)
5630042|NCT00779662|Rheumatic Heart Disease|rheumatic heart disease
5630043|NCT00779662|Streptococcus|streptococcus
5630045|NCT00779649|Colonoscopy,|colonoscopy,
5630046|NCT00779649|Prep|prep
5630047|NCT00779649|MoviPrep|moviprep
5630048|NCT00779649|HalfLytely|halflytely
5630049|NCT00779649|The effectiveness of colonoscopy preps|the effectiveness of colonoscopy preps
5630050|NCT00779597|self care|self care
5630051|NCT00779597|symptom management|symptom management
5630052|NCT00779597|pain|pain
5630053|NCT00779597|cancer|cancer
5630054|NCT00779597|nurse coaching|nurse coaching
5630055|NCT00779597|patient education|patient education
5630056|NCT00779571|Polycystic Ovary Syndrome|polycystic ovary syndrome
5630057|NCT00779571|Morbid Obesity|morbid obesity
5630058|NCT00779571|Type 2 DM|type 2 dm
5630059|NCT00779571|Coronary heart disease|coronary heart disease
5630060|NCT00779532|Electrocardiography|electrocardiography
5630061|NCT00779532|Pharmacokinetics|pharmacokinetics
5630062|NCT00779519|Obesity|obesity
5630063|NCT00779519|Class 1|class 1
5630064|NCT00779519|Class 2|class 2
5630065|NCT00779519|Weight Loss|weight loss
5630066|NCT00779519|AgRP|agrp
5630067|NCT00779519|TTP435|ttp435
5630068|NCT00779519|alphaMSH|alphamsh
5630069|NCT00779519|Agouti-Related Protein|agouti-related protein
5630070|NCT00779519|alpha-melanocyte stimulating hormone|alpha-melanocyte stimulating hormone
5630071|NCT00779506|Acute schizophrenia|acute schizophrenia
5630072|NCT00779506|PANSS|panss
5630073|NCT00779493|irritable bowel syndrome|irritable bowel syndrome
5630074|NCT00779493|constipation|constipation
5630075|NCT00779493|diarrhea|diarrhea
5630076|NCT00779493|gas|gas
5630077|NCT00779493|bloating|bloating
5630078|NCT00779493|abdominal pain|abdominal pain
5630079|NCT00779493|disturbance of defecation|disturbance of defecation
5630080|NCT00779493|irritable colon|irritable colon
5630081|NCT00779480|Acute Myelogenous Leukemia|acute myelogenous leukemia
5630082|NCT00779480|Safety|safety
5630083|NCT00779480|Dose Tolerance|dose tolerance
5630084|NCT00779480|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5630085|NCT00779480|FLT-3|flt-3
5630086|NCT00779467|non narcotic|non narcotic
5630087|NCT00779467|epidural|epidural
5630088|NCT00779467|labor pain|labor pain
5630089|NCT00779467|Non narcotic treatment of labor pain|non narcotic treatment of labor pain
5630090|NCT00779454|KRAS wild-type|kras wild-type
5630091|NCT00779454|Cholangiocarcinoma|cholangiocarcinoma
5630092|NCT00779454|Inoperable|inoperable
5630093|NCT00779441|Bioequivalence zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
5630094|NCT00779428|This is an open-label continuing treatment protocol in patients with advanced malignancies who will receive Tanespimycin|this is an open-label continuing treatment protocol in patients with advanced malignancies who will receive tanespimycin
5630095|NCT00779415|Partial Thickness|partial thickness
5630096|NCT00779415|Rotator Cuff|rotator cuff
5630097|NCT00779402|cancer|cancer
5630098|NCT00779402|prostate cancer|prostate cancer
5630099|NCT00779402|prostatectomy|prostatectomy
5630100|NCT00779402|PSA|psa
5630101|NCT00779402|sipuleucel-T|sipuleucel-t
5630102|NCT00779402|PROVENGE|provenge
5630103|NCT00779402|APC8015|apc8015
5630104|NCT00779402|non-metastatic|non-metastatic
5630105|NCT00779402|nonmetastatic|nonmetastatic
5630106|NCT00779402|androgen-sensitive|androgen-sensitive
5630107|NCT00779402|androgen sensitive|androgen sensitive
5630108|NCT00779402|biochemical recurrence|biochemical recurrence
5630109|NCT00779402|biochemically recurrent|biochemically recurrent
5630110|NCT00779402|immune therapy|immune therapy
5630111|NCT00779402|immunotherapy|immunotherapy
5630112|NCT00779402|vaccine|vaccine
5630113|NCT00779402|dendritic cells|dendritic cells
5630114|NCT00779402|antigen-presenting cells|antigen-presenting cells
5630115|NCT00779402|antigen presenting cells|antigen presenting cells
5630116|NCT00779402|cancer vaccine|cancer vaccine
5630117|NCT00779402|therapeutic vaccine|therapeutic vaccine
5630118|NCT00779402|therapeutic cancer vaccine|therapeutic cancer vaccine
5630119|NCT00779402|biologic|biologic
5630120|NCT00779402|booster|booster
5630121|NCT00779389|Head and Neck cancer|head and neck cancer
5630122|NCT00779376|Bioequivalence|bioequivalence
5630123|NCT00779363|obese,|obese,
5630124|NCT00779363|Diabetes|diabetes
5630125|NCT00779350|Bioequivalence sertraline 100 mg tablets fasting conditions|bioequivalence sertraline 100 mg tablets fasting conditions
5630126|NCT00779337|Epstein-Barr virus|epstein-barr virus
5630127|NCT00779337|lymphoma|lymphoma
5630128|NCT00779337|immunotherapy|immunotherapy
5630129|NCT00779324|traumatic brain injury|traumatic brain injury
5630130|NCT00779324|irritability|irritability
5630131|NCT00779324|aggression|aggression
5630132|NCT00779324|amantadine|amantadine
5630133|NCT00779324|behavior|behavior
5630134|NCT00779311|Metastatic Colorectal Cancer|metastatic colorectal cancer
5630135|NCT00779298|rye whole-meal bread|rye whole-meal bread
5630136|NCT00779298|white-wheat bread|white-wheat bread
5630137|NCT00779298|gastric emptying rate|gastric emptying rate
5630138|NCT00779298|postprandial glucose response|postprandial glucose response
5630139|NCT00779298|healthy subjects|healthy subjects
5630140|NCT00779272|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5630141|NCT00779272|clinically postoperative outcome|clinically postoperative outcome
5630142|NCT00779272|liver regeneration after liver resection|liver regeneration after liver resection
5630143|NCT00779259|quinine sulfate|quinine sulfate
5630144|NCT00779259|theophylline|theophylline
5630145|NCT00779259|drug interactions|drug interactions
5630146|NCT00779259|cytochrome p450|cytochrome p450
5630147|NCT00779259|humans|humans
5630148|NCT00779259|male|male
5630149|NCT00779259|adult|adult
5630150|NCT00779246|Methicillin resistance|methicillin resistance
5630151|NCT00779246|Infection control|infection control
5630152|NCT00779246|Staphylococcus aureus|staphylococcus aureus
5630153|NCT00779246|Cross infection|cross infection
5630154|NCT00779246|Epidemiology|epidemiology
5630155|NCT00779246|Chlorhexidine|chlorhexidine
5630156|NCT00779233|Bioequivalence|bioequivalence
5630157|NCT00779207|obesity|obesity
5630158|NCT00779207|aging|aging
5630159|NCT00779207|exercise|exercise
5630160|NCT00779207|diet|diet
5630161|NCT00779207|weight loss|weight loss
5630162|NCT00779207|physical function|physical function
5630163|NCT00779207|Obesity in the Elderly|obesity in the elderly
5630164|NCT00779181|Hypertension|hypertension
5630165|NCT00779181|High blood pressure|high blood pressure
5630167|NCT00779181|Addrenex|addrenex
5630168|NCT00779168|recurrent prostate cancer|recurrent prostate cancer
5630169|NCT00779168|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5630170|NCT00779142|resistant diabetic macular edema|resistant diabetic macular edema
5630171|NCT00779103|puberty|puberty
5630172|NCT00779103|precocious puberty|precocious puberty
5630173|NCT00779103|early puberty|early puberty
5630174|NCT00779103|early onset puberty|early onset puberty
5630175|NCT00779103|histrelin|histrelin
5630176|NCT00779103|histrelin subcutaneous implant|histrelin subcutaneous implant
5680374|NCT00577993|Novantrone|novantrone
5630177|NCT00779103|implant therapy|implant therapy
5630178|NCT00779077|device characteristics|device characteristics
5630179|NCT00779064|Atrial Fibrillation|atrial fibrillation
5630180|NCT00779051|Bioequivalence Zolpidem 10mg tablets|bioequivalence zolpidem 10mg tablets
5630181|NCT00779038|IONSYS|ionsys
5630182|NCT00779038|Fentanyl Iontophoretic Transdermal System|fentanyl iontophoretic transdermal system
5630183|NCT00779038|Postoperative pain|postoperative pain
5630184|NCT00778986|heart failure|heart failure
5630185|NCT00778986|remote patient monitoring|remote patient monitoring
5630186|NCT00778986|telemonitoring|telemonitoring
5630187|NCT00778986|home monitoring|home monitoring
5630188|NCT00778986|randomized controlled trial|randomized controlled trial
5630190|NCT00778973|Bioequivalence sertraline 100 mg tablets under fed conditions|bioequivalence sertraline 100 mg tablets under fed conditions
5630191|NCT00778947|Breast Reconstruction|breast reconstruction
5630192|NCT00778947|Halmonic Scalpel|halmonic scalpel
5630193|NCT00778947|diathermy|diathermy
5630194|NCT00778947|Free Tissue Transfer|free tissue transfer
5630195|NCT00778921|Aliskiren|aliskiren
5630196|NCT00778921|Amlodipine|amlodipine
5630197|NCT00778921|Non-responder to Amlodipine|non-responder to amlodipine
5630198|NCT00778908|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5630199|NCT00778908|Locally advanced disease|locally advanced disease
5630200|NCT00778908|Intensity-modulated radiation therapy|intensity-modulated radiation therapy
5630201|NCT00778908|Accelerated hyperfractionation|accelerated hyperfractionation
5630202|NCT00778908|Concomitant boost radiation therapy|concomitant boost radiation therapy
5630203|NCT00778908|Concurrent chemotherapy|concurrent chemotherapy
5630205|NCT00778895|Safety|safety
5630206|NCT00778895|Immunogenicity|immunogenicity
5630207|NCT00778895|Flu vaccine|flu vaccine
5630208|NCT00778895|Influenza|influenza
5630209|NCT00778895|Virus|virus
5630210|NCT00778882|Chronic Granulomatous Disease|chronic granulomatous disease
5630211|NCT00778882|Retroviral Vector|retroviral vector
5630212|NCT00778882|Gene Therapy|gene therapy
5630213|NCT00778843|Chronic hepatitis C|chronic hepatitis c
5630214|NCT00778843|Oxidative stress|oxidative stress
5630215|NCT00778843|Antioxidant|antioxidant
5630216|NCT00778843|Cytokines|cytokines
5611844|NCT00850902|ELBW|elbw
5630217|NCT00778843|Nutritional supplement|nutritional supplement
5630218|NCT00778830|mCRC|mcrc
5630219|NCT00778804|CVD risk|cvd risk
5630220|NCT00778804|self monitoring|self monitoring
5630221|NCT00778804|Internet|internet
5630222|NCT00778804|telemedicine|telemedicine
5630223|NCT00778791|Bioequivalence metformin HC1 750 mg extended-release tablets|bioequivalence metformin hc1 750 mg extended-release tablets
5630224|NCT00778778|Bioequivalence cefprozil 500mg tablets fasting conditions|bioequivalence cefprozil 500mg tablets fasting conditions
5630225|NCT00778765|Bioequivalence gabapentin fed conditions|bioequivalence gabapentin fed conditions
5630226|NCT00778752|Multiple Myeloma|multiple myeloma
5630227|NCT00778752|Stem Cell Transplantation|stem cell transplantation
5630228|NCT00778752|Revlimid|revlimid
5798775|NCT00111124|Enbrel®|enbrel®
5630229|NCT00778752|Lenalidomide|lenalidomide
5630230|NCT00778739|bioequivalence 1) CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL fed conditions|bioequivalence 1) cefprozil for oral suspension usp 250 mg/ 5 ml fed conditions
5630231|NCT00778726|Bioequivalence benazepril and hydrochlorothiazide tablets|bioequivalence benazepril and hydrochlorothiazide tablets
5630232|NCT00778713|Bioequivalence|bioequivalence
5671707|NCT00614718|pace/sense lead|pace/sense lead
5630233|NCT00778674|Bioequivalence Benazepril HCl Hydrochlorothiazide Tablets|bioequivalence benazepril hcl hydrochlorothiazide tablets
5630234|NCT00778661|Bioequivalence|bioequivalence
5630235|NCT00778648|Common cold|common cold
5630236|NCT00778648|prevention|prevention
5630237|NCT00778648|dietary supplement|dietary supplement
5630238|NCT00778609|Combined Oral Contraceptives|combined oral contraceptives
5630239|NCT00778609|Pelvic Pain|pelvic pain
5630240|NCT00778609|Headache|headache
5630241|NCT00778596|Hepatitis B|hepatitis b
5630242|NCT00778596|Telbivudine|telbivudine
5630243|NCT00778596|Prednisolone|prednisolone
5630244|NCT00778583|Bioequivalence Nitrofurantoin capsules|bioequivalence nitrofurantoin capsules
5630245|NCT00778557|CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL, Bioequivalence fasting conditions|cefprozil for oral suspension usp 250 mg/ 5 ml, bioequivalence fasting conditions
5630246|NCT00778544|Bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin-clavulanic acid 600 mg 42.9 mg per 5 ml oral suspension
5630247|NCT00778518|growth hormone|growth hormone
5630248|NCT00778518|growth hormone deficiency|growth hormone deficiency
5630250|NCT00778518|PEG|peg
5630251|NCT00778518|pegylated|pegylated
5630252|NCT00778518|IGF-1|igf-1
5630253|NCT00778505|Anesthesia|anesthesia
5630254|NCT00778492|Thrombelastogram|thrombelastogram
5630255|NCT00778492|Microvascular bleeding|microvascular bleeding
5630256|NCT00778492|antiplatelet medication|antiplatelet medication
5630257|NCT00778492|cardiac surgery|cardiac surgery
5630258|NCT00778492|consumption of blood products|consumption of blood products
5630259|NCT00778492|preoperative platelet mapping derived from modified TEG|preoperative platelet mapping derived from modified teg
5630260|NCT00778492|postoperative bleeding|postoperative bleeding
5680375|NCT00577993|Mitoxantrone|mitoxantrone
5680376|NCT00577993|Decadron|decadron
5630261|NCT00778466|Bioequivalence metformin hydrochloride 1000 mg tablets fed conditions|bioequivalence metformin hydrochloride 1000 mg tablets fed conditions
5630262|NCT00778453|stroke rehabilitation|stroke rehabilitation
5630263|NCT00778453|kinematic analysis|kinematic analysis
5630264|NCT00778453|upper extremity training|upper extremity training
5630266|NCT00778440|Injuries|injuries
5630267|NCT00778440|Traffic Injuries|traffic injuries
5630268|NCT00778440|Preventive medicine|preventive medicine
5630269|NCT00778440|Observational studies|observational studies
5630270|NCT00778440|Primary care|primary care
5623968|NCT00803855|single dose|single dose
5863023|NCT00001413|Corticosteroids|corticosteroids
5630271|NCT00778427|Bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions|bioequivalence metformin hydrochloride 1000 mg tablets fasting conditions
5630272|NCT00778414|Bioequivalence Amoxicillin Clavulanic acid 600mg 42.9 mg per 5 mL oral suspension|bioequivalence amoxicillin clavulanic acid 600mg 42.9 mg per 5 ml oral suspension
5630273|NCT00778401|Bioequivalence Gabapentin tablets 800 mg fasting conditions|bioequivalence gabapentin tablets 800 mg fasting conditions
5630275|NCT00778375|Leukemia|leukemia
5630276|NCT00778375|Acute Myeloid Leukemia|acute myeloid leukemia
5630277|NCT00778375|Myelodysplastic Syndrome|myelodysplastic syndrome
5630278|NCT00778375|AML|aml
5630279|NCT00778375|MDS|mds
5630280|NCT00778375|Clofarabine|clofarabine
5630281|NCT00778375|Ara-C|ara-c
5630282|NCT00778375|Cytarabine|cytarabine
5630283|NCT00778375|Decitabine|decitabine
5630284|NCT00778362|OPSI|opsi
5630285|NCT00778362|Splenectomy|splenectomy
5630286|NCT00778349|Bioavailability Metformin solution 100 mg/mL|bioavailability metformin solution 100 mg/ml
5630287|NCT00778336|Peripheral Thrombosis|peripheral thrombosis
5630288|NCT00778336|DVT|dvt
5630289|NCT00778336|Limb Ischemia|limb ischemia
5630290|NCT00778336|AV Access|av access
5630291|NCT00778336|AngioJet|angiojet
5630292|NCT00778336|Thrombectomy|thrombectomy
5630293|NCT00778323|remote ischemic preconditioning|remote ischemic preconditioning
5630294|NCT00778323|cervical compression myelopathy|cervical compression myelopathy
5630295|NCT00778323|spinal cord|spinal cord
5630296|NCT00778323|neuron-specific enolase|neuron-specific enolase
5630297|NCT00778323|s-100B|s-100b
5630385|NCT00777816|Rheumatoid|rheumatoid
5611947|NCT00850473|PET|pet
5630298|NCT00778310|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5630299|NCT00778310|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5630300|NCT00778310|ADHD|adhd
5630301|NCT00778297|prevention|prevention
5630302|NCT00778297|influenza|influenza
5630303|NCT00778297|infection|infection
5630304|NCT00778297|vaccine|vaccine
5630305|NCT00778297|Influenza vaccine|influenza vaccine
5630306|NCT00778297|Influenza in humans|influenza in humans
5630307|NCT00778284|Bioequivalence|bioequivalence
5630308|NCT00778271|Bioequivalence gabapentin 400mg capsules fasting conditions|bioequivalence gabapentin 400mg capsules fasting conditions
5630309|NCT00778258|Food Allergy|food allergy
5630310|NCT00778258|Milk Allergy|milk allergy
5630311|NCT00778245|Bioequivalence cefprozil 500mg tablets fed conditions|bioequivalence cefprozil 500mg tablets fed conditions
5630312|NCT00778232|Bioequivalence Gabapentin tablets 800 mg fed conditions|bioequivalence gabapentin tablets 800 mg fed conditions
5630313|NCT00778219|heart rate variability, tracheal intubation|heart rate variability, tracheal intubation
5630314|NCT00778206|Phenylketonuria|phenylketonuria
5630315|NCT00778206|Hyperphenylalaninemia|hyperphenylalaninemia
5630316|NCT00778206|PKU|pku
5630317|NCT00778206|Phenylalanine|phenylalanine
5630318|NCT00778193|NSAID|nsaid
5630319|NCT00778193|ulcer|ulcer
5630320|NCT00778193|gastroduodenal ulcer|gastroduodenal ulcer
5630321|NCT00778193|naproxen|naproxen
5630322|NCT00778193|aspirin|aspirin
5630323|NCT00778193|ASA|asa
5630324|NCT00778193|celecoxib|celecoxib
5630325|NCT00778193|clopidogrel|clopidogrel
5630326|NCT00778193|healing|healing
5630327|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
5630328|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5630329|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5630330|NCT00778193|Wound Healing|wound healing
5630331|NCT00778180|Bioequivalence furosemide 80 mg tablets|bioequivalence furosemide 80 mg tablets
5630332|NCT00778141|Bioequivalecne metformin HC1 750 mg extended-release tablets|bioequivalecne metformin hc1 750 mg extended-release tablets
5630333|NCT00778128|CP-4126|cp-4126
5630334|NCT00778128|Cancer|cancer
5630335|NCT00778128|Metastatic|metastatic
5630336|NCT00778128|Solid tumours|solid tumours
5630337|NCT00778128|Gemzitabine|gemzitabine
5630338|NCT00778128|Gemzar|gemzar
5630339|NCT00778115|Bioequivalence Loperamide HCl 2 mg and simethicone 125 mg tablets|bioequivalence loperamide hcl 2 mg and simethicone 125 mg tablets
5630340|NCT00778089|skin test|skin test
5630341|NCT00778089|ArteFill|artefill
5630342|NCT00778089|Skin test prior to administration of ArteFill® implant|skin test prior to administration of artefill® implant
5630343|NCT00778076|Knee OA, Hyaluronic acid, Gait, Pain, Synovial fluid|knee oa, hyaluronic acid, gait, pain, synovial fluid
5630344|NCT00778063|dexmedetomidine|dexmedetomidine
5630345|NCT00778063|pressure equalization tubes in the ear|pressure equalization tubes in the ear
5630346|NCT00778063|myringotomy|myringotomy
5630347|NCT00778063|sevoflurane|sevoflurane
5630348|NCT00778050|Bioequivalence, amoxicillin 600mg fasting conditions|bioequivalence, amoxicillin 600mg fasting conditions
5630349|NCT00778037|Bioequivalence Cyclobenzaprine hydrochloride 10 mg tablet fasting conditions|bioequivalence cyclobenzaprine hydrochloride 10 mg tablet fasting conditions
5630350|NCT00778024|Bioequivalence fluoxetine HCL 40 mg capsules fasting conditions|bioequivalence fluoxetine hcl 40 mg capsules fasting conditions
5630351|NCT00778011|Nausea|nausea
5630352|NCT00778011|Vomiting|vomiting
5630353|NCT00778011|Ondansetron|ondansetron
5630354|NCT00778011|Metoclopramide|metoclopramide
5630355|NCT00778011|Randomized|randomized
5630356|NCT00778011|Double-Blind|double-blind
5624107|NCT00803322|TB|tb
5630359|NCT00777998|Stem Cell Transplantation|stem cell transplantation
5630360|NCT00777998|Thalidomide|thalidomide
5630361|NCT00777998|DLI|dli
5630362|NCT00777985|Cardiovascular system|cardiovascular system
5630363|NCT00777985|Sleep|sleep
5630364|NCT00777985|Endothelial function|endothelial function
5630365|NCT00777985|Endothelin system|endothelin system
5630366|NCT00777972|Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions|bioequivalence fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions
5630367|NCT00777946|Aliskiren, Amlodipine, Non-responder to aliskiren|aliskiren, amlodipine, non-responder to aliskiren
5630368|NCT00777907|neurovascular embolization|neurovascular embolization
5630369|NCT00777907|therapeutic embolization|therapeutic embolization
5630370|NCT00777894|advanced adult primary liver cancer|advanced adult primary liver cancer
5630371|NCT00777894|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5630372|NCT00777894|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5630373|NCT00777855|warfarin|warfarin
5630374|NCT00777855|pharmacokinetics|pharmacokinetics
5630375|NCT00777855|drug transporter|drug transporter
5630376|NCT00777855|healthy volunteer|healthy volunteer
5630377|NCT00777855|drug interaction|drug interaction
5630378|NCT00777855|rifampin|rifampin
5630379|NCT00777829|Nap|nap
5630380|NCT00777829|Pharmacology|pharmacology
5630381|NCT00777829|Memory|memory
5630382|NCT00777829|Visual Learning|visual learning
5630383|NCT00777829|Verbal Memory|verbal memory
5630384|NCT00777829|Motor Learning|motor learning
5630386|NCT00777816|Arthritis|arthritis
5630387|NCT00777790|Meningitis|meningitis
5630388|NCT00777790|Meningococcemia|meningococcemia
5630389|NCT00777790|Neisseria meningitidis|neisseria meningitidis
5630390|NCT00777777|multi-vessel, therapy, surgery, CABG|multi-vessel, therapy, surgery, cabg
5630391|NCT00777764|Xolair|xolair
5630392|NCT00777764|Asthma|asthma
5630393|NCT00777764|Skin Tests|skin tests
5630394|NCT00777751|Chest Tumor|chest tumor
5630395|NCT00777751|Heart|heart
5630396|NCT00777751|Lung Cancer|lung cancer
5630397|NCT00777751|Esophageal Cancer|esophageal cancer
5630398|NCT00777751|Thymoma|thymoma
5630399|NCT00777751|Radiation dose to the heart|radiation dose to the heart
5630400|NCT00777751|Cardiac Enzymes|cardiac enzymes
5630401|NCT00777751|Cardiac Biomarkers|cardiac biomarkers
5630402|NCT00777751|Radiation Therapy|radiation therapy
5630403|NCT00777751|RT|rt
5630404|NCT00777751|Electrocardiograms|electrocardiograms
5630405|NCT00777751|ECG|ecg
5630406|NCT00777738|Advanced Waldenström's macroglobulinemia|advanced waldenström's macroglobulinemia
5630407|NCT00777738|Bortezomib|bortezomib
5630408|NCT00777738|Dexamethasone|dexamethasone
5630411|NCT00777712|Wound healing|wound healing
5630413|NCT00777712|inflammatory cell|inflammatory cell
5630414|NCT00777712|monocyte|monocyte
5630415|NCT00777712|leukocyte|leukocyte
5630416|NCT00777712|macrophage|macrophage
5630417|NCT00777699|Cancer|cancer
5630418|NCT00777699|Solid Tumors|solid tumors
5630419|NCT00777699|NSCLC|nsclc
5630420|NCT00777686|Intracranial Glioblastoma|intracranial glioblastoma
5630421|NCT00777686|Intracranial Gliosarcoma|intracranial gliosarcoma
5630422|NCT00777686|glioblastoma|glioblastoma
5630423|NCT00777686|recurrent glioblastoma|recurrent glioblastoma
5630424|NCT00777686|gliosarcoma|gliosarcoma
5630425|NCT00777686|brain cancer|brain cancer
5630426|NCT00777686|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5630427|NCT00777686|MRS|mrs
5630428|NCT00777686|magnetic resonance imaging|magnetic resonance imaging
5630429|NCT00777686|MRI|mri
5630430|NCT00777686|MRI/MRS|mri/mrs
5630431|NCT00777686|Recurrent Glioblastoma Treated with Antiangiogenic agents|recurrent glioblastoma treated with antiangiogenic agents
5630432|NCT00777686|contrast enhanced MRI|contrast enhanced mri
5630433|NCT00777686|DCE-MRI|dce-mri
5630434|NCT00777686|diffusion-weighted MRI|diffusion-weighted mri
5630435|NCT00777686|DSC|dsc
5630436|NCT00777686|DW-MRI|dw-mri
5630437|NCT00777673|Breast Cancer|breast cancer
5630438|NCT00777673|Triple Negative|triple negative
5630439|NCT00777673|Neoadjuvant|neoadjuvant
5630440|NCT00777673|Neoadjuvant therapy|neoadjuvant therapy
5630441|NCT00777673|ER, PR and HER2 Negative|er, pr and her2 negative
5630442|NCT00777634|Binge Eating Disorder|binge eating disorder
5630443|NCT00777634|Eating Disorder|eating disorder
5630445|NCT00777595|CHF 4226 HFA|chf 4226 hfa
5630446|NCT00777595|pMDI|pmdi
5630447|NCT00777595|Carmoterol|carmoterol
5630448|NCT00777582|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
5630449|NCT00777582|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
5630450|NCT00777582|Advanced solid tumours|advanced solid tumours
5630451|NCT00777569|Smoking|smoking
5630452|NCT00777569|PREPS|preps
5630453|NCT00777569|Harm reduction|harm reduction
5630454|NCT00777569|Biomarkers of tobacco exposure|biomarkers of tobacco exposure
5630455|NCT00777569|Compensatory smoking|compensatory smoking
5630456|NCT00777543|Bioavailability|bioavailability
5630457|NCT00777543|Ferulic acid|ferulic acid
5630458|NCT00777543|Phenolic compounds|phenolic compounds
5630459|NCT00777543|Colonic metabolites|colonic metabolites
5630460|NCT00777543|Immunomodulatory effects|immunomodulatory effects
5630461|NCT00777543|No disease|no disease
5630462|NCT00777517|Cardiovascular Diseases|cardiovascular diseases
5630463|NCT00777504|angiogenesis|angiogenesis
5630464|NCT00777504|inhibitor|inhibitor
5630465|NCT00777504|duration of therapy|duration of therapy
5630466|NCT00777504|GIST|gist
5630467|NCT00777491|stage II bladder cancer|stage ii bladder cancer
5630468|NCT00777491|stage III bladder cancer|stage iii bladder cancer
5630469|NCT00777491|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5630470|NCT00777478|Sunitinib|sunitinib
5630471|NCT00777478|Capecitabine|capecitabine
5630472|NCT00777478|Irinotecan|irinotecan
5630473|NCT00777478|colorectal cancer|colorectal cancer
5630474|NCT00777465|Acute kidney injury|acute kidney injury
5630475|NCT00777465|Kidney failure|kidney failure
5630476|NCT00777465|Risk factors|risk factors
5630477|NCT00777465|Clinical outcomes|clinical outcomes
5630478|NCT00777465|Cardiac valve surgery|cardiac valve surgery
5630479|NCT00777465|Coronary artery bypass grafting|coronary artery bypass grafting
5630480|NCT00777465|Morbidity|morbidity
5630481|NCT00777465|Mortality|mortality
5630482|NCT00777452|quality of life|quality of life
5630483|NCT00777452|localized prostate cancer|localized prostate cancer
5630484|NCT00777452|FACT-P|fact-p
5630485|NCT00777439|Dopamine|dopamine
5630486|NCT00777439|Domperidone|domperidone
5630487|NCT00777439|Gastroparesis|gastroparesis
5630585|NCT00777101|Nerlynx|nerlynx
5630488|NCT00777439|Gastrointestinal Diseases|gastrointestinal diseases
5630489|NCT00777439|Neurologic Manifestations|neurologic manifestations
5630490|NCT00777439|Stomach Diseases|stomach diseases
5630491|NCT00777439|Digestive System Diseases|digestive system diseases
5630492|NCT00777439|Esophagitis|esophagitis
5630493|NCT00777439|Esophageal Disorders|esophageal disorders
5630494|NCT00777439|Paralysis|paralysis
5630495|NCT00777426|HIV positive with HAD|hiv positive with had
5630496|NCT00777413|Bioequiavlence Minocycline Tablets|bioequiavlence minocycline tablets
5630497|NCT00777400|Kidney transplant|kidney transplant
5630498|NCT00777400|T regulatory cells|t regulatory cells
5630499|NCT00777400|Efalizumab|efalizumab
5630500|NCT00777400|Rejection|rejection
5630501|NCT00777400|Safely convert renal transplant from mycophenolate mofetil and Calcineurin inhibitor to efalizumab and sirolimus|safely convert renal transplant from mycophenolate mofetil and calcineurin inhibitor to efalizumab and sirolimus
5630502|NCT00777387|human oocyte cryopreservation|human oocyte cryopreservation
5630504|NCT00777387|vitrification|vitrification
5630505|NCT00777361|Mass balance|mass balance
5630506|NCT00777361|AZD3480, Pharmacokinetics, Healthy volunteers|azd3480, pharmacokinetics, healthy volunteers
5630508|NCT00777322|pellucid marginal degeneration|pellucid marginal degeneration
5630509|NCT00777322|corneal ectasia|corneal ectasia
5630510|NCT00777322|collagen cross-linking|collagen cross-linking
5630511|NCT00777322|riboflavin|riboflavin
5630512|NCT00777322|UV light|uv light
5630513|NCT00777322|excimer laser|excimer laser
5630514|NCT00777322|Topography-Computer Assisted Treatment (T-Cat)|topography-computer assisted treatment (t-cat)
5630515|NCT00777322|Wavelight Allegretto laser|wavelight allegretto laser
5630516|NCT00777309|NSCLC|nsclc
5630517|NCT00777296|Cystic Fibrosis|cystic fibrosis
5630518|NCT00777296|Respiratory Infections|respiratory infections
5630519|NCT00777296|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5630520|NCT00777296|CFTR|cftr
5630521|NCT00777270|episiotomy|episiotomy
5630522|NCT00777270|perineal lesion|perineal lesion
5630523|NCT00777270|vaginal trauma|vaginal trauma
5630524|NCT00777257|Meningitis|meningitis
5630525|NCT00777257|Meningococcemia|meningococcemia
5630526|NCT00777257|Pertussis|pertussis
5630527|NCT00777257|Neisseria meningitidis|neisseria meningitidis
5630528|NCT00777257|Tetanus|tetanus
5630529|NCT00777257|Diphtheria|diphtheria
5630530|NCT00777244|mitotane|mitotane
5630531|NCT00777244|adjuvant therapy|adjuvant therapy
5630532|NCT00777244|disease free survival|disease free survival
5630533|NCT00777231|Sickle Cell|sickle cell
5630534|NCT00777231|Stem Cell|stem cell
5630535|NCT00777231|Tolerance|tolerance
5630536|NCT00777231|Bone Marrow Transplant|bone marrow transplant
5630537|NCT00777231|Total Body Irradiation (TBI)|total body irradiation (tbi)
5630538|NCT00777231|Apheresis|apheresis
5630539|NCT00777231|Aplastic Anemia|aplastic anemia
5630540|NCT00777231|Hemoglobinopathies|hemoglobinopathies
5630541|NCT00777231|Non Malignant|non malignant
5630542|NCT00777218|migraine|migraine
5630543|NCT00777205|Peer Support|peer support
5630544|NCT00777205|Quality of Life|quality of life
5630545|NCT00777205|Telephone|telephone
5630546|NCT00777192|colon cancer|colon cancer
5630547|NCT00777192|Cancers of the colon and rectum|cancers of the colon and rectum
5630548|NCT00777192|Oxaliplatin|oxaliplatin
5630549|NCT00777192|oxaliplatin chemotherapy|oxaliplatin chemotherapy
5630550|NCT00777192|inflammatory cytokines|inflammatory cytokines
5630551|NCT00777192|neurocognitive symptoms|neurocognitive symptoms
5630552|NCT00777192|neuropsychiatric symptoms|neuropsychiatric symptoms
5630553|NCT00777179|Vandetanib, NSCLC, Maintenance, Phase II|vandetanib, nsclc, maintenance, phase ii
5630554|NCT00777166|oxytocin|oxytocin
5630555|NCT00777166|ST depression|st depression
5630556|NCT00777166|cesarean section|cesarean section
5630557|NCT00777166|blood loss|blood loss
5630558|NCT00777153|Cancer|cancer
5630559|NCT00777153|Tumour|tumour
5630560|NCT00777153|Advanced Solid Tumour|advanced solid tumour
5630561|NCT00777153|GBM|gbm
5630562|NCT00777153|Glioblastoma|glioblastoma
5630563|NCT00777140|Stroke|stroke
5630564|NCT00777140|Ischemic Stroke|ischemic stroke
5630565|NCT00777140|Thrombolytic treatment|thrombolytic treatment
5630566|NCT00777140|Middle cerebral artery occlusion|middle cerebral artery occlusion
5630567|NCT00777140|Deferoxamine|deferoxamine
5630568|NCT00777140|Iron chelator|iron chelator
5630569|NCT00777140|Acute Ischemic Stroke treated with Intravenous Thrombolytic|acute ischemic stroke treated with intravenous thrombolytic
5630570|NCT00777127|actinic keratosis|actinic keratosis
5630571|NCT00777127|invasive SCC|invasive scc
5630572|NCT00777127|in situ SCC|in situ scc
5630573|NCT00777127|histological classification|histological classification
5630574|NCT00777127|histological progression|histological progression
5630575|NCT00777127|clinical clearance|clinical clearance
5630576|NCT00777127|cryotherapy|cryotherapy
5630577|NCT00777114|relapsed non-Hodgkin's lymphoma|relapsed non-hodgkin's lymphoma
5630578|NCT00777101|HER2|her2
5630579|NCT00777101|ErbB2|erbb2
5630580|NCT00777101|metastatic|metastatic
5630581|NCT00777101|neratinib|neratinib
5630582|NCT00777101|lapatinib|lapatinib
5630583|NCT00777101|capecitabine|capecitabine
5630584|NCT00777101|HKI-272|hki-272
5630586|NCT00777101|PB-272|pb-272
5630587|NCT00777088|neurovascular embolization|neurovascular embolization
5630588|NCT00777088|therapeutic embolization|therapeutic embolization
5630589|NCT00777075|nitrate|nitrate
5630590|NCT00777075|nitric oxide|nitric oxide
5630591|NCT00777075|asymmetric dimethylarginine|asymmetric dimethylarginine
5630592|NCT00777075|blood pressure|blood pressure
5630593|NCT00777075|NOS|nos
5630594|NCT00777075|IIEF|iief
5630595|NCT00777062|alcohol|alcohol
5630596|NCT00777062|cocaine|cocaine
5630597|NCT00777062|addiction|addiction
5630598|NCT00777062|alcoholism|alcoholism
5630599|NCT00777062|substance dependence|substance dependence
5630600|NCT00777062|substance abuse|substance abuse
5630601|NCT00777036|Leukemia, Pediatric|leukemia, pediatric
5630602|NCT00777023|Hot Flashes|hot flashes
5630603|NCT00777023|Hot Flushes|hot flushes
5630604|NCT00777023|Postmenopausal symptoms|postmenopausal symptoms
5630605|NCT00777023|Vasomotor symptoms|vasomotor symptoms
5630606|NCT00777010|memory loss|memory loss
5630608|NCT00777010|forgetfulness|forgetfulness
5630609|NCT00776997|Gastroesophageal Reflux|gastroesophageal reflux
5671708|NCT00614718|ICD complication|icd complication
5630610|NCT00776958|A Lynne Cohen Consortium Project|a lynne cohen consortium project
5630611|NCT00776958|Multi-Center Database Registry|multi-center database registry
5630612|NCT00776958|High Risk|high risk
5630614|NCT00776958|Breast|breast
5630615|NCT00776958|BRCA1 or BRCA2 gene|brca1 or brca2 gene
5630616|NCT00776958|Ovary|ovary
5630617|NCT00776958|Questionnaire|questionnaire
5630618|NCT00776919|Acne Vulgaris|acne vulgaris
5630619|NCT00776919|Acne|acne
5630620|NCT00776880|Surgical operation|surgical operation
5630621|NCT00776867|Pediatric|pediatric
5630622|NCT00776867|solid tumors|solid tumors
5630623|NCT00776867|Pediatric solid tumors|pediatric solid tumors
5630624|NCT00776867|08-091|08-091
5630625|NCT00776841|Phase-I|phase-i
5630626|NCT00776841|Hypercholesterolemia|hypercholesterolemia
5630627|NCT00776841|Obesity|obesity
5630628|NCT00776841|fatty liver|fatty liver
5630629|NCT00776841|Part A: Healthy male volunteers Part B: Mildly overweight, otherwise healthy hypercholesterolemic male volunteers|part a: healthy male volunteers part b: mildly overweight, otherwise healthy hypercholesterolemic male volunteers
5630630|NCT00776828|cilostazol|cilostazol
5630631|NCT00776828|clopidogrel|clopidogrel
5630632|NCT00776828|statin|statin
5630633|NCT00776828|drug-eluting stent|drug-eluting stent
5630634|NCT00776802|GCS-100|gcs-100
5630635|NCT00776802|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5630636|NCT00776802|DLBCL|dlbcl
5630637|NCT00776802|Relapsed or refractory DLBCL|relapsed or refractory dlbcl
5630638|NCT00776802|Etoposide; Dexamethasone|etoposide; dexamethasone
5630639|NCT00776789|Skin to skin contact|skin to skin contact
5630640|NCT00776789|Salivary cortisol|salivary cortisol
5630641|NCT00776789|Breast feeding Behavior|breast feeding behavior
5630642|NCT00776776|BMI > 40|bmi > 40
5630643|NCT00776776|Obesity|obesity
5630644|NCT00776776|Adolescents|adolescents
5630645|NCT00776776|Weight Loss Surgery|weight loss surgery
5630646|NCT00776737|Attention Deficit Disorder|attention deficit disorder
5630647|NCT00776737|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5630648|NCT00776737|Computer Aided Learning|computer aided learning
5630649|NCT00776737|Attention Deficits|attention deficits
5630650|NCT00776737|Healthy Volunteer|healthy volunteer
5630652|NCT00776724|breast ca|breast ca
5630653|NCT00776724|phase III|phase iii
5630654|NCT00776724|Tailored neoadjuvant chemotherapy|tailored neoadjuvant chemotherapy
5630655|NCT00776724|stage II/III|stage ii/iii
5630656|NCT00776711|Healthy|healthy
5630657|NCT00776711|Avian Influenza|avian influenza
5630658|NCT00776711|Immunity|immunity
5630659|NCT00776711|Preventive|preventive
5630660|NCT00776711|Bird Flu|bird flu
5630661|NCT00776711|Healthy Volunteer|healthy volunteer
5630662|NCT00776711|HV|hv
5630663|NCT00776711|Influenza|influenza
5630664|NCT00776672|Bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
5630665|NCT00776659|An Observational Study of Indian Breast Cancer Patients Receiving Adjuvant Therapy with Aromasin|an observational study of indian breast cancer patients receiving adjuvant therapy with aromasin
5630666|NCT00776659|Antineoplastic Hormonal Drugs|antineoplastic hormonal drugs
5630667|NCT00776659|Aromasin|aromasin
5630668|NCT00776646|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions|bioequivalence hydrochlorothiazide 50 mg tablet fasting conditions
5630669|NCT00776633|aspirin|aspirin
5630670|NCT00776633|clopidogrel|clopidogrel
5630671|NCT00776633|oral anticoagulation|oral anticoagulation
5630672|NCT00776633|warfarin|warfarin
5630673|NCT00776633|drug eluting stent|drug eluting stent
5630674|NCT00776633|phenprocoumon|phenprocoumon
5630675|NCT00776620|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
5630676|NCT00776607|LADA|lada
5630677|NCT00776607|Latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
5630678|NCT00776607|Type 1.5|type 1.5
5630679|NCT00776607|Slowly progressive type 1 diabetes|slowly progressive type 1 diabetes
5630680|NCT00776594|Androgen deprivation therapy|androgen deprivation therapy
5630681|NCT00776594|ADT|adt
5630682|NCT00776594|bevacizumab|bevacizumab
5630871|NCT00775645|neuropathy|neuropathy
5630687|NCT00776542|bioequivalence Minocycline Tablets|bioequivalence minocycline tablets
5630688|NCT00776529|sensorimotor training|sensorimotor training
5630689|NCT00776529|Strengthening|strengthening
5630690|NCT00776529|Balance|balance
5630691|NCT00776516|Healthy volunteer subjects|healthy volunteer subjects
5630692|NCT00776516|CYP3A4 inducer|cyp3a4 inducer
5630693|NCT00776516|rifampin|rifampin
5630694|NCT00776516|drug interaction|drug interaction
5630695|NCT00776516|pharmacokinetics|pharmacokinetics
5630696|NCT00776516|YM178|ym178
5630697|NCT00776516|mirabegron|mirabegron
5630698|NCT00776503|Epigenetic|epigenetic
5630699|NCT00776503|Myelodysplasia|myelodysplasia
5630700|NCT00776503|Cytarabine|cytarabine
5630701|NCT00776490|Bioequivalence Glimepiride Tablets|bioequivalence glimepiride tablets
5630702|NCT00776451|AMD|amd
5630703|NCT00776438|Influenza|influenza
5630704|NCT00776438|Orthomyxoviruses|orthomyxoviruses
5630705|NCT00776438|Myxovirus Infection|myxovirus infection
5630706|NCT00776438|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5630707|NCT00776438|Adults|adults
5630708|NCT00776438|Elderly|elderly
5630709|NCT00776412|Immunologic Non-Responder|immunologic non-responder
5630710|NCT00776412|Cardiovascular Disease|cardiovascular disease
5630711|NCT00776412|Antiretroviral|antiretroviral
5630712|NCT00776412|Mortality|mortality
5630713|NCT00776412|HIV Positive|hiv positive
5630714|NCT00776412|HIV Negative|hiv negative
5630715|NCT00776412|Healthy Volunteer|healthy volunteer
5630717|NCT00776399|Colorectal cancer|colorectal cancer
5630718|NCT00776399|lung metastasis|lung metastasis
5630719|NCT00776399|radiofrequency ablation|radiofrequency ablation
5630720|NCT00776399|metastasectomy|metastasectomy
5630721|NCT00776399|Lung metastasis from colorectal cancer|lung metastasis from colorectal cancer
5630722|NCT00776373|ALL|all
5630723|NCT00776373|Burkitt's Lymphoma|burkitt's lymphoma
5630724|NCT00776373|Adult T-Cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5630725|NCT00776373|Lymphoblastic leukemia|lymphoblastic leukemia
5630726|NCT00776373|CML in lymphoid blast crisis patients|cml in lymphoid blast crisis patients
5630727|NCT00776373|HiVAC|hivac
5630728|NCT00776373|Rapamycin|rapamycin
5630729|NCT00776360|oxytocin|oxytocin
5630730|NCT00776360|gastroparesis|gastroparesis
5630731|NCT00776360|diabetics|diabetics
5630732|NCT00776360|The effect of oxytocin on gastric emptying|the effect of oxytocin on gastric emptying
5630733|NCT00776347|Dementia with Lewy bodies (DLB)|dementia with lewy bodies (dlb)
5630734|NCT00776347|FDG-PET|fdg-pet
5630735|NCT00776334|bioequivalence Fosinopril Tablets|bioequivalence fosinopril tablets
5630736|NCT00776321|hypercholesterolemia|hypercholesterolemia
5630738|NCT00776321|thyroid|thyroid
5630739|NCT00776321|safety|safety
5630740|NCT00776308|molecular breast imaging|molecular breast imaging
5630741|NCT00776308|breast cancer|breast cancer
5630742|NCT00776308|mammography|mammography
5630743|NCT00776295|Small Cell Lung Cancer|small cell lung cancer
5630744|NCT00776295|SCLC|sclc
5630745|NCT00776295|Limited Stage Small Cell Lung Cancer|limited stage small cell lung cancer
5630746|NCT00776282|bioequivalence loratadine 10 mg orally disintegrating|bioequivalence loratadine 10 mg orally disintegrating
5630747|NCT00776282|tablets fed conditions|tablets fed conditions
5630748|NCT00776269|Argon laser|argon laser
5630749|NCT00776269|Trichiasis|trichiasis
5630750|NCT00776269|Radiofrequency|radiofrequency
5630751|NCT00776269|Patients with trichiasis|patients with trichiasis
5630752|NCT00776256|satiety|satiety
5630753|NCT00776256|food intake|food intake
5630754|NCT00776243|incretin|incretin
5630755|NCT00776243|GLP-1|glp-1
5630756|NCT00776243|GIP|gip
5630757|NCT00776243|intensive insulin therapy|intensive insulin therapy
5630758|NCT00776217|bioequivalence loratadine 10 mg orally disintegrating tablets fasting|bioequivalence loratadine 10 mg orally disintegrating tablets fasting
5630759|NCT00776204|Coronary Artery Disease|coronary artery disease
5630760|NCT00776204|Drug eluting stent|drug eluting stent
5630761|NCT00776204|Percutaneous Coronary Interventions|percutaneous coronary interventions
5630762|NCT00776204|Optical Coherence Tomography|optical coherence tomography
5630763|NCT00776191|Physioneal 35|physioneal 35
5630764|NCT00776191|Physioneal 40|physioneal 40
5630765|NCT00776191|children|children
5630766|NCT00776191|chronic peritoneal dialysis|chronic peritoneal dialysis
5630771|NCT00776139|Cetirizine Hydrochloride 10 mg tablet fasting conditions|cetirizine hydrochloride 10 mg tablet fasting conditions
5630772|NCT00776126|Breast|breast
5630773|NCT00776126|3D Digital Mammography|3d digital mammography
5612454|NCT00848263|Fracture|fracture
5630774|NCT00776126|Digital Breast Tomosynthesis|digital breast tomosynthesis
5630775|NCT00776113|Bioequivalence Carvedilol fasting|bioequivalence carvedilol fasting
5630776|NCT00776100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5630782|NCT00776087|Medical costs|medical costs
5630783|NCT00776087|Telemonitoring|telemonitoring
5630784|NCT00776087|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5630785|NCT00776074|Leiomyoma|leiomyoma
5630786|NCT00776074|Uterine Fibroids|uterine fibroids
5630787|NCT00776074|Drug Therapy|drug therapy
5630788|NCT00776074|Uterine Neoplasms|uterine neoplasms
5630789|NCT00776074|Fibroid Tumor|fibroid tumor
5630790|NCT00776035|Obesity|obesity
5630791|NCT00776035|Heart|heart
5630792|NCT00776035|Failure|failure
5630793|NCT00776035|PET|pet
5630794|NCT00776035|radiation|radiation
5630795|NCT00776035|metabolism|metabolism
5630796|NCT00776022|Bioequivalence Cetirizine Hydrochloride 10 mg tablet fed conditions|bioequivalence cetirizine hydrochloride 10 mg tablet fed conditions
5630797|NCT00776009|ADHD, children, subjects, laboratory classroom|adhd, children, subjects, laboratory classroom
5630798|NCT00775996|bioequivalence Clorazepate Tablets|bioequivalence clorazepate tablets
5630799|NCT00775970|Obesity|obesity
5630800|NCT00775970|Weight loss maintenance|weight loss maintenance
5630801|NCT00775970|Spontaneous physical activity|spontaneous physical activity
5630802|NCT00775970|Lipid oxydation|lipid oxydation
5630803|NCT00775970|Walking|walking
5630804|NCT00775944|Tobacco|tobacco
5630805|NCT00775944|Cigarette|cigarette
5630808|NCT00775944|Nicotine Replacement Therapy|nicotine replacement therapy
5630810|NCT00775944|Quitline|quitline
5630811|NCT00775944|Helpline|helpline
5630812|NCT00775931|osteopetrosis|osteopetrosis
5630813|NCT00775918|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
5630814|NCT00775905|Bioequivalence amlodipine tablets fasting|bioequivalence amlodipine tablets fasting
5630815|NCT00775892|ACL|acl
5630816|NCT00775892|Ligament|ligament
5630817|NCT00775879|Général anesthesia|général anesthesia
5630818|NCT00775879|Gynecology|gynecology
5630819|NCT00775866|prostate cancer, magnetic resonance imaging, guided imagery|prostate cancer, magnetic resonance imaging, guided imagery
5630827|NCT00775840|Cardiac Failure|cardiac failure
5630828|NCT00775840|Congestive Heart Failure|congestive heart failure
5630829|NCT00775840|Drug Therapy|drug therapy
5630830|NCT00775840|Hypertension|hypertension
5630831|NCT00775840|Diabetes Mellitus|diabetes mellitus
5630832|NCT00775827|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
5630833|NCT00775814|Hypertension|hypertension
5630834|NCT00775814|Drug Therapy|drug therapy
5630835|NCT00775814|Blood Pressure|blood pressure
5630836|NCT00775814|Insulin, Resistant|insulin, resistant
5630837|NCT00775788|Fat Injection to Breast|fat injection to breast
5630838|NCT00775788|Fat Grafting to Breast|fat grafting to breast
5630839|NCT00775762|Symptomatic Polyvascular disease|symptomatic polyvascular disease
5630840|NCT00775762|Multiple recurrent cardiovascular events|multiple recurrent cardiovascular events
5630841|NCT00775749|post operative nausea and vomiting|post operative nausea and vomiting
5630842|NCT00775749|gynecological surgery|gynecological surgery
5630843|NCT00775749|outpatient surgery|outpatient surgery
5630844|NCT00775749|nicotine patch|nicotine patch
5630845|NCT00775749|laparoscopic surgery|laparoscopic surgery
5630846|NCT00775723|6sulphatoxymelatonin|6sulphatoxymelatonin
5630847|NCT00775723|preterm infants|preterm infants
5630848|NCT00775723|melatonin is low in preterm infants at least until the age of 6 months|melatonin is low in preterm infants at least until the age of 6 months
5630849|NCT00775697|wheezing|wheezing
5630850|NCT00775697|children|children
5630851|NCT00775697|montelukast|montelukast
5630852|NCT00775697|bronchodilators|bronchodilators
5630853|NCT00775697|lung function|lung function
5630854|NCT00775697|Rint|rint
5630855|NCT00775684|Exenatide|exenatide
5630856|NCT00775684|Sitagliptin|sitagliptin
5630857|NCT00775684|Glimepiride|glimepiride
5630858|NCT00775684|Glucagon-Like Peptide-1|glucagon-like peptide-1
5630859|NCT00775684|Impaired Fasting Glucose|impaired fasting glucose
5630860|NCT00775684|Type 2 Diabetes|type 2 diabetes
5630861|NCT00775684|Beta-cell Function|beta-cell function
5630863|NCT00775684|Glucose-potentiated arginine|glucose-potentiated arginine
5630864|NCT00775658|allergy|allergy
5630865|NCT00775658|skin testing|skin testing
5630866|NCT00775658|eye drops|eye drops
5630867|NCT00775658|antihistamines|antihistamines
5630868|NCT00775645|neurotoxicity|neurotoxicity
5630869|NCT00775645|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5630870|NCT00775645|fatigue|fatigue
5630872|NCT00775645|stage IA breast cancer|stage ia breast cancer
5630873|NCT00775645|stage IB breast cancer|stage ib breast cancer
5630874|NCT00775645|stage II breast cancer|stage ii breast cancer
5630875|NCT00775645|stage IIIA breast cancer|stage iiia breast cancer
5630876|NCT00775645|stage IIIB breast cancer|stage iiib breast cancer
5630877|NCT00775645|stage IIIC breast cancer|stage iiic breast cancer
5630878|NCT00775632|Graft Versus Host Disease|graft versus host disease
5630879|NCT00775632|Alemtuzumab|alemtuzumab
5630881|NCT00775632|Bone Marrow Transplants|bone marrow transplants
5630882|NCT00775619|bioequivalence Carvedilol 12.5 mg tablets fed conditions|bioequivalence carvedilol 12.5 mg tablets fed conditions
5630883|NCT00775606|AIDS, HIV|aids, hiv
5630884|NCT00775593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5630885|NCT00775593|adult acute basophilic leukemia|adult acute basophilic leukemia
5630886|NCT00775593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5630887|NCT00775593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5630888|NCT00775593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5630889|NCT00775593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5630890|NCT00775593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5630891|NCT00775593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5630892|NCT00775593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5630893|NCT00775593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5630894|NCT00775593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5630895|NCT00775593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5630896|NCT00775593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5630897|NCT00775593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5630898|NCT00775593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5630899|NCT00775593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5630900|NCT00775580|bioequivalence Atenolol Tablets|bioequivalence atenolol tablets
5630902|NCT00775567|Intolerance|intolerance
5630903|NCT00775567|Adaptation|adaptation
5630904|NCT00775567|Prebiotic|prebiotic
5630905|NCT00775567|Healthy men or women 18-40|healthy men or women 18-40
5630906|NCT00775541|Diabetes|diabetes
5630907|NCT00775541|Type 2 Diabetes|type 2 diabetes
5630908|NCT00775528|Cystic Fibrosis|cystic fibrosis
5630909|NCT00775528|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5630911|NCT00775515|prostatitis|prostatitis
5630912|NCT00775515|prostate|prostate
5630913|NCT00775515|pain|pain
5630914|NCT00775515|pelvic|pelvic
5630915|NCT00775515|pelvis|pelvis
5630916|NCT00775515|inflamation|inflamation
5630917|NCT00775502|Multiple myeloma|multiple myeloma
5630918|NCT00775502|GM-2 ganglioside|gm-2 ganglioside
5630919|NCT00775502|monoclonal antibody|monoclonal antibody
5630920|NCT00775502|Potelligent design|potelligent design
5630921|NCT00775502|Treatment of subjects who have failed previous treatment|treatment of subjects who have failed previous treatment
5630922|NCT00775489|glaucoma, steroid, nasal|glaucoma, steroid, nasal
5630923|NCT00775476|Systemic lupus erythematosus (SLE), an autoimmune disease|systemic lupus erythematosus (sle), an autoimmune disease
5630924|NCT00775463|Scleroderma, Diffuse|scleroderma, diffuse
5630925|NCT00775463|Scleroderma, Limited|scleroderma, limited
5630926|NCT00775463|Scleroderma, Systemic|scleroderma, systemic
5630927|NCT00775463|Ulcer|ulcer
5630928|NCT00775463|prostacyclin|prostacyclin
5630929|NCT00775450|Influenza|influenza
5630930|NCT00775450|Orthomyxovirus Infection|orthomyxovirus infection
5630931|NCT00775450|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5630932|NCT00775450|Elderly|elderly
5630933|NCT00775437|juvenile idiopathic arthritis|juvenile idiopathic arthritis
5630934|NCT00775437|compassionate use|compassionate use
5630935|NCT00775437|open label|open label
5630936|NCT00775424|HIV infection|hiv infection
5630937|NCT00775424|DNA vaccine|dna vaccine
5630938|NCT00775424|IL-12 adjuvant|il-12 adjuvant
5630939|NCT00775424|IL-15 adjuvant|il-15 adjuvant
5630940|NCT00775398|Hemostasis|hemostasis
5630941|NCT00775398|Thrombin-JMI|thrombin-jmi
5630942|NCT00775398|Thrombin|thrombin
5630943|NCT00775398|Blood Coagulation|blood coagulation
5630944|NCT00775385|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5630945|NCT00775372|Bioequivalence study of clarithromycin 250mg/5mL powdder|bioequivalence study of clarithromycin 250mg/5ml powdder
5630946|NCT00775359|bioequivalence fenofibrate tablets|bioequivalence fenofibrate tablets
5630947|NCT00775333|Carpal Tunnel Syndrome|carpal tunnel syndrome
5630948|NCT00775333|Diabetes|diabetes
5630949|NCT00775333|APB strength|apb strength
5630950|NCT00775333|Sensory Function|sensory function
5630951|NCT00775333|Pillar Pain|pillar pain
5630952|NCT00775333|Cold Intolerance|cold intolerance
5630953|NCT00775333|Patient Satisfaction|patient satisfaction
5630954|NCT00775320|Brain scan|brain scan
5630955|NCT00775307|Non-small cell lung cancer|non-small cell lung cancer
5630956|NCT00775307|Stage I|stage i
5630957|NCT00775307|adjuvant therapy|adjuvant therapy
5630958|NCT00775307|Adjuvant Drug Therapy|adjuvant drug therapy
5630959|NCT00775281|Tachykinin receptors|tachykinin receptors
5630960|NCT00775281|Protein expression|protein expression
5630961|NCT00775281|Contractile proteins|contractile proteins
5630962|NCT00775281|Inflammatory proteins|inflammatory proteins
5630963|NCT00775268|18F Fluorothymidine|18f fluorothymidine
5630964|NCT00775268|PET/CT|pet/ct
5630965|NCT00775268|FLT|flt
5630966|NCT00775268|Lymphoma|lymphoma
5630967|NCT00775268|FDG|fdg
5612644|NCT00847509|[F-18]FDG|[f-18]fdg
5630968|NCT00775255|Bioequiavelnce clarithromycin|bioequiavelnce clarithromycin
5630969|NCT00775242|Menopause|menopause
5630970|NCT00775242|Hormone Replacement Therapy|hormone replacement therapy
5630971|NCT00775242|Microspheres|microspheres
5630972|NCT00775242|Progesterone|progesterone
5630973|NCT00775242|Estradiol|estradiol
5630974|NCT00775242|Hot flashes|hot flashes
5630975|NCT00775229|hair pulling|hair pulling
5630976|NCT00775203|Unipolar|unipolar
5630977|NCT00775190|birth control pills|birth control pills
5630978|NCT00775190|oral contraceptives|oral contraceptives
5630979|NCT00775190|brand name|brand name
5630980|NCT00775190|generic|generic
5630981|NCT00775190|side effects|side effects
5630982|NCT00775190|oral contraceptive side effects|oral contraceptive side effects
5630983|NCT00775190|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5630984|NCT00775190|pre-menstrual symptoms|pre-menstrual symptoms
5630985|NCT00775177|Bioequivalence Doxycycline monohydrate 100mg tablets fed conditions|bioequivalence doxycycline monohydrate 100mg tablets fed conditions
5630986|NCT00775164|Obese children with insulin resistance|obese children with insulin resistance
5630987|NCT00775151|Bioequivalence amlodipine 10 mg tablet under fed conditions|bioequivalence amlodipine 10 mg tablet under fed conditions
5630988|NCT00775138|Bronchiectasis|bronchiectasis
5630989|NCT00775138|Respiratory Infections|respiratory infections
5630990|NCT00775138|Amikacin|amikacin
5630991|NCT00775138|Respiratory Tract Diseases|respiratory tract diseases
5630992|NCT00775138|Respiratory Tract Infections|respiratory tract infections
5630993|NCT00775138|Lung Diseases|lung diseases
5630994|NCT00775138|Pseudomonas aeruginosa|pseudomonas aeruginosa
5630995|NCT00775138|Amikacin liposome inhalation suspension (ALIS)|amikacin liposome inhalation suspension (alis)
5630996|NCT00775125|VX-950-TiDP24-C124|vx-950-tidp24-c124
5630997|NCT00775125|VX-950-C124|vx-950-c124
5630998|NCT00775125|HCV|hcv
5630999|NCT00775125|DDI|ddi
5631000|NCT00775125|telaprevir|telaprevir
5631001|NCT00775125|darunavir|darunavir
5631002|NCT00775125|ritonavir|ritonavir
5631003|NCT00775125|fosamprenavir|fosamprenavir
5631004|NCT00775125|interaction|interaction
5631005|NCT00775125|pharmacokinetics|pharmacokinetics
5631006|NCT00775125|steady-state|steady-state
5631007|NCT00775112|supportive care|supportive care
5631008|NCT00775112|lumbar puncture|lumbar puncture
5631009|NCT00775112|childhood disease|childhood disease
5631010|NCT00775112|pediatric hemato-oncology|pediatric hemato-oncology
5631011|NCT00775099|Air Pollution|air pollution
5631012|NCT00775099|Particles|particles
5631013|NCT00775099|Particulate Matter|particulate matter
5631014|NCT00775099|Vascular function|vascular function
5631015|NCT00775099|Endothelial function|endothelial function
5631016|NCT00775099|Thrombosis|thrombosis
5631017|NCT00775086|ORTHO EVRA|ortho evra
5631018|NCT00775086|contraception|contraception
5631019|NCT00775086|NGMN|ngmn
5631020|NCT00775086|contraceptive patch|contraceptive patch
5631021|NCT00775086|bioequivalence|bioequivalence
5631022|NCT00775086|EE|ee
5631023|NCT00775086|norelgestromin|norelgestromin
5631024|NCT00775086|ethinyl estradiol|ethinyl estradiol
5631025|NCT00775073|Liver cancer|liver cancer
5631026|NCT00775073|HCC|hcc
5631027|NCT00775047|depo medroxyprogesterone acetate|depo medroxyprogesterone acetate
5631028|NCT00775047|Depo Provera|depo provera
5631029|NCT00775047|contraceptive compliance|contraceptive compliance
5631030|NCT00775047|pharmacists|pharmacists
5631031|NCT00775047|Compliance in receiving additional Depo Provera injections|compliance in receiving additional depo provera injections
5631032|NCT00775047|Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic|satisfaction in receiving depo provera injections at a pharmacy compared with usual clinic
5631033|NCT00775008|weight loss, health information, e-health|weight loss, health information, e-health
5631034|NCT00774995|Engerix-B|engerix-b
5631035|NCT00774995|Hepatitis B|hepatitis b
5631036|NCT00774982|Crohns Disease|crohns disease
5631037|NCT00774982|Pharmacokinetics|pharmacokinetics
5631038|NCT00774982|Local Targeted Delivery to the Ileum|local targeted delivery to the ileum
5631039|NCT00774982|Delayed Release|delayed release
5631040|NCT00774982|Immunology Measurements|immunology measurements
5631041|NCT00774982|Pharmacokinetics in Crohns Disease Patients|pharmacokinetics in crohns disease patients
5863024|NCT00001413|Osteoporosis|osteoporosis
5631042|NCT00774943|Systemic lupus erythematosus|systemic lupus erythematosus
5631043|NCT00774943|ICOSL|icosl
5631044|NCT00774943|B7RP-1|b7rp-1
5631045|NCT00774943|Costimulation|costimulation
5631046|NCT00774930|Carcinoid tumor|carcinoid tumor
5631047|NCT00774930|Somatuline Depot|somatuline depot
5631048|NCT00774930|Lanreotide Autogel|lanreotide autogel
5631049|NCT00774930|Neuroendocrine tumor|neuroendocrine tumor
5631050|NCT00774930|NET|net
5631051|NCT00774930|Diarrhea|diarrhea
5631052|NCT00774930|Flushing|flushing
5631053|NCT00774930|Carcinoid tumour|carcinoid tumour
5631054|NCT00774930|Neuroendocrine tumour|neuroendocrine tumour
5631055|NCT00774930|Diarrhoea|diarrhoea
5631056|NCT00774917|numen|numen
5631057|NCT00774917|hyperplasia|hyperplasia
5631058|NCT00774904|Type 2 Diabetes|type 2 diabetes
5631059|NCT00774904|Diabetic Nephropathy|diabetic nephropathy
5631060|NCT00774904|Glucose Metabolism|glucose metabolism
5612742|NCT00847158|iStent|istent
5631061|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5631062|NCT00774891|Echocardiography- exercise|echocardiography- exercise
5631063|NCT00774891|Echocardiography- dobutamine|echocardiography- dobutamine
5631064|NCT00774891|Wall stress|wall stress
5631065|NCT00774891|Ventricular volume-left|ventricular volume-left
5631066|NCT00774891|Ischemia|ischemia
5631067|NCT00774891|Angina|angina
5631068|NCT00774891|Heart diseases|heart diseases
5631069|NCT00774891|Stress echocardiography|stress echocardiography
5631070|NCT00774891|Ventricular volume|ventricular volume
5631071|NCT00774891|Vascular diseases|vascular diseases
5631072|NCT00774878|Breast cancer|breast cancer
5631073|NCT00774878|Breast Tumors|breast tumors
5631074|NCT00774878|Anti IGF-1R|anti igf-1r
5631075|NCT00774878|Hormonosensitivity|hormonosensitivity
5631076|NCT00774865|Robotic|robotic
5631077|NCT00774865|CABG|cabg
5631078|NCT00774865|LITA|lita
5631079|NCT00774865|Patency|patency
5631080|NCT00774865|Long|long
5631081|NCT00774865|Term|term
5631082|NCT00774852|lupus|lupus
5631083|NCT00774852|systemic lupus erythematosus|systemic lupus erythematosus
5631084|NCT00774852|lupus nephritis|lupus nephritis
5631085|NCT00774852|SLE|sle
5631086|NCT00774852|abatacept|abatacept
5631087|NCT00774852|CTLA4|ctla4
5631088|NCT00774852|CTLA4Ig|ctla4ig
5631089|NCT00774852|glomerulonephritis|glomerulonephritis
5631090|NCT00774839|Newly Diagnosed|newly diagnosed
5631092|NCT00774839|Stage II|stage ii
5631093|NCT00774839|Stage III|stage iii
5631094|NCT00774826|Follicular lymphoma|follicular lymphoma
5631095|NCT00774826|Rituximab|rituximab
5631096|NCT00774813|Depression|depression
5631098|NCT00774813|Moderate|moderate
5631099|NCT00774813|Anxiety|anxiety
5631100|NCT00774813|Kalaco Scientific, Inc.|kalaco scientific, inc.
5631101|NCT00774800|Recombinant Hyaluronidase|recombinant hyaluronidase
5631102|NCT00774800|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5631103|NCT00774800|Humalog|humalog
5631104|NCT00774800|Humulin R|humulin r
5631105|NCT00774800|rHuPH20|rhuph20
5631106|NCT00774800|Hylenex|hylenex
5631107|NCT00774787|Combination treatment|combination treatment
5631108|NCT00774787|Imiquimod|imiquimod
5631109|NCT00774787|Cryotherapy|cryotherapy
5631110|NCT00774774|Influenza, human|influenza, human
5631111|NCT00774774|Masks|masks
5631112|NCT00774774|Disease Transmission, Horizontal|disease transmission, horizontal
5631113|NCT00774761|Chronic|chronic
5631114|NCT00774761|Obstructive|obstructive
5631115|NCT00774761|Pulmonary|pulmonary
5631116|NCT00774761|Disease|disease
5631117|NCT00774761|COPD|copd
5631118|NCT00774761|Pharmacodynamic|pharmacodynamic
5631119|NCT00774761|Pharmacokinetic|pharmacokinetic
5631120|NCT00774748|low molecular weight heparin|low molecular weight heparin
5631121|NCT00774748|enoxaparin|enoxaparin
5631122|NCT00774748|Lovenox|lovenox
5631123|NCT00774748|Insuflon|insuflon
5631124|NCT00774748|subcutaneous catheter|subcutaneous catheter
5631125|NCT00774748|once or twice daily dosing of subcutaneous enoxaparin|once or twice daily dosing of subcutaneous enoxaparin
5631126|NCT00774735|healthy volunteer|healthy volunteer
5631127|NCT00774735|darunavir|darunavir
5631128|NCT00774735|lopinavir|lopinavir
5631129|NCT00774735|ritonavir|ritonavir
5631130|NCT00774735|GSK1349572|gsk1349572
5615797|NCT00834483|Safety|safety
5631131|NCT00774735|integrase|integrase
5631132|NCT00774735|pharmacokinetics|pharmacokinetics
5631133|NCT00774709|Heart failure|heart failure
5631134|NCT00774709|Preserved ejection fraction|preserved ejection fraction
5631135|NCT00774709|Diastolic dysfunction|diastolic dysfunction
5631136|NCT00774709|Dyssynchrony|dyssynchrony
5631137|NCT00774709|Echocardiography|echocardiography
5631138|NCT00774709|Patients with acute heart failure clinically|patients with acute heart failure clinically
5631139|NCT00774709|diagnosed|diagnosed
5631140|NCT00774709|BNP level > 100 ng / l or NT-proBNP > 300 ng /l|bnp level > 100 ng / l or nt-probnp > 300 ng /l
5631141|NCT00774709|Preserved left ventricular ejection fraction(LVEF|preserved left ventricular ejection fraction(lvef
5631142|NCT00774709|≥ 45%)|≥ 45%)
5631143|NCT00774696|Bioequivalence study of clarithromycin|bioequivalence study of clarithromycin
5631144|NCT00774683|Pilot|pilot
5631145|NCT00774683|Pharmacokinetics|pharmacokinetics
5631154|NCT00774657|Two dimensional echocardiography|two dimensional echocardiography
5631155|NCT00774657|Three dimensional echocardiography|three dimensional echocardiography
5631160|NCT00774618|Thoracic Injuries|thoracic injuries
5631162|NCT00774618|Rib Fracture Repair|rib fracture repair
5631163|NCT00774618|Rib Fracture ORIF|rib fracture orif
5631164|NCT00774618|Chronic rib fractures|chronic rib fractures
5631165|NCT00774618|Non-healing rib fractures|non-healing rib fractures
5631166|NCT00774618|Rib Fracture Non-union|rib fracture non-union
5631167|NCT00774605|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch|percutaneous, transcutaneous, topical, varenicline, transdermal, transdermal delivery system, patch
5631168|NCT00774592|Adolescent Risk Reduction|adolescent risk reduction
5631169|NCT00774592|HIV/AIDS Prevention|hiv/aids prevention
5631170|NCT00774592|Behavioral Change|behavioral change
5631171|NCT00774592|HIV|hiv
5631172|NCT00774579|growth hormone|growth hormone
5631173|NCT00774579|growth hormone deficiency|growth hormone deficiency
5631174|NCT00774579|liver fat|liver fat
5631175|NCT00774579|liver steatosis|liver steatosis
5631176|NCT00774579|growth hormone replacement|growth hormone replacement
5631177|NCT00774566|catheter ablation|catheter ablation
5631178|NCT00774566|randomized|randomized
5631179|NCT00774566|cryo|cryo
5631180|NCT00774566|radiofrequency|radiofrequency
5631181|NCT00774566|atrial fibrillation|atrial fibrillation
5631182|NCT00774566|cryo-balloon|cryo-balloon
5631183|NCT00774566|PV-Isolation|pv-isolation
5631184|NCT00774553|Type 2 diabetes|type 2 diabetes
5631185|NCT00774540|Acute pain|acute pain
5631186|NCT00774540|Inflammatory pain|inflammatory pain
5631187|NCT00774540|Inflammatory mediators|inflammatory mediators
5631188|NCT00774540|Pain relief|pain relief
5631189|NCT00774540|Microdialysis|microdialysis
5631190|NCT00774514|Air Pollution|air pollution
5631191|NCT00774514|Nitrogen Dioxide|nitrogen dioxide
5631192|NCT00774514|NO2|no2
5631193|NCT00774514|Endothelial dysfunction|endothelial dysfunction
5631194|NCT00774501|Anesthesia|anesthesia
5631195|NCT00774501|suspended ventilation|suspended ventilation
5631196|NCT00774488|Euglycemic-hyperinsulinemic clamp|euglycemic-hyperinsulinemic clamp
5631198|NCT00774488|microarray analysis|microarray analysis
5631199|NCT00774488|quantitative real time PCR|quantitative real time pcr
5631200|NCT00774488|overnutrition|overnutrition
5631201|NCT00774488|low grade-inflammation|low grade-inflammation
5631202|NCT00774475|Clopidogrel therapy|clopidogrel therapy
5631203|NCT00774475|platelet function inhibition|platelet function inhibition
5631204|NCT00774462|Myositis|myositis
5631205|NCT00774462|Anti-synthetase|anti-synthetase
5631206|NCT00774462|Anti-SRP|anti-srp
5631207|NCT00774462|Myasthenia gravis|myasthenia gravis
5631208|NCT00774462|Rituximab|rituximab
5631209|NCT00774449|lung transplantation|lung transplantation
5631210|NCT00774449|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5631211|NCT00774449|broncholaveolar lavage|broncholaveolar lavage
5631212|NCT00774449|high-resolution computertomography|high-resolution computertomography
5631213|NCT00774449|quality of life|quality of life
5631214|NCT00774436|focal cryotherapy|focal cryotherapy
5631215|NCT00774436|low-risk prostate cancer|low-risk prostate cancer
5631216|NCT00774423|Spinal muscular atrophies (SMA)|spinal muscular atrophies (sma)
5631217|NCT00774423|Degeneration of the motor neurons|degeneration of the motor neurons
5631218|NCT00774423|Anterior horn of the spinal cord|anterior horn of the spinal cord
5631219|NCT00774423|Riluzole|riluzole
5631220|NCT00774384|Neisseria meningitidis|neisseria meningitidis
5631222|NCT00774384|Vaccination|vaccination
5631223|NCT00774384|Immunity|immunity
5631224|NCT00774384|T cells|t cells
5631225|NCT00774384|T regulatory cells|t regulatory cells
5631226|NCT00774371|Overweight|overweight
5631227|NCT00774371|Obese|obese
5631228|NCT00774371|Breast cancer survivors|breast cancer survivors
5631229|NCT00774371|Weight loss|weight loss
5631230|NCT00774371|Physical activity|physical activity
5631231|NCT00774371|Exercise|exercise
5631232|NCT00774371|Cognitive behavioral therapy|cognitive behavioral therapy
5631233|NCT00774358|Primary Immunodeficiency|primary immunodeficiency
5631234|NCT00774319|HNSCC|hnscc
5631235|NCT00774319|neo Adjuvant|neo adjuvant
5631236|NCT00774319|Chemoradiation therapy|chemoradiation therapy
5631237|NCT00774319|TPF|tpf
5631238|NCT00774306|vascular risk|vascular risk
5631239|NCT00774306|lipid fractions|lipid fractions
5631240|NCT00774306|lipoprotein(a)|lipoprotein(a)
5631241|NCT00774306|C-reactive protein|c-reactive protein
5631242|NCT00774306|subarachnoid hemorrhage|subarachnoid hemorrhage
5631243|NCT00774306|antiepileptic drug|antiepileptic drug
5631244|NCT00774306|randomized|randomized
5631245|NCT00774306|seizure|seizure
5631246|NCT00774306|cholesterol|cholesterol
5631247|NCT00774293|Homoeopathic treatment,|homoeopathic treatment,
5631248|NCT00774293|heart surgery,|heart surgery,
5631249|NCT00774293|randomized clinical trial|randomized clinical trial
5631607|NCT00772746|respiration|respiration
5631253|NCT00774228|Cataract or intraocular lens placement surgery|cataract or intraocular lens placement surgery
5631254|NCT00774215|Pelvic Organ Prolapse|pelvic organ prolapse
5631255|NCT00774215|Cystocele|cystocele
5631256|NCT00774215|Rectocele|rectocele
5631257|NCT00774215|Enterocele|enterocele
5631258|NCT00774215|Synthetic Mesh|synthetic mesh
5631259|NCT00774215|Vaginal Mesh|vaginal mesh
5631260|NCT00774215|Transobturator|transobturator
5631261|NCT00774202|Pts w/ Chronic ITP who have fail/relap after Rituxan rx|pts w/ chronic itp who have fail/relap after rituxan rx
5631262|NCT00774189|Bioequivalence clarithromycin 250mg tablets fasting|bioequivalence clarithromycin 250mg tablets fasting
5631263|NCT00774176|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5631264|NCT00774176|COPD|copd
5631265|NCT00774176|COPD Exacerbation|copd exacerbation
5631266|NCT00774176|Genetic markers COPD|genetic markers copd
5631267|NCT00774176|Gene expression in COPD exacerbations|gene expression in copd exacerbations
5631268|NCT00774176|COPD Exacerbation Symptom Reporting|copd exacerbation symptom reporting
5631269|NCT00774176|COPD Exacerbation Disease Management|copd exacerbation disease management
5631270|NCT00774176|COPD Treatment|copd treatment
5631271|NCT00774176|Breathing disorders|breathing disorders
5631272|NCT00774176|Emphysema|emphysema
5631273|NCT00774176|COPD with Healthy Control comparators for genetic association studies.|copd with healthy control comparators for genetic association studies.
5631274|NCT00774163|probiotics|probiotics
5631275|NCT00774163|lactobacillus|lactobacillus
5631276|NCT00774163|reuteri|reuteri
5631277|NCT00774163|none (safety only)|none (safety only)
5631278|NCT00774150|Neural correlates of pediatric anxiety disorder|neural correlates of pediatric anxiety disorder
5631279|NCT00774150|Social correlates of pediatric anxiety disorder|social correlates of pediatric anxiety disorder
5631280|NCT00774150|Generalized Anxiety Disorder in pediatric populations|generalized anxiety disorder in pediatric populations
5631281|NCT00774150|Separation Anxiety Disorder in pediatric populations|separation anxiety disorder in pediatric populations
5631282|NCT00774150|Social Phobia in pediatric populations|social phobia in pediatric populations
5631283|NCT00774137|Acute Kidney Injury|acute kidney injury
5631284|NCT00774137|IL-18|il-18
5631285|NCT00774137|NGAL|ngal
5631286|NCT00774137|Cystatin C|cystatin c
5631287|NCT00774137|Biomarkers|biomarkers
5631288|NCT00774137|Dialysis|dialysis
5633687|NCT00764127|obesity|obesity
5631290|NCT00774111|healthy volunteer|healthy volunteer
5631291|NCT00774111|pharmacokinetics|pharmacokinetics
5631292|NCT00774111|GSK1349572|gsk1349572
5631293|NCT00774111|integrase|integrase
5631294|NCT00774111|etravirine|etravirine
5631295|NCT00774098|all adult patients (>18 years) planned to undergo a major liver resection|all adult patients (>18 years) planned to undergo a major liver resection
5631296|NCT00774085|Schizophrenia|schizophrenia
5631297|NCT00774085|Risperidone|risperidone
5631298|NCT00774085|Risperdal Consta|risperdal consta
5631299|NCT00774085|Propective|propective
5631300|NCT00774085|Retrospective|retrospective
5631301|NCT00774085|Mental disorders|mental disorders
5631302|NCT00774085|Observational|observational
5631303|NCT00774072|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways|subjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways
5631304|NCT00774059|Breast ptosis, Breast lift|breast ptosis, breast lift
5631305|NCT00774046|Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia|therapy-related myelodysplastic syndrome/ therapy -related acute myeloid leukemia
5631306|NCT00774046|Myelodysplastic syndrome|myelodysplastic syndrome
5631307|NCT00774046|Acute myeloid leukemia|acute myeloid leukemia
5631308|NCT00774033|Keratinocytes|keratinocytes
5631309|NCT00774033|Cell spray|cell spray
5631310|NCT00774033|Deep partial thickness burns|deep partial thickness burns
5631311|NCT00774033|Full thickness burns|full thickness burns
5631312|NCT00774020|Paget's Disease of Bone|paget's disease of bone
5631313|NCT00774020|Serum Alkaline Phosphatase|serum alkaline phosphatase
5631314|NCT00774007|Irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells|irritable bowel syndrome, abdominal pain, abdominal bloating, immune cells, mast cells
5631315|NCT00773994|anterior palatal eminence|anterior palatal eminence
5631316|NCT00773994|palatal elevation above the maxillary plane|palatal elevation above the maxillary plane
5631317|NCT00773994|anterior uvular prolapse|anterior uvular prolapse
5631318|NCT00773994|"inverted-V present in base view."|"inverted-v present in base view."
5631319|NCT00773981|anastomotic leakage|anastomotic leakage
5631320|NCT00773942|Medication therapy management|medication therapy management
5631322|NCT00773942|Chronic care|chronic care
5631323|NCT00773942|Medicare|medicare
5631324|NCT00773942|Medicaid|medicaid
5631325|NCT00773942|Medication reconciliation|medication reconciliation
5631326|NCT00773942|Adverse drug events|adverse drug events
5631327|NCT00773942|Drug related problems|drug related problems
5631329|NCT00773916|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5631330|NCT00773916|Hyperkinetic Syndrome|hyperkinetic syndrome
5631331|NCT00773916|Family Function|family function
5631332|NCT00773916|Adverse Factors|adverse factors
5631333|NCT00773916|Parental Psychopathology|parental psychopathology
5631334|NCT00773877|RNFL thickness|rnfl thickness
5631608|NCT00772746|anxiety|anxiety
5631335|NCT00773864|Healthcare employees who work in the rehabilitation center|healthcare employees who work in the rehabilitation center
5631336|NCT00773851|ventral hernia|ventral hernia
5631337|NCT00773851|laparoscopy|laparoscopy
5631338|NCT00773851|mesh|mesh
5631339|NCT00773851|recurrence|recurrence
5631340|NCT00773825|Genomic imprinting|genomic imprinting
5631341|NCT00773825|Reproductive techniques, assisted|reproductive techniques, assisted
5631342|NCT00773825|Beckwith-Wiedemann syndrome|beckwith-wiedemann syndrome
5631343|NCT00773825|Angelman syndrome|angelman syndrome
5631344|NCT00773812|Autistic Disorder|autistic disorder
5631345|NCT00773812|Autism|autism
5631346|NCT00773812|Mecamylamine|mecamylamine
5631347|NCT00773812|Pervasive Developmental Disorder-Not Otherwise Specified|pervasive developmental disorder-not otherwise specified
5613039|NCT00845988|Antipsychotic|antipsychotic
5631348|NCT00773799|To define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and|to define activities and patient characteristics likely to lead to dissemination of resistant bacteria in rehabilitation centers and
5631349|NCT00773799|To define specific risk factors for acquisition of resistant bacteria (ESBL producers and MRSA) in rehabilitation centers.|to define specific risk factors for acquisition of resistant bacteria (esbl producers and mrsa) in rehabilitation centers.
5631350|NCT00773799|ESBL producers|esbl producers
5631351|NCT00773799|MRSA|mrsa
5631352|NCT00773786|COPD|copd
5631353|NCT00773786|Bronchodilator|bronchodilator
5631354|NCT00773786|arformoterol|arformoterol
5631355|NCT00773786|tiotropium|tiotropium
5631356|NCT00773773|Biomarkers - PSA, hK2 and solubilized|biomarkers - psa, hk2 and solubilized
5631357|NCT00773773|urokinase-receptor forms (su-PAR)|urokinase-receptor forms (su-par)
5631358|NCT00773773|08-114|08-114
5631359|NCT00773760|opioids|opioids
5631360|NCT00773760|COMT|comt
5631361|NCT00773760|SNP|snp
5631362|NCT00773760|analgesia|analgesia
5631363|NCT00773760|postoperative pain|postoperative pain
5631364|NCT00773747|Neoplasms, Plasma Cell|neoplasms, plasma cell
5631365|NCT00773747|Neoplasms by Histologic Type|neoplasms by histologic type
5631366|NCT00773747|Neoplasms|neoplasms
5631367|NCT00773747|Hemostatic Disorders|hemostatic disorders
5631368|NCT00773747|Vascular Diseases|vascular diseases
5633791|NCT00763737|feto|feto
5631369|NCT00773747|Cardiovascular Diseases|cardiovascular diseases
5631370|NCT00773747|Paraproteinemias|paraproteinemias
5631371|NCT00773747|Blood Protein Disorders|blood protein disorders
5631372|NCT00773747|Hematologic Diseases|hematologic diseases
5631373|NCT00773747|Hemorrhagic Disorders|hemorrhagic disorders
5685472|NCT00555958|Vagal blocking|vagal blocking
5631374|NCT00773747|Lymphoproliferative Disorders|lymphoproliferative disorders
5631375|NCT00773747|Immunoproliferative Disorders|immunoproliferative disorders
5631376|NCT00773747|Immune System Diseases|immune system diseases
5631377|NCT00773747|Vorinostat|vorinostat
5631378|NCT00773747|Bortezomib|bortezomib
5631379|NCT00773747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5631380|NCT00773747|Analgesics, Non-Narcotic|analgesics, non-narcotic
5631381|NCT00773747|Analgesics|analgesics
5631382|NCT00773747|Sensory System Agents|sensory system agents
5631383|NCT00773747|Peripheral Nervous System Agents|peripheral nervous system agents
5631384|NCT00773747|Physiological Effects of Drugs|physiological effects of drugs
5631385|NCT00773747|Pharmacologic Actions|pharmacologic actions
5631386|NCT00773747|Anti-Inflammatory Agents|anti-inflammatory agents
5631387|NCT00773747|Therapeutic Uses|therapeutic uses
5631388|NCT00773747|Antirheumatic Agents|antirheumatic agents
5631389|NCT00773747|Antineoplastic Agents|antineoplastic agents
5631390|NCT00773747|Enzyme Inhibitors|enzyme inhibitors
5631391|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5631392|NCT00773747|Anticarcinogenic Agents|anticarcinogenic agents
5631393|NCT00773734|moderate-to-severe plaque-type psoriasis|moderate-to-severe plaque-type psoriasis
5631394|NCT00773708|HIV infection|hiv infection
5631395|NCT00773708|Discordant patient|discordant patient
5631396|NCT00773708|CD4 recovery|cd4 recovery
5631397|NCT00773708|intensification antiretroviral therapy|intensification antiretroviral therapy
5631398|NCT00773708|raltegravir|raltegravir
5631399|NCT00773708|"HIV-1 infected patient classified as discordant who showed high level of CD8+HLADR+CD38+ and cell death values at the screening"|"hiv-1 infected patient classified as discordant who showed high level of cd8+hladr+cd38+ and cell death values at the screening"
5631400|NCT00773682|osteoarthritis|osteoarthritis
5631401|NCT00773682|hands|hands
5631402|NCT00773682|mud-packs therapy|mud-packs therapy
5631403|NCT00773682|balneotherapy|balneotherapy
5631404|NCT00773682|Osteoarthritis of the hands|osteoarthritis of the hands
5631405|NCT00773669|male breast cancer|male breast cancer
5631406|NCT00773669|Male breast cancer patients diagnosed and/or|male breast cancer patients diagnosed and/or
5631407|NCT00773669|treated at Summa Health System/Akron City Hospital|treated at summa health system/akron city hospital
5631408|NCT00773669|from the reference year of 1995 through 2007.|from the reference year of 1995 through 2007.
5631409|NCT00773656|Radiotherapy|radiotherapy
5631410|NCT00773656|Biologically effective dose|biologically effective dose
5631411|NCT00773656|Radiation injury|radiation injury
5631412|NCT00773643|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,|to procure human temporalis muscle, subcutaneous adipose (fat), and bone tissue samples from children with craniosynostosis,
5631413|NCT00773643|to grow cells from these tissues in vitro|to grow cells from these tissues in vitro
5631609|NCT00772746|exercise|exercise
5631414|NCT00773643|to evaluate the osteogenic potentials of these cell types.|to evaluate the osteogenic potentials of these cell types.
5631415|NCT00773617|Bulimia Nervosa|bulimia nervosa
5631416|NCT00773617|Treatment Efficacy|treatment efficacy
5631417|NCT00773617|Integrative Cognitive Affective Therapy|integrative cognitive affective therapy
5631418|NCT00773617|Cognitive Behavior Therapy|cognitive behavior therapy
5631419|NCT00773604|blepharospasm|blepharospasm
5631420|NCT00773604|Deep brain Stimulation|deep brain stimulation
5631421|NCT00773604|cervical dystonia|cervical dystonia
5631422|NCT00773604|cranial dystonia|cranial dystonia
5631423|NCT00773604|generalized dystonia|generalized dystonia
5631424|NCT00773604|subthalamic nucleus|subthalamic nucleus
5631425|NCT00773604|DBS|dbs
5631426|NCT00773591|Sleep-related breathing disorders|sleep-related breathing disorders
5631427|NCT00773591|Snoring|snoring
5631428|NCT00773578|Children|children
5631429|NCT00773578|Tobacco smoke exposure|tobacco smoke exposure
5631430|NCT00773578|Exhaled nitric oxide|exhaled nitric oxide
5631431|NCT00773578|Nasal lavage|nasal lavage
5631432|NCT00773578|Cytokines|cytokines
5631433|NCT00773565|patients with obesity (BMI > 30 kg/m2)|patients with obesity (bmi > 30 kg/m2)
5631434|NCT00773552|OAB|oab
5631435|NCT00773552|overactive bladder|overactive bladder
5631436|NCT00773552|urinary urge|urinary urge
5631437|NCT00773552|urge incontinence|urge incontinence
5631438|NCT00773552|urge|urge
5631439|NCT00773539|atrial fibrillation|atrial fibrillation
5631440|NCT00773539|pulmonary veins|pulmonary veins
5631441|NCT00773539|ablation|ablation
5631442|NCT00773500|Medication Errors|medication errors
5631443|NCT00773487|Asthma GINA 1|asthma gina 1
5631444|NCT00773487|Mild intermittant asthma|mild intermittant asthma
5631445|NCT00773448|Cancer|cancer
5631446|NCT00773448|Screening|screening
5631447|NCT00773435|Upper respiratory tract infections|upper respiratory tract infections
5631448|NCT00773435|Children|children
5631449|NCT00773435|Echinacea|echinacea
5631450|NCT00773435|Prevention|prevention
5631451|NCT00773435|Immune modulation|immune modulation
5631452|NCT00773422|smoking lapse behavior|smoking lapse behavior
5631453|NCT00773422|smoking cessation|smoking cessation
5631454|NCT00773422|varenicline|varenicline
5631455|NCT00773422|naltrexone|naltrexone
5631456|NCT00773422|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5631457|NCT00773370|stroke|stroke
5631458|NCT00773370|exercise|exercise
5631459|NCT00773357|smoking lapse behavior|smoking lapse behavior
5631460|NCT00773357|smoking cessation|smoking cessation
5631461|NCT00773357|guanfacine|guanfacine
5631462|NCT00773357|carvedilol|carvedilol
5631463|NCT00773357|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5631464|NCT00773357|medication effect on smoking cessation|medication effect on smoking cessation
5631465|NCT00773357|stress|stress
5631466|NCT00773357|gender differences|gender differences
5631467|NCT00773344|Solid Tumors (dose escalation/Phase 1)|solid tumors (dose escalation/phase 1)
5631468|NCT00773344|Breast Cancer (recommended dose phase/Phase 2)|breast cancer (recommended dose phase/phase 2)
5631469|NCT00773318|LM/SL|lm/sl
5631470|NCT00773318|SPECT/low-dose multislice CT|spect/low-dose multislice ct
5631471|NCT00773305|seed implantation|seed implantation
5631472|NCT00773292|HAM/TSP|ham/tsp
5631473|NCT00773266|Aphakia|aphakia
5631474|NCT00773266|Secondary IOL-Implantation|secondary iol-implantation
5631475|NCT00773266|Iris-Fixated IOL|iris-fixated iol
5631476|NCT00773266|Artisan|artisan
5631477|NCT00773266|Anterior Segment OCT|anterior segment oct
5631478|NCT00773266|Aphakia - secondary iris-fixated IOL position|aphakia - secondary iris-fixated iol position
5631479|NCT00773253|dystonia|dystonia
5631480|NCT00773253|cervical dystonia|cervical dystonia
5631481|NCT00773253|Botox|botox
5631482|NCT00773253|idiopathic primary cervical dystonia|idiopathic primary cervical dystonia
5631483|NCT00773227|Oculopharyngeal muscular dystrophy|oculopharyngeal muscular dystrophy
5631484|NCT00773227|Swallowing disorders, dysphagia|swallowing disorders, dysphagia
5631485|NCT00773227|Pharyngeal propulsion|pharyngeal propulsion
5631486|NCT00773227|Upper oesophageal sphincter|upper oesophageal sphincter
5631487|NCT00773227|Cricopharyngeal muscle|cricopharyngeal muscle
5631488|NCT00773227|Autologous myoblasts|autologous myoblasts
5631489|NCT00773227|Autograft|autograft
5631490|NCT00773227|Myotomy of the upper oesophageal sphincter|myotomy of the upper oesophageal sphincter
5631491|NCT00773227|Fibroscopy of swallowing|fibroscopy of swallowing
5631492|NCT00773227|Videofluoroscopy of swallowing|videofluoroscopy of swallowing
5631493|NCT00773214|Obesity|obesity
5631494|NCT00773214|Appetite|appetite
5631495|NCT00773214|Body composition|body composition
5631496|NCT00773214|Energy compensation|energy compensation
5631497|NCT00773201|Long QT syndrome|long qt syndrome
5631498|NCT00773201|Cardiac repolarisation|cardiac repolarisation
5631499|NCT00773201|Genome-wide association|genome-wide association
5631500|NCT00773201|Electrophysiology|electrophysiology
5631501|NCT00773201|Drugs/adverse effects|drugs/adverse effects
5631503|NCT00773175|hylenex|hylenex
5631504|NCT00773175|subcutaneous infusion|subcutaneous infusion
5631505|NCT00773175|hyaluronidase|hyaluronidase
5631506|NCT00773175|rHuPH20|rhuph20
5631507|NCT00773175|recombinant human hyaluronidase|recombinant human hyaluronidase
5631508|NCT00773149|Adult Acute Lymphocytic Leukemia|adult acute lymphocytic leukemia
5631509|NCT00773149|Alemtuzumab|alemtuzumab
5631510|NCT00773136|Bimatoprost|bimatoprost
5631511|NCT00773136|Eyelash lengthening|eyelash lengthening
5631512|NCT00773136|Prostaglandin Analogs|prostaglandin analogs
5631513|NCT00773136|Cosmetics|cosmetics
5631514|NCT00773123|RT-View|rt-view
5631515|NCT00773123|Spectral domain OCT|spectral domain oct
5631516|NCT00773123|Ganglion cell layer|ganglion cell layer
5631517|NCT00773123|RNFL|rnfl
5631518|NCT00773123|Visual field defect|visual field defect
5631519|NCT00773110|hemolysis|hemolysis
5613266|NCT00844987|HGF|hgf
5631520|NCT00773110|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5631521|NCT00773110|cardiopulmonary bypass|cardiopulmonary bypass
5631522|NCT00773110|albumin|albumin
5631523|NCT00773097|Prevention|prevention
5631524|NCT00773097|Colorectal Cancer|colorectal cancer
5631525|NCT00773084|Diastolic Heart Failure|diastolic heart failure
5631526|NCT00773084|Hispanic Americans|hispanic americans
5631527|NCT00773084|Aliskiren|aliskiren
5631528|NCT00773084|Spironolactone|spironolactone
5631529|NCT00773084|Lisinopril|lisinopril
5631530|NCT00773084|Diastolic Heart Failure in Hispanic Americans|diastolic heart failure in hispanic americans
5631531|NCT00773071|Cervical cancer, vulvar cancer, LM/SL, SPECT/CT|cervical cancer, vulvar cancer, lm/sl, spect/ct
5631532|NCT00773058|acute respiratory distress syndrome|acute respiratory distress syndrome
5631533|NCT00773058|glucocorticoid|glucocorticoid
5631534|NCT00773058|adrenal insufficiency|adrenal insufficiency
5631535|NCT00773045|pain scores|pain scores
5631536|NCT00773045|critically ill patients|critically ill patients
5631538|NCT00773045|pain management|pain management
5631539|NCT00773045|pain measurement|pain measurement
5631540|NCT00773019|infusion pump|infusion pump
5631541|NCT00773019|implantable|implantable
5631542|NCT00773019|performance|performance
5631543|NCT00773006|coronary artery disease|coronary artery disease
5631544|NCT00773006|percutaneous coronary intervention|percutaneous coronary intervention
5631545|NCT00773006|anticoagulation|anticoagulation
5631546|NCT00772993|glaucoma|glaucoma
5631548|NCT00772993|myopia with glaucoma|myopia with glaucoma
5631549|NCT00772993|normal control|normal control
5631550|NCT00772954|Clostridium difficile diarrhea|clostridium difficile diarrhea
5631551|NCT00772954|Clostridium difficile toxoid vaccine|clostridium difficile toxoid vaccine
5631552|NCT00772928|Pertussis|pertussis
5631553|NCT00772928|Whooping cough|whooping cough
5631554|NCT00772928|Diphtheria|diphtheria
5631555|NCT00772928|Tetanus|tetanus
5631556|NCT00772928|Haemophilus influenzae|haemophilus influenzae
5631557|NCT00772928|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5631558|NCT00772915|stage I multiple myeloma|stage i multiple myeloma
5631559|NCT00772915|stage II multiple myeloma|stage ii multiple myeloma
5631560|NCT00772915|stage III multiple myeloma|stage iii multiple myeloma
5631561|NCT00772902|HIV-1|hiv-1
5631562|NCT00772902|LDL|ldl
5631563|NCT00772902|HDL|hdl
5631564|NCT00772902|non-HDL cholesterol|non-hdl cholesterol
5631565|NCT00772902|triglycerides|triglycerides
5631566|NCT00772902|cholesterol|cholesterol
5631567|NCT00772889|Elderly|elderly
5631568|NCT00772889|Vaccine|vaccine
5631569|NCT00772889|Influenza|influenza
5631570|NCT00772876|P1446A-05|p1446a-05
5631571|NCT00772876|Advanced refractory malignancies|advanced refractory malignancies
5631572|NCT00772876|Phase I|phase i
5631573|NCT00772850|Humeral fracture; Antegrade nailing; Rotator cuff|humeral fracture; antegrade nailing; rotator cuff
5631574|NCT00772837|Functional Dyspepsia|functional dyspepsia
5631575|NCT00772837|Helicobacter Pylori eradication|helicobacter pylori eradication
5631576|NCT00772837|Quality of Life|quality of life
5631577|NCT00772837|Dyspeptic Symptoms|dyspeptic symptoms
5631578|NCT00772824|Breast cancer|breast cancer
5631579|NCT00772824|Chemotherapy|chemotherapy
5631580|NCT00772824|Epirubicin|epirubicin
5631581|NCT00772824|Glutamine|glutamine
5631582|NCT00772824|FEC chemotherapy|fec chemotherapy
5631583|NCT00772798|ovarian cancer|ovarian cancer
5631584|NCT00772798|HDAC inhibitor|hdac inhibitor
5631585|NCT00772798|vorinostat|vorinostat
5631586|NCT00772785|opioid dependence|opioid dependence
5631587|NCT00772785|opioid addiction|opioid addiction
5631588|NCT00772785|buprenorphine|buprenorphine
5631589|NCT00772785|methadone|methadone
5631590|NCT00772785|heroin|heroin
5631591|NCT00772785|implant|implant
5631592|NCT00772785|opioid withdrawal|opioid withdrawal
5631593|NCT00772785|opioid pain medication|opioid pain medication
5631594|NCT00772785|suboxone|suboxone
5631595|NCT00772772|Vitamin D3 repletion|vitamin d3 repletion
5631597|NCT00772772|intestinal permeability|intestinal permeability
5631598|NCT00772772|accelerated atherosclerosis|accelerated atherosclerosis
5631599|NCT00772759|AZD3199|azd3199
5631600|NCT00772759|Japanese Healthy Volunteers|japanese healthy volunteers
5631601|NCT00772759|Phase I study|phase i study
5631602|NCT00772759|Single and Multiple Ascending Dose|single and multiple ascending dose
5631603|NCT00772759|safety|safety
5631604|NCT00772759|tolerability|tolerability
5631605|NCT00772759|PK|pk
5631606|NCT00772746|panic|panic
5631610|NCT00772746|cognition|cognition
5631611|NCT00772733|Quality assurance|quality assurance
5631612|NCT00772733|rehabilitation|rehabilitation
5631613|NCT00772733|chronic care model|chronic care model
5631615|NCT00772707|contact lens solution|contact lens solution
5631616|NCT00772707|OPTI-FREE RepleniSH|opti-free replenish
5631617|NCT00772707|contact lenses|contact lenses
5631618|NCT00772694|testicular cancer|testicular cancer
5631619|NCT00772694|germ cell cancer|germ cell cancer
5631620|NCT00772694|sorafenib|sorafenib
5631621|NCT00772668|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5631622|NCT00772668|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5613332|NCT00844701|neurobiology|neurobiology
5631623|NCT00772668|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5631624|NCT00772668|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5631625|NCT00772668|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5631626|NCT00772668|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5631627|NCT00772655|Follicular Lymphoma|follicular lymphoma
5631628|NCT00772655|First line therapy|first line therapy
5631629|NCT00772655|Zevalin|zevalin
5631630|NCT00772655|90Yttrium-Ibritumomab Tiuxetan|90yttrium-ibritumomab tiuxetan
5631631|NCT00772655|Yttrium|yttrium
5631632|NCT00772655|Rituximab|rituximab
5631633|NCT00772655|Radio-immuno therapy|radio-immuno therapy
5631634|NCT00772642|Cross-Sectional|cross-sectional
5631635|NCT00772642|Plasmodium Falciparum Malaria|plasmodium falciparum malaria
5631636|NCT00772642|Cord Blood|cord blood
5631637|NCT00772642|Immunology|immunology
5631638|NCT00772642|Mali|mali
5631639|NCT00772642|Malaria|malaria
5631640|NCT00772629|Menactra®|menactra®
5631641|NCT00772629|Meningitis|meningitis
5631642|NCT00772629|Meningococcemia|meningococcemia
5631643|NCT00772629|Neisseria meningitidis|neisseria meningitidis
5631644|NCT00772616|Anesthesia|anesthesia
5631645|NCT00772616|Analgesia|analgesia
5631646|NCT00772616|Patient-Controlled Analgesia|patient-controlled analgesia
5631647|NCT00772616|Hyperalgesia|hyperalgesia
5631648|NCT00772603|Partial onset epilepsy|partial onset epilepsy
5631650|NCT00772590|HIV|hiv
5631651|NCT00772590|antiretroviral therapy intensification|antiretroviral therapy intensification
5631652|NCT00772590|suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
5631653|NCT00772590|virological suppression|virological suppression
5631654|NCT00772590|bovine colostrum|bovine colostrum
5631655|NCT00772590|raltegravir|raltegravir
5671709|NCT00614718|inappropriate therapy|inappropriate therapy
5631656|NCT00772577|Hypertension, Obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2|hypertension, obese, aliskiren, hydrochlorothiazide, systolic blood pressure, diastolic blood pressure, ramipril, stage 2
5631657|NCT00772564|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
5631658|NCT00772525|Visual acuity|visual acuity
5631659|NCT00772525|Contrast sensitivity|contrast sensitivity
5631660|NCT00772525|Visual Evoked Potentials|visual evoked potentials
5631661|NCT00772525|Optical Coherence Tomography|optical coherence tomography
5631662|NCT00772512|PF-04802540, polysomnography, REM, cross over|pf-04802540, polysomnography, rem, cross over
5631663|NCT00772486|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5631664|NCT00772486|Leukemia|leukemia
5631665|NCT00772486|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5631666|NCT00772486|Leukemia, B-Cell|leukemia, b-cell
5631667|NCT00772486|Immune System Diseases|immune system diseases
5631668|NCT00772486|Rituximab|rituximab
5631669|NCT00772486|Fludarabine|fludarabine
5631670|NCT00772486|Cyclophosphamide|cyclophosphamide
5631671|NCT00772486|ISF35|isf35
5631672|NCT00772486|Ad-ISF35|ad-isf35
5631674|NCT00772486|Resistant|resistant
5631675|NCT00772486|17p-|17p-
5631676|NCT00772486|del 17p|del 17p
5631677|NCT00772486|17p|17p
5631678|NCT00772486|Resistant CLL|resistant cll
5631679|NCT00772486|Refractory CLL|refractory cll
5631680|NCT00772486|17p- CLL|17p- cll
5631681|NCT00772486|CLL|cll
5631682|NCT00772460|patient warming|patient warming
5631683|NCT00772460|convective warming|convective warming
5631684|NCT00772460|conductive warming|conductive warming
5631685|NCT00772460|intraoperative normothermia|intraoperative normothermia
5631686|NCT00772460|accidental hypothermia|accidental hypothermia
5631687|NCT00772460|intraoperative hypothermia|intraoperative hypothermia
5631688|NCT00772447|Skin Infections|skin infections
5631689|NCT00772447|Complicated Bacterial Skin and Skin Structure Infection due to Gram-positive Pathogens|complicated bacterial skin and skin structure infection due to gram-positive pathogens
5631690|NCT00772421|Epilepsy|epilepsy
5631691|NCT00772421|Recruitment rhythm|recruitment rhythm
5631692|NCT00772421|DBS|dbs
5631698|NCT00772395|Periprosthetic bone loss risedronate bisphosphonates|periprosthetic bone loss risedronate bisphosphonates
5631699|NCT00772382|Chronic Kidney Disease|chronic kidney disease
5631700|NCT00772382|Dialysis|dialysis
5631701|NCT00772382|Hyperphosphatemia|hyperphosphatemia
5631702|NCT00772382|Phosphate binder|phosphate binder
5631703|NCT00772369|Pertussis|pertussis
5631704|NCT00772369|Whooping cough|whooping cough
5631705|NCT00772369|Diphtheria|diphtheria
5631706|NCT00772369|Tetanus|tetanus
5631707|NCT00772369|Haemophilus influenzae|haemophilus influenzae
5631708|NCT00772369|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5631709|NCT00772343|Diarrhea|diarrhea
5631710|NCT00772343|Clostridium difficile infection|clostridium difficile infection
5631711|NCT00772343|Clostridium difficile toxoid|clostridium difficile toxoid
5631712|NCT00772330|MIDI Arrow|midi arrow
5631713|NCT00772330|Glaucoma Drainage Device|glaucoma drainage device
5631715|NCT00772330|InnFocus|innfocus
5631716|NCT00772330|Glaucoma treatment|glaucoma treatment
5631717|NCT00772317|Recurrent|recurrent
5631718|NCT00772317|prostate cancer|prostate cancer
5631719|NCT00772317|ebrt|ebrt
5631720|NCT00772317|hifu|hifu
5631721|NCT00772304|rhinitis|rhinitis
5631722|NCT00772291|inguinal|inguinal
5631723|NCT00772291|hernia|hernia
5631724|NCT00772291|chronic|chronic
5631725|NCT00772291|pain|pain
5631726|NCT00772291|pregabalin|pregabalin
5631727|NCT00772291|chronic pain after inguinal herniorraphy|chronic pain after inguinal herniorraphy
5631728|NCT00772278|carotid stenosis|carotid stenosis
5631729|NCT00772278|asymptomatic|asymptomatic
5631730|NCT00772278|carotid stenting|carotid stenting
5631731|NCT00772278|carotid endarterectomy|carotid endarterectomy
5631732|NCT00772265|Bioequivalence|bioequivalence
5631733|NCT00772265|pharmacokinetic|pharmacokinetic
5631734|NCT00772265|Pharmacodynamic|pharmacodynamic
5631735|NCT00772265|Isophane insulin|isophane insulin
5631736|NCT00772252|Liver support treatment|liver support treatment
5631737|NCT00772239|Coagulation Management|coagulation management
5631738|NCT00772239|Cardiac surgery|cardiac surgery
5631739|NCT00772239|Bleeding|bleeding
5631740|NCT00772239|Rotem|rotem
5631741|NCT00772226|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5631742|NCT00772226|pain|pain
5631743|NCT00772226|PONV|ponv
5631744|NCT00772226|music|music
5631745|NCT00772226|therapy|therapy
5631746|NCT00772226|fatigue after elective laparoscopic cholecystectomy|fatigue after elective laparoscopic cholecystectomy
5631747|NCT00772213|multiple trauma|multiple trauma
5631748|NCT00772213|outcome and process assessment|outcome and process assessment
5631749|NCT00772187|Laparoscopic surgery (general surgery).|laparoscopic surgery (general surgery).
5631750|NCT00772174|Glucose Metabolism Disorder|glucose metabolism disorder
5631751|NCT00772174|Dysmetabolic Syndrome|dysmetabolic syndrome
5631752|NCT00772174|Type II Diabetes|type ii diabetes
5631753|NCT00772174|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5631754|NCT00772174|Dyslipidemia|dyslipidemia
5631755|NCT00772174|Drug Therapy|drug therapy
5631757|NCT00772161|Attention Deficit Disorder|attention deficit disorder
5631758|NCT00772161|Attention Deficit an Disruptive Behavior Disorders|attention deficit an disruptive behavior disorders
5631759|NCT00772161|Children|children
5631760|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants
5631761|NCT00772161|Methylphenidate|methylphenidate
5631762|NCT00772161|Pharmacokinetics|pharmacokinetics
5631763|NCT00772161|Area Under Curve|area under curve
5631764|NCT00772161|Therapeutic Equivalency|therapeutic equivalency
5631765|NCT00772161|Psychopharmacology|psychopharmacology
5631766|NCT00772148|Liver|liver
5631767|NCT00772148|Hepatic|hepatic
5631768|NCT00772148|Transplantation|transplantation
5631769|NCT00772148|Immunosuppression|immunosuppression
5631770|NCT00772148|Tacrolimus|tacrolimus
5631771|NCT00772148|Prograf|prograf
5631772|NCT00772135|pulmonary hypertension|pulmonary hypertension
5631773|NCT00772135|congenital heart defects|congenital heart defects
5631774|NCT00772135|exercise|exercise
5631775|NCT00772135|phosphodiesterase inhibitors|phosphodiesterase inhibitors
5631776|NCT00772135|Exercise induced pulmonary arterial hypertensive response in congenital heart disease|exercise induced pulmonary arterial hypertensive response in congenital heart disease
5631777|NCT00772122|Recurrent Miscarriage|recurrent miscarriage
5631779|NCT00772122|pregnancy outcome|pregnancy outcome
5631780|NCT00772122|pregnancy outcome of pregnancies treated with G-CSF|pregnancy outcome of pregnancies treated with g-csf
5631781|NCT00772122|treatment of recurrent miscarriage|treatment of recurrent miscarriage
5631782|NCT00772109|Influenza|influenza
5631783|NCT00772109|Orthomyxoviruses|orthomyxoviruses
5631784|NCT00772109|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5631786|NCT00772109|Adults|adults
5631787|NCT00772070|Menactra®|menactra®
5631788|NCT00772070|Menomune®|menomune®
5631789|NCT00772070|Meningitis|meningitis
5631790|NCT00772070|Meningococcemia|meningococcemia
5631791|NCT00772070|Neisseria meningitidis|neisseria meningitidis
5631792|NCT00772044|OSA|osa
5631793|NCT00772044|sleep apnea|sleep apnea
5631794|NCT00772044|apnea|apnea
5631795|NCT00772044|AHI|ahi
5631796|NCT00772031|chronic migraine, migraine prevention, chronic headache|chronic migraine, migraine prevention, chronic headache
5631797|NCT00772018|stage 0 bladder cancer|stage 0 bladder cancer
5631798|NCT00771992|Asthma GINA 1|asthma gina 1
5631799|NCT00771979|Healthy Volunteers|healthy volunteers
5631800|NCT00771979|Relative Bioavailability|relative bioavailability
5631801|NCT00771966|patients with cancer in the prostate|patients with cancer in the prostate
5631802|NCT00771953|apricoxib|apricoxib
5631803|NCT00771953|docetaxel|docetaxel
5631804|NCT00771953|pemetrexed|pemetrexed
5631805|NCT00771953|Stage IIIb or Stage IV|stage iiib or stage iv
5631806|NCT00771927|Vimpat®|vimpat®
5631807|NCT00771927|Lacosamide|lacosamide
5631808|NCT00771927|LCM|lcm
5631809|NCT00771927|epilepsy|epilepsy
5631810|NCT00771927|epilepsies|epilepsies
5631811|NCT00771927|seizure|seizure
5631812|NCT00771927|partial seizure|partial seizure
5631813|NCT00771927|partial onset|partial onset
5631814|NCT00771927|seizure disorder|seizure disorder
5631815|NCT00771927|single seizure|single seizure
5631816|NCT00771927|motor seizure|motor seizure
5631817|NCT00771927|convulsions|convulsions
5631818|NCT00771927|add-on|add-on
5631819|NCT00771927|AED|aed
5631820|NCT00771927|anti-epileptic|anti-epileptic
5631821|NCT00771927|anti-epileptic drug|anti-epileptic drug
5631822|NCT00771927|seizure control|seizure control
5631823|NCT00771927|open-label|open-label
5631824|NCT00771927|post authorization|post authorization
5631825|NCT00771927|PASS|pass
5631826|NCT00771927|late stage|late stage
5631827|NCT00771927|trial|trial
5631828|NCT00771927|study|study
5631829|NCT00771927|phase 4|phase 4
5631830|NCT00771927|phase IV|phase iv
5631831|NCT00771914|aspirin|aspirin
5631832|NCT00771914|omega 3 fatty acids|omega 3 fatty acids
5631833|NCT00771914|Lovaza|lovaza
5631834|NCT00771914|myocardial infarction|myocardial infarction
5631835|NCT00771914|aspirin resistance|aspirin resistance
5631836|NCT00771914|cardiovascular disease|cardiovascular disease
5631837|NCT00771901|obesity|obesity
5631838|NCT00771901|insulin resistance|insulin resistance
5631839|NCT00771901|type II diabetes|type ii diabetes
5631840|NCT00771862|pain|pain
5631841|NCT00771862|amputation|amputation
5631842|NCT00771862|phantom limb|phantom limb
5631843|NCT00771862|stump pain|stump pain
5631844|NCT00771862|catheter|catheter
5631845|NCT00771862|nerve block|nerve block
5631846|NCT00771862|peripheral nerve block|peripheral nerve block
5631847|NCT00771862|ucsd|ucsd
5631848|NCT00771862|post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
5631849|NCT00771849|Meningitis|meningitis
5631850|NCT00771849|Meningococcemia|meningococcemia
5631851|NCT00771849|Neisseria meningitidis|neisseria meningitidis
5631852|NCT00771836|Stem cell transplantation|stem cell transplantation
5631853|NCT00771836|Airway hyper-reactivity|airway hyper-reactivity
5631854|NCT00771836|methacholine|methacholine
5631856|NCT00771810|Ovarian Cancer|ovarian cancer
5631857|NCT00771810|Thrombocytopenia|thrombocytopenia
5631858|NCT00771810|Cytopenia|cytopenia
5631859|NCT00771810|Chemotherapy|chemotherapy
5631860|NCT00771797|PAOD|paod
5631861|NCT00771797|diabetis|diabetis
5631862|NCT00771797|vascular function|vascular function
5631863|NCT00771797|in diabetics with PAOD|in diabetics with paod
5631864|NCT00771784|Endotracheal intubation|endotracheal intubation
5631865|NCT00771784|tracheostomy|tracheostomy
5631866|NCT00771784|laryngeal mask|laryngeal mask
5631867|NCT00771771|Stroke|stroke
5631868|NCT00771771|Rehabilitation|rehabilitation
5631869|NCT00771771|Early Supported Discharge|early supported discharge
5631870|NCT00771771|ESD|esd
5631871|NCT00771771|RCT|rct
5631872|NCT00771758|Vertebral compression fracture|vertebral compression fracture
5631873|NCT00771758|Osteoporosis|osteoporosis
5631874|NCT00771758|Acute pain|acute pain
5631875|NCT00771758|Analgesic|analgesic
5631876|NCT00771758|Oxycodone|oxycodone
5631877|NCT00771758|Tapentadol|tapentadol
5631878|NCT00771732|toe nail fungus|toe nail fungus
5631879|NCT00771719|VAP|vap
5631880|NCT00771706|Pediatric Cough, Quality of Life|pediatric cough, quality of life
5631881|NCT00771706|Drug (including placebo)|drug (including placebo)
5631882|NCT00771693|NIDDM|niddm
5631883|NCT00771693|Platelet Activation|platelet activation
5631884|NCT00771693|Postprandial hyperglycemia|postprandial hyperglycemia
5631885|NCT00771693|insulin|insulin
5631886|NCT00771667|Interleukin-12|interleukin-12
5631887|NCT00771667|Inflammation|inflammation
5631888|NCT00771667|Research study|research study
5631889|NCT00771667|Ustekinumab|ustekinumab
5631890|NCT00771667|CNTO1275|cnto1275
5631891|NCT00771667|Interleukin-23|interleukin-23
5631892|NCT00771641|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5631893|NCT00771641|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5631894|NCT00771641|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5631895|NCT00771641|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5631896|NCT00771641|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5631897|NCT00771641|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5631898|NCT00771641|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5631999|NCT00771186|pediatric|pediatric
5631899|NCT00771641|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5631900|NCT00771641|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5631901|NCT00771641|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5631902|NCT00771641|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5631903|NCT00771641|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5631904|NCT00771641|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5631905|NCT00771628|Intubation, Flex-It, stylet, GlideScope|intubation, flex-it, stylet, glidescope
5631906|NCT00771615|human|human
5631907|NCT00771615|Avian|avian
5631908|NCT00771615|safety|safety
5631909|NCT00771615|vaccines|vaccines
5631910|NCT00771615|influenza|influenza
5631911|NCT00771615|pandemic|pandemic
5631912|NCT00771615|immunogenicity|immunogenicity
5631913|NCT00771615|H5N1|h5n1
5631914|NCT00771602|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5631915|NCT00771602|Leukemia|leukemia
5631916|NCT00771602|CLL|cll
5631917|NCT00771602|PLL|pll
5631918|NCT00771602|SLL|sll
5631919|NCT00771602|Rituximab|rituximab
5631920|NCT00771602|Rituxan|rituxan
5631921|NCT00771602|Alemtuzumab|alemtuzumab
5631922|NCT00771602|Campath|campath
5631923|NCT00771576|Diabetes Mellitus|diabetes mellitus
5631924|NCT00771576|T1DM|t1dm
5631925|NCT00771563|Non-Small Cell Lung Cancer|non-small cell lung cancer
5631926|NCT00771563|chemotherapy|chemotherapy
5631927|NCT00771563|Low Molecular Weight Heparin|low molecular weight heparin
5631928|NCT00771537|HIV Testing|hiv testing
5631929|NCT00771537|Persuasion|persuasion
5631930|NCT00771537|Health Communication|health communication
5631931|NCT00771537|Clinical Trials Participation|clinical trials participation
5631932|NCT00771537|Attitudes toward Health|attitudes toward health
5631933|NCT00771537|Diagnostic Tests|diagnostic tests
5631934|NCT00771537|Behavioral Research|behavioral research
5631935|NCT00771537|Intervention Studies|intervention studies
5631936|NCT00771524|Pharmacokinetics|pharmacokinetics
5631937|NCT00771524|Hip replacement|hip replacement
5631938|NCT00771524|Ceftobiprole|ceftobiprole
5631939|NCT00771498|rifampin|rifampin
5631940|NCT00771498|lopinavir|lopinavir
5631941|NCT00771498|drug interaction|drug interaction
5631942|NCT00771498|pharmacokinetic|pharmacokinetic
5631943|NCT00771459|Local infiltration analgesia|local infiltration analgesia
5631944|NCT00771459|postoperative pain|postoperative pain
5631945|NCT00771459|ropivacaine|ropivacaine
5631946|NCT00771446|Hepatitis, acute|hepatitis, acute
5631947|NCT00771446|Acute Hepatitis OR Chronic Hepatitis|acute hepatitis or chronic hepatitis
5631948|NCT00771433|neutropenia|neutropenia
5631949|NCT00771433|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5631950|NCT00771433|recurrent breast cancer|recurrent breast cancer
5631951|NCT00771433|stage I breast cancer|stage i breast cancer
5631952|NCT00771433|stage II breast cancer|stage ii breast cancer
5631953|NCT00771433|stage IIIA breast cancer|stage iiia breast cancer
5631954|NCT00771433|stage IIIB breast cancer|stage iiib breast cancer
5631955|NCT00771433|stage IIIC breast cancer|stage iiic breast cancer
5631956|NCT00771433|stage IV breast cancer|stage iv breast cancer
5631957|NCT00771407|Ostomy creation|ostomy creation
5631958|NCT00771407|Parastomal hernia|parastomal hernia
5631959|NCT00771394|Vesicare|vesicare
5631960|NCT00771394|Solifenacin succinate|solifenacin succinate
5631961|NCT00771394|Tamsulosin|tamsulosin
5631962|NCT00771394|Overactive Bladder|overactive bladder
5631964|NCT00771381|18F-FAZA|18f-faza
5631965|NCT00771381|18F-FDG|18f-fdg
5631966|NCT00771381|Positron Emission Tomography|positron emission tomography
5631967|NCT00771381|Cell Hypoxia|cell hypoxia
5631968|NCT00771303|Pregnancy|pregnancy
5631969|NCT00771303|Pulmonary embolism|pulmonary embolism
5631970|NCT00771303|MSCT|msct
5631971|NCT00771290|Rectal sparing|rectal sparing
5631972|NCT00771290|Colon cancer|colon cancer
5631973|NCT00771277|Brain Injuries|brain injuries
5631974|NCT00771277|Caregivers|caregivers
5631975|NCT00771277|Volunteer Workers|volunteer workers
5631976|NCT00771277|Social Networks|social networks
5631977|NCT00771264|Overactive Bladder|overactive bladder
5631978|NCT00771251|Rheumatoid arthritis|rheumatoid arthritis
5863025|NCT00001413|Depression|depression
5631979|NCT00771251|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5631980|NCT00771251|CNTO148|cnto148
5631981|NCT00771251|Golimumab|golimumab
5631982|NCT00771238|pressure ulcers|pressure ulcers
5631983|NCT00771238|Therapy mattresses|therapy mattresses
5631984|NCT00771238|Incidence of pressure ulcers|incidence of pressure ulcers
5631985|NCT00771225|genital prolapse|genital prolapse
5631986|NCT00771225|surgery|surgery
5631987|NCT00771225|fascial repair|fascial repair
5631988|NCT00771225|mesh|mesh
5631989|NCT00771225|prolift|prolift
5631990|NCT00771212|Pain|pain
5631991|NCT00771212|Observational|observational
5631992|NCT00771212|Taiwan|taiwan
5631993|NCT00771199|Cancer pain|cancer pain
5631994|NCT00771199|Pain|pain
5631995|NCT00771199|Fentanyl|fentanyl
5631996|NCT00771199|Durogesic|durogesic
5631997|NCT00771199|Cancer|cancer
5631998|NCT00771199|Transdermal|transdermal
5632000|NCT00771186|Laryngeal EMG|laryngeal emg
5632001|NCT00771173|Phenazopyrdine|phenazopyrdine
5632002|NCT00771173|post operative bladder catheritization|post operative bladder catheritization
5632003|NCT00771173|VAS scores|vas scores
5632004|NCT00771173|Bladder pain related to indwelling foley catheters.|bladder pain related to indwelling foley catheters.
5632005|NCT00771173|Bladder irritaion related to indwelling foley catheters.|bladder irritaion related to indwelling foley catheters.
5632006|NCT00771147|Advanced Renal Cell Carcinoma ( RCC)|advanced renal cell carcinoma ( rcc)
5632007|NCT00771134|Depression|depression
5632008|NCT00771134|Bipolar I Disorder|bipolar i disorder
5632009|NCT00771134|Bipolar II Disorder|bipolar ii disorder
5632010|NCT00771134|Placebo-controlled|placebo-controlled
5632011|NCT00771134|Double-blind|double-blind
5632012|NCT00771134|Randomised controlled|randomised controlled
5632013|NCT00771134|Multicenter|multicenter
5632014|NCT00771134|Clinical study|clinical study
5632015|NCT00771134|Mania|mania
5632016|NCT00771108|NAFLD|nafld
5632017|NCT00771108|Obesity|obesity
5632018|NCT00771108|Metabolic Syndrome|metabolic syndrome
5632019|NCT00771108|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5632020|NCT00771095|weight loss|weight loss
5632021|NCT00771095|elaboration|elaboration
5632022|NCT00771095|self efficacy|self efficacy
5632023|NCT00771082|inflammatory markers|inflammatory markers
5632024|NCT00771082|bone markers|bone markers
5632026|NCT00771069|Hypertension|hypertension
5632027|NCT00771069|Type II DM|type ii dm
5632028|NCT00771069|DM related complication|dm related complication
5632029|NCT00771069|JNC7|jnc7
5632030|NCT00771069|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5632031|NCT00771069|survey|survey
5632032|NCT00771056|untreated|untreated
5632033|NCT00771017|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5632034|NCT00771017|recurrent prostate cancer|recurrent prostate cancer
5632035|NCT00771017|stage II prostate cancer|stage ii prostate cancer
5632036|NCT00771017|stage III prostate cancer|stage iii prostate cancer
5632037|NCT00771017|stage I prostate cancer|stage i prostate cancer
5632038|NCT00771004|drug effects|drug effects
5632039|NCT00771004|Type II Diabetes|type ii diabetes
5632040|NCT00771004|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5632041|NCT00771004|Drug Therapy|drug therapy
5632042|NCT00771004|Heart|heart
5632043|NCT00771004|physiology|physiology
5632044|NCT00771004|function|function
5632045|NCT00770991|Polyp, Familial Adenomatous Polyposis, Prevention|polyp, familial adenomatous polyposis, prevention
5632046|NCT00770978|ICU|icu
5632047|NCT00770965|Plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease|plaque psoriasis, skin condition, thickening, flaking, skin disease, autoimmune disease
5632048|NCT00770952|Glucose Metabolism Disorder|glucose metabolism disorder
5632049|NCT00770952|Dysmetabolic Syndrome|dysmetabolic syndrome
5632050|NCT00770952|Type II Diabetes|type ii diabetes
5632051|NCT00770952|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5632052|NCT00770952|Dyslipidemia|dyslipidemia
5632053|NCT00770952|Drug Therapy|drug therapy
5632054|NCT00770939|Complete healing of chronic diabetic foot ulcers|complete healing of chronic diabetic foot ulcers
5632055|NCT00770939|Platelet Rich Fibrin|platelet rich fibrin
5632056|NCT00770939|Vivostat|vivostat
5632057|NCT00770939|Growth factor treatment|growth factor treatment
5632058|NCT00770939|Treatment of chronic diabetic foot ulcers|treatment of chronic diabetic foot ulcers
5632059|NCT00770926|risk reduction|risk reduction
5632060|NCT00770926|minority|minority
5632061|NCT00770926|diabetes prevention|diabetes prevention
5632062|NCT00770926|lifestyle program|lifestyle program
5632063|NCT00770926|behavior change|behavior change
5632064|NCT00770913|reflux esophagitis|reflux esophagitis
5632065|NCT00770913|rabeprazole|rabeprazole
5632066|NCT00770913|GERD|gerd
5632067|NCT00770913|Japan|japan
5632068|NCT00770887|Undesired fertility|undesired fertility
5632069|NCT00770861|nebivolol|nebivolol
5632070|NCT00770861|Bystolic ™|bystolic ™
5632071|NCT00770861|Hypertension|hypertension
5632072|NCT00770861|Hispanic|hispanic
5632073|NCT00770861|Hypertension in Hispanic patients|hypertension in hispanic patients
5632074|NCT00770848|CRPC|crpc
5632075|NCT00770835|Glucose Metabolism Disorder|glucose metabolism disorder
5632076|NCT00770835|Dysmetabolic Syndrome|dysmetabolic syndrome
5632077|NCT00770835|Type II Diabetes|type ii diabetes
5632078|NCT00770835|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5632079|NCT00770835|Dyslipidemia|dyslipidemia
5632080|NCT00770835|Drug Therapy|drug therapy
5632081|NCT00770822|Primary|primary
5632082|NCT00770822|Prostate|prostate
5632083|NCT00770822|Cancer|cancer
5632084|NCT00770822|Primary T1c/T2a organ confined prostate cancer|primary t1c/t2a organ confined prostate cancer
5632085|NCT00770822|organ-confined|organ-confined
5632086|NCT00770796|Contrast induced nephropathy|contrast induced nephropathy
5632087|NCT00770770|Macular edema secondary to RVO|macular edema secondary to rvo
5632088|NCT00770744|Schizophrenia|schizophrenia
5632089|NCT00770744|Antipsychotic|antipsychotic
5632090|NCT00770744|Olanzapine|olanzapine
5632091|NCT00770744|Lu 31-130|lu 31-130
5632092|NCT00770731|Torisel|torisel
5632093|NCT00770731|Temsirolimus|temsirolimus
5632094|NCT00770731|Hycamtin|hycamtin
5632095|NCT00770731|Topotecan hydrochloride|topotecan hydrochloride
5632096|NCT00770731|Velcade|velcade
5632097|NCT00770731|Bortezomib|bortezomib
5632098|NCT00770731|FDG-PET Scans|fdg-pet scans
5632099|NCT00770731|18F-Fluoro-2-Deoxyglucose Positron Emission Tomography|18f-fluoro-2-deoxyglucose positron emission tomography
5632100|NCT00770718|intracranial hemorrhage|intracranial hemorrhage
5632101|NCT00770718|warfarin|warfarin
5632102|NCT00770718|anticoagulant|anticoagulant
5632103|NCT00770718|Factor VII|factor vii
5632104|NCT00770718|Prothrombin|prothrombin
5632105|NCT00770692|insomnia|insomnia
5632106|NCT00770692|primary insomnia|primary insomnia
5632107|NCT00770692|insomnia associated with psychiatric or physical disorder(s)|insomnia associated with psychiatric or physical disorder(s)
5632108|NCT00770666|Tobacco dependence treatment|tobacco dependence treatment
5632109|NCT00770653|Glucose Metabolism Disorder|glucose metabolism disorder
5632110|NCT00770653|Dysmetabolic Syndrome|dysmetabolic syndrome
5632111|NCT00770653|Type II Diabetes|type ii diabetes
5632112|NCT00770653|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5632113|NCT00770653|Dyslipidemia|dyslipidemia
5632114|NCT00770653|Hyperlipidemias|hyperlipidemias
5632115|NCT00770653|Drug Therapy|drug therapy
5632116|NCT00770640|Glucose Metabolism Disorder|glucose metabolism disorder
5632117|NCT00770640|Dysmetabolic Syndrome|dysmetabolic syndrome
5632118|NCT00770640|Type II Diabetes|type ii diabetes
5632119|NCT00770640|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5632120|NCT00770640|Dyslipidemia|dyslipidemia
5632121|NCT00770640|Drug Therapy|drug therapy
5632122|NCT00770627|160 children|160 children
5632123|NCT00770627|parallel group|parallel group
5632124|NCT00770614|Contrast Induced Nephropathy|contrast induced nephropathy
5632125|NCT00770601|NOMID|nomid
5632126|NCT00770601|CINCA Syndrome|cinca syndrome
5632127|NCT00770601|Canakinumab|canakinumab
5632128|NCT00770588|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5632129|NCT00770588|Gefitinib|gefitinib
5632130|NCT00770575|Biological Markers|biological markers
5632131|NCT00770575|Biochemical Markers|biochemical markers
5632132|NCT00770575|Carotid Artery, Internal|carotid artery, internal
5632134|NCT00770575|Marker, Surrogate|marker, surrogate
5632135|NCT00770575|Vascular Diseases|vascular diseases
5632136|NCT00770575|Diabetes Mellitus|diabetes mellitus
5632137|NCT00770575|Drug Therapy|drug therapy
5632138|NCT00770536|fallopian tube cancer|fallopian tube cancer
5632139|NCT00770536|Gynecological Malignancy|gynecological malignancy
5632140|NCT00770536|primary peritoneal cancer of predominantly epithelial origin|primary peritoneal cancer of predominantly epithelial origin
5632141|NCT00770536|Stage II to IV ovarian cancer|stage ii to iv ovarian cancer
5632142|NCT00770523|patients without comorbidity|patients without comorbidity
5632143|NCT00770510|Primary insomnia|primary insomnia
5632144|NCT00770497|drug effects|drug effects
5632145|NCT00770497|Hypertension|hypertension
5632146|NCT00770497|Vascular Resistance|vascular resistance
5632147|NCT00770497|Drug Therapy|drug therapy
5632148|NCT00770497|physiopathology, vascular|physiopathology, vascular
5632149|NCT00770484|Exercise|exercise
5632150|NCT00770484|Propanolol|propanolol
5632151|NCT00770484|Beta blockers|beta blockers
5632152|NCT00770471|adult glioblastoma|adult glioblastoma
5632153|NCT00770471|adult gliosarcoma|adult gliosarcoma
5632154|NCT00770471|adult giant cell glioblastoma|adult giant cell glioblastoma
5632155|NCT00770458|Down Syndrome|down syndrome
5632156|NCT00770445|Glucose Metabolism Disorder|glucose metabolism disorder
5632157|NCT00770445|Dysmetabolic Syndrome|dysmetabolic syndrome
5632158|NCT00770445|Type II Diabetes|type ii diabetes
5632159|NCT00770445|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5632160|NCT00770445|Dyslipidemia|dyslipidemia
5632161|NCT00770445|Drug Therapy|drug therapy
5632162|NCT00770432|Human Experimentation|human experimentation
5632163|NCT00770419|depression|depression
5632164|NCT00770419|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5632165|NCT00770419|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5632166|NCT00770419|acute undifferentiated leukemia|acute undifferentiated leukemia
5632167|NCT00770419|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5632168|NCT00770419|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5632169|NCT00770419|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5632170|NCT00770419|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5632171|NCT00770419|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5632172|NCT00770419|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5632173|NCT00770419|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5632174|NCT00770419|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5632175|NCT00770419|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5632176|NCT00770419|mast cell leukemia|mast cell leukemia
5632177|NCT00770419|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5632178|NCT00770419|prolymphocytic leukemia|prolymphocytic leukemia
5632245|NCT00770302|Pharmacokinetics|pharmacokinetics
5632179|NCT00770419|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5632180|NCT00770419|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5632181|NCT00770419|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5632182|NCT00770419|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5632183|NCT00770419|refractory hairy cell leukemia|refractory hairy cell leukemia
5632184|NCT00770419|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5632185|NCT00770419|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5632186|NCT00770419|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5632187|NCT00770419|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5632188|NCT00770419|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5632189|NCT00770419|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5632190|NCT00770419|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5632191|NCT00770419|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5632192|NCT00770419|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5632193|NCT00770419|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5632194|NCT00770419|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5632195|NCT00770419|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5632196|NCT00770419|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5632197|NCT00770419|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5632198|NCT00770419|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5632199|NCT00770419|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5632200|NCT00770419|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5632201|NCT00770419|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5632202|NCT00770419|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5847441|NCT00038961|venous thromboembolism|venous thromboembolism
5632203|NCT00770419|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5632204|NCT00770419|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5632205|NCT00770419|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5632206|NCT00770419|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5632207|NCT00770419|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5632208|NCT00770419|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5632209|NCT00770419|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5632210|NCT00770419|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5632211|NCT00770419|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5632212|NCT00770419|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5632213|NCT00770419|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5632214|NCT00770419|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5632215|NCT00770419|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5632216|NCT00770419|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5632217|NCT00770419|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5632218|NCT00770419|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5632219|NCT00770419|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5632220|NCT00770419|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5632221|NCT00770419|intraocular lymphoma|intraocular lymphoma
5632222|NCT00770419|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5632223|NCT00770419|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5632224|NCT00770419|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5632225|NCT00770419|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5632226|NCT00770419|primary myelofibrosis|primary myelofibrosis
5632227|NCT00770419|primary systemic amyloidosis|primary systemic amyloidosis
5632228|NCT00770419|refractory multiple myeloma|refractory multiple myeloma
5863026|NCT00001413|DEXA Scan|dexa scan
5632229|NCT00770419|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5632231|NCT00770419|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5632232|NCT00770393|squamous cell carcinoma of the pyriform sinus|squamous cell carcinoma of the pyriform sinus
5632233|NCT00770393|laryngeal preservation|laryngeal preservation
5632234|NCT00770393|patients with biopsy-proven previously untreated resectable T3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus|patients with biopsy-proven previously untreated resectable t3 with fixed cord involvement squamous cell carcinoma of the pyriform sinus
5632235|NCT00770380|smoking|smoking
5632236|NCT00770367|Cardiovascular risk|cardiovascular risk
5632237|NCT00770367|biological markers|biological markers
5632238|NCT00770354|Breast cancer|breast cancer
5632239|NCT00770328|Plasma PAI-1 level at 0, 4, 8 weeks|plasma pai-1 level at 0, 4, 8 weeks
5632240|NCT00770328|Plasma hsCRP level at 0, 4, 8 weeks|plasma hscrp level at 0, 4, 8 weeks
5632241|NCT00770328|Plasma TNF-a level at 0, 4, 8 weeks|plasma tnf-a level at 0, 4, 8 weeks
5632242|NCT00770302|DPP-4 inhibitors|dpp-4 inhibitors
5632243|NCT00770302|HBA1c|hba1c
5632244|NCT00770302|Incretins|incretins
5632246|NCT00770276|obesity WHO I-III|obesity who i-iii
5632247|NCT00770276|metabolic syndrome|metabolic syndrome
5632248|NCT00770276|Framingham risk score|framingham risk score
5632249|NCT00770276|subclinical atherosclerosis|subclinical atherosclerosis
5632250|NCT00770276|endothelial dysfunction|endothelial dysfunction
5632251|NCT00770263|any solid tumors|any solid tumors
5632252|NCT00770250|asthma symptoms|asthma symptoms
5632253|NCT00770250|words used by patients and physicians|words used by patients and physicians
5632254|NCT00770250|express asthma symptoms|express asthma symptoms
5632255|NCT00770237|Smoking|smoking
5632256|NCT00770237|Nicotine|nicotine
5632257|NCT00770237|Schizophrenia|schizophrenia
5613998|NCT00841919|Insulin|insulin
5613999|NCT00841919|Insulin pen|insulin pen
5632258|NCT00770224|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5632259|NCT00770224|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5632260|NCT00770224|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5632261|NCT00770224|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5632262|NCT00770224|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5632697|NCT00768859|carboplatin|carboplatin
5632263|NCT00770224|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5632264|NCT00770224|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5632265|NCT00770224|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5632266|NCT00770224|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5632267|NCT00770224|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5632268|NCT00770224|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5632269|NCT00770224|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5632272|NCT00770198|HCV|hcv
5632273|NCT00770185|endometrial adenocarcinoma|endometrial adenocarcinoma
5632275|NCT00770185|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5632276|NCT00770185|endometrial papillary carcinoma|endometrial papillary carcinoma
5671710|NCT00614718|Defibrillators|defibrillators
5632277|NCT00770185|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5632278|NCT00770185|stage III endometrial carcinoma|stage iii endometrial carcinoma
5632279|NCT00770185|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5632280|NCT00770172|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5632281|NCT00770172|neutropenia|neutropenia
5632282|NCT00770172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5632283|NCT00770120|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5632284|NCT00770120|stage II malignant mesothelioma|stage ii malignant mesothelioma
5632285|NCT00770120|stage III malignant mesothelioma|stage iii malignant mesothelioma
5632286|NCT00770120|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5632288|NCT00770094|Laser Vision correction|laser vision correction
5632289|NCT00770094|Myopia|myopia
5632290|NCT00770094|Myopia with astigmatism|myopia with astigmatism
5632291|NCT00770094|Nearsighted|nearsighted
5632292|NCT00770081|Type 2 diabetes|type 2 diabetes
5632293|NCT00770081|vildagliptin|vildagliptin
5632294|NCT00770068|Mood Disorders|mood disorders
5632295|NCT00770068|Major Depressive Disorder|major depressive disorder
5632296|NCT00770068|Bipolar Disorder|bipolar disorder
5632297|NCT00770068|Tree Pollen|tree pollen
5632298|NCT00770068|Ragweed Pollen|ragweed pollen
5632299|NCT00770068|Rhinitis|rhinitis
5632300|NCT00770068|Allergic|allergic
5632301|NCT00770068|Seasonal|seasonal
5632302|NCT00770068|Allergens|allergens
5632303|NCT00770055|stage IV breast cancer|stage iv breast cancer
5632304|NCT00770055|recurrent breast cancer|recurrent breast cancer
5632305|NCT00770016|insulin sensitivity|insulin sensitivity
5632306|NCT00770016|Substrate metabolism|substrate metabolism
5632307|NCT00770016|Fatty liver|fatty liver
5632308|NCT00770016|intramyocellular lipid|intramyocellular lipid
5632309|NCT00770016|intracellular signaling|intracellular signaling
5632311|NCT00770003|allergic rhinitis|allergic rhinitis
5632312|NCT00770003|tolerability|tolerability
5632313|NCT00770003|safety|safety
5632314|NCT00770003|nasal symptoms|nasal symptoms
5632315|NCT00769990|bone metastases|bone metastases
5632316|NCT00769990|pain|pain
5632317|NCT00769990|recurrent breast cancer|recurrent breast cancer
5632318|NCT00769990|stage IV breast cancer|stage iv breast cancer
5632319|NCT00769990|recurrent prostate cancer|recurrent prostate cancer
5632320|NCT00769990|stage IV prostate cancer|stage iv prostate cancer
5632321|NCT00769990|recurrent melanoma|recurrent melanoma
5632322|NCT00769990|stage IV melanoma|stage iv melanoma
5632323|NCT00769990|recurrent renal cell cancer|recurrent renal cell cancer
5632324|NCT00769990|stage IV renal cell cancer|stage iv renal cell cancer
5632325|NCT00769990|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5632326|NCT00769990|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5632327|NCT00769990|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5632328|NCT00769990|recurrent small cell lung cancer|recurrent small cell lung cancer
5632329|NCT00769964|Healthy (Dysmenorrhea)|healthy (dysmenorrhea)
5632330|NCT00769951|pain|pain
5632331|NCT00769951|depression|depression
5632332|NCT00769951|weight changes|weight changes
5632333|NCT00769951|cognitive/functional effects|cognitive/functional effects
5632334|NCT00769951|malnutrition|malnutrition
5632335|NCT00769951|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5632336|NCT00769951|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5632337|NCT00769951|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5632338|NCT00769938|Atrial fibrillation|atrial fibrillation
5632339|NCT00769938|Percutaneous coronary stenting|percutaneous coronary stenting
5632340|NCT00769938|Bleeding complications|bleeding complications
5632341|NCT00769938|Triple therapy|triple therapy
5632342|NCT00769925|Generalized Anxiety|generalized anxiety
5632343|NCT00769925|Social Phobia|social phobia
5632344|NCT00769925|Separation Anxiety|separation anxiety
5632345|NCT00769925|Phobia|phobia
5632346|NCT00769899|AZD7325|azd7325
5632347|NCT00769899|Japanese Healthy Volunteers|japanese healthy volunteers
5632348|NCT00769899|Phase I study|phase i study
5632349|NCT00769899|Single Ascending Dose|single ascending dose
5632350|NCT00769873|anticoagulation|anticoagulation
5632351|NCT00769873|thrombosis|thrombosis
5632352|NCT00769873|portal vein thrombosis|portal vein thrombosis
5632353|NCT00769873|splenic vein thrombosis|splenic vein thrombosis
5632354|NCT00769873|splenectomy|splenectomy
5632355|NCT00769873|randomized|randomized
5632356|NCT00769873|laparoscopic splenectomy|laparoscopic splenectomy
5632357|NCT00769873|lovenox|lovenox
5632358|NCT00769860|myositis|myositis
5632359|NCT00769860|IBM|ibm
5632360|NCT00769860|inclusion body myositis|inclusion body myositis
5632361|NCT00769847|Endoscopic, craniosynostosis, sagittal, synostosis|endoscopic, craniosynostosis, sagittal, synostosis
5632362|NCT00769834|chronic kidney disease|chronic kidney disease
5632363|NCT00769834|chronic renal insufficiency|chronic renal insufficiency
5632366|NCT00769834|papilledema|papilledema
5632367|NCT00769834|idiopathic intracranial hypertension|idiopathic intracranial hypertension
5632368|NCT00769834|pseudotumor cerebri|pseudotumor cerebri
5632369|NCT00769821|lymphedema|lymphedema
5632370|NCT00769821|perioperative/postoperative complications|perioperative/postoperative complications
5632371|NCT00769821|cancer survivor|cancer survivor
5632372|NCT00769821|stage I breast cancer|stage i breast cancer
5632373|NCT00769821|stage II breast cancer|stage ii breast cancer
5632374|NCT00769821|stage IIIA breast cancer|stage iiia breast cancer
5632375|NCT00769821|stage IIIB breast cancer|stage iiib breast cancer
5632376|NCT00769821|stage IIIC breast cancer|stage iiic breast cancer
5632377|NCT00769821|stage IV breast cancer|stage iv breast cancer
5632378|NCT00769795|prostate cancer|prostate cancer
5632379|NCT00769795|prostatic neoplasm|prostatic neoplasm
5632698|NCT00768846|PCI|pci
5632380|NCT00769795|androgen deprivation therapy|androgen deprivation therapy
5632381|NCT00769795|insulin-like growth factor receptor I|insulin-like growth factor receptor i
5632382|NCT00769795|neoadjuvant|neoadjuvant
5632383|NCT00769795|prostatectomy|prostatectomy
5680377|NCT00577993|Dexamethasone|dexamethasone
5632384|NCT00769782|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5632385|NCT00769782|liver metastases|liver metastases
5632386|NCT00769769|Health Status|health status
5632387|NCT00769756|Different Strategies to Fight Obesity in Families|different strategies to fight obesity in families
5632388|NCT00769730|hepatocellular carcinoma|hepatocellular carcinoma
5632389|NCT00769730|hepatitis B virus|hepatitis b virus
5632390|NCT00769730|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5632391|NCT00769717|obesity|obesity
5632392|NCT00769717|wellness|wellness
5632393|NCT00769717|cardiovascular disease prevention|cardiovascular disease prevention
5632394|NCT00769717|health at every size|health at every size
5632395|NCT00769717|weight loss|weight loss
5632396|NCT00769704|Melanoma|melanoma
5632397|NCT00769704|OncoVEX^GM-CSF|oncovex^gm-csf
5632398|NCT00769704|GM-CSF|gm-csf
5626142|NCT00794950|Bladder Cancer|bladder cancer
5632399|NCT00769704|Stage IIIb, IIIc and IV Disease|stage iiib, iiic and iv disease
5632400|NCT00769704|oncolytic|oncolytic
5632401|NCT00769704|OncoVex|oncovex
5632402|NCT00769704|T-Vec|t-vec
5632403|NCT00769704|talimogene laherparepvec|talimogene laherparepvec
5632404|NCT00769691|Cardiac surgery|cardiac surgery
5632405|NCT00769691|Cerebral blood flow autoregulation|cerebral blood flow autoregulation
5632406|NCT00769678|Biventricular Pacing|biventricular pacing
5632407|NCT00769665|Dry Eye|dry eye
5632408|NCT00769665|re-wetting drops|re-wetting drops
5632409|NCT00769652|malnutrition|malnutrition
5632410|NCT00769652|non-small cell lung cancer|non-small cell lung cancer
5632411|NCT00769652|small cell lung cancer|small cell lung cancer
5632412|NCT00769652|stage III prostate cancer|stage iii prostate cancer
5632413|NCT00769652|stage IV prostate cancer|stage iv prostate cancer
5632414|NCT00769652|pancreatic cancer|pancreatic cancer
5632415|NCT00769652|weight changes|weight changes
5632416|NCT00769626|Low Back Pain|low back pain
5632417|NCT00769626|Clinical Practice Guidelines|clinical practice guidelines
5632418|NCT00769626|Spinal Manipulation|spinal manipulation
5632419|NCT00769626|Physical Therapy Techniques|physical therapy techniques
5632420|NCT00769613|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5632421|NCT00769613|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5632422|NCT00769613|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5632423|NCT00769613|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5632424|NCT00769613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5632425|NCT00769613|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5632426|NCT00769613|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5632427|NCT00769613|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5632428|NCT00769613|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5614201|NCT00841139|perhexiline|perhexiline
5632429|NCT00769613|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5632430|NCT00769613|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5632431|NCT00769613|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5632432|NCT00769613|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5632433|NCT00769613|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5632434|NCT00769613|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5632435|NCT00769613|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5632436|NCT00769613|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5632437|NCT00769613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5632438|NCT00769613|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5632439|NCT00769613|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5632440|NCT00769613|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5632441|NCT00769613|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5632442|NCT00769613|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5632443|NCT00769613|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5632444|NCT00769613|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5632445|NCT00769613|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5632446|NCT00769613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5632447|NCT00769613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5632448|NCT00769613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5632449|NCT00769613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5632450|NCT00769613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5632451|NCT00769613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5632452|NCT00769613|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5632453|NCT00769613|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5632454|NCT00769613|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5632455|NCT00769613|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5632456|NCT00769613|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5632457|NCT00769613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5632458|NCT00769613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5632459|NCT00769613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5632460|NCT00769613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5632461|NCT00769613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5632462|NCT00769613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5632463|NCT00769613|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5632464|NCT00769613|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5632465|NCT00769613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5632466|NCT00769613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5632467|NCT00769613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5632468|NCT00769613|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5632469|NCT00769613|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5632470|NCT00769613|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5632471|NCT00769613|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5632472|NCT00769613|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5632473|NCT00769613|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5632474|NCT00769613|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5632475|NCT00769613|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5632476|NCT00769613|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5632477|NCT00769613|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5632478|NCT00769613|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5632479|NCT00769613|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5632480|NCT00769613|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5632481|NCT00769613|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5632482|NCT00769613|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5632483|NCT00769613|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5632484|NCT00769613|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5632485|NCT00769613|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5632486|NCT00769613|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5632487|NCT00769613|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5632488|NCT00769613|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5632489|NCT00769613|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5632490|NCT00769613|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5632491|NCT00769613|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5632492|NCT00769613|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5632493|NCT00769613|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5632494|NCT00769613|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5632495|NCT00769613|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5685473|NCT00555958|VBLOC(TM) therapy|vbloc(tm) therapy
5632496|NCT00769613|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5632497|NCT00769613|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5632498|NCT00769613|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5632499|NCT00769613|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5632500|NCT00769613|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5632501|NCT00769613|refractory hairy cell leukemia|refractory hairy cell leukemia
5632502|NCT00769613|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5632503|NCT00769613|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5632504|NCT00769613|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5632505|NCT00769613|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5632506|NCT00769613|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5632507|NCT00769613|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5632508|NCT00769613|primary myelofibrosis|primary myelofibrosis
5632509|NCT00769613|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5632510|NCT00769613|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5632511|NCT00769613|disseminated neuroblastoma|disseminated neuroblastoma
5632512|NCT00769613|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5632513|NCT00769613|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5632514|NCT00769613|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5632515|NCT00769613|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5632516|NCT00769613|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5617344|NCT00828178|SLE|sle
5632517|NCT00769613|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5632518|NCT00769613|recurrent neuroblastoma|recurrent neuroblastoma
5632519|NCT00769613|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5632520|NCT00769613|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5632521|NCT00769613|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5632522|NCT00769613|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5632523|NCT00769613|stage I multiple myeloma|stage i multiple myeloma
5632524|NCT00769613|stage II multiple myeloma|stage ii multiple myeloma
5632525|NCT00769613|stage III multiple myeloma|stage iii multiple myeloma
5632526|NCT00769613|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5863027|NCT00001413|Body Mass|body mass
5632531|NCT00769613|stage IIIB breast cancer|stage iiib breast cancer
5632532|NCT00769613|stage IIIC breast cancer|stage iiic breast cancer
5632533|NCT00769613|stage IV breast cancer|stage iv breast cancer
5632534|NCT00769613|refractory multiple myeloma|refractory multiple myeloma
5632535|NCT00769613|cytomegalovirus infection|cytomegalovirus infection
5632536|NCT00769600|Recurrent Non-Small Cell Lung Cancer|recurrent non-small cell lung cancer
5632537|NCT00769587|aggressive systemic mastocytosis|aggressive systemic mastocytosis
5632538|NCT00769587|smoldering systemic mastocytosis|smoldering systemic mastocytosis
5632539|NCT00769561|Temporomandibular disorders|temporomandibular disorders
5632540|NCT00769561|Biofeedback|biofeedback
5632541|NCT00769561|Cognitive behavioral therapy|cognitive behavioral therapy
5632543|NCT00769548|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5632544|NCT00769548|stage I prostate cancer|stage i prostate cancer
5632545|NCT00769548|stage IIB prostate cancer|stage iib prostate cancer
5632546|NCT00769548|stage IIA prostate cancer|stage iia prostate cancer
5632547|NCT00769548|stage III prostate cancer|stage iii prostate cancer
5632548|NCT00769548|stage IV prostate cancer|stage iv prostate cancer
5632549|NCT00769535|heat shock protein70|heat shock protein70
5632550|NCT00769535|tumor necrosis factor-alpha promoter|tumor necrosis factor-alpha promoter
5632551|NCT00769535|polymorphism|polymorphism
5633219|NCT00766220|Liver|liver
5632552|NCT00769522|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5632553|NCT00769522|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5632554|NCT00769522|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5632555|NCT00769522|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5632556|NCT00769522|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5632557|NCT00769522|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5632558|NCT00769509|energy expenditure|energy expenditure
5632559|NCT00769509|indirect calorimetry|indirect calorimetry
5632560|NCT00769509|human milk|human milk
5632561|NCT00769509|preterm formula|preterm formula
5632562|NCT00769509|premature infant|premature infant
5632563|NCT00769483|Pancreas|pancreas
5632564|NCT00769483|Pancreatic Cancer|pancreatic cancer
5632565|NCT00769483|Advanced cancer of the pancreas|advanced cancer of the pancreas
5632566|NCT00769483|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5632567|NCT00769483|MK-0646|mk-0646
5632568|NCT00769483|Gemcitabine|gemcitabine
5632569|NCT00769483|Gemzar|gemzar
5632570|NCT00769483|Erlotinib hydrochloride|erlotinib hydrochloride
5632571|NCT00769483|Erlotinib|erlotinib
5632572|NCT00769483|OSI-774|osi-774
5632573|NCT00769483|Tarceva|tarceva
5632574|NCT00769470|stage I breast cancer|stage i breast cancer
5632575|NCT00769470|stage II breast cancer|stage ii breast cancer
5632576|NCT00769470|stage IIIA breast cancer|stage iiia breast cancer
5635163|NCT00757523|Akne|akne
5632577|NCT00769470|stage IIIB breast cancer|stage iiib breast cancer
5632578|NCT00769470|stage IIIC breast cancer|stage iiic breast cancer
5632579|NCT00769470|HER2-positive breast cancer|her2-positive breast cancer
5632580|NCT00769431|stage I prostate cancer|stage i prostate cancer
5632581|NCT00769431|stage IIB prostate cancer|stage iib prostate cancer
5632582|NCT00769431|stage IIA prostate cancer|stage iia prostate cancer
5632583|NCT00769405|recurrent colon cancer|recurrent colon cancer
5632584|NCT00769405|stage IV colon cancer|stage iv colon cancer
5632585|NCT00769405|recurrent rectal cancer|recurrent rectal cancer
5632586|NCT00769405|stage IV rectal cancer|stage iv rectal cancer
5632587|NCT00769405|peritoneal carcinomatosis|peritoneal carcinomatosis
5632588|NCT00769392|Macular Degeneration|macular degeneration
5632589|NCT00769392|Intravitreal injections|intravitreal injections
5632590|NCT00769392|Eye anesthesia-Topical/subconjunctival|eye anesthesia-topical/subconjunctival
5632591|NCT00769392|Eye-surgical procedures|eye-surgical procedures
5632592|NCT00769392|Ophthalmologic anesthesia methods|ophthalmologic anesthesia methods
5632593|NCT00769327|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5632594|NCT00769327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5632595|NCT00769301|Symptoms|symptoms
5632596|NCT00769301|pain|pain
5632597|NCT00769301|fatigue|fatigue
5632598|NCT00769301|depression|depression
5632599|NCT00769301|sleeplessness|sleeplessness
5632600|NCT00769301|genetic markers|genetic markers
5632601|NCT00769301|caregiver burden.|caregiver burden.
5632602|NCT00769275|silent ischemia|silent ischemia
5632603|NCT00769275|type 2 diabetes mellitus|type 2 diabetes mellitus
5632604|NCT00769275|screening|screening
5632605|NCT00769275|cardiac outcome|cardiac outcome
5626453|NCT00793637|Handling test|handling test
5632606|NCT00769275|Prevalence silent myocardial ischemia|prevalence silent myocardial ischemia
5632607|NCT00769275|Cardiac outcome in screened and not-screened subjects|cardiac outcome in screened and not-screened subjects
5632608|NCT00769262|Premature neonates|premature neonates
5632609|NCT00769262|Thermoregulation|thermoregulation
5632610|NCT00769262|Isolette|isolette
5632611|NCT00769262|Feeding status|feeding status
5632612|NCT00769249|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5632613|NCT00769249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5632614|NCT00769223|radiation toxicity|radiation toxicity
5632615|NCT00769223|recurrent prostate cancer|recurrent prostate cancer
5632616|NCT00769223|stage IIB prostate cancer|stage iib prostate cancer
5632617|NCT00769223|stage IIA prostate cancer|stage iia prostate cancer
5632618|NCT00769223|stage III prostate cancer|stage iii prostate cancer
5632619|NCT00769223|stage I prostate cancer|stage i prostate cancer
5632620|NCT00769223|stage IV prostate cancer|stage iv prostate cancer
5632621|NCT00769223|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5632622|NCT00769197|optic disc cupping|optic disc cupping
5632623|NCT00769197|cerebral palsy|cerebral palsy
5632624|NCT00769197|static encephalopathy|static encephalopathy
5632625|NCT00769197|optic disc|optic disc
5632626|NCT00769197|optic nerve|optic nerve
5632627|NCT00769197|periventricular Leukomalacia|periventricular leukomalacia
5632628|NCT00769184|chronic plaque psoriasis|chronic plaque psoriasis
5632629|NCT00769171|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5632630|NCT00769158|Alcohol|alcohol
5632631|NCT00769158|Alcoholism|alcoholism
5632632|NCT00769158|Alcohol Dependence|alcohol dependence
5632633|NCT00769145|Corneal neovascularization|corneal neovascularization
5632634|NCT00769145|Ranibizumab|ranibizumab
5632635|NCT00769145|Corneal transplantation|corneal transplantation
5632636|NCT00769119|bronchiectasis|bronchiectasis
5632637|NCT00769119|Phase II|phase ii
5632638|NCT00769106|hepatocellular carcinoma|hepatocellular carcinoma
5632639|NCT00769106|recurrent|recurrent
5633677|NCT00764153|Function|function
5632640|NCT00769106|cytokine-induced killer cell|cytokine-induced killer cell
5632641|NCT00769093|ferumoxytol|ferumoxytol
5632642|NCT00769093|diagnostic imaging|diagnostic imaging
5632643|NCT00769080|PSP|psp
5632644|NCT00769080|Standard Treatment|standard treatment
5632645|NCT00769080|Standard Treatment plus PSP|standard treatment plus psp
5632646|NCT00769067|Lung cancer|lung cancer
5632647|NCT00769067|advanced|advanced
5632648|NCT00769067|second or third line|second or third line
5632649|NCT00769054|Postoperative pain|postoperative pain
5632650|NCT00769054|PONV|ponv
5632651|NCT00769028|Systemic sclerosis|systemic sclerosis
5632652|NCT00769028|Diffuse cutaneous systemic sclerosis|diffuse cutaneous systemic sclerosis
5632653|NCT00769028|Scleroderma|scleroderma
5632654|NCT00769028|Biological|biological
5632655|NCT00769028|Hyperimmune caprine serum|hyperimmune caprine serum
5632656|NCT00769028|Goat Serum|goat serum
5632657|NCT00769015|age-related macular degeneration|age-related macular degeneration
5632658|NCT00769015|depression|depression
5632659|NCT00769015|vision loss|vision loss
5632660|NCT00769002|influenza|influenza
5632661|NCT00769002|flu|flu
5632662|NCT00769002|vaccine|vaccine
5632663|NCT00769002|vaccination|vaccination
5632664|NCT00769002|immune response|immune response
5632665|NCT00769002|FluShield|flushield
5632666|NCT00769002|FluMist|flumist
5632667|NCT00769002|PET-CT|pet-ct
5632668|NCT00769002|Healthy Volunteers|healthy volunteers
5632669|NCT00768989|Combination Therapy|combination therapy
5632670|NCT00768976|Participant must have participated in a clinical trial conducted by the Summa Health System Hospitals Cancer Research Program.|participant must have participated in a clinical trial conducted by the summa health system hospitals cancer research program.
5671241|NCT00616590|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5671711|NCT00614679|biofilm|biofilm
5632671|NCT00768976|Participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.|participant should have been registered for clinical trial participation three months prior to receiving the satisfaction survey.
5632672|NCT00768963|ranibizumab|ranibizumab
5632673|NCT00768963|pterygium|pterygium
5632674|NCT00768950|Seronegative spondyloarthropathies|seronegative spondyloarthropathies
5632675|NCT00768950|Endoscopic capsule examination|endoscopic capsule examination
5632676|NCT00768950|Small bowel and colon lesions|small bowel and colon lesions
5632677|NCT00768950|Nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5632678|NCT00768950|Anti TNF Alpha Drugs|anti tnf alpha drugs
5632679|NCT00768937|hepatocellular carcinoma|hepatocellular carcinoma
5632680|NCT00768937|sorafenib|sorafenib
5680379|NCT00577993|Anti-CD20|anti-cd20
5632681|NCT00768937|transarterial chemoembolization|transarterial chemoembolization
5632682|NCT00768937|tumor angiogenesis|tumor angiogenesis
5632683|NCT00768937|angiogenic factors|angiogenic factors
5632684|NCT00768924|Bone Void Filler|bone void filler
5632685|NCT00768924|Post-Harvest Iliac Crest|post-harvest iliac crest
5632686|NCT00768924|Ability of CopiOs to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.|ability of copios to fill the post-harvest iliac crest bone void created by a surgeon during spinal fusion.
5632687|NCT00768911|glioblastoma|glioblastoma
5632688|NCT00768911|Glioblastoma multiforme (newly diagnosed)|glioblastoma multiforme (newly diagnosed)
5632689|NCT00768898|conjunctival|conjunctival
5632690|NCT00768898|staining|staining
5632691|NCT00768872|activity, spinal cord stimulation, pain|activity, spinal cord stimulation, pain
5632692|NCT00768859|breast cancer|breast cancer
5632693|NCT00768859|HER2 positive|her2 positive
5632694|NCT00768859|neo-adjuvant|neo-adjuvant
5632695|NCT00768859|trastuzumab|trastuzumab
5632696|NCT00768859|paclitaxel|paclitaxel
5632699|NCT00768846|Stent|stent
5632701|NCT00768846|CAD|cad
5632702|NCT00768833|S.pneumoniae healthy subjects|s.pneumoniae healthy subjects
5632703|NCT00768833|Healthy subjects|healthy subjects
5632704|NCT00768820|Velocardiofacial syndrome|velocardiofacial syndrome
5632705|NCT00768820|Williams syndrome|williams syndrome
5632706|NCT00768820|fragile X syndrome|fragile x syndrome
5632707|NCT00768820|cognitive phenotype|cognitive phenotype
5632708|NCT00768820|psychiatric phenotype|psychiatric phenotype
5632709|NCT00768794|thrush|thrush
5632710|NCT00768781|insomnia|insomnia
5632711|NCT00768781|hyperarousal|hyperarousal
5632712|NCT00768781|mindfulness meditation|mindfulness meditation
5632713|NCT00768781|complementary and alternative medicine|complementary and alternative medicine
5632714|NCT00768781|cognitive-behavioral therapy|cognitive-behavioral therapy
5632715|NCT00768768|iontophoresis|iontophoresis
5632716|NCT00768768|terbinafine|terbinafine
5632717|NCT00768768|onychomycosis|onychomycosis
5632718|NCT00768755|non-squamous NSCLC|non-squamous nsclc
5632719|NCT00768755|axitinib|axitinib
5632720|NCT00768755|pemetrexed/cisplatin|pemetrexed/cisplatin
5632721|NCT00768742|Uterine Fibroid RF Ablation|uterine fibroid rf ablation
5632722|NCT00768742|Intrauterine Ultrasound|intrauterine ultrasound
5632723|NCT00768742|VizAblate|vizablate
5632724|NCT00768729|End stage renal disease|end stage renal disease
5632725|NCT00768729|Kidney transplantation|kidney transplantation
5632726|NCT00768729|Renal transplantation|renal transplantation
5632727|NCT00768729|Kidney failure|kidney failure
5632728|NCT00768729|Children|children
5632729|NCT00768729|Adolescents|adolescents
5632730|NCT00768729|Sirolimus|sirolimus
5632731|NCT00768729|Rapamycin|rapamycin
5632732|NCT00768729|CellCept|cellcept
5633678|NCT00764153|Pain|pain
5632733|NCT00768729|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5632734|NCT00768729|Azathioprine|azathioprine
5632735|NCT00768703|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5632736|NCT00768703|lung-head ratio|lung-head ratio
5632737|NCT00768703|percutaneous tracheal occlusion|percutaneous tracheal occlusion
5632738|NCT00768703|fetal intervention|fetal intervention
5632739|NCT00768677|binge eating behavior|binge eating behavior
5632740|NCT00768677|adolescents|adolescents
5632741|NCT00768664|recurrent or metastatic squamous cell cancer of the Head and Neck; no prior systemic therapy for recurrence|recurrent or metastatic squamous cell cancer of the head and neck; no prior systemic therapy for recurrence
5632742|NCT00768638|Chronic kidney disease|chronic kidney disease
5632743|NCT00768612|Acute, Schizophrenia, Phase2a, Vabicaserin|acute, schizophrenia, phase2a, vabicaserin
5632744|NCT00768599|Econazole|econazole
5632745|NCT00768599|Foam|foam
5632746|NCT00768599|Quinnova|quinnova
5632747|NCT00768573|taste test|taste test
5632748|NCT00768534|Acute Otitis Media|acute otitis media
5632749|NCT00768534|Serotype distribution|serotype distribution
5632750|NCT00768508|Alcohol|alcohol
5632751|NCT00768508|Alcohol Dependence|alcohol dependence
5632752|NCT00768508|Alcoholism|alcoholism
5632753|NCT00768495|revascularization|revascularization
5632754|NCT00768495|claudication|claudication
5632755|NCT00768495|hyperspectral|hyperspectral
5632756|NCT00768495|oxygenation|oxygenation
5632757|NCT00768495|limb ischemia|limb ischemia
5632758|NCT00768482|opioid dependence|opioid dependence
5632759|NCT00768482|opioid addiction|opioid addiction
5632760|NCT00768482|buprenorphine|buprenorphine
5632761|NCT00768482|methadone|methadone
5632762|NCT00768482|heroin|heroin
5632763|NCT00768482|implant|implant
5632764|NCT00768482|opioid withdrawal|opioid withdrawal
5632765|NCT00768482|opioid pain medication|opioid pain medication
5632766|NCT00768482|suboxone|suboxone
5632767|NCT00768469|HKI-272|hki-272
5632768|NCT00768469|Paclitaxel|paclitaxel
5632769|NCT00768469|Combination|combination
5632770|NCT00768469|Solid Tumor|solid tumor
5632771|NCT00768443|GERD|gerd
5632773|NCT00768417|Nuts|nuts
5632774|NCT00768417|Lipids|lipids
5632775|NCT00768417|Mastication|mastication
5632776|NCT00768417|Bioaccessibility|bioaccessibility
5632777|NCT00768417|Satiety|satiety
5632778|NCT00768417|Hormones|hormones
5632779|NCT00768417|Human|human
5632780|NCT00768391|Tumors|tumors
5632781|NCT00768391|Lymphoma|lymphoma
5617673|NCT00826969|Asthma|asthma
5632782|NCT00768391|Antibodies, Monoclonal|antibodies, monoclonal
5632783|NCT00768378|Physical Therapy (Specialty)|physical therapy (specialty)
5632784|NCT00768378|Balance dysfunction or disorder|balance dysfunction or disorder
5632785|NCT00768378|Vestibular|vestibular
5632786|NCT00768378|Rehabilitation|rehabilitation
5632787|NCT00768365|adrenal incidentaloma|adrenal incidentaloma
5632788|NCT00768365|cardiovascular risk|cardiovascular risk
5632789|NCT00768352|Pediatric|pediatric
5632790|NCT00768352|Resident|resident
5632791|NCT00768352|Depression|depression
5632792|NCT00768352|Screening|screening
5632793|NCT00768352|Substance Abuse|substance abuse
5632794|NCT00768352|Pediatric Resident knowledge of mental health topics|pediatric resident knowledge of mental health topics
5632795|NCT00768352|Pediatric Resident current practices for screening and treating mental health disorders|pediatric resident current practices for screening and treating mental health disorders
5632796|NCT00768352|Pediatric Resident mental health care competency|pediatric resident mental health care competency
5632797|NCT00768339|antisense|antisense
5632798|NCT00768339|AEG35156|aeg35156
5632799|NCT00768339|lymphocytic|lymphocytic
5632800|NCT00768339|lymphoma|lymphoma
5632801|NCT00768339|leukemia|leukemia
5632802|NCT00768339|B-cell|b-cell
5632803|NCT00768326|Schizophrenia|schizophrenia
5632804|NCT00768326|Antipsychotic|antipsychotic
5632805|NCT00768326|Lu 31-130|lu 31-130
5632806|NCT00768313|scoliosis correction rod strength adolescent|scoliosis correction rod strength adolescent
5632807|NCT00768300|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5632808|NCT00768300|interstitial lung disease|interstitial lung disease
5632809|NCT00768300|ambrisentan|ambrisentan
5632810|NCT00768274|Cholesterol|cholesterol
5632811|NCT00768274|High density lipoprotein|high density lipoprotein
5632812|NCT00768274|Dyslipidemia|dyslipidemia
5632813|NCT00768274|Atherosclerosis|atherosclerosis
5632814|NCT00768274|Apolipoprotein A-I|apolipoprotein a-i
5632815|NCT00768261|Dementia of the Alzheimer type|dementia of the alzheimer type
5632816|NCT00768248|pain|pain
5632817|NCT00768248|phantom limb|phantom limb
5632818|NCT00768248|stump pain|stump pain
5632819|NCT00768248|catheter|catheter
5632820|NCT00768248|nerve block|nerve block
5632821|NCT00768248|peripheral nerve block|peripheral nerve block
5632822|NCT00768248|NMCSD|nmcsd
5632823|NCT00768248|Post-Amputation Phantom Limb or Stump Pain|post-amputation phantom limb or stump pain
5632824|NCT00768235|Sedentary elderly women that had medical assignment|sedentary elderly women that had medical assignment
5632825|NCT00768222|wound healing|wound healing
5632826|NCT00768209|Pharmacokinetics|pharmacokinetics
5632827|NCT00768196|GERD|gerd
5632828|NCT00768196|Korea|korea
5632829|NCT00768196|typical symptom|typical symptom
5632830|NCT00768196|quality of life|quality of life
5632831|NCT00768196|Naturalistic|naturalistic
5632832|NCT00768196|epidemiological|epidemiological
5632833|NCT00768183|KADIAN|kadian
5632834|NCT00768183|morphine|morphine
5632835|NCT00768183|alcohol|alcohol
5632836|NCT00768183|water|water
5632837|NCT00768183|Ethanol|ethanol
5632838|NCT00768183|solution|solution
5632840|NCT00768183|fasting|fasting
5632841|NCT00768157|hepatocellular carcinoma|hepatocellular carcinoma
5632842|NCT00768157|hepatitis B virus|hepatitis b virus
5632843|NCT00768157|surgery|surgery
5632844|NCT00768157|anti-virus|anti-virus
5632845|NCT00768157|recurrence|recurrence
5632846|NCT00768144|Sutent|sutent
5632847|NCT00768144|sunitinib|sunitinib
5632848|NCT00768118|healthy, no evidence of disease|healthy, no evidence of disease
5632849|NCT00768105|Type 2 diabetes|type 2 diabetes
5632850|NCT00768079|Benralizumab|benralizumab
5632851|NCT00768079|MEDI-563|medi-563
5632852|NCT00768079|Asthma|asthma
5632853|NCT00768066|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
5632854|NCT00768053|EULAR-RAID|eular-raid
5632855|NCT00768053|active rheumatoid arthritis|active rheumatoid arthritis
5632857|NCT00768040|Diabetes|diabetes
5632858|NCT00768040|Macular edema|macular edema
5632859|NCT00768040|Aliskiren|aliskiren
5632860|NCT00768040|Diabetic retinopathy|diabetic retinopathy
5632861|NCT00768040|Diabetes mellitus type 1|diabetes mellitus type 1
5632862|NCT00768040|Diabetes mellitus type 2|diabetes mellitus type 2
5632863|NCT00768027|hyperspectral imaging|hyperspectral imaging
5820974|NCT00076752|SLE|sle
5632864|NCT00768027|tissue oxygenation|tissue oxygenation
5632865|NCT00768027|wounds|wounds
5632866|NCT00768027|wound healing|wound healing
5632867|NCT00768027|prevention|prevention
5632868|NCT00768027|hyperbaric|hyperbaric
5632869|NCT00767988|Probiotics|probiotics
5632870|NCT00767988|Spina Bifida|spina bifida
5632871|NCT00767988|Dietary Supplements|dietary supplements
5632872|NCT00767988|Bacteriuria|bacteriuria
5632873|NCT00767988|Urinary Tract Infection (UTI)|urinary tract infection (uti)
5632874|NCT00767962|recurrent primary spontaneous pneumothorax|recurrent primary spontaneous pneumothorax
5632875|NCT00767949|wet|wet
5632876|NCT00767949|AMD|amd
5632877|NCT00767923|hyperspectral imaging|hyperspectral imaging
5632878|NCT00767923|tissue oxygenation|tissue oxygenation
5632879|NCT00767923|foot amputation|foot amputation
5617692|NCT00826878|AV-951|av-951
5632880|NCT00767923|critical limb ischemia|critical limb ischemia
5632881|NCT00767923|tissue necrosis|tissue necrosis
5632882|NCT00767897|Dose response relationship|dose response relationship
5632883|NCT00767897|immunity|immunity
5632884|NCT00767884|panretinal photocoagulation|panretinal photocoagulation
5632885|NCT00767884|diabetic retinopathy|diabetic retinopathy
5632886|NCT00767884|optic nerve head changes|optic nerve head changes
5632887|NCT00767871|Panic disorder|panic disorder
5632888|NCT00767871|PET|pet
5632889|NCT00767871|Escitaopram|escitaopram
5632892|NCT00767858|Human Genetic Research|human genetic research
5632893|NCT00767858|Cultural Congruence|cultural congruence
5632894|NCT00767858|Interview|interview
5632895|NCT00767845|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5632896|NCT00767845|stage I prostate cancer|stage i prostate cancer
5632897|NCT00767845|stage II prostate cancer|stage ii prostate cancer
5632898|NCT00767845|stage III prostate cancer|stage iii prostate cancer
5632899|NCT00767819|progressive GIST|progressive gist
5632900|NCT00767819|progressive sarcoma|progressive sarcoma
5632901|NCT00767767|anesthetic drugs, associative memory, fear|anesthetic drugs, associative memory, fear
5632902|NCT00767754|panic disorder|panic disorder
5632903|NCT00767754|paroxetine|paroxetine
5632904|NCT00767754|PET|pet
5632905|NCT00767741|diabetes|diabetes
5632906|NCT00767741|post prandial glucose level|post prandial glucose level
5632907|NCT00767741|insulin|insulin
5632908|NCT00767741|pharmacokinetics|pharmacokinetics
5632909|NCT00767741|pharmacodynamics|pharmacodynamics
5632910|NCT00767728|UC|uc
5632911|NCT00767728|ulcerative colitis|ulcerative colitis
5632912|NCT00767728|IBD|ibd
5632913|NCT00767728|Inflammatory Bowel Disease|inflammatory bowel disease
5632914|NCT00767702|Genetic/Genomic Researchers|genetic/genomic researchers
5632915|NCT00767702|Human Genetic Variation|human genetic variation
5632916|NCT00767702|Interviews|interviews
5632917|NCT00767702|Research Design|research design
5632918|NCT00767702|Race/Ethnicity|race/ethnicity
5632919|NCT00767702|Interview|interview
5632920|NCT00767676|Contact sensitization|contact sensitization
5632921|NCT00767676|Healthy Adult Volunteers|healthy adult volunteers
5632922|NCT00767650|Aplastic Anemia|aplastic anemia
5614760|NCT00838799|neuropathic|neuropathic
5632923|NCT00767650|Cyclosporine|cyclosporine
5632924|NCT00767650|Campath|campath
5632925|NCT00767650|Neurophyschological Side Effect|neurophyschological side effect
5632926|NCT00767611|Infertility|infertility
5632927|NCT00767611|Sperm|sperm
5632928|NCT00767611|Embryo Development|embryo development
5632929|NCT00767611|In Vitro Fertilization|in vitro fertilization
5632930|NCT00767598|CYP3A5|cyp3a5
5632931|NCT00767598|sildenafil|sildenafil
5632932|NCT00767598|udenafil|udenafil
5632933|NCT00767598|vardenafil|vardenafil
5632934|NCT00767585|breast cancer|breast cancer
5632935|NCT00767585|aromatase inhibitors|aromatase inhibitors
5632936|NCT00767585|bone mineral density|bone mineral density
5632937|NCT00767585|osteoporosis|osteoporosis
5632938|NCT00767572|Coarctation of the aorta|coarctation of the aorta
5632939|NCT00767572|cross over design|cross over design
5632940|NCT00767572|atorvastatin|atorvastatin
5632941|NCT00767572|endothelial function|endothelial function
5632942|NCT00767559|Deep Vein Thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox|deep vein thrombosis, anticoagulants, surgery, pulmonary embolus, warfarin, fondaparinox
5632943|NCT00767546|seborrhic dermatitis|seborrhic dermatitis
5632944|NCT00767546|parkinson's disease|parkinson's disease
5632945|NCT00767546|Parkinson disease parkinsonism and seborrhic dermatitis|parkinson disease parkinsonism and seborrhic dermatitis
5632946|NCT00767520|Advanced Estrogen Receptor Positive Breast Cancer|advanced estrogen receptor positive breast cancer
5632948|NCT00767494|OH|oh
5632949|NCT00767494|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
5632950|NCT00767481|glaucoma|glaucoma
5632951|NCT00767481|Patients with open-angle glaucoma or ocular hypertension|patients with open-angle glaucoma or ocular hypertension
5632952|NCT00767468|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5632953|NCT00767468|advanced adult primary liver cancer|advanced adult primary liver cancer
5632954|NCT00767468|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5671712|NCT00614679|catheter lock solution|catheter lock solution
5632955|NCT00767468|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5632956|NCT00767455|cumulative irritation|cumulative irritation
5632957|NCT00767455|healthy adult volunteers|healthy adult volunteers
5632958|NCT00767429|accelerometer|accelerometer
5632960|NCT00767429|target group|target group
5632961|NCT00767429|field measurements|field measurements
5632962|NCT00767416|MEDI-559|medi-559
5632963|NCT00767416|Respiratory Syncytial Virus|respiratory syncytial virus
5632965|NCT00767416|Pediatric|pediatric
5632966|NCT00767416|Vaccine|vaccine
5632967|NCT00767416|respiratory syncytial virus, RSV, pediatric, vaccine|respiratory syncytial virus, rsv, pediatric, vaccine
5632968|NCT00767390|ACL Patch Placement|acl patch placement
5632969|NCT00767377|Time to Progression|time to progression
5632970|NCT00767377|Overall survival|overall survival
5632971|NCT00767377|Response rate|response rate
5632972|NCT00767377|Quality of Live|quality of live
5632973|NCT00767377|Toxicities|toxicities
5632974|NCT00767364|Infant|infant
5632975|NCT00767338|Infertility|infertility
5632976|NCT00767338|Pregnancy|pregnancy
5632977|NCT00767338|Men|men
5632978|NCT00767338|Palpable varicocele|palpable varicocele
5632979|NCT00767338|Abnormal semen analysis|abnormal semen analysis
5632980|NCT00767338|Intrauterine insemination|intrauterine insemination
5626843|NCT00791726|uveitis|uveitis
5632981|NCT00767338|Microsurgical varicocelectomy|microsurgical varicocelectomy
5632983|NCT00767312|Natural History|natural history
5632984|NCT00767286|stage IIB prostate cancer|stage iib prostate cancer
5632985|NCT00767286|stage IIA prostate cancer|stage iia prostate cancer
5632986|NCT00767286|stage III prostate cancer|stage iii prostate cancer
5632987|NCT00767286|stage IV prostate cancer|stage iv prostate cancer
5632988|NCT00767260|type 2 diabetes mellitus|type 2 diabetes mellitus
5632989|NCT00767260|bone marrow mononuclear cell|bone marrow mononuclear cell
5632990|NCT00767260|hyperbaric oxygen therapy|hyperbaric oxygen therapy
5632991|NCT00767247|Arterial Hypertension|arterial hypertension
5632992|NCT00767208|type 2 diabetic subjects|type 2 diabetic subjects
5632993|NCT00767195|pulmonary edema|pulmonary edema
5632994|NCT00767195|cardiogenic|cardiogenic
5632995|NCT00767195|non-cardiogenic|non-cardiogenic
5632996|NCT00767195|mortality|mortality
5632997|NCT00767195|length of stay|length of stay
5632998|NCT00767182|preeclampsia|preeclampsia
5632999|NCT00767182|eclampsia|eclampsia
5633000|NCT00767182|retroplacental hematoma|retroplacental hematoma
5633001|NCT00767182|vascular IUGR|vascular iugr
5633002|NCT00767182|IUFD|iufd
5633003|NCT00767182|placental volume|placental volume
5633004|NCT00767169|Edentatio (Toothlessness)|edentatio (toothlessness)
5633005|NCT00767156|Sea buckthorn oil, Oral and topical treatment, Skin aging|sea buckthorn oil, oral and topical treatment, skin aging
5633006|NCT00767130|single nucleotide polymorphisms, SNP, LDL cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin|single nucleotide polymorphisms, snp, ldl cholesterol, statin myopathy, atorvastatin, simvastatin, rosuvastatin
5633007|NCT00767117|TMC125-C197|tmc125-c197
5633008|NCT00767117|TMC125-TiDP2-C197|tmc125-tidp2-c197
5633009|NCT00767117|HIV|hiv
5633010|NCT00767117|DDI|ddi
5633011|NCT00767117|Lopinavir|lopinavir
5633012|NCT00767117|Intelence|intelence
5633013|NCT00767117|Kaletra|kaletra
5633014|NCT00767117|Ritonavir|ritonavir
5633015|NCT00767117|Etravirine|etravirine
5633016|NCT00767117|Interaction|interaction
5633017|NCT00767117|Pharmacokinetics|pharmacokinetics
5633018|NCT00767117|Steady-state|steady-state
5633019|NCT00767091|Parkinson's disease|parkinson's disease
5633020|NCT00767091|Apathy|apathy
5633021|NCT00767091|Rivastigmine|rivastigmine
5633022|NCT00767091|transdermal patch|transdermal patch
5633023|NCT00767091|anticholinesterasic|anticholinesterasic
5633024|NCT00767091|acetylcholine|acetylcholine
5633025|NCT00767052|Healthy Volunteer|healthy volunteer
5633027|NCT00767052|Tolerability|tolerability
5633028|NCT00767052|Pharmacokinetics|pharmacokinetics
5633029|NCT00767052|AZD1236|azd1236
5633030|NCT00767039|Very Premature|very premature
5633031|NCT00767039|RDS|rds
5633032|NCT00767039|Surfactant|surfactant
5633033|NCT00767026|Epilepsy|epilepsy
5633034|NCT00767026|Caregiver Burden|caregiver burden
5633035|NCT00767026|Parenting a Child with a Chronic Illness|parenting a child with a chronic illness
5633036|NCT00767013|DSCT, coronary artery disease, aortic valve stenosis|dsct, coronary artery disease, aortic valve stenosis
5633037|NCT00766987|coronary artery disease|coronary artery disease
5633038|NCT00766987|FDG PET viability imaging|fdg pet viability imaging
5633039|NCT00766987|morbidity and mortality|morbidity and mortality
5633040|NCT00766987|revascularization|revascularization
5633041|NCT00766987|resource utilization|resource utilization
5633042|NCT00766974|Chronic Venous Disease|chronic venous disease
5633043|NCT00766974|C3|c3
5633044|NCT00766974|Edema|edema
5633045|NCT00766974|Compression Garments|compression garments
5633046|NCT00766974|Compression Stockings|compression stockings
5633047|NCT00766974|Bioimpedance|bioimpedance
5633048|NCT00766961|Peptic ulcer bleeding uncontrolled by endoscopic therapy.|peptic ulcer bleeding uncontrolled by endoscopic therapy.
5633049|NCT00766935|Lymphedema|lymphedema
5633050|NCT00766935|Bioimpedance|bioimpedance
5633051|NCT00766909|Insulin pulsatility|insulin pulsatility
5633052|NCT00766909|Insulin secretion|insulin secretion
5633053|NCT00766909|Insulin sensitivity|insulin sensitivity
5633054|NCT00766909|Calcineurin inhibitor|calcineurin inhibitor
5633055|NCT00766909|Cyclosporine|cyclosporine
5633056|NCT00766909|Tacrolimus|tacrolimus
5633057|NCT00766896|Stroke|stroke
5633058|NCT00766896|Cerebral Infarction|cerebral infarction
5633059|NCT00766896|Acute Coronary Syndrome|acute coronary syndrome
5633060|NCT00766896|Cardiovascular Diseases|cardiovascular diseases
5633061|NCT00766896|Vascular Diseases|vascular diseases
5633062|NCT00766896|Platelet Activation|platelet activation
5633063|NCT00766896|Platelets|platelets
5633064|NCT00766896|Platelet Function Tests|platelet function tests
5633065|NCT00766896|Aspirin|aspirin
5633066|NCT00766896|Atherosclerosis|atherosclerosis
5633067|NCT00766896|Ischemia|ischemia
5633068|NCT00766896|Thrombosis|thrombosis
5633069|NCT00766883|Allogeneic HSCT|allogeneic hsct
5633070|NCT00766883|Psychosocial Distress|psychosocial distress
5633071|NCT00766883|Coping|coping
5633072|NCT00766883|Cognitive Behavior Therapy|cognitive behavior therapy
5633073|NCT00766883|Self Efficacy|self efficacy
5633074|NCT00766883|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5633075|NCT00766870|Efficacy|efficacy
5633076|NCT00766870|Safety|safety
5633077|NCT00766870|Depression|depression
5633078|NCT00766870|Interventional|interventional
5633079|NCT00766870|Placebo|placebo
5633080|NCT00766870|Short-term|short-term
5633081|NCT00766870|Major Depressive Disorder|major depressive disorder
5633082|NCT00766870|Major Depressive Episode|major depressive episode
5633083|NCT00766857|Exenatide|exenatide
5633084|NCT00766857|Type 2 diabetes mellitus|type 2 diabetes mellitus
5633085|NCT00766857|Congestive heart failure|congestive heart failure
5633086|NCT00766857|Incretin hormones|incretin hormones
5633087|NCT00766857|GLP-1 agonist|glp-1 agonist
5633088|NCT00766857|Cardiac metabolism|cardiac metabolism
5633089|NCT00766857|Insulin resistance|insulin resistance
5633090|NCT00766857|Cardiac MRI|cardiac mri
5633091|NCT00766844|vasospasm|vasospasm
5633092|NCT00766844|spinal cord stimulation|spinal cord stimulation
5633093|NCT00766844|aneurysm|aneurysm
5633094|NCT00766844|subarachnoid hemorrhage|subarachnoid hemorrhage
5633095|NCT00766831|Cancer pain|cancer pain
5633096|NCT00766831|Hydromorphone OROS|hydromorphone oros
5633097|NCT00766831|Jurnista|jurnista
5633098|NCT00766779|hematopoietic cell transplantation|hematopoietic cell transplantation
5633099|NCT00766779|Acute Myeloid Leukemia|acute myeloid leukemia
5633100|NCT00766779|first Complete Remission|first complete remission
5633101|NCT00766766|Environmental Tobacco Exposure|environmental tobacco exposure
5633102|NCT00766753|HLA-A2 positive|hla-a2 positive
5633103|NCT00766753|Malignant Gliomas|malignant gliomas
5633104|NCT00766753|Vaccine|vaccine
5633105|NCT00766740|ST elevation myocardial infarction|st elevation myocardial infarction
5633106|NCT00766740|thrombectomy|thrombectomy
5633107|NCT00766740|primary PCI|primary pci
5633108|NCT00766675|Pain|pain
5633109|NCT00766675|Fibromyalgia|fibromyalgia
5633110|NCT00766675|Ultracet|ultracet
5633111|NCT00766675|Tramadol Hydrochloride|tramadol hydrochloride
5633112|NCT00766675|Acetaminophen|acetaminophen
5633113|NCT00766662|Malaria|malaria
5633114|NCT00766662|Intermittent Preventive Treatment|intermittent preventive treatment
5633115|NCT00766662|EPI vaccine coverage|epi vaccine coverage
5633116|NCT00766662|Resistance of P. falciparum to Sulfadoxine- Pyrimethamine|resistance of p. falciparum to sulfadoxine- pyrimethamine
5633117|NCT00766649|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5633118|NCT00766649|Geographic Atrophy|geographic atrophy
5633119|NCT00766649|Sirolimus|sirolimus
5633120|NCT00766649|Age-Related Macular Degeneration|age-related macular degeneration
5633121|NCT00766649|AMD|amd
5633122|NCT00766636|Adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
5633123|NCT00766636|Pancreaticoduodenectomy|pancreaticoduodenectomy
5633124|NCT00766636|Preoperative chemotherapy|preoperative chemotherapy
5633125|NCT00766636|Chemoradiation|chemoradiation
5633126|NCT00766636|Resectable pancreatic cancer|resectable pancreatic cancer
5633127|NCT00766636|Surgical removal of the pancreas and duodenum|surgical removal of the pancreas and duodenum
5633128|NCT00766636|External-beam radiation therapy|external-beam radiation therapy
5633129|NCT00766636|EBRT|ebrt
5633130|NCT00766636|Gemcitabine|gemcitabine
5633131|NCT00766636|Erlotinib|erlotinib
5633132|NCT00766623|endothelium,|endothelium,
5633133|NCT00766623|postprandial|postprandial
5633134|NCT00766623|microvascular|microvascular
5633135|NCT00766623|macrovascular|macrovascular
5633136|NCT00766597|Treatment Experienced|treatment experienced
5633137|NCT00766584|Aging|aging
5633138|NCT00766584|Autonomic nervous system|autonomic nervous system
5633139|NCT00766584|stroke|stroke
5633140|NCT00766584|Myocardiac infarction|myocardiac infarction
5633141|NCT00766584|Prospective cohort|prospective cohort
5633142|NCT00766584|Sleep apnea/hypopnea|sleep apnea/hypopnea
5633143|NCT00766571|VACTERL Association|vacterl association
5633144|NCT00766571|VATER Association|vater association
5633145|NCT00766571|Multiple Congenital Anomalies|multiple congenital anomalies
5633147|NCT00766571|Congenital Defects|congenital defects
5633148|NCT00766571|Birth Defects|birth defects
5633149|NCT00766571|Congenital Abnormalities|congenital abnormalities
5633151|NCT00766558|bulimia|bulimia
5633152|NCT00766558|eating disorder not otherwise specified|eating disorder not otherwise specified
5633153|NCT00766519|fluid responsiveness|fluid responsiveness
5633154|NCT00766519|monitoring|monitoring
5633155|NCT00766519|arterial pulse pressure|arterial pulse pressure
5633156|NCT00766506|IONSYS|ionsys
5633157|NCT00766506|Fentanyl|fentanyl
5633158|NCT00766506|Morphine|morphine
5633160|NCT00766506|Postoperative pain|postoperative pain
5633161|NCT00766506|Mobilization|mobilization
5633162|NCT00766493|carotid artery stenosis|carotid artery stenosis
5633163|NCT00766493|embolic protection device|embolic protection device
5633164|NCT00766493|distal embolic filter|distal embolic filter
5680380|NCT00577993|IDEC-C2B8|idec-c2b8
5633165|NCT00766493|minimizing risks of carotid artery stenting|minimizing risks of carotid artery stenting
5633166|NCT00766480|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5633167|NCT00766480|stage IIA esophageal cancer|stage iia esophageal cancer
5633168|NCT00766480|stage IIB esophageal cancer|stage iib esophageal cancer
5633169|NCT00766480|stage IIIA esophageal cancer|stage iiia esophageal cancer
5633170|NCT00766480|stage IIIB esophageal cancer|stage iiib esophageal cancer
5633171|NCT00766480|stage IIIC esophageal cancer|stage iiic esophageal cancer
5633172|NCT00766467|armodafinil|armodafinil
5633173|NCT00766467|Nuvigil|nuvigil
5633174|NCT00766467|fatigue|fatigue
5633175|NCT00766454|breast cancer|breast cancer
5633176|NCT00766441|diabetes|diabetes
5633177|NCT00766441|hypoglycemia|hypoglycemia
5633178|NCT00766441|ramadan|ramadan
5633179|NCT00766441|fasting|fasting
5633180|NCT00766415|COPD|copd
5633181|NCT00766415|Moderate to severe COPD|moderate to severe copd
5633182|NCT00766402|Spondylitis, ankylosing|spondylitis, ankylosing
5633183|NCT00766402|Pain|pain
5633184|NCT00766402|Ultracet|ultracet
5633185|NCT00766402|Diclofenac|diclofenac
5633186|NCT00766402|Voltaren|voltaren
5633187|NCT00766402|Tramadol/acetaminophen|tramadol/acetaminophen
5633188|NCT00766389|Glaucoma|glaucoma
5633189|NCT00766389|Retinal nerve fiber layer|retinal nerve fiber layer
5633190|NCT00766389|Cirrus OCT|cirrus oct
5633191|NCT00766389|Stratus OCT|stratus oct
5633192|NCT00766363|Alzheimer's Disease|alzheimer's disease
5633316|NCT00765817|insulin glargine|insulin glargine
5633193|NCT00766363|Central Nervous System Diseases|central nervous system diseases
5633194|NCT00766363|Pharmacokinetics|pharmacokinetics
5633195|NCT00766363|Cognition|cognition
5633196|NCT00766350|fibromyalgia|fibromyalgia
5633197|NCT00766350|quetiapine|quetiapine
5633198|NCT00766350|amitriptyline|amitriptyline
5633199|NCT00766337|wet AMD|wet amd
5633200|NCT00766298|Exercise|exercise
5633201|NCT00766298|Weight Loss|weight loss
5633202|NCT00766298|Physical Activity|physical activity
5633203|NCT00766298|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5633204|NCT00766285|Baculovirus, influenza, stem cell transplant|baculovirus, influenza, stem cell transplant
5633205|NCT00766272|Rehabilitation|rehabilitation
5633206|NCT00766272|Treadmill|treadmill
5633207|NCT00766272|MS|ms
5633208|NCT00766272|Gait|gait
5633209|NCT00766272|Robot|robot
5633210|NCT00766259|methicillin-resistant Staphylococcus|methicillin-resistant staphylococcus
5633211|NCT00766259|colonization|colonization
5633212|NCT00766246|Non-Small Cell Lung Cancer|non-small cell lung cancer
5633213|NCT00766246|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5633214|NCT00766246|Lung Cancer|lung cancer
5633215|NCT00766233|Hyperthermia|hyperthermia
5633216|NCT00766233|superficial tumor treatment|superficial tumor treatment
5633217|NCT00766233|superficial tumors|superficial tumors
5633218|NCT00766220|Colon|colon
5633220|NCT00766220|Colorectal cancer|colorectal cancer
5633221|NCT00766220|Colorectal cancer metastases to the liver|colorectal cancer metastases to the liver
5633222|NCT00766220|Metastases to the liver|metastases to the liver
5633223|NCT00766220|Colorectal cancer mets to liver|colorectal cancer mets to liver
5633224|NCT00766220|Colon cancer metastasized to liver|colon cancer metastasized to liver
5633225|NCT00766220|Yttrium microspheres|yttrium microspheres
5633226|NCT00766220|SIR-Spheres|sir-spheres
5633227|NCT00766220|Yttrium-90|yttrium-90
5633228|NCT00766220|Cetuximab|cetuximab
5633229|NCT00766220|C225|c225
5633230|NCT00766220|Erbitux|erbitux
5633231|NCT00766220|IMC-C225|imc-c225
5633232|NCT00766220|Irinotecan|irinotecan
5633233|NCT00766220|CPT-11|cpt-11
5633234|NCT00766220|Liver directed therapy|liver directed therapy
5633235|NCT00766207|Teratogens|teratogens
5633236|NCT00766207|Abnormalities, Drug-Induced|abnormalities, drug-induced
5633237|NCT00766207|Contraception|contraception
5633238|NCT00766181|IV placement; Parent satisfaction level|iv placement; parent satisfaction level
5633239|NCT00766168|contact lens|contact lens
5633240|NCT00766168|rigid gas permeable|rigid gas permeable
5633241|NCT00766168|refractive index|refractive index
5633242|NCT00766155|stage II rectal cancer|stage ii rectal cancer
5633243|NCT00766155|stage III rectal cancer|stage iii rectal cancer
5633244|NCT00766155|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5633245|NCT00766142|adenocarcinoma of the colon|adenocarcinoma of the colon
5633246|NCT00766142|recurrent colon cancer|recurrent colon cancer
5633247|NCT00766142|stage IV colon cancer|stage iv colon cancer
5633248|NCT00766142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5633249|NCT00766142|recurrent rectal cancer|recurrent rectal cancer
5633250|NCT00766142|stage IV rectal cancer|stage iv rectal cancer
5633251|NCT00766142|peritoneal carcinomatosis|peritoneal carcinomatosis
5633252|NCT00766129|saphenous vein graft, TAXUS stent, Chopin stent|saphenous vein graft, taxus stent, chopin stent
5633253|NCT00766116|AML|aml
5633254|NCT00766103|Cerebral metabolism, perfusion, induced hypothermia|cerebral metabolism, perfusion, induced hypothermia
5633255|NCT00766064|posttraumatic stress disorder|posttraumatic stress disorder
5633256|NCT00766051|Neurophysiologically Based Occupational Therapy Intervention (NBOTI)|neurophysiologically based occupational therapy intervention (nboti)
5633257|NCT00766051|NBOTI|nboti
5633258|NCT00766051|NICU|nicu
5633259|NCT00766051|NCCU|nccu
5633260|NCT00766051|Developmental Biology|developmental biology
5633261|NCT00766051|Critical Period|critical period
5633262|NCT00766051|Brain Development|brain development
5633263|NCT00766051|Sensory Integration|sensory integration
5633264|NCT00766051|Neurodevelopment|neurodevelopment
5633265|NCT00766051|Sensitive Period|sensitive period
5633266|NCT00766038|Mood disorders|mood disorders
5633267|NCT00766038|Cognitive disorders|cognitive disorders
5633268|NCT00766038|Fatigue|fatigue
5863028|NCT00001413|Dual X-Ray|dual x-ray
5633269|NCT00766038|Metabolic disorders|metabolic disorders
5633270|NCT00766025|Taiwanese Subjects|taiwanese subjects
5633271|NCT00766025|CYP2C19|cyp2c19
5633272|NCT00766025|Poor Metabolizers|poor metabolizers
5633273|NCT00766025|Extensive Metabolizers|extensive metabolizers
5633274|NCT00766025|Taiwanese Subjects identified as CYP2C19 Poor or Extensive Metabolizers|taiwanese subjects identified as cyp2c19 poor or extensive metabolizers
5633275|NCT00766012|safety|safety
5633276|NCT00766012|tolerability|tolerability
5633277|NCT00766012|pharmacokinetics|pharmacokinetics
5633278|NCT00766012|AZD2066|azd2066
5633279|NCT00766012|Japanese|japanese
5633280|NCT00765999|Constipation|constipation
5633281|NCT00765999|Chronic Constipation|chronic constipation
5633282|NCT00765999|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
5633283|NCT00765999|Linaclotide|linaclotide
5633284|NCT00765986|18F-FAZA|18f-faza
5633285|NCT00765986|18F-FDG|18f-fdg
5633286|NCT00765986|Positron Emission Tomography|positron emission tomography
5633287|NCT00765973|Other Advanced Solid Tumors|other advanced solid tumors
5633288|NCT00765960|Vision|vision
5633289|NCT00765947|Essential Hypertension ( mild to moderate)|essential hypertension ( mild to moderate)
5633290|NCT00765934|Healthy|healthy
5633291|NCT00765921|glaucoma, neovascular|glaucoma, neovascular
5633292|NCT00765921|macular edema|macular edema
5633293|NCT00765921|eye enucleation|eye enucleation
5615139|NCT00837317|Phenols|phenols
5633294|NCT00765921|antibodies, monoclonal|antibodies, monoclonal
5633295|NCT00765921|radiation oncology|radiation oncology
5633296|NCT00765895|idiopathic gastroparesis|idiopathic gastroparesis
5633297|NCT00765882|Constipation|constipation
5633298|NCT00765882|Chronic Constipation|chronic constipation
5633299|NCT00765882|Linaclotide|linaclotide
5633300|NCT00765869|Decision support techniques|decision support techniques
5633301|NCT00765856|Opioid tolerant|opioid tolerant
5633302|NCT00765856|Pediatric|pediatric
5633303|NCT00765856|Male 6-17 years of age|male 6-17 years of age
5633304|NCT00765856|Female 6-17 years of age|female 6-17 years of age
5633305|NCT00765856|Pain|pain
5633306|NCT00765856|Non malignant|non malignant
5633307|NCT00765856|Malignant|malignant
5633308|NCT00765843|heel pain|heel pain
5633309|NCT00765830|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5633310|NCT00765817|diabetes|diabetes
5633311|NCT00765817|exenatide|exenatide
5633312|NCT00765817|Amylin|amylin
5633313|NCT00765817|Lilly|lilly
5633314|NCT00765817|metformin|metformin
5633315|NCT00765817|pioglitazone|pioglitazone
5633317|NCT00765804|Dry Eye|dry eye
5633318|NCT00765804|Iontophoresis|iontophoresis
5633319|NCT00765804|Ophthalmic Delivery|ophthalmic delivery
5633320|NCT00765791|head and neck cancer|head and neck cancer
5633321|NCT00765791|oral cancer|oral cancer
5633322|NCT00765791|oropharyngeal cancer|oropharyngeal cancer
5633323|NCT00765791|laryngeal cancer|laryngeal cancer
5633324|NCT00765791|selective neck dissection|selective neck dissection
5633325|NCT00765791|submuscular recess|submuscular recess
5633326|NCT00765791|level 2b|level 2b
5633327|NCT00765778|resistant bacteria rehabilitation centers|resistant bacteria rehabilitation centers
5633328|NCT00765765|stage IV breast cancer|stage iv breast cancer
5633329|NCT00765765|recurrent breast cancer|recurrent breast cancer
5633330|NCT00765765|male breast cancer|male breast cancer
5633331|NCT00765752|Insomnia|insomnia
5633332|NCT00765752|depression|depression
5633333|NCT00765752|GABA|gaba
5633334|NCT00765752|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5633335|NCT00765752|MRS|mrs
5633336|NCT00765752|Sleep|sleep
5633337|NCT00765752|antidepressant medication use|antidepressant medication use
5633338|NCT00765739|muscle fibers|muscle fibers
5633339|NCT00765739|aging|aging
5633340|NCT00765726|hemophilia|hemophilia
5633341|NCT00765726|hemophilia A|hemophilia a
5633342|NCT00765726|ReFacto|refacto
5633343|NCT00765726|Xyntha|xyntha
5633344|NCT00765726|moroctocog alfa|moroctocog alfa
5633345|NCT00765726|bleeding disorder|bleeding disorder
5633346|NCT00765713|Sleep apnea|sleep apnea
5633347|NCT00765713|CPAP|cpap
5633348|NCT00765713|Ventricular arrhythmias|ventricular arrhythmias
5633349|NCT00765713|Defibrillator therapies|defibrillator therapies
5633350|NCT00765700|Sprain|sprain
5633351|NCT00765700|Strain|strain
5633352|NCT00765700|Pain|pain
5633353|NCT00765700|Ankle Pain|ankle pain
5633354|NCT00765700|Shoulder Pain|shoulder pain
5633355|NCT00765700|Elbow Pain|elbow pain
5633356|NCT00765700|Tennis Elbow|tennis elbow
5633357|NCT00765700|Knee pain|knee pain
5633358|NCT00765700|Wrist Pain|wrist pain
5633359|NCT00765700|Hand Pain|hand pain
5633360|NCT00765700|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5633362|NCT00765674|antihypertensive|antihypertensive
5633363|NCT00765674|hypertension|hypertension
5633364|NCT00765674|renin inhibitor|renin inhibitor
5633365|NCT00765674|moderate-severe hypertension|moderate-severe hypertension
5633366|NCT00765661|Kidney|kidney
5633367|NCT00765661|Transplantation|transplantation
5633368|NCT00765661|Immunosuppression|immunosuppression
5633369|NCT00765661|Tacrolimus|tacrolimus
5633370|NCT00765661|Prograf|prograf
5633371|NCT00765648|hypertension|hypertension
5633372|NCT00765648|emergency department|emergency department
5633373|NCT00765648|Nicardipine|nicardipine
5633374|NCT00765648|Labetalol|labetalol
5633375|NCT00765648|hypertensive emergency|hypertensive emergency
5633376|NCT00765648|hypertensive urgency|hypertensive urgency
5633377|NCT00765635|complete occlusion of the ear canal due to cerumen|complete occlusion of the ear canal due to cerumen
5633378|NCT00765622|Urinary incontinence|urinary incontinence
5633379|NCT00765622|pelvic floor|pelvic floor
5633380|NCT00765622|functional evaluation|functional evaluation
5633381|NCT00765609|Paediatric|paediatric
5633382|NCT00765609|Analgesic|analgesic
5633383|NCT00765609|Prescribing|prescribing
5633384|NCT00765609|Parents|parents
5633385|NCT00765596|Obesity|obesity
5633386|NCT00765596|Insulin resistance|insulin resistance
5633387|NCT00765596|Gastric tube|gastric tube
5633388|NCT00765596|Ghrelin|ghrelin
5633389|NCT00765583|Wrinkles (Nasolabial Folds)|wrinkles (nasolabial folds)
5633390|NCT00765570|large tumors in the head & neck, lung, abdomen or pelvis|large tumors in the head & neck, lung, abdomen or pelvis
5633391|NCT00765557|Laxative therapy|laxative therapy
5633392|NCT00765557|URGE Syndrome|urge syndrome
5633393|NCT00765557|Pediatric constipation|pediatric constipation
5633395|NCT00765544|Rehabilitation|rehabilitation
5633396|NCT00765544|Treadmill|treadmill
5633397|NCT00765544|Robot|robot
5633398|NCT00765544|Foot-drop|foot-drop
5615308|NCT00836719|MRI|mri
5633399|NCT00765531|Determine prevalence of genetic mutations in a population.|determine prevalence of genetic mutations in a population.
5633400|NCT00765531|Identify stone formers w/significant family history.|identify stone formers w/significant family history.
5633401|NCT00765531|follow a cohort of pediatric stone formers & their families.|follow a cohort of pediatric stone formers & their families.
5633402|NCT00765531|Report long-term recurrence rates & therapeutic outcomes.|report long-term recurrence rates & therapeutic outcomes.
5633403|NCT00765518|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
5633404|NCT00765518|Non-Ischemic Dilated Cardiomyopathy|non-ischemic dilated cardiomyopathy
5633405|NCT00765518|ixmyelocel-T|ixmyelocel-t
5633406|NCT00765505|Insulin Resistance|insulin resistance
5633407|NCT00765505|Obesity|obesity
5633408|NCT00765505|Exercise Training|exercise training
5633409|NCT00765505|Physical Activity|physical activity
5633410|NCT00765492|Phase I|phase i
5633411|NCT00765479|stage IIB prostate cancer|stage iib prostate cancer
5633412|NCT00765479|stage IIA prostate cancer|stage iia prostate cancer
5633679|NCT00764153|Quality of life|quality of life
5633413|NCT00765466|Explore the effect of AVR118 4.0 mL, given subcutaneously on appetite|explore the effect of avr118 4.0 ml, given subcutaneously on appetite
5633414|NCT00765453|Heart attack|heart attack
5633415|NCT00765453|Anterior Myocardial infarction (MI)|anterior myocardial infarction (mi)
5633416|NCT00765453|adult stem cells|adult stem cells
5633417|NCT00765453|bone marrow progenitor cells|bone marrow progenitor cells
5633418|NCT00765453|bone marrow stem cells|bone marrow stem cells
5633420|NCT00765453|left ventricular function|left ventricular function
5633421|NCT00765453|intracoronary injection|intracoronary injection
5633422|NCT00765440|infection|infection
5633423|NCT00765440|malnutrition|malnutrition
5633424|NCT00765440|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5633425|NCT00765440|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5633426|NCT00765440|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5633427|NCT00765440|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5633428|NCT00765440|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5633429|NCT00765440|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5633430|NCT00765440|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5633431|NCT00765440|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5633432|NCT00765440|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5633433|NCT00765440|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5633434|NCT00765440|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5633435|NCT00765440|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5633436|NCT00765440|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5633437|NCT00765440|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5633438|NCT00765440|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5633439|NCT00765440|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5633440|NCT00765440|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5633441|NCT00765440|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5633442|NCT00765440|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5633443|NCT00765440|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5633444|NCT00765440|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5633445|NCT00765440|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5633446|NCT00765440|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5633447|NCT00765440|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5633448|NCT00765440|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5633449|NCT00765440|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5633450|NCT00765440|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5633451|NCT00765440|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5633452|NCT00765440|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5633453|NCT00765440|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5633454|NCT00765440|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5633455|NCT00765440|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5633457|NCT00765401|Abdominal Pain|abdominal pain
5633458|NCT00765401|Cystic Fibrosis|cystic fibrosis
5633459|NCT00765401|H. pylori|h. pylori
5633460|NCT00765401|Children|children
5633461|NCT00765388|urostomy, 1-piece, cross-over, randomised, preference|urostomy, 1-piece, cross-over, randomised, preference
5633462|NCT00765375|acne|acne
5633463|NCT00765375|Botox|botox
5633464|NCT00765375|cosmetic treatments|cosmetic treatments
5615344|NCT00836459|Motivation|motivation
5633465|NCT00765336|Spermatogenesis in Healthy Males|spermatogenesis in healthy males
5633466|NCT00765323|Octreotide|octreotide
5633467|NCT00765323|Sandostatin LAR|sandostatin lar
5633468|NCT00765323|Growth hormone|growth hormone
5633469|NCT00765323|IGF-1|igf-1
5633470|NCT00765310|atherosclerosis|atherosclerosis
5633471|NCT00765310|lipoic acid|lipoic acid
5633472|NCT00765310|thioctic acid|thioctic acid
5633473|NCT00765310|triglycerides|triglycerides
5633474|NCT00765310|overweight|overweight
5633475|NCT00765310|obesity|obesity
5633476|NCT00765310|oxidative stress|oxidative stress
5633477|NCT00765310|inflammation|inflammation
5633478|NCT00765297|fall risk|fall risk
5633479|NCT00765297|movement characteristics|movement characteristics
5633480|NCT00765297|stumble detection|stumble detection
5633481|NCT00765297|accelerometry|accelerometry
5633484|NCT00765284|Cholesterol|cholesterol
5633485|NCT00765245|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5633580|NCT00764647|caregiver depressive symptoms|caregiver depressive symptoms
5633486|NCT00765245|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5633487|NCT00765245|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5633488|NCT00765245|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5633489|NCT00765245|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5633491|NCT00765232|donor|donor
5633492|NCT00765232|nephrectomy|nephrectomy
5633493|NCT00765219|Generalized Anxiety Disorder|generalized anxiety disorder
5633494|NCT00765219|Geriatric|geriatric
5633495|NCT00765180|colonoscopy|colonoscopy
5633496|NCT00765180|hood|hood
5633497|NCT00765180|NBI|nbi
5633498|NCT00765141|wound debridement|wound debridement
5633499|NCT00765141|removed orthopedic implants|removed orthopedic implants
5633500|NCT00765141|removed catheters or shunts|removed catheters or shunts
5633501|NCT00765141|excised tonsils|excised tonsils
5633502|NCT00765141|amputated tissue|amputated tissue
5633503|NCT00765141|sputum, stool|sputum, stool
5633504|NCT00765141|or other excretions.|or other excretions.
5633506|NCT00765128|Nephrolithotomy|nephrolithotomy
5633507|NCT00765128|Kidney stones|kidney stones
5633508|NCT00765102|Multiple Myelonoma|multiple myelonoma
5633510|NCT00765102|Bortezomib|bortezomib
5633511|NCT00765076|Vaccine|vaccine
5633512|NCT00765076|Elderly|elderly
5633513|NCT00765076|Influenza|influenza
5633514|NCT00765063|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
5633515|NCT00765050|Cellular therapy|cellular therapy
5633516|NCT00765050|CD133+|cd133+
5633517|NCT00765024|strongyloidiasis, ivermectin, albendazole|strongyloidiasis, ivermectin, albendazole
5633518|NCT00765011|Head and Neck Cancer|head and neck cancer
5633519|NCT00764998|Influenza|influenza
5633520|NCT00764998|HIV|hiv
5633521|NCT00764998|Influenza Vaccine|influenza vaccine
5633522|NCT00764998|Efficacy|efficacy
5633523|NCT00764985|Syncope|syncope
5633524|NCT00764985|Pre-Syncope|pre-syncope
5633525|NCT00764985|Fainting|fainting
5680381|NCT00577993|Chimeric Anti-CD20 Antibody|chimeric anti-cd20 antibody
5680382|NCT00577993|Interferon|interferon
5633526|NCT00764972|To evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined|to evaluate the use of sorafenib added to vinorelbine chemotherapy, to find out which are the doses of two drugs can be safely combined
5633527|NCT00764933|information programme|information programme
5633528|NCT00764933|anxiety reduction|anxiety reduction
5633529|NCT00764933|multicenter trial|multicenter trial
5633530|NCT00764933|intensive care|intensive care
5633531|NCT00764933|critical care|critical care
5633532|NCT00764920|human skin|human skin
5633533|NCT00764907|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5627425|NCT00789620|pain|pain
5633534|NCT00764907|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5633535|NCT00764907|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5633537|NCT00764881|Sexual dysfunction|sexual dysfunction
5633538|NCT00764881|Libido|libido
5633539|NCT00764829|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5633540|NCT00764829|fludarabine|fludarabine
5633541|NCT00764829|mycophenolate mofetil|mycophenolate mofetil
5633542|NCT00764829|mycophenolic acid|mycophenolic acid
5633543|NCT00764829|biomarkers|biomarkers
5633544|NCT00764816|Chronic kidney disease, stages 3 and 4|chronic kidney disease, stages 3 and 4
5633545|NCT00764816|phosphaturia|phosphaturia
5633546|NCT00764816|phosphorus|phosphorus
5633547|NCT00764816|PTH|pth
5633548|NCT00764816|FGF23|fgf23
5633549|NCT00764816|Dietary protein source|dietary protein source
5633550|NCT00764777|Peripheral Vascular Disease|peripheral vascular disease
5633551|NCT00764777|Intermittent Claudication|intermittent claudication
5633552|NCT00764777|Critical limb Ischemia|critical limb ischemia
5633553|NCT00764777|TASC A|tasc a
5633554|NCT00764777|TASC B|tasc b
5633555|NCT00764777|TASC C|tasc c
5633556|NCT00764777|TASC D|tasc d
5633557|NCT00764777|balloon-expandable stent|balloon-expandable stent
5633558|NCT00764777|Self-expanding stent|self-expanding stent
5633559|NCT00764777|TASC|tasc
5633560|NCT00764764|shoulder pain|shoulder pain
5633561|NCT00764764|rotator cuff|rotator cuff
5633562|NCT00764764|impingement|impingement
5633563|NCT00764764|cervical referred pain|cervical referred pain
5633564|NCT00764764|neural tension|neural tension
5633565|NCT00764738|ARMD|armd
5633566|NCT00764738|AMD|amd
5633567|NCT00764738|exudative AMD|exudative amd
5633568|NCT00764712|Tight glycemia control|tight glycemia control
5633569|NCT00764712|cardiac surgery patients|cardiac surgery patients
5633570|NCT00764699|poor growth|poor growth
5633571|NCT00764699|inflammatory bowel disease|inflammatory bowel disease
5633572|NCT00764686|Exercise|exercise
5633573|NCT00764686|Education|education
5633574|NCT00764686|Hydrotherapy|hydrotherapy
5633575|NCT00764686|Physical Therapy Modalities|physical therapy modalities
5633576|NCT00764647|family caregivers|family caregivers
5633577|NCT00764647|caregiver education|caregiver education
5633578|NCT00764647|caregiver burden|caregiver burden
5633579|NCT00764647|caregiver hardiness|caregiver hardiness
5633676|NCT00764153|Treatment|treatment
5633581|NCT00764621|Gadolinium ethoxybenzyl DTPA|gadolinium ethoxybenzyl dtpa
5633582|NCT00764621|Contrast media|contrast media
5633583|NCT00764621|Outcome Assessment (Health Care)|outcome assessment (health care)
5633584|NCT00764621|Magnetic Resonance Imaging|magnetic resonance imaging
5633585|NCT00764621|Tomography, X-Ray Computed|tomography, x-ray computed
5633587|NCT00764595|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5633588|NCT00764595|liver metastases|liver metastases
5633589|NCT00764582|Corneal penetration of levofloxacin and moxifloxacin|corneal penetration of levofloxacin and moxifloxacin
5633590|NCT00764569|oral tissue|oral tissue
5633591|NCT00764556|Glucose|glucose
5633592|NCT00764556|Insulin|insulin
5633593|NCT00764556|COPD|copd
5633594|NCT00764556|Exacerbations|exacerbations
5633595|NCT00764556|Tight glycaemic control|tight glycaemic control
5633596|NCT00764556|Acute hospital ward|acute hospital ward
5633597|NCT00764543|Unilateral hydronephrosis|unilateral hydronephrosis
5633598|NCT00764543|Multicystic-dysplastic Kidney|multicystic-dysplastic kidney
5633599|NCT00764465|Healthy Subjects|healthy subjects
5633600|NCT00764465|Pharmacokinetics study|pharmacokinetics study
5633601|NCT00764465|Pharmacokinetics of medications|pharmacokinetics of medications
5633602|NCT00764426|alcoholic beverages|alcoholic beverages
5633603|NCT00764426|non-alcoholic beverages|non-alcoholic beverages
5633604|NCT00764426|inflammation|inflammation
5633605|NCT00764426|Serum concentration of inflammatory markers before and after intervention|serum concentration of inflammatory markers before and after intervention
5633606|NCT00764413|EDSS|edss
5633607|NCT00764413|methylprednisolone|methylprednisolone
5633608|NCT00764413|circadian rhythms|circadian rhythms
5633609|NCT00764413|MSFC|msfc
5633610|NCT00764400|aphasia|aphasia
5633611|NCT00764400|anomia|anomia
5633612|NCT00764400|speech therapy|speech therapy
5633613|NCT00764400|rehabilitation|rehabilitation
5633614|NCT00764387|Neoplastic CNS lesions|neoplastic cns lesions
5633615|NCT00764387|Contrast enhanced MRI|contrast enhanced mri
5633616|NCT00764387|Comparison|comparison
5633617|NCT00764374|YM443|ym443
5633618|NCT00764374|Z-338|z-338
5633619|NCT00764374|Acotiamide|acotiamide
5633620|NCT00764374|Rome III|rome iii
5633621|NCT00764374|Signs and symptoms, digestive|signs and symptoms, digestive
5633622|NCT00764361|Diabetic|diabetic
5633623|NCT00764361|Ulcer|ulcer
5633624|NCT00764361|Wound|wound
5633625|NCT00764348|Acute and Chronic Wounds|acute and chronic wounds
5633626|NCT00764322|menopausal symptoms|menopausal symptoms
5633627|NCT00764322|recurrent breast cancer|recurrent breast cancer
5633628|NCT00764322|stage I breast cancer|stage i breast cancer
5633629|NCT00764322|stage II breast cancer|stage ii breast cancer
5633630|NCT00764322|stage IIIA breast cancer|stage iiia breast cancer
5633631|NCT00764322|stage IIIB breast cancer|stage iiib breast cancer
5633632|NCT00764322|stage IIIC breast cancer|stage iiic breast cancer
5633633|NCT00764322|stage IV breast cancer|stage iv breast cancer
5633634|NCT00764322|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5633635|NCT00764322|breast cancer in situ|breast cancer in situ
5633636|NCT00764296|acute wounds and chronic wounds|acute wounds and chronic wounds
5633637|NCT00764270|atherosclerosis|atherosclerosis
5633638|NCT00764270|lipoic acid|lipoic acid
5633639|NCT00764270|thioctic acid|thioctic acid
5633640|NCT00764270|triglycerides|triglycerides
5633641|NCT00764270|overweight|overweight
5633642|NCT00764270|obesity|obesity
5633643|NCT00764270|oxidative stress|oxidative stress
5633644|NCT00764270|inflammation|inflammation
5633645|NCT00764244|Diabetes|diabetes
5633646|NCT00764244|Macular edema|macular edema
5633647|NCT00764244|Optical Coherence tomography|optical coherence tomography
5633648|NCT00764244|VitrectomyLaser therapy|vitrectomylaser therapy
5633649|NCT00764244|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
5633650|NCT00764231|acute myeloid leukemia|acute myeloid leukemia
5633651|NCT00764231|exercise|exercise
5633652|NCT00764231|fatigue|fatigue
5633653|NCT00764231|quality of life|quality of life
5633654|NCT00764231|home-based|home-based
5633655|NCT00764231|AML|aml
5633656|NCT00764218|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5633657|NCT00764218|Hypertension|hypertension
5633658|NCT00764218|Cardiovascular phenotype|cardiovascular phenotype
5633659|NCT00764205|ACS|acs
5633660|NCT00764205|non STEMI|non stemi
5633661|NCT00764205|ECG troponin|ecg troponin
5633662|NCT00764205|iSTAT|istat
5633663|NCT00764205|Acute coronary syndrome without ST-segment elevation|acute coronary syndrome without st-segment elevation
5633664|NCT00764192|hemodialysis|hemodialysis
5633665|NCT00764192|Flow-mediated dilation|flow-mediated dilation
5633666|NCT00764192|nictric oxide|nictric oxide
5633667|NCT00764192|endothelial function|endothelial function
5633668|NCT00764179|Neonates with intra-uterine growth delay|neonates with intra-uterine growth delay
5633669|NCT00764166|PSA (biochemical)|psa (biochemical)
5633670|NCT00764166|Progression- free Survival|progression- free survival
5633671|NCT00764166|Clinical progress|clinical progress
5633672|NCT00764166|Overall survival|overall survival
5633673|NCT00764166|Tolerance to the treatment|tolerance to the treatment
5633674|NCT00764166|Quality of Live|quality of live
5633675|NCT00764153|Displaced Femoral Neck Fractures|displaced femoral neck fractures
5633680|NCT00764153|Complications|complications
5633681|NCT00764153|Reoperations|reoperations
5633682|NCT00764153|Internal Fixation|internal fixation
5633683|NCT00764153|Hemiarthroplasty|hemiarthroplasty
5633684|NCT00764153|Activities of Daily Living|activities of daily living
5633685|NCT00764140|tumor growth factor|tumor growth factor
5633688|NCT00764127|bariatric surgery|bariatric surgery
5633689|NCT00764127|eating|eating
5633690|NCT00764114|Spondylodiscitis|spondylodiscitis
5633691|NCT00764114|Duration treatment|duration treatment
5633692|NCT00764114|Antibiotic|antibiotic
5633693|NCT00764114|men or women more than 18 years|men or women more than 18 years
5633694|NCT00764114|proved bacterial spondylodiscitis|proved bacterial spondylodiscitis
5633695|NCT00764114|patient for which is decided a treatment antibiotic|patient for which is decided a treatment antibiotic
5633696|NCT00764114|the diagnosis on clinical|the diagnosis on clinical
5633697|NCT00764114|Radiological|radiological
5633698|NCT00764114|microbiological criteria|microbiological criteria
5633699|NCT00764088|full Thickness wounds|full thickness wounds
5633700|NCT00764075|heart failure; EF<35%; NYHA II, III or IV|heart failure; ef<35%; nyha ii, iii or iv
5633701|NCT00764062|Amoxicillin|amoxicillin
5633702|NCT00764062|Drug resistance, microbial|drug resistance, microbial
5633703|NCT00764062|Streptococcus|streptococcus
5633704|NCT00764062|Surgery, oral|surgery, oral
5633705|NCT00764049|Albumin dialysis|albumin dialysis
5633706|NCT00764049|Artificial liver support|artificial liver support
5633707|NCT00764049|Acute on chronic liver failure|acute on chronic liver failure
5633708|NCT00764036|phase I|phase i
5633709|NCT00764036|safety|safety
5633710|NCT00764023|wound debridement|wound debridement
5633711|NCT00764023|removed orthopedic implants|removed orthopedic implants
5633712|NCT00764023|removed catheters or shunts|removed catheters or shunts
5633713|NCT00764023|excised tonsils, amputated tissue|excised tonsils, amputated tissue
5633714|NCT00764023|sputum|sputum
5633715|NCT00764023|stool|stool
5633716|NCT00764023|other excretions.|other excretions.
5633717|NCT00763997|dipyrone|dipyrone
5633718|NCT00763997|platelet aggregation|platelet aggregation
5633719|NCT00763997|neuraxial blockage|neuraxial blockage
5633721|NCT00763997|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib|platelet aggregation under dipyrone compared to ibuprofen, acetaminophen and parecoxib/valdecoxib
5633722|NCT00763997|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone|neuraxial blockage in patients receiving ibuprofen is critical in special circumstances, but traditionally not fpr dipyrone
5633723|NCT00763984|Bladder Control for Women|bladder control for women
5633724|NCT00763984|Exercising Your Pelvic Muscles|exercising your pelvic muscles
5633762|NCT00763867|Sildenafil|sildenafil
5633763|NCT00763867|Exercise Capacity|exercise capacity
5633764|NCT00763841|Auditory hallucinations|auditory hallucinations
5633765|NCT00763828|Myocardial Infarction|myocardial infarction
5633766|NCT00763828|Hypothermia, Induced|hypothermia, induced
5633767|NCT00763815|hyperglycemia GLP-1 pioglitazone|hyperglycemia glp-1 pioglitazone
5633769|NCT00763789|remifentanil|remifentanil
5633770|NCT00763789|hysteroscopic surgery|hysteroscopic surgery
5633771|NCT00763789|anesthesia recovery period|anesthesia recovery period
5633772|NCT00763789|ambulatory surgery|ambulatory surgery
5633773|NCT00763789|patient satisfaction|patient satisfaction
5633774|NCT00763789|length of stay|length of stay
5633775|NCT00763776|Liver cirrhosis|liver cirrhosis
5633776|NCT00763776|Hepatectomy|hepatectomy
5633777|NCT00763776|Liver parenchyma transection|liver parenchyma transection
5633778|NCT00763776|Randomized controlled trial|randomized controlled trial
5633786|NCT00763737|congenital diaphragmatic hernia|congenital diaphragmatic hernia
5633787|NCT00763737|fetal surgery|fetal surgery
5633788|NCT00763737|pulmonary hypoplasia|pulmonary hypoplasia
5633789|NCT00763737|observed/expected lung to head ratio|observed/expected lung to head ratio
5633790|NCT00763737|liver position|liver position
5633792|NCT00763737|fetoscopic endoluminal tracheal occlusion|fetoscopic endoluminal tracheal occlusion
5633793|NCT00763737|standardized neonatal care|standardized neonatal care
5633794|NCT00763711|Urinary Incontinence|urinary incontinence
5633795|NCT00763711|ISD|isd
5633796|NCT00763698|Left heart pacing lead|left heart pacing lead
5633797|NCT00763698|Cardiac resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5633798|NCT00763698|Heart failure|heart failure
5633799|NCT00763698|ICD|icd
5633800|NCT00763685|preoperative pain prophylaxis|preoperative pain prophylaxis
5633801|NCT00763685|postoperative pain|postoperative pain
5633802|NCT00763672|Preeclampsia|preeclampsia
5633803|NCT00763672|Hypertension|hypertension
5633804|NCT00763672|Intra uterine growth retardation|intra uterine growth retardation
5633805|NCT00763672|Antiangiogenic factor|antiangiogenic factor
5633806|NCT00763672|Prevention|prevention
5633807|NCT00763646|Gastric or Gastroesophageal Junction Adenocarcinoma|gastric or gastroesophageal junction adenocarcinoma
5633808|NCT00763633|nausea|nausea
5633809|NCT00763633|vomiting|vomiting
5633810|NCT00763633|pregnancy|pregnancy
5633811|NCT00763633|B6|b6
5633812|NCT00763620|Community acquired pneumonia|community acquired pneumonia
5633813|NCT00763620|Nosocomial pneumonia|nosocomial pneumonia
5633814|NCT00763620|Mini bronchoalveolar lavage|mini bronchoalveolar lavage
5633815|NCT00763620|Endotracheal aspirates|endotracheal aspirates
5633816|NCT00763620|Expectorated sputum|expectorated sputum
5633817|NCT00763607|non small cell lung cancer patients|non small cell lung cancer patients
5633818|NCT00763594|Major Depression|major depression
5633819|NCT00763594|Interpersonal Psychotherapy|interpersonal psychotherapy
5633820|NCT00763594|Brief Relational Therapy|brief relational therapy
5633821|NCT00763594|Outcome research|outcome research
5633822|NCT00763581|Patient Non-Adherence|patient non-adherence
5633823|NCT00763581|Patient Non-Compliance|patient non-compliance
5633824|NCT00763581|Patient Nonadherence|patient nonadherence
5633825|NCT00763581|Patient Noncompliance|patient noncompliance
5633826|NCT00763581|Patient Refusal of Treatment|patient refusal of treatment
5633827|NCT00763581|Treatment Refusal|treatment refusal
5633828|NCT00763581|Refusal of Treatment|refusal of treatment
5633829|NCT00763568|Chronic hepatitis C|chronic hepatitis c
5633830|NCT00763568|Viral hepatitis|viral hepatitis
5633831|NCT00763555|psoriasis|psoriasis
5633832|NCT00763555|spray|spray
5633833|NCT00763555|calcitriol|calcitriol
5633834|NCT00763516|Pancreatic Cancer|pancreatic cancer
5633835|NCT00763516|Proton radiation|proton radiation
5633836|NCT00763516|Chemotherapy|chemotherapy
5633837|NCT00763516|Xeloda|xeloda
5633838|NCT00763516|Gemzar|gemzar
5633839|NCT00763516|Resectable|resectable
5633840|NCT00763516|Surgery|surgery
5633841|NCT00763503|psoriasis|psoriasis
5633842|NCT00763503|PK|pk
5633843|NCT00763503|calcitriol|calcitriol
5633844|NCT00763490|umbilical cord blood|umbilical cord blood
5633845|NCT00763490|stem cell transplant|stem cell transplant
5633846|NCT00763490|leukemia|leukemia
5633847|NCT00763490|multiple myeloma|multiple myeloma
5633848|NCT00763490|lymphoma|lymphoma
5633849|NCT00763477|Cystic fibrosis|cystic fibrosis
5633850|NCT00763477|Weight|weight
5633851|NCT00763477|Appetite|appetite
5633852|NCT00763477|Ghrelin|ghrelin
5633853|NCT00763477|Cystic fibrosis with low BMI|cystic fibrosis with low bmi
5633854|NCT00763464|Coronary Artery Disease|coronary artery disease
5633855|NCT00763464|ischemia diagnostic|ischemia diagnostic
5633856|NCT00763451|hyperglycemia, GLP-1|hyperglycemia, glp-1
5633857|NCT00763438|Schizophrenia|schizophrenia
5633858|NCT00763438|Sertindole|sertindole
5633859|NCT00763438|Safety study|safety study
5633860|NCT00763425|polypectomy|polypectomy
5633861|NCT00763425|colonic polyp|colonic polyp
5633862|NCT00763425|colorectal polyp|colorectal polyp
5633863|NCT00763425|colorectal cancer prevention|colorectal cancer prevention
5633864|NCT00763412|Cystic Fibrosis|cystic fibrosis
5633865|NCT00763412|Diabetes|diabetes
5633866|NCT00763412|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5633867|NCT00763412|Pre-diabetes|pre-diabetes
5633868|NCT00763412|oral hypoglycemic agents|oral hypoglycemic agents
5633869|NCT00763412|Repaglinide|repaglinide
5633870|NCT00763412|treatment|treatment
5633872|NCT00763412|Lung function|lung function
5633873|NCT00763412|nutrition|nutrition
5633874|NCT00763399|probiotics|probiotics
5633875|NCT00763386|Total Knee Arthroplasty|total knee arthroplasty
5633876|NCT00763386|Osteoarthritis|osteoarthritis
5633877|NCT00763386|Knee|knee
5633878|NCT00763373|Lower respiratory infection|lower respiratory infection
5633879|NCT00763373|Upper respiratory infection|upper respiratory infection
5633880|NCT00763373|Urinary tract infection|urinary tract infection
5633881|NCT00763373|Soft tissue infection|soft tissue infection
5633882|NCT00763373|Hepatobiliary infection|hepatobiliary infection
5633883|NCT00763360|Cataract|cataract
5633884|NCT00763347|Glucose Metabolism Disorder|glucose metabolism disorder
5633885|NCT00763347|Dysmetabolic Syndrome|dysmetabolic syndrome
5633886|NCT00763347|Type II Diabetes|type ii diabetes
5633887|NCT00763347|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5633888|NCT00763347|Dyslipidemia|dyslipidemia
5633889|NCT00763347|Drug Therapy|drug therapy
5633890|NCT00763321|Effect on sleep interference by pain|effect on sleep interference by pain
5633892|NCT00763308|Blood Pressure|blood pressure
5633893|NCT00763308|Smoking Status|smoking status
5633894|NCT00763308|Cardiovascular Risk Profile|cardiovascular risk profile
5633895|NCT00763295|latent tuberculosis|latent tuberculosis
5633896|NCT00763295|HIV|hiv
5633897|NCT00763295|IFN-γ based assay|ifn-γ based assay
5633898|NCT00763282|Spinal cord injuries|spinal cord injuries
5633899|NCT00763282|Pressure ulcers|pressure ulcers
5633900|NCT00763282|Health behavior|health behavior
5633901|NCT00763282|self management|self management
5633902|NCT00763282|Rehabilitation|rehabilitation
5633903|NCT00763282|Outcome assessment|outcome assessment
5633904|NCT00763282|QUERI|queri
5633905|NCT00763282|Veterans|veterans
5680383|NCT00577993|Interferon Alpha-2b|interferon alpha-2b
5633906|NCT00763243|profound bilateral hearing loss with cochlear implants|profound bilateral hearing loss with cochlear implants
5633907|NCT00763230|Depression|depression
5633908|NCT00763230|Treatment|treatment
5633909|NCT00763230|Transcranial direct current stimulation|transcranial direct current stimulation
5633910|NCT00763217|inflammation|inflammation
5633911|NCT00763217|coagulation|coagulation
5633912|NCT00763217|neuroprotection|neuroprotection
5633913|NCT00763217|drugs|drugs
5633914|NCT00763217|clinical neurology|clinical neurology
5633915|NCT00763217|pharmacology|pharmacology
5633916|NCT00763217|biological factors|biological factors
5633917|NCT00763204|Plaque Type Psoriasis|plaque type psoriasis
5633918|NCT00763204|Topical|topical
5633919|NCT00763178|PTSD|ptsd
5633920|NCT00763152|prostate|prostate
5633921|NCT00763152|prostate bed|prostate bed
5633922|NCT00763152|periprostatic|periprostatic
5633923|NCT00763139|RA|ra
5633924|NCT00763139|Rheumatoid Arthritis|rheumatoid arthritis
5633925|NCT00763126|parturient|parturient
5633926|NCT00763126|epidural analgesia|epidural analgesia
5633927|NCT00763126|labor|labor
5633928|NCT00763126|spouse|spouse
5633929|NCT00763126|Stress levels|stress levels
5633930|NCT00763126|Salivary amylase|salivary amylase
5633931|NCT00763100|Breast cancer|breast cancer
5633932|NCT00763100|Three dimensional versus two dimensional|three dimensional versus two dimensional
5633933|NCT00763100|Breast cancer surveillance|breast cancer surveillance
5633934|NCT00763100|Tomosynthesis|tomosynthesis
5633935|NCT00763087|diabetes mellitus|diabetes mellitus
5633936|NCT00763087|peripheral neuropathy|peripheral neuropathy
5633937|NCT00763087|exercise|exercise
5633938|NCT00763074|Intra-Abdominal Fat|intra-abdominal fat
5633939|NCT00763074|Adipokines|adipokines
5633940|NCT00763074|Exercise|exercise
5633941|NCT00763074|Diet therapy|diet therapy
5633942|NCT00763061|Glaucoma|glaucoma
5633943|NCT00763035|Coronary Artery Disease|coronary artery disease
5633944|NCT00763035|Coronary Vessels|coronary vessels
5633945|NCT00763035|Myocardial Ischemia|myocardial ischemia
5633946|NCT00763035|Coronary Disease|coronary disease
5633947|NCT00763035|Ischemic heart disease|ischemic heart disease
5633948|NCT00763035|asthma|asthma
5633949|NCT00763035|copd|copd
5633950|NCT00763022|Glucose Metabolism Disorder|glucose metabolism disorder
5633951|NCT00763022|Dysmetabolic Syndrome|dysmetabolic syndrome
5633952|NCT00763022|Type II Diabetes|type ii diabetes
5633953|NCT00763022|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5633954|NCT00763022|Dyslipidemia|dyslipidemia
5633955|NCT00763022|Drug Therapy|drug therapy
5633956|NCT00762957|Glucose Metabolism Disorder|glucose metabolism disorder
5633957|NCT00762957|Dysmetabolic Syndrome|dysmetabolic syndrome
5633958|NCT00762957|Type II Diabetes|type ii diabetes
5633959|NCT00762957|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5633960|NCT00762957|Dyslipidemia|dyslipidemia
5633961|NCT00762957|Drug Therapy|drug therapy
5634060|NCT00762710|Drink|drink
5634061|NCT00762710|Heavy|heavy
5633962|NCT00762944|Patients requiring total joint reconstruction due to:|patients requiring total joint reconstruction due to:
5633963|NCT00762944|Arthritis (osteo-, rheumatoid, traumatic) malignancy|arthritis (osteo-, rheumatoid, traumatic) malignancy
5633964|NCT00762944|Ankylosis functional deformity|ankylosis functional deformity
5627884|NCT00788060|Rad001|rad001
5633965|NCT00762944|Avascular necrosis revisions|avascular necrosis revisions
5633966|NCT00762944|Benign neoplasms fracture|benign neoplasms fracture
5633967|NCT00762944|Multiple operated joints|multiple operated joints
5633969|NCT00762931|neuromodulation|neuromodulation
5633970|NCT00762931|neurostimulation|neurostimulation
5633971|NCT00762931|vagus nerve stimulation|vagus nerve stimulation
5633972|NCT00762931|vagal nerve stimulation|vagal nerve stimulation
5633973|NCT00762931|nVNS|nvns
5633974|NCT00762931|VNS|vns
5633975|NCT00762931|non invasive|non invasive
5633976|NCT00762931|gammacore|gammacore
5633977|NCT00762918|cystic fibrosis|cystic fibrosis
5633978|NCT00762918|vitamin d|vitamin d
5633979|NCT00762918|inflammation|inflammation
5633980|NCT00762905|cyanoacrylate|cyanoacrylate
5633981|NCT00762905|LiquiBand Laparoscopic|liquiband laparoscopic
5633982|NCT00762905|Dermabond|dermabond
5633983|NCT00762905|The rate of complete dermal apposition|the rate of complete dermal apposition
5633984|NCT00762905|The rate of wound infections and wound dehiscence|the rate of wound infections and wound dehiscence
5633985|NCT00762905|The rate of optimal cosmesis|the rate of optimal cosmesis
5633986|NCT00762892|Raltegravir|raltegravir
5633987|NCT00762892|Integrase inhibitor|integrase inhibitor
5633988|NCT00762892|Protease inhibitor|protease inhibitor
5633989|NCT00762892|Naive patients|naive patients
5633990|NCT00762892|HIV disease|hiv disease
5633992|NCT00762892|Treatment Naïve|treatment naïve
5633993|NCT00762879|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5633994|NCT00762879|JIA|jia
5633995|NCT00762879|Arthritis|arthritis
5633996|NCT00762879|Osteoporosis|osteoporosis
5633997|NCT00762879|Osteoporosis in Children|osteoporosis in children
5633998|NCT00762866|Major Depressive Disorder|major depressive disorder
5633999|NCT00762866|Depression|depression
5634000|NCT00762866|Bipolar I Disorder|bipolar i disorder
5634001|NCT00762866|Bipolar II Disorder|bipolar ii disorder
5634002|NCT00762866|Bipolar Disorder NOS|bipolar disorder nos
5634003|NCT00762866|Psychotic Disorder|psychotic disorder
5634004|NCT00762866|Schizophrenia|schizophrenia
5634005|NCT00762866|Schizoaffective Disorder|schizoaffective disorder
5634006|NCT00762840|Periapical lesions|periapical lesions
5634007|NCT00762840|Apical Periodontitis|apical periodontitis
5634008|NCT00762840|endodontic procedure|endodontic procedure
5634009|NCT00762840|root canal treatment|root canal treatment
5634010|NCT00762814|Parkinson disease|parkinson disease
5634011|NCT00762814|Individuals|individuals
5634012|NCT00762814|frequent|frequent
5634013|NCT00762814|freezing|freezing
5634014|NCT00762814|during|during
5634015|NCT00762814|gait|gait
5634016|NCT00762801|RLIP76|rlip76
5634017|NCT00762801|Cancer|cancer
5634018|NCT00762801|apoptosis|apoptosis
5634019|NCT00762775|Bone resorption|bone resorption
5634020|NCT00762775|Calcium homeostasis|calcium homeostasis
5634021|NCT00762775|Bone markers|bone markers
5634022|NCT00762775|Calcium and Vitamin D supplementation|calcium and vitamin d supplementation
5634023|NCT00762775|Parathyroid hormone levels|parathyroid hormone levels
5634024|NCT00762775|Interaction between calcium and vitamin D supplementation|interaction between calcium and vitamin d supplementation
5634025|NCT00762736|Glucose Metabolism Disorder|glucose metabolism disorder
5634026|NCT00762736|Dysmetabolic Syndrome|dysmetabolic syndrome
5634027|NCT00762736|Type II Diabetes|type ii diabetes
5634028|NCT00762736|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634029|NCT00762736|Dyslipidemia|dyslipidemia
5634030|NCT00762736|Drug Therapy|drug therapy
5634031|NCT00762723|Degenerative Disc Disease|degenerative disc disease
5634032|NCT00762723|Spinal Stenosis|spinal stenosis
5634033|NCT00762723|Spondylolisthesis|spondylolisthesis
5634034|NCT00762723|ALIF|alif
5634035|NCT00762723|fusion success|fusion success
5634036|NCT00762723|Anterior Lumbar Plate|anterior lumbar plate
5634037|NCT00762723|fixed versus variable screw configurations|fixed versus variable screw configurations
5634038|NCT00762723|Anterior Lumbar Interbody Fusion to treat spinal instability|anterior lumbar interbody fusion to treat spinal instability
5634039|NCT00762710|Alcohol|alcohol
5634040|NCT00762710|Abuse|abuse
5634041|NCT00762710|Use|use
5634042|NCT00762710|Disorder|disorder
5634043|NCT00762710|Dependence|dependence
5634044|NCT00762710|Symptoms|symptoms
5634045|NCT00762710|Alcoholic|alcoholic
5634046|NCT00762710|Alcoholism|alcoholism
5634047|NCT00762710|Prazosin|prazosin
5634048|NCT00762710|Drug|drug
5634049|NCT00762710|Medicine|medicine
5634050|NCT00762710|Medication|medication
5634051|NCT00762710|Treatment|treatment
5634052|NCT00762710|Study|study
5634053|NCT00762710|Placebo|placebo
5634054|NCT00762710|Medical|medical
5634055|NCT00762710|Management|management
5634056|NCT00762710|Craving|craving
5634057|NCT00762710|Consumption|consumption
5634058|NCT00762710|Binge|binge
5634059|NCT00762710|Drinking|drinking
5634062|NCT00762697|diabetic, venous insufficiency|diabetic, venous insufficiency
5634063|NCT00762684|Glucose Metabolism Disorder|glucose metabolism disorder
5634064|NCT00762684|Dysmetabolic Syndrome|dysmetabolic syndrome
5634065|NCT00762684|Type II Diabetes|type ii diabetes
5815790|NCT00081419|HV|hv
5634074|NCT00762593|urinary stress incontinence|urinary stress incontinence
5634075|NCT00762593|urinary stress incontinence in women|urinary stress incontinence in women
5634076|NCT00762580|rotator cuff|rotator cuff
5634077|NCT00762580|rehabilitation|rehabilitation
5634078|NCT00762554|analgesia|analgesia
5634079|NCT00762554|cesarean section|cesarean section
5634080|NCT00762554|fentanyl|fentanyl
5634081|NCT00762554|Depodur|depodur
5634082|NCT00762554|Post-cesarean section analgesia|post-cesarean section analgesia
5634084|NCT00762541|Laser In Situ Keratomileusis|laser in situ keratomileusis
5634085|NCT00762541|Laser Therapy|laser therapy
5634086|NCT00762541|Laser Corneal Surgery|laser corneal surgery
5634087|NCT00762541|Refractive Surgical Procedures|refractive surgical procedures
5634088|NCT00762541|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5634089|NCT00762541|Operative Surgical Procedures|operative surgical procedures
5634090|NCT00762541|Therapeutics|therapeutics
5634091|NCT00762489|Temporal artery thermometry|temporal artery thermometry
5634092|NCT00762489|Rectal temperature|rectal temperature
5634093|NCT00762489|Axillary temperature|axillary temperature
5634094|NCT00762489|Newborns|newborns
5634095|NCT00762489|Temperature measurement|temperature measurement
5634096|NCT00762476|cold, common|cold, common
5634097|NCT00762476|rhinovirus|rhinovirus
5634098|NCT00762424|Kidney stone|kidney stone
5634099|NCT00762424|Ureterolithiasis|ureterolithiasis
5634100|NCT00762424|Tamsulosin|tamsulosin
5634101|NCT00762424|Flowmax|flowmax
5634102|NCT00762424|Emergency Department|emergency department
5634103|NCT00762411|Alzheimer's Disease|alzheimer's disease
5634104|NCT00762398|Major surgery, excpected blood loss, arterial line|major surgery, excpected blood loss, arterial line
5634105|NCT00762372|anesthesia|anesthesia
5634106|NCT00762372|desflurane|desflurane
5634107|NCT00762359|Curling Ulcer|curling ulcer
5634108|NCT00762359|Gastric Ulcer|gastric ulcer
5634109|NCT00762359|Aspirin|aspirin
5634110|NCT00762359|Acetylsalicylic Acid|acetylsalicylic acid
5634111|NCT00762359|Drug Therapy|drug therapy
5634112|NCT00762346|non small cell lung cancer|non small cell lung cancer
5634113|NCT00762346|NTX|ntx
5634114|NCT00762346|zometa|zometa
5634115|NCT00762320|HIV|hiv
5634116|NCT00762320|Kaletra|kaletra
5634117|NCT00762320|treatment Experienced|treatment experienced
5634118|NCT00762294|breast cancer|breast cancer
5634119|NCT00762294|arimidex|arimidex
5634120|NCT00762294|femara|femara
5634121|NCT00762294|bone health|bone health
5634122|NCT00762281|Hyperopia|hyperopia
5634123|NCT00762281|Laser In Situ Keratomileusis|laser in situ keratomileusis
5634124|NCT00762281|Laser Therapy|laser therapy
5634125|NCT00762281|Laser Corneal Surgery|laser corneal surgery
5634126|NCT00762281|Refractive Surgical Procedures|refractive surgical procedures
5634127|NCT00762281|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5634128|NCT00762281|Operative Surgical Procedures|operative surgical procedures
5634129|NCT00762281|Therapeutics|therapeutics
5634130|NCT00762268|SAMe|same
5634131|NCT00762268|alternative treatments|alternative treatments
5634132|NCT00762268|bipolar disorder|bipolar disorder
5634133|NCT00762268|depression|depression
5634134|NCT00762268|bipolar depression|bipolar depression
5634135|NCT00762268|treatment-resistant depression|treatment-resistant depression
5634136|NCT00762255|recurrent glioblastoma|recurrent glioblastoma
5634137|NCT00762255|multiple agents|multiple agents
5634138|NCT00762255|immunotherapy|immunotherapy
5634139|NCT00762255|chemotherapy|chemotherapy
5634140|NCT00762255|brain and nervous system|brain and nervous system
5634141|NCT00762242|metabolomics|metabolomics
5634142|NCT00762242|flow-mediated vasodilation|flow-mediated vasodilation
5634143|NCT00762229|Cholesterol|cholesterol
5634144|NCT00762229|Ezetimibe|ezetimibe
5634145|NCT00762216|Cataract|cataract
5634146|NCT00762190|Glucose Metabolism Disorder|glucose metabolism disorder
5634147|NCT00762190|Dysmetabolic Syndrome|dysmetabolic syndrome
5634148|NCT00762190|Type II Diabetes|type ii diabetes
5634149|NCT00762190|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634150|NCT00762190|Dyslipidemia|dyslipidemia
5634151|NCT00762190|Drug Therapy|drug therapy
5634152|NCT00762164|Hypercholesterolemia|hypercholesterolemia
5634153|NCT00762164|Statins|statins
5634154|NCT00762164|Ezetimibe|ezetimibe
5634155|NCT00762151|Dental Plaque|dental plaque
5634156|NCT00762138|Platelet rich plasma|platelet rich plasma
5634164|NCT00762125|Physical Therapy|physical therapy
5634165|NCT00762125|Psychotherapy|psychotherapy
5634166|NCT00762125|Group Counseling|group counseling
5634167|NCT00762125|Individual Counseling|individual counseling
5634168|NCT00762125|Chronic Pain|chronic pain
5634169|NCT00762112|Glucose Metabolism Disorder|glucose metabolism disorder
5634170|NCT00762112|Dysmetabolic Syndrome|dysmetabolic syndrome
5634171|NCT00762112|Type II Diabetes|type ii diabetes
5634172|NCT00762112|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634173|NCT00762112|Dyslipidemia|dyslipidemia
5634174|NCT00762112|Drug Therapy.|drug therapy.
5634175|NCT00762099|Arthroplasty, Hip|arthroplasty, hip
5634176|NCT00762099|Hip replacement|hip replacement
5634177|NCT00762099|Pain Management|pain management
5634178|NCT00762099|Functional Rehabilitation|functional rehabilitation
5634179|NCT00762099|Anxiety|anxiety
5634180|NCT00762099|Perioperative|perioperative
5634182|NCT00762099|Arthroplasty|arthroplasty
5634183|NCT00762086|Peripheral Arterial Disease|peripheral arterial disease
5634184|NCT00762086|intermittent pneumatic compression treatment|intermittent pneumatic compression treatment
5634185|NCT00762086|Initial claudication|initial claudication
5634186|NCT00762073|eosinophilic esophagitis|eosinophilic esophagitis
5634187|NCT00762060|colorectal surgery|colorectal surgery
5634188|NCT00762047|Fecal Incontinence|fecal incontinence
5634189|NCT00762021|cataract|cataract
5634190|NCT00762008|biomarkers|biomarkers
5634191|NCT00761995|Raised IOP|raised iop
5616036|NCT00833404|Nicotine Patch|nicotine patch
5634192|NCT00761969|peripheral arterial disease|peripheral arterial disease
5634193|NCT00761969|secondary prevention|secondary prevention
5634194|NCT00761969|cardiovascular /atherothrombotic events|cardiovascular /atherothrombotic events
5634195|NCT00761969|European guidelines|european guidelines
5634196|NCT00761969|Cardiovascular disease prevention|cardiovascular disease prevention
5634197|NCT00761956|Total Knee Arthroplasty|total knee arthroplasty
5634198|NCT00761956|Osteoarthritis|osteoarthritis
5634199|NCT00761956|Knee|knee
5634200|NCT00761943|Adhesive Capsulitis|adhesive capsulitis
5634201|NCT00761943|Bursitis|bursitis
5634202|NCT00761943|Frozen Shoulder|frozen shoulder
5634203|NCT00761904|hypertension|hypertension
5634204|NCT00761904|hyperlipidemia|hyperlipidemia
5634205|NCT00761904|free generic samples|free generic samples
5634206|NCT00761891|aspirin|aspirin
5634207|NCT00761891|cyclooxygenase-1|cyclooxygenase-1
5634208|NCT00761891|aspirin resistance|aspirin resistance
5634209|NCT00761891|aspirin nonresponse|aspirin nonresponse
5634210|NCT00761891|platelet|platelet
5634211|NCT00761891|Normal volunteers|normal volunteers
5634212|NCT00761878|Skin aging|skin aging
5634213|NCT00761878|Skin wrinkling|skin wrinkling
5634214|NCT00761865|Lateral Ankle Sprin|lateral ankle sprin
5634215|NCT00761865|Air Cast Stirrup Brace|air cast stirrup brace
5634216|NCT00761865|High Tide Fracture Boot|high tide fracture boot
5634217|NCT00761839|wound healing|wound healing
5634218|NCT00761839|self-management|self-management
5634219|NCT00761839|patient education|patient education
5634220|NCT00761826|Mixed Astigmatism|mixed astigmatism
5634221|NCT00761826|Laser In Situ Keratomileusis|laser in situ keratomileusis
5634222|NCT00761826|Laser Therapy|laser therapy
5634223|NCT00761826|Laser Corneal Surgery|laser corneal surgery
5634224|NCT00761826|Refractive Surgical Procedures|refractive surgical procedures
5634225|NCT00761826|Ophthalmologic Surgical Procedure|ophthalmologic surgical procedure
5634226|NCT00761826|Operative Surgical Procedures|operative surgical procedures
5634227|NCT00761826|Therapeutics|therapeutics
5634228|NCT00761813|Sliding Hip Screw Fixation|sliding hip screw fixation
5634229|NCT00761813|Cannulated Screw Fixation|cannulated screw fixation
5634230|NCT00761787|allograft|allograft
5634231|NCT00761787|rejection|rejection
5634232|NCT00761787|biopsy|biopsy
5634233|NCT00761787|gene|gene
5634234|NCT00761787|expression|expression
5634235|NCT00761787|cardiology|cardiology
5634236|NCT00761787|heart|heart
5634237|NCT00761787|transplant|transplant
5634238|NCT00761774|Epilepsy|epilepsy
5634239|NCT00761774|Monotherapy|monotherapy
5634240|NCT00761774|Partial Onset Seizures|partial onset seizures
5634241|NCT00761761|Sensoril|sensoril
5634242|NCT00761761|Bipolar Illness|bipolar illness
5634243|NCT00761761|Cognitive enhancement|cognitive enhancement
5634244|NCT00761748|Urostomy,|urostomy,
5634245|NCT00761748|2-piece,|2-piece,
5634246|NCT00761748|preference,|preference,
5634247|NCT00761722|Acute Myeloid Leukemia|acute myeloid leukemia
5634248|NCT00761722|Myelodysplastic Syndromes|myelodysplastic syndromes
5634249|NCT00761722|Lymphoma|lymphoma
5634250|NCT00761722|Multiple Myeloma|multiple myeloma
5634251|NCT00761722|Chronic Myelomonocytic Leukemia (CMML)|chronic myelomonocytic leukemia (cmml)
5634252|NCT00761709|Open Angle Glaucoma|open angle glaucoma
5634253|NCT00761709|Ocular Hypertension|ocular hypertension
5634254|NCT00761696|solid tumor malignancies|solid tumor malignancies
5634255|NCT00761683|Endometriosis|endometriosis
5634257|NCT00761657|Chronic Kidney Disease|chronic kidney disease
5634258|NCT00761657|CKD|ckd
5634259|NCT00761657|Stage 3 or 4 Chronic Kidney Disease|stage 3 or 4 chronic kidney disease
5634260|NCT00761657|Renal|renal
5634261|NCT00761657|Anemia|anemia
5634262|NCT00761657|Oral anemia treatment|oral anemia treatment
5634263|NCT00761657|Hemoglobin levels|hemoglobin levels
5634264|NCT00761657|Blood count|blood count
5634265|NCT00761657|Erythropoietin|erythropoietin
5634266|NCT00761644|Metastatic cancer|metastatic cancer
5634267|NCT00761644|Doxil|doxil
5634268|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin
5634269|NCT00761644|Doxorubicin hydrochloride (liposomal)|doxorubicin hydrochloride (liposomal)
5634270|NCT00761644|Avastin|avastin
5634271|NCT00761644|Bevacizumab|bevacizumab
5634272|NCT00761644|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5634273|NCT00761644|rhuMAb-VEGF|rhumab-vegf
5634274|NCT00761644|Torisel|torisel
5634275|NCT00761644|Temsirolimus|temsirolimus
5634276|NCT00761644|CCI-779|cci-779
5634277|NCT00761644|Dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
5634278|NCT00761644|DCE-MRI scan|dce-mri scan
5634279|NCT00761618|Intrapleural catheter|intrapleural catheter
5634280|NCT00761618|IPC|ipc
5634281|NCT00761618|Pleurodesis|pleurodesis
5634282|NCT00761618|PD|pd
5634283|NCT00761618|Pleural effusion|pleural effusion
5634284|NCT00761618|Fluid in the chest cavity|fluid in the chest cavity
5634285|NCT00761618|Recurrent malignant pleural effusion|recurrent malignant pleural effusion
5634286|NCT00761618|MPE|mpe
5634287|NCT00761618|Pleural inflammatory response|pleural inflammatory response
5634288|NCT00761605|Schizophrenia|schizophrenia
5634289|NCT00761605|Paliperidone|paliperidone
5634290|NCT00761605|Paliperidone extended-release|paliperidone extended-release
5634291|NCT00761605|Antipsychotics Agents|antipsychotics agents
5634292|NCT00761579|Schizophrenia|schizophrenia
5634293|NCT00761579|Paliperidone|paliperidone
5634294|NCT00761579|Antipsychotics Agents|antipsychotics agents
5634295|NCT00761566|Elite swimmers|elite swimmers
5634296|NCT00761566|Exercise|exercise
5634297|NCT00761566|Preconditioning|preconditioning
5634298|NCT00761553|The study is designed to determine the effects of food supplements and strength training.|the study is designed to determine the effects of food supplements and strength training.
5634299|NCT00761501|Phase I|phase i
5634300|NCT00761501|Healthy Volunteer|healthy volunteer
5634301|NCT00761488|Visual acuity,|visual acuity,
5634302|NCT00761488|corneal and|corneal and
5634303|NCT00761488|refractive|refractive
5634304|NCT00761488|cylinder|cylinder
5634305|NCT00761488|following|following
5634306|NCT00761488|implantation of the|implantation of the
5634307|NCT00761488|AcrySof® Toric|acrysof® toric
5634308|NCT00761475|incisional hernia|incisional hernia
5634309|NCT00761462|Pediatrics|pediatrics
5634310|NCT00761462|Safety|safety
5634311|NCT00761462|Musculoskeletal System|musculoskeletal system
5634312|NCT00761462|Neurologic Manifestations|neurologic manifestations
5634313|NCT00761462|Joint Diseases|joint diseases
5634314|NCT00761462|Joint Deformities, Acquired|joint deformities, acquired
5634315|NCT00761449|MDS|mds
5634316|NCT00761449|AML|aml
5634317|NCT00761449|Lenalidomide|lenalidomide
5634318|NCT00761449|monosomy 5|monosomy 5
5634319|NCT00761449|del5q|del5q
5634320|NCT00761410|Arthroplasty|arthroplasty
5634322|NCT00761410|Replacement|replacement
5634323|NCT00761410|High Flexion|high flexion
5634324|NCT00761410|PFC Sigma RP-F|pfc sigma rp-f
5634325|NCT00761397|Oropharyngeal cancer|oropharyngeal cancer
5634326|NCT00761397|Dysphagic|dysphagic
5634327|NCT00761397|Swallowing exercises|swallowing exercises
5634328|NCT00761397|Swallowing rehabilitative regimens|swallowing rehabilitative regimens
5634329|NCT00761397|PREPARE|prepare
5634330|NCT00761397|Patients' Radiation Expectations|patients' radiation expectations
5634331|NCT00761397|Prevention, Adherence, Rehabilitative Exercises|prevention, adherence, rehabilitative exercises
5634332|NCT00761384|B-cell lymphoma|b-cell lymphoma
5634333|NCT00761384|Refractory|refractory
5634334|NCT00761384|Recurrent|recurrent
5634335|NCT00761384|90Y-ibritumomab|90y-ibritumomab
5634336|NCT00761384|Stem cells support|stem cells support
5634337|NCT00761384|Dosimetry study|dosimetry study
5634338|NCT00761371|external genital and perianal warts|external genital and perianal warts
5634339|NCT00761358|Acotiamide|acotiamide
5634340|NCT00761345|pancreatic cancer|pancreatic cancer
5634341|NCT00761345|locally advanced|locally advanced
5634342|NCT00761345|unresectable|unresectable
5634343|NCT00761345|metastatic pancreatic cancer|metastatic pancreatic cancer
5634344|NCT00761319|Open-angle glaucoma|open-angle glaucoma
5634345|NCT00761319|ocular hypertension|ocular hypertension
5634346|NCT00761306|Major Depressive Disorder|major depressive disorder
5634347|NCT00761306|Long-term|long-term
5634348|NCT00761306|Safety|safety
5634349|NCT00761306|Open-label|open-label
5634350|NCT00761280|Anaplastic astrocytoma|anaplastic astrocytoma
5634351|NCT00761280|Glioblastoma|glioblastoma
5634352|NCT00761280|Antisense|antisense
5634353|NCT00761280|Cancer|cancer
5634354|NCT00761280|Transforming Growth Factor beta 2|transforming growth factor beta 2
5634355|NCT00761280|Targeted therapy|targeted therapy
5634356|NCT00761280|Brain tumor|brain tumor
5634357|NCT00761280|Glioma|glioma
5634358|NCT00761280|Central Nervous System (CNS)|central nervous system (cns)
5634359|NCT00761280|Convection Enhanced Delivery (CED)|convection enhanced delivery (ced)
5634360|NCT00761280|Intratumoral administration|intratumoral administration
5634361|NCT00761267|Anidulafungin|anidulafungin
5634362|NCT00761267|pediatrics|pediatrics
5634363|NCT00761267|candidemia|candidemia
5634364|NCT00761267|invasive candidiasis|invasive candidiasis
5634365|NCT00761267|safety|safety
5634366|NCT00761254|Domperidone|domperidone
5634367|NCT00761254|Gastroparesis|gastroparesis
5634368|NCT00761241|pancreas cancer|pancreas cancer
5634369|NCT00761241|combined modality therapy|combined modality therapy
5634370|NCT00761228|Vegetative State|vegetative state
5634371|NCT00761228|Minimally Conscious State|minimally conscious state
5634372|NCT00761228|Coma|coma
5634373|NCT00761228|Traumatic Brain Injury|traumatic brain injury
5634374|NCT00761215|Skin|skin
5634375|NCT00761215|Infection|infection
5634376|NCT00761215|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
5634379|NCT00761189|Schizophrenia|schizophrenia
5634380|NCT00761176|Diabetes|diabetes
5634381|NCT00761176|Ulcers|ulcers
5634382|NCT00761176|Wounds|wounds
5634383|NCT00761163|The purpose of this study is to identify the body's response to aerobic vs. resistance exercise|the purpose of this study is to identify the body's response to aerobic vs. resistance exercise
5634384|NCT00761150|Effect on sleep interference by pain|effect on sleep interference by pain
5634385|NCT00761137|sialorrhea|sialorrhea
5634386|NCT00761137|drooling|drooling
5634387|NCT00761137|excessive salivation|excessive salivation
5616216|NCT00832637|Tarceva|tarceva
5634388|NCT00761137|parkinson's disease|parkinson's disease
5634389|NCT00761124|PSA screening|psa screening
5634390|NCT00761124|Prostate cancer and Latino men|prostate cancer and latino men
5634391|NCT00761111|information booklet|information booklet
5634392|NCT00761111|low back beliefs|low back beliefs
5634393|NCT00761111|education|education
5634394|NCT00761111|disc hernia|disc hernia
5634395|NCT00761111|discectomy|discectomy
5634396|NCT00761111|A common monoradicular sciatica|a common monoradicular sciatica
5634397|NCT00761111|on a slipped disc|on a slipped disc
5680384|NCT00577993|IFN|ifn
5634398|NCT00761111|with a clinical radio|with a clinical radio
5634399|NCT00761111|agreement requiring a surgical treatment|agreement requiring a surgical treatment
5634400|NCT00761111|carried out|carried out
5634401|NCT00761111|one duration|one duration
5634402|NCT00761111|of evolution higher|of evolution higher
5634403|NCT00761111|than four weeks|than four weeks
5634404|NCT00761111|at naive subjects|at naive subjects
5634405|NCT00761111|of any rachidian interventional treatment|of any rachidian interventional treatment
5634406|NCT00761111|after failure of an good ambulatory|after failure of an good ambulatory
5634407|NCT00761098|Cirrhosis|cirrhosis
5634409|NCT00761072|Propofol|propofol
5634410|NCT00761072|Remifentanil|remifentanil
5634411|NCT00761072|Total Intravenous Anesthesia|total intravenous anesthesia
5634412|NCT00761059|analgesia|analgesia
5634413|NCT00761059|infant, premature|infant, premature
5634414|NCT00761059|glucose|glucose
5634415|NCT00761059|nasopharyngeal suctioning|nasopharyngeal suctioning
5685474|NCT00555945|Intertrochanteric fracture|intertrochanteric fracture
5634416|NCT00761033|children undergoing intravenous placement in the pediatric emergency department|children undergoing intravenous placement in the pediatric emergency department
5634418|NCT00761020|Diagnosis|diagnosis
5634419|NCT00761020|Biomarker|biomarker
5634420|NCT00761007|Irritable Bowel Syndrome|irritable bowel syndrome
5634421|NCT00761007|Bowel disease|bowel disease
5634422|NCT00760994|Alcohol|alcohol
5634423|NCT00760994|Alcoholic|alcoholic
5634424|NCT00760994|Alcoholism|alcoholism
5634425|NCT00760994|Post-traumatic stress disorder|post-traumatic stress disorder
5634426|NCT00760994|PTSD|ptsd
5634427|NCT00760994|Experiential acceptance|experiential acceptance
5634428|NCT00760994|Mindfulness|mindfulness
5634429|NCT00760994|Meditation|meditation
5634430|NCT00760994|Meditate|meditate
5634431|NCT00760994|Cognitive restructuring|cognitive restructuring
5634432|NCT00760994|Cognitive|cognitive
5634433|NCT00760994|Behavioral|behavioral
5634434|NCT00760994|Therapy|therapy
5634435|NCT00760994|Treatment|treatment
5634436|NCT00760994|Study|study
5634437|NCT00760994|Intervention|intervention
5634438|NCT00760968|Rheumatoid Arthritis|rheumatoid arthritis
5634439|NCT00760968|Drug Therapy|drug therapy
5634440|NCT00760955|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5634441|NCT00760955|Diabetic Amyotrophy|diabetic amyotrophy
5634442|NCT00760955|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5634443|NCT00760955|Diabetic Polyneuropathy|diabetic polyneuropathy
5634444|NCT00760955|Neuralgia, Diabetic|neuralgia, diabetic
5634445|NCT00760955|Symmetric Diabetic Proximal Motor Neuropathy|symmetric diabetic proximal motor neuropathy
5634446|NCT00760955|Drug Therapy|drug therapy
5634447|NCT00760942|Low birth weight|low birth weight
5634448|NCT00760942|neonates|neonates
5634449|NCT00760942|premature infants|premature infants
5634450|NCT00760942|nutrition|nutrition
5634451|NCT00760942|human milk fortification|human milk fortification
5634452|NCT00760942|Infant|infant
5634453|NCT00760916|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5634454|NCT00760903|Moderate brain trauma|moderate brain trauma
5634455|NCT00760890|Iron, breastfed infant|iron, breastfed infant
5634456|NCT00760877|MYELOGENOUS|myelogenous
5634457|NCT00760877|LEUKEMIA|leukemia
5634458|NCT00760877|Chronic Phase|chronic phase
5634460|NCT00760864|Rheumatoid Arthritis|rheumatoid arthritis
5634461|NCT00760864|Drug Therapy|drug therapy
5634462|NCT00760851|Probiotics|probiotics
5634463|NCT00760851|Child, preschool|child, preschool
5634464|NCT00760851|Child Day Care Centers|child day care centers
5634465|NCT00760851|Health|health
5634466|NCT00760851|Immune system|immune system
5634467|NCT00760838|Inadequately controlled severe asthma|inadequately controlled severe asthma
5634468|NCT00760825|cholera|cholera
5634469|NCT00760825|vibrios|vibrios
5634470|NCT00760825|oral cholera vaccine|oral cholera vaccine
5634471|NCT00760812|Autism|autism
5634472|NCT00760812|Autism Spectrum Disorders|autism spectrum disorders
5637068|NCT00750204|ALI|ali
5634473|NCT00760812|Pervasive Developmental Disorders|pervasive developmental disorders
5634474|NCT00760812|Toddlers|toddlers
5634475|NCT00760812|Intervention|intervention
5634476|NCT00760799|Lumbar Disc Herniation|lumbar disc herniation
5634477|NCT00760786|IVUS-VH|ivus-vh
5634478|NCT00760786|Plaque characterization|plaque characterization
5634479|NCT00760786|Omega3-fatty acid|omega3-fatty acid
5634480|NCT00760786|Atorvastatin|atorvastatin
5634481|NCT00760773|Probiotic treatment|probiotic treatment
5634482|NCT00760773|Daycare attendance|daycare attendance
5634483|NCT00760773|Pediatric|pediatric
5634484|NCT00760773|Emergency department|emergency department
5634485|NCT00760747|ADHD|adhd
5634486|NCT00760747|Children|children
5634487|NCT00760747|Stimulant|stimulant
5634488|NCT00760747|Atomoxetine|atomoxetine
5634489|NCT00760747|Adolescents|adolescents
5634490|NCT00760734|Chronic traumatic brain injury|chronic traumatic brain injury
5634491|NCT00760734|Post concussion syndrome|post concussion syndrome
5634492|NCT00760734|Post traumatic stress disorder|post traumatic stress disorder
5634493|NCT00760734|Chronic post traumatic stress disorder|chronic post traumatic stress disorder
5634494|NCT00760721|Hepatitis B Screening|hepatitis b screening
5634495|NCT00760721|Korean Americans|korean americans
5634496|NCT00760708|nucleosides|nucleosides
5634497|NCT00760708|neurotransmitter|neurotransmitter
5634498|NCT00760708|myocardial ischemia|myocardial ischemia
5634499|NCT00760708|Adenosine|adenosine
5634500|NCT00760695|anorexia nervosa|anorexia nervosa
5634501|NCT00760695|chronic|chronic
5634502|NCT00760695|dronabinol|dronabinol
5634503|NCT00760695|weight gain|weight gain
5634504|NCT00760695|EDI|edi
5634505|NCT00760682|osteoradionecrosis|osteoradionecrosis
5634506|NCT00760682|hyperbaric oxygen|hyperbaric oxygen
5634507|NCT00760682|sequestrectomy|sequestrectomy
5634508|NCT00760669|Spondylitis, Ankylosing|spondylitis, ankylosing
5634509|NCT00760669|Arthritis, Rheumatoid|arthritis, rheumatoid
5634510|NCT00760669|Psoriasis|psoriasis
5634511|NCT00760669|Arthritis, Psoriatic|arthritis, psoriatic
5634512|NCT00760669|Infliximab|infliximab
5634514|NCT00760656|Health outcomes in adults who survived pediatric cancer|health outcomes in adults who survived pediatric cancer
5634515|NCT00760656|Survivors of Pediatric Cancer|survivors of pediatric cancer
5634516|NCT00760630|abnormal stress test|abnormal stress test
5634517|NCT00760630|fractional flow reserve|fractional flow reserve
5634518|NCT00760630|pressure drop coefficient|pressure drop coefficient
5634519|NCT00760630|lesion flow coefficient|lesion flow coefficient
5634520|NCT00760617|Influenza|influenza
5634521|NCT00760617|Elderly|elderly
5634522|NCT00760604|Esophageal neoplasms|esophageal neoplasms
5634523|NCT00760604|Esophagectomy|esophagectomy
5634524|NCT00760591|Acute kidney failure|acute kidney failure
5634525|NCT00760591|Colonoscopy|colonoscopy
5634526|NCT00760591|Neutrophil gelatinase-associated lipocalin|neutrophil gelatinase-associated lipocalin
5634527|NCT00760552|Hypertension|hypertension
5634528|NCT00760552|Adherence|adherence
5634529|NCT00760552|Pharmacist|pharmacist
5634530|NCT00760552|Interdisciplinary|interdisciplinary
5634531|NCT00760552|Randomized Controlled|randomized controlled
5634532|NCT00760552|Primary Care|primary care
5634533|NCT00760539|Glaucoma|glaucoma
5634534|NCT00760539|Hypertension|hypertension
5634535|NCT00760526|Continuous Glucose Monitor|continuous glucose monitor
5634659|NCT00760006|Unasyn|unasyn
5634536|NCT00760513|non alcoholic fatty liver disease|non alcoholic fatty liver disease
5634537|NCT00760513|NAFLD|nafld
5634538|NCT00760513|fish oil|fish oil
5634539|NCT00760513|intervention|intervention
5634540|NCT00760513|RCT|rct
5634541|NCT00760513|biomarkers|biomarkers
5634542|NCT00760487|Cataract AcrySof Toric IOL|cataract acrysof toric iol
5634543|NCT00760487|Bilateral cataract|bilateral cataract
5634546|NCT00760435|Infliximab|infliximab
5634547|NCT00760435|Remicade|remicade
5634548|NCT00760435|Pediatrics|pediatrics
5634549|NCT00760409|recurrent tumor|recurrent tumor
5634550|NCT00760396|healthy volunteers|healthy volunteers
5634551|NCT00760383|Total Knee Arthroplasty|total knee arthroplasty
5634552|NCT00760383|Osteoarthritis|osteoarthritis
5634553|NCT00760383|Muscle Metabolism|muscle metabolism
5634554|NCT00760383|Rehabilitation|rehabilitation
5634555|NCT00760383|Physical Therapy|physical therapy
5634556|NCT00760370|bone marker|bone marker
5634557|NCT00760370|bisphosphonate|bisphosphonate
5634558|NCT00760370|Zometa|zometa
5634559|NCT00760370|retention|retention
5634560|NCT00760370|breast cancer|breast cancer
5634561|NCT00760370|multiple myeloma|multiple myeloma
5634562|NCT00760370|CTX|ctx
5634563|NCT00760370|bone specific ALP|bone specific alp
5634564|NCT00760357|Critical Ischemia|critical ischemia
5634565|NCT00760344|Glucose Metabolism Disorder|glucose metabolism disorder
5634566|NCT00760344|Dysmetabolic Syndrome|dysmetabolic syndrome
5634567|NCT00760344|Type II Diabetes|type ii diabetes
5634568|NCT00760344|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634569|NCT00760344|Dyslipidemia|dyslipidemia
5634570|NCT00760344|Drug Therapy|drug therapy
5634572|NCT00760331|TCF2|tcf2
5634573|NCT00760331|MODY-5|mody-5
5634574|NCT00760331|CAKUT|cakut
5634575|NCT00760331|Anomaly of renal development|anomaly of renal development
5634576|NCT00760318|cervical dystonia, keppra, botox, spasmodic torticollis|cervical dystonia, keppra, botox, spasmodic torticollis
5634577|NCT00760305|cancer pain|cancer pain
5634578|NCT00760305|bone metastasis|bone metastasis
5634579|NCT00760305|patient education|patient education
5634580|NCT00760305|psychoeducational education|psychoeducational education
5634581|NCT00760305|side effects|side effects
5634582|NCT00760305|analgesics|analgesics
5634583|NCT00760292|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5634584|NCT00760292|Genetic Variants|genetic variants
5634585|NCT00760292|SNP|snp
5634586|NCT00760292|DNA microarray|dna microarray
5634587|NCT00760279|Bacterial infection|bacterial infection
5634588|NCT00760279|Azithromycin|azithromycin
5634589|NCT00760266|Hypertension|hypertension
5634590|NCT00760266|older population|older population
5634591|NCT00760266|aliskiren|aliskiren
5634592|NCT00760266|hydrochlorothiazide|hydrochlorothiazide
5634593|NCT00760266|systolic blood pressure|systolic blood pressure
5634594|NCT00760266|diastolic blood pressure|diastolic blood pressure
5634595|NCT00760266|amlodipine, stage 2|amlodipine, stage 2
5634596|NCT00760253|target control infusion|target control infusion
5634597|NCT00760253|alfentanyl|alfentanyl
5634598|NCT00760253|propofol|propofol
5634599|NCT00760253|BIS|bis
5634600|NCT00760240|compliance|compliance
5634601|NCT00760240|eyedrop instillation|eyedrop instillation
5634602|NCT00760240|How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.|how patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.
5634603|NCT00760214|Essential Hypertension|essential hypertension
5634604|NCT00760214|Hypertension|hypertension
5634605|NCT00760214|Drug Therapy|drug therapy
5634606|NCT00760214|Blood Pressure, High|blood pressure, high
5634607|NCT00760214|Vascular Disease|vascular disease
5634608|NCT00760214|Cardiovascular Disease|cardiovascular disease
5634609|NCT00760201|executive|executive
5634610|NCT00760201|administrator|administrator
5634611|NCT00760201|perceptions|perceptions
5634612|NCT00760201|legal counsel|legal counsel
5634613|NCT00760201|end of life|end of life
5634614|NCT00760188|knee replacement|knee replacement
5634615|NCT00760175|Lung transplant Recipients|lung transplant recipients
5634616|NCT00760175|Vaxigrip|vaxigrip
5634617|NCT00760162|Chronic Kidney failure stage three and four|chronic kidney failure stage three and four
5634618|NCT00760162|Probiotics|probiotics
5634619|NCT00760162|Kibow Biotics|kibow biotics
5634620|NCT00760162|Enteric Dialysis|enteric dialysis
5634621|NCT00760162|Gut based removal uremic toxin removal|gut based removal uremic toxin removal
5634622|NCT00760149|tuberculosis|tuberculosis
5634623|NCT00760149|rifampicin|rifampicin
5634624|NCT00760149|pharmacokinetics|pharmacokinetics
5634625|NCT00760149|pharmacodynamics|pharmacodynamics
5634626|NCT00760136|patellofemoral pain|patellofemoral pain
5634627|NCT00760136|quadriceps contraction|quadriceps contraction
5634628|NCT00760123|Lymphedema|lymphedema
5634629|NCT00760123|Prevention|prevention
5634630|NCT00760123|Breast cancer|breast cancer
5634631|NCT00760123|Physical therapy|physical therapy
5634632|NCT00760110|Morning BP|morning bp
5634633|NCT00760110|Clinic BP|clinic bp
5634634|NCT00760110|micro- and macrovascular complications|micro- and macrovascular complications
5634635|NCT00760084|Acute Myelogenous Leukemia|acute myelogenous leukemia
5634636|NCT00760084|Myelodysplastic Syndrome|myelodysplastic syndrome
5634637|NCT00760084|Dacogen|dacogen
5634638|NCT00760084|Decitabine|decitabine
5634639|NCT00760071|cystic fibrosis,|cystic fibrosis,
5634640|NCT00760071|lung disease,|lung disease,
5634641|NCT00760071|MRI,|mri,
5634642|NCT00760071|morphology,|morphology,
5634643|NCT00760071|function|function
5634644|NCT00760071|morphological MRI|morphological mri
5634645|NCT00760071|functional MRI|functional mri
5634646|NCT00760071|correlation to clinical data|correlation to clinical data
5634647|NCT00760058|cataract, intraocular lens|cataract, intraocular lens
5634648|NCT00760032|Cirrhosis|cirrhosis
5634649|NCT00760032|Ascites|ascites
5634650|NCT00760032|Lipopolysaccharide binding protein|lipopolysaccharide binding protein
5634651|NCT00760032|Infections|infections
5634652|NCT00760032|Cytokines|cytokines
5634653|NCT00760032|Ciprofloxacin|ciprofloxacin
5634654|NCT00760019|vascular inflammation|vascular inflammation
5634655|NCT00760019|endothelium-dependent flow-mediated blood vessel function|endothelium-dependent flow-mediated blood vessel function
5634656|NCT00760006|cleft secondary palate|cleft secondary palate
5634657|NCT00760006|primary closure of secondary cleft palate|primary closure of secondary cleft palate
5634658|NCT00760006|Prophylactic Antibiotics|prophylactic antibiotics
5634660|NCT00760006|Cleft Palate|cleft palate
5634661|NCT00759993|weight gain|weight gain
5634662|NCT00759993|Obesity|obesity
5634663|NCT00759993|Psychiatry|psychiatry
5634664|NCT00759993|Medication|medication
5634665|NCT00759993|Induced|induced
5634666|NCT00759980|Thrombocytopenia|thrombocytopenia
5634667|NCT00759980|Platelet transfusion|platelet transfusion
5634669|NCT00759967|Cross-Over|cross-over
5634670|NCT00759967|Conventional|conventional
5634671|NCT00759967|Daily|daily
5634672|NCT00759967|Hemodialysis|hemodialysis
5634673|NCT00759954|bioequivalence|bioequivalence
5634674|NCT00759954|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5634675|NCT00759954|KADIAN capsules|kadian capsules
5634676|NCT00759954|200 mg|200 mg
5634677|NCT00759954|applesauce|applesauce
5634678|NCT00759941|Glaucoma|glaucoma
5634679|NCT00759928|Refractory Solid Tumors|refractory solid tumors
5634680|NCT00759928|Unresectable Stage III/IV|unresectable stage iii/iv
5634681|NCT00759928|Sorafenib|sorafenib
5634682|NCT00759928|Erlotinib|erlotinib
5634683|NCT00759928|Pharmacokinetics|pharmacokinetics
5634684|NCT00759915|10 mg|10 mg
5634685|NCT00759915|KADIAN capsules|kadian capsules
5634686|NCT00759915|20 mg|20 mg
5634687|NCT00759915|fed conditions|fed conditions
5634688|NCT00759915|bioequivalence|bioequivalence
5634689|NCT00759902|bioequivalence|bioequivalence
5634690|NCT00759902|10 mg|10 mg
5634691|NCT00759902|KADIAN capsules|kadian capsules
5634692|NCT00759902|20 mg|20 mg
5634693|NCT00759902|under fasted conditions|under fasted conditions
5634694|NCT00759889|venous leg ulcer|venous leg ulcer
5634695|NCT00759876|Duchenne muscular dystrophy|duchenne muscular dystrophy
5634696|NCT00759876|Nonsense mutation|nonsense mutation
5634697|NCT00759876|Premature stop codon|premature stop codon
5634699|NCT00759876|PTC124|ptc124
5634700|NCT00759876|Ataluren|ataluren
5634701|NCT00759850|Acute Myocardial Infarction|acute myocardial infarction
5634702|NCT00759850|Drug Eluting Stent|drug eluting stent
5634703|NCT00759850|Primary PCI|primary pci
5634704|NCT00759824|Small cell lung carcinoma|small cell lung carcinoma
5634705|NCT00759824|Valproic acid|valproic acid
5634706|NCT00759824|Adriamycin|adriamycin
5634707|NCT00759824|Cyclophosphamide|cyclophosphamide
5634708|NCT00759824|Vindesine|vindesine
5634709|NCT00759824|Second-line chemotherapy|second-line chemotherapy
5634710|NCT00759811|Heart Failure|heart failure
5634711|NCT00759811|Myocardial Ischemia|myocardial ischemia
5634713|NCT00759811|Inflammation|inflammation
5634714|NCT00759811|Anti-Inflammatory Agents|anti-inflammatory agents
5634715|NCT00759811|Inflammation Mediators|inflammation mediators
5634716|NCT00759798|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5634717|NCT00759798|Leukemia|leukemia
5634718|NCT00759798|FCR|fcr
5634719|NCT00759798|Fludarabine|fludarabine
5634720|NCT00759798|Cyclophosphamide|cyclophosphamide
5634721|NCT00759798|Rituximab|rituximab
5634722|NCT00759772|Anorexia Nervosa|anorexia nervosa
5634723|NCT00759772|Disordered Eating|disordered eating
5634724|NCT00759772|Osteoporosis|osteoporosis
5634725|NCT00759772|Parathyroid Hormone|parathyroid hormone
5634726|NCT00759772|Bone|bone
5634727|NCT00759759|bioequivalence|bioequivalence
5634728|NCT00759759|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5634729|NCT00759759|KADIAN capsules|kadian capsules
5634730|NCT00759759|200 mg|200 mg
5634731|NCT00759746|Weight loss maintenance|weight loss maintenance
5634732|NCT00759733|pregnancy|pregnancy
5634733|NCT00759733|heart disease|heart disease
5634734|NCT00759733|heart function testing|heart function testing
5634735|NCT00759733|echocardiography|echocardiography
5634736|NCT00759733|B-type natriuretic peptide|b-type natriuretic peptide
5634737|NCT00759733|obstetrical care|obstetrical care
5634738|NCT00759720|Glucose Metabolism Disorder|glucose metabolism disorder
5634739|NCT00759720|Dysmetabolic Syndrome|dysmetabolic syndrome
5634740|NCT00759720|Type II Diabetes|type ii diabetes
5634741|NCT00759720|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634742|NCT00759720|Dyslipidemia|dyslipidemia
5634743|NCT00759720|Drug Therapy|drug therapy
5634744|NCT00759707|saphenous vein bypass grafts|saphenous vein bypass grafts
5634745|NCT00759707|flow-mediated vasodilation|flow-mediated vasodilation
5634746|NCT00759681|Arterial Surgery|arterial surgery
5634747|NCT00759681|Open vascular Surgery|open vascular surgery
5634748|NCT00759681|Sealant|sealant
5634749|NCT00759655|hemophilia A|hemophilia a
5634750|NCT00759655|Xyntha|xyntha
5634751|NCT00759655|ReFacto|refacto
5634752|NCT00759655|moroctocog alfa|moroctocog alfa
5634753|NCT00759655|bleeding disorder|bleeding disorder
5634754|NCT00759642|breast cancer|breast cancer
5634755|NCT00759642|hormone receptor positive|hormone receptor positive
5634756|NCT00759642|HER-2 negative|her-2 negative
5634757|NCT00759616|Knee Replacement|knee replacement
5634758|NCT00759603|Leukemia|leukemia
5634759|NCT00759603|CLL|cll
5634760|NCT00759603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5634761|NCT00759603|SLL|sll
5634762|NCT00759603|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5634763|NCT00759603|Lenalidomide|lenalidomide
5634764|NCT00759603|Revlimid|revlimid
5634765|NCT00759603|Rituximab|rituximab
5634766|NCT00759603|Rituxan|rituxan
5634767|NCT00759551|Blood Pressure|blood pressure
5634768|NCT00759551|Drug Therapy|drug therapy
5634769|NCT00759551|Systolic Pressure|systolic pressure
5634770|NCT00759551|Diastolic Pressure|diastolic pressure
5634771|NCT00759551|Vascular Diseases|vascular diseases
5634772|NCT00759538|Lung Transplantation|lung transplantation
5634773|NCT00759538|Pulmonary Rehabilitation|pulmonary rehabilitation
5634774|NCT00759538|Exercise tolerance|exercise tolerance
5634775|NCT00759538|Quality of Life|quality of life
5634776|NCT00759499|study of debridement tissue for research purposes.|study of debridement tissue for research purposes.
5634777|NCT00759499|open wound|open wound
5634778|NCT00759486|craniofacial fracture|craniofacial fracture
5634779|NCT00759486|Subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture|subjects who are in the active phase of craniofacial skeletal growth, and have sustained a craniofacial fracture
5634780|NCT00759473|substance-related disorders|substance-related disorders
5634781|NCT00759460|Schizophrenia|schizophrenia
5634782|NCT00759447|Breast cancer|breast cancer
5634783|NCT00759447|tomosynthesis|tomosynthesis
5634784|NCT00759434|Varicose veins|varicose veins
5634785|NCT00759434|Chronic venous insufficiency|chronic venous insufficiency
5634786|NCT00759434|Venous ulceration|venous ulceration
5634787|NCT00759434|Surgery|surgery
5634788|NCT00759434|Endovenous Laser|endovenous laser
5634789|NCT00759421|Schizophrenia|schizophrenia
5680385|NCT00577993|Doxorubicin|doxorubicin
5634790|NCT00759408|primary pulmonary hypertension|primary pulmonary hypertension
5634791|NCT00759408|secondary pulmonary hypertension due to left heart failure|secondary pulmonary hypertension due to left heart failure
5634792|NCT00759408|secondary pulmonary hypertension due to other causes|secondary pulmonary hypertension due to other causes
5634793|NCT00759408|patients without pulmonary disease or pulmonary hypertension|patients without pulmonary disease or pulmonary hypertension
5634794|NCT00759395|Anxious Major Depressive Disorder|anxious major depressive disorder
5634795|NCT00759382|Non small cell lung carcinoma|non small cell lung carcinoma
5634796|NCT00759382|PET scan|pet scan
5634797|NCT00759382|Observational study|observational study
5634798|NCT00759382|Non metastatic|non metastatic
5634799|NCT00759382|treated|treated
5634800|NCT00759382|curative intent|curative intent
5634801|NCT00759369|ADPKD|adpkd
5634802|NCT00759356|bioavailability|bioavailability
5634803|NCT00759356|KADIAN|kadian
5634804|NCT00759356|200 mg|200 mg
5634805|NCT00759356|morphine sulfate sustained release capsules|morphine sulfate sustained release capsules
5634806|NCT00759356|100 mg|100 mg
5634807|NCT00759356|fed conditions|fed conditions
5634808|NCT00759343|Kidney stones|kidney stones
5634809|NCT00759343|urinary stone disease|urinary stone disease
5634810|NCT00759343|urinary stones|urinary stones
5634811|NCT00759343|urine|urine
5634812|NCT00759343|serum|serum
5634813|NCT00759330|Flurbiprofen, low back pain, chronic low back pain|flurbiprofen, low back pain, chronic low back pain
5634814|NCT00759317|normal controls|normal controls
5634815|NCT00759304|Aging|aging
5634816|NCT00759304|cardiovascular risk factors|cardiovascular risk factors
5634817|NCT00759304|Autonomic nervous system|autonomic nervous system
5634818|NCT00759304|stroke|stroke
5634819|NCT00759304|Myocardiac infarction|myocardiac infarction
5634820|NCT00759304|Neuropsychological evaluation|neuropsychological evaluation
5634821|NCT00759304|Prospective cohort|prospective cohort
5634822|NCT00759291|free fatty acids|free fatty acids
5634823|NCT00759291|insulin-mediated|insulin-mediated
5634824|NCT00759291|endothelium-dependent vasodilation|endothelium-dependent vasodilation
5634825|NCT00759291|metabolic syndrome|metabolic syndrome
5634826|NCT00759278|pregnancy|pregnancy
5634827|NCT00759278|umbilical artery systolic to diastolic flow ratio|umbilical artery systolic to diastolic flow ratio
5634828|NCT00759278|middle cerebral artery peak systolic flow|middle cerebral artery peak systolic flow
5634829|NCT00759278|antihypertensive medication|antihypertensive medication
5634830|NCT00759265|Muscle strength|muscle strength
5634831|NCT00759265|Physical activity|physical activity
5634832|NCT00759265|Mobility|mobility
5634833|NCT00759265|Gait analysis|gait analysis
5634834|NCT00759252|diagnosis of dementia|diagnosis of dementia
5634835|NCT00759252|perceptions of risk|perceptions of risk
5634836|NCT00759252|dementia screening|dementia screening
5634837|NCT00759239|Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension|open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component), or ocular hypertension
5634838|NCT00759226|esophageal cancer|esophageal cancer
5634839|NCT00759226|Gemcitabine|gemcitabine
5634840|NCT00759226|Cisplatin|cisplatin
5634843|NCT00759226|inoperable esophageal cancer|inoperable esophageal cancer
5634844|NCT00759213|Discharge planning|discharge planning
5634845|NCT00759213|Family needs|family needs
5634846|NCT00759213|Family concerns|family concerns
5634847|NCT00759213|NICU|nicu
5634848|NCT00759213|Infants|infants
5634849|NCT00759200|Chronic hepatitis C|chronic hepatitis c
5634850|NCT00759200|genotype 2|genotype 2
5634851|NCT00759200|genotype 3|genotype 3
5634852|NCT00759200|albumin interferon alfa-2b|albumin interferon alfa-2b
5634853|NCT00759200|alb-interferon|alb-interferon
5634854|NCT00759174|Optic Neuropathy Acute NAION PDE5 Inhibitor|optic neuropathy acute naion pde5 inhibitor
5634855|NCT00759161|Plaque Type Psoriasis|plaque type psoriasis
5634856|NCT00759161|Topical|topical
5634857|NCT00759148|pink eye|pink eye
5634859|NCT00759148|moxifloxacin|moxifloxacin
5634860|NCT00759148|fluoroquinolone|fluoroquinolone
5634861|NCT00759135|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5634862|NCT00759135|BPH|bph
5634863|NCT00759135|Enlarged Prostate|enlarged prostate
5634864|NCT00759122|mdd|mdd
5634865|NCT00759122|major depressive disorder|major depressive disorder
5634866|NCT00759122|depression|depression
5634867|NCT00759096|bilateral implantation|bilateral implantation
5634868|NCT00759096|ReSTOR Aspheric IOL|restor aspheric iol
5634869|NCT00759096|uniocular unaided distance|uniocular unaided distance
5634870|NCT00759096|binocular unaided distance|binocular unaided distance
5634871|NCT00759096|intermediate visual acuity|intermediate visual acuity
5634872|NCT00759096|near visual acuity|near visual acuity
5634873|NCT00759083|HIT|hit
5634874|NCT00759083|HITTS|hitts
5634875|NCT00759070|Treatment Naïve|treatment naïve
5634876|NCT00759057|Spinal Stenosis|spinal stenosis
5634877|NCT00759057|Spinal Instability|spinal instability
5634878|NCT00759057|Leg Pain|leg pain
5634879|NCT00759018|GVHD|gvhd
5634880|NCT00759018|Prochymal|prochymal
5634881|NCT00759018|Graft vs Host Disease|graft vs host disease
5634882|NCT00758992|gene transfer|gene transfer
5634883|NCT00758966|OCD,|ocd,
5634884|NCT00758966|naltrexone,|naltrexone,
5634885|NCT00758966|fluoxetine,|fluoxetine,
5634886|NCT00758966|obsessive-compulsive disorder|obsessive-compulsive disorder
5634887|NCT00758940|Clinical|clinical
5634888|NCT00758940|assessment|assessment
5634889|NCT00758940|of visual|of visual
5634890|NCT00758940|function|function
5634891|NCT00758940|with the Acrysof ReSTOR|with the acrysof restor
5634892|NCT00758940|multifocal IOL|multifocal iol
5634893|NCT00758927|diabetes mellitus|diabetes mellitus
5634894|NCT00758927|combined hyperlipidemia|combined hyperlipidemia
5634895|NCT00758927|OMACOR|omacor
5634896|NCT00758927|small dense LDL|small dense ldl
5634897|NCT00758927|HDL subfraction|hdl subfraction
5634898|NCT00758914|Vitamin E|vitamin e
5634899|NCT00758849|NOH|noh
5634900|NCT00758849|Orthostatic hypotension|orthostatic hypotension
5634901|NCT00758849|PAF|paf
5634902|NCT00758849|MSA|msa
5634903|NCT00758849|Shy-Drager syndrome|shy-drager syndrome
5634904|NCT00758849|Olivopontocerebellar atrophy|olivopontocerebellar atrophy
5634905|NCT00758849|Striatonigral degeneration|striatonigral degeneration
5634906|NCT00758849|Autonomic Failure|autonomic failure
5634907|NCT00758849|Parkinson|parkinson
5634908|NCT00758849|Fipamezole|fipamezole
5634909|NCT00758849|JP-1730|jp-1730
5634910|NCT00758823|head lice|head lice
5634911|NCT00758810|Health Education|health education
5634912|NCT00758810|Myocardial Infarction|myocardial infarction
5634913|NCT00758810|Acute Coronary Syndrome|acute coronary syndrome
5634914|NCT00758810|Quality of Life|quality of life
5634915|NCT00758797|metastatic melanoma|metastatic melanoma
5634916|NCT00758758|Anterior Cervical Discectomy and Fusion,|anterior cervical discectomy and fusion,
5634917|NCT00758758|Degenerative Disc Disease,|degenerative disc disease,
5634918|NCT00758758|Cervical Spine,|cervical spine,
5634919|NCT00758758|Herniated Disc|herniated disc
5634920|NCT00758745|Cataract|cataract
5634921|NCT00758745|Patients|patients
5634922|NCT00758745|bilateral|bilateral
5634923|NCT00758745|age related|age related
5634924|NCT00758745|undergoing|undergoing
5634925|NCT00758745|phacoemulsification|phacoemulsification
5634926|NCT00758732|Cancer|cancer
5634927|NCT00758732|Ovarian cancer|ovarian cancer
5634928|NCT00758732|Chemotherapy|chemotherapy
5634929|NCT00758732|Docetaxel|docetaxel
5634930|NCT00758732|Carboplatin|carboplatin
5634931|NCT00758732|Pegylated doxorubicin|pegylated doxorubicin
5634932|NCT00758732|Platinum sensitive|platinum sensitive
5634935|NCT00758706|COPD|copd
5634936|NCT00758693|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5634937|NCT00758693|Bendamustine|bendamustine
5634938|NCT00758693|Treanda|treanda
5634939|NCT00758693|Rituximab|rituximab
5634940|NCT00758693|Rituxan|rituxan
5634941|NCT00758667|capsular contracture|capsular contracture
5634942|NCT00758667|capsulectomy|capsulectomy
5634943|NCT00758667|mesna|mesna
5634944|NCT00758667|Capsular contracture after breast implant placement|capsular contracture after breast implant placement
5634945|NCT00758654|myocardial strain|myocardial strain
5634946|NCT00758654|Strain-Encoded MRI|strain-encoded mri
5634947|NCT00758654|dobutamine stress MRI|dobutamine stress mri
5634948|NCT00758654|ischemia|ischemia
5634949|NCT00758654|strain rate reserve|strain rate reserve
5634950|NCT00758641|plantar fasciitis|plantar fasciitis
5634951|NCT00758641|platelet rich plasma|platelet rich plasma
5634952|NCT00758641|GPS|gps
5634953|NCT00758615|Obesity|obesity
5634954|NCT00758615|Physical activity|physical activity
5634955|NCT00758615|Injury Prevention|injury prevention
5634956|NCT00758615|Pedestrian safety|pedestrian safety
5634957|NCT00758615|Self efficacy|self efficacy
5634958|NCT00758615|School|school
5634959|NCT00758615|Walking School Bus|walking school bus
5634960|NCT00758615|Safe Routes to School|safe routes to school
5634961|NCT00758589|Asthma|asthma
5634962|NCT00758576|Cataract|cataract
5634963|NCT00758550|Visual function;|visual function;
5634964|NCT00758550|Refractive cylinder;|refractive cylinder;
5634965|NCT00758550|AcrySof® Toric;|acrysof® toric;
5634966|NCT00758550|AcrySof® Natural|acrysof® natural
5634967|NCT00758537|Assessment of tryptophan and tryptophan catabolites and IDO-activity in patients with chronic kidney disease|assessment of tryptophan and tryptophan catabolites and ido-activity in patients with chronic kidney disease
5634970|NCT00758524|antihypertensive agent|antihypertensive agent
5634973|NCT00758511|pain management|pain management
5634974|NCT00758511|preterm infants|preterm infants
5634975|NCT00758511|sucrose|sucrose
5634976|NCT00758511|facilitated tucking|facilitated tucking
5634977|NCT00758459|COPD|copd
5634978|NCT00758433|Adverse Events|adverse events
5634979|NCT00758433|Erythema Rating|erythema rating
5634980|NCT00758433|Pharmacokinetics|pharmacokinetics
5634981|NCT00758433|Civamide|civamide
5634982|NCT00758433|Phase 1|phase 1
5634983|NCT00758433|Pain|pain
5634984|NCT00758433|Patch|patch
5634985|NCT00758420|Varicose Veins|varicose veins
5634986|NCT00758407|Fatigue, Cancer, Methylphenidate,|fatigue, cancer, methylphenidate,
5634987|NCT00758381|pancreatic cancer|pancreatic cancer
5634988|NCT00758381|advanced or metastatic|advanced or metastatic
5634989|NCT00758381|sorafenib|sorafenib
5634990|NCT00758368|Parkinson's disease|parkinson's disease
5634991|NCT00758368|PD|pd
5634992|NCT00758368|pulsatile apomorphine|pulsatile apomorphine
5634993|NCT00758368|dyskinesia|dyskinesia
5634994|NCT00758368|apomorphine|apomorphine
5634995|NCT00758368|continuous dopaminergic stimulation|continuous dopaminergic stimulation
5634996|NCT00758342|IOP lowering efficacy and safety of Azopt plus Travatan|iop lowering efficacy and safety of azopt plus travatan
5634997|NCT00758316|Malignant|malignant
5634998|NCT00758316|Pleural|pleural
5634999|NCT00758316|Effusions|effusions
5635000|NCT00758316|Thoracoscopy|thoracoscopy
5635001|NCT00758316|Catheter|catheter
5635002|NCT00758303|Triglycerides|triglycerides
5635003|NCT00758303|Cholesterol|cholesterol
5635004|NCT00758277|prevention of alcohol relapse|prevention of alcohol relapse
5635005|NCT00758264|Safety|safety
5635006|NCT00758264|Routine infancy vaccination|routine infancy vaccination
5635007|NCT00758264|Meningococcal vaccine|meningococcal vaccine
5635008|NCT00758264|Immunogenicity|immunogenicity
5635009|NCT00758264|Pneumococcal vaccine|pneumococcal vaccine
5635010|NCT00758251|Schizophrenia|schizophrenia
5635011|NCT00758251|Seroquel XR|seroquel xr
5635012|NCT00758251|CGI|cgi
5635013|NCT00758238|hypertension|hypertension
5635014|NCT00758238|self-management|self-management
5635015|NCT00758238|e-health|e-health
5635016|NCT00758225|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5635017|NCT00758225|DMD|dmd
5635018|NCT00758225|Duchenne|duchenne
5635019|NCT00758225|Idebenone|idebenone
5635020|NCT00758212|Influenza in Humans|influenza in humans
5635021|NCT00758212|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5635022|NCT00758212|Immunization, Active|immunization, active
5635023|NCT00758186|Colorectal cancer|colorectal cancer
5635024|NCT00758186|Endoscopic stent|endoscopic stent
5635025|NCT00758186|Intestinal obstruction|intestinal obstruction
5635026|NCT00758186|Laparoscopy|laparoscopy
5635027|NCT00758173|prostate cancer|prostate cancer
5635028|NCT00758160|Attention Deficit Disorder With Hyperactivity|attention deficit disorder with hyperactivity
5635029|NCT00758160|Methylphenidate|methylphenidate
5635030|NCT00758160|Concerta|concerta
5635031|NCT00758147|force feedback joystick|force feedback joystick
5635032|NCT00758147|stroke|stroke
5635033|NCT00758147|haptics|haptics
5635034|NCT00758147|kinematics|kinematics
5635035|NCT00758147|rehabilitation|rehabilitation
5635036|NCT00758147|robotics|robotics
5635037|NCT00758147|Force feedback joystick in stroke rehabilitation|force feedback joystick in stroke rehabilitation
5635038|NCT00758108|Genotype/Phenotype Correlation|genotype/phenotype correlation
5635039|NCT00758108|Energy Homeostasis|energy homeostasis
5635040|NCT00758108|Nociception|nociception
5635041|NCT00758108|Obesity|obesity
5635042|NCT00758108|Behavior and Neurocognition|behavior and neurocognition
5635043|NCT00758108|WAGR Syndrome|wagr syndrome
5635044|NCT00758108|Wilm's Tumor|wilm's tumor
5635045|NCT00758108|Aniridia|aniridia
5635046|NCT00758108|Mental Retardation|mental retardation
5635047|NCT00758108|Urogenital Abnormalities|urogenital abnormalities
5635048|NCT00758108|Healthy Volunteer|healthy volunteer
5635049|NCT00758082|type 1 diabetes|type 1 diabetes
5635050|NCT00758082|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
5635052|NCT00758056|endometrial cancer|endometrial cancer
5635053|NCT00758043|Genotype 1|genotype 1
5635054|NCT00758030|Schizophrenia|schizophrenia
5635055|NCT00758030|Paliperidone|paliperidone
5635056|NCT00758017|low back pain|low back pain
5635057|NCT00758017|acupuncture|acupuncture
5635058|NCT00758004|Cardiovascular Diseases|cardiovascular diseases
5635059|NCT00757991|healthy, no evidence of disease|healthy, no evidence of disease
5635060|NCT00757978|Schizophrenia|schizophrenia
5635061|NCT00757978|negative symptoms|negative symptoms
5635062|NCT00757978|clozapine|clozapine
5635063|NCT00757965|colon cancer|colon cancer
5635064|NCT00757965|rectal cancer|rectal cancer
5635065|NCT00757952|ovarian epithelial cancer|ovarian epithelial cancer
5635066|NCT00757939|Alzheimer's Disease, MRI, PET|alzheimer's disease, mri, pet
5635067|NCT00757900|influenza, human|influenza, human
5635069|NCT00757887|plasmodium|plasmodium
5635070|NCT00757887|falciparum|falciparum
5635071|NCT00757887|human|human
5635072|NCT00757887|experimental infection|experimental infection
5635073|NCT00757874|Female urogenital disease|female urogenital disease
5635074|NCT00757874|skin disease|skin disease
5635075|NCT00757848|cystic fibrosis|cystic fibrosis
5635076|NCT00757835|24-hour IOP|24-hour iop
5635077|NCT00757835|exfoliative glaucoma|exfoliative glaucoma
5635078|NCT00757835|travoprost/timolol|travoprost/timolol
5635079|NCT00757835|latanoprost/timolol|latanoprost/timolol
5635080|NCT00757835|fixed combinations|fixed combinations
5635081|NCT00757783|HIV|hiv
5635082|NCT00757783|AIDS|aids
5635083|NCT00757783|Immunodeficiency Virus, Human|immunodeficiency virus, human
5635084|NCT00757783|PREZISTA|prezista
5635085|NCT00757783|darunavir|darunavir
5635086|NCT00757783|TMC114|tmc114
5635087|NCT00757783|Protease Inhibitor|protease inhibitor
5635088|NCT00757783|Truvada|truvada
5635089|NCT00757783|Atazanavir|atazanavir
5635090|NCT00757783|REYATAZ|reyataz
5635091|NCT00757783|HIV Infections|hiv infections
5635092|NCT00757783|Treatment Naïve|treatment naïve
5635093|NCT00757770|Gastroenteritis|gastroenteritis
5619903|NCT00818961|de novo MDS|de novo mds
5635094|NCT00757757|Prostate cancer|prostate cancer
5635095|NCT00757757|bone metastases|bone metastases
5635096|NCT00757757|anti-M-CSF|anti-m-csf
5635097|NCT00757757|M-CSF antibody|m-csf antibody
5635098|NCT00757757|M-CSF|m-csf
5635099|NCT00757757|Prostate Cancer with bone metastases|prostate cancer with bone metastases
5635100|NCT00757744|drug counseling|drug counseling
5635101|NCT00757744|HIV risks|hiv risks
5635102|NCT00757744|methadone maintenance|methadone maintenance
5635103|NCT00757744|HIV Seronegativity|hiv seronegativity
5635104|NCT00757718|Sleep Disordered Breathing|sleep disordered breathing
5635105|NCT00757718|Obstructive Sleep Apnea|obstructive sleep apnea
5635107|NCT00757718|Preeclampsia|preeclampsia
5635108|NCT00757705|Schizophrenia|schizophrenia
5635109|NCT00757705|Paliperidone Extended-Release|paliperidone extended-release
5635110|NCT00757692|Vandetanib (ZD6474)|vandetanib (zd6474)
5635111|NCT00757692|Hormone|hormone
5635112|NCT00757692|Refractory|refractory
5635113|NCT00757692|Prostate Cancer|prostate cancer
5635114|NCT00757692|Chemotherapy|chemotherapy
5635115|NCT00757692|Naïve|naïve
5635116|NCT00757666|Pacemaker|pacemaker
5635117|NCT00757640|gastric cancer, surgery, prophylactic cholecystectomy|gastric cancer, surgery, prophylactic cholecystectomy
5635118|NCT00757614|AIDS-related lymphoma|aids-related lymphoma
5635119|NCT00757614|cutaneous lymphoma|cutaneous lymphoma
5635120|NCT00757614|adult Hodgkin lymphoma|adult hodgkin lymphoma
5635121|NCT00757614|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5635122|NCT00757614|intraocular lymphoma|intraocular lymphoma
5635123|NCT00757614|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5635124|NCT00757614|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5635125|NCT00757614|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5635126|NCT00757614|noncutaneous extranodal lymphoma|noncutaneous extranodal lymphoma
5635127|NCT00757614|adult astrocytic tumors|adult astrocytic tumors
5635128|NCT00757614|adult brain stem glioma|adult brain stem glioma
5635129|NCT00757614|adult choroid plexus tumor|adult choroid plexus tumor
5635130|NCT00757614|adult craniopharyngioma|adult craniopharyngioma
5635131|NCT00757614|adult embryonal tumor|adult embryonal tumor
5635132|NCT00757614|adult ependymal tumors|adult ependymal tumors
5635133|NCT00757614|adult meningeal tumor|adult meningeal tumor
5635134|NCT00757614|adult oligodendroglial tumors|adult oligodendroglial tumors
5635135|NCT00757614|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5635136|NCT00757614|adult brain tumor|adult brain tumor
5635137|NCT00757614|intraocular melanoma|intraocular melanoma
5629005|NCT00784199|MDD|mdd
5635139|NCT00757614|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5635140|NCT00757614|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5635141|NCT00757614|esophageal cancer|esophageal cancer
5635142|NCT00757614|melanoma|melanoma
5635143|NCT00757614|pancreatic cancer|pancreatic cancer
5635144|NCT00757614|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5635145|NCT00757614|renal cell carcinoma|renal cell carcinoma
5635146|NCT00757614|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5635147|NCT00757614|transitional cell cancer of the renal pelvis and ureter|transitional cell cancer of the renal pelvis and ureter
5635148|NCT00757575|PNEUMONET JAPAN STUDY|pneumonet japan study
5635149|NCT00757549|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5635150|NCT00757549|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5635151|NCT00757549|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5635152|NCT00757549|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5635153|NCT00757549|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5635154|NCT00757549|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5635155|NCT00757549|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5635156|NCT00757549|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5635157|NCT00757549|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5635158|NCT00757536|Rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5635160|NCT00757536|encircling band|encircling band
5635161|NCT00757536|endolaser treatment|endolaser treatment
5635162|NCT00757523|Acne Vulgaris|acne vulgaris
5635164|NCT00757523|Acne|acne
5635165|NCT00757523|Akne Vulgaris|akne vulgaris
5635166|NCT00757510|Congenital Heart Disease|congenital heart disease
5635167|NCT00757497|Treatment Study|treatment study
5635168|NCT00757497|Psychosis|psychosis
5635169|NCT00757497|Electrical Stimulation|electrical stimulation
5635170|NCT00757497|Refractory|refractory
5635171|NCT00757497|Novel|novel
5635172|NCT00757497|Childhood Onset Psychotic Disorders|childhood onset psychotic disorders
5635173|NCT00757497|Schizophrenia|schizophrenia
5635174|NCT00757471|Macular hole surgery|macular hole surgery
5635175|NCT00757471|membranepeeling|membranepeeling
5635176|NCT00757471|closure rate|closure rate
5635177|NCT00757471|vitreoretinal dyes|vitreoretinal dyes
5635178|NCT00757458|Propofol|propofol
5635179|NCT00757458|Bacterial growth|bacterial growth
5635180|NCT00757458|Fungal growth|fungal growth
5635181|NCT00757458|EDTA|edta
5635182|NCT00757458|Target controlled infusion|target controlled infusion
5635183|NCT00757445|Antibiotic therapy|antibiotic therapy
5635184|NCT00757445|Microbiological diagnosis|microbiological diagnosis
5635185|NCT00757419|Safety|safety
5635186|NCT00757419|tolerability|tolerability
5635187|NCT00757419|healthy subjects|healthy subjects
5635188|NCT00757406|Lymphedema|lymphedema
5635189|NCT00757406|Bioimpedance|bioimpedance
5635190|NCT00757393|Growth hormone|growth hormone
5635191|NCT00757393|Pediatrics|pediatrics
5635192|NCT00757393|Vitamin D|vitamin d
5635193|NCT00757393|Calcium|calcium
5635194|NCT00757393|Exercise|exercise
5635195|NCT00757380|epiretinal membranes|epiretinal membranes
5635196|NCT00757380|vitreoretinal dyes|vitreoretinal dyes
5635197|NCT00757380|membranepeeling|membranepeeling
5635198|NCT00757367|Healthy subjects|healthy subjects
5635199|NCT00757367|insulin|insulin
5635200|NCT00757367|bronchoscope|bronchoscope
5635201|NCT00757367|serum insulin|serum insulin
5635202|NCT00757367|serum C-Peptide|serum c-peptide
5635203|NCT00757367|BAL fluid|bal fluid
5635204|NCT00757367|FDKP|fdkp
5635205|NCT00757328|Bipolar depression Treatment|bipolar depression treatment
5635206|NCT00757315|acne keloidalis nuchae|acne keloidalis nuchae
5635207|NCT00757315|NdYag laser|ndyag laser
5635209|NCT00757315|acne keloidalis|acne keloidalis
5635210|NCT00757315|AK|ak
5635211|NCT00757315|dermatitis papillaris capillitii|dermatitis papillaris capillitii
5635212|NCT00757315|folliculitis keloidalis nuchae|folliculitis keloidalis nuchae
5635213|NCT00757315|sycosis nuchae|sycosis nuchae
5635214|NCT00757315|acne keloid|acne keloid
5635215|NCT00757315|keloidal folliculitis|keloidal folliculitis
5635216|NCT00757315|lichen keloidalis nuchae|lichen keloidalis nuchae
5635217|NCT00757315|folliculitis nuchae scleroticans|folliculitis nuchae scleroticans
5635218|NCT00757315|sycosis framboesiformis|sycosis framboesiformis
5635219|NCT00757302|breast cancer|breast cancer
5635220|NCT00757302|CarolIReS|carolires
5635221|NCT00757302|intraoperative gamma camera|intraoperative gamma camera
5635222|NCT00757302|lymphoscintigraphy|lymphoscintigraphy
5635223|NCT00757302|sentinel lymph node|sentinel lymph node
5635224|NCT00757302|Hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.|hundred and ten patients with infiltrative breast cancer or ductal carcinoma in situ (dcis), diagnosed preoperatively by core biopsy or cytology.
5635225|NCT00757289|Tennis Elbow|tennis elbow
5635226|NCT00757276|Copeptin|copeptin
5635228|NCT00757276|diagnostic marker|diagnostic marker
5635229|NCT00757276|Vasopressin|vasopressin
5635230|NCT00757276|antidiuretic hormone (ADH)|antidiuretic hormone (adh)
5635231|NCT00757263|ovarian epithelial cancer|ovarian epithelial cancer
5635232|NCT00757263|ovarian germ cell tumor|ovarian germ cell tumor
5635233|NCT00757263|ovarian sarcoma|ovarian sarcoma
5635234|NCT00757263|ovarian stromal cancer|ovarian stromal cancer
5635235|NCT00757250|HIV|hiv
5635236|NCT00757250|AIDS|aids
5635237|NCT00757250|Human Immunodeficiency Virus|human immunodeficiency virus
5635238|NCT00757250|CD4+ T-lymphocytes|cd4+ t-lymphocytes
5635239|NCT00757250|treatment Experienced|treatment experienced
5635240|NCT00757237|aztreonam lysine|aztreonam lysine
5635241|NCT00757237|tobramycin inhalation solution|tobramycin inhalation solution
5635242|NCT00757237|tobramycin nebuliser solution|tobramycin nebuliser solution
5635243|NCT00757237|cystic fibrosis|cystic fibrosis
5635244|NCT00757237|pseudomonas aeruginosa|pseudomonas aeruginosa
5635245|NCT00757237|lung infection|lung infection
5635246|NCT00757237|CFQ-R|cfq-r
5635247|NCT00757237|inhaled antibiotic|inhaled antibiotic
5635248|NCT00757211|breast cancer|breast cancer
5635249|NCT00757211|male breast cancer|male breast cancer
5635250|NCT00757198|pain, postoperative, opioid, PCA, cardiac surgery|pain, postoperative, opioid, pca, cardiac surgery
5635251|NCT00757185|skin blood flow|skin blood flow
5635252|NCT00757185|microcirculation|microcirculation
5635253|NCT00757172|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5635254|NCT00757172|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5635255|NCT00757172|stage II esophageal cancer|stage ii esophageal cancer
5635256|NCT00757172|stage III esophageal cancer|stage iii esophageal cancer
5635257|NCT00757172|stage IV esophageal cancer|stage iv esophageal cancer
5635258|NCT00757159|Periodontal disease|periodontal disease
5635259|NCT00757159|Hydroxyapatite|hydroxyapatite
5635260|NCT00757159|Enamel matrix protein|enamel matrix protein
5635261|NCT00757159|Regeneration|regeneration
5635262|NCT00757159|Human|human
5635263|NCT00757146|chronic lung disease|chronic lung disease
5635264|NCT00757146|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5635265|NCT00757146|inhaled nitric oxide|inhaled nitric oxide
5635266|NCT00757146|premature infants|premature infants
5635267|NCT00757120|COPD|copd
5617141|NCT00828789|Healthy volunteer|healthy volunteer
5635268|NCT00757120|Cigarette Smoke-Induced Inflammation|cigarette smoke-induced inflammation
5635269|NCT00757120|EMMPRIN|emmprin
5635270|NCT00757120|Matrix Metalloproteinase|matrix metalloproteinase
5635271|NCT00757107|Short femoral stem|short femoral stem
5635272|NCT00757107|Stress shielding|stress shielding
5635273|NCT00757107|Stem migration|stem migration
5635274|NCT00757107|Implant Survival|implant survival
5635275|NCT00757107|DEXA|dexa
5635276|NCT00757107|Radiostereometric analysis|radiostereometric analysis
5635277|NCT00757094|Fasting|fasting
5635278|NCT00757094|Chemotherapy|chemotherapy
5635279|NCT00757094|Cancer|cancer
5635280|NCT00757068|Non-smoking|non-smoking
5635281|NCT00757068|Women|women
5635282|NCT00757068|Pregnancy|pregnancy
5635283|NCT00757068|Treatment|treatment
5635284|NCT00757068|Mood|mood
5635285|NCT00757068|Weight|weight
5635286|NCT00757068|Supportive|supportive
5635287|NCT00757068|Adjustment|adjustment
5635288|NCT00757055|Heart failure|heart failure
5635289|NCT00757055|Diastolic heart failure|diastolic heart failure
5635290|NCT00757055|Heart failure with preserved systolic function|heart failure with preserved systolic function
5635291|NCT00757055|Heart failure with normal ejection fraction|heart failure with normal ejection fraction
5635292|NCT00757055|Ivabradine|ivabradine
5635293|NCT00757055|Diastolic dysfunction|diastolic dysfunction
5635294|NCT00757042|atopic dermatitis|atopic dermatitis
5635295|NCT00757042|skin diseases|skin diseases
5635296|NCT00757042|healthy volunteer|healthy volunteer
5635297|NCT00757029|ADHD,|adhd,
5635298|NCT00757029|norepinephrine transporter|norepinephrine transporter
5635299|NCT00757029|pharmacogenetics|pharmacogenetics
5635300|NCT00757016|low back pain|low back pain
5635301|NCT00757016|randomised controlled trial|randomised controlled trial
5635302|NCT00757016|slow release corticosteroid|slow release corticosteroid
5635303|NCT00757016|injection treatment|injection treatment
5635304|NCT00756977|Colonoscopy|colonoscopy
5635305|NCT00756977|screening|screening
5635306|NCT00756964|cardiac surgery|cardiac surgery
5635307|NCT00756964|hyperuricemia|hyperuricemia
5635308|NCT00756951|SCV-07|scv-07
5635309|NCT00756951|Oral Mucositis|oral mucositis
5635310|NCT00756925|CRH|crh
5635311|NCT00756925|cocaine|cocaine
5635312|NCT00756925|functional magnetic resonance imaging|functional magnetic resonance imaging
5635313|NCT00756925|gender differences|gender differences
5635314|NCT00756912|ANC|anc
5635315|NCT00756912|BMT|bmt
5635316|NCT00756912|graft versus leukemia|graft versus leukemia
5635317|NCT00756912|graft vs. host disease|graft vs. host disease
5635318|NCT00756912|MD2 (endotoxin binding-protein)|md2 (endotoxin binding-protein)
5635319|NCT00756912|undergo allogeneic BMT|undergo allogeneic bmt
5635320|NCT00756912|myeloablative|myeloablative
5635321|NCT00756912|conditioning|conditioning
5635322|NCT00756912|therapy|therapy
5629211|NCT00783068|Endotoxin|endotoxin
5635323|NCT00756899|Vitamin D deficiency, insulin resistance, obesity, bone|vitamin d deficiency, insulin resistance, obesity, bone
5635324|NCT00756873|Elective tonsillectomy|elective tonsillectomy
5635325|NCT00756847|Solid Tumors|solid tumors
5635327|NCT00756847|Ovarian Cancer|ovarian cancer
5635328|NCT00756847|Endometrial Cancer|endometrial cancer
5635329|NCT00756821|Spinal Muscular Atrophy|spinal muscular atrophy
5635330|NCT00756821|Blood Biomarkers|blood biomarkers
5635331|NCT00756821|Urine Biomarkers|urine biomarkers
5635332|NCT00756821|Type I Spinal Muscular Atrophy|type i spinal muscular atrophy
5635333|NCT00756821|Type II Spinal Muscular Atrophy|type ii spinal muscular atrophy
5635334|NCT00756821|Type III Spinal Muscular Atrophy|type iii spinal muscular atrophy
5635335|NCT00756821|Modified Hammersmith Functional Motor Scale|modified hammersmith functional motor scale
5635336|NCT00756821|Disease severity|disease severity
5635337|NCT00756821|Biomarkers|biomarkers
5635338|NCT00756808|latent tuberculosis in elderly|latent tuberculosis in elderly
5635339|NCT00756782|hepatocellular carcinoma|hepatocellular carcinoma
5635341|NCT00756756|Myocardial infarction|myocardial infarction
5635342|NCT00756743|PF-04802540 multiple dose safety study|pf-04802540 multiple dose safety study
5635343|NCT00756730|lopinavir|lopinavir
5635344|NCT00756730|ritonavir|ritonavir
5635345|NCT00756730|atazanavir|atazanavir
5635346|NCT00756730|fosamprenavir|fosamprenavir
5635347|NCT00756730|darunavir|darunavir
5635348|NCT00756730|anti-retroviral|anti-retroviral
5635349|NCT00756730|AIDS|aids
5635350|NCT00756730|HIV|hiv
5635351|NCT00756730|LARD|lard
5635352|NCT00756730|triglyceride|triglyceride
5635353|NCT00756730|protease inhibitors|protease inhibitors
5635354|NCT00756730|treatment Experienced|treatment experienced
5635355|NCT00756717|MK-0752|mk-0752
5635356|NCT00756717|Tamoxifen|tamoxifen
5635357|NCT00756717|Letroxole|letroxole
5635358|NCT00756704|Smoking Cessation|smoking cessation
5635359|NCT00756704|Emergency Medicine|emergency medicine
5635360|NCT00756704|Emergency Nursing|emergency nursing
5635361|NCT00756704|Effectiveness Trial|effectiveness trial
5635362|NCT00756704|Implementation|implementation
5635363|NCT00756704|Relapse prevention|relapse prevention
5635364|NCT00756691|18F-FAZA|18f-faza
5635365|NCT00756691|Positron Emission Tomography|positron emission tomography
5635366|NCT00756691|Radiation dosimetry|radiation dosimetry
5635367|NCT00756691|Pharmacokinetics|pharmacokinetics
5635368|NCT00756665|prostate|prostate
5635369|NCT00756665|cancer|cancer
5680386|NCT00577993|Vincristine|vincristine
5635370|NCT00756639|small cell carcinoma of the bladder|small cell carcinoma of the bladder
5635371|NCT00756639|urothelial carcinoma|urothelial carcinoma
5635372|NCT00756639|genitourinary bladder|genitourinary bladder
5635373|NCT00756639|urothelium|urothelium
5635374|NCT00756639|bladder|bladder
5635375|NCT00756639|bladder cancer|bladder cancer
5635376|NCT00756639|prophylactic cranial irradiation|prophylactic cranial irradiation
5635377|NCT00756639|PCI|pci
5635378|NCT00756639|brain metastasis|brain metastasis
5635379|NCT00756639|genitourinary|genitourinary
5635380|NCT00756639|radiation|radiation
5635381|NCT00756639|TCC|tcc
5635382|NCT00756639|adenocarcinoma|adenocarcinoma
5635384|NCT00756626|Bottle Feeding|bottle feeding
5635385|NCT00756626|Overweight in toddlers|overweight in toddlers
5635386|NCT00756626|Bottle use|bottle use
5635387|NCT00756626|excess weight for length|excess weight for length
5635388|NCT00756600|Infants|infants
5635389|NCT00756600|scheduled|scheduled
5635390|NCT00756600|unilateral|unilateral
5635391|NCT00756600|bilateral|bilateral
5635392|NCT00756600|repair|repair
5635393|NCT00756587|Cup Feeding|cup feeding
5635394|NCT00756587|late Preterm|late preterm
5635395|NCT00756574|N95|n95
5635396|NCT00756574|Respirator|respirator
5635397|NCT00756574|mask|mask
5635398|NCT00756574|influenza|influenza
5635399|NCT00756574|efficacy|efficacy
5635400|NCT00756561|Fine Needle Aspiration|fine needle aspiration
5635401|NCT00756561|Male Health|male health
5635402|NCT00756561|Male Contraception|male contraception
5635403|NCT00756548|colonoscopy|colonoscopy
5635404|NCT00756548|screening|screening
5635405|NCT00756535|Exercise Therapy|exercise therapy
5635406|NCT00756535|Length of Stay|length of stay
5635407|NCT00756535|Disability Evaluation|disability evaluation
5635409|NCT00756509|unresectable or metastatic GIST|unresectable or metastatic gist
5635410|NCT00756509|1st. line treatment|1st. line treatment
5635411|NCT00756483|Resistance|resistance
5635412|NCT00756483|Exercise|exercise
5635413|NCT00756470|Breast Cancer|breast cancer
5635414|NCT00756470|Inflammatory Breast Cancer|inflammatory breast cancer
5635415|NCT00756470|IBC|ibc
5635416|NCT00756470|ErbB2 overexpression|erbb2 overexpression
5635417|NCT00756470|Lapatinib|lapatinib
5635418|NCT00756470|Paclitaxel|paclitaxel
5635419|NCT00756470|5-Fluorouracil|5-fluorouracil
5635420|NCT00756470|Epirubicin|epirubicin
5635421|NCT00756470|Cyclophosphamide|cyclophosphamide
5635422|NCT00756470|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5635423|NCT00756457|PTTD|pttd
5635424|NCT00756457|Tendinopathy|tendinopathy
5635425|NCT00756457|Tendon Injuries|tendon injuries
5635426|NCT00756457|Muscular Diseases|muscular diseases
5635427|NCT00756457|Foot Diseases|foot diseases
5635428|NCT00756444|PK Study, Metastatic Recurrent|pk study, metastatic recurrent
5635429|NCT00756405|Adults|adults
5635869|NCT00755027|Apathy|apathy
5635430|NCT00756405|Antioxidants|antioxidants
5635431|NCT00756405|Inflammatory markers|inflammatory markers
5635432|NCT00756405|Diet|diet
5635433|NCT00756405|Supplements|supplements
5635434|NCT00756392|3T MR Spectroscopy|3t mr spectroscopy
5635435|NCT00756392|Prostate Imaging|prostate imaging
5635436|NCT00756379|Cardiovascular disease|cardiovascular disease
5635437|NCT00756379|Atherosclerosis|atherosclerosis
5635438|NCT00756379|Coronary artery disease|coronary artery disease
5635439|NCT00756379|Coronary perfusion defect|coronary perfusion defect
5635440|NCT00756379|Absolute coronary flow|absolute coronary flow
5635441|NCT00756379|Lifestyle management|lifestyle management
5635442|NCT00756379|Cardiovascular rehabilitation|cardiovascular rehabilitation
5635443|NCT00756379|Cardiovascular dietary guidelines|cardiovascular dietary guidelines
5635444|NCT00756366|positron emission tomography|positron emission tomography
5635445|NCT00756366|myocardial energetics|myocardial energetics
5635446|NCT00756366|sympathetic nerve function|sympathetic nerve function
5635447|NCT00756353|Heroin|heroin
5635448|NCT00756353|Buprenorphine use|buprenorphine use
5635449|NCT00756327|pediatric eyes|pediatric eyes
5635450|NCT00756327|bilateral cataract|bilateral cataract
5635451|NCT00756327|IOL implantation|iol implantation
5635452|NCT00756327|Aqualase capsule wash|aqualase capsule wash
5635453|NCT00756327|posterior capsule opacification|posterior capsule opacification
5635454|NCT00756314|Ambulatory Care Facilities|ambulatory care facilities
5635455|NCT00756314|abortion care|abortion care
5635456|NCT00756314|contraception|contraception
5635457|NCT00756314|counseling|counseling
5635458|NCT00756314|outpatient clinic|outpatient clinic
5635459|NCT00756288|Actinic Keratoses|actinic keratoses
5635460|NCT00756288|Blue light therapy|blue light therapy
5635461|NCT00756288|photosensitizer|photosensitizer
5635462|NCT00756288|Retinoid|retinoid
5635463|NCT00756275|Tobacco Smoking|tobacco smoking
5635464|NCT00756275|Smoking Cessation|smoking cessation
5635465|NCT00756275|Nicotine Dependence|nicotine dependence
5617285|NCT00828451|newborn|newborn
5635466|NCT00756275|Tobacco Use Disorder|tobacco use disorder
5635467|NCT00756262|Vancomycin Resistant enterococcal colonization|vancomycin resistant enterococcal colonization
5635468|NCT00756262|Probiotics|probiotics
5635469|NCT00756262|LGG|lgg
5635470|NCT00756262|Lactobacillus rhamnosus|lactobacillus rhamnosus
5680387|NCT00577993|Bleomycin|bleomycin
5635471|NCT00756249|Acute ischemic stroke|acute ischemic stroke
5635472|NCT00756249|Erythropoietin|erythropoietin
5635473|NCT00756249|Carbamylated|carbamylated
5635474|NCT00756249|Neuroprotection|neuroprotection
5635475|NCT00756197|Radiation Proctitis|radiation proctitis
5635476|NCT00756197|Radiation Induced Proctitis|radiation induced proctitis
5635477|NCT00756184|Glaucoma|glaucoma
5635478|NCT00756184|Adherence|adherence
5635479|NCT00756184|Teaching|teaching
5635480|NCT00756171|Cholestatic|cholestatic
5635481|NCT00756171|pruritus|pruritus
5635482|NCT00756171|of any cause|of any cause
5635483|NCT00756158|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5635484|NCT00756158|dopaminergic|dopaminergic
5635485|NCT00756158|noradrenergic|noradrenergic
5635486|NCT00756158|endophenotype|endophenotype
5635487|NCT00756158|molecular genetics|molecular genetics
5635488|NCT00756158|candidate gene|candidate gene
5635489|NCT00756158|Family-based Association study|family-based association study
5635490|NCT00756145|stage V|stage v
5635491|NCT00756145|treated|treated
5635492|NCT00756145|hemodiafiltration|hemodiafiltration
5635493|NCT00756132|Breast|breast
5635494|NCT00756132|Neoplasm|neoplasm
5635495|NCT00756132|Locally Advanced|locally advanced
5635496|NCT00756132|Stage IV|stage iv
5635497|NCT00756132|Stage III|stage iii
5635498|NCT00756132|Cognitive Function|cognitive function
5635499|NCT00756132|Cytokines|cytokines
5635500|NCT00756132|Inflammatory|inflammatory
5635501|NCT00756132|Node positive|node positive
5635502|NCT00756106|adult glioblastoma|adult glioblastoma
5635503|NCT00756106|adult giant cell glioblastoma|adult giant cell glioblastoma
5635504|NCT00756106|adult gliosarcoma|adult gliosarcoma
5635505|NCT00756106|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5635506|NCT00756106|adult anaplastic ependymoma|adult anaplastic ependymoma
5635507|NCT00756106|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5635508|NCT00756106|adult mixed glioma|adult mixed glioma
5635509|NCT00756093|Dry Eye, Artificial Tears,|dry eye, artificial tears,
5635510|NCT00756067|Streptococcus pneumoniae|streptococcus pneumoniae
5635511|NCT00756067|pneumococcal vaccine|pneumococcal vaccine
5635512|NCT00756041|Diabetic Mononeuropathy|diabetic mononeuropathy
5635513|NCT00756041|Diabetic Neuralgia|diabetic neuralgia
5635514|NCT00756041|Mononeuropathy, Diabetic|mononeuropathy, diabetic
5635515|NCT00756041|Neuralgia, Diabetic|neuralgia, diabetic
5635516|NCT00756041|Diabetic Polyneuropathy|diabetic polyneuropathy
5635517|NCT00756041|Drug Therapy|drug therapy
5635518|NCT00756028|OHSS|ohss
5635519|NCT00756028|quality of life|quality of life
5635520|NCT00756028|IVF|ivf
5635521|NCT00756028|ICSI|icsi
5635522|NCT00756028|GnRH-agonist|gnrh-agonist
5635523|NCT00756028|GnRH-antagonist|gnrh-antagonist
5635524|NCT00756015|rotator cuff|rotator cuff
5635525|NCT00756015|post-operative immobilization protocol|post-operative immobilization protocol
5635526|NCT00756015|post-operative early motion protocol|post-operative early motion protocol
5635527|NCT00756015|physical therapy|physical therapy
5635528|NCT00756015|cuff repair integrity|cuff repair integrity
5635530|NCT00756002|Chronic Insomnia|chronic insomnia
5635531|NCT00756002|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5635532|NCT00756002|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5635533|NCT00756002|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5635534|NCT00756002|Transient Insomnia|transient insomnia
5635535|NCT00756002|Drug Therapy|drug therapy
5635536|NCT00756002|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5635537|NCT00755976|stage IV melanoma|stage iv melanoma
5635539|NCT00755950|Hepatitis|hepatitis
5635540|NCT00755950|Silymarin|silymarin
5635541|NCT00755950|Global Health|global health
5635542|NCT00755911|dental|dental
5635543|NCT00755911|tooth|tooth
5635544|NCT00755911|implant|implant
5635545|NCT00755911|extraction|extraction
5635546|NCT00755911|Oral|oral
5635547|NCT00755911|Surgical|surgical
5635549|NCT00755898|cancer|cancer
5635550|NCT00755898|diagnostic test|diagnostic test
5635551|NCT00755898|urine|urine
5635552|NCT00755898|amantadine acetylation|amantadine acetylation
5635553|NCT00755885|stage IIIA breast cancer|stage iiia breast cancer
5635554|NCT00755885|stage IIIB breast cancer|stage iiib breast cancer
5635555|NCT00755885|stage IIIC breast cancer|stage iiic breast cancer
5635556|NCT00755885|stage IV breast cancer|stage iv breast cancer
5635557|NCT00755885|recurrent breast cancer|recurrent breast cancer
5635558|NCT00755885|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5635559|NCT00755885|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5635560|NCT00755859|IgA nephropathy|iga nephropathy
5635561|NCT00755859|steroids|steroids
5635562|NCT00755859|azathioprine|azathioprine
5635563|NCT00755859|chronic kidney disease progression|chronic kidney disease progression
5635564|NCT00755859|proteinuria|proteinuria
5635565|NCT00755846|Diabetes Mellitus|diabetes mellitus
5635566|NCT00755846|Drug Therapy|drug therapy
5635567|NCT00755846|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5635568|NCT00755846|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5635569|NCT00755846|Hyperinsulinism|hyperinsulinism
5635570|NCT00755846|Insulin Resistance|insulin resistance
5635571|NCT00755807|Central Neuropathic Pain|central neuropathic pain
5635572|NCT00755807|Multiple Sclerosis|multiple sclerosis
5635573|NCT00755781|lung transplant|lung transplant
5635574|NCT00755781|lung transplant recipient|lung transplant recipient
5635575|NCT00755781|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5635576|NCT00755781|bronchiolitis obliterans|bronchiolitis obliterans
5635577|NCT00755781|single lung transplant|single lung transplant
5635578|NCT00755781|double lung transplant|double lung transplant
5635579|NCT00755781|heart-lung transplant|heart-lung transplant
5635580|NCT00755781|Aerosol|aerosol
5635581|NCT00755768|hemodialysis|hemodialysis
5635582|NCT00755768|phosphate|phosphate
5635583|NCT00755768|calcium phosphate product|calcium phosphate product
5635584|NCT00755768|dietician|dietician
5635585|NCT00755768|dietetic advice|dietetic advice
5635586|NCT00755742|obesity|obesity
5635587|NCT00755742|insulin resistance|insulin resistance
5635588|NCT00755742|metabolic syndrome|metabolic syndrome
5635589|NCT00755742|hepatitis C|hepatitis c
5635590|NCT00755742|adipokine|adipokine
5635592|NCT00755742|leptin|leptin
5635593|NCT00755742|adiponectin|adiponectin
5635594|NCT00755742|fatigue|fatigue
5635595|NCT00755742|mood|mood
5635596|NCT00755742|depression|depression
5635597|NCT00755742|exercise|exercise
5635598|NCT00755742|diet|diet
5635599|NCT00755742|counseling|counseling
5635600|NCT00755742|behavior modification|behavior modification
5635601|NCT00755729|Preoperative oral carbohydrate|preoperative oral carbohydrate
5635602|NCT00755729|Insulin resistance|insulin resistance
5635603|NCT00755729|phosphatidylinositol-3-kinase|phosphatidylinositol-3-kinase
5635604|NCT00755716|nicotine patch|nicotine patch
5635605|NCT00755716|smoking|smoking
5635606|NCT00755716|topiramate|topiramate
5635607|NCT00755703|Influenza|influenza
5635608|NCT00755703|Vaccine|vaccine
5635609|NCT00755703|Pandemic|pandemic
5635610|NCT00755703|Avian influenza|avian influenza
5635611|NCT00755703|Adenovirus strain 5|adenovirus strain 5
5635612|NCT00755703|Vectored vaccine|vectored vaccine
5635613|NCT00755703|Intranasal|intranasal
5635614|NCT00755703|Tissue-culture derived|tissue-culture derived
5635615|NCT00755703|Non-replicating|non-replicating
5635616|NCT00755690|Chronic Kidney Disease|chronic kidney disease
5635617|NCT00755690|CKD|ckd
5635618|NCT00755690|Diet|diet
5635619|NCT00755690|Dietary Phosphate|dietary phosphate
5635620|NCT00755690|Mineral Metabolism|mineral metabolism
5635621|NCT00755690|FGF-23|fgf-23
5635622|NCT00755664|homocysteine|homocysteine
5635623|NCT00755664|folate acid,|folate acid,
5635624|NCT00755664|vitamin B|vitamin b
5635625|NCT00755664|random controlled trail|random controlled trail
5635626|NCT00755651|Menorrhagia|menorrhagia
5635627|NCT00755651|Uterine fibroids|uterine fibroids
5635628|NCT00755651|Endometrial polyps|endometrial polyps
5635629|NCT00755651|Endometrial cancer|endometrial cancer
5635630|NCT00755599|Papanicolaou Smear|papanicolaou smear
5635631|NCT00755599|Vaginitis|vaginitis
5635632|NCT00755599|Patient Satisfaction|patient satisfaction
5635633|NCT00755586|Brachial plexus|brachial plexus
5635634|NCT00755586|Muscle denervation|muscle denervation
5635635|NCT00755586|Stem cell transplantation|stem cell transplantation
5635636|NCT00755586|Bone marrow cells|bone marrow cells
5635637|NCT00755586|Satellite cells|satellite cells
5635638|NCT00755586|Fibrosis|fibrosis
5635640|NCT00755573|Neuropathic pain|neuropathic pain
5635641|NCT00755560|Toxocara|toxocara
5635643|NCT00755560|Albendazole|albendazole
5635644|NCT00755560|eosinophilia|eosinophilia
5635645|NCT00755560|parasitology|parasitology
5635646|NCT00755560|pediatric clinical pharmacology|pediatric clinical pharmacology
5635647|NCT00755547|Childhood|childhood
5635648|NCT00755547|insulin sensitivity|insulin sensitivity
5635649|NCT00755547|steatosis, spectroscopy|steatosis, spectroscopy
5635650|NCT00755534|Metastatic colorectal cancer|metastatic colorectal cancer
5635651|NCT00755534|Second line|second line
5635652|NCT00755534|Irinotecan|irinotecan
5635653|NCT00755534|Cetuximab (Erbitux)|cetuximab (erbitux)
5635654|NCT00755534|Capecitabine (Xeloda)|capecitabine (xeloda)
5635655|NCT00755521|Fibromyalgia|fibromyalgia
5635656|NCT00755521|tenderness|tenderness
5635657|NCT00755521|widespread pain|widespread pain
5635658|NCT00755521|comrbidity|comrbidity
5635659|NCT00755508|Chronic Insomnia|chronic insomnia
5635660|NCT00755508|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5635661|NCT00755508|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5635662|NCT00755508|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5635663|NCT00755508|Transient Insomnia|transient insomnia
5635664|NCT00755508|Drug Therapy|drug therapy
5635665|NCT00755508|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5635666|NCT00755495|Chronic Insomnia|chronic insomnia
5635667|NCT00755495|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5635668|NCT00755495|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5635669|NCT00755495|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5635670|NCT00755495|Transient Insomnia|transient insomnia
5635671|NCT00755495|Drug Therapy|drug therapy
5635672|NCT00755495|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5635673|NCT00755482|Osteoarthritis|osteoarthritis
5635674|NCT00755482|Clinical trial|clinical trial
5635675|NCT00755482|Aquamin F|aquamin f
5635676|NCT00755482|NSAID|nsaid
5635677|NCT00755469|Reperfusion injury|reperfusion injury
5635678|NCT00755469|Post-Conditioning|post-conditioning
5635679|NCT00755469|Infarct size|infarct size
5635680|NCT00755456|Peritoneal dialysis|peritoneal dialysis
5635681|NCT00755456|L-carnitine|l-carnitine
5635682|NCT00755456|Insulin resistance|insulin resistance
5635683|NCT00755456|Glucose homeostasis|glucose homeostasis
5635684|NCT00755456|Dyslipidemia|dyslipidemia
5635685|NCT00755430|autism spectrum disorders (ASD)|autism spectrum disorders (asd)
5635686|NCT00755430|structural and functional connectivity|structural and functional connectivity
5635687|NCT00755430|diffusion spectrum imaging (DSI)|diffusion spectrum imaging (dsi)
5635688|NCT00755430|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5635689|NCT00755430|siblings|siblings
5635690|NCT00755430|repeated follow-up measurement|repeated follow-up measurement
5635691|NCT00755417|Hot flashes|hot flashes
5635692|NCT00755417|Hot flushes|hot flushes
5635693|NCT00755417|Postmenopausal symptoms|postmenopausal symptoms
5635694|NCT00755417|Vasomotor symptoms|vasomotor symptoms
5635695|NCT00755404|Peritoneal dialysis|peritoneal dialysis
5635696|NCT00755404|L-carnitine|l-carnitine
5635697|NCT00755404|Diabetes|diabetes
5635698|NCT00755404|Glucose homeostasis|glucose homeostasis
5635699|NCT00755404|Dyslipidemia|dyslipidemia
5635700|NCT00755391|BN and subthreshold BN|bn and subthreshold bn
5635701|NCT00755378|Phase I|phase i
5635702|NCT00755365|pelvic fractures|pelvic fractures
5635703|NCT00755365|angioembolism|angioembolism
5635704|NCT00755365|Treatment at Hershey Medical Center|treatment at hershey medical center
5635705|NCT00755365|Angioembolization in Operating Room|angioembolization in operating room
5635706|NCT00755339|Repetitive TMS (rTMS)|repetitive tms (rtms)
5635707|NCT00755339|Magnetoencephalogram|magnetoencephalogram
5635708|NCT00755339|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5635709|NCT00755339|Tourette Syndrome|tourette syndrome
5635710|NCT00755339|Tic Disorder|tic disorder
5635711|NCT00755339|Tourete Syndrome|tourete syndrome
5635712|NCT00755326|OA|oa
5635713|NCT00755313|cognitive/functional effects|cognitive/functional effects
5635714|NCT00755313|fatigue|fatigue
5635715|NCT00755313|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5635716|NCT00755313|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5635717|NCT00755313|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5635718|NCT00755313|neurotoxicity|neurotoxicity
5635719|NCT00755313|stage IA breast cancer|stage ia breast cancer
5635720|NCT00755313|stage IB breast cancer|stage ib breast cancer
5635721|NCT00755313|stage II breast cancer|stage ii breast cancer
5635722|NCT00755313|stage IIIA breast cancer|stage iiia breast cancer
5635723|NCT00755313|stage IIIB breast cancer|stage iiib breast cancer
5635724|NCT00755313|stage IIIC breast cancer|stage iiic breast cancer
5635725|NCT00755313|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5635726|NCT00755313|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5635727|NCT00755313|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5635728|NCT00755313|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5635729|NCT00755300|Total knee replacement|total knee replacement
5635730|NCT00755300|esophageal echocardiography|esophageal echocardiography
5635731|NCT00755274|Influenza|influenza
5635732|NCT00755274|Orthomyxoviruses|orthomyxoviruses
5635733|NCT00755274|Orthomyxoviridae Infections|orthomyxoviridae infections
5635734|NCT00755274|Influenza vaccine|influenza vaccine
5635735|NCT00755261|STS|sts
5635736|NCT00755248|Coronary Artery Bypass Grafting (CABG)|coronary artery bypass grafting (cabg)
5635738|NCT00755248|saphenous graft patency|saphenous graft patency
5635739|NCT00755248|biochemical factors|biochemical factors
5635740|NCT00755248|genomics|genomics
5635741|NCT00755235|Depression|depression
5635742|NCT00755235|Primary care|primary care
5635743|NCT00755235|Effectiveness|effectiveness
5635744|NCT00755235|Care management|care management
5635745|NCT00755222|Peyronie's disease|peyronie's disease
5635746|NCT00755222|penile plaque|penile plaque
5635747|NCT00755222|penile curvature|penile curvature
5635748|NCT00755209|Traumatic brain injury (TBI)|traumatic brain injury (tbi)
5635749|NCT00755209|Adults|adults
5635750|NCT00755209|Moderately severe TBI|moderately severe tbi
5617568|NCT00827242|BPH-LUTS|bph-luts
5635751|NCT00755209|Delayed traumatic intracranial haemorrhage|delayed traumatic intracranial haemorrhage
5635752|NCT00755209|Expanding traumatic intracranial haemorrhage|expanding traumatic intracranial haemorrhage
5635753|NCT00755209|Progressive intracranial haemorrhage (PIH)|progressive intracranial haemorrhage (pih)
5635754|NCT00755209|Antifibrinolytic agent|antifibrinolytic agent
5635755|NCT00755209|Tranexamic acid (TXA)|tranexamic acid (txa)
5635756|NCT00755209|Randomised, placebo-controlled trial|randomised, placebo-controlled trial
5635757|NCT00755209|Human|human
5635758|NCT00755196|Plaque Type Psoriasis|plaque type psoriasis
5635759|NCT00755196|Topical|topical
5635760|NCT00755183|Meibomian Gland Dysfunction|meibomian gland dysfunction
5635761|NCT00755183|Dry Eye Syndrome|dry eye syndrome
5635762|NCT00755170|Vinorelbine|vinorelbine
5635763|NCT00755170|Bevacizumab|bevacizumab
5635764|NCT00755170|Chemotherapy|chemotherapy
5635765|NCT00755157|Cancer|cancer
5635766|NCT00755157|SCLC|sclc
5635767|NCT00755157|Docetaxel|docetaxel
5635768|NCT00755157|Bevacizumab|bevacizumab
5635769|NCT00755157|Chemotherapy|chemotherapy
5635770|NCT00755131|Cardiac Rehabilitation|cardiac rehabilitation
5635771|NCT00755131|High Mobility Group Box proteins|high mobility group box proteins
5635772|NCT00755131|Inflammatory markers|inflammatory markers
5635773|NCT00755131|Cardiopulmonary Functional Capacity|cardiopulmonary functional capacity
5635774|NCT00755131|Maximal Oxygen Consumption|maximal oxygen consumption
5635775|NCT00755131|Echocardiography|echocardiography
5635776|NCT00755131|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5635777|NCT00755131|Left Ventricular Chambers Dilation|left ventricular chambers dilation
5635778|NCT00755131|Left Ventricular Remodeling|left ventricular remodeling
5635779|NCT00755131|Left Atrium Remodeling|left atrium remodeling
5635780|NCT00755131|Cardiac Remodeling|cardiac remodeling
5635781|NCT00755131|Exercise Training|exercise training
5635782|NCT00755118|Metastatic colorectal cancer|metastatic colorectal cancer
5635783|NCT00755118|Second line|second line
5635784|NCT00755118|Irinotecan|irinotecan
5635785|NCT00755118|Cetuximab|cetuximab
5635786|NCT00755118|Bevacizumab|bevacizumab
5635787|NCT00755105|body iron excretion|body iron excretion
5635788|NCT00755105|Iron isotopes|iron isotopes
5635789|NCT00755092|Doula|doula
5635790|NCT00755092|Psychological care|psychological care
5635791|NCT00755092|Labor analgesia|labor analgesia
5635792|NCT00755079|spinal cord injury|spinal cord injury
5635793|NCT00755079|beta-2 agonist|beta-2 agonist
5635794|NCT00755079|respiratory muscle strength|respiratory muscle strength
5635795|NCT00755079|pulmonary function test|pulmonary function test
5635796|NCT00755053|Clotrimazole|clotrimazole
5635797|NCT00755053|Ovule|ovule
5635798|NCT00755053|Tablet|tablet
5635799|NCT00755053|Vulvovaginal candidiasis|vulvovaginal candidiasis
5635800|NCT00755053|Non-inferiority|non-inferiority
5635801|NCT00755040|graft versus host disease|graft versus host disease
5635802|NCT00755040|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5635803|NCT00755040|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5635804|NCT00755040|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5863029|NCT00001413|Energy Absorptiometry|energy absorptiometry
5635805|NCT00755040|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5635806|NCT00755040|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5635870|NCT00755027|Rasagiline|rasagiline
5635807|NCT00755040|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5635808|NCT00755040|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5635809|NCT00755040|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5635810|NCT00755040|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5635811|NCT00755040|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5635812|NCT00755040|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5635813|NCT00755040|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5635814|NCT00755040|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5635815|NCT00755040|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5635816|NCT00755040|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5635817|NCT00755040|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5635818|NCT00755040|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5635819|NCT00755040|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5638283|NCT00746174|content|content
5635820|NCT00755040|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5635821|NCT00755040|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5635822|NCT00755040|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5635823|NCT00755040|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5635824|NCT00755040|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5635825|NCT00755040|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5635826|NCT00755040|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5635827|NCT00755040|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5635828|NCT00755040|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5635829|NCT00755040|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5635830|NCT00755040|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5635831|NCT00755040|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5635832|NCT00755040|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5680388|NCT00577993|Cyclophosphamide|cyclophosphamide
5680389|NCT00577993|Etoposide|etoposide
5635833|NCT00755040|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5685475|NCT00555945|Gamma3 intramedullary nail|gamma3 intramedullary nail
5635834|NCT00755040|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5635835|NCT00755040|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5635836|NCT00755040|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5635837|NCT00755040|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5635838|NCT00755040|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5635839|NCT00755040|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5635840|NCT00755040|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5635841|NCT00755040|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5635842|NCT00755040|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5635843|NCT00755040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5635844|NCT00755040|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5635845|NCT00755040|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5635846|NCT00755040|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5635847|NCT00755040|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5635848|NCT00755040|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5635849|NCT00755040|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5635850|NCT00755040|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5635851|NCT00755040|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5635852|NCT00755040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5635853|NCT00755040|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5635854|NCT00755040|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5635855|NCT00755040|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5635856|NCT00755040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5635857|NCT00755040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5635858|NCT00755040|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5635860|NCT00755040|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5635861|NCT00755040|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5635862|NCT00755040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5635863|NCT00755040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5635864|NCT00755040|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5635865|NCT00755040|stage I multiple myeloma|stage i multiple myeloma
5635866|NCT00755040|stage II multiple myeloma|stage ii multiple myeloma
5635867|NCT00755040|stage III multiple myeloma|stage iii multiple myeloma
5635868|NCT00755027|Parkinson's disease|parkinson's disease
5635871|NCT00755001|Total Hip Replacement|total hip replacement
5635872|NCT00754949|Blepharoconjunctivitis,|blepharoconjunctivitis,
5635873|NCT00754949|Ophthalmology|ophthalmology
5635874|NCT00754936|Depression|depression
5635875|NCT00754923|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5635876|NCT00754923|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5635877|NCT00754923|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5635878|NCT00754923|adenocarcinoma of the lung|adenocarcinoma of the lung
5635879|NCT00754923|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5635880|NCT00754923|large cell lung cancer|large cell lung cancer
5635881|NCT00754910|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5635882|NCT00754910|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5635883|NCT00754910|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5638441|NCT00745511|AMD|amd
5635884|NCT00754910|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5635885|NCT00754910|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5635886|NCT00754910|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5635887|NCT00754897|Phone Interview|phone interview
5635888|NCT00754897|Anesthesia|anesthesia
5635889|NCT00754897|Siblings|siblings
5635890|NCT00754897|Inguinal Hernia|inguinal hernia
5635891|NCT00754897|Neurologic Examination|neurologic examination
5635892|NCT00754897|Developmental Delay Disorders|developmental delay disorders
5635893|NCT00754884|salmon calcitonin|salmon calcitonin
5635894|NCT00754884|endorphins|endorphins
5635895|NCT00754884|treatment|treatment
5635896|NCT00754884|fibromyalgia|fibromyalgia
5635897|NCT00754858|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5635898|NCT00754845|stage I breast cancer|stage i breast cancer
5635899|NCT00754845|stage II breast cancer|stage ii breast cancer
5635900|NCT00754845|stage IIIA breast cancer|stage iiia breast cancer
5635901|NCT00754845|stage IIIB breast cancer|stage iiib breast cancer
5635902|NCT00754845|stage IIIC breast cancer|stage iiic breast cancer
5635903|NCT00754832|Multiple sclerosis|multiple sclerosis
5635904|NCT00754832|fatigue|fatigue
5635905|NCT00754832|ginseng|ginseng
5635906|NCT00754806|HALS|hals
5635907|NCT00754806|open splenectomy|open splenectomy
5635908|NCT00754806|splenomegaly|splenomegaly
5635909|NCT00754806|HALS as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery|hals as a hybrid approach of pure laparoscopy and open surgery has some definite advantages over open surgery
5635910|NCT00754806|In the HALS group, incision length is significantly shorter|in the hals group, incision length is significantly shorter
5635911|NCT00754806|In the HALS group, postoperative pain is less than with open surgery|in the hals group, postoperative pain is less than with open surgery
5635912|NCT00754806|In the HALS group, postoperative hospital stay is shorter than with open surgery|in the hals group, postoperative hospital stay is shorter than with open surgery
5635913|NCT00754780|NF1|nf1
5635914|NCT00754780|plexiform neurofibroma|plexiform neurofibroma
5635915|NCT00754767|neurotoxicity|neurotoxicity
5635916|NCT00754767|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5635917|NCT00754767|stage IV breast cancer|stage iv breast cancer
5635918|NCT00754767|recurrent breast cancer|recurrent breast cancer
5635919|NCT00754754|brain|brain
5635920|NCT00754754|surgery|surgery
5635921|NCT00754754|retraction|retraction
5635922|NCT00754754|injury|injury
5635923|NCT00754754|monitoring|monitoring
5635924|NCT00754741|medication adherence|medication adherence
5635925|NCT00754741|motivational interviewing|motivational interviewing
5635926|NCT00754715|Multiple dosing study,|multiple dosing study,
5635927|NCT00754715|safety|safety
5635928|NCT00754702|Vinorelbine metronomic-lapatinib|vinorelbine metronomic-lapatinib
5635929|NCT00754702|Chemotherapy|chemotherapy
5635930|NCT00754702|Targeted therapy|targeted therapy
5635931|NCT00754689|Rimonabant/metformin combination|rimonabant/metformin combination
5635932|NCT00754663|exercise|exercise
5635933|NCT00754663|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5635934|NCT00754663|arrhythmia|arrhythmia
5635935|NCT00754637|Joint|joint
5635936|NCT00754637|Osteoarthritis|osteoarthritis
5635937|NCT00754637|Avascular Necrosis|avascular necrosis
5635938|NCT00754546|exercise;|exercise;
5635939|NCT00754546|treadmill;|treadmill;
5635940|NCT00754546|cycle ergometer;|cycle ergometer;
5635941|NCT00754546|breathlessness;|breathlessness;
5635942|NCT00754546|leg discomfort|leg discomfort
5635943|NCT00754533|cardiac rehabilitation|cardiac rehabilitation
5635944|NCT00754533|coronary heart disease|coronary heart disease
5635945|NCT00754533|interval training|interval training
5635946|NCT00754533|continuous training|continuous training
5635947|NCT00754533|ventilatory threshold|ventilatory threshold
5635948|NCT00754481|Paediatrics|paediatrics
5635949|NCT00754468|Barrett's Esophagus|barrett's esophagus
5635950|NCT00754468|Esophageal Cancer|esophageal cancer
5635951|NCT00754468|Esophageal Dysplasia|esophageal dysplasia
5635952|NCT00754468|Low Grade Dysplasia|low grade dysplasia
5635953|NCT00754468|High Grade Dysplasia|high grade dysplasia
5635954|NCT00754442|hyperparathyroidism|hyperparathyroidism
5635955|NCT00754442|parathyroid|parathyroid
5635956|NCT00754442|vitamin D|vitamin d
5635957|NCT00754442|vitamin D deficiency|vitamin d deficiency
5635958|NCT00754416|Shoulder Replacement|shoulder replacement
5635959|NCT00754403|Glucose Metabolism Disorder|glucose metabolism disorder
5635960|NCT00754403|Dysmetabolic Syndrome|dysmetabolic syndrome
5635961|NCT00754403|Type II Diabetes|type ii diabetes
5635962|NCT00754403|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5635963|NCT00754403|Dyslipidemia|dyslipidemia
5635964|NCT00754403|Drug Therapy|drug therapy
5635965|NCT00754390|dietary zinc absorption|dietary zinc absorption
5635966|NCT00754390|dietary phytic acid|dietary phytic acid
5635967|NCT00754390|dietary calcium|dietary calcium
5635968|NCT00754377|Education|education
5635969|NCT00754377|Program Evaluation|program evaluation
5635970|NCT00754377|Quality of Health Care|quality of health care
5635971|NCT00754377|Medical Residents|medical residents
5635972|NCT00754351|docetaxel|docetaxel
5635973|NCT00754351|gemcitabine|gemcitabine
5635974|NCT00754351|bevacizumab|bevacizumab
5635981|NCT00754299|nonunion/malunion osseous fractures|nonunion/malunion osseous fractures
5635982|NCT00754299|nicotine dependent|nicotine dependent
5635983|NCT00754299|chronic osseous infection|chronic osseous infection
5635984|NCT00754299|infected osseous nonunions|infected osseous nonunions
5635985|NCT00754299|Fracture nonunion or infection|fracture nonunion or infection
5635986|NCT00754286|Aromatherapy|aromatherapy
5635987|NCT00754247|Keloid|keloid
5635988|NCT00754247|Hypertrophic scar|hypertrophic scar
5635989|NCT00754247|Hydrocortisone, silicone, vitamin E lotion|hydrocortisone, silicone, vitamin e lotion
5617840|NCT00826254|vitamin K|vitamin k
5635991|NCT00754247|Onion extract gel|onion extract gel
5635992|NCT00754247|OE|oe
5635993|NCT00754247|Cetearyl alcohol lotion|cetearyl alcohol lotion
5635994|NCT00754247|CEA|cea
5635995|NCT00754234|iron absorption|iron absorption
5635996|NCT00754234|iron requirements|iron requirements
5635997|NCT00754234|dietary guidelines|dietary guidelines
5635998|NCT00754234|MyPyramid|mypyramid
5635999|NCT00754221|Phase 3, safety study, [S,S]-Reboxetine, Fibromyalgia|phase 3, safety study, [s,s]-reboxetine, fibromyalgia
5636000|NCT00754208|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5636001|NCT00754208|Stimulant Treatment|stimulant treatment
5636002|NCT00754208|Young Children|young children
5636003|NCT00754195|Thoracotomy|thoracotomy
5636004|NCT00754182|thyroidectomy|thyroidectomy
5636005|NCT00754182|surgery|surgery
5636006|NCT00754182|synthetic glue|synthetic glue
5636007|NCT00754182|subcuticular suture|subcuticular suture
5636008|NCT00754169|Traumatic Brain Injury|traumatic brain injury
5636009|NCT00754169|Brain Imaging|brain imaging
5636010|NCT00754169|Brain Plasticity|brain plasticity
5636011|NCT00754169|Neuroplasticity|neuroplasticity
5636012|NCT00754169|Neuropsychological Testing|neuropsychological testing
5636013|NCT00754169|Head Injury|head injury
5636014|NCT00754169|Healthy Volunteer|healthy volunteer
5636015|NCT00754156|Closure, Wounds|closure, wounds
5636016|NCT00754143|Type 1 or Type 2 diabetes|type 1 or type 2 diabetes
5636017|NCT00754143|proteinuria|proteinuria
5636018|NCT00754117|diffuse large b cell lymphoma|diffuse large b cell lymphoma
5636019|NCT00754117|newly diagnosed|newly diagnosed
5636020|NCT00754078|tomotherapy|tomotherapy
5636021|NCT00754065|Oral contraceptive|oral contraceptive
5636022|NCT00754065|Estradiol valerate and dienogest|estradiol valerate and dienogest
5636023|NCT00754065|EV/DNG|ev/dng
5636024|NCT00754065|comparative tolerability|comparative tolerability
5636025|NCT00754052|Pediatric|pediatric
5636026|NCT00754052|Down syndrome|down syndrome
5636027|NCT00754052|Downs|downs
5636028|NCT00754052|Cognitive Dysfunction of Down syndrome|cognitive dysfunction of down syndrome
5636029|NCT00754039|Mixed hyperlipidemia|mixed hyperlipidemia
5636030|NCT00754026|Shoulder surgery|shoulder surgery
5636031|NCT00754013|pediatric|pediatric
5636032|NCT00754013|Down syndrome|down syndrome
5636033|NCT00754013|cognitive dysfunction|cognitive dysfunction
5636034|NCT00754013|Downs|downs
5636035|NCT00754013|Aricept|aricept
5636036|NCT00754013|children with Down syndrome|children with down syndrome
5636037|NCT00753987|Cystic Fibrosis|cystic fibrosis
5636038|NCT00753987|Hypertonic Saline|hypertonic saline
5636039|NCT00753987|Infants|infants
5636040|NCT00753961|Shiftworkers|shiftworkers
5636041|NCT00753961|volunteers|volunteers
5636048|NCT00753935|aspirin|aspirin
5636049|NCT00753935|aspirin resistance|aspirin resistance
5636050|NCT00753935|aspirin nonresponse|aspirin nonresponse
5636051|NCT00753935|cyclooxygenase|cyclooxygenase
5636052|NCT00753935|thromboxane|thromboxane
5636053|NCT00753935|oxidative stress|oxidative stress
5636054|NCT00753922|Breast Reconstruction|breast reconstruction
5636055|NCT00753922|Breast Augmentation|breast augmentation
5636056|NCT00753922|Revision|revision
5636057|NCT00753922|Silicone breast implants|silicone breast implants
5636265|NCT00753233|Arrhythmias|arrhythmias
5636058|NCT00753922|Round low-bleed|round low-bleed
5636059|NCT00753909|Non Small Cell Lung Cancer|non small cell lung cancer
5636060|NCT00753909|Paclitaxel|paclitaxel
5636061|NCT00753909|Carboplatin|carboplatin
5636062|NCT00753909|Bevacizumab|bevacizumab
5636063|NCT00753896|Amylin|amylin
5636064|NCT00753896|Lilly|lilly
5636065|NCT00753896|exenatide once weekly|exenatide once weekly
5636066|NCT00753896|thiazolidinedione|thiazolidinedione
5636067|NCT00753896|metformin|metformin
5636069|NCT00753870|no health problems|no health problems
5636070|NCT00753870|no daily cough from smoking|no daily cough from smoking
5636071|NCT00753857|risk communication|risk communication
5636072|NCT00753857|probability sample by random digit dialing|probability sample by random digit dialing
5636073|NCT00753844|peptide vaccine|peptide vaccine
5636074|NCT00753844|URLC10|urlc10
5636075|NCT00753831|Blepharoptosis|blepharoptosis
5636076|NCT00753831|Ophthalmoplegia|ophthalmoplegia
5636077|NCT00753831|Blepharospasm|blepharospasm
5636078|NCT00753818|infant formula|infant formula
5636079|NCT00753818|visual development|visual development
5636081|NCT00753805|atopic dermatitis|atopic dermatitis
5636082|NCT00753805|endogenous eczema|endogenous eczema
5636083|NCT00753805|SCORAD|scorad
5636084|NCT00753805|Bifidobacteria|bifidobacteria
5636085|NCT00753792|multiple sclerosis|multiple sclerosis
5636086|NCT00753792|relapse|relapse
5636087|NCT00753792|methylprednisolone|methylprednisolone
5636088|NCT00753766|A1c|a1c
5636089|NCT00753766|Blood Glucose Management|blood glucose management
5636090|NCT00753766|Blood Pressure|blood pressure
5636091|NCT00753766|Case Management|case management
5636092|NCT00753766|Diabetes Mellitus|diabetes mellitus
5636093|NCT00753766|Intervention study|intervention study
5636094|NCT00753766|Multifactorial|multifactorial
5636095|NCT00753766|Peri-operative complications|peri-operative complications
5636096|NCT00753766|Pre-operative|pre-operative
5636097|NCT00753753|stent thrombosis|stent thrombosis
5636098|NCT00753753|clopidogrel|clopidogrel
5636099|NCT00753753|aspirin|aspirin
5636100|NCT00753753|bleeding|bleeding
5636101|NCT00753753|coronary|coronary
5636102|NCT00753753|angioplasty|angioplasty
5636103|NCT00753740|Cancer|cancer
5636104|NCT00753740|Neoplasms|neoplasms
5636105|NCT00753740|Solid Tumor|solid tumor
5636106|NCT00753740|Ovarian Cancer|ovarian cancer
5636107|NCT00753740|Solid Malignancies|solid malignancies
5636108|NCT00753727|soft tissue|soft tissue
5636109|NCT00753727|Sarcoma|sarcoma
5636110|NCT00753727|Sunitinib|sunitinib
5636111|NCT00753727|neoadjuvant|neoadjuvant
5636112|NCT00753727|radiotherapy|radiotherapy
5636114|NCT00753714|VANDETANIB|vandetanib
5636115|NCT00753714|ZACTIMA|zactima
5636116|NCT00753714|ADVANCED|advanced
5636117|NCT00753714|NSCLC|nsclc
5636118|NCT00753714|LUNG CANCER|lung cancer
5636119|NCT00753714|ELDERLY PATIENTS|elderly patients
5636120|NCT00753714|GEMCITABINE|gemcitabine
5636121|NCT00753714|PHASE II|phase ii
5636122|NCT00753714|RANDOMIZED|randomized
5636123|NCT00753714|DOUBLE-BLIND|double-blind
5636124|NCT00753714|histologically or cytologically-confirmed advanced (stage IIIB with supraclavicular lymph node metastases or pleural effusion or stage IV) NSCLC|histologically or cytologically-confirmed advanced (stage iiib with supraclavicular lymph node metastases or pleural effusion or stage iv) nsclc
5636125|NCT00753688|metastatic soft-tissue sarcoma|metastatic soft-tissue sarcoma
5636126|NCT00753688|pazopanib|pazopanib
5636127|NCT00753688|Soft Tissue Sarcoma|soft tissue sarcoma
5636128|NCT00753688|placebo|placebo
5636129|NCT00753675|Intrahepatic|intrahepatic
5636130|NCT00753675|Cholangiocarcinoma|cholangiocarcinoma
5636131|NCT00753675|Vandetanib|vandetanib
5636132|NCT00753675|Zactima|zactima
5636133|NCT00753675|Advanced|advanced
5636134|NCT00753675|Biliary|biliary
5636135|NCT00753675|Tract|tract
5636136|NCT00753675|Gallbladder|gallbladder
5636137|NCT00753675|Extrahepatic Bile Duct|extrahepatic bile duct
5636138|NCT00753675|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5636139|NCT00753675|Ampullary Carcinoma|ampullary carcinoma
5636140|NCT00753662|TMS AD H2 coil|tms ad h2 coil
5636141|NCT00753649|Infant|infant
5636142|NCT00753649|First nation|first nation
5636143|NCT00753649|Aboriginal|aboriginal
5636144|NCT00753649|Canada|canada
5636145|NCT00753636|Parkinson's disease|parkinson's disease
5636146|NCT00753636|Isradipine|isradipine
5636147|NCT00753636|Neuroprotection|neuroprotection
5636148|NCT00753623|Pain|pain
5636149|NCT00753623|Neuropathic pain|neuropathic pain
5636150|NCT00753623|Pain scores|pain scores
5636151|NCT00753610|EPC|epc
5636152|NCT00753610|CCRT|ccrt
5636153|NCT00753610|Cervical cancer|cervical cancer
5636154|NCT00753597|B cell depletion|b cell depletion
5636155|NCT00753597|steroidogenesis|steroidogenesis
5636156|NCT00753571|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5636157|NCT00753571|Cistanche Total Glycosides|cistanche total glycosides
5636158|NCT00753571|Randomized Control Trial Study|randomized control trial study
5636159|NCT00753545|Serous,|serous,
5636160|NCT00753545|Ovarian cancer,|ovarian cancer,
5636161|NCT00753545|PARP,|parp,
5636162|NCT00753545|BRCA1,|brca1,
5636163|NCT00753545|BRCA2,|brca2,
5636164|NCT00753545|Poly(ADP ribose) polymerases,|poly(adp ribose) polymerases,
5636165|NCT00753545|Platinum sensitive,|platinum sensitive,
5636166|NCT00753545|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
5636167|NCT00753532|Carotid artery stenoses|carotid artery stenoses
5636168|NCT00753532|Brain ischaemia|brain ischaemia
5636170|NCT00753532|Lipid abnormalities|lipid abnormalities
5636171|NCT00753532|Fatty Liver|fatty liver
5636172|NCT00753519|Parkinson's Disease|parkinson's disease
5636173|NCT00753519|Brain Stimulation|brain stimulation
5636174|NCT00753519|Motor Cortex|motor cortex
5636175|NCT00753519|Bradykinesia|bradykinesia
5636176|NCT00753519|Parkinson Disease|parkinson disease
5636177|NCT00753519|PD|pd
5636178|NCT00753480|EOC|eoc
5636179|NCT00753480|PPC|ppc
5636180|NCT00753480|FTC|ftc
5636181|NCT00753467|HBV|hbv
5636182|NCT00753467|Treatment|treatment
5636183|NCT00753467|Interferon-gamma|interferon-gamma
5636184|NCT00753467|combination|combination
5636185|NCT00753467|Hepsera|hepsera
5636186|NCT00753467|Actimmune|actimmune
5636187|NCT00753467|HBV DNA|hbv dna
5636188|NCT00753454|Rheumatoid Arthritis|rheumatoid arthritis
5636189|NCT00753454|Joint Disease|joint disease
5636190|NCT00753454|Arthritis|arthritis
5636191|NCT00753454|Certolizumab pegol|certolizumab pegol
5636192|NCT00753454|Cimzia|cimzia
5636193|NCT00753441|Pancreatic cancer|pancreatic cancer
5636194|NCT00753441|Bile duct obstruction|bile duct obstruction
5636195|NCT00753441|Stent|stent
5636196|NCT00753441|Bypass|bypass
5636197|NCT00753428|HIV-free survival|hiv-free survival
5636198|NCT00753428|Community based evaluation|community based evaluation
5636199|NCT00753428|Pregnancy|pregnancy
5636200|NCT00753428|Under 2 child survival|under 2 child survival
5636201|NCT00753428|PMTCT|pmtct
5636202|NCT00753428|Pediatric HIV infection|pediatric hiv infection
5636203|NCT00753428|HAART|haart
5636204|NCT00753428|Routine ART|routine art
5636205|NCT00753428|HIV Seronegativity|hiv seronegativity
5636206|NCT00753415|Urinary Bladder Neoplasms|urinary bladder neoplasms
5636207|NCT00753415|Breast Neoplasms|breast neoplasms
5636208|NCT00753415|Renal Cell carcinoma|renal cell carcinoma
5636209|NCT00753415|Melanoma|melanoma
5636210|NCT00753415|Prostatic Neoplasms|prostatic neoplasms
5636211|NCT00753415|Colonic Neoplasms|colonic neoplasms
5636212|NCT00753415|Urologic Neoplasms|urologic neoplasms
5636213|NCT00753415|Urogenital Neoplasms|urogenital neoplasms
5636214|NCT00753415|Urinary Bladder Diseases|urinary bladder diseases
5636215|NCT00753415|Urologic Diseases|urologic diseases
5636216|NCT00753415|Breast Diseases|breast diseases
5636217|NCT00753415|Skin Diseases|skin diseases
5636218|NCT00753415|Neoplasms|neoplasms
5636219|NCT00753415|Glandular and Epithelial Neoplasms by Histologic Type|glandular and epithelial neoplasms by histologic type
5636220|NCT00753415|Adenocarcinoma|adenocarcinoma
5636221|NCT00753415|Kidney Neoplasms|kidney neoplasms
5636222|NCT00753415|Kidney Diseases|kidney diseases
5636223|NCT00753415|Neuroendocrine Tumors|neuroendocrine tumors
5636224|NCT00753415|Neuroectodermal Tumors|neuroectodermal tumors
5636225|NCT00753415|Neoplasms, Germ Cell and Embryonal|neoplasms, germ cell and embryonal
5636226|NCT00753415|Neoplasms, Nerve Tissue|neoplasms, nerve tissue
5636227|NCT00753415|Nevi and Melanomas|nevi and melanomas
5636228|NCT00753415|Genital Neoplasms|genital neoplasms
5636229|NCT00753415|Male Genital Diseases|male genital diseases
5636230|NCT00753415|Male, Prostatic Diseases|male, prostatic diseases
5636231|NCT00753415|Colorectal Neoplasms|colorectal neoplasms
5636232|NCT00753415|Intestinal Neoplasms|intestinal neoplasms
5636233|NCT00753389|Postoperative residual curarization,|postoperative residual curarization,
5636234|NCT00753389|muscle relaxants,|muscle relaxants,
5636235|NCT00753389|morbidity mortality|morbidity mortality
5636236|NCT00753363|Glucose Metabolism|glucose metabolism
5636237|NCT00753350|obesity|obesity
5636238|NCT00753324|PMTCT|pmtct
5636239|NCT00753324|HAART|haart
5636240|NCT00753324|Pregnancy|pregnancy
5636241|NCT00753324|HIV Infection|hiv infection
5636242|NCT00753324|HIV Transmission|hiv transmission
5636243|NCT00753324|HIV Seronegativity|hiv seronegativity
5636244|NCT00753311|migraine|migraine
5636245|NCT00753311|rizatriptan|rizatriptan
5636246|NCT00753311|unilateral trigeminal autonomic symptoms|unilateral trigeminal autonomic symptoms
5636247|NCT00753311|Migraine with or without aura|migraine with or without aura
5636248|NCT00753272|Efficacy|efficacy
5636249|NCT00753272|Influenza Vaccines|influenza vaccines
5636250|NCT00753272|Influenza|influenza
5636251|NCT00753272|Vaccine|vaccine
5636252|NCT00753272|Elderly|elderly
5636253|NCT00753259|atrial fibrillation|atrial fibrillation
5636254|NCT00753259|disease management program|disease management program
5636255|NCT00753259|integrated chronic care program|integrated chronic care program
5636256|NCT00753259|guideline|guideline
5636257|NCT00753259|stroke|stroke
5636258|NCT00753259|heart failure|heart failure
5636259|NCT00753259|quality of life|quality of life
5636260|NCT00753259|costs|costs
5636261|NCT00753246|glioblastoma multiforma|glioblastoma multiforma
5636262|NCT00753233|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5636263|NCT00753233|Children|children
5636264|NCT00753233|Sudden Death|sudden death
5636266|NCT00753233|Electrophysiology Study|electrophysiology study
5636267|NCT00753220|Metastatic|metastatic
5636268|NCT00753220|Androgen|androgen
5636269|NCT00753220|Independent|independent
5636270|NCT00753220|Prostate Cancer|prostate cancer
5636271|NCT00753220|(AIPC),|(aipc),
5636272|NCT00753220|Hormone-refractory|hormone-refractory
5636273|NCT00753220|(HRPC),|(hrpc),
5636274|NCT00753220|cryotherapy,|cryotherapy,
5636275|NCT00753220|dendritic cell,|dendritic cell,
5636276|NCT00753220|immunotherapy|immunotherapy
5636277|NCT00753220|Chemo-naïve|chemo-naïve
5636278|NCT00753220|lymph nodes|lymph nodes
5636279|NCT00753220|bone|bone
5636280|NCT00753207|stage IV breast cancer|stage iv breast cancer
5636281|NCT00753207|recurrent breast cancer|recurrent breast cancer
5636282|NCT00753194|hearing|hearing
5636283|NCT00753194|newborn|newborn
5636284|NCT00753194|otoacoustic emissions|otoacoustic emissions
5636285|NCT00753168|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure|glaucoma, open angle, ocular hypertension, beta blocker, beta adrenergic, intraocular pressure
5636286|NCT00753155|HRQoL;|hrqol;
5636287|NCT00753155|exercise|exercise
5636288|NCT00753155|capacity|capacity
5636289|NCT00753142|Hyperglycemia|hyperglycemia
5636290|NCT00753129|Prone position|prone position
5636291|NCT00753129|ALI/ARDS|ali/ards
5636292|NCT00753129|Head elevation|head elevation
5636293|NCT00753103|Infliximab|infliximab
5636294|NCT00753103|Vasculitis|vasculitis
5636295|NCT00753103|antitnf monoclonal antibody|antitnf monoclonal antibody
5636296|NCT00753064|Red Scorpion envenomation|red scorpion envenomation
5636297|NCT00753064|Composite clinical scoring system|composite clinical scoring system
5636298|NCT00753064|AScVS|ascvs
5636299|NCT00753064|Prazosin|prazosin
5636300|NCT00753064|Superiority|superiority
5636301|NCT00753051|clozapine-resistant schizophrenics|clozapine-resistant schizophrenics
5636302|NCT00753051|haloperidol augmenting clozapine|haloperidol augmenting clozapine
5636303|NCT00753051|electroconvulsive therapy augmenting clozapine|electroconvulsive therapy augmenting clozapine
5636304|NCT00753038|carcinoma|carcinoma
5636305|NCT00753038|squamous cell|squamous cell
5636306|NCT00753038|head|head
5636307|NCT00753038|neck|neck
5636308|NCT00753038|REOLYSIN|reolysin
5636309|NCT00753038|chemotherapy|chemotherapy
5636310|NCT00753038|Carboplatin|carboplatin
5636311|NCT00753038|Paclitaxel|paclitaxel
5636312|NCT00753025|lower extremity ischemia|lower extremity ischemia
5636313|NCT00753025|Bone marrow|bone marrow
5636314|NCT00753025|Progenitor cells|progenitor cells
5636315|NCT00753025|Neoangiogenesis|neoangiogenesis
5636316|NCT00753012|cardiovascular testing|cardiovascular testing
5636317|NCT00753012|home blood pressure monitoring|home blood pressure monitoring
5636318|NCT00753012|office home blood pressure monitoring|office home blood pressure monitoring
5636319|NCT00753012|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5636320|NCT00753012|transthoracic echocardiography|transthoracic echocardiography
5636321|NCT00753012|Lisdexamfetamine|lisdexamfetamine
5636322|NCT00753012|Vyvanse|vyvanse
5636323|NCT00753012|normotensive and hypertensive adults with ADHD|normotensive and hypertensive adults with adhd
5636324|NCT00753012|ADHD medication.|adhd medication.
5636326|NCT00752999|Lupus|lupus
5636327|NCT00752986|ZD6474|zd6474
5636328|NCT00752986|Vandetanib|vandetanib
5636329|NCT00752986|Zactima|zactima
5636330|NCT00752986|Fulvestrant|fulvestrant
5636331|NCT00752986|Faslodex|faslodex
5636332|NCT00752986|Breast Cancer|breast cancer
5636333|NCT00752986|Advanced, Metastatic|advanced, metastatic
5636334|NCT00752986|Hormone Receptor Positive|hormone receptor positive
5636335|NCT00752986|Post-Menopausal Patients|post-menopausal patients
5636336|NCT00752986|post-menopausal women with hormone receptor positive advanced breast cancer|post-menopausal women with hormone receptor positive advanced breast cancer
5636337|NCT00752973|Head Lice|head lice
5636338|NCT00752960|single nucleotide polymorphism, SNP, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome|single nucleotide polymorphism, snp, aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone, metabolic syndrome
5636339|NCT00752934|nursing homes|nursing homes
5636340|NCT00752934|children|children
5636341|NCT00752934|ages 1-18 years|ages 1-18 years
5636342|NCT00752934|spastic quadriplegia|spastic quadriplegia
5636343|NCT00752921|Etoricoxib, Fasting Headache, Headache, Yom Kippur|etoricoxib, fasting headache, headache, yom kippur
5636344|NCT00752895|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5636345|NCT00752895|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5636346|NCT00752895|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5636347|NCT00752895|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5636348|NCT00752882|Ceftazidime|ceftazidime
5636349|NCT00752882|Pharmacokinetics|pharmacokinetics
5636350|NCT00752882|Pseudomonas|pseudomonas
5636351|NCT00752882|aeruginosa|aeruginosa
5636352|NCT00752882|Meningitis|meningitis
5636353|NCT00752882|Patients|patients
5636354|NCT00752882|hospitalised|hospitalised
5636355|NCT00752882|cerebrolesion|cerebrolesion
5636356|NCT00752882|acquired|acquired
5636357|NCT00752882|pneumopathy|pneumopathy
5636358|NCT00752882|mechanic|mechanic
5636359|NCT00752882|ventilation|ventilation
5636464|NCT00752414|COPD|copd
5636360|NCT00752869|low testosterone|low testosterone
5636361|NCT00752856|HIV treatment|hiv treatment
5636362|NCT00752856|Treatment-naive|treatment-naive
5636363|NCT00752856|Adult|adult
5636364|NCT00752843|mifepristone|mifepristone
5636365|NCT00752843|CORLUX|corlux
5636366|NCT00752843|fluvastatin|fluvastatin
5636367|NCT00752843|Lescol|lescol
5636368|NCT00752843|drug-drug interaction|drug-drug interaction
5636370|NCT00752843|pharmacokinetics|pharmacokinetics
5636371|NCT00752830|AZD0328|azd0328
5636372|NCT00752830|Food Effect|food effect
5636373|NCT00752817|Virtual Reality|virtual reality
5636374|NCT00752817|Simulator|simulator
5636375|NCT00752817|Proficiency|proficiency
5636376|NCT00752817|Laparoscopic|laparoscopic
5636377|NCT00752817|Colectomy|colectomy
5636378|NCT00752817|Education|education
5636379|NCT00752817|Surgical Training|surgical training
5636380|NCT00752804|ICU patients with acute renal failure after cardiac surgery|icu patients with acute renal failure after cardiac surgery
5636382|NCT00752791|Drug Therapy|drug therapy
5636383|NCT00752791|Peritoneal Dialysis.|peritoneal dialysis.
5636384|NCT00752778|MRI, PET scan|mri, pet scan
5636385|NCT00752765|knee osteoarthritis|knee osteoarthritis
5636386|NCT00752765|bariatric surgery|bariatric surgery
5636387|NCT00752765|weight loss|weight loss
5636388|NCT00752765|knee pain|knee pain
5636389|NCT00752752|Marathon Running|marathon running
5636390|NCT00752752|Cardiac Ischemia|cardiac ischemia
5636391|NCT00752752|Magnetic Resonance Imaging|magnetic resonance imaging
5636392|NCT00752739|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5636393|NCT00752739|stage I prostate cancer|stage i prostate cancer
5636394|NCT00752739|stage II prostate cancer|stage ii prostate cancer
5636395|NCT00752739|stage III prostate cancer|stage iii prostate cancer
5618239|NCT00824837|albumin|albumin
5636396|NCT00752739|stage IV prostate cancer|stage iv prostate cancer
5636397|NCT00752726|overweight, orlistat, body composition|overweight, orlistat, body composition
5636398|NCT00752713|AMI,|ami,
5636399|NCT00752713|Reperfusion|reperfusion
5636400|NCT00752713|successful|successful
5636401|NCT00752700|Patients|patients
5636402|NCT00752700|radically|radically
5636403|NCT00752700|treated|treated
5636404|NCT00752687|Phase 1|phase 1
5636405|NCT00752674|Low back pain|low back pain
5636406|NCT00752674|physical therapy|physical therapy
5636407|NCT00752674|pain|pain
5636408|NCT00752661|osteoarthritis|osteoarthritis
5636409|NCT00752661|low back pain|low back pain
5636410|NCT00752661|oral drug|oral drug
5636411|NCT00752661|tramadol|tramadol
5680390|NCT00577993|Cisplatin|cisplatin
5636412|NCT00752648|TMC435350-TiDP16-C106|tmc435350-tidp16-c106
5636413|NCT00752648|TMC435350-C106|tmc435350-c106
5636414|NCT00752648|Bioavailability|bioavailability
5636415|NCT00752648|Pharmacokinetics|pharmacokinetics
5636416|NCT00752635|TriCilest|tricilest
5636417|NCT00752635|acne vulgaris|acne vulgaris
5636418|NCT00752609|Anemia|anemia
5636419|NCT00752609|Drug Therapy|drug therapy
5636420|NCT00752609|Hemodialysis|hemodialysis
5636421|NCT00752609|Kidney Failure|kidney failure
5636422|NCT00752596|patients|patients
5636423|NCT00752596|with ICD|with icd
5636424|NCT00752583|Chronic renal insufficiency (patients under dialysis)|chronic renal insufficiency (patients under dialysis)
5636425|NCT00752570|Metastatic Colorectal Cancer|metastatic colorectal cancer
5636426|NCT00752570|colorectal cancer|colorectal cancer
5636427|NCT00752570|colon cancer|colon cancer
5636428|NCT00752557|Bone mineral density|bone mineral density
5636429|NCT00752557|bone morphogenetic protein|bone morphogenetic protein
5636430|NCT00752557|osteoporosis|osteoporosis
5636431|NCT00752544|TMC435350|tmc435350
5636433|NCT00752544|Hepatitis C|hepatitis c
5636434|NCT00752544|TMC435350-TiDP16-C109|tmc435350-tidp16-c109
5636435|NCT00752544|TMC435350-C109|tmc435350-c109
5636436|NCT00752531|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5636437|NCT00752531|COPD|copd
5636438|NCT00752518|bolus|bolus
5636439|NCT00752518|intravenous|intravenous
5636440|NCT00752518|proteasome inhibitor|proteasome inhibitor
5636441|NCT00752518|multiple myeloma|multiple myeloma
5636442|NCT00752518|refractory|refractory
5636443|NCT00752518|relapse|relapse
5636444|NCT00752505|Fibromyalgia|fibromyalgia
5636445|NCT00752492|Isocapnic hyperpnoea|isocapnic hyperpnoea
5636446|NCT00752492|obesity|obesity
5636447|NCT00752492|isoflurane|isoflurane
5636448|NCT00752492|Recovery of obese patient from isoflurane anesthesia|recovery of obese patient from isoflurane anesthesia
5636449|NCT00752479|living|living
5636450|NCT00752479|related|related
5636451|NCT00752466|Healthy volunteers|healthy volunteers
5636452|NCT00752466|drug interaction|drug interaction
5636453|NCT00752466|Flunarizine|flunarizine
5636454|NCT00752466|Topiramate|topiramate
5636455|NCT00752466|Migraine|migraine
5636456|NCT00752453|ICU|icu
5636457|NCT00752453|patients|patients
5636458|NCT00752453|lactate|lactate
5636459|NCT00752453|acidosis|acidosis
5636460|NCT00752440|Diabetes Mellitus|diabetes mellitus
5636461|NCT00752440|Autonomic Neuropathy|autonomic neuropathy
5636462|NCT00752440|Inspiratory Muscle training|inspiratory muscle training
5636463|NCT00752427|Schizophrenia: paliperidone|schizophrenia: paliperidone
5636465|NCT00752414|Patients|patients
5636466|NCT00752401|Vitamin D|vitamin d
5636467|NCT00752401|Cholecalciferol|cholecalciferol
5636468|NCT00752401|Vitamin D3|vitamin d3
5636469|NCT00752401|25-hydroxyvitamin D3|25-hydroxyvitamin d3
5636470|NCT00752401|Immunomodulation|immunomodulation
5636471|NCT00752401|Vitamin D deficiency|vitamin d deficiency
5636472|NCT00752401|Kidney transplantation|kidney transplantation
5636473|NCT00752401|Renal transplantation|renal transplantation
5636474|NCT00752401|Graft function|graft function
5636475|NCT00752401|Acute rejection|acute rejection
5636476|NCT00752401|Renal osteodystrophy|renal osteodystrophy
5636477|NCT00752401|Posttransplant bone loss|posttransplant bone loss
5636478|NCT00752375|pyelonephritis|pyelonephritis
5636479|NCT00752375|pediatric pyelonephritis|pediatric pyelonephritis
5636480|NCT00752375|vesicoureteral reflux|vesicoureteral reflux
5636482|NCT00752362|Supralimus®,|supralimus®,
5636483|NCT00752362|Infinnium®,|infinnium®,
5636484|NCT00752362|Matrix®,|matrix®,
5636485|NCT00752362|Restenosis|restenosis
5636486|NCT00752362|Percutaneous|percutaneous
5636487|NCT00752362|Revascularization|revascularization
5636488|NCT00752362|Techniques|techniques
5636489|NCT00752362|Metallic|metallic
5636490|NCT00752362|Platform|platform
5636492|NCT00752362|Antiproliferative|antiproliferative
5636493|NCT00752362|Properties|properties
5636494|NCT00752349|Videofluoroscopic|videofluoroscopic
5636495|NCT00752349|swallowing|swallowing
5636496|NCT00752349|study|study
5636497|NCT00752349|(VFSS)|(vfss)
5636498|NCT00752349|ultrasound|ultrasound
5636499|NCT00752336|HRQoL|hrqol
5636500|NCT00752336|exercise capacity|exercise capacity
5636501|NCT00752323|adult giant cell glioblastoma|adult giant cell glioblastoma
5636502|NCT00752323|adult glioblastoma|adult glioblastoma
5636503|NCT00752323|adult gliosarcoma|adult gliosarcoma
5636504|NCT00752323|recurrent adult brain tumor|recurrent adult brain tumor
5636505|NCT00752310|TMC114-TiDP29-C169|tmc114-tidp29-c169
5636506|NCT00752310|TMC114-C169|tmc114-c169
5636507|NCT00752310|Darunavir (suspension formulation)|darunavir (suspension formulation)
5636508|NCT00752297|Botulinum Toxin Type A|botulinum toxin type a
5636509|NCT00752297|Botulinum Toxin|botulinum toxin
5636510|NCT00752297|Glabellar Rhytides|glabellar rhytides
5636511|NCT00752297|Rhytides|rhytides
5636512|NCT00752297|Frown Lines|frown lines
5636513|NCT00752297|Neuromuscular Agents|neuromuscular agents
5636514|NCT00752297|Neurotoxin|neurotoxin
5636515|NCT00752297|Forehead|forehead
5636516|NCT00752297|Eyebrow|eyebrow
5636517|NCT00752297|Wrinkle|wrinkle
5636518|NCT00752284|coronectomy|coronectomy
5636519|NCT00752284|neurosensory deficit|neurosensory deficit
5636520|NCT00752284|third molar surgery|third molar surgery
5636521|NCT00752271|Arthroscopic|arthroscopic
5636522|NCT00752258|Botulinum Toxin Type A|botulinum toxin type a
5636523|NCT00752258|Botulinum Toxin|botulinum toxin
5636524|NCT00752258|Glabellar Rhytides|glabellar rhytides
5636525|NCT00752258|Rhytides|rhytides
5636526|NCT00752258|Frown Lines|frown lines
5636527|NCT00752258|Neuromuscular Agents|neuromuscular agents
5636528|NCT00752258|Neurotoxin|neurotoxin
5636529|NCT00752258|Forehead|forehead
5636530|NCT00752258|Eyebrow|eyebrow
5636531|NCT00752258|Wrinkle|wrinkle
5636532|NCT00752258|Frown Lines Between the Eyebrows|frown lines between the eyebrows
5636533|NCT00752245|ICU patients with acute renal failure with sepsis/multi-organ failure|icu patients with acute renal failure with sepsis/multi-organ failure
5636534|NCT00752232|Phase IIa|phase iia
5636535|NCT00752232|multiple ascending dose study of ACC-001|multiple ascending dose study of acc-001
5636536|NCT00752206|AZD0530|azd0530
5636537|NCT00752206|Saracatinib|saracatinib
5636538|NCT00752206|Osteosarcoma|osteosarcoma
5636539|NCT00752206|Recurrent|recurrent
5636540|NCT00752206|Localized|localized
5636541|NCT00752206|to the Lung|to the lung
5636542|NCT00752180|pharmacokinetics|pharmacokinetics
5636543|NCT00752180|pharmacodynamics|pharmacodynamics
5636544|NCT00752180|type 1 diabetics|type 1 diabetics
5636545|NCT00752180|recombinant human insulin|recombinant human insulin
5636546|NCT00752167|exercise induced bronchospasm|exercise induced bronchospasm
5636547|NCT00752167|asthma|asthma
5636548|NCT00752167|athlete|athlete
5636549|NCT00752167|sports|sports
5636550|NCT00752167|eucapnic voluntary hyperventilation|eucapnic voluntary hyperventilation
5636551|NCT00752167|albuterol|albuterol
5636552|NCT00752154|Subjects|subjects
5636553|NCT00752154|active|active
5636554|NCT00752154|Rheumatoid|rheumatoid
5636555|NCT00752154|Arthritis|arthritis
5636556|NCT00752154|revised|revised
5636557|NCT00752154|American|american
5636558|NCT00752154|College|college
5636559|NCT00752154|Rheumatology|rheumatology
5636560|NCT00752154|Criteria|criteria
5636561|NCT00752128|Drug Eluting Stent|drug eluting stent
5636562|NCT00752128|Interventional Cardiology|interventional cardiology
5636563|NCT00752128|Percutaneous Coronary Intervention|percutaneous coronary intervention
5636564|NCT00752115|non-small cell lung cancer|non-small cell lung cancer
5636565|NCT00752115|previously untreated|previously untreated
5636566|NCT00752102|Secondary Hyperparathryoidism|secondary hyperparathryoidism
5636567|NCT00752102|Chronic Kidney Disease|chronic kidney disease
5636568|NCT00752102|Vitamin D|vitamin d
5636569|NCT00752102|Coronary Calcification|coronary calcification
5636570|NCT00752102|Bone metabolism|bone metabolism
5636573|NCT00752089|enamel remineralization|enamel remineralization
5636574|NCT00752076|EGFR mutation|egfr mutation
5636575|NCT00752076|NSCLC cell line|nsclc cell line
5636576|NCT00752076|Malignant pleural effusion|malignant pleural effusion
5636577|NCT00752063|Sorafenib|sorafenib
5636578|NCT00752063|Capecitabine|capecitabine
5636579|NCT00752063|Oxaliplatin|oxaliplatin
5636580|NCT00752063|Advanced Hepatocellular Carcinoma|advanced hepatocellular carcinoma
5636581|NCT00752063|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5636582|NCT00752050|Botulinum Toxin Type A|botulinum toxin type a
5636583|NCT00752050|Botulinum Toxin|botulinum toxin
5636584|NCT00752050|Glabellar Rhytides|glabellar rhytides
5636585|NCT00752050|Rhytides|rhytides
5636586|NCT00752050|Frown Lines|frown lines
5636587|NCT00752050|Neuromuscular Agents|neuromuscular agents
5636588|NCT00752050|Neurotoxin|neurotoxin
5636589|NCT00752050|Forehead|forehead
5636590|NCT00752050|Eyebrow|eyebrow
5636591|NCT00752050|Wrinkle|wrinkle
5636592|NCT00752037|HIV|hiv
5636593|NCT00752037|Protease Inhibitor|protease inhibitor
5636594|NCT00752037|Integrase Inhibitor|integrase inhibitor
5636595|NCT00752037|Treatment Experienced|treatment experienced
5636596|NCT00752037|Naive|naive
5636597|NCT00752024|HICH|hich
5636598|NCT00752024|Suction drainages|suction drainages
5636599|NCT00752024|TTAC|ttac
5636600|NCT00752011|Cancer|cancer
5636601|NCT00752011|Solid Tumors|solid tumors
5636602|NCT00752011|Advanced Cancer|advanced cancer
5636603|NCT00752011|Carboplatin|carboplatin
5636604|NCT00752011|Paraplatin|paraplatin
5636605|NCT00752011|TAS-106|tas-106
5636606|NCT00752011|Antitumor Activity|antitumor activity
5636607|NCT00752011|Biomarkers|biomarkers
5636608|NCT00751998|biliary|biliary
5636609|NCT00751998|ERCP|ercp
5636610|NCT00751998|cholangioscopy|cholangioscopy
5636611|NCT00751998|pancreatic|pancreatic
5636612|NCT00751985|Heavy drinking|heavy drinking
5636613|NCT00751985|Ultra-brief intervention|ultra-brief intervention
5636614|NCT00751985|Brief intervention|brief intervention
5636615|NCT00751985|Alcohol prevention|alcohol prevention
5636616|NCT00751985|Randomized trial|randomized trial
5680391|NCT00577993|Ara-C|ara-c
5636617|NCT00751985|Personal normative feedback|personal normative feedback
5636618|NCT00751985|Self-help material|self-help material
5636619|NCT00751985|Web-based|web-based
5636620|NCT00751985|Intervention Studies|intervention studies
5636621|NCT00751985|prevention & control|prevention & control
5636622|NCT00751959|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5636623|NCT00751959|extremely preterm infant|extremely preterm infant
5636624|NCT00751959|Idiopathic respiratory distress syndrome (IRDS)|idiopathic respiratory distress syndrome (irds)
5636625|NCT00751959|Surfactant|surfactant
5636626|NCT00751946|Posttraumatic Stress Disorder|posttraumatic stress disorder
5636627|NCT00751946|PTSD|ptsd
5636628|NCT00751946|psychotherapy|psychotherapy
5636629|NCT00751946|adolescents|adolescents
5636630|NCT00751946|clinical trial|clinical trial
5636631|NCT00751933|Ulcerative colitis|ulcerative colitis
5636632|NCT00751933|Vaccines|vaccines
5636633|NCT00751933|Oats|oats
5636634|NCT00751920|Magnetic Resonance Imaging|magnetic resonance imaging
5636635|NCT00751920|Pediatrics|pediatrics
5636636|NCT00751920|Multi-Detector Computed Tomography|multi-detector computed tomography
5636637|NCT00751920|Computed Tomography|computed tomography
5636638|NCT00751920|Detection|detection
5636639|NCT00751907|Cerebral blood flow|cerebral blood flow
5636640|NCT00751894|Children|children
5636641|NCT00751894|cancer|cancer
5636642|NCT00751894|Bone marrow transplantation|bone marrow transplantation
5636643|NCT00751894|Stem cell mobilization|stem cell mobilization
5636644|NCT00751894|G-CSF|g-csf
5636645|NCT00751894|Children with solid malignancies|children with solid malignancies
5636646|NCT00751881|relapsing multiple sclerosis|relapsing multiple sclerosis
5636647|NCT00751868|breast cancer|breast cancer
5636648|NCT00751842|Diabetes|diabetes
5636649|NCT00751842|Juvenile Diabetes|juvenile diabetes
5636650|NCT00751842|Diabetes type 1|diabetes type 1
5636651|NCT00751842|Autoimmune Diabetes|autoimmune diabetes
5636652|NCT00751842|Insulin dependent Diabetes|insulin dependent diabetes
5636653|NCT00751842|Type 1 diabetes|type 1 diabetes
5636654|NCT00751842|Type 1 diabetes mellitus|type 1 diabetes mellitus
5636655|NCT00751842|Diamyd|diamyd
5636656|NCT00751842|rhGAD65|rhgad65
5636658|NCT00751842|GAD-alum|gad-alum
5636659|NCT00751816|musculoskeletal complications|musculoskeletal complications
5636660|NCT00751816|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5636661|NCT00751816|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5636662|NCT00751816|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5636663|NCT00751816|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5636664|NCT00751816|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5636666|NCT00751816|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5671713|NCT00614679|catheter salvage|catheter salvage
5636667|NCT00751816|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5636668|NCT00751816|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5636669|NCT00751816|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5636670|NCT00751816|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5636671|NCT00751816|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5636672|NCT00751816|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5636673|NCT00751816|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5636674|NCT00751816|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5636675|NCT00751816|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5636676|NCT00751816|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5636677|NCT00751816|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5636678|NCT00751816|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5636679|NCT00751816|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5636680|NCT00751816|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5636681|NCT00751816|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5636682|NCT00751816|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5636683|NCT00751816|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5636684|NCT00751816|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5636685|NCT00751816|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5636686|NCT00751816|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5636687|NCT00751816|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5636688|NCT00751816|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5636689|NCT00751816|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5636690|NCT00751816|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5636691|NCT00751816|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5636692|NCT00751816|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5636693|NCT00751816|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5636694|NCT00751816|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5636695|NCT00751816|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5636696|NCT00751816|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5636697|NCT00751816|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5636698|NCT00751816|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5636699|NCT00751816|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5636700|NCT00751816|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5636701|NCT00751816|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5636702|NCT00751816|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5636703|NCT00751816|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5636704|NCT00751816|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5636705|NCT00751816|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5636706|NCT00751816|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5636707|NCT00751816|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5636708|NCT00751816|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5636709|NCT00751816|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5636710|NCT00751816|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5636711|NCT00751816|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5636712|NCT00751816|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5636713|NCT00751816|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5636714|NCT00751816|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5636820|NCT00751348|second year of life|second year of life
5636715|NCT00751816|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5636716|NCT00751816|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5636888|NCT00751062|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
5636717|NCT00751816|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5636718|NCT00751816|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5636719|NCT00751816|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5636720|NCT00751816|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5636721|NCT00751816|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5636722|NCT00751816|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5636723|NCT00751816|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5636724|NCT00751816|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5636725|NCT00751816|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5636726|NCT00751816|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5636727|NCT00751816|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5636728|NCT00751816|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5636729|NCT00751816|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5636730|NCT00751816|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5636731|NCT00751816|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5636732|NCT00751816|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5636733|NCT00751816|stage I salivary gland cancer|stage i salivary gland cancer
5636734|NCT00751816|stage II salivary gland cancer|stage ii salivary gland cancer
5636735|NCT00751816|stage III salivary gland cancer|stage iii salivary gland cancer
5636736|NCT00751816|stage IV salivary gland cancer|stage iv salivary gland cancer
5685476|NCT00555945|Sliding hip screw|sliding hip screw
5636737|NCT00751790|triptorelin, 6-month formulation, advanced prostate cancer|triptorelin, 6-month formulation, advanced prostate cancer
5636738|NCT00751712|Aortic Arch|aortic arch
5636739|NCT00751699|Pharmacokinetics|pharmacokinetics
5636740|NCT00751686|Gastroenteritis|gastroenteritis
5636741|NCT00751686|Burden|burden
5636742|NCT00751686|Rotavirus|rotavirus
5636743|NCT00751686|< 5 years|< 5 years
5636744|NCT00751686|Greece|greece
5636745|NCT00751686|Children|children
5636746|NCT00751660|small cell lung cancer|small cell lung cancer
5636747|NCT00751660|non-small cell lung cancer|non-small cell lung cancer
5636748|NCT00751660|tobacco use disorder|tobacco use disorder
5636750|NCT00751634|subarachnoid hemorrhage|subarachnoid hemorrhage
5636751|NCT00751634|intracerebral hemorrhage|intracerebral hemorrhage
5636752|NCT00751634|fever|fever
5636753|NCT00751621|Immune globulin subcutaneous|immune globulin subcutaneous
5636754|NCT00751621|SCIG|scig
5636755|NCT00751621|primary immunodeficiency|primary immunodeficiency
5636757|NCT00751608|Familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, ApoAI-mimetic, endothelial dependent vasodilation|familial hypercholesterolemia, endothelial function, venous occlusion plethysmography, forearm blood flow, apoai-mimetic, endothelial dependent vasodilation
5636758|NCT00751595|HIV|hiv
5636759|NCT00751595|Tat protein|tat protein
5636760|NCT00751595|Therapeutic vaccine|therapeutic vaccine
5636761|NCT00751595|HAART|haart
5636762|NCT00751595|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5636763|NCT00751595|Treatment Experienced|treatment experienced
5636764|NCT00751582|nutrition|nutrition
5636765|NCT00751582|education|education
5636766|NCT00751582|supplementation|supplementation
5636767|NCT00751569|umbilical cord blood|umbilical cord blood
5636768|NCT00751556|Naproxen Sodium|naproxen sodium
5636769|NCT00751556|Bioavailability|bioavailability
5636770|NCT00751543|To evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion MDCT|to evaluate the longitudinal change of tumor perfusion in the course of radiation therapy in adenocarcinoma and squamous cell carcinoma using perfusion mdct
5636771|NCT00751543|Comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion MDCT|comparison between adenocarcinoma and squamous cell carcinoma will be evaluated according to the derived perfusion parameter obtained from perfusion mdct
5636772|NCT00751530|HIV|hiv
5636773|NCT00751530|AIDS|aids
5636774|NCT00751530|raltegravir|raltegravir
5636775|NCT00751530|BRAVO|bravo
5636776|NCT00751530|protease inhibitor|protease inhibitor
5636777|NCT00751530|treatment Experienced|treatment experienced
5636778|NCT00751517|Vasculitis|vasculitis
5636779|NCT00751517|Cyclophosphamide|cyclophosphamide
5636780|NCT00751517|Methotrexate|methotrexate
5636781|NCT00751517|Systemic Necrotizing Vasculitides|systemic necrotizing vasculitides
5636782|NCT00751504|Quetiapine|quetiapine
5636783|NCT00751504|Psychotic depression|psychotic depression
5636786|NCT00751491|Myonecrosis|myonecrosis
5636788|NCT00751478|morphine|morphine
5636789|NCT00751478|Determination of the relative pharmacodynamic effects|determination of the relative pharmacodynamic effects
5636889|NCT00751049|open angle glaucoma ocular hypertension|open angle glaucoma ocular hypertension
5636790|NCT00751478|(including drug-liking), pharmacokinetics, and safety of|(including drug-liking), pharmacokinetics, and safety of
5636791|NCT00751478|ALO-01 when administered whole or crushed and compared to|alo-01 when administered whole or crushed and compared to
5636792|NCT00751478|equivalent doses of immediate release morphine and placebo|equivalent doses of immediate release morphine and placebo
5636793|NCT00751465|Social Anxiety Disorder|social anxiety disorder
5636795|NCT00751465|Fear of blushing|fear of blushing
5636796|NCT00751465|attention|attention
5636797|NCT00751465|attention training|attention training
5636798|NCT00751465|cognitive behavior therapy|cognitive behavior therapy
5636799|NCT00751452|Children|children
5636800|NCT00751452|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5636801|NCT00751452|Intestinal damage|intestinal damage
5636802|NCT00751452|Citrulline|citrulline
5636803|NCT00751452|Graft versus Host Disease|graft versus host disease
5636804|NCT00751452|0 to 18 years old|0 to 18 years old
5636805|NCT00751439|Oximeter|oximeter
5636806|NCT00751439|Arterial blood gas|arterial blood gas
5636807|NCT00751439|comparison|comparison
5636808|NCT00751426|Interferon-alpha|interferon-alpha
5636809|NCT00751426|hepatitis c|hepatitis c
5636810|NCT00751426|Drug addiction|drug addiction
5636811|NCT00751426|methadone|methadone
5636812|NCT00751426|psychiatric disorder|psychiatric disorder
5618671|NCT00823511|Carcinogenesis|carcinogenesis
5636813|NCT00751426|Safety and efficacy of Interferon-alpha i patients with a psychiatric disorder.|safety and efficacy of interferon-alpha i patients with a psychiatric disorder.
5636814|NCT00751400|Non-prescription|non-prescription
5636815|NCT00751361|Rheopheresis|rheopheresis
5636816|NCT00751361|Dry Age Related Macular Degeneration|dry age related macular degeneration
5636817|NCT00751361|AMD|amd
5636818|NCT00751361|apheresis|apheresis
5636819|NCT00751361|microcirculation|microcirculation
5636821|NCT00751348|one-dose schedule|one-dose schedule
5636822|NCT00751348|varicella|varicella
5636823|NCT00751348|rubella|rubella
5636824|NCT00751348|measles|measles
5636826|NCT00751335|Obstructive Sleep Apnea|obstructive sleep apnea
5636827|NCT00751335|Humidification|humidification
5636828|NCT00751335|Continuous Positive Airway Pressure|continuous positive airway pressure
5636829|NCT00751322|Pulmonary|pulmonary
5636830|NCT00751322|Protein|protein
5636831|NCT00751309|allograft|allograft
5636832|NCT00751309|rejection|rejection
5636833|NCT00751309|biopsy|biopsy
5636834|NCT00751309|gene|gene
5636835|NCT00751309|expression|expression
5636836|NCT00751309|pulmonary|pulmonary
5636837|NCT00751309|lung|lung
5636838|NCT00751309|transplant|transplant
5636839|NCT00751296|Lenalidomide|lenalidomide
5636840|NCT00751296|immunomodulatory drug (IMiD®)|immunomodulatory drug (imid®)
5636841|NCT00751296|Thalidomide analogues|thalidomide analogues
5636842|NCT00751270|Immunotherapy|immunotherapy
5636843|NCT00751270|Gene therapy|gene therapy
5636844|NCT00751270|Tumor Vaccine|tumor vaccine
5636845|NCT00751270|Cytotoxicity|cytotoxicity
5636846|NCT00751270|Radiation|radiation
5636847|NCT00751257|Nicotine|nicotine
5636848|NCT00751257|N-acetylcysteine|n-acetylcysteine
5636849|NCT00751257|smoking reduction|smoking reduction
5636850|NCT00751244|women|women
5636851|NCT00751244|posttraumatic stress disorder|posttraumatic stress disorder
5636852|NCT00751244|PTSD|ptsd
5636853|NCT00751244|psychotherapy|psychotherapy
5636854|NCT00751244|clinical trial|clinical trial
5636855|NCT00751244|emotion regulation|emotion regulation
5636856|NCT00751231|PCI|pci
5636857|NCT00751231|percutaneous coronary intervention|percutaneous coronary intervention
5636858|NCT00751205|Peripheral Neuropathy|peripheral neuropathy
5636859|NCT00751205|Prostate Carcinoma|prostate carcinoma
5636860|NCT00751205|Ovarian Carcinoma|ovarian carcinoma
5636861|NCT00751192|Men who have sex with men|men who have sex with men
5636862|NCT00751192|Peru|peru
5636863|NCT00751192|HIV testing|hiv testing
5636864|NCT00751192|video|video
5636865|NCT00751192|online|online
5636866|NCT00751192|Internet|internet
5636867|NCT00751192|HIV Seronegativity|hiv seronegativity
5636868|NCT00751153|drug substitution|drug substitution
5636869|NCT00751153|Raltegravir|raltegravir
5636870|NCT00751153|Atazanavir|atazanavir
5636871|NCT00751153|treatment Experienced|treatment experienced
5636872|NCT00751140|surgical candidates|surgical candidates
5636873|NCT00751140|upper urinary tract|upper urinary tract
5636874|NCT00751140|urothelial carcinoma|urothelial carcinoma
5636875|NCT00751140|lymph node dissection|lymph node dissection
5636876|NCT00751127|open angle glaucoma|open angle glaucoma
5636877|NCT00751127|ocular hypertension|ocular hypertension
5636878|NCT00751101|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5636879|NCT00751101|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5636880|NCT00751101|stage IV breast cancer|stage iv breast cancer
5636881|NCT00751101|recurrent breast cancer|recurrent breast cancer
5636883|NCT00751088|sling|sling
5636884|NCT00751088|stress incontinence|stress incontinence
5636885|NCT00751088|surgery|surgery
5636886|NCT00751088|treatment|treatment
5636887|NCT00751088|Female urinary stress incontinence|female urinary stress incontinence
5636890|NCT00751036|GIST|gist
5636891|NCT00751023|Methamphetamine|methamphetamine
5636892|NCT00751023|Modafinil|modafinil
5636893|NCT00751023|Addiction|addiction
5636894|NCT00751023|Craving|craving
5636896|NCT00751010|Vulvar pain|vulvar pain
5636897|NCT00751010|Vulvodynia|vulvodynia
5636898|NCT00751010|Interstitial cystitis|interstitial cystitis
5636899|NCT00750971|ASSIST|assist
5636900|NCT00750971|SLE|sle
5636901|NCT00750971|Stem Cell Transplantation|stem cell transplantation
5636902|NCT00750971|Tolerance|tolerance
5636903|NCT00750958|cardiac rhythm changes|cardiac rhythm changes
5636904|NCT00750945|Parkinson's disease|parkinson's disease
5636905|NCT00750945|Cueing training|cueing training
5636906|NCT00750945|Treadmill training|treadmill training
5636907|NCT00750945|Music|music
5636908|NCT00750893|Gastroenteritis|gastroenteritis
5636909|NCT00750867|multiple system atrophy, MSA,|multiple system atrophy, msa,
5636910|NCT00750867|intravenous immunoglobulin, IVIg|intravenous immunoglobulin, ivig
5636911|NCT00750854|arthritis|arthritis
5636912|NCT00750854|osteoarthritis|osteoarthritis
5636913|NCT00750854|fibromyalgia|fibromyalgia
5636914|NCT00750854|connective tissue disorder|connective tissue disorder
5636915|NCT00750841|advanced cancer|advanced cancer
5636916|NCT00750841|metastatic|metastatic
5636917|NCT00750841|rifampicin|rifampicin
5636918|NCT00750841|pharmacokinetics|pharmacokinetics
5636919|NCT00750841|Phase I|phase i
5636920|NCT00750841|Advanced solid tumours|advanced solid tumours
5636921|NCT00750828|Saliva|saliva
5636922|NCT00750828|Sjögren's Syndrome|sjögren's syndrome
5636923|NCT00750828|GCF|gcf
5636924|NCT00750828|Oral Mucosal Wetness|oral mucosal wetness
5636925|NCT00750815|B Cell|b cell
5636926|NCT00750815|hematologic malignancy|hematologic malignancy
5636927|NCT00750815|plasma|plasma
5636928|NCT00750815|bone marrow|bone marrow
5636929|NCT00750802|Phase I|phase i
5636930|NCT00750776|Quality assurance|quality assurance
5636931|NCT00750776|medical treatment|medical treatment
5636932|NCT00750776|Patient satisfaction|patient satisfaction
5636933|NCT00750763|Mucosal inflammation|mucosal inflammation
5636934|NCT00750763|Fleet|fleet
5636935|NCT00750763|Picoprep|picoprep
5636936|NCT00750763|Colonlytely|colonlytely
5636937|NCT00750763|Colonoscopy|colonoscopy
5636938|NCT00750763|tolerability|tolerability
5636939|NCT00750763|efficacy|efficacy
5636940|NCT00750737|Hematologic Malignancies|hematologic malignancies
5636941|NCT00750737|Blood Cancer|blood cancer
5636942|NCT00750737|Lymphatic Cancer|lymphatic cancer
5636943|NCT00750737|Amphotericin B Lipid Complex|amphotericin b lipid complex
5636944|NCT00750737|Amphotericin B|amphotericin b
5636945|NCT00750737|ABLC|ablc
5636946|NCT00750737|Fungizone|fungizone
5636947|NCT00750737|Noxafil|noxafil
5636948|NCT00750737|SCH56592|sch56592
5636949|NCT00750737|Posaconazole|posaconazole
5637075|NCT00750204|Cytokines|cytokines
5636950|NCT00750737|Invasive fungal infections|invasive fungal infections
5636951|NCT00750737|IFI|ifi
5636952|NCT00750737|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5636953|NCT00750737|HSCT|hsct
5636954|NCT00750737|Bone Marrow Transplant|bone marrow transplant
5636955|NCT00750737|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5636956|NCT00750724|Hyaluronic acid,|hyaluronic acid,
5636957|NCT00750724|OA knee,|oa knee,
5636958|NCT00750724|MRI|mri
5636959|NCT00750698|lung cancer|lung cancer
5636960|NCT00750698|non small cell lung cancer|non small cell lung cancer
5636961|NCT00750685|Primary Breast Reconstruction|primary breast reconstruction
5636962|NCT00750672|Endometrial neoplasia|endometrial neoplasia
5636963|NCT00750672|Follow-up care|follow-up care
5636964|NCT00750672|survivorship|survivorship
5636965|NCT00750672|Primary care provider|primary care provider
5636966|NCT00750659|Chronic myeloid leukemia|chronic myeloid leukemia
5636967|NCT00750659|Ph+ acute lymphoblastic leukemia|ph+ acute lymphoblastic leukemia
5636968|NCT00750659|stem cell transplantation|stem cell transplantation
5636969|NCT00750659|nilotinib|nilotinib
5636970|NCT00750646|compliance|compliance
5636971|NCT00750646|eye drop administration|eye drop administration
5636972|NCT00750646|MEMS|mems
5636973|NCT00750646|adherence|adherence
5636974|NCT00750633|swimmer's ear|swimmer's ear
5636975|NCT00750633|ear drops|ear drops
5636976|NCT00750633|ear infection|ear infection
5636977|NCT00750633|ear pain|ear pain
5636978|NCT00750633|ear inflammation|ear inflammation
5636979|NCT00750620|mild, moderate, and severe renal impaired subjects|mild, moderate, and severe renal impaired subjects
5636980|NCT00750620|normal renal function subjects|normal renal function subjects
5636981|NCT00750620|Glomerular filtration rate (GFR)|glomerular filtration rate (gfr)
5636982|NCT00750620|Modification of Diet in Renal Disease (MDRD) formula|modification of diet in renal disease (mdrd) formula
5636983|NCT00750620|YM178|ym178
5636984|NCT00750620|pharmacokinetics|pharmacokinetics
5636985|NCT00750594|Children|children
5636986|NCT00750594|Migraine headaches|migraine headaches
5636987|NCT00750581|Patent Ductus Arteriosus|patent ductus arteriosus
5636988|NCT00750568|Bronchial asthma|bronchial asthma
5636989|NCT00750568|Asthma, bronchial|asthma, bronchial
5636990|NCT00750568|Status Asthmaticus|status asthmaticus
5636991|NCT00750568|Terbutaline sulfate|terbutaline sulfate
5636992|NCT00750555|squamous cell cancer of head and neck|squamous cell cancer of head and neck
5636993|NCT00750555|SCCHN|scchn
5636994|NCT00750529|sleep|sleep
5636995|NCT00750529|Alzheimer|alzheimer
5636996|NCT00750529|old patients|old patients
5636997|NCT00750516|Lactic acid|lactic acid
5636998|NCT00750516|hypotension|hypotension
5636999|NCT00750516|sepsis|sepsis
5637000|NCT00750503|tobacco cessation|tobacco cessation
5637001|NCT00750503|behavioral therapy|behavioral therapy
5637002|NCT00750503|pharmacotherapy|pharmacotherapy
5637003|NCT00750503|workplace|workplace
5637004|NCT00750503|oral cancer screening|oral cancer screening
5637005|NCT00750503|Tobacco Quit rates|tobacco quit rates
5637006|NCT00750477|osteoarthritis|osteoarthritis
5637007|NCT00750477|arthritis|arthritis
5637008|NCT00750477|knee|knee
5637009|NCT00750477|eggshell|eggshell
5637010|NCT00750477|membrane|membrane
5637011|NCT00750477|OPTION|option
5637012|NCT00750451|fertilization in vitro|fertilization in vitro
5637013|NCT00750451|assisted reproduction|assisted reproduction
5637014|NCT00750451|recurrent implantation failure|recurrent implantation failure
5637015|NCT00750451|low molecular weight heparin|low molecular weight heparin
5637016|NCT00750451|heparin|heparin
5637017|NCT00750451|luteal phase|luteal phase
5637018|NCT00750438|Obesity|obesity
5637019|NCT00750438|Short chain fatty acids|short chain fatty acids
5637020|NCT00750438|Appetite|appetite
5637021|NCT00750438|Body weight|body weight
5637022|NCT00750438|Insulin sensitivity|insulin sensitivity
5637023|NCT00750438|Propionate|propionate
5637024|NCT00750438|Propionate ester|propionate ester
5637025|NCT00750425|advanced cancer,|advanced cancer,
5637026|NCT00750425|metastatic|metastatic
5637027|NCT00750425|ketoconazole|ketoconazole
5637028|NCT00750425|pharmacokinetics|pharmacokinetics
5637029|NCT00750425|Phase I|phase i
5637030|NCT00750412|TeenScreen|teenscreen
5637031|NCT00750412|Mental Health|mental health
5637032|NCT00750412|Adolescent Mental Health|adolescent mental health
5637034|NCT00750399|radiation|radiation
5637035|NCT00750399|retinopathy|retinopathy
5637036|NCT00750399|ranibizumab|ranibizumab
5637037|NCT00750399|melanoma|melanoma
5637038|NCT00750399|choroid|choroid
5637039|NCT00750386|Cancer|cancer
5637040|NCT00750386|Ovarian cancer|ovarian cancer
5637041|NCT00750386|Dose-dense chemotherapy|dose-dense chemotherapy
5637042|NCT00750373|Endocarditis|endocarditis
5637043|NCT00750360|Influenza|influenza
5637044|NCT00750360|Korea|korea
5637045|NCT00750360|FluarixTM|fluarixtm
5637046|NCT00750347|pain,|pain,
5637047|NCT00750347|analgesia|analgesia
5637048|NCT00750347|Healthy volunteers|healthy volunteers
5637049|NCT00750334|Oral Clofarabine,|oral clofarabine,
5637050|NCT00750334|relapsed/refractory MDS,|relapsed/refractory mds,
5637051|NCT00750334|Myelodysplastic|myelodysplastic
5637052|NCT00750295|Chronic kidney disease,|chronic kidney disease,
5637053|NCT00750295|hemodialysis,|hemodialysis,
5637054|NCT00750295|serum phosphorus,|serum phosphorus,
5637055|NCT00750295|phosphate binders|phosphate binders
5637056|NCT00750282|Alzheimer Disease|alzheimer disease
5637057|NCT00750282|Amyloid beta-Protein|amyloid beta-protein
5637058|NCT00750269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5637059|NCT00750256|tolerability|tolerability
5637060|NCT00750256|Safety|safety
5637061|NCT00750256|pharmacokinetics|pharmacokinetics
5637062|NCT00750230|arthritis|arthritis
5637063|NCT00750230|osteoarthritis|osteoarthritis
5637064|NCT00750230|fibromyalgia|fibromyalgia
5637065|NCT00750230|connective tissue disorder|connective tissue disorder
5637066|NCT00750217|transfer methadone buprenorphine patch heroin addiction|transfer methadone buprenorphine patch heroin addiction
5637067|NCT00750204|Acute Lung Injury|acute lung injury
5637069|NCT00750204|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5637070|NCT00750204|Mechanical Ventilation|mechanical ventilation
5637071|NCT00750204|Sedation|sedation
5637072|NCT00750204|Critical Illness|critical illness
5637073|NCT00750204|Ventilator Induced Lung Injury|ventilator induced lung injury
5637074|NCT00750204|VILI|vili
5637076|NCT00750204|Protective Ventilation|protective ventilation
5637077|NCT00750204|Airway Pressure Release Ventilation|airway pressure release ventilation
5637078|NCT00750204|APRV|aprv
5637079|NCT00750204|Breathing Comfort|breathing comfort
5637080|NCT00750204|Dyssynchrony|dyssynchrony
5637081|NCT00750204|Asynchrony|asynchrony
5637082|NCT00750191|Lower Back Pain|lower back pain
5637083|NCT00750165|Obstructive Sleep Apnea|obstructive sleep apnea
5637084|NCT00750165|Humidification|humidification
5637085|NCT00750165|Continuous Positive Airway Pressure|continuous positive airway pressure
5637087|NCT00750152|jock itch|jock itch
5637088|NCT00750139|Tinea Pedis|tinea pedis
5637089|NCT00750139|Athlete's foot|athlete's foot
5637090|NCT00750126|Allograft|allograft
5637091|NCT00750126|Children|children
5637092|NCT00750126|malignancy|malignancy
5637093|NCT00750126|Reduced Intensity Conditioning|reduced intensity conditioning
5637094|NCT00750126|Fludarabin|fludarabin
5637095|NCT00750126|Busulfex|busulfex
5637096|NCT00750126|Thymoglobulin|thymoglobulin
5637097|NCT00750100|infertility|infertility
5637098|NCT00750100|IVF|ivf
5637100|NCT00750100|primary infertility|primary infertility
5637101|NCT00750100|secondary infertility|secondary infertility
5637102|NCT00750100|patients requiring in-vitro fertilisation|patients requiring in-vitro fertilisation
5637103|NCT00750087|Schizophrenia|schizophrenia
5637104|NCT00750074|mechanical ventilation|mechanical ventilation
5637105|NCT00750061|Spinal Cord Injury|spinal cord injury
5637106|NCT00750048|pain,|pain,
5637107|NCT00750048|sensitization,|sensitization,
5637108|NCT00750048|analgesia|analgesia
5637109|NCT00750035|Total hysterectomy|total hysterectomy
5637110|NCT00750035|subtotal hysterectomy|subtotal hysterectomy
5637111|NCT00750035|urinary function|urinary function
5637112|NCT00750035|bowel function|bowel function
5637113|NCT00750035|sexual function|sexual function
5637114|NCT00750035|Quality of life|quality of life
5637115|NCT00750035|Psychological function|psychological function
5637116|NCT00750009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5637117|NCT00750009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5637118|NCT00750009|acute undifferentiated leukemia|acute undifferentiated leukemia
5637119|NCT00750009|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5637120|NCT00750009|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5618965|NCT00822445|Neurological sequelae|neurological sequelae
5637121|NCT00750009|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5637122|NCT00750009|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5637123|NCT00750009|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5637124|NCT00750009|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5637125|NCT00750009|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5680392|NCT00577993|Methyl-Prednisolone|methyl-prednisolone
5637126|NCT00750009|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5637127|NCT00750009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5637128|NCT00750009|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5637129|NCT00750009|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5637130|NCT00750009|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5637131|NCT00750009|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5637132|NCT00750009|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5637133|NCT00750009|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5637134|NCT00750009|mast cell leukemia|mast cell leukemia
5637135|NCT00750009|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5637136|NCT00750009|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5637137|NCT00750009|prolymphocytic leukemia|prolymphocytic leukemia
5637138|NCT00750009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5637139|NCT00750009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5637140|NCT00750009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5637141|NCT00750009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5637142|NCT00750009|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5637143|NCT00750009|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5637144|NCT00750009|refractory hairy cell leukemia|refractory hairy cell leukemia
5637145|NCT00750009|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5637146|NCT00750009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5637147|NCT00750009|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5637148|NCT00750009|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5637149|NCT00750009|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5637150|NCT00750009|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5637151|NCT00750009|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5637152|NCT00750009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5637153|NCT00750009|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5637154|NCT00750009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5637155|NCT00750009|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5637156|NCT00750009|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5637157|NCT00750009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5637158|NCT00750009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5637159|NCT00750009|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5637160|NCT00750009|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5637161|NCT00750009|untreated hairy cell leukemia|untreated hairy cell leukemia
5637162|NCT00750009|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5637163|NCT00750009|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5637164|NCT00750009|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5637165|NCT00750009|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5637166|NCT00750009|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5637167|NCT00750009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5637168|NCT00750009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5637169|NCT00750009|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5637170|NCT00750009|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5637171|NCT00750009|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5637172|NCT00750009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5637173|NCT00750009|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5637174|NCT00750009|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5637175|NCT00750009|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5637176|NCT00750009|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5637177|NCT00750009|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5637178|NCT00750009|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5637179|NCT00750009|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5637180|NCT00750009|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5637181|NCT00750009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5637182|NCT00750009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5637183|NCT00750009|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5637184|NCT00750009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5637185|NCT00750009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5637186|NCT00750009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5637187|NCT00750009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5680393|NCT00577993|Procarbazine|procarbazine
5637188|NCT00750009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5637189|NCT00750009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5637190|NCT00750009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5637191|NCT00750009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5637192|NCT00750009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5637193|NCT00750009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5637194|NCT00750009|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5637195|NCT00750009|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5637196|NCT00750009|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5637197|NCT00750009|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5637198|NCT00750009|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5637199|NCT00750009|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5637200|NCT00750009|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5637201|NCT00750009|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5637202|NCT00750009|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5637203|NCT00750009|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5637204|NCT00750009|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5637205|NCT00750009|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5637206|NCT00750009|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5637207|NCT00750009|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5637208|NCT00750009|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5637209|NCT00750009|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5637210|NCT00750009|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5637211|NCT00750009|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5637212|NCT00750009|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5637213|NCT00750009|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5637214|NCT00750009|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5637215|NCT00750009|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5637216|NCT00750009|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5637217|NCT00750009|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5637219|NCT00750009|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5637220|NCT00750009|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5637221|NCT00750009|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5637222|NCT00750009|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5637223|NCT00750009|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5825970|NCT00066209|SARS|sars
5637224|NCT00750009|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5637225|NCT00750009|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5637226|NCT00750009|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5637227|NCT00750009|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5637228|NCT00750009|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5637229|NCT00750009|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5637230|NCT00750009|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5637231|NCT00750009|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5637232|NCT00750009|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5637233|NCT00750009|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5637234|NCT00750009|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5637235|NCT00750009|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5637236|NCT00750009|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5637237|NCT00750009|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5637238|NCT00750009|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5619209|NCT00821340|LCA|lca
5637239|NCT00750009|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5637240|NCT00750009|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5637241|NCT00750009|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5637242|NCT00750009|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5637243|NCT00750009|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5685477|NCT00555932|Intracranial Thrombosis|intracranial thrombosis
5637244|NCT00750009|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5680394|NCT00577993|Prednisone|prednisone
5637245|NCT00750009|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5637246|NCT00750009|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5637247|NCT00750009|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5637248|NCT00750009|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5637249|NCT00750009|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5637250|NCT00750009|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5637251|NCT00750009|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5637252|NCT00750009|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5637253|NCT00750009|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5637254|NCT00750009|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5637255|NCT00750009|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5637256|NCT00750009|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5637257|NCT00750009|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5637258|NCT00750009|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5637259|NCT00750009|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5637260|NCT00750009|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5637261|NCT00750009|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5637262|NCT00750009|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5637263|NCT00750009|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5637264|NCT00750009|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5637265|NCT00750009|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5637266|NCT00750009|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5637267|NCT00750009|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5637268|NCT00750009|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5637269|NCT00750009|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5637270|NCT00750009|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5637271|NCT00750009|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5637272|NCT00750009|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5637273|NCT00750009|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5637274|NCT00750009|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5637275|NCT00750009|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5631289|NCT00774124|GDM, pregnancy, macrosomia|gdm, pregnancy, macrosomia
5637276|NCT00750009|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5637277|NCT00750009|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5637279|NCT00750009|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5637280|NCT00750009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5671715|NCT00614666|Valley Fever|valley fever
5637281|NCT00750009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5637282|NCT00750009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5637283|NCT00750009|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5637284|NCT00750009|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5637285|NCT00750009|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5637286|NCT00750009|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5637287|NCT00750009|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5637288|NCT00750009|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5637289|NCT00750009|Burkitt lymphoma|burkitt lymphoma
5637290|NCT00750009|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5637291|NCT00750009|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5637292|NCT00750009|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5637293|NCT00750009|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5637294|NCT00750009|intraocular lymphoma|intraocular lymphoma
5637295|NCT00750009|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5637296|NCT00750009|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5637297|NCT00750009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5637298|NCT00750009|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5637299|NCT00750009|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5637300|NCT00750009|primary myelofibrosis|primary myelofibrosis
5637301|NCT00750009|essential thrombocythemia|essential thrombocythemia
5637302|NCT00750009|polycythemia vera|polycythemia vera
5637303|NCT00750009|extramedullary plasmacytoma|extramedullary plasmacytoma
5637304|NCT00750009|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5637305|NCT00750009|stage I multiple myeloma|stage i multiple myeloma
5637306|NCT00750009|stage II multiple myeloma|stage ii multiple myeloma
5637307|NCT00750009|stage III multiple myeloma|stage iii multiple myeloma
5622194|NCT00810823|Diabetes|diabetes
5637308|NCT00750009|primary systemic amyloidosis|primary systemic amyloidosis
5637309|NCT00750009|refractory multiple myeloma|refractory multiple myeloma
5637310|NCT00750009|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5637311|NCT00750009|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5637312|NCT00750009|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5637313|NCT00750009|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5637314|NCT00750009|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5637315|NCT00750009|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5637316|NCT00750009|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5637317|NCT00750009|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5637318|NCT00750009|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5637319|NCT00750009|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5637320|NCT00749970|schizophrenia|schizophrenia
5637321|NCT00749970|subjective well-being|subjective well-being
5637322|NCT00749970|psychometric validation|psychometric validation
5637323|NCT00749957|AAV|aav
5637324|NCT00749957|adeno-associated virus|adeno-associated virus
5637325|NCT00749957|RPE65|rpe65
5637326|NCT00749957|Leber congenital amaurosis|leber congenital amaurosis
5637327|NCT00749957|LCA|lca
5637328|NCT00749957|gene therapy|gene therapy
5637329|NCT00749957|human gene transfer|human gene transfer
5637330|NCT00749944|nicotine withdrawal, smoking cessation, varenicline|nicotine withdrawal, smoking cessation, varenicline
5637331|NCT00749931|IDC, DCIS, ILC|idc, dcis, ilc
5637332|NCT00749918|vitamin D|vitamin d
5637333|NCT00749918|Cholecalciferol|cholecalciferol
5637334|NCT00749918|Insulin sensitivity|insulin sensitivity
5637335|NCT00749918|MinMod Millennium|minmod millennium
5637336|NCT00749918|FSIGT|fsigt
5637337|NCT00749918|modified frequently sampled IV glucose tolerance test|modified frequently sampled iv glucose tolerance test
5637338|NCT00749879|PK|pk
5637339|NCT00749879|Pharmacokinetics|pharmacokinetics
5637340|NCT00749866|Nebulised antibiotics|nebulised antibiotics
5637341|NCT00749866|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5637342|NCT00749866|Bacterial Load|bacterial load
5637343|NCT00749866|Inflammation|inflammation
5637344|NCT00749866|Quality of Life|quality of life
5637345|NCT00749866|Side Effects|side effects
5637346|NCT00749853|ovarian stimulation|ovarian stimulation
5637347|NCT00749853|FSH|fsh
5637349|NCT00749853|polymorphism|polymorphism
5637350|NCT00749840|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5637351|NCT00749840|Human Immunodeficiency Virus|human immunodeficiency virus
5637352|NCT00749840|Questionnaire|questionnaire
5637353|NCT00749840|AIDS|aids
5637354|NCT00749840|HIV|hiv
5637355|NCT00749840|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5637356|NCT00749840|HAART|haart
5637357|NCT00749840|Steps of HIV Care|steps of hiv care
5637358|NCT00749840|CDC|cdc
5637359|NCT00749827|Contrast Induced Nephropathy, fluid prophylaxis|contrast induced nephropathy, fluid prophylaxis
5637360|NCT00749814|sleep patterns in children in the night prior to surgery and post surgery.|sleep patterns in children in the night prior to surgery and post surgery.
5637361|NCT00749814|the influence of melatonin on sleep patterns|the influence of melatonin on sleep patterns
5637362|NCT00749801|drug naive|drug naive
5637369|NCT00749775|Good post-marketing study Practice|good post-marketing study practice
5637370|NCT00749775|Drug use Investigation|drug use investigation
5637371|NCT00749775|Regulatory Post Marketing Commitment Plan|regulatory post marketing commitment plan
5637373|NCT00749762|DURING|during
5637374|NCT00749762|PRONE|prone
5637375|NCT00749762|SUPINE|supine
5637376|NCT00749762|POSITIONING|positioning
5637377|NCT00749749|Abdominal Hysterectomy|abdominal hysterectomy
5637378|NCT00749749|Postoperative pain|postoperative pain
5637379|NCT00749736|vitamin D|vitamin d
5637380|NCT00749736|determine|determine
5637381|NCT00749736|normal|normal
5637382|NCT00749736|intrapatient|intrapatient
5637383|NCT00749736|interpatient|interpatient
5637384|NCT00749736|variability|variability
5637385|NCT00749736|measures|measures
5637386|NCT00749736|immune system|immune system
5637387|NCT00749723|brain tumor|brain tumor
5637388|NCT00749723|relapse|relapse
5637389|NCT00749723|children|children
5637390|NCT00749723|etoposide|etoposide
5637391|NCT00749723|intraventricular|intraventricular
5637392|NCT00749723|temozolomide|temozolomide
5637393|NCT00749710|femoral neck fractures|femoral neck fractures
5637394|NCT00749710|pertrochanteric fractures|pertrochanteric fractures
5637395|NCT00749710|antiaggregant therapy|antiaggregant therapy
5637396|NCT00749710|clopidogrel|clopidogrel
5637397|NCT00749710|plavix|plavix
5637398|NCT00749697|radioiodine|radioiodine
5637399|NCT00749697|differentiated thyroid cancers|differentiated thyroid cancers
5637400|NCT00749697|dosimetry|dosimetry
5637401|NCT00749697|metastases|metastases
5637402|NCT00749684|interferon-alpha|interferon-alpha
5637403|NCT00749658|Tobacco|tobacco
5637404|NCT00749658|Nicotine|nicotine
5637405|NCT00749658|Smoking|smoking
5637406|NCT00749658|Varenicline|varenicline
5637407|NCT00749658|Bupropion|bupropion
5637408|NCT00749658|Human laboratory study|human laboratory study
5637409|NCT00749658|Stress tolerance|stress tolerance
5637410|NCT00749658|Startle response|startle response
5637411|NCT00749658|Cognitive assessment|cognitive assessment
5637412|NCT00749658|Progressive ratio|progressive ratio
5637413|NCT00749658|Motivation|motivation
5637414|NCT00749645|Arthritis, Rheumatoid, Andrographolides treatment, Efficacy.|arthritis, rheumatoid, andrographolides treatment, efficacy.
5637415|NCT00749632|urinary incontinence, urge|urinary incontinence, urge
5637416|NCT00749632|urinary urge incontinence|urinary urge incontinence
5637417|NCT00749632|urge incontinence|urge incontinence
5637418|NCT00749632|over active bladder|over active bladder
5637419|NCT00749619|Tunneled Cuffed Catheter|tunneled cuffed catheter
5637420|NCT00749619|Catheter Lock Solution|catheter lock solution
5637421|NCT00749619|Catheter Related Bacteremia|catheter related bacteremia
5637422|NCT00749606|Obesity|obesity
5637423|NCT00749606|Metabolic syndrome|metabolic syndrome
5637424|NCT00749606|Weight loss|weight loss
5637425|NCT00749606|Diabetes prevention|diabetes prevention
5637426|NCT00749593|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5637427|NCT00749593|Quality of Life|quality of life
5637428|NCT00749593|Genotype|genotype
5637429|NCT00749593|Metabolic outcomes|metabolic outcomes
5637430|NCT00749580|Safety|safety
5637431|NCT00749567|NSCLC|nsclc
5637432|NCT00749567|TKI's|tki's
5637433|NCT00749567|Anti-VEGF|anti-vegf
5637434|NCT00749554|Cooled Radiofrequency|cooled radiofrequency
5637435|NCT00749554|Disc biacuplasty|disc biacuplasty
5637436|NCT00749554|TransDiscal system|transdiscal system
5637437|NCT00749554|Discogenic pain|discogenic pain
5637438|NCT00749541|vitamin d coronary catheterization|vitamin d coronary catheterization
5637439|NCT00749528|Wheezing|wheezing
5637440|NCT00749528|Hair trace elements|hair trace elements
5637441|NCT00749528|Hair toxic metals|hair toxic metals
5637442|NCT00749528|Oxidative stress|oxidative stress
5637443|NCT00749515|Thalassemia|thalassemia
5637444|NCT00749515|Iron|iron
5637445|NCT00749515|Chelation|chelation
5637446|NCT00749502|Neoplasms|neoplasms
5637447|NCT00749502|Ovarian neoplasms|ovarian neoplasms
5637448|NCT00749502|Prostatic neoplasms|prostatic neoplasms
5637449|NCT00749502|Endocrine gland neoplasms|endocrine gland neoplasms
5637450|NCT00749502|Ovarian diseases|ovarian diseases
5637451|NCT00749502|Adnexal diseases|adnexal diseases
5637452|NCT00749502|Genital diseases, female|genital diseases, female
5637453|NCT00749502|Genital diseases, male|genital diseases, male
5637454|NCT00749502|Genital neoplasms, female|genital neoplasms, female
5637455|NCT00749502|Urogenital neoplasms|urogenital neoplasms
5637456|NCT00749502|Endocrine system diseases|endocrine system diseases
5637457|NCT00749502|Gonadal disorders|gonadal disorders
5637458|NCT00749502|Genital neoplasms, male|genital neoplasms, male
5637459|NCT00749502|Prostatic diseases|prostatic diseases
5637460|NCT00749489|Pain|pain
5637461|NCT00749489|Hip Fractures|hip fractures
5637462|NCT00749489|Femoral Fractures|femoral fractures
5637463|NCT00749489|Analgesics|analgesics
5637464|NCT00749489|Opioid|opioid
5637465|NCT00749489|Nerve Block|nerve block
5637466|NCT00749489|Geriatric|geriatric
5637467|NCT00749489|Nerve Stimulation|nerve stimulation
5637468|NCT00749463|nicotine dependence, smoking cessation, NRT|nicotine dependence, smoking cessation, nrt
5637469|NCT00749450|stage II colon cancer|stage ii colon cancer
5637470|NCT00749450|stage III colon cancer|stage iii colon cancer
5637473|NCT00749437|stage I breast cancer|stage i breast cancer
5637474|NCT00749437|stage II breast cancer|stage ii breast cancer
5637475|NCT00749437|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5637476|NCT00749437|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5637477|NCT00749437|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5637478|NCT00749437|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5637479|NCT00749437|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5637480|NCT00749437|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5637481|NCT00749437|breast cancer in situ|breast cancer in situ
5637482|NCT00749411|COPD|copd
5637483|NCT00749411|long-acting beta agonist|long-acting beta agonist
5637484|NCT00749411|Emphysema|emphysema
5637485|NCT00749411|Chronic Bronchitis|chronic bronchitis
5637486|NCT00749411|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5637487|NCT00749411|bronchodilator|bronchodilator
5619472|NCT00820339|overall survival|overall survival
5637488|NCT00749411|long acting muscarinic antagonist|long acting muscarinic antagonist
5637489|NCT00749359|healthy volunteers|healthy volunteers
5637490|NCT00749359|paroxetine|paroxetine
5637491|NCT00749346|TTFields|ttfields
5637492|NCT00749346|NSCLC|nsclc
5637493|NCT00749346|Alimta|alimta
5637494|NCT00749346|Pemetrexed|pemetrexed
5637495|NCT00749333|Healthy Volunteer|healthy volunteer
5637496|NCT00749333|Safety|safety
5637497|NCT00749333|Tolerability|tolerability
5637498|NCT00749333|AZD8566|azd8566
5637499|NCT00749333|study|study
5637503|NCT00749307|Heart rate variability|heart rate variability
5637504|NCT00749307|Docosahexaenoic acid|docosahexaenoic acid
5637505|NCT00749307|DHA|dha
5637506|NCT00749307|Long chain fatty acids|long chain fatty acids
5637507|NCT00749307|Long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5637508|NCT00749307|Algal fatty acids|algal fatty acids
5637509|NCT00749307|Schizochytrium|schizochytrium
5637510|NCT00749307|Omega 3|omega 3
5637511|NCT00749307|Death, Sudden, Cardiac|death, sudden, cardiac
5637512|NCT00749307|Arrhythmias, Cardiac|arrhythmias, cardiac
5637513|NCT00749281|atherosclerosis|atherosclerosis
5637514|NCT00749281|ngal|ngal
5637515|NCT00749281|coronary artery disease|coronary artery disease
5637516|NCT00749268|hernia|hernia
5637517|NCT00749255|Breast Cancer|breast cancer
5637518|NCT00749255|Digital archiver software|digital archiver software
5637519|NCT00749242|Traumatic vertebral fracture|traumatic vertebral fracture
5637520|NCT00749242|Vertebroplasty|vertebroplasty
5637521|NCT00749242|Balloon kyphoplasty|balloon kyphoplasty
5637522|NCT00749242|Bohler bracing|bohler bracing
5637523|NCT00749229|Traumatic vertebral fracture|traumatic vertebral fracture
5637524|NCT00749229|Balloon Kyphoplasty|balloon kyphoplasty
5637525|NCT00749229|type A3.2, or A3.3 or B1 or C1 in the MAGERL CLASSIFICATION|type a3.2, or a3.3 or b1 or c1 in the magerl classification
5637526|NCT00749203|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5637527|NCT00749203|PTSD|ptsd
5637528|NCT00749203|anxiety disorder|anxiety disorder
5637529|NCT00749203|ketamine|ketamine
5637530|NCT00749203|depression|depression
5637531|NCT00749203|depressed mood|depressed mood
5637532|NCT00749177|traditional healing|traditional healing
5637533|NCT00749177|anxiety|anxiety
5637534|NCT00749177|depression|depression
5637535|NCT00749177|aboriginal|aboriginal
5637536|NCT00749177|children|children
5637537|NCT00749177|youth|youth
5637538|NCT00749164|Mesenchymal stem cells|mesenchymal stem cells
5637539|NCT00749164|Umbilical cord|umbilical cord
5637540|NCT00749164|graft-vs-host disease|graft-vs-host disease
5637541|NCT00749164|Steroid resistant|steroid resistant
5637542|NCT00749151|smoking cessation|smoking cessation
5637543|NCT00749151|telephone help line|telephone help line
5637544|NCT00749138|hepatitis C, tamoxifen|hepatitis c, tamoxifen
5637545|NCT00749125|Emotional Circuitry|emotional circuitry
5637546|NCT00749125|fMRI|fmri
5637547|NCT00749112|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5637548|NCT00749112|Anemia|anemia
5637549|NCT00749112|Hemolytic|hemolytic
5637550|NCT00749112|Autoimmune|autoimmune
5637551|NCT00749112|Alemtuzumab|alemtuzumab
5637552|NCT00749112|Rituximab|rituximab
5637555|NCT00749086|Vertebral compression|vertebral compression
5637556|NCT00749086|Balloon kyphoplasty|balloon kyphoplasty
5637557|NCT00749086|Vertebroplasty|vertebroplasty
5637558|NCT00749073|Spinal Stenosis|spinal stenosis
5637559|NCT00749073|Lumbar Spinal Stenosis|lumbar spinal stenosis
5637561|NCT00749073|Laminectomy|laminectomy
5637562|NCT00749073|Spine Surgery|spine surgery
5637563|NCT00749060|osteoporosis|osteoporosis
5637564|NCT00749060|non-traumatic vertebral fracture|non-traumatic vertebral fracture
5637565|NCT00749060|vertebral compression|vertebral compression
5637566|NCT00749060|Balloon kyphoplasty|balloon kyphoplasty
5637567|NCT00749060|vertebroplasty|vertebroplasty
5637568|NCT00749047|Pioglitazone|pioglitazone
5637569|NCT00749047|Open study|open study
5637570|NCT00749047|Proteinuria|proteinuria
5637571|NCT00749047|Glomerular selectivity indices|glomerular selectivity indices
5637572|NCT00749034|Safety|safety
5637573|NCT00749034|Immunogenicity|immunogenicity
5637574|NCT00749034|Tuberculosis|tuberculosis
5637575|NCT00749034|Vaccination|vaccination
5637576|NCT00749034|Vaccination against tuberculosis|vaccination against tuberculosis
5637577|NCT00749034|Safety and immunogenicity of VPM1002 in comparison with BCG|safety and immunogenicity of vpm1002 in comparison with bcg
5637578|NCT00749021|choroidal neovascularization|choroidal neovascularization
5637579|NCT00749021|vascularized|vascularized
5637580|NCT00749008|Cerebral palsy|cerebral palsy
5637581|NCT00749008|Generalized movements|generalized movements
5637582|NCT00749008|Fidgety movements|fidgety movements
5637583|NCT00749008|Prechtl|prechtl
5637584|NCT00748982|AZD1305|azd1305
5637585|NCT00748982|anti-arrhythmics|anti-arrhythmics
5637586|NCT00748982|safety|safety
5637587|NCT00748969|MPS I|mps i
5637588|NCT00748969|MPS II|mps ii
5637589|NCT00748969|MPS VI|mps vi
5637590|NCT00748969|growth hormone|growth hormone
5637591|NCT00748969|short stature|short stature
5637592|NCT00748956|Mood Disorder|mood disorder
5637593|NCT00748956|Anxiety Disorders|anxiety disorders
5637594|NCT00748943|chlorine|chlorine
5637595|NCT00748943|dioxide|dioxide
5637596|NCT00748943|mouthwash|mouthwash
5637597|NCT00748943|halitosis|halitosis
5637598|NCT00748943|bacteria|bacteria
5637599|NCT00748943|saliva|saliva
5637600|NCT00748904|cirrhosis of liver and progressive renal failure|cirrhosis of liver and progressive renal failure
5637601|NCT00748891|Cancer|cancer
5637602|NCT00748891|tumour|tumour
5637603|NCT00748891|advanced sold tumour|advanced sold tumour
5637604|NCT00748891|imaging|imaging
5637605|NCT00748891|DCE-CT Scan|dce-ct scan
5637606|NCT00748891|DCE-MRI scan|dce-mri scan
5637607|NCT00748891|Cediranib|cediranib
5637608|NCT00748891|Recentin|recentin
5637609|NCT00748878|To better understand platelet function during ECMO|to better understand platelet function during ecmo
5637610|NCT00748865|Dry Eye|dry eye
5637611|NCT00748865|Artificial Tears|artificial tears
5637613|NCT00748839|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5637614|NCT00748839|heparin treatment|heparin treatment
5637615|NCT00748839|venous thrombosis|venous thrombosis
5637616|NCT00748839|arterial thrombosis|arterial thrombosis
5637617|NCT00748839|predictive clinical score|predictive clinical score
5637618|NCT00748839|biological test|biological test
5637619|NCT00748839|anti-H-PF4 antibodies|anti-h-pf4 antibodies
5637620|NCT00748813|Influenza vaccine|influenza vaccine
5637621|NCT00748800|HIV prevention|hiv prevention
5637622|NCT00748800|HIV seronegativity|hiv seronegativity
5637623|NCT00748774|Primary Brain Tumor|primary brain tumor
5637624|NCT00748774|Caregivers|caregivers
5637625|NCT00748774|Symptom Severity|symptom severity
5637626|NCT00748774|Questionnaire|questionnaire
5637627|NCT00748774|M.D. Anderson Symptom Inventory-Brain Tumor|m.d. anderson symptom inventory-brain tumor
5637628|NCT00748774|MDASI-BT|mdasi-bt
5637629|NCT00748761|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5637630|NCT00748761|OCD|ocd
5637631|NCT00748761|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5637632|NCT00748761|CBT|cbt
5637633|NCT00748761|MRSI|mrsi
5637634|NCT00748761|Glutamate|glutamate
5637635|NCT00748735|cardiac resynchronization therapy|cardiac resynchronization therapy
5637636|NCT00748735|echocardiography|echocardiography
5637637|NCT00748735|heart failure|heart failure
5637638|NCT00748735|left ventricular function|left ventricular function
5637639|NCT00748735|pacing|pacing
5637640|NCT00748735|myocardial deformation imaging|myocardial deformation imaging
5637641|NCT00748735|Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy|optimal definition of left ventricular lead position in cardiac resynchronization therapy
5637642|NCT00748722|Breast reconstruction|breast reconstruction
5637643|NCT00748722|Perforator flaps|perforator flaps
5637644|NCT00748722|CT Angiography|ct angiography
5637645|NCT00748696|sarcopenia|sarcopenia
5637646|NCT00748696|elderly|elderly
5637647|NCT00748696|resistance training|resistance training
5637648|NCT00748696|oral nutritional supplement|oral nutritional supplement
5637649|NCT00748683|elderly|elderly
5637650|NCT00748683|longterm care|longterm care
5637651|NCT00748644|Wegener's granulomatosis,|wegener's granulomatosis,
5637652|NCT00748644|microscopic polyangiitis,|microscopic polyangiitis,
5637653|NCT00748644|ANCA-associated vasculitis,|anca-associated vasculitis,
5637654|NCT00748644|rituximab,|rituximab,
5637655|NCT00748644|azathioprine|azathioprine
5637656|NCT00748631|Vertebral fracture|vertebral fracture
5637657|NCT00748631|Vertebral compression fracture|vertebral compression fracture
5637658|NCT00748631|Multiple Myeloma Bone marrow diseases|multiple myeloma bone marrow diseases
5637659|NCT00748631|Vertebral metastases|vertebral metastases
5637660|NCT00748631|Balloon Kyphoplasty|balloon kyphoplasty
5637661|NCT00748618|Kidney transplantation (KTX)|kidney transplantation (ktx)
5637662|NCT00748618|Vitamin D deficiency|vitamin d deficiency
5637663|NCT00748618|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5637664|NCT00748618|Vascular risk|vascular risk
5637665|NCT00748618|Parathyroid hormone (PTH)|parathyroid hormone (pth)
5637666|NCT00748618|Carotid intima media thickness (CIMT)|carotid intima media thickness (cimt)
5637667|NCT00748618|Insulin resistance (IR)|insulin resistance (ir)
5637668|NCT00748605|Obesity|obesity
5637669|NCT00748592|Insomnia, Primary Insomnia, Chronic Insomnia, DIMS (Disorders of Initiating and Maintaining Sleep), Disorders of Initiating and Maintaining Sleep|insomnia, primary insomnia, chronic insomnia, dims (disorders of initiating and maintaining sleep), disorders of initiating and maintaining sleep
5637670|NCT00748566|Ziprasidone|ziprasidone
5637671|NCT00748566|metabolic syndrome|metabolic syndrome
5637672|NCT00748566|risk factors|risk factors
5637673|NCT00748566|schizophrenia|schizophrenia
5637674|NCT00748566|psychotic disorders.|psychotic disorders.
5637675|NCT00748540|sensorineural hearing loss|sensorineural hearing loss
5637676|NCT00748540|conductive hearing loss|conductive hearing loss
5637677|NCT00748540|mixed hearing loss|mixed hearing loss
5637678|NCT00748527|fallopian tube cancer|fallopian tube cancer
5637679|NCT00748527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5637680|NCT00748527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5637681|NCT00748527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5637682|NCT00748527|peritoneal cavity cancer|peritoneal cavity cancer
5637683|NCT00748514|capsular incision|capsular incision
5637684|NCT00748514|biochemical recurrence|biochemical recurrence
5637685|NCT00748514|radical perineal prostatectomy|radical perineal prostatectomy
5637686|NCT00748501|Amyotrophic Lateral Sclerosis,|amyotrophic lateral sclerosis,
5637688|NCT00748501|Lou Gehrig's Disease|lou gehrig's disease
5637689|NCT00748488|Parkinson|parkinson
5637690|NCT00748488|Physical Therapy|physical therapy
5680395|NCT00577993|FND|fnd
5622589|NCT00809276|Cytoxan|cytoxan
5637691|NCT00748488|Physical Activity|physical activity
5637692|NCT00748462|Acne scar, Wrinkle, Pigmentation, Fractional CO2 laser|acne scar, wrinkle, pigmentation, fractional co2 laser
5637693|NCT00748449|Colorectal advanced adenoma|colorectal advanced adenoma
5637694|NCT00748449|Colorectal cancer polypectomy (endoscopic)|colorectal cancer polypectomy (endoscopic)
5637695|NCT00748449|Colectomy|colectomy
5637696|NCT00748449|Colonoscopy with anaesthesia|colonoscopy with anaesthesia
5637697|NCT00748449|CT-colonography|ct-colonography
5637698|NCT00748436|Obese females|obese females
5637699|NCT00748436|Weight loss|weight loss
5637700|NCT00748436|Betahistine|betahistine
5637701|NCT00748423|Inhaled drug|inhaled drug
5637702|NCT00748423|Acute lung injury|acute lung injury
5637703|NCT00748423|Nitric oxide|nitric oxide
5637704|NCT00748423|Sickle cell|sickle cell
5637705|NCT00748410|CD11b|cd11b
5637706|NCT00748410|Ulcerative colitis|ulcerative colitis
5637707|NCT00748410|99mTc-HMPAO-labelled leukocyte scintigraphy|99mtc-hmpao-labelled leukocyte scintigraphy
5637708|NCT00748384|HMP, CNV, AMD, PHP, HPHP, foresee|hmp, cnv, amd, php, hphp, foresee
5637709|NCT00748371|platelet aggregation|platelet aggregation
5637710|NCT00748371|granule secretion|granule secretion
5637711|NCT00748371|thromboxane production|thromboxane production
5637712|NCT00748371|prostacyclin production|prostacyclin production
5637713|NCT00748358|metastatic prostate carcinoma|metastatic prostate carcinoma
5637714|NCT00748358|sunitinib [Substance Name]|sunitinib [substance name]
5637715|NCT00748358|Clinical Trial, Phase II [Publication Type]|clinical trial, phase ii [publication type]
5637716|NCT00748345|Caspofungin,|caspofungin,
5637717|NCT00748345|burn patients,|burn patients,
5637718|NCT00748345|pharmacokinetics,|pharmacokinetics,
5637719|NCT00748345|optimal dose,|optimal dose,
5637720|NCT00748345|antifungal treatment|antifungal treatment
5637721|NCT00748319|Receptors KIR|receptors kir
5637722|NCT00748319|Polymerase chain reaction|polymerase chain reaction
5637723|NCT00748319|Diagnosis|diagnosis
5637724|NCT00748319|Lymphoma T-cell cutaneous|lymphoma t-cell cutaneous
5637725|NCT00748319|Mycosis fungicides|mycosis fungicides
5637726|NCT00748319|Sezary syndrome|sezary syndrome
5637727|NCT00748319|Differential diagnosis from dermatitis|differential diagnosis from dermatitis
5637728|NCT00748306|challenge|challenge
5637729|NCT00748306|early asthmatic response|early asthmatic response
5637730|NCT00748306|mild asthmatics|mild asthmatics
5637731|NCT00748306|Allergen|allergen
5637732|NCT00748306|methacholine|methacholine
5637733|NCT00748293|Colonoscopy|colonoscopy
5637734|NCT00748293|Colon cleansing|colon cleansing
5637735|NCT00748293|Low-reside diet|low-reside diet
5637736|NCT00748293|Compliance|compliance
5637737|NCT00748293|PEG-ELS|peg-els
5637738|NCT00748280|Endodontics|endodontics
5637739|NCT00748280|CEM cement|cem cement
5637740|NCT00748280|Calcium enriched mixture|calcium enriched mixture
5637742|NCT00748280|Root Canal Therapy|root canal therapy
5637743|NCT00748280|Pain|pain
5637744|NCT00748280|Pulpotomy|pulpotomy
5637745|NCT00748280|Human|human
5637746|NCT00748280|Permanent|permanent
5637747|NCT00748280|Molar teeth|molar teeth
5637748|NCT00748267|anxiety disorder|anxiety disorder
5637749|NCT00748267|pain|pain
5637750|NCT00748267|nausea and vomiting|nausea and vomiting
5637751|NCT00748267|breast cancer|breast cancer
5637752|NCT00748254|Rheumatoid arthritis|rheumatoid arthritis
5637753|NCT00748215|diarrhea|diarrhea
5637754|NCT00748215|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5637755|NCT00748215|recurrent colon cancer|recurrent colon cancer
5637859|NCT00747838|Maze|maze
5637756|NCT00748215|recurrent rectal cancer|recurrent rectal cancer
5637757|NCT00748215|stage IV colon cancer|stage iv colon cancer
5637758|NCT00748215|stage IV rectal cancer|stage iv rectal cancer
5637759|NCT00748202|Hereditary angioedema|hereditary angioedema
5637760|NCT00748202|C1-Esterase inhibitor|c1-esterase inhibitor
5637761|NCT00748202|intravenous|intravenous
5637762|NCT00748202|subcutaneous|subcutaneous
5637763|NCT00748202|pharmacokinetic|pharmacokinetic
5637764|NCT00748189|Safety|safety
5637765|NCT00748189|Untreated|untreated
5637766|NCT00748189|Efficacy|efficacy
5637767|NCT00748189|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5637768|NCT00748189|Chronic Lymphocytic Leukemia (CLL), untreated|chronic lymphocytic leukemia (cll), untreated
5637769|NCT00748189|Ofatumumab|ofatumumab
5637770|NCT00748189|Oncology|oncology
5637771|NCT00748163|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5637773|NCT00748150|influenza|influenza
5637774|NCT00748150|influenza vaccine antigen|influenza vaccine antigen
5637775|NCT00748150|immunogenicity|immunogenicity
5637776|NCT00748150|antibody response|antibody response
5637777|NCT00748150|intra muscular|intra muscular
5637778|NCT00748150|elderly|elderly
5637779|NCT00748150|non-elderly|non-elderly
5637781|NCT00748137|Youth|youth
5637782|NCT00748137|Insulin dose|insulin dose
5637783|NCT00748111|Sudden death|sudden death
5637784|NCT00748111|Out of hospital cardiac arrest|out of hospital cardiac arrest
5637785|NCT00748111|Acute myocardial infarction|acute myocardial infarction
5637786|NCT00748111|Acute coronary syndrome|acute coronary syndrome
5622709|NCT00808964|CABG|cabg
5637788|NCT00748098|Restless Legs Syndrome|restless legs syndrome
5637789|NCT00748098|gabapentin enacarbil|gabapentin enacarbil
5637790|NCT00748098|XP13512|xp13512
5637791|NCT00748098|GSK1838262|gsk1838262
5637792|NCT00748098|sleep disturbance|sleep disturbance
5637794|NCT00748098|polysomnography|polysomnography
5637795|NCT00748085|Malignant Airway Disease|malignant airway disease
5637796|NCT00748085|Lung Cancer|lung cancer
5637797|NCT00748085|Inoperable Lung Cancer|inoperable lung cancer
5637798|NCT00748085|Mesothelioma|mesothelioma
5637799|NCT00748085|Endoluminal Tumor|endoluminal tumor
5637800|NCT00748072|Vasopressin|vasopressin
5637801|NCT00748072|bleeding|bleeding
5637802|NCT00748072|biopsy|biopsy
5637803|NCT00748072|ultrasonography|ultrasonography
5637804|NCT00748059|autonomic nervous system diseases|autonomic nervous system diseases
5637805|NCT00748059|blood pressure|blood pressure
5637806|NCT00748059|congenital|congenital
5637807|NCT00748059|orthostasis|orthostasis
5637808|NCT00748059|catecholamines|catecholamines
5637809|NCT00748046|Biodistribution|biodistribution
5637810|NCT00748046|Radiation dosimetry|radiation dosimetry
5637811|NCT00748046|Pharmacokinetics|pharmacokinetics
5637812|NCT00748046|Safety|safety
5637813|NCT00748007|Down syndrome, cholinesterase inhibitor, Rivastigmine|down syndrome, cholinesterase inhibitor, rivastigmine
5637814|NCT00747994|Paget's disease of bone|paget's disease of bone
5637815|NCT00747994|Relatives|relatives
5637816|NCT00747994|Mutations screening|mutations screening
5637817|NCT00747994|Haplotypes analysis|haplotypes analysis
5637818|NCT00747994|Linkage analysis|linkage analysis
5637819|NCT00747994|< 55 years|< 55 years
5637820|NCT00747994|4 > or = WAFFECTED Bones|4 > or = waffected bones
5637821|NCT00747994|bone deformity|bone deformity
5637822|NCT00747981|CT Scan|ct scan
5637823|NCT00747981|Endoscopy|endoscopy
5637824|NCT00747981|Aspiration|aspiration
5637825|NCT00747981|Foreign Bodies|foreign bodies
5637826|NCT00747955|Human Performance|human performance
5637827|NCT00747955|Physical Disability|physical disability
5637828|NCT00747955|Functional Outcome Measures|functional outcome measures
5637829|NCT00747955|Health Volunteer|health volunteer
5637830|NCT00747955|HV|hv
5637831|NCT00747942|overweight|overweight
5637832|NCT00747942|physical inactivity|physical inactivity
5637833|NCT00747942|physical fitness|physical fitness
5637834|NCT00747942|lifestyle change|lifestyle change
5637835|NCT00747929|Obesity|obesity
5637836|NCT00747916|Parietal pleura|parietal pleura
5637837|NCT00747916|Neoplasms|neoplasms
5637838|NCT00747916|Pleural Surface|pleural surface
5637839|NCT00747916|Pleural Neoplasms|pleural neoplasms
5637840|NCT00747916|Lung Cancer|lung cancer
5637841|NCT00747903|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5637842|NCT00747903|recurrent skin cancer|recurrent skin cancer
5637843|NCT00747877|stage II multiple myeloma|stage ii multiple myeloma
5637844|NCT00747877|stage III multiple myeloma|stage iii multiple myeloma
5637845|NCT00747877|refractory multiple myeloma|refractory multiple myeloma
5637846|NCT00747877|stage I multiple myeloma|stage i multiple myeloma
5637847|NCT00747864|Gestational Age|gestational age
5637848|NCT00747864|Urine|urine
5637849|NCT00747864|Concentration|concentration
5637850|NCT00747864|of S100B|of s100b
5637851|NCT00747851|protein|protein
5637852|NCT00747851|synthesis|synthesis
5637853|NCT00747851|response|response
5637854|NCT00747851|PAF-stimulated|paf-stimulated
5637855|NCT00747851|PMNs|pmns
5637856|NCT00747851|collected|collected
5637857|NCT00747838|Afib|afib
5637858|NCT00747838|Atrial Fibrillation|atrial fibrillation
5637860|NCT00747838|Mini-Maze|mini-maze
5637861|NCT00747825|cancer|cancer
5637862|NCT00747825|oncology|oncology
5637863|NCT00747825|melanoma|melanoma
5637864|NCT00747825|tumor|tumor
5637865|NCT00747812|Headache|headache
5637866|NCT00747812|Migraine|migraine
5637867|NCT00747812|Refractory|refractory
5637868|NCT00747812|Chronic|chronic
5637869|NCT00747812|Pain|pain
5637870|NCT00747799|recurrent or metastatic Nasopharyngeal Neoplasms|recurrent or metastatic nasopharyngeal neoplasms
5637871|NCT00747773|Lung Cancer|lung cancer
5637872|NCT00747773|CryoPsray Ablation|cryopsray ablation
5637873|NCT00747773|CSA therapy|csa therapy
5637874|NCT00747773|CSA treatment|csa treatment
5637875|NCT00747773|Lobectomy|lobectomy
5637876|NCT00747773|lung resection|lung resection
5637877|NCT00747760|TSH Receptor, resistance TSH, Hyperthyrortropinemia|tsh receptor, resistance tsh, hyperthyrortropinemia
5637878|NCT00747747|Sinusitis|sinusitis
5637879|NCT00747734|Neuropilin-1|neuropilin-1
5637880|NCT00747734|NRP1|nrp1
5637881|NCT00747734|anti-NRP1|anti-nrp1
5637882|NCT00747734|anti-angiogenic|anti-angiogenic
5637883|NCT00747708|heart failure|heart failure
5637884|NCT00747708|coronary heart disease|coronary heart disease
5637885|NCT00747708|adult stem cells|adult stem cells
5637886|NCT00747708|bone marrow progenitor cells|bone marrow progenitor cells
5637887|NCT00747708|bone marrow stem cells|bone marrow stem cells
5637889|NCT00747708|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5637890|NCT00747708|left ventricular function|left ventricular function
5637891|NCT00747708|intracoronary injection|intracoronary injection
5637892|NCT00747708|intramyocardial injection|intramyocardial injection
5637893|NCT00747695|Pediatric Pharmacokinetics|pediatric pharmacokinetics
5637894|NCT00747695|Pediatric Pharmacodynamics|pediatric pharmacodynamics
5637895|NCT00747695|Rabeprazole|rabeprazole
5637896|NCT00747695|Pediatric GERD|pediatric gerd
5637897|NCT00747695|Aciphex|aciphex
5637898|NCT00747682|Cerebral Perfusion,|cerebral perfusion,
5637899|NCT00747682|Oxygenation,|oxygenation,
5637900|NCT00747682|Electrical|electrical
5637901|NCT00747682|Activity|activity
5637902|NCT00747656|Electrocardiography|electrocardiography
5637903|NCT00747656|Emergency medical services|emergency medical services
5637904|NCT00747656|Emergency medicine|emergency medicine
5637905|NCT00747656|Health services|health services
5637906|NCT00747656|Cost effectiveness|cost effectiveness
5637907|NCT00747643|tobacco|tobacco
5637908|NCT00747643|nicotine|nicotine
5637909|NCT00747643|smoking|smoking
5637910|NCT00747643|reward|reward
5637911|NCT00747643|reinforcement|reinforcement
5637912|NCT00747643|craving|craving
5637913|NCT00747643|cues|cues
5637914|NCT00747643|conditioned stimuli|conditioned stimuli
5637915|NCT00747643|cue reactivity|cue reactivity
5637916|NCT00747630|Fetal Alcohol Syndrome|fetal alcohol syndrome
5637917|NCT00747630|Teen pregnancy|teen pregnancy
5637918|NCT00747617|polycystic ovary syndrome|polycystic ovary syndrome
5637919|NCT00747617|androgens|androgens
5637920|NCT00747617|ovary|ovary
5637922|NCT00747604|Growth Hormone (GH) Insensitivity Syndrome|growth hormone (gh) insensitivity syndrome
5637923|NCT00747604|Insulin-like Growth Factor Deficiency (IGFD)|insulin-like growth factor deficiency (igfd)
5637924|NCT00747604|Short Stature|short stature
5637925|NCT00747604|Insulin-like Growth Factor (IGF-1)|insulin-like growth factor (igf-1)
5637926|NCT00747604|Growth|growth
5637927|NCT00747591|urine|urine
5637928|NCT00747591|concentration|concentration
5637929|NCT00747591|of S100B|of s100b
5637930|NCT00747578|ankylosing spondylitis (AS), costs,|ankylosing spondylitis (as), costs,
5637931|NCT00747578|rheumatoid arthritis (RA),|rheumatoid arthritis (ra),
5637932|NCT00747578|systemic lupus erythematosus (SLE),|systemic lupus erythematosus (sle),
5637933|NCT00747578|health-related|health-related
5637934|NCT00747578|quality of life (HRQOL)|quality of life (hrqol)
5637935|NCT00747578|compare|compare
5637936|NCT00747578|utility|utility
5637937|NCT00747578|patients|patients
5637938|NCT00747565|cataract, tecnis, multifocal, intraocular lens|cataract, tecnis, multifocal, intraocular lens
5637939|NCT00747552|IAP measurements|iap measurements
5637940|NCT00747552|Abdominal compartment syndrome|abdominal compartment syndrome
5637941|NCT00747552|NICU patients|nicu patients
5637942|NCT00747552|Intra-abdominal Hypertension|intra-abdominal hypertension
5637943|NCT00747539|Hepatitis C Virus|hepatitis c virus
5637944|NCT00747539|HCV|hcv
5826899|NCT00063804|CXCR4|cxcr4
5637945|NCT00747539|Human Immunodeficiency Virus|human immunodeficiency virus
5637946|NCT00747539|Coinfection|coinfection
5637947|NCT00747526|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5637948|NCT00747526|Pediatrics|pediatrics
5637949|NCT00747526|Pharmacokinetics|pharmacokinetics
5637950|NCT00747526|Pharmacodynamics|pharmacodynamics
5637951|NCT00747526|Rabeprazole|rabeprazole
5637952|NCT00747526|GERD|gerd
5637953|NCT00747526|Aciphex|aciphex
5637954|NCT00747513|school|school
5637955|NCT00747513|prevention|prevention
5637956|NCT00747513|overweight|overweight
5637957|NCT00747513|children|children
5637958|NCT00747513|diet|diet
5637959|NCT00747513|physical activity|physical activity
5637960|NCT00747513|fitness|fitness
5637961|NCT00747487|Leber|leber
5637962|NCT00747487|LHON|lhon
5637963|NCT00747487|Leber's Hereditary Optic Neuropathy|leber's hereditary optic neuropathy
5637964|NCT00747487|Idebenone|idebenone
5637965|NCT00747461|Benign Airway Disease|benign airway disease
5637966|NCT00747461|Airway Injury|airway injury
5637967|NCT00747461|Sarcoidosis|sarcoidosis
5637968|NCT00747461|Wegener's Granulomatosis|wegener's granulomatosis
5637969|NCT00747461|Rhinoscleroma|rhinoscleroma
5637970|NCT00747461|Recurrent Respiratory Papillomatosis(RRP)|recurrent respiratory papillomatosis(rrp)
5637971|NCT00747448|Barrett's Esophagus|barrett's esophagus
5637972|NCT00747448|High Grade Dysplasia|high grade dysplasia
5637973|NCT00747448|Low Grade Dysplasia|low grade dysplasia
5637974|NCT00747448|Squamous Dysplasia|squamous dysplasia
5637975|NCT00747448|Esophageal Cancer|esophageal cancer
5637976|NCT00747448|CryoSpray Ablation|cryospray ablation
5637977|NCT00747448|Cryotherapy|cryotherapy
5637978|NCT00747448|Cryospray|cryospray
5637979|NCT00747435|sensorineural hearing loss|sensorineural hearing loss
5637981|NCT00747435|electric acoustic stimulation|electric acoustic stimulation
5637982|NCT00747409|postprandial glucose, diastolic function, analogue insulins|postprandial glucose, diastolic function, analogue insulins
5637983|NCT00747396|Romania,|romania,
5637984|NCT00747396|children,|children,
5637985|NCT00747396|foster care,|foster care,
5637986|NCT00747396|institutionalization,|institutionalization,
5637987|NCT00747396|brain function,|brain function,
5637988|NCT00747396|MRI,|mri,
5637989|NCT00747396|attachment,|attachment,
5637990|NCT00747396|language,|language,
5637991|NCT00747396|growth,|growth,
5637992|NCT00747396|IQ,|iq,
5637993|NCT00747396|psychiatric symptomatology|psychiatric symptomatology
5637994|NCT00747396|early intervention|early intervention
5637995|NCT00747383|Diabetes Mellitus|diabetes mellitus
5637996|NCT00747383|GLP1|glp1
5637997|NCT00747383|DPP4|dpp4
5637998|NCT00747370|stress urinary incontinence|stress urinary incontinence
5637999|NCT00747370|Tension free vaginal tape|tension free vaginal tape
5638000|NCT00747370|tension free vaginal tape obturator|tension free vaginal tape obturator
5638001|NCT00747370|genital prolapse|genital prolapse
5638002|NCT00747344|Psoriasis|psoriasis
5638003|NCT00747344|Psoriatic Arthritis|psoriatic arthritis
5638004|NCT00747344|Ustekinumab|ustekinumab
5638005|NCT00747344|CNTO 1275|cnto 1275
5638006|NCT00747331|Cardiopulmonary bypass|cardiopulmonary bypass
5638007|NCT00747331|Lactic acidosis|lactic acidosis
5638008|NCT00747331|Oxygen delivery|oxygen delivery
5638009|NCT00747331|Acute renal failure|acute renal failure
5638010|NCT00747331|outcome|outcome
5638011|NCT00747331|cardiac|cardiac
5638012|NCT00747331|surgery|surgery
5638013|NCT00747318|Moderate to Severe|moderate to severe
5638014|NCT00747305|stage IV renal cell cancer|stage iv renal cell cancer
5638015|NCT00747305|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5638016|NCT00747305|recurrent renal cell cancer|recurrent renal cell cancer
5638017|NCT00747292|laparoscopic|laparoscopic
5638018|NCT00747292|colon|colon
5638019|NCT00747292|analgesia|analgesia
5638020|NCT00747292|fluid optimised|fluid optimised
5638021|NCT00747253|laser interstitial thermal therapy|laser interstitial thermal therapy
5638022|NCT00747253|laser therapy|laser therapy
5638023|NCT00747253|thermal therapy|thermal therapy
5638024|NCT00747253|brain tumors|brain tumors
5638025|NCT00747253|recurrent brain tumor|recurrent brain tumor
5638026|NCT00747253|progressive brain tumor|progressive brain tumor
5638027|NCT00747253|glioblastoma multiforme tumor|glioblastoma multiforme tumor
5638028|NCT00747240|Ile198Thr|ile198thr
5638029|NCT00747240|Ala379Val|ala379val
5638030|NCT00747240|variants|variants
5638031|NCT00747240|PAF-AH|paf-ah
5638032|NCT00747227|cataract|cataract
5638033|NCT00747227|monofocal|monofocal
5638034|NCT00747227|intraocular lens|intraocular lens
5638035|NCT00747227|acrylic|acrylic
5638036|NCT00747214|Rheumatoid Arthritis|rheumatoid arthritis
5638037|NCT00747214|RA|ra
5638038|NCT00747214|DMARD|dmard
5638039|NCT00747214|CRP|crp
5638040|NCT00747201|Replicating Effective Programs|replicating effective programs
5638041|NCT00747201|Care Management|care management
5638042|NCT00747201|Implementation|implementation
5638043|NCT00747201|Intervention|intervention
5638044|NCT00747188|Problem-based learning (PBL)|problem-based learning (pbl)
5638046|NCT00747188|nursing|nursing
5638047|NCT00747188|education|education
5638048|NCT00747188|none of students had any prior exposure to PBL|none of students had any prior exposure to pbl
5638049|NCT00747175|Type 2 diabetes|type 2 diabetes
5638050|NCT00747162|Compartment Syndrome|compartment syndrome
5638051|NCT00747162|Muscle Oxygenation|muscle oxygenation
5638052|NCT00747162|Skin Pigmentation|skin pigmentation
5638053|NCT00747149|diabetes|diabetes
5638054|NCT00747149|type 2|type 2
5638055|NCT00747136|Barrett's|barrett's
5638056|NCT00747136|Dysplasia|dysplasia
5638057|NCT00747136|esophageal cancer|esophageal cancer
5638058|NCT00747136|Patients|patients
5638059|NCT00747110|5-ASA|5-asa
5638060|NCT00747110|mesalamine|mesalamine
5638061|NCT00747110|mesalazine|mesalazine
5638062|NCT00747110|budesonide|budesonide
5638063|NCT00747110|ulcerative colitis|ulcerative colitis
5638064|NCT00747084|unsedated colonoscopy|unsedated colonoscopy
5638065|NCT00747071|Clostridium difficile|clostridium difficile
5638066|NCT00747071|diarrhea|diarrhea
5638067|NCT00747071|colostrum|colostrum
5638068|NCT00747058|phase 1, human study, healthy volunteers|phase 1, human study, healthy volunteers
5638069|NCT00747045|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5638070|NCT00747045|Lung Injury|lung injury
5638071|NCT00747045|Ventilation Strategies|ventilation strategies
5638072|NCT00746993|Contraception|contraception
5638073|NCT00746993|Counseling|counseling
5638074|NCT00746980|alopecia|alopecia
5638076|NCT00746980|universalis|universalis
5638077|NCT00746980|severe|severe
5638078|NCT00746980|ophiasis|ophiasis
5638079|NCT00746980|variants|variants
5638080|NCT00746954|buspirone|buspirone
5638081|NCT00746954|acetazolamide|acetazolamide
5638082|NCT00746941|PML|pml
5638083|NCT00746941|Human Polyomavirus JC|human polyomavirus jc
5638085|NCT00746941|Central Nervous System Disease|central nervous system disease
5638086|NCT00746941|Mefloquine|mefloquine
5638087|NCT00746941|JC Virus|jc virus
5638088|NCT00746928|Blood pressure|blood pressure
5638089|NCT00746928|Hypertension|hypertension
5638090|NCT00746928|sympathetic control|sympathetic control
5638091|NCT00746928|chemosensitivity|chemosensitivity
5638092|NCT00746928|baroreflex|baroreflex
5680396|NCT00577980|Prostate Cancer|prostate cancer
5638093|NCT00746915|Patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy|patients undergoing elective pain relief treatment of lumbar epidural steroid injection under fluoroscopy
5638094|NCT00746902|Refractory hypertension|refractory hypertension
5638095|NCT00746902|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5638096|NCT00746902|Obesity|obesity
5638097|NCT00746902|Leptinemia|leptinemia
5638098|NCT00746902|RHOOSAS study|rhoosas study
5638099|NCT00746889|osteoarthritis|osteoarthritis
5638100|NCT00746889|knee|knee
5638101|NCT00746889|corticosteroids|corticosteroids
5638102|NCT00746889|ultrasound|ultrasound
5638103|NCT00746876|Hip|hip
5638104|NCT00746876|Fracture|fracture
5638105|NCT00746876|Femoral neck|femoral neck
5638106|NCT00746876|Hemiarthroplasty|hemiarthroplasty
5638107|NCT00746876|Bipolar|bipolar
5638108|NCT00746876|Unipolar|unipolar
5638109|NCT00746876|Displaced femoral neck fractures|displaced femoral neck fractures
5638110|NCT00746863|mid-urethral sling|mid-urethral sling
5638111|NCT00746863|pubovaginal sling|pubovaginal sling
5638112|NCT00746863|postoperative pain|postoperative pain
5638113|NCT00746863|visual analog scale|visual analog scale
5638114|NCT00746863|suprapubic approach|suprapubic approach
5638115|NCT00746863|SPARC sling|sparc sling
5638116|NCT00746850|acute cholecystitis|acute cholecystitis
5638117|NCT00746850|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5638118|NCT00746850|conversion rate|conversion rate
5638119|NCT00746850|morbidity|morbidity
5638120|NCT00746850|mortality|mortality
5638121|NCT00746850|postoperative pain|postoperative pain
5638122|NCT00746850|hospital stay|hospital stay
5638123|NCT00746837|AZD5672|azd5672
5638124|NCT00746824|Obesity|obesity
5638125|NCT00746824|weight loss|weight loss
5638126|NCT00746824|7TM Pharma|7tm pharma
5638127|NCT00746824|TM30339|tm30339
5638128|NCT00746824|Y4 receptor antagonist|y4 receptor antagonist
5638129|NCT00746811|cholesterol|cholesterol
5638130|NCT00746811|hypercholesterolemia|hypercholesterolemia
5638131|NCT00746811|omega 3|omega 3
5638132|NCT00746798|West Nile Fever|west nile fever
5638133|NCT00746798|ChimeriVax|chimerivax
5638134|NCT00746798|West Nile Virus Vaccine|west nile virus vaccine
5638135|NCT00746785|Olanzapine|olanzapine
5638136|NCT00746772|antioxidant|antioxidant
5638137|NCT00746772|oral lichen planus|oral lichen planus
5638138|NCT00746772|treatment|treatment
5638139|NCT00746772|purslane|purslane
5638140|NCT00746759|Lung Cancer|lung cancer
5638141|NCT00746759|Smoker|smoker
5638142|NCT00746759|Former Smoker|former smoker
5638143|NCT00746759|Gene Expression|gene expression
5638144|NCT00746759|Bronchoscopy|bronchoscopy
5638145|NCT00746746|Advanced Melanoma|advanced melanoma
5638146|NCT00746733|Drug|drug
5638147|NCT00746733|Interaction|interaction
5638148|NCT00746733|Study|study
5638149|NCT00746720|hip replacement|hip replacement
5638150|NCT00746720|osteoarthritis|osteoarthritis
5638151|NCT00746720|etoricoxib|etoricoxib
5638153|NCT00746720|cerebrospinal fluid|cerebrospinal fluid
5638154|NCT00746720|pharmacokinetics|pharmacokinetics
5847442|NCT00038961|pulmonary embolism|pulmonary embolism
5638155|NCT00746707|adhesive glue, perineal tear, suture|adhesive glue, perineal tear, suture
5638157|NCT00746668|Macular Degeneration|macular degeneration
5638158|NCT00746668|Rehabilitation|rehabilitation
5638159|NCT00746668|Vision, Low|vision, low
5638160|NCT00746655|Hepatocellular|hepatocellular
5638161|NCT00746642|glucose measurements|glucose measurements
5638162|NCT00746616|Total Hip Arthroplasty,|total hip arthroplasty,
5638163|NCT00746616|Acetabular Cup,|acetabular cup,
5638164|NCT00746616|Hip Resurfacing|hip resurfacing
5638165|NCT00746616|Young,|young,
5638166|NCT00746616|active|active
5638167|NCT00746616|patients|patients
5638168|NCT00746590|hepatocellular carcinoma|hepatocellular carcinoma
5638169|NCT00746590|liver cancer|liver cancer
5638170|NCT00746590|Prolarix|prolarix
5638171|NCT00746590|tretazicar|tretazicar
5638172|NCT00746590|caricotamide|caricotamide
5638173|NCT00746590|Phase 2|phase 2
5638174|NCT00746590|tumor|tumor
5638175|NCT00746590|chemotherapy|chemotherapy
5638176|NCT00746564|Implantable Cardiac Monitor|implantable cardiac monitor
5638177|NCT00746564|Arrhythmias|arrhythmias
5638178|NCT00746564|Atrial Fibrillation|atrial fibrillation
5638179|NCT00746551|iron deficiency anemia|iron deficiency anemia
5638180|NCT00746551|pregnancy|pregnancy
5638181|NCT00746551|third trimester|third trimester
5638182|NCT00746551|intravenous iron|intravenous iron
5638183|NCT00746551|efficacy|efficacy
5638184|NCT00746551|a randomized trial|a randomized trial
5638185|NCT00746551|Female|female
5638186|NCT00746551|Ferric Compounds/therapeutic use*|ferric compounds/therapeutic use*
5638187|NCT00746551|Infusions, Intravenous|infusions, intravenous
5638188|NCT00746551|Hematologic/therapy*|hematologic/therapy*
5638189|NCT00746538|Hilar cholangiocarcinoma|hilar cholangiocarcinoma
5638190|NCT00746538|biliary stent|biliary stent
5638191|NCT00746538|plastic stent|plastic stent
5638192|NCT00746538|metallic stent|metallic stent
5638193|NCT00746538|quality of life|quality of life
5638194|NCT00746525|stroke|stroke
5638195|NCT00746525|motor learning|motor learning
5638196|NCT00746525|rehabilitation of upper extremity|rehabilitation of upper extremity
5638197|NCT00746525|functional electrical stimulation|functional electrical stimulation
5638199|NCT00746525|brain computer interface|brain computer interface
5638200|NCT00746525|BCI|bci
5638201|NCT00746525|coordination|coordination
5638202|NCT00746525|motor control|motor control
5638203|NCT00746460|primary prevention|primary prevention
5638204|NCT00746460|patient knowledge|patient knowledge
5638205|NCT00746460|nurse|nurse
5638206|NCT00746460|exercise|exercise
5638207|NCT00746460|smoking cessation|smoking cessation
5638208|NCT00746460|weight loss|weight loss
5638209|NCT00746447|maintenance|maintenance
5638210|NCT00746447|5-ASA|5-asa
5638211|NCT00746447|mesalamine|mesalamine
5638212|NCT00746447|mesalazine|mesalazine
5638213|NCT00746447|ulcerative colitis|ulcerative colitis
5638214|NCT00746434|Mild plaque psoriasis,|mild plaque psoriasis,
5638215|NCT00746434|Moderate plaque psoriasis,|moderate plaque psoriasis,
5638216|NCT00746434|0.5% Roflumilast cream|0.5% roflumilast cream
5638217|NCT00746421|Cognition|cognition
5638218|NCT00746421|attention|attention
5638219|NCT00746421|bipolar|bipolar
5638220|NCT00746421|disability|disability
5638221|NCT00746408|Internet|internet
5638222|NCT00746408|Information supply|information supply
5638223|NCT00746408|Tailoring|tailoring
5638224|NCT00746408|Patient empowerment|patient empowerment
5638225|NCT00746408|Headaches|headaches
5638226|NCT00746408|Consumer Health Information|consumer health information
5638227|NCT00746408|Information Services|information services
5638228|NCT00746408|Information Storage and Retrieval|information storage and retrieval
5638229|NCT00746408|Information Systems|information systems
5638230|NCT00746395|capsule|capsule
5638231|NCT00746395|endoscopy|endoscopy
5638232|NCT00746395|prokinetic|prokinetic
5638233|NCT00746395|lubiprostone|lubiprostone
5638234|NCT00746395|Normal|normal
5638235|NCT00746395|volunteers|volunteers
5638236|NCT00746382|Mild atopic dermatitis, Roflumilast cream 0.5%|mild atopic dermatitis, roflumilast cream 0.5%
5638237|NCT00746369|HIV|hiv
5638238|NCT00746369|Prevention|prevention
5638239|NCT00746369|Adolescents|adolescents
5638240|NCT00746369|HIV Seronegativity|hiv seronegativity
5638241|NCT00746356|heart failure|heart failure
5638242|NCT00746356|cardiac resynchronization therapy|cardiac resynchronization therapy
5638243|NCT00746356|autocapture|autocapture
5638244|NCT00746356|Current RF|current rf
5638245|NCT00746356|Promote RF|promote rf
5638246|NCT00746343|Bipolar I Disorder|bipolar i disorder
5638247|NCT00746343|Medical Risks|medical risks
5638248|NCT00746343|Integrated Risk Reduction Intervention|integrated risk reduction intervention
5638249|NCT00746343|Currently in Remission|currently in remission
5638250|NCT00746343|BMI|bmi
5638251|NCT00746330|Asthma|asthma
5638252|NCT00746330|Children|children
5638255|NCT00746304|esotropia|esotropia
5638256|NCT00746278|Ovarian Cysts|ovarian cysts
5638257|NCT00746278|Electrocoagulation|electrocoagulation
5638258|NCT00746278|Ovarian Function Tests|ovarian function tests
5638259|NCT00746278|Laparoscopy|laparoscopy
5638260|NCT00746265|behavioral interventions for weight loss|behavioral interventions for weight loss
5638261|NCT00746252|bipolar|bipolar
5638262|NCT00746252|children|children
5638263|NCT00746252|antipsychotic|antipsychotic
5638264|NCT00746252|side effect|side effect
5638265|NCT00746239|insomnia|insomnia
5638266|NCT00746239|sleep difficulty|sleep difficulty
5638267|NCT00746239|panic disorder|panic disorder
5638268|NCT00746239|nocturnal panic attacks|nocturnal panic attacks
5638269|NCT00746239|anxiety|anxiety
5638270|NCT00746226|birch pollen|birch pollen
5638271|NCT00746213|Thoracotomy|thoracotomy
5638272|NCT00746213|Chronic Pain|chronic pain
5638273|NCT00746200|chronic constipation|chronic constipation
5638274|NCT00746200|electroacupuncture|electroacupuncture
5638275|NCT00746200|randomized controlled trial|randomized controlled trial
5638276|NCT00746174|insulin sensitivity|insulin sensitivity
5638277|NCT00746174|magnetic resonance spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5638278|NCT00746174|lipotoxicity|lipotoxicity
5638279|NCT00746174|lipid oxidation|lipid oxidation
5638280|NCT00746174|thiazolidinediones|thiazolidinediones
5638281|NCT00746174|intracellular|intracellular
5638282|NCT00746174|triglyceride|triglyceride
5638284|NCT00746161|total gastrectomy|total gastrectomy
5638285|NCT00746161|double tract reconstruction|double tract reconstruction
5638286|NCT00746161|gastric cancer|gastric cancer
5638287|NCT00746161|Total gastrectomy in patients with gastric cancer|total gastrectomy in patients with gastric cancer
5638288|NCT00746148|Polycystic Ovary Syndrome|polycystic ovary syndrome
5638289|NCT00746148|Reflexology|reflexology
5620197|NCT00817895|liver resection|liver resection
5638290|NCT00746148|Complementary and Alternative Medicine|complementary and alternative medicine
5638291|NCT00746148|Endocrinopathy|endocrinopathy
5638292|NCT00746148|Oligo|oligo
5638293|NCT00746148|Amenorrhoea|amenorrhoea
5638294|NCT00746135|Heart failure (NYHA class III and IV)|heart failure (nyha class iii and iv)
5638295|NCT00746135|Ventricular Dyssynchrony|ventricular dyssynchrony
5638296|NCT00746122|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5638297|NCT00746109|randomized|randomized
5638298|NCT00746109|clinical trial|clinical trial
5638299|NCT00746109|ultrasound|ultrasound
5638300|NCT00746109|prospective|prospective
5638302|NCT00746109|packing|packing
5638303|NCT00746109|incision and drainage|incision and drainage
5638304|NCT00746109|superficial soft tissue infection|superficial soft tissue infection
5638305|NCT00746083|pediatric|pediatric
5638306|NCT00746083|obesity|obesity
5638307|NCT00746083|African American|african american
5638308|NCT00746083|adolescents|adolescents
5638309|NCT00746083|intervention|intervention
5638310|NCT00746083|home-based|home-based
5638311|NCT00746083|community-based|community-based
5638312|NCT00746070|cardiovascular disease, endothelium function, aldosterone|cardiovascular disease, endothelium function, aldosterone
5638313|NCT00746057|Renal graft|renal graft
5638314|NCT00746057|chronic rejection|chronic rejection
5638315|NCT00746057|tolerance|tolerance
5638316|NCT00746057|DNA chip|dna chip
5638317|NCT00746057|biopsy|biopsy
5638318|NCT00746044|Healthy|healthy
5638319|NCT00746031|MTI|mti
5638320|NCT00746031|Fibroids|fibroids
5638321|NCT00746031|Novel|novel
5638322|NCT00746031|MR imaging|mr imaging
5638323|NCT00746031|techniques|techniques
5638324|NCT00746018|ovary|ovary
5638325|NCT00746018|uterus|uterus
5638326|NCT00746018|cervix|cervix
5638327|NCT00746018|08-092|08-092
5638328|NCT00746005|mild cognitive impairment|mild cognitive impairment
5638329|NCT00745992|Voriconazole|voriconazole
5638330|NCT00745992|Antifungal Agents|antifungal agents
5638331|NCT00745992|Invasive fungal infections|invasive fungal infections
5638332|NCT00745992|Therapeutic drug monitoring|therapeutic drug monitoring
5638333|NCT00745992|CYP Genetic polymorphism|cyp genetic polymorphism
5638334|NCT00745966|Bipolar|bipolar
5638335|NCT00745966|atypical antipsychotics|atypical antipsychotics
5638336|NCT00745966|quality of life|quality of life
5638337|NCT00745966|observational|observational
5638338|NCT00745953|Metabolic syndrome|metabolic syndrome
5638339|NCT00745953|Lipotoxicity|lipotoxicity
5638340|NCT00745953|Insulin sensitivity|insulin sensitivity
5638341|NCT00745953|Myocardial triglyceride levels|myocardial triglyceride levels
5638342|NCT00745953|Hepatic triglyceride levels|hepatic triglyceride levels
5638343|NCT00745953|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5638344|NCT00745940|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5638345|NCT00745940|MBCT|mbct
5638346|NCT00745940|Depression|depression
5638347|NCT00745940|Traumatic Brain Injury|traumatic brain injury
5638348|NCT00745940|TBI|tbi
5638349|NCT00745927|Colorectal neoplasm|colorectal neoplasm
5638350|NCT00745927|Colorectal cancer|colorectal cancer
5638351|NCT00745927|Screening colonoscopy|screening colonoscopy
5638352|NCT00745927|CO2 insufflations|co2 insufflations
5638354|NCT00745914|PPAR-gamma, diabetic, kidney disease, atherosclerosis|ppar-gamma, diabetic, kidney disease, atherosclerosis
5638355|NCT00745901|contraception|contraception
5638356|NCT00745901|bleeding|bleeding
5638357|NCT00745901|cycle control|cycle control
5638358|NCT00745888|oxidative stress|oxidative stress
5638359|NCT00745888|intensive care|intensive care
5638360|NCT00745888|Postoperative intensive care|postoperative intensive care
5638361|NCT00745875|NSCLC|nsclc
5638362|NCT00745875|Phase II|phase ii
5638363|NCT00745875|ZD4054|zd4054
5638364|NCT00745875|Pemetrexed|pemetrexed
5638365|NCT00745875|Lung Cancer|lung cancer
5638366|NCT00745862|Skin|skin
5638367|NCT00745849|non-allergic rhinitis, laryngopharyngeal reflux|non-allergic rhinitis, laryngopharyngeal reflux
5638368|NCT00745836|insulin sensitivity|insulin sensitivity
5638369|NCT00745823|HIV Infections|hiv infections
5638370|NCT00745823|Treatment Naïve|treatment naïve
5638371|NCT00745810|cardiopulmonary bypass|cardiopulmonary bypass
5638372|NCT00745810|oxidative injuries|oxidative injuries
5638373|NCT00745797|nonsmall cell lung cancer|nonsmall cell lung cancer
5638374|NCT00745797|brain metastasis|brain metastasis
5638375|NCT00745797|prophylactic cranial irradiation|prophylactic cranial irradiation
5638376|NCT00745784|Young Bereaved Spouses|young bereaved spouses
5638377|NCT00745771|pharmacokinetics|pharmacokinetics
5638378|NCT00745771|of Diractin®|of diractin®
5638379|NCT00745771|safety|safety
5638380|NCT00745771|efficacy|efficacy
5638381|NCT00745771|exercise|exercise
5638382|NCT00745758|SAH, vasospasm, ADMA|sah, vasospasm, adma
5638383|NCT00745732|Non-Small Cell Lung Cancer|non-small cell lung cancer
5638384|NCT00745732|Lung Cancer|lung cancer
5638385|NCT00745732|NSCLC|nsclc
5638386|NCT00745732|ZD6474|zd6474
5638387|NCT00745732|ZACTIMA|zactima
5638388|NCT00745732|Vandetanib|vandetanib
5638389|NCT00745732|Inoperable NSCLC|inoperable nsclc
5638390|NCT00745732|Unresectable NSCLC|unresectable nsclc
5638391|NCT00745732|Radiation Therapy|radiation therapy
5638392|NCT00745732|Palliative radiation therapy|palliative radiation therapy
5638393|NCT00745732|Angiogenesis|angiogenesis
5638394|NCT00745719|parathyroidectomy|parathyroidectomy
5638395|NCT00745719|cardiovascular|cardiovascular
5638396|NCT00745719|bone|bone
5638397|NCT00745719|endstage renal disease|endstage renal disease
5638399|NCT00745693|Air pollution|air pollution
5638400|NCT00745693|Diesel exhaust|diesel exhaust
5638401|NCT00745693|Vascular function|vascular function
5638402|NCT00745693|exposure|exposure
5638403|NCT00745680|Left ventricular remodeling, acute myocardial infarction|left ventricular remodeling, acute myocardial infarction
5638404|NCT00745667|laparoscopic|laparoscopic
5638405|NCT00745667|peptic ulcer|peptic ulcer
5638406|NCT00745654|Lung Transplantation|lung transplantation
5638407|NCT00745654|Chronic pain|chronic pain
5638408|NCT00745654|Thoracotomy|thoracotomy
5638409|NCT00745641|radiation injury|radiation injury
5638410|NCT00745641|computed tomography|computed tomography
5638411|NCT00745641|reactive oxygen species|reactive oxygen species
5638412|NCT00745641|free radicals|free radicals
5638413|NCT00745628|coronary heart disease|coronary heart disease
5638414|NCT00745628|secondary prevention|secondary prevention
5638415|NCT00745602|direct current cardioversion, cerebral blood flow|direct current cardioversion, cerebral blood flow
5638416|NCT00745589|vascular,|vascular,
5638417|NCT00745589|valvular calcification,|valvular calcification,
5638418|NCT00745589|phosphate binder,|phosphate binder,
5638419|NCT00745589|sevelamer,|sevelamer,
5638420|NCT00745589|endstage renal disease|endstage renal disease
5638421|NCT00745589|peritoneal dialysis|peritoneal dialysis
5638422|NCT00745563|infertility|infertility
5638423|NCT00745563|insemination|insemination
5638424|NCT00745563|slow release|slow release
5638425|NCT00745550|SB1518|sb1518
5638426|NCT00745550|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5638427|NCT00745550|Myeloproliferative disorders|myeloproliferative disorders
5638428|NCT00745550|Polycythemia Vera|polycythemia vera
5638429|NCT00745550|Essential Thrombocythemia|essential thrombocythemia
5638430|NCT00745550|JAK2 inhibitor|jak2 inhibitor
5638431|NCT00745537|postpartum major depression|postpartum major depression
5638432|NCT00745537|adolescent mothers|adolescent mothers
5638433|NCT00745537|telephone depression care management|telephone depression care management
5638434|NCT00745537|barriers to depression care|barriers to depression care
5638435|NCT00745524|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5638436|NCT00745524|adolescent|adolescent
5638437|NCT00745524|adult|adult
5638438|NCT00745524|high risk population|high risk population
5638439|NCT00745524|functional impairment|functional impairment
5638440|NCT00745524|quality of life|quality of life
5638442|NCT00745511|Avastin|avastin
5638443|NCT00745511|ORA102|ora102
5638444|NCT00745511|macular degeneration|macular degeneration
5638445|NCT00745511|neo-vascular age related macular degeneration (AMD)|neo-vascular age related macular degeneration (amd)
5638446|NCT00745498|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5638447|NCT00745498|vitrectomy|vitrectomy
5638448|NCT00745498|bevacizumab|bevacizumab
5638449|NCT00745498|vitreous hemorrhage|vitreous hemorrhage
5638451|NCT00745485|zoledronic acid|zoledronic acid
5638452|NCT00745485|postmenopausal women|postmenopausal women
5638453|NCT00745472|AEP|aep
5638454|NCT00745472|experimental pain|experimental pain
5638455|NCT00745472|healthy volunteers|healthy volunteers
5638456|NCT00745459|Patients|patients
5638457|NCT00745459|undergoing|undergoing
5638458|NCT00745459|gastric|gastric
5638459|NCT00745459|endoscopy|endoscopy
5638460|NCT00745446|Air pollution|air pollution
5638461|NCT00745446|Diesel exhaust|diesel exhaust
5638462|NCT00745446|Endothelial function|endothelial function
5638463|NCT00745446|Vascular function|vascular function
5638464|NCT00745446|Particle trap|particle trap
5638465|NCT00745446|Thrombosis|thrombosis
5638466|NCT00745446|effects|effects
5638467|NCT00745446|inhalation|inhalation
5638468|NCT00745420|Sickle Cell Disease|sickle cell disease
5638469|NCT00745420|Sickle Cell Anemia|sickle cell anemia
5638470|NCT00745407|adipocytokines|adipocytokines
5638471|NCT00745407|insulin sensitivity|insulin sensitivity
5638472|NCT00745407|hypertriglyceridemic patients|hypertriglyceridemic patients
5638473|NCT00745394|NIRS|nirs
5638474|NCT00745394|bypass|bypass
5638475|NCT00745394|cardiopulmonary|cardiopulmonary
5638476|NCT00745394|CPB|cpb
5638477|NCT00745394|monitoring|monitoring
5638478|NCT00745394|system|system
5638479|NCT00745381|PANCREAS|pancreas
5638480|NCT00745381|STOMACH|stomach
5638481|NCT00745381|Questionnaire|questionnaire
5638482|NCT00745381|08-105|08-105
5638483|NCT00745368|HIV|hiv
5638484|NCT00745368|Raltegravir|raltegravir
5638485|NCT00745368|pharmacokinetics|pharmacokinetics
5638486|NCT00745368|Treatment Experienced|treatment experienced
5638487|NCT00745355|Quality of Life|quality of life
5638489|NCT00745355|08-076|08-076
5638490|NCT00745342|type 1 diabetes|type 1 diabetes
5638491|NCT00745342|glycemic control|glycemic control
5638492|NCT00745342|family conflict|family conflict
5638493|NCT00745342|quality of life|quality of life
5638494|NCT00745342|parental involvement|parental involvement
5638495|NCT00745316|Heart Failure|heart failure
5638496|NCT00745316|Renal Insufficiency|renal insufficiency
5638498|NCT00745303|Tai Chi Chuan; Lipid; Cytokine|tai chi chuan; lipid; cytokine
5638499|NCT00745290|Total knee arthroplasty|total knee arthroplasty
5638500|NCT00745290|Pain|pain
5638501|NCT00745290|Analgesia|analgesia
5638502|NCT00745264|heat|heat
5638503|NCT00745264|exercise|exercise
5638504|NCT00745251|Sleep apnea; obesity|sleep apnea; obesity
5638505|NCT00745238|endothelial function|endothelial function
5638506|NCT00745238|peripheral arterial tone|peripheral arterial tone
5638507|NCT00745238|systemic inflammation|systemic inflammation
5638508|NCT00745238|oxidative stress|oxidative stress
5638509|NCT00745238|respiratory and peripheral muscular function|respiratory and peripheral muscular function
5638510|NCT00745225|peritoneal dialysis, cardiovascular, PPAR-gamma|peritoneal dialysis, cardiovascular, ppar-gamma
5638511|NCT00745212|venous thromboembolism diseases|venous thromboembolism diseases
5638512|NCT00745212|placental vascular pathologies|placental vascular pathologies
5638513|NCT00745212|antithrombotic treatment|antithrombotic treatment
5638514|NCT00745212|symptomatic thromboembolic events|symptomatic thromboembolic events
5638515|NCT00745212|pregnant women|pregnant women
5638516|NCT00745212|score|score
5638517|NCT00745212|therapeutic strategies|therapeutic strategies
5638518|NCT00745212|heparin|heparin
5638519|NCT00745212|aspirin|aspirin
5638520|NCT00745212|pregnancy pathology|pregnancy pathology
5638521|NCT00745199|End Stage Renal Disease|end stage renal disease
5638522|NCT00745199|Cromolyn Sodium|cromolyn sodium
5638523|NCT00745199|Pruritus|pruritus
5638524|NCT00745199|Tryptase|tryptase
5638525|NCT00745160|Questionaires|questionaires
5638526|NCT00745147|constipation|constipation
5638527|NCT00745147|traditional Chinese medicine|traditional chinese medicine
5638528|NCT00745147|Chinese herbal formula|chinese herbal formula
5638529|NCT00745147|lactulose|lactulose
5638530|NCT00745147|cost-effective|cost-effective
5638531|NCT00745147|long-term care|long-term care
5638532|NCT00745095|Safety|safety
5638533|NCT00745095|Efficacy|efficacy
5638534|NCT00745095|Colonoscopy|colonoscopy
5638535|NCT00745095|PIEE|piee
5638536|NCT00745095|MoviPrep|moviprep
5638537|NCT00745095|Neostigmine|neostigmine
5638538|NCT00745095|Glycopyrrolate|glycopyrrolate
5638539|NCT00745069|Tapentadol|tapentadol
5638540|NCT00745069|Osteoarthritis|osteoarthritis
5638541|NCT00745069|Analgesia|analgesia
5638542|NCT00745069|Chronic pain|chronic pain
5638543|NCT00745056|Cognition|cognition
5638544|NCT00745056|Memory|memory
5638545|NCT00745056|Hormone Therapy|hormone therapy
5638546|NCT00745056|HT|ht
5638547|NCT00745043|COPD|copd
5638548|NCT00745043|Betablockers|betablockers
5638549|NCT00745043|bronchodilator|bronchodilator
5638550|NCT00745043|exercise capacity|exercise capacity
5638551|NCT00745043|methacholine challenge|methacholine challenge
5638552|NCT00745030|Parkinson's disease|parkinson's disease
5638553|NCT00745030|Multiple Systems Atrophy|multiple systems atrophy
5638554|NCT00745030|Lewy Body Dementia|lewy body dementia
5638556|NCT00745017|major depressive disorder|major depressive disorder
5638557|NCT00745017|interpersonal therapy|interpersonal therapy
5638558|NCT00745017|cognitive behavioral therapy|cognitive behavioral therapy
5638559|NCT00745017|antidepressant therapies|antidepressant therapies
5638563|NCT00744978|Efficacy|efficacy
5638564|NCT00744978|Safety|safety
5638565|NCT00744978|Pharmacokinetics|pharmacokinetics
5638566|NCT00744978|Alzheimer's disease|alzheimer's disease
5638567|NCT00744952|Large-vessel vasculitis|large-vessel vasculitis
5638568|NCT00744939|Gadolinium|gadolinium
5638569|NCT00744939|NSF|nsf
5638570|NCT00744939|Renal Impairment|renal impairment
5638863|NCT00743912|midazolam|midazolam
5638571|NCT00744939|chemically induced|chemically induced
5638572|NCT00744939|adverse effects|adverse effects
5638573|NCT00744939|Contrast Media|contrast media
5638574|NCT00744939|complications|complications
5638575|NCT00744913|Pregnancy|pregnancy
5638576|NCT00744913|Women|women
5638577|NCT00744913|Nicotine replacement therapy|nicotine replacement therapy
5638578|NCT00744913|Smoking cessation|smoking cessation
5638579|NCT00744900|Pemetrexed, Non-Small Cell Lung Cancer, brain metastasis|pemetrexed, non-small cell lung cancer, brain metastasis
5638580|NCT00744887|TMC114-TiDP3-C181|tmc114-tidp3-c181
5638581|NCT00744887|TMC114-C181, health volunteers, Darunavir, ritonavir oral solution|tmc114-c181, health volunteers, darunavir, ritonavir oral solution
5638582|NCT00744874|atrial fibrillation|atrial fibrillation
5638583|NCT00744861|Lumbar Fusion|lumbar fusion
5638584|NCT00744861|exospine|exospine
5638585|NCT00744861|Exo-Spine|exo-spine
5638586|NCT00744848|hemorrhoids|hemorrhoids
5638587|NCT00744835|atrial fibrillation|atrial fibrillation
5638588|NCT00744822|Lung Transplantation|lung transplantation
5638589|NCT00744822|Infections|infections
5638590|NCT00744822|Graft Rejection|graft rejection
5638591|NCT00744809|TMC278-C152|tmc278-c152
5638592|NCT00744809|TMC278-TiDP6-C152|tmc278-tidp6-c152
5638593|NCT00744809|Healthy Volunteers|healthy volunteers
5638594|NCT00744809|QT/QTc interval|qt/qtc interval
5638595|NCT00744796|Endothelial Dystrophy|endothelial dystrophy
5638596|NCT00744796|Fuchs' Endothelial Corneal Dystrophy|fuchs' endothelial corneal dystrophy
5638598|NCT00744770|TMC278-C121|tmc278-c121
5638599|NCT00744770|open-label|open-label
5638600|NCT00744770|drug-drug interaction|drug-drug interaction
5638601|NCT00744770|methadone|methadone
5638602|NCT00744770|TMC278|tmc278
5638603|NCT00744757|5-aza-2'-deoxycytidine|5-aza-2'-deoxycytidine
5638604|NCT00744757|decitabine|decitabine
5638605|NCT00744757|dacogen|dacogen
5638606|NCT00744757|Myelodysplastic Syndrome|myelodysplastic syndrome
5638607|NCT00744744|stage 0 bladder cancer|stage 0 bladder cancer
5638608|NCT00744731|Partial-onset Seizures|partial-onset seizures
5638609|NCT00744731|Simple Partial Seizures|simple partial seizures
5638610|NCT00744731|Complex Partial Seizures|complex partial seizures
5638611|NCT00744705|Retinal nerve fiber layer|retinal nerve fiber layer
5638612|NCT00744705|Glaucoma|glaucoma
5638613|NCT00744705|Myopia|myopia
5638614|NCT00744692|Immunodeficiencies|immunodeficiencies
5638615|NCT00744692|Congenital Marrow Failures|congenital marrow failures
5638616|NCT00744692|Hemoglobinopathies|hemoglobinopathies
5638617|NCT00744692|Inborn Errors of Metabolism|inborn errors of metabolism
5638618|NCT00744692|SCIDS|scids
5638619|NCT00744692|Wiskott Aldrich|wiskott aldrich
5638620|NCT00744692|FEL|fel
5638621|NCT00744692|HLH|hlh
5638622|NCT00744692|IPEX|ipex
5638623|NCT00744692|LAD|lad
5638624|NCT00744692|Sickle Cell|sickle cell
5638625|NCT00744692|Thalassemia|thalassemia
5638626|NCT00744692|Omenn's Syndrome|omenn's syndrome
5638627|NCT00744692|Hurler's Syndrome|hurler's syndrome
5638628|NCT00744692|MLD|mld
5638629|NCT00744692|ALD|ald
5638630|NCT00744692|Sanfilippo|sanfilippo
5638631|NCT00744692|Krabbe|krabbe
5638632|NCT00744692|Hunter's syndrome|hunter's syndrome
5638633|NCT00744692|TaySachs|taysachs
5638634|NCT00744692|Diamond Blackfan Anemia|diamond blackfan anemia
5638635|NCT00744692|transplant|transplant
5638636|NCT00744692|MPS|mps
5638637|NCT00744692|Gaucher|gaucher
5638638|NCT00744679|MS|ms
5638639|NCT00744679|Multiple Sclerosis|multiple sclerosis
5638640|NCT00744666|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5638641|NCT00744666|Side-effects|side-effects
5638642|NCT00744666|Ocular hypertension|ocular hypertension
5638643|NCT00744666|Glaucoma|glaucoma
5638644|NCT00744666|Prevention|prevention
5638645|NCT00744666|Vitreoretinal diseases requiring IVTA for treatment|vitreoretinal diseases requiring ivta for treatment
5638646|NCT00744653|Breast Cancer|breast cancer
5638647|NCT00744653|Recurrence|recurrence
5638648|NCT00744640|advanced pancreatic cancer|advanced pancreatic cancer
5638649|NCT00744640|palliative chemotherapy|palliative chemotherapy
5638650|NCT00744640|first-line therapy|first-line therapy
5638651|NCT00744640|capecitabine|capecitabine
5638652|NCT00744640|oxaliplatin|oxaliplatin
5638653|NCT00744640|gemcitabine|gemcitabine
5638654|NCT00744640|dose-finding study|dose-finding study
5638655|NCT00744640|Phase II|phase ii
5638656|NCT00744627|Generalized Anxiety Disorder|generalized anxiety disorder
5638657|NCT00744627|Anxiety Disorders|anxiety disorders
5638659|NCT00744614|PC02|pc02
5638660|NCT00744614|Respiratory Rate|respiratory rate
5638661|NCT00744614|Arterial blood gas|arterial blood gas
5638662|NCT00744614|Intubation|intubation
5638663|NCT00744614|Capnography|capnography
5638664|NCT00744601|impulsivity|impulsivity
5638665|NCT00744601|cocaine dependence|cocaine dependence
5638666|NCT00744601|relapse|relapse
5638667|NCT00744601|neuroimaging|neuroimaging
5638668|NCT00744601|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5638669|NCT00744601|single photon emission computed tomography (SPECT)|single photon emission computed tomography (spect)
5638670|NCT00744588|substance abuse|substance abuse
5638968|NCT00743509|sarcoma|sarcoma
5638671|NCT00744588|alcohol dependence|alcohol dependence
5638672|NCT00744588|hypothalamic-pituitary-adrenal (HPA) system|hypothalamic-pituitary-adrenal (hpa) system
5638673|NCT00744588|cosyntropin|cosyntropin
5638674|NCT00744588|corticotropin-releasing Hormone (CRH)|corticotropin-releasing hormone (crh)
5638675|NCT00744588|pituitary-adrenal system|pituitary-adrenal system
5638677|NCT00744588|trauma|trauma
5638678|NCT00744588|neurosteroids|neurosteroids
5638679|NCT00744588|cortisol|cortisol
5638680|NCT00744588|relapse|relapse
5638681|NCT00744575|back pain|back pain
5638682|NCT00744575|eeg|eeg
5638683|NCT00744575|chronic pain|chronic pain
5638684|NCT00744562|Phase 1,|phase 1,
5638685|NCT00744562|dose escalation,|dose escalation,
5638686|NCT00744562|histologically|histologically
5638687|NCT00744562|confirmed|confirmed
5638688|NCT00744562|malignancy|malignancy
5638689|NCT00744562|metastatic|metastatic
5638690|NCT00744549|Male Urogenital Diseases|male urogenital diseases
5638691|NCT00744549|Antioxidants|antioxidants
5638692|NCT00744549|Vitamin E|vitamin e
5638693|NCT00744549|Vitamin D|vitamin d
5638694|NCT00744549|Lycopene|lycopene
5638695|NCT00744549|Selenium|selenium
5638696|NCT00744536|Myelodysplastic syndrome|myelodysplastic syndrome
5638697|NCT00744536|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5638698|NCT00744536|High intermediate risk and high risk IPSS score|high intermediate risk and high risk ipss score
5638699|NCT00744536|Angiogenesis|angiogenesis
5638700|NCT00744536|Metronomic chemotherapy|metronomic chemotherapy
5638701|NCT00744536|Myelodysplastic Myeloproliferative Diseases|myelodysplastic myeloproliferative diseases
5638702|NCT00744523|carotid artery stenting|carotid artery stenting
5638703|NCT00744523|stroke|stroke
5638704|NCT00744523|cerebral protection|cerebral protection
5638705|NCT00744523|high surgical risk|high surgical risk
5638706|NCT00744510|Polycystic Ovary Syndrome|polycystic ovary syndrome
5638707|NCT00744510|Reflexology|reflexology
5638708|NCT00744510|Complementary and Alternative Medicine|complementary and alternative medicine
5638709|NCT00744510|Endocrinopathy|endocrinopathy
5638710|NCT00744510|Oligo|oligo
5638711|NCT00744510|Amenorrhoea|amenorrhoea
5638712|NCT00744484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5638713|NCT00744484|COPD|copd
5638714|NCT00744484|Physical group training|physical group training
5638715|NCT00744484|Water exercise|water exercise
5638716|NCT00744484|Cardiorespiratory fitness|cardiorespiratory fitness
5638717|NCT00744484|Functional exercise capacity|functional exercise capacity
5638718|NCT00744484|Health related quality of life|health related quality of life
5638719|NCT00744471|monoclonal antibody RN624 PF-04383119 nerve growth factor anti-nerve growth OA|monoclonal antibody rn624 pf-04383119 nerve growth factor anti-nerve growth oa
5638720|NCT00744458|Primary Health care in rural Africa|primary health care in rural africa
5638721|NCT00744458|Chronic non-communicable diseases|chronic non-communicable diseases
5638722|NCT00744458|Patient Compliance|patient compliance
5638723|NCT00744458|Treatment adherence|treatment adherence
5638724|NCT00744445|hemodialysis|hemodialysis
5638725|NCT00744445|erythropoietin|erythropoietin
5638726|NCT00744419|GERD|gerd
5638727|NCT00744419|pharmacokinetics|pharmacokinetics
5638728|NCT00744419|pantoprazole|pantoprazole
5638729|NCT00744419|neonates|neonates
5638730|NCT00744419|infants|infants
5638731|NCT00744406|recurrent depression|recurrent depression
5638732|NCT00744406|major depressive disorder|major depressive disorder
5638733|NCT00744406|interpersonal therapy|interpersonal therapy
5638734|NCT00744406|cognitive behavioral therapy|cognitive behavioral therapy
5638735|NCT00744406|antidepressant treatment|antidepressant treatment
5638736|NCT00744406|outcome predictors|outcome predictors
5638737|NCT00744406|personality dimensions|personality dimensions
5638738|NCT00744393|sleep|sleep
5638739|NCT00744393|critically ill|critically ill
5638740|NCT00744393|mechanical ventilation|mechanical ventilation
5638741|NCT00744380|Analgesia|analgesia
5638742|NCT00744380|Mechanical ventilation|mechanical ventilation
5638743|NCT00744354|refractory multiple myeloma|refractory multiple myeloma
5638744|NCT00744354|stage I multiple myeloma|stage i multiple myeloma
5638745|NCT00744354|stage II multiple myeloma|stage ii multiple myeloma
5638746|NCT00744354|stage III multiple myeloma|stage iii multiple myeloma
5671242|NCT00616590|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5789063|NCT00150085|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal|diabetes, glucose, tacrolimus, cyclosporine micro-emulsion, liver, kidney, renal
5638747|NCT00744341|SLV320; Acute Decompensated Heart Failure (ADHF); chronic heart failure; renal failure; I.V. doses; hospitalization|slv320; acute decompensated heart failure (adhf); chronic heart failure; renal failure; i.v. doses; hospitalization
5638748|NCT00744328|Postpartum depression|postpartum depression
5638749|NCT00744328|estradiol|estradiol
5638750|NCT00744328|Postpartum major depressive disorder|postpartum major depressive disorder
5638751|NCT00744315|myocardial revascularization|myocardial revascularization
5638752|NCT00744315|myocardial ischemia|myocardial ischemia
5638753|NCT00744315|genetics, medical|genetics, medical
5638754|NCT00744315|Angiogenesis Inducing Agents|angiogenesis inducing agents
5638755|NCT00744302|Dialysate calcium|dialysate calcium
5638756|NCT00744302|Mineral metabolism|mineral metabolism
5638757|NCT00744302|Parathyroid hormone|parathyroid hormone
5638758|NCT00744302|Calcification|calcification
5638759|NCT00744302|Cardiovascular disease|cardiovascular disease
5638760|NCT00744302|Haemodialysis|haemodialysis
5638761|NCT00744289|Hepatitis B|hepatitis b
5638762|NCT00744289|People who inject drugs|people who inject drugs
5638763|NCT00744289|Financial incentive|financial incentive
5638764|NCT00744289|Vaccine completion|vaccine completion
5638765|NCT00744276|fibrocystic breast disease|fibrocystic breast disease
5638766|NCT00744276|fibrocystic disease of breast|fibrocystic disease of breast
5638767|NCT00744276|breast pain|breast pain
5638768|NCT00744276|mastalgia|mastalgia
5638769|NCT00744276|cyclic mastalgia|cyclic mastalgia
5638770|NCT00744276|cystic breast disease|cystic breast disease
5638771|NCT00744250|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5638772|NCT00744250|Chronic Pancreatitis|chronic pancreatitis
5638773|NCT00744250|Cystic fibrosis|cystic fibrosis
5638774|NCT00744250|Pancrelipase|pancrelipase
5638775|NCT00744250|Pancrecarb|pancrecarb
5638776|NCT00744250|Intraduodenal aspiration|intraduodenal aspiration
5638777|NCT00744250|Bioavailability|bioavailability
5638778|NCT00744237|nebivolol|nebivolol
5638779|NCT00744237|Bystolic ™|bystolic ™
5638780|NCT00744237|Hypertension|hypertension
5638781|NCT00744237|Diabetes|diabetes
5638782|NCT00744198|Autologous|autologous
5638783|NCT00744198|Biological|biological
5638785|NCT00744198|Polypropylene|polypropylene
5638787|NCT00744198|Synthetic|synthetic
5638788|NCT00744198|Stress incontinence|stress incontinence
5638789|NCT00744198|Surgery|surgery
5638791|NCT00744198|Treatment|treatment
5638792|NCT00744185|infantile capillary hemangiomas|infantile capillary hemangiomas
5638793|NCT00744185|propranolol|propranolol
5638794|NCT00744185|ultrasonography|ultrasonography
5638795|NCT00744172|hysterectomy|hysterectomy
5638796|NCT00744172|vaginal|vaginal
5638797|NCT00744172|laparoscopy|laparoscopy
5638798|NCT00744172|abdominal|abdominal
5638799|NCT00744172|complication|complication
5638800|NCT00744172|quality of life|quality of life
5638801|NCT00744172|cost-effectiveness|cost-effectiveness
5638802|NCT00744172|Morbidity of three types of hysterectomy|morbidity of three types of hysterectomy
5638803|NCT00744159|colon cancer|colon cancer
5638804|NCT00744159|laparoscopic colorectal surgery|laparoscopic colorectal surgery
5638805|NCT00744159|cellular immunity|cellular immunity
5638806|NCT00744159|HLA-DR expression on monocyte|hla-dr expression on monocyte
5638807|NCT00744133|Plasmodium falciparum, NF54, Anopheles stephensi, mosquito, malaria|plasmodium falciparum, nf54, anopheles stephensi, mosquito, malaria
5638808|NCT00744120|cancer|cancer
5638809|NCT00744107|Ischemic coronary artery disease in native coronary arteries|ischemic coronary artery disease in native coronary arteries
5638810|NCT00744107|Single stent|single stent
5638811|NCT00744107|RVD 2.5- 4.0mm|rvd 2.5- 4.0mm
5638812|NCT00744107|Lesion length up to 26mm|lesion length up to 26mm
5638813|NCT00744107|de novo or previously unstented lesions|de novo or previously unstented lesions
5638814|NCT00744094|resistance training|resistance training
5638815|NCT00744094|protein supplementation|protein supplementation
5638816|NCT00744094|hypertrophy|hypertrophy
5638817|NCT00744068|Stimulant|stimulant
5638818|NCT00744068|Drug treatment|drug treatment
5638819|NCT00744068|Continuing care|continuing care
5638820|NCT00744068|Telephone support|telephone support
5638821|NCT00744068|Aftercare|aftercare
5638822|NCT00744055|alcohol dependence|alcohol dependence
5638823|NCT00744055|post traumatic stress disorder|post traumatic stress disorder
5638824|NCT00744055|treatment|treatment
5638825|NCT00744055|prazosin|prazosin
5638826|NCT00744042|Hypophosphatasia|hypophosphatasia
5638828|NCT00744042|Bone Disease|bone disease
5638829|NCT00744042|Soft Bones|soft bones
5638830|NCT00744042|Low Alkaline Phosphatase|low alkaline phosphatase
5638831|NCT00744042|genetic metabolic disorder|genetic metabolic disorder
5638832|NCT00744042|alkaline phosphatase|alkaline phosphatase
5638833|NCT00744042|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5638834|NCT00744042|rickets|rickets
5638835|NCT00744042|osteomalacia|osteomalacia
5638836|NCT00744029|prehospital delays|prehospital delays
5638837|NCT00744029|intervention|intervention
5638838|NCT00744029|population-based|population-based
5638839|NCT00744029|stroke|stroke
5638840|NCT00744016|UC|uc
5638841|NCT00744016|Ulcerative colitis|ulcerative colitis
5638842|NCT00744016|IBD|ibd
5632700|NCT00768846|DES|des
5638843|NCT00744016|Inflammatory bowel disease|inflammatory bowel disease
5638844|NCT00743990|Cough symptoms|cough symptoms
5638845|NCT00743990|Cold symptoms|cold symptoms
5638846|NCT00743990|Congestion|congestion
5638847|NCT00743990|Children|children
5638849|NCT00743990|Alternative cough symptom treatment|alternative cough symptom treatment
5638850|NCT00743951|patient decision aids|patient decision aids
5638851|NCT00743951|patient preferences|patient preferences
5638852|NCT00743951|osteoarthritis|osteoarthritis
5638853|NCT00743951|joint replacement|joint replacement
5638854|NCT00743951|waiting times|waiting times
5638855|NCT00743925|Unstable Angina|unstable angina
5638856|NCT00743925|STEMI|stemi
5638857|NCT00743925|NSTEMI|nstemi
5638858|NCT00743925|ACS|acs
5638859|NCT00743925|Acute Coronary Syndrome|acute coronary syndrome
5638860|NCT00743925|C14.280.647.124|c14.280.647.124
5638861|NCT00743925|C14.280.647.500|c14.280.647.500
5638862|NCT00743912|rifaximin|rifaximin
5638864|NCT00743912|pharmacokinetics|pharmacokinetics
5638865|NCT00743899|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5638866|NCT00743899|Everolimus-eluting stent|everolimus-eluting stent
5638867|NCT00743873|medial retinaculum tear s/p patella dislocation|medial retinaculum tear s/p patella dislocation
5638868|NCT00743860|darapladib|darapladib
5638869|NCT00743860|pharmacokinetics|pharmacokinetics
5638870|NCT00743860|metabolite|metabolite
5638871|NCT00743860|SB-480848|sb-480848
5638872|NCT00743847|schizophrenia, treatment, cognition|schizophrenia, treatment, cognition
5638873|NCT00743808|hypertension|hypertension
5638874|NCT00743808|diabetes|diabetes
5638875|NCT00743808|quality improvement|quality improvement
5638876|NCT00743808|blood pressure|blood pressure
5638877|NCT00743795|Hepatitis C|hepatitis c
5638878|NCT00743795|HCV|hcv
5638879|NCT00743795|Rapid Virologic Response|rapid virologic response
5638880|NCT00743795|Sustained Virologic Response|sustained virologic response
5638881|NCT00743795|HCV RNA|hcv rna
5638882|NCT00743795|Polymerase inhibitor|polymerase inhibitor
5638883|NCT00743795|GS-9190|gs-9190
5638884|NCT00743782|Hypoparathyroidism|hypoparathyroidism
5638885|NCT00743782|Parathyroid Hormone 1-34|parathyroid hormone 1-34
5638886|NCT00743769|Myocardial Infarction|myocardial infarction
5638887|NCT00743769|Myocardial Ischemia|myocardial ischemia
5638888|NCT00743769|Myocardial Diseases|myocardial diseases
5638889|NCT00743769|Infarction|infarction
5638890|NCT00743756|obesity|obesity
5638891|NCT00743756|diabetes|diabetes
5638892|NCT00743756|endothelial function|endothelial function
5638893|NCT00743756|insulin sensitivity|insulin sensitivity
5638894|NCT00743743|dementia|dementia
5638895|NCT00743743|Alzheimer disease|alzheimer disease
5638896|NCT00743743|cognition|cognition
5638897|NCT00743743|function|function
5638898|NCT00743743|behavior|behavior
5638899|NCT00743743|treatment|treatment
5638900|NCT00743730|developmental delay|developmental delay
5638901|NCT00743730|cognitive impairment|cognitive impairment
5638902|NCT00743730|pain control|pain control
5638903|NCT00743730|post operative pain|post operative pain
5638904|NCT00743730|opioid|opioid
5638905|NCT00743730|pain assessment|pain assessment
5638906|NCT00743730|Parent Nurse controlled Analgesic|parent nurse controlled analgesic
5638907|NCT00743730|patient controlled analgesic|patient controlled analgesic
5638908|NCT00743730|children|children
5638909|NCT00743730|pain|pain
5638910|NCT00743730|analgesic|analgesic
5638911|NCT00743730|safety|safety
5638912|NCT00743730|parent satisfaction|parent satisfaction
5638913|NCT00743730|nurse satisfaction|nurse satisfaction
5638914|NCT00743730|Pediatric|pediatric
5638915|NCT00743717|total knee arthroplasty|total knee arthroplasty
5638916|NCT00743717|osteoarthritis|osteoarthritis
5638917|NCT00743717|ceramic bearing|ceramic bearing
5638918|NCT00743717|zirconia|zirconia
5638919|NCT00743691|Ethiopia|ethiopia
5638920|NCT00743691|Community|community
5638921|NCT00743691|Community based|community based
5638922|NCT00743691|Health extension Worker|health extension worker
5638923|NCT00743691|Health Extension Program|health extension program
5638924|NCT00743678|Colorectal Cancer|colorectal cancer
5638925|NCT00743678|Unresectable liver metastasis|unresectable liver metastasis
5638926|NCT00743678|FOLFOX6|folfox6
5638927|NCT00743678|Cetuximab|cetuximab
5638928|NCT00743678|Neoadjuvant therapy|neoadjuvant therapy
5638929|NCT00743665|Youth|youth
5638930|NCT00743665|consensus|consensus
5638931|NCT00743665|criteria|criteria
5638932|NCT00743665|CVS|cvs
5638933|NCT00743652|13 valent Pneumococcal Conjugate Vaccine|13 valent pneumococcal conjugate vaccine
5638934|NCT00743652|Antibody Response|antibody response
5638935|NCT00743652|safety|safety
5638936|NCT00743652|Alaskan Native Children|alaskan native children
5638937|NCT00743639|Cardiomyopathy|cardiomyopathy
5638938|NCT00743639|stem cell|stem cell
5638939|NCT00743639|cardiac failure|cardiac failure
5638940|NCT00743626|Pap test|pap test
5638941|NCT00743626|HPV|hpv
5638942|NCT00743626|Healthy patients screened for cervical cancer tests.|healthy patients screened for cervical cancer tests.
5638943|NCT00743613|Erectile Dysfunction|erectile dysfunction
5638944|NCT00743613|ED|ed
5638945|NCT00743613|Peripheral Arterial Disease|peripheral arterial disease
5638946|NCT00743613|PAD|pad
5638948|NCT00743613|ABI|abi
5638953|NCT00743561|ambulatory polygraphy|ambulatory polygraphy
5638954|NCT00743561|polysomnography|polysomnography
5638955|NCT00743548|interdental self-care aids|interdental self-care aids
5638956|NCT00743548|plaque|plaque
5638957|NCT00743548|bleeding gums|bleeding gums
5638958|NCT00743535|Cystocele|cystocele
5638959|NCT00743535|Mesh|mesh
5638960|NCT00743535|Prolapse|prolapse
5638961|NCT00743535|Sling|sling
5638962|NCT00743535|Stress incontinence|stress incontinence
5638963|NCT00743535|Surgery|surgery
5638964|NCT00743535|TOT|tot
5638965|NCT00743535|TVT|tvt
5638966|NCT00743535|Treatment|treatment
5638967|NCT00743522|Reducing shocks|reducing shocks
5638969|NCT00743509|Cyclophosphamide|cyclophosphamide
5638970|NCT00743509|Sirolimus|sirolimus
5638971|NCT00743509|Progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, Ewing's or soft tissue sarcoma previously treated with chemotherapy.|progressive or recurrent, advanced (unresectable or metastatic) high-grade osteosarcoma, ewing's or soft tissue sarcoma previously treated with chemotherapy.
5638972|NCT00743483|cystic fibrosis|cystic fibrosis
5638973|NCT00743483|pancreatic insufficiency|pancreatic insufficiency
5638974|NCT00743483|bucelipase alfa|bucelipase alfa
5638975|NCT00743483|bile salt stimulating lipase|bile salt stimulating lipase
5638976|NCT00743483|BSSL|bssl
5638977|NCT00743483|coefficient of fat absorption|coefficient of fat absorption
5638978|NCT00743470|HIV co-infected with tuberculosis|hiv co-infected with tuberculosis
5638979|NCT00743457|Possible VPS failure with symptom such as headache|possible vps failure with symptom such as headache
5638980|NCT00743457|vomiting|vomiting
5638984|NCT00743444|transient lower esophageal sphincter relaxations (TLESRs)|transient lower esophageal sphincter relaxations (tlesrs)
5638985|NCT00743444|reflux|reflux
5638986|NCT00743405|schizophrenia|schizophrenia
5638987|NCT00743405|M1 receptor agonist|m1 receptor agonist
5638988|NCT00743405|safety|safety
5638989|NCT00743405|pharmacokinetics|pharmacokinetics
5638990|NCT00743405|GSK1034702|gsk1034702
5638991|NCT00743379|Phase 1/2|phase 1/2
5638992|NCT00743379|Advanced Solid Tumors|advanced solid tumors
5638993|NCT00743379|Hypoxia|hypoxia
5638994|NCT00743379|Prodrug|prodrug
5638995|NCT00743379|Dose-Escalation|dose-escalation
5638996|NCT00743379|Evofosfamide|evofosfamide
5638997|NCT00743366|quetiapine|quetiapine
5638998|NCT00743366|smoked marijuana|smoked marijuana
5638999|NCT00743366|marijuana use|marijuana use
5639000|NCT00743353|laryngeal|laryngeal
5639001|NCT00743353|squamous cell|squamous cell
5639002|NCT00743353|anaplastic astrocytoma|anaplastic astrocytoma
5639003|NCT00743353|oligodendroglioma|oligodendroglioma
5639004|NCT00743353|glioblastoma multiforme|glioblastoma multiforme
5639005|NCT00743340|HIV-1 infection|hiv-1 infection
5639006|NCT00743340|emtricitabine|emtricitabine
5639007|NCT00743340|pediatrics|pediatrics
5639008|NCT00743340|pediatric patients|pediatric patients
5639009|NCT00743327|hormone therapy|hormone therapy
5639010|NCT00743314|lymphedema|lymphedema
5639011|NCT00743314|stage I breast cancer|stage i breast cancer
5639012|NCT00743314|stage II breast cancer|stage ii breast cancer
5639013|NCT00743301|CVD|cvd
5639014|NCT00743301|Palm olein|palm olein
5639015|NCT00743301|Olive oil|olive oil
5639016|NCT00743301|Lard|lard
5639017|NCT00743301|healthy men|healthy men
5639018|NCT00743301|metabolic syndrome|metabolic syndrome
5639019|NCT00743301|Risk of cardiovascular disease and metabolic syndrome|risk of cardiovascular disease and metabolic syndrome
5639020|NCT00743288|stage I multiple myeloma|stage i multiple myeloma
5639021|NCT00743288|stage II multiple myeloma|stage ii multiple myeloma
5639022|NCT00743288|stage III multiple myeloma|stage iii multiple myeloma
5639023|NCT00743288|refractory multiple myeloma|refractory multiple myeloma
5639024|NCT00743275|Influenza|influenza
5639025|NCT00743262|laryngectomy|laryngectomy
5639026|NCT00743262|larynx cancer|larynx cancer
5639027|NCT00743249|Dry eye|dry eye
5639028|NCT00743249|Tear duct|tear duct
5639029|NCT00743249|Punctal plug|punctal plug
5639030|NCT00743236|perioperative/postoperative complications|perioperative/postoperative complications
5639031|NCT00743236|urinary complications|urinary complications
5639032|NCT00743236|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5639033|NCT00743236|stage I renal cell cancer|stage i renal cell cancer
5639034|NCT00743223|temporomandibular disorder|temporomandibular disorder
5639035|NCT00743223|orofacial pain|orofacial pain
5639036|NCT00743223|posture of the head|posture of the head
5639037|NCT00743210|pregnancy|pregnancy
5639038|NCT00743210|obesity|obesity
5639039|NCT00743210|asymmetric dimethylarginine|asymmetric dimethylarginine
5639040|NCT00743210|L-arginine|l-arginine
5639041|NCT00743210|L-citrulline|l-citrulline
5639042|NCT00743197|coronary artery disease (CAD)|coronary artery disease (cad)
5639043|NCT00743197|chest pain|chest pain
5639044|NCT00743197|myocardial ischemia|myocardial ischemia
5639045|NCT00743197|endothelial function|endothelial function
5639047|NCT00743184|LUTS|luts
5632856|NCT00768053|etanercept|etanercept
5639048|NCT00743184|Lower urinary tract symptoms (LUTS)|lower urinary tract symptoms (luts)
5639049|NCT00743171|Lung transplantation|lung transplantation
5639050|NCT00743171|Home spirometry|home spirometry
5639051|NCT00743171|non-adherence|non-adherence
5639053|NCT00743171|bronchiolitis obliterans|bronchiolitis obliterans
5639054|NCT00743158|ztr|ztr
5639055|NCT00743158|transfer impedance|transfer impedance
5639056|NCT00743158|cystic fibrosis|cystic fibrosis
5639057|NCT00743158|pulmonary function test|pulmonary function test
5639058|NCT00743158|pft|pft
5639059|NCT00743145|naltrexone|naltrexone
5639060|NCT00743145|smoked marijuana|smoked marijuana
5639061|NCT00743145|marijuana use|marijuana use
5639062|NCT00743132|evaluation|evaluation
5639063|NCT00743132|incidence|incidence
5639064|NCT00743132|liver surgery|liver surgery
5639065|NCT00743132|resection|resection
5639067|NCT00743132|postoperative|postoperative
5639068|NCT00743132|mortality|mortality
5639069|NCT00743119|oral thc|oral thc
5639070|NCT00743119|cannabis|cannabis
5639071|NCT00743119|pain|pain
5639072|NCT00743119|analgesic effects|analgesic effects
5639073|NCT00743119|dronabinol|dronabinol
5639074|NCT00743106|nephrectomy|nephrectomy
5639075|NCT00743106|fenoldopam|fenoldopam
5639076|NCT00743106|atrophic minimally functioning kidney|atrophic minimally functioning kidney
5639077|NCT00743093|acetaminophen|acetaminophen
5639078|NCT00743093|protein adducts|protein adducts
5639079|NCT00743093|drug safety|drug safety
5639080|NCT00743093|alanine aminotransferase|alanine aminotransferase
5639081|NCT00743093|Alanine Amino Transferase|alanine amino transferase
5639082|NCT00743080|laparoscopy|laparoscopy
5639083|NCT00743080|myomectomy|myomectomy
5639084|NCT00743080|myomas|myomas
5639085|NCT00743080|morcellator|morcellator
5639086|NCT00743080|supracervical hysterectomy|supracervical hysterectomy
5639087|NCT00743080|surgery|surgery
5639088|NCT00743080|symptomatic uterine myomas|symptomatic uterine myomas
5639089|NCT00743067|XL880|xl880
5639090|NCT00743067|MET inhibitor|met inhibitor
5639091|NCT00743067|GSK1363089|gsk1363089
5639092|NCT00743067|Solid Tumors|solid tumors
5639093|NCT00743067|c-Met|c-met
5639094|NCT00743054|Carcinoma, Renal Cell|carcinoma, renal cell
5639095|NCT00743054|MicroRNAs|micrornas
5620923|NCT00815503|Local infiltration|local infiltration
5639096|NCT00743041|PTSD, EFT, depression, anxiety, telephone|ptsd, eft, depression, anxiety, telephone
5639097|NCT00743028|Other hematological and non-hematological malignancies|other hematological and non-hematological malignancies
5639098|NCT00743002|TT223|tt223
5639099|NCT00742989|osteopathic|osteopathic
5639100|NCT00742989|lymphatic|lymphatic
5639101|NCT00742989|treatment|treatment
5639103|NCT00742989|normal|normal
5639104|NCT00742976|Weight gain in insulin treated type 2 diabetes|weight gain in insulin treated type 2 diabetes
5639105|NCT00742976|extracellular volume|extracellular volume
5639106|NCT00742976|insulin treatment|insulin treatment
5639107|NCT00742976|sodium retention|sodium retention
5639108|NCT00742963|TH-302|th-302
5639109|NCT00742963|Advanced Soft Tissue Sarcoma|advanced soft tissue sarcoma
5639110|NCT00742963|Doxorubicin|doxorubicin
5639111|NCT00742963|Phase 1/2|phase 1/2
5639112|NCT00742950|Corneal incision|corneal incision
5639113|NCT00742950|Cataract surgery|cataract surgery
5639114|NCT00742950|Phacoemulsification|phacoemulsification
5639115|NCT00742950|Surgically induced astigmatism|surgically induced astigmatism
5639116|NCT00742950|Corneal Topography|corneal topography
5639117|NCT00742937|Hypovitaminosis A|hypovitaminosis a
5639118|NCT00742924|metastatic osteosarcoma|metastatic osteosarcoma
5639119|NCT00742911|Solid Tumors, Liver|solid tumors, liver
5639120|NCT00742898|Quasi-experimental design|quasi-experimental design
5639121|NCT00742898|Non-targeted opt-out rapid HIV screening|non-targeted opt-out rapid hiv screening
5639122|NCT00742898|Diagnostic rapid HIV testing|diagnostic rapid hiv testing
5639123|NCT00742898|Emergency department|emergency department
5639124|NCT00742898|Effectiveness|effectiveness
5639125|NCT00742898|Efficiency|efficiency
5639126|NCT00742898|Health services research|health services research
5639127|NCT00742898|Program evaluation|program evaluation
5639128|NCT00742898|Effectiveness and efficiency of non-targeted rapid HIV screening in the ED|effectiveness and efficiency of non-targeted rapid hiv screening in the ed
5639129|NCT00742885|Immunogenicity|immunogenicity
5639130|NCT00742885|Safety|safety
5639131|NCT00742885|Pandemic Influenza|pandemic influenza
5639132|NCT00742872|Mosapride|mosapride
5639133|NCT00742872|Irritable Bowel Syndrome|irritable bowel syndrome
5639134|NCT00742872|Constipation|constipation
5639135|NCT00742859|Atrial Fibrillation|atrial fibrillation
5639136|NCT00742859|Betrixaban|betrixaban
5639137|NCT00742859|Factor Xa inhibitor|factor xa inhibitor
5639138|NCT00742859|Warfarin|warfarin
5639139|NCT00742846|Adhesive Capsulitis|adhesive capsulitis
5639140|NCT00742846|Subacromial injection|subacromial injection
5639141|NCT00742846|Intraarticular injection|intraarticular injection
5639142|NCT00742833|Overactive bladder|overactive bladder
5639143|NCT00742833|Frequency|frequency
5639145|NCT00742833|Urgency|urgency
5639146|NCT00742833|Urge urinary incontinence|urge urinary incontinence
5639147|NCT00742833|β3-agonist|β3-agonist
5632964|NCT00767416|RSV|rsv
5639148|NCT00742820|bioequivalence|bioequivalence
5639149|NCT00742807|sensation|sensation
5639150|NCT00742807|relief|relief
5639151|NCT00742807|during|during
5639152|NCT00742807|surgery|surgery
5639153|NCT00742781|Crohn's|crohn's
5639154|NCT00742781|vitamin D|vitamin d
5639155|NCT00742768|absorption|absorption
5639156|NCT00742768|encapsulation|encapsulation
5639157|NCT00742768|menaquinone|menaquinone
5639158|NCT00742768|Bio-availability|bio-availability
5639159|NCT00742755|Follow-up of breast abnormalities|follow-up of breast abnormalities
5639160|NCT00742755|Korean American immigrants|korean american immigrants
5639161|NCT00742742|Walnut|walnut
5639162|NCT00742742|Lipids|lipids
5639163|NCT00742742|Blood Glucose|blood glucose
5639164|NCT00742729|Colorectal cancer screening|colorectal cancer screening
5639165|NCT00742729|Fecal occult blood test|fecal occult blood test
5639166|NCT00742729|Endoscopies|endoscopies
5639167|NCT00742729|Filipino American immigrants|filipino american immigrants
5639168|NCT00742729|Community based organizations and churches|community based organizations and churches
5639169|NCT00742716|Parathyroid Diseases|parathyroid diseases
5639170|NCT00742716|Renal Insufficiency|renal insufficiency
5639171|NCT00742716|Kidney Failure, Chronic|kidney failure, chronic
5639172|NCT00742716|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5639173|NCT00742716|Vitamin D|vitamin d
5639174|NCT00742716|Hyperparathyroidism|hyperparathyroidism
5639175|NCT00742716|Renal Insufficiency, Chronic|renal insufficiency, chronic
5639176|NCT00742716|Kidney Diseases|kidney diseases
5639177|NCT00742716|Kidney Failure|kidney failure
5639179|NCT00742690|type 1 hepatorenal syndrome|type 1 hepatorenal syndrome
5639180|NCT00742690|terlipressin|terlipressin
5639181|NCT00742690|albumin|albumin
5639182|NCT00742690|effective circulating volume|effective circulating volume
5639183|NCT00742690|Patients|patients
5639184|NCT00742690|with|with
5639185|NCT00742677|female reproductive cancer|female reproductive cancer
5639186|NCT00742664|Prader-Willi Syndrome|prader-willi syndrome
5639187|NCT00742664|Compulsive behavior|compulsive behavior
5639188|NCT00742664|Hoarding|hoarding
5639189|NCT00742664|Obsessive-compulsive disorder|obsessive-compulsive disorder
5639190|NCT00742664|Children|children
5639191|NCT00742664|Treatment|treatment
5639192|NCT00742664|genetically|genetically
5639193|NCT00742664|confirmed|confirmed
5639194|NCT00742664|diagnosis|diagnosis
5639195|NCT00742638|CCMD-3,|ccmd-3,
5639196|NCT00742638|CRF,|crf,
5639197|NCT00742638|EPS,|eps,
5639198|NCT00742638|GCP,|gcp,
5639199|NCT00742638|ICH,|ich,
5639200|NCT00742638|ITT,|itt,
5639201|NCT00742638|LOCF,|locf,
5639202|NCT00742638|MADRS,|madrs,
5639203|NCT00742638|PANSS,|panss,
5639204|NCT00742638|YMRS.|ymrs.
5639205|NCT00742638|Acute|acute
5639206|NCT00742638|manic|manic
5639207|NCT00742638|patients|patients
5639208|NCT00742638|with|with
5639209|NCT00742638|bipolar|bipolar
5639210|NCT00742638|disorder|disorder
5639211|NCT00742612|Carotid Endarterectomy|carotid endarterectomy
5639212|NCT00742612|von Willebrand Factor|von willebrand factor
5639213|NCT00742612|Microembolic Signal|microembolic signal
5639214|NCT00742599|Stomach Diseases|stomach diseases
5639215|NCT00742586|Gene Expression Changes in Blood Cells|gene expression changes in blood cells
5639217|NCT00742586|Pure Autonomic Failure|pure autonomic failure
5639218|NCT00742586|Multiply System Atrophy|multiply system atrophy
5639219|NCT00742586|Parkinson's Plus|parkinson's plus
5639220|NCT00742573|Major Depressive Disorder|major depressive disorder
5639221|NCT00742573|Mood Disorders|mood disorders
5639222|NCT00742573|Hispanic|hispanic
5639223|NCT00742560|Multiple Myeloma|multiple myeloma
5639224|NCT00742547|prevention|prevention
5639225|NCT00742547|health services research|health services research
5639226|NCT00742534|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5639227|NCT00742534|Prematurity|prematurity
5639228|NCT00742534|Lung Disease|lung disease
5639229|NCT00742534|preterm infants|preterm infants
5639230|NCT00742521|cortisol|cortisol
5639231|NCT00742521|catecholamines|catecholamines
5639232|NCT00742521|Type 1 DM|type 1 dm
5639233|NCT00742508|carvedilol phosphate|carvedilol phosphate
5639234|NCT00742508|ß-blocker|ß-blocker
5639235|NCT00742508|SK&F-105517-D|sk&f-105517-d
5639236|NCT00742508|Chronic heart failure(CHF)|chronic heart failure(chf)
5639237|NCT00742469|TD|td
5639238|NCT00742469|traveller's diarrhea|traveller's diarrhea
5639239|NCT00742469|campylobacter|campylobacter
5639240|NCT00742469|shigella|shigella
5639241|NCT00742469|salmonella|salmonella
5639242|NCT00742469|E. coli|e. coli
5639243|NCT00742469|diarrhea|diarrhea
5639244|NCT00742456|Microcirculation|microcirculation
5639245|NCT00742456|Insulin|insulin
5639246|NCT00742456|Hypertension|hypertension
5639247|NCT00742456|Obesity|obesity
5639248|NCT00742443|Scar Revision|scar revision
5639249|NCT00742430|aspirin resistance|aspirin resistance
5639250|NCT00742430|coronary artery disease|coronary artery disease
5639251|NCT00742430|clopidogrel resistance|clopidogrel resistance
5639252|NCT00742430|major adverse cardiac events|major adverse cardiac events
5789064|NCT00150072|chordoma|chordoma
5639253|NCT00742430|multiplate platelet function analyser|multiplate platelet function analyser
5639254|NCT00742430|percutaneous coronary intervention|percutaneous coronary intervention
5639255|NCT00742417|Alzheimer's|alzheimer's
5639256|NCT00742417|Dementia|dementia
5639258|NCT00742417|Loss of cognitive abilities|loss of cognitive abilities
5639259|NCT00742417|Old age|old age
5639260|NCT00742417|Elderly|elderly
5639261|NCT00742417|Aging|aging
5639262|NCT00742417|Albumin|albumin
5639263|NCT00742417|Caregiver|caregiver
5639264|NCT00742417|amyloid|amyloid
5639265|NCT00742417|beta amyloid|beta amyloid
5639266|NCT00742417|Central Nervous System Diseases|central nervous system diseases
5639267|NCT00742417|Brain Disease|brain disease
5639268|NCT00742417|Mental Disorders|mental disorders
5639269|NCT00742417|Plasma Exchange|plasma exchange
5639270|NCT00742404|stage I multiple myeloma|stage i multiple myeloma
5639271|NCT00742404|stage II multiple myeloma|stage ii multiple myeloma
5639272|NCT00742404|stage III multiple myeloma|stage iii multiple myeloma
5639273|NCT00742391|Peplin|peplin
5639274|NCT00742391|Actinic keratosis|actinic keratosis
5639275|NCT00742391|PEP005|pep005
5639276|NCT00742378|Glaucoma|glaucoma
5639277|NCT00742378|Retinal nerve fiber layer|retinal nerve fiber layer
5639278|NCT00742378|Cirrus OCT|cirrus oct
5639279|NCT00742365|Seasonal Affective Disorder|seasonal affective disorder
5639280|NCT00742365|Light Therapy|light therapy
5639281|NCT00742365|Seasonal Depression|seasonal depression
5639283|NCT00742365|Bright Light|bright light
5639284|NCT00742365|Major Depressive Disorder|major depressive disorder
5639285|NCT00742365|Bipolar Disorder|bipolar disorder
5639286|NCT00742339|cirrhosis|cirrhosis
5639287|NCT00742339|hepatorenal syndrome|hepatorenal syndrome
5639288|NCT00742339|terlipressin|terlipressin
5639289|NCT00742339|midodrine|midodrine
5639290|NCT00742339|octreotide|octreotide
5639291|NCT00742339|human albumin|human albumin
5639292|NCT00742339|effective circulating volume|effective circulating volume
5639293|NCT00742339|The criteria which will be used for the diagnosis of HRS will be the criteria which were recently published by the International Ascites Club|the criteria which will be used for the diagnosis of hrs will be the criteria which were recently published by the international ascites club
5639294|NCT00742339|Patients with cirrhosis and type 2 HRS only with serum creatinine value > 2.5 mg/dl|patients with cirrhosis and type 2 hrs only with serum creatinine value > 2.5 mg/dl
5639295|NCT00742339|All patients with cirrhosis and type 1 HRS|all patients with cirrhosis and type 1 hrs
5639297|NCT00742326|Hepatitis C|hepatitis c
5639298|NCT00742326|Liver Disease|liver disease
5639299|NCT00742326|Fatty Liver|fatty liver
5639300|NCT00742326|Steatosis|steatosis
5639301|NCT00742313|Endoscopic|endoscopic
5639302|NCT00742313|saphenous|saphenous
5639303|NCT00742313|vein|vein
5639304|NCT00742313|harvest|harvest
5639305|NCT00742300|ASCT|asct
5639306|NCT00742300|Tolerance induction|tolerance induction
5639308|NCT00742300|Transplantation|transplantation
5639309|NCT00742300|Autoimmune diseases|autoimmune diseases
5639310|NCT00742287|smoking|smoking
5639311|NCT00742287|oligomeric proanthocyanidins|oligomeric proanthocyanidins
5639312|NCT00742287|polyphenols|polyphenols
5639313|NCT00742287|supplementation|supplementation
5639314|NCT00742287|vascular function|vascular function
5639315|NCT00742287|oxidative stress|oxidative stress
5639316|NCT00742287|inflammation|inflammation
5639317|NCT00742261|Pharmacokinetics|pharmacokinetics
5639318|NCT00742261|Safety|safety
5639319|NCT00742261|MET|met
5639320|NCT00742261|Bioavailability|bioavailability
5639321|NCT00742261|Patients|patients
5639322|NCT00742261|GSK1363089A|gsk1363089a
5639323|NCT00742261|GSK1363089G|gsk1363089g
5639324|NCT00742261|GSK1363089|gsk1363089
5639325|NCT00742261|Relative|relative
5639326|NCT00742248|COPD|copd
5639327|NCT00742222|Electronic brachytherapy registry|electronic brachytherapy registry
5639328|NCT00742222|Multi-society registry|multi-society registry
5639329|NCT00742222|Breast cancer registry|breast cancer registry
5639330|NCT00742209|migraine|migraine
5639331|NCT00742209|prophylaxis|prophylaxis
5639332|NCT00742209|prevention|prevention
5639333|NCT00742196|Parapapillary atrophy|parapapillary atrophy
5639334|NCT00742196|Retinal nerve fiber layer thickness|retinal nerve fiber layer thickness
5639335|NCT00742196|Glaucoma|glaucoma
5639336|NCT00742196|Cirrus OCT|cirrus oct
5639337|NCT00742170|opioid dependence|opioid dependence
5639338|NCT00742170|opioid detoxification|opioid detoxification
5639339|NCT00742170|electroacupuncture|electroacupuncture
5639340|NCT00742170|adjunctive treatment|adjunctive treatment
5639341|NCT00742170|alternative/complementary medicine|alternative/complementary medicine
5639342|NCT00742157|Growth Hormone|growth hormone
5639343|NCT00742157|TPN|tpn
5639344|NCT00742157|Total Parenteral Nutrition|total parenteral nutrition
5639345|NCT00742157|Glutamine|glutamine
5639346|NCT00742157|Short Bowel Syndrome|short bowel syndrome
5828291|NCT00061243|HIV|hiv
5639347|NCT00742157|Increase in absorption of small bowel.|increase in absorption of small bowel.
5639348|NCT00742144|CD20 positive|cd20 positive
5639349|NCT00742144|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5639351|NCT00742144|GSK1841157|gsk1841157
5639352|NCT00742144|Japanese patient|japanese patient
5639353|NCT00742144|Ofatumumab|ofatumumab
5639354|NCT00742131|MET inhibitor|met inhibitor
5639355|NCT00742131|c-Met|c-met
5639356|NCT00742131|XL880|xl880
5639357|NCT00742131|GSK1363089|gsk1363089
5639358|NCT00742131|Solid Tumors|solid tumors
5639359|NCT00742105|PI3K|pi3k
5639360|NCT00742105|mTOR|mtor
5639361|NCT00742105|Advanced solid tumor|advanced solid tumor
5639362|NCT00742105|Adult|adult
5639363|NCT00742079|Paranoid Schizophrenia|paranoid schizophrenia
5639364|NCT00742079|Paranoid Delusions|paranoid delusions
5639366|NCT00742079|D-Cycloserine|d-cycloserine
5639367|NCT00742066|Hypertension|hypertension
5639368|NCT00742066|Insulin resistance|insulin resistance
5639369|NCT00742066|Microcirculation|microcirculation
5639370|NCT00742066|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5639371|NCT00742053|ECG PICC|ecg picc
5639372|NCT00742053|Patients undergoing PICC placement|patients undergoing picc placement
5639373|NCT00742040|up-titration|up-titration
5639374|NCT00742040|captopril|captopril
5639375|NCT00742040|pediatric|pediatric
5639376|NCT00742040|cardiac patients|cardiac patients
5639377|NCT00742027|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
5639378|NCT00742027|Classical Hodgkin's Lymphoma|classical hodgkin's lymphoma
5639379|NCT00742027|Hodgkin Lymphoma|hodgkin lymphoma
5639380|NCT00742027|Hodgkin's Lymphoma|hodgkin's lymphoma
5639381|NCT00742027|Nodular sclerosing|nodular sclerosing
5639382|NCT00742027|Mixed-cellularity|mixed-cellularity
5639383|NCT00742027|Lymphocyte-rich|lymphocyte-rich
5639384|NCT00742027|Lymphocyte depleted|lymphocyte depleted
5639385|NCT00742027|HL|hl
5639386|NCT00742027|Classical HL|classical hl
5639387|NCT00742027|Refractory Hodgkin's Lymphoma|refractory hodgkin's lymphoma
5639388|NCT00742027|Refractory Hodgkin Lymphoma|refractory hodgkin lymphoma
5639389|NCT00742027|Refractory HL|refractory hl
5639390|NCT00742014|Pulmonary arterial hypertension|pulmonary arterial hypertension
5639391|NCT00742014|Pediatrics|pediatrics
5639392|NCT00742014|Sildenafil|sildenafil
5639393|NCT00742014|Catheterization|catheterization
5639394|NCT00742014|Right ventricular contractility|right ventricular contractility
5639395|NCT00742001|red blood cells|red blood cells
5639396|NCT00742001|transfusion|transfusion
5639398|NCT00742001|feasibility|feasibility
5639399|NCT00742001|white blood cell inactivation|white blood cell inactivation
5639400|NCT00741988|Non-Small Cell Lung Cancer|non-small cell lung cancer
5639401|NCT00741988|Advanced Disease|advanced disease
5639402|NCT00741988|Untreated|untreated
5639403|NCT00741988|Ixabepilone|ixabepilone
5639404|NCT00741988|Carboplatin|carboplatin
5639405|NCT00741988|Bevacizumab|bevacizumab
5639406|NCT00741975|HIV prevention|hiv prevention
5639407|NCT00741949|Respiratory failure|respiratory failure
5639408|NCT00741949|Target Controlled Infusion|target controlled infusion
5639409|NCT00741949|TCI|tci
5639410|NCT00741949|Propofol|propofol
5639411|NCT00741949|Noninvasive ventilation|noninvasive ventilation
5639412|NCT00741949|Broncho-alveolar lavage|broncho-alveolar lavage
5639413|NCT00741936|Functional Constipation|functional constipation
5639414|NCT00741936|Chinese Herbal Medicine|chinese herbal medicine
5639415|NCT00741936|MaZiRenWan|mazirenwan
5639416|NCT00741936|Hemp Seed Pill|hemp seed pill
5639417|NCT00741936|Traditional Chinese Medicine|traditional chinese medicine
5639418|NCT00741936|Herbal Medicine|herbal medicine
5639419|NCT00741923|beans|beans
5639420|NCT00741923|pulses|pulses
5639421|NCT00741923|satiety|satiety
5639422|NCT00741923|appetite|appetite
5639423|NCT00741923|obesity|obesity
5639424|NCT00741923|overweight|overweight
5639425|NCT00741923|diabetes|diabetes
5639426|NCT00741923|metabolic syndrome|metabolic syndrome
5639427|NCT00741923|hypertension|hypertension
5639428|NCT00741923|blood glucose|blood glucose
5639429|NCT00741923|insulin|insulin
5639430|NCT00741923|cholesterol|cholesterol
5639431|NCT00741923|HDL|hdl
5639432|NCT00741923|LDL|ldl
5639433|NCT00741923|leptin|leptin
5639434|NCT00741923|GLP-1|glp-1
5639435|NCT00741923|adiponectin|adiponectin
5639436|NCT00741923|Peptide YY|peptide yy
5639437|NCT00741923|diet|diet
5639438|NCT00741910|Crohn's Disease|crohn's disease
5639439|NCT00741910|TNF-alpha inhibitor|tnf-alpha inhibitor
5639440|NCT00741910|MAP Kinase inhibitor|map kinase inhibitor
5639441|NCT00741910|CNI-1493|cni-1493
5639442|NCT00741871|Lymphoid malignancies|lymphoid malignancies
5639443|NCT00741871|Hodgkin's Lymphoma|hodgkin's lymphoma
5639444|NCT00741871|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5639445|NCT00741858|Chiari malformation;|chiari malformation;
5639446|NCT00741858|Duraplasty;|duraplasty;
5639447|NCT00741858|Posterior fossa decompression;|posterior fossa decompression;
5639448|NCT00741858|Duragen;|duragen;
5639449|NCT00741858|Duraguard|duraguard
5639457|NCT00741819|PAH|pah
5639458|NCT00741819|treprostinil sodium|treprostinil sodium
5639459|NCT00741819|inhalation|inhalation
5639460|NCT00741819|ventavis|ventavis
5639461|NCT00741819|iloprost|iloprost
5639463|NCT00741806|avian|avian
5639464|NCT00741793|Rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis|rheumatoid arthritis; psoriatic arthritis; axial spondyloarthritis
5639465|NCT00741793|Remicade®|remicade®
5639466|NCT00741793|Simponi®|simponi®
5639467|NCT00741793|Simponi® I.V|simponi® i.v
5639468|NCT00741793|Stelara®|stelara®
5639469|NCT00741793|Registry|registry
5639470|NCT00741793|BioTRAC|biotrac
5639471|NCT00741767|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5639472|NCT00741767|COPD|copd
5639473|NCT00741767|Sleep|sleep
5639474|NCT00741767|Sleep quality|sleep quality
5639475|NCT00741767|Lung hyperinflation|lung hyperinflation
5639476|NCT00741754|salivary flow|salivary flow
5639477|NCT00741754|oral neoplasm|oral neoplasm
5639478|NCT00741754|calcium hydroxide|calcium hydroxide
5639479|NCT00741754|sodium dodecylsulphate|sodium dodecylsulphate
5639480|NCT00741754|radiotherapy.|radiotherapy.
5639481|NCT00741741|TMC278-C150|tmc278-c150
5639482|NCT00741741|TMC278-TiDP15-C150|tmc278-tidp15-c150
5639483|NCT00741741|HIV-1 infected patients|hiv-1 infected patients
5639484|NCT00741741|Intramuscular or subcutaneous injection|intramuscular or subcutaneous injection
5639485|NCT00741741|Nanosuspension|nanosuspension
5639486|NCT00741741|Therapy|therapy
5639487|NCT00741741|Prevention|prevention
5639488|NCT00741741|Healthy volunteers|healthy volunteers
5639489|NCT00741741|HIV Infections|hiv infections
5639490|NCT00741728|epidemiology|epidemiology
5639491|NCT00741728|risk factors|risk factors
5639492|NCT00741728|heart rate|heart rate
5639493|NCT00741728|baroreflex sensitivity|baroreflex sensitivity
5639494|NCT00741728|sudden death|sudden death
5639495|NCT00741715|primary hypercholesterolemia|primary hypercholesterolemia
5639496|NCT00741702|Hypertension|hypertension
5639497|NCT00741702|Type 2 diabetes|type 2 diabetes
5639498|NCT00741702|First Nations populations|first nations populations
5639499|NCT00741689|Japanese|japanese
5639500|NCT00741689|healthy|healthy
5639501|NCT00741689|volunteers|volunteers
5639502|NCT00741663|cirrhosis|cirrhosis
5639503|NCT00741663|ascites|ascites
5639504|NCT00741663|diuretic therapy|diuretic therapy
5639505|NCT00741663|potassium canrenoate|potassium canrenoate
5639506|NCT00741663|furosemide|furosemide
5639507|NCT00741663|hyperkalemia|hyperkalemia
5639508|NCT00741663|plasma renin activity|plasma renin activity
5639509|NCT00741663|nitric oxide|nitric oxide
5639510|NCT00741663|serum sodium concentration|serum sodium concentration
5639511|NCT00741663|refractory ascites|refractory ascites
5639512|NCT00741663|Nonazotemic patients with cirrhosis and moderate ascites|nonazotemic patients with cirrhosis and moderate ascites
5639513|NCT00741650|Musculoskeletal pain|musculoskeletal pain
5639514|NCT00741650|Brief cognitive intervention|brief cognitive intervention
5639515|NCT00741650|Cognitive behavior therapy|cognitive behavior therapy
5639516|NCT00741650|Intervention Study|intervention study
5639517|NCT00741650|Health prevention|health prevention
5639518|NCT00741650|workplace intervention|workplace intervention
5639519|NCT00741637|Vibrio Cholerae|vibrio cholerae
5639521|NCT00741637|Live oral Vaccines|live oral vaccines
5639522|NCT00741637|Immunogenicity|immunogenicity
5639523|NCT00741637|Safety|safety
5639525|NCT00741624|refractive surgery|refractive surgery
5639526|NCT00741585|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5639527|NCT00741585|Chronotherapy|chronotherapy
5639528|NCT00741585|Circadian|circadian
5639529|NCT00741585|Non-dipper|non-dipper
5639530|NCT00741585|Type 2 diabetes|type 2 diabetes
5639531|NCT00741585|Resistant hypertension|resistant hypertension
5639532|NCT00741585|Total mortality|total mortality
5639533|NCT00741572|sarcoidosis|sarcoidosis
5639534|NCT00741572|fibrosis|fibrosis
5639535|NCT00741572|oxidative stress|oxidative stress
5639536|NCT00741572|inflammation|inflammation
5639537|NCT00741572|triggers|triggers
5639538|NCT00741572|individual sensitivity|individual sensitivity
5639539|NCT00741559|epilepsy|epilepsy
5639540|NCT00741559|pediatrics|pediatrics
5639541|NCT00741559|magnetoencephalography|magnetoencephalography
5639542|NCT00741559|electroencephalography|electroencephalography
5639543|NCT00741559|positron emission tomography|positron emission tomography
5639544|NCT00741546|Vitamin D|vitamin d
5639545|NCT00741546|malnutrition|malnutrition
5639546|NCT00741546|cardiac surgery|cardiac surgery
5639547|NCT00741546|study|study
5639548|NCT00741546|emphasize|emphasize
5639549|NCT00741546|importance|importance
5639550|NCT00741546|significant|significant
5639551|NCT00741546|high risk patient|high risk patient
5639552|NCT00741520|Obstructive Sleep Apnea|obstructive sleep apnea
5639553|NCT00741520|Blood Pressure|blood pressure
5639554|NCT00741520|PreHypertension|prehypertension
5639555|NCT00741520|Masked Hypertension|masked hypertension
5639556|NCT00741507|Anesthetics|anesthetics
5639557|NCT00741507|Sedatives|sedatives
5639558|NCT00741507|Analgesics|analgesics
5639559|NCT00741494|infertility|infertility
5639560|NCT00741494|ICSI|icsi
5639561|NCT00741494|hyaluronan binding|hyaluronan binding
5639562|NCT00741494|sperm|sperm
5639563|NCT00741494|sperm selection|sperm selection
5639564|NCT00741494|male factor|male factor
5639566|NCT00741494|sperm maturity|sperm maturity
5639567|NCT00741494|clinical pregnancy rates|clinical pregnancy rates
5639568|NCT00741494|hyaluronan binding assay|hyaluronan binding assay
5639570|NCT00741494|PICSI|picsi
5639571|NCT00741481|metastatic colorectal cancer|metastatic colorectal cancer
5639572|NCT00741481|fdg pet|fdg pet
5639573|NCT00741481|response evaluation|response evaluation
5639574|NCT00741468|Drug-drug interactions|drug-drug interactions
5639576|NCT00741455|Non-myeloablative transplant|non-myeloablative transplant
5639577|NCT00741455|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5639578|NCT00741455|Acute Myelogenous Leukemia|acute myelogenous leukemia
5639579|NCT00741455|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5639580|NCT00741455|Multiple Myeloma|multiple myeloma
5639581|NCT00741455|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5639582|NCT00741455|Myelodysplastic syndrome|myelodysplastic syndrome
5639583|NCT00741455|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5639584|NCT00741455|Hodgkin's Disease|hodgkin's disease
5639585|NCT00741416|Heart Disease|heart disease
5639586|NCT00741416|Biorepository|biorepository
5639587|NCT00741416|Biobank|biobank
5639588|NCT00741403|Phase I|phase i
5639589|NCT00741403|malignancies|malignancies
5639590|NCT00741403|refractory|refractory
5639591|NCT00741403|relapsed|relapsed
5639592|NCT00741390|Diabetes|diabetes
5639594|NCT00741390|Pain|pain
5639595|NCT00741377|Multiple myeloma|multiple myeloma
5639596|NCT00741377|bone disease|bone disease
5639597|NCT00741377|antibody|antibody
5639598|NCT00741364|vitamin D|vitamin d
5639599|NCT00741364|prostate cancer|prostate cancer
5639600|NCT00741364|prostatectomy|prostatectomy
5639601|NCT00741364|pathology|pathology
5639602|NCT00741364|immunohistochemistry|immunohistochemistry
5639603|NCT00741351|Anesthesia|anesthesia
5639604|NCT00741351|Craniotomy|craniotomy
5639605|NCT00741351|Neurosurgery|neurosurgery
5639606|NCT00741338|MPS I, Mucopolysaccharidosis, Hurler syndrome|mps i, mucopolysaccharidosis, hurler syndrome
5639607|NCT00741312|pregnancy|pregnancy
5639608|NCT00741312|preeclampsia|preeclampsia
5639609|NCT00741312|exercise|exercise
5639610|NCT00741299|bipolar affective disorder, Smoking|bipolar affective disorder, smoking
5639611|NCT00741286|Cerebral infarction|cerebral infarction
5639612|NCT00741286|Cilostazol|cilostazol
5639613|NCT00741286|Aspirin|aspirin
5639614|NCT00741286|Transcranial Doppler|transcranial doppler
5639615|NCT00741286|Pulsatile Index|pulsatile index
5639616|NCT00741260|Solid Tumor|solid tumor
5639617|NCT00741260|erbB2+ Breast Cancer|erbb2+ breast cancer
5639618|NCT00741260|Prior trastuzumab|prior trastuzumab
5639619|NCT00741260|Metastatic|metastatic
5639620|NCT00741260|Neratinib|neratinib
5639621|NCT00741260|HKI-272|hki-272
5639622|NCT00741260|Nerlynx|nerlynx
5639623|NCT00741260|HER2|her2
5639624|NCT00741260|PB-272|pb-272
5639625|NCT00741247|staging|staging
5639626|NCT00741247|Endobronchial ultrasound|endobronchial ultrasound
5639627|NCT00741247|Endoscopic ultrasound|endoscopic ultrasound
5639628|NCT00741234|SB939|sb939
5639629|NCT00741234|Myelodysplastic Syndrome|myelodysplastic syndrome
5639630|NCT00741234|Combination with azacitidine|combination with azacitidine
5639631|NCT00741234|Solid malignancies|solid malignancies
5639632|NCT00741234|Hematologic malignancies|hematologic malignancies
5639633|NCT00741234|HDAC inhibitor|hdac inhibitor
5639634|NCT00741234|Refractory to standard therapy|refractory to standard therapy
5639635|NCT00741221|Cancer|cancer
5639636|NCT00741221|NSCLC|nsclc
5639637|NCT00741221|Docetaxel|docetaxel
5639638|NCT00741221|Bevacizumab|bevacizumab
5639639|NCT00741208|asthma|asthma
5639640|NCT00741208|soy isoflavone|soy isoflavone
5639641|NCT00741208|genistein|genistein
5639642|NCT00741208|soy|soy
5639643|NCT00741195|Cancer|cancer
5639644|NCT00741195|NSCLC|nsclc
5639645|NCT00741195|Docetaxel|docetaxel
5639646|NCT00741195|Bevacizumab|bevacizumab
5639647|NCT00741182|Fracture|fracture
5639648|NCT00741182|Osteoporosis|osteoporosis
5639649|NCT00741182|Forsteo|forsteo
5639650|NCT00741182|Teriparatide|teriparatide
5639651|NCT00741182|Fracture healing|fracture healing
5639652|NCT00741169|TMC435350-TiDP16-C105|tmc435350-tidp16-c105
5639653|NCT00741169|TMC435350-C105|tmc435350-c105
5639654|NCT00741169|Hepatitis C|hepatitis c
5639655|NCT00741169|HCV|hcv
5639656|NCT00741169|Rifampin|rifampin
5828625|NCT00060866|NCS|ncs
5639657|NCT00741156|pediatric|pediatric
5639658|NCT00741156|hypertension|hypertension
5639659|NCT00741156|congestive cardiomyopathy|congestive cardiomyopathy
5639660|NCT00741156|angiotensin-converting enzyme inhibitor|angiotensin-converting enzyme inhibitor
5639661|NCT00741156|cardiac catheterization|cardiac catheterization
5639662|NCT00741143|Food Fortification|food fortification
5639663|NCT00741143|Iron deficiency|iron deficiency
5639664|NCT00741143|NaFeEdta|nafeedta
5639665|NCT00741143|Iron deficiency anemia|iron deficiency anemia
5639666|NCT00741143|Cognition|cognition
5639667|NCT00741130|retinal nerve fiber layer|retinal nerve fiber layer
5639668|NCT00741130|optic nerve head|optic nerve head
5639671|NCT00741117|Blood Gas Analysis|blood gas analysis
5639672|NCT00741117|Liver Disease|liver disease
5639673|NCT00741117|Hyperbilirubinemia|hyperbilirubinemia
5639674|NCT00741091|Cerebrovascular Disease|cerebrovascular disease
5639675|NCT00741091|Carotid Stent|carotid stent
5639676|NCT00741091|Stent|stent
5639677|NCT00741091|Carotid Endarterectomy (CEA)|carotid endarterectomy (cea)
5639678|NCT00741078|endothelial|endothelial
5639679|NCT00741078|function|function
5639680|NCT00741078|insulin|insulin
5639681|NCT00741078|sensitivity|sensitivity
5639682|NCT00741065|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5639683|NCT00741065|Myocardial Regeneration|myocardial regeneration
5639684|NCT00741052|V. cholerae,|v. cholerae,
5639685|NCT00741052|ciprofloxacin,|ciprofloxacin,
5639686|NCT00741052|azithromycin,|azithromycin,
5639687|NCT00741052|randomized|randomized
5639688|NCT00741039|Breast|breast
5639689|NCT00741039|Lung|lung
5639690|NCT00741039|Prostate|prostate
5639691|NCT00741039|Vaccine|vaccine
5639692|NCT00741026|Insulin Resistance|insulin resistance
5639693|NCT00741026|Diabetes mellitus|diabetes mellitus
5639694|NCT00741026|Antipsychotic|antipsychotic
5639695|NCT00741013|randomized|randomized
5639696|NCT00741013|positron emission tomography|positron emission tomography
5639697|NCT00741013|lung inflammation|lung inflammation
5639698|NCT00741013|lovastatin|lovastatin
5639699|NCT00741013|recombinant human activated protein C|recombinant human activated protein c
5639701|NCT00741013|fluorodeoxyglucose|fluorodeoxyglucose
5639702|NCT00740987|Mechanical device|mechanical device
5639703|NCT00740987|Intermittent pneumatic compression|intermittent pneumatic compression
5639704|NCT00740987|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5639705|NCT00740987|Intensive care unit|intensive care unit
5639706|NCT00740987|Hospitalization|hospitalization
5639707|NCT00740987|Intensive|intensive
5639708|NCT00740987|Care|care
5639709|NCT00740987|Unit|unit
5639710|NCT00740961|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5639711|NCT00740961|cognitive/functional effects|cognitive/functional effects
5639712|NCT00740961|breast cancer|breast cancer
5639713|NCT00740961|colon cancer|colon cancer
5639714|NCT00740948|Sjogren's disease|sjogren's disease
5639715|NCT00740948|Rituximab|rituximab
5639716|NCT00740948|Treatment|treatment
5639717|NCT00740948|anti CD20|anti cd20
5639718|NCT00740935|prevention|prevention
5639719|NCT00740935|rotavirus vaccine|rotavirus vaccine
5639720|NCT00740935|gastroenteritis|gastroenteritis
5639721|NCT00740935|systematic vaccination|systematic vaccination
5639722|NCT00740935|infants|infants
5639723|NCT00740935|aged 6 to 12 weeks|aged 6 to 12 weeks
5639724|NCT00740922|Becaplermin gel|becaplermin gel
5639725|NCT00740922|Target Ulcer|target ulcer
5639726|NCT00740922|Retrospective Studies|retrospective studies
5639727|NCT00740922|Diabetic Foot|diabetic foot
5639728|NCT00740922|Neoplasms|neoplasms
5639729|NCT00740922|Long-Term Safety|long-term safety
5639730|NCT00740922|Topical Administration|topical administration
5639731|NCT00740909|Trich|trich
5639732|NCT00740909|Hair Pulling|hair pulling
5639733|NCT00740909|Cognitive Behavioral Therapy|cognitive behavioral therapy
5639734|NCT00740909|Behavioral Therapy|behavioral therapy
5639735|NCT00740896|Cigarette Smoking|cigarette smoking
5639736|NCT00740896|Airway dendritic cells|airway dendritic cells
5639737|NCT00740883|venous thromboembolism|venous thromboembolism
5639738|NCT00740883|warfarin|warfarin
5639739|NCT00740883|duration of anticoagulation|duration of anticoagulation
5639740|NCT00740883|recurrent venous thromboembolism|recurrent venous thromboembolism
5639741|NCT00740883|anticoagulant-related bleeding|anticoagulant-related bleeding
5639742|NCT00740857|Dental pain analgesia|dental pain analgesia
5639743|NCT00740844|Intermittent pneumatic compression|intermittent pneumatic compression
5639744|NCT00740844|Hospitalization|hospitalization
5639745|NCT00740844|Intensive care unit|intensive care unit
5639746|NCT00740844|High bleeding risk|high bleeding risk
5639747|NCT00740844|Venous thromboembolism prophylaxis|venous thromboembolism prophylaxis
5639748|NCT00740831|Uterine Myomas|uterine myomas
5639749|NCT00740779|prostatitis, chronic pelvic pain|prostatitis, chronic pelvic pain
5639750|NCT00740766|Perinatal Outcomes|perinatal outcomes
5639752|NCT00740766|Pregnant women|pregnant women
5828727|NCT00060684|Rituxan|rituxan
5639753|NCT00740753|liver tumor|liver tumor
5639754|NCT00740753|cancer|cancer
5639755|NCT00740753|hepatoma|hepatoma
5639756|NCT00740753|yttrium|yttrium
5639757|NCT00740740|Aneurysm|aneurysm
5639758|NCT00740740|Rupture|rupture
5639759|NCT00740727|Disaster|disaster
5639760|NCT00740727|Mass casualty incident|mass casualty incident
5639761|NCT00740727|Prehospital|prehospital
5639762|NCT00740727|Rehydration|rehydration
5639763|NCT00740727|Intravascular access|intravascular access
5639764|NCT00740714|Parkinson disease|parkinson disease
5639765|NCT00740714|PD|pd
5639766|NCT00740714|Coenzyme Q10|coenzyme q10
5639767|NCT00740714|CoQ|coq
5639770|NCT00740701|verbal working memory|verbal working memory
5639771|NCT00740701|classical conditioning|classical conditioning
5639773|NCT00740701|classical eyeblink conditioning|classical eyeblink conditioning
5639774|NCT00740701|Healthy subjects|healthy subjects
5639775|NCT00740701|Memory|memory
5639776|NCT00740675|adverse drug events|adverse drug events
5639777|NCT00740675|outpatient|outpatient
5639778|NCT00740662|morbid obesity|morbid obesity
5639779|NCT00740662|small bowel|small bowel
5639780|NCT00740662|gastric bypass|gastric bypass
5639781|NCT00740662|weight loss|weight loss
5639782|NCT00740636|TEMOZOLOMIDE|temozolomide
5639783|NCT00740636|Lung|lung
5639784|NCT00740623|Partial Onset Seizures|partial onset seizures
5639785|NCT00740623|Simple Partial Seizures|simple partial seizures
5639786|NCT00740623|Complex Partial Seizures|complex partial seizures
5639787|NCT00740597|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5639788|NCT00740597|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5639789|NCT00740597|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5639790|NCT00740597|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5639791|NCT00740597|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5639792|NCT00740597|adult epithelioid sarcoma|adult epithelioid sarcoma
5639793|NCT00740597|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5639794|NCT00740597|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5639795|NCT00740597|adult fibrosarcoma|adult fibrosarcoma
5639796|NCT00740597|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5639797|NCT00740597|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5639798|NCT00740597|adult malignant mesenchymoma|adult malignant mesenchymoma
5639799|NCT00740597|adult neurofibrosarcoma|adult neurofibrosarcoma
5639800|NCT00740597|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5639801|NCT00740597|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5639802|NCT00740584|Prevention|prevention
5639803|NCT00740571|neuralgia|neuralgia
5639804|NCT00740571|off-label|off-label
5639805|NCT00740571|cancer|cancer
5639807|NCT00740558|Activator|activator
5639808|NCT00740558|Chiropractic|chiropractic
5639809|NCT00740558|VLF|vlf
5639810|NCT00740558|HF|hf
5639812|NCT00740558|LF/HF|lf/hf
5639813|NCT00740532|EGFR, HER-2, HER-3, MET, KRAS|egfr, her-2, her-3, met, kras
5639814|NCT00740506|Behavioral|behavioral
5639815|NCT00740506|Environmental|environmental
5639816|NCT00740506|Delivery|delivery
5639817|NCT00740506|Pregnancy|pregnancy
5639818|NCT00740493|recurrent venous thromboembolism|recurrent venous thromboembolism
5639819|NCT00740493|idiopathic deep vein thrombosis|idiopathic deep vein thrombosis
5621563|NCT00813254|Ovarian Cancer|ovarian cancer
5639820|NCT00740493|optimal duration of anticoagulation|optimal duration of anticoagulation
5639821|NCT00740480|Evaluation|evaluation
5639822|NCT00740480|ENTact™|entact™
5639823|NCT00740480|Septal|septal
5639824|NCT00740480|Staple|staple
5639825|NCT00740480|System|system
5639826|NCT00740480|tissue|tissue
5639827|NCT00740480|approximation|approximation
5639828|NCT00740480|during|during
5639829|NCT00740480|septoplasties|septoplasties
5639830|NCT00740467|graft versus host disease|graft versus host disease
5639831|NCT00740467|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5639832|NCT00740467|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5639833|NCT00740467|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5639834|NCT00740467|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5639835|NCT00740467|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5639836|NCT00740467|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5639837|NCT00740467|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5639838|NCT00740467|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5639839|NCT00740467|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5639840|NCT00740467|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5639841|NCT00740467|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5639842|NCT00740467|refractory multiple myeloma|refractory multiple myeloma
5639843|NCT00740467|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5639844|NCT00740467|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5639845|NCT00740467|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5639846|NCT00740467|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5639847|NCT00740467|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5639848|NCT00740467|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5639849|NCT00740467|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5639850|NCT00740467|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5639851|NCT00740467|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5639852|NCT00740467|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5639853|NCT00740467|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5639854|NCT00740467|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5639855|NCT00740467|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5639856|NCT00740467|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5639857|NCT00740467|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5639858|NCT00740467|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5639859|NCT00740467|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5639860|NCT00740467|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5639861|NCT00740467|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5639862|NCT00740467|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5639863|NCT00740467|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5639864|NCT00740467|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5639865|NCT00740467|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5639866|NCT00740467|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5639867|NCT00740467|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5639868|NCT00740467|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5639869|NCT00740454|pregnancy|pregnancy
5639870|NCT00740454|postpartum|postpartum
5639871|NCT00740454|deep vein thrombosis|deep vein thrombosis
5639872|NCT00740454|venous thromboembolism|venous thromboembolism
5639873|NCT00740454|diagnosis|diagnosis
5639874|NCT00740454|compression ultrasonography|compression ultrasonography
5639875|NCT00740441|renal cell carcinoma|renal cell carcinoma
5639877|NCT00740441|kidney cancer|kidney cancer
5639878|NCT00740428|Pelvic floor,|pelvic floor,
5639879|NCT00740428|muscular dysfunction,|muscular dysfunction,
5639880|NCT00740428|urinary incontinence|urinary incontinence
5639881|NCT00740415|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5639882|NCT00740415|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5639883|NCT00740415|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5639884|NCT00740415|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5639886|NCT00740389|TMC125-TiDP2-C187|tmc125-tidp2-c187
5639888|NCT00740389|AIDS|aids
5639889|NCT00740389|Fungal Infection|fungal infection
5639890|NCT00740389|Pharmacokinetics|pharmacokinetics
5639891|NCT00740376|osteoarthritis|osteoarthritis
5639892|NCT00740363|renal transplantation|renal transplantation
5639893|NCT00740363|diabetes|diabetes
5639894|NCT00740363|glucose intolerance|glucose intolerance
5639895|NCT00740363|impaired glucose tolerance|impaired glucose tolerance
5639896|NCT00740337|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5639897|NCT00740337|COPD|copd
5639898|NCT00740337|Emphysema|emphysema
5639899|NCT00740337|Natural Killer T-cell|natural killer t-cell
5639900|NCT00740337|Interleukin-13|interleukin-13
5639901|NCT00740337|Innate Immune Signaling|innate immune signaling
5639902|NCT00740324|During|during
5639903|NCT00740324|Endoscopy|endoscopy
5639904|NCT00740324|Gastric|gastric
5639905|NCT00740324|Peristalsis|peristalsis
5639906|NCT00740311|Prevention of the reduction of the alveolar crest|prevention of the reduction of the alveolar crest
5639907|NCT00740298|infants|infants
5639908|NCT00740298|undergoing|undergoing
5639909|NCT00740298|vaccinations|vaccinations
5639910|NCT00740285|scleroderma|scleroderma
5639911|NCT00740285|scleroderma - limited or diffuse types|scleroderma - limited or diffuse types
5639912|NCT00740285|lidocaine|lidocaine
5639913|NCT00740285|effectiveness|effectiveness
5639914|NCT00740272|brady-tachy syndrome|brady-tachy syndrome
5639915|NCT00740272|AF ablation|af ablation
5639916|NCT00740259|flunarizine|flunarizine
5639917|NCT00740259|schizophrenia|schizophrenia
5639918|NCT00740259|antipsychotic|antipsychotic
5639919|NCT00740233|fibromyalgia|fibromyalgia
5639920|NCT00740233|irritable bowel syndrome|irritable bowel syndrome
5639921|NCT00740233|interstitial cystitis|interstitial cystitis
5639922|NCT00740233|chronic fatigue syndrome|chronic fatigue syndrome
5639923|NCT00740233|vulvodynia|vulvodynia
5639924|NCT00740233|chronic stress|chronic stress
5639925|NCT00740233|chronic pain|chronic pain
5639926|NCT00740233|stress-related conditions|stress-related conditions
5639927|NCT00740233|functional GI disorders|functional gi disorders
5639928|NCT00740220|hypoxemia|hypoxemia
5639929|NCT00740220|anoxia|anoxia
5639930|NCT00740220|oxygen|oxygen
5639931|NCT00740220|dyspnea|dyspnea
5639932|NCT00740220|pulmonary disease|pulmonary disease
5639933|NCT00740220|chronic obstructive|chronic obstructive
5639934|NCT00740194|Physiology|physiology
5639935|NCT00740194|males|males
5639936|NCT00740181|myelodysplasia|myelodysplasia
5639937|NCT00740181|refractory leukemia|refractory leukemia
5639938|NCT00740181|acute leukemia|acute leukemia
5639939|NCT00740168|bevacizumab|bevacizumab
5639940|NCT00740168|cancer|cancer
5639941|NCT00740155|Dengue virus|dengue virus
5639942|NCT00740155|Dengue fever|dengue fever
5789065|NCT00150072|imatinib|imatinib
5639943|NCT00740155|Dengue hemorrhagic fever|dengue hemorrhagic fever
5639944|NCT00740155|Dengue diseases|dengue diseases
5639945|NCT00740142|L ornithine L aspartate|l ornithine l aspartate
5639946|NCT00740142|Lactulose|lactulose
5639947|NCT00740142|Hepatic encephalopathy|hepatic encephalopathy
5639948|NCT00740142|LOLA|lola
5639949|NCT00740129|Paget's Disease|paget's disease
5639950|NCT00740129|Zoledronic acid|zoledronic acid
5639951|NCT00740129|Reclast®/Aclasta®|reclast®/aclasta®
5639952|NCT00740129|infusion|infusion
5639953|NCT00740129|re-treatment|re-treatment
5639954|NCT00740129|re-lapse|re-lapse
5639955|NCT00740116|Tumor of ovary|tumor of ovary
5639956|NCT00740116|Surgical blood loss|surgical blood loss
5639957|NCT00740116|Postoperative blood loss|postoperative blood loss
5639958|NCT00740116|Preventive therapy|preventive therapy
5639959|NCT00740116|Thromboembolism|thromboembolism
5639960|NCT00740103|Semapimod|semapimod
5639961|NCT00740103|Crohn's Disease|crohn's disease
5639962|NCT00740103|TNF-alpha inhibitor|tnf-alpha inhibitor
5639963|NCT00740103|MAP Kinase inhibitor|map kinase inhibitor
5639964|NCT00740103|CNI-1493|cni-1493
5639965|NCT00740090|Malaria|malaria
5639966|NCT00740090|Reactogenicity, Safety, Immunogenicity|reactogenicity, safety, immunogenicity
5639967|NCT00740090|Maleria Endemic|maleria endemic
5639968|NCT00740090|Plasmodium Falciparum|plasmodium falciparum
5639969|NCT00740090|Dose Escalating|dose escalating
5639970|NCT00740077|cranberry|cranberry
5639971|NCT00740077|flavonoid|flavonoid
5639972|NCT00740077|phenolic acid|phenolic acid
5639973|NCT00740077|phytochemical|phytochemical
5639974|NCT00740077|bioavailability|bioavailability
5639975|NCT00740064|HIV infections|hiv infections
5639976|NCT00740038|Stress Management|stress management
5639977|NCT00740038|Quality of Life|quality of life
5639978|NCT00740038|Exercise|exercise
5639979|NCT00740038|Cancer|cancer
5639980|NCT00740038|Chemotherapy|chemotherapy
5639981|NCT00740025|QD dose|qd dose
5639982|NCT00740025|BID dosing|bid dosing
5639983|NCT00740025|peak estradiol|peak estradiol
5639984|NCT00740025|oocytes|oocytes
5639985|NCT00740025|implantation rate|implantation rate
5639986|NCT00740025|pregnancy rate|pregnancy rate
5639987|NCT00740012|Nocturnal glucose profiles|nocturnal glucose profiles
5639988|NCT00740012|continuous glucose profiles|continuous glucose profiles
5639989|NCT00739999|heterozygous familial hypercholesterolemia (HeFH); atorvastatin; pediatric|heterozygous familial hypercholesterolemia (hefh); atorvastatin; pediatric
5639990|NCT00739986|Crohn's Disease|crohn's disease
5639991|NCT00739986|TNF-alpha|tnf-alpha
5639992|NCT00739986|IL-6|il-6
5639993|NCT00739986|MAP Kinase|map kinase
5639994|NCT00739986|CNI-1493|cni-1493
5639995|NCT00739973|Hypertension, Aliskiren, Amlodipine|hypertension, aliskiren, amlodipine
5639996|NCT00739947|Observational|observational
5639997|NCT00739947|rotator cuff tear|rotator cuff tear
5639998|NCT00739947|arthroscopic|arthroscopic
5639999|NCT00739947|surgical|surgical
5640000|NCT00739947|outcome study|outcome study
5640001|NCT00739934|Open-Label|open-label
5640002|NCT00739934|Pharmacokinetics|pharmacokinetics
5640003|NCT00739934|Intravenous to oral switch|intravenous to oral switch
5640004|NCT00739934|Safety|safety
5640005|NCT00739934|Voriconazole|voriconazole
5640006|NCT00739934|Immunocompromise|immunocompromise
5640007|NCT00739934|Children|children
5640008|NCT00739934|High Risk For Systemic Fungal Infection.|high risk for systemic fungal infection.
5640009|NCT00739921|PCR Analysis|pcr analysis
5640010|NCT00739921|Allergic fungal sinusitis|allergic fungal sinusitis
5640011|NCT00739921|Chronic rhinosinusitis|chronic rhinosinusitis
5640012|NCT00739921|Nasal Polyps|nasal polyps
5640013|NCT00739908|MDD|mdd
5640014|NCT00739895|athletes|athletes
5640015|NCT00739882|Efalizumab,|efalizumab,
5640016|NCT00739882|Chronic plaque psoriasis|chronic plaque psoriasis
5640017|NCT00739882|moderate to severe|moderate to severe
5640018|NCT00739882|involving|involving
5640019|NCT00739882|hands|hands
5640020|NCT00739882|feet|feet
5640021|NCT00739869|Silent Infarcts|silent infarcts
5640022|NCT00739869|Magnetic Resonance Imaging|magnetic resonance imaging
5640023|NCT00739869|MRI|mri
5640024|NCT00739869|Subclinical Cerebrovascular Disease|subclinical cerebrovascular disease
5640025|NCT00739869|White Matter Grade Abnormalities|white matter grade abnormalities
5640026|NCT00739869|Total Brain Volume|total brain volume
5640027|NCT00739869|Ventricular and Hippocampal Volume|ventricular and hippocampal volume
5640028|NCT00739869|Subclinical Vascular Abnormalities|subclinical vascular abnormalities
5640029|NCT00739869|Cerebrovascular Disease|cerebrovascular disease
5640030|NCT00739869|CVD|cvd
5640031|NCT00739869|Subclinical CVD|subclinical cvd
5640032|NCT00739856|posttraumatic stress disorder|posttraumatic stress disorder
5640033|NCT00739856|electroconvulsive therapy|electroconvulsive therapy
5640034|NCT00739856|medication refractoriness|medication refractoriness
5640035|NCT00739843|Dementia,|dementia,
5640036|NCT00739843|Cognitive Disorders,|cognitive disorders,
5640037|NCT00739843|Hemodialysis|hemodialysis
5640038|NCT00739791|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5640039|NCT00739791|stage I prostate cancer|stage i prostate cancer
5640040|NCT00739791|stage IIB prostate cancer|stage iib prostate cancer
5640041|NCT00739791|stage IIA prostate cancer|stage iia prostate cancer
5640043|NCT00739765|Psychotherapy|psychotherapy
5640044|NCT00739765|Anxiety|anxiety
5640045|NCT00739752|Attitude to Health|attitude to health
5640046|NCT00739752|Communication|communication
5640047|NCT00739752|Intervention Studies|intervention studies
5640048|NCT00739752|Health Promotion|health promotion
5640049|NCT00739752|Psychology, Medical|psychology, medical
5640050|NCT00739752|Sexual Behavior|sexual behavior
5640051|NCT00739752|Behavioral Research|behavioral research
5640052|NCT00739752|Vaccination|vaccination
5640053|NCT00739713|dry eye|dry eye
5640054|NCT00739713|sea buckthorn|sea buckthorn
5640055|NCT00739713|Hippophaë|hippophaë
5640056|NCT00739700|hemodynamics|hemodynamics
5640057|NCT00739700|blood pressure|blood pressure
5640058|NCT00739700|blood pressure monitors|blood pressure monitors
5640059|NCT00739687|Chronic Heart Failure|chronic heart failure
5640060|NCT00739661|Systemic Hedgehog|systemic hedgehog
5640061|NCT00739661|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5640062|NCT00739648|COPD|copd
5640063|NCT00739648|Patients|patients
5640064|NCT00739622|TMC278-TiDP6-C136|tmc278-tidp6-c136
5640065|NCT00739622|TMC278-C136|tmc278-c136
5640066|NCT00739622|Healthy Volunteer|healthy volunteer
5640067|NCT00739596|Hypertension|hypertension
5640068|NCT00739596|African American|african american
5640069|NCT00739596|aliskiren|aliskiren
5640070|NCT00739596|hydrochlorothiazide|hydrochlorothiazide
5640071|NCT00739596|systolic blood pressure|systolic blood pressure
5640072|NCT00739596|diastolic blood pressure|diastolic blood pressure
5640073|NCT00739596|amlodipine|amlodipine
5640074|NCT00739596|stage 2|stage 2
5640075|NCT00739583|Skin preparation|skin preparation
5640076|NCT00739583|Skin marking|skin marking
5640077|NCT00739583|site marking|site marking
5640078|NCT00739583|Site identification|site identification
5640079|NCT00739570|Activator|activator
5640080|NCT00739570|EMG|emg
5640081|NCT00739570|Thermography|thermography
5640082|NCT00739570|Diagnostic|diagnostic
5640083|NCT00739570|X-Rays|x-rays
5640084|NCT00739557|elective TAAA repair|elective taaa repair
5640085|NCT00739544|Reference Values|reference values
5640086|NCT00739544|Sensory Thresholds|sensory thresholds
5640087|NCT00739544|Pain Threshold|pain threshold
5640088|NCT00739544|Breast Neoplasms|breast neoplasms
5640089|NCT00739531|Asthma|asthma
5640090|NCT00739531|nitric oxide|nitric oxide
5640091|NCT00739531|eNO|eno
5640092|NCT00739531|FENO|feno
5640093|NCT00739531|Apieron INSIGHT|apieron insight
5640094|NCT00739531|Aerocrine NIOX|aerocrine niox
5640095|NCT00739518|Neurological|neurological
5640096|NCT00739518|MRI|mri
5640097|NCT00739505|Hypophosphatasia|hypophosphatasia
5640098|NCT00739505|Bone Disease|bone disease
5640099|NCT00739505|Soft Bones|soft bones
5640100|NCT00739505|Low Alkaline Phosphatase|low alkaline phosphatase
5640101|NCT00739505|genetic metabolic disorder|genetic metabolic disorder
5640102|NCT00739505|alkaline phosphatase|alkaline phosphatase
5640103|NCT00739505|tissue non-specific alkaline phosphatase|tissue non-specific alkaline phosphatase
5640104|NCT00739505|rickets|rickets
5640105|NCT00739505|osteomalacia|osteomalacia
5640106|NCT00739492|weight loss, obesity, financial incentives|weight loss, obesity, financial incentives
5640107|NCT00739479|Metabolic Syndrome|metabolic syndrome
5640108|NCT00739479|METS|mets
5640109|NCT00739479|Obesity|obesity
5640110|NCT00739479|Partially Hydrolyzed Whey Protein|partially hydrolyzed whey protein
5640111|NCT00739479|Partially Hydrolyzed Gelatin|partially hydrolyzed gelatin
5640112|NCT00739479|PHWP|phwp
5640113|NCT00739479|PHG|phg
5640114|NCT00739479|Weight Loss|weight loss
5640115|NCT00739466|Liposomal Alendronate|liposomal alendronate
5640116|NCT00739466|Percutaneous coronary intervention|percutaneous coronary intervention
5640117|NCT00739466|Coronary stenting|coronary stenting
5640118|NCT00739466|de novo stenotic lesions|de novo stenotic lesions
5640119|NCT00739466|Native coronary arteries|native coronary arteries
5640120|NCT00739466|Restenosis|restenosis
5640121|NCT00739466|Bare metal stent|bare metal stent
5640122|NCT00739466|Presillion CoCr coronary stent|presillion cocr coronary stent
5640123|NCT00739453|Pancreatic cancer|pancreatic cancer
5640124|NCT00739453|Advanced cancer|advanced cancer
5640125|NCT00739453|Prostate cancer|prostate cancer
5640126|NCT00739453|Non-small cell lung cancer|non-small cell lung cancer
5640127|NCT00739453|Colorectal cancer|colorectal cancer
5640128|NCT00739414|Histone Deacetylases|histone deacetylases
5640129|NCT00739414|HDAC inhibitor|hdac inhibitor
5640131|NCT00739414|Advanced solid tumor|advanced solid tumor
5640132|NCT00739414|Adult|adult
5640134|NCT00739401|Aneurysm|aneurysm
5640135|NCT00739401|Suprarenal|suprarenal
5640136|NCT00739401|Proximal|proximal
5640137|NCT00739401|Cuff|cuff
5640138|NCT00739401|Extension|extension
5640139|NCT00739401|Endograft|endograft
5640140|NCT00739401|Endovascular repair|endovascular repair
5640141|NCT00739401|EVAR|evar
5640142|NCT00739401|Endoleak|endoleak
5640143|NCT00739401|Type I|type i
5640144|NCT00739388|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5633891|NCT00763308|Weight|weight
5640145|NCT00739388|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5640146|NCT00739388|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5640147|NCT00739388|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5640148|NCT00739388|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5640149|NCT00739388|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5640150|NCT00739388|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5640154|NCT00739388|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5640155|NCT00739388|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5640156|NCT00739388|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5640157|NCT00739388|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5640158|NCT00739375|Influence|influence
5640159|NCT00739375|of av access|of av access
5640161|NCT00739375|development|development
5640167|NCT00739349|Dry Eye|dry eye
5640168|NCT00739349|Cyclosporine|cyclosporine
5640169|NCT00739336|diabetes mellitus|diabetes mellitus
5640170|NCT00739336|obesity|obesity
5640171|NCT00739336|prevention|prevention
5640172|NCT00739310|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5640173|NCT00739310|Cerebral Palsy|cerebral palsy
5640174|NCT00739310|Restrictive lung disease|restrictive lung disease
5640175|NCT00739297|Chronic asthma|chronic asthma
5640176|NCT00739284|preferred|preferred
5640177|NCT00739284|procedure|procedure
5640178|NCT00739284|drainage|drainage
5640179|NCT00739284|obstructed|obstructed
5640180|NCT00739284|kidney|kidney
5640181|NCT00739284|stone|stone
5640182|NCT00739258|HIV-infected person|hiv-infected person
5640183|NCT00739258|Entamoeba|entamoeba
5640184|NCT00739258|Cryptosporidium|cryptosporidium
5640185|NCT00739258|Giardia|giardia
5640186|NCT00739258|ELISA|elisa
5640187|NCT00739258|PCR|pcr
5640188|NCT00739258|IDU|idu
5640189|NCT00739258|Gonorrhea|gonorrhea
5640190|NCT00739258|Chlamydial trachomatis|chlamydial trachomatis
5640191|NCT00739258|Syphilis|syphilis
5640192|NCT00739258|Genital warts|genital warts
5640193|NCT00739258|Herpes simplex virus|herpes simplex virus
5640194|NCT00739232|Safety and tolerability of HSD-016|safety and tolerability of hsd-016
5640195|NCT00739219|Asthma|asthma
5640196|NCT00739219|inflammation|inflammation
5640197|NCT00739219|nitric oxide|nitric oxide
5640198|NCT00739219|eNO|eno
5640199|NCT00739219|FENO|feno
5640200|NCT00739206|uncomplicated|uncomplicated
5640201|NCT00739206|severe|severe
5640202|NCT00739206|treatment|treatment
5640203|NCT00739206|Plasmodium Falciparum|plasmodium falciparum
5640204|NCT00739193|Blood Pressure|blood pressure
5640205|NCT00739180|Childhood obesity|childhood obesity
5640206|NCT00739180|Abdominal obesity|abdominal obesity
5640207|NCT00739180|Visceral fat|visceral fat
5640208|NCT00739180|Insulin resistance|insulin resistance
5640209|NCT00739180|Liver fat|liver fat
5640210|NCT00739180|Skeletal muscle lipid|skeletal muscle lipid
5640211|NCT00739180|Fitness|fitness
5640212|NCT00739167|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5640213|NCT00739167|advanced adult primary liver cancer|advanced adult primary liver cancer
5640214|NCT00739167|liver metastases|liver metastases
5640215|NCT00739167|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5640216|NCT00739154|glaucoma|glaucoma
5640217|NCT00739154|Phenytoin|phenytoin
5640218|NCT00739154|retinal nerve fiber layer|retinal nerve fiber layer
5640219|NCT00739154|corrected pattern standard deviation|corrected pattern standard deviation
5640220|NCT00739154|visual acuity|visual acuity
5640221|NCT00739154|optic disc cupping|optic disc cupping
5640222|NCT00739141|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5640223|NCT00739141|CYCLOSPORINE A|cyclosporine a
5640224|NCT00739141|FLUDARABINE|fludarabine
5640225|NCT00739141|G-CSF|g-csf
5640226|NCT00739141|MYCOPHENOLATE MOFETIL (MMF)|mycophenolate mofetil (mmf)
5640227|NCT00739141|THI0TEPA|thi0tepa
5640228|NCT00739141|UMBILICAL CORD BLOOD (UCB)|umbilical cord blood (ucb)
5640229|NCT00739141|08-087|08-087
5640230|NCT00739128|celiac disease|celiac disease
5640231|NCT00739128|hepatitis B vaccine|hepatitis b vaccine
5640232|NCT00739115|Respiratory|respiratory
5640233|NCT00739115|Distress|distress
5640234|NCT00739115|Prematurity|prematurity
5640235|NCT00739115|Heliox|heliox
5640236|NCT00739115|CPAP|cpap
5640237|NCT00739102|Superficial Femoral Artery|superficial femoral artery
5640238|NCT00739102|Nitinol Self-Expandable Stent System|nitinol self-expandable stent system
5640239|NCT00739089|hemodynamics|hemodynamics
5640240|NCT00739089|oxygen|oxygen
5640241|NCT00739089|renal dialysis|renal dialysis
5640242|NCT00739089|shock|shock
5640243|NCT00739089|sepsis|sepsis
5640244|NCT00739089|hypotension|hypotension
5640245|NCT00739089|lactic acidosis|lactic acidosis
5640246|NCT00739063|Breast cancer|breast cancer
5640247|NCT00739063|Carcinoma of the breast|carcinoma of the breast
5640248|NCT00739063|Stage IV|stage iv
5640249|NCT00739063|Triple receptor-negative|triple receptor-negative
5640250|NCT00739063|Triple receptor-negative breast cancer|triple receptor-negative breast cancer
5640251|NCT00739063|Metastatic triple receptor-negative breast cancer|metastatic triple receptor-negative breast cancer
5640252|NCT00739063|Epidermal growth factor receptor|epidermal growth factor receptor
5640254|NCT00739063|EGFR-overexpressing|egfr-overexpressing
5640255|NCT00739063|GFR inhibitor erlotinib|gfr inhibitor erlotinib
5640256|NCT00739063|Erlotinib hydrochloride|erlotinib hydrochloride
5640257|NCT00739063|Erlotinib|erlotinib
5640258|NCT00739063|Tarceva|tarceva
5640259|NCT00739063|OSI-774|osi-774
5640260|NCT00739024|Migraine|migraine
5640261|NCT00739024|Headache|headache
5640262|NCT00738998|Breast Cancer|breast cancer
5640263|NCT00738998|Aromatase Inhibitors|aromatase inhibitors
5640264|NCT00738998|Symptom Assessment|symptom assessment
5640265|NCT00738998|Questionnaire|questionnaire
5640266|NCT00738998|Survey|survey
5640267|NCT00738998|Phone Call|phone call
5640268|NCT00738998|Arimidex|arimidex
5640269|NCT00738998|Anastrozole|anastrozole
5640270|NCT00738959|AZD0328|azd0328
5640271|NCT00738959|Japanese|japanese
5640272|NCT00738959|Caucasian|caucasian
5640273|NCT00738959|pharmacokinetics|pharmacokinetics
5640274|NCT00738959|safety|safety
5640275|NCT00738959|tolerability|tolerability
5640276|NCT00738946|Intermittent Preventive treatment|intermittent preventive treatment
5640277|NCT00738946|insecticide treated bednets|insecticide treated bednets
5640278|NCT00738946|malaria|malaria
5640279|NCT00738933|Atherosclerosis|atherosclerosis
5640280|NCT00738933|Plant sterols|plant sterols
5640281|NCT00738933|Plant stanols|plant stanols
5640282|NCT00738933|Aortic valve|aortic valve
5640283|NCT00738907|Type 1 diabetes|type 1 diabetes
5640284|NCT00738894|cryptogenic|cryptogenic
5640285|NCT00738894|stroke|stroke
5640286|NCT00738894|transient ischemic attack|transient ischemic attack
5640287|NCT00738894|TIA|tia
5640288|NCT00738894|PFO|pfo
5640289|NCT00738894|Patent foramen ovale|patent foramen ovale
5640290|NCT00738894|HELEX|helex
5640291|NCT00738894|Septal Occluder|septal occluder
5640292|NCT00738894|PFO Occluder|pfo occluder
5640293|NCT00738868|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5640294|NCT00738868|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5640295|NCT00738868|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5640296|NCT00738868|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5640297|NCT00738868|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5640298|NCT00738868|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5640299|NCT00738868|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5640300|NCT00738868|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5640301|NCT00738868|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5640302|NCT00738868|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5640303|NCT00738868|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5640304|NCT00738868|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5640305|NCT00738868|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5640306|NCT00738868|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5640307|NCT00738868|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5640308|NCT00738868|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5640309|NCT00738868|recurrent salivary gland cancer|recurrent salivary gland cancer
5640310|NCT00738868|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5640311|NCT00738868|stage III salivary gland cancer|stage iii salivary gland cancer
5640312|NCT00738855|Adhesions|adhesions
5640313|NCT00738855|Oral contrast|oral contrast
5640314|NCT00738855|Exploration|exploration
5640315|NCT00738842|Uric|uric
5640316|NCT00738842|Acid|acid
5640317|NCT00738842|Level|level
5640318|NCT00738829|CLL|cll
5640319|NCT00738829|untreated|untreated
5640320|NCT00738829|immune therapy|immune therapy
5640321|NCT00738829|dose escalation|dose escalation
5640322|NCT00738829|maximum tolerated dose|maximum tolerated dose
5640323|NCT00738829|maintenance therapy|maintenance therapy
5640324|NCT00738829|Lenalidomide|lenalidomide
5640325|NCT00738829|Rituximab|rituximab
5640326|NCT00738829|Fludarabine|fludarabine
5640327|NCT00738816|Medication review|medication review
5640328|NCT00738816|Patient|patient
5640329|NCT00738816|Safety|safety
5640330|NCT00738816|Drug|drug
5640331|NCT00738816|Prescriptions|prescriptions
5640332|NCT00738816|Drug-use|drug-use
5640333|NCT00738803|leg length|leg length
5640334|NCT00738803|hip arthroplasty|hip arthroplasty
5640335|NCT00738803|offset|offset
5634083|NCT00762541|Myopia|myopia
5640337|NCT00738790|preoperative radiotherapy and local excision|preoperative radiotherapy and local excision
5640338|NCT00738777|pre-operative|pre-operative
5640341|NCT00738764|cancer|cancer
5640342|NCT00738764|antibody|antibody
5640343|NCT00738764|Phase 1 Clinical Trial|phase 1 clinical trial
5640344|NCT00738751|NSCLC|nsclc
5640345|NCT00738751|Metastatic|metastatic
5640346|NCT00738751|erlotinib|erlotinib
5640347|NCT00738751|aerodigestive tract cancers|aerodigestive tract cancers
5640348|NCT00738751|non-small cell lung cancer|non-small cell lung cancer
5640349|NCT00738751|H&N cancer|h&n cancer
5640350|NCT00738738|Generalized Anxiety Disorder Elderly|generalized anxiety disorder elderly
5640351|NCT00738725|High risk plaque|high risk plaque
5640352|NCT00738725|High-risk plaque|high-risk plaque
5640353|NCT00738725|Vulnerable plaque|vulnerable plaque
5640354|NCT00738725|Atherosclerotic Disease|atherosclerotic disease
5640355|NCT00738725|Heart Disease|heart disease
5640356|NCT00738725|Stroke|stroke
5640357|NCT00738712|Vascular MRI|vascular mri
5640358|NCT00738712|Abdominal MRI|abdominal mri
5640359|NCT00738712|Pelvic MRI|pelvic mri
5640360|NCT00738712|Breast MRI|breast mri
5640361|NCT00738712|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5640362|NCT00738699|ovarian cancer|ovarian cancer
5640363|NCT00738699|relapsed ovarian cancer|relapsed ovarian cancer
5640364|NCT00738699|refractory ovarian cancer|refractory ovarian cancer
5640365|NCT00738686|coronary artery disease|coronary artery disease
5640366|NCT00738686|drug-eluting stent|drug-eluting stent
5640367|NCT00738686|percutaneous coronary intervention|percutaneous coronary intervention
5640368|NCT00738686|major adverse cardiac event|major adverse cardiac event
5640369|NCT00738686|in-stent restenosis|in-stent restenosis
5640370|NCT00738686|stent thrombosis|stent thrombosis
5640371|NCT00738673|Hormone refractory prostate cancer|hormone refractory prostate cancer
5640372|NCT00738673|Agonist treatment failure|agonist treatment failure
5640373|NCT00738660|type1 DM|type1 dm
5640374|NCT00738660|microalbuminuria|microalbuminuria
5640375|NCT00738660|nephropathy|nephropathy
5640376|NCT00738660|albumin excretion rate|albumin excretion rate
5640377|NCT00738660|dual blockade|dual blockade
5640378|NCT00738660|ACEI|acei
5640380|NCT00738647|Filling materials|filling materials
5640381|NCT00738647|Restorative materials|restorative materials
5640382|NCT00738647|clinical trial|clinical trial
5640383|NCT00738647|Resin based composite|resin based composite
5640384|NCT00738634|Depression|depression
5640385|NCT00738634|Motor Activity|motor activity
5640386|NCT00738634|Adolescent|adolescent
5640387|NCT00738621|PONV|ponv
5640388|NCT00738621|breast surgery|breast surgery
5640389|NCT00738621|prevention|prevention
5640390|NCT00738621|antiemetics|antiemetics
5640391|NCT00738608|morphine|morphine
5640392|NCT00738608|consumption|consumption
5640393|NCT00738608|postoperative|postoperative
5640394|NCT00738608|pain|pain
5640395|NCT00738608|Pain during 24h postoperative|pain during 24h postoperative
5640396|NCT00738608|Morphine consumption in 24h postoperative|morphine consumption in 24h postoperative
5640397|NCT00738595|Smoking Cessation|smoking cessation
5640398|NCT00738569|Chronic inflammation|chronic inflammation
5640399|NCT00738569|memory cells|memory cells
5640400|NCT00738569|activated t-lymphocytes|activated t-lymphocytes
5640401|NCT00738543|Antiseptics|antiseptics
5640402|NCT00738543|Administration, cutaneous|administration, cutaneous
5640403|NCT00738543|Iodophors|iodophors
5640404|NCT00738543|Chlorine compounds|chlorine compounds
5640405|NCT00738543|Anti-infecting agents, local|anti-infecting agents, local
5640406|NCT00738517|heart failure|heart failure
5640407|NCT00738517|coronary heart disease|coronary heart disease
5640408|NCT00738517|autoantibodies|autoantibodies
5640409|NCT00738517|immunoadsorption|immunoadsorption
5640410|NCT00738517|immunoglobulin substitution|immunoglobulin substitution
5640411|NCT00738504|Intensive insulin therapy|intensive insulin therapy
5640412|NCT00738504|Carbohydrate restrictive strategy|carbohydrate restrictive strategy
5640413|NCT00738504|RIFLE Criteria|rifle criteria
5640414|NCT00738504|Acute Kidney Injury|acute kidney injury
5640415|NCT00738504|Critically ill patients|critically ill patients
5640416|NCT00738504|Acute|acute
5640417|NCT00738491|Angina pectoris|angina pectoris
5640418|NCT00738491|Exercise capacity|exercise capacity
5643085|NCT00728676|Tyr|tyr
5640419|NCT00738491|Myocardial ischaemia|myocardial ischaemia
5640420|NCT00738491|Air pollution|air pollution
5640421|NCT00738478|distal gastrectomy|distal gastrectomy
5640422|NCT00738478|quality of life|quality of life
5640423|NCT00738452|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5640424|NCT00738452|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5640425|NCT00738452|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5640426|NCT00738452|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5640427|NCT00738439|scoliosis|scoliosis
5640428|NCT00738439|kyphosis|kyphosis
5640429|NCT00738439|treatment outcomes|treatment outcomes
5640430|NCT00738439|spinal deformity|spinal deformity
5640431|NCT00738426|non-invasive body contouring of waists hips and thighs|non-invasive body contouring of waists hips and thighs
5640432|NCT00738413|Iron chelation|iron chelation
5640433|NCT00738413|Iron balance|iron balance
5640434|NCT00738413|Secondary iron overload|secondary iron overload
5640435|NCT00738413|deferoxamine|deferoxamine
5640437|NCT00738400|Vardenafil|vardenafil
5640438|NCT00738400|Erectile Dysfunction|erectile dysfunction
5640439|NCT00738400|Double-blind study|double-blind study
5640440|NCT00738387|Tumor vascular disrupting agent|tumor vascular disrupting agent
5640441|NCT00738387|VDA|vda
5640442|NCT00738387|ASA404|asa404
5640443|NCT00738387|non-small cell lung cancer|non-small cell lung cancer
5640444|NCT00738387|NSCLC|nsclc
5640445|NCT00738361|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5640446|NCT00738361|iris melanoma|iris melanoma
5640447|NCT00738361|metastatic intraocular melanoma|metastatic intraocular melanoma
5640448|NCT00738361|recurrent intraocular melanoma|recurrent intraocular melanoma
5640449|NCT00738361|extraocular extension melanoma|extraocular extension melanoma
5640450|NCT00738348|surgery|surgery
5640451|NCT00738335|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5640452|NCT00738335|tumors metastatic to brain|tumors metastatic to brain
5640453|NCT00738335|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5640454|NCT00738322|AZD1305|azd1305
5640455|NCT00738322|safety|safety
5640456|NCT00738322|pharmacokinetics|pharmacokinetics
5640457|NCT00738322|single ascending doses|single ascending doses
5640458|NCT00738322|Japanese|japanese
5640459|NCT00738322|male|male
5640460|NCT00738309|Treatment Outcomes|treatment outcomes
5640461|NCT00738309|Spinal Deformity|spinal deformity
5640462|NCT00738309|Scheuermann's Kyphosis|scheuermann's kyphosis
5640463|NCT00738283|Zinc|zinc
5640464|NCT00738283|Copper|copper
5640465|NCT00738283|Neonate|neonate
5640466|NCT00738257|Renal|renal
5640467|NCT00738257|transplant,|transplant,
5640468|NCT00738257|pamidronate,|pamidronate,
5640469|NCT00738257|ciclosporin,|ciclosporin,
5640470|NCT00738257|Ciclosporin A,|ciclosporin a,
5640471|NCT00738257|steroids,|steroids,
5640472|NCT00738257|bone mineral density,|bone mineral density,
5640473|NCT00738257|fracture rates|fracture rates
5640474|NCT00738257|immunosuppressive|immunosuppressive
5640475|NCT00738257|regimen|regimen
5640476|NCT00738244|hearing aid algorithm|hearing aid algorithm
5640477|NCT00738244|wind-noise suppression|wind-noise suppression
5640478|NCT00738231|risk factors; coronary arterial hearth disease|risk factors; coronary arterial hearth disease
5640479|NCT00738218|Coronary Artery Disease|coronary artery disease
5640480|NCT00738218|Computed Tomography|computed tomography
5640481|NCT00738218|Angiography|angiography
5640482|NCT00738205|Electronic device|electronic device
5640483|NCT00738205|Growth hormone treatment|growth hormone treatment
5640484|NCT00738192|Postoperative analgesia|postoperative analgesia
5640485|NCT00738192|Opioids|opioids
5640486|NCT00738192|Laparoscopic surgery|laparoscopic surgery
5640487|NCT00738179|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
5640488|NCT00738179|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5640489|NCT00738179|Cardiovascular (CV)|cardiovascular (cv)
5640490|NCT00738179|Cardiovascular Disease|cardiovascular disease
5640491|NCT00738179|Clinical Trial|clinical trial
5640492|NCT00738166|diet, organic, health|diet, organic, health
5640493|NCT00738166|healthy people|healthy people
5640494|NCT00738140|insulin sensitivity|insulin sensitivity
5640495|NCT00738140|Diabetes Prevention Program|diabetes prevention program
5640496|NCT00738140|lifestyle intervention|lifestyle intervention
5640497|NCT00738127|Acute trans-scaphoid perilunate dislocations|acute trans-scaphoid perilunate dislocations
5640498|NCT00738127|Open reduction and internal fixation|open reduction and internal fixation
5640499|NCT00738127|Kirschner-wire|kirschner-wire
5640500|NCT00738127|Range of motion|range of motion
5640501|NCT00738114|non-cardiac|non-cardiac
5640502|NCT00738114|surgery|surgery
5640503|NCT00738114|mortality|mortality
5640504|NCT00738114|morbidity|morbidity
5640505|NCT00738114|perioperative|perioperative
5640506|NCT00738114|period|period
5640507|NCT00738101|Omega-3|omega-3
5640508|NCT00738101|Omegaven|omegaven
5640509|NCT00738101|Cholestasis|cholestasis
5640510|NCT00738101|Liver damage|liver damage
5640511|NCT00738088|Sulphonylurea|sulphonylurea
5640512|NCT00738088|Pharmacogenetics|pharmacogenetics
5847443|NCT00039715|Glucocorticoid Receptor|glucocorticoid receptor
5640514|NCT00738062|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5640515|NCT00738062|Orthostatic hypotension|orthostatic hypotension
5640517|NCT00738062|Pure Autonomic Failure|pure autonomic failure
5640518|NCT00738062|MSA|msa
5640519|NCT00738062|Multiple System Atrophy|multiple system atrophy
5640520|NCT00738062|Neuropathy|neuropathy
5640521|NCT00738062|Autonomic Failure|autonomic failure
5640522|NCT00738062|Parkinson|parkinson
5640523|NCT00738062|Dopamine Deficiency|dopamine deficiency
5640524|NCT00738062|Dopamine|dopamine
5640525|NCT00738062|Droxidopa|droxidopa
5640526|NCT00738049|atherosclerosis|atherosclerosis
5640527|NCT00738049|coronary artery disease|coronary artery disease
5640528|NCT00738049|myocardial perfusion defect|myocardial perfusion defect
5640529|NCT00738049|endothelial dysfunction|endothelial dysfunction
5640531|NCT00738036|Analgesics|analgesics
5640532|NCT00738036|Opioid|opioid
5640533|NCT00738036|Opioid maintenance therapy|opioid maintenance therapy
5640534|NCT00738036|Acute pain|acute pain
5640535|NCT00738023|diabetes,|diabetes,
5640536|NCT00738023|hypertension,|hypertension,
5640537|NCT00738023|free-fatty acids|free-fatty acids
5640538|NCT00738010|NMES|nmes
5640539|NCT00738010|ACL|acl
5640540|NCT00738010|Atrophy Prevention|atrophy prevention
5640541|NCT00738010|Accelerated Recovery|accelerated recovery
5640542|NCT00738010|Knee Surgery|knee surgery
5640543|NCT00737997|Pediatrics|pediatrics
5640544|NCT00737997|Scoliosis|scoliosis
5640545|NCT00737997|Morphine|morphine
5640546|NCT00737997|Surgery|surgery
5640547|NCT00737997|Analgesia|analgesia
5640548|NCT00737984|Infertility|infertility
5640549|NCT00737984|Clinical pregnancy rate|clinical pregnancy rate
5640550|NCT00737971|avastin|avastin
5640551|NCT00737971|bevacizumab|bevacizumab
5640552|NCT00737971|triamcinolone|triamcinolone
5640553|NCT00737971|diabetic macular edema|diabetic macular edema
5640554|NCT00737971|macular edema|macular edema
5640555|NCT00737971|intravitreal injection|intravitreal injection
5640556|NCT00737958|Angina pectoris|angina pectoris
5640557|NCT00737958|Air pollution|air pollution
5640558|NCT00737958|Diesel exhaust|diesel exhaust
5640559|NCT00737958|Myocardial ischaemia|myocardial ischaemia
5640560|NCT00737958|Exercise capacity|exercise capacity
5640561|NCT00737919|Cholesterol|cholesterol
5640562|NCT00737919|Plant sterols|plant sterols
5640563|NCT00737919|Atherosclerotic carotid plaques|atherosclerotic carotid plaques
5640564|NCT00737906|Chronic rhinitis|chronic rhinitis
5640565|NCT00737906|Nasal Obstruction|nasal obstruction
5640566|NCT00737906|Nasal Obstruction Symptoms|nasal obstruction symptoms
5640567|NCT00737906|Failed Medical Management for Nasal Obstruction|failed medical management for nasal obstruction
5640568|NCT00737906|Inflammation of the nasal mucosa|inflammation of the nasal mucosa
5640569|NCT00737906|Pediatric Turbinate reduction|pediatric turbinate reduction
5640570|NCT00737906|Coblation|coblation
5640571|NCT00737906|Arthrocare|arthrocare
5640572|NCT00737906|ENT|ent
5640573|NCT00737906|Failed Medical Management for Chronic Sinusitis|failed medical management for chronic sinusitis
5640574|NCT00737906|Turbinate|turbinate
5640575|NCT00737906|Inferior Turbinate Hypertrophy|inferior turbinate hypertrophy
5640576|NCT00737906|Bilateral Inferior Turbinate Hypertrophy|bilateral inferior turbinate hypertrophy
5640577|NCT00737906|Turbinate Hypertrophy|turbinate hypertrophy
5640578|NCT00737906|Inferior Turbinate|inferior turbinate
5640579|NCT00737906|Bilateral Inferior Turbinate|bilateral inferior turbinate
5640580|NCT00737893|Erythropoietin|erythropoietin
5640581|NCT00737893|Radical Prostatectomy|radical prostatectomy
5640582|NCT00737893|Erectile Dysfunction|erectile dysfunction
5640583|NCT00737893|Prostate Cancer|prostate cancer
5640584|NCT00737880|Pancreas Clinical, Donor|pancreas clinical, donor
5640585|NCT00737880|Pancreas Clinical, Preservation Solutions|pancreas clinical, preservation solutions
5640586|NCT00737880|Organ Preservation and Procurement, Surgery|organ preservation and procurement, surgery
5640587|NCT00737880|Organ Procurement, Ischemia reperfusion Injury|organ procurement, ischemia reperfusion injury
5640588|NCT00737880|Organ Preservation and Procurement|organ preservation and procurement
5640589|NCT00737867|lung cancer|lung cancer
5640590|NCT00737867|chemotherapy|chemotherapy
5640591|NCT00737867|vinorelbine|vinorelbine
5640592|NCT00737867|gemcitabine|gemcitabine
5640593|NCT00737867|carboplatin|carboplatin
5640594|NCT00737867|advanced lung cancer|advanced lung cancer
5640595|NCT00737867|non-small cell lung cancer|non-small cell lung cancer
5640597|NCT00737854|Free Soft Tissue Graft|free soft tissue graft
5640598|NCT00737854|Treatment|treatment
5640599|NCT00737841|stress|stress
5640600|NCT00737841|brain-gut interactions|brain-gut interactions
5640601|NCT00737841|visceral perception|visceral perception
5640602|NCT00737841|gastrointestinal motility|gastrointestinal motility
5640603|NCT00737841|emotion|emotion
5640604|NCT00737828|Cardiopulmonary exercise test|cardiopulmonary exercise test
5640605|NCT00737828|CPX|cpx
5640606|NCT00737828|CPEX|cpex
5640607|NCT00737828|surgical outcome|surgical outcome
5640608|NCT00737828|colorectal surgery|colorectal surgery
5640609|NCT00737828|risk stratification|risk stratification
5640614|NCT00737802|GERD|gerd
5640615|NCT00737802|Heartburn|heartburn
5829617|NCT00059670|UES|ues
5640616|NCT00737802|Esophageal reflux|esophageal reflux
5640617|NCT00737802|Barretts esophagus|barretts esophagus
5640618|NCT00737802|Normal subjects|normal subjects
5640619|NCT00737763|efalizumab|efalizumab
5640620|NCT00737763|Raptiva|raptiva
5640621|NCT00737763|Diabetes|diabetes
5640622|NCT00737763|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5640623|NCT00737750|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5640624|NCT00737750|Knee Surgery|knee surgery
5640625|NCT00737750|Anterior cruciate ligament|anterior cruciate ligament
5640626|NCT00737750|Atrophy Prevention|atrophy prevention
5640627|NCT00737750|Accelerated Recovery|accelerated recovery
5640628|NCT00737737|Analgesia|analgesia
5634378|NCT00761189|R076477|r076477
5640629|NCT00737737|Chronic Pain|chronic pain
5640630|NCT00737737|Neuroendocrine Axis|neuroendocrine axis
5640631|NCT00737737|Degenerative Diseases|degenerative diseases
5640936|NCT00736762|Balance|balance
5640632|NCT00737724|Enzyme-Linked ImmunoSpot|enzyme-linked immunospot
5640633|NCT00737724|Deferred treatment|deferred treatment
5640634|NCT00737724|Immune Recovery Inflammatory Syndrome|immune recovery inflammatory syndrome
5640635|NCT00737698|COPD|copd
5640636|NCT00737698|exercise|exercise
5640637|NCT00737698|repetitive magnetic stimulation|repetitive magnetic stimulation
5640638|NCT00737698|quadriceps strength|quadriceps strength
5640639|NCT00737685|Pediatric|pediatric
5640640|NCT00737685|UBMT|ubmt
5640641|NCT00737685|Severe|severe
5640642|NCT00737672|Hemodialysis|hemodialysis
5640643|NCT00737672|Stent Graft|stent graft
5640644|NCT00737672|Venous Anastomosis|venous anastomosis
5640645|NCT00737672|Arteriovenous Grafts|arteriovenous grafts
5640646|NCT00737659|Renal Transplant|renal transplant
5640647|NCT00737659|Renal|renal
5640648|NCT00737659|Transplant|transplant
5640649|NCT00737659|MMF|mmf
5640650|NCT00737659|MPA|mpa
5640651|NCT00737659|Recipients|recipients
5640652|NCT00737646|Cancer|cancer
5640653|NCT00737646|Colorectal cancer|colorectal cancer
5640654|NCT00737646|Patient education|patient education
5640655|NCT00737646|Physician education|physician education
5640656|NCT00737633|Diabetes|diabetes
5640657|NCT00737633|Type 2 Diabetes|type 2 diabetes
5640658|NCT00737633|Diabetes Mellitus|diabetes mellitus
5640659|NCT00737633|Metabolic Diseases|metabolic diseases
5640660|NCT00737633|Glucose Metabolism Disorders|glucose metabolism disorders
5640661|NCT00737633|Glycemic Control|glycemic control
5640662|NCT00737620|Renal Failure, End Stage|renal failure, end stage
5640663|NCT00737620|Blood Vessel Grafting|blood vessel grafting
5640664|NCT00737620|Hemodialysis|hemodialysis
5640665|NCT00737620|Surgical Arteriovenous Shunt|surgical arteriovenous shunt
5640667|NCT00737607|surgery|surgery
5640668|NCT00737607|lumbar spinal stenosis|lumbar spinal stenosis
5640669|NCT00737607|minimally invasive|minimally invasive
5640670|NCT00737581|Subject's|subject's
5640671|NCT00737581|response|response
5640672|NCT00737581|changes|changes
5640673|NCT00737581|in spinal|in spinal
5640675|NCT00737581|stimulation|stimulation
5640676|NCT00737581|during|during
5640677|NCT00737581|postural|postural
5640678|NCT00737568|Tenofovir DF|tenofovir df
5640679|NCT00737568|Emtricitabine|emtricitabine
5640680|NCT00737568|Chronic hepatitis B|chronic hepatitis b
5640681|NCT00737568|Combination therapy|combination therapy
5640682|NCT00737555|Solid tumour|solid tumour
5640683|NCT00737555|Solid tumor|solid tumor
5640684|NCT00737555|Pharmacokinetic|pharmacokinetic
5640685|NCT00737555|Interaction|interaction
5640686|NCT00737555|dose escalation|dose escalation
5640687|NCT00737555|cancer|cancer
5640688|NCT00737555|paclitaxel|paclitaxel
5640689|NCT00737542|management|management
5640690|NCT00737542|post|post
5640691|NCT00737529|Mantle Cell Lymphoma|mantle cell lymphoma
5640692|NCT00737529|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5640693|NCT00737529|CC-5013|cc-5013
5640694|NCT00737529|Revlimid|revlimid
5640695|NCT00737529|Lenalidomide|lenalidomide
5640696|NCT00737516|Registry|registry
5640697|NCT00737516|Unrelated Umbilical Cord Blood donor|unrelated umbilical cord blood donor
5640698|NCT00737516|Hematopoietic Reconstitution|hematopoietic reconstitution
5640699|NCT00737516|Center for Cord Blood|center for cord blood
5640700|NCT00737516|Bone Marrow Transplantation|bone marrow transplantation
5640701|NCT00737503|vaccine effectiveness, rotavirus, diarrhoea, Bangladesh|vaccine effectiveness, rotavirus, diarrhoea, bangladesh
5640702|NCT00737451|urticaria|urticaria
5640703|NCT00737451|goiter|goiter
5640704|NCT00737438|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5640705|NCT00737438|CAPECITABINE (ORAL)|capecitabine (oral)
5640706|NCT00737438|CISPLATIN|cisplatin
5640717|NCT00737425|low intensity ultrasound|low intensity ultrasound
5640718|NCT00737412|Bio-K+CL1285|bio-k+cl1285
5640720|NCT00737412|Traveler's Diarrhea|traveler's diarrhea
5640721|NCT00737412|Lactobacillus Acidophilus|lactobacillus acidophilus
5640722|NCT00737412|Lactobacillus Casei|lactobacillus casei
5640723|NCT00737399|depression|depression
5640724|NCT00737399|anxiety|anxiety
5640725|NCT00737399|pain|pain
5640726|NCT00737399|insomnia|insomnia
5640727|NCT00737399|cancer|cancer
5640728|NCT00737399|cholangiocarcinoma|cholangiocarcinoma
5640729|NCT00737399|EFT (Emotional Freedom Techniques)|eft (emotional freedom techniques)
5640730|NCT00737386|Leishmania tropica|leishmania tropica
5640731|NCT00737386|Hyrax|hyrax
5640732|NCT00737386|Sandfly|sandfly
5640733|NCT00737347|type 2 diabetes|type 2 diabetes
5640734|NCT00737347|obesity|obesity
5640735|NCT00737347|weight gain|weight gain
5641037|NCT00736424|SUDEP|sudep
5640736|NCT00737347|thiazolidinediones|thiazolidinediones
5640737|NCT00737334|Carotid stenosis|carotid stenosis
5640738|NCT00737334|EEGo|eego
5640739|NCT00737334|nonlinear EEG|nonlinear eeg
5640741|NCT00737334|cerebral oximetry|cerebral oximetry
5640742|NCT00737334|FORE-SIGHT cerebral oximeter|fore-sight cerebral oximeter
5640743|NCT00737334|cerebral monitoring|cerebral monitoring
5640744|NCT00737334|arterial jugular venous lactate difference|arterial jugular venous lactate difference
5640746|NCT00737334|carotid endarterectomy|carotid endarterectomy
5640747|NCT00737321|Impact of ischemia|impact of ischemia
5640748|NCT00737321|Impact of stress and|impact of stress and
5640749|NCT00737321|Identify patterns of gene expression|identify patterns of gene expression
5640751|NCT00737308|ceramics|ceramics
5640752|NCT00737295|Biliary|biliary
5640753|NCT00737295|Dyskinesia|dyskinesia
5640754|NCT00737295|Gallbladder|gallbladder
5640755|NCT00737295|Cholecystitis|cholecystitis
5640756|NCT00737282|Uterine Fibroids|uterine fibroids
5640757|NCT00737269|Complicated Skin and Soft-Tissue Infection|complicated skin and soft-tissue infection
5640758|NCT00737269|Skin Infection|skin infection
5640759|NCT00737269|Skin Infection Registry|skin infection registry
5640760|NCT00737269|cSSTI Registry|cssti registry
5640761|NCT00737243|Carcinoma of Unknown Primary Site|carcinoma of unknown primary site
5640762|NCT00737243|Molecular profiling assay|molecular profiling assay
5640763|NCT00737243|Bevacizumab|bevacizumab
5640764|NCT00737243|Erlotinib|erlotinib
5640765|NCT00737243|Paclitaxel|paclitaxel
5640766|NCT00737243|Carboplatin|carboplatin
5640767|NCT00737230|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5640768|NCT00737230|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5640769|NCT00737230|gastrointestinal complications|gastrointestinal complications
5640770|NCT00737230|radiation toxicity|radiation toxicity
5640771|NCT00737230|prostate cancer|prostate cancer
5640772|NCT00737230|bladder cancer|bladder cancer
5640773|NCT00737230|vulvar cancer|vulvar cancer
5640774|NCT00737230|vaginal cancer|vaginal cancer
5640775|NCT00737230|cervical cancer|cervical cancer
5640776|NCT00737230|endometrial cancer|endometrial cancer
5640777|NCT00737230|anal cancer|anal cancer
5640778|NCT00737230|rectal cancer|rectal cancer
5640779|NCT00737230|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5640781|NCT00737204|AIDS|aids
5640782|NCT00737204|Armodafinil|armodafinil
5640783|NCT00737204|Depression|depression
5640784|NCT00737191|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5640785|NCT00737191|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5640787|NCT00737178|IUD|iud
5640788|NCT00737178|Intrauterine device|intrauterine device
5640789|NCT00737178|Intrauterine contraception|intrauterine contraception
5640790|NCT00737178|Medication abortion|medication abortion
5640791|NCT00737178|Medical abortion|medical abortion
5640792|NCT00737165|Suicide, Prevention|suicide, prevention
5640793|NCT00737165|Community|community
5640794|NCT00737152|RAS 130|ras 130
5640795|NCT00737152|Exercise|exercise
5640796|NCT00737152|Diabetes Mellitus|diabetes mellitus
5640797|NCT00737152|Type II Diabetes|type ii diabetes
5640798|NCT00737152|Diabetes|diabetes
5640799|NCT00737152|Aerobic|aerobic
5640800|NCT00737139|Hip|hip
5640801|NCT00737139|Knee|knee
5640802|NCT00737139|Arthroplasty|arthroplasty
5640803|NCT00737139|Epinephrine|epinephrine
5640804|NCT00737139|Hemostasis|hemostasis
5640805|NCT00737126|Diabetic nephropathies|diabetic nephropathies
5640806|NCT00737126|Hyperhomocysteinemia|hyperhomocysteinemia
5640807|NCT00737126|Folic acid|folic acid
5640808|NCT00737126|Endothelial dysfunction|endothelial dysfunction
5640809|NCT00737113|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5640810|NCT00737113|Engrafted|engrafted
5640811|NCT00737113|subjects|subjects
5640812|NCT00737087|total shoulder replacement|total shoulder replacement
5640813|NCT00737087|rotator cuff|rotator cuff
5640814|NCT00737087|osteoarthritis|osteoarthritis
5640815|NCT00737087|rheumatoid arthritis|rheumatoid arthritis
5640816|NCT00737087|Delta Extend|delta extend
5640817|NCT00737074|Fibrovascular proliferation|fibrovascular proliferation
5640818|NCT00737074|Internal limiting membrane peeling|internal limiting membrane peeling
5640819|NCT00737074|Macular detachment|macular detachment
5640820|NCT00737074|Macular hole|macular hole
5640821|NCT00737074|Proliferative diabetic retinopathy.|proliferative diabetic retinopathy.
5640822|NCT00737061|Female|female
5640823|NCT00737061|Sterilization|sterilization
5640824|NCT00737048|Pain|pain
5640825|NCT00737048|Tooth extraction|tooth extraction
5640826|NCT00737048|Oral surgery|oral surgery
5640827|NCT00737048|Postoperative pain|postoperative pain
5640828|NCT00737048|JNS013|jns013
5640829|NCT00737048|Tramadol hydrochloride|tramadol hydrochloride
5640830|NCT00737048|Acetaminophen|acetaminophen
5640831|NCT00737035|Intimate Partner Homicide|intimate partner homicide
5640832|NCT00737035|Parental Homicide|parental homicide
5640833|NCT00737035|Guardians of Child Survivors of Parental Homicide|guardians of child survivors of parental homicide
5640834|NCT00737035|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5640835|NCT00737035|Uxoricide Project|uxoricide project
5640836|NCT00737022|Diabetic vitrectomy|diabetic vitrectomy
5640837|NCT00737022|Epiretinal membrane (ERM)|epiretinal membrane (erm)
5640838|NCT00737022|Macular appearance|macular appearance
5640839|NCT00737022|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5640840|NCT00737022|Visual function|visual function
5640841|NCT00737009|Breast cancer|breast cancer
5640843|NCT00737009|anastrozole|anastrozole
5640844|NCT00737009|post-menopausal women|post-menopausal women
5640845|NCT00736996|Metabolic Syndrome|metabolic syndrome
5640846|NCT00736996|Mild Cognitive Impairment|mild cognitive impairment
5640847|NCT00736996|Insulin Resistance|insulin resistance
5640848|NCT00736996|Endurance Exercise|endurance exercise
5640849|NCT00736983|Perianal fistulas|perianal fistulas
5640850|NCT00736983|Crohn's disease|crohn's disease
5640851|NCT00736970|ridaforolimus|ridaforolimus
5640852|NCT00736970|deforolimus|deforolimus
5640853|NCT00736970|AP23573|ap23573
5640854|NCT00736970|breast cancer|breast cancer
5640855|NCT00736957|Chronic Pain|chronic pain
5640856|NCT00736957|Acetaminophen|acetaminophen
5640857|NCT00736957|Tramadol|tramadol
5640858|NCT00736957|JNS013|jns013
5640859|NCT00736931|Brivaracetam|brivaracetam
5640860|NCT00736931|Cognitive neurophysiological tests (CNT)|cognitive neurophysiological tests (cnt)
5640861|NCT00736931|Neuropsychological assessments|neuropsychological assessments
5640862|NCT00736918|Suicide Attempt|suicide attempt
5640863|NCT00736905|TMC278-TiDP6-C130|tmc278-tidp6-c130
5640864|NCT00736905|TMC278-C130|tmc278-c130
5640865|NCT00736905|healthy volunteer|healthy volunteer
5640866|NCT00736905|hepatic impairment|hepatic impairment
5640867|NCT00736905|HIV Infections|hiv infections
5640868|NCT00736892|Acute lung injury|acute lung injury
5640869|NCT00736892|Acute respiratory distress syndrome|acute respiratory distress syndrome
5640870|NCT00736892|Mechanical ventilation|mechanical ventilation
5640871|NCT00736892|Prognosis|prognosis
5640872|NCT00736892|Definitions|definitions
5640873|NCT00736879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5640874|NCT00736879|Diabetes Mellitus|diabetes mellitus
5640875|NCT00736879|Endocrine System Diseases|endocrine system diseases
5640876|NCT00736879|Glucose Metabolism Disorders|glucose metabolism disorders
5640877|NCT00736879|Metabolic Diseases|metabolic diseases
5640878|NCT00736866|acetylcysteine|acetylcysteine
5640879|NCT00736866|contrast-induced nephropathy|contrast-induced nephropathy
5640880|NCT00736866|angiography|angiography
5640881|NCT00736866|angioplasty with or without Stent|angioplasty with or without stent
5640882|NCT00736853|Chronic pain|chronic pain
5640883|NCT00736853|Acetoaminophen|acetoaminophen
5640884|NCT00736853|Tramadol|tramadol
5640885|NCT00736853|Osteoarthritis of the knee|osteoarthritis of the knee
5640886|NCT00736853|Low back pain|low back pain
5640887|NCT00736840|Methacetin|methacetin
5640889|NCT00736840|Test|test
5640890|NCT00736840|Cirrhosis|cirrhosis
5640891|NCT00736827|BK virus|bk virus
5640892|NCT00736827|acute renal failure|acute renal failure
5640893|NCT00736827|hemodiafiltration|hemodiafiltration
5640894|NCT00736827|humans|humans
5640895|NCT00736827|patients|patients
5640896|NCT00736827|polytrauma|polytrauma
5640897|NCT00736827|surgery|surgery
5640898|NCT00736827|complement|complement
5640899|NCT00736827|inflammation|inflammation
5640900|NCT00736827|inflammatory response|inflammatory response
5640901|NCT00736827|biomarkers|biomarkers
5640902|NCT00736827|cytokines|cytokines
5640903|NCT00736827|cell surface markers|cell surface markers
5640904|NCT00736827|functional polymorphisms|functional polymorphisms
5640905|NCT00736827|infections|infections
5640906|NCT00736827|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5640907|NCT00736827|SIRS|sirs
5640908|NCT00736827|sepsis|sepsis
5640909|NCT00736827|severe sepsis|severe sepsis
5640910|NCT00736827|shock|shock
5640911|NCT00736827|organ dysfunctions|organ dysfunctions
5640912|NCT00736827|SOFA|sofa
5640913|NCT00736827|severity of disease|severity of disease
5640914|NCT00736827|APACHEII|apacheii
5640915|NCT00736827|SAPSII|sapsii
5640916|NCT00736827|SPAPS3|spaps3
5640917|NCT00736827|length of stay|length of stay
5640918|NCT00736827|outcome|outcome
5640919|NCT00736827|mortality|mortality
5640920|NCT00736814|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5640921|NCT00736814|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5640922|NCT00736801|Airway hyperresponsiveness|airway hyperresponsiveness
5640923|NCT00736788|AZD1704,|azd1704,
5640924|NCT00736788|Japanese|japanese
5640925|NCT00736788|Healthy|healthy
5640926|NCT00736788|Volunteers,|volunteers,
5640927|NCT00736788|Phase I study,|phase i study,
5640928|NCT00736788|Single Ascending Dose|single ascending dose
5640929|NCT00736788|Safety,|safety,
5640930|NCT00736788|Tolerability|tolerability
5640931|NCT00736788|Pharmacokinetics|pharmacokinetics
5640932|NCT00736775|AD|ad
5640933|NCT00736775|Alzheimer's|alzheimer's
5640934|NCT00736775|Alzheimers|alzheimers
5640935|NCT00736762|Global postural re-education|global postural re-education
5640937|NCT00736762|Physical therapy|physical therapy
5640938|NCT00736762|older people|older people
5640939|NCT00736723|NT-proBNP|nt-probnp
5640940|NCT00736723|myocardial dysfunction|myocardial dysfunction
5640941|NCT00736723|humans|humans
5640942|NCT00736723|patients|patients
5640943|NCT00736723|polytrauma|polytrauma
5640944|NCT00736723|complement|complement
5640945|NCT00736723|inflammation|inflammation
5640946|NCT00736723|inflammatory response|inflammatory response
5640947|NCT00736723|biomarkers|biomarkers
5640948|NCT00736723|cytokines|cytokines
5640949|NCT00736723|cell surface markers|cell surface markers
5640950|NCT00736723|functional polymorphisms|functional polymorphisms
5640951|NCT00736723|infections|infections
5640952|NCT00736723|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5640953|NCT00736723|SIRS|sirs
5640954|NCT00736723|sepsis|sepsis
5640955|NCT00736723|severe sepsis|severe sepsis
5640956|NCT00736723|shock|shock
5640957|NCT00736723|organ dysfunctions|organ dysfunctions
5640958|NCT00736723|SOFA|sofa
5640959|NCT00736723|severity of disease|severity of disease
5640960|NCT00736723|APACHEII|apacheii
5640961|NCT00736723|SAPSII|sapsii
5640962|NCT00736723|SPAPS3|spaps3
5640963|NCT00736723|length of stay|length of stay
5640964|NCT00736723|outcome|outcome
5640965|NCT00736723|mortality|mortality
5640966|NCT00736710|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5640967|NCT00736710|Cigarette smoking|cigarette smoking
5640968|NCT00736710|Schizophrenia|schizophrenia
5640969|NCT00736710|Randomized|randomized
5640970|NCT00736710|Double-blind|double-blind
5640971|NCT00736710|Placebo-controlled|placebo-controlled
5640972|NCT00736710|longitudinal|longitudinal
5640973|NCT00736710|nicotine patch|nicotine patch
5640974|NCT00736684|Femoral fractures [MeSH]|femoral fractures [mesh]
5640975|NCT00736684|hip fractures [MeSH]|hip fractures [mesh]
5640976|NCT00736684|trochanteric fractures (femoral neck fractures [MeSH])|trochanteric fractures (femoral neck fractures [mesh])
5640977|NCT00736684|intramedullary nailing (fracture fixation, intramedullary [MeSH])|intramedullary nailing (fracture fixation, intramedullary [mesh])
5640978|NCT00736684|complex femoral fractures|complex femoral fractures
5640979|NCT00736684|femoral nail|femoral nail
5640980|NCT00736684|surgical treatment (surgical procedures, operative [MeSH])|surgical treatment (surgical procedures, operative [mesh])
5640981|NCT00736684|complications|complications
5640982|NCT00736658|Japanese|japanese
5640983|NCT00736658|MAD|mad
5640984|NCT00736658|Multiple ascending dose|multiple ascending dose
5640985|NCT00736658|Chronic pain|chronic pain
5640986|NCT00736645|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5640987|NCT00736645|stage I prostate cancer|stage i prostate cancer
5640988|NCT00736645|stage II prostate cancer|stage ii prostate cancer
5640989|NCT00736632|Vitamin D|vitamin d
5640990|NCT00736632|Insulin Resistance|insulin resistance
5640991|NCT00736632|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5640992|NCT00736632|Cardiovascular Disease|cardiovascular disease
5640993|NCT00736619|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
5640995|NCT00736619|Radiation Therapy|radiation therapy
5640996|NCT00736619|08-084|08-084
5640997|NCT00736606|simvastatin|simvastatin
5640998|NCT00736606|AZD5672|azd5672
5640999|NCT00736593|Wound|wound
5641000|NCT00736593|Healing|healing
5641001|NCT00736580|Cesarean delivery|cesarean delivery
5641002|NCT00736580|Surgical Needles|surgical needles
5641003|NCT00736580|blunt-tip needles|blunt-tip needles
5641004|NCT00736580|surgical glove perforation|surgical glove perforation
5641005|NCT00736567|Diarrhea|diarrhea
5641006|NCT00736567|Diagnostic|diagnostic
5641007|NCT00736567|Pediatric|pediatric
5641008|NCT00736554|Staphylococcus aureus|staphylococcus aureus
5641009|NCT00736554|CA-MRSA|ca-mrsa
5641010|NCT00736554|skin and soft tissue infections|skin and soft tissue infections
5641011|NCT00736554|resistance|resistance
5641012|NCT00736554|emergency department|emergency department
5641013|NCT00736541|ARF|arf
5641014|NCT00736541|OLT|olt
5641015|NCT00736541|NAC|nac
5641016|NCT00736541|I/R injury|i/r injury
5641017|NCT00736528|safety, tolerability, pharmacokinetics, cognition|safety, tolerability, pharmacokinetics, cognition
5641018|NCT00736515|combination therapy,monotherapy,gliclazide MR,insulin,CGMS|combination therapy,monotherapy,gliclazide mr,insulin,cgms
5641019|NCT00736489|Asthma|asthma
5641020|NCT00736489|airway obstruction|airway obstruction
5641021|NCT00736489|beta2-agonist|beta2-agonist
5641022|NCT00736489|efficacy|efficacy
5641023|NCT00736489|inhalation|inhalation
5641024|NCT00736476|helicobacter pylori infection|helicobacter pylori infection
5641025|NCT00736476|vaccination|vaccination
5641026|NCT00736476|adults|adults
5641027|NCT00736463|HDL cholesterol|hdl cholesterol
5641028|NCT00736463|statin|statin
5641029|NCT00736463|inflammation|inflammation
5641030|NCT00736463|atherosclerosis|atherosclerosis
5641031|NCT00736463|prevention|prevention
5641032|NCT00736463|patients with low baseline HDL cholesterol|patients with low baseline hdl cholesterol
5641033|NCT00736437|UV-induced|uv-induced
5641034|NCT00736437|Herpes labialis|herpes labialis
5641035|NCT00736437|time to healing|time to healing
5641036|NCT00736424|Epilepsy|epilepsy
5641038|NCT00736424|DBS|dbs
5641039|NCT00736411|infertility|infertility
5641040|NCT00736411|IVF|ivf
5641041|NCT00736411|acupuncture|acupuncture
5641042|NCT00736385|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5641043|NCT00736372|cancer|cancer
5641044|NCT00736372|metastatic cancer|metastatic cancer
5789066|NCT00150072|PDGFR|pdgfr
5641045|NCT00736372|advanced or metastatic cancer|advanced or metastatic cancer
5641046|NCT00736346|Panic Disorder|panic disorder
5641047|NCT00736346|anxiety|anxiety
5641048|NCT00736346|chest pain|chest pain
5641049|NCT00736346|emergency department|emergency department
5641050|NCT00736346|cognitive-behavioral treatment|cognitive-behavioral treatment
5641051|NCT00736320|Hodgkin Lymphoma|hodgkin lymphoma
5641052|NCT00736320|early stage|early stage
5641053|NCT00736320|PET|pet
5641054|NCT00736307|limbal stem cell deficiency|limbal stem cell deficiency
5641055|NCT00736294|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5641056|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5641057|NCT00736281|Sublingual Immunotherapy for Food Allergy|sublingual immunotherapy for food allergy
5641058|NCT00736281|Food Drops for Food Allergy|food drops for food allergy
5641059|NCT00736268|Lung Disease|lung disease
5641060|NCT00736268|Chronic Bronchitis|chronic bronchitis
5641061|NCT00736268|Emphysema|emphysema
5641062|NCT00736268|Caregiver stress|caregiver stress
5641063|NCT00736268|COPD|copd
5641064|NCT00736268|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5641065|NCT00736255|ADHD|adhd
5641066|NCT00736255|Smoking|smoking
5641067|NCT00736242|HIV|hiv
5641068|NCT00736229|hyperglycemia|hyperglycemia
5641069|NCT00736229|acute coronary syndromes|acute coronary syndromes
5641070|NCT00736229|myocardial infarction|myocardial infarction
5641071|NCT00736216|cervical cancer|cervical cancer
5641072|NCT00736216|human papilloma virus infection|human papilloma virus infection
5641074|NCT00736203|non-smokers|non-smokers
5641075|NCT00736190|Hepatitis B|hepatitis b
5641076|NCT00736190|Hepatitis|hepatitis
5641077|NCT00736190|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5641078|NCT00736190|Tenofovir DF|tenofovir df
5641079|NCT00736190|Asian-American|asian-american
5641080|NCT00736177|IVF|ivf
5641081|NCT00736177|blastocyst transfer|blastocyst transfer
5641082|NCT00736177|endometrium|endometrium
5641083|NCT00736177|embryo cryopreservation|embryo cryopreservation
5641084|NCT00736164|stage I prostate cancer|stage i prostate cancer
5641085|NCT00736164|stage II prostate cancer|stage ii prostate cancer
5641086|NCT00736164|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5641087|NCT00736125|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5641088|NCT00736125|total knee arthroplasty|total knee arthroplasty
5641089|NCT00736125|cerebral emboli|cerebral emboli
5641090|NCT00736125|carbon dioxide lavage|carbon dioxide lavage
5641091|NCT00736125|pulsatile saline lavage|pulsatile saline lavage
5641092|NCT00736112|Food Allergy in Children|food allergy in children
5641093|NCT00736112|Otitis Media with Effusion (OME)|otitis media with effusion (ome)
5641096|NCT00736112|Food Allergy and Otitis Media with Effusion|food allergy and otitis media with effusion
5641097|NCT00736112|Recurrent middle ear fluid in children <4 years old|recurrent middle ear fluid in children <4 years old
5641098|NCT00736112|Chronic ear infections in children <4 years old|chronic ear infections in children <4 years old
5641099|NCT00736086|femoral artery|femoral artery
5641100|NCT00736086|post-percutaneous cardiac catheterization|post-percutaneous cardiac catheterization
5641101|NCT00736086|post-percutaneous peripheral vascular catheterization|post-percutaneous peripheral vascular catheterization
5641102|NCT00736086|post-percutaneous diagnostic catheterization|post-percutaneous diagnostic catheterization
5641103|NCT00736086|early ambulation|early ambulation
5641104|NCT00736086|vascular closure|vascular closure
5641105|NCT00736073|pancreatitis|pancreatitis
5641106|NCT00736060|Fever|fever
5641107|NCT00736060|Blood cultures|blood cultures
5641108|NCT00736047|Smokers|smokers
5641109|NCT00736047|smoking cessation|smoking cessation
5641110|NCT00736047|vaccine|vaccine
5641111|NCT00736047|antibodies|antibodies
5641112|NCT00736047|anti-nicotine|anti-nicotine
5641113|NCT00736034|Age Associated Memory Impairment|age associated memory impairment
5641114|NCT00736021|PTSD|ptsd
5641115|NCT00736021|Pharmacological Treatment|pharmacological treatment
5641116|NCT00736021|SSRI|ssri
5641117|NCT00736021|Escitalopram|escitalopram
5641118|NCT00736021|Anxiety Disorders|anxiety disorders
5641119|NCT00736008|Factor V Leiden|factor v leiden
5641120|NCT00736008|Prothrombin Mutation|prothrombin mutation
5641121|NCT00736008|Hypercoagulability|hypercoagulability
5641122|NCT00736008|Pediatrics|pediatrics
5641123|NCT00735969|Non-Responder|non-responder
5641124|NCT00735969|Relapser|relapser
5641125|NCT00735969|High Dose Ribavirin|high dose ribavirin
5641126|NCT00735969|Peginterferon|peginterferon
5641127|NCT00735969|Chronic Hepatitis C|chronic hepatitis c
5641128|NCT00735956|Screening|screening
5641129|NCT00735956|Brief Intervention|brief intervention
5641130|NCT00735943|Pegaptanib|pegaptanib
5641131|NCT00735943|macular degeneration|macular degeneration
5641492|NCT00734864|Dasatinib|dasatinib
5641132|NCT00735943|vascular endothelial growth factor|vascular endothelial growth factor
5641133|NCT00735904|AG-013736|ag-013736
5641134|NCT00735904|axitinib|axitinib
5641135|NCT00735904|cisplatin|cisplatin
5641136|NCT00735904|gemcitabine|gemcitabine
5641137|NCT00735904|NSCLC|nsclc
5641138|NCT00735904|squamous cell|squamous cell
5641139|NCT00735904|lung cancer|lung cancer
5641140|NCT00735878|Lung Cancer|lung cancer
5641144|NCT00735865|Punctal Occlusion|punctal occlusion
5641145|NCT00735865|Punctal Plugs|punctal plugs
5641146|NCT00735865|Tear Drainage duct blockage|tear drainage duct blockage
5641147|NCT00735852|endometriosis|endometriosis
5641148|NCT00735852|chronic cyclical pelvic pain|chronic cyclical pelvic pain
5641149|NCT00735826|resectable|resectable
5641150|NCT00735826|stage I-III|stage i-iii
5641151|NCT00735826|NSCLC|nsclc
5641152|NCT00735826|vorinostat|vorinostat
5641153|NCT00735826|esophagus|esophagus
5641154|NCT00735826|head and neck|head and neck
5641155|NCT00735826|proof of principle|proof of principle
5641156|NCT00735813|Catheterization, Central|catheterization, central
5641157|NCT00735813|Catheterization, Peripheral|catheterization, peripheral
5641158|NCT00735813|Infection|infection
5641159|NCT00735813|Methods|methods
5641160|NCT00735813|Sepsis|sepsis
5641161|NCT00735813|Microscopy, Electron, Scanning|microscopy, electron, scanning
5641162|NCT00735813|Sonication|sonication
5641163|NCT00735813|Taurolidine|taurolidine
5641164|NCT00735813|Catheters, Indwelling|catheters, indwelling
5641165|NCT00735813|Pediatrics|pediatrics
5641166|NCT00735800|Dementia|dementia
5641167|NCT00735800|Caregivers|caregivers
5641168|NCT00735800|Alzheimer's disease|alzheimer's disease
5641169|NCT00735774|Healthy volunteer study|healthy volunteer study
5641170|NCT00735748|Patients who will undergo a general anesthesia for a procedure in short stay|patients who will undergo a general anesthesia for a procedure in short stay
5641171|NCT00735735|low back pain|low back pain
5641173|NCT00735735|Substance P|substance p
5641176|NCT00735709|Depression|depression
5641177|NCT00735709|Depressive Disorder|depressive disorder
5641178|NCT00735709|Mood Disorder|mood disorder
5641179|NCT00735709|Mental Disorder|mental disorder
5641180|NCT00735709|Melancholia, Involutional|melancholia, involutional
5641181|NCT00735709|Paraphrenia, Involutional|paraphrenia, involutional
5641182|NCT00735709|Drug Therapy|drug therapy
5641183|NCT00735696|Non Small Cell Lung Cancer|non small cell lung cancer
5641184|NCT00735696|Lung|lung
5641185|NCT00735696|NSCLC|nsclc
5641186|NCT00735683|Weight loss|weight loss
5641187|NCT00735683|Weight-loss drugs|weight-loss drugs
5641188|NCT00735683|Obesity|obesity
5641189|NCT00735683|Overweight|overweight
5641190|NCT00735683|Body weight|body weight
5641191|NCT00735683|Diet|diet
5641192|NCT00735683|Metabolic Disorder|metabolic disorder
5641193|NCT00735683|Nutrition Disorder|nutrition disorder
5641194|NCT00735670|SCI|sci
5641195|NCT00735657|Efficiency|efficiency
5641196|NCT00735657|Pars|pars
5641197|NCT00735657|Plana|plana
5641198|NCT00735657|Vitrectomy|vitrectomy
5641199|NCT00735644|Japanese encephalitis, Hepatitis A, Inactivated Mouse-Brain|japanese encephalitis, hepatitis a, inactivated mouse-brain
5641200|NCT00735631|Patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.|patients entering the post-operative cardiac intensive care unit following coronary artery reconstruction surgery.
5641201|NCT00735618|Advanced Cancer|advanced cancer
5641202|NCT00735618|Cancer Patients|cancer patients
5641203|NCT00735618|Relaxation Therapy|relaxation therapy
5641204|NCT00735618|Relaxation and Heart Rate Variability|relaxation and heart rate variability
5641205|NCT00735618|Guided Relaxation|guided relaxation
5641206|NCT00735618|HRV|hrv
5641207|NCT00735618|Stress, Anxiety, and Panic Disorder|stress, anxiety, and panic disorder
5641208|NCT00735605|obstructed defecation|obstructed defecation
5641209|NCT00735605|constipation|constipation
5641210|NCT00735605|puborectalis|puborectalis
5641211|NCT00735592|X rays findings|x rays findings
5641212|NCT00735579|major abdominal surgery|major abdominal surgery
5641213|NCT00735579|coagulation|coagulation
5641214|NCT00735579|extracellular matrix proteins|extracellular matrix proteins
5641215|NCT00735579|wound healing after major abdominal surgery|wound healing after major abdominal surgery
5641216|NCT00735566|gastric cancer|gastric cancer
5641217|NCT00735566|antiangiogenic factors|antiangiogenic factors
5641218|NCT00735566|TNM stage|tnm stage
5641219|NCT00735553|Uterine Fibroids|uterine fibroids
5641220|NCT00735527|seizures|seizures
5641221|NCT00735527|status epilepticus|status epilepticus
5641222|NCT00735527|lorazepam|lorazepam
5641223|NCT00735527|intra-nasal|intra-nasal
5641224|NCT00735514|radiation toxicity|radiation toxicity
5641225|NCT00735514|sexuality and reproductive issues|sexuality and reproductive issues
5641226|NCT00735514|stage I endometrial carcinoma|stage i endometrial carcinoma
5641227|NCT00735514|stage II endometrial carcinoma|stage ii endometrial carcinoma
5641228|NCT00735514|stage IB cervical cancer|stage ib cervical cancer
5641229|NCT00735514|stage IIA cervical cancer|stage iia cervical cancer
5641230|NCT00735514|stage IIB cervical cancer|stage iib cervical cancer
5641231|NCT00735514|stage III cervical cancer|stage iii cervical cancer
5641232|NCT00735488|Thalassemia|thalassemia
5641233|NCT00735488|Sickle cell anemia|sickle cell anemia
5641234|NCT00735488|Carrier detection|carrier detection
5641235|NCT00735488|Prenatal Diagnosis|prenatal diagnosis
5641236|NCT00735488|Genetic counseling|genetic counseling
5641237|NCT00735462|external genital warts|external genital warts
5641238|NCT00735462|perianal warts|perianal warts
5641239|NCT00735462|condylomata acuminata|condylomata acuminata
5641240|NCT00735462|human papilloma virus|human papilloma virus
5641241|NCT00735462|HPV types 6 and 11|hpv types 6 and 11
5641242|NCT00735436|Malignant glioma|malignant glioma
5641243|NCT00735436|Glioblastoma multiforme|glioblastoma multiforme
5641245|NCT00735436|Gliosarcoma|gliosarcoma
5641246|NCT00735436|Gliadel|gliadel
5641247|NCT00735436|Carmustine|carmustine
5641248|NCT00735436|Irinotecan|irinotecan
5641249|NCT00735436|CPT-11|cpt-11
5641250|NCT00735436|Camptosar|camptosar
5641251|NCT00735436|Avastin|avastin
5641252|NCT00735436|Bevacizumab|bevacizumab
5641253|NCT00735423|Healthy children|healthy children
5641254|NCT00735423|Brain Function|brain function
5641255|NCT00735423|Diet|diet
5641256|NCT00735423|Nutrition|nutrition
5641257|NCT00735423|Language|language
5641258|NCT00735423|fMRI|fmri
5641259|NCT00735423|ERP|erp
5641260|NCT00735423|Behavior|behavior
5641261|NCT00735410|Influenza vaccine|influenza vaccine
5641262|NCT00735410|Seasonal|seasonal
5641263|NCT00735410|Split|split
5641264|NCT00735397|Partial onset seizures|partial onset seizures
5641265|NCT00735384|sepsis|sepsis
5641266|NCT00735384|critical illness|critical illness
5641267|NCT00735384|muscle, skeletal|muscle, skeletal
5641268|NCT00735384|myopathy|myopathy
5641269|NCT00735384|isometric contraction|isometric contraction
5641270|NCT00735384|intensive care units|intensive care units
5641271|NCT00735384|torque|torque
5641272|NCT00735384|muscular atrophy|muscular atrophy
5641273|NCT00735384|malignant hyperthermia|malignant hyperthermia
5641274|NCT00735384|skin resistance|skin resistance
5641275|NCT00735358|gastric variceal bleeding|gastric variceal bleeding
5641276|NCT00735358|cyanoacrylate|cyanoacrylate
5641277|NCT00735358|rebleeding|rebleeding
5641278|NCT00735358|complication|complication
5641279|NCT00735358|survival|survival
5641280|NCT00735358|acute gastric variceal bleeding|acute gastric variceal bleeding
5641281|NCT00735345|Esophageal cancer|esophageal cancer
5641282|NCT00735345|Pre-operative|pre-operative
5641283|NCT00735345|Chemo-immunotherapy|chemo-immunotherapy
5641284|NCT00735345|Radiochemo-immunotherapy|radiochemo-immunotherapy
5641285|NCT00735345|EGFR|egfr
5641286|NCT00735345|Radiosensitivity|radiosensitivity
5641287|NCT00735345|Resection|resection
5641288|NCT00735332|Melanoma|melanoma
5641289|NCT00735332|Metastatic Melanoma|metastatic melanoma
5641290|NCT00735332|Phase II|phase ii
5641291|NCT00735332|Skin Cancer|skin cancer
5641292|NCT00735319|Neonatal Jaundice|neonatal jaundice
5641293|NCT00735319|Physiological Neonatal Jaundice|physiological neonatal jaundice
5641294|NCT00735319|Neonatal Hyperbilirubinemia|neonatal hyperbilirubinemia
5641295|NCT00735319|Transcutaneous Bilirubinometer|transcutaneous bilirubinometer
5641296|NCT00735306|Locally advanced|locally advanced
5641297|NCT00735306|Unresectable|unresectable
5641298|NCT00735293|hyperhidrosis|hyperhidrosis
5641299|NCT00735293|bromidrosis|bromidrosis
5641300|NCT00735293|bromhidrosis|bromhidrosis
5641301|NCT00735293|osmidrosis|osmidrosis
5641302|NCT00735293|hircismus|hircismus
5641303|NCT00735293|excessive|excessive
5641304|NCT00735293|underarm|underarm
5641305|NCT00735293|sweat|sweat
5641306|NCT00735293|perspiration|perspiration
5641307|NCT00735293|Body Odor|body odor
5641308|NCT00735280|Coronary artery disease, stent, heparin|coronary artery disease, stent, heparin
5641309|NCT00735267|Generalized Anxiety Disorder|generalized anxiety disorder
5641310|NCT00735254|post|post
5641311|NCT00735254|surgical|surgical
5641312|NCT00735241|colon cancer|colon cancer
5641313|NCT00735241|colorectal cancer|colorectal cancer
5641314|NCT00735241|liver metastases|liver metastases
5641315|NCT00735241|SIR-Spheres Microspheres|sir-spheres microspheres
5641316|NCT00735241|yttrium-90|yttrium-90
5641317|NCT00735241|FOLFOX|folfox
5641318|NCT00735241|Bevacizumab|bevacizumab
5641319|NCT00735241|chemo-radiation|chemo-radiation
5641320|NCT00735228|surgery|surgery
5641321|NCT00735228|artificial pancreas|artificial pancreas
5641322|NCT00735228|tight glycemic control|tight glycemic control
5641323|NCT00735228|Liver|liver
5641324|NCT00735215|Breast cancer,|breast cancer,
5641325|NCT00735215|fulvestrant,|fulvestrant,
5641326|NCT00735215|postmenopausal,|postmenopausal,
5641327|NCT00735215|women|women
5641328|NCT00735215|locally advanced,|locally advanced,
5641329|NCT00735215|hormone receptor-positive.|hormone receptor-positive.
5641330|NCT00735189|warfarin|warfarin
5641331|NCT00735189|anticoagulation|anticoagulation
5641332|NCT00735189|anticoagulation clinics|anticoagulation clinics
5641333|NCT00735176|Radiculopathy, cervical|radiculopathy, cervical
5641493|NCT00734864|Sprycel|sprycel
5641336|NCT00735176|Intervertebral Disk Displacement|intervertebral disk displacement
5641338|NCT00735176|Spinal Osteophytosis|spinal osteophytosis
5641339|NCT00735176|Arthroplasty, replacement|arthroplasty, replacement
5641340|NCT00735176|Diskectomy|diskectomy
5641342|NCT00735163|algorithm|algorithm
5641343|NCT00735163|tight glycemic control|tight glycemic control
5641344|NCT00735163|glucose control|glucose control
5641345|NCT00735163|intensive care|intensive care
5641346|NCT00735163|insulin|insulin
5641347|NCT00735163|ICU|icu
5641348|NCT00735150|Breast|breast
5641349|NCT00735150|Ovary|ovary
5641350|NCT00735150|Mutation carrier|mutation carrier
5641351|NCT00735137|Twins|twins
5641352|NCT00735137|Short cervix|short cervix
5641353|NCT00735137|Preterm birth|preterm birth
5641354|NCT00735137|Vaginal pessary|vaginal pessary
5641355|NCT00735124|analgesia requirement and post operative pain|analgesia requirement and post operative pain
5641356|NCT00735111|QOL|qol
5641357|NCT00735111|Quality of Life|quality of life
5641358|NCT00735111|KPS|kps
5641359|NCT00735111|Karnofsky Performance Status|karnofsky performance status
5641360|NCT00735111|Cancer|cancer
5641361|NCT00735098|Knee Osteoarthritis|knee osteoarthritis
5641362|NCT00735098|arthritis|arthritis
5641363|NCT00735085|Brain Injury|brain injury
5641364|NCT00735072|HIV infection|hiv infection
5641365|NCT00735072|T cell activation|t cell activation
5641366|NCT00735072|Antiretroviral Therapy|antiretroviral therapy
5641367|NCT00735072|CCR5|ccr5
5641368|NCT00735072|Maraviroc|maraviroc
5641369|NCT00735059|dialysis membrane|dialysis membrane
5641370|NCT00735059|Polynephron|polynephron
5641371|NCT00735059|Elisio H|elisio h
5641372|NCT00735059|Polyethersulfone|polyethersulfone
5641373|NCT00735059|Diapes|diapes
5641374|NCT00735059|PES-DS|pes-ds
5641375|NCT00735059|online post-dilution hemodiafiltration|online post-dilution hemodiafiltration
5641376|NCT00735059|hemodialysis|hemodialysis
5641377|NCT00735059|protein-bound toxins|protein-bound toxins
5641378|NCT00735059|beta-2-microglobulin|beta-2-microglobulin
5641379|NCT00735059|hemodialysis patients|hemodialysis patients
5641380|NCT00735046|Early dementia in Alzheimer's disease (MMSE ≥ 21)|early dementia in alzheimer's disease (mmse ≥ 21)
5641381|NCT00735033|Physical therapy|physical therapy
5641382|NCT00735033|Physical therapy modalities|physical therapy modalities
5641383|NCT00735033|Cerebral Vascular Accident (CVA)|cerebral vascular accident (cva)
5641384|NCT00735020|influenza|influenza
5641385|NCT00735020|vaccine|vaccine
5641386|NCT00735020|adjuvants|adjuvants
5641387|NCT00735020|flu|flu
5641388|NCT00735007|Multiple Sclerosis|multiple sclerosis
5626049|NCT00795457|vaccine|vaccine
5641389|NCT00734968|Urinary tract infection (UTI)|urinary tract infection (uti)
5641390|NCT00734968|suburethral sling|suburethral sling
5641391|NCT00734968|Prevention|prevention
5641392|NCT00734968|Nitrofurantoin|nitrofurantoin
5641393|NCT00734968|Prophylaxis|prophylaxis
5641397|NCT00734942|young carers|young carers
5641398|NCT00734942|family support|family support
5641399|NCT00734942|children (up to the age of 18) of chronically ill parents|children (up to the age of 18) of chronically ill parents
5641401|NCT00734929|nausea|nausea
5641402|NCT00734929|emesis|emesis
5641403|NCT00734929|antiemetics|antiemetics
5641404|NCT00734929|aprepitant|aprepitant
5641405|NCT00734929|ondansetron|ondansetron
5641406|NCT00734929|dexamethasone|dexamethasone
5641407|NCT00734916|total parenteral nutrition|total parenteral nutrition
5641408|NCT00734916|infections|infections
5641409|NCT00734916|Infectious complications related to parenteral nutrition|infectious complications related to parenteral nutrition
5641410|NCT00734903|Women|women
5641411|NCT00734903|Substance Use Disorders|substance use disorders
5641412|NCT00734903|Treatment Efficacy|treatment efficacy
5641413|NCT00734903|Women's Health|women's health
5641414|NCT00734903|Outcome Assessment (Health Care)|outcome assessment (health care)
5641415|NCT00734890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5641416|NCT00734890|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5641417|NCT00734890|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5641418|NCT00734890|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5641419|NCT00734890|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5641420|NCT00734890|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5641421|NCT00734890|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5641422|NCT00734890|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5641423|NCT00734890|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5641424|NCT00734890|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5641425|NCT00734890|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5641426|NCT00734890|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5641427|NCT00734890|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5641428|NCT00734890|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5641429|NCT00734890|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5641430|NCT00734890|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5641431|NCT00734890|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5635159|NCT00757536|primary vitrectomy|primary vitrectomy
5641432|NCT00734890|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5641433|NCT00734890|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5641434|NCT00734890|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5641435|NCT00734890|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5641436|NCT00734890|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5641437|NCT00734890|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5641438|NCT00734890|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5641439|NCT00734890|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5641440|NCT00734890|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5641441|NCT00734890|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5641442|NCT00734890|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5641443|NCT00734890|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5641444|NCT00734890|Waldenström macroglobulinemia|waldenström macroglobulinemia
5641445|NCT00734890|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5641446|NCT00734890|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5641447|NCT00734890|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5641448|NCT00734890|intraocular lymphoma|intraocular lymphoma
5641449|NCT00734890|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5641450|NCT00734890|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5641451|NCT00734890|small intestine lymphoma|small intestine lymphoma
5641452|NCT00734890|adenocarcinoma of the lung|adenocarcinoma of the lung
5641453|NCT00734890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5641454|NCT00734890|large cell lung cancer|large cell lung cancer
5641455|NCT00734890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5641456|NCT00734890|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5641457|NCT00734890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5641458|NCT00734890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5641459|NCT00734890|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5641460|NCT00734890|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5641461|NCT00734890|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5641462|NCT00734890|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5641463|NCT00734890|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5641464|NCT00734890|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5641465|NCT00734890|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5641466|NCT00734890|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5641467|NCT00734890|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5641468|NCT00734890|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5641469|NCT00734890|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5641470|NCT00734890|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5641471|NCT00734890|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5641472|NCT00734890|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5641473|NCT00734890|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5641474|NCT00734890|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5641475|NCT00734890|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5641476|NCT00734890|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5641477|NCT00734890|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5641478|NCT00734890|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5641479|NCT00734890|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5671716|NCT00614666|nikkomycin Z|nikkomycin z
5641480|NCT00734890|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5641481|NCT00734890|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5641482|NCT00734890|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5641483|NCT00734890|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5641484|NCT00734890|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5641485|NCT00734890|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5641486|NCT00734890|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5641487|NCT00734890|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5641488|NCT00734890|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5641489|NCT00734890|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5641490|NCT00734890|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5641491|NCT00734890|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5641494|NCT00734864|Temozolomide|temozolomide
5641495|NCT00734864|Temodar|temodar
5641496|NCT00734864|Recurrent Malignant Glioma|recurrent malignant glioma
5641497|NCT00734864|Malignant Glioma|malignant glioma
5641498|NCT00734864|glioblastoma multiforme|glioblastoma multiforme
5641499|NCT00734864|gliosarcoma|gliosarcoma
5641500|NCT00734864|anaplastic astrocytoma|anaplastic astrocytoma
5641501|NCT00734864|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5641502|NCT00734864|anaplastic mixed glioma|anaplastic mixed glioma
5641503|NCT00734864|glioma|glioma
5641504|NCT00734851|prostate cancer|prostate cancer
5641505|NCT00734851|sunitinib|sunitinib
5641506|NCT00734851|docetaxel|docetaxel
5641508|NCT00734851|radiation|radiation
5641509|NCT00734851|PSA recurrence|psa recurrence
5641510|NCT00734851|No metastatic disease|no metastatic disease
5641511|NCT00734838|Breast Cancer|breast cancer
5641512|NCT00734838|Breast Biopsy|breast biopsy
5641513|NCT00734838|Reduction mammoplasty|reduction mammoplasty
5641514|NCT00734825|Appendicitis|appendicitis
5641515|NCT00734825|IV Contrast|iv contrast
5641516|NCT00734825|Oral Contrast|oral contrast
5641517|NCT00734825|CT scan|ct scan
5641518|NCT00734812|Hysterectomy|hysterectomy
5641519|NCT00734812|Laparoscopic|laparoscopic
5641520|NCT00734799|Posttraumatic Stress Disorder|posttraumatic stress disorder
5641521|NCT00734799|Insomnia,|insomnia,
5641522|NCT00734799|Imagery Rehearsal Therapy,|imagery rehearsal therapy,
5641523|NCT00734799|IRT,|irt,
5641524|NCT00734799|Cognitive Behavioral Therapy for Insomnia,|cognitive behavioral therapy for insomnia,
5641525|NCT00734799|CBTI.|cbti.
5641526|NCT00734786|gonyautoxin|gonyautoxin
5641527|NCT00734773|neurotoxicity|neurotoxicity
5641528|NCT00734773|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5641529|NCT00734773|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5641530|NCT00734760|patient education|patient education
5641531|NCT00734760|acute coronary syndrome|acute coronary syndrome
5641532|NCT00734760|prehospital delay to treatment|prehospital delay to treatment
5641534|NCT00734747|Gastroesophageal Reflux|gastroesophageal reflux
5641535|NCT00734747|Fundoplication|fundoplication
5641536|NCT00734747|Endoluminal|endoluminal
5641537|NCT00734747|Gastroesophageal Flap Valve|gastroesophageal flap valve
5641538|NCT00734734|Prophylaxis of Influenza|prophylaxis of influenza
5641539|NCT00734734|Influenza Vaccines|influenza vaccines
5641540|NCT00734734|MF59C.1|mf59c.1
5641541|NCT00734721|intravitreal injection|intravitreal injection
5641542|NCT00734695|BURN|burn
5641543|NCT00734695|EYE|eye
5641544|NCT00734695|VITAMIN C|vitamin c
5641545|NCT00734695|ASCORBIC ACID|ascorbic acid
5641546|NCT00734682|Glioblastoma|glioblastoma
5641547|NCT00734682|Gliosarcoma|gliosarcoma
5641548|NCT00734682|Anaplastic Astrocytoma|anaplastic astrocytoma
5641549|NCT00734682|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
5641550|NCT00734682|Anaplastic Mixed Oligoastrocytoma|anaplastic mixed oligoastrocytoma
5641551|NCT00734682|Malignant Astrocytoma NOS|malignant astrocytoma nos
5641552|NCT00734682|Nanoliposomal CPT-11|nanoliposomal cpt-11
5641554|NCT00734669|Diabetes|diabetes
5641555|NCT00734669|Hypoglycemia|hypoglycemia
5641556|NCT00734656|steroid 5Alpha Reductase|steroid 5alpha reductase
5641557|NCT00734656|dutasteride|dutasteride
5641558|NCT00734656|neuroactive steroid|neuroactive steroid
5641559|NCT00734643|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5641560|NCT00734643|Family coping|family coping
5641561|NCT00734643|Complex Congenital Heart Disease|complex congenital heart disease
5641562|NCT00734630|nebivolol|nebivolol
5641563|NCT00734630|Bystolic ™|bystolic ™
5641564|NCT00734630|lisinopril|lisinopril
5641565|NCT00734630|losartan|losartan
5641566|NCT00734630|Hypertension|hypertension
5641567|NCT00734617|Cigarette|cigarette
5641568|NCT00734617|Nicotine|nicotine
5641569|NCT00734591|Observational Study Exubera|observational study exubera
5641570|NCT00734565|vaccine|vaccine
5641571|NCT00734565|prevention|prevention
5641572|NCT00734565|haemophilus influenzae type b|haemophilus influenzae type b
5641573|NCT00734565|children|children
5641574|NCT00734552|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5641575|NCT00734552|α-Keto Acid|α-keto acid
5641576|NCT00734552|Low Protein Diet|low protein diet
5641577|NCT00734552|Residual Renal Function|residual renal function
5641578|NCT00734539|Candida|candida
5641579|NCT00734539|Neonate|neonate
5641580|NCT00734539|Fluconazole|fluconazole
5641581|NCT00734539|Prophylaxis|prophylaxis
5641582|NCT00734539|Colonization|colonization
5641583|NCT00734539|Resistance|resistance
5641584|NCT00734526|Glioblastoma|glioblastoma
5641585|NCT00734526|Gliosarcoma|gliosarcoma
5641586|NCT00734526|Brain Cancer|brain cancer
5641587|NCT00734526|Sorafenib|sorafenib
5641588|NCT00734526|Temozolomide|temozolomide
5641589|NCT00734526|Radiation|radiation
5641590|NCT00734526|Radiotherapy|radiotherapy
5641591|NCT00734526|XRT|xrt
5641592|NCT00734513|GI Cancer|gi cancer
5641593|NCT00734513|Emotional Disclosure|emotional disclosure
5641998|NCT00732992|neoplasms|neoplasms
5641594|NCT00734513|Behavioral Intervention|behavioral intervention
5641595|NCT00734513|Partner|partner
5641596|NCT00734513|Couples|couples
5641597|NCT00734487|Spectral Domain Optical Coherence Tomography|spectral domain optical coherence tomography
5641598|NCT00734487|Optical Coherence Tomography|optical coherence tomography
5641599|NCT00734487|AREDS2|areds2
5641601|NCT00734487|Age-related macular degeneration|age-related macular degeneration
5641602|NCT00734487|Drusen|drusen
5641603|NCT00734474|Diabetes, type 2 diabetes|diabetes, type 2 diabetes
5641604|NCT00734461|Non-physically dependent subjects|non-physically dependent subjects
5641605|NCT00734461|history of opioid abuse|history of opioid abuse
5641606|NCT00734448|gestational diabetes mellitus|gestational diabetes mellitus
5641607|NCT00734448|carbohydrate intolerance|carbohydrate intolerance
5641608|NCT00734448|myo-inositol|myo-inositol
5641609|NCT00734448|insulin resistance|insulin resistance
5641610|NCT00734435|schizophrenia|schizophrenia
5641611|NCT00734435|schizophreniform|schizophreniform
5641612|NCT00734435|schizoaffective disorder|schizoaffective disorder
5641613|NCT00734435|Zyprexa|zyprexa
5641614|NCT00734435|olanzapine|olanzapine
5641615|NCT00734422|Phobic Disorders (Fear of Flying)|phobic disorders (fear of flying)
5641616|NCT00734422|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5641617|NCT00734422|Fear extinction|fear extinction
5641618|NCT00734422|Yohimbine|yohimbine
5641619|NCT00734409|Mechanical ventilation|mechanical ventilation
5641620|NCT00734409|Human|human
5641621|NCT00734409|conscious sedation|conscious sedation
5641622|NCT00734409|bispectral index|bispectral index
5641623|NCT00734409|monitoring|monitoring
5641624|NCT00734409|critical care|critical care
5641625|NCT00734409|propofol|propofol
5641626|NCT00734396|Mesenchymal stem cells|mesenchymal stem cells
5641627|NCT00734396|Allograft rejection|allograft rejection
5641628|NCT00734396|Subclinical rejection|subclinical rejection
5641629|NCT00734383|coronary artery bypass surgery|coronary artery bypass surgery
5641630|NCT00734383|coronary artery bypass grafting|coronary artery bypass grafting
5641631|NCT00734383|cardiopulmonary bypass|cardiopulmonary bypass
5641633|NCT00734383|myocardial injury markers,|myocardial injury markers,
5641634|NCT00734383|sex differences|sex differences
5641635|NCT00734383|cardiac anesthesia|cardiac anesthesia
5641636|NCT00734383|inhalational anesthetics|inhalational anesthetics
5641637|NCT00734370|Panic Disorder and Agoraphobia|panic disorder and agoraphobia
5641638|NCT00734370|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5641639|NCT00734357|contrast|contrast
5641640|NCT00734357|ct|ct
5641641|NCT00734357|cat scan|cat scan
5641642|NCT00734357|kidney|kidney
5641643|NCT00734357|nephrotoxicity|nephrotoxicity
5641644|NCT00734357|Computerized Emission Tomography|computerized emission tomography
5641645|NCT00734331|inflammatory bowel disease|inflammatory bowel disease
5641646|NCT00734331|micro RNA|micro rna
5641647|NCT00734331|cholinergic tone|cholinergic tone
5641648|NCT00734331|inflammation|inflammation
5641649|NCT00734318|Severe asthma|severe asthma
5641650|NCT00734318|Fluticasone|fluticasone
5641651|NCT00734318|Formoterol|formoterol
5641652|NCT00734305|cancer, solid tumors, oncology, Phase I, ErbB3, HER3|cancer, solid tumors, oncology, phase i, erbb3, her3
5641653|NCT00734305|(erbB-3, HER-3)|(erbb-3, her-3)
5641654|NCT00734292|Asthma|asthma
5641655|NCT00734292|Asthma Mild to Moderate|asthma mild to moderate
5641656|NCT00734279|Puberty|puberty
5641657|NCT00734279|Delayed|delayed
5641658|NCT00734279|Early|early
5641659|NCT00734279|Precocious|precocious
5641660|NCT00734279|Peripubertal|peripubertal
5641661|NCT00734279|Gonadotropin|gonadotropin
5641662|NCT00734279|FSH|fsh
5641663|NCT00734279|LH|lh
5641664|NCT00734266|COPD|copd
5641665|NCT00734266|CPB|cpb
5641666|NCT00734266|Leukotrienes|leukotrienes
5641667|NCT00734253|Nephropathy|nephropathy
5641668|NCT00734253|Kidney Disease|kidney disease
5641669|NCT00734253|Diabetes|diabetes
5641670|NCT00734253|Pyridoxamine|pyridoxamine
5641671|NCT00734253|Pyridorin|pyridorin
5641672|NCT00734253|NephroGenex|nephrogenex
5641673|NCT00734253|PYR-210|pyr-210
5641674|NCT00734227|Survival and control of hemorrhage|survival and control of hemorrhage
5641675|NCT00734214|Parenteral Fluids|parenteral fluids
5641676|NCT00734214|Isotonic|isotonic
5641677|NCT00734214|Hypotonic|hypotonic
5641678|NCT00734214|Pediatric|pediatric
5641679|NCT00734214|Fluid overload|fluid overload
5641680|NCT00734201|Study effects on blood pressure and weight in obese subjects|study effects on blood pressure and weight in obese subjects
5641681|NCT00734175|Vaccine|vaccine
5641682|NCT00734175|Influenza|influenza
5641683|NCT00734162|tenofovir|tenofovir
5641684|NCT00734162|adolescents|adolescents
5641685|NCT00734162|chronic hepatitis B|chronic hepatitis b
5641686|NCT00734149|Multiple myeloma|multiple myeloma
5641687|NCT00734136|Angiogenic Factors|angiogenic factors
5641688|NCT00734136|Hepatorenal Syndrome|hepatorenal syndrome
5641689|NCT00734136|Liver Disease|liver disease
5641690|NCT00734136|Renal Failure|renal failure
5641691|NCT00734136|Liver Cirrhosis|liver cirrhosis
5641692|NCT00734136|Ascites|ascites
5641693|NCT00734123|Atherosclerosis|atherosclerosis
5641695|NCT00734123|Carotid Intima-Media Thickness|carotid intima-media thickness
5641697|NCT00734110|Arthroplasty, Replacement, Knee, P.F.C. Sigma RPF, Sigma RP|arthroplasty, replacement, knee, p.f.c. sigma rpf, sigma rp
5641698|NCT00734097|heartburn|heartburn
5641699|NCT00734097|reflux|reflux
5641700|NCT00734097|proton|proton
5641701|NCT00734097|pump|pump
5641702|NCT00734097|inhibitor|inhibitor
5641704|NCT00734084|Knee|knee
5641705|NCT00734084|UKA|uka
5641706|NCT00734084|Partial|partial
5641707|NCT00734084|Preservation|preservation
5641708|NCT00734071|Generalized Anxiety Disorder|generalized anxiety disorder
5641709|NCT00734071|Mood Disorder|mood disorder
5641710|NCT00734071|Affective Disorder|affective disorder
5641711|NCT00734071|Anxiety Disorder|anxiety disorder
5641712|NCT00734071|Drug Therapy|drug therapy
5641713|NCT00734058|Ablation|ablation
5641714|NCT00734058|AF|af
5641715|NCT00734058|Atrial Fibrillation|atrial fibrillation
5641716|NCT00734058|Cardiac|cardiac
5641717|NCT00734058|Endocardial|endocardial
5641718|NCT00734058|Endocardium|endocardium
5641719|NCT00734058|EP|ep
5641720|NCT00734058|Electrophysiology|electrophysiology
5641721|NCT00734058|Epicardial|epicardial
5641722|NCT00734058|Epicardium|epicardium
5641723|NCT00734058|Heart|heart
5641724|NCT00734058|Interventional|interventional
5641725|NCT00734058|Lesion|lesion
5641726|NCT00734058|PVI|pvi
5641727|NCT00734058|Pulmonary Vein|pulmonary vein
5641728|NCT00734058|MAZE|maze
5641729|NCT00734058|Surgery|surgery
5641730|NCT00734058|Surgical|surgical
5641731|NCT00734058|Treatment|treatment
5641732|NCT00734058|Patients with persistent AF with 3 months duration|patients with persistent af with 3 months duration
5641733|NCT00734058|Requiring concomitant open heart surgery|requiring concomitant open heart surgery
5641734|NCT00734045|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5641735|NCT00734045|NT-proBNP|nt-probnp
5641736|NCT00734032|SB-480848|sb-480848
5641737|NCT00734032|Dyslipidaemia|dyslipidaemia
5641739|NCT00734006|Cortico-cortical|cortico-cortical
5641740|NCT00734006|connectivity|connectivity
5641741|NCT00734006|Transcranial|transcranial
5641742|NCT00734006|Magnetic|magnetic
5641743|NCT00734006|Stimulation|stimulation
5641744|NCT00733993|substance abuse|substance abuse
5641745|NCT00733993|cocaine|cocaine
5641746|NCT00733993|caffeine|caffeine
5641747|NCT00733993|impulsivity|impulsivity
5641748|NCT00733980|Depressive Disorder, Major|depressive disorder, major
5641749|NCT00733967|Methamphetamine|methamphetamine
5641750|NCT00733967|Chantix|chantix
5641751|NCT00733967|Varenicline|varenicline
5626446|NCT00793663|Sevoflurane|sevoflurane
5641752|NCT00733941|Exercise test|exercise test
5641753|NCT00733941|Running|running
5641754|NCT00733941|Arterial diameter|arterial diameter
5641755|NCT00733941|Monitoring, physiologic|monitoring, physiologic
5641756|NCT00733941|Oxygen Consumption|oxygen consumption
5641757|NCT00733928|Arthroplasty,|arthroplasty,
5641758|NCT00733928|Replacement,|replacement,
5641759|NCT00733928|Knee,|knee,
5641760|NCT00733928|P.F.C.|p.f.c.
5641761|NCT00733928|Sigma|sigma
5641762|NCT00733928|all-polyethylene|all-polyethylene
5641763|NCT00733915|Arthroplasty, knee, TKA, TKR, Duofix, Porocoat, LCS|arthroplasty, knee, tka, tkr, duofix, porocoat, lcs
5641764|NCT00733902|monoclonal antibody|monoclonal antibody
5641765|NCT00733902|RN624|rn624
5641766|NCT00733902|PF-04383119|pf-04383119
5641767|NCT00733902|nerve growth factor|nerve growth factor
5641768|NCT00733902|anti-nerve growth factor|anti-nerve growth factor
5641769|NCT00733902|OA|oa
5641770|NCT00733902|pain|pain
5641771|NCT00733889|esophageal carcinoma|esophageal carcinoma
5641772|NCT00733889|cetuximab|cetuximab
5641773|NCT00733889|docetaxel|docetaxel
5641774|NCT00733889|cisplatin|cisplatin
5641775|NCT00733889|5-fluorouracil|5-fluorouracil
5641776|NCT00733876|Acute Renal Failure Cardiac Surgery Stem Cell|acute renal failure cardiac surgery stem cell
5641777|NCT00733863|Active immunization|active immunization
5641778|NCT00733863|Alzheimer disease|alzheimer disease
5641779|NCT00733863|Antibody|antibody
5641780|NCT00733863|Central Nervous System Diseases|central nervous system diseases
5641781|NCT00733863|Neurodegenerative diseases|neurodegenerative diseases
5641782|NCT00733863|Vaccine|vaccine
5641783|NCT00733824|Plerixafor|plerixafor
5641784|NCT00733824|Lymphoma|lymphoma
5641785|NCT00733824|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5641786|NCT00733824|Transplantation, Autologous|transplantation, autologous
5641787|NCT00733824|Receptors, CXCR4|receptors, cxcr4
5641788|NCT00733811|thalassemia major|thalassemia major
5641789|NCT00733811|chelation treatment|chelation treatment
5641790|NCT00733811|secondary hemochromatosis|secondary hemochromatosis
5641791|NCT00733798|Melanoma|melanoma
5641792|NCT00733798|Malignant melanoma|malignant melanoma
5641793|NCT00733798|metastatic melanoma|metastatic melanoma
5641794|NCT00733798|Phase 1|phase 1
5641795|NCT00733798|Phase 2|phase 2
5641796|NCT00733785|Rosiglitazone XR|rosiglitazone xr
5641797|NCT00733785|Pharmacokinetics|pharmacokinetics
5641798|NCT00733785|Strength Equivalence.|strength equivalence.
5641799|NCT00733785|Alzheimers Disease|alzheimers disease
5641800|NCT00733785|Repeat dose|repeat dose
5641801|NCT00733785|Dose proportionality|dose proportionality
5641802|NCT00733772|flaxseed|flaxseed
5641803|NCT00733772|lignans|lignans
5641804|NCT00733772|alpha-Linolenic Acid|alpha-linolenic acid
5641805|NCT00733772|LDL Cholesterol|ldl cholesterol
5641806|NCT00733746|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5641807|NCT00733746|stage I pancreatic cancer|stage i pancreatic cancer
5641808|NCT00733746|stage II pancreatic cancer|stage ii pancreatic cancer
5641809|NCT00733733|kidney|kidney
5641810|NCT00733733|transplantation|transplantation
5641811|NCT00733733|non-heart-beating donor|non-heart-beating donor
5641812|NCT00733733|delayed graft function|delayed graft function
5641813|NCT00733733|Antithymocyte globulin|antithymocyte globulin
5641814|NCT00733733|ischemia-reperfusion damage|ischemia-reperfusion damage
5641815|NCT00733707|adherence|adherence
5641816|NCT00733707|oral contraceptive pills|oral contraceptive pills
5641817|NCT00733707|contraception|contraception
5641818|NCT00733707|text messaging|text messaging
5641819|NCT00733694|Arthroplasty, Replacement, Knee,LCS|arthroplasty, replacement, knee,lcs
5641820|NCT00733681|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5641821|NCT00733681|Prosthesis Failure|prosthesis failure
5641822|NCT00733681|Revision surgery|revision surgery
5641823|NCT00733668|considered|considered
5641824|NCT00733668|entry|entry
5641825|NCT00733668|into|into
5641826|NCT00733668|the study|the study
5641827|NCT00733668|SSRI|ssri
5641828|NCT00733668|Seroquel|seroquel
5641829|NCT00733668|Quetiapine|quetiapine
5641830|NCT00733668|fumarate|fumarate
5641831|NCT00733668|antipsychotic|antipsychotic
5641832|NCT00733642|antibody amyloid Alzheimer's Disease AD|antibody amyloid alzheimer's disease ad
5641833|NCT00733616|advanced gastric adenocarcinoma|advanced gastric adenocarcinoma
5641834|NCT00733616|docetaxel|docetaxel
5641835|NCT00733616|oxaliplatin|oxaliplatin
5641836|NCT00733616|capecitabine|capecitabine
5641837|NCT00733616|intermediate general status|intermediate general status
5641838|NCT00733603|Interstitial Cystitis|interstitial cystitis
5641840|NCT00733603|Painful Bladder Syndrome|painful bladder syndrome
5641841|NCT00733603|PBS|pbs
5641842|NCT00733603|Bladder Pain|bladder pain
5641843|NCT00733603|Pelvic Pain|pelvic pain
5641844|NCT00733590|defibrillator, implanted|defibrillator, implanted
5641845|NCT00733590|genomics|genomics
5641846|NCT00733590|electrocardiography|electrocardiography
5641847|NCT00733590|electrophysiological study|electrophysiological study
5641848|NCT00733590|proteomics|proteomics
5641849|NCT00733577|diabetes|diabetes
5641850|NCT00733577|pharmacodynamics|pharmacodynamics
5641851|NCT00733577|safety|safety
5641852|NCT00733577|pharmacokinetics|pharmacokinetics
5641853|NCT00733564|Local anesthetic|local anesthetic
5641854|NCT00733564|Propofol|propofol
5641855|NCT00733564|Sevoflurane|sevoflurane
5641856|NCT00733551|motilin|motilin
5641857|NCT00733551|gastric emptying|gastric emptying
5641858|NCT00733551|GSK962040|gsk962040
5641859|NCT00733551|oral dose|oral dose
5641860|NCT00733538|stage I multiple myeloma|stage i multiple myeloma
5641861|NCT00733525|Bulimia Nervosa|bulimia nervosa
5641862|NCT00733512|ReSTOR Aspheric +4 IOL|restor aspheric +4 iol
5641863|NCT00733499|Arthroplasty, replacement, Knee, LCS Duofix, Porocoat|arthroplasty, replacement, knee, lcs duofix, porocoat
5641864|NCT00733486|Arthroplasty, Replacement, Knee, LCS Complete APG (MeSH);|arthroplasty, replacement, knee, lcs complete apg (mesh);
5641865|NCT00733473|Wheezing|wheezing
5641866|NCT00733473|Acute asthma|acute asthma
5641867|NCT00733473|Children|children
5641868|NCT00733460|BFPET|bfpet
5641869|NCT00733460|Coronary Artery Disease|coronary artery disease
5641870|NCT00733460|Myocardial Perfusion Imaging|myocardial perfusion imaging
5641871|NCT00733460|Radiation Dosimetry|radiation dosimetry
5641872|NCT00733447|Biventricular failure|biventricular failure
5641873|NCT00733434|Microsurgery|microsurgery
5641874|NCT00733434|Head and neck|head and neck
5641875|NCT00733434|Prostaglandin E1|prostaglandin e1
5641876|NCT00733434|Thrombosis|thrombosis
5641877|NCT00733434|Complication|complication
5641878|NCT00733421|Day surgery|day surgery
5641879|NCT00733421|Hallux Valgus|hallux valgus
5641880|NCT00733421|Pain|pain
5641881|NCT00733421|Analgesics|analgesics
5641882|NCT00733395|Muscle pain|muscle pain
5641883|NCT00733382|migraine|migraine
5641884|NCT00733382|dexamethasone|dexamethasone
5641885|NCT00733382|dihydroergotamine|dihydroergotamine
5641886|NCT00733369|Arthroplasty|arthroplasty
5641887|NCT00733369|Replacement|replacement
5641888|NCT00733369|Knee|knee
5641889|NCT00733369|PFC Sigma RPF|pfc sigma rpf
5641890|NCT00733369|PFC Sigma RP|pfc sigma rp
5641891|NCT00733356|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5641892|NCT00733356|ADHD|adhd
5641894|NCT00733356|reading|reading
5641895|NCT00733356|brain hemodynamics|brain hemodynamics
5641896|NCT00733356|brain imaging|brain imaging
5641897|NCT00733356|attention|attention
5641898|NCT00733356|Near-Infrared Spectroscopy|near-infrared spectroscopy
5641900|NCT00733356|MSIT|msit
5641901|NCT00733343|heart failure|heart failure
5641902|NCT00733343|sleep disordered breathing|sleep disordered breathing
5641903|NCT00733343|sleep apnea|sleep apnea
5641904|NCT00733343|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5641905|NCT00733343|SBAS|sbas
5641906|NCT00733343|HF|hf
5641907|NCT00733330|Arthroplasty, Knee, TKA, TKR, CAS, minimally invasive|arthroplasty, knee, tka, tkr, cas, minimally invasive
5641908|NCT00733317|Wheezing|wheezing
5641909|NCT00733317|Acute asthma|acute asthma
5641911|NCT00733317|Budesonide|budesonide
5641912|NCT00733317|Emergency room|emergency room
5641913|NCT00733304|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5641914|NCT00733304|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5641915|NCT00733304|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5641916|NCT00733304|pazopanib|pazopanib
5641917|NCT00733304|angiogenesis|angiogenesis
5641918|NCT00733291|Daily disposable contact lenses|daily disposable contact lenses
5641919|NCT00733291|Multi-purpose disinfecting solutions|multi-purpose disinfecting solutions
5641920|NCT00733278|Postpartum contraception|postpartum contraception
5641921|NCT00733278|Copper IUD|copper iud
5641922|NCT00733265|Renal Impairment|renal impairment
5641923|NCT00733252|non-small cell lung cancer|non-small cell lung cancer
5641924|NCT00733252|small cell lung cancer|small cell lung cancer
5641925|NCT00733252|benign respiratory tract neoplasm|benign respiratory tract neoplasm
5641926|NCT00733252|lung papilloma|lung papilloma
5641927|NCT00733252|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5641928|NCT00733252|squamous lung dysplasia|squamous lung dysplasia
5641929|NCT00733252|malignant mesothelioma|malignant mesothelioma
5641930|NCT00733252|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5641931|NCT00733252|lung metastases|lung metastases
5641932|NCT00733239|methadone|methadone
5641933|NCT00733239|opioid dependence|opioid dependence
5641934|NCT00733239|opioid|opioid
5641935|NCT00733226|wheezing|wheezing
5641936|NCT00733226|asthma|asthma
5641937|NCT00733226|childhood|childhood
5641938|NCT00733226|OM-85 BV|om-85 bv
5641939|NCT00733226|Broncho-Vaxom|broncho-vaxom
5641940|NCT00733213|Prostate Cancer, Treatment alternatives, Metastasis|prostate cancer, treatment alternatives, metastasis
5641941|NCT00733200|Minor Liver Resection|minor liver resection
5641942|NCT00733200|Major Liver Resection|major liver resection
5641943|NCT00733200|Hilar|hilar
5641944|NCT00733174|IGT|igt
5641945|NCT00733161|passive leg exercise|passive leg exercise
5641946|NCT00733161|congestive heart failure|congestive heart failure
5641947|NCT00733161|endothelium-derived factors|endothelium-derived factors
5641948|NCT00733161|elderly|elderly
5641949|NCT00733148|glucose, interstitial, intensive care|glucose, interstitial, intensive care
5641950|NCT00733135|peripheral vascular disease|peripheral vascular disease
5641951|NCT00733135|atherectomy|atherectomy
5641952|NCT00733135|atherosclerosis|atherosclerosis
5641953|NCT00733135|calcified lesions|calcified lesions
5641954|NCT00733109|CIN2|cin2
5641955|NCT00733109|management|management
5641956|NCT00733096|radiculopathy|radiculopathy
5641957|NCT00733096|sciatica|sciatica
5641958|NCT00733096|low back pain|low back pain
5641959|NCT00733083|tonsillectomy|tonsillectomy
5641960|NCT00733083|paediatric|paediatric
5641961|NCT00733083|pain|pain
5641963|NCT00733083|opiates|opiates
5641964|NCT00733083|pre-emptive|pre-emptive
5641965|NCT00733083|oxycodone|oxycodone
5641966|NCT00733083|morphine|morphine
5641967|NCT00733083|dexamethasone|dexamethasone
5641968|NCT00733070|CTO|cto
5641969|NCT00733070|Chronic Total Occlusion|chronic total occlusion
5641970|NCT00733070|Revascularization|revascularization
5641971|NCT00733057|Minocycline|minocycline
5641972|NCT00733057|Schizophrenia|schizophrenia
5641973|NCT00733057|Negative symptoms|negative symptoms
5641974|NCT00733057|Cognitive|cognitive
5641975|NCT00733044|Objective tinnitus|objective tinnitus
5641976|NCT00733044|Tinnitus|tinnitus
5641977|NCT00733044|RCT|rct
5641978|NCT00733044|Specialised treatment|specialised treatment
5641979|NCT00733044|Usual care|usual care
5641980|NCT00733044|Cost-effectiveness|cost-effectiveness
5641981|NCT00733031|Phase I,|phase i,
5641982|NCT00733031|cancer,|cancer,
5641983|NCT00733031|solid tumors,|solid tumors,
5641984|NCT00733031|advanced solid malignancies,|advanced solid malignancies,
5641985|NCT00733031|dose escalation,|dose escalation,
5641986|NCT00733031|combination treatment,|combination treatment,
5641987|NCT00733031|TRK inhibitor|trk inhibitor
5641988|NCT00733018|Nutrigenomics|nutrigenomics
5641989|NCT00733018|Gene Expression|gene expression
5641990|NCT00733018|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5641991|NCT00733018|Life Style|life style
5641992|NCT00733018|Health Behavior|health behavior
5641993|NCT00732992|Solid tumor|solid tumor
5641994|NCT00732992|malignancy|malignancy
5641995|NCT00732992|sunitinib|sunitinib
5641996|NCT00732992|pemetrexed|pemetrexed
5641997|NCT00732992|phase 1|phase 1
5641999|NCT00732979|Elective|elective
5642000|NCT00732979|hepatic|hepatic
5642001|NCT00732979|resection|resection
5642002|NCT00732979|due to any|due to any
5642003|NCT00732979|reason.|reason.
5642004|NCT00732966|cyp2c9|cyp2c9
5642005|NCT00732966|losartan|losartan
5642006|NCT00732966|pharmacogenetics|pharmacogenetics
5642007|NCT00732966|pharmacokinetics|pharmacokinetics
5642008|NCT00732966|pharmacodynamics|pharmacodynamics
5642009|NCT00732953|patients with coronary artery disease|patients with coronary artery disease
5642010|NCT00732953|percutaneous coronary intervention|percutaneous coronary intervention
5642011|NCT00732953|stent implantation|stent implantation
5642013|NCT00732953|angiographic follow-up|angiographic follow-up
5642014|NCT00732953|clinical follow-up|clinical follow-up
5642016|NCT00732940|Lupus|lupus
5642017|NCT00732940|Systemic Lupus Erythematosus|systemic lupus erythematosus
5642018|NCT00732940|Antibodies|antibodies
5642019|NCT00732940|Autoimmune Diseases|autoimmune diseases
5642020|NCT00732940|Belimumab|belimumab
5642021|NCT00732927|thrombosis, vein, retina|thrombosis, vein, retina
5642022|NCT00732914|Renal Cell Carcinoma|renal cell carcinoma
5642023|NCT00732914|Sunitinib|sunitinib
5642024|NCT00732914|Sorafenib|sorafenib
5642025|NCT00732914|Sequential|sequential
5642026|NCT00732901|substance abuse|substance abuse
5642027|NCT00732901|cocaine|cocaine
5642028|NCT00732901|impulsivity|impulsivity
5642029|NCT00732901|serotonin|serotonin
5642030|NCT00732901|Remeron|remeron
5642031|NCT00732901|Mirtzapine|mirtzapine
5642032|NCT00732901|Lexapro|lexapro
5642033|NCT00732901|Escatilopram|escatilopram
5642034|NCT00732888|Pharmacokinetics|pharmacokinetics
5642035|NCT00732888|Healthy volunteers|healthy volunteers
5642036|NCT00732888|No condition|no condition
5642037|NCT00732888|Pharmacokinetics study|pharmacokinetics study
5642038|NCT00732862|Type 2 diabetes|type 2 diabetes
5642039|NCT00732862|intensive therapy|intensive therapy
5642040|NCT00732849|immunonutrition|immunonutrition
5642041|NCT00732849|surgical patients|surgical patients
5642042|NCT00732849|postoperative period|postoperative period
5642043|NCT00732836|Liver Cancer|liver cancer
5642044|NCT00732836|Solid Cancer|solid cancer
5642045|NCT00732836|Abraxane|abraxane
5642046|NCT00732836|nab paclitaxel|nab paclitaxel
5642047|NCT00732836|HAI abraxane|hai abraxane
5642048|NCT00732836|HAI|hai
5642049|NCT00732836|hepatic arterial infusion|hepatic arterial infusion
5642050|NCT00732836|hepatic metastases|hepatic metastases
5642051|NCT00732797|Dizziness|dizziness
5642052|NCT00732797|Self-management|self-management
5642053|NCT00732797|booklet-based|booklet-based
5642054|NCT00732797|vestibular rehabilitation|vestibular rehabilitation
5642055|NCT00732784|Pharmacokinetics|pharmacokinetics
5642056|NCT00732784|Healthy volunteers|healthy volunteers
5642057|NCT00732784|No condition|no condition
5642058|NCT00732784|Pharmacokinetics study|pharmacokinetics study
5642059|NCT00732771|primary hyperaldosteronism|primary hyperaldosteronism
5642060|NCT00732771|hypokalemia|hypokalemia
5642061|NCT00732771|hypertension|hypertension
5642062|NCT00732771|aldosterone synthase inhibitor|aldosterone synthase inhibitor
5642063|NCT00732758|Vitamin D Deficiency|vitamin d deficiency
5642064|NCT00732758|Vitamin D Insufficiency|vitamin d insufficiency
5642065|NCT00732758|Child|child
5642066|NCT00732758|Adolescent|adolescent
5642067|NCT00732758|African American|african american
5642068|NCT00732758|Caucasian|caucasian
5642069|NCT00732758|Definition|definition
5642070|NCT00732758|Preadolescent|preadolescent
5642071|NCT00732745|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5642072|NCT00732745|adenocarcinoma of the gastroesophageal junction|adenocarcinoma of the gastroesophageal junction
5642073|NCT00732745|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5642074|NCT00732745|stage III esophageal cancer|stage iii esophageal cancer
5642075|NCT00732745|stage IV esophageal cancer|stage iv esophageal cancer
5642076|NCT00732745|recurrent esophageal cancer|recurrent esophageal cancer
5642077|NCT00732732|diarrhea|diarrhea
5642078|NCT00732732|Plantain|plantain
5642079|NCT00732732|Green banana|green banana
5642080|NCT00732732|Infants|infants
5642081|NCT00732732|Children|children
5642082|NCT00732706|FNB|fnb
5642083|NCT00732706|Femoral Nerve|femoral nerve
5642084|NCT00732706|Sartorius Twitch|sartorius twitch
5642085|NCT00732706|Quadriceps Twitch|quadriceps twitch
5642086|NCT00732706|Analgesia|analgesia
5642087|NCT00732706|Anesthesia|anesthesia
5642088|NCT00732693|Premature ovarian failure|premature ovarian failure
5642089|NCT00732693|Sex hormone replacement|sex hormone replacement
5642090|NCT00732693|HRT|hrt
5642091|NCT00732693|Blood pressure|blood pressure
5642092|NCT00732693|Bone mineral density|bone mineral density
5642093|NCT00732693|Bone metabolism|bone metabolism
5642094|NCT00732693|Uterine function|uterine function
5642095|NCT00732680|Empty nose syndrome|empty nose syndrome
5642096|NCT00732680|Over resection of turbinate|over resection of turbinate
5642097|NCT00732680|Atrophic rhinitis|atrophic rhinitis
5642098|NCT00732654|Food Allergy|food allergy
5642099|NCT00732654|Oral Immunotherapy|oral immunotherapy
5642572|NCT00730587|Body Fat|body fat
5642100|NCT00732654|Immunoglobulin E|immunoglobulin e
5642101|NCT00732615|Hypoparathyroidism|hypoparathyroidism
5642102|NCT00732602|Glucagon|glucagon
5642103|NCT00732602|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
5642104|NCT00732602|Glucagon-Like peptide 2|glucagon-like peptide 2
5642105|NCT00732589|suprascapular nerve block|suprascapular nerve block
5642106|NCT00732589|shoulder pain|shoulder pain
5642107|NCT00732589|hemiplegia|hemiplegia
5642108|NCT00732576|Cardiovascular|cardiovascular
5642109|NCT00732576|Calcification|calcification
5642110|NCT00732563|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5642111|NCT00732563|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5642112|NCT00732550|cholelithiasis|cholelithiasis
5642113|NCT00732550|cholecystitis|cholecystitis
5642114|NCT00732537|Hypoxia|hypoxia
5642115|NCT00732537|Respiratory failure|respiratory failure
5642116|NCT00732537|Infant, term|infant, term
5642117|NCT00732537|Nitric oxide|nitric oxide
5642118|NCT00732524|Hyperglycemia|hyperglycemia
5642119|NCT00732524|Glucose toxicity|glucose toxicity
5642120|NCT00732524|Glargine|glargine
5642121|NCT00732524|Glipizide|glipizide
5642122|NCT00732511|Endothelial dysfunction|endothelial dysfunction
5642123|NCT00732511|Blood vessel stiffness|blood vessel stiffness
5642124|NCT00732511|Nitric oxide|nitric oxide
5642125|NCT00732511|Oxidative stress|oxidative stress
5642126|NCT00732498|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5642127|NCT00732498|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5642128|NCT00732498|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5642129|NCT00732498|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5642130|NCT00732498|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5642131|NCT00732498|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5642132|NCT00732498|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5642133|NCT00732498|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5642134|NCT00732498|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5642135|NCT00732498|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5642136|NCT00732498|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5642137|NCT00732498|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5642138|NCT00732498|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5642139|NCT00732498|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5642140|NCT00732498|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5642141|NCT00732485|Burn injury|burn injury
5642142|NCT00732485|Fenofibrate|fenofibrate
5642143|NCT00732485|Insulin resistance|insulin resistance
5642144|NCT00732485|Mitochondrial function|mitochondrial function
5626835|NCT00791739|fibromyalgia|fibromyalgia
5642145|NCT00732485|Fat oxidation|fat oxidation
5642147|NCT00732485|Protein|protein
5642148|NCT00732485|Glucose|glucose
5642149|NCT00732485|Wound|wound
5642150|NCT00732472|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5642151|NCT00732472|Magnesium stearate|magnesium stearate
5642152|NCT00732472|GSK573719|gsk573719
5642153|NCT00732459|myocardial protection|myocardial protection
5642154|NCT00732459|cardiac surgery|cardiac surgery
5642155|NCT00732459|heart valve replacement|heart valve replacement
5642156|NCT00732446|moxifloxacin|moxifloxacin
5642157|NCT00732446|dexamethasone|dexamethasone
5642158|NCT00732446|ocular inflammation|ocular inflammation
5642159|NCT00732446|ocular infection|ocular infection
5642160|NCT00732420|pazopanib|pazopanib
5642162|NCT00732420|topotecan|topotecan
5642163|NCT00732420|Advanced Solid Tumors|advanced solid tumors
5642164|NCT00732407|aliskiren|aliskiren
5642165|NCT00732407|arteial stiffness|arteial stiffness
5642166|NCT00732407|platelet function|platelet function
5642167|NCT00732407|diabetes mellitus|diabetes mellitus
5642168|NCT00732355|syphilis|syphilis
5642169|NCT00732342|Alcohol Abuse|alcohol abuse
5642170|NCT00732342|Contingency Management|contingency management
5642171|NCT00732342|Treatment Duration|treatment duration
5642172|NCT00732316|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5642173|NCT00732316|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5642174|NCT00732316|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5642175|NCT00732316|acute undifferentiated leukemia|acute undifferentiated leukemia
5642176|NCT00732316|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5642177|NCT00732316|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5642178|NCT00732316|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5642179|NCT00732316|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5642180|NCT00732316|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5642181|NCT00732316|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5642182|NCT00732316|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5642183|NCT00732316|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5642188|NCT00732316|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5642189|NCT00732316|refractory anemia with excess blasts|refractory anemia with excess blasts
5642190|NCT00732316|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5642191|NCT00732316|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5642192|NCT00732316|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5642193|NCT00732290|Healthy volunteer|healthy volunteer
5642194|NCT00732290|Pharmacokinetic|pharmacokinetic
5642202|NCT00732277|children|children
5642203|NCT00732251|Bipolar Disorder|bipolar disorder
5642204|NCT00732251|Stable Bipolar Disorder|stable bipolar disorder
5642205|NCT00732251|Mania|mania
5642206|NCT00732251|Mixed mania|mixed mania
5642207|NCT00732251|Allopurinol|allopurinol
5642208|NCT00732238|Spinal Cord Injury|spinal cord injury
5642209|NCT00732238|Urinary Tract Infection|urinary tract infection
5642210|NCT00732238|Catheter Dependent|catheter dependent
5642211|NCT00732225|DisCoVisc OVD|discovisc ovd
5642212|NCT00732225|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
5642220|NCT00732199|apneic threshold|apneic threshold
5642221|NCT00732199|central apnea|central apnea
5642222|NCT00732199|intermittent hypoxia|intermittent hypoxia
5642223|NCT00732199|aging|aging
5642224|NCT00732199|ventilation|ventilation
5642225|NCT00732199|chemoresponsiveness|chemoresponsiveness
5642226|NCT00732199|carbon-dioxide reserve|carbon-dioxide reserve
5642227|NCT00732173|stage I endometrial carcinoma|stage i endometrial carcinoma
5642228|NCT00732173|stage II endometrial carcinoma|stage ii endometrial carcinoma
5642229|NCT00732160|Glucose|glucose
5642230|NCT00732160|Insulin|insulin
5642231|NCT00732147|triglycerides|triglycerides
5642232|NCT00732147|endogenous|endogenous
5642233|NCT00732147|glucose|glucose
5642234|NCT00732147|production|production
5642235|NCT00732121|Type 2 Diabetes|type 2 diabetes
5642236|NCT00732108|migraine|migraine
5642237|NCT00732108|headache|headache
5642238|NCT00732108|dizziness|dizziness
5642239|NCT00732108|vertigo|vertigo
5642240|NCT00732108|topiramate|topiramate
5642241|NCT00732108|Topamax|topamax
5642242|NCT00732095|Self-change|self-change
5642243|NCT00732095|Natural recovery|natural recovery
5642244|NCT00732095|Alcohol Drinking|alcohol drinking
5642245|NCT00732095|Mechanisms of Change|mechanisms of change
5642246|NCT00732095|Advertisements|advertisements
5642247|NCT00732082|LAG-3 and gemcitabine treatment for advanced pancreas cancer|lag-3 and gemcitabine treatment for advanced pancreas cancer
5642248|NCT00732069|hemodialysis|hemodialysis
5642249|NCT00732069|oxidative stress|oxidative stress
5642250|NCT00732069|inflammation|inflammation
5642251|NCT00732069|kallikrein-kinin|kallikrein-kinin
5642252|NCT00732069|angiotensin receptor blockade|angiotensin receptor blockade
5642253|NCT00732069|angiotensin converting enzyme inhibition|angiotensin converting enzyme inhibition
5642254|NCT00732069|RAAS|raas
5642255|NCT00732069|fibrinolysis|fibrinolysis
5642256|NCT00732069|endothelial dysfunction|endothelial dysfunction
5642257|NCT00732056|Metastatic Breast Cancer|metastatic breast cancer
5642258|NCT00732056|Recurrent Breast Cancer|recurrent breast cancer
5642259|NCT00732043|prostate cancer|prostate cancer
5642260|NCT00732043|prostate-specific antigen|prostate-specific antigen
5642262|NCT00732043|pomegranate|pomegranate
5642263|NCT00732030|Toric IOL|toric iol
5642264|NCT00732017|Sprain|sprain
5642265|NCT00732017|Electric stimulation|electric stimulation
5642266|NCT00732017|Physical trauma|physical trauma
5642267|NCT00732017|Inflammation|inflammation
5642268|NCT00731991|Muscle|muscle
5642269|NCT00731978|Near-Infrared Spectroscopy|near-infrared spectroscopy
5642270|NCT00731978|Intraoperative Care|intraoperative care
5642271|NCT00731965|Arthritis, Juvenile Rheumatoid|arthritis, juvenile rheumatoid
5671717|NCT00614653|Pancreatic Cancer|pancreatic cancer
5642272|NCT00731965|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5642273|NCT00731965|Serology|serology
5642274|NCT00731965|Lymphocytes|lymphocytes
5642275|NCT00731952|surgically resectable|surgically resectable
5642276|NCT00731939|Erectile Dysfunction|erectile dysfunction
5642277|NCT00731939|Penile implant|penile implant
5642278|NCT00731939|Titan|titan
5642279|NCT00731913|Surgical wounds|surgical wounds
5642280|NCT00731913|Sutures|sutures
5642281|NCT00731900|pharmacogenetic|pharmacogenetic
5642282|NCT00731900|study|study
5642283|NCT00731900|Topirmate|topirmate
5642284|NCT00731900|induced|induced
5642285|NCT00731887|Burn injury|burn injury
5642286|NCT00731887|Burn recovery|burn recovery
5642287|NCT00731874|Kidney transplantation|kidney transplantation
5642288|NCT00731874|Immunosuppression|immunosuppression
5642289|NCT00731874|Minimization|minimization
5642290|NCT00731874|Tacrolimus|tacrolimus
5642291|NCT00731874|Prograf|prograf
5642292|NCT00731874|Thymoglobulin|thymoglobulin
5642293|NCT00731848|prostate cancer|prostate cancer
5642294|NCT00731848|prostate-specific antigens|prostate-specific antigens
5642295|NCT00731848|PSA|psa
5642296|NCT00731835|Vascular|vascular
5642297|NCT00731822|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5642298|NCT00731822|Novel Dry Powder Inhaler|novel dry powder inhaler
5642299|NCT00731822|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5642301|NCT00731809|Crohn's disease|crohn's disease
5642302|NCT00731796|Stroke|stroke
5642303|NCT00731796|Retrochiasmatic|retrochiasmatic
5642304|NCT00731796|Vision|vision
5642305|NCT00731796|VFD|vfd
5642306|NCT00731783|Abscesses|abscesses
5642307|NCT00731783|Furunculosis|furunculosis
5642308|NCT00731783|Staphylococcus aureus colonization|staphylococcus aureus colonization
5642309|NCT00731783|Staphylococcal Skin Infections|staphylococcal skin infections
5642310|NCT00731783|MRSA|mrsa
5642311|NCT00731770|COPD|copd
5642312|NCT00731770|sleep|sleep
5642313|NCT00731770|daytime somnolence|daytime somnolence
5642314|NCT00731718|Head Lice|head lice
5642315|NCT00731692|FTY720, primary progressive multiple sclerosis,PPMS|fty720, primary progressive multiple sclerosis,ppms
5642316|NCT00731679|IBS|ibs
5642317|NCT00731679|Abdominal pain|abdominal pain
5642318|NCT00731679|Bloating|bloating
5642319|NCT00731679|Diarrhea|diarrhea
5642320|NCT00731679|Rifaximin|rifaximin
5642321|NCT00731666|penile length|penile length
5642322|NCT00731666|IPP|ipp
5642323|NCT00731666|Erectile dysfunction|erectile dysfunction
5642324|NCT00731653|depression|depression
5642325|NCT00731653|combination|combination
5642326|NCT00731640|AcrySof|acrysof
5642327|NCT00731640|ReSTOR|restor
5642328|NCT00731640|Multifocal|multifocal
5642329|NCT00731640|Intraocular Lens|intraocular lens
5642330|NCT00731627|intracranial aneurysm|intracranial aneurysm
5642331|NCT00731614|cognitive therapy|cognitive therapy
5642332|NCT00731614|mirror training|mirror training
5642333|NCT00731614|nondirective therapy|nondirective therapy
5642334|NCT00731614|veterans|veterans
5642335|NCT00731614|amputees|amputees
5642336|NCT00731601|shock|shock
5642337|NCT00731601|peptic ulcer bleeding|peptic ulcer bleeding
5642339|NCT00731575|asthma|asthma
5642340|NCT00731575|child|child
5642341|NCT00731575|pathogenesis|pathogenesis
5642342|NCT00731575|rhinovirus|rhinovirus
5642343|NCT00731575|prednisolone|prednisolone
5642344|NCT00731575|Prevention|prevention
5642345|NCT00731575|pediatric|pediatric
5642346|NCT00731562|food, varenicline, pharmacokinetics, bioavailability|food, varenicline, pharmacokinetics, bioavailability
5642347|NCT00731549|Aripiprazole|aripiprazole
5642348|NCT00731549|IM Depot|im depot
5642349|NCT00731549|Schizophrenia|schizophrenia
5642350|NCT00731549|Intramuscular|intramuscular
5642351|NCT00731536|Hepatosplenic T-cell Lymphoma|hepatosplenic t-cell lymphoma
5642352|NCT00731536|Remicade|remicade
5642353|NCT00731536|Infliximab|infliximab
5642354|NCT00731536|Dutch national database of pathology|dutch national database of pathology
5642355|NCT00731536|PALGA|palga
5642356|NCT00731536|Autoimmune disease|autoimmune disease
5642357|NCT00731536|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5642358|NCT00731523|FTY720, Pharmacokinetics, Renal insufficiency|fty720, pharmacokinetics, renal insufficiency
5642359|NCT00731510|Acute mountain sickness|acute mountain sickness
5642360|NCT00731510|Body composition,Hypoxia|body composition,hypoxia
5642368|NCT00731497|Disinfection|disinfection
5642369|NCT00731497|Intervention Trial|intervention trial
5642370|NCT00731484|Dry Eye Disease|dry eye disease
5642371|NCT00731484|Tear Osmolarity|tear osmolarity
5642372|NCT00731484|Tear Osmolality|tear osmolality
5642373|NCT00731458|OCT;|oct;
5642374|NCT00731458|Cirrus;|cirrus;
5642375|NCT00731458|Stratus;|stratus;
5671718|NCT00614653|Bevacizumab|bevacizumab
5642376|NCT00731458|macular thickness|macular thickness
5642377|NCT00731445|Z-208|z-208
5642378|NCT00731432|gingivitis, diabetes mellitus, herbal, oral inflammation|gingivitis, diabetes mellitus, herbal, oral inflammation
5642379|NCT00731419|biliary|biliary
5642380|NCT00731419|obstruction|obstruction
5642381|NCT00731419|malignant|malignant
5642382|NCT00731419|stent|stent
5642383|NCT00731419|palliation|palliation
5642384|NCT00731393|Thiomersal-free influenza split vaccine 2003/2004|thiomersal-free influenza split vaccine 2003/2004
5642385|NCT00731393|Influsplit SSW®/Fluarix™ 2003/2004|influsplit ssw®/fluarix™ 2003/2004
5642386|NCT00731393|Influenza|influenza
5642387|NCT00731380|Abraxane|abraxane
5642388|NCT00731380|Head and Neck Cancer|head and neck cancer
5642389|NCT00731380|Determine|determine
5642390|NCT00731380|Maximum|maximum
5642391|NCT00731380|Tolerated dose|tolerated dose
5642392|NCT00731380|ABI-007|abi-007
5642393|NCT00731380|Combination|combination
5642394|NCT00731380|Cisplatin|cisplatin
5642395|NCT00731380|5-Fluorouracil|5-fluorouracil
5642396|NCT00731380|Patients|patients
5642397|NCT00731354|lipoplasty|lipoplasty
5642398|NCT00731354|liposuction|liposuction
5642399|NCT00731354|VASER|vaser
5642400|NCT00731354|body contouring|body contouring
5642401|NCT00731354|body sculpting|body sculpting
5642402|NCT00731354|Any patient|any patient
5642403|NCT00731354|expressing|expressing
5642404|NCT00731354|interest|interest
5642405|NCT00731354|in elective surgery|in elective surgery
5642406|NCT00731341|Uterine fibroids|uterine fibroids
5642407|NCT00731341|Leiomyoma|leiomyoma
5642408|NCT00731341|Menorrhagia|menorrhagia
5642409|NCT00731341|Hysteroscopic cryoablation|hysteroscopic cryoablation
5642410|NCT00731341|Minimally invasive|minimally invasive
5642411|NCT00731328|refractory anemia|refractory anemia
5642412|NCT00731328|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5642413|NCT00731328|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5642414|NCT00731328|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5642415|NCT00731328|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5642416|NCT00731328|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5642417|NCT00731328|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5642418|NCT00731328|aplastic anemia|aplastic anemia
5642419|NCT00731328|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5642420|NCT00731315|UTI|uti
5642421|NCT00731315|Kiosk|kiosk
5642422|NCT00731315|Computer Assisted Care|computer assisted care
5642423|NCT00731315|cystitis|cystitis
5642424|NCT00731289|Osteoarthritis|osteoarthritis
5642425|NCT00731289|Knee|knee
5642426|NCT00731289|Hyaluronan|hyaluronan
5642427|NCT00731289|Gait Analysis|gait analysis
5642428|NCT00731276|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5642429|NCT00731263|Cancer|cancer
5642430|NCT00731263|Advance solid tumours|advance solid tumours
5642431|NCT00731263|Dose Escalation|dose escalation
5642432|NCT00731263|Preliminary efficacy|preliminary efficacy
5642433|NCT00731263|AZD8055|azd8055
5642434|NCT00731263|Tor kinase inhibitor|tor kinase inhibitor
5642435|NCT00731263|Oral administration|oral administration
5642436|NCT00731250|Capsaicin challenge|capsaicin challenge
5642437|NCT00731237|Drug Eluting Stent|drug eluting stent
5642438|NCT00731237|Percutaneous Coronary Intervention|percutaneous coronary intervention
5642439|NCT00731237|Everolimus|everolimus
5642440|NCT00731224|Alzheimer's disease, rivastigmine, patch|alzheimer's disease, rivastigmine, patch
5642441|NCT00731211|Renal Cell Carcinoma|renal cell carcinoma
5642443|NCT00731211|Pazopanib|pazopanib
5642444|NCT00731211|Previously-treated|previously-treated
5642445|NCT00731198|ERCP|ercp
5642446|NCT00731198|Drotaverine hydrochloride|drotaverine hydrochloride
5642447|NCT00731198|Hyoscine-N-butylbromide|hyoscine-n-butylbromide
5642448|NCT00731185|functional|functional
5642449|NCT00731185|endoscopic|endoscopic
5642450|NCT00731185|sinus|sinus
5642451|NCT00731185|surgery|surgery
5642452|NCT00731172|crohns disease|crohns disease
5645047|NCT00720967|Renal dysfunction|renal dysfunction
5642453|NCT00731146|Interscalene Brachial Plexus Block|interscalene brachial plexus block
5642454|NCT00731146|Regional Anesthesia|regional anesthesia
5642455|NCT00731146|Ultrasound guided peripheral nerve block|ultrasound guided peripheral nerve block
5642456|NCT00731146|Minimum Effective Anesthetic Volume|minimum effective anesthetic volume
5642457|NCT00731146|Nerve Stimulator guided peripheral nerve block|nerve stimulator guided peripheral nerve block
5642458|NCT00731133|disulfiram|disulfiram
5642459|NCT00731133|methamphetamine dependence|methamphetamine dependence
5642460|NCT00731133|open label|open label
5642461|NCT00731120|Generalized Anxiety Disorder|generalized anxiety disorder
5642462|NCT00731120|Mood Disorder|mood disorder
5642463|NCT00731120|Affective Disorder|affective disorder
5642464|NCT00731120|Anxiety Disorder|anxiety disorder
5642465|NCT00731120|Drug Therapy|drug therapy
5642466|NCT00731107|Veress Needle|veress needle
5642467|NCT00731107|XCEL bladeless trocar|xcel bladeless trocar
5642468|NCT00731107|Laparoscopic entry techniques|laparoscopic entry techniques
5642469|NCT00731094|overweight|overweight
5642470|NCT00731094|sedentary lifestyle|sedentary lifestyle
5642471|NCT00731094|exercise|exercise
5642472|NCT00731094|primary health care|primary health care
5642473|NCT00731094|controlled clinical trials, randomized|controlled clinical trials, randomized
5642474|NCT00731068|Achilles tendon|achilles tendon
5642475|NCT00731042|Skin health|skin health
5642476|NCT00731029|Influenza|influenza
5642477|NCT00731029|Thiomersal-free influenza split vaccine 2002/2003|thiomersal-free influenza split vaccine 2002/2003
5642573|NCT00730587|Infant|infant
5642478|NCT00731029|Influsplit SSW®/Fluarix™ 2002/2003|influsplit ssw®/fluarix™ 2002/2003
5642479|NCT00731003|serotonin|serotonin
5642480|NCT00731003|gut permeability|gut permeability
5642481|NCT00731003|visceral sensitivity|visceral sensitivity
5642482|NCT00731003|irritable bowel syndrome|irritable bowel syndrome
5642483|NCT00730990|Positron Emission Tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.|positron emission tomography study in healthy volunteers for ligand qualification and receptor occupancy determination.
5642484|NCT00730964|Surveillance|surveillance
5642485|NCT00730964|Optison|optison
5642486|NCT00730964|Perflutren|perflutren
5642487|NCT00730964|Echocardiography|echocardiography
5642488|NCT00730964|Subjects receive Optison during enhanced echocardiography|subjects receive optison during enhanced echocardiography
5642489|NCT00730938|fibrin|fibrin
5642490|NCT00730938|endophthalmitis|endophthalmitis
5642491|NCT00730938|cataract extraction|cataract extraction
5642492|NCT00730938|Lens|lens
5642493|NCT00730938|implantation,|implantation,
5642494|NCT00730938|intraocular|intraocular
5642495|NCT00730886|Uterine Fibroids|uterine fibroids
5642496|NCT00730886|Unexplained Infertility|unexplained infertility
5642497|NCT00730886|MRgFUS|mrgfus
5642498|NCT00730886|ExAblate|exablate
5642499|NCT00730886|Focused Ultrasound|focused ultrasound
5642500|NCT00730886|Myomectomy|myomectomy
5642501|NCT00730860|radiofrequency ablation|radiofrequency ablation
5642502|NCT00730860|Cancer of Liver|cancer of liver
5642503|NCT00730860|postoperative|postoperative
5642504|NCT00730860|transhepatic arterial chemoembolization|transhepatic arterial chemoembolization
5642505|NCT00730860|prospective|prospective
5642506|NCT00730847|Cervarix|cervarix
5642507|NCT00730847|Filipinos|filipinos
5642508|NCT00730847|Safety and reactogenicity|safety and reactogenicity
5642509|NCT00730847|Human papillomavirus|human papillomavirus
5642510|NCT00730834|tinnitus|tinnitus
5642511|NCT00730834|ringing in the ears|ringing in the ears
5642512|NCT00730834|buzzing|buzzing
5642513|NCT00730834|static|static
5642514|NCT00730834|hyperacusis|hyperacusis
5642515|NCT00730834|loudness discomfort|loudness discomfort
5642516|NCT00730834|Clinically|clinically
5642517|NCT00730834|significant|significant
5642518|NCT00730834|discomfort|discomfort
5642519|NCT00730808|Enteral nutritional regimen prior to surgery|enteral nutritional regimen prior to surgery
5642520|NCT00730795|Tuberculosis vaccine|tuberculosis vaccine
5642521|NCT00730769|Valganciclovir|valganciclovir
5642522|NCT00730769|Ganciclovir|ganciclovir
5642523|NCT00730769|Pharmacokinetics|pharmacokinetics
5642524|NCT00730769|Solid organ transplantation|solid organ transplantation
5642525|NCT00730769|Transplant|transplant
5642526|NCT00730756|Adolescents|adolescents
5642527|NCT00730756|Irritant(non-allergic)rhinitis|irritant(non-allergic)rhinitis
5642528|NCT00730756|Adults|adults
5642529|NCT00730756|GW685698|gw685698
5642530|NCT00730756|Air Pollution|air pollution
5642531|NCT00730730|Iliac Artery, Peripheral Vascular Disease (PVD)|iliac artery, peripheral vascular disease (pvd)
5642532|NCT00730704|Human Papilloma Virus vaccines|human papilloma virus vaccines
5642535|NCT00730704|Post partum|post partum
5642536|NCT00730691|Generalized Anxiety Disorder|generalized anxiety disorder
5642537|NCT00730691|Mood Disorder|mood disorder
5642538|NCT00730691|Affective Disorder|affective disorder
5642539|NCT00730691|Anxiety Disorder|anxiety disorder
5642540|NCT00730691|Drug Therapy|drug therapy
5642541|NCT00730678|Metabolism|metabolism
5642542|NCT00730678|Pharmacogenetic testing|pharmacogenetic testing
5642543|NCT00730665|PPI partial responders with non-erosive GERD.|ppi partial responders with non-erosive gerd.
5642544|NCT00730652|Medarex Inc.|medarex inc.
5642545|NCT00730626|Probiotics|probiotics
5642547|NCT00730626|Immune response|immune response
5642548|NCT00730626|Intestinal microflora|intestinal microflora
5642549|NCT00730626|Blood lipids|blood lipids
5642550|NCT00730626|Phagocytosis activity|phagocytosis activity
5642551|NCT00730613|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5642552|NCT00730613|adult diffuse astrocytoma|adult diffuse astrocytoma
5642553|NCT00730613|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5642554|NCT00730613|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5642555|NCT00730613|adult anaplastic ependymoma|adult anaplastic ependymoma
5642556|NCT00730613|adult ependymoma|adult ependymoma
5642557|NCT00730613|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5642558|NCT00730613|adult subependymoma|adult subependymoma
5642559|NCT00730613|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5642560|NCT00730613|adult oligodendroglioma|adult oligodendroglioma
5642561|NCT00730613|adult brain stem glioma|adult brain stem glioma
5642562|NCT00730613|adult giant cell glioblastoma|adult giant cell glioblastoma
5642563|NCT00730613|adult glioblastoma|adult glioblastoma
5642564|NCT00730613|recurrent adult brain tumor|recurrent adult brain tumor
5642565|NCT00730613|adult gliosarcoma|adult gliosarcoma
5642566|NCT00730613|adult mixed glioma|adult mixed glioma
5642567|NCT00730613|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5642568|NCT00730600|Thai Traditional massage|thai traditional massage
5642569|NCT00730600|Bone Formation|bone formation
5642570|NCT00730600|Bone Resorption|bone resorption
5642571|NCT00730587|Nutrition|nutrition
5642574|NCT00730587|Healthy Babies|healthy babies
5642575|NCT00730561|nerve conduction velocity|nerve conduction velocity
5642576|NCT00730561|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5642577|NCT00730535|Overactive bladder, Tolterodine,Symptoms Relapse, Predictor|overactive bladder, tolterodine,symptoms relapse, predictor
5642578|NCT00730522|Methamphetamine|methamphetamine
5642579|NCT00730522|Dependency|dependency
5642580|NCT00730522|Addiction|addiction
5642581|NCT00730522|vigabatrin|vigabatrin
5642582|NCT00730509|cystic fibrosis|cystic fibrosis
5642583|NCT00730509|folate|folate
5642584|NCT00730509|vitamin B12|vitamin b12
5642585|NCT00730496|Embryo culture supernatant|embryo culture supernatant
5642586|NCT00730496|injection|injection
5642587|NCT00730496|embryo transfer|embryo transfer
5642588|NCT00730496|embryo implantation rate|embryo implantation rate
5642589|NCT00730483|liver metastases|liver metastases
5642590|NCT00730483|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5642591|NCT00730483|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5642592|NCT00730483|islet cell carcinoma|islet cell carcinoma
5642593|NCT00730483|gastrinoma|gastrinoma
5642594|NCT00730483|insulinoma|insulinoma
5642595|NCT00730483|glucagonoma|glucagonoma
5642596|NCT00730483|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5642597|NCT00730483|somatostatinoma|somatostatinoma
5642598|NCT00730470|Human Epidermal Growth Factor Receptor 3|human epidermal growth factor receptor 3
5642600|NCT00730470|Heregulin|heregulin
5642601|NCT00730470|erb B3|erb b3
5642602|NCT00730470|Solid Tumors|solid tumors
5642603|NCT00730470|Phase I Clinical Study|phase i clinical study
5642604|NCT00730457|influenza|influenza
5642605|NCT00730457|recombinant|recombinant
5642606|NCT00730457|hemagglutinin|hemagglutinin
5642607|NCT00730457|vaccine|vaccine
5642608|NCT00730444|Neuroblastoma|neuroblastoma
5642609|NCT00730444|Nuclear medicine|nuclear medicine
5642610|NCT00730444|Diagnostic scintigraphy|diagnostic scintigraphy
5642611|NCT00730444|Known and suspected neuroblastoma|known and suspected neuroblastoma
5642612|NCT00730431|Hepatitis C, healthy volunteers|hepatitis c, healthy volunteers
5642613|NCT00730418|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5642614|NCT00730418|alpha Adrenergic Blockers|alpha adrenergic blockers
5642615|NCT00730418|alpha-1 Adrenergic Receptor|alpha-1 adrenergic receptor
5642616|NCT00730405|Distal, Subungual onychomycosis|distal, subungual onychomycosis
5642617|NCT00730405|onychomycosis|onychomycosis
5642618|NCT00730405|nail fungus|nail fungus
5642619|NCT00730405|Toenail fungus|toenail fungus
5642620|NCT00730392|Type 1 diabetes, Etanercept, honeymoon period|type 1 diabetes, etanercept, honeymoon period
5642621|NCT00730366|Malaria|malaria
5642622|NCT00730366|Pregnancy|pregnancy
5642623|NCT00730366|Intermittent Preventive Treatment|intermittent preventive treatment
5642624|NCT00730340|Tonsillectomy, tonsillar fossa, wound closure|tonsillectomy, tonsillar fossa, wound closure
5642625|NCT00730314|unrelated|unrelated
5642626|NCT00730314|BMT|bmt
5642627|NCT00730314|HSCT|hsct
5642628|NCT00730314|bone marrow transplantation|bone marrow transplantation
5642629|NCT00730314|sickle cell disease|sickle cell disease
5642630|NCT00730314|thalassemia|thalassemia
5642631|NCT00730314|CGD|cgd
5642632|NCT00730314|HLH|hlh
5642633|NCT00730314|Blackfan-Diamond anemia|blackfan-diamond anemia
5642634|NCT00730314|Hurler|hurler
5642635|NCT00730314|leukodystrophy|leukodystrophy
5642636|NCT00730314|LAD I|lad i
5642637|NCT00730314|Genetic diseases|genetic diseases
5642638|NCT00730314|Red blood cell defects|red blood cell defects
5642639|NCT00730314|Leukocyte defects and immune deficiencies|leukocyte defects and immune deficiencies
5642640|NCT00730314|Hereditary Lymphohistiocytosis|hereditary lymphohistiocytosis
5642641|NCT00730314|chronic granulomatous disease|chronic granulomatous disease
5642642|NCT00730314|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5642643|NCT00730314|Chediak Higashi syndrome|chediak higashi syndrome
5642644|NCT00730314|CD40 ligand deficiency|cd40 ligand deficiency
5642645|NCT00730314|Hyper IgM syndrome|hyper igm syndrome
5642646|NCT00730314|leucocytes adhesion defect type 1|leucocytes adhesion defect type 1
5642647|NCT00730314|Osteopetrosis|osteopetrosis
5642648|NCT00730314|congenital neutropenia|congenital neutropenia
5642649|NCT00730314|X-linked lymphoproliferative disease|x-linked lymphoproliferative disease
5642650|NCT00730314|Platelets defects|platelets defects
5642651|NCT00730314|Congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5642652|NCT00730314|Metabolic and storage disorders|metabolic and storage disorders
5642653|NCT00730314|Hurler disease|hurler disease
5642654|NCT00730314|leukodystrophies|leukodystrophies
5642655|NCT00730314|Niemann-Pick disease|niemann-pick disease
5642656|NCT00730314|Fucosidosis|fucosidosis
5642657|NCT00730314|Stem cell defects|stem cell defects
5642658|NCT00730314|reticular agenesis|reticular agenesis
5642659|NCT00730301|Emphysema|emphysema
5642660|NCT00730301|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5642661|NCT00730301|Lung volume reduction|lung volume reduction
5642662|NCT00730301|Lung function|lung function
5642663|NCT00730288|Dengue|dengue
5642664|NCT00730288|Dengue fever|dengue fever
5642665|NCT00730288|Dengue hemorrhagic fever|dengue hemorrhagic fever
5642666|NCT00730288|Dengue virus|dengue virus
5642667|NCT00730262|Glioblastoma Multiforme (GBM)|glioblastoma multiforme (gbm)
5642668|NCT00730262|Phase II|phase ii
5642669|NCT00730262|Brain Cancer|brain cancer
5642670|NCT00730249|ADHD|adhd
5642671|NCT00730249|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5642672|NCT00730249|adult|adult
5642673|NCT00730249|methylphenidate hydrochloride|methylphenidate hydrochloride
5642674|NCT00730249|Medikinet retard|medikinet retard
5642675|NCT00730249|controlled clinical trial|controlled clinical trial
5642676|NCT00730249|safety|safety
5642677|NCT00730249|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
5642678|NCT00730249|treatment|treatment
5642679|NCT00730249|central nervous system stimulants|central nervous system stimulants
5642680|NCT00730249|therapeutic uses|therapeutic uses
5642681|NCT00730223|Nevirapine|nevirapine
5642682|NCT00730223|Efavirenz|efavirenz
5642683|NCT00730223|pharmacokinetics|pharmacokinetics
5642684|NCT00730223|healthy|healthy
5642685|NCT00730223|CYP2B6|cyp2b6
5642686|NCT00730223|HIV/AIDS|hiv/aids
5642688|NCT00730210|HypoPTH|hypopth
5642689|NCT00730210|PTH|pth
5642690|NCT00730184|acid-base|acid-base
5642691|NCT00730184|potassium|potassium
5642692|NCT00730184|acidosis|acidosis
5642693|NCT00730184|osteoporosis|osteoporosis
5642694|NCT00730184|sarcopenia|sarcopenia
5642695|NCT00730184|calcium absorption|calcium absorption
5642696|NCT00730184|dietary protein|dietary protein
5642697|NCT00730145|pharmacokinetics, PD-0332334, hemodialysis, renal dialysis|pharmacokinetics, pd-0332334, hemodialysis, renal dialysis
5642698|NCT00730119|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
5642699|NCT00730119|GE Monitor|ge monitor
5642700|NCT00730119|Temperature|temperature
5642701|NCT00730119|SpO2|spo2
5642702|NCT00730119|Respiration, ECG|respiration, ecg
5642703|NCT00730106|Gastroesophageal reflux disease|gastroesophageal reflux disease
5642704|NCT00730106|Alarm symptoms|alarm symptoms
5642705|NCT00730106|Gastrointestinal endoscopy|gastrointestinal endoscopy
5642706|NCT00730093|Vitamin B12 absorption|vitamin b12 absorption
5642707|NCT00730093|Pregnancy|pregnancy
5642708|NCT00730080|phenylketonuria|phenylketonuria
5642709|NCT00730080|sapropterin|sapropterin
5642710|NCT00730080|Kuvan|kuvan
5642711|NCT00730080|cognition|cognition
5642712|NCT00730080|executive abilities|executive abilities
5642713|NCT00730080|brain|brain
5642714|NCT00730067|COPD|copd
5642715|NCT00730067|Pulmonary hypertension|pulmonary hypertension
5642716|NCT00730067|Sildenafil|sildenafil
5642717|NCT00730067|NT-pro BNP|nt-pro bnp
5642718|NCT00730067|apelin|apelin
5642719|NCT00730054|Remifentanil|remifentanil
5642720|NCT00730054|clonidine|clonidine
5642721|NCT00730054|acute pain|acute pain
5642722|NCT00730054|respiration|respiration
5642723|NCT00730054|sedation|sedation
5642724|NCT00730054|cognitive function|cognitive function
5642725|NCT00730041|obstructive sleep apnea|obstructive sleep apnea
5642726|NCT00730041|continuous positive air pressure|continuous positive air pressure
5642727|NCT00730028|Methicillin-resistant Staphylococcus aureus (MRSA), cellulitis, abscess, children, elderly|methicillin-resistant staphylococcus aureus (mrsa), cellulitis, abscess, children, elderly
5642728|NCT00730002|Lupus|lupus
5642729|NCT00729989|Meconium Aspiration|meconium aspiration
5642730|NCT00729989|Respiratory Distress|respiratory distress
5642731|NCT00729989|Meconium Stained Amniotic Fluid|meconium stained amniotic fluid
5642732|NCT00729976|Ibuprofen|ibuprofen
5642733|NCT00729976|Suppository|suppository
5642734|NCT00729976|febrile children|febrile children
5642735|NCT00729937|Methicillin, Staphylococcus aureus, MRSA|methicillin, staphylococcus aureus, mrsa
5642736|NCT00729924|Raltegravir|raltegravir
5642737|NCT00729924|CSF|csf
5642738|NCT00729924|ABCB1 SNP|abcb1 snp
5642739|NCT00729924|HIV/AIDS|hiv/aids
5642740|NCT00729911|Atrial fibrillation Ablation|atrial fibrillation ablation
5642741|NCT00729885|Vertigo|vertigo
5642742|NCT00729885|Benign Paroxysmal Positional Vertigo|benign paroxysmal positional vertigo
5642743|NCT00729885|BPPV|bppv
5642744|NCT00729885|Positional Vertigo|positional vertigo
5642745|NCT00729872|AG011|ag011
5642746|NCT00729872|Ulcerative Colitis|ulcerative colitis
5642747|NCT00729872|human Interleukin-10|human interleukin-10
5642748|NCT00729859|HDL|hdl
5642749|NCT00729859|Insulin sensitivity|insulin sensitivity
5642750|NCT00729859|testosterone|testosterone
5642751|NCT00729859|estradiol|estradiol
5642752|NCT00729859|cholesterol|cholesterol
5642753|NCT00729846|choroidal neovascularization|choroidal neovascularization
5642754|NCT00729846|macular degeneration|macular degeneration
5642755|NCT00729846|macular edema|macular edema
5642756|NCT00729846|intravitreal bevacizumab|intravitreal bevacizumab
5642757|NCT00729846|vegf|vegf
5642758|NCT00729846|verteporfin PDT|verteporfin pdt
5642759|NCT00729820|PERSONALITY|personality
5642760|NCT00729820|COGNITIVE PERFORMANCE|cognitive performance
5642761|NCT00729820|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior|the practical usefulness (validity) of processing speed, accuracy of performance and personality measures in predicting impulsive behavior
5642762|NCT00729807|recurrent melanoma|recurrent melanoma
5642763|NCT00729794|Vasopressin|vasopressin
5642764|NCT00729794|Epinephrine|epinephrine
5642765|NCT00729794|Adrenal Cortex Hormones|adrenal cortex hormones
5642766|NCT00729794|Heart Arrest|heart arrest
5642767|NCT00729781|nasal obstruction|nasal obstruction
5642768|NCT00729781|airway resistance|airway resistance
5642769|NCT00729781|soft tissue collapse|soft tissue collapse
5642770|NCT00729781|cosmetic contour deformity|cosmetic contour deformity
5642771|NCT00729768|Renal transplant|renal transplant
5642772|NCT00729768|Raptiva|raptiva
5642773|NCT00729755|Creatine|creatine
5642774|NCT00729755|Augmentation|augmentation
5642775|NCT00729755|Major Depressive Disorder|major depressive disorder
5642776|NCT00729755|Efficacy|efficacy
5642777|NCT00729755|Brain Energy Metabolism|brain energy metabolism
5642778|NCT00729729|Comparative|comparative
5642779|NCT00729729|bioavailability|bioavailability
5642780|NCT00729729|of PCA|of pca
5642781|NCT00729729|formulations|formulations
5642782|NCT00729716|Microfracture|microfracture
5642783|NCT00729716|Cartilage repair|cartilage repair
5642784|NCT00729716|Autologous chondrocyte implantation|autologous chondrocyte implantation
5642786|NCT00729703|Minimized|minimized
5642787|NCT00729703|ventricular|ventricular
5642788|NCT00729703|pacing|pacing
5642789|NCT00729703|indication|indication
5642790|NCT00729703|Clinical outcome|clinical outcome
5642791|NCT00729703|Inappropriate shock|inappropriate shock
5642792|NCT00729690|Pregabalin|pregabalin
5642793|NCT00729690|CSF|csf
5642794|NCT00729690|Neurotransmitter|neurotransmitter
5642795|NCT00729677|nausea and vomiting|nausea and vomiting
5642796|NCT00729677|colon cancer|colon cancer
5642797|NCT00729677|rectal cancer|rectal cancer
5642798|NCT00729638|relapsed multiple myeloma|relapsed multiple myeloma
5642799|NCT00729638|refractory multiple myeloma|refractory multiple myeloma
5642800|NCT00729638|RAD001|rad001
5642801|NCT00729638|lenalidomide|lenalidomide
5642802|NCT00729625|stroke, rehabilitation, robotics|stroke, rehabilitation, robotics
5642803|NCT00729612|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5642804|NCT00729612|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5642805|NCT00729612|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5642806|NCT00729612|squamous cell lung cancer|squamous cell lung cancer
5642807|NCT00729573|Microbicide|microbicide
5642808|NCT00729573|HIV Seronegativity|hiv seronegativity
5642809|NCT00729573|Bone Mineral Density|bone mineral density
5642810|NCT00729560|PCOS|pcos
5642811|NCT00729547|Depression|depression
5642812|NCT00729547|Biofeedback|biofeedback
5642813|NCT00729547|Psychophysiology|psychophysiology
5642814|NCT00729534|Perception|perception
5642815|NCT00729534|Focus Group|focus group
5685560|NCT00555607|exacerbation|exacerbation
5642816|NCT00729534|Perception of Clinical Research Participation|perception of clinical research participation
5642818|NCT00729521|Fall injury emergency department visit|fall injury emergency department visit
5642819|NCT00729521|Fall injury death|fall injury death
5642820|NCT00729508|Cat allergy|cat allergy
5642821|NCT00729508|Immunotherapy|immunotherapy
5642822|NCT00729508|Cat-PAD|cat-pad
5642823|NCT00729508|Environmental Exposure Chamber|environmental exposure chamber
5642824|NCT00729495|Phase I,|phase i,
5642825|NCT00729495|Healthy|healthy
5642826|NCT00729495|Volunteer|volunteer
5642827|NCT00729495|Study|study
5642828|NCT00729482|RAD001 (everolimus)|rad001 (everolimus)
5642829|NCT00729482|second-line treatment|second-line treatment
5642830|NCT00729482|advanced gastric cancer|advanced gastric cancer
5642831|NCT00729469|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5642832|NCT00729469|Menopausal symptoms|menopausal symptoms
5642834|NCT00729469|Urogenital atrophy|urogenital atrophy
5642835|NCT00729456|Diabetes|diabetes
5642836|NCT00729456|Education|education
5642837|NCT00729456|Ulcer|ulcer
5642838|NCT00729456|Foot|foot
5642839|NCT00729456|Behaviour|behaviour
5642840|NCT00729443|Single dose|single dose
5642841|NCT00729443|Phase 1|phase 1
5642842|NCT00729443|Safety of AZD3241|safety of azd3241
5642843|NCT00729443|tolerability of AZD3241|tolerability of azd3241
5642844|NCT00729430|Heart Attack|heart attack
5642845|NCT00729430|Sudden Cardiac Death|sudden cardiac death
5642846|NCT00729430|Peri-infarct Zone|peri-infarct zone
5642847|NCT00729430|Omega-3 Fatty Acids|omega-3 fatty acids
5642848|NCT00729430|Biological Markers|biological markers
5642849|NCT00729430|Cytogenetic Analysis|cytogenetic analysis
5642850|NCT00729430|Cardiac Arrest|cardiac arrest
5642851|NCT00729417|incontinence|incontinence
5642852|NCT00729417|obstetric risk factors|obstetric risk factors
5642853|NCT00729417|women|women
5642854|NCT00729417|of age 18|of age 18
5642855|NCT00729417|above|above
5642856|NCT00729404|Female Contraception|female contraception
5642857|NCT00729404|Ovulation Inhibition|ovulation inhibition
5642858|NCT00729391|HIV|hiv
5642859|NCT00729391|Sexual Risk|sexual risk
5642860|NCT00729391|Substance Abuse|substance abuse
5642861|NCT00729391|Victimization|victimization
5642862|NCT00729391|Violence|violence
5642863|NCT00729391|Voluntary Counseling and Testing (VCT)|voluntary counseling and testing (vct)
5643164|NCT00728260|Meningitis|meningitis
5642864|NCT00729365|Urine albumin excretion rates|urine albumin excretion rates
5642865|NCT00729365|Nighttime and daytime blood pressure|nighttime and daytime blood pressure
5642866|NCT00729365|Endothelial Dysfunction|endothelial dysfunction
5642867|NCT00729352|NQO1, ozone, airway mucociliary clearance.|nqo1, ozone, airway mucociliary clearance.
5642868|NCT00729339|Gastroesophageal reflux disease|gastroesophageal reflux disease
5642869|NCT00729339|Mosapride|mosapride
5642870|NCT00729339|Lansoprazole|lansoprazole
5642871|NCT00729326|diabetes|diabetes
5642872|NCT00729326|exenatide|exenatide
5642873|NCT00729326|sitagliptin|sitagliptin
5642874|NCT00729326|Amylin|amylin
5642875|NCT00729326|Lilly|lilly
5642876|NCT00729326|metformin|metformin
5642877|NCT00729326|thiazolidinedione|thiazolidinedione
5642878|NCT00729313|Treatment|treatment
5642879|NCT00729300|cocaine|cocaine
5642880|NCT00729300|disulfiram|disulfiram
5642881|NCT00729300|antabuse|antabuse
5642882|NCT00729300|addiction|addiction
5642883|NCT00729300|stimulant|stimulant
5642884|NCT00729287|stage 0 bladder cancer|stage 0 bladder cancer
5642885|NCT00729287|stage I bladder cancer|stage i bladder cancer
5642886|NCT00729287|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5642887|NCT00729261|mechanical ventilation|mechanical ventilation
5642888|NCT00729261|extubation|extubation
5642889|NCT00729261|outcomes|outcomes
5642890|NCT00729261|brain injury|brain injury
5642891|NCT00729248|Transplants|transplants
5642892|NCT00729248|Kidney Transplantation|kidney transplantation
5642893|NCT00729248|Immunosuppression|immunosuppression
5642894|NCT00729248|Assay|assay
5642895|NCT00729248|Graft Rejection|graft rejection
5642896|NCT00729235|Slow VT, CRT-D, ATP therapy|slow vt, crt-d, atp therapy
5642897|NCT00729235|Incidence|incidence
5642898|NCT00729235|of slow VTs|of slow vts
5642899|NCT00729235|in CRT-D patients|in crt-d patients
5642900|NCT00729235|Clinical|clinical
5642901|NCT00729235|relevance|relevance
5642902|NCT00729235|treatment|treatment
5642903|NCT00729235|VTs|vts
5642904|NCT00729235|during|during
5642905|NCT00729235|2-years|2-years
5642906|NCT00729235|follow-up|follow-up
5642907|NCT00729196|Obesity|obesity
5642908|NCT00729196|Type 2 Diabetes|type 2 diabetes
5642909|NCT00729196|Glycemic Load|glycemic load
5642910|NCT00729196|Weight Loss|weight loss
5642911|NCT00729196|Glycated Hemoglobin|glycated hemoglobin
5642912|NCT00729170|Milk|milk
5642913|NCT00729170|Calcium|calcium
5642914|NCT00729170|Weight loss|weight loss
5642915|NCT00729170|Bone density|bone density
5642916|NCT00729170|Appetite|appetite
5642917|NCT00729144|fecal incontinence|fecal incontinence
5642918|NCT00729144|bowel incontinence|bowel incontinence
5642919|NCT00729144|pelvic floor disorder|pelvic floor disorder
5642920|NCT00729131|Ozone, TNF, TNF promoter polymorphism, airway hyperresponsiveness.|ozone, tnf, tnf promoter polymorphism, airway hyperresponsiveness.
5642921|NCT00729118|stage I multiple myeloma|stage i multiple myeloma
5642922|NCT00729118|stage II multiple myeloma|stage ii multiple myeloma
5642923|NCT00729118|stage III multiple myeloma|stage iii multiple myeloma
5642924|NCT00729118|refractory multiple myeloma|refractory multiple myeloma
5642926|NCT00729092|PAIN LEVELS|pain levels
5642927|NCT00729079|Diabetes Prevention|diabetes prevention
5642928|NCT00729079|Pre-Diabetes|pre-diabetes
5642929|NCT00729079|Exercise|exercise
5642930|NCT00729079|Fat Intake|fat intake
5642931|NCT00729079|Fasting blood sugar|fasting blood sugar
5642932|NCT00729079|tobacco cessation|tobacco cessation
5642933|NCT00729053|renal|renal
5642934|NCT00729053|cell|cell
5642935|NCT00729053|renal carcinoma|renal carcinoma
5642936|NCT00729053|metastatic|metastatic
5642937|NCT00729053|recurrent|recurrent
5642938|NCT00729053|treatment naive|treatment naive
5642940|NCT00729040|weight|weight
5642941|NCT00729040|Overweight|overweight
5642942|NCT00729040|bmi|bmi
5642943|NCT00729040|diabetes|diabetes
5642944|NCT00729040|type 2|type 2
5642945|NCT00729040|diabetic|diabetic
5642946|NCT00729040|walk|walk
5642947|NCT00729040|walk*|walk*
5642948|NCT00729040|diab*|diab*
5642949|NCT00729040|obese|obese
5642950|NCT00729040|exercise|exercise
5642951|NCT00729040|activity|activity
5642952|NCT00729040|coronary|coronary
5642953|NCT00729040|pedometer|pedometer
5642954|NCT00729027|hypercholesterolemia|hypercholesterolemia
5642955|NCT00729014|herbal nephropathy|herbal nephropathy
5642956|NCT00729014|Chinese herbal nephropathy|chinese herbal nephropathy
5642957|NCT00729014|nephrotoxicity|nephrotoxicity
5642958|NCT00729014|renal disease|renal disease
5642959|NCT00729014|adverse drug reaction|adverse drug reaction
5642960|NCT00729014|Chinese herbal medicine|chinese herbal medicine
5642961|NCT00729001|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5642962|NCT00729001|Human rotavirus vaccine|human rotavirus vaccine
5642963|NCT00728988|Asia Lipitor Pre-treatment in Acute Coronary Syndrome|asia lipitor pre-treatment in acute coronary syndrome
5642964|NCT00728975|constipation|constipation
5642965|NCT00728975|cancer|cancer
5642966|NCT00728975|palliative care|palliative care
5642967|NCT00728975|terminal|terminal
5642968|NCT00728975|bowel|bowel
5642969|NCT00728962|dental implants|dental implants
5642970|NCT00728962|Osseotite Certain Prevail|osseotite certain prevail
5642971|NCT00728962|multicenter|multicenter
5642972|NCT00728962|observational|observational
5642973|NCT00728962|clinical study|clinical study
5642974|NCT00728962|partial edentulism|partial edentulism
5642975|NCT00728962|single stage|single stage
5642976|NCT00728962|immediate occlusal loading|immediate occlusal loading
5642977|NCT00728962|crestal bone level|crestal bone level
5642978|NCT00728962|short fixed bridge|short fixed bridge
5642979|NCT00728949|breast cancer|breast cancer
5642980|NCT00728949|Postmenopausal|postmenopausal
5642981|NCT00728949|Hormones|hormones
5642982|NCT00728949|Antiestrogen|antiestrogen
5642983|NCT00728936|Hepatitis C|hepatitis c
5642984|NCT00728936|unresponsive to pegylated interferon and ribavirin therapy|unresponsive to pegylated interferon and ribavirin therapy
5642985|NCT00728936|hepatitis C virus|hepatitis c virus
5642986|NCT00728923|OCD|ocd
5642987|NCT00728910|Low HDL cholesterol|low hdl cholesterol
5642988|NCT00728910|High triglycerides|high triglycerides
5642989|NCT00728910|niacin|niacin
5642990|NCT00728910|fibrate|fibrate
5642991|NCT00728897|Healthy volunteer|healthy volunteer
5642992|NCT00728897|relative bioavailability.|relative bioavailability.
5642993|NCT00728884|dental implants|dental implants
5642994|NCT00728884|Certain Prevail|certain prevail
5642995|NCT00728884|multicenter|multicenter
5642996|NCT00728884|clinical study|clinical study
5642997|NCT00728884|partial edentulism|partial edentulism
5642998|NCT00728884|total edentulism|total edentulism
5642999|NCT00728884|platform switching|platform switching
5643000|NCT00728884|single stage|single stage
5643001|NCT00728884|early loading|early loading
5643002|NCT00728884|crestal bone level|crestal bone level
5643003|NCT00728884|single tooth replacements|single tooth replacements
5643004|NCT00728884|short or long fixed bridges|short or long fixed bridges
5643005|NCT00728884|overdenture|overdenture
5643006|NCT00728884|fixed denture|fixed denture
5643007|NCT00728871|cervical cancer, HPV, immunity|cervical cancer, hpv, immunity
5643008|NCT00728858|Hypertension|hypertension
5643009|NCT00728858|SNP|snp
5643010|NCT00728858|Nifedipine|nifedipine
5643011|NCT00728858|Barnidipine|barnidipine
5643012|NCT00728845|adenocarcinoma of the lung|adenocarcinoma of the lung
5643013|NCT00728845|large cell lung cancer|large cell lung cancer
5643014|NCT00728845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5643015|NCT00728845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5643016|NCT00728845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5643017|NCT00728832|extended release epidural morphine|extended release epidural morphine
5643018|NCT00728832|morphine|morphine
5643019|NCT00728832|thoracic epidural|thoracic epidural
5643020|NCT00728832|pharmacokinetics|pharmacokinetics
5643021|NCT00728832|pharmacodynamics|pharmacodynamics
5643022|NCT00728832|postoperative pain|postoperative pain
5643023|NCT00728832|upper abdominal surgery|upper abdominal surgery
5643024|NCT00728819|Inpatients|inpatients
5643025|NCT00728819|Requiring|requiring
5643026|NCT00728819|DL PICC|dl picc
5643027|NCT00728819|Access|access
5643028|NCT00728819|Medications|medications
5643029|NCT00728819|Blood|blood
5643030|NCT00728806|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5643031|NCT00728806|Ultrafiltration failure|ultrafiltration failure
5643032|NCT00728806|Biomarker|biomarker
5643033|NCT00728806|Proteomics|proteomics
5643034|NCT00728793|Advanced Solid Tumors|advanced solid tumors
5643035|NCT00728793|EGFR|egfr
5643036|NCT00728793|HDAC|hdac
5643037|NCT00728793|Her2|her2
5643038|NCT00728793|Open-Label|open-label
5643039|NCT00728793|Dose-Escalation|dose-escalation
5643040|NCT00728780|Adverse events|adverse events
5643041|NCT00728780|Pharmacokinetic variables|pharmacokinetic variables
5643042|NCT00728767|Heavy drinking|heavy drinking
5643043|NCT00728767|Brief intervention|brief intervention
5643044|NCT00728767|Alcohol prevention|alcohol prevention
5643045|NCT00728767|Randomized trial|randomized trial
5643046|NCT00728767|Motivational interviewing|motivational interviewing
5643047|NCT00728767|Intervention Studies|intervention studies
5643048|NCT00728767|prevention & control|prevention & control
5643049|NCT00728754|dental implants|dental implants
5643050|NCT00728754|Osseotite Certain Prevail|osseotite certain prevail
5643052|NCT00728754|non-lateralized|non-lateralized
5643053|NCT00728754|Osseotite Certain|osseotite certain
5643054|NCT00728754|multicenter|multicenter
5643055|NCT00728754|randomized|randomized
5643056|NCT00728754|clinical study|clinical study
5643057|NCT00728754|partial edentulism|partial edentulism
5643058|NCT00728754|single stage|single stage
5643059|NCT00728754|early loading|early loading
5643060|NCT00728754|crestal bone level|crestal bone level
5643061|NCT00728754|short fixed bridge|short fixed bridge
5643062|NCT00728741|Neural Networks|neural networks
5643063|NCT00728741|Cortical Activation|cortical activation
5643064|NCT00728741|Strategy|strategy
5643065|NCT00728741|fMRI|fmri
5643066|NCT00728741|Healthy Volunteer|healthy volunteer
5643067|NCT00728741|HV|hv
5643068|NCT00728728|pregnenolone|pregnenolone
5643780|NCT00726323|c-Met|c-met
5643069|NCT00728728|schizophrenia|schizophrenia
5643070|NCT00728728|cognitive|cognitive
5643071|NCT00728728|positive symptom|positive symptom
5643072|NCT00728728|negative symptom|negative symptom
5643073|NCT00728728|placebo control|placebo control
5643074|NCT00728715|Budesonide|budesonide
5643075|NCT00728715|Formoterol|formoterol
5643076|NCT00728715|Non cystic fibrosis bronchiectasis|non cystic fibrosis bronchiectasis
5643077|NCT00728689|Orthopoxviral|orthopoxviral
5643078|NCT00728689|Smallpox|smallpox
5643079|NCT00728689|Monkey pox|monkey pox
5643080|NCT00728676|PKU,|pku,
5643081|NCT00728676|Phe,|phe,
5643082|NCT00728676|PAH,|pah,
5643083|NCT00728676|Kuvan,|kuvan,
5643084|NCT00728676|Trp,|trp,
5643086|NCT00728663|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5643087|NCT00728663|recurrent prostate cancer|recurrent prostate cancer
5643213|NCT00728104|L-Carnitine|l-carnitine
5643088|NCT00728663|stage IV prostate cancer|stage iv prostate cancer
5643089|NCT00728650|hepatocellular carcinoma|hepatocellular carcinoma
5863030|NCT00001413|Normal Volunteer|normal volunteer
5643090|NCT00728650|colorectal carcinoma metastatic to liver|colorectal carcinoma metastatic to liver
5643092|NCT00728637|Prevention|prevention
5643093|NCT00728624|Antibiotic susceptibility; beta lactamase; ESBLs|antibiotic susceptibility; beta lactamase; esbls
5643094|NCT00728598|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5643095|NCT00728598|Angiogenesis|angiogenesis
5643096|NCT00728598|Vitreous levels|vitreous levels
5643097|NCT00728598|Vascular endothelial growth factor|vascular endothelial growth factor
5643098|NCT00728598|Fractalkine|fractalkine
5643099|NCT00728598|Growth factor|growth factor
5643100|NCT00728559|laparoscopy|laparoscopy
5643101|NCT00728559|preemptive|preemptive
5643102|NCT00728559|postoperative|postoperative
5643103|NCT00728559|pain|pain
5643104|NCT00728559|trocar|trocar
5643105|NCT00728559|site|site
5643106|NCT00728546|tuberculosis|tuberculosis
5643107|NCT00728546|isoniazid|isoniazid
5643108|NCT00728546|Arylamine N-acetyl transferase|arylamine n-acetyl transferase
5643109|NCT00728546|genotyping|genotyping
5643110|NCT00728546|hepatotoxicity|hepatotoxicity
5643111|NCT00728546|pharmacogenetics|pharmacogenetics
5643112|NCT00728533|Prostate Cancer requiring Androgen Ablation Therapy|prostate cancer requiring androgen ablation therapy
5643113|NCT00728520|Leukemia|leukemia
5643114|NCT00728520|Azacitidine|azacitidine
5643115|NCT00728520|Untreated|untreated
5643116|NCT00728520|Elderly|elderly
5643117|NCT00728507|Tuberculosis|tuberculosis
5643118|NCT00728507|Moxifloxacin|moxifloxacin
5643119|NCT00728507|Rifapentine|rifapentine
5643121|NCT00728468|PF-00299804|pf-00299804
5643122|NCT00728468|Dextromethorphan|dextromethorphan
5643123|NCT00728468|CYP2D6 Inhibition|cyp2d6 inhibition
5643124|NCT00728468|Cancer Patients|cancer patients
5643125|NCT00728442|Clinical practice guidelines|clinical practice guidelines
5643126|NCT00728442|Guideline adherence|guideline adherence
5643127|NCT00728442|Clinical decision support systems|clinical decision support systems
5643128|NCT00728442|Randomized controlled trial|randomized controlled trial
5643129|NCT00728442|Intervention study|intervention study
5643130|NCT00728429|cardiac toxicity|cardiac toxicity
5643131|NCT00728429|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5643132|NCT00728429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5643133|NCT00728390|advanced cancer refractory advanced non-small cell lung cancer|advanced cancer refractory advanced non-small cell lung cancer
5643134|NCT00728377|gestational diabetes|gestational diabetes
5643135|NCT00728377|physical activity|physical activity
5643136|NCT00728377|behavior change|behavior change
5643137|NCT00728377|glucose tolerance|glucose tolerance
5643138|NCT00728377|pregnancy|pregnancy
5643139|NCT00728364|Anderson Fabry disease|anderson fabry disease
5643140|NCT00728364|chronic kidney disease|chronic kidney disease
5643141|NCT00728364|prevalence|prevalence
5643142|NCT00728351|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5643143|NCT00728338|docosahexenoic acid (DHA)|docosahexenoic acid (dha)
5643144|NCT00728338|dietary supplement|dietary supplement
5643145|NCT00728338|n-3 polyunsaturated fatty acid|n-3 polyunsaturated fatty acid
5643146|NCT00728338|cardiovascular disease|cardiovascular disease
5643147|NCT00728325|PTSD|ptsd
5643148|NCT00728325|Vocational Rehabilitation|vocational rehabilitation
5643149|NCT00728325|Supported Employment|supported employment
5643150|NCT00728312|Methamphetamine|methamphetamine
5643151|NCT00728312|Therapeutics|therapeutics
5643152|NCT00728312|Psychopharmacology|psychopharmacology
5643153|NCT00728312|Amphetamine|amphetamine
5643154|NCT00728299|Coronary artery disease, carotid intima-media thickness|coronary artery disease, carotid intima-media thickness
5643155|NCT00728286|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5643156|NCT00728286|Acute Coronary Syndrome|acute coronary syndrome
5643157|NCT00728286|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
5643158|NCT00728273|Efficacy|efficacy
5643160|NCT00728273|school children|school children
5643161|NCT00728273|anemia|anemia
5643162|NCT00728273|fortification|fortification
5643163|NCT00728273|micronutrient|micronutrient
5643165|NCT00728260|Meningococcal disease|meningococcal disease
5643166|NCT00728260|Menactra vaccine|menactra vaccine
5643167|NCT00728247|Cervical Spine|cervical spine
5643168|NCT00728247|Kinematics|kinematics
5643169|NCT00728247|Manipulation|manipulation
5643170|NCT00728247|Biomechanics|biomechanics
5643171|NCT00728234|aEEG|aeeg
5643172|NCT00728234|preterm infants|preterm infants
5643173|NCT00728234|predictive value|predictive value
5643174|NCT00728234|outcome|outcome
5643175|NCT00728221|Ginseng|ginseng
5643176|NCT00728221|Korean Red Ginseng|korean red ginseng
5643177|NCT00728221|Ginsenoside|ginsenoside
5643178|NCT00728221|Flow Mediated Dilation|flow mediated dilation
5643179|NCT00728221|Endothelial Function|endothelial function
5643180|NCT00728221|Hypertension|hypertension
5643181|NCT00728208|Young|young
5643182|NCT00728208|Elderly|elderly
5643183|NCT00728208|Randomised|randomised
5643184|NCT00728208|GSK372475|gsk372475
5643185|NCT00728195|Schizophrenia|schizophrenia
5643186|NCT00728195|Central Nervous System|central nervous system
5643188|NCT00728182|Stroke|stroke
5643189|NCT00728182|Vascular cognitive impairment|vascular cognitive impairment
5643190|NCT00728182|Coiling|coiling
5643191|NCT00728182|Endovascular repair|endovascular repair
5643192|NCT00728182|Brain aneurysm|brain aneurysm
5643193|NCT00728182|NA-1|na-1
5643194|NCT00728169|Asthma|asthma
5643195|NCT00728169|Focus Group|focus group
5643196|NCT00728169|Community Based Participatory Research|community based participatory research
5643197|NCT00728156|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5643198|NCT00728156|Coronary artery disease|coronary artery disease
5643199|NCT00728156|Platelet dependent thrombogenicity|platelet dependent thrombogenicity
5643200|NCT00728156|Aspirin|aspirin
5643201|NCT00728156|Clopidogrel|clopidogrel
5643202|NCT00728156|Badimon Chamber|badimon chamber
5643203|NCT00728130|carcinoma|carcinoma
5643204|NCT00728130|upper|upper
5643205|NCT00728130|aerodigestive|aerodigestive
5643206|NCT00728130|tract|tract
5643207|NCT00728130|submandibular|submandibular
5643208|NCT00728130|gland|gland
5643209|NCT00728117|indomethacin|indomethacin
5643210|NCT00728117|ibuprofen|ibuprofen
5643211|NCT00728117|preterm infant|preterm infant
5643212|NCT00728104|Learn|learn
5643214|NCT00728104|Co-enzyme Q10|co-enzyme q10
5643215|NCT00728104|Effective|effective
5643216|NCT00728104|These supplements|these supplements
5643217|NCT00728104|Compared|compared
5643218|NCT00728104|Standard|standard
5643220|NCT00728091|SIADH|siadh
5643221|NCT00728078|hepatocellular carcinoma|hepatocellular carcinoma
5643222|NCT00728078|liver cancer|liver cancer
5643223|NCT00728078|radiofrequency ablation|radiofrequency ablation
5643224|NCT00728078|thalidomide|thalidomide
5643225|NCT00728052|Tolerability|tolerability
5643226|NCT00728052|dose escalation|dose escalation
5643227|NCT00728052|GSK598809|gsk598809
5643228|NCT00728052|Pharmacodynamics|pharmacodynamics
5643229|NCT00728052|Safety|safety
5643230|NCT00728052|single|single
5643231|NCT00728052|placebo|placebo
5643232|NCT00728052|Smokers|smokers
5643233|NCT00728052|Pharmacokinetics|pharmacokinetics
5643234|NCT00728039|Youth|youth
5643235|NCT00728039|Consensus|consensus
5643236|NCT00728039|Criteria|criteria
5643237|NCT00728039|CVS|cvs
5643238|NCT00728026|Chart must reveal the following procedures:|chart must reveal the following procedures:
5643239|NCT00728026|Heart rate variability,|heart rate variability,
5643240|NCT00728026|Deep Breathing Test,|deep breathing test,
5643241|NCT00728026|Valsalva maneuver,|valsalva maneuver,
5643243|NCT00728026|Thermoregulatory Sweat Testing,|thermoregulatory sweat testing,
5643244|NCT00728026|Quantitative Sudomotor Axon Reflex Test (QSART),|quantitative sudomotor axon reflex test (qsart),
5643245|NCT00728026|Vital signs,|vital signs,
5643246|NCT00728026|postural changes in heart rate and blood pressure,|postural changes in heart rate and blood pressure,
5643247|NCT00728026|composite autonomic score|composite autonomic score
5643248|NCT00728013|Acute coronary syndrome|acute coronary syndrome
5643249|NCT00728013|intensive lipid-lowering|intensive lipid-lowering
5643250|NCT00728013|statins|statins
5643251|NCT00728000|Pancreatic Cancer|pancreatic cancer
5643252|NCT00727987|Rheumatoid arthritis|rheumatoid arthritis
5643253|NCT00727987|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5643254|NCT00727987|CNTO148|cnto148
5643255|NCT00727987|Golimumab|golimumab
5643256|NCT00727974|Genome Wide Scan (GWS)|genome wide scan (gws)
5643257|NCT00727974|Mitochondrial scan|mitochondrial scan
5643258|NCT00727974|Family trios|family trios
5643259|NCT00727948|Breast cancer|breast cancer
5643260|NCT00727948|Angiogenesis|angiogenesis
5643261|NCT00727948|Aspirin|aspirin
5643262|NCT00727948|Tamoxifen|tamoxifen
5643263|NCT00727935|Women|women
5643264|NCT00727935|parturients|parturients
5643265|NCT00727935|with|with
5643266|NCT00727935|realization|realization
5643267|NCT00727935|episiotomy|episiotomy
5643268|NCT00727922|Neuropathy|neuropathy
5643269|NCT00727922|Oxaliplatin|oxaliplatin
5643270|NCT00727922|Mangafodipir|mangafodipir
5643271|NCT00727909|Hearing loss|hearing loss
5643272|NCT00727909|Hearing Aids|hearing aids
5643273|NCT00727909|Speech Perception|speech perception
5643274|NCT00727909|Persons with Hearing Impairment|persons with hearing impairment
5643275|NCT00727896|Life style modification,|life style modification,
5643276|NCT00727896|Type 2 diabetes,|type 2 diabetes,
5643277|NCT00727896|SMS,|sms,
5643278|NCT00727896|Patient adherence|patient adherence
5643279|NCT00727883|Breast Cancer|breast cancer
5643280|NCT00727883|Adjuvant TAM|adjuvant tam
5643281|NCT00727883|post-menopausal|post-menopausal
5643282|NCT00727883|women|women
5643283|NCT00727870|Shave Biopsy management|shave biopsy management
5643284|NCT00727870|"Biopsy/adverse effects[Mesh]"|"biopsy/adverse effects[mesh]"
5643285|NCT00727870|"Biopsy/complications[Mesh])"|"biopsy/complications[mesh])"
5643286|NCT00727857|Glucose Metabolism Disorder|glucose metabolism disorder
5643287|NCT00727857|Dysmetabolic Syndrome|dysmetabolic syndrome
5643288|NCT00727857|Type II Diabetes|type ii diabetes
5643289|NCT00727857|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5643290|NCT00727857|Dyslipidemia|dyslipidemia
5643291|NCT00727857|Drug Therapy|drug therapy
5643293|NCT00727844|Linezolid|linezolid
5643294|NCT00727844|Drug Resistance|drug resistance
5643295|NCT00727844|Computed Tomography|computed tomography
5643296|NCT00727844|Pharmacokinetics|pharmacokinetics
5643297|NCT00727844|Tuberculosis|tuberculosis
5643298|NCT00727844|Drug Resistance Tuberculosis|drug resistance tuberculosis
5643299|NCT00727844|MDR-TB|mdr-tb
5643300|NCT00727831|neurotoxicity|neurotoxicity
5643301|NCT00727831|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5643302|NCT00727831|mucositis|mucositis
5643303|NCT00727831|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5643304|NCT00727831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5643305|NCT00727831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5643306|NCT00727831|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5643307|NCT00727831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5643308|NCT00727831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5643309|NCT00727792|participants|participants
5643310|NCT00727792|scheduled|scheduled
5643311|NCT00727792|clinically|clinically
5643312|NCT00727792|ordered|ordered
5643314|NCT00727779|diabetes, metabolic syndrome, type 2 diabetes|diabetes, metabolic syndrome, type 2 diabetes
5643315|NCT00727766|Clofarabine|clofarabine
5643316|NCT00727766|Clolar|clolar
5643317|NCT00727766|AML|aml
5643318|NCT00727766|Consolidation|consolidation
5643319|NCT00727753|Macular Degeneration|macular degeneration
5643320|NCT00727753|Age-Related Maculopathies|age-related maculopathies
5643321|NCT00727740|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5643322|NCT00727740|Pancreatitis|pancreatitis
5643323|NCT00727740|Indomethacin|indomethacin
5643324|NCT00727727|Piribedil (trade name: Clarium)|piribedil (trade name: clarium)
5643325|NCT00727727|non-ergot dopamine agonist|non-ergot dopamine agonist
5643326|NCT00727727|Morbus Parkinson|morbus parkinson
5643327|NCT00727727|Tolerability|tolerability
5643328|NCT00727727|Efficacy|efficacy
5643329|NCT00727727|Post Marketing Surveillance|post marketing surveillance
5643330|NCT00727714|Cement dust exposure|cement dust exposure
5643331|NCT00727714|Cross-shift study|cross-shift study
5643332|NCT00727714|Lung function indices|lung function indices
5643333|NCT00727714|Exhaled nitric oxide|exhaled nitric oxide
5643334|NCT00727714|Serum inflammatory markers|serum inflammatory markers
5643335|NCT00727701|varicose ulcer|varicose ulcer
5643336|NCT00727701|veteran|veteran
5643337|NCT00727701|recurrence|recurrence
5643338|NCT00727701|aftercare|aftercare
5643339|NCT00727675|chronic pain|chronic pain
5643340|NCT00727675|opioid dependence|opioid dependence
5643341|NCT00727675|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5643342|NCT00727662|Breast Cancer|breast cancer
5643343|NCT00727662|Fatigue|fatigue
5643344|NCT00727662|Proinflammatory Cytokines|proinflammatory cytokines
5643345|NCT00727662|Physical functioning|physical functioning
5643346|NCT00727662|Quality of life|quality of life
5643347|NCT00727649|fecal incontinence|fecal incontinence
5643348|NCT00727649|adults|adults
5643349|NCT00727649|diarrhea|diarrhea
5643350|NCT00727636|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5643351|NCT00727636|immunogenicity|immunogenicity
5643352|NCT00727636|safety|safety
5643353|NCT00727636|HPV|hpv
5643354|NCT00727636|Gardasil|gardasil
5643355|NCT00727636|vaccine|vaccine
5643356|NCT00727623|acute coronary syndrome|acute coronary syndrome
5643357|NCT00727623|myocardial infarction|myocardial infarction
5643358|NCT00727623|predictors of mortality|predictors of mortality
5643359|NCT00727623|reperfusion therapy|reperfusion therapy
5643360|NCT00727610|Adverse drug event|adverse drug event
5643361|NCT00727610|harm|harm
5643362|NCT00727610|patient safety|patient safety
5643363|NCT00727610|clinical decision support|clinical decision support
5643364|NCT00727610|Adverse drug related event|adverse drug related event
5643368|NCT00727571|Chronic Kidney Disease|chronic kidney disease
5643369|NCT00727571|Quality of Life|quality of life
5643370|NCT00727571|CKD|ckd
5643371|NCT00727571|Chronic Renal Insufficiency|chronic renal insufficiency
5643372|NCT00727558|refractive error|refractive error
5643373|NCT00727532|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5643374|NCT00727532|hereditary clear cell renal cell carcinoma|hereditary clear cell renal cell carcinoma
5643375|NCT00727532|recurrent renal cell cancer|recurrent renal cell cancer
5643376|NCT00727532|stage I renal cell cancer|stage i renal cell cancer
5643377|NCT00727532|stage II renal cell cancer|stage ii renal cell cancer
5643378|NCT00727532|stage III renal cell cancer|stage iii renal cell cancer
5643379|NCT00727532|stage IV renal cell cancer|stage iv renal cell cancer
5643380|NCT00727519|Hemodialysis|hemodialysis
5643381|NCT00727519|Nephrology|nephrology
5643382|NCT00727519|Pomegranate Juice|pomegranate juice
5643383|NCT00727519|Israel|israel
5643384|NCT00727493|osteoporosis,|osteoporosis,
5643385|NCT00727493|bisphosphonate|bisphosphonate
5643386|NCT00727493|therapy|therapy
5643387|NCT00727493|dental implant|dental implant
5643388|NCT00727480|vascularity|vascularity
5643389|NCT00727480|fingertips|fingertips
5643390|NCT00727467|auditory cueing device|auditory cueing device
5643391|NCT00727467|Parkinson's disease|parkinson's disease
5643392|NCT00727467|freezing|freezing
5643393|NCT00727467|gait|gait
5643394|NCT00727467|mobility|mobility
5643395|NCT00727454|Obstructive sleep apnea|obstructive sleep apnea
5643396|NCT00727454|CPAP|cpap
5643397|NCT00727454|Heart remodeling|heart remodeling
5643398|NCT00727454|Cardiovascular disease|cardiovascular disease
5643403|NCT00727428|FluLaval® TF|flulaval® tf
5643404|NCT00727428|Safety|safety
5643405|NCT00727428|Immunogenicity|immunogenicity
5643406|NCT00727428|Influenza|influenza
5643407|NCT00727415|advanced or progressive chronic lymphocytic leukemia|advanced or progressive chronic lymphocytic leukemia
5643408|NCT00727415|Lenalidomide|lenalidomide
5643409|NCT00727415|Fludarabine|fludarabine
5643410|NCT00727389|Prevention|prevention
5643411|NCT00727389|Quality of Health Care|quality of health care
5643412|NCT00727389|Health Care Evaluation Mechanisms|health care evaluation mechanisms
5643413|NCT00727376|esophageal|esophageal
5643414|NCT00727376|stenting|stenting
5643415|NCT00727363|probiotics|probiotics
5643416|NCT00727363|lactobacillus reuteri|lactobacillus reuteri
5643417|NCT00727363|preterm infants|preterm infants
5643419|NCT00727363|necrotizing enterocolitis|necrotizing enterocolitis
5643420|NCT00727350|NSCLC|nsclc
5643421|NCT00727350|Novalis|novalis
5643422|NCT00727350|Stereotactic|stereotactic
5643423|NCT00727350|SBRT|sbrt
5643424|NCT00727350|T1, T2 or T3NO NSCLC|t1, t2 or t3no nsclc
5643425|NCT00727337|auditory perception|auditory perception
5643426|NCT00727337|rehabilitation of hearing impaired|rehabilitation of hearing impaired
5643427|NCT00727324|Ulcerative Colitis|ulcerative colitis
5643428|NCT00727324|UC|uc
5643429|NCT00727324|moderate|moderate
5643430|NCT00727324|severe|severe
5643431|NCT00727324|LPS|lps
5643432|NCT00727324|Alkaline Phosphatase|alkaline phosphatase
5643433|NCT00727324|AP|ap
5643434|NCT00727324|BIAP|biap
5643435|NCT00727324|Mucositis|mucositis
5643436|NCT00727285|Cystic Fibrosis|cystic fibrosis
5643437|NCT00727285|pulmonary exacerbation|pulmonary exacerbation
5643438|NCT00727285|gene expression|gene expression
5643439|NCT00727285|biomarker|biomarker
5643440|NCT00727285|inflammation|inflammation
5643441|NCT00727285|CF pulmonary exacerbation|cf pulmonary exacerbation
5643442|NCT00727272|Bioavailability|bioavailability
5643443|NCT00727246|Traumatic Brain Injury|traumatic brain injury
5643445|NCT00727246|Memory|memory
5643446|NCT00727246|Cognition|cognition
5643447|NCT00727246|Neuropsychology|neuropsychology
5643448|NCT00727233|Neuroblastosis Type I|neuroblastosis type i
5643449|NCT00727233|Plexiform Neurofibromas|plexiform neurofibromas
5643450|NCT00727233|Angiogenesis Inhibitor|angiogenesis inhibitor
5643451|NCT00727233|Kinase Inhibitor|kinase inhibitor
5643452|NCT00727233|Neurofibromatosis Type 1|neurofibromatosis type 1
5643454|NCT00727233|Plexiform Neurofibroma|plexiform neurofibroma
5643455|NCT00727220|type 1 diabetes|type 1 diabetes
5643456|NCT00727220|continuous glucose sensor monitoring|continuous glucose sensor monitoring
5643457|NCT00727207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5643458|NCT00727207|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5643459|NCT00727207|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5643460|NCT00727207|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5643461|NCT00727207|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5643991|NCT00725400|Cetuximab|cetuximab
5643473|NCT00727168|glaucoma|glaucoma
5643474|NCT00727142|NPH|nph
5643475|NCT00727142|Hydrocephalus|hydrocephalus
5643476|NCT00727142|Shunt|shunt
5643477|NCT00727129|vasomotor symptoms|vasomotor symptoms
5643478|NCT00727129|estrogen|estrogen
5643479|NCT00727129|estradiol|estradiol
5643480|NCT00727129|hot flashes|hot flashes
5643481|NCT00727103|Varenicline|varenicline
5643482|NCT00727103|Smoking cessation|smoking cessation
5643483|NCT00727103|Schizophrenia|schizophrenia
5643484|NCT00727103|Schizoaffective disorder|schizoaffective disorder
5643485|NCT00727103|Alcohol dependence|alcohol dependence
5643486|NCT00727103|Nicotine dependence|nicotine dependence
5643487|NCT00727064|Healthy Subjects|healthy subjects
5643488|NCT00727051|invasive coronary angiography|invasive coronary angiography
5625019|NCT00799721|ROP|rop
5643489|NCT00727051|multidetector coronary CTA|multidetector coronary cta
5643490|NCT00727051|coronary artery disease|coronary artery disease
5643491|NCT00727051|detecting coronary artery disease|detecting coronary artery disease
5643502|NCT00727025|skin closure devices|skin closure devices
5643503|NCT00727025|linear scars|linear scars
5643504|NCT00727012|mitral valve|mitral valve
5643505|NCT00727012|heart valve|heart valve
5643506|NCT00727012|valve repair|valve repair
5643507|NCT00727012|valve disorder|valve disorder
5643508|NCT00727012|valve disease|valve disease
5643509|NCT00727012|cardiac surgery|cardiac surgery
5643510|NCT00726999|Gabapentin|gabapentin
5643511|NCT00726999|Pediatric Spinal Fusion|pediatric spinal fusion
5643513|NCT00726986|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5643515|NCT00726960|Heroin abuse|heroin abuse
5643516|NCT00726960|Opioids|opioids
5643517|NCT00726960|Opiates|opiates
5643518|NCT00726960|Substance abuse|substance abuse
5643519|NCT00726960|Addiction|addiction
5643520|NCT00726934|Neutropenic Diet|neutropenic diet
5643521|NCT00726934|Food Safety Guidelines|food safety guidelines
5643522|NCT00726934|child|child
5643523|NCT00726934|cancer|cancer
5643524|NCT00726908|Obesity|obesity
5643525|NCT00726908|diet|diet
5643526|NCT00726908|carbohydrate|carbohydrate
5643527|NCT00726908|insulin|insulin
5643528|NCT00726895|Bioavailability|bioavailability
5643529|NCT00726882|HCV Infection|hcv infection
5643530|NCT00726869|Patients After One to three Prior Therapies|patients after one to three prior therapies
5643531|NCT00726843|Headache|headache
5643532|NCT00726843|Complementary and Alternative Medicine|complementary and alternative medicine
5643533|NCT00726843|Pediatric|pediatric
5643534|NCT00726843|Yoga|yoga
5643535|NCT00726830|pain|pain
5643536|NCT00726830|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5643537|NCT00726830|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5643538|NCT00726830|acute undifferentiated leukemia|acute undifferentiated leukemia
5643539|NCT00726830|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5643540|NCT00726830|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5643541|NCT00726830|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5643542|NCT00726830|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5643543|NCT00726830|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5643544|NCT00726830|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5643545|NCT00726830|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5643546|NCT00726830|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5643547|NCT00726830|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5643548|NCT00726830|mast cell leukemia|mast cell leukemia
5643549|NCT00726830|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5643550|NCT00726830|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5643551|NCT00726830|prolymphocytic leukemia|prolymphocytic leukemia
5643552|NCT00726830|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5643553|NCT00726830|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5643554|NCT00726830|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5643555|NCT00726830|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5643556|NCT00726830|refractory hairy cell leukemia|refractory hairy cell leukemia
5643557|NCT00726830|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5643558|NCT00726830|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5643559|NCT00726830|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5643560|NCT00726830|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5643561|NCT00726830|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5643562|NCT00726830|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5643563|NCT00726830|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5643564|NCT00726830|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5643565|NCT00726830|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5643566|NCT00726830|untreated hairy cell leukemia|untreated hairy cell leukemia
5643567|NCT00726830|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5643568|NCT00726830|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5643569|NCT00726830|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5643570|NCT00726830|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5643571|NCT00726830|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5643572|NCT00726830|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5643573|NCT00726830|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5643574|NCT00726830|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5643575|NCT00726830|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5643576|NCT00726830|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5643577|NCT00726830|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5643578|NCT00726830|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5643579|NCT00726830|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5643580|NCT00726830|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5643581|NCT00726830|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5643582|NCT00726830|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5643583|NCT00726830|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5643584|NCT00726830|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5643585|NCT00726830|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5643586|NCT00726830|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5643587|NCT00726830|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5643588|NCT00726830|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5643589|NCT00726830|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5643590|NCT00726830|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5643591|NCT00726830|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5643592|NCT00726830|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5643593|NCT00726830|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5643594|NCT00726830|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5643595|NCT00726830|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5643596|NCT00726830|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5643597|NCT00726830|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5643598|NCT00726830|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5643599|NCT00726830|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5643600|NCT00726830|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5643601|NCT00726830|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5643602|NCT00726830|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5643603|NCT00726830|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5643604|NCT00726830|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5643605|NCT00726830|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5643606|NCT00726830|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5643607|NCT00726830|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5643608|NCT00726830|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5643609|NCT00726830|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5643610|NCT00726830|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5643611|NCT00726830|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5643612|NCT00726830|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5643613|NCT00726830|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5643614|NCT00726830|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5643615|NCT00726830|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5643616|NCT00726830|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5643617|NCT00726830|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5643618|NCT00726830|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5643619|NCT00726830|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5643620|NCT00726830|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5643621|NCT00726830|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5643622|NCT00726830|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5643623|NCT00726830|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5643624|NCT00726830|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5643625|NCT00726830|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5643626|NCT00726830|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5643627|NCT00726830|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5643628|NCT00726830|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5643629|NCT00726830|intraocular lymphoma|intraocular lymphoma
5643630|NCT00726830|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5643631|NCT00726830|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5643632|NCT00726830|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5643633|NCT00726830|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5643634|NCT00726830|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5643635|NCT00726830|primary myelofibrosis|primary myelofibrosis
5643636|NCT00726830|essential thrombocythemia|essential thrombocythemia
5643637|NCT00726830|polycythemia vera|polycythemia vera
5643638|NCT00726830|extramedullary plasmacytoma|extramedullary plasmacytoma
5643639|NCT00726830|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5643640|NCT00726830|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5643641|NCT00726830|stage II multiple myeloma|stage ii multiple myeloma
5643642|NCT00726830|stage III multiple myeloma|stage iii multiple myeloma
5643643|NCT00726830|primary systemic amyloidosis|primary systemic amyloidosis
5643644|NCT00726830|refractory multiple myeloma|refractory multiple myeloma
5643645|NCT00726830|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5643646|NCT00726830|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5643647|NCT00726830|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5643648|NCT00726830|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5643649|NCT00726830|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5643650|NCT00726830|Waldenström macroglobulinemia|waldenström macroglobulinemia
5643651|NCT00726817|butyrate, visceral perception, compliance|butyrate, visceral perception, compliance
5643653|NCT00726791|pain disorder|pain disorder
5643654|NCT00726778|race/ethnicity|race/ethnicity
5643655|NCT00726778|insulin senistivity|insulin senistivity
5643656|NCT00726778|genetic admixture|genetic admixture
5643657|NCT00726778|type 2 diabetes|type 2 diabetes
5643658|NCT00726778|obesity|obesity
5643659|NCT00726778|body composition|body composition
5643660|NCT00726778|Insulin dynamics|insulin dynamics
5643661|NCT00726778|Racial/ethnic differences|racial/ethnic differences
5643662|NCT00726752|solid tumor|solid tumor
5643663|NCT00726752|Axitinib|axitinib
5643664|NCT00726752|Pharmacokinetics|pharmacokinetics
5643665|NCT00726752|Phase 1|phase 1
5643666|NCT00726739|recurrent melanoma|recurrent melanoma
5643667|NCT00726713|Metanx|metanx
5643668|NCT00726713|diabetes|diabetes
5643669|NCT00726713|neuropathy|neuropathy
5643670|NCT00726713|folic acid|folic acid
5643671|NCT00726713|folate|folate
5643672|NCT00726713|L-methylfolate|l-methylfolate
5643674|NCT00726713|Pyridoxal 5'-phosphate|pyridoxal 5'-phosphate
5643675|NCT00726713|vitamin B12|vitamin b12
5643676|NCT00726713|methylcobalamin|methylcobalamin
5643677|NCT00726700|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5643678|NCT00726700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5643679|NCT00726700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5643680|NCT00726700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5643681|NCT00726700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5643682|NCT00726700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5643683|NCT00726700|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5643684|NCT00726700|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5643685|NCT00726700|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5643686|NCT00726700|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5643687|NCT00726700|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5680397|NCT00577980|Castration-Resistant Prostate Cancer|castration-resistant prostate cancer
5643688|NCT00726700|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5643689|NCT00726700|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5643781|NCT00726323|Papillary Renal Cell Carcinoma(PRC)|papillary renal cell carcinoma(prc)
5643690|NCT00726700|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5643691|NCT00726700|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5643692|NCT00726700|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5643693|NCT00726700|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5643694|NCT00726700|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5643695|NCT00726700|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5643696|NCT00726700|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5643697|NCT00726700|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5643698|NCT00726700|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5643699|NCT00726700|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5643700|NCT00726700|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5672498|NCT00611676|antidepressant|antidepressant
5643701|NCT00726700|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5643702|NCT00726700|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5643703|NCT00726700|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5643704|NCT00726700|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5643705|NCT00726700|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5643706|NCT00726700|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5643707|NCT00726700|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5643709|NCT00726687|Indibulin|indibulin
5643710|NCT00726687|Capecitabine|capecitabine
5643711|NCT00726687|Xeloda|xeloda
5643712|NCT00726674|Diabetes HbA1C|diabetes hba1c
5643713|NCT00726661|Metastatic Breast Cancer|metastatic breast cancer
5643714|NCT00726661|Locally Recurrent Breast Cancer|locally recurrent breast cancer
5643715|NCT00726661|Avastin|avastin
5643716|NCT00726648|CDP323|cdp323
5643717|NCT00726648|Relapsing multiple sclerosis|relapsing multiple sclerosis
5643718|NCT00726648|Blood biomarkers|blood biomarkers
5643719|NCT00726622|rectal cancer|rectal cancer
5643720|NCT00726622|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5643721|NCT00726596|recurrent prostate cancer|recurrent prostate cancer
5643728|NCT00726583|PI3 kinase|pi3 kinase
5643729|NCT00726583|PI3K|pi3k
5643730|NCT00726570|Disorders, Blood coagulation|disorders, blood coagulation
5643731|NCT00726570|Deep Vein Thrombosis|deep vein thrombosis
5643732|NCT00726570|Perioperative Care|perioperative care
5643733|NCT00726570|Digestive System Surgical Procedures|digestive system surgical procedures
5643734|NCT00726544|thrombocytopenia|thrombocytopenia
5643735|NCT00726544|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia
5643736|NCT00726544|von Willebrand Factor|von willebrand factor
5643737|NCT00726544|ADAMTS13|adamts13
5643738|NCT00726531|Falls prevention|falls prevention
5643739|NCT00726531|Exercise promotion|exercise promotion
5643740|NCT00726531|Older people|older people
5643741|NCT00726466|Age Related Macular Degeneration|age related macular degeneration
5643742|NCT00726466|AMD|amd
5643743|NCT00726466|CNV|cnv
5643744|NCT00726453|TARGET VESSEL REVASCULARIZATION (TVR)|target vessel revascularization (tvr)
5643745|NCT00726453|MYOCARDIAL INFARCTION (MI)|myocardial infarction (mi)
5643746|NCT00726453|TARGET VESSEL FAILURE (TVF)|target vessel failure (tvf)
5643747|NCT00726453|TARGET LESION REVASCULARIZATION (TLR)|target lesion revascularization (tlr)
5643748|NCT00726453|TARGET LESION FAILURE (TLF)|target lesion failure (tlf)
5643749|NCT00726453|STENT THROMBOSIS|stent thrombosis
5643750|NCT00726453|RESTENOTIC LESION|restenotic lesion
5643751|NCT00726453|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5643752|NCT00726440|Type 1 Diabetes|type 1 diabetes
5643753|NCT00726440|Real Time Continuous Glucose Monitoring System|real time continuous glucose monitoring system
5643754|NCT00726440|HbA1c|hba1c
5643755|NCT00726440|Navigator®|navigator®
5643756|NCT00726427|pharmacokinetics|pharmacokinetics
5643757|NCT00726427|pharmacodynamics|pharmacodynamics
5643758|NCT00726427|AZD1656|azd1656
5643759|NCT00726427|safety|safety
5643760|NCT00726427|tolerability|tolerability
5643761|NCT00726427|Healthy Volunteers|healthy volunteers
5643762|NCT00726414|Bioavailability|bioavailability
5643763|NCT00726401|Allergies|allergies
5643764|NCT00726401|Nasal|nasal
5643765|NCT00726401|Congestion|congestion
5643766|NCT00726401|Sneezing|sneezing
5643767|NCT00726401|Pruritus|pruritus
5643768|NCT00726401|Teary|teary
5643769|NCT00726401|Eyes|eyes
5643770|NCT00726388|safety|safety
5643771|NCT00726388|diclofenac|diclofenac
5643772|NCT00726388|pain, postoperative|pain, postoperative
5643773|NCT00726375|(GVHD)|(gvhd)
5643774|NCT00726362|Statin|statin
5643775|NCT00726362|LDL-C|ldl-c
5643776|NCT00726336|healthy volunteer|healthy volunteer
5643777|NCT00726336|pharmacokinetics|pharmacokinetics
5643778|NCT00726336|GSK1349572|gsk1349572
5643779|NCT00726336|integrase|integrase
5643783|NCT00726323|Clear cell renal carcinoma|clear cell renal carcinoma
5643784|NCT00726323|Hereditary papillary renal cell carcinoma,|hereditary papillary renal cell carcinoma,
5643786|NCT00726310|Instability|instability
5643788|NCT00726271|obesity|obesity
5643789|NCT00726271|appetite set point|appetite set point
5643790|NCT00726219|Major|major
5643791|NCT00726219|knee|knee
5643792|NCT00726219|surgery|surgery
5643793|NCT00726180|Breast cancer|breast cancer
5643794|NCT00726180|Women|women
5643795|NCT00726180|w/Her2|w/her2
5643796|NCT00726180|positive|positive
5643797|NCT00726180|ERnegative|ernegative
5643798|NCT00726180|not metastasized|not metastasized
5643799|NCT00726167|Ventilator associated Pneumonia|ventilator associated pneumonia
5643800|NCT00726167|mechanically ventilated|mechanically ventilated
5643801|NCT00726167|procalcitonin|procalcitonin
5643802|NCT00726167|pneumonia scores|pneumonia scores
5643803|NCT00726154|Bipolar Disorder|bipolar disorder
5643804|NCT00726154|Circadian Rhythm|circadian rhythm
5643805|NCT00726154|Moderators|moderators
5643806|NCT00726154|Lithium|lithium
5643807|NCT00726154|Quetiapine|quetiapine
5643808|NCT00726141|Brief Intervention|brief intervention
5643809|NCT00726141|Smoking Cessation|smoking cessation
5643810|NCT00726141|Motivational Interviewing|motivational interviewing
5643811|NCT00726141|Expert System|expert system
5643812|NCT00726141|Readiness to Change|readiness to change
5643813|NCT00726141|Hormonal Contraceptive|hormonal contraceptive
5643814|NCT00726141|Adolescents|adolescents
5643816|NCT00726102|Zinc nutrition|zinc nutrition
5643817|NCT00726102|Growth|growth
5643818|NCT00726102|Development|development
5643819|NCT00726102|China|china
5643820|NCT00726102|Infants|infants
5643821|NCT00726102|Toddlers|toddlers
5643822|NCT00726076|Epilepsy|epilepsy
5643823|NCT00726076|Medication|medication
5643824|NCT00726076|Stress|stress
5643825|NCT00726076|Sleep|sleep
5643826|NCT00726076|Lifestyle Management|lifestyle management
5643827|NCT00726063|dental implants|dental implants
5643828|NCT00726063|Nanotite implant|nanotite implant
5643829|NCT00726063|Osseotite implants|osseotite implants
5643830|NCT00726063|multicenter|multicenter
5643831|NCT00726063|randomized|randomized
5643832|NCT00726063|clinical study|clinical study
5643833|NCT00726063|partial edentulism|partial edentulism
5643834|NCT00726063|prosthesis|prosthesis
5643835|NCT00726050|Theta Burst Stimulation|theta burst stimulation
5643836|NCT00726050|Somatosensory Stimulation|somatosensory stimulation
5643837|NCT00726050|Somatosensory Cortex|somatosensory cortex
5643838|NCT00726050|Tactile Discrimination|tactile discrimination
5643839|NCT00726050|Healthy Volunteer|healthy volunteer
5643840|NCT00726050|HV|hv
5643841|NCT00726037|Denileukin diftitox|denileukin diftitox
5643842|NCT00726037|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5643843|NCT00726037|Ontak|ontak
5643844|NCT00726037|Regulatory T-cell|regulatory t-cell
5643845|NCT00726011|due|due
5643846|NCT00726011|cancer treatment|cancer treatment
5643847|NCT00725998|Cochlear Implantation.|cochlear implantation.
5643848|NCT00725998|Cochlear nerve.|cochlear nerve.
5643849|NCT00725998|Child.|child.
5643850|NCT00725998|study|study
5643851|NCT00725998|ECAP|ecap
5643852|NCT00725998|During|during
5643853|NCT00725998|First year|first year
5643854|NCT00725985|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5643855|NCT00725985|Early MS|early ms
5643856|NCT00725985|Multiple Sclerosis|multiple sclerosis
5643857|NCT00725972|Improve|improve
5643858|NCT00725972|Patient care|patient care
5643859|NCT00725972|Applying|applying
5643860|NCT00725972|Systematic|systematic
5643861|NCT00725972|Fashion|fashion
5643862|NCT00725972|Proven|proven
5643863|NCT00725972|Resuscitation|resuscitation
5643864|NCT00725972|Algorithms|algorithms
5643865|NCT00725972|High risk|high risk
5643866|NCT00725972|Surgical|surgical
5643867|NCT00725959|HIV Prevention|hiv prevention
5643868|NCT00725959|Social Networking|social networking
5643869|NCT00725959|Technology Based Intervention|technology based intervention
5643870|NCT00725920|PTSD,|ptsd,
5643871|NCT00725920|posttraumatic|posttraumatic
5643872|NCT00725920|stress|stress
5643873|NCT00725920|disorder,|disorder,
5643874|NCT00725920|randomization,|randomization,
5643875|NCT00725920|placebo,|placebo,
5643876|NCT00725920|controlled|controlled
5643877|NCT00725907|PRP|prp
5643878|NCT00725907|ATFL|atfl
5643879|NCT00725881|PAD|pad
5643880|NCT00725881|Peripheral arterial disease|peripheral arterial disease
5643881|NCT00725881|Peripheral artery disease|peripheral artery disease
5643882|NCT00725881|Intermittent claudication|intermittent claudication
5643883|NCT00725881|IC|ic
5643884|NCT00725881|atherosclerosis|atherosclerosis
5643885|NCT00725881|leg pain|leg pain
5643886|NCT00725881|walking pain|walking pain
5643887|NCT00725868|Major adverse|major adverse
5643990|NCT00725400|Erbitux|erbitux
5643889|NCT00725855|P50 Sensory Gating|p50 sensory gating
5643890|NCT00725855|Mismatched Negativity|mismatched negativity
5643891|NCT00725829|coagulation|coagulation
5643892|NCT00725829|cholesterol|cholesterol
5643893|NCT00725829|acute ischemia|acute ischemia
5643894|NCT00725829|fibrin clot|fibrin clot
5643895|NCT00725803|Hepatitis C|hepatitis c
5643896|NCT00725803|HCV|hcv
5643897|NCT00725803|Fibrosis|fibrosis
5643898|NCT00725803|Apoptosis|apoptosis
5643899|NCT00725803|GS-9450|gs-9450
5643900|NCT00725790|Erectile Dysfunction|erectile dysfunction
5643901|NCT00725790|Spinal Cord Injury|spinal cord injury
5643902|NCT00725764|VEGFR2|vegfr2
5643903|NCT00725764|XL880|xl880
5643904|NCT00725764|foretinib|foretinib
5643905|NCT00725764|Squamous Cell Cancer of the Head and Neck|squamous cell cancer of the head and neck
5643906|NCT00725764|MET|met
5643907|NCT00725764|GSK1363089|gsk1363089
5643908|NCT00725738|Myocardial|myocardial
5643909|NCT00725738|Infarction,|infarction,
5643910|NCT00725738|Stem|stem
5643911|NCT00725738|Cell|cell
5643912|NCT00725738|Therapy|therapy
5643913|NCT00725712|c-Met|c-met
5643914|NCT00725712|Metastatic Gastric Carcinoma|metastatic gastric carcinoma
5643915|NCT00725712|adenocarcinoma|adenocarcinoma
5643916|NCT00725712|Gastric cancer|gastric cancer
5643917|NCT00725712|GSK1363089|gsk1363089
5643918|NCT00725712|XL880|xl880
5643919|NCT00725712|MET inhibitor|met inhibitor
5643920|NCT00725686|"Choroidal Neovascularization (CNV) WET AMD"|"choroidal neovascularization (cnv) wet amd"
5643921|NCT00725673|COPD|copd
5643922|NCT00725673|Osteoporosis|osteoporosis
5643923|NCT00725673|BMD|bmd
5643924|NCT00725673|DEXA-scan|dexa-scan
5643925|NCT00725660|pre eclampsia|pre eclampsia
5643926|NCT00725660|doppler|doppler
5643927|NCT00725660|uterine|uterine
5643928|NCT00725660|arteries|arteries
5643929|NCT00725660|angiogenic|angiogenic
5643930|NCT00725660|factors|factors
5643931|NCT00725647|N terminal B type natriuretic peptide|n terminal b type natriuretic peptide
5625528|NCT00797693|oral|oral
5643932|NCT00725647|echocardiography|echocardiography
5643933|NCT00725647|diagnosis|diagnosis
5643934|NCT00725647|atrial natriuretic peptides|atrial natriuretic peptides
5643936|NCT00725634|Neoplasms,|neoplasms,
5643937|NCT00725634|Lymphoma,|lymphoma,
5643938|NCT00725634|Multiple Myeloma,|multiple myeloma,
5643939|NCT00725634|Neoplasms, Plasma Cell,|neoplasms, plasma cell,
5643940|NCT00725634|Neoplasms by Histologic Type,|neoplasms by histologic type,
5643941|NCT00725634|Lymphoproliferative Disorders,|lymphoproliferative disorders,
5643942|NCT00725634|Lymphatic Diseases, Immunoproliferative Disorders|lymphatic diseases, immunoproliferative disorders
5643943|NCT00725634|Immune System Diseases Hemostatic Disorders|immune system diseases hemostatic disorders
5643944|NCT00725634|Vascular Diseases|vascular diseases
5643945|NCT00725634|Cardiovascular Diseases|cardiovascular diseases
5643946|NCT00725634|Paraproteinemias|paraproteinemias
5643947|NCT00725634|Blood Protein Disorders|blood protein disorders
5643948|NCT00725634|Hematologic Diseases|hematologic diseases
5643949|NCT00725634|Hemorrhagic Disorders|hemorrhagic disorders
5643950|NCT00725634|Erlotinib|erlotinib
5643951|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors
5643952|NCT00725634|Enzyme Inhibitors,|enzyme inhibitors,
5643953|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5643954|NCT00725634|Pharmacologic Actions|pharmacologic actions
5643955|NCT00725608|Suboxone|suboxone
5643956|NCT00725608|Subutex|subutex
5643957|NCT00725608|Buprenorphine|buprenorphine
5643958|NCT00725608|Naloxone|naloxone
5643959|NCT00725595|Cheyne Stocks respiration|cheyne stocks respiration
5643960|NCT00725595|heart failure|heart failure
5643961|NCT00725595|sleep apnea|sleep apnea
5643962|NCT00725595|ventilator|ventilator
5643963|NCT00725569|Caesarian Section|caesarian section
5643964|NCT00725569|Homeopathy|homeopathy
5643965|NCT00725569|Pain|pain
5643966|NCT00725569|Analgesia|analgesia
5643967|NCT00725556|Autism|autism
5643968|NCT00725556|Asperger Syndrome|asperger syndrome
5643969|NCT00725530|Lens deposits|lens deposits
5643970|NCT00725530|Soft contact lens wearers|soft contact lens wearers
5643971|NCT00725517|Icodextrin|icodextrin
5643972|NCT00725517|ultrafiltration|ultrafiltration
5643973|NCT00725517|creatinine clearance|creatinine clearance
5643974|NCT00725517|urea nitrogen clearance|urea nitrogen clearance
5643975|NCT00725491|Reproductive|reproductive
5643976|NCT00725491|techniques|techniques
5643977|NCT00725491|assisted|assisted
5643978|NCT00725478|Piribedil (trade name: CLARIUM)|piribedil (trade name: clarium)
5643979|NCT00725478|non-ergot dopamine agonist|non-ergot dopamine agonist
5643980|NCT00725478|Morbus Parkinson|morbus parkinson
5643981|NCT00725478|Tolerability|tolerability
5643982|NCT00725478|Efficacy|efficacy
5643983|NCT00725478|Post Marketing Surveillance|post marketing surveillance
5643984|NCT00725465|laparoscopy|laparoscopy
5643985|NCT00725465|CO2 colonoscopy|co2 colonoscopy
5643986|NCT00725465|intraoperative CO2 colonoscopy|intraoperative co2 colonoscopy
5643987|NCT00725465|combined Lap-CO2 procedure|combined lap-co2 procedure
5643988|NCT00725426|healthy subjects|healthy subjects
5643989|NCT00725400|Colorectal Cancer|colorectal cancer
5643993|NCT00725400|Radiation|radiation
5643994|NCT00725348|Psoriasis|psoriasis
5643995|NCT00725335|ischemia|ischemia
5643996|NCT00725335|liver cancer|liver cancer
5643997|NCT00725335|radical excision|radical excision
5643998|NCT00725335|prognosis|prognosis
5643999|NCT00725309|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5644000|NCT00725309|COPD|copd
5644001|NCT00725309|Elastin|elastin
5644002|NCT00725309|ELN|eln
5644003|NCT00725283|Leukemia|leukemia
5644004|NCT00725283|ASCI|asci
5644005|NCT00725283|Complete remission|complete remission
5644006|NCT00725283|Immunotherapy|immunotherapy
5644007|NCT00725283|adult|adult
5644008|NCT00725283|Acute Myeloid Leukemia|acute myeloid leukemia
5644009|NCT00725283|Tumor antigen|tumor antigen
5644010|NCT00725283|WT1|wt1
5644011|NCT00725244|Radiation Injuries|radiation injuries
5644012|NCT00725244|Telangiectasis|telangiectasis
5644013|NCT00725244|Bipolar Eletrocoagulation|bipolar eletrocoagulation
5644014|NCT00725244|Argon Plasma Coagulation|argon plasma coagulation
5644015|NCT00725231|T cell lymphoma|t cell lymphoma
5644016|NCT00725218|NSAIDs|nsaids
5644017|NCT00725218|Postoperative pain|postoperative pain
5644018|NCT00725218|Analgesia|analgesia
5644019|NCT00725218|Abortion|abortion
5644020|NCT00725192|PTSD|ptsd
5644021|NCT00725192|Posttraumatic Stress Disorder|posttraumatic stress disorder
5644022|NCT00725192|Physical Assault|physical assault
5644023|NCT00725192|Physical Abuse|physical abuse
5644024|NCT00725192|Sexual Assault|sexual assault
5644025|NCT00725192|Sexual Abuse|sexual abuse
5644026|NCT00725192|Interpersonal Assault|interpersonal assault
5644027|NCT00725192|Cognitive Processing Therapy|cognitive processing therapy
5644028|NCT00725192|Sleep Impairment|sleep impairment
5644029|NCT00725192|Insomnia|insomnia
5644030|NCT00725192|Hypnosis|hypnosis
5644031|NCT00725179|acetaminophen toxicity|acetaminophen toxicity
5644032|NCT00725179|n-acetylcysteine|n-acetylcysteine
5644033|NCT00725179|liver toxicity|liver toxicity
5644034|NCT00725166|Aging|aging
5644035|NCT00725166|Biopsy|biopsy
5644036|NCT00725166|Skeletal muscle|skeletal muscle
5644037|NCT00725166|Molecular biology|molecular biology
5644038|NCT00725166|Genetic markers|genetic markers
5644039|NCT00725166|Gene expression regulation|gene expression regulation
5644040|NCT00725166|Young and old men|young and old men
5644041|NCT00725166|Healthy volunteers|healthy volunteers
5644042|NCT00725153|Contact lens deposits|contact lens deposits
5644043|NCT00725153|Soft contact lenses|soft contact lenses
5644044|NCT00725153|Myopia|myopia
5644045|NCT00725140|Migraine|migraine
5644046|NCT00725140|Early intervention|early intervention
5644047|NCT00725140|Primary Care|primary care
5644048|NCT00725140|Almotriptan|almotriptan
5644049|NCT00725127|Aspirin|aspirin
5644050|NCT00725127|Chronotherapy|chronotherapy
5644051|NCT00725127|Primary prevention|primary prevention
5644052|NCT00725127|Impaired fasting glucose|impaired fasting glucose
5644053|NCT00725127|Type 2 diabetes|type 2 diabetes
5644054|NCT00725127|Total mortality|total mortality
5644055|NCT00725127|Myocardial infarction|myocardial infarction
5644056|NCT00725127|Stroke|stroke
5644057|NCT00725127|Angina pectoris|angina pectoris
5644058|NCT00725127|Chronic kidney disease|chronic kidney disease
5644059|NCT00725114|due|due
5644060|NCT00725114|cancer|cancer
5644061|NCT00725114|treatment|treatment
5644062|NCT00725088|ST-Elevated Myocardial Infarction|st-elevated myocardial infarction
5644063|NCT00725088|Exercise Training|exercise training
5644064|NCT00725088|Rehabilitation|rehabilitation
5644065|NCT00725075|Negative symptoms|negative symptoms
5644066|NCT00725075|Glycine Uptake inhibitor|glycine uptake inhibitor
5644067|NCT00725075|Add-on treatment|add-on treatment
5644068|NCT00725075|Second Generation Antipsychotic|second generation antipsychotic
5644069|NCT00725062|graft versus host disease|graft versus host disease
5644070|NCT00725062|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5644071|NCT00725062|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5644072|NCT00725062|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5644073|NCT00725062|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5644074|NCT00725062|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5644075|NCT00725062|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5644076|NCT00725062|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5644077|NCT00725062|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5644078|NCT00725062|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5644079|NCT00725062|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5644080|NCT00725062|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5644081|NCT00725062|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5644082|NCT00725062|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5644083|NCT00725062|stage I multiple myeloma|stage i multiple myeloma
5644084|NCT00725062|stage II multiple myeloma|stage ii multiple myeloma
5644085|NCT00725062|stage III multiple myeloma|stage iii multiple myeloma
5644086|NCT00725062|refractory multiple myeloma|refractory multiple myeloma
5644087|NCT00725062|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5644088|NCT00725062|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5644089|NCT00725062|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5644090|NCT00725062|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5644091|NCT00725062|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5644092|NCT00725062|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5644093|NCT00725062|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5644094|NCT00725062|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5644095|NCT00725062|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5644096|NCT00725062|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5644097|NCT00725062|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5644098|NCT00725062|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5644099|NCT00725062|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5644100|NCT00725062|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5644101|NCT00725062|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5644102|NCT00725062|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5644103|NCT00725062|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5644104|NCT00725062|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5644105|NCT00725062|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5644106|NCT00725062|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5644107|NCT00725062|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5644108|NCT00725062|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5644109|NCT00725062|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5644110|NCT00725062|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5789067|NCT00150059|atopic dermatitis, eczema, mild to moderate, children, IGA|atopic dermatitis, eczema, mild to moderate, children, iga
5644111|NCT00725062|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5644112|NCT00725062|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5644113|NCT00725062|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5644114|NCT00725062|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5644115|NCT00725062|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5644116|NCT00725062|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5644117|NCT00725062|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5644118|NCT00725062|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5644119|NCT00725062|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5644120|NCT00725062|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5644121|NCT00725062|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5644122|NCT00725062|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5644123|NCT00725062|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5644124|NCT00725062|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5644125|NCT00725062|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5644126|NCT00725062|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5644127|NCT00725062|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5644128|NCT00725049|dental implants|dental implants
5644129|NCT00725049|Nanotite Certain implant|nanotite certain implant
5644130|NCT00725049|Osseotite|osseotite
5644131|NCT00725049|multicenter|multicenter
5644132|NCT00725049|randomized|randomized
5644133|NCT00725049|clinical study|clinical study
5644134|NCT00725049|partial edentulism|partial edentulism
5644136|NCT00725049|short fixed bridge|short fixed bridge
5644137|NCT00725049|cost analysis|cost analysis
5644138|NCT00725023|Pain, chronic pain, tennis elbow, lateral epicondylitis|pain, chronic pain, tennis elbow, lateral epicondylitis
5644139|NCT00724997|live attenuated flu vaccines|live attenuated flu vaccines
5644140|NCT00724997|Influenza A (H1N1)|influenza a (h1n1)
5644141|NCT00724997|intranasally application|intranasally application
5644142|NCT00724997|replication-deficient influenza virus|replication-deficient influenza virus
5644143|NCT00724984|PCI-24781|pci-24781
5644144|NCT00724984|Lymphoma|lymphoma
5644145|NCT00724984|Hodgkin Disease|hodgkin disease
5644146|NCT00724984|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5644147|NCT00724984|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5644148|NCT00724984|Lymphoma, Follicular|lymphoma, follicular
5644149|NCT00724984|Lymphoma, B-Cell, Marginal Zone|lymphoma, b-cell, marginal zone
5644150|NCT00724984|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5644151|NCT00724984|Lymphoma, Mantle Cell|lymphoma, mantle cell
5644152|NCT00724984|Lymphoma, T-Cell, Cutaneous|lymphoma, t-cell, cutaneous
5644153|NCT00724984|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5644154|NCT00724971|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5644157|NCT00724906|Essential Tremor|essential tremor
5644158|NCT00724906|Parkinsonian Tremor|parkinsonian tremor
5644159|NCT00724906|Parkinson Disease|parkinson disease
5644160|NCT00724906|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
5644161|NCT00724906|Diagnosis|diagnosis
5644162|NCT00724906|Subjects|subjects
5644163|NCT00724906|Upper|upper
5644164|NCT00724906|Extremity|extremity
5644165|NCT00724906|Tremor|tremor
5644166|NCT00724906|Less|less
5644167|NCT00724906|Than 2 years|than 2 years
5644168|NCT00724880|coronary artery bypass grafting|coronary artery bypass grafting
5644169|NCT00724880|clopidogrel|clopidogrel
5644170|NCT00724880|post-operative bleeding|post-operative bleeding
5644171|NCT00724867|Systemic Lupus Erythematosus|systemic lupus erythematosus
5644172|NCT00724867|Belimumab|belimumab
5644174|NCT00724867|Antibodies|antibodies
5644175|NCT00724867|Lupus|lupus
5644176|NCT00724867|Autoimmune Diseases|autoimmune diseases
5644177|NCT00724828|Bacterial otitis media|bacterial otitis media
5644178|NCT00724828|pneumoniae|pneumoniae
5644179|NCT00724828|sepsis|sepsis
5644180|NCT00724828|bacteremia|bacteremia
5644181|NCT00724828|meningitis|meningitis
5644182|NCT00724828|Streptococcus pneumoniae carriage rate|streptococcus pneumoniae carriage rate
5644183|NCT00724802|babies with canavan disease|babies with canavan disease
5644184|NCT00724789|Neonatal outcome|neonatal outcome
5644185|NCT00724789|Congenital malformations|congenital malformations
5644186|NCT00724789|In-Vitro fertilization|in-vitro fertilization
5644187|NCT00724789|Controlled ovarian stimulation|controlled ovarian stimulation
5644188|NCT00724789|Follow-up|follow-up
5644189|NCT00724776|Chronic hepatitis C, Albinterferon alfa 2b, phase I, Japan|chronic hepatitis c, albinterferon alfa 2b, phase i, japan
5644190|NCT00724763|acupuncture, high blood pressure, HRV|acupuncture, high blood pressure, hrv
5644191|NCT00724724|Stroke|stroke
5644192|NCT00724724|Transient Ischemic Attack|transient ischemic attack
5644193|NCT00724711|HIV|hiv
5644194|NCT00724711|HIV 1|hiv 1
5644195|NCT00724685|Ropivacaine|ropivacaine
5644196|NCT00724685|elastomeric pump|elastomeric pump
5644197|NCT00724685|patient controlled analgesia|patient controlled analgesia
5644198|NCT00724685|morphine consumption|morphine consumption
5644200|NCT00724659|Contrast|contrast
5644201|NCT00724659|Joint|joint
5644202|NCT00724659|Ultrasound|ultrasound
5644203|NCT00724646|parents|parents
5644204|NCT00724646|medically fragile|medically fragile
5644205|NCT00724646|death|death
5644206|NCT00724646|end-of-life care|end-of-life care
5644207|NCT00724646|surveys|surveys
5644208|NCT00724633|dialysate|dialysate
5644209|NCT00724633|sodium|sodium
5644210|NCT00724633|hemodialysis|hemodialysis
5644211|NCT00724633|blood pressure|blood pressure
5644212|NCT00724633|thirst|thirst
5644213|NCT00724633|intradialytic symptoms|intradialytic symptoms
5644214|NCT00724633|interdialytic weight gain|interdialytic weight gain
5644215|NCT00724633|extracellular fluid balance|extracellular fluid balance
5644216|NCT00724633|mechanisms|mechanisms
5644217|NCT00724607|Concussion, traumatic brain injury|concussion, traumatic brain injury
5644218|NCT00724607|Screening|screening
5644219|NCT00724607|neuroimaging|neuroimaging
5644220|NCT00724607|Posttraumatic stress disorder|posttraumatic stress disorder
5644221|NCT00724594|chorioamnionitis|chorioamnionitis
5644222|NCT00724594|maternal chorioamnionitis|maternal chorioamnionitis
5644223|NCT00724594|neonatal white matter injury|neonatal white matter injury
5644224|NCT00724594|N-acetylcysteine|n-acetylcysteine
5644225|NCT00724594|NAC|nac
5644226|NCT00724594|anti-oxidant treatment|anti-oxidant treatment
5644227|NCT00724581|Atrial fibrillation, amiodarone|atrial fibrillation, amiodarone
5644228|NCT00724568|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5644229|NCT00724555|stroke|stroke
5644230|NCT00724555|tissue plasminogen activator|tissue plasminogen activator
5644231|NCT00724555|tPA|tpa
5644232|NCT00724529|Crohn's Disease|crohn's disease
5644233|NCT00724529|Ankylosing Spondylitis|ankylosing spondylitis
5644234|NCT00724516|Mammogram|mammogram
5644235|NCT00724516|Biopsy|biopsy
5644236|NCT00724516|Needle|needle
5644237|NCT00724516|Wire|wire
5644238|NCT00724516|Localization|localization
5644239|NCT00724516|Compression|compression
5644240|NCT00724516|Paddle|paddle
5644241|NCT00724503|colon cancer|colon cancer
5644242|NCT00724503|Colorectal carcinoma|colorectal carcinoma
5644243|NCT00724503|liver metastases|liver metastases
5644244|NCT00724503|SIR-Spheres microspheres|sir-spheres microspheres
5644245|NCT00724503|yttrium-90|yttrium-90
5644246|NCT00724503|FOLFOX|folfox
5644247|NCT00724503|bevacizumab|bevacizumab
5644248|NCT00724503|metastatic colorectal cancer|metastatic colorectal cancer
5644249|NCT00724490|Deep Brain Stimulation|deep brain stimulation
5644250|NCT00724490|Obsessive Compulsive Disorder|obsessive compulsive disorder
5644251|NCT00724490|Nucleus Accumbens|nucleus accumbens
5644252|NCT00724438|Contraception|contraception
5644254|NCT00724438|Obesity|obesity
5644255|NCT00724438|Blood spots|blood spots
5644256|NCT00724438|Implant|implant
5644257|NCT00724438|Pharmacokinetics|pharmacokinetics
5644258|NCT00724412|Dry Eye|dry eye
5644259|NCT00724412|Corneal Staining|corneal staining
5644260|NCT00724360|relapsed/refractory|relapsed/refractory
5644262|NCT00724360|positive|positive
5644263|NCT00724360|B-ALL|b-all
5644264|NCT00724360|trastuzumab|trastuzumab
5644265|NCT00724347|Auditory Perception|auditory perception
5644266|NCT00724347|Hearing Loss|hearing loss
5644267|NCT00724347|Presbycusis|presbycusis
5644268|NCT00724347|Perceptual Learning|perceptual learning
5644269|NCT00724347|Hearing Prosthesis|hearing prosthesis
5644270|NCT00724347|Speech Discrimination|speech discrimination
5644271|NCT00724347|Delayed Treatment|delayed treatment
5644272|NCT00724334|myelofibrosis|myelofibrosis
5644273|NCT00724321|iloprost|iloprost
5644274|NCT00724321|hypoxic|hypoxic
5644275|NCT00724321|pulmonary|pulmonary
5644276|NCT00724321|vasoconstriction|vasoconstriction
5644277|NCT00724321|altitude|altitude
5644278|NCT00724308|Smoking|smoking
5644279|NCT00724308|Smoking Cessation|smoking cessation
5644280|NCT00724308|Tobacco|tobacco
5644281|NCT00724308|Mental Health|mental health
5644282|NCT00724282|sleep|sleep
5644283|NCT00724282|eszopiclone|eszopiclone
5644284|NCT00724282|insulin secretion|insulin secretion
5644285|NCT00724282|insulin action|insulin action
5644286|NCT00724282|glucose tolerance|glucose tolerance
5644287|NCT00724269|Contact lens wear|contact lens wear
5644288|NCT00724269|multi-purpose solution|multi-purpose solution
5644289|NCT00724269|corneal staining|corneal staining
5644290|NCT00724256|Pyelonephritis.|pyelonephritis.
5644291|NCT00724256|Urinary Tract Infections.|urinary tract infections.
5644292|NCT00724256|Children.|children.
5644293|NCT00724256|Randomised controlled trial.|randomised controlled trial.
5644294|NCT00724256|Therapy.|therapy.
5644295|NCT00724256|Ceftibuten.|ceftibuten.
5644296|NCT00724204|probiotics|probiotics
5644298|NCT00724204|fecal microbiota|fecal microbiota
5644299|NCT00724204|infections|infections
5644300|NCT00724178|Pediatric HIV infection, bone mineral content, bone mineral density, Vitamin D, calcium Dual x-ray absorptiometry|pediatric hiv infection, bone mineral content, bone mineral density, vitamin d, calcium dual x-ray absorptiometry
5644301|NCT00724165|physical activity|physical activity
5644302|NCT00724165|Latinas|latinas
5644303|NCT00724152|coping skills|coping skills
5644304|NCT00724152|psychology|psychology
5644305|NCT00724152|audiology|audiology
5644306|NCT00724152|veterans|veterans
5644307|NCT00724152|tinnitus|tinnitus
5644308|NCT00724152|adult|adult
5644309|NCT00724152|intervention studies|intervention studies
5644310|NCT00724152|tinnitus, noise induced|tinnitus, noise induced
5644311|NCT00724152|noise|noise
5644312|NCT00724152|auditory perception|auditory perception
5644313|NCT00724126|Diarrhea|diarrhea
5644314|NCT00724126|Rifaximin|rifaximin
5644315|NCT00724126|IBS|ibs
5644316|NCT00724126|Abdominal pain|abdominal pain
5644317|NCT00724126|Bloating|bloating
5644318|NCT00724113|Shoulder capsulitis|shoulder capsulitis
5644319|NCT00724113|ARTHRO distension|arthro distension
5644320|NCT00724113|Mobilisation|mobilisation
5644321|NCT00724113|Randomised clinical trial|randomised clinical trial
5644322|NCT00724100|Malignancy|malignancy
5644323|NCT00724100|Solid tumor|solid tumor
5644324|NCT00724100|Tubulin inhibitor|tubulin inhibitor
5644325|NCT00724087|short sleep duration|short sleep duration
5644326|NCT00724087|energy expenditure|energy expenditure
5644327|NCT00724087|insulin secretion|insulin secretion
5644328|NCT00724087|insulin action|insulin action
5644329|NCT00724087|lipid turnover|lipid turnover
5644330|NCT00724087|free fatty acids|free fatty acids
5644331|NCT00724074|Arthritis of the knee|arthritis of the knee
5644332|NCT00724074|Knee replacement|knee replacement
5644333|NCT00724074|Osteoarthritis, knee|osteoarthritis, knee
5644334|NCT00724074|Arthroplasty, knee|arthroplasty, knee
5644335|NCT00724061|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5644336|NCT00724061|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5644337|NCT00724061|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5644338|NCT00724061|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5644339|NCT00724061|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5644340|NCT00724061|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5644341|NCT00724061|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5644342|NCT00724061|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5644343|NCT00724061|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5644344|NCT00724061|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5644345|NCT00724048|Huntington Disease|huntington disease
5644347|NCT00724035|Upper extremity|upper extremity
5644348|NCT00724035|Nerve block|nerve block
5644349|NCT00724035|Ultrasound|ultrasound
5644350|NCT00724035|Brachial plexus|brachial plexus
5644351|NCT00724022|Kidney transplant status|kidney transplant status
5644352|NCT00724022|Steroid free|steroid free
5644353|NCT00724022|Reduced|reduced
5644354|NCT00724022|Calcineurin|calcineurin
5644356|NCT00724022|Immunosuppression|immunosuppression
5644357|NCT00723970|Major Depressive Disorder|major depressive disorder
5644358|NCT00723970|Insomnia|insomnia
5644359|NCT00723970|Hot Flashes|hot flashes
5644360|NCT00723970|Menopause|menopause
5644361|NCT00723970|Quetiapine|quetiapine
5644362|NCT00723944|dental implants|dental implants
5644363|NCT00723944|Osseotite Certain Prevail|osseotite certain prevail
5644364|NCT00723944|Lateralized|lateralized
5644365|NCT00723944|non-lateralized|non-lateralized
5644366|NCT00723944|Osseotite Certain|osseotite certain
5644367|NCT00723944|multicenter|multicenter
5644368|NCT00723944|randomized|randomized
5644369|NCT00723944|clinical study|clinical study
5644370|NCT00723944|partial edentulism|partial edentulism
5644371|NCT00723944|single stage|single stage
5644372|NCT00723944|early loading|early loading
5644373|NCT00723944|crestal bone level|crestal bone level
5644374|NCT00723944|short fixed bridge|short fixed bridge
5644375|NCT00723918|HIV-associated neuropathy|hiv-associated neuropathy
5644376|NCT00723918|HIV|hiv
5644377|NCT00723918|AIDS|aids
5644378|NCT00723918|cannabinoid|cannabinoid
5644379|NCT00723918|Cannabis|cannabis
5644380|NCT00723918|methadone|methadone
5644381|NCT00723918|distal sensory polyneuropathy|distal sensory polyneuropathy
5644382|NCT00723918|polyneuropathy|polyneuropathy
5644383|NCT00723905|Crohn's Disease, Rheumatoid Arthritis|crohn's disease, rheumatoid arthritis
5644384|NCT00723866|Botulinum toxin, Spasticity, Stroke, Rehabilitation.|botulinum toxin, spasticity, stroke, rehabilitation.
5644385|NCT00723853|Obesity|obesity
5644386|NCT00723853|Type 2 diabetes|type 2 diabetes
5644387|NCT00723853|African American children|african american children
5644388|NCT00723853|African American youth|african american youth
5644389|NCT00723853|Community based|community based
5644390|NCT00723853|Family oriented|family oriented
5644391|NCT00723853|Obesity & Risk of type 2 diabetes|obesity & risk of type 2 diabetes
5644392|NCT00723840|EuroQOL (EQ-5D)|euroqol (eq-5d)
5644393|NCT00723814|normal|normal
5644394|NCT00723801|Marfan syndrome|marfan syndrome
5644395|NCT00723801|Losartan|losartan
5644396|NCT00723801|Atenolol|atenolol
5644397|NCT00723801|Diastolic Function|diastolic function
5644398|NCT00723801|Aortic Stiffness|aortic stiffness
5644399|NCT00723788|Appendicitis|appendicitis
5644400|NCT00723788|Children|children
5644401|NCT00723788|Magnetic Resonance Imaging|magnetic resonance imaging
5644402|NCT00723775|KALETRA|kaletra
5644403|NCT00723775|GSK706769|gsk706769
5644404|NCT00723775|HIV|hiv
5644405|NCT00723775|healthy volunteers|healthy volunteers
5644406|NCT00723762|Valproic acid|valproic acid
5644407|NCT00723762|Urea cycle|urea cycle
5644408|NCT00723762|Ornithine|ornithine
5644409|NCT00723762|Valproate|valproate
5644410|NCT00723762|Side effect|side effect
5644411|NCT00723749|Suboxone|suboxone
5644412|NCT00723749|Subutex|subutex
5644413|NCT00723749|Buprenorphine|buprenorphine
5644414|NCT00723749|Naloxone|naloxone
5644415|NCT00723697|Subutex|subutex
5644416|NCT00723684|ADHD|adhd
5644417|NCT00723684|Children|children
5644418|NCT00723684|EEG-Neurofeedback|eeg-neurofeedback
5644419|NCT00723658|Waldenström macroglobulinemia|waldenström macroglobulinemia
5644420|NCT00723619|asthma|asthma
5644421|NCT00723619|spirometry|spirometry
5644422|NCT00723619|FENO|feno
5644423|NCT00723619|normal values for spirometry in childhood|normal values for spirometry in childhood
5644424|NCT00723619|normal values for FENO in childhood|normal values for feno in childhood
5644425|NCT00723606|Intramuscular ziprasidone, agitation, efficacy and safety|intramuscular ziprasidone, agitation, efficacy and safety
5644426|NCT00723593|Graft-Versus-Host Disease|graft-versus-host disease
5644427|NCT00723593|Gastrointestinal|gastrointestinal
5644428|NCT00723593|Apoptotic Assay|apoptotic assay
5644429|NCT00723593|Serum Proteomic Pattern Analysis|serum proteomic pattern analysis
5644430|NCT00723593|Mucosal Biopsy|mucosal biopsy
5644431|NCT00723593|Graft Versus Host Disease|graft versus host disease
5644432|NCT00723593|GVHD|gvhd
5644433|NCT00723580|Kabuki Syndrome|kabuki syndrome
5644434|NCT00723580|Actigraphy|actigraphy
5644435|NCT00723580|Treatment Response Measurement|treatment response measurement
5644436|NCT00723567|Spectrin Gene|spectrin gene
5644437|NCT00723567|Hereditary Elliptocytosis (HE)|hereditary elliptocytosis (he)
5644438|NCT00723567|Hereditary Pyropoikilocytosis (HPP)|hereditary pyropoikilocytosis (hpp)
5644439|NCT00723567|Genetics|genetics
5644440|NCT00723554|pulmonary arterial hypertension|pulmonary arterial hypertension
5644441|NCT00723554|inhaled therapy|inhaled therapy
5644442|NCT00723554|power disc-15|power disc-15
5644443|NCT00723528|Psoriasis|psoriasis
5644444|NCT00723528|Ustekinumab|ustekinumab
5644445|NCT00723528|CNTO 1275|cnto 1275
5644446|NCT00723515|White spot lesion|white spot lesion
5644447|NCT00723515|Tooth remineralization|tooth remineralization
5644448|NCT00723515|Fluoride varnishes|fluoride varnishes
5644449|NCT00723502|Helicobacter pylori|helicobacter pylori
5644450|NCT00723502|Eradication|eradication
5644451|NCT00723502|Dyspepsia|dyspepsia
5644452|NCT00723489|Yellow Fever Vaccine|yellow fever vaccine
5644454|NCT00723489|Atopic Dermatitis|atopic dermatitis
5644455|NCT00723489|IgG antibodies|igg antibodies
5644456|NCT00723476|Quality of Life|quality of life
5644457|NCT00723476|Adolescent|adolescent
5644458|NCT00723476|Advance Care Planning|advance care planning
5644459|NCT00723476|Palliative Care|palliative care
5644460|NCT00723476|End-of-Life Care|end-of-life care
5644461|NCT00723476|HIV/AIDS|hiv/aids
5644462|NCT00723476|Psychological Adjustment|psychological adjustment
5644463|NCT00723450|Bipolar I pediatric lamictal adolescent|bipolar i pediatric lamictal adolescent
5644464|NCT00723437|nail, psoriasis, NAPSI,acitretin|nail, psoriasis, napsi,acitretin
5644465|NCT00723424|AZD5672|azd5672
5644466|NCT00723424|digoxin|digoxin
5644467|NCT00723411|Diabetes|diabetes
5644468|NCT00723411|Juvenile Diabetes|juvenile diabetes
5644469|NCT00723411|Diabetes type 1|diabetes type 1
5644470|NCT00723411|Autoimmune Diabetes|autoimmune diabetes
5644471|NCT00723411|Insulin dependent Diabetes|insulin dependent diabetes
5644472|NCT00723411|Type 1 diabetes|type 1 diabetes
5644473|NCT00723411|Type 1 diabetes mellitus|type 1 diabetes mellitus
5644474|NCT00723411|Diamyd|diamyd
5644475|NCT00723411|rhGAD65|rhgad65
5644477|NCT00723411|GAD-alum|gad-alum
5644478|NCT00723398|omega-3 fatty acids|omega-3 fatty acids
5644479|NCT00723398|antiestrogens|antiestrogens
5644480|NCT00723398|breast cancer prevention|breast cancer prevention
5644481|NCT00723398|breast density|breast density
5644482|NCT00723398|biomarkers of mammary carcinogenesis|biomarkers of mammary carcinogenesis
5644483|NCT00723385|cholesterol|cholesterol
5644484|NCT00723385|LDL-cholesterol|ldl-cholesterol
5644485|NCT00723385|cholecalciferol|cholecalciferol
5644486|NCT00723385|lipids|lipids
5644487|NCT00723385|C-reactive protein|c-reactive protein
5644488|NCT00723359|Multiple Myeloma|multiple myeloma
5644489|NCT00723359|Refractory|refractory
5644490|NCT00723359|Relapsed|relapsed
5644491|NCT00723346|Relapse|relapse
5644492|NCT00723346|Lymphoma lymphoblastic|lymphoma lymphoblastic
5644493|NCT00723333|Bone Marrow Transplant|bone marrow transplant
5644494|NCT00723333|Myelofibrosis|myelofibrosis
5644495|NCT00723333|Stem Cell Transplant|stem cell transplant
5644496|NCT00723333|Allogenic Transplant|allogenic transplant
5644497|NCT00723320|Atherosclerosis|atherosclerosis
5644498|NCT00723320|Atorvastatin|atorvastatin
5644499|NCT00723320|Therapeutic lifestyle change|therapeutic lifestyle change
5644501|NCT00723320|ABI|abi
5644502|NCT00723320|PWV|pwv
5644503|NCT00723307|No diabetes mellitus|no diabetes mellitus
5644504|NCT00723307|Elevated waist circumference|elevated waist circumference
5644505|NCT00723294|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5644506|NCT00723294|male breast cancer|male breast cancer
5644507|NCT00723294|stage IA breast cancer|stage ia breast cancer
5644508|NCT00723294|stage IB breast cancer|stage ib breast cancer
5644509|NCT00723294|stage II breast cancer|stage ii breast cancer
5644510|NCT00723281|transplant coronary artery disease|transplant coronary artery disease
5644511|NCT00723281|CT angiography|ct angiography
5644512|NCT00723281|conventional angiography|conventional angiography
5644513|NCT00723281|intravascular ultrasound|intravascular ultrasound
5644514|NCT00723281|Heart transplant patients with known transplant coronary artery disease|heart transplant patients with known transplant coronary artery disease
5644515|NCT00723268|Oral ulcers|oral ulcers
5644516|NCT00723216|Prevention|prevention
5644517|NCT00723216|venous thromboembolism|venous thromboembolism
5644518|NCT00723216|curative surgery|curative surgery
5644519|NCT00723203|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5644520|NCT00723203|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5644521|NCT00723203|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5644522|NCT00723190|CLONICEL|clonicel
5644523|NCT00723190|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5644524|NCT00723190|clonidine HCl sustained release|clonidine hcl sustained release
5644525|NCT00723177|opioid withdrawal, analgesia|opioid withdrawal, analgesia
5644526|NCT00723164|Sevoflurane induction|sevoflurane induction
5644527|NCT00723164|Premedication|premedication
5644528|NCT00723164|laryngeal mask airway|laryngeal mask airway
5644529|NCT00723164|Anesthesia, inhalation [E03.155.197.197]|anesthesia, inhalation [e03.155.197.197]
5644530|NCT00723125|Breast Cancer|breast cancer
5644531|NCT00723112|Myelodysplastic Syndrome|myelodysplastic syndrome
5644532|NCT00723112|Erythropoiesis|erythropoiesis
5644533|NCT00723112|Ineffective Hematopoiesis|ineffective hematopoiesis
5644534|NCT00723112|Erythroid Progenitors|erythroid progenitors
5644535|NCT00723112|Dyserythropoiesis|dyserythropoiesis
5644536|NCT00723086|docetaxel, prednisolone, drug combination|docetaxel, prednisolone, drug combination
5644537|NCT00723073|micafungin, caspofungin, febrile neutropenia|micafungin, caspofungin, febrile neutropenia
5644539|NCT00723047|CD complicated|cd complicated
5644540|NCT00723047|least|least
5644541|NCT00723047|One perianal fistula|one perianal fistula
5644542|NCT00723047|Draining|draining
5644543|NCT00723047|2 months duration|2 months duration
5644544|NCT00723021|Bronchodilator|bronchodilator
5644545|NCT00723008|anxiety|anxiety
5644546|NCT00723008|insomnia|insomnia
5644547|NCT00723008|pain|pain
5629224|NCT00783042|Crestor|crestor
5644548|NCT00723008|Alpha Stim|alpha stim
5644549|NCT00723008|Cranial electrotherapy stimulation|cranial electrotherapy stimulation
5644550|NCT00722995|Morbid obesity|morbid obesity
5644551|NCT00722995|Sleeve gastrectomy|sleeve gastrectomy
5644552|NCT00722995|Gastric bypass|gastric bypass
5644553|NCT00722995|Complications|complications
5644554|NCT00722995|Efficacity|efficacity
5644555|NCT00722995|Safety|safety
5644556|NCT00722995|Compare|compare
5644557|NCT00722982|coxarthrosis|coxarthrosis
5644558|NCT00722982|hip|hip
5644559|NCT00722982|RSA|rsa
5644560|NCT00722982|DXA|dxa
5644561|NCT00722982|C-stem AMT|c-stem amt
5644562|NCT00722982|Marathon|marathon
5644563|NCT00722969|non-small cell lung cancer|non-small cell lung cancer
5644564|NCT00722969|erlotinib|erlotinib
5644565|NCT00722969|sorafenib|sorafenib
5644566|NCT00722956|atorvastatin|atorvastatin
5644567|NCT00722956|AZD5672|azd5672
5644568|NCT00722943|infant|infant
5644569|NCT00722943|premature|premature
5644570|NCT00722943|message|message
5644571|NCT00722943|therapy|therapy
5644572|NCT00722943|NICU|nicu
5672500|NCT00611676|single-blind|single-blind
5644573|NCT00722943|neonatal intensive care unit|neonatal intensive care unit
5644574|NCT00722943|cortisol level|cortisol level
5644575|NCT00722943|stress|stress
5644576|NCT00722943|postnatal|postnatal
5644577|NCT00722943|weight gain|weight gain
5644578|NCT00722943|DMT|dmt
5644579|NCT00722943|Development Message Therapy|development message therapy
5644580|NCT00722943|growth|growth
5644581|NCT00722930|Follicular Lymphoma|follicular lymphoma
5644582|NCT00722930|High-risk FLIPI|high-risk flipi
5644583|NCT00722930|R-CHOP|r-chop
5644584|NCT00722930|GOTEL|gotel
5644585|NCT00722930|Partial|partial
5644586|NCT00722930|Complete|complete
5644587|NCT00722930|Response|response
5644588|NCT00722930|Induction|induction
5644589|NCT00722930|Chemotherapy|chemotherapy
5644590|NCT00722917|Glucose Metabolism Disorder|glucose metabolism disorder
5644591|NCT00722917|Dysmetabolic Syndrome|dysmetabolic syndrome
5644592|NCT00722917|Type II Diabetes|type ii diabetes
5644593|NCT00722917|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5644594|NCT00722917|Dyslipidemia|dyslipidemia
5644595|NCT00722917|Drug Therapy|drug therapy
5644596|NCT00722904|post-intervention surveillance of aortic coarctation|post-intervention surveillance of aortic coarctation
5644597|NCT00722904|MRA and 2D phase contrast imaging|mra and 2d phase contrast imaging
5644598|NCT00722904|4D Flow velocity mapping|4d flow velocity mapping
5644599|NCT00722904|Patients undergoing routine post-intervention surveillance of aortic coarctation|patients undergoing routine post-intervention surveillance of aortic coarctation
5644600|NCT00722904|Healthy volunteers|healthy volunteers
5644601|NCT00722891|Eye Diseases|eye diseases
5644602|NCT00722878|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5644603|NCT00722865|Avastin|avastin
5644604|NCT00722865|bevacizumab|bevacizumab
5644605|NCT00722865|ABVD|abvd
5644606|NCT00722865|angiogenesis|angiogenesis
5644607|NCT00722865|antiangiogenic|antiangiogenic
5644608|NCT00722865|Hodgkin|hodgkin
5644609|NCT00722839|cytomegalovirus infection|cytomegalovirus infection
5644610|NCT00722826|Pulmonary Regurgitation|pulmonary regurgitation
5644611|NCT00722826|Tetralogy of Fallot|tetralogy of fallot
5644612|NCT00722800|YAZ|yaz
5644613|NCT00722800|oral contraceptive|oral contraceptive
5644614|NCT00722800|hidradenitis suppurativa|hidradenitis suppurativa
5644615|NCT00722774|Vaccine|vaccine
5644616|NCT00722774|Influenza|influenza
5644617|NCT00722761|YAZ|yaz
5644618|NCT00722761|oral contraceptive|oral contraceptive
5644619|NCT00722761|Acne vulgaris|acne vulgaris
5644620|NCT00722748|Genebank|genebank
5644621|NCT00722748|Gene registry|gene registry
5644622|NCT00722748|Cardiac Arrythmia Disease|cardiac arrythmia disease
5644623|NCT00722735|uncomplicated Urinary Tract Infection in Women|uncomplicated urinary tract infection in women
5644624|NCT00722735|Antibacterial Chemotherapy|antibacterial chemotherapy
5644625|NCT00722735|Proof-of-Concept|proof-of-concept
5644626|NCT00722709|Pain|pain
5644627|NCT00722709|Fatigue|fatigue
5644628|NCT00722709|Colon|colon
5644629|NCT00722709|Surgery|surgery
5644630|NCT00722709|ERAS|eras
5644631|NCT00722709|Fastrack|fastrack
5644632|NCT00722709|Local anaesthetic|local anaesthetic
5644633|NCT00722709|Peritoneum|peritoneum
5644634|NCT00722709|Metabolic|metabolic
5644635|NCT00722709|Endocrine|endocrine
5644636|NCT00722709|Post surgical metabolic response|post surgical metabolic response
5644637|NCT00722709|Complications|complications
5644638|NCT00722709|Time to passage of flatus|time to passage of flatus
5644639|NCT00722709|Time to passage of stool|time to passage of stool
5644640|NCT00722709|Time to discharge from facility|time to discharge from facility
5644641|NCT00722709|Re-admission rate|re-admission rate
5644642|NCT00722696|Metabolism|metabolism
5644643|NCT00722696|Muscles|muscles
5644644|NCT00722696|Exercise|exercise
5644645|NCT00722670|risk reduction|risk reduction
5644647|NCT00722670|HIV prevention|hiv prevention
5644648|NCT00722657|asthma|asthma
5644649|NCT00722657|epidemiology|epidemiology
5644650|NCT00722644|HIV|hiv
5644651|NCT00722644|Medication Adherence|medication adherence
5644652|NCT00722644|Stress Management|stress management
5645449|NCT00719810|complicated|complicated
5644653|NCT00722644|CD4/Viral Loads|cd4/viral loads
5644654|NCT00722644|Cognitive Behavioral Treatment|cognitive behavioral treatment
5644655|NCT00722618|Infertility|infertility
5644656|NCT00722605|lung|lung
5644657|NCT00722605|esophageal|esophageal
5644658|NCT00722605|cone beam ct scan|cone beam ct scan
5644659|NCT00722592|cancer|cancer
5644660|NCT00722592|ovarian|ovarian
5644661|NCT00722592|platinum-resistant|platinum-resistant
5644662|NCT00722592|Phase II|phase ii
5644663|NCT00722592|EC145|ec145
5644664|NCT00722592|EC20|ec20
5644665|NCT00722579|Coronary Artery Disease|coronary artery disease
5644666|NCT00722553|Transitional Cell Carcinoma of the Urinary Bladder|transitional cell carcinoma of the urinary bladder
5644667|NCT00722553|Transitional Cell Carcinoma|transitional cell carcinoma
5644668|NCT00722553|Bladder Cancer|bladder cancer
5644669|NCT00722553|Urinary Bladder Cancer|urinary bladder cancer
5644670|NCT00722553|Bladder|bladder
5644671|NCT00722553|Carcinoma|carcinoma
5644672|NCT00722553|Urinary|urinary
5644673|NCT00722553|Metastatic|metastatic
5644675|NCT00722527|Primary Familial and Congenital Polycythemia|primary familial and congenital polycythemia
5644676|NCT00722527|Polycythemia|polycythemia
5644677|NCT00722527|Molecular Biology|molecular biology
5644678|NCT00722527|Genetics|genetics
5644679|NCT00722527|Erythropoiesis|erythropoiesis
5644680|NCT00722527|EPOR mutation|epor mutation
5644681|NCT00722527|Thrombocytosis|thrombocytosis
5644682|NCT00722527|Hypoxia|hypoxia
5644683|NCT00722475|recurrent miscarriage|recurrent miscarriage
5644684|NCT00722475|immunology|immunology
5644685|NCT00722475|intravenous immunoglobulin|intravenous immunoglobulin
5644686|NCT00722475|miscarriage|miscarriage
5644687|NCT00722462|Infertility|infertility
5644689|NCT00722462|Acupuncture|acupuncture
5644690|NCT00722436|antifibrinolytic, tranexamic acid|antifibrinolytic, tranexamic acid
5644691|NCT00722423|Hepatitis C|hepatitis c
5644692|NCT00722423|integrated care|integrated care
5644693|NCT00722423|alpha interferon|alpha interferon
5644694|NCT00722423|mental health|mental health
5644695|NCT00722410|Carbapenem|carbapenem
5644696|NCT00722410|resistant|resistant
5644697|NCT00722410|Klebsiella pneumoniae|klebsiella pneumoniae
5644698|NCT00722410|Carpapenemases|carpapenemases
5644699|NCT00722410|Probiotics|probiotics
5644700|NCT00722410|VSL3|vsl3
5644701|NCT00722397|genetics, pediatrics|genetics, pediatrics
5644702|NCT00722384|AMD|amd
5644703|NCT00722384|Macular Degeneration|macular degeneration
5644704|NCT00722384|Opko Health|opko health
5644705|NCT00722384|Acuity Pharmaceuticals|acuity pharmaceuticals
5644706|NCT00722384|bevasiranib|bevasiranib
5644707|NCT00722384|Cand5|cand5
5644708|NCT00722384|Age-Related|age-related
5644709|NCT00722345|Obesity|obesity
5644710|NCT00722345|Physical activity|physical activity
5644711|NCT00722345|Adolescents|adolescents
5644712|NCT00722345|Exercise counseling intervention|exercise counseling intervention
5644713|NCT00722332|HBIG (Hepatitis B Immune Globulin)|hbig (hepatitis b immune globulin)
5644714|NCT00722332|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
5644715|NCT00722332|Liver Transplant|liver transplant
5644716|NCT00722319|oral anticoagulation|oral anticoagulation
5644717|NCT00722319|warfarin|warfarin
5644718|NCT00722319|percutaneous coronary intervention|percutaneous coronary intervention
5644719|NCT00722319|stent|stent
5644720|NCT00722319|antiplatelet agents|antiplatelet agents
5644721|NCT00722306|non-restorative|non-restorative
5644722|NCT00722306|sleep|sleep
5644723|NCT00722293|Solid tumors|solid tumors
5644724|NCT00722293|Cancer|cancer
5644725|NCT00722293|Neoplasms, Ovarian|neoplasms, ovarian
5644726|NCT00722293|doxorubicin|doxorubicin
5644727|NCT00722293|epirubicin|epirubicin
5644728|NCT00722293|anti-angiogenesis|anti-angiogenesis
5644729|NCT00722293|pharmacodynamics|pharmacodynamics
5644730|NCT00722293|pazopanib (GW786034)|pazopanib (gw786034)
5644731|NCT00722293|pharmacokinetics|pharmacokinetics
5644732|NCT00722293|Soft Tissue|soft tissue
5644733|NCT00722293|Sarcoma|sarcoma
5644734|NCT00722280|Amputation, upper limb, composite tissue, immunosuppression|amputation, upper limb, composite tissue, immunosuppression
5644735|NCT00722267|severe COPD|severe copd
5644736|NCT00722267|COPD symptoms|copd symptoms
5644737|NCT00722267|variability of symptoms|variability of symptoms
5644738|NCT00722267|patient's perception|patient's perception
5644739|NCT00722254|Myeloproliferative Disorder|myeloproliferative disorder
5644740|NCT00722254|Primary Myelofibrosis|primary myelofibrosis
5644741|NCT00722254|Primary Pulmonary Hypertension|primary pulmonary hypertension
5644742|NCT00722254|Secondary Myelofibrosis|secondary myelofibrosis
5644743|NCT00722254|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5644744|NCT00722254|Flolan|flolan
5644745|NCT00722254|Clonality|clonality
5644746|NCT00722254|CD34+ cells|cd34+ cells
5647246|NCT00713544|RA|ra
5644747|NCT00722254|Hematologic abnormalities|hematologic abnormalities
5644748|NCT00722241|Continuous Glucose Monitoring|continuous glucose monitoring
5644749|NCT00722241|Interstitial Fluid|interstitial fluid
5644750|NCT00722241|Diabetes Mellitus|diabetes mellitus
5644751|NCT00722215|Endothelin antagonist|endothelin antagonist
5644752|NCT00722215|Chronic kidney disease|chronic kidney disease
5644753|NCT00722215|Proteinuria|proteinuria
5644754|NCT00722215|Cardiovascular disease|cardiovascular disease
5644755|NCT00722215|Blood pressure|blood pressure
5644756|NCT00722215|Arterial stiffness|arterial stiffness
5644757|NCT00722215|Endothelial function|endothelial function
5644758|NCT00722189|Mycoses|mycoses
5644759|NCT00722176|Schizophrenia|schizophrenia
5644760|NCT00722163|Cognitive Behavioural therapy|cognitive behavioural therapy
5644761|NCT00722163|Psychosis|psychosis
5644762|NCT00722150|Artesunate|artesunate
5644763|NCT00722150|Plasmodium Falciparum|plasmodium falciparum
5644764|NCT00722150|Cambodia|cambodia
5644765|NCT00722124|tobacco use|tobacco use
5644766|NCT00722124|cigarettes|cigarettes
5644767|NCT00722124|smokers|smokers
5644768|NCT00722111|tongue|tongue
5644769|NCT00722111|pressure|pressure
5644770|NCT00722098|Melanoma|melanoma
5644771|NCT00722098|Dendritic Cell|dendritic cell
5644772|NCT00722098|Vaccine|vaccine
5644773|NCT00722098|Immunotherapy|immunotherapy
5644774|NCT00722098|Cyclophosphamide|cyclophosphamide
5644775|NCT00722085|Amniotic Fluid Sludge|amniotic fluid sludge
5644776|NCT00722085|Cerclage|cerclage
5644777|NCT00722085|Ultrasound|ultrasound
5644778|NCT00722085|Preterm Delivery|preterm delivery
5644779|NCT00722085|Neonatal|neonatal
5644780|NCT00722072|male breast cancer|male breast cancer
5644781|NCT00722072|stage IIIA breast cancer|stage iiia breast cancer
5644782|NCT00722072|stage IIIB breast cancer|stage iiib breast cancer
5644783|NCT00722072|stage IIIC breast cancer|stage iiic breast cancer
5644784|NCT00722072|stage IV breast cancer|stage iv breast cancer
5644785|NCT00722072|recurrent breast cancer|recurrent breast cancer
5644786|NCT00722046|Alzheimer's disease|alzheimer's disease
5644787|NCT00722046|antibody|antibody
5644788|NCT00722046|amyloid|amyloid
5644789|NCT00722033|preterm|preterm
5644790|NCT00722033|aEEG|aeeg
5644791|NCT00722033|apneas|apneas
5644792|NCT00722033|surfactant|surfactant
5644793|NCT00722033|indomethacin|indomethacin
5644794|NCT00722033|aminophyline|aminophyline
5644795|NCT00722020|Asthma|asthma
5644796|NCT00722020|Bronchial Disease|bronchial disease
5644797|NCT00722020|Status Asthmaticus|status asthmaticus
5644798|NCT00722020|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5644800|NCT00722020|HFCWO|hfcwo
5644801|NCT00722007|hip resurfacing|hip resurfacing
5644802|NCT00722007|osteoarthritis|osteoarthritis
5644803|NCT00722007|avascular necrosis|avascular necrosis
5644804|NCT00722007|rheumatoid arthritis|rheumatoid arthritis
5644805|NCT00721994|hip resurfacing|hip resurfacing
5644806|NCT00721994|osteoarthritis|osteoarthritis
5644807|NCT00721994|avascular necrosis|avascular necrosis
5644808|NCT00721994|rheumatoid arthritis|rheumatoid arthritis
5644809|NCT00721981|patient preference|patient preference
5644810|NCT00721981|oncology|oncology
5644811|NCT00721981|chemotherapy|chemotherapy
5644812|NCT00721981|NSCLC|nsclc
5644813|NCT00721968|Open angle|open angle
5644814|NCT00721968|Glaucoma|glaucoma
5644815|NCT00721968|Cataract|cataract
5644816|NCT00721968|Surgery|surgery
5644817|NCT00721955|Bipolar 1 disorder,|bipolar 1 disorder,
5644818|NCT00721955|agitation,|agitation,
5644819|NCT00721955|acute,|acute,
5644820|NCT00721955|treatment|treatment
5644821|NCT00721929|adrenal glands, adrenal masses|adrenal glands, adrenal masses
5644822|NCT00721890|chemoprevention|chemoprevention
5644823|NCT00721890|green tea|green tea
5644824|NCT00721890|relapse free-survival|relapse free-survival
5644825|NCT00721890|proteases|proteases
5644826|NCT00721864|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5644827|NCT00721864|PIG-A Mutation|pig-a mutation
5644828|NCT00721864|Prion Protein|prion protein
5644829|NCT00721864|Hematopoietic stem cells|hematopoietic stem cells
5644830|NCT00721864|Clonal disorder|clonal disorder
5644831|NCT00721838|adolescent obesity|adolescent obesity
5644832|NCT00721838|eating behavior|eating behavior
5644833|NCT00721838|dietary intake|dietary intake
5644834|NCT00721825|Stroke|stroke
5644835|NCT00721825|Cerebral infarct|cerebral infarct
5644836|NCT00721825|Rehabilitation|rehabilitation
5644837|NCT00721825|Double blind Randomized|double blind randomized
5644838|NCT00721825|Placebo controlled|placebo controlled
5644839|NCT00721825|Traditional Chinese Medicine|traditional chinese medicine
5644840|NCT00721825|Neuroaid|neuroaid
5644841|NCT00721812|pharmacokinetics|pharmacokinetics
5644842|NCT00721812|Phase 1|phase 1
5644843|NCT00721812|first time in humans|first time in humans
5644844|NCT00721812|IBD|ibd
5644845|NCT00721812|safety|safety
5644846|NCT00721812|human volunteers|human volunteers
5644847|NCT00721799|Positron-Emission Tomography|positron-emission tomography
5644848|NCT00721799|radiation therapy|radiation therapy
5644849|NCT00721799|cisplatin|cisplatin
5644850|NCT00721799|chemotherapy|chemotherapy
5644852|NCT00721786|Smoking cessation|smoking cessation
5644853|NCT00721786|Cigarette smoking|cigarette smoking
5644854|NCT00721786|Tobacco smoking|tobacco smoking
5644855|NCT00721786|Internet interventions|internet interventions
5644856|NCT00721786|Spanish-speaking|spanish-speaking
5644857|NCT00721773|Continuous Ambulatory Peritoneal Dialysis|continuous ambulatory peritoneal dialysis
5644858|NCT00721773|Angiotensin-converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor
5644859|NCT00721773|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5644860|NCT00721773|Renin angiotensin system inhibitor|renin angiotensin system inhibitor
5644861|NCT00721773|Residual Renal Function|residual renal function
5644862|NCT00721760|Hip fractures|hip fractures
5644863|NCT00721760|Heparin Low-Molecular-Weight|heparin low-molecular-weight
5644864|NCT00721760|Randomized Controlled Trial|randomized controlled trial
5644865|NCT00721747|breast cancer patients her2 negative pathological responses|breast cancer patients her2 negative pathological responses
5644866|NCT00721734|Myeloma|myeloma
5644867|NCT00721734|Renal Insufficiency|renal insufficiency
5644868|NCT00721734|Proteasome|proteasome
5644869|NCT00721734|Hematological|hematological
5644870|NCT00721734|carfilzomib|carfilzomib
5644871|NCT00721734|PR-171|pr-171
5644872|NCT00721721|Dietary Sodium|dietary sodium
5644873|NCT00721721|Dietary Potassium|dietary potassium
5644874|NCT00721721|Genes|genes
5644875|NCT00721721|Genomics|genomics
5644876|NCT00721708|histidine dipeptides|histidine dipeptides
5644877|NCT00721708|carnosine|carnosine
5644878|NCT00721708|anserine|anserine
5644879|NCT00721695|Cataract|cataract
5644880|NCT00721695|Cataract Extraction|cataract extraction
5644881|NCT00721695|Lens Implantation|lens implantation
5644882|NCT00721695|Phacoemulsification|phacoemulsification
5644883|NCT00721682|Pediatry|pediatry
5644884|NCT00721682|Ill-treatment|ill-treatment
5644885|NCT00721682|Pain|pain
5644886|NCT00721682|maltreated children|maltreated children
5644887|NCT00721669|solid tumor|solid tumor
5644888|NCT00721656|Dry eye syndromes|dry eye syndromes
5644889|NCT00721656|Corneal diseases|corneal diseases
5644890|NCT00721656|Conjunctival Diseases|conjunctival diseases
5644891|NCT00721643|Angelica keiskei|angelica keiskei
5644892|NCT00721643|absorption kinetics|absorption kinetics
5644893|NCT00721643|quercetin|quercetin
5644894|NCT00721630|CAPECITABINE|capecitabine
5644895|NCT00721630|LAPATINIB|lapatinib
5644896|NCT00721604|shock|shock
5644897|NCT00721604|fluid responsiveness|fluid responsiveness
5644898|NCT00721604|volume expansion|volume expansion
5644899|NCT00721591|Recurrent Pregnancy Loss|recurrent pregnancy loss
5644903|NCT00721591|Inherited thrombophilia|inherited thrombophilia
5644904|NCT00721578|Observational study|observational study
5644905|NCT00721578|Effectiveness|effectiveness
5644906|NCT00721578|Safety|safety
5644907|NCT00721578|Tolerability|tolerability
5644908|NCT00721578|Systemic Fungal Infection|systemic fungal infection
5644909|NCT00721565|Breast Cancer|breast cancer
5644910|NCT00721565|Exercise|exercise
5644911|NCT00721565|Social Cognitive Theory|social cognitive theory
5644912|NCT00721565|Adherence|adherence
5644913|NCT00721565|Symptoms|symptoms
5644914|NCT00721565|Body Composition|body composition
5644915|NCT00721552|beta-cell function|beta-cell function
5644916|NCT00721552|glucocorticoid-induced diabetes|glucocorticoid-induced diabetes
5644917|NCT00721552|glucocorticoid|glucocorticoid
5644918|NCT00721552|DPP-4 inhibitors|dpp-4 inhibitors
5644919|NCT00721552|sitagliptin|sitagliptin
5644920|NCT00721552|diabetes mellitus|diabetes mellitus
5644921|NCT00721552|steroid diabetes|steroid diabetes
5644922|NCT00721552|insulin resistance|insulin resistance
5644923|NCT00721552|insulin sensitivity|insulin sensitivity
5644924|NCT00721526|alcohol dependence|alcohol dependence
5644925|NCT00721526|alcoholism|alcoholism
5644926|NCT00721526|anxiety disorder|anxiety disorder
5644927|NCT00721526|pharmacotherapy|pharmacotherapy
5644928|NCT00721526|disulfiram|disulfiram
5644929|NCT00721526|lorazepam|lorazepam
5644930|NCT00721513|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5644931|NCT00721513|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5644932|NCT00721513|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5644933|NCT00721513|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5644934|NCT00721513|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5644935|NCT00721513|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5644936|NCT00721513|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5644937|NCT00721513|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5644938|NCT00721487|C. albicans|c. albicans
5644939|NCT00721487|fluconazole|fluconazole
5644941|NCT00721461|Tolerability|tolerability
5644942|NCT00721461|MedPulser DDS device|medpulser dds device
5644943|NCT00721448|Pharmacokinetics|pharmacokinetics
5644944|NCT00721422|Pharmacokinetics of PD 0332334 in subjects with renal insufficiency|pharmacokinetics of pd 0332334 in subjects with renal insufficiency
5644945|NCT00721409|hormone-receptor positive advanced breast cancer|hormone-receptor positive advanced breast cancer
5644946|NCT00721396|Meningococcal disease,|meningococcal disease,
5644947|NCT00721396|Neisseria meningitidis serogroup B,|neisseria meningitidis serogroup b,
5644948|NCT00721396|Prevention,|prevention,
5644949|NCT00721396|Vaccination,|vaccination,
5644951|NCT00721383|caregiving, Alzheimer's disease, physical activity|caregiving, alzheimer's disease, physical activity
5644952|NCT00721370|sentinel lymph node mapping|sentinel lymph node mapping
5644953|NCT00721370|breast cancer|breast cancer
5644954|NCT00721370|near infrared imaging|near infrared imaging
5644955|NCT00721357|muscles|muscles
5644956|NCT00721357|work|work
5644957|NCT00721357|Magnetic Resonance Imaging|magnetic resonance imaging
5644958|NCT00721357|control groups|control groups
5644959|NCT00721344|Healthy males and females|healthy males and females
5644960|NCT00721331|CombinatoRx|combinatorx
5644961|NCT00721331|Atopic|atopic
5644962|NCT00721331|Dermatitis|dermatitis
5644963|NCT00721331|Topical|topical
5644964|NCT00721331|CRx-197|crx-197
5644965|NCT00721331|Normal Healthy Volunteers|normal healthy volunteers
5644966|NCT00721318|chronic widespread pain|chronic widespread pain
5644967|NCT00721318|fibromyalgia|fibromyalgia
5644968|NCT00721318|rheumatoid arthritis|rheumatoid arthritis
5644969|NCT00721318|Estonia|estonia
5644970|NCT00721305|Type 1 human immunodeficiency virus infection|type 1 human immunodeficiency virus infection
5644972|NCT00721305|Adaptive Immunity|adaptive immunity
5644973|NCT00721305|Cellular cholesterol|cellular cholesterol
5644974|NCT00721305|Rho GTPases|rho gtpases
5644975|NCT00721305|Lymphocyte function-associated antigen-1|lymphocyte function-associated antigen-1
5644976|NCT00721253|ReSTOR|restor
5644977|NCT00721240|responder|responder
5644978|NCT00721240|leucotriene antagonist|leucotriene antagonist
5644979|NCT00721214|Myelodysplastic Syndrome|myelodysplastic syndrome
5644980|NCT00721214|5-azacytidine|5-azacytidine
5644981|NCT00721214|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5644982|NCT00721201|subclinical Cushing's|subclinical cushing's
5644983|NCT00721175|biliary stent|biliary stent
5644984|NCT00721175|plastic stent|plastic stent
5644985|NCT00721175|metallic stent|metallic stent
5644986|NCT00721175|Complex hilar cholangiocarcinoma (Bismuth type II,III,IV)|complex hilar cholangiocarcinoma (bismuth type ii,iii,iv)
5644987|NCT00721162|Ovarian Cancer,|ovarian cancer,
5644988|NCT00721162|Fallopian Tube Cancer|fallopian tube cancer
5644989|NCT00721162|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5644990|NCT00721149|Atrial Fibrillation|atrial fibrillation
5644991|NCT00721149|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5644992|NCT00721149|Ablation|ablation
5644993|NCT00721149|Non-randomized|non-randomized
5644994|NCT00721136|bleeding|bleeding
5644995|NCT00721136|anticoagulation|anticoagulation
5644996|NCT00721136|pacemaker|pacemaker
5644997|NCT00721136|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5644998|NCT00721136|"patients undergoing implantation of a pacemaker or defibrillator (ICD)"|"patients undergoing implantation of a pacemaker or defibrillator (icd)"
5644999|NCT00721110|pain control|pain control
5645000|NCT00721110|nausea|nausea
5645001|NCT00721110|surgery recovery|surgery recovery
5645002|NCT00721097|Severe asthma|severe asthma
5645003|NCT00721097|exacerbation|exacerbation
5645004|NCT00721097|predictive factors|predictive factors
5645005|NCT00721097|Severe|severe
5645006|NCT00721084|short sleep duration|short sleep duration
5645007|NCT00721084|maximal aerobic capacity|maximal aerobic capacity
5645008|NCT00721084|body fat|body fat
5645009|NCT00721084|visceral adiposity|visceral adiposity
5645010|NCT00721084|activity-related energy expenditure|activity-related energy expenditure
5645011|NCT00721084|energy metabolism|energy metabolism
5645012|NCT00721071|Pediatrics|pediatrics
5645013|NCT00721071|Cystic Fibrosis|cystic fibrosis
5645014|NCT00721071|Hypertonic Saline|hypertonic saline
5645015|NCT00721071|Induced Sputum|induced sputum
5645017|NCT00721058|Eligible|eligible
5645018|NCT00721058|Operable|operable
5645019|NCT00721058|Disease|disease
5645020|NCT00721058|Conserving|conserving
5645021|NCT00721058|Therapy|therapy
5645022|NCT00721058|Visible mass on mammography|visible mass on mammography
5645023|NCT00721058|Ultrasound > 0.5 cm|ultrasound > 0.5 cm
5645024|NCT00721058|Histologically|histologically
5645025|NCT00721058|Proven|proven
5645026|NCT00721045|Heart Failure|heart failure
5645027|NCT00721045|Congestive Heart Failure|congestive heart failure
5645028|NCT00721032|Ventricular tachycardia (VT)|ventricular tachycardia (vt)
5645029|NCT00721032|Implantable cardioverter-defibrillator (ICD)|implantable cardioverter-defibrillator (icd)
5645030|NCT00721032|Ablation|ablation
5645031|NCT00721032|Cardiomyopathy|cardiomyopathy
5645032|NCT00721032|Electrophysiology study|electrophysiology study
5645033|NCT00721019|short sleep duration|short sleep duration
5645034|NCT00721019|glucose clamp technique|glucose clamp technique
5645035|NCT00721019|insulin secretion|insulin secretion
5645036|NCT00721019|insulin action|insulin action
5645037|NCT00721019|lipid turnover|lipid turnover
5645038|NCT00721019|free fatty acids|free fatty acids
5645039|NCT00721006|peripheral artery disease|peripheral artery disease
5645040|NCT00721006|peripheral vascular disease|peripheral vascular disease
5645042|NCT00721006|PVD|pvd
5645043|NCT00720993|Colorectal cancer screening|colorectal cancer screening
5645044|NCT00720993|Gene expression|gene expression
5645045|NCT00720993|RTPCR|rtpcr
5645046|NCT00720980|granuloma annulare, ROM|granuloma annulare, rom
5645053|NCT00720954|Malignant pleural diseases|malignant pleural diseases
5645054|NCT00720954|Mesothelioma|mesothelioma
5645055|NCT00720954|Diagnosis|diagnosis
5645056|NCT00720954|Pleurisy tuberculosis|pleurisy tuberculosis
5645057|NCT00720954|Patients with pleural diseases and pleural effusion should have been included in the study.|patients with pleural diseases and pleural effusion should have been included in the study.
5645064|NCT00720928|Behcet's disease|behcet's disease
5645065|NCT00720928|posterior uveitis|posterior uveitis
5645066|NCT00720928|flucinolone acetonide|flucinolone acetonide
5645067|NCT00720928|RETISERT|retisert
5645068|NCT00720915|unprovoked deep vein thrombosis|unprovoked deep vein thrombosis
5645069|NCT00720915|unprovoked pulmonary embolism|unprovoked pulmonary embolism
5645070|NCT00720915|anticoagulant therapy|anticoagulant therapy
5645071|NCT00720889|short sleep duration|short sleep duration
5645072|NCT00720889|glucose clamp technique|glucose clamp technique
5645073|NCT00720889|insulin secretion|insulin secretion
5645074|NCT00720889|insulin action|insulin action
5645075|NCT00720889|lipid turnover|lipid turnover
5645076|NCT00720889|free fatty acids|free fatty acids
5645077|NCT00720876|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5645078|NCT00720876|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5645079|NCT00720876|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5645080|NCT00720876|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5645081|NCT00720876|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5645082|NCT00720876|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5645083|NCT00720876|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5645084|NCT00720876|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5645085|NCT00720876|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5645086|NCT00720876|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5645087|NCT00720876|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5645088|NCT00720876|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5645089|NCT00720876|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5645090|NCT00720876|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5645091|NCT00720876|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5645092|NCT00720876|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5645093|NCT00720876|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5645094|NCT00720876|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5645095|NCT00720876|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5645096|NCT00720876|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5645097|NCT00720876|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5645098|NCT00720876|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5645099|NCT00720876|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5645100|NCT00720876|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5645101|NCT00720876|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5645102|NCT00720876|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5645103|NCT00720876|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5645104|NCT00720876|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5645105|NCT00720876|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5645106|NCT00720876|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5645107|NCT00720876|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5645108|NCT00720876|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5645109|NCT00720876|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5645113|NCT00720850|monosomy 5|monosomy 5
5645114|NCT00720850|monosomy del5q|monosomy del5q
5645115|NCT00720837|Brain Tumor|brain tumor
5645116|NCT00720837|Brain Cancer|brain cancer
5645117|NCT00720837|MR-guided laser thermal ablation of brain tumors|mr-guided laser thermal ablation of brain tumors
5645118|NCT00720837|Visualase® Thermal Therapy System|visualase® thermal therapy system
5645119|NCT00720837|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5645120|NCT00720837|MRTI|mrti
5645121|NCT00720837|Visualase Cooled Laser Application System|visualase cooled laser application system
5645122|NCT00720837|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5645123|NCT00720837|LITT|litt
5645124|NCT00720824|Immunizations|immunizations
5645125|NCT00720824|Children|children
5645126|NCT00720824|Injections|injections
5645127|NCT00720824|aged 4-6 Years|aged 4-6 years
5645128|NCT00720824|Hypnosis|hypnosis
5645129|NCT00720811|Malaria ACT|malaria act
5645130|NCT00720811|Rapid|rapid
5645131|NCT00720811|Diagnosis|diagnosis
5645132|NCT00720811|Community|community
5645133|NCT00720811|health|health
5645134|NCT00720811|worker|worker
5645135|NCT00720811|Artemesinin|artemesinin
5645136|NCT00720811|based|based
5645137|NCT00720811|Combination|combination
5645138|NCT00720811|Therapy|therapy
5645139|NCT00720811|Anti Malarial|anti malarial
5645140|NCT00720811|Treatment|treatment
5645141|NCT00720811|antibiotics|antibiotics
5645142|NCT00720785|Metastatic Solid Tumor|metastatic solid tumor
5645143|NCT00720785|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5645144|NCT00720785|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5645145|NCT00720785|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5645146|NCT00720785|Multiple Myeloma|multiple myeloma
5645147|NCT00720785|Lung Cancer|lung cancer
5645148|NCT00720785|Prostate Cancer|prostate cancer
5645149|NCT00720785|Colon Cancer|colon cancer
5645150|NCT00720785|Kidney Cancer|kidney cancer
5645151|NCT00720785|Pancreatic Cancer|pancreatic cancer
5645152|NCT00720785|Leukemia|leukemia
5645153|NCT00720785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5645155|NCT00720785|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5645156|NCT00720785|SLL|sll
5645157|NCT00720785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5645158|NCT00720785|CLL|cll
5645159|NCT00720772|coronary calcification|coronary calcification
5645160|NCT00720772|vascular calcification|vascular calcification
5645161|NCT00720772|sodium thiosulfate|sodium thiosulfate
5645162|NCT00720759|stroke|stroke
5645163|NCT00720759|hemiparesis|hemiparesis
5645164|NCT00720759|randomized controlled trial|randomized controlled trial
5645165|NCT00720759|d-cycloserine|d-cycloserine
5645166|NCT00720759|distributed practice|distributed practice
5645167|NCT00720759|constraint induced movement therapy|constraint induced movement therapy
5645168|NCT00720733|HIV|hiv
5645169|NCT00720733|Mood|mood
5645170|NCT00720733|Emotion|emotion
5645171|NCT00720733|Coping|coping
5645172|NCT00720733|Aids|aids
5645173|NCT00720733|Affect|affect
5645174|NCT00720733|Adults|adults
5645175|NCT00720733|Diagnosed|diagnosed
5645176|NCT00720707|Coronally advanced flap|coronally advanced flap
5645177|NCT00720707|gingival recession|gingival recession
5645178|NCT00720707|enamel matrix protein|enamel matrix protein
5638827|NCT00744042|HPP|hpp
5645179|NCT00720707|acellular dermal matrix|acellular dermal matrix
5645181|NCT00720668|hepatitis B|hepatitis b
5645182|NCT00720668|hepatocellular carcinoma|hepatocellular carcinoma
5645183|NCT00720668|radiofrequency ablation|radiofrequency ablation
5645184|NCT00720668|reactivation|reactivation
5645185|NCT00720655|coronary heart disease|coronary heart disease
5645186|NCT00720629|graft versus host disease|graft versus host disease
5645187|NCT00720629|GVHD|gvhd
5645188|NCT00720629|allogeneic transplant|allogeneic transplant
5645189|NCT00720629|GVHD prevention|gvhd prevention
5645190|NCT00720629|unrelated donors|unrelated donors
5645191|NCT00720629|mismatched unrelated donors|mismatched unrelated donors
5645192|NCT00720629|hematological malignancies|hematological malignancies
5645193|NCT00720629|Leukemia|leukemia
5645194|NCT00720629|Lymphoma|lymphoma
5645195|NCT00720629|Myelodysplastic Syndrome|myelodysplastic syndrome
5645196|NCT00720629|Myelofibrosis|myelofibrosis
5645197|NCT00720629|Aplastic Anemia|aplastic anemia
5645198|NCT00720629|Multiple Myeloma|multiple myeloma
5645199|NCT00720616|Growth hormone|growth hormone
5645200|NCT00720616|Metabolic syndrome|metabolic syndrome
5645201|NCT00720616|Insulin sensitivity|insulin sensitivity
5645202|NCT00720603|Autologous Stem Cell Transplant|autologous stem cell transplant
5645203|NCT00720577|Peripheral Arterial Disease|peripheral arterial disease
5645204|NCT00720577|PAD|pad
5645205|NCT00720577|Lower extremity peripheral arterial atherosclerotic plaque|lower extremity peripheral arterial atherosclerotic plaque
5645206|NCT00720577|RNA Expression|rna expression
5645207|NCT00720577|Lipid Biomarkers|lipid biomarkers
5645208|NCT00720564|adult glioblastoma|adult glioblastoma
5645209|NCT00720564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5645210|NCT00720564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5645211|NCT00720564|adult gliosarcoma|adult gliosarcoma
5645212|NCT00720564|adult mixed glioma|adult mixed glioma
5645213|NCT00720551|STISIM|stisim
5645214|NCT00720551|Alcohol|alcohol
5645215|NCT00720538|Inflammatory bowel diseases.|inflammatory bowel diseases.
5645216|NCT00720538|Crohn disease.|crohn disease.
5645217|NCT00720538|Ulcerative, colitis.|ulcerative, colitis.
5645218|NCT00720538|Randomised controlled trial.|randomised controlled trial.
5645219|NCT00720538|Therapy.|therapy.
5645220|NCT00720538|Thalidomide.|thalidomide.
5645221|NCT00720538|Children.|children.
5645222|NCT00720525|arterial stiffness|arterial stiffness
5645223|NCT00720525|arterial wave reflections|arterial wave reflections
5645224|NCT00720525|diastolic heart failure|diastolic heart failure
5645225|NCT00720512|adenocarcinoma of the colon|adenocarcinoma of the colon
5645226|NCT00720512|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5645227|NCT00720512|recurrent colon cancer|recurrent colon cancer
5645228|NCT00720512|recurrent rectal cancer|recurrent rectal cancer
5645229|NCT00720512|stage IV colon cancer|stage iv colon cancer
5629852|NCT00780481|Obesity|obesity
5645230|NCT00720512|stage IV rectal cancer|stage iv rectal cancer
5645231|NCT00720512|stage III rectal cancer|stage iii rectal cancer
5645232|NCT00720512|stage III colon cancer|stage iii colon cancer
5645233|NCT00720473|Bipolar depression|bipolar depression
5645234|NCT00720473|Elderly|elderly
5645235|NCT00720473|Lamotrigine|lamotrigine
5645236|NCT00720473|Brain energy metabolism|brain energy metabolism
5645237|NCT00720460|Magnetic Resonance Imaging|magnetic resonance imaging
5645238|NCT00720460|Minimally Invasive Therapy|minimally invasive therapy
5645239|NCT00720460|Transcatheter Therapeutics|transcatheter therapeutics
5645240|NCT00720460|Healthy Volunteers|healthy volunteers
5645241|NCT00720460|Gadolinium Contrast|gadolinium contrast
5645242|NCT00720460|Healthy Volunteer|healthy volunteer
5645243|NCT00720460|HV|hv
5645244|NCT00720447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5645245|NCT00720447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5645246|NCT00720421|Phase I|phase i
5645247|NCT00720421|pharmacodynamic study|pharmacodynamic study
5645248|NCT00720408|Immunosuppressant|immunosuppressant
5645249|NCT00720408|Graft loss|graft loss
5645250|NCT00720408|Combination drug therapy|combination drug therapy
5645251|NCT00720408|Randomized controlled trial|randomized controlled trial
5645252|NCT00720408|Open level method|open level method
5645253|NCT00720395|Psychiatry|psychiatry
5645254|NCT00720395|Pregnancy|pregnancy
5645255|NCT00720369|Bipolar depression|bipolar depression
5645256|NCT00720369|elderly|elderly
5645257|NCT00720369|Coenzyme Q10|coenzyme q10
5645258|NCT00720369|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5645259|NCT00720356|adult glioblastoma|adult glioblastoma
5645260|NCT00720356|adult gliosarcoma|adult gliosarcoma
5645261|NCT00720330|Inguinal Herniorrhaphy|inguinal herniorrhaphy
5645262|NCT00720330|Pain assessment|pain assessment
5645263|NCT00720330|Outcomes|outcomes
5645264|NCT00720317|Diabetic Retinopathy|diabetic retinopathy
5645265|NCT00720317|Sickle Cell Trait|sickle cell trait
5645266|NCT00720317|Vision Loss|vision loss
5645267|NCT00720317|Eye disease|eye disease
5645268|NCT00720304|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5645269|NCT00720304|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5638848|NCT00743990|URI|uri
5645271|NCT00720304|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5645272|NCT00720304|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5645273|NCT00720304|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5645274|NCT00720304|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5645275|NCT00720304|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5645276|NCT00720304|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5645277|NCT00720304|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5645278|NCT00720304|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5645279|NCT00720304|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5645280|NCT00720304|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5645281|NCT00720304|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5645282|NCT00720304|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5645285|NCT00720291|Pregnancy|pregnancy
5645286|NCT00720265|Organ Transplantation|organ transplantation
5645287|NCT00720265|Tacrolimus|tacrolimus
5645288|NCT00720265|Prograf|prograf
5645289|NCT00720265|FK506MR|fk506mr
5645290|NCT00720226|COPD|copd
5645291|NCT00720226|emphysema|emphysema
5645292|NCT00720226|angiotensin receptor blocker|angiotensin receptor blocker
5645293|NCT00720200|Communication|communication
5645294|NCT00720200|Intensive Care Units|intensive care units
5645295|NCT00720200|Palliative Care|palliative care
5645296|NCT00720200|End-of-Life Issues|end-of-life issues
5645297|NCT00720200|Talking with Your Doctor|talking with your doctor
5645298|NCT00720200|Coping with Chronic Illness|coping with chronic illness
5645299|NCT00720161|metformin, spina bifida, duchenne, insulin resistance|metformin, spina bifida, duchenne, insulin resistance
5645300|NCT00720148|Solid tumors|solid tumors
5645301|NCT00720122|Bone density|bone density
5645302|NCT00720122|Bone turnover markers|bone turnover markers
5645303|NCT00720122|rhIGF-1|rhigf-1
5645304|NCT00720122|Bone structure|bone structure
5645305|NCT00720122|Anorexia nervosa|anorexia nervosa
5645306|NCT00720096|Persistent Ovarian Cancer|persistent ovarian cancer
5645307|NCT00720096|Genomic directed salvage chemotherapy|genomic directed salvage chemotherapy
5645308|NCT00720096|Genomic Microarray|genomic microarray
5645450|NCT00719810|skin|skin
5645309|NCT00720083|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5847444|NCT00039715|Traumatic Reminders|traumatic reminders
5645310|NCT00720083|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5645311|NCT00720083|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5645312|NCT00720083|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5645313|NCT00720083|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5645314|NCT00720083|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5645315|NCT00720083|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5645316|NCT00720083|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5645317|NCT00720070|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5645318|NCT00720070|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5645319|NCT00720070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5645320|NCT00720070|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5645321|NCT00720070|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5645322|NCT00720070|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5645323|NCT00720070|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5645324|NCT00720070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5645325|NCT00720070|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5645326|NCT00720070|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5645327|NCT00720070|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5645328|NCT00720070|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5645329|NCT00720070|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5645330|NCT00720070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5645331|NCT00720070|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5638949|NCT00743600|ultrasound|ultrasound
5638951|NCT00743561|MSA|msa
5645332|NCT00720070|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5645333|NCT00720070|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5645334|NCT00720070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5645337|NCT00720057|Analgesia|analgesia
5645338|NCT00720031|Melanoma,|melanoma,
5645339|NCT00720031|Melan-A tumor reactive T cell clones,|melan-a tumor reactive t cell clones,
5645340|NCT00720031|immunotherapy|immunotherapy
5645341|NCT00720031|HLA-A2 melanoma patients with|hla-a2 melanoma patients with
5645342|NCT00720031|either loco-regional or lymphnode metastasis|either loco-regional or lymphnode metastasis
5645343|NCT00720031|transit nodules not surgically resectable|transit nodules not surgically resectable
5645344|NCT00720031|-measurable cutaneous or visceral metastasis .|-measurable cutaneous or visceral metastasis .
5645345|NCT00720031|Patients' tumor express Melan-A/MART-1 antigen.|patients' tumor express melan-a/mart-1 antigen.
5645346|NCT00720005|Cataract|cataract
5645347|NCT00720005|cataract extraction|cataract extraction
5645348|NCT00720005|intraocular lens|intraocular lens
5645349|NCT00720005|age related|age related
5645350|NCT00719992|Exercise tolerance test|exercise tolerance test
5645351|NCT00719992|HS-CRP|hs-crp
5645352|NCT00719992|Coronary angiography|coronary angiography
5645353|NCT00719992|Patients|patients
5645354|NCT00719979|Major Depressive Disorder|major depressive disorder
5645355|NCT00719979|Cognitive Behavior Therapy|cognitive behavior therapy
5645356|NCT00719979|Technology Assisted|technology assisted
5645358|NCT00719979|Primary Care|primary care
5645359|NCT00719966|stage IA breast cancer|stage ia breast cancer
5645360|NCT00719966|stage IB breast cancer|stage ib breast cancer
5645361|NCT00719966|stage II breast cancer|stage ii breast cancer
5645362|NCT00719966|stage IIIA breast cancer|stage iiia breast cancer
5645363|NCT00719966|stage IIIB breast cancer|stage iiib breast cancer
5645364|NCT00719966|stage IIIC breast cancer|stage iiic breast cancer
5645365|NCT00719966|stage IV breast cancer|stage iv breast cancer
5645366|NCT00719966|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5645367|NCT00719953|Cognitex|cognitex
5645368|NCT00719953|subjects|subjects
5645369|NCT00719940|tinnitus, cognitive behavioral therapy, CBT|tinnitus, cognitive behavioral therapy, cbt
5645370|NCT00719927|Social Support|social support
5645371|NCT00719914|eptifibatide|eptifibatide
5645372|NCT00719914|Integrilin|integrilin
5645373|NCT00719914|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5645374|NCT00719914|Acute Myocardial Infarction|acute myocardial infarction
5645375|NCT00719849|chronic myelogenous leukemia|chronic myelogenous leukemia
5645376|NCT00719849|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5645377|NCT00719849|acute myeloid leukemia|acute myeloid leukemia
5645378|NCT00719849|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5645379|NCT00719849|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5645380|NCT00719849|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5647920|NCT00711139|AD|ad
5645381|NCT00719849|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5630044|NCT00779662|Fiji|fiji
5645382|NCT00719849|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5645383|NCT00719849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5645384|NCT00719849|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5645385|NCT00719849|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5645386|NCT00719849|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5645387|NCT00719849|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5645388|NCT00719849|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5645389|NCT00719849|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5645390|NCT00719849|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5645391|NCT00719849|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5645392|NCT00719849|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5645393|NCT00719849|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5645394|NCT00719849|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5645395|NCT00719849|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5645396|NCT00719849|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5645397|NCT00719849|refractory multiple myeloma|refractory multiple myeloma
5645398|NCT00719849|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5645399|NCT00719849|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5645400|NCT00719849|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5645401|NCT00719849|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5645402|NCT00719849|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5645403|NCT00719849|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5645404|NCT00719849|refractory anemia|refractory anemia
5645405|NCT00719849|refractory anemia with excess blasts|refractory anemia with excess blasts
5645406|NCT00719849|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5645407|NCT00719849|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5645408|NCT00719849|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5645409|NCT00719849|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5645410|NCT00719849|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5645411|NCT00719849|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5645412|NCT00719849|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5645413|NCT00719849|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5645414|NCT00719849|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5645415|NCT00719849|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5645416|NCT00719849|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5645417|NCT00719849|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5645418|NCT00719849|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5645419|NCT00719849|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5645420|NCT00719849|stage II multiple myeloma|stage ii multiple myeloma
5645421|NCT00719849|stage III multiple myeloma|stage iii multiple myeloma
5645422|NCT00719849|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5645423|NCT00719849|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5645424|NCT00719849|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5645425|NCT00719849|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5645426|NCT00719849|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5645427|NCT00719849|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5645428|NCT00719849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5645429|NCT00719849|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5645430|NCT00719849|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5645431|NCT00719849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5645432|NCT00719849|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5645433|NCT00719849|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5645434|NCT00719849|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5645435|NCT00719849|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5645436|NCT00719849|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5645437|NCT00719849|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5645438|NCT00719849|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5645439|NCT00719849|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5645440|NCT00719849|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5645441|NCT00719849|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5645442|NCT00719849|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5645443|NCT00719849|essential thrombocythemia|essential thrombocythemia
5645445|NCT00719836|SB1518|sb1518
5645446|NCT00719836|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5630204|NCT00778895|Flu|flu
5645454|NCT00719797|stage III colon cancer|stage iii colon cancer
5645456|NCT00719784|Pulmonary|pulmonary
5645457|NCT00719784|Thoracic|thoracic
5645458|NCT00719784|Chest|chest
5645459|NCT00719784|Lung|lung
5645460|NCT00719771|Osteoarthritis|osteoarthritis
5645461|NCT00719771|Glenohumeral joint|glenohumeral joint
5645462|NCT00719771|Glenoid|glenoid
5645463|NCT00719771|Shoulder arthroplasty|shoulder arthroplasty
5645464|NCT00719758|TRK-100STP,|trk-100stp,
5645465|NCT00719758|beraprost sodium,|beraprost sodium,
5645466|NCT00719758|Careload LA|careload la
5645467|NCT00719758|AST-120|ast-120
5645468|NCT00719758|Spherical carbon adsorbent|spherical carbon adsorbent
5645469|NCT00719758|Drug-drug interaction|drug-drug interaction
5645470|NCT00719745|Organ transplantation|organ transplantation
5645471|NCT00719745|Tacrolimus|tacrolimus
5645472|NCT00719745|Prograf|prograf
5645473|NCT00719745|MR4|mr4
5645474|NCT00719732|ReSTOR Aspheric +3 IOL|restor aspheric +3 iol
5645482|NCT00719706|Bipolar disorder|bipolar disorder
5645483|NCT00719706|Bipolar depression|bipolar depression
5645484|NCT00719706|Natural substances|natural substances
5645485|NCT00719706|Depression|depression
5645486|NCT00719693|Food effect, phase I|food effect, phase i
5645487|NCT00719693|adverse events|adverse events
5645488|NCT00719680|CVID|cvid
5645489|NCT00719680|XLA|xla
5645490|NCT00719667|OPCAB|opcab
5645491|NCT00719667|coronary|coronary
5645492|NCT00719667|bypass|bypass
5645493|NCT00719667|grafting|grafting
5645494|NCT00719667|off pump|off pump
5645495|NCT00719654|Preeclampsia|preeclampsia
5645496|NCT00719654|Proteome|proteome
5645497|NCT00719654|Pregnancy|pregnancy
5645498|NCT00719641|Colonoscopy|colonoscopy
5645499|NCT00719641|Looping|looping
5645500|NCT00719641|Prevent Looping|prevent looping
5645501|NCT00719641|Colon Cancer Screening|colon cancer screening
5645502|NCT00719641|Segmental Stiffening Wire|segmental stiffening wire
5645503|NCT00719628|Postoperative|postoperative
5645504|NCT00719628|Cognitive|cognitive
5645505|NCT00719628|Dysfunction|dysfunction
5645506|NCT00719615|Thyroid Cancer|thyroid cancer
5645507|NCT00719615|Thyroid Nodules|thyroid nodules
5645508|NCT00719615|Vitamin D|vitamin d
5645509|NCT00719602|Coinfection|coinfection
5645510|NCT00719589|Voiding Dysfunction|voiding dysfunction
5645511|NCT00719589|Interstim|interstim
5645512|NCT00719576|Cartilage legions|cartilage legions
5645513|NCT00719576|symptomatic focal cartilage defects|symptomatic focal cartilage defects
5645514|NCT00719576|microfracture|microfracture
5645515|NCT00719576|MACI|maci
5645516|NCT00719576|autologous chondrocyte|autologous chondrocyte
5645517|NCT00719563|fatigue|fatigue
5627198|NCT00790452|VTE|vte
5645518|NCT00719563|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5645519|NCT00719563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5645520|NCT00719563|acute undifferentiated leukemia|acute undifferentiated leukemia
5645521|NCT00719563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5645522|NCT00719563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5645523|NCT00719563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5645524|NCT00719563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5645525|NCT00719563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5645526|NCT00719563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5645527|NCT00719563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5645528|NCT00719563|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5645529|NCT00719563|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5645530|NCT00719563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5645531|NCT00719563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5645532|NCT00719563|mast cell leukemia|mast cell leukemia
5645533|NCT00719563|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5645534|NCT00719563|prolymphocytic leukemia|prolymphocytic leukemia
5645535|NCT00719563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5645536|NCT00719563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5645537|NCT00719563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5645538|NCT00719563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5645539|NCT00719563|refractory hairy cell leukemia|refractory hairy cell leukemia
5645540|NCT00719563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5645541|NCT00719563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5645542|NCT00719563|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5645543|NCT00719563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5645544|NCT00719563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5645545|NCT00719563|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5645546|NCT00719563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5630249|NCT00778518|GHD|ghd
5645547|NCT00719563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5645548|NCT00719563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5645549|NCT00719563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5645550|NCT00719563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5645551|NCT00719563|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5645552|NCT00719563|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5645553|NCT00719563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5645554|NCT00719563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5645555|NCT00719563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5645556|NCT00719563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5645557|NCT00719563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5645558|NCT00719563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5645559|NCT00719563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5645560|NCT00719563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5645561|NCT00719563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5645562|NCT00719563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5645563|NCT00719563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5645564|NCT00719563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5645565|NCT00719563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5645566|NCT00719563|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5645567|NCT00719563|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5645568|NCT00719563|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5645569|NCT00719563|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5645570|NCT00719563|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5645571|NCT00719563|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5645572|NCT00719563|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5645573|NCT00719563|Waldenström macroglobulinemia|waldenström macroglobulinemia
5645574|NCT00719563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5645575|NCT00719563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5627298|NCT00790140|Esophageal Cancer|esophageal cancer
5645576|NCT00719563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5645577|NCT00719563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5645578|NCT00719563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5645579|NCT00719563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5645580|NCT00719563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5645581|NCT00719563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5645582|NCT00719563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5645583|NCT00719563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5645584|NCT00719563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5645585|NCT00719563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5645586|NCT00719563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5645587|NCT00719563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5645588|NCT00719563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5645589|NCT00719563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5645590|NCT00719563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5645591|NCT00719563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5645592|NCT00719563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5645593|NCT00719563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5645594|NCT00719563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5645595|NCT00719563|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5645596|NCT00719563|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5645597|NCT00719563|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5645598|NCT00719563|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5645599|NCT00719563|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5645600|NCT00719563|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5645601|NCT00719563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5645602|NCT00719563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5645873|NCT00718666|Immunogenicity|immunogenicity
5645603|NCT00719563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5645604|NCT00719563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5645605|NCT00719563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5645606|NCT00719563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5645607|NCT00719563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5645608|NCT00719563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5645609|NCT00719563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5645610|NCT00719563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5645611|NCT00719563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5645612|NCT00719563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5645613|NCT00719563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5645614|NCT00719563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5645615|NCT00719563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5645616|NCT00719563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5645617|NCT00719563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5645618|NCT00719563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5645619|NCT00719563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5645620|NCT00719563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5645621|NCT00719563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5645622|NCT00719563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5645623|NCT00719563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5645624|NCT00719563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5645625|NCT00719563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5645626|NCT00719563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5645627|NCT00719563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5645628|NCT00719563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5645633|NCT00719563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5645634|NCT00719563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5645635|NCT00719563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5645636|NCT00719563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5645637|NCT00719563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5627431|NCT00789607|MRI|mri
5645638|NCT00719563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5645639|NCT00719563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5645640|NCT00719563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5645641|NCT00719563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5645642|NCT00719563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5645643|NCT00719563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5645644|NCT00719563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5645645|NCT00719563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5645646|NCT00719563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5645647|NCT00719563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5645648|NCT00719563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5645649|NCT00719563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5645651|NCT00719563|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5645652|NCT00719563|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5645653|NCT00719563|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5645654|NCT00719563|primary myelofibrosis|primary myelofibrosis
5645655|NCT00719563|essential thrombocythemia|essential thrombocythemia
5645657|NCT00719563|extramedullary plasmacytoma|extramedullary plasmacytoma
5645658|NCT00719563|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5645659|NCT00719563|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5645660|NCT00719563|stage I multiple myeloma|stage i multiple myeloma
5645661|NCT00719563|stage II multiple myeloma|stage ii multiple myeloma
5645662|NCT00719563|stage III multiple myeloma|stage iii multiple myeloma
5847446|NCT00039715|Hippocampus|hippocampus
5645663|NCT00719563|primary systemic amyloidosis|primary systemic amyloidosis
5645664|NCT00719563|refractory multiple myeloma|refractory multiple myeloma
5645665|NCT00719563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5645666|NCT00719563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5645874|NCT00718666|Meningococcal vaccine|meningococcal vaccine
5645667|NCT00719563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5645668|NCT00719563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5645669|NCT00719550|Locally Advanced|locally advanced
5645670|NCT00719550|Metastatic|metastatic
5645671|NCT00719537|preeclampsia|preeclampsia
5645672|NCT00719537|progesterone|progesterone
5645673|NCT00719537|aspirin|aspirin
5645674|NCT00719537|prevent|prevent
5645675|NCT00719537|soluble fms-like tyrosine kinase (sFlt-1)|soluble fms-like tyrosine kinase (sflt-1)
5645676|NCT00719537|Placental Growth Factor (PlGF)|placental growth factor (plgf)
5645677|NCT00719537|risk|risk
5645678|NCT00719524|Neoplasms|neoplasms
5645679|NCT00719524|Antineoplastic Combined Chemotherapy Protocol|antineoplastic combined chemotherapy protocol
5645680|NCT00719511|Rhinoconjunctivitis|rhinoconjunctivitis
5645681|NCT00719511|Allergic|allergic
5645682|NCT00719498|Epo-alpha|epo-alpha
5645683|NCT00719498|Cardiac arrest|cardiac arrest
5645684|NCT00719498|Mild hypothermia|mild hypothermia
5645685|NCT00719485|lumbar decompression|lumbar decompression
5645686|NCT00719472|Follicular NHL|follicular nhl
5645687|NCT00719472|NHL|nhl
5645688|NCT00719472|Large B-Cell NHL|large b-cell nhl
5645689|NCT00719446|Acute Lung Injury|acute lung injury
5645690|NCT00719433|stroke|stroke
5645691|NCT00719433|chronic|chronic
5645692|NCT00719433|rehabilitation|rehabilitation
5645693|NCT00719433|robot therapy|robot therapy
5645694|NCT00719433|arm therapy|arm therapy
5645695|NCT00719420|Randomized clinical trial|randomized clinical trial
5645696|NCT00719420|Helicobacter pylori|helicobacter pylori
5645697|NCT00719420|clarithromycin|clarithromycin
5645698|NCT00719420|metronidazole|metronidazole
5645699|NCT00719420|amoxicillin|amoxicillin
5645700|NCT00719420|proton pump inhibitor|proton pump inhibitor
5639452|NCT00741832|dyspnea|dyspnea
5645701|NCT00719420|Colombia|colombia
5645702|NCT00719407|birth asphyxia|birth asphyxia
5645703|NCT00719407|neonatal encephalopathy|neonatal encephalopathy
5645704|NCT00719407|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5645705|NCT00719407|neuroprotection|neuroprotection
5645706|NCT00719407|neonate|neonate
5645707|NCT00719394|alzheimer Disease|alzheimer disease
5645708|NCT00719368|Groin hernia|groin hernia
5645709|NCT00719368|pain|pain
5645710|NCT00719368|chronic|chronic
5645711|NCT00719368|quantitative sensory testing|quantitative sensory testing
5645712|NCT00719368|Persistent postoperative pain|persistent postoperative pain
5645713|NCT00719342|Retinal vessel diameter|retinal vessel diameter
5645714|NCT00719342|Flicker-induced vasodilatation|flicker-induced vasodilatation
5645715|NCT00719342|Optic nerve head blood flow|optic nerve head blood flow
5645716|NCT00719342|Ocular Physiology|ocular physiology
5645717|NCT00719342|Regional Blood Flow|regional blood flow
5645718|NCT00719329|chlorhexidine|chlorhexidine
5645719|NCT00719329|umbilical cord|umbilical cord
5645720|NCT00719316|Renin inhibitor|renin inhibitor
5645721|NCT00719316|Patients|patients
5645722|NCT00719316|ACE inhibitor or ARB|ace inhibitor or arb
5645723|NCT00719316|Chronic Kidney Disease|chronic kidney disease
5645724|NCT00719316|Hypertension|hypertension
5645725|NCT00719290|Primary Angle Closure Glaucoma|primary angle closure glaucoma
5645726|NCT00719290|Phacoemulsification|phacoemulsification
5645727|NCT00719290|Goniosynechialysis|goniosynechialysis
5645728|NCT00719290|Outflow facility|outflow facility
5645729|NCT00719277|cardiac arrhythmia|cardiac arrhythmia
5645730|NCT00719277|syncope|syncope
5645731|NCT00719277|ECG|ecg
5645732|NCT00719277|implantable ECG monitor|implantable ecg monitor
5645733|NCT00719277|ILR|ilr
5645734|NCT00719264|Renal cell carcinoma|renal cell carcinoma
5645735|NCT00719264|Adults|adults
5645736|NCT00719264|Bevacizumab|bevacizumab
5645737|NCT00719264|RAD001|rad001
5645738|NCT00719264|Everolimus|everolimus
5645739|NCT00719264|Interferon|interferon
5645740|NCT00719264|Clear|clear
5645741|NCT00719264|Roferon|roferon
5645742|NCT00719264|Avastin|avastin
5645743|NCT00719264|Nephrectomy|nephrectomy
5645744|NCT00719264|newly diagnosed|newly diagnosed
5645745|NCT00719251|Complications of Diabetes Mellitus|complications of diabetes mellitus
5645746|NCT00719251|Electric stimulation|electric stimulation
5645747|NCT00719251|Low-Level Laser Therapy|low-level laser therapy
5645748|NCT00719199|Colorectal cancer|colorectal cancer
5645749|NCT00719199|metastatic cancer|metastatic cancer
5645750|NCT00719199|prior therapy|prior therapy
5645751|NCT00719199|1b|1b
5645752|NCT00719186|Polycystic Ovary Syndrome|polycystic ovary syndrome
5645753|NCT00719186|Infertility|infertility
5645754|NCT00719186|Pregnancy|pregnancy
5645755|NCT00719186|Women|women
5645756|NCT00719173|nausea and vomiting|nausea and vomiting
5645757|NCT00719173|breast cancer|breast cancer
5645758|NCT00719160|Gastric acid|gastric acid
5645759|NCT00719160|Dietary protein|dietary protein
5645760|NCT00719160|Calcium|calcium
5847447|NCT00039715|Flashbacks|flashbacks
5645761|NCT00719160|Intestinal absorption|intestinal absorption
5645762|NCT00719160|Calcium sensing receptor|calcium sensing receptor
5645763|NCT00719108|Diabetes, Healthy Volunteers|diabetes, healthy volunteers
5645764|NCT00719095|prescription opioid|prescription opioid
5645765|NCT00719095|opioid detoxification|opioid detoxification
5645766|NCT00719095|buprenorphine|buprenorphine
5645767|NCT00719095|naltrexone|naltrexone
5645768|NCT00719095|community reinforcement approach|community reinforcement approach
5645769|NCT00719095|prescription opioid abuse|prescription opioid abuse
5645770|NCT00719082|Human Stability|human stability
5645771|NCT00719082|Geriatric|geriatric
5645772|NCT00719082|Posturography|posturography
5645773|NCT00719056|teicoplanin|teicoplanin
5645774|NCT00719056|prophylaxis|prophylaxis
5645775|NCT00719056|arthroplasty|arthroplasty
5645776|NCT00719056|surgical site infections|surgical site infections
5645777|NCT00719043|Influenza|influenza
5645778|NCT00719043|H5N1|h5n1
5645779|NCT00719043|Avian|avian
5645780|NCT00719043|Vaccines|vaccines
5645781|NCT00719043|Safety|safety
5645782|NCT00719043|Immunogenicity|immunogenicity
5645783|NCT00719043|Pandemic|pandemic
5645784|NCT00719043|Human|human
5645785|NCT00719017|Brachytherapy|brachytherapy
5645786|NCT00719017|Early stage edometrial cancer|early stage edometrial cancer
5645787|NCT00719017|Quality of life|quality of life
5645788|NCT00719017|Recurrence|recurrence
5645789|NCT00719017|Treatment|treatment
5645790|NCT00719017|Vaginectomy|vaginectomy
5645791|NCT00719004|Anatomy|anatomy
5645792|NCT00719004|Foot|foot
5645793|NCT00719004|Sonography|sonography
5645795|NCT00718991|CLI|cli
5645796|NCT00718991|excimer laser|excimer laser
5645797|NCT00718991|debulking|debulking
5645798|NCT00718978|bioengineered|bioengineered
5645799|NCT00718978|ski|ski
5645800|NCT00718978|keratinocytes|keratinocytes
5645801|NCT00718978|fibroblasts|fibroblasts
5645802|NCT00718978|skin|skin
5645803|NCT00718978|culture|culture
5645804|NCT00718978|autologous|autologous
5645805|NCT00718978|CSS|css
5645806|NCT00718978|full-thickness loss of substance from:|full-thickness loss of substance from:
5645808|NCT00718978|ulcers|ulcers
5645809|NCT00718978|giant nevi|giant nevi
5645810|NCT00718978|cicatricial outcomes|cicatricial outcomes
5645811|NCT00718965|Primary hypercholesterolemia|primary hypercholesterolemia
5645812|NCT00718952|Pulmonary Hypertension|pulmonary hypertension
5645813|NCT00718939|Diastolic Heart Failure|diastolic heart failure
5645814|NCT00718939|Cardiac dysfunction|cardiac dysfunction
5645815|NCT00718939|Heart Failure|heart failure
5645816|NCT00718926|dry eye|dry eye
5645817|NCT00718926|Thiol redox|thiol redox
5645818|NCT00718926|Oxidative stress|oxidative stress
5645819|NCT00718913|Adjuvant Gastric Cancer|adjuvant gastric cancer
5645820|NCT00718913|Adjuvant chemotherapy|adjuvant chemotherapy
5645821|NCT00718913|Adjuvant chemo-radiation|adjuvant chemo-radiation
5645822|NCT00718913|Capecitabine|capecitabine
5645823|NCT00718874|obesity, puberty, diabetes,insulin dynamics|obesity, puberty, diabetes,insulin dynamics
5645824|NCT00718861|Osteoporosis|osteoporosis
5645825|NCT00718861|zoledronic acid|zoledronic acid
5645826|NCT00718861|post-menopausal|post-menopausal
5645827|NCT00718848|hemodialysis|hemodialysis
5645828|NCT00718848|left ventricular hypertrophy|left ventricular hypertrophy
5645829|NCT00718848|left ventricular systolic function|left ventricular systolic function
5645830|NCT00718835|smoking cessation|smoking cessation
5645831|NCT00718835|behavioral treatment|behavioral treatment
5645832|NCT00718835|contingency management|contingency management
5645833|NCT00718835|opioid maintenance|opioid maintenance
5645834|NCT00718835|methadone|methadone
5645835|NCT00718835|buprenorphine|buprenorphine
5645836|NCT00718822|clinical outcome|clinical outcome
5645837|NCT00718822|ICSI cycles|icsi cycles
5645838|NCT00718822|low oxygen|low oxygen
5645839|NCT00718822|poor responders|poor responders
5645840|NCT00718822|pregnancy rate|pregnancy rate
5645841|NCT00718822|prospective randomized study|prospective randomized study
5645842|NCT00718796|cardiovascular disease|cardiovascular disease
5645843|NCT00718796|naturopathic medicine|naturopathic medicine
5645844|NCT00718796|natural health products|natural health products
5645845|NCT00718796|lifestyle intervention|lifestyle intervention
5645846|NCT00718796|dietary advice|dietary advice
5645847|NCT00718796|coronary heart disease|coronary heart disease
5645848|NCT00718770|Not respond|not respond
5645849|NCT00718770|Radioactive iodine|radioactive iodine
5645850|NCT00718770|Therapy|therapy
5645851|NCT00718770|Shows signs|shows signs
5645852|NCT00718770|Aggressive behavior|aggressive behavior
5645853|NCT00718744|Allergen-extract|allergen-extract
5645854|NCT00718744|Standardization|standardization
5645855|NCT00718731|Alzheimer Disease|alzheimer disease
5645856|NCT00718718|Arthritis, Rheumatoid|arthritis, rheumatoid
5645857|NCT00718718|Rheumatoid Arthritis|rheumatoid arthritis
5645858|NCT00718718|Active Rheumatoid Arthritis|active rheumatoid arthritis
5645859|NCT00718718|CNTO 136|cnto 136
5645860|NCT00718718|Interleukin-6|interleukin-6
5645861|NCT00718718|Anti-interleukin-6 monoclonal antibody|anti-interleukin-6 monoclonal antibody
5645862|NCT00718718|Methotrexate|methotrexate
5645863|NCT00718718|Placebo|placebo
5645864|NCT00718705|Prematurity|prematurity
5645865|NCT00718705|Ureaplasma spp|ureaplasma spp
5645866|NCT00718705|Mycoplasma Hominis|mycoplasma hominis
5645867|NCT00718705|Amniotic fluid|amniotic fluid
5645868|NCT00718705|Josamycine|josamycine
5645869|NCT00718692|Idiopathic|idiopathic
5645870|NCT00718692|ITP|itp
5645871|NCT00718666|Safety|safety
5645872|NCT00718666|Vaccines, conjugate|vaccines, conjugate
5645875|NCT00718666|Booster vaccination|booster vaccination
5645876|NCT00718666|Primary vaccination|primary vaccination
5645877|NCT00718666|Neisseria meningitides|neisseria meningitides
5645878|NCT00718666|Toddlers|toddlers
5645879|NCT00718666|Humans|humans
5645880|NCT00718666|Meningococcal disease|meningococcal disease
5645881|NCT00718653|Macular pigment, lutein, green tea extract, antioxidant|macular pigment, lutein, green tea extract, antioxidant
5645882|NCT00718640|Multiple Myeloma|multiple myeloma
5645883|NCT00718640|Velcade|velcade
5645884|NCT00718640|Bortezomib|bortezomib
5645885|NCT00718640|Dexamethasone|dexamethasone
5645886|NCT00718627|Urea cycle Disorders|urea cycle disorders
5645887|NCT00718627|Carbamoylphosphate synthetase I deficiency|carbamoylphosphate synthetase i deficiency
5645888|NCT00718627|Ornithine transcarbamoylase deficiency|ornithine transcarbamoylase deficiency
5645889|NCT00718627|Argininosuccinate synthase deficiency|argininosuccinate synthase deficiency
5645890|NCT00718627|Citrullinemia|citrullinemia
5645891|NCT00718627|newborns|newborns
5645892|NCT00718627|infants|infants
5645893|NCT00718627|liver cell transplantation|liver cell transplantation
5645894|NCT00718627|liver cell infusion|liver cell infusion
5645895|NCT00718614|Choroidal blood flow|choroidal blood flow
5645896|NCT00718614|Laser Doppler flowmetry|laser doppler flowmetry
5645897|NCT00718614|Diabetic Retinopathy|diabetic retinopathy
5645898|NCT00718614|Diabetic Neuropathy|diabetic neuropathy
5645899|NCT00718601|Myeloma|myeloma
5645900|NCT00718601|Multiple Myeloma|multiple myeloma
5645901|NCT00718601|Relapsed Multiple Myeloma|relapsed multiple myeloma
5645902|NCT00718601|Refractory Multiple Myeloma|refractory multiple myeloma
5645903|NCT00718601|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5645905|NCT00718575|Liver Disease|liver disease
5645907|NCT00718562|nilotinib|nilotinib
5645908|NCT00718562|AMN107|amn107
5645909|NCT00718562|Sunitinib|sunitinib
5645910|NCT00718562|Sunitinib malate|sunitinib malate
5645911|NCT00718562|Imatinib|imatinib
5645912|NCT00718562|Imatinib mesylate|imatinib mesylate
5645913|NCT00718562|Tyrosine|tyrosine
5645914|NCT00718536|Atazanavir|atazanavir
5645915|NCT00718536|Raltegravir|raltegravir
5645916|NCT00718536|once-daily|once-daily
5645917|NCT00718536|pharmacokinetics|pharmacokinetics
5645918|NCT00718536|HIV|hiv
5645919|NCT00718497|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5645920|NCT00718497|Cerebrospinal Fluid|cerebrospinal fluid
5645921|NCT00718497|Neurodegenerative Disease|neurodegenerative disease
5645922|NCT00718497|Motor Neuron Disease|motor neuron disease
5645923|NCT00718497|Autonomic Nervous System|autonomic nervous system
5645924|NCT00718497|Neurodegenerative Diseases|neurodegenerative diseases
5645925|NCT00718497|Movement Disorders|movement disorders
5645926|NCT00718484|Sarcoma|sarcoma
5645927|NCT00718484|Soft Tissue Sarcoma|soft tissue sarcoma
5645928|NCT00718484|Doxorubicin|doxorubicin
5645929|NCT00718484|anthracyclin|anthracyclin
5645930|NCT00718484|Palifosfamide|palifosfamide
5645931|NCT00718484|IFOS|ifos
5645932|NCT00718471|STEMI|stemi
5645933|NCT00718471|Primary PCI|primary pci
5645934|NCT00718471|Anticoagulation|anticoagulation
5645935|NCT00718458|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5645936|NCT00718458|Cerebrospinal Fluid|cerebrospinal fluid
5645937|NCT00718458|Neurodegenerative Disease|neurodegenerative disease
5645938|NCT00718458|Motor Neuron Disease|motor neuron disease
5645939|NCT00718458|Autonomic Nervous System|autonomic nervous system
5645940|NCT00718458|Neurodegenerative Diseases|neurodegenerative diseases
5645941|NCT00718458|Movement Disorders|movement disorders
5645942|NCT00718445|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5645943|NCT00718445|Cerebrospinal Fluid|cerebrospinal fluid
5645944|NCT00718445|Neurodegenerative Disease|neurodegenerative disease
5645945|NCT00718445|Motor Neuron Disease|motor neuron disease
5645946|NCT00718445|Autonomic Nervous System|autonomic nervous system
5645947|NCT00718445|Neurodegenerative Diseases|neurodegenerative diseases
5645948|NCT00718445|Movement Disorders|movement disorders
5645950|NCT00718432|Osteoporosis|osteoporosis
5645951|NCT00718432|Depression|depression
5645952|NCT00718419|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5645953|NCT00718419|Multiple Myeloma|multiple myeloma
5645954|NCT00718406|Acute coronary syndrome|acute coronary syndrome
5645955|NCT00718406|Chest pain|chest pain
5645956|NCT00718406|Betablockers|betablockers
5645957|NCT00718406|Morphine|morphine
5645958|NCT00718406|Prehospital phase|prehospital phase
5645959|NCT00718393|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5645960|NCT00718393|Cerebrospinal Fluid|cerebrospinal fluid
5645961|NCT00718393|Neurodegenerative Disease|neurodegenerative disease
5645962|NCT00718393|Motor Neuron Disease|motor neuron disease
5847448|NCT00039715|PTSD|ptsd
5645963|NCT00718393|Autonomic Nervous System|autonomic nervous system
5645964|NCT00718393|Neurodegenerative Diseases|neurodegenerative diseases
5645965|NCT00718393|Movement Disorders|movement disorders
5645966|NCT00718354|Bleeding events|bleeding events
5645967|NCT00718341|Fragile X Syndrome, adults, efficacy|fragile x syndrome, adults, efficacy
5645968|NCT00718328|Intracerebral|intracerebral
5645970|NCT00718328|Edema|edema
5645972|NCT00718302|Ankle Fractures|ankle fractures
5645973|NCT00718302|Displaced Lateral Malleolus Fractures|displaced lateral malleolus fractures
5645974|NCT00718302|Antiglide Plating|antiglide plating
5645975|NCT00718302|Lateral Plating|lateral plating
5645976|NCT00718289|Citric acid|citric acid
5645977|NCT00718289|citrate|citrate
5645978|NCT00718289|acetic acid|acetic acid
5645979|NCT00718289|acetate|acetate
5645980|NCT00718289|haemodialysis|haemodialysis
5645981|NCT00718289|calcium|calcium
5645982|NCT00718289|hypotension|hypotension
5645983|NCT00718289|haemodynamics|haemodynamics
5645984|NCT00718289|Dialysate for Haemodialysis|dialysate for haemodialysis
5645985|NCT00718276|Healthy postmenopausal women|healthy postmenopausal women
5645986|NCT00718250|Acute myeloid leukaemia|acute myeloid leukaemia
5645987|NCT00718250|Cancer vaccines|cancer vaccines
5645988|NCT00718250|Immunotherapy|immunotherapy
5645989|NCT00718237|Gastroenteritis|gastroenteritis
5645990|NCT00718237|Rotavirus|rotavirus
5645991|NCT00718224|Knee surgery|knee surgery
5645992|NCT00718224|VTE prevention|vte prevention
5645993|NCT00718198|Inpatient|inpatient
5645994|NCT00718198|Computer Physician Order Entry|computer physician order entry
5645995|NCT00718198|Diabetes Mellitus|diabetes mellitus
5645996|NCT00718185|Sildenafil|sildenafil
5645997|NCT00718185|Pediatrics|pediatrics
5645998|NCT00718172|Ribavirin Pretreatment|ribavirin pretreatment
5645999|NCT00718172|Gene Expression|gene expression
5646000|NCT00718172|Peginterferon|peginterferon
5646001|NCT00718172|Hepatitis C|hepatitis c
5646002|NCT00718172|Liver Biopsy|liver biopsy
5646004|NCT00718159|Acute Myeloid Leukemia|acute myeloid leukemia
5646005|NCT00718159|Myeloid Leukemia|myeloid leukemia
5646006|NCT00718159|Relapsed|relapsed
5646007|NCT00718159|Refractory|refractory
5646008|NCT00718146|Influenza|influenza
5646009|NCT00718146|Orthomyxoviridae Infections|orthomyxoviridae infections
5646010|NCT00718146|Orthomyxoviruses|orthomyxoviruses
5646011|NCT00718146|Split-virion influenza vaccine|split-virion influenza vaccine
5646012|NCT00718133|Asthma|asthma
5646013|NCT00718133|Allergy|allergy
5646014|NCT00718133|Respiratory|respiratory
5646015|NCT00718133|Pollution|pollution
5646016|NCT00718133|Children|children
5646017|NCT00718133|Air pollution|air pollution
5646018|NCT00718120|Fluviral|fluviral
5646019|NCT00718120|Influenza|influenza
5646020|NCT00718107|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5646021|NCT00718107|Cerebrospinal Fluid|cerebrospinal fluid
5646022|NCT00718107|Neurodegenerative Disease|neurodegenerative disease
5646023|NCT00718107|Motor Neuron Disease|motor neuron disease
5646024|NCT00718107|Autonomic Nervous System|autonomic nervous system
5646025|NCT00718107|Neurodegenerative Diseases|neurodegenerative diseases
5646026|NCT00718107|Movement Disorders|movement disorders
5646027|NCT00718107|Quality of Life|quality of life
5646028|NCT00718094|Ulcerative colitis|ulcerative colitis
5646029|NCT00718094|EGCG|egcg
5646030|NCT00718094|Green tea polyphenols|green tea polyphenols
5646031|NCT00718094|Inflammatory bowel disease|inflammatory bowel disease
5646032|NCT00718094|Colitis|colitis
5646034|NCT00718094|Green tea|green tea
5646035|NCT00718068|Potassium chloride|potassium chloride
5646036|NCT00718068|Preparations, Pharmaceutical|preparations, pharmaceutical
5646037|NCT00718068|Hypokalemia|hypokalemia
5646038|NCT00718068|Critical Care|critical care
5646039|NCT00718068|Adult|adult
5646040|NCT00718068|Randomized Controlled Trial|randomized controlled trial
5646041|NCT00718055|MRI|mri
5646042|NCT00718055|liverspecific|liverspecific
5646043|NCT00718055|contrast|contrast
5646044|NCT00718055|colorectal|colorectal
5646045|NCT00718055|metastases|metastases
5646046|NCT00718042|healthy donors|healthy donors
5646047|NCT00718029|Human Immunodeficiency Virus|human immunodeficiency virus
5646048|NCT00718029|Cerebrospinal Fluid|cerebrospinal fluid
5646049|NCT00718029|Raltegravir|raltegravir
5646050|NCT00718029|Drug Concentrations|drug concentrations
5646051|NCT00718016|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5646052|NCT00718016|Cerebrospinal Fluid|cerebrospinal fluid
5646053|NCT00718016|Neurodegenerative Disease|neurodegenerative disease
5646054|NCT00718016|Motor Neuron Disease|motor neuron disease
5646055|NCT00718016|Autonomic Nervous System|autonomic nervous system
5646056|NCT00718016|Neurodegenerative Diseases|neurodegenerative diseases
5646057|NCT00718016|Movement Disorders|movement disorders
5646058|NCT00718003|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5646059|NCT00718003|Cerebrospinal Fluid|cerebrospinal fluid
5646060|NCT00718003|Neurodegenerative Disease|neurodegenerative disease
5646061|NCT00718003|Motor Neuron Disease|motor neuron disease
5646062|NCT00718003|Autonomic Nervous System|autonomic nervous system
5646063|NCT00718003|Neurodegenerative Diseases|neurodegenerative diseases
5646065|NCT00717990|Colorectal cancer|colorectal cancer
5646066|NCT00717990|Bevacizumab|bevacizumab
5646067|NCT00717990|XELIRI|xeliri
5646068|NCT00717951|advanced breast cancer|advanced breast cancer
5646069|NCT00717951|docetaxol|docetaxol
5646070|NCT00717951|capecitabine|capecitabine
5646071|NCT00717951|cisplatin|cisplatin
5646072|NCT00717925|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5646074|NCT00717912|BLOOD GLUCOSE|blood glucose
5646075|NCT00717912|glycemic index|glycemic index
5646076|NCT00717912|rates of digestion and absorption of food|rates of digestion and absorption of food
5646077|NCT00717899|Asthma|asthma
5646078|NCT00717899|Allergy|allergy
5646079|NCT00717899|Respiratory|respiratory
5646080|NCT00717899|Pollution|pollution
5646081|NCT00717899|Children|children
5646082|NCT00717899|Air pollution|air pollution
5646083|NCT00717886|Breast|breast
5646084|NCT00717886|Lymph Nodes|lymph nodes
5646085|NCT00717873|Mucus Clearance|mucus clearance
5646086|NCT00717873|Secretion Clearance|secretion clearance
5646087|NCT00717873|HFCWO|hfcwo
5646088|NCT00717808|Tranilast|tranilast
5646089|NCT00717808|Rheumatoid Arthritis|rheumatoid arthritis
5646090|NCT00717808|Pharmacokinetics|pharmacokinetics
5646091|NCT00717808|Methotrexate|methotrexate
5646092|NCT00717795|Survivor|survivor
5646093|NCT00717795|Physical Activity|physical activity
5646095|NCT00717795|08-067|08-067
5646096|NCT00717782|botulinum toxin|botulinum toxin
5646097|NCT00717782|thrombosed external haemorrhoids|thrombosed external haemorrhoids
5646098|NCT00717782|pain|pain
5646099|NCT00717769|Atopic Dermatitis|atopic dermatitis
5646101|NCT00717743|RCC|rcc
5646102|NCT00717743|patients|patients
5646103|NCT00717743|scheduled|scheduled
5646104|NCT00717743|nephrectomy|nephrectomy
5646105|NCT00717730|Nutrition|nutrition
5646106|NCT00717730|Children|children
5646107|NCT00717730|Folate|folate
5646108|NCT00717730|Vitamin B12|vitamin b12
5646109|NCT00717730|India|india
5646110|NCT00717730|Homocysteine|homocysteine
5646111|NCT00717730|Methyl Malonic Acid|methyl malonic acid
5646112|NCT00717717|Cancer Survivor|cancer survivor
5646113|NCT00717717|Physical Activity|physical activity
5646114|NCT00717717|Health Behavior|health behavior
5646115|NCT00717717|Psychosocial Well-being|psychosocial well-being
5646116|NCT00717717|Coaching|coaching
5646117|NCT00717717|Long Term|long term
5646118|NCT00717717|Consequences|consequences
5646119|NCT00717717|Chemotherapy|chemotherapy
5646120|NCT00717717|Motivation|motivation
5646121|NCT00717704|Malignant solid tumor|malignant solid tumor
5646122|NCT00717704|Phase 1|phase 1
5646123|NCT00717704|Dose escalation|dose escalation
5646124|NCT00717704|Metastatic or locally advanced/unresectable|metastatic or locally advanced/unresectable
5646125|NCT00717704|Disease progression through standard therapy|disease progression through standard therapy
5646126|NCT00717691|Hallux Limitus|hallux limitus
5646127|NCT00717691|Dynamic Splinting|dynamic splinting
5646128|NCT00717691|Dynasplint|dynasplint
5646129|NCT00717678|Immunosuppressant|immunosuppressant
5646130|NCT00717678|Combination drug therapy|combination drug therapy
5646131|NCT00717678|Graft loss|graft loss
5646132|NCT00717678|Randomized controlled trial|randomized controlled trial
5646133|NCT00717678|Open level method|open level method
5646134|NCT00717665|Hypertension|hypertension
5646135|NCT00717665|Telemanagement|telemanagement
5646136|NCT00717665|Home blood pressure monitoring|home blood pressure monitoring
5646137|NCT00717665|Self care|self care
5646138|NCT00717639|diagnostic accuracy|diagnostic accuracy
5646139|NCT00717639|magnetic resonance angiography|magnetic resonance angiography
5646140|NCT00717639|steady state|steady state
5646141|NCT00717639|digital subtraction angiography|digital subtraction angiography
5646142|NCT00717639|peripheral arteries|peripheral arteries
5646143|NCT00717626|Hemophilia|hemophilia
5646144|NCT00717626|Prophylaxis|prophylaxis
5646145|NCT00717626|Youth|youth
5646146|NCT00717626|Young Adults|young adults
5646147|NCT00717626|Feasibility|feasibility
5646148|NCT00717600|bacteriuria|bacteriuria
5646149|NCT00717600|urinary tract infection|urinary tract infection
5646150|NCT00717600|probiotics|probiotics
5646151|NCT00717600|lactobacillus|lactobacillus
5646152|NCT00717600|vagina|vagina
5646153|NCT00717600|bladder|bladder
5646154|NCT00717600|neurogenic bladder|neurogenic bladder
5646155|NCT00717600|spina bifida|spina bifida
5646156|NCT00717600|myelomeningocele|myelomeningocele
5646157|NCT00717600|neuropathic bladder|neuropathic bladder
5646158|NCT00717587|stage IV renal cell cancer|stage iv renal cell cancer
5646159|NCT00717587|recurrent renal cell cancer|recurrent renal cell cancer
5646160|NCT00717574|depth of sedation|depth of sedation
5646161|NCT00717574|nitrous oxide|nitrous oxide
5646162|NCT00717574|general anesthesia|general anesthesia
5646163|NCT00717574|anesthesia indices|anesthesia indices
5646164|NCT00717561|CAP|cap
5646165|NCT00717561|Community-acquired pneumonia|community-acquired pneumonia
5646166|NCT00717548|Somatic Complaints|somatic complaints
5646167|NCT00717535|health status unknown|health status unknown
5646168|NCT00717522|Soft Tissue Sarcoma|soft tissue sarcoma
5646169|NCT00717522|CC-4047|cc-4047
5646170|NCT00717522|Pomalidomide|pomalidomide
5646171|NCT00717509|schizophrenia|schizophrenia
5646172|NCT00717509|metabolic side effect|metabolic side effect
5646173|NCT00717509|clozapine|clozapine
5646174|NCT00717509|genetic polymorphism|genetic polymorphism
5646175|NCT00717496|Breastfeeding|breastfeeding
5646176|NCT00717496|Telephone Support|telephone support
5646177|NCT00717496|Latino|latino
5646178|NCT00717470|Kidney|kidney
5646179|NCT00717470|Prograf|prograf
5646180|NCT00717470|Transplant|transplant
5646181|NCT00717470|Advagraf|advagraf
5646182|NCT00717470|Immunosuppression|immunosuppression
5646183|NCT00717470|FK506|fk506
5646184|NCT00717444|Substance Abuse|substance abuse
5646185|NCT00717444|HIV|hiv
5646186|NCT00717444|Contingency Management|contingency management
5646187|NCT00717444|Physical Activity|physical activity
5646188|NCT00717431|Deep Brain Stimulation|deep brain stimulation
5646189|NCT00717431|Seizures|seizures
5646190|NCT00717431|Epilepsy|epilepsy
5646191|NCT00717392|ADHD|adhd
5646192|NCT00717392|ASD|asd
5646193|NCT00717379|Organ Transplantation|organ transplantation
5646194|NCT00717379|Tacrolimus|tacrolimus
5646195|NCT00717379|Prograf|prograf
5646196|NCT00717379|Kidney|kidney
5646197|NCT00717379|Immunosuppression|immunosuppression
5646198|NCT00717340|tivozanib|tivozanib
5646199|NCT00717340|AV-951|av-951
5646200|NCT00717327|MRL|mrl
5646201|NCT00717327|Adolescents|adolescents
5646202|NCT00717327|Health Literacy|health literacy
5646203|NCT00717301|TBI, traumatic brain injury, S100B, head CT scan|tbi, traumatic brain injury, s100b, head ct scan
5646204|NCT00717288|diabetes|diabetes
5646205|NCT00717288|hyperglycemia|hyperglycemia
5646206|NCT00717288|open heart surgery|open heart surgery
5646207|NCT00717288|cardiothoracic surgery|cardiothoracic surgery
5646208|NCT00717288|detemir|detemir
5646209|NCT00717288|insulin infusion|insulin infusion
5646210|NCT00717288|intravenous insulin|intravenous insulin
5646211|NCT00717275|Brain Metastases|brain metastases
5646212|NCT00717275|Temozolomide|temozolomide
5646213|NCT00717275|Temodar|temodar
5646214|NCT00717275|TMZ|tmz
5646215|NCT00717275|Stereotactic Radiosurgery|stereotactic radiosurgery
5646216|NCT00717275|SRS|srs
5646217|NCT00717236|Certolizumab pegol|certolizumab pegol
5646218|NCT00717236|Cimzia|cimzia
5646219|NCT00717236|Rheumatoid Arthritis|rheumatoid arthritis
5646220|NCT00717236|Joint Disease|joint disease
5646221|NCT00717236|Chronic Arthritis|chronic arthritis
5646222|NCT00717223|Diabetes|diabetes
5646223|NCT00717223|Type 1 diabetes mellitus|type 1 diabetes mellitus
5646224|NCT00717223|Type 2 diabetes mellitus|type 2 diabetes mellitus
5646225|NCT00717223|Literacy|literacy
5646226|NCT00717223|Glycemic control|glycemic control
5646227|NCT00717210|1p/19q loss|1p/19q loss
5646228|NCT00717210|MGMT|mgmt
5646229|NCT00717210|prognostic factors|prognostic factors
5646231|NCT00717210|temozolomide|temozolomide
5646232|NCT00717197|HGG|hgg
5646233|NCT00717197|anaplastic astrocytoma|anaplastic astrocytoma
5646234|NCT00717197|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5646235|NCT00717197|anaplastic mixed glioma|anaplastic mixed glioma
5646236|NCT00717197|glioblastoma multiforme|glioblastoma multiforme
5646237|NCT00717197|GBM|gbm
5646238|NCT00717197|Xeloda|xeloda
5646239|NCT00717197|capecitabine|capecitabine
5646240|NCT00717171|electrical stimulation|electrical stimulation
5646241|NCT00717171|pain|pain
5646242|NCT00717171|medication|medication
5646243|NCT00717171|edema|edema
5646244|NCT00717171|interferential|interferential
5646245|NCT00717171|neuromuscular|neuromuscular
5646246|NCT00717171|high voltage pulsed current|high voltage pulsed current
5646247|NCT00717171|knee|knee
5646248|NCT00717158|Health Behavior|health behavior
5646249|NCT00717158|Lifestyle|lifestyle
5646250|NCT00717158|health care costs|health care costs
5646251|NCT00717158|quality of life|quality of life
5646252|NCT00717145|bioequivalence|bioequivalence
5646253|NCT00717132|weight|weight
5646254|NCT00717132|cost effectiveness|cost effectiveness
5646255|NCT00717132|obesity|obesity
5646256|NCT00717132|family based behavioral treatment|family based behavioral treatment
5646257|NCT00717119|GI|gi
5646258|NCT00717119|NSAID|nsaid
5646259|NCT00717119|Complications|complications
5646261|NCT00717119|Patients|patients
5646262|NCT00717106|ILR|ilr
5646263|NCT00717106|ECG monitoring|ecg monitoring
5646264|NCT00717106|cardiac arrhythmia|cardiac arrhythmia
5646265|NCT00717106|syncope|syncope
5646266|NCT00717106|presyncope|presyncope
5646267|NCT00717106|fainting|fainting
5646268|NCT00717080|Retinitis Pigmentosa|retinitis pigmentosa
5646269|NCT00717080|Cataract|cataract
5646270|NCT00717067|maraviroc, pharmacokinetics, renal impairment|maraviroc, pharmacokinetics, renal impairment
5646271|NCT00717054|postoperative nausea and vomiting|postoperative nausea and vomiting
5646272|NCT00717041|Depression|depression
5646273|NCT00717041|Anxiety|anxiety
5646274|NCT00717041|Cognitive Impairment|cognitive impairment
5646275|NCT00717041|Emergency medicine|emergency medicine
5646276|NCT00717041|prehospital care|prehospital care
5646277|NCT00717028|Cerebral palsy|cerebral palsy
5646278|NCT00717028|Dysphagia|dysphagia
5646279|NCT00717028|Deglutition|deglutition
5646280|NCT00717028|Endoscopy|endoscopy
5646281|NCT00717015|Hormone Receptor Positive Breast Cancer|hormone receptor positive breast cancer
5646282|NCT00716989|Cutaneous immune system|cutaneous immune system
5646283|NCT00716989|innate immunity|innate immunity
5646284|NCT00716989|tuberculin skin tests|tuberculin skin tests
5646285|NCT00716989|intradermal vaccination|intradermal vaccination
5646286|NCT00716989|pathophysiology|pathophysiology
5646287|NCT00716989|Healthy subjects|healthy subjects
5646288|NCT00716989|Immunosuppressed patients|immunosuppressed patients
5646289|NCT00716976|ototoxicity|ototoxicity
5646290|NCT00716976|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5646291|NCT00716976|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5646292|NCT00716976|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5646293|NCT00716976|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5646294|NCT00716976|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5646295|NCT00716976|childhood teratoma|childhood teratoma
5646296|NCT00716976|childhood medulloblastoma|childhood medulloblastoma
5646297|NCT00716976|disseminated neuroblastoma|disseminated neuroblastoma
5646298|NCT00716976|regional neuroblastoma|regional neuroblastoma
5646299|NCT00716976|localized resectable neuroblastoma|localized resectable neuroblastoma
5646300|NCT00716976|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5646301|NCT00716976|stage 4S neuroblastoma|stage 4s neuroblastoma
5646302|NCT00716976|localized osteosarcoma|localized osteosarcoma
5646303|NCT00716976|metastatic osteosarcoma|metastatic osteosarcoma
5646304|NCT00716976|childhood hepatoblastoma|childhood hepatoblastoma
5646305|NCT00716976|stage I childhood liver cancer|stage i childhood liver cancer
5646306|NCT00716976|stage II childhood liver cancer|stage ii childhood liver cancer
5646307|NCT00716976|stage III childhood liver cancer|stage iii childhood liver cancer
5646308|NCT00716976|stage IV childhood liver cancer|stage iv childhood liver cancer
5646309|NCT00716963|late allergic response|late allergic response
5646310|NCT00716963|fluticasone propionate|fluticasone propionate
5646311|NCT00716937|pilonidal sinus|pilonidal sinus
5646312|NCT00716937|karydakis|karydakis
5646313|NCT00716937|laying open|laying open
5646314|NCT00716911|cytomegalovirus infection|cytomegalovirus infection
5646315|NCT00716911|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5646316|NCT00716911|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5646317|NCT00716911|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5646318|NCT00716911|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5646319|NCT00716911|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5646320|NCT00716911|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5646321|NCT00716911|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5646322|NCT00716911|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5646323|NCT00716911|refractory hairy cell leukemia|refractory hairy cell leukemia
5646324|NCT00716911|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5646325|NCT00716911|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5646326|NCT00716911|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5646327|NCT00716911|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5646328|NCT00716911|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5628199|NCT00787293|Mitral Regurgitation|mitral regurgitation
5646329|NCT00716911|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5646330|NCT00716911|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5646331|NCT00716911|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5646332|NCT00716911|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5646333|NCT00716911|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5646334|NCT00716911|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5646335|NCT00716911|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5646336|NCT00716911|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5646337|NCT00716911|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5646338|NCT00716911|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5646339|NCT00716911|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5646340|NCT00716911|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5646341|NCT00716911|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5646342|NCT00716911|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5646343|NCT00716911|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5646344|NCT00716911|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5646345|NCT00716911|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5646346|NCT00716911|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5646347|NCT00716911|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5847449|NCT00039715|Type II GR Receptor|type ii gr receptor
5646348|NCT00716911|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5646349|NCT00716911|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5646350|NCT00716911|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5646351|NCT00716911|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5646352|NCT00716911|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5646353|NCT00716911|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5646354|NCT00716911|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5646355|NCT00716911|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5646356|NCT00716911|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5646357|NCT00716911|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5646358|NCT00716911|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5646359|NCT00716911|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5646360|NCT00716911|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5646361|NCT00716911|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5646362|NCT00716911|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5646363|NCT00716911|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5646364|NCT00716911|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5646365|NCT00716911|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5646366|NCT00716911|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5646367|NCT00716911|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5646368|NCT00716911|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5646369|NCT00716911|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5646370|NCT00716911|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5646371|NCT00716911|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5646372|NCT00716911|primary myelofibrosis|primary myelofibrosis
5646373|NCT00716911|stage II multiple myeloma|stage ii multiple myeloma
5646374|NCT00716911|stage III multiple myeloma|stage iii multiple myeloma
5646375|NCT00716911|refractory multiple myeloma|refractory multiple myeloma
5646376|NCT00716911|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5789068|NCT00150046|Heart transplantation|heart transplantation
5646377|NCT00716911|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5646378|NCT00716911|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5646379|NCT00716911|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5646380|NCT00716911|stage I multiple myeloma|stage i multiple myeloma
5646383|NCT00716898|Patients|patients
5646384|NCT00716898|Thrombosis|thrombosis
5646385|NCT00716898|Unstable|unstable
5646386|NCT00716898|Angina|angina
5646387|NCT00716898|Pectoris|pectoris
5646388|NCT00716885|Heart failure|heart failure
5646389|NCT00716885|Oxidative stress|oxidative stress
5646390|NCT00716885|Endothelial Progenitor Cells|endothelial progenitor cells
5646391|NCT00716885|White blood cells|white blood cells
5646392|NCT00716872|cancer|cancer
5646393|NCT00716872|sleep|sleep
5646394|NCT00716872|insomnia|insomnia
5646395|NCT00716872|Internet|internet
5646396|NCT00716872|SHUTi|shuti
5646397|NCT00716833|pain|pain
5646398|NCT00716833|coxibe|coxibe
5646399|NCT00716833|preemptive|preemptive
5646400|NCT00716833|abdominothoracic|abdominothoracic
5628300|NCT00786838|ET743|et743
5646401|NCT00716833|sensibilisation|sensibilisation
5646402|NCT00716833|Analgesia|analgesia
5646403|NCT00716807|BMS|bms
5646405|NCT00716794|Prostate cancer|prostate cancer
5646406|NCT00716794|HE3235|he3235
5646407|NCT00716794|Apoptone|apoptone
5646408|NCT00716781|Group B streptococcus|group b streptococcus
5646409|NCT00716781|Sepsis|sepsis
5646410|NCT00716781|Infants|infants
5646411|NCT00716781|Diagnosis|diagnosis
5646412|NCT00716781|Physical examination|physical examination
5646413|NCT00716781|Laboratory tests|laboratory tests
5646414|NCT00716768|Laparoscopic|laparoscopic
5646415|NCT00716768|Inguinal Hernia|inguinal hernia
5646416|NCT00716768|Infants|infants
5646417|NCT00716755|Positron emission tomography|positron emission tomography
5646418|NCT00716755|antipsychotics|antipsychotics
5646419|NCT00716755|risperidone|risperidone
5646420|NCT00716755|olanzapine|olanzapine
5646423|NCT00716755|elderly|elderly
5646424|NCT00716755|schizophrenia|schizophrenia
5646425|NCT00716755|schizoaffective disorder|schizoaffective disorder
5646426|NCT00716755|schizophreniform disorder|schizophreniform disorder
5646427|NCT00716755|delusional disorder|delusional disorder
5646428|NCT00716755|psychotic disorder NOS|psychotic disorder nos
5646429|NCT00716729|Questionnaire|questionnaire
5646430|NCT00716729|Hip|hip
5646431|NCT00716729|Groin|groin
5646432|NCT00716729|Disability|disability
5646433|NCT00716729|Strength|strength
5646434|NCT00716729|To develop two new outcome measures for patients with hip and groin disability|to develop two new outcome measures for patients with hip and groin disability
5646435|NCT00716716|Hemophilia B severe, previously treated patients|hemophilia b severe, previously treated patients
5646436|NCT00716703|Appendicitis|appendicitis
5646437|NCT00716703|Computed tomography|computed tomography
5646438|NCT00716703|pediatric|pediatric
5646439|NCT00716703|child|child
5646440|NCT00716703|sensitivity|sensitivity
5646441|NCT00716703|specificity|specificity
5646442|NCT00716703|contrast administration route|contrast administration route
5646444|NCT00716690|Stem cell transplantation|stem cell transplantation
5646445|NCT00716690|GVHD|gvhd
5646446|NCT00716677|difficult asthma|difficult asthma
5646447|NCT00716677|respiratory inductance plethysmography|respiratory inductance plethysmography
5646448|NCT00716664|cystic fibrosis|cystic fibrosis
5646449|NCT00716664|musculoskeletal|musculoskeletal
5646450|NCT00716664|exercise capacity|exercise capacity
5646452|NCT00716664|lung function|lung function
5646453|NCT00716664|physical functioning|physical functioning
5646454|NCT00716612|Coenzyme Q 10|coenzyme q 10
5646455|NCT00716612|Statin|statin
5646456|NCT00716612|Myalgia|myalgia
5646457|NCT00716599|malaria|malaria
5646458|NCT00716599|diagnosis|diagnosis
5646459|NCT00716599|rapid diagnostic test|rapid diagnostic test
5646460|NCT00716599|rapid diagnostic tests|rapid diagnostic tests
5646461|NCT00716599|fever case management|fever case management
5646462|NCT00716599|training|training
5646463|NCT00716599|fever case management in malaria-endemic areas|fever case management in malaria-endemic areas
5646464|NCT00716573|Cardiac transplantation|cardiac transplantation
5646465|NCT00716573|Chronic renal insufficiency|chronic renal insufficiency
5646466|NCT00716573|Everolimus|everolimus
5646467|NCT00716521|mobile actigraphy inpatient polysomnography actigraphy ambien|mobile actigraphy inpatient polysomnography actigraphy ambien
5646468|NCT00716508|Patella tendon rupute, suture anchors, repair patella tendon|patella tendon rupute, suture anchors, repair patella tendon
5646469|NCT00716482|breast|breast
5646470|NCT00716482|lesion|lesion
5646471|NCT00716482|ultrasound|ultrasound
5646472|NCT00716482|BI-RADS|bi-rads
5646473|NCT00716482|malignancy|malignancy
5646474|NCT00716482|women|women
5646475|NCT00716469|Neurofibroma|neurofibroma
5646476|NCT00716469|Plexiform|plexiform
5646477|NCT00716469|NF1|nf1
5646478|NCT00716469|Photo dynamic therapy|photo dynamic therapy
5646479|NCT00716456|MAB C225(CETUXIMAB)(ANTI-EGFR)|mab c225(cetuximab)(anti-egfr)
5646480|NCT00716456|OSI-774, TARCEVA (ERLOTINIB)|osi-774, tarceva (erlotinib)
5646481|NCT00716456|Lung|lung
5646482|NCT00716456|Adenocarcinoma|adenocarcinoma
5646483|NCT00716456|Lung cancer|lung cancer
5646484|NCT00716443|Nasolabial folds|nasolabial folds
5646485|NCT00716443|wrinkles|wrinkles
5646486|NCT00716443|topical anesthetic|topical anesthetic
5646487|NCT00716430|acute coronary syndromes|acute coronary syndromes
5646488|NCT00716430|quality improvement|quality improvement
5646489|NCT00716404|FlowMedica|flowmedica
5646490|NCT00716404|Benephit|benephit
5646491|NCT00716404|TRT|trt
5646492|NCT00716404|Patients|patients
5646493|NCT00716404|Components|components
5646494|NCT00716404|Benephit Infusion System|benephit infusion system
5646495|NCT00716404|Planned|planned
5646496|NCT00716404|To be used|to be used
5646497|NCT00716391|Head and Neck Cancer|head and neck cancer
5646498|NCT00716378|Simulated Driving|simulated driving
5646499|NCT00716378|Risky Driving Behavior|risky driving behavior
5646500|NCT00716378|Social Influences|social influences
5646501|NCT00716365|angiography|angiography
5646502|NCT00716365|hemostasis|hemostasis
5646503|NCT00716365|femoral artery|femoral artery
5646504|NCT00716365|duplex|duplex
5646505|NCT00716352|non-ST elevation acute coronary syndrome|non-st elevation acute coronary syndrome
5646506|NCT00716352|educational intervention|educational intervention
5646507|NCT00716352|evidence based practice|evidence based practice
5646508|NCT00716352|guidelines|guidelines
5646509|NCT00716339|pseudophakic accommodation|pseudophakic accommodation
5646510|NCT00716326|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5646511|NCT00716326|Chronic pain|chronic pain
5646512|NCT00716326|Neuropathic pain|neuropathic pain
5646513|NCT00716326|Short-term efficacy|short-term efficacy
5646514|NCT00716326|Long-term efficacy|long-term efficacy
5646515|NCT00716300|obesity|obesity
5646516|NCT00716300|CVD|cvd
5646517|NCT00716300|HDL kinetics|hdl kinetics
5646518|NCT00716300|Anti-inflammatory and anti-oxidation studies|anti-inflammatory and anti-oxidation studies
5646519|NCT00716300|30 subjects recruited (15 MetS and 15 lean controls)|30 subjects recruited (15 mets and 15 lean controls)
5646520|NCT00716261|Parkinson's disease|parkinson's disease
5646521|NCT00716261|Audio feedback|audio feedback
5646522|NCT00716261|postural control|postural control
5646524|NCT00716235|ASD|asd
5646525|NCT00716235|PDD|pdd
5646526|NCT00716235|DCD|dcd
5646527|NCT00716235|Executive Functions|executive functions
5646528|NCT00716196|thin prep|thin prep
5646529|NCT00716196|EUS|eus
5646530|NCT00716183|mastitis|mastitis
5646531|NCT00716183|Staphylococcus|staphylococcus
5646532|NCT00716183|Streptococcus|streptococcus
5646533|NCT00716183|lactation|lactation
5646534|NCT00716183|breastfeeding|breastfeeding
5646535|NCT00716170|Diabetes Mellitus|diabetes mellitus
5646536|NCT00716170|Glucagon|glucagon
5646537|NCT00716170|Insulin|insulin
5646538|NCT00716170|Incretin hormones|incretin hormones
5646544|NCT00716131|Cerebrospinal Fluid|cerebrospinal fluid
5646545|NCT00716131|Neurodegenerative Disease|neurodegenerative disease
5646546|NCT00716131|Motor Neuron Disease|motor neuron disease
5646547|NCT00716131|Autonomic Nervous System|autonomic nervous system
5646548|NCT00716131|Neurodegenerative Diseases|neurodegenerative diseases
5646549|NCT00716131|Movement Disorders|movement disorders
5646550|NCT00716118|Oocyte Cryopreservation|oocyte cryopreservation
5646551|NCT00716118|Slow-Freeze|slow-freeze
5646552|NCT00716118|Egg Freezing|egg freezing
5646553|NCT00716118|Meiotic Spindle|meiotic spindle
5646554|NCT00716118|Mitochondria|mitochondria
5646555|NCT00716118|Human Oocytes Freezing.|human oocytes freezing.
5646556|NCT00716105|Infant formula|infant formula
5646557|NCT00716105|Protein metabolism|protein metabolism
5646558|NCT00716079|Cerebral Hemorrhage|cerebral hemorrhage
5646560|NCT00716079|antihypertensive drugs|antihypertensive drugs
5646561|NCT00716079|blood pressure|blood pressure
5646562|NCT00716079|disability|disability
5646563|NCT00716079|clinical trial|clinical trial
5646564|NCT00716079|outcomes|outcomes
5646565|NCT00716066|neurologic autoimmune disease|neurologic autoimmune disease
5646566|NCT00716066|autologous transplant autoimmune|autologous transplant autoimmune
5646567|NCT00716066|multiple sclerosis transplant|multiple sclerosis transplant
5646568|NCT00716066|MS stem cell transplant|ms stem cell transplant
5646569|NCT00716066|multiple sclerosis stem cell transplant|multiple sclerosis stem cell transplant
5646570|NCT00716066|Stiff Person Syndrome|stiff person syndrome
5646571|NCT00716066|HCT for neurologic autoimmune disorders|hct for neurologic autoimmune disorders
5646572|NCT00716066|CIDP transplant|cidp transplant
5646573|NCT00716066|myasthenia gravis transplant|myasthenia gravis transplant
5646574|NCT00716053|emphysema|emphysema
5646575|NCT00716053|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5646577|NCT00716053|lung volume reduction|lung volume reduction
5646579|NCT00716053|BLVR|blvr
5646580|NCT00716053|Aeris|aeris
5646581|NCT00716040|AIDS treatment|aids treatment
5646582|NCT00716040|HAART adherence|haart adherence
5646583|NCT00716040|intervention|intervention
5646584|NCT00716014|Pachyonychia Congenita|pachyonychia congenita
5646585|NCT00716014|siRNA|sirna
5646586|NCT00716001|patients with chronic renal failure undergoing elective percutaneous coronary intervention|patients with chronic renal failure undergoing elective percutaneous coronary intervention
5646587|NCT00715988|Methadone|methadone
5646588|NCT00715988|analgesia|analgesia
5646589|NCT00715988|newborns|newborns
5646590|NCT00715988|QT prolongation|qt prolongation
5646591|NCT00715988|Young Infants|young infants
5646592|NCT00715975|clobetasol|clobetasol
5646593|NCT00715975|halobetasol|halobetasol
5646594|NCT00715975|psoriasis|psoriasis
5646595|NCT00715975|evaluating the efficacy and tolerability of the drug Halobetasol propionate|evaluating the efficacy and tolerability of the drug halobetasol propionate
5646596|NCT00715962|Hospitalization|hospitalization
5646597|NCT00715962|Aged|aged
5646598|NCT00715949|traumatic brain injury|traumatic brain injury
5646599|NCT00715949|pediatric|pediatric
5646600|NCT00715949|neurocognitive|neurocognitive
5646601|NCT00715949|concussion|concussion
5646602|NCT00715936|Integrated early child development, growth and health|integrated early child development, growth and health
5646603|NCT00715936|Psychosocial stimulation|psychosocial stimulation
5646604|NCT00715936|Care for child development|care for child development
5646605|NCT00715923|informed consent document|informed consent document
5646606|NCT00715923|ethics|ethics
5646607|NCT00715910|Meningococcal vaccine|meningococcal vaccine
5646608|NCT00715910|Booster vaccination|booster vaccination
5646609|NCT00715910|Immunogenicity|immunogenicity
5646610|NCT00715910|Meningococcal disease|meningococcal disease
5646611|NCT00715910|Safety|safety
5646612|NCT00715897|chronic neurological deficient due to stroke|chronic neurological deficient due to stroke
5646613|NCT00715884|Atherosclerosis|atherosclerosis
5646614|NCT00715884|de novo native coronary lesion|de novo native coronary lesion
5646615|NCT00715871|smoking|smoking
5646616|NCT00715871|smoke cessation|smoke cessation
5646617|NCT00715871|stop smoking|stop smoking
5646618|NCT00715871|quit smoking|quit smoking
5646619|NCT00715871|nicotine replacement therapy|nicotine replacement therapy
5646620|NCT00715871|Smoke Break|smoke break
5646621|NCT00715871|liquid cigarette|liquid cigarette
5646622|NCT00715871|liquid nicotine cigarette|liquid nicotine cigarette
5646623|NCT00715858|Alzheimer's disease|alzheimer's disease
5646624|NCT00715858|dementia|dementia
5646625|NCT00715858|inflammation|inflammation
5646626|NCT00715858|cytokine|cytokine
5646627|NCT00715858|biomarker|biomarker
5646628|NCT00715858|cerebrospinal fluid|cerebrospinal fluid
5646629|NCT00715858|serum|serum
5646630|NCT00715858|doxycycline|doxycycline
5646631|NCT00715858|rifampin|rifampin
5646632|NCT00715845|cardiovascular disease|cardiovascular disease
5646633|NCT00715845|embolism|embolism
5646634|NCT00715845|microemboli|microemboli
5646635|NCT00715845|cognitive decline|cognitive decline
5646636|NCT00715845|mitral valve repair|mitral valve repair
5646637|NCT00715845|cerebral microemboli|cerebral microemboli
5646638|NCT00715845|coronary artery bypass graft|coronary artery bypass graft
5646639|NCT00715845|CABG|cabg
5646640|NCT00715845|transcranial doppler|transcranial doppler
5646641|NCT00715845|transesophageal echocardiogram|transesophageal echocardiogram
5646642|NCT00715845|magnetic resonance imaging|magnetic resonance imaging
5646643|NCT00715845|carbon dioxide|carbon dioxide
5646644|NCT00715832|Breast cancer|breast cancer
5646645|NCT00715832|Dendritic cell vaccine|dendritic cell vaccine
5646646|NCT00715832|OFA/iLRP|ofa/ilrp
5646647|NCT00715832|Patients|patients
5646648|NCT00715832|Line|line
5646649|NCT00715832|Chemotherapy|chemotherapy
5646650|NCT00715832|Setting|setting
5646651|NCT00715832|Four different lines|four different lines
5646652|NCT00715806|claustrophobia|claustrophobia
5646653|NCT00715806|magnetic resonance imaging|magnetic resonance imaging
5646655|NCT00715806|anxiety|anxiety
5646656|NCT00715806|open design|open design
5646657|NCT00715806|severely anxious patients|severely anxious patients
5646658|NCT00715793|Decitabine|decitabine
5646659|NCT00715793|Temozolomide|temozolomide
5646660|NCT00715793|Metastatic|metastatic
5646662|NCT00715793|Non-resectable|non-resectable
5646663|NCT00715793|Stage IIIB melanoma|stage iiib melanoma
5646664|NCT00715793|stage IV melanoma|stage iv melanoma
5646665|NCT00715793|TMZ|tmz
5646666|NCT00715793|DTIC|dtic
5646667|NCT00715793|promoter methylation|promoter methylation
5646668|NCT00715793|skin cancer|skin cancer
5646669|NCT00715793|chemotherapy|chemotherapy
5646670|NCT00715767|BLS training|bls training
5646671|NCT00715767|CPR|cpr
5646672|NCT00715767|post graduate education|post graduate education
5646673|NCT00715767|resource-limited settings|resource-limited settings
5646674|NCT00715767|medical education|medical education
5646675|NCT00715767|CPR retention|cpr retention
5646676|NCT00715767|cultural barriers|cultural barriers
5646677|NCT00715741|atelectasis|atelectasis
5646678|NCT00715741|oxygen|oxygen
5646679|NCT00715741|saturation|saturation
5646680|NCT00715728|Plastic surgery|plastic surgery
5646681|NCT00715728|Warming|warming
5646682|NCT00715728|Core temperature|core temperature
5646683|NCT00715728|Bair Hugger|bair hugger
5646684|NCT00715728|Hot Dog heating system|hot dog heating system
5646685|NCT00715715|Hepatitis B e Antigen|hepatitis b e antigen
5646686|NCT00715715|HBeAg-positive chronic hepatitis B|hbeag-positive chronic hepatitis b
5646687|NCT00715702|AZD5672|azd5672
5646688|NCT00715676|Osteoporosis|osteoporosis
5646689|NCT00715676|2-methylene-19-nor-(20S)-1a, 25-dihydroxyvitamin D3|2-methylene-19-nor-(20s)-1a, 25-dihydroxyvitamin d3
5646691|NCT00715676|Bone Density Conservation Agents|bone density conservation agents
5646692|NCT00715676|Bone Regeneration|bone regeneration
5646693|NCT00715650|Rehabilitation, Vocational|rehabilitation, vocational
5646694|NCT00715650|Compensation and Redress|compensation and redress
5646695|NCT00715650|disability evaluation|disability evaluation
5646696|NCT00715637|AML|aml
5646697|NCT00715637|Leukemia|leukemia
5646698|NCT00715637|MDS|mds
5646699|NCT00715637|Amonafide|amonafide
5646700|NCT00715637|Cytarabine|cytarabine
5646701|NCT00715637|Daunorubicin|daunorubicin
5646702|NCT00715637|Lymphatic disorders|lymphatic disorders
5646703|NCT00715624|hyperglycemia, GLP-1, metformin, insulin|hyperglycemia, glp-1, metformin, insulin
5646704|NCT00715611|pemetrexed|pemetrexed
5646705|NCT00715611|cisplatin|cisplatin
5646706|NCT00715611|IMRT|imrt
5646707|NCT00715611|PLEURA|pleura
5646708|NCT00715611|Malignant|malignant
5646709|NCT00715611|08-053|08-053
5646710|NCT00715598|Pain Assessment|pain assessment
5646711|NCT00715598|Measurement|measurement
5646712|NCT00715585|diabetes|diabetes
5646713|NCT00715585|education|education
5646714|NCT00715585|health literacy|health literacy
5646715|NCT00715572|hypothyroidism, treatment, thyroxine, triiodothyronine|hypothyroidism, treatment, thyroxine, triiodothyronine
5646716|NCT00715559|Major depressive disorder, depression|major depressive disorder, depression
5646717|NCT00715559|neurotrophic|neurotrophic
5646718|NCT00715559|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5646719|NCT00715559|antidepressant|antidepressant
5646720|NCT00715559|cysteamine|cysteamine
5646721|NCT00715546|Adipose-derived stem cell|adipose-derived stem cell
5646722|NCT00715546|Lipodystrophy|lipodystrophy
5646723|NCT00715533|acute (< 24 hours) stroke|acute (< 24 hours) stroke
5646724|NCT00715533|stroke|stroke
5646725|NCT00715533|TIA|tia
5646726|NCT00715533|MRI|mri
5646727|NCT00715533|imaging|imaging
5646729|NCT00715520|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5646730|NCT00715520|Rehabilitation|rehabilitation
5646731|NCT00715520|Stroke|stroke
5646732|NCT00715520|Plasticity|plasticity
5646733|NCT00715507|decision making|decision making
5646734|NCT00715507|graphic display|graphic display
5646735|NCT00715494|brain injuries, dementia, myopathies, muscle disorders|brain injuries, dementia, myopathies, muscle disorders
5646736|NCT00715481|Type 2 diabetes|type 2 diabetes
5646737|NCT00715481|Cardiovascular disease|cardiovascular disease
5646738|NCT00715481|Diabetic Nephropathy|diabetic nephropathy
5646739|NCT00715481|Glomerular filtration rate|glomerular filtration rate
5646740|NCT00715481|Albuminuria|albuminuria
5646741|NCT00715455|CAD|cad
5646742|NCT00715455|PCI|pci
5646743|NCT00715455|ANTICOAGULANT|anticoagulant
5646744|NCT00715442|Kidney|kidney
5646745|NCT00715442|Renal Cell Carcinoma|renal cell carcinoma
5646746|NCT00715442|RCC|rcc
5646747|NCT00715442|Sutent|sutent
5646748|NCT00715442|Sunitinib malate|sunitinib malate
5646750|NCT00715442|SU011248|su011248
5646751|NCT00715442|Nephrectomy|nephrectomy
5646752|NCT00715442|Surgical removal of kidney|surgical removal of kidney
5646753|NCT00715442|Cytoreductive nephrectomy|cytoreductive nephrectomy
5646754|NCT00715429|Leg cramps|leg cramps
5646755|NCT00715429|vitamin D deficiency|vitamin d deficiency
5646756|NCT00715416|peripheral vascular diseases|peripheral vascular diseases
5646757|NCT00715416|Intermittent Claudication|intermittent claudication
5646758|NCT00715416|Angioplasty|angioplasty
5646759|NCT00715390|Children|children
5646760|NCT00715390|Cardiac Arrhythmia|cardiac arrhythmia
5646761|NCT00715390|General Anesthesia|general anesthesia
5646762|NCT00715377|benztropine|benztropine
5646763|NCT00715377|Anticholinergic antiparkinsonian agents|anticholinergic antiparkinsonian agents
5646764|NCT00715377|antipsychotics|antipsychotics
5646765|NCT00715377|elderly population|elderly population
5646766|NCT00715377|side-effects|side-effects
5646767|NCT00715338|Exhaled Breath Condensate|exhaled breath condensate
5646768|NCT00715338|elective surgery|elective surgery
5646769|NCT00715338|mechanical ventilation|mechanical ventilation
5646770|NCT00715338|Isofurans|isofurans
5646771|NCT00715338|thrombomodulin|thrombomodulin
5646772|NCT00715338|requiring|requiring
5646773|NCT00715338|mechanical|mechanical
5646774|NCT00715338|ventilation|ventilation
5646775|NCT00715325|colonoscopy|colonoscopy
5646776|NCT00715325|disposable|disposable
5646777|NCT00715325|single use|single use
5646778|NCT00715312|Inflammation|inflammation
5646779|NCT00715312|LDL|ldl
5646780|NCT00715312|Oleic acid|oleic acid
5646781|NCT00715312|Palmitic acid|palmitic acid
5646782|NCT00715312|trans fatty acid|trans fatty acid
5646783|NCT00715312|C-reactive protein|c-reactive protein
5646784|NCT00715286|epithelial ovarian cancer|epithelial ovarian cancer
5646785|NCT00715286|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5646786|NCT00715286|randomized study|randomized study
5646787|NCT00715273|Magnetic Resonance Imaging|magnetic resonance imaging
5646788|NCT00715273|Atherosclerotic Plaque|atherosclerotic plaque
5646789|NCT00715273|Lipid Lowering Therapy|lipid lowering therapy
5646793|NCT00715247|Essential Thrombocythemia|essential thrombocythemia
5646794|NCT00715247|Myelofibrosis|myelofibrosis
5646795|NCT00715247|Genetics|genetics
5646796|NCT00715247|Chronic Leukemia|chronic leukemia
5646797|NCT00715234|adolescent reminder/recall|adolescent reminder/recall
5646798|NCT00715234|adolescent vaccines|adolescent vaccines
5646800|NCT00715234|Meningococcal|meningococcal
5646801|NCT00715234|HPV|hpv
5646802|NCT00715234|Reminder cards|reminder cards
5646803|NCT00715234|Recall messages|recall messages
5646804|NCT00715234|vaccine|vaccine
5646805|NCT00715234|conjugate|conjugate
5646806|NCT00715221|Diabetes|diabetes
5646807|NCT00715195|Cognitive behavioral|cognitive behavioral
5646808|NCT00715195|Long-term study|long-term study
5646809|NCT00715195|Education|education
5646810|NCT00715182|Renal Cell Cancer|renal cell cancer
5646811|NCT00715156|allergy, peach, birch|allergy, peach, birch
5646812|NCT00715156|recombinants allergens diagnosis|recombinants allergens diagnosis
5646813|NCT00715156|OAS|oas
5646814|NCT00715156|LTP|ltp
5646815|NCT00715156|systemic reactions|systemic reactions
5646816|NCT00715156|subjects with severe reaction to other fruits|subjects with severe reaction to other fruits
5646817|NCT00715143|hip|hip
5646818|NCT00715143|replacement|replacement
5646819|NCT00715143|ceramic|ceramic
5646820|NCT00715143|orthopaedic|orthopaedic
5646821|NCT00715143|joint|joint
5646822|NCT00715143|degenerative|degenerative
5646823|NCT00715143|non-inflammatory|non-inflammatory
5646824|NCT00715143|osteoarthritis|osteoarthritis
5646825|NCT00715143|avascular necrosis|avascular necrosis
5646826|NCT00715143|congenital hip dysplasia|congenital hip dysplasia
5646827|NCT00715143|traumatic arthritis|traumatic arthritis
5646828|NCT00715130|Energy|energy
5646829|NCT00715130|Obesity|obesity
5646830|NCT00715130|Energy Balance|energy balance
5646831|NCT00715130|Physical Activity|physical activity
5646832|NCT00715130|Dietary Intake|dietary intake
5646833|NCT00715130|Overweight|overweight
5646834|NCT00715130|Sedentary|sedentary
5646836|NCT00715130|Body Mass Index|body mass index
5646837|NCT00715130|Weight Maintenance|weight maintenance
5646838|NCT00715117|children|children
5646839|NCT00715117|pediatric|pediatric
5646840|NCT00715117|Crohn's Disease|crohn's disease
5646841|NCT00715117|naltrexone|naltrexone
5646842|NCT00715117|LDN|ldn
5646843|NCT00715117|IBD|ibd
5646844|NCT00715117|Inflammatory bowel disease|inflammatory bowel disease
5646845|NCT00715091|NSAIDS|nsaids
5646846|NCT00715091|ankylosing spondylitis|ankylosing spondylitis
5646848|NCT00715091|Spondyloarthritis|spondyloarthritis
5646849|NCT00715091|radiographic changes|radiographic changes
5646850|NCT00715078|prostate cancer|prostate cancer
5646851|NCT00715078|prostate|prostate
5646852|NCT00715078|immune therapy|immune therapy
5646853|NCT00715078|immunotherapy|immunotherapy
5646854|NCT00715078|vaccine|vaccine
5646855|NCT00715078|dendritic cells|dendritic cells
5646856|NCT00715078|antigen-presenting cells|antigen-presenting cells
5646857|NCT00715078|antigen presenting cells|antigen presenting cells
5646858|NCT00715078|cancer vaccine|cancer vaccine
5646859|NCT00715078|prostate specific antigen (PSA)|prostate specific antigen (psa)
5646860|NCT00715078|prostatic adenocarcinoma|prostatic adenocarcinoma
5646861|NCT00715065|syncope|syncope
5646862|NCT00715065|faint|faint
5646863|NCT00715065|blood|blood
5646864|NCT00715065|blood injury phobia|blood injury phobia
5646865|NCT00715065|phobia|phobia
5646866|NCT00715052|neurologic deficiency due traumatic brain injury|neurologic deficiency due traumatic brain injury
5646867|NCT00715039|generalized anxiety disorder|generalized anxiety disorder
5646868|NCT00715039|onset of efficacy|onset of efficacy
5646869|NCT00715039|Daily Assessment of Symptoms-Anxiety (DAS-A)|daily assessment of symptoms-anxiety (das-a)
5646870|NCT00715039|Methods|methods
5646871|NCT00715026|Arthritis|arthritis
5646872|NCT00715026|Total Hip|total hip
5646873|NCT00715026|Ceramic|ceramic
5646874|NCT00715026|Hip Replacement|hip replacement
5646875|NCT00715026|Total Hip Arthroplasty (THA)|total hip arthroplasty (tha)
5646876|NCT00715026|Joint Disease|joint disease
5646877|NCT00715013|recurrent Glioblastoma|recurrent glioblastoma
5646878|NCT00715000|Preterm babies hydration|preterm babies hydration
5646879|NCT00715000|Oral rehydration solution|oral rehydration solution
5646880|NCT00715000|Continuous gastric drip|continuous gastric drip
5646881|NCT00715000|Fluid therapy|fluid therapy
5646882|NCT00715000|Premature babies comfort|premature babies comfort
5646883|NCT00715000|Infant care|infant care
5646884|NCT00715000|Technical challenge for the nurses/doctors in charge|technical challenge for the nurses/doctors in charge
5646885|NCT00714987|ARDS|ards
5646886|NCT00714987|Mechanical ventilation|mechanical ventilation
5646887|NCT00714987|PEEP with low level|peep with low level
5646900|NCT00714935|Risk Reduction Behavior|risk reduction behavior
5646901|NCT00714935|Counseling|counseling
5646902|NCT00714909|Breast cancer|breast cancer
5646903|NCT00714909|Catheter related thrombosis|catheter related thrombosis
5646904|NCT00714909|Diagnosis|diagnosis
5646905|NCT00714909|Echography doppler|echography doppler
5646906|NCT00714909|Risk factors|risk factors
5646907|NCT00714896|smoking cessation|smoking cessation
5646908|NCT00714896|nicotine dependence|nicotine dependence
5647031|NCT00714493|enbrel|enbrel
5646909|NCT00714896|stage-based intervention|stage-based intervention
5646910|NCT00714896|nicotine replacement medications|nicotine replacement medications
5646911|NCT00714896|counseling|counseling
5646912|NCT00714896|substance abuse treatment|substance abuse treatment
5646913|NCT00714883|drug-eluting stents|drug-eluting stents
5646914|NCT00714883|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5646916|NCT00714870|Quality of life|quality of life
5646917|NCT00714857|ICU patients|icu patients
5646918|NCT00714857|Dexmedetomidine|dexmedetomidine
5646919|NCT00714857|Sedation|sedation
5646920|NCT00714857|Judged|judged
5646921|NCT00714857|Attending|attending
5646922|NCT00714857|Physician|physician
5646923|NCT00714844|insulin therapy|insulin therapy
5646924|NCT00714844|insulin detemir|insulin detemir
5646925|NCT00714844|waist circumference|waist circumference
5646926|NCT00714831|Physical activity promotion|physical activity promotion
5646927|NCT00714831|Primary health care|primary health care
5646928|NCT00714831|Adherence|adherence
5646929|NCT00714818|Schizophrenia|schizophrenia
5646930|NCT00714818|Bipolar Disorder|bipolar disorder
5646931|NCT00714818|Schizoaffective disorder|schizoaffective disorder
5646932|NCT00714818|Genetic Counseling|genetic counseling
5646933|NCT00714818|Risk perception|risk perception
5646934|NCT00714818|Stigma|stigma
5646935|NCT00714818|Control|control
5646936|NCT00714818|Knowledge|knowledge
5646937|NCT00714818|family members|family members
5646938|NCT00714818|Sibling parent or child with schizophrenia|sibling parent or child with schizophrenia
5646939|NCT00714818|Sibling parent or child with bipolar disorder|sibling parent or child with bipolar disorder
5646940|NCT00714818|Sibling parent or child with schizoaffective disorder|sibling parent or child with schizoaffective disorder
5646941|NCT00714805|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5646942|NCT00714805|Gastric Motility|gastric motility
5646943|NCT00714805|Autonomic Nervous System|autonomic nervous system
5646944|NCT00714805|Neurodegenerative Diseases|neurodegenerative diseases
5646945|NCT00714805|Movement Disorders|movement disorders
5646946|NCT00714805|Gastrointestinal Motility|gastrointestinal motility
5646947|NCT00714779|Major depressive Disorder|major depressive disorder
5646948|NCT00714779|fluoxetine|fluoxetine
5646949|NCT00714779|short-term psychodynamic psychotherapy|short-term psychodynamic psychotherapy
5646951|NCT00714753|stage I prostate cancer|stage i prostate cancer
5646952|NCT00714753|stage II prostate cancer|stage ii prostate cancer
5646953|NCT00714753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5646954|NCT00714740|apnea, sleep, altitude, hypoxia|apnea, sleep, altitude, hypoxia
5646955|NCT00714727|migraine|migraine
5646956|NCT00714727|headache|headache
5646957|NCT00714727|acupuncture|acupuncture
5646958|NCT00714714|acne|acne
5646959|NCT00714714|irritation|irritation
5646960|NCT00714714|objective sensory methods|objective sensory methods
5646961|NCT00714688|Adult|adult
5646963|NCT00714688|Concerta|concerta
5646964|NCT00714675|citrulline|citrulline
5646965|NCT00714675|protein-energy malnutrition|protein-energy malnutrition
5646966|NCT00714675|aged|aged
5646967|NCT00714675|protein biosynthesis|protein biosynthesis
5646968|NCT00714675|amino acid|amino acid
5646969|NCT00714662|high flux hemodialysis|high flux hemodialysis
5646970|NCT00714649|Head and Neck Squamous Cell Carcinoma treated with surgery|head and neck squamous cell carcinoma treated with surgery
5646971|NCT00714649|and/or radiotherapy|and/or radiotherapy
5646972|NCT00714636|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5640707|NCT00737438|EPIRUBICIN|epirubicin
5646973|NCT00714636|Cerebrospinal Fluid|cerebrospinal fluid
5646974|NCT00714636|Neurodegenerative Disease|neurodegenerative disease
5646975|NCT00714636|Motor Neuron Disease|motor neuron disease
5646976|NCT00714636|Autonomic Nervous System|autonomic nervous system
5646977|NCT00714636|Neurodegenerative Diseases|neurodegenerative diseases
5646978|NCT00714636|Movement Disorders|movement disorders
5646979|NCT00714623|Coronary Artery Disease|coronary artery disease
5646980|NCT00714623|Coronary Restenosis|coronary restenosis
5646981|NCT00714623|Coronary Thrombosis|coronary thrombosis
5646982|NCT00714623|Drug-Eluting Stents|drug-eluting stents
5646983|NCT00714623|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5646984|NCT00714610|Serum metal ion concentration|serum metal ion concentration
5646985|NCT00714597|Venous thrombosis|venous thrombosis
5646986|NCT00714597|Primary prevention|primary prevention
5646987|NCT00714584|Infusions, Intravenous|infusions, intravenous
5646988|NCT00714584|Safety|safety
5646989|NCT00714584|Pharmacokinetics|pharmacokinetics
5646990|NCT00714584|Naltrexone|naltrexone
5646991|NCT00714584|Administration, Oral|administration, oral
5646992|NCT00714571|cognitive rehabilitation|cognitive rehabilitation
5646993|NCT00714571|explicit memory training|explicit memory training
5646994|NCT00714571|mild cognitive impairment|mild cognitive impairment
5646995|NCT00714571|Alzheimer's disease|alzheimer's disease
5646996|NCT00714571|traumatic brain injury|traumatic brain injury
5646997|NCT00714571|veterans|veterans
5646998|NCT00714558|Pharmacokinetics|pharmacokinetics
5646999|NCT00714558|Administration, Oral|administration, oral
5647000|NCT00714558|Naltrexone|naltrexone
5647001|NCT00714558|Biological Availability|biological availability
5647002|NCT00714558|Infusions, Intravenous|infusions, intravenous
5647003|NCT00714558|Fentanyl|fentanyl
5647004|NCT00714558|Safety|safety
5647005|NCT00714558|Naloxone|naloxone
5647006|NCT00714545|Coronary Artery Disease|coronary artery disease
5647007|NCT00714545|Coronary Restenosis|coronary restenosis
5647008|NCT00714545|Brachytherapy|brachytherapy
5647009|NCT00714532|smoking cessation|smoking cessation
5647010|NCT00714532|Asian American|asian american
5647011|NCT00714532|Chinese American|chinese american
5647012|NCT00714532|smoking reduction|smoking reduction
5647013|NCT00714532|stage-based intervention|stage-based intervention
5647014|NCT00714532|expert system|expert system
5647015|NCT00714532|nicotine replacement|nicotine replacement
5647016|NCT00714532|counseling|counseling
5647017|NCT00714519|Xenaderm|xenaderm
5647018|NCT00714519|partial|partial
5647019|NCT00714519|thickness|thickness
5647020|NCT00714519|wounds|wounds
5647021|NCT00714519|Nursing Homes|nursing homes
5647022|NCT00714506|obesity|obesity
5647023|NCT00714506|physical activity|physical activity
5647024|NCT00714506|older adults|older adults
5647025|NCT00714506|functional disability|functional disability
5647026|NCT00714493|rheumatoid arthritis|rheumatoid arthritis
5647027|NCT00714493|remicade|remicade
5647028|NCT00714493|infliximab|infliximab
5647029|NCT00714493|Centocor|centocor
5647030|NCT00714493|etanercept|etanercept
5647032|NCT00714493|adalimumab|adalimumab
5647034|NCT00714493|restart|restart
5647035|NCT00714493|swollen joints|swollen joints
5647036|NCT00714493|tender joints.|tender joints.
5647037|NCT00714480|Thymoglobulin|thymoglobulin
5647038|NCT00714480|Renal Transplant|renal transplant
5647039|NCT00714480|Kidney Transplant|kidney transplant
5647040|NCT00714480|Immunosuppression|immunosuppression
5647041|NCT00714480|Induction therapy|induction therapy
5647044|NCT00714467|Chinese American|chinese american
5647045|NCT00714467|family support|family support
5647046|NCT00714467|social support|social support
5647047|NCT00714467|stage-based intervention|stage-based intervention
5647048|NCT00714441|Diabetes Type 2|diabetes type 2
5647049|NCT00714441|Distress|distress
5647050|NCT00714441|Problem Solving Therapy|problem solving therapy
5647051|NCT00714441|Computer Automated Self-Management (CASM)|computer automated self-management (casm)
5647052|NCT00714428|Traumatic Brain Injury|traumatic brain injury
5647053|NCT00714428|Quality of Life|quality of life
5647054|NCT00714402|UTI|uti
5647055|NCT00714389|Urogynecology|urogynecology
5647056|NCT00714376|Prostate cancer|prostate cancer
5647057|NCT00714376|High-risk prostate cancer|high-risk prostate cancer
5647058|NCT00714376|Radical prostatectomy|radical prostatectomy
5647059|NCT00714376|Early rising PSA|early rising psa
5647060|NCT00714376|Taxotere|taxotere
5647061|NCT00714376|Docetaxel|docetaxel
5647062|NCT00714350|Information Display|information display
5647063|NCT00714350|situational awareness|situational awareness
5647064|NCT00714350|Create intuitive visualization|create intuitive visualization
5647066|NCT00714337|pharmacokinetics|pharmacokinetics
5647067|NCT00714324|Nutrition|nutrition
5647068|NCT00714324|Screening|screening
5647069|NCT00714311|borderline personality disorder|borderline personality disorder
5647070|NCT00714311|randomized controlled trial|randomized controlled trial
5647071|NCT00714311|Transference-Focused Psychotherapy|transference-focused psychotherapy
5647072|NCT00714311|treatment by experienced community psychotherapists|treatment by experienced community psychotherapists
5647073|NCT00714298|biological markers|biological markers
5647074|NCT00714298|emergency service hospital|emergency service hospital
5647075|NCT00714298|heart fatty acid binding protein|heart fatty acid binding protein
5647076|NCT00714298|ischemia modified albumin|ischemia modified albumin
5647077|NCT00714285|Primary study|primary study
5647078|NCT00714285|immunogenicity|immunogenicity
5647079|NCT00714285|safety|safety
5647080|NCT00714259|Low Grade B Cell Malignancies|low grade b cell malignancies
5647081|NCT00714259|nonmyeloablative transplant|nonmyeloablative transplant
5647082|NCT00714259|allogeneic|allogeneic
5647083|NCT00714246|advanced non small cell lung cancer|advanced non small cell lung cancer
5647084|NCT00714233|Polycystic Ovary Syndrome|polycystic ovary syndrome
5647085|NCT00714233|Overweight Adolescent Girls|overweight adolescent girls
5647086|NCT00714233|Irregular Menstrual Cycles|irregular menstrual cycles
5647087|NCT00714220|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5647088|NCT00714220|Gastric Motility|gastric motility
5647089|NCT00714220|Autonomic Nervous System|autonomic nervous system
5647090|NCT00714220|Neurodegenerative Diseases|neurodegenerative diseases
5647091|NCT00714220|Movement Disorders|movement disorders
5647092|NCT00714220|Substrate Utilization|substrate utilization
5647093|NCT00714207|adolescents|adolescents
5647094|NCT00714207|smoking|smoking
5647095|NCT00714207|smoking cessation|smoking cessation
5647096|NCT00714207|tobacco use|tobacco use
5647097|NCT00714194|sedation|sedation
5647098|NCT00714194|delirium|delirium
5647099|NCT00714194|sleep|sleep
5647100|NCT00714194|sedation withdrawal|sedation withdrawal
5647101|NCT00714194|ICU patients|icu patients
5647102|NCT00714181|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5647103|NCT00714168|Weight Loss|weight loss
5647104|NCT00714168|Weight Control|weight control
5647105|NCT00714155|Colpocleisis|colpocleisis
5647106|NCT00714142|Renal blood flow|renal blood flow
5647107|NCT00714142|PET imaging|pet imaging
5647110|NCT00714116|safety|safety
5647111|NCT00714116|pharmacokinetics|pharmacokinetics
5647112|NCT00714103|Leukemia|leukemia
5647113|NCT00714103|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5647114|NCT00714103|CLL|cll
5647115|NCT00714103|8-Chloro-Adenosine|8-chloro-adenosine
5647116|NCT00714103|purine analogues|purine analogues
5647117|NCT00714103|Cancer|cancer
5628981|NCT00784303|Thyroid Cancer|thyroid cancer
5628983|NCT00784277|Arthritis|arthritis
5647118|NCT00714090|repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5647119|NCT00714090|Major depressive disorders|major depressive disorders
5647120|NCT00714090|Depression|depression
5647121|NCT00714090|Venlafaxine|venlafaxine
5647122|NCT00714077|rectal cancer|rectal cancer
5647123|NCT00714077|concurrent chemoradiotherapy|concurrent chemoradiotherapy
5647124|NCT00714077|adjuvant therapy|adjuvant therapy
5647125|NCT00714077|phase III study|phase iii study
5647126|NCT00714038|Quality development project|quality development project
5647127|NCT00714038|primary care nurses|primary care nurses
5647128|NCT00714038|asthma|asthma
5647129|NCT00714038|patient compliance|patient compliance
5647130|NCT00714038|follow-up|follow-up
5647131|NCT00714025|RAD001|rad001
5647138|NCT00714012|visualizations are intuitive|visualizations are intuitive
5647139|NCT00713999|Sexually transmitted infections|sexually transmitted infections
5647140|NCT00713999|Urogenital schistosomiasis|urogenital schistosomiasis
5647141|NCT00713999|Schistosoma haematobium|schistosoma haematobium
5647142|NCT00713999|Reproductive health|reproductive health
5647143|NCT00713999|Pelvic examination|pelvic examination
5647144|NCT00713999|Ultrasonography|ultrasonography
5647145|NCT00713999|Questionnaire|questionnaire
5647146|NCT00713999|Madagascar|madagascar
5647147|NCT00713986|Pain|pain
5647148|NCT00713986|Newborn Infant|newborn infant
5647149|NCT00713986|Analgesia|analgesia
5647150|NCT00713960|Quality development project|quality development project
5647151|NCT00713960|primary care nurses|primary care nurses
5647152|NCT00713960|cardiovascular disease|cardiovascular disease
5647153|NCT00713960|secondary prevention|secondary prevention
5647154|NCT00713960|follow-up|follow-up
5647155|NCT00713947|Gastric lesions induced by low dose of aspirin|gastric lesions induced by low dose of aspirin
5647156|NCT00713947|Helicobacter pylori|helicobacter pylori
5647157|NCT00713934|Autologous Bone marrow stem cells|autologous bone marrow stem cells
5647158|NCT00713934|Cirrhosis|cirrhosis
5647159|NCT00713921|Female|female
5647160|NCT00713921|Diabetics|diabetics
5647161|NCT00713921|Stroke|stroke
5647162|NCT00713908|Voiding dysfunction following TVT placement|voiding dysfunction following tvt placement
5647163|NCT00713895|smoking cessation|smoking cessation
5647164|NCT00713895|randomized trial|randomized trial
5647165|NCT00713895|Asian|asian
5647166|NCT00713895|Chinese American|chinese american
5647167|NCT00713895|stages of change|stages of change
5647168|NCT00713882|Survivors|survivors
5647169|NCT00713882|Quality of Life|quality of life
5647170|NCT00713869|Oocyte cryopreservation|oocyte cryopreservation
5647171|NCT00713869|Slow freeze|slow freeze
5647172|NCT00713843|Neck Pain|neck pain
5647173|NCT00713843|Manuel Therapy Utrecht|manuel therapy utrecht
5647174|NCT00713843|Physiotherapy|physiotherapy
5647175|NCT00713830|hyperglycemia, GLP-1|hyperglycemia, glp-1
5647176|NCT00713817|Pain|pain
5647177|NCT00713817|Peripheral Neuropathy|peripheral neuropathy
5647178|NCT00713804|Schizophrenia|schizophrenia
5647180|NCT00713804|Schizoaffective disorder|schizoaffective disorder
5647181|NCT00713804|Genetic Counseling|genetic counseling
5647182|NCT00713804|Risk perception|risk perception
5647184|NCT00713804|Control|control
5647185|NCT00713804|Knowledge|knowledge
5647186|NCT00713791|Healthy Volunteers|healthy volunteers
5647187|NCT00713791|ZD4054|zd4054
5647188|NCT00713778|Ovarian Cysts|ovarian cysts
5647189|NCT00713778|Electrocoagulation|electrocoagulation
5647190|NCT00713778|Ovarian Function Tests|ovarian function tests
5647191|NCT00713778|Laparoscopy|laparoscopy
5647192|NCT00713765|Healthy volunteers|healthy volunteers
5647193|NCT00713752|HIV-negative|hiv-negative
5647194|NCT00713739|kidney stones|kidney stones
5647195|NCT00713739|ureteral stones|ureteral stones
5647196|NCT00713739|medical expulsion therapy|medical expulsion therapy
5647197|NCT00713726|Pain|pain
5647198|NCT00713726|Analgesia|analgesia
5647199|NCT00713726|Newborn Infant|newborn infant
5647200|NCT00713726|Opioids|opioids
5647201|NCT00713726|Side-effects|side-effects
5647202|NCT00713726|Intensive care|intensive care
5647203|NCT00713726|Postoperative|postoperative
5647204|NCT00713713|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5647205|NCT00713713|Tidal volume|tidal volume
5647206|NCT00713713|cardiac output|cardiac output
5647207|NCT00713713|Respiration, Artificial|respiration, artificial
5647208|NCT00713713|Protective ventilation|protective ventilation
5647209|NCT00713700|patent ductus arteriosus|patent ductus arteriosus
5647211|NCT00713687|photodynamic therapy|photodynamic therapy
5647212|NCT00713687|PDT|pdt
5647213|NCT00713687|gemcitabine|gemcitabine
5647214|NCT00713687|oxaliplatin|oxaliplatin
5647215|NCT00713687|cholangiocarcinoma|cholangiocarcinoma
5647216|NCT00713674|Methicillin resistance|methicillin resistance
5647217|NCT00713661|Colorectal Anastomosis|colorectal anastomosis
5647218|NCT00713661|Colorectal Resection|colorectal resection
5647219|NCT00713661|Tachosil|tachosil
5647220|NCT00713635|Congenital Heart Disease|congenital heart disease
5647221|NCT00713622|Partial|partial
5647222|NCT00713622|onset|onset
5647229|NCT00713596|fibrin glue|fibrin glue
5647230|NCT00713596|fibrinogen|fibrinogen
5647231|NCT00713596|Swelling|swelling
5647232|NCT00713596|fibrin|fibrin
5647233|NCT00713596|tisseel|tisseel
5647234|NCT00713583|Cocaine, levodopa, contingency management|cocaine, levodopa, contingency management
5647235|NCT00713570|intellectual functioning|intellectual functioning
5647236|NCT00713570|memory,visual-spatial and perceptual functions|memory,visual-spatial and perceptual functions
5647237|NCT00713570|cognitive abilities|cognitive abilities
5647239|NCT00713570|BDNF|bdnf
5647240|NCT00713570|neuron biological systemic pathway candidate genes|neuron biological systemic pathway candidate genes
5647241|NCT00713570|Chinese|chinese
5647242|NCT00713570|Taiwan|taiwan
5647243|NCT00713570|Healthy subjects|healthy subjects
5647244|NCT00713557|coronary angioplasty|coronary angioplasty
5647245|NCT00713544|Rheumatoid Arthritis|rheumatoid arthritis
5647247|NCT00713544|AZD5672|azd5672
5647248|NCT00713531|HIV-negative|hiv-negative
5647249|NCT00713531|male and female clients|male and female clients
5647250|NCT00713531|ages 18-50 years|ages 18-50 years
5647251|NCT00713531|seeking HIV counseling|seeking hiv counseling
5647252|NCT00713531|testing at TRCARC|testing at trcarc
5647253|NCT00713518|AMD Age Related Macular Degeneration Choroidal Neovascularization Monet|amd age related macular degeneration choroidal neovascularization monet
5647254|NCT00713505|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5647255|NCT00713505|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5647256|NCT00713505|cancer survivor|cancer survivor
5672501|NCT00611663|Pneumococcal vaccine|pneumococcal vaccine
5647257|NCT00713505|cognitive/functional effects|cognitive/functional effects
5647258|NCT00713505|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5647259|NCT00713505|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5647260|NCT00713505|childhood anaplastic large cell lymphoma|childhood anaplastic large cell lymphoma
5647261|NCT00713505|childhood large cell lymphoma|childhood large cell lymphoma
5647262|NCT00713505|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5647263|NCT00713505|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5647264|NCT00713505|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5647265|NCT00713505|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5647266|NCT00713505|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5647272|NCT00713479|methamphetamine|methamphetamine
5647273|NCT00713479|varenicline|varenicline
5647274|NCT00713479|Chantix|chantix
5647275|NCT00713479|stimulant|stimulant
5647276|NCT00713479|crystal meth|crystal meth
5647277|NCT00713466|CLIPP cases|clipp cases
5647278|NCT00713466|Pediatric clerkship|pediatric clerkship
5647279|NCT00713466|Standardizing|standardizing
5647280|NCT00713466|Students' exposure|students' exposure
5647281|NCT00713466|Essential|essential
5647282|NCT00713466|Enhancing|enhancing
5647286|NCT00713453|enzyme replacement therapy|enzyme replacement therapy
5647287|NCT00713440|Incretin Effect|incretin effect
5647288|NCT00713440|Steroids|steroids
5647289|NCT00713440|Glucagon-Like Peptide 1|glucagon-like peptide 1
5647290|NCT00713440|Gastric Inhibitory Peptide|gastric inhibitory peptide
5647291|NCT00713440|Glucose-dependent Insulinotropic Polypeptide|glucose-dependent insulinotropic polypeptide
5647292|NCT00713440|Insulin|insulin
5647293|NCT00713440|C-peptide|c-peptide
5647294|NCT00713440|Glucagon|glucagon
5647295|NCT00713427|Biliary|biliary
5647296|NCT00713427|Strictures|strictures
5647297|NCT00713427|Malignant|malignant
5647298|NCT00713427|Neoplasm|neoplasm
5647299|NCT00713427|Palliation|palliation
5647300|NCT00713414|Spasmodic Dysphonia|spasmodic dysphonia
5647301|NCT00713414|Dystonia|dystonia
5647302|NCT00713414|Basal Ganglia|basal ganglia
5647303|NCT00713414|PET Imaging|pet imaging
5647304|NCT00713414|fMRI|fmri
5647305|NCT00713414|Voice Disorder|voice disorder
5647306|NCT00713414|Healthy Volunteer|healthy volunteer
5647307|NCT00713414|HV|hv
5647308|NCT00713375|Autonomic Nervous System|autonomic nervous system
5647309|NCT00713375|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5647310|NCT00713375|Intracranial Hemorrhages|intracranial hemorrhages
5647311|NCT00713375|Cerebral Hemorrhage|cerebral hemorrhage
5647312|NCT00713362|Aspiration, chest tube, pneumothorax, thoracoscopic surgery|aspiration, chest tube, pneumothorax, thoracoscopic surgery
5647313|NCT00713349|White|white
5647314|NCT00713349|Petrolatum|petrolatum
5647315|NCT00713349|Xenaderm|xenaderm
5647316|NCT00713349|Vehicle|vehicle
5647317|NCT00713349|Partial thickness wounds|partial thickness wounds
5647319|NCT00713349|Cryo-surgery|cryo-surgery
5647320|NCT00713336|ZD4054|zd4054
5647321|NCT00713336|Healthy Volunteers|healthy volunteers
5647322|NCT00713336|QT interval|qt interval
5647323|NCT00713323|Pain|pain
5647324|NCT00713323|Peripheral Neuropathy|peripheral neuropathy
5647325|NCT00713297|medication errors|medication errors
5647326|NCT00713297|computerized physician order entry|computerized physician order entry
5647327|NCT00713297|pharmaceutical care|pharmaceutical care
5647328|NCT00713297|chemotherapeutic agents|chemotherapeutic agents
5647329|NCT00713297|reengineering|reengineering
5647330|NCT00713284|Kidney transplantation|kidney transplantation
5647331|NCT00713284|Sirolimus|sirolimus
5647332|NCT00713284|Immunosuppression|immunosuppression
5647333|NCT00713284|Tacrolimus|tacrolimus
5647334|NCT00713271|Healthy male|healthy male
5647335|NCT00713271|tolerability|tolerability
5647336|NCT00713271|safety|safety
5647337|NCT00713271|inhalation|inhalation
5647338|NCT00713258|Postmenopausal women|postmenopausal women
5647339|NCT00713258|Back pain|back pain
5647340|NCT00713258|Osteoporosis related fracture|osteoporosis related fracture
5647341|NCT00713245|Pompe disease|pompe disease
5647342|NCT00713245|late onset|late onset
5647343|NCT00713232|naming test|naming test
5647344|NCT00713219|IMRT|imrt
5647345|NCT00713219|cetuximab|cetuximab
5647346|NCT00713219|docetaxel|docetaxel
5647347|NCT00713206|Dental implants, maxilla, sinus lift, augmentation|dental implants, maxilla, sinus lift, augmentation
5647348|NCT00713193|Idiopathic TTP|idiopathic ttp
5647349|NCT00713193|Treatment|treatment
5647350|NCT00713193|Exacerbation|exacerbation
5647351|NCT00713193|Relapse|relapse
5647352|NCT00713193|Plasma Exchange|plasma exchange
5647353|NCT00713167|Grape Seed Extract|grape seed extract
5647354|NCT00713167|Hyperlipidemia|hyperlipidemia
5647355|NCT00713154|Radiotherapy|radiotherapy
5647356|NCT00713154|induced|induced
5647357|NCT00713128|nausea vomiting colorectal cancer|nausea vomiting colorectal cancer
5647358|NCT00713115|laparoscopy, needlescopy, adrenalectomy|laparoscopy, needlescopy, adrenalectomy
5647359|NCT00713102|in-flight emergency|in-flight emergency
5647361|NCT00713089|Asthma|asthma
5647362|NCT00713089|Allergic rhinitis|allergic rhinitis
5647363|NCT00713089|Singapore|singapore
5647364|NCT00713089|Indonesia|indonesia
5647365|NCT00713089|Gastrointestinal Flora|gastrointestinal flora
5647366|NCT00713076|multi-purpose solution|multi-purpose solution
5647367|NCT00713076|contact lens wearers|contact lens wearers
5647368|NCT00713076|Contact lense wearers|contact lense wearers
5647369|NCT00713063|smoking cessation|smoking cessation
5647370|NCT00713063|exercise|exercise
5647371|NCT00713063|physical activity|physical activity
5647372|NCT00713063|health education|health education
5647373|NCT00713050|stroke|stroke
5647374|NCT00713050|aphasia|aphasia
5647375|NCT00713050|imitation|imitation
5647376|NCT00713050|mirror neuron|mirror neuron
5647377|NCT00713037|fluoromisonidazole|fluoromisonidazole
5647378|NCT00713037|PET scan|pet scan
5647379|NCT00713037|Hypoxia-PET|hypoxia-pet
5647380|NCT00713037|IMPT|impt
5647381|NCT00713024|Pain; Functional neuroimaging; Neuropathy; Thermal sensation|pain; functional neuroimaging; neuropathy; thermal sensation
5647382|NCT00713011|Adalat XL|adalat xl
5647383|NCT00713011|Diltiazem|diltiazem
5647384|NCT00713011|Tiazac XC|tiazac xc
5647385|NCT00713011|Proteinuria|proteinuria
5647386|NCT00712998|radiation injuries|radiation injuries
5647387|NCT00712998|free radicals|free radicals
5647388|NCT00712998|reactive oxygen species|reactive oxygen species
5647389|NCT00712998|radiation injury from X-ray computed tomography|radiation injury from x-ray computed tomography
5647390|NCT00712998|free radical production|free radical production
5647391|NCT00712998|blood reactive oxygen species level|blood reactive oxygen species level
5647392|NCT00712985|Breast cancer|breast cancer
5647393|NCT00712985|aromatase inhibitors|aromatase inhibitors
5647394|NCT00712972|knee injection|knee injection
5647395|NCT00712972|parapatellar|parapatellar
5647396|NCT00712959|Pertussis|pertussis
5647397|NCT00712959|Tetanus|tetanus
5647398|NCT00712959|Diphtheria|diphtheria
5647399|NCT00712959|Acellular pertussis|acellular pertussis
5647400|NCT00712959|ADACEL®,|adacel®,
5647401|NCT00712959|Tdap vaccine|tdap vaccine
5647403|NCT00712933|Belimumab|belimumab
5647404|NCT00712933|Antibodies|antibodies
5647405|NCT00712933|Systemic Lupus Erythematosus|systemic lupus erythematosus
5647406|NCT00712933|Lupus|lupus
5647407|NCT00712933|Autoimmune Diseases|autoimmune diseases
5647408|NCT00712907|vitamin C|vitamin c
5647409|NCT00712907|retinal blood flow|retinal blood flow
5647410|NCT00712907|intraocular pressure|intraocular pressure
5647411|NCT00712907|retinal vessel diameter|retinal vessel diameter
5647412|NCT00712894|Acute myocardial infarction|acute myocardial infarction
5647413|NCT00712894|Percutaneous coronary intervention|percutaneous coronary intervention
5647414|NCT00712894|No-reflow phenomenon|no-reflow phenomenon
5647415|NCT00712894|Vasodilator agents|vasodilator agents
5647416|NCT00712855|Liver Cancer|liver cancer
5647417|NCT00712842|Diabetes|diabetes
5647418|NCT00712842|ocular blood flow|ocular blood flow
5647419|NCT00712829|Prostate cancer|prostate cancer
5647420|NCT00712829|Imaging|imaging
5647421|NCT00712816|osteoarthritis|osteoarthritis
5647422|NCT00712816|total knee arthroplasty|total knee arthroplasty
5647423|NCT00712816|cryotherapy|cryotherapy
5647424|NCT00712790|First line treatment for Hepatocellular Carcinoma|first line treatment for hepatocellular carcinoma
5647425|NCT00712777|Brimonidine|brimonidine
5647426|NCT00712777|alpha 2 receptor polymorphism|alpha 2 receptor polymorphism
5647427|NCT00712777|Intraocular Pressure|intraocular pressure
5647428|NCT00712764|Adenosine|adenosine
5647429|NCT00712764|Choroidal blood flow|choroidal blood flow
5647430|NCT00712764|Suction cup|suction cup
5647431|NCT00712751|Rectum|rectum
5647432|NCT00712751|Quality of Life|quality of life
5647433|NCT00712751|Sexual Health|sexual health
5647434|NCT00712751|08-073|08-073
5647435|NCT00712738|Nifedipine|nifedipine
5647436|NCT00712738|Thalassemia|thalassemia
5647437|NCT00712738|Hemochromatosis|hemochromatosis
5647438|NCT00712738|Iron Overload|iron overload
5647439|NCT00712738|Iron Excretion|iron excretion
5647440|NCT00712712|bone metastases|bone metastases
5647441|NCT00712712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5647442|NCT00712712|pain|pain
5647443|NCT00712699|Preschool|preschool
5647444|NCT00712699|Children|children
5647445|NCT00712699|ADHD|adhd
5647446|NCT00712699|Medication|medication
5647447|NCT00712699|Controlled Study|controlled study
5647448|NCT00712699|Placebo|placebo
5647449|NCT00712699|Mixed Amphetamine Salts|mixed amphetamine salts
5647450|NCT00712673|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
5647451|NCT00712660|prevention|prevention
5647452|NCT00712660|relapse|relapse
5647453|NCT00712660|schizophrenia|schizophrenia
5647454|NCT00712634|cytomegalovirus infection|cytomegalovirus infection
5647455|NCT00712621|Genetics Home Reference related topics|genetics home reference related topics
5647456|NCT00712621|breast cancer|breast cancer
5647457|NCT00712621|breast cancer related to depression|breast cancer related to depression
5647458|NCT00712621|Condition|condition
5647459|NCT00712621|Stage I-IV Carcinoma of Breast|stage i-iv carcinoma of breast
5647460|NCT00712608|Term|term
5647461|NCT00712608|Infant|infant
5647462|NCT00712608|Formula|formula
5647463|NCT00712595|Uterine fibroids|uterine fibroids
5647464|NCT00712595|mifepristone|mifepristone
5647465|NCT00712595|antiprogestins|antiprogestins
5647466|NCT00712582|Non-Hodgkin|non-hodgkin
5647467|NCT00712582|Lymphoma|lymphoma
5647468|NCT00712582|Rituximab|rituximab
5647469|NCT00712582|Cyclophosphamide|cyclophosphamide
5647470|NCT00712582|Doxorubicin|doxorubicin
5647471|NCT00712582|Vincristine|vincristine
5647472|NCT00712582|ifosfamide|ifosfamide
5647473|NCT00712582|etoposide|etoposide
5647474|NCT00712582|carboplatin|carboplatin
5647475|NCT00712582|stem cell transplant|stem cell transplant
5647476|NCT00712582|08-026|08-026
5647477|NCT00712569|Communication|communication
5647478|NCT00712569|Internet|internet
5647479|NCT00712569|Physician|physician
5647480|NCT00712569|Patient|patient
5647481|NCT00712569|08-079|08-079
5647482|NCT00712556|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5647483|NCT00712556|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5647484|NCT00712556|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5789069|NCT00150046|Everolimus|everolimus
5647485|NCT00712556|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5647486|NCT00712556|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5647487|NCT00712556|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5647488|NCT00712556|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5647489|NCT00712556|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5647490|NCT00712556|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5647491|NCT00712556|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5647492|NCT00712556|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5647493|NCT00712556|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5647494|NCT00712556|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5647495|NCT00712556|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5647496|NCT00712556|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5647497|NCT00712556|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5647498|NCT00712556|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5647499|NCT00712556|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5647500|NCT00712556|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5647501|NCT00712556|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5647502|NCT00712556|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5647503|NCT00712556|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5647504|NCT00712556|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5647505|NCT00712556|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5647506|NCT00712556|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5647510|NCT00712556|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5647511|NCT00712556|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5647512|NCT00712556|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5647513|NCT00712556|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5647514|NCT00712556|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5647515|NCT00712556|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5647516|NCT00712556|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5647517|NCT00712556|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5647518|NCT00712556|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5647519|NCT00712556|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5647520|NCT00712556|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5647521|NCT00712556|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5647522|NCT00712556|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5647523|NCT00712556|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5647524|NCT00712556|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5647525|NCT00712556|NC stage II adult immunoblastic large cell lymphoma|nc stage ii adult immunoblastic large cell lymphoma
5647526|NCT00712556|NC stage II adult lymphoblastic lymphoma|nc stage ii adult lymphoblastic lymphoma
5647527|NCT00712556|NC stage II grade 1 follicular lymphoma|nc stage ii grade 1 follicular lymphoma
5647528|NCT00712556|NC stage II grade 2 follicular lymphoma|nc stage ii grade 2 follicular lymphoma
5647529|NCT00712556|NC stage II grade 3 follicular lymphoma|nc stage ii grade 3 follicular lymphoma
5672502|NCT00611663|SLE|sle
5647530|NCT00712556|NC stage II mantle cell lymphoma|nc stage ii mantle cell lymphoma
5647531|NCT00712556|NC stage II marginal zone lymphoma|nc stage ii marginal zone lymphoma
5647532|NCT00712556|NC stage II small lymphocytic lymphoma|nc stage ii small lymphocytic lymphoma
5647533|NCT00712543|constipation|constipation
5647534|NCT00712543|laxative|laxative
5647536|NCT00712543|Kristalose®|kristalose®
5647537|NCT00712530|HIV|hiv
5647538|NCT00712530|Vaccine|vaccine
5647539|NCT00712530|Immune Therapy|immune therapy
5647540|NCT00712530|DermaVir|dermavir
5647541|NCT00712517|postoperative pain|postoperative pain
5647542|NCT00712517|Piritramid|piritramid
5647543|NCT00712517|propofol|propofol
5647544|NCT00712517|sevoflurane|sevoflurane
5647545|NCT00712517|varicose vein|varicose vein
5647546|NCT00712517|Anesthesia|anesthesia
5647547|NCT00712504|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (SUTENT), docetaxel (Taxotere), Angiogenesis Inhibitors|advanced solid tumors, non small cell lung cancer, pulmonary neoplasms, sunitinib (sutent), docetaxel (taxotere), angiogenesis inhibitors
5647548|NCT00712491|wet AMD|wet amd
5647550|NCT00712465|Atrial fibrillation|atrial fibrillation
5647551|NCT00712465|interaction|interaction
5647552|NCT00712465|pharmacokinetic|pharmacokinetic
5647553|NCT00712452|fertility|fertility
5647554|NCT00712452|chemotherapy|chemotherapy
5647555|NCT00712439|DPN,|dpn,
5647556|NCT00712439|Diabetic|diabetic
5647557|NCT00712439|Peripheral|peripheral
5647558|NCT00712439|Neuropathy|neuropathy
5647559|NCT00712439|Painful|painful
5647560|NCT00712426|Huntington's disease|huntington's disease
5647561|NCT00712426|Creatine|creatine
5647562|NCT00712426|Mitochondrial Dysfunction|mitochondrial dysfunction
5647563|NCT00712426|Total Functional Capacity|total functional capacity
5647565|NCT00712413|Helicobacter pylori infection|helicobacter pylori infection
5647566|NCT00712413|Quadruple therapy|quadruple therapy
5647567|NCT00712413|Safety|safety
5647568|NCT00712413|Efficacy|efficacy
5647569|NCT00712413|Tolerability|tolerability
5647570|NCT00712413|BID dosing|bid dosing
5647571|NCT00712400|Latanoprost|latanoprost
5647572|NCT00712400|Choroidal Blood Flow|choroidal blood flow
5647573|NCT00712400|Intraocular Pressure|intraocular pressure
5647574|NCT00712374|Malaria|malaria
5647575|NCT00712374|All causes mortality|all causes mortality
5647576|NCT00712374|Cost effectiveness|cost effectiveness
5647577|NCT00712361|Invasive|invasive
5647578|NCT00712361|Non-Invasive|non-invasive
5647579|NCT00712361|Peripheral blood parameters|peripheral blood parameters
5647580|NCT00712361|Finger mounted device|finger mounted device
5647581|NCT00712361|Blood tissue|blood tissue
5647582|NCT00712361|Tissue color distribution|tissue color distribution
5647583|NCT00712361|Accuracy|accuracy
5647584|NCT00712361|Tissue pigmentation|tissue pigmentation
5647585|NCT00712361|pH|ph
5647586|NCT00712361|Hemoglobin|hemoglobin
5647587|NCT00712361|Hematocrit|hematocrit
5647588|NCT00712361|SpO2|spo2
5647589|NCT00712361|Blood pressure|blood pressure
5647590|NCT00712361|Pulse|pulse
5647591|NCT00712361|CO2|co2
5647592|NCT00712348|Gaucher disease|gaucher disease
5647593|NCT00712348|imiglucerase|imiglucerase
5647594|NCT00712348|glucocerebrosidase|glucocerebrosidase
5647595|NCT00712348|enzyme replacement therapy|enzyme replacement therapy
5647596|NCT00712348|lysosomal storage disorder|lysosomal storage disorder
5647597|NCT00712335|asthmatics|asthmatics
5647598|NCT00712335|smokers|smokers
5647599|NCT00712335|inhaled corticosteroids|inhaled corticosteroids
5647600|NCT00712335|leukotriene receptor antagonists|leukotriene receptor antagonists
5647601|NCT00712322|Pediatric, Children, Urodynamics, Oral Suspension, Overactive bladder, Dose-finding, Neurogenic Detrusor Overactivity, Meningomyelocele, Spinal cord injury|pediatric, children, urodynamics, oral suspension, overactive bladder, dose-finding, neurogenic detrusor overactivity, meningomyelocele, spinal cord injury
5647602|NCT00712309|atherosclerotic|atherosclerotic
5647603|NCT00712309|lesions|lesions
5647604|NCT00712296|Asthma|asthma
5647605|NCT00712296|alternative medicine|alternative medicine
5647606|NCT00712296|complementary medicine|complementary medicine
5647607|NCT00712296|herbal therapy|herbal therapy
5647608|NCT00712283|fitness to drive|fitness to drive
5647609|NCT00712283|operate machines|operate machines
5647610|NCT00712283|To determine the fitness to drive and operate machines.|to determine the fitness to drive and operate machines.
5647611|NCT00712270|Schizophrenia|schizophrenia
5647612|NCT00712270|Antipsychotic drug treatment response|antipsychotic drug treatment response
5647613|NCT00712270|Risperidone|risperidone
5647614|NCT00712270|Aripiprazole|aripiprazole
5647615|NCT00712270|Fallypride|fallypride
5647616|NCT00712270|Positron emission tomography|positron emission tomography
5647617|NCT00712270|Magnetic Resonance Imaging|magnetic resonance imaging
5647618|NCT00712270|Dopamine D2 Receptors|dopamine d2 receptors
5647619|NCT00712257|treatment of superficial femoral artery instent restenosis|treatment of superficial femoral artery instent restenosis
5647620|NCT00712244|Discovisc|discovisc
5647621|NCT00712244|Ophthalmic Viscosurgical Device|ophthalmic viscosurgical device
5647622|NCT00712231|pseudophakic|pseudophakic
5647623|NCT00712231|anterior chamber depth|anterior chamber depth
5647624|NCT00712231|Pentacam|pentacam
5647625|NCT00712218|Ovarian cancer, FIGO stage IIB-IV|ovarian cancer, figo stage iib-iv
5647626|NCT00712205|Asthma|asthma
5647627|NCT00712205|Vitamin D|vitamin d
5647628|NCT00712192|coronary artery bypass grafting|coronary artery bypass grafting
5647629|NCT00712192|endoscopic vein harvest|endoscopic vein harvest
5647630|NCT00712192|saphenous vein|saphenous vein
5647631|NCT00712192|endothelial cells|endothelial cells
5647632|NCT00712192|eNOS|enos
5647633|NCT00712192|ET-1|et-1
5632287|NCT00770094|LASIK|lasik
5647634|NCT00712179|Stroke|stroke
5647635|NCT00712179|walking|walking
5647636|NCT00712179|Treadmill|treadmill
5647637|NCT00712179|body weight support system|body weight support system
5647638|NCT00712166|cystic fibrosis|cystic fibrosis
5647639|NCT00712166|pseudomonas aeruginosa|pseudomonas aeruginosa
5647640|NCT00712166|lung infection|lung infection
5647641|NCT00712166|CFQ-R|cfq-r
5647642|NCT00712166|inhaled antibiotic|inhaled antibiotic
5647643|NCT00712166|aztreonam lysine|aztreonam lysine
5647644|NCT00712153|multislice computed tomography|multislice computed tomography
5647645|NCT00712153|coronary artery bypass grafting|coronary artery bypass grafting
5647646|NCT00712153|Patients|patients
5647647|NCT00712153|underwent|underwent
5647648|NCT00712153|surgeries|surgeries
5647649|NCT00712140|stage IA breast cancer|stage ia breast cancer
5647650|NCT00712140|stage IB breast cancer|stage ib breast cancer
5647651|NCT00712140|stage II breast cancer|stage ii breast cancer
5647652|NCT00712140|stage IIIA breast cancer|stage iiia breast cancer
5647653|NCT00712140|HER2-positive breast cancer|her2-positive breast cancer
5647654|NCT00712127|Body Fat|body fat
5647655|NCT00712127|Exercise|exercise
5647656|NCT00712127|Metabolic syndrome|metabolic syndrome
5647657|NCT00712127|Obesity|obesity
5647658|NCT00712127|Nutrition|nutrition
5647659|NCT00712127|Physical Activity|physical activity
5647660|NCT00712127|Weight Loss|weight loss
5647661|NCT00712114|phase I|phase i
5647662|NCT00712114|safety|safety
5647663|NCT00712114|tolerance|tolerance
5647664|NCT00712114|rheumatoid arthritis|rheumatoid arthritis
5647665|NCT00712114|pharmacokinetics|pharmacokinetics
5647666|NCT00712114|methotrexate|methotrexate
5647667|NCT00712114|anti-inflammatory|anti-inflammatory
5647668|NCT00712101|infarction|infarction
5647669|NCT00712101|intervention|intervention
5647670|NCT00712101|stent|stent
5647671|NCT00712101|abciximab|abciximab
5647672|NCT00712101|platelets|platelets
5647673|NCT00712088|HIV|hiv
5647674|NCT00712088|Unsafe Sex|unsafe sex
5647675|NCT00712088|High Risk Sex|high risk sex
5647676|NCT00712088|HIV Prevention|hiv prevention
5647677|NCT00712088|African-American|african-american
5647678|NCT00712088|gay|gay
5647679|NCT00712088|bisexual|bisexual
5647680|NCT00712088|intervention trial|intervention trial
5647681|NCT00712075|Cognitive Behavioral Therapy|cognitive behavioral therapy
5647682|NCT00712075|Social Skills Training|social skills training
5647683|NCT00712075|Experience Sampling Method|experience sampling method
5647684|NCT00712075|Computer-assisted therapy|computer-assisted therapy
5647685|NCT00712075|schizophrenia|schizophrenia
5647687|NCT00712062|Pemetrexed|pemetrexed
5647688|NCT00712062|Alimta|alimta
5647689|NCT00712062|Recurrent|recurrent
5647690|NCT00712062|Progressive|progressive
5647691|NCT00712049|intima-media-thickness|intima-media-thickness
5647692|NCT00712049|dyslipidemia|dyslipidemia
5647693|NCT00712049|progression of atherosclerosis|progression of atherosclerosis
5647694|NCT00712049|peripheral artery disease|peripheral artery disease
5647695|NCT00712049|major cardiovascular events|major cardiovascular events
5647696|NCT00712036|Heroin dependence|heroin dependence
5647697|NCT00712036|Interim Methadone Treatment|interim methadone treatment
5647698|NCT00712036|Counseling|counseling
5647699|NCT00712023|Hypothermia|hypothermia
5647700|NCT00712023|Vascular surgery|vascular surgery
5647701|NCT00712023|Forced-air warming mattress|forced-air warming mattress
5647702|NCT00712023|Circulating-water mattress|circulating-water mattress
5647703|NCT00712010|Glucose|glucose
5647704|NCT00712010|Insulin|insulin
5647705|NCT00711997|H19 gene, plasmid, diphtheria toxin, pancreatic cancer|h19 gene, plasmid, diphtheria toxin, pancreatic cancer
5647809|NCT00711568|depression|depression
5647706|NCT00711997|inodiftagene vixteplasmid|inodiftagene vixteplasmid
5647707|NCT00711997|BC-819|bc-819
5647708|NCT00711984|renal artery stenosis|renal artery stenosis
5647709|NCT00711984|stent|stent
5647710|NCT00711984|comparison of treatments|comparison of treatments
5647711|NCT00711984|progression|progression
5647712|NCT00711984|atherosclerosis|atherosclerosis
5647713|NCT00711984|peripheral artery disease|peripheral artery disease
5647714|NCT00711984|major cardiovascular events|major cardiovascular events
5647715|NCT00711958|Chemotherapy associated anemia in cancer patients|chemotherapy associated anemia in cancer patients
5647716|NCT00711945|Crohn's disease|crohn's disease
5647717|NCT00711945|Relapse|relapse
5647718|NCT00711945|outcomes|outcomes
5647719|NCT00711945|growth|growth
5647720|NCT00711932|Ovarian Cancer|ovarian cancer
5647721|NCT00711932|TRA-8|tra-8
5647722|NCT00711932|Monoclonal Antibody|monoclonal antibody
5647723|NCT00711932|Tissue Slice Technology|tissue slice technology
5647724|NCT00711906|Malaria|malaria
5647725|NCT00711906|Pregnancy|pregnancy
5647727|NCT00711906|Intermittent Preventive Treatment|intermittent preventive treatment
5647728|NCT00711906|Safety|safety
5647729|NCT00711906|Efficacy|efficacy
5647730|NCT00711880|Pain|pain
5647731|NCT00711880|Peripheral Neuropathy|peripheral neuropathy
5647732|NCT00711854|Staphylococcal infection|staphylococcal infection
5647733|NCT00711841|HELLP syndrome|hellp syndrome
5647734|NCT00711841|dexamethasone|dexamethasone
5647735|NCT00711841|postpartum period|postpartum period
5647736|NCT00711841|class I HELLP syndrome|class i hellp syndrome
5647737|NCT00711815|Women of the state of Alabama|women of the state of alabama
5647738|NCT00711815|CIN 1|cin 1
5647739|NCT00711815|negative biopsy|negative biopsy
5647740|NCT00711815|normal colposcopy|normal colposcopy
5647741|NCT00711815|HPV|hpv
5647742|NCT00711802|Complicated|complicated
5647743|NCT00711802|Skin|skin
5647744|NCT00711802|Structure|structure
5647745|NCT00711789|Acute renal failure|acute renal failure
5647746|NCT00711789|Septic shock|septic shock
5647747|NCT00711789|angiotensin II|angiotensin ii
5647748|NCT00711789|neutrophil gelatinase associated lipocalin (NGAL)|neutrophil gelatinase associated lipocalin (ngal)
5647749|NCT00711789|cystatin C|cystatin c
5647750|NCT00711776|Aciclovir cream 5%|aciclovir cream 5%
5647751|NCT00711776|Volunteer|volunteer
5647752|NCT00711776|Japanese|japanese
5647753|NCT00711776|Male|male
5647754|NCT00711776|Bioequivalence|bioequivalence
5647755|NCT00711763|Preterm Infant|preterm infant
5647756|NCT00711763|Parenteral nutrition cycling|parenteral nutrition cycling
5647757|NCT00711763|TPN cycling|tpn cycling
5647758|NCT00711763|Hypercalcuria|hypercalcuria
5647759|NCT00711750|underwent|underwent
5647760|NCT00711750|specific|specific
5647762|NCT00711750|hospital|hospital
5647763|NCT00711750|November 2003|november 2003
5647764|NCT00711750|October 2005|october 2005
5647765|NCT00711737|metabolic parameters|metabolic parameters
5647766|NCT00711737|escitalopram|escitalopram
5647767|NCT00711737|metabolic syndrome|metabolic syndrome
5647768|NCT00711737|antidepressant|antidepressant
5647769|NCT00711724|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5647770|NCT00711724|Adolescent|adolescent
5647771|NCT00711711|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
5647772|NCT00711711|Arthroplasty replacement knee|arthroplasty replacement knee
5647773|NCT00711711|Treatment outcome|treatment outcome
5647774|NCT00711685|Topical vancomycin|topical vancomycin
5647775|NCT00711685|mediastinitis|mediastinitis
5647776|NCT00711685|coronary|coronary
5647777|NCT00711685|artery|artery
5647778|NCT00711685|bypass|bypass
5647779|NCT00711685|graft|graft
5647780|NCT00711685|Patients|patients
5647781|NCT00711672|Personal Communication|personal communication
5647782|NCT00711672|Doctor Patient Relations|doctor patient relations
5647783|NCT00711672|Narrative Medicine|narrative medicine
5647784|NCT00711659|Physical exam|physical exam
5647785|NCT00711659|Pediatric clerkship|pediatric clerkship
5647786|NCT00711659|Medical students|medical students
5647787|NCT00711646|Spasticity|spasticity
5647788|NCT00711646|Multiple Sclerosis|multiple sclerosis
5647789|NCT00711633|Premature birth,|premature birth,
5647791|NCT00711633|infant formula,|infant formula,
5647792|NCT00711633|bacterial colonization,|bacterial colonization,
5647793|NCT00711633|Bifidobacterium,|bifidobacterium,
5647794|NCT00711633|calprotectin|calprotectin
5647795|NCT00711620|sepsis|sepsis
5647796|NCT00711620|Immunotherapy|immunotherapy
5647797|NCT00711620|Thymosin|thymosin
5647798|NCT00711607|pharmacokinetics (PK)|pharmacokinetics (pk)
5647799|NCT00711607|combined oral contraceptive|combined oral contraceptive
5647800|NCT00711607|nomegestrol acetate|nomegestrol acetate
5647801|NCT00711607|estradiol|estradiol
5647802|NCT00711607|NOMAC|nomac
5647803|NCT00711607|E2|e2
5647804|NCT00711607|NOMAC-E2|nomac-e2
5647805|NCT00711607|pharmacokinetics|pharmacokinetics
5647806|NCT00711581|Cholecystectomy|cholecystectomy
5647807|NCT00711581|Cholecystectomy, Laparoscopic|cholecystectomy, laparoscopic
5647808|NCT00711581|Laparoscopy|laparoscopy
5647810|NCT00711568|magnetic stimulation|magnetic stimulation
5647811|NCT00711555|nausea|nausea
5647812|NCT00711555|vomiting|vomiting
5647813|NCT00711555|multiple days|multiple days
5647814|NCT00711555|chemotherapy|chemotherapy
5647815|NCT00711555|serotonin receptor antagonist|serotonin receptor antagonist
5647816|NCT00711555|quality of life|quality of life
5647817|NCT00711555|therapy|therapy
5647818|NCT00711555|corticosteroids|corticosteroids
5647819|NCT00711555|aprepitant|aprepitant
5647820|NCT00711555|rescue therapy|rescue therapy
5647821|NCT00711542|intracoronary progenitor cell therapy|intracoronary progenitor cell therapy
5647822|NCT00711542|NSTEMI|nstemi
5647823|NCT00711542|coronary flow reserve|coronary flow reserve
5647824|NCT00711542|randomized doubleblind Placebo-controlled trial|randomized doubleblind placebo-controlled trial
5647825|NCT00711529|hot flashes|hot flashes
5647826|NCT00711529|breast cancer|breast cancer
5647827|NCT00711529|Hypnotherapy|hypnotherapy
5647828|NCT00711529|Quality of Life|quality of life
5647829|NCT00711529|Gabapentin|gabapentin
5647830|NCT00711503|endogenous insulin production|endogenous insulin production
5647831|NCT00711503|C-peptide level|c-peptide level
5647832|NCT00711503|insulin requirement|insulin requirement
5647833|NCT00711490|Diabetic Macular Edema|diabetic macular edema
5647834|NCT00711490|Diabetic Retinopathy|diabetic retinopathy
5647835|NCT00711490|Rapamycin|rapamycin
5647836|NCT00711490|Sirolimus|sirolimus
5647837|NCT00711490|Diabetes|diabetes
5647838|NCT00711477|obesity|obesity
5647839|NCT00711477|overweight|overweight
5647840|NCT00711477|magnetic resonance imaging|magnetic resonance imaging
5647841|NCT00711477|naltrexone|naltrexone
5647842|NCT00711477|bupropion|bupropion
5647843|NCT00711464|cognition, pharmacology, memory, attention|cognition, pharmacology, memory, attention
5647844|NCT00711451|systemic vascular resistance|systemic vascular resistance
5647845|NCT00711451|pregnancy|pregnancy
5647846|NCT00711451|scheduled cesarean delivery|scheduled cesarean delivery
5647847|NCT00711451|syncytiotrophoblast apoptosis|syncytiotrophoblast apoptosis
5647848|NCT00711451|continuous wave Doppler|continuous wave doppler
5647849|NCT00711438|Breathlessness|breathlessness
5647850|NCT00711438|Dyspnoea|dyspnoea
5647851|NCT00711438|Dyspnea|dyspnea
5647852|NCT00711438|Palliative care|palliative care
5647853|NCT00711438|RCT|rct
5647854|NCT00711438|Randomised controlled trial|randomised controlled trial
5647855|NCT00711438|COPD|copd
5647856|NCT00711438|Chronic respiratory disease|chronic respiratory disease
5647857|NCT00711425|Jaw, Edentulous, Partially (posterior mandible)|jaw, edentulous, partially (posterior mandible)
5647858|NCT00711412|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5647859|NCT00711412|stage I esophageal cancer|stage i esophageal cancer
5647860|NCT00711412|stage II esophageal cancer|stage ii esophageal cancer
5647861|NCT00711412|stage III esophageal cancer|stage iii esophageal cancer
5647862|NCT00711412|stage IV esophageal cancer|stage iv esophageal cancer
5647863|NCT00711399|Respiratory sounds|respiratory sounds
5647864|NCT00711399|Wheeze|wheeze
5647865|NCT00711399|Cough|cough
5647866|NCT00711386|pharmacokinetics|pharmacokinetics
5647867|NCT00711386|CCR5|ccr5
5647868|NCT00711386|Healthy volunteers|healthy volunteers
5647869|NCT00711386|GSK706769|gsk706769
5647870|NCT00711373|VCA|vca
5647871|NCT00711373|composite tissue allotransplantation|composite tissue allotransplantation
5647872|NCT00711373|amputation|amputation
5647873|NCT00711373|Hand|hand
5647874|NCT00711360|heart failure|heart failure
5647875|NCT00711360|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5647876|NCT00711360|intrathoracic impedance|intrathoracic impedance
5647877|NCT00711360|cardiac resynchronization therapy|cardiac resynchronization therapy
5647878|NCT00711360|home monitoring|home monitoring
5647879|NCT00711347|Discovisc|discovisc
5647880|NCT00711347|Ophthalmic Visco Surgical Device|ophthalmic visco surgical device
5647881|NCT00711321|Alzheimer|alzheimer
5647882|NCT00711321|Morbus Alzheimer|morbus alzheimer
5647883|NCT00711321|Vaccine|vaccine
5647896|NCT00711256|Clothing|clothing
5647897|NCT00711243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5647898|NCT00711243|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5647899|NCT00711243|stage III gastric cancer|stage iii gastric cancer
5647900|NCT00711243|stage IV gastric cancer|stage iv gastric cancer
5647901|NCT00711230|HIV|hiv
5647902|NCT00711230|Vaccine|vaccine
5647903|NCT00711230|Immune Therapy|immune therapy
5647904|NCT00711230|DermaVir|dermavir
5647905|NCT00711204|Severe|severe
5647906|NCT00711204|Alzheimer's Disease|alzheimer's disease
5647907|NCT00711191|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; CD40|pancreas cancer; cancer of the pancreas; gemcitabine; chemotherapy; monoclonal antibody; immunotherapy; cd40
5647908|NCT00711165|Asthma|asthma
5647909|NCT00711165|Nitric Oxide|nitric oxide
5647910|NCT00711165|Exhaled Breath Condensate|exhaled breath condensate
5647911|NCT00711165|Methacholine Challenge|methacholine challenge
5647912|NCT00711152|diabetes|diabetes
5647913|NCT00711152|protocol-driven structured care|protocol-driven structured care
5647914|NCT00711152|web-based|web-based
5647915|NCT00711152|joint asia diabetes evaluation|joint asia diabetes evaluation
5647916|NCT00711139|Alzheimer|alzheimer
5647917|NCT00711139|Morbus Alzheimer|morbus alzheimer
5647918|NCT00711139|Alzheimer Vaccine|alzheimer vaccine
5647919|NCT00711139|Vaccine|vaccine
5647921|NCT00711139|A-beta immunotherapy|a-beta immunotherapy
5647922|NCT00711126|intravenous,|intravenous,
5672503|NCT00611663|Vaccination|vaccination
5647923|NCT00711126|tolerability|tolerability
5647924|NCT00711126|pharmacokinetics,|pharmacokinetics,
5647925|NCT00711126|oral,|oral,
5647926|NCT00711126|pharmacodynamics,|pharmacodynamics,
5647927|NCT00711126|safety,|safety,
5647928|NCT00711126|GW642444,|gw642444,
5647929|NCT00711126|inhaled,|inhaled,
5647930|NCT00711113|Jaw, Edentulous, Partially (posterior maxilla)|jaw, edentulous, partially (posterior maxilla)
5647931|NCT00711100|Substitution for cigarettes|substitution for cigarettes
5647932|NCT00711100|Oral tobacco products|oral tobacco products
5647933|NCT00711087|Spinal Cord Injury|spinal cord injury
5647934|NCT00711087|Bladder|bladder
5647935|NCT00711087|Botulinum toxin (BOTOX-A|botulinum toxin (botox-a
5647936|NCT00711087|Detrusor External Sphincter Dyssynergia|detrusor external sphincter dyssynergia
5647937|NCT00711074|pharmacokinetics|pharmacokinetics
5647938|NCT00711074|mass balance|mass balance
5647939|NCT00711074|radiolabel|radiolabel
5647940|NCT00711074|AZD5672|azd5672
5647941|NCT00711048|GERD|gerd
5647942|NCT00711048|healthy volunteer|healthy volunteer
5647943|NCT00711048|esophagus|esophagus
5647944|NCT00711048|pain|pain
5647945|NCT00711035|CMV|cmv
5647946|NCT00711035|Adenovirus|adenovirus
5647947|NCT00711035|EBV|ebv
5647948|NCT00711035|non-myeloablative transplants|non-myeloablative transplants
5647949|NCT00711035|Prior allogeneic hematopoietic stem cell transplant|prior allogeneic hematopoietic stem cell transplant
5647950|NCT00711022|Jaw, Edentulous (maxilla, with poor bone quality and quantity)|jaw, edentulous (maxilla, with poor bone quality and quantity)
5647951|NCT00711009|Human Immunodeficiency Virus infection|human immunodeficiency virus infection
5647952|NCT00710996|AcrySof IQ IOL|acrysof iq iol
5647953|NCT00710983|Mortality|mortality
5647954|NCT00710983|Morbidity|morbidity
5647955|NCT00710983|Growth|growth
5647956|NCT00710983|Immunology|immunology
5647957|NCT00710970|Urinary Bladder Neoplasms|urinary bladder neoplasms
5647958|NCT00710970|Previous Chemotherapy|previous chemotherapy
5647959|NCT00710970|Tamoxifen|tamoxifen
5647960|NCT00710970|Anti-tumor activity|anti-tumor activity
5647961|NCT00710957|Vitamin D|vitamin d
5647962|NCT00710957|Physical Function|physical function
5647963|NCT00710957|Falls|falls
5647964|NCT00710957|Aging|aging
5647966|NCT00710944|Jaw, Edentulous, Partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))|jaw, edentulous, partially (missing/extracted/avulsed teeth in the maxilla within zone 15(4)-25(13))
5647967|NCT00710931|Bilateral Cataract|bilateral cataract
5647968|NCT00710931|IOL|iol
5647969|NCT00710931|ReSTOR|restor
5647970|NCT00710931|Aspheric|aspheric
5647971|NCT00710905|Cataract IOL ReSTOR Aspheric|cataract iol restor aspheric
5647972|NCT00710905|Bilateral cataract|bilateral cataract
5647973|NCT00710892|suicide gene-modified allodepleted donor lymphocytes|suicide gene-modified allodepleted donor lymphocytes
5647974|NCT00710892|given to recipients of haploidentical stem cell transplants|given to recipients of haploidentical stem cell transplants
5647975|NCT00710892|Stage III|stage iii
5647976|NCT00710892|Stage IV|stage iv
5647977|NCT00710892|Myelodysplastic syndrome|myelodysplastic syndrome
5647978|NCT00710892|AML after first relapse|aml after first relapse
5647979|NCT00710892|primary refractory disease|primary refractory disease
5647980|NCT00710892|CML|cml
5647981|NCT00710892|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5647982|NCT00710892|familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
5647983|NCT00710892|viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
5647984|NCT00710892|Severe chronic active Epstein Barr virus infection (SCAEBV)|severe chronic active epstein barr virus infection (scaebv)
5647985|NCT00710892|T or NK cell malignancy|t or nk cell malignancy
5647986|NCT00710892|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
5647987|NCT00710879|Efficacy|efficacy
5647988|NCT00710866|Influenza Vaccines|influenza vaccines
5647989|NCT00710866|Infant|infant
5647990|NCT00710866|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5647991|NCT00710853|Geriatric|geriatric
5647992|NCT00710853|Qi gong|qi gong
5647993|NCT00710853|Yoga|yoga
5647994|NCT00710853|Tai chi|tai chi
5647995|NCT00710853|Geriatric Assessment|geriatric assessment
5647996|NCT00710840|Knee Replacement|knee replacement
5647997|NCT00710840|Knee OA|knee oa
5647998|NCT00710840|OA|oa
5647999|NCT00710827|NEBIDO,|nebido,
5648000|NCT00710827|Hypogonadism,|hypogonadism,
5648001|NCT00710827|Symptomatic late onset,|symptomatic late onset,
5648002|NCT00710827|Testosterone deficiency|testosterone deficiency
5648003|NCT00710814|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5648004|NCT00710814|Leptin|leptin
5648005|NCT00710814|Bariatric surgery|bariatric surgery
5629803|NCT00780741|Simple probing|simple probing
5648006|NCT00710814|Overweight after Roux-en-Y gastric bypass surgery|overweight after roux-en-y gastric bypass surgery
5648007|NCT00710801|Hepatitis C Virus|hepatitis c virus
5648008|NCT00710801|HCV|hcv
5648009|NCT00710801|Liver Transplant|liver transplant
5648010|NCT00710801|Cyclosporine|cyclosporine
5648012|NCT00710801|Myfortic|myfortic
5648013|NCT00710788|QT interval|qt interval
5648014|NCT00710788|QT dispersion|qt dispersion
5648015|NCT00710788|arrhythmias|arrhythmias
5648017|NCT00710788|TC score|tc score
5648018|NCT00710775|Aortic valve stenosis|aortic valve stenosis
5648020|NCT00710775|Endovascular techniques|endovascular techniques
5648021|NCT00710749|Lower urinary tract symptoms leading to lower flow rates|lower urinary tract symptoms leading to lower flow rates
5648022|NCT00710697|Bladder Cancer|bladder cancer
5648023|NCT00710697|Breast Cancer|breast cancer
5648024|NCT00710697|Colorectal Cancer|colorectal cancer
5648025|NCT00710697|Gastrointestinal Neoplasm|gastrointestinal neoplasm
5648026|NCT00710697|Head and Neck Cancer|head and neck cancer
5648027|NCT00710697|Lung Cancer|lung cancer
5648028|NCT00710697|Ovarian Cancer|ovarian cancer
5648029|NCT00710697|Pancreatic Cancer|pancreatic cancer
5648030|NCT00710697|Prostrate Cancer|prostrate cancer
5648031|NCT00710684|Alzheimer's disease cognition SB-742457|alzheimer's disease cognition sb-742457
5648032|NCT00710671|HIV positive|hiv positive
5648033|NCT00710671|YMSM|ymsm
5648034|NCT00710671|risk factors|risk factors
5648035|NCT00710671|coping|coping
5648036|NCT00710671|identity development|identity development
5648037|NCT00710671|psychosocial needs|psychosocial needs
5648038|NCT00710658|Internet support|internet support
5648039|NCT00710658|Tailored information|tailored information
5648040|NCT00710658|Self-management|self-management
5648041|NCT00710658|Quality of life|quality of life
5648042|NCT00710658|Online messaging|online messaging
5648043|NCT00710658|Online discussion groups|online discussion groups
5648044|NCT00710645|Multiple Sclerosis|multiple sclerosis
5648045|NCT00710645|Spasticity|spasticity
5648046|NCT00710632|cachexia|cachexia
5648047|NCT00710632|lung cancer|lung cancer
5648048|NCT00710632|gastrointestinal cancer|gastrointestinal cancer
5648049|NCT00710632|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5648050|NCT00710632|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5648051|NCT00710606|contraceptive ring|contraceptive ring
5648052|NCT00710606|obesity|obesity
5648053|NCT00710606|pharmacokinetics|pharmacokinetics
5648054|NCT00710606|pharmacodynamics|pharmacodynamics
5648055|NCT00710606|Pharmacokinetics of the contraceptive ring in obese women.|pharmacokinetics of the contraceptive ring in obese women.
5648056|NCT00710593|Highly-active antiretroviral therapy|highly-active antiretroviral therapy
5650770|NCT00698737|Opioid|opioid
5648057|NCT00710593|Human papillomavirus|human papillomavirus
5648059|NCT00710567|Heart Failure|heart failure
5648060|NCT00710567|LVAS|lvas
5648061|NCT00710567|LVAD|lvad
5648062|NCT00710567|Rotary Pump|rotary pump
5648063|NCT00710554|Pain|pain
5648064|NCT00710554|Peripheral Neuropathy|peripheral neuropathy
5648065|NCT00710554|Allodynia|allodynia
5648066|NCT00710541|non invasive ventilation|non invasive ventilation
5648067|NCT00710541|COPD|copd
5648068|NCT00710541|hypercapnia|hypercapnia
5648069|NCT00710541|GOLD stage IV|gold stage iv
5648070|NCT00710528|CLL|cll
5648071|NCT00710528|NHL|nhl
5648072|NCT00710528|AML|aml
5648073|NCT00710528|MM|mm
5648074|NCT00710528|Phosphatidylinositol 3-kinase|phosphatidylinositol 3-kinase
5648075|NCT00710515|Melanoma|melanoma
5648076|NCT00710515|Phase I|phase i
5648077|NCT00710515|AZD6244|azd6244
5648078|NCT00710502|Transvaginal|transvaginal
5648079|NCT00710502|NOTES|notes
5648080|NCT00710502|Cholecystectomy|cholecystectomy
5648081|NCT00710502|Laparoscopic|laparoscopic
5648082|NCT00710489|Acne|acne
5648083|NCT00710489|Actinic Keratosis|actinic keratosis
5648084|NCT00710489|Dysplastic Nevi|dysplastic nevi
5648085|NCT00710489|Eczema|eczema
5648086|NCT00710489|Psoriasis|psoriasis
5648087|NCT00710489|Vitiligo|vitiligo
5648088|NCT00710489|Skin Cancer|skin cancer
5648089|NCT00710489|Rosacea|rosacea
5648090|NCT00710489|Leg or Foot Ulcers|leg or foot ulcers
5648091|NCT00710489|Atopic Dermatosis|atopic dermatosis
5648092|NCT00710463|COPD|copd
5648093|NCT00710463|non invasive ventilation|non invasive ventilation
5648094|NCT00710463|pulmonary rehabilitation|pulmonary rehabilitation
5648095|NCT00710450|IL13|il13
5648096|NCT00710450|leukotriene|leukotriene
5648097|NCT00710450|histamine|histamine
5648098|NCT00710450|IL4|il4
5648099|NCT00710450|Must be allergic asthma or allergic rhinitis|must be allergic asthma or allergic rhinitis
5648100|NCT00710437|Dexmedetomidine|dexmedetomidine
5648101|NCT00710437|Carotid Endarterectomy|carotid endarterectomy
5648102|NCT00710437|Electroencephalogram|electroencephalogram
5648103|NCT00710424|Pain|pain
5648104|NCT00710424|diabetic neuropathy|diabetic neuropathy
5648105|NCT00710411|humans|humans
5648106|NCT00710411|patients|patients
5648107|NCT00710411|polytrauma|polytrauma
5648108|NCT00710411|complement|complement
5648109|NCT00710411|inflammation|inflammation
5648110|NCT00710411|inflammatory response|inflammatory response
5648111|NCT00710411|biomarkers|biomarkers
5648112|NCT00710411|cytokines|cytokines
5648113|NCT00710411|cell surface markers|cell surface markers
5648114|NCT00710411|apoptosis|apoptosis
5648115|NCT00710411|NF-kappaB|nf-kappab
5648116|NCT00710411|functional polymorphisms|functional polymorphisms
5648117|NCT00710411|mesenchymal stem cell|mesenchymal stem cell
5648118|NCT00710411|severity of injury|severity of injury
5648119|NCT00710411|ISS|iss
5648120|NCT00710411|infections|infections
5648121|NCT00710411|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5648122|NCT00710411|SIRS|sirs
5648123|NCT00710411|sepsis|sepsis
5648124|NCT00710411|severe sepsis|severe sepsis
5648125|NCT00710411|shock|shock
5648126|NCT00710411|organ dysfunctions|organ dysfunctions
5648127|NCT00710411|SOFA|sofa
5648128|NCT00710411|severity of disease|severity of disease
5648129|NCT00710411|APACHEII|apacheii
5648130|NCT00710411|SAPSII|sapsii
5648131|NCT00710411|SPAPS3|spaps3
5648132|NCT00710411|length of stay|length of stay
5648133|NCT00710411|wound healing|wound healing
5648134|NCT00710411|outcome|outcome
5648135|NCT00710411|mortality|mortality
5648136|NCT00710398|Dairy Products|dairy products
5648137|NCT00710398|Dietary Protein|dietary protein
5648138|NCT00710398|Body Composition|body composition
5648139|NCT00710398|Fat mass loss|fat mass loss
5648140|NCT00710398|Lean mass gain|lean mass gain
5648141|NCT00710398|Pre-menopausal Women|pre-menopausal women
5648142|NCT00710359|Cobalamin deficiency|cobalamin deficiency
5648143|NCT00710359|Infant|infant
5648144|NCT00710359|Nutrition|nutrition
5648145|NCT00710359|Cobalamin supplementation|cobalamin supplementation
5648146|NCT00710359|Feeding problems|feeding problems
5648147|NCT00710359|Gastrointestinal symptoms|gastrointestinal symptoms
5648148|NCT00710346|Leiomyoma|leiomyoma
5648150|NCT00710346|Fibroids|fibroids
5648151|NCT00710346|Surgical|surgical
5648152|NCT00710320|Children core temperature,|children core temperature,
5648153|NCT00710320|Pediatric surgery,|pediatric surgery,
5648154|NCT00710320|Anesthesia induction|anesthesia induction
5648155|NCT00710294|Refractory Hypertension|refractory hypertension
5648156|NCT00710294|High Blood Pressure|high blood pressure
5648157|NCT00710294|Uncontrolled Blood Pressure|uncontrolled blood pressure
5648158|NCT00710281|Intracranial Aneurysm|intracranial aneurysm
5648159|NCT00710281|Subarachnoid arterial aneurysm|subarachnoid arterial aneurysm
5648160|NCT00710281|Aneurysm|aneurysm
5648161|NCT00710281|Brain Aneurysm|brain aneurysm
5648162|NCT00710281|Cerebral Aneurysm|cerebral aneurysm
5648163|NCT00710281|Wall Shear Stress(WSS)|wall shear stress(wss)
5648164|NCT00710281|Hemodynamic Stress|hemodynamic stress
5648165|NCT00710281|Subarachnoid Hemorrhage(SAH)|subarachnoid hemorrhage(sah)
5648166|NCT00710268|Bevacizumab|bevacizumab
5648167|NCT00710268|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5648168|NCT00710268|Metastatic Solid Tumours|metastatic solid tumours
5648169|NCT00710268|PARP inhibitor|parp inhibitor
5648170|NCT00710255|Asthma|asthma
5648171|NCT00710255|Exercise induced bronchospasm|exercise induced bronchospasm
5648173|NCT00710255|leukotrienes|leukotrienes
5648174|NCT00710255|adenosine|adenosine
5648175|NCT00710255|exhaled breath condensate|exhaled breath condensate
5648176|NCT00710242|prolonged labor|prolonged labor
5648177|NCT00710229|age related macular degeneration|age related macular degeneration
5648178|NCT00710229|Ranibizumab-Lucentis|ranibizumab-lucentis
5648179|NCT00710229|Bevacizumab-Avastin|bevacizumab-avastin
5648180|NCT00710216|Viral kinetics|viral kinetics
5648181|NCT00710216|Viral dynamics|viral dynamics
5648182|NCT00710216|Telbivudine|telbivudine
5648183|NCT00710216|Lamivudine|lamivudine
5648184|NCT00710203|Dermatosis Papulosa Nigra|dermatosis papulosa nigra
5648185|NCT00710203|seborrheic keratoses|seborrheic keratoses
5648186|NCT00710190|Drug Resistant Hypertension|drug resistant hypertension
5648187|NCT00710190|Refractory Hypertension|refractory hypertension
5648188|NCT00710190|High Blood Pressure|high blood pressure
5648189|NCT00710190|Baroreflex Hypertension Therapy|baroreflex hypertension therapy
5648190|NCT00710177|PPHN|pphn
5648191|NCT00710177|PTGS1|ptgs1
5648192|NCT00710177|NSAID|nsaid
5648193|NCT00710151|neurotoxicity|neurotoxicity
5648194|NCT00710151|cognition in survivors|cognition in survivors
5648195|NCT00710151|diagnostic imaging|diagnostic imaging
5648196|NCT00710138|Cobalamin deficiency|cobalamin deficiency
5648197|NCT00710138|Infant|infant
5648198|NCT00710138|Nutrition|nutrition
5648199|NCT00710138|Cobalamin supplementation|cobalamin supplementation
5648200|NCT00710138|Neurodevelopment|neurodevelopment
5648201|NCT00710138|Neurological symptoms|neurological symptoms
5648203|NCT00710112|VLBW infants|vlbw infants
5648204|NCT00710112|Toll like Receptors|toll like receptors
5648205|NCT00710112|Biomarkers|biomarkers
5648206|NCT00710099|iontophoresis|iontophoresis
5648207|NCT00710099|cutaneous microcirculation|cutaneous microcirculation
5648208|NCT00710099|sildenafil|sildenafil
5648209|NCT00710099|Healthy volunteers|healthy volunteers
5648210|NCT00710086|Remifentanil|remifentanil
5648211|NCT00710086|Patient-controlled analgesia|patient-controlled analgesia
5648212|NCT00710086|Intravenous analgesia|intravenous analgesia
5648213|NCT00710073|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5648214|NCT00710073|Neuromodulation|neuromodulation
5648216|NCT00710060|Popular Opinion Leader|popular opinion leader
5648217|NCT00710060|POL|pol
5648218|NCT00710060|Behavioral Intervention|behavioral intervention
5648219|NCT00710060|STD|std
5648220|NCT00710060|STI|sti
5648221|NCT00710060|Community|community
5648222|NCT00710060|Prevention|prevention
5648223|NCT00710060|International|international
5648224|NCT00710060|Global|global
5648225|NCT00710047|ZD4054|zd4054
5648226|NCT00710047|Zibotentan|zibotentan
5648227|NCT00710047|Healthy Volunteers|healthy volunteers
5648228|NCT00710034|Oral Tobacco Products|oral tobacco products
5648229|NCT00710034|Snus|snus
5648230|NCT00710034|Smoking Substitution|smoking substitution
5648231|NCT00710034|Harm Reduction|harm reduction
5648232|NCT00710034|Biomarkers of Tobacco Exposure|biomarkers of tobacco exposure
5648233|NCT00710021|Systemic lupus erythematosus|systemic lupus erythematosus
5648234|NCT00710021|SLE|sle
5648235|NCT00710021|Vitamin D3|vitamin d3
5648236|NCT00710021|Vitamin D deficiency|vitamin d deficiency
5648237|NCT00710021|IFN alpha expression|ifn alpha expression
5648238|NCT00710008|type 2 diabetes,|type 2 diabetes,
5648239|NCT00710008|exercise training,|exercise training,
5648240|NCT00710008|ATP-synthesis,|atp-synthesis,
5648241|NCT00710008|intramyocellular lipids,|intramyocellular lipids,
5648242|NCT00710008|hepatocellular lipids|hepatocellular lipids
5648243|NCT00710008|first degree relatives of|first degree relatives of
5648244|NCT00710008|patients|patients
5648245|NCT00709982|Norgestimate|norgestimate
5648246|NCT00709982|Contraceptives, Oral|contraceptives, oral
5648247|NCT00709982|Ortho-Cyclen|ortho-cyclen
5648249|NCT00709982|Ethinyl Estradiol|ethinyl estradiol
5648250|NCT00709969|Malaria|malaria
5648251|NCT00709969|co-artemether|co-artemether
5648252|NCT00709969|auditory|auditory
5648253|NCT00709969|Plasmodium falciparum|plasmodium falciparum
5648254|NCT00709969|marsh fever|marsh fever
5648255|NCT00709969|remittent fever|remittent fever
5648256|NCT00709969|artemether|artemether
5648257|NCT00709969|artemisinins|artemisinins
5648258|NCT00709969|lumefantrine|lumefantrine
5648259|NCT00709969|child|child
5648260|NCT00709969|infant|infant
5648261|NCT00709969|Africa|africa
5648262|NCT00709956|Ventavis|ventavis
5648263|NCT00709956|iloprost|iloprost
5648264|NCT00709956|inhaled treatment|inhaled treatment
5648265|NCT00709956|pulmonary arterial hypertension|pulmonary arterial hypertension
5648269|NCT00709878|skin rash, lapatinib, cetuximab, erlotinib, panitumumab|skin rash, lapatinib, cetuximab, erlotinib, panitumumab
5648270|NCT00709865|renal insufficiency|renal insufficiency
5648271|NCT00709865|diuretic|diuretic
5648272|NCT00709865|congestive heart failure|congestive heart failure
5648273|NCT00709865|acute decompensated heart failure|acute decompensated heart failure
5641962|NCT00733083|child|child
5648274|NCT00709852|Patients referred for a contrast-enhanced MRI of the CNS|patients referred for a contrast-enhanced mri of the cns
5648275|NCT00709852|CNS Imaging|cns imaging
5648276|NCT00709839|glucocorticoid|glucocorticoid
5648277|NCT00709839|hydrocortisone|hydrocortisone
5648278|NCT00709839|carbohydrate metabolism|carbohydrate metabolism
5648279|NCT00709839|appetite-regulatory hormones|appetite-regulatory hormones
5648280|NCT00709813|Symptom management|symptom management
5648281|NCT00709813|Cancer|cancer
5648282|NCT00709813|Patient-centered care|patient-centered care
5648283|NCT00709800|Pandemic Influenza|pandemic influenza
5648284|NCT00709800|Avian Influenza|avian influenza
5648285|NCT00709800|DNA Vaccines|dna vaccines
5648286|NCT00709800|Antibody|antibody
5648287|NCT00709800|T Cells|t cells
5648288|NCT00709800|HA/NP/M2|ha/np/m2
5648289|NCT00709787|Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication|epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication
5648290|NCT00709761|Erbb2|erbb2
5648291|NCT00709761|ABRAXANE|abraxane
5648293|NCT00709761|first or second line therapy|first or second line therapy
5648294|NCT00709761|Metastatic Breast Cancer|metastatic breast cancer
5648295|NCT00709761|TYKERB|tykerb
5648296|NCT00709748|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5648297|NCT00709748|TENS|tens
5648298|NCT00709748|Empi|empi
5648299|NCT00709748|Electrotherapy|electrotherapy
5648300|NCT00709748|Back pain|back pain
5648301|NCT00709748|Lower back pain|lower back pain
5648408|NCT00709371|bupropion|bupropion
5648302|NCT00709748|Chronic lower back pain|chronic lower back pain
5648303|NCT00709735|stress disorders|stress disorders
5648304|NCT00709735|post-traumatic|post-traumatic
5648305|NCT00709735|memory|memory
5648306|NCT00709735|propranolol|propranolol
5648307|NCT00709735|psychophysiology|psychophysiology
5648308|NCT00709722|Lupus nephritis|lupus nephritis
5648309|NCT00709722|Deoxyspergualin|deoxyspergualin
5648310|NCT00709722|Immunosuppression|immunosuppression
5648311|NCT00709709|stenosis|stenosis
5648312|NCT00709709|coronaropathy|coronaropathy
5648313|NCT00709709|stent|stent
5648314|NCT00709709|bypass surgery|bypass surgery
5648315|NCT00709709|suspect|suspect
5648316|NCT00709709|known|known
5648317|NCT00709696|Tobacco|tobacco
5648318|NCT00709696|nicotine|nicotine
5648319|NCT00709696|smoking|smoking
5648320|NCT00709696|varenicline|varenicline
5648321|NCT00709696|human laboratory study|human laboratory study
5648322|NCT00709696|stress tolerance|stress tolerance
5648323|NCT00709696|startle response|startle response
5648324|NCT00709696|cognitive assessment|cognitive assessment
5648325|NCT00709696|progressive ratio|progressive ratio
5648326|NCT00709670|MSCT|msct
5648327|NCT00709670|Echocardiography|echocardiography
5648328|NCT00709670|Coronarography|coronarography
5648329|NCT00709670|Acute coronary syndrome without ST segment elevation|acute coronary syndrome without st segment elevation
5648330|NCT00709670|normal ECG|normal ecg
5648331|NCT00709670|normal troponin|normal troponin
5648332|NCT00709670|Acute|acute
5648333|NCT00709657|Age-related macular degeneration|age-related macular degeneration
5648334|NCT00709657|anti-VEGF|anti-vegf
5648335|NCT00709644|Ortho Tri-Cyclen Lo|ortho tri-cyclen lo
5648336|NCT00709644|Contraceptives, Oral|contraceptives, oral
5648337|NCT00709644|Norgestimate|norgestimate
5648338|NCT00709644|Ethinyl Estradiol|ethinyl estradiol
5648339|NCT00709644|Folic Acid|folic acid
5648340|NCT00709644|Female Contraception|female contraception
5648341|NCT00709631|Malignant transformation of leg ulcer|malignant transformation of leg ulcer
5648342|NCT00709631|MARJOLIN's ulcer|marjolin's ulcer
5648343|NCT00709631|Biopsy|biopsy
5648344|NCT00709631|Leg ulcer|leg ulcer
5648345|NCT00709631|Chronic wound|chronic wound
5648346|NCT00709631|Squamous cell carcinoma|squamous cell carcinoma
5648347|NCT00709631|Basal cell carcinoma|basal cell carcinoma
5648348|NCT00709618|Erbb2|erbb2
5648350|NCT00709618|First or Second line therapy|first or second line therapy
5648351|NCT00709618|Metastatic Breast Cancer|metastatic breast cancer
5648352|NCT00709618|Vinorelbine|vinorelbine
5648353|NCT00709618|Tykerb|tykerb
5648354|NCT00709605|HIV Negative|hiv negative
5648355|NCT00709605|Healthy|healthy
5648356|NCT00709605|Immunity|immunity
5648357|NCT00709605|Preventive|preventive
5648358|NCT00709605|Virus|virus
5648359|NCT00709605|Healthy Volunteer|healthy volunteer
5648360|NCT00709605|HV|hv
5648361|NCT00709592|total body irradiation|total body irradiation
5648362|NCT00709592|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
5648363|NCT00709592|thymoglobulin|thymoglobulin
5648364|NCT00709579|Patients needing an oral corticotherapy|patients needing an oral corticotherapy
5648365|NCT00709579|Patients needing a topical corticotherapy|patients needing a topical corticotherapy
5648366|NCT00709579|Corticotherapy|corticotherapy
5648367|NCT00709566|Hip|hip
5648368|NCT00709566|osteoarthritis|osteoarthritis
5648369|NCT00709566|exercise|exercise
5648370|NCT00709566|manual therapy|manual therapy
5648371|NCT00709553|ZD4054|zd4054
5648372|NCT00709553|Healthy Volunteers|healthy volunteers
5648373|NCT00709527|AMD|amd
5648375|NCT00709514|DCB-WH1|dcb-wh1
5648376|NCT00709514|DCB-WH1-CP001|dcb-wh1-cp001
5648377|NCT00709514|chronic|chronic
5648378|NCT00709514|diabetic|diabetic
5648379|NCT00709514|foot ulcers|foot ulcers
5648380|NCT00709514|topical ointment|topical ointment
5648381|NCT00709501|weight loss|weight loss
5648382|NCT00709501|obesity|obesity
5648383|NCT00709501|overweight|overweight
5648384|NCT00709488|Litx™ BPH System|litx™ bph system
5648385|NCT00709488|LS11|ls11
5648386|NCT00709488|Talaporfin sodium|talaporfin sodium
5648387|NCT00709462|Breast cancer|breast cancer
5648388|NCT00709462|Colorectal cancer|colorectal cancer
5648389|NCT00709462|Pancreatic cancer|pancreatic cancer
5648390|NCT00709462|Bladder cancer|bladder cancer
5648391|NCT00709462|Ovarian cancer|ovarian cancer
5648392|NCT00709462|Metastatic cancer|metastatic cancer
5648393|NCT00709462|Locally advanced cancer|locally advanced cancer
5648394|NCT00709462|Cancer Vaccine|cancer vaccine
5648396|NCT00709449|Age-related macular degeneration|age-related macular degeneration
5648397|NCT00709449|Glaucoma|glaucoma
5648398|NCT00709436|orthopedic|orthopedic
5648399|NCT00709436|ketamine|ketamine
5648400|NCT00709436|pain|pain
5648401|NCT00709410|Cholera, Diarrhea, Vaccination, Vaccines|cholera, diarrhea, vaccination, vaccines
5648402|NCT00709397|HIV-1|hiv-1
5648403|NCT00709397|drug resistance|drug resistance
5648404|NCT00709397|raltegravir|raltegravir
5648405|NCT00709397|integrase inhibitor|integrase inhibitor
5648406|NCT00709371|obesity|obesity
5648407|NCT00709371|zonisamide|zonisamide
5648409|NCT00709358|bacteria|bacteria
5648410|NCT00709358|fungi|fungi
5648411|NCT00709358|real time PCR|real time pcr
5648412|NCT00709358|adequate antimicrobial therapy|adequate antimicrobial therapy
5648413|NCT00709358|microbial DNA|microbial dna
5648414|NCT00709358|microbial diagnosis|microbial diagnosis
5648415|NCT00709345|Antipsychotic Medications|antipsychotic medications
5648416|NCT00709345|Behavioral Interventions|behavioral interventions
5648417|NCT00709332|Norgestimate|norgestimate
5648418|NCT00709332|Folic Acid|folic acid
5648419|NCT00709332|Ortho-Cyclen|ortho-cyclen
5648420|NCT00709332|Female contraception|female contraception
5648421|NCT00709332|Ethinyl Estradiol|ethinyl estradiol
5648422|NCT00709332|Drug Interactions|drug interactions
5648423|NCT00709332|Pharmacokinetics|pharmacokinetics
5648424|NCT00709332|Contraceptives, Oral|contraceptives, oral
5648425|NCT00709319|Diabetic retinopathy|diabetic retinopathy
5648426|NCT00709319|Diabetic macular edema|diabetic macular edema
5648427|NCT00709319|dme|dme
5648428|NCT00709319|vitrectomy|vitrectomy
5648429|NCT00709293|Ischemia Reperfusion Injury|ischemia reperfusion injury
5648430|NCT00709293|Pediatric Heart Transplant|pediatric heart transplant
5648431|NCT00709293|ATG|atg
5648432|NCT00709293|Induction Therapy|induction therapy
5648433|NCT00709280|Cystic Fibrosis|cystic fibrosis
5648434|NCT00709280|hypertonic saline|hypertonic saline
5648435|NCT00709280|inhaled saline|inhaled saline
5648436|NCT00709267|Folic Acid|folic acid
5648437|NCT00709267|Chemistry, Analytical|chemistry, analytical
5648438|NCT00709267|Administration, Oral|administration, oral
5648439|NCT00709267|Infusions, Intravenous|infusions, intravenous
5648440|NCT00709267|Biological Availability|biological availability
5648441|NCT00709267|Safety|safety
5648442|NCT00709254|AeroLEF|aerolef
5648443|NCT00709254|fentanyl|fentanyl
5648444|NCT00709254|pharmacokinetics|pharmacokinetics
5648445|NCT00709254|liposome|liposome
5648446|NCT00709254|encapsulated|encapsulated
5648447|NCT00709241|Heart failure|heart failure
5648448|NCT00709241|Psychosocial factors|psychosocial factors
5648449|NCT00709241|Depression|depression
5648450|NCT00709241|Patient compliance|patient compliance
5648451|NCT00709215|refractory TdT-positive leukemia|refractory tdt-positive leukemia
5648452|NCT00709215|ALL|all
5648453|NCT00709215|AML|aml
5648454|NCT00709215|blastic CML|blastic cml
5648455|NCT00709189|Pharmacokinetics|pharmacokinetics
5648456|NCT00709189|Ethinyl Estradiol|ethinyl estradiol
5648457|NCT00709189|Drug Interactions|drug interactions
5648458|NCT00709189|Norgestimate|norgestimate
5648459|NCT00709189|Contraceptives, Oral|contraceptives, oral
5648460|NCT00709189|Ortho-Cyclen|ortho-cyclen
5648461|NCT00709189|Folic Acid|folic acid
5648462|NCT00709176|Quality of Life|quality of life
5648463|NCT00709176|Randomized Clinical Trial|randomized clinical trial
5648464|NCT00709176|Advanced Cancer|advanced cancer
5648465|NCT00709176|Breast Cancer|breast cancer
5648467|NCT00709176|Lung Cancer|lung cancer
5648468|NCT00709176|Prostate Cancer|prostate cancer
5648469|NCT00709176|Family caregiver|family caregiver
5648470|NCT00709176|cancer survivorship|cancer survivorship
5648471|NCT00709176|coping|coping
5648472|NCT00709176|communication|communication
5648473|NCT00709176|uncertainty|uncertainty
5648474|NCT00709176|support|support
5648475|NCT00709176|depression|depression
5648476|NCT00709176|self-efficacy|self-efficacy
5648477|NCT00709176|benefits of illness|benefits of illness
5648478|NCT00709176|Caregivers|caregivers
5648479|NCT00709163|Pediatric|pediatric
5648480|NCT00709163|Dilated Cardiomyopathy|dilated cardiomyopathy
5648481|NCT00709163|Nesiritide|nesiritide
5648482|NCT00709150|Major Depression|major depression
5648483|NCT00709150|Diabetes|diabetes
5648484|NCT00709150|Hispanics|hispanics
5648485|NCT00709150|Collaborative Depression Care Management|collaborative depression care management
5648486|NCT00709137|resistant hypertensions|resistant hypertensions
5648487|NCT00709137|spironolactone|spironolactone
5648488|NCT00709137|amiloride|amiloride
5648489|NCT00709137|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5648490|NCT00709124|Respiration, Artificial|respiration, artificial
5648491|NCT00709124|Critical Illness|critical illness
5648492|NCT00709124|Intensive Care Units|intensive care units
5648493|NCT00709124|Electric Stimulation Therapy|electric stimulation therapy
5648494|NCT00709124|Muscle Weakness|muscle weakness
5648495|NCT00709124|Paresis|paresis
5648496|NCT00709124|Mechanically|mechanically
5648497|NCT00709124|Ventilated|ventilated
5648498|NCT00709124|Patients|patients
5648499|NCT00709124|Admitted|admitted
5648500|NCT00709124|Medical|medical
5648501|NCT00709111|CCR5 antagonist|ccr5 antagonist
5648502|NCT00709111|CD4 T-cell count|cd4 t-cell count
5648503|NCT00709111|immune activation|immune activation
5648504|NCT00709111|treatment experienced|treatment experienced
5648505|NCT00709098|pulmonary arterial hypertension|pulmonary arterial hypertension
5648506|NCT00709098|inhaled treatment|inhaled treatment
5648507|NCT00709098|inhalation solution|inhalation solution
5648508|NCT00709098|iloprost|iloprost
5648509|NCT00709098|Ventavis|ventavis
5648510|NCT00709085|single nucleotide polymorphism|single nucleotide polymorphism
5648511|NCT00709072|stuttering|stuttering
5648512|NCT00709072|relapse|relapse
5648513|NCT00709072|Lidcombe Program|lidcombe program
5648514|NCT00709072|Preschool children|preschool children
5648515|NCT00709059|hepatitis C|hepatitis c
5648516|NCT00709046|Endoscopic treatment|endoscopic treatment
5648517|NCT00709046|Peptic ulcer|peptic ulcer
5648518|NCT00709046|Bleeding|bleeding
5648519|NCT00709046|Thermocoagulation|thermocoagulation
5648520|NCT00709046|Proton pump inhibitors|proton pump inhibitors
5648521|NCT00709033|refractory|refractory
5648522|NCT00709033|relapsed|relapsed
5648524|NCT00709033|intermediate-grade|intermediate-grade
5648525|NCT00709033|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5648526|NCT00709033|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5648527|NCT00709020|cancer survivor|cancer survivor
5648528|NCT00709020|breast cancer|breast cancer
5648529|NCT00708981|Diabetic Nephropathy|diabetic nephropathy
5648530|NCT00708968|randomized clinical trial|randomized clinical trial
5648532|NCT00708968|quality of life|quality of life
5648533|NCT00708968|family|family
5648534|NCT00708968|family caregiver|family caregiver
5648535|NCT00708968|cancer survivorship|cancer survivorship
5648536|NCT00708968|communication|communication
5648537|NCT00708968|uncertainty|uncertainty
5648538|NCT00708968|support|support
5648539|NCT00708968|family education|family education
5648540|NCT00708968|Caregivers|caregivers
5648541|NCT00708955|Evaluation and Treatment|evaluation and treatment
5648542|NCT00708955|Eye Diseases|eye diseases
5648543|NCT00708942|Cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5648544|NCT00708929|Age-related macular degeneration|age-related macular degeneration
5648545|NCT00708929|Complement factor H|complement factor h
5648546|NCT00708929|Choroidal blood flow|choroidal blood flow
5648547|NCT00708916|Cutaneous lupus|cutaneous lupus
5648548|NCT00708916|Intervention|intervention
5648549|NCT00708916|Discoid lupus|discoid lupus
5648550|NCT00708916|Phosphodiesterase 5 inhibitor|phosphodiesterase 5 inhibitor
5648551|NCT00708903|Thorough QTc study|thorough qtc study
5648552|NCT00708890|Substance use disorders|substance use disorders
5648553|NCT00708890|Self-help groups|self-help groups
5648554|NCT00708890|Twelve Step groups|twelve step groups
5648555|NCT00708877|cancer|cancer
5648556|NCT00708877|cholangiocarcinoma|cholangiocarcinoma
5648557|NCT00708851|psoriasis|psoriasis
5648558|NCT00708812|Non-small Cell Lung Cancer|non-small cell lung cancer
5648559|NCT00708812|Endostar|endostar
5648560|NCT00708812|Paclitaxel|paclitaxel
5648561|NCT00708812|Carboplatin|carboplatin
5648562|NCT00708760|web based learning|web based learning
5648563|NCT00708760|moderate sedation|moderate sedation
5648564|NCT00708747|Immunoglobulins|immunoglobulins
5648565|NCT00708747|inhibitor proteins|inhibitor proteins
5648566|NCT00708747|human albumin|human albumin
5648573|NCT00708721|myelodysplastic syndromes|myelodysplastic syndromes
5648574|NCT00708708|Plaque-type psoriasis|plaque-type psoriasis
5648575|NCT00708695|nurse|nurse
5648576|NCT00708695|home visits|home visits
5648577|NCT00708695|pregnancy|pregnancy
5648578|NCT00708695|welfare|welfare
5648579|NCT00708695|child development|child development
5648580|NCT00708695|Child Rearing|child rearing
5648581|NCT00708695|Reproductive Behavior|reproductive behavior
5648582|NCT00708695|Risk Reduction Behavior|risk reduction behavior
5648584|NCT00708656|Colitis|colitis
5648585|NCT00708656|UC|uc
5648586|NCT00708630|yellow fever vaccine|yellow fever vaccine
5648587|NCT00708630|patient information|patient information
5648588|NCT00708630|symptom reports|symptom reports
5648595|NCT00708604|Diabetes Mellitus|diabetes mellitus
5648596|NCT00708604|Kidney Transplantation|kidney transplantation
5648597|NCT00708604|Islet Transplantation|islet transplantation
5648598|NCT00708604|Sirolimus/Tacrolimus/MMF-based Immunosuppressive Regimen|sirolimus/tacrolimus/mmf-based immunosuppressive regimen
5648599|NCT00708565|To study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude|to study the effects of iloprost on hypoxic pulmonary vasoconstriction at high altitude
5648600|NCT00708552|Alzheimer's disease|alzheimer's disease
5648601|NCT00708552|Cognition|cognition
5648602|NCT00708552|SB-742457|sb-742457
5648603|NCT00708526|hypercapnia|hypercapnia
5648604|NCT00708526|hyperpnoea|hyperpnoea
5648605|NCT00708526|accelerated recovery|accelerated recovery
5648606|NCT00708513|Cell Saver|cell saver
5648607|NCT00708513|Liver Tumors|liver tumors
5648608|NCT00708513|Liver Cancer|liver cancer
5649005|NCT00706836|Lyrica|lyrica
5648609|NCT00708513|Surgical Oncology|surgical oncology
5648610|NCT00708513|Whipple|whipple
5648611|NCT00708513|Blood Transfusion|blood transfusion
5648612|NCT00708513|Blood salvage|blood salvage
5648613|NCT00708513|cancer surgery|cancer surgery
5648614|NCT00708513|blood loss|blood loss
5648615|NCT00708500|Treatment failure|treatment failure
5648616|NCT00708487|in vitro fertilization|in vitro fertilization
5648617|NCT00708487|oxygen concentration|oxygen concentration
5648618|NCT00708487|blastocyst|blastocyst
5648619|NCT00708487|live birth|live birth
5648620|NCT00708487|embryo|embryo
5648621|NCT00708474|Bone graft|bone graft
5648622|NCT00708474|Bone void filler|bone void filler
5648623|NCT00708474|Bone plug|bone plug
5648624|NCT00708474|OsseoFit™|osseofit™
5648625|NCT00708474|knee|knee
5648626|NCT00708474|bone graft sites in the knee|bone graft sites in the knee
5648627|NCT00708461|obesity|obesity
5648628|NCT00708461|obesity prevention|obesity prevention
5648629|NCT00708461|worksite|worksite
5648630|NCT00708461|environment|environment
5648631|NCT00708461|intervention|intervention
5648632|NCT00708448|NSCLC|nsclc
5648633|NCT00708435|Anticoagulant reversal|anticoagulant reversal
5648634|NCT00708435|Prothrombin|prothrombin
5648635|NCT00708435|Complex|complex
5648636|NCT00708435|Concentrate|concentrate
5648637|NCT00708435|Coagulopathy|coagulopathy
5648638|NCT00708435|induced by|induced by
5648639|NCT00708435|coumarin|coumarin
5648640|NCT00708435|derivatives|derivatives
5648641|NCT00708435|Kcentra|kcentra
5648642|NCT00708422|Ocular surface health|ocular surface health
5648643|NCT00708422|OSDI|osdi
5648644|NCT00708422|TFBUT|tfbut
5648645|NCT00708422|Glaucoma|glaucoma
5648646|NCT00708422|Ocular hypertension|ocular hypertension
5648647|NCT00708422|Corneal staining|corneal staining
5648648|NCT00708409|Ross operation|ross operation
5648649|NCT00708409|autograft procedure|autograft procedure
5648650|NCT00708409|pulmonary homograft|pulmonary homograft
5648651|NCT00708409|root replacement technique|root replacement technique
5648652|NCT00708409|subcoronary implantation technique|subcoronary implantation technique
5648653|NCT00708396|Patients|patients
5648654|NCT00708396|suffer|suffer
5648655|NCT00708396|from|from
5648656|NCT00708383|embryo development|embryo development
5648657|NCT00708383|embryo quality|embryo quality
5648658|NCT00708383|implantation|implantation
5648659|NCT00708383|IVF/ICSI outcome|ivf/icsi outcome
5648660|NCT00708383|multiple pregnancy|multiple pregnancy
5648661|NCT00708370|Interventional|interventional
5648662|NCT00708370|Non-drug|non-drug
5648663|NCT00708370|Disease Management Program|disease management program
5648664|NCT00708370|Cardiovascular Risk Control|cardiovascular risk control
5648665|NCT00708370|Dyslipidemias|dyslipidemias
5648666|NCT00708370|Primary Care Centers|primary care centers
5648667|NCT00708357|eNOS Gene Polymorphism|enos gene polymorphism
5648668|NCT00708357|ocular blood flow|ocular blood flow
5648669|NCT00708331|Cataract|cataract
5648670|NCT00708331|Extraction|extraction
5648671|NCT00708331|Intraocular Lens|intraocular lens
5648672|NCT00708331|Hydrophilic Acrylic|hydrophilic acrylic
5648674|NCT00708318|fentanyl|fentanyl
5648675|NCT00708318|pharmacokinetic|pharmacokinetic
5648676|NCT00708318|liposome|liposome
5648677|NCT00708318|encapsulated|encapsulated
5648678|NCT00708305|toothpaste|toothpaste
5648679|NCT00708305|plaque fluid|plaque fluid
5648680|NCT00708305|fluoride|fluoride
5648681|NCT00708292|AUY922|auy922
5648682|NCT00708292|Multiple Myeloma|multiple myeloma
5648683|NCT00708292|HSP90 inhibitors|hsp90 inhibitors
5648684|NCT00708292|Phase I/II|phase i/ii
5648685|NCT00708279|angina pectoris, osteopathic manipulation|angina pectoris, osteopathic manipulation
5648686|NCT00708266|Obesity|obesity
5648687|NCT00708266|Diabetes|diabetes
5648688|NCT00708266|Non-esterified fatty acids|non-esterified fatty acids
5648689|NCT00708266|Cytokines|cytokines
5648690|NCT00708266|Inflammation|inflammation
5648691|NCT00708266|Subcutaneous fat|subcutaneous fat
5648692|NCT00708266|Adipose tissue|adipose tissue
5648693|NCT00708253|balloon assisted enteroscopy|balloon assisted enteroscopy
5648694|NCT00708253|single balloon enteroscopy|single balloon enteroscopy
5648695|NCT00708253|double balloon enteroscopy|double balloon enteroscopy
5648696|NCT00708253|insertion depth|insertion depth
5648697|NCT00708227|Asthma|asthma
5648698|NCT00708227|Pharmacogenetics|pharmacogenetics
5648699|NCT00708227|Salmeterol|salmeterol
5648700|NCT00708227|African American|african american
5648701|NCT00708227|White|white
5648702|NCT00708201|ileus|ileus
5648704|NCT00708188|Stroke, ischemic, etiology, TOAST, CT, multidetector|stroke, ischemic, etiology, toast, ct, multidetector
5648705|NCT00708175|Glucose Metabolism Disorder|glucose metabolism disorder
5648706|NCT00708175|Dysmetabolic Syndrome|dysmetabolic syndrome
5648707|NCT00708175|Type II Diabetes|type ii diabetes
5648708|NCT00708175|Diabetes Mellitus|diabetes mellitus
5648709|NCT00708175|Lipoatrophic|lipoatrophic
5648710|NCT00708175|Postmenopausal|postmenopausal
5648711|NCT00708162|HIV|hiv
5648712|NCT00708162|HIV I|hiv i
5648713|NCT00708162|Treatment Experienced|treatment experienced
5648714|NCT00708149|lansoprazole, weaning,stress ulcer prophylaxis|lansoprazole, weaning,stress ulcer prophylaxis
5648715|NCT00708136|Falls|falls
5648716|NCT00708136|elderly|elderly
5648717|NCT00708136|Balance|balance
5648718|NCT00708136|speed of stepping|speed of stepping
5648719|NCT00708136|Stability|stability
5648720|NCT00708136|ELDERLY FALLERS|elderly fallers
5648721|NCT00708123|remineralization|remineralization
5648722|NCT00708123|enamel|enamel
5648723|NCT00708123|fluoride|fluoride
5648724|NCT00708123|caries|caries
5648725|NCT00708123|in situ|in situ
5648726|NCT00708110|dose-ranging study|dose-ranging study
5648727|NCT00708110|phase IIa|phase iia
5648728|NCT00708110|integrase inhibitor|integrase inhibitor
5648729|NCT00708110|HIV-1 infection|hiv-1 infection
5648730|NCT00708097|fluoride|fluoride
5648731|NCT00708097|in situ|in situ
5648732|NCT00708097|remineralization|remineralization
5648733|NCT00708097|enamel|enamel
5648734|NCT00708097|caries|caries
5648735|NCT00708084|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
5648736|NCT00708084|Monoclonal antibody|monoclonal antibody
5648737|NCT00708058|Implanted cardiac defibrillators|implanted cardiac defibrillators
5648738|NCT00708058|Congestive Heart Failure|congestive heart failure
5648739|NCT00708058|Emergency Department|emergency department
5648740|NCT00708045|Breast Cancer|breast cancer
5648741|NCT00708019|cancer pain|cancer pain
5648742|NCT00708019|bone metastasis|bone metastasis
5648743|NCT00708019|psychoeducational intervention|psychoeducational intervention
5648744|NCT00708019|nurse coaching|nurse coaching
5648745|NCT00708019|patient education|patient education
5648746|NCT00708019|breast cancer|breast cancer
5648747|NCT00707993|Glucose Metabolism Disorder|glucose metabolism disorder
5648748|NCT00707993|Dysmetabolic Syndrome|dysmetabolic syndrome
5648749|NCT00707993|Type II Diabetes|type ii diabetes
5648750|NCT00707993|Diabetes Mellitus|diabetes mellitus
5648751|NCT00707993|Lipoatrophic|lipoatrophic
5648752|NCT00707993|Dyslipidemia|dyslipidemia
5648753|NCT00707993|Drug Therapy|drug therapy
5648754|NCT00707980|Major Depressive Disorder|major depressive disorder
5648755|NCT00707980|Depression|depression
5648756|NCT00707980|Melancholia|melancholia
5648757|NCT00707980|Mood Disorder|mood disorder
5648758|NCT00707980|Dysthymic Disorder|dysthymic disorder
5648759|NCT00707980|Drug Therapy|drug therapy
5648760|NCT00707967|Tuberculosis vaccine|tuberculosis vaccine
5648761|NCT00707954|Diabetes|diabetes
5648762|NCT00707954|TA-7284|ta-7284
5648763|NCT00707941|Influenza like illness|influenza like illness
5648765|NCT00707941|Bronchiolitis|bronchiolitis
5648766|NCT00707941|Upper respiratory tract illness|upper respiratory tract illness
5648767|NCT00707941|Otitis media|otitis media
5648768|NCT00707941|Viral shedding|viral shedding
5648769|NCT00707941|Nasopharyngeal wash|nasopharyngeal wash
5648770|NCT00707941|Viral culture|viral culture
5648772|NCT00707928|retained placenta|retained placenta
5648773|NCT00707915|aged|aged
5648774|NCT00707915|benzodiazepines|benzodiazepines
5648775|NCT00707915|hypnotics|hypnotics
5648776|NCT00707915|cognition|cognition
5648778|NCT00707902|Sore throats,|sore throats,
5648779|NCT00707902|Pharyngitis|pharyngitis
5648780|NCT00707902|Acute|acute
5648781|NCT00707876|Peripheral arterial disease (PAD); Magnetic Resonance Angiography (MRA); Magnetic Resonance Imaging (MRI), imaging agent or biomarker|peripheral arterial disease (pad); magnetic resonance angiography (mra); magnetic resonance imaging (mri), imaging agent or biomarker
5648782|NCT00707863|Escitalopram|escitalopram
5648783|NCT00707863|Lexapro|lexapro
5648784|NCT00707863|fMRI|fmri
5648785|NCT00707863|pictures|pictures
5648786|NCT00707850|Hepatitis C|hepatitis c
5648788|NCT00707850|Pegasys|pegasys
5648789|NCT00707850|Ribavirin|ribavirin
5648790|NCT00707824|pruritus|pruritus
5648791|NCT00707824|epidural morphine|epidural morphine
5648792|NCT00707811|Dyspnea|dyspnea
5648793|NCT00707811|Shortness of Breath|shortness of breath
5648794|NCT00707811|Trouble Breathing|trouble breathing
5648795|NCT00707811|ST2|st2
5648796|NCT00707811|IL-33|il-33
5648797|NCT00707798|Young adults|young adults
5648798|NCT00707798|Pneumococcal vaccine,|pneumococcal vaccine,
5648799|NCT00707798|Streptococcus pneumoniae,|streptococcus pneumoniae,
5648800|NCT00707785|vitamin A|vitamin a
5648801|NCT00707785|Treatment|treatment
5648802|NCT00707785|neonates|neonates
5648803|NCT00707785|newborn|newborn
5648804|NCT00707785|sepsis|sepsis
5648805|NCT00707785|necrotizing enterocolitis|necrotizing enterocolitis
5648806|NCT00707785|meningitis|meningitis
5648807|NCT00707785|pneumonia|pneumonia
5648808|NCT00707772|Hepatitis C|hepatitis c
5648809|NCT00707772|Hemophilia|hemophilia
5648810|NCT00707772|Pegasys|pegasys
5648811|NCT00707772|Ribavirin|ribavirin
5648812|NCT00707759|Pediatric renal transplantation,Bone metabolism (DXA-pQCT)|pediatric renal transplantation,bone metabolism (dxa-pqct)
5648813|NCT00707759|mRNAFOXP3/IL-17,Steroid withdrawal|mrnafoxp3/il-17,steroid withdrawal
5648814|NCT00707746|statin intolerant|statin intolerant
5648815|NCT00707746|hypercholesterolemia|hypercholesterolemia
5649205|NCT00705900|psoriasis|psoriasis
5648816|NCT00707707|breast cancer|breast cancer
5648817|NCT00707707|triple negative|triple negative
5648818|NCT00707707|metastatic|metastatic
5648819|NCT00707694|95 years of age and older|95 years of age and older
5648820|NCT00707681|microbio, MS-20, Hepatoma, Advanced Hepatocellular Carcinoma|microbio, ms-20, hepatoma, advanced hepatocellular carcinoma
5648821|NCT00707668|Diabetes|diabetes
5648822|NCT00707668|metabolic syndrome|metabolic syndrome
5648823|NCT00707668|dyslipidemia|dyslipidemia
5648824|NCT00707668|osteoporosis|osteoporosis
5648825|NCT00707642|West Nile Virus|west nile virus
5648826|NCT00707642|West Nile Vaccine|west nile vaccine
5648827|NCT00707642|West Nile virus disease|west nile virus disease
5648828|NCT00707642|Hawaii Biotech|hawaii biotech
5648829|NCT00707629|type 1 diabetes|type 1 diabetes
5648830|NCT00707629|neurocognitive measures|neurocognitive measures
5648831|NCT00707629|behavioral measures|behavioral measures
5648832|NCT00707603|Insulin resistance|insulin resistance
5648833|NCT00707603|Liver fat|liver fat
5648834|NCT00707603|Muscle fat|muscle fat
5648835|NCT00707603|Abdominal fat|abdominal fat
5648836|NCT00707603|Cytokines|cytokines
5648837|NCT00707577|Worksite Wellness|worksite wellness
5648838|NCT00707577|Weight loss and maintenance|weight loss and maintenance
5648839|NCT00707577|Physical Activity|physical activity
5648840|NCT00707577|Health and Fitness interventions|health and fitness interventions
5648841|NCT00707577|Healthy eating|healthy eating
5648842|NCT00707577|Weight loss|weight loss
5648843|NCT00707577|Maintenance programs|maintenance programs
5648844|NCT00707564|hemostasis|hemostasis
5648845|NCT00707564|tooth extractions|tooth extractions
5648846|NCT00707551|AZD1305|azd1305
5648847|NCT00707551|Verapamil|verapamil
5648848|NCT00707551|Ketoconazole|ketoconazole
5648849|NCT00707551|pharmacokinetics|pharmacokinetics
5648850|NCT00707525|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis|aneuploidies, natural cycle, stimulated cycle, preimplantation genetic diagnosis
5648851|NCT00707486|Hemostasis, tooth extractions, third molar|hemostasis, tooth extractions, third molar
5648852|NCT00707460|Diabetes|diabetes
5648853|NCT00707460|Cardiovascular|cardiovascular
5648854|NCT00707460|Obesity|obesity
5648855|NCT00707460|First.Nation|first.nation
5648856|NCT00707460|Aboriginal (Health)|aboriginal (health)
5648857|NCT00707460|Dietary|dietary
5648858|NCT00707460|Intervention|intervention
5648859|NCT00707460|Nutrition|nutrition
5648860|NCT00707460|Traditional (Diet)|traditional (diet)
5648862|NCT00707460|(High) protein|(high) protein
5648863|NCT00707460|(High) fibre (er)|(high) fibre (er)
5648864|NCT00707460|(Low) carbohydrate|(low) carbohydrate
5648865|NCT00707447|diabetes-prevention|diabetes-prevention
5648866|NCT00707447|lifestyle modification|lifestyle modification
5648867|NCT00707447|behavior therapy|behavior therapy
5648868|NCT00707447|self-management|self-management
5648869|NCT00707434|Continuous Glucose Monitor|continuous glucose monitor
5648870|NCT00707434|Medtronic Guardian|medtronic guardian
5648871|NCT00707434|Guardian® blood-sugar monitoring device|guardian® blood-sugar monitoring device
5648872|NCT00707434|Glucose Monitoring|glucose monitoring
5648873|NCT00707434|Critically Ill|critically ill
5648875|NCT00707434|Intensive Care Unit|intensive care unit
5648876|NCT00707434|Glycemic Excursions|glycemic excursions
5648877|NCT00707434|Glucose Control|glucose control
5648878|NCT00707434|Glucose Testing|glucose testing
5648879|NCT00707434|Hyperglycemia|hyperglycemia
5648880|NCT00707434|Hypoglycemia|hypoglycemia
5648881|NCT00707434|Insulin Infusion|insulin infusion
5648882|NCT00707382|Pharmacogenetics|pharmacogenetics
5648883|NCT00707382|Compliance|compliance
5648884|NCT00707382|Antipsychotic drugs|antipsychotic drugs
5648885|NCT00707382|Schizophrenia|schizophrenia
5648886|NCT00707369|Periodontitis|periodontitis
5648887|NCT00707369|Mechanical Debridement|mechanical debridement
5648888|NCT00707369|Antibiotics|antibiotics
5648889|NCT00707369|Attachment loss|attachment loss
5648890|NCT00707369|Randomized controlled trial|randomized controlled trial
5648891|NCT00707356|Prostatic disease|prostatic disease
5648892|NCT00707356|genital neoplasm, male|genital neoplasm, male
5648893|NCT00707356|Urogenital neoplasm|urogenital neoplasm
5648894|NCT00707356|Genital disease|genital disease
5648896|NCT00707356|Male urogenital disease|male urogenital disease
5648897|NCT00707356|Neoplasms|neoplasms
5648898|NCT00707356|Neoplasm by site|neoplasm by site
5648899|NCT00707356|prostatic neoplasm|prostatic neoplasm
5648900|NCT00707356|Carcinoma|carcinoma
5648901|NCT00707330|oxidative stress|oxidative stress
5648902|NCT00707330|8-oxo-deoxyguanine|8-oxo-deoxyguanine
5648904|NCT00707330|clarithromycin|clarithromycin
5648905|NCT00707330|malondialdehyde|malondialdehyde
5648907|NCT00707330|vitamine C|vitamine c
5648908|NCT00707330|ascorbic acid|ascorbic acid
5648909|NCT00707317|M. tuberculosis|m. tuberculosis
5648910|NCT00707317|latent tuberculosis infection|latent tuberculosis infection
5648911|NCT00707317|Quantiferon assay|quantiferon assay
5648912|NCT00707317|ELISPOT assay|elispot assay
5648913|NCT00707317|tuberculin skin test|tuberculin skin test
5648914|NCT00707317|immunocompromised patients|immunocompromised patients
5648915|NCT00707304|Non Small Cell Lung Cancer|non small cell lung cancer
5648916|NCT00707304|Talactoferrin|talactoferrin
5648917|NCT00707304|Dendritic Cell Recruiter and Activator|dendritic cell recruiter and activator
5648918|NCT00707304|Immunomodulatory agent|immunomodulatory agent
5648919|NCT00707291|contact lens|contact lens
5648920|NCT00707291|normal|normal
5648921|NCT00707252|Non-small cell lung cancer|non-small cell lung cancer
5648922|NCT00707252|Erlotinib|erlotinib
5648923|NCT00707252|Polyphenon E|polyphenon e
5648924|NCT00707252|Tarceva|tarceva
5648925|NCT00707252|Advanced Non-small Cell Lung Cancer Stage IIIb or IV|advanced non-small cell lung cancer stage iiib or iv
5648926|NCT00707239|Hospital-acquired pneumonia|hospital-acquired pneumonia
5648927|NCT00707239|Ventilator-associated pneumonia|ventilator-associated pneumonia
5648928|NCT00707226|Laser Doppler flowmetry|laser doppler flowmetry
5648929|NCT00707226|Choroidal blood flow|choroidal blood flow
5648930|NCT00707226|Fundus pulsation amplitude|fundus pulsation amplitude
5648931|NCT00707226|Intraocular Pressure|intraocular pressure
5648932|NCT00707200|severe malarial anemia (SMA)|severe malarial anemia (sma)
5648933|NCT00707200|cerebral malarial (CM)|cerebral malarial (cm)
5648934|NCT00707200|lactic acidosis|lactic acidosis
5648935|NCT00707200|hyperparasitemia|hyperparasitemia
5648936|NCT00707200|respiratory distress|respiratory distress
5648937|NCT00707200|hypoxia|hypoxia
5648938|NCT00707200|death|death
5648939|NCT00707200|transfusion|transfusion
5648940|NCT00707187|systemic sclerosis|systemic sclerosis
5648941|NCT00707187|scleroderma|scleroderma
5648942|NCT00707187|raynaud phenomenon|raynaud phenomenon
5648943|NCT00707174|Lentigo Maligna|lentigo maligna
5648944|NCT00707148|pertussis, diptheria, tetanus, vaccine, Tdap|pertussis, diptheria, tetanus, vaccine, tdap
5648945|NCT00707122|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill|serum albumin, severe sepsis, septic shock, fluid therapy, hypoalbuminemia, critically ill
5648946|NCT00707083|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5648947|NCT00707083|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5648948|NCT00707083|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5648949|NCT00707083|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5648950|NCT00707070|psoriasis|psoriasis
5648951|NCT00707070|acitretin|acitretin
5648952|NCT00707070|efalizumab|efalizumab
5648953|NCT00707031|hyperglycemia, GLP-1, metformin|hyperglycemia, glp-1, metformin
5648954|NCT00707005|antibiotic susceptibility|antibiotic susceptibility
5648955|NCT00707005|bacterial flora|bacterial flora
5648956|NCT00707005|fluoroquinolone|fluoroquinolone
5648957|NCT00707005|LASIK|lasik
5648958|NCT00707005|refractive surgery|refractive surgery
5648959|NCT00706992|MART-1 Peptide|mart-1 peptide
5648960|NCT00706992|Melanoma|melanoma
5648961|NCT00706992|Adjuvant Therapy|adjuvant therapy
5648962|NCT00706992|Gene Therapy|gene therapy
5648963|NCT00706992|T Cell Persistence|t cell persistence
5648964|NCT00706979|smoking|smoking
5648965|NCT00706979|smoking cessation|smoking cessation
5648966|NCT00706979|nicotine replacement therapy|nicotine replacement therapy
5648967|NCT00706966|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5648968|NCT00706966|stage IIB prostate cancer|stage iib prostate cancer
5648969|NCT00706966|stage IIA prostate cancer|stage iia prostate cancer
5648970|NCT00706966|benign prostatic hyperplasia|benign prostatic hyperplasia
5648971|NCT00706953|pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5648972|NCT00706953|VELCADE|velcade
5648973|NCT00706953|DOXIL|doxil
5648974|NCT00706953|relapsed|relapsed
5648975|NCT00706953|Multiple Myeloma|multiple myeloma
5648976|NCT00706940|dry eye|dry eye
5648977|NCT00706940|Optical coherence tomography|optical coherence tomography
5648978|NCT00706927|xalacom|xalacom
5648979|NCT00706927|combigan|combigan
5648980|NCT00706927|ocular blood flow|ocular blood flow
5648981|NCT00706914|Airflow Obstruction, Chronic|airflow obstruction, chronic
5648982|NCT00706914|Chronic Airflow Obstruction|chronic airflow obstruction
5648983|NCT00706914|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5648984|NCT00706914|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5648985|NCT00706914|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5648986|NCT00706914|COPD|copd
5648987|NCT00706914|COAD|coad
5648989|NCT00706901|IHMD|ihmd
5648990|NCT00706888|Reduction of cardiovascular factor of risk|reduction of cardiovascular factor of risk
5648991|NCT00706875|GTD survivors|gtd survivors
5648992|NCT00706875|questionnaires|questionnaires
5648993|NCT00706875|GTD|gtd
5648994|NCT00706862|Non small cell lung cancer|non small cell lung cancer
5648995|NCT00706862|Talactoferrin|talactoferrin
5648996|NCT00706862|Dendritic cell recruiter and activator|dendritic cell recruiter and activator
5648997|NCT00706862|DCRA|dcra
5648998|NCT00706862|Immunomodulatory agent|immunomodulatory agent
5648999|NCT00706862|Lactoferrin|lactoferrin
5649000|NCT00706849|familial hypercholesterolemia|familial hypercholesterolemia
5649001|NCT00706836|anxiety|anxiety
5649002|NCT00706836|functional magnetic resonance imaging|functional magnetic resonance imaging
5649003|NCT00706836|fMRI|fmri
5649004|NCT00706836|pregabalin|pregabalin
5649006|NCT00706823|Endotracheal Intubation|endotracheal intubation
5649007|NCT00706823|Supraglottic Airway|supraglottic airway
5649008|NCT00706810|Cancer|cancer
5649009|NCT00706810|Brain cancer|brain cancer
5649010|NCT00706810|Meningioma|meningioma
5649011|NCT00706797|Moderate Rheumatoid Arthritis|moderate rheumatoid arthritis
5649012|NCT00706784|Healthy women 18-40 years of age|healthy women 18-40 years of age
5649013|NCT00706771|sodium bicarbonate|sodium bicarbonate
5649014|NCT00706771|serum neutrophil gelatinase associated lipocalin|serum neutrophil gelatinase associated lipocalin
5649015|NCT00706771|renal impairment|renal impairment
5649016|NCT00706771|renal failure|renal failure
5649017|NCT00706771|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5649018|NCT00706771|defined|defined
5649019|NCT00706771|by serum NGAL ≥ 100 ng/ml.|by serum ngal ≥ 100 ng/ml.
5649020|NCT00706758|Irritable bowel syndrome|irritable bowel syndrome
5649021|NCT00706758|Patient education|patient education
5649022|NCT00706745|atherosclerosis|atherosclerosis
5649023|NCT00706745|dietary supplements|dietary supplements
5649024|NCT00706745|randomised controlled trial|randomised controlled trial
5649025|NCT00706745|arterial stiffness|arterial stiffness
5649026|NCT00706745|linoleic acid|linoleic acid
5649027|NCT00706732|Influenza|influenza
5649028|NCT00706732|Flu|flu
5649029|NCT00706732|A/Wyoming/03/2003|a/wyoming/03/2003
5649030|NCT00706732|Alphavirus|alphavirus
5649031|NCT00706719|Adult Onset Idiopathic Hypothalamic Hypogonadism (AIHH)|adult onset idiopathic hypothalamic hypogonadism (aihh)
5649032|NCT00706719|Secondary hypogonadism|secondary hypogonadism
5649033|NCT00706719|Semen volume|semen volume
5649034|NCT00706719|Sperm count|sperm count
5649035|NCT00706719|Sperm motility|sperm motility
5649036|NCT00706706|sunitinib Phase IV metastatic renal cell carcinoma Chinese|sunitinib phase iv metastatic renal cell carcinoma chinese
5649037|NCT00706693|hypoglycemia|hypoglycemia
5649038|NCT00706693|treatment|treatment
5649039|NCT00706693|glucose|glucose
5649040|NCT00706693|sucrose|sucrose
5649041|NCT00706693|fructose|fructose
5649042|NCT00706654|Aripiprazole|aripiprazole
5649043|NCT00706654|Intramuscular (IM) depot|intramuscular (im) depot
5649044|NCT00706654|Schizophrenia|schizophrenia
5649045|NCT00706615|stage IV breast cancer|stage iv breast cancer
5649046|NCT00706615|recurrent breast cancer|recurrent breast cancer
5649047|NCT00706602|COPD|copd
5649048|NCT00706602|prognosis|prognosis
5649050|NCT00706602|health-related quality of life|health-related quality of life
5649051|NCT00706602|risk factors|risk factors
5649052|NCT00706602|derivation|derivation
5649053|NCT00706602|validation|validation
5649054|NCT00706602|exacerbation|exacerbation
5649055|NCT00706602|mortality|mortality
5649056|NCT00706602|primary care|primary care
5649057|NCT00706602|treatment|treatment
5649058|NCT00706602|decision making|decision making
5649059|NCT00706589|Chronic Motor Tic disorder|chronic motor tic disorder
5649060|NCT00706589|Chronic Phonic Tic disorder|chronic phonic tic disorder
5649061|NCT00706589|Tourette's disorder|tourette's disorder
5649062|NCT00706589|Aripiprazole|aripiprazole
5649063|NCT00706589|Abilify|abilify
5649064|NCT00706589|Children|children
5649065|NCT00706589|Adolescent|adolescent
5649066|NCT00706576|Hepatocellular cancer|hepatocellular cancer
5649068|NCT00706576|Opioid growth factor|opioid growth factor
5649069|NCT00706576|OGF|ogf
5649070|NCT00706576|Cirrhosis|cirrhosis
5649071|NCT00706550|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5649072|NCT00706537|Pharmacokinetic safety NASH patients|pharmacokinetic safety nash patients
5649073|NCT00706511|OSA|osa
5649074|NCT00706511|Diabetes|diabetes
5649075|NCT00706511|Metabolism|metabolism
5649076|NCT00706511|Gender|gender
5649077|NCT00706485|Y-90 plaque applicator|y-90 plaque applicator
5649078|NCT00706485|dural brachytherapy|dural brachytherapy
5649079|NCT00706446|Asthma|asthma
5649080|NCT00706446|Pharmacogenetics|pharmacogenetics
5649081|NCT00706446|Beta agonists|beta agonists
5649082|NCT00706446|salmeterol|salmeterol
5649083|NCT00706446|formoterol|formoterol
5649084|NCT00706446|tiotropium|tiotropium
5649085|NCT00706446|beta adrenergic receptor|beta adrenergic receptor
5649086|NCT00706446|single nucleotide polymorphism|single nucleotide polymorphism
5649087|NCT00706433|Photodynamic Therapy|photodynamic therapy
5649088|NCT00706420|Diabetes Mellitus|diabetes mellitus
5649089|NCT00706420|Islet Transplantation Alone|islet transplantation alone
5649090|NCT00706420|Glucocorticoid-free Immunosuppressive Regimen|glucocorticoid-free immunosuppressive regimen
5649091|NCT00706394|Powerlink|powerlink
5649092|NCT00706394|34mm|34mm
5649093|NCT00706394|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5649094|NCT00706394|EVAR|evar
5649095|NCT00706381|Deiodinase|deiodinase
5649096|NCT00706381|Bile Acids|bile acids
5649097|NCT00706381|Cholecystokinin|cholecystokinin
5649098|NCT00706381|Thyroid Hormones|thyroid hormones
5649099|NCT00706381|Energy Expenditure|energy expenditure
5649100|NCT00706381|Health Volunteer|health volunteer
5649101|NCT00706381|HV|hv
5649102|NCT00706368|Sexually transmitted infections|sexually transmitted infections
5649103|NCT00706368|Acceptability|acceptability
5649104|NCT00706368|Adolescent vaginitis|adolescent vaginitis
5649105|NCT00706342|Adult Refractory Immune Thrombocytopenic Purpura (ITP)|adult refractory immune thrombocytopenic purpura (itp)
5649106|NCT00706329|Minimally invasive surgery|minimally invasive surgery
5649107|NCT00706329|Umbilical hernia|umbilical hernia
5649108|NCT00706329|Infant|infant
5649109|NCT00706316|Nasopharygneal Cancer|nasopharygneal cancer
5649110|NCT00706316|Epstein Barr Virus|epstein barr virus
5649111|NCT00706316|(EBV)-Specific Cytotoxic T-Lymphocytes|(ebv)-specific cytotoxic t-lymphocytes
5649112|NCT00706316|Recurrent|recurrent
5649113|NCT00706316|Metastatic|metastatic
5649114|NCT00706316|EBV-Positive Nasopharygneal Cancer|ebv-positive nasopharygneal cancer
5649115|NCT00706303|COPD|copd
5649116|NCT00706303|self management|self management
5649117|NCT00706290|anxiety|anxiety
5649118|NCT00706290|depression|depression
5649119|NCT00706290|quality of life|quality of life
5672504|NCT00611663|Immunosuppression|immunosuppression
5649120|NCT00706290|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5649121|NCT00706290|advanced cancer|advanced cancer
5649122|NCT00706290|metastatic cancer|metastatic cancer
5649123|NCT00706290|stage IV cancer|stage iv cancer
5649124|NCT00706290|cognitive behavioral therapy|cognitive behavioral therapy
5649125|NCT00706277|forced vital capacity|forced vital capacity
5649126|NCT00706277|forced expired volume in 1 s|forced expired volume in 1 s
5649127|NCT00706264|Short cervix|short cervix
5649128|NCT00706264|preterm birth|preterm birth
5649129|NCT00706264|arabin pessary|arabin pessary
5649130|NCT00706238|metastatic,|metastatic,
5649131|NCT00706238|Melanoma,|melanoma,
5649132|NCT00706238|Antigen-Specific Cancer Immunotherapeutic,|antigen-specific cancer immunotherapeutic,
5649134|NCT00706238|MAGE-A3|mage-a3
5649135|NCT00706238|tumor antigen,|tumor antigen,
5649136|NCT00706199|bone marrow|bone marrow
5649137|NCT00706199|antigen expression|antigen expression
5649138|NCT00706199|volunteers|volunteers
5649139|NCT00706186|Mild Alzheimer's|mild alzheimer's
5649140|NCT00706186|Disease|disease
5649141|NCT00706173|Post-traumatic stress disorder|post-traumatic stress disorder
5649142|NCT00706173|PTSD|ptsd
5649143|NCT00706173|Cortisol|cortisol
5649144|NCT00706173|hydrocortisone|hydrocortisone
5649145|NCT00706173|pharmacological treatment|pharmacological treatment
5649146|NCT00706160|Epilepsy|epilepsy
5649147|NCT00706160|Language|language
5649149|NCT00706160|Magnetoencephalogram|magnetoencephalogram
5649150|NCT00706160|Temporal Lobe Epilepsy|temporal lobe epilepsy
5649151|NCT00706160|Partial Epilepsy|partial epilepsy
5649152|NCT00706160|Healthy Volunteer|healthy volunteer
5649154|NCT00706147|Hereditary ALS|hereditary als
5649155|NCT00706147|Hereditary neurological disease|hereditary neurological disease
5649156|NCT00706147|Lou Gehrig's Disease|lou gehrig's disease
5649157|NCT00706147|Motor Neuron Disease|motor neuron disease
5649158|NCT00706147|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5649159|NCT00706147|Familial ALS|familial als
5649160|NCT00706147|Neuromuscular disease|neuromuscular disease
5649161|NCT00706147|SOD1 mutation|sod1 mutation
5649163|NCT00706147|SOD1 positive ALS|sod1 positive als
5649164|NCT00706147|inherited ALS|inherited als
5649165|NCT00706134|Hypertension|hypertension
5649166|NCT00706134|≥ 65 years|≥ 65 years
5649168|NCT00706134|placebo|placebo
5649169|NCT00706134|light meal|light meal
5649170|NCT00706121|colon cancer|colon cancer
5649171|NCT00706121|rectal cancer|rectal cancer
5649172|NCT00706121|adenomatous polyp|adenomatous polyp
5649173|NCT00706095|Cancer|cancer
5649174|NCT00706095|advanced solid tumors|advanced solid tumors
5649175|NCT00706069|Metastatic Breast Cancer|metastatic breast cancer
5649176|NCT00706069|Vinorelbine oral|vinorelbine oral
5649177|NCT00706069|Capecitabine|capecitabine
5649178|NCT00706043|Low back pain|low back pain
5649179|NCT00706030|Metastatic breast cancer|metastatic breast cancer
5649181|NCT00706030|Neratinib|neratinib
5649182|NCT00706030|Nerlynx|nerlynx
5649183|NCT00706030|PB-272|pb-272
5649184|NCT00706004|constipation|constipation
5649185|NCT00706004|cystic fibrosis|cystic fibrosis
5649186|NCT00706004|lubiprostone|lubiprostone
5649187|NCT00706004|Constipation in adults with cystic fibrosis|constipation in adults with cystic fibrosis
5649188|NCT00705978|Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis|pancreatic exocrine insufficiency due to chronic pancreatitis
5649189|NCT00705965|Coronary artery disease|coronary artery disease
5649190|NCT00705965|depression|depression
5649191|NCT00705965|psychotherapy|psychotherapy
5649192|NCT00705965|randomized controlled trial|randomized controlled trial
5649193|NCT00705952|No diabetes medications|no diabetes medications
5649194|NCT00705952|New onset|new onset
5649195|NCT00705939|Gaucher Disease|gaucher disease
5649196|NCT00705939|Enzyme replacement therapy|enzyme replacement therapy
5649197|NCT00705926|Acute Infection|acute infection
5649198|NCT00705926|HIV|hiv
5649199|NCT00705926|HAART|haart
5649200|NCT00705926|Treatment Naive|treatment naive
5649201|NCT00705913|aortic valve|aortic valve
5649202|NCT00705913|heart valve|heart valve
5649203|NCT00705913|valve replacement|valve replacement
5649204|NCT00705913|valve disease|valve disease
5649206|NCT00705887|Ultraviolet Rays|ultraviolet rays
5649207|NCT00705887|Motivation|motivation
5649208|NCT00705887|Health Education|health education
5649209|NCT00705887|Randomized Controlled Trial|randomized controlled trial
5649210|NCT00705887|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5649211|NCT00705874|cancer|cancer
5649212|NCT00705874|advanced cancer|advanced cancer
5649213|NCT00705874|solid tumors|solid tumors
5649214|NCT00705874|lymphoma|lymphoma
5649215|NCT00705874|CGC-11047|cgc-11047
5649216|NCT00705861|Erectile dysfunction|erectile dysfunction
5649217|NCT00705861|Diabetes Mellitus|diabetes mellitus
5649218|NCT00705861|SK3530|sk3530
5649219|NCT00705848|trachea|trachea
5649220|NCT00705848|malacia|malacia
5649221|NCT00705848|stenosis|stenosis
5649222|NCT00705835|Prostate|prostate
5649223|NCT00705835|ALHYDROGEL|alhydrogel
5649224|NCT00705835|RS-PSMA|rs-psma
5649225|NCT00705809|Epidemiology|epidemiology
5649226|NCT00705809|Peripheral T-Cell Lymphoma|peripheral t-cell lymphoma
5649227|NCT00705796|Hypogonadism|hypogonadism
5649228|NCT00705796|Spermatogenesis|spermatogenesis
5649229|NCT00705796|Quality of Life|quality of life
5649230|NCT00705783|Aripiprazole|aripiprazole
5649231|NCT00705783|Intramuscular (IM) depot|intramuscular (im) depot
5649232|NCT00705783|Schizophrenia|schizophrenia
5649233|NCT00705770|Open-Angle Glaucoma|open-angle glaucoma
5649234|NCT00705770|Intraocular Pressure|intraocular pressure
5649235|NCT00705770|Anecortave Acetate|anecortave acetate
5649236|NCT00705757|periocular skin pigmentation|periocular skin pigmentation
5649237|NCT00705757|Lumigan|lumigan
5649238|NCT00705757|Travatan|travatan
5649239|NCT00705757|Xalatan|xalatan
5649240|NCT00705757|latanoprost|latanoprost
5649241|NCT00705757|bimatoprost|bimatoprost
5649242|NCT00705757|travoprost|travoprost
5649243|NCT00705731|Colorectal cancer (CRC)|colorectal cancer (crc)
5649244|NCT00705731|Colorectal cancer screening|colorectal cancer screening
5649245|NCT00705731|Colonoscopy|colonoscopy
5649246|NCT00705731|Fecal occult blood test (FOBT)|fecal occult blood test (fobt)
5649247|NCT00705731|Cost-effectiveness|cost-effectiveness
5649248|NCT00705718|Endurant Stent Graft System|endurant stent graft system
5649249|NCT00705718|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5649250|NCT00705718|Endovascular Treatment|endovascular treatment
5649292|NCT00705523|alcohol|alcohol
5649293|NCT00705523|treatment|treatment
5649294|NCT00705523|nicotinic acetylcholine receptors|nicotinic acetylcholine receptors
5649295|NCT00705523|pharmacotherapy|pharmacotherapy
5649296|NCT00705523|outpatient|outpatient
5649297|NCT00705510|Cyclosporine|cyclosporine
5649298|NCT00705510|Unstable tear film|unstable tear film
5649299|NCT00705510|Meibomian gland|meibomian gland
5649300|NCT00705510|Meibomian gland dysfunction|meibomian gland dysfunction
5649301|NCT00705497|Radiofrequency tumor ablation|radiofrequency tumor ablation
5649303|NCT00705458|stress myocardial perfusion imaging|stress myocardial perfusion imaging
5652019|NCT00693511|obesity|obesity
5649304|NCT00705458|coronary computed tomography angiography|coronary computed tomography angiography
5649313|NCT00705354|Chronic Sinusitis|chronic sinusitis
5649314|NCT00705354|Nasal Surgery|nasal surgery
5649315|NCT00705354|Functional Endoscopic Sinus Surgery (FESS)|functional endoscopic sinus surgery (fess)
5649316|NCT00705354|Enoscopic Sinus Surgery (ESS)|enoscopic sinus surgery (ess)
5649317|NCT00705341|Normal Controls|normal controls
5649318|NCT00705328|low-income families|low-income families
5649319|NCT00705328|children|children
5649320|NCT00705328|recreation|recreation
5649321|NCT00705328|family healthy lifestyle|family healthy lifestyle
5649322|NCT00705328|linkages to community resources|linkages to community resources
5649323|NCT00705328|Families with low incomes|families with low incomes
5649324|NCT00705328|working poor|working poor
5649325|NCT00705328|welfare recipients|welfare recipients
5649326|NCT00705315|breast cancer|breast cancer
5649327|NCT00705315|chemotherapy|chemotherapy
5649328|NCT00705315|biological therapy|biological therapy
5649329|NCT00705302|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5649331|NCT00705302|Patient education|patient education
5649332|NCT00705302|Pulmonary rehabilitation|pulmonary rehabilitation
5649333|NCT00705302|Self-management|self-management
5649334|NCT00705250|Bendamustine HCL|bendamustine hcl
5649335|NCT00705237|sinusitis|sinusitis
5649336|NCT00705185|Major Depressive Disorder|major depressive disorder
5649337|NCT00705185|Blood Test|blood test
5649338|NCT00705159|Blepharokeratoconjunctivitis|blepharokeratoconjunctivitis
5649339|NCT00705146|Osteoarthritis, carpometacarpal joint|osteoarthritis, carpometacarpal joint
5649340|NCT00705146|Thumb splints|thumb splints
5649341|NCT00705146|AUSCAN-HI 3.1|auscan-hi 3.1
5649342|NCT00705146|Grip and pinch strength|grip and pinch strength
5649343|NCT00705133|pulmonary hypertension|pulmonary hypertension
5649344|NCT00705133|pulmonary fibrosis|pulmonary fibrosis
5649345|NCT00705133|interstitial lung disease|interstitial lung disease
5649346|NCT00705120|Osteogenesis Imperfecta|osteogenesis imperfecta
5649347|NCT00705120|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5649348|NCT00705120|Mesenchymal Stem Cells|mesenchymal stem cells
5649349|NCT00705120|Stem Cell Transplantation, Mesenchymal|stem cell transplantation, mesenchymal
5649350|NCT00705094|cardiovascular risk factors|cardiovascular risk factors
5649351|NCT00705094|cardiac function|cardiac function
5649353|NCT00705094|Chemotherapy|chemotherapy
5649354|NCT00705055|Anthropometry|anthropometry
5649355|NCT00705055|face recognition|face recognition
5649356|NCT00705055|genetic disease|genetic disease
5649357|NCT00705055|newborn infant|newborn infant
5649358|NCT00705016|Randomized treatment|randomized treatment
5649359|NCT00705016|open-label|open-label
5649360|NCT00705016|controlled|controlled
5649361|NCT00705016|recurrent|recurrent
5649362|NCT00705016|metastatic|metastatic
5649363|NCT00705016|SCCHN|scchn
5649364|NCT00705016|suitable|suitable
5649365|NCT00705016|for local therapy|for local therapy
5649366|NCT00705003|depression|depression
5649367|NCT00704990|Attention Deficit Disorder|attention deficit disorder
5649368|NCT00704990|Pediatrics|pediatrics
5649369|NCT00704990|Attention|attention
5649370|NCT00704990|Impulsivity|impulsivity
5649371|NCT00704990|Complementary Therapies|complementary therapies
5649372|NCT00704938|recurrent renal cell cancer|recurrent renal cell cancer
5649373|NCT00704938|stage IV renal cell cancer|stage iv renal cell cancer
5649374|NCT00704938|recurrent melanoma|recurrent melanoma
5649375|NCT00704938|stage IV melanoma|stage iv melanoma
5649376|NCT00704938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5649377|NCT00704925|Lambert Eaton Myasthenic Syndrome|lambert eaton myasthenic syndrome
5649378|NCT00704925|3,4 DAP|3,4 dap
5649379|NCT00704925|3,4 Diaminopyridine|3,4 diaminopyridine
5649380|NCT00704912|Polycystic Ovary Syndrome|polycystic ovary syndrome
5649381|NCT00704886|dementia|dementia
5649382|NCT00704860|healthy volunteers treatment resistant major depression hippocampus atrophy MRI serotonin genotyping|healthy volunteers treatment resistant major depression hippocampus atrophy mri serotonin genotyping
5649383|NCT00704847|Osteoarthritis, oral salmon calcitonin, treatment, efficacy,|osteoarthritis, oral salmon calcitonin, treatment, efficacy,
5649384|NCT00704847|tolerability|tolerability
5649391|NCT00704821|Cancer|cancer
5649392|NCT00704821|PTC299|ptc299
5649393|NCT00704821|VEGF|vegf
5649394|NCT00704821|Angiogenesis|angiogenesis
5649395|NCT00704821|Post-transcriptional control|post-transcriptional control
5649396|NCT00704821|Docetaxel|docetaxel
5649397|NCT00704743|Colles fracture treatment|colles fracture treatment
5649398|NCT00704743|Displaced fracture of distal radius|displaced fracture of distal radius
5649399|NCT00704743|distal radius fracture treatment|distal radius fracture treatment
5649400|NCT00704743|RCT|rct
5649401|NCT00704743|Emergency Department|emergency department
5649402|NCT00704743|cast|cast
5649403|NCT00704743|splint|splint
5649404|NCT00704743|treatment|treatment
5649405|NCT00704730|Medullary Thyroid Cancer|medullary thyroid cancer
5649406|NCT00704730|MTC|mtc
5649407|NCT00704704|high risk MDS|high risk mds
5649408|NCT00704704|IPSS|ipss
5649409|NCT00704704|5-AZA-Cytidine|5-aza-cytidine
5649410|NCT00704704|Thalidomide|thalidomide
5649411|NCT00704704|response rate|response rate
5649412|NCT00704704|cytogenetic response|cytogenetic response
5649413|NCT00704704|QOL questionaries|qol questionaries
5649414|NCT00704704|INT-2 or High risk MDS|int-2 or high risk mds
5649415|NCT00704678|Chronic Kidney Disease|chronic kidney disease
5649416|NCT00704678|hemodialysis|hemodialysis
5649417|NCT00704678|hyperphosphatemia|hyperphosphatemia
5649418|NCT00704678|Asian|asian
5649419|NCT00704678|patients|patients
5649420|NCT00704665|Diffuse Scleroderma|diffuse scleroderma
5649421|NCT00704665|Skin score|skin score
5649422|NCT00704639|Head and Neck|head and neck
5649423|NCT00704639|Cetuximab|cetuximab
5649424|NCT00704639|Carboplatin|carboplatin
5649425|NCT00704639|Radiotherapy|radiotherapy
5649426|NCT00704626|Multiple Sclerosis|multiple sclerosis
5649427|NCT00704626|Autoimmune disease|autoimmune disease
5643051|NCT00728754|Lateralized|lateralized
5649428|NCT00704626|Inflammatory disease|inflammatory disease
5649429|NCT00704626|Myasthenia Gravis|myasthenia gravis
5649430|NCT00704626|Transverse Myelitis|transverse myelitis
5649431|NCT00704600|Locally advanced rectal cancer|locally advanced rectal cancer
5649432|NCT00704600|nelfinavir|nelfinavir
5649433|NCT00704600|radiosensitivity|radiosensitivity
5649434|NCT00704600|chemoradiation|chemoradiation
5649435|NCT00704587|cancer occurence|cancer occurence
5649436|NCT00704587|cancer recurrence|cancer recurrence
5649437|NCT00704587|neo-adjuvant treatment response measurement|neo-adjuvant treatment response measurement
5649438|NCT00704561|Acute Myocardial Infarction|acute myocardial infarction
5649439|NCT00704561|Percutaneous Coronary Interventions|percutaneous coronary interventions
5649440|NCT00704561|Optical Coherence Tomography|optical coherence tomography
5649441|NCT00704561|Thrombus|thrombus
5649442|NCT00704509|Schizophrenia|schizophrenia
5649443|NCT00704509|Antipsychotic|antipsychotic
5649444|NCT00704509|Bifeprunox|bifeprunox
5649445|NCT00704496|Sleep, Pseudoephedrine|sleep, pseudoephedrine
5649446|NCT00704483|Chronic Kidney Disease|chronic kidney disease
5649447|NCT00704483|hemodialysis|hemodialysis
5649448|NCT00704483|hyperphosphatemia|hyperphosphatemia
5649449|NCT00704483|hemodiafiltration|hemodiafiltration
5649450|NCT00704470|Patient Simulation|patient simulation
5649451|NCT00704470|Education, Medical, Continuing|education, medical, continuing
5649452|NCT00704470|Education, Medical, Graduate|education, medical, graduate
5649453|NCT00704470|Stress|stress
5649454|NCT00704457|Interstitial Cystitis|interstitial cystitis
5649455|NCT00704457|IC|ic
5649456|NCT00704457|Sacral Nerve Stimulation|sacral nerve stimulation
5649457|NCT00704431|SB-480848|sb-480848
5649458|NCT00704431|darapladib|darapladib
5649459|NCT00704431|tolerability|tolerability
5649460|NCT00704418|Cataract extraction|cataract extraction
5649461|NCT00704418|intraocular lens implantation|intraocular lens implantation
5649462|NCT00704405|hepatitis C|hepatitis c
5649463|NCT00704392|Solid tumors|solid tumors
5649464|NCT00704392|NSCLC|nsclc
5649465|NCT00704379|traumatic brain injury|traumatic brain injury
5649466|NCT00704379|TBI|tbi
5649467|NCT00704379|mood disorders|mood disorders
5649468|NCT00704379|anxiety disorders|anxiety disorders
5649469|NCT00704379|community reintegration|community reintegration
5649470|NCT00704379|executive function|executive function
5649471|NCT00704379|sertraline|sertraline
5649472|NCT00704379|diffusion tensor imaging|diffusion tensor imaging
5649473|NCT00704366|Advanced carcinoma|advanced carcinoma
5649474|NCT00704327|Cognitive Functions|cognitive functions
5649475|NCT00704327|Brain Ischemia|brain ischemia
5649476|NCT00704327|Cerebral Atrophy|cerebral atrophy
5649477|NCT00704327|Dementia|dementia
5649478|NCT00704327|Intracranial atherosclerosis|intracranial atherosclerosis
5649479|NCT00704327|Memory impairment|memory impairment
5649480|NCT00704314|Insulin resistance|insulin resistance
5649481|NCT00704314|Statins|statins
5649482|NCT00704314|Muscle and liver triglycerides|muscle and liver triglycerides
5649483|NCT00704301|Delirium|delirium
5649484|NCT00704301|Confusion|confusion
5649485|NCT00704288|GBM|gbm
5649486|NCT00704288|Malignant gliomas|malignant gliomas
5649487|NCT00704275|dry eye|dry eye
5649488|NCT00704249|HIV infection|hiv infection
5649489|NCT00704249|nevirapine|nevirapine
5649490|NCT00704249|Treatment Experienced|treatment experienced
5649491|NCT00704236|Traditional Chinese Treatment|traditional chinese treatment
5649492|NCT00704210|Low Back Pain|low back pain
5649493|NCT00704171|Elective pulmonary resection via open thoracotomy.|elective pulmonary resection via open thoracotomy.
5649494|NCT00704158|CR011-vcMMAE|cr011-vcmmae
5649495|NCT00704158|locally advanced breast cancer|locally advanced breast cancer
5649496|NCT00704158|metastatic breast cancer|metastatic breast cancer
5649497|NCT00704158|breast cancer|breast cancer
5649498|NCT00704158|CuraGen|curagen
5649499|NCT00704145|Drug Eluting Stents|drug eluting stents
5649500|NCT00704145|Percutaneous Coronary Interventions|percutaneous coronary interventions
5649501|NCT00704145|Optical Coherence Tomography|optical coherence tomography
5649502|NCT00704119|Rhudex|rhudex
5649503|NCT00704119|pharmacokinetic study|pharmacokinetic study
5649504|NCT00704106|Hepatitis B|hepatitis b
5649505|NCT00704106|HBV|hbv
5649506|NCT00704106|Treatment|treatment
5649508|NCT00704093|perfusion|perfusion
5649509|NCT00704093|oxidative metabolism|oxidative metabolism
5649510|NCT00704093|efficiency|efficiency
5649511|NCT00704080|GBM|gbm
5649512|NCT00704080|Anaplastic glioma|anaplastic glioma
5649513|NCT00704067|vocational rehabilitation|vocational rehabilitation
5649514|NCT00704067|supported employment|supported employment
5649515|NCT00704067|cognitive training|cognitive training
5649516|NCT00704067|cognitive remediation|cognitive remediation
5649517|NCT00704067|cognitive rehabilitation|cognitive rehabilitation
5649518|NCT00704067|veterans|veterans
5649519|NCT00704054|Pediatric|pediatric
5649520|NCT00704054|Solid Tumor|solid tumor
5649521|NCT00704054|CNS Tumor|cns tumor
5649522|NCT00704054|Lymphoma|lymphoma
5649523|NCT00704015|Smoking cessation|smoking cessation
5649524|NCT00704015|Acute injury|acute injury
5649525|NCT00704015|Musculoskeletal|musculoskeletal
5672654|NCT00611325|Avastin|avastin
5649526|NCT00704015|Postoperative complications|postoperative complications
5649527|NCT00704002|neck fracture of the fifth metacarpal|neck fracture of the fifth metacarpal
5649528|NCT00704002|displacement|displacement
5649529|NCT00704002|antegrade intramedullary splinting|antegrade intramedullary splinting
5649530|NCT00704002|conservative treatment|conservative treatment
5649531|NCT00703989|hyperglycemia|hyperglycemia
5649532|NCT00703989|diabetic complications|diabetic complications
5649533|NCT00703989|advanced glycation endproducts|advanced glycation endproducts
5649534|NCT00703989|hexosamine pathway|hexosamine pathway
5649535|NCT00703989|prostacyclin synthase|prostacyclin synthase
5649536|NCT00703989|reactive oxygen species|reactive oxygen species
5649537|NCT00703976|head and neck cancers|head and neck cancers
5649538|NCT00703963|International normalized ratio (INR)|international normalized ratio (inr)
5649539|NCT00703950|Sucking patterns|sucking patterns
5649540|NCT00703950|preterm infants|preterm infants
5649541|NCT00703950|breastfeeding|breastfeeding
5649542|NCT00703924|cutaneous leishmaniasis topical treatment safety efficacy|cutaneous leishmaniasis topical treatment safety efficacy
5649544|NCT00703898|nevirapine|nevirapine
5649545|NCT00703898|durability|durability
5649546|NCT00703898|AIDS|aids
5649547|NCT00703898|Treatment Naïve|treatment naïve
5649548|NCT00703885|functional magnetic resonance imaging|functional magnetic resonance imaging
5649549|NCT00703885|fMRI|fmri
5649550|NCT00703885|alprazolam|alprazolam
5649551|NCT00703885|anxiety disorders|anxiety disorders
5649552|NCT00703872|Chronic Hepatitis C|chronic hepatitis c
5649553|NCT00703872|Naive|naive
5649554|NCT00703872|Nonresponders|nonresponders
5649555|NCT00703872|Interferon|interferon
5649556|NCT00703872|Patients with Chronic Hepatitis C|patients with chronic hepatitis c
5649557|NCT00703859|Radiotherapy plus temozolomide plus DCA|radiotherapy plus temozolomide plus dca
5649558|NCT00703859|PK profile of DCA|pk profile of dca
5649559|NCT00703859|MGMT promoter methylation status|mgmt promoter methylation status
5649560|NCT00703859|Newly diagnosed Glioblastoma multiform tumours|newly diagnosed glioblastoma multiform tumours
5649561|NCT00703846|Phase 4|phase 4
5649562|NCT00703846|Seborrheic|seborrheic
5649563|NCT00703846|Ketoconazole|ketoconazole
5649564|NCT00703846|Dermatitis|dermatitis
5649565|NCT00703794|ev3 Neurovascular|ev3 neurovascular
5649566|NCT00703794|aneurysms|aneurysms
5649567|NCT00703794|cerebrovascular|cerebrovascular
5649568|NCT00703794|endovascular|endovascular
5649569|NCT00703794|neurovascular therapies|neurovascular therapies
5649570|NCT00703794|RACER|racer
5649571|NCT00703794|AXIUM|axium
5649572|NCT00703794|The AXIUM Progressive Coil System|the axium progressive coil system
5649573|NCT00703794|ev3|ev3
5649574|NCT00703794|MTI|mti
5649575|NCT00703794|Micro Therapeutics|micro therapeutics
5624994|NCT00799773|TTP|ttp
5649576|NCT00703794|FX detachable coil system|fx detachable coil system
5649577|NCT00703794|K060747|k060747
5649578|NCT00703794|brain diseases|brain diseases
5649579|NCT00703781|Cataract extraction with intraocular lens implantation|cataract extraction with intraocular lens implantation
5649580|NCT00703768|Quality of Life|quality of life
5649581|NCT00703768|Androgen Deprivation Therapy|androgen deprivation therapy
5649582|NCT00703768|Goserelin|goserelin
5649583|NCT00703755|Diabetes|diabetes
5649584|NCT00703755|Hypertriglyceridaemia|hypertriglyceridaemia
5649585|NCT00703755|Metabolic Syndrome|metabolic syndrome
5649586|NCT00703716|mini-invasive|mini-invasive
5649587|NCT00703716|dynamic screw-plate|dynamic screw-plate
5649588|NCT00703716|Surfix|surfix
5649589|NCT00703716|Lock-screw|lock-screw
5649590|NCT00703703|Heart rate, overactive bladder|heart rate, overactive bladder
5649591|NCT00703677|progressive supranuclear palsy|progressive supranuclear palsy
5649592|NCT00703677|corticobasal degeneration|corticobasal degeneration
5649593|NCT00703677|PSP|psp
5649594|NCT00703677|CBD|cbd
5649595|NCT00703677|lithium|lithium
5649596|NCT00703677|tau|tau
5649597|NCT00703651|Influenza|influenza
5649598|NCT00703651|Orthomyxoviridae Infection|orthomyxoviridae infection
5649599|NCT00703651|Inactivated, Split-virion influenza vaccine|inactivated, split-virion influenza vaccine
5649600|NCT00703651|Intradermal injection|intradermal injection
5649601|NCT00703651|Adults.|adults.
5649602|NCT00703612|Diabetes Mellitus|diabetes mellitus
5649603|NCT00703612|Adipose-derived stem cells|adipose-derived stem cells
5649608|NCT00703599|Adipose-derived stem cells|adipose-derived stem cells
5649609|NCT00703599|Adipose stromal vascular fraction|adipose stromal vascular fraction
5649610|NCT00703599|Autologous|autologous
5649611|NCT00703599|Insulin-dependence|insulin-dependence
5649612|NCT00703586|Maraviroc|maraviroc
5649613|NCT00703586|Treatment Experienced|treatment experienced
5649614|NCT00703573|Atopic Dermatitis|atopic dermatitis
5649616|NCT00703560|Genotype 1|genotype 1
5649617|NCT00703560|HIV co-infection|hiv co-infection
5649618|NCT00703560|viral kinetics|viral kinetics
5649619|NCT00703560|HCV quasi-species|hcv quasi-species
5649620|NCT00703560|Hepatitis C genotype 1|hepatitis c genotype 1
5649621|NCT00703560|HIV Infections|hiv infections
5649622|NCT00703547|Depression|depression
5649623|NCT00703534|GERD|gerd
5649624|NCT00703534|Acid Reflux|acid reflux
5649625|NCT00703534|Heartburn|heartburn
5649626|NCT00703534|Regurgitation|regurgitation
5649627|NCT00703534|non-acid reflux|non-acid reflux
5649628|NCT00703534|PRO measures|pro measures
5649629|NCT00703521|rabies vaccination|rabies vaccination
5649630|NCT00703521|pre-exposure prophylaxis|pre-exposure prophylaxis
5649631|NCT00703521|rabies virus neutralizing antibody|rabies virus neutralizing antibody
5649632|NCT00703521|Antibody response|antibody response
5649633|NCT00703521|immunologic memory of rabies vaccination|immunologic memory of rabies vaccination
5649634|NCT00703521|Safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes|safety of rabies vaccination administered in pre-exposure regimens both intramuscular and intradermal routes
5649636|NCT00703495|traumatic|traumatic
5649637|NCT00703495|brain injury|brain injury
5649638|NCT00703495|brain regional oxygen saturation (rSO2)|brain regional oxygen saturation (rso2)
5649639|NCT00703495|brain tissue oxygenation (PbtO2)|brain tissue oxygenation (pbto2)
5649640|NCT00703495|cerebral perfusion pressure (CPP)|cerebral perfusion pressure (cpp)
5649641|NCT00703482|Ventricular diastolic Function|ventricular diastolic function
5649642|NCT00703482|Diabetes|diabetes
5649643|NCT00703469|Hep C|hep c
5649644|NCT00703456|Functional ankle instability|functional ankle instability
5649645|NCT00703456|Balance training|balance training
5649646|NCT00703443|Genetics|genetics
5649647|NCT00703443|Dilated Cardiomyopathy|dilated cardiomyopathy
5649648|NCT00703443|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5649649|NCT00703443|Mitochondrial Cardiomyopathy|mitochondrial cardiomyopathy
5649650|NCT00703443|Noncompaction Cardiomyopathy|noncompaction cardiomyopathy
5649651|NCT00703443|Restrictive Cardiomyopathy|restrictive cardiomyopathy
5649652|NCT00703443|Heart Failure|heart failure
5649653|NCT00703430|Alzheimer's disease, agitation, aggression, dementia|alzheimer's disease, agitation, aggression, dementia
5649654|NCT00703417|osteoporosis|osteoporosis
5649655|NCT00703417|diabetes|diabetes
5649656|NCT00703404|Anti-Retroviral Therapy|anti-retroviral therapy
5649657|NCT00703404|HIV|hiv
5649658|NCT00703404|Virologic Response|virologic response
5649659|NCT00703404|Treatment Naïve|treatment naïve
5649660|NCT00703391|Chronic|chronic
5649661|NCT00703391|obstructive|obstructive
5649662|NCT00703391|pulmonary|pulmonary
5649663|NCT00703391|lung|lung
5649664|NCT00703391|respiratory disease|respiratory disease
5649665|NCT00703391|tolerability|tolerability
5649666|NCT00703391|placebo-controlled|placebo-controlled
5649667|NCT00703391|pharmacokinetics|pharmacokinetics
5649668|NCT00703391|COPD|copd
5649669|NCT00703365|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5649670|NCT00703352|Transposition of the great arteries.|transposition of the great arteries.
5649671|NCT00703352|Transposition of the great vessels.|transposition of the great vessels.
5649672|NCT00703352|Mustard.|mustard.
5649673|NCT00703352|Senning.|senning.
5649674|NCT00703339|fibrosis, pulmonary|fibrosis, pulmonary
5649675|NCT00703339|hypertension, pulmonary|hypertension, pulmonary
5649676|NCT00703339|exercise, aerobic|exercise, aerobic
5649677|NCT00703326|Metastatic breast cancer|metastatic breast cancer
5649678|NCT00703326|HER2 negative breast cancer|her2 negative breast cancer
5649679|NCT00703326|locally recurrent breast cancer|locally recurrent breast cancer
5649680|NCT00703313|Study drug concentration in human tears|study drug concentration in human tears
5649681|NCT00703274|ischemic stroke|ischemic stroke
5649682|NCT00703274|stroke|stroke
5649683|NCT00703274|cerebrovascular stroke|cerebrovascular stroke
5649684|NCT00703274|cerebrovascular accident|cerebrovascular accident
5649685|NCT00703274|CVA|cva
5649686|NCT00703274|community health services|community health services
5649687|NCT00703274|community health workers|community health workers
5649688|NCT00703274|navigators|navigators
5649689|NCT00703274|health education|health education
5649690|NCT00703274|barriers to care|barriers to care
5649691|NCT00703274|healthcare access|healthcare access
5649692|NCT00703274|healthcare disparities|healthcare disparities
5649693|NCT00703248|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5649694|NCT00703248|complementary therapies|complementary therapies
5649695|NCT00703222|high-risk neuroblastoma|high-risk neuroblastoma
5649696|NCT00703222|single autologous stem cell rescue|single autologous stem cell rescue
5649697|NCT00703209|symptomatic diabetic neuropathy|symptomatic diabetic neuropathy
5649698|NCT00703209|diabetes|diabetes
5649699|NCT00703209|burning feet|burning feet
5649700|NCT00703209|Diabetic Neuropathy|diabetic neuropathy
5649701|NCT00703209|Loss of sensation in the foot|loss of sensation in the foot
5649702|NCT00703209|Neuropathy|neuropathy
5649703|NCT00703209|Painful Diabetic Neuropathy|painful diabetic neuropathy
5649704|NCT00703196|cervical cancer|cervical cancer
5649705|NCT00703196|human papilloma virus infection|human papilloma virus infection
5649706|NCT00703196|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5649707|NCT00703196|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5649708|NCT00703196|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5649709|NCT00703196|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5649710|NCT00703196|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5649711|NCT00703196|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5649713|NCT00703144|piperacillin/tazobactam.|piperacillin/tazobactam.
5649714|NCT00703144|Septic patients|septic patients
5649715|NCT00703144|oliguric renal failure|oliguric renal failure
5649716|NCT00703144|continuous veno-venous hemodiafiltration.|continuous veno-venous hemodiafiltration.
5649718|NCT00703131|anal fistula|anal fistula
5649719|NCT00703118|Hepatitis C, Chronic|hepatitis c, chronic
5649720|NCT00703118|Telaprevir|telaprevir
5649721|NCT00703118|Peg-IFN-alfa-2a|peg-ifn-alfa-2a
5649722|NCT00703118|Ribavirin|ribavirin
5649723|NCT00703105|ovarian cancer|ovarian cancer
5649724|NCT00703105|Tregs|tregs
5649725|NCT00703105|vaccine|vaccine
5649726|NCT00703105|Recurrent Ovarian Cancer|recurrent ovarian cancer
5649727|NCT00703079|Acromegaly|acromegaly
5649729|NCT00703079|IGF-I|igf-i
5649730|NCT00703079|Octreotide-LAR|octreotide-lar
5649731|NCT00703079|Lanreotide|lanreotide
5649732|NCT00703079|Transsphenoidal surgery|transsphenoidal surgery
5649733|NCT00703066|Malaria|malaria
5649734|NCT00703066|Vaccine|vaccine
5649735|NCT00703066|GMZ2|gmz2
5649736|NCT00703066|Safety|safety
5649737|NCT00703066|African|african
5649738|NCT00703066|immunogenicity|immunogenicity
5649739|NCT00703053|influenza, H5N1, vaccine, avian influenza, parent protocol|influenza, h5n1, vaccine, avian influenza, parent protocol
5649740|NCT00703040|Care engagement|care engagement
5649741|NCT00703040|Linkage to care|linkage to care
5649742|NCT00703040|HIV Infections|hiv infections
5649743|NCT00703027|diabetes mellitus|diabetes mellitus
5649744|NCT00703027|care decision|care decision
5649745|NCT00703027|data mining|data mining
5649746|NCT00703014|Neonatal outcome|neonatal outcome
5649747|NCT00703014|Congenital malformations|congenital malformations
5649748|NCT00703014|In-Vitro fertilization|in-vitro fertilization
5649749|NCT00703014|Controlled ovarian stimulation|controlled ovarian stimulation
5649750|NCT00703014|Follow-up|follow-up
5649751|NCT00702988|Neonatal outcome|neonatal outcome
5649752|NCT00702988|Congenital malformations|congenital malformations
5649753|NCT00702988|In-Vitro Fertilization|in-vitro fertilization
5649754|NCT00702988|Controlled ovarian stimulation|controlled ovarian stimulation
5649755|NCT00702988|Follow-up|follow-up
5649756|NCT00702975|phase II|phase ii
5649757|NCT00702975|NSCLC|nsclc
5649758|NCT00702975|bevacizumab|bevacizumab
5649759|NCT00702975|erlotinib|erlotinib
5649760|NCT00702975|metastatic NSCLC|metastatic nsclc
5649761|NCT00702962|lung cancer|lung cancer
5649762|NCT00702962|small cell lung cancer|small cell lung cancer
5649763|NCT00702949|breast cancer|breast cancer
5649764|NCT00702949|hot flashes|hot flashes
5649765|NCT00702923|Stage D0 Prostate Cancer|stage d0 prostate cancer
5649766|NCT00702923|Rising PSA|rising psa
5649767|NCT00702923|Casodex|casodex
5649768|NCT00702923|Tremelimumab|tremelimumab
5649769|NCT00702910|Asthma patients|asthma patients
5649770|NCT00702910|Magnesium stearate|magnesium stearate
5649771|NCT00702910|Tolerability|tolerability
5649772|NCT00702910|Safety|safety
5649773|NCT00702910|Lactose|lactose
5649774|NCT00702910|GW642444M|gw642444m
5649775|NCT00702910|Pharmacodynamics|pharmacodynamics
5649776|NCT00702910|Efficacy|efficacy
5649777|NCT00702910|Pharmacokinetics|pharmacokinetics
5649778|NCT00702884|recurrent esophageal cancer|recurrent esophageal cancer
5649779|NCT00702884|stage IIIA esophageal cancer|stage iiia esophageal cancer
5649780|NCT00702884|stage IIIB esophageal cancer|stage iiib esophageal cancer
5649781|NCT00702884|stage IIIC esophageal cancer|stage iiic esophageal cancer
5649782|NCT00702884|stage IV esophageal cancer|stage iv esophageal cancer
5649783|NCT00702871|Ventilator Associated Pneumonia|ventilator associated pneumonia
5649784|NCT00702871|antimicrobial susceptibility pattern|antimicrobial susceptibility pattern
5649785|NCT00702871|stress ulcer prophylaxis|stress ulcer prophylaxis
5649786|NCT00702858|Breast Cancer|breast cancer
5649790|NCT00702845|Pharmacological effects of drugs|pharmacological effects of drugs
5649792|NCT00702845|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5649793|NCT00702845|Pharmacological Actions|pharmacological actions
5649794|NCT00702845|Randomized|randomized
5649795|NCT00702845|Multi-center|multi-center
5649796|NCT00702845|Multi-national|multi-national
5649797|NCT00702845|Double-blind|double-blind
5649799|NCT00702845|Equivalence|equivalence
5649800|NCT00702832|Vestibular rehabilitation|vestibular rehabilitation
5649801|NCT00702832|acute vestibular injury|acute vestibular injury
5649802|NCT00702832|Dizziness|dizziness
5649804|NCT00702832|Nystagmus|nystagmus
5649805|NCT00702832|Daily life activities|daily life activities
5649806|NCT00702832|Balance|balance
5649807|NCT00702832|physiotherapy|physiotherapy
5649808|NCT00702819|Pan-Vascular Endothelial Growth Factor Blockade|pan-vascular endothelial growth factor blockade
5649809|NCT00702819|Safety|safety
5649810|NCT00702806|Pharmacological effects of drugs|pharmacological effects of drugs
5649811|NCT00702806|Hormones|hormones
5649812|NCT00702806|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5649813|NCT00702806|Pharmacological Actions|pharmacological actions
5643453|NCT00727233|NF1|nf1
5649814|NCT00702806|Randomized|randomized
5649815|NCT00702806|Multi-center|multi-center
5649816|NCT00702806|Multi-national|multi-national
5649817|NCT00702793|Smoking cessation|smoking cessation
5649818|NCT00702793|schizophrenia|schizophrenia
5649819|NCT00702793|schizoaffective|schizoaffective
5649820|NCT00702793|psychosis|psychosis
5649821|NCT00702793|varenicline|varenicline
5649823|NCT00702793|chantix|chantix
5649824|NCT00702793|nicotine dependence|nicotine dependence
5649825|NCT00702780|Alzheimer's disease|alzheimer's disease
5649826|NCT00702780|escitalopram|escitalopram
5649827|NCT00702780|MRI|mri
5649828|NCT00702767|This study was completed in October 2006|this study was completed in october 2006
5649829|NCT00702741|Knee|knee
5649830|NCT00702741|Meniscus|meniscus
5649831|NCT00702741|Meniscectomy|meniscectomy
5649832|NCT00702741|Mesenchymal Stem Cells|mesenchymal stem cells
5649833|NCT00702741|MSCs|mscs
5649834|NCT00702741|Adult Human Stem Cells|adult human stem cells
5649835|NCT00702741|Osiris|osiris
5649836|NCT00702741|Chondrogen|chondrogen
5649837|NCT00702728|Contrast induced nephropathy|contrast induced nephropathy
5649838|NCT00702728|Furosemide|furosemide
5649839|NCT00702728|Percutaneous coronary interventions|percutaneous coronary interventions
5649840|NCT00702728|Saline hydration|saline hydration
5649841|NCT00702702|Uterine fibroids|uterine fibroids
5649842|NCT00702702|Anemia|anemia
5649843|NCT00702689|Skin Sclerosis|skin sclerosis
5649844|NCT00702689|Graft Versus Host Disease|graft versus host disease
5649845|NCT00702676|Healthy Volunteers|healthy volunteers
5649846|NCT00702663|Hepatitis B|hepatitis b
5649847|NCT00702663|Hepatitis B vaccination|hepatitis b vaccination
5649848|NCT00702663|booster effect|booster effect
5649849|NCT00702663|Taiwan|taiwan
5649850|NCT00702663|young adults|young adults
5649851|NCT00702637|Traumatic Brain Injury|traumatic brain injury
5649852|NCT00702637|Fatigue|fatigue
5649853|NCT00702637|Modafinil|modafinil
5649854|NCT00702637|Somnolence|somnolence
5649855|NCT00702624|Neonatal outcome|neonatal outcome
5649856|NCT00702624|Congenital malformations|congenital malformations
5649857|NCT00702624|In-Vitro fertilization|in-vitro fertilization
5649858|NCT00702624|Controlled ovarian stimulation|controlled ovarian stimulation
5649859|NCT00702624|Follow-up|follow-up
5649860|NCT00702611|Ulcerative Colitis|ulcerative colitis
5649861|NCT00702611|Inflammatory Bowel disease|inflammatory bowel disease
5649862|NCT00702611|Steroid dependent|steroid dependent
5649863|NCT00702611|Adacolumn|adacolumn
5649864|NCT00702611|Apheresis|apheresis
5649865|NCT00702611|Granulocyte Monocyte apheresis|granulocyte monocyte apheresis
5649866|NCT00702611|GMA apheresis|gma apheresis
5649867|NCT00702611|Granulocytapheresis|granulocytapheresis
5649868|NCT00702598|Depression|depression
5649869|NCT00702598|occupational function|occupational function
5649870|NCT00702598|rating scales|rating scales
5649871|NCT00702598|RCT|rct
5649872|NCT00702598|cognitive behaviour therapy|cognitive behaviour therapy
5649873|NCT00702598|CBT|cbt
5649874|NCT00702598|escitalopram|escitalopram
5649875|NCT00702598|antidepressants|antidepressants
5649876|NCT00702585|Ovulation Induction|ovulation induction
5649877|NCT00702585|Pharmacological effects of drugs|pharmacological effects of drugs
5649878|NCT00702585|Hormones|hormones
5649879|NCT00702585|Hormone substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5649880|NCT00702585|Pharmacological Actions|pharmacological actions
5649888|NCT00702546|Cumulative pregnancy data|cumulative pregnancy data
5652594|NCT00691288|HIV|hiv
5649899|NCT00702520|Neonatal outcome|neonatal outcome
5649900|NCT00702520|Congenital malformations|congenital malformations
5649901|NCT00702520|In-Vitro fertilization|in-vitro fertilization
5649902|NCT00702520|Controlled ovarian stimulation|controlled ovarian stimulation
5649904|NCT00702507|Diaper dermatitis complicated by candidiasis|diaper dermatitis complicated by candidiasis
5649905|NCT00702494|placental growth factor|placental growth factor
5649906|NCT00702494|monoclonal antibody|monoclonal antibody
5649907|NCT00702494|Phase I|phase i
5649908|NCT00702494|solid tumors|solid tumors
5649909|NCT00702494|Patients with solid tumors|patients with solid tumors
5649910|NCT00702481|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
5649911|NCT00702481|Chemoradiation|chemoradiation
5649912|NCT00702481|EGFR monoclonal antibody|egfr monoclonal antibody
5649913|NCT00702468|Spasticity|spasticity
5649914|NCT00702468|Multiple Sclerosis|multiple sclerosis
5649915|NCT00702455|Weight loss maintenance.|weight loss maintenance.
5649916|NCT00702455|Interactive phone and mail-based intervention.|interactive phone and mail-based intervention.
5649917|NCT00702442|Nausea, Vomiting|nausea, vomiting
5649918|NCT00702442|Vomiting episodes|vomiting episodes
5649919|NCT00702416|Analgesia, Patient-controlled|analgesia, patient-controlled
5649920|NCT00702416|Anesthesia, Regional|anesthesia, regional
5649921|NCT00702416|Ultrasound|ultrasound
5649922|NCT00702416|Postoperative Pain|postoperative pain
5649923|NCT00702416|Brachial Plexus|brachial plexus
5649924|NCT00702364|Attention|attention
5649925|NCT00702364|Traumatic Brain INjury|traumatic brain injury
5649926|NCT00702364|Atomoxetine|atomoxetine
5649927|NCT00702364|Strattera|strattera
5649928|NCT00702351|Infertility|infertility
5649929|NCT00702351|Pharmacological effects of drugs|pharmacological effects of drugs
5649930|NCT00702351|Drug therapy|drug therapy
5649931|NCT00702351|Hormones|hormones
5649932|NCT00702351|GnRH agonist|gnrh agonist
5649933|NCT00702351|RecFSH|recfsh
5649934|NCT00702351|Corifollitropin alfa|corifollitropin alfa
5649935|NCT00702351|Open-label|open-label
5649936|NCT00702338|Neonatal outcome|neonatal outcome
5649937|NCT00702338|Congenital malformations|congenital malformations
5649938|NCT00702338|Ovulation Induction|ovulation induction
5649939|NCT00702338|Follow-up|follow-up
5649940|NCT00702325|Asthma|asthma
5649941|NCT00702312|Blood pressure|blood pressure
5649942|NCT00702299|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5649943|NCT00702299|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5649944|NCT00702299|peritoneal cavity cancer|peritoneal cavity cancer
5649945|NCT00702299|fallopian tube cancer|fallopian tube cancer
5649946|NCT00702286|Surface acoustic ultrasound|surface acoustic ultrasound
5649947|NCT00702286|biofilm formation|biofilm formation
5649948|NCT00702286|percoutaneous nephrostomy tube|percoutaneous nephrostomy tube
5649949|NCT00702286|Patients requiring per coetaneous drainage due to urinary|patients requiring per coetaneous drainage due to urinary
5649950|NCT00702286|tract obstruction|tract obstruction
5649951|NCT00702286|To evaluate the efficacy of surface acoustic wave in|to evaluate the efficacy of surface acoustic wave in
5649952|NCT00702286|reducing pain and improving drainage|reducing pain and improving drainage
5649953|NCT00702273|In-vitro fertilization|in-vitro fertilization
5649954|NCT00702273|Controlled Ovarian Stimulation|controlled ovarian stimulation
5649955|NCT00702273|Cumulative pregnancy data|cumulative pregnancy data
5649956|NCT00702273|Follow-up|follow-up
5649957|NCT00702247|Multiple Myeloma - Nonmyeloablative transplantation - Autologous Transplant - Graft versus myeloma|multiple myeloma - nonmyeloablative transplantation - autologous transplant - graft versus myeloma
5649958|NCT00702247|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5649959|NCT00702247|Tandem Auto-Allo Transplant|tandem auto-allo transplant
5649960|NCT00702247|Overall survival|overall survival
5649961|NCT00702247|Event free survival|event free survival
5649962|NCT00702247|Disease response|disease response
5649963|NCT00702234|Neonatal outcome|neonatal outcome
5649964|NCT00702234|Congenital malformations|congenital malformations
5649965|NCT00702234|In-Vitro fertilization|in-vitro fertilization
5649966|NCT00702234|Controlled ovarian stimulation|controlled ovarian stimulation
5649967|NCT00702234|Follow-up|follow-up
5649968|NCT00702221|high blood pressure|high blood pressure
5649969|NCT00702221|vaccines|vaccines
5649970|NCT00702208|cervical cytology|cervical cytology
5649971|NCT00702208|Pap smear|pap smear
5649972|NCT00702208|self-sampling|self-sampling
5649973|NCT00702208|abnormal|abnormal
5649974|NCT00702208|normal|normal
5649975|NCT00702195|Neonatal outcome|neonatal outcome
5649976|NCT00702195|Congenital malformations|congenital malformations
5649977|NCT00702195|In-Vitro Fertilization|in-vitro fertilization
5649978|NCT00702195|Controlled ovarian stimulation|controlled ovarian stimulation
5649979|NCT00702195|Follow-up|follow-up
5649980|NCT00702195|Ovulation Induction|ovulation induction
5649981|NCT00702195|Neonates|neonates
5649982|NCT00702182|Lung Cancer|lung cancer
5649983|NCT00702182|Vinorelbine|vinorelbine
5649984|NCT00702182|Erlotinib|erlotinib
5649985|NCT00702182|Phase 1|phase 1
5649986|NCT00702169|high frequency ventilation monitoring|high frequency ventilation monitoring
5649987|NCT00702169|lung disease|lung disease
5649988|NCT00702169|Respiratory distress syndrome|respiratory distress syndrome
5649989|NCT00702169|lung barotrauma|lung barotrauma
5649990|NCT00702169|mechanical ventilation|mechanical ventilation
5649991|NCT00702169|endotracheal tube displacement|endotracheal tube displacement
5649992|NCT00702169|endotracheal tube occlusion|endotracheal tube occlusion
5649993|NCT00702169|one lung intubation|one lung intubation
5649994|NCT00702156|Heart Failure|heart failure
5649995|NCT00702156|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5649996|NCT00702156|Beta-blockers|beta-blockers
5649997|NCT00702156|Pulmonary Function|pulmonary function
5649998|NCT00702130|Ventilator Associated Pneumonia|ventilator associated pneumonia
5649999|NCT00702104|prostate cancer|prostate cancer
5650001|NCT00702078|home-based treatment|home-based treatment
5650002|NCT00702078|early intervention|early intervention
5650003|NCT00702065|Multiple Sclerosis Quality of life|multiple sclerosis quality of life
5650004|NCT00702052|Mantle Cell Lymphoma|mantle cell lymphoma
5650006|NCT00702052|B-Cell Lymphoma|b-cell lymphoma
5650007|NCT00702052|Mantle Zone Lymphoma|mantle zone lymphoma
5650008|NCT00702052|Refractory Lymphoma|refractory lymphoma
5650009|NCT00702052|Aggressive Lymphoma|aggressive lymphoma
5650010|NCT00702052|PILLAR-1|pillar-1
5650011|NCT00702026|Irritable Bowel Syndrome|irritable bowel syndrome
5650012|NCT00702026|Hypersensitivity|hypersensitivity
5650013|NCT00702026|Probiotics|probiotics
5650014|NCT00702026|Multispecies|multispecies
5650015|NCT00702013|P-glycoprotein|p-glycoprotein
5650016|NCT00702013|lymphocyte|lymphocyte
5650017|NCT00702013|HIV|hiv
5650018|NCT00702013|children|children
5650019|NCT00702013|ontogenesis|ontogenesis
5650020|NCT00702013|Ontogenesis P-gp in human lymphocytes|ontogenesis p-gp in human lymphocytes
5650021|NCT00702013|Study of the influence of HIV infection|study of the influence of hiv infection
5650022|NCT00702013|Antiretroviral treatments on P-gp activity|antiretroviral treatments on p-gp activity
5650023|NCT00702013|Expression in human lymphocytes|expression in human lymphocytes
5650024|NCT00702000|ICU acquired paresis|icu acquired paresis
5650025|NCT00701987|Cutaneous Metastatic Melanoma|cutaneous metastatic melanoma
5650026|NCT00701974|Non-inferiority based on efficiency|non-inferiority based on efficiency
5650027|NCT00701961|Mefloquine-artesunate|mefloquine-artesunate
5650028|NCT00701961|Malaria|malaria
5650029|NCT00701961|Pregnancy|pregnancy
5650030|NCT00701961|Pharmacokinetics|pharmacokinetics
5650031|NCT00701961|Sub-Saharan Africa|sub-saharan africa
5650032|NCT00701961|P falciparum malaria infection in pregnancy|p falciparum malaria infection in pregnancy
5650033|NCT00701948|Late onset neonatal sepsis|late onset neonatal sepsis
5650034|NCT00701948|Nosocomial bacterial infection|nosocomial bacterial infection
5650035|NCT00701948|Inflammatory markers|inflammatory markers
5650036|NCT00701948|multiplex dosage|multiplex dosage
5650037|NCT00701935|diabetes mellitus|diabetes mellitus
5650038|NCT00701935|Amylin|amylin
5650039|NCT00701935|Lilly|lilly
5650040|NCT00701922|lung transplantation|lung transplantation
5650041|NCT00701922|Bronchiolitis Obliterans|bronchiolitis obliterans
5650042|NCT00701922|Epstein-Barr Virus Infections|epstein-barr virus infections
5650043|NCT00701922|Paramyxoviridae Infections|paramyxoviridae infections
5650044|NCT00701922|Herpesviridae|herpesviridae
5650045|NCT00701909|wound care|wound care
5650046|NCT00701909|procedural pain intensity|procedural pain intensity
5650047|NCT00701909|procedural hyperalgesia|procedural hyperalgesia
5650048|NCT00701909|wound care pain intensity|wound care pain intensity
5650049|NCT00701909|wound care hyperalgesia|wound care hyperalgesia
5650050|NCT00701909|Wound care pain quality|wound care pain quality
5650051|NCT00701909|Level of drowsiness|level of drowsiness
5650052|NCT00701909|level of nausea|level of nausea
5650053|NCT00701909|Level of vomiting|level of vomiting
5650054|NCT00701909|Level of hallucinations|level of hallucinations
5650055|NCT00701909|Level of dysphoria|level of dysphoria
5650056|NCT00701896|HIV|hiv
5650057|NCT00701896|Positive|positive
5650058|NCT00701896|Smokers|smokers
5650059|NCT00701896|Varenicline|varenicline
5650060|NCT00701883|Cholesterol|cholesterol
5650061|NCT00701883|Hyperlipidemia|hyperlipidemia
5650062|NCT00701883|HDL|hdl
5650063|NCT00701883|LDL|ldl
5650064|NCT00701883|Triglycerides|triglycerides
5650065|NCT00701883|Dyslipidemia|dyslipidemia
5650066|NCT00701870|NSCLC|nsclc
5650555|NCT00699686|Endothelium|endothelium
5650067|NCT00701870|Chemotherapy induced neutropenia|chemotherapy induced neutropenia
5650069|NCT00701857|stage III esophageal cancer|stage iii esophageal cancer
5650070|NCT00701857|stage IV esophageal cancer|stage iv esophageal cancer
5650071|NCT00701844|Aplastic Anemia|aplastic anemia
5650072|NCT00701844|Lymphatic Diseases|lymphatic diseases
5650073|NCT00701844|Leukemia|leukemia
5650074|NCT00701844|Leukemia, Lymphoid|leukemia, lymphoid
5650075|NCT00701844|Immunoproliferative Disorders|immunoproliferative disorders
5650076|NCT00701844|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5650077|NCT00701844|Anemia|anemia
5650078|NCT00701844|Quality of Life|quality of life
5650079|NCT00701844|Lymphoproliferative Disorders|lymphoproliferative disorders
5650080|NCT00701844|Lymphoma|lymphoma
5650081|NCT00701844|Multiple Myeloma|multiple myeloma
5650082|NCT00701805|Secondary hyperparathyroidism|secondary hyperparathyroidism
5650085|NCT00701792|cirrhosis transplantation|cirrhosis transplantation
5650086|NCT00701779|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5650087|NCT00701779|Dutasteride|dutasteride
5650088|NCT00701779|Tamsulosin|tamsulosin
5650089|NCT00701753|Pharmacogenetic|pharmacogenetic
5650090|NCT00701753|DNA|dna
5650091|NCT00701753|RNA|rna
5650092|NCT00701753|Antipsychotic|antipsychotic
5650093|NCT00701753|Olanzapine|olanzapine
5650094|NCT00701753|Risperidone|risperidone
5650095|NCT00701753|Quetiapine|quetiapine
5650096|NCT00701753|Personalized medicine|personalized medicine
5650097|NCT00701740|photoaging|photoaging
5650098|NCT00701740|isotretinoin|isotretinoin
5650099|NCT00701740|profilometry|profilometry
5650100|NCT00701740|digital analysis|digital analysis
5650101|NCT00701727|metabolic diseases|metabolic diseases
5650102|NCT00701727|metabolic disorder|metabolic disorder
5650103|NCT00701727|dyslipidemias|dyslipidemias
5650104|NCT00701727|lipid metabolism disorders|lipid metabolism disorders
5650105|NCT00701714|Treatment|treatment
5650106|NCT00701714|associated|associated
5650107|NCT00701714|with CRI|with cri
5650108|NCT00701688|Mucositis, Oral|mucositis, oral
5650109|NCT00701688|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5650110|NCT00701688|Allogeneic Transplantation|allogeneic transplantation
5650111|NCT00701688|Pharmacokinetics|pharmacokinetics
5650112|NCT00701688|Maximum Tolerated Dose|maximum tolerated dose
5650113|NCT00701675|sertraline|sertraline
5650114|NCT00701675|pharmacotherapy|pharmacotherapy
5650115|NCT00701675|geriatric|geriatric
5650116|NCT00701649|mild essential hypertension|mild essential hypertension
5650117|NCT00701649|moderate essential hypertension|moderate essential hypertension
5650118|NCT00701636|Daptomycin|daptomycin
5650119|NCT00701636|Antibiotic Prophylaxis|antibiotic prophylaxis
5650120|NCT00701636|Pharmacokinetics|pharmacokinetics
5650121|NCT00701636|Surgical Wound Infection|surgical wound infection
5650122|NCT00701636|Staphylococcus aureus|staphylococcus aureus
5650123|NCT00701636|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
5650124|NCT00701623|The intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.|the intention of this work is to verify the effectiveness and safety of sodium heparin in the treatment of burns of the skin.
5650125|NCT00701610|Von Willebramd Factor (VWF)|von willebramd factor (vwf)
5650126|NCT00701610|All infants born in our hospital since August 2007 ill august 2009 will enter.|all infants born in our hospital since august 2007 ill august 2009 will enter.
5650127|NCT00701610|Therombocytopenia, maternal aspirin will be excluded|therombocytopenia, maternal aspirin will be excluded
5650128|NCT00701597|ocular blood flow dysregulation, glaucoma, endothelin-1|ocular blood flow dysregulation, glaucoma, endothelin-1
5650129|NCT00701584|Phytoestrogens|phytoestrogens
5650130|NCT00701584|Isoflavones|isoflavones
5650132|NCT00701584|Breast cancer survival|breast cancer survival
5650133|NCT00701584|breast cancer recurrence|breast cancer recurrence
5650134|NCT00701571|Virtual Reality|virtual reality
5650135|NCT00701571|Oncology|oncology
5650136|NCT00701571|Lumbar puncture|lumbar puncture
5650137|NCT00701545|von Willebrand disease|von willebrand disease
5650138|NCT00701545|VWD, Humate-P®|vwd, humate-p®
5650139|NCT00701545|Infusion volume reduced|infusion volume reduced
5650141|NCT00701532|Cocaine|cocaine
5650142|NCT00701532|Substance abuse|substance abuse
5650143|NCT00701532|Addiction|addiction
5650144|NCT00701532|Dependence|dependence
5650145|NCT00701532|Modafinil|modafinil
5650146|NCT00701532|Brain imaging|brain imaging
5650147|NCT00701519|CHF,|chf,
5650148|NCT00701519|Sleep apnea,|sleep apnea,
5650149|NCT00701519|Obstructive sleep apnea,|obstructive sleep apnea,
5650150|NCT00701519|Heart failure|heart failure
5650151|NCT00701506|Knee|knee
5650152|NCT00701506|Osteoarthritis|osteoarthritis
5650153|NCT00701506|Treatment|treatment
5650154|NCT00701506|Electrostimulation|electrostimulation
5650155|NCT00701493|Topiramate|topiramate
5650156|NCT00701493|Topiramate oral liquid|topiramate oral liquid
5650157|NCT00701493|TOPAMAX Sprinkle capsule|topamax sprinkle capsule
5650158|NCT00701493|topiramate capsules|topiramate capsules
5650159|NCT00701480|acne|acne
5650160|NCT00701480|skin cleanser|skin cleanser
5650161|NCT00701480|Hibiscus sabdariffa|hibiscus sabdariffa
5650162|NCT00701480|Roselle|roselle
5650163|NCT00701480|safety|safety
5650164|NCT00701480|efficacy|efficacy
5650165|NCT00701467|ICD|icd
5650166|NCT00701467|ICD implanted patients|icd implanted patients
5650167|NCT00701454|Thai-muslim|thai-muslim
5650168|NCT00701454|Thai-HALAL|thai-halal
5650169|NCT00701454|Diabetes|diabetes
5650170|NCT00701454|Hypertension|hypertension
5650171|NCT00701454|Hyperlipidemia|hyperlipidemia
5650172|NCT00701454|Metabolic syndrome|metabolic syndrome
5650173|NCT00701441|sleep apnea,|sleep apnea,
5650174|NCT00701441|oxidative stress|oxidative stress
5650175|NCT00701428|Hypertension|hypertension
5650176|NCT00701428|Sleep Apnea|sleep apnea
5650177|NCT00701428|Angiotensin II antagonist|angiotensin ii antagonist
5650178|NCT00701428|CPAP|cpap
5650179|NCT00701415|α-GAL, α-Galactosidase-A, r-hαGAL|α-gal, α-galactosidase-a, r-hαgal
5650180|NCT00701402|time to lipid-lowering drug implementation|time to lipid-lowering drug implementation
5650181|NCT00701402|dyslipidemic patients|dyslipidemic patients
5650182|NCT00701376|Gastric Bypass surgery|gastric bypass surgery
5650183|NCT00701376|Hepatic disease|hepatic disease
5650184|NCT00701376|Hepatic function|hepatic function
5650186|NCT00701350|Intra-amniotic Infection|intra-amniotic infection
5650187|NCT00701350|Preterm Birth|preterm birth
5650188|NCT00701350|Preterm Premature Rupture of Membranes|preterm premature rupture of membranes
5650189|NCT00701337|Estrogen Replacement Therapy|estrogen replacement therapy
5650190|NCT00701337|menopausal women|menopausal women
5650191|NCT00701311|Prostatitis|prostatitis
5650192|NCT00701311|Pelvic pain|pelvic pain
5650193|NCT00701285|heart failure|heart failure
5650194|NCT00701285|pitavastatin|pitavastatin
5650195|NCT00701285|pravastatin|pravastatin
5650196|NCT00701285|statin|statin
5650197|NCT00701259|Frequent heartburn, proton pump inhibitor, lansoprazole|frequent heartburn, proton pump inhibitor, lansoprazole
5650198|NCT00701259|Treatment of|treatment of
5650199|NCT00701259|over 14 days|over 14 days
5650200|NCT00701246|Anemia|anemia
5650201|NCT00701246|Iron deficiency anemia|iron deficiency anemia
5650202|NCT00701246|Infants|infants
5650203|NCT00701246|Children|children
5650204|NCT00701246|Clinical trials|clinical trials
5650205|NCT00701246|Ferrous sulfate|ferrous sulfate
5650206|NCT00701246|Folic acid|folic acid
5650207|NCT00701246|Daycare centers|daycare centers
5650208|NCT00701246|Anaemia in children|anaemia in children
5650209|NCT00701246|born at term|born at term
5650210|NCT00701246|non-twins|non-twins
5650211|NCT00701246|with parental approval for participation in the study|with parental approval for participation in the study
5650212|NCT00701246|growth|growth
5650213|NCT00701220|Cardiovascular Disease|cardiovascular disease
5650215|NCT00701220|Heart Disease|heart disease
5650216|NCT00701220|Myocardial Disease|myocardial disease
5650217|NCT00701220|Myocardial Ischemia|myocardial ischemia
5650218|NCT00701207|To determine if nicotine treatment reduces lung inflammation|to determine if nicotine treatment reduces lung inflammation
5650219|NCT00701194|placement instability|placement instability
5650220|NCT00701194|disruptive behavior disorders|disruptive behavior disorders
5650221|NCT00701194|school readiness|school readiness
5650222|NCT00701194|developmental delays|developmental delays
5650223|NCT00701194|cortisol|cortisol
5650224|NCT00701194|executive functioning|executive functioning
5650225|NCT00701194|therapeutic foster care|therapeutic foster care
5650226|NCT00701194|prevention|prevention
5650227|NCT00701194|early intervention|early intervention
5650228|NCT00701181|Phase II|phase ii
5650229|NCT00701181|Prospective|prospective
5650230|NCT00701181|Randomized|randomized
5650231|NCT00701181|Diabetic Macular Edema|diabetic macular edema
5650232|NCT00701181|PF-04523655|pf-04523655
5650233|NCT00701181|Laser|laser
5650234|NCT00701129|Glycogenesis 2|glycogenesis 2
5650235|NCT00701129|Acid|acid
5650236|NCT00701129|Maltase|maltase
5650237|NCT00701129|Deficiency|deficiency
5650238|NCT00701090|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5650239|NCT00701090|Non Insulin Dependent|non insulin dependent
5650240|NCT00701077|Brugada syndrome|brugada syndrome
5650241|NCT00701077|Electrophysiological study|electrophysiological study
5650242|NCT00701077|Ion channel blockade|ion channel blockade
5650243|NCT00701064|posttraumatic stress disorder|posttraumatic stress disorder
5650244|NCT00701064|phototherapy|phototherapy
5650245|NCT00701064|anxiety|anxiety
5650246|NCT00701064|depression|depression
5650247|NCT00701064|sleep|sleep
5650248|NCT00701064|negative ion generator|negative ion generator
5650249|NCT00701038|Sleep apnea,|sleep apnea,
5650250|NCT00701038|obstructive sleep apnea,|obstructive sleep apnea,
5650251|NCT00701038|heart failure,|heart failure,
5650253|NCT00701025|inflammation in asthmatic and non-asthmatic participants|inflammation in asthmatic and non-asthmatic participants
5650254|NCT00701012|low or high ligation|low or high ligation
5650255|NCT00700986|Electroretinography|electroretinography
5650256|NCT00700986|Rheumatoid Arthritis|rheumatoid arthritis
5650257|NCT00700986|Anti-TNF|anti-tnf
5650258|NCT00700986|Disease Modifying Anti-Rheumatic Drugs (DMARD)|disease modifying anti-rheumatic drugs (dmard)
5650259|NCT00700973|anger|anger
5650265|NCT00700947|Mitral Valve Insufficiency|mitral valve insufficiency
5650266|NCT00700947|Heart Surgery|heart surgery
5650267|NCT00700947|Heart Valve Surgery|heart valve surgery
5650268|NCT00700934|FEV1|fev1
5650269|NCT00700934|mortality|mortality
5650270|NCT00700934|Quality of life|quality of life
5650271|NCT00700908|type 2 diabetes|type 2 diabetes
5650272|NCT00700908|telephone intervention|telephone intervention
5650273|NCT00700908|automated|automated
5650279|NCT00700869|Altered level of consciousness|altered level of consciousness
5650280|NCT00700869|Tracheal tube withdrawal|tracheal tube withdrawal
5650281|NCT00700869|Respiration|respiration
5650282|NCT00700869|Artificial Respiration|artificial respiration
5650283|NCT00700869|Physiology|physiology
5650284|NCT00700856|diabetes|diabetes
5650285|NCT00700856|cardiovascular disease|cardiovascular disease
5650286|NCT00700856|pioglitazone|pioglitazone
5650287|NCT00700856|sulphonylurea|sulphonylurea
5650288|NCT00700856|metformin monotherapy|metformin monotherapy
5650289|NCT00700856|hypoglycemic therapy|hypoglycemic therapy
5650290|NCT00700843|bariatric surgery|bariatric surgery
5650291|NCT00700843|long term follow up|long term follow up
5650292|NCT00700843|gastric partitioning surgery|gastric partitioning surgery
5650293|NCT00700843|Roux-en-Y gastric bypass surgery|roux-en-y gastric bypass surgery
5650294|NCT00700843|obesity|obesity
5650295|NCT00700804|Calcium retention|calcium retention
5650296|NCT00700804|dietary protein|dietary protein
5650297|NCT00700804|dietary calcium|dietary calcium
5650298|NCT00700791|Single and bilateral body contouring surgical sites.|single and bilateral body contouring surgical sites.
5650299|NCT00700778|breast cancer|breast cancer
5650300|NCT00700778|BRCA1 mutation carrier|brca1 mutation carrier
5650301|NCT00700739|Cervical|cervical
5650303|NCT00700739|Arthroplasty|arthroplasty
5650304|NCT00700739|Spinal|spinal
5650305|NCT00700726|blood test|blood test
5650306|NCT00700726|asthma|asthma
5650307|NCT00700726|skin test|skin test
5650308|NCT00700713|Meningitis|meningitis
5650309|NCT00700713|Meningococcemia|meningococcemia
5650310|NCT00700713|Neisseria meningitidis|neisseria meningitidis
5650311|NCT00700713|Menactra®|menactra®
5650312|NCT00700700|Congestive Heart Failure|congestive heart failure
5650313|NCT00700700|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5650314|NCT00700700|Dyspnea|dyspnea
5650315|NCT00700700|Exercise Tolerance|exercise tolerance
5650316|NCT00700687|cardiovascular prophylactic therapy|cardiovascular prophylactic therapy
5650317|NCT00700674|EEG entropy|eeg entropy
5650318|NCT00700674|Elderly|elderly
5650319|NCT00700674|Decreases|decreases
5650320|NCT00700674|POCD|pocd
5650321|NCT00700674|Use of EEG entropy|use of eeg entropy
5650322|NCT00700674|Geriatric|geriatric
5650323|NCT00700635|Meningitis; Meningococcal infection, Neisseria meningitidis|meningitis; meningococcal infection, neisseria meningitidis
5650324|NCT00700609|Depression|depression
5650325|NCT00700609|Family Therapy|family therapy
5650326|NCT00700609|Adolescents|adolescents
5650328|NCT00700596|SA|sa
5650329|NCT00700596|Salvinorin|salvinorin
5650330|NCT00700596|Psychotomimetic Effects|psychotomimetic effects
5650331|NCT00700583|nocturia|nocturia
5650332|NCT00700583|bladder|bladder
5650333|NCT00700583|urination disorders|urination disorders
5650334|NCT00700583|hydrochlorothiazide|hydrochlorothiazide
5650335|NCT00700583|terazosin|terazosin
5650336|NCT00700557|Antibiotic Associated Diarrhea|antibiotic associated diarrhea
5650337|NCT00700557|probiotics|probiotics
5650338|NCT00700557|treatment|treatment
5650339|NCT00700544|AML|aml
5650340|NCT00700544|elderly patients|elderly patients
5650341|NCT00700544|Treatment outcome|treatment outcome
5650342|NCT00700531|Hemodialysis|hemodialysis
5650343|NCT00700531|Multiple myeloma|multiple myeloma
5650344|NCT00700531|Cast nephropathy|cast nephropathy
5650345|NCT00700531|Kidney failure|kidney failure
5650346|NCT00700518|Raynaud's Syndrome|raynaud's syndrome
5650347|NCT00700518|Raynaud's Disease|raynaud's disease
5650348|NCT00700518|RP|rp
5650349|NCT00700505|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5650350|NCT00700505|BPH|bph
5650351|NCT00700505|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5650352|NCT00700505|Urinary Retention|urinary retention
5650353|NCT00700505|Shy Bladder|shy bladder
5650354|NCT00700505|Urinary Hesitancy|urinary hesitancy
5650355|NCT00700505|Bashful Bladder|bashful bladder
5650356|NCT00700505|Paruresis|paruresis
5650357|NCT00700492|subfertility|subfertility
5650358|NCT00700492|pregnancy rate|pregnancy rate
5650359|NCT00700492|miscarriage|miscarriage
5650360|NCT00700479|vascular endothelium|vascular endothelium
5650361|NCT00700479|nitric oxide|nitric oxide
5650362|NCT00700479|aldosterone|aldosterone
5650363|NCT00700479|vascular biology|vascular biology
5650364|NCT00700466|Outcome assessment, patients;|outcome assessment, patients;
5650365|NCT00700466|autonomic nervous system;|autonomic nervous system;
5650366|NCT00700466|perioperative care;|perioperative care;
5650367|NCT00700466|adrenergic beta antagonist|adrenergic beta antagonist
5650368|NCT00700466|Autonomic regulation|autonomic regulation
5650369|NCT00700466|Perioperative beta-blockade|perioperative beta-blockade
5650370|NCT00700466|outcome|outcome
5650371|NCT00700440|Radiotherapy|radiotherapy
5650372|NCT00700440|chemotherapy|chemotherapy
5650373|NCT00700440|Drug Targeting|drug targeting
5650374|NCT00700440|loco-regionally advanced nasopharyngeal carcinoma|loco-regionally advanced nasopharyngeal carcinoma
5650375|NCT00700440|Safety.|safety.
5650376|NCT00700440|efficacy|efficacy
5650377|NCT00700427|ADHD|adhd
5650378|NCT00700427|Adult|adult
5650379|NCT00700427|long term|long term
5650380|NCT00700427|maintenance of response|maintenance of response
5650381|NCT00700427|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5650382|NCT00700388|Chronic bronchitis|chronic bronchitis
5650383|NCT00700388|COPD|copd
5650384|NCT00700388|Bronchiectasis|bronchiectasis
5650385|NCT00700375|Patients undergoing an emergent coronary procedure|patients undergoing an emergent coronary procedure
5650386|NCT00700362|Complications|complications
5650388|NCT00700362|Insulin infusion|insulin infusion
5650389|NCT00700349|depression|depression
5650390|NCT00700349|stress|stress
5650391|NCT00700349|microcredit|microcredit
5650392|NCT00700349|poverty|poverty
5650393|NCT00700349|South Africa|south africa
5650394|NCT00700336|malignant pleural mesothelioma|malignant pleural mesothelioma
5650395|NCT00700336|solid tumors|solid tumors
5650396|NCT00700323|ADHD|adhd
5650397|NCT00700323|ADHD diagnosed children|adhd diagnosed children
5650398|NCT00700310|Partial onset seizures|partial onset seizures
5650399|NCT00700310|E2007|e2007
5650400|NCT00700310|perampanel|perampanel
5650401|NCT00700310|refractory partial seizures|refractory partial seizures
5650402|NCT00700310|adjunctive therapy|adjunctive therapy
5650403|NCT00700310|seizure frequency|seizure frequency
5650404|NCT00700310|reduction in seizure frequency|reduction in seizure frequency
5650405|NCT00700310|safety|safety
5650406|NCT00700310|concomitant AED(s)|concomitant aed(s)
5650407|NCT00700297|Oral aphthosis|oral aphthosis
5650408|NCT00700297|Genital aphthosis|genital aphthosis
5650409|NCT00700297|Psuedofolliculitis|psuedofolliculitis
5650410|NCT00700297|Erythem nodusom|erythem nodusom
5650411|NCT00700297|Joint manifestations|joint manifestations
5650412|NCT00700297|Colchicine|colchicine
5650413|NCT00700284|HIV-I|hiv-i
5650414|NCT00700284|Reverse transcriptase inhibitors|reverse transcriptase inhibitors
5650415|NCT00700284|HIV Seronegativity|hiv seronegativity
5650416|NCT00700271|Hypertension|hypertension
5650417|NCT00700271|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5650418|NCT00700245|Obese|obese
5650419|NCT00700245|Adults|adults
5650420|NCT00700232|genetics|genetics
5650421|NCT00700232|gene expression|gene expression
5650422|NCT00700232|MDR3|mdr3
5650423|NCT00700232|estrogens|estrogens
5650425|NCT00700232|pregnancy|pregnancy
5650426|NCT00700232|controls|controls
5650427|NCT00700219|Preterm Labor|preterm labor
5650428|NCT00700219|Preterm Birth|preterm birth
5650429|NCT00700219|Intra-amniotic Infection|intra-amniotic infection
5650430|NCT00700219|Pregnancy|pregnancy
5650431|NCT00700219|Women|women
5650432|NCT00700206|Hematology|hematology
5650433|NCT00700206|MDS|mds
5650434|NCT00700206|Myelodysplastic Syndrome|myelodysplastic syndrome
5650435|NCT00700206|Low Risk MDS|low risk mds
5650436|NCT00700206|Intermediate-1 risk MDS|intermediate-1 risk mds
5650437|NCT00700206|Int-1 risk MDS|int-1 risk mds
5650438|NCT00700206|Telintra|telintra
5650439|NCT00700206|ezatiostat hydrochloride|ezatiostat hydrochloride
5650440|NCT00700206|ezatiostat|ezatiostat
5650441|NCT00700206|TLK199|tlk199
5650442|NCT00700206|Glutathione|glutathione
5650443|NCT00700206|Glutathione analog|glutathione analog
5650444|NCT00700206|Glutathione Transferase|glutathione transferase
5650445|NCT00700206|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5650446|NCT00700206|Glutathione Transferase P1-1 inhibitor|glutathione transferase p1-1 inhibitor
5650447|NCT00700206|GSTp1-1 inhibitor|gstp1-1 inhibitor
5650448|NCT00700206|Apoptosis|apoptosis
5650449|NCT00700206|Differentiation|differentiation
5650450|NCT00700206|Enzyme inhibitor|enzyme inhibitor
5650451|NCT00700167|ANTIGENBEARING DENDRITIC CELLS|antigenbearing dendritic cells
5650452|NCT00700167|98-098|98-098
5650453|NCT00700154|Vascular Surgery|vascular surgery
5650454|NCT00700154|Complications|complications
5650455|NCT00700154|Hyperglycemia|hyperglycemia
5650456|NCT00700154|Insulin infusion|insulin infusion
5650457|NCT00700154|Diabetic ulcers|diabetic ulcers
5650458|NCT00700154|Infection|infection
5650459|NCT00700141|Tachosil|tachosil
5650460|NCT00700141|thyroid|thyroid
5650461|NCT00700141|parathyroid|parathyroid
5651046|NCT00697632|Solid tumor|solid tumor
5650462|NCT00700141|fleece-bound hemostasispathologic processes|fleece-bound hemostasispathologic processes
5650463|NCT00700141|hemorrhage|hemorrhage
5650464|NCT00700141|thyroid surgery|thyroid surgery
5650465|NCT00700128|headaches|headaches
5650466|NCT00700128|migraines|migraines
5650467|NCT00700128|breakthrough bleeding|breakthrough bleeding
5650468|NCT00700128|breakthrough spotting|breakthrough spotting
5650469|NCT00700128|menstrually associated migraines|menstrually associated migraines
5650470|NCT00700128|breakthrough bleeding or breakthrough spotting|breakthrough bleeding or breakthrough spotting
5650471|NCT00700115|HAART|haart
5650472|NCT00700115|lopinavir/ritonavir|lopinavir/ritonavir
5650473|NCT00700115|raltegravir|raltegravir
5650474|NCT00700115|HIV/AIDS patients on HAART|hiv/aids patients on haart
5650475|NCT00700115|Treatment Experienced|treatment experienced
5650476|NCT00700089|Attempted suicide|attempted suicide
5650477|NCT00700089|Assertive intervention|assertive intervention
5650478|NCT00700089|Prevention|prevention
5650479|NCT00700089|Treatment|treatment
5650480|NCT00700076|ORG 25935|org 25935
5650481|NCT00700076|Ketamine|ketamine
5650482|NCT00700076|healthy subjects|healthy subjects
5650483|NCT00700063|Peplin|peplin
5650484|NCT00700063|Actinic keratosis|actinic keratosis
5650485|NCT00700063|PEP005|pep005
5650486|NCT00700050|Cystic Fibrosis|cystic fibrosis
5650487|NCT00700050|Sex hormones|sex hormones
5650488|NCT00700050|Pseudomonas aeruginosa|pseudomonas aeruginosa
5650489|NCT00700050|Paediatrics|paediatrics
5650490|NCT00700024|Body composition|body composition
5650491|NCT00700024|Physical activity|physical activity
5650492|NCT00700024|Metabolic syndrome|metabolic syndrome
5650493|NCT00700011|Myelodysplastic Syndromes|myelodysplastic syndromes
5650495|NCT00699985|Psychological Symptoms|psychological symptoms
5650496|NCT00699985|Behcet's Disease|behcet's disease
5650497|NCT00699972|E2007|e2007
5650498|NCT00699972|perampanel|perampanel
5650499|NCT00699972|refractory partial seizures|refractory partial seizures
5650500|NCT00699972|adjunctive therapy|adjunctive therapy
5650501|NCT00699972|seizure frequency|seizure frequency
5650502|NCT00699972|partial onset seizures|partial onset seizures
5650503|NCT00699972|reduction in seizure frequency|reduction in seizure frequency
5650504|NCT00699972|safety|safety
5650505|NCT00699972|concomitant AED(s)|concomitant aed(s)
5650506|NCT00699959|Coronary patients|coronary patients
5650507|NCT00699959|heart failure|heart failure
5650508|NCT00699959|dyslipidemia|dyslipidemia
5650509|NCT00699946|delirium, atypical antipsychotics, olanzapine, orthopedic|delirium, atypical antipsychotics, olanzapine, orthopedic
5650510|NCT00699933|acute pancreatitis|acute pancreatitis
5650511|NCT00699933|interventional therapy|interventional therapy
5650512|NCT00699933|CT-guided drainage therapy|ct-guided drainage therapy
5650513|NCT00699933|percutaneous necrosectomy|percutaneous necrosectomy
5650514|NCT00699933|Comparison of different diagnostic procedures: MRI, CT, Ultrasound|comparison of different diagnostic procedures: mri, ct, ultrasound
5650515|NCT00699933|Evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies|evaluation of interventional therapy including percutaneous drainage techniques und necrosectomies
5650516|NCT00699907|Ovarian epithelial cancer|ovarian epithelial cancer
5650517|NCT00699907|High risk|high risk
5650518|NCT00699907|Biomarkers|biomarkers
5650520|NCT00699894|prevention of postoperative nausea and vomiting|prevention of postoperative nausea and vomiting
5650521|NCT00699894|aprepitant|aprepitant
5650522|NCT00699894|ondansetron|ondansetron
5650523|NCT00699894|orthognathic surgery|orthognathic surgery
5650524|NCT00699881|Time to Progression|time to progression
5650525|NCT00699881|Toxicity|toxicity
5650526|NCT00699881|Overall survival|overall survival
5650527|NCT00699881|Response rate|response rate
5650528|NCT00699881|Quality of live|quality of live
5650529|NCT00699855|Growth Hormon Deficiency and|growth hormon deficiency and
5650530|NCT00699855|Turner Syndrome in pre-pubertal children|turner syndrome in pre-pubertal children
5650531|NCT00699855|Long term follow-up of predictive markers|long term follow-up of predictive markers
5650532|NCT00699842|Myelodysplastic Syndrome|myelodysplastic syndrome
5650534|NCT00699842|Low to Intermediate-1 MDS|low to intermediate-1 mds
5650535|NCT00699842|Non-deletion 5q|non-deletion 5q
5650536|NCT00699842|Lenalidomide|lenalidomide
5650537|NCT00699790|Diabetes|diabetes
5650539|NCT00699764|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
5650540|NCT00699764|Herpes simplex|herpes simplex
5650541|NCT00699751|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5650542|NCT00699751|Bone Metastases|bone metastases
5650543|NCT00699751|Radium-223|radium-223
5650544|NCT00699738|Healthy women during pregnancy and in the postpartum period|healthy women during pregnancy and in the postpartum period
5650545|NCT00699725|Compliance|compliance
5650546|NCT00699725|gastroprotector therapy|gastroprotector therapy
5650547|NCT00699725|NSAID|nsaid
5650548|NCT00699725|risk factors|risk factors
5650549|NCT00699712|ADHF|adhf
5650550|NCT00699712|AHF|ahf
5650551|NCT00699712|HF|hf
5650552|NCT00699699|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5650553|NCT00699686|Diabetes|diabetes
5650554|NCT00699686|Insulin|insulin
5650556|NCT00699686|Cardiovascular disease|cardiovascular disease
5650557|NCT00699686|Stem cells|stem cells
5650558|NCT00699673|Brain natriuretic peptide|brain natriuretic peptide
5650559|NCT00699673|EuroScore|euroscore
5650560|NCT00699673|Cardiac surgery|cardiac surgery
5650561|NCT00699673|Cardiopulmonary bypass|cardiopulmonary bypass
5650562|NCT00699673|Coronary artery disease|coronary artery disease
5650563|NCT00699673|Valvular disease|valvular disease
5650564|NCT00699673|Risk stratification in cardiac surgery|risk stratification in cardiac surgery
5650565|NCT00699660|Disability Examination|disability examination
5650566|NCT00699660|Clinician Administered PTSD Scale|clinician administered ptsd scale
5650567|NCT00699660|Quality of Care|quality of care
5650568|NCT00699634|Neuropathic|neuropathic
5650569|NCT00699634|Pain|pain
5650570|NCT00699634|Phantom|phantom
5650571|NCT00699634|Limb|limb
5650572|NCT00699621|Intracerebral hemorrhage|intracerebral hemorrhage
5650573|NCT00699621|Hematoma enlargement|hematoma enlargement
5650574|NCT00699621|Antiplatelet agent|antiplatelet agent
5650575|NCT00699621|Platelet transfusion|platelet transfusion
5650576|NCT00699621|Outcome|outcome
5650577|NCT00699608|Zopiclone|zopiclone
5650578|NCT00699608|Hypnotic|hypnotic
5650579|NCT00699608|Residual effects|residual effects
5650580|NCT00699608|Eszopiclone|eszopiclone
5650581|NCT00699582|E2007 (perampanel)|e2007 (perampanel)
5650582|NCT00699582|refractory partial seizures|refractory partial seizures
5650583|NCT00699582|adjunctive therapy|adjunctive therapy
5650584|NCT00699582|seizure frequency|seizure frequency
5650585|NCT00699582|reduction in seizure frequency|reduction in seizure frequency
5650586|NCT00699582|partial onset seizures|partial onset seizures
5650587|NCT00699582|safety|safety
5650588|NCT00699582|concomitant AED(s)|concomitant aed(s)
5650589|NCT00699569|hyperimmune colostrum|hyperimmune colostrum
5650590|NCT00699569|mucositis|mucositis
5650591|NCT00699556|alcohol|alcohol
5650592|NCT00699556|nicotine|nicotine
5650593|NCT00699556|smoking cessation|smoking cessation
5650594|NCT00699556|smoking cessation medications|smoking cessation medications
5650595|NCT00699530|Prolactin|prolactin
5650596|NCT00699530|Insulin resistance|insulin resistance
5650597|NCT00699530|Glucose tolerance|glucose tolerance
5650598|NCT00699530|Body Composition|body composition
5650599|NCT00699530|Substrate metabolism|substrate metabolism
5650600|NCT00699517|tubulin modulator|tubulin modulator
5650601|NCT00699517|endothelium|endothelium
5650602|NCT00699517|combretastatin|combretastatin
5650603|NCT00699517|cisplatin|cisplatin
5650605|NCT00699504|QT|qt
5650606|NCT00699504|Effect of study drug on healthy volunteers|effect of study drug on healthy volunteers
5650607|NCT00699478|vitamin B12 deficiency|vitamin b12 deficiency
5650608|NCT00699478|post total gastrectomy|post total gastrectomy
5650609|NCT00699478|stomach cancer|stomach cancer
5650610|NCT00699465|Thromboprophylaxis|thromboprophylaxis
5672655|NCT00611325|Bevacizumab|bevacizumab
5650611|NCT00699465|Prevention of venous thromboembolism after ICH|prevention of venous thromboembolism after ich
5650612|NCT00699465|Enoxaparin|enoxaparin
5650613|NCT00699465|Intermittent pneumatic compression|intermittent pneumatic compression
5650614|NCT00699452|aortic stenosis|aortic stenosis
5650615|NCT00699452|valve|valve
5650616|NCT00699452|candesartan|candesartan
5650618|NCT00699439|Asthma|asthma
5650619|NCT00699439|Emergency Service, Hospital|emergency service, hospital
5650620|NCT00699439|Bayesian Method|bayesian method
5650621|NCT00699387|Chagas disease|chagas disease
5650622|NCT00699387|Pediatrics|pediatrics
5650623|NCT00699387|benznidazole|benznidazole
5650624|NCT00699387|population pharmacokinetics|population pharmacokinetics
5650625|NCT00699387|neglected diseases|neglected diseases
5650626|NCT00699387|parasitology|parasitology
5650627|NCT00699387|pediatric clinical pharmacology|pediatric clinical pharmacology
5650628|NCT00699374|sunitinib|sunitinib
5650629|NCT00699374|phase 3|phase 3
5650630|NCT00699374|randomized|randomized
5650631|NCT00699374|hepatocellular|hepatocellular
5650632|NCT00699374|liver|liver
5650633|NCT00699361|Pantoprazole|pantoprazole
5650634|NCT00699361|congestive heart failure|congestive heart failure
5650635|NCT00699335|pain|pain
5650636|NCT00699335|fentanyl|fentanyl
5650637|NCT00699335|transdermal patch|transdermal patch
5650638|NCT00699322|glucose variability|glucose variability
5650639|NCT00699322|oxidative stress|oxidative stress
5650640|NCT00699322|sitagliptin|sitagliptin
5650641|NCT00699322|glimepiride|glimepiride
5650642|NCT00699309|Total Hip Replacement|total hip replacement
5650643|NCT00699309|Total Hip Arthroplasty|total hip arthroplasty
5650644|NCT00699309|Minimally Invasive|minimally invasive
5650645|NCT00699309|Microplasty|microplasty
5650646|NCT00699309|Hip Arthritis|hip arthritis
5650647|NCT00699296|LBH589|lbh589
5650648|NCT00699296|HDAC inhibitor|hdac inhibitor
5650649|NCT00699296|cutaneous T-ceII lymphoma|cutaneous t-ceii lymphoma
5650650|NCT00699296|adult T-cell leukemia|adult t-cell leukemia
5650651|NCT00699283|Epilepsy; Monotherapy|epilepsy; monotherapy
5650652|NCT00699283|Partial Onset Seizures|partial onset seizures
5650653|NCT00699283|Adults and Adolescents|adults and adolescents
5650654|NCT00699270|Total Shoulder Arthroplasty|total shoulder arthroplasty
5651047|NCT00697606|Seprafilm®|seprafilm®
5650668|NCT00699231|Engerix™-B|engerix™-b
5650669|NCT00699231|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5650671|NCT00699218|Bipolar|bipolar
5650672|NCT00699218|Depression|depression
5650673|NCT00699218|TMS|tms
5650674|NCT00699218|repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5650675|NCT00699218|treatment|treatment
5650676|NCT00699218|Efficacy|efficacy
5650677|NCT00699218|Safety|safety
5650678|NCT00699192|Blood pressure|blood pressure
5650679|NCT00699192|hypertension|hypertension
5650680|NCT00699192|elderly|elderly
5650681|NCT00699166|IBS|ibs
5650682|NCT00699166|Diarrhea|diarrhea
5650683|NCT00699166|gastrointestinal functional disorder|gastrointestinal functional disorder
5650684|NCT00699166|IBS-D|ibs-d
5650685|NCT00699127|anxiety|anxiety
5650686|NCT00699127|parents|parents
5650687|NCT00699127|NICU|nicu
5650688|NCT00699127|prematurity|prematurity
5650689|NCT00699127|Anxiety of parents to NICU infants|anxiety of parents to nicu infants
5650690|NCT00699114|Pain|pain
5650691|NCT00699114|Analgesics|analgesics
5650692|NCT00699114|Molar|molar
5650693|NCT00699114|Third|third
5650694|NCT00699114|Acetaminophen|acetaminophen
5650695|NCT00699114|Paracetamol|paracetamol
5650696|NCT00699114|Ibuprofen|ibuprofen
5650697|NCT00699114|Codeine|codeine
5650698|NCT00699114|Placebo|placebo
5650699|NCT00699101|Breast Cancer|breast cancer
5650700|NCT00699101|Conture®|conture®
5650701|NCT00699101|Brachytherapy|brachytherapy
5650702|NCT00699088|Total Hip Arthroplasty|total hip arthroplasty
5650703|NCT00699088|Total Hip Replacement|total hip replacement
5650704|NCT00699088|Minimally Invasive|minimally invasive
5650705|NCT00699088|Microplasty|microplasty
5650706|NCT00699062|antileukotriene|antileukotriene
5650707|NCT00699062|small airway|small airway
5650708|NCT00699062|airway remodeling|airway remodeling
5650709|NCT00699062|HRCT|hrct
5650710|NCT00699049|Alpha blocker|alpha blocker
5650711|NCT00699049|Tamsulosin|tamsulosin
5650712|NCT00699049|Solifenacin|solifenacin
5650713|NCT00699049|Overactive Bladder|overactive bladder
5650714|NCT00699049|Urgency incontinence|urgency incontinence
5650715|NCT00699036|nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5650716|NCT00699036|fatty liver|fatty liver
5650717|NCT00699036|insulin resistance|insulin resistance
5650718|NCT00699023|postprandial lipemia|postprandial lipemia
5650719|NCT00699023|type 2 diabetes|type 2 diabetes
5650720|NCT00699023|ezetimibe|ezetimibe
5650721|NCT00699023|hypercholesterolemia|hypercholesterolemia
5650722|NCT00699010|Abuse Liability|abuse liability
5650723|NCT00699010|Abuse Prevention|abuse prevention
5650724|NCT00699010|Abuse Resistance|abuse resistance
5650725|NCT00699010|Abuse Deterrence|abuse deterrence
5671243|NCT00616590|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5650738|NCT00698984|Soy Isoflavones, Bone Mineral Density, Bone Mineral Content, postmenopausal Women, Bone Markers, Bone Health, Phytoestrogens|soy isoflavones, bone mineral density, bone mineral content, postmenopausal women, bone markers, bone health, phytoestrogens
5650739|NCT00698958|Respiratory insufficiency|respiratory insufficiency
5644253|NCT00724438|Implanon|implanon
5650740|NCT00698958|Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage|hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage
5650741|NCT00698932|DPP-4 inhibitors|dpp-4 inhibitors
5650743|NCT00698932|Incretins|incretins
5650744|NCT00698919|Bacterial DNA|bacterial dna
5650745|NCT00698919|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5650746|NCT00698919|Infection|infection
5650747|NCT00698919|Intensive Care Unit|intensive care unit
5650748|NCT00698906|Hepatitis B|hepatitis b
5650749|NCT00698906|HBV-MPL|hbv-mpl
5650750|NCT00698906|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5650751|NCT00698893|Herpes simplex|herpes simplex
5650752|NCT00698893|Herpes simplex candidate (gD) vaccine|herpes simplex candidate (gd) vaccine
5650753|NCT00698880|Portal vein embolization|portal vein embolization
5650754|NCT00698880|Hepatic vein embolization|hepatic vein embolization
5650755|NCT00698880|Liver regeneration|liver regeneration
5650756|NCT00698867|Total Elbow Arthroplasty|total elbow arthroplasty
5650757|NCT00698867|Total Elbow Replacement|total elbow replacement
5650758|NCT00698867|Osteoarthritis|osteoarthritis
5650759|NCT00698867|Elbow arthritis|elbow arthritis
5650760|NCT00698854|Total Knee Arthroplasty|total knee arthroplasty
5650761|NCT00698854|Total Knee Replacement|total knee replacement
5650762|NCT00698854|Knee Arthritis|knee arthritis
5650763|NCT00698828|Cachexia, COPD, Chronic Obstructive Pulmonary Disease|cachexia, copd, chronic obstructive pulmonary disease
5650764|NCT00698763|An ischaemic cerebrovascular event (stroke or TIA)|an ischaemic cerebrovascular event (stroke or tia)
5650765|NCT00698750|Fractured Humeral Head|fractured humeral head
5650766|NCT00698750|Traumatic Arthritis|traumatic arthritis
5650767|NCT00698750|Resurfacing Shoulder|resurfacing shoulder
5650768|NCT00698750|Shoulder Replacement|shoulder replacement
5650769|NCT00698750|Shoulder Arthritis|shoulder arthritis
5650771|NCT00698737|Cocaine|cocaine
5650772|NCT00698711|Prostate cancer|prostate cancer
5650773|NCT00698711|MUC-2-KLH|muc-2-klh
5650774|NCT00698711|QS 21|qs 21
5650775|NCT00698698|tear proteins|tear proteins
5650776|NCT00698698|diabetic retinopathy|diabetic retinopathy
5650777|NCT00698698|HPLC|hplc
5650778|NCT00698698|Mass spectroscopy|mass spectroscopy
5650779|NCT00698685|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5650780|NCT00698685|Preparative Regimen|preparative regimen
5650781|NCT00698685|Pentostatin|pentostatin
5650782|NCT00698685|Alemtuzumab|alemtuzumab
5650783|NCT00698685|Hodgkin Disease and Lymphoma, non-Hodgkin|hodgkin disease and lymphoma, non-hodgkin
5650784|NCT00698685|leukemia, myeloid, acute|leukemia, myeloid, acute
5650785|NCT00698685|leukemia, lymphocytic, acute|leukemia, lymphocytic, acute
5650786|NCT00698685|leukemia, myeloid, chronic|leukemia, myeloid, chronic
5650787|NCT00698685|leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
5650788|NCT00698685|Multiple Myeloma|multiple myeloma
5650789|NCT00698685|Myelodysplastic Syndromes|myelodysplastic syndromes
5650790|NCT00698685|Carcinoma, Renal Cell|carcinoma, renal cell
5650791|NCT00698672|RSA|rsa
5650792|NCT00698646|Systolic blood pressure|systolic blood pressure
5650793|NCT00698646|Diastolic blood pressure|diastolic blood pressure
5650794|NCT00698646|Valsartan|valsartan
5650795|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide
5650796|NCT00698633|Hip arthroplasty|hip arthroplasty
5650797|NCT00698607|Everolimus|everolimus
5650798|NCT00698607|Sirolimus|sirolimus
5650799|NCT00698607|drug eluting stent|drug eluting stent
5650800|NCT00698607|Clopidogrel|clopidogrel
5650805|NCT00698555|Hepatitis B|hepatitis b
5650806|NCT00698555|HBV-MPL|hbv-mpl
5650807|NCT00698555|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5650808|NCT00698542|PSST|psst
5650809|NCT00698542|sepsis|sepsis
5650810|NCT00698542|Neuro Care Unit|neuro care unit
5650811|NCT00698542|Surviving Sepsis Campaign|surviving sepsis campaign
5650812|NCT00698542|SSC|ssc
5650813|NCT00698529|Technology Transfer|technology transfer
5650814|NCT00698529|HIV Seronegativity|hiv seronegativity
5650815|NCT00698516|Bevacizumab|bevacizumab
5650816|NCT00698516|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5650817|NCT00698516|Topotecan|topotecan
5650818|NCT00698503|Metal on Metal|metal on metal
5650819|NCT00698503|Total Hip Arthroplasty|total hip arthroplasty
5650820|NCT00698503|Total Hip Replacement|total hip replacement
5650821|NCT00698490|Herpes simplex|herpes simplex
5650822|NCT00698490|Herpes simplex candidate vaccine|herpes simplex candidate vaccine
5650823|NCT00698464|Pasireotide|pasireotide
5650824|NCT00698464|PK profile,|pk profile,
5650825|NCT00698464|Single dose|single dose
5650826|NCT00698464|Pasireotide subcutaneous injection|pasireotide subcutaneous injection
5650827|NCT00698464|Safety|safety
5650828|NCT00698464|Mild hepatic impaired patients|mild hepatic impaired patients
5650829|NCT00698464|Moderate hepatic impaired patients|moderate hepatic impaired patients
5650830|NCT00698464|Severe hepatic impaired patients|severe hepatic impaired patients
5650831|NCT00698451|Ovarian cancer|ovarian cancer
5650832|NCT00698451|fallopian tube cancer|fallopian tube cancer
5650833|NCT00698451|primary peritoneal cancer|primary peritoneal cancer
5650834|NCT00698451|DOXIL|doxil
5650835|NCT00698451|carboplatin|carboplatin
5650836|NCT00698451|bevacizumab|bevacizumab
5650837|NCT00698438|At least 18 years of age|at least 18 years of age
5650839|NCT00698425|Iontophoresis|iontophoresis
5650840|NCT00698425|Ophthalmology|ophthalmology
5650841|NCT00698412|Knee osteoarthritis|knee osteoarthritis
5650842|NCT00698412|Daily cane use|daily cane use
5650844|NCT00698412|Function|function
5650845|NCT00698412|Quality of life|quality of life
5650846|NCT00698412|Energy consumption during the gait|energy consumption during the gait
5650848|NCT00698399|transplant|transplant
5650849|NCT00698399|TMAO|tmao
5650850|NCT00698399|NGAL|ngal
5650851|NCT00698399|cystatin-C|cystatin-c
5650852|NCT00698399|Ischemia Reperfusion Injury|ischemia reperfusion injury
5650853|NCT00698399|Liver Transplant|liver transplant
5650855|NCT00698399|allantion|allantion
5650856|NCT00698386|Micronutrient Zinc|micronutrient zinc
5650857|NCT00698386|Category I PTB|category i ptb
5650858|NCT00698386|RNTCP|rntcp
5650859|NCT00698386|DOTS|dots
5650860|NCT00698386|Sputum smear conversion|sputum smear conversion
5650861|NCT00698386|Reduced relapse|reduced relapse
5650862|NCT00698386|Immunopathogenesis|immunopathogenesis
5650863|NCT00698386|Category-I|category-i
5650864|NCT00698373|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
5650865|NCT00698373|Positron emission tomography,|positron emission tomography,
5650866|NCT00698373|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
5650867|NCT00698373|Lung cancer,|lung cancer,
5650868|NCT00698360|chronic kidney disease|chronic kidney disease
5650869|NCT00698360|melatonin|melatonin
5650870|NCT00698360|erythropoietin|erythropoietin
5650871|NCT00698360|circadian rhythm|circadian rhythm
5650872|NCT00698347|Total Knee Replacement|total knee replacement
5650873|NCT00698347|Total Knee Arthroplasty|total knee arthroplasty
5650874|NCT00698347|Hip Arthritis|hip arthritis
5650875|NCT00698334|HIV infection|hiv infection
5650876|NCT00698334|Acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5650877|NCT00698334|Tuberculosis|tuberculosis
5650878|NCT00698321|HIV/STD Prevention|hiv/std prevention
5650879|NCT00698321|HIV Seronegativity|hiv seronegativity
5650880|NCT00698295|schizophrenia|schizophrenia
5650881|NCT00698295|atypical antipsychotics|atypical antipsychotics
5650882|NCT00698295|EEG|eeg
5650883|NCT00698243|OSI-027|osi-027
5650884|NCT00698243|Solid tumor|solid tumor
5650885|NCT00698243|Lymphoma|lymphoma
5650886|NCT00698204|Mucositis|mucositis
5650887|NCT00698204|Head and Neck Cancer|head and neck cancer
5650888|NCT00698204|Head and Neck Neoplasms|head and neck neoplasms
5650889|NCT00698204|Stomatitis|stomatitis
5650890|NCT00698191|Lupus Erythematosus,Systemic|lupus erythematosus,systemic
5650891|NCT00698191|Lupus Nephritis|lupus nephritis
5650892|NCT00698191|Mesenchymal Stem Cells|mesenchymal stem cells
5650893|NCT00698191|Transplantation|transplantation
5650894|NCT00698178|Gastroesophageal reflux disease|gastroesophageal reflux disease
5653552|NCT00688168|Pain|pain
5650895|NCT00698178|Waist circumference|waist circumference
5650896|NCT00698178|Body mass index|body mass index
5650897|NCT00698178|Obesity|obesity
5650898|NCT00698152|Total Hip Arthroplasty|total hip arthroplasty
5650899|NCT00698152|Total Hip Replacement|total hip replacement
5650900|NCT00698152|Hip Arthritis|hip arthritis
5650901|NCT00698152|Polyethylene|polyethylene
5650902|NCT00698139|heart failure|heart failure
5650903|NCT00698139|chronotropic incompetence|chronotropic incompetence
5650904|NCT00698113|anxiety|anxiety
5650905|NCT00698113|depression|depression
5650906|NCT00698113|stress|stress
5650907|NCT00698113|cancer symptoms|cancer symptoms
5650908|NCT00698113|pediatric cancer|pediatric cancer
5650909|NCT00698113|massage|massage
5650910|NCT00698113|parent delivered massage|parent delivered massage
5650911|NCT00698100|DNA|dna
5650912|NCT00698100|HU & MOUSE|hu & mouse
5650913|NCT00698100|TYROSINASE|tyrosinase
5650914|NCT00698087|Hepatitis B|hepatitis b
5650915|NCT00698087|Engerix™-B|engerix™-b
5650916|NCT00698087|Adjuvanted recombinant hepatitis B vaccine|adjuvanted recombinant hepatitis b vaccine
5650917|NCT00698061|Hepatitis B|hepatitis b
5650918|NCT00698061|Adjuvanted vaccine|adjuvanted vaccine
5650919|NCT00698048|Sepsis|sepsis
5650920|NCT00698048|Septic Shock|septic shock
5650921|NCT00698048|Vasopressin|vasopressin
5650922|NCT00698048|Copeptin|copeptin
5650923|NCT00698048|Paediatrics|paediatrics
5650924|NCT00698035|Vaginal Testosterone Cream|vaginal testosterone cream
5650925|NCT00698035|ESTRING|estring
5650926|NCT00698022|healthy|healthy
5650927|NCT00698022|weight gain|weight gain
5650928|NCT00698022|anti-psychotic|anti-psychotic
5650929|NCT00698022|risperidone|risperidone
5650930|NCT00698022|mifepristone|mifepristone
5650931|NCT00698022|mitigation|mitigation
5650932|NCT00698022|weight loss|weight loss
5650933|NCT00698009|Neuroblastoma|neuroblastoma
5650934|NCT00698009|Natural Killer Cell|natural killer cell
5650935|NCT00698009|NK Cell Infusion|nk cell infusion
5650936|NCT00698009|Haploidentical Natural Killer (NK) Cells|haploidentical natural killer (nk) cells
5650937|NCT00698009|Fludarabine|fludarabine
5650938|NCT00698009|Fludarabine Phosphate|fludarabine phosphate
5650940|NCT00698009|Cyclophosphamide|cyclophosphamide
5650941|NCT00698009|Cytoxan|cytoxan
5650942|NCT00698009|Neosar|neosar
5650943|NCT00698009|Interleukin-2|interleukin-2
5650944|NCT00698009|IL-2|il-2
5650945|NCT00698009|Proleukin|proleukin
5650946|NCT00698009|Mesna|mesna
5650947|NCT00698009|Mesnex|mesnex
5650948|NCT00698009|Infusion of NK cells|infusion of nk cells
5650949|NCT00698009|Pediatric NK Cell Infusion|pediatric nk cell infusion
5650950|NCT00698009|Pediatric Neuroblastoma|pediatric neuroblastoma
5650951|NCT00698009|Pediatric NK|pediatric nk
5650952|NCT00698009|Pediatric|pediatric
5650953|NCT00697983|Osteoporosis|osteoporosis
5650954|NCT00697983|ATP|atp
5650955|NCT00697983|Purinergic receptors|purinergic receptors
5650956|NCT00697983|Bone mineral density|bone mineral density
5650957|NCT00697983|Single nucleotide polymorphism|single nucleotide polymorphism
5650958|NCT00697970|Hepatitis B|hepatitis b
5650959|NCT00697970|Engerix™-B|engerix™-b
5650960|NCT00697970|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5650961|NCT00697970|Adjuvant|adjuvant
5650962|NCT00697957|acceleration|acceleration
5650963|NCT00697957|bone density|bone density
5650964|NCT00697957|cardiovascular diseases|cardiovascular diseases
5650965|NCT00697957|exercise|exercise
5650966|NCT00697957|female|female
5650967|NCT00697957|fragility fractures|fragility fractures
5650968|NCT00697957|impact intensity|impact intensity
5650969|NCT00697957|intervention studies|intervention studies
5650970|NCT00697957|osteoporosis|osteoporosis
5650971|NCT00697957|premenopause|premenopause
5650972|NCT00697944|FUNGAL INFECTION|fungal infection
5650973|NCT00697944|SEPSIS|sepsis
5650974|NCT00697944|INTENSIVE CARE|intensive care
5650975|NCT00697944|AMBISOME|ambisome
5650976|NCT00697944|PREEMPTIVE TREATMENT|preemptive treatment
5650977|NCT00697944|Sepsis with candida colonisation|sepsis with candida colonisation
5650978|NCT00697931|Hepatitis B|hepatitis b
5650979|NCT00697931|Engerix™-B|engerix™-b
5650980|NCT00697931|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5650981|NCT00697931|Adjuvant|adjuvant
5650982|NCT00697918|Partial onset seizure|partial onset seizure
5650983|NCT00697918|Adjunctive therapy|adjunctive therapy
5650984|NCT00697905|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5650985|NCT00697905|Gemcitabine-Carboplatin|gemcitabine-carboplatin
5650986|NCT00697892|Human Immunodeficiency Virus|human immunodeficiency virus
5650987|NCT00697892|Drug Interactions|drug interactions
5650988|NCT00697879|tumour|tumour
5650989|NCT00697879|Solid tumour|solid tumour
5650990|NCT00697879|histone deacetylase inhibitor|histone deacetylase inhibitor
5650991|NCT00697879|dose escalation|dose escalation
5650992|NCT00697879|cancer|cancer
5650993|NCT00697866|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5650994|NCT00697866|Hepatitis B|hepatitis b
5651121|NCT00697268|Unipolar Depression|unipolar depression
5650995|NCT00697866|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5650996|NCT00697853|Hepatitis B|hepatitis b
5650997|NCT00697853|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5651002|NCT00697840|Adjuvant|adjuvant
5651003|NCT00697814|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5651004|NCT00697814|Prolactinoma|prolactinoma
5651005|NCT00697788|pediatric|pediatric
5651006|NCT00697788|burn|burn
5651007|NCT00697788|sedation|sedation
5651008|NCT00697775|Hepatitis B|hepatitis b
5651009|NCT00697775|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651010|NCT00697775|Adjuvant|adjuvant
5651011|NCT00697762|Partial onset seizure|partial onset seizure
5651012|NCT00697762|Adjunctive therapy|adjunctive therapy
5651013|NCT00697749|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651014|NCT00697749|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5651015|NCT00697749|Hepatitis B|hepatitis b
5651016|NCT00697736|Systemic Scleroderma|systemic scleroderma
5651017|NCT00697736|Echocardiography|echocardiography
5651018|NCT00697723|Coronary artery bypass graft|coronary artery bypass graft
5651019|NCT00697723|Intra-aortic balloon pump|intra-aortic balloon pump
5651020|NCT00697723|transit-time flowmetry|transit-time flowmetry
5651021|NCT00697710|Atopic Dermatitis|atopic dermatitis
5651022|NCT00697697|asthmatic children|asthmatic children
5651023|NCT00697684|Reduced Intensity Allogeneic Stem Cell Transplant|reduced intensity allogeneic stem cell transplant
5651024|NCT00697684|Clofarabine|clofarabine
5651025|NCT00697684|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
5651026|NCT00697684|Total Lymphoid Radiation|total lymphoid radiation
5651027|NCT00697671|NK cell infusion|nk cell infusion
5651028|NCT00697671|Immunotherapy|immunotherapy
5651029|NCT00697671|hematologic malignancy|hematologic malignancy
5651030|NCT00697671|Miltenyi Biotec device|miltenyi biotec device
5651031|NCT00697671|haploidentical donor|haploidentical donor
5651032|NCT00697658|Paliperidone ER|paliperidone er
5651033|NCT00697658|Schizophrenia|schizophrenia
5651035|NCT00697645|Cerebrovascular disease,|cerebrovascular disease,
5651036|NCT00697645|Transcranial magnetic stimulation,|transcranial magnetic stimulation,
5651037|NCT00697645|rehabilitation|rehabilitation
5651038|NCT00697632|MET|met
5651039|NCT00697632|AXL|axl
5651040|NCT00697632|VEGFR|vegfr
5651041|NCT00697632|NSCLC|nsclc
5789070|NCT00150046|Heart transplant recipient|heart transplant recipient
5651042|NCT00697632|HNSCC (Head and neck squamous cell carcinoma)|hnscc (head and neck squamous cell carcinoma)
5651044|NCT00697632|Safety|safety
5651045|NCT00697632|Phase 1|phase 1
5651053|NCT00697593|Chronic Plaque Psoriasis|chronic plaque psoriasis
5651054|NCT00697593|Transition from systemic therapies on to Efalizumab|transition from systemic therapies on to efalizumab
5651055|NCT00697580|Obesity|obesity
5651056|NCT00697580|Type 2 Diabetes|type 2 diabetes
5651057|NCT00697580|Cardiovascular risk|cardiovascular risk
5651058|NCT00697580|Cancer|cancer
5651059|NCT00697580|Latino|latino
5651060|NCT00697580|Adolescents|adolescents
5651061|NCT00697580|Strength Training|strength training
5651062|NCT00697580|Circuit Training|circuit training
5651063|NCT00697580|Nutrition|nutrition
5651064|NCT00697567|Herpes simplex|herpes simplex
5651065|NCT00697567|Herpes simplex vaccine|herpes simplex vaccine
5651066|NCT00697554|Hepatitis B|hepatitis b
5651067|NCT00697554|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5651068|NCT00697541|erythematous rosacea|erythematous rosacea
5651069|NCT00697541|facial gel|facial gel
5651070|NCT00697541|brimonidine|brimonidine
5651071|NCT00697541|ophthalmic solution|ophthalmic solution
5651072|NCT00697528|Graves|graves
5651073|NCT00697528|Color Doppler Imaging|color doppler imaging
5651074|NCT00697528|Graves' Ophthalmopathy|graves' ophthalmopathy
5651075|NCT00697528|Orbital Venous Flow|orbital venous flow
5651076|NCT00697489|Pelvic organ prolapse|pelvic organ prolapse
5651077|NCT00697489|Urinary incontinence|urinary incontinence
5651078|NCT00697489|Mesh|mesh
5651079|NCT00697476|second line chemotherapy|second line chemotherapy
5651080|NCT00697463|Teriparatide|teriparatide
5651081|NCT00697463|Forteo|forteo
5651082|NCT00697463|Osteopenia|osteopenia
5651083|NCT00697463|Osteoporosis|osteoporosis
5651084|NCT00697463|Fracture|fracture
5651085|NCT00697463|Low Bone Density|low bone density
5651086|NCT00697463|Premenopausal women|premenopausal women
5651090|NCT00697372|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5651091|NCT00697372|Drug-Eluting Stents|drug-eluting stents
5651092|NCT00697359|Atrial fibrillation|atrial fibrillation
5651093|NCT00697359|Monitoring|monitoring
5651094|NCT00697359|Pulmonary vein isolation|pulmonary vein isolation
5651095|NCT00697359|Implantable loop recorder|implantable loop recorder
5651096|NCT00697346|Drug therapy|drug therapy
5651097|NCT00697333|NSCLC|nsclc
5651098|NCT00697333|FDG-PET|fdg-pet
5651099|NCT00697333|Radiotherapy|radiotherapy
5651100|NCT00697333|planning|planning
5651101|NCT00697333|target volumes|target volumes
5651102|NCT00697307|bioequivalence|bioequivalence
5651103|NCT00697307|contraception|contraception
5651104|NCT00697307|contraceptive patch|contraceptive patch
5651105|NCT00697307|ORTHO EVRA|ortho evra
5651106|NCT00697307|norelgestromin|norelgestromin
5651107|NCT00697307|NGMN|ngmn
5651108|NCT00697307|ethinyl estradiol|ethinyl estradiol
5651109|NCT00697307|EE|ee
5651110|NCT00697294|Vitamin D deficiency|vitamin d deficiency
5651111|NCT00697294|Infants|infants
5651112|NCT00697294|Breast feeding|breast feeding
5651113|NCT00697281|allergic rhinitis|allergic rhinitis
5651114|NCT00697281|human|human
5651115|NCT00697281|clinical trial|clinical trial
5651116|NCT00697281|efficacy|efficacy
5651117|NCT00697281|safety|safety
5651118|NCT00697281|challenge test|challenge test
5651119|NCT00697268|Depression|depression
5651120|NCT00697268|Depression Treatment|depression treatment
5651122|NCT00697268|Citalopram|citalopram
5651123|NCT00697268|Serotonin|serotonin
5651124|NCT00697268|Major Depression|major depression
5651125|NCT00697268|Healthy Volunteer|healthy volunteer
5651126|NCT00697268|HV|hv
5651127|NCT00697255|Pharmacological effects of drugs|pharmacological effects of drugs
5651128|NCT00697255|Hormones|hormones
5651129|NCT00697255|Hormone Substitutes and Hormone Antagonists|hormone substitutes and hormone antagonists
5651130|NCT00697255|Pharmacological Actions|pharmacological actions
5651131|NCT00697255|Monofollicular growth|monofollicular growth
5651132|NCT00697255|Randomized|randomized
5651133|NCT00697255|Open-label|open-label
5651134|NCT00697255|Active-controlled|active-controlled
5651135|NCT00697242|Hepatitis B|hepatitis b
5651136|NCT00697242|Engerix™-B|engerix™-b
5651137|NCT00697242|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5651138|NCT00697229|Hepatitis B|hepatitis b
5651139|NCT00697229|Engerix™-B|engerix™-b
5651140|NCT00697229|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651141|NCT00697216|Hepatitis B|hepatitis b
5651142|NCT00697216|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651143|NCT00697216|Adjuvanted hepatitis B vaccine|adjuvanted hepatitis b vaccine
5651144|NCT00697177|Gastro-oesophageal reflux|gastro-oesophageal reflux
5651145|NCT00697177|24 hour oesophageal pH monitoring|24 hour oesophageal ph monitoring
5651146|NCT00697177|Physiotherapy Airway clearance techniques|physiotherapy airway clearance techniques
5651147|NCT00697177|Exercise|exercise
5651148|NCT00697164|Malaria|malaria
5651149|NCT00697164|Treatment|treatment
5651150|NCT00697164|Adjunctive|adjunctive
5651151|NCT00697164|Erythropoietin|erythropoietin
5651152|NCT00697164|Survival|survival
5651153|NCT00697151|cerebrovascular diseases|cerebrovascular diseases
5651154|NCT00697151|ischemic stroke|ischemic stroke
5651155|NCT00697151|patent foramen ovale|patent foramen ovale
5651156|NCT00697151|warfarin|warfarin
5651157|NCT00697151|aspirin|aspirin
5651158|NCT00697151|transesophageal echocardiography|transesophageal echocardiography
5651159|NCT00697138|Cocaine|cocaine
5651160|NCT00697138|Dependence|dependence
5651161|NCT00697138|Pharmacotherapies|pharmacotherapies
5651162|NCT00697125|Hepatitis B|hepatitis b
5651163|NCT00697125|Engerix™-B|engerix™-b
5651164|NCT00697125|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651165|NCT00697099|VTE prevention|vte prevention
5651166|NCT00697099|Total Hip Replacement|total hip replacement
5651167|NCT00697099|Heparin Low-Molecular-Weight|heparin low-molecular-weight
5651168|NCT00697086|Heart disease|heart disease
5651169|NCT00697073|Friedreich's Ataxia|friedreich's ataxia
5651170|NCT00697073|Idebenone|idebenone
5651171|NCT00697073|ICARS|icars
5651172|NCT00697060|Metastatic|metastatic
5651173|NCT00697060|Previously treated|previously treated
5651174|NCT00697047|Colorectal Neoplasms|colorectal neoplasms
5651175|NCT00697047|Mass Screening|mass screening
5651176|NCT00697047|Population Surveillance|population surveillance
5651177|NCT00697047|Randomized controlled trial|randomized controlled trial
5651178|NCT00697047|Occult Blood|occult blood
5651179|NCT00697047|Colonoscopy|colonoscopy
5651180|NCT00697047|Sigmoidoscopy|sigmoidoscopy
5651181|NCT00697047|Health Behavior|health behavior
5651182|NCT00697047|Colorectal Screening|colorectal screening
5651183|NCT00697021|Thromboelastography|thromboelastography
5651184|NCT00697021|Aspirin|aspirin
5651185|NCT00697021|Clopidogrel|clopidogrel
5651186|NCT00697021|Plavix|plavix
5651187|NCT00697021|Resistance|resistance
5651188|NCT00697021|Platelet|platelet
5651189|NCT00697021|Coronary Stenting|coronary stenting
5651190|NCT00697021|Bare Metal Stent|bare metal stent
5651191|NCT00697021|Dual antiplatelet therapy|dual antiplatelet therapy
5651192|NCT00697021|Overreactivity|overreactivity
5651193|NCT00697021|Primary Coronary Intervention|primary coronary intervention
5651194|NCT00697008|GERD|gerd
5651195|NCT00697008|CLINICAL GUIDELINE|clinical guideline
5651196|NCT00697008|Symptoms|symptoms
5651197|NCT00697008|clinical outcome|clinical outcome
5651198|NCT00696982|Arterial stiffness|arterial stiffness
5651199|NCT00696982|Augmentation index|augmentation index
5651200|NCT00696982|diabetes mellitus|diabetes mellitus
5651201|NCT00696956|local drug delivery|local drug delivery
5651202|NCT00696956|balloon angioplasty|balloon angioplasty
5798779|NCT00111098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5651203|NCT00696956|safety and tolerance of paclitaxel coated PTA balloons|safety and tolerance of paclitaxel coated pta balloons
5651204|NCT00696956|in inhibiting restenosis of below the knee arteries|in inhibiting restenosis of below the knee arteries
5651205|NCT00696956|Efficacy of paclitaxel coated PTA balloons|efficacy of paclitaxel coated pta balloons
5651206|NCT00696956|in inhibiting restenosis of below the knee arteries (late lumen loss)|in inhibiting restenosis of below the knee arteries (late lumen loss)
5651208|NCT00696943|PET imaging|pet imaging
5651209|NCT00696943|brain metastases|brain metastases
5651210|NCT00696943|stereotactic radiosurgery|stereotactic radiosurgery
5651211|NCT00696930|Malignant Carcinoid Tumors|malignant carcinoid tumors
5651212|NCT00696917|Hepatitis B|hepatitis b
5651213|NCT00696917|Adjuvanted Hepatitis B vaccine|adjuvanted hepatitis b vaccine
5651214|NCT00696917|Recombinant Hepatitis B vaccine|recombinant hepatitis b vaccine
5651215|NCT00696891|Adjuvanted hepatitis B vaccine, hepatitis B, Engerix™-B|adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b
5651216|NCT00696878|Infertility|infertility
5651217|NCT00696878|Pharmacological effects of drugs|pharmacological effects of drugs
5651218|NCT00696878|Hormones, Hormone Substitutes and Hormone Antagonists|hormones, hormone substitutes and hormone antagonists
5651219|NCT00696878|Pharmacological Actions|pharmacological actions
5651220|NCT00696878|Multi-center|multi-center
5651221|NCT00696865|Safety|safety
5651222|NCT00696865|Tolerability|tolerability
5651223|NCT00696865|Phase I|phase i
5651224|NCT00696852|Mindfulness|mindfulness
5651225|NCT00696852|Meditation|meditation
5651226|NCT00696852|Yoga|yoga
5651227|NCT00696852|Inflammatory Markers|inflammatory markers
5651228|NCT00696839|Behavior Therapy|behavior therapy
5651229|NCT00696839|Anti-Retroviral Agents|anti-retroviral agents
5651230|NCT00696839|Relaxation|relaxation
5651231|NCT00696839|Clinical Nursing Research|clinical nursing research
5651232|NCT00696839|Complementary Therapies|complementary therapies
5651233|NCT00696813|Registry|registry
5651234|NCT00696813|Healthcare Utilization|healthcare utilization
5651235|NCT00696813|Outcome|outcome
5651236|NCT00696813|Safety|safety
5651237|NCT00696813|Efficacy|efficacy
5651238|NCT00696813|Cost-effectiveness|cost-effectiveness
5651239|NCT00696813|Paliperidone ER|paliperidone er
5651240|NCT00696813|Invega®|invega®
5651241|NCT00696813|Oral antipsychotics|oral antipsychotics
5651242|NCT00696800|Infertility|infertility
5651243|NCT00696800|Pharmacological effect of drugs|pharmacological effect of drugs
5651244|NCT00696800|Hormones|hormones
5651245|NCT00696800|Hormone substitutes and hormone antagonists|hormone substitutes and hormone antagonists
5651246|NCT00696800|Pharmacological actions|pharmacological actions
5651248|NCT00696800|Multi-center|multi-center
5651249|NCT00696800|Multi-national|multi-national
5651250|NCT00696800|Double-blind|double-blind
5651251|NCT00696800|Active-controlled|active-controlled
5651252|NCT00696800|Non-inferiority|non-inferiority
5651254|NCT00696761|BPH|bph
5651255|NCT00696761|bladder outlet obstruction|bladder outlet obstruction
5651256|NCT00696761|bladder contractility|bladder contractility
5651257|NCT00696748|metabolic syndrome|metabolic syndrome
5651258|NCT00696748|hypogonadism|hypogonadism
5651259|NCT00696748|testosterone undecanoate|testosterone undecanoate
5651260|NCT00696735|Phase III study patients with follicular lymphoma|phase iii study patients with follicular lymphoma
5651261|NCT00696709|Herpes Zoster (Shingles)|herpes zoster (shingles)
5651262|NCT00696696|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5651263|NCT00696696|metastatic|metastatic
5651264|NCT00696696|EGRF inhibitor|egrf inhibitor
5651265|NCT00696696|targeted therapy|targeted therapy
5651266|NCT00696696|combined cancer therapy|combined cancer therapy
5651267|NCT00696696|kinase inhibitor|kinase inhibitor
5651268|NCT00696696|VEGF-R inhibitor|vegf-r inhibitor
5651269|NCT00696683|scorpion|scorpion
5651270|NCT00696683|sting|sting
5651271|NCT00696683|envenomation|envenomation
5651272|NCT00696683|antivenom|antivenom
5651273|NCT00696631|Heart disease|heart disease
5651274|NCT00696631|morbidity|morbidity
5651275|NCT00696618|HIV prevention|hiv prevention
5651276|NCT00696618|MSM|msm
5651277|NCT00696618|Enema|enema
5651278|NCT00696618|HIV Seronegativity|hiv seronegativity
5651279|NCT00696605|Hypoosmolality|hypoosmolality
5651280|NCT00696605|Hyperosmolality|hyperosmolality
5651281|NCT00696605|Copeptin|copeptin
5651282|NCT00696605|Vasopressin|vasopressin
5651283|NCT00696592|Age-Related Macular Degeneration|age-related macular degeneration
5651284|NCT00696592|Choroidal Neovascularization|choroidal neovascularization
5651285|NCT00696592|Bevacizumab|bevacizumab
5651286|NCT00696592|Photodynamic Therapy|photodynamic therapy
5651287|NCT00696579|BCG|bcg
5651288|NCT00696579|Gemcitabine|gemcitabine
5651289|NCT00696579|Intravesical|intravesical
5651290|NCT00696579|Therapy|therapy
5651291|NCT00696579|Superficial|superficial
5651292|NCT00696579|Transitional|transitional
5651293|NCT00696579|Cell carcinoma|cell carcinoma
5651294|NCT00696566|Thrombosis|thrombosis
5651295|NCT00696566|Platelet aggregation inhibitor|platelet aggregation inhibitor
5651296|NCT00696566|Blood platelets|blood platelets
5651297|NCT00696566|P2 receptor|p2 receptor
5651298|NCT00696566|Cytochrome P450|cytochrome p450
5651299|NCT00696540|Bronchiolitis, respiratory distress, hypertonic saline|bronchiolitis, respiratory distress, hypertonic saline
5651300|NCT00696527|Infiltrative breast cancer-Clinical practice|infiltrative breast cancer-clinical practice
5651301|NCT00696527|Women with infiltrative breast cancer|women with infiltrative breast cancer
5651302|NCT00696514|fracture|fracture
5651303|NCT00696514|cognition|cognition
5651304|NCT00696501|Neuromuscular mapping|neuromuscular mapping
5651305|NCT00696501|Spinal surgery|spinal surgery
5651306|NCT00696501|Neurodiagnostics|neurodiagnostics
5651307|NCT00696501|Segmental root innervation|segmental root innervation
5651308|NCT00696501|Dermatomal innervation|dermatomal innervation
5651309|NCT00696501|Myotomal innervation|myotomal innervation
5651310|NCT00696501|Nerve roots|nerve roots
5651311|NCT00696501|Sensory|sensory
5651312|NCT00696501|Signs and Symptoms|signs and symptoms
5651313|NCT00696462|forced-air warming|forced-air warming
5651314|NCT00696462|Bair Hugger|bair hugger
5651315|NCT00696462|cesarean section|cesarean section
5651316|NCT00696462|postoperative infection|postoperative infection
5651317|NCT00696462|surgical site infections|surgical site infections
5651318|NCT00696436|Essential Hypertension|essential hypertension
5651319|NCT00696436|Cardiovascular Disease|cardiovascular disease
5651320|NCT00696436|High Blood Pressure|high blood pressure
5651321|NCT00696436|Drug Therapy|drug therapy
5651322|NCT00696423|Infanrix/Hib|infanrix/hib
5651323|NCT00696423|Chinese children|chinese children
5651324|NCT00696410|Heart Failure|heart failure
5651325|NCT00696410|Cardiomyopathy|cardiomyopathy
5651326|NCT00696410|Remodeling|remodeling
5651327|NCT00696410|Antioxidant|antioxidant
5651328|NCT00696410|Zinc|zinc
5651329|NCT00696410|Copper|copper
5651330|NCT00696384|Essential Hypertension|essential hypertension
5651331|NCT00696384|Cardiovascular Disease|cardiovascular disease
5651332|NCT00696384|High Blood Pressure|high blood pressure
5651333|NCT00696384|Drug Therapy|drug therapy
5651334|NCT00696371|Neuroinflammation|neuroinflammation
5651335|NCT00696371|PBR28|pbr28
5651337|NCT00696371|Health Volunteer|health volunteer
5651338|NCT00696371|HV|hv
5651339|NCT00696358|Vitiligo|vitiligo
5651340|NCT00696345|colorectal cancer|colorectal cancer
5651341|NCT00696345|screening|screening
5651342|NCT00696345|biomarker|biomarker
5651343|NCT00696345|plasma|plasma
5651344|NCT00696345|blood|blood
5651345|NCT00696332|ALS|als
5651353|NCT00696306|Susceptibility Weighted Imaging|susceptibility weighted imaging
5651354|NCT00696306|Outcome|outcome
5651355|NCT00696306|Axonal Injury|axonal injury
5651356|NCT00696280|nausea|nausea
5651357|NCT00696280|vomiting|vomiting
5651358|NCT00696280|Carboplatin|carboplatin
5651359|NCT00696280|cancer|cancer
5651360|NCT00696280|delayed emesis following treatment with carboplatin|delayed emesis following treatment with carboplatin
5651361|NCT00696241|Essential Hypertension|essential hypertension
5651362|NCT00696241|Cardiovascular Disease|cardiovascular disease
5651363|NCT00696241|High Blood Pressure|high blood pressure
5651364|NCT00696241|Drug Therapy|drug therapy
5651365|NCT00696215|Parkinson's disease|parkinson's disease
5651366|NCT00696215|rasagiline|rasagiline
5651367|NCT00696215|cognition|cognition
5651368|NCT00696215|MAO-B|mao-b
5651369|NCT00696202|Mirena|mirena
5651370|NCT00696202|Levonorgestrel|levonorgestrel
5651371|NCT00696202|Intrauterine device|intrauterine device
5651372|NCT00696202|Efficacy|efficacy
5651373|NCT00696202|Tolerability|tolerability
5651374|NCT00696202|First year of use|first year of use
5651375|NCT00696189|Post operative visual loss (POVL)|post operative visual loss (povl)
5651376|NCT00696189|Intraocular pressure (IOP)|intraocular pressure (iop)
5651377|NCT00696189|Nitrous oxide|nitrous oxide
5651378|NCT00696176|STAT 3 DECOY|stat 3 decoy
5651379|NCT00696150|ultrasound|ultrasound
5651380|NCT00696150|hip|hip
5651381|NCT00696150|pain|pain
5651382|NCT00696137|Chronic Pain|chronic pain
5651383|NCT00696137|Ventilatory Response to Hypercapnia (VRH)|ventilatory response to hypercapnia (vrh)
5651384|NCT00696124|lower leg ischemia|lower leg ischemia
5651385|NCT00696124|peripheral artery disease|peripheral artery disease
5651386|NCT00696111|PCOS|pcos
5651387|NCT00696111|OSA|osa
5651388|NCT00696111|Metabolism|metabolism
5651389|NCT00696111|Diabetes|diabetes
5651390|NCT00696085|fetal alcohol exposure|fetal alcohol exposure
5651391|NCT00696085|blood markers of alcohol use|blood markers of alcohol use
5651392|NCT00696085|brief intervention|brief intervention
5651393|NCT00696059|Rheumatoid arthritis|rheumatoid arthritis
5651394|NCT00696059|Computed tomography|computed tomography
5651395|NCT00696059|Magnetic resonance imaging|magnetic resonance imaging
5651396|NCT00696059|Radiography|radiography
5651397|NCT00696059|Tumor necrosis factor alpha antagonists|tumor necrosis factor alpha antagonists
5651398|NCT00696046|CORD BLOOD CELLS|cord blood cells
5651399|NCT00696046|INTRA BONE MARROW INJECTION|intra bone marrow injection
5651400|NCT00696046|ENGRAFTMENT|engraftment
5651401|NCT00696046|transplants|transplants
5651402|NCT00696033|Benzodiazepines|benzodiazepines
5651403|NCT00696033|Lorazepam|lorazepam
5651404|NCT00696033|Diazepam|diazepam
5651405|NCT00696033|Memory|memory
5651406|NCT00696033|Perceptual priming|perceptual priming
5651407|NCT00696033|Functional brain imaging|functional brain imaging
5651409|NCT00696007|Upper GU Tract Transitional Cell Carinoma|upper gu tract transitional cell carinoma
5651410|NCT00696007|Nephroureterectomy|nephroureterectomy
5651411|NCT00696007|Chemotherapy|chemotherapy
5651412|NCT00696007|Gemcitabine|gemcitabine
5651413|NCT00696007|Cisplatin|cisplatin
5632839|NCT00768183|fed|fed
5651422|NCT00695955|Essential Hypertension|essential hypertension
5651423|NCT00695955|Cardiovascular Disease|cardiovascular disease
5651424|NCT00695955|High Blood Pressure|high blood pressure
5651425|NCT00695955|Drug Therapy|drug therapy
5651426|NCT00695942|preeclampsia|preeclampsia
5651427|NCT00695942|eclampsia|eclampsia
5651428|NCT00695942|retroplacental hematoma|retroplacental hematoma
5651429|NCT00695942|vascular IUGR|vascular iugr
5651430|NCT00695942|IUFD|iufd
5651432|NCT00695929|cardiac surgery with cardiopulmonary bypass|cardiac surgery with cardiopulmonary bypass
5651433|NCT00695903|Gram-positive bacterial infections|gram-positive bacterial infections
5651434|NCT00695903|Staph Aureus|staph aureus
5651435|NCT00695903|Bacteremia|bacteremia
5651436|NCT00695903|MRSA|mrsa
5651437|NCT00695903|Infective Endocarditis|infective endocarditis
5651438|NCT00695903|Right-sided Infective endocarditis|right-sided infective endocarditis
5651439|NCT00695903|SABIE|sabie
5651440|NCT00695903|SAIE|saie
5651441|NCT00695903|RIE|rie
5651442|NCT00695890|Pupillometry|pupillometry
5651443|NCT00695890|Sevoflorane|sevoflorane
5651444|NCT00695890|Propofol|propofol
5651445|NCT00695877|HIV Seronegativity|hiv seronegativity
5651446|NCT00695877|HIV Preventive Vaccine|hiv preventive vaccine
5651447|NCT00695851|PCK3145|pck3145
5651448|NCT00695851|Prostate|prostate
5651449|NCT00695838|GERD symptoms- Waist circumference|gerd symptoms- waist circumference
5651450|NCT00695838|Patients with symptomatic GERD|patients with symptomatic gerd
5651451|NCT00695812|Neurodevelopmental disorders|neurodevelopmental disorders
5651452|NCT00695812|Autism Spectrum Disorders|autism spectrum disorders
5651453|NCT00695812|Broader autism phenotype|broader autism phenotype
5651454|NCT00695812|Siblings|siblings
5651455|NCT00695812|Cognitive language and social emotional development|cognitive language and social emotional development
5651456|NCT00695812|to identify siblings who manifest any autism or broader autism phenotype characteristics|to identify siblings who manifest any autism or broader autism phenotype characteristics
5651457|NCT00695799|Propofol|propofol
5651458|NCT00695799|Anesthesia care provider|anesthesia care provider
5651459|NCT00695799|Pollution|pollution
5651460|NCT00695799|Operating room|operating room
5651461|NCT00695799|Environment|environment
5651462|NCT00695773|Prostate Cancer Surgery|prostate cancer surgery
5651463|NCT00695773|Laparoscopic surgery for Prostate Cancer|laparoscopic surgery for prostate cancer
5651464|NCT00695773|Prostatectomy|prostatectomy
5651465|NCT00695773|Urologic Surgical Procedures|urologic surgical procedures
5651466|NCT00695747|Glaucoma|glaucoma
5651467|NCT00695747|Cataracts|cataracts
5651468|NCT00695747|Phacoemulsification(IOL)|phacoemulsification(iol)
5651469|NCT00695747|Trabeculectomy|trabeculectomy
5651470|NCT00695734|hemodialysis|hemodialysis
5651471|NCT00695734|end stage renal failure|end stage renal failure
5651472|NCT00695734|tuberculosis|tuberculosis
5651473|NCT00695734|latent tuberculosis infection|latent tuberculosis infection
5651474|NCT00695734|Patients under hemodialysis for end stage renal failure|patients under hemodialysis for end stage renal failure
5651475|NCT00695708|schizophrenia|schizophrenia
5651476|NCT00695708|neuroplasticity|neuroplasticity
5651477|NCT00695708|sensory gating|sensory gating
5651478|NCT00695708|cognitive impairment|cognitive impairment
5651480|NCT00695708|Disorders with Psychotic Features|disorders with psychotic features
5651481|NCT00695695|Parents|parents
5651482|NCT00695695|Down Syndrome|down syndrome
5651483|NCT00695695|Hope|hope
5651484|NCT00695695|Uncertainty|uncertainty
5651485|NCT00695695|Adaptation|adaptation
5651486|NCT00695695|DS|ds
5651487|NCT00695695|Survey|survey
5651488|NCT00695682|Remicade|remicade
5651489|NCT00695682|Infliximab|infliximab
5651490|NCT00695682|CSME|csme
5651491|NCT00695682|BDR|bdr
5651492|NCT00695682|CNV|cnv
5651493|NCT00695682|AMD|amd
5651494|NCT00695669|H5N1|h5n1
5651495|NCT00695669|immunogenicity|immunogenicity
5651496|NCT00695669|influenza|influenza
5651497|NCT00695669|Avian|avian
5651498|NCT00695669|pandemic|pandemic
5651499|NCT00695669|vaccines|vaccines
5651500|NCT00695669|human|human
5651501|NCT00695669|safety|safety
5651502|NCT00695656|Hypertension|hypertension
5651503|NCT00695656|general practitioner consultation|general practitioner consultation
5651504|NCT00695656|Patients with hypertension|patients with hypertension
5651505|NCT00695630|conscious sedation|conscious sedation
5651506|NCT00695630|dental anxiety/drug therapy|dental anxiety/drug therapy
5651507|NCT00695630|behavior/drug effects|behavior/drug effects
5651508|NCT00695617|MARS treatment|mars treatment
5651509|NCT00695617|Citrate anticoagulation|citrate anticoagulation
5651510|NCT00695604|Acute asthma|acute asthma
5651511|NCT00695604|fluticasone|fluticasone
5651512|NCT00695604|inhaled corticosteroids|inhaled corticosteroids
5651513|NCT00695591|Home sleep testing neuromuscular disease|home sleep testing neuromuscular disease
5651514|NCT00695591|Neuromuscular disease patients with FEV1<50% of predicted|neuromuscular disease patients with fev1<50% of predicted
5651516|NCT00695539|Rosuvastatin|rosuvastatin
5651517|NCT00695539|hypercholesterolaemia|hypercholesterolaemia
5651518|NCT00695526|cranberry|cranberry
5651519|NCT00695526|total to HDL cholesterol ratio|total to hdl cholesterol ratio
5651520|NCT00695526|type 2 diabetes|type 2 diabetes
5651521|NCT00695513|Food supplement|food supplement
5651522|NCT00695513|Haemodialysis|haemodialysis
5651523|NCT00695500|Varenicline|varenicline
5651524|NCT00695500|Alcohol|alcohol
5651525|NCT00695500|Alcohol Use|alcohol use
5651526|NCT00695487|Anesthesia|anesthesia
5651528|NCT00695487|Postoperative Nausea|postoperative nausea
5651529|NCT00695474|Hypovitaminosis D|hypovitaminosis d
5651530|NCT00695474|Type 2 diabetes|type 2 diabetes
5651531|NCT00695474|Glycemic control|glycemic control
5651532|NCT00695474|Inflammation|inflammation
5651533|NCT00695474|Blood pressure|blood pressure
5651534|NCT00695461|Colorectal surgery|colorectal surgery
5651535|NCT00695461|Probiotics|probiotics
5651536|NCT00695461|Lactobacillus|lactobacillus
5651537|NCT00695461|Bacterial translocation|bacterial translocation
5651538|NCT00695461|Postoperative complications|postoperative complications
5651539|NCT00695461|Inflammatory reaction|inflammatory reaction
5651540|NCT00695448|Phosphoinositide 3-kinase inhibitor|phosphoinositide 3-kinase inhibitor
5651541|NCT00695448|solid tumors|solid tumors
5651542|NCT00695435|normal volunteers|normal volunteers
5651543|NCT00695435|anti-infective|anti-infective
5651544|NCT00695435|tobramycin|tobramycin
5651545|NCT00695422|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5651546|NCT00695422|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5651547|NCT00695422|human papilloma virus infection|human papilloma virus infection
5651548|NCT00695422|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5685561|NCT00555594|corneal neovascularization|corneal neovascularization
5651549|NCT00695422|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5651550|NCT00695422|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5651551|NCT00695422|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5651552|NCT00695422|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5651553|NCT00695422|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5651554|NCT00695422|AIDS-related malignancies|aids-related malignancies
5651555|NCT00695422|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5651556|NCT00695422|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5651557|NCT00695422|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5651558|NCT00695422|multicentric Castleman disease|multicentric castleman disease
5651559|NCT00695422|HIV Infections|hiv infections
5651560|NCT00695409|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5651561|NCT00695409|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5651562|NCT00695409|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5651563|NCT00695409|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5651564|NCT00695409|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5651565|NCT00695409|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5651566|NCT00695409|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5651567|NCT00695409|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5651568|NCT00695409|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5651569|NCT00695409|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5651570|NCT00695409|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5651571|NCT00695409|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5651572|NCT00695409|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5651573|NCT00695409|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5651574|NCT00695409|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5651575|NCT00695409|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5651576|NCT00695409|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5651577|NCT00695409|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5651579|NCT00695396|Myelodysplastic syndromes|myelodysplastic syndromes
5651581|NCT00695396|Epoetin alfa|epoetin alfa
5651582|NCT00695396|EPO|epo
5651583|NCT00695383|Exercise therapy|exercise therapy
5651584|NCT00695383|Physiotherapy|physiotherapy
5651585|NCT00695383|Critical illness|critical illness
5651586|NCT00695383|Intensive care|intensive care
5651587|NCT00695383|Muscle weakness|muscle weakness
5651588|NCT00695383|Mechanical ventilation|mechanical ventilation
5651589|NCT00695370|Children|children
5651590|NCT00695370|cancer|cancer
5651591|NCT00695370|Bone marrow transplantation|bone marrow transplantation
5651592|NCT00695370|Mobilization|mobilization
5651593|NCT00695370|G-CSF|g-csf
5654257|NCT00685321|TMS|tms
5651594|NCT00695370|Children with solid malignancies|children with solid malignancies
5651595|NCT00695357|Asthma treatment|asthma treatment
5651596|NCT00695357|GINA 2006|gina 2006
5651597|NCT00695357|patient perception|patient perception
5651598|NCT00695344|Effect of everolimus in graft vascular cardiac illness|effect of everolimus in graft vascular cardiac illness
5651599|NCT00695331|Labor Augmentation|labor augmentation
5651600|NCT00695331|Misoprostol|misoprostol
5651601|NCT00695331|Oxytocin|oxytocin
5632982|NCT00767312|HIV|hiv
5651603|NCT00695318|Age-Related Macular Degeneration|age-related macular degeneration
5651604|NCT00695318|Geographic Atrophy|geographic atrophy
5651605|NCT00695318|GA|ga
5651606|NCT00695305|rilapladib,|rilapladib,
5651607|NCT00695305|Lp-PLA2,|lp-pla2,
5651608|NCT00695305|atherosclerosis|atherosclerosis
5651609|NCT00695305|SB-659032,|sb-659032,
5651610|NCT00695305|FDG-PET,|fdg-pet,
5651611|NCT00695292|Small Cell Lung Cancer|small cell lung cancer
5651612|NCT00695292|Extensive Stage|extensive stage
5651613|NCT00695292|irinotecan|irinotecan
5651614|NCT00695292|carboplatin|carboplatin
5651615|NCT00695292|sunitinib|sunitinib
5651616|NCT00695279|Gene therapy|gene therapy
5651617|NCT00695253|AAA|aaa
5651618|NCT00695240|Continuous bupivacaine infusion|continuous bupivacaine infusion
5651619|NCT00695240|Analgesia|analgesia
5651620|NCT00695227|laryngopharyngeal reflux|laryngopharyngeal reflux
5651621|NCT00695227|extraesophageal reflux symptoms|extraesophageal reflux symptoms
5651622|NCT00695214|Obstructive Sleep Apnea|obstructive sleep apnea
5651623|NCT00695214|Propofol|propofol
5651624|NCT00695214|Sleep Endoscopy|sleep endoscopy
5651625|NCT00695201|DEXAMETHASONE|dexamethasone
5651626|NCT00695201|FLOXURIDINE|floxuridine
5651627|NCT00695201|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5651628|NCT00695201|OXALIPLATIN|oxaliplatin
5651722|NCT00694811|Re-feeding|re-feeding
5651631|NCT00695188|clinical outcome|clinical outcome
5651632|NCT00695175|Hypertension|hypertension
5651633|NCT00695175|Private cardiology consultation|private cardiology consultation
5651634|NCT00695175|Patients with hypertension|patients with hypertension
5651635|NCT00695162|noise|noise
5651636|NCT00695162|speech intelligibility|speech intelligibility
5651637|NCT00695162|cognition|cognition
5651638|NCT00695149|Spinal cord Injury|spinal cord injury
5651639|NCT00695149|Central nervous system|central nervous system
5651640|NCT00695149|Regeneration|regeneration
5651641|NCT00695149|Bone marrow stromal cells|bone marrow stromal cells
5651642|NCT00695149|Transplantation|transplantation
5651644|NCT00695136|Cognitive Disorder|cognitive disorder
5651645|NCT00695136|Sleep|sleep
5651646|NCT00695136|Autism Spectrum Disorder|autism spectrum disorder
5651647|NCT00695136|ASD|asd
5651648|NCT00695123|Bone Marrow Transplant|bone marrow transplant
5645154|NCT00720785|CML|cml
5651649|NCT00695123|Sickle Cell Disease|sickle cell disease
5651650|NCT00695123|G-CSF|g-csf
5651651|NCT00695123|Apheresis|apheresis
5651652|NCT00695110|testosterone|testosterone
5651653|NCT00695110|male hypogonadism|male hypogonadism
5651654|NCT00695110|low testosterone|low testosterone
5651655|NCT00695097|Rituximab|rituximab
5651656|NCT00695097|Renal Transplant Rejection|renal transplant rejection
5651657|NCT00695097|B cells|b cells
5651658|NCT00695097|Patients with biopsy proven acute rejection cellular infiltrate, B cells|patients with biopsy proven acute rejection cellular infiltrate, b cells
5651659|NCT00695084|multiple sclerosis|multiple sclerosis
5651660|NCT00695071|Healthy Volunteers|healthy volunteers
5651661|NCT00695058|Stress incontinence|stress incontinence
5651662|NCT00695058|urge incontinence|urge incontinence
5651663|NCT00695058|overactive bladder syndrome|overactive bladder syndrome
5651664|NCT00695058|vibration|vibration
5651665|NCT00695058|nerve stimulation|nerve stimulation
5651666|NCT00695045|Pain, Postoperative|pain, postoperative
5651667|NCT00695045|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5651668|NCT00695045|Morphine|morphine
5651669|NCT00695045|Injections, Intrathecal|injections, intrathecal
5651670|NCT00695032|renal toxicity|renal toxicity
5651671|NCT00695032|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5651672|NCT00695032|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5651673|NCT00695019|Prevention of Relapse|prevention of relapse
5651674|NCT00695019|HCV genotype 1b|hcv genotype 1b
5651675|NCT00695019|Recurrence|recurrence
5651676|NCT00695006|manual therapy, cervical traction, cervical radiculopathy|manual therapy, cervical traction, cervical radiculopathy
5651677|NCT00694993|first time in human|first time in human
5651678|NCT00694993|Allergic rhinitis,|allergic rhinitis,
5651679|NCT00694980|UC|uc
5651680|NCT00694980|Ulcerative Colitis|ulcerative colitis
5651681|NCT00694967|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone|short cervix, cervical funneling, spontaneous preterm birth, cerclage, progesterone
5651682|NCT00694954|Iron deficiency anemia|iron deficiency anemia
5651683|NCT00694954|Wireless capsule endoscopy|wireless capsule endoscopy
5651684|NCT00694954|Obscure-occult gastrointestinal bleeding|obscure-occult gastrointestinal bleeding
5651685|NCT00694941|ONO-2506PO|ono-2506po
5651686|NCT00694941|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5651687|NCT00694941|ALS|als
5651688|NCT00694915|STCC (Superficial Transitional Cell Carcinoma)|stcc (superficial transitional cell carcinoma)
5651689|NCT00694902|Healthy Volunteers|healthy volunteers
5651690|NCT00694889|Psychosis|psychosis
5651691|NCT00694889|First Episode|first episode
5651692|NCT00694889|Schizophrenia|schizophrenia
5651693|NCT00694889|Cognitive Remediation|cognitive remediation
5651694|NCT00694876|Health Literacy|health literacy
5651695|NCT00694876|Patient Nonadherence|patient nonadherence
5651696|NCT00694876|Patient Noncompliance|patient noncompliance
5651697|NCT00694876|Follow Up|follow up
5651698|NCT00694876|India|india
5651699|NCT00694876|Glaucoma|glaucoma
5651700|NCT00694863|high risk for ESRD|high risk for esrd
5651701|NCT00694863|immunosuppressive treatment|immunosuppressive treatment
5651702|NCT00694863|membranous nephropathy|membranous nephropathy
5651705|NCT00694837|glioblastoma|glioblastoma
5651706|NCT00694837|nelfinavir|nelfinavir
5651707|NCT00694837|functional imaging|functional imaging
5651708|NCT00694837|AKT pathway|akt pathway
5651709|NCT00694824|Coronary artery calcification|coronary artery calcification
5651710|NCT00694824|calcium score|calcium score
5651711|NCT00694824|(TGF) b1,|(tgf) b1,
5651712|NCT00694824|fetuin A|fetuin a
5651713|NCT00694824|osteoprotegerin (OPG)|osteoprotegerin (opg)
5651714|NCT00694824|fibroblast growth factor (FGF) 23,|fibroblast growth factor (fgf) 23,
5651715|NCT00694824|matrix gla protein (MGP)|matrix gla protein (mgp)
5651716|NCT00694824|hemodialysis patients|hemodialysis patients
5651717|NCT00694811|Obesity|obesity
5651718|NCT00694811|Weight loss|weight loss
5651719|NCT00694811|Diet|diet
5651720|NCT00694811|Very-low-energy diet|very-low-energy diet
5651721|NCT00694811|Predictive factors|predictive factors
5651723|NCT00694798|STCC|stcc
5651724|NCT00694798|Superficial Transitional Cell Carcinoma- BCG refractor|superficial transitional cell carcinoma- bcg refractor
5651725|NCT00694772|Obstructive sleep apnea|obstructive sleep apnea
5651726|NCT00694772|OSA|osa
5651727|NCT00694772|Apnea hypopnea index|apnea hypopnea index
5651728|NCT00694772|AHI|ahi
5651729|NCT00694772|Coblation|coblation
5651730|NCT00694772|Electrocautery|electrocautery
5651731|NCT00694772|Tonsillectomy|tonsillectomy
5651733|NCT00694759|Polycystic ovary syndrome|polycystic ovary syndrome
5651734|NCT00694759|insulin|insulin
5651735|NCT00694759|PCOS|pcos
5651736|NCT00694759|cortisol regulation|cortisol regulation
5651737|NCT00694759|regulation|regulation
5651738|NCT00694746|ALT|alt
5651739|NCT00694746|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5651740|NCT00694746|Adolescents|adolescents
5651741|NCT00694746|Overweight|overweight
5651742|NCT00694746|Treatment|treatment
5651743|NCT00694733|Obesity|obesity
5651744|NCT00694733|Menopausal Syndrome|menopausal syndrome
5651745|NCT00694733|Cortisol|cortisol
5651746|NCT00694720|Cheyne-stokes breathing|cheyne-stokes breathing
5651749|NCT00694694|Child|child
5651750|NCT00694681|Telephonic care management|telephonic care management
5651751|NCT00694668|Deliberate Self-Harm|deliberate self-harm
5651752|NCT00694668|Self-Injurious Behaviour|self-injurious behaviour
5651753|NCT00694668|Suicidal Behaviour|suicidal behaviour
5651754|NCT00694668|Cognitive behavioural therapy|cognitive behavioural therapy
5651755|NCT00694668|Mindfulness Based cognitive therapy|mindfulness based cognitive therapy
5651756|NCT00694655|Yellow Fever|yellow fever
5651757|NCT00694655|Vaccine|vaccine
5651758|NCT00694655|Immunity|immunity
5651759|NCT00694655|yellow fever vaccine|yellow fever vaccine
5651760|NCT00694655|CD8 T cell responses|cd8 t cell responses
5651761|NCT00694642|Refractory angina|refractory angina
5651762|NCT00694629|pulmonary tuberculosis|pulmonary tuberculosis
5651763|NCT00694629|treatment|treatment
5651764|NCT00694616|Obstructive sleep apnea|obstructive sleep apnea
5651765|NCT00694616|Metabolic syndrome|metabolic syndrome
5651766|NCT00694616|Insulin resistance|insulin resistance
5651767|NCT00694616|Hypertension|hypertension
5651768|NCT00694616|Dyslipidemia|dyslipidemia
5651769|NCT00694616|Continuous positive airway pressure (CPAP)|continuous positive airway pressure (cpap)
5651770|NCT00694603|cetuximab|cetuximab
5651771|NCT00694603|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5651772|NCT00694590|AMD3100|amd3100
5651773|NCT00694590|Rituximab|rituximab
5651774|NCT00694590|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5651775|NCT00694590|CLL|cll
5651776|NCT00694590|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5651777|NCT00694590|SLL|sll
5651778|NCT00694577|non-invasive breast cancer|non-invasive breast cancer
5651779|NCT00694577|early invasive breast cancer|early invasive breast cancer
5651780|NCT00694577|radiation|radiation
5651781|NCT00694577|PBI|pbi
5651782|NCT00694564|abdominal pain|abdominal pain
5651783|NCT00694564|children|children
5651784|NCT00694551|vaccine|vaccine
5651785|NCT00694551|PSMA|psma
5651786|NCT00694551|TARP|tarp
5651787|NCT00694551|immunology|immunology
5651788|NCT00694551|PSA|psa
5651789|NCT00694538|Interferential laser therapy|interferential laser therapy
5651790|NCT00694525|21OHD|21ohd
5651791|NCT00694525|21-hydroxylase deficiency|21-hydroxylase deficiency
5651792|NCT00694525|CAH|cah
5651793|NCT00694499|Morbidity|morbidity
5651794|NCT00694499|Mortality|mortality
5651795|NCT00694486|otitis|otitis
5651796|NCT00694486|Eustachian tube function|eustachian tube function
5651797|NCT00694486|Normal middle ear status|normal middle ear status
5651798|NCT00694473|hyperglycemia|hyperglycemia
5651799|NCT00694473|hypoglycemia|hypoglycemia
5651800|NCT00694473|insulin|insulin
5651801|NCT00694473|critical illness|critical illness
5651802|NCT00694473|intensive insulin therapy|intensive insulin therapy
5651803|NCT00694473|continuous glucose monitoring|continuous glucose monitoring
5651804|NCT00694473|CGM|cgm
5651805|NCT00694473|interstitial fluid glucose|interstitial fluid glucose
5651806|NCT00694473|intensive care unit|intensive care unit
5651807|NCT00694473|Blood glucose|blood glucose
5651808|NCT00694460|rabies vaccination|rabies vaccination
5651809|NCT00694460|pre-exposure prophylaxis|pre-exposure prophylaxis
5651810|NCT00694460|rabies virus neutralizing antibody|rabies virus neutralizing antibody
5651811|NCT00694434|Cryopreservation|cryopreservation
5651812|NCT00694434|Frozen embryo transfer|frozen embryo transfer
5651813|NCT00694434|Graduated Embryo Score|graduated embryo score
5651814|NCT00694421|otitis|otitis
5651815|NCT00694421|Eustachian tube|eustachian tube
5651816|NCT00694421|virus|virus
5651817|NCT00694421|Middle ear disease|middle ear disease
5651818|NCT00694408|End stage liver disease|end stage liver disease
5651819|NCT00694408|Paediatric liver transplantation|paediatric liver transplantation
5651820|NCT00694408|Steroid free immunosuppression|steroid free immunosuppression
5651821|NCT00694395|Qualitative study|qualitative study
5651822|NCT00694395|stroke|stroke
5651823|NCT00694395|20 patients, Family or caregivers|20 patients, family or caregivers
5651824|NCT00694395|acute ischemic stroke|acute ischemic stroke
5651825|NCT00694395|delayed to receive thrombolytic therapy.|delayed to receive thrombolytic therapy.
5651826|NCT00694382|chemotherapy|chemotherapy
5651827|NCT00694369|Postoperative Dental Pain|postoperative dental pain
5651828|NCT00694343|Cesarean section|cesarean section
5651829|NCT00694343|spinal anesthesia|spinal anesthesia
5651830|NCT00694343|hypotension|hypotension
5651831|NCT00694330|vaccine|vaccine
5651832|NCT00694330|GM-K562|gm-k562
5651833|NCT00694330|malignant glioma|malignant glioma
5651834|NCT00694304|Major Depressive Disorder|major depressive disorder
5651835|NCT00694304|Long-term|long-term
5651836|NCT00694304|Safety|safety
5651837|NCT00694304|Open-label|open-label
5651838|NCT00694291|Rising PSA|rising psa
5651839|NCT00694265|Carpal Tunnel Syndrome|carpal tunnel syndrome
5651840|NCT00694265|Median Nerve|median nerve
5651841|NCT00694265|Ultrasonography|ultrasonography
5651842|NCT00694265|Prospective cohort study|prospective cohort study
5651843|NCT00694252|Breast cancer|breast cancer
5651844|NCT00694252|Tykerb|tykerb
5651845|NCT00694252|CTCs|ctcs
5651846|NCT00694239|hypertension|hypertension
5651847|NCT00694239|compliance|compliance
5651848|NCT00694226|Adolescent|adolescent
5651849|NCT00694226|Substance use|substance use
5651850|NCT00694226|Brief intervention|brief intervention
5651851|NCT00694226|Child psychiatry|child psychiatry
5651852|NCT00694213|Pandemic Influenza|pandemic influenza
5651853|NCT00694213|Avian Influenza|avian influenza
5651854|NCT00694213|DNA Vaccines|dna vaccines
5651855|NCT00694213|Antibody|antibody
5651856|NCT00694213|T Cells|t cells
5651857|NCT00694213|HA/NP/M2|ha/np/m2
5651858|NCT00694213|Biojector|biojector
5651859|NCT00694200|breast cancer|breast cancer
5651860|NCT00694200|chemotherapy|chemotherapy
5651861|NCT00694200|anti-angiogenesis therapy|anti-angiogenesis therapy
5651862|NCT00694174|Procedural Pain in Newborn Infants|procedural pain in newborn infants
5651863|NCT00694174|newborn infant|newborn infant
5651864|NCT00694174|acute procedural pain|acute procedural pain
5651865|NCT00694174|skin blood flow changes|skin blood flow changes
5651866|NCT00694174|sucrose analgesia|sucrose analgesia
5651867|NCT00694174|laser doppler imager|laser doppler imager
5651868|NCT00694174|neonatal infant pain scale|neonatal infant pain scale
5651869|NCT00694161|Transthyretin|transthyretin
5651871|NCT00694161|ATTR|attr
5651872|NCT00694161|TTR amyloidosis|ttr amyloidosis
5651873|NCT00694161|cardiomyopathy|cardiomyopathy
5651874|NCT00694161|V122I|v122i
5651875|NCT00694161|wild-type TTR|wild-type ttr
5651876|NCT00694161|SSA|ssa
5651877|NCT00694161|Patients with V122I or wild-type TTR amyloid cardiomyopathy|patients with v122i or wild-type ttr amyloid cardiomyopathy
5651878|NCT00694148|Treatment of glabellar frown lines|treatment of glabellar frown lines
5651879|NCT00694135|Iontophoresis|iontophoresis
5651880|NCT00694135|Non-Infectious Acute Anterior Segment Uveitis|non-infectious acute anterior segment uveitis
5651881|NCT00694135|Ophthalmology|ophthalmology
5651882|NCT00694122|glucose|glucose
5651883|NCT00694122|cortisol|cortisol
5651884|NCT00694122|growth hormone|growth hormone
5651885|NCT00694122|glucagon|glucagon
5651886|NCT00694122|insulin|insulin
5651887|NCT00694109|Familial Hypercholesterolemia|familial hypercholesterolemia
5651888|NCT00694109|FH|fh
5651889|NCT00694109|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5651890|NCT00694109|HeFH|hefh
5651891|NCT00694109|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5651892|NCT00694109|HoFH|hofh
5651893|NCT00694057|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5651895|NCT00694057|HbA1c|hba1c
5651896|NCT00694044|Safety, Tolerability, Pharmacokinetics, Cognition|safety, tolerability, pharmacokinetics, cognition
5651897|NCT00694031|Mortality|mortality
5651898|NCT00694031|Convective therapies|convective therapies
5651899|NCT00694031|On-line Hemodiafiltration|on-line hemodiafiltration
5651900|NCT00694031|Dialysis Adequacy|dialysis adequacy
5651901|NCT00694031|Age 18 or older|age 18 or older
5651902|NCT00694031|Undergoing hemodialysis|undergoing hemodialysis
5651904|NCT00694018|walking|walking
5651905|NCT00694005|stent|stent
5651906|NCT00694005|bifurcation|bifurcation
5651907|NCT00694005|balloon angioplasty|balloon angioplasty
5651908|NCT00693966|HPV, Vaccine|hpv, vaccine
5651909|NCT00693953|Evoked Potentials|evoked potentials
5651910|NCT00693953|Evoked Potentials, Auditory|evoked potentials, auditory
5651911|NCT00693953|Evoked Potentials, Visual|evoked potentials, visual
5651912|NCT00693953|Electroencephalography|electroencephalography
5651913|NCT00693953|Brain Mapping|brain mapping
5651914|NCT00693940|Peripheral Arterial Disease|peripheral arterial disease
5651915|NCT00693940|PAD|pad
5651916|NCT00693927|Hematopoietic cell transplantation|hematopoietic cell transplantation
5651917|NCT00693927|Allogeneic|allogeneic
5651918|NCT00693927|Nonmyeloablative|nonmyeloablative
5651919|NCT00693927|CD8-depletion|cd8-depletion
5651920|NCT00693927|PBSC|pbsc
5651921|NCT00693927|GVHD|gvhd
5651922|NCT00693927|Hematological malignancies and renal cell carcinoma|hematological malignancies and renal cell carcinoma
5651923|NCT00693914|Brain Tumor|brain tumor
5651924|NCT00693914|Cognitive Late Effects|cognitive late effects
5651925|NCT00693914|Radiation Therapy|radiation therapy
5651926|NCT00693914|Working Memory|working memory
5651927|NCT00693888|dementia|dementia
5651928|NCT00693888|system of care|system of care
5651929|NCT00693888|level of care|level of care
5651930|NCT00693888|interventional study|interventional study
5651931|NCT00693888|evaluation|evaluation
5651932|NCT00693888|dementia diagnostic|dementia diagnostic
5672657|NCT00611325|Velcade|velcade
5651933|NCT00693888|Evaluation of the care study|evaluation of the care study
5651934|NCT00693875|incidence|incidence
5651935|NCT00693875|awareness|awareness
5651936|NCT00693875|general anesthesia|general anesthesia
5651937|NCT00693875|relevant factor|relevant factor
5651938|NCT00693875|the incidence of intra-operative awareness in China|the incidence of intra-operative awareness in china
5651939|NCT00693875|the relevant factors|the relevant factors
5651940|NCT00693862|Focus of the study is pharmacokinetics of the study drug|focus of the study is pharmacokinetics of the study drug
5651941|NCT00693849|depression|depression
5651942|NCT00693849|CNS|cns
5651943|NCT00693849|iSPOT|ispot
5651944|NCT00693849|MDD|mdd
5651949|NCT00693836|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5651950|NCT00693836|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5651951|NCT00693836|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5651952|NCT00693836|limited stage small cell lung cancer|limited stage small cell lung cancer
5651953|NCT00693836|recurrent small cell lung cancer|recurrent small cell lung cancer
5651955|NCT00693823|stent|stent
5651956|NCT00693823|angioplasty|angioplasty
5651957|NCT00693823|covered stent|covered stent
5651958|NCT00693797|ventricular hypertrophy|ventricular hypertrophy
5651959|NCT00693797|collagen|collagen
5651960|NCT00693797|aortic stenosis|aortic stenosis
5651961|NCT00693784|Intervertebral Disk|intervertebral disk
5651962|NCT00693784|chronic low back pain|chronic low back pain
5651963|NCT00693784|internal disc disruption|internal disc disruption
5651964|NCT00693784|degenerative disc disease|degenerative disc disease
5651965|NCT00693758|MRI|mri
5651966|NCT00693758|coronary reactivity|coronary reactivity
5651967|NCT00693758|coronary physiology|coronary physiology
5651968|NCT00693745|Acutely|acutely
5651969|NCT00693719|recurrent breast cancer|recurrent breast cancer
5651970|NCT00693719|stage IIIA breast cancer|stage iiia breast cancer
5651971|NCT00693719|stage IIIB breast cancer|stage iiib breast cancer
5651972|NCT00693719|stage IIIC breast cancer|stage iiic breast cancer
5651973|NCT00693719|stage IV breast cancer|stage iv breast cancer
5651974|NCT00693706|cell culture|cell culture
5651975|NCT00693706|Safety|safety
5651976|NCT00693706|Influenza|influenza
5651977|NCT00693706|Humans|humans
5651978|NCT00693706|Adults|adults
5651979|NCT00693706|Immunogenicity|immunogenicity
5651980|NCT00693706|Influenza vaccine|influenza vaccine
5651981|NCT00693706|Vaccine|vaccine
5651982|NCT00693680|depression|depression
5651983|NCT00693680|antidepressant treatment|antidepressant treatment
5651984|NCT00693680|zinc|zinc
5651985|NCT00693680|placebo|placebo
5651986|NCT00693667|osteoporosis|osteoporosis
5651987|NCT00693667|postmenopausal women|postmenopausal women
5651988|NCT00693667|botanical drug|botanical drug
5651989|NCT00693654|Uremic Pruritis|uremic pruritis
5651990|NCT00693641|Jellyfish|jellyfish
5651991|NCT00693641|Cyanea sp|cyanea sp
5651992|NCT00693641|Safe Sea|safe sea
5651993|NCT00693641|Prevention|prevention
5651994|NCT00693641|treatment|treatment
5651995|NCT00693641|Pain relief|pain relief
5651996|NCT00693641|Prevention of pain|prevention of pain
5651998|NCT00693628|healing|healing
5651999|NCT00693628|shrinker|shrinker
5652000|NCT00693628|transtibial amputation|transtibial amputation
5652001|NCT00693628|individuals who have undergone transtibial amputation|individuals who have undergone transtibial amputation
5652003|NCT00693589|endothelial function|endothelial function
5652004|NCT00693589|flow mediated dilatation|flow mediated dilatation
5652005|NCT00693589|rosuvastatin|rosuvastatin
5652006|NCT00693589|folic acid|folic acid
5652007|NCT00693589|B vitamins|b vitamins
5652008|NCT00693576|renal transplant|renal transplant
5652009|NCT00693576|panel reactive antibody|panel reactive antibody
5652010|NCT00693576|sensitization|sensitization
5652011|NCT00693576|simvastatin|simvastatin
5652012|NCT00693576|immunological|immunological
5652013|NCT00693563|Spinal Cord Injury|spinal cord injury
5652014|NCT00693550|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5652015|NCT00693550|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5652016|NCT00693524|liver allograft transplantation|liver allograft transplantation
5652017|NCT00693524|sequential therapy|sequential therapy
5652018|NCT00693524|tacrolimus|tacrolimus
5652093|NCT00693225|omeprazole/sodium bicarbonate|omeprazole/sodium bicarbonate
5652094|NCT00693212|ADHD|adhd
5652095|NCT00693212|Adult|adult
5652096|NCT00693212|crossover|crossover
5652097|NCT00693212|randomized|randomized
5652098|NCT00693212|Long-term|long-term
5652099|NCT00693212|Open-label|open-label
5652100|NCT00693212|methylphenidate|methylphenidate
5652101|NCT00693212|Social adjustment|social adjustment
5652102|NCT00693199|Amlodipine|amlodipine
5652103|NCT00693199|Terazosin|terazosin
5652104|NCT00693199|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5652105|NCT00693199|Essential hypertension|essential hypertension
5652106|NCT00693199|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5652107|NCT00693199|Quality Of Life (QOL)|quality of life (qol)
5652109|NCT00693173|cancer|cancer
5652110|NCT00693173|rectal|rectal
5652113|NCT00693173|sparing|sparing
5652114|NCT00693173|drop|drop
5652115|NCT00693173|technique|technique
5652116|NCT00693160|healthy volunteers|healthy volunteers
5652117|NCT00693160|analgesia|analgesia
5652118|NCT00693160|pain|pain
5652119|NCT00693160|Healthy subjects|healthy subjects
5652120|NCT00693147|Goiter [C19.874.283]|goiter [c19.874.283]
5652121|NCT00693147|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5652122|NCT00693121|Traumatic Brain Injury|traumatic brain injury
5652123|NCT00693121|Posttraumatic Confusional State|posttraumatic confusional state
5652124|NCT00693121|Delirium|delirium
5652125|NCT00693121|Amantadine|amantadine
5652126|NCT00693121|Clinical trial|clinical trial
5652127|NCT00693108|Poor|poor
5652128|NCT00693108|Response|response
5652129|NCT00693108|Ovarian|ovarian
5652130|NCT00693108|Stimulation|stimulation
5652131|NCT00693108|IVF|ivf
5652132|NCT00693108|Patients|patients
5652133|NCT00693095|Grade IV Glioblastoma Multiforme|grade iv glioblastoma multiforme
5652134|NCT00693095|Newly-diagnosed|newly-diagnosed
5652135|NCT00693095|CMV positive|cmv positive
5652136|NCT00693082|PCOS|pcos
5652137|NCT00693082|flaxseed|flaxseed
5652138|NCT00693069|angioplasty|angioplasty
5652139|NCT00693069|clopidogrel|clopidogrel
5652140|NCT00693069|coronary artery disease|coronary artery disease
5652141|NCT00693069|platelets|platelets
5652142|NCT00693069|Percutaneous coronary intervention|percutaneous coronary intervention
5652143|NCT00693056|Erectile Dysfunctions|erectile dysfunctions
5652144|NCT00693056|ED|ed
5652145|NCT00693043|Pain control|pain control
5652146|NCT00693030|Coronary Artery Disease|coronary artery disease
5652147|NCT00693030|Percutaneous Coronary Interventions|percutaneous coronary interventions
5652148|NCT00693030|Drug-Eluting stents|drug-eluting stents
5652149|NCT00693030|Optical Coherence Tomography|optical coherence tomography
5652150|NCT00693030|Thrombosis|thrombosis
5652151|NCT00693030|Long lesions in native vessel requiring stents in overlap|long lesions in native vessel requiring stents in overlap
5652152|NCT00692991|Microvascular Obstruction|microvascular obstruction
5652153|NCT00692991|Cardiac MRI|cardiac mri
5652154|NCT00692991|Alcohol Ablation|alcohol ablation
5652155|NCT00692991|Diagnostic PCI|diagnostic pci
5652156|NCT00692978|Monodisperse aerosols|monodisperse aerosols
5652157|NCT00692978|Healthy Volunteers|healthy volunteers
5652158|NCT00692978|Asthmatics|asthmatics
5652159|NCT00692978|Pharmacokinetics|pharmacokinetics
5652160|NCT00692978|Randomized|randomized
5652161|NCT00692965|HIV|hiv
5652162|NCT00692965|Sleep Quality|sleep quality
5652163|NCT00692965|Sleep apnea|sleep apnea
5652164|NCT00692965|Berlin Questionnaire|berlin questionnaire
5652165|NCT00692965|Pittsburgh Sleep Quality Index|pittsburgh sleep quality index
5652166|NCT00692952|contraceptive efficacy|contraceptive efficacy
5652167|NCT00692939|Stem cell transplantation|stem cell transplantation
5652168|NCT00692939|Crohn's Disease|crohn's disease
5652169|NCT00692926|ALDHbr|aldhbr
5652170|NCT00692926|Umbilical Cord Blood|umbilical cord blood
5652171|NCT00692926|Transplantation|transplantation
5652172|NCT00692926|Hematological malignancy|hematological malignancy
5652173|NCT00692926|MDS|mds
5652174|NCT00692926|severe aplastic anemia|severe aplastic anemia
5652175|NCT00692926|inborn error of metabolism|inborn error of metabolism
5652176|NCT00692926|congenital marrow failure or congenital immunodeficiency syndrome|congenital marrow failure or congenital immunodeficiency syndrome
5652177|NCT00692926|Hurler's Disease|hurler's disease
5652178|NCT00692926|Tay Sach's|tay sach's
5652179|NCT00692926|PMD|pmd
5652180|NCT00692926|Hunter's Syndrome|hunter's syndrome
5652181|NCT00692926|Krabbe|krabbe
5652182|NCT00692926|MLD|mld
5652183|NCT00692926|ALD|ald
5652184|NCT00692926|ALL|all
5652185|NCT00692926|AML|aml
5652186|NCT00692887|AMD|amd
5652187|NCT00692874|Quality of Life|quality of life
5652188|NCT00692861|Celiac Disease|celiac disease
5652189|NCT00692861|Ataxia|ataxia
5652190|NCT00692861|Adults|adults
5652191|NCT00692861|Health Volunteer|health volunteer
5652192|NCT00692861|HV|hv
5652193|NCT00692848|Procalcitonin|procalcitonin
5652194|NCT00692848|Antibiotic|antibiotic
5652195|NCT00692848|Fever without source|fever without source
5652196|NCT00692848|Fever without focus|fever without focus
5652197|NCT00692848|bacteremia|bacteremia
5652198|NCT00692848|Urinary tract infection|urinary tract infection
5652199|NCT00692835|Goiter [C19.874.283]|goiter [c19.874.283]
5652200|NCT00692835|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5652201|NCT00692822|Neisseria gonorrheae|neisseria gonorrheae
5652202|NCT00692822|Antimicrobial Susceptibility|antimicrobial susceptibility
5652203|NCT00692822|Quinolone Resistance|quinolone resistance
5652204|NCT00692822|Sexually transmitted diseases|sexually transmitted diseases
5652205|NCT00692809|Latent tuberculosis infection|latent tuberculosis infection
5652206|NCT00692809|Human immunodeficiency virus|human immunodeficiency virus
5652207|NCT00692809|Tuberculosis|tuberculosis
5652208|NCT00692809|Natural Killer T Cells|natural killer t cells
5652209|NCT00692809|Invariant Natural Killer T Cells|invariant natural killer t cells
5652210|NCT00692809|Regulatory T cells|regulatory t cells
5652211|NCT00692809|Interferon-gamma|interferon-gamma
5652212|NCT00692796|Pulmonary fibrosis|pulmonary fibrosis
5652213|NCT00692796|Pulmonary rehabilitation|pulmonary rehabilitation
5652215|NCT00692796|Quality of life|quality of life
5652216|NCT00692783|candida|candida
5652217|NCT00692783|dubliniensis|dubliniensis
5652218|NCT00692783|candidiasis|candidiasis
5652219|NCT00692783|HIV|hiv
5652220|NCT00692783|AIDS|aids
5652221|NCT00692783|azole resistance.|azole resistance.
5652222|NCT00692770|Hepatocellular carcinoma|hepatocellular carcinoma
5652223|NCT00692770|Sorafenib|sorafenib
5652224|NCT00692770|Adjuvant|adjuvant
5652225|NCT00692770|Surgical resection|surgical resection
5652226|NCT00692770|Ablation|ablation
5652227|NCT00692770|Nexavar|nexavar
5652228|NCT00692770|Adjuvant therapy|adjuvant therapy
5652229|NCT00692770|Liver cancer|liver cancer
5652230|NCT00692770|HCC|hcc
5652231|NCT00692770|STORM|storm
5652232|NCT00692757|Hypochlorous Acid|hypochlorous acid
5652233|NCT00692757|Colony forming units|colony forming units
5652234|NCT00692757|surgical site infection|surgical site infection
5652235|NCT00692757|nosocomial infection|nosocomial infection
5652236|NCT00692757|bacterial bioburden|bacterial bioburden
5652237|NCT00692757|wound healing|wound healing
5652238|NCT00692744|Subarachnoid hemorrhage|subarachnoid hemorrhage
5652239|NCT00692744|Cerebral aneurysm|cerebral aneurysm
5652240|NCT00692744|Elderly|elderly
5652241|NCT00692731|green tea,|green tea,
5652242|NCT00692731|polyphenols,|polyphenols,
5652243|NCT00692731|weight loss,|weight loss,
5652244|NCT00692731|body fat|body fat
5652245|NCT00692705|Alzheimer´s Disease|alzheimer´s disease
5652246|NCT00692705|amyloid deposits|amyloid deposits
5652247|NCT00692705|Positron Emission Tomography|positron emission tomography
5652248|NCT00692705|phase I|phase i
5652249|NCT00692653|Localized prostate cancer|localized prostate cancer
5652250|NCT00692653|Treatment decision making|treatment decision making
5652251|NCT00692653|Tailored decision aid|tailored decision aid
5652252|NCT00692640|Cancer|cancer
5652253|NCT00692640|Solid Tumors|solid tumors
5652254|NCT00692640|NSCLC|nsclc
5652255|NCT00692627|Falciparum|falciparum
5652256|NCT00692627|malaria|malaria
5652257|NCT00692627|volume|volume
5652258|NCT00692627|haemodynamics|haemodynamics
5652259|NCT00692601|Acute Exercise protocol|acute exercise protocol
5652260|NCT00692601|Crossover design|crossover design
5652261|NCT00692601|Oxygen consumption (VO2)|oxygen consumption (vo2)
5652262|NCT00692601|Respiratory Exchange Ratio (RER)|respiratory exchange ratio (rer)
5652263|NCT00692601|Adrenergic System Agonism|adrenergic system agonism
5652264|NCT00692601|Capsiate Natura|capsiate natura
5652265|NCT00692601|Young|young
5652266|NCT00692601|Male|male
5652267|NCT00692588|Alzheimer's Disease|alzheimer's disease
5652268|NCT00692588|Magnetic Resonance Imaging|magnetic resonance imaging
5652269|NCT00692588|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5652270|NCT00692588|Diffusion Tensor Imaging|diffusion tensor imaging
5652271|NCT00692588|Susceptibility Weighted Imaging|susceptibility weighted imaging
5652272|NCT00692588|Doxycycline|doxycycline
5652273|NCT00692588|Rifampicin|rifampicin
5652274|NCT00692575|Brain Injuries, Traumatic|brain injuries, traumatic
5652275|NCT00692575|Caregivers|caregivers
5652276|NCT00692562|Islets of Langerhans Transplantation|islets of langerhans transplantation
5652277|NCT00692562|Kidney Transplantation|kidney transplantation
5652278|NCT00692562|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5652279|NCT00692562|alemtuzumab|alemtuzumab
5652280|NCT00692549|ultrasound|ultrasound
5652281|NCT00692549|iv access|iv access
5652282|NCT00692549|Patients with difficult iv access in emergency departments.|patients with difficult iv access in emergency departments.
5652283|NCT00692536|Obesity|obesity
5652284|NCT00692536|Postmenopausal|postmenopausal
5652285|NCT00692536|Diet intervention|diet intervention
5652286|NCT00692523|Stroke|stroke
5652287|NCT00692523|rehabilitation|rehabilitation
5652288|NCT00692523|Nintendo Wii|nintendo wii
5652289|NCT00692510|AZD3480|azd3480
5652290|NCT00692510|Cocktail|cocktail
5652291|NCT00692510|caffeine|caffeine
5652292|NCT00692510|bupropion|bupropion
5652293|NCT00692510|omeprazole|omeprazole
5652294|NCT00692510|midazolam|midazolam
5652295|NCT00692510|rosiglitazone|rosiglitazone
5652296|NCT00692510|metabolism|metabolism
5652297|NCT00692510|Drug Drug Interaction|drug drug interaction
5652298|NCT00692497|One-Stop|one-stop
5652299|NCT00692497|Public Health Research|public health research
5652300|NCT00692497|Delivery of Health Care/*standards|delivery of health care/*standards
5652301|NCT00692497|Evaluation Studies|evaluation studies
5652302|NCT00692497|Referral|referral
5652303|NCT00692497|Surgery, Outpatient|surgery, outpatient
5652304|NCT00692497|Surgery, Day|surgery, day
5652305|NCT00692497|Telemedicine|telemedicine
5652306|NCT00692484|Antimicrobial|antimicrobial
5652307|NCT00692484|Antisepsis|antisepsis
5652308|NCT00692484|Topical antisepsis|topical antisepsis
5652309|NCT00692471|Sleep|sleep
5652310|NCT00692471|Orthostatic tachycardia|orthostatic tachycardia
5652311|NCT00692471|POTS|pots
5652312|NCT00692445|depression|depression
5685562|NCT00555594|Bevacizumab (Avastin)|bevacizumab (avastin)
5652313|NCT00692432|Macrophage Migration Inhibitory Factor|macrophage migration inhibitory factor
5652315|NCT00692432|Cardiopulmonary bypass|cardiopulmonary bypass
5652317|NCT00692432|inflammation|inflammation
5652318|NCT00692432|inflammatory marker|inflammatory marker
5652319|NCT00692432|myocardial depression|myocardial depression
5652320|NCT00692432|myocardial depressant factor|myocardial depressant factor
5652321|NCT00692419|pain|pain
5652322|NCT00692419|sexual dysfunction|sexual dysfunction
5652323|NCT00692419|depression|depression
5652324|NCT00692419|symptoms|symptoms
5652325|NCT00692380|gated IMRT|gated imrt
5652326|NCT00692367|Body fat|body fat
5652327|NCT00692367|Exercise|exercise
5652328|NCT00692367|Fatty acids|fatty acids
5652329|NCT00692367|Impaired glucose tolerance|impaired glucose tolerance
5652330|NCT00692367|Insulin resistance|insulin resistance
5652331|NCT00692367|Insulin Sensitivity|insulin sensitivity
5652332|NCT00692367|Metabolic syndrome|metabolic syndrome
5652333|NCT00692367|Obesity|obesity
5652334|NCT00692367|Physical activity|physical activity
5652335|NCT00692367|Weight Loss|weight loss
5652336|NCT00692354|Advanced|advanced
5652337|NCT00692354|Solid|solid
5652338|NCT00692354|Tumour|tumour
5652339|NCT00692354|Tumor|tumor
5652340|NCT00692354|Oral|oral
5652341|NCT00692341|hepatic impairment|hepatic impairment
5652342|NCT00692328|fatigue; TMS; MEP|fatigue; tms; mep
5652343|NCT00692315|glutathione|glutathione
5652344|NCT00692315|methionine|methionine
5652345|NCT00692315|folinic acid|folinic acid
5652346|NCT00692315|redox|redox
5652347|NCT00692315|oxidative stress|oxidative stress
5652348|NCT00692315|behavior|behavior
5652349|NCT00692302|Suicide Attempts|suicide attempts
5652350|NCT00692302|Adolescents|adolescents
5652351|NCT00692302|Suicidal|suicidal
5652352|NCT00692302|Adolescent Suicide Attempters|adolescent suicide attempters
5652353|NCT00692289|Quality of Life|quality of life
5652354|NCT00692263|Healthy subjects|healthy subjects
5652355|NCT00692250|Familial Hypercholesterolemia|familial hypercholesterolemia
5652356|NCT00692237|Type 2 diabetes mellitus|type 2 diabetes mellitus
5652357|NCT00692237|Endothelial dysfunction|endothelial dysfunction
5652358|NCT00692237|Sildenafil|sildenafil
5652359|NCT00692224|neonatal jaundice|neonatal jaundice
5652360|NCT00692224|zinc|zinc
5652361|NCT00692224|hyperbilirubinemia|hyperbilirubinemia
5652362|NCT00692224|enterohepatic circulation|enterohepatic circulation
5652363|NCT00692224|bilirubin|bilirubin
5652364|NCT00692211|screening|screening
5652365|NCT00692198|COPD|copd
5652366|NCT00692185|Anorexia Nervosa|anorexia nervosa
5652367|NCT00692172|psoriasis|psoriasis
5652368|NCT00692172|alefacept|alefacept
5652369|NCT00692172|intramuscular|intramuscular
5652370|NCT00692159|TRC102|trc102
5652371|NCT00692159|Methoxyamine HCL|methoxyamine hcl
5652372|NCT00692159|Pemetrexed|pemetrexed
5652373|NCT00692159|Alimta|alimta
5652374|NCT00692159|Tracon|tracon
5652375|NCT00692159|Phase 1|phase 1
5652376|NCT00692159|Cancer|cancer
5652377|NCT00692159|BER|ber
5652378|NCT00692159|Base Excision Repair|base excision repair
5652379|NCT00692159|Small Molecule|small molecule
5652381|NCT00692159|Solid Tumor|solid tumor
5652382|NCT00692159|Neoplastic Processes|neoplastic processes
5652383|NCT00692159|Pathologic Processes|pathologic processes
5652384|NCT00692159|Pathological Conditions, Signs and Symptoms|pathological conditions, signs and symptoms
5652385|NCT00692146|Proof of Mechanism|proof of mechanism
5652386|NCT00692146|Capsaicin evoked pain|capsaicin evoked pain
5652387|NCT00692133|schizophrenia|schizophrenia
5652388|NCT00692133|bipolar disorder|bipolar disorder
5652389|NCT00692133|antipsychotic treatment|antipsychotic treatment
5652390|NCT00692133|patients´preferences|patients´preferences
5652391|NCT00692107|Radiotherapy|radiotherapy
5652392|NCT00692107|Dose|dose
5652393|NCT00692094|melatonin|melatonin
5652394|NCT00692094|circadian rhythms|circadian rhythms
5652395|NCT00692094|sleep|sleep
5652396|NCT00692081|adolescents|adolescents
5652397|NCT00692081|borderline intellectual functioning|borderline intellectual functioning
5652398|NCT00692081|social competence training|social competence training
5652399|NCT00692081|vocational training|vocational training
5652400|NCT00692081|group intervention|group intervention
5652401|NCT00692081|cognitive behavioral therapy|cognitive behavioral therapy
5652402|NCT00692081|Adolescents with borderline intellectual functioning|adolescents with borderline intellectual functioning
5652403|NCT00692068|residual renal function|residual renal function
5652404|NCT00692068|oxidative stress|oxidative stress
5652405|NCT00692068|carbonyl stress|carbonyl stress
5652406|NCT00692068|peritoneal dialysis|peritoneal dialysis
5652407|NCT00692042|Safety|safety
5652408|NCT00692042|tolerability|tolerability
5652409|NCT00692029|Normal|normal
5652410|NCT00692029|Healthy Volunteers|healthy volunteers
5652411|NCT00692016|Naproxen Sodium|naproxen sodium
5652412|NCT00691990|Goiter [C19.874.283]|goiter [c19.874.283]
5652418|NCT00691938|histone deacetylase|histone deacetylase
5652419|NCT00691938|methylation|methylation
5652420|NCT00691938|hypomethylation|hypomethylation
5652421|NCT00691925|refractive surgery|refractive surgery
5652422|NCT00691886|sedation|sedation
5652423|NCT00691873|Allergic|allergic
5652424|NCT00691873|Asthma|asthma
5652425|NCT00691873|Immunotherapy|immunotherapy
5652426|NCT00691860|Parastomal hernias|parastomal hernias
5652427|NCT00691860|Tolerance of lightweight meshes|tolerance of lightweight meshes
5652428|NCT00691860|Paracolostomy hernias|paracolostomy hernias
5652429|NCT00691860|Peristomal hernias|peristomal hernias
5652430|NCT00691847|Refractive surgery|refractive surgery
5652431|NCT00691834|Magnetic resonance Imaging|magnetic resonance imaging
5652432|NCT00691821|Negative-Pressure Wound Therapy|negative-pressure wound therapy
5652433|NCT00691821|Bandages|bandages
5652434|NCT00691821|Community Health Services|community health services
5652435|NCT00691795|Analgesia|analgesia
5652436|NCT00691795|Epidural|epidural
5652437|NCT00691795|Pregnancy|pregnancy
5652438|NCT00691795|Labor|labor
5652439|NCT00691795|Clonidine|clonidine
5652440|NCT00691795|Fentanyl|fentanyl
5652441|NCT00691795|Bupivacaine|bupivacaine
5652442|NCT00691795|Childbirth|childbirth
5652443|NCT00691782|African American females between the ages of 21 and 60|african american females between the ages of 21 and 60
5652444|NCT00691769|alopecia|alopecia
5652445|NCT00691769|lupus|lupus
5652451|NCT00691743|Upper GI Symptoms|upper gi symptoms
5652452|NCT00691743|GERD|gerd
5652453|NCT00691743|NSAIDs|nsaids
5652454|NCT00691717|Anecortave acetate|anecortave acetate
5652455|NCT00691717|Open-angle glaucoma|open-angle glaucoma
5652456|NCT00691717|IOP|iop
5652457|NCT00691717|OHT|oht
5652458|NCT00691704|Multiple Myeloma|multiple myeloma
5652459|NCT00691691|Liver malignancy|liver malignancy
5652460|NCT00691691|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5633727|NCT00763984|Pelvic Floor Disorders|pelvic floor disorders
5652461|NCT00691691|Efficacy of SBRT in liver tumors|efficacy of sbrt in liver tumors
5652462|NCT00691691|Hepatic toxicity with SBRT|hepatic toxicity with sbrt
5652463|NCT00691678|breast cancer|breast cancer
5652464|NCT00691678|aromatase inhibitor|aromatase inhibitor
5652465|NCT00691678|supportive care|supportive care
5652466|NCT00691665|Rhinitis|rhinitis
5652467|NCT00691665|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5652468|NCT00691665|allergies|allergies
5652469|NCT00691652|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5652470|NCT00691652|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5652471|NCT00691652|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5652472|NCT00691652|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5652473|NCT00691652|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5652474|NCT00691652|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5652475|NCT00691652|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5652815|NCT00690638|DPP4 inhibitor|dpp4 inhibitor
5652476|NCT00691652|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5652477|NCT00691652|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5652478|NCT00691652|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5652479|NCT00691652|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5652480|NCT00691652|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5652481|NCT00691652|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5652482|NCT00691652|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5652483|NCT00691652|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5652484|NCT00691652|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5652485|NCT00691652|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5652487|NCT00691639|IOP|iop
5652488|NCT00691626|posttraumatic stress|posttraumatic stress
5652489|NCT00691626|nightmares|nightmares
5652490|NCT00691626|sleep|sleep
5652491|NCT00691626|psychotherapy|psychotherapy
5652492|NCT00691626|imagery rehearsal|imagery rehearsal
5652493|NCT00691626|insomnia|insomnia
5652494|NCT00691626|behavioral treatment|behavioral treatment
5652495|NCT00691626|veterans|veterans
5652496|NCT00691626|Operation Iraqi Freedom|operation iraqi freedom
5652497|NCT00691626|Operation Enduring Freedom|operation enduring freedom
5652498|NCT00691613|Apoptosis|apoptosis
5652499|NCT00691613|Annexin|annexin
5652500|NCT00691613|Hypoxia|hypoxia
5652501|NCT00691613|Ischemia-Reperfusion Injury|ischemia-reperfusion injury
5652502|NCT00691600|abscess|abscess
5652846|NCT00690547|Extension|extension
5652503|NCT00691600|Abscesses in the pediatric emergency population|abscesses in the pediatric emergency population
5652504|NCT00691587|mechanical ventilation|mechanical ventilation
5652505|NCT00691587|mechanically ventilated|mechanically ventilated
5652506|NCT00691587|Pseudomonas aeruginosa|pseudomonas aeruginosa
5652507|NCT00691587|ventilator associated pneumonia|ventilator associated pneumonia
5652508|NCT00691574|Smith-Magenis Syndrome|smith-magenis syndrome
5652509|NCT00691574|melatonin|melatonin
5652510|NCT00691574|circadian rhythm|circadian rhythm
5652511|NCT00691574|sleep|sleep
5652512|NCT00691561|HIV Prevention|hiv prevention
5652513|NCT00691561|African American|african american
5652514|NCT00691561|Black|black
5652515|NCT00691561|gay|gay
5652516|NCT00691561|Men who have sex men|men who have sex men
5652517|NCT00691561|HIV Seronegativity|hiv seronegativity
5652518|NCT00691548|Stage IV cancer|stage iv cancer
5652519|NCT00691522|PERITUMORAL BRAIN EDEMA|peritumoral brain edema
5652520|NCT00691522|PRIMARY MALIGNANT BRAIN TUMORS|primary malignant brain tumors
5652521|NCT00691522|METASTATIC BRAIN TUMORS|metastatic brain tumors
5652522|NCT00691509|breast cancer|breast cancer
5652523|NCT00691496|HIV Prevention|hiv prevention
5652524|NCT00691496|African-American|african-american
5652525|NCT00691496|gay|gay
5652526|NCT00691496|bisexual|bisexual
5652527|NCT00691496|intervention trial|intervention trial
5652528|NCT00691496|HIV Seronegativity|hiv seronegativity
5652529|NCT00691483|smoking cessation|smoking cessation
5652530|NCT00691483|smoking treatment|smoking treatment
5652531|NCT00691483|patient self-selected quit date|patient self-selected quit date
5652532|NCT00691470|Anticoagulation|anticoagulation
5652533|NCT00691470|Vitamin K-dependent clotting factor inhibitor|vitamin k-dependent clotting factor inhibitor
5652534|NCT00691470|Coumadin|coumadin
5652535|NCT00691470|Warfarin|warfarin
5652536|NCT00691470|Atrial fibrillation|atrial fibrillation
5652537|NCT00691470|Prosthetic heart valve|prosthetic heart valve
5652538|NCT00691470|Venous thromboembolic disease|venous thromboembolic disease
5652539|NCT00691470|Myocardial infarction or cardiomyopathy|myocardial infarction or cardiomyopathy
5633779|NCT00763763|Imatinib mesylate|imatinib mesylate
5652540|NCT00691470|Patients with one or more of the following indications for chronic warfarin anticoagulation:|patients with one or more of the following indications for chronic warfarin anticoagulation:
5652541|NCT00691470|Atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ECG) or atrial flutter;|atrial fibrillation (paroxysmal, persistent or permanent, not due to a reversible cause, documented by ecg) or atrial flutter;
5652542|NCT00691470|A prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;|a prosthetic heart valve in the aortic or mitral position that requires chronic anticoagulation;
5652543|NCT00691470|A history of venous thromboembolic disease (DVT and/or PE) requiring long term anticoagulation (> 6 months);|a history of venous thromboembolic disease (dvt and/or pe) requiring long term anticoagulation (> 6 months);
5652544|NCT00691470|A history of myocardial infarction or cardiomyopathy requiring anticoagulation.|a history of myocardial infarction or cardiomyopathy requiring anticoagulation.
5652545|NCT00691470|Currently receiving chronic warfarin therapy for another indication not listed, with Sponsor approval.|currently receiving chronic warfarin therapy for another indication not listed, with sponsor approval.
5652546|NCT00691457|Contact lens|contact lens
5652547|NCT00691457|solution|solution
5652548|NCT00691457|confocal microscope|confocal microscope
5652549|NCT00691444|melatonin|melatonin
5652550|NCT00691444|circadian rhythms|circadian rhythms
5652551|NCT00691444|sleep|sleep
5652552|NCT00691418|perinatal|perinatal
5652553|NCT00691418|premature|premature
5652554|NCT00691418|pregnancy|pregnancy
5652555|NCT00691418|gestation|gestation
5652556|NCT00691405|Arformoterol|arformoterol
5652557|NCT00691405|(R,R)-formoterol|(r,r)-formoterol
5652558|NCT00691392|Multi-Drug Resistant Tuberculosis|multi-drug resistant tuberculosis
5652559|NCT00691392|Extensively Drug Resistant Tuberculosis|extensively drug resistant tuberculosis
5652561|NCT00691392|XDR TB|xdr tb
5652562|NCT00691392|MDR|mdr
5652563|NCT00691392|XDR|xdr
5652564|NCT00691379|Breast cancer|breast cancer
5652565|NCT00691379|Triple negative|triple negative
5652566|NCT00691379|Chemotherapy|chemotherapy
5652567|NCT00691379|Anti-angiogenesis therapy|anti-angiogenesis therapy
5652568|NCT00691353|Bipolar Disorder|bipolar disorder
5652569|NCT00691353|antipsychotics|antipsychotics
5652570|NCT00691353|social functioning|social functioning
5652571|NCT00691353|mood stabilizers|mood stabilizers
5652572|NCT00691353|Bipolar Disorder Type I|bipolar disorder type i
5652573|NCT00691353|atypical antipsychotics|atypical antipsychotics
5652574|NCT00691353|monotherapy|monotherapy
5652575|NCT00691353|cotherapy|cotherapy
5652576|NCT00691340|POAG|poag
5652577|NCT00691340|Alzheimer's disease|alzheimer's disease
5652578|NCT00691340|cellular proteome|cellular proteome
5652579|NCT00691340|human leucocytes|human leucocytes
5652580|NCT00691340|vasospasm|vasospasm
5652581|NCT00691340|Healthy subjects|healthy subjects
5652582|NCT00691327|Revision of augmentation or reconstruction|revision of augmentation or reconstruction
5652583|NCT00691314|Stroke|stroke
5652584|NCT00691314|Transietn Ischemic Attack|transietn ischemic attack
5652585|NCT00691314|Stents|stents
5652586|NCT00691314|Stenosis|stenosis
5652587|NCT00691301|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5652588|NCT00691301|recurrent cervical cancer|recurrent cervical cancer
5652592|NCT00691288|omega-3 fatty acid|omega-3 fatty acid
5652593|NCT00691288|hypertriglyceridemia|hypertriglyceridemia
5652595|NCT00691288|pediatric|pediatric
5652596|NCT00691288|HAART|haart
5652597|NCT00691275|dehydration|dehydration
5652598|NCT00691275|acute gastroenteritis|acute gastroenteritis
5652599|NCT00691275|ondansetron|ondansetron
5652600|NCT00691275|rehydration|rehydration
5652601|NCT00691262|Atopic dermatitis|atopic dermatitis
5652602|NCT00691262|Prograf|prograf
5652603|NCT00691262|Tacrolimus|tacrolimus
5652604|NCT00691262|FK506|fk506
5652605|NCT00691262|Tacrolimus ointment|tacrolimus ointment
5652606|NCT00691249|Diabetes|diabetes
5652607|NCT00691249|Diet|diet
5652608|NCT00691249|Fiber|fiber
5652609|NCT00691236|osteosarcoma|osteosarcoma
5652610|NCT00691236|zoledronic acid|zoledronic acid
5652612|NCT00691236|adjuvant to chemotherapy|adjuvant to chemotherapy
5652618|NCT00691210|Hodgkin's Disease|hodgkin's disease
5652619|NCT00691210|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5652620|NCT00691184|Onychomycosis, Toenail fungal infection, Terbinafine HCl, Pharmacokinetics|onychomycosis, toenail fungal infection, terbinafine hcl, pharmacokinetics
5652621|NCT00691171|gastroesophageal reflux disease|gastroesophageal reflux disease
5652622|NCT00691171|GERD|gerd
5652623|NCT00691171|nonsteroidal anti-inflammatory drugs|nonsteroidal anti-inflammatory drugs
5652624|NCT00691171|peptic ulcer|peptic ulcer
5652625|NCT00691171|Diagnosed GERD|diagnosed gerd
5652626|NCT00691171|Atypical GERD symptoms|atypical gerd symptoms
5652627|NCT00691171|chronic NSAID therapy|chronic nsaid therapy
5652628|NCT00691171|Risk for ulcer|risk for ulcer
5652629|NCT00691145|Atopic dermatitis|atopic dermatitis
5652630|NCT00691145|Tacrolimus ointment|tacrolimus ointment
5652631|NCT00691132|non-small cell lung cancer|non-small cell lung cancer
5652632|NCT00691132|small cell lung cancer|small cell lung cancer
5652633|NCT00691132|tobacco use disorder|tobacco use disorder
5652634|NCT00691119|breast cancer|breast cancer
5652635|NCT00691119|radiation|radiation
5633871|NCT00763412|inflammatory markers|inflammatory markers
5652636|NCT00691119|Relaxation and Visualization Therapy|relaxation and visualization therapy
5652637|NCT00691119|relaxation|relaxation
5652638|NCT00691119|visualization|visualization
5652639|NCT00691119|RVT|rvt
5652640|NCT00691119|complementary and alternative medicine|complementary and alternative medicine
5652641|NCT00691119|CAM|cam
5652642|NCT00691119|alternative medicine|alternative medicine
5652643|NCT00691093|observational|observational
5652644|NCT00691080|Melatonin|melatonin
5652645|NCT00691080|Sleep|sleep
5652646|NCT00691080|Autism|autism
5652647|NCT00691080|ASD|asd
5652648|NCT00691080|Sleep problems in children with autism spectrum disorder|sleep problems in children with autism spectrum disorder
5652649|NCT00691054|recurrent pancreatic cancer|recurrent pancreatic cancer
5652650|NCT00691054|stage III pancreatic cancer|stage iii pancreatic cancer
5652651|NCT00691054|stage IV pancreatic cancer|stage iv pancreatic cancer
5652652|NCT00691041|HIV Prevention|hiv prevention
5652653|NCT00691041|Men who have sex with men|men who have sex with men
5652654|NCT00691041|African American|african american
5652655|NCT00691041|Unprotected sex|unprotected sex
5652656|NCT00691041|HIV Seronegativity|hiv seronegativity
5652657|NCT00691028|Rheumatoid Arthritis|rheumatoid arthritis
5652658|NCT00691028|RA|ra
5652659|NCT00691028|Infliximab|infliximab
5652660|NCT00691028|TA-650|ta-650
5652661|NCT00691028|Remicade|remicade
5652662|NCT00691015|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5652663|NCT00691015|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5652664|NCT00691015|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5652665|NCT00691015|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5652666|NCT00691015|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5652667|NCT00691015|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5652668|NCT00691015|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5652669|NCT00691015|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5652670|NCT00691015|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5652671|NCT00691015|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5652672|NCT00691015|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5652673|NCT00691015|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5652674|NCT00691015|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5652675|NCT00691015|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5652676|NCT00691015|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5652677|NCT00691015|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5652678|NCT00691015|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5652679|NCT00691015|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5652680|NCT00691015|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5652681|NCT00691015|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5652682|NCT00691015|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5652683|NCT00691015|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5652684|NCT00691015|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5652685|NCT00691015|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5652686|NCT00691015|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5652687|NCT00691015|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5652688|NCT00691015|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5652689|NCT00691015|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5652690|NCT00691015|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5652691|NCT00691015|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5652692|NCT00691015|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5652693|NCT00691015|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5652694|NCT00691015|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5652695|NCT00691015|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5652696|NCT00691015|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5652697|NCT00691015|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5652698|NCT00691015|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5652699|NCT00691015|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5652700|NCT00691015|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5652701|NCT00691015|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5652702|NCT00691015|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5652703|NCT00691015|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5652704|NCT00691015|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5652705|NCT00691015|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5652706|NCT00691015|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5652707|NCT00691015|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5652708|NCT00691015|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5652709|NCT00691015|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5652710|NCT00691015|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5652711|NCT00691015|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5652712|NCT00691015|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5652713|NCT00691015|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5652714|NCT00691015|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5652715|NCT00691015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5652716|NCT00691015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5652717|NCT00691015|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5652718|NCT00691015|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5652719|NCT00691015|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5652720|NCT00691015|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5652722|NCT00691015|stage II multiple myeloma|stage ii multiple myeloma
5652723|NCT00691015|stage III multiple myeloma|stage iii multiple myeloma
5652724|NCT00691015|primary myelofibrosis|primary myelofibrosis
5652725|NCT00691015|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5652726|NCT00691015|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5652727|NCT00691015|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5652728|NCT00691015|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5652730|NCT00690989|Adherence|adherence
5652731|NCT00690989|Followup|followup
5652732|NCT00690976|HIV Seronegativity|hiv seronegativity
5652733|NCT00690976|HIV risk behavior|hiv risk behavior
5652734|NCT00690976|Unprotected sex|unprotected sex
5652735|NCT00690976|men who have sex with men|men who have sex with men
5652737|NCT00690976|Latino|latino
5652738|NCT00690976|Unsafe Sex|unsafe sex
5652739|NCT00690963|Radiotherapy|radiotherapy
5652740|NCT00690963|Intensity-Modulated|intensity-modulated
5652741|NCT00690963|Dose Fractionation|dose fractionation
5652742|NCT00690950|BPH|bph
5652743|NCT00690937|hypercholesterolemia, bile acid sequestrant, LDL-cholesterol|hypercholesterolemia, bile acid sequestrant, ldl-cholesterol
5652744|NCT00690924|lung cancer|lung cancer
5652745|NCT00690924|tobacco use disorder|tobacco use disorder
5652746|NCT00690924|squamous lung dysplasia|squamous lung dysplasia
5652747|NCT00690885|chronic cough|chronic cough
5652748|NCT00690885|COPD|copd
5652749|NCT00690885|IPF|ipf
5652750|NCT00690885|interferon alpha|interferon alpha
5652751|NCT00690872|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5652752|NCT00690872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5652753|NCT00690872|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5652754|NCT00690872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5652755|NCT00690859|Bipolar disorders|bipolar disorders
5652756|NCT00690859|Predictors of recurrence|predictors of recurrence
5652757|NCT00690820|Cystic Fibrosis|cystic fibrosis
5672658|NCT00611312|Alzheimer's disease|alzheimer's disease
5652758|NCT00690820|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5652759|NCT00690807|eczema|eczema
5652760|NCT00690781|casein|casein
5652761|NCT00690781|milk soluble proteins|milk soluble proteins
5652762|NCT00690781|protein feeding pattern|protein feeding pattern
5652763|NCT00690781|overweight|overweight
5652764|NCT00690781|obesity|obesity
5652765|NCT00690781|energy restriction|energy restriction
5652766|NCT00690781|protein metabolism|protein metabolism
5652767|NCT00690781|lean body mass|lean body mass
5652768|NCT00690781|body composition|body composition
5652769|NCT00690781|nitrogen balance|nitrogen balance
5652770|NCT00690781|protein synthesis|protein synthesis
5652771|NCT00690781|proteolysis|proteolysis
5652772|NCT00690781|spread|spread
5652773|NCT00690781|pulse|pulse
5652774|NCT00690768|Diabetic Retinopathy|diabetic retinopathy
5652775|NCT00690768|Retinal detachment|retinal detachment
5652776|NCT00690768|Vitreous Hemorrhage|vitreous hemorrhage
5652777|NCT00690768|Bevacizumab|bevacizumab
5652778|NCT00690768|preoperative|preoperative
5652779|NCT00690768|pars plana vitrectomy|pars plana vitrectomy
5652780|NCT00690755|Diabetic|diabetic
5652781|NCT00690716|Nasal CO2|nasal co2
5652782|NCT00690716|Phase II|phase ii
5652783|NCT00690716|Adaptive|adaptive
5652784|NCT00690716|Randomized|randomized
5652785|NCT00690716|Double-Blind|double-blind
5652786|NCT00690716|Placebo-Controlled|placebo-controlled
5652787|NCT00690716|Multiple-Dose|multiple-dose
5652788|NCT00690716|Multi-center|multi-center
5652789|NCT00690716|Safety|safety
5652790|NCT00690716|Efficacy|efficacy
5652791|NCT00690716|Mild Headache|mild headache
5652792|NCT00690716|Migraineur|migraineur
5652793|NCT00690703|non small cell lung cancer|non small cell lung cancer
5652794|NCT00690703|pulmonary metastases|pulmonary metastases
5652795|NCT00690703|radiofrequency ablation|radiofrequency ablation
5652796|NCT00690690|HIV Seronegativity|hiv seronegativity
5652797|NCT00690690|HIV risk behavior|hiv risk behavior
5652798|NCT00690690|Unprotected sex|unprotected sex
5652799|NCT00690690|men who have sex with men|men who have sex with men
5652800|NCT00690690|gay|gay
5652801|NCT00690690|Latino|latino
5652802|NCT00690690|unsafe sex|unsafe sex
5652803|NCT00690690|high risk sex|high risk sex
5652804|NCT00690677|LBH589|lbh589
5652805|NCT00690677|Metastatic Colorectal Cancer|metastatic colorectal cancer
5652806|NCT00690677|Refractory Colorectal Cancer|refractory colorectal cancer
5652807|NCT00690664|Hair characteristics|hair characteristics
5652808|NCT00690651|ankle|ankle
5652809|NCT00690651|fracture|fracture
5652810|NCT00690651|mobilisation|mobilisation
5652811|NCT00690651|bed rest|bed rest
5652812|NCT00690651|internal fixation|internal fixation
5652813|NCT00690638|dutogliptin|dutogliptin
5652814|NCT00690638|PHX1149|phx1149
5652816|NCT00690625|Myofacial pain|myofacial pain
5652817|NCT00690625|Omega 3 fatty acids|omega 3 fatty acids
5652819|NCT00690612|renal disease|renal disease
5652820|NCT00690612|high blood pressure|high blood pressure
5652821|NCT00690599|Patient satisfaction|patient satisfaction
5652822|NCT00690599|Dentist-Patient relations|dentist-patient relations
5652823|NCT00690599|Answering services|answering services
5652824|NCT00690586|Nephrotic syndrome|nephrotic syndrome
5652825|NCT00690586|Underfill and overfill theory|underfill and overfill theory
5652826|NCT00690586|Steroid resistance|steroid resistance
5652827|NCT00690586|Urine proteomics|urine proteomics
5652828|NCT00690586|AVP|avp
5652829|NCT00690586|ANP|anp
5652830|NCT00690586|Angiotensin II|angiotensin ii
5652831|NCT00690586|Renin and Aldosterone|renin and aldosterone
5652832|NCT00690573|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5652833|NCT00690560|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5652834|NCT00690560|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5652835|NCT00690560|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5652836|NCT00690560|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5652837|NCT00690560|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5652838|NCT00690547|Functionality|functionality
5652839|NCT00690547|Deliberately|deliberately
5652840|NCT00690547|Activated|activated
5652841|NCT00690547|Quadriceps|quadriceps
5652842|NCT00690547|Femoris|femoris
5652843|NCT00690547|During|during
5652844|NCT00690547|After|after
5652845|NCT00690547|Active|active
5652847|NCT00690534|sarcopenia|sarcopenia
5652848|NCT00690534|aging|aging
5652849|NCT00690534|muscle metabolism|muscle metabolism
5652850|NCT00690521|congestive heart failure|congestive heart failure
5652851|NCT00690521|diuretics|diuretics
5652852|NCT00690521|combination|combination
5652853|NCT00690508|Intubation, Trachea, Sternum,|intubation, trachea, sternum,
5652854|NCT00690508|Tube tip, Tube placement, Tube tip palpation,|tube tip, tube placement, tube tip palpation,
5652855|NCT00690508|Validate|validate
5652857|NCT00690508|SSTTP|ssttp
5652858|NCT00690508|corrrect|corrrect
5652859|NCT00690508|placement|placement
5652860|NCT00690495|Anesthesia|anesthesia
5652861|NCT00690495|Induction|induction
5652862|NCT00690495|Pain|pain
5652863|NCT00690482|COPD|copd
5652864|NCT00690456|Randomized Controlled Trial|randomized controlled trial
5652865|NCT00690456|Metformin|metformin
5652866|NCT00690443|Hyperlipidemia|hyperlipidemia
5652867|NCT00690430|Carcinoid|carcinoid
5652868|NCT00690430|neuroendocrine|neuroendocrine
5652869|NCT00690430|gastroenteropancreatic|gastroenteropancreatic
5652870|NCT00690430|somatostatin analogue|somatostatin analogue
5652871|NCT00690430|Symptomatic Refractory Resistant Carcinoid Disease|symptomatic refractory resistant carcinoid disease
5652872|NCT00690404|formulation|formulation
5652873|NCT00690404|pharmacokinetic|pharmacokinetic
5652874|NCT00690404|crossover formulation|crossover formulation
5652875|NCT00690404|food effect|food effect
5652876|NCT00690404|oral solution|oral solution
5652877|NCT00690404|healthy volunteers|healthy volunteers
5652878|NCT00690391|surgery|surgery
5652879|NCT00690391|prognostic|prognostic
5652880|NCT00690391|palliation|palliation
5652881|NCT00690365|Switching|switching
5652882|NCT00690365|Quetiapine|quetiapine
5652883|NCT00690365|schizophrenia|schizophrenia
5652884|NCT00690365|unsuccessfully treated|unsuccessfully treated
5652885|NCT00690365|antipsychotics|antipsychotics
5652886|NCT00690352|Specialized Substance Abuse Supervision|specialized substance abuse supervision
5652887|NCT00690352|SSAS|ssas
5652888|NCT00690352|substance use disorder|substance use disorder
5652889|NCT00690352|felony drug offender|felony drug offender
5652890|NCT00690352|probation|probation
5652891|NCT00690352|parole|parole
5652892|NCT00690352|cognitive behavioral therapy|cognitive behavioral therapy
5652893|NCT00690352|CBT|cbt
5652894|NCT00690326|physical activity|physical activity
5652895|NCT00690326|Diabetes mellitus|diabetes mellitus
5652896|NCT00690326|Behavioral change communication|behavioral change communication
5652897|NCT00690326|Household physical activity|household physical activity
5652898|NCT00690313|Vigamox, topical antibiotics, Intravitreal injections, macular degeneration, endophthalmitis|vigamox, topical antibiotics, intravitreal injections, macular degeneration, endophthalmitis
5652899|NCT00690300|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5652900|NCT00690300|pancreatic cancer|pancreatic cancer
5652901|NCT00690300|pancreas carcinoma|pancreas carcinoma
5652902|NCT00690300|advanced pancreatic cancer|advanced pancreatic cancer
5652903|NCT00690300|metastatic pancreatic cancer|metastatic pancreatic cancer
5652904|NCT00690300|second line|second line
5652905|NCT00690300|palliative|palliative
5652906|NCT00690300|Oxaliplatin|oxaliplatin
5652907|NCT00690300|Docetaxel|docetaxel
5652908|NCT00690300|Taxotere|taxotere
5652909|NCT00690300|Eloxatin|eloxatin
5652910|NCT00690300|Cancer of pancreas|cancer of pancreas
5652911|NCT00690300|Pancreas cancer|pancreas cancer
5652912|NCT00690287|Type 2 diabetes|type 2 diabetes
5652913|NCT00690274|schizophrenia|schizophrenia
5655511|NCT00680147|HPV|hpv
5652914|NCT00690274|cognitive deficients|cognitive deficients
5652915|NCT00690274|cognitive enhancing|cognitive enhancing
5652916|NCT00690274|antipsychotics|antipsychotics
5652917|NCT00690261|tumor associated macrophage|tumor associated macrophage
5652918|NCT00690261|lung cancer|lung cancer
5652920|NCT00690248|Acute mania|acute mania
5652921|NCT00690248|Bipolar disorder|bipolar disorder
5652922|NCT00690248|depressive symptoms|depressive symptoms
5652923|NCT00690248|mixed mania|mixed mania
5652924|NCT00690235|Schizophrenia|schizophrenia
5652925|NCT00690235|Schizoaffective|schizoaffective
5652926|NCT00690235|Olanzapine|olanzapine
5652927|NCT00690235|Zyprexa|zyprexa
5652928|NCT00690235|Clozapine|clozapine
5652929|NCT00690235|Clozaril|clozaril
5652930|NCT00690235|Pramlintide|pramlintide
5652931|NCT00690235|Diabetes|diabetes
5652932|NCT00690235|Weight Gain|weight gain
5652933|NCT00690235|Obesity|obesity
5652934|NCT00690235|Metabolic Syndrome|metabolic syndrome
5652935|NCT00690222|cataract surgery|cataract surgery
5652936|NCT00690222|phacoemulsification|phacoemulsification
5652937|NCT00690222|pupil|pupil
5652938|NCT00690222|dilation|dilation
5652939|NCT00690222|mydriasis|mydriasis
5652940|NCT00690222|intracameral|intracameral
5652941|NCT00690222|topical|topical
5652942|NCT00690222|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5652943|NCT00690209|Chronic ischemic cardiomyopathy with residual viability|chronic ischemic cardiomyopathy with residual viability
5652944|NCT00690209|surgical coronary revascularization|surgical coronary revascularization
5652945|NCT00690209|stem cell therapy|stem cell therapy
5652946|NCT00690209|Chronic ischemic heart disease|chronic ischemic heart disease
5652947|NCT00690209|severe impairment of global contractility left ventricular dilation|severe impairment of global contractility left ventricular dilation
5652948|NCT00690209|residual viability|residual viability
5652949|NCT00690183|physical activity|physical activity
5652950|NCT00690183|stem cells|stem cells
5652951|NCT00690183|lifestyle|lifestyle
5652952|NCT00690170|ketamine|ketamine
5652953|NCT00690170|nicotine|nicotine
5652954|NCT00690170|schizophrenia|schizophrenia
5652955|NCT00690170|cognitive deficits|cognitive deficits
5652956|NCT00690170|P300 oddball paradigm|p300 oddball paradigm
5652957|NCT00690170|Mismatch Negativity|mismatch negativity
5652958|NCT00690170|P50 gating|p50 gating
5652959|NCT00690157|heart failure, prognosis, markers,heart transplantation|heart failure, prognosis, markers,heart transplantation
5652961|NCT00690144|medical education|medical education
5685563|NCT00555594|Immunologic rejection|immunologic rejection
5652962|NCT00690144|performance of clinical reasoning and skills|performance of clinical reasoning and skills
5652963|NCT00690131|Smoking cessation, severe mental illness, behavioral treatment|smoking cessation, severe mental illness, behavioral treatment
5652964|NCT00690118|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5652965|NCT00690118|survival time|survival time
5652966|NCT00690118|ALS functioning Rating Scale|als functioning rating scale
5652967|NCT00690118|quality of life|quality of life
5652968|NCT00690118|non-invasive ventilation|non-invasive ventilation
5652969|NCT00690118|clinical tolerability|clinical tolerability
5652970|NCT00690118|survival|survival
5652971|NCT00690105|Dermatitis, Atopic|dermatitis, atopic
5652972|NCT00690105|Dermatologic Agents|dermatologic agents
5634256|NCT00761657|Kidney|kidney
5652973|NCT00690105|Topical Drug Administration|topical drug administration
5652974|NCT00690105|Tacrolimus|tacrolimus
5652975|NCT00690105|Calcineurin|calcineurin
5652976|NCT00690105|Corticosteroid|corticosteroid
5652977|NCT00690105|Fluticasone propionate|fluticasone propionate
5652978|NCT00690105|Face|face
5652979|NCT00690092|Coccidioidin|coccidioidin
5652980|NCT00690092|Coccidioidin SD|coccidioidin sd
5652981|NCT00690092|Spherule-derived coccidioidin|spherule-derived coccidioidin
5652982|NCT00690092|Coccidioidomycosis|coccidioidomycosis
5652983|NCT00690092|Valley Fever|valley fever
5652984|NCT00690092|Coccidioides immitis|coccidioides immitis
5652985|NCT00690079|MAD|mad
5652986|NCT00690079|Multiple ascending dose|multiple ascending dose
5652987|NCT00690079|Chronic pain|chronic pain
5652988|NCT00690079|pain|pain
5652989|NCT00690066|T1DM|t1dm
5652990|NCT00690066|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5652991|NCT00690066|Type 1 Diabetes|type 1 diabetes
5652992|NCT00690066|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5652993|NCT00690066|Juvenile Diabetes|juvenile diabetes
5652994|NCT00690066|Adult Human Stem Cells|adult human stem cells
5652995|NCT00690066|Mesenchymal Stem Cells|mesenchymal stem cells
5652996|NCT00690066|MSCs|mscs
5652997|NCT00690066|Insulin|insulin
5652998|NCT00690066|Osiris|osiris
5652999|NCT00690066|Prochymal|prochymal
5653000|NCT00690053|Toxicity|toxicity
5653001|NCT00690053|PET|pet
5653002|NCT00690053|HX-4|hx-4
5653003|NCT00690053|cancer|cancer
5653004|NCT00690040|Induction of labor|induction of labor
5653005|NCT00690040|Ripening|ripening
5653006|NCT00690040|Single balloon catheter|single balloon catheter
5653007|NCT00690040|Double balloon catheter|double balloon catheter
5653008|NCT00690014|OAT|oat
5653009|NCT00690014|GFR|gfr
5653010|NCT00690014|renal function|renal function
5653011|NCT00690014|PAH|pah
5653012|NCT00690001|HIV-1 infection|hiv-1 infection
5653013|NCT00690001|Treatment Experienced|treatment experienced
5653014|NCT00689988|Down syndrome|down syndrome
5653015|NCT00689988|communication AIDS for disabled|communication aids for disabled
5653016|NCT00689988|language development disorders|language development disorders
5653017|NCT00689988|vocabulary|vocabulary
5653018|NCT00689988|gestures|gestures
5653019|NCT00689988|language tests|language tests
5653021|NCT00689975|stage IA breast cancer|stage ia breast cancer
5653022|NCT00689975|stage IB breast cancer|stage ib breast cancer
5653023|NCT00689975|stage II breast cancer|stage ii breast cancer
5653024|NCT00689975|stage IIIA breast cancer|stage iiia breast cancer
5653025|NCT00689975|stage IIIB breast cancer|stage iiib breast cancer
5653026|NCT00689975|stage IIIC breast cancer|stage iiic breast cancer
5653027|NCT00689962|Lisfranc|lisfranc
5653028|NCT00689962|fracture|fracture
5653029|NCT00689962|dislocation|dislocation
5653030|NCT00689962|bioabsorbable|bioabsorbable
5653031|NCT00689949|folic acid|folic acid
5653032|NCT00689949|folate|folate
5653033|NCT00689949|p-aminobenzoylglutamate|p-aminobenzoylglutamate
5653034|NCT00689949|formiminoglutamate|formiminoglutamate
5653035|NCT00689949|homocysteine|homocysteine
5653036|NCT00689949|experimental validation of a new biomarker|experimental validation of a new biomarker
5653037|NCT00689936|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5653038|NCT00689936|Lenalidomide|lenalidomide
5653039|NCT00689936|Revlimid|revlimid
5653040|NCT00689936|phase III|phase iii
5653041|NCT00689910|pharmacokinetics|pharmacokinetics
5653042|NCT00689910|pregnancy|pregnancy
5653043|NCT00689910|Raltegravir|raltegravir
5653044|NCT00689910|HIV|hiv
5653045|NCT00689910|antiretroviral|antiretroviral
5653046|NCT00689910|Treatment of HIV in pregnant women with Raltegravir|treatment of hiv in pregnant women with raltegravir
5653047|NCT00689897|Primary Dysmenorrhea|primary dysmenorrhea
5653048|NCT00689897|Deqi|deqi
5653049|NCT00689897|acupuncture|acupuncture
5653050|NCT00689897|psychology|psychology
5653051|NCT00689858|Healthy volunteers|healthy volunteers
5653052|NCT00689845|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5653053|NCT00689845|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5653054|NCT00689845|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5653055|NCT00689845|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5653056|NCT00689845|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5653057|NCT00689832|Dermatitis, Atopic|dermatitis, atopic
5653058|NCT00689832|Dermatologic Agents|dermatologic agents
5653059|NCT00689832|Topical Drug Administration|topical drug administration
5653060|NCT00689832|Tacrolimus|tacrolimus
5653061|NCT00689832|Calcineurin|calcineurin
5653062|NCT00689832|Corticosteroid|corticosteroid
5653063|NCT00689832|Fluticasone propionate|fluticasone propionate
5653064|NCT00689832|Child|child
5653065|NCT00689819|Hypertension|hypertension
5653066|NCT00689819|High blood pressure|high blood pressure
5653067|NCT00689819|Pre-clinical cardiac dysfunction|pre-clinical cardiac dysfunction
5653068|NCT00689806|Asthma|asthma
5653069|NCT00689793|Fatigue|fatigue
5653070|NCT00689793|Blood donation|blood donation
5653071|NCT00689793|Iron deficiency|iron deficiency
5653072|NCT00689793|Ferrous sulphate|ferrous sulphate
5653073|NCT00689793|Donation|donation
5653074|NCT00689793|Donors|donors
5653075|NCT00689793|Iron|iron
5653076|NCT00689793|Ferritin|ferritin
5653077|NCT00689793|Hemoglobin|hemoglobin
5653078|NCT00689793|Anemia|anemia
5653079|NCT00689793|Anaemia|anaemia
5653080|NCT00689793|Haemoglobin|haemoglobin
5653081|NCT00689793|Don|don
5653082|NCT00689793|Women blood donors|women blood donors
5653083|NCT00689780|Pain|pain
5653084|NCT00689780|safety|safety
5653085|NCT00689780|chronic low back pain|chronic low back pain
5653086|NCT00689767|drug eluting stent|drug eluting stent
5653087|NCT00689754|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5653088|NCT00689754|gastrointestinal intubation|gastrointestinal intubation
5653089|NCT00689754|endoscopy|endoscopy
5653090|NCT00689741|HPV|hpv
5653091|NCT00689741|vaccine|vaccine
5653092|NCT00689715|Cystic tumor|cystic tumor
5653093|NCT00689715|Pancreas|pancreas
5653094|NCT00689715|EUS|eus
5653095|NCT00689702|cetuximab|cetuximab
5653096|NCT00689702|capecitabine|capecitabine
5653097|NCT00689702|radiotherapy|radiotherapy
5653098|NCT00689702|rectal cancer|rectal cancer
5653099|NCT00689676|expressive language|expressive language
5653100|NCT00689676|cognition|cognition
5653101|NCT00689676|early development|early development
5653102|NCT00689676|very low birt weight|very low birt weight
5653103|NCT00689676|prematurity|prematurity
5653104|NCT00689663|cholecystectomy|cholecystectomy
5653105|NCT00689637|AZD3480|azd3480
5653106|NCT00689637|Warfarin|warfarin
5653107|NCT00689637|Drug interaction|drug interaction
5653108|NCT00689624|Colorectal Cancer|colorectal cancer
5653109|NCT00689624|Cetuximab|cetuximab
5653110|NCT00689624|FOLFOXIRI|folfoxiri
5653111|NCT00689611|Acute coronary syndrome|acute coronary syndrome
5653112|NCT00689611|Myocardial infarction|myocardial infarction
5653113|NCT00689611|Smoking cessation|smoking cessation
5653118|NCT00689585|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5653119|NCT00689585|RSD|rsd
5653120|NCT00689585|Chronic Pain|chronic pain
5653121|NCT00689585|Ethosuximide|ethosuximide
5653122|NCT00689585|Zarontin|zarontin
5653123|NCT00689585|Anticonvulsant|anticonvulsant
5653124|NCT00689572|cocaine dependence|cocaine dependence
5653125|NCT00689572|cocaine abuse|cocaine abuse
5653126|NCT00689572|cocaine|cocaine
5653127|NCT00689572|crack|crack
5653128|NCT00689559|Alzheimer's disease|alzheimer's disease
5653129|NCT00689559|AZD3480|azd3480
5653130|NCT00689559|Aripiprazole|aripiprazole
5653131|NCT00689533|VEPTR|veptr
5653133|NCT00689533|scoliosis|scoliosis
5653134|NCT00689533|juvenile|juvenile
5653135|NCT00689520|Venous thromboembolism|venous thromboembolism
5653136|NCT00689520|low molecular weight heparin|low molecular weight heparin
5653137|NCT00689520|Vitamin K antagonist|vitamin k antagonist
5653138|NCT00689520|Longterm|longterm
5653139|NCT00689507|Multiple Myeloma|multiple myeloma
5653140|NCT00689507|Relapsed|relapsed
5653141|NCT00689507|Refractory|refractory
5653142|NCT00689507|Bortezomib|bortezomib
5653143|NCT00689507|Velcade|velcade
5653144|NCT00689494|Nanopaz device|nanopaz device
5653145|NCT00689494|Blood progesterone measure in using the device|blood progesterone measure in using the device
5653146|NCT00689494|Delivery progesterone|delivery progesterone
5653349|NCT00688844|Diet|diet
5653147|NCT00689494|Progesterone levonorgestrel|progesterone levonorgestrel
5653148|NCT00689481|Plaque-type Psoriasis|plaque-type psoriasis
5653149|NCT00689481|psoriasis|psoriasis
5653150|NCT00689468|Otitis media|otitis media
5653151|NCT00689468|Echinacea|echinacea
5653152|NCT00689468|Osteopathic Medicine|osteopathic medicine
5653153|NCT00689455|Metabolic Syndrome|metabolic syndrome
5653154|NCT00689455|Lipids|lipids
5653155|NCT00689455|Waist Circumference|waist circumference
5653156|NCT00689429|Pilon Fractures|pilon fractures
5653157|NCT00689416|imaging biomarkers|imaging biomarkers
5653158|NCT00689416|MRI|mri
5653159|NCT00689416|FDG-PET/CT scanning|fdg-pet/ct scanning
5653160|NCT00689416|Crestor|crestor
5653161|NCT00689403|AZD1305|azd1305
5653162|NCT00689403|pharmacokinetics|pharmacokinetics
5653163|NCT00689403|Properties of different ER formulations|properties of different er formulations
5653164|NCT00689377|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5653165|NCT00689377|Cardiovascular Disease (CVD)|cardiovascular disease (cvd)
5653166|NCT00689377|Atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5653167|NCT00689377|Atherosclerosis|atherosclerosis
5653168|NCT00689377|Primary CVD prevention|primary cvd prevention
5653169|NCT00689364|Cohort Study|cohort study
5653170|NCT00689364|Colorectal Cancer|colorectal cancer
5653171|NCT00689364|Traditional Chinese Medicine|traditional chinese medicine
5653172|NCT00689364|Risk of recurrence and metastasis|risk of recurrence and metastasis
5653173|NCT00689351|Prevention|prevention
5653183|NCT00689338|Critical Care Unit|critical care unit
5653184|NCT00689338|Anidulafungin|anidulafungin
5653185|NCT00689338|Ecalta|ecalta
5653186|NCT00689338|Eraxis|eraxis
5653187|NCT00689338|Fluconazole|fluconazole
5653188|NCT00689338|Voriconazole|voriconazole
5653189|NCT00689325|Schizophrenia|schizophrenia
5653190|NCT00689325|remission|remission
5653191|NCT00689325|subjective well-being and effectiveness|subjective well-being and effectiveness
5653192|NCT00689325|Quality of Life|quality of life
5653193|NCT00689312|Gastroenteritis|gastroenteritis
5653194|NCT00689312|Pediatrics|pediatrics
5653195|NCT00689312|Rehydration therapy|rehydration therapy
5653196|NCT00689299|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
5653197|NCT00689299|Non-seasonal allergic rhinitis|non-seasonal allergic rhinitis
5653198|NCT00689299|Immunotherapy|immunotherapy
5653199|NCT00689299|Allergic rhinitis|allergic rhinitis
5653201|NCT00689299|Perennial allergy|perennial allergy
5653202|NCT00689299|Non-seasonal allergy|non-seasonal allergy
5653203|NCT00689286|Knee Osteoarthritis|knee osteoarthritis
5653204|NCT00689286|Neuromuscular stimulator|neuromuscular stimulator
5653205|NCT00689273|PF-04136309 CCR2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled|pf-04136309 ccr2 osteoarthritic pain knee, phase 2 placebo multicenter double-blind placebo-controlled
5653206|NCT00689247|AZD1305|azd1305
5653207|NCT00689247|ADME|adme
5653208|NCT00689247|pharmacokinetic|pharmacokinetic
5653209|NCT00689247|Absorption|absorption
5653210|NCT00689247|distribution|distribution
5653211|NCT00689247|metabolism|metabolism
5653212|NCT00689247|excretion|excretion
5653213|NCT00689221|newly diagnosed Glioblastoma (WHO Grade IV)|newly diagnosed glioblastoma (who grade iv)
5653214|NCT00689221|Cilengitide|cilengitide
5653215|NCT00689221|Temozolomide|temozolomide
5653216|NCT00689221|Radiotherapy|radiotherapy
5653217|NCT00689208|Clamp|clamp
5653218|NCT00689195|Curcumin|curcumin
5653219|NCT00689195|Ashwagandha|ashwagandha
5653220|NCT00689195|osteosarcoma|osteosarcoma
5653221|NCT00689195|Pharmacokinetics of curcumin and ashwagandha formulation|pharmacokinetics of curcumin and ashwagandha formulation
5653222|NCT00689195|response|response
5653223|NCT00689182|iron reduction|iron reduction
5653224|NCT00689182|iron overload|iron overload
5653225|NCT00689182|phlebotomy|phlebotomy
5653226|NCT00689182|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5653227|NCT00689169|Lymphoma|lymphoma
5653228|NCT00689169|Lymphoma Diffuse|lymphoma diffuse
5653229|NCT00689169|B-Cell lymphoma|b-cell lymphoma
5653230|NCT00689169|Aggressive lymphoma|aggressive lymphoma
5653231|NCT00689156|Epirubicin|epirubicin
5653232|NCT00689156|docetaxel|docetaxel
5653233|NCT00689156|Adjuvant chemotherapy|adjuvant chemotherapy
5653234|NCT00689156|DNA Topoisomerases, Type II|dna topoisomerases, type ii
5653235|NCT00689130|Analgesia|analgesia
5653236|NCT00689130|Bispectral Index|bispectral index
5653237|NCT00689130|BIS Variability|bis variability
5653238|NCT00689130|Electroencephalography|electroencephalography
5653239|NCT00689130|Electromyography|electromyography
5653240|NCT00689130|Monitoring, Intraoperative|monitoring, intraoperative
5653241|NCT00689130|Movement|movement
5653242|NCT00689130|Pain, Postoperative|pain, postoperative
5653243|NCT00689130|Somatic Events|somatic events
5653350|NCT00688844|Body Fat|body fat
5653351|NCT00688844|Bone Density|bone density
5653244|NCT00689130|Patients under general anesthesia undergoing a moderately painful procedure.|patients under general anesthesia undergoing a moderately painful procedure.
5653245|NCT00689117|Acne Vulgaris|acne vulgaris
5653246|NCT00689117|Acne|acne
5653247|NCT00689104|Micturition|micturition
5653248|NCT00689104|Urinary incontinence|urinary incontinence
5653249|NCT00689104|Urinary urge incontinence|urinary urge incontinence
5653250|NCT00689104|Overactive bladder (OAB)|overactive bladder (oab)
5653251|NCT00689104|Urgency|urgency
5653252|NCT00689104|YM178|ym178
5653253|NCT00689104|Frequency|frequency
5653254|NCT00689091|Awareness|awareness
5653255|NCT00689091|BIS Monitor|bis monitor
5653256|NCT00689091|electronic alerts|electronic alerts
5653257|NCT00689091|minimum|minimum
5653258|NCT00689091|alveolar|alveolar
5653259|NCT00689091|concentration|concentration
5653260|NCT00689078|Allergic conjunctivitis|allergic conjunctivitis
5653261|NCT00689065|siRNA|sirna
5653262|NCT00689065|RNA interference (RNAi)|rna interference (rnai)
5653263|NCT00689065|Cyclodextrin|cyclodextrin
5653264|NCT00689065|Cancer|cancer
5653265|NCT00689065|Neoplasms|neoplasms
5653266|NCT00689065|Solid Tumor|solid tumor
5653267|NCT00689065|Ovarian Cancer|ovarian cancer
5653268|NCT00689065|Lung Cancer|lung cancer
5653269|NCT00689065|Non Small Cell Lung Cancer|non small cell lung cancer
5653270|NCT00689065|Pancreatic Cancer|pancreatic cancer
5653271|NCT00689065|Breast Cancer|breast cancer
5653272|NCT00689065|Colon Cancer|colon cancer
5653273|NCT00689065|Endometrial Cancer|endometrial cancer
5653274|NCT00689065|Kidney (Renal Cell) Cancer|kidney (renal cell) cancer
5653275|NCT00689065|Melanoma|melanoma
5653276|NCT00689065|Prostate Cancer|prostate cancer
5653277|NCT00689065|Skin Cancer|skin cancer
5653278|NCT00689065|Thyroid Cancer|thyroid cancer
5653279|NCT00689065|Solid Malignancies|solid malignancies
5653281|NCT00689039|safety|safety
5653282|NCT00689039|pharmacokinetics|pharmacokinetics
5653283|NCT00689039|multiple ascending doses|multiple ascending doses
5653284|NCT00689039|Safety and pharmacokinetics|safety and pharmacokinetics
5653285|NCT00689026|Colonoscopy|colonoscopy
5653286|NCT00689026|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5653287|NCT00689026|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5653288|NCT00689026|Cleansing|cleansing
5653289|NCT00689026|Preparation|preparation
5653291|NCT00689026|Quality|quality
5653292|NCT00689013|Herpes Zoster|herpes zoster
5653293|NCT00689013|Prevention & control|prevention & control
5653294|NCT00689013|Pharmacists|pharmacists
5653295|NCT00689013|Pharmacy|pharmacy
5653296|NCT00689013|Pharmacies|pharmacies
5653297|NCT00689013|Aged|aged
5653298|NCT00689013|Immunization|immunization
5653299|NCT00689013|Vaccination|vaccination
5653300|NCT00689000|Leukemia|leukemia
5653301|NCT00689000|AML|aml
5653302|NCT00689000|MDS|mds
5653303|NCT00689000|MM|mm
5653304|NCT00689000|Acute Myeloid Leukemia|acute myeloid leukemia
5653305|NCT00689000|Myelodysplastic Syndrome|myelodysplastic syndrome
5653306|NCT00689000|Multiple Myeloma|multiple myeloma
5653307|NCT00689000|Cancer|cancer
5653308|NCT00689000|Hematological malignancies|hematological malignancies
5653309|NCT00689000|Elderly|elderly
5653311|NCT00689000|Blood|blood
5653312|NCT00688974|type 2 diabetes|type 2 diabetes
5653313|NCT00688974|obesity|obesity
5653314|NCT00688974|gastric bypass|gastric bypass
5653315|NCT00688974|adjustable gastric banding|adjustable gastric banding
5653316|NCT00688974|BMI > 35.|bmi > 35.
5653317|NCT00688974|obesity for more than 5 years|obesity for more than 5 years
5653318|NCT00688961|omega-3 fatty acids|omega-3 fatty acids
5653319|NCT00688961|aspirin|aspirin
5653320|NCT00688961|platelet aggregation|platelet aggregation
5653321|NCT00688961|Healthy volunteers; no disease|healthy volunteers; no disease
5653322|NCT00688948|pilot clinical trial|pilot clinical trial
5653323|NCT00688935|melatonin|melatonin
5653324|NCT00688935|circadian rhythms|circadian rhythms
5653325|NCT00688935|sleep|sleep
5653326|NCT00688935|sleep disorders|sleep disorders
5653327|NCT00688909|breast cancer|breast cancer
5653328|NCT00688909|adjuvant treatment in post menopausal women|adjuvant treatment in post menopausal women
5653329|NCT00688909|letrozole|letrozole
5653330|NCT00688909|arthralgia-myalgia|arthralgia-myalgia
5653331|NCT00688883|Fludarabine|fludarabine
5653332|NCT00688883|Purine analog|purine analog
5653333|NCT00688883|Indolent lymphoma|indolent lymphoma
5653334|NCT00688870|Prevention against pneumococcal disease|prevention against pneumococcal disease
5653335|NCT00688844|PKU|pku
5653336|NCT00688844|Phenylketonuria|phenylketonuria
5653337|NCT00688844|BH4|bh4
5653338|NCT00688844|Kuvan|kuvan
5653339|NCT00688844|Tetrahydrobiopterin|tetrahydrobiopterin
5653340|NCT00688844|Sapropterin Dihydrochloride|sapropterin dihydrochloride
5653341|NCT00688844|Nutrition|nutrition
5653342|NCT00688844|PHE|phe
5653343|NCT00688844|Phenylalanine|phenylalanine
5653344|NCT00688844|PAH|pah
5653345|NCT00688844|Phenylalanine hydroxylase|phenylalanine hydroxylase
5653346|NCT00688844|Neurotransmitters|neurotransmitters
5653347|NCT00688844|Serotonin|serotonin
5653348|NCT00688844|Catecholamines|catecholamines
5653352|NCT00688831|AZD1305|azd1305
5653353|NCT00688831|SAD|sad
5653354|NCT00688831|safety|safety
5653355|NCT00688831|pharmcokinetics|pharmcokinetics
5653356|NCT00688831|Safety and tolerability|safety and tolerability
5653357|NCT00688818|Co-morbid depressive and anxiety disorders|co-morbid depressive and anxiety disorders
5653358|NCT00688818|Quetiapine|quetiapine
5653359|NCT00688818|Randomized|randomized
5653360|NCT00688818|Placebo-controlled|placebo-controlled
5653361|NCT00688818|Double-blind|double-blind
5653362|NCT00688818|Major depressive disorder|major depressive disorder
5653363|NCT00688818|Dysthymic disorder|dysthymic disorder
5653364|NCT00688818|Anxiety disorders|anxiety disorders
5653365|NCT00688818|Generalized anxiety disorder|generalized anxiety disorder
5653366|NCT00688818|Social anxiety disorder|social anxiety disorder
5653367|NCT00688818|Panic disorder|panic disorder
5653368|NCT00688818|Post-traumatic stress disorder|post-traumatic stress disorder
5653369|NCT00688805|Propanolol|propanolol
5653370|NCT00688805|Substance Abuse|substance abuse
5653371|NCT00688805|Craving|craving
5653372|NCT00688805|Imagery|imagery
5653373|NCT00688805|Drug Cues|drug cues
5653374|NCT00688805|Cocaine|cocaine
5653375|NCT00688792|Asthma|asthma
5653376|NCT00688792|Children|children
5653378|NCT00688792|Maternal factors|maternal factors
5653379|NCT00688779|Healthy male|healthy male
5653380|NCT00688779|allergic rhinitis|allergic rhinitis
5653381|NCT00688779|tolerability|tolerability
5653382|NCT00688779|safety|safety
5653383|NCT00688779|intranasally|intranasally
5653384|NCT00688779|Healthy subjects|healthy subjects
5653385|NCT00688766|GIST|gist
5653386|NCT00688766|Metastatic and/or Unresectable Gastrointestinal Stromal|metastatic and/or unresectable gastrointestinal stromal
5653387|NCT00688753|renal cell carcinoma|renal cell carcinoma
5653388|NCT00688753|non clear cell carcinoma|non clear cell carcinoma
5653389|NCT00688753|papillary cell renal carcinoma|papillary cell renal carcinoma
5653390|NCT00688753|adults|adults
5653391|NCT00688753|everolimus|everolimus
5653392|NCT00688740|adjuvant treatment|adjuvant treatment
5653393|NCT00688727|non epileptic seizures|non epileptic seizures
5653394|NCT00688727|cognitive behavioural therapy|cognitive behavioural therapy
5653395|NCT00688727|dissociative disorders|dissociative disorders
5653396|NCT00688727|Seizure disorders|seizure disorders
5653397|NCT00688727|randomised controlled trial|randomised controlled trial
5653398|NCT00688714|Antiplatelet|antiplatelet
5653399|NCT00688701|hyperglycemia, GLP-1|hyperglycemia, glp-1
5653400|NCT00688688|Frequency|frequency
5653401|NCT00688688|Overactive Bladder|overactive bladder
5653402|NCT00688688|Urgency|urgency
5653403|NCT00688688|Urinary urge incontinence|urinary urge incontinence
5653404|NCT00688688|Urinary incontinence|urinary incontinence
5653405|NCT00688688|Micturition|micturition
5653406|NCT00688675|GERD|gerd
5653407|NCT00688675|Pharmacoepidemiology|pharmacoepidemiology
5653408|NCT00688662|Sphincter of Oddi Dysfunction|sphincter of oddi dysfunction
5653409|NCT00688662|Pancreatitis|pancreatitis
5653410|NCT00688662|Sphincterotomy|sphincterotomy
5653411|NCT00688623|Neuroendocrine tumors|neuroendocrine tumors
5653412|NCT00688623|non functioning neuroendocrine tumors|non functioning neuroendocrine tumors
5653413|NCT00688623|Non syndromic neuroendocrine tumors|non syndromic neuroendocrine tumors
5653414|NCT00688623|carcinoids|carcinoids
5653415|NCT00688623|non-functioning carcinoids|non-functioning carcinoids
5653416|NCT00688623|adults|adults
5653417|NCT00688623|everolimus|everolimus
5653418|NCT00688623|NET|net
5653419|NCT00688623|RAMSETE|ramsete
5653420|NCT00688623|CRAD001|crad001
5653421|NCT00688623|non-functioning neuroendocrine tumors carcinoids|non-functioning neuroendocrine tumors carcinoids
5653422|NCT00688610|primary care|primary care
5653423|NCT00688610|procalcitonin|procalcitonin
5653424|NCT00688610|antibiotic prescription|antibiotic prescription
5653425|NCT00688597|Amicus Therapeutics|amicus therapeutics
5653426|NCT00688597|Duvoglustat|duvoglustat
5653427|NCT00688597|AT2220|at2220
5653428|NCT00688584|problem drinking|problem drinking
5653429|NCT00688584|randomized control trial|randomized control trial
5653430|NCT00688584|Pamphlet-based personalized alcohol feedback (PAF)|pamphlet-based personalized alcohol feedback (paf)
5653431|NCT00688571|Pulmonary Valve|pulmonary valve
5653432|NCT00688571|Congenital Heart Disease|congenital heart disease
5653433|NCT00688545|Celecoxib|celecoxib
5653434|NCT00688545|COX-2|cox-2
5653435|NCT00688545|NSAIDs|nsaids
5653436|NCT00688545|observational study|observational study
5653437|NCT00688545|noninterventional study|noninterventional study
5653438|NCT00688545|cohort study|cohort study
5653439|NCT00688545|registry|registry
5653440|NCT00688545|epidemiologic study|epidemiologic study
5653441|NCT00688545|pediatrics|pediatrics
5653442|NCT00688545|rheumatology|rheumatology
5653443|NCT00688545|phase iv study|phase iv study
5653444|NCT00688532|Prostate cancer|prostate cancer
5653445|NCT00688532|pharmacoepidemiology study|pharmacoepidemiology study
5653446|NCT00688519|Plaque-type Psoriasis|plaque-type psoriasis
5653447|NCT00688519|Psoriasis|psoriasis
5653448|NCT00688506|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5653449|NCT00688506|Neuromodulation|neuromodulation
5653450|NCT00688506|Brain effects|brain effects
5653451|NCT00688506|Neuroimaging|neuroimaging
5653452|NCT00688493|QT|qt
5653453|NCT00688493|Healthy volunteers|healthy volunteers
5653454|NCT00688480|CKD|ckd
5653455|NCT00688480|LVH|lvh
5653456|NCT00688480|Echo LVH|echo lvh
5653457|NCT00688480|Chronic Stage 3|chronic stage 3
5653458|NCT00688467|Neutrophilic Asthma|neutrophilic asthma
5653459|NCT00688454|Hyperlipidemia|hyperlipidemia
5653460|NCT00688454|Rosuvastatin|rosuvastatin
5653461|NCT00688454|Efficacy|efficacy
5653462|NCT00688454|tolerability|tolerability
5653463|NCT00688454|CRESTOR therapy|crestor therapy
5653464|NCT00688441|Randomized|randomized
5653465|NCT00688441|Double-Blind|double-blind
5653466|NCT00688441|Multi-Center|multi-center
5653467|NCT00688441|Placebo-Controlled|placebo-controlled
5653468|NCT00688441|Phase II|phase ii
5653469|NCT00688441|Nasal Carbon Dioxide|nasal carbon dioxide
5653470|NCT00688441|Carbon Dioxide|carbon dioxide
5653471|NCT00688441|Efficacy|efficacy
5653472|NCT00688441|Safety|safety
5653473|NCT00688441|Total Nasal Symptom Score|total nasal symptom score
5653474|NCT00688441|RQLQ|rqlq
5653475|NCT00688428|esomeprazole|esomeprazole
5653476|NCT00688428|upper gi symptoms|upper gi symptoms
5653477|NCT00688428|low dose Aspirin treatment|low dose aspirin treatment
5653478|NCT00688402|Reflux Inhibitor|reflux inhibitor
5653479|NCT00688402|GERD|gerd
5653480|NCT00688402|formulations|formulations
5653481|NCT00688389|Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP,|dengue fever, clec5a, mannose receptor, dc-sign, nalp,
5653482|NCT00688389|decoy receptor 3 (DcR3), Toll-like receptors(TLRs),|decoy receptor 3 (dcr3), toll-like receptors(tlrs),
5653483|NCT00688389|(Nod)-like receptors (NLRs)|(nod)-like receptors (nlrs)
5653484|NCT00688376|Attention|attention
5653485|NCT00688376|cancer|cancer
5653486|NCT00688376|chemotherapy|chemotherapy
5653487|NCT00688376|donepezil|donepezil
5653488|NCT00688376|acetylcholinesterase|acetylcholinesterase
5653489|NCT00688376|inhibitor|inhibitor
5653490|NCT00688363|Diabetes control|diabetes control
5653491|NCT00688363|glycated haemoglobin|glycated haemoglobin
5653492|NCT00688363|blood-glucose-self-monitoring|blood-glucose-self-monitoring
5653493|NCT00688363|type 2-diabetes|type 2-diabetes
5653494|NCT00688363|conventional insulin therapy|conventional insulin therapy
5653495|NCT00688350|Hypertension|hypertension
5653496|NCT00688350|Aging|aging
5653497|NCT00688350|Medication adherence|medication adherence
5653498|NCT00688350|Medication compliance|medication compliance
5653499|NCT00688337|Breast cancer|breast cancer
5653500|NCT00688337|lymph nodes|lymph nodes
5653501|NCT00688337|gene-expression|gene-expression
5653502|NCT00688337|oncotype|oncotype
5653503|NCT00688337|Age over 18|age over 18
5653504|NCT00688337|Newly diagnosed breast cancer prior to surgery or treatment.|newly diagnosed breast cancer prior to surgery or treatment.
5653505|NCT00688337|No evidence of clinical nodal disease|no evidence of clinical nodal disease
5653506|NCT00688324|schizophrenia|schizophrenia
5653507|NCT00688324|schizoaffective disorder|schizoaffective disorder
5653508|NCT00688324|glutamate|glutamate
5653509|NCT00688324|NMDA receptor|nmda receptor
5653510|NCT00688324|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5653511|NCT00688324|acamprosate|acamprosate
5653518|NCT00688311|Human Immunodeficiency Virus|human immunodeficiency virus
5653519|NCT00688285|chronic kidney disease|chronic kidney disease
5653520|NCT00688285|clinical alerts|clinical alerts
5653521|NCT00688285|late referral|late referral
5653522|NCT00688285|electronic medical record|electronic medical record
5653523|NCT00688285|Computerized clinical decision support systems (CDSS)|computerized clinical decision support systems (cdss)
5653524|NCT00688272|Safety|safety
5653525|NCT00688272|Photoirritant|photoirritant
5653526|NCT00688272|Photosensitivity|photosensitivity
5653527|NCT00688272|Placebo control|placebo control
5653528|NCT00688272|Ciprofloxacin|ciprofloxacin
5653529|NCT00688272|Eltrombopag|eltrombopag
5653530|NCT00688259|clinical trials|clinical trials
5653531|NCT00688259|psychotherapy|psychotherapy
5653532|NCT00688246|osteoporosis|osteoporosis
5653533|NCT00688246|breast cancer|breast cancer
5653534|NCT00688233|Seifi's Functional, Class II/1, Mandibular Retrognathism|seifi's functional, class ii/1, mandibular retrognathism
5653535|NCT00688220|Arthritis|arthritis
5653536|NCT00688220|Carpel tunnel syndrome|carpel tunnel syndrome
5653537|NCT00688220|Epicondylitis|epicondylitis
5653538|NCT00688207|PPAR agonist,|ppar agonist,
5653539|NCT00688207|Rosiglitazone XR,|rosiglitazone xr,
5653540|NCT00688207|BRL-049653.|brl-049653.
5653541|NCT00688207|Alzheimer's disease,|alzheimer's disease,
5653542|NCT00688194|stage IV breast cancer|stage iv breast cancer
5653543|NCT00688194|recurrent breast cancer|recurrent breast cancer
5653544|NCT00688168|Multiple Myeloma|multiple myeloma
5653545|NCT00688168|Phone Call|phone call
5653546|NCT00688168|Treatment Naive|treatment naive
5653547|NCT00688168|Inflammatory Cytokines|inflammatory cytokines
5653548|NCT00688168|Questionnaire|questionnaire
5653549|NCT00688168|Survey|survey
5653556|NCT00688129|foster care|foster care
5653557|NCT00688129|maltreatment|maltreatment
5653558|NCT00688129|literacy|literacy
5653559|NCT00688129|social emotional skills|social emotional skills
5653560|NCT00688129|self regulation|self regulation
5653561|NCT00688129|caregiver involvement|caregiver involvement
5653562|NCT00688116|metastatic cancer|metastatic cancer
5653563|NCT00688116|solid tumor|solid tumor
5653564|NCT00688116|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable|histologically or cytologically confirmed non-hematological malignancy that is metastatic or unresectable
5653565|NCT00688116|STA-9090|sta-9090
5653566|NCT00688116|ganetespib|ganetespib
5653567|NCT00688090|Immunotherapy, Melanoma, Cancer Vaccine|immunotherapy, melanoma, cancer vaccine
5653568|NCT00688077|Fibroblast growth factor - 23|fibroblast growth factor - 23
5653570|NCT00688064|Acne|acne
5653571|NCT00688051|Cystic Fibrosis|cystic fibrosis
5653572|NCT00688051|Adherence to treatment|adherence to treatment
5653573|NCT00688038|Advanced Cancer|advanced cancer
5653574|NCT00688038|Bone Metastases|bone metastases
5653575|NCT00688038|Laser Ablation|laser ablation
5653576|NCT00688038|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5653577|NCT00688038|Laser Induced Thermal Therapy|laser induced thermal therapy
5653578|NCT00688038|MRTI|mrti
5653579|NCT00688038|LITT|litt
5653580|NCT00688012|antisense|antisense
5653581|NCT00688012|microRna antagonist|microrna antagonist
5653582|NCT00688012|anti-miR-122|anti-mir-122
5653585|NCT00687999|Chronic hepatitis C|chronic hepatitis c
5653586|NCT00687999|diabetes|diabetes
5653587|NCT00687999|Insulin resistance|insulin resistance
5653588|NCT00687999|combination therapy|combination therapy
5653589|NCT00687986|surgery|surgery
5653590|NCT00687986|stereotactic radiotherapy|stereotactic radiotherapy
5653591|NCT00687986|tumor control|tumor control
5653592|NCT00687986|quality of life|quality of life
5653593|NCT00687960|Diabetes|diabetes
5653594|NCT00687960|Diet|diet
5653595|NCT00687960|Fiber|fiber
5653597|NCT00687947|FHM|fhm
5653598|NCT00687947|MA|ma
5653599|NCT00687947|healthy controls|healthy controls
5653600|NCT00687947|CGRP|cgrp
5653601|NCT00687934|metastatic cancer|metastatic cancer
5653602|NCT00687934|solid tumor|solid tumor
5653603|NCT00687934|histologically or cytologically confirmed non-hematological|histologically or cytologically confirmed non-hematological
5653604|NCT00687934|malignancy that is metastatic or unresectable for which no|malignancy that is metastatic or unresectable for which no
5653605|NCT00687934|standard therapy exists|standard therapy exists
5653606|NCT00687934|STA-9090|sta-9090
5653607|NCT00687934|ganetespib|ganetespib
5653608|NCT00687921|Knee trauma|knee trauma
5653609|NCT00687921|MRI|mri
5653610|NCT00687921|arthroscopy|arthroscopy
5656211|NCT00677534|Endstage renal disease|endstage renal disease
5653611|NCT00687921|Patients over the age of 18 who had knee trauma intent to or had MRI assessment scheduled for arthroscopy|patients over the age of 18 who had knee trauma intent to or had mri assessment scheduled for arthroscopy
5653613|NCT00687895|malaria microscopy primary health care children|malaria microscopy primary health care children
5653619|NCT00687869|stroke|stroke
5653620|NCT00687869|rehabilitation|rehabilitation
5653621|NCT00687869|patient care management|patient care management
5653622|NCT00687869|patient participation|patient participation
5653623|NCT00687856|Left Ventricular Assist Device|left ventricular assist device
5653624|NCT00687843|Gastric Cancer|gastric cancer
5653625|NCT00687843|TS-1|ts-1
5653626|NCT00687843|PSK|psk
5653627|NCT00687843|Relapse-free survival|relapse-free survival
5653628|NCT00687830|Afternoon colonoscopy|afternoon colonoscopy
5653629|NCT00687830|Morning|morning
5653630|NCT00687830|Evening|evening
5653631|NCT00687830|Bowel Preparation|bowel preparation
5653632|NCT00687830|Efficacy|efficacy
5653633|NCT00687830|Satisfaction|satisfaction
5653634|NCT00687817|NSCLC|nsclc
5653635|NCT00687804|DME|dme
5653636|NCT00687804|Diabetic|diabetic
5653637|NCT00687804|macula|macula
5653638|NCT00687804|edema|edema
5653639|NCT00687804|ranibizumab|ranibizumab
5653640|NCT00687804|RESTORE|restore
5653641|NCT00687791|patients with cataract and glaucoma|patients with cataract and glaucoma
5653642|NCT00687791|ologen|ologen
5653643|NCT00687791|oculusgen|oculusgen
5653644|NCT00687791|collagen matrix|collagen matrix
5653645|NCT00687791|Phacotrabeculectomy|phacotrabeculectomy
5653646|NCT00687791|Aeon Astron|aeon astron
5653647|NCT00687791|trabeculectomy|trabeculectomy
5653648|NCT00687791|tissue engineering|tissue engineering
5653649|NCT00687791|mitomycin-C|mitomycin-c
5653650|NCT00687778|C11-Acetate|c11-acetate
5653651|NCT00687778|FDG|fdg
5653652|NCT00687778|sarcoma|sarcoma
5653653|NCT00687778|Measurement of C11-Acetate uptake in tumors which are often non-FDG avid.|measurement of c11-acetate uptake in tumors which are often non-fdg avid.
5653654|NCT00687778|Soft tissue sarcomas|soft tissue sarcomas
5653655|NCT00687778|well-differentiated thyroid cancer|well-differentiated thyroid cancer
5653656|NCT00687778|well-differentiated and bronchoalveolar lung cancer|well-differentiated and bronchoalveolar lung cancer
5653657|NCT00687778|indolent lymphomas, neuroendocrine tumors|indolent lymphomas, neuroendocrine tumors
5653658|NCT00687778|GIST|gist
5653659|NCT00687778|uterine malignancies|uterine malignancies
5653660|NCT00687778|mucin-producing cancer|mucin-producing cancer
5653661|NCT00687778|teratoma, hepatoma|teratoma, hepatoma
5653662|NCT00687778|HCC|hcc
5653663|NCT00687778|lobular breast carcinoma|lobular breast carcinoma
5653664|NCT00687765|patients with newly diagnosed glioblastoma|patients with newly diagnosed glioblastoma
5653665|NCT00687752|fetal deglutition|fetal deglutition
5653666|NCT00687752|larynx|larynx
5653667|NCT00687752|fetal CNS pathology|fetal cns pathology
5653668|NCT00687752|sonography|sonography
5653669|NCT00687752|hydramnios|hydramnios
5653670|NCT00687739|hormone therapy|hormone therapy
5653671|NCT00687739|obesity|obesity
5653672|NCT00687739|postmenopause|postmenopause
5653673|NCT00687739|disease /disorder proneness /risk|disease /disorder proneness /risk
5653674|NCT00687739|insulin sensitivity /resistance|insulin sensitivity /resistance
5653675|NCT00687739|metabolic syndrome|metabolic syndrome
5653676|NCT00687739|women's health|women's health
5653677|NCT00687726|osteoarthritis|osteoarthritis
5653678|NCT00687726|knee|knee
5653679|NCT00687726|exercise|exercise
5653680|NCT00687726|balance|balance
5653681|NCT00687700|propranolol|propranolol
5653682|NCT00687700|B2-agonist,|b2-agonist,
5653683|NCT00687700|B-antagonist,|b-antagonist,
5646950|NCT00714779|PET|pet
5789071|NCT00150033|thyroid disease|thyroid disease
5789072|NCT00150033|Quality of Life|quality of life
5685478|NCT00555932|Cerebral Sinovenous Thrombosis|cerebral sinovenous thrombosis
5685479|NCT00555932|Pediatrics|pediatrics
5653684|NCT00687687|Patients must have advanced (stage III or IV), persistent or recurrent uterine carcinosarcoma with documented disease progression.|patients must have advanced (stage iii or iv), persistent or recurrent uterine carcinosarcoma with documented disease progression.
5653685|NCT00687674|refractory multiple myeloma|refractory multiple myeloma
5653686|NCT00687661|Chronic Kidney Failure|chronic kidney failure
5653687|NCT00687661|Vascular Calcification|vascular calcification
5653688|NCT00687661|Bisphosphonates|bisphosphonates
5653689|NCT00687648|stage IV breast cancer|stage iv breast cancer
5653690|NCT00687648|recurrent breast cancer|recurrent breast cancer
5653691|NCT00687648|HER2-negative breast cancer|her2-negative breast cancer
5653692|NCT00687648|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5653821|NCT00687050|chronic kidney disease|chronic kidney disease
5653693|NCT00687648|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5653694|NCT00687622|MEK inhibitor|mek inhibitor
5653695|NCT00687622|solid tumors|solid tumors
5653696|NCT00687622|First Time in Human|first time in human
5653697|NCT00687622|GSK1120212|gsk1120212
5653698|NCT00687622|Oncology|oncology
5653699|NCT00687622|melanoma|melanoma
5653700|NCT00687609|Attention Deficit Hyperactivity Disorder with Cannabis Abuse|attention deficit hyperactivity disorder with cannabis abuse
5653701|NCT00687609|Marihuana Abuse|marihuana abuse
5653702|NCT00687609|Comorbid Cannabis Abuse|comorbid cannabis abuse
5653703|NCT00687583|pediatrics|pediatrics
5653704|NCT00687583|anesthesia|anesthesia
5653705|NCT00687583|head movements|head movements
5653706|NCT00687583|endotracheal tube|endotracheal tube
5653711|NCT00687570|Nutritional status|nutritional status
5653712|NCT00687570|complications with traditional bowel preparation|complications with traditional bowel preparation
5653713|NCT00687570|Complications|complications
5653714|NCT00687570|Physiological status|physiological status
5653716|NCT00687492|hypercholesterolemia|hypercholesterolemia
5653717|NCT00687492|NCEP ATP III guidelines|ncep atp iii guidelines
5653718|NCT00687492|survey|survey
5653719|NCT00687479|insulin sensitivity|insulin sensitivity
5653720|NCT00687479|insulin secretion|insulin secretion
5653721|NCT00687479|infant outcome|infant outcome
5653722|NCT00687466|Cystic Fibrosis|cystic fibrosis
5653723|NCT00687466|Glucose Intolerance|glucose intolerance
5653724|NCT00687453|Glargine|glargine
5653725|NCT00687453|Type 2 diabetes|type 2 diabetes
5653726|NCT00687453|Basal insulin|basal insulin
5653727|NCT00687414|gene expression|gene expression
5653728|NCT00687414|gene sequencing|gene sequencing
5653729|NCT00687414|gene encoding|gene encoding
5653730|NCT00687414|MPD|mpd
5653731|NCT00687414|MDS|mds
5653732|NCT00687414|AML|aml
5653733|NCT00687414|mDia|mdia
5653734|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors
5653735|NCT00687388|Alpha Blockers|alpha blockers
5653736|NCT00687388|Treatment Outcome|treatment outcome
5653737|NCT00687375|Inguinal|inguinal
5653738|NCT00687375|Groin hernia|groin hernia
5653739|NCT00687375|TAPP|tapp
5653740|NCT00687375|TEP|tep
5653741|NCT00687375|Comparing|comparing
5653742|NCT00687375|Two|two
5637741|NCT00748280|MTA|mta
5653743|NCT00687375|Techniques|techniques
5653748|NCT00687336|Treatment|treatment
5653749|NCT00687336|Upper gastrointestinal bleeding|upper gastrointestinal bleeding
5653750|NCT00687310|Asthma education|asthma education
5653751|NCT00687310|satisfaction adherence|satisfaction adherence
5653752|NCT00687310|Quality of Life|quality of life
5653753|NCT00687310|PIKO meter cluster|piko meter cluster
5653754|NCT00687310|Symbicort® Turbuhaler®|symbicort® turbuhaler®
5653755|NCT00687297|Stage IIIB Non Small Cell Lung Cancer|stage iiib non small cell lung cancer
5653756|NCT00687297|Stage IV Non Small Cell Lung Cancer|stage iv non small cell lung cancer
5653757|NCT00687297|Vandetanib|vandetanib
5653758|NCT00687297|Docetaxel plus carboplatin|docetaxel plus carboplatin
5653759|NCT00687258|Anemia|anemia
5653760|NCT00687258|Oxidative Stress|oxidative stress
5653761|NCT00687258|Erythropoietin|erythropoietin
5653762|NCT00687258|dialyser membrane|dialyser membrane
5653763|NCT00687258|Vitamin E|vitamin e
5653764|NCT00687258|Erythropoietin responsiveness|erythropoietin responsiveness
5653765|NCT00687258|Erythropoietin resistance|erythropoietin resistance
5653766|NCT00687258|hemodialysis|hemodialysis
5653767|NCT00687245|children|children
5653768|NCT00687245|reflux|reflux
5653770|NCT00687245|pediatric|pediatric
5653771|NCT00687232|Phase I|phase i
5653772|NCT00687232|Japan|japan
5653773|NCT00687232|Japanese|japanese
5653774|NCT00687232|inhalation|inhalation
5653775|NCT00687219|hepatitis C|hepatitis c
5653776|NCT00687193|Phase 2 monotherapy in Japan|phase 2 monotherapy in japan
5653777|NCT00687180|Prednisolone dosage|prednisolone dosage
5653778|NCT00687167|Therapeutic Equivalency|therapeutic equivalency
5653779|NCT00687154|DME|dme
5653780|NCT00687154|Laser|laser
5653781|NCT00687154|macular edema|macular edema
5653782|NCT00687154|retinopathy|retinopathy
5653783|NCT00687154|scatter photocoagulation|scatter photocoagulation
5653784|NCT00687141|Safety|safety
5653785|NCT00687141|tolerability|tolerability
5653786|NCT00687141|AZD0328|azd0328
5653787|NCT00687128|Insulin resistance|insulin resistance
5647033|NCT00714493|humira|humira
5653801|NCT00687089|Subutex|subutex
5653802|NCT00687089|Buprenorphine|buprenorphine
5653803|NCT00687089|Patients who addicted to opiates|patients who addicted to opiates
5653804|NCT00687076|Endovascular Intervention|endovascular intervention
5653805|NCT00687076|MRI|mri
5653806|NCT00687076|Ultrasound|ultrasound
5653807|NCT00687076|Cholesterol Medications|cholesterol medications
5653808|NCT00687076|High Cholesterol|high cholesterol
5653809|NCT00687076|Peripheral Arterial disease|peripheral arterial disease
5653810|NCT00687076|Claudication|claudication
5653811|NCT00687076|Leg Pain|leg pain
5653812|NCT00687076|Niaspan|niaspan
5653813|NCT00687076|Extended Release Niacin|extended release niacin
5653814|NCT00687076|Zetia|zetia
5653815|NCT00687076|Ezetimibe|ezetimibe
5653816|NCT00687076|Simvastatin|simvastatin
5653817|NCT00687076|Zocor|zocor
5653818|NCT00687076|Atorvastatin|atorvastatin
5653819|NCT00687076|Lipitor|lipitor
5653820|NCT00687050|end-stage renal disease|end-stage renal disease
5653822|NCT00687037|oral hygiene|oral hygiene
5653823|NCT00687024|Epilepsy|epilepsy
5653824|NCT00687024|Magnetic Resonance Imaging|magnetic resonance imaging
5653825|NCT00687024|Magnetoencephalography|magnetoencephalography
5653826|NCT00687011|Antiemetic|antiemetic
5653827|NCT00686998|Schizophrenia|schizophrenia
5653828|NCT00686985|Docetaxel|docetaxel
5653829|NCT00686985|Carboplatin|carboplatin
5653830|NCT00686985|chemotherapy|chemotherapy
5653831|NCT00686985|relapse SCLC|relapse sclc
5653832|NCT00686972|Bariatric Surgery|bariatric surgery
5653833|NCT00686972|Glucose Regulation|glucose regulation
5653834|NCT00686972|Cardiac Function|cardiac function
5653835|NCT00686972|Body Composition|body composition
5653836|NCT00686946|Severe mental illness|severe mental illness
5653837|NCT00686946|Antipsychotic medications|antipsychotic medications
5653838|NCT00686946|Pregnancy|pregnancy
5653839|NCT00686946|Evidence-based guidelines|evidence-based guidelines
5653840|NCT00686946|Maternal and infant health and wellbeing|maternal and infant health and wellbeing
5653841|NCT00686933|Attention-Deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5653842|NCT00686907|melatonin, circadian rhythms, sleep|melatonin, circadian rhythms, sleep
5653843|NCT00686881|hepatitis C|hepatitis c
5653844|NCT00686868|GSK1841157;|gsk1841157;
5653845|NCT00686868|rheumatoid arthritis,|rheumatoid arthritis,
5653846|NCT00686868|B-cell depletion|b-cell depletion
5653847|NCT00686868|anti-CD20 monoclonal antibody,|anti-cd20 monoclonal antibody,
5653848|NCT00686855|tacrolimus|tacrolimus
5653849|NCT00686855|dexamethasone|dexamethasone
5653850|NCT00686855|oral rinse|oral rinse
5653851|NCT00686842|HIV infection|hiv infection
5653852|NCT00686842|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5653853|NCT00686842|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5653854|NCT00686842|Treatment Experienced|treatment experienced
5653856|NCT00686829|Treatment Experienced|treatment experienced
5653857|NCT00686816|pre-diabetic|pre-diabetic
5653858|NCT00686816|obese|obese
5653859|NCT00686803|hypertension|hypertension
5653860|NCT00686803|controlled hypertension|controlled hypertension
5653861|NCT00686803|hypertensives|hypertensives
5653862|NCT00686790|Hepatitis D|hepatitis d
5653863|NCT00686790|Hepatitis B|hepatitis b
5653864|NCT00686777|hepatitis C|hepatitis c
5653865|NCT00686764|trans-femoral amputation|trans-femoral amputation
5653866|NCT00686738|osteosarcoma|osteosarcoma
5653867|NCT00686738|transforming growth factor-beta 1|transforming growth factor-beta 1
5653868|NCT00686738|nuclear factor-kappa B|nuclear factor-kappa b
5653869|NCT00686738|positron emission tomography/computed tomography|positron emission tomography/computed tomography
5653870|NCT00686738|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5653871|NCT00686738|predicting response to neoadjuvant chemotherapy|predicting response to neoadjuvant chemotherapy
5653872|NCT00686712|Glargine|glargine
5653873|NCT00686712|Type 2 diabetes|type 2 diabetes
5653874|NCT00686712|Basal insulin|basal insulin
5653875|NCT00686699|Anti-Dyskinesia Agents|anti-dyskinesia agents
5653876|NCT00686699|Antipsychotic Agents|antipsychotic agents
5653877|NCT00686673|DECISION AIDS|decision aids
5653878|NCT00686660|copd|copd
5653879|NCT00686660|rehabilitation|rehabilitation
5653880|NCT00686660|quality of life|quality of life
5653881|NCT00686660|inflammation|inflammation
5653882|NCT00686647|Coronary Angioplasty|coronary angioplasty
5653883|NCT00686647|Coronary Stents|coronary stents
5653884|NCT00686647|Scoring Balloons|scoring balloons
5647132|NCT00714025|TCC|tcc
5653890|NCT00686556|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5653891|NCT00686556|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5653892|NCT00686556|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5653893|NCT00686556|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5653894|NCT00686556|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5653895|NCT00686556|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5653896|NCT00686556|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5653897|NCT00686556|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5653898|NCT00686556|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5653901|NCT00686543|Antifungal Agents|antifungal agents
5653902|NCT00686543|Anti-Infective Agents|anti-infective agents
5653903|NCT00686530|Fetal Death|fetal death
5653904|NCT00686530|Magnetic Resonance Imaging|magnetic resonance imaging
5653905|NCT00686530|Autopsy|autopsy
5653906|NCT00686530|Telencephalon|telencephalon
5653907|NCT00686530|Pyramidal Tracts|pyramidal tracts
5653908|NCT00686504|Pain|pain
5653910|NCT00686504|Phase 1|phase 1
5653911|NCT00686504|Analgesia|analgesia
5653912|NCT00686504|Positron Emission Tomography|positron emission tomography
5653913|NCT00686504|mGlu5 receptor|mglu5 receptor
5653914|NCT00686504|Dose finding|dose finding
5653915|NCT00686504|Analgesia/Pain|analgesia/pain
5653916|NCT00686491|Asthma|asthma
5653917|NCT00686491|Environment|environment
5653918|NCT00686491|Type of sport|type of sport
5653919|NCT00686491|Cardiovascular disease|cardiovascular disease
5653920|NCT00686491|Athletes|athletes
5653921|NCT00686478|burn|burn
5653922|NCT00686478|hypertrophic scar|hypertrophic scar
5653923|NCT00686478|fibroproliferative disorder|fibroproliferative disorder
5653924|NCT00686465|recurrent cancer|recurrent cancer
5653925|NCT00686465|PET/CT|pet/ct
5653926|NCT00686465|FDG|fdg
5653927|NCT00686465|planned management|planned management
5653928|NCT00686465|actual treatment|actual treatment
5653929|NCT00686452|Asthma|asthma
5653930|NCT00686452|Airway hyperresponsiveness|airway hyperresponsiveness
5653931|NCT00686452|Swimmers|swimmers
5653932|NCT00686452|Airway inflammation|airway inflammation
5653933|NCT00686452|Airway remodelling|airway remodelling
5653934|NCT00686439|osteoarthritis|osteoarthritis
5653935|NCT00686439|adalimumab|adalimumab
5653936|NCT00686439|mri|mri
5653937|NCT00686426|Obesity|obesity
5653938|NCT00686426|Weight gain|weight gain
5653939|NCT00686426|regain|regain
5653940|NCT00686426|dairy|dairy
5653941|NCT00686426|calcium|calcium
5653942|NCT00686413|PET|pet
5653943|NCT00686413|AZD3480|azd3480
5653944|NCT00686413|PET examination|pet examination
5653945|NCT00686400|schizophrenia|schizophrenia
5653946|NCT00686400|first-episode|first-episode
5653947|NCT00686400|infection|infection
5653948|NCT00686400|Toxoplasma gondii|toxoplasma gondii
5653949|NCT00686400|levels of IgG antibodies to TG|levels of igg antibodies to tg
5653950|NCT00686387|Tissue Bank|tissue bank
5653951|NCT00686387|Glioblastoma Multiforme|glioblastoma multiforme
5653952|NCT00686387|NAT2|nat2
5653953|NCT00686387|EGFR|egfr
5653954|NCT00686387|MGMT|mgmt
5653955|NCT00686387|Brain and Spinal TumorGliomas|brain and spinal tumorgliomas
5653956|NCT00686374|Crohn's Disease|crohn's disease
5653957|NCT00686374|adalimumab|adalimumab
5653958|NCT00686361|Cystic Fibrosis|cystic fibrosis
5653959|NCT00686361|choline nutrition|choline nutrition
5653960|NCT00686361|choline and methyl metabolism|choline and methyl metabolism
5653961|NCT00686361|CF and oxidative stress|cf and oxidative stress
5653962|NCT00686348|acromegaly|acromegaly
5653963|NCT00686335|asthma|asthma
5653964|NCT00686335|nocturnal asthma|nocturnal asthma
5653965|NCT00686335|glucocorticoid dependent persistent asthma|glucocorticoid dependent persistent asthma
5653966|NCT00686335|signs and symptoms|signs and symptoms
5653967|NCT00686335|lung function|lung function
5653968|NCT00686335|prednisone|prednisone
5653969|NCT00686322|chemotherapy|chemotherapy
5653970|NCT00686322|radiotherapy|radiotherapy
5653971|NCT00686322|lung cancer|lung cancer
5653972|NCT00686309|exhaled NO|exhaled no
5653973|NCT00686309|off line|off line
5653974|NCT00686309|on line|on line
5653975|NCT00686309|comparison|comparison
5653976|NCT00686309|Bland altman method|bland altman method
5653977|NCT00686296|soft tissue abscess requiring incision and drainage|soft tissue abscess requiring incision and drainage
5653978|NCT00686283|Adolescents|adolescents
5653980|NCT00686283|Exercise|exercise
5653981|NCT00686270|HIV-1 infection|hiv-1 infection
5653982|NCT00686270|NRTI resistance|nrti resistance
5653983|NCT00686270|M184V mutation|m184v mutation
5653984|NCT00686270|reverse transcriptase|reverse transcriptase
5653985|NCT00686270|apricitabine|apricitabine
5653986|NCT00686270|drug resistance|drug resistance
5653987|NCT00686270|safety and tolerability|safety and tolerability
5653988|NCT00686270|therapy failure|therapy failure
5653989|NCT00686270|Treatment Experienced|treatment experienced
5653990|NCT00686257|acute respiratory insufficiency|acute respiratory insufficiency
5653991|NCT00686257|noninvasive ventilation|noninvasive ventilation
5653992|NCT00686257|oronasal face mask|oronasal face mask
5653993|NCT00686257|total face mask|total face mask
5653994|NCT00686244|metabolic syndrome|metabolic syndrome
5653995|NCT00686244|physical activity|physical activity
5653996|NCT00686244|overweight|overweight
5653997|NCT00686244|malnutrition|malnutrition
5653998|NCT00686244|prevention|prevention
5653999|NCT00686231|To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation|to determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation
5654000|NCT00686231|To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization|to determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization
5654001|NCT00686218|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5654002|NCT00686205|healthy donors|healthy donors
5654003|NCT00686205|HIV positives|hiv positives
5654005|NCT00686192|Calcium carbonate|calcium carbonate
5654006|NCT00686192|Dietary Supplements|dietary supplements
5654007|NCT00686192|Lipolysis|lipolysis
5654009|NCT00686179|ECG|ecg
5654010|NCT00686179|QT|qt
5654011|NCT00686179|QTc|qtc
5654012|NCT00686179|AZD3480|azd3480
5654013|NCT00686179|ECG(QTc effects)|ecg(qtc effects)
5654014|NCT00686166|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5654015|NCT00686166|stage IIA rectal cancer|stage iia rectal cancer
5654016|NCT00686166|stage IIB rectal cancer|stage iib rectal cancer
5654017|NCT00686166|stage IIC rectal cancer|stage iic rectal cancer
5654018|NCT00686166|stage IIIA rectal cancer|stage iiia rectal cancer
5654019|NCT00686166|stage IIIB rectal cancer|stage iiib rectal cancer
5654020|NCT00686166|stage IIIC rectal cancer|stage iiic rectal cancer
5654021|NCT00686140|Schizophrenia|schizophrenia
5654022|NCT00686140|clinical trial|clinical trial
5654023|NCT00686140|risperidone|risperidone
5654024|NCT00686140|immune|immune
5654025|NCT00686140|celecoxib|celecoxib
5654026|NCT00686127|breast cancer|breast cancer
5654027|NCT00686127|neuropathic pain|neuropathic pain
5654028|NCT00686127|topical lidocaine|topical lidocaine
5654029|NCT00686127|postmastectomy pain|postmastectomy pain
5654030|NCT00686127|breast symptoms|breast symptoms
5654031|NCT00686127|breast pain|breast pain
5654032|NCT00686114|Esophageal cancer|esophageal cancer
5654033|NCT00686114|chemoradiation|chemoradiation
5654034|NCT00686114|radiosensitivity|radiosensitivity
5654035|NCT00686114|EGFR inhibition|egfr inhibition
5654036|NCT00686101|Perception of risk|perception of risk
5654037|NCT00686101|Smoking risks|smoking risks
5654038|NCT00686101|Smoking consequences|smoking consequences
5654039|NCT00686101|Quitting smoking|quitting smoking
5654040|NCT00686101|Motivation to quit smoking|motivation to quit smoking
5654041|NCT00686101|Schizophrenia|schizophrenia
5654042|NCT00686088|prostate cancer|prostate cancer
5654043|NCT00686088|locally recurrent|locally recurrent
5654044|NCT00686088|PRX302|prx302
5654045|NCT00686075|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5654046|NCT00686075|Parainfluenza Virus Type 3 (PIV3)|parainfluenza virus type 3 (piv3)
5654047|NCT00686075|MEDI-534|medi-534
5654048|NCT00686062|Prenatal testing|prenatal testing
5654049|NCT00686062|Amniocentesis|amniocentesis
5654050|NCT00686062|Decision making|decision making
5654051|NCT00686062|Down syndrome|down syndrome
5654052|NCT00686049|HIV Treatment Readiness Measure (HTRM)|hiv treatment readiness measure (htrm)
5654053|NCT00686049|Highly Active Antiretroviral Treatment (HAART)|highly active antiretroviral treatment (haart)
5654054|NCT00686049|Adherence|adherence
5654055|NCT00686049|Treatment readiness|treatment readiness
5654056|NCT00686049|HIV|hiv
5654057|NCT00686036|prostate cancer|prostate cancer
5654058|NCT00686036|hormone treatment|hormone treatment
5654059|NCT00686023|pertrochanteric femur fracture|pertrochanteric femur fracture
5654060|NCT00686023|DHS|dhs
5654061|NCT00686023|IMN|imn
5654062|NCT00686010|CETP Inhibitor|cetp inhibitor
5654063|NCT00686010|HDL-C|hdl-c
5654064|NCT00686010|LDL-C|ldl-c
5654065|NCT00686010|Apolipoprotein|apolipoprotein
5654066|NCT00685997|Malignant lymphoma|malignant lymphoma
5654067|NCT00685997|Hodgkin's disease|hodgkin's disease
5654068|NCT00685997|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5654070|NCT00685997|Whole-Body MRI|whole-body mri
5654072|NCT00685997|Radiation|radiation
5654073|NCT00685984|Type 2 diabetes|type 2 diabetes
5654074|NCT00685984|silent myocardial ischemia|silent myocardial ischemia
5647318|NCT00713349|Healing|healing
5654075|NCT00685984|endothelial function|endothelial function
5654076|NCT00685971|Cystic Fibrosis|cystic fibrosis
5654077|NCT00685971|Vitamin D deficiency|vitamin d deficiency
5654078|NCT00685958|Blood thinner|blood thinner
5654079|NCT00685958|enoxaparin|enoxaparin
5654080|NCT00685958|hip fracture surgery|hip fracture surgery
5654081|NCT00685958|bleeding|bleeding
5654082|NCT00685958|thromboembolism|thromboembolism
5654083|NCT00685945|Bradykinin|bradykinin
5654084|NCT00685945|Obesity|obesity
5654085|NCT00685945|Nitric Oxide Donor|nitric oxide donor
5654086|NCT00685945|tissue type plasminogen activator|tissue type plasminogen activator
5654087|NCT00685945|isosorbide dinitrate|isosorbide dinitrate
5654088|NCT00685945|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5654089|NCT00685945|Renin-Angiotensin Aldosterone System|renin-angiotensin aldosterone system
5654090|NCT00685945|Fibrinolysis|fibrinolysis
5654091|NCT00685945|Angiotensin converting enzyme|angiotensin converting enzyme
5654092|NCT00685932|Postpartum pain|postpartum pain
5654093|NCT00685932|Post-cesarean pain|post-cesarean pain
5654094|NCT00685932|Surgical retractor|surgical retractor
5654095|NCT00685932|Elastic retractor|elastic retractor
5654096|NCT00685919|Dopamine|dopamine
5654097|NCT00685919|Natriuresis|natriuresis
5654098|NCT00685919|Catecholamines|catecholamines
5654099|NCT00685906|oral contraceptive|oral contraceptive
5654100|NCT00685906|birth control|birth control
5654101|NCT00685906|Healthy volunteers|healthy volunteers
5654102|NCT00685893|End-of-life issues|end-of-life issues
5654103|NCT00685893|Talking with your doctor|talking with your doctor
5654104|NCT00685893|Coping with chronic illness|coping with chronic illness
5654105|NCT00685880|thumb carpo metacarpal joint osteoarthritis|thumb carpo metacarpal joint osteoarthritis
5654106|NCT00685880|prolotherapy|prolotherapy
5654107|NCT00685880|intra articular steroid|intra articular steroid
5654108|NCT00685880|hand therapy|hand therapy
5654109|NCT00685867|Staphylococcus aureus|staphylococcus aureus
5654110|NCT00685867|Resistance|resistance
5654111|NCT00685867|Prevention|prevention
5654112|NCT00685854|Macular Telangiectasia|macular telangiectasia
5654113|NCT00685854|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5654114|NCT00685854|Ranibizumab|ranibizumab
5654115|NCT00685841|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5654116|NCT00685828|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5654117|NCT00685815|IV Iron|iv iron
5654118|NCT00685815|Restless Legs Syndrome|restless legs syndrome
5654120|NCT00685815|Iron|iron
5654121|NCT00685789|Bell's palsy，deqi，acupuncture, neuropsychology|bell's palsy，deqi，acupuncture, neuropsychology
5654122|NCT00685776|CHD/CHD risk-equivalent disease|chd/chd risk-equivalent disease
5654123|NCT00685776|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5654124|NCT00685763|Pancreatic cancer|pancreatic cancer
5654125|NCT00685763|Unresectable|unresectable
5654126|NCT00685763|Proton radiation|proton radiation
5654127|NCT00685763|Chemotherapy|chemotherapy
5654128|NCT00685750|tumor antigen|tumor antigen
5654129|NCT00685750|biomarkers|biomarkers
5654130|NCT00685737|Hyperlipidemia|hyperlipidemia
5654131|NCT00685724|pathological gambling|pathological gambling
5654132|NCT00685724|cognitive-behavioral therapy|cognitive-behavioral therapy
5654133|NCT00685724|motivational enhancement therapy|motivational enhancement therapy
5654134|NCT00685711|Cat allergy|cat allergy
5654135|NCT00685711|Immunotherapy|immunotherapy
5654136|NCT00685711|Cat-PAD|cat-pad
5654137|NCT00685698|Diabetic Foot Infections, DFI, Nemonoxacin|diabetic foot infections, dfi, nemonoxacin
5654138|NCT00685685|Therapeutic Equivalency|therapeutic equivalency
5654139|NCT00685672|labor analgesia|labor analgesia
5654140|NCT00685672|fentanyl|fentanyl
5654141|NCT00685672|epinephrine|epinephrine
5654142|NCT00685659|cocaine dependence|cocaine dependence
5654143|NCT00685659|treatment|treatment
5638198|NCT00746525|FES|fes
5654144|NCT00685659|continuing care|continuing care
5654145|NCT00685659|outcomes|outcomes
5654146|NCT00685659|incentives|incentives
5654147|NCT00685659|adaptive|adaptive
5654148|NCT00685646|bone metastases|bone metastases
5654149|NCT00685646|stage IV prostate cancer|stage iv prostate cancer
5654150|NCT00685633|stage I prostate cancer|stage i prostate cancer
5654151|NCT00685633|stage II prostate cancer|stage ii prostate cancer
5654152|NCT00685633|stage III prostate cancer|stage iii prostate cancer
5654153|NCT00685633|recurrent prostate cancer|recurrent prostate cancer
5654154|NCT00685607|Pilot Study|pilot study
5654155|NCT00685607|Outcome Measures|outcome measures
5654156|NCT00685594|diabetes|diabetes
5654157|NCT00685594|vitamin D|vitamin d
5654158|NCT00685594|cholecalciferol|cholecalciferol
5654159|NCT00685594|glucose tolerance|glucose tolerance
5654160|NCT00685581|TFA|tfa
5654161|NCT00685581|SFA|sfa
5654162|NCT00685581|Clinical trial|clinical trial
5654163|NCT00685581|fat milk|fat milk
5654164|NCT00685568|colon cancer|colon cancer
5654165|NCT00685568|rectal cancer|rectal cancer
5654166|NCT00685568|familial adenomatous polyposis|familial adenomatous polyposis
5654167|NCT00685555|Screen time|screen time
5654168|NCT00685555|Fruits and Vegetable Consumption|fruits and vegetable consumption
5654169|NCT00685555|Physical Activity|physical activity
5654170|NCT00685555|Obesity|obesity
5654177|NCT00685529|formoterol|formoterol
5654178|NCT00685516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5654179|NCT00685516|recurrent prostate cancer|recurrent prostate cancer
5654180|NCT00685516|stage I prostate cancer|stage i prostate cancer
5654181|NCT00685516|stage II prostate cancer|stage ii prostate cancer
5654182|NCT00685516|stage III prostate cancer|stage iii prostate cancer
5654183|NCT00685516|stage IV prostate cancer|stage iv prostate cancer
5654184|NCT00685503|Macular Telangiectasia|macular telangiectasia
5654185|NCT00685503|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5654186|NCT00685503|Ranibizumab|ranibizumab
5654187|NCT00685503|Neovascularization|neovascularization
5654188|NCT00685490|branch retinal vein occlusion|branch retinal vein occlusion
5654189|NCT00685490|internal limiting membrane|internal limiting membrane
5654190|NCT00685490|macular edema|macular edema
5654191|NCT00685490|vitrectomy|vitrectomy
5654192|NCT00685477|CCK infusion|cck infusion
5654193|NCT00685477|Gallbladder ejection fraction|gallbladder ejection fraction
5654194|NCT00685477|Normal volunteers|normal volunteers
5654195|NCT00685464|Abciximab|abciximab
5654196|NCT00685464|Reo-Pro|reo-pro
5654197|NCT00685464|Intracoronary|intracoronary
5654199|NCT00685451|cognitive behavior therapy|cognitive behavior therapy
5654200|NCT00685451|addiction|addiction
5654201|NCT00685451|PTSD|ptsd
5654202|NCT00685438|Environmental Medicine|environmental medicine
5654203|NCT00685438|Altitude|altitude
5654204|NCT00685438|Ultraviolet Rays|ultraviolet rays
5654205|NCT00685438|Antioxidants|antioxidants
5654206|NCT00685438|Oxidative Stress|oxidative stress
5654207|NCT00685438|Erythema|erythema
5654208|NCT00685425|Asthma|asthma
5654209|NCT00685425|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
5654210|NCT00685412|CIN 2 or 3|cin 2 or 3
5654211|NCT00685412|cervical cancer|cervical cancer
5654212|NCT00685399|Uveitis|uveitis
5654213|NCT00685399|eye|eye
5654214|NCT00685399|IL-17|il-17
5654215|NCT00685399|IL-17A|il-17a
5654216|NCT00685399|IL17|il17
5654217|NCT00685399|AIN457|ain457
5654218|NCT00685399|Vogt-Koyanagi-Harada|vogt-koyanagi-harada
5654219|NCT00685399|Behcet's|behcet's
5654220|NCT00685399|Behcet|behcet
5654221|NCT00685399|Sympathetic ophthalmia|sympathetic ophthalmia
5654222|NCT00685399|Multifocal choroiditis|multifocal choroiditis
5654223|NCT00685399|Birdshot|birdshot
5654224|NCT00685399|HLA-B27|hla-b27
5654225|NCT00685399|Birdshot retinochoroiditis|birdshot retinochoroiditis
5654226|NCT00685399|Retinal vasculitis|retinal vasculitis
5654227|NCT00685399|Sarcoidosis|sarcoidosis
5654228|NCT00685399|Intermediate uveitis|intermediate uveitis
5654229|NCT00685399|Panuveitis|panuveitis
5654230|NCT00685399|Posterior uveitis|posterior uveitis
5654231|NCT00685386|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5654232|NCT00685386|carbon dioxide|carbon dioxide
5654233|NCT00685386|randomized controlled clinical trial|randomized controlled clinical trial
5654234|NCT00685373|Cryopyrin-associated periodic syndromes (CAPS):|cryopyrin-associated periodic syndromes (caps):
5654235|NCT00685373|Familial Cold Autoinflammatory Syndrome (FCAS),|familial cold autoinflammatory syndrome (fcas),
5654236|NCT00685373|Muckle-Wells Syndrome (MWS),|muckle-wells syndrome (mws),
5654237|NCT00685373|MWS with overlapping symptoms of Neonatal Onset Multisystem Inflammatory Disease (NOMID) or Neonatal Onset Multisystem Inflammatory Disease (NOMID),|mws with overlapping symptoms of neonatal onset multisystem inflammatory disease (nomid) or neonatal onset multisystem inflammatory disease (nomid),
5654238|NCT00685373|children,|children,
5654239|NCT00685373|systemic autoinflammatory disease,|systemic autoinflammatory disease,
5654240|NCT00685373|CIAS-1 gene,|cias-1 gene,
5654241|NCT00685373|NALP-3,|nalp-3,
5654242|NCT00685373|ACZ885,|acz885,
5654243|NCT00685373|human monoclonal anti-human interleukin-1beta (IL-1beta),|human monoclonal anti-human interleukin-1beta (il-1beta),
5654244|NCT00685373|antibody,|antibody,
5654245|NCT00685373|autosomal dominant,|autosomal dominant,
5654246|NCT00685373|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5654247|NCT00685360|Tuberculosis|tuberculosis
5654248|NCT00685360|Pulmonary|pulmonary
5654249|NCT00685360|Multidrug resistant|multidrug resistant
5654250|NCT00685360|Antitubercular Agents|antitubercular agents
5654251|NCT00685360|OPC 67683|opc 67683
5654252|NCT00685347|Asthma|asthma
5654253|NCT00685347|Exercised induced bronchoconstriction|exercised induced bronchoconstriction
5654254|NCT00685334|Atypical Antipsychotics|atypical antipsychotics
5654255|NCT00685334|Anorexia Nervosa|anorexia nervosa
5654256|NCT00685321|schizophrenia|schizophrenia
5654258|NCT00685321|brain stimulation|brain stimulation
5654259|NCT00685321|negative symptoms|negative symptoms
5654260|NCT00685321|clinical improvement|clinical improvement
5654261|NCT00685321|cognitive improvement|cognitive improvement
5654262|NCT00685308|Atherosclerosis|atherosclerosis
5654263|NCT00685308|Intracranial artery|intracranial artery
5654264|NCT00685308|Angioplasty|angioplasty
5654265|NCT00685308|Stent|stent
5654266|NCT00685295|Emergency Department|emergency department
5654267|NCT00685295|acute|acute
5654268|NCT00685269|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5654269|NCT00685269|OSAS|osas
5654270|NCT00685256|breast cancer|breast cancer
5654271|NCT00685256|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5654272|NCT00685243|Fraxel|fraxel
5654273|NCT00685243|Pulsed dye laser|pulsed dye laser
5654274|NCT00685243|Surgical scars|surgical scars
5654275|NCT00685230|scorpion sting|scorpion sting
5654276|NCT00685230|envenomation|envenomation
5654277|NCT00685230|alacramyn|alacramyn
5654278|NCT00685191|Raltegravir|raltegravir
5654279|NCT00685191|HIV|hiv
5654280|NCT00685191|dynamics|dynamics
5654281|NCT00685191|viral load|viral load
5654282|NCT00685191|Treatment Experienced|treatment experienced
5654283|NCT00685178|addiction|addiction
5654284|NCT00685178|drug dependence|drug dependence
5654285|NCT00685178|stimulant|stimulant
5654286|NCT00685139|Therapeutic Equivalency|therapeutic equivalency
5654287|NCT00685126|RAD|rad
5654288|NCT00685126|Reactive Airways Disease|reactive airways disease
5654289|NCT00685126|Levalbuterol|levalbuterol
5654290|NCT00685126|Racemic albuterol|racemic albuterol
5654291|NCT00685100|IVTA; CNV; age-related macular degeneration; PDT|ivta; cnv; age-related macular degeneration; pdt
5685480|NCT00555932|Cranial Ultrasound|cranial ultrasound
5654292|NCT00685087|To define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (CP).|to define the natural history and the clinical, laboratory and histomorphometric features of chronic pancreatitis (cp).
5654293|NCT00685087|To identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with CP.|to identify clinical and laboratory parameters that correlate with the pathophysiologic state in patients with cp.
5654294|NCT00685087|To quantify the behavioral abnormalities associated with CP.|to quantify the behavioral abnormalities associated with cp.
5798780|NCT00111085|delayed ischemic neurological deficits (DIND)|delayed ischemic neurological deficits (dind)
5654306|NCT00685022|Racemic albuterol|racemic albuterol
5654307|NCT00685009|Cognition|cognition
5654308|NCT00685009|Memory|memory
5654309|NCT00685009|Hormone Therapy|hormone therapy
5654310|NCT00684983|IGF-1R|igf-1r
5654311|NCT00684983|IMC-A12|imc-a12
5654312|NCT00684970|CRPC|crpc
5654313|NCT00684970|HRPC|hrpc
5654314|NCT00684970|metastatic prostate cancer|metastatic prostate cancer
5654315|NCT00684931|Attention|attention
5654316|NCT00684931|Deficit|deficit
5654317|NCT00684931|Disorder|disorder
5654318|NCT00684931|Hyperactivity|hyperactivity
5654319|NCT00684931|cerebellum|cerebellum
5654320|NCT00684931|alteration|alteration
5654321|NCT00684931|fronto-cerebello-frontal loops|fronto-cerebello-frontal loops
5654322|NCT00684918|AML, obatoclax|aml, obatoclax
5654323|NCT00684905|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5654324|NCT00684905|recurrent prostate cancer|recurrent prostate cancer
5654325|NCT00684905|stage I prostate cancer|stage i prostate cancer
5654326|NCT00684905|stage II prostate cancer|stage ii prostate cancer
5654327|NCT00684905|stage III prostate cancer|stage iii prostate cancer
5654328|NCT00684892|Emphysema|emphysema
5654329|NCT00684892|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
5654330|NCT00684879|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5654331|NCT00684879|Health Belief Model|health belief model
5654332|NCT00684879|Illness Perceptions|illness perceptions
5654333|NCT00684879|Screening|screening
5654334|NCT00684879|HHT|hht
5654335|NCT00684866|Asthma|asthma
5654336|NCT00684866|Levalbuterol|levalbuterol
5654337|NCT00684866|Racemic Albuterol|racemic albuterol
5654338|NCT00684853|AMD|amd
5654339|NCT00684853|PDT|pdt
5654340|NCT00684853|Avastin|avastin
5654341|NCT00684853|Bevacizumab|bevacizumab
5654342|NCT00684853|Full fluence|full fluence
5654343|NCT00684853|exudative|exudative
5654344|NCT00684853|CNV|cnv
5654345|NCT00684853|Drusen|drusen
5654346|NCT00684853|ARMD|armd
5654347|NCT00684853|Vetaporfin|vetaporfin
5654348|NCT00684853|efficacy|efficacy
5654349|NCT00684853|treatment|treatment
5654350|NCT00684840|Behavioral Economics|behavioral economics
5654351|NCT00684840|Drug self administration|drug self administration
5654352|NCT00684840|Opioid|opioid
5654353|NCT00684827|Asthma|asthma
5654354|NCT00684827|Racemic albuterol|racemic albuterol
5654355|NCT00684814|equivalency|equivalency
5654356|NCT00684814|Therapeutic equivalency|therapeutic equivalency
5654357|NCT00684801|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5654358|NCT00684801|recurrent small cell lung cancer|recurrent small cell lung cancer
5654359|NCT00684801|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5654360|NCT00684801|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5654361|NCT00684801|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5654362|NCT00684801|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5654363|NCT00684801|recurrent pancreatic cancer|recurrent pancreatic cancer
5654364|NCT00684801|stage III pancreatic cancer|stage iii pancreatic cancer
5654365|NCT00684801|stage IV pancreatic cancer|stage iv pancreatic cancer
5654366|NCT00684801|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5654367|NCT00684801|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5654368|NCT00684801|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5654369|NCT00684801|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5654370|NCT00684801|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5654371|NCT00684801|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5654372|NCT00684801|recurrent colon cancer|recurrent colon cancer
5654373|NCT00684801|stage III colon cancer|stage iii colon cancer
5654374|NCT00684801|stage IV colon cancer|stage iv colon cancer
5654375|NCT00684801|recurrent rectal cancer|recurrent rectal cancer
5654376|NCT00684801|stage III rectal cancer|stage iii rectal cancer
5654377|NCT00684801|stage IV rectal cancer|stage iv rectal cancer
5654378|NCT00684788|opiate dependence|opiate dependence
5654379|NCT00684788|naltrexone|naltrexone
5654380|NCT00684788|reinforcement|reinforcement
5654381|NCT00684788|behavior therapy|behavior therapy
5654382|NCT00684788|cocaine dependence|cocaine dependence
5654383|NCT00684788|risk reduction behavior|risk reduction behavior
5654384|NCT00684749|Mentor BodyLogic TM System|mentor bodylogic tm system
5654385|NCT00684749|Breast augmentation|breast augmentation
5654386|NCT00684749|Breast implant choice|breast implant choice
5654387|NCT00684749|Reoperation rates|reoperation rates
5654388|NCT00684736|septic shock|septic shock
5654390|NCT00684736|serotonin|serotonin
5654391|NCT00684736|kynurenine|kynurenine
5654392|NCT00684736|tryptophan|tryptophan
5654393|NCT00684723|Therapeutic Equivalency|therapeutic equivalency
5654394|NCT00684710|Alzheimer Disease|alzheimer disease
5654395|NCT00684697|premature infants iron neurodevelopment|premature infants iron neurodevelopment
5654396|NCT00684684|Bronchoscopy|bronchoscopy
5654397|NCT00684684|Clinically indicated for routine diagnostic bronchoscopy|clinically indicated for routine diagnostic bronchoscopy
5654398|NCT00684671|Immune memory|immune memory
5654399|NCT00684671|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5654400|NCT00684671|> 41 years old|> 41 years old
5654401|NCT00684658|Type 1 Diabetes|type 1 diabetes
5654402|NCT00684658|Children and Teenagers|children and teenagers
5654403|NCT00684658|Coping with Chronic Illness|coping with chronic illness
5654404|NCT00684658|Adolescence|adolescence
5654405|NCT00684658|Internet psychosocial program|internet psychosocial program
5654406|NCT00684658|Coping Skills Training|coping skills training
5654407|NCT00684645|Safety and tolerability of SUTENT® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.|safety and tolerability of sutent® in patients with metastatic or advanced renal cell carcinoma after failure of cytokines in real-life setting.
5654408|NCT00684632|Pain, cancer|pain, cancer
5654409|NCT00684606|Induction of Labor|induction of labor
5654410|NCT00684606|Low Bishop Score|low bishop score
5654411|NCT00684606|Transcervical Foley Catheter.|transcervical foley catheter.
5654412|NCT00684606|IV Oxytocin|iv oxytocin
5654413|NCT00684580|St. Jude Alumni|st. jude alumni
5654414|NCT00684580|St. Jude Life Participants|st. jude life participants
5654415|NCT00684554|Heroin Dependence|heroin dependence
5654416|NCT00684554|Opioid Dependence|opioid dependence
5654417|NCT00684554|Primary Care|primary care
5654418|NCT00684554|Buprenorphine|buprenorphine
5654419|NCT00684541|Social Anxiety|social anxiety
5654420|NCT00684541|Information Processing|information processing
5654421|NCT00684541|Interpretation|interpretation
5654422|NCT00684528|DM 2|dm 2
5654423|NCT00684528|Metformin|metformin
5654424|NCT00684528|Januvia|januvia
5654425|NCT00684528|Community setting|community setting
5654426|NCT00684528|newly diagnosed diadetics, or diabetes patients not treated during the last year|newly diagnosed diadetics, or diabetes patients not treated during the last year
5654427|NCT00684502|Safety|safety
5654428|NCT00684502|tolerability|tolerability
5654429|NCT00684502|AZD2066|azd2066
5654430|NCT00684502|Pain conditions|pain conditions
5654431|NCT00684489|hypertension|hypertension
5654432|NCT00684489|renin-guided therapeutics|renin-guided therapeutics
5654433|NCT00684463|Antiemetic|antiemetic
5654434|NCT00684450|titration of protamine|titration of protamine
5654435|NCT00684450|exact dose|exact dose
5654436|NCT00684450|protamine|protamine
5654437|NCT00684450|neutralize heparin|neutralize heparin
5654438|NCT00684437|Health Literacy|health literacy
5654439|NCT00684437|Smoking Risk|smoking risk
5654440|NCT00684437|Focus Group|focus group
5654441|NCT00684437|Questionnaire|questionnaire
5654442|NCT00684437|Survey|survey
5654443|NCT00684411|T NHL|t nhl
5654444|NCT00684411|Gleevec|gleevec
5654445|NCT00684411|imatinib mesylate|imatinib mesylate
5654446|NCT00684398|Neurofibromatosis Type 1|neurofibromatosis type 1
5654447|NCT00684398|Quality of Life|quality of life
5654448|NCT00684398|Adaptation|adaptation
5654449|NCT00684398|Stress and Coping Model|stress and coping model
5654451|NCT00684398|Survey|survey
5654452|NCT00684359|Patients having PCI with a drug eluting stent|patients having pci with a drug eluting stent
5654453|NCT00684346|18FDG-PET imaging|18fdg-pet imaging
5654454|NCT00684346|airway inflammation|airway inflammation
5654455|NCT00684346|cystic fibrosis|cystic fibrosis
5654457|NCT00684346|pulmonary exacerbation|pulmonary exacerbation
5654458|NCT00684333|painless Injections|painless injections
5654459|NCT00684333|Subcutaneous Injections|subcutaneous injections
5654460|NCT00684333|Subcutaneous Injections to healthy volunteers|subcutaneous injections to healthy volunteers
5654461|NCT00684320|Social Anxiety Disorder|social anxiety disorder
5654462|NCT00684320|Information Processing|information processing
5654463|NCT00684320|Attention Bias|attention bias
5654464|NCT00684307|Anticoagulant Treatment|anticoagulant treatment
5654465|NCT00684307|Risk Factors For Stroke|risk factors for stroke
5654477|NCT00684255|Reduced Intensity Transplant|reduced intensity transplant
5654478|NCT00684242|Advanced Cancer|advanced cancer
5654479|NCT00684242|Refractory Cancer Pain|refractory cancer pain
5654480|NCT00684242|Lenalidomide|lenalidomide
5654481|NCT00684242|Revlimid|revlimid
5654482|NCT00684242|CC-5103|cc-5103
5654483|NCT00684229|Anesthesia; regional|anesthesia; regional
5654484|NCT00684229|Cancer recurrence|cancer recurrence
5654485|NCT00684229|Anesthesia; inhalational|anesthesia; inhalational
5654486|NCT00684229|Analgesia; opioid|analgesia; opioid
5654487|NCT00684216|metastatic|metastatic
5654488|NCT00684216|ER positive|er positive
5654489|NCT00684216|PD during/after first line hormonal treatment|pd during/after first line hormonal treatment
5654490|NCT00684190|Reflux Inhibitor|reflux inhibitor
5654491|NCT00684190|GERD|gerd
5654492|NCT00684190|PPI Interaction|ppi interaction
5654493|NCT00684177|infection|infection
5654494|NCT00684177|retapamulin|retapamulin
5654495|NCT00684177|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
5654496|NCT00684177|placebo|placebo
5654497|NCT00684164|Euvolemic Hyponatremia|euvolemic hyponatremia
5654498|NCT00684164|Hypervolemic Hyponatremia|hypervolemic hyponatremia
5654499|NCT00684164|Neurological injury|neurological injury
5654500|NCT00684151|Lipid-lowering|lipid-lowering
5654501|NCT00684138|cataract|cataract
5654502|NCT00684138|cataract surgery|cataract surgery
5654503|NCT00684138|IOL|iol
5654504|NCT00684138|intraocular lens|intraocular lens
5654505|NCT00684138|ReSTOR|restor
5654506|NCT00684138|Replacement of cataract|replacement of cataract
5654507|NCT00684125|late cardiac tamponade|late cardiac tamponade
5654508|NCT00684112|pediatrics|pediatrics
5654509|NCT00684112|Scoliosis|scoliosis
5654510|NCT00684112|Gabapentin|gabapentin
5654511|NCT00684099|NSCLC|nsclc
5654512|NCT00684099|Pemetrexed|pemetrexed
5654513|NCT00684099|Docetaxel|docetaxel
5654514|NCT00684073|Suboxone|suboxone
5654515|NCT00684073|Subutex|subutex
5654516|NCT00684073|Buprenorphine|buprenorphine
5654517|NCT00684073|Naloxone|naloxone
5654518|NCT00684060|Acute Myocardial Infarction|acute myocardial infarction
5654519|NCT00684060|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
5654520|NCT00684060|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
5654521|NCT00684060|Left Ventricular Mass|left ventricular mass
5654522|NCT00684060|Infarct Size|infarct size
5654523|NCT00684060|End Systolic Volume|end systolic volume
5654524|NCT00684060|End Diastolic Volume|end diastolic volume
5654525|NCT00684047|Fibrin Sealant|fibrin sealant
5654526|NCT00684047|Hemostasis|hemostasis
5654527|NCT00684047|Peripheral Vascular Surgery|peripheral vascular surgery
5654528|NCT00684034|Redox state in the course of chronic renal insufficiency and hemodialysis.|redox state in the course of chronic renal insufficiency and hemodialysis.
5654529|NCT00684021|Acute Myocardial Infarction|acute myocardial infarction
5654530|NCT00684021|Global Left Ventricular Ejection Fraction|global left ventricular ejection fraction
5654531|NCT00684021|Regional Left Ventricular Ejection Fraction|regional left ventricular ejection fraction
5654532|NCT00684021|Left Ventricular Mass|left ventricular mass
5654533|NCT00684021|Infarct Size|infarct size
5654534|NCT00684021|End Systolic Volume|end systolic volume
5654535|NCT00684021|End Diastolic Volume|end diastolic volume
5654536|NCT00684008|interleukin-7|interleukin-7
5654537|NCT00684008|immune based therapies|immune based therapies
5654538|NCT00684008|graft vs host disease|graft vs host disease
5654539|NCT00684008|immune reconstitution|immune reconstitution
5654541|NCT00684008|lymphopenia|lymphopenia
5654542|NCT00684008|hematopoetic stem cell transplantation|hematopoetic stem cell transplantation
5654543|NCT00684008|bone marrow transplantation|bone marrow transplantation
5654544|NCT00684008|peripheral blood stem cell transplant|peripheral blood stem cell transplant
5654545|NCT00684008|immunosuppression|immunosuppression
5654546|NCT00683995|Pain, Cancer|pain, cancer
5654547|NCT00683982|nitazoxanide|nitazoxanide
5654548|NCT00683982|Probiotics|probiotics
5654549|NCT00683982|Diarrhea|diarrhea
5654550|NCT00683982|Rotavirus|rotavirus
5654551|NCT00683982|Children|children
5654552|NCT00683943|Spinocerebellar Ataxia|spinocerebellar ataxia
5654553|NCT00683943|Lithium|lithium
5654554|NCT00683917|Uterine fibroids|uterine fibroids
5654555|NCT00683917|Fibroids|fibroids
5654556|NCT00683891|FOCUS|focus
5654557|NCT00683891|Weight gain|weight gain
5654558|NCT00683891|Sialorrhea|sialorrhea
5654559|NCT00683891|Treatment refractory schizophrenia|treatment refractory schizophrenia
5654560|NCT00683891|FazaClo|fazaclo
5654561|NCT00683891|Treatment resistant schizophrenia|treatment resistant schizophrenia
5654578|NCT00683839|Smokeless tobacco|smokeless tobacco
5654579|NCT00683826|Leucine|leucine
5654580|NCT00683826|Weight Loss|weight loss
5654581|NCT00683813|cardiac rehabilitation|cardiac rehabilitation
5654582|NCT00683813|telehealth|telehealth
5654583|NCT00683813|Internet|internet
5654584|NCT00683800|Menopause|menopause
5654585|NCT00683800|Hot Flush|hot flush
5654586|NCT00683800|Hot Flash|hot flash
5654587|NCT00683800|Desvenlafaxine succinate Sustained Release|desvenlafaxine succinate sustained release
5654588|NCT00683787|recurrent gastric cancer|recurrent gastric cancer
5654589|NCT00683787|stage IV gastric cancer|stage iv gastric cancer
5654590|NCT00683787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5654591|NCT00683761|High grade recurrent glioma|high grade recurrent glioma
5654592|NCT00683761|Phase 2|phase 2
5654593|NCT00683761|Phase 1|phase 1
5654594|NCT00683761|Multi-center|multi-center
5654595|NCT00683761|Open label|open label
5654596|NCT00683761|Multiple dose|multiple dose
5654597|NCT00683761|Brain Cancer|brain cancer
5654598|NCT00683761|Brain Tumor|brain tumor
5654599|NCT00683761|GBM|gbm
5654600|NCT00683761|glioma|glioma
5654601|NCT00683761|glioblastoma|glioblastoma
5654602|NCT00683761|astrocytoma|astrocytoma
5654603|NCT00683761|oligodendroglioma|oligodendroglioma
5654604|NCT00683761|131I-TM601|131i-tm601
5654605|NCT00683761|TM601|tm601
5654606|NCT00683748|Transplantation|transplantation
5654607|NCT00683748|Immunological monitoring|immunological monitoring
5654608|NCT00683748|Immunological risk|immunological risk
5654609|NCT00683748|T cell reactivity|t cell reactivity
5654610|NCT00683748|Cellular immunity|cellular immunity
5654611|NCT00683735|Incretin, DPP-4, metformin, sitagliptin, insulin secretion|incretin, dpp-4, metformin, sitagliptin, insulin secretion
5654612|NCT00683722|COPD|copd
5654996|NCT00682201|Pregnancy|pregnancy
5654613|NCT00683722|Airflow Obstruction, Chronic|airflow obstruction, chronic
5654614|NCT00683722|Chronic Airflow Obstruction|chronic airflow obstruction
5654615|NCT00683722|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5654616|NCT00683722|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5654617|NCT00683722|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5654618|NCT00683722|Pulmonary Emphysema|pulmonary emphysema
5654619|NCT00683722|Chronic Bronchitis|chronic bronchitis
5654620|NCT00683722|Mesenchymal Stem Cells|mesenchymal stem cells
5654621|NCT00683722|MSCs|mscs
5654622|NCT00683722|Adult Human Stem Cells|adult human stem cells
5654623|NCT00683722|Osiris|osiris
5654624|NCT00683722|Prochymal|prochymal
5654625|NCT00683709|Bipolar and Schizoaffective Disorder|bipolar and schizoaffective disorder
5654626|NCT00683709|Clozapine|clozapine
5654627|NCT00683709|Metabolic Side Effects|metabolic side effects
5654628|NCT00683709|Diet & Exercise|diet & exercise
5654629|NCT00683709|BMI|bmi
5654630|NCT00683696|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5654631|NCT00683696|Heart Failure|heart failure
5654632|NCT00683696|Ventricular Dyssynchrony|ventricular dyssynchrony
5654633|NCT00683696|Mechanical Dyssynchrony|mechanical dyssynchrony
5654634|NCT00683696|Intraventricular Dyssynchrony|intraventricular dyssynchrony
5654635|NCT00683696|Echocardiography|echocardiography
5654636|NCT00683696|Normal QRS|normal qrs
5654637|NCT00683696|Heart Disease|heart disease
5654638|NCT00683696|EchoCRT|echocrt
5654639|NCT00683683|cardiac arrest, hypothermia, knowledge translation|cardiac arrest, hypothermia, knowledge translation
5654640|NCT00683644|tinnitus, zinc|tinnitus, zinc
5654641|NCT00683631|liver cancer|liver cancer
5654643|NCT00683631|HCC|hcc
5654644|NCT00683631|hepatocellular carcinoma|hepatocellular carcinoma
5654645|NCT00683631|hepatoma|hepatoma
5654646|NCT00683618|HMG-CoA|hmg-coa
5654647|NCT00683618|LDL-C|ldl-c
5654649|NCT00683579|HAART|haart
5654650|NCT00683579|DHHS guidelines|dhhs guidelines
5654651|NCT00683579|Treatment Naive|treatment naive
5654652|NCT00683566|parkinson|parkinson
5654653|NCT00683553|Acute Renal Failure|acute renal failure
5654654|NCT00683553|Acute Kidney Injury|acute kidney injury
5654655|NCT00683540|implementation|implementation
5654656|NCT00683540|evaluation|evaluation
5654657|NCT00683540|research methodology|research methodology
5654658|NCT00683540|intervention|intervention
5654659|NCT00683527|Iron supplementation|iron supplementation
5654660|NCT00683527|Timing|timing
5654661|NCT00683527|Serum ferritin|serum ferritin
5654662|NCT00683527|Very low birth weight infants|very low birth weight infants
5654663|NCT00683514|Untreated locally advanced inoperable stage IIIA or stage IIIB NSCLC amenable to radical radiotherapy to a dose of 66 Gy|untreated locally advanced inoperable stage iiia or stage iiib nsclc amenable to radical radiotherapy to a dose of 66 gy
5654664|NCT00683501|ocular hypertension|ocular hypertension
5654665|NCT00683501|elevated IOP|elevated iop
5654666|NCT00683501|glaucoma|glaucoma
5654667|NCT00683501|neuroprotection|neuroprotection
5654668|NCT00683488|Substance Abuse|substance abuse
5654669|NCT00683488|Adolescent community reinforcement approach|adolescent community reinforcement approach
5654670|NCT00683488|Adolescent Risk Behavior Assessment|adolescent risk behavior assessment
5654671|NCT00683488|Child and Adolescent Services Assessment|child and adolescent services assessment
5654672|NCT00683488|Cognitive behavioral therapy|cognitive behavioral therapy
5654673|NCT00683488|Cognitive Therapy Rating Scale|cognitive therapy rating scale
5654674|NCT00683488|Individual behavior therapy|individual behavior therapy
5654675|NCT00683488|Individual cognitive problem solving|individual cognitive problem solving
5654795|NCT00683033|Contingency Management|contingency management
5654676|NCT00683488|Motivational enhancement therapy|motivational enhancement therapy
5654677|NCT00683488|HIV-Positive Youth With Substance Abuse|hiv-positive youth with substance abuse
5654678|NCT00683488|Complementary Therapies|complementary therapies
5654679|NCT00683475|Prostate Cancer|prostate cancer
5654680|NCT00683449|Asthma|asthma
5654681|NCT00683449|Dose-Escalation|dose-escalation
5654682|NCT00683449|Controlled|controlled
5654683|NCT00683449|MN-221|mn-221
5654684|NCT00683436|insomnia|insomnia
5654685|NCT00683397|assess|assess
5654686|NCT00683397|prevalence|prevalence
5654687|NCT00683397|thrombophilia|thrombophilia
5654688|NCT00683397|common|common
5654689|NCT00683397|VTE|vte
5654690|NCT00683397|risk factors|risk factors
5654691|NCT00683397|patients|patients
5654692|NCT00683384|Arthritis|arthritis
5654693|NCT00683384|psoriatic|psoriatic
5654694|NCT00683371|Chronic Rhinosinusitis|chronic rhinosinusitis
5654695|NCT00683371|Sinus Disease|sinus disease
5654696|NCT00683371|Allergy|allergy
5654697|NCT00683371|Maxillary Sinus|maxillary sinus
5654698|NCT00683371|Microarray|microarray
5654699|NCT00683358|cancer|cancer
5654700|NCT00683358|pancreas|pancreas
5654701|NCT00683358|advanced|advanced
5654702|NCT00683358|peptide|peptide
5654703|NCT00683358|vaccination|vaccination
5654705|NCT00683358|HLA|hla
5654706|NCT00683358|gemcitabine|gemcitabine
5654707|NCT00683358|IFA|ifa
5654708|NCT00683358|Cancer of Pancreas|cancer of pancreas
5654999|NCT00682188|Overweight|overweight
5654709|NCT00683358|Neoplasms, Pancreatic|neoplasms, pancreatic
5654710|NCT00683358|Pancreas Cancer|pancreas cancer
5654711|NCT00683332|Observational study|observational study
5654712|NCT00683332|Tigecycline|tigecycline
5654713|NCT00683332|infection|infection
5654714|NCT00683332|skin|skin
5654715|NCT00683332|abdominal|abdominal
5654716|NCT00683319|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5654717|NCT00683319|cognitive/functional effects|cognitive/functional effects
5654718|NCT00683319|ototoxicity|ototoxicity
5654719|NCT00683319|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5654720|NCT00683319|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5654721|NCT00683293|Laparoscopic Hysterectomy|laparoscopic hysterectomy
5654722|NCT00683293|Robot-assisted Laparoscopic Hysterectomy|robot-assisted laparoscopic hysterectomy
5654723|NCT00683293|Robot-assisted Surgery|robot-assisted surgery
5654724|NCT00683280|Contingency Management|contingency management
5654725|NCT00683280|Cigarette Smoking Cessation|cigarette smoking cessation
5654726|NCT00683280|varenicline|varenicline
5654727|NCT00683267|THA, Total hip arthroplasty, total hip replacement|tha, total hip arthroplasty, total hip replacement
5654728|NCT00683254|nasal obstruction|nasal obstruction
5654729|NCT00683254|nasal stent|nasal stent
5654730|NCT00683241|Vaccine|vaccine
5654731|NCT00683241|Ovarian|ovarian
5654732|NCT00683241|Peritoneal|peritoneal
5654733|NCT00683228|Second hand Smoke|second hand smoke
5654734|NCT00683202|Assisted reproduction|assisted reproduction
5654735|NCT00683202|Ovarian response|ovarian response
5654736|NCT00683202|Uteroplacental hemodynamics|uteroplacental hemodynamics
5654737|NCT00683202|Doppler ultrasonography|doppler ultrasonography
5654738|NCT00683202|Implantation rate|implantation rate
5654739|NCT00683202|Pregnancy rate|pregnancy rate
5654740|NCT00683202|Live birth rate|live birth rate
5654742|NCT00683176|Diabetic Macular Edema|diabetic macular edema
5654744|NCT00683163|Combination of PTH and ibandronate|combination of pth and ibandronate
5654745|NCT00683163|Bone marker formation|bone marker formation
5654746|NCT00683163|Postmenopausal|postmenopausal
5654747|NCT00683163|Trabecular spine BMD|trabecular spine bmd
5654748|NCT00683150|Endothelial Function|endothelial function
5654749|NCT00683150|Abdominal Surgery|abdominal surgery
5654750|NCT00683150|Thoracic Surgery|thoracic surgery
5654751|NCT00683150|Vendy's-DTM Machine|vendy's-dtm machine
5654752|NCT00683150|Digital Thermal Monitoring|digital thermal monitoring
5654753|NCT00683150|DTM|dtm
5654754|NCT00683124|Marfan Syndrome|marfan syndrome
5654755|NCT00683124|Losartan|losartan
5654756|NCT00683124|Nebivolol|nebivolol
5654757|NCT00683124|Transforming Growth Factor Beta|transforming growth factor beta
5654758|NCT00683124|Aortic Root Dilation|aortic root dilation
5654759|NCT00683111|acute coronary syndrome|acute coronary syndrome
5654760|NCT00683111|acute myocardial infarction|acute myocardial infarction
5654761|NCT00683111|aspirin|aspirin
5654762|NCT00683111|clopidogrel|clopidogrel
5654763|NCT00683111|heparin|heparin
5654764|NCT00683111|thrombolytic|thrombolytic
5654765|NCT00683111|famotidine|famotidine
5654766|NCT00683111|esomeprazole|esomeprazole
5654767|NCT00683098|recurrent hernia|recurrent hernia
5654768|NCT00683098|endoscopic total extraperitoneal repair|endoscopic total extraperitoneal repair
5654769|NCT00683098|inguinal pain|inguinal pain
5654770|NCT00683098|questionnaire|questionnaire
5654771|NCT00683085|cancer|cancer
5654772|NCT00683085|pancreas|pancreas
5654773|NCT00683085|advanced|advanced
5654774|NCT00683085|peptide|peptide
5654775|NCT00683085|vaccination|vaccination
5654776|NCT00683085|VEGFR1|vegfr1
5654777|NCT00683085|HLA|hla
5654778|NCT00683085|gemcitabine|gemcitabine
5654779|NCT00683085|IFA|ifa
5654780|NCT00683085|Cancer of Pancreas|cancer of pancreas
5654781|NCT00683085|Neoplasms, Pancreas|neoplasms, pancreas
5654782|NCT00683085|Pancreas Cancer|pancreas cancer
5654783|NCT00683072|Ventilator|ventilator
5654784|NCT00683072|patient-ventilator asynchrony|patient-ventilator asynchrony
5654785|NCT00683046|Relapsed or refractory acute myelogenous or lymphoid leukemia.|relapsed or refractory acute myelogenous or lymphoid leukemia.
5654786|NCT00683046|Acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.Chronic myelogenous leukemia in accelerated phase or blast-crisis.|acute myeloid or lymphocytic leukemia in first remission at high-risk for recurrence.chronic myelogenous leukemia in accelerated phase or blast-crisis.
5654787|NCT00683046|Chronic myelogenous leukemia in chronic phase|chronic myelogenous leukemia in chronic phase
5654788|NCT00683046|Chronic myelogenous leukemia in accelerated phase or blast-crisis|chronic myelogenous leukemia in accelerated phase or blast-crisis
5654789|NCT00683046|Recurrent or refractory malignant lymphoma or Hodgkin's disease.|recurrent or refractory malignant lymphoma or hodgkin's disease.
5654790|NCT00683046|Chronic lymphocytic leukemia, relapsed or with poor prognostic features.|chronic lymphocytic leukemia, relapsed or with poor prognostic features.
5654791|NCT00683046|Myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.|myeloproliferative disorder (polycythemia vera, myelofibrosis) with poor prognostic features.
5654792|NCT00683046|Severe aplastic anemia after failure of immunosuppressive therapy.|severe aplastic anemia after failure of immunosuppressive therapy.
5654793|NCT00683046|Myelodysplastic syndromes (including PNH)|myelodysplastic syndromes (including pnh)
5654997|NCT00682201|Blood pressure|blood pressure
5654794|NCT00683046|Multiple myeloma at high risk for disease recurrence.|multiple myeloma at high risk for disease recurrence.
5654796|NCT00683033|Cigarette Smoking Cessation|cigarette smoking cessation
5654797|NCT00683033|Substance Abusers|substance abusers
5654798|NCT00683020|Chronic Diseases|chronic diseases
5654799|NCT00683020|Diabetes|diabetes
5654800|NCT00683020|Vulnerable population|vulnerable population
5654801|NCT00683020|Urban populations|urban populations
5654802|NCT00683020|Disease Management|disease management
5654803|NCT00683020|Health Information Technology|health information technology
5654804|NCT00683020|Safety|safety
5654805|NCT00683020|Health Literacy|health literacy
5654806|NCT00683020|Level of English Proficiency|level of english proficiency
5654807|NCT00683007|TE echo|te echo
5654808|NCT00683007|hemodilution|hemodilution
5654809|NCT00683007|hypertonic|hypertonic
5654810|NCT00683007|saline|saline
5654811|NCT00683007|Arterial Pressure Cardiac Output|arterial pressure cardiac output
5654812|NCT00682994|Advanced Cancer|advanced cancer
5654813|NCT00682994|Family Member|family member
5654814|NCT00682994|Palliative Care|palliative care
5654815|NCT00682994|Decision Making|decision making
5654816|NCT00682994|Information Disclosure|information disclosure
5654817|NCT00682994|Interview|interview
5654818|NCT00682994|Survey|survey
5654819|NCT00682994|Questionnaire|questionnaire
5654820|NCT00682981|ES-SCLC|es-sclc
5654821|NCT00682981|Obatoclax|obatoclax
5654822|NCT00682968|patient non-adherence|patient non-adherence
5654823|NCT00682968|antihypertensive agents|antihypertensive agents
5654824|NCT00682968|hypertension|hypertension
5654825|NCT00682955|Diarrhea|diarrhea
5654826|NCT00682955|Zinc Sulphate|zinc sulphate
5654827|NCT00682955|Efficacy|efficacy
5654828|NCT00682929|cannabis|cannabis
5654829|NCT00682929|marijuana|marijuana
5648058|NCT00710593|HPV vaccine|hpv vaccine
5654830|NCT00682929|Multiple Sclerosis|multiple sclerosis
5654831|NCT00682929|spasticity|spasticity
5654832|NCT00682916|Obesity|obesity
5654833|NCT00682916|Diabetes|diabetes
5654834|NCT00682916|Soluble Fiber|soluble fiber
5654835|NCT00682916|Overweight|overweight
5654836|NCT00682903|glucose|glucose
5654837|NCT00682903|diabetes|diabetes
5654838|NCT00682903|glycemia|glycemia
5654839|NCT00682877|gastroparesis|gastroparesis
5654840|NCT00682877|Digestive|digestive
5654841|NCT00682877|Gastrointestinal|gastrointestinal
5654842|NCT00682877|Stomach|stomach
5654843|NCT00682877|Motility|motility
5654844|NCT00682877|Non-Invasive|non-invasive
5654845|NCT00682877|Capsule|capsule
5654847|NCT00682877|Device|device
5654848|NCT00682877|Digestive System Diseases|digestive system diseases
5654849|NCT00682838|Treatment compliance|treatment compliance
5654850|NCT00682838|Self-management|self-management
5654851|NCT00682838|Telemedicine|telemedicine
5654852|NCT00682825|Anesthesia|anesthesia
5654853|NCT00682825|Awareness|awareness
5654854|NCT00682825|Bispectral|bispectral
5654856|NCT00682825|Recall|recall
5654857|NCT00682799|RC|rc
5654858|NCT00682799|RIC|ric
5654859|NCT00682799|MDS|mds
5654860|NCT00682799|SCT|sct
5654861|NCT00682786|rectal|rectal
5654862|NCT00682786|rectum|rectum
5654863|NCT00682786|cancer|cancer
5654864|NCT00682786|carcinoma|carcinoma
5654865|NCT00682760|Botulinum Toxin Type A|botulinum toxin type a
5654866|NCT00682760|Blepharospasm|blepharospasm
5654867|NCT00682747|xerostomia|xerostomia
5654868|NCT00682747|hyperbaric oxygenation|hyperbaric oxygenation
5654869|NCT00682747|radiotherapy|radiotherapy
5654870|NCT00682721|Bacterial Vaginosis|bacterial vaginosis
5654871|NCT00682721|Herpes Simplex Virus Type II|herpes simplex virus type ii
5654872|NCT00682708|malnutrition|malnutrition
5654873|NCT00682708|ready to use food|ready to use food
5654874|NCT00682708|Niger|niger
5654875|NCT00682695|stroke|stroke
5654876|NCT00682695|brain attack|brain attack
5654877|NCT00682695|hemorrhagic stroke|hemorrhagic stroke
5654878|NCT00682695|risk factors|risk factors
5654879|NCT00682682|Pain distraction|pain distraction
5654880|NCT00682682|Analgesic interventions|analgesic interventions
5654881|NCT00682682|Burn patients|burn patients
5654882|NCT00682669|Asthma|asthma
5654883|NCT00682669|Mindfulness-based stress reduction|mindfulness-based stress reduction
5654884|NCT00682669|Peak expiratory flow rate|peak expiratory flow rate
5654885|NCT00682669|Spirometry|spirometry
5654886|NCT00682669|Quality of life|quality of life
5654887|NCT00682656|cutaneous leishmaniasis|cutaneous leishmaniasis
5654888|NCT00682656|azithromycin|azithromycin
5654889|NCT00682656|N- methyl glucamine|n- methyl glucamine
5654890|NCT00682643|Perennial Allergic Rhinitis|perennial allergic rhinitis
5654891|NCT00682643|fluticasone furoate|fluticasone furoate
5654892|NCT00682643|ocular safety|ocular safety
5654893|NCT00682630|Malaria|malaria
5654894|NCT00682630|anti-malarial|anti-malarial
5654895|NCT00682630|pyronaridine|pyronaridine
5654896|NCT00682630|ACT|act
5654897|NCT00682617|hip|hip
5654898|NCT00682617|osteoarthritis|osteoarthritis
5654899|NCT00682617|exercise|exercise
5654900|NCT00682617|disability|disability
5654901|NCT00682617|physical function|physical function
5654998|NCT00682201|Cardiac output|cardiac output
5654902|NCT00682604|Family Health Program; Food consumption; Nutritional status|family health program; food consumption; nutritional status
5654903|NCT00682591|hepatitis C|hepatitis c
5654904|NCT00682591|drug substitution|drug substitution
5654905|NCT00682591|neurocognitive|neurocognitive
5654906|NCT00682591|patients with stable drug substitution therapy|patients with stable drug substitution therapy
5654907|NCT00682591|patients with interferon-based antiviral therapy|patients with interferon-based antiviral therapy
5654908|NCT00682578|falciparum malaria|falciparum malaria
5654909|NCT00682578|vivax malaria|vivax malaria
5654910|NCT00682578|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5654911|NCT00682539|diabetic retinopathy|diabetic retinopathy
5654912|NCT00682539|macular edema|macular edema
5654913|NCT00682539|intravitreal Avastin/ Triamcinolone / Lucentis|intravitreal avastin/ triamcinolone / lucentis
5654914|NCT00682526|EMS patients with intention to treat with coronary reperfusion therapy (PCI or thrombolytics) based on their initial presentation|ems patients with intention to treat with coronary reperfusion therapy (pci or thrombolytics) based on their initial presentation
5654915|NCT00682513|dystonia|dystonia
5654916|NCT00682513|parkinsonism|parkinsonism
5654917|NCT00682513|rapid-onset dystonia-parkinsonism|rapid-onset dystonia-parkinsonism
5654919|NCT00682513|Alternating Hemiplegia of Childhood|alternating hemiplegia of childhood
5654920|NCT00682513|AHC|ahc
5844118|NCT00050791|Fat|fat
5654921|NCT00682500|Pneumonia|pneumonia
5654922|NCT00682500|Aspiration|aspiration
5654923|NCT00682500|Drowning|drowning
5654924|NCT00682500|inhalation|inhalation
5654925|NCT00682487|Myocardial infarction|myocardial infarction
5654926|NCT00682487|Stress|stress
5654927|NCT00682487|Hair Cortisol|hair cortisol
5654928|NCT00682474|Cigarette smoking|cigarette smoking
5654929|NCT00682474|Nicotine dependence|nicotine dependence
5654930|NCT00682474|Adolescents|adolescents
5654936|NCT00682448|Zyprexa|zyprexa
5654937|NCT00682448|Weight Gain|weight gain
5654938|NCT00682448|Antipsychotics|antipsychotics
5654939|NCT00682448|Metformin|metformin
5654940|NCT00682448|Glucophage|glucophage
5654941|NCT00682448|Bipolar Disorder|bipolar disorder
5654942|NCT00682448|Schizophrenia|schizophrenia
5654943|NCT00682448|Depression|depression
5654944|NCT00682448|Diabetes|diabetes
5654945|NCT00682448|Side effects|side effects
5654946|NCT00682448|Metabolic complications|metabolic complications
5654947|NCT00682448|Prevention|prevention
5654948|NCT00682448|Treatment|treatment
5654949|NCT00682448|Metabolic side effects of olanzapine|metabolic side effects of olanzapine
5654950|NCT00682435|Nonelderly patients with acute moderate to severe pain|nonelderly patients with acute moderate to severe pain
5654951|NCT00682422|pediatrics, overweight, obese, behavioral intervention|pediatrics, overweight, obese, behavioral intervention
5654952|NCT00682383|Advanced NSCLC|advanced nsclc
5654953|NCT00682383|Lung Cancer|lung cancer
5654954|NCT00682383|Mount Sinai Medical Center CCOP|mount sinai medical center ccop
5654955|NCT00682357|Osteoarthritis, intra articular steroids|osteoarthritis, intra articular steroids
5654956|NCT00682318|Fish oil|fish oil
5654957|NCT00682318|red wine|red wine
5654958|NCT00682318|alcohol|alcohol
5654959|NCT00682318|oxidative stress|oxidative stress
5654960|NCT00682318|Healthy volunteers|healthy volunteers
5654961|NCT00682305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5654962|NCT00682305|Hematopoeitic Stem Cell Transplantation|hematopoeitic stem cell transplantation
5654963|NCT00682292|Renal transplantation|renal transplantation
5654964|NCT00682292|Immunisation|immunisation
5654965|NCT00682292|Acute rejection|acute rejection
5654966|NCT00682292|Induction therapy|induction therapy
5654967|NCT00682292|Thymoglobulin|thymoglobulin
5654968|NCT00682292|Daclizumab|daclizumab
5654969|NCT00682292|Rejection in sensitized renal transplant recipients|rejection in sensitized renal transplant recipients
5654970|NCT00682279|lapatinib|lapatinib
5654971|NCT00682279|GW572016|gw572016
5654972|NCT00682279|topotecan|topotecan
5654973|NCT00682279|oral topotecan|oral topotecan
5654974|NCT00682279|SK&F-104864|sk&f-104864
5654975|NCT00682279|EGFR|egfr
5654976|NCT00682279|ErbB1|erbb1
5654977|NCT00682279|HER-2/neu|her-2/neu
5654978|NCT00682279|ErbB2|erbb2
5654979|NCT00682279|BCRP|bcrp
5654980|NCT00682266|Adolescent|adolescent
5654981|NCT00682266|Overweight|overweight
5654982|NCT00682266|Exercise|exercise
5654983|NCT00682266|multidisciplinary approach|multidisciplinary approach
5654984|NCT00682266|Oxygen uptake|oxygen uptake
5654985|NCT00682266|Flow mediated dilatation|flow mediated dilatation
5654986|NCT00682266|Cardiovascular Risk Factors|cardiovascular risk factors
5654987|NCT00682253|SPECT/CT|spect/ct
5654988|NCT00682253|MRI|mri
5654989|NCT00682253|Breast neoplasms|breast neoplasms
5654990|NCT00682240|retinal morphology|retinal morphology
5654991|NCT00682240|laser treatment|laser treatment
5654992|NCT00682240|pascal laser|pascal laser
5654993|NCT00682240|HD-OCT|hd-oct
5654994|NCT00682227|Epitope peptide, CTL, Esophageal cancer, Vaccination|epitope peptide, ctl, esophageal cancer, vaccination
5654995|NCT00682214|25(OH)D, muscle strength|25(oh)d, muscle strength
5655000|NCT00682188|Obesity|obesity
5655001|NCT00682188|Adolescents|adolescents
5655002|NCT00682188|Youth|youth
5655003|NCT00682188|School health|school health
5655004|NCT00682188|Randomized controlled trial|randomized controlled trial
5655005|NCT00682188|Intervention study|intervention study
5655006|NCT00682175|Congestive Heart Failure|congestive heart failure
5655007|NCT00682162|acupuncture|acupuncture
5655008|NCT00682162|randomised controlled trial|randomised controlled trial
5655009|NCT00682162|placebo|placebo
5655010|NCT00682162|sham laser|sham laser
5655011|NCT00682162|vasomotor rhinitis|vasomotor rhinitis
5655012|NCT00682149|Oxidative stress|oxidative stress
5655013|NCT00682149|malondialdehyde|malondialdehyde
5655014|NCT00682149|glutathione|glutathione
5655015|NCT00682149|diabetes|diabetes
5655016|NCT00682149|polyphenol containing antioxidants|polyphenol containing antioxidants
5655017|NCT00682149|diet rich in vegetables|diet rich in vegetables
5655018|NCT00682149|weekly aerobic exercise|weekly aerobic exercise
5655019|NCT00682136|postoperative analgesia|postoperative analgesia
5655020|NCT00682136|abdominal surgery|abdominal surgery
5655021|NCT00682136|ropivacaine|ropivacaine
5655022|NCT00682136|local anaesthesia|local anaesthesia
5655023|NCT00682136|tap block|tap block
5655024|NCT00682136|pain management|pain management
5655025|NCT00682123|19-norandrostenedione|19-norandrostenedione
5655026|NCT00682123|steroids|steroids
5655027|NCT00682123|drugs in sport|drugs in sport
5655028|NCT00682123|World Anti-Doping Agency|world anti-doping agency
5655030|NCT00682110|Hemodynamic measurements|hemodynamic measurements
5636169|NCT00753532|stroke|stroke
5655031|NCT00682110|Hyperdynamic circulation|hyperdynamic circulation
5655032|NCT00682110|Pulmonary artery catheter|pulmonary artery catheter
5655033|NCT00682110|Cardiac output|cardiac output
5655034|NCT00682084|Cushing's syndrome|cushing's syndrome
5655035|NCT00682084|Glucose tolerance|glucose tolerance
5655036|NCT00682084|Insulin sensitivity|insulin sensitivity
5655037|NCT00682084|Substrate metabolism|substrate metabolism
5655038|NCT00682084|Body composition|body composition
5655039|NCT00682071|Ultrasound-guided|ultrasound-guided
5655040|NCT00682071|embryo transfer|embryo transfer
5655041|NCT00682071|in-vitro fertilization|in-vitro fertilization
5655042|NCT00682058|body composition|body composition
5655043|NCT00682058|weight loss|weight loss
5655045|NCT00682058|fat distribution|fat distribution
5655046|NCT00682058|fat free mass|fat free mass
5655047|NCT00682058|organ|organ
5655048|NCT00682058|resting energy expenditure|resting energy expenditure
5655049|NCT00682045|tuberculosis|tuberculosis
5655050|NCT00682045|transplantation|transplantation
5655051|NCT00682032|NSCLC|nsclc
5655052|NCT00682019|Erectile Dysfunction|erectile dysfunction
5655053|NCT00682019|Vardenafil|vardenafil
5655054|NCT00682006|Omphalitis|omphalitis
5655055|NCT00682006|4% Chlorhexidine|4% chlorhexidine
5655056|NCT00682006|Newborns|newborns
5655057|NCT00681993|cosmetic|cosmetic
5655058|NCT00681993|effect|effect
5655059|NCT00681993|breast|breast
5655060|NCT00681993|irradiation|irradiation
5655061|NCT00681993|concurrent|concurrent
5655062|NCT00681993|chemotherapy|chemotherapy
5655063|NCT00681993|potential acute|potential acute
5655064|NCT00681993|late skin|late skin
5655065|NCT00681993|subcutaneous toxicities|subcutaneous toxicities
5655066|NCT00681980|TSP/HAM, HTLV-1, treatment|tsp/ham, htlv-1, treatment
5655067|NCT00681967|squamous cell cancer of the head & neck|squamous cell cancer of the head & neck
5655068|NCT00681967|Gefitinib|gefitinib
5655069|NCT00681967|IRESSA|iressa
5655070|NCT00681967|EGFR Inhibitor|egfr inhibitor
5655071|NCT00681967|EGFR-tyrosine kinase inhibitor|egfr-tyrosine kinase inhibitor
5655072|NCT00681967|Subjects with histologically proven squamous cell cancer of the head & neck|subjects with histologically proven squamous cell cancer of the head & neck
5655073|NCT00681967|Cohort 1:qualifying for postoperative radiotherapy|cohort 1:qualifying for postoperative radiotherapy
5655074|NCT00681967|(pT3, pT4, pN2b, pN2c, pN3).|(pt3, pt4, pn2b, pn2c, pn3).
5655075|NCT00681967|Cohort 2:qualifying for definite chemoradiotherapy|cohort 2:qualifying for definite chemoradiotherapy
5655076|NCT00681967|(Lateral oropharynx, tonsils: T1N2b-3, T2N1-3, T3any N;|(lateral oropharynx, tonsils: t1n2b-3, t2n1-3, t3any n;
5655077|NCT00681967|Base of tongue, vallecula: T1N1-3, T2-4 any N; Oral cavity,|base of tongue, vallecula: t1n1-3, t2-4 any n; oral cavity,
5655078|NCT00681967|glottic and supraglottic larynx; Any TN1-3, T3-4 any N;|glottic and supraglottic larynx; any tn1-3, t3-4 any n;
5655079|NCT00681967|Hypopharynx: T1N1-3, T2-4 and N)|hypopharynx: t1n1-3, t2-4 and n)
5655080|NCT00681954|TRALI|trali
5655081|NCT00681954|Randomized Autologous Transfusion|randomized autologous transfusion
5655082|NCT00681954|Intra-Operative Testing of Pulmonary Function|intra-operative testing of pulmonary function
5655083|NCT00681928|stage I breast cancer|stage i breast cancer
5655084|NCT00681928|stage II breast cancer|stage ii breast cancer
5655085|NCT00681928|stage IIIA breast cancer|stage iiia breast cancer
5655086|NCT00681928|stage IIIB breast cancer|stage iiib breast cancer
5655087|NCT00681928|stage IIIC breast cancer|stage iiic breast cancer
5655088|NCT00681915|Phase I|phase i
5655089|NCT00681915|Pharmacokinetics|pharmacokinetics
5655090|NCT00681902|Pediatric|pediatric
5655091|NCT00681902|Pain|pain
5655092|NCT00681902|Needle|needle
5655093|NCT00681902|Emergency|emergency
5655094|NCT00681902|Phlebotomy|phlebotomy
5655095|NCT00681902|Intravenous|intravenous
5655096|NCT00681902|Lidocaine|lidocaine
5655097|NCT00681902|Local|local
5655098|NCT00681902|Anesthesia|anesthesia
5655099|NCT00681876|Metastatic colorectal cancer|metastatic colorectal cancer
5655100|NCT00681876|Second line|second line
5655101|NCT00681876|Irinotecan|irinotecan
5655102|NCT00681876|Erbitux (Cetuximab)|erbitux (cetuximab)
5655103|NCT00681876|Avastin (Bevacizumab)|avastin (bevacizumab)
5655104|NCT00681850|Diabetes|diabetes
5655105|NCT00681850|Benchmarking|benchmarking
5655106|NCT00681850|quality of patient care|quality of patient care
5655107|NCT00681850|Diabetic Population|diabetic population
5655108|NCT00681837|gastroesophageal reflux|gastroesophageal reflux
5655109|NCT00681837|prevalence|prevalence
5655110|NCT00681837|childhood|childhood
5655111|NCT00681837|France|france
5655112|NCT00681811|Metazyme|metazyme
5655113|NCT00681811|Late Infantile Metachromatic Leukodystrophy|late infantile metachromatic leukodystrophy
5655114|NCT00681798|pancreatic cancer|pancreatic cancer
5655115|NCT00681798|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5655116|NCT00681798|pancreas cancer|pancreas cancer
5655117|NCT00681798|dose escalation study|dose escalation study
5655118|NCT00681798|locally advanced unresectable pancreatic adenocarcinoma|locally advanced unresectable pancreatic adenocarcinoma
5655119|NCT00681798|Zactima|zactima
5655120|NCT00681798|Vandetanib|vandetanib
5655122|NCT00681785|thrombophylaxis and transurethral surgery|thrombophylaxis and transurethral surgery
5655123|NCT00681772|Erectile Dysfunction|erectile dysfunction
5655124|NCT00681772|Vardenafil|vardenafil
5655125|NCT00681759|Low Dose Aspirin (LDA)|low dose aspirin (lda)
5655126|NCT00681759|Cardiovascular disease|cardiovascular disease
5655127|NCT00681759|Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease|low dose aspirin (lda) use in in subjects with cardiovascular risk or disease
5655128|NCT00681746|Anxiety|anxiety
5655129|NCT00681746|GABA receptors|gaba receptors
5655130|NCT00681746|Positron Emission Tomography|positron emission tomography
5655131|NCT00681746|PET|pet
5655132|NCT00681746|phase I|phase i
5655133|NCT00681733|NASH Pentoxifylline Pioglitazone|nash pentoxifylline pioglitazone
5655134|NCT00681720|Anxiety|anxiety
5655135|NCT00681720|GABA receptors|gaba receptors
5655136|NCT00681720|Positron Emission Tomography|positron emission tomography
5655137|NCT00681720|PET|pet
5655138|NCT00681720|phase I|phase i
5655139|NCT00681707|Hypertension|hypertension
5655140|NCT00681707|Post stroke|post stroke
5655141|NCT00681707|JNC7|jnc7
5655142|NCT00681707|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5655143|NCT00681707|survey|survey
5655144|NCT00681694|brachytherapy|brachytherapy
5655145|NCT00681694|radioactive seed implants|radioactive seed implants
5655146|NCT00681681|stroke|stroke
5655147|NCT00681681|vascular marker|vascular marker
5655148|NCT00681681|stroke risk|stroke risk
5655149|NCT00681681|risk factors|risk factors
5655150|NCT00681681|sex differences|sex differences
5655151|NCT00681668|Postpartum Depression|postpartum depression
5655152|NCT00681668|Quetiapine|quetiapine
5655153|NCT00681668|Psychotic Symptoms|psychotic symptoms
5655154|NCT00681642|Corneal epithelial wound|corneal epithelial wound
5655155|NCT00681642|Human autoserum|human autoserum
5655156|NCT00681642|Cord blood|cord blood
5655157|NCT00681629|Schizophrenia|schizophrenia
5655158|NCT00681629|Integrated Care|integrated care
5655159|NCT00681629|Quetiapine|quetiapine
5655160|NCT00681616|Anterior compartment syndrome|anterior compartment syndrome
5655161|NCT00681616|Tibia|tibia
5655162|NCT00681616|Trauma|trauma
5655163|NCT00681616|Blood circulation|blood circulation
5655164|NCT00681616|Nerve compression syndromes|nerve compression syndromes
5655165|NCT00681603|corneal neovascularization|corneal neovascularization
5655166|NCT00681603|lipid keratopathy|lipid keratopathy
5655167|NCT00681603|penetrating keratopathy|penetrating keratopathy
5655168|NCT00681603|bevacizumab|bevacizumab
5655169|NCT00681603|Avastin|avastin
5655170|NCT00681603|subconjunctival injection|subconjunctival injection
5655171|NCT00681590|vitamin D|vitamin d
5655172|NCT00681590|deficiency|deficiency
5655173|NCT00681590|elderly|elderly
5655174|NCT00681577|Peptide Vaccine|peptide vaccine
5655175|NCT00681577|URLC10|urlc10
5655176|NCT00681577|KOC1|koc1
5655177|NCT00681577|VEGFR1|vegfr1
5655178|NCT00681577|VEGFR2|vegfr2
5655179|NCT00681564|Periodontitis|periodontitis
5655180|NCT00681564|Oral health|oral health
5655181|NCT00681564|Cardiovascular disease|cardiovascular disease
5655182|NCT00681551|Detection of brain metastasis by MRI|detection of brain metastasis by mri
5655183|NCT00681551|Magnevist|magnevist
5655184|NCT00681551|Brain metastasis|brain metastasis
5655185|NCT00681551|Meglumine gadopentetate|meglumine gadopentetate
5655186|NCT00681538|Spasticity|spasticity
5655187|NCT00681538|Multiple Sclerosis|multiple sclerosis
5655188|NCT00681512|NSCLC|nsclc
5655189|NCT00681512|lung cancer|lung cancer
5655190|NCT00681512|non small cell lung cancer|non small cell lung cancer
5655191|NCT00681512|lung carcinoma|lung carcinoma
5655192|NCT00681499|Quality of Life|quality of life
5655193|NCT00681499|Liver Neoplasms|liver neoplasms
5655194|NCT00681499|Surgical procedures, Operative|surgical procedures, operative
5655195|NCT00681486|Ghrelin|ghrelin
5655196|NCT00681486|Nutrition|nutrition
5655197|NCT00681486|Cancer patients|cancer patients
5655198|NCT00681486|Survival|survival
5655199|NCT00681473|proton radiation therapy|proton radiation therapy
5655200|NCT00681473|photon radiation therapy|photon radiation therapy
5655201|NCT00681460|gestational diabetes|gestational diabetes
5655202|NCT00681460|birth weight|birth weight
5655203|NCT00681460|fetal growth|fetal growth
5655204|NCT00681460|insulin resistance|insulin resistance
5655205|NCT00681460|oxidative stress|oxidative stress
5655206|NCT00681460|inflammatory reaction|inflammatory reaction
5655207|NCT00681460|Fetal Development|fetal development
5655208|NCT00681447|lumbar disc herniation|lumbar disc herniation
5655209|NCT00681447|discogenic pain|discogenic pain
5655210|NCT00681447|lumbar interlaminar epidural|lumbar interlaminar epidural
5655211|NCT00681447|injections|injections
5655212|NCT00681434|stroke|stroke
5655213|NCT00681434|upper extremity|upper extremity
5655214|NCT00681434|hemiparesis|hemiparesis
5655215|NCT00681421|Peptide Vaccine|peptide vaccine
5655216|NCT00681421|URLC10|urlc10
5655217|NCT00681421|VEGFR1|vegfr1
5655218|NCT00681421|VEGFR2|vegfr2
5655219|NCT00681408|Steatohepatitis|steatohepatitis
5655220|NCT00681408|NASH|nash
5655221|NCT00681408|NAFLD|nafld
5655222|NCT00681408|omega 3 fatty acids|omega 3 fatty acids
5655230|NCT00681369|fulvestrant|fulvestrant
5655231|NCT00681369|longitudinal study|longitudinal study
5655232|NCT00681369|France|france
5655233|NCT00681356|TKA|tka
5655234|NCT00681356|Total knee arthroplasty|total knee arthroplasty
5655235|NCT00681356|Total knee replacement|total knee replacement
5655236|NCT00681356|Knee surgery|knee surgery
5655237|NCT00681343|Randomized|randomized
5655238|NCT00681343|study|study
5655239|NCT00681343|effectiveness/toxicity|effectiveness/toxicity
5655240|NCT00681343|induction therapy|induction therapy
5655241|NCT00681343|recipients|recipients
5655242|NCT00681330|Peptide Vaccine|peptide vaccine
5655243|NCT00681330|URLC10|urlc10
5655245|NCT00681330|KOC1|koc1
5655246|NCT00681317|Phase I|phase i
5655247|NCT00681317|Pharmacokinetics|pharmacokinetics
5655248|NCT00681304|Resected Breast Cancer|resected breast cancer
5655249|NCT00681304|Breast Cancer|breast cancer
5655250|NCT00681291|surgical mesh|surgical mesh
5655251|NCT00681291|inguinal hernia repair|inguinal hernia repair
5655252|NCT00681291|chronic groin pain|chronic groin pain
5655253|NCT00681278|Hypertension|hypertension
5655254|NCT00681278|Type II DM|type ii dm
5655255|NCT00681278|JNC7|jnc7
5655256|NCT00681278|2007 ESH-ESC guidelines|2007 esh-esc guidelines
5655257|NCT00681278|survey|survey
5655258|NCT00681265|ocular lubricants|ocular lubricants
5655259|NCT00681252|Peptide Vaccine|peptide vaccine
5655260|NCT00681252|URLC10|urlc10
5655261|NCT00681252|VEGFR1|vegfr1
5655262|NCT00681252|VEGFR2|vegfr2
5655263|NCT00681239|childhood|childhood
5655264|NCT00681239|epilepsy|epilepsy
5655265|NCT00681239|intractable|intractable
5655266|NCT00681239|seizures|seizures
5655267|NCT00681239|Atkins|atkins
5655268|NCT00681239|ketogenic|ketogenic
5655269|NCT00681226|peripheral arterial disease|peripheral arterial disease
5655270|NCT00681226|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5655271|NCT00681226|exercise|exercise
5655272|NCT00681200|Blood Pressure Reduction|blood pressure reduction
5655273|NCT00681200|Stress Reactivity and Recovery|stress reactivity and recovery
5655274|NCT00681200|Meditation|meditation
5655275|NCT00681200|Transcendental Meditation|transcendental meditation
5655276|NCT00681200|Stress Reduction|stress reduction
5655277|NCT00681200|Stress Management|stress management
5655278|NCT00681174|Care, Postoperative|care, postoperative
5655279|NCT00681174|Analgesia|analgesia
5655280|NCT00681174|Analgesics, Opioid|analgesics, opioid
5655281|NCT00681174|Morphine|morphine
5655282|NCT00681174|Remifentanil|remifentanil
5655283|NCT00681174|Oxycodone|oxycodone
5655284|NCT00681174|Anesthesia, Regional|anesthesia, regional
5655285|NCT00681174|Anesthesia, Intravenous|anesthesia, intravenous
5655286|NCT00681174|Preanesthetic Medication|preanesthetic medication
5655287|NCT00681174|Analgesia, Patient-Controlled|analgesia, patient-controlled
5655288|NCT00681161|obstructive sleep apnea|obstructive sleep apnea
5655289|NCT00681161|OSA|osa
5655290|NCT00681161|diabetes|diabetes
5655291|NCT00681161|pre-diabetic condition|pre-diabetic condition
5655292|NCT00681161|obesity|obesity
5655293|NCT00681161|blood glucose|blood glucose
5655294|NCT00681161|continuous positive airway pressure|continuous positive airway pressure
5655295|NCT00681161|CPAP|cpap
5655296|NCT00681148|Prostate specific antigen (PSA)|prostate specific antigen (psa)
5655297|NCT00681148|Prostate cancer|prostate cancer
5655298|NCT00681148|Lower urinary tract symptoms|lower urinary tract symptoms
5655299|NCT00681148|Radioactive seed implantation|radioactive seed implantation
5655301|NCT00681135|toothbrush|toothbrush
5655302|NCT00681135|interdental brush|interdental brush
5655303|NCT00681135|oral hygiene|oral hygiene
5655304|NCT00681122|Breast Cancer|breast cancer
5655305|NCT00681122|hormone therapy|hormone therapy
5655306|NCT00681122|aromatase inhibitor|aromatase inhibitor
5655307|NCT00681096|Low back pain in nurses|low back pain in nurses
5655308|NCT00681083|Obstructive Sleep Apnea|obstructive sleep apnea
5655309|NCT00681083|Humidification|humidification
5655310|NCT00681083|Continuous Positive Airway Pressure|continuous positive airway pressure
5655311|NCT00681070|laceration|laceration
5655312|NCT00681070|wound management|wound management
5655313|NCT00681070|absorbable sutures|absorbable sutures
5655314|NCT00681070|cosmetic outcomes|cosmetic outcomes
5655315|NCT00681044|monoclonal immunoglobulin deposition disease|monoclonal immunoglobulin deposition disease
5655316|NCT00681044|light chain deposition disease|light chain deposition disease
5655317|NCT00681018|premature|premature
5655319|NCT00681005|PPI test|ppi test
5655320|NCT00681005|gastroesophageal reflux disease|gastroesophageal reflux disease
5655321|NCT00681005|CYP2C19|cyp2c19
5655322|NCT00681005|rabeprazole|rabeprazole
5655323|NCT00681005|pantoprazole|pantoprazole
5655324|NCT00680992|Giant Cell Tumor of Bone|giant cell tumor of bone
5655325|NCT00680979|Prevention|prevention
5655326|NCT00680979|Obesity|obesity
5655327|NCT00680979|Binge Eating|binge eating
5655328|NCT00680979|Adolescents|adolescents
5655329|NCT00680979|Overweight|overweight
5655330|NCT00680979|Weight Gain|weight gain
5655331|NCT00680966|Treatment efficacy|treatment efficacy
5655332|NCT00680966|Family therapy|family therapy
5655333|NCT00680966|Teens|teens
5655334|NCT00680966|Substance abuse|substance abuse
5655335|NCT00680966|Substance dependence|substance dependence
5655336|NCT00680940|NSCLC|nsclc
5655337|NCT00680927|Atrial Fibrillation|atrial fibrillation
5655338|NCT00680927|Risk of cardiac arrhythmias|risk of cardiac arrhythmias
5655339|NCT00680927|Loop recorder|loop recorder
5655340|NCT00680914|Streptococcus pneumoniae|streptococcus pneumoniae
5655341|NCT00680914|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5655342|NCT00680901|unresectable|unresectable
5655344|NCT00680901|TYVERB|tyverb
5655345|NCT00680901|ErbB2|erbb2
5655346|NCT00680901|TYKERB|tykerb
5655347|NCT00680901|capecitabine|capecitabine
5655348|NCT00680901|CapeOx|capeox
5655349|NCT00680901|gastric/esophageal cancer|gastric/esophageal cancer
5655350|NCT00680901|GE junction|ge junction
5655351|NCT00680901|metastatic|metastatic
5655352|NCT00680901|lapatinib|lapatinib
5655353|NCT00680901|oxaliplatin|oxaliplatin
5655354|NCT00680888|Psychosis|psychosis
5655355|NCT00680888|adolescents|adolescents
5655356|NCT00680888|adherence|adherence
5655357|NCT00680888|quetiapine|quetiapine
5655358|NCT00680875|School Based Services|school based services
5655359|NCT00680875|Prevention|prevention
5655360|NCT00680875|Children|children
5655362|NCT00680862|screening|screening
5655363|NCT00680849|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5655364|NCT00680849|Coronary Disease|coronary disease
5655365|NCT00680836|Irritable Bowel Syndrome|irritable bowel syndrome
5655366|NCT00680836|Diarrhea|diarrhea
5655367|NCT00680836|Gulf War|gulf war
5655368|NCT00680836|Veterans|veterans
5655369|NCT00680836|Small intestinal bacterial overgrowth (SIBO)|small intestinal bacterial overgrowth (sibo)
5655370|NCT00680823|Headache|headache
5655371|NCT00680823|Migraine|migraine
5655372|NCT00680823|Ropivacaine|ropivacaine
5655373|NCT00680797|Aging|aging
5655374|NCT00680797|Hormones|hormones
5655375|NCT00680797|Insulin resistance|insulin resistance
5655376|NCT00680784|sprain|sprain
5655377|NCT00680784|ankle|ankle
5655378|NCT00680784|pain|pain
5655379|NCT00680771|Primary Insomnia|primary insomnia
5655380|NCT00680771|Insomnia|insomnia
5655381|NCT00680771|Good Sleepers|good sleepers
5655382|NCT00680771|Hep B|hep b
5655383|NCT00680771|Vaccine|vaccine
5655384|NCT00680758|male breast cancer|male breast cancer
5655385|NCT00680758|stage IV breast cancer|stage iv breast cancer
5655386|NCT00680745|Dapagliflozin|dapagliflozin
5655387|NCT00680745|efficacy|efficacy
5655388|NCT00680745|safety|safety
5655389|NCT00680745|sulphonylurea|sulphonylurea
5655390|NCT00680745|Type 2 diabetes|type 2 diabetes
5655391|NCT00680732|Malaria|malaria
5655392|NCT00680732|Pregnancy|pregnancy
5655393|NCT00680732|Prevention|prevention
5655394|NCT00680732|Chloroquine|chloroquine
5655395|NCT00680732|Sulphadoxine pyrimethamine|sulphadoxine pyrimethamine
5655396|NCT00680732|Maternal anaemia|maternal anaemia
5655397|NCT00680732|Birth weight|birth weight
5655398|NCT00680732|Foetal anaemia|foetal anaemia
5655399|NCT00680719|substance abuse|substance abuse
5655400|NCT00680719|HIV risk|hiv risk
5655401|NCT00680719|Behavior and Mental Disorders|behavior and mental disorders
5655402|NCT00680719|HIV Seronegativity|hiv seronegativity
5655403|NCT00680693|IBS, functional gastrointestinal disease|ibs, functional gastrointestinal disease
5655504|NCT00680173|Chronic Hepatitis C|chronic hepatitis c
5655404|NCT00680680|Urinary retention secondary to benign prostatic hyperplasia|urinary retention secondary to benign prostatic hyperplasia
5655405|NCT00680667|ductal breast carcinoma|ductal breast carcinoma
5655406|NCT00680667|stage I breast cancer|stage i breast cancer
5655407|NCT00680667|stage II breast cancer|stage ii breast cancer
5655408|NCT00680667|stage IIIA breast cancer|stage iiia breast cancer
5655409|NCT00680667|stage IIIB breast cancer|stage iiib breast cancer
5655410|NCT00680667|stage IIIC breast cancer|stage iiic breast cancer
5655411|NCT00680667|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5655412|NCT00680667|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5655413|NCT00680654|Pulmonary hypertension|pulmonary hypertension
5655415|NCT00680641|Emphysema|emphysema
5655416|NCT00680641|Simvastatin|simvastatin
5655417|NCT00680628|Pulmonary Embolism|pulmonary embolism
5655418|NCT00680628|Tenecteplase|tenecteplase
5655419|NCT00680628|Enoxaparin|enoxaparin
5648703|NCT00708201|POI|poi
5655421|NCT00680628|Fibrinolytics|fibrinolytics
5655422|NCT00680615|Smokeless tobacco|smokeless tobacco
5655423|NCT00680602|behavior therapy|behavior therapy
5655424|NCT00680602|group therapy|group therapy
5655425|NCT00680602|psychopharmacology|psychopharmacology
5655426|NCT00680589|TYRP2 DNA Vaccine|tyrp2 dna vaccine
5655427|NCT00680576|adolescent substance abuse|adolescent substance abuse
5655428|NCT00680550|Atrial Fibrillation|atrial fibrillation
5655429|NCT00680550|Risk of cardiac Arrhythmias|risk of cardiac arrhythmias
5655430|NCT00680550|Loop recorder|loop recorder
5655431|NCT00680537|physical therapy program|physical therapy program
5655432|NCT00680524|telephone-based intervention for PTSD|telephone-based intervention for ptsd
5655433|NCT00680511|methamphetamine abuse|methamphetamine abuse
5655434|NCT00680498|Age-Related Macular Degeneration|age-related macular degeneration
5655435|NCT00680498|Ranibizumab|ranibizumab
5655436|NCT00680498|Lucentis|lucentis
5655437|NCT00680498|Photodynamic Therapy|photodynamic therapy
5655438|NCT00680498|Verteporfin|verteporfin
5655439|NCT00680498|Visudyne|visudyne
5655440|NCT00680485|GSK580416|gsk580416
5655441|NCT00680485|ketoconazole interaction|ketoconazole interaction
5655442|NCT00680485|pleuromutilin|pleuromutilin
5655443|NCT00680485|oral dose|oral dose
5655444|NCT00680472|Shoulder pain|shoulder pain
5655446|NCT00680472|Ketoprofen|ketoprofen
5655447|NCT00680472|Topical Patch|topical patch
5655448|NCT00680459|central line infection|central line infection
5655449|NCT00680459|70% ethanol|70% ethanol
5655450|NCT00680459|Sepsis|sepsis
5655451|NCT00680446|Primary Immune Deficiency|primary immune deficiency
5655452|NCT00680446|Subcutaneous|subcutaneous
5655453|NCT00680446|Immunoglobulin G|immunoglobulin g
5655454|NCT00680420|pancreas cancer|pancreas cancer
5655455|NCT00680420|pancreas cyst|pancreas cyst
5655456|NCT00680420|DNA microarray|dna microarray
5655457|NCT00680407|NASH|nash
5655458|NCT00680407|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5655459|NCT00680394|abortion|abortion
5655460|NCT00680394|medical abortion|medical abortion
5655461|NCT00680394|mifepristone|mifepristone
5655462|NCT00680394|misoprostol|misoprostol
5655463|NCT00680381|adolescent substance abuse|adolescent substance abuse
5655464|NCT00680368|Feasibility|feasibility
5655465|NCT00680368|Supervision|supervision
5655466|NCT00680368|Assessing|assessing
5655467|NCT00680355|golden rice carotenoids|golden rice carotenoids
5655468|NCT00680355|healthy volunteers|healthy volunteers
5655469|NCT00680355|retinol equivalence|retinol equivalence
5655470|NCT00680342|hepatitis C|hepatitis c
5655471|NCT00680329|Adherence|adherence
5655472|NCT00680329|Compliance|compliance
5655473|NCT00680329|Glaucoma|glaucoma
5655474|NCT00680329|Ocular Hypertension|ocular hypertension
5655475|NCT00680316|Pulmozyme|pulmozyme
5655476|NCT00680316|CF|cf
5655477|NCT00680303|Early Stuttering|early stuttering
5655478|NCT00680303|Lidcombe Program|lidcombe program
5655479|NCT00680303|Stuttering Treatment|stuttering treatment
5655480|NCT00680303|Efficiency|efficiency
5655481|NCT00680303|Efficacy|efficacy
5655482|NCT00680303|Service Delivery|service delivery
5655483|NCT00680303|Models of intervention|models of intervention
5655484|NCT00680290|exercise, quality of life, cpx|exercise, quality of life, cpx
5655485|NCT00680277|spirulina|spirulina
5655486|NCT00680277|carotenoids|carotenoids
5655487|NCT00680264|Treatment Outcomes|treatment outcomes
5655488|NCT00680264|Scoliosis|scoliosis
5655489|NCT00680264|Cerebral Palsy|cerebral palsy
5655490|NCT00680238|Pregnancy|pregnancy
5655491|NCT00680238|implantation|implantation
5655492|NCT00680238|miscarriage|miscarriage
5655493|NCT00680238|sHLA-G|shla-g
5655494|NCT00680225|Choroidal melanoma|choroidal melanoma
5655495|NCT00680225|Lucentis|lucentis
5655496|NCT00680225|TTT-ICG|ttt-icg
5655497|NCT00680212|dietary beta-carotene|dietary beta-carotene
5655498|NCT00680212|vitamin A status|vitamin a status
5655499|NCT00680212|intrinsically labeled plant foods|intrinsically labeled plant foods
5655500|NCT00680199|Insomnia|insomnia
5655501|NCT00680199|Primary Insomnia|primary insomnia
5655502|NCT00680199|Good Sleepers|good sleepers
5655503|NCT00680199|ERP|erp
5655505|NCT00680173|Single nucleotide polymorphisms|single nucleotide polymorphisms
5655506|NCT00680173|Sustained virological response|sustained virological response
5655507|NCT00680173|Peginterferon|peginterferon
5655508|NCT00680173|Ribavirin|ribavirin
5655509|NCT00680160|Onychomycosis|onychomycosis
5655510|NCT00680160|Fungal Nail|fungal nail
5655512|NCT00680147|Gardasil|gardasil
5655513|NCT00680147|African-American|african-american
5655514|NCT00680147|adolescent|adolescent
5655515|NCT00680147|health behavior|health behavior
5655516|NCT00680147|sexually transmitted infections|sexually transmitted infections
5672659|NCT00611312|Cognitive training|cognitive training
5655517|NCT00680147|This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.|this will enroll 300 mothers of teenage girls and boys to identify barriers to hpv vaccination among low-income, african-american teens.
5655518|NCT00680134|Onychomycosis|onychomycosis
5655519|NCT00680134|Fungal Nail|fungal nail
5655520|NCT00680121|Alcoholism|alcoholism
5655523|NCT00680095|Onychomycosis|onychomycosis
5655524|NCT00680095|Fungal Nail|fungal nail
5655526|NCT00680082|rosuvastatin|rosuvastatin
5655527|NCT00680082|cross sectional study|cross sectional study
5655529|NCT00680082|CV risk factors|cv risk factors
5655530|NCT00680069|avian influenza,H5N1,Influenza,parent protocol|avian influenza,h5n1,influenza,parent protocol
5655531|NCT00680056|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5655532|NCT00680056|Tiotropium|tiotropium
5655533|NCT00680056|Formoterol|formoterol
5655534|NCT00680056|Bronchodilator Agents|bronchodilator agents
5655535|NCT00680056|Exercise Tolerance|exercise tolerance
5655536|NCT00680056|Randomized Controlled Trial [Publication Type]|randomized controlled trial [publication type]
5655537|NCT00680056|COPD|copd
5655538|NCT00680043|anemia|anemia
5655539|NCT00680043|chronic kidney disease|chronic kidney disease
5655540|NCT00680043|CKD|ckd
5655541|NCT00680043|chronic renal failure|chronic renal failure
5655542|NCT00680043|CRF|crf
5655543|NCT00680043|erythropoietin|erythropoietin
5655544|NCT00680043|EPO|epo
5655545|NCT00680043|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5655546|NCT00680043|ESA|esa
5655547|NCT00680043|Hematide™|hematide™
5655548|NCT00680043|hemoglobin|hemoglobin
5655549|NCT00680043|Hb|hb
5655550|NCT00680043|Hgb|hgb
5655551|NCT00680043|Omontys|omontys
5655552|NCT00680043|peginesatide|peginesatide
5655553|NCT00680043|red blood cell|red blood cell
5655933|NCT00678535|Xeloda|xeloda
5655554|NCT00680043|red blood cell production|red blood cell production
5655555|NCT00680030|impedance|impedance
5655556|NCT00680030|manometry|manometry
5655557|NCT00680030|motility disorders|motility disorders
5655558|NCT00680030|ineffective motility|ineffective motility
5655559|NCT00680030|diffuse esophageal spasms|diffuse esophageal spasms
5655560|NCT00680030|achlasia-like dysmotility|achlasia-like dysmotility
5655561|NCT00680017|Dyslipidemia|dyslipidemia
5655562|NCT00680017|Kidney Disease|kidney disease
5655563|NCT00680004|Dynamic CTA|dynamic cta
5655564|NCT00680004|follow-up|follow-up
5655565|NCT00680004|EVAR|evar
5655566|NCT00679991|arteriovenous fistula|arteriovenous fistula
5655567|NCT00679991|AVF|avf
5655568|NCT00679991|hemodialysis|hemodialysis
5655569|NCT00679991|vascular access|vascular access
5655570|NCT00679991|PRT 201|prt 201
5655571|NCT00679991|dose escalation|dose escalation
5655572|NCT00679991|dialysis|dialysis
5655573|NCT00679991|fistula|fistula
5655574|NCT00679991|access|access
5655575|NCT00679991|vonapanitase|vonapanitase
5655576|NCT00679991|kidney|kidney
5655577|NCT00679991|renal|renal
5655578|NCT00679978|osteoporosis|osteoporosis
5655579|NCT00679978|glucocorticoid|glucocorticoid
5655580|NCT00679978|bone mineral density|bone mineral density
5655581|NCT00679978|osteonecrosis of the femoral head|osteonecrosis of the femoral head
5655582|NCT00679965|Onychomycosis|onychomycosis
5655583|NCT00679965|Fungal Nail|fungal nail
5655584|NCT00679952|Pancreatic fistula|pancreatic fistula
5655585|NCT00679952|Pancreatic duct stent|pancreatic duct stent
5655586|NCT00679952|Closed suction drainage|closed suction drainage
5655587|NCT00679939|Type 2 diabetes mellitus|type 2 diabetes mellitus
5655588|NCT00679939|bone|bone
5655589|NCT00679939|x-ray absorptiometry|x-ray absorptiometry
5655590|NCT00679939|bone biomarkers|bone biomarkers
5655591|NCT00679939|dual-energy|dual-energy
5655592|NCT00679939|bone mineral density|bone mineral density
5655593|NCT00679926|HIV|hiv
5655594|NCT00679926|AIDS|aids
5655595|NCT00679926|HIV/AIDS|hiv/aids
5655596|NCT00679926|Treatment Naive|treatment naive
5655597|NCT00679913|Pancreatic cancer|pancreatic cancer
5655598|NCT00679913|Pancreaticoduodenectomy|pancreaticoduodenectomy
5655599|NCT00679913|Extended lymphadenectomy|extended lymphadenectomy
5655600|NCT00679900|Primary Insomnia|primary insomnia
5655601|NCT00679900|Sleep Maintenance Difficulties|sleep maintenance difficulties
5655602|NCT00679887|chiropractic|chiropractic
5655603|NCT00679887|myofascial trigger points|myofascial trigger points
5655604|NCT00679887|ischemic compression|ischemic compression
5655605|NCT00679887|shoulder pain|shoulder pain
5655606|NCT00679874|Cardiovascular Magnetic Resonance Imaging|cardiovascular magnetic resonance imaging
5655607|NCT00679874|Cardiotoxicity|cardiotoxicity
5655608|NCT00679874|Anthracyclines|anthracyclines
5655609|NCT00679874|Trastuzumab|trastuzumab
5655610|NCT00679874|Breast cancer|breast cancer
5655611|NCT00679874|Toxicity|toxicity
5655612|NCT00679861|primary medical care|primary medical care
5655613|NCT00679861|computer expert system|computer expert system
5655614|NCT00679861|motivational interviewing|motivational interviewing
5655615|NCT00679861|health behavior change counselling|health behavior change counselling
5655616|NCT00679861|stages of change|stages of change
5655617|NCT00679848|Weight Loss|weight loss
5655618|NCT00679848|Transoral Suturing|transoral suturing
5655619|NCT00679848|Experimental|experimental
5655620|NCT00679822|OSA|osa
5655621|NCT00679822|sleep apnea|sleep apnea
5655622|NCT00679822|heart failure|heart failure
5655623|NCT00679822|CHF|chf
5655624|NCT00679822|heart clinic|heart clinic
5655625|NCT00679822|clinic|clinic
5655626|NCT00679822|obstructive sleep apnea|obstructive sleep apnea
5655627|NCT00679809|Resident|resident
5655628|NCT00679809|Safety|safety
5655629|NCT00679809|Fatigue|fatigue
5655630|NCT00679809|Continuity|continuity
5655631|NCT00679809|ICU|icu
5655632|NCT00679796|varicella|varicella
5655633|NCT00679796|case-control|case-control
5655634|NCT00679783|Breast cancer|breast cancer
5655635|NCT00679783|Ovarian cancer|ovarian cancer
5655636|NCT00679783|BRCA|brca
5655637|NCT00679783|Triple negative|triple negative
5655638|NCT00679783|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5655639|NCT00679783|Known BRCA or Recurrent High Grade Serious/ Undifferentiated Tubo- Ovarian Carcinoma|known brca or recurrent high grade serious/ undifferentiated tubo- ovarian carcinoma
5655640|NCT00679783|Known BRCA or Triple Negative Breast Cancer|known brca or triple negative breast cancer
5655641|NCT00679770|Onychomycosis|onychomycosis
5655642|NCT00679770|Fungal Nail|fungal nail
5655643|NCT00679757|Sleep apnea|sleep apnea
5655648|NCT00679744|Sandhoff disease.|sandhoff disease.
5655649|NCT00679744|GM2 Gangliosidosis.|gm2 gangliosidosis.
5655650|NCT00679744|β-hexosaminidase deficiency.|β-hexosaminidase deficiency.
5655651|NCT00679744|Hexosaminidase|hexosaminidase
5655652|NCT00679744|Phase I clinical trial.|phase i clinical trial.
5655653|NCT00679731|Psoriasis|psoriasis
5655654|NCT00679705|Hemodynamics and arterial function of healthy females|hemodynamics and arterial function of healthy females
5655655|NCT00679692|GH,IGF-1, IGFBP-3|gh,igf-1, igfbp-3
5655656|NCT00679679|Polycystic ovary syndrome|polycystic ovary syndrome
5655657|NCT00679679|Treatment|treatment
5655658|NCT00679679|Metformin|metformin
5655659|NCT00679666|keratoconus|keratoconus
5655660|NCT00679666|ectasia|ectasia
5655661|NCT00679666|cross-linking|cross-linking
5655662|NCT00679666|riboflavin|riboflavin
5655663|NCT00679666|UVA light|uva light
5655664|NCT00679666|cornea|cornea
5655665|NCT00679640|candesartan|candesartan
5655666|NCT00679640|heart failure|heart failure
5655667|NCT00679640|cohort study|cohort study
5655668|NCT00679640|France|france
5655669|NCT00679627|Alzheimer's Disease|alzheimer's disease
5655670|NCT00679627|Galantamine|galantamine
5655671|NCT00679627|Dementia, Alzheimer type|dementia, alzheimer type
5655672|NCT00679627|Memory loss|memory loss
5655673|NCT00679614|Tramacet|tramacet
5655674|NCT00679614|naloxone|naloxone
5655675|NCT00679614|morphine|morphine
5655676|NCT00679614|analgesia|analgesia
5655677|NCT00679614|elderly|elderly
5655678|NCT00679614|elderly patients|elderly patients
5655679|NCT00679601|Onychomycosis|onychomycosis
5655680|NCT00679601|Fungal Nail|fungal nail
5655681|NCT00679588|Digestive System Surgical Procedure|digestive system surgical procedure
5655682|NCT00679588|Urologic Surgical Procedure|urologic surgical procedure
5655683|NCT00679588|Prevention of venous thromboembolism|prevention of venous thromboembolism
5655684|NCT00679588|Abdominal surgery|abdominal surgery
5655685|NCT00679575|statins|statins
5655686|NCT00679575|myocardial infarction|myocardial infarction
5655687|NCT00679575|case-referent study|case-referent study
5655688|NCT00679575|France|france
5655689|NCT00679549|Heart Failure|heart failure
5655690|NCT00679549|Obstructive Sleep Apnea|obstructive sleep apnea
5655692|NCT00679549|CHF|chf
5655693|NCT00679549|Sleep apnea|sleep apnea
5655694|NCT00679549|CHD|chd
5655695|NCT00679536|Reduced Toxicity|reduced toxicity
5655696|NCT00679536|Toxicity|toxicity
5655697|NCT00679536|Event Free Survival|event free survival
5655698|NCT00679536|Graft vs Host Disease|graft vs host disease
5655699|NCT00679523|Onychomycosis|onychomycosis
5655700|NCT00679523|Fungal Nail|fungal nail
5655701|NCT00679510|Rheumatoid Arthritis|rheumatoid arthritis
5655702|NCT00679510|Rosuvastatin|rosuvastatin
5655703|NCT00679510|Cardiovascular|cardiovascular
5655704|NCT00679510|Intima media thickness|intima media thickness
5655705|NCT00679497|Low risk HIV infection|low risk hiv infection
5655706|NCT00679497|HIV Seronegativity|hiv seronegativity
5656105|NCT00677911|cytokines|cytokines
5655707|NCT00679497|HIV Preventive Vaccine|hiv preventive vaccine
5655708|NCT00679471|pre-term infants|pre-term infants
5655709|NCT00679471|full-term infants|full-term infants
5655711|NCT00679471|brain structure development|brain structure development
5655712|NCT00679471|pre term|pre term
5655713|NCT00679471|full term|full term
5655714|NCT00679458|analgesia|analgesia
5655716|NCT00679458|buprenorphine|buprenorphine
5655717|NCT00679458|opioid|opioid
5655718|NCT00679458|naloxone|naloxone
5655719|NCT00679445|Macular|macular
5655720|NCT00679445|Degeneration|degeneration
5655721|NCT00679445|AMD|amd
5655722|NCT00679445|Wet Age-related macular degeneration|wet age-related macular degeneration
5655723|NCT00679432|Ulcerative colitis|ulcerative colitis
5655724|NCT00679406|Chronic Insomnia lasting more than 1 month|chronic insomnia lasting more than 1 month
5655725|NCT00679393|Calcaneus|calcaneus
5655726|NCT00679393|Intra-articular fracture|intra-articular fracture
5655727|NCT00679393|open reduction internal fixation|open reduction internal fixation
5655728|NCT00679393|primary subtalar fusion|primary subtalar fusion
5655730|NCT00679367|primary systemic amyloidosis|primary systemic amyloidosis
5655731|NCT00679341|HER2-positive breast cancer|her2-positive breast cancer
5655732|NCT00679341|HER2|her2
5655733|NCT00679341|Herceptin|herceptin
5655734|NCT00679341|Taxotere|taxotere
5655735|NCT00679341|MBC|mbc
5655736|NCT00679341|Breast cancer|breast cancer
5655737|NCT00679341|TDM1|tdm1
5655738|NCT00679341|TDM-1|tdm-1
5655739|NCT00679341|HER2-positive|her2-positive
5655740|NCT00679341|HER2+|her2+
5655741|NCT00679341|HER2 positive breast cancer|her2 positive breast cancer
5655742|NCT00679341|HER2+ breast cancer|her2+ breast cancer
5655743|NCT00679341|Armed Herceptin|armed herceptin
5655744|NCT00679341|Trastuzumab emtansine|trastuzumab emtansine
5655745|NCT00679341|Trastuzumab DM1|trastuzumab dm1
5655746|NCT00679315|female voiding dysfunction|female voiding dysfunction
5655747|NCT00679315|alpha adrenoreceptor antagonists|alpha adrenoreceptor antagonists
5655748|NCT00679315|IPSS or American Urological Association symptom index|ipss or american urological association symptom index
5636787|NCT00751478|ALO-01|alo-01
5655749|NCT00679302|skin abscess|skin abscess
5655750|NCT00679302|CA-MRSA|ca-mrsa
5655751|NCT00679289|KW2871|kw2871
5655752|NCT00679289|Ecromeximab|ecromeximab
5655753|NCT00679289|Anti-ganglioside|anti-ganglioside
5655754|NCT00679289|Antibody|antibody
5655755|NCT00679289|Interferon alpha|interferon alpha
5655756|NCT00679289|Metastatic melanoma|metastatic melanoma
5655757|NCT00679276|vaginal prolapse|vaginal prolapse
5655758|NCT00679263|asthma|asthma
5655759|NCT00679263|randomized|randomized
5655760|NCT00679263|placebo controlled|placebo controlled
5655761|NCT00679263|dose escalation|dose escalation
5655762|NCT00679263|safety|safety
5655763|NCT00679263|efficacy|efficacy
5655764|NCT00679263|single blind|single blind
5655765|NCT00679263|MN-221|mn-221
5655766|NCT00679250|allergic rhinitis|allergic rhinitis
5655767|NCT00679250|levocetirizine|levocetirizine
5655768|NCT00679250|nasal provocation testing|nasal provocation testing
5655769|NCT00679250|nasal allergen challenge|nasal allergen challenge
5655770|NCT00679250|nasal adenosine monophosphate challenge|nasal adenosine monophosphate challenge
5655771|NCT00679224|Pulmonary Arterial Hypertesion|pulmonary arterial hypertesion
5655772|NCT00679224|observational safety|observational safety
5655773|NCT00679211|HER2-positive breast cancer|her2-positive breast cancer
5655774|NCT00679211|HER2|her2
5655775|NCT00679211|MBC|mbc
5655776|NCT00679211|Trastuzumab emtansine|trastuzumab emtansine
5655777|NCT00679198|osteoporosis|osteoporosis
5655778|NCT00679198|fracture|fracture
5655779|NCT00679198|communication|communication
5655780|NCT00679198|prescription medication|prescription medication
5655781|NCT00679185|fatigue|fatigue
5655782|NCT00679185|stage I breast cancer|stage i breast cancer
5655783|NCT00679185|stage II breast cancer|stage ii breast cancer
5655784|NCT00679185|stage IIIA breast cancer|stage iiia breast cancer
5655785|NCT00679185|stage IIIB breast cancer|stage iiib breast cancer
5655786|NCT00679185|stage IIIC breast cancer|stage iiic breast cancer
5655787|NCT00679185|lymphedema|lymphedema
5655788|NCT00679133|c-Met|c-met
5655789|NCT00679133|VEGFR|vegfr
5655790|NCT00679133|Ron|ron
5655791|NCT00679133|Cancer|cancer
5655792|NCT00679133|Tumor|tumor
5655793|NCT00679133|Safety|safety
5655794|NCT00679133|Phase 1|phase 1
5655795|NCT00679120|Unicompartmental osteoarthrosis|unicompartmental osteoarthrosis
5655796|NCT00679120|RSA|rsa
5655797|NCT00679120|Bone-remodelling|bone-remodelling
5655798|NCT00679107|Degenerative Disc Disease|degenerative disc disease
5655799|NCT00679068|respiratory mechanics|respiratory mechanics
5655800|NCT00679068|bosentan|bosentan
5655801|NCT00679068|exercise capacity|exercise capacity
5655802|NCT00679042|Diabetes Mellitus Type 1|diabetes mellitus type 1
5655803|NCT00679042|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5655804|NCT00679042|Islets of Langerhans Transplantation|islets of langerhans transplantation
5655805|NCT00679042|Allogeneic Islet transplantation|allogeneic islet transplantation
5655806|NCT00679003|Crohn's disease|crohn's disease
5655811|NCT00678990|Islets of Langerhans|islets of langerhans
5655812|NCT00678990|islets|islets
5655813|NCT00678990|heparin|heparin
5655814|NCT00678977|pharmacokinetics|pharmacokinetics
5655815|NCT00678977|cisplatin|cisplatin
5655816|NCT00678977|pazopanib (GW786034)|pazopanib (gw786034)
5655817|NCT00678977|Solid tumors|solid tumors
5655818|NCT00678977|anti-angiogenesis|anti-angiogenesis
5655819|NCT00678977|gemcitabine|gemcitabine
5655821|NCT00678964|Elderly patients|elderly patients
5655822|NCT00678938|smoking reduction|smoking reduction
5655823|NCT00678938|smoking cessation|smoking cessation
5655824|NCT00678938|stages of change|stages of change
5655825|NCT00678938|expert system interventions|expert system interventions
5655826|NCT00678912|mechanical ventilation|mechanical ventilation
5655827|NCT00678912|automated weaning|automated weaning
5655828|NCT00678912|children|children
5655829|NCT00678899|High frequency severe to profound|high frequency severe to profound
5655830|NCT00678886|Type 1 diabetes|type 1 diabetes
5655831|NCT00678886|new onset type 1 diabetes|new onset type 1 diabetes
5655832|NCT00678886|T1DM|t1dm
5655833|NCT00678886|Type l diabetes|type l diabetes
5655834|NCT00678886|juvenile diabetes|juvenile diabetes
5655835|NCT00678873|Single Incision|single incision
5655836|NCT00678873|Single Access|single access
5655838|NCT00678873|Cholecystectomy|cholecystectomy
5655839|NCT00678860|Questionnaire|questionnaire
5655840|NCT00678860|Computer Assisted Interface|computer assisted interface
5655841|NCT00678860|Quality of Life|quality of life
5655842|NCT00678860|Dry Eye|dry eye
5655843|NCT00678860|Ocular Surface Disease|ocular surface disease
5655844|NCT00678860|Healthy Volunteer|healthy volunteer
5655846|NCT00678847|bio-electrical stimulation therapy|bio-electrical stimulation therapy
5798781|NCT00111085|vasospasm|vasospasm
5655847|NCT00678847|chronic venous ulcers|chronic venous ulcers
5655848|NCT00678847|microcurrent|microcurrent
5655849|NCT00678847|chronic wounds|chronic wounds
5655850|NCT00678847|complete healing|complete healing
5655855|NCT00678795|Detrusor overactivity|detrusor overactivity
5655856|NCT00678795|Multiple Sclerosis|multiple sclerosis
5655857|NCT00678782|knee|knee
5655858|NCT00678782|synovitis|synovitis
5655859|NCT00678782|arthritis|arthritis
5655860|NCT00678782|rheumatoid arthritis|rheumatoid arthritis
5655861|NCT00678782|psoriatic arthritis|psoriatic arthritis
5655862|NCT00678782|spondyloarthropathies|spondyloarthropathies
5655863|NCT00678782|intraarticular|intraarticular
5655864|NCT00678782|etanercept|etanercept
5655865|NCT00678756|Psoriasis vulgaris,|psoriasis vulgaris,
5655866|NCT00678756|vitamin D, UVB-phototherapy, ketokonazol,|vitamin d, uvb-phototherapy, ketokonazol,
5655867|NCT00678756|Optical Coherence Tomography,|optical coherence tomography,
5655868|NCT00678756|local PASI, Nizoral|local pasi, nizoral
5655869|NCT00678743|cholesterol|cholesterol
5655870|NCT00678743|dyslipidemia|dyslipidemia
5655871|NCT00678743|omega 3|omega 3
5655872|NCT00678730|THC|thc
5655873|NCT00678730|COMT gene polymorphism|comt gene polymorphism
5655874|NCT00678730|schizophrenia|schizophrenia
5655875|NCT00678730|cannabis use|cannabis use
5655876|NCT00678717|abdominal|abdominal
5655877|NCT00678717|Pelvic|pelvic
5655878|NCT00678717|Pain|pain
5655879|NCT00678717|SCS|scs
5655880|NCT00678717|Healthy and Chronic Visceral Pain patients|healthy and chronic visceral pain patients
5655881|NCT00678717|Chronic Visceral Pain and spinal cord stimulator|chronic visceral pain and spinal cord stimulator
5655882|NCT00678704|Vardenafil|vardenafil
5655883|NCT00678704|PDE5 inhibitor|pde5 inhibitor
5655884|NCT00678704|Erectile Dysfunction|erectile dysfunction
5655885|NCT00678704|Diabetes Mellitus|diabetes mellitus
5655886|NCT00678704|Sexual Dysfunction|sexual dysfunction
5655887|NCT00678691|fibromyalgia|fibromyalgia
5655888|NCT00678691|fatigue|fatigue
5655889|NCT00678678|Physiotherapy|physiotherapy
5655890|NCT00678678|Breathing exercises|breathing exercises
5655891|NCT00678678|Bariatric Surgery|bariatric surgery
5655892|NCT00678678|Laparoscopy|laparoscopy
5655893|NCT00678665|ecg|ecg
5655894|NCT00678665|TSA2000|tsa2000
5655895|NCT00678665|Heart rate variability|heart rate variability
5655896|NCT00678665|wavelets|wavelets
5655897|NCT00678652|Meningococcal vaccine|meningococcal vaccine
5655898|NCT00678652|Neisseria meningitidis|neisseria meningitidis
5655899|NCT00678639|ACS|acs
5655900|NCT00678639|Acute Coronary Syndrome|acute coronary syndrome
5655901|NCT00678639|Chest pain|chest pain
5655902|NCT00678639|Cardiac MRI|cardiac mri
5655903|NCT00678639|CMR|cmr
5655904|NCT00678639|Risk Stratification|risk stratification
5655905|NCT00678639|Emergency Department|emergency department
5656003|NCT00678327|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5655906|NCT00678626|Key words: Docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;HER-2 negative; Stage IIIB or IV breast cancer.|key words: docetaxel; breast cancer; breast diseases; breast neoplasms; antineoplastic agents; neoplasms;her-2 negative; stage iiib or iv breast cancer.
5655907|NCT00678613|probiotics|probiotics
5655908|NCT00678613|cirrhosis|cirrhosis
5655909|NCT00678613|prophylaxis|prophylaxis
5655910|NCT00678613|cirrhotic|cirrhotic
5655911|NCT00678613|patients|patients
5655912|NCT00678613|with|with
5655913|NCT00678613|ascites|ascites
5655914|NCT00678613|using|using
5655915|NCT00678600|Informatics|informatics
5655916|NCT00678600|Alerts|alerts
5655917|NCT00678600|Toxicity|toxicity
5655918|NCT00678600|Virologic failure|virologic failure
5655919|NCT00678600|Suboptimal follow up|suboptimal follow up
5655920|NCT00678587|elective invasive procedure.|elective invasive procedure.
5655921|NCT00678587|platelet transfusion|platelet transfusion
5655922|NCT00678587|chronic liver disease-related thrombocytopenia|chronic liver disease-related thrombocytopenia
5655924|NCT00678587|thrombopoietin|thrombopoietin
5655925|NCT00678574|hormones|hormones
5655926|NCT00678574|menses|menses
5655927|NCT00678574|PMS|pms
5655928|NCT00678574|PMDD|pmdd
5655929|NCT00678561|chronic plaque psoriasis, topical treatment|chronic plaque psoriasis, topical treatment
5655930|NCT00678535|1st line treatment for Gastric Cancer|1st line treatment for gastric cancer
5655931|NCT00678535|Cetuximab|cetuximab
5655932|NCT00678535|Capecitabine|capecitabine
5655934|NCT00678535|Cisplatin|cisplatin
5655980|NCT00678405|Lung cancer|lung cancer
5655981|NCT00678405|COPD|copd
5655982|NCT00678405|Heart failure|heart failure
5655983|NCT00678405|Chronic respiratory disease|chronic respiratory disease
5655984|NCT00678392|Axitinib in Second Line Treatment of Patients With Metastatic Renal Cell Cancer|axitinib in second line treatment of patients with metastatic renal cell cancer
5655985|NCT00678379|Tonsillectomy|tonsillectomy
5655986|NCT00678379|Postoperative Pain|postoperative pain
5655987|NCT00678379|Clonidine|clonidine
5655988|NCT00678379|Anesthetics, Local|anesthetics, local
5655989|NCT00678366|laparoscopy|laparoscopy
5655990|NCT00678366|carbon dioxide|carbon dioxide
5655991|NCT00678366|oxygen|oxygen
5655993|NCT00678366|inflammation|inflammation
5655994|NCT00678353|Degenerative disc disease|degenerative disc disease
5655995|NCT00678340|Randomized Controlled Trial|randomized controlled trial
5655996|NCT00678340|Single-Blind Study|single-blind study
5655997|NCT00678340|Catheter Ablation|catheter ablation
5655998|NCT00678327|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5655999|NCT00678327|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5656000|NCT00678327|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5656001|NCT00678327|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5656002|NCT00678327|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5656004|NCT00678327|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5656005|NCT00678314|Anesthetics|anesthetics
5656007|NCT00678314|ropivacaine|ropivacaine
5656008|NCT00678314|Surgery|surgery
5656009|NCT00678314|Hand|hand
5656010|NCT00678314|carpel tunnel|carpel tunnel
5656011|NCT00678314|Carpal tunnel surgery|carpal tunnel surgery
5656012|NCT00678301|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5656013|NCT00678301|Streptococcus pneumoniae|streptococcus pneumoniae
5656014|NCT00678288|Renal Cell Cancer|renal cell cancer
5656015|NCT00678288|Interferon|interferon
5656016|NCT00678275|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5656017|NCT00678262|pain|pain
5656018|NCT00678262|ECG|ecg
5656019|NCT00678262|Heart rate variability|heart rate variability
5656020|NCT00678262|wavelets|wavelets
5656021|NCT00678249|Hemodialysis|hemodialysis
5656022|NCT00678249|Vascular Prosthesis|vascular prosthesis
5656023|NCT00678249|stenoses|stenoses
5656024|NCT00678249|grafts|grafts
5656025|NCT00678236|RSA|rsa
5656026|NCT00678236|Gonarthritis|gonarthritis
5656027|NCT00678236|Bone Cement|bone cement
5656028|NCT00678210|dose response; PASI 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis|dose response; pasi 75 response endpoint; subjects with moderate to severe chronic plaque psoriasis
5656029|NCT00678197|Quality of care|quality of care
5656030|NCT00678197|Access to care|access to care
5656031|NCT00678197|Health Outcomes|health outcomes
5656032|NCT00678184|Atorvastatin|atorvastatin
5656033|NCT00678184|healthy|healthy
5656034|NCT00678184|sodium excretion|sodium excretion
5656035|NCT00678184|hemodynamics|hemodynamics
5656036|NCT00678184|tubular function|tubular function
5656037|NCT00678171|Degenerative Disc Disease|degenerative disc disease
5656038|NCT00678158|High Does Single Fraction IGRT|high does single fraction igrt
5656040|NCT00678158|Lymph Nodes|lymph nodes
5656041|NCT00678158|Soft Tissue|soft tissue
5656042|NCT00678145|Diabetes|diabetes
5656043|NCT00678145|Hypoglycemia|hypoglycemia
5656044|NCT00678145|HAAF|haaf
5656045|NCT00678145|Counterregulation|counterregulation
5656046|NCT00678132|PARP Inhibitor|parp inhibitor
5656047|NCT00678132|Combination Study|combination study
5656048|NCT00678132|Chemotherapy|chemotherapy
5656049|NCT00678132|Advanced Cancer|advanced cancer
5656056|NCT00678106|dalbavancin adolescent subjects|dalbavancin adolescent subjects
5656057|NCT00678093|Low back pain|low back pain
5656058|NCT00678093|Manual therapy|manual therapy
5656059|NCT00678093|Mulligan snag|mulligan snag
5656060|NCT00678080|Type 2 diabetes mellitus|type 2 diabetes mellitus
5656061|NCT00678080|Pregnancy|pregnancy
5656062|NCT00678080|Metformin|metformin
5656063|NCT00678080|Insulin|insulin
5656064|NCT00678080|Pregnant women|pregnant women
5656065|NCT00678067|Hypercholesterolemic children|hypercholesterolemic children
5656066|NCT00678067|Docosahexaenoic acid|docosahexaenoic acid
5656067|NCT00678067|Eicosapentaenoic acid|eicosapentaenoic acid
5656068|NCT00678067|Blood lipid profile|blood lipid profile
5656069|NCT00678041|urinary catheterization|urinary catheterization
5656070|NCT00678041|urinary tract infection|urinary tract infection
5656071|NCT00678041|urinary incontinence|urinary incontinence
5656072|NCT00678041|pelvic floor prolapse|pelvic floor prolapse
5656073|NCT00678041|antibiotics|antibiotics
5656074|NCT00678028|MBL, UTI|mbl, uti
5656075|NCT00678015|NDGA|ndga
5656076|NCT00678015|Prostate Cancer|prostate cancer
5656077|NCT00678002|solid organ transplant|solid organ transplant
5656078|NCT00677989|perforated appendicitis|perforated appendicitis
5656079|NCT00677989|laparoscopic appendectomy|laparoscopic appendectomy
5656080|NCT00677989|open appendectomy|open appendectomy
5656081|NCT00677989|cytokines|cytokines
5656082|NCT00677989|free radicals|free radicals
5656083|NCT00677989|oxidized proteins|oxidized proteins
5656084|NCT00677976|fMRI|fmri
5656085|NCT00677976|IBS|ibs
5656086|NCT00677976|Brain Activation|brain activation
5656087|NCT00677963|carotid|carotid
5656088|NCT00677963|atherosclerosis|atherosclerosis
5656089|NCT00677963|arteriosclerosis|arteriosclerosis
5656090|NCT00677963|plaque|plaque
5656091|NCT00677963|neovascularization|neovascularization
5656092|NCT00677963|carotid endarterectomy|carotid endarterectomy
5656093|NCT00677950|Degenerative Disc Disease|degenerative disc disease
5656094|NCT00677937|diabetes mellitus|diabetes mellitus
5656095|NCT00677937|prevention|prevention
5656096|NCT00677937|education|education
5649312|NCT00705354|Sinusitis|sinusitis
5656097|NCT00677937|impaired glucose tolerance|impaired glucose tolerance
5656098|NCT00677937|multi-ethnic|multi-ethnic
5656099|NCT00677924|Colorectal Neoplasms|colorectal neoplasms
5656100|NCT00677924|Colorectal Tumors|colorectal tumors
5656101|NCT00677924|Colorectal Carcinoma|colorectal carcinoma
5656102|NCT00677911|Chronic pain|chronic pain
5656103|NCT00677911|Interleukin-6|interleukin-6
5656104|NCT00677911|pain catastrophizing|pain catastrophizing
5656106|NCT00677911|cortisol|cortisol
5656107|NCT00677898|Patient-Centered Care|patient-centered care
5656108|NCT00677898|Adverse effects|adverse effects
5656109|NCT00677898|Antipsychotics|antipsychotics
5656110|NCT00677885|Alzheimer Disease|alzheimer disease
5656111|NCT00677885|Parkinson's Disease|parkinson's disease
5656112|NCT00677885|Frontotemporal Dementia|frontotemporal dementia
5656113|NCT00677885|PET Imaging|pet imaging
5656114|NCT00677885|AD|ad
5656115|NCT00677885|Parkinson Disease|parkinson disease
5656116|NCT00677885|PD|pd
5656117|NCT00677872|Moderate to severe COPD and coincident pulmonary hypertension|moderate to severe copd and coincident pulmonary hypertension
5656118|NCT00677859|Leukemia|leukemia
5656119|NCT00677859|Graft vs. Host Disease|graft vs. host disease
5656120|NCT00677859|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5656121|NCT00677859|Bone Marrow Transplant|bone marrow transplant
5656122|NCT00677859|Myelodysplasia|myelodysplasia
5656123|NCT00677846|contrast agent ultrasound, vein thrombosis, vascularization|contrast agent ultrasound, vein thrombosis, vascularization
5656124|NCT00677833|P. Falciparum Malaria|p. falciparum malaria
5656125|NCT00677833|drug treatment|drug treatment
5656126|NCT00677833|clinical trial|clinical trial
5656127|NCT00677820|Influenza|influenza
5656128|NCT00677820|FluMist|flumist
5656129|NCT00677820|vaccine|vaccine
5656130|NCT00677820|prevention|prevention
5656131|NCT00677820|trivalent|trivalent
5656132|NCT00677807|COPD|copd
5656133|NCT00677807|adults|adults
5656134|NCT00677807|β2-agonist|β2-agonist
5656135|NCT00677807|indacaterol|indacaterol
5656136|NCT00677794|Video Capsule Endoscopy|video capsule endoscopy
5656137|NCT00677794|Small Bowel|small bowel
5656138|NCT00677768|Biomarkers|biomarkers
5656139|NCT00677768|Plasma|plasma
5656140|NCT00677768|Cerebrospinal Fluid|cerebrospinal fluid
5656141|NCT00677768|DNA|dna
5656142|NCT00677768|Serum|serum
5656143|NCT00677755|Medical abortion|medical abortion
5656144|NCT00677755|emergency contraception|emergency contraception
5656145|NCT00677755|mifepristone|mifepristone
5656146|NCT00677742|oral contraception|oral contraception
5656150|NCT00677729|bronchiolitis|bronchiolitis
5656151|NCT00677729|hypertonic saline|hypertonic saline
5656153|NCT00677716|glioblastoma multiforme|glioblastoma multiforme
5656154|NCT00677716|GBM|gbm
5656155|NCT00677716|brain cancer|brain cancer
5656156|NCT00677716|Cotara|cotara
5656157|NCT00677716|radioactive isotope|radioactive isotope
5656158|NCT00677716|monoclonal antibody|monoclonal antibody
5656159|NCT00677716|Glioblastoma multiforme at first relapse|glioblastoma multiforme at first relapse
5656160|NCT00677703|birth control pills|birth control pills
5656161|NCT00677703|contraception|contraception
5656162|NCT00677703|continuation|continuation
5656163|NCT00677703|text messaging|text messaging
5656164|NCT00677703|contraceptive continuation|contraceptive continuation
5656165|NCT00677703|contraceptive knowledge|contraceptive knowledge
5656166|NCT00677690|COPD|copd
5656167|NCT00677677|Lung transplant|lung transplant
5656168|NCT00677677|Liver transplant|liver transplant
5656169|NCT00677677|Kidney transplant|kidney transplant
5656170|NCT00677677|Pancreas transplant|pancreas transplant
5656171|NCT00677677|HPV|hpv
5656172|NCT00677677|Human Papillomavirus Quadrivalent Vaccine|human papillomavirus quadrivalent vaccine
5656173|NCT00677664|diabetic retinopathy|diabetic retinopathy
5656174|NCT00677664|panretinal photocoagulation|panretinal photocoagulation
5656175|NCT00677664|copaxone|copaxone
5656176|NCT00677664|nerve fiber layer thickness|nerve fiber layer thickness
5656177|NCT00677664|retinal function|retinal function
5656178|NCT00677651|adipose|adipose
5656179|NCT00677651|lean|lean
5656180|NCT00677651|obese|obese
5656181|NCT00677651|overweight|overweight
5656182|NCT00677651|healthy|healthy
5656183|NCT00677625|Liver|liver
5656184|NCT00677625|Transplant|transplant
5656185|NCT00677612|HLA-A*0201|hla-a*0201
5656186|NCT00677612|Peptide Vaccine|peptide vaccine
5656187|NCT00677612|VEGFR1|vegfr1
5656188|NCT00677612|VEGFR2|vegfr2
5656189|NCT00677599|Cardiovascular disease|cardiovascular disease
5656190|NCT00677599|type 2 diabetes|type 2 diabetes
5656191|NCT00677599|flavonoids|flavonoids
5656192|NCT00677599|cocoa|cocoa
5656193|NCT00677599|soy|soy
5656194|NCT00677599|epicatechin|epicatechin
5656195|NCT00677599|postmenopausal|postmenopausal
5656196|NCT00677599|carotid intima media thickness|carotid intima media thickness
5656197|NCT00677599|plaque volume|plaque volume
5656198|NCT00677586|colorectal neoplasms|colorectal neoplasms
5656199|NCT00677586|liver metastasis|liver metastasis
5656200|NCT00677586|surgery|surgery
5656201|NCT00677573|ART|art
5656202|NCT00677573|poor responder|poor responder
5656203|NCT00677573|GnRH antagonist|gnrh antagonist
5656204|NCT00677573|Gonadotropins|gonadotropins
5656205|NCT00677560|resistance|resistance
5656206|NCT00677560|reactance|reactance
5656207|NCT00677560|inflammation|inflammation
5656208|NCT00677547|Kidney|kidney
5656209|NCT00677547|Influenza vaccine|influenza vaccine
5656210|NCT00677547|CMI|cmi
5656215|NCT00677508|Fecal incontinence|fecal incontinence
5656217|NCT00677508|Health related quality of life|health related quality of life
5656218|NCT00677495|Gluten-free diet|gluten-free diet
5656219|NCT00677495|Celiac Disease|celiac disease
5656220|NCT00677495|Genetic predisposition|genetic predisposition
5656221|NCT00677495|Phage display library|phage display library
5656222|NCT00677495|Autoimmune diseases|autoimmune diseases
5656223|NCT00677482|liver transplant|liver transplant
5656224|NCT00677482|lung transplant|lung transplant
5656225|NCT00677482|kidney transplant|kidney transplant
5656226|NCT00677482|heart transplant|heart transplant
5656227|NCT00677482|CMV microRNA|cmv microrna
5656228|NCT00677469|Hyperthyroidism|hyperthyroidism
5656229|NCT00677469|Cholestyramine|cholestyramine
5656230|NCT00677456|Gastric Cancer|gastric cancer
5656231|NCT00677456|total gastrectomy|total gastrectomy
5656232|NCT00677456|reconstruction|reconstruction
5656233|NCT00677456|life quality|life quality
5656234|NCT00677443|metastatic colorectal cancer|metastatic colorectal cancer
5656236|NCT00677443|Capecitabine|capecitabine
5656237|NCT00677443|Oxaliplatin|oxaliplatin
5656238|NCT00677443|non-inferiority study|non-inferiority study
5656239|NCT00677430|Breast Cancer|breast cancer
5656240|NCT00677430|Breast Reconstruction|breast reconstruction
5656241|NCT00677430|Digital Imaging|digital imaging
5656242|NCT00677430|Questionnaire|questionnaire
5656243|NCT00677430|Survey|survey
5656244|NCT00677404|Peripheral vascular diseases|peripheral vascular diseases
5656245|NCT00677404|chronic lower limb ischemia|chronic lower limb ischemia
5656246|NCT00677391|Obesity|obesity
5656247|NCT00677378|TRPV1|trpv1
5656248|NCT00677378|Nerve growth factor|nerve growth factor
5656249|NCT00677378|Capsaicin|capsaicin
5656250|NCT00677378|TrkA|trka
5656251|NCT00677378|Retrosternal pain|retrosternal pain
5656252|NCT00677378|Epigastric pain|epigastric pain
5656253|NCT00677378|Esophagitis|esophagitis
5656254|NCT00677378|Gastrointestinal symptoms|gastrointestinal symptoms
5656255|NCT00677352|Panic Disorder|panic disorder
5656256|NCT00677339|Tuberculosis|tuberculosis
5656257|NCT00677339|Adjunctive therapy|adjunctive therapy
5656258|NCT00677339|L-arginine|l-arginine
5656259|NCT00677339|Nitric oxide|nitric oxide
5656260|NCT00677339|Vitamin D|vitamin d
5656261|NCT00677326|HLA-A*0201|hla-a*0201
5656262|NCT00677326|Peptide Vaccine|peptide vaccine
5656264|NCT00677326|VEGFR2|vegfr2
5656265|NCT00677313|metreleptin|metreleptin
5656266|NCT00677313|leptin|leptin
5656267|NCT00677313|Amylin|amylin
5656268|NCT00677313|diabetes mellitus|diabetes mellitus
5656269|NCT00677313|hypertriglyceridemia|hypertriglyceridemia
5656270|NCT00677313|lipodystrophy|lipodystrophy
5656271|NCT00677300|HIV|hiv
5656272|NCT00677300|Treatment Naive|treatment naive
5656273|NCT00677287|HLA-A*2402|hla-a*2402
5656274|NCT00677287|Peptide Vaccine|peptide vaccine
5656275|NCT00677287|RNF43|rnf43
5656276|NCT00677287|TOMM34|tomm34
5656277|NCT00677287|VEGFR1|vegfr1
5656278|NCT00677287|VEGFR2|vegfr2
5656279|NCT00677274|Epidural analgesia|epidural analgesia
5656280|NCT00677274|Patient-controlled analgesia|patient-controlled analgesia
5656281|NCT00677261|Knee|knee
5656282|NCT00677261|Arthroplasty|arthroplasty
5656283|NCT00677261|Sciatic|sciatic
5656284|NCT00677261|Nerve|nerve
5656285|NCT00677261|Block|block
5656286|NCT00677261|Regional|regional
5656288|NCT00677261|Infiltration|infiltration
5656289|NCT00677261|Local Anesthetic|local anesthetic
5656290|NCT00677261|Analgesia|analgesia
5656291|NCT00677248|Eprotirome|eprotirome
5656292|NCT00677248|KB2115|kb2115
5656293|NCT00677248|dyslipidemia|dyslipidemia
5656294|NCT00677248|hypercholesterolemia|hypercholesterolemia
5656295|NCT00677248|hypertriglyceridemia|hypertriglyceridemia
5656296|NCT00677235|Hemodialysis|hemodialysis
5656297|NCT00677235|Vascular Prosthesis|vascular prosthesis
5656298|NCT00677235|Stenosis|stenosis
5656299|NCT00677235|End-stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5656300|NCT00677222|Acute Myocardial Infarction, Heart Attack|acute myocardial infarction, heart attack
5656301|NCT00677209|house dust mite|house dust mite
5656302|NCT00677209|asthma|asthma
5656303|NCT00677209|autovaccine|autovaccine
5656304|NCT00677209|allergy|allergy
5656305|NCT00677196|PNL|pnl
5656306|NCT00677196|Lithoclast|lithoclast
5656307|NCT00677196|Stonebreaker|stonebreaker
5656308|NCT00677196|efficiency stone fragmentation|efficiency stone fragmentation
5656309|NCT00677183|NASH|nash
5656310|NCT00677183|Biomarker|biomarker
5656316|NCT00677144|Colorectal Neoplasm|colorectal neoplasm
5656317|NCT00677144|S-1|s-1
5656318|NCT00677144|Capecitabine|capecitabine
5656319|NCT00677144|Oxaliplatin|oxaliplatin
5656320|NCT00677131|pediatrics|pediatrics
5656321|NCT00677131|antibiotics|antibiotics
5656322|NCT00677131|patient education|patient education
5656323|NCT00677118|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5656324|NCT00677118|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5656330|NCT00677105|Advanced Cancer|advanced cancer
5656331|NCT00677092|Treatment|treatment
5656332|NCT00677092|Chronic kidney disease|chronic kidney disease
5656333|NCT00677092|Fibrosing disorders|fibrosing disorders
5656334|NCT00677092|Imatinib mesylate|imatinib mesylate
5671244|NCT00616590|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5637218|NCT00750009|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5656335|NCT00677079|BRCA-1 or BRCA-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer|brca-1 or brca-2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer
5656337|NCT00677079|BRCA-2|brca-2
5656338|NCT00677066|bronchiolitis|bronchiolitis
5656339|NCT00677066|oxygen|oxygen
5656340|NCT00677066|children|children
5656341|NCT00677053|Unstable Angina|unstable angina
5656342|NCT00677053|Myocardial Infarction|myocardial infarction
5656343|NCT00677053|Thrombolysis|thrombolysis
5656344|NCT00677053|Anticoagulant|anticoagulant
5656345|NCT00677053|Acute Coronary Syndrome|acute coronary syndrome
5656346|NCT00677027|Beta-glucan|beta-glucan
5656347|NCT00677027|immune system|immune system
5656348|NCT00677027|Healthy subjects|healthy subjects
5656349|NCT00677014|Heart Failure|heart failure
5656351|NCT00677014|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5656353|NCT00677014|Optimization|optimization
5656354|NCT00677014|SmartDelay|smartdelay
5656355|NCT00677014|Echocardiography|echocardiography
5656356|NCT00677014|AV Delay|av delay
5656357|NCT00677001|Solid tumors|solid tumors
5656358|NCT00677001|solid malignancies|solid malignancies
5656359|NCT00677001|neoplasms|neoplasms
5656360|NCT00677001|refractory solid tumors|refractory solid tumors
5656361|NCT00677001|advanced solid tumors|advanced solid tumors
5656362|NCT00676988|Luminal Crohn's Disease|luminal crohn's disease
5656363|NCT00676988|Infliximab|infliximab
5656364|NCT00676975|Irritable Bowel disease|irritable bowel disease
5656365|NCT00676975|Traditional Chinese Medicine|traditional chinese medicine
5656366|NCT00676962|Implementation|implementation
5656367|NCT00676962|facilitation|facilitation
5656368|NCT00676962|psychotherapy|psychotherapy
5656369|NCT00676962|training|training
5656370|NCT00676949|epitope peptide|epitope peptide
5656371|NCT00676949|cyclophosphamide|cyclophosphamide
5656372|NCT00676949|interleukin-2|interleukin-2
5656373|NCT00676936|Cancer|cancer
5656374|NCT00676936|pain|pain
5656375|NCT00676936|corticosteroids|corticosteroids
5656376|NCT00676936|palliative|palliative
5656377|NCT00676936|supportive care|supportive care
5656378|NCT00676936|Cancer patients with pain|cancer patients with pain
5656379|NCT00676910|Advanced Cancer|advanced cancer
5656380|NCT00676910|Malignancies|malignancies
5656381|NCT00676910|Neoplasms|neoplasms
5656382|NCT00676910|Incurable Solid Cancers|incurable solid cancers
5656383|NCT00676897|statin, sepsis, septic shock, simvastatin|statin, sepsis, septic shock, simvastatin
5656384|NCT00676884|atopic eczema|atopic eczema
5656385|NCT00676884|atopic dermatitis|atopic dermatitis
5656386|NCT00676884|allergy|allergy
5656387|NCT00676858|Embolism|embolism
5656388|NCT00676858|Argon|argon
5656389|NCT00676845|Arterial stiffness|arterial stiffness
5656390|NCT00676845|Vascular protection|vascular protection
5656391|NCT00676832|colitis|colitis
5656392|NCT00676832|ulcerative|ulcerative
5656393|NCT00676832|moderate|moderate
5656394|NCT00676832|severe|severe
5656395|NCT00676806|Umbilical cord blood transplantation|umbilical cord blood transplantation
5656396|NCT00676806|full ablation conditioning|full ablation conditioning
5656397|NCT00676806|reduced intensity conditioning|reduced intensity conditioning
5656398|NCT00676793|breast cancer|breast cancer
5656399|NCT00676793|EGCG|egcg
5656400|NCT00676793|Polyphenon E|polyphenon e
5656401|NCT00676793|c-Met|c-met
5656402|NCT00676793|VEGF|vegf
5656403|NCT00676793|HGF|hgf
5656404|NCT00676780|EGCG|egcg
5656405|NCT00676780|polyphenols|polyphenols
5656406|NCT00676780|biomarkers|biomarkers
5656407|NCT00676780|prostate specific antigen|prostate specific antigen
5656408|NCT00676767|Aging|aging
5656409|NCT00676767|Diabetes|diabetes
5656410|NCT00676767|Diet|diet
5656411|NCT00676767|Fiber|fiber
5656412|NCT00676754|Multidrug-Resistant Tuberculosis, tuberculosis, Peru|multidrug-resistant tuberculosis, tuberculosis, peru
5656413|NCT00676728|Advanced or Refractory Leukemia|advanced or refractory leukemia
5656414|NCT00676728|Myelodysplastic Syndromes|myelodysplastic syndromes
5656415|NCT00676728|JNJ 26481585|jnj 26481585
5656416|NCT00676728|Histone-Deacetylase Inhibitor|histone-deacetylase inhibitor
5656417|NCT00676728|Advanced Leukemia|advanced leukemia
5656418|NCT00676728|Refractory Leukemia|refractory leukemia
5656419|NCT00676702|Pancrelipase|pancrelipase
5656425|NCT00676702|Amylases|amylases
5656426|NCT00676702|Peptide Hydrolases|peptide hydrolases
5656427|NCT00676702|Intubation|intubation
5656428|NCT00676702|Safety|safety
5656429|NCT00676702|Capsules|capsules
5656435|NCT00676676|Depression|depression
5656436|NCT00676676|Major Depressive Disorder|major depressive disorder
5656437|NCT00676663|Breast Neoplasms|breast neoplasms
5656438|NCT00676663|Breast Tumor|breast tumor
5656439|NCT00676663|Mammary Neoplasms|mammary neoplasms
5656440|NCT00676650|Docetaxel-refractory mCRPC|docetaxel-refractory mcrpc
5656441|NCT00676650|Second-line treatment with sunitinib and prednisone|second-line treatment with sunitinib and prednisone
5656442|NCT00676637|Adherence|adherence
5656443|NCT00676637|Compliance|compliance
5656444|NCT00676637|Glaucoma|glaucoma
5656445|NCT00676637|Ocular Hypertension|ocular hypertension
5656446|NCT00676624|uveitis|uveitis
5656447|NCT00676624|vitrectomy|vitrectomy
5656448|NCT00676624|infection|infection
5656450|NCT00676611|Acetabular Fractures|acetabular fractures
5656451|NCT00676598|therapeutic hypothermia|therapeutic hypothermia
5656452|NCT00676585|Cardiac Arrest, Shock, Steroids|cardiac arrest, shock, steroids
5656453|NCT00676572|severe asthma|severe asthma
5656454|NCT00676572|corticosteroid insensitivity|corticosteroid insensitivity
5656455|NCT00676559|Diabetic|diabetic
5656456|NCT00676559|Macular|macular
5656457|NCT00676559|Edema|edema
5656458|NCT00676559|DME|dme
5656459|NCT00676559|Clinically Significant Macular Edema (CSME)|clinically significant macular edema (csme)
5656460|NCT00676533|Cipro|cipro
5656461|NCT00676533|Urinary Tract Infection|urinary tract infection
5656462|NCT00676520|Angioplasty|angioplasty
5656463|NCT00676520|Coronary Restenosis|coronary restenosis
5656464|NCT00676520|Coronary Artery Disease|coronary artery disease
5656465|NCT00676520|Coronary Artery Restenosis|coronary artery restenosis
5656466|NCT00676520|Coronary Artery Stenosis|coronary artery stenosis
5656467|NCT00676520|Total Artery Occlusion|total artery occlusion
5656468|NCT00676520|Stents|stents
5656469|NCT00676520|Stent Thrombosis|stent thrombosis
5656470|NCT00676520|Total Coronary Occlusion|total coronary occlusion
5656471|NCT00676520|Vascular Disease|vascular disease
5656472|NCT00676520|Myocardial Ischemia|myocardial ischemia
5656473|NCT00676507|Gene therapy|gene therapy
5656474|NCT00676507|Flow cytometry|flow cytometry
5798782|NCT00111085|clazosentan|clazosentan
5656475|NCT00676507|Immunoenzyme technique|immunoenzyme technique
5656476|NCT00676507|Laboratory biomarker analysis|laboratory biomarker analysis
5656477|NCT00676507|Quality-of-life-assessment|quality-of-life-assessment
5656478|NCT00676507|Tumor cell-derivative vaccine therapy|tumor cell-derivative vaccine therapy
5656479|NCT00676481|Patient Education|patient education
5656480|NCT00676481|Emergency Medicine|emergency medicine
5656481|NCT00676481|HIV Prevention|hiv prevention
5656482|NCT00676481|HIV Seronegativity|hiv seronegativity
5656483|NCT00676468|Asthma|asthma
5656484|NCT00676468|Inflammation|inflammation
5656485|NCT00676468|Airway|airway
5656486|NCT00676468|Fish Oil|fish oil
5656487|NCT00676468|Singulair|singulair
5656488|NCT00676455|CT Software|ct software
5656489|NCT00676455|MeVis™|mevis™
5656490|NCT00676455|Metastatic pulmonary and hepatic lesion growth|metastatic pulmonary and hepatic lesion growth
5656491|NCT00676416|General anesthesia|general anesthesia
5656492|NCT00676416|Propofol|propofol
5656493|NCT00676416|Immunity|immunity
5656494|NCT00676416|Alveolar Macrophages|alveolar macrophages
5656495|NCT00676403|pregabalin, RLS, efficacy, safety|pregabalin, rls, efficacy, safety
5656496|NCT00676390|Heart Failure|heart failure
5656497|NCT00676377|Neostigmine, Post Operative, Ileus|neostigmine, post operative, ileus
5656498|NCT00676364|pediatric patients|pediatric patients
5656499|NCT00676364|pain|pain
5656500|NCT00676364|anxiety|anxiety
5656501|NCT00676364|topical anesthetic|topical anesthetic
5656502|NCT00676364|randomized control trial|randomized control trial
5656503|NCT00676338|Amylin|amylin
5656504|NCT00676338|Lilly|lilly
5656505|NCT00676338|exenatide once weekly|exenatide once weekly
5656507|NCT00676338|Januvia|januvia
5656508|NCT00676338|sitagliptin|sitagliptin
5656509|NCT00676338|thiazolidinedione|thiazolidinedione
5656510|NCT00676325|anterior vaginal prolapse|anterior vaginal prolapse
5656511|NCT00676325|traditional treatment|traditional treatment
5656512|NCT00676325|mesh, graft|mesh, graft
5656513|NCT00676325|NAZCA TC™ POP REPAIR SYSTEM|nazca tc™ pop repair system
5656514|NCT00676325|colporrhaphy|colporrhaphy
5656515|NCT00676312|Osteoporosis|osteoporosis
5656516|NCT00676312|parathyroid hormone|parathyroid hormone
5656517|NCT00676312|pharmacodynamic|pharmacodynamic
5656518|NCT00676312|pharmacokinetic|pharmacokinetic
5656519|NCT00676299|Advanced Solid Cancers|advanced solid cancers
5656520|NCT00676299|Refractory Solid Cancers|refractory solid cancers
5656521|NCT00676299|Protein Kinase Inhibitors|protein kinase inhibitors
5656522|NCT00676299|Phase 1 Study|phase 1 study
5656523|NCT00676299|Oral Chemotherapy|oral chemotherapy
5656524|NCT00676286|Prostate cancer active surveillance|prostate cancer active surveillance
5656525|NCT00676286|3 Tesla MR biological imaging in prostate cancer|3 tesla mr biological imaging in prostate cancer
5656526|NCT00676286|tumor gene re-arrangements in prostate cancer|tumor gene re-arrangements in prostate cancer
5656527|NCT00676260|Glucose Metabolism Disorder|glucose metabolism disorder
5656532|NCT00676260|Dyslipidemia|dyslipidemia
5656533|NCT00676260|Drug Therapy|drug therapy
5656534|NCT00676247|Ultrasonography|ultrasonography
5656535|NCT00676247|Doppler|doppler
5656536|NCT00676247|Hemodynamics|hemodynamics
5656537|NCT00676247|Neurobehavioral development|neurobehavioral development
5656538|NCT00676234|erythropoietin|erythropoietin
5656539|NCT00676221|Renal transplant recipient|renal transplant recipient
5656540|NCT00676221|Immunosuppression|immunosuppression
5656541|NCT00676221|Gastro-intestinal symptoms|gastro-intestinal symptoms
5656542|NCT00676221|Quality of life|quality of life
5656543|NCT00676221|Cellcept|cellcept
5656544|NCT00676221|Myfortic|myfortic
5656545|NCT00676221|Kidney transplant patients.|kidney transplant patients.
5656546|NCT00676208|Shared Medical Appointments|shared medical appointments
5656547|NCT00676208|Diabetes|diabetes
5656548|NCT00676208|Education|education
5656549|NCT00676195|N-Acetyl Cysteine|n-acetyl cysteine
5656550|NCT00676169|Pseudomonas aeruginosa|pseudomonas aeruginosa
5656551|NCT00676169|EPIC|epic
5656552|NCT00676156|multiple sclerosis|multiple sclerosis
5656553|NCT00676156|lipoic acid|lipoic acid
5656555|NCT00676156|pharmacokinetics|pharmacokinetics
5656556|NCT00676156|immunological effects|immunological effects
5656557|NCT00676143|antibody|antibody
5656558|NCT00676143|immunotherapy|immunotherapy
5656559|NCT00676130|Cellulitis|cellulitis
5656560|NCT00676130|Bactrim|bactrim
5656561|NCT00676130|Trimethoprim Sulfamethoxazole|trimethoprim sulfamethoxazole
5656562|NCT00676130|MRSA|mrsa
5656563|NCT00676130|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5656564|NCT00676117|male|male
5656565|NCT00676117|Japan|japan
5656566|NCT00676117|Japanese|japanese
5656567|NCT00676117|Healthy volunteers|healthy volunteers
5656568|NCT00676104|Traumatic Brain Injury|traumatic brain injury
5656569|NCT00676104|Trauma|trauma
5656570|NCT00676104|Hypothermia|hypothermia
5656571|NCT00676091|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5656572|NCT00676065|Contraception|contraception
5656573|NCT00676065|Thromboembolism|thromboembolism
5656574|NCT00676065|Breast Cancer|breast cancer
5656575|NCT00676052|COPD|copd
5656576|NCT00676052|Multicenter|multicenter
5656577|NCT00676052|GSK233705B|gsk233705b
5656578|NCT00676052|double-blind|double-blind
5656579|NCT00676052|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5656580|NCT00676052|randomized|randomized
5656581|NCT00676039|Therapeutic Equivalency|therapeutic equivalency
5656582|NCT00676039|Human Experimentation|human experimentation
5656583|NCT00676039|Bioequivalence|bioequivalence
5656584|NCT00676039|Brand name|brand name
5656585|NCT00676039|Generic|generic
5656586|NCT00676039|Antidepressant|antidepressant
5656587|NCT00676039|Healthy volunteers|healthy volunteers
5656588|NCT00676026|menses|menses
5656589|NCT00676026|women|women
5656590|NCT00676026|healthy controls|healthy controls
5656591|NCT00676026|Healthy females with regular menstrual cycles|healthy females with regular menstrual cycles
5656592|NCT00676013|Burns|burns
5656593|NCT00676013|Skin grafting|skin grafting
5656594|NCT00676013|AlloDerm|alloderm
5656595|NCT00676013|Integra|integra
5656596|NCT00676013|Homograft|homograft
5656597|NCT00676013|Autograft|autograft
5656598|NCT00676013|Burn Scar|burn scar
5656599|NCT00675987|Impaired Fasting Glucose FPG >100-<126 mg/dL|impaired fasting glucose fpg >100-<126 mg/dl
5656600|NCT00675974|Burn|burn
5656601|NCT00675974|Scar|scar
5656602|NCT00675974|Pressure garments|pressure garments
5656603|NCT00675974|Wound healing|wound healing
5656604|NCT00675974|Burn Injury|burn injury
5656605|NCT00675961|Tomsk|tomsk
5656606|NCT00675961|TB-Alcohol|tb-alcohol
5656607|NCT00675961|Alcohol and co-occurring disease|alcohol and co-occurring disease
5656608|NCT00675961|Brief counseling intervention|brief counseling intervention
5656609|NCT00675961|Naltrexone|naltrexone
5656610|NCT00675948|Palliative Care|palliative care
5656611|NCT00675948|Pain|pain
5656612|NCT00675948|Cancer|cancer
5656613|NCT00675935|Patient falls|patient falls
5656614|NCT00675935|fall risk|fall risk
5656615|NCT00675935|fall prevention|fall prevention
5656616|NCT00675922|Burn|burn
5656617|NCT00675922|Wounds|wounds
5656618|NCT00675922|Wound infection|wound infection
5656619|NCT00675922|Topical antimicrobials|topical antimicrobials
5656620|NCT00675922|Cerium|cerium
5656621|NCT00675922|Dakins|dakins
5656622|NCT00675922|Sulfamylon Soaks|sulfamylon soaks
5656623|NCT00675922|Silver Nitrate|silver nitrate
5656624|NCT00675909|Sedation|sedation
5656625|NCT00675909|Anxiety|anxiety
5656626|NCT00675909|Minor procedures|minor procedures
5656627|NCT00675909|Emergency Department|emergency department
5649787|NCT00702858|Joint Pain|joint pain
5656628|NCT00675896|major depression with comorbid fibromyalgia.|major depression with comorbid fibromyalgia.
5656629|NCT00675870|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5656631|NCT00675870|Leukemia|leukemia
5656632|NCT00675870|APL|apl
5656633|NCT00675870|ATRA|atra
5656634|NCT00675870|Tretinoid|tretinoid
5656635|NCT00675870|Vesanoid|vesanoid
5656636|NCT00675870|Retinoic Acid Receptor Alpha|retinoic acid receptor alpha
5656637|NCT00675870|All Trans Retinoic Acid|all trans retinoic acid
5656638|NCT00675870|Arsenic Trioxide|arsenic trioxide
5656639|NCT00675870|Trisenox|trisenox
5656640|NCT00675870|Retinoid|retinoid
5656641|NCT00675870|Relapsed or Refractory Acute Promyelocytic Leukemia|relapsed or refractory acute promyelocytic leukemia
5656642|NCT00675857|Type II diabetes|type ii diabetes
5656643|NCT00675857|Metabolic syndrome|metabolic syndrome
5656644|NCT00675844|Extension study|extension study
5656645|NCT00675844|HIV-1 infection|hiv-1 infection
5656646|NCT00675844|Treatment Naive|treatment naive
5656647|NCT00675831|CD25+|cd25+
5656648|NCT00675831|Tregs|tregs
5656649|NCT00675831|DLI|dli
5656650|NCT00675831|Donor lymphocyte infusion|donor lymphocyte infusion
5656651|NCT00675818|acute kidney injury|acute kidney injury
5656652|NCT00675818|renal replacement therapy|renal replacement therapy
5656653|NCT00675818|critical care unit|critical care unit
5656654|NCT00675818|hemodialysis|hemodialysis
5656655|NCT00675818|hemofiltration|hemofiltration
5656656|NCT00675805|intravenous immunoglobulin|intravenous immunoglobulin
5656657|NCT00675805|IVIG|ivig
5656658|NCT00675805|adverse reactions|adverse reactions
5656659|NCT00675779|endometriosis|endometriosis
5656660|NCT00675779|atorvastatin|atorvastatin
5656661|NCT00675779|oral|oral
5656662|NCT00675779|contraception|contraception
5656663|NCT00675779|pain|pain
5656664|NCT00675779|relief|relief
5656665|NCT00675779|pelvic pain in women with endometriosis|pelvic pain in women with endometriosis
5656666|NCT00675753|Genes|genes
5656667|NCT00675753|Ethnology|ethnology
5656668|NCT00675753|Cytokines|cytokines
5656669|NCT00675753|prematurity|prematurity
5656670|NCT00675727|Melanoma|melanoma
5656671|NCT00675727|Mycobacterium w|mycobacterium w
5656672|NCT00675714|anabolic agents|anabolic agents
5656673|NCT00675714|exercise|exercise
5656674|NCT00675701|To determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the QTc interval.|to determine whether lixivaptan administration at supratherapeutic or therapeutic doses results in the prolongation of the qtc interval.
5656675|NCT00675688|Menopause|menopause
5656676|NCT00675675|Tourette Syndrome|tourette syndrome
5656677|NCT00675675|Chronic Tic Disorder|chronic tic disorder
5656678|NCT00675675|Tics|tics
5656679|NCT00675675|Behavior Therapy|behavior therapy
5656680|NCT00675675|Habit Reversal Training|habit reversal training
5656681|NCT00675675|Child|child
5656682|NCT00675675|Adolescent|adolescent
5656683|NCT00675675|Neuroimaging|neuroimaging
5656684|NCT00675662|Obesity|obesity
5656685|NCT00675662|overweight|overweight
5656686|NCT00675662|BMI|bmi
5656687|NCT00675662|ifestyle|ifestyle
5656688|NCT00675662|diet|diet
5656689|NCT00675662|nutrition|nutrition
5656690|NCT00675662|physical activity|physical activity
5656691|NCT00675662|pre-school|pre-school
5656692|NCT00675662|toddlers|toddlers
5656693|NCT00675662|children|children
5656694|NCT00675662|Prevention of overweight and obesity in pre-school children|prevention of overweight and obesity in pre-school children
5656695|NCT00675649|Injections|injections
5656696|NCT00675649|Severe, persistent asthma|severe, persistent asthma
5656697|NCT00675636|colon cancer|colon cancer
5656698|NCT00675636|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
5656699|NCT00675636|rectal cancer|rectal cancer
5656700|NCT00675636|familial adenomatous polyposis|familial adenomatous polyposis
5656701|NCT00675623|Alzheimer's disease, clinical trial, memory loss, mitochondria,|alzheimer's disease, clinical trial, memory loss, mitochondria,
5656702|NCT00675623|investigational drug, neurodegenerative disease, dementia|investigational drug, neurodegenerative disease, dementia
5656703|NCT00675610|communication|communication
5656704|NCT00675610|HIV/AIDS|hiv/aids
5656705|NCT00675610|Treatment Experienced|treatment experienced
5656706|NCT00675597|Bevacizumab (Avastin)|bevacizumab (avastin)
5656707|NCT00675597|Taxotere (Docetaxel)|taxotere (docetaxel)
5656708|NCT00675597|Vinorelbine Tartrate (Navelbine)|vinorelbine tartrate (navelbine)
5656710|NCT00675558|Obesity|obesity
5656711|NCT00675558|morbid obesity|morbid obesity
5656712|NCT00675558|bariatric surgery|bariatric surgery
5656713|NCT00675532|Opioids, vivitrol, naltrexone, primary care|opioids, vivitrol, naltrexone, primary care
5656714|NCT00675519|problem drinkers|problem drinkers
5656715|NCT00675506|Growth Hormone Releasing Hormone|growth hormone releasing hormone
5656716|NCT00675506|Growth Hormone Pulse|growth hormone pulse
5656717|NCT00675506|Visceral Adipose Tissue|visceral adipose tissue
5656718|NCT00675506|Carotid Intima-Media Thickness|carotid intima-media thickness
5656900|NCT00674908|Prevention|prevention
5656719|NCT00675480|myocardial infarction, thrombectomy, salvage index|myocardial infarction, thrombectomy, salvage index
5656720|NCT00675467|Pediatric Cancer|pediatric cancer
5656721|NCT00675467|Focus Group|focus group
5656722|NCT00675467|Pediatric cancer patients|pediatric cancer patients
5656723|NCT00675467|Parents of Pediatric cancer patients|parents of pediatric cancer patients
5656724|NCT00675467|Pediatric Palliative Care Program|pediatric palliative care program
5656726|NCT00675454|Lung Volume Reduction Surgery|lung volume reduction surgery
5656727|NCT00675454|Lung Transplant|lung transplant
5656728|NCT00675454|Quality of Life|quality of life
5656729|NCT00675441|Chronic Graft-versus-Host Disease|chronic graft-versus-host disease
5656730|NCT00675441|cGVHD|cgvhd
5656731|NCT00675441|GVHD|gvhd
5656732|NCT00675441|Lenalidomide|lenalidomide
5656733|NCT00675441|Revlimid|revlimid
5656734|NCT00675441|CC-5013|cc-5013
5656735|NCT00675441|Stem Cell Transplant|stem cell transplant
5672660|NCT00611299|Probiotics|probiotics
5656736|NCT00675441|Allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5656737|NCT00675441|Allogeneic HSCT|allogeneic hsct
5656738|NCT00675441|HSCT|hsct
5656739|NCT00675441|Post-Transplant Prophylactic Immunosuppressive Therapy|post-transplant prophylactic immunosuppressive therapy
5656740|NCT00675441|Steroids|steroids
5637553|NCT00749086|Osteoporosis|osteoporosis
5656741|NCT00675441|Standard-of-care steroid treatment|standard-of-care steroid treatment
5656742|NCT00675441|Corticosteroids|corticosteroids
5656743|NCT00675441|Prednisone|prednisone
5656744|NCT00675441|Medrol|medrol
5656745|NCT00675428|Relapsed or refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5656746|NCT00675415|Hypoxemia|hypoxemia
5656747|NCT00675415|Capnography|capnography
5656748|NCT00675415|Apnea|apnea
5656749|NCT00675415|Sedation|sedation
5656750|NCT00675415|ERCP|ercp
5656751|NCT00675415|EUS|eus
5656752|NCT00675389|HIV|hiv
5656753|NCT00675389|AIDS|aids
5656754|NCT00675389|Community Health Workers|community health workers
5656755|NCT00675389|Mobile Phones|mobile phones
5656756|NCT00675389|Adherence|adherence
5656757|NCT00675389|Antiretroviral Therapy|antiretroviral therapy
5656758|NCT00675376|COPD|copd
5656759|NCT00675376|Lung Transplant|lung transplant
5656760|NCT00675376|Quality of Life|quality of life
5656761|NCT00675376|End Stage Lung Disease|end stage lung disease
5656762|NCT00675363|ICU|icu
5656763|NCT00675363|Sedation strategies|sedation strategies
5656764|NCT00675363|Daily sedative interruption|daily sedative interruption
5656765|NCT00675363|Sedation protocols|sedation protocols
5656766|NCT00675363|Mechanical Ventilation|mechanical ventilation
5656767|NCT00675363|Sedation|sedation
5656768|NCT00675350|Omacetaxine|omacetaxine
5656769|NCT00675350|Homoharringtonine|homoharringtonine
5656771|NCT00675350|Solid and hematologic malignant tumors|solid and hematologic malignant tumors
5656772|NCT00675337|iron stores|iron stores
5656773|NCT00675337|anemia|anemia
5656774|NCT00675337|iron deficiency|iron deficiency
5656775|NCT00675337|infancy|infancy
5656776|NCT00675337|placental transfusion|placental transfusion
5656777|NCT00675337|iron deficiency in infancy|iron deficiency in infancy
5656778|NCT00675337|anemia in infancy|anemia in infancy
5656779|NCT00675337|placement of neonate|placement of neonate
5656780|NCT00675324|Colonoscopy|colonoscopy
5656781|NCT00675324|Bowel preparation|bowel preparation
5656782|NCT00675324|Salt and electrolyte balance|salt and electrolyte balance
5656783|NCT00675324|Patients undergoing colonoscopy|patients undergoing colonoscopy
5656784|NCT00675324|Complication with traditional bowel preparation|complication with traditional bowel preparation
5656785|NCT00675324|Bowel purity degree without traditional bowel preparation|bowel purity degree without traditional bowel preparation
5656786|NCT00675311|Remote monitoring|remote monitoring
5656787|NCT00675311|Type 1 Diabetes|type 1 diabetes
5656788|NCT00675311|Type 2 diabetes|type 2 diabetes
5656789|NCT00675298|Prostatitis|prostatitis
5656790|NCT00675298|Cystitis, Interstitial|cystitis, interstitial
5656791|NCT00675298|Urinary Bladder, Overactive|urinary bladder, overactive
5656792|NCT00675298|Chronic pelvic pain syndrome|chronic pelvic pain syndrome
5656793|NCT00675298|Painful bladder syndrome|painful bladder syndrome
5656794|NCT00675298|Urgency|urgency
5656795|NCT00675298|Frequency|frequency
5656796|NCT00675285|airway inflammation|airway inflammation
5656797|NCT00675285|childhood asthma|childhood asthma
5656798|NCT00675285|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5656799|NCT00675285|leukotriene receptor antagonists|leukotriene receptor antagonists
5656800|NCT00675285|lung function|lung function
5656801|NCT00675272|brain death|brain death
5656802|NCT00675272|subarachnoid hemorrhage|subarachnoid hemorrhage
5656803|NCT00675272|traumatic brain injury|traumatic brain injury
5656804|NCT00675272|brain injury|brain injury
5656805|NCT00675272|intracerebral hemorrhage|intracerebral hemorrhage
5656806|NCT00675272|organ donation|organ donation
5656807|NCT00675259|stage II breast cancer|stage ii breast cancer
5656808|NCT00675259|stage IIIA breast cancer|stage iiia breast cancer
5656809|NCT00675259|stage IIIB breast cancer|stage iiib breast cancer
5656810|NCT00675259|stage IIIC breast cancer|stage iiic breast cancer
5656811|NCT00675246|corticoid therapy|corticoid therapy
5656812|NCT00675246|fetal lung maturation|fetal lung maturation
5656813|NCT00675246|late preterm|late preterm
5656814|NCT00675246|respiratory distress syndrome|respiratory distress syndrome
5656815|NCT00675246|neonatal death|neonatal death
5650000|NCT00702078|COPD|copd
5656816|NCT00675233|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5656817|NCT00675233|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5656818|NCT00675233|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5656819|NCT00675233|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5656820|NCT00675233|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5656822|NCT00675207|ocular hypertension|ocular hypertension
5656823|NCT00675207|adjunctive treatment|adjunctive treatment
5656824|NCT00675207|prostaglandin|prostaglandin
5656825|NCT00675207|prostaglandin analog|prostaglandin analog
5656826|NCT00675207|brimonidine|brimonidine
5656827|NCT00675207|dorzolamide|dorzolamide
5656828|NCT00675207|brinzolamide|brinzolamide
5656829|NCT00675207|alpha agonist|alpha agonist
5656830|NCT00675207|carbonic anhydrase inhibitor|carbonic anhydrase inhibitor
5656831|NCT00675207|intraocular pressure|intraocular pressure
5656832|NCT00675194|cisplatin|cisplatin
5656833|NCT00675194|capecitabine|capecitabine
5656834|NCT00675194|gastric|gastric
5656835|NCT00675194|irinotecan|irinotecan
5656836|NCT00675194|metastatic|metastatic
5656837|NCT00675194|chemotherapy|chemotherapy
5656838|NCT00675181|melatonin|melatonin
5656839|NCT00675181|skin blood flow|skin blood flow
5656840|NCT00675181|choroidal blood flow|choroidal blood flow
5656841|NCT00675181|vasospastic subjects|vasospastic subjects
5656842|NCT00675181|normal subjects|normal subjects
5656843|NCT00675168|Lung Cancer|lung cancer
5656844|NCT00675168|PET/CT|pet/ct
5656845|NCT00675168|Diagnosis|diagnosis
5656846|NCT00675155|Apoplexy|apoplexy
5656847|NCT00675155|Cerebral Stroke|cerebral stroke
5656848|NCT00675155|Cerebrovascular Accident|cerebrovascular accident
5656849|NCT00675155|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5656850|NCT00675155|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5656851|NCT00675155|Cerebrovascular Stroke|cerebrovascular stroke
5656852|NCT00675142|Infertility|infertility
5656853|NCT00675142|Intra-uterine insemination|intra-uterine insemination
5656854|NCT00675142|ovarian stimulation|ovarian stimulation
5656855|NCT00675116|safety,|safety,
5656856|NCT00675116|healthy volunteers,|healthy volunteers,
5656857|NCT00675116|GW823296,|gw823296,
5656858|NCT00675116|pharmacokinetics|pharmacokinetics
5656859|NCT00675103|Gout|gout
5656860|NCT00675103|Gouty Arthritis|gouty arthritis
5656861|NCT00675103|Anti-Gout preparations|anti-gout preparations
5656862|NCT00675090|Alzheimers Disease|alzheimers disease
5656863|NCT00675077|Akinetic-Rigid Variant of Huntington Disease|akinetic-rigid variant of huntington disease
5680398|NCT00577980|Testosterone Replacement Therapy|testosterone replacement therapy
5656864|NCT00675077|Chorea, Chronic Progressive Hereditary (Huntington)|chorea, chronic progressive hereditary (huntington)
5656865|NCT00675077|Chronic Progressive Hereditary Chorea (Huntington)|chronic progressive hereditary chorea (huntington)
5656867|NCT00675077|Huntington Chronic Progressive Hereditary Chorea|huntington chronic progressive hereditary chorea
5656868|NCT00675077|Huntington Disease, Akinetic-Rigid Variant|huntington disease, akinetic-rigid variant
5656869|NCT00675077|Huntington Disease, Juvenile|huntington disease, juvenile
5656870|NCT00675077|Huntington Disease, Juvenile-Onset|huntington disease, juvenile-onset
5656871|NCT00675064|pharmacokinetics,|pharmacokinetics,
5656873|NCT00675064|single ascending dose,|single ascending dose,
5656874|NCT00675064|Healthy volunteers,|healthy volunteers,
5656875|NCT00675051|To determine if there is a trans-pulmonary gradient in the levels of EMPs in patients with PH|to determine if there is a trans-pulmonary gradient in the levels of emps in patients with ph
5656876|NCT00675051|To determine if the EMPs measured at the pulmonary capillary wedge position correlates even more strongly with the severity of PH than the circulating levels|to determine if the emps measured at the pulmonary capillary wedge position correlates even more strongly with the severity of ph than the circulating levels
5656877|NCT00675051|To determine if PH therapy with ET-1 receptor blocker will modify EMPs levels|to determine if ph therapy with et-1 receptor blocker will modify emps levels
5656878|NCT00675012|NGR-hTNF|ngr-htnf
5656879|NCT00675012|Capecitabine|capecitabine
5656880|NCT00675012|Oxaliplatin|oxaliplatin
5656881|NCT00675012|Colon cancer|colon cancer
5656882|NCT00674999|Burn|burn
5656883|NCT00674999|Partial thickness burn|partial thickness burn
5656884|NCT00674960|Brain Atrophy, Circumscribed Lobar|brain atrophy, circumscribed lobar
5656885|NCT00674960|Circumscribed Lobar Atrophy of the Brain|circumscribed lobar atrophy of the brain
5656886|NCT00674960|Lobar Atrophy (Brain)|lobar atrophy (brain)
5656887|NCT00674960|Pick Disease|pick disease
5656888|NCT00674960|Pick's Disease|pick's disease
5656889|NCT00674960|Picks Disease of Brain|picks disease of brain
5656890|NCT00674947|Relapsed|relapsed
5656891|NCT00674947|Refractory|refractory
5656892|NCT00674934|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5656893|NCT00674934|Multiple Sclerosis, Acute Fulminating|multiple sclerosis, acute fulminating
5656894|NCT00674934|Sclerosis, Disseminated|sclerosis, disseminated
5656895|NCT00674921|Opportunistic Infections|opportunistic infections
5656896|NCT00674921|AIDS|aids
5656897|NCT00674921|HIV|hiv
5656898|NCT00674921|Treatment Experienced|treatment experienced
5656899|NCT00674908|Vaccine|vaccine
5656901|NCT00674908|Diphtheria|diphtheria
5656903|NCT00674908|Pertussis|pertussis
5656904|NCT00674908|Hepatitis B|hepatitis b
5656905|NCT00674908|Haemophilus influenzae type b|haemophilus influenzae type b
5656906|NCT00674908|Vaccine interchangeability|vaccine interchangeability
5656907|NCT00674908|Single vs mixed sequence|single vs mixed sequence
5656908|NCT00674908|Healthy infants|healthy infants
5656909|NCT00674895|Idiopathic Parkinson's Disease|idiopathic parkinson's disease
5656910|NCT00674895|Lewy Body Parkinson's Disease|lewy body parkinson's disease
5656911|NCT00674895|Paralysis Agitans|paralysis agitans
5672661|NCT00611299|Immune response|immune response
5656912|NCT00674895|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
5656913|NCT00674895|Parkinson's Disease, Lewy Body|parkinson's disease, lewy body
5656915|NCT00674882|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5656916|NCT00674882|Follow-up studies|follow-up studies
5656917|NCT00674882|Outcomes research|outcomes research
5656918|NCT00674882|Data collection|data collection
5656919|NCT00674869|sealant|sealant
5656920|NCT00674869|pit|pit
5656921|NCT00674869|child|child
5656922|NCT00674869|over|over
5656923|NCT00674869|6 years old|6 years old
5656924|NCT00674869|least|least
5656925|NCT00674843|MYOTONIC DYSTROPHY|myotonic dystrophy
5656926|NCT00674843|MYOPATHIES|myopathies
5656927|NCT00674843|Distal Myopathies|distal myopathies
5656928|NCT00674843|Muscular Dystrophy, Duchenne|muscular dystrophy, duchenne
5656929|NCT00674843|Phosphorylase Deficiency (McArdle Disease)|phosphorylase deficiency (mcardle disease)
5656930|NCT00674817|salbutamol,|salbutamol,
5656931|NCT00674817|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5656932|NCT00674817|GSK961081 muscarinic receptor antagonist,|gsk961081 muscarinic receptor antagonist,
5656933|NCT00674817|COPD|copd
5656934|NCT00674817|ipratropium bromide,|ipratropium bromide,
5656935|NCT00674817|Asthma|asthma
5656936|NCT00674817|ß2-adrenergic agonist,|ß2-adrenergic agonist,
5656937|NCT00674804|Communicating a Diagnosis|communicating a diagnosis
5656938|NCT00674804|Cancer Diagnosis|cancer diagnosis
5656939|NCT00674804|Recurrence of Cancer|recurrence of cancer
5656940|NCT00674804|Initial Cancer Diagnosis|initial cancer diagnosis
5656941|NCT00674791|Immunotherapeutic vaccine|immunotherapeutic vaccine
5656942|NCT00674791|breast cancer|breast cancer
5656943|NCT00674791|TxN2-3M0 breast cancer|txn2-3m0 breast cancer
5656944|NCT00674791|metastatic breast cancer|metastatic breast cancer
5656945|NCT00674791|immunotherapy|immunotherapy
5656946|NCT00674791|antigen|antigen
5659451|NCT00665353|HIV|hiv
5656953|NCT00674739|perianal warts|perianal warts
5656954|NCT00674739|condylomata acuminata|condylomata acuminata
5656955|NCT00674739|venereal warts|venereal warts
5656956|NCT00674739|HPV types 6 and 11|hpv types 6 and 11
5656957|NCT00674726|appendicitis|appendicitis
5656958|NCT00674726|gastroenteritis|gastroenteritis
5656959|NCT00674726|temperature|temperature
5656960|NCT00674726|fever|fever
5656961|NCT00674726|acute abdomen|acute abdomen
5656962|NCT00674726|Axilo-rectal temperature in appendicitis|axilo-rectal temperature in appendicitis
5656963|NCT00674726|Axilo-rectal temperature in gastroenteritis|axilo-rectal temperature in gastroenteritis
5656964|NCT00674713|Patients undergoing laparoscopic cholecystectomy for cholelithiasis|patients undergoing laparoscopic cholecystectomy for cholelithiasis
5656965|NCT00674700|House dust mites allergy|house dust mites allergy
5656966|NCT00674674|topotecan|topotecan
5656967|NCT00674674|pharmacokinetics|pharmacokinetics
5656968|NCT00674674|neoplastic|neoplastic
5656969|NCT00674674|meningitis|meningitis
5656970|NCT00674661|ectasia|ectasia
5656971|NCT00674661|cross-linking|cross-linking
5656972|NCT00674661|crosslinking|crosslinking
5656973|NCT00674661|cornea|cornea
5656974|NCT00674661|riboflavin|riboflavin
5656975|NCT00674661|UVA|uva
5656976|NCT00674648|Multiple Diseases|multiple diseases
5656977|NCT00674648|Hematopoietic System|hematopoietic system
5656978|NCT00674648|CMV-PP65 PROTEIN SPECIFIC T CELLS|cmv-pp65 protein specific t cells
5656979|NCT00674635|adaptive study,|adaptive study,
5656980|NCT00674635|DAS28,|das28,
5656981|NCT00674635|monoclonal antibody|monoclonal antibody
5656982|NCT00674635|GSK315234A;|gsk315234a;
5656983|NCT00674635|rheumatoid arthritis,|rheumatoid arthritis,
5656984|NCT00674622|Lateral epicondylitis|lateral epicondylitis
5656986|NCT00674622|Prolotherapy|prolotherapy
5656987|NCT00674609|Palliative Care|palliative care
5656988|NCT00674609|Pain|pain
5656989|NCT00674609|Cancer|cancer
5656990|NCT00674596|PTX3, ramipril, endothelial dysfunction|ptx3, ramipril, endothelial dysfunction
5656991|NCT00674596|1- Diabetic proteinuria|1- diabetic proteinuria
5656992|NCT00674596|2- The aim of this study was to find out whether the|2- the aim of this study was to find out whether the
5656993|NCT00674596|beneficial effects of RAS blockage in diabetic|beneficial effects of ras blockage in diabetic
5657396|NCT00673114|AML|aml
5657397|NCT00673114|ALL|all
5657007|NCT00674557|recurrent breast cancer|recurrent breast cancer
5657008|NCT00674557|stage IIIA breast cancer|stage iiia breast cancer
5657009|NCT00674557|stage IIIB breast cancer|stage iiib breast cancer
5657010|NCT00674557|stage IIIC breast cancer|stage iiic breast cancer
5657011|NCT00674557|stage IV breast cancer|stage iv breast cancer
5657012|NCT00674557|HER2-negative breast cancer|her2-negative breast cancer
5657013|NCT00674557|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5657014|NCT00674557|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5657018|NCT00674544|physical activity|physical activity
5657019|NCT00674544|nutrition|nutrition
5657020|NCT00674544|fitness|fitness
5657021|NCT00674544|family|family
5657022|NCT00674531|Arteriosclerosis|arteriosclerosis
5657023|NCT00674531|Arterial Occlusive Diseases|arterial occlusive diseases
5657024|NCT00674531|Enterovirus|enterovirus
5657025|NCT00674531|Artery resection|artery resection
5657026|NCT00674518|Health Promotion|health promotion
5657027|NCT00674518|Health Behavior Change|health behavior change
5657028|NCT00674518|Physical Activity|physical activity
5657029|NCT00674518|Dietary Change|dietary change
5657030|NCT00674518|Weight Loss|weight loss
5657031|NCT00674518|Obesity|obesity
5657047|NCT00674466|GLP-1, incretin, type 2 diabetes|glp-1, incretin, type 2 diabetes
5657048|NCT00674453|Osteoporosis|osteoporosis
5657049|NCT00674453|lasofoxifene|lasofoxifene
5657050|NCT00674453|bone density|bone density
5657051|NCT00674453|bone markers|bone markers
5657059|NCT00674427|AML|aml
5657060|NCT00674427|ALL|all
5657061|NCT00674427|MDS|mds
5657062|NCT00674427|CLL|cll
5657063|NCT00674427|Multiple Myeloma|multiple myeloma
5657064|NCT00674414|stage IA breast cancer|stage ia breast cancer
5657065|NCT00674414|stage IB breast cancer|stage ib breast cancer
5657066|NCT00674414|stage II breast cancer|stage ii breast cancer
5657067|NCT00674414|stage IIIA breast cancer|stage iiia breast cancer
5657068|NCT00674414|HER2-positive breast cancer|her2-positive breast cancer
5657069|NCT00674388|Children|children
5657070|NCT00674388|Anesthesia|anesthesia
5657071|NCT00674388|Surgery|surgery
5657072|NCT00674388|Complication|complication
5657073|NCT00674375|Chest Pain|chest pain
5657074|NCT00674375|Acute Myocardial Infarction|acute myocardial infarction
5657075|NCT00674375|Patient Safety|patient safety
5657076|NCT00674375|Misdiagnosis|misdiagnosis
5657077|NCT00674362|Rheumatoid Arthritis|rheumatoid arthritis
5657078|NCT00674362|Moderate to Low Disease activity|moderate to low disease activity
5657079|NCT00674362|Certolizumab pegol|certolizumab pegol
5657080|NCT00674336|Norovirus|norovirus
5657081|NCT00674336|Gastroenteritis|gastroenteritis
5657082|NCT00674336|Clinical Trial|clinical trial
5657083|NCT00674336|Stomach flu|stomach flu
5657084|NCT00674336|Oysters|oysters
5657085|NCT00674336|Shellfish|shellfish
5657086|NCT00674336|high hydrostatic pressures|high hydrostatic pressures
5657087|NCT00674323|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5657088|NCT00674323|PCV|pcv
5657089|NCT00674323|Age-related macular degeneration (AMD) variant|age-related macular degeneration (amd) variant
5657091|NCT00674323|polyps|polyps
5657398|NCT00673114|CML|cml
5657092|NCT00674323|indocyanine green angiography|indocyanine green angiography
5657093|NCT00674323|verteporfin|verteporfin
5657094|NCT00674323|ranibizumab|ranibizumab
5657095|NCT00674323|photodynamic therapy|photodynamic therapy
5657096|NCT00674297|Persistently Antiphospholipid Antibody Positive Patients|persistently antiphospholipid antibody positive patients
5657097|NCT00674271|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5657098|NCT00674271|Mannose-Binding lectin|mannose-binding lectin
5657099|NCT00674271|Toll-Like Receptors|toll-like receptors
5657100|NCT00674271|Atherosclerosis|atherosclerosis
5657101|NCT00674271|Carotid Arteries|carotid arteries
5657102|NCT00674271|Diabetes Complications|diabetes complications
5657103|NCT00674271|Diabetic Angiopathies|diabetic angiopathies
5657104|NCT00674258|HLA-A*2402|hla-a*2402
5657105|NCT00674258|Peptide Vaccine|peptide vaccine
5657107|NCT00674258|TTK|ttk
5657108|NCT00674258|KOC1|koc1
5657109|NCT00674245|heartburn|heartburn
5657110|NCT00674245|acid reflux|acid reflux
5657111|NCT00674245|GERD|gerd
5657112|NCT00674245|spectrum analysis|spectrum analysis
5657113|NCT00674245|electroencephalogram|electroencephalogram
5657114|NCT00674245|esophagitis|esophagitis
5657115|NCT00674245|peptic|peptic
5657116|NCT00674232|incomplete abortion|incomplete abortion
5657117|NCT00674232|spontaneous miscarriage|spontaneous miscarriage
5657118|NCT00674219|Obsessive-compulsive disorder|obsessive-compulsive disorder
5657119|NCT00674219|Generalized anxiety disorder|generalized anxiety disorder
5657120|NCT00674219|Memantine|memantine
5657121|NCT00674219|Namenda|namenda
5657122|NCT00674206|Metastatic breast cancer|metastatic breast cancer
5657123|NCT00674154|Vitamin D|vitamin d
5657124|NCT00674154|Primary hyperparathyroidism|primary hyperparathyroidism
5657125|NCT00674154|hypercalcemia|hypercalcemia
5657126|NCT00674141|Multiple Sclerosis, relapsing remitting, Dexamethasone|multiple sclerosis, relapsing remitting, dexamethasone
5657127|NCT00674128|pacemaker|pacemaker
5657128|NCT00674128|cardioverter-defibrillator|cardioverter-defibrillator
5657130|NCT00674128|cardiac resynchronization device|cardiac resynchronization device
5657131|NCT00674128|cyanoacrylate|cyanoacrylate
5657132|NCT00674128|suture|suture
5657133|NCT00674128|Dermabond|dermabond
5657134|NCT00674128|Vicryl|vicryl
5657135|NCT00674102|Vascular disrupting agent|vascular disrupting agent
5657137|NCT00674089|IMR|imr
5657138|NCT00674089|Newborn Mortality|newborn mortality
5657139|NCT00674089|Vitamin A Effectiveness|vitamin a effectiveness
5657140|NCT00674089|Premature Mortality|premature mortality
5657141|NCT00674089|Mortality|mortality
5657142|NCT00674063|Chronic Plaque Psoriasis|chronic plaque psoriasis
5657143|NCT00674063|Alefacept|alefacept
5657144|NCT00674050|Healthy Males or Females subjects|healthy males or females subjects
5657145|NCT00674037|recruitment|recruitment
5657146|NCT00674037|physicians participating in the recruitment of patients|physicians participating in the recruitment of patients
5657147|NCT00674024|Pazopanib|pazopanib
5657148|NCT00674024|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5657149|NCT00674024|Advanced Cancer|advanced cancer
5657150|NCT00674024|Pharmacokinetics|pharmacokinetics
5657151|NCT00674024|Cancer|cancer
5657152|NCT00674024|Solid Tumor|solid tumor
5657153|NCT00674024|Lymphoma|lymphoma
5657154|NCT00674011|hypertension|hypertension
5657155|NCT00674011|bevacizumab|bevacizumab
5657156|NCT00674011|metastatic breast cancer|metastatic breast cancer
5657157|NCT00673998|Isokinetic|isokinetic
5657158|NCT00673998|Fatigue|fatigue
5657159|NCT00673998|Strength|strength
5657160|NCT00673998|Older|older
5657161|NCT00673985|SFA, Edwards, Popliteal, LifeStent, PTA, Nitinol|sfa, edwards, popliteal, lifestent, pta, nitinol
5657162|NCT00673972|Functional dyspepsia|functional dyspepsia
5657163|NCT00673972|Gastric emptying|gastric emptying
5657164|NCT00673972|Helicobacter pylori|helicobacter pylori
5657165|NCT00673972|Lansoprazole|lansoprazole
5657166|NCT00673972|Epigastric pain syndrome|epigastric pain syndrome
5657167|NCT00673972|Postprandial distress syndrome|postprandial distress syndrome
5657168|NCT00673959|Dry eye|dry eye
5657169|NCT00673959|artificial tears|artificial tears
5657170|NCT00673946|bronchiolitis|bronchiolitis
5657172|NCT00673946|oximetry|oximetry
5657173|NCT00673946|pediatrics|pediatrics
5657174|NCT00673920|RA|ra
5657175|NCT00673907|Wood smoke|wood smoke
5657176|NCT00673907|Health effects|health effects
5657177|NCT00673907|Human|human
5657178|NCT00673907|Airway inflammation|airway inflammation
5657179|NCT00673907|Cardiovascular effects|cardiovascular effects
5657180|NCT00673855|Dry eye|dry eye
5657181|NCT00673855|Artificial tear|artificial tear
5657182|NCT00673842|Noninvasive assessment|noninvasive assessment
5657183|NCT00673842|Holter|holter
5657184|NCT00673829|Breast Cancer|breast cancer
5657185|NCT00673829|T cells|t cells
5657186|NCT00673829|Gene Transfer|gene transfer
5657187|NCT00673816|Von Hippel Lindau|von hippel lindau
5657188|NCT00673816|Sunitinib Malate|sunitinib malate
5657189|NCT00673816|Sutent|sutent
5657190|NCT00673816|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5657191|NCT00673816|VHL|vhl
5657214|NCT00673751|Glucagon-Like Peptide 2|glucagon-like peptide 2
5657215|NCT00673738|Lung|lung
5657216|NCT00673738|Thoracic|thoracic
5657217|NCT00673738|Immunotherapy|immunotherapy
5657218|NCT00673738|Radiotherapy|radiotherapy
5657219|NCT00673738|LA - NSCLC|la - nsclc
5657220|NCT00673738|Non-Small Cell Lung Cancer|non-small cell lung cancer
5657221|NCT00673725|Atopic Dermatitis|atopic dermatitis
5657222|NCT00673712|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5657223|NCT00673712|Pneumonia|pneumonia
5657224|NCT00673712|Surgical Site Infection|surgical site infection
5657225|NCT00673699|NBI|nbi
5657226|NCT00673699|gastroscopy|gastroscopy
5657227|NCT00673699|biopsy|biopsy
5657228|NCT00673699|intestinal metaplasia|intestinal metaplasia
5657229|NCT00673686|Oral contraceptive|oral contraceptive
5657230|NCT00673686|Ovulation|ovulation
5657231|NCT00673686|Missing pills|missing pills
5657232|NCT00673686|Intake compliance|intake compliance
5657233|NCT00673686|Cycle control|cycle control
5657234|NCT00673660|Statins|statins
5657235|NCT00673660|Compliance|compliance
5657236|NCT00673660|Dyslipidemia|dyslipidemia
5657237|NCT00673647|cannabis|cannabis
5657238|NCT00673647|dependence|dependence
5657239|NCT00673647|marijuana|marijuana
5657240|NCT00673647|CBT|cbt
5657241|NCT00673647|efficacy of CBT for cannabis use disorders|efficacy of cbt for cannabis use disorders
5657242|NCT00673634|preoxygenation|preoxygenation
5657243|NCT00673634|method|method
5657244|NCT00673634|efficiency|efficiency
5657245|NCT00673634|obesity|obesity
5657246|NCT00673634|BiPAP|bipap
5657247|NCT00673634|FeO2|feo2
5657248|NCT00673621|Asthmatics and non-asthmatic male and female subjects|asthmatics and non-asthmatic male and female subjects
5657249|NCT00673608|Haemoglobinopathies,|haemoglobinopathies,
5657250|NCT00673608|Myelodysplastic Syndromes,|myelodysplastic syndromes,
5657251|NCT00673608|Transfusional iron overload,|transfusional iron overload,
5657252|NCT00673608|cardiac iron load|cardiac iron load
5657253|NCT00673595|smoking|smoking
5657254|NCT00673595|varenicline|varenicline
5657255|NCT00673595|flow-mediated dilation|flow-mediated dilation
5657256|NCT00673595|blood pressure|blood pressure
5657257|NCT00673595|baroreflex|baroreflex
5657258|NCT00673582|Statins|statins
5657259|NCT00673582|Intima Media Thickness|intima media thickness
5657260|NCT00673582|Plaque Area|plaque area
5657261|NCT00673569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5657262|NCT00673569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5657263|NCT00673569|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5657264|NCT00673569|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5657265|NCT00673556|Chronic Plaque Psoriasis|chronic plaque psoriasis
5657266|NCT00673556|Alefacept|alefacept
5657267|NCT00673543|Corticosteroids|corticosteroids
5657268|NCT00673543|Pregnancy|pregnancy
5657269|NCT00673543|Glucose control|glucose control
5657270|NCT00673530|Hospital malnutrition|hospital malnutrition
5657271|NCT00673530|Nutritional Status|nutritional status
5657272|NCT00673530|Nutrition Assessment|nutrition assessment
5657273|NCT00673530|Enteral Nutrition|enteral nutrition
5657274|NCT00673530|Parenteral Nutrition|parenteral nutrition
5657275|NCT00673530|Severity of illness index|severity of illness index
5657276|NCT00673530|cost analysis|cost analysis
5657277|NCT00673517|Acute respiratory distress syndrome|acute respiratory distress syndrome
5657278|NCT00673517|Ventilator induced lung injury|ventilator induced lung injury
5657279|NCT00673517|High frequency oscillation|high frequency oscillation
5657280|NCT00673517|Lung protective ventilation|lung protective ventilation
5657281|NCT00673517|Biomarkers|biomarkers
5657282|NCT00673517|Biotrauma|biotrauma
5657283|NCT00673504|cancer|cancer
5657284|NCT00673504|pancreatic cancer|pancreatic cancer
5657285|NCT00673504|gemcitabine|gemcitabine
5657286|NCT00673504|sunitinib|sunitinib
5657287|NCT00673504|Phase 2|phase 2
5657288|NCT00673491|Critical Pathways|critical pathways
5657289|NCT00673491|Stroke|stroke
5657290|NCT00673491|Randomized Controlled Trial|randomized controlled trial
5657291|NCT00673491|Effectiveness|effectiveness
5657594|NCT00672295|Paclitaxel|paclitaxel
5657292|NCT00673439|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5657293|NCT00673439|thrombocytopenia|thrombocytopenia
5657295|NCT00673439|thrombosis|thrombosis
5657296|NCT00673439|blood clot|blood clot
5657297|NCT00673439|blood thinner|blood thinner
5657298|NCT00673439|anticoagulant|anticoagulant
5657299|NCT00673439|heparin|heparin
5657300|NCT00673439|warfarin|warfarin
5657301|NCT00673439|fondaparinux|fondaparinux
5657302|NCT00673439|Arixtra|arixtra
5657303|NCT00673426|enoxaparin|enoxaparin
5657304|NCT00673426|chronic renal disease|chronic renal disease
5657305|NCT00673426|Anticoagulant activity of enoxaparin sodic|anticoagulant activity of enoxaparin sodic
5657306|NCT00673413|Perception|perception
5657307|NCT00673413|Emotions|emotions
5657308|NCT00673413|Adaptation|adaptation
5657309|NCT00673413|Estomia|estomia
5657310|NCT00673400|Obstructed defecation syndrome|obstructed defecation syndrome
5657312|NCT00673400|Rectocele|rectocele
5657313|NCT00673400|Intussusception|intussusception
5657314|NCT00673400|STARR|starr
5657315|NCT00673387|overweight|overweight
5657316|NCT00673387|obesity|obesity
5657317|NCT00673387|pramlintide|pramlintide
5657318|NCT00673387|metreleptin|metreleptin
5657319|NCT00673387|Amylin|amylin
5657320|NCT00673374|emergency|emergency
5657321|NCT00673374|acute|acute
5657322|NCT00673374|nontraumatic|nontraumatic
5657323|NCT00673374|abdominal pain|abdominal pain
5657324|NCT00673374|tenderness|tenderness
5657325|NCT00673374|CT scan|ct scan
5657326|NCT00673374|radiation|radiation
5657327|NCT00673374|diagnosis|diagnosis
5657328|NCT00673348|Mycoses|mycoses
5657329|NCT00673348|Voriconazole|voriconazole
5657330|NCT00673335|breast cancer|breast cancer
5657331|NCT00673335|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5657332|NCT00673335|BRCA1 mutation carrier|brca1 mutation carrier
5657333|NCT00673335|BRCA2 mutation carrier|brca2 mutation carrier
5657334|NCT00673322|Colorectal Cancer|colorectal cancer
5657335|NCT00673322|T cells|t cells
5657336|NCT00673322|Gene Transfer|gene transfer
5657337|NCT00673309|burns|burns
5657338|NCT00673296|Bevacizumab|bevacizumab
5657339|NCT00673296|Diabetic premacular hemorrhage|diabetic premacular hemorrhage
5657340|NCT00673296|Intravitreal gas|intravitreal gas
5657341|NCT00673283|lung cancer|lung cancer
5657342|NCT00673283|nodules|nodules
5657343|NCT00673283|radiography|radiography
5657344|NCT00673283|CT|ct
5657345|NCT00673283|Stereoscopy|stereoscopy
5657346|NCT00673257|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5657347|NCT00673244|Renal Replacement Therapy|renal replacement therapy
5657348|NCT00673244|Dialysis|dialysis
5657349|NCT00673231|Dapagliflozin|dapagliflozin
5657350|NCT00673231|efficacy|efficacy
5657351|NCT00673231|safety|safety
5657352|NCT00673231|add on to insulin|add on to insulin
5657353|NCT00673231|Oral AntiDiabetic|oral antidiabetic
5657354|NCT00673231|Type 2 diabetes|type 2 diabetes
5657355|NCT00673218|IL13|il13
5657356|NCT00673218|Cytokines|cytokines
5657357|NCT00673218|Basophil stimulation|basophil stimulation
5657358|NCT00673205|androgen antagonists|androgen antagonists
5657359|NCT00673205|prostate neoplasms|prostate neoplasms
5657360|NCT00673179|Doxorubicin|doxorubicin
5657362|NCT00673179|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5657363|NCT00673179|Cisplatin|cisplatin
5657364|NCT00673179|Paraplatin®|paraplatin®
5657365|NCT00673179|Methotrexate|methotrexate
5657366|NCT00673179|Ifosfamide|ifosfamide
5657367|NCT00673179|Osteosarcoma|osteosarcoma
5657368|NCT00673179|Sargramostim|sargramostim
5657369|NCT00673179|Leukine™|leukine™
5657370|NCT00673179|Leucovorin|leucovorin
5657371|NCT00673179|Gemcitabine|gemcitabine
5657373|NCT00673179|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5657374|NCT00673179|GM-CSF|gm-csf
5657375|NCT00673179|Questionnaire|questionnaire
5657376|NCT00673179|Survey|survey
5657377|NCT00673166|Staff motivation|staff motivation
5657378|NCT00673166|Hospital mortality|hospital mortality
5657379|NCT00673166|Perception of quality of care|perception of quality of care
5657380|NCT00673140|ALS (Amyotrophic Lateral Sclerosis)|als (amyotrophic lateral sclerosis)
5657381|NCT00673140|Amyotrophic Lateral Sclerosis With Dementia|amyotrophic lateral sclerosis with dementia
5657382|NCT00673140|Amyotrophic Lateral Sclerosis, Guam Form|amyotrophic lateral sclerosis, guam form
5657383|NCT00673140|Dementia With Amyotrophic Lateral Sclerosis|dementia with amyotrophic lateral sclerosis
5657384|NCT00673140|Gehrig's Disease|gehrig's disease
5657385|NCT00673140|Guam Form of Amyotrophic Lateral Sclerosis|guam form of amyotrophic lateral sclerosis
5657386|NCT00673140|Lou Gehrig Disease|lou gehrig disease
5657387|NCT00673127|hormone refractory|hormone refractory
5657388|NCT00673127|KHAD|khad
5657389|NCT00673127|ketoconazole|ketoconazole
5657390|NCT00673127|dutasteride|dutasteride
5657391|NCT00673127|hydrocortisone|hydrocortisone
5657392|NCT00673114|Haplo/cord|haplo/cord
5657393|NCT00673114|hematologic malignancy|hematologic malignancy
5657394|NCT00673114|MDS|mds
5657395|NCT00673114|Aplastic Anemia|aplastic anemia
5657399|NCT00673101|liver fibrosis, cirrhosis|liver fibrosis, cirrhosis
5657400|NCT00673101|FibroScan|fibroscan
5657401|NCT00673101|transient elastography|transient elastography
5657402|NCT00673101|elastometry|elastometry
5657403|NCT00673101|methotrexate|methotrexate
5657404|NCT00673101|non invasive blood markers|non invasive blood markers
5657405|NCT00673101|FibroTest|fibrotest
5657406|NCT00673101|treatment|treatment
5657407|NCT00673075|carvedilol|carvedilol
5657408|NCT00673075|Coreg (TM)|coreg (tm)
5657409|NCT00673075|hypertension|hypertension
5657410|NCT00673075|blood pressure|blood pressure
5657411|NCT00673075|coronary artery disease|coronary artery disease
5657412|NCT00673075|Nebivolol|nebivolol
5657413|NCT00673075|BYSTOLIC (TM)|bystolic (tm)
5657415|NCT00673049|Non small cell lung cancer|non small cell lung cancer
5657416|NCT00673049|CP-751|cp-751
5657417|NCT00673049|871|871
5657418|NCT00673049|Figitumumab|figitumumab
5657419|NCT00673036|Coronary syndrome|coronary syndrome
5657420|NCT00673036|Myocardial infarction|myocardial infarction
5657421|NCT00673036|French registry|french registry
5657422|NCT00673010|124-IODINE|124-iodine
5657423|NCT00673010|I-131 METAIODOBENZ SULF (MIBG)|i-131 metaiodobenz sulf (mibg)
5657424|NCT00673010|Thyroid|thyroid
5657425|NCT00673010|Parathyroid|parathyroid
5657426|NCT00672997|Glaucoma|glaucoma
5657427|NCT00672997|Hypertension|hypertension
5657428|NCT00672984|QT/QTc|qt/qtc
5657429|NCT00672958|Major Depressive Disorder|major depressive disorder
5657430|NCT00672958|Depression|depression
5657431|NCT00672958|Drug Therapy|drug therapy
5657432|NCT00672958|Major Depressive Episode|major depressive episode
5657433|NCT00672932|raltegravir|raltegravir
5657434|NCT00672932|central nervous system (CNS)|central nervous system (cns)
5657435|NCT00672932|HIV-1|hiv-1
5657436|NCT00672932|AIDS|aids
5657437|NCT00672932|cerebrospinal fluid (CSF)|cerebrospinal fluid (csf)
5657438|NCT00672932|immunoactivation|immunoactivation
5657439|NCT00672932|antiretroviral therapy|antiretroviral therapy
5657440|NCT00672932|suppression|suppression
5657441|NCT00672919|Glucose Metabolism Disorder|glucose metabolism disorder
5657442|NCT00672919|Dysmetabolic Syndrome|dysmetabolic syndrome
5657443|NCT00672919|Type II Diabetes|type ii diabetes
5657444|NCT00672919|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5657445|NCT00672919|Dyslipidemia|dyslipidemia
5657446|NCT00672919|Drug Therapy|drug therapy
5657447|NCT00672906|anorexia nervosa|anorexia nervosa
5657448|NCT00672906|group parent training|group parent training
5657449|NCT00672906|caregiver burden|caregiver burden
5657450|NCT00672906|eating disorders|eating disorders
5657451|NCT00672906|treatment|treatment
5672662|NCT00611299|Blood lipids|blood lipids
5657452|NCT00672893|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment|central airway stenosis, lung sounds, airway obstruction, bronchial obstruction, bronchoscopic treatment
5657453|NCT00672880|Chronic low back pain accompanied by depression|chronic low back pain accompanied by depression
5657454|NCT00672854|parenteral nutrition|parenteral nutrition
5657455|NCT00672854|lipid emulsion|lipid emulsion
5657456|NCT00672854|nosocomial infection|nosocomial infection
5657458|NCT00672854|endothelial function|endothelial function
5657459|NCT00672854|inflammatory markers|inflammatory markers
5657460|NCT00672854|oxidative stress|oxidative stress
5657461|NCT00672854|immune function|immune function
5657462|NCT00672854|autonomic nervous system|autonomic nervous system
5657463|NCT00672854|insulin sensitivity|insulin sensitivity
5657464|NCT00672854|carbohydrate metabolism|carbohydrate metabolism
5657465|NCT00672841|candidemia|candidemia
5657466|NCT00672841|invasive candidiasis|invasive candidiasis
5657467|NCT00672841|preemptive antifungal therapy|preemptive antifungal therapy
5657468|NCT00672841|surveillance|surveillance
5657469|NCT00672841|β-D-Glucan (BDG)|β-d-glucan (bdg)
5657470|NCT00672828|colon cancer|colon cancer
5657471|NCT00672828|rectal cancer|rectal cancer
5657472|NCT00672815|coordinated school health|coordinated school health
5657473|NCT00672815|school health policy evaluation|school health policy evaluation
5657474|NCT00672815|physical activity|physical activity
5657475|NCT00672802|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5657477|NCT00672802|Insomnia|insomnia
5657478|NCT00672802|Drug Therapy|drug therapy
5657479|NCT00672789|Sickle cell anemia|sickle cell anemia
5657480|NCT00672789|Children|children
5657481|NCT00672789|Hydroxyurea|hydroxyurea
5657482|NCT00672789|Treatment Adherence|treatment adherence
5657483|NCT00672776|hippocampus|hippocampus
5657484|NCT00672776|paroxetine|paroxetine
5657485|NCT00672776|stress|stress
5657486|NCT00672776|PTSD|ptsd
5657487|NCT00672763|Crohn's Disease|crohn's disease
5657488|NCT00672763|Inflammatory Bowel Disease|inflammatory bowel disease
5657489|NCT00672763|Vitamin D|vitamin d
5657490|NCT00672763|Randomised|randomised
5657491|NCT00672763|Placebo|placebo
5657492|NCT00672750|laparoscopic|laparoscopic
5657493|NCT00672750|myomectomy|myomectomy
5657494|NCT00672750|menorrhagia|menorrhagia
5657495|NCT00672750|pelvic pain|pelvic pain
5657496|NCT00672724|Insomnia|insomnia
5657497|NCT00672724|Sleep Disorder|sleep disorder
5657595|NCT00672295|Taxol|taxol
5657498|NCT00672724|Drug Therapy|drug therapy
5657499|NCT00672711|Complex Regional Pain Syndrome|complex regional pain syndrome
5657500|NCT00672711|Chronic Post-surgical Pain|chronic post-surgical pain
5657501|NCT00672711|Genetic susceptibility|genetic susceptibility
5657502|NCT00672711|COMT|comt
5657503|NCT00672698|SURGICAL RISK|surgical risk
5657504|NCT00672698|ELDERLY|elderly
5657505|NCT00672698|MAJOR SURGERY|major surgery
5657506|NCT00672698|P-POSSUM|p-possum
5657507|NCT00672698|SAPS II|saps ii
5657508|NCT00672685|Cognitive decline|cognitive decline
5657509|NCT00672685|omega-3 fatty acids|omega-3 fatty acids
5657510|NCT00672685|nutrition|nutrition
5657511|NCT00672685|physical exercise|physical exercise
5657512|NCT00672685|cognitive training|cognitive training
5657513|NCT00672685|social activities|social activities
5657514|NCT00672685|frailty|frailty
5680399|NCT00577980|Testosterone|testosterone
5680400|NCT00577980|CRPC|crpc
5657515|NCT00672672|Wound healing of surgical site treated with autologous platlet gel|wound healing of surgical site treated with autologous platlet gel
5657516|NCT00672659|Lost of interest, Depressed Mood|lost of interest, depressed mood
5657517|NCT00672646|Analgesic effect|analgesic effect
5657518|NCT00672633|Omega 3 Fatty Acids|omega 3 fatty acids
5657519|NCT00672633|Triglycerides|triglycerides
5657520|NCT00672633|Lovaza|lovaza
5657521|NCT00672633|Trial|trial
5657522|NCT00672620|Major Depressive Disorder|major depressive disorder
5657523|NCT00672620|Depression|depression
5657524|NCT00672620|Drug Therapy|drug therapy
5657525|NCT00672620|Major Depressive Episode|major depressive episode
5657526|NCT00672607|premenstual syndrome, PMS, clinical trial|premenstual syndrome, pms, clinical trial
5657527|NCT00672581|Hepatic Impairment|hepatic impairment
5657528|NCT00672568|Rotator cuff, Shoulder, Arthroscopic shoulder surgery|rotator cuff, shoulder, arthroscopic shoulder surgery
5657529|NCT00672555|pilonidal sinus|pilonidal sinus
5657530|NCT00672555|recurrence|recurrence
5657531|NCT00672555|Limberg flap|limberg flap
5657532|NCT00672542|melanoma|melanoma
5657533|NCT00672542|dendritic cell|dendritic cell
5657534|NCT00672542|immunoproteasome|immunoproteasome
5657535|NCT00672542|vaccine|vaccine
5657536|NCT00672529|Childhood Asthma|childhood asthma
5657537|NCT00672529|Inhaled Corticosteroids|inhaled corticosteroids
5657538|NCT00672529|Alternative Medicine|alternative medicine
5657539|NCT00672529|Vitamins, minerals, and fish oil as Add-on Treatment|vitamins, minerals, and fish oil as add-on treatment
5657540|NCT00672516|hemorrhage|hemorrhage
5657541|NCT00672516|cardiopulmonary bypass|cardiopulmonary bypass
5657542|NCT00672516|blood component transfusion|blood component transfusion
5657543|NCT00672516|hemostasis, surgical|hemostasis, surgical
5657544|NCT00672503|indwelling urinary catheters|indwelling urinary catheters
5657545|NCT00672503|urinary tract infections|urinary tract infections
5657546|NCT00672503|foley-catheter related infections|foley-catheter related infections
5657547|NCT00672503|hospital acquired CA-UTI|hospital acquired ca-uti
5657549|NCT00672490|Bipolar Disorder|bipolar disorder
5657550|NCT00672490|Quetiapine Fumarate|quetiapine fumarate
5657551|NCT00672490|Lithium|lithium
5657552|NCT00672477|opioid-induced constipation|opioid-induced constipation
5657553|NCT00672464|Schizophrenia|schizophrenia
5657554|NCT00672464|Schizoaffective|schizoaffective
5657555|NCT00672464|Cardiovascular|cardiovascular
5657556|NCT00672464|Olanzapine|olanzapine
5657557|NCT00672464|Metformin|metformin
5657558|NCT00672464|Simvastatin|simvastatin
5657559|NCT00672451|diabetic kidney disease|diabetic kidney disease
5657566|NCT00672386|Diabetes|diabetes
5657567|NCT00672386|Type 2 Diabetes|type 2 diabetes
5657568|NCT00672386|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
5657569|NCT00672386|Metabolic Syndrome|metabolic syndrome
5657570|NCT00672386|HbA1c|hba1c
5657571|NCT00672386|Body Weight|body weight
5657572|NCT00672386|Metformin|metformin
5657573|NCT00672373|Tardive Dyskinesia|tardive dyskinesia
5657574|NCT00672373|Schizophrenia|schizophrenia
5657575|NCT00672373|Extract of Gingko Biloba|extract of gingko biloba
5657576|NCT00672360|Autism Spectrum Disorder|autism spectrum disorder
5657577|NCT00672347|caudal anesthesia, clonidine, morphine, bupivacaine|caudal anesthesia, clonidine, morphine, bupivacaine
5657578|NCT00672334|Cardiac surgery|cardiac surgery
5657579|NCT00672334|Cardiopulmonary bypass|cardiopulmonary bypass
5657580|NCT00672334|Oxidative stress|oxidative stress
5657581|NCT00672334|Acute renal dysfunction|acute renal dysfunction
5657582|NCT00672334|Sodium bicarbonate|sodium bicarbonate
5657583|NCT00672321|recurrent melanoma|recurrent melanoma
5657584|NCT00672321|stage IB melanoma|stage ib melanoma
5657585|NCT00672321|stage II melanoma|stage ii melanoma
5657586|NCT00672321|stage IIIA melanoma|stage iiia melanoma
5657587|NCT00672308|Cholera, benefiber, ORS|cholera, benefiber, ors
5657588|NCT00672295|Ovarian Cancer|ovarian cancer
5657589|NCT00672295|Peritoneal Cancer|peritoneal cancer
5657590|NCT00672295|Tubal Cancer|tubal cancer
5638353|NCT00745927|Colonoscopy|colonoscopy
5657591|NCT00672295|Fallopian Tube Cancer|fallopian tube cancer
5657592|NCT00672295|Dasatinib|dasatinib
5657593|NCT00672295|Sprycel|sprycel
5657596|NCT00672295|Carboplatin|carboplatin
5657598|NCT00672282|androgen antagonists|androgen antagonists
5657599|NCT00672282|prostate neoplasms|prostate neoplasms
5657600|NCT00672269|carcinoid|carcinoid
5657601|NCT00672269|family members|family members
5657602|NCT00672269|familial|familial
5657603|NCT00672269|tumors|tumors
5657604|NCT00672269|cancer|cancer
5657605|NCT00672256|Smoking|smoking
5657606|NCT00672256|fMRI|fmri
5657608|NCT00672243|Brain tumor|brain tumor
5657609|NCT00672243|Erlotinib|erlotinib
5657610|NCT00672243|Sirolimus|sirolimus
5657611|NCT00672243|Glioblastoma multiforme|glioblastoma multiforme
5657612|NCT00672243|Glioblastoma|glioblastoma
5657613|NCT00672243|Gliosarcoma3|gliosarcoma3
5657614|NCT00672243|Tarceva|tarceva
5657615|NCT00672243|Rapamune|rapamune
5657616|NCT00672230|Lactation|lactation
5657617|NCT00672230|Breast milk|breast milk
5657618|NCT00672230|Lutein|lutein
5657619|NCT00672230|Lutein supplement|lutein supplement
5657620|NCT00672217|Breast cancer survivors, insomnia, quality of life|breast cancer survivors, insomnia, quality of life
5657621|NCT00672204|Islet transplant|islet transplant
5657622|NCT00672204|Diabetes Mellitus|diabetes mellitus
5657623|NCT00672204|Hypoglycemia|hypoglycemia
5657625|NCT00672191|Human immunodeficiency virus|human immunodeficiency virus
5657626|NCT00672191|Immunodeficiency Virus, Human|immunodeficiency virus, human
5657627|NCT00672191|HIV-1|hiv-1
5657628|NCT00672191|ART|art
5657629|NCT00672191|antiretroviral therapy|antiretroviral therapy
5657630|NCT00672191|HAART|haart
5657631|NCT00672191|highly active retroviral therapy|highly active retroviral therapy
5657632|NCT00672191|cluster of differentiation CD 4+ T cell counts|cluster of differentiation cd 4+ t cell counts
5657633|NCT00672191|HIV-1 Subjects successfully ART treated|hiv-1 subjects successfully art treated
5657634|NCT00672191|Treatment Experienced|treatment experienced
5657635|NCT00672178|RCC|rcc
5657636|NCT00672178|metastatic|metastatic
5657637|NCT00672178|sorafenib|sorafenib
5657638|NCT00672165|MAB HUM 195 ACTINIUM-225 LABELED|mab hum 195 actinium-225 labeled
5657639|NCT00672165|HEMATOPOIETIC SYSTEM|hematopoietic system
5657640|NCT00672165|02-017|02-017
5657641|NCT00672152|Autologous transplantation|autologous transplantation
5657642|NCT00672152|Allogeneic transplantation|allogeneic transplantation
5657643|NCT00672139|Opioid-Induced Constipation|opioid-induced constipation
5657644|NCT00672100|Peripheral Nerve Infusion,|peripheral nerve infusion,
5657645|NCT00672100|continuous brachial plexus block,|continuous brachial plexus block,
5657646|NCT00672100|post-operative pain|post-operative pain
5657647|NCT00672100|diaphragmatic paresis|diaphragmatic paresis
5657648|NCT00672087|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
5657649|NCT00672087|Chronic Bacterial Prostatitis|chronic bacterial prostatitis
5657650|NCT00672087|Asymptomatic Inflammatory Prostatitis|asymptomatic inflammatory prostatitis
5657651|NCT00672087|Painful Bladder Syndrome|painful bladder syndrome
5657652|NCT00672087|Cystitis, Interstitial|cystitis, interstitial
5657653|NCT00672074|Postoperative Ileus|postoperative ileus
5657654|NCT00672061|Sleep Apnea, Obstructive|sleep apnea, obstructive
5657655|NCT00672061|Insomnia|insomnia
5657656|NCT00672061|Drug Therapy|drug therapy
5657657|NCT00672048|glaucoma|glaucoma
5657658|NCT00672048|optometrists|optometrists
5657660|NCT00672035|Healthy Adults|healthy adults
5657661|NCT00672035|Dose Ranging|dose ranging
5657662|NCT00672035|Patch|patch
5657663|NCT00672035|Vaccine|vaccine
5657664|NCT00672009|prostate cancer|prostate cancer
5657665|NCT00672009|radical prostatectomy|radical prostatectomy
5657666|NCT00672009|ixabepilone|ixabepilone
5657667|NCT00671970|Glioblastoma|glioblastoma
5657668|NCT00671970|Gliosarcoma|gliosarcoma
5657669|NCT00671970|Recurrent MG|recurrent mg
5657670|NCT00671970|Malignant glioma|malignant glioma
5657671|NCT00671970|Glioma|glioma
5657672|NCT00671970|Glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5657674|NCT00671970|Brain tumor|brain tumor
5657675|NCT00671970|Anaplastic astrocytoma|anaplastic astrocytoma
5657676|NCT00671970|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5657677|NCT00671970|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5657678|NCT00671970|Bevacizumab|bevacizumab
5657679|NCT00671970|Avastin|avastin
5657680|NCT00671970|Erlotinib|erlotinib
5657681|NCT00671970|Tarceva|tarceva
5657682|NCT00671957|Obesity|obesity
5657683|NCT00671957|Bariatric|bariatric
5657684|NCT00671957|Surgery|surgery
5657685|NCT00671957|Activity|activity
5657686|NCT00671944|protein|protein
5657687|NCT00671944|calcium|calcium
5657688|NCT00671944|parathyroid hormone|parathyroid hormone
5657689|NCT00671944|bone markers|bone markers
5657690|NCT00671944|calcium kinetics|calcium kinetics
5657691|NCT00671944|absorption|absorption
5657692|NCT00671931|dexmedetomidine|dexmedetomidine
5657693|NCT00671931|neuromonitoring|neuromonitoring
5657694|NCT00671931|spine procedures|spine procedures
5657695|NCT00671931|safe dose|safe dose
5657798|NCT00671606|Sentinel Node Identification|sentinel node identification
5657799|NCT00671606|Lymph Node|lymph node
5660142|NCT00662415|fMRI|fmri
5657696|NCT00671931|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring|1- safe dose of dexmedetomidine when used in total intravenous anesthesia for procedures require neuromonitoring
5657697|NCT00671931|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring|2- safe dose of propofol when uses in comination with dexmedetomidine in neuromontoring
5657698|NCT00671931|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials|3effect of dexmedetomidine on somatosensory evoked potential and motor evoked potentials
5657699|NCT00671918|breast cancer|breast cancer
5657701|NCT00671918|melanoma|melanoma
5657702|NCT00671918|surgery|surgery
5657703|NCT00671905|atrial fibrillation|atrial fibrillation
5657704|NCT00671905|PV isolation|pv isolation
5657705|NCT00671905|ablation|ablation
5657706|NCT00671905|ganglionic plexi|ganglionic plexi
5680401|NCT00577980|TRT|trt
5657707|NCT00671905|parasympathetic denervation|parasympathetic denervation
5657708|NCT00671892|LPS endotoxin|lps endotoxin
5657709|NCT00671892|asthma|asthma
5657710|NCT00671866|OP|op
5657711|NCT00671866|Pesticides|pesticides
5657712|NCT00671866|Long-Term Low Level Exposure|long-term low level exposure
5657713|NCT00671866|Occupational Health|occupational health
5657714|NCT00671866|Neurobehavioral Effects|neurobehavioral effects
5657715|NCT00671853|Bipolar Disorder|bipolar disorder
5657716|NCT00671853|Anxiety|anxiety
5657717|NCT00671853|Anxiety Disorders|anxiety disorders
5657718|NCT00671853|Substance Use Disorders|substance use disorders
5657719|NCT00671827|Gynecologic Cancer|gynecologic cancer
5657720|NCT00671827|Cervical Cancer|cervical cancer
5657721|NCT00671827|Endometrial Cancer|endometrial cancer
5657722|NCT00671827|Fallopian Tube Cancer|fallopian tube cancer
5657723|NCT00671827|Ovarian Cancer|ovarian cancer
5657724|NCT00671827|Uterine Cancer|uterine cancer
5657725|NCT00671827|Vaginal Cancer|vaginal cancer
5657726|NCT00671827|Vulvar Cancer|vulvar cancer
5657727|NCT00671827|Questionnaire|questionnaire
5657728|NCT00671827|Survey|survey
5657729|NCT00671827|Robot-Assisted Surgery|robot-assisted surgery
5657730|NCT00671814|antibiotic|antibiotic
5657731|NCT00671801|Malignant Gliomas|malignant gliomas
5657732|NCT00671801|Glioblastoma Multiforme|glioblastoma multiforme
5657733|NCT00671801|Gliosarcoma|gliosarcoma
5657734|NCT00671801|Anaplastic Astrocytoma|anaplastic astrocytoma
5657735|NCT00671801|Anaplastic Oligodendroglioma|anaplastic oligodendroglioma
5657736|NCT00671801|Anaplastic Oligoastrocytoma|anaplastic oligoastrocytoma
5657737|NCT00671801|Camptosar|camptosar
5657738|NCT00671801|Irinotecan|irinotecan
5657739|NCT00671801|CPT-11|cpt-11
5657740|NCT00671801|Lenalidomide|lenalidomide
5657741|NCT00671801|Revlimid|revlimid
5657742|NCT00671801|CC-5013|cc-5013
5657743|NCT00671775|Bariatric Surgery|bariatric surgery
5657744|NCT00671775|Obesity|obesity
5657745|NCT00671775|Cognitive Function|cognitive function
5657746|NCT00671736|cystic fibrosis|cystic fibrosis
5657747|NCT00671736|Moli1901|moli1901
5657748|NCT00671736|Lancovutide|lancovutide
5657749|NCT00671736|2622U90|2622u90
5657750|NCT00671736|duramycin|duramycin
5657751|NCT00671736|lung|lung
5657752|NCT00671723|Atelectasis|atelectasis
5657753|NCT00671710|malignant glial brain tumors|malignant glial brain tumors
5657759|NCT00671684|Endoscopy, digestive system|endoscopy, digestive system
5657760|NCT00671684|Diagnosis|diagnosis
5657761|NCT00671684|Colonoscopy|colonoscopy
5657762|NCT00671658|Lymphoma|lymphoma
5657763|NCT00671658|HYPER-CVAD|hyper-cvad
5657764|NCT00671658|Leukemia|leukemia
5657765|NCT00671658|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5657766|NCT00671658|ALL|all
5657767|NCT00671658|Remission Duration|remission duration
5657768|NCT00671658|Chemotherapy|chemotherapy
5657769|NCT00671658|Asparaginase|asparaginase
5657770|NCT00671658|Cyclophosphamide|cyclophosphamide
5657771|NCT00671658|Cytarabine|cytarabine
5657772|NCT00671658|Dexamethasone|dexamethasone
5657773|NCT00671658|Doxorubicin|doxorubicin
5657774|NCT00671658|Leukine|leukine
5657775|NCT00671658|Methotrexate|methotrexate
5657776|NCT00671658|Rituximab|rituximab
5657777|NCT00671658|Vincristine|vincristine
5657778|NCT00671645|pilot study|pilot study
5657779|NCT00671645|rectal|rectal
5657780|NCT00671645|carcinoma|carcinoma
5657781|NCT00671645|phase II|phase ii
5657782|NCT00671645|preoperative|preoperative
5657783|NCT00671645|RadioChemo|radiochemo
5657784|NCT00671645|molecular|molecular
5657785|NCT00671645|target|target
5657786|NCT00671645|therapy|therapy
5657787|NCT00671645|T3|t3
5657788|NCT00671645|ABCSG|abcsg
5657789|NCT00671645|TAKO|tako
5657790|NCT00671645|R04|r04
5657791|NCT00671645|08|08
5657792|NCT00671632|Addiction|addiction
5657793|NCT00671619|opthalmology|opthalmology
5657794|NCT00671619|antibody fragment|antibody fragment
5657795|NCT00671619|TNF alpha|tnf alpha
5657796|NCT00671606|Endometrial Cancer|endometrial cancer
5657797|NCT00671606|Lymphatic Mapping|lymphatic mapping
5658170|NCT00670254|Sepsis|sepsis
5657800|NCT00671606|Intraoperative lymphatic mapping|intraoperative lymphatic mapping
5657801|NCT00671606|Total hysterectomy|total hysterectomy
5657802|NCT00671606|Bilateral salpingooophorectomy|bilateral salpingooophorectomy
5657803|NCT00671606|Lymph node staging|lymph node staging
5657804|NCT00671606|Laparotomy|laparotomy
5657805|NCT00671606|Laparoscopy|laparoscopy
5657806|NCT00671593|Allergy|allergy
5657807|NCT00671593|Asthma|asthma
5657808|NCT00671593|healthy|healthy
5657809|NCT00671593|Normal|normal
5657810|NCT00671580|Skin Infections|skin infections
5657811|NCT00671580|Complicated Skin and Skin Structure Infections|complicated skin and skin structure infections
5657812|NCT00671567|Sleep Disorder|sleep disorder
5657813|NCT00671567|Insomnia|insomnia
5657814|NCT00671554|Melanoma|melanoma
5657815|NCT00671554|Dendritic cells|dendritic cells
5657816|NCT00671554|Cell therapy|cell therapy
5657817|NCT00671554|BCG vaccine|bcg vaccine
5657818|NCT00671528|Impetiginous|impetiginous
5657819|NCT00671515|Depressive Disorder, Major|depressive disorder, major
5657820|NCT00671515|Metabolic Syndrome X|metabolic syndrome x
5657821|NCT00671515|pioglitazone|pioglitazone
5657822|NCT00671489|Patients|patients
5657823|NCT00671489|high-energy|high-energy
5657824|NCT00671489|admitted|admitted
5657825|NCT00671489|intensive care unit|intensive care unit
5657826|NCT00671489|motor vehicle accident|motor vehicle accident
5657827|NCT00671489|falling from height|falling from height
5657828|NCT00671489|other accident|other accident
5657829|NCT00671476|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5657830|NCT00671463|Pancreas surgery|pancreas surgery
5657831|NCT00671463|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5657832|NCT00671463|Pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor
5657833|NCT00671463|Pancreatic duct stenting|pancreatic duct stenting
5657834|NCT00671437|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5657835|NCT00671424|Interaction,|interaction,
5657836|NCT00671424|Diabetes,|diabetes,
5657837|NCT00671424|healthy male subjects|healthy male subjects
5657838|NCT00671424|GSK189075,|gsk189075,
5657839|NCT00671424|Diuretics,|diuretics,
5657840|NCT00671411|Ultrasound|ultrasound
5657841|NCT00671411|07-165|07-165
5657842|NCT00671398|Insomnia|insomnia
5657843|NCT00671398|Sleep Disorder|sleep disorder
5657844|NCT00671398|Drug Therapy|drug therapy
5657845|NCT00671385|screening|screening
5657846|NCT00671385|compositional analysis|compositional analysis
5657847|NCT00671385|metabolism|metabolism
5657848|NCT00671385|breast|breast
5657849|NCT00671385|breast cyst|breast cyst
5657850|NCT00671385|breast infection|breast infection
5657851|NCT00671385|breast inflammation|breast inflammation
5657852|NCT00671385|lipoma|lipoma
5657853|NCT00671385|benign growth|benign growth
5657854|NCT00671385|Women without a diagnosis for a region of interest in the breast|women without a diagnosis for a region of interest in the breast
5657855|NCT00671372|CRC|crc
5657856|NCT00671372|Metastatic CRC|metastatic crc
5657857|NCT00671372|APO2L/TRAIL|apo2l/trail
5657858|NCT00671359|Food effects|food effects
5657859|NCT00671346|Cancer|cancer
5657860|NCT00671346|Coronary artery disease|coronary artery disease
5657862|NCT00671346|Cerebrovascular stroke|cerebrovascular stroke
5657863|NCT00671346|Homocysteine|homocysteine
5657864|NCT00671346|Vitamin B Complex|vitamin b complex
5657865|NCT00671346|Folic acid|folic acid
5657866|NCT00671346|Vitamin B12|vitamin b12
5657867|NCT00671346|Vitamin B6|vitamin b6
5657868|NCT00671346|Pyridoxal phosphate|pyridoxal phosphate
5657869|NCT00671346|Osteoporotic fractures|osteoporotic fractures
5657870|NCT00671346|Diabetes|diabetes
5657871|NCT00671333|Randomized|randomized
5657872|NCT00671333|Prospective|prospective
5657873|NCT00671333|Procedure / Surgery|procedure / surgery
5657874|NCT00671320|acute ankle sprain, acute pain, South America|acute ankle sprain, acute pain, south america
5657875|NCT00671307|Gelsolin|gelsolin
5657876|NCT00671307|Trauma|trauma
5657877|NCT00671307|Pneumonia|pneumonia
5657878|NCT00671307|Peritonitis|peritonitis
5657879|NCT00671307|Burn|burn
5657880|NCT00671307|Infection|infection
5657881|NCT00671307|Sepsis|sepsis
5657882|NCT00671307|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5657883|NCT00671294|Insomnia|insomnia
5657884|NCT00671281|FESS|fess
5657885|NCT00671281|Tranexamic acid|tranexamic acid
5657886|NCT00671281|Hemostasis|hemostasis
5657887|NCT00671281|Visualization|visualization
5657888|NCT00671268|Grass pollen allergy|grass pollen allergy
5657889|NCT00671268|specific immunotherapy|specific immunotherapy
5657890|NCT00671255|Chronic Insomnia|chronic insomnia
5657891|NCT00671255|Drug Therapy|drug therapy
5657892|NCT00671255|Elderly|elderly
5657893|NCT00671242|Fluorine-18-α-methyltyrosine,|fluorine-18-α-methyltyrosine,
5657894|NCT00671242|Positron emission tomography,|positron emission tomography,
5657895|NCT00671242|Fluorine-18-fluorodeoxyglucose,|fluorine-18-fluorodeoxyglucose,
5657896|NCT00671242|Lung cancer,|lung cancer,
5657897|NCT00671242|Angiogenesis|angiogenesis
5657898|NCT00671242|The median VEGF rate was 45% (range, 10-78%).|the median vegf rate was 45% (range, 10-78%).
5657983|NCT00671086|Drug Therapy|drug therapy
5658171|NCT00670254|Septic|septic
5657899|NCT00671242|High expression was seen in 30 patients (81%, 30/37).|high expression was seen in 30 patients (81%, 30/37).
5657900|NCT00671242|VEGF expression was statistically associated with progressively growing microvessel count.|vegf expression was statistically associated with progressively growing microvessel count.
5657901|NCT00671229|Healthy|healthy
5657902|NCT00671229|Asthma|asthma
5657903|NCT00671229|Nitric Oxide|nitric oxide
5657904|NCT00671216|safety|safety
5657905|NCT00671216|pharmacodynamics|pharmacodynamics
5657906|NCT00671216|Muscarinic Receptor Antagonist|muscarinic receptor antagonist
5657907|NCT00671216|tolerability|tolerability
5657908|NCT00671216|healthy subjects|healthy subjects
5657909|NCT00671216|GS642444|gs642444
5657910|NCT00671216|GSK233705|gsk233705
5657911|NCT00671216|Anticholinergic|anticholinergic
5657912|NCT00671216|ß2 agonist|ß2 agonist
5657913|NCT00671216|pharmacokinetics|pharmacokinetics
5657914|NCT00671203|Tissue oximetry|tissue oximetry
5657915|NCT00671203|Ischemia|ischemia
5657916|NCT00671203|Aortic Aneurysm Repair|aortic aneurysm repair
5657917|NCT00671203|Aortic Stent|aortic stent
5657918|NCT00671203|Vascular Stent|vascular stent
5657919|NCT00671203|Aortic graft|aortic graft
5657920|NCT00671203|Vascular graft|vascular graft
5657921|NCT00671190|Sleep Disorder|sleep disorder
5657922|NCT00671190|Circadian Rhythm Sleep Disorder|circadian rhythm sleep disorder
5657923|NCT00671190|Drug Therapy|drug therapy
5657924|NCT00671177|colonoscopy|colonoscopy
5657925|NCT00671177|diagnostic techniques|diagnostic techniques
5657926|NCT00671177|digestive system|digestive system
5657927|NCT00671177|endoscopy|endoscopy
5657928|NCT00671177|gastrointestinal|gastrointestinal
5657929|NCT00671151|COPD exacerbation|copd exacerbation
5657930|NCT00671151|histone|histone
5657931|NCT00671151|steroid resistance|steroid resistance
5657932|NCT00671151|inflammation|inflammation
5657933|NCT00671151|theophylline|theophylline
5657934|NCT00671138|Celiac disease|celiac disease
5657935|NCT00671138|Parasitic infections|parasitic infections
5657936|NCT00671138|necator americanus|necator americanus
5657937|NCT00671138|Immunity|immunity
5657938|NCT00671125|Sleep Disorder|sleep disorder
5657939|NCT00671125|Insomnia|insomnia
5847941|NCT00037531|Kidney|kidney
5657940|NCT00671125|Drug Therapy|drug therapy
5657941|NCT00671112|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5657942|NCT00671112|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5657943|NCT00671112|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5657944|NCT00671112|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5657945|NCT00671112|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5657946|NCT00671112|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5657947|NCT00671112|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5657948|NCT00671112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5657950|NCT00671112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5657951|NCT00671112|refractory hairy cell leukemia|refractory hairy cell leukemia
5657952|NCT00671112|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5657953|NCT00671112|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5657955|NCT00671112|cutaneous B and T cell lymphoma|cutaneous b and t cell lymphoma
5657956|NCT00671112|transformed lymphoma|transformed lymphoma
5657957|NCT00671112|transformed B and T cell cutaneous lymphoma|transformed b and t cell cutaneous lymphoma
5657958|NCT00671112|relapsed or refractory diffuse large B cell lymphoma|relapsed or refractory diffuse large b cell lymphoma
5657959|NCT00671112|extranodal T cell lymphomas|extranodal t cell lymphomas
5657960|NCT00671112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5657961|NCT00671112|angioimmunoblastic T cell lymphoma|angioimmunoblastic t cell lymphoma
5657962|NCT00671112|PTCL-NOS|ptcl-nos
5657963|NCT00671112|nasal or disseminated extranodal T/NK lymphoma|nasal or disseminated extranodal t/nk lymphoma
5657964|NCT00671112|enteropathy-associated T cell lymphoma|enteropathy-associated t cell lymphoma
5657965|NCT00671112|hepatosplenic gamma/delta T cell lymphoma|hepatosplenic gamma/delta t cell lymphoma
5657966|NCT00671112|subcutaneous panniculitis-like T cell lymphoma|subcutaneous panniculitis-like t cell lymphoma
5657967|NCT00671112|T-prolymphocytic leukemia|t-prolymphocytic leukemia
5657968|NCT00671112|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5657969|NCT00671112|large granular lymphocytic leukemia|large granular lymphocytic leukemia
5657970|NCT00671112|aggressive NK leukemia|aggressive nk leukemia
5657971|NCT00671099|Patients|patients
5657972|NCT00671099|with high-energy|with high-energy
5657973|NCT00671099|admitted|admitted
5657974|NCT00671099|intensive care unit|intensive care unit
5657975|NCT00671099|motor vehicle accident|motor vehicle accident
5657976|NCT00671099|falling from height|falling from height
5657977|NCT00671099|other accident|other accident
5657978|NCT00671086|Chronic Insomnia|chronic insomnia
5657979|NCT00671086|DIMS (Disorders of Initiating and Maintaining Sleep)|dims (disorders of initiating and maintaining sleep)
5657980|NCT00671086|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5657981|NCT00671086|Insomnia Disorder Sleep Initiation Dysfunction|insomnia disorder sleep initiation dysfunction
5657988|NCT00671073|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5657989|NCT00671073|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5657991|NCT00671073|COAD|coad
5657992|NCT00671060|intrauterine fetal death|intrauterine fetal death
5657993|NCT00671060|misoprostol|misoprostol
5657994|NCT00671047|Autoimmune Diseases|autoimmune diseases
5657995|NCT00671047|Lupus|lupus
5657996|NCT00671021|platelet aggregation|platelet aggregation
5657997|NCT00671021|aspirin|aspirin
5680402|NCT00577967|Uremic pruritis|uremic pruritis
5680403|NCT00577954|Coma|coma
5657998|NCT00670995|Tobacco use among middle and junior high school students remains a concern among health educators.|tobacco use among middle and junior high school students remains a concern among health educators.
5657999|NCT00670995|The use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.|the use of tobacco prevention programs and their integration into school-based curricula has been lacking due to a number of factors.
5658000|NCT00670982|HER2 positive|her2 positive
5658001|NCT00670982|bevacizumab|bevacizumab
5658002|NCT00670982|vinorelbine|vinorelbine
5658003|NCT00670982|trastuzumab|trastuzumab
5658004|NCT00670969|Obesity|obesity
5658005|NCT00670956|prenatal steroids|prenatal steroids
5658006|NCT00670956|hydrops|hydrops
5658007|NCT00670956|congenital cystic adenomatoid malformation of the lung|congenital cystic adenomatoid malformation of the lung
5658008|NCT00670956|prenatal intervention|prenatal intervention
5658009|NCT00670956|betamethasone|betamethasone
5658010|NCT00670956|prenatal diagnosis|prenatal diagnosis
5658011|NCT00670943|Clopidogrel discontinuation|clopidogrel discontinuation
5658012|NCT00670943|Platelet aggregation|platelet aggregation
5671720|NCT00614653|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5658013|NCT00670930|Asthma, adults, anti-immunoglobulin E ( IgE), omalizumab, airway inflammation, airway remodeling, allergy|asthma, adults, anti-immunoglobulin e ( ige), omalizumab, airway inflammation, airway remodeling, allergy
5658014|NCT00670917|pain|pain
5658015|NCT00670917|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5658016|NCT00670904|Smoking cessation|smoking cessation
5658017|NCT00670904|Pharmacist-delivered|pharmacist-delivered
5658018|NCT00670865|Hospitalization|hospitalization
5658019|NCT00670865|Continuity of care|continuity of care
5658020|NCT00670865|Discharge summary|discharge summary
5658021|NCT00670865|Quality improvement|quality improvement
5658022|NCT00670865|Medical records systems|medical records systems
5658023|NCT00670865|Hospital information systems|hospital information systems
5658024|NCT00670852|Glenoid component|glenoid component
5658025|NCT00670852|radiolucent lines|radiolucent lines
5658026|NCT00670852|Glenoid loosening|glenoid loosening
5658027|NCT00670852|glenohumeral arthritis|glenohumeral arthritis
5658028|NCT00670852|autologous bone graft|autologous bone graft
5658029|NCT00670839|Hepatitis B vaccination|hepatitis b vaccination
5658030|NCT00670839|GenHevac-B Pasteur|genhevac-b pasteur
5658031|NCT00670839|HIV infection|hiv infection
5658032|NCT00670826|Patient warming|patient warming
5658033|NCT00670813|Depression|depression
5658034|NCT00670813|(total) sleep deprivation|(total) sleep deprivation
5658035|NCT00670813|Modafinil|modafinil
5658036|NCT00670813|polysomnography sleep|polysomnography sleep
5658037|NCT00670800|Polycystic Ovary Syndrome|polycystic ovary syndrome
5658038|NCT00670800|Insulin resistance|insulin resistance
5658039|NCT00670800|Metformin|metformin
5658040|NCT00670800|Brain function|brain function
5658041|NCT00670787|Hypertension|hypertension
5658042|NCT00670787|combination pill|combination pill
5658043|NCT00670787|compliance|compliance
5658044|NCT00670774|Kidney|kidney
5658045|NCT00670774|Transplant|transplant
5658046|NCT00670774|donor|donor
5658047|NCT00670761|misoprostol|misoprostol
5658048|NCT00670761|incomplete abortion|incomplete abortion
5658049|NCT00670761|sublingual|sublingual
5658050|NCT00670761|postabortion care|postabortion care
5658052|NCT00670748|Metastatic Cancer|metastatic cancer
5658053|NCT00670748|Gene Therapy|gene therapy
5658054|NCT00670748|Immunotherapy|immunotherapy
5658055|NCT00670748|Tumor Regression|tumor regression
5658056|NCT00670748|Metastatic Melanoma|metastatic melanoma
5658057|NCT00670748|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5658058|NCT00670735|Pediatric Hydrocephalus|pediatric hydrocephalus
5658059|NCT00670709|encephalography|encephalography
5658060|NCT00670709|quantitative|quantitative
5658061|NCT00670709|biomarkers|biomarkers
5658062|NCT00670696|Topical anesthesia|topical anesthesia
5658063|NCT00670696|Rapydan|rapydan
5658065|NCT00670657|candidemia|candidemia
5658066|NCT00670657|invasive candidiasis|invasive candidiasis
5658067|NCT00670657|Ambisome|ambisome
5658068|NCT00670657|liposomal amphotericin B|liposomal amphotericin b
5658069|NCT00670644|male breast cancer|male breast cancer
5658070|NCT00670644|recurrent breast cancer|recurrent breast cancer
5658071|NCT00670644|stage I breast cancer|stage i breast cancer
5658072|NCT00670644|stage II breast cancer|stage ii breast cancer
5658073|NCT00670644|stage IIIA breast cancer|stage iiia breast cancer
5658074|NCT00670644|stage IIIB breast cancer|stage iiib breast cancer
5658075|NCT00670644|stage IIIC breast cancer|stage iiic breast cancer
5658076|NCT00670644|stage IV breast cancer|stage iv breast cancer
5658077|NCT00670631|Multiple Myeloma|multiple myeloma
5658078|NCT00670631|myeloma|myeloma
5658079|NCT00670605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5658080|NCT00670605|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5658081|NCT00670592|HCD122|hcd122
5658082|NCT00670592|CD40|cd40
5658083|NCT00670592|NHL|nhl
5658084|NCT00670592|HL|hl
5658085|NCT00670579|TIVAD|tivad
5658086|NCT00670579|complications|complications
5658087|NCT00670579|nursing|nursing
5658088|NCT00670579|cystic fibrosis|cystic fibrosis
5658089|NCT00670579|implanted|implanted
5658090|NCT00670553|Prostate,|prostate,
5658091|NCT00670553|Head & Neck,|head & neck,
5658092|NCT00670553|Esophageal|esophageal
5658093|NCT00670540|pulmonary embolism|pulmonary embolism
5658094|NCT00670540|duplex ultrasound examination|duplex ultrasound examination
5658095|NCT00670540|recurrence|recurrence
5658096|NCT00670527|Prostate cancer|prostate cancer
5658097|NCT00670527|[18F] Fluorocholine PET/CT|[18f] fluorocholine pet/ct
5658098|NCT00670527|FCH|fch
5658099|NCT00670527|lymph node metastasis|lymph node metastasis
5658100|NCT00670527|staging|staging
5658101|NCT00670527|sensitivity|sensitivity
5658102|NCT00670527|specificity|specificity
5658103|NCT00670527|PROPET|propet
5658104|NCT00670514|RCT|rct
5658105|NCT00670514|tobacco|tobacco
5658106|NCT00670514|treatment intensity|treatment intensity
5658107|NCT00670514|dentistry|dentistry
5658108|NCT00670514|follow-up|follow-up
5658109|NCT00670514|Smoking cessation|smoking cessation
5658110|NCT00670514|Cost effectiveness|cost effectiveness
5658111|NCT00670475|osteoarthritis|osteoarthritis
5658112|NCT00670475|Knee|knee
5658113|NCT00670475|virgin olive oil|virgin olive oil
5658114|NCT00670475|piroxicam|piroxicam
5658115|NCT00670475|Topical|topical
5658116|NCT00670462|obesity, weight loss, treatment|obesity, weight loss, treatment
5658117|NCT00670449|FTY720|fty720
5658118|NCT00670449|multiple sclerosis|multiple sclerosis
5658119|NCT00670449|MS|ms
5658120|NCT00670423|Tacrolimus|tacrolimus
5658121|NCT00670423|Sirolimus|sirolimus
5658122|NCT00670423|Bortezomib|bortezomib
5658123|NCT00670423|Acute Graft Versus Host Disease|acute graft versus host disease
5658124|NCT00670423|Allogeneic Peripheral Blood Stem Cell Transplantation|allogeneic peripheral blood stem cell transplantation
5658125|NCT00670410|Neuroblastoma|neuroblastoma
5658126|NCT00670410|Autologous Transplant|autologous transplant
5658127|NCT00670410|Allogeneic Transplant|allogeneic transplant
5658128|NCT00670410|Immunotherapy|immunotherapy
5658129|NCT00670397|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5658130|NCT00670397|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5658131|NCT00670397|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5658133|NCT00670384|Immunotherapy|immunotherapy
5658134|NCT00670384|Short ragweed|short ragweed
5658136|NCT00670384|Seasonal allergic rhinitis|seasonal allergic rhinitis
5658137|NCT00670371|Caregiver burden|caregiver burden
5658138|NCT00670358|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5658139|NCT00670358|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5658140|NCT00670358|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5658141|NCT00670358|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5658142|NCT00670358|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5658143|NCT00670358|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5658144|NCT00670358|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5658145|NCT00670358|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5658146|NCT00670345|tranexamic acid|tranexamic acid
5658147|NCT00670345|prostatectomy|prostatectomy
5658148|NCT00670345|surgery|surgery
5658149|NCT00670332|coronary artery disease|coronary artery disease
5658150|NCT00670332|echocardiography|echocardiography
5658151|NCT00670332|cardiac imaging|cardiac imaging
5658152|NCT00670332|heart disease|heart disease
5658153|NCT00670332|ultrasound contrast agent|ultrasound contrast agent
5658154|NCT00670332|prognosis|prognosis
5660555|NCT00661141|ALDH2|aldh2
5658155|NCT00670306|Cetrorelix|cetrorelix
5658157|NCT00670293|Anorexia Nervosa|anorexia nervosa
5658158|NCT00670293|PET Imaging|pet imaging
5658159|NCT00670293|Dopamine|dopamine
5658160|NCT00670280|Neonatal Intensive Care Units|neonatal intensive care units
5658161|NCT00670280|Infant Morbidity|infant morbidity
5658162|NCT00670280|Low Birth Weight|low birth weight
5658163|NCT00670280|Low Income Populations|low income populations
5658164|NCT00670280|MCH Research|mch research
5658165|NCT00670280|Respiratory Illnesses|respiratory illnesses
5658166|NCT00670280|Substance Exposed Infants|substance exposed infants
5658167|NCT00670280|Counseling|counseling
5658168|NCT00670267|Asthma|asthma
5658169|NCT00670267|hyperresponsiveness|hyperresponsiveness
5658172|NCT00670254|Shock|shock
5658173|NCT00670254|Glucocorticoids|glucocorticoids
5658174|NCT00670254|Hydrocortisone|hydrocortisone
5658175|NCT00670215|Prevention of infectious complications|prevention of infectious complications
5658176|NCT00670215|transrectal needle biopsies of the prostate|transrectal needle biopsies of the prostate
5658177|NCT00670215|TRNBP|trnbp
5658178|NCT00670202|Patients scheduled for elective carotid endarterectomy|patients scheduled for elective carotid endarterectomy
5680405|NCT00577954|Stroke|stroke
5658179|NCT00670163|Men Who Have Sex With Men|men who have sex with men
5658180|NCT00670111|Heart failure|heart failure
5658181|NCT00670111|exercise capacity|exercise capacity
5658182|NCT00670111|ejection fraction|ejection fraction
5658183|NCT00670111|Heart failure normal ejection fraction|heart failure normal ejection fraction
5658184|NCT00670059|Single embryo transfer/ aneuploidy screening|single embryo transfer/ aneuploidy screening
5658185|NCT00670046|recurrent prostate cancer|recurrent prostate cancer
5658186|NCT00670046|stage I prostate cancer|stage i prostate cancer
5658187|NCT00670046|stage IIB prostate cancer|stage iib prostate cancer
5658188|NCT00670046|stage IIA prostate cancer|stage iia prostate cancer
5658189|NCT00670046|stage III prostate cancer|stage iii prostate cancer
5658190|NCT00670046|stage IV prostate cancer|stage iv prostate cancer
5658191|NCT00670033|IOP|iop
5658192|NCT00670033|Open-angle glaucoma|open-angle glaucoma
5658193|NCT00670033|Ocular Hypertension|ocular hypertension
5658194|NCT00670020|Women undergoing Cesarean section after the onset of labor|women undergoing cesarean section after the onset of labor
5658195|NCT00670007|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
5658196|NCT00670007|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
5658197|NCT00670007|Emphysema|emphysema
5658198|NCT00670007|Emphysema due to Alpha 1-proteinase inhibitor deficiency|emphysema due to alpha 1-proteinase inhibitor deficiency
5658199|NCT00669994|UTI|uti
5658200|NCT00669994|Urinary Tract Infection|urinary tract infection
5658201|NCT00669981|PTSD|ptsd
5658202|NCT00669981|Relationship Distress|relationship distress
5658203|NCT00669981|Couple Therapy|couple therapy
5658204|NCT00669968|PET myocardial perfusion imaging|pet myocardial perfusion imaging
5658205|NCT00669968|Cardiac PET|cardiac pet
5658206|NCT00669968|Rubidium|rubidium
5658207|NCT00669968|Coronary Artery CT Angiogram|coronary artery ct angiogram
5658208|NCT00669968|Coronary Flow Reserve|coronary flow reserve
5658209|NCT00669968|Adenosine stress test|adenosine stress test
5658210|NCT00669955|H. Pylori|h. pylori
5658211|NCT00669955|Quadruple therapy|quadruple therapy
5658212|NCT00669955|Eradication rate|eradication rate
5658213|NCT00669955|Multinational trial|multinational trial
5658214|NCT00669955|Resistance to antibiotics|resistance to antibiotics
5658215|NCT00669955|Subjects with confirmed Helicobacter Pylori infection|subjects with confirmed helicobacter pylori infection
5658216|NCT00669942|Rheumatoid Arthritis|rheumatoid arthritis
5651408|NCT00696033|FMRI|fmri
5658217|NCT00669929|Cost effectiveness analysis of rotavirus vaccination|cost effectiveness analysis of rotavirus vaccination
5658220|NCT00669890|JMML|jmml
5658221|NCT00669890|MDS|mds
5658222|NCT00669890|Allogenic Atem Cell Transplant|allogenic atem cell transplant
5658223|NCT00669890|Gemtuzumab Ozogamicin|gemtuzumab ozogamicin
5658224|NCT00669877|Burkitt's Lymphoma|burkitt's lymphoma
5658225|NCT00669877|Burkitt's Like Lymphoma|burkitt's like lymphoma
5658226|NCT00669877|Leukemia|leukemia
5658227|NCT00669877|Hyper-CVAD|hyper-cvad
5658228|NCT00669877|Rituximab|rituximab
5658229|NCT00669877|Methotrexate|methotrexate
5658230|NCT00669877|Cytarabine|cytarabine
5658231|NCT00669851|coronary artery disease|coronary artery disease
5658232|NCT00669851|echocardiography|echocardiography
5658233|NCT00669851|cardiac imaging|cardiac imaging
5658234|NCT00669851|heart disease|heart disease
5658235|NCT00669851|ultrasound contrast agent|ultrasound contrast agent
5658236|NCT00669851|myocardial contrast enhancement|myocardial contrast enhancement
5658237|NCT00669851|myocardial perfusion|myocardial perfusion
5658238|NCT00669838|Anesthesia, Local|anesthesia, local
5658239|NCT00669838|Lidocaine|lidocaine
5658240|NCT00669838|Dental care|dental care
5658241|NCT00669838|Arrhythmias, Cardiac|arrhythmias, cardiac
5658242|NCT00669838|Anxiety|anxiety
5658243|NCT00669825|Celiac Disease|celiac disease
5658244|NCT00669812|small intestine lymphoma|small intestine lymphoma
5658245|NCT00669812|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5658246|NCT00669812|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5658247|NCT00669812|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5658248|NCT00669812|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5658249|NCT00669786|Ongoing Pregnancy Rate|ongoing pregnancy rate
5658250|NCT00669760|cystic fibrosis|cystic fibrosis
5658251|NCT00669760|Staphylococcus aureus|staphylococcus aureus
5658252|NCT00669760|persistent colonization-infection|persistent colonization-infection
5658253|NCT00669760|clinical status|clinical status
5658254|NCT00669760|lung function|lung function
5658255|NCT00669747|Ductal Carcinoma In Situ|ductal carcinoma in situ
5658256|NCT00669747|DCIS|dcis
5658257|NCT00669747|Breast Cancer|breast cancer
5658258|NCT00669747|Carboplatin|carboplatin
5658259|NCT00669747|Intraductal|intraductal
5658260|NCT00669721|osteoprotegerin|osteoprotegerin
5658261|NCT00669721|RANKL|rankl
5658262|NCT00669721|heparin|heparin
5658263|NCT00669721|hemodialysis|hemodialysis
5658264|NCT00669721|anticoagulation|anticoagulation
5658265|NCT00669721|vascular calcification|vascular calcification
5658266|NCT00669708|dry skin|dry skin
5658267|NCT00669708|cooling|cooling
5658268|NCT00669708|itch|itch
5658269|NCT00669695|statins|statins
5658270|NCT00669695|cardiovascular risk|cardiovascular risk
5658271|NCT00669695|Obstructive sleep apnea syndrome (OSAS) patients|obstructive sleep apnea syndrome (osas) patients
5658272|NCT00669643|Leprosy|leprosy
5658273|NCT00669643|Communicable Diseases|communicable diseases
5658274|NCT00669643|Skin Diseases|skin diseases
5658275|NCT00669643|Multidrug Therapy|multidrug therapy
5658277|NCT00669643|Uniform Multidrug Therapy|uniform multidrug therapy
5658278|NCT00669643|U-MDT|u-mdt
5658279|NCT00669630|Community-based Participatory Research (CBPR)|community-based participatory research (cbpr)
5658280|NCT00669630|Vulnerable population|vulnerable population
5658281|NCT00669630|High-risk population|high-risk population
5658282|NCT00669630|African-Americans|african-americans
5658283|NCT00669630|Health Disparities|health disparities
5658284|NCT00669630|Clinical Trial|clinical trial
5658285|NCT00669617|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5658286|NCT00669617|COPD|copd
5658287|NCT00669617|indacaterol|indacaterol
5658288|NCT00669617|adults|adults
5658289|NCT00669604|Mother to child transmission of HIV|mother to child transmission of hiv
5658290|NCT00669604|HIV infected children|hiv infected children
5658291|NCT00669591|breast cancer|breast cancer
5658292|NCT00669591|docetaxel chemotherapy|docetaxel chemotherapy
5658293|NCT00669591|bavituximab|bavituximab
5658294|NCT00669591|monoclonal antibody|monoclonal antibody
5658295|NCT00669578|secondary myelofibrosis|secondary myelofibrosis
5658296|NCT00669578|polycythemia vera|polycythemia vera
5658297|NCT00669578|essential thrombocythemia|essential thrombocythemia
5658298|NCT00669578|primary myelofibrosis|primary myelofibrosis
5658299|NCT00669565|Locally Advanced or Metastatic Breast Cancer|locally advanced or metastatic breast cancer
5658300|NCT00669539|Amblyopia associated with strabismus|amblyopia associated with strabismus
5658301|NCT00669539|Refractive error|refractive error
5658302|NCT00669526|anxiety|anxiety
5658303|NCT00669526|depression|depression
5658304|NCT00669526|Major Depressive Disorder|major depressive disorder
5658305|NCT00669526|child|child
5658306|NCT00669526|adolescent|adolescent
5658308|NCT00669526|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5658309|NCT00669526|primary care|primary care
5658310|NCT00669513|partial sleep deprivation|partial sleep deprivation
5658311|NCT00669513|endothelial dysfunction|endothelial dysfunction
5658312|NCT00669513|sympathetic activity|sympathetic activity
5658314|NCT00669500|dietary intake|dietary intake
5658315|NCT00669500|genetic predisposition|genetic predisposition
5658316|NCT00669500|body composition|body composition
5658317|NCT00669487|HIV/AIDS patients|hiv/aids patients
5658318|NCT00669461|Constipation|constipation
5658319|NCT00669461|Parkinson's Disease|parkinson's disease
5658320|NCT00669448|Multiple chemical sensitivities|multiple chemical sensitivities
5658321|NCT00669448|MCS|mcs
5658322|NCT00669448|Mindfulness-based cognitive therapy|mindfulness-based cognitive therapy
5658323|NCT00669448|MBCT|mbct
5658324|NCT00669448|Behavioural intervention|behavioural intervention
5658325|NCT00669448|Stress|stress
5658326|NCT00669448|Illness perceptions|illness perceptions
5658327|NCT00669448|Pilot trial|pilot trial
5658328|NCT00669435|Essential hypertension|essential hypertension
5658329|NCT00669435|Liver steatosis|liver steatosis
5658330|NCT00669422|Ovarian Cancer|ovarian cancer
5658331|NCT00669422|Fallopian Tube Cancer|fallopian tube cancer
5658332|NCT00669422|Peritoneal Cancer|peritoneal cancer
5658333|NCT00669422|Uterine Neoplasms|uterine neoplasms
5658334|NCT00669422|Vulvar Cancer|vulvar cancer
5658335|NCT00669422|Endometrial Cancer|endometrial cancer
5658336|NCT00669422|Cervical Cancer|cervical cancer
5658337|NCT00669422|Assay|assay
5658338|NCT00669422|Chemotherapy|chemotherapy
5658339|NCT00669422|Recurrent|recurrent
5658340|NCT00669422|Refractory|refractory
5658341|NCT00669422|Persistent|persistent
5658342|NCT00669422|Chemoresponse|chemoresponse
5658343|NCT00669422|Sensitivity|sensitivity
5658344|NCT00669422|Precision Therapeutics|precision therapeutics
5658345|NCT00669422|ChemoFx|chemofx
5658346|NCT00669409|monoclonal antibody|monoclonal antibody
5658347|NCT00669396|contraception|contraception
5658348|NCT00669396|emergency contraception|emergency contraception
5658349|NCT00669396|pregnancy prevention after unprotected intercourse|pregnancy prevention after unprotected intercourse
5658350|NCT00669383|premature delivery|premature delivery
5658351|NCT00669383|respiratory distress syndrome|respiratory distress syndrome
5658352|NCT00669370|advanced gastric cancer|advanced gastric cancer
5658353|NCT00669370|adenocarcinoma|adenocarcinoma
5658354|NCT00669357|End stage heart disease|end stage heart disease
5658355|NCT00669344|cognition|cognition
5658356|NCT00669344|stroke|stroke
5658358|NCT00669344|VCIND|vcind
5658359|NCT00669344|Cognitive Impairment, No Dementia|cognitive impairment, no dementia
5658364|NCT00669318|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5658365|NCT00669318|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5658371|NCT00669292|esophageal cancer|esophageal cancer
5658372|NCT00669292|peptide|peptide
5658373|NCT00669292|URLC10|urlc10
5658374|NCT00669292|TTK|ttk
5658375|NCT00669292|CpG7909|cpg7909
5658377|NCT00669214|Moderate plaque psoriasis|moderate plaque psoriasis
5658378|NCT00669214|Severe plaque psoriasis|severe plaque psoriasis
5658379|NCT00669214|Scalp|scalp
5658380|NCT00669201|cartilage|cartilage
5658381|NCT00669201|osteoarthritis|osteoarthritis
5658382|NCT00669201|T2 mapping|t2 mapping
5658383|NCT00669201|MRI|mri
5658384|NCT00669201|Wrist|wrist
5658385|NCT00669175|Naloxone|naloxone
5658386|NCT00669175|Neonate|neonate
5658387|NCT00669175|Pain|pain
5658388|NCT00669149|ptca|ptca
5658389|NCT00669149|antiaggregant therapy|antiaggregant therapy
5658390|NCT00669149|anticoagulant therapy|anticoagulant therapy
5658391|NCT00669136|AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost|afp + gm-csf plasmid prime and afp adenoviral vector boost
5658392|NCT00669136|AFP Immunization|afp immunization
5658393|NCT00669123|Chondroitin sulphate|chondroitin sulphate
5658394|NCT00669123|Knee osteoarthritis|knee osteoarthritis
5658395|NCT00669123|Psoriasis|psoriasis
5658396|NCT00669110|MDD|mdd
5658397|NCT00669110|Depression|depression
5658398|NCT00669110|Pediatrics|pediatrics
5658399|NCT00669110|Major Depressive Disorder|major depressive disorder
5658400|NCT00669097|ADME|adme
5658401|NCT00669097|TKI258|tki258
5658402|NCT00669097|RTKs inhibitor|rtks inhibitor
5658403|NCT00669097|PDGRF inhibitor|pdgrf inhibitor
5658404|NCT00669097|VEGFER inhibitor|vegfer inhibitor
5658405|NCT00669084|Innate Immunity|innate immunity
5658406|NCT00669084|Malaria|malaria
5658407|NCT00669084|Plasmodium|plasmodium
5658408|NCT00669084|Hemoglobinopathy|hemoglobinopathy
5658409|NCT00669084|G6PD Deficiency|g6pd deficiency
5658410|NCT00669058|hygiene|hygiene
5658411|NCT00669045|TNKase|tnkase
5658412|NCT00669045|AMI|ami
5658413|NCT00669006|neuropathic pain|neuropathic pain
5658414|NCT00669006|database|database
5658415|NCT00669006|prospective|prospective
5658416|NCT00669006|national|national
5658417|NCT00668980|Down syndrome|down syndrome
5658418|NCT00668980|symbolic representation|symbolic representation
5658419|NCT00668980|gestures|gestures
5658420|NCT00668980|expressive language development|expressive language development
5658421|NCT00668967|Cardiovascular Diseases|cardiovascular diseases
5658422|NCT00668967|Hypertension|hypertension
5658423|NCT00668954|Diabetes|diabetes
5658424|NCT00668954|Pomegranate|pomegranate
5658425|NCT00668954|Biomarkers|biomarkers
5658426|NCT00668954|Antioxidant|antioxidant
5658427|NCT00668941|Bone Density|bone density
5658428|NCT00668941|Bone Turnover|bone turnover
5658429|NCT00668941|Histomorphometry|histomorphometry
5658431|NCT00668902|Pantoprazole|pantoprazole
5658432|NCT00668902|Genotype|genotype
5658433|NCT00668902|Pharmacokinetics|pharmacokinetics
5658434|NCT00668902|Metabolism|metabolism
5658435|NCT00668889|Hygiene|hygiene
5658436|NCT00668876|immunonutrition|immunonutrition
5658437|NCT00668876|pancreaticoduodenectomy|pancreaticoduodenectomy
5658438|NCT00668876|Th1|th1
5658439|NCT00668876|Th2|th2
5658440|NCT00668876|Th17|th17
5658441|NCT00668837|Paliperidone|paliperidone
5658442|NCT00668837|schizophrenia|schizophrenia
5658443|NCT00668824|Congenital Heart Disease (CHD)|congenital heart disease (chd)
5658444|NCT00668811|thyroid cancer|thyroid cancer
5658445|NCT00668811|metastatic thyroid cancer|metastatic thyroid cancer
5658446|NCT00668811|differentiated thyroid cancer|differentiated thyroid cancer
5658447|NCT00668811|papillary thyroid cancer|papillary thyroid cancer
5658448|NCT00668811|follicular thyroid cancer|follicular thyroid cancer
5658449|NCT00668811|Histologically confirmed|histologically confirmed
5658450|NCT00668811|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer|metastatic stage 2,stage 3, or stage 4 differentiated thyroid cancer
5658451|NCT00668798|cytomegalovirus breast milk preterm infants transmission|cytomegalovirus breast milk preterm infants transmission
5658452|NCT00668798|transmission of CMV via thawed frozen breast milk|transmission of cmv via thawed frozen breast milk
5658453|NCT00668785|Ranibizumab|ranibizumab
5658454|NCT00668785|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5798783|NCT00111085|cerebral vasospasm|cerebral vasospasm
5658455|NCT00668785|Macular Edema following Panretinal Photocoagulation|macular edema following panretinal photocoagulation
5658456|NCT00668785|Safety and Efficacy|safety and efficacy
5658457|NCT00668785|Intravitreal Injection|intravitreal injection
5658458|NCT00668759|atrial fibrillation|atrial fibrillation
5658459|NCT00668759|atrial fib|atrial fib
5659347|NCT00665821|sick leave|sick leave
5658461|NCT00668746|chronic periodontitis, antibiotic resistance|chronic periodontitis, antibiotic resistance
5658462|NCT00668733|Actinic keratoses|actinic keratoses
5658463|NCT00668733|Dermatologic disease|dermatologic disease
5658464|NCT00668720|tinnitus|tinnitus
5658465|NCT00668720|transcranial magnetic stimulation|transcranial magnetic stimulation
5658466|NCT00668707|melatonin|melatonin
5658467|NCT00668707|natural health product (NHP)|natural health product (nhp)
5658468|NCT00668707|lung cancer|lung cancer
5658469|NCT00668707|complementary and alternative medicine (CAM)|complementary and alternative medicine (cam)
5658470|NCT00668707|randomized clinical trial|randomized clinical trial
5680406|NCT00577954|SAH|sah
5680407|NCT00577954|Cerebral Anoxia|cerebral anoxia
5680408|NCT00577954|Multimodal MRI|multimodal mri
5639257|NCT00742417|Senile|senile
5658471|NCT00668694|Psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of IDA infants.|psychosocial stimulation in addition to iron supplementation will improve mental and psychomotor development, language, behavior and growth of ida infants.
5658472|NCT00668694|With the addition of stimulation IDA infants will catch up to the non-anemic infants.|with the addition of stimulation ida infants will catch up to the non-anemic infants.
5658473|NCT00668681|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5658474|NCT00668655|Rosacea, metronidazole|rosacea, metronidazole
5658475|NCT00668629|Hygiene|hygiene
5658476|NCT00668616|breast cancer with 1-3 afflicted axillary lymph nodes|breast cancer with 1-3 afflicted axillary lymph nodes
5658477|NCT00668603|Postmenopausal vasomotor symptoms|postmenopausal vasomotor symptoms
5658478|NCT00668603|Hot flush|hot flush
5658479|NCT00668603|Vascular function|vascular function
5658480|NCT00668603|Cardiac function|cardiac function
5658481|NCT00668603|Cardiovascular risk factor|cardiovascular risk factor
5658482|NCT00668590|Diabetes|diabetes
5658483|NCT00668577|Hygiene|hygiene
5658484|NCT00668564|Inborn errors of metabolism|inborn errors of metabolism
5658485|NCT00668564|Sphingolipidoses|sphingolipidoses
5658486|NCT00668564|Recessive Leukodystrophies- GLD, Krabbe disease, MLD|recessive leukodystrophies- gld, krabbe disease, mld
5658487|NCT00668564|Peroxisomal Disorders|peroxisomal disorders
5658488|NCT00668564|Wolman syndrome|wolman syndrome
5658489|NCT00668564|Niemann-Pick B patients|niemann-pick b patients
5658490|NCT00668564|Niemann-Pick C subtype 2|niemann-pick c subtype 2
5658491|NCT00668551|Parkinson disease|parkinson disease
5658492|NCT00668551|Telemedicine|telemedicine
5658493|NCT00668538|Miconazole|miconazole
5658494|NCT00668538|CYP1A2|cyp1a2
5658495|NCT00668538|CYP3A4|cyp3a4
5658496|NCT00668538|Women|women
5658497|NCT00668538|Healthy Subjects|healthy subjects
5658498|NCT00668525|Depression|depression
5658499|NCT00668525|Major Depressive Disorder|major depressive disorder
5658500|NCT00668525|Escitalopram|escitalopram
5658501|NCT00668512|metastatic cutaneous melanoma|metastatic cutaneous melanoma
5658502|NCT00668512|alpha-gal glycolipids|alpha-gal glycolipids
5658503|NCT00668486|Hygiene|hygiene
5658504|NCT00668473|systemic sclerosis angiogenesis|systemic sclerosis angiogenesis
5658505|NCT00668460|hygiene|hygiene
5658506|NCT00668447|bone density|bone density
5658507|NCT00668447|bone loss|bone loss
5658508|NCT00668447|postmenopausal|postmenopausal
5658509|NCT00668434|Back Pain|back pain
5658510|NCT00668434|Leg Pain|leg pain
5658511|NCT00668421|Myelofibrosis|myelofibrosis
5658512|NCT00668421|Essential Thrombocythemia|essential thrombocythemia
5658513|NCT00668421|Polycythemia Vera|polycythemia vera
5658514|NCT00668421|JAK2 V617F Mutation|jak2 v617f mutation
5658515|NCT00668421|Lestaurtinib|lestaurtinib
5658516|NCT00668408|OTLT|otlt
5658517|NCT00668408|COPD|copd
5658518|NCT00668408|CHRONIC HYPOXEMIA|chronic hypoxemia
5658519|NCT00668408|CHF|chf
5658520|NCT00668395|CYP2B6|cyp2b6
5658521|NCT00668395|Efavirenz|efavirenz
5658522|NCT00668395|Pharmacokinetics|pharmacokinetics
5658523|NCT00668395|Pharmacogenetics|pharmacogenetics
5658524|NCT00668395|Drug-Interactions|drug-interactions
5658525|NCT00668382|Cancerous solid tumors|cancerous solid tumors
5658526|NCT00668382|Alpha-Gal Glycosphingolipids|alpha-gal glycosphingolipids
5658527|NCT00668369|Liver Transplantation|liver transplantation
5658528|NCT00668369|Tolerance|tolerance
5658529|NCT00668369|Hepatitis C virus infection|hepatitis c virus infection
5658530|NCT00668369|Immune responses|immune responses
5658531|NCT00668369|Allograft tolerance|allograft tolerance
5658532|NCT00668369|Immunosuppression weaning|immunosuppression weaning
5658533|NCT00668369|Immunosuppression minimization|immunosuppression minimization
5658534|NCT00668356|HIV disease in children|hiv disease in children
5658535|NCT00668356|HIV|hiv
5658536|NCT00668356|children|children
5658537|NCT00668356|didanosine|didanosine
5658538|NCT00668356|bioequivalence|bioequivalence
5658539|NCT00668356|pharmacokinetics|pharmacokinetics
5658540|NCT00668356|treatment experienced|treatment experienced
5658541|NCT00668343|edss attack|edss attack
5658542|NCT00668330|Bone mineral density|bone mineral density
5658543|NCT00668330|ibandronate|ibandronate
5658544|NCT00668330|alfacalcidol|alfacalcidol
5658545|NCT00668317|Hyper-responsiveness, reflux cough|hyper-responsiveness, reflux cough
5658546|NCT00668304|Sinusitis|sinusitis
5658547|NCT00668291|Endocrinology, CARNEY Complex,|endocrinology, carney complex,
5658548|NCT00668291|primary pigmented nodular adrenocortical disease (PPNAD),|primary pigmented nodular adrenocortical disease (ppnad),
5658549|NCT00668291|PRKAR1A|prkar1a
5658550|NCT00668278|Supraglottic airway|supraglottic airway
5658551|NCT00668278|I-gel|i-gel
5658552|NCT00668278|Laryngeal mask|laryngeal mask
5658553|NCT00668278|Controlled ventilation|controlled ventilation
5658554|NCT00668278|Peak airway pressure|peak airway pressure
5658555|NCT00668278|Seal pressure|seal pressure
5658556|NCT00668278|Anaesthesia|anaesthesia
5658557|NCT00668278|Surgery|surgery
5658558|NCT00668265|Generalized Anxiety Disorder|generalized anxiety disorder
5658559|NCT00668265|Opiate Dependence|opiate dependence
5658560|NCT00668265|Methadone-Maintenance|methadone-maintenance
5658561|NCT00668265|Drug Addiction Treatment|drug addiction treatment
5658562|NCT00668252|endothelial progenitor cells|endothelial progenitor cells
5658563|NCT00668252|estrogen|estrogen
5658564|NCT00668252|menopause|menopause
5658565|NCT00668252|cardiovascular risk|cardiovascular risk
5658566|NCT00668239|diffuse macular oedema|diffuse macular oedema
5658567|NCT00668239|type 2 diabetes mellitus|type 2 diabetes mellitus
5658568|NCT00668239|laser therapy|laser therapy
5658569|NCT00668226|Hygiene|hygiene
5658570|NCT00668213|Macular Degeneration|macular degeneration
5658571|NCT00668200|Paget's|paget's
5658572|NCT00668200|hypocalcemia|hypocalcemia
5658573|NCT00668200|zoledronic acid|zoledronic acid
5658574|NCT00668200|serum calcium|serum calcium
5658575|NCT00668187|Tay-Sachs disease|tay-sachs disease
5658576|NCT00668187|Sandhoff disease|sandhoff disease
5658577|NCT00668187|Late Onset Tay-Sachs disease|late onset tay-sachs disease
5658578|NCT00668187|LOTS|lots
5658579|NCT00668187|hexosaminidase A deficiency|hexosaminidase a deficiency
5658580|NCT00668187|hexosaminidase A and B deficiency|hexosaminidase a and b deficiency
5658581|NCT00668187|infantile Tay-Sachs disease|infantile tay-sachs disease
5658582|NCT00668187|adult-onset Tay-Sachs disease|adult-onset tay-sachs disease
5658583|NCT00668187|prospective|prospective
5658584|NCT00668187|natural history|natural history
5671721|NCT00614653|rhuMAb-VEGF|rhumab-vegf
5848863|NCT00032838|Emotion|emotion
5658585|NCT00668187|GM1 gangliosidosis|gm1 gangliosidosis
5658586|NCT00668187|gangliosidoses|gangliosidoses
5658587|NCT00668187|β-galactosidase|β-galactosidase
5658588|NCT00668187|β-galactosidase deficiency|β-galactosidase deficiency
5658589|NCT00668187|hexosaminidase|hexosaminidase
5658590|NCT00668187|hexosaminidase deficiency|hexosaminidase deficiency
5658591|NCT00668187|Tay-Sachs|tay-sachs
5658592|NCT00668187|Sandhoff|sandhoff
5658593|NCT00668187|juvenile Tay-Sachs|juvenile tay-sachs
5658594|NCT00668187|juvenile Tay-Sachs disease|juvenile tay-sachs disease
5658595|NCT00668187|late onset Tay-Sachs|late onset tay-sachs
5658596|NCT00668187|juvenile Sandhoff|juvenile sandhoff
5658597|NCT00668187|juvenile Sandhoff disease|juvenile sandhoff disease
5658598|NCT00668187|GM2 gangliosidosis|gm2 gangliosidosis
5658599|NCT00668148|Sarcoma|sarcoma
5658600|NCT00668148|Ewing's sarcoma / peripheral neuroectodermal tumor (PNET);|ewing's sarcoma / peripheral neuroectodermal tumor (pnet);
5658601|NCT00668148|rhabdomyosarcoma;|rhabdomyosarcoma;
5658602|NCT00668148|leiomyosarcoma;|leiomyosarcoma;
5658603|NCT00668148|adipocytic sarcoma|adipocytic sarcoma
5658604|NCT00668148|synovial sarcoma|synovial sarcoma
5658607|NCT00668109|Erectile Dysfunction|erectile dysfunction
5658608|NCT00668109|Diabetes mellitus|diabetes mellitus
5658609|NCT00668109|Hypertension|hypertension
5658610|NCT00668109|Hyperlipidemia|hyperlipidemia
5658611|NCT00668109|Vardenafil|vardenafil
5658612|NCT00668096|Erectile Dysfunction|erectile dysfunction
5658613|NCT00668096|PDE5 inhibitors|pde5 inhibitors
5658614|NCT00668083|second line|second line
5658615|NCT00668083|Prostate Cancer|prostate cancer
5658616|NCT00668083|bicalutamide|bicalutamide
5685481|NCT00555919|Metastatic breast cancer stage IV|metastatic breast cancer stage iv
5685482|NCT00555919|Metastatic breast cancer|metastatic breast cancer
5658617|NCT00668083|biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg|biochemical relapse/progression in patients with prostate cancer treated with bicalutamide 150mg
5658619|NCT00668070|Chronic liver disease|chronic liver disease
5658620|NCT00668057|Male Erectile Dysfunction|male erectile dysfunction
5658621|NCT00668044|Ciprofloxacin regimen in compromised patients|ciprofloxacin regimen in compromised patients
5658622|NCT00668044|Ciprofloxacin|ciprofloxacin
5658623|NCT00668044|Burned patients|burned patients
5658624|NCT00668031|Transfusion requirements|transfusion requirements
5658625|NCT00668031|Hip replacement surgery|hip replacement surgery
5658626|NCT00668031|Prevention of blood loss|prevention of blood loss
5658627|NCT00668031|Bloodloss|bloodloss
5658628|NCT00668018|Male Erectile Dysfunction|male erectile dysfunction
5658629|NCT00668018|Vardenafil|vardenafil
5658630|NCT00668005|Erectile Dysfunction|erectile dysfunction
5658631|NCT00668005|Arterial hypertension|arterial hypertension
5658632|NCT00668005|Vardenafil|vardenafil
5658633|NCT00667992|Asthma hyperreactivity|asthma hyperreactivity
5658634|NCT00667979|Erectile Dysfunction|erectile dysfunction
5658635|NCT00667979|Vardenafil|vardenafil
5658636|NCT00667966|Spinal cord injury|spinal cord injury
5658637|NCT00667966|Urodynamic|urodynamic
5658638|NCT00667966|Erectile dysfunction|erectile dysfunction
5658639|NCT00667966|Vardenafil|vardenafil
5658640|NCT00667953|Temzolomide|temzolomide
5658641|NCT00667953|Gleevec|gleevec
5658642|NCT00667953|Melanoma|melanoma
5658643|NCT00667953|Advanced melanoma|advanced melanoma
5658644|NCT00667953|Phase II|phase ii
5658645|NCT00667940|Medical education|medical education
5658646|NCT00667940|faculty development|faculty development
5658647|NCT00667940|rater training|rater training
5658648|NCT00667940|clinical competence|clinical competence
5658649|NCT00667940|assessment|assessment
5658650|NCT00667927|Autologous bone marrow transplant|autologous bone marrow transplant
5658651|NCT00667927|gene marking|gene marking
5658652|NCT00667914|Hip-unit|hip-unit
5639462|NCT00741806|vaccination|vaccination
5658653|NCT00667914|Geriatric care|geriatric care
5658654|NCT00667914|Mobility|mobility
5658655|NCT00667914|Site of residence|site of residence
5658656|NCT00667901|stage III melanoma|stage iii melanoma
5658657|NCT00667901|stage IV melanoma|stage iv melanoma
5658658|NCT00667888|Prostate Cancer|prostate cancer
5658659|NCT00667888|Radiation|radiation
5658660|NCT00667888|Radiotherapy|radiotherapy
5658661|NCT00667888|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5658663|NCT00667888|Hypofractionated Intensity Modulated Radiotherapy|hypofractionated intensity modulated radiotherapy
5658665|NCT00667875|Alcohol Dependence|alcohol dependence
5658666|NCT00667875|Alcoholism|alcoholism
5658667|NCT00667875|Naltrexone|naltrexone
5658668|NCT00667875|Aripiprazole|aripiprazole
5658669|NCT00667875|Substance Abuse|substance abuse
5658670|NCT00667862|Prostate|prostate
5658671|NCT00667862|Cancer|cancer
5658672|NCT00667862|Adenocarcinoma|adenocarcinoma
5658673|NCT00667862|Prostate-Specific Antigen|prostate-specific antigen
5658674|NCT00667862|metastatic|metastatic
5658675|NCT00667862|male|male
5658676|NCT00667862|HRPC|hrpc
5658677|NCT00667862|DACi|daci
5658678|NCT00667849|Tibia|tibia
5658679|NCT00667836|Neurofibromatosis Type 1|neurofibromatosis type 1
5658680|NCT00667836|NF1|nf1
5658681|NCT00667836|Spinal Anomalies|spinal anomalies
5658682|NCT00667823|SERAPHIN|seraphin
5658683|NCT00667823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5658684|NCT00667823|ACT-064992|act-064992
5658685|NCT00667810|antibody|antibody
5658686|NCT00667810|immunotherapy|immunotherapy
5658687|NCT00667797|Asthma|asthma
5658688|NCT00667797|COPD|copd
5658689|NCT00667797|chronic emphysema|chronic emphysema
5658690|NCT00667797|chronic bronchitis|chronic bronchitis
5658691|NCT00667784|pediatric stem cell donor|pediatric stem cell donor
5658692|NCT00667784|emotional sequelae|emotional sequelae
5658693|NCT00667784|physical sequelae|physical sequelae
5658694|NCT00667784|psychological consequences of minor donation|psychological consequences of minor donation
5658695|NCT00667784|Bone Marrow Transplantation|bone marrow transplantation
5658696|NCT00667784|Questionnaire|questionnaire
5658697|NCT00667784|Survey|survey
5658698|NCT00667784|Sibling Donor|sibling donor
5658699|NCT00667784|Stem Cell Transplant|stem cell transplant
5658700|NCT00667784|Well-Being|well-being
5658701|NCT00667771|Alcohol|alcohol
5658702|NCT00667771|Naltrexone|naltrexone
5658703|NCT00667771|fMRI|fmri
5658704|NCT00667771|Alcoholism|alcoholism
5658705|NCT00667771|Alcoholics|alcoholics
5658706|NCT00667771|Alcohol Dependence|alcohol dependence
5658708|NCT00667745|Symptoms|symptoms
5658709|NCT00667745|Medication Changes|medication changes
5658710|NCT00667732|diabetes|diabetes
5658711|NCT00667732|insulin|insulin
5658712|NCT00667732|byetta|byetta
5658713|NCT00667732|glucose|glucose
5658714|NCT00667732|blood sugar|blood sugar
5658715|NCT00667732|metformin|metformin
5658716|NCT00667732|A1c|a1c
5658717|NCT00667719|essential hypertension|essential hypertension
5658718|NCT00667719|high blood pressure|high blood pressure
5658719|NCT00667693|intubation|intubation
5658720|NCT00667693|obese|obese
5658721|NCT00667680|tDCS, major depression|tdcs, major depression
5658722|NCT00667667|whole body vibration|whole body vibration
5658723|NCT00667667|exercise|exercise
5658724|NCT00667667|postmenopausal|postmenopausal
5658725|NCT00667667|BMD|bmd
5658726|NCT00667667|bone|bone
5658727|NCT00667667|elderly females|elderly females
5658728|NCT00667667|Caucasian race|caucasian race
5658729|NCT00667654|Osteoarthritis, Knee|osteoarthritis, knee
5658730|NCT00667641|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5658731|NCT00667641|recurrent breast cancer|recurrent breast cancer
5658732|NCT00667641|stage IV breast cancer|stage iv breast cancer
5658733|NCT00667641|recurrent prostate cancer|recurrent prostate cancer
5658734|NCT00667641|stage IV prostate cancer|stage iv prostate cancer
5658735|NCT00667641|recurrent colon cancer|recurrent colon cancer
5658736|NCT00667641|stage IV colon cancer|stage iv colon cancer
5658737|NCT00667641|recurrent pancreatic cancer|recurrent pancreatic cancer
5658738|NCT00667641|stage IV pancreatic cancer|stage iv pancreatic cancer
5658739|NCT00667641|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5658740|NCT00667641|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5658741|NCT00667641|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5658742|NCT00667641|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5658743|NCT00667641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5658744|NCT00667641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5658745|NCT00667641|recurrent melanoma|recurrent melanoma
5658746|NCT00667641|stage IV melanoma|stage iv melanoma
5658747|NCT00667641|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5658754|NCT00667615|Quality of life|quality of life
5658755|NCT00667615|08-045|08-045
5658756|NCT00667602|Meningococcal|meningococcal
5658757|NCT00667602|ACWY|acwy
5658758|NCT00667602|Conjugate Vaccine|conjugate vaccine
5658759|NCT00667602|Meningitis|meningitis
5658760|NCT00667602|Toddlers|toddlers
5658761|NCT00667602|Infants|infants
5658762|NCT00667602|Concomitant Vaccination|concomitant vaccination
5658763|NCT00667589|sorafenib|sorafenib
5658764|NCT00667589|rash|rash
5658765|NCT00667589|hand foot skin reaction|hand foot skin reaction
5658766|NCT00667576|chronic kidney disease|chronic kidney disease
5658767|NCT00667576|secondary hyperparathyroidism|secondary hyperparathyroidism
5658768|NCT00667576|hemodialysis|hemodialysis
5658769|NCT00667576|paricalcitol|paricalcitol
5658770|NCT00667576|maxacalcitol|maxacalcitol
5658771|NCT00667563|human papilloma virus infection|human papilloma virus infection
5658772|NCT00667563|cervical cancer|cervical cancer
5658773|NCT00667563|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5658774|NCT00667563|HIV infection|hiv infection
5658775|NCT00667550|Lower urinary tract symptoms|lower urinary tract symptoms
5658776|NCT00667550|Colorectal disorders|colorectal disorders
5658777|NCT00667550|Urinary incontinence|urinary incontinence
5658778|NCT00667550|Fecal incontinence|fecal incontinence
5658779|NCT00667550|Voiding dysfunction|voiding dysfunction
5658780|NCT00667550|Urgency frequency|urgency frequency
5658781|NCT00667550|Sexual dysfunction|sexual dysfunction
5658782|NCT00667550|Colorectal malignancies|colorectal malignancies
5671722|NCT00614653|Erlotinib|erlotinib
5658783|NCT00667550|Inflammatory bowel disease|inflammatory bowel disease
5658784|NCT00667524|Eosinophilic Esophagitis|eosinophilic esophagitis
5658785|NCT00667524|Dysphagia|dysphagia
5658786|NCT00667524|Esophageal bougienage|esophageal bougienage
5658787|NCT00667524|Esophageal Dilation|esophageal dilation
5658788|NCT00667511|ESRD|esrd
5658789|NCT00667511|End Stage Renal Disease|end stage renal disease
5658790|NCT00667511|Daily Hemodialysis|daily hemodialysis
5658791|NCT00667511|Nocturnal Hemodialysis|nocturnal hemodialysis
5658792|NCT00667511|Hemodialysis|hemodialysis
5658793|NCT00667511|Kidney Failure|kidney failure
5658794|NCT00667511|Kidney Disease|kidney disease
5658795|NCT00667498|Pediatric Obesity|pediatric obesity
5658796|NCT00667498|Insulin Resistance|insulin resistance
5658797|NCT00667498|Hyperinsulinemia|hyperinsulinemia
5658798|NCT00667498|Metformin|metformin
5658799|NCT00667498|Glucose Tolerance|glucose tolerance
5658800|NCT00667498|Microalbuminuria|microalbuminuria
5658801|NCT00667498|Adolescents|adolescents
5658802|NCT00667498|Visceral Fat|visceral fat
5658803|NCT00667472|port wine stain birthmarks|port wine stain birthmarks
5658804|NCT00667459|Cervical Disc|cervical disc
5658805|NCT00667446|GnRH analog|gnrh analog
5651997|NCT00693628|volume|volume
5658806|NCT00667446|Luteinizing hormone (LH)|luteinizing hormone (lh)
5658807|NCT00667446|Gonadotrophin-releasing hormone agonist(GnRHa)|gonadotrophin-releasing hormone agonist(gnrha)
5658808|NCT00667446|Suppression of LH|suppression of lh
5658809|NCT00667446|Gonadotrophin-releasing hormone (GnRH)|gonadotrophin-releasing hormone (gnrh)
5658811|NCT00667446|Leuprolide acetate|leuprolide acetate
5658812|NCT00667446|Central Precocious Puberty|central precocious puberty
5658813|NCT00667446|Depot formulation|depot formulation
5658814|NCT00667446|Lupron|lupron
5658815|NCT00667446|Tanner staging|tanner staging
5658816|NCT00667446|Pediatrics|pediatrics
5658817|NCT00667433|HIV|hiv
5658818|NCT00667433|African American|african american
5658819|NCT00667433|treatment naïve|treatment naïve
5658820|NCT00667420|gastric|gastric
5658821|NCT00667420|esophageal|esophageal
5658822|NCT00667420|panitumumab|panitumumab
5658823|NCT00667407|Asthma|asthma
5658824|NCT00667394|Brain Tumor|brain tumor
5658825|NCT00667394|Chemotherapy|chemotherapy
5658826|NCT00667394|Radiation|radiation
5658827|NCT00667394|Anti-Angiogenesis|anti-angiogenesis
5658828|NCT00667394|Glioblastoma|glioblastoma
5658829|NCT00667394|Glioma|glioma
5658830|NCT00667381|Ultrasound guidance|ultrasound guidance
5658831|NCT00667381|Vascular access|vascular access
5658832|NCT00667381|Vascular complications|vascular complications
5658840|NCT00667355|Ankylosing Spondylitis|ankylosing spondylitis
5658841|NCT00667329|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5658842|NCT00667329|Lymphoma|lymphoma
5658843|NCT00667329|2CdA|2cda
5658844|NCT00667329|Cladribine|cladribine
5658845|NCT00667329|Leustatin|leustatin
5658846|NCT00667329|Cyclophosphamide|cyclophosphamide
5658847|NCT00667329|Cytoxan|cytoxan
5658848|NCT00667329|Neosar|neosar
5658849|NCT00667329|Rituxan|rituxan
5658850|NCT00667329|Rituximab|rituximab
5658855|NCT00667303|Hematopoietic stem cell transplant|hematopoietic stem cell transplant
5658856|NCT00667290|functional ability|functional ability
5658857|NCT00667290|gait|gait
5658858|NCT00667290|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5658859|NCT00667290|peripheral blood vessel disorder|peripheral blood vessel disorder
5658860|NCT00667277|Myelofibrosis|myelofibrosis
5658861|NCT00667277|Idiopathic|idiopathic
5658862|NCT00667277|Bevacizumab|bevacizumab
5658863|NCT00667277|Avastin|avastin
5658864|NCT00667277|bone marrow fibrosis|bone marrow fibrosis
5658865|NCT00667277|bone marrow angiogenesis|bone marrow angiogenesis
5658866|NCT00667277|JAK2|jak2
5658867|NCT00667264|pain|pain
5658868|NCT00667264|phantom limb|phantom limb
5658869|NCT00667264|stump pain|stump pain
5658870|NCT00667264|catheter|catheter
5658871|NCT00667264|nerve block|nerve block
5658872|NCT00667264|peripheral nerve block|peripheral nerve block
5658873|NCT00667264|ucsd|ucsd
5658874|NCT00667264|Post-amputation phantom limb or stump pain|post-amputation phantom limb or stump pain
5658879|NCT00667212|intermittent|intermittent
5658880|NCT00667212|explosive|explosive
5658881|NCT00667199|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5658882|NCT00667199|Bone Metastases|bone metastases
5658883|NCT00667199|Radium-223|radium-223
5658884|NCT00667199|Palliation of bone pain|palliation of bone pain
5658886|NCT00667186|Prevention|prevention
5658887|NCT00667186|Public Health|public health
5658888|NCT00667186|Screening|screening
5658889|NCT00667160|Mild Atopic Dermatitis|mild atopic dermatitis
5658890|NCT00667160|Protopic|protopic
5658891|NCT00667160|Pediatric|pediatric
5658892|NCT00667134|systemic sclerosis autoantibodies|systemic sclerosis autoantibodies
5658893|NCT00667121|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5658894|NCT00667121|breast cancer|breast cancer
5658895|NCT00667121|hot flashes|hot flashes
5658896|NCT00667121|depression|depression
5658897|NCT00667095|OAB|oab
5658898|NCT00667095|Over Active Bladder|over active bladder
5658899|NCT00667095|overactive bladder|overactive bladder
5658900|NCT00667095|Urinary Urge Incontinence|urinary urge incontinence
5658901|NCT00667095|Urinary Incontinence|urinary incontinence
5658902|NCT00667095|Botox|botox
5658903|NCT00667095|DMSO|dmso
5658904|NCT00667095|bladder instillation|bladder instillation
5658905|NCT00667095|instillation|instillation
5658906|NCT00667095|detrusor hyperreflexia|detrusor hyperreflexia
5658907|NCT00667095|urge incontinence|urge incontinence
5658908|NCT00667082|Non small Cell Lung Cancer|non small cell lung cancer
5658909|NCT00667082|Pancreatic Cancer|pancreatic cancer
5658910|NCT00667082|Melanoma|melanoma
5658911|NCT00667082|Lymphoma|lymphoma
5658912|NCT00667082|Multiple Myeloma|multiple myeloma
5658913|NCT00667069|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5659035|NCT00666549|Polycythemia Vera|polycythemia vera
5658914|NCT00667069|stage III prostate cancer|stage iii prostate cancer
5658915|NCT00667069|stage IV prostate cancer|stage iv prostate cancer
5658916|NCT00667056|Chronic Allergic Contact Dermatitis|chronic allergic contact dermatitis
5658917|NCT00667056|Protopic|protopic
5658918|NCT00667043|therapeutic hypothermia|therapeutic hypothermia
5658919|NCT00667043|cardiac arrest|cardiac arrest
5658920|NCT00667043|sedation|sedation
5658921|NCT00667043|remifentanil|remifentanil
5658922|NCT00667043|propofol|propofol
5658923|NCT00667043|fentanyl|fentanyl
5658924|NCT00667043|midazolam|midazolam
5658925|NCT00667030|Inflammation|inflammation
5658927|NCT00667030|Metabolism|metabolism
5658928|NCT00667030|Exercise|exercise
5658929|NCT00667017|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5658930|NCT00667017|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5658931|NCT00666991|ovarian cancer|ovarian cancer
5658932|NCT00666991|Mullerian tumors|mullerian tumors
5658933|NCT00666991|peritoneal cavity carcinoma|peritoneal cavity carcinoma
5658934|NCT00666991|gastrointestinal tract tumor|gastrointestinal tract tumor
5658935|NCT00666991|GI tract tumor|gi tract tumor
5658936|NCT00666991|pancreatic cancer|pancreatic cancer
5658937|NCT00666991|colon cancer|colon cancer
5658938|NCT00666978|bladder cancer|bladder cancer
5658939|NCT00666978|cervical cancer|cervical cancer
5658940|NCT00666978|esophageal cancer|esophageal cancer
5658941|NCT00666978|gastric cancer|gastric cancer
5658942|NCT00666978|renal cell carcinoma|renal cell carcinoma
5658943|NCT00666978|adult primary liver cancer|adult primary liver cancer
5658944|NCT00666978|non-small cell lung cancer|non-small cell lung cancer
5658945|NCT00666978|small cell lung cancer|small cell lung cancer
5658946|NCT00666978|pancreatic cancer|pancreatic cancer
5658947|NCT00666978|hypopharyngeal cancer|hypopharyngeal cancer
5658948|NCT00666978|laryngeal cancer|laryngeal cancer
5658949|NCT00666978|lip and oral cavity cancer|lip and oral cavity cancer
5658950|NCT00666978|nasopharyngeal cancer|nasopharyngeal cancer
5658951|NCT00666978|oropharyngeal cancer|oropharyngeal cancer
5658952|NCT00666978|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5658953|NCT00666978|adult acute myeloid leukemia|adult acute myeloid leukemia
5658954|NCT00666978|tobacco use disorder|tobacco use disorder
5658955|NCT00666965|SPM 962|spm 962
5658956|NCT00666965|rotigotine|rotigotine
5658957|NCT00666965|Idiopathic Restless Legs Syndrome|idiopathic restless legs syndrome
5658959|NCT00666926|Pancreatic Neoplasm|pancreatic neoplasm
5658960|NCT00666926|Head and Neck neoplasm|head and neck neoplasm
5658961|NCT00666926|Prostatic neoplasms; Focal Adhesion Kinase|prostatic neoplasms; focal adhesion kinase
5658962|NCT00666926|Phase 1|phase 1
5658963|NCT00666926|Pharmacodynamics|pharmacodynamics
5658964|NCT00666926|FDG-PET|fdg-pet
5658965|NCT00666913|breast cancer in situ|breast cancer in situ
5658966|NCT00666913|stage I breast cancer|stage i breast cancer
5658967|NCT00666913|stage II breast cancer|stage ii breast cancer
5639768|NCT00740701|TMS|tms
5658968|NCT00666913|stage IIIA breast cancer|stage iiia breast cancer
5658969|NCT00666913|stage IIIB breast cancer|stage iiib breast cancer
5658970|NCT00666913|stage IIIC breast cancer|stage iiic breast cancer
5658971|NCT00666913|hot flashes|hot flashes
5658972|NCT00666887|Multiple Sclerosis|multiple sclerosis
5658973|NCT00666887|Clinically Isolated Syndrome|clinically isolated syndrome
5658975|NCT00666887|Placebo|placebo
5658976|NCT00666874|Obesity, lifestyle, vascular inflammation|obesity, lifestyle, vascular inflammation
5658977|NCT00666848|Metabolic syndrome|metabolic syndrome
5658978|NCT00666848|Hypertension|hypertension
5658979|NCT00666848|Sitagliptin|sitagliptin
5658980|NCT00666848|Enalapril|enalapril
5658981|NCT00666835|Treatment of anemia in hemodialysis patients|treatment of anemia in hemodialysis patients
5658982|NCT00666822|stage I breast cancer|stage i breast cancer
5658983|NCT00666822|stage II breast cancer|stage ii breast cancer
5658984|NCT00666822|stage IIIA breast cancer|stage iiia breast cancer
5658985|NCT00666809|Vardenafil,|vardenafil,
5658986|NCT00666809|Tinnitus|tinnitus
5658987|NCT00666757|Severe Depressive Episode|severe depressive episode
5658988|NCT00666744|exercise|exercise
5658989|NCT00666744|frequency|frequency
5658990|NCT00666744|duration|duration
5658991|NCT00666731|male breast cancer|male breast cancer
5658992|NCT00666731|breast cancer|breast cancer
5658993|NCT00666731|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5658994|NCT00666731|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5658995|NCT00666731|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5658996|NCT00666705|maraviroc|maraviroc
5658997|NCT00666705|raltegravir|raltegravir
5658998|NCT00666705|drug interaction study|drug interaction study
5658999|NCT00666705|healthy volunteers|healthy volunteers
5659000|NCT00666692|cancer|cancer
5659001|NCT00666692|carcinoma|carcinoma
5659002|NCT00666692|monoclonal antibody therapy|monoclonal antibody therapy
5659003|NCT00666692|anti-angiogenesis|anti-angiogenesis
5659004|NCT00666666|prostate Cancer|prostate cancer
5659005|NCT00666666|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5659006|NCT00666666|stage IV prostate cancer|stage iv prostate cancer
5659007|NCT00666666|newly diagnosed stage IV prostate cancer|newly diagnosed stage iv prostate cancer
5659008|NCT00666653|Parkinson's disease|parkinson's disease
5659009|NCT00666653|Dopamine Agonist|dopamine agonist
5659010|NCT00666653|Levodopa|levodopa
5659011|NCT00666653|Pharmacokinetics|pharmacokinetics
5659012|NCT00666653|Dyskinesia|dyskinesia
5659013|NCT00666640|Osteoporosis|osteoporosis
5659014|NCT00666640|Fracture|fracture
5659015|NCT00666640|DXA|dxa
5659016|NCT00666640|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5659018|NCT00666640|3D DXA|3d dxa
5659019|NCT00666627|Osteoporosis|osteoporosis
5659020|NCT00666627|Post-menopausal osteoporosis|post-menopausal osteoporosis
5659021|NCT00666627|Bisphosphonates|bisphosphonates
5659022|NCT00666627|Alendronate|alendronate
5659023|NCT00666627|Ibandronate|ibandronate
5659024|NCT00666627|Risedronate|risedronate
5659025|NCT00666614|Sleep|sleep
5659026|NCT00666614|Fatigue|fatigue
5659027|NCT00666614|High Dose Chemotherapy|high dose chemotherapy
5659028|NCT00666601|Microdialysis|microdialysis
5659029|NCT00666601|Antibiotic|antibiotic
5659030|NCT00666601|Healthy subjects|healthy subjects
5659031|NCT00666549|Myeloproliferative Disease|myeloproliferative disease
5659032|NCT00666549|Myelofibrosis|myelofibrosis
5659033|NCT00666549|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5659034|NCT00666549|Essential Thrombocythemia|essential thrombocythemia
5659036|NCT00666536|Hypertension|hypertension
5659037|NCT00666536|adults|adults
5659038|NCT00666536|Valsartan + Amlodipine|valsartan + amlodipine
5659039|NCT00666536|Angiotensin Receptor Blockers|angiotensin receptor blockers
5659040|NCT00666523|osteoarthritis, knee or hip|osteoarthritis, knee or hip
5659041|NCT00666510|nitric oxide|nitric oxide
5659042|NCT00666510|bronchospasm|bronchospasm
5659043|NCT00666510|anesthesia|anesthesia
5659044|NCT00666510|induced sputum|induced sputum
5659045|NCT00666510|asthma|asthma
5659046|NCT00666497|Acute Myeloid Leukemia|acute myeloid leukemia
5659047|NCT00666497|Myelodysplastic Syndrome|myelodysplastic syndrome
5659048|NCT00666497|Azacitidine|azacitidine
5659049|NCT00666497|Vidaza|vidaza
5659050|NCT00666497|MGCD0103|mgcd0103
5659055|NCT00666484|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5659056|NCT00666484|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5659057|NCT00666484|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5659058|NCT00666484|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5659059|NCT00666484|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5659060|NCT00666484|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5659061|NCT00666484|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5659062|NCT00666484|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5659063|NCT00666471|epistaxis|epistaxis
5659064|NCT00666471|Epistaxis refractory to emergency physician treatment|epistaxis refractory to emergency physician treatment
5659065|NCT00666458|Type 2 diabetes|type 2 diabetes
5659066|NCT00666458|metformin|metformin
5659067|NCT00666445|Alzheimer's Disease|alzheimer's disease
5659068|NCT00666445|Diagnosis|diagnosis
5659069|NCT00666445|Neuronal function|neuronal function
5659070|NCT00666445|Cognitive Impairment|cognitive impairment
5659071|NCT00666445|Magnetoencephalography|magnetoencephalography
5659072|NCT00666432|schizophrenia|schizophrenia
5659073|NCT00666432|bipolar|bipolar
5659074|NCT00666432|eye movements|eye movements
5659075|NCT00666432|phenotype|phenotype
5659076|NCT00666432|biochemical|biochemical
5659077|NCT00666432|relatives|relatives
5659078|NCT00666419|nonspecific low back pain|nonspecific low back pain
5659079|NCT00666419|schoolchildren|schoolchildren
5659080|NCT00666419|prevalence|prevalence
5659081|NCT00666393|IONSYS™|ionsys™
5659082|NCT00666393|Pain, Postoperative|pain, postoperative
5659083|NCT00666393|Analgesia, Patient-Controlled|analgesia, patient-controlled
5659084|NCT00666393|Opioids|opioids
5659085|NCT00666393|Pediatrics|pediatrics
5659086|NCT00666380|Malaria|malaria
5659087|NCT00666380|Vaccine|vaccine
5659088|NCT00666380|MSP-1 (merozoite surface protein-1)|msp-1 (merozoite surface protein-1)
5659089|NCT00666380|Phase 1|phase 1
5659090|NCT00666367|COPD|copd
5659091|NCT00666354|Nail Psoriasis|nail psoriasis
5659092|NCT00666354|Psoriasis|psoriasis
5659093|NCT00666354|Fingernail Psoriasis|fingernail psoriasis
5659094|NCT00666354|Methotrexate|methotrexate
5659095|NCT00666328|Hypertension|hypertension
5659096|NCT00666328|Hemorrhage|hemorrhage
5659097|NCT00666328|Intracranial Pressure|intracranial pressure
5659098|NCT00666328|Antihypertensive Agent|antihypertensive agent
5659099|NCT00666328|Calcium Channel Blocker|calcium channel blocker
5659100|NCT00666315|Consecutive euthyroid patients with multinodular goiter for whom a total Thyroidectomy under general anesthesia is indicated|consecutive euthyroid patients with multinodular goiter for whom a total thyroidectomy under general anesthesia is indicated
5659101|NCT00666302|Atopic Dermatitis|atopic dermatitis
5659102|NCT00666302|Protopic|protopic
5659103|NCT00666302|Elidel|elidel
5659104|NCT00666289|polycythemia vera|polycythemia vera
5659105|NCT00666289|essential thrombocythemia|essential thrombocythemia
5659106|NCT00666289|idiopathic myelofibrosis|idiopathic myelofibrosis
5659107|NCT00666289|family clusters|family clusters
5659108|NCT00666250|blood pressure|blood pressure
5659109|NCT00666250|dyslipidemia|dyslipidemia
5659110|NCT00666250|hyperglycemia|hyperglycemia
5659111|NCT00666237|Glaucoma|glaucoma
5659112|NCT00666237|Tube shunt surgery|tube shunt surgery
5659113|NCT00666237|Trabeculectomy|trabeculectomy
5789073|NCT00150033|Patient reported outcome|patient reported outcome
5659114|NCT00666224|Clinically Definite Multiple Sclerosis|clinically definite multiple sclerosis
5659115|NCT00666224|Clinically Isolated Syndrome|clinically isolated syndrome
5659116|NCT00666224|Multiple Sclerosis|multiple sclerosis
5659118|NCT00666211|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5659119|NCT00666211|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5659120|NCT00666211|acute undifferentiated leukemia|acute undifferentiated leukemia
5659121|NCT00666211|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5659122|NCT00666211|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5685484|NCT00555919|Stage IV breast cancer|stage iv breast cancer
5659123|NCT00666211|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5659124|NCT00666211|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5659125|NCT00666211|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5659126|NCT00666211|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5659127|NCT00666211|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5659128|NCT00666211|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5661505|NCT00657163|Fluoxetine|fluoxetine
5659129|NCT00666211|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5659541|NCT00665002|Neoplasms|neoplasms
5659130|NCT00666211|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5659131|NCT00666211|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5659132|NCT00666211|mast cell leukemia|mast cell leukemia
5659133|NCT00666211|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5659134|NCT00666211|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5659135|NCT00666211|prolymphocytic leukemia|prolymphocytic leukemia
5659136|NCT00666211|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5659137|NCT00666211|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5659138|NCT00666211|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5659139|NCT00666211|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5659140|NCT00666211|refractory hairy cell leukemia|refractory hairy cell leukemia
5659141|NCT00666211|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5659142|NCT00666211|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5659143|NCT00666211|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5659144|NCT00666211|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5659145|NCT00666211|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5659146|NCT00666211|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5659352|NCT00665795|color doppler|color doppler
5659147|NCT00666211|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5659148|NCT00666211|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5659149|NCT00666211|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5659150|NCT00666211|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5659151|NCT00666211|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5659152|NCT00666211|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5659153|NCT00666211|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5659154|NCT00666211|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5659155|NCT00666211|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5659156|NCT00666211|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5659157|NCT00666211|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5659158|NCT00666211|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5659159|NCT00666211|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5659160|NCT00666211|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5659161|NCT00666211|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5659162|NCT00666211|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5659163|NCT00666211|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5659164|NCT00666211|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5659165|NCT00666211|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5659166|NCT00666211|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5659167|NCT00666211|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5659168|NCT00666211|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5659169|NCT00666211|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5659170|NCT00666211|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5659171|NCT00666211|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5659172|NCT00666211|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5659173|NCT00666211|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5659174|NCT00666211|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5659175|NCT00666211|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5659176|NCT00666211|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5659177|NCT00666211|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5659178|NCT00666211|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5659179|NCT00666211|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5659180|NCT00666211|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5659181|NCT00666211|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5659182|NCT00666211|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5659183|NCT00666211|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5659184|NCT00666211|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5659185|NCT00666211|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5659186|NCT00666211|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5659187|NCT00666211|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5659188|NCT00666211|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5798784|NCT00111085|computer tomography scan (CT scan)|computer tomography scan (ct scan)
5659189|NCT00666211|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5659190|NCT00666211|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5659191|NCT00666211|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5659192|NCT00666211|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5659193|NCT00666211|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5659194|NCT00666211|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5659195|NCT00666211|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5659196|NCT00666211|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5659197|NCT00666211|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5659198|NCT00666211|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5659199|NCT00666211|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5659200|NCT00666211|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5659201|NCT00666211|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5659202|NCT00666211|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5640042|NCT00739765|Trauma|trauma
5659203|NCT00666211|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5659204|NCT00666211|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5659205|NCT00666211|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5659206|NCT00666211|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5659207|NCT00666211|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5659208|NCT00666211|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5659209|NCT00666211|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5659210|NCT00666211|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5659211|NCT00666211|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5671723|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride
5659212|NCT00666211|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5659213|NCT00666211|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5659214|NCT00666211|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5659215|NCT00666211|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5659216|NCT00666211|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5659217|NCT00666211|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5659218|NCT00666211|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5659219|NCT00666211|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5659220|NCT00666211|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5659221|NCT00666211|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5659222|NCT00666211|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5659223|NCT00666211|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5659224|NCT00666211|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5659225|NCT00666211|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5659226|NCT00666211|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5659227|NCT00666211|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5659228|NCT00666211|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5659229|NCT00666211|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5659230|NCT00666211|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5659231|NCT00666211|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5659232|NCT00666211|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5659233|NCT00666211|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5659234|NCT00666211|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5659235|NCT00666211|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5659236|NCT00666211|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5659237|NCT00666211|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5659238|NCT00666211|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5659239|NCT00666211|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5659240|NCT00666211|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5659241|NCT00666211|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5659242|NCT00666211|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5659243|NCT00666211|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5659244|NCT00666211|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5659245|NCT00666211|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5659246|NCT00666211|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5659247|NCT00666211|intraocular lymphoma|intraocular lymphoma
5659248|NCT00666211|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5659249|NCT00666211|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5659250|NCT00666211|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5659251|NCT00666211|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5659252|NCT00666211|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5659253|NCT00666211|primary myelofibrosis|primary myelofibrosis
5659254|NCT00666211|essential thrombocythemia|essential thrombocythemia
5659255|NCT00666211|polycythemia vera|polycythemia vera
5659256|NCT00666211|extramedullary plasmacytoma|extramedullary plasmacytoma
5659257|NCT00666211|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5659258|NCT00666211|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5659259|NCT00666211|stage I multiple myeloma|stage i multiple myeloma
5659260|NCT00666211|stage II multiple myeloma|stage ii multiple myeloma
5659261|NCT00666211|stage III multiple myeloma|stage iii multiple myeloma
5659262|NCT00666211|primary systemic amyloidosis|primary systemic amyloidosis
5659263|NCT00666211|refractory multiple myeloma|refractory multiple myeloma
5659264|NCT00666211|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5659265|NCT00666211|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5659266|NCT00666211|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5680410|NCT00577915|MRI spectroscopy|mri spectroscopy
5659267|NCT00666211|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5659268|NCT00666211|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5659269|NCT00666185|Micafungin|micafungin
5659270|NCT00666185|Esophageal Candidiasis|esophageal candidiasis
5659271|NCT00666185|Fluconazole|fluconazole
5659272|NCT00666172|Women's Health|women's health
5659274|NCT00666172|Metabolic Syndrome|metabolic syndrome
5659275|NCT00666172|Arterial Function|arterial function
5659276|NCT00666172|Lipoproteins|lipoproteins
5659277|NCT00666172|Overweight|overweight
5659278|NCT00666159|Atopic Dermatitis|atopic dermatitis
5659279|NCT00666159|Protopic|protopic
5659280|NCT00666159|Pediatric|pediatric
5659281|NCT00666146|Schizophrenia|schizophrenia
5659282|NCT00666146|Genetics|genetics
5659283|NCT00666146|Eyetracking|eyetracking
5659284|NCT00666133|Preeclampsia|preeclampsia
5659285|NCT00666133|Eclampsia|eclampsia
5659286|NCT00666133|Magnesium Sulfate|magnesium sulfate
5659289|NCT00666107|Gardasil|gardasil
5659290|NCT00666107|Vaccine|vaccine
5659291|NCT00666094|Type 2-diabetes|type 2-diabetes
5659292|NCT00666094|exercise therapy|exercise therapy
5659294|NCT00666094|Norway|norway
5659295|NCT00666081|Pazopanib, paclitaxel, carboplatin|pazopanib, paclitaxel, carboplatin
5659296|NCT00666068|Patients with hypopituitarism|patients with hypopituitarism
5659297|NCT00666055|Sex|sex
5659298|NCT00666055|Aging|aging
5659299|NCT00666055|Antiretroviral|antiretroviral
5659300|NCT00666055|Pharmacokinetics|pharmacokinetics
5659301|NCT00666055|post-menopausal women with HIV infection|post-menopausal women with hiv infection
5659302|NCT00666055|pre-menopausal women with HIV infection|pre-menopausal women with hiv infection
5659303|NCT00666029|metabolic syndrome|metabolic syndrome
5659304|NCT00666029|Volunteers recruited from the community|volunteers recruited from the community
5659305|NCT00666016|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection ALT AST new drug candidate interventional study TRO19622 Trophos cholest-4-en-3-one oxime|non alcoholic steatohepatitis nash hepatoprotective hepatoprotection alt ast new drug candidate interventional study tro19622 trophos cholest-4-en-3-one oxime
5659306|NCT00666003|Hemodynamics|hemodynamics
5659307|NCT00665977|Obstructive Sleep Apnea|obstructive sleep apnea
5659308|NCT00665977|Nasal Congestion|nasal congestion
5659309|NCT00665977|Sinus congestion|sinus congestion
5659310|NCT00665964|osteoarthritis|osteoarthritis
5659311|NCT00665964|knee|knee
5659312|NCT00665964|total knee arthroplasty|total knee arthroplasty
5659314|NCT00665964|polyethylene|polyethylene
5659315|NCT00665964|posterior stabilized|posterior stabilized
5659316|NCT00665951|pediatric|pediatric
5659317|NCT00665951|pharmacokinetics|pharmacokinetics
5659318|NCT00665951|HIV infection|hiv infection
5659319|NCT00665938|Physical development|physical development
5659320|NCT00665899|breast cancer|breast cancer
5659321|NCT00665899|couples|couples
5659322|NCT00665899|cognitive behavioral therapy|cognitive behavioral therapy
5659323|NCT00665899|Women with early stage breast cancer and their partners.|women with early stage breast cancer and their partners.
5659324|NCT00665886|Peripheral venous catheter|peripheral venous catheter
5659325|NCT00665886|Catheter-related complication|catheter-related complication
5659326|NCT00665886|Bacterial Colonization|bacterial colonization
5659327|NCT00665886|Dwell time|dwell time
5659328|NCT00665886|Closed system|closed system
5659329|NCT00665886|Costs|costs
5659330|NCT00665886|Polyurethane|polyurethane
5659331|NCT00665886|Teflon|teflon
5659332|NCT00665873|Totally Implantable Venous Access Devices|totally implantable venous access devices
5659333|NCT00665873|Infections|infections
5659334|NCT00665873|Chemotherapy|chemotherapy
5659335|NCT00665873|Valuated infections TIVAD|valuated infections tivad
5659336|NCT00665860|Osteoporosis|osteoporosis
5659337|NCT00665860|Soy isoflavones|soy isoflavones
5659338|NCT00665860|Postmenopausal women|postmenopausal women
5659339|NCT00665860|Safety|safety
5659340|NCT00665860|Efficacy|efficacy
5659341|NCT00665860|Effective dosage|effective dosage
5659342|NCT00665847|HIV-1|hiv-1
5659343|NCT00665847|TMC125-TiDP35-C213|tmc125-tidp35-c213
5659344|NCT00665847|TMC125-C213|tmc125-c213
5659345|NCT00665821|nonspecific low back pain|nonspecific low back pain
5659346|NCT00665821|disability|disability
5659348|NCT00665821|catastrophizing|catastrophizing
5659349|NCT00665821|workers|workers
5659350|NCT00665795|Dysthyroid Optic Neuropathy|dysthyroid optic neuropathy
5659351|NCT00665795|multidetector computed tomography|multidetector computed tomography
5659353|NCT00665795|Grave´s Orbitopathy|grave´s orbitopathy
5659354|NCT00665795|Grave´s Disease|grave´s disease
5659355|NCT00665795|morphometric analysis|morphometric analysis
5659356|NCT00665782|anxiety disorder|anxiety disorder
5659357|NCT00665782|depression|depression
5659358|NCT00665782|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5659359|NCT00665782|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5659360|NCT00665782|breast cancer in situ|breast cancer in situ
5659361|NCT00665782|stage I breast cancer|stage i breast cancer
5659362|NCT00665782|stage II breast cancer|stage ii breast cancer
5659363|NCT00665782|stage IIIA breast cancer|stage iiia breast cancer
5659364|NCT00665782|stage IIIB breast cancer|stage iiib breast cancer
5659365|NCT00665782|stage IIIC breast cancer|stage iiic breast cancer
5659366|NCT00665769|hypercapnia|hypercapnia
5659367|NCT00665769|normocapnia|normocapnia
5659368|NCT00665769|chronic lung disease|chronic lung disease
5659369|NCT00665769|periventricular leukomalacia|periventricular leukomalacia
5659370|NCT00665769|intraventricular hemorrhage|intraventricular hemorrhage
5659371|NCT00665769|hypotension|hypotension
5659372|NCT00665769|cerebral autoregulation|cerebral autoregulation
5659373|NCT00665769|heart rate variability|heart rate variability
5659374|NCT00665769|autonomic nervous system|autonomic nervous system
5659375|NCT00665769|detrended fluctuation analysis|detrended fluctuation analysis
5659376|NCT00665756|Glaucoma|glaucoma
5659377|NCT00665756|Drainage implant|drainage implant
5659378|NCT00665756|Ahmed valve|ahmed valve
5659379|NCT00665756|Second trabeculectomy|second trabeculectomy
5659380|NCT00665717|interaction|interaction
5659381|NCT00665717|statins|statins
5659382|NCT00665717|pharmacokinetics|pharmacokinetics
5659383|NCT00665704|Smoking Cessation|smoking cessation
5659384|NCT00665704|Internet|internet
5659385|NCT00665704|Intervention Studies|intervention studies
5659386|NCT00665704|Health Services Accessibility|health services accessibility
5659387|NCT00665691|All Malignancies|all malignancies
5659388|NCT00665652|Neuropathy|neuropathy
5659389|NCT00665652|Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)|nonmalignant monoclonal gammopathy of undetermined significance (mgus)
5659390|NCT00665652|MGUS|mgus
5659391|NCT00665639|Micafungin|micafungin
5659392|NCT00665639|Esophageal Candidiasis|esophageal candidiasis
5659393|NCT00665639|caspofungin|caspofungin
5659394|NCT00665613|warfarin use|warfarin use
5659395|NCT00665600|COPD|copd
5659396|NCT00665600|Chronic Bronchitis|chronic bronchitis
5659397|NCT00665600|Chronic Emphysema|chronic emphysema
5659398|NCT00665587|Atrial fibrillation|atrial fibrillation
5659399|NCT00665587|Maze procedure|maze procedure
5659400|NCT00665587|Mid-term results|mid-term results
5659401|NCT00665587|Long-term results|long-term results
5659402|NCT00665587|Surgical ablation|surgical ablation
5659403|NCT00665561|Maraviroc|maraviroc
5659404|NCT00665561|HIV-1|hiv-1
5659405|NCT00665561|Safety|safety
5659406|NCT00665561|Non-interventional|non-interventional
5659407|NCT00665548|Knee Osteoarthritis|knee osteoarthritis
5659408|NCT00665548|magnetic resonance imaging|magnetic resonance imaging
5659409|NCT00665548|x rays|x rays
5659411|NCT00665535|Nursing facilities|nursing facilities
5659412|NCT00665535|Elderly|elderly
5659413|NCT00665535|At risk for pressure ulcers|at risk for pressure ulcers
5659414|NCT00665522|Pain|pain
5659415|NCT00665522|Postoperative Analgesia|postoperative analgesia
5659416|NCT00665522|Patient-Controlled Opioids|patient-controlled opioids
5659417|NCT00665509|Influenza|influenza
5659418|NCT00665509|Vaccine|vaccine
5659419|NCT00665509|CHMP criteria|chmp criteria
5659420|NCT00665496|Erectile Dysfunction|erectile dysfunction
5659421|NCT00665496|Vardenafil|vardenafil
5659422|NCT00665496|Onset of action|onset of action
5659423|NCT00665470|Malignant Melanoma|malignant melanoma
5659424|NCT00665470|HLA-A2|hla-a2
5659425|NCT00665470|Immunotherapy|immunotherapy
5659426|NCT00665470|Clinical Response|clinical response
5659427|NCT00665470|Skin Cancer|skin cancer
5659428|NCT00665457|stage II breast cancer|stage ii breast cancer
5659429|NCT00665457|stage IIIA breast cancer|stage iiia breast cancer
5659430|NCT00665457|stage IIIB breast cancer|stage iiib breast cancer
5659431|NCT00665457|stage IIIC breast cancer|stage iiic breast cancer
5659432|NCT00665444|bipolar disorder|bipolar disorder
5659433|NCT00665444|sedation|sedation
5659434|NCT00665444|overweight|overweight
5659435|NCT00665444|Abilify|abilify
5659436|NCT00665444|medication|medication
5659437|NCT00665418|Anesthesia|anesthesia
5659441|NCT00665405|Atelectasis|atelectasis
5659442|NCT00665392|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5659443|NCT00665392|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5659444|NCT00665392|tongue cancer|tongue cancer
5659445|NCT00665379|leg lymphedema|leg lymphedema
5659446|NCT00665379|volume measurement|volume measurement
5659447|NCT00665379|compression therapy|compression therapy
5659448|NCT00665379|interface pressure|interface pressure
5659449|NCT00665379|static stiffness index (SSI)|static stiffness index (ssi)
5659450|NCT00665379|volume change|volume change
5659453|NCT00665340|Erectile Dysfunction|erectile dysfunction
5659454|NCT00665340|Vardenafil|vardenafil
5659455|NCT00665327|Community Acquired Pneumonia|community acquired pneumonia
5659456|NCT00665327|Pneumonia,|pneumonia,
5659457|NCT00665327|CAP|cap
5659458|NCT00665314|Mobilisation stem cells|mobilisation stem cells
5659459|NCT00665314|G-CSF Mobilisation Regimen|g-csf mobilisation regimen
5659460|NCT00665314|Lymphoma|lymphoma
5659461|NCT00665314|Multiple Myeloma|multiple myeloma
5640336|NCT00738790|rectal cancer|rectal cancer
5659462|NCT00665314|Adult patients with lymphoma (Non Hodgkin's Lymphoma, Hodgkin's Disease) or Multiple Myeloma who previously failed Stem Cell Collections or Collection attempts.|adult patients with lymphoma (non hodgkin's lymphoma, hodgkin's disease) or multiple myeloma who previously failed stem cell collections or collection attempts.
5659463|NCT00665301|Non-invasive Cardiac Output|non-invasive cardiac output
5659464|NCT00665288|cardiac arrest|cardiac arrest
5659465|NCT00665288|heart arrest|heart arrest
5659466|NCT00665288|CPR|cpr
5659467|NCT00665288|resuscitation|resuscitation
5659468|NCT00665288|bystander CPR|bystander cpr
5659469|NCT00665275|complementary|complementary
5659470|NCT00665275|alternative|alternative
5659471|NCT00665275|medicine|medicine
5659472|NCT00665262|analgesia|analgesia
5659473|NCT00665262|hip arthroplasty|hip arthroplasty
5659474|NCT00665262|knee arthroplasty|knee arthroplasty
5659475|NCT00665249|problem drinking|problem drinking
5659476|NCT00665249|heavy drinking|heavy drinking
5659477|NCT00665249|Alcohol|alcohol
5659478|NCT00665249|moderation|moderation
5659479|NCT00665249|motivational interviewing|motivational interviewing
5659480|NCT00665236|Migraine|migraine
5659481|NCT00665223|Huntington's Disease|huntington's disease
5659482|NCT00665210|hip arthritis|hip arthritis
5659483|NCT00665210|implant sizing|implant sizing
5659484|NCT00665197|Esophageal cancer|esophageal cancer
5659485|NCT00665197|Brachytherapy|brachytherapy
5659486|NCT00665197|Radiotherapy|radiotherapy
5659487|NCT00665197|Palliation|palliation
5659488|NCT00665197|Dysphagia|dysphagia
5659489|NCT00665184|Hypokinesia|hypokinesia
5659490|NCT00665184|Gait|gait
5659491|NCT00665184|Quality of life|quality of life
5659492|NCT00665184|Dopamine replacement|dopamine replacement
5659493|NCT00665184|Resistance training|resistance training
5659494|NCT00665171|Polycystic ovary syndrome|polycystic ovary syndrome
5659495|NCT00665171|Single nucleotide polymorphism|single nucleotide polymorphism
5659496|NCT00665171|Whole genome analysis|whole genome analysis
5659497|NCT00665171|Multigenerational family study|multigenerational family study
5659498|NCT00665158|Abdominal obesity, exercise, behaviour modification|abdominal obesity, exercise, behaviour modification
5659499|NCT00665145|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5659500|NCT00665145|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5659501|NCT00665145|Diabetic Polyneuropathy|diabetic polyneuropathy
5659502|NCT00665145|Stem Cells|stem cells
5659503|NCT00665132|wrist|wrist
5659504|NCT00665132|hand|hand
5659505|NCT00665132|pain|pain
5659506|NCT00665132|failed CTR|failed ctr
5659507|NCT00665132|carpal tunnel syndrome|carpal tunnel syndrome
5659508|NCT00665132|CTS|cts
5659509|NCT00665132|CTR|ctr
5659510|NCT00665132|carpel tunnel release|carpel tunnel release
5659511|NCT00665132|Peripheral nerve|peripheral nerve
5659512|NCT00665132|Median nerve|median nerve
5659513|NCT00665119|Respiratory Insufficiency|respiratory insufficiency
5659514|NCT00665119|Respiration, Artificial|respiration, artificial
5659515|NCT00665119|Remifentanil|remifentanil
5659516|NCT00665119|Respiratory Mechanics|respiratory mechanics
5659517|NCT00665119|Work of Breathing|work of breathing
5659518|NCT00665106|Diabetic macular edema|diabetic macular edema
5659519|NCT00665106|Diabetes|diabetes
5659520|NCT00665106|Diabetic retinopathy|diabetic retinopathy
5659521|NCT00665067|Myeloproliferative Disease|myeloproliferative disease
5659522|NCT00665067|Myelofibrosis|myelofibrosis
5659523|NCT00665067|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5659524|NCT00665067|Essential Thrombocythemia|essential thrombocythemia
5659525|NCT00665067|Polycythemia Vera|polycythemia vera
5659526|NCT00665067|Biomarkers|biomarkers
5659527|NCT00665067|Philadelphia Chromosome Negative|philadelphia chromosome negative
5659528|NCT00665067|Clonal Hematopoietic malignancies|clonal hematopoietic malignancies
5659529|NCT00665054|Vardenafil|vardenafil
5659530|NCT00665054|Erectile dysfunction|erectile dysfunction
5659531|NCT00665054|SSES-E (sexual self-efficacy scale - erectile function)|sses-e (sexual self-efficacy scale - erectile function)
5659532|NCT00665028|Anesthesia|anesthesia
5659533|NCT00665028|Postoperative myocardial ischemia|postoperative myocardial ischemia
5659534|NCT00665028|ST monitoring|st monitoring
5659535|NCT00665015|pleural effusion|pleural effusion
5659536|NCT00665015|coronary artery bypass|coronary artery bypass
5659537|NCT00665015|heart valve replacement|heart valve replacement
5659539|NCT00665002|Monocytic|monocytic
5659540|NCT00665002|Hematopoietic|hematopoietic
5659542|NCT00665002|Acute Myelogenous Leukemia|acute myelogenous leukemia
5659544|NCT00665002|Myelodysplastic Syndrome|myelodysplastic syndrome
5659545|NCT00665002|MDS|mds
5659546|NCT00664989|Hemiarthroplasty Stemmed Resurfacing Conventional Shoulder|hemiarthroplasty stemmed resurfacing conventional shoulder
5659547|NCT00664976|bipolar depression|bipolar depression
5659548|NCT00664976|Electroconvulsive therapy|electroconvulsive therapy
5659549|NCT00664963|Arterial Occlusive Diseases|arterial occlusive diseases
5659550|NCT00664963|Peripheral Vascular Diseases|peripheral vascular diseases
5659551|NCT00664963|Drug eluting stent|drug eluting stent
5659552|NCT00664963|Restenosis|restenosis
5659553|NCT00664963|Below the knee|below the knee
5659554|NCT00664963|Intervention|intervention
5659555|NCT00664950|intertrochanteric hip fracture fixation|intertrochanteric hip fracture fixation
5659556|NCT00664950|interTAN IM Nail|intertan im nail
5659557|NCT00664950|sliding hip screw|sliding hip screw
5659558|NCT00664924|ICU|icu
5659559|NCT00664898|anti-CD40|anti-cd40
5659560|NCT00664898|Myeloma|myeloma
5659561|NCT00664885|non-psychiatric|non-psychiatric
5659563|NCT00664872|case manager|case manager
5659564|NCT00664872|suicide|suicide
5659565|NCT00664872|attempt|attempt
5659566|NCT00664872|effectiveness|effectiveness
5659567|NCT00664859|LCP-AtorFen|lcp-atorfen
5659568|NCT00664859|Non-HDL cholesterol|non-hdl cholesterol
5659569|NCT00664859|Triglycerides|triglycerides
5659570|NCT00664859|HDL cholesterol|hdl cholesterol
5659571|NCT00664859|LDL cholesterol|ldl cholesterol
5659572|NCT00664859|Atorvastatin|atorvastatin
5659573|NCT00664859|Fenofibrate|fenofibrate
5659574|NCT00664846|Stroke|stroke
5659575|NCT00664846|Prevention Therapy|prevention therapy
5659576|NCT00664833|Erectile dysfunction|erectile dysfunction
5659577|NCT00664833|Phosphodiesterase Type 5 Inhibitors|phosphodiesterase type 5 inhibitors
5659578|NCT00664833|Patient education|patient education
5659579|NCT00664833|Impotence|impotence
5659580|NCT00664833|Vardenafil|vardenafil
5659581|NCT00664820|Rheumatoid Arthritics|rheumatoid arthritics
5659582|NCT00664820|probiotics|probiotics
5659583|NCT00664820|Lactobacillus|lactobacillus
5659584|NCT00664781|stage IIIA breast cancer|stage iiia breast cancer
5659585|NCT00664781|stage IIIB breast cancer|stage iiib breast cancer
5659586|NCT00664781|stage IIIC breast cancer|stage iiic breast cancer
5659587|NCT00664781|stage IV breast cancer|stage iv breast cancer
5659588|NCT00664781|recurrent breast cancer|recurrent breast cancer
5659589|NCT00664781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5659590|NCT00664781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5659591|NCT00664781|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5659592|NCT00664781|ovarian stromal cancer|ovarian stromal cancer
5659593|NCT00664781|ovarian sarcoma|ovarian sarcoma
5659594|NCT00664781|BRCA1 mutation carrier|brca1 mutation carrier
5659595|NCT00664781|BRCA2 mutation carrier|brca2 mutation carrier
5659596|NCT00664781|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5659720|NCT00664235|Pressure Ulcers|pressure ulcers
5659597|NCT00664781|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5659598|NCT00664781|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5659599|NCT00664781|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5659600|NCT00664781|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5659601|NCT00664781|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5652919|NCT00690261|outcome|outcome
5659602|NCT00664781|ovarian papillary serous carcinoma|ovarian papillary serous carcinoma
5659603|NCT00664768|hypoallergenicity|hypoallergenicity
5659604|NCT00664768|Cow Milk Allergy|cow milk allergy
5659606|NCT00664768|Stool microflora|stool microflora
5659607|NCT00664768|Stool characteristics|stool characteristics
5659608|NCT00664755|Menstrual Cycle effects|menstrual cycle effects
5659609|NCT00664755|Cue Reactivity|cue reactivity
5659610|NCT00664755|Smoking Cessation|smoking cessation
5659611|NCT00664755|Impulsivity|impulsivity
5659612|NCT00664742|Metabolic syndrome,dyslipidemia,fluvastatin extended release|metabolic syndrome,dyslipidemia,fluvastatin extended release
5659613|NCT00664729|Abdominal|abdominal
5659614|NCT00664729|obesity|obesity
5659615|NCT00664729|exercise|exercise
5659616|NCT00664729|intensity|intensity
5659617|NCT00664729|weight loss|weight loss
5659618|NCT00664729|women|women
5659619|NCT00664716|Rheumatoid Arthritis|rheumatoid arthritis
5659621|NCT00664716|DMARD inadequate response|dmard inadequate response
5659622|NCT00664716|Methotrexate|methotrexate
5659623|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors
5659624|NCT00664703|Dopamine|dopamine
5659626|NCT00664703|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
5659627|NCT00664703|Neurologic Manifestations|neurologic manifestations
5659628|NCT00664703|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5659629|NCT00664703|Hyperkinesis|hyperkinesis
5659630|NCT00664703|Dyskinesias|dyskinesias
5659631|NCT00664690|shoulder surgery|shoulder surgery
5659632|NCT00664690|analgesia|analgesia
5659633|NCT00664677|Adult|adult
5659634|NCT00664677|Leukemia|leukemia
5659635|NCT00664677|Terameprocol|terameprocol
5659636|NCT00664677|Survivin|survivin
5659637|NCT00664677|AML|aml
5659638|NCT00664677|ALL|all
5659639|NCT00664677|ATL|atl
5659640|NCT00664677|CML|cml
5659641|NCT00664677|CLL|cll
5659642|NCT00664677|CMML|cmml
5659643|NCT00664677|MDS|mds
5659644|NCT00664664|insomnia|insomnia
5659645|NCT00664664|sleep maintenance insomnia|sleep maintenance insomnia
5659646|NCT00664664|sleep quality|sleep quality
5659647|NCT00664664|non-restorative sleep|non-restorative sleep
5659648|NCT00664664|multiple awakenings|multiple awakenings
5659649|NCT00664651|joint contracture|joint contracture
5659650|NCT00664651|total knee arthroplasty|total knee arthroplasty
5659651|NCT00664612|Cervical Spine|cervical spine
5659652|NCT00664599|Ocular lesions, Visual Acuity, Retinal Vasculitis|ocular lesions, visual acuity, retinal vasculitis
5659653|NCT00664586|Terameprocol (EM-1421)|terameprocol (em-1421)
5659654|NCT00664586|Phase 1|phase 1
5659655|NCT00664586|Infusion|infusion
5659656|NCT00664586|Refractory Solid Tumors|refractory solid tumors
5659657|NCT00664586|Lymphoma|lymphoma
5659658|NCT00664586|Maximum Tolerated Dose|maximum tolerated dose
5659659|NCT00664586|Tumor Response|tumor response
5659660|NCT00664586|Tumor Markers|tumor markers
5659661|NCT00664586|Pharmacokinetics|pharmacokinetics
5659662|NCT00664573|Safety|safety
5659663|NCT00664573|Rheumatoid Arthritis|rheumatoid arthritis
5659664|NCT00664573|Baminercept alfa|baminercept alfa
5659665|NCT00664573|Methotrexate|methotrexate
5659666|NCT00664573|BG9924|bg9924
5659667|NCT00664573|Efficacy|efficacy
5659668|NCT00664547|obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
5659669|NCT00664508|Arthroplasty|arthroplasty
5659670|NCT00664508|Hip Replacement|hip replacement
5659671|NCT00664508|motion analysis|motion analysis
5659672|NCT00664495|Obesity, exercise, diet, insulin resistance|obesity, exercise, diet, insulin resistance
5659673|NCT00664456|stage IIB prostate cancer|stage iib prostate cancer
5659674|NCT00664456|stage IIA prostate cancer|stage iia prostate cancer
5659675|NCT00664456|stage I prostate cancer|stage i prostate cancer
5659676|NCT00664443|cardiac arrest|cardiac arrest
5659677|NCT00664443|CPR|cpr
5659678|NCT00664443|resuscitation|resuscitation
5659679|NCT00664443|bystander CPR|bystander cpr
5659680|NCT00664443|dispatch-assisted CPR|dispatch-assisted cpr
5659681|NCT00664430|Dialysis|dialysis
5659682|NCT00664430|Calcitriol Resistant|calcitriol resistant
5659683|NCT00664430|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5659684|NCT00664417|Influenza|influenza
5659685|NCT00664417|A/H5N1|a/h5n1
5659686|NCT00664417|Orthomyxoviridae Infections|orthomyxoviridae infections
5659687|NCT00664417|Influenza Pandemics|influenza pandemics
5659688|NCT00664404|Smoking|smoking
5659689|NCT00664404|Smoking Cessation|smoking cessation
5659690|NCT00664404|Nicotine Withdrawal|nicotine withdrawal
5659691|NCT00664404|Nicotine Dependence|nicotine dependence
5659692|NCT00664404|Neuroregulatory Effects|neuroregulatory effects
5659693|NCT00664404|Magnetic Resonance Imaging|magnetic resonance imaging
5659694|NCT00664404|MRI|mri
5659695|NCT00664378|Multiple myeloma, relapsed, refractory|multiple myeloma, relapsed, refractory
5659696|NCT00664365|Premature ejaculation.|premature ejaculation.
5659697|NCT00664365|FTIH,|ftih,
5659698|NCT00664365|GSK958108,|gsk958108,
5659699|NCT00664365|5HT1a antagonist,|5ht1a antagonist,
5659700|NCT00664352|Double blind|double blind
5659701|NCT00664352|Placebo controlled|placebo controlled
5659702|NCT00664352|wound healing|wound healing
5659708|NCT00664313|Linezolid|linezolid
5659709|NCT00664313|Zyvox|zyvox
5659710|NCT00664313|Peripheral Neuropathy|peripheral neuropathy
5659711|NCT00664313|Optic Neuropathy|optic neuropathy
5659712|NCT00664313|Anemia|anemia
5659713|NCT00664313|Thrombocytopenia|thrombocytopenia
5659714|NCT00664300|Gilles de la Tourette's syndrome|gilles de la tourette's syndrome
5659715|NCT00664300|Facial expression recognition of emotion|facial expression recognition of emotion
5659716|NCT00664300|Frequency levels|frequency levels
5659717|NCT00664300|Automatic and voluntary information treatment|automatic and voluntary information treatment
5659718|NCT00664300|Patient with Gilles de la Tourette's syndrome|patient with gilles de la tourette's syndrome
5659719|NCT00664261|tobacco use disorder|tobacco use disorder
5659721|NCT00664235|Tissue Injury|tissue injury
5659722|NCT00664222|heart failure|heart failure
5659723|NCT00664222|insulin resistance|insulin resistance
5659724|NCT00664222|inflammatory cytokine|inflammatory cytokine
5659725|NCT00664222|spironolactone|spironolactone
5659726|NCT00664222|furosemide|furosemide
5659727|NCT00664209|Parkinson's disease|parkinson's disease
5659728|NCT00664209|levodopa|levodopa
5659729|NCT00664209|Helicobacter pylori|helicobacter pylori
5659730|NCT00664196|Prostate Cancer|prostate cancer
5659731|NCT00664196|T cells|t cells
5659732|NCT00664196|Gene Transfer|gene transfer
5659733|NCT00664183|diabetic retinopathy|diabetic retinopathy
5659734|NCT00664157|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5659735|NCT00664157|L-Dopa|l-dopa
5659736|NCT00664157|Deep Brain stimulation|deep brain stimulation
5659737|NCT00664157|Facial expression recognition of emotion|facial expression recognition of emotion
5659738|NCT00664157|Frequency levels|frequency levels
5659739|NCT00664157|Automatic and voluntary information treatment|automatic and voluntary information treatment
5659740|NCT00664157|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5659741|NCT00664131|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5659742|NCT00664131|ALL survivors|all survivors
5659743|NCT00664131|ALL neurologic symptoms|all neurologic symptoms
5659744|NCT00664131|ALL neurologic disability|all neurologic disability
5659745|NCT00664131|ALL late effects|all late effects
5659746|NCT00664118|Doula|doula
5659747|NCT00664118|Patient-controlled epidural analgesia|patient-controlled epidural analgesia
5659748|NCT00664118|Neuraxial analgesia|neuraxial analgesia
5659749|NCT00664118|Labor analgesia|labor analgesia
5659750|NCT00664105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5659751|NCT00664105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5659752|NCT00664092|Substance Abuse|substance abuse
5659753|NCT00664092|Ex-Offenders|ex-offenders
5659754|NCT00664092|Substance Abuse Recovery|substance abuse recovery
5659755|NCT00664079|Thyroid Deficiency|thyroid deficiency
5659756|NCT00664079|Thyroid Stimulating Hormone|thyroid stimulating hormone
5659757|NCT00664053|bone mineral density|bone mineral density
5659758|NCT00664053|bone turnover markers|bone turnover markers
5659759|NCT00664053|strength|strength
5659760|NCT00664053|balance|balance
5659761|NCT00664014|hyponatremia|hyponatremia
5659762|NCT00664014|Non-acute and non hypovolemic hyponatremia|non-acute and non hypovolemic hyponatremia
5659763|NCT00663988|face transplantation|face transplantation
5659764|NCT00663975|cystic fibrosis|cystic fibrosis
5659765|NCT00663975|pancreatic insufficiency|pancreatic insufficiency
5659766|NCT00663975|pancreatic enzymes|pancreatic enzymes
5659767|NCT00663975|pediatrics|pediatrics
5659768|NCT00663962|Thoracotomy|thoracotomy
5659769|NCT00663962|Post-surgical|post-surgical
5659770|NCT00663962|Pregabalin|pregabalin
5659771|NCT00663949|diabetes|diabetes
5659772|NCT00663949|proteinuria|proteinuria
5659773|NCT00663949|pentoxifylline|pentoxifylline
5659774|NCT00663936|Alzheimer's Disease|alzheimer's disease
5659775|NCT00663936|Alzheimer's|alzheimer's
5659776|NCT00663923|Excimer Laser|excimer laser
5659777|NCT00663923|photorefractive keratectomy|photorefractive keratectomy
5659778|NCT00663923|astigmatism|astigmatism
5659779|NCT00663910|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5659780|NCT00663910|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5659781|NCT00663910|recurrent skin cancer|recurrent skin cancer
5659782|NCT00663897|functional dyspepsia|functional dyspepsia
5659783|NCT00663897|epigastric pain syndrome|epigastric pain syndrome
5659784|NCT00663897|postprandial distress syndrome|postprandial distress syndrome
5659785|NCT00663897|proton pump inhibitor|proton pump inhibitor
5659786|NCT00663897|5 HT-4 receptor agonist|5 ht-4 receptor agonist
5659787|NCT00663884|diabetes mellitus, Type 2|diabetes mellitus, type 2
5659788|NCT00663884|mitiglinide|mitiglinide
5659789|NCT00663871|Fish Oil|fish oil
5659790|NCT00663871|Omega-3 fatty acids|omega-3 fatty acids
5659791|NCT00663871|Affect|affect
5659792|NCT00663871|Depression|depression
5659793|NCT00663871|Anger|anger
5659794|NCT00663871|Nutrition|nutrition
5659795|NCT00663871|Impulsivity|impulsivity
5659796|NCT00663871|Aggression|aggression
5659797|NCT00663871|Cognition|cognition
5659798|NCT00663871|Behavior|behavior
5659799|NCT00663845|Male Erectile Dysfunction|male erectile dysfunction
5659800|NCT00663845|Dyslipidemia|dyslipidemia
5659801|NCT00663845|Vardenafil|vardenafil
5659802|NCT00663832|Male|male
5659803|NCT00663832|Prostate|prostate
5659804|NCT00663832|Cancer|cancer
5659805|NCT00663832|HRPC|hrpc
5659806|NCT00663832|DACi|daci
5659807|NCT00663819|Low anterior colon resection|low anterior colon resection
5659808|NCT00663819|Proctectomy|proctectomy
5659809|NCT00663819|Proctocolectomy|proctocolectomy
5659810|NCT00663819|Anastomosis|anastomosis
5659811|NCT00663819|Rectal Cancer|rectal cancer
5659812|NCT00663819|Ileostomy|ileostomy
5659813|NCT00663806|UTI|uti
5659814|NCT00663793|Male Contraception|male contraception
5659815|NCT00663793|Hypogonadism|hypogonadism
5659816|NCT00663793|Testosterone|testosterone
5659817|NCT00663780|pharmacogenomics|pharmacogenomics
5659818|NCT00663780|polymorphisms|polymorphisms
5659819|NCT00663780|wound healing|wound healing
5659820|NCT00663754|Body Image|body image
5659821|NCT00663741|Unresectable / recurrent gastric cancer|unresectable / recurrent gastric cancer
5659823|NCT00663741|S-1|s-1
5659824|NCT00663741|Gastric|gastric
5659825|NCT00663741|Cisplatin|cisplatin
5659826|NCT00663741|CDDP|cddp
5659827|NCT00663728|Erectile Dysfunction|erectile dysfunction
5659828|NCT00663728|Vardenafil|vardenafil
5659829|NCT00663715|Sciatic Nerve|sciatic nerve
5659830|NCT00663715|Peripheral Nerve Block|peripheral nerve block
5659831|NCT00663715|Lower extremity surgery|lower extremity surgery
5659832|NCT00663715|Local Anesthesia|local anesthesia
5659833|NCT00663715|Ultrasound guided nerve blocks|ultrasound guided nerve blocks
5659834|NCT00663689|erlotinib|erlotinib
5659835|NCT00663650|Basal Cell Carcinoma|basal cell carcinoma
5659837|NCT00663650|Periocular BCC|periocular bcc
5659838|NCT00663650|Frozen Section Control|frozen section control
5659839|NCT00663650|Permanent Section Control|permanent section control
5659840|NCT00663650|Recurrence Rates|recurrence rates
5659841|NCT00663637|endotracheal tube obstruction, occlusion|endotracheal tube obstruction, occlusion
5659842|NCT00663637|mechanical ventilation, complication|mechanical ventilation, complication
5659843|NCT00663637|work of breathing|work of breathing
5659844|NCT00663637|airway resistance|airway resistance
5659845|NCT00663637|secretions|secretions
5659846|NCT00663637|pneumonia, ventilator associated|pneumonia, ventilator associated
5659847|NCT00663637|biofilms|biofilms
5659848|NCT00663637|endotracheal tube|endotracheal tube
5659849|NCT00663611|Immune Function|immune function
5659850|NCT00663611|Metabolism|metabolism
5659851|NCT00663611|Pulsatile Growth Hormone|pulsatile growth hormone
5659852|NCT00663598|Erectile Dysfunction|erectile dysfunction
5659853|NCT00663598|Vardenafil|vardenafil
5659854|NCT00663585|Migraine|migraine
5659855|NCT00663585|Headache|headache
5659856|NCT00663585|Vipassana|vipassana
5659857|NCT00663585|Meditation|meditation
5659858|NCT00663585|Intensive|intensive
5659859|NCT00663572|Newborn|newborn
5659860|NCT00663572|nutrition|nutrition
5659861|NCT00663572|genetic|genetic
5659862|NCT00663572|feeding behaviour|feeding behaviour
5659863|NCT00663572|psychomotor development|psychomotor development
5659864|NCT00663572|long-term effects|long-term effects
5659865|NCT00663572|nutritional imprinting.|nutritional imprinting.
5659866|NCT00663559|renal|renal
5659867|NCT00663559|Sunitinib|sunitinib
5659868|NCT00663559|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
5659869|NCT00663546|Malaria|malaria
5659870|NCT00663546|Plasmodium|plasmodium
5659871|NCT00663546|Hemoglobin E|hemoglobin e
5659872|NCT00663546|Alpha-thalssemia|alpha-thalssemia
5659873|NCT00663546|G6PD Deficiency|g6pd deficiency
5659874|NCT00663533|Vasectomy|vasectomy
5659875|NCT00663533|Contraception|contraception
5659876|NCT00663520|Cardiac disease|cardiac disease
5659877|NCT00663520|vascular dysfunction|vascular dysfunction
5659878|NCT00663520|women|women
5659879|NCT00663520|chest pain|chest pain
5659880|NCT00663520|echocardiography|echocardiography
5659881|NCT00663507|Sickle Cell Disease|sickle cell disease
5659882|NCT00663507|Immunosuppression|immunosuppression
5659883|NCT00663507|Organ & Tissue Transplantation|organ & tissue transplantation
5659884|NCT00663507|Transplantation Immunology|transplantation immunology
5659885|NCT00663494|heart failure|heart failure
5659886|NCT00663494|MMP|mmp
5659887|NCT00663494|coronary sinus|coronary sinus
5659888|NCT00663481|CoFactor|cofactor
5659889|NCT00663481|ANX-510|anx-510
5659890|NCT00663468|determine changes in patient pain level|determine changes in patient pain level
5659891|NCT00663468|determine changes in patient functionality|determine changes in patient functionality
5659892|NCT00663468|determine changes in patient life quality|determine changes in patient life quality
5659893|NCT00663455|kidney transplant recipients|kidney transplant recipients
5789074|NCT00150033|questionnaire|questionnaire
5659894|NCT00663455|children and adolescents with kidney transplants|children and adolescents with kidney transplants
5659896|NCT00663442|side effects|side effects
5659897|NCT00663442|sleep|sleep
5659898|NCT00663442|dopamine|dopamine
5659899|NCT00663442|pharmacogenetics|pharmacogenetics
5659900|NCT00663403|daptomycin|daptomycin
5659901|NCT00663403|pharmacokinetics|pharmacokinetics
5659902|NCT00663403|renal replacement therapy|renal replacement therapy
5659903|NCT00663403|critical illness|critical illness
5659904|NCT00663403|intensive care units|intensive care units
5659905|NCT00663377|Heart Failure|heart failure
5659906|NCT00663377|Insulin Resistance|insulin resistance
5659907|NCT00663377|Losartan|losartan
5659908|NCT00663377|ACE inhibitor|ace inhibitor
5659909|NCT00663377|Inflammatory cytokine|inflammatory cytokine
5659910|NCT00663364|dry skin|dry skin
5659911|NCT00663351|Arthritis|arthritis
5659912|NCT00663351|Osteoarthritis|osteoarthritis
5659913|NCT00663351|Traumatic Arthritis|traumatic arthritis
5659914|NCT00663351|Degenerative Joint Disease|degenerative joint disease
5659915|NCT00663351|Avascular Necrosis|avascular necrosis
5659916|NCT00663338|Stroke|stroke
5659917|NCT00663338|Hemispatial neglect|hemispatial neglect
5659918|NCT00663338|Unilateral neglect|unilateral neglect
5659919|NCT00663338|Spatial neglect|spatial neglect
5659920|NCT00663338|Motor|motor
5659921|NCT00663338|Weakness|weakness
5659922|NCT00663312|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5659923|NCT00663312|Deep Brain stimulation|deep brain stimulation
5659924|NCT00663312|Hepatic glucose production|hepatic glucose production
5659925|NCT00663312|Insulin|insulin
5659926|NCT00663312|Weight gain|weight gain
5659927|NCT00663312|Patient with an Idiopathic Parkinson's disease|patient with an idiopathic parkinson's disease
5659928|NCT00663299|Intracranial aneurysm|intracranial aneurysm
5659929|NCT00663247|Diverticular disease|diverticular disease
5659930|NCT00663247|Inflammation|inflammation
5659931|NCT00663247|Mesalazine|mesalazine
5659932|NCT00663234|Treatment Experienced|treatment experienced
5659933|NCT00663221|Osteoporosis prevention|osteoporosis prevention
5659934|NCT00663195|heart failure|heart failure
5659935|NCT00663195|fibrosis|fibrosis
5659936|NCT00663195|MMP|mmp
5659937|NCT00663195|spironolactone|spironolactone
5659938|NCT00663195|furosemide|furosemide
5659939|NCT00663182|Entecavir|entecavir
5659940|NCT00663182|cirrhosis|cirrhosis
5659941|NCT00663182|anti-viral|anti-viral
5659942|NCT00663182|therapy|therapy
5659943|NCT00663169|Arthritis Gouty|arthritis gouty
5659944|NCT00663169|ACZ885|acz885
5659945|NCT00663169|IL1B protein|il1b protein
5659946|NCT00663169|Pain|pain
5659947|NCT00663156|lipoaugmentation|lipoaugmentation
5659948|NCT00663156|breast augmentation|breast augmentation
5659949|NCT00663156|fat grafting|fat grafting
5659950|NCT00663156|liposuction|liposuction
5659951|NCT00663156|lipoinfiltration|lipoinfiltration
5659952|NCT00663156|Spear|spear
5659953|NCT00663156|breast implants|breast implants
5659954|NCT00663156|ASERF|aserf
5659955|NCT00663156|Lipivage|lipivage
5659956|NCT00663156|Baker|baker
5659958|NCT00663156|autologous|autologous
5659959|NCT00663156|Georgetown|georgetown
5659960|NCT00663143|investigate|investigate
5659961|NCT00663143|TZD exposure|tzd exposure
5659962|NCT00663143|in vitro|in vitro
5659963|NCT00663143|alters|alters
5659964|NCT00663143|bone|bone
5659965|NCT00663143|formation|formation
5659966|NCT00663143|differentiation|differentiation
5659967|NCT00663143|capacity|capacity
5659968|NCT00663143|bone marrow|bone marrow
5659969|NCT00663143|stromal cells|stromal cells
5659970|NCT00663130|Erectile Dysfunction|erectile dysfunction
5659971|NCT00663130|Vardenafil|vardenafil
5659972|NCT00663117|naltrexone|naltrexone
5659973|NCT00663117|LDN|ldn
5659974|NCT00663117|IBD|ibd
5659975|NCT00663117|Inflammatory bowel disease|inflammatory bowel disease
5659976|NCT00663104|early menopause|early menopause
5659977|NCT00663104|exercise|exercise
5659978|NCT00663104|phytoestrogen|phytoestrogen
5659979|NCT00663104|bone|bone
5659980|NCT00663104|CHD-risk factors|chd-risk factors
5659981|NCT00663091|WPP-201|wpp-201
5659982|NCT00663078|Cognitive Behavioral Therapy|cognitive behavioral therapy
5659983|NCT00663078|expert patient programme|expert patient programme
5659984|NCT00663078|deprived population|deprived population
5659985|NCT00663078|women|women
5659986|NCT00663065|Healthy subjects over 65|healthy subjects over 65
5659987|NCT00663065|healthy subjects|healthy subjects
5659988|NCT00663052|Enbrel|enbrel
5659989|NCT00663052|Psoriasis|psoriasis
5659990|NCT00663052|Topical Psoriasis|topical psoriasis
5659991|NCT00663052|Wyeth Psoriasis|wyeth psoriasis
5659992|NCT00663052|Active Psoriasis|active psoriasis
5659993|NCT00663039|Schizophrenia|schizophrenia
5659994|NCT00663039|Eye movements|eye movements
5659995|NCT00663039|phenotype|phenotype
5659996|NCT00663039|biochemical|biochemical
5659997|NCT00663039|relatives|relatives
5659998|NCT00663026|antibody|antibody
5659999|NCT00663026|immunotherapy|immunotherapy
5660000|NCT00663013|burn|burn
5660001|NCT00663013|pain|pain
5660002|NCT00663013|anxiety|anxiety
5660003|NCT00663000|acromegaly|acromegaly
5660004|NCT00663000|diabetes|diabetes
5660005|NCT00663000|insulin resistance|insulin resistance
5660006|NCT00663000|impaired glucose tolerance|impaired glucose tolerance
5660007|NCT00662987|tonsillectomy|tonsillectomy
5660008|NCT00662987|antibiotics|antibiotics
5660009|NCT00662961|Plastic Surgery|plastic surgery
5660010|NCT00662948|Folicular Lymphoma|folicular lymphoma
5660011|NCT00662948|Consolidation|consolidation
5660012|NCT00662948|Maintenance|maintenance
5660013|NCT00662935|deep brain stimulation|deep brain stimulation
5660014|NCT00662935|cluster headache|cluster headache
5660015|NCT00662935|hypothalamus|hypothalamus
5660016|NCT00662922|critical illness|critical illness
5660017|NCT00662922|hypoglycemia|hypoglycemia
5660018|NCT00662922|neurocognitive dysfunction|neurocognitive dysfunction
5660019|NCT00662922|intensive insulin therapy|intensive insulin therapy
5660020|NCT00662909|Frequency|frequency
5660021|NCT00662909|YM178|ym178
5660022|NCT00662909|Overactive bladder (OAB)|overactive bladder (oab)
5660023|NCT00662909|Micturition|micturition
5660024|NCT00662909|Urgency|urgency
5660025|NCT00662909|Urinary urge incontinence|urinary urge incontinence
5660026|NCT00662909|Urinary incontinence|urinary incontinence
5660027|NCT00662883|ketamine|ketamine
5660028|NCT00662883|corticosteroid|corticosteroid
5660029|NCT00662883|intranasal|intranasal
5660030|NCT00662883|phase I|phase i
5660031|NCT00662883|Healthy volunteers|healthy volunteers
5660032|NCT00662870|DAPTACEL|daptacel
5660033|NCT00662870|Diphtheria|diphtheria
5660034|NCT00662870|Tetanus|tetanus
5660035|NCT00662870|Whooping Cough|whooping cough
5660036|NCT00662870|Polio|polio
5660037|NCT00662870|Haemophilus influenzae type b|haemophilus influenzae type b
5660038|NCT00662870|Pertussis|pertussis
5660039|NCT00662857|Diabetic adult male, diabetic adult female|diabetic adult male, diabetic adult female
5660136|NCT00662441|Erectile Dysfunction|erectile dysfunction
5660040|NCT00662844|Vitamin D insufficiency,vitamin D3 treatment,young women|vitamin d insufficiency,vitamin d3 treatment,young women
5660041|NCT00662831|Diabetic Foot Ulcers Neuroischaemic|diabetic foot ulcers neuroischaemic
5660042|NCT00662805|pharmacovigilance|pharmacovigilance
5660043|NCT00662805|COPD|copd
5660044|NCT00662779|asthma|asthma
5660045|NCT00662779|exercise induced bronchospasm|exercise induced bronchospasm
5660046|NCT00662779|prevention|prevention
5660047|NCT00662779|EIB|eib
5660048|NCT00662779|children|children
5660049|NCT00662766|Black currant|black currant
5660050|NCT00662766|Berry seed|berry seed
5660051|NCT00662766|Press residue|press residue
5660052|NCT00662766|Tocopherol|tocopherol
5660053|NCT00662766|Fatty acids|fatty acids
5660054|NCT00662766|Fiber|fiber
5660055|NCT00662766|Total phenols|total phenols
5660056|NCT00662766|TEAC|teac
5660057|NCT00662766|Comet assay|comet assay
5660058|NCT00662766|Dihydroxybenzoic acid|dihydroxybenzoic acid
5671724|NCT00614653|Tarceva|tarceva
5660059|NCT00662753|hypertension|hypertension
5660060|NCT00662753|home blood pressure monitoring|home blood pressure monitoring
5660061|NCT00662753|nurse telephone follow up|nurse telephone follow up
5660062|NCT00662753|medically underserved populations|medically underserved populations
5660063|NCT00662727|Extracorporeal Shockwave Therapy|extracorporeal shockwave therapy
5660064|NCT00662727|Myocardial Ischemia|myocardial ischemia
5660065|NCT00662727|Refractory Angina|refractory angina
5660066|NCT00662701|Atrial Fibrillation|atrial fibrillation
5660067|NCT00662688|thromboembolism|thromboembolism
5660068|NCT00662688|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5660069|NCT00662688|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5660070|NCT00662688|stage IV pancreatic cancer|stage iv pancreatic cancer
5660071|NCT00662688|recurrent pancreatic cancer|recurrent pancreatic cancer
5660072|NCT00662675|Exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5660073|NCT00662675|Steatorrhea|steatorrhea
5660074|NCT00662675|Malabsorption syndromes|malabsorption syndromes
5660075|NCT00662675|Cystic fibrosis|cystic fibrosis
5660076|NCT00662675|Pediatrics|pediatrics
5660077|NCT00662675|Adult|adult
5660078|NCT00662675|Pancrelipase|pancrelipase
5660079|NCT00662662|Oropharyngeal Cancer|oropharyngeal cancer
5660080|NCT00662662|Non-Oropharyngeal Cancer|non-oropharyngeal cancer
5660081|NCT00662662|Head and Neck Cancer|head and neck cancer
5660082|NCT00662662|Squamous Cell Carcinoma|squamous cell carcinoma
5660083|NCT00662662|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5660084|NCT00662662|SCCHN|scchn
5660085|NCT00662662|HPV-16|hpv-16
5660086|NCT00662662|Questionnaire|questionnaire
5660087|NCT00662662|Sexual Behavior|sexual behavior
5660088|NCT00662662|Survey|survey
5660089|NCT00662649|Multiple sclerosis.|multiple sclerosis.
5660090|NCT00662649|Relapse-remitting|relapse-remitting
5660091|NCT00662649|Fingolimod|fingolimod
5660092|NCT00662623|Chronic Obstructive Sleep Apnea|chronic obstructive sleep apnea
5660093|NCT00662623|Sleep Apnea|sleep apnea
5660094|NCT00662623|Sleep Apnea Treatment|sleep apnea treatment
5660095|NCT00662597|Tumor vascular disrupting agent|tumor vascular disrupting agent
5660097|NCT00662597|ASA404|asa404
5660098|NCT00662597|non-small cell lung cancer|non-small cell lung cancer
5660102|NCT00662571|nucleotide polymorphisms|nucleotide polymorphisms
5660103|NCT00662571|disequilibrium haplotype|disequilibrium haplotype
5660104|NCT00662571|acamprosate|acamprosate
5660105|NCT00662571|differentiate|differentiate
5660106|NCT00662571|pharmacogenomic|pharmacogenomic
5660107|NCT00662571|effective individualized treatment|effective individualized treatment
5660108|NCT00662571|alcohol dependent|alcohol dependent
5660109|NCT00662571|N-methyl-D-aspartate receptor (NMDA)|n-methyl-d-aspartate receptor (nmda)
5660110|NCT00662571|metabotropic glutamate receptor|metabotropic glutamate receptor
5660111|NCT00662571|decreasing craving|decreasing craving
5660112|NCT00662571|abstinence maintenance|abstinence maintenance
5660113|NCT00662558|Chronic low back pain|chronic low back pain
5660115|NCT00662545|Hepatitis B|hepatitis b
5660116|NCT00662545|treatment experienced|treatment experienced
5660117|NCT00662532|Peri-implantitis; antibiotic|peri-implantitis; antibiotic
5660118|NCT00662493|knee pain|knee pain
5660119|NCT00662493|exercise|exercise
5660120|NCT00662493|rehabilitation|rehabilitation
5660121|NCT00662480|population|population
5660122|NCT00662480|screening|screening
5660123|NCT00662480|abdominal aortic aneurysms|abdominal aortic aneurysms
5660125|NCT00662480|hypertension|hypertension
5660126|NCT00662480|Prevention|prevention
5660127|NCT00662467|Myocardial Infarction|myocardial infarction
5660128|NCT00662467|Hemorrhage|hemorrhage
5660129|NCT00662467|Thromboembolism|thromboembolism
5660130|NCT00662467|Clopidogrel|clopidogrel
5660131|NCT00662467|Aspirin|aspirin
5660132|NCT00662467|Warfarin|warfarin
5660133|NCT00662454|contraceptive|contraceptive
5660134|NCT00662454|efficacy|efficacy
5660135|NCT00662454|body weight|body weight
5660137|NCT00662441|Vardenafil|vardenafil
5660138|NCT00662428|cost-benefit analysis|cost-benefit analysis
5660139|NCT00662428|practice guideline|practice guideline
5660140|NCT00662428|inpatients|inpatients
5660141|NCT00662415|phantom limb pain|phantom limb pain
5660143|NCT00662415|mirror therapy|mirror therapy
5660144|NCT00662402|K Grant|k grant
5660145|NCT00662402|Career Advancement|career advancement
5660146|NCT00662402|Award|award
5660147|NCT00662402|Consultation|consultation
5660148|NCT00662402|Application|application
5660150|NCT00662402|The NIH priority score of the reviewed proposal.|the nih priority score of the reviewed proposal.
5660151|NCT00662402|Percent of subjects who obtain funding for proposal.|percent of subjects who obtain funding for proposal.
5660152|NCT00662402|Percent of subjects who submit proposals for funding.|percent of subjects who submit proposals for funding.
5660153|NCT00662389|skin laxity, wrinkles, rhytids|skin laxity, wrinkles, rhytids
5660154|NCT00662363|constipation|constipation
5660155|NCT00662363|opioid|opioid
5660156|NCT00662363|rehabilitation|rehabilitation
5660157|NCT00662363|post-operative|post-operative
5660158|NCT00662363|orthopedic|orthopedic
5660159|NCT00662350|BPH|bph
5660160|NCT00662337|Bioequivalence, diphenhydramine hydrochloride|bioequivalence, diphenhydramine hydrochloride
5660161|NCT00662298|severe asthma|severe asthma
5660162|NCT00662298|prednisolone pharmacokinetics|prednisolone pharmacokinetics
5660163|NCT00662298|anti-inflammatory effects|anti-inflammatory effects
5660164|NCT00662285|iron status|iron status
5660165|NCT00662285|blood donors|blood donors
5660166|NCT00662272|Flu|flu
5660167|NCT00662272|Influenza vaccine|influenza vaccine
5660168|NCT00662272|Adjuvant|adjuvant
5660169|NCT00662272|Safety of an adjuvanted vaccine|safety of an adjuvanted vaccine
5660170|NCT00662272|Immune response to an adjuvanted vaccine|immune response to an adjuvanted vaccine
5660171|NCT00662259|Anxiety disorders|anxiety disorders
5660172|NCT00662259|Generalized anxiety|generalized anxiety
5660173|NCT00662233|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5660174|NCT00662233|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5660175|NCT00662233|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5660176|NCT00662233|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5660177|NCT00662233|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5660178|NCT00662233|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5660179|NCT00662233|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5660180|NCT00662233|ovarian sarcoma|ovarian sarcoma
5660181|NCT00662233|stage II uterine sarcoma|stage ii uterine sarcoma
5660182|NCT00662233|stage III uterine sarcoma|stage iii uterine sarcoma
5660183|NCT00662233|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5660184|NCT00662220|chronic|chronic
5660185|NCT00662220|hepatitis C|hepatitis c
5660186|NCT00662220|ribavirin|ribavirin
5660189|NCT00662220|genotype four|genotype four
5660190|NCT00662207|electric stimulation|electric stimulation
5660191|NCT00662207|urethral obstruction|urethral obstruction
5660192|NCT00662207|urodynamics|urodynamics
5660193|NCT00662207|urology|urology
5660194|NCT00662194|HIV|hiv
5660195|NCT00662194|HBV|hbv
5660196|NCT00662194|HCV|hcv
5660197|NCT00662194|co-infection|co-infection
5660198|NCT00662194|innate immunity|innate immunity
5660199|NCT00662181|growth hormone|growth hormone
5660200|NCT00662181|quality of life|quality of life
5660201|NCT00662181|fat redistribution|fat redistribution
5660202|NCT00662181|sugar metabolism|sugar metabolism
5660203|NCT00662181|fat metabolism|fat metabolism
5660204|NCT00662181|cytokines|cytokines
5660205|NCT00662168|carcinoid|carcinoid
5660206|NCT00662168|familial|familial
5660207|NCT00662168|Collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma|collect and describe information about the medical and environmental factors associated with each cases of carcinoid carcinoma
5660208|NCT00662168|Develop a genogram representing the family cancer history of cases of Carcinoid.|develop a genogram representing the family cancer history of cases of carcinoid.
5660209|NCT00662155|Primary Insomnia|primary insomnia
5660210|NCT00662155|Cognitive Behavioral Therapy|cognitive behavioral therapy
5660211|NCT00662155|Insomnia|insomnia
5660212|NCT00662155|Sleep|sleep
5660213|NCT00662155|Zolpidem|zolpidem
5660214|NCT00662155|Ambien|ambien
5660215|NCT00662155|CBT|cbt
5660216|NCT00662155|CBT-I|cbt-i
5660217|NCT00662142|DHA|dha
5660218|NCT00662142|fMRI|fmri
5660221|NCT00662129|recurrent breast cancer|recurrent breast cancer
5660222|NCT00662116|diastolic heart failure|diastolic heart failure
5660223|NCT00662103|fatigue|fatigue
5660224|NCT00662103|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5660225|NCT00662103|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5660226|NCT00662103|cancer survivor|cancer survivor
5660227|NCT00662103|stage IA breast cancer|stage ia breast cancer
5660228|NCT00662103|stage IB breast cancer|stage ib breast cancer
5660229|NCT00662103|stage II breast cancer|stage ii breast cancer
5660230|NCT00662103|stage IIIA breast cancer|stage iiia breast cancer
5660231|NCT00662103|stage IIIB breast cancer|stage iiib breast cancer
5660232|NCT00662103|stage IIIC breast cancer|stage iiic breast cancer
5660233|NCT00662103|breast cancer in situ|breast cancer in situ
5660234|NCT00662090|MDS|mds
5660235|NCT00662090|JMML|jmml
5660236|NCT00662090|EWOG-MDS|ewog-mds
5660237|NCT00662090|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5660238|NCT00662090|Juvenile Myelomonocytic Leukemia (JMML)|juvenile myelomonocytic leukemia (jmml)
5660239|NCT00662077|osteoporosis|osteoporosis
5660240|NCT00662077|bifosfonates|bifosfonates
5660241|NCT00662077|ibandronate|ibandronate
5660242|NCT00662064|Lower urinary tract|lower urinary tract
5660243|NCT00662064|Physiology|physiology
5660244|NCT00662064|Pathology|pathology
5660245|NCT00662064|Immunohistochemistry|immunohistochemistry
5660246|NCT00662064|Urinary bladder|urinary bladder
5660247|NCT00662051|Asthma|asthma
5660248|NCT00662051|Exhaled Nitric Oxide|exhaled nitric oxide
5660249|NCT00662051|Asthma Control Test|asthma control test
5660250|NCT00662038|idiopathic|idiopathic
5660251|NCT00662038|pulmonary|pulmonary
5660252|NCT00662038|fibrosis|fibrosis
5660253|NCT00662012|Leishmaniasis|leishmaniasis
5660254|NCT00662012|Sodium stibogluconate|sodium stibogluconate
5660255|NCT00662012|Pentostam|pentostam
5660256|NCT00662012|sand fly|sand fly
5660257|NCT00661999|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5660258|NCT00661999|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5660259|NCT00661999|extramedullary plasmacytoma|extramedullary plasmacytoma
5660260|NCT00661999|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5660261|NCT00661999|refractory multiple myeloma|refractory multiple myeloma
5660262|NCT00661999|stage I multiple myeloma|stage i multiple myeloma
5660263|NCT00661999|stage II multiple myeloma|stage ii multiple myeloma
5660264|NCT00661999|stage III multiple myeloma|stage iii multiple myeloma
5660265|NCT00661999|primary systemic amyloidosis|primary systemic amyloidosis
5660266|NCT00661999|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5660267|NCT00661999|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5660268|NCT00661999|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5660269|NCT00661999|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5660270|NCT00661999|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5660271|NCT00661999|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5660272|NCT00661999|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5660273|NCT00661999|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5660274|NCT00661999|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5660275|NCT00661999|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5653612|NCT00687908|Acne|acne
5660278|NCT00661999|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5660279|NCT00661999|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5660280|NCT00661999|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5660281|NCT00661999|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5660282|NCT00661999|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5660283|NCT00661999|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5660284|NCT00661999|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5660286|NCT00661999|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5660287|NCT00661999|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5660288|NCT00661999|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5660289|NCT00661999|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5660290|NCT00661999|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5660291|NCT00661999|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5660292|NCT00661999|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5660293|NCT00661999|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5660294|NCT00661999|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5660295|NCT00661999|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5685485|NCT00555919|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5660296|NCT00661999|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5660297|NCT00661999|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5660298|NCT00661999|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5660299|NCT00661999|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5660300|NCT00661999|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5660301|NCT00661999|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5660363|NCT00661999|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5660302|NCT00661999|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5660303|NCT00661999|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5660304|NCT00661999|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5660305|NCT00661999|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5660306|NCT00661999|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5660307|NCT00661999|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5660308|NCT00661999|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5660309|NCT00661999|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5660310|NCT00661999|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5660311|NCT00661999|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5660312|NCT00661999|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5680411|NCT00577915|Diagnostic radiology|diagnostic radiology
5644297|NCT00724204|safety|safety
5660313|NCT00661999|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5660314|NCT00661999|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5641244|NCT00735436|GBM|gbm
5660315|NCT00661999|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5660316|NCT00661999|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5660317|NCT00661999|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5660318|NCT00661999|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5660319|NCT00661999|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5660320|NCT00661999|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5660321|NCT00661999|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5660322|NCT00661999|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5660323|NCT00661999|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5660324|NCT00661999|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5660325|NCT00661999|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5660326|NCT00661999|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5660327|NCT00661999|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5653708|NCT00687570|Bowel purity degree|bowel purity degree
5660328|NCT00661999|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5660329|NCT00661999|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5660330|NCT00661999|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5660331|NCT00661999|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5660332|NCT00661999|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5660333|NCT00661999|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5660334|NCT00661999|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5660335|NCT00661999|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5660336|NCT00661999|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5660337|NCT00661999|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5660338|NCT00661999|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5660339|NCT00661999|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5660340|NCT00661999|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5660341|NCT00661999|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5660342|NCT00661999|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5660343|NCT00661999|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5660344|NCT00661999|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5660345|NCT00661999|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5660346|NCT00661999|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5660347|NCT00661999|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5660348|NCT00661999|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5660349|NCT00661999|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5660350|NCT00661999|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5685486|NCT00555893|randomized|randomized
5660351|NCT00661999|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5660352|NCT00661999|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5660353|NCT00661999|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5660354|NCT00661999|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5660355|NCT00661999|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5660356|NCT00661999|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5660357|NCT00661999|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5660358|NCT00661999|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5660359|NCT00661999|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5660360|NCT00661999|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5660361|NCT00661999|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5660362|NCT00661999|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5660364|NCT00661999|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5660365|NCT00661999|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5660366|NCT00661999|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5660367|NCT00661999|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5660368|NCT00661999|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5660369|NCT00661999|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5660370|NCT00661999|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5660371|NCT00661999|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5660372|NCT00661999|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5660373|NCT00661999|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5660374|NCT00661999|refractory hairy cell leukemia|refractory hairy cell leukemia
5660375|NCT00661999|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5660376|NCT00661999|prolymphocytic leukemia|prolymphocytic leukemia
5660378|NCT00661999|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5660379|NCT00661999|acute undifferentiated leukemia|acute undifferentiated leukemia
5660380|NCT00661999|mast cell leukemia|mast cell leukemia
5660381|NCT00661999|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5660382|NCT00661999|untreated hairy cell leukemia|untreated hairy cell leukemia
5660383|NCT00661973|asthma|asthma
5660384|NCT00661973|airway smooth muscle|airway smooth muscle
5660385|NCT00661973|inhaled corticosteroids|inhaled corticosteroids
5660386|NCT00661960|HIV Positive|hiv positive
5660387|NCT00661960|AIDS|aids
5660388|NCT00661960|Antiretroviral Therapy|antiretroviral therapy
5660389|NCT00661960|Gastrointestinal-Associated Lymphoid Tissue|gastrointestinal-associated lymphoid tissue
5660390|NCT00661960|Immune Reconstitution|immune reconstitution
5660391|NCT00661960|treatment experienced|treatment experienced
5660392|NCT00661947|fructose|fructose
5660393|NCT00661947|sucrose|sucrose
5660394|NCT00661947|high fructose corn syrup|high fructose corn syrup
5660395|NCT00661947|serum uric acid|serum uric acid
5660396|NCT00661947|lactate|lactate
5660397|NCT00661947|glucose|glucose
5660398|NCT00661947|triglycerides|triglycerides
5789075|NCT00150033|Quality of Life measurement|quality of life measurement
5660399|NCT00661947|Bioavailability of fructose from two formulations|bioavailability of fructose from two formulations
5660400|NCT00661934|Subject undergoing Dialysis and Subject suffering from Cardiac Malfunction|subject undergoing dialysis and subject suffering from cardiac malfunction
5660401|NCT00661921|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5660403|NCT00661921|HbA1C|hba1c
5660404|NCT00661921|glucose|glucose
5660405|NCT00661921|metformin|metformin
5660406|NCT00661921|sulfonylurea|sulfonylurea
5660407|NCT00661921|IL-1 Inhibitor|il-1 inhibitor
5660408|NCT00661921|biologic|biologic
5660409|NCT00661921|subcutaneous injection|subcutaneous injection
5660410|NCT00661895|African American|african american
5660411|NCT00661882|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5660412|NCT00661882|recurrent pancreatic cancer|recurrent pancreatic cancer
5660413|NCT00661882|stage I pancreatic cancer|stage i pancreatic cancer
5660414|NCT00661882|stage II pancreatic cancer|stage ii pancreatic cancer
5660415|NCT00661882|stage III pancreatic cancer|stage iii pancreatic cancer
5660416|NCT00661856|Soy Isoflavones, Bone Mineral Density, Post menopausal women|soy isoflavones, bone mineral density, post menopausal women
5660417|NCT00661843|insomnia|insomnia
5660418|NCT00661843|geriatric|geriatric
5660419|NCT00661843|yoga|yoga
5660420|NCT00661843|sleep|sleep
5660421|NCT00661843|electrocardiogram|electrocardiogram
5660422|NCT00661830|advanced|advanced
5660423|NCT00661830|metastatic|metastatic
5660426|NCT00661817|Exercise|exercise
5660427|NCT00661817|Physical Fitness|physical fitness
5660428|NCT00661817|Patient Compliance|patient compliance
5660429|NCT00661817|Health Behavior|health behavior
5660430|NCT00661791|preterm infants|preterm infants
5660431|NCT00661791|massage|massage
5660432|NCT00661791|physical activity|physical activity
5660433|NCT00661791|weight gain|weight gain
5660434|NCT00661791|length of hospital stay|length of hospital stay
5660435|NCT00661791|NICU|nicu
5660436|NCT00661765|varenicline bioavailability transdermal smoking cessation|varenicline bioavailability transdermal smoking cessation
5660437|NCT00661739|palliative|palliative
5660438|NCT00661739|Breast cancer|breast cancer
5660439|NCT00661739|metastatic|metastatic
5660440|NCT00661739|Bendamustine|bendamustine
5660442|NCT00661726|Thalassemia Intermedia|thalassemia intermedia
5660443|NCT00661713|Meningococcal disease|meningococcal disease
5660444|NCT00661713|Neisseria meningitidis serogroup B|neisseria meningitidis serogroup b
5660445|NCT00661713|prevention|prevention
5660446|NCT00661713|vaccination|vaccination
5660447|NCT00661713|adolescents|adolescents
5660448|NCT00661700|Erectile Dysfunction|erectile dysfunction
5660449|NCT00661700|Quality of Life|quality of life
5660450|NCT00661674|Palonosetron|palonosetron
5660451|NCT00661674|Hydroxyzine|hydroxyzine
5660452|NCT00661674|Acute opioid withdrawal|acute opioid withdrawal
5660453|NCT00661661|Long term open label study in Japan|long term open label study in japan
5660454|NCT00661661|CP-690|cp-690
5660461|NCT00661609|Kinesin Spindle Protein Inhibitor|kinesin spindle protein inhibitor
5660462|NCT00661609|Urothelial Cancer|urothelial cancer
5660464|NCT00661609|Renal Pelvis Cancer|renal pelvis cancer
5660465|NCT00661609|Urethra Cancer|urethra cancer
5660466|NCT00661609|Ureter Cancer|ureter cancer
5660467|NCT00661609|Recurrent|recurrent
5660468|NCT00661609|Advanced|advanced
5660469|NCT00661609|Stage IV|stage iv
5660470|NCT00661596|Erectile Dysfunction|erectile dysfunction
5660471|NCT00661596|Vardenafil|vardenafil
5660472|NCT00661583|trabeculectomy|trabeculectomy
5660473|NCT00661583|glaucoma|glaucoma
5660474|NCT00661583|ranibizumab|ranibizumab
5660475|NCT00661570|laryngectomy|laryngectomy
5660476|NCT00661570|larynx cancer|larynx cancer
5660477|NCT00661557|Booster vaccination|booster vaccination
5660478|NCT00661557|Meningococcal vaccine|meningococcal vaccine
5660479|NCT00661557|Meningococcal disease|meningococcal disease
5660480|NCT00661557|Safety|safety
5660481|NCT00661557|immunogenicity|immunogenicity
5660482|NCT00661544|Multiple Myeloma|multiple myeloma
5660483|NCT00661544|Ascorbic Acid|ascorbic acid
5660484|NCT00661544|Vitamin C|vitamin c
5660485|NCT00661544|Arsenic Trioxide|arsenic trioxide
5660486|NCT00661544|Trisenox|trisenox
5660487|NCT00661544|Melphalan|melphalan
5660488|NCT00661544|Autologous Stem Cell Transplant|autologous stem cell transplant
5660489|NCT00661544|Stem Cell Transplantation|stem cell transplantation
5660490|NCT00661531|Breast cancer|breast cancer
5660491|NCT00661531|Metastatic breast cancer|metastatic breast cancer
5660492|NCT00661531|ER positive breast cancer|er positive breast cancer
5660493|NCT00661531|Hormonal therapy|hormonal therapy
5660494|NCT00661492|Androgen-independent prostate cancer(AIPC)|androgen-independent prostate cancer(aipc)
5660495|NCT00661466|Gastrointestinal surgery|gastrointestinal surgery
5660496|NCT00661466|Post operative pain|post operative pain
5660497|NCT00661453|Spinal Muscular Atrophy|spinal muscular atrophy
5660498|NCT00661453|SMA|sma
5660499|NCT00661453|Valproic Acid|valproic acid
5660500|NCT00661427|Head and Neck cancer|head and neck cancer
5660501|NCT00661427|Cetuximab|cetuximab
5660502|NCT00661414|Cancer|cancer
5660503|NCT00661414|Solid tumors|solid tumors
5660504|NCT00661401|gammaglobulin|gammaglobulin
5653909|NCT00686504|PET|pet
5660505|NCT00661401|subcutaneous infusion|subcutaneous infusion
5660506|NCT00661401|specific antibodies|specific antibodies
5660507|NCT00661401|primary antibody deficiency|primary antibody deficiency
5660508|NCT00661375|BAY 43-9006|bay 43-9006
5660509|NCT00661375|Phase II|phase ii
5660510|NCT00661375|Renal cell carcinoma|renal cell carcinoma
5660511|NCT00661375|Response rate|response rate
5660512|NCT00661362|DPP-4 inhibitors|dpp-4 inhibitors
5660514|NCT00661362|Incretins|incretins
5660515|NCT00661349|Kaletra|kaletra
5660516|NCT00661349|Nevirapina|nevirapina
5660517|NCT00661349|HCV chronic infection|hcv chronic infection
5660518|NCT00661349|Fibroscan|fibroscan
5660519|NCT00661349|hepatic fibrosis|hepatic fibrosis
5660520|NCT00661349|treatment experienced|treatment experienced
5660521|NCT00661336|stage III melanoma|stage iii melanoma
5660522|NCT00661336|recurrent melanoma|recurrent melanoma
5660523|NCT00661310|re-admissions|re-admissions
5660524|NCT00661310|medicines|medicines
5660525|NCT00661310|management|management
5660526|NCT00661310|patients|patients
5660527|NCT00661310|80 years and older|80 years and older
5660528|NCT00661310|acute|acute
5660529|NCT00661310|admissions|admissions
5660530|NCT00661310|hospital|hospital
5660531|NCT00661297|Erectile Dysfunction|erectile dysfunction
5660532|NCT00661297|Vardenafil|vardenafil
5660533|NCT00661271|mindfulness|mindfulness
5660534|NCT00661271|meditation|meditation
5660535|NCT00661271|urban youth|urban youth
5660536|NCT00661271|stress reduction|stress reduction
5660537|NCT00661271|adolescent|adolescent
5660538|NCT00661271|Stress reduction for urban youth|stress reduction for urban youth
5660539|NCT00661258|HIV antiretroviral treatment adherence intervention China|hiv antiretroviral treatment adherence intervention china
5685487|NCT00555893|blinded|blinded
5660540|NCT00661258|adherence to antiretroviral treatment|adherence to antiretroviral treatment
5660541|NCT00661258|treatment experienced|treatment experienced
5660542|NCT00661232|Myocardial Viability|myocardial viability
5660543|NCT00661232|Delayed Enhancement Magnetic Resonance Imaging|delayed enhancement magnetic resonance imaging
5660544|NCT00661232|Functional Recovery|functional recovery
5660545|NCT00661206|Clopidogrel|clopidogrel
5660546|NCT00661206|Drug-eluting stent|drug-eluting stent
5660556|NCT00661128|Sudden Cardiac Arrest|sudden cardiac arrest
5660557|NCT00661115|Erectile dysfunction|erectile dysfunction
5660558|NCT00661115|Sexual Dysfunction|sexual dysfunction
5660559|NCT00661089|stroke|stroke
5660560|NCT00661089|shoulder pain|shoulder pain
5660561|NCT00661089|spasticity|spasticity
5660562|NCT00661063|neuropathic pain|neuropathic pain
5660563|NCT00661063|ketamine|ketamine
5660564|NCT00661063|clonidine|clonidine
5660565|NCT00661063|association|association
5660566|NCT00661024|thyroid surgery|thyroid surgery
5660567|NCT00661024|recurrent laryngeal nerves visualization|recurrent laryngeal nerves visualization
5660568|NCT00661024|intraoperative neuromonitoring|intraoperative neuromonitoring
5660569|NCT00661024|predictive values|predictive values
5660570|NCT00661011|Non-small cell lung carcinoma|non-small cell lung carcinoma
5660571|NCT00661011|Concomitant radiochemotherapy|concomitant radiochemotherapy
5660572|NCT00661011|Cisplatin|cisplatin
5660573|NCT00661011|Vinorelbine|vinorelbine
5660574|NCT00661011|Radiotherapy|radiotherapy
5660575|NCT00661011|Chemotherapy|chemotherapy
5671725|NCT00614653|OSI-774|osi-774
5660576|NCT00661011|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
5660578|NCT00661011|Unresectable stage III non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy|unresectable stage iii non-small cell lung carcinoma not suitable for radical radiotherapy after objective response to induction chemotherapy
5660579|NCT00660998|Erectile dysfunction|erectile dysfunction
5660580|NCT00660998|Diabetes mellitus type 1|diabetes mellitus type 1
5660581|NCT00660998|Vardenafil|vardenafil
5660582|NCT00660985|Acne vulgaris|acne vulgaris
5660583|NCT00660985|Differin|differin
5660584|NCT00660985|Adapalene|adapalene
5660585|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors
5660586|NCT00660972|HIV Nucleoside Reverse Transcriptase Inhibitors|hiv nucleoside reverse transcriptase inhibitors
5660587|NCT00660972|Treatment Naive|treatment naive
5660588|NCT00660972|Viral Load|viral load
5660589|NCT00660959|Euvolemic|euvolemic
5660590|NCT00660959|Hyponatremia|hyponatremia
5660591|NCT00660959|Serum Sodium|serum sodium
5660592|NCT00660959|Fluid Overload|fluid overload
5660593|NCT00660959|Vasopressin Antagonist|vasopressin antagonist
5660594|NCT00660946|anticoagulation in dialysis patients|anticoagulation in dialysis patients
5660595|NCT00660946|chronic anticoagulation|chronic anticoagulation
5660596|NCT00660946|warfarin|warfarin
5660597|NCT00660946|hemodialysis|hemodialysis
5660598|NCT00660946|INR|inr
5660599|NCT00660946|Point of Care|point of care
5660600|NCT00660933|postpartum anemia|postpartum anemia
5660601|NCT00660933|intravenous iron|intravenous iron
5660602|NCT00660907|Dapagliflozin|dapagliflozin
5660603|NCT00660907|efficacy|efficacy
5660604|NCT00660907|safety|safety
5660605|NCT00660907|metformin|metformin
5660606|NCT00660907|Type 2 diabetes|type 2 diabetes
5660607|NCT00660894|adenocarcinoma of the colon|adenocarcinoma of the colon
5654008|NCT00686179|TQT|tqt
5660608|NCT00660894|stage III colon cancer|stage iii colon cancer
5660609|NCT00660881|Lupus|lupus
5660610|NCT00660881|Monoclonal antibody|monoclonal antibody
5660611|NCT00660881|B-Cell immunotherapy|b-cell immunotherapy
5660612|NCT00660868|smell|smell
5660613|NCT00660868|olfaction|olfaction
5660614|NCT00660868|olfactory sensitivity|olfactory sensitivity
5660615|NCT00660868|smell loss|smell loss
5660616|NCT00660868|chemoreception|chemoreception
5660617|NCT00660855|laparoscopy|laparoscopy
5660618|NCT00660842|quality of life|quality of life
5660619|NCT00660842|weekly therapy|weekly therapy
5660620|NCT00660842|neurotoxicity|neurotoxicity
5660621|NCT00660816|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5660622|NCT00660816|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5660623|NCT00660816|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5660624|NCT00660803|Advanced Breast Cancer|advanced breast cancer
5660625|NCT00660803|Hormone Therapy|hormone therapy
5660626|NCT00660790|diabetes mellitus type II, therapy non-responders|diabetes mellitus type ii, therapy non-responders
5660627|NCT00660777|oropharyngeal exercises|oropharyngeal exercises
5660628|NCT00660777|obstructive sleep apnea|obstructive sleep apnea
5660629|NCT00660777|speech therapy|speech therapy
5660630|NCT00660764|cholesterol|cholesterol
5660631|NCT00660764|coronary heart disease|coronary heart disease
5660632|NCT00660764|rosuvastatin|rosuvastatin
5660633|NCT00660764|LDL-C goal|ldl-c goal
5660634|NCT00660764|hypercholesterolemia|hypercholesterolemia
5660635|NCT00660764|secondary prevention|secondary prevention
5660636|NCT00660764|primary prevention|primary prevention
5660637|NCT00660764|CVA|cva
5660638|NCT00660751|Physiology of Serotonergic and Adrenergic systems|physiology of serotonergic and adrenergic systems
5685488|NCT00555893|controlled|controlled
5660639|NCT00660738|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5660640|NCT00660738|walking|walking
5660641|NCT00660738|exercise test|exercise test
5660642|NCT00660738|quality of life|quality of life
5660643|NCT00660738|dyspnea|dyspnea
5660644|NCT00660738|desaturation|desaturation
5660645|NCT00660725|Gemcitabine|gemcitabine
5660646|NCT00660725|Oxaliplatin|oxaliplatin
5660647|NCT00660725|Vandetanib|vandetanib
5660648|NCT00660725|Phase I|phase i
5660649|NCT00660712|Bipolar disorder|bipolar disorder
5660650|NCT00660712|patient characteristics|patient characteristics
5660651|NCT00660712|treatment characteristics|treatment characteristics
5660652|NCT00660699|Cholangiocarcinoma|cholangiocarcinoma
5660653|NCT00660699|Gallbladder|gallbladder
5660654|NCT00660699|Pancreatic|pancreatic
5660655|NCT00660699|Ampullary|ampullary
5660656|NCT00660699|Cancer|cancer
5660657|NCT00660686|randomized clinical trial|randomized clinical trial
5660658|NCT00660686|elderly|elderly
5660659|NCT00660686|cancer survivor|cancer survivor
5660660|NCT00660686|bone health|bone health
5660661|NCT00660686|body composition|body composition
5660662|NCT00660686|signs and symptoms|signs and symptoms
5660663|NCT00660686|Androgen Deprivation Therapy|androgen deprivation therapy
5660664|NCT00660673|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
5660665|NCT00660673|Severe Motor Fluctuations|severe motor fluctuations
5660666|NCT00660673|Levodopa|levodopa
5660667|NCT00660673|Carbidopa|carbidopa
5660668|NCT00660673|Parkinson's Disease|parkinson's disease
5660669|NCT00660673|Dyskinesia|dyskinesia
5660670|NCT00660660|GERD|gerd
5660671|NCT00660660|Esophageal Reflux|esophageal reflux
5660672|NCT00660660|Gastro-Esophageal Reflux|gastro-esophageal reflux
5660673|NCT00660660|Regurgitation|regurgitation
5660674|NCT00660660|Gastric|gastric
5660675|NCT00660647|Rheumatoid arthritis, adalimumab, efficacy, adverse events|rheumatoid arthritis, adalimumab, efficacy, adverse events
5660676|NCT00660634|Peripheral arterial obstructive disease|peripheral arterial obstructive disease
5660677|NCT00660634|Intermittent Claudication|intermittent claudication
5660678|NCT00660634|Endovascular treatment|endovascular treatment
5660679|NCT00660634|Flow-mediated dilation|flow-mediated dilation
5660680|NCT00660621|High Grade|high grade
5644674|NCT00722553|Relapsed|relapsed
5660681|NCT00660621|Malignant|malignant
5660683|NCT00660608|Transfusion regulation|transfusion regulation
5660684|NCT00660595|Schizophrenia|schizophrenia
5660685|NCT00660595|Schizoaffective psychosis|schizoaffective psychosis
5660686|NCT00660595|Schizophreniformic psychosis|schizophreniformic psychosis
5660687|NCT00660595|Pilot study|pilot study
5660688|NCT00660595|Quetiapine Prolong|quetiapine prolong
5660689|NCT00660595|Risperidone|risperidone
5660690|NCT00660582|Erbitux|erbitux
5660691|NCT00660582|Colorectal cancer|colorectal cancer
5660692|NCT00660582|Oxaliplatin|oxaliplatin
5660693|NCT00660582|Flox|flox
5660694|NCT00660582|Fluorouracil + folinic acid|fluorouracil + folinic acid
5660695|NCT00660582|K-RAS|k-ras
5660696|NCT00660569|asthma treatment|asthma treatment
5660697|NCT00660569|utilization|utilization
5660698|NCT00660569|real life practice|real life practice
5660699|NCT00660530|stage 5|stage 5
5660700|NCT00660530|chronic|chronic
5660701|NCT00660530|hemodialysis|hemodialysis
5660702|NCT00660504|Extensive Disease-Small Cell Lung Cancer|extensive disease-small cell lung cancer
5660703|NCT00660491|flow mediated dilatation|flow mediated dilatation
5660704|NCT00660491|maximal oxygen uptake|maximal oxygen uptake
5660705|NCT00660491|blood lipid|blood lipid
5660706|NCT00660465|Regional BOLD signal dependency on arterial PaCO2.|regional bold signal dependency on arterial paco2.
5660707|NCT00660465|Effect of breathing exercises on brain regional O2 level.|effect of breathing exercises on brain regional o2 level.
5660709|NCT00660452|Allergy|allergy
5660710|NCT00660452|SLIT|slit
5660711|NCT00660452|Asthma|asthma
5660712|NCT00660452|House Dust Mites|house dust mites
5660713|NCT00660439|PTSD|ptsd
5660714|NCT00660426|cancer|cancer
5660715|NCT00660426|gastrointestinal|gastrointestinal
5660716|NCT00660426|tumor|tumor
5660717|NCT00660413|Acceleromyography|acceleromyography
5660718|NCT00660413|Mechanomyography|mechanomyography
5660719|NCT00660413|Neuromuscular block|neuromuscular block
5660720|NCT00660413|Neuromuscular monitoring|neuromuscular monitoring
5660721|NCT00660413|Dose-response|dose-response
5660722|NCT00660413|Potency|potency
5660723|NCT00660413|Rocuronium|rocuronium
5660724|NCT00660400|Myeloid|myeloid
5660725|NCT00660400|Monocytic|monocytic
5660726|NCT00660387|levodopa-carbidopa|levodopa-carbidopa
5660727|NCT00660387|Carbidopa|carbidopa
5660728|NCT00660387|levodopa|levodopa
5660729|NCT00660387|dyskinesia|dyskinesia
5660730|NCT00660387|Duodopa|duodopa
5660731|NCT00660387|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5660732|NCT00660387|Severe Motor Fluctuations|severe motor fluctuations
5660733|NCT00660387|levodopa/carbidopa suspension|levodopa/carbidopa suspension
5660734|NCT00660387|DUOPA|duopa
5660735|NCT00660361|HIV|hiv
5660736|NCT00660361|HBV|hbv
5660737|NCT00660361|co-infection|co-infection
5660738|NCT00660361|drug resistance|drug resistance
5660739|NCT00660361|tenofovir|tenofovir
5660740|NCT00660361|HIV-HBV co-infection|hiv-hbv co-infection
5660741|NCT00660348|recurrent pancreatic cancer|recurrent pancreatic cancer
5660742|NCT00660348|stage III pancreatic cancer|stage iii pancreatic cancer
5660743|NCT00660348|stage IV pancreatic cancer|stage iv pancreatic cancer
5660744|NCT00660348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5660745|NCT00660348|pain|pain
5660746|NCT00660348|stage II pancreatic cancer|stage ii pancreatic cancer
5660747|NCT00660335|secretin, RG1068, MRCP, pancreas|secretin, rg1068, mrcp, pancreas
5660748|NCT00660322|Asthma|asthma
5660749|NCT00660322|Telemedicine|telemedicine
5660750|NCT00660322|Randomized controlled trial|randomized controlled trial
5660751|NCT00660309|Type 2 diabetes mellitus|type 2 diabetes mellitus
5660752|NCT00660309|renal disease|renal disease
5660753|NCT00660309|hypertension|hypertension
5660754|NCT00660309|renal blood flow|renal blood flow
5660755|NCT00660309|retinal blood flow|retinal blood flow
5660756|NCT00660309|aliskiren|aliskiren
5660757|NCT00660309|irbesartan|irbesartan
5660758|NCT00660309|captopril|captopril
5660760|NCT00660296|pain|pain
5660761|NCT00660296|colonoscopy|colonoscopy
5660762|NCT00660296|cancer|cancer
5660763|NCT00660296|screening|screening
5660764|NCT00660283|GBM|gbm
5660765|NCT00660283|Newly|newly
5660766|NCT00660283|diagnosed|diagnosed
5660767|NCT00660283|malignant|malignant
5660768|NCT00660283|high grade|high grade
5660769|NCT00660270|Chemotherapy|chemotherapy
5660770|NCT00660270|Radiation|radiation
5660771|NCT00660244|Arimidex|arimidex
5660772|NCT00660244|Post menopausal|post menopausal
5660773|NCT00660244|arthralgia|arthralgia
5660774|NCT00660231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5660775|NCT00660231|stage IB mycosis fungoides/Sezary syndrome|stage ib mycosis fungoides/sezary syndrome
5660776|NCT00660231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5660777|NCT00660231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5660778|NCT00660231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5660779|NCT00660231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5660780|NCT00660231|stage IB cutaneous T-cell non-Hodgkin lymphoma|stage ib cutaneous t-cell non-hodgkin lymphoma
5660781|NCT00660231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5660782|NCT00660231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5660783|NCT00660231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5660784|NCT00660218|Stage III and IV head and neck cancer|stage iii and iv head and neck cancer
5660785|NCT00660205|DVT|dvt
5660786|NCT00660205|PE|pe
5660787|NCT00660205|D-dimer|d-dimer
5660788|NCT00660205|cancer|cancer
5660789|NCT00660205|VTE|vte
5660790|NCT00660192|Migraine, refractory migraine, Pain, Botulinum Toxin , Botox|migraine, refractory migraine, pain, botulinum toxin , botox
5660791|NCT00660179|pulmonary arterial hypertension SERAPHIN|pulmonary arterial hypertension seraphin
5660792|NCT00660166|Natural killer cells|natural killer cells
5660793|NCT00660166|autologous stem cell transplant|autologous stem cell transplant
5660794|NCT00660166|immunotherapy|immunotherapy
5660795|NCT00660153|Advanced Colorectal Cancer and Other Gastrointestinal Cancers|advanced colorectal cancer and other gastrointestinal cancers
5660796|NCT00660153|tivozanib|tivozanib
5660797|NCT00660153|AV-951|av-951
5660798|NCT00660140|Cholangiocarcinoma|cholangiocarcinoma
5660799|NCT00660140|Gallbladder|gallbladder
5660800|NCT00660140|Cancer|cancer
5660816|NCT00660062|nortriptyline|nortriptyline
5660817|NCT00660036|Acute myeloid leukemia|acute myeloid leukemia
5660818|NCT00660036|Refractory|refractory
5660819|NCT00660036|Relapsed|relapsed
5660820|NCT00660036|Second line|second line
5660821|NCT00660036|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5660822|NCT00660036|Mitoxantrone|mitoxantrone
5660823|NCT00660036|Etoposide|etoposide
5660824|NCT00660036|Phase I|phase i
5660825|NCT00660036|Phase II|phase ii
5660826|NCT00660010|CPP|cpp
5660827|NCT00660010|central precocious puberty|central precocious puberty
5660828|NCT00660010|pediatrics|pediatrics
5660829|NCT00660010|suppression of LH|suppression of lh
5660830|NCT00660010|Lupron|lupron
5660831|NCT00660010|leuprolide acetate|leuprolide acetate
5660832|NCT00660010|depot formulation|depot formulation
5660833|NCT00660010|GnRHa|gnrha
5660834|NCT00660010|GnRH agonist|gnrh agonist
5660835|NCT00660010|GNRH analog|gnrh analog
5660836|NCT00660010|LH|lh
5660837|NCT00660010|Tanner staging|tanner staging
5660838|NCT00659997|Ascariasis|ascariasis
5660839|NCT00659997|Trichuriasis|trichuriasis
5660840|NCT00659997|Drug resistance|drug resistance
5660841|NCT00659984|recurrent neuroblastoma|recurrent neuroblastoma
5660842|NCT00659971|oral candidiasis|oral candidiasis
5660843|NCT00659958|zonisamide|zonisamide
5660844|NCT00659958|partial onset seizures|partial onset seizures
5660845|NCT00659958|effectiveness|effectiveness
5660846|NCT00659958|tolerability|tolerability
5660847|NCT00659945|Postoperation, nausea, vomiting, anesthesia, plastic surgery|postoperation, nausea, vomiting, anesthesia, plastic surgery
5660848|NCT00659932|diabetes|diabetes
5660849|NCT00659932|cognitive behavioural therapy|cognitive behavioural therapy
5660850|NCT00659906|randomized clinical trial|randomized clinical trial
5660851|NCT00659906|cancer survivor|cancer survivor
5660852|NCT00659906|bone health|bone health
5660853|NCT00659906|body composition|body composition
5660854|NCT00659906|signs and symptoms|signs and symptoms
5660855|NCT00659893|Peplin|peplin
5660856|NCT00659893|PEP005|pep005
5660857|NCT00659893|Actinic Keratosis|actinic keratosis
5660858|NCT00659880|Meniscus transplant|meniscus transplant
5660859|NCT00659880|Meniscal allograft|meniscal allograft
5660860|NCT00659880|MAT|mat
5660861|NCT00659880|Knee|knee
5660862|NCT00659867|Ulcerative Colitis|ulcerative colitis
5660863|NCT00659867|Endomicroscopy|endomicroscopy
5660864|NCT00659867|Chromoendoscopy|chromoendoscopy
5660865|NCT00659867|Confocal colonoscope|confocal colonoscope
5660866|NCT00659867|Surveillance colonoscopy|surveillance colonoscopy
5660867|NCT00659854|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5660868|NCT00659854|The study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes|the study examines the response of infants diagnosed with obstructive sleep apnea syndrome to diet changes
5660869|NCT00659841|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5660870|NCT00659841|Ciclesonide|ciclesonide
5660871|NCT00659841|Hay Fever|hay fever
5660872|NCT00659841|SAR|sar
5660873|NCT00659828|Congenital leptin deficiency|congenital leptin deficiency
5660874|NCT00659828|Obesity|obesity
5660875|NCT00659828|Metabolic Syndrome|metabolic syndrome
5660876|NCT00659828|Diabetes|diabetes
5660877|NCT00659776|ferumoxytol|ferumoxytol
5660878|NCT00659763|IBS|ibs
5660879|NCT00659763|Diagnosis|diagnosis
5660880|NCT00659750|Perennial Allergic Rhinitis|perennial allergic rhinitis
5660881|NCT00659750|Ciclesonide|ciclesonide
5660882|NCT00659750|PAR|par
5660883|NCT00659737|Post-operative Nausea and Vomiting (PONV)|post-operative nausea and vomiting (ponv)
5660884|NCT00659724|Dialyzer|dialyzer
5660885|NCT00659698|surgical|surgical
5660886|NCT00659698|site|site
5654305|NCT00685022|Asthma|asthma
5660889|NCT00659685|Ondansetron ODT|ondansetron odt
5660890|NCT00659685|Fasting|fasting
5660891|NCT00659685|To Determine Bioequivalence Under Fasting conditions|to determine bioequivalence under fasting conditions
5660892|NCT00659672|hypertension|hypertension
5660893|NCT00659672|prehypertension|prehypertension
5660894|NCT00659672|high blood pressure|high blood pressure
5660895|NCT00659672|blood pressure|blood pressure
5660896|NCT00659672|heart disease|heart disease
5660897|NCT00659646|Diabetes|diabetes
5660898|NCT00659646|ulcers|ulcers
5660899|NCT00659646|ulcerations|ulcerations
5660900|NCT00659646|infection|infection
5660901|NCT00659633|lidocaine|lidocaine
5660902|NCT00659633|allodynia|allodynia
5660903|NCT00659633|chronic regional pain syndrome|chronic regional pain syndrome
5660904|NCT00659633|pain|pain
5660905|NCT00659620|Kidney Transplant|kidney transplant
5660906|NCT00659620|Chronic Allograft Nephropathy|chronic allograft nephropathy
5660907|NCT00659620|Mesenchymal Stem Cell infusion|mesenchymal stem cell infusion
5660908|NCT00659594|Seasonal Allergic rhinitis|seasonal allergic rhinitis
5660909|NCT00659594|Ciclesonide|ciclesonide
5660910|NCT00659594|Hay Fever|hay fever
5660911|NCT00659594|SAR|sar
5660912|NCT00659568|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5660913|NCT00659568|stage III renal cell cancer|stage iii renal cell cancer
5660914|NCT00659568|stage IV renal cell cancer|stage iv renal cell cancer
5660915|NCT00659568|recurrent renal cell cancer|recurrent renal cell cancer
5660916|NCT00659568|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5660917|NCT00659568|stage III endometrial carcinoma|stage iii endometrial carcinoma
5660918|NCT00659568|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5660919|NCT00659568|recurrent breast cancer|recurrent breast cancer
5660920|NCT00659568|stage IIIA breast cancer|stage iiia breast cancer
5660921|NCT00659568|stage IIIB breast cancer|stage iiib breast cancer
5660922|NCT00659568|stage IIIC breast cancer|stage iiic breast cancer
5660923|NCT00659568|stage IV breast cancer|stage iv breast cancer
5660924|NCT00659568|recurrent small cell lung cancer|recurrent small cell lung cancer
5660925|NCT00659568|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5660926|NCT00659568|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5660927|NCT00659568|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5660928|NCT00659568|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5660929|NCT00659568|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5660930|NCT00659568|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5660931|NCT00659568|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5660932|NCT00659568|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5660933|NCT00659568|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5661007|NCT00659464|Tilt Table Testing|tilt table testing
5847450|NCT00039715|Hydrocortisone|hydrocortisone
5660934|NCT00659568|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5660935|NCT00659568|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5685489|NCT00555893|efficacy|efficacy
5660936|NCT00659568|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5660937|NCT00659568|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5660938|NCT00659568|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5660939|NCT00659568|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5660940|NCT00659568|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5660941|NCT00659568|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5660942|NCT00659568|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5660943|NCT00659568|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5660944|NCT00659568|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5660945|NCT00659568|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5660946|NCT00659568|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5660947|NCT00659568|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5660948|NCT00659568|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5660949|NCT00659568|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5660950|NCT00659568|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5660951|NCT00659568|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5660952|NCT00659568|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5660953|NCT00659568|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5644971|NCT00721305|Lovastatin|lovastatin
5660954|NCT00659568|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5660955|NCT00659568|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5660956|NCT00659568|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5660957|NCT00659568|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5660958|NCT00659568|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5654389|NCT00684736|shock|shock
5660964|NCT00659568|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5660965|NCT00659568|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5660966|NCT00659568|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5660967|NCT00659568|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5660968|NCT00659568|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5660970|NCT00659568|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5660971|NCT00659568|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5660972|NCT00659568|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5660973|NCT00659568|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5660974|NCT00659568|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5660975|NCT00659568|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5660976|NCT00659568|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5660977|NCT00659568|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5660978|NCT00659568|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5660979|NCT00659568|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5660980|NCT00659568|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5660981|NCT00659568|Waldenström macroglobulinemia|waldenström macroglobulinemia
5660982|NCT00659555|vascular endothelial growth factor,|vascular endothelial growth factor,
5660983|NCT00659555|drug interaction,|drug interaction,
5660984|NCT00659555|pharmacokinetics,|pharmacokinetics,
5660985|NCT00659555|age-related macular degeneration,|age-related macular degeneration,
5660986|NCT00659555|pazopanib,|pazopanib,
5660987|NCT00659555|angiogenesis,|angiogenesis,
5660988|NCT00659555|ketoconazole|ketoconazole
5660989|NCT00659542|inguinal hernia|inguinal hernia
5660990|NCT00659542|inguinal hernioplasty|inguinal hernioplasty
5660991|NCT00659542|mesh fixation|mesh fixation
5660992|NCT00659542|Lichtenstein hernioplasty|lichtenstein hernioplasty
5660993|NCT00659529|cystic fibrosis|cystic fibrosis
5660994|NCT00659529|inflammation|inflammation
5660996|NCT00659529|EBC|ebc
5660997|NCT00659529|sputum biomarkers|sputum biomarkers
5660998|NCT00659529|phosphodiesterase inhibitors|phosphodiesterase inhibitors
5660999|NCT00659503|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5661000|NCT00659503|Ciclesonide|ciclesonide
5661001|NCT00659503|Hay Fever|hay fever
5661002|NCT00659503|SAR|sar
5661003|NCT00659490|Analgesic effect|analgesic effect
5661004|NCT00659490|Molar extraction|molar extraction
5661005|NCT00659464|Infrared Spectroscopy|infrared spectroscopy
5661006|NCT00659464|Syncope|syncope
5661008|NCT00659451|Hypertension|hypertension
5661009|NCT00659451|Diabetes mellitus|diabetes mellitus
5661010|NCT00659451|Heart|heart
5661011|NCT00659425|Moxetumomab pasudotox|moxetumomab pasudotox
5661012|NCT00659412|Psoriatic arthritis|psoriatic arthritis
5661013|NCT00659412|psoriasis|psoriasis
5661014|NCT00659412|Alefacept|alefacept
5661015|NCT00659399|Pretreated Ovarian Carcinoma|pretreated ovarian carcinoma
5661016|NCT00659386|Heart failure|heart failure
5661017|NCT00659386|Parvovirus B19|parvovirus b19
5661018|NCT00659386|Intravenous immuneglobulin|intravenous immuneglobulin
5661019|NCT00659373|cognitive/functional effects|cognitive/functional effects
5671726|NCT00614653|Capecitabine|capecitabine
5661020|NCT00659373|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5661021|NCT00659373|fatigue|fatigue
5661022|NCT00659373|sleep disorders|sleep disorders
5661023|NCT00659373|stage IA breast cancer|stage ia breast cancer
5661024|NCT00659373|stage IB breast cancer|stage ib breast cancer
5661025|NCT00659373|stage II breast cancer|stage ii breast cancer
5661026|NCT00659373|stage IIIA breast cancer|stage iiia breast cancer
5661027|NCT00659334|Combidex|combidex
5661028|NCT00659334|Diagnostic imaging|diagnostic imaging
5661029|NCT00659308|pain|pain
5661030|NCT00659308|bullous keratopathy|bullous keratopathy
5661031|NCT00659308|amniotic membrane|amniotic membrane
5661032|NCT00659308|anterior stromal puncture|anterior stromal puncture
5661033|NCT00659269|Vitamin B-12|vitamin b-12
5661034|NCT00659269|Vitamin B-6|vitamin b-6
5661035|NCT00659269|Chemotherapy-Induced Neuropathy|chemotherapy-induced neuropathy
5661036|NCT00659269|Taxanes|taxanes
5661037|NCT00659269|Vinca alkaloid|vinca alkaloid
5661038|NCT00659269|Heavy metals|heavy metals
5661039|NCT00659269|Neuropathy|neuropathy
5661040|NCT00659269|Nerve pain|nerve pain
5661041|NCT00659256|Hepatitis C Virus|hepatitis c virus
5661042|NCT00659256|Atherosclerosis|atherosclerosis
5661043|NCT00659256|Intima-Media Thickness|intima-media thickness
5661044|NCT00659256|Coronary Artery Calcium Score|coronary artery calcium score
5661045|NCT00659256|Hepatitis C|hepatitis c
5661046|NCT00659243|Replacement therapy|replacement therapy
5661047|NCT00659243|Pasteurized breast milk|pasteurized breast milk
5661048|NCT00659243|Preterm infants|preterm infants
5661049|NCT00659243|BSSL|bssl
5661050|NCT00659230|PTSD|ptsd
5661051|NCT00659230|Veterans|veterans
5661052|NCT00659230|Nepicastat|nepicastat
5661053|NCT00659230|OIF/OEF|oif/oef
5661054|NCT00659217|Mesenchymal Stem Cells|mesenchymal stem cells
5661055|NCT00659217|lupus Nephritis|lupus nephritis
5661056|NCT00659191|Healthy volunteer,|healthy volunteer,
5661057|NCT00659191|HIV infected subjects|hiv infected subjects
5661058|NCT00659178|Doxil,|doxil,
5661059|NCT00659178|pegylated liposomal doxorubicin,|pegylated liposomal doxorubicin,
5661060|NCT00659178|ovarian cancer|ovarian cancer
5661061|NCT00659178|IL-18,|il-18,
5661062|NCT00659178|combination study,|combination study,
5661063|NCT00659178|immunotherapy,|immunotherapy,
5661064|NCT00659178|cytokine,|cytokine,
5661065|NCT00659165|diabetes|diabetes
5661066|NCT00659165|insulin dependent diabetes|insulin dependent diabetes
5661067|NCT00659165|diabetes mellitus|diabetes mellitus
5661068|NCT00659165|detemir|detemir
5661069|NCT00659165|levemir|levemir
5661070|NCT00659165|glargine|glargine
5661071|NCT00659165|lantus|lantus
5661072|NCT00659165|insulin|insulin
5661073|NCT00659165|appetite|appetite
5661074|NCT00659165|satiety|satiety
5661075|NCT00659165|centrally acting mediators of satiety|centrally acting mediators of satiety
5661076|NCT00659165|three factor eating questionnaire|three factor eating questionnaire
5661078|NCT00659165|ghrelin|ghrelin
5661079|NCT00659165|leptin|leptin
5661080|NCT00659152|ALI/ARDS|ali/ards
5661081|NCT00659113|stage IIA esophageal cancer|stage iia esophageal cancer
5661082|NCT00659113|stage IIB esophageal cancer|stage iib esophageal cancer
5661083|NCT00659113|stage IIIA esophageal cancer|stage iiia esophageal cancer
5661084|NCT00659113|stage IIIB esophageal cancer|stage iiib esophageal cancer
5661085|NCT00659113|stage IIIC esophageal cancer|stage iiic esophageal cancer
5661086|NCT00659113|stage IV esophageal cancer|stage iv esophageal cancer
5661087|NCT00659087|Total Knee|total knee
5661088|NCT00659087|Range of Motion|range of motion
5661089|NCT00659087|Pain|pain
5661090|NCT00659074|bioequivalence|bioequivalence
5661091|NCT00659074|Ondansetron ODT|ondansetron odt
5661092|NCT00659074|Fasting|fasting
5661093|NCT00659074|To Determine Bioequivalence Under Fasting Conditions|to determine bioequivalence under fasting conditions
5661094|NCT00659061|micronutrients|micronutrients
5661095|NCT00659048|Perennial Allergic Rhinitis|perennial allergic rhinitis
5661096|NCT00659048|Ciclesonide|ciclesonide
5661098|NCT00659035|driving|driving
5661099|NCT00659035|opioids|opioids
5661100|NCT00659035|impairment|impairment
5661101|NCT00659035|ability|ability
5661102|NCT00659035|patients|patients
5661103|NCT00659035|receiving|receiving
5661104|NCT00659035|oral morphine|oral morphine
5661105|NCT00659035|severe|severe
5661106|NCT00659022|colorectal cancer|colorectal cancer
5661107|NCT00659022|liver metastases|liver metastases
5661108|NCT00659022|angiogenesis|angiogenesis
5661110|NCT00659009|environmental|environmental
5661111|NCT00659009|hypobaric hypoxia|hypobaric hypoxia
5661112|NCT00659009|sleep|sleep
5661113|NCT00659009|respiratory-disturbance|respiratory-disturbance
5661114|NCT00659009|neurobehavioral performance|neurobehavioral performance
5661115|NCT00659009|Effect of altitude on sleep-related respiratory disturbance|effect of altitude on sleep-related respiratory disturbance
5661116|NCT00658970|Open label|open label
5661117|NCT00658970|Dose escalation|dose escalation
5661118|NCT00658957|Diabetes|diabetes
5661120|NCT00658944|Stress urinary incontinence|stress urinary incontinence
5671728|NCT00614640|HAART|haart
5661121|NCT00658944|Mixed urinary incontinence|mixed urinary incontinence
5661122|NCT00658944|surgery|surgery
5661123|NCT00658944|trans obturator tape|trans obturator tape
5661124|NCT00658944|Maximum urethral closure pressure|maximum urethral closure pressure
5661125|NCT00658944|Valsalva leak point pressure|valsalva leak point pressure
5661126|NCT00658944|outcome|outcome
5661127|NCT00658931|Depression|depression
5661128|NCT00658931|Bereavement|bereavement
5661129|NCT00658931|Pilot Projects|pilot projects
5661130|NCT00658931|Antidepressant Drugs|antidepressant drugs
5661131|NCT00658918|Perennial Allergic Rhinitis|perennial allergic rhinitis
5661132|NCT00658918|Ciclesonide|ciclesonide
5661133|NCT00658918|Hay Fever|hay fever
5661135|NCT00658905|Preterm infants|preterm infants
5661136|NCT00658905|Replacement therapy|replacement therapy
5661137|NCT00658905|Infant formula|infant formula
5661138|NCT00658905|BSSL|bssl
5680412|NCT00577902|head and neck cancer|head and neck cancer
5834413|NCT00036712|pain|pain
5661139|NCT00658905|BSSL is present in fresh mother's milk but not in infant formula.|bssl is present in fresh mother's milk but not in infant formula.
5661140|NCT00658892|recurrent melanoma|recurrent melanoma
5661141|NCT00658892|stage IV melanoma|stage iv melanoma
5661142|NCT00658866|ertapenem tissue PK|ertapenem tissue pk
5661143|NCT00658853|COPD|copd
5661144|NCT00658853|training|training
5661145|NCT00658853|VO2peak|vo2peak
5661146|NCT00658853|performance|performance
5661147|NCT00658853|ventilation|ventilation
5661148|NCT00658853|high aerobic intensity treadmill walking|high aerobic intensity treadmill walking
5661149|NCT00658853|one leg training by cycling|one leg training by cycling
5661150|NCT00658827|Inflammatory Bowel Disease|inflammatory bowel disease
5661151|NCT00658827|Rheumatoid Arthritis|rheumatoid arthritis
5661152|NCT00658827|Psoriatic Arthritis|psoriatic arthritis
5661153|NCT00658827|Ankylosing Spondylitis|ankylosing spondylitis
5661154|NCT00658827|Psoriasis|psoriasis
5661155|NCT00658827|Pregnant women exposed to infliximab|pregnant women exposed to infliximab
5661156|NCT00658775|GERD|gerd
5661157|NCT00658775|erosive GERD|erosive gerd
5661158|NCT00658775|erosive esophagitis|erosive esophagitis
5661159|NCT00658749|AIR645|air645
5661160|NCT00658749|Altair Therapeutics|altair therapeutics
5661161|NCT00658749|IL4|il4
5661162|NCT00658749|IL13|il13
5661163|NCT00658749|IL-4|il-4
5661164|NCT00658749|IL-13|il-13
5661165|NCT00658710|hemiplegia|hemiplegia
5661166|NCT00658710|stroke|stroke
5661167|NCT00658710|TRIDENT|trident
5661168|NCT00658697|Rising PSA|rising psa
5661169|NCT00658697|androgen deprivation|androgen deprivation
5661170|NCT00658697|bevacizumab (avastin)|bevacizumab (avastin)
5661171|NCT00658697|docetaxel|docetaxel
5661172|NCT00658697|lupron|lupron
5661173|NCT00658697|zoladex|zoladex
5661174|NCT00658697|bicalutamide|bicalutamide
5661175|NCT00658658|Epidermal Growth Factor|epidermal growth factor
5661176|NCT00658658|Pediatric|pediatric
5661177|NCT00658658|Solid Tumors|solid tumors
5661178|NCT00658658|Panitumumab|panitumumab
5661179|NCT00658658|Dose Limiting Toxicity|dose limiting toxicity
5661180|NCT00658645|Schizophrenia|schizophrenia
5661181|NCT00658645|Antipsychotic|antipsychotic
5661182|NCT00658645|Bifeprunox|bifeprunox
5661183|NCT00658632|GERD|gerd
5661184|NCT00658632|erosive GERD|erosive gerd
5661185|NCT00658632|erosive esophagitis|erosive esophagitis
5661186|NCT00658606|plaque psoriasis|plaque psoriasis
5661187|NCT00658606|alefacept|alefacept
5661188|NCT00658606|Amevive|amevive
5661189|NCT00658606|narrow band ultraviolet B|narrow band ultraviolet b
5661190|NCT00658606|phototherapy|phototherapy
5661191|NCT00658593|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5661192|NCT00658593|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5661193|NCT00658593|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5661194|NCT00658593|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5661195|NCT00658593|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5661196|NCT00658593|unresectable gallbladder cancer|unresectable gallbladder cancer
5661197|NCT00658593|recurrent gallbladder cancer|recurrent gallbladder cancer
5661198|NCT00658593|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5661199|NCT00658580|Small cell lung carcinoma|small cell lung carcinoma
5661200|NCT00658580|Chemotherapy|chemotherapy
5661201|NCT00658580|Phase III randomised study|phase iii randomised study
5661202|NCT00658528|GERD|gerd
5661203|NCT00658528|erosive GERD|erosive gerd
5663739|NCT00646568|IVF|ivf
5661204|NCT00658528|erosive esophagitis|erosive esophagitis
5661205|NCT00658476|Adolescent Depression|adolescent depression
5661206|NCT00658476|Depression|depression
5661207|NCT00658476|Teenage Depression|teenage depression
5661208|NCT00658476|Los Angeles|los angeles
5661209|NCT00658463|Diabetes|diabetes
5661210|NCT00658463|Triglycerides|triglycerides
5661211|NCT00658463|HDL-cholesterol|hdl-cholesterol
5661212|NCT00658463|kinetic|kinetic
5661213|NCT00658463|rosuvastatin|rosuvastatin
5661214|NCT00658450|Malaria, Cerebral|malaria, cerebral
5661215|NCT00658437|Melanoma, Stage IV, Phase II|melanoma, stage iv, phase ii
5661216|NCT00658411|AML|aml
5661217|NCT00658411|ALL|all
5661218|NCT00658411|MDS|mds
5661219|NCT00658411|iron overload|iron overload
5661220|NCT00658411|deferoxamine|deferoxamine
5661221|NCT00658398|Alcohol|alcohol
5661222|NCT00658398|dependency|dependency
5661223|NCT00658385|GCSF|gcsf
5661224|NCT00658372|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
5661225|NCT00658359|Immunosuppression|immunosuppression
5661226|NCT00658359|JAK inhibitor|jak inhibitor
5661227|NCT00658359|kidney transplantation|kidney transplantation
5661228|NCT00658346|HIV-1 group O|hiv-1 group o
5661229|NCT00658346|HIV-1 group M|hiv-1 group m
5661230|NCT00658346|Cameroon|cameroon
5661231|NCT00658346|HIV-1 infection|hiv-1 infection
5661232|NCT00658346|treatment naïve|treatment naïve
5661233|NCT00658333|Renal Transplantation|renal transplantation
5661234|NCT00658333|Immunosuppression|immunosuppression
5661235|NCT00658333|Renal transplant recipients|renal transplant recipients
5661236|NCT00658333|Gastrointestinal symptoms associated with MMF therapy|gastrointestinal symptoms associated with mmf therapy
5661237|NCT00658320|Renal transplantation|renal transplantation
5661238|NCT00658320|everolimus|everolimus
5661239|NCT00658320|mycophenolate mofetil|mycophenolate mofetil
5661240|NCT00658320|cyclosporine|cyclosporine
5661241|NCT00658320|corticosteroid|corticosteroid
5661242|NCT00658320|basiliximab|basiliximab
5661243|NCT00658320|Banff diagnosis|banff diagnosis
5661244|NCT00658320|Acute rejection|acute rejection
5661245|NCT00658320|Therapeutic drug monitoring (TDM)|therapeutic drug monitoring (tdm)
5661246|NCT00658320|de novo renal transplant recipient|de novo renal transplant recipient
5661247|NCT00658307|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5661248|NCT00658307|double-blind|double-blind
5661249|NCT00658307|sham-controlled|sham-controlled
5661250|NCT00658307|randomized|randomized
5661251|NCT00658281|Breast Cancer|breast cancer
5661252|NCT00658281|On Board Imager Kilovoltage|on board imager kilovoltage
5661253|NCT00658281|Cone Beam Computed Tomography|cone beam computed tomography
5661254|NCT00658281|Electronic Portal Imaging Device|electronic portal imaging device
5661255|NCT00658281|Lymph Nodes|lymph nodes
5661256|NCT00658281|CBCT|cbct
5661257|NCT00658281|OBI KV|obi kv
5661258|NCT00658268|Surgical procedures operative|surgical procedures operative
5661259|NCT00658268|Prosthesis implantation|prosthesis implantation
5661260|NCT00658268|Arthroplasty replacement|arthroplasty replacement
5661261|NCT00658255|stable asthma|stable asthma
5661262|NCT00658255|adults|adults
5661263|NCT00658255|formoterol|formoterol
5661264|NCT00658255|Symbicort|symbicort
5661265|NCT00658255|Oxis Turbuhaler|oxis turbuhaler
5661266|NCT00658255|bronchodilation|bronchodilation
5661267|NCT00658242|craniofacial|craniofacial
5661268|NCT00658242|maxillofacial|maxillofacial
5661269|NCT00658242|osteotomy|osteotomy
5661270|NCT00658242|craniectomy|craniectomy
5661271|NCT00658242|craniotomy|craniotomy
5661272|NCT00658229|Exercise|exercise
5661273|NCT00658229|Prostatic|prostatic
5661274|NCT00658229|Neoplasm|neoplasm
5661275|NCT00658229|Androgen|androgen
5661276|NCT00658229|Deprivation|deprivation
5661277|NCT00658216|Diagnosis and prognosis|diagnosis and prognosis
5661278|NCT00658216|Very elderly population|very elderly population
5661279|NCT00658216|Heart failure|heart failure
5661280|NCT00658216|Brain natriuretic peptide|brain natriuretic peptide
5661281|NCT00658216|Observational prospective study|observational prospective study
5661282|NCT00658216|Older|older
5661283|NCT00658216|Dyspneic patients aged 80|dyspneic patients aged 80
5661284|NCT00658203|CRT-P|crt-p
5661285|NCT00658203|PEA|pea
5661286|NCT00658203|Severe Heart Failure (NYHA Class III or IV)|severe heart failure (nyha class iii or iv)
5661287|NCT00658203|Cardiomyopathy of any etiology|cardiomyopathy of any etiology
5661288|NCT00658203|Sinus rhythm|sinus rhythm
5661289|NCT00658203|Reduced Left-Ventricular Ejection Fraction|reduced left-ventricular ejection fraction
5661290|NCT00658203|LVEDD>30 mm/m2|lvedd>30 mm/m2
5661291|NCT00658203|QRS Duration: > 150 ms or > 120 ms|qrs duration: > 150 ms or > 120 ms
5661292|NCT00658203|Aortic Pre-Ejection Delay > 140 ms|aortic pre-ejection delay > 140 ms
5661293|NCT00658203|Interventricular Mechanical Delay > 40 ms|interventricular mechanical delay > 40 ms
5661294|NCT00658203|Delayed activation of postero-lateral Left Ventricular wall|delayed activation of postero-lateral left ventricular wall
5661295|NCT00658203|Optimal and stable pharmacological treatment|optimal and stable pharmacological treatment
5661296|NCT00658190|Cervical cancer, automation, Internet, telecytology|cervical cancer, automation, internet, telecytology
5661297|NCT00658177|Erectile dysfunction|erectile dysfunction
5661298|NCT00658177|Vardenafil|vardenafil
5847451|NCT00039715|Memory|memory
5661299|NCT00658164|Nonalcoholic fatty liver disease associated with increased iron stores|nonalcoholic fatty liver disease associated with increased iron stores
5661300|NCT00658151|focus|focus
5661301|NCT00658151|study|study
5661302|NCT00658151|evaluate|evaluate
5661303|NCT00658151|sonographic|sonographic
5661304|NCT00658151|findings|findings
5661305|NCT00658151|colon|colon
5661306|NCT00658151|patients|patients
5661307|NCT00658151|developed|developed
5661308|NCT00658086|ALN-RSV01|aln-rsv01
5661309|NCT00658086|Respiratory Syncytial Virus|respiratory syncytial virus
5661310|NCT00658073|Kidney transplant|kidney transplant
5661311|NCT00658073|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
5661312|NCT00658060|FMF, Exertional leg pain|fmf, exertional leg pain
5661313|NCT00658047|Arthritis, Rheumatoid|arthritis, rheumatoid
5661314|NCT00658047|Phase II|phase ii
5661315|NCT00658047|Rheumatoid Arthritis|rheumatoid arthritis
5661316|NCT00658034|Cancer|cancer
5661317|NCT00658034|Fatigue|fatigue
5661318|NCT00658034|Acupuncture|acupuncture
5661319|NCT00658021|diabetes|diabetes
5661320|NCT00658021|adolescents|adolescents
5661321|NCT00658021|exenatide|exenatide
5661322|NCT00658021|Astra Zeneca|astra zeneca
5661323|NCT00658008|PD 0332334 phase 3 pivotal trial|pd 0332334 phase 3 pivotal trial
5661324|NCT00657995|pancreatogenic|pancreatogenic
5661325|NCT00657995|diabetes|diabetes
5661326|NCT00657995|artificial|artificial
5661327|NCT00657995|pancreas|pancreas
5661328|NCT00657969|Polymorphism, genetic|polymorphism, genetic
5661329|NCT00657969|Risk factors|risk factors
5661330|NCT00657969|Carotid Artery, Internal, Dissection|carotid artery, internal, dissection
5661331|NCT00657969|Vertebral Artery Dissection|vertebral artery dissection
5661332|NCT00657969|Genetic predisposition|genetic predisposition
5661333|NCT00657969|Outcome|outcome
5661334|NCT00657969|Therapy|therapy
5661335|NCT00657956|osteoarthritis|osteoarthritis
5661336|NCT00657956|arthroplasty|arthroplasty
5661337|NCT00657956|knee joint|knee joint
5661338|NCT00657956|radiography|radiography
5661339|NCT00657956|surgery|surgery
5661340|NCT00657956|Bone Density|bone density
5661341|NCT00657956|Outcome Assessment (Health Care)|outcome assessment (health care)
5661342|NCT00657943|carotid|carotid
5661343|NCT00657943|intima|intima
5661344|NCT00657943|media|media
5661345|NCT00657943|thickness|thickness
5661346|NCT00657943|insulin|insulin
5661347|NCT00657943|metformin|metformin
5661348|NCT00657917|leishmaniasis|leishmaniasis
5661349|NCT00657917|cutaneous|cutaneous
5661350|NCT00657917|Old World|old world
5661351|NCT00657917|Leishmania major|leishmania major
5661352|NCT00657917|Treatment|treatment
5661353|NCT00657904|androgen antagonists|androgen antagonists
5661354|NCT00657904|prostate neoplasms|prostate neoplasms
5661355|NCT00657891|Allergic Asthma|allergic asthma
5661356|NCT00657891|Anti IgE|anti ige
5661357|NCT00657891|Xolair|xolair
5661358|NCT00657891|Basophil|basophil
5661359|NCT00657891|IL-13|il-13
5661360|NCT00657891|IL-4|il-4
5661361|NCT00657891|Histamine|histamine
5661362|NCT00657878|platinum free interval|platinum free interval
5661363|NCT00657878|chemotherapy|chemotherapy
5661364|NCT00657852|pamidronate,bone loss, liver transplantation|pamidronate,bone loss, liver transplantation
5661365|NCT00657839|Benign Prostate Hyperplasia|benign prostate hyperplasia
5661366|NCT00657839|Vardenafil|vardenafil
5661367|NCT00657839|Genital Disease|genital disease
5661368|NCT00657839|Male: Signs and symptoms of Benign Prostate Hyperplasia|male: signs and symptoms of benign prostate hyperplasia
5661369|NCT00657826|Diseased Heart Valve, Replacement|diseased heart valve, replacement
5661370|NCT00657813|Alzheimer|alzheimer
5661371|NCT00657813|SPECT|spect
5661372|NCT00657800|diabetes, inpatient, education,|diabetes, inpatient, education,
5661373|NCT00657787|Posttraumatic Stress Disorder|posttraumatic stress disorder
5661374|NCT00657787|Veterans|veterans
5661375|NCT00657787|Health Services|health services
5661376|NCT00657774|Asthma|asthma
5661377|NCT00657774|Mild to Moderate|mild to moderate
5661378|NCT00657748|Leukodystrophy|leukodystrophy
5661379|NCT00657748|Canavan disease,|canavan disease,
5661380|NCT00657748|Aspartoacylase,|aspartoacylase,
5661381|NCT00657748|Lithium,|lithium,
5661382|NCT00657748|Glyceryl Triacetate|glyceryl triacetate
5661383|NCT00657735|bipolar|bipolar
5661384|NCT00657735|depression|depression
5661385|NCT00657735|prefrontal|prefrontal
5661386|NCT00657735|cortex|cortex
5661387|NCT00657735|antidepressant|antidepressant
5661388|NCT00657735|response|response
5661389|NCT00657722|Pulmonary hypertension|pulmonary hypertension
5661390|NCT00657722|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5661391|NCT00657722|Operability|operability
5661392|NCT00657722|Thromboendarteriectomy|thromboendarteriectomy
5661393|NCT00657722|Operative mortality rate|operative mortality rate
5661394|NCT00657722|Technical failure|technical failure
5661395|NCT00657722|Pulmonary angiography|pulmonary angiography
5661396|NCT00657722|Computed tomography|computed tomography
5661397|NCT00657709|infant|infant
5661398|NCT00657709|Meningococcal disease|meningococcal disease
5661399|NCT00657709|prevention|prevention
5661400|NCT00657709|vaccination|vaccination
5661401|NCT00657696|primary health care|primary health care
5661403|NCT00657696|learning|learning
5661404|NCT00657696|quality of health care|quality of health care
5661405|NCT00657683|GBS|gbs
5661406|NCT00657683|GBS prevention|gbs prevention
5661407|NCT00657670|refractive error|refractive error
5661408|NCT00657670|spectacles|spectacles
5661409|NCT00657670|ready made spectacles|ready made spectacles
5661410|NCT00657670|vision|vision
5661411|NCT00657670|cost effectiveness|cost effectiveness
5661412|NCT00657657|Hepatitis|hepatitis
5661413|NCT00657657|vaccine|vaccine
5661414|NCT00657644|Erectile Dysfunction|erectile dysfunction
5661415|NCT00657631|Acceptance and Commitment Therapy|acceptance and commitment therapy
5661416|NCT00657631|Delusions|delusions
5661417|NCT00657618|Leishmaniasis, Sodium stibogluconate, Pentostam, sand fly|leishmaniasis, sodium stibogluconate, pentostam, sand fly
5661418|NCT00657605|Congenital leptin deficiency|congenital leptin deficiency
5661419|NCT00657605|Obesity|obesity
5661420|NCT00657605|Metabolic syndrome|metabolic syndrome
5661421|NCT00657605|Diabetes|diabetes
5661422|NCT00657566|intraabdominal|intraabdominal
5661423|NCT00657566|peritonitis|peritonitis
5661424|NCT00657566|sepsis|sepsis
5661425|NCT00657566|duration|duration
5661426|NCT00657566|antibiotics|antibiotics
5661427|NCT00657540|black widow spider|black widow spider
5661428|NCT00657540|antivenom|antivenom
5661429|NCT00657540|latrodectism|latrodectism
5661430|NCT00657527|Crestor|crestor
5661431|NCT00657527|Rosuvastatin|rosuvastatin
5661432|NCT00657527|Cholesterol|cholesterol
5661433|NCT00657527|Coronary artery disease|coronary artery disease
5661434|NCT00657527|Myocardial ischaemia.|myocardial ischaemia.
5661435|NCT00657514|hemoglobin desaturation kinetics|hemoglobin desaturation kinetics
5661436|NCT00657514|peripheral arterial disease|peripheral arterial disease
5661437|NCT00657514|chronic angina|chronic angina
5661438|NCT00657514|exercise tolerance|exercise tolerance
5661439|NCT00657501|testosterone|testosterone
5661440|NCT00657501|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5661441|NCT00657501|menopause|menopause
5661442|NCT00657488|Multiple Myeloma, Thalidomide, dose, dexamethasone|multiple myeloma, thalidomide, dose, dexamethasone
5661443|NCT00657475|Heparin low dose|heparin low dose
5661444|NCT00657475|Inflammation|inflammation
5661445|NCT00657475|Blood loss|blood loss
5661446|NCT00657462|Medical Informatics Applications|medical informatics applications
5661447|NCT00657462|Software|software
5661448|NCT00657462|Utilization|utilization
5661449|NCT00657449|sprains and strains|sprains and strains
5661450|NCT00657436|Acute Coronary Syndrome|acute coronary syndrome
5661451|NCT00657436|Myocardial Infarction|myocardial infarction
5661452|NCT00657436|Coronary Artery Disease|coronary artery disease
5661453|NCT00657423|Lung Neoplasms|lung neoplasms
5661454|NCT00657423|Endostatins|endostatins
5661455|NCT00657423|Vascular Endothelial Growth Factors|vascular endothelial growth factors
5661456|NCT00657423|Fibroblast Growth Factors|fibroblast growth factors
5661457|NCT00657423|Survival Rate|survival rate
5661458|NCT00657410|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5661459|NCT00657397|Methadone|methadone
5661460|NCT00657397|Substance Dependence|substance dependence
5661461|NCT00657384|Specify the primary condition or disease being studied Major Hepatectomy|specify the primary condition or disease being studied major hepatectomy
5661462|NCT00657371|Colorectal Cancer|colorectal cancer
5661463|NCT00657371|Colonoscopy|colonoscopy
5661464|NCT00657371|Third Eye Retroscope|third eye retroscope
5661465|NCT00657371|Third Eye Retroscope Auxiliary Imaging System|third eye retroscope auxiliary imaging system
5661466|NCT00657371|Polypectomy|polypectomy
5661467|NCT00657358|lidocaine|lidocaine
5661468|NCT00657358|allodynia|allodynia
5661469|NCT00657358|chronic regional pain syndrome|chronic regional pain syndrome
5661470|NCT00657358|pain|pain
5661471|NCT00657345|trastuzumab|trastuzumab
5661472|NCT00657345|breast cancer|breast cancer
5661473|NCT00657345|her2 positive breast cancer|her2 positive breast cancer
5661474|NCT00657306|Cirrhosis|cirrhosis
5661475|NCT00657306|Ascites|ascites
5661476|NCT00657306|Adrenal insufficiency|adrenal insufficiency
5661477|NCT00657306|Hepatorenal syndrome|hepatorenal syndrome
5661478|NCT00657306|Portal hypertension|portal hypertension
5661479|NCT00657293|COPD|copd
5661480|NCT00657293|arm training|arm training
5661481|NCT00657293|dyspnoea|dyspnoea
5661482|NCT00657293|quality of life|quality of life
5661483|NCT00657267|recurrent glioblastoma|recurrent glioblastoma
5661484|NCT00657267|temodar|temodar
5661485|NCT00657267|temozolomide|temozolomide
5661486|NCT00657254|Extension|extension
5661487|NCT00657254|Sorafenib|sorafenib
5661488|NCT00657254|Survival|survival
5661489|NCT00657241|cardiac work|cardiac work
5661490|NCT00657241|coreg cr|coreg cr
5661491|NCT00657241|valsartan|valsartan
5661492|NCT00657241|tonometry|tonometry
5661493|NCT00657228|Anaphylaxis|anaphylaxis
5661494|NCT00657228|Anaphylactoid reactions|anaphylactoid reactions
5661496|NCT00657202|neurofibroma|neurofibroma
5661497|NCT00657202|ranibizumab|ranibizumab
5661498|NCT00657202|Lucentis|lucentis
5661499|NCT00657189|Sifalimumab|sifalimumab
5661500|NCT00657189|MEDI-545|medi-545
5661501|NCT00657189|Lupus erythematosus, systemic|lupus erythematosus, systemic
5661502|NCT00657163|Stroke recovery|stroke recovery
5661503|NCT00657163|Pharmacological modulation|pharmacological modulation
5661507|NCT00657163|Ischemic Stroke and Motor impairment|ischemic stroke and motor impairment
5685564|NCT00555594|vascular endothelial growth factor|vascular endothelial growth factor
5661508|NCT00657163|Modulation of recovery and cerebral plasticity by Fluoxetine|modulation of recovery and cerebral plasticity by fluoxetine
5661510|NCT00657137|locally advanced or metastatic|locally advanced or metastatic
5661511|NCT00657124|AEN|aen
5661512|NCT00657111|influenza, elderly, United Kingdom|influenza, elderly, united kingdom
5661513|NCT00657111|Vaxart|vaxart
5661514|NCT00657098|Side effects|side effects
5661515|NCT00657098|Angiogenesis inhibitors|angiogenesis inhibitors
5661516|NCT00657098|Epidermal growth factor receptor inhibitors|epidermal growth factor receptor inhibitors
5661517|NCT00657098|Tyrosinekinase inhibitors|tyrosinekinase inhibitors
5661518|NCT00657085|Laser hair removal|laser hair removal
5661519|NCT00657072|scapholunate instability|scapholunate instability
5661520|NCT00657072|neural networks|neural networks
5661521|NCT00657072|scaphoid|scaphoid
5661522|NCT00657072|lunate|lunate
5661523|NCT00657072|Suspected torn scapholunate interosseous ligament|suspected torn scapholunate interosseous ligament
5661524|NCT00657072|Suspected other torn wrist ligaments|suspected other torn wrist ligaments
5661525|NCT00657059|IgA nephropathy|iga nephropathy
5661526|NCT00657059|mycophenolate mofetil|mycophenolate mofetil
5661527|NCT00657033|Erectile Dysfunction|erectile dysfunction
5661528|NCT00657020|nicotine|nicotine
5661529|NCT00657020|therapy|therapy
5661530|NCT00657020|fMRI/EEG|fmri/eeg
5661531|NCT00657020|replacement|replacement
5661532|NCT00657007|lupus|lupus
5661534|NCT00656994|Sleep Disorder|sleep disorder
5661535|NCT00656994|Insomnia|insomnia
5661536|NCT00656981|Moderate Acne Vulgaris|moderate acne vulgaris
5661537|NCT00656981|Acne|acne
5661538|NCT00656968|peptic ulcer disease|peptic ulcer disease
5661539|NCT00656968|gastric cancer|gastric cancer
5661540|NCT00656968|therapeutics|therapeutics
5661546|NCT00656942|Pain|pain
5661547|NCT00656929|Vitamin D|vitamin d
5661548|NCT00656929|Viral URI|viral uri
5661549|NCT00656929|Influenza|influenza
5661550|NCT00656929|Colds|colds
5661551|NCT00656916|Post-Transplant Constrictive Bronchiolitis|post-transplant constrictive bronchiolitis
5661552|NCT00656916|Bronchiolitis|bronchiolitis
5661553|NCT00656916|Fluticasone Propionate|fluticasone propionate
5661554|NCT00656916|Inhaled Corticosteroids|inhaled corticosteroids
5661555|NCT00656916|Lung Condition|lung condition
5661556|NCT00656916|PTCB|ptcb
5661557|NCT00656903|Lucentis|lucentis
5661558|NCT00656903|Indocyanine Green Angiography|indocyanine green angiography
5661559|NCT00656903|Choroidal Neovascularization|choroidal neovascularization
5661560|NCT00656903|Macular Degeneration|macular degeneration
5661561|NCT00656903|Ranibizumab|ranibizumab
5661562|NCT00656903|Age-Related Macular Degeneration|age-related macular degeneration
5661563|NCT00656903|AMD|amd
5661564|NCT00656890|ulcerative colitis, rectal bleeding|ulcerative colitis, rectal bleeding
5661565|NCT00656877|Fat Embolism Total Knee Arthroplasty|fat embolism total knee arthroplasty
5661566|NCT00656864|Diabetes|diabetes
5661567|NCT00656864|pioglitazone|pioglitazone
5661568|NCT00656864|GIP|gip
5661569|NCT00656851|HIV/AIDS|hiv/aids
5661570|NCT00656851|Heart disease|heart disease
5661571|NCT00656851|Diabetes|diabetes
5661572|NCT00656851|Cardiovascular disease risk|cardiovascular disease risk
5661573|NCT00656851|Dyslipidemia|dyslipidemia
5661574|NCT00656851|Visceral adiposity|visceral adiposity
5661575|NCT00656851|treatment experienced|treatment experienced
5661576|NCT00656838|colon|colon
5661577|NCT00656838|rectal|rectal
5661578|NCT00656838|cancer|cancer
5661579|NCT00656838|screening|screening
5661580|NCT00656825|P144|p144
5661581|NCT00656825|TGF-β1|tgf-β1
5661582|NCT00656825|Healthy volunteers|healthy volunteers
5661583|NCT00656825|Cutaneous tolerability|cutaneous tolerability
5661584|NCT00656825|Skin fibrosis|skin fibrosis
5661585|NCT00656825|systemic scleroderma|systemic scleroderma
5661586|NCT00656825|systemic sclerosis|systemic sclerosis
5661587|NCT00656825|Safety|safety
5661588|NCT00656812|advanced MALT lymphoma|advanced malt lymphoma
5661589|NCT00656812|Rituximab|rituximab
5661590|NCT00656812|2CdA|2cda
5661591|NCT00656812|chemotherapy|chemotherapy
5661592|NCT00656812|immunotherapy|immunotherapy
5661593|NCT00656773|morphine, sufentanil, acute pain, opioid, Prehospital Emergency Care|morphine, sufentanil, acute pain, opioid, prehospital emergency care
5661594|NCT00656760|unknown primary, head and neck cancer, squamous cell carcinoma|unknown primary, head and neck cancer, squamous cell carcinoma
5661595|NCT00656760|Unknown primary head and neck cancer|unknown primary head and neck cancer
5661596|NCT00656747|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5661597|NCT00656747|Acute exacerbation of COPD (AECOPD)|acute exacerbation of copd (aecopd)
5661598|NCT00656747|chronic bronchitis|chronic bronchitis
5661600|NCT00656747|chest infection|chest infection
5661601|NCT00656747|smoking|smoking
5661602|NCT00656747|lung disease|lung disease
5661603|NCT00656747|lung|lung
5661604|NCT00656747|lungs|lungs
5661605|NCT00656734|Medarex Inc.|medarex inc.
5661606|NCT00656721|bronchiectasis|bronchiectasis
5661607|NCT00656721|physiotherapy|physiotherapy
5661608|NCT00656721|flutter valve|flutter valve
5661609|NCT00656721|impulse oscillation technique|impulse oscillation technique
5661610|NCT00656708|Burns|burns
5661611|NCT00656708|Wounds|wounds
5661612|NCT00656708|Healthcare associated infections|healthcare associated infections
5661613|NCT00656708|MRSA|mrsa
5661614|NCT00656708|VRE|vre
5661615|NCT00656695|Iminoral|iminoral
5661616|NCT00656695|Neoral|neoral
5661617|NCT00656695|Acute renal transplant rejection|acute renal transplant rejection
5661618|NCT00656682|Prevention & Control|prevention & control
5661619|NCT00656682|Hyperglycemia|hyperglycemia
5661620|NCT00656682|Obesity|obesity
5661621|NCT00656682|Diabetes Mellitus|diabetes mellitus
5661622|NCT00656682|Cost Benefit Analysis|cost benefit analysis
5661623|NCT00656669|newly diagnosed breast cancer|newly diagnosed breast cancer
5661624|NCT00656669|neoadjuvant therapy|neoadjuvant therapy
5661625|NCT00656656|pemphigus|pemphigus
5661626|NCT00656656|rituximab|rituximab
5661627|NCT00656656|immunoadsorption|immunoadsorption
5661628|NCT00656656|dexamethasone|dexamethasone
5661629|NCT00656656|treatment|treatment
5661630|NCT00656656|management|management
5661631|NCT00656617|Acute Myeloid Leukemia|acute myeloid leukemia
5661632|NCT00656617|(AML)|(aml)
5661633|NCT00656617|Myelodysplastic syndrome|myelodysplastic syndrome
5661634|NCT00656617|(MDS)|(mds)
5661635|NCT00656617|Leukemia|leukemia
5661636|NCT00656617|Idarubicin|idarubicin
5661637|NCT00656617|Cytarabine|cytarabine
5661638|NCT00656617|Vorinostat|vorinostat
5645794|NCT00719004|Medical|medical
5661639|NCT00656617|Ara-C|ara-c
5661640|NCT00656604|recurrent breast cancer|recurrent breast cancer
5661641|NCT00656604|stage I breast cancer|stage i breast cancer
5661642|NCT00656604|stage II breast cancer|stage ii breast cancer
5661643|NCT00656604|stage IIIA breast cancer|stage iiia breast cancer
5661644|NCT00656604|stage IIIB breast cancer|stage iiib breast cancer
5661645|NCT00656604|stage IIIC breast cancer|stage iiic breast cancer
5661646|NCT00656591|Child mortality, Nepal, Community, care practices|child mortality, nepal, community, care practices
5661647|NCT00656578|Foot|foot
5661648|NCT00656578|Bunion|bunion
5661649|NCT00656578|Bunionectomy|bunionectomy
5661650|NCT00656578|Hallux Valgus Deformity|hallux valgus deformity
5661651|NCT00656578|Surgery for Transpositional first metatarsal osteotomy - Bunionectomy|surgery for transpositional first metatarsal osteotomy - bunionectomy
5661652|NCT00656565|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer|measure inspiratory spirometry with dry powder inhaler device in series with the spirometer
5661653|NCT00656526|analgesia, postlaminectomy , lidocaine, dorsal root|analgesia, postlaminectomy , lidocaine, dorsal root
5661654|NCT00656513|hypopharyngeal cancer|hypopharyngeal cancer
5661655|NCT00656513|laryngeal cancer|laryngeal cancer
5661656|NCT00656513|lip and oral cavity cancer|lip and oral cavity cancer
5661657|NCT00656513|nasopharyngeal cancer|nasopharyngeal cancer
5661658|NCT00656513|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5661659|NCT00656513|oropharyngeal cancer|oropharyngeal cancer
5661660|NCT00656513|salivary gland cancer|salivary gland cancer
5661661|NCT00656513|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5661662|NCT00656513|xerostomia|xerostomia
5661663|NCT00656513|tongue cancer|tongue cancer
5661664|NCT00656500|surgical patients|surgical patients
5661665|NCT00656500|cigarette smoking|cigarette smoking
5661666|NCT00656500|postoperative complications|postoperative complications
5661667|NCT00656500|telephone counseling|telephone counseling
5661668|NCT00656500|quitlines|quitlines
5661669|NCT00656487|Cannabis Dependence|cannabis dependence
5661670|NCT00656487|Marijuana Dependence|marijuana dependence
5661671|NCT00656487|Cannabis Withdrawal|cannabis withdrawal
5661672|NCT00656487|Rimonabant|rimonabant
5661673|NCT00656487|cannabinoid receptor type 1 (CB1) inverse agonist|cannabinoid receptor type 1 (cb1) inverse agonist
5661674|NCT00656487|Neuropsychology|neuropsychology
5661675|NCT00656487|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5661676|NCT00656487|Endocannabinoids|endocannabinoids
5661677|NCT00656487|Cortisol|cortisol
5661678|NCT00656474|burn wounds|burn wounds
5661679|NCT00656474|wound healing|wound healing
5661680|NCT00656461|Advanced cancer|advanced cancer
5661681|NCT00656448|Acute Myelogenous Leukemia|acute myelogenous leukemia
5661682|NCT00656448|AML|aml
5661683|NCT00656448|Myelodysplastic Syndrome|myelodysplastic syndrome
5661684|NCT00656448|MDS|mds
5661685|NCT00656448|Leukemia|leukemia
5661686|NCT00656448|Procrit|procrit
5661687|NCT00656448|Epoetin Alfa|epoetin alfa
5661688|NCT00656448|Epogen|epogen
5661689|NCT00656435|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5661690|NCT00656435|bevacizumab (Avastin)|bevacizumab (avastin)
5661691|NCT00656435|vitreous hemorrhage|vitreous hemorrhage
5661692|NCT00656435|long acting gas|long acting gas
5661693|NCT00656422|insulin therapy|insulin therapy
5661694|NCT00656422|hepatic fat|hepatic fat
5661695|NCT00656422|type 2 diabetes|type 2 diabetes
5661696|NCT00656422|body composition|body composition
5661697|NCT00656422|comparison of insulin detemir and insulin glargine|comparison of insulin detemir and insulin glargine
5661698|NCT00656422|Changes in Hepatic Fat|changes in hepatic fat
5661700|NCT00656409|Ataxia telangiectasia,|ataxia telangiectasia,
5661701|NCT00656409|Conjugated pneumococcal,|conjugated pneumococcal,
5661702|NCT00656409|Prevenar,|prevenar,
5661703|NCT00656409|Immunogenicity ,|immunogenicity ,
5661705|NCT00656396|Blood loss|blood loss
5661706|NCT00656396|Point of care monitoring|point of care monitoring
5661707|NCT00656396|FFP|ffp
5661708|NCT00656396|Major surgery|major surgery
5661709|NCT00656396|Prothrombin Time|prothrombin time
5661710|NCT00656396|Blood coagulation tests|blood coagulation tests
5661711|NCT00656383|venous ulcer, leg ulcer, stasis ulcer|venous ulcer, leg ulcer, stasis ulcer
5661713|NCT00656370|subcutaneous infusion|subcutaneous infusion
5661714|NCT00656370|hyaluronidase|hyaluronidase
5661715|NCT00656370|rHuPH20|rhuph20
5661716|NCT00656370|recombinant human hyaluronidase|recombinant human hyaluronidase
5661717|NCT00656344|PTSD|ptsd
5661718|NCT00656344|Substance Abuse|substance abuse
5661719|NCT00656344|WTC attacks|wtc attacks
5661720|NCT00656344|Iraq War|iraq war
5661721|NCT00656318|women|women
5661722|NCT00656318|menses|menses
5661723|NCT00656318|oral contraceptives|oral contraceptives
5661724|NCT00656318|Healthy menstruating females|healthy menstruating females
5661725|NCT00656305|Bone Cancer|bone cancer
5661726|NCT00656305|Pain Palliation|pain palliation
5661727|NCT00656305|Metastasis|metastasis
5661728|NCT00656305|Multiple Myeloma|multiple myeloma
5661729|NCT00656305|Breast Cancer|breast cancer
5661730|NCT00656305|Lung Cancer|lung cancer
5661731|NCT00656305|Prostate Cancer|prostate cancer
5645656|NCT00719563|polycythemia vera|polycythemia vera
5661732|NCT00656305|cancer related Pain|cancer related pain
5661733|NCT00656305|Tumors|tumors
5661734|NCT00656292|Plasma concentrations of inflammatory markers|plasma concentrations of inflammatory markers
5661735|NCT00656292|C-Reactive Protein (CRP)|c-reactive protein (crp)
5661736|NCT00656292|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5661737|NCT00656292|Tumor Necrosis Factor-Alpha (TNF)|tumor necrosis factor-alpha (tnf)
5661738|NCT00656292|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
5661739|NCT00656292|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
5661740|NCT00656292|Creatine Kinase (CK)|creatine kinase (ck)
5661741|NCT00656279|chronic kidney disease|chronic kidney disease
5661742|NCT00656279|predialysis|predialysis
5661743|NCT00656279|hyperphosphatemia|hyperphosphatemia
5661744|NCT00656279|dietary intervention|dietary intervention
5661745|NCT00656279|intensive dietary education|intensive dietary education
5661746|NCT00656279|low phosphorus diet|low phosphorus diet
5661747|NCT00656266|renal insufficiency and/or renal failure after liver transplantation|renal insufficiency and/or renal failure after liver transplantation
5661748|NCT00656214|Lichen Planus|lichen planus
5661749|NCT00656201|Infertility|infertility
5661750|NCT00656201|In vitro fertilization|in vitro fertilization
5661751|NCT00656201|Embryo transfer|embryo transfer
5661752|NCT00656201|Crinone|crinone
5661753|NCT00656201|Intramuscular Progesterone|intramuscular progesterone
5661754|NCT00656201|Progesterone support|progesterone support
5661755|NCT00656188|Erectile Dysfunction|erectile dysfunction
5661756|NCT00656188|Vardenafil|vardenafil
5661757|NCT00656175|lipodystrophy|lipodystrophy
5661759|NCT00656175|visceral fat|visceral fat
5661760|NCT00656175|HIV|hiv
5661761|NCT00656175|women|women
5661762|NCT00656175|raltegravir|raltegravir
5661763|NCT00656175|ART|art
5661764|NCT00656175|anti HIV therapy|anti hiv therapy
5661765|NCT00656175|NNRTI|nnrti
5661766|NCT00656175|Protease inhibitor|protease inhibitor
5661767|NCT00656175|integrase inhibitor|integrase inhibitor
5661768|NCT00656175|treatment experienced|treatment experienced
5661769|NCT00656149|telerehabilitation|telerehabilitation
5661770|NCT00656149|functional electrical stimulation|functional electrical stimulation
5661771|NCT00656149|spinal cord injury|spinal cord injury
5661772|NCT00656149|hand function rehabilitation|hand function rehabilitation
5661773|NCT00656123|adenocarcinoma of the colon|adenocarcinoma of the colon
5661774|NCT00656123|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5661775|NCT00656123|stage IV colon cancer|stage iv colon cancer
5661776|NCT00656123|stage IV rectal cancer|stage iv rectal cancer
5661777|NCT00656110|Restless legs syndrome|restless legs syndrome
5661778|NCT00656110|Morton's neuroma|morton's neuroma
5661779|NCT00656110|Randomized controlled trial|randomized controlled trial
5661780|NCT00656097|Rabies post-exposure prophylaxis|rabies post-exposure prophylaxis
5661781|NCT00656071|ARDS|ards
5661782|NCT00656071|Acute respiratory distress syndrome|acute respiratory distress syndrome
5661783|NCT00656071|Adult respiratory distress syndrome|adult respiratory distress syndrome
5661784|NCT00656071|respiratory distress|respiratory distress
5661785|NCT00656058|Leukotriene|leukotriene
5661786|NCT00656058|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5661787|NCT00656058|Montelukast|montelukast
5661788|NCT00656058|Stem Cell Transplant|stem cell transplant
5661789|NCT00656058|Bronchiolitis Obliterans|bronchiolitis obliterans
5661790|NCT00656045|Obesity|obesity
5661791|NCT00656045|Physical Activity|physical activity
5661792|NCT00656045|Weight Loss|weight loss
5661793|NCT00656045|Exercise|exercise
5661795|NCT00656045|Energy|energy
5661796|NCT00656045|Behavioral|behavioral
5661797|NCT00656045|Healthy Eating|healthy eating
5661798|NCT00656032|insulin resistance|insulin resistance
5661799|NCT00656032|end stage renal disease|end stage renal disease
5661800|NCT00656006|Hepatitis C|hepatitis c
5661801|NCT00656006|Chronic|chronic
5661802|NCT00656006|Genotype 2 or 3|genotype 2 or 3
5661803|NCT00656006|Treatment naive|treatment naive
5661804|NCT00655993|COPD|copd
5661805|NCT00655993|Inflammation|inflammation
5661806|NCT00655993|CRP levels|crp levels
5661807|NCT00655993|simvastatin|simvastatin
5661808|NCT00655954|COPD|copd
5661809|NCT00655954|asthma|asthma
5661810|NCT00655954|smokers|smokers
5661811|NCT00655954|healthy volunteers|healthy volunteers
5661812|NCT00655954|bronchiectasis|bronchiectasis
5661813|NCT00655954|cystic fibrosis|cystic fibrosis
5661814|NCT00655941|Osteoarthritis|osteoarthritis
5661815|NCT00655941|Obesity|obesity
5661816|NCT00655941|Weight loss|weight loss
5661817|NCT00655941|Dietary instruction|dietary instruction
5661818|NCT00655941|Exercise|exercise
5661819|NCT00655941|Attention|attention
5661820|NCT00655928|Acute lung injury|acute lung injury
5661821|NCT00655928|Lung resection|lung resection
5661822|NCT00655902|Trans fat|trans fat
5661823|NCT00655902|Obesity|obesity
5661824|NCT00655902|Insulin sensitivity|insulin sensitivity
5661825|NCT00655876|stage IIA esophageal cancer|stage iia esophageal cancer
5661826|NCT00655876|stage IIB esophageal cancer|stage iib esophageal cancer
5661827|NCT00655876|stage IIIA esophageal cancer|stage iiia esophageal cancer
5680413|NCT00577824|diabetes|diabetes
5661828|NCT00655876|stage IIIB esophageal cancer|stage iiib esophageal cancer
5661829|NCT00655876|stage IIIC esophageal cancer|stage iiic esophageal cancer
5661831|NCT00655876|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5661832|NCT00655863|Glucose Metabolism Disorder|glucose metabolism disorder
5661833|NCT00655863|Dysmetabolic Syndrome|dysmetabolic syndrome
5661834|NCT00655863|Type II Diabetes|type ii diabetes
5661835|NCT00655863|Diabetes Mellitus|diabetes mellitus
5661836|NCT00655863|Lipoatrophic; Dyslipidemia|lipoatrophic; dyslipidemia
5661837|NCT00655863|Drug Therapy|drug therapy
5661838|NCT00655850|Lung Cancer|lung cancer
5661839|NCT00655850|Non-Small Cell Lung Cancer|non-small cell lung cancer
5661840|NCT00655850|Metronomic Chemotherapy|metronomic chemotherapy
5661841|NCT00655837|Antigens, CD40|antigens, cd40
5661842|NCT00655837|Antibodies, Monoclonal|antibodies, monoclonal
5642785|NCT00729703|ICD|icd
5661843|NCT00655837|Combined Modality Therapy|combined modality therapy
5661844|NCT00655837|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5661845|NCT00655837|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5661846|NCT00655837|Hematologic Diseases|hematologic diseases
5661847|NCT00655837|Immunoproliferative Disorders|immunoproliferative disorders
5661848|NCT00655837|Lymphatic Diseases|lymphatic diseases
5661849|NCT00655837|Lymphoproliferative Disorders|lymphoproliferative disorders
5661850|NCT00655837|Lymphoma|lymphoma
5661851|NCT00655811|Healthy volunteers|healthy volunteers
5661852|NCT00655785|Epitope peptide|epitope peptide
5661853|NCT00655785|CTL|ctl
5661854|NCT00655785|Pancreatic cancer|pancreatic cancer
5661855|NCT00655785|Vaccination VEGFR1|vaccination vegfr1
5661856|NCT00655785|VEGFR2|vegfr2
5661857|NCT00655772|chlorine|chlorine
5661858|NCT00655772|dioxide|dioxide
5661859|NCT00655772|mouthwash|mouthwash
5661860|NCT00655772|organoleptic|organoleptic
5661861|NCT00655772|measurements|measurements
5661862|NCT00655772|volatile|volatile
5661863|NCT00655772|sulfur|sulfur
5661864|NCT00655772|compounds|compounds
5661865|NCT00655746|Healthy Subjects|healthy subjects
5661866|NCT00655720|infant formula|infant formula
5661867|NCT00655707|Adult stem cell therapy|adult stem cell therapy
5661868|NCT00655694|COPD|copd
5661869|NCT00655694|smokers|smokers
5661870|NCT00655694|healthy volunteers|healthy volunteers
5661871|NCT00655681|pediatric osteoporosis|pediatric osteoporosis
5661872|NCT00655681|pediatric osteopenia|pediatric osteopenia
5661873|NCT00655681|pamidronate|pamidronate
5661874|NCT00655681|post operative osteopenia|post operative osteopenia
5661875|NCT00655668|NHL, Non-Hodgkin's Lymphoma, T-cell Lymphoma|nhl, non-hodgkin's lymphoma, t-cell lymphoma
5661876|NCT00655629|Erectile Dysfunction|erectile dysfunction
5661877|NCT00655603|GLP-1|glp-1
5661878|NCT00655603|Glucagon secretion|glucagon secretion
5661879|NCT00655603|Glucose turn-over|glucose turn-over
5661880|NCT00655590|Erectile Dysfunction|erectile dysfunction
5661881|NCT00655590|Sildenafil|sildenafil
5661882|NCT00655590|Vardenafil|vardenafil
5661883|NCT00655590|Spermatogenesis|spermatogenesis
5661884|NCT00655590|Sperm concentration|sperm concentration
5661885|NCT00655590|Sperm count|sperm count
5661886|NCT00655590|Morphology|morphology
5661887|NCT00655590|Motility|motility
5661888|NCT00655590|Reproductive hormonal|reproductive hormonal
5661889|NCT00655577|Aging|aging
5661890|NCT00655577|Osteoporosis|osteoporosis
5661891|NCT00655577|Exercise|exercise
5661892|NCT00655577|Population based|population based
5661893|NCT00655577|Randomized trial|randomized trial
5661894|NCT00655577|Falls|falls
5661895|NCT00655577|Fractures|fractures
5661896|NCT00655551|epilepsy|epilepsy
5661897|NCT00655551|seizures|seizures
5661898|NCT00655551|Lacosamide|lacosamide
5661899|NCT00655551|Vimpat|vimpat
5661900|NCT00655551|intravenous|intravenous
5661901|NCT00655525|inflammation|inflammation
5661902|NCT00655525|end stage renal disease|end stage renal disease
5661903|NCT00655512|pimecrolimus|pimecrolimus
5661904|NCT00655512|hydrocortison|hydrocortison
5661905|NCT00655512|betamethasone|betamethasone
5661906|NCT00655512|clobetasol-17-Propionat|clobetasol-17-propionat
5661907|NCT00655512|Optical Coherence Tomography|optical coherence tomography
5661908|NCT00655512|skin healthy probands|skin healthy probands
5661909|NCT00655499|adenocarcinoma of the colon|adenocarcinoma of the colon
5661910|NCT00655499|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5661911|NCT00655499|stage IV colon cancer|stage iv colon cancer
5661912|NCT00655499|recurrent rectal cancer|recurrent rectal cancer
5661913|NCT00655499|stage IV rectal cancer|stage iv rectal cancer
5661914|NCT00655499|recurrent colon cancer|recurrent colon cancer
5661915|NCT00655486|Epilepsy|epilepsy
5661916|NCT00655486|seizures|seizures
5661917|NCT00655486|antiepileptic|antiepileptic
5661918|NCT00655486|Lacosamide|lacosamide
5661919|NCT00655486|Vimpat|vimpat
5661920|NCT00655486|safety|safety
5661921|NCT00655486|adjunctive|adjunctive
5661922|NCT00655460|Glucose|glucose
5661923|NCT00655460|Insulin|insulin
5661924|NCT00655460|computer|computer
5661925|NCT00655460|critical care|critical care
5661926|NCT00655447|oophorectomy|oophorectomy
5661927|NCT00655447|ovarian conservation|ovarian conservation
5661928|NCT00655447|stroke|stroke
5661929|NCT00655447|breast cancer|breast cancer
5661930|NCT00655447|ovarian cancer|ovarian cancer
5661931|NCT00655447|other cancer|other cancer
5661932|NCT00655447|hip fracture|hip fracture
5661933|NCT00655434|Herpes simplex virus 2|herpes simplex virus 2
5661934|NCT00655434|HSV 2|hsv 2
5661935|NCT00655434|Antibody status to Herpesvirus 2, Human|antibody status to herpesvirus 2, human
5661936|NCT00655421|screening|screening
5661937|NCT00655421|oral precancers|oral precancers
5661938|NCT00655421|tobacco users|tobacco users
5661939|NCT00655421|VELScope|velscope
5661940|NCT00655421|Visual Inspection|visual inspection
5661941|NCT00655421|Toluidine Blue|toluidine blue
5661942|NCT00655408|Infants|infants
5661943|NCT00655408|Prevalence|prevalence
5661944|NCT00655408|Iron|iron
5661945|NCT00655408|Deficiency|deficiency
5661946|NCT00655408|Treatment|treatment
5661947|NCT00655395|Leukemia|leukemia
5661949|NCT00655382|dynamic pelvic mri|dynamic pelvic mri
5661950|NCT00655382|dynamic mri|dynamic mri
5661951|NCT00655382|STARR procedure|starr procedure
5661952|NCT00655382|STARR|starr
5661953|NCT00655382|ODS|ods
5661954|NCT00655382|obstructive defecation syndrome|obstructive defecation syndrome
5661955|NCT00655382|outlet obstruction|outlet obstruction
5661956|NCT00655382|obstructed defecation|obstructed defecation
5661957|NCT00655382|stapled trans anal rectal resection|stapled trans anal rectal resection
5661958|NCT00655356|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
5661959|NCT00655343|GvHD|gvhd
5661960|NCT00655343|aGvHD prophylaxis|agvhd prophylaxis
5661961|NCT00655343|Matched unrelated donor|matched unrelated donor
5661962|NCT00655343|ATG|atg
5661963|NCT00655343|SCT|sct
5661964|NCT00655343|BMT|bmt
5661965|NCT00655343|polyclonal antibody|polyclonal antibody
5661966|NCT00655343|GvHD prophylaxis for patients with ALL, AML, CML, MDS, OMF|gvhd prophylaxis for patients with all, aml, cml, mds, omf
5661967|NCT00655343|Patients with allogeneic BM or PBSC transplantation|patients with allogeneic bm or pbsc transplantation
5661968|NCT00655343|Patients with a matched unrelated donor|patients with a matched unrelated donor
5661969|NCT00655330|Type 2 diabetes mellitus|type 2 diabetes mellitus
5661970|NCT00655330|Nephropathy|nephropathy
5661971|NCT00655330|valsartan|valsartan
5661972|NCT00655330|probucol|probucol
5661973|NCT00655330|Proteinuria|proteinuria
5661974|NCT00655317|acupuncture|acupuncture
5661975|NCT00655317|colon surgery|colon surgery
5661976|NCT00655317|post operative ileus|post operative ileus
5661977|NCT00655317|post ileus|post ileus
5661978|NCT00655317|ileus|ileus
5661979|NCT00655317|colectomy|colectomy
5661980|NCT00655317|colorectal pathology|colorectal pathology
5661981|NCT00655291|pain|pain
5661982|NCT00655278|Movement Disorder|movement disorder
5661983|NCT00655252|Expanded access|expanded access
5661984|NCT00655252|metastatic renal cell cancer|metastatic renal cell cancer
5661985|NCT00655252|progression despite VEGF receptors|progression despite vegf receptors
5661986|NCT00655239|Ultra High Risk of Schizophrenia|ultra high risk of schizophrenia
5661987|NCT00655239|Prodrome|prodrome
5661988|NCT00655239|Psychosis|psychosis
5661989|NCT00655239|Schizophrenia|schizophrenia
5661990|NCT00655239|Cognitive Remediation|cognitive remediation
5661991|NCT00655226|Cognitive Behavior Therapy|cognitive behavior therapy
5661992|NCT00655226|Interferon-alpha|interferon-alpha
5662195|NCT00654446|Renal|renal
5661995|NCT00655226|Depression|depression
5661996|NCT00655226|Hepatitis, Chronic|hepatitis, chronic
5661997|NCT00655226|Interferons|interferons
5661998|NCT00655226|Ribavirin|ribavirin
5661999|NCT00655226|Hepatitis, Viral, Human|hepatitis, viral, human
5662000|NCT00655226|Infection|infection
5662001|NCT00655226|Hepatitis|hepatitis
5662002|NCT00655226|Mood Disorders|mood disorders
5662003|NCT00655226|Peginterferon alfa-2a|peginterferon alfa-2a
5662004|NCT00655226|Hepatitis C|hepatitis c
5662005|NCT00655226|Interferon Alfa-2a|interferon alfa-2a
5662006|NCT00655226|Interferon Alfa-2b|interferon alfa-2b
5662007|NCT00655226|Depressive Disorder, Major|depressive disorder, major
5662008|NCT00655226|Depressive Disorder|depressive disorder
5662009|NCT00655213|Pacing, AV conduction disorders, minimized ventricular pacing, AF|pacing, av conduction disorders, minimized ventricular pacing, af
5662010|NCT00655174|autism|autism
5662011|NCT00655174|fluvoxamine|fluvoxamine
5662012|NCT00655174|sertraline|sertraline
5662013|NCT00655174|selective seratonin reuptake inhibitors|selective seratonin reuptake inhibitors
5662014|NCT00655174|paediatrics|paediatrics
5662015|NCT00655161|NSCLC|nsclc
5662016|NCT00655161|Cancer Immunotherapy|cancer immunotherapy
5662017|NCT00655148|DTaP-IPV|dtap-ipv
5662018|NCT00655148|Clinical Trial|clinical trial
5662019|NCT00655148|Safety|safety
5662020|NCT00655148|Immunogenicity|immunogenicity
5662021|NCT00655109|Allergic conjunctivitis|allergic conjunctivitis
5662022|NCT00655109|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5662026|NCT00655083|Infantile colic|infantile colic
5662027|NCT00655083|Abdominal Cramps|abdominal cramps
5662028|NCT00655083|Colicky Pain|colicky pain
5662029|NCT00655083|Functional gastrointestinal disorders|functional gastrointestinal disorders
5662030|NCT00655070|Hibernating Myocardium|hibernating myocardium
5662031|NCT00655070|Blood Flow|blood flow
5662032|NCT00655070|Ultrasound|ultrasound
5662033|NCT00655070|PET imaging|pet imaging
5662034|NCT00655057|Dopamine Transporter|dopamine transporter
5662035|NCT00655057|Biomarker|biomarker
5662036|NCT00655057|SPECT Brain Imaging|spect brain imaging
5662037|NCT00655057|Antidepressant Therapy|antidepressant therapy
5662038|NCT00655031|Punicaceae|punicaceae
5662039|NCT00655031|Pomegranate|pomegranate
5662040|NCT00655018|Non-Alcoholic Fatty Liver Disease (NAFLD)|non-alcoholic fatty liver disease (nafld)
5662041|NCT00655018|Non-Alcoholic Steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5662042|NCT00655018|Liver histology|liver histology
5662043|NCT00655018|Insulin Resistance|insulin resistance
5662044|NCT00655018|Weight loss|weight loss
5662045|NCT00655018|Alpha-tocopherol|alpha-tocopherol
5662046|NCT00655018|ascorbic acid|ascorbic acid
5662047|NCT00655005|head and neck cancer|head and neck cancer
5662048|NCT00654966|Urotensin II|urotensin ii
5662049|NCT00654966|Soluble epoxide hydrolase|soluble epoxide hydrolase
5662050|NCT00654966|Iontophoresis|iontophoresis
5662051|NCT00654966|Healthy volunteers|healthy volunteers
5662052|NCT00654953|cocaine dependence|cocaine dependence
5662053|NCT00654953|depressive symptoms|depressive symptoms
5662054|NCT00654953|relapse|relapse
5662055|NCT00654953|sertraline|sertraline
5662056|NCT00654953|gabapentin|gabapentin
5662057|NCT00654927|multiple sclerosis|multiple sclerosis
5662059|NCT00654927|walking|walking
5662060|NCT00654927|leg strength|leg strength
5662061|NCT00654927|demyelination|demyelination
5662062|NCT00654914|Sexual Dysfunction|sexual dysfunction
5662063|NCT00654901|Diphtheria|diphtheria
5662064|NCT00654901|Tetanus|tetanus
5662065|NCT00654901|Pertussis|pertussis
5662066|NCT00654901|Hepatitis B|hepatitis b
5662067|NCT00654901|Poliomyelitis|poliomyelitis
5662068|NCT00654901|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
5662069|NCT00654901|Haemophilus Influenzae Type B Infection|haemophilus influenzae type b infection
5662070|NCT00654888|cataract extraction|cataract extraction
5662071|NCT00654888|surgery|surgery
5662072|NCT00654888|corneal disease|corneal disease
5662073|NCT00654875|Essential Hypertension|essential hypertension
5662074|NCT00654849|Electrosurgery|electrosurgery
5662075|NCT00654849|Gyrus Pk|gyrus pk
5662076|NCT00654849|abdominal hysterectomy|abdominal hysterectomy
5662077|NCT00654849|Blood Loss, Surgical|blood loss, surgical
5662078|NCT00654849|Length of stay|length of stay
5662079|NCT00654849|Overall cost|overall cost
5662080|NCT00654836|recurrent breast cancer|recurrent breast cancer
5662081|NCT00654836|stage III breast cancer|stage iii breast cancer
5662082|NCT00654836|stage IV breast cancer|stage iv breast cancer
5662083|NCT00654810|functional ability|functional ability
5662084|NCT00654810|gait|gait
5662085|NCT00654810|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5662086|NCT00654810|peripheral blood vessel disorder|peripheral blood vessel disorder
5662087|NCT00654797|Glucose|glucose
5662088|NCT00654797|Insulin|insulin
5662089|NCT00654797|computer|computer
5662090|NCT00654797|critical care|critical care
5662091|NCT00654784|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5662093|NCT00654784|Duchenne|duchenne
5662094|NCT00654771|protein/creatinine ratio|protein/creatinine ratio
5662095|NCT00654771|clean catch urine|clean catch urine
5662096|NCT00654771|catheterized urine|catheterized urine
5662097|NCT00654758|cancer|cancer
5662098|NCT00654758|carcinoma|carcinoma
5662099|NCT00654758|chemotherapy|chemotherapy
5662100|NCT00654758|monoclonal antibody therapy|monoclonal antibody therapy
5662101|NCT00654758|anti-angiogenesis|anti-angiogenesis
5662105|NCT00654706|Schizophrenia|schizophrenia
5662106|NCT00654706|Cognition|cognition
5662107|NCT00654706|MATRICS Consensus Cognitive Battery|matrics consensus cognitive battery
5662108|NCT00654693|NTX|ntx
5662109|NCT00654693|Nihon Kohden|nihon kohden
5662110|NCT00654693|mobile monitoring|mobile monitoring
5662111|NCT00654693|monitoring|monitoring
5662112|NCT00654693|nihon|nihon
5662113|NCT00654693|kohden|kohden
5662114|NCT00654693|monitoring device|monitoring device
5662115|NCT00654693|remote monitoring|remote monitoring
5662116|NCT00654693|wireless|wireless
5662117|NCT00654680|Erectile Dysfunction|erectile dysfunction
5662118|NCT00654680|Traumatic spinal cord injury|traumatic spinal cord injury
5662119|NCT00654680|Vardenafil|vardenafil
5662120|NCT00654667|Resveratrol|resveratrol
5662121|NCT00654667|Insulin Resistance|insulin resistance
5662122|NCT00654667|Metabolic Syndrome|metabolic syndrome
5662123|NCT00654667|Sirtuin 1|sirtuin 1
5662124|NCT00654667|IGF-1|igf-1
5662125|NCT00654667|Satiety|satiety
5662126|NCT00654667|Leptin|leptin
5662127|NCT00654667|Adiponectin|adiponectin
5662128|NCT00654641|Surgical Wound Dehiscence|surgical wound dehiscence
5662129|NCT00654641|Wound Infection|wound infection
5662130|NCT00654641|Obesity|obesity
5662131|NCT00654641|Cesarean Delivery|cesarean delivery
5662132|NCT00654641|Wound Closure|wound closure
5662133|NCT00654641|Negative Pressure wound closure|negative pressure wound closure
5662134|NCT00654615|unstable metaphyseal distal radius fractures|unstable metaphyseal distal radius fractures
5662135|NCT00654615|randomized controlled trial|randomized controlled trial
5662136|NCT00654615|surgical fixation|surgical fixation
5662137|NCT00654615|volar plate|volar plate
5662142|NCT00654602|Rosuvastatin|rosuvastatin
5662143|NCT00654602|Crestor|crestor
5662144|NCT00654589|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5662145|NCT00654589|HCT|hct
5662146|NCT00654589|iron overload|iron overload
5662147|NCT00654589|chelators|chelators
5662148|NCT00654589|ICL670|icl670
5662149|NCT00654589|deferasirox|deferasirox
5662150|NCT00654589|serum ferritin|serum ferritin
5662151|NCT00654589|LIC|lic
5662152|NCT00654589|transfusional hemosiderosis|transfusional hemosiderosis
5662153|NCT00654589|blood transfusions|blood transfusions
5662154|NCT00654589|adults|adults
5662155|NCT00654589|iron chelation|iron chelation
5662156|NCT00654589|3-6 months|3-6 months
5662157|NCT00654589|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5662158|NCT00654576|schizophrenia|schizophrenia
5662159|NCT00654576|antipsychotic|antipsychotic
5662160|NCT00654576|outcome|outcome
5662161|NCT00654576|psychosocial intervention|psychosocial intervention
5662162|NCT00654563|Memory Disorders|memory disorders
5662163|NCT00654563|Memory loss|memory loss
5662164|NCT00654563|Age Associated Memory Impairment|age associated memory impairment
5662165|NCT00654550|Photorefractive keratectomy|photorefractive keratectomy
5662166|NCT00654550|Re-epithelialization|re-epithelialization
5662167|NCT00654550|Nexagon|nexagon
5662168|NCT00654550|PRK|prk
5662169|NCT00654550|Coda|coda
5662170|NCT00654537|Cholesterol|cholesterol
5662171|NCT00654537|hypercholesterolemia|hypercholesterolemia
5662172|NCT00654537|low density lipoproteins|low density lipoproteins
5662173|NCT00654524|Endometriosis|endometriosis
5662174|NCT00654524|Recurrence|recurrence
5662175|NCT00654524|Pregnancy Rate|pregnancy rate
5662176|NCT00654524|Laparoscopy|laparoscopy
5662177|NCT00654524|Gonadotropin-Releasing Hormone|gonadotropin-releasing hormone
5662178|NCT00654511|Dexmedetomidine,|dexmedetomidine,
5662179|NCT00654511|fentanyl,|fentanyl,
5662180|NCT00654511|tonsillectomy|tonsillectomy
5662181|NCT00654511|and adenoidectomy,|and adenoidectomy,
5662182|NCT00654485|Cholesterol|cholesterol
5662183|NCT00654485|hypercholesterolemia|hypercholesterolemia
5662184|NCT00654485|low density lipoproteins|low density lipoproteins
5662185|NCT00654485|metabolic syndrome|metabolic syndrome
5662186|NCT00654485|Rosuvastatin|rosuvastatin
5662187|NCT00654472|magnetic resonance imaging, mitral valve area|magnetic resonance imaging, mitral valve area
5662188|NCT00654446|Cholesterol|cholesterol
5662189|NCT00654446|low density lipoproteins|low density lipoproteins
5662190|NCT00654446|dyslipidaemia|dyslipidaemia
5662191|NCT00654446|Rosuvastatin|rosuvastatin
5662192|NCT00654446|Crestor|crestor
5662193|NCT00654446|Simvastatin|simvastatin
5662194|NCT00654446|Zocor|zocor
5662196|NCT00654446|kidney|kidney
5662197|NCT00654433|Hurler Syndrome|hurler syndrome
5662198|NCT00654433|MPS I|mps i
5662199|NCT00654433|Hurler-Scheie Syndrome|hurler-scheie syndrome
5662200|NCT00654433|Hunter Syndrome|hunter syndrome
5662201|NCT00654433|MPS II|mps ii
5662202|NCT00654433|Sanfilippo Syndrome|sanfilippo syndrome
5662203|NCT00654433|MPS III|mps iii
5662204|NCT00654433|Maroteaux-Lamy Syndrome|maroteaux-lamy syndrome
5662205|NCT00654433|MPS VI|mps vi
5662206|NCT00654433|Krabbe Disease|krabbe disease
5662207|NCT00654433|Globoid Leukodystrophy|globoid leukodystrophy
5662208|NCT00654433|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5662210|NCT00654433|Adrenoleukodystrophy|adrenoleukodystrophy
5662211|NCT00654433|ALD|ald
5662212|NCT00654433|Adrenomyeloneuropathy|adrenomyeloneuropathy
5662213|NCT00654433|AMN|amn
5662214|NCT00654433|Sandhoff Disease|sandhoff disease
5662215|NCT00654433|Tay Sachs Disease|tay sachs disease
5662216|NCT00654433|Pelizaeus Merzbacher|pelizaeus merzbacher
5662217|NCT00654433|PMD|pmd
5662218|NCT00654433|Niemann-Pick Disease A|niemann-pick disease a
5662219|NCT00654433|Niemann-Pick Disease B|niemann-pick disease b
5662220|NCT00654433|Alpha-mannosidosis|alpha-mannosidosis
5662221|NCT00654433|Inherited metabolic diseases|inherited metabolic diseases
5662222|NCT00654433|Inborn errors of metabolism|inborn errors of metabolism
5662223|NCT00654433|Lysosomal storage diseases|lysosomal storage diseases
5662224|NCT00654433|Peroxisomal storage diseases|peroxisomal storage diseases
5662225|NCT00654433|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5662226|NCT00654433|Umbilical cord blood transplantation|umbilical cord blood transplantation
5662227|NCT00654433|Mucopolysaccharidosis|mucopolysaccharidosis
5662228|NCT00654433|Mucopolysaccharidosis I|mucopolysaccharidosis i
5662229|NCT00654433|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5662230|NCT00654433|Mucopolysaccharidosis III|mucopolysaccharidosis iii
5662231|NCT00654433|Mucopolysaccharidosis VI|mucopolysaccharidosis vi
5662232|NCT00654433|I Cell disease|i cell disease
5662233|NCT00654433|Fucosidosis|fucosidosis
5662234|NCT00654433|GM1 Gangliosidosis|gm1 gangliosidosis
5662235|NCT00654433|Canavan Disease|canavan disease
5662236|NCT00654407|Cholesterol|cholesterol
5662237|NCT00654407|hypercholesterolemia|hypercholesterolemia
5662238|NCT00654407|Coronary Heart disease|coronary heart disease
5662239|NCT00654407|low density lipoproteins|low density lipoproteins
5662240|NCT00654407|Rosuvastatin|rosuvastatin
5662241|NCT00654407|Atorvastatin|atorvastatin
5662242|NCT00654407|simvastatin|simvastatin
5662243|NCT00654394|Cholesterol|cholesterol
5662244|NCT00654394|Carotid Artery Stenosis|carotid artery stenosis
5662245|NCT00654394|Hypercholesterolemia|hypercholesterolemia
5662246|NCT00654394|Rosuvastatin|rosuvastatin
5662248|NCT00654368|Amgen|amgen
5662249|NCT00654355|atopic dermatitis|atopic dermatitis
5662250|NCT00654355|eczema|eczema
5662251|NCT00654342|Sentinel lymph node-colon cancer|sentinel lymph node-colon cancer
5662252|NCT00654329|Dexmedetomidine, transmucosal, myringotomy,|dexmedetomidine, transmucosal, myringotomy,
5662253|NCT00654316|TB|tb
5662254|NCT00654316|Tuberculosis|tuberculosis
5662255|NCT00654316|MVA85A|mva85a
5662256|NCT00654316|Vaccine|vaccine
5662257|NCT00654316|BCG|bcg
5662258|NCT00654303|Cholesterol|cholesterol
5662259|NCT00654303|Hypercholesterolaemia|hypercholesterolaemia
5662260|NCT00654303|Statins|statins
5662261|NCT00654290|Atrial fibrillation|atrial fibrillation
5662262|NCT00654290|coronary bypass|coronary bypass
5662263|NCT00654290|Amiodarone|amiodarone
5662264|NCT00654290|Propranolol|propranolol
5662265|NCT00654290|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
5662266|NCT00654277|bioequivalence|bioequivalence
5662267|NCT00654277|Ondansetron ODT|ondansetron odt
5662268|NCT00654277|Fasting|fasting
5662269|NCT00654277|To determine bioequivalence under fasting conditions|to determine bioequivalence under fasting conditions
5662270|NCT00654251|Spinocerebellar ataxia|spinocerebellar ataxia
5662271|NCT00654251|Machado-Joseph disease|machado-joseph disease
5662272|NCT00654251|Gait monitoring|gait monitoring
5662273|NCT00654251|Functional vision assessment|functional vision assessment
5662274|NCT00654238|Thyroid Cancer|thyroid cancer
5662275|NCT00654238|Anaplastic|anaplastic
5662276|NCT00654238|Medullary|medullary
5662277|NCT00654238|sorafenib|sorafenib
5662278|NCT00654225|Cholesterol|cholesterol
5662279|NCT00654225|low density lipoproteins|low density lipoproteins
5662280|NCT00654225|dyslipidaemia|dyslipidaemia
5662281|NCT00654225|Rosuvastatin|rosuvastatin
5662282|NCT00654225|Crestor|crestor
5662283|NCT00654225|Atorvastatin|atorvastatin
5662284|NCT00654225|Lipitor|lipitor
5662285|NCT00654225|South Asian|south asian
5662286|NCT00654212|stenting, laparoscopic surgery, colon cancer|stenting, laparoscopic surgery, colon cancer
5662287|NCT00654199|CABG|cabg
5662288|NCT00654199|Ventricular Asynchrony|ventricular asynchrony
5662289|NCT00654199|Normal Sinus Rhythm|normal sinus rhythm
5662290|NCT00654186|Androgen Independent Prostate Cancer (AIPC)|androgen independent prostate cancer (aipc)
5662291|NCT00654186|Chemo naive|chemo naive
5662292|NCT00654173|Cholesterol|cholesterol
5662293|NCT00654173|low density lipoproteins|low density lipoproteins
5662294|NCT00654173|dyslipidaemia|dyslipidaemia
5662295|NCT00654173|Rosuvastatin|rosuvastatin
5662296|NCT00654173|Crestor|crestor
5662297|NCT00654173|Atorvastatin|atorvastatin
5662298|NCT00654173|Lipitor|lipitor
5662299|NCT00654173|Zocor|zocor
5662300|NCT00654173|simvastatin|simvastatin
5662301|NCT00654160|stage IIIB anal cancer|stage iiib anal cancer
5662302|NCT00654160|stage IV anal cancer|stage iv anal cancer
5662303|NCT00654160|recurrent anal cancer|recurrent anal cancer
5662304|NCT00654160|carcinoma of the appendix|carcinoma of the appendix
5662305|NCT00654160|stage III colon cancer|stage iii colon cancer
5662306|NCT00654160|stage IV colon cancer|stage iv colon cancer
5662307|NCT00654160|recurrent colon cancer|recurrent colon cancer
5662308|NCT00654160|stage III rectal cancer|stage iii rectal cancer
5662309|NCT00654160|stage IV rectal cancer|stage iv rectal cancer
5662310|NCT00654160|recurrent rectal cancer|recurrent rectal cancer
5662311|NCT00654160|stage III esophageal cancer|stage iii esophageal cancer
5662312|NCT00654160|stage IV esophageal cancer|stage iv esophageal cancer
5662313|NCT00654160|recurrent esophageal cancer|recurrent esophageal cancer
5662314|NCT00654160|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5662315|NCT00654160|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5662316|NCT00654160|unresectable gallbladder cancer|unresectable gallbladder cancer
5662317|NCT00654160|recurrent gallbladder cancer|recurrent gallbladder cancer
5662318|NCT00654160|stage III gastric cancer|stage iii gastric cancer
5662319|NCT00654160|stage IV gastric cancer|stage iv gastric cancer
5662320|NCT00654160|recurrent gastric cancer|recurrent gastric cancer
5662321|NCT00654160|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5662322|NCT00654160|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5662323|NCT00654160|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5662324|NCT00654160|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5662325|NCT00654160|advanced adult primary liver cancer|advanced adult primary liver cancer
5789076|NCT00150020|Renal/Kidney|renal/kidney
5662326|NCT00654160|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5662327|NCT00654160|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5662328|NCT00654160|stage II pancreatic cancer|stage ii pancreatic cancer
5662329|NCT00654160|stage III pancreatic cancer|stage iii pancreatic cancer
5662330|NCT00654160|stage IV pancreatic cancer|stage iv pancreatic cancer
5662331|NCT00654160|recurrent pancreatic cancer|recurrent pancreatic cancer
5662332|NCT00654160|recurrent small intestine cancer|recurrent small intestine cancer
5662333|NCT00654160|small intestine adenocarcinoma|small intestine adenocarcinoma
5662334|NCT00654160|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5662335|NCT00654160|small intestine lymphoma|small intestine lymphoma
5662337|NCT00654147|antiretroviral therapy naive|antiretroviral therapy naive
5662338|NCT00654147|Integrase inhibitor|integrase inhibitor
5662339|NCT00654147|HIV/AIDS|hiv/aids
5662340|NCT00654147|treatment naïve|treatment naïve
5662341|NCT00654121|prevention|prevention
5662342|NCT00654108|Escherichia coli, cholera, diarrhea, vaccine|escherichia coli, cholera, diarrhea, vaccine
5662343|NCT00654069|Pain|pain
5662344|NCT00654056|Type 2 diabetes|type 2 diabetes
5662345|NCT00654056|Severe insulin resistance|severe insulin resistance
5662346|NCT00654043|Bioequivalence|bioequivalence
5662347|NCT00654043|Torsemide Tablets|torsemide tablets
5662349|NCT00654043|To determine bioequivalence under fed conditions.|to determine bioequivalence under fed conditions.
5662350|NCT00654030|Lung Cancer Vaccine|lung cancer vaccine
5662351|NCT00654030|Early Stage Lung Cancer|early stage lung cancer
5662352|NCT00654030|Lung Cancer|lung cancer
5662353|NCT00654004|trifunctional|trifunctional
5662354|NCT00654004|protein|protein
5662355|NCT00654004|deficiency|deficiency
5662356|NCT00654004|TFP|tfp
5662357|NCT00654004|weight|weight
5662358|NCT00654004|regulation|regulation
5662359|NCT00653991|HIV/AIDS Prevention|hiv/aids prevention
5662360|NCT00653991|Men Who Have Sex With Men (MSM)|men who have sex with men (msm)
5662361|NCT00653991|Risky Sexual Behavior|risky sexual behavior
5662362|NCT00653991|Socially Optimized Learning in a Virtual Environment (SOLVE)|socially optimized learning in a virtual environment (solve)
5662363|NCT00653991|HIV Seronegativity|hiv seronegativity
5662364|NCT00653978|ERCP|ercp
5662365|NCT00653978|cholangiocarcinoma|cholangiocarcinoma
5662366|NCT00653978|hilar stricture|hilar stricture
5662367|NCT00653965|Cholesterol|cholesterol
5662368|NCT00653965|low density lipoproteins|low density lipoproteins
5662369|NCT00653965|dyslipidaemia|dyslipidaemia
5662370|NCT00653965|Rosuvastatin|rosuvastatin
5662371|NCT00653965|Crestor|crestor
5662372|NCT00653965|Atorvastatin|atorvastatin
5662373|NCT00653965|Lipitor|lipitor
5662374|NCT00653965|Hispanic|hispanic
5662375|NCT00653952|Paclitaxel HCl|paclitaxel hcl
5662376|NCT00653952|CAELYX|caelyx
5662377|NCT00653952|DOXIL|doxil
5662378|NCT00653952|Ovarian Carcinoma|ovarian carcinoma
5662379|NCT00653952|Doxorubicin HCl|doxorubicin hcl
5662380|NCT00653939|non-small cell lung cancer|non-small cell lung cancer
5662381|NCT00653939|non-small cell lung carcinoma|non-small cell lung carcinoma
5662382|NCT00653939|neoplasms, lung|neoplasms, lung
5662383|NCT00653939|lung cancer|lung cancer
5662384|NCT00653939|tumors|tumors
5662385|NCT00653939|NSCLC|nsclc
5662386|NCT00653926|Postoperative pain|postoperative pain
5662387|NCT00653926|Local infiltration analgesia|local infiltration analgesia
5662388|NCT00653926|Knee arthroplasty|knee arthroplasty
5662389|NCT00653926|Postoperative pain management following unicompartmental knee arthroplasty|postoperative pain management following unicompartmental knee arthroplasty
5662391|NCT00653900|platelet function|platelet function
5662392|NCT00653900|platelet function testing|platelet function testing
5853923|NCT00002042|Anemia|anemia
5662393|NCT00653900|bleeding risk|bleeding risk
5662394|NCT00653900|periprocedural bleeding|periprocedural bleeding
5662395|NCT00653900|clopidogrel|clopidogrel
5662396|NCT00653900|Our initial goal is to establish if a certain degree of|our initial goal is to establish if a certain degree of
5662397|NCT00653900|platelet function abnormality can predict a higher bleeding|platelet function abnormality can predict a higher bleeding
5662398|NCT00653900|or higher transfusions.|or higher transfusions.
5662399|NCT00653887|Biofeedback|biofeedback
5662400|NCT00653887|anal sphincter|anal sphincter
5662401|NCT00653887|cortical excitability|cortical excitability
5662402|NCT00653887|magnetic stimulation|magnetic stimulation
5662403|NCT00653887|incontinence|incontinence
5662404|NCT00653887|constipation|constipation
5662405|NCT00653874|jaundice|jaundice
5662406|NCT00653874|neonates|neonates
5662407|NCT00653874|transcutaneous bilirubinometry|transcutaneous bilirubinometry
5662408|NCT00653874|clinical assessment of bilirubin|clinical assessment of bilirubin
5662409|NCT00653861|Aesthetic correction|aesthetic correction
5662410|NCT00653848|Adjuvant treatment, high risk, radical radiotherapy|adjuvant treatment, high risk, radical radiotherapy
5662411|NCT00653822|Amevive|amevive
5662412|NCT00653822|alefacept|alefacept
5662413|NCT00653822|pharmacokinetics|pharmacokinetics
5662414|NCT00653822|Japanese|japanese
5662415|NCT00653783|Parkinson disease|parkinson disease
5662416|NCT00653783|Multiple System Atrophy|multiple system atrophy
5662418|NCT00653783|Progressive Supranuclear Palsy|progressive supranuclear palsy
5662420|NCT00653783|observational|observational
5662421|NCT00653783|biomarker|biomarker
5680414|NCT00577824|exenatide|exenatide
5662422|NCT00653757|stage I prostate cancer|stage i prostate cancer
5662423|NCT00653757|stage II prostate cancer|stage ii prostate cancer
5662424|NCT00653757|stage III prostate cancer|stage iii prostate cancer
5662425|NCT00653757|stage IV prostate cancer|stage iv prostate cancer
5662426|NCT00653744|Cholesterol|cholesterol
5662427|NCT00653744|low density lipoproteins|low density lipoproteins
5662428|NCT00653744|dyslipidaemia|dyslipidaemia
5662429|NCT00653744|Rosuvastatin|rosuvastatin
5662431|NCT00653744|Atorvastatin|atorvastatin
5662432|NCT00653744|Lipitor|lipitor
5662433|NCT00653744|African American|african american
5662434|NCT00653731|dementia|dementia
5662435|NCT00653731|snoezelen|snoezelen
5662436|NCT00653731|structured reminiscence therapy|structured reminiscence therapy
5662437|NCT00653731|10-minutes activation|10-minutes activation
5662438|NCT00653731|apathy|apathy
5662439|NCT00653718|Pain|pain
5662440|NCT00653718|Characterize musculoskeletal pain|characterize musculoskeletal pain
5662441|NCT00653718|Breast cancer patients treated with aromatase inhibitors|breast cancer patients treated with aromatase inhibitors
5662442|NCT00653705|Probiotics|probiotics
5662443|NCT00653705|Children|children
5662444|NCT00653705|Child Care Center|child care center
5662445|NCT00653705|Nutrition|nutrition
5662446|NCT00653705|Health promotion|health promotion
5662447|NCT00653692|Substance abuse|substance abuse
5662448|NCT00653692|fetal development|fetal development
5662449|NCT00653692|vagal tone|vagal tone
5662450|NCT00653679|exercise|exercise
5662451|NCT00653679|muscle protein signalling|muscle protein signalling
5662452|NCT00653679|protein synthesis|protein synthesis
5662453|NCT00653666|CPT1A|cpt1a
5662454|NCT00653666|steatosis|steatosis
5662455|NCT00653666|deficiency|deficiency
5662456|NCT00653666|metabolic|metabolic
5662457|NCT00653666|response|response
5662458|NCT00653666|fasting|fasting
5662459|NCT00653653|pharmacogenetics|pharmacogenetics
5662460|NCT00653653|pharmacoeconomics|pharmacoeconomics
5662461|NCT00653653|adverse events|adverse events
5662462|NCT00653653|drug metabolism|drug metabolism
5662463|NCT00653640|rehabilitation|rehabilitation
5662464|NCT00653640|head injury|head injury
5662465|NCT00653640|3 months post injury|3 months post injury
5662466|NCT00653640|require manual assistance or walking aids to walk|require manual assistance or walking aids to walk
5662467|NCT00653640|very slow walking speed|very slow walking speed
5662468|NCT00653640|able to follow two step commands|able to follow two step commands
5662469|NCT00653614|Oral contraception|oral contraception
5662470|NCT00653601|GPI|gpi
5662471|NCT00653601|glycoprotein IIb/IIIa inhibitor|glycoprotein iib/iiia inhibitor
5662472|NCT00653601|Aggrastat|aggrastat
5662473|NCT00653601|Tirofiban|tirofiban
5662474|NCT00653601|Verify now|verify now
5662475|NCT00653601|platelet function testing|platelet function testing
5662476|NCT00653601|bridge therapy|bridge therapy
5662477|NCT00653588|Cholesterol|cholesterol
5662478|NCT00653588|low density lipoproteins|low density lipoproteins
5662479|NCT00653588|Hypercholesterolemia|hypercholesterolemia
5662480|NCT00653588|Coronary Heart Disease|coronary heart disease
5662481|NCT00653588|Rosuvastatin|rosuvastatin
5662482|NCT00653588|Crestor|crestor
5662483|NCT00653588|Atorvastatin|atorvastatin
5662484|NCT00653588|Lipitor|lipitor
5662485|NCT00653575|Sexual Behavior|sexual behavior
5662486|NCT00653575|HIV|hiv
5664944|NCT00641303|fatigue|fatigue
5662487|NCT00653575|Sexually Transmitted Diseases|sexually transmitted diseases
5904185|NCT00050310|Anthrax|anthrax
5662489|NCT00653562|zolpidem|zolpidem
5662490|NCT00653562|Sleep disorders|sleep disorders
5662491|NCT00653562|adolescent|adolescent
5662492|NCT00653549|Bioequivalence|bioequivalence
5662493|NCT00653549|Torsemide Tablets|torsemide tablets
5662495|NCT00653536|stroke|stroke
5662496|NCT00653536|neuroflo|neuroflo
5662497|NCT00653536|device|device
5662498|NCT00653536|failure to recanalize|failure to recanalize
5662499|NCT00653510|Type 2 diabetes|type 2 diabetes
5662500|NCT00653510|Dysregulation|dysregulation
5662501|NCT00653510|Metabolism|metabolism
5662502|NCT00653510|Cardiac output|cardiac output
5662503|NCT00653497|Osteoarthritis|osteoarthritis
5662504|NCT00653484|colon cancer|colon cancer
5662505|NCT00653484|rectal cancer|rectal cancer
5662506|NCT00653484|obesity|obesity
5662507|NCT00653471|obesity|obesity
5662508|NCT00653471|osa|osa
5662509|NCT00653471|capnography|capnography
5662510|NCT00653471|general anesthesia|general anesthesia
5662511|NCT00653458|bioequivalence|bioequivalence
5662512|NCT00653458|Ondansetron ODT|ondansetron odt
5662513|NCT00653458|fed|fed
5662514|NCT00653458|To determine bioequivalence under fed conditions|to determine bioequivalence under fed conditions
5662515|NCT00653445|Low density lipoproteins|low density lipoproteins
5662516|NCT00653445|Hypercholesterolemia|hypercholesterolemia
5662517|NCT00653445|Coronary Heart Disease|coronary heart disease
5662518|NCT00653445|Rosuvastatin|rosuvastatin
5662519|NCT00653445|Crestor|crestor
5662520|NCT00653445|Ezetimibe|ezetimibe
5662521|NCT00653432|Treatment|treatment
5662522|NCT00653432|Osteoarthritis|osteoarthritis
5662529|NCT00653406|Pharmacokinetics|pharmacokinetics
5662530|NCT00653393|bioequivalence, single- dose, fasting|bioequivalence, single- dose, fasting
5662531|NCT00653380|bioequivalence|bioequivalence
5662532|NCT00653380|doxycycline monohydrate|doxycycline monohydrate
5662534|NCT00653367|Thoracotomy|thoracotomy
5662535|NCT00653367|Nerve section|nerve section
5662536|NCT00653367|QST|qst
5662537|NCT00653367|Quantitative Sensory Test|quantitative sensory test
5662538|NCT00653367|Muscle sparing Posterolateral thoracotomy|muscle sparing posterolateral thoracotomy
5662539|NCT00653367|Chest|chest
5662540|NCT00653367|Wall|wall
5662541|NCT00653367|Surgical|surgical
5662542|NCT00653367|Incision|incision
5662543|NCT00653367|Tumors or cancer of the lung|tumors or cancer of the lung
5662544|NCT00653354|hallux valgus|hallux valgus
5662545|NCT00653341|insulin naive|insulin naive
5662546|NCT00653328|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5662547|NCT00653328|fallopian tube cancer|fallopian tube cancer
5662548|NCT00653328|peritoneal cavity cancer|peritoneal cavity cancer
5662549|NCT00653315|Bioequivalence, Tramadol APAP, fasting|bioequivalence, tramadol apap, fasting
5662550|NCT00653263|methamphetamine|methamphetamine
5662551|NCT00653263|drug abuse|drug abuse
5662552|NCT00653263|withdrawal|withdrawal
5662553|NCT00653250|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5662554|NCT00653250|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5662555|NCT00653250|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5662556|NCT00653224|levocetirizine|levocetirizine
5662557|NCT00653224|Xyzal|xyzal
5662558|NCT00653224|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5662559|NCT00653224|total symptom score|total symptom score
5662560|NCT00653224|quality of life|quality of life
5662561|NCT00653198|Rotavirus severe gastroenteritis (RV SGE)|rotavirus severe gastroenteritis (rv sge)
5662562|NCT00653185|Glucose Metabolism Disorder|glucose metabolism disorder
5662563|NCT00653185|Dysmetabolic Syndrome|dysmetabolic syndrome
5662564|NCT00653185|Type II Diabetes|type ii diabetes
5662565|NCT00653185|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5662566|NCT00653185|Dyslipidemia|dyslipidemia
5662567|NCT00653185|Hyperglycemia|hyperglycemia
5662568|NCT00653172|CAP|cap
5662569|NCT00653172|community acquired pneumonia|community acquired pneumonia
5662570|NCT00653159|Intrauterine device, contraception, unplanned pregnancy|intrauterine device, contraception, unplanned pregnancy
5662571|NCT00653146|cervical cancer|cervical cancer
5662572|NCT00653146|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5662573|NCT00653146|human papilloma virus infection|human papilloma virus infection
5662574|NCT00653146|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5662575|NCT00653146|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5662576|NCT00653133|ultrasonography|ultrasonography
5662577|NCT00653133|peripheral nerve block|peripheral nerve block
5662578|NCT00653133|peripheral nerve stimulation|peripheral nerve stimulation
5662872|NCT00651820|scarring|scarring
5662579|NCT00653120|Bioequivalence, Propranolol ER capsules, fasting|bioequivalence, propranolol er capsules, fasting
5662580|NCT00653107|Palliation|palliation
5662581|NCT00653107|Cancer oesophagus|cancer oesophagus
5662583|NCT00653107|Brachytherapy|brachytherapy
5662584|NCT00653107|Randomized|randomized
5662585|NCT00653094|crohn|crohn
5662586|NCT00653094|fistula|fistula
5662587|NCT00653094|surgery|surgery
5662588|NCT00653094|fibrin glue|fibrin glue
5662589|NCT00653094|seton drainage|seton drainage
5662590|NCT00653081|Shoulder pain|shoulder pain
5662591|NCT00653081|Supervised Exercises|supervised exercises
5662592|NCT00653081|Radial Shock Wave Therapy|radial shock wave therapy
5662593|NCT00653055|Bioequivalence|bioequivalence
5662594|NCT00653055|Cabergoline|cabergoline
5662595|NCT00653055|Fasting|fasting
5662596|NCT00653042|Myocardial Ischemia|myocardial ischemia
5662597|NCT00653042|kidney failure|kidney failure
5662598|NCT00653042|CABG|cabg
5662599|NCT00653042|cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
5662600|NCT00653042|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5662601|NCT00653042|heart surgery|heart surgery
5662602|NCT00653042|nesiritide|nesiritide
5662603|NCT00653042|Coronary Heart Disease|coronary heart disease
5662604|NCT00653029|Post concussion syndrome|post concussion syndrome
5662605|NCT00653029|Mild traumatic brain injury|mild traumatic brain injury
5662606|NCT00653029|Effort|effort
5662607|NCT00653029|fmri|fmri
5662608|NCT00653016|Contraception|contraception
5662609|NCT00653016|norelgestromin|norelgestromin
5662610|NCT00653016|ethinyl estradiol|ethinyl estradiol
5656050|NCT00678132|Neoplasms|neoplasms
5662614|NCT00653003|Bioequivalence, Leflunomide, fed|bioequivalence, leflunomide, fed
5662616|NCT00652977|Ritgen maneuver|ritgen maneuver
5662617|NCT00652977|perineal tears|perineal tears
5662618|NCT00652977|prevention|prevention
5662619|NCT00652977|delivery|delivery
5662620|NCT00652964|sleep apnea, PHOX2B, hypoventilation, polysomnography|sleep apnea, phox2b, hypoventilation, polysomnography
5662621|NCT00652938|Co-administration|co-administration
5662622|NCT00652938|HPV vaccine|hpv vaccine
5662623|NCT00652938|Cervical cancer|cervical cancer
5662624|NCT00652925|arthritis|arthritis
5662625|NCT00652925|juvenile|juvenile
5662626|NCT00652912|bioequivalence, Clonazepam ODT , fasting|bioequivalence, clonazepam odt , fasting
5662627|NCT00652899|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5662628|NCT00652899|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5662629|NCT00652899|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5662630|NCT00652899|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5662631|NCT00652899|fallopian tube cancer|fallopian tube cancer
5662632|NCT00652899|peritoneal cavity cancer|peritoneal cavity cancer
5662633|NCT00652886|Bioequivalence, Oxandrolone,fasting|bioequivalence, oxandrolone,fasting
5662634|NCT00652873|Bioequivalence|bioequivalence
5662635|NCT00652873|Cabergoline|cabergoline
5662636|NCT00652873|Fed|fed
5662637|NCT00652860|lung metastases|lung metastases
5662638|NCT00652860|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5662639|NCT00652834|Renal transplant recipients|renal transplant recipients
5662640|NCT00652834|Gastrointestinal findings in small bowel capsule endoscopy|gastrointestinal findings in small bowel capsule endoscopy
5662641|NCT00652834|Mycophenolic acid|mycophenolic acid
5662642|NCT00652834|Mycophenolate Mofetil|mycophenolate mofetil
5662643|NCT00652834|Mycophenolate Sodium|mycophenolate sodium
5662644|NCT00652821|bioequivalence, single-dose, fed|bioequivalence, single-dose, fed
5662645|NCT00652808|knee, OA patients|knee, oa patients
5662646|NCT00652795|bioequivalence|bioequivalence
5662647|NCT00652795|doxycycline monohydrate|doxycycline monohydrate
5662648|NCT00652795|fasting|fasting
5662649|NCT00652769|Lung|lung
5662650|NCT00652769|Cancer|cancer
5662651|NCT00652769|Staging|staging
5662652|NCT00652769|Endobronchial|endobronchial
5662653|NCT00652769|Ultrasound|ultrasound
5662654|NCT00652769|Endoscopic|endoscopic
5662655|NCT00652756|Respiration, Artificial|respiration, artificial
5662656|NCT00652756|Transportation of Patients|transportation of patients
5662657|NCT00652756|Intubation, Intratracheal|intubation, intratracheal
5662658|NCT00652756|Tracheostomy|tracheostomy
5662659|NCT00652743|immunogenicity|immunogenicity
5662660|NCT00652743|safety|safety
5662661|NCT00652743|GSK pandemic candidate vaccine|gsk pandemic candidate vaccine
5662662|NCT00652730|bioequivalence|bioequivalence
5662663|NCT00652730|buspirone HCl|buspirone hcl
5662664|NCT00652730|fed|fed
5662665|NCT00652704|Bioequivalence|bioequivalence
5662666|NCT00652704|Doxycycline Monohydrate|doxycycline monohydrate
5662667|NCT00652704|Fed|fed
5662668|NCT00652691|peritoneal cavity cancer|peritoneal cavity cancer
5662669|NCT00652691|ovarian clear cell tumor with proliferating activity|ovarian clear cell tumor with proliferating activity
5662670|NCT00652691|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5662671|NCT00652691|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5662672|NCT00652691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5662771|NCT00652249|Hydrocephalus|hydrocephalus
5662673|NCT00652691|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5665140|NCT00640497|Ricin A|ricin a
5662674|NCT00652691|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5662675|NCT00652691|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5662676|NCT00652678|Breast cancer|breast cancer
5662677|NCT00652678|Radiation effects|radiation effects
5662678|NCT00652665|Bioequivalence, single-dose, fasting|bioequivalence, single-dose, fasting
5662679|NCT00652652|Congestive Heart Failure (CHF)|congestive heart failure (chf)
5662680|NCT00652652|Heart Failure|heart failure
5662681|NCT00652652|Chronic Heart Failure|chronic heart failure
5662683|NCT00652652|nesiritide|nesiritide
5662684|NCT00652652|Natrecor|natrecor
5662685|NCT00652639|bioequivalence, Clonazepam tablets, fasting|bioequivalence, clonazepam tablets, fasting
5662686|NCT00652626|MDS|mds
5662687|NCT00652626|AML|aml
5662688|NCT00652626|Solid Tumors|solid tumors
5662689|NCT00652626|Azacitidine|azacitidine
5662690|NCT00652626|PK|pk
5662691|NCT00652626|Pharmacokinetics|pharmacokinetics
5662692|NCT00652626|Renal Impairment|renal impairment
5662693|NCT00652626|Multiple Myeloma|multiple myeloma
5662694|NCT00652626|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5662695|NCT00652626|Hodgkin's Disease|hodgkin's disease
5662697|NCT00652613|IMRT|imrt
5662698|NCT00652613|HNSCC|hnscc
5662699|NCT00652613|Quality of life|quality of life
5662700|NCT00652613|Major salivary gland sparing|major salivary gland sparing
5662701|NCT00652613|Pattern of local and loco-regional recurrence|pattern of local and loco-regional recurrence
5662702|NCT00652613|Disease Free Survival (DFS) & Overall Survival (OAS)|disease free survival (dfs) & overall survival (oas)
5662703|NCT00652613|Dose reduction to normal structures with IMRT|dose reduction to normal structures with imrt
5662704|NCT00652600|Bioequivalence, Propranolol ER capsules, fed|bioequivalence, propranolol er capsules, fed
5662705|NCT00652587|hepatocellular carcinoma|hepatocellular carcinoma
5662707|NCT00652587|chemoembolization|chemoembolization
5662708|NCT00652587|randomized controlled trial|randomized controlled trial
5662709|NCT00652587|prognosis|prognosis
5662710|NCT00652574|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5662711|NCT00652574|Dasatinib|dasatinib
5662712|NCT00652574|BMS-354825|bms-354825
5662713|NCT00652574|Sprycel|sprycel
5662714|NCT00652574|MPM|mpm
5662715|NCT00652548|Clavicle|clavicle
5662716|NCT00652548|Fracture|fracture
5662717|NCT00652548|Ultrasound|ultrasound
5662718|NCT00652548|Radiation|radiation
5662719|NCT00652522|AF ablation|af ablation
5662720|NCT00652522|Pulmonary vein isolation(PVI)|pulmonary vein isolation(pvi)
5662721|NCT00652522|reduced LV ejection fraction|reduced lv ejection fraction
5662722|NCT00652522|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5662723|NCT00652522|persistent AF|persistent af
5662724|NCT00652470|infants|infants
5662725|NCT00652470|Hydrocephalus|hydrocephalus
5662726|NCT00652470|Cerebrospinal Fluid Shunt|cerebrospinal fluid shunt
5662727|NCT00652470|Ventriculostomy|ventriculostomy
5662728|NCT00652470|neurosurgery|neurosurgery
5662729|NCT00652418|Magnevist|magnevist
5662730|NCT00652418|Magnetic Resonance Angiography|magnetic resonance angiography
5662731|NCT00652418|Meglumine gadopentetate|meglumine gadopentetate
5662732|NCT00652418|Determination of effective dose in MRA|determination of effective dose in mra
5662733|NCT00652405|cephalic phase reflex|cephalic phase reflex
5662734|NCT00652405|gene expression|gene expression
5662735|NCT00652405|inflammation|inflammation
5662736|NCT00652405|adiponectin|adiponectin
5662737|NCT00652405|pancreatic polypeptide|pancreatic polypeptide
5662738|NCT00652392|asthma|asthma
5662739|NCT00652392|adolescents|adolescents
5662740|NCT00652392|adults|adults
5662741|NCT00652392|Symbicort|symbicort
5662742|NCT00652392|budesonide/formoterol|budesonide/formoterol
5662743|NCT00652392|budesonide|budesonide
5662744|NCT00652379|Acromegaly|acromegaly
5662745|NCT00652379|Insulin sensitivity|insulin sensitivity
5662746|NCT00652379|Glucose tolerance|glucose tolerance
5662747|NCT00652379|Body composition|body composition
5662748|NCT00652379|Growth Hormone|growth hormone
5662749|NCT00652353|Clinical decision rule|clinical decision rule
5662750|NCT00652353|Ottawa Ankle Rule|ottawa ankle rule
5662751|NCT00652353|Ottawa Foot Rule|ottawa foot rule
5662752|NCT00652353|Ankle|ankle
5662753|NCT00652353|Trauma|trauma
5662754|NCT00652353|Education|education
5662755|NCT00652353|Foot Trauma|foot trauma
5662756|NCT00652314|Hemostatic products|hemostatic products
5662757|NCT00652314|Surgical hemostasis|surgical hemostasis
5662758|NCT00652314|Thrombi-gel|thrombi-gel
5662759|NCT00652314|Gelatin Sponge|gelatin sponge
5662760|NCT00652314|Time to hemostasis|time to hemostasis
5662761|NCT00652288|Type I Diabetes Mellitus|type i diabetes mellitus
5662762|NCT00652275|Malaria|malaria
5662763|NCT00652275|vaccine|vaccine
5662764|NCT00652275|Merozoite surface Antigene|merozoite surface antigene
5662765|NCT00652275|Mali|mali
5662766|NCT00652275|Children|children
5662767|NCT00652262|Vardenafil|vardenafil
5662768|NCT00652262|PDE5 inhibitor|pde5 inhibitor
5662769|NCT00652262|Erectile dysfunction|erectile dysfunction
5662770|NCT00652262|Spinal cord injury|spinal cord injury
5662772|NCT00652249|shunt dysfunction|shunt dysfunction
5662773|NCT00652249|shunt flow|shunt flow
5662774|NCT00652236|Low back pain|low back pain
5662775|NCT00652236|Economics|economics
5662776|NCT00652236|Cost-effectiveness|cost-effectiveness
5662777|NCT00652210|Bladder cancer|bladder cancer
5662778|NCT00652210|prostate cancer|prostate cancer
5662779|NCT00652210|multiphoton microscopy|multiphoton microscopy
5662780|NCT00652197|Hydrocephalus|hydrocephalus
5662781|NCT00652197|shunt dysfunction|shunt dysfunction
5662782|NCT00652197|shunt flow|shunt flow
5662783|NCT00652184|antiviral|antiviral
5662784|NCT00652184|herpes zoster|herpes zoster
5662785|NCT00652184|postherpetic neuralgia|postherpetic neuralgia
5662786|NCT00652184|varicella zoster virus|varicella zoster virus
5662787|NCT00652184|shingles|shingles
5662788|NCT00652171|Treatment|treatment
5662789|NCT00652171|Augmentation|augmentation
5662790|NCT00652171|Resistant depression|resistant depression
5662791|NCT00652171|Lamotrigine|lamotrigine
5662792|NCT00652145|ulcerative colitis|ulcerative colitis
5662793|NCT00652145|inflammatory bowel disease|inflammatory bowel disease
5662794|NCT00652132|ototoxicity|ototoxicity
5662795|NCT00652132|childhood hepatoblastoma|childhood hepatoblastoma
5662796|NCT00652132|stage I childhood liver cancer|stage i childhood liver cancer
5662797|NCT00652132|stage II childhood liver cancer|stage ii childhood liver cancer
5662798|NCT00652132|stage III childhood liver cancer|stage iii childhood liver cancer
5662799|NCT00652119|Ovarian Cancer|ovarian cancer
5662800|NCT00652119|Peritoneal Cancer|peritoneal cancer
5662801|NCT00652119|Fallopian Tube Cancer|fallopian tube cancer
5662802|NCT00652119|Carcinoma of Mullerian Origin|carcinoma of mullerian origin
5662803|NCT00652119|Paclitaxel|paclitaxel
5662805|NCT00652119|Carboplatin|carboplatin
5662806|NCT00652119|Paraplatin®|paraplatin®
5662807|NCT00652119|Avastin|avastin
5662808|NCT00652119|Bevacizumab|bevacizumab
5662809|NCT00652119|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5662810|NCT00652119|rhuMAb-VEGF|rhumab-vegf
5662811|NCT00652067|Mycobacterium avium-intracellulare|mycobacterium avium-intracellulare
5662812|NCT00652041|Multiple Myeloma|multiple myeloma
5662813|NCT00652041|Relapsed|relapsed
5662814|NCT00652041|Refractary|refractary
5662815|NCT00652028|Pharmacokinetics|pharmacokinetics
5662816|NCT00652028|Pharmacodynamics|pharmacodynamics
5662817|NCT00652028|Escalating dose|escalating dose
5662818|NCT00652028|Dexmedotimidine|dexmedotimidine
5662819|NCT00652028|Intubated|intubated
5662820|NCT00652028|Mechanically ventilated|mechanically ventilated
5662821|NCT00652028|Pediatrics|pediatrics
5662822|NCT00652015|in-stent-thrombosis|in-stent-thrombosis
5662823|NCT00652015|CD39|cd39
5662824|NCT00652015|CD73|cd73
5662825|NCT00652015|EPC|epc
5662826|NCT00652002|Asthma|asthma
5662827|NCT00652002|Symbicort|symbicort
5662828|NCT00652002|budesonide/formoterol|budesonide/formoterol
5662829|NCT00652002|budesonide|budesonide
5662830|NCT00652002|formoterol|formoterol
5662831|NCT00651989|optical coherence tomography|optical coherence tomography
5662832|NCT00651989|spectral domain|spectral domain
5662833|NCT00651989|time domain|time domain
5662834|NCT00651976|stage IA breast cancer|stage ia breast cancer
5662835|NCT00651976|stage IB breast cancer|stage ib breast cancer
5662836|NCT00651976|stage II breast cancer|stage ii breast cancer
5662837|NCT00651976|stage III breast cancer|stage iii breast cancer
5662838|NCT00651976|HER2-negative breast cancer|her2-negative breast cancer
5662839|NCT00651976|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5662840|NCT00651950|Hydrocephalus|hydrocephalus
5662841|NCT00651950|shunt dysfunction|shunt dysfunction
5662842|NCT00651950|shunt flow|shunt flow
5662843|NCT00651937|Multiple Myeloma|multiple myeloma
5662844|NCT00651937|Primary Amyloidosis|primary amyloidosis
5662845|NCT00651937|Cytokine Modulation|cytokine modulation
5662846|NCT00651937|Melphalan|melphalan
5662847|NCT00651937|Alkeran|alkeran
5662848|NCT00651937|Transplant Induced Symptoms|transplant induced symptoms
5662849|NCT00651937|Stem Cell Infusion|stem cell infusion
5662850|NCT00651937|Autologous stem cell transplant|autologous stem cell transplant
5662851|NCT00651937|ASCT|asct
5662852|NCT00651937|Granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5662853|NCT00651937|G-CSF|g-csf
5662854|NCT00651937|Apheresis|apheresis
5662855|NCT00651924|chronic pain|chronic pain
5662856|NCT00651924|IVR|ivr
5662857|NCT00651924|cognitive-behavior therapy|cognitive-behavior therapy
5662858|NCT00651898|abdominal surgery|abdominal surgery
5662859|NCT00651898|hypothermia|hypothermia
5662860|NCT00651898|circulating water mattress|circulating water mattress
5662861|NCT00651885|UT-15C|ut-15c
5662862|NCT00651885|Peripheral Vascular Disease|peripheral vascular disease
5662863|NCT00651885|Treprostinil|treprostinil
5662864|NCT00651872|Posttraumatic Stress Disorder|posttraumatic stress disorder
5662865|NCT00651872|Functional Impairment|functional impairment
5662866|NCT00651872|Veterans|veterans
5662867|NCT00651872|Military Personnel|military personnel
5662868|NCT00651846|Contraception|contraception
5662869|NCT00651846|Hemostasis|hemostasis
5662870|NCT00651846|Blood Coagulation|blood coagulation
5662871|NCT00651820|wound healing|wound healing
5662873|NCT00651820|collagenase|collagenase
5662874|NCT00651820|Santyl|santyl
5662875|NCT00651794|Neonatal Resuscitation|neonatal resuscitation
5662876|NCT00651794|Patient Care Team|patient care team
5662878|NCT00651781|Acute Myeloid Leukemia|acute myeloid leukemia
5662879|NCT00651781|Relapsed|relapsed
5662880|NCT00651781|Refractory|refractory
5662881|NCT00651768|asthma|asthma
5662882|NCT00651768|adults|adults
5662883|NCT00651768|adolescents|adolescents
5662884|NCT00651768|safety|safety
5662885|NCT00651768|Symbicort|symbicort
5662886|NCT00651768|budesonide/formoterol|budesonide/formoterol
5662887|NCT00651768|budesonide|budesonide
5662888|NCT00651755|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5662889|NCT00651755|Lymphoma|lymphoma
5662890|NCT00651755|Nausea|nausea
5662891|NCT00651755|Cyclophosphamide|cyclophosphamide
5662892|NCT00651755|Cytoxan|cytoxan
5662893|NCT00651755|Neosar|neosar
5662894|NCT00651755|Doxorubicin|doxorubicin
5662896|NCT00651755|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5662897|NCT00651755|Vincristine|vincristine
5662898|NCT00651755|Prednisone|prednisone
5662899|NCT00651755|Rituximab|rituximab
5662900|NCT00651755|Rituxan|rituxan
5662901|NCT00651755|Aprepitant|aprepitant
5662902|NCT00651755|Emend|emend
5662903|NCT00651755|L754030|l754030
5662904|NCT00651755|MK869|mk869
5662905|NCT00651755|Drug Metabolism|drug metabolism
5662906|NCT00651755|CHOP|chop
5662907|NCT00651755|R-CHOP|r-chop
5662909|NCT00651716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5662910|NCT00651716|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5662911|NCT00651716|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5662912|NCT00651716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5680415|NCT00577824|LY2148568|ly2148568
5662913|NCT00651716|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5662914|NCT00651716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5662915|NCT00651716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5662916|NCT00651716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5662917|NCT00651716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5662918|NCT00651716|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5662919|NCT00651716|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5662920|NCT00651716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5662921|NCT00651716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5662922|NCT00651716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5662923|NCT00651716|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5662924|NCT00651716|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5662925|NCT00651716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5662926|NCT00651716|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5662927|NCT00651716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5662928|NCT00651716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5662929|NCT00651716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5662930|NCT00651716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5662931|NCT00651716|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5662932|NCT00651716|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5662933|NCT00651716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5662934|NCT00651716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5662935|NCT00651716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5662936|NCT00651716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5662937|NCT00651716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5662938|NCT00651716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5662939|NCT00651716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5662940|NCT00651716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5662941|NCT00651716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5662942|NCT00651716|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5662943|NCT00651716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5662944|NCT00651716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5662945|NCT00651716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5662946|NCT00651716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5662947|NCT00651716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5662948|NCT00651716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5662949|NCT00651716|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5662950|NCT00651716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5662951|NCT00651716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5662952|NCT00651716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5662953|NCT00651716|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5662954|NCT00651716|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5662955|NCT00651716|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5662956|NCT00651716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5662957|NCT00651716|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5662958|NCT00651716|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5662959|NCT00651716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5662960|NCT00651716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5662961|NCT00651716|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5662962|NCT00651716|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5662963|NCT00651716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5662964|NCT00651716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5662965|NCT00651716|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5662966|NCT00651716|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5662967|NCT00651716|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5662968|NCT00651716|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5662969|NCT00651716|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5662970|NCT00651716|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5662971|NCT00651716|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5680416|NCT00577824|Byetta|byetta
5662972|NCT00651716|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5662973|NCT00651716|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5662974|NCT00651716|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5662975|NCT00651716|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5662976|NCT00651716|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5662977|NCT00651716|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5662978|NCT00651716|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5662979|NCT00651716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5662980|NCT00651716|refractory hairy cell leukemia|refractory hairy cell leukemia
5662981|NCT00651716|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5662982|NCT00651716|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5662983|NCT00651716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5662984|NCT00651716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5662985|NCT00651716|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5662986|NCT00651716|primary myelofibrosis|primary myelofibrosis
5662987|NCT00651716|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5662988|NCT00651716|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5662989|NCT00651716|disseminated neuroblastoma|disseminated neuroblastoma
5662990|NCT00651716|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5662991|NCT00651716|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5662992|NCT00651716|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5662993|NCT00651716|recurrent neuroblastoma|recurrent neuroblastoma
5662994|NCT00651716|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5662995|NCT00651716|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5662996|NCT00651716|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5662997|NCT00651716|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5662998|NCT00651716|stage I multiple myeloma|stage i multiple myeloma
5662999|NCT00651716|stage II multiple myeloma|stage ii multiple myeloma
5663000|NCT00651716|stage III multiple myeloma|stage iii multiple myeloma
5663001|NCT00651716|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5663002|NCT00651716|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5663003|NCT00651716|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5663004|NCT00651716|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5663005|NCT00651716|stage IIIA breast cancer|stage iiia breast cancer
5663006|NCT00651716|stage IIIB breast cancer|stage iiib breast cancer
5663007|NCT00651716|stage IIIC breast cancer|stage iiic breast cancer
5663008|NCT00651716|stage IV breast cancer|stage iv breast cancer
5663009|NCT00651716|refractory multiple myeloma|refractory multiple myeloma
5663010|NCT00651677|hand assisted laparoscopy|hand assisted laparoscopy
5663011|NCT00651677|rectal cancer|rectal cancer
5663012|NCT00651677|short term outcomes|short term outcomes
5663013|NCT00651677|straight laparoscopy|straight laparoscopy
5663014|NCT00651651|Asthma|asthma
5663015|NCT00651651|Symbicort|symbicort
5663016|NCT00651651|budesonide/formoterol|budesonide/formoterol
5663017|NCT00651651|budesonide|budesonide
5663018|NCT00651651|formoterol|formoterol
5663019|NCT00651638|PK and safety profile of ARQ 197|pk and safety profile of arq 197
5663020|NCT00651625|arthrocentesis|arthrocentesis
5663021|NCT00651625|injections|injections
5663022|NCT00651625|anesthesia|anesthesia
5663023|NCT00651625|biopsy|biopsy
5663024|NCT00651625|aspiration|aspiration
5663025|NCT00651625|syringe|syringe
5663026|NCT00651625|safety|safety
5663027|NCT00651625|pain|pain
5663028|NCT00651599|Vasomotor symptoms|vasomotor symptoms
5663029|NCT00651599|Vasomotor System|vasomotor system
5663030|NCT00651573|Surgery|surgery
5663031|NCT00651573|Cardiopulmonary bypass|cardiopulmonary bypass
5663032|NCT00651573|Coronary artery bypass graft|coronary artery bypass graft
5663033|NCT00651573|Valve procedure|valve procedure
5663034|NCT00651573|Hematocrit level|hematocrit level
5663035|NCT00651573|Outcomes|outcomes
5663036|NCT00651547|Asthma|asthma
5663037|NCT00651547|Symbicort|symbicort
5663038|NCT00651547|budesonide/formoterol|budesonide/formoterol
5663039|NCT00651547|budesonide|budesonide
5663040|NCT00651547|formoterol|formoterol
5663041|NCT00651547|children|children
5663042|NCT00651534|Formulation Drug Study, healthy postmenopausal|formulation drug study, healthy postmenopausal
5663043|NCT00651521|Angiographic CAD|angiographic cad
5663044|NCT00651521|Chronic kidney disease|chronic kidney disease
5663045|NCT00651521|Left ventricular dysfunction|left ventricular dysfunction
5663046|NCT00651521|Body mass index|body mass index
5663047|NCT00651521|Cardiovascular mortality|cardiovascular mortality
5663048|NCT00651521|Coronary angiography|coronary angiography
5663049|NCT00651508|Patients with Advanced or Metastatic stage IIIB/IV Non-Small Cell Lung Cancer|patients with advanced or metastatic stage iiib/iv non-small cell lung cancer
5663050|NCT00651495|Decision aids|decision aids
5663051|NCT00651495|Seniors|seniors
5663052|NCT00651495|Chronic disease management|chronic disease management
5646962|NCT00714688|ADHD|adhd
5663053|NCT00651495|Advance directives|advance directives
5663054|NCT00651469|Moderate Acne Vulgaris|moderate acne vulgaris
5663055|NCT00651469|Acne|acne
5663056|NCT00651443|galiximab|galiximab
5663057|NCT00651443|Untreated NHL|untreated nhl
5663058|NCT00651443|antibody|antibody
5663059|NCT00651443|open-label|open-label
5663060|NCT00651430|Balance|balance
5663061|NCT00651430|Voluntary stepping|voluntary stepping
5663062|NCT00651430|function|function
5663063|NCT00651430|disability|disability
5663064|NCT00651430|fear of falls|fear of falls
5663065|NCT00651430|Total Hip Arthroplasty|total hip arthroplasty
5663066|NCT00651417|Organic germanium|organic germanium
5663067|NCT00651417|fatigue|fatigue
5663068|NCT00651417|radiation therapy|radiation therapy
5663069|NCT00651417|breast cancer|breast cancer
5663070|NCT00651417|prostate cancer|prostate cancer
5663071|NCT00651365|Advanced solid tumors|advanced solid tumors
5663072|NCT00651365|Refractory solid tumor|refractory solid tumor
5663073|NCT00651365|Antineoplastic protocol|antineoplastic protocol
5663074|NCT00651365|Drug therapy|drug therapy
5663075|NCT00651365|Pharmacokinetics|pharmacokinetics
5663076|NCT00651365|Met inhibitor|met inhibitor
5663078|NCT00651352|Bioequivalence|bioequivalence
5663079|NCT00651352|Nicotine|nicotine
5663080|NCT00651339|Cerebral Palsy|cerebral palsy
5663081|NCT00651339|Balance|balance
5663082|NCT00651339|Gait|gait
5663083|NCT00651326|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5663084|NCT00651326|stage I prostate cancer|stage i prostate cancer
5663085|NCT00651326|stage II prostate cancer|stage ii prostate cancer
5663086|NCT00651326|stage III prostate cancer|stage iii prostate cancer
5663087|NCT00651326|stage IV prostate cancer|stage iv prostate cancer
5663088|NCT00651313|Dysmenorrhea|dysmenorrhea
5663089|NCT00651313|Periods|periods
5663090|NCT00651313|Menstrual|menstrual
5663091|NCT00651313|Primary dysmenorrhea in women with recurrent dysmenorrhea|primary dysmenorrhea in women with recurrent dysmenorrhea
5663092|NCT00651261|adult acute basophilic leukemia|adult acute basophilic leukemia
5663093|NCT00651261|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5663094|NCT00651261|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5663095|NCT00651261|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5663096|NCT00651261|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5663097|NCT00651261|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5663098|NCT00651261|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5663099|NCT00651261|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5663100|NCT00651261|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5663101|NCT00651261|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5663102|NCT00651261|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5663103|NCT00651261|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5663104|NCT00651261|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5663105|NCT00651261|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5663106|NCT00651261|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5904186|NCT00050310|Natural History|natural history
5663107|NCT00651261|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5663108|NCT00651261|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5663109|NCT00651248|Saliva|saliva
5663110|NCT00651248|Oral health|oral health
5663112|NCT00651209|Hepatitis B, chronic|hepatitis b, chronic
5663113|NCT00651209|Telbivudine|telbivudine
5663114|NCT00651209|Tenofovir|tenofovir
5663115|NCT00651209|Roadmap Concept|roadmap concept
5663116|NCT00651196|Type 1 diabetes|type 1 diabetes
5663117|NCT00651196|bone|bone
5663118|NCT00651170|Median block nerve|median block nerve
5663119|NCT00651170|Ultrasound|ultrasound
5663120|NCT00651131|post-surgical|post-surgical
5663121|NCT00651131|wound infection|wound infection
5663122|NCT00651131|superficial|superficial
5663123|NCT00651131|deep|deep
5663124|NCT00651131|surgical|surgical
5663125|NCT00651105|Diabetes|diabetes
5663126|NCT00651105|Hyperglycemia|hyperglycemia
5663127|NCT00651105|Healthy|healthy
5663128|NCT00651105|Vildagliptin|vildagliptin
5663130|NCT00651092|turbinectomy|turbinectomy
5663131|NCT00651079|GSK1247303,|gsk1247303,
5663132|NCT00651079|Integrase,|integrase,
5663133|NCT00651079|First Time in Human|first time in human
5663135|NCT00651066|Tuberculosis|tuberculosis
5663136|NCT00651066|Rifabutin|rifabutin
5663137|NCT00651066|Pharmacokinetics|pharmacokinetics
5663139|NCT00651040|Polymyositis|polymyositis
5663140|NCT00651040|Dermatomyositis|dermatomyositis
5663141|NCT00651040|Glucocorticoids|glucocorticoids
5663142|NCT00651040|Methotrexate|methotrexate
5663143|NCT00651001|fructose|fructose
5663144|NCT00651001|leptin|leptin
5663145|NCT00651001|metabolic syndrome|metabolic syndrome
5663146|NCT00651001|blood pressure|blood pressure
5663147|NCT00651001|inflammation|inflammation
5663148|NCT00651001|Relationship of fructose intake to leptin levels|relationship of fructose intake to leptin levels
5663149|NCT00651001|Relationship of fructose to metabolic syndrome|relationship of fructose to metabolic syndrome
5663150|NCT00651001|Relationship of fructose to inflammation parameters|relationship of fructose to inflammation parameters
5663151|NCT00651001|Relationship of fructose to blood pressure|relationship of fructose to blood pressure
5663152|NCT00650988|Barrett's Esophagus|barrett's esophagus
5663153|NCT00650988|Cryospray ablation|cryospray ablation
5663154|NCT00650988|High Grade Dysplasia|high grade dysplasia
5663155|NCT00650988|Early Esophageal Cancers|early esophageal cancers
5663156|NCT00650988|Esophageal Neoplasms|esophageal neoplasms
5663157|NCT00650988|Esophageal Intramucosal Cancer (IMCA)|esophageal intramucosal cancer (imca)
5663158|NCT00650988|Esophageal Cancer limited to esophageal wall|esophageal cancer limited to esophageal wall
5663159|NCT00650988|Barretts esophagus High Grade Dysplasia (HGD)|barretts esophagus high grade dysplasia (hgd)
5663160|NCT00650975|STEMI|stemi
5663161|NCT00650975|Laser|laser
5663162|NCT00650975|Thrombus|thrombus
5663163|NCT00650975|Thrombectomy|thrombectomy
5663165|NCT00650962|Preshock CPR|preshock cpr
5663166|NCT00650962|OHCA|ohca
5663167|NCT00650962|EMS|ems
5663168|NCT00650949|Glioblastoma multiforme|glioblastoma multiforme
5663169|NCT00650949|Glioma|glioma
5663170|NCT00650949|Phase Ib/II|phase ib/ii
5663171|NCT00650949|CYT997|cyt997
5663172|NCT00650936|Atrial|atrial
5663173|NCT00650936|Septal|septal
5663174|NCT00650936|Defect|defect
5663175|NCT00650910|lapatinib|lapatinib
5663176|NCT00650910|Metastatic ErbB2 positive breast cancer|metastatic erbb2 positive breast cancer
5663177|NCT00650910|digoxin|digoxin
5663178|NCT00650897|Efficacy|efficacy
5663179|NCT00650897|Antidepressant|antidepressant
5663180|NCT00650897|Escitalopram|escitalopram
5663181|NCT00650897|Major Depression|major depression
5663182|NCT00650897|Diabetes Mellitus|diabetes mellitus
5663183|NCT00650897|Self Care|self care
5663184|NCT00650884|Dynamic Splinting for low-load, prolonged-duration stretch|dynamic splinting for low-load, prolonged-duration stretch
5663185|NCT00650871|sleep,|sleep,
5663186|NCT00650871|polysomnography.|polysomnography.
5663187|NCT00650871|GW679769,|gw679769,
5663188|NCT00650871|primary insomnia,|primary insomnia,
5663189|NCT00650871|cognitive function,|cognitive function,
5663190|NCT00650858|Intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5663191|NCT00650858|rt-PA|rt-pa
5663192|NCT00650845|contrast-induced nephropathy, creatinemia|contrast-induced nephropathy, creatinemia
5663193|NCT00650832|HIV, anti-infectives|hiv, anti-infectives
5663194|NCT00650806|Obesity|obesity
5663195|NCT00650806|Overweight|overweight
5663196|NCT00650806|Weight loss|weight loss
5663197|NCT00650806|Anti-Obesity Agents|anti-obesity agents
5663198|NCT00650806|Human|human
5663199|NCT00650793|Schizophrenia|schizophrenia
5663200|NCT00650793|paliperidone|paliperidone
5663201|NCT00650780|Viatmin D, 25-hydroxyvitamin D, Vitamin D binding protein|viatmin d, 25-hydroxyvitamin d, vitamin d binding protein
5663202|NCT00650754|DHEA|dhea
5663203|NCT00650754|Pregnancy|pregnancy
5663204|NCT00650741|Endothelial Dysfunction|endothelial dysfunction
5663205|NCT00650741|FMD|fmd
5663206|NCT00650728|radiofrequency ablation|radiofrequency ablation
5663207|NCT00650715|Fibromyalgia|fibromyalgia
5663208|NCT00650715|Whole-Body vibration|whole-body vibration
5663209|NCT00650715|Exercise|exercise
5663309|NCT00649701|MSM|msm
5663211|NCT00650702|glaucoma, ocular hypertension, IOP|glaucoma, ocular hypertension, iop
5663212|NCT00650624|knee osteoarthritis; Japan|knee osteoarthritis; japan
5663213|NCT00650598|anterior cruciate ligament, arthroscopy, knee, post-surgical pain|anterior cruciate ligament, arthroscopy, knee, post-surgical pain
5663214|NCT00650585|smoking|smoking
5663215|NCT00650585|alcohol|alcohol
5663216|NCT00650585|prevention|prevention
5663217|NCT00650585|prevention & control|prevention & control
5663218|NCT00650572|human epidermal growth factor receptor 2|human epidermal growth factor receptor 2
5663219|NCT00650572|epidermal growth factor receptor|epidermal growth factor receptor
5663220|NCT00650572|EGFR|egfr
5663221|NCT00650572|type I receptor tyrosine kinase|type i receptor tyrosine kinase
5663222|NCT00650559|COPD|copd
5663223|NCT00650559|Emphysema|emphysema
5663224|NCT00650559|thorax enlargement|thorax enlargement
5663225|NCT00650559|LVRS|lvrs
5663226|NCT00650546|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5663228|NCT00650507|children|children
5663229|NCT00650507|cardiac surgery|cardiac surgery
5663230|NCT00650507|remote ischemic preconditioning|remote ischemic preconditioning
5663231|NCT00650507|SHAM|sham
5663232|NCT00650507|ischemia-reperfusion|ischemia-reperfusion
5656770|NCT00675350|HHT|hht
5663234|NCT00650468|Prograf|prograf
5663235|NCT00650455|valdecoxib, severe rheumatoid arthritis|valdecoxib, severe rheumatoid arthritis
5663236|NCT00650260|intraoperative warming|intraoperative warming
5663237|NCT00650260|anesthesia|anesthesia
5663238|NCT00650260|hypothermia|hypothermia
5663239|NCT00650260|body temperature|body temperature
5663240|NCT00650182|patch|patch
5663241|NCT00650182|fentanyl|fentanyl
5663242|NCT00650182|chronic pain|chronic pain
5663243|NCT00650143|Stem cell|stem cell
5663244|NCT00650143|Myocardial infarction|myocardial infarction
5663245|NCT00650143|G-CSF|g-csf
5663246|NCT00650143|CD26-inhibition|cd26-inhibition
5663247|NCT00650130|driving under the influence|driving under the influence
5663248|NCT00650130|psychoactive substances|psychoactive substances
5663249|NCT00650130|oral fluid|oral fluid
5663250|NCT00650130|whole blood|whole blood
5663251|NCT00650130|plasma|plasma
5663252|NCT00650130|Ratio of psychoactive substances in whole blood-plasma-oral fluid|ratio of psychoactive substances in whole blood-plasma-oral fluid
5663253|NCT00650130|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
5663254|NCT00650104|ropinirole IR|ropinirole ir
5663255|NCT00650104|efficacy|efficacy
5663256|NCT00650104|safety|safety
5663257|NCT00650104|open-label|open-label
5663258|NCT00650104|long term safety; REQUIP|long term safety; requip
5663259|NCT00650104|ropinirole XL|ropinirole xl
5663260|NCT00650104|ropinirole CR|ropinirole cr
5663261|NCT00650104|Parkinson's disease|parkinson's disease
5663262|NCT00650091|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5663263|NCT00650091|Prednisone|prednisone
5663264|NCT00650091|Azathioprine|azathioprine
5663266|NCT00650091|N-acetylcysteine|n-acetylcysteine
5663267|NCT00650078|Signs and Symptoms|signs and symptoms
5663268|NCT00650078|Autoimmune Diseases|autoimmune diseases
5663269|NCT00650078|Joint Diseases|joint diseases
5663270|NCT00650078|Arthritis|arthritis
5663271|NCT00650078|Connective Tissue Diseases|connective tissue diseases
5663272|NCT00650078|Arthritis, Rheumatoid|arthritis, rheumatoid
5663273|NCT00650078|Rheumatic Diseases|rheumatic diseases
5663274|NCT00650078|Predniso(lo)ne|predniso(lo)ne
5663275|NCT00650039|Post surgical pain|post surgical pain
5663276|NCT00650039|Anterior Cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5663277|NCT00650039|Arthroscopy|arthroscopy
5663278|NCT00650039|Perioperative pain|perioperative pain
5663279|NCT00649961|Premature Birth|premature birth
5663280|NCT00649961|Brain injury|brain injury
5663281|NCT00649961|Neuroprotection|neuroprotection
5663282|NCT00649961|Melatonin|melatonin
5663283|NCT00649961|Pharmacokinetics|pharmacokinetics
5663284|NCT00649922|Vaccines with adalimumab dosing|vaccines with adalimumab dosing
5663285|NCT00649909|Diabetes Mellitus|diabetes mellitus
5663286|NCT00649909|Type II|type ii
5663287|NCT00649909|Aspirin|aspirin
5663288|NCT00649909|Resistance|resistance
5663289|NCT00649883|Influenza|influenza
5663290|NCT00649883|vaccine|vaccine
5663291|NCT00649883|children|children
5663292|NCT00649792|multiple sclerosis|multiple sclerosis
5663293|NCT00649792|MS|ms
5663294|NCT00649792|walking|walking
5663295|NCT00649792|leg strength|leg strength
5663296|NCT00649792|demyelination|demyelination
5663297|NCT00649766|tailored health messages|tailored health messages
5663298|NCT00649766|glaucoma|glaucoma
5663299|NCT00649766|diabetic retinopathy|diabetic retinopathy
5663300|NCT00649766|dilated fundus exams|dilated fundus exams
5663301|NCT00649766|health behavior|health behavior
5663302|NCT00649753|sacroiliac joint dysfunction|sacroiliac joint dysfunction
5663303|NCT00649753|algometer|algometer
5855173|NCT00000976|IgG|igg
5663304|NCT00649753|Chiropractic|chiropractic
5663305|NCT00649753|Manual Therapy|manual therapy
5663306|NCT00649753|indicator points associated with sacroiliac joint dysfunction|indicator points associated with sacroiliac joint dysfunction
5663307|NCT00649701|HIV|hiv
5663308|NCT00649701|Internet|internet
5663310|NCT00649701|Condom Use|condom use
5663311|NCT00649701|Disclosure|disclosure
5663312|NCT00649610|acute low back pain|acute low back pain
5663313|NCT00649584|Antigens, CD30|antigens, cd30
5663314|NCT00649584|Antibody-Drug Conjugate|antibody-drug conjugate
5663315|NCT00649584|Antibodies, Monoclonal|antibodies, monoclonal
5663316|NCT00649584|monomethyl auristatin E|monomethyl auristatin e
5663317|NCT00649584|Combined Modality Therapy|combined modality therapy
5663318|NCT00649584|Drug Therapy|drug therapy
5663319|NCT00649584|Immunotherapy|immunotherapy
5663320|NCT00649584|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5663321|NCT00649584|Disease, Hodgkin|disease, hodgkin
5663322|NCT00649584|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5663323|NCT00649584|Hematologic Diseases|hematologic diseases
5663324|NCT00649584|Lymphoma|lymphoma
5663325|NCT00649428|Treatment of moderate to severe bilateral nasolabial fold wrinkles|treatment of moderate to severe bilateral nasolabial fold wrinkles
5663327|NCT00649337|ultrasound|ultrasound
5663328|NCT00649337|breast cancer|breast cancer
5663329|NCT00649337|screening|screening
5663330|NCT00649298|Randomized Controlled Trial|randomized controlled trial
5663337|NCT00649298|Renal Dialysis|renal dialysis
5663338|NCT00649298|Renal Replacement Therapy|renal replacement therapy
5663339|NCT00649298|Nocturnal Dialysis|nocturnal dialysis
5663340|NCT00649298|Extended dialysis|extended dialysis
5663341|NCT00649298|Quality of Life|quality of life
5663342|NCT00649298|Quality Adjusted Life Year|quality adjusted life year
5663343|NCT00649298|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5663344|NCT00649298|Blood Pressure|blood pressure
5663345|NCT00649298|Hypertension|hypertension
5663346|NCT00649298|Anemia|anemia
5663347|NCT00649298|Hematinics|hematinics
5663348|NCT00649298|Erythropoiesis Stimulating Agents|erythropoiesis stimulating agents
5663349|NCT00649298|Cost-utility Analysis|cost-utility analysis
5663350|NCT00649298|Economic Evaluation|economic evaluation
5663351|NCT00649298|Health Care Utilisation|health care utilisation
5663352|NCT00649298|Health Care Costs|health care costs
5663353|NCT00649298|Health Expenditures|health expenditures
5663354|NCT00649298|Hospitalization|hospitalization
5663355|NCT00649298|Cost Analysis|cost analysis
5663356|NCT00649298|Cardiovascular Diseases|cardiovascular diseases
5663357|NCT00649298|Acute Coronary Syndrome|acute coronary syndrome
5663358|NCT00649298|Myocardial Infarction|myocardial infarction
5663359|NCT00649298|Stroke|stroke
5663360|NCT00649298|Cerebrovascular Disorders|cerebrovascular disorders
5663361|NCT00649298|Mortality|mortality
5663362|NCT00649298|Arteriovenous Fistula|arteriovenous fistula
5663363|NCT00649298|Arteriovenous Shunt, Surgical|arteriovenous shunt, surgical
5663364|NCT00649298|Thrombosis|thrombosis
5663365|NCT00649298|Infection|infection
5663366|NCT00649246|genetics|genetics
5663367|NCT00649246|type 1 diabetes|type 1 diabetes
5663368|NCT00649246|biomarkers|biomarkers
5663369|NCT00649246|autoimmunity|autoimmunity
5663370|NCT00649207|WBRT|wbrt
5663371|NCT00649207|Brain Metastases|brain metastases
5663372|NCT00649207|Radiation|radiation
5663373|NCT00649207|ABT-888|abt-888
5663374|NCT00649207|PARP|parp
5663375|NCT00649142|Groin hernia|groin hernia
5663376|NCT00649142|Chronic postsurgical pain|chronic postsurgical pain
5663377|NCT00649142|open mesh repair|open mesh repair
5663378|NCT00649142|laparoscopic mesh glue fixation|laparoscopic mesh glue fixation
5663379|NCT00649142|Sensory changes after groin hernia repair|sensory changes after groin hernia repair
5663380|NCT00649025|Asthma|asthma
5663381|NCT00649025|Asthma Moderate to Severe|asthma moderate to severe
5663382|NCT00648999|Kaletra|kaletra
5663383|NCT00648986|brittle nails|brittle nails
5663384|NCT00648986|Tazarotene|tazarotene
5663385|NCT00648986|Tazorac|tazorac
5663386|NCT00648973|Seasonal Allergic Rhinitis, nasal congestion|seasonal allergic rhinitis, nasal congestion
5663387|NCT00648908|multiple sclerosis|multiple sclerosis
5663388|NCT00648908|MS|ms
5663389|NCT00648908|walking|walking
5663390|NCT00648908|leg strength|leg strength
5663391|NCT00648908|demyelination|demyelination
5663392|NCT00648895|Hypertension|hypertension
5663393|NCT00648895|Blood pressure|blood pressure
5663394|NCT00648895|Nebivolol|nebivolol
5663395|NCT00648895|Bystolic (TM)|bystolic (tm)
5663396|NCT00648895|Metoprolol ER (TM)|metoprolol er (tm)
5663397|NCT00648869|pharmaceutical preparations|pharmaceutical preparations
5663398|NCT00648817|HIV-1|hiv-1
5663399|NCT00648817|tenofovir DF|tenofovir df
5904187|NCT00050310|Vaccinated Healthy Volunteer|vaccinated healthy volunteer
5663400|NCT00648739|B-cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5663401|NCT00648739|Leukemia|leukemia
5663402|NCT00648739|Multiple Myeloma|multiple myeloma
5663403|NCT00648739|CD200|cd200
5663404|NCT00648739|Anti-CD200|anti-cd200
5663405|NCT00648687|prematurity|prematurity
5663406|NCT00648687|retinopathy of prematurity|retinopathy of prematurity
5663407|NCT00648687|pain|pain
5663411|NCT00648635|Quality of Life|quality of life
5663412|NCT00648635|QOL|qol
5663413|NCT00648635|Questionnaire|questionnaire
5663414|NCT00648635|Survey|survey
5663415|NCT00648609|Community based self management of COPD with palliative care|community based self management of copd with palliative care
5663416|NCT00648479|Fracture Fixation|fracture fixation
5663417|NCT00648453|Fontain II-III stage|fontain ii-iii stage
5663418|NCT00648375|Propanolol|propanolol
5663419|NCT00648375|Beta Blockers|beta blockers
5663420|NCT00648375|Reconsolidation|reconsolidation
5663421|NCT00648375|Cognitive Therapy|cognitive therapy
5663422|NCT00648375|PTSD|ptsd
5663423|NCT00648323|Benign Prostate Hyperplasia|benign prostate hyperplasia
5663424|NCT00648284|Type 2 diabetes|type 2 diabetes
5663425|NCT00648284|CV risk|cv risk
5663427|NCT00648284|AVANDIA|avandia
5663428|NCT00648258|osteoarthritis, knee|osteoarthritis, knee
5663429|NCT00648258|osteoarthritis, hip|osteoarthritis, hip
5663430|NCT00648245|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5663432|NCT00648245|Chronic bronchitis|chronic bronchitis
5663434|NCT00648232|AIDS|aids
5663435|NCT00648232|Prevention|prevention
5663436|NCT00648232|VCT|vct
5663437|NCT00648232|Voluntary Counseling and Testing|voluntary counseling and testing
5663438|NCT00648206|driving under the influence|driving under the influence
5663439|NCT00648206|psychoactive substances|psychoactive substances
5663440|NCT00648206|blood samples|blood samples
5663441|NCT00648206|Prevalence of psychoactive substances in road traffic|prevalence of psychoactive substances in road traffic
5663442|NCT00648167|ESRD|esrd
5663443|NCT00648167|end-stage renal disease|end-stage renal disease
5663444|NCT00648167|end stage renal disease|end stage renal disease
5663445|NCT00648167|hemodialysis|hemodialysis
5663446|NCT00648167|dialysis|dialysis
5663447|NCT00648167|kidney failure|kidney failure
5663448|NCT00648167|renal failure|renal failure
5663449|NCT00648167|kidney|kidney
5663450|NCT00648167|renal|renal
5663451|NCT00648167|phosphate binder|phosphate binder
5663452|NCT00648167|phosphorus|phosphorus
5663453|NCT00648115|Veterans|veterans
5663454|NCT00648115|Substance-Related Disorders|substance-related disorders
5663455|NCT00648115|Mental Health|mental health
5663456|NCT00648102|Breast cancer|breast cancer
5663457|NCT00648102|Colorectal cancer|colorectal cancer
5663458|NCT00648102|Pancreatic cancer|pancreatic cancer
5663459|NCT00648102|Bladder cancer|bladder cancer
5663460|NCT00648102|Ovarian cancer|ovarian cancer
5663461|NCT00648102|Metastatic cancer|metastatic cancer
5663462|NCT00648102|Locally advanced cancer|locally advanced cancer
5663463|NCT00648102|Cancer Vaccine|cancer vaccine
5663464|NCT00648102|Vaccine|vaccine
5663465|NCT00648089|Acute ST Elevation Myocardial Infarction|acute st elevation myocardial infarction
5663466|NCT00648037|RITUXIMAB|rituximab
5663467|NCT00648037|Lymphoma|lymphoma
5663468|NCT00647998|Surgical complications|surgical complications
5663469|NCT00647998|Spinal ischemia|spinal ischemia
5663470|NCT00647998|Stroke|stroke
5663471|NCT00647998|Neuroprotection|neuroprotection
5663472|NCT00647946|lipodystrophy|lipodystrophy
5663473|NCT00647933|Females|females
5663474|NCT00647933|Corifollitropin alfa|corifollitropin alfa
5663475|NCT00647933|Antibodies|antibodies
5663476|NCT00647933|Pharmacokinetics|pharmacokinetics
5663477|NCT00647933|Pharmacodynamics|pharmacodynamics
5663478|NCT00647868|pharmacokinetics|pharmacokinetics
5663479|NCT00647868|testosterone|testosterone
5663480|NCT00647868|hypogonadism|hypogonadism
5663481|NCT00647829|pharyngitis, sore throat|pharyngitis, sore throat
5663482|NCT00647790|PET imaging|pet imaging
5663483|NCT00647790|invasive breast cancer|invasive breast cancer
5663484|NCT00647725|Epidural analgesia|epidural analgesia
5663485|NCT00647725|Latent analgesia|latent analgesia
5663486|NCT00647725|Active analgesia|active analgesia
5663487|NCT00647725|Labor delivery|labor delivery
5663488|NCT00647699|keratoconus|keratoconus
5663489|NCT00647699|cross-linking|cross-linking
5663490|NCT00647699|riboflavin|riboflavin
5663491|NCT00647699|UVA light|uva light
5663492|NCT00647699|cornea|cornea
5663493|NCT00647595|Obesity|obesity
5663494|NCT00647595|Physical activity|physical activity
5663495|NCT00647595|Pregnancy|pregnancy
5663496|NCT00647595|Diabetes mellitus|diabetes mellitus
5663497|NCT00647582|stage I breast cancer|stage i breast cancer
5663498|NCT00647582|stage II breast cancer|stage ii breast cancer
5663499|NCT00647569|vertical rectus abdominis musculocutaneus flap|vertical rectus abdominis musculocutaneus flap
5663500|NCT00647569|mesh repair|mesh repair
5663501|NCT00647569|salvage surgery|salvage surgery
5663502|NCT00647530|adenocarcinoma of the colon|adenocarcinoma of the colon
5663503|NCT00647530|stage I colon cancer|stage i colon cancer
5663504|NCT00647530|stage II colon cancer|stage ii colon cancer
5663505|NCT00647530|stage III colon cancer|stage iii colon cancer
5663506|NCT00647504|stent thrombosis|stent thrombosis
5663507|NCT00647504|stent restenosis|stent restenosis
5663508|NCT00647504|intravascular ultrasound|intravascular ultrasound
5663509|NCT00647478|Insulin-like Growth Factor|insulin-like growth factor
5663510|NCT00647478|Insulin-like Growth Factor binding protein 3|insulin-like growth factor binding protein 3
5663511|NCT00647478|Insulin-like Growth Factor-I system component levels|insulin-like growth factor-i system component levels
5663512|NCT00647478|Insulin-like Growth Factor-I polymorphism|insulin-like growth factor-i polymorphism
5663513|NCT00647478|Alzheimer's disease|alzheimer's disease
5663514|NCT00647478|Mild Cognitive Impairment|mild cognitive impairment
5663515|NCT00647478|Normal cognitive function|normal cognitive function
5663516|NCT00647478|Observational cross sectional study|observational cross sectional study
5663517|NCT00647465|Influenza vaccine|influenza vaccine
5663518|NCT00647465|interferon|interferon
5663519|NCT00647465|adjuvant|adjuvant
5663520|NCT00647465|the elderly|the elderly
5663521|NCT00647452|Lipid metabolism|lipid metabolism
5663523|NCT00647452|Exercise|exercise
5663524|NCT00647452|Lipid metabolism in exercise|lipid metabolism in exercise
5663525|NCT00647439|OCULAR INFLAMMATORY DISEASE|ocular inflammatory disease
5663527|NCT00647439|Gene Expression Patterns|gene expression patterns
5663528|NCT00647439|Diabetic Retinopathy|diabetic retinopathy
5663529|NCT00647439|Age-Related Macular Degeneration|age-related macular degeneration
5663531|NCT00647439|Uveitis|uveitis
5663532|NCT00647426|Stage IIIB/IV|stage iiib/iv
5663533|NCT00647413|smoking|smoking
5663534|NCT00647413|passive smoking|passive smoking
5680417|NCT00577824|Lilly|lilly
5663535|NCT00647413|exposure to environmental smoke|exposure to environmental smoke
5663536|NCT00647413|home smoking ban|home smoking ban
5663537|NCT00647413|urinary cotinine|urinary cotinine
5663538|NCT00647400|Psoriasis|psoriasis
5663539|NCT00647387|muscular|muscular
5663540|NCT00647387|ventricular|ventricular
5663542|NCT00647387|defects|defects
5663543|NCT00647387|VSD|vsd
5663544|NCT00647361|respiratory insufficiency|respiratory insufficiency
5663545|NCT00647361|respiration|respiration
5663546|NCT00647361|ventilators|ventilators
5663547|NCT00647361|diaphragm|diaphragm
5663548|NCT00647361|electromyography|electromyography
5663549|NCT00647361|mechanical ventilation|mechanical ventilation
5663550|NCT00647348|Secondary progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5663551|NCT00647348|Simvastatin|simvastatin
5663552|NCT00647348|MRI|mri
5663553|NCT00647322|Intractable epilepsy, Drug Reduction, Antiepileptic medication|intractable epilepsy, drug reduction, antiepileptic medication
5663554|NCT00647296|ALS|als
5663555|NCT00647296|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5663556|NCT00647296|Lou Gehrig|lou gehrig
5663557|NCT00647296|Lou Gehrig's|lou gehrig's
5663558|NCT00647296|Lou Gehrig's disease|lou gehrig's disease
5663559|NCT00647296|Motor Neuron Disease|motor neuron disease
5663560|NCT00647296|Nervous System Diseases|nervous system diseases
5663561|NCT00647296|KNS-760704|kns-760704
5663562|NCT00647283|Liver Transplantation|liver transplantation
5663563|NCT00647283|Tolerance|tolerance
5663564|NCT00647283|Allograft tolerance|allograft tolerance
5663565|NCT00647283|Immunosuppression minimization|immunosuppression minimization
5663566|NCT00647283|Immunosuppression weaning|immunosuppression weaning
5663567|NCT00647283|Immunological tolerance|immunological tolerance
5663568|NCT00647257|Sick Sinus Syndrome; Atrial Fibrillation; Pacemaker|sick sinus syndrome; atrial fibrillation; pacemaker
5663569|NCT00647244|Tenofovir|tenofovir
5663570|NCT00647244|Abacavir|abacavir
5663571|NCT00647244|Antiretroviral therapy|antiretroviral therapy
5663572|NCT00647244|HIV|hiv
5663573|NCT00647244|Nucleoside analogue reverse transcriptase inhibitor|nucleoside analogue reverse transcriptase inhibitor
5663574|NCT00647231|Osteoarthritis,Knee,Ketoprofen,Pain,Patch,Analgesic|osteoarthritis,knee,ketoprofen,pain,patch,analgesic
5663575|NCT00647218|stage II breast cancer|stage ii breast cancer
5663576|NCT00647218|stage IIIA breast cancer|stage iiia breast cancer
5644500|NCT00723320|CIMT|cimt
5663577|NCT00647218|stage IIIB breast cancer|stage iiib breast cancer
5663578|NCT00647218|stage IIIC breast cancer|stage iiic breast cancer
5663579|NCT00647205|Interferon, gamma|interferon, gamma
5663580|NCT00647205|HIV Infections|hiv infections
5663581|NCT00647205|Tuberculosis|tuberculosis
5663582|NCT00647192|atrial fibrillation|atrial fibrillation
5663583|NCT00647192|electrical cardioversion|electrical cardioversion
5663584|NCT00647192|prevention of atrial fibrillation recurrence|prevention of atrial fibrillation recurrence
5663585|NCT00647192|mineralocorticoid receptor blocker|mineralocorticoid receptor blocker
5663586|NCT00647192|eplerenone|eplerenone
5663587|NCT00647192|Recurrence of atrial fibrillation after cardioversion|recurrence of atrial fibrillation after cardioversion
5663588|NCT00647179|Acromegaly|acromegaly
5663589|NCT00647179|Growth Hormone|growth hormone
5663590|NCT00647179|Insulin resistance|insulin resistance
5663591|NCT00647179|Glucose tolerance|glucose tolerance
5663592|NCT00647179|Body Composition|body composition
5663593|NCT00647179|Substrate metabolism|substrate metabolism
5663594|NCT00647166|Vasculitis|vasculitis
5663595|NCT00647166|Polyarteritis nodosa (PAN)|polyarteritis nodosa (pan)
5663596|NCT00647166|Microscopic polyangiitis (MPA)|microscopic polyangiitis (mpa)
5663597|NCT00647166|Eosinophilic granulomatosis with polyangiitis (EGPA)|eosinophilic granulomatosis with polyangiitis (egpa)
5663598|NCT00647166|Churg Strauss syndrome (CSS)|churg strauss syndrome (css)
5663599|NCT00647166|Azathioprine|azathioprine
5663600|NCT00647153|stage I colon cancer|stage i colon cancer
5663601|NCT00647153|stage II colon cancer|stage ii colon cancer
5663602|NCT00647153|stage III colon cancer|stage iii colon cancer
5663603|NCT00647153|stage IV colon cancer|stage iv colon cancer
5663604|NCT00647153|stage I rectal cancer|stage i rectal cancer
5663605|NCT00647153|stage II rectal cancer|stage ii rectal cancer
5663606|NCT00647153|stage III rectal cancer|stage iii rectal cancer
5663607|NCT00647153|stage IV rectal cancer|stage iv rectal cancer
5663608|NCT00647140|Thyroid neoplasm|thyroid neoplasm
5663609|NCT00647140|Thyroid carcinoma|thyroid carcinoma
5663610|NCT00647140|Medullary carcinoma|medullary carcinoma
5663611|NCT00647140|Positron Emission Tomography (PET)|positron emission tomography (pet)
5663612|NCT00647140|18F-L DOPA|18f-l dopa
5663614|NCT00647140|Carcinoembryonic Antibodies|carcinoembryonic antibodies
5663615|NCT00647140|Cervical ultrasonography|cervical ultrasonography
5663616|NCT00647140|Cervical-chest-abdomen tomography|cervical-chest-abdomen tomography
5663617|NCT00647140|Cervical-chest-abdomen magnetic resonance imaging|cervical-chest-abdomen magnetic resonance imaging
5663618|NCT00647140|Osseous radionuclide imaging|osseous radionuclide imaging
5663619|NCT00647140|Post-PET surgery|post-pet surgery
5663620|NCT00647140|Post-PET biopsy|post-pet biopsy
5663621|NCT00647140|Post-PET histology|post-pet histology
5663622|NCT00647127|Buprenorphine|buprenorphine
5663623|NCT00647127|Fentanyl|fentanyl
5663624|NCT00647127|Analgesic effect|analgesic effect
5663625|NCT00647127|Anti-hyperalgesic effect|anti-hyperalgesic effect
5663626|NCT00647127|Experimental pain|experimental pain
5663627|NCT00647114|Cancers expressing HER-2 and/or CEA|cancers expressing her-2 and/or cea
5663628|NCT00647088|Aortic Valve stenosis|aortic valve stenosis
5663630|NCT00647088|Mineralisation inhibitors|mineralisation inhibitors
5663631|NCT00647075|Breast cancer|breast cancer
5663632|NCT00647075|undergoing|undergoing
5663633|NCT00647075|adjuvant/neoadjuvant chemotherapy|adjuvant/neoadjuvant chemotherapy
5663634|NCT00647075|symptomatic therapy|symptomatic therapy
5663635|NCT00647036|Parenteral nutrition, Infants, Dipeotiven, Microbial invasion|parenteral nutrition, infants, dipeotiven, microbial invasion
5663636|NCT00646997|atrial fibrillation, left atrium, velocity vector imaging|atrial fibrillation, left atrium, velocity vector imaging
5663637|NCT00646984|Lipodystrophy|lipodystrophy
5663638|NCT00646984|Treatment interruption|treatment interruption
5663639|NCT00646984|HIV|hiv
5663640|NCT00646971|Isoprostane|isoprostane
5663641|NCT00646971|Alkane|alkane
5663642|NCT00646971|Exhaled condensate|exhaled condensate
5663643|NCT00646971|Peripheral arterial tonometry|peripheral arterial tonometry
5663644|NCT00646971|Polysomnography|polysomnography
5663645|NCT00646971|Obstructive Sleep Apnea|obstructive sleep apnea
5663646|NCT00646971|Hypoxia|hypoxia
5663647|NCT00646945|Patient in a oncology unit who has to undergo a painful or invasive procedure|patient in a oncology unit who has to undergo a painful or invasive procedure
5663648|NCT00646906|acetaminophen|acetaminophen
5663649|NCT00646906|low dose aspirin|low dose aspirin
5663650|NCT00646906|cyclooxygenase|cyclooxygenase
5663651|NCT00646906|prostaglandin|prostaglandin
5663652|NCT00646906|drug interaction|drug interaction
5663653|NCT00646906|platelet inhibition|platelet inhibition
5663654|NCT00646906|urinary prostaglandin metabolites|urinary prostaglandin metabolites
5663655|NCT00646906|oxidant stress|oxidant stress
5663656|NCT00646906|smoking|smoking
5663657|NCT00646893|aneuploidy|aneuploidy
5663658|NCT00646893|miscarriage|miscarriage
5663659|NCT00646893|pregnancy loss|pregnancy loss
5663660|NCT00646893|PGD|pgd
5663661|NCT00646893|PGS|pgs
5663662|NCT00646893|Preimplantation Genetic Diagnosis|preimplantation genetic diagnosis
5663663|NCT00646893|chromosome abnormalities|chromosome abnormalities
5663664|NCT00646893|IVF|ivf
5663665|NCT00646893|ART|art
5663666|NCT00646867|Tetrix cream, contact dermatitis, effect on burning and itching|tetrix cream, contact dermatitis, effect on burning and itching
5663667|NCT00646854|Lymphoma, T-Cell|lymphoma, t-cell
5663668|NCT00646854|Lymphoma, T-Cell, Peripheral|lymphoma, t-cell, peripheral
5663669|NCT00646854|MabCampath|mabcampath
5663670|NCT00646854|Campath|campath
5663671|NCT00646854|CHOP-14|chop-14
5663672|NCT00646854|CD52 expression|cd52 expression
5663673|NCT00646841|Essential hypertension, doxazosin, ambulatory blood pressure monitoring|essential hypertension, doxazosin, ambulatory blood pressure monitoring
5663674|NCT00646828|Pseudohypoaldosteronism type 1|pseudohypoaldosteronism type 1
5663675|NCT00646828|Mineralocorticoid receptor|mineralocorticoid receptor
5663676|NCT00646828|Aldosterone|aldosterone
5663677|NCT00646828|Cardiovascular disease|cardiovascular disease
5663678|NCT00646815|insulin sensitivity|insulin sensitivity
5663679|NCT00646815|substrate metabolism|substrate metabolism
5663680|NCT00646815|fatty liver|fatty liver
5663681|NCT00646815|intramyocellular lipids|intramyocellular lipids
5663682|NCT00646815|growth hormone deficiency|growth hormone deficiency
5663683|NCT00646815|Growth hormone deficiency (Adult)|growth hormone deficiency (adult)
5663685|NCT00646750|Autologous|autologous
5663686|NCT00646750|Lymphoma|lymphoma
5663687|NCT00646750|GELTAMO|geltamo
5663688|NCT00646737|Kidney transplantation|kidney transplantation
5663690|NCT00646737|mycophenolate mofetil|mycophenolate mofetil
5663691|NCT00646737|mycophenolate sodium,|mycophenolate sodium,
5663692|NCT00646737|tacrolimus|tacrolimus
5663693|NCT00646724|Islets of Langerhans Transplantation|islets of langerhans transplantation
5663694|NCT00646724|Mesenchymal Stem Cells|mesenchymal stem cells
5663695|NCT00646724|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5663696|NCT00646698|VLDL-TG kinetics|vldl-tg kinetics
5663697|NCT00646698|Obesity|obesity
5663698|NCT00646698|Body composition|body composition
5663699|NCT00646698|Tracers|tracers
5663700|NCT00646698|Tissue biopsies|tissue biopsies
5663701|NCT00646672|ECMO|ecmo
5663702|NCT00646672|Cerebral Perfusion|cerebral perfusion
5663703|NCT00646672|Carotid Artery|carotid artery
5663704|NCT00646672|Aneurysm|aneurysm
5663705|NCT00646672|Cerebral Circulation|cerebral circulation
5657294|NCT00673439|HIT|hit
5663706|NCT00646672|Common Carotid Artery Occlusion|common carotid artery occlusion
5663707|NCT00646659|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5663708|NCT00646659|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5663709|NCT00646659|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5663710|NCT00646659|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5663711|NCT00646659|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5663712|NCT00646659|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5663713|NCT00646659|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5663714|NCT00646659|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5663715|NCT00646659|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5663716|NCT00646646|Sedation|sedation
5663717|NCT00646646|Eye Movements|eye movements
5663718|NCT00646633|Cancer|cancer
5663719|NCT00646633|Acupuncture|acupuncture
5663720|NCT00646620|asthma|asthma
5663721|NCT00646620|bronchodilatation|bronchodilatation
5663722|NCT00646620|Symbicort|symbicort
5663723|NCT00646620|budesonide/formoterol|budesonide/formoterol
5663724|NCT00646620|Advair Diskus|advair diskus
5663725|NCT00646620|Ventolin|ventolin
5663726|NCT00646607|colorectal neoplasm|colorectal neoplasm
5663727|NCT00646607|high risk|high risk
5663728|NCT00646607|stage II/III|stage ii/iii
5663729|NCT00646594|Asthma|asthma
5663730|NCT00646594|inhaled cortocisteroids|inhaled cortocisteroids
5663731|NCT00646594|Symbicort|symbicort
5663732|NCT00646594|budesonide/formoterol|budesonide/formoterol
5663733|NCT00646594|Advair|advair
5663734|NCT00646594|fluticasone/salmeterol|fluticasone/salmeterol
5663735|NCT00646581|Schizophrenia|schizophrenia
5663736|NCT00646581|Memory|memory
5663737|NCT00646581|Concentration|concentration
5663738|NCT00646581|Insulin|insulin
5663740|NCT00646568|ovarian reserve|ovarian reserve
5663741|NCT00646568|androgens|androgens
5663742|NCT00646568|thecal cells|thecal cells
5663743|NCT00646568|Fertility Agents, Female|fertility agents, female
5663744|NCT00646555|Tissue Samples|tissue samples
5663745|NCT00646555|VEGF Receptors|vegf receptors
5663746|NCT00646555|VEGF|vegf
5663747|NCT00646555|Microvessel Density|microvessel density
5663748|NCT00646555|Hypoxia Inducible Factor|hypoxia inducible factor
5663749|NCT00646555|Inflammatory Breast Cancer|inflammatory breast cancer
5663750|NCT00646555|IBC|ibc
5663751|NCT00646542|Type 2 diabetes, vildagliptin|type 2 diabetes, vildagliptin
5663752|NCT00646529|asthma|asthma
5663753|NCT00646529|children|children
5663754|NCT00646529|Symbicort|symbicort
5663755|NCT00646529|budesonide/formoterol|budesonide/formoterol
5663756|NCT00646529|Pulmicort|pulmicort
5663757|NCT00646529|budesonide|budesonide
5663758|NCT00646516|Asthma|asthma
5663759|NCT00646516|inhaled corticosteroids|inhaled corticosteroids
5663760|NCT00646516|Symbicort|symbicort
5663761|NCT00646516|budesonide/formoterol|budesonide/formoterol
5663762|NCT00646516|budesonide|budesonide
5663763|NCT00646503|Hepatitis B, Chronic|hepatitis b, chronic
5663764|NCT00646503|Telbivudine|telbivudine
5663765|NCT00646503|Polymerase Chain reaction|polymerase chain reaction
5663766|NCT00646490|serum, pleural effusion, procalcitonin, pneumonia|serum, pleural effusion, procalcitonin, pneumonia
5663767|NCT00646464|CPT|cpt
5663768|NCT00646464|ADHD|adhd
5663769|NCT00646451|Essential tremor|essential tremor
5671729|NCT00614640|Therapeutic vaccine|therapeutic vaccine
5663770|NCT00646451|Activities of Daily Living (ADL's)|activities of daily living (adl's)
5663771|NCT00646438|Diabetes|diabetes
5663772|NCT00646438|CABG|cabg
5663773|NCT00646425|Non-infectious uveitis|non-infectious uveitis
5663774|NCT00646412|randomized, controlled, single-blind study|randomized, controlled, single-blind study
5663775|NCT00646412|Adhesion Prophylaxis|adhesion prophylaxis
5663776|NCT00646412|Abdominal Surgery|abdominal surgery
5663777|NCT00646412|Laparotomy, median|laparotomy, median
5663778|NCT00646399|Staphylococcal|staphylococcal
5663779|NCT00646399|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
5663780|NCT00646399|Monoclonal antibodies|monoclonal antibodies
5663781|NCT00646399|Very Low Birth Weight Infants|very low birth weight infants
5663782|NCT00646399|Prophylaxis|prophylaxis
5663783|NCT00646373|Cardiac surgery|cardiac surgery
5663784|NCT00646373|Pump prime|pump prime
5663785|NCT00646373|Blood transfusions|blood transfusions
5663786|NCT00646360|birth size, gestational age, development, child growth,|birth size, gestational age, development, child growth,
5663787|NCT00646360|prenatal nutrition, DHA|prenatal nutrition, dha
5663788|NCT00646347|stroke|stroke
5663789|NCT00646347|upper limb rehabilitation|upper limb rehabilitation
5663790|NCT00646347|treatment|treatment
5663791|NCT00646347|movement recovery from sever paralytic upper limb|movement recovery from sever paralytic upper limb
5663792|NCT00646347|neuro hand orthosis|neuro hand orthosis
5663793|NCT00646347|self practice program|self practice program
5663794|NCT00646347|subacute|subacute
5663795|NCT00646334|Large Pore Size Propylene Mesh|large pore size propylene mesh
5663797|NCT00646334|Randomized Controlled Double-blind Study|randomized controlled double-blind study
5663798|NCT00646321|asthma|asthma
5663799|NCT00646321|children|children
5663800|NCT00646321|adolescents|adolescents
5663801|NCT00646321|Symbicort|symbicort
5663802|NCT00646321|budesonide/ formoterol|budesonide/ formoterol
5663803|NCT00646321|budesonide|budesonide
5663804|NCT00646308|growth hormone deficiency, pituitary tumors|growth hormone deficiency, pituitary tumors
5663805|NCT00646295|TRO|tro
5680419|NCT00577811|Special Need Plans|special need plans
5680420|NCT00577811|Fee for Services|fee for services
5680421|NCT00577811|Access to Care|access to care
5663806|NCT00646269|Dementia ; Alzheimer's Disease ; Non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment|dementia ; alzheimer's disease ; non pharmacological treatments ; cognitive training ; reminiscence therapy ; efficacy assessment
5663807|NCT00646256|schizoaffective|schizoaffective
5663808|NCT00646256|schizotypal|schizotypal
5663809|NCT00646243|Heart failure|heart failure
5663810|NCT00646243|echocardiography|echocardiography
5663811|NCT00646243|cardiac resynchronization therapy|cardiac resynchronization therapy
5663812|NCT00646243|left ventricular dyssynchrony|left ventricular dyssynchrony
5663813|NCT00646230|recurrent neuroblastoma|recurrent neuroblastoma
5663814|NCT00646217|SELF Care Talk|self care talk
5663815|NCT00646217|stroke|stroke
5663816|NCT00646217|caregivers|caregivers
5663817|NCT00646217|Caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke|caregiving as experienced by older adults caring for a spouse/partner with a first-ever stroke
5663818|NCT00646204|Parkinson's disease|parkinson's disease
5663819|NCT00646204|non-motor symptoms|non-motor symptoms
5663820|NCT00646165|Leukemia, CLL|leukemia, cll
5663821|NCT00646152|Antiviral|antiviral
5663822|NCT00646152|Influenza|influenza
5663823|NCT00646152|Interferon|interferon
5663824|NCT00646152|Prophylaxis|prophylaxis
5663825|NCT00646152|SARS|sars
5663826|NCT00646152|Healthy Volunteer|healthy volunteer
5663827|NCT00646152|HV|hv
5663828|NCT00646139|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5663829|NCT00646139|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5663830|NCT00646139|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5663831|NCT00646139|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5663832|NCT00646139|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5663938|NCT00645918|Platelet Function Tests|platelet function tests
5663833|NCT00646139|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5663834|NCT00646139|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5663835|NCT00646139|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5663836|NCT00646139|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5663837|NCT00646139|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5663838|NCT00646139|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5663839|NCT00646139|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5644799|NCT00722020|the Vest|the vest
5663840|NCT00646139|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5663841|NCT00646139|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5663842|NCT00646139|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5663843|NCT00646139|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5663844|NCT00646139|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5663845|NCT00646139|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5663846|NCT00646139|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5855874|NCT00000876|PRO 542|pro 542
5663847|NCT00646139|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5663848|NCT00646139|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5663849|NCT00646139|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5847452|NCT00039715|Major Depression|major depression
5663850|NCT00646139|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5663851|NCT00646139|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5663852|NCT00646139|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5663853|NCT00646139|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5663854|NCT00646139|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5663855|NCT00646139|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5663856|NCT00646139|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5663857|NCT00646139|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5664040|NCT00645411|Egg-Derived|egg-derived
5663858|NCT00646139|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5663859|NCT00646139|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5663860|NCT00646139|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5663861|NCT00646139|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5663863|NCT00646139|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5663864|NCT00646139|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5663865|NCT00646139|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5663866|NCT00646139|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5663867|NCT00646139|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5663868|NCT00646139|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5663869|NCT00646139|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5680422|NCT00577811|Medicaid|medicaid
5663870|NCT00646139|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5663871|NCT00646139|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5663872|NCT00646139|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5663873|NCT00646139|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5663874|NCT00646139|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5663875|NCT00646139|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5663876|NCT00646139|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5663877|NCT00646139|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5663878|NCT00646139|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5663879|NCT00646139|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5663880|NCT00646139|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5663881|NCT00646139|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5663882|NCT00646139|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5663883|NCT00646139|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5663884|NCT00646139|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5663885|NCT00646139|intraocular lymphoma|intraocular lymphoma
5663886|NCT00646139|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5663887|NCT00646139|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5663888|NCT00646139|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5663889|NCT00646139|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5663890|NCT00646139|small intestine lymphoma|small intestine lymphoma
5663891|NCT00646100|hepatocellular carcinoma|hepatocellular carcinoma
5663892|NCT00646100|transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5663893|NCT00646100|prospective control study|prospective control study
5663894|NCT00646100|best support care|best support care
5663895|NCT00646100|survival|survival
5663896|NCT00646074|Caregiver|caregiver
5663897|NCT00646074|Alzheimer's disease|alzheimer's disease
5663898|NCT00646074|Caregiving as experienced by older adults caring for a spouse with Alzheimer's disease or dementia|caregiving as experienced by older adults caring for a spouse with alzheimer's disease or dementia
5663899|NCT00646061|renal colic|renal colic
5663900|NCT00646048|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5663902|NCT00646048|TriVascular Stent-Graft System|trivascular stent-graft system
5663903|NCT00646048|Stent-Graft|stent-graft
5663904|NCT00646022|Neuroendocrine|neuroendocrine
5663906|NCT00646022|Gastrointestinal|gastrointestinal
5663907|NCT00646022|Serotonin|serotonin
5663908|NCT00646022|Carcinoid Tumor|carcinoid tumor
5663909|NCT00646022|Gastrointestinal Carcinoid Tumor|gastrointestinal carcinoid tumor
5663910|NCT00646022|Familial Cancer Tumor|familial cancer tumor
5663911|NCT00646009|asthma|asthma
5663912|NCT00646009|adults|adults
5663913|NCT00646009|Symbicort|symbicort
5663914|NCT00646009|budesonide/formoterol|budesonide/formoterol
5663915|NCT00646009|Advair Diskus|advair diskus
5663916|NCT00646009|Ventolin|ventolin
5663917|NCT00645996|Probiotics|probiotics
5663918|NCT00645996|vaccines|vaccines
5663919|NCT00645996|Measles|measles
5663920|NCT00645996|Mumps|mumps
5663921|NCT00645996|Rubella|rubella
5663922|NCT00645983|Chamomile|chamomile
5663923|NCT00645983|Anxiety|anxiety
5663924|NCT00645983|Complementary and Alternative Medicine|complementary and alternative medicine
5663928|NCT00645970|multiple traumas|multiple traumas
5663930|NCT00645957|drainage|drainage
5663931|NCT00645957|irrigation|irrigation
5663932|NCT00645931|Bone Marrow|bone marrow
5663933|NCT00645931|Bone Marrow Transplant|bone marrow transplant
5663934|NCT00645931|Pediatric|pediatric
5663935|NCT00645931|Psychological Impact|psychological impact
5663936|NCT00645931|Psychology|psychology
5663937|NCT00645918|Platelets|platelets
5663939|NCT00645918|Clopidogrel|clopidogrel
5663940|NCT00645918|Drug Eluting Stents|drug eluting stents
5663941|NCT00645918|Acute Coronary Syndrome|acute coronary syndrome
5663942|NCT00645918|Myocardial Ischemia|myocardial ischemia
5663943|NCT00645918|Stent Thrombosis|stent thrombosis
5663944|NCT00645918|Heart Diseases|heart diseases
5663945|NCT00645918|Coronary Disease|coronary disease
5663946|NCT00645918|Arterial Occlusive Disease|arterial occlusive disease
5663947|NCT00645879|Propionic Acidemia|propionic acidemia
5663950|NCT00645879|glutamine|glutamine
5663951|NCT00645879|ornithine alpha ketoglutarate|ornithine alpha ketoglutarate
5663952|NCT00645879|citrate|citrate
5663953|NCT00645866|stage IIIA breast cancer|stage iiia breast cancer
5663954|NCT00645866|stage IIIB breast cancer|stage iiib breast cancer
5663955|NCT00645866|stage IIIC breast cancer|stage iiic breast cancer
5663956|NCT00645840|Type 1 diabetes mellitus|type 1 diabetes mellitus
5663957|NCT00645840|IL1 beta|il1 beta
5663958|NCT00645840|Anakinra|anakinra
5663959|NCT00645827|Insulin|insulin
5663960|NCT00645827|Blood Glucose|blood glucose
5663961|NCT00645801|Routine screening colonoscopy|routine screening colonoscopy
5663962|NCT00645801|Colonoscopy Preparation|colonoscopy preparation
5663963|NCT00645801|Amitiza|amitiza
5663964|NCT00645801|GoLYTELY|golytely
5663965|NCT00645801|Pegylated Electrolytes|pegylated electrolytes
5663966|NCT00645801|Preparation Solution|preparation solution
5663967|NCT00645801|Colonoscopy Solution|colonoscopy solution
5663968|NCT00645788|Ciprofloxacin|ciprofloxacin
5663969|NCT00645788|cystic fibrosis|cystic fibrosis
5663970|NCT00645788|sweat test|sweat test
5663971|NCT00645788|pulmonary function test|pulmonary function test
5663972|NCT00645775|Weight loss|weight loss
5663973|NCT00645775|Antiobesity|antiobesity
5663974|NCT00645775|Metabolic syndrome|metabolic syndrome
5663975|NCT00645775|Leptin|leptin
5663976|NCT00645762|Chronic rhinosinusitis|chronic rhinosinusitis
5663977|NCT00645762|Chronic sinusitis|chronic sinusitis
5663978|NCT00645762|Maxillary sinus|maxillary sinus
5663979|NCT00645762|Anterior ethmoid sinus|anterior ethmoid sinus
5663980|NCT00645762|Ethmoid infundibulum|ethmoid infundibulum
5663981|NCT00645762|Balloon dilation|balloon dilation
5663982|NCT00645762|Endoscopic visualization|endoscopic visualization
5663983|NCT00645762|Local anesthesia|local anesthesia
5663984|NCT00645762|Canine fossa|canine fossa
5663985|NCT00645762|Less invasive|less invasive
5663986|NCT00645736|Chronic Hepatitis B|chronic hepatitis b
5663987|NCT00645723|Acinetobacter baumanii|acinetobacter baumanii
5663988|NCT00645723|Ventilator-associated pneumonia|ventilator-associated pneumonia
5663989|NCT00645697|tuberculosis|tuberculosis
5663990|NCT00645697|Multifocal serpiginous choroiditis|multifocal serpiginous choroiditis
5663991|NCT00645697|histoplasmosis|histoplasmosis
5663992|NCT00645697|Harada toxoplasmosis|harada toxoplasmosis
5663993|NCT00645684|Gastrointestinal Anastomosis|gastrointestinal anastomosis
5663994|NCT00645684|Multicentre|multicentre
5663995|NCT00645684|Randomized controlled single-blind study|randomized controlled single-blind study
5663996|NCT00645684|synthetic, absorbable, braided and coated suture material|synthetic, absorbable, braided and coated suture material
5663997|NCT00645684|Laparotomy|laparotomy
5664002|NCT00645632|localized osteosarcoma|localized osteosarcoma
5664003|NCT00645619|Pneumonia,viral|pneumonia,viral
5664004|NCT00645619|Pneumonia,bacterial|pneumonia,bacterial
5664005|NCT00645619|TREM-1 protein,human|trem-1 protein,human
5664006|NCT00645606|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5664007|NCT00645606|Maintenance in first-line treatment|maintenance in first-line treatment
5664008|NCT00645606|Elderly patients|elderly patients
5664009|NCT00645593|Bladder Cancer|bladder cancer
5664010|NCT00645567|Biomechanics|biomechanics
5664011|NCT00645567|Ergonomics|ergonomics
5664012|NCT00645567|Spinal Cord Injury|spinal cord injury
5664013|NCT00645567|Pain|pain
5664014|NCT00645567|Shoulder|shoulder
5664015|NCT00645554|Galantamine oral solution|galantamine oral solution
5664016|NCT00645554|Galantamine tablet|galantamine tablet
5664017|NCT00645554|Bioequivalence|bioequivalence
5664018|NCT00645541|Breast Cancer|breast cancer
5664019|NCT00645541|Carcinoma of the Breast|carcinoma of the breast
5664020|NCT00645541|Lymph Nodes|lymph nodes
5664021|NCT00645541|Lymphazurin|lymphazurin
5664022|NCT00645541|Axillary Reverse Mapping|axillary reverse mapping
5664025|NCT00645502|Schizophrenia|schizophrenia
5664026|NCT00645502|Risperidone|risperidone
5664027|NCT00645502|Orally-disintegrating tablet|orally-disintegrating tablet
5664028|NCT00645502|Bioequivalence|bioequivalence
5664029|NCT00645489|heart failure intervention|heart failure intervention
5664030|NCT00645450|Stress|stress
5664031|NCT00645450|Posttraumatic|posttraumatic
5664032|NCT00645450|PTSD|ptsd
5664033|NCT00645450|Propranolol|propranolol
5664034|NCT00645450|Treatment|treatment
5664035|NCT00645437|renal diseases|renal diseases
5664036|NCT00645437|levofloxacin|levofloxacin
5664037|NCT00645411|Influenza|influenza
5664039|NCT00645411|Cell Culture-Derived|cell culture-derived
5664041|NCT00645411|Healthy Children|healthy children
5664042|NCT00645411|Healthy Adolescents|healthy adolescents
5664043|NCT00645411|Safety|safety
5664044|NCT00645411|Immunogenicity|immunogenicity
5664045|NCT00645411|Trivalent|trivalent
5664046|NCT00645411|Inactivated|inactivated
5664047|NCT00645411|Vaccination|vaccination
5664048|NCT00645385|GBM|gbm
5664049|NCT00645385|AA|aa
5664050|NCT00645385|AO|ao
5664051|NCT00645385|Brain|brain
5664052|NCT00645385|Tumors|tumors
5664053|NCT00645385|Malignant|malignant
5664055|NCT00645385|Multiforme|multiforme
5664056|NCT00645385|Carmustine|carmustine
5664057|NCT00645385|implant|implant
5664058|NCT00645385|BCNU|bcnu
5664059|NCT00645385|Gliadel|gliadel
5664060|NCT00645385|Wafers|wafers
5664062|NCT00645385|Spectroscopy|spectroscopy
5664063|NCT00645359|dMRI|dmri
5664064|NCT00645359|diffusion MRI|diffusion mri
5664065|NCT00645359|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5664066|NCT00645359|DLBCL|dlbcl
5664067|NCT00645346|GBS|gbs
5664068|NCT00645333|breast cancer|breast cancer
5664069|NCT00645333|Phase I clinical trial|phase i clinical trial
5664070|NCT00645333|cancer stem cells|cancer stem cells
5648019|NCT00710775|Heart surgery|heart surgery
5664071|NCT00645333|agents with other mechanisms of action|agents with other mechanisms of action
5664072|NCT00645333|Notch inhibitors|notch inhibitors
5664073|NCT00645307|paliperidone|paliperidone
5664074|NCT00645307|Schizophrenia|schizophrenia
5664075|NCT00645294|Hepatitis B|hepatitis b
5664076|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil
5664077|NCT00645294|Children|children
5664078|NCT00645294|Adolescents|adolescents
5664079|NCT00645294|Pharmacokinetics|pharmacokinetics
5664080|NCT00645190|Alzheimer Disease|alzheimer disease
5664081|NCT00645190|galantamine|galantamine
5664082|NCT00645177|Breast Cancer|breast cancer
5664083|NCT00645164|wound healing|wound healing
5664084|NCT00645164|photoallergenicity|photoallergenicity
5664085|NCT00645164|Healthy subjects|healthy subjects
5664086|NCT00645138|breast carcinoma|breast carcinoma
5664087|NCT00645138|breast cancer|breast cancer
5664088|NCT00645138|paravertebral block|paravertebral block
5664089|NCT00645138|comparison of paravertebral block and general anesthesia|comparison of paravertebral block and general anesthesia
5664090|NCT00645138|ultrasound|ultrasound
5664091|NCT00645125|pediatric taste test|pediatric taste test
5664092|NCT00645125|antibiotic taste test|antibiotic taste test
5664093|NCT00645125|cefdinir|cefdinir
5664094|NCT00645125|amoxicillin|amoxicillin
5664095|NCT00645099|Paliperidone ER|paliperidone er
5664096|NCT00645099|Olanzapine|olanzapine
5664097|NCT00645099|Schizophrenia|schizophrenia
5664098|NCT00645073|Acute Bacterial Sinusitis|acute bacterial sinusitis
5664100|NCT00645047|PTSD|ptsd
5664101|NCT00645047|Telemedicine|telemedicine
5664102|NCT00645047|Patient-Centered Care|patient-centered care
5664103|NCT00645047|Professional Patient Relationship|professional patient relationship
5664104|NCT00645047|Psychotherapy|psychotherapy
5664105|NCT00645047|Cognitive Therapy|cognitive therapy
5664106|NCT00645008|Stressors|stressors
5664107|NCT00645008|Patient Satisfaction|patient satisfaction
5664108|NCT00645008|Cardiothoracic-Intensive Care Unit|cardiothoracic-intensive care unit
5664109|NCT00645008|Coronary bypass patient|coronary bypass patient
5664110|NCT00644995|Depression|depression
5664111|NCT00644995|Smoking|smoking
5664112|NCT00644995|Physical Activity|physical activity
5664113|NCT00644930|ARDS,|ards,
5664114|NCT00644930|noninvasive ventilation,|noninvasive ventilation,
5664115|NCT00644930|intubation,|intubation,
5664116|NCT00644930|mortality,|mortality,
5664117|NCT00644930|intensive care|intensive care
5664118|NCT00644917|wound healing|wound healing
5664119|NCT00644917|phototoxicity|phototoxicity
5664120|NCT00644917|Healthy Subjects|healthy subjects
5664121|NCT00644904|Multiple Sclerosis|multiple sclerosis
5664122|NCT00644904|Vitamin D|vitamin d
5664124|NCT00644891|Pediatric taste test|pediatric taste test
5664125|NCT00644891|Antibiotic taste test|antibiotic taste test
5664126|NCT00644891|cefdinir|cefdinir
5664127|NCT00644891|amoxicillin|amoxicillin
5664128|NCT00644878|leukemia|leukemia
5847690|NCT00038532|treatment experienced|treatment experienced
5664129|NCT00644878|chronic myelogenous leukemia|chronic myelogenous leukemia
5664130|NCT00644878|chronic phase|chronic phase
5664131|NCT00644878|molecular response|molecular response
5664132|NCT00644878|nilotinib|nilotinib
5664133|NCT00644878|ENABL|enabl
5664134|NCT00644852|Schizophrenia|schizophrenia
5664135|NCT00644852|Schizoaffective disorder|schizoaffective disorder
5664136|NCT00644852|Risperidone long-acting injectable, Long-term evaluation|risperidone long-acting injectable, long-term evaluation
5664137|NCT00644826|randomized controlled trial|randomized controlled trial
5664138|NCT00644826|public health|public health
5664139|NCT00644826|Preventive Health Services|preventive health services
5664140|NCT00644813|Scapula fracture involving glenoid neck|scapula fracture involving glenoid neck
5664141|NCT00644813|Forelimb dysfunction|forelimb dysfunction
5664142|NCT00644787|Pain|pain
5664143|NCT00644787|Cancer|cancer
5664144|NCT00644787|Fentanyl|fentanyl
5664145|NCT00644787|JNS020QD|jns020qd
5664146|NCT00644787|JNS005|jns005
5664147|NCT00644774|pediatric taste test|pediatric taste test
5664148|NCT00644774|antibiotic taste test|antibiotic taste test
5664149|NCT00644774|cefdinir|cefdinir
5664150|NCT00644774|azithromycin|azithromycin
5664151|NCT00644761|Hepatitis B|hepatitis b
5664152|NCT00644761|Post-Liver Transplantation|post-liver transplantation
5664153|NCT00644761|Adefovir Dipivoxil|adefovir dipivoxil
5664154|NCT00644761|Tacrolimus|tacrolimus
5664155|NCT00644761|Cyclosporine|cyclosporine
5664156|NCT00644735|Erosive Esophagitis|erosive esophagitis
5664157|NCT00644735|Nexium|nexium
5664158|NCT00644735|Esomeprazole|esomeprazole
5664159|NCT00644735|Lansoprazole|lansoprazole
5664160|NCT00644735|Heartburn|heartburn
5664161|NCT00644722|Intubation|intubation
5664162|NCT00644722|Out-of-hospital|out-of-hospital
5664163|NCT00644722|Laryngoscope|laryngoscope
5664164|NCT00644722|Blades|blades
5664165|NCT00644722|Emergency|emergency
5664166|NCT00644696|Neuroblastoma|neuroblastoma
5664167|NCT00644696|Irinotecan|irinotecan
5664168|NCT00644696|Bortezomib|bortezomib
5664169|NCT00644683|premenopausal women with breast cancer|premenopausal women with breast cancer
5664170|NCT00644657|Platelets, platelet aggregation inhibitors|platelets, platelet aggregation inhibitors
5664172|NCT00644644|Nihon Kohden|nihon kohden
5664173|NCT00644644|mobile monitoring|mobile monitoring
5664174|NCT00644618|pancreatic cancer|pancreatic cancer
5664175|NCT00644618|locally advanced|locally advanced
5664176|NCT00644592|Healthy Volunteers|healthy volunteers
5664177|NCT00644579|wart|wart
5664178|NCT00644579|cutaneous|cutaneous
5664179|NCT00644579|transplant|transplant
5664180|NCT00644579|Cutaneous warts in immune suppressed, kidney transplant patients|cutaneous warts in immune suppressed, kidney transplant patients
5664181|NCT00644566|ADHD|adhd
5664182|NCT00644566|Primary Care|primary care
5664183|NCT00644566|Pediatrics|pediatrics
5664184|NCT00644566|Health services|health services
5664185|NCT00644566|shared care|shared care
5664186|NCT00644566|care manager|care manager
5664187|NCT00644566|screening|screening
5664188|NCT00644540|Influenza|influenza
5664189|NCT00644540|vaccines|vaccines
5664190|NCT00644540|children|children
5664191|NCT00644527|depression|depression
5664192|NCT00644527|music|music
5664193|NCT00644527|sound|sound
5664194|NCT00644527|randomized controlled trial|randomized controlled trial
5664195|NCT00644514|LPS endotoxin|lps endotoxin
5664196|NCT00644514|Asthma|asthma
5664197|NCT00644501|type 1 diabetes|type 1 diabetes
5664198|NCT00644501|beta cells|beta cells
5664199|NCT00644501|immunomodulation|immunomodulation
5664200|NCT00644501|immunointervention|immunointervention
5664201|NCT00644475|Hypertension|hypertension
5664202|NCT00644475|Insulin sensitivity|insulin sensitivity
5664203|NCT00644475|Fibrinolysis|fibrinolysis
5664204|NCT00644462|wheeze detection|wheeze detection
5664205|NCT00644436|tetrix cream|tetrix cream
5664206|NCT00644436|substantivity|substantivity
5664207|NCT00644436|resistance to a gentle wash|resistance to a gentle wash
5664208|NCT00644436|Tetrix Cream remaining on hands after gentle washing with soap and water.|tetrix cream remaining on hands after gentle washing with soap and water.
5664209|NCT00644423|PTSD|ptsd
5664210|NCT00644423|Cognition|cognition
5664211|NCT00644423|Fish Oil|fish oil
5664212|NCT00644423|Omega-3 Fatty Acid|omega-3 fatty acid
5664213|NCT00644410|heart failure|heart failure
5664214|NCT00644410|stem cell|stem cell
5664215|NCT00644410|mesenchymal stromal cell|mesenchymal stromal cell
5664216|NCT00644410|mesenchymal stem cell|mesenchymal stem cell
5664217|NCT00644397|distal femur fracture|distal femur fracture
5664218|NCT00644397|locked plates|locked plates
5664219|NCT00644397|functional outcomes|functional outcomes
5664220|NCT00644397|cost management|cost management
5664221|NCT00644397|femur head|femur head
5664222|NCT00644397|femur neck|femur neck
5664223|NCT00644384|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5664224|NCT00644384|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5664225|NCT00644371|Allogeneic|allogeneic
5664226|NCT00644371|Lymphoma|lymphoma
5664227|NCT00644371|GELTAMO|geltamo
5664228|NCT00644371|Z-RIC|z-ric
5664229|NCT00644345|Microvolt T wave alternans|microvolt t wave alternans
5664230|NCT00644345|reproducibility|reproducibility
5664231|NCT00644319|malignant pleural effusion|malignant pleural effusion
5664232|NCT00644306|Multiple Myeloma, very elderly patients, thalidomide|multiple myeloma, very elderly patients, thalidomide
5664233|NCT00644280|Glaucoma,Ahmed Valve|glaucoma,ahmed valve
5664234|NCT00644267|hypertension|hypertension
5664235|NCT00644267|cardiovascular risk|cardiovascular risk
5664237|NCT00644254|Prognosis|prognosis
5664238|NCT00644254|Extracapsular lymph node involvement|extracapsular lymph node involvement
5664239|NCT00644241|stem cell therapy|stem cell therapy
5664240|NCT00644241|T2DM|t2dm
5664241|NCT00644241|Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus|efficacy of autologous bone marrow derived stem cell transplantation in patients with type 2 diabetes mellitus
5664242|NCT00644215|injected bleb|injected bleb
5664243|NCT00644215|mitomycin drop|mitomycin drop
5664244|NCT00644215|5-Fu injection|5-fu injection
5664245|NCT00644215|early bleb failure|early bleb failure
5664246|NCT00644202|weight control|weight control
5664247|NCT00644189|clofarabine|clofarabine
5664249|NCT00644189|lymphoma|lymphoma
5664250|NCT00644189|NHL|nhl
5664251|NCT00644189|oral chemotherapy|oral chemotherapy
5664252|NCT00644163|HIV|hiv
5664253|NCT00644163|STI|sti
5664254|NCT00644163|Risk Reduction|risk reduction
5664263|NCT00644137|no cravings|no cravings
5664264|NCT00644137|desire to smoke|desire to smoke
5664265|NCT00644124|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5664266|NCT00644124|angiogenesis inhibitors|angiogenesis inhibitors
5664267|NCT00644124|CHOP protocol|chop protocol
5664268|NCT00644111|Minimally Invasive Decompression and Fusion|minimally invasive decompression and fusion
5664269|NCT00644111|Postoperative analgesia|postoperative analgesia
5664270|NCT00644111|Epidural|epidural
5664271|NCT00644111|Lumbar|lumbar
5664272|NCT00644085|IVF and ICSI|ivf and icsi
5664273|NCT00644072|Hsp90 Inhibitor|hsp90 inhibitor
5664274|NCT00644072|Her2|her2
5664275|NCT00644072|Neoplasms|neoplasms
5664276|NCT00644072|Advanced Cancer|advanced cancer
5664277|NCT00644072|Cancer|cancer
5664278|NCT00644072|Solid Tumor|solid tumor
5664279|NCT00644072|Lymphoma|lymphoma
5664280|NCT00644059|Influenza|influenza
5664281|NCT00644059|vaccine|vaccine
5664282|NCT00644059|children|children
5664283|NCT00644046|Chronic Kidney Disease|chronic kidney disease
5664284|NCT00644046|Prevention|prevention
5664285|NCT00644046|Cardiovascular disease|cardiovascular disease
5664286|NCT00644020|Hepatocellular carcinoma|hepatocellular carcinoma
5664287|NCT00644020|recurrence|recurrence
5664288|NCT00644007|Erectile dysfunction|erectile dysfunction
5664289|NCT00644007|Hypertension|hypertension
5664290|NCT00644007|SK3530|sk3530
5664291|NCT00643994|Prostate Cancer|prostate cancer
5664292|NCT00643994|CyberKnife|cyberknife
5664293|NCT00643994|Stereotactic Radiosurgery|stereotactic radiosurgery
5664294|NCT00643994|Radiotherapy|radiotherapy
5664295|NCT00643994|Radiation|radiation
5664296|NCT00643994|Prostate Tumor|prostate tumor
5664297|NCT00643994|Prostate Surgery|prostate surgery
5664298|NCT00643968|HIV virological control|hiv virological control
5664299|NCT00643968|Lipid profile and morphological fat distribution|lipid profile and morphological fat distribution
5664300|NCT00643968|Treatment Experienced|treatment experienced
5664301|NCT00643955|Evaluation of muscle strength and central activation|evaluation of muscle strength and central activation
5664302|NCT00643929|thrombopoietin receptor agonist|thrombopoietin receptor agonist
5664303|NCT00643929|ocular safety|ocular safety
5664304|NCT00643929|HCV|hcv
5664305|NCT00643929|SB-497115-GR|sb-497115-gr
5664306|NCT00643929|CIT|cit
5664307|NCT00643929|ITP|itp
5664308|NCT00643929|cataract|cataract
5664309|NCT00643929|eltrombopag olamine|eltrombopag olamine
5664310|NCT00643929|lens opacity|lens opacity
5664311|NCT00643916|Meningitis; Meningococcal Infection|meningitis; meningococcal infection
5664312|NCT00643903|Side Effects|side effects
5664313|NCT00643903|Adherence|adherence
5664314|NCT00643903|Coping|coping
5664315|NCT00643903|HIV|hiv
5664316|NCT00643903|AIDS|aids
5664317|NCT00643903|Complementary Therapies|complementary therapies
5664318|NCT00643890|Keywords:|keywords:
5664319|NCT00643890|Parkinson's disease|parkinson's disease
5664320|NCT00643890|Gene transfer|gene transfer
5664321|NCT00643890|Gene therapy|gene therapy
5664322|NCT00643890|Subthalamic nucleus|subthalamic nucleus
5664323|NCT00643890|Adeno-associated virus|adeno-associated virus
5664324|NCT00643890|Study placed in the following topic categories:|study placed in the following topic categories:
5664325|NCT00643890|Ganglion Cysts|ganglion cysts
5664326|NCT00643890|Movement Disorders|movement disorders
5664327|NCT00643890|Parkinson Disease|parkinson disease
5664328|NCT00643890|Basal Ganglia Diseases|basal ganglia diseases
5645284|NCT00720291|BV|bv
5664329|NCT00643890|Central Nervous System Diseases|central nervous system diseases
5664330|NCT00643890|Parkinsonian Disorders|parkinsonian disorders
5664331|NCT00643890|Neurodegenerative Diseases|neurodegenerative diseases
5664332|NCT00643890|Brain Diseases|brain diseases
5664333|NCT00643890|Additional relevant MeSH terms:|additional relevant mesh terms:
5664334|NCT00643890|Nervous System Diseases|nervous system diseases
5664335|NCT00643877|Colorectal Neoplasms|colorectal neoplasms
5664336|NCT00643877|Regional|regional
5664337|NCT00643877|Liver|liver
5664338|NCT00643877|Neoplasm Metastasis|neoplasm metastasis
5664339|NCT00643864|mirror training|mirror training
5664340|NCT00643864|stroke|stroke
5664341|NCT00643864|hemiparesis|hemiparesis
5664342|NCT00643864|rehabilitation|rehabilitation
5664343|NCT00643825|Temozolomide|temozolomide
5664344|NCT00643825|Phase II|phase ii
5664345|NCT00643825|Chemotherapy|chemotherapy
5664346|NCT00643825|Glioblastoma|glioblastoma
5664347|NCT00643825|Progression-free Survival|progression-free survival
5664348|NCT00643812|Firearm storage|firearm storage
5664351|NCT00643812|Alaska Native|alaska native
5664352|NCT00643812|Suicide Attempt|suicide attempt
5664353|NCT00643773|Elderly|elderly
5664354|NCT00643760|Peripheral Diabetic Neuropathy (PDN)|peripheral diabetic neuropathy (pdn)
5664355|NCT00643760|Neuropathic Pain|neuropathic pain
5664356|NCT00643747|retinal dystrophy|retinal dystrophy
5664357|NCT00643747|Leber congenital amaurosis|leber congenital amaurosis
5664358|NCT00643747|RPE65|rpe65
5664359|NCT00643747|gene therapy|gene therapy
5664360|NCT00643721|Young healthy athletes|young healthy athletes
5664361|NCT00643708|anovulation|anovulation
5664362|NCT00643708|laser|laser
5664363|NCT00643708|ovarian interstitial|ovarian interstitial
5664364|NCT00643708|polycystic ovary syndrome|polycystic ovary syndrome
5664365|NCT00643708|ultrasound-guided|ultrasound-guided
5664366|NCT00643695|hepatitis C|hepatitis c
5664367|NCT00643695|depression|depression
5664368|NCT00643695|exercise|exercise
5664369|NCT00643682|colonoscopy|colonoscopy
5664370|NCT00643682|bowel preparation|bowel preparation
5664371|NCT00643682|patient education|patient education
5664372|NCT00643682|polyp detection|polyp detection
5664373|NCT00643656|Liver biopsy|liver biopsy
5664374|NCT00643643|HIV|hiv
5664375|NCT00643643|Treatment Naïve|treatment naïve
5664376|NCT00643630|Tetrix crea|tetrix crea
5664377|NCT00643630|skin barrier|skin barrier
5664378|NCT00643630|antigen reaction|antigen reaction
5664379|NCT00643630|prevention|prevention
5664380|NCT00643630|The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.|the efficacy of tetrix cream to prevent an antigen reaction on the skin.
5664381|NCT00643617|Prostate Cancer|prostate cancer
5664382|NCT00643617|CyberKnife|cyberknife
5664383|NCT00643617|Stereotactic Radiosurgery|stereotactic radiosurgery
5664384|NCT00643617|Radiosurgery|radiosurgery
5664385|NCT00643617|Prostate Tumor|prostate tumor
5664386|NCT00643617|Prostate Surgery|prostate surgery
5664387|NCT00643604|Pulmonary arterial hypertension|pulmonary arterial hypertension
5664388|NCT00643604|treatment satisfaction|treatment satisfaction
5664389|NCT00643604|rapid switch|rapid switch
5664390|NCT00643604|remodulin|remodulin
5664391|NCT00643604|Quality of life|quality of life
5664392|NCT00643591|high grade glioma|high grade glioma
5664393|NCT00643591|FDG-PET-CT|fdg-pet-ct
5664394|NCT00643591|blood proteins|blood proteins
5664395|NCT00643591|prognosis|prognosis
5664396|NCT00643578|formoterol|formoterol
5664397|NCT00643578|methacholine challenge|methacholine challenge
5664398|NCT00643552|Muscle Strength|muscle strength
5664399|NCT00643526|Rheumatoid arthritis|rheumatoid arthritis
5664400|NCT00643526|Psoriatic arthritis|psoriatic arthritis
5664401|NCT00643526|Ankylosing spondylitis|ankylosing spondylitis
5664402|NCT00643526|Psoriasis|psoriasis
5664403|NCT00643526|Autoinjector|autoinjector
5664404|NCT00643513|QUALITY OF LIFE|quality of life
5664405|NCT00643513|POSTMENOPAUSAL WOMEN|postmenopausal women
5664406|NCT00643513|HORMONE RECEPTOR POSITIVE DISSEMINATED BREAST CANCER|hormone receptor positive disseminated breast cancer
5664407|NCT00643513|FASLODEX|faslodex
5664408|NCT00643500|Levetiracetam|levetiracetam
5664409|NCT00643500|Keppra|keppra
5664410|NCT00643487|Knee physiology|knee physiology
5664411|NCT00643487|Anterior compartment knee|anterior compartment knee
5664412|NCT00643487|Infrapatellar plica|infrapatellar plica
5664413|NCT00643487|Ligamentum mucosum|ligamentum mucosum
5664414|NCT00643487|Enthesis organ|enthesis organ
5664415|NCT00643487|Fat pad of the knee|fat pad of the knee
5664416|NCT00643487|Patellofemoral kinematics|patellofemoral kinematics
5664417|NCT00643435|self-efficacy|self-efficacy
5664418|NCT00643435|chronic illness|chronic illness
5664419|NCT00643435|health behavior|health behavior
5664420|NCT00643435|education, medical, residency|education, medical, residency
5664422|NCT00643396|small cell lung cancer|small cell lung cancer
5664423|NCT00643396|radiotherapy|radiotherapy
5664424|NCT00643370|lung cancer|lung cancer
5664425|NCT00643370|tumor motion|tumor motion
5664426|NCT00643357|children with burns|children with burns
5664427|NCT00643357|Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care|child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care
5664428|NCT00643344|obesity|obesity
5664429|NCT00643344|mindfulness based stress reduction|mindfulness based stress reduction
5664430|NCT00643344|diet and exercise|diet and exercise
5664431|NCT00643344|mindful eating|mindful eating
5664432|NCT00643344|stress|stress
5664433|NCT00643331|Osteoporosis|osteoporosis
5664434|NCT00643331|Exercise|exercise
5664435|NCT00643331|Low bone density|low bone density
5664436|NCT00643331|Falls|falls
5664437|NCT00643318|lung cancer|lung cancer
5664438|NCT00643318|lung tumor|lung tumor
5664439|NCT00643318|non-small cell lung cancer|non-small cell lung cancer
5664440|NCT00643318|NSCLC|nsclc
5664441|NCT00643318|CyberKnife|cyberknife
5664442|NCT00643318|radiosurgery|radiosurgery
5664443|NCT00643318|lung surgery|lung surgery
5664445|NCT00643305|Motivational Interviewing|motivational interviewing
5664446|NCT00643305|Skills|skills
5664447|NCT00643305|Prevention|prevention
5664448|NCT00643305|Mental illness|mental illness
5664449|NCT00643305|Risk reduction|risk reduction
5664450|NCT00643305|HIV/AIDS|hiv/aids
5664451|NCT00643305|HIV Seronegativity|hiv seronegativity
5664452|NCT00643279|implantable hemodynamic monitor|implantable hemodynamic monitor
5664453|NCT00643279|Intracardiac pressures|intracardiac pressures
5664454|NCT00643266|recollection training|recollection training
5664455|NCT00643266|aging|aging
5664456|NCT00643266|amnestic mild cognitive impairment|amnestic mild cognitive impairment
5664457|NCT00643266|fMRI|fmri
5664458|NCT00643253|exclusive breastfeeding|exclusive breastfeeding
5664459|NCT00643253|breastfeeding promotion|breastfeeding promotion
5664460|NCT00643253|health promotion|health promotion
5664461|NCT00643240|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5664462|NCT00643240|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5664463|NCT00643240|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5664464|NCT00643214|Tetrix Cream|tetrix cream
5664465|NCT00643214|Antigen reaction|antigen reaction
5664466|NCT00643214|effect on healing|effect on healing
5664467|NCT00643214|To determine if application of Tetrix Cream to lesions of contact dermatitis interferes with their rate of healing|to determine if application of tetrix cream to lesions of contact dermatitis interferes with their rate of healing
5664468|NCT00643188|Atrial fibrillation|atrial fibrillation
5664469|NCT00643188|Ablation|ablation
5664470|NCT00643188|Heart failure|heart failure
5664471|NCT00643188|Home Monitoring|home monitoring
5685565|NCT00555581|Systemic Sclerosis|systemic sclerosis
5664472|NCT00643175|The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.|the main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.
5664473|NCT00643162|Depression|depression
5664474|NCT00643162|Massage|massage
5664475|NCT00643162|Lexapro|lexapro
5664476|NCT00643162|Alternative Therapy|alternative therapy
5664477|NCT00643162|Anti-depressant|anti-depressant
5664478|NCT00643123|Bipolar Disorder|bipolar disorder
5664479|NCT00643123|Mania|mania
5664480|NCT00643123|Mixed mania|mixed mania
5664481|NCT00643123|Allopurinol|allopurinol
5664482|NCT00643123|Treatment-Resistant mania|treatment-resistant mania
5664483|NCT00643110|Hypoglycemia|hypoglycemia
5664484|NCT00643097|adult giant cell glioblastoma|adult giant cell glioblastoma
5664485|NCT00643097|adult gliosarcoma|adult gliosarcoma
5664486|NCT00643097|adult glioblastoma|adult glioblastoma
5664487|NCT00643084|Colorectal|colorectal
5664488|NCT00643084|Bowel preparation|bowel preparation
5664489|NCT00643084|Laparoscopic surgery|laparoscopic surgery
5664490|NCT00643071|Ulcerative colitis|ulcerative colitis
5664491|NCT00643071|Tacrolimus|tacrolimus
5664492|NCT00643071|FK506|fk506
5664493|NCT00643071|Treatment outcome|treatment outcome
5664494|NCT00643058|LPS endotoxin|lps endotoxin
5664495|NCT00643045|Parkinson Disease|parkinson disease
5664496|NCT00643019|Sexually Transmitted Infections|sexually transmitted infections
5664497|NCT00643019|Secondary Prevention|secondary prevention
5664498|NCT00643019|Cognitive Behavioral Intervention|cognitive behavioral intervention
5664499|NCT00643006|Fibromyalgia|fibromyalgia
5664500|NCT00643006|Physical activity|physical activity
5664501|NCT00643006|Function|function
5664502|NCT00643006|Pain|pain
5664503|NCT00643006|Exercise|exercise
5664504|NCT00643006|Inflammation|inflammation
5664505|NCT00642980|Pregnancy|pregnancy
5664506|NCT00642980|Preterm delivery|preterm delivery
5664507|NCT00642980|Bacterial vaginosis|bacterial vaginosis
5664508|NCT00642980|Randomized Clinical Trial|randomized clinical trial
5664509|NCT00642980|Clindamycin|clindamycin
5664510|NCT00642928|Excessive Daytime Sleepiness|excessive daytime sleepiness
5664511|NCT00642928|Parkinson's disease|parkinson's disease
5664512|NCT00642902|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5664513|NCT00642902|Atacicept|atacicept
5664514|NCT00642889|Parkinson's disease|parkinson's disease
5664515|NCT00642863|iron deficiency|iron deficiency
5664516|NCT00642863|iron deficiency anemia|iron deficiency anemia
5664517|NCT00642863|infant|infant
5664518|NCT00642863|development|development
5664519|NCT00642863|behavior|behavior
5664520|NCT00642837|Health-Related Quality of Life|health-related quality of life
5664521|NCT00642837|KEQ-5D|keq-5d
5664522|NCT00642837|Sleep disturbance|sleep disturbance
5664523|NCT00642837|Sleep quality|sleep quality
5664524|NCT00642837|SF-1|sf-1
5664525|NCT00642837|Pain intensity|pain intensity
5664526|NCT00642837|Pain relief|pain relief
5664527|NCT00642837|Tramadol|tramadol
5664528|NCT00642837|Acetaminophen|acetaminophen
5664529|NCT00642811|coronary artery disease (CAD)|coronary artery disease (cad)
5664530|NCT00642811|heart attack|heart attack
5664531|NCT00642811|stable angina|stable angina
5664532|NCT00642785|herpes|herpes
5664534|NCT00642785|zoster|zoster
5664535|NCT00642785|HZV|hzv
5664536|NCT00642785|shingles|shingles
5664537|NCT00642772|Osteoarthritis|osteoarthritis
5664538|NCT00642772|Veterans|veterans
5664539|NCT00642772|Physical Therapy|physical therapy
5664540|NCT00642772|Health Services Research|health services research
5664541|NCT00642759|NSCLC|nsclc
5664542|NCT00642759|Abraxane|abraxane
5664543|NCT00642759|Carboplatin|carboplatin
5664544|NCT00642759|Bevacizumab|bevacizumab
5664545|NCT00642759|Avastin|avastin
5664546|NCT00642746|Colon|colon
5664547|NCT00642746|Cancer|cancer
5664548|NCT00642746|Metastatic|metastatic
5664549|NCT00642746|Colorectal|colorectal
5664551|NCT00642707|Treatment Naïve|treatment naïve
5664552|NCT00642694|MDD|mdd
5664553|NCT00642694|Major Depressive Disorder|major depressive disorder
5664554|NCT00642694|Depression|depression
5664555|NCT00642694|Initial Insomnia|initial insomnia
5664556|NCT00642694|sleep|sleep
5664557|NCT00642694|difficulty sleeping|difficulty sleeping
5664558|NCT00642694|down|down
5664559|NCT00642694|sad|sad
5664560|NCT00642694|Major Depressive Disorder(MDD) and initial insomnia|major depressive disorder(mdd) and initial insomnia
5664561|NCT00642655|IVIG|ivig
5664562|NCT00642655|Rituximab|rituximab
5664563|NCT00642655|Highly Sensitized|highly sensitized
5664564|NCT00642655|Kidney Transplantation|kidney transplantation
5664565|NCT00642642|Acne|acne
5664566|NCT00642590|Fertility|fertility
5664567|NCT00642590|Pregnancy|pregnancy
5664568|NCT00642590|Conception|conception
5648531|NCT00708968|coping|coping
5664569|NCT00642590|Infertility|infertility
5664570|NCT00642590|Behavioral|behavioral
5664571|NCT00642590|Lifestyle|lifestyle
5664572|NCT00642590|Nutrition|nutrition
5664573|NCT00642564|Epilepsy|epilepsy
5664574|NCT00642564|Headache|headache
5664575|NCT00642564|Migraine|migraine
5664576|NCT00642551|vitamin K2|vitamin k2
5664577|NCT00642551|menaquinone-7|menaquinone-7
5664578|NCT00642551|bone health|bone health
5664579|NCT00642551|vascular health|vascular health
5664580|NCT00642538|Diabetic adult male, diabetic postmenopausal women|diabetic adult male, diabetic postmenopausal women
5664581|NCT00642525|detection of anastomotic leakage|detection of anastomotic leakage
5664582|NCT00642525|esophageal resection|esophageal resection
5664583|NCT00642525|diagnostic safety|diagnostic safety
5664584|NCT00642512|CINV|cinv
5664585|NCT00642512|chemotherapy|chemotherapy
5664586|NCT00642512|nausea|nausea
5664587|NCT00642512|vomiting|vomiting
5664588|NCT00642512|retching|retching
5664590|NCT00642499|AIDS|aids
5664591|NCT00642499|nausea|nausea
5664592|NCT00642499|vomiting|vomiting
5664593|NCT00642499|HAART|haart
5664594|NCT00642499|Treatment Experienced|treatment experienced
5664595|NCT00642499|HIV Infections|hiv infections
5664596|NCT00642486|treatment|treatment
5664597|NCT00642486|positive airway pressure|positive airway pressure
5664598|NCT00642486|compliance|compliance
5664599|NCT00642486|cost effectiveness|cost effectiveness
5664600|NCT00642486|clinical trial|clinical trial
5664601|NCT00642447|noninvasive ventilation|noninvasive ventilation
5664602|NCT00642447|helium|helium
5664603|NCT00642447|oxygen|oxygen
5664604|NCT00642447|sulfur mustard|sulfur mustard
5664605|NCT00642447|chronic bronchitis|chronic bronchitis
5664606|NCT00642447|bronchiolitis|bronchiolitis
5664607|NCT00642434|diabetes blood pressure oxidative stress|diabetes blood pressure oxidative stress
5664608|NCT00642421|Acromegaly|acromegaly
5664609|NCT00642395|Multiple Myeloma|multiple myeloma
5664610|NCT00642395|Autologous Stem Cells Transplantation|autologous stem cells transplantation
5664611|NCT00642395|High Dose Melphalan|high dose melphalan
5664612|NCT00642395|Bortezomib|bortezomib
5664613|NCT00642382|Osteoarthritis|osteoarthritis
5664614|NCT00642382|Hyaluronic Acid|hyaluronic acid
5664615|NCT00642369|Polysomnograph|polysomnograph
5664616|NCT00642356|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5664617|NCT00642356|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
5664618|NCT00642356|non-motor symptoms|non-motor symptoms
5664619|NCT00642356|motor-symptoms|motor-symptoms
5664620|NCT00642343|Balance|balance
5664621|NCT00642343|Severe, Profound deafness|severe, profound deafness
5664622|NCT00642343|Children|children
5664623|NCT00642343|unilateral/bilateral cochlear implants|unilateral/bilateral cochlear implants
5664624|NCT00642343|unilateral cochlear implant|unilateral cochlear implant
5664625|NCT00642343|bilateral cochlear implants|bilateral cochlear implants
5664626|NCT00642330|patent|patent
5664627|NCT00642330|ductus|ductus
5664628|NCT00642330|arteriosus|arteriosus
5664629|NCT00642330|ibuprofen|ibuprofen
5664630|NCT00642330|premature|premature
5664631|NCT00642330|infant|infant
5664632|NCT00642317|Healthy Control|healthy control
5664633|NCT00642317|Tobacco Use|tobacco use
5664634|NCT00642317|Tobacco Initiation|tobacco initiation
5664635|NCT00642317|Smoking|smoking
5664636|NCT00642317|Questionnaire|questionnaire
5664637|NCT00642317|Survey|survey
5664638|NCT00642291|Emtricitabine|emtricitabine
5664639|NCT00642291|Pediatric|pediatric
5664640|NCT00642291|HIV-1|hiv-1
5664641|NCT00642291|Treatment of HIV-1|treatment of hiv-1
5664642|NCT00642278|Type 2 diabetes mellitus|type 2 diabetes mellitus
5664643|NCT00642278|Metformin|metformin
5664644|NCT00642278|Hemoglobin A1c|hemoglobin a1c
5664645|NCT00642252|remineraliation|remineraliation
5664646|NCT00642252|pre-existing white-spot (non-cavitated) enamel lesions|pre-existing white-spot (non-cavitated) enamel lesions
5664648|NCT00642226|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5664649|NCT00642226|BRVO|brvo
5664650|NCT00642226|Macular Edema|macular edema
5664652|NCT00642226|Vitrectomy|vitrectomy
5664653|NCT00642213|stroke|stroke
5664654|NCT00642213|ischemic|ischemic
5664655|NCT00642213|TIA|tia
5664656|NCT00642213|hemorrhage|hemorrhage
5664657|NCT00642213|incidence|incidence
5664658|NCT00642213|case-fatality|case-fatality
5664659|NCT00642213|risk factors|risk factors
5664660|NCT00642213|genetic|genetic
5664661|NCT00642187|Asthma|asthma
5664662|NCT00642187|Pulmicort|pulmicort
5664663|NCT00642187|Turbuhaler|turbuhaler
5664664|NCT00642187|Budesonide|budesonide
5664665|NCT00642187|Flexhaler|flexhaler
5664666|NCT00642161|Asthma|asthma
5664667|NCT00642161|Pulmicort|pulmicort
5664668|NCT00642161|Children|children
5664669|NCT00642161|Paediatrics|paediatrics
5664670|NCT00642161|budesonide|budesonide
5664671|NCT00642161|Flexhaler|flexhaler
5664672|NCT00642148|GW856553|gw856553
5664673|NCT00642148|p38 MAPK|p38 mapk
5664674|NCT00642148|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5664675|NCT00642135|premature|premature
5664676|NCT00642135|neonates|neonates
5664677|NCT00642135|infants|infants
5664678|NCT00642135|children|children
5664679|NCT00642135|Mydriasert®|mydriasert®
5664680|NCT00642135|mydriasis|mydriasis
5664681|NCT00642135|fundus|fundus
5664682|NCT00642135|Tropicamide|tropicamide
5664683|NCT00642135|Phenylephrine|phenylephrine
5664684|NCT00642135|clinical trial|clinical trial
5664685|NCT00642135|Infant|infant
5664686|NCT00642135|premature newborns|premature newborns
5664687|NCT00642135|bilateral diagnosis fundus|bilateral diagnosis fundus
5664688|NCT00642122|Asthma|asthma
5664689|NCT00642122|Pulmicort|pulmicort
5664690|NCT00642122|budesonide|budesonide
5664691|NCT00642122|respules|respules
5664692|NCT00642122|turbuhaler|turbuhaler
5664693|NCT00642096|High blood pressure|high blood pressure
5664694|NCT00642096|hypertension|hypertension
5664695|NCT00642096|(TOPROL-XL)|(toprol-xl)
5664696|NCT00642096|metoprolol succinate|metoprolol succinate
5664697|NCT00642096|hydrochlorothiazide|hydrochlorothiazide
5664698|NCT00642083|outflow stenosis|outflow stenosis
5664699|NCT00642083|stentgraft|stentgraft
5664700|NCT00642070|Current symptoms of urinary tract infection|current symptoms of urinary tract infection
5664704|NCT00642044|Keratoconus|keratoconus
5664705|NCT00642031|Hematologic Malignancies|hematologic malignancies
5664706|NCT00642031|Leukemia|leukemia
5664707|NCT00642031|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5664708|NCT00642031|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5664709|NCT00642031|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5664710|NCT00642031|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5664711|NCT00642031|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5664712|NCT00642031|Triciribine Phosphate Monohydrate|triciribine phosphate monohydrate
5664713|NCT00642031|Triciribine|triciribine
5664714|NCT00642031|TCN-PM|tcn-pm
5664715|NCT00642031|VD-0002|vd-0002
5664716|NCT00642018|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5664717|NCT00642005|Humidification|humidification
5664718|NCT00642005|Laparoscopy|laparoscopy
5664719|NCT00642005|Colon|colon
5664720|NCT00642005|Hemicolectomy|hemicolectomy
5664721|NCT00642005|Warming|warming
5664722|NCT00641992|amebic liver abscess|amebic liver abscess
5664723|NCT00641992|failure|failure
5664724|NCT00641992|prognosis|prognosis
5664725|NCT00641979|Allergic rhinitis|allergic rhinitis
5664726|NCT00641979|Nasal symptoms|nasal symptoms
5664727|NCT00641979|Congestion|congestion
5664728|NCT00641979|Rhinorrhea|rhinorrhea
5664729|NCT00641979|Sneeze|sneeze
5664730|NCT00641979|budesonide|budesonide
5664731|NCT00641979|Rhinocort AQUA|rhinocort aqua
5664732|NCT00641953|Foot Pain|foot pain
5664733|NCT00641953|Diabetic Neuropathy Pain|diabetic neuropathy pain
5664734|NCT00641953|Diabetic Peripheral Neuropathy foot pain|diabetic peripheral neuropathy foot pain
5664735|NCT00641940|Prevention|prevention
5664736|NCT00641940|Girls|girls
5664737|NCT00641940|Resilience|resilience
5664738|NCT00641927|bipolar disorder|bipolar disorder
5664739|NCT00641927|bipolar type II disorder|bipolar type ii disorder
5664740|NCT00641927|antidepressant|antidepressant
5664741|NCT00641927|mood stabilizer|mood stabilizer
5664742|NCT00641927|venlafaxine|venlafaxine
5664743|NCT00641927|lithium carbonate|lithium carbonate
5664745|NCT00641914|Pulmicort|pulmicort
5664746|NCT00641914|budesonide|budesonide
5664747|NCT00641901|gingivitis|gingivitis
5664748|NCT00641901|pregnancy|pregnancy
5664749|NCT00641901|pre-term birth|pre-term birth
5664750|NCT00641888|Cardiovascular risk|cardiovascular risk
5664751|NCT00641888|Inflammatory biomarkers|inflammatory biomarkers
5664752|NCT00641888|Human immunodeficiency virus|human immunodeficiency virus
5664753|NCT00641875|arterial stiffness|arterial stiffness
5664754|NCT00641875|artery|artery
5664755|NCT00641875|aortic pulse wave velocity|aortic pulse wave velocity
5664756|NCT00641875|pulse wave analysis|pulse wave analysis
5664757|NCT00641875|augmentation index|augmentation index
5664758|NCT00641875|end stage renal disease|end stage renal disease
5664759|NCT00641875|nocturnal hemodialysis|nocturnal hemodialysis
5664760|NCT00641875|extended hours of hemodialysis|extended hours of hemodialysis
5664762|NCT00641875|hemodialysis|hemodialysis
5664763|NCT00641862|Pregnancy|pregnancy
5664764|NCT00641862|Maternal Nutritional Status|maternal nutritional status
5664765|NCT00641862|Vitamin B12|vitamin b12
5664767|NCT00641849|Physical Activity|physical activity
5664768|NCT00641849|Food|food
5664769|NCT00641849|Nutrition|nutrition
5664770|NCT00641849|Dietary behaviors|dietary behaviors
5664771|NCT00641849|Diet|diet
5664772|NCT00641849|Adult|adult
5664773|NCT00641849|Adults|adults
5664775|NCT00641849|Fats|fats
5664776|NCT00641849|Self monitoring|self monitoring
5664777|NCT00641849|Automated feedback|automated feedback
5664778|NCT00641823|Orthopedic Surgical Procedures|orthopedic surgical procedures
5664779|NCT00641810|Caffeine|caffeine
5664780|NCT00641810|Snoring|snoring
5664781|NCT00641810|Sleep|sleep
5664782|NCT00641797|Canalith Repositioning Technique|canalith repositioning technique
5664783|NCT00641797|Vertigo|vertigo
5664784|NCT00641784|Composite Early neonatal Outcome|composite early neonatal outcome
5664785|NCT00641784|Late Neurological neonatal outcome|late neurological neonatal outcome
5664786|NCT00641758|Coronary Artery Disease|coronary artery disease
5664787|NCT00641758|endothelial dysfunction|endothelial dysfunction
5664790|NCT00641745|Schizophrenia|schizophrenia
5664791|NCT00641745|Latuda|latuda
5664792|NCT00641732|venous thromboembolism|venous thromboembolism
5664793|NCT00641732|oral anticoagulant|oral anticoagulant
5664794|NCT00641732|direct factor Xa inhibitor|direct factor xa inhibitor
5664795|NCT00641732|total knee replacement|total knee replacement
5664796|NCT00641732|drug therapy|drug therapy
5664797|NCT00641693|Allergic rhinitis|allergic rhinitis
5664798|NCT00641693|Paediatric|paediatric
5664799|NCT00641693|Nasal symptoms|nasal symptoms
5664800|NCT00641693|Congestion|congestion
5664801|NCT00641693|Rhinorrhea|rhinorrhea
5664802|NCT00641693|Sneeze|sneeze
5664803|NCT00641693|budesonide|budesonide
5664804|NCT00641693|Rhinocort AQUA|rhinocort aqua
5664805|NCT00641680|Seasonal allergic rhinitis|seasonal allergic rhinitis
5664806|NCT00641680|Nasal symptoms|nasal symptoms
5664807|NCT00641680|Congestion|congestion
5664808|NCT00641680|Rhinorrhea|rhinorrhea
5664809|NCT00641680|Sneeze|sneeze
5664810|NCT00641680|budesonide|budesonide
5664811|NCT00641680|Rhinocort AQUA|rhinocort aqua
5664812|NCT00641680|Fluticasone propionate|fluticasone propionate
5664813|NCT00641680|Flonase|flonase
5664814|NCT00641667|Pain|pain
5664815|NCT00641667|Cancer|cancer
5664816|NCT00641667|Fentanyl|fentanyl
5664817|NCT00641667|JNS020QD|jns020qd
5664818|NCT00641654|Chronic hepatitis C|chronic hepatitis c
5664819|NCT00641654|genotype 2 or 3|genotype 2 or 3
5664820|NCT00641654|relapse|relapse
5664821|NCT00641654|pegylated interferon|pegylated interferon
5664822|NCT00641654|ribavirin|ribavirin
5664823|NCT00641641|Viral compartments|viral compartments
5664824|NCT00641641|integrase inhibitor therapy|integrase inhibitor therapy
5664825|NCT00641641|viral species|viral species
5664826|NCT00641628|Nipple sparing mastectomy|nipple sparing mastectomy
5664827|NCT00641628|NAC conservation|nac conservation
5664828|NCT00641602|Erosive Esophagitis|erosive esophagitis
5664829|NCT00641602|Nexium|nexium
5664830|NCT00641602|Heartburn|heartburn
5664831|NCT00641589|Chronic Kidney Disease|chronic kidney disease
5664832|NCT00641589|anemia|anemia
5664833|NCT00641589|epoetin alfa|epoetin alfa
5664834|NCT00641576|Endosseous implants|endosseous implants
5664835|NCT00641563|dexmedetomidine|dexmedetomidine
5664837|NCT00641563|remifentanil|remifentanil
5664838|NCT00641563|Electroencephalography|electroencephalography
5664839|NCT00641563|Event related potentials|event related potentials
5664840|NCT00641563|BIS|bis
5664841|NCT00641563|Bispectral Index|bispectral index
5664842|NCT00641563|Response Entropy|response entropy
5664843|NCT00641563|State Entropy|state entropy
5664844|NCT00641550|physical exercise|physical exercise
5664845|NCT00641550|maternal complications|maternal complications
5664846|NCT00641550|preterm labor|preterm labor
5664847|NCT00641550|birthweight|birthweight
5664849|NCT00641524|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5664850|NCT00641524|liver fibrosis|liver fibrosis
5664851|NCT00641524|metabolic syndrome|metabolic syndrome
5664852|NCT00641524|iron overload|iron overload
5664853|NCT00641524|phlebotomy|phlebotomy
5664854|NCT00641511|PTSD|ptsd
5664855|NCT00641498|suicide|suicide
5664856|NCT00641498|parasuicide|parasuicide
5664857|NCT00641498|prevention|prevention
5664943|NCT00641303|pain|pain
5664858|NCT00641498|individual supportive psychotherapy|individual supportive psychotherapy
5664859|NCT00641472|Asthma|asthma
5664860|NCT00641472|Pulmicort|pulmicort
5664861|NCT00641472|Children|children
5664862|NCT00641472|paediatrics|paediatrics
5664863|NCT00641472|budesonide|budesonide
5664864|NCT00641459|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5664865|NCT00641459|BPSD|bpsd
5664866|NCT00641459|NPI|npi
5664867|NCT00641459|CGI|cgi
5664869|NCT00641446|Children|children
5664870|NCT00641446|Asthma|asthma
5664871|NCT00641446|Varivax|varivax
5664872|NCT00641446|varicella|varicella
5664873|NCT00641446|Pulmicort|pulmicort
5664874|NCT00641446|budesonide|budesonide
5664875|NCT00641433|chemocautery|chemocautery
5664876|NCT00641420|Acne scarring|acne scarring
5664877|NCT00641420|Post inflammatory hyperpigmentation|post inflammatory hyperpigmentation
5664878|NCT00641407|Bedtime insulins|bedtime insulins
5664879|NCT00641407|Poorly controlled type 2 diabetes|poorly controlled type 2 diabetes
5664880|NCT00641407|Glycemic control|glycemic control
5664881|NCT00641407|HbA1c|hba1c
5664882|NCT00641394|cortisol|cortisol
5664883|NCT00641394|hydrocortisone|hydrocortisone
5664884|NCT00641394|psychotherapy|psychotherapy
5664885|NCT00641394|Emotional Freedom Techniques (EFT)|emotional freedom techniques (eft)
5664886|NCT00641394|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5664887|NCT00641394|depression|depression
5664888|NCT00641394|anxiety|anxiety
5664889|NCT00641381|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5664890|NCT00641381|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5664891|NCT00641381|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5664892|NCT00641381|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5664893|NCT00641381|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5664894|NCT00641381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5664895|NCT00641381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5664896|NCT00641381|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5664897|NCT00641381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5664898|NCT00641381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5664899|NCT00641381|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5664900|NCT00641381|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5664901|NCT00641381|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5664902|NCT00641381|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5664903|NCT00641381|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5664904|NCT00641381|Burkitt lymphoma|burkitt lymphoma
5664905|NCT00641381|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5664906|NCT00641381|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5664907|NCT00641381|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5664908|NCT00641381|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5664909|NCT00641381|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5664910|NCT00641381|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5664911|NCT00641381|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5664912|NCT00641381|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5664913|NCT00641381|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5664914|NCT00641381|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5664915|NCT00641381|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5664916|NCT00641381|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5664917|NCT00641381|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5664918|NCT00641381|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5664920|NCT00641381|Treatment Experienced|treatment experienced
5664921|NCT00641368|Adolescent|adolescent
5664922|NCT00641368|Child|child
5664923|NCT00641368|Computer|computer
5664924|NCT00641368|Depression|depression
5664925|NCT00641368|Resilience|resilience
5664926|NCT00641342|Parastomal hernia|parastomal hernia
5664927|NCT00641342|Onlay mesh|onlay mesh
5664928|NCT00641342|Sublay mesh|sublay mesh
5664929|NCT00641342|Pain|pain
5664930|NCT00641342|Health questionnaire|health questionnaire
5664931|NCT00641329|ADHD|adhd
5664933|NCT00641329|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5664935|NCT00641329|Clonidine|clonidine
5664936|NCT00641329|CLONICEL|clonicel
5664937|NCT00641329|Addrenex|addrenex
5664938|NCT00641316|Freeze-dried bone allograft|freeze-dried bone allograft
5664939|NCT00641316|Platelet-rich plasma|platelet-rich plasma
5664940|NCT00641316|Platelet-derived growth factors|platelet-derived growth factors
5664941|NCT00641316|Laser-threaded dental implants|laser-threaded dental implants
5664942|NCT00641316|Resorbable blast textured dental implants|resorbable blast textured dental implants
5664945|NCT00641303|hot flashes|hot flashes
5664946|NCT00641303|sleep disorders|sleep disorders
5664947|NCT00641303|depression|depression
5664948|NCT00641303|anxiety disorder|anxiety disorder
5664949|NCT00641303|stage I breast cancer|stage i breast cancer
5664950|NCT00641303|stage II breast cancer|stage ii breast cancer
5664951|NCT00641303|stage IIIA breast cancer|stage iiia breast cancer
5664952|NCT00641303|stage IIIB breast cancer|stage iiib breast cancer
5664953|NCT00641303|stage IIIC breast cancer|stage iiic breast cancer
5664954|NCT00641290|CABG|cabg
5664955|NCT00641290|Valve surgery|valve surgery
5664956|NCT00641277|endosseous dental implants|endosseous dental implants
5664957|NCT00641277|dental aesthetics|dental aesthetics
5664958|NCT00641264|Laryngopharyngeal reflux (LPR)|laryngopharyngeal reflux (lpr)
5664959|NCT00641264|Omeprazole|omeprazole
5664960|NCT00641264|Losec|losec
5664961|NCT00641264|Quality of Life|quality of life
5664962|NCT00641264|Laryngitis|laryngitis
5664963|NCT00641251|T2 Diabetes|t2 diabetes
5664964|NCT00641251|Type 2 diabetes CVD event rates and mortality|type 2 diabetes cvd event rates and mortality
5664965|NCT00641238|NSCLC|nsclc
5664966|NCT00641238|lung cancer|lung cancer
5664967|NCT00641225|Ascending Single Dose|ascending single dose
5664968|NCT00641225|Safety|safety
5664969|NCT00641225|Pharmacokinetics|pharmacokinetics
5664970|NCT00641225|Open-label|open-label
5664971|NCT00641212|Allergic rhinitis|allergic rhinitis
5664972|NCT00641212|Perennial allergic rhinitis|perennial allergic rhinitis
5664973|NCT00641212|Paediatric|paediatric
5664974|NCT00641212|Growth|growth
5664975|NCT00641212|budesonide|budesonide
5664976|NCT00641212|Rhinocort AQUA|rhinocort aqua
5664977|NCT00641199|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
5664978|NCT00641199|Probiotic|probiotic
5664979|NCT00641199|Quality of life|quality of life
5664980|NCT00641199|Antibiotics|antibiotics
5664981|NCT00641186|excessive daytime somnolence|excessive daytime somnolence
5664982|NCT00641186|Parkinson disease|parkinson disease
5664983|NCT00641186|sleep disturbance|sleep disturbance
5664985|NCT00641173|cortisol|cortisol
5664986|NCT00641173|hippocampus|hippocampus
5664987|NCT00641173|memory|memory
5664988|NCT00641160|vinorelbine|vinorelbine
5664989|NCT00641160|metronomic dosing|metronomic dosing
5664990|NCT00641160|oral administration|oral administration
5664991|NCT00641160|nonhematologic malignancies|nonhematologic malignancies
5664992|NCT00641160|pharmacokinetics|pharmacokinetics
5664993|NCT00641134|Cardiac Rehabilitation|cardiac rehabilitation
5664994|NCT00641134|Old age|old age
5664995|NCT00641134|Home physical training|home physical training
5664996|NCT00641108|SPECT Brain Imaging|spect brain imaging
5664997|NCT00641108|Cognitive Therapy|cognitive therapy
5664998|NCT00641108|Serotonin Transporter Binding|serotonin transporter binding
5664999|NCT00641108|Predictive Biomarker|predictive biomarker
5665000|NCT00641095|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5665001|NCT00641095|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5665002|NCT00641095|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5665003|NCT00641095|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5665004|NCT00641095|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5665005|NCT00641069|Cardiac arrest|cardiac arrest
5665006|NCT00641069|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5665007|NCT00641056|diabetes|diabetes
5665008|NCT00641056|exenatide|exenatide
5665009|NCT00641056|exenatide once weekly|exenatide once weekly
5665010|NCT00641056|metformin|metformin
5665011|NCT00641056|sulfonylurea|sulfonylurea
5665012|NCT00641056|insulin glargine|insulin glargine
5665013|NCT00641056|Amylin|amylin
5665014|NCT00641056|Lilly|lilly
5665015|NCT00641030|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5665016|NCT00641030|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5665017|NCT00641030|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5665018|NCT00641030|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5665019|NCT00641030|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5665020|NCT00641030|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5665021|NCT00641030|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5665022|NCT00641030|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5665023|NCT00641030|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5665024|NCT00641030|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5665025|NCT00641030|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5665026|NCT00641030|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5665027|NCT00641030|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5665028|NCT00641030|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5665029|NCT00641030|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5665030|NCT00641030|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5665131|NCT00640588|Compliance|compliance
5665031|NCT00641030|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5665032|NCT00641030|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5665033|NCT00640991|Clinical Trial|clinical trial
5665034|NCT00640991|Insulin|insulin
5665035|NCT00640978|Pancreatic Cancer|pancreatic cancer
5665036|NCT00640978|Advanced Pancreatic Cancer|advanced pancreatic cancer
5665037|NCT00640978|Unresectable|unresectable
5665038|NCT00640978|Metastatic|metastatic
5665039|NCT00640978|RAD001|rad001
5665040|NCT00640978|Everolimus|everolimus
5665041|NCT00640978|Erlotinib|erlotinib
5665042|NCT00640978|OSI-774|osi-774
5665043|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride
5665044|NCT00640978|Tarceva|tarceva
5665045|NCT00640952|Parkinson's disease|parkinson's disease
5665046|NCT00640952|impulse control behaviors|impulse control behaviors
5665047|NCT00640952|dopa-dysregulation|dopa-dysregulation
5665048|NCT00640939|Tendonitis|tendonitis
5665049|NCT00640939|Bursitis|bursitis
5665050|NCT00640913|Defunctioning stoma|defunctioning stoma
5665051|NCT00640913|Low anterior resection|low anterior resection
5665052|NCT00640913|TME surgery|tme surgery
5665053|NCT00640913|Early stoma reversal|early stoma reversal
5665054|NCT00640900|overweight|overweight
5665055|NCT00640900|obesity|obesity
5665056|NCT00640900|weight loss|weight loss
5665057|NCT00640900|commercial weight loss program|commercial weight loss program
5665059|NCT00640887|Tuberculosis|tuberculosis
5665060|NCT00640887|Rifabutin|rifabutin
5665061|NCT00640887|Pharmacokinetics|pharmacokinetics
5665062|NCT00640887|South Africa|south africa
5665063|NCT00640874|Prophylaxis|prophylaxis
5665064|NCT00640874|pandemic influenza|pandemic influenza
5665065|NCT00640874|influenza A|influenza a
5665066|NCT00640874|H5N1 virus|h5n1 virus
5665067|NCT00640861|stage II breast cancer|stage ii breast cancer
5665068|NCT00640861|stage IIIA breast cancer|stage iiia breast cancer
5665069|NCT00640861|stage IIIB breast cancer|stage iiib breast cancer
5665070|NCT00640861|stage IIIC breast cancer|stage iiic breast cancer
5665071|NCT00640861|stage IA breast cancer|stage ia breast cancer
5665072|NCT00640861|stage IB breast cancer|stage ib breast cancer
5665073|NCT00640861|triple-negative breast cancer|triple-negative breast cancer
5665074|NCT00640861|HER2-positive breast cancer|her2-positive breast cancer
5665075|NCT00640835|Opioid dependence|opioid dependence
5665076|NCT00640809|Bowel Disease|bowel disease
5665077|NCT00640796|Hematologic malignancies, non-B lineage|hematologic malignancies, non-b lineage
5665078|NCT00640796|NK cell expansion|nk cell expansion
5665079|NCT00640796|CliniMACS device|clinimacs device
5665080|NCT00640796|Immunotherapy|immunotherapy
5665081|NCT00640783|Metabolic syndrome|metabolic syndrome
5665082|NCT00640783|Mediterranean diet|mediterranean diet
5665083|NCT00640783|Inflammatory markers|inflammatory markers
5665084|NCT00640783|Endothelial function|endothelial function
5665085|NCT00640757|Methionine|methionine
5665086|NCT00640757|Metabolic syndrome|metabolic syndrome
5665087|NCT00640757|Glucose Metabolism|glucose metabolism
5665088|NCT00640757|Amino acid|amino acid
5665089|NCT00640757|Insulin clamp|insulin clamp
5665090|NCT00640744|Atherogenesis|atherogenesis
5665091|NCT00640744|Atheroma|atheroma
5665092|NCT00640744|Arteriosclerosis|arteriosclerosis
5665093|NCT00640731|DVT|dvt
5665094|NCT00640731|Peripheral Vascular Disease|peripheral vascular disease
5665095|NCT00640731|Venous Thrombosis|venous thrombosis
5665096|NCT00640731|Deep Vein Thrombosis|deep vein thrombosis
5665097|NCT00640718|heart and respiratory monitoring|heart and respiratory monitoring
5665098|NCT00640692|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5665099|NCT00640692|GIST|gist
5665100|NCT00640692|Sunitinib|sunitinib
5665102|NCT00640679|Clopidogrel|clopidogrel
5665103|NCT00640679|Drug-eluting Stent|drug-eluting stent
5665104|NCT00640666|Breast cancer|breast cancer
5665105|NCT00640666|Exercise|exercise
5665106|NCT00640666|Biomarkers|biomarkers
5665107|NCT00640653|Sexual Behavior|sexual behavior
5665108|NCT00640653|Abstinence|abstinence
5665109|NCT00640653|Intervention Studies|intervention studies
5665110|NCT00640653|HIV|hiv
5665111|NCT00640653|Sexually Transmitted Infection|sexually transmitted infection
5665112|NCT00640653|Theory of Planned Behavior|theory of planned behavior
5665113|NCT00640653|HIV Seronegativity|hiv seronegativity
5665114|NCT00640640|IOP|iop
5665115|NCT00640640|OPA|opa
5665116|NCT00640640|AMD|amd
5665117|NCT00640640|bevacizumab|bevacizumab
5665118|NCT00640640|ranibizumab|ranibizumab
5665119|NCT00640640|choroidal blood flow|choroidal blood flow
5665120|NCT00640640|DCT|dct
5645906|NCT00718575|Transplantation|transplantation
5665121|NCT00640640|Ocular Pulse Amplitude change following anti VEGF|ocular pulse amplitude change following anti vegf
5665122|NCT00640640|Ocular Pulse Amplitude|ocular pulse amplitude
5665123|NCT00640614|Dermatitis, Contact|dermatitis, contact
5665125|NCT00640601|schizophrenia|schizophrenia
5665126|NCT00640601|Extended Release|extended release
5665127|NCT00640588|Hepatitis B, chronic|hepatitis b, chronic
5665128|NCT00640588|Viral kinetics|viral kinetics
5665129|NCT00640588|Telbivudine|telbivudine
5665130|NCT00640588|Adefovir|adefovir
5665132|NCT00640562|Schizophrenia|schizophrenia
5665133|NCT00640562|Depression|depression
5665134|NCT00640562|Quetiapine|quetiapine
5665135|NCT00640549|LDL-subfractions, HDL-subfractions, non insulin dependent diabetes mellitus (NIDDM), hyperlipidemia, atorvastatin|ldl-subfractions, hdl-subfractions, non insulin dependent diabetes mellitus (niddm), hyperlipidemia, atorvastatin
5665136|NCT00640497|acute GVHD|acute gvhd
5665137|NCT00640497|immunotoxin|immunotoxin
5665138|NCT00640497|anti-CD3|anti-cd3
5665139|NCT00640497|anti-CD7|anti-cd7
5665141|NCT00640471|recurrent colon cancer|recurrent colon cancer
5665142|NCT00640471|stage IV colon cancer|stage iv colon cancer
5665143|NCT00640471|recurrent rectal cancer|recurrent rectal cancer
5665144|NCT00640471|stage IV rectal cancer|stage iv rectal cancer
5665145|NCT00640445|Clinical Trial|clinical trial
5665146|NCT00640445|Combat Disorders|combat disorders
5665147|NCT00640445|PTSD|ptsd
5665148|NCT00640445|Internet-Based Intervention|internet-based intervention
5665149|NCT00640445|Mental Health Services|mental health services
5665150|NCT00640445|Post-deployment Reintegration|post-deployment reintegration
5665151|NCT00640393|Etanercept, UVB, Enbrel, Psoriasis.|etanercept, uvb, enbrel, psoriasis.
5665152|NCT00640380|cervical|cervical
5665153|NCT00640380|paravertebral|paravertebral
5665154|NCT00640380|block|block
5665155|NCT00640367|Acute ischemic stroke|acute ischemic stroke
5665156|NCT00640367|thrombolysis|thrombolysis
5665157|NCT00640367|intra-arterial thrombolysis|intra-arterial thrombolysis
5665158|NCT00640354|Automated External Defibrillator|automated external defibrillator
5665159|NCT00640354|Resuscitation|resuscitation
5665160|NCT00640354|Pediatric|pediatric
5665161|NCT00640328|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5649133|NCT00706238|ASCI|asci
5665162|NCT00640328|ofatumumab|ofatumumab
5665163|NCT00640328|multiple sclerosis|multiple sclerosis
5665164|NCT00640315|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5665165|NCT00640315|COPD|copd
5665166|NCT00640315|Pulmonary hypertension|pulmonary hypertension
5665167|NCT00640302|Index cases|index cases
5665168|NCT00640302|pandemic influenza|pandemic influenza
5665169|NCT00640302|influenza A|influenza a
5665170|NCT00640302|H5N1 virus|h5n1 virus
5665171|NCT00640289|Factor XIII Deficiency|factor xiii deficiency
5665172|NCT00640289|Rare Bleeding Disorder|rare bleeding disorder
5665173|NCT00640289|Hemophilia|hemophilia
5665174|NCT00640289|Fibrogammin P|fibrogammin p
5665175|NCT00640276|pitavastatin|pitavastatin
5665176|NCT00640276|metabolic syndrome|metabolic syndrome
5665177|NCT00640276|metabolic syndrome risk score|metabolic syndrome risk score
5665178|NCT00640276|hypercholesterolemia|hypercholesterolemia
5665179|NCT00640263|HIV-1|hiv-1
5665180|NCT00640263|Breastfeeding|breastfeeding
5665181|NCT00640263|Prevention|prevention
5665182|NCT00640263|lamivudine|lamivudine
5665183|NCT00640263|lopinavir/ritonavir|lopinavir/ritonavir
5665184|NCT00640250|Dermatitis, Contact, Bronopol, Disperse Blue 106|dermatitis, contact, bronopol, disperse blue 106
5665185|NCT00640237|Vitamine D State|vitamine d state
5665186|NCT00640211|Prophylaxis|prophylaxis
5665187|NCT00640211|pandemic influenza|pandemic influenza
5665188|NCT00640211|influenza A|influenza a
5665189|NCT00640211|H5N1 virus|h5n1 virus
5665190|NCT00640198|Aphasia|aphasia
5665191|NCT00640198|Memantine|memantine
5665192|NCT00640198|Constraint-induced language therapy|constraint-induced language therapy
5665193|NCT00640198|Event-related potentials|event-related potentials
5665194|NCT00640159|Parkinson's disease|parkinson's disease
5665195|NCT00640159|selegiline to Zelapar switch|selegiline to zelapar switch
5665196|NCT00640159|orally disintegrating formulation|orally disintegrating formulation
5665197|NCT00640133|Deep Brain Stimulation|deep brain stimulation
5665198|NCT00640133|Treatment Refractory|treatment refractory
5665199|NCT00640133|Ventral Internal Capsule/Ventral Striatum|ventral internal capsule/ventral striatum
5665200|NCT00640133|Neurosurgery|neurosurgery
5665201|NCT00640133|Neuroimaging|neuroimaging
5665202|NCT00640120|wheeze detection|wheeze detection
5665203|NCT00640107|Magnetic Resonance Imaging|magnetic resonance imaging
5665204|NCT00640094|Melatonin|melatonin
5665205|NCT00640094|Acute myocardial infarction|acute myocardial infarction
5665206|NCT00640094|Primary angioplasty|primary angioplasty
5665207|NCT00640081|adenocarcinoma of the colon|adenocarcinoma of the colon
5665208|NCT00640081|stage IV colon cancer|stage iv colon cancer
5665209|NCT00640081|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5665210|NCT00640081|stage IV rectal cancer|stage iv rectal cancer
5665211|NCT00640081|stage III colon cancer|stage iii colon cancer
5665212|NCT00640081|stage III rectal cancer|stage iii rectal cancer
5665213|NCT00640081|recurrent colon cancer|recurrent colon cancer
5665214|NCT00640081|recurrent rectal cancer|recurrent rectal cancer
5665215|NCT00640068|coronary artery disease|coronary artery disease
5665216|NCT00640068|chest pain|chest pain
5665217|NCT00640068|coronary artery bypass graft|coronary artery bypass graft
5665218|NCT00640068|stress test|stress test
5665219|NCT00640068|Coronary Angiography|coronary angiography
5665220|NCT00640055|verbal autopsy|verbal autopsy
5665221|NCT00640055|stillbirth|stillbirth
5665222|NCT00640055|neonatal death|neonatal death
5665223|NCT00640042|pain|pain
5665224|NCT00640042|opioid|opioid
5665225|NCT00640042|abuse|abuse
5665226|NCT00640042|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time|moderate-severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time
5665227|NCT00640029|Arthroplasty|arthroplasty
5665228|NCT00640029|Arthrodesis|arthrodesis
5665229|NCT00640029|Prosthesis|prosthesis
5665230|NCT00640029|Disc replacement|disc replacement
5665231|NCT00640029|Spine|spine
5665232|NCT00640029|Lumbar|lumbar
5665233|NCT00640029|Cervical|cervical
5665234|NCT00640029|Intervertebral disk|intervertebral disk
5665235|NCT00640029|Cervical or lumbar intervertebral disk|cervical or lumbar intervertebral disk
5665236|NCT00640029|Degenerative pathology|degenerative pathology
5665237|NCT00640016|Asthma|asthma
5665239|NCT00640016|Tralokinumab|tralokinumab
5665240|NCT00640003|AT|at
5665241|NCT00640003|Ataxia|ataxia
5665242|NCT00640003|Telangiectasia|telangiectasia
5665243|NCT00639990|Intraabdominal pressure|intraabdominal pressure
5665244|NCT00639977|Intraocular Pressure|intraocular pressure
5665245|NCT00639977|Acupuncture|acupuncture
5665246|NCT00639977|Healthy Volunteers|healthy volunteers
5665247|NCT00639964|diabetes|diabetes
5665248|NCT00639964|pregnancy|pregnancy
5665249|NCT00639964|macrosomia|macrosomia
5665250|NCT00639964|lipidics markers|lipidics markers
5665251|NCT00639964|nutritional factors|nutritional factors
5665252|NCT00639964|placenta|placenta
5665253|NCT00639964|umbilical blood cord|umbilical blood cord
5665254|NCT00639951|Snake Bite|snake bite
5665255|NCT00639951|Antivenin Treatment|antivenin treatment
5665256|NCT00639938|Pregnancy, High-Risk|pregnancy, high-risk
5665257|NCT00639938|HIV Seronegativity|hiv seronegativity
5665258|NCT00639912|contrast induced nephropathy STEMI PCI|contrast induced nephropathy stemi pci
5665259|NCT00639899|Varicocele|varicocele
5665260|NCT00639873|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5665261|NCT00639860|extraction|extraction
5665262|NCT00639860|implant|implant
5665263|NCT00639860|alveolar ridge preservation|alveolar ridge preservation
5665264|NCT00639847|Asthma management|asthma management
5665265|NCT00639847|cost|cost
5665266|NCT00639847|disease management|disease management
5665267|NCT00639847|respiratory care|respiratory care
5665268|NCT00639847|nursing|nursing
5665269|NCT00639847|health care utilization|health care utilization
5665270|NCT00639847|health related quality of life|health related quality of life
5665271|NCT00639834|rheumatoid|rheumatoid
5665272|NCT00639834|arthritis|arthritis
5665273|NCT00639834|RA|ra
5665274|NCT00639834|joint inflammation|joint inflammation
5665275|NCT00639834|autoimmune|autoimmune
5665276|NCT00639834|Medarex|medarex
5665277|NCT00639834|Rheumatology|rheumatology
5665278|NCT00639821|Gene expression microarray|gene expression microarray
5665279|NCT00639821|Inflammatory bowel disease|inflammatory bowel disease
5665280|NCT00639821|Infliximab|infliximab
5665281|NCT00639808|delayed gastric emptying|delayed gastric emptying
5665282|NCT00639808|symptomatic gastroparesis|symptomatic gastroparesis
5665283|NCT00639808|diabetes mellitus|diabetes mellitus
5665284|NCT00639795|Thoracic paravertebral block|thoracic paravertebral block
5665285|NCT00639795|Cytokines|cytokines
5665286|NCT00639795|Video assisted thorascopic surgery|video assisted thorascopic surgery
5665287|NCT00639795|Pain|pain
5665288|NCT00639782|thromboembolism|thromboembolism
5665289|NCT00639782|mechanical heart valves|mechanical heart valves
5665290|NCT00639782|randomized|randomized
5665291|NCT00639769|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5671730|NCT00614614|Meningococcal disease|meningococcal disease
5665292|NCT00639769|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5665293|NCT00639769|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5665294|NCT00639769|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5665295|NCT00639769|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5665296|NCT00639769|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5665297|NCT00639769|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5665298|NCT00639769|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5665299|NCT00639769|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5665300|NCT00639769|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5665301|NCT00639769|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5665422|NCT00639223|Cardiovascular Diseases|cardiovascular diseases
5665302|NCT00639769|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5847692|NCT00038519|treatment experienced|treatment experienced
5665304|NCT00639769|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5665305|NCT00639769|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5665306|NCT00639769|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5665307|NCT00639769|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5665308|NCT00639769|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5665309|NCT00639769|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5665310|NCT00639769|recurrent salivary gland cancer|recurrent salivary gland cancer
5665311|NCT00639769|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5665312|NCT00639769|stage IV salivary gland cancer|stage iv salivary gland cancer
5665313|NCT00639756|Uric acid|uric acid
5665314|NCT00639756|Fructose|fructose
5665315|NCT00639756|Hypertension|hypertension
5665316|NCT00639756|Insulin|insulin
5665317|NCT00639756|Glucose|glucose
5665323|NCT00639730|Epilepsy|epilepsy
5665324|NCT00639717|GVHD|gvhd
5665326|NCT00639704|SPECT|spect
5665327|NCT00639704|Cardiac function|cardiac function
5665328|NCT00639691|Asthma, Anti-immunoglobin E, omalizumab|asthma, anti-immunoglobin e, omalizumab
5665329|NCT00639678|healthy volunteers|healthy volunteers
5665330|NCT00639665|Cocoa, diabetes, polyphenols|cocoa, diabetes, polyphenols
5665331|NCT00639652|Carcinoma, Basal Cell|carcinoma, basal cell
5665332|NCT00639652|3D-histology|3d-histology
5665333|NCT00639652|Micrographic surgery|micrographic surgery
5665334|NCT00639652|Mohs surgery|mohs surgery
5665335|NCT00639652|Shave excision|shave excision
5665336|NCT00639652|Recurrence|recurrence
5665337|NCT00639652|Esthetic outcome|esthetic outcome
5665340|NCT00639587|Cetirizine|cetirizine
5665341|NCT00639587|Zyrtec|zyrtec
5665342|NCT00639574|Pain, morphine, nefopam, co analgesia, ureteral calculi, emergency|pain, morphine, nefopam, co analgesia, ureteral calculi, emergency
5665343|NCT00639561|digestive system|digestive system
5665345|NCT00639548|Deep Sedation|deep sedation
5665346|NCT00639548|EEG|eeg
5665347|NCT00639548|Event-Related Potentials|event-related potentials
5665348|NCT00639548|Evoked potentials, auditory|evoked potentials, auditory
5665349|NCT00639548|BIS-Index|bis-index
5665350|NCT00639548|Entropy|entropy
5665351|NCT00639548|ICU|icu
5665352|NCT00639535|Radiology|radiology
5665353|NCT00639535|MRI|mri
5665354|NCT00639535|Positron emission tomography|positron emission tomography
5665355|NCT00639535|Breast Abnormalities|breast abnormalities
5665356|NCT00639535|Dense Breast Tissue|dense breast tissue
5665357|NCT00639522|Liposomal paclitaxel|liposomal paclitaxel
5665358|NCT00639522|Maximum tolerated dose|maximum tolerated dose
5665359|NCT00639522|Pharmacokinetics|pharmacokinetics
5665360|NCT00639522|Gastric carcinoma|gastric carcinoma
5665361|NCT00639496|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5665362|NCT00639470|Patient Education Handout|patient education handout
5665363|NCT00639470|Parents|parents
5665364|NCT00639470|Patient Education|patient education
5665365|NCT00639457|PPAR-gamma agonist|ppar-gamma agonist
5665366|NCT00639457|glucose metabolism|glucose metabolism
5665367|NCT00639457|inflammation|inflammation
5665368|NCT00639457|adipose tissue distribution|adipose tissue distribution
5665369|NCT00639457|cardiac function|cardiac function
5665370|NCT00639457|vascular function|vascular function
5665371|NCT00639457|mass spectrometry|mass spectrometry
5665372|NCT00639457|Treatment Experienced|treatment experienced
5665373|NCT00639431|phantom limb pain|phantom limb pain
5665374|NCT00639431|limb amputation|limb amputation
5665375|NCT00639431|Amputation|amputation
5665376|NCT00639431|Phantom Limb|phantom limb
5665377|NCT00639431|Pain|pain
5665378|NCT00639405|Parathyroid|parathyroid
5665379|NCT00639405|MRI|mri
5665380|NCT00639405|SPECT|spect
5665381|NCT00639392|Sickle cell disease|sickle cell disease
5665382|NCT00639379|toric contact lenses|toric contact lenses
5665383|NCT00639379|vision|vision
5665384|NCT00639379|comfort|comfort
5665385|NCT00639379|toric fit characteristics|toric fit characteristics
5665386|NCT00639379|slit lamp findings|slit lamp findings
5665387|NCT00639366|recurrent breast cancer|recurrent breast cancer
5665388|NCT00639366|stage IIIA breast cancer|stage iiia breast cancer
5665389|NCT00639366|stage IIIB breast cancer|stage iiib breast cancer
5665390|NCT00639366|stage IIIC breast cancer|stage iiic breast cancer
5665391|NCT00639366|stage IV breast cancer|stage iv breast cancer
5665392|NCT00639327|Stomach Neoplasms|stomach neoplasms
5665393|NCT00639327|Second line chemotherapy|second line chemotherapy
5665394|NCT00639327|Refractory to S-1|refractory to s-1
5665395|NCT00639327|irinotecan|irinotecan
5665396|NCT00639327|S-1 and Irinotecan Combination|s-1 and irinotecan combination
5665397|NCT00639327|Phase III study|phase iii study
5665398|NCT00639314|pylorus-preserving pancreaticoduodenectomy|pylorus-preserving pancreaticoduodenectomy
5665399|NCT00639314|pylorus-resecting pancreaticoduodenectomy|pylorus-resecting pancreaticoduodenectomy
5665400|NCT00639314|randomized controlled trial|randomized controlled trial
5665401|NCT00639314|delayed gastric empty|delayed gastric empty
5665402|NCT00639314|quality of life|quality of life
5665404|NCT00639301|Quality of Life|quality of life
5665405|NCT00639301|Eye|eye
5665406|NCT00639288|Alcohol Dependence|alcohol dependence
5665407|NCT00639288|PTSD|ptsd
5665408|NCT00639288|CPT-C|cpt-c
5665409|NCT00639262|Sorafenib|sorafenib
5665410|NCT00639262|Radiation Therapy|radiation therapy
5665411|NCT00639262|Radiotherapy|radiotherapy
5665412|NCT00639262|Temozolomide|temozolomide
5665413|NCT00639262|Brain Metastases|brain metastases
5665414|NCT00639262|Brain Tumors|brain tumors
5665415|NCT00639236|COPD|copd
5665416|NCT00639236|Hypertonic saline|hypertonic saline
5665417|NCT00639236|Quality of life|quality of life
5665418|NCT00639236|Dyspnoea.|dyspnoea.
5665419|NCT00639223|Statin related myalgia|statin related myalgia
5665420|NCT00639223|Hyperlipidemia|hyperlipidemia
5665421|NCT00639223|Red yeast rice|red yeast rice
5665423|NCT00639223|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5665424|NCT00639210|breast cancer|breast cancer
5665425|NCT00639210|exercise|exercise
5665426|NCT00639210|osteoporosis|osteoporosis
5665427|NCT00639210|fracture|fracture
5665428|NCT00639210|quality of life|quality of life
5665429|NCT00639197|Tunneling|tunneling
5665430|NCT00639197|Short term|short term
5665431|NCT00639197|central venous catheters|central venous catheters
5665432|NCT00639197|Ultrasound Guided|ultrasound guided
5665433|NCT00639197|Internal jugular|internal jugular
5665434|NCT00639197|Assess safety and improve technical difficulty|assess safety and improve technical difficulty
5665435|NCT00639184|asphyxia|asphyxia
5665436|NCT00639184|neurodevelopmental outcome|neurodevelopmental outcome
5665437|NCT00639184|home counseling|home counseling
5665438|NCT00639171|breast|breast
5665439|NCT00639171|diagnostic radiology|diagnostic radiology
5665440|NCT00639171|suspicious breast tumors|suspicious breast tumors
5665441|NCT00639171|MRI|mri
5665442|NCT00639145|HIV|hiv
5665443|NCT00639145|Pregnancy|pregnancy
5665444|NCT00639145|Antiretrovirals|antiretrovirals
5665445|NCT00639145|HIV Seronegativity|hiv seronegativity
5665446|NCT00639145|Treatment Experienced|treatment experienced
5665447|NCT00639132|Natural History|natural history
5665448|NCT00639132|Metachromatic Leukodystrophy|metachromatic leukodystrophy
5665449|NCT00639132|Disease Progression|disease progression
5665450|NCT00639106|Breast expander|breast expander
5665451|NCT00639106|Breast reconstruction|breast reconstruction
5665452|NCT00639106|implants|implants
5665453|NCT00639106|08-024|08-024
5665454|NCT00639093|cigarette smoking|cigarette smoking
5665455|NCT00639093|psychoeducational and motivational program|psychoeducational and motivational program
5665456|NCT00639093|virtual reality|virtual reality
5665457|NCT00639080|Type 2 diabetes|type 2 diabetes
5665458|NCT00639080|Dyslipidemia|dyslipidemia
5665459|NCT00639067|Cancer of Lung|cancer of lung
5665460|NCT00639067|Cancer of the Lung|cancer of the lung
5665461|NCT00639067|Lung Cancer|lung cancer
5665462|NCT00639067|Neoplasms, Lung|neoplasms, lung
5665463|NCT00639067|Neoplasms, Pulmonary|neoplasms, pulmonary
5665464|NCT00639067|Pulmonary Cancer|pulmonary cancer
5665465|NCT00639067|Pulmonary Neoplasms|pulmonary neoplasms
5665466|NCT00639054|classification|classification
5665467|NCT00639054|diagnosis|diagnosis
5665468|NCT00639054|genetics|genetics
5665469|NCT00639054|mortality|mortality
5665470|NCT00639054|pathology|pathology
5665471|NCT00639041|n-3 LC-PUFA|n-3 lc-pufa
5665472|NCT00639041|hypertriglyceridemic|hypertriglyceridemic
5665473|NCT00639041|human|human
5665474|NCT00639041|TAG|tag
5665475|NCT00639028|ankle|ankle
5665476|NCT00639028|diagnosis|diagnosis
5665477|NCT00639028|sprain|sprain
5665478|NCT00639028|care|care
5665479|NCT00639028|injury|injury
5665480|NCT00639028|stress radiography|stress radiography
5665481|NCT00639028|ultrasonography|ultrasonography
5665482|NCT00639015|Sepsis|sepsis
5665483|NCT00639015|Septic Shock|septic shock
5665484|NCT00639015|phenylephrine|phenylephrine
5665485|NCT00639015|norepinephrine|norepinephrine
5665486|NCT00639015|catecholamine|catecholamine
5665487|NCT00638989|Asthma|asthma
5665488|NCT00638989|CAT-354|cat-354
5665489|NCT00638989|Tralokinumab|tralokinumab
5665490|NCT00638989|Healthy|healthy
5665491|NCT00638976|Eptifibatide|eptifibatide
5665492|NCT00638976|IV eptifibatide|iv eptifibatide
5665493|NCT00638976|GP IIB/IIIA inhibitors|gp iib/iiia inhibitors
5665494|NCT00638976|DES stent|des stent
5665495|NCT00638950|n-3 LC-PUFA|n-3 lc-pufa
5665496|NCT00638950|Rheumatoid arthritis|rheumatoid arthritis
5665497|NCT00638950|disease activity|disease activity
5665498|NCT00638950|inflammation|inflammation
5665499|NCT00638950|oxidative stress|oxidative stress
5665500|NCT00638950|immune system|immune system
5665501|NCT00638924|healthy sedentary women|healthy sedentary women
5665502|NCT00638885|PTSD|ptsd
5665503|NCT00638885|hippocampus|hippocampus
5665504|NCT00638885|twins|twins
5665505|NCT00638872|diabetes|diabetes
5665506|NCT00638872|foot ulcer|foot ulcer
5665507|NCT00638872|polydeoxyribonucleotide|polydeoxyribonucleotide
5665508|NCT00638859|Community-Acquired pneumonia|community-acquired pneumonia
5665510|NCT00638859|children|children
5665511|NCT00638859|Child|child
5665512|NCT00638846|toric contact lenses|toric contact lenses
5665513|NCT00638846|vision|vision
5665514|NCT00638846|comfort|comfort
5665515|NCT00638846|toric fit characteristics|toric fit characteristics
5665516|NCT00638846|slit lamp findings|slit lamp findings
5665517|NCT00638833|Multiple Sclerosis|multiple sclerosis
5665518|NCT00638820|osteopetrosis|osteopetrosis
5665519|NCT00638794|Myocardial Infarction|myocardial infarction
5665520|NCT00638794|Myocardial Ischemia|myocardial ischemia
5665521|NCT00638781|Acute ischemic stroke|acute ischemic stroke
5665522|NCT00638768|physical therapy|physical therapy
5665523|NCT00638768|rehabilitation|rehabilitation
5665524|NCT00638768|pain|pain
5665525|NCT00638768|osteoporosis|osteoporosis
5665526|NCT00638768|vertebral fracture|vertebral fracture
5665527|NCT00638755|Allergic Rhinitis|allergic rhinitis
5665528|NCT00638755|Perennial Allergic Rhinitis|perennial allergic rhinitis
5665529|NCT00638755|Allergies to perennial allergens|allergies to perennial allergens
5665530|NCT00638755|Allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)|allergies to perennial allergens (e.g. dog, cat, dust mites, etc.)
5665531|NCT00638742|Latanoprost Pediatrics Pharmacokinetics Safety|latanoprost pediatrics pharmacokinetics safety
5665532|NCT00638729|bispectral index|bispectral index
5665533|NCT00638729|sedation|sedation
5665534|NCT00638729|stress hormones|stress hormones
5665535|NCT00638729|cognitive function|cognitive function
5665536|NCT00638716|Type 2 Diabetes Mellitus, incretins, GLP-1, HbA1c, metformin|type 2 diabetes mellitus, incretins, glp-1, hba1c, metformin
5665537|NCT00638703|hyperoxaluria|hyperoxaluria
5665538|NCT00638703|PH|ph
5665539|NCT00638703|oxalate|oxalate
5665540|NCT00638690|Metastatic Castration-Resistant Prostate Cancer|metastatic castration-resistant prostate cancer
5665541|NCT00638690|CRPC|crpc
5665542|NCT00638690|Abiraterone Acetate|abiraterone acetate
5665543|NCT00638690|CB7630|cb7630
5665544|NCT00638677|Oral microbiology|oral microbiology
5665545|NCT00638664|conventional pulse sequences for MR|conventional pulse sequences for mr
5665546|NCT00638664|cardiac chambers and walls|cardiac chambers and walls
5665547|NCT00638664|cardio-thoracic vasculature|cardio-thoracic vasculature
5665548|NCT00638664|the great vessels|the great vessels
5665549|NCT00638664|coronary vasculature|coronary vasculature
5665551|NCT00638664|great vessels|great vessels
5665552|NCT00638651|Tattoos|tattoos
5665553|NCT00638651|Black/blue tattoos|black/blue tattoos
5665554|NCT00638638|Myocardial infarction|myocardial infarction
5665555|NCT00638638|Angioplasty|angioplasty
5665556|NCT00638638|Coronary stenting|coronary stenting
5665557|NCT00638638|Abciximab|abciximab
5665558|NCT00638638|Myocardial reperfusion|myocardial reperfusion
5665559|NCT00638638|Microcirculation|microcirculation
5665560|NCT00638638|EKG|ekg
5665561|NCT00638638|ST elevation myocardial infarction within 6 h of symptom onset|st elevation myocardial infarction within 6 h of symptom onset
5665562|NCT00638625|Needle biopsy|needle biopsy
5665563|NCT00638625|CT Scan|ct scan
5665564|NCT00638625|Lung Tumor|lung tumor
5665565|NCT00638625|Lung Mass|lung mass
5665566|NCT00638612|Immunotherapy|immunotherapy
5665567|NCT00638612|Gene Therapy|gene therapy
5665568|NCT00638612|Cytotoxicity|cytotoxicity
5665569|NCT00638612|Tumor vaccine|tumor vaccine
5665570|NCT00638612|Radiation|radiation
5665571|NCT00638612|Surgery|surgery
5665572|NCT00638612|Chemoradiation|chemoradiation
5665573|NCT00638599|Intubation, intratracheal|intubation, intratracheal
5665574|NCT00638599|Homeostasis|homeostasis
5665575|NCT00638599|Mastectomy, modified radical|mastectomy, modified radical
5665576|NCT00638599|Breast Neoplasms|breast neoplasms
5665577|NCT00638560|PGC-1alpha|pgc-1alpha
5665578|NCT00638560|PPARgamma|ppargamma
5665579|NCT00638560|oxidative stress|oxidative stress
5665580|NCT00638560|training intervention|training intervention
5665581|NCT00638547|Hurler Syndrome|hurler syndrome
5665582|NCT00638547|mucopolysaccharidosis type I|mucopolysaccharidosis type i
5665583|NCT00638547|Iduronidase deficiency|iduronidase deficiency
5665584|NCT00638534|Acute Otitis Media|acute otitis media
5665585|NCT00638534|AOM|aom
5665586|NCT00638534|children|children
5665587|NCT00638534|Child|child
5665588|NCT00638521|lipids|lipids
5665589|NCT00638521|proteins|proteins
5665590|NCT00638521|membrane|membrane
5665591|NCT00638521|lipid raft|lipid raft
5665592|NCT00638482|Dent's disease|dent's disease
5665593|NCT00638482|Nephrolithiasis|nephrolithiasis
5665594|NCT00638482|clinical trial|clinical trial
5665595|NCT00638482|thiazides|thiazides
5665596|NCT00638469|Psoriasis|psoriasis
5665597|NCT00638469|Biologic|biologic
5665598|NCT00638469|adalimumab|adalimumab
5665599|NCT00638469|narrowband UVB|narrowband uvb
5665600|NCT00638469|phototherapy|phototherapy
5665601|NCT00638469|half-side comparison|half-side comparison
5665602|NCT00638456|Eosinophils|eosinophils
5665603|NCT00638456|Esophagitis|esophagitis
5665604|NCT00638456|Microscopy|microscopy
5665605|NCT00638443|Neurogenic claudication, lumbar spinal stenosis, treadmill testing|neurogenic claudication, lumbar spinal stenosis, treadmill testing
5665606|NCT00638430|myopia|myopia
5665607|NCT00638430|Humphery Matrix 30-2 test|humphery matrix 30-2 test
5665608|NCT00638404|Preoperative somatic questions|preoperative somatic questions
5665790|NCT00637676|talc pleurodesis|talc pleurodesis
5665609|NCT00638404|Preoperative audio tone evaluations|preoperative audio tone evaluations
5665610|NCT00638404|Preoperative anxiety and previous experience with postop pain|preoperative anxiety and previous experience with postop pain
5665611|NCT00638391|Primary early MCa|primary early mca
5665612|NCT00638391|Arimidex|arimidex
5665613|NCT00638378|Prostate Cancer|prostate cancer
5665614|NCT00638365|Cystic Fibrosis, Pseudomonas aeruginosa, Pulmonary CF|cystic fibrosis, pseudomonas aeruginosa, pulmonary cf
5665615|NCT00638352|Core Biopsy|core biopsy
5665616|NCT00638352|Needle Biopsy|needle biopsy
5665617|NCT00638352|Percutaneous Biopsy|percutaneous biopsy
5665618|NCT00638339|Respiration, artificial|respiration, artificial
5665619|NCT00638339|respiratory insufficiency|respiratory insufficiency
5665620|NCT00638339|noninvasive ventilation|noninvasive ventilation
5665621|NCT00638339|sleep deprivation|sleep deprivation
5665622|NCT00638339|intensive care units|intensive care units
5665623|NCT00638326|Clopidogrel, thrombosis, Percutaneous Transluminal Coronary Angioplasty, stents|clopidogrel, thrombosis, percutaneous transluminal coronary angioplasty, stents
5665625|NCT00638300|hemodialysis|hemodialysis
5665626|NCT00638300|iron|iron
5665627|NCT00638300|inflammation|inflammation
5665628|NCT00638300|atomic absorption|atomic absorption
5665629|NCT00638300|dialysate|dialysate
5665630|NCT00638300|advanced oxidation protein products|advanced oxidation protein products
5665631|NCT00638300|large pore dialysate|large pore dialysate
5665632|NCT00638300|bicarbonate|bicarbonate
5665633|NCT00638300|calcium|calcium
5665634|NCT00638300|citrate|citrate
5665635|NCT00638300|ligand|ligand
5665636|NCT00638287|Subjects with pituitary disease undergoing testing for GH|subjects with pituitary disease undergoing testing for gh
5665637|NCT00638287|deficiency|deficiency
5665638|NCT00638287|Subjects with suspicion for (or diagnosis of) acromegaly|subjects with suspicion for (or diagnosis of) acromegaly
5665639|NCT00638287|undergoing OGTT testing|undergoing ogtt testing
5685566|NCT00555568|mental health|mental health
5665640|NCT00638287|Normal controls without evidence of pituitary dysfunction|normal controls without evidence of pituitary dysfunction
5665641|NCT00638274|Quality of pain relief with 2 different methods of identifying epidural space|quality of pain relief with 2 different methods of identifying epidural space
5665642|NCT00638261|Psoriasis|psoriasis
5665643|NCT00638261|Biologic|biologic
5665644|NCT00638261|Adalimumab|adalimumab
5665645|NCT00638261|Narrow-band UVB|narrow-band uvb
5665646|NCT00638261|phototherapy|phototherapy
5665647|NCT00638261|half-side comparison|half-side comparison
5665648|NCT00638248|Acute ischemic stroke|acute ischemic stroke
5665649|NCT00638235|Pelvic floor repair|pelvic floor repair
5665650|NCT00638235|prolapse|prolapse
5665651|NCT00638235|mesh|mesh
5665652|NCT00638222|Carvedilol|carvedilol
5665653|NCT00638222|Heart Disease|heart disease
5665654|NCT00638222|Vascular Disease|vascular disease
5665655|NCT00638222|Kidney|kidney
5665656|NCT00638196|relapsing multiple sclerosis|relapsing multiple sclerosis
5665657|NCT00638196|polyunsaturated fatty acids|polyunsaturated fatty acids
5665658|NCT00638196|omega-6 fatty acids|omega-6 fatty acids
5665659|NCT00638170|Urinary Tract Infections|urinary tract infections
5665660|NCT00638170|Cranberry|cranberry
5665661|NCT00638170|Prevention|prevention
5671731|NCT00614614|Toddlers|toddlers
5665662|NCT00638157|Gram-positive bacterial infections|gram-positive bacterial infections
5665664|NCT00638157|endocarditis|endocarditis
5665665|NCT00638157|bacteremia|bacteremia
5665666|NCT00638157|methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5665667|NCT00638144|Hepatitis C|hepatitis c
5665668|NCT00638144|liver transplantation|liver transplantation
5665669|NCT00638144|antibodies mediated neutralization|antibodies mediated neutralization
5665670|NCT00638144|monoclonal antibodies|monoclonal antibodies
5665671|NCT00638092|hypothyroxinemia|hypothyroxinemia
5665672|NCT00638092|preterm infants|preterm infants
5665673|NCT00638092|iodine|iodine
5665674|NCT00638092|neurodevelopmental outcome|neurodevelopmental outcome
5665675|NCT00638092|Iodine supplementation|iodine supplementation
5665676|NCT00638092|Randomised controlled trial|randomised controlled trial
5665677|NCT00638079|Pharmacokinetics|pharmacokinetics
5665678|NCT00638079|Food Effect|food effect
5665679|NCT00638079|Bioavailability|bioavailability
5665680|NCT00638079|Megace ES|megace es
5665681|NCT00638066|vaginismus|vaginismus
5665682|NCT00638066|botulinum toxin A|botulinum toxin a
5665683|NCT00638066|dyspareunia|dyspareunia
5665684|NCT00638066|unconsummated marriage|unconsummated marriage
5665685|NCT00638040|hypoxia|hypoxia
5665686|NCT00638040|lactate|lactate
5665688|NCT00638040|tumor microenvironments|tumor microenvironments
5665689|NCT00638040|survival|survival
5847693|NCT00038519|HIV|hiv
5665690|NCT00638027|multiple sclerosis|multiple sclerosis
5665691|NCT00638014|Sternal wound closure|sternal wound closure
5665692|NCT00638014|cardiac surgery|cardiac surgery
5665693|NCT00638014|sternal nonunion|sternal nonunion
5665694|NCT00638001|patients with haemophilia A moderate or severe|patients with haemophilia a moderate or severe
5665695|NCT00638001|patients with haemophilia B moderate or severe|patients with haemophilia b moderate or severe
5665696|NCT00637988|Barrett's Esophagus|barrett's esophagus
5665697|NCT00637988|Nexium|nexium
5665698|NCT00637975|neuropathic pain|neuropathic pain
5665699|NCT00637975|oxycodone|oxycodone
5665700|NCT00637975|pregabalin|pregabalin
5665701|NCT00637975|Patients with cancer and presenting a neuropathic pain|patients with cancer and presenting a neuropathic pain
5665703|NCT00637962|AIDS|aids
5665704|NCT00637962|Vaccine|vaccine
5665705|NCT00637962|intravaginal|intravaginal
5665706|NCT00637962|mucosal|mucosal
5665707|NCT00637962|HIV Seronegativity|hiv seronegativity
5665708|NCT00637949|Osteoarthritis|osteoarthritis
5665709|NCT00637949|lumiracoxib|lumiracoxib
5665710|NCT00637949|rofecoxib|rofecoxib
5665711|NCT00637949|Cox-2|cox-2
5665712|NCT00637949|Osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)|osteoarthritis (primary osteoarthritis hip, hand, knee or spine (cervical or lumbar)
5665713|NCT00637936|perioperative oxygen|perioperative oxygen
5665714|NCT00637936|respiratory complications|respiratory complications
5665715|NCT00637923|Hepatitis C, Chronic|hepatitis c, chronic
5665716|NCT00637910|Advanced NSCLC|advanced nsclc
5665717|NCT00637910|EGFR|egfr
5665718|NCT00637910|EGFR copy number|egfr copy number
5665719|NCT00637910|Kras mutations|kras mutations
5665720|NCT00637910|EGRF mutations|egrf mutations
5665721|NCT00637910|Docetaxel|docetaxel
5665722|NCT00637910|Erlotinib|erlotinib
5665723|NCT00637910|Polymorphisms|polymorphisms
5665724|NCT00637897|recurrent breast cancer|recurrent breast cancer
5665725|NCT00637897|stage IV breast cancer|stage iv breast cancer
5665726|NCT00637871|Casodex|casodex
5665727|NCT00637871|bicalutamide|bicalutamide
5665728|NCT00637871|Tamoxifen|tamoxifen
5665729|NCT00637871|Gynaecomastia|gynaecomastia
5665730|NCT00637871|Prostate Cancer|prostate cancer
5665731|NCT00637845|Nexium|nexium
5665732|NCT00637845|Esomeprazole Magnesium|esomeprazole magnesium
5665733|NCT00637845|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5665734|NCT00637845|Heartburn|heartburn
5665735|NCT00637832|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5665736|NCT00637832|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5665737|NCT00637832|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5665738|NCT00637832|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5665739|NCT00637832|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5665740|NCT00637832|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5665741|NCT00637832|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5665742|NCT00637832|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5665743|NCT00637832|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5665744|NCT00637832|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5665745|NCT00637832|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5665746|NCT00637832|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5665747|NCT00637832|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5665748|NCT00637832|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5665749|NCT00637832|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5665751|NCT00637806|Anorexia|anorexia
5665752|NCT00637806|Cachexia|cachexia
5665753|NCT00637806|Cancer|cancer
5665754|NCT00637806|Unintended weight loss|unintended weight loss
5665755|NCT00637806|Body weight|body weight
5665756|NCT00637806|Appetite|appetite
5665757|NCT00637806|Megace ES|megace es
5665758|NCT00637793|Xerostomia|xerostomia
5665759|NCT00637793|Sjogren's Syndrome|sjogren's syndrome
5665760|NCT00637780|Sulfasalazine delayed release tablets|sulfasalazine delayed release tablets
5665761|NCT00637780|azulfidine entabs|azulfidine entabs
5665762|NCT00637780|Pharmacokinetics|pharmacokinetics
5665763|NCT00637780|Juvenile Idiopathic Arthritis (JIA)|juvenile idiopathic arthritis (jia)
5665764|NCT00637767|stage I multiple myeloma|stage i multiple myeloma
5665765|NCT00637767|stage II multiple myeloma|stage ii multiple myeloma
5665766|NCT00637767|stage III multiple myeloma|stage iii multiple myeloma
5665768|NCT00637754|Sports|sports
5665769|NCT00637741|Peripheral Vascular Disease|peripheral vascular disease
5665770|NCT00637741|Intermittent claudication|intermittent claudication
5665771|NCT00637741|Critical Limb Ischemia|critical limb ischemia
5665772|NCT00637741|TASC|tasc
5665773|NCT00637728|Megestrol acetate|megestrol acetate
5665774|NCT00637728|Anorexia|anorexia
5665775|NCT00637728|Cachexia|cachexia
5665776|NCT00637728|Lung cancer|lung cancer
5665777|NCT00637728|Pancreatic cancer|pancreatic cancer
5665778|NCT00637728|Unintended weight loss|unintended weight loss
5665779|NCT00637728|Body weight|body weight
5665780|NCT00637728|Appetite|appetite
5665781|NCT00637728|Megace ES|megace es
5665782|NCT00637689|Chronic graft versus host disease|chronic graft versus host disease
5665783|NCT00637689|Allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5665784|NCT00637689|Biomarkers|biomarkers
5665785|NCT00637689|Response criteria|response criteria
5665786|NCT00637689|Surrogate endpoints|surrogate endpoints
5665787|NCT00637689|Natural history|natural history
5646654|NCT00715806|MRI|mri
5665788|NCT00637676|malignant pleural effusion|malignant pleural effusion
5665789|NCT00637676|subcutaneous tunneled drainage|subcutaneous tunneled drainage
5665791|NCT00637663|Chronic hepatitis B|chronic hepatitis b
5665792|NCT00637663|Lamivudine|lamivudine
5665793|NCT00637663|Entecavir|entecavir
5665794|NCT00637637|tumors metastatic to brain|tumors metastatic to brain
5665795|NCT00637637|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5665796|NCT00637637|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5665797|NCT00637637|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5665798|NCT00637637|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5665800|NCT00637637|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5665801|NCT00637637|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5665802|NCT00637637|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5665803|NCT00637637|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5665804|NCT00637637|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5665805|NCT00637637|stage IV anal cancer|stage iv anal cancer
5665806|NCT00637637|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5665807|NCT00637637|stage IV bladder cancer|stage iv bladder cancer
5665808|NCT00637637|stage IV borderline ovarian surface epithelial-stromal tumor|stage iv borderline ovarian surface epithelial-stromal tumor
5665809|NCT00637637|stage IV breast cancer|stage iv breast cancer
5665810|NCT00637637|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5665811|NCT00637637|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5665812|NCT00637637|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5665813|NCT00637637|stage IV childhood liver cancer|stage iv childhood liver cancer
5665814|NCT00637637|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5665815|NCT00637637|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5665816|NCT00637637|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5665817|NCT00637637|stage IV colon cancer|stage iv colon cancer
5665818|NCT00637637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5665819|NCT00637637|stage IV esophageal cancer|stage iv esophageal cancer
5665820|NCT00637637|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5665821|NCT00637637|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5665822|NCT00637637|stage IV gastric cancer|stage iv gastric cancer
5665823|NCT00637637|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5665824|NCT00637637|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5665825|NCT00637637|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5665826|NCT00637637|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5671732|NCT00614614|Neisseria meningitidis|neisseria meningitidis
5665827|NCT00637637|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5665828|NCT00637637|stage IV laryngeal cancer|stage iv laryngeal cancer
5665829|NCT00637637|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5665830|NCT00637637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5665831|NCT00637637|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5665832|NCT00637637|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5665833|NCT00637637|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5665834|NCT00637637|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5665835|NCT00637637|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5665836|NCT00637637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5665837|NCT00637637|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5665838|NCT00637637|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5665839|NCT00637637|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5665840|NCT00637637|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5665841|NCT00637637|stage IV pancreatic cancer|stage iv pancreatic cancer
5665842|NCT00637637|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5665843|NCT00637637|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5665844|NCT00637637|stage IV penile cancer|stage iv penile cancer
5665845|NCT00637637|stage IV prostate cancer|stage iv prostate cancer
5665846|NCT00637637|stage IV rectal cancer|stage iv rectal cancer
5665847|NCT00637637|stage IV renal cell cancer|stage iv renal cell cancer
5668379|NCT00627653|PPAR|ppar
5665848|NCT00637637|stage IV salivary gland cancer|stage iv salivary gland cancer
5665849|NCT00637637|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5665850|NCT00637637|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5665851|NCT00637637|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5665852|NCT00637637|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5665853|NCT00637637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5665854|NCT00637637|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5665855|NCT00637637|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5665856|NCT00637637|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5665857|NCT00637637|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5665858|NCT00637637|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5665860|NCT00637637|stage IV Wilms tumor|stage iv wilms tumor
5665861|NCT00637637|stage IVB cervical cancer|stage ivb cervical cancer
5665862|NCT00637637|stage IVB vaginal cancer|stage ivb vaginal cancer
5665863|NCT00637637|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
5665864|NCT00637637|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
5665865|NCT00637637|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5665866|NCT00637637|metastatic parathyroid cancer|metastatic parathyroid cancer
5665867|NCT00637637|metastatic pheochromocytoma|metastatic pheochromocytoma
5665868|NCT00637637|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5665869|NCT00637637|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5665870|NCT00637637|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5665871|NCT00637637|disseminated neuroblastoma|disseminated neuroblastoma
5665872|NCT00637637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5665873|NCT00637637|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5665876|NCT00637624|Cisplatin|cisplatin
5665877|NCT00637624|Neuropathy|neuropathy
5665878|NCT00637624|Antioxidants|antioxidants
5665879|NCT00637598|Diagnostic Imaging|diagnostic imaging
5665880|NCT00637598|Mammography|mammography
5665881|NCT00637598|Breast Tomosynthesis|breast tomosynthesis
5665882|NCT00637572|Weight loss|weight loss
5665883|NCT00637572|Cachexia|cachexia
5665884|NCT00637572|Anorexia|anorexia
5665885|NCT00637572|Megestrol acetate oral suspension|megestrol acetate oral suspension
5665886|NCT00637572|Nanocrystal dispersion|nanocrystal dispersion
5665887|NCT00637572|Nanocrystal technology|nanocrystal technology
5665888|NCT00637572|Body weight changes|body weight changes
5665889|NCT00637572|AIDS wasting|aids wasting
5665890|NCT00637572|HIV wasting|hiv wasting
5665891|NCT00637572|Emaciation|emaciation
5665892|NCT00637572|Megace ES|megace es
5665894|NCT00637572|Treatment Experienced|treatment experienced
5665895|NCT00637559|Nexium|nexium
5665896|NCT00637559|Barrett's esophagus|barrett's esophagus
5665897|NCT00637546|Treatment|treatment
5665898|NCT00637546|Efficacy|efficacy
5665899|NCT00637546|Diabetes|diabetes
5665900|NCT00637546|Gait|gait
5665901|NCT00637546|Balance|balance
5665902|NCT00637520|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5665903|NCT00637520|Insulin Resistance|insulin resistance
5665904|NCT00637520|Lipid Metabolism|lipid metabolism
5665905|NCT00637507|High-Frequency Ventilation|high-frequency ventilation
5665906|NCT00637507|Tracheal Gas Insufflation|tracheal gas insufflation
5665907|NCT00637507|Respiration, Artificial|respiration, artificial
5665908|NCT00637507|Respiratory Distress Syndrome|respiratory distress syndrome
5665909|NCT00637507|Adult|adult
5665910|NCT00637494|psychotic depression|psychotic depression
5665911|NCT00637494|major depression with psychotic features|major depression with psychotic features
5665912|NCT00637494|psychosis|psychosis
5665913|NCT00637416|horseness|horseness
5665914|NCT00637403|renal impairment|renal impairment
5665915|NCT00637403|end stage renal disease|end stage renal disease
5665916|NCT00637403|megestrol acetate|megestrol acetate
5665917|NCT00637403|pharmacokinetics|pharmacokinetics
5665918|NCT00637403|hemodialysis|hemodialysis
5665919|NCT00637403|renal dialysis|renal dialysis
5665920|NCT00637403|kidney failure, chronic|kidney failure, chronic
5665921|NCT00637403|renal insufficiency|renal insufficiency
5665922|NCT00637403|Megace ES|megace es
5665923|NCT00637377|Eye diseases|eye diseases
5665924|NCT00637377|Vision Impairment and Blindness|vision impairment and blindness
5665925|NCT00637377|Eyes and Vision|eyes and vision
5665926|NCT00637377|Seniors|seniors
5665927|NCT00637377|Neovascular Age-Related Macular Degeneration (AMD)|neovascular age-related macular degeneration (amd)
5665928|NCT00637377|Retinal Disease|retinal disease
5665929|NCT00637364|pain|pain
5665930|NCT00637364|pancreas|pancreas
5665931|NCT00637364|pancreatic cancer|pancreatic cancer
5665932|NCT00637364|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5665933|NCT00637364|ductal adenocarcinoma|ductal adenocarcinoma
5665934|NCT00637338|Long-acting GLP-1 Diabetes|long-acting glp-1 diabetes
5665935|NCT00637325|trastuzumab optimization in breast cancer|trastuzumab optimization in breast cancer
5665936|NCT00637299|COPD|copd
5665937|NCT00637286|Zolmitriptan|zolmitriptan
5665938|NCT00637286|ZOMIG|zomig
5665939|NCT00637286|migraine|migraine
5665940|NCT00637286|headache response|headache response
5665941|NCT00637286|headache|headache
5665942|NCT00637286|headache pain|headache pain
5665943|NCT00637286|MIDAS|midas
5665944|NCT00637286|HCPC|hcpc
5665945|NCT00637273|diabetes|diabetes
5665946|NCT00637273|exenatide once weekly|exenatide once weekly
5665953|NCT00637273|Pioglitazone|pioglitazone
5665954|NCT00637260|motorcortex stimulation|motorcortex stimulation
5659543|NCT00665002|AML|aml
5665955|NCT00637260|Parkinson's disease|parkinson's disease
5665957|NCT00637247|pancreatic cancer|pancreatic cancer
5665958|NCT00637247|metastatic|metastatic
5665959|NCT00637247|chemotherapy naive|chemotherapy naive
5665961|NCT00637221|Tolerability|tolerability
5665962|NCT00637208|prostate cancer|prostate cancer
5665963|NCT00637208|venography|venography
5665964|NCT00637208|male patients|male patients
5665965|NCT00637208|Localized microscopic prostate cancer up to Gleason 6 (3+3)|localized microscopic prostate cancer up to gleason 6 (3+3)
5665966|NCT00637208|PSA level <14|psa level <14
5665967|NCT00637208|presence of varicocele|presence of varicocele
5665968|NCT00637195|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5665969|NCT00637195|Hepatitis B|hepatitis b
5665970|NCT00637195|Cervical cancer|cervical cancer
5665972|NCT00637195|Papillomavirus|papillomavirus
5665973|NCT00637182|Gynecomastia|gynecomastia
5665974|NCT00637182|Anastrazole|anastrazole
5665975|NCT00637182|Arimidex|arimidex
5665976|NCT00637182|Pubertal|pubertal
5665977|NCT00637182|males|males
5665978|NCT00637182|boys|boys
5665979|NCT00637169|oxygen therapy|oxygen therapy
5665980|NCT00637169|neurodevelopmental impairment|neurodevelopmental impairment
5665981|NCT00637156|Symptomatic DDD at Two Adjacent Levels of cervical spine|symptomatic ddd at two adjacent levels of cervical spine
5665982|NCT00637143|Renal transplant|renal transplant
5665983|NCT00637143|Cyclosporine|cyclosporine
5665984|NCT00637143|Tacrolimus|tacrolimus
5665985|NCT00637143|Intervention|intervention
5665986|NCT00637143|Interstitial Fibrosis Tubular Atrophy|interstitial fibrosis tubular atrophy
5665987|NCT00637143|Chronic Renal Allograft Failure|chronic renal allograft failure
5665988|NCT00637117|Lymphoma, Dendritic, Vaccine, Radiotherapy|lymphoma, dendritic, vaccine, radiotherapy
5665989|NCT00637104|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5665991|NCT00637104|restenosis|restenosis
5665992|NCT00637104|biocompatible materials|biocompatible materials
5665993|NCT00637104|ceramics|ceramics
5665994|NCT00637078|hypertension|hypertension
5665995|NCT00637078|hypercholesterolemia|hypercholesterolemia
5665996|NCT00637078|family physicians|family physicians
5665997|NCT00637078|fixed dose combination therapy|fixed dose combination therapy
5665998|NCT00637078|cluster randomized controlled trial|cluster randomized controlled trial
5665999|NCT00637065|Pulmonary hypertension|pulmonary hypertension
5666000|NCT00637065|Interstitial lung disease|interstitial lung disease
5666001|NCT00637065|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5666002|NCT00637065|Nonspecific interstitial pneumonia|nonspecific interstitial pneumonia
5666003|NCT00637065|Bosentan|bosentan
5666004|NCT00637065|Endothelin receptor antagonists|endothelin receptor antagonists
5666005|NCT00637065|Pulmonary vascular resistance|pulmonary vascular resistance
5666006|NCT00637052|preleukemia|preleukemia
5666007|NCT00637052|dysplasia of myeloid blood cells|dysplasia of myeloid blood cells
5666008|NCT00637039|Advanced cancer|advanced cancer
5666009|NCT00637039|Solid tumour|solid tumour
5666010|NCT00637039|Solid malignancies|solid malignancies
5666011|NCT00637039|Neoplasms|neoplasms
5666012|NCT00637026|Iressa, Gefitinib, Breast Cancer, Surgery|iressa, gefitinib, breast cancer, surgery
5666018|NCT00637000|Opioid dependence|opioid dependence
5666019|NCT00637000|Opioid withdrawal symptoms|opioid withdrawal symptoms
5666020|NCT00636987|aortic valve|aortic valve
5666021|NCT00636987|mitral valve|mitral valve
5666022|NCT00636987|heart valve|heart valve
5666023|NCT00636987|tissue valve|tissue valve
5666024|NCT00636987|bioprosthesis|bioprosthesis
5666025|NCT00636987|valve disorder|valve disorder
5666026|NCT00636987|valve disease|valve disease
5666027|NCT00636987|cardiac surgery|cardiac surgery
5666028|NCT00636987|aortic valve regurgitation|aortic valve regurgitation
5666029|NCT00636987|aortic valve stenosis|aortic valve stenosis
5666030|NCT00636987|mitral valve regurgitation|mitral valve regurgitation
5666031|NCT00636987|mitral valve stenosis|mitral valve stenosis
5666032|NCT00636974|Patients who are going to have regional anaesthesia for lower limbs surgery.|patients who are going to have regional anaesthesia for lower limbs surgery.
5666033|NCT00636974|Leg Surgery.|leg surgery.
5646915|NCT00714870|BMI|bmi
5666034|NCT00636961|COPD, Indacaterol Maleate, Exercise testing|copd, indacaterol maleate, exercise testing
5666035|NCT00636948|Rectal cancer surgery|rectal cancer surgery
5666036|NCT00636948|Symptomatic anastomotic leakage|symptomatic anastomotic leakage
5666037|NCT00636948|Defunctioning stoma|defunctioning stoma
5666038|NCT00636948|TME surgery|tme surgery
5666039|NCT00636935|Pneumocystis jirovecii Pneumonia|pneumocystis jirovecii pneumonia
5666040|NCT00636935|Corticosteroid Therapy|corticosteroid therapy
5666041|NCT00636935|HIV|hiv
5666042|NCT00636935|Pneumonia|pneumonia
5666043|NCT00636935|Pulmonary Function Testing|pulmonary function testing
5666044|NCT00636935|Antibiotics|antibiotics
5666045|NCT00636935|Prednisone|prednisone
5666046|NCT00636935|Human Immunodeficiency Virus|human immunodeficiency virus
5666047|NCT00636935|CD4|cd4
5666048|NCT00636935|CD8|cd8
5666049|NCT00636935|Viral Load|viral load
5666050|NCT00636935|Bactrim|bactrim
5666051|NCT00636935|Pentamidine|pentamidine
5666052|NCT00636935|Atovaquone|atovaquone
5666053|NCT00636935|Primaquine/Clindamycin|primaquine/clindamycin
5666054|NCT00636935|Trimethoprim/Dapsone|trimethoprim/dapsone
5666055|NCT00636922|Acute Myeloid Leukemia|acute myeloid leukemia
5666056|NCT00636922|Elderly|elderly
5666057|NCT00636922|Unfit|unfit
5666058|NCT00636922|Everolimus|everolimus
5666059|NCT00636922|RAD001|rad001
5666061|NCT00636909|ALL|all
5666062|NCT00636909|CML|cml
5666063|NCT00636909|CLL|cll
5666064|NCT00636909|MDS|mds
5666065|NCT00636909|NHL|nhl
5666066|NCT00636909|HODGKIN'S LYMPHOMA|hodgkin's lymphoma
5666067|NCT00636909|APLASTIC ANEMIA|aplastic anemia
5666068|NCT00636909|MULTIPLE MYELOMA|multiple myeloma
5666069|NCT00636909|MYELOPROLIFERATIVE DISORDER|myeloproliferative disorder
5666070|NCT00636909|ALLOGENEIC|allogeneic
5666071|NCT00636909|STEM CELL TRANSPLANT|stem cell transplant
5666072|NCT00636909|HEMATOLOGIC DISORDERS|hematologic disorders
5666073|NCT00636909|CYCLOPHOSPHAMIDE|cyclophosphamide
5666074|NCT00636909|FLUDARABINE|fludarabine
5666075|NCT00636909|CYCLOSPORINE|cyclosporine
5666076|NCT00636909|METHOTREXATE|methotrexate
5666077|NCT00636909|G-CSF|g-csf
5666078|NCT00636909|GVHD|gvhd
5666079|NCT00636909|ENGRAFTMENT|engraftment
5666080|NCT00636909|CHIMERISM|chimerism
5666081|NCT00636896|weight gain|weight gain
5666082|NCT00636896|olanzapine|olanzapine
5666083|NCT00636896|atypical antipsychotic|atypical antipsychotic
5666084|NCT00636883|Pancreatic cancer|pancreatic cancer
5666085|NCT00636857|Water-Electrolyte Imbalance|water-electrolyte imbalance
5666086|NCT00636844|chemotherapy, cardiotoxicity|chemotherapy, cardiotoxicity
5666087|NCT00636831|Prophylactic|prophylactic
5666088|NCT00636831|Antibiotic|antibiotic
5666089|NCT00636831|Infection|infection
5666090|NCT00636831|Primary case|primary case
5666091|NCT00636805|Aloxi|aloxi
5666092|NCT00636805|Brain Neoplasm, Primary|brain neoplasm, primary
5666093|NCT00636805|Brain Neoplasms, Malignant|brain neoplasms, malignant
5666094|NCT00636766|cardiovascular events|cardiovascular events
5666095|NCT00636753|Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.|metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.
5666096|NCT00636740|Prostate cancer, hormone resistant, bisphosphonate|prostate cancer, hormone resistant, bisphosphonate
5666097|NCT00636727|arthrocentesis|arthrocentesis
5666098|NCT00636727|arthroscopy|arthroscopy
5666099|NCT00636727|arthroplasty|arthroplasty
5666100|NCT00636714|intensive insulin therapy|intensive insulin therapy
5666101|NCT00636714|glucose control|glucose control
5666102|NCT00636714|nurse directed|nurse directed
5666103|NCT00636714|nomogram directed|nomogram directed
5666104|NCT00636701|Cerebrovascular Accident|cerebrovascular accident
5666105|NCT00636701|rehabilitation|rehabilitation
5666106|NCT00636688|Obesity|obesity
5666107|NCT00636688|Lifestyle changes|lifestyle changes
5666108|NCT00636675|Accidental falls|accidental falls
5666109|NCT00636649|Eating disorder|eating disorder
5666110|NCT00636636|Postherpetic Neuralgia (PHN), shingles|postherpetic neuralgia (phn), shingles
5666111|NCT00636623|Pilates Exercises|pilates exercises
5666112|NCT00636623|Connective Tissue Massage|connective tissue massage
5666113|NCT00636610|Hedgehog|hedgehog
5666114|NCT00636610|CRC|crc
5666115|NCT00636610|Colorectal Cancer|colorectal cancer
5666116|NCT00636610|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5666117|NCT00636584|sodium nitroprusside|sodium nitroprusside
5666118|NCT00636584|thyroid hormones|thyroid hormones
5666119|NCT00636584|thoracic surgery|thoracic surgery
5666120|NCT00636571|Exercise|exercise
5666121|NCT00636571|Non-Small Cell Lung Cancer|non-small cell lung cancer
5666122|NCT00636571|Cardiopulmonary Fitness|cardiopulmonary fitness
5666123|NCT00636558|coxsackie virus|coxsackie virus
5666124|NCT00636558|melanoma|melanoma
5666125|NCT00636558|breast cancer|breast cancer
5666126|NCT00636558|prostate cancer|prostate cancer
5666127|NCT00636545|Genasense|genasense
5666128|NCT00636545|oblimersen|oblimersen
5666129|NCT00636545|antisense|antisense
5666130|NCT00636545|Bcl-2 antisense|bcl-2 antisense
5666131|NCT00636545|Solid Tumors|solid tumors
5666132|NCT00636519|Botulism Antitoxin,Heptavalent,Bivalent,EDB Muscle,Paralysis|botulism antitoxin,heptavalent,bivalent,edb muscle,paralysis
5666133|NCT00636506|Erectile dysfunction|erectile dysfunction
5666134|NCT00636506|Impotence|impotence
5666135|NCT00636493|retinal vein occlusion|retinal vein occlusion
5666136|NCT00636493|sustained drug delivery implant|sustained drug delivery implant
5666137|NCT00636493|steroid|steroid
5666138|NCT00636493|macular edema|macular edema
5666139|NCT00636480|Antimicrobial|antimicrobial
5666140|NCT00636480|Antisepsis|antisepsis
5666141|NCT00636467|Breast cancer (tumors> 2 cm)|breast cancer (tumors> 2 cm)
5666142|NCT00636467|Detection|detection
5666143|NCT00636467|Axillary sentinel lymph node|axillary sentinel lymph node
5666144|NCT00636454|OA|oa
5666145|NCT00636454|Pain|pain
5666146|NCT00636454|Cognitive Therapy|cognitive therapy
5666147|NCT00636454|Behavior Therapy|behavior therapy
5666148|NCT00636454|Knee OA|knee oa
5666149|NCT00636454|Hip OA|hip oa
5666150|NCT00636441|Early-Stage Breast Cancer|early-stage breast cancer
5666151|NCT00636441|Preoperative systemic chemotherapy (PST)|preoperative systemic chemotherapy (pst)
5666152|NCT00636441|Genomic|genomic
5666153|NCT00636441|Genomic Predictor|genomic predictor
5666155|NCT00636441|Randomized|randomized
5666156|NCT00636441|Pathologic complete response (pCR)|pathologic complete response (pcr)
5666157|NCT00636441|HER2 negative|her2 negative
5666158|NCT00636441|Doxorubicin and docetaxel|doxorubicin and docetaxel
5666159|NCT00636441|Doxorubicin and cyclophosphamide|doxorubicin and cyclophosphamide
5666160|NCT00636428|endoscopy|endoscopy
5666161|NCT00636428|Midazolam|midazolam
5666162|NCT00636428|pediatric|pediatric
5666163|NCT00636428|sedation|sedation
5666164|NCT00636428|comfort|comfort
5666165|NCT00636415|Analgesia|analgesia
5666166|NCT00636415|Morphine|morphine
5666167|NCT00636415|Bupivacaine|bupivacaine
5666168|NCT00636415|Osteoarthritis|osteoarthritis
5666169|NCT00636415|Knee|knee
5666170|NCT00636402|Vessel Sealing System|vessel sealing system
5666171|NCT00636402|Cold Knife|cold knife
5666172|NCT00636402|Tonsillectomy|tonsillectomy
5666173|NCT00636402|Pain|pain
5666174|NCT00636402|Postoperative|postoperative
5666175|NCT00636389|Hemodialysis|hemodialysis
5666176|NCT00636389|Dialysis, Renal|dialysis, renal
5666177|NCT00636389|Dialysis, Extracorporeal|dialysis, extracorporeal
5666178|NCT00636389|Extracorporeal Dialysis|extracorporeal dialysis
5666179|NCT00636376|elevated intracranial pressure|elevated intracranial pressure
5666180|NCT00636376|inadequate cerebral perfusion|inadequate cerebral perfusion
5666181|NCT00636376|secondary brain damage|secondary brain damage
5666182|NCT00636350|pepper carotenoids|pepper carotenoids
5666184|NCT00636350|healthy volunteers|healthy volunteers
5666185|NCT00636337|Pediatric|pediatric
5666186|NCT00636337|Brain Tumor|brain tumor
5666187|NCT00636337|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5666188|NCT00636337|Inattention|inattention
5666189|NCT00636337|Childhood cancer survivors|childhood cancer survivors
5666190|NCT00636324|Respiratory distress syndrome|respiratory distress syndrome
5666191|NCT00636324|Preterm infants|preterm infants
5666192|NCT00636324|Extubation failure|extubation failure
5666193|NCT00636324|Pneumothorax|pneumothorax
5666194|NCT00636324|Lung injury|lung injury
5666195|NCT00636324|Airway pressure|airway pressure
5666196|NCT00636311|Hodgkin disease|hodgkin disease
5666197|NCT00636311|Salvage therapy|salvage therapy
5666198|NCT00636311|Bortezomib|bortezomib
5666199|NCT00636311|Transplantation|transplantation
5666200|NCT00636298|esophageal carcinoma|esophageal carcinoma
5666201|NCT00636298|cancer of the esophagus|cancer of the esophagus
5666202|NCT00636298|locally advanced or metastatic esophageal cancer|locally advanced or metastatic esophageal cancer
5666205|NCT00636272|ICD|icd
5666206|NCT00636272|CRT-D|crt-d
5666207|NCT00636259|Prostate cancer|prostate cancer
5666208|NCT00636259|Casodex|casodex
5666209|NCT00636233|anencephaly|anencephaly
5666210|NCT00636233|acrania|acrania
5666211|NCT00636220|HIV-1 Infections|hiv-1 infections
5666212|NCT00636155|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5666213|NCT00636155|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5666214|NCT00636155|EL625|el625
5666215|NCT00636155|cenersen|cenersen
5666216|NCT00636129|relaxation|relaxation
5666217|NCT00636129|relaxation response|relaxation response
5666218|NCT00636129|meditation|meditation
5666219|NCT00636129|nitric oxide|nitric oxide
5666220|NCT00636129|stress management|stress management
5666221|NCT00636129|stress|stress
5666222|NCT00636129|Relaxation Techniques|relaxation techniques
5666223|NCT00636116|snake bite|snake bite
5666224|NCT00636116|antivenin treatment|antivenin treatment
5666225|NCT00636103|Traditional Chinese Medicine|traditional chinese medicine
5666226|NCT00636103|Asthma|asthma
5666227|NCT00636103|Paediatric|paediatric
5666228|NCT00636077|Hemodialysis|hemodialysis
5666229|NCT00636077|Dialysis, Renal|dialysis, renal
5666230|NCT00636051|evidence based practice beliefs|evidence based practice beliefs
5666231|NCT00636051|evidence based practice implementation|evidence based practice implementation
5666232|NCT00636051|evidence based practice dissemination|evidence based practice dissemination
5666233|NCT00636038|beta-carotene|beta-carotene
5666234|NCT00636038|yellow maize|yellow maize
5666235|NCT00636038|vitamin A|vitamin a
5666237|NCT00636012|Acupuncture points|acupuncture points
5666238|NCT00635986|Analgesia|analgesia
5666239|NCT00635986|Fentanyl|fentanyl
5666240|NCT00635986|Orthopedic|orthopedic
5666241|NCT00635986|Mechanism of action|mechanism of action
5666242|NCT00635986|Surgery|surgery
5666243|NCT00635973|Iressa|iressa
5666244|NCT00635973|Gefitinib|gefitinib
5666245|NCT00635973|Cancer|cancer
5666246|NCT00635973|Patients diagnosed with cancer who have previously received Iressa in an Iressa clinical trial|patients diagnosed with cancer who have previously received iressa in an iressa clinical trial
5666247|NCT00635960|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5666248|NCT00635960|ALS|als
5666249|NCT00635960|Growth Hormone|growth hormone
5666250|NCT00635960|IGF-I|igf-i
5666251|NCT00635947|Amniotic fluid index|amniotic fluid index
5666252|NCT00635947|maternal hydration|maternal hydration
5666253|NCT00635947|isotonic solution|isotonic solution
5666254|NCT00635947|Amniotic Fluid|amniotic fluid
5659822|NCT00663741|Sorafenib|sorafenib
5666255|NCT00635934|Lumbar Degenerative Disc Disease at One Level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
5666256|NCT00635921|Borderline Personality Disorder|borderline personality disorder
5666258|NCT00635895|Fibromyalgia|fibromyalgia
5666259|NCT00635895|Manual Lymphatic Drainage|manual lymphatic drainage
5666260|NCT00635895|Connective Tissue Massage|connective tissue massage
5666261|NCT00635895|Pain|pain
5666262|NCT00635895|Health Related Quality of Life|health related quality of life
5666512|NCT00634933|anti CD20|anti cd20
5666263|NCT00635895|Randomized Controlled Trial|randomized controlled trial
5666264|NCT00635882|mometasone|mometasone
5666265|NCT00635882|formoterol|formoterol
5666266|NCT00635869|evidence based practice beliefs|evidence based practice beliefs
5666267|NCT00635869|evidence based practice implementation|evidence based practice implementation
5666268|NCT00635869|evidence based practice knowledge|evidence based practice knowledge
5666269|NCT00635869|nurse physician collaboration|nurse physician collaboration
5666270|NCT00635856|Iressa|iressa
5666271|NCT00635856|Gefitinib|gefitinib
5666272|NCT00635856|Prostate Cancer|prostate cancer
5666273|NCT00635856|PSA|psa
5666274|NCT00635843|Lumbar degenerative disc disease at one level from L4-S1|lumbar degenerative disc disease at one level from l4-s1
5666275|NCT00635817|CPP|cpp
5666276|NCT00635817|central precocious puberty|central precocious puberty
5666277|NCT00635817|pediatrics|pediatrics
5666278|NCT00635817|suppression of luteinizing hormone|suppression of luteinizing hormone
5666279|NCT00635817|Lupron|lupron
5666280|NCT00635817|leuprolide acetate|leuprolide acetate
5666281|NCT00635817|depot formulation|depot formulation
5666282|NCT00635817|GnRHa|gnrha
5666283|NCT00635817|GnRH agonist|gnrh agonist
5666284|NCT00635817|GnRH analog|gnrh analog
5666285|NCT00635817|luteinizing hormone|luteinizing hormone
5666286|NCT00635791|Malignant Solid Tumour|malignant solid tumour
5666287|NCT00635791|Renal cell carcinoma|renal cell carcinoma
5666288|NCT00635791|Non small cell lung carcinoma|non small cell lung carcinoma
5666289|NCT00635765|Acromegaly|acromegaly
5666290|NCT00635752|TF-CBT|tf-cbt
5666291|NCT00635752|Effectiveness study|effectiveness study
5666292|NCT00635752|Trauma|trauma
5666293|NCT00635752|Therapy|therapy
5666294|NCT00635739|Whey protein|whey protein
5666295|NCT00635739|Resistance exercise|resistance exercise
5666296|NCT00635739|Physical activity|physical activity
5666297|NCT00635739|Mobility disability|mobility disability
5666298|NCT00635739|Physical function|physical function
5666299|NCT00635739|Muscle mass|muscle mass
5666300|NCT00635739|Muscle strength|muscle strength
5666301|NCT00635739|Older Adults|older adults
5666302|NCT00635739|Mobility-Limited|mobility-limited
5666303|NCT00635726|Bladder Cancer|bladder cancer
5666304|NCT00635713|Advanced breast cancer, FASLODEX, ARIMIDEX, Fulvestrant, Anastrozole, postmenopausal|advanced breast cancer, faslodex, arimidex, fulvestrant, anastrozole, postmenopausal
5666305|NCT00635700|psychosis|psychosis
5666306|NCT00635700|schizophrenia|schizophrenia
5666307|NCT00635700|prodrome|prodrome
5666308|NCT00635700|ziprasidone|ziprasidone
5666309|NCT00635700|placebo|placebo
5666310|NCT00635687|variceal bleeding|variceal bleeding
5666311|NCT00635687|transient elastography|transient elastography
5666312|NCT00635674|sleep apnea|sleep apnea
5666313|NCT00635674|risk factors|risk factors
5666314|NCT00635674|continuous positive airway pressure|continuous positive airway pressure
5666315|NCT00635674|insulin resistance|insulin resistance
5666316|NCT00635674|metabolic syndrome|metabolic syndrome
5666317|NCT00635674|compliance|compliance
5666318|NCT00635661|function|function
5666319|NCT00635661|disability|disability
5666320|NCT00635635|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5666321|NCT00635635|Anxiety,|anxiety,
5666322|NCT00635635|Depression,|depression,
5666323|NCT00635635|Guided Imagery|guided imagery
5666324|NCT00635635|Military Sexual Trauma|military sexual trauma
5666325|NCT00635622|Bacterial Vaginosis|bacterial vaginosis
5666326|NCT00635622|BV|bv
5666327|NCT00635622|UCSF|ucsf
5666328|NCT00635622|SFGH|sfgh
5666329|NCT00635596|MT110|mt110
5666330|NCT00635596|solid tumors|solid tumors
5666331|NCT00635596|phase I|phase i
5666332|NCT00635596|BiTE|bite
5666333|NCT00635596|bispecific T-cell engager|bispecific t-cell engager
5666334|NCT00635583|Bone|bone
5666335|NCT00635583|Dairy Intervention|dairy intervention
5666336|NCT00635583|Girls|girls
5666337|NCT00635583|Boys|boys
5666338|NCT00635583|Calcium|calcium
5666339|NCT00635583|Bone Mineralization|bone mineralization
5666340|NCT00635583|Peak Bone Mass|peak bone mass
5666341|NCT00635583|Bone and Bones|bone and bones
5666342|NCT00635583|Female|female
5666343|NCT00635583|Male|male
5666344|NCT00635583|Adolescent|adolescent
5666345|NCT00635583|Healthy|healthy
5666346|NCT00635570|Contraception, Compliance, Acceptability|contraception, compliance, acceptability
5666347|NCT00635557|Recurrent|recurrent
5666348|NCT00635557|Relapsed|relapsed
5666349|NCT00635557|Glioblastoma|glioblastoma
5666350|NCT00635557|Multiforme|multiforme
5666351|NCT00635544|Adolescence|adolescence
5666352|NCT00635544|Overweight|overweight
5666353|NCT00635544|Dietary Fiber|dietary fiber
5666354|NCT00635544|Glycemic Index|glycemic index
5666355|NCT00635544|Healthy lifestyle|healthy lifestyle
5666356|NCT00635518|Health Plan Implementation|health plan implementation
5666357|NCT00635518|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5666358|NCT00635518|Breast Feeding|breast feeding
5666359|NCT00635518|Overweight|overweight
5666360|NCT00635518|Child|child
5666361|NCT00635518|Infant Nutrition Physiology|infant nutrition physiology
5666362|NCT00635518|Public Health|public health
5666363|NCT00635505|Asthma|asthma
5666364|NCT00635505|albuterol|albuterol
5666366|NCT00635492|diabetes|diabetes
5666367|NCT00635492|insulin|insulin
5666368|NCT00635492|exenatide|exenatide
5666369|NCT00635492|Byetta|byetta
5666370|NCT00635492|Amylin|amylin
5666371|NCT00635492|Lilly|lilly
5666372|NCT00635479|Fractures|fractures
5666373|NCT00635479|Pelvic bones|pelvic bones
5666374|NCT00635479|Acetabulum|acetabulum
5666375|NCT00635479|Hip bones|hip bones
5666376|NCT00635466|laparoscopic surgery, rectal carcinoma, phase II trial|laparoscopic surgery, rectal carcinoma, phase ii trial
5666377|NCT00635453|Breast Feeding|breast feeding
5666378|NCT00635453|Child|child
5666379|NCT00635453|Infant Nutrition Physiology|infant nutrition physiology
5666380|NCT00635453|Public Health|public health
5666381|NCT00635453|Morbidity|morbidity
5666382|NCT00635453|Health Plan Implementation|health plan implementation
5666383|NCT00635440|skeletal muscle|skeletal muscle
5666384|NCT00635440|ubiquitin|ubiquitin
5666386|NCT00635440|IGF-1|igf-1
5666387|NCT00635440|MGF|mgf
5666388|NCT00635440|protein catabolism|protein catabolism
5666389|NCT00635440|neuromuscular electrical stimulation|neuromuscular electrical stimulation
5666513|NCT00634920|De novo renal transplantation|de novo renal transplantation
5666390|NCT00635440|Investigate effect of NMES on muscle metabolism of catabolic patients|investigate effect of nmes on muscle metabolism of catabolic patients
5666391|NCT00635427|VPRIV|vpriv
5666392|NCT00635427|Enzyme Replacement Therapy|enzyme replacement therapy
5666393|NCT00635427|Gaucher disease|gaucher disease
5666394|NCT00635427|glucocerebrosidase|glucocerebrosidase
5666395|NCT00635427|beta-glucocerebrosidase|beta-glucocerebrosidase
5666396|NCT00635427|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5666397|NCT00635427|glucosylceramidase|glucosylceramidase
5666398|NCT00635427|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5666399|NCT00635427|gene activation|gene activation
5666400|NCT00635427|human|human
5666401|NCT00635414|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
5666402|NCT00635362|Contraception|contraception
5666403|NCT00635362|Contraceptive Devices|contraceptive devices
5666404|NCT00635362|Intrauterine Devices|intrauterine devices
5666405|NCT00635362|Unplanned Pregnancy|unplanned pregnancy
5666406|NCT00635362|Postpartum Period|postpartum period
5666407|NCT00635349|WOMAC|womac
5666408|NCT00635349|Knee osteoarthritis pain|knee osteoarthritis pain
5666409|NCT00635349|Pain intensity|pain intensity
5666410|NCT00635349|Tramadol|tramadol
5666411|NCT00635349|Acetaminophen|acetaminophen
5666412|NCT00635349|Meloxicam|meloxicam
5666413|NCT00635349|Aceclofenac|aceclofenac
5666414|NCT00635336|Epitope peptide|epitope peptide
5666416|NCT00635336|Advanced bladder cancer|advanced bladder cancer
5666417|NCT00635336|Vaccination|vaccination
5666418|NCT00635336|advanced bladder cancer which showed resistance for standard treatments|advanced bladder cancer which showed resistance for standard treatments
5666419|NCT00635310|Chronic hepatitis C|chronic hepatitis c
5666420|NCT00635310|Chronic hepatitis B|chronic hepatitis b
5666421|NCT00635310|Liver biopsy|liver biopsy
5666422|NCT00635310|Hemodialysis|hemodialysis
5666423|NCT00635310|1-Deamino-8- D-Arginine Vasopressin|1-deamino-8- d-arginine vasopressin
5666424|NCT00635297|osteoporosis|osteoporosis
5666425|NCT00635297|vertebroplasty|vertebroplasty
5666426|NCT00635297|prophylactic|prophylactic
5666427|NCT00635297|vertebrae|vertebrae
5666428|NCT00635297|fracture|fracture
5666429|NCT00635271|Asthma|asthma
5666430|NCT00635271|Biomarker|biomarker
5666431|NCT00635271|Exhaled Breath Condensate|exhaled breath condensate
5666432|NCT00635271|Cytokine|cytokine
5666433|NCT00635271|Healthy Volunteer|healthy volunteer
5666435|NCT00635258|GnRH antagonist|gnrh antagonist
5666436|NCT00635258|oocyte donation|oocyte donation
5666437|NCT00635258|pregnancy|pregnancy
5666438|NCT00635258|implantation|implantation
5666439|NCT00635245|stage IA breast cancer|stage ia breast cancer
5666440|NCT00635245|stage IB breast cancer|stage ib breast cancer
5666441|NCT00635245|stage II breast cancer|stage ii breast cancer
5666442|NCT00635232|Hypertension|hypertension
5666443|NCT00635232|High Blood Pressure|high blood pressure
5666444|NCT00635219|Major depressive disorder|major depressive disorder
5666445|NCT00635219|Placebo-controlled|placebo-controlled
5666446|NCT00635219|Active reference|active reference
5666447|NCT00635219|Multicenter study|multicenter study
5666448|NCT00635219|Randomised study|randomised study
5666449|NCT00635219|Acute treatment|acute treatment
5666450|NCT00635206|OSA|osa
5666451|NCT00635193|Ovarian neoplasms|ovarian neoplasms
5666452|NCT00635193|Angiogenesis inhibitors|angiogenesis inhibitors
5666453|NCT00635193|Angiogenesis|angiogenesis
5666456|NCT00635193|Antibody|antibody
5666457|NCT00635193|Monoclonals|monoclonals
5666458|NCT00635180|Isometric exercise|isometric exercise
5666459|NCT00635180|intraocular pressure|intraocular pressure
5666460|NCT00635180|Physiological changes in intraocular pressure during isometric exercise|physiological changes in intraocular pressure during isometric exercise
5666461|NCT00635167|Prostate cancer|prostate cancer
5666462|NCT00635167|prostatic vascularity|prostatic vascularity
5666463|NCT00635167|External Beam Radiation treatment|external beam radiation treatment
5666464|NCT00635167|Contrast Enhanced transrectal Ultrasound|contrast enhanced transrectal ultrasound
5666465|NCT00635154|stage I multiple myeloma|stage i multiple myeloma
5666466|NCT00635154|stage II multiple myeloma|stage ii multiple myeloma
5666467|NCT00635154|stage III multiple myeloma|stage iii multiple myeloma
5666468|NCT00635141|Cystic Fibrosis|cystic fibrosis
5666469|NCT00635141|Lung Clearance Index|lung clearance index
5666470|NCT00635141|Hypertonic Saline|hypertonic saline
5666471|NCT00635141|Pediatrics|pediatrics
5666472|NCT00635128|Diphtheria|diphtheria
5666473|NCT00635128|vaccine|vaccine
5666474|NCT00635128|DTP|dtp
5666475|NCT00635128|Poliomyelitis|poliomyelitis
5666476|NCT00635128|Pertussis|pertussis
5666477|NCT00635128|Booster|booster
5666478|NCT00635128|Tetanus|tetanus
5685567|NCT00555568|group processes|group processes
5666479|NCT00635102|Alcohol Dependence, Alcoholism, Glycine, D-Cycloserine|alcohol dependence, alcoholism, glycine, d-cycloserine
5666480|NCT00635089|Eosinophilic Esophagitis|eosinophilic esophagitis
5666481|NCT00635089|Cinquil|cinquil
5666482|NCT00635063|Cancer Breakthrough Pain|cancer breakthrough pain
5666483|NCT00635050|Breast cancer|breast cancer
5666484|NCT00635037|Myofascial pain syndrome|myofascial pain syndrome
5666485|NCT00635037|Acupuncture|acupuncture
5666486|NCT00635037|Nonsteroidal anti-inflammatory agents|nonsteroidal anti-inflammatory agents
5666487|NCT00635037|Muscle relaxants, central|muscle relaxants, central
5666488|NCT00635037|Quality of life.|quality of life.
5666489|NCT00635037|muscle relaxants, analgesia|muscle relaxants, analgesia
5666490|NCT00635024|refractory multiple myeloma|refractory multiple myeloma
5666491|NCT00635024|stage I multiple myeloma|stage i multiple myeloma
5666492|NCT00635024|stage II multiple myeloma|stage ii multiple myeloma
5666493|NCT00635024|stage III multiple myeloma|stage iii multiple myeloma
5666494|NCT00635011|comorbidity|comorbidity
5666495|NCT00635011|Quality of Life|quality of life
5666496|NCT00635011|Body Weight Changes|body weight changes
5666497|NCT00634998|Vitamin C|vitamin c
5666498|NCT00634998|Ascorbic Acid|ascorbic acid
5666499|NCT00634998|Diabetic Neuropathies|diabetic neuropathies
5666500|NCT00634972|Retinopathy of Prematurity|retinopathy of prematurity
5666501|NCT00634972|Premature Infants|premature infants
5666502|NCT00634972|ACULAR|acular
5666503|NCT00634972|Refresh Tears|refresh tears
5666504|NCT00634959|HIV Infections|hiv infections
5666505|NCT00634959|Treatment Naïve|treatment naïve
5666506|NCT00634946|Chemonucleolysis|chemonucleolysis
5666507|NCT00634946|Lumbar Vertebrae|lumbar vertebrae
5666508|NCT00634946|Hernia|hernia
5666509|NCT00634933|active|active
5666510|NCT00634933|rheumatoid|rheumatoid
5666511|NCT00634933|arthritis|arthritis
5666514|NCT00634907|Genotyping|genotyping
5666515|NCT00634907|Warfarin dosing|warfarin dosing
5666516|NCT00634907|arthroplasty|arthroplasty
5666517|NCT00634894|Ovarian Cancer|ovarian cancer
5666518|NCT00634894|Fallopian Tube Cancer|fallopian tube cancer
5666519|NCT00634894|Peritoneal Cancer|peritoneal cancer
5666520|NCT00634894|Femara|femara
5666521|NCT00634894|Letrozole|letrozole
5666522|NCT00634894|Placebo|placebo
5666523|NCT00634881|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5666524|NCT00634881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5666525|NCT00634881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5666526|NCT00634881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5666527|NCT00634881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5666528|NCT00634868|ulcer wound diabetes|ulcer wound diabetes
5666529|NCT00634855|Endothelial progenitor cells|endothelial progenitor cells
5666530|NCT00634855|Endothelial dysfunction|endothelial dysfunction
5666531|NCT00634777|HNSCC biopsy-proven|hnscc biopsy-proven
5666532|NCT00634777|T1-T4 oral cavity oropharynx hypopharynx larynx|t1-t4 oral cavity oropharynx hypopharynx larynx
5666533|NCT00634777|N+ scheduled for an organ preservation treatment protocol based on concomitant|n+ scheduled for an organ preservation treatment protocol based on concomitant
5666534|NCT00634777|chemoradiation|chemoradiation
5666733|NCT00633906|Adolescents|adolescents
5666535|NCT00634764|Maternal weight gain|maternal weight gain
5666536|NCT00634764|Neonatal birth weight|neonatal birth weight
5666537|NCT00634764|Weight gain attitude|weight gain attitude
5666538|NCT00634764|Pregnancy|pregnancy
5666539|NCT00634764|Body fat|body fat
5666540|NCT00634764|Maternal Behavior|maternal behavior
5666541|NCT00634764|Birth outcomes|birth outcomes
5666542|NCT00634751|advanced pancreatic and biliary tract carcinomas|advanced pancreatic and biliary tract carcinomas
5666543|NCT00634738|ischemic compression;carpal tunnel syndrome|ischemic compression;carpal tunnel syndrome
5666545|NCT00634725|stage III pancreatic cancer|stage iii pancreatic cancer
5666546|NCT00634712|Congestive Heart Failure|congestive heart failure
5666547|NCT00634712|Atacand|atacand
5666548|NCT00634712|Candesartan|candesartan
5666549|NCT00634686|Omega-3 fatty acids|omega-3 fatty acids
5666550|NCT00634686|immune response|immune response
5666551|NCT00634673|Serum Fatty Acids|serum fatty acids
5666552|NCT00634673|FABP2 Gene|fabp2 gene
5666553|NCT00634673|Polymorphism Ala54Thr|polymorphism ala54thr
5666554|NCT00634647|Chemotherapy|chemotherapy
5666555|NCT00634647|Pharmacokinetics|pharmacokinetics
5666556|NCT00634647|Gene Polymorphisms|gene polymorphisms
5666557|NCT00634647|Prostate Cancer|prostate cancer
5666558|NCT00634634|breast cancer|breast cancer
5666559|NCT00634634|Postmenopausal Women with Hormone Receptor-Positive Locally Advanced Breast Cancer|postmenopausal women with hormone receptor-positive locally advanced breast cancer
5666560|NCT00634621|Bladder|bladder
5666561|NCT00634621|Cancer|cancer
5666562|NCT00634621|Cystoscopy|cystoscopy
5666563|NCT00634621|Hexaminolevulinate|hexaminolevulinate
5666564|NCT00634621|Hexvix|hexvix
5666565|NCT00634595|clinical trial|clinical trial
5666566|NCT00634595|randomized|randomized
5666567|NCT00634595|Endostatin|endostatin
5666568|NCT00634595|gene therapy|gene therapy
5666569|NCT00634595|head and neck cancer|head and neck cancer
5685568|NCT00555555|Factor VIII deficiency|factor viii deficiency
5666570|NCT00634595|head and neck squamous carcinoma|head and neck squamous carcinoma
5666571|NCT00634582|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5666572|NCT00634582|stage IV prostate cancer|stage iv prostate cancer
5666573|NCT00634582|recurrent prostate cancer|recurrent prostate cancer
5666574|NCT00634582|bone metastases|bone metastases
5666575|NCT00634569|CVID, XLA, hyper IgM syndrome, Wiskott-Aldrich Syndrome|cvid, xla, hyper igm syndrome, wiskott-aldrich syndrome
5666576|NCT00634556|Tourette Syndrome|tourette syndrome
5666577|NCT00634556|fMRI|fmri
5666578|NCT00634556|levodopa|levodopa
5666579|NCT00634556|working memory|working memory
5666580|NCT00634556|dopamine|dopamine
5666581|NCT00634543|Diabetic neuropathy|diabetic neuropathy
5666582|NCT00634543|Ultracet|ultracet
5666583|NCT00634543|Tramadol hydrochloride|tramadol hydrochloride
5666584|NCT00634543|Acetaminophen|acetaminophen
5666585|NCT00634543|Gabapentin|gabapentin
5666586|NCT00634530|Pregnancy|pregnancy
5666587|NCT00634530|Prenatal Care|prenatal care
5666588|NCT00634530|Weight|weight
5666589|NCT00634530|Nutritional Status|nutritional status
5666590|NCT00634504|high dose methotrexate|high dose methotrexate
5666591|NCT00634504|Voraxaze|voraxaze
5666592|NCT00634504|leucovorin|leucovorin
5666593|NCT00634504|delayed elimination|delayed elimination
5666594|NCT00634504|methotrexate toxicity|methotrexate toxicity
5666595|NCT00634504|rescue|rescue
5666596|NCT00634504|renal insufficiency|renal insufficiency
5666597|NCT00634478|essential tremor|essential tremor
5666598|NCT00634478|deep brain stimulation|deep brain stimulation
5666599|NCT00634452|Hodgkin's|hodgkin's
5666600|NCT00634452|Cancer|cancer
5666601|NCT00634452|bi-measurable disease|bi-measurable disease
5666602|NCT00634452|Lymphoma|lymphoma
5666603|NCT00634439|cerebrovascular accident|cerebrovascular accident
5666604|NCT00634439|stroke|stroke
5666605|NCT00634439|transient ischemic attack|transient ischemic attack
5666606|NCT00634439|TIA|tia
5666607|NCT00634439|CVA|cva
5666608|NCT00634439|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5666609|NCT00634439|ADHD|adhd
5666610|NCT00634426|Spine|spine
5666611|NCT00634426|Neoplasm metastasis|neoplasm metastasis
5666612|NCT00634426|Treatment, surgical|treatment, surgical
5666613|NCT00634426|Treatment, nonoperative|treatment, nonoperative
5666614|NCT00634426|Quality of life|quality of life
5666615|NCT00634413|COPD|copd
5666616|NCT00634400|Congestive Heart Failure|congestive heart failure
5666617|NCT00634400|Atacand|atacand
5666618|NCT00634400|Candesartan|candesartan
5666619|NCT00634374|Rx medibottle|rx medibottle
5666620|NCT00634374|Oral syringe|oral syringe
5666621|NCT00634374|Liquid medication|liquid medication
5666622|NCT00634374|Bitter-tasting|bitter-tasting
5666623|NCT00634374|Infants|infants
5666624|NCT00634322|osteosarcoma|osteosarcoma
5666625|NCT00634322|high dose methotrexate|high dose methotrexate
5666626|NCT00634322|leucovorin|leucovorin
5666627|NCT00634309|Congestive Heart Failure|congestive heart failure
5666628|NCT00634309|Atacand|atacand
5666629|NCT00634309|Candesartan|candesartan
5666630|NCT00634296|Heart failure|heart failure
5666631|NCT00634296|Systolic dysfunction|systolic dysfunction
5666632|NCT00634296|Inspiratory muscle weakness|inspiratory muscle weakness
5666734|NCT00633906|Prevention|prevention
5666633|NCT00634270|Plexiform, Neurofibromatosis Type 1, Sirolimus, Phase II|plexiform, neurofibromatosis type 1, sirolimus, phase ii
5666634|NCT00634257|Advanced Cancer|advanced cancer
5666635|NCT00634257|Solid Tumors|solid tumors
5666636|NCT00634257|Spirituality|spirituality
5666637|NCT00634257|Religiosity|religiosity
5666638|NCT00634257|Symptom Distress|symptom distress
5666639|NCT00634257|Quality of Life|quality of life
5666640|NCT00634257|Caregivers|caregivers
5666641|NCT00634257|Questionnaire|questionnaire
5666643|NCT00634244|Acute Myelogenous Leukemia (AML), Carboplatin, Topotecan, Flavopiridol, Mitoxantrone, Cytosine Arabinoside, Sirolimus, Etoposide|acute myelogenous leukemia (aml), carboplatin, topotecan, flavopiridol, mitoxantrone, cytosine arabinoside, sirolimus, etoposide
5666644|NCT00634231|Malignant glioma|malignant glioma
5666645|NCT00634231|Glioblastoma multiforme|glioblastoma multiforme
5666646|NCT00634231|Anaplastic astrocytoma|anaplastic astrocytoma
5666647|NCT00634231|Recurrent ependymoma|recurrent ependymoma
5666648|NCT00634231|Gene therapy|gene therapy
5666649|NCT00634231|Immunotherapy|immunotherapy
5666650|NCT00634218|nicotine|nicotine
5666651|NCT00634218|smoking|smoking
5666652|NCT00634218|smoking cessation|smoking cessation
5666653|NCT00634205|Mesothelioma|mesothelioma
5666654|NCT00634205|Valproate|valproate
5666655|NCT00634205|Doxorubicin|doxorubicin
5666656|NCT00634205|Chemotherapy|chemotherapy
5666657|NCT00634205|Phase II|phase ii
5666658|NCT00634192|Chronic infection with P. aeruginosa in Cystic Fibrosis subjects|chronic infection with p. aeruginosa in cystic fibrosis subjects
5666659|NCT00634179|Lymphoma|lymphoma
5666660|NCT00634166|thermal injuries|thermal injuries
5666661|NCT00634166|burns|burns
5666662|NCT00634166|Burn Patients (Subjects with Thermal Injuries Requiring Meshed Autografts)|burn patients (subjects with thermal injuries requiring meshed autografts)
5666663|NCT00634140|gallbladder|gallbladder
5685569|NCT00555555|Von Willebrand disease|von willebrand disease
5666664|NCT00634140|ezetimibe for 4 to 6 weeks prior to gallbladder removal|ezetimibe for 4 to 6 weeks prior to gallbladder removal
5666665|NCT00634114|Reflux Esophagitis|reflux esophagitis
5666666|NCT00634075|Severe sepsis|severe sepsis
5666667|NCT00634075|Proinflammatory cytokines|proinflammatory cytokines
5666669|NCT00634062|Affective Lability|affective lability
5666670|NCT00634062|Borderline Personality Disorder|borderline personality disorder
5666671|NCT00634062|Pharmacotherapy|pharmacotherapy
5671733|NCT00614614|Meningococcal vaccines|meningococcal vaccines
5666672|NCT00634049|invasive fungal infections caused by rare molds, rare yeasts|invasive fungal infections caused by rare molds, rare yeasts
5666673|NCT00634049|BAL8557|bal8557
5666674|NCT00634049|Isavuconazole|isavuconazole
5666675|NCT00634049|Aspergillosis|aspergillosis
5666676|NCT00634049|or by dimorphic fungi|or by dimorphic fungi
5666677|NCT00634049|ASP9766|asp9766
5666678|NCT00634036|Asthma|asthma
5666679|NCT00634036|obesity|obesity
5666680|NCT00634036|exacerbation|exacerbation
5666681|NCT00634036|asthmatics|asthmatics
5666682|NCT00634036|fat|fat
5666683|NCT00634036|overweight|overweight
5666684|NCT00634036|adipose tissue|adipose tissue
5666685|NCT00634036|leptin|leptin
5666686|NCT00634036|adiponectin|adiponectin
5666687|NCT00634036|pioglitazone|pioglitazone
5666688|NCT00634036|Actos|actos
5666689|NCT00634036|wheezing|wheezing
5666690|NCT00634036|Pittsburgh|pittsburgh
5666691|NCT00634036|Pennsylvania|pennsylvania
5666692|NCT00634036|pulmonary|pulmonary
5666693|NCT00634036|lung|lung
5666694|NCT00634010|Advanced Cancer|advanced cancer
5666695|NCT00634010|Solid Tumors|solid tumors
5666696|NCT00634010|Cancer Pain|cancer pain
5666697|NCT00634010|Opioid Pain Killer|opioid pain killer
5666698|NCT00634010|Morphine|morphine
5666699|NCT00634010|Methadone|methadone
5666700|NCT00633997|Diabetes mellitus|diabetes mellitus
5666701|NCT00633997|type 2 diabetes|type 2 diabetes
5666702|NCT00633997|vildagliptin|vildagliptin
5666703|NCT00633997|pharmacokinetics|pharmacokinetics
5666704|NCT00633984|Social Anxiety Disorder|social anxiety disorder
5666705|NCT00633984|Cognitive Behavioral Group Therapy|cognitive behavioral group therapy
5666706|NCT00633984|D-cycloserine|d-cycloserine
5666707|NCT00633971|Post thrombotic syndrome|post thrombotic syndrome
5666708|NCT00633971|Thrombosis|thrombosis
5666709|NCT00633971|Deep vein thrombosis|deep vein thrombosis
5666710|NCT00633971|Venous thrombosis|venous thrombosis
5666711|NCT00633971|Edema|edema
5666712|NCT00633971|stasis ulcers|stasis ulcers
5666713|NCT00633958|18F-FLT|18f-flt
5666714|NCT00633958|FLT|flt
5666715|NCT00633958|PET|pet
5666716|NCT00633958|CNS tumors|cns tumors
5666717|NCT00633958|Newly|newly
5666718|NCT00633958|diagnosed|diagnosed
5666719|NCT00633945|Cutaneous Lupus Erythematosus|cutaneous lupus erythematosus
5666720|NCT00633945|CLE|cle
5666721|NCT00633945|lenalidomide|lenalidomide
5666722|NCT00633945|revlimid|revlimid
5666723|NCT00633945|thalidomide derivative|thalidomide derivative
5666724|NCT00633945|drug|drug
5666725|NCT00633945|lupus|lupus
5666726|NCT00633932|Reflux Esophagitis|reflux esophagitis
5666727|NCT00633919|House dust mites|house dust mites
5666728|NCT00633919|Sublingual immunotherapy|sublingual immunotherapy
5666729|NCT00633919|Allergy|allergy
5666730|NCT00633919|Allergic asthma|allergic asthma
5666731|NCT00633906|HIV|hiv
5666732|NCT00633906|Sexually Transmitted diseases|sexually transmitted diseases
5666735|NCT00633906|HIV Seronegativity|hiv seronegativity
5666736|NCT00633880|NOH|noh
5666737|NCT00633880|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5666738|NCT00633880|Orthostatic hypotension|orthostatic hypotension
5666739|NCT00633880|PAF|paf
5666740|NCT00633880|Pure Autonomic Failure|pure autonomic failure
5666741|NCT00633880|MSA|msa
5666742|NCT00633880|Multiple System Atrophy|multiple system atrophy
5666743|NCT00633880|Neuropathy|neuropathy
5666744|NCT00633880|Autonomic Failure|autonomic failure
5666745|NCT00633880|Parkinson|parkinson
5666746|NCT00633880|Dopamine Deficiency|dopamine deficiency
5666747|NCT00633880|Dopamine|dopamine
5666748|NCT00633880|Droxidopa|droxidopa
5666749|NCT00633867|Tracheal intubation|tracheal intubation
5666750|NCT00633867|Laryngoscopy|laryngoscopy
5666751|NCT00633867|videolaryngoscope|videolaryngoscope
5666752|NCT00633867|McGrath|mcgrath
5666753|NCT00633867|success|success
5666754|NCT00633867|time|time
5666755|NCT00633854|annular array ultrasound|annular array ultrasound
5666756|NCT00633854|ophthalmic ultrasound|ophthalmic ultrasound
5666757|NCT00633854|posterior vitreous detachment (PVD)|posterior vitreous detachment (pvd)
5666758|NCT00633841|Alzheimer|alzheimer
5666759|NCT00633841|Morbus Alzheimer|morbus alzheimer
5666760|NCT00633841|Alzheimer Vaccine|alzheimer vaccine
5666761|NCT00633841|Vaccine|vaccine
5666762|NCT00633841|AD|ad
5666763|NCT00633841|Aβ immunotherapy|aβ immunotherapy
5666764|NCT00633828|Bone Density|bone density
5666765|NCT00633828|Bone mass|bone mass
5666766|NCT00633828|Bone mineral density|bone mineral density
5666767|NCT00633828|Bone structure|bone structure
5666768|NCT00633828|Cardiovascular risk factors|cardiovascular risk factors
5666769|NCT00633828|Fat Mass|fat mass
5666770|NCT00633828|Adiposity|adiposity
5666771|NCT00633815|Supine|supine
5666772|NCT00633815|Upright|upright
5666773|NCT00633802|Risperidone|risperidone
5666774|NCT00633802|Borderlone Personality Disorder|borderlone personality disorder
5666775|NCT00633776|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5666776|NCT00633776|COPD|copd
5666777|NCT00633776|Chronic bronchitis|chronic bronchitis
5666778|NCT00633776|Emphysema|emphysema
5666779|NCT00633776|Perforomist|perforomist
5859687|NCT00006168|MTX|mtx
5666780|NCT00633776|Foradil|foradil
5666781|NCT00633776|CT|ct
5666782|NCT00633776|lung function|lung function
5666783|NCT00633763|Diagnostic|diagnostic
5666784|NCT00633763|PET/CT imaging of pancreas|pet/ct imaging of pancreas
5666785|NCT00633763|Detecting pancreatic beta cell loss during diabetes|detecting pancreatic beta cell loss during diabetes
5666786|NCT00633750|stage I breast cancer|stage i breast cancer
5666787|NCT00633750|stage II breast cancer|stage ii breast cancer
5666788|NCT00633750|stage IIIA breast cancer|stage iiia breast cancer
5666789|NCT00633750|stage IIIB breast cancer|stage iiib breast cancer
5666790|NCT00633737|Psychology|psychology
5666791|NCT00633737|Laparoscopy|laparoscopy
5666792|NCT00633737|Cholecystectomy|cholecystectomy
5666793|NCT00633737|Psychoneuroimmunology|psychoneuroimmunology
5666794|NCT00633737|Wound healing|wound healing
5666795|NCT00633737|Preparation for surgery|preparation for surgery
5666796|NCT00633737|Stress reduction|stress reduction
5666797|NCT00633737|Stress|stress
5666798|NCT00633737|Relaxation|relaxation
5666799|NCT00633711|OSAS|osas
5666800|NCT00633711|blood pressure|blood pressure
5666801|NCT00633711|sympathetic nervous system|sympathetic nervous system
5666802|NCT00633711|treatment|treatment
5666803|NCT00633711|CPAP|cpap
5666804|NCT00633698|lipoprotein(a)|lipoprotein(a)
5666805|NCT00633698|niacin|niacin
5666806|NCT00633698|placebo|placebo
5666807|NCT00633698|intervention|intervention
5666808|NCT00633685|Posttraumatic Stress Disorder|posttraumatic stress disorder
5666809|NCT00633685|Fluoxetine|fluoxetine
5666810|NCT00633685|Factors predicting response|factors predicting response
5666811|NCT00633685|Resilience|resilience
5666812|NCT00633685|Pharmacologic augmentation strategies|pharmacologic augmentation strategies
5666813|NCT00633672|NSAID|nsaid
5666814|NCT00633672|Nexium|nexium
5666815|NCT00633672|esomeprazole|esomeprazole
5666816|NCT00633672|Gastric Ulcers|gastric ulcers
5666817|NCT00633659|Hemospan|hemospan
5666818|NCT00633659|Oxygen carriers|oxygen carriers
5666819|NCT00633659|Blood substitutes|blood substitutes
5666820|NCT00633659|Ischemia|ischemia
5666821|NCT00633659|Tissue oxygenation|tissue oxygenation
5666822|NCT00633646|nitrogen balance|nitrogen balance
5666823|NCT00633646|malnutrition|malnutrition
5666824|NCT00633646|chronic kidney disease|chronic kidney disease
5666825|NCT00633646|diet|diet
5666826|NCT00633646|glomerular filtration rate|glomerular filtration rate
5666827|NCT00633633|Heart Failure|heart failure
5666828|NCT00633633|Lifestyle Intervention|lifestyle intervention
5666829|NCT00633633|Exercise|exercise
5666831|NCT00633620|colonoscopy|colonoscopy
5666832|NCT00633620|narrow band imaging|narrow band imaging
5666833|NCT00633620|adenoma|adenoma
5666834|NCT00633620|diagnosis|diagnosis
5666835|NCT00633620|colonoscopic adenoma detection|colonoscopic adenoma detection
5666836|NCT00633594|Mantle Cell Lymphoma|mantle cell lymphoma
5666837|NCT00633594|Rituximab|rituximab
5666838|NCT00633594|Lenalidomide|lenalidomide
5666839|NCT00633594|Bortezomib|bortezomib
5666840|NCT00633594|Phase 1/2|phase 1/2
5666841|NCT00633581|fatigue|fatigue
5666842|NCT00633581|ascorbic acid|ascorbic acid
5666843|NCT00633581|oxidative stress|oxidative stress
5666844|NCT00633568|Non-small cell lung carcinoma|non-small cell lung carcinoma
5666845|NCT00633568|Concomitant radiochemotherapy|concomitant radiochemotherapy
5666846|NCT00633568|Cisplatin|cisplatin
5666848|NCT00633568|Radiotherapy|radiotherapy
5666849|NCT00633568|Chemotherapy|chemotherapy
5666850|NCT00633568|Unresectable stage III non-small cell lung carcinoma|unresectable stage iii non-small cell lung carcinoma
5666852|NCT00633542|maintenance|maintenance
5666853|NCT00633542|interferon|interferon
5666854|NCT00633542|dexamethasone|dexamethasone
5666855|NCT00633542|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5666856|NCT00633542|relapsed refractory multiple myeloma|relapsed refractory multiple myeloma
5666857|NCT00633529|Phase 1b|phase 1b
5666858|NCT00633529|Non-Small Cell Lung Cancer|non-small cell lung cancer
5666859|NCT00633529|Advanced or Metastatic Disease|advanced or metastatic disease
5666860|NCT00633529|Prior chemotherapy|prior chemotherapy
5666861|NCT00633516|moles|moles
5666862|NCT00633516|melanoma|melanoma
5666863|NCT00633503|free tissue transfer|free tissue transfer
5666864|NCT00633503|pedicle tissue transfer|pedicle tissue transfer
5666865|NCT00633503|complications|complications
5666866|NCT00633503|modulated imaging spectroscopy|modulated imaging spectroscopy
5666867|NCT00633503|observation|observation
5666868|NCT00633503|clinical observation/diagnosis|clinical observation/diagnosis
5666869|NCT00633503|tissue defects requiring free tissue transfer|tissue defects requiring free tissue transfer
5666870|NCT00633503|tissue defects requiring pedicle tissue transfer|tissue defects requiring pedicle tissue transfer
5650939|NCT00698009|Fludara|fludara
5666871|NCT00633490|Toxicity|toxicity
5666872|NCT00633490|Efficacy|efficacy
5666873|NCT00633477|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5666874|NCT00633477|Septic Shock|septic shock
5666875|NCT00633477|Septicemia|septicemia
5666876|NCT00633477|Drug Therapy|drug therapy
5666877|NCT00633451|shoulder pain|shoulder pain
5666878|NCT00633451|shoulder impingement syndrome|shoulder impingement syndrome
5666879|NCT00633451|manual therapy|manual therapy
5666880|NCT00633451|rehabilitation|rehabilitation
5666881|NCT00633438|Knee Surgery Arthroscopic Surgery|knee surgery arthroscopic surgery
5666882|NCT00633412|NSAID|nsaid
5666883|NCT00633412|Nexium|nexium
5666884|NCT00633412|esomeprazole|esomeprazole
5666885|NCT00633412|Gastric Ulcers|gastric ulcers
5666886|NCT00633399|Major Depressive Disorder|major depressive disorder
5666887|NCT00633399|Major Depression|major depression
5666888|NCT00633399|Depression|depression
5666889|NCT00633399|Geodon|geodon
5666890|NCT00633399|Ziprasidone|ziprasidone
5666891|NCT00633399|SSRI Augmentation|ssri augmentation
5666892|NCT00633399|Treatment Resistant Depression|treatment resistant depression
5666893|NCT00633386|Knee Surgery|knee surgery
5666894|NCT00633386|Arthroscopic Surgery|arthroscopic surgery
5666895|NCT00633373|lung|lung
5666896|NCT00633373|transplant|transplant
5666897|NCT00633373|transplant rejection|transplant rejection
5666898|NCT00633373|Cyclosporine|cyclosporine
5666899|NCT00633373|bronchiolitis obliterans|bronchiolitis obliterans
5666900|NCT00633373|aerosol|aerosol
5666901|NCT00633360|Women|women
5666902|NCT00633360|PMS|pms
5666903|NCT00633360|Depression|depression
5666904|NCT00633347|oocyte donation|oocyte donation
5666905|NCT00633347|endometrial preparation|endometrial preparation
5666906|NCT00633334|Cancer|cancer
5666907|NCT00633334|GI|gi
5666908|NCT00633334|Tumor|tumor
5666909|NCT00633334|Gastrointestinal|gastrointestinal
5666910|NCT00633334|high risk|high risk
5666911|NCT00633321|smoking cessation|smoking cessation
5666912|NCT00633321|quit smoking|quit smoking
5666913|NCT00633321|smoking vaccine|smoking vaccine
5666914|NCT00633321|nicotine vaccine|nicotine vaccine
5666915|NCT00633321|TA-NIC|ta-nic
5666916|NCT00633321|Aid for smoking cessation in smokers motivated to quit|aid for smoking cessation in smokers motivated to quit
5666917|NCT00633308|hemodialysis|hemodialysis
5666918|NCT00633295|GIST|gist
5666919|NCT00633295|TKI|tki
5666920|NCT00633295|IMATINIB|imatinib
5666921|NCT00633295|NILOTINIB|nilotinib
5666922|NCT00633295|AMN107|amn107
5666923|NCT00633282|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5666924|NCT00633282|Pioglitazone|pioglitazone
5666925|NCT00633282|Berberine|berberine
5666926|NCT00633282|Impaired Glucose Metabolism|impaired glucose metabolism
5666927|NCT00633269|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5666928|NCT00633269|Metastatic Solid Tumours|metastatic solid tumours
5666929|NCT00633230|hepatitis C virus|hepatitis c virus
5666930|NCT00633230|complementary and alternative medicine|complementary and alternative medicine
5666931|NCT00633230|peginterferon alfa and ribavirin|peginterferon alfa and ribavirin
5666932|NCT00633217|DISKUS|diskus
5666933|NCT00633217|Salmeterol|salmeterol
5666934|NCT00633217|Fluticasone Propionate|fluticasone propionate
5666935|NCT00633217|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5667031|NCT00632788|angioplasty|angioplasty
5666936|NCT00633217|Hydroflouroalkane|hydroflouroalkane
5666937|NCT00633217|COPD|copd
5666938|NCT00633217|HFA MDI|hfa mdi
5666939|NCT00633204|Epitope peptide, CTL, TUR-Bt, Bladder cancer, Vaccination|epitope peptide, ctl, tur-bt, bladder cancer, vaccination
5660441|NCT00661739|phase I|phase i
5666940|NCT00633204|Bladder cancer after surgery|bladder cancer after surgery
5666941|NCT00633191|Cystic fibrosis|cystic fibrosis
5666942|NCT00633191|Prevention|prevention
5666943|NCT00633191|Infection|infection
5666944|NCT00633191|Pseudomonas aeruginosa|pseudomonas aeruginosa
5666945|NCT00633191|Gargle|gargle
5666946|NCT00633178|Prenatal Depression|prenatal depression
5666947|NCT00633178|Postpartum Depression|postpartum depression
5666948|NCT00633178|Fetal Development|fetal development
5666949|NCT00633178|Interpersonal Therapy|interpersonal therapy
5666950|NCT00633165|sarcoma|sarcoma
5666951|NCT00633165|myxoid liposarcoma|myxoid liposarcoma
5666952|NCT00633152|complicated skin and skin structure infections|complicated skin and skin structure infections
5666953|NCT00633152|linezolid|linezolid
5666954|NCT00633152|ceftaroline|ceftaroline
5666955|NCT00633152|clinical response|clinical response
5666956|NCT00633152|microbiological response|microbiological response
5666957|NCT00633152|Cellulitis|cellulitis
5666958|NCT00633152|Abscess|abscess
5666959|NCT00633152|Wound infection|wound infection
5666960|NCT00633152|Deeper soft tissue|deeper soft tissue
5666961|NCT00633152|Significant surgical intervention|significant surgical intervention
5685570|NCT00555555|FVIII/VWF concentrate|fviii/vwf concentrate
5666962|NCT00633152|Gram-positive bacterial infection|gram-positive bacterial infection
5666963|NCT00633152|Gram-negative bacterial infection|gram-negative bacterial infection
5666964|NCT00633152|bacterial infection|bacterial infection
5666965|NCT00633152|cephalosporin|cephalosporin
5666966|NCT00633152|broad-spectrum activity|broad-spectrum activity
5666967|NCT00633139|Metazym|metazym
5666968|NCT00633139|Late infantile|late infantile
5666969|NCT00633139|Metachromatic leukodystrophy|metachromatic leukodystrophy
5666970|NCT00633139|Long-term safety|long-term safety
5666971|NCT00633126|PK|pk
5666972|NCT00633126|Pharmacokinetics|pharmacokinetics
5666973|NCT00633113|Total Knee Arthroplasty|total knee arthroplasty
5666974|NCT00633113|Minimally Invasive Knee Replacement|minimally invasive knee replacement
5666975|NCT00633113|Knee Osteoarthritis|knee osteoarthritis
5666976|NCT00633113|Cost effectiveness minimally invasive knee surgery|cost effectiveness minimally invasive knee surgery
5666977|NCT00633074|Influenza|influenza
5666978|NCT00633061|Childhood Cancer|childhood cancer
5666979|NCT00633061|Central Venous Catheter|central venous catheter
5666980|NCT00633061|Deep Vein Thrombosis|deep vein thrombosis
5666981|NCT00633061|Catheter-related Infection|catheter-related infection
5666982|NCT00633061|Catheter-related Occlusion|catheter-related occlusion
5666983|NCT00633048|ascending single-dose study|ascending single-dose study
5666984|NCT00633048|healthy subjects|healthy subjects
5666985|NCT00633035|ulcer|ulcer
5666986|NCT00633035|esomeprazole|esomeprazole
5666987|NCT00633035|famotidine|famotidine
5666988|NCT00633035|Neurosurgery|neurosurgery
5666989|NCT00633022|FDG-PET/CT, atherosclerosis|fdg-pet/ct, atherosclerosis
5666990|NCT00633009|Leishmaniasis|leishmaniasis
5666991|NCT00633009|Delayed-Type Hypersensitivity (DTH)|delayed-type hypersensitivity (dth)
5666992|NCT00633009|Skin Test|skin test
5666993|NCT00633009|Conversion|conversion
5666994|NCT00633009|Prior exposure to Leishmania major|prior exposure to leishmania major
5666995|NCT00632996|shoulder pain|shoulder pain
5666996|NCT00632996|shoulder impingement syndrome|shoulder impingement syndrome
5666997|NCT00632996|manual therapy|manual therapy
5666998|NCT00632996|rehabilitation|rehabilitation
5666999|NCT00632970|Raltegravir|raltegravir
5667000|NCT00632970|Lopinavir|lopinavir
5667001|NCT00632918|Image quality|image quality
5667002|NCT00632918|Dual-source CT|dual-source ct
5667003|NCT00632918|Coronary angiography|coronary angiography
5667004|NCT00632918|Heart rate|heart rate
5667005|NCT00632905|Prostate Cancer|prostate cancer
5667006|NCT00632905|Prostatic adenoma|prostatic adenoma
5667007|NCT00632905|Prostatic neoplasm|prostatic neoplasm
5667008|NCT00632892|oxidative stress markers in urine|oxidative stress markers in urine
5667009|NCT00632892|urine norepinephrine|urine norepinephrine
5667010|NCT00632892|renal tubular enzyme markers|renal tubular enzyme markers
5667011|NCT00632866|auto-immune diseases|auto-immune diseases
5667012|NCT00632866|hydroxychloroquine|hydroxychloroquine
5667013|NCT00632866|primary Sjögren's syndrome|primary sjögren's syndrome
5667014|NCT00632866|inflammatory arthritides|inflammatory arthritides
5667015|NCT00632866|inflammatory rheumatic diseases|inflammatory rheumatic diseases
5667016|NCT00632866|dryness|dryness
5667017|NCT00632866|joint diseases|joint diseases
5847694|NCT00038506|HIV-1 TRIZIVIR Tenofovir|hiv-1 trizivir tenofovir
5667018|NCT00632853|limited stage small cell lung cancer|limited stage small cell lung cancer
5667019|NCT00632814|Kogenate,|kogenate,
5667020|NCT00632814|Children,|children,
5667021|NCT00632814|Factor VIII,|factor viii,
5667022|NCT00632814|Hemophilia A,|hemophilia a,
5667023|NCT00632814|Prophylactic|prophylactic
5667024|NCT00632801|elective laparoscopic colectomy|elective laparoscopic colectomy
5667025|NCT00632801|chewing gum|chewing gum
5667026|NCT00632801|ileus|ileus
5667027|NCT00632801|post-operative care|post-operative care
5667028|NCT00632801|colectomy|colectomy
5667029|NCT00632788|myocardial infarction|myocardial infarction
5667030|NCT00632788|catheterization|catheterization
5667032|NCT00632788|door-to-balloon time|door-to-balloon time
5667033|NCT00632775|pediatrics|pediatrics
5667034|NCT00632775|Hyponatremia|hyponatremia
5667035|NCT00632775|Sodium Chloride|sodium chloride
5667036|NCT00632775|maintenance fluids|maintenance fluids
5667037|NCT00632762|Amantadine benefit|amantadine benefit
5667038|NCT00632762|Dyskinesia|dyskinesia
5667039|NCT00632762|Parkinson's disease|parkinson's disease
5667040|NCT00632736|ropinirole XL|ropinirole xl
5667041|NCT00632736|REQUIP|requip
5667042|NCT00632736|Parkinson's disease|parkinson's disease
5667043|NCT00632736|long term safety|long term safety
5667044|NCT00632736|efficacy|efficacy
5667045|NCT00632736|safety|safety
5667046|NCT00632736|ropinirole CR|ropinirole cr
5667047|NCT00632736|ropinirole IR|ropinirole ir
5667048|NCT00632736|open-label|open-label
5667049|NCT00632723|oestrogen receptor|oestrogen receptor
5667050|NCT00632723|ER negative tumours|er negative tumours
5667051|NCT00632723|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5667052|NCT00632710|rheumatoid arthritis|rheumatoid arthritis
5667053|NCT00632710|hands|hands
5667054|NCT00632710|randomized controlled|randomized controlled
5667055|NCT00632710|low level laser|low level laser
5667056|NCT00632697|endometriosis|endometriosis
5667057|NCT00632697|immunomodulation|immunomodulation
5667058|NCT00632697|infertility|infertility
5667059|NCT00632697|laparoscopic surgery|laparoscopic surgery
5667060|NCT00632697|pentoxifylline|pentoxifylline
5667061|NCT00632684|Family Caregiving|family caregiving
5667062|NCT00632684|Dementia|dementia
5667063|NCT00632671|Obesity cohort|obesity cohort
5667065|NCT00632645|Huntington|huntington
5667066|NCT00632645|Neuroleptic|neuroleptic
5667067|NCT00632645|Unified Huntington Disease Rating Scale (UHDRS)|unified huntington disease rating scale (uhdrs)
5667068|NCT00632645|Independence Scale|independence scale
5667069|NCT00632645|Neuroleptic Prescription required|neuroleptic prescription required
5667070|NCT00632632|World Trade Center Victims|world trade center victims
5667071|NCT00632632|Iraq War Veterans|iraq war veterans
5667072|NCT00632632|PTSD|ptsd
5667073|NCT00632619|Subthreshold Manic States in Children|subthreshold manic states in children
5667074|NCT00632619|ADHD|adhd
5667075|NCT00632606|pregnant women|pregnant women
5667076|NCT00632593|Early Complications of both techniques|early complications of both techniques
5667077|NCT00632593|Fistula rate|fistula rate
5667078|NCT00632593|Dehiscence rate|dehiscence rate
5667079|NCT00632593|reoperation rate and cause|reoperation rate and cause
5667080|NCT00632580|Pain, Postoperative|pain, postoperative
5667081|NCT00632567|Anal incontinence|anal incontinence
5667082|NCT00632567|First delivery was traumatic|first delivery was traumatic
5667083|NCT00632567|No anal incontinence|no anal incontinence
5667084|NCT00632528|MEOPA|meopa
5667085|NCT00632528|spasticity|spasticity
5667086|NCT00632528|multilevel surgery|multilevel surgery
5667087|NCT00632528|cerebral palsy|cerebral palsy
5667088|NCT00632528|children|children
5667089|NCT00632515|Colorectal Cancer|colorectal cancer
5667091|NCT00632515|Familial CRC|familial crc
5667092|NCT00632515|Cancer Screening|cancer screening
5667093|NCT00632515|Questionnaire|questionnaire
5667094|NCT00632515|First Degree Relatives|first degree relatives
5667095|NCT00632515|FDRs|fdrs
5667096|NCT00632515|Risk Communication|risk communication
5667097|NCT00632489|Refractory Malignancy|refractory malignancy
5667098|NCT00632489|Breast Cancer|breast cancer
5667099|NCT00632489|LBH589|lbh589
5667100|NCT00632489|Capecitabine|capecitabine
5667101|NCT00632489|Lapatinib|lapatinib
5667102|NCT00632476|Smoking During Pregnancy|smoking during pregnancy
5667103|NCT00632476|Vitamin C|vitamin c
5667104|NCT00632476|Newborn Lung Function|newborn lung function
5667105|NCT00632476|Ascorbic Acid|ascorbic acid
5667106|NCT00632463|Transplant|transplant
5667107|NCT00632463|Immunosuppression|immunosuppression
5667108|NCT00632437|Brain Tumor|brain tumor
5667109|NCT00632437|Craniotomy Surgery|craniotomy surgery
5667110|NCT00632437|Brain Function|brain function
5667111|NCT00632437|Intraoperative Optical Imaging|intraoperative optical imaging
5667112|NCT00632437|Speckle-Contrast Imaging|speckle-contrast imaging
5667113|NCT00632437|Cortical Mapping|cortical mapping
5667114|NCT00632437|Somatosensory Cortex|somatosensory cortex
5667115|NCT00632437|Cerebral blood flow|cerebral blood flow
5667116|NCT00632437|CBF|cbf
5667117|NCT00632437|Laser Speckle Contrast Imaging|laser speckle contrast imaging
5667118|NCT00632437|Multi-Spectral Imaging|multi-spectral imaging
5667119|NCT00632398|massage|massage
5667120|NCT00632398|oncology massage|oncology massage
5667121|NCT00632398|palliative care|palliative care
5667122|NCT00632398|supportive care|supportive care
5667123|NCT00632398|integrative oncology|integrative oncology
5667124|NCT00632398|informal caregiving|informal caregiving
5667125|NCT00632398|spouse caregiving|spouse caregiving
5667126|NCT00632398|family caregiving|family caregiving
5667127|NCT00632398|caregiver education|caregiver education
5667128|NCT00632398|psychosocial oncology|psychosocial oncology
5667129|NCT00632398|caregiver stress|caregiver stress
5667130|NCT00632398|coping with cancer|coping with cancer
5667131|NCT00632398|quality of life|quality of life
5667132|NCT00632398|end of life care|end of life care
5667133|NCT00632359|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5667135|NCT00632359|Lenalidomide|lenalidomide
5667137|NCT00632346|childhood abuse|childhood abuse
5667138|NCT00632346|overweight|overweight
5667139|NCT00632346|obesity|obesity
5667140|NCT00632346|BMI as a young adult|bmi as a young adult
5667141|NCT00632346|childhood physical abuse|childhood physical abuse
5667142|NCT00632346|childhood emotional abuse|childhood emotional abuse
5667143|NCT00632346|childhood sexual abuse|childhood sexual abuse
5667144|NCT00632346|childhood physical neglect|childhood physical neglect
5667145|NCT00632346|childhood emotional neglect|childhood emotional neglect
5667146|NCT00632346|childhood witnessing of domestic violence|childhood witnessing of domestic violence
5667147|NCT00632346|parental marital discord|parental marital discord
5667148|NCT00632346|household members with substance abuse|household members with substance abuse
5667149|NCT00632346|household members with mental illness|household members with mental illness
5667150|NCT00632346|household members with criminal behavior|household members with criminal behavior
5667151|NCT00632346|cumulative adverse childhood experiences|cumulative adverse childhood experiences
5667152|NCT00632333|Epitope peptide|epitope peptide
5667153|NCT00632333|Vaccination|vaccination
5667154|NCT00632333|Chemoradiation|chemoradiation
5667155|NCT00632333|Esophageal cancer|esophageal cancer
5667156|NCT00632320|Ventilator, mechanical|ventilator, mechanical
5667157|NCT00632320|Ventilator weaning|ventilator weaning
5667158|NCT00632320|Rapid shallow breathing index|rapid shallow breathing index
5667159|NCT00632320|Continuous positive airway pressure|continuous positive airway pressure
5667160|NCT00632320|Receiver operating characteristic curve|receiver operating characteristic curve
5667161|NCT00632320|COPD|copd
5667162|NCT00632307|lung tumor|lung tumor
5667163|NCT00632307|pleural tumor|pleural tumor
5860221|NCT00005766|ALS|als
5667164|NCT00632307|interstitial lung disease|interstitial lung disease
5667165|NCT00632307|airway infection|airway infection
5667166|NCT00632307|COPD|copd
5667167|NCT00632307|sleep apnea|sleep apnea
5667168|NCT00632307|ion mobility spectrometry|ion mobility spectrometry
5667169|NCT00632307|breath analysis|breath analysis
5667170|NCT00632294|Bone Cancer|bone cancer
5667171|NCT00632294|Allograft Retrieval|allograft retrieval
5667172|NCT00632294|Allograft Bone|allograft bone
5667173|NCT00632294|Bone Mineral Density|bone mineral density
5667174|NCT00632268|mTOR inhibitor|mtor inhibitor
5667175|NCT00632268|RAD001|rad001
5667176|NCT00632268|everolimus|everolimus
5667177|NCT00632268|chemotherapy|chemotherapy
5667178|NCT00632268|cisplatin|cisplatin
5667179|NCT00632268|high-dose 5-FU|high-dose 5-fu
5667180|NCT00632255|Chronic Myeloid Leukemia|chronic myeloid leukemia
5667181|NCT00632255|Long term Imatinib therapy compliance|long term imatinib therapy compliance
5667182|NCT00632255|Newly diagnosed|newly diagnosed
5667183|NCT00632255|Late side effects|late side effects
5667184|NCT00632229|Obsessive-Compulsive Disorder; Adults; Medication; Treatment|obsessive-compulsive disorder; adults; medication; treatment
5667185|NCT00632190|cervical cancer|cervical cancer
5667186|NCT00632190|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5667187|NCT00632190|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5667188|NCT00632190|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5667189|NCT00632138|sexual dysfunction|sexual dysfunction
5667190|NCT00632138|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5667191|NCT00632138|prostate cancer|prostate cancer
5667192|NCT00632138|benign prostatic hyperplasia|benign prostatic hyperplasia
5667193|NCT00632138|urinary incontinence|urinary incontinence
5667194|NCT00632125|CKD subjects with or without dialysis treatment|ckd subjects with or without dialysis treatment
5667195|NCT00632112|large volume nebulizer|large volume nebulizer
5667196|NCT00632099|cocaine|cocaine
5667197|NCT00632099|treatment|treatment
5667198|NCT00632099|progesterone|progesterone
5667199|NCT00632086|PK|pk
5667200|NCT00632073|HIV Infections|hiv infections
5667201|NCT00632073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5667202|NCT00632073|treatment experienced|treatment experienced
5667203|NCT00632060|Low Back Pain|low back pain
5667204|NCT00632060|Manual / Manipulative Therapy|manual / manipulative therapy
5667205|NCT00632047|breast cancer|breast cancer
5667206|NCT00632047|cervical cancer|cervical cancer
5667207|NCT00632034|fracture|fracture
5667208|NCT00632034|tibia|tibia
5667209|NCT00632034|stem cell|stem cell
5667210|NCT00632021|Low Health Literacy|low health literacy
5667211|NCT00632021|Medication Errors|medication errors
5667212|NCT00632021|Cardiovascular Disease|cardiovascular disease
5667213|NCT00632021|Pharmacist|pharmacist
5667214|NCT00632021|Care Transition|care transition
5667215|NCT00631995|Neisseria meningitidis|neisseria meningitidis
5667216|NCT00631982|in vitro maturation oocytes|in vitro maturation oocytes
5667217|NCT00631969|Erectile Dysfunction|erectile dysfunction
5667218|NCT00631917|Hypertension, aliskiren, ramipril, colonoscopy|hypertension, aliskiren, ramipril, colonoscopy
5667219|NCT00631904|Pacemaker|pacemaker
5667220|NCT00631878|Staphylococcal|staphylococcal
5667221|NCT00631878|Monoclonal antibodies|monoclonal antibodies
5667322|NCT00631527|Sutent|sutent
5667222|NCT00631878|Very Low Birth Weight Infants|very low birth weight infants
5667223|NCT00631878|Prophylaxis|prophylaxis
5667225|NCT00631852|Breast Cancer, Biomarkers, Ginseng Root|breast cancer, biomarkers, ginseng root
5667226|NCT00631839|Thoracic Neoplasms|thoracic neoplasms
5667227|NCT00631839|Platinum-based chemotherapy|platinum-based chemotherapy
5667228|NCT00631839|3-D Conformal Radiotherapy|3-d conformal radiotherapy
5667229|NCT00631839|Chemo-radiotherapy induced lung injury|chemo-radiotherapy induced lung injury
5667230|NCT00631839|Chemo-radiotherapy induced esophagus injury|chemo-radiotherapy induced esophagus injury
5667231|NCT00631826|Shoulder|shoulder
5667232|NCT00631826|Injuries|injuries
5667233|NCT00631826|Flexiblity|flexiblity
5667234|NCT00631826|Rotational resistance|rotational resistance
5667235|NCT00631800|Staphylococcal|staphylococcal
5667236|NCT00631800|Monoclonal antibodies|monoclonal antibodies
5667237|NCT00631800|Very Low Birth Weight Infants|very low birth weight infants
5667238|NCT00631800|Prophylaxis|prophylaxis
5667239|NCT00631787|Nitric Oxide|nitric oxide
5667240|NCT00631787|Hemolysis|hemolysis
5667241|NCT00631787|Plasma Hemoglobin|plasma hemoglobin
5667242|NCT00631787|Dimethyl Sulfoxide|dimethyl sulfoxide
5667243|NCT00631787|Organ Dysfuntion|organ dysfuntion
5667244|NCT00631787|Healthy Volunteer|healthy volunteer
5667245|NCT00631787|HV|hv
5667246|NCT00631774|type 2 diabetes|type 2 diabetes
5667247|NCT00631774|meal replacement|meal replacement
5667248|NCT00631774|postprandial response|postprandial response
5667249|NCT00631774|Glucerna SR|glucerna sr
5667250|NCT00631761|urethrocystoscopy|urethrocystoscopy
5667251|NCT00631761|cystoscopy|cystoscopy
5667252|NCT00631761|objective structured assessment of surgical skills (OSATS)|objective structured assessment of surgical skills (osats)
5667253|NCT00631748|cocaine|cocaine
5667254|NCT00631748|quetiapine fumarate|quetiapine fumarate
5667255|NCT00631748|dependence|dependence
5667256|NCT00631748|abuse|abuse
5667257|NCT00631748|addiction|addiction
5667258|NCT00631748|treatment|treatment
5667259|NCT00631735|cancer|cancer
5667260|NCT00631735|qualitative|qualitative
5667261|NCT00631722|PANSS|panss
5667262|NCT00631722|Acute Episode of Schizophrenia|acute episode of schizophrenia
5667263|NCT00631696|Healthy males Human volunteers pregabalin or placebo sperm quality and quantity|healthy males human volunteers pregabalin or placebo sperm quality and quantity
5667264|NCT00631657|placebo controlled|placebo controlled
5667265|NCT00631657|randomized|randomized
5667266|NCT00631657|double blind|double blind
5667267|NCT00631644|Adolescents|adolescents
5667268|NCT00631644|Eating Behavior|eating behavior
5667269|NCT00631644|Eating in the Absence of Hunger|eating in the absence of hunger
5667270|NCT00631644|Disordered Eating|disordered eating
5667271|NCT00631644|Food Intake|food intake
5667272|NCT00631644|Macronutrient Composition|macronutrient composition
5667273|NCT00631644|Obesity|obesity
5667274|NCT00631644|Adolescent|adolescent
5667275|NCT00631644|Healthy Volunteer|healthy volunteer
5667277|NCT00631631|Drug Therapy|drug therapy
5667278|NCT00631605|eating disorders|eating disorders
5667279|NCT00631605|ghrelin|ghrelin
5667280|NCT00631605|leptin|leptin
5667281|NCT00631605|BIA|bia
5667282|NCT00631592|GSK1349572,|gsk1349572,
5667283|NCT00631592|healthy volunteers,|healthy volunteers,
5667284|NCT00631592|repeat dose,|repeat dose,
5667285|NCT00631592|relative bioavailability|relative bioavailability
5667286|NCT00631592|Healthy subjects|healthy subjects
5667287|NCT00631566|HIV|hiv
5667288|NCT00631566|Methicillin-resistant Staphylococcus aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5667289|NCT00631566|HIV and Staphylococcus aureus infection|hiv and staphylococcus aureus infection
5667290|NCT00631540|renal artery stenosis|renal artery stenosis
5667291|NCT00631540|hypertension|hypertension
5667292|NCT00631540|renovascular|renovascular
5667293|NCT00631540|renal artery blockage|renal artery blockage
5667294|NCT00631540|renal artery disease|renal artery disease
5667295|NCT00631540|renal arteries|renal arteries
5667296|NCT00631540|angioplasty renal artery|angioplasty renal artery
5667297|NCT00631540|renal artery stent|renal artery stent
5667298|NCT00631540|renal artery doppler|renal artery doppler
5667299|NCT00631540|renovascular hypertension|renovascular hypertension
5667300|NCT00631540|kidney stenosis|kidney stenosis
5667301|NCT00631540|renal artery|renal artery
5667302|NCT00631540|stent|stent
5667303|NCT00631540|stenting|stenting
5847695|NCT00038493|GBM|gbm
5667304|NCT00631540|kidney disease|kidney disease
5667305|NCT00631540|renal failure|renal failure
5667306|NCT00631540|atherosclerosis|atherosclerosis
5667307|NCT00631540|arterial hypertension|arterial hypertension
5667308|NCT00631540|stenosis|stenosis
5667309|NCT00631527|Prostate Cancer|prostate cancer
5667310|NCT00631527|Radiation Therapy|radiation therapy
5667311|NCT00631527|RT|rt
5667312|NCT00631527|Radiotherapy|radiotherapy
5667313|NCT00631527|Hormone Ablation|hormone ablation
5667314|NCT00631527|Sunitinib Malate|sunitinib malate
5667315|NCT00631527|Leuprolide|leuprolide
5667316|NCT00631527|Lupron|lupron
5667317|NCT00631527|Zoladex|zoladex
5667318|NCT00631527|Goserelin|goserelin
5667319|NCT00631527|Casodex|casodex
5667320|NCT00631527|Bicalutamide|bicalutamide
5667321|NCT00631527|SU011248|su011248
5667323|NCT00631527|Angiogenesis inhibitor|angiogenesis inhibitor
5667324|NCT00631514|antihypertensive drugs|antihypertensive drugs
5667325|NCT00631514|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5667326|NCT00631514|interaction|interaction
5667327|NCT00631514|family practice|family practice
5667328|NCT00631514|arterial blood pressure|arterial blood pressure
5667329|NCT00631501|tendinopathy|tendinopathy
5667330|NCT00631501|tennis elbow|tennis elbow
5667331|NCT00631501|lateral epicondylitis|lateral epicondylitis
5667332|NCT00631501|lateral epicondylalgia|lateral epicondylalgia
5667333|NCT00631501|MMP-inhibitor|mmp-inhibitor
5667334|NCT00631475|Actelion|actelion
5667335|NCT00631475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5667336|NCT00631475|bosentan|bosentan
5667337|NCT00631475|Tracleer|tracleer
5667338|NCT00631475|Interstitial Lung Disease|interstitial lung disease
5667339|NCT00631475|BUILD 3 (NCT00391443)|build 3 (nct00391443)
5667340|NCT00631462|primary myelofibrosis|primary myelofibrosis
5667341|NCT00631462|post-polycythemia vera myelofibrosis|post-polycythemia vera myelofibrosis
5667342|NCT00631462|post-essential thrombocythemia myelofibrosis|post-essential thrombocythemia myelofibrosis
5667344|NCT00631449|Treatment intensification|treatment intensification
5667345|NCT00631449|Low level viremia|low level viremia
5667346|NCT00631449|Suboptimal CD4+ T cell response|suboptimal cd4+ t cell response
5667347|NCT00631449|treatment experienced|treatment experienced
5667348|NCT00631436|Diffusion Tensor Imaging|diffusion tensor imaging
5667349|NCT00631436|Electroencephalography|electroencephalography
5667350|NCT00631436|Blast Injury|blast injury
5667351|NCT00631436|Traumatic Brain Injury|traumatic brain injury
5667354|NCT00631410|SU011248|su011248
5667355|NCT00631410|Sunitinib|sunitinib
5667356|NCT00631410|FOLFOX|folfox
5667357|NCT00631410|Colorectal cancer|colorectal cancer
5667358|NCT00631410|metastatic carcinoma of the colon or rectum|metastatic carcinoma of the colon or rectum
5667359|NCT00631397|weakening of the bones|weakening of the bones
5667360|NCT00631384|Voluntary Counseling and Testing|voluntary counseling and testing
5667362|NCT00631384|HIV seronegativity|hiv seronegativity
5667363|NCT00631371|temsirolimus|temsirolimus
5667364|NCT00631371|renal cell carcinoma|renal cell carcinoma
5667365|NCT00631371|kidney cancer|kidney cancer
5667366|NCT00631371|urogenital cancer|urogenital cancer
5667367|NCT00631358|Ocular inflammation|ocular inflammation
5667368|NCT00631345|prediabetes|prediabetes
5667369|NCT00631345|overweight|overweight
5667370|NCT00631345|obesity|obesity
5667371|NCT00631345|metabolic syndrome|metabolic syndrome
5667372|NCT00631345|community health worker|community health worker
5667373|NCT00631332|women, dementia, cognition.|women, dementia, cognition.
5667374|NCT00631332|non-demented women at least age 65|non-demented women at least age 65
5667375|NCT00631319|OA|oa
5667376|NCT00631319|Chronic Pain|chronic pain
5667377|NCT00631319|Osteoarthritis|osteoarthritis
5667378|NCT00631319|OA Pain|oa pain
5667379|NCT00631319|Osteoarthritis Pain|osteoarthritis pain
5667380|NCT00631319|Pain|pain
5667381|NCT00631319|Hip Pain|hip pain
5667382|NCT00631319|Knee Pain|knee pain
5667383|NCT00631319|Joint Pain|joint pain
5667384|NCT00631293|Healthy volunteers|healthy volunteers
5667385|NCT00631280|Decision Aid|decision aid
5667386|NCT00631280|Informed Choice|informed choice
5667387|NCT00631280|Adherence|adherence
5667388|NCT00631267|reduction|reduction
5667389|NCT00631267|satisfaction|satisfaction
5667390|NCT00631267|visual-analog scale|visual-analog scale
5667391|NCT00631267|complications|complications
5667392|NCT00631267|functional outcome|functional outcome
5667393|NCT00631267|radiological outcome|radiological outcome
5667394|NCT00631241|Cervical Cancer|cervical cancer
5667395|NCT00631241|Parametrial Lymph Nodes|parametrial lymph nodes
5667396|NCT00631241|Sentinel Nodes|sentinel nodes
5667397|NCT00631241|Intraoperative Lymphatic Mapping|intraoperative lymphatic mapping
5667398|NCT00631241|Single Photon Emission Computed Tomography|single photon emission computed tomography
5667399|NCT00631241|SPECT/CT|spect/ct
5667400|NCT00631228|drug eluting stents|drug eluting stents
5667401|NCT00631228|stents|stents
5667402|NCT00631228|Angioplasty|angioplasty
5667403|NCT00631228|coronary artery disease|coronary artery disease
5667404|NCT00631228|total coronary occlusion|total coronary occlusion
5667405|NCT00631228|coronary artery restenosis|coronary artery restenosis
5667406|NCT00631228|stent thrombosis|stent thrombosis
5667407|NCT00631228|vascular disease|vascular disease
5667408|NCT00631228|myocardial ischemia|myocardial ischemia
5667409|NCT00631228|coronary artery stenosis|coronary artery stenosis
5667410|NCT00631215|Hyperbaric|hyperbaric
5667411|NCT00631215|Oxygen|oxygen
5667412|NCT00631215|autism|autism
5667413|NCT00631202|FRDA|frda
5667414|NCT00631202|Erythropoietin|erythropoietin
5667415|NCT00631202|Epoetin alfa|epoetin alfa
5667416|NCT00631189|dyslipidemia|dyslipidemia
5667417|NCT00631176|oral intubation|oral intubation
5667418|NCT00631176|just in time|just in time
5667419|NCT00631176|simulation education|simulation education
5667420|NCT00631176|high fidelity training|high fidelity training
5667421|NCT00631176|intubation training|intubation training
5667422|NCT00631176|intubation success|intubation success
5667423|NCT00631163|Iron Overload,|iron overload,
5667424|NCT00631163|Chelation,|chelation,
5667426|NCT00631163|Chronic Anemia,|chronic anemia,
5667427|NCT00631163|Deferasirox,|deferasirox,
5667428|NCT00631163|Transfusional hemosiderosis,|transfusional hemosiderosis,
5667429|NCT00631150|Levetiracetam|levetiracetam
5667430|NCT00631150|Keppra|keppra
5667431|NCT00631137|musculoskeletal complications|musculoskeletal complications
5667432|NCT00631137|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5667433|NCT00631137|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5667434|NCT00631137|adult giant cell glioblastoma|adult giant cell glioblastoma
5667435|NCT00631137|adult glioblastoma|adult glioblastoma
5667436|NCT00631137|adult gliosarcoma|adult gliosarcoma
5667437|NCT00631124|Contraception|contraception
5667438|NCT00631111|dental pain|dental pain
5667439|NCT00631111|analgesic|analgesic
5667440|NCT00631111|NSAID|nsaid
5667441|NCT00631111|ibuprofen|ibuprofen
5667442|NCT00631111|aspirin|aspirin
5667443|NCT00631098|Resuscitation|resuscitation
5667444|NCT00631098|venous cannulation|venous cannulation
5667445|NCT00631098|external jugular vein|external jugular vein
5667446|NCT00631098|cubital vein|cubital vein
5667447|NCT00631085|healthy nonsmoking nonasthmatic volunteers|healthy nonsmoking nonasthmatic volunteers
5667448|NCT00631072|iNKT|inkt
5667449|NCT00631072|in vitro autologous iNKT|in vitro autologous inkt
5667450|NCT00631059|Hitachi|hitachi
5667451|NCT00631059|Leukemia|leukemia
5667452|NCT00631059|Relapse|relapse
5667453|NCT00631059|Chemotherapy Resistance|chemotherapy resistance
5667454|NCT00631046|n-3 LCPUFA|n-3 lcpufa
5667455|NCT00631046|Fish oil|fish oil
5667456|NCT00631046|essential fatty acids|essential fatty acids
5667457|NCT00631046|infant growth|infant growth
5667458|NCT00631046|obesity|obesity
5667459|NCT00631046|Intestinal microbiota|intestinal microbiota
5667460|NCT00631033|obesity|obesity
5667461|NCT00631033|hyperinsulinism|hyperinsulinism
5667462|NCT00631033|diazoxide|diazoxide
5667463|NCT00631033|metformin|metformin
5667464|NCT00631020|Youth|youth
5667465|NCT00631020|Smoking|smoking
5667466|NCT00631020|Tobacco|tobacco
5667467|NCT00631020|Adolescent|adolescent
5667468|NCT00631020|Dependence|dependence
5667469|NCT00631020|Teen smoking|teen smoking
5667470|NCT00631020|Smoking and youth|smoking and youth
5667471|NCT00631020|Youth and tobacco|youth and tobacco
5667472|NCT00631007|Type 2 diabetes|type 2 diabetes
5667473|NCT00631007|diabetes|diabetes
5667474|NCT00631007|diabetes mellitus|diabetes mellitus
5667475|NCT00631007|diabetes mellitus, type 2|diabetes mellitus, type 2
5667476|NCT00631007|non-TZD|non-tzd
5667477|NCT00631007|thiazolidinedione|thiazolidinedione
5667478|NCT00631007|selective peroxisome proliferator-activated receptor gamma modulator|selective peroxisome proliferator-activated receptor gamma modulator
5667479|NCT00631007|SPPARM|spparm
5667480|NCT00631007|peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
5667481|NCT00631007|PPAR gamma|ppar gamma
5667482|NCT00631007|insulin sensitizer|insulin sensitizer
5667483|NCT00631007|glucose control|glucose control
5667484|NCT00631007|endocrinopathy|endocrinopathy
5667485|NCT00631007|hypoglycemic agent|hypoglycemic agent
5667486|NCT00631007|sulfonylurea|sulfonylurea
5667487|NCT00631007|metformin|metformin
5667488|NCT00631007|pioglitazone|pioglitazone
5667489|NCT00631007|nutritional and metabolic diseases|nutritional and metabolic diseases
5667490|NCT00630994|primary myelofibrosis|primary myelofibrosis
5667491|NCT00630994|secondary myelofibrosis|secondary myelofibrosis
5667492|NCT00630994|essential thrombocythemia|essential thrombocythemia
5667493|NCT00630994|polycythemia vera|polycythemia vera
5667494|NCT00630981|dissociative disorders|dissociative disorders
5667495|NCT00630968|Levetiracetam|levetiracetam
5667496|NCT00630968|Keppra|keppra
5667497|NCT00630955|Alcohol Drinking|alcohol drinking
5667498|NCT00630955|Memantine|memantine
5667500|NCT00630916|Aortic valve insufficiency|aortic valve insufficiency
5667501|NCT00630916|Aortic valve|aortic valve
5667502|NCT00630916|Aortic disease|aortic disease
5667503|NCT00630916|Aortic incompetence|aortic incompetence
5667504|NCT00630890|Hilar Cholangiocarcinoma (Klatskin Tumor)|hilar cholangiocarcinoma (klatskin tumor)
5667505|NCT00630890|External Beam Radiation|external beam radiation
5667506|NCT00630890|Cyberknife|cyberknife
5847696|NCT00038493|Glioma|glioma
5667507|NCT00630890|Capecitabine|capecitabine
5648374|NCT00709514|Oneness|oneness
5667508|NCT00630864|Transthyretin, TTR, amyloidosis, TTR amyloidosis, polyneuropathy|transthyretin, ttr, amyloidosis, ttr amyloidosis, polyneuropathy
5667509|NCT00630838|Hirschsprung disease|hirschsprung disease
5667510|NCT00630838|enterocolitis|enterocolitis
5667511|NCT00630838|probiotics|probiotics
5667512|NCT00630812|cystic fibrosis|cystic fibrosis
5667513|NCT00630812|mannitol|mannitol
5667514|NCT00630812|mucoactive|mucoactive
5667515|NCT00630799|prostate|prostate
5667516|NCT00630799|cancer|cancer
5667517|NCT00630773|CPR|cpr
5667518|NCT00630773|compression sensor|compression sensor
5667519|NCT00630773|chest compression adjuncts|chest compression adjuncts
5667520|NCT00630747|Hunter syndrome|hunter syndrome
5667521|NCT00630747|hunters syndrome|hunters syndrome
5667522|NCT00630747|hunter's syndrome|hunter's syndrome
5667523|NCT00630747|hunter disease|hunter disease
5667525|NCT00630747|hunter's disease|hunter's disease
5667526|NCT00630747|MPS II|mps ii
5667527|NCT00630747|MPSII|mpsii
5667528|NCT00630747|MPS2|mps2
5667529|NCT00630747|MPS 2|mps 2
5667530|NCT00630747|mucopolysaccharides|mucopolysaccharides
5667531|NCT00630747|lysosomal storage disease|lysosomal storage disease
5667532|NCT00630747|lysosomal storage disorder|lysosomal storage disorder
5667533|NCT00630747|chronic ear infection|chronic ear infection
5667534|NCT00630747|enlarged adenoids|enlarged adenoids
5667535|NCT00630747|mps symptoms|mps symptoms
5667536|NCT00630747|mps diagnosis|mps diagnosis
5667537|NCT00630747|mps ii therapy|mps ii therapy
5667538|NCT00630747|MPS II treatment|mps ii treatment
5667539|NCT00630747|ert treatment|ert treatment
5667540|NCT00630747|elaprase|elaprase
5667541|NCT00630747|idursulfase|idursulfase
5667542|NCT00630747|iduronate sulfatase|iduronate sulfatase
5667543|NCT00630747|iduronate 2 sulfatase|iduronate 2 sulfatase
5667544|NCT00630747|enzyme replacement therapy|enzyme replacement therapy
5667545|NCT00630747|hunter syndrome treatment|hunter syndrome treatment
5667546|NCT00630747|hunter's syndrome treatment|hunter's syndrome treatment
5667547|NCT00630747|hunter syndrome therapy|hunter syndrome therapy
5667548|NCT00630747|hunter's disease treatment|hunter's disease treatment
5667549|NCT00630747|mps society|mps society
5667551|NCT00630734|Pravastatin|pravastatin
5667552|NCT00630734|Darunavir|darunavir
5667553|NCT00630734|Ritonavir|ritonavir
5667554|NCT00630734|Genetic|genetic
5667555|NCT00630708|Renal insufficiency|renal insufficiency
5667556|NCT00630708|Benazepril|benazepril
5667557|NCT00630708|Losartan|losartan
5667558|NCT00630708|combination treatment|combination treatment
5667559|NCT00630708|Safety|safety
5667560|NCT00630695|Axillary lymphocele breast cancer|axillary lymphocele breast cancer
5667561|NCT00630682|Methamphetamine|methamphetamine
5667562|NCT00630682|Drug Abuse|drug abuse
5667563|NCT00630682|Drug Treatment|drug treatment
5667564|NCT00630682|Addiction|addiction
5667565|NCT00630682|Meth|meth
5667566|NCT00630682|Treatment for Methamphetamine Dependence|treatment for methamphetamine dependence
5667567|NCT00630669|Internal hemorrhoids|internal hemorrhoids
5667568|NCT00630669|Rubber band ligation|rubber band ligation
5667569|NCT00630669|Bipolar coagulation|bipolar coagulation
5667570|NCT00630656|sepsis|sepsis
5667571|NCT00630656|talactoferrin|talactoferrin
5667572|NCT00630656|lactoferrin|lactoferrin
5667573|NCT00630656|recombinant human lactoferrin|recombinant human lactoferrin
5667574|NCT00630630|Levetiracetam|levetiracetam
5667575|NCT00630630|Keppra|keppra
5667576|NCT00630617|Obesity|obesity
5667577|NCT00630617|Prevention|prevention
5667578|NCT00630617|Childhood|childhood
5667579|NCT00630617|Children|children
5667580|NCT00630617|Primary care-giver|primary care-giver
5667581|NCT00630604|ultrasonography|ultrasonography
5667582|NCT00630604|knee|knee
5667583|NCT00630604|early degeneration|early degeneration
5667584|NCT00630604|cartilage|cartilage
5667585|NCT00630591|Daughters And MothErS Against Breast Cancer|daughters and mothers against breast cancer
5667586|NCT00630591|DAMES|dames
5667587|NCT00630591|Breast Cancer|breast cancer
5667588|NCT00630591|Weight Loss|weight loss
5667589|NCT00630591|Home-based weight loss|home-based weight loss
5667590|NCT00630591|Quality of Life|quality of life
5667591|NCT00630591|Diet|diet
5667592|NCT00630591|Exercise|exercise
5667593|NCT00630591|Daughter|daughter
5667594|NCT00630591|Mother|mother
5667595|NCT00630591|Cancer Prevention|cancer prevention
5667596|NCT00630591|Prevention|prevention
5667597|NCT00630578|PTSD|ptsd
5667598|NCT00630578|Posttraumatic Stress Disorder|posttraumatic stress disorder
5667599|NCT00630578|Physical Assault|physical assault
5667600|NCT00630578|Physical Abuse|physical abuse
5667601|NCT00630578|Sexual Assault|sexual assault
5667602|NCT00630578|Sexual Abuse|sexual abuse
5667603|NCT00630578|Interpersonal Assault|interpersonal assault
5667604|NCT00630578|Cognitive Processing Therapy|cognitive processing therapy
5667605|NCT00630565|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5667606|NCT00630565|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5667607|NCT00630565|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5648523|NCT00709033|low|low
5667608|NCT00630565|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5667609|NCT00630565|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5667610|NCT00630565|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5667611|NCT00630565|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5667612|NCT00630552|AMG 479|amg 479
5667613|NCT00630552|Gemcitabine|gemcitabine
5667614|NCT00630552|TR-2|tr-2
5667615|NCT00630552|IGF-1R|igf-1r
5667616|NCT00630552|AMG 655|amg 655
5667617|NCT00630552|Pancreatic cancer|pancreatic cancer
5667618|NCT00630552|Adenocarcinoma of the Pancreas|adenocarcinoma of the pancreas
5667619|NCT00630552|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5667620|NCT00630539|Menopausal symptoms|menopausal symptoms
5667622|NCT00630539|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5667623|NCT00630539|Vaginal atrophy|vaginal atrophy
5667624|NCT00630513|localized community acquired intra-abdominal infection (IAI)|localized community acquired intra-abdominal infection (iai)
5667625|NCT00630513|antibiotics|antibiotics
5667626|NCT00630513|localized peritonitis|localized peritonitis
5667627|NCT00630513|ertapenem|ertapenem
5667628|NCT00630500|Dementia associated with Parkinson's disease|dementia associated with parkinson's disease
5667629|NCT00630500|Dementia with Lewy bodies|dementia with lewy bodies
5667630|NCT00630500|Memantine|memantine
5667631|NCT00630500|Placebo-controlled|placebo-controlled
5667632|NCT00630500|Parallel group|parallel group
5667633|NCT00630474|sleep apnea, rhinitis|sleep apnea, rhinitis
5667634|NCT00630461|mild asthma, mild allergies|mild asthma, mild allergies
5667635|NCT00630435|Premarin®|premarin®
5667636|NCT00630422|Rett Syndrome|rett syndrome
5667637|NCT00630422|Selfcare|selfcare
5667638|NCT00630422|Mobility limitation|mobility limitation
5667639|NCT00630422|Interpersonal relations|interpersonal relations
5667640|NCT00630422|This study avaliated patients with Rett Syndrome|this study avaliated patients with rett syndrome
5667641|NCT00630409|Renal cell carcinoma|renal cell carcinoma
5667642|NCT00630409|Kidney Cancer|kidney cancer
5667644|NCT00630409|Doxil|doxil
5667645|NCT00630409|Chemotherapy|chemotherapy
5667646|NCT00630396|stroke|stroke
5667647|NCT00630396|ischemic|ischemic
5667648|NCT00630396|neuroprotection|neuroprotection
5667649|NCT00630396|minocycline|minocycline
5667650|NCT00630396|tissue plasminogen activator (tPA)|tissue plasminogen activator (tpa)
5667651|NCT00630396|biomarkers|biomarkers
5667652|NCT00630396|pharmacokinetics|pharmacokinetics
5667653|NCT00630396|antiapoptotic|antiapoptotic
5667654|NCT00630396|anti-inflammatory|anti-inflammatory
5667655|NCT00630396|treatment|treatment
5667656|NCT00630396|matrix metalloproteinase-9 (MMP-9)|matrix metalloproteinase-9 (mmp-9)
5667657|NCT00630396|thrombolysis|thrombolysis
5667658|NCT00630396|Minocycline to Improve Neurologic Outcome in Stroke (MINOS)|minocycline to improve neurologic outcome in stroke (minos)
5667659|NCT00630396|cerebrovascular stroke|cerebrovascular stroke
5667660|NCT00630396|cerebrovascular accident|cerebrovascular accident
5667661|NCT00630396|cerebral stroke|cerebral stroke
5667662|NCT00630396|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
5667663|NCT00630383|Parasite|parasite
5667664|NCT00630383|Necator|necator
5667665|NCT00630383|immune regulation|immune regulation
5667666|NCT00630383|regulatory T cells|regulatory t cells
5667667|NCT00630383|foxp3|foxp3
5667668|NCT00630383|cytokines|cytokines
5667669|NCT00630383|multiple sclerosis|multiple sclerosis
5667670|NCT00630383|hygiene hypothesis|hygiene hypothesis
5667671|NCT00630357|Levetiracetam|levetiracetam
5667672|NCT00630357|Keppra|keppra
5667673|NCT00630344|RAD001|rad001
5667674|NCT00630344|bicalutamide|bicalutamide
5667675|NCT00630344|androgen independent prostate cancer|androgen independent prostate cancer
5667676|NCT00630331|Influenza|influenza
5667677|NCT00630331|Flu|flu
5667678|NCT00630331|Cell Culture-Derived|cell culture-derived
5667679|NCT00630331|Egg-Derived|egg-derived
5667680|NCT00630331|Healthy Adults|healthy adults
5667681|NCT00630331|Efficacy|efficacy
5667682|NCT00630331|Safety|safety
5667683|NCT00630331|Immunogenicity|immunogenicity
5667684|NCT00630331|Trivalent|trivalent
5667685|NCT00630331|Inactivated|inactivated
5667686|NCT00630331|Influenza-Like Illness|influenza-like illness
5667687|NCT00630331|Vaccination|vaccination
5667688|NCT00630318|MR scanning|mr scanning
5667689|NCT00630305|toric|toric
5667690|NCT00630305|endothelial bleb|endothelial bleb
5667691|NCT00630279|pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5667692|NCT00630279|chronic pancreatitis|chronic pancreatitis
5667693|NCT00630266|Heart failure|heart failure
5667694|NCT00630266|left ventricular dilation|left ventricular dilation
5667695|NCT00630266|mitral valve repair|mitral valve repair
5667696|NCT00630266|mitral valve replacement|mitral valve replacement
5667697|NCT00630253|Fanconi anemia|fanconi anemia
5667698|NCT00630240|epirubicin|epirubicin
5667699|NCT00630240|mitomycin C|mitomycin c
5667700|NCT00630240|cisplatin|cisplatin
5667701|NCT00630240|Hepatocellular carcinoma|hepatocellular carcinoma
5667702|NCT00630227|emphysema|emphysema
5667703|NCT00630227|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5667704|NCT00630227|lung volume reduction|lung volume reduction
5667705|NCT00630214|Total thyroidectomy|total thyroidectomy
5667706|NCT00630214|CND|cnd
5667707|NCT00630214|hypocalcemia|hypocalcemia
5667708|NCT00630214|calcium|calcium
5667709|NCT00630214|vitamin D|vitamin d
5667710|NCT00630201|opioid dependence|opioid dependence
5667711|NCT00630201|opioid addiction|opioid addiction
5667712|NCT00630201|buprenorphine|buprenorphine
5667713|NCT00630201|methadone|methadone
5667714|NCT00630201|heroin|heroin
5667715|NCT00630201|implant|implant
5667716|NCT00630201|opioid withdrawal|opioid withdrawal
5667717|NCT00630201|opioid pain medication|opioid pain medication
5667718|NCT00630201|suboxone|suboxone
5667719|NCT00630188|prostate cancer screening|prostate cancer screening
5667720|NCT00630188|shared decision making|shared decision making
5667721|NCT00630188|prostate-specific antigen|prostate-specific antigen
5667722|NCT00630188|decision making|decision making
5667723|NCT00630188|physician-patient relations|physician-patient relations
5667724|NCT00630175|Insomnia|insomnia
5667725|NCT00630162|protozoa|protozoa
5667727|NCT00630149|Nasopharyngeal Neoplasms|nasopharyngeal neoplasms
5667728|NCT00630149|Pemetrexed|pemetrexed
5667729|NCT00630110|Non Small Cell Lung|non small cell lung
5667730|NCT00630097|methamphetamine addiction, meth dependence|methamphetamine addiction, meth dependence
5667731|NCT00630084|chronic hepatitis C|chronic hepatitis c
5667732|NCT00630084|sustained virological response|sustained virological response
5667733|NCT00630084|peginterferon|peginterferon
5667734|NCT00630084|ribavirin|ribavirin
5667735|NCT00630084|neoplasms|neoplasms
5667736|NCT00630071|Diagnostic Appendicitis|diagnostic appendicitis
5667737|NCT00630071|Procalcitonin|procalcitonin
5667738|NCT00630058|Chronic Hepatitis C|chronic hepatitis c
5667739|NCT00630058|Protease Inhibitor|protease inhibitor
5667740|NCT00630058|Telaprevir|telaprevir
5667741|NCT00630032|stage II breast cancer|stage ii breast cancer
5667742|NCT00630032|stage IIIA breast cancer|stage iiia breast cancer
5667743|NCT00630032|stage IIIB breast cancer|stage iiib breast cancer
5667744|NCT00630032|stage IIIC breast cancer|stage iiic breast cancer
5667745|NCT00630019|Aqueous humor penetration by anti-infectives|aqueous humor penetration by anti-infectives
5667746|NCT00629993|cervical cancer screening|cervical cancer screening
5667747|NCT00629993|medically underserved women|medically underserved women
5667749|NCT00629967|chronic hepatitis C|chronic hepatitis c
5667750|NCT00629967|genotype 1|genotype 1
5667751|NCT00629967|rapid virological response|rapid virological response
5667752|NCT00629967|sustained virological response|sustained virological response
5667753|NCT00629967|peginterferon|peginterferon
5667754|NCT00629967|ribavirin|ribavirin
5667755|NCT00629967|treatment duration|treatment duration
5667756|NCT00629954|ABUJA HEART STUDY NIGERIA|abuja heart study nigeria
5667757|NCT00629954|CARDIOVASCULAR DISEASES|cardiovascular diseases
5667758|NCT00629928|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
5667759|NCT00629915|Moyamoya|moyamoya
5667760|NCT00629915|stroke|stroke
5667761|NCT00629902|Heart valve prosthesis|heart valve prosthesis
5667762|NCT00629889|seizure|seizure
5667763|NCT00629889|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5667764|NCT00629889|adult diffuse astrocytoma|adult diffuse astrocytoma
5667765|NCT00629889|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5667766|NCT00629889|adult glioblastoma|adult glioblastoma
5667767|NCT00629889|adult gliosarcoma|adult gliosarcoma
5667768|NCT00629889|adult giant cell glioblastoma|adult giant cell glioblastoma
5667769|NCT00629889|adult brain stem glioma|adult brain stem glioma
5667770|NCT00629889|adult ependymoblastoma|adult ependymoblastoma
5667771|NCT00629889|adult medulloblastoma|adult medulloblastoma
5667772|NCT00629889|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5667773|NCT00629889|adult ependymoma|adult ependymoma
5667774|NCT00629889|adult anaplastic ependymoma|adult anaplastic ependymoma
5667775|NCT00629889|adult anaplastic meningioma|adult anaplastic meningioma
5667776|NCT00629889|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5667777|NCT00629889|adult oligodendroglioma|adult oligodendroglioma
5667778|NCT00629889|adult pineoblastoma|adult pineoblastoma
5667779|NCT00629889|adult pineocytoma|adult pineocytoma
5667780|NCT00629889|adult mixed glioma|adult mixed glioma
5667781|NCT00629889|adult papillary meningioma|adult papillary meningioma
5667782|NCT00629889|recurrent adult brain tumor|recurrent adult brain tumor
5667783|NCT00629889|adult grade II meningioma|adult grade ii meningioma
5667784|NCT00629876|Chemotherapy|chemotherapy
5667785|NCT00629876|Drug Therapy|drug therapy
5667786|NCT00629863|stage I gastric cancer|stage i gastric cancer
5667787|NCT00629863|stage II gastric cancer|stage ii gastric cancer
5667788|NCT00629863|stage III gastric cancer|stage iii gastric cancer
5667789|NCT00629863|stage I esophageal cancer|stage i esophageal cancer
5667790|NCT00629863|stage II esophageal cancer|stage ii esophageal cancer
5667791|NCT00629863|stage III esophageal cancer|stage iii esophageal cancer
5667792|NCT00629850|spinal cord injury|spinal cord injury
5667793|NCT00629850|respiratory muscle training|respiratory muscle training
5667794|NCT00629850|sleep quality|sleep quality
5667795|NCT00629837|FVIII|fviii
5667796|NCT00629837|Long acting|long acting
5667797|NCT00629837|pk|pk
5667798|NCT00629824|chronic hepatitis C|chronic hepatitis c
5667799|NCT00629824|sustained virological response|sustained virological response
5667800|NCT00629824|rapid virological response|rapid virological response
5667801|NCT00629824|peginterferon|peginterferon
5667802|NCT00629824|ribavirin|ribavirin
5667803|NCT00629824|old age|old age
5667804|NCT00629811|Cicatrix|cicatrix
5667805|NCT00629811|Scar|scar
5667806|NCT00629811|TGFβ3|tgfβ3
5667807|NCT00629811|Avotermin|avotermin
5667808|NCT00629811|Juvista|juvista
5667809|NCT00629811|RN1001|rn1001
5667810|NCT00629798|Busulfan|busulfan
5667811|NCT00629798|Melphalan|melphalan
5667812|NCT00629798|Fludarabine|fludarabine
5667815|NCT00629785|pulmonary function tests|pulmonary function tests
5667816|NCT00629785|obesity|obesity
5667817|NCT00629772|Palmoplantar psoriasis|palmoplantar psoriasis
5667818|NCT00629772|Infliximab|infliximab
5667819|NCT00629759|Jennerex|jennerex
5667820|NCT00629759|unresectable liver tumors|unresectable liver tumors
5667821|NCT00629759|primary liver cancer|primary liver cancer
5667822|NCT00629759|metastatic liver cancer|metastatic liver cancer
5667823|NCT00629759|oncolytic virus|oncolytic virus
5667824|NCT00629759|vaccinia virus|vaccinia virus
5667825|NCT00629759|Pexa-Vec|pexa-vec
5667826|NCT00629746|Thyroid|thyroid
5667827|NCT00629746|RLN|rln
5667828|NCT00629746|EMG|emg
5667829|NCT00629733|pharmacokinetics|pharmacokinetics
5667830|NCT00629733|ultra low molecular weight heparin|ultra low molecular weight heparin
5667831|NCT00629720|elevated detrusor leak point pressure|elevated detrusor leak point pressure
5667832|NCT00629707|diabetic ketoacidosis|diabetic ketoacidosis
5667833|NCT00629707|DKA|dka
5667834|NCT00629707|cerebral edema|cerebral edema
5667835|NCT00629707|brain edema|brain edema
5685571|NCT00555555|Bleeding disorders|bleeding disorders
5667836|NCT00629694|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy|adenoidectomy, myringotomy, tubes insertion, otitis media, adenoid hyperthophy
5667837|NCT00629655|fMRI|fmri
5667838|NCT00629655|spinal cord|spinal cord
5667840|NCT00629655|health|health
5667841|NCT00629655|cerebral infarction|cerebral infarction
5667842|NCT00629655|healthy|healthy
5667843|NCT00629642|Neurogenic bladder|neurogenic bladder
5667844|NCT00629642|Vesicare|vesicare
5667845|NCT00629629|Health Plan Implementation|health plan implementation
5667846|NCT00629629|Feeding and Eating Disorders of Childhood|feeding and eating disorders of childhood
5667847|NCT00629629|Breastfeeding|breastfeeding
5667848|NCT00629629|Complementary feeding|complementary feeding
5667849|NCT00629629|Morbidity|morbidity
5667850|NCT00629629|Anemia|anemia
5667851|NCT00629629|Public policy|public policy
5667852|NCT00629616|stage II breast cancer|stage ii breast cancer
5667853|NCT00629616|stage IIIA breast cancer|stage iiia breast cancer
5667854|NCT00629616|stage IIIB breast cancer|stage iiib breast cancer
5667855|NCT00629616|stage IIIC breast cancer|stage iiic breast cancer
5667856|NCT00629603|hepatitis C virus infection|hepatitis c virus infection
5667857|NCT00629603|chronic liver disease|chronic liver disease
5667858|NCT00629603|fibrosis-related cytokine|fibrosis-related cytokine
5667859|NCT00629577|cervical cancer|cervical cancer
5667860|NCT00629577|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5667861|NCT00629577|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5667862|NCT00629577|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5667863|NCT00629564|Gastroesophageal Reflux Disease (GERD), esomeprazole, Nexium|gastroesophageal reflux disease (gerd), esomeprazole, nexium
5667864|NCT00629551|Major Depressive Disorder|major depressive disorder
5667865|NCT00629551|Depression|depression
5667866|NCT00629551|Major Depressive Episode|major depressive episode
5667867|NCT00629551|Antidepressant|antidepressant
5667868|NCT00629538|congestive heart failure|congestive heart failure
5667869|NCT00629538|thoracentesis|thoracentesis
5667870|NCT00629538|transudative pleural effusions|transudative pleural effusions
5667871|NCT00629512|NSAID, Nexium, esomeprazole, Gastric Ulcers|nsaid, nexium, esomeprazole, gastric ulcers
5667872|NCT00629499|Early Stage Breast Cancer|early stage breast cancer
5667873|NCT00629499|Her2-positive|her2-positive
5667874|NCT00629499|nab paclitaxel|nab paclitaxel
5667875|NCT00629499|cyclophosphamide|cyclophosphamide
5667876|NCT00629499|trastuzumab|trastuzumab
5667877|NCT00629486|cytokine gene|cytokine gene
5667878|NCT00629486|hepatitis B|hepatitis b
5667879|NCT00629486|hepatocellular carcinoma|hepatocellular carcinoma
5667880|NCT00629486|chronic liver disease|chronic liver disease
5667881|NCT00629473|multiple myeloma|multiple myeloma
5667882|NCT00629473|leukemias (inc. CLL)|leukemias (inc. cll)
5667883|NCT00629473|lymphomas|lymphomas
5667884|NCT00629473|cutaneous lymphoma|cutaneous lymphoma
5667885|NCT00629473|marginal zone lymphoma|marginal zone lymphoma
5667886|NCT00629473|advanced malignancies without standard treatment options|advanced malignancies without standard treatment options
5667887|NCT00629460|Pulmonary Nodules|pulmonary nodules
5667888|NCT00629447|Primary Brain Tumor|primary brain tumor
5667889|NCT00629447|Venous Thromboembolism|venous thromboembolism
5667890|NCT00629447|Heparin|heparin
5667891|NCT00629434|Diabetes Education|diabetes education
5667892|NCT00629434|Telemedicine|telemedicine
5667893|NCT00629395|pediatric|pediatric
5667894|NCT00629395|brain tumor|brain tumor
5667895|NCT00629395|survivors|survivors
5667896|NCT00629382|abdominal sepsis|abdominal sepsis
5667897|NCT00629382|abdominal surgery|abdominal surgery
5667898|NCT00629382|septic shock|septic shock
5667899|NCT00629382|polymyxin B|polymyxin b
5667900|NCT00629382|hemoperfusion|hemoperfusion
5667901|NCT00629382|Endotoxins|endotoxins
5667902|NCT00629343|Soft Tissue Sarcoma|soft tissue sarcoma
5667903|NCT00629343|Mesothelioma|mesothelioma
5667904|NCT00629343|Azacitidine|azacitidine
5667905|NCT00629343|Temozolomide|temozolomide
5667906|NCT00629343|Temodar|temodar
5667908|NCT00629330|prostate cancer screening|prostate cancer screening
5667909|NCT00629330|prostate specific antigen|prostate specific antigen
5667910|NCT00629330|African American males|african american males
5667911|NCT00629317|Skin Aging|skin aging
5667912|NCT00629317|Rejuvenation|rejuvenation
5667913|NCT00629317|Photodynamic Therapy|photodynamic therapy
5667914|NCT00629317|Methyl Aminolevulinate|methyl aminolevulinate
5667915|NCT00629304|type 1 diabetes|type 1 diabetes
5667916|NCT00629304|PDA phone (Personal Digital Assistant)|pda phone (personal digital assistant)
5667917|NCT00629304|HbA1c|hba1c
5667918|NCT00629291|iron overload|iron overload
5667919|NCT00629291|Thalassemia|thalassemia
5667920|NCT00629291|Anemia, Sickle Cell|anemia, sickle cell
5667921|NCT00629291|Magnetic Resonance Imaging|magnetic resonance imaging
5667922|NCT00629278|stage IA breast cancer|stage ia breast cancer
5667923|NCT00629278|stage IB breast cancer|stage ib breast cancer
5667924|NCT00629278|stage II breast cancer|stage ii breast cancer
5667925|NCT00629278|stage IIIA breast cancer|stage iiia breast cancer
5667926|NCT00629278|HER2-positive breast cancer|her2-positive breast cancer
5667927|NCT00629265|Dysphagia|dysphagia
5685572|NCT00555555|Blood disorders|blood disorders
5667928|NCT00629265|Neuromuscular Electrical Stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5667929|NCT00629265|Head & Neck Cancer|head & neck cancer
5667930|NCT00629265|Radiation and ChemoTherapy|radiation and chemotherapy
5667931|NCT00629252|Schizophrenia|schizophrenia
5667934|NCT00629252|CANTAB|cantab
5667935|NCT00629252|sensory gating|sensory gating
5667936|NCT00629252|Schizophrenic patients according to DSM-IV|schizophrenic patients according to dsm-iv
5667937|NCT00629239|COPD|copd
5667938|NCT00629239|tolerability|tolerability
5667939|NCT00629239|inhalation|inhalation
5667940|NCT00629226|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5667941|NCT00629226|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5667942|NCT00629226|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5667943|NCT00629226|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5667944|NCT00629226|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5667945|NCT00629226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5667946|NCT00629226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5667947|NCT00629226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5667948|NCT00629226|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5667949|NCT00629226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5667950|NCT00629226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5667951|NCT00629213|prevention,|prevention,
5667952|NCT00629213|type 2 diabetes,|type 2 diabetes,
5667953|NCT00629213|metabolic syndrome,|metabolic syndrome,
5667954|NCT00629213|acarbose treatment|acarbose treatment
5667955|NCT00629200|Advanced Malignancies|advanced malignancies
5667956|NCT00629200|Solid Tumors|solid tumors
5667957|NCT00629200|Melanoma|melanoma
5667958|NCT00629200|Renal Cell Carcinoma|renal cell carcinoma
5667959|NCT00629200|Phase I Studies|phase i studies
5667960|NCT00629200|Sodium Stibogluconate|sodium stibogluconate
5667961|NCT00629200|Interferon Alpha-2b|interferon alpha-2b
5667962|NCT00629200|Intron A|intron a
5667963|NCT00629200|SSG|ssg
5667964|NCT00629187|Lung Neoplasm|lung neoplasm
5667965|NCT00629187|Breast Neoplasm|breast neoplasm
5667966|NCT00629187|Melanoma|melanoma
5667967|NCT00629187|Central Nervous System Neoplasms|central nervous system neoplasms
5667968|NCT00629187|Neoplasm Metastasis|neoplasm metastasis
5667969|NCT00629187|Neoplasm Second Primary|neoplasm second primary
5667970|NCT00629187|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5667971|NCT00629174|Cognitive function|cognitive function
5667972|NCT00629174|Elderly|elderly
5667973|NCT00629174|Exercise|exercise
5667974|NCT00629174|Mental activity|mental activity
5667975|NCT00629148|metastasis|metastasis
5667976|NCT00629148|chemotherapy|chemotherapy
5667977|NCT00629148|breast cancer|breast cancer
5667978|NCT00629148|Vinorelbine|vinorelbine
5667979|NCT00629148|Capecitabine|capecitabine
5667980|NCT00629148|sequential chemotherapy|sequential chemotherapy
5667981|NCT00629148|TTF|ttf
5667982|NCT00629135|abscess|abscess
5667983|NCT00629135|intraabdominal abscess|intraabdominal abscess
5667985|NCT00629135|Moxifloxacin|moxifloxacin
5667986|NCT00629135|Metronidazole|metronidazole
5667987|NCT00629135|Tazobactam|tazobactam
5667988|NCT00629135|Piperacilline|piperacilline
5667989|NCT00629135|Piperacillin|piperacillin
5667990|NCT00629135|Tazobac|tazobac
5667991|NCT00629122|Kidney Transplantation|kidney transplantation
5667992|NCT00629122|Tacrolimus (Prograf)|tacrolimus (prograf)
5667993|NCT00629122|Pharmacokinetics|pharmacokinetics
5667994|NCT00629122|Sublingual administration|sublingual administration
5661599|NCT00656747|bronchitis|bronchitis
5667995|NCT00629122|Drug interactions (Cytochrome P450 and p-glycoprotein)|drug interactions (cytochrome p450 and p-glycoprotein)
5667996|NCT00629096|Dilated Cardiomyopathy|dilated cardiomyopathy
5667997|NCT00629096|Marrow stem cells|marrow stem cells
5667998|NCT00629096|Myocardial regeneration|myocardial regeneration
5667999|NCT00629096|Mesenchymal stem cells|mesenchymal stem cells
5668000|NCT00629096|Marrow-derived endothelial progenitor cells|marrow-derived endothelial progenitor cells
5668001|NCT00629083|SUI|sui
5668002|NCT00629083|Bulkamid|bulkamid
5668003|NCT00629083|Urinary Incontinence|urinary incontinence
5668004|NCT00629070|cerebral palsy|cerebral palsy
5668005|NCT00629070|muscle strength|muscle strength
5668006|NCT00629070|muscle architecture|muscle architecture
5668007|NCT00629070|ultrasound|ultrasound
5668008|NCT00629070|rehabilitation|rehabilitation
5668009|NCT00629070|rectus femoris|rectus femoris
5668010|NCT00629070|quadriceps muscle|quadriceps muscle
5668011|NCT00629057|androgen-insensitive, non-metastatic, prostate, cancer|androgen-insensitive, non-metastatic, prostate, cancer
5668012|NCT00629031|Visceral leishmaniasis|visceral leishmaniasis
5668013|NCT00629031|Paromomycin|paromomycin
5668014|NCT00629018|Stem Cells|stem cells
5668015|NCT00629018|Heart Failure|heart failure
5668016|NCT00629018|Dilated Cardiomyopathy|dilated cardiomyopathy
5668017|NCT00629005|rehabilitation|rehabilitation
5668018|NCT00629005|upper extremity|upper extremity
5668019|NCT00629005|motor skills|motor skills
5668020|NCT00628992|COPD: chronic obstructive pulmonary disease and acute respiratory failure|copd: chronic obstructive pulmonary disease and acute respiratory failure
5668021|NCT00628966|Heart Attack|heart attack
5668022|NCT00628966|ICD|icd
5668023|NCT00628966|Risk Stratification|risk stratification
5668024|NCT00628966|Arrhythmia|arrhythmia
5668025|NCT00628953|Asthma|asthma
5668026|NCT00628953|Acid Reflux|acid reflux
5668027|NCT00628953|Nexium|nexium
5668028|NCT00628953|Esomeprazole|esomeprazole
5668029|NCT00628914|Major Depressive Disorder|major depressive disorder
5668030|NCT00628914|Insomnia|insomnia
5668031|NCT00628914|Escitalopram|escitalopram
5668032|NCT00628914|Lexapro|lexapro
5668033|NCT00628914|Eszopiclone|eszopiclone
5668034|NCT00628914|Lunesta|lunesta
5668035|NCT00628914|Cordance|cordance
5668036|NCT00628901|Leiomyoma|leiomyoma
5668037|NCT00628901|Uterine Fibroids|uterine fibroids
5668038|NCT00628901|Uterine Fibroid Embolization (UFE)|uterine fibroid embolization (ufe)
5668039|NCT00628901|Uterine Artery Embolization (UAE)|uterine artery embolization (uae)
5668040|NCT00628901|Uterine Neoplasms|uterine neoplasms
5668041|NCT00628901|Menorrhagia|menorrhagia
5668042|NCT00628888|Unipolar Depression|unipolar depression
5668043|NCT00628888|Anxiety|anxiety
5668044|NCT00628888|Adolescent|adolescent
5668045|NCT00628888|Emotion|emotion
5668046|NCT00628888|Cognitive Behavioral|cognitive behavioral
5668047|NCT00628875|mechanical ventilation|mechanical ventilation
5668048|NCT00628875|thoracic impedence|thoracic impedence
5668049|NCT00628875|defibrillator pads|defibrillator pads
5668050|NCT00628875|ventilation detection|ventilation detection
5668051|NCT00628875|pediatric ventilation|pediatric ventilation
5668052|NCT00628862|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5668053|NCT00628862|COPD|copd
5668054|NCT00628849|Mandible|mandible
5668055|NCT00628849|fracture|fracture
5668056|NCT00628849|Champy|champy
5668057|NCT00628849|AO technique|ao technique
5668058|NCT00628836|Neuromuscular stimulator|neuromuscular stimulator
5668059|NCT00628836|Shoulder subluxation|shoulder subluxation
5668060|NCT00628823|Celiac Disease|celiac disease
5668061|NCT00628823|Endomysial antibodies|endomysial antibodies
5668062|NCT00628823|Mild enteropathy|mild enteropathy
5668063|NCT00628823|Treatment|treatment
5668064|NCT00628823|Gluten-free diet|gluten-free diet
5668065|NCT00628810|adenocarcinoma of the colon|adenocarcinoma of the colon
5668066|NCT00628810|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5668067|NCT00628810|stage IV colon cancer|stage iv colon cancer
5668068|NCT00628810|stage IV rectal cancer|stage iv rectal cancer
5668069|NCT00628810|recurrent colon cancer|recurrent colon cancer
5668070|NCT00628810|recurrent rectal cancer|recurrent rectal cancer
5668071|NCT00628797|systemic sclerosis|systemic sclerosis
5668072|NCT00628797|skin fibrosis|skin fibrosis
5668073|NCT00628784|Dysplasia|dysplasia
5668074|NCT00628784|Ablation|ablation
5668075|NCT00628784|Squamous dysplasia|squamous dysplasia
5668076|NCT00628784|Early esophageal adenocarcinoma|early esophageal adenocarcinoma
5668077|NCT00628784|Cryotherapy|cryotherapy
5668078|NCT00628771|HIV Prevention|hiv prevention
5668079|NCT00628771|Teen Pregnancy|teen pregnancy
5668082|NCT00628771|Prenatal Care|prenatal care
5668083|NCT00628771|STD Prevention|std prevention
5668084|NCT00628771|Gonorrhea|gonorrhea
5668085|NCT00628771|Chlamydia|chlamydia
5668086|NCT00628771|Adolescent Health|adolescent health
5668087|NCT00628771|Community Health Centers|community health centers
5668088|NCT00628771|CenteringPregnancy Plus|centeringpregnancy plus
5668089|NCT00628771|HIV seronegativity|hiv seronegativity
5668090|NCT00628758|Symbicort|symbicort
5668091|NCT00628758|Turbuhaler|turbuhaler
5668092|NCT00628758|Persistent Asthma|persistent asthma
5668096|NCT00628732|Cyclophosphamide|cyclophosphamide
5668097|NCT00628732|Topotecan|topotecan
5668099|NCT00628732|Children|children
5668100|NCT00628732|Relapsed solid tumors|relapsed solid tumors
5668101|NCT00628719|Visceral leishmaniasis|visceral leishmaniasis
5668102|NCT00628719|India|india
5668103|NCT00628719|Liposomal Amphotericin B|liposomal amphotericin b
5668104|NCT00628719|Amphotericin B deoxycholate|amphotericin b deoxycholate
5668105|NCT00628706|tetrahydrocannabinol|tetrahydrocannabinol
5668106|NCT00628706|memory|memory
5668107|NCT00628706|reward|reward
5668108|NCT00628706|magnetic resonance imaging|magnetic resonance imaging
5668109|NCT00628706|endocannabinoids|endocannabinoids
5668110|NCT00628693|CPR|cpr
5668111|NCT00628680|Renal Disease|renal disease
5668112|NCT00628680|Kidney Failure|kidney failure
5668113|NCT00628680|End Stage Renal Disease|end stage renal disease
5668114|NCT00628667|Chronic Posterior Laryngitis|chronic posterior laryngitis
5668115|NCT00628667|CPL|cpl
5668116|NCT00628667|Pharyngeal acid reflux|pharyngeal acid reflux
5668117|NCT00628667|Esomeprazole|esomeprazole
5668118|NCT00628667|Nexium|nexium
5668119|NCT00628654|ovarian germ cell tumor|ovarian germ cell tumor
5668120|NCT00628654|ovarian epithelial cancer|ovarian epithelial cancer
5668121|NCT00628628|Tumor Lysis Syndrome|tumor lysis syndrome
5668122|NCT00628628|TLS|tls
5668123|NCT00628628|hyperuricemia|hyperuricemia
5668124|NCT00628628|Leukemia|leukemia
5668125|NCT00628628|Lymphoma|lymphoma
5668126|NCT00628628|Acute myeloid leukemia|acute myeloid leukemia
5668127|NCT00628628|Chronic myelocytic leukemia|chronic myelocytic leukemia
5668128|NCT00628628|CML|cml
5668129|NCT00628628|lactate dehydrogenase|lactate dehydrogenase
5668130|NCT00628628|LDH|ldh
5668131|NCT00628628|Myelodysplastic Syndrome|myelodysplastic syndrome
5668132|NCT00628628|Rasburicase|rasburicase
5668133|NCT00628628|Elitek™|elitek™
5668134|NCT00628615|Urodynamics|urodynamics
5668135|NCT00628615|Overactive bladder syndrome|overactive bladder syndrome
5668136|NCT00628615|Lower urinary tract symptoms LUTS|lower urinary tract symptoms luts
5668137|NCT00628602|Neuromuscular stimulator|neuromuscular stimulator
5668138|NCT00628602|Pressure ulcer prevention|pressure ulcer prevention
5668139|NCT00628589|schizophrenia, agitation, inhaled loxapine, ADASUVE|schizophrenia, agitation, inhaled loxapine, adasuve
5668140|NCT00628576|Deep Venous Thrombosis|deep venous thrombosis
5668141|NCT00628576|lower extremities|lower extremities
5668142|NCT00628576|Chronic Venous Insufficiency|chronic venous insufficiency
5668143|NCT00628576|Postthrombotic Syndrome|postthrombotic syndrome
5668144|NCT00628576|Heparins|heparins
5668145|NCT00628576|Low-molecular- weight heparin|low-molecular- weight heparin
5668146|NCT00628576|Tinzaparin|tinzaparin
5668147|NCT00628550|cardiac arrest|cardiac arrest
5668148|NCT00628550|cardiopulmonary arrest|cardiopulmonary arrest
5668149|NCT00628550|vasopressin|vasopressin
5668150|NCT00628550|epinephrine|epinephrine
5668151|NCT00628550|pediatrics|pediatrics
5668152|NCT00628550|in hospital cardiopulmonary resuscitation|in hospital cardiopulmonary resuscitation
5668153|NCT00628537|Neuromuscular stimulator|neuromuscular stimulator
5668154|NCT00628537|Flexor deformities of wrist and fingers|flexor deformities of wrist and fingers
5668155|NCT00628498|VOD|vod
5668156|NCT00628485|swallowing function|swallowing function
5668157|NCT00628485|neuromuscular stimulator|neuromuscular stimulator
5668158|NCT00628472|botulinum toxin a|botulinum toxin a
5668159|NCT00628472|botox|botox
5668160|NCT00628472|Decreasing botox injection pain|decreasing botox injection pain
5668161|NCT00628472|injections|injections
5668162|NCT00628459|iron|iron
5668163|NCT00628459|multiple micronutrient|multiple micronutrient
5668164|NCT00628459|malaria|malaria
5668165|NCT00628459|anemia|anemia
5668166|NCT00628459|preschool children|preschool children
5668167|NCT00628446|spinal cord injury|spinal cord injury
5668168|NCT00628446|Coronary artery calcium|coronary artery calcium
5668169|NCT00628446|Dyslipidemia|dyslipidemia
5668170|NCT00628433|phase I/II|phase i/ii
5668171|NCT00628433|ulcerative colitis|ulcerative colitis
5668172|NCT00628433|safety|safety
5668173|NCT00628433|tolerance|tolerance
5668174|NCT00628433|pharmacokinetics|pharmacokinetics
5668175|NCT00628420|Schizophrenia|schizophrenia
5668176|NCT00628420|N-desmethylclozapine|n-desmethylclozapine
5668177|NCT00628420|clozapine|clozapine
5668178|NCT00628420|psychosis|psychosis
5668179|NCT00628420|randomized|randomized
5668180|NCT00628420|placebo studies|placebo studies
5668181|NCT00628407|leaning|leaning
5668182|NCT00628407|CPR|cpr
5668183|NCT00628407|sternal pressure|sternal pressure
5668184|NCT00628407|incomplete release|incomplete release
5668185|NCT00628407|chest compressions|chest compressions
5668186|NCT00628407|pediatric|pediatric
5668187|NCT00628394|Cognition|cognition
5668188|NCT00628394|schizophrenia|schizophrenia
5668189|NCT00628394|Atomoxetine|atomoxetine
5668190|NCT00628394|Strattera|strattera
5668191|NCT00628394|cognitive remediation|cognitive remediation
5668192|NCT00628381|sepsis|sepsis
5668193|NCT00628381|microcirculation|microcirculation
5668194|NCT00628381|nitric oxide|nitric oxide
5668195|NCT00628381|citrulline|citrulline
5668196|NCT00628368|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5661699|NCT00656422|Obesity|obesity
5668198|NCT00628368|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5668199|NCT00628368|recurrent rectal cancer|recurrent rectal cancer
5668200|NCT00628368|stage I rectal cancer|stage i rectal cancer
5668201|NCT00628368|stage II rectal cancer|stage ii rectal cancer
5668202|NCT00628368|stage III rectal cancer|stage iii rectal cancer
5668203|NCT00628368|stage IV rectal cancer|stage iv rectal cancer
5668204|NCT00628368|recurrent esophageal cancer|recurrent esophageal cancer
5668205|NCT00628368|stage I esophageal cancer|stage i esophageal cancer
5668206|NCT00628368|stage II esophageal cancer|stage ii esophageal cancer
5668207|NCT00628368|stage III esophageal cancer|stage iii esophageal cancer
5668208|NCT00628368|stage IV esophageal cancer|stage iv esophageal cancer
5668209|NCT00628355|lidocaine|lidocaine
5668210|NCT00628355|ischemic compression|ischemic compression
5668211|NCT00628355|chronic pelvic pain|chronic pelvic pain
5668212|NCT00628355|myofascial pain syndrome|myofascial pain syndrome
5668213|NCT00628342|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5668214|NCT00628342|GERD|gerd
5668215|NCT00628342|Esomeprazole|esomeprazole
5668216|NCT00628342|Heartburn|heartburn
5668217|NCT00628342|Nexium|nexium
5668218|NCT00628329|asthma, retinol, cis-retinoic acid|asthma, retinol, cis-retinoic acid
5668219|NCT00628316|tinnitus|tinnitus
5668220|NCT00628316|caffeine|caffeine
5668221|NCT00628303|Good health|good health
5668222|NCT00628277|Obesity|obesity
5668223|NCT00628277|coronary heart disease|coronary heart disease
5668224|NCT00628277|coronary risk factors|coronary risk factors
5668225|NCT00628277|weight loss|weight loss
5668226|NCT00628277|exercise|exercise
5668227|NCT00628264|cardiac surgery|cardiac surgery
5668228|NCT00628264|coronary artery bypass grafting|coronary artery bypass grafting
5668229|NCT00628264|valve surgery|valve surgery
5668230|NCT00628264|acute kidney injury|acute kidney injury
5668231|NCT00628251|Advanced ovarian cancer|advanced ovarian cancer
5668232|NCT00628251|BRCA1 protein|brca1 protein
5668233|NCT00628251|BRCA2 protein|brca2 protein
5668234|NCT00628251|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5668235|NCT00628238|Chronic Lymphocytic Leukemia Research Consortium|chronic lymphocytic leukemia research consortium
5668236|NCT00628238|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5668238|NCT00628238|CLL Research Consortium|cll research consortium
5668239|NCT00628238|CRC|crc
5668240|NCT00628238|Revlimid|revlimid
5668241|NCT00628238|lenalidomide|lenalidomide
5668242|NCT00628238|Rituximab|rituximab
5668243|NCT00628238|Rituxan|rituxan
5668244|NCT00628238|First-line|first-line
5668245|NCT00628238|therapy|therapy
5668246|NCT00628238|untreated|untreated
5668247|NCT00628238|Frontline|frontline
5668248|NCT00628225|Smoking cessation|smoking cessation
5668249|NCT00628212|insulin resistance|insulin resistance
5668250|NCT00628186|pancreaticoduodenectomy|pancreaticoduodenectomy
5668251|NCT00628186|stent|stent
5668252|NCT00628186|pancreaticojejunostomy|pancreaticojejunostomy
5668253|NCT00628186|hospital stay|hospital stay
5668254|NCT00628186|complication|complication
5668255|NCT00628186|pancreatic fistula|pancreatic fistula
5668256|NCT00628160|Septic shock|septic shock
5668257|NCT00628160|Cirrhosis|cirrhosis
5668258|NCT00628160|Survival|survival
5668259|NCT00628147|colonic neoplasms|colonic neoplasms
5668260|NCT00628147|colonoscopy|colonoscopy
5668261|NCT00628147|narrow band imaging|narrow band imaging
5668262|NCT00628147|diagnostic techniques|diagnostic techniques
5668263|NCT00628134|cystic fibrosis|cystic fibrosis
5668264|NCT00628134|surfactant|surfactant
5668265|NCT00628134|aerosol|aerosol
5668266|NCT00628134|inhaled drug|inhaled drug
5668267|NCT00628134|inhaled antibiotic|inhaled antibiotic
5668268|NCT00628121|infertility, menstrual cycle, LH surge|infertility, menstrual cycle, lh surge
5668269|NCT00628108|Xyzal|xyzal
5668270|NCT00628108|Levocetirizine|levocetirizine
5668271|NCT00628108|Allergy|allergy
5668272|NCT00628108|Children|children
5668273|NCT00628108|Seasonal Allergies|seasonal allergies
5668274|NCT00628095|rheumatoid arthritis DMARD methotrexate|rheumatoid arthritis dmard methotrexate
5668275|NCT00628082|Cardiac Energetics|cardiac energetics
5668276|NCT00628082|Dynamic Diastolic filling Assessment|dynamic diastolic filling assessment
5668277|NCT00628082|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5668278|NCT00628082|Arterial and Ventricular Stiffening|arterial and ventricular stiffening
5668279|NCT00628069|Orthopedics|orthopedics
5668280|NCT00628069|bone fixation|bone fixation
5668281|NCT00628056|Perhexiline|perhexiline
5668282|NCT00628056|diabetes|diabetes
5668283|NCT00628056|diabetic cardiomyopathy|diabetic cardiomyopathy
5668284|NCT00628056|high energy phosphate kinetics|high energy phosphate kinetics
5668285|NCT00628056|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5668286|NCT00628043|Cancer|cancer
5668287|NCT00628043|patients|patients
5668288|NCT00628043|with|with
5668289|NCT00628043|chemotherapy|chemotherapy
5668290|NCT00628043|induced|induced
5668291|NCT00628043|anemia|anemia
5668292|NCT00628030|Behavioral intervention|behavioral intervention
5668293|NCT00628030|Obesity prevention|obesity prevention
5668294|NCT00628017|polyunsaturated fatty acids|polyunsaturated fatty acids
5668295|NCT00628017|Alzheimer's disease|alzheimer's disease
5668296|NCT00628017|mild cognitive impairment|mild cognitive impairment
5668297|NCT00628017|fish oil|fish oil
5668298|NCT00628017|cognition|cognition
5668299|NCT00627978|breast|breast
5668300|NCT00627965|Sildenafil citrate|sildenafil citrate
5668301|NCT00627965|Prevention|prevention
5668302|NCT00627965|High Altitude Pulmonary Edema|high altitude pulmonary edema
5668303|NCT00627965|Acute Mountain Sickness|acute mountain sickness
5668304|NCT00627965|Healthy Lowland Subjects|healthy lowland subjects
5668305|NCT00627965|Pulmonary Artery Systolic Pressure|pulmonary artery systolic pressure
5668306|NCT00627952|hypertension|hypertension
5668307|NCT00627952|intraglomerular pressure|intraglomerular pressure
5668308|NCT00627926|Genotype 1|genotype 1
5668309|NCT00627913|Floppy Iris Syndrome|floppy iris syndrome
5668310|NCT00627900|drug-eluting stents|drug-eluting stents
5668311|NCT00627887|Depressive Disorder, Major|depressive disorder, major
5668312|NCT00627887|Electroconvulsive Therapy|electroconvulsive therapy
5668313|NCT00627887|Lithium Carbonate|lithium carbonate
5668314|NCT00627887|venlafaxine|venlafaxine
5668315|NCT00627848|Alzheimer's disease|alzheimer's disease
5668316|NCT00627848|fmri|fmri
5668317|NCT00627848|face recognition|face recognition
5668318|NCT00627848|rivastigmine|rivastigmine
5668319|NCT00627835|squamous cell carcinoma|squamous cell carcinoma
5668320|NCT00627835|head and neck|head and neck
5668321|NCT00627835|Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation|neoadjuvant sorafenib and concurrent sorafenib, cisplatin and radiation
5668322|NCT00627822|Medical students|medical students
5668323|NCT00627822|Medical education|medical education
5668324|NCT00627822|Private hospital|private hospital
5668325|NCT00627822|Patient satisfaction|patient satisfaction
5668326|NCT00627822|Questionnaires|questionnaires
5668327|NCT00627809|coronary microcirculation|coronary microcirculation
5668328|NCT00627809|acut myocardial infarction|acut myocardial infarction
5668329|NCT00627809|infarct size|infarct size
5668330|NCT00627809|streptokinase|streptokinase
5668331|NCT00627809|reperfusion|reperfusion
5668333|NCT00627796|IGF-I|igf-i
5668334|NCT00627796|tumor|tumor
5668335|NCT00627796|lanreotide|lanreotide
5668336|NCT00627770|Physical Therapy - Therapeutics - Edema|physical therapy - therapeutics - edema
5668337|NCT00627770|Arthroplasty replacement knee|arthroplasty replacement knee
5668338|NCT00627770|Treatment outcome|treatment outcome
5668339|NCT00627757|metabolic syndrome|metabolic syndrome
5668340|NCT00627757|weight gain|weight gain
5668341|NCT00627757|antipsychotic drugs|antipsychotic drugs
5668342|NCT00627757|Metabolic syndrome and treatment with antipsychotic drugs|metabolic syndrome and treatment with antipsychotic drugs
5668343|NCT00627744|Type 2 diabetes, IGT, Myocardial infarction, Incretins|type 2 diabetes, igt, myocardial infarction, incretins
5668344|NCT00627731|Asthma Patients|asthma patients
5668345|NCT00627718|Age-related macular degeneration|age-related macular degeneration
5668346|NCT00627718|HRT|hrt
5668347|NCT00627718|Macular edema|macular edema
5668348|NCT00627718|Screening for disease|screening for disease
5668349|NCT00627692|Constipation in elderly patients|constipation in elderly patients
5668350|NCT00627679|Pediatric asthma|pediatric asthma
5668351|NCT00627666|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5668352|NCT00627666|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5668353|NCT00627666|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5668354|NCT00627666|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5668355|NCT00627666|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5668356|NCT00627666|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5668357|NCT00627666|acute lymphocytic leukemia|acute lymphocytic leukemia
5668358|NCT00627666|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5668359|NCT00627666|acute undifferentiated leukemia|acute undifferentiated leukemia
5668360|NCT00627666|mast cell leukemia|mast cell leukemia
5668361|NCT00627666|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5668473|NCT00627250|Brain Injury|brain injury
5668362|NCT00627666|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5668363|NCT00627666|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5668364|NCT00627666|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5668365|NCT00627666|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5847697|NCT00038493|Brain Tumor|brain tumor
5668366|NCT00627666|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5668367|NCT00627666|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5668368|NCT00627666|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5668369|NCT00627666|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5668370|NCT00627666|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5668371|NCT00627666|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5668372|NCT00627666|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5668457|NCT00627302|Quality of Vision|quality of vision
5668373|NCT00627666|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5668374|NCT00627666|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5668375|NCT00627666|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5668376|NCT00627666|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5668377|NCT00627666|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5668378|NCT00627666|refractory anemia with excess blasts|refractory anemia with excess blasts
5668380|NCT00627653|PET study|pet study
5668381|NCT00627653|heart metabolism|heart metabolism
5668382|NCT00627614|stage I breast cancer|stage i breast cancer
5668383|NCT00627614|stage II breast cancer|stage ii breast cancer
5668384|NCT00627614|stage IIIA breast cancer|stage iiia breast cancer
5668385|NCT00627614|stage IIIB breast cancer|stage iiib breast cancer
5668386|NCT00627614|stage IIIC breast cancer|stage iiic breast cancer
5668387|NCT00627614|stage IV breast cancer|stage iv breast cancer
5668388|NCT00627588|ProSavin|prosavin
5668389|NCT00627588|Parkinson's Disease|parkinson's disease
5668390|NCT00627588|Gene Therapy|gene therapy
5668391|NCT00627575|drug interaction|drug interaction
5668392|NCT00627575|pharmacokinetics|pharmacokinetics
5668393|NCT00627575|healthy volunteers|healthy volunteers
5668394|NCT00627562|robotic|robotic
5668395|NCT00627562|robot assisted|robot assisted
5668396|NCT00627562|minimally invasive|minimally invasive
5668397|NCT00627562|tumors of head and neck|tumors of head and neck
5668398|NCT00627549|cystocele, anterior repair, mesh|cystocele, anterior repair, mesh
5668399|NCT00627536|scarring, Juvista, avotermin, transforming growth factor beta 3, TGFB3|scarring, juvista, avotermin, transforming growth factor beta 3, tgfb3
5668400|NCT00627510|Therapeutic Drug Monitoring (TDM)|therapeutic drug monitoring (tdm)
5668401|NCT00627510|Antidepressant|antidepressant
5668402|NCT00627510|Antipsychotic|antipsychotic
5668403|NCT00627510|Treatment adherence|treatment adherence
5668404|NCT00627510|Compliance|compliance
5668405|NCT00627510|Metabolism|metabolism
5668406|NCT00627510|Do patients take their psychiatric medication as prescribed?|do patients take their psychiatric medication as prescribed?
5668407|NCT00627510|Do psychiatric patients metabolize their medication faster than expected?|do psychiatric patients metabolize their medication faster than expected?
5668408|NCT00627510|What are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are BELOW those intended?|what are the exact odds that the patient of a physician prescribing antidepressants or antipsychotics has plasma levels that are below those intended?
5668409|NCT00627484|Insulin resistance|insulin resistance
5668410|NCT00627484|Insulin sensitivity|insulin sensitivity
5668411|NCT00627484|bariatric surgery|bariatric surgery
5668412|NCT00627484|diabetes|diabetes
5668413|NCT00627484|calorie restriction|calorie restriction
5668414|NCT00627484|body composition|body composition
5668415|NCT00627458|Hexavalent vaccine|hexavalent vaccine
5668416|NCT00627458|Booster|booster
5668417|NCT00627432|stage III bladder cancer|stage iii bladder cancer
5668418|NCT00627432|stage IV bladder cancer|stage iv bladder cancer
5668419|NCT00627432|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5668420|NCT00627406|GnRH antagonist|gnrh antagonist
5668421|NCT00627406|GnRH agonist|gnrh agonist
5668422|NCT00627406|hCG|hcg
5668423|NCT00627406|OHSS|ohss
5668424|NCT00627406|In vitro fertilization|in vitro fertilization
5668425|NCT00627406|ovulation induction|ovulation induction
5668426|NCT00627406|Clinical pregnancy rate|clinical pregnancy rate
5668427|NCT00627393|Granulocyte Transfusions|granulocyte transfusions
5668428|NCT00627380|HIV|hiv
5668429|NCT00627380|AIDS|aids
5668430|NCT00627380|insulin resistance|insulin resistance
5668431|NCT00627380|diabetes|diabetes
5668432|NCT00627380|dyslipidemia|dyslipidemia
5668433|NCT00627380|visceral adiposity|visceral adiposity
5668434|NCT00627380|subcutaneous adipose wasting|subcutaneous adipose wasting
5668435|NCT00627380|cardiovascular disease|cardiovascular disease
5668436|NCT00627380|hypertension|hypertension
5668437|NCT00627380|endothelial function|endothelial function
5668438|NCT00627380|quality of life|quality of life
5668439|NCT00627380|Complementary Therapies|complementary therapies
5668440|NCT00627367|Acute Pain, Emergency Department, ED, Hydromorphone, Dilaudid Protocolized Nonprotocolized Usual Care|acute pain, emergency department, ed, hydromorphone, dilaudid protocolized nonprotocolized usual care
5668441|NCT00627354|stage IV prostate cancer|stage iv prostate cancer
5668442|NCT00627354|recurrent prostate cancer|recurrent prostate cancer
5668443|NCT00627354|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5668444|NCT00627341|Exposure Therapy|exposure therapy
5668445|NCT00627341|Relapse Prevention|relapse prevention
5668446|NCT00627341|Anorexia Nervosa|anorexia nervosa
5668447|NCT00627328|Physiologic Pacing|physiologic pacing
5668448|NCT00627328|Dual Chamber Pacing|dual chamber pacing
5668449|NCT00627328|Atrioventricular Block|atrioventricular block
5668450|NCT00627328|Bradycardia|bradycardia
5668451|NCT00627328|Sick Sinus Syndrome|sick sinus syndrome
5668452|NCT00627315|Obesity|obesity
5668453|NCT00627315|Insulin Resistance|insulin resistance
5668454|NCT00627315|Bariatric Surgery|bariatric surgery
5668455|NCT00627315|Gastric Banding|gastric banding
5668460|NCT00627289|neuropathic pain|neuropathic pain
5668461|NCT00627289|chronic postoperative pain|chronic postoperative pain
5668462|NCT00627289|Postherniotomy pain|postherniotomy pain
5668463|NCT00627289|Neuroplastic changes|neuroplastic changes
5668464|NCT00627276|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5668465|NCT00627276|atypical ductal breast hyperplasia|atypical ductal breast hyperplasia
5668466|NCT00627263|ICD|icd
5668467|NCT00627263|Cardiac Arrhythmia|cardiac arrhythmia
5668468|NCT00627263|Arrhythmia|arrhythmia
5668469|NCT00627263|Stress|stress
5668470|NCT00627263|Anger|anger
5668471|NCT00627250|Irritability|irritability
5668472|NCT00627250|Aggression|aggression
5668474|NCT00627250|Amantadine|amantadine
5668475|NCT00627250|Irritability and Aggression Due to Traumatic Brain Injury|irritability and aggression due to traumatic brain injury
5668476|NCT00627237|Brain Injuries|brain injuries
5668477|NCT00627237|Cognitive Rehabilitation|cognitive rehabilitation
5668478|NCT00627237|Executive Functioning|executive functioning
5668479|NCT00627211|quality assessment|quality assessment
5668480|NCT00627211|pain reduction|pain reduction
5668481|NCT00627211|gastroscopy|gastroscopy
5685573|NCT00555542|B-cell|b-cell
5668482|NCT00627211|carbondioxide insufflation|carbondioxide insufflation
5668483|NCT00627211|Patient satisfaction|patient satisfaction
5668484|NCT00627185|Tobacco control|tobacco control
5668485|NCT00627185|Tobacco cessation|tobacco cessation
5668486|NCT00627185|Tobacco use|tobacco use
5668487|NCT00627172|Coronary artery disease|coronary artery disease
5668489|NCT00627172|Positron emission tomography|positron emission tomography
5668490|NCT00627172|Ultrasound|ultrasound
5668491|NCT00627159|community-based|community-based
5668492|NCT00627159|culturally-sensitive|culturally-sensitive
5668493|NCT00627159|high risk assessment|high risk assessment
5668494|NCT00627159|education classes|education classes
5668495|NCT00627159|cardiovascular risk profile|cardiovascular risk profile
5668496|NCT00627159|Indo-Asian population|indo-asian population
5668497|NCT00627146|Diabetes Mellitus, type 1|diabetes mellitus, type 1
5668498|NCT00627146|ChAgly CD3|chagly cd3
5668499|NCT00627133|Alcohol seizure|alcohol seizure
5668500|NCT00627120|healthy volunteers|healthy volunteers
5668501|NCT00627107|ReWalk, Paraplegia, SCI|rewalk, paraplegia, sci
5668502|NCT00627068|cardiovascular|cardiovascular
5668503|NCT00627068|vasodilation|vasodilation
5668504|NCT00627068|endothelium|endothelium
5668505|NCT00627068|Subjects with high cardiovascular risk|subjects with high cardiovascular risk
5668506|NCT00627055|Second line antiretroviral therapy|second line antiretroviral therapy
5668507|NCT00627055|HIV genotypic resistance|hiv genotypic resistance
5668508|NCT00627055|Kaletra monotherapy|kaletra monotherapy
5668509|NCT00627055|Thailand|thailand
5668510|NCT00627055|48-week efficacy and safety between 2 NRTIs plus lopinavir/ritonavir (LPV/r) and LPV/r monotherapy in patients failing a standard NNRTI-based treatment regimen|48-week efficacy and safety between 2 nrtis plus lopinavir/ritonavir (lpv/r) and lpv/r monotherapy in patients failing a standard nnrti-based treatment regimen
5668511|NCT00627055|treatment experienced|treatment experienced
5668512|NCT00627042|Liver disease|liver disease
5668513|NCT00627042|Neoplasms|neoplasms
5668514|NCT00627042|Liver neoplasms|liver neoplasms
5668515|NCT00627042|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5668516|NCT00627029|Care coordination|care coordination
5668517|NCT00627029|Disease management|disease management
5668518|NCT00627029|Medicare|medicare
5668519|NCT00627029|Fee-for-service|fee-for-service
5668520|NCT00627029|Random assignment|random assignment
5668521|NCT00627029|Elderly|elderly
5668522|NCT00627016|Non-Erosive Gastroesophageal Reflux Disease|non-erosive gastroesophageal reflux disease
5668523|NCT00627016|GERD|gerd
5668524|NCT00627016|heartburn|heartburn
5668525|NCT00627016|sleep disturbance|sleep disturbance
5668526|NCT00627016|nocturnal Reflux|nocturnal reflux
5668527|NCT00626990|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5668528|NCT00626990|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5668529|NCT00626977|Analgesia|analgesia
5668530|NCT00626977|Obstetrical|obstetrical
5668531|NCT00626977|Anesthesia|anesthesia
5668532|NCT00626977|Epidural|epidural
5668533|NCT00626977|Newborn|newborn
5668534|NCT00626977|Anesthetics, local|anesthetics, local
5668535|NCT00626977|Clonidine|clonidine
5668536|NCT00626977|Pregnant women|pregnant women
5668537|NCT00626977|Infant, newborn|infant, newborn
5668538|NCT00626964|Arterial stiffness|arterial stiffness
5668539|NCT00626964|PulseWave velocity|pulsewave velocity
5668540|NCT00626964|Body composition|body composition
5847698|NCT00038480|Lopinavir|lopinavir
5668548|NCT00626964|Bariatric Surgery|bariatric surgery
5668549|NCT00626964|Low Energy Diet|low energy diet
5668550|NCT00626951|LMA Supreme|lma supreme
5668551|NCT00626951|LMA ProSeal|lma proseal
5668552|NCT00626951|Laryngeal mask airway|laryngeal mask airway
5668553|NCT00626951|Ventilation|ventilation
5668554|NCT00626938|sarcoidosis|sarcoidosis
5668555|NCT00626938|protein profile|protein profile
5668556|NCT00626938|CYP-450|cyp-450
5668557|NCT00626938|TNF-alpha polymorphisms|tnf-alpha polymorphisms
5668559|NCT00626925|Randomized Trial|randomized trial
5668560|NCT00626925|Medication for Heavy Drinking|medication for heavy drinking
5668561|NCT00626925|Topiramate Treatment|topiramate treatment
5668562|NCT00626912|large aneurysm|large aneurysm
5668563|NCT00626912|recurrence|recurrence
5668564|NCT00626912|hydrocoil|hydrocoil
5668565|NCT00626899|Validation of Cardiac Output measurement in hypothermic patients|validation of cardiac output measurement in hypothermic patients
5668566|NCT00626886|Herniorrhaphy|herniorrhaphy
5668567|NCT00626886|Inguinal Hernia Repair|inguinal hernia repair
5668568|NCT00626886|Postoperative pain|postoperative pain
5668569|NCT00626873|ovarian germ cell tumor|ovarian germ cell tumor
5668570|NCT00626873|ovarian epithelial cancer|ovarian epithelial cancer
5668571|NCT00626860|melanoma|melanoma
5668572|NCT00626847|primary open angle glaucoma|primary open angle glaucoma
5668573|NCT00626847|Nuclear Genetics|nuclear genetics
5668574|NCT00626847|Mitochondrial DNA|mitochondrial dna
5668575|NCT00626847|POAG|poag
5668576|NCT00626834|cocaine addiction|cocaine addiction
5668577|NCT00626834|vigabatrin|vigabatrin
5668578|NCT00626834|ovation pharmaceuticals|ovation pharmaceuticals
5668579|NCT00626834|cocaine|cocaine
5668580|NCT00626834|cocaine related disorders|cocaine related disorders
5668581|NCT00626834|behavior addictive|behavior addictive
5668582|NCT00626834|mental disorders|mental disorders
5668583|NCT00626834|therapeutic uses|therapeutic uses
5668584|NCT00626834|physiologic effects of drugs|physiologic effects of drugs
5668585|NCT00626834|disorder of environmental origin|disorder of environmental origin
5668586|NCT00626834|central nervous system stimulants|central nervous system stimulants
5668587|NCT00626834|central nervous system agents|central nervous system agents
5668588|NCT00626834|pharmacological actions|pharmacological actions
5668589|NCT00626834|substance related disorders|substance related disorders
5668590|NCT00626821|Stoma|stoma
5668591|NCT00626821|Ostomy|ostomy
5668592|NCT00626782|glaucoma|glaucoma
5668593|NCT00626782|glucoma filtering surgery|glucoma filtering surgery
5668594|NCT00626782|ranibizumab|ranibizumab
5668595|NCT00626782|mitomycin C|mitomycin c
5668596|NCT00626782|patients requiring first time glaucoma filtering surgery|patients requiring first time glaucoma filtering surgery
5668597|NCT00626769|Genistein|genistein
5668598|NCT00626769|Bone mineral density|bone mineral density
5668599|NCT00626769|digital mammography|digital mammography
5668600|NCT00626769|safety|safety
5668601|NCT00626756|fluid|fluid
5668602|NCT00626756|Lidco technology|lidco technology
5668603|NCT00626756|guided therapy|guided therapy
5668604|NCT00626756|fluid management guided by Lidco technology|fluid management guided by lidco technology
5668605|NCT00626730|adult grade II meningioma|adult grade ii meningioma
5668606|NCT00626730|adult grade III meningioma|adult grade iii meningioma
5668607|NCT00626717|Keratoconus|keratoconus
5668608|NCT00626717|Cross linking|cross linking
5668609|NCT00626717|Riboflavin|riboflavin
5668610|NCT00626704|Sarcoma|sarcoma
5668611|NCT00626704|Soft Tissue Sarcoma|soft tissue sarcoma
5668612|NCT00626704|Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma|locally advanced or metastatic, unresectable soft tissue sarcoma
5668613|NCT00626704|AMG 655|amg 655
5668614|NCT00626704|STS|sts
5668615|NCT00626704|Doxorubicin|doxorubicin
5668616|NCT00626704|Death receptor|death receptor
5668617|NCT00626704|TRAIL receptor|trail receptor
5668618|NCT00626704|Apoptosis|apoptosis
5668619|NCT00626691|antioxidant|antioxidant
5668620|NCT00626691|walnut|walnut
5668621|NCT00626691|nutritional status|nutritional status
5668622|NCT00626691|Antioxidant capacity|antioxidant capacity
5668623|NCT00626678|Pemphigus Vulgaris|pemphigus vulgaris
5668624|NCT00626678|Azathioprine|azathioprine
5668625|NCT00626678|Prednisone|prednisone
5668626|NCT00626665|Raynaud disease|raynaud disease
5668627|NCT00626665|Scleroderma|scleroderma
5668628|NCT00626639|palifermin|palifermin
5668629|NCT00626639|Clinical Trial|clinical trial
5668630|NCT00626639|Oncology|oncology
5668631|NCT00626639|Head & Neck|head & neck
5668632|NCT00626626|leukemia|leukemia
5668633|NCT00626626|myelodysplastic syndrome|myelodysplastic syndrome
5668634|NCT00626626|chronic myelogenous leukemia|chronic myelogenous leukemia
5668635|NCT00626626|lymphoma|lymphoma
5668636|NCT00626626|mantle cell lymphoma|mantle cell lymphoma
5668637|NCT00626600|Oxycodone Hydrochloride 50mg/mL|oxycodone hydrochloride 50mg/ml
5668638|NCT00626600|Observational|observational
5668639|NCT00626600|Infusion|infusion
5668640|NCT00626600|Severe cancer pain|severe cancer pain
5668641|NCT00626587|Endobronchial ultrasonography|endobronchial ultrasonography
5668642|NCT00626587|Peripheral pulmonary lesions|peripheral pulmonary lesions
5668643|NCT00626587|Transbronchial needle aspiration|transbronchial needle aspiration
5668644|NCT00626587|Probe location|probe location
5668645|NCT00626587|Diagnostic yield|diagnostic yield
5668646|NCT00626587|EBUS guided TBNA for peripheral pulmonary lesions|ebus guided tbna for peripheral pulmonary lesions
5668647|NCT00626574|Epoetin alfa|epoetin alfa
5668648|NCT00626574|aneurysm|aneurysm
5668649|NCT00626574|subarachnoid hemorrhage|subarachnoid hemorrhage
5668650|NCT00626561|Cervical Cancer|cervical cancer
5668651|NCT00626561|Uterine Cancer|uterine cancer
5668653|NCT00626561|Avastin|avastin
5668654|NCT00626561|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5668655|NCT00626561|rhuMAb-VEGF|rhumab-vegf
5668656|NCT00626561|Paclitaxel|paclitaxel
5668657|NCT00626561|Taxol|taxol
5668658|NCT00626548|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5668659|NCT00626548|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5668660|NCT00626548|Endothelin A|endothelin a
5668661|NCT00626548|Endothelin A antagonist|endothelin a antagonist
5668662|NCT00626535|Symptomatic Gastroesophageal Reflux Disease (sGERD)|symptomatic gastroesophageal reflux disease (sgerd)
5668663|NCT00626535|Nexium|nexium
5668664|NCT00626535|Esomeprazole|esomeprazole
5668665|NCT00626522|Bronchitis|bronchitis
5668666|NCT00626522|Chronic|chronic
5668667|NCT00626522|Emphysema|emphysema
5668668|NCT00626522|Smokers or ex-Smokers|smokers or ex-smokers
5668669|NCT00626509|stage IV renal cell cancer|stage iv renal cell cancer
5668670|NCT00626483|adult giant cell glioblastoma|adult giant cell glioblastoma
5668671|NCT00626483|adult gliosarcoma|adult gliosarcoma
5668672|NCT00626470|Trochanter|trochanter
5668673|NCT00626470|Femur|femur
5668674|NCT00626470|Fracture|fracture
5668675|NCT00626431|Lupron Depot|lupron depot
5668676|NCT00626431|prostate cancer|prostate cancer
5668677|NCT00626431|leuprolide acetate|leuprolide acetate
5668678|NCT00626405|stage IV melanoma|stage iv melanoma
5668679|NCT00626379|Coronary Heart Disease|coronary heart disease
5668680|NCT00626379|Subclinical Atherosclerosis|subclinical atherosclerosis
5668681|NCT00626379|CVD-Related Markers of Inflammation|cvd-related markers of inflammation
5668682|NCT00626379|Mortality|mortality
5668683|NCT00626366|Nasal Spray|nasal spray
5668684|NCT00626366|Nasal Drop|nasal drop
5668685|NCT00626366|Intranasal Medication|intranasal medication
5668686|NCT00626353|Stroke|stroke
5668687|NCT00626353|rehabilitation|rehabilitation
5668688|NCT00626353|motor recovery|motor recovery
5668689|NCT00626353|cognition|cognition
5668690|NCT00626353|quality of life|quality of life
5668691|NCT00626340|menopause|menopause
5668692|NCT00626340|women|women
5668693|NCT00626340|major depressive disorder|major depressive disorder
5668694|NCT00626340|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5668695|NCT00626327|vaccine|vaccine
5668696|NCT00626327|toddlers|toddlers
5668697|NCT00626327|healthy|healthy
5668698|NCT00626327|meningitis|meningitis
5668699|NCT00626327|meningococcal|meningococcal
5668700|NCT00626327|measles|measles
5668701|NCT00626327|mumps|mumps
5668702|NCT00626327|rubella|rubella
5668703|NCT00626327|varicella|varicella
5668704|NCT00626327|Prevention of Meningococcal disease types ACWY|prevention of meningococcal disease types acwy
5668705|NCT00626301|efficacy|efficacy
5668706|NCT00626301|safety|safety
5668707|NCT00626301|pharmacokinetics|pharmacokinetics
5668708|NCT00626301|LPV/r monotherapy|lpv/r monotherapy
5668709|NCT00626301|Thai children|thai children
5668710|NCT00626301|efficacy safety LPV/r monotherapy maintenance|efficacy safety lpv/r monotherapy maintenance
5668711|NCT00626301|treatment experienced|treatment experienced
5668712|NCT00626288|Mesalazine in Irritable Bowel Syndrome|mesalazine in irritable bowel syndrome
5668713|NCT00626275|Rheumatoid arthritis|rheumatoid arthritis
5668714|NCT00626275|arthritis|arthritis
5668715|NCT00626262|Gastroesophageal reflux disease|gastroesophageal reflux disease
5668716|NCT00626262|Nexium|nexium
5668717|NCT00626262|Esomeprazole|esomeprazole
5668718|NCT00626262|Administration methods.|administration methods.
5668719|NCT00626249|Nephropathy|nephropathy
5668720|NCT00626249|Kidney Disease|kidney disease
5668721|NCT00626249|Diabetic|diabetic
5668722|NCT00626249|Renal|renal
5668723|NCT00626249|Diabetics|diabetics
5668724|NCT00626236|ADHD and conduct problems|adhd and conduct problems
5668725|NCT00626223|ESRD patients|esrd patients
5668726|NCT00626223|C-reactive protein|c-reactive protein
5668727|NCT00626223|homocysteine|homocysteine
5668728|NCT00626223|5-MTHF|5-mthf
5668729|NCT00626223|survival|survival
5668730|NCT00626223|Hemodialysis patients|hemodialysis patients
5847699|NCT00038480|HIV-1|hiv-1
5668731|NCT00626210|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5668732|NCT00626210|Sleep|sleep
5668733|NCT00626210|Fatigue|fatigue
5668734|NCT00626210|Memory|memory
5668736|NCT00626197|Lupus|lupus
5668737|NCT00626197|BELONG|belong
5668738|NCT00626184|Celiac Disease|celiac disease
5668739|NCT00626171|smoking|smoking
5668740|NCT00626171|asthma|asthma
5668741|NCT00626171|sputum|sputum
5668742|NCT00626158|pancreatic cancer|pancreatic cancer
5668743|NCT00626158|biliary cancer|biliary cancer
5668744|NCT00626158|gemcitabine|gemcitabine
5668745|NCT00626158|capecitabine|capecitabine
5668746|NCT00626145|BMMNC|bmmnc
5668747|NCT00626145|STEMI|stemi
5668748|NCT00626145|stem cell|stem cell
5668749|NCT00626145|intracoronary delivery|intracoronary delivery
5668750|NCT00626132|Blood pressure|blood pressure
5668751|NCT00626132|Herbs|herbs
5668752|NCT00626132|Food|food
5668753|NCT00626119|breast cancer|breast cancer
5668754|NCT00626106|postmenopausal|postmenopausal
5668930|NCT00625560|Lamivudine|lamivudine
5668755|NCT00626106|hormone receptor positive|hormone receptor positive
5668757|NCT00626106|metastatic|metastatic
5668758|NCT00626080|Insulin|insulin
5668759|NCT00626080|Detemir|detemir
5668760|NCT00626080|Brain|brain
5668761|NCT00626080|Glucose metabolism|glucose metabolism
5668762|NCT00626067|Travatan Dosing Aid|travatan dosing aid
5668763|NCT00626067|compliance monitoring dispenser|compliance monitoring dispenser
5668764|NCT00626054|Colonoscopy|colonoscopy
5668765|NCT00626054|PEG Solution|peg solution
5668766|NCT00626041|Community pharmacies|community pharmacies
5668767|NCT00626041|Primary care networks|primary care networks
5668768|NCT00626041|Global risk assessment|global risk assessment
5668769|NCT00626041|Blood pressure screening|blood pressure screening
5668770|NCT00626028|Pulmonary Vasculature|pulmonary vasculature
5668771|NCT00626028|Nitric Oxide|nitric oxide
5668772|NCT00626028|INOmax®|inomax®
5668773|NCT00626028|Acute Lung Injury|acute lung injury
5668774|NCT00626028|Pulmonary Vasodilator Testing|pulmonary vasodilator testing
5668775|NCT00626028|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5668776|NCT00626028|Congenital Heart Disease|congenital heart disease
5668777|NCT00626028|reversible pulmonary hypertension|reversible pulmonary hypertension
5668778|NCT00626028|vasoreactivity|vasoreactivity
5668779|NCT00626028|Congenital Heart Disease with Pulmonary Hypertension|congenital heart disease with pulmonary hypertension
5668780|NCT00626015|adult glioblastoma|adult glioblastoma
5668781|NCT00626015|adult giant cell glioblastoma|adult giant cell glioblastoma
5668782|NCT00626015|adult gliosarcoma|adult gliosarcoma
5668783|NCT00626015|adult high grade glioma|adult high grade glioma
5668784|NCT00626002|Open label|open label
5668785|NCT00625989|asthma|asthma
5668786|NCT00625989|atopy|atopy
5668787|NCT00625989|allergen challenge|allergen challenge
5668788|NCT00625989|sputum myeloid and plasmacytoid dendritic cells|sputum myeloid and plasmacytoid dendritic cells
5668789|NCT00625976|Complex regional pain syndrome type I|complex regional pain syndrome type i
5668790|NCT00625976|Graded exposure in vivo|graded exposure in vivo
5668791|NCT00625976|Physiotherapy|physiotherapy
5668792|NCT00625976|Pain-related fear|pain-related fear
5668793|NCT00625963|Pulmonary Hypertension;|pulmonary hypertension;
5668794|NCT00625963|ILD;|ild;
5668795|NCT00625963|CT Imaging;|ct imaging;
5668796|NCT00625963|Echocardiogram;|echocardiogram;
5668797|NCT00625963|Hemodynamic measurements of RHC.|hemodynamic measurements of rhc.
5668798|NCT00625963|Pulmonary Function Tests|pulmonary function tests
5668799|NCT00625950|Hyperprolactinemia|hyperprolactinemia
5668800|NCT00625950|Endometriosis|endometriosis
5668801|NCT00625950|laparoscopy|laparoscopy
5668802|NCT00625950|angiogenesis, VEGF|angiogenesis, vegf
5668803|NCT00625937|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5668804|NCT00625937|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5668805|NCT00625937|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5668806|NCT00625937|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5668807|NCT00625937|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5668808|NCT00625937|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5668809|NCT00625937|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5668810|NCT00625937|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5668811|NCT00625937|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5668812|NCT00625937|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5668813|NCT00625937|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5668814|NCT00625937|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5668815|NCT00625937|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5668816|NCT00625937|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5668817|NCT00625937|tongue cancer|tongue cancer
5668818|NCT00625924|Plastic surgery|plastic surgery
5668821|NCT00625911|minimally invasive direct coronary artery bypass|minimally invasive direct coronary artery bypass
5668822|NCT00625911|ketamine|ketamine
5668823|NCT00625911|pain|pain
5668824|NCT00625898|HER2 positive breast cancer|her2 positive breast cancer
5668825|NCT00625898|invasive breast cancer|invasive breast cancer
5668826|NCT00625898|bevacizumab|bevacizumab
5668827|NCT00625898|NSABP|nsabp
5668828|NCT00625898|Roche|roche
5668829|NCT00625898|CIRG|cirg
5668830|NCT00625898|trastuzumab|trastuzumab
5668831|NCT00625898|cyclophosphamide|cyclophosphamide
5668832|NCT00625898|docetaxel|docetaxel
5668833|NCT00625898|carboplatin|carboplatin
5668834|NCT00625898|5-fluorouracil|5-fluorouracil
5668835|NCT00625898|epirubicin|epirubicin
5668836|NCT00625885|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
5668837|NCT00625885|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
5668838|NCT00625885|Knee injuries/surgery|knee injuries/surgery
5668839|NCT00625885|Outcomes research|outcomes research
5668840|NCT00625885|Prospective Studies|prospective studies
5668841|NCT00625859|pharmacodynamics|pharmacodynamics
5668842|NCT00625859|Healthy adult male volunteers,|healthy adult male volunteers,
5668843|NCT00625859|pharmacokinetics,|pharmacokinetics,
5668845|NCT00625820|Albuminuria|albuminuria
5668846|NCT00625820|Glomerular filtration rate|glomerular filtration rate
5668849|NCT00625807|stress reduction|stress reduction
5668850|NCT00625807|fMRI|fmri
5668851|NCT00625807|behavioral|behavioral
5668852|NCT00625781|Gestational diabetes mellitus|gestational diabetes mellitus
5668853|NCT00625781|Impaired glucose Tolerance|impaired glucose tolerance
5668854|NCT00625781|Pregnancy|pregnancy
5668855|NCT00625781|Fetal macrosomia|fetal macrosomia
5668856|NCT00625781|Treatment|treatment
5668857|NCT00625781|Perinatal morbidity|perinatal morbidity
5668858|NCT00625768|Antibody|antibody
5668859|NCT00625768|safety|safety
5668860|NCT00625768|tolerability|tolerability
5668861|NCT00625768|efficacy|efficacy
5668862|NCT00625768|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5668863|NCT00625768|metastatic malignant melanoma|metastatic malignant melanoma
5668864|NCT00625755|renal cell carcinoma|renal cell carcinoma
5668865|NCT00625755|AJCC Stage IV (primary or relasped) renal cell carcinoma|ajcc stage iv (primary or relasped) renal cell carcinoma
5668866|NCT00625742|Advanced Cancer|advanced cancer
5668867|NCT00625742|Cancer Cachexia|cancer cachexia
5668868|NCT00625742|Cachexia|cachexia
5668869|NCT00625742|Melatonin|melatonin
5668870|NCT00625742|Juven|juven
5668871|NCT00625742|Exercise Training|exercise training
5668872|NCT00625742|Weight Loss|weight loss
5668873|NCT00625729|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5668874|NCT00625729|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5668875|NCT00625729|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5668876|NCT00625729|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5668877|NCT00625729|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5668878|NCT00625729|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5668879|NCT00625729|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5668880|NCT00625729|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5668881|NCT00625729|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5668882|NCT00625729|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5668883|NCT00625729|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5668884|NCT00625729|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5668885|NCT00625729|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5668886|NCT00625729|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5668887|NCT00625729|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5668888|NCT00625729|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5668889|NCT00625703|Pharmacokinetic|pharmacokinetic
5668890|NCT00625690|lung cancer|lung cancer
5668891|NCT00625677|meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5668892|NCT00625677|reduced dose|reduced dose
5668893|NCT00625677|meningococcal serogroup C conjugate vaccine|meningococcal serogroup c conjugate vaccine
5668894|NCT00625677|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5668895|NCT00625664|Cancer|cancer
5668896|NCT00625664|Neoplasms|neoplasms
5668897|NCT00625664|Bladder|bladder
5668898|NCT00625664|Urothelial Tract|urothelial tract
5668899|NCT00625651|Colon Cancer|colon cancer
5668900|NCT00625651|Colorectal Cancer|colorectal cancer
5668901|NCT00625651|Rectal Cancer|rectal cancer
5668902|NCT00625651|AMG 655|amg 655
5668903|NCT00625651|Bevacizumab|bevacizumab
5668904|NCT00625651|Modified FOLFOX6|modified folfox6
5668905|NCT00625651|mFOLFOX6|mfolfox6
5668906|NCT00625651|FOLFOX|folfox
5668907|NCT00625638|Advanced Cancer|advanced cancer
5668908|NCT00625638|Caregiver|caregiver
5668909|NCT00625638|Interactive Voice Response|interactive voice response
5668910|NCT00625638|Symptom Control|symptom control
5668911|NCT00625638|IVR System|ivr system
5668912|NCT00625638|Questionnaire|questionnaire
5668913|NCT00625625|stage I colon cancer|stage i colon cancer
5668914|NCT00625625|stage II colon cancer|stage ii colon cancer
5668915|NCT00625625|stage III colon cancer|stage iii colon cancer
5668916|NCT00625625|stage I rectal cancer|stage i rectal cancer
5668917|NCT00625625|stage II rectal cancer|stage ii rectal cancer
5668918|NCT00625625|stage III rectal cancer|stage iii rectal cancer
5668919|NCT00625586|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5668920|NCT00625586|stage IV pancreatic cancer|stage iv pancreatic cancer
5668921|NCT00625586|recurrent pancreatic cancer|recurrent pancreatic cancer
5668922|NCT00625573|Colon Cancer|colon cancer
5668923|NCT00625573|Abraxis Oncology|abraxis oncology
5668924|NCT00625573|Abraxane|abraxane
5668925|NCT00625573|Phase II|phase ii
5668926|NCT00625573|Colorectal|colorectal
5668927|NCT00625573|Mt. Sinai Medical Center|mt. sinai medical center
5668928|NCT00625573|CCOP|ccop
5668929|NCT00625560|Chronic hepatitis B|chronic hepatitis b
5668931|NCT00625560|Entecavir|entecavir
5668933|NCT00625534|Laparoscopy|laparoscopy
5668934|NCT00625534|Pain|pain
5668935|NCT00625534|Sexual|sexual
5668936|NCT00625534|Quality|quality
5668937|NCT00625521|Discoid lupus erythematosus|discoid lupus erythematosus
5668938|NCT00625495|Gastroesophageal reflux disease|gastroesophageal reflux disease
5668939|NCT00625495|Nexium|nexium
5668940|NCT00625495|Esomeprazole|esomeprazole
5668941|NCT00625495|Administration methods.|administration methods.
5668942|NCT00625482|BCG vaccine|bcg vaccine
5668943|NCT00625482|Oral polio vaccine|oral polio vaccine
5668944|NCT00625482|Vitamin A supplementation|vitamin a supplementation
5668945|NCT00625482|Low-birth-weigth|low-birth-weigth
5668946|NCT00625482|Sex-differential|sex-differential
5668947|NCT00625482|Prevention|prevention
5668948|NCT00625482|Immunological parameters|immunological parameters
5668949|NCT00625469|pulmonary arterial hypertension|pulmonary arterial hypertension
5668950|NCT00625469|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5668951|NCT00625469|bosentan|bosentan
5668952|NCT00625456|phase I|phase i
5668953|NCT00625456|advanced metastatic solid tumors|advanced metastatic solid tumors
5668954|NCT00625456|oncolytic virus|oncolytic virus
5668955|NCT00625456|vaccinia virus|vaccinia virus
5668956|NCT00625456|melanoma|melanoma
5668957|NCT00625456|lung cancer|lung cancer
5668958|NCT00625456|renal cell carcinoma|renal cell carcinoma
5685574|NCT00555542|rituximab|rituximab
5668959|NCT00625456|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5668960|NCT00625456|Pexa-Vec|pexa-vec
5668961|NCT00625443|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5668963|NCT00625443|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5668964|NCT00625430|Prostate Cancer|prostate cancer
5668965|NCT00625430|Gene Therapy|gene therapy
5668966|NCT00625430|Fludarabine|fludarabine
5668967|NCT00625430|Adenovirus|adenovirus
5668968|NCT00625430|phase I|phase i
5668969|NCT00625417|male breast cancer|male breast cancer
5668970|NCT00625417|stage IA breast cancer|stage ia breast cancer
5668971|NCT00625417|stage IB breast cancer|stage ib breast cancer
5668972|NCT00625417|stage II breast cancer|stage ii breast cancer
5668973|NCT00625417|stage IIIA breast cancer|stage iiia breast cancer
5668974|NCT00625417|stage IIIB breast cancer|stage iiib breast cancer
5668975|NCT00625417|stage IIIC breast cancer|stage iiic breast cancer
5668976|NCT00625417|stage IV breast cancer|stage iv breast cancer
5668977|NCT00625404|Aspartate Aminotransferase (AST)|aspartate aminotransferase (ast)
5668978|NCT00625404|Alanine Aminotransferase (ALT)|alanine aminotransferase (alt)
5668979|NCT00625404|HIV|hiv
5668980|NCT00625404|HIV Prevention|hiv prevention
5668981|NCT00625404|Oral PrEP|oral prep
5668982|NCT00625404|Truvada|truvada
5668983|NCT00625404|women|women
5668984|NCT00625404|Tenofovir|tenofovir
5668985|NCT00625404|TDF|tdf
5668986|NCT00625404|FTC|ftc
5668987|NCT00625404|emtricitabine|emtricitabine
5668988|NCT00625404|hepatitis|hepatitis
5668989|NCT00625404|Pre-exposure Prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5668990|NCT00625404|HIV Seronegativity|hiv seronegativity
5668991|NCT00625391|postmenopausal, bone, dietary supplement, mind-body exercise|postmenopausal, bone, dietary supplement, mind-body exercise
5668992|NCT00625378|Cancer|cancer
5668993|NCT00625378|Sorafenib|sorafenib
5668994|NCT00625378|Extension program|extension program
5668995|NCT00625365|DEFINITY|definity
5668996|NCT00625365|Safety|safety
5668997|NCT00625365|Survelliance|survelliance
5668998|NCT00625352|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5668999|NCT00625352|Aged|aged
5669000|NCT00625352|Gemcitabine|gemcitabine
5669001|NCT00625352|UFT|uft
5669002|NCT00625339|Chronic hepatitis B|chronic hepatitis b
5669003|NCT00625339|Lamivudine|lamivudine
5669004|NCT00625339|Entecavir|entecavir
5669005|NCT00625326|psoriasis|psoriasis
5669006|NCT00625313|Cataract|cataract
5669007|NCT00625313|aphakia|aphakia
5669008|NCT00625313|intraocular lens|intraocular lens
5669009|NCT00625313|IOL|iol
5669010|NCT00625313|Optical correction of aphakia|optical correction of aphakia
5669011|NCT00625300|repetitive transcranial stimulation|repetitive transcranial stimulation
5669012|NCT00625300|Parkinson's Disease|parkinson's disease
5669014|NCT00625274|esomeprazole|esomeprazole
5669015|NCT00625274|lansoprazole|lansoprazole
5669016|NCT00625274|pantoprazole|pantoprazole
5669017|NCT00625274|Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
5669018|NCT00625261|Language delay|language delay
5669019|NCT00625261|Speech and language disorders|speech and language disorders
5669020|NCT00625261|Early language intervention|early language intervention
5669021|NCT00625261|Parent-based language intervention|parent-based language intervention
5669022|NCT00625235|Obesity|obesity
5669023|NCT00625235|Weight loss|weight loss
5669024|NCT00625235|Weight maintenance|weight maintenance
5669025|NCT00625235|VLED|vled
5669026|NCT00625222|Electroencephalography|electroencephalography
5669027|NCT00625222|Seizure frequency|seizure frequency
5669028|NCT00625222|Seizure severity|seizure severity
5669029|NCT00625209|septic shock|septic shock
5669030|NCT00625209|coagulation|coagulation
5669031|NCT00625209|immunomodulation|immunomodulation
5669032|NCT00625209|survival|survival
5669033|NCT00625196|Healthy Japanese volunteers|healthy japanese volunteers
5669034|NCT00625183|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5669035|NCT00625183|stage II rectal cancer|stage ii rectal cancer
5669036|NCT00625183|stage III rectal cancer|stage iii rectal cancer
5669037|NCT00625170|Antipsychotics|antipsychotics
5669038|NCT00625170|Olanzapine|olanzapine
5669039|NCT00625170|Haloperidol|haloperidol
5669040|NCT00625170|Insulin resistance|insulin resistance
5669041|NCT00625170|Dyslipidemia|dyslipidemia
5669042|NCT00625131|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5669043|NCT00625131|Tobacco Use Disorder|tobacco use disorder
5669044|NCT00625118|Hib conjugate vaccine|hib conjugate vaccine
5669045|NCT00625118|reactogenicity|reactogenicity
5669046|NCT00625118|local reactions|local reactions
5669047|NCT00625118|systemic symptoms|systemic symptoms
5669048|NCT00625092|peritoneal cavity cancer|peritoneal cavity cancer
5669049|NCT00625079|pulmonary hypertension|pulmonary hypertension
5669050|NCT00625079|pulmonary arterial hypertension|pulmonary arterial hypertension
5669051|NCT00625079|interstitial lung disease|interstitial lung disease
5669052|NCT00625079|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5669053|NCT00625066|precancerous condition|precancerous condition
5669054|NCT00625066|colon cancer|colon cancer
5669055|NCT00625066|rectal cancer|rectal cancer
5669056|NCT00625053|Neuroticism|neuroticism
5669057|NCT00625053|Hernia, ventral|hernia, ventral
5669058|NCT00625053|Laparoscopy|laparoscopy
5669059|NCT00625053|Quality of life|quality of life
5669060|NCT00625040|Incretin effect|incretin effect
5669061|NCT00625040|Gastric banding|gastric banding
5669062|NCT00625040|Glucagon|glucagon
5669063|NCT00625040|Glucagon-Like Peptide 1|glucagon-like peptide 1
5669064|NCT00625040|Gastric Inhibitory Peptide|gastric inhibitory peptide
5669065|NCT00625040|Glucose Intestinal Peptide|glucose intestinal peptide
5669066|NCT00625040|Insulin|insulin
5669067|NCT00625040|C-peptide|c-peptide
5669068|NCT00625027|Emergency Department Visit|emergency department visit
5669069|NCT00625027|Telehealth Ontario|telehealth ontario
5669070|NCT00625027|Triage Levels|triage levels
5669071|NCT00625014|Insulin resistance|insulin resistance
5669072|NCT00625014|Dyslipidemia|dyslipidemia
5669073|NCT00625014|Haloperidol|haloperidol
5669074|NCT00625001|Turner Syndrome|turner syndrome
5669075|NCT00625001|bone mineral density|bone mineral density
5669076|NCT00625001|estrogen replacement therapy|estrogen replacement therapy
5669077|NCT00625001|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5669078|NCT00624988|Spinal cord injury|spinal cord injury
5669079|NCT00624988|vibration therapy|vibration therapy
5669080|NCT00624988|bone density|bone density
5669081|NCT00624962|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5669082|NCT00624962|neuroblastoma|neuroblastoma
5669083|NCT00624962|childhood hepatoblastoma|childhood hepatoblastoma
5669084|NCT00624962|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5669085|NCT00624962|childhood ependymoma|childhood ependymoma
5669086|NCT00624962|childhood brain stem glioma|childhood brain stem glioma
5669087|NCT00624962|childhood meningioma|childhood meningioma
5669088|NCT00624962|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5669089|NCT00624962|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5669090|NCT00624962|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5669091|NCT00624962|central nervous system neoplasm|central nervous system neoplasm
5669092|NCT00624962|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5669093|NCT00624962|childhood brain tumor|childhood brain tumor
5669094|NCT00624962|childhood medulloblastoma|childhood medulloblastoma
5669095|NCT00624949|Turner syndrome|turner syndrome
5669096|NCT00624949|aortic dimensions|aortic dimensions
5669097|NCT00624949|blood pressure|blood pressure
5669098|NCT00624949|aortic dilatation|aortic dilatation
5669099|NCT00624949|aortic rupture|aortic rupture
5669100|NCT00624936|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5669101|NCT00624936|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5669102|NCT00624936|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5669103|NCT00624936|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5669104|NCT00624936|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5669105|NCT00624936|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5669106|NCT00624936|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5669107|NCT00624936|myelodysplastic syndromes|myelodysplastic syndromes
5669108|NCT00624936|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5669109|NCT00624923|Coronary Artery Disease|coronary artery disease
5669110|NCT00624923|Inflammation|inflammation
5669111|NCT00624923|Overweight|overweight
5669112|NCT00624923|Metabolic Syndrome|metabolic syndrome
5669113|NCT00624923|Salsalate|salsalate
5669114|NCT00624910|Post Operative Pain|post operative pain
5669115|NCT00624910|Hysterectomy|hysterectomy
5669116|NCT00624884|Aortic regurgitation,velocity vector imaging|aortic regurgitation,velocity vector imaging
5669117|NCT00624871|Interleukin 1-beta|interleukin 1-beta
5669118|NCT00624871|Interleukin 6|interleukin 6
5669119|NCT00624871|Vitamin C|vitamin c
5669121|NCT00624871|neonates|neonates
5669122|NCT00624858|Depression|depression
5669123|NCT00624858|depressed|depressed
5669124|NCT00624858|overweight|overweight
5669125|NCT00624858|obese|obese
5669126|NCT00624845|Meniscectomy|meniscectomy
5669127|NCT00624832|Asthma|asthma
5669128|NCT00624832|allergen challenge|allergen challenge
5669129|NCT00624832|bronchoprovocation|bronchoprovocation
5669130|NCT00624832|Methacholine challenge|methacholine challenge
5669131|NCT00624832|serum Immunoglobulin E|serum immunoglobulin e
5669132|NCT00624832|Nitric Oxide|nitric oxide
5669133|NCT00624832|skin prick test|skin prick test
5669134|NCT00624819|Streptococcus pneumoniae|streptococcus pneumoniae
5669135|NCT00624819|Haemophilus influenzae|haemophilus influenzae
5669136|NCT00624819|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5669137|NCT00624819|Antibody persistence|antibody persistence
5669138|NCT00624806|Pressure ulcer|pressure ulcer
5669139|NCT00624806|Telemedicine|telemedicine
5669140|NCT00624793|Nausea|nausea
5669141|NCT00624793|Vomiting|vomiting
5669142|NCT00624793|Retching|retching
5669143|NCT00624793|HIV/AIDS|hiv/aids
5669144|NCT00624793|Symptom Management|symptom management
5669145|NCT00624793|Complementary Therapies|complementary therapies
5669146|NCT00624767|insulin|insulin
5669147|NCT00624767|insulin aspart|insulin aspart
5669148|NCT00624767|Type 2 Diabetes|type 2 diabetes
5669149|NCT00624767|diabetes mellitus|diabetes mellitus
5669150|NCT00624754|Obstructive airway disease|obstructive airway disease
5669151|NCT00624754|bronchiolitis obliterans|bronchiolitis obliterans
5669152|NCT00624754|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5669153|NCT00624754|bone marrow transplantation|bone marrow transplantation
5669154|NCT00624754|inhaled treatment|inhaled treatment
5669155|NCT00624754|Budesonide Formoterol|budesonide formoterol
5669156|NCT00624741|Parkinson's disease|parkinson's disease
5669157|NCT00624741|Antiparkinsonian|antiparkinsonian
5669158|NCT00624741|Compassionate use|compassionate use
5669159|NCT00624728|Positron-Emission Tomography|positron-emission tomography
5669160|NCT00624728|Alovudine [Substance Name]|alovudine [substance name]
5669161|NCT00624728|18F-FLT|18f-flt
5669162|NCT00624728|Magnetic Resonance Imaging|magnetic resonance imaging
5669163|NCT00624728|Astrocytoma|astrocytoma
5669164|NCT00624728|Glioblastoma|glioblastoma
5669165|NCT00624702|Asthma, cough, spirometry, maleate, xinafoate, acetate, SDDPI (single dose dry powder inhaler)|asthma, cough, spirometry, maleate, xinafoate, acetate, sddpi (single dose dry powder inhaler)
5669166|NCT00624689|Body composition|body composition
5669167|NCT00624689|Glucose tolerance|glucose tolerance
5669168|NCT00624689|Intima-media thickness|intima-media thickness
5669169|NCT00624689|Visual acuity|visual acuity
5669170|NCT00624689|Neurological development|neurological development
5669171|NCT00624676|Acne|acne
5669172|NCT00624676|lipophilic hydroxy acid|lipophilic hydroxy acid
5669173|NCT00624676|benzoyl peroxide|benzoyl peroxide
5669174|NCT00624663|Rivastigmine, Repeated administration, Healthy Volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects|rivastigmine, repeated administration, healthy volunteers, organophosphate poisoning, protection, pharmacokinetics, behavioral effects
5669175|NCT00624650|Acute Lung Injury|acute lung injury
5669176|NCT00624650|Extravascular Lung Water|extravascular lung water
5669177|NCT00624650|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5669178|NCT00624637|aromatherapy|aromatherapy
5669179|NCT00624637|massage|massage
5669180|NCT00624637|comfort|comfort
5669181|NCT00624637|postoperative|postoperative
5669182|NCT00624637|infants|infants
5669183|NCT00624637|craniofacial surgery|craniofacial surgery
5669184|NCT00624624|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5669185|NCT00624624|bariatric surgery|bariatric surgery
5669186|NCT00624624|serum androgen levels|serum androgen levels
5669187|NCT00624624|bone density|bone density
5669189|NCT00624611|red blood cell washing|red blood cell washing
5669191|NCT00624585|MDS/MPD|mds/mpd
5669192|NCT00624585|MDS/AML|mds/aml
5669193|NCT00624585|CMML|cmml
5669194|NCT00624585|Excess Marrow Blasts|excess marrow blasts
5669195|NCT00624572|primary teeth|primary teeth
5669196|NCT00624572|chlorexidine|chlorexidine
5669197|NCT00624572|root canal therapy|root canal therapy
5669198|NCT00624572|Pulpectomy|pulpectomy
5669199|NCT00624559|Salt sensitivity of Blood Pressure|salt sensitivity of blood pressure
5669200|NCT00624546|GERD|gerd
5669201|NCT00624546|gastroesophageal reflux|gastroesophageal reflux
5669202|NCT00624546|antireflux surgery|antireflux surgery
5669203|NCT00624546|Barrett's|barrett's
5669204|NCT00624546|Esophagus|esophagus
5669205|NCT00624546|Esophagitis|esophagitis
5669206|NCT00624533|Low back Pain|low back pain
5669207|NCT00624533|Physical Therapy Modalities|physical therapy modalities
5669208|NCT00624533|Exercise Movement Techniques|exercise movement techniques
5669209|NCT00624533|Primary Health Care|primary health care
5669210|NCT00624520|Stress, Psychological|stress, psychological
5669211|NCT00624520|Tachycardia, Ventricular|tachycardia, ventricular
5669212|NCT00624520|Defibrillators, Implantable|defibrillators, implantable
5669214|NCT00624520|Cognitive Therapy|cognitive therapy
5669215|NCT00624520|Anger|anger
5669216|NCT00624494|venous oxygen saturation|venous oxygen saturation
5669217|NCT00624494|transpulmonary thermodilution|transpulmonary thermodilution
5669218|NCT00624481|osteoporosis|osteoporosis
5669219|NCT00624481|osteopenia|osteopenia
5669220|NCT00624481|bone mineral density|bone mineral density
5669221|NCT00624481|teriparatide|teriparatide
5669222|NCT00624468|atacicept|atacicept
5669223|NCT00624468|neuritis|neuritis
5669224|NCT00624455|Gabapentin|gabapentin
5669225|NCT00624455|tonsillectomy|tonsillectomy
5669226|NCT00624455|post-operative pain|post-operative pain
5669227|NCT00624455|morphine requirements|morphine requirements
5669228|NCT00624455|randomized double blind|randomized double blind
5669229|NCT00624455|adenotonsillectomy|adenotonsillectomy
5669230|NCT00624429|Asthma|asthma
5669231|NCT00624429|Children|children
5669232|NCT00624416|Obesity therapy|obesity therapy
5669234|NCT00624416|drug mechanism|drug mechanism
5669235|NCT00624416|adipose tissue|adipose tissue
5669236|NCT00624416|cellular pharmacology|cellular pharmacology
5669237|NCT00624403|Anesthesia|anesthesia
5669238|NCT00624403|Laryngeal mask airway|laryngeal mask airway
5669239|NCT00624351|Lupus|lupus
5669240|NCT00624351|Monoclonal antibody|monoclonal antibody
5669241|NCT00624351|B-Cell immunotherapy|b-cell immunotherapy
5669242|NCT00624338|Atacicept 75 and 150 mg|atacicept 75 and 150 mg
5669243|NCT00624338|Placebo|placebo
5669244|NCT00624325|genotype 1 nonresponders|genotype 1 nonresponders
5669245|NCT00624312|Procrit|procrit
5669246|NCT00624312|Erythropoietin|erythropoietin
5669247|NCT00624312|Patients undergoing major surgical oncology operations|patients undergoing major surgical oncology operations
5669248|NCT00624299|botox|botox
5669249|NCT00624299|limb reconstructions|limb reconstructions
5669250|NCT00624299|limb reconstruction surgery|limb reconstruction surgery
5669251|NCT00624286|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5669252|NCT00624286|COPD|copd
5669253|NCT00624286|indacaterol|indacaterol
5669254|NCT00624273|digital ulcers,|digital ulcers,
5669255|NCT00624273|systemic sclerosis,|systemic sclerosis,
5669256|NCT00624273|sildenafil,|sildenafil,
5669257|NCT00624273|vasoactive therapies|vasoactive therapies
5669258|NCT00624260|Colorectal cancer|colorectal cancer
5669259|NCT00624260|Recurrence|recurrence
5669260|NCT00624260|Positron Emission Tomography|positron emission tomography
5669261|NCT00624260|Colorectal Cancer with high risk of recurrence stage III|colorectal cancer with high risk of recurrence stage iii
5669262|NCT00624260|Colorectal Cancer with high risk of recurrence stage IV|colorectal cancer with high risk of recurrence stage iv
5669263|NCT00624260|T4N0M0 operated in emergency( because of perforation)|t4n0m0 operated in emergency( because of perforation)
5669264|NCT00624247|routine HIV testing|routine hiv testing
5669265|NCT00624247|jails|jails
5669266|NCT00624247|criminal justice system|criminal justice system
5669267|NCT00624247|substance abuse|substance abuse
5669268|NCT00624247|mental illness|mental illness
5669269|NCT00624247|HIV|hiv
5669270|NCT00624234|neurofibromatosis type 1|neurofibromatosis type 1
5669271|NCT00624234|reading disabilities|reading disabilities
5669272|NCT00624234|NF-1|nf-1
5669273|NCT00624234|learning disabilities|learning disabilities
5669274|NCT00624234|tutoring intervention|tutoring intervention
5669275|NCT00624208|Randomized|randomized
5669276|NCT00624208|double-blind|double-blind
5669277|NCT00624208|4-group clinical interventional study|4-group clinical interventional study
5669278|NCT00624195|HIV Dementia|hiv dementia
5669279|NCT00624195|HAART|haart
5669280|NCT00624195|Cognitive Impairment|cognitive impairment
5669281|NCT00624195|Antiretroviral Regimen|antiretroviral regimen
5669282|NCT00624195|Viral Load|viral load
5669283|NCT00624195|CNS Drug Penetration|cns drug penetration
5669284|NCT00624169|Perforated peptic ulcer|perforated peptic ulcer
5669285|NCT00624169|Mortality|mortality
5669286|NCT00624156|Breast Cancer|breast cancer
5847700|NCT00038480|Drug Therapy, Combination|drug therapy, combination
5669287|NCT00624143|Antifungal prophylaxis, acute leukemia induction,|antifungal prophylaxis, acute leukemia induction,
5669289|NCT00624130|Cycle control,|cycle control,
5669290|NCT00624130|Bleeding pattern|bleeding pattern
5669291|NCT00624117|shoulder joint|shoulder joint
5669292|NCT00624117|recovery of function|recovery of function
5669293|NCT00624117|effectiveness of rehabilitation|effectiveness of rehabilitation
5669294|NCT00624117|rehabilitation|rehabilitation
5669295|NCT00624104|VLDL|vldl
5669296|NCT00624104|Kinetics|kinetics
5669297|NCT00624104|Hyperinsulinaemia|hyperinsulinaemia
5669298|NCT00624104|Obesity|obesity
5669299|NCT00624091|Early-surgery, infective endocarditis, in-hospital mortality|early-surgery, infective endocarditis, in-hospital mortality
5669300|NCT00624078|faboterapics|faboterapics
5669301|NCT00624078|treatment|treatment
5669302|NCT00624078|scorpion sting|scorpion sting
5650327|NCT00700596|Salvia|salvia
5669303|NCT00624078|envenomation|envenomation
5669304|NCT00624065|target blood pressure|target blood pressure
5669305|NCT00624065|hypertension|hypertension
5669306|NCT00624065|COREG CR|coreg cr
5669307|NCT00624065|carvedilol CR|carvedilol cr
5669308|NCT00624065|Stage 1 or 2 essential hypertension|stage 1 or 2 essential hypertension
5669309|NCT00624065|lisinopril|lisinopril
5669310|NCT00624039|presbyopia|presbyopia
5669311|NCT00624013|Diabetes|diabetes
5669312|NCT00624013|Depression|depression
5669313|NCT00624013|diabetes outcomes|diabetes outcomes
5669314|NCT00624013|quality of life|quality of life
5669315|NCT00624000|Ischemic Stroke|ischemic stroke
5669316|NCT00623987|Residual vein thrombosis|residual vein thrombosis
5669317|NCT00623987|Optimal duration|optimal duration
5669318|NCT00623987|Oral anticoagulants|oral anticoagulants
5669319|NCT00623974|Hypocalcemia|hypocalcemia
5669320|NCT00623974|Teriparatide|teriparatide
5669321|NCT00623974|Forteo|forteo
5669322|NCT00623974|Calcium|calcium
5669323|NCT00623974|Calcitriol|calcitriol
5669324|NCT00623974|Rocaltrol|rocaltrol
5669325|NCT00623961|Neuropathic Pain|neuropathic pain
5669326|NCT00623948|Pressure ulcers|pressure ulcers
5669327|NCT00623948|Electrical Stimulation|electrical stimulation
5669328|NCT00623948|Spinal Cord Injury|spinal cord injury
5669330|NCT00623922|Patient education|patient education
5669331|NCT00623922|Nurse consultation|nurse consultation
5669332|NCT00623922|Arthritis|arthritis
5669333|NCT00623922|Wellbeing|wellbeing
5669334|NCT00623922|Coping|coping
5669335|NCT00623922|Health related quality of life|health related quality of life
5669336|NCT00623909|Laser Therapy|laser therapy
5669337|NCT00623909|Post Thoracotomy Pain|post thoracotomy pain
5669338|NCT00623909|AvicennaTM laser|avicennatm laser
5669340|NCT00623896|ST Elevation Myocardial Infarcton|st elevation myocardial infarcton
5669341|NCT00623896|STEMI|stemi
5669342|NCT00623896|ECG|ecg
5669343|NCT00623883|Human Colonic Aberrant Crypt Foci|human colonic aberrant crypt foci
5669344|NCT00623857|Micronutrients|micronutrients
5669345|NCT00623857|Zinc|zinc
5669346|NCT00623857|Vitamins|vitamins
5653569|NCT00688077|Calcitonin|calcitonin
5669347|NCT00623857|Trace elements|trace elements
5669348|NCT00623857|Minerals|minerals
5669349|NCT00623857|Vitamin A|vitamin a
5669350|NCT00623857|Vitamin B1|vitamin b1
5669351|NCT00623857|Vitamin B2|vitamin b2
5669352|NCT00623857|Niacin|niacin
5669353|NCT00623857|Vitamin B6|vitamin b6
5669354|NCT00623857|Folic acid|folic acid
5669355|NCT00623857|Vitamin B12|vitamin b12
5669356|NCT00623857|Vitamin C|vitamin c
5669357|NCT00623857|Vitamin D|vitamin d
5669358|NCT00623857|Vitamin E|vitamin e
5669359|NCT00623857|Vitamin K|vitamin k
5669360|NCT00623857|Iron|iron
5669361|NCT00623857|Iodine|iodine
5669362|NCT00623857|Copper|copper
5669363|NCT00623857|Selenium|selenium
5669364|NCT00623857|Magnesium|magnesium
5669365|NCT00623857|Calcium|calcium
5669366|NCT00623857|Malaria|malaria
5669367|NCT00623857|Immunity|immunity
5669368|NCT00623857|Anthropometry|anthropometry
5669369|NCT00623844|Prevention|prevention
5669370|NCT00623844|Physical activity|physical activity
5669371|NCT00623844|Obesity|obesity
5669372|NCT00623844|Motor skills|motor skills
5669373|NCT00623844|Kindergarten|kindergarten
5669374|NCT00623831|MBV|mbv
5669375|NCT00623831|Mixed Bacterial Vaccine|mixed bacterial vaccine
5669376|NCT00623831|NY-ESO-1|ny-eso-1
5669377|NCT00623818|Mirror Therapy|mirror therapy
5669378|NCT00623818|Phantom Limb Pain|phantom limb pain
5669379|NCT00623818|Amputee|amputee
5669380|NCT00623818|Healthy Volunteer|healthy volunteer
5669381|NCT00623818|HV|hv
5669382|NCT00623792|Morbid obesity|morbid obesity
5669383|NCT00623792|Diet therapy|diet therapy
5669384|NCT00623792|Bariatric Surgery|bariatric surgery
5669385|NCT00623792|Gastric bypass|gastric bypass
5669386|NCT00623792|Behavior therapy|behavior therapy
5669387|NCT00623792|Randomized controlled trial|randomized controlled trial
5669388|NCT00623792|Weight loss|weight loss
5669389|NCT00623753|Vaccine|vaccine
5669390|NCT00623753|Prevention|prevention
5669391|NCT00623753|HIV|hiv
5669392|NCT00623753|AIDS|aids
5669393|NCT00623753|Human Immunodeficiency Virus|human immunodeficiency virus
5669394|NCT00623753|HIV Seronegativity, HIV Preventive Vaccine|hiv seronegativity, hiv preventive vaccine
5669395|NCT00623740|Hydrocortisone|hydrocortisone
5669396|NCT00623740|Very low birth weight|very low birth weight
5669397|NCT00623740|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5669398|NCT00623740|Prevention Cerebral palsy|prevention cerebral palsy
5669399|NCT00623727|Hemophilia A|hemophilia a
5669400|NCT00623727|FVIII disease|fviii disease
5669401|NCT00623727|rFVIII|rfviii
5669402|NCT00623701|sublingual grass pollen preparation|sublingual grass pollen preparation
5669403|NCT00623701|IgE-mediated Allergic Disease attributed to grass pollen|ige-mediated allergic disease attributed to grass pollen
5669404|NCT00623688|Metered Dose Inhalers|metered dose inhalers
5669405|NCT00623688|Nebulizers|nebulizers
5669406|NCT00623688|Randomized Controlled Trial|randomized controlled trial
5669407|NCT00623675|zeolites|zeolites
5669408|NCT00623675|nutraceuticals|nutraceuticals
5669409|NCT00623675|natural supplements|natural supplements
5669410|NCT00623675|Healthy volunteers|healthy volunteers
5669411|NCT00623662|Glucose infusion|glucose infusion
5669412|NCT00623662|Liver function|liver function
5669413|NCT00623662|Liver resection|liver resection
5669414|NCT00623662|Albumin synthesis|albumin synthesis
5669415|NCT00623662|Stable isotopes|stable isotopes
5669416|NCT00623636|Migraine|migraine
5669417|NCT00623610|Diabetes mellitus, type 1|diabetes mellitus, type 1
5669418|NCT00623610|pancreatic beta cell|pancreatic beta cell
5669419|NCT00623610|transplantation|transplantation
5669420|NCT00623584|penetrating keratoplasty|penetrating keratoplasty
5669421|NCT00623584|corneal transplantation|corneal transplantation
5669422|NCT00623584|corneal grafting|corneal grafting
5669423|NCT00623584|corneal grafts|corneal grafts
5669424|NCT00623584|culture media|culture media
5669425|NCT00623584|corneal culturing|corneal culturing
5669426|NCT00623584|in vitro culturing|in vitro culturing
5669427|NCT00623571|frail elderly|frail elderly
5669428|NCT00623571|hospital at home|hospital at home
5669429|NCT00623571|heart failure|heart failure
5669430|NCT00623571|Acute exacerbation of chronic heart failure|acute exacerbation of chronic heart failure
5669431|NCT00623558|head and neck neoplasm|head and neck neoplasm
5669432|NCT00623558|cetuximab|cetuximab
5669433|NCT00623558|docetaxel|docetaxel
5669434|NCT00623558|cisplatin|cisplatin
5669435|NCT00623558|radiotherapy|radiotherapy
5669436|NCT00623545|Exenatide|exenatide
5669437|NCT00623545|Byetta|byetta
5669438|NCT00623545|weight loss|weight loss
5669439|NCT00623545|energy expenditure|energy expenditure
5669440|NCT00623545|normal volunteers|normal volunteers
5669441|NCT00623532|Tertiary prevention of disability|tertiary prevention of disability
5669442|NCT00623519|Adjuvant postmenopausal breast cancer women|adjuvant postmenopausal breast cancer women
5669444|NCT00623506|Pregnenolone|pregnenolone
5669445|NCT00623506|Cognition|cognition
5669446|NCT00623493|Screening|screening
5669447|NCT00623493|Suicide|suicide
5669448|NCT00623493|Emergency Department|emergency department
5669449|NCT00623493|Children and Adolescents|children and adolescents
5669450|NCT00623493|Suicide Risk|suicide risk
5669451|NCT00623480|Hemophilia A|hemophilia a
5669452|NCT00623467|Central Nervous System Imaging|central nervous system imaging
5669453|NCT00623467|Diagnostic Imaging|diagnostic imaging
5669454|NCT00623454|anxiety|anxiety
5669455|NCT00623454|panic disorder|panic disorder
5669456|NCT00623454|chest pain|chest pain
5669457|NCT00623454|palpitations|palpitations
5669458|NCT00623441|Coronary Artery Disease|coronary artery disease
5669459|NCT00623441|Drug-eluting stent|drug-eluting stent
5669460|NCT00623402|Metastatic melanoma|metastatic melanoma
5669461|NCT00623402|Pegylated interferon|pegylated interferon
5669462|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors
5669463|NCT00623402|Sorafenib|sorafenib
5669464|NCT00623402|PegIntron|pegintron
5669465|NCT00623402|Therapeutic Uses|therapeutic uses
5669466|NCT00623402|melanoma (skin)|melanoma (skin)
5669467|NCT00623389|Neurologic disorders|neurologic disorders
5669468|NCT00623389|Rare disease|rare disease
5669469|NCT00623389|Spinal cord injuries|spinal cord injuries
5669470|NCT00623389|Stroke|stroke
5669471|NCT00623389|Paraplegia|paraplegia
5669472|NCT00623389|Tetraplegia|tetraplegia
5669473|NCT00623363|Parkinson's Disease|parkinson's disease
5669474|NCT00623363|motor complications|motor complications
5669475|NCT00623363|dyskinesia|dyskinesia
5669476|NCT00623363|Motor complications associated with Parkinson's|motor complications associated with parkinson's
5669477|NCT00623350|Telemedicine|telemedicine
5669478|NCT00623350|Stroke, Acute|stroke, acute
5669479|NCT00623350|Rural|rural
5669480|NCT00623350|Thrombolysis|thrombolysis
5669481|NCT00623350|Consultation|consultation
5669482|NCT00623337|care seeking|care seeking
5669483|NCT00623337|pregnancy and childbirth|pregnancy and childbirth
5669484|NCT00623337|newborn care practices|newborn care practices
5669485|NCT00623337|low birth weight babies|low birth weight babies
5669486|NCT00623298|Posttraumatic stress disorder|posttraumatic stress disorder
5669487|NCT00623298|depression|depression
5669488|NCT00623298|Narrative Exposure Therapy|narrative exposure therapy
5669489|NCT00623298|Interpersonal Psychotherapy|interpersonal psychotherapy
5669490|NCT00623285|Pain.|pain.
5669492|NCT00623285|CABG.|cabg.
5669493|NCT00623272|The assessment of left ventricular ejection fraction (LVEF)|the assessment of left ventricular ejection fraction (lvef)
5669494|NCT00623246|Obstructive Sleep Apnea|obstructive sleep apnea
5669495|NCT00623246|OSA|osa
5669496|NCT00623246|Adherence|adherence
5669497|NCT00623246|CPAP|cpap
5669498|NCT00623246|Cognition|cognition
5669499|NCT00623233|Breast Neoplasm|breast neoplasm
5669500|NCT00623220|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide|pain, retinopathy of prematurity, infant, premature, eye exam, nitrous oxide
5669501|NCT00623207|Chest Pain Low work Capacity Rate Incompetence|chest pain low work capacity rate incompetence
5669502|NCT00623181|Influenza|influenza
5669503|NCT00623181|Influenza virus|influenza virus
5669504|NCT00623168|Ribavirin|ribavirin
5669505|NCT00623168|Hemorrhagic Fever with Renal Syndrome|hemorrhagic fever with renal syndrome
5669506|NCT00623155|malaria|malaria
5669507|NCT00623155|intermittent preventive treatment|intermittent preventive treatment
5669509|NCT00623155|children|children
5669510|NCT00623142|Myocardial protection|myocardial protection
5669511|NCT00623142|Ischemic Reperfusion Injury|ischemic reperfusion injury
5669512|NCT00623142|Hyperbaric Oxygen|hyperbaric oxygen
5669514|NCT00623129|hypopharyngeal cancer|hypopharyngeal cancer
5669515|NCT00623129|lip and oral cavity cancer|lip and oral cavity cancer
5669516|NCT00623129|laryngeal cancer|laryngeal cancer
5669517|NCT00623129|nasopharyngeal cancer|nasopharyngeal cancer
5669518|NCT00623129|oropharyngeal cancer|oropharyngeal cancer
5669519|NCT00623129|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5669520|NCT00623129|salivary gland cancer|salivary gland cancer
5669521|NCT00623129|xerostomia|xerostomia
5669522|NCT00623129|radiation toxicity|radiation toxicity
5669523|NCT00623116|Kallmann Syndrome|kallmann syndrome
5669524|NCT00623116|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5669525|NCT00623103|Parkinson's disease dementia|parkinson's disease dementia
5669526|NCT00623103|cholinesterase inhibitor|cholinesterase inhibitor
5669527|NCT00623103|rivastigmine|rivastigmine
5669528|NCT00623090|prostate cancer screening education|prostate cancer screening education
5669529|NCT00623090|behavioral oncology|behavioral oncology
5669530|NCT00623090|randomized trial|randomized trial
5669531|NCT00623077|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5669532|NCT00623077|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5669533|NCT00623077|childhood hepatoblastoma|childhood hepatoblastoma
5669534|NCT00623077|recurrent childhood liver cancer|recurrent childhood liver cancer
5669535|NCT00623077|stage IV childhood liver cancer|stage iv childhood liver cancer
5669536|NCT00623077|adult primary liver cancer|adult primary liver cancer
5669537|NCT00623077|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5669538|NCT00623077|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5669539|NCT00623077|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5669540|NCT00623077|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5669541|NCT00623077|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5669542|NCT00623077|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5669543|NCT00623077|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5669544|NCT00623077|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5669545|NCT00623077|stage IV Wilms tumor|stage iv wilms tumor
5669546|NCT00623077|stage V Wilms tumor|stage v wilms tumor
5669547|NCT00623077|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5669548|NCT00623077|stage IV renal cell cancer|stage iv renal cell cancer
5669549|NCT00623077|childhood mixed glioma|childhood mixed glioma
5669550|NCT00623077|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5669551|NCT00623077|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5669552|NCT00623077|recurrent childhood ependymoma|recurrent childhood ependymoma
5669553|NCT00623077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5669554|NCT00623077|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5669555|NCT00623077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5669556|NCT00623077|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5669557|NCT00623077|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5669558|NCT00623077|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5669559|NCT00623077|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5669560|NCT00623077|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5669561|NCT00623077|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5669562|NCT00623077|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5669563|NCT00623077|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5669564|NCT00623077|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5669565|NCT00623077|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5669566|NCT00623077|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5669567|NCT00623077|recurrent retinoblastoma|recurrent retinoblastoma
5669568|NCT00623077|extraocular retinoblastoma|extraocular retinoblastoma
5669569|NCT00623077|intraocular retinoblastoma|intraocular retinoblastoma
5669570|NCT00623077|childhood renal cell carcinoma|childhood renal cell carcinoma
5669571|NCT00623077|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5669572|NCT00623077|recurrent renal cell cancer|recurrent renal cell cancer
5669573|NCT00623077|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5669574|NCT00623077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5669575|NCT00623077|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5669576|NCT00623064|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5669577|NCT00623064|stage IV bladder cancer|stage iv bladder cancer
5669578|NCT00623064|stage III bladder cancer|stage iii bladder cancer
5669579|NCT00623064|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5663111|NCT00651248|Aged|aged
5789077|NCT00150020|Transplantation|transplantation
5669580|NCT00623064|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5669581|NCT00623051|male circumcision|male circumcision
5669583|NCT00623051|sexual behavior|sexual behavior
5669584|NCT00623051|HIV prevention|hiv prevention
5669585|NCT00623051|HIV Seronegativity|hiv seronegativity
5669586|NCT00623038|Apgar score|apgar score
5669587|NCT00623038|neonatal assessment|neonatal assessment
5669588|NCT00623038|preterm infants|preterm infants
5669589|NCT00623038|resuscitation|resuscitation
5669590|NCT00623025|HIV|hiv
5669591|NCT00623025|Steatorrhea|steatorrhea
5669592|NCT00622999|Malnutrition|malnutrition
5669593|NCT00622999|Colon cancer|colon cancer
5669594|NCT00622999|Colon surgery|colon surgery
5669595|NCT00622999|Outcome|outcome
5669596|NCT00622999|Complication rate|complication rate
5669597|NCT00622973|Prostate cancer|prostate cancer
5669598|NCT00622973|Bladder cancer|bladder cancer
5669599|NCT00622973|Pelvic lymph node metastases|pelvic lymph node metastases
5669600|NCT00622973|Diffusion-weighted MRI|diffusion-weighted mri
5669601|NCT00622973|Sinerem (USPIO)-enhanced MRI|sinerem (uspio)-enhanced mri
5669602|NCT00622973|Imaging influence on surgery|imaging influence on surgery
5669603|NCT00622973|Noninvasive detection of pelvic lymph node metastases|noninvasive detection of pelvic lymph node metastases
5669604|NCT00622973|Influence of imaging protocol on surgical outcome|influence of imaging protocol on surgical outcome
5669606|NCT00622960|type 2 diabetes|type 2 diabetes
5669607|NCT00622960|weight loss|weight loss
5669608|NCT00622960|monounsaturated fat|monounsaturated fat
5669609|NCT00622960|diet|diet
5669610|NCT00622947|Depression|depression
5669611|NCT00622947|antidepressant effect|antidepressant effect
5669612|NCT00622947|rTMS|rtms
5669613|NCT00622947|sham|sham
5669614|NCT00622947|cognition|cognition
5669616|NCT00622947|brain derived neurotropic factor|brain derived neurotropic factor
5669617|NCT00622934|multiple trauma|multiple trauma
5669618|NCT00622921|PTSD|ptsd
5669619|NCT00622921|alcohol dependence|alcohol dependence
5669620|NCT00622895|scleroderma|scleroderma
5669621|NCT00622895|systemic sclerosis|systemic sclerosis
5669622|NCT00622882|Staphylococcus aureus|staphylococcus aureus
5669623|NCT00622882|Bacteremia|bacteremia
5669624|NCT00622882|Outcome|outcome
5669625|NCT00622882|Mortality|mortality
5669626|NCT00622882|Recurrence|recurrence
5669627|NCT00622882|Infectious Diseases specialists|infectious diseases specialists
5669628|NCT00622869|Liver transplantation|liver transplantation
5669629|NCT00622869|everolimus|everolimus
5669630|NCT00622869|calcineurin inhibitors|calcineurin inhibitors
5669631|NCT00622869|tacrolimus|tacrolimus
5669632|NCT00622869|renal function|renal function
5669633|NCT00622869|MDRD formula|mdrd formula
5669634|NCT00622869|progression of fibrosis|progression of fibrosis
5669635|NCT00622856|diabetes|diabetes
5669636|NCT00622856|adolescents|adolescents
5669637|NCT00622856|psychological therapy|psychological therapy
5669638|NCT00622843|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5669639|NCT00622843|polysaccharide vaccine|polysaccharide vaccine
5669640|NCT00622843|PPV|ppv
5669641|NCT00622843|PCV|pcv
5669642|NCT00622843|Streptococcus pneumoniae|streptococcus pneumoniae
5669643|NCT00622843|Prevnar|prevnar
5669644|NCT00622843|Pneumovax|pneumovax
5669645|NCT00622843|HIV|hiv
5669646|NCT00622830|darapladib,|darapladib,
5669647|NCT00622830|SB480848,|sb480848,
5669648|NCT00622830|Japanese healthy volunteers|japanese healthy volunteers
5669649|NCT00622817|Epinephrine|epinephrine
5669650|NCT00622817|Nasal decongestant|nasal decongestant
5669651|NCT00622817|RSV|rsv
5669652|NCT00622817|xylometazoline|xylometazoline
5669653|NCT00622817|Bronchiolitis|bronchiolitis
5669654|NCT00622804|Stomach cancer|stomach cancer
5669655|NCT00622804|Gastrectomy|gastrectomy
5669656|NCT00622804|Postgastrectomy syndrome|postgastrectomy syndrome
5669657|NCT00622791|Cardiopulmonary bypass|cardiopulmonary bypass
5669658|NCT00622791|coronary artery bypass graft|coronary artery bypass graft
5669659|NCT00622791|coronary artery disease|coronary artery disease
5669661|NCT00622791|pharmacokinetics|pharmacokinetics
5669662|NCT00622791|pharmacodynamics|pharmacodynamics
5669663|NCT00622778|intracranial bleeding|intracranial bleeding
5669664|NCT00622778|computed tomography scan|computed tomography scan
5669665|NCT00622765|Obesity, Overweight, Body Weight, Body Size, Nutritional and Metabolic Diseases|obesity, overweight, body weight, body size, nutritional and metabolic diseases
5669666|NCT00622752|Smoking cessation|smoking cessation
5669667|NCT00622752|Craving|craving
5669668|NCT00622752|Smokers|smokers
5669669|NCT00622739|Bipolar Disorder|bipolar disorder
5669670|NCT00622739|Children|children
5669671|NCT00622739|Adolescents|adolescents
5669672|NCT00622739|Treatment|treatment
5669673|NCT00622726|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5669674|NCT00622726|Angiogenesis Inhibitor|angiogenesis inhibitor
5669675|NCT00622726|Premature infants|premature infants
5669676|NCT00622726|Bevacizumab|bevacizumab
5669677|NCT00622726|Zone I or Posterior Zone II ROP|zone i or posterior zone ii rop
5669678|NCT00622726|Aggressive Posterior ROP|aggressive posterior rop
5669679|NCT00622726|Stage 3 ROP|stage 3 rop
5669680|NCT00622726|Neonatal Intensive Care Unit|neonatal intensive care unit
5669681|NCT00622713|Alzheimer's disease|alzheimer's disease
5669784|NCT00622245|Depression|depression
5669682|NCT00622713|cholinesterase inhibitor|cholinesterase inhibitor
5669683|NCT00622713|rivastigmine|rivastigmine
5669684|NCT00622700|MS|ms
5669685|NCT00622700|Clinically Isolated Syndrome|clinically isolated syndrome
5669686|NCT00622700|CIS|cis
5669687|NCT00622700|CDMS|cdms
5669688|NCT00622700|relapses|relapses
5669689|NCT00622687|iloprost|iloprost
5669690|NCT00622687|systemic sclerosis|systemic sclerosis
5669691|NCT00622687|digital ulcers|digital ulcers
5669692|NCT00622687|observational study|observational study
5669693|NCT00622687|randomized|randomized
5669694|NCT00622674|recurrent breast cancer|recurrent breast cancer
5669695|NCT00622674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5669696|NCT00622674|recurrent small cell lung cancer|recurrent small cell lung cancer
5669697|NCT00622674|recurrent colon cancer|recurrent colon cancer
5669698|NCT00622674|recurrent pancreatic cancer|recurrent pancreatic cancer
5669699|NCT00622674|recurrent head and neck cancer|recurrent head and neck cancer
5669700|NCT00622674|recurrent sarcoma|recurrent sarcoma
5669701|NCT00622674|recurrent kidney cancer|recurrent kidney cancer
5669702|NCT00622674|recurrent renal cell cancer|recurrent renal cell cancer
5669703|NCT00622661|Glycemic response|glycemic response
5669704|NCT00622661|Glycemic index|glycemic index
5669705|NCT00622661|Obesity|obesity
5669706|NCT00622661|Carbohydrates|carbohydrates
5669707|NCT00622661|Insulin|insulin
5669708|NCT00622661|Blood glucose|blood glucose
5669709|NCT00622648|Medical prevention therapy|medical prevention therapy
5669710|NCT00622635|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5669711|NCT00622635|COPD|copd
5669712|NCT00622635|indacaterol|indacaterol
5669713|NCT00622609|first time in human,|first time in human,
5669714|NCT00622609|MAG|mag
5669715|NCT00622609|monoclonal antibody,|monoclonal antibody,
5669716|NCT00622609|healthy subjects,|healthy subjects,
5669717|NCT00622609|GSK249320,|gsk249320,
5669718|NCT00622596|opiate dependence|opiate dependence
5669719|NCT00622596|buprenorphine|buprenorphine
5669720|NCT00622583|Herniorrhaphy|herniorrhaphy
5669721|NCT00622570|Traumatic brain injury, barbiturate coma|traumatic brain injury, barbiturate coma
5669722|NCT00622544|Microalbuminuria|microalbuminuria
5669723|NCT00622544|Proteinuria|proteinuria
5669724|NCT00622531|heart failure|heart failure
5669725|NCT00622531|BNP|bnp
5669726|NCT00622531|natriuretic peptide|natriuretic peptide
5669727|NCT00622518|otitis media|otitis media
5669728|NCT00622518|children|children
5669729|NCT00622505|Multiple myeloma|multiple myeloma
5669730|NCT00622505|zoledronic acid|zoledronic acid
5669731|NCT00622505|skeletal complications|skeletal complications
5669732|NCT00622505|bone|bone
5669733|NCT00622492|VV-ECMO|vv-ecmo
5669734|NCT00622492|VA-ECMO|va-ecmo
5669735|NCT00622492|PPHN|pphn
5669736|NCT00622492|organ circulation|organ circulation
5669737|NCT00622479|Sorafenib|sorafenib
5669738|NCT00622479|Hypophosphatemia|hypophosphatemia
5669739|NCT00622479|Left ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
5669740|NCT00622479|Beta-type Natriuretic Peptide (BNP)|beta-type natriuretic peptide (bnp)
5669741|NCT00622466|stage IV breast cancer|stage iv breast cancer
5669742|NCT00622466|male breast cancer|male breast cancer
5669743|NCT00622466|recurrent breast cancer|recurrent breast cancer
5669744|NCT00622466|HER2-negative breast cancer|her2-negative breast cancer
5669745|NCT00622440|HSIL|hsil
5669746|NCT00622440|HGAIN|hgain
5669747|NCT00622440|AIN|ain
5669748|NCT00622440|neoplasia|neoplasia
5669749|NCT00622440|dysplasia|dysplasia
5669750|NCT00622440|TCM|tcm
5669751|NCT00622440|Traditional Chinese Medicine|traditional chinese medicine
5669752|NCT00622401|stage IV breast cancer|stage iv breast cancer
5669753|NCT00622401|dendritic cell vaccine|dendritic cell vaccine
5669754|NCT00622401|tumor fusion vaccine|tumor fusion vaccine
5669755|NCT00622401|IL-12|il-12
5672235|NCT00612703|Tumor|tumor
5669756|NCT00622375|Pharmacokinetic study|pharmacokinetic study
5669757|NCT00622375|Healthy subjects|healthy subjects
5669758|NCT00622362|Immunotherapy|immunotherapy
5669759|NCT00622362|Allergy|allergy
5669760|NCT00622362|Allergoid|allergoid
5669761|NCT00622362|Depigmented|depigmented
5669762|NCT00622362|Polymerized|polymerized
5669763|NCT00622362|Allergen-extract|allergen-extract
5669764|NCT00622362|mites|mites
5669765|NCT00622362|Asthma|asthma
5669766|NCT00622349|Randomised phase III|randomised phase iii
5669767|NCT00622349|Chemotherapy|chemotherapy
5669768|NCT00622349|Advanced non-small cell lung carcinoma|advanced non-small cell lung carcinoma
5669769|NCT00622336|Multiple Myeloma|multiple myeloma
5669770|NCT00622336|Revlimid|revlimid
5669771|NCT00622323|diabetes|diabetes
5669772|NCT00622323|exenatide|exenatide
5669773|NCT00622323|metformin|metformin
5669774|NCT00622323|sulfonylurea|sulfonylurea
5669776|NCT00622323|Amylin|amylin
5669777|NCT00622323|Lilly|lilly
5669778|NCT00622271|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5669779|NCT00622271|Adolescents and Families|adolescents and families
5669780|NCT00622271|Group Therapy Intervention|group therapy intervention
5669781|NCT00622258|everolimus|everolimus
5669788|NCT00622245|Multicenter|multicenter
5669789|NCT00622245|Clinical study|clinical study
5669790|NCT00622245|Mania|mania
5669791|NCT00622232|HIV-1|hiv-1
5669792|NCT00622232|treatment experienced, complementary therapies|treatment experienced, complementary therapies
5669793|NCT00622219|Alcohol abuse|alcohol abuse
5669794|NCT00622219|Drug abuse|drug abuse
5669795|NCT00622206|Pharmacokinetics|pharmacokinetics
5669796|NCT00622206|ritonavir|ritonavir
5669797|NCT00622206|saquinavir|saquinavir
5669798|NCT00622206|safety and toxicity|safety and toxicity
5669799|NCT00622206|treatment experienced|treatment experienced
5669800|NCT00622193|NSCLC|nsclc
5669801|NCT00622180|Vitiligo|vitiligo
5669802|NCT00622180|Light treatment for vitiligo|light treatment for vitiligo
5669803|NCT00622180|Excilite|excilite
5669804|NCT00622167|Plaque characteristics|plaque characteristics
5669805|NCT00622167|DSCT|dsct
5669806|NCT00622167|IVUS|ivus
5669807|NCT00622141|bioequivalence|bioequivalence
5669808|NCT00622141|ritonavir boosted generic GPO saquinavir|ritonavir boosted generic gpo saquinavir
5669809|NCT00622141|saftey|saftey
5669810|NCT00622141|pharmacokinetics|pharmacokinetics
5669811|NCT00622128|Behavioral Research|behavioral research
5669813|NCT00622128|Aggression|aggression
5669814|NCT00622102|warfarin|warfarin
5669815|NCT00622102|adherence|adherence
5669816|NCT00622102|Mechanical heart valves|mechanical heart valves
5669817|NCT00622089|diabetes|diabetes
5654069|NCT00685997|Imaging|imaging
5669818|NCT00622089|type 2 diabetes|type 2 diabetes
5669819|NCT00622089|cholesterol|cholesterol
5669820|NCT00622076|postoperative|postoperative
5669821|NCT00622076|Catheterization|catheterization
5669822|NCT00622076|colporrhaphy|colporrhaphy
5669823|NCT00622076|cystocele|cystocele
5669824|NCT00622076|cystitis|cystitis
5669825|NCT00622063|cancer, solid tumor|cancer, solid tumor
5669826|NCT00622024|Arrhythmia|arrhythmia
5669827|NCT00622024|Depression|depression
5669828|NCT00622024|Coronary Artery Disease|coronary artery disease
5669829|NCT00621998|Risperidone|risperidone
5669830|NCT00621998|Olanzapine|olanzapine
5669831|NCT00621998|Tardive dyskinesia|tardive dyskinesia
5669832|NCT00621972|acute renal failure|acute renal failure
5669833|NCT00621972|arteriovenous fistula|arteriovenous fistula
5669834|NCT00621972|KIM-1|kim-1
5669835|NCT00621972|chronic kidney disease|chronic kidney disease
5669836|NCT00621959|levocetirizine|levocetirizine
5669837|NCT00621959|Xyzal|xyzal
5669838|NCT00621959|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5669839|NCT00621959|total symptom score|total symptom score
5669840|NCT00621959|quality of life|quality of life
5669841|NCT00621946|Asthma|asthma
5669842|NCT00621946|Depression|depression
5669843|NCT00621946|Escitalopram|escitalopram
5669844|NCT00621907|randomized|randomized
5669845|NCT00621907|analgesic|analgesic
5669846|NCT00621907|caesarean scars|caesarean scars
5669847|NCT00621907|locoregional anaesthesia|locoregional anaesthesia
5669848|NCT00621907|infiltration|infiltration
5669849|NCT00621907|levobupivacaïne|levobupivacaïne
5669850|NCT00621907|Chirocaïne|chirocaïne
5669851|NCT00621907|caesarian|caesarian
5669852|NCT00621907|unique administration|unique administration
5669853|NCT00621907|post-caesarian analgesic|post-caesarian analgesic
5669854|NCT00621894|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
5669855|NCT00621894|thrombopoietin mimetic|thrombopoietin mimetic
5669856|NCT00621894|ITP|itp
5669857|NCT00621881|hepatic impairment|hepatic impairment
5669858|NCT00621868|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5669859|NCT00621868|ASP1941|asp1941
5669860|NCT00621842|Geriatric Psychiatry|geriatric psychiatry
5669861|NCT00621842|Aged|aged
5669862|NCT00621842|lamotrigine|lamotrigine
5669863|NCT00621816|nitroprusside|nitroprusside
5669864|NCT00621816|intensive care unit|intensive care unit
5669865|NCT00621816|hypertension|hypertension
5669866|NCT00621816|blood pressure reduction|blood pressure reduction
5669867|NCT00621803|Probiotic|probiotic
5669868|NCT00621803|Pseudomonas aeruginosa|pseudomonas aeruginosa
5669869|NCT00621803|Gastric colonization|gastric colonization
5669870|NCT00621803|Respiratory tract colonization|respiratory tract colonization
5669871|NCT00621803|Ventilator aquired pneumoniae|ventilator aquired pneumoniae
5671245|NCT00616590|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5671734|NCT00614614|Immunogenicity|immunogenicity
5669872|NCT00621803|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by P. aeruginosa|determine the effect of oral administration of this probiotic on gastric and respiratory tract colonisation/infection by p. aeruginosa
5669873|NCT00621790|fenoldopam|fenoldopam
5669874|NCT00621790|acute renal failure|acute renal failure
5669875|NCT00621790|renal replacement therapy|renal replacement therapy
5669876|NCT00621790|mortality|mortality
5669877|NCT00621790|cardiac surgery|cardiac surgery
5669878|NCT00621790|cardiac anesthesia|cardiac anesthesia
5669879|NCT00621790|intensive care unit|intensive care unit
5669880|NCT00621777|schizophrenia|schizophrenia
5669881|NCT00621777|bipolar disorder|bipolar disorder
5669882|NCT00621777|varenicline|varenicline
5669883|NCT00621777|smoking cessation|smoking cessation
5669884|NCT00621777|relapse prevention|relapse prevention
5669885|NCT00621777|cognitive behavioral therapy|cognitive behavioral therapy
5669886|NCT00621764|Japanese encephalitis (JE)|japanese encephalitis (je)
5669887|NCT00621764|Hepatitis A|hepatitis a
5669888|NCT00621764|Inactivated Mouse-Brain|inactivated mouse-brain
5669889|NCT00621751|Brain Injury|brain injury
5669890|NCT00621751|Irritability|irritability
5669891|NCT00621751|Aggression|aggression
5669892|NCT00621738|mental stress|mental stress
5669893|NCT00621738|cardiovascular risk factor|cardiovascular risk factor
5669894|NCT00621738|platelet adhesion|platelet adhesion
5669895|NCT00621725|Advanced cancer|advanced cancer
5669896|NCT00621725|metastatic|metastatic
5669897|NCT00621725|hepatic impairment|hepatic impairment
5669898|NCT00621712|Renal Dialysis|renal dialysis
5669899|NCT00621712|Dialysis, Extracorporeal|dialysis, extracorporeal
5669900|NCT00621712|Dialysis, Renal|dialysis, renal
5669901|NCT00621712|Extracorporeal Dialysis|extracorporeal dialysis
5669902|NCT00621699|pharmacokinetics|pharmacokinetics
5669903|NCT00621699|drug interactions|drug interactions
5669904|NCT00621699|ezetimibe|ezetimibe
5669905|NCT00621699|tacrolimus|tacrolimus
5669906|NCT00621699|human experimentation|human experimentation
5669907|NCT00621686|adult glioblastoma|adult glioblastoma
5669908|NCT00621686|adult giant cell glioblastoma|adult giant cell glioblastoma
5669909|NCT00621686|adult gliosarcoma|adult gliosarcoma
5669910|NCT00621686|recurrent adult brain tumor|recurrent adult brain tumor
5669911|NCT00621673|Hemophilia A,|hemophilia a,
5669912|NCT00621673|Inhibitor formation,|inhibitor formation,
5669914|NCT00621660|Acupuncture therapy|acupuncture therapy
5669916|NCT00621660|Emesis|emesis
5669917|NCT00621660|Expectations|expectations
5669918|NCT00621660|Placebo|placebo
5669919|NCT00621647|Seroquel|seroquel
5669920|NCT00621647|dementia|dementia
5669921|NCT00621647|agitation symptoms|agitation symptoms
5669922|NCT00621647|Alzheimer's disease|alzheimer's disease
5669923|NCT00621647|vascular dementia|vascular dementia
5669924|NCT00621647|quetiapine fumarate|quetiapine fumarate
5669925|NCT00621634|Tardive dyskinesia|tardive dyskinesia
5669926|NCT00621634|Schizophrenia|schizophrenia
5669927|NCT00621634|Essential fatty acids|essential fatty acids
5669928|NCT00621621|atrioventricular nodal reentrant tachycardia|atrioventricular nodal reentrant tachycardia
5669929|NCT00621621|AVNRT|avnrt
5669930|NCT00621608|Chronic ulcers|chronic ulcers
5669931|NCT00621608|Diabetes|diabetes
5669932|NCT00621608|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5669933|NCT00621595|School Breakfast|school breakfast
5669934|NCT00621595|Diet|diet
5669935|NCT00621595|Nutrition|nutrition
5669936|NCT00621595|Brain Function|brain function
5669937|NCT00621595|Cognition|cognition
5669938|NCT00621595|USDA|usda
5669939|NCT00621595|Healthy Children|healthy children
5669940|NCT00621569|Blood Pressure|blood pressure
5669941|NCT00621569|Dash Diet|dash diet
5669942|NCT00621543|Intrauterine Device|intrauterine device
5669943|NCT00621543|Induced Abortion|induced abortion
5669944|NCT00621543|Medical Abortion|medical abortion
5669945|NCT00621530|Total hip arthroplasty|total hip arthroplasty
5669946|NCT00621530|Total hip replacement|total hip replacement
5669947|NCT00621530|Pain, postoperative|pain, postoperative
5669948|NCT00621530|Ketorolac|ketorolac
5669949|NCT00621530|Patients undergoing unilateral total hip arthroplasty|patients undergoing unilateral total hip arthroplasty
5669950|NCT00621517|Restless Legs Syndrome|restless legs syndrome
5669951|NCT00621517|Bupropion|bupropion
5669952|NCT00621504|ceftaroline|ceftaroline
5669953|NCT00621504|Community-acquired pneumonia|community-acquired pneumonia
5669954|NCT00621504|CAP|cap
5669955|NCT00621504|IV (intravenous)|iv (intravenous)
5669956|NCT00621504|Streptococcus pneumoniae|streptococcus pneumoniae
5669957|NCT00621504|Haemophilus influenzae|haemophilus influenzae
5669958|NCT00621504|Mycoplasma pneumoniae|mycoplasma pneumoniae
5669959|NCT00621504|Chlamydophila spp|chlamydophila spp
5669960|NCT00621504|Legionella spp|legionella spp
5669961|NCT00621504|Multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
5669962|NCT00621504|antimicrobial resistance|antimicrobial resistance
5669963|NCT00621504|pneumococci|pneumococci
5669964|NCT00621504|Ceftriaxone|ceftriaxone
5669965|NCT00621504|bacteria|bacteria
5669966|NCT00621504|ß-lactam|ß-lactam
5669967|NCT00621504|beta-lactam|beta-lactam
5669968|NCT00621504|antibiotic|antibiotic
5669969|NCT00621491|cardiac pacing|cardiac pacing
5669970|NCT00621491|pacing complication|pacing complication
5669971|NCT00621491|venous thrombosis|venous thrombosis
5669972|NCT00621491|warfarin|warfarin
5663530|NCT00647439|AMD|amd
5669973|NCT00621491|anticoagulation|anticoagulation
5669974|NCT00621491|randomized trial|randomized trial
5669975|NCT00621465|Psychosis|psychosis
5669976|NCT00621465|Homelessness|homelessness
5669977|NCT00621465|Case Management|case management
5651043|NCT00697632|Tumor|tumor
5669978|NCT00621465|Severe Mental Illness|severe mental illness
5669979|NCT00621439|ocular melanoma|ocular melanoma
5669980|NCT00621426|T wave alternans (TWA)|t wave alternans (twa)
5669981|NCT00621426|dialysis|dialysis
5669982|NCT00621426|end stage renal disease|end stage renal disease
5669983|NCT00621426|sudden cardiac death|sudden cardiac death
5670082|NCT00621049|Carboplatin|carboplatin
5669984|NCT00621426|T-wave alternans|t-wave alternans
5669985|NCT00621426|Cardiac electrical instability|cardiac electrical instability
5669986|NCT00621426|Sympathetic and electrolyte-induced alterations|sympathetic and electrolyte-induced alterations
5669987|NCT00621426|Ventricular repolarization|ventricular repolarization
5669988|NCT00621413|prostate|prostate
5669989|NCT00621413|cancer|cancer
5669990|NCT00621413|intermediate risk|intermediate risk
5669991|NCT00621413|high risk|high risk
5669992|NCT00621413|brachytherapy|brachytherapy
5669993|NCT00621413|Cesium-131|cesium-131
5669994|NCT00621413|seed brachytherapy|seed brachytherapy
5669995|NCT00621413|intermediate and high risk cancer of the prostate|intermediate and high risk cancer of the prostate
5669996|NCT00621400|newly-diagnosed light-chain (AL)-amyloidosis|newly-diagnosed light-chain (al)-amyloidosis
5669997|NCT00621387|reactive arthritis|reactive arthritis
5669998|NCT00621387|antibiotics|antibiotics
5669999|NCT00621374|Pain Management|pain management
5670000|NCT00621374|Cognitive Behavior Therapy|cognitive behavior therapy
5670001|NCT00621374|Hypnosis|hypnosis
5670002|NCT00621361|Lung Cancer|lung cancer
5670003|NCT00621361|AZD2171|azd2171
5670004|NCT00621361|cediranib|cediranib
5670005|NCT00621361|RECENTIN|recentin
5670006|NCT00621361|etoposide|etoposide
5670007|NCT00621361|cisplatin|cisplatin
5670008|NCT00621348|maintenance fluids|maintenance fluids
5670009|NCT00621348|hyponatremia|hyponatremia
5670010|NCT00621348|vasopressin|vasopressin
5670011|NCT00621348|children|children
5670012|NCT00621335|Open angle glaucoma|open angle glaucoma
5670013|NCT00621335|Ocular hypertension|ocular hypertension
5670014|NCT00621335|Parallel comparison|parallel comparison
5670015|NCT00621335|Combigan|combigan
5670016|NCT00621335|Cosopt|cosopt
5670017|NCT00621322|Tuberculosis vaccine|tuberculosis vaccine
5670018|NCT00621309|drug interactions|drug interactions
5670019|NCT00621309|cytochrome P4503A4|cytochrome p4503a4
5670020|NCT00621309|Pregnane X-receptor|pregnane x-receptor
5670021|NCT00621309|induction|induction
5670022|NCT00621309|drug metabolism|drug metabolism
5670023|NCT00621296|Chronic Hepatitis C|chronic hepatitis c
5670024|NCT00621296|Protease Inhibitor|protease inhibitor
5670025|NCT00621270|Major Depression Neurogenesis|major depression neurogenesis
5670026|NCT00621270|Major Depressive Disorder with Concomitant Anxiety|major depressive disorder with concomitant anxiety
5670028|NCT00621257|Inflammatory Bowel Disease|inflammatory bowel disease
5670029|NCT00621257|Crohn's Disease|crohn's disease
5670030|NCT00621257|Ulcerative Colitis|ulcerative colitis
5670031|NCT00621257|Vitamin D|vitamin d
5670032|NCT00621244|HDAC inhibitor|hdac inhibitor
5670033|NCT00621244|Oral|oral
5670034|NCT00621244|LBH589|lbh589
5670035|NCT00621244|Lymphoma|lymphoma
5670036|NCT00621244|Leukemia|leukemia
5670037|NCT00621244|Multiple myeloma|multiple myeloma
5670038|NCT00621231|Protein Function|protein function
5670039|NCT00621231|normal versus high protein intake|normal versus high protein intake
5670040|NCT00621218|tretinoin, efficacy, safety, rosacea|tretinoin, efficacy, safety, rosacea
5670041|NCT00621205|Insulin resistance, weight reduction, adipose tissue, peripheral|insulin resistance, weight reduction, adipose tissue, peripheral
5670042|NCT00621205|mononuclear cells, gene expression profile, transcriptomics|mononuclear cells, gene expression profile, transcriptomics
5670043|NCT00621192|meropenem|meropenem
5670044|NCT00621192|infants|infants
5670045|NCT00621192|intra-abdominal infection|intra-abdominal infection
5670046|NCT00621192|pharmacokinetics|pharmacokinetics
5670047|NCT00621192|safety|safety
5670048|NCT00621179|Endometriosis,infertility,in vitro fertilization|endometriosis,infertility,in vitro fertilization
5670049|NCT00621166|Generic lopinavir/ritonavir|generic lopinavir/ritonavir
5670050|NCT00621166|Pharmacokinetics|pharmacokinetics
5670051|NCT00621166|Pregnancy|pregnancy
5670052|NCT00621166|Antiviral activity|antiviral activity
5670054|NCT00621153|Candesartan Cilexetil|candesartan cilexetil
5670055|NCT00621153|hydrochlorothiazide|hydrochlorothiazide
5670056|NCT00621153|severe hypertension|severe hypertension
5670057|NCT00621114|Dialysis, Extracorporeal|dialysis, extracorporeal
5670058|NCT00621114|Dialysis, Renal|dialysis, renal
5670059|NCT00621114|Extracorporeal Dialysis|extracorporeal dialysis
5670060|NCT00621114|Hemodialysis|hemodialysis
5670061|NCT00621101|pharmacokinetics|pharmacokinetics
5670062|NCT00621101|drug interactions|drug interactions
5670063|NCT00621101|ezetimibe|ezetimibe
5670064|NCT00621101|sirolimus|sirolimus
5670065|NCT00621101|human experimentation|human experimentation
5670066|NCT00621075|PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs|pah; v/q scan;rhc;echo;ct scans; angiography;pfts
5670067|NCT00621062|varicose|varicose
5670068|NCT00621062|vein|vein
5670070|NCT00621062|laser|laser
5670071|NCT00621062|foam|foam
5670072|NCT00621062|sclerotherapy|sclerotherapy
5670073|NCT00621062|radiofrequency|radiofrequency
5670074|NCT00621062|duplex|duplex
5670075|NCT00621062|sf36|sf36
5670076|NCT00621062|Aberdeen|aberdeen
5670077|NCT00621062|VCSS|vcss
5670078|NCT00621062|quality|quality
5670079|NCT00621062|recurrence|recurrence
5670080|NCT00621049|Non-Small Cell Lung Cancer|non-small cell lung cancer
5670081|NCT00621049|Resected|resected
5670083|NCT00621049|Docetaxel|docetaxel
5670084|NCT00621049|Bevacizumab|bevacizumab
5670085|NCT00621049|Erlotinib|erlotinib
5670086|NCT00621036|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5670087|NCT00621036|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5670088|NCT00621036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5670089|NCT00621036|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5670090|NCT00621036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5670091|NCT00621036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5670092|NCT00621036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5670093|NCT00621036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5670094|NCT00621036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5670095|NCT00621036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5670096|NCT00621036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5670097|NCT00621036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5670098|NCT00621036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5670099|NCT00621036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5670100|NCT00621036|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5670101|NCT00621036|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5670102|NCT00621036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5670103|NCT00621036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5670104|NCT00621036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5670105|NCT00621036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5670106|NCT00621036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5670107|NCT00621036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5670108|NCT00621036|intraocular lymphoma|intraocular lymphoma
5670109|NCT00621036|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5670110|NCT00621036|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5670111|NCT00621036|Waldenström macroglobulinemia|waldenström macroglobulinemia
5670112|NCT00621036|small intestine lymphoma|small intestine lymphoma
5670113|NCT00621023|Myelodysplastic syndrome|myelodysplastic syndrome
5670115|NCT00620997|cornea|cornea
5670116|NCT00620997|analgesia|analgesia
5670117|NCT00620997|topical|topical
5670118|NCT00620997|anesthetic|anesthetic
5670119|NCT00620984|Staphylococcus aureus|staphylococcus aureus
5670120|NCT00620984|Breastfeeding|breastfeeding
5670121|NCT00620984|Lactational Mastitis|lactational mastitis
5670122|NCT00620984|Polymerase Chain Reaction (PCR) amplification analysis|polymerase chain reaction (pcr) amplification analysis
5670123|NCT00620984|staphylococcal infections|staphylococcal infections
5670124|NCT00620984|staphylococcal Carrier State|staphylococcal carrier state
5670125|NCT00620971|Non Small Cell Lung Cancer|non small cell lung cancer
5670126|NCT00620971|Cisplatin|cisplatin
5670127|NCT00620971|VInorelbine|vinorelbine
5670128|NCT00620971|Docetaxel|docetaxel
5670129|NCT00620971|Gemcitabine|gemcitabine
5670130|NCT00620971|Bevacizumab|bevacizumab
5670131|NCT00620958|Mediation|mediation
5670132|NCT00620958|Outcome|outcome
5670133|NCT00620958|CBT|cbt
5670134|NCT00620958|Child Anxiety Intervention|child anxiety intervention
5670135|NCT00620945|Congenital heart surgery|congenital heart surgery
5670136|NCT00620945|Cardiopulmonary bypass|cardiopulmonary bypass
5670137|NCT00620945|Phenoxybenzamine|phenoxybenzamine
5670138|NCT00620906|manipulation|manipulation
5670139|NCT00620906|manual therapy|manual therapy
5670140|NCT00620906|Sacroiliac joint|sacroiliac joint
5670141|NCT00620906|effects on manipulation on sacroiliac joint|effects on manipulation on sacroiliac joint
5670142|NCT00620893|Dry eye signs and symptoms|dry eye signs and symptoms
5670143|NCT00620893|refractive regression|refractive regression
5670144|NCT00620841|Tacrolimus|tacrolimus
5670145|NCT00620841|Renal Transplantation|renal transplantation
5671835|NCT00614172|Proton|proton
5670146|NCT00620841|genetic polymorphisms|genetic polymorphisms
5670147|NCT00620841|Drug drug interactions|drug drug interactions
5670148|NCT00620815|avian flu|avian flu
5670149|NCT00620815|seasonal influenza vaccine|seasonal influenza vaccine
5670150|NCT00620815|influenza vaccine|influenza vaccine
5670151|NCT00620815|prepandemic vaccine|prepandemic vaccine
5670152|NCT00620815|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
5663684|NCT00646750|Z-BEAM|z-beam
5670153|NCT00620815|tetravalent vaccine|tetravalent vaccine
5670154|NCT00620815|Prophylaxis of influenza|prophylaxis of influenza
5670155|NCT00620802|Platelet function testing|platelet function testing
5670156|NCT00620802|Healthy volunteers|healthy volunteers
5670157|NCT00620789|Insomnia|insomnia
5670158|NCT00620789|Depression|depression
5670159|NCT00620776|Generalized Anxiety Disorder|generalized anxiety disorder
5670160|NCT00620776|Cognitive Behavioral Therapy|cognitive behavioral therapy
5670161|NCT00620776|Psychotherapy plus medication|psychotherapy plus medication
5670162|NCT00620776|Combined treatment|combined treatment
5670163|NCT00620763|Meat protein|meat protein
5670164|NCT00620763|acid load|acid load
5671684|NCT00614848|restenosis|restenosis
5670165|NCT00620763|calcium retention|calcium retention
5670166|NCT00620763|postmenopausal women|postmenopausal women
5670167|NCT00620750|Alcohol dependence|alcohol dependence
5670168|NCT00620711|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5670170|NCT00620711|Neonatal encephalopathy|neonatal encephalopathy
5670171|NCT00620711|Cooling|cooling
5670172|NCT00620711|hypothermia|hypothermia
5670173|NCT00620698|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5670174|NCT00620698|motor neuron disease|motor neuron disease
5670175|NCT00620698|outcome measure|outcome measure
5670176|NCT00620698|biomarker|biomarker
5670177|NCT00620698|impedance|impedance
5670178|NCT00620685|Arthritis, rheumatoid|arthritis, rheumatoid
5670179|NCT00620672|n-3 supplementation during pregnancy|n-3 supplementation during pregnancy
5670180|NCT00620672|DHA and pregnancy, infant development|dha and pregnancy, infant development
5670181|NCT00620672|n-3 status and gestation|n-3 status and gestation
5670182|NCT00620672|DHA and visual acuity and cognition during infancy|dha and visual acuity and cognition during infancy
5670183|NCT00620646|clopidogrel|clopidogrel
5670184|NCT00620646|platelets|platelets
5670185|NCT00620646|percutaneous coronary intervention|percutaneous coronary intervention
5670186|NCT00620633|Bone Marrow|bone marrow
5670187|NCT00620620|Healthy adult volunteers|healthy adult volunteers
5670188|NCT00620607|gastric|gastric
5670189|NCT00620594|Neoplasms|neoplasms
5654450|NCT00684398|NF1|nf1
5670190|NCT00620594|breast neoplasms|breast neoplasms
5670191|NCT00620594|breast diseases|breast diseases
5670192|NCT00620594|solid tumors|solid tumors
5670193|NCT00620594|BEZ235|bez235
5670194|NCT00620594|breast cancer|breast cancer
5670195|NCT00620594|PI3K Inhibitor|pi3k inhibitor
5670196|NCT00620594|Phosphatidylinositol 3|phosphatidylinositol 3
5670197|NCT00620594|kinase|kinase
5670198|NCT00620594|advanced|advanced
5670199|NCT00620568|Safety|safety
5670200|NCT00620568|Tolerability|tolerability
5670201|NCT00620568|Schizophrenia|schizophrenia
5670202|NCT00620542|Coronary artery disease|coronary artery disease
5670203|NCT00620529|polycystic ovary syndrome|polycystic ovary syndrome
5670204|NCT00620529|cardiovascular risk|cardiovascular risk
5670205|NCT00620529|metabolism|metabolism
5670206|NCT00620529|blood pressure|blood pressure
5670207|NCT00620529|liver fat|liver fat
5670208|NCT00620529|heart rate variability|heart rate variability
5670209|NCT00620503|PK|pk
5670210|NCT00620503|Pharmacokinetics|pharmacokinetics
5670211|NCT00620490|Epidural analgesia|epidural analgesia
5670212|NCT00620490|Contraindications|contraindications
5670213|NCT00620490|Paravertebral nerve block analgesia|paravertebral nerve block analgesia
5670214|NCT00620490|ropivacaine|ropivacaine
5670215|NCT00620490|Visual analogical scale|visual analogical scale
5670216|NCT00620490|Morphine|morphine
5670217|NCT00620490|Side effects|side effects
5670218|NCT00620490|Pain and thoracotomy|pain and thoracotomy
5670219|NCT00620451|Treatment|treatment
5670220|NCT00620451|Active|active
5670221|NCT00620451|Celiac|celiac
5670222|NCT00620451|Remission|remission
5670223|NCT00620451|Induction|induction
5670224|NCT00620438|Lumefantrine|lumefantrine
5670225|NCT00620438|Efavirenz|efavirenz
5670226|NCT00620438|Nevirapine|nevirapine
5670227|NCT00620438|Rifampicin|rifampicin
5670228|NCT00620438|HIV|hiv
5670229|NCT00620425|sumatriptan|sumatriptan
5670230|NCT00620425|Intraject|intraject
5670231|NCT00620425|Local Site Reactions|local site reactions
5670232|NCT00620412|influenza|influenza
5670233|NCT00620412|vaccines|vaccines
5672673|NCT00611260|ICD|icd
5670234|NCT00620412|probiotics|probiotics
5670235|NCT00620412|LGG|lgg
5670236|NCT00620399|lumbar fusion|lumbar fusion
5670237|NCT00620386|Intubating conditions|intubating conditions
5670238|NCT00620386|Bonfils intubation fiberscope|bonfils intubation fiberscope
5670239|NCT00620386|Macintosh laryngoscope|macintosh laryngoscope
5670240|NCT00620386|neuromuscular blockade|neuromuscular blockade
5670241|NCT00620373|Dense breast tissue|dense breast tissue
5670242|NCT00620373|Breast Cancer Screening|breast cancer screening
5670243|NCT00620373|Molecular Breast Imaging|molecular breast imaging
5670244|NCT00620373|Breast Cancer|breast cancer
5670246|NCT00620360|dietary fructose|dietary fructose
5670247|NCT00620360|plasma lipids|plasma lipids
5670248|NCT00620360|healthy humans|healthy humans
5670249|NCT00620360|gender differences|gender differences
5670250|NCT00620360|hepatic de novo lipogenesis|hepatic de novo lipogenesis
5670251|NCT00620347|SCLC (small cell lung cancer)|sclc (small cell lung cancer)
5670252|NCT00620347|ED (extensive disease)|ed (extensive disease)
5670253|NCT00620347|RR (response rate)|rr (response rate)
5670255|NCT00620295|recurrent pancreatic cancer|recurrent pancreatic cancer
5670256|NCT00620295|recurrent breast cancer|recurrent breast cancer
5670257|NCT00620295|recurrent small cell lung cancer|recurrent small cell lung cancer
5670258|NCT00620295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5670259|NCT00620295|recurrent colon cancer|recurrent colon cancer
5670260|NCT00620295|recurrent prostate cancer|recurrent prostate cancer
5670261|NCT00620295|recurrent head and neck cancer|recurrent head and neck cancer
5670262|NCT00620295|ovarian cancer|ovarian cancer
5670263|NCT00620295|recurrent uterine cancer|recurrent uterine cancer
5670264|NCT00620295|recurrent kidney cancer|recurrent kidney cancer
5670265|NCT00620295|recurrent osteosarcoma|recurrent osteosarcoma
5670266|NCT00620269|NSCLC|nsclc
5670267|NCT00620269|EGFR mutation|egfr mutation
5670268|NCT00620269|Erlotinib|erlotinib
5670269|NCT00620269|IP chemotherapy|ip chemotherapy
5670270|NCT00620269|CCRT|ccrt
5670271|NCT00620256|Glaucoma|glaucoma
5670272|NCT00620256|Hypertension|hypertension
5670273|NCT00620243|Ovarian cancer|ovarian cancer
5670274|NCT00620243|PET|pet
5670275|NCT00620243|CT|ct
5670276|NCT00620243|04-064|04-064
5685575|NCT00555542|Rheumatoid Arthritis|rheumatoid arthritis
5670277|NCT00620230|Allergic rhinitis, anti-interleukin 4|allergic rhinitis, anti-interleukin 4
5670278|NCT00620217|heart ischemia|heart ischemia
5670279|NCT00620217|coronary artery disease|coronary artery disease
5670280|NCT00620217|plasmid|plasmid
5670281|NCT00620217|VEGF|vegf
5670282|NCT00620217|FGF|fgf
5670283|NCT00620217|percutaneous|percutaneous
5670284|NCT00620217|gene therapy|gene therapy
5670285|NCT00620217|SPECT|spect
5670286|NCT00620217|nuclear magnetic resonance|nuclear magnetic resonance
5670287|NCT00620204|atorvastatin|atorvastatin
5670288|NCT00620204|Angina Pectoris, Variant|angina pectoris, variant
5670289|NCT00620204|endothelial dysfunction|endothelial dysfunction
5670290|NCT00620191|metformin|metformin
5670291|NCT00620191|mild cognitive impairment|mild cognitive impairment
5670292|NCT00620191|alzheimer's disease|alzheimer's disease
5670293|NCT00620191|overweight|overweight
5670294|NCT00620191|insulin|insulin
5670295|NCT00620178|candesartan|candesartan
5670296|NCT00620178|losartan|losartan
5670297|NCT00620178|blood pressure|blood pressure
5670298|NCT00620178|cardiovascular disease|cardiovascular disease
5670299|NCT00620178|health care consumption|health care consumption
5670300|NCT00620165|tremor|tremor
5670301|NCT00620165|writing|writing
5670302|NCT00620165|feeding|feeding
5670303|NCT00620165|pouring|pouring
5670304|NCT00620139|head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5670305|NCT00620139|chemoradiotherapy|chemoradiotherapy
5670306|NCT00620139|molecular effects|molecular effects
5670307|NCT00620139|05-016|05-016
5670308|NCT00620126|Inflammatory bowel disease|inflammatory bowel disease
5670309|NCT00620126|Ulcerative colitis|ulcerative colitis
5670310|NCT00620126|Telemedicine|telemedicine
5670311|NCT00620126|Telemanagement|telemanagement
5670312|NCT00620126|Chronic disease|chronic disease
5670313|NCT00620087|Atypical lobular hyperplasia|atypical lobular hyperplasia
5670314|NCT00620087|Atypical ductal hyperplasia|atypical ductal hyperplasia
5670315|NCT00620087|Lobular carcinoma in situ|lobular carcinoma in situ
5670316|NCT00620087|Molecular Breast Imaging|molecular breast imaging
5670317|NCT00620074|invasive aspergillosis, opportunistic mold infection|invasive aspergillosis, opportunistic mold infection
5670318|NCT00620048|heart|heart
5670319|NCT00620048|stem Cells|stem cells
5670320|NCT00620048|low EF|low ef
5670321|NCT00620048|heart attack|heart attack
5670322|NCT00620048|cardiomyopathy|cardiomyopathy
5670323|NCT00620048|congestive heart failure|congestive heart failure
5670324|NCT00620048|cardiovascular disease|cardiovascular disease
5670325|NCT00620048|Heart Failure|heart failure
5670326|NCT00620048|Low Ejection Fraction|low ejection fraction
5670327|NCT00620022|indacaterol|indacaterol
5670328|NCT00620022|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5670329|NCT00620022|exercise endurance|exercise endurance
5670330|NCT00620022|moderate to severe chronic obstructive pulmonary disease|moderate to severe chronic obstructive pulmonary disease
5670331|NCT00620022|COPD|copd
5670332|NCT00620009|Empathy|empathy
5670333|NCT00620009|Feedback|feedback
5670334|NCT00620009|Psychotherapy|psychotherapy
5670335|NCT00619996|Prostate Cancer|prostate cancer
5670336|NCT00619996|Sorafenib|sorafenib
5670337|NCT00619996|Nexavar|nexavar
5670338|NCT00619996|Docetaxel|docetaxel
5670339|NCT00619996|Pisa|pisa
5670340|NCT00619996|Ricci|ricci
5670341|NCT00619983|Asymmetric Diabetic Proximal Motor Neuropathy|asymmetric diabetic proximal motor neuropathy
5670342|NCT00619983|Diabetic Autonomic Neuropathy|diabetic autonomic neuropathy
5670343|NCT00619983|Diabetic Neuralgia|diabetic neuralgia
5670344|NCT00619983|Diabetic Neuropathy, Painful|diabetic neuropathy, painful
5670345|NCT00619983|Neuralgia, Diabetic|neuralgia, diabetic
5670346|NCT00619983|Low back pain, chronic|low back pain, chronic
5670347|NCT00619944|HIV|hiv
5670348|NCT00619944|lumefantrine|lumefantrine
5670349|NCT00619944|lopinavir|lopinavir
5670350|NCT00619944|Africa|africa
5670355|NCT00619918|hypertonic saline|hypertonic saline
5670356|NCT00619905|Rheumatoid Arthritis|rheumatoid arthritis
5670357|NCT00619905|Anti-interleukin-1 beta|anti-interleukin-1 beta
5670358|NCT00619905|ACZ885|acz885
5670359|NCT00619892|SSRI Resistant|ssri resistant
5651479|NCT00695708|MEG|meg
5670360|NCT00619892|Seroquel SR|seroquel sr
5670361|NCT00619892|Seroquel XR|seroquel xr
5670362|NCT00619892|Panic Disorder|panic disorder
5670363|NCT00619892|Comorbid Panic Disorder|comorbid panic disorder
5670364|NCT00619892|Quetiapine SR|quetiapine sr
5670365|NCT00619892|Quetiapine XR|quetiapine xr
5670366|NCT00619879|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
5670367|NCT00619879|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
5670368|NCT00619879|Leukemia, Myelogenous, Acute|leukemia, myelogenous, acute
5670369|NCT00619879|Myeloproliferative-Myelodysplastic Diseases|myeloproliferative-myelodysplastic diseases
5670370|NCT00619879|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5670371|NCT00619879|Dysmyelopoietic Syndromes|dysmyelopoietic syndromes
5670372|NCT00619879|Lymphoma, Malignant|lymphoma, malignant
5670373|NCT00619879|Stem Cell Transplantation, Hematopoietic|stem cell transplantation, hematopoietic
5670374|NCT00619879|Allogeneic Transplantation|allogeneic transplantation
5670375|NCT00619879|Human Leukocyte Antigens|human leukocyte antigens
5670376|NCT00619879|Busulfan|busulfan
5670377|NCT00619879|Total Body Irradiation|total body irradiation
5670378|NCT00619879|VP-16|vp-16
5670379|NCT00619879|Etoposide|etoposide
5670380|NCT00619879|Cyclophosphamide|cyclophosphamide
5670381|NCT00619879|Graft-Versus-Host Disease|graft-versus-host disease
5670382|NCT00619866|bone mineral density|bone mineral density
5670383|NCT00619866|Pelvic Pain|pelvic pain
5670384|NCT00619866|estradiol|estradiol
5670385|NCT00619866|NBI-56418|nbi-56418
5654642|NCT00683631|liver tumor|liver tumor
5670386|NCT00619853|Improving the assisting hand function in children with Hemiplegic Cerebral palsy|improving the assisting hand function in children with hemiplegic cerebral palsy
5670387|NCT00619840|ADHD|adhd
5670388|NCT00619840|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5670389|NCT00619840|adult|adult
5670390|NCT00619840|methylphenidate hydrochloride|methylphenidate hydrochloride
5670391|NCT00619840|Medikinet retard|medikinet retard
5670392|NCT00619840|long-term observation|long-term observation
5670393|NCT00619840|controlled clinical trial|controlled clinical trial
5670394|NCT00619840|safety|safety
5670395|NCT00619840|randomized, double-blind, placebo-controlled trial|randomized, double-blind, placebo-controlled trial
5670396|NCT00619840|treatment|treatment
5670397|NCT00619840|central nervous system stimulants|central nervous system stimulants
5670398|NCT00619840|therapeutic uses|therapeutic uses
5670399|NCT00619827|Sublingual immunotherapy|sublingual immunotherapy
5670400|NCT00619827|Rhinitis|rhinitis
5670401|NCT00619827|Conjunctivitis|conjunctivitis
5670402|NCT00619827|Allergen challenge|allergen challenge
5670403|NCT00619827|Allergen exposition chamber|allergen exposition chamber
5670404|NCT00619827|Grass pollen tablet|grass pollen tablet
5670405|NCT00619827|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5670406|NCT00619814|Colon polyps|colon polyps
5670407|NCT00619814|Fecal occult blood test|fecal occult blood test
5670408|NCT00619814|Double contrast barium enema|double contrast barium enema
5670409|NCT00619814|Colonoscopy|colonoscopy
5670410|NCT00619801|Xyzal|xyzal
5670411|NCT00619801|Levocetirizine|levocetirizine
5670412|NCT00619801|Allergy|allergy
5670413|NCT00619801|Children|children
5670414|NCT00619801|Seasonal Allergies|seasonal allergies
5670415|NCT00619775|Carotid Artery Disease|carotid artery disease
5670416|NCT00619775|Embolic Protection|embolic protection
5670417|NCT00619762|Breast reconstruction|breast reconstruction
5670418|NCT00619736|Healthy|healthy
5670419|NCT00619710|skin infections|skin infections
5670420|NCT00619710|MERREM|merrem
5670421|NCT00619710|PRIMAXIN IV|primaxin iv
5670422|NCT00619710|complex abscess|complex abscess
5670423|NCT00619710|perirectal abscess|perirectal abscess
5670424|NCT00619710|wound infections|wound infections
5670425|NCT00619710|infected ischemic/diabetic ulcers|infected ischemic/diabetic ulcers
5670426|NCT00619710|cellulitis|cellulitis
5670427|NCT00619710|Meropenem|meropenem
5670428|NCT00619710|Imipenem-cilastatin|imipenem-cilastatin
5670430|NCT00619671|Rituximab|rituximab
5670431|NCT00619671|Myasthenia Gravis|myasthenia gravis
5670432|NCT00619671|MG|mg
5670433|NCT00619658|telephone follow-up|telephone follow-up
5670434|NCT00619658|medical abortion|medical abortion
5670435|NCT00619658|induced abortion|induced abortion
5670436|NCT00619645|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5670437|NCT00619645|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5670438|NCT00619645|refractory anemia with excess blasts|refractory anemia with excess blasts
5663925|NCT00645970|chronic pain|chronic pain
5670440|NCT00619645|refractory anemia|refractory anemia
5670441|NCT00619645|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5670442|NCT00619645|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5670443|NCT00619645|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5670444|NCT00619645|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5670445|NCT00619645|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5670446|NCT00619645|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5670447|NCT00619645|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5670448|NCT00619645|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5670449|NCT00619645|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5670450|NCT00619645|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5670451|NCT00619645|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5670452|NCT00619645|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5670453|NCT00619645|refractory multiple myeloma|refractory multiple myeloma
5670454|NCT00619645|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5670455|NCT00619645|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5670456|NCT00619645|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5670457|NCT00619645|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5670458|NCT00619645|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5670459|NCT00619645|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5670460|NCT00619645|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5670461|NCT00619645|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5670462|NCT00619645|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5670463|NCT00619645|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5670464|NCT00619645|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5670465|NCT00619645|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5670466|NCT00619645|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5670467|NCT00619645|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5670468|NCT00619645|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5670469|NCT00619645|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5670470|NCT00619645|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5670471|NCT00619645|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5670472|NCT00619645|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5670473|NCT00619645|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5670474|NCT00619645|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5670475|NCT00619645|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5670476|NCT00619645|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5670477|NCT00619645|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5670478|NCT00619645|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5670479|NCT00619645|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5670480|NCT00619645|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5670481|NCT00619645|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5670482|NCT00619645|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5670483|NCT00619645|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5670484|NCT00619645|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5670485|NCT00619645|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5670486|NCT00619645|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5670487|NCT00619645|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5670488|NCT00619645|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5670489|NCT00619645|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5670490|NCT00619645|stage I multiple myeloma|stage i multiple myeloma
5670491|NCT00619645|stage II multiple myeloma|stage ii multiple myeloma
5670492|NCT00619645|stage III multiple myeloma|stage iii multiple myeloma
5670493|NCT00619645|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5670494|NCT00619645|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5670495|NCT00619619|MDD|mdd
5670496|NCT00619619|Child|child
5670497|NCT00619619|Adolescent|adolescent
5670498|NCT00619619|Pharmacokinetic|pharmacokinetic
5670499|NCT00619619|Outpatient|outpatient
5670500|NCT00619619|Pediatrics|pediatrics
5670501|NCT00619619|Depressive Disorder|depressive disorder
5670502|NCT00619619|Major|major
5670503|NCT00619606|prevention of hypoxia|prevention of hypoxia
5670504|NCT00619606|prevention of hypercapnia|prevention of hypercapnia
5670505|NCT00619593|Heart failure|heart failure
5670506|NCT00619593|Ventricular Fibrillation|ventricular fibrillation
5670507|NCT00619593|Sudden cardiac death|sudden cardiac death
5670508|NCT00619593|Hospitalization due to heart failure|hospitalization due to heart failure
5670509|NCT00619593|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5670510|NCT00619593|Risk of 1st heart failure hospitalization|risk of 1st heart failure hospitalization
5670511|NCT00619580|E coli|e coli
5670512|NCT00619567|Cognition|cognition
5670513|NCT00619567|Rehabilitation|rehabilitation
5670514|NCT00619567|Cognitive Stimulation|cognitive stimulation
5670515|NCT00619567|Human Immunodeficiency Virus|human immunodeficiency virus
5670516|NCT00619567|AIDS|aids
5670517|NCT00619554|Healthy volunteers|healthy volunteers
5670518|NCT00619541|HCC|hcc
5670519|NCT00619541|Sorafenib|sorafenib
5670520|NCT00619541|Pisa|pisa
5670521|NCT00619541|Ricci|ricci
5670522|NCT00619541|5-FU|5-fu
5670523|NCT00619541|5FU|5fu
5670524|NCT00619541|5 FU|5 fu
5670525|NCT00619541|Advanced HCC|advanced hcc
5670526|NCT00619528|Transplants|transplants
5670527|NCT00619528|Kidney Transplantation|kidney transplantation
5670528|NCT00619528|Immunosuppression|immunosuppression
5670529|NCT00619528|HLA Antigens|hla antigens
5670530|NCT00619528|Stem Cells|stem cells
5670531|NCT00619528|Bone Marrow|bone marrow
5670532|NCT00619515|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5670533|NCT00619515|stage I prostate cancer|stage i prostate cancer
5670534|NCT00619515|stage II prostate cancer|stage ii prostate cancer
5670535|NCT00619502|Hepatitis B|hepatitis b
5670536|NCT00619502|Polio|polio
5670537|NCT00619502|Diphtheria|diphtheria
5670538|NCT00619502|Pertussis|pertussis
5670539|NCT00619502|H.influenzae type b|h.influenzae type b
5670540|NCT00619476|Neuropathic Pain|neuropathic pain
5670541|NCT00619476|Post-herpetic neuralgia|post-herpetic neuralgia
5670543|NCT00619463|Traumatic Brain Injury|traumatic brain injury
5670544|NCT00619463|Exercise|exercise
5670545|NCT00619463|Cognition|cognition
5670546|NCT00619463|Brain Derived Neurotrophic Factor (BDNF)|brain derived neurotrophic factor (bdnf)
5670547|NCT00619463|peripheral vascular endothelial growth factor (VEGF)|peripheral vascular endothelial growth factor (vegf)
5670548|NCT00619450|atrial fibrillation|atrial fibrillation
5670549|NCT00619450|cardiac pacing|cardiac pacing
5670550|NCT00619450|CAT scanner|cat scanner
5670551|NCT00619437|schizophrenia|schizophrenia
5670552|NCT00619437|genetics|genetics
5670553|NCT00619437|family|family
5670554|NCT00619437|multiplex|multiplex
5670555|NCT00619437|haplotypes|haplotypes
5670556|NCT00619424|erlotinib|erlotinib
5670557|NCT00619424|pharmacokinetics|pharmacokinetics
5670558|NCT00619424|Solid tumors|solid tumors
5670559|NCT00619424|pemetrexed|pemetrexed
5670560|NCT00619424|anti-angiogenesis|anti-angiogenesis
5670561|NCT00619424|pazopanib (GW786034)|pazopanib (gw786034)
5670562|NCT00619424|cytokine and angiogenic factors|cytokine and angiogenic factors
5670563|NCT00619411|Major Depression|major depression
5670564|NCT00619411|Dysthymic Disorder|dysthymic disorder
5670565|NCT00619411|Adjustment Disorder|adjustment disorder
5670566|NCT00619411|With Depressed Mood|with depressed mood
5670567|NCT00619411|Depressive|depressive
5670568|NCT00619411|Disorder Not|disorder not
5670569|NCT00619411|Otherwise|otherwise
5670570|NCT00619411|Specified|specified
5670571|NCT00619411|Adolescent|adolescent
5670572|NCT00619411|Psychotherapy|psychotherapy
5670573|NCT00619398|FK506|fk506
5670574|NCT00619398|tacrolimus|tacrolimus
5670575|NCT00619398|prograf|prograf
5670576|NCT00619398|Liver transplantation|liver transplantation
5670577|NCT00619385|Pharmacokinetics|pharmacokinetics
5670578|NCT00619372|OKT3|okt3
5670579|NCT00619372|beta-glucosylceramide|beta-glucosylceramide
5670580|NCT00619372|oral tolerance|oral tolerance
5670581|NCT00619372|anti-CD3|anti-cd3
5670582|NCT00619372|Safety assessment and healthy volunteers|safety assessment and healthy volunteers
5670583|NCT00619346|Safety|safety
5670584|NCT00619346|Tolerability|tolerability
5670585|NCT00619346|Assessment of potential adverse events and/or laboratory abnormalities|assessment of potential adverse events and/or laboratory abnormalities
5670586|NCT00619320|HIV primary prevention|hiv primary prevention
5670587|NCT00619320|Health promotion|health promotion
5670588|NCT00619320|Health behavior|health behavior
5670589|NCT00619320|Risk reduction behavior|risk reduction behavior
5670590|NCT00619320|Sexual behavior|sexual behavior
5670591|NCT00619320|Safe sex|safe sex
5670592|NCT00619320|Women's health|women's health
5670593|NCT00619320|Minority health|minority health
5670594|NCT00619320|Pregnant Women|pregnant women
5670595|NCT00619320|HIV seronegativity|hiv seronegativity
5670596|NCT00619294|Coronary Vasospasm|coronary vasospasm
5670597|NCT00619294|Endothelium, Vascular|endothelium, vascular
5670598|NCT00619294|Vasodilation|vasodilation
5670599|NCT00619294|Hyperemia|hyperemia
5670600|NCT00619281|Cardiac surgery|cardiac surgery
5670601|NCT00619281|Low cardiac output syndrome|low cardiac output syndrome
5670602|NCT00619281|Mortality|mortality
5670603|NCT00619281|Morbidity|morbidity
5670604|NCT00619268|Temsirolimus|temsirolimus
5670605|NCT00619268|Bevacizumab|bevacizumab
5670606|NCT00619268|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5670607|NCT00619268|Non-progression|non-progression
5670609|NCT00619255|Quality Assurance and Improvement|quality assurance and improvement
5670610|NCT00619255|Substance Abuse|substance abuse
5670611|NCT00619255|Posttraumatic Stress|posttraumatic stress
5670612|NCT00619255|Family Centered Care|family centered care
5670613|NCT00619255|Trauma Systems|trauma systems
5670614|NCT00619242|Esophageal cancer|esophageal cancer
5670615|NCT00619229|Alprostadil|alprostadil
5670616|NCT00619229|prostaglandin E1|prostaglandin e1
5670617|NCT00619229|Prostavasin®|prostavasin®
5670618|NCT00619229|macular degeneration|macular degeneration
5670619|NCT00619216|Orthotopic Liver Transplant Recipients with GI disturbance|orthotopic liver transplant recipients with gi disturbance
5651747|NCT00694694|Malaria|malaria
5670620|NCT00619203|Bacterial meningitis|bacterial meningitis
5670621|NCT00619203|glycerol|glycerol
5670622|NCT00619203|high dose paracetamol|high dose paracetamol
5670623|NCT00619203|children|children
5670624|NCT00619190|open label|open label
5670625|NCT00619190|aripiprazole|aripiprazole
5670626|NCT00619190|children|children
5670627|NCT00619190|adolescents|adolescents
5671685|NCT00614835|Gemcitabine|gemcitabine
5670628|NCT00619190|autism spectrum disorders|autism spectrum disorders
5670629|NCT00619164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5670630|NCT00619164|Coronary Stenosis|coronary stenosis
5670631|NCT00619164|Coronary Thrombosis|coronary thrombosis
5670632|NCT00619151|aortic valve|aortic valve
5670633|NCT00619151|heart valve|heart valve
5670634|NCT00619151|valve replacement|valve replacement
5670635|NCT00619151|Valve disease|valve disease
5670636|NCT00619138|Cognitive therapy|cognitive therapy
5670637|NCT00619138|Stepped care|stepped care
5670638|NCT00619138|Self-help|self-help
5670639|NCT00619138|Internet|internet
5670640|NCT00619138|Anxiety|anxiety
5670641|NCT00619112|adult glioblastoma|adult glioblastoma
5670642|NCT00619112|adult gliosarcoma|adult gliosarcoma
5670643|NCT00619112|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5670644|NCT00619112|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5670645|NCT00619112|adult mixed glioma|adult mixed glioma
5670646|NCT00619112|recurrent adult brain tumor|recurrent adult brain tumor
5670647|NCT00619099|Myelodysplastic Syndrome|myelodysplastic syndrome
5670648|NCT00619099|Decitabine|decitabine
5670649|NCT00619099|Dacogen|dacogen
5670650|NCT00619099|MGI PHARMA, Inc.|mgi pharma, inc.
5670651|NCT00619086|thyroidectomy|thyroidectomy
5670652|NCT00619086|dexamethasone|dexamethasone
5670653|NCT00619086|steroid|steroid
5670654|NCT00619086|nausea|nausea
5670655|NCT00619073|blood platelets|blood platelets
5670656|NCT00619073|platelet aggregation inhibitors|platelet aggregation inhibitors
5670657|NCT00619073|antiplatelet drugs|antiplatelet drugs
5670658|NCT00619073|clopidogrel|clopidogrel
5670659|NCT00619060|skin cancer|skin cancer
5670660|NCT00619060|healthy, no evidence of disease|healthy, no evidence of disease
5670661|NCT00619021|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5670662|NCT00619021|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5670663|NCT00619021|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5670664|NCT00619008|obesity|obesity
5670665|NCT00619008|low carbohydrate diet|low carbohydrate diet
5670666|NCT00619008|high complex carbohydrate diet|high complex carbohydrate diet
5670667|NCT00619008|weight regulation hormones|weight regulation hormones
5670668|NCT00619008|hunger|hunger
5670669|NCT00619008|satiety|satiety
5670670|NCT00619008|energy expenditure|energy expenditure
5670671|NCT00619008|body composition|body composition
5670672|NCT00619008|weight loss|weight loss
5670673|NCT00618982|Kidney cancer,|kidney cancer,
5670674|NCT00618982|Sorafenib,|sorafenib,
5670675|NCT00618982|Dose escalation,|dose escalation,
5670676|NCT00618982|No previous treatment|no previous treatment
5670677|NCT00618969|Haploidentical|haploidentical
5670678|NCT00618969|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5670679|NCT00618969|leukemia|leukemia
5670680|NCT00618969|myeloma|myeloma
5670681|NCT00618969|Hodgkin's disease|hodgkin's disease
5670682|NCT00618969|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5670683|NCT00618956|NSRI|nsri
5670684|NCT00618956|milnacipran|milnacipran
5670685|NCT00618956|fibromyalgia|fibromyalgia
5670686|NCT00618956|blood pressure|blood pressure
5670687|NCT00618956|hypertension|hypertension
5670688|NCT00618917|NSCLC|nsclc
5670689|NCT00618917|lung cancer|lung cancer
5670690|NCT00618917|chemotherapy|chemotherapy
5670691|NCT00618917|radiation therapy|radiation therapy
5670692|NCT00618917|radiation toxicity|radiation toxicity
5670694|NCT00618904|Functional Gastrointestinal Symptoms|functional gastrointestinal symptoms
5670695|NCT00618865|Omega-3 Fatty Acids|omega-3 fatty acids
5670696|NCT00618865|Major Depressive Disorder|major depressive disorder
5670697|NCT00618865|Pregnancy|pregnancy
5670698|NCT00618865|Women during pregnancy and after childbirth are more vulnerable to psychiatric disorders|women during pregnancy and after childbirth are more vulnerable to psychiatric disorders
5670699|NCT00618865|Pharmacotherapy for depression during pregnancy is a clinical dilemma.|pharmacotherapy for depression during pregnancy is a clinical dilemma.
5670700|NCT00618865|Omega-3 polyunsaturated fatty acids (PUFAs) might be a promising alternative of treatment for pregnant women with depression.|omega-3 polyunsaturated fatty acids (pufas) might be a promising alternative of treatment for pregnant women with depression.
5670701|NCT00618852|Pediatrics|pediatrics
5670702|NCT00618852|Erythrocyte Transfusion|erythrocyte transfusion
5670703|NCT00618852|Furosemide|furosemide
5670704|NCT00618852|Fluid Overload|fluid overload
5670705|NCT00618839|Complex skin defects|complex skin defects
5670706|NCT00618839|Burns|burns
5670707|NCT00618839|Wound infection|wound infection
5670708|NCT00618839|Skin trauma|skin trauma
5670709|NCT00618826|Breast cancer|breast cancer
5670710|NCT00618800|Falls|falls
5670711|NCT00618800|Elderly|elderly
5670712|NCT00618800|Injury|injury
5670713|NCT00618800|Medication|medication
5670714|NCT00618800|Pharmacy|pharmacy
5670715|NCT00618800|Pharmacist|pharmacist
5670716|NCT00618761|glucose clamp|glucose clamp
5670717|NCT00618761|beta-cell|beta-cell
5670718|NCT00618748|Bipolar|bipolar
5670719|NCT00618709|Healthy volunteers|healthy volunteers
5670720|NCT00618696|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5670721|NCT00618696|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5670722|NCT00618696|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5670723|NCT00618696|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5670724|NCT00618696|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5670725|NCT00618696|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5670726|NCT00618696|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5685576|NCT00555529|COPD|copd
5670727|NCT00618696|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5670728|NCT00618696|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5670729|NCT00618696|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5670730|NCT00618696|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5670732|NCT00618683|Atrioventricular|atrioventricular
5670733|NCT00618683|nodal reentrant circuit|nodal reentrant circuit
5670734|NCT00618683|nodal reentrant tachycardia|nodal reentrant tachycardia
5670735|NCT00618683|Paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia
5670736|NCT00618670|aging|aging
5670737|NCT00618670|gait|gait
5670738|NCT00618670|musculoskeletal disorder therapy|musculoskeletal disorder therapy
5670739|NCT00618670|peripheral blood vessel disorder|peripheral blood vessel disorder
5670740|NCT00618670|muscle function|muscle function
5670741|NCT00618670|muscle strength|muscle strength
5670742|NCT00618670|quality of life|quality of life
5670743|NCT00618657|pre-operative|pre-operative
5670744|NCT00618657|neo-adjuvant|neo-adjuvant
5670745|NCT00618657|triple negative|triple negative
5670746|NCT00618657|HER2 positive|her2 positive
5670747|NCT00618657|hormone receptor positive|hormone receptor positive
5670748|NCT00618657|breast|breast
5670749|NCT00618657|Carboplatin|carboplatin
5670750|NCT00618657|Nab-paclitaxel|nab-paclitaxel
5670751|NCT00618657|Trastuzumab|trastuzumab
5670752|NCT00618657|Bevacizumab|bevacizumab
5670753|NCT00618657|Inflammatory|inflammatory
5670754|NCT00618631|Smoking|smoking
5670755|NCT00618631|Nicotine|nicotine
5670756|NCT00618631|Endogenous Opioids|endogenous opioids
5670757|NCT00618631|PET Study|pet study
5670758|NCT00618631|Carfentanil|carfentanil
5670759|NCT00618605|HIV Seronegativity|hiv seronegativity
5670760|NCT00618605|HIV Preventative Vaccine|hiv preventative vaccine
5670761|NCT00618592|carbohydrate supplementation|carbohydrate supplementation
5670762|NCT00618592|cardiac surgery|cardiac surgery
5670763|NCT00618592|spine surgery|spine surgery
5670764|NCT00618592|insulin resistance|insulin resistance
5670765|NCT00618592|insulin sensitivity|insulin sensitivity
5670766|NCT00618592|short insulin tolerance test|short insulin tolerance test
5670767|NCT00618592|HOMA|homa
5670768|NCT00618592|outcomes|outcomes
5670769|NCT00618579|Interaction with LMWH or warfarin|interaction with lmwh or warfarin
5670770|NCT00618566|Women with physical Disabilities|women with physical disabilities
5670771|NCT00618566|Secondary Conditions|secondary conditions
5670772|NCT00618566|Depression|depression
5670773|NCT00618566|Cognitive Behavioral Therapy|cognitive behavioral therapy
5670774|NCT00618566|Consumer Control|consumer control
5670775|NCT00618553|Lung Cancer|lung cancer
5670776|NCT00618553|Pulmonary Rehabilitation|pulmonary rehabilitation
5670777|NCT00618553|Questionnaire|questionnaire
5670778|NCT00618553|Survey|survey
5670779|NCT00618553|Lung Function|lung function
5670780|NCT00618553|Quality of Life|quality of life
5670781|NCT00618540|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5671836|NCT00614172|Radiation|radiation
5670782|NCT00618527|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5670783|NCT00618527|multiple sclerosis|multiple sclerosis
5670784|NCT00618514|Varicose Veins|varicose veins
5670785|NCT00618514|Laser Ablation|laser ablation
5670786|NCT00618514|Laser Wire Fibers|laser wire fibers
5670787|NCT00618501|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5670788|NCT00618488|Probiotics|probiotics
5670789|NCT00618488|BB12|bb12
5670790|NCT00618488|Gastrointestinal Symptoms|gastrointestinal symptoms
5670791|NCT00618475|Depression|depression
5670792|NCT00618475|End Stage Renal Disease|end stage renal disease
5670793|NCT00618475|Kidney Disease|kidney disease
5670794|NCT00618475|Mental Health|mental health
5670795|NCT00618462|Cognitive Behavioral Therapy|cognitive behavioral therapy
5670796|NCT00618462|Pathological Gambling|pathological gambling
5670797|NCT00618449|Trachoma|trachoma
5670798|NCT00618449|Chlamydia trachomatis|chlamydia trachomatis
5670799|NCT00618436|Seizures|seizures
5670800|NCT00618436|Traumatic Brain Injury|traumatic brain injury
5670801|NCT00618436|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5670802|NCT00618423|Neuropathic pain|neuropathic pain
5670803|NCT00618423|Chronic pain|chronic pain
5670804|NCT00618423|Acute postoperative pain|acute postoperative pain
5670805|NCT00618423|Ketamine|ketamine
5670806|NCT00618423|Back surgery|back surgery
5670807|NCT00618423|Anesthesia|anesthesia
5670808|NCT00618423|Perioperative|perioperative
5670809|NCT00618397|ketamine|ketamine
5670810|NCT00618397|pharmacokinetics|pharmacokinetics
5670811|NCT00618397|sedation|sedation
5670812|NCT00618397|critical care|critical care
5670813|NCT00618397|opioid tolerance|opioid tolerance
5670814|NCT00618397|NMDA Antagonist|nmda antagonist
5670815|NCT00618384|TACE|tace
5670816|NCT00618384|hepatocellular carcinoma|hepatocellular carcinoma
5670817|NCT00618371|Intensification|intensification
5670818|NCT00618371|HIV viremia|hiv viremia
5670819|NCT00618371|Human Immunodeficiency Virus|human immunodeficiency virus
5670820|NCT00618345|refractory multiple myeloma|refractory multiple myeloma
5670821|NCT00618293|intraoperative bleeding|intraoperative bleeding
5670822|NCT00618293|aortic-valve replacement|aortic-valve replacement
5670824|NCT00618293|Von Willebrand|von willebrand
5670825|NCT00618293|HEAMATE|heamate
5670826|NCT00618254|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
5670827|NCT00618241|interactions|interactions
5670828|NCT00618241|neuropathic pain|neuropathic pain
5670829|NCT00618241|pharmacokinetics|pharmacokinetics
5670830|NCT00618215|cluster-randomised trial|cluster-randomised trial
5670831|NCT00618215|routine oral examination|routine oral examination
5670832|NCT00618215|implementation research|implementation research
5670833|NCT00618215|practice based research|practice based research
5670834|NCT00618215|CPG|cpg
5670835|NCT00618215|recall interval assignment for routine oral examination|recall interval assignment for routine oral examination
5670836|NCT00618215|prescription bitewing radiographs|prescription bitewing radiographs
5670837|NCT00618215|preventive advice and feed back oral disease|preventive advice and feed back oral disease
5670838|NCT00618176|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5670839|NCT00618176|adverse effects|adverse effects
5670840|NCT00618176|Treatment Outcome|treatment outcome
5670841|NCT00618176|Drug Resistance, Viral|drug resistance, viral
5670842|NCT00618176|treatment naïve|treatment naïve
5670843|NCT00618163|Anti-inflammatory|anti-inflammatory
5670844|NCT00618150|GERD|gerd
5670845|NCT00618150|Dyspepsia|dyspepsia
5670846|NCT00618150|Education|education
5670847|NCT00618150|Information|information
5670848|NCT00618137|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5670849|NCT00618137|Gene expression profiling|gene expression profiling
5670850|NCT00618137|Inert dusts|inert dusts
5670851|NCT00618137|Natural course|natural course
5670852|NCT00618137|Prospective assessment|prospective assessment
5670853|NCT00618124|solid tumor malignancy, SU011248, sunitinib, capecitabine, Phase 1|solid tumor malignancy, su011248, sunitinib, capecitabine, phase 1
5670854|NCT00618111|Prevention of nausea and vomiting associated with radiation or chemotherapy|prevention of nausea and vomiting associated with radiation or chemotherapy
5670855|NCT00618098|anticoagulant reversal|anticoagulant reversal
5670856|NCT00618098|urgent surgery|urgent surgery
5670857|NCT00618098|invasive procedures|invasive procedures
5670858|NCT00618098|vitamin K|vitamin k
5670859|NCT00618098|prothrombin complex concentrate|prothrombin complex concentrate
5670860|NCT00618072|hyperinsulinemia|hyperinsulinemia
5670861|NCT00618072|insulin resistance|insulin resistance
5670862|NCT00618072|perimenopause|perimenopause
5670863|NCT00618072|obesity|obesity
5670864|NCT00618072|overweight|overweight
5670865|NCT00618072|women|women
5670866|NCT00618033|Hemodialysis|hemodialysis
5670867|NCT00618033|ESRD|esrd
5670868|NCT00618020|CTO|cto
5670869|NCT00618020|Chronic Total Occlusion|chronic total occlusion
5670870|NCT00618020|Revascularization|revascularization
5670871|NCT00617994|psoriasis|psoriasis
5670872|NCT00617981|hepatocellular carcinoma|hepatocellular carcinoma
5670873|NCT00617981|liver cancer|liver cancer
5670874|NCT00617942|Breast Cancer|breast cancer
5670875|NCT00617929|chronic myelogenous leukemia|chronic myelogenous leukemia
5670876|NCT00617929|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5670877|NCT00617929|chronic myeloid leukemia|chronic myeloid leukemia
5670878|NCT00617929|lymphoblastic leukemia|lymphoblastic leukemia
5670879|NCT00617929|acute myeloid leukemia|acute myeloid leukemia
5670880|NCT00617929|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5670881|NCT00617929|primary myelofibrosis|primary myelofibrosis
5670882|NCT00617929|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5670883|NCT00617929|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5670884|NCT00617929|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5670885|NCT00617929|disseminated neuroblastoma|disseminated neuroblastoma
5670886|NCT00617929|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5670887|NCT00617929|Burkitt lymphoma|burkitt lymphoma
5670888|NCT00617929|rhabdomyosarcoma|rhabdomyosarcoma
5670889|NCT00617929|myelodysplastic syndromes|myelodysplastic syndromes
5670890|NCT00617929|Hodgkin lymphoma|hodgkin lymphoma
5670891|NCT00617929|lymphoblastic lymphoma|lymphoblastic lymphoma
5670892|NCT00617929|breast cancer|breast cancer
5670893|NCT00617929|follicular lymphoma|follicular lymphoma
5670894|NCT00617929|mantle cell lymphoma|mantle cell lymphoma
5670895|NCT00617929|marginal zone lymphoma|marginal zone lymphoma
5670896|NCT00617929|recurrent neuroblastoma|recurrent neuroblastoma
5670897|NCT00617929|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5670898|NCT00617929|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5670899|NCT00617929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5670900|NCT00617929|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5671686|NCT00614835|Docetaxel|docetaxel
5670901|NCT00617929|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5670902|NCT00617929|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5670903|NCT00617929|refractory hairy cell leukemia|refractory hairy cell leukemia
5670904|NCT00617929|refractory multiple myeloma|refractory multiple myeloma
5670905|NCT00617929|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5670906|NCT00617929|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5670907|NCT00617929|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5670908|NCT00617929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5670909|NCT00617929|stage I multiple myeloma|stage i multiple myeloma
5670910|NCT00617929|stage II multiple myeloma|stage ii multiple myeloma
5670911|NCT00617929|stage III multiple myeloma|stage iii multiple myeloma
5670912|NCT00617929|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5670913|NCT00617929|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5670914|NCT00617929|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5670915|NCT00617929|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5670916|NCT00617929|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5670917|NCT00617929|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5670918|NCT00617929|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5670919|NCT00617929|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5670920|NCT00617929|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5670921|NCT00617929|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5670922|NCT00617929|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5670923|NCT00617929|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5670924|NCT00617929|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5670925|NCT00617929|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5670926|NCT00617929|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5670927|NCT00617929|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5670928|NCT00617929|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5670929|NCT00617929|stage IIIA breast cancer|stage iiia breast cancer
5670930|NCT00617929|stage IIIB breast cancer|stage iiib breast cancer
5670931|NCT00617929|stage IIIC breast cancer|stage iiic breast cancer
5670932|NCT00617929|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5670933|NCT00617929|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5670934|NCT00617929|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5670935|NCT00617929|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5670936|NCT00617929|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5670937|NCT00617929|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5670938|NCT00617929|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5670939|NCT00617929|stage IV breast cancer|stage iv breast cancer
5670940|NCT00617929|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5670941|NCT00617929|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5670942|NCT00617929|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5670943|NCT00617929|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5670944|NCT00617929|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5670945|NCT00617929|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5670946|NCT00617929|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5670947|NCT00617929|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5670948|NCT00617929|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5670949|NCT00617916|hyperspectral imaging|hyperspectral imaging
5670950|NCT00617916|tissue oxygenation|tissue oxygenation
5789078|NCT00150020|MPA|mpa
5670951|NCT00617916|diabetic foot ulcers|diabetic foot ulcers
5670953|NCT00617916|prevention|prevention
5670954|NCT00617903|rosacea|rosacea
5670955|NCT00617903|papulopustular|papulopustular
5670956|NCT00617903|azelaic acid|azelaic acid
5670957|NCT00617903|foam|foam
5670958|NCT00617890|anti-IGF-1R|anti-igf-1r
5670959|NCT00617851|Influenza|influenza
5670960|NCT00617851|adults|adults
5670961|NCT00617851|different lots|different lots
5670962|NCT00617851|trivalent subunit influenza virus vaccine (IVV)|trivalent subunit influenza virus vaccine (ivv)
5670963|NCT00617851|trivalent subunit influenza vaccine|trivalent subunit influenza vaccine
5670964|NCT00617838|Celiac disease|celiac disease
5670965|NCT00617838|genetic risk|genetic risk
5670966|NCT00617838|gluten introduction|gluten introduction
5670967|NCT00617838|predicting antibodies|predicting antibodies
5670968|NCT00617825|chronic venous disorders|chronic venous disorders
5670969|NCT00617825|cryotherapy|cryotherapy
5670970|NCT00617825|skin microcirculation|skin microcirculation
5670971|NCT00617825|skin temperature|skin temperature
5670972|NCT00617812|Vaccine|vaccine
5670973|NCT00617812|Prevention|prevention
5670974|NCT00617812|Diphtheria|diphtheria
5670975|NCT00617812|Tetanus|tetanus
5670976|NCT00617812|Pertussis|pertussis
5670977|NCT00617812|Hepatitis B|hepatitis b
5670978|NCT00617812|Haemophilus influenzae type b|haemophilus influenzae type b
5670979|NCT00617812|Healthy infants|healthy infants
5670980|NCT00617799|stage IV renal cell cancer|stage iv renal cell cancer
5670981|NCT00617799|stage IV melanoma|stage iv melanoma
5670982|NCT00617786|urinary urgency|urinary urgency
5670983|NCT00617786|urinary frequency|urinary frequency
5670984|NCT00617786|urge incontinence|urge incontinence
5670985|NCT00617786|sacral neuromodulation therapy|sacral neuromodulation therapy
5670987|NCT00617786|frequency|frequency
5670988|NCT00617773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5670989|NCT00617773|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5670990|NCT00617773|recurrent primary peritoneal cancer|recurrent primary peritoneal cancer
5670991|NCT00617747|Zolmitriptan|zolmitriptan
5670993|NCT00617747|migraine|migraine
5670994|NCT00617747|headache response|headache response
5670995|NCT00617747|headache|headache
5670996|NCT00617747|headache pain|headache pain
5670997|NCT00617734|Squamous Cell Carcinoma in Head and Neck|squamous cell carcinoma in head and neck
5670998|NCT00617734|Prior Platinum-based chemotherapy|prior platinum-based chemotherapy
5670999|NCT00617734|Cetuximab|cetuximab
5671000|NCT00617734|Erbitux|erbitux
5671001|NCT00617734|IMC-A12|imc-a12
5671002|NCT00617721|Defective gene(s) in plasma membrane remodelling.|defective gene(s) in plasma membrane remodelling.
5671003|NCT00617721|Scott syndrome,|scott syndrome,
5671004|NCT00617721|Reduced prothrombin consumption,|reduced prothrombin consumption,
5671005|NCT00617721|Circulating biomakers of scott syndrome|circulating biomakers of scott syndrome
5671006|NCT00617695|Zolmitriptan|zolmitriptan
5671007|NCT00617695|ZOMIG|zomig
5671008|NCT00617695|migraine|migraine
5671009|NCT00617695|headache response|headache response
5671010|NCT00617695|headache|headache
5671011|NCT00617695|headache pain|headache pain
5671012|NCT00617682|Maternal immunization|maternal immunization
5671013|NCT00617682|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5671014|NCT00617682|Otitis media|otitis media
5671015|NCT00617669|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5671016|NCT00617669|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5671017|NCT00617669|Endothelin A|endothelin a
5671018|NCT00617669|Endothelin A antagonist|endothelin a antagonist
5671019|NCT00617656|LUNG CANCER|lung cancer
5671020|NCT00617643|Nevirapine|nevirapine
5671021|NCT00617643|Rifampicin|rifampicin
5671022|NCT00617643|Pharmacokinetics|pharmacokinetics
5671023|NCT00617617|isoflavones|isoflavones
5671024|NCT00617617|soy|soy
5671025|NCT00617604|kidney transplant|kidney transplant
5671026|NCT00617604|alefacept|alefacept
5671027|NCT00617591|Lenalidomide|lenalidomide
5671028|NCT00617591|Revlimid|revlimid
5671029|NCT00617591|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5671030|NCT00617591|Doxil|doxil
5671031|NCT00617591|Dexamethasone|dexamethasone
5671032|NCT00617591|Decadron|decadron
5671033|NCT00617578|Antitachy pacing|antitachy pacing
5671034|NCT00617578|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5671035|NCT00617552|postoperative ileus|postoperative ileus
5671036|NCT00617552|POI|poi
5671037|NCT00617552|major open abdominal surgery|major open abdominal surgery
5671038|NCT00617539|recurrent breast cancer|recurrent breast cancer
5671039|NCT00617539|stage IV breast cancer|stage iv breast cancer
5671040|NCT00617539|male breast cancer|male breast cancer
5671041|NCT00617539|tumors metastatic to brain|tumors metastatic to brain
5671043|NCT00617526|treatment naïve|treatment naïve
5671044|NCT00617500|climacteric|climacteric
5671045|NCT00617500|complementary therapy|complementary therapy
5671046|NCT00617500|hormonal replacement therapy|hormonal replacement therapy
5671047|NCT00617474|erythropoietin|erythropoietin
5671048|NCT00617474|kidney allograft survival|kidney allograft survival
5671049|NCT00617474|Recombinant Erythropoietin|recombinant erythropoietin
5789079|NCT00150020|EC-MPS|ec-mps
5671050|NCT00617474|erythropoietin (Epo)-induced protein 29, human|erythropoietin (epo)-induced protein 29, human
5671051|NCT00617461|Post-herpetic neuralgia(PHN)|post-herpetic neuralgia(phn)
5671053|NCT00617448|diathermy hemorrhoids|diathermy hemorrhoids
5671054|NCT00617448|Ligasure|ligasure
5671055|NCT00617448|randomized controlled trial|randomized controlled trial
5671056|NCT00617448|Postoperative pain|postoperative pain
5671057|NCT00617448|Surgical Procedure, Ambulatory|surgical procedure, ambulatory
5671058|NCT00617448|Local Anesthesia|local anesthesia
5671059|NCT00617448|Safety procedure long term|safety procedure long term
5671060|NCT00617448|Day Surgery|day surgery
5671061|NCT00617435|Trans fatty acid|trans fatty acid
5671062|NCT00617435|Insulin resistance|insulin resistance
5671063|NCT00617435|Skeletal muscle|skeletal muscle
5671064|NCT00617435|Adipose tissue|adipose tissue
5671065|NCT00617409|SCLC|sclc
5671066|NCT00617409|vaccine|vaccine
5671067|NCT00617409|immunize|immunize
5671068|NCT00617396|Irritable Bowel Syndrome|irritable bowel syndrome
5671069|NCT00617396|Seroquel|seroquel
5671070|NCT00617396|Abdominal Pain|abdominal pain
5671071|NCT00617383|demyelinating disease|demyelinating disease
5671072|NCT00617383|multiple sclerosis|multiple sclerosis
5671073|NCT00617383|female monozygotic identical twins|female monozygotic identical twins
5671074|NCT00617383|MS|ms
5671082|NCT00617370|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5671083|NCT00617357|incisional hernia|incisional hernia
5671084|NCT00617357|abdominal hernia repair|abdominal hernia repair
5671085|NCT00617357|Ventral incisional hernia repair|ventral incisional hernia repair
5671086|NCT00617344|Dengue fever|dengue fever
5671087|NCT00617344|Dengue hemorrhagic fever|dengue hemorrhagic fever
5671088|NCT00617344|Dengue virus|dengue virus
5671089|NCT00617331|vaccine, priming, influenza, flu, A/H9N2|vaccine, priming, influenza, flu, a/h9n2
5671090|NCT00617318|Pomegranate|pomegranate
5671091|NCT00617318|Influenza|influenza
5671092|NCT00617318|Common Cold|common cold
5671093|NCT00617318|Cough|cough
5671094|NCT00617318|Severity|severity
5671095|NCT00617318|Efficacy|efficacy
5671096|NCT00617305|ambrisentan|ambrisentan
5671098|NCT00617305|combination therapy|combination therapy
5671099|NCT00617305|phosphodiesterase type-5 inhibitor (PDE-5i)|phosphodiesterase type-5 inhibitor (pde-5i)
5671100|NCT00617305|cardiovascular|cardiovascular
5671101|NCT00617305|endothelin receptor antagonist|endothelin receptor antagonist
5671102|NCT00617305|ERA|era
5671103|NCT00617292|21-hydroxylase deficiency|21-hydroxylase deficiency
5671104|NCT00617292|21OHD|21ohd
5671105|NCT00617292|CAH|cah
5671106|NCT00617266|tobacco, cessation, BPO, RCT, KAP|tobacco, cessation, bpo, rct, kap
5671107|NCT00617240|antipsychotic|antipsychotic
5671108|NCT00617240|metformin|metformin
5671109|NCT00617240|children|children
5671110|NCT00617240|adolescents|adolescents
5671111|NCT00617227|Enteral vancomycin therapy, serum vancomycin levels, renal failure|enteral vancomycin therapy, serum vancomycin levels, renal failure
5671112|NCT00617214|Schizophrenia|schizophrenia
5671113|NCT00617214|Integrated care program|integrated care program
5671114|NCT00617214|Seroquel|seroquel
5671115|NCT00617201|cocaine|cocaine
5671116|NCT00617201|dependence|dependence
5671117|NCT00617201|stimulants|stimulants
5671118|NCT00617188|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5671119|NCT00617175|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5671120|NCT00617175|therapies reduction|therapies reduction
5671121|NCT00617175|Shocks|shocks
5671122|NCT00617175|Quality of Life|quality of life
5671123|NCT00617149|exercise,|exercise,
5671124|NCT00617149|excessive weight gain during pregnancy|excessive weight gain during pregnancy
5671125|NCT00617136|Surgery|surgery
5671126|NCT00617136|Anesthesia|anesthesia
5671127|NCT00617136|Hypothermia|hypothermia
5671128|NCT00617136|Temperature|temperature
5671129|NCT00617136|Perioperative|perioperative
5671130|NCT00617136|Temperature Management|temperature management
5671131|NCT00617110|diesel exhaust particles|diesel exhaust particles
5671132|NCT00617110|live attenuated influenza virus vaccine|live attenuated influenza virus vaccine
5671133|NCT00617110|flu vaccine|flu vaccine
5671134|NCT00617097|Pain associated with first trimester surgical abortion|pain associated with first trimester surgical abortion
5671135|NCT00617084|Drug Eluting Stents|drug eluting stents
5671136|NCT00617084|Interventional Cardiology|interventional cardiology
5671137|NCT00617071|colon cancer|colon cancer
5671138|NCT00617071|rectal cancer|rectal cancer
5671139|NCT00617058|antipsychotic|antipsychotic
5671141|NCT00617058|children|children
5671142|NCT00617058|adolescents|adolescents
5671143|NCT00617045|Post Partum Depression|post partum depression
5671144|NCT00617006|Anesthesia Workspace|anesthesia workspace
5671145|NCT00617006|Hospital Acquired Infections|hospital acquired infections
5671147|NCT00617006|Alcohol Based Cleanser|alcohol based cleanser
5671148|NCT00617006|Bacterial Contamination|bacterial contamination
5671149|NCT00616980|PAD|pad
5671150|NCT00616980|PVD|pvd
5671151|NCT00616980|CLI|cli
5671152|NCT00616980|Stem Cells|stem cells
5671159|NCT00616954|mismatched|mismatched
5671160|NCT00616954|Stem cell transplatation|stem cell transplatation
5664744|NCT00641914|Asthma|asthma
4955343|NCT04268108|liquid tumor-infiltrating lymphocytes|liquid tumor-infiltrating lymphocytes
4955344|NCT04268108|anti-PD-1|anti-pd-1
4955404|NCT04267692|Indigenous Medicine|indigenous medicine
4955405|NCT04267692|American Indian|american indian
4955406|NCT04267692|Alaska Native|alaska native
4955407|NCT04267692|alcohol use disorder|alcohol use disorder
4955408|NCT04267692|alcohol treatment|alcohol treatment
4955409|NCT04267692|treatment efficacy|treatment efficacy
4955410|NCT04267692|quality of life|quality of life
4955411|NCT04267692|cultural connectedness|cultural connectedness
4955412|NCT04267666|Inspiratory|inspiratory
4955413|NCT04267666|Spirometer|spirometer
4955414|NCT04267666|Postmenopausal|postmenopausal
4955416|NCT04267653|Iron deficiency anemia|iron deficiency anemia
4955417|NCT04267653|Lactoferrin|lactoferrin
4955418|NCT04267653|Ferrous sulfate|ferrous sulfate
4955428|NCT04267549|unresectable|unresectable
4955429|NCT04267549|metastatic gastric cancer|metastatic gastric cancer
4955508|NCT04267003|schizophrenia|schizophrenia
4955510|NCT04267003|tDCS|tdcs
4955511|NCT04267003|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4955512|NCT04267003|cognitive control|cognitive control
4955513|NCT04267003|transcranial direct current stimulation|transcranial direct current stimulation
4955514|NCT04267003|GABA|gaba
4955515|NCT04267003|MR spectroscopy|mr spectroscopy
4955516|NCT04266990|Epilepsy|epilepsy
4955517|NCT04266990|Seizures|seizures
4955518|NCT04266990|Seizure detection|seizure detection
4955519|NCT04266990|Medical detection dogs|medical detection dogs
4955520|NCT04266990|Dog olfaction|dog olfaction
4955525|NCT04266925|youth soccer injury|youth soccer injury
4955526|NCT04266899|Cerebrovascular Stroke|cerebrovascular stroke
4955527|NCT04266899|Cerebral Stroke|cerebral stroke
4955528|NCT04266899|Cerebrovascular Accident|cerebrovascular accident
4955529|NCT04266899|Neurorehabilitation|neurorehabilitation
4955530|NCT04266899|Gait Rehabilitation|gait rehabilitation
4955531|NCT04266847|unilateral cataract|unilateral cataract
4955532|NCT04266847|binocular functional vision|binocular functional vision
4955533|NCT04266847|Multifocal Intraocular Lenses|multifocal intraocular lenses
4955534|NCT04266808|Spinal cord injury|spinal cord injury
4955535|NCT04266808|Pressure Ulcer|pressure ulcer
4955537|NCT04266743|Gait analysis|gait analysis
4955538|NCT04266743|Stroke|stroke
4955539|NCT04266743|FeetMe|feetme
4955540|NCT04266743|GaitRite|gaitrite
4955546|NCT04266717|development|development
4955547|NCT04266717|infant|infant
4955603|NCT04266327|Recurrent|recurrent
4955604|NCT04266327|Metastatic Squamous cell carcinomas|metastatic squamous cell carcinomas
4955605|NCT04266314|Cannabis|cannabis
4955606|NCT04266301|MBG453|mbg453
4955607|NCT04266301|Phase III|phase iii
4955608|NCT04266301|TIM-3|tim-3
4955609|NCT04266301|azacitidine|azacitidine
4955610|NCT04266301|myelodysplastic syndrome|myelodysplastic syndrome
4955611|NCT04266301|MDS|mds
4955612|NCT04266301|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
4955613|NCT04266301|CMML-2|cmml-2
4955614|NCT04266288|Ketamine|ketamine
4955615|NCT04266288|Depression|depression
4955616|NCT04266288|Suicidal Ideation|suicidal ideation
4955617|NCT04266288|Emergency Department|emergency department
4955618|NCT04266275|Cancer|cancer
4955619|NCT04266275|HIV|hiv
4955620|NCT04266275|Oncology|oncology
4955800|NCT04265391|intrauterine fetal growth|intrauterine fetal growth
4955801|NCT04265391|low birth weight|low birth weight
4955802|NCT04265391|randomized controlled trial|randomized controlled trial
4955803|NCT04265391|protein supplementation|protein supplementation
4955804|NCT04265378|memory|memory
4955805|NCT04265378|brain stimulation|brain stimulation
4955886|NCT04264754|HCC|hcc
4955897|NCT04264676|Metronidazole|metronidazole
4955898|NCT04264676|Gut Microbiota|gut microbiota
4955899|NCT04264676|Postoperative Chemotherapy|postoperative chemotherapy
4955900|NCT04264663|Allergic|allergic
4955901|NCT04264663|Penicillin|penicillin
4955902|NCT04264663|Rescue Therapy|rescue therapy
4955903|NCT04264663|Tetracycline|tetracycline
4955904|NCT04264663|Furazolidone|furazolidone
4955908|NCT04264611|Foot Core System|foot core system
4955909|NCT04264611|Plantar Intrinsic Foot Muscles|plantar intrinsic foot muscles
4955910|NCT04264611|Short Foot Exercise|short foot exercise
4955911|NCT04264611|Towel Curl Exercise|towel curl exercise
4955912|NCT04264611|Medial Longitudinal Arch|medial longitudinal arch
4955913|NCT04264611|Pedobarography;|pedobarography;
4955914|NCT04264611|Balance|balance
4955922|NCT04264559|stable angina pectoris|stable angina pectoris
4955923|NCT04264559|meridian|meridian
4955997|NCT04264169|Risk factors|risk factors
4955998|NCT04264156|intubation|intubation
4955999|NCT04264156|surfactant|surfactant
4956000|NCT04264156|continuous positive airway pressure|continuous positive airway pressure
4956001|NCT04264156|aerosol|aerosol
4956002|NCT04264156|respiratory distress syndrome|respiratory distress syndrome
4956008|NCT04264117|Atrial fibrillation|atrial fibrillation
4956009|NCT04264117|Atrial Fibrillation ablation|atrial fibrillation ablation
4956010|NCT04264117|Prospective randomized trial|prospective randomized trial
4956015|NCT04264052|excessive dynamic airway collapse|excessive dynamic airway collapse
5665509|NCT00638859|CAP|cap
4956016|NCT04264052|tracheobronchomalacia|tracheobronchomalacia
4956017|NCT04264052|large airways collapse|large airways collapse
4956018|NCT04264026|Veterans|veterans
4956019|NCT04264026|Refractory PTSD|refractory ptsd
4956020|NCT04264026|PTSD|ptsd
4956021|NCT04264026|MDMA|mdma
4956022|NCT04264013|Muscle|muscle
4956023|NCT04264013|Diet|diet
4956092|NCT04263610|Chronic Plaque Psoriasis|chronic plaque psoriasis
4956093|NCT04263584|Copanlisib|copanlisib
4956094|NCT04263571|hemoglobin|hemoglobin
4956095|NCT04263571|hepcidin|hepcidin
4956096|NCT04263493|Achilles Tendon Surgery|achilles tendon surgery
4956097|NCT04263480|MYD88 mutation|myd88 mutation
4956194|NCT04262804|Breast Cancer Metastatic|breast cancer metastatic
4956195|NCT04262804|MBC|mbc
4956196|NCT04262804|Margetuximab|margetuximab
4956197|NCT04262791|Nocturnal Scratch Algorithm|nocturnal scratch algorithm
4956198|NCT04262791|Atopic Dermatitis (AD)|atopic dermatitis (ad)
4956199|NCT04262791|Wrist Actigraphy|wrist actigraphy
4956200|NCT04262778|Chemotherapy induced peripheral neuropathy (CIPN)|chemotherapy induced peripheral neuropathy (cipn)
4956201|NCT04262778|child|child
4956202|NCT04262778|outcome|outcome
4956203|NCT04262778|electrochemical skin conductances (ESC)|electrochemical skin conductances (esc)
4956291|NCT04262115|exercise|exercise
4956292|NCT04262115|physical activity|physical activity
4956293|NCT04262115|weight loss|weight loss
4956294|NCT04262102|Children food neophobia|children food neophobia
4956295|NCT04262102|Fruit and vegetables|fruit and vegetables
4956296|NCT04262102|Mother's diet|mother's diet
4956297|NCT04262102|Breastfeeding|breastfeeding
4956298|NCT04262102|Baby-led weaning|baby-led weaning
4956299|NCT04262102|Spoon feeding|spoon feeding
4956300|NCT04262102|Nutrition|nutrition
4956301|NCT04262102|Weaning|weaning
4956390|NCT04261556|Cognitive training|cognitive training
4956391|NCT04261556|Cognitive rehabilitation|cognitive rehabilitation
4956392|NCT04261556|Cognitive remediation|cognitive remediation
4956393|NCT04261556|Neuromodulation|neuromodulation
4956394|NCT04261556|Transcranial direct current stimulation|transcranial direct current stimulation
4956395|NCT04261556|HD-tDCS|hd-tdcs
4956396|NCT04261556|Focal tDCS|focal tdcs
4956397|NCT04261543|protein|protein
4956398|NCT04261543|exercise|exercise
4956399|NCT04261543|muscle|muscle
4956400|NCT04261530|Chronic pain|chronic pain
4956401|NCT04261530|Self-hypnosis|self-hypnosis
4956402|NCT04261530|Self-care|self-care
4956403|NCT04261530|Music-therapy|music-therapy
4956404|NCT04261530|Psycho-education|psycho-education
4956405|NCT04261517|Pneumonia|pneumonia
4956408|NCT04261478|Thrombectomy|thrombectomy
4956485|NCT04260672|Child toothbrushing|child toothbrushing
4956486|NCT04260672|Parental feeding practices|parental feeding practices
4956487|NCT04260672|Parental self-efficacy|parental self-efficacy
4956488|NCT04260659|Opioid free anesthesia|opioid free anesthesia
4956489|NCT04260659|Laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
4956490|NCT04260620|Breast Screening|breast screening
4956491|NCT04260620|Breast Imaging|breast imaging
4956589|NCT04259983|Exercise Capacity|exercise capacity
4956590|NCT04259983|Respiratory Functions|respiratory functions
4956591|NCT04259983|Children|children
4956597|NCT04259957|Virtual Reality|virtual reality
4956598|NCT04259944|liquid biopsy|liquid biopsy
4956599|NCT04259944|colon cancer|colon cancer
4956600|NCT04259944|adjuvant treatment|adjuvant treatment
4956601|NCT04259944|ctDNA|ctdna
4956602|NCT04259931|Clostridium difficile|clostridium difficile
4956603|NCT04259931|relapse|relapse
4956604|NCT04259931|microbiome|microbiome
4956605|NCT04259905|active video game|active video game
4956606|NCT04259905|telemedicine|telemedicine
4956791|NCT04258774|brain metabolism|brain metabolism
4956792|NCT04258774|oxygen extraction fraction|oxygen extraction fraction
4956793|NCT04258774|cerebral vascular reactivity|cerebral vascular reactivity
4956794|NCT04258774|carbon dioxide|carbon dioxide
4956795|NCT04258722|telemedicine|telemedicine
4956796|NCT04258722|simulation|simulation
4956797|NCT04258722|neonatal resuscitation|neonatal resuscitation
4956798|NCT04258709|antenatal milk expression|antenatal milk expression
4956799|NCT04258709|antenatal colostrum|antenatal colostrum
4956800|NCT04258696|Gingival retraction|gingival retraction
4956817|NCT04258592|PET/CT|pet/ct
4956887|NCT04258215|Positive pressure ventilation|positive pressure ventilation
4956888|NCT04258215|Extraglottic Airway Device|extraglottic airway device
4956891|NCT04258163|Metastatic Breast Cancer|metastatic breast cancer
4956892|NCT04258163|Maintenance Chemotherapy|maintenance chemotherapy
4956893|NCT04258163|Maintenance Endocrine Therapy|maintenance endocrine therapy
4956991|NCT04257630|pulmonary rehabilitation|pulmonary rehabilitation
4956992|NCT04257617|solid tumors and hematologic malignancies|solid tumors and hematologic malignancies
4956993|NCT04257617|anti-CD47 antibody|anti-cd47 antibody
4956994|NCT04257604|Perampanel|perampanel
4957012|NCT04257487|Elderly|elderly
4957088|NCT04257071|Cost communication|cost communication
4957089|NCT04257071|Cost optimization|cost optimization
4957090|NCT04257071|Price transparency|price transparency
4957091|NCT04257071|Financial navigation|financial navigation
4957092|NCT04257058|Behavioral study|behavioral study
4957190|NCT04256460|primary healthcare|primary healthcare
4957195|NCT04256369|Parenteral Nutrition|parenteral nutrition
4957196|NCT04256369|Hyperkalemia|hyperkalemia
4957197|NCT04256369|Hypermagnesemia|hypermagnesemia
4957198|NCT04256369|Hyperphosphatemia|hyperphosphatemia
4957199|NCT04256369|Hypercalcemia|hypercalcemia
4957203|NCT04256343|Muscle|muscle
4957204|NCT04256343|Muscle protein synthesis|muscle protein synthesis
4957205|NCT04256343|Deuterium|deuterium
4957206|NCT04256291|total hip arthroplasty|total hip arthroplasty
4957207|NCT04256291|ceramic-on-ceramic|ceramic-on-ceramic
4957208|NCT04256291|total hip replacement|total hip replacement
4957209|NCT04256278|sperm|sperm
4957210|NCT04256278|infertility|infertility
4957211|NCT04256278|asthenospermia|asthenospermia
4957212|NCT04256278|oligospermia|oligospermia
4957213|NCT04256278|teratozoospermia|teratozoospermia
4957291|NCT04255758|glymphatic system|glymphatic system
4957292|NCT04255758|cerebral perfusion|cerebral perfusion
4957293|NCT04255758|aerobic exercise|aerobic exercise
4957294|NCT04255745|cardiovascular disease prevention|cardiovascular disease prevention
4957295|NCT04255745|muscle weakness|muscle weakness
4957296|NCT04255745|aging|aging
4957297|NCT04255745|exercise|exercise
4957303|NCT04255693|GERD|gerd
4957304|NCT04255693|NERD|nerd
4957305|NCT04255693|erosive esophagitis|erosive esophagitis
4957306|NCT04255693|diet|diet
4957307|NCT04255693|food|food
4957308|NCT04255693|adherence|adherence
4957310|NCT04255667|eyelid margin|eyelid margin
4957311|NCT04255667|hemostasis|hemostasis
4957316|NCT04255589|CKD-495|ckd-495
4957387|NCT04255173|anthropometrics|anthropometrics
4957388|NCT04255173|body composition|body composition
4957389|NCT04255160|Perimenopause|perimenopause
4957483|NCT04254380|T1DM|t1dm
4957484|NCT04254380|Diabetes Mellitus|diabetes mellitus
4957485|NCT04254380|Insulin Dependent Diabetes|insulin dependent diabetes
4957488|NCT04254367|empowerment|empowerment
4957582|NCT04253925|Stress Urinary Incontinence|stress urinary incontinence
4957583|NCT04253899|Perforated appendicitis|perforated appendicitis
4957584|NCT04253899|Pediatric appendicitis|pediatric appendicitis
4957585|NCT04253899|Appendectomy|appendectomy
4957586|NCT04253899|Appendiceal abscess|appendiceal abscess
4957587|NCT04253899|Antibiotic Therapy|antibiotic therapy
4957588|NCT04253860|Diabetic neuropathy peripheral|diabetic neuropathy peripheral
4957589|NCT04253860|diabetic complications|diabetic complications
4957590|NCT04253860|TENS|tens
4957591|NCT04253860|Neuropathic treatments|neuropathic treatments
4957592|NCT04253847|Radical antegrade modular pancreatosplenectomy|radical antegrade modular pancreatosplenectomy
4957593|NCT04253847|Standard retrograde pancreatosplenectomy|standard retrograde pancreatosplenectomy
4957679|NCT04253431|lancet|lancet
4957680|NCT04253431|fingerprick|fingerprick
4957681|NCT04253431|capillary blood|capillary blood
4957682|NCT04253431|self-monitoring of blood glucose|self-monitoring of blood glucose
4957685|NCT04253327|anxiety|anxiety
4957781|NCT04252586|Cannabidiol|cannabidiol
4957782|NCT04252586|CBD|cbd
4957783|NCT04252586|Epidiolex|epidiolex
4957784|NCT04252586|GWP42003-P|gwp42003-p
4957785|NCT04252573|Paravisceral Abdominal Aortic Aneurysm|paravisceral abdominal aortic aneurysm
4957977|NCT04251468|fluorescence assay|fluorescence assay
4957978|NCT04251468|ECG-based potassium estimation|ecg-based potassium estimation
4957982|NCT04251429|participatory|participatory
4958079|NCT04250805|Radiological guidance|radiological guidance
4958081|NCT04250805|Ropivacaine|ropivacaine
4958082|NCT04250805|Pain|pain
4958083|NCT04250792|Low dose naltrexone|low dose naltrexone
4958084|NCT04250792|psoriasis|psoriasis
4958085|NCT04250792|Psoriasis area severity index|psoriasis area severity index
4958086|NCT04250766|Uterine fibroma|uterine fibroma
4958087|NCT04250766|Suspect uterine sarcoma|suspect uterine sarcoma
4958088|NCT04250766|Echo-guided biopsy|echo-guided biopsy
4958179|NCT04250142|Cavity lining|cavity lining
4958180|NCT04250142|Minimally invasive dentistry|minimally invasive dentistry
4958181|NCT04250142|Deep caries lesions|deep caries lesions
4958275|NCT04249544|dopamine agonists|dopamine agonists
4958277|NCT04249505|photo refraction|photo refraction
4958278|NCT04249505|auto refraction|auto refraction
4958375|NCT04248881|Physical Activity|physical activity
4958376|NCT04248881|Health Literacy|health literacy
4958377|NCT04248881|Health Behaviors|health behaviors
4958378|NCT04248855|Phase 1|phase 1
4958379|NCT04248855|Double blind|double blind
4958380|NCT04248855|Multicenter|multicenter
4958381|NCT04248842|Continuous monitoring|continuous monitoring
4958472|NCT04248283|Urinary Incontinence|urinary incontinence
4958473|NCT04248283|Urination Disorders|urination disorders
4958474|NCT04248283|Urination Involuntary|urination involuntary
4958475|NCT04248283|Urologic Diseases|urologic diseases
4958568|NCT04247594|Sickle Cell Disease, SCD|sickle cell disease, scd
4958569|NCT04247568|weight loss; hypnosis; adults; behavior change|weight loss; hypnosis; adults; behavior change
4958573|NCT04247516|Self-Regulation|self-regulation
4958574|NCT04247516|Engagement|engagement
4958575|NCT04247516|Gamification|gamification
4958576|NCT04247516|Executive Function|executive function
4958577|NCT04247490|Autoimmune hepatitis|autoimmune hepatitis
4958669|NCT04246801|Cataract surgery|cataract surgery
4958770|NCT04246307|bleeding management|bleeding management
4958771|NCT04246307|coagulopathy|coagulopathy
4958772|NCT04246307|thromboelastography|thromboelastography
4958773|NCT04246307|viscoelastic coagulation monitoring|viscoelastic coagulation monitoring
4958774|NCT04246307|thromboeleastometry|thromboeleastometry
4958775|NCT04246307|ClotPro|clotpro
4958776|NCT04246294|Sleep Apnea|sleep apnea
4958777|NCT04246294|Continuous Positive Airway Pressure|continuous positive airway pressure
4958966|NCT04245345|Transcatheter Pacing|transcatheter pacing
4958967|NCT04245345|Normal Sinus Node Function|normal sinus node function
4958968|NCT04245345|Leadless Pacemaker|leadless pacemaker
4958972|NCT04245280|Regional anesthesia|regional anesthesia
4958973|NCT04245267|Diabetes outcomes|diabetes outcomes
4958974|NCT04245267|glycemic control|glycemic control
4958975|NCT04245267|self-care|self-care
4958976|NCT04245267|quality of life|quality of life
4958977|NCT04245228|Caregiver|caregiver
4959063|NCT04244799|Behavioral nudge|behavioral nudge
4959064|NCT04244799|Contextual cue|contextual cue
4959065|NCT04244799|Philippines|philippines
4959160|NCT04244396|Radiofrequency Ablation|radiofrequency ablation
4959161|NCT04244396|Heart Disease|heart disease
4959162|NCT04244396|Tachycardia|tachycardia
4959163|NCT04244396|Cardiovascular Diseases|cardiovascular diseases
4959164|NCT04244396|Cardiac Conduction System Disease|cardiac conduction system disease
4959165|NCT04244396|Atrial Fibrillation|atrial fibrillation
4959264|NCT04243720|Tumor Biopsy|tumor biopsy
4959265|NCT04243720|Circulation Tumor DNA|circulation tumor dna
4959267|NCT04243720|Microbiome|microbiome
4959268|NCT04243720|Radiomics|radiomics
4959269|NCT04243720|Immune Analysis|immune analysis
4959270|NCT04243720|Immunohistochemistry|immunohistochemistry
4959271|NCT04243694|caregiver stress|caregiver stress
4959361|NCT04243096|pain sensitization|pain sensitization
4959362|NCT04243096|physical activity|physical activity
4959363|NCT04243070|Holter ECG recording|holter ecg recording
4959365|NCT04243018|Self-Stigma|self-stigma
4959459|NCT04242472|Treatment outcome|treatment outcome
4959460|NCT04242472|SMS|sms
4959461|NCT04242459|Cancer|cancer
4959462|NCT04242459|Oropharynx|oropharynx
4959463|NCT04242459|HPV|hpv
4959464|NCT04242459|Base of Skull|base of skull
4959465|NCT04242446|Bimekizumab|bimekizumab
4959466|NCT04242446|UCB4940|ucb4940
4959467|NCT04242446|HS|hs
4959468|NCT04242446|Hidradenitis Suppurativa|hidradenitis suppurativa
4959469|NCT04242446|Acne inversa|acne inversa
4959470|NCT04242433|Resistance associated substitutions|resistance associated substitutions
4959471|NCT04242433|HCV|hcv
4959472|NCT04242420|connexin 37+43|connexin 37+43
4959473|NCT04242420|Lung function|lung function
4959474|NCT04242420|Interleukin 8|interleukin 8
4959475|NCT04242407|Abdominoplasty|abdominoplasty
4959476|NCT04242407|Pain|pain
4959477|NCT04242407|Dexmedetomidine|dexmedetomidine
4959478|NCT04242407|Transdermal|transdermal
4959562|NCT04241978|Hip osteoarthritis|hip osteoarthritis
4959563|NCT04241978|Patient decision aids|patient decision aids
4959564|NCT04241978|Person-centred care|person-centred care
4959565|NCT04241978|Randomized controlled trial|randomized controlled trial
4959566|NCT04241978|Shared decision-making|shared decision-making
4959567|NCT04241978|Web-based intervention|web-based intervention
4959568|NCT04241952|Stroke|stroke
4959660|NCT04241354|Regenerative orthopedics and sports medicine|regenerative orthopedics and sports medicine
4959661|NCT04241354|ROSM|rosm
4959662|NCT04241354|EmCyte|emcyte
4959663|NCT04241341|Axillary Lymph Node Dissection|axillary lymph node dissection
4959741|NCT04240834|ACS|acs
4959763|NCT04240769|accelerometry|accelerometry
4959764|NCT04240743|Basicervical|basicervical
4959765|NCT04240743|Cervicobasiler|cervicobasiler
4959766|NCT04240743|Hip|hip
4959767|NCT04240743|Fracture|fracture
4959768|NCT04240743|Prospective randomized|prospective randomized
4959777|NCT04240704|CLL|cll
4959865|NCT04239677|valvular heart surgery|valvular heart surgery
4959866|NCT04239651|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4959867|NCT04239651|Internet-Delivered Cognitive Behavior Therapy|internet-delivered cognitive behavior therapy
4959964|NCT04239053|Erector Spinae Plane Block|erector spinae plane block
4959965|NCT04239040|Neuroblastoma|neuroblastoma
4959966|NCT04239040|Pediatric Solid Tumor|pediatric solid tumor
4959967|NCT04239040|Immunotherapy|immunotherapy
4959968|NCT04239040|GVAX Vaccine|gvax vaccine
4959969|NCT04239040|Nivolumab|nivolumab
4959970|NCT04239040|Ipilimumab|ipilimumab
4959971|NCT04239027|age-related macular degeneration, wetAMD, nAMD, neovascular, choroidal neovascularization, CNV, OCT-angiography|age-related macular degeneration, wetamd, namd, neovascular, choroidal neovascularization, cnv, oct-angiography
4959972|NCT04239014|Platinum Sensitive Relapsed Epithelial Ovarian Cancer|platinum sensitive relapsed epithelial ovarian cancer
4959973|NCT04239014|Polyadenosine 5'diphosphoribose (poly [ADP ribose]) polymerase inhibitor (PARPi)|polyadenosine 5'diphosphoribose (poly [adp ribose]) polymerase inhibitor (parpi)
4960057|NCT04238533|transradial|transradial
4960058|NCT04238533|upper extremity|upper extremity
4960059|NCT04238533|amputee|amputee
4960060|NCT04238533|forearm|forearm
4960061|NCT04238520|Dementia|dementia
4960062|NCT04238520|Caregiver|caregiver
4960063|NCT04238520|Family Relations|family relations
4960064|NCT04238520|Oral Hygiene|oral hygiene
4960065|NCT04238520|Cognitive Impairment|cognitive impairment
4960066|NCT04238520|Functional Level|functional level
4960067|NCT04238520|Oral Health Education|oral health education
4960070|NCT04238481|ASP5354|asp5354
4960071|NCT04238481|ureter visualization|ureter visualization
4960153|NCT04238000|dual-task|dual-task
4960154|NCT04238000|dual-task walking|dual-task walking
4960155|NCT04238000|turning|turning
4960156|NCT04237987|Interleukin-2|interleukin-2
4960157|NCT04237987|Cyclosporin A|cyclosporin a
4960158|NCT04237948|tDCS|tdcs
4960159|NCT04237948|transcranial direct current stimulation|transcranial direct current stimulation
4960161|NCT04237948|postural instability|postural instability
4960162|NCT04237948|wearing sensors|wearing sensors
4960253|NCT04237389|thoracoscopic ablation|thoracoscopic ablation
4960254|NCT04237389|LAA removal|laa removal
4960278|NCT04237181|PCT|pct
4960458|NCT04236180|Paediatrics|paediatrics
4960459|NCT04236180|Palliative Care|palliative care
4960460|NCT04236167|laser|laser
4960461|NCT04236167|fractional CO2 laser|fractional co2 laser
4960463|NCT04236115|Carticaine|carticaine
4960464|NCT04236115|dental extraction|dental extraction
4960465|NCT04236115|injections|injections
4960466|NCT04236115|prilocaine|prilocaine
4960467|NCT04236089|mirror therapy|mirror therapy
4960471|NCT04236050|rocuronium|rocuronium
4960557|NCT04235582|contingency management|contingency management
4960558|NCT04235582|dynamicare|dynamicare
4960559|NCT04235569|warfarin|warfarin
4960564|NCT04235556|oncology|oncology
4960657|NCT04235114|PET/CT|pet/ct
4960757|NCT04234581|advanced glycation|advanced glycation
4960758|NCT04234555|dyspareunia|dyspareunia
4960759|NCT04234555|electromyography|electromyography
4960760|NCT04234555|transcranial magnetic stimulation|transcranial magnetic stimulation
4960761|NCT04234555|pressure pain threshold|pressure pain threshold
4960762|NCT04234555|temporal summation|temporal summation
4960763|NCT04234555|vaginismus|vaginismus
4960764|NCT04234555|provoked vestibulodynia|provoked vestibulodynia
4960765|NCT04234542|vulvar pain|vulvar pain
4960766|NCT04234542|pelvic floor|pelvic floor
4960767|NCT04234542|low level laser therapy|low level laser therapy
4960768|NCT04234542|laser|laser
4960801|NCT04234399|PSA|psa
4960955|NCT04233671|peer mentors|peer mentors
4960956|NCT04233632|Female condom|female condom
4960957|NCT04233632|Pregnancy Prevention|pregnancy prevention
4960958|NCT04233632|Sexually transmitted infection prevention|sexually transmitted infection prevention
4960959|NCT04233632|Condom acceptability|condom acceptability
4960960|NCT04233632|FC2|fc2
4960961|NCT04233632|Cupid|cupid
4960962|NCT04233606|Vasopressin, Heart Rate Variability, Cardiovascular Function|vasopressin, heart rate variability, cardiovascular function
4960963|NCT04233593|PET TSPO Imaging|pet tspo imaging
4960964|NCT04233593|Microglia Activation/Proliferation|microglia activation/proliferation
4960965|NCT04233593|Lipopolysaccharide|lipopolysaccharide
4960966|NCT04233528|laser speckle contrast imaging|laser speckle contrast imaging
4960967|NCT04233515|Atrial fibrillation|atrial fibrillation
4960968|NCT04233515|Stroke prevention|stroke prevention
4960969|NCT04233489|mother-infant dyad|mother-infant dyad
4960972|NCT04233489|synchrony|synchrony
4961058|NCT04233021|IFCT|ifct
4961059|NCT04233021|NSCLC|nsclc
4961060|NCT04233021|EGFR|egfr
4961061|NCT04233008|Maternal outcomes|maternal outcomes
4961158|NCT04232423|Olanzapine|olanzapine
4961159|NCT04232423|Chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
4961160|NCT04232423|Carboplatin|carboplatin
4961161|NCT04232423|Gynecologic cancer|gynecologic cancer
4961351|NCT04231175|Peritoneal Carcinomatosis|peritoneal carcinomatosis
4961352|NCT04231175|MRI|mri
4961353|NCT04231175|Randomization|randomization
4961354|NCT04231162|Stool frequency|stool frequency
4961355|NCT04231162|Probiotic|probiotic
4961356|NCT04231162|Lactic bacteria|lactic bacteria
4961357|NCT04231162|Bifidobacteria|bifidobacteria
4961358|NCT04231162|Transit|transit
4961359|NCT04231162|Quality of life|quality of life
4961360|NCT04231162|Constipation symptoms|constipation symptoms
4961361|NCT04231162|Diet supplement|diet supplement
4961363|NCT04231123|PENG Block|peng block
4961454|NCT04230655|Intragastric balloon|intragastric balloon
4961455|NCT04230655|Group treatment|group treatment
4961456|NCT04230655|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4961457|NCT04230655|Quality of life|quality of life
4961458|NCT04230655|Body weight|body weight
4961649|NCT04229459|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4961650|NCT04229459|Cetuximab|cetuximab
4961651|NCT04229459|Nivolumab|nivolumab
4961652|NCT04229420|erector spinae|erector spinae
4961839|NCT04228289|Mental Health|mental health
4961840|NCT04228289|Psychophysiology|psychophysiology
4961843|NCT04228276|Dopamine|dopamine
4961935|NCT04227691|localized hyperhidrosis|localized hyperhidrosis
4961936|NCT04227691|Nd YAG laser treatment|nd yag laser treatment
4961937|NCT04227691|OCT scan|oct scan
5665893|NCT00637572|Megace|megace
4961938|NCT04227691|Axillary hyperhidrosis|axillary hyperhidrosis
4961939|NCT04227691|IPL|ipl
4961940|NCT04227652|sepsis|sepsis
4961941|NCT04227652|severe sepsis|severe sepsis
4961942|NCT04227652|septic shock|septic shock
4961943|NCT04227652|fever|fever
4961944|NCT04227652|ibuprofen|ibuprofen
4961945|NCT04227652|physiological reserves|physiological reserves
4961946|NCT04227626|closed loop|closed loop
4961947|NCT04227626|insulin|insulin
4961948|NCT04227626|dextrose|dextrose
4961949|NCT04227613|Humans|humans
4962136|NCT04226482|Patient Safety|patient safety
4962137|NCT04226443|Midazolam|midazolam
4962138|NCT04226443|Remifentanil|remifentanil
4962139|NCT04226443|Benzodiazepine|benzodiazepine
4962140|NCT04226443|Opioid|opioid
4962141|NCT04226443|Chronic Kidney Diseases|chronic kidney diseases
4962143|NCT04226443|Sedation|sedation
4962144|NCT04226443|Adverse Reaction|adverse reaction
4962237|NCT04225962|Intimate life|intimate life
4962238|NCT04225910|mCRPC, PSMA radioligand therapy, efficacy, safety|mcrpc, psma radioligand therapy, efficacy, safety
4962239|NCT04225897|RV521|rv521
4962240|NCT04225897|Pediatrics|pediatrics
4962241|NCT04225897|Children|children
4962242|NCT04225897|LRTI|lrti
4962243|NCT04225897|Wheezing|wheezing
4962244|NCT04225897|Rhinitis|rhinitis
4962245|NCT04225897|Cough|cough
4962342|NCT04225403|Inflammatory Bowel Disease|inflammatory bowel disease
4962343|NCT04225403|Smoking cessation|smoking cessation
4962345|NCT04225403|Smoking|smoking
4962346|NCT04225403|Advanced practice nurse|advanced practice nurse
4962347|NCT04225403|Motivational intervention|motivational intervention
4962348|NCT04225390|immune checkpoint blockade|immune checkpoint blockade
4962436|NCT04224766|regional anesthesia|regional anesthesia
4962437|NCT04224766|interscalene brachial plexus block|interscalene brachial plexus block
4962531|NCT04224064|New non-invasive biological test|new non-invasive biological test
4962532|NCT04224038|Geroscience|geroscience
4962533|NCT04224038|biological aging and identifying targetable biomarkers|biological aging and identifying targetable biomarkers
4962534|NCT04224038|The Inspire Bio-resource Research Platform for Healthy Aging|the inspire bio-resource research platform for healthy aging
4962535|NCT04224038|Aged 30 years-old or over|aged 30 years-old or over
4962536|NCT04224038|age-related chronic diseases|age-related chronic diseases
4962537|NCT04223999|Recurrent glioblastoma|recurrent glioblastoma
4962538|NCT04223999|Glioblastoma|glioblastoma
4962539|NCT04223999|Glioblastom|glioblastom
4962624|NCT04223557|Hypercholesteremia,Dyslipidemias,ASCVD|hypercholesteremia,dyslipidemias,ascvd
4962625|NCT04223544|Influenza|influenza
4962626|NCT04223544|Vaccination Coverage Rate|vaccination coverage rate
4962627|NCT04223544|Healthcare Workers|healthcare workers
4962628|NCT04223544|General Practice|general practice
4962629|NCT04223544|Point of Care Testing|point of care testing
4962630|NCT04223518|serum bovine immunoglobulin|serum bovine immunoglobulin
4962644|NCT04223440|MRI|mri
4962750|NCT04222946|Stabilometry|stabilometry
4962751|NCT04222946|Platform|platform
4962752|NCT04222946|Dry needling|dry needling
4962753|NCT04222946|trigger point|trigger point
4962754|NCT04222920|Adalimumab|adalimumab
4962755|NCT04222920|Rheumatoid arthritis|rheumatoid arthritis
4962756|NCT04222920|Therapeutic Drug Monitoring|therapeutic drug monitoring
4962757|NCT04222920|Drug level|drug level
4962758|NCT04222920|Dose reduction|dose reduction
4962759|NCT04222894|body weight|body weight
4962760|NCT04222894|blood pressure|blood pressure
4962761|NCT04222894|lipids|lipids
4962762|NCT04222894|nutrition|nutrition
4962763|NCT04222881|End to side anastomosis of arteriovenous fistula|end to side anastomosis of arteriovenous fistula
4962764|NCT04222868|atrial fibrillation|atrial fibrillation
4962765|NCT04222868|registry|registry
4962766|NCT04222868|anticoagulant|anticoagulant
4962767|NCT04222829|Shoulder joints|shoulder joints
4962768|NCT04222829|Shinbaro pharmacopuncture|shinbaro pharmacopuncture
4962769|NCT04222829|Megadose shinbaro pharmacopuncture|megadose shinbaro pharmacopuncture
4962770|NCT04222829|Chronic shoulder pain|chronic shoulder pain
4962771|NCT04222829|Shoulder pain|shoulder pain
4962772|NCT04222816|Bipolar affective disorder|bipolar affective disorder
4962773|NCT04222816|Lithium|lithium
4962774|NCT04222816|Manic depressive psychosis|manic depressive psychosis
4962775|NCT04222816|Sodium chloride|sodium chloride
4962776|NCT04222777|Cervical Motion|cervical motion
4962777|NCT04222777|Physiological movement|physiological movement
4962778|NCT04222777|Cervical spine|cervical spine
4962779|NCT04222777|Segmental Rage of Motion|segmental rage of motion
4962780|NCT04222777|Elderly|elderly
4962781|NCT04222777|Lower Cervical Spine|lower cervical spine
4962785|NCT04222764|Lung Diseases|lung diseases
4962821|NCT04222582|Schizoaffective disorder|schizoaffective disorder
4962822|NCT04222582|EEG|eeg
4962823|NCT04222582|Brain imaging|brain imaging
4962824|NCT04222582|Cognition|cognition
4962830|NCT04222556|American Indian|american indian
4962831|NCT04222556|Adolescent|adolescent
4962832|NCT04222556|Parenting|parenting
4962833|NCT04222556|Family|family
4962834|NCT04222556|Prevention|prevention
4962835|NCT04222543|Tumour microenvironment|tumour microenvironment
4962836|NCT04222543|Chemoradiotherapy|chemoradiotherapy
4962837|NCT04222543|Oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
4962838|NCT04222543|Human papilloma virus|human papilloma virus
4962839|NCT04222543|Positron emission tomography|positron emission tomography
4962840|NCT04222530|linear endoscopic ultrasonography|linear endoscopic ultrasonography
4962917|NCT04222140|hyaluronic acid|hyaluronic acid
4962918|NCT04222140|post-traumatic osteoarthritis|post-traumatic osteoarthritis
4962919|NCT04222127|Gastric Varices|gastric varices
4962921|NCT04222127|Cyanoacrylate|cyanoacrylate
4962922|NCT04222114|Stomach Neoplasms|stomach neoplasms
4962923|NCT04222114|Peritoneal metastasis|peritoneal metastasis
4962924|NCT04222114|catumaxomab|catumaxomab
4962925|NCT04222101|pediatrics|pediatrics
4962926|NCT04222088|malaria|malaria
4962928|NCT04222088|Plasmodium falciparum|plasmodium falciparum
4962929|NCT04222088|Arthemeter-lumefantrine|arthemeter-lumefantrine
4962930|NCT04222088|Plasmodium vivax|plasmodium vivax
4962931|NCT04222088|Chloroquine|chloroquine
4962942|NCT04222036|Turkish|turkish
4963115|NCT04220892|Cyclin-dependent kinase 6 (CDK6)|cyclin-dependent kinase 6 (cdk6)
4963116|NCT04220892|Folate antimetabolite|folate antimetabolite
4963117|NCT04220879|Malignant Glaucoma|malignant glaucoma
4963118|NCT04220879|Biometric Measurements|biometric measurements
4963119|NCT04220866|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
4963120|NCT04220866|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
4963121|NCT04220853|nasal obstruction|nasal obstruction
4963122|NCT04220853|septoplasty|septoplasty
4963123|NCT04220853|turbinoplasty|turbinoplasty
4963124|NCT04220853|nasal mucosa|nasal mucosa
4963125|NCT04220853|nasal septum|nasal septum
4963213|NCT04220047|left atrial appendage|left atrial appendage
4963214|NCT04220047|Marshall ligament|marshall ligament
4963215|NCT04219956|Abdominal surgery|abdominal surgery
4963332|NCT04219176|Uveitis|uveitis
4963409|NCT04218643|catheter to vein ratio|catheter to vein ratio
4963410|NCT04218630|Reformer pilates|reformer pilates
4963412|NCT04218630|Fibromyalgia|fibromyalgia
4963413|NCT04218630|Exercise|exercise
4963414|NCT04218617|C79.40|c79.40
4963415|NCT04218617|C79.49|c79.49
4963416|NCT04218617|C79.51|c79.51
4963417|NCT04218617|C79.52|c79.52
4963439|NCT04218500|HECSI|hecsi
4963606|NCT04217330|COPD|copd
4963607|NCT04217252|severe infection|severe infection
4963608|NCT04217252|high throughput sequencing|high throughput sequencing
4963609|NCT04217252|infectious pathogen|infectious pathogen
4963665|NCT04216836|Glucose|glucose
4963704|NCT04216511|Tumor Autoantibody|tumor autoantibody
4963705|NCT04216511|Early Detection|early detection
4963706|NCT04216511|Indeterminate Pulmonary Nodule|indeterminate pulmonary nodule
4963707|NCT04216446|m-Health coaching|m-health coaching
4963708|NCT04216446|Pregnancy|pregnancy
4963709|NCT04216446|Diet|diet
4963710|NCT04216446|Supplement use|supplement use
4963711|NCT04216446|Lifestyle|lifestyle
4963712|NCT04216420|Tuberculosis|tuberculosis
4963713|NCT04216420|Pillbox|pillbox
4963714|NCT04216420|Self-administered therapy|self-administered therapy
4963715|NCT04216420|Directly observed therapy (DOT)|directly observed therapy (dot)
4963716|NCT04216420|Adherence|adherence
4963717|NCT04216420|Treatement outcome|treatement outcome
4963804|NCT04215692|pediatric intensive care|pediatric intensive care
4963805|NCT04215692|lenght of stay|lenght of stay
4963806|NCT04215679|Virtual reality|virtual reality
4963807|NCT04215679|Rehabilitation|rehabilitation
4963809|NCT04215666|Definitions|definitions
4963810|NCT04215666|high-altitude|high-altitude
4963811|NCT04215627|Critically Ill patients|critically ill patients
4963812|NCT04215627|blood pressure|blood pressure
4963813|NCT04215627|vital signs|vital signs
4963814|NCT04215627|non-invasive monitoring|non-invasive monitoring
4963908|NCT04215042|Contrast-Induced Nephropathy|contrast-induced nephropathy
4963909|NCT04215042|Contrast-Associated Acute Kidney Injury|contrast-associated acute kidney injury
4963910|NCT04215042|Contrast media|contrast media
4964105|NCT04213807|cardiac arrhythmia|cardiac arrhythmia
4964106|NCT04213781|Oocyte retrieval|oocyte retrieval
4964107|NCT04213781|Sedation|sedation
4964109|NCT04213729|Diet|diet
4964205|NCT04213079|body rocking|body rocking
4964206|NCT04213079|body swaying|body swaying
4964207|NCT04213079|Habituation of velocity storage|habituation of velocity storage
4964208|NCT04213066|Amblyopia|amblyopia
4964209|NCT04213066|Amblyopic training|amblyopic training
4964304|NCT04212494|Thrombus Aspiration|thrombus aspiration
4964305|NCT04212494|Coronary Intervention|coronary intervention
4964306|NCT04212494|Thrombus Burden|thrombus burden
4964307|NCT04212494|ST Elevation Myocardial Infarction|st elevation myocardial infarction
4964399|NCT04211987|fast track care|fast track care
4964400|NCT04211987|Total Hip Arthroplasty|total hip arthroplasty
4964401|NCT04211974|spinal cord astrocytoma; whole-exome sequencing;|spinal cord astrocytoma; whole-exome sequencing;
4964402|NCT04211948|Robotic assisted surgery|robotic assisted surgery
4964403|NCT04211831|URO-902|uro-902
4964404|NCT04211831|hMaxi-K|hmaxi-k
4964493|NCT04211168|common bile duct cancer|common bile duct cancer
4964594|NCT04210596|volumetric analysis|volumetric analysis
4964595|NCT04210570|Anesthesia|anesthesia
4964596|NCT04210570|Inhalation|inhalation
4964597|NCT04210570|Vapour|vapour
4964598|NCT04210570|CO2 Absorber|co2 absorber
4964599|NCT04210570|Minimal Flow Anesthesia|minimal flow anesthesia
4964600|NCT04210570|Memsorb|memsorb
4964694|NCT04209920|Hypomineralized|hypomineralized
4964695|NCT04209920|First permanent molar|first permanent molar
4964696|NCT04209920|Molar defects|molar defects
4964697|NCT04209920|PMMA|pmma
4964698|NCT04209920|cast adhesive coping|cast adhesive coping
4964702|NCT04209881|Ankylosing spondylitis|ankylosing spondylitis
5656914|NCT00674895|Primary Parkinsonism|primary parkinsonism
4964703|NCT04209881|fertility|fertility
4964704|NCT04209881|anti-müllerian hormone|anti-müllerian hormone
4964705|NCT04209881|ovarian reserve|ovarian reserve
4964706|NCT04209855|Platinum-resistant|platinum-resistant
4964995|NCT04208425|SSI|ssi
4964791|NCT04209413|Anterior Cruciate Ligament operation|anterior cruciate ligament operation
4964792|NCT04209413|Skeletal muscle|skeletal muscle
4964793|NCT04209413|Mitochondria|mitochondria
4964794|NCT04209413|Calcium|calcium
4964795|NCT04209413|Mitochondrial permeability transition pore opening (mPTP opening)|mitochondrial permeability transition pore opening (mptp opening)
4964799|NCT04209400|Phase 3|phase 3
4964893|NCT04208958|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
4964894|NCT04208958|GEJ Adenocarcinoma|gej adenocarcinoma
4964895|NCT04208958|Colorectal Cancer|colorectal cancer
4964896|NCT04208958|CRC-MSS|crc-mss
4964897|NCT04208958|Vedanta|vedanta
4965009|NCT04208269|preventative|preventative
4965010|NCT04208269|postcard|postcard
4965011|NCT04208269|vaccinate|vaccinate
4965015|NCT04208217|implementation science|implementation science
4965016|NCT04208217|quality improvement|quality improvement
4965017|NCT04208217|modeling to learn|modeling to learn
4965018|NCT04208217|usual quality improvement|usual quality improvement
4965099|NCT04207801|Psoriasis|psoriasis
4965100|NCT04207775|NSCLC|nsclc
4965204|NCT04207164|Foot Functional Index revised,|foot functional index revised,
4965205|NCT04207164|Translation and cultural adaption|translation and cultural adaption
4965206|NCT04207164|Reliability|reliability
4965207|NCT04207164|Validity|validity
4965208|NCT04207164|Responsiveness|responsiveness
4965209|NCT04207138|Labor Pain|labor pain
4965210|NCT04207112|Bedaquiline|bedaquiline
4965211|NCT04207112|Pretomanid|pretomanid
4965212|NCT04207112|Linezolid|linezolid
4965213|NCT04207112|Clofazimine|clofazimine
4965214|NCT04207112|Moxifloxacin|moxifloxacin
4965215|NCT04207112|Economic Evaluation|economic evaluation
4965216|NCT04207112|Pharmacoeconomics|pharmacoeconomics
4965225|NCT04207073|two-point discrimination|two-point discrimination
4965226|NCT04207073|neural mobilization|neural mobilization
4965227|NCT04207073|tactile sensation|tactile sensation
4965228|NCT04207021|Curcumin|curcumin
4965229|NCT04207008|Adolescents and young adults|adolescents and young adults
4965304|NCT04206592|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
4965305|NCT04206579|Oral Dextrose|oral dextrose
4965306|NCT04206579|Blood Sugar|blood sugar
4965307|NCT04206579|Sprint Velocity|sprint velocity
4965308|NCT04206579|Athletes|athletes
4965309|NCT04206527|Person-Centered Care|person-centered care
4965310|NCT04206514|post abortion|post abortion
4965311|NCT04206514|person-centered care|person-centered care
4965312|NCT04206501|ICD|icd
4965313|NCT04206501|OptiVol-Monitor|optivol-monitor
4965314|NCT04206501|Cardiac Compass|cardiac compass
4965315|NCT04206501|Garmin Vivo Smart|garmin vivo smart
4965324|NCT04206423|Pain|pain
4965503|NCT04205305|endovascular thrombectomy|endovascular thrombectomy
4965508|NCT04205253|tongue|tongue
4965598|NCT04204551|Neuroimaging|neuroimaging
4965599|NCT04204538|Food Frequency Questionnaire|food frequency questionnaire
4965600|NCT04204538|Dietary patterns|dietary patterns
4965601|NCT04204538|Risk factors|risk factors
4965602|NCT04204538|metabolic syndrome|metabolic syndrome
4965603|NCT04204538|Nutritional transition|nutritional transition
4965604|NCT04204525|chronic whiplash associated disorders|chronic whiplash associated disorders
4965605|NCT04204525|central sensitization|central sensitization
4965696|NCT04204005|Gut microbiota|gut microbiota
4965697|NCT04204005|Microbial uremic toxins|microbial uremic toxins
4965794|NCT04203160|Gallbladder cancer|gallbladder cancer
4965796|NCT04203108|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
4965797|NCT04203108|antithymocyte globulin|antithymocyte globulin
4965798|NCT04203108|graft-versus-host disease|graft-versus-host disease
4965799|NCT04203095|Chromosomal aneuploidy detection|chromosomal aneuploidy detection
4965800|NCT04203095|lung cancer|lung cancer
4965801|NCT04203095|PD-1/PD-L1|pd-1/pd-l1
4966097|NCT04201418|V122I|v122i
4966192|NCT04200963|Immunoncology|immunoncology
4966193|NCT04200963|Aryl Hydrocarbon Receptor Inhibitor|aryl hydrocarbon receptor inhibitor
4966195|NCT04200963|Aryl Hydrocarbon Receptor Antagonist|aryl hydrocarbon receptor antagonist
4966196|NCT04200963|Antagonist|antagonist
4966197|NCT04200963|Inhibitor|inhibitor
4966198|NCT04200885|Dexamethasone|dexamethasone
4966199|NCT04200885|Applied Kinesiology|applied kinesiology
4966200|NCT04200885|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
4966201|NCT04200885|Teeth, Impacted|teeth, impacted
4966202|NCT04200885|Edema|edema
4966203|NCT04200885|Trismus|trismus
4966204|NCT04200885|Postoperative Pain|postoperative pain
4966205|NCT04200859|chest tube,|chest tube,
4966288|NCT04200391|very low carbohydrate diet|very low carbohydrate diet
4966289|NCT04200391|ketogenic diet|ketogenic diet
4966290|NCT04200391|nutritional ketosis|nutritional ketosis
4966291|NCT04200391|glucagon|glucagon
5657016|NCT00674544|children|children
4966292|NCT04200391|hypoglycemia|hypoglycemia
4966293|NCT04200391|glycogen|glycogen
4966294|NCT04200391|ketosis|ketosis
4966295|NCT04200391|ketones|ketones
4966296|NCT04200365|Chronic Graft-versus-host-disease|chronic graft-versus-host-disease
4966393|NCT04199741|Small cell lung cancer|small cell lung cancer
4966394|NCT04199741|Small Cell Lung Carcinoma|small cell lung carcinoma
4966395|NCT04199741|89Zr-DFO-SC16.56|89zr-dfo-sc16.56
4966397|NCT04199741|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4966403|NCT04199715|Hepatitis B|hepatitis b
4966404|NCT04199715|Hep B|hep b
4966405|NCT04199715|Vaccine|vaccine
4966406|NCT04199715|Immunosuppression|immunosuppression
4966407|NCT04199715|HBV|hbv
4966408|NCT04199637|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
4966409|NCT04199637|Therapeutic Video games|therapeutic video games
4966410|NCT04199637|Childhood cancer|childhood cancer
4966595|NCT04198415|Relapsed/Refractory|relapsed/refractory
4966596|NCT04198415|Venetoclax|venetoclax
4966597|NCT04198363|Drug Therapy|drug therapy
4966598|NCT04198350|Type 1 Diabetes|type 1 diabetes
4966600|NCT04198311|alcohol|alcohol
4966601|NCT04198311|drinking|drinking
4966694|NCT04197752|Peripheral nerve blocks|peripheral nerve blocks
4966695|NCT04197752|Performance|performance
4966696|NCT04197752|Complication|complication
4966697|NCT04197739|Urinary Tract Infections|urinary tract infections
4966698|NCT04197739|Aminoglycosides|aminoglycosides
4966699|NCT04197739|Amikacin|amikacin
4966700|NCT04197739|Elderly|elderly
4966701|NCT04197726|Glycaemic response|glycaemic response
4966702|NCT04197726|Resistant starch|resistant starch
4966703|NCT04197726|Bread|bread
4966796|NCT04197180|Endoscopic Ablation|endoscopic ablation
4966805|NCT04197128|Lateral augmentation|lateral augmentation
4966806|NCT04197128|Ribose cross-linked collagen|ribose cross-linked collagen
4966807|NCT04197128|Dental Implant|dental implant
4966808|NCT04197115|sepsis|sepsis
4966809|NCT04197115|septic shock|septic shock
4966810|NCT04197115|Vitamin C|vitamin c
4966811|NCT04197115|Hydrocortisone|hydrocortisone
4966812|NCT04197115|Mortality|mortality
4966814|NCT04197089|Cancer|cancer
4966899|NCT04196595|Reproductive Health|reproductive health
4966900|NCT04196582|LMA gastro airway|lma gastro airway
4966901|NCT04196582|Gastro-laryngeal tube|gastro-laryngeal tube
4966902|NCT04196582|ERCP|ercp
4966903|NCT04196582|airway complications|airway complications
4966904|NCT04196569|trifocal lens|trifocal lens
4966905|NCT04196569|trifocal intraocular lens|trifocal intraocular lens
4966906|NCT04196569|aberrometry|aberrometry
4966907|NCT04196556|Childhood obesity|childhood obesity
4966908|NCT04196556|Primary Health Care|primary health care
4966909|NCT04196556|Nursing intervention|nursing intervention
4966910|NCT04196556|Family educational intervention|family educational intervention
4966911|NCT04196530|TLR|tlr
4966912|NCT04196530|Immuno-oncology|immuno-oncology
4966927|NCT04196426|nutrition education|nutrition education
4966928|NCT04196426|nutrition intervention|nutrition intervention
4966929|NCT04196426|calcium intake|calcium intake
4966930|NCT04196426|calcium-rich foods|calcium-rich foods
4966931|NCT04196400|hypospadias, edema, failure, fistula, steroids|hypospadias, edema, failure, fistula, steroids
4966932|NCT04196387|antibiotics, urine, resistance|antibiotics, urine, resistance
4966933|NCT04196361|Ultrasound|ultrasound
4966939|NCT04196348|Obesity|obesity
4967100|NCT04195269|CBD|cbd
4967200|NCT04194697|Smartphone application|smartphone application
4967201|NCT04194606|Anatomical snuffbox|anatomical snuffbox
4967202|NCT04194606|Percutaneous coronary intervention|percutaneous coronary intervention
4967203|NCT04194606|Radial access|radial access
4967218|NCT04194411|Tau|tau
4967297|NCT04193982|Saraglitazar|saraglitazar
4967298|NCT04193982|Vitamin E|vitamin e
4967299|NCT04193969|low back pain|low back pain
4967394|NCT04193423|intervention|intervention
4967401|NCT04193397|Physical exercise|physical exercise
4967402|NCT04193397|Obesity|obesity
4967403|NCT04193397|Bariatric surgery|bariatric surgery
4967404|NCT04193397|Health|health
4967405|NCT04193397|Cardiovascular risk|cardiovascular risk
4967406|NCT04193384|Obesity|obesity
4967407|NCT04193384|Bariatric Surgery|bariatric surgery
4967408|NCT04193384|Weight Gain|weight gain
4967409|NCT04193384|Predictive Factors|predictive factors
4967410|NCT04193371|PCOS|pcos
4967411|NCT04193371|Overweight|overweight
4967412|NCT04193371|Obesity|obesity
4967422|NCT04193332|NIR|nir
4967494|NCT04193059|non-triple negative breast cancer|non-triple negative breast cancer
4967495|NCT04193033|mental health|mental health
4967496|NCT04193007|Non Small Cell Lung Cancer|non small cell lung cancer
4967497|NCT04193007|Brain Metastases|brain metastases
4967502|NCT04192968|Cochlear implantation|cochlear implantation
4967503|NCT04192968|Automated cortical auditory evoked potentials|automated cortical auditory evoked potentials
4967504|NCT04192968|Speech-language therapy|speech-language therapy
4967505|NCT04192968|Children|children
4967506|NCT04192916|Efficacy and safety profile|efficacy and safety profile
4967507|NCT04192916|Direct oral anticoagulants|direct oral anticoagulants
4967592|NCT04192409|Diabetes Mellitus|diabetes mellitus
4967593|NCT04192409|Smartphone Application|smartphone application
4967693|NCT04191889|anti-angiogenic targeted therapy|anti-angiogenic targeted therapy
4967694|NCT04191889|Apatinib|apatinib
4967695|NCT04191876|financial incentives|financial incentives
4967696|NCT04191876|medication adherence|medication adherence
4967697|NCT04191876|severe mental illness|severe mental illness
4967698|NCT04191863|Valproic acid, enuresis, epilepsy.|valproic acid, enuresis, epilepsy.
4967699|NCT04191837|Knee Osteoarthritis|knee osteoarthritis
4967701|NCT04191811|BOLD-fMRI|bold-fmri
4967795|NCT04191109|Intensive Rehabilitation|intensive rehabilitation
4967796|NCT04191109|Time|time
4967797|NCT04191109|Physiotherapy|physiotherapy
4967798|NCT04191109|Occupational Therapy|occupational therapy
4967799|NCT04191109|Speech language therapy|speech language therapy
4967802|NCT04191083|Motor imagery|motor imagery
4967803|NCT04191083|Action observation|action observation
4967804|NCT04191057|free light chains|free light chains
4967805|NCT04191057|healthy twins|healthy twins
4967806|NCT04191044|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4967807|NCT04191018|sustained virological response|sustained virological response
4967815|NCT04190979|EVAR|evar
4967887|NCT04190628|Colorectal Cancer|colorectal cancer
4967888|NCT04190628|Glioblastoma|glioblastoma
4967965|NCT04190186|ICM|icm
4967988|NCT04189952|Non-Germinal Center Diffuse Large B Cell Lymphoma|non-germinal center diffuse large b cell lymphoma
4967989|NCT04189939|ECT treatment|ect treatment
4967990|NCT04189939|treatment-resistant depression|treatment-resistant depression
4967991|NCT04189939|neural changes|neural changes
4967992|NCT04189926|Obesity|obesity
4968086|NCT04189445|Gastro-esophageal junction cancer|gastro-esophageal junction cancer
4968088|NCT04189445|Myeloid neoplasm|myeloid neoplasm
4968180|NCT04188834|Brain circuits modulation|brain circuits modulation
4968181|NCT04188834|Steady-state evoked potentials|steady-state evoked potentials
4968279|NCT04188171|Sclerotherapy|sclerotherapy
4968280|NCT04188171|Polidocanol foam|polidocanol foam
4968281|NCT04188171|Hemorrhoidal disease|hemorrhoidal disease
4968282|NCT04188093|PACU|pacu
4968380|NCT04187222|Bleeding on probing|bleeding on probing
4968382|NCT04187209|Acute Stroke|acute stroke
4968383|NCT04187209|Subacute Stroke|subacute stroke
4968384|NCT04187209|Robotics|robotics
4968385|NCT04187209|Physiotherapy|physiotherapy
4968386|NCT04187209|Rehabilitation|rehabilitation
4968387|NCT04187209|Powered exoskeleton|powered exoskeleton
4968388|NCT04187209|Walking|walking
4968389|NCT04187209|Exercises|exercises
4968390|NCT04187209|Ambulation|ambulation
4968391|NCT04187196|Cardioversion|cardioversion
4968392|NCT04187196|Propofol|propofol
4968393|NCT04187196|Deep sedation|deep sedation
4968394|NCT04187196|Intravenous anesthetics|intravenous anesthetics
4968478|NCT04186650|SIN retroviral vector|sin retroviral vector
4968479|NCT04186650|Type VII collagen|type vii collagen
4968576|NCT04186039|Blood Oxygen Level Dependent effect|blood oxygen level dependent effect
4968577|NCT04186039|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
4968678|NCT04185389|human papillomavirus|human papillomavirus
4968679|NCT04185389|cervix screening|cervix screening
4968680|NCT04185363|Cholestasis|cholestasis
4968681|NCT04185363|Maralixibat|maralixibat
4968682|NCT04185363|Mutation|mutation
4968683|NCT04185363|PFIC|pfic
4968776|NCT04184674|Transpulmonary pressure|transpulmonary pressure
4968777|NCT04184674|Right ventricle failure|right ventricle failure
4968778|NCT04184648|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
4968779|NCT04184648|high-flow nasal cannula|high-flow nasal cannula
4968780|NCT04184648|noninvasive ventilation|noninvasive ventilation
4968781|NCT04184648|Ventilation mode|ventilation mode
4968782|NCT04184648|premature infant|premature infant
4968783|NCT04184635|cardiogenic shock|cardiogenic shock
4969073|NCT04182919|allergic rhinitis|allergic rhinitis
4969074|NCT04182906|Adverse Childhood Experiences|adverse childhood experiences
4969076|NCT04182906|Social Determinants of Health|social determinants of health
4969077|NCT04182906|Child Mental Health|child mental health
4969078|NCT04182906|Resiliency|resiliency
4969172|NCT04182334|Anxiety|anxiety
4969173|NCT04182334|Cognition|cognition
4969174|NCT04182321|Metformin|metformin
4969269|NCT04181762|SoC background therapy|soc background therapy
4969270|NCT04181736|guanfacine|guanfacine
4969271|NCT04181736|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
4969273|NCT04181736|MDD|mdd
4969274|NCT04181736|cognitive dysfunction|cognitive dysfunction
4969275|NCT04181710|Kidney transplantation|kidney transplantation
4969365|NCT04180891|empathy|empathy
4969366|NCT04180891|emotional intelligence|emotional intelligence
4969367|NCT04180891|multiple mini-interviews|multiple mini-interviews
4969368|NCT04180878|Gestational weight gain|gestational weight gain
4969369|NCT04180878|Physical activity|physical activity
4969370|NCT04180865|Parkinson Disease|parkinson disease
4969371|NCT04180865|Treatment naive|treatment naive
4969466|NCT04180358|PREIS|preis
5847043|NCT00041938|aspirin|aspirin
4969571|NCT04179799|diaphragm pacing|diaphragm pacing
4969670|NCT04179396|RAMP|ramp
4969671|NCT04179396|homologous recombination|homologous recombination
4969672|NCT04179396|DNA repair|dna repair
4969673|NCT04179396|DNA defect|dna defect
5675450|NCT00599222|AMD|amd
4969674|NCT04179396|DNA anomaly|dna anomaly
4969675|NCT04179396|mCRPC|mcrpc
4969676|NCT04179396|enzalutamide|enzalutamide
4969677|NCT04179396|abiraterone|abiraterone
4969678|NCT04179396|Zytiga|zytiga
4969679|NCT04179396|Xtandi|xtandi
4970066|NCT04177420|Procollagen-I N-telopeptide, PINP|procollagen-i n-telopeptide, pinp
4970067|NCT04177420|C-telopeptide of type I collagen, CTx|c-telopeptide of type i collagen, ctx
4970068|NCT04177420|osteocalcin|osteocalcin
4970069|NCT04177420|Pittsburgh sleep quality index, PSQI|pittsburgh sleep quality index, psqi
4970070|NCT04177420|numeric rating scale-knee, NRS-knee|numeric rating scale-knee, nrs-knee
4970071|NCT04177420|Geriatric depression Scale-15, GDS-15|geriatric depression scale-15, gds-15
4970072|NCT04177420|Total Antioxidant Capacity, TAC|total antioxidant capacity, tac
4970073|NCT04177420|Infrared-C|infrared-c
4970074|NCT04177420|Hyperglycemia|hyperglycemia
4970075|NCT04177407|Extralevator abdominoperineal excision|extralevator abdominoperineal excision
4970076|NCT04177394|MitraClip|mitraclip
4970077|NCT04177394|MitraClip G4|mitraclip g4
4970078|NCT04177394|Mitral Regurgitation|mitral regurgitation
4970079|NCT04177342|achalasia|achalasia
4970080|NCT04177342|Peroral endoscopic myotomy|peroral endoscopic myotomy
4970083|NCT04177316|recurrence|recurrence
4970165|NCT04176809|Health Related Quality of Life|health related quality of life
4970166|NCT04176809|Compliance|compliance
4970167|NCT04176809|Endocrine Therapy|endocrine therapy
4970168|NCT04176809|Therapeutic Information|therapeutic information
4970169|NCT04176796|Heart Transplant|heart transplant
4970170|NCT04176796|Transplant Survival|transplant survival
4970263|NCT04176211|Myasthenia Gravis Disease|myasthenia gravis disease
4970264|NCT04176211|Neuromuscular Diseases|neuromuscular diseases
4970265|NCT04176211|Neuromuscular Junction Diseases|neuromuscular junction diseases
4970266|NCT04176211|Nervous System Diseases|nervous system diseases
4970267|NCT04176211|Autoimmune Diseases|autoimmune diseases
4970268|NCT04176211|Autoimmune Diseases of the Nervous System|autoimmune diseases of the nervous system
4970269|NCT04176211|Ocular Myasthenia Gravis|ocular myasthenia gravis
4970270|NCT04176211|Generalized Myasthenia Gravis|generalized myasthenia gravis
4970271|NCT04176211|Myasthenia Gravis, Generalized|myasthenia gravis, generalized
4970272|NCT04176185|House Dust Mite|house dust mite
4970273|NCT04176185|Allergic rhinitis|allergic rhinitis
4970274|NCT04176185|Allergic conjunctivitis|allergic conjunctivitis
4970359|NCT04175743|Surgical Pain|surgical pain
4970360|NCT04175743|Acute Pain|acute pain
4970361|NCT04175743|Non-Opioid|non-opioid
4970362|NCT04175743|Neuropathy|neuropathy
4970363|NCT04175743|Chronic Neuropathy|chronic neuropathy
4970364|NCT04175691|acute ischemic stroke|acute ischemic stroke
4970365|NCT04175691|noncoding RNA|noncoding rna
4970366|NCT04175691|clinical significance|clinical significance
4970367|NCT04175691|outcome|outcome
4970368|NCT04175678|Hispanic Men|hispanic men
4970369|NCT04175678|Healthy Men|healthy men
4970370|NCT04175678|Obese Men|obese men
4971054|NCT04171700|HRD|hrd
4970461|NCT04175184|mobilisation with movement|mobilisation with movement
4970462|NCT04175184|exercises|exercises
4970463|NCT04175145|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
4970464|NCT04175145|posterior instrumentation|posterior instrumentation
4970465|NCT04175145|metal density|metal density
4970468|NCT04175119|Brain|brain
4970557|NCT04174547|Immune escape|immune escape
4970560|NCT04174469|ivermectin|ivermectin
4970653|NCT04173858|Naloxegol, PAMORA|naloxegol, pamora
4970654|NCT04173806|Education, Medical|education, medical
4970655|NCT04173806|Online Social Networking|online social networking
4970656|NCT04173806|Computer User Training|computer user training
4970657|NCT04173806|Telemedicine|telemedicine
4970658|NCT04173793|HeFH|hefh
4970659|NCT04173793|LDL-C|ldl-c
4970660|NCT04173780|Myopia (Progressing)|myopia (progressing)
4970661|NCT04173780|Childhood|childhood
4970662|NCT04173780|Atropine 0,01%|atropine 0,01%
4970663|NCT04173754|Shoulder joints|shoulder joints
4970665|NCT04173754|Shoulder disorder|shoulder disorder
4970666|NCT04173754|MSAT|msat
4970758|NCT04173234|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
4970760|NCT04173234|Ultrasonography|ultrasonography
4970761|NCT04173234|Motor Function|motor function
4970762|NCT04173221|Microcirculation|microcirculation
4970763|NCT04173221|Intensive Care|intensive care
4970764|NCT04173221|Critical care|critical care
4970765|NCT04173221|shock|shock
4970766|NCT04173221|risk stratification|risk stratification
4970767|NCT04173221|SDF-measurement|sdf-measurement
4970768|NCT04173221|fluid resuscitation|fluid resuscitation
4970769|NCT04173208|Transplant|transplant
4970770|NCT04173208|Cesarean section|cesarean section
4970771|NCT04173208|inflammatory response|inflammatory response
4970772|NCT04173208|Infant|infant
4970856|NCT04172519|adenomectomy|adenomectomy
4971055|NCT04171700|platinum sensitive|platinum sensitive
4971056|NCT04171700|platinum resistant|platinum resistant
4971057|NCT04171700|primary peritoneal cancer|primary peritoneal cancer
4971058|NCT04171700|fallopian tube cancer|fallopian tube cancer
4971059|NCT04171700|tumor agnostic|tumor agnostic
4971060|NCT04171700|basket study|basket study
4971061|NCT04171700|basket trial|basket trial
4971062|NCT04171700|metastatic|metastatic
4971063|NCT04171700|locally advanced|locally advanced
4971250|NCT04170452|Viral hepatitis B|viral hepatitis b
4971252|NCT04170452|Viral hepatitis Delta|viral hepatitis delta
4971253|NCT04170452|iver biopsy|iver biopsy
4971347|NCT04169867|Metagenome|metagenome
4971348|NCT04169867|Neoplasms|neoplasms
4971349|NCT04169867|Intestinal microbiota|intestinal microbiota
4971350|NCT04169867|Nivolumab|nivolumab
4971351|NCT04169867|Ipilimumab|ipilimumab
4971352|NCT04169867|Atezolizumab|atezolizumab
4971356|NCT04169841|immunotherapy|immunotherapy
4971357|NCT04169841|olaparib|olaparib
4971358|NCT04169841|durvalumab|durvalumab
4971359|NCT04169841|tremelimumab|tremelimumab
4971360|NCT04169841|genes mutation|genes mutation
4971551|NCT04168489|Primary Dysmenorrhea|primary dysmenorrhea
4971553|NCT04168476|Hand Strength|hand strength
4971554|NCT04168476|Brachial plexus|brachial plexus
4971555|NCT04168476|Physical Therapy Modalities|physical therapy modalities
4971556|NCT04168476|Neck Pain|neck pain
4971649|NCT04167943|pulpotomy|pulpotomy
4971650|NCT04167943|TheraCal|theracal
4971651|NCT04167943|primary molars|primary molars
4971652|NCT04167930|traffic accident|traffic accident
4971653|NCT04167930|traditional Korean medicine|traditional korean medicine
4971654|NCT04167930|car insurance|car insurance
4971655|NCT04167930|whiplash injury|whiplash injury
4971656|NCT04167904|Troponin I|troponin i
4971657|NCT04167904|Myocardial Infarction|myocardial infarction
4971658|NCT04167904|Sensitivity and Specificity|sensitivity and specificity
4971659|NCT04167904|Receiver operation characteristics curve|receiver operation characteristics curve
4971660|NCT04167904|Biomarkers|biomarkers
4971664|NCT04167865|Pectus Excavatum|pectus excavatum
4971665|NCT04167865|Orthosis|orthosis
4971666|NCT04167865|Exercise|exercise
4971667|NCT04167852|Pain|pain
4971668|NCT04167852|postoperative|postoperative
4971669|NCT04167852|meditation|meditation
4971670|NCT04167852|opioid use|opioid use
4971671|NCT04167852|bariatric|bariatric
4971672|NCT04167800|Pectus Carinatum|pectus carinatum
4971751|NCT04167436|Nutritional supplement|nutritional supplement
4971779|NCT04167319|QST|qst
4971852|NCT04166799|Skin toxicity|skin toxicity
4971853|NCT04166786|Testosterone|testosterone
4971854|NCT04166786|Ethanol|ethanol
4971855|NCT04166786|Anti-doping control|anti-doping control
4971856|NCT04166786|Athletic performance|athletic performance
4971862|NCT04166734|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
4971863|NCT04166734|mesothelioma|mesothelioma
4971864|NCT04166734|pembrolizumab|pembrolizumab
4971865|NCT04166734|radiotherapy|radiotherapy
4971866|NCT04166734|SBRT|sbrt
4971867|NCT04166734|External Beam Stereotactic Body Radiotherapy|external beam stereotactic body radiotherapy
4971868|NCT04166708|Professional Flamenco Dancer|professional flamenco dancer
4971869|NCT04166708|Footwork step|footwork step
4971870|NCT04166708|Ground Reaction Force|ground reaction force
4971952|NCT04166136|musculoskeletal pain|musculoskeletal pain
4971953|NCT04166136|physiotherapy|physiotherapy
4971954|NCT04166136|military|military
4971955|NCT04166136|running|running
4971956|NCT04166123|frailty|frailty
4971957|NCT04166123|older adults|older adults
4971958|NCT04166123|instrument|instrument
4971959|NCT04166123|community|community
4971960|NCT04166110|community-acquired pneumonia|community-acquired pneumonia
4971961|NCT04166110|antibiotic therapy duration strategy|antibiotic therapy duration strategy
4971962|NCT04166110|non-inferiority trial|non-inferiority trial
4971963|NCT04166084|lipedema|lipedema
4971964|NCT04166084|postural stability|postural stability
4971965|NCT04166084|trunk stabilization exercises|trunk stabilization exercises
4971966|NCT04166071|social support|social support
4971967|NCT04166071|fear extinction|fear extinction
4972047|NCT04165720|Physical Activity|physical activity
4972048|NCT04165720|Mental Disorder|mental disorder
4972049|NCT04165720|Recommendation Behaviour|recommendation behaviour
4972050|NCT04165720|Mental Health|mental health
4972148|NCT04165356|artificial respiration|artificial respiration
4972149|NCT04165356|cross infection|cross infection
4972150|NCT04165356|ventilator-associated pneumonia|ventilator-associated pneumonia
4972155|NCT04165278|Parkinson's disease, temperature, hyperthermic baths|parkinson's disease, temperature, hyperthermic baths
4972156|NCT04165265|Hospitalization|hospitalization
4972157|NCT04165265|Reduction in stay|reduction in stay
4972158|NCT04165265|Ulcerative Colitis|ulcerative colitis
5657457|NCT00672854|mortality|mortality
4972159|NCT04165265|Inflammatory Bowel Disease|inflammatory bowel disease
4972160|NCT04165265|eHealth|ehealth
4972161|NCT04165265|Colectomy|colectomy
4972162|NCT04165265|Rescue therapy|rescue therapy
4972163|NCT04165265|Infliximab|infliximab
4972169|NCT04165239|Mitochondrial|mitochondrial
4972170|NCT04165239|Oxidative Phosphorylation (OXPHOS)|oxidative phosphorylation (oxphos)
4972172|NCT04165239|MIDD|midd
4972245|NCT04164849|Gliolan|gliolan
4972246|NCT04164849|UVA-PIT|uva-pit
4972247|NCT04164836|epistaxis|epistaxis
4972248|NCT04164836|rhinoscope|rhinoscope
4972249|NCT04164823|Primary Dysmenorrhea|primary dysmenorrhea
4972349|NCT04164316|Kinesio Taping|kinesio taping
4972350|NCT04164316|Biomechanics|biomechanics
4972351|NCT04164316|Iliotibial Band Friction Syndrome|iliotibial band friction syndrome
4972450|NCT04163835|Deficiency of both Qi and Yin Syndrome|deficiency of both qi and yin syndrome
4972451|NCT04163835|Heart Vessel Stasis and Obstruction Syndrome|heart vessel stasis and obstruction syndrome
4972452|NCT04163835|Traditional Chinese Medicine|traditional chinese medicine
4972453|NCT04163835|arrhythmia|arrhythmia
4972454|NCT04163822|bronchopulmonary dysplasia|bronchopulmonary dysplasia
4972455|NCT04163822|fibrosis|fibrosis
4972456|NCT04163822|cyst|cyst
4972457|NCT04163822|radiograph|radiograph
4972548|NCT04163302|Chimeric antigen receptor|chimeric antigen receptor
4972647|NCT04162769|Moderate-to-severe atopic dermatitis|moderate-to-severe atopic dermatitis
4972648|NCT04162769|Etrasimod|etrasimod
4972649|NCT04162769|APD334|apd334
4972650|NCT04162717|Patients with cancer|patients with cancer
4972746|NCT04162197|Gait Training|gait training
4972747|NCT04162197|Rehabilitation|rehabilitation
4972748|NCT04162197|Balance|balance
4972749|NCT04162197|Functional Recovery|functional recovery
4972750|NCT04162197|Robot-Assisted Gait Training|robot-assisted gait training
4972751|NCT04162184|family planning|family planning
4972848|NCT04161625|Aged 70 and over|aged 70 and over
4972850|NCT04161625|Computers handheld|computers handheld
4972851|NCT04161625|Motivation|motivation
4972852|NCT04161625|Behaviour change|behaviour change
4973058|NCT04160481|gut microbiome|gut microbiome
4973059|NCT04160481|carciovascular risk factor|carciovascular risk factor
4973063|NCT04160455|Antiretroviral therapy|antiretroviral therapy
4973064|NCT04160455|basal autophagy|basal autophagy
4973065|NCT04160455|GALIG gene|galig gene
4973067|NCT04160455|apoptosis|apoptosis
4973068|NCT04160403|Cerebral palsy, spastic, motor function, socioeconomic status, progress, physical therapy|cerebral palsy, spastic, motor function, socioeconomic status, progress, physical therapy
4973072|NCT04160351|Hemodialysis-Associated Amyloidosis|hemodialysis-associated amyloidosis
4973073|NCT04160351|Dialysis Amyloidosis|dialysis amyloidosis
4973074|NCT04160351|Quality of Life|quality of life
4973075|NCT04160286|Hippocampus|hippocampus
4973076|NCT04160286|Depression|depression
4973077|NCT04160286|Electroconvulsive therapy|electroconvulsive therapy
4973078|NCT04160286|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
4973079|NCT04160286|Magnetic Resonance Imaging|magnetic resonance imaging
4973080|NCT04160273|Posttraumatic stress disorder|posttraumatic stress disorder
4973084|NCT04160221|Medical Abortion|medical abortion
4973085|NCT04160221|Mifepristone|mifepristone
4973086|NCT04160221|Misoprostol|misoprostol
4973087|NCT04160208|male infertility|male infertility
4973089|NCT04160208|DFI|dfi
4973154|NCT04159792|mobility|mobility
4973155|NCT04159792|posture|posture
4973157|NCT04159779|Venetoclax|venetoclax
4973253|NCT04159142|Nab-paclitaxel|nab-paclitaxel
4973254|NCT04159142|Carboplatin|carboplatin
4973255|NCT04159142|Capecitabine|capecitabine
4973256|NCT04159142|Triple Negative Breast Cancer|triple negative breast cancer
4973257|NCT04159142|Maintenance therapy|maintenance therapy
4973258|NCT04159129|walking speed|walking speed
4973259|NCT04159129|dyspnoe|dyspnoe
4973260|NCT04159129|stress|stress
4973261|NCT04159129|anxiety|anxiety
4973262|NCT04159129|traffic light|traffic light
4973272|NCT04159103|Moderna|moderna
4973350|NCT04158388|nutrition|nutrition
4973449|NCT04157478|Stupp regimen|stupp regimen
4973450|NCT04157478|Temozolomide|temozolomide
4973451|NCT04157478|Radiation therapy|radiation therapy
4973452|NCT04157478|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
4973453|NCT04157465|cirrhosis|cirrhosis
4973454|NCT04157465|Acute-On-Chronic Liver Failure|acute-on-chronic liver failure
4973455|NCT04157465|liposomal amphotericin B|liposomal amphotericin b
4973456|NCT04157465|Invasive Fungal Infections|invasive fungal infections
4973457|NCT04157465|empiric antifungal|empiric antifungal
4973458|NCT04157465|pre-emptive antifungal|pre-emptive antifungal
4973459|NCT04157439|Integrated Neuromuscular Inhibition Technique|integrated neuromuscular inhibition technique
4973460|NCT04157439|Muscle Energy Technique|muscle energy technique
4973461|NCT04157439|Neck Disability Index|neck disability index
4973464|NCT04157413|stunting|stunting
4973548|NCT04156984|Personalized medicine|personalized medicine
4973549|NCT04156984|Comparisons of European with US label|comparisons of european with us label
4973550|NCT04156971|Childhood obesity|childhood obesity
5657548|NCT00672490|Acute Mania|acute mania
4973640|NCT04156438|acute respiratory distress syndrome|acute respiratory distress syndrome
4973642|NCT04156425|Major Depressive Disorder|major depressive disorder
4973747|NCT04155801|Gastrointestinal Disorders, Functional|gastrointestinal disorders, functional
4973748|NCT04155788|eating disorder|eating disorder
4973852|NCT04155372|sports medicine|sports medicine
4973853|NCT04155372|rehydration|rehydration
5666668|NCT00634075|ICU|icu
4973854|NCT04155372|ingestion rate|ingestion rate
4973855|NCT04155346|Exercise|exercise
4973856|NCT04155346|Nutrition|nutrition
4973863|NCT04155294|Women|women
4973952|NCT04154735|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
4973953|NCT04154722|XDR TYPHOID FEVER|xdr typhoid fever
4973954|NCT04154696|Steatotic liver graft|steatotic liver graft
4973955|NCT04154696|Liver transplantation|liver transplantation
4973956|NCT04154696|Normothermic perfusion|normothermic perfusion
4973957|NCT04154683|salpingectomy|salpingectomy
4974050|NCT04154228|Non Hodgkin Lymphoma|non hodgkin lymphoma
5653715|NCT00687544|HIV|hiv
4974051|NCT04154228|Follicular Lymphoma|follicular lymphoma
4974052|NCT04154189|Osteosarcoma|osteosarcoma
4974053|NCT04154189|Lenvatinib|lenvatinib
4974054|NCT04154189|Ifosfamide|ifosfamide
4974055|NCT04154189|Etoposide|etoposide
4974057|NCT04154189|Relapsed or Refractory Osteosarcoma|relapsed or refractory osteosarcoma
4974151|NCT04153656|Nurse burnout|nurse burnout
4974152|NCT04153617|Saciety|saciety
4974153|NCT04153617|Honey|honey
4974154|NCT04153617|Fiber|fiber
4974155|NCT04153617|Polyphenols|polyphenols
4974156|NCT04153617|Visual Analogue Scale|visual analogue scale
4974157|NCT04153617|Cross-over|cross-over
4974158|NCT04153617|Parallel|parallel
4974159|NCT04153565|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
4974160|NCT04153565|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
4974161|NCT04153552|Natural|natural
4974162|NCT04153552|Supplement|supplement
4974163|NCT04153539|Traffic-related pollution|traffic-related pollution
4974164|NCT04153539|Randomized controlled trial|randomized controlled trial
4974165|NCT04153539|Acute health effects|acute health effects
4974166|NCT04153487|Transfusion Reaction|transfusion reaction
4974168|NCT04153487|Acute Lung Injury|acute lung injury
4974251|NCT04153227|Metabolic acidosis|metabolic acidosis
4974252|NCT04153227|Vertebral fracture assessment|vertebral fracture assessment
4974253|NCT04153214|Cardiometabolic health|cardiometabolic health
4974254|NCT04153214|Sedentary Behavior|sedentary behavior
4974255|NCT04153214|Active workstation|active workstation
4974256|NCT04153214|Cycling desk|cycling desk
4974257|NCT04153201|antiphospholipid antibody titers|antiphospholipid antibody titers
4974258|NCT04153201|thrombosis prevention|thrombosis prevention
4974259|NCT04153201|hydroxychloroquine|hydroxychloroquine
4974260|NCT04153201|antimalarials|antimalarials
4974261|NCT04153201|antiphospholipid syndrome|antiphospholipid syndrome
4974262|NCT04153188|Erythema|erythema
4974263|NCT04153188|Rosacea|rosacea
4974264|NCT04153188|Telangiectasia|telangiectasia
4974265|NCT04153188|pulsed dye laser|pulsed dye laser
4974266|NCT04153188|oxymetazoline hydrochloride 1% cream|oxymetazoline hydrochloride 1% cream
4974284|NCT04153136|HIV|hiv
4974285|NCT04153136|Sacubitril/valsartan|sacubitril/valsartan
4974286|NCT04153136|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4974287|NCT04153136|Aldosterone|aldosterone
4974288|NCT04153136|Natriuretic Peptides|natriuretic peptides
4974289|NCT04153136|Myocardial Dysfunction|myocardial dysfunction
4974290|NCT04153136|Cardiovascular Disease|cardiovascular disease
4974291|NCT04153123|ocular flow|ocular flow
4974294|NCT04153123|ocular Doppler|ocular doppler
4974346|NCT04152785|nutrient profiling|nutrient profiling
4974347|NCT04152772|safety memory|safety memory
4974348|NCT04152772|PTSD|ptsd
4974349|NCT04152772|tDCS|tdcs
4974350|NCT04152772|ventromedial prefrontal cortex|ventromedial prefrontal cortex
4974351|NCT04152772|fear conditioning|fear conditioning
4974352|NCT04152746|Adenoid Hypertrophy|adenoid hypertrophy
4974353|NCT04152746|Periostin|periostin
4974354|NCT04152720|CAUTI|cauti
4974355|NCT04152720|Catheter-associated urinary tract infection|catheter-associated urinary tract infection
4974356|NCT04152720|Prevention of infection Foley Catheter|prevention of infection foley catheter
4974357|NCT04152681|Apatinib|apatinib
4974358|NCT04152681|Radiation-induced brain injury|radiation-induced brain injury
4974359|NCT04152668|Peri-implantitis|peri-implantitis
4974360|NCT04152668|Air-polishing|air-polishing
4974361|NCT04152668|Erythritol|erythritol
4974362|NCT04152616|Stroke|stroke
4974363|NCT04152616|postural asymmetry|postural asymmetry
4974364|NCT04152616|sitting balance|sitting balance
4974365|NCT04152577|Lenalidomide，rituximab，chemotherapy，highly aggressive B-NHL|lenalidomide，rituximab，chemotherapy，highly aggressive b-nhl
4974372|NCT04152525|Mindfulness|mindfulness
4974373|NCT04152525|Theory|theory
4974387|NCT04152395|EVAR|evar
4974542|NCT04151472|Individualized Treatment|individualized treatment
4974543|NCT04151459|Polycystic Ovary Syndrome|polycystic ovary syndrome
4974544|NCT04151459|Severe Obesity|severe obesity
4974545|NCT04151459|Laparoscopic Sleeve Gastrectomy|laparoscopic sleeve gastrectomy
4974546|NCT04151459|Live Birth Rate|live birth rate
4974548|NCT04151446|Sclera|sclera
4974641|NCT04150835|Traditional Chinese Medicine|traditional chinese medicine
4974642|NCT04150835|Double-Blind|double-blind
4974643|NCT04150835|Randomized Controlled Trial|randomized controlled trial
4974644|NCT04150796|Hernia Repair|hernia repair
4974645|NCT04150796|Minimally-invasive surgery|minimally-invasive surgery
4974646|NCT04150796|General surgery|general surgery
4974648|NCT04150744|immunosuppressant|immunosuppressant
4974655|NCT04150679|duodenal access|duodenal access
4974656|NCT04150679|hepaticojejonostomy|hepaticojejonostomy
4974658|NCT04150666|surgery therapy|surgery therapy
4974738|NCT04150042|autologous stem cell infusion|autologous stem cell infusion
4974739|NCT04150042|oligometastatic pancreatic cancer|oligometastatic pancreatic cancer
4974740|NCT04150042|stage 4 pancreatic cancer|stage 4 pancreatic cancer
4974741|NCT04150042|metastatic pancreatic cancer|metastatic pancreatic cancer
4974749|NCT04150003|Pulmonary Embolism|pulmonary embolism
4974947|NCT04148950|Functional Capacity|functional capacity
4974956|NCT04148898|leptomeningeal metastasis|leptomeningeal metastasis
4974957|NCT04148898|non small cell lung cancer|non small cell lung cancer
4974958|NCT04148898|EGFR Activating Mutation|egfr activating mutation
4974959|NCT04148898|Osimertinib|osimertinib
4974960|NCT04148898|Bevacizumab|bevacizumab
4974961|NCT04148885|castration-resistant prostate cancer|castration-resistant prostate cancer
4974962|NCT04148885|paclitaxel (albumin-binding)|paclitaxel (albumin-binding)
4974963|NCT04148885|carboplatin|carboplatin
4974965|NCT04148859|controlled amnioreduction|controlled amnioreduction
4975041|NCT04148157|Quality of Life|quality of life
4975042|NCT04148157|Questionnaire|questionnaire
4975043|NCT04148144|Low back pain|low back pain
4975044|NCT04148144|Adolescent|adolescent
4975045|NCT04148144|Parent|parent
4975046|NCT04148144|Prognosis|prognosis
4975047|NCT04148144|General practice|general practice
4975048|NCT04148131|Brachial Plexus|brachial plexus
4975049|NCT04148131|birth injury|birth injury
4975050|NCT04148118|Anthrax|anthrax
4975051|NCT04148118|Nanoemulsion adjuvant|nanoemulsion adjuvant
4975052|NCT04148118|Nasal Vaccine|nasal vaccine
4975090|NCT04147793|child|child
4975147|NCT04147559|Osteoarthritis|osteoarthritis
4975148|NCT04147559|avascular necrosis|avascular necrosis
4975149|NCT04147559|ankylosis|ankylosis
4975150|NCT04147559|protrusio acetabuli|protrusio acetabuli
4975151|NCT04147559|painful hip dysplasia|painful hip dysplasia
4975155|NCT04147468|Virtual Reality|virtual reality
4975156|NCT04147468|Functional Strength Training|functional strength training
4975157|NCT04147468|Arm Function|arm function
4975158|NCT04147455|Behavioral intervention|behavioral intervention
4975159|NCT04147455|Violent behavior|violent behavior
4975161|NCT04147377|Parkinson's disease|parkinson's disease
4975162|NCT04147377|Freezing of gait|freezing of gait
4975242|NCT04146831|FH-deficient|fh-deficient
4975243|NCT04146831|Sintilimab|sintilimab
4975244|NCT04146831|Second-line|second-line
4975245|NCT04146818|Mild Cognitive Impairment|mild cognitive impairment
4975349|NCT04146064|immunotherapy|immunotherapy
4975350|NCT04146064|predictive biomarker|predictive biomarker
4975351|NCT04146051|Descartes-08|descartes-08
4975352|NCT04146051|CART|cart
4975353|NCT04146051|CAR-T|car-t
4975354|NCT04146051|Autoimmune|autoimmune
4975355|NCT04146051|Auto-antibody|auto-antibody
4975356|NCT04146051|Auto antibody|auto antibody
4975361|NCT04145908|incisional hernia|incisional hernia
4975449|NCT04145375|prostate cancer|prostate cancer
4975450|NCT04145362|preterm|preterm
4975451|NCT04145362|actigraphy|actigraphy
4975452|NCT04145362|sleep|sleep
4975456|NCT04145336|ERCP|ercp
4975457|NCT04145336|PEP|pep
4975458|NCT04145336|Post-ERCP pancreatitis|post-ercp pancreatitis
4975459|NCT04145336|Pancreatic duct stent|pancreatic duct stent
4975460|NCT04145323|mastectomy|mastectomy
4975461|NCT04145323|Breast reconstruction|breast reconstruction
4975462|NCT04145323|necrosis|necrosis
4975463|NCT04145323|Indocyanine Green|indocyanine green
4975553|NCT04144686|dual-tasking|dual-tasking
4975555|NCT04144686|rehabilitation|rehabilitation
4975656|NCT04144075|Self-compassion|self-compassion
4975657|NCT04144075|Schizophrenia|schizophrenia
4975659|NCT04144062|Zirconium|zirconium
4975660|NCT04144062|Computer-Aided Design|computer-aided design
4975661|NCT04144036|Graft-versus-host disease|graft-versus-host disease
4975662|NCT04144036|Neihulizumab|neihulizumab
4975663|NCT04143971|intermittent fasting|intermittent fasting
4975664|NCT04143971|hypertriglyceridemia|hypertriglyceridemia
4975756|NCT04143399|quality of life|quality of life
4975757|NCT04143386|lower extremity arterial disease|lower extremity arterial disease
4975758|NCT04143386|hemodynamics|hemodynamics
4975759|NCT04143386|arterial stiffness|arterial stiffness
4975760|NCT04143386|metabolism|metabolism
4975761|NCT04143386|metabolomics|metabolomics
4975762|NCT04143386|inflammation|inflammation
4975763|NCT04143386|oxidative stress|oxidative stress
4975764|NCT04143386|biomarkers|biomarkers
4975765|NCT04143386|prognosis|prognosis
4975768|NCT04143347|Traumatic Brain injury|traumatic brain injury
4975769|NCT04143347|Transfer|transfer
4975857|NCT04142866|speech therapy|speech therapy
4975858|NCT04142827|Bronchiectasis|bronchiectasis
4975859|NCT04142827|High Flow Therapy|high flow therapy
4975860|NCT04142827|Humidifcation|humidifcation
4975861|NCT04142827|Lung Infection|lung infection
4975862|NCT04142827|Quality of life|quality of life
4975873|NCT04142801|Cognition|cognition
4975874|NCT04142801|motivation|motivation
4975875|NCT04142801|technology|technology
5653886|NCT00686634|sitagliptin|sitagliptin
4975876|NCT04142801|non pharmacological intervention|non pharmacological intervention
4975877|NCT04142736|Prone position|prone position
4975878|NCT04142736|High flow oxygen therapy|high flow oxygen therapy
4975955|NCT04142333|genetic testing|genetic testing
4976056|NCT04141761|Recent onset|recent onset
4976057|NCT04141761|Visbiome|visbiome
4976058|NCT04141761|Probiotic|probiotic
4976061|NCT04141735|SOS|sos
4976062|NCT04141722|Emotional Memory|emotional memory
4976063|NCT04141722|Memory Consolidation|memory consolidation
4976064|NCT04141722|Age-Related Positivity Effect|age-related positivity effect
4976065|NCT04141709|Oligometastasis|oligometastasis
4976066|NCT04141709|Prostate Cancer|prostate cancer
4976067|NCT04141709|high-dose radiation therapy|high-dose radiation therapy
4976068|NCT04141709|resistant prostate cancer|resistant prostate cancer
4976073|NCT04141683|tricuspid regurgitation|tricuspid regurgitation
4976154|NCT04141241|T2DM with Recent Cardiovascular Complications|t2dm with recent cardiovascular complications
4976155|NCT04141202|Exercise therapy|exercise therapy
4976156|NCT04141202|Exercise physiology|exercise physiology
4976157|NCT04141189|Intrauterine Growth Restriction|intrauterine growth restriction
4976158|NCT04141189|fetal surveillance|fetal surveillance
4976159|NCT04141189|fetal doppler|fetal doppler
4976259|NCT04140630|electronic cigarette|electronic cigarette
4976260|NCT04140630|passive exposure|passive exposure
4976261|NCT04140617|vaping|vaping
4976262|NCT04140617|electronic cigarette|electronic cigarette
4976453|NCT04139577|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
4976454|NCT04139577|Fecal Microbiota Transplant|fecal microbiota transplant
4976455|NCT04139551|wearable technology|wearable technology
4976456|NCT04139551|Saccadic eye movements|saccadic eye movements
4976457|NCT04139551|Gait assessment|gait assessment
4976458|NCT04139551|Cognitive tests|cognitive tests
4976488|NCT04139408|Marker|marker
4976548|NCT04138927|Warm Antibody Autoimmune Hemolytic Anemia|warm antibody autoimmune hemolytic anemia
4976549|NCT04138927|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
4976550|NCT04138901|Postoperative pain|postoperative pain
4976551|NCT04138901|Stomach neoplasms|stomach neoplasms
4976552|NCT04138901|Nerve block|nerve block
4976553|NCT04138888|Olmesartan medoxomil/hydrochlorothiazide|olmesartan medoxomil/hydrochlorothiazide
4976554|NCT04138888|Bioequivalence|bioequivalence
4976555|NCT04138888|Olmetec Plus®|olmetec plus®
4976646|NCT04138238|Vascular Diseases|vascular diseases
4976647|NCT04138238|Coronary Intervention|coronary intervention
4976648|NCT04138238|Observational Registry|observational registry
4976649|NCT04138238|Ultra-thin Strut Biodegradable Polymer|ultra-thin strut biodegradable polymer
4976846|NCT04137172|ventral hernia - LVHR-transfacial repair|ventral hernia - lvhr-transfacial repair
4976847|NCT04137120|Aflibercept|aflibercept
4976848|NCT04137120|Intravitreal injection|intravitreal injection
4976849|NCT04137120|Ocular disease|ocular disease
4976850|NCT04137120|Wet age-related macular degeneration (wAMD)|wet age-related macular degeneration (wamd)
4976851|NCT04137120|Diabetic macular edema (DME)|diabetic macular edema (dme)
4976852|NCT04137120|Macular edema secondary to central retinal vein occlusion (CRVO)|macular edema secondary to central retinal vein occlusion (crvo)
4976947|NCT04136665|leukemia|leukemia
4976948|NCT04136665|physical activity adapted|physical activity adapted
4976949|NCT04136652|vaginal laser CO2|vaginal laser co2
4976950|NCT04136613|Long acting reversible contraception|long acting reversible contraception
4976953|NCT04136613|Safety|safety
4977048|NCT04135976|core set validation|core set validation
4977049|NCT04135976|musculoskeletal conditions|musculoskeletal conditions
4977050|NCT04135937|Human Immunodeficiency Virus|human immunodeficiency virus
4977051|NCT04135937|Smoking|smoking
4977056|NCT04135885|Placebo|placebo
4977146|NCT04135235|Chronic Hepatitis B|chronic hepatitis b
4977152|NCT04135209|Myopia|myopia
4977244|NCT04134741|soccer|soccer
4977245|NCT04134741|football|football
4977246|NCT04134741|female|female
4977247|NCT04134741|sport injury|sport injury
4977263|NCT04134663|EEG|eeg
4977340|NCT04134117|Relapsed Primary CNS Lymphoma|relapsed primary cns lymphoma
4977341|NCT04134065|Vitamin D|vitamin d
4977342|NCT04134065|Crohn Disease|crohn disease
4977343|NCT04134065|recurrence|recurrence
4977347|NCT04134013|Chiropractic manipulation|chiropractic manipulation
4977348|NCT04134013|spinal manipulation therapy|spinal manipulation therapy
4977349|NCT04134013|osteopathic manipulation|osteopathic manipulation
4977352|NCT04134000|näive|näive
4977441|NCT04133480|CBD|cbd
4977443|NCT04133454|Cognition Disorders|cognition disorders
4977444|NCT04133454|Alzheimer Disease|alzheimer disease
4977445|NCT04133454|AAV|aav
4977446|NCT04133454|Dementia|dementia
4977447|NCT04133454|Gene therapy|gene therapy
4977448|NCT04133454|telomere|telomere
4977449|NCT04133454|telomerase|telomerase
4977450|NCT04133428|Heart failure|heart failure
4977542|NCT04132986|Biosynthetic absorbable mesh|biosynthetic absorbable mesh
4977543|NCT04132986|Descriptive study|descriptive study
4977544|NCT04132973|acceptability|acceptability
4977545|NCT04132973|feasibility|feasibility
4977546|NCT04132973|self-management|self-management
4977547|NCT04132960|DS-8201a|ds-8201a
4977549|NCT04132960|HER2|her2
5653979|NCT00686283|Diabetes|diabetes
4977550|NCT04132960|metastatic breast cancer|metastatic breast cancer
4977551|NCT04132895|Osteosarcoma|osteosarcoma
4977552|NCT04132895|Biobank|biobank
4977553|NCT04132895|Genomics|genomics
4977554|NCT04132895|Tumour markers|tumour markers
4977555|NCT04132882|Cisplatin|cisplatin
4977645|NCT04132232|fetal carboxyhemoglobin|fetal carboxyhemoglobin
4977646|NCT04132219|cancer survivor|cancer survivor
4977647|NCT04132219|overweight|overweight
4977750|NCT04131426|Cachexia; Cancer|cachexia; cancer
4977751|NCT04131426|Weight Loss|weight loss
4977752|NCT04131426|Exercise|exercise
4977753|NCT04131426|Nutritional Supplement|nutritional supplement
4977844|NCT04130711|neurofeedback|neurofeedback
4977845|NCT04130711|tendon vibration|tendon vibration
4977846|NCT04130711|virtual reality|virtual reality
4977848|NCT04130672|Hot tampon|hot tampon
4977849|NCT04130672|hot saline|hot saline
4977850|NCT04130672|adenoidectomy|adenoidectomy
4977851|NCT04130672|hemostasis|hemostasis
4977852|NCT04130672|bleeding control|bleeding control
4977859|NCT04130620|Magnesium deficiency|magnesium deficiency
4977862|NCT04130594|vaccine|vaccine
4977943|NCT04129892|Resilience|resilience
4978046|NCT04129164|Sjögren's Syndrome|sjögren's syndrome
4978048|NCT04129164|VIB4920|vib4920
4978049|NCT04129164|MEDI4920|medi4920
4978050|NCT04129151|Relapsed or refractory Ewing sarcoma|relapsed or refractory ewing sarcoma
4978051|NCT04129151|Solid Tumor, Childhood|solid tumor, childhood
4978052|NCT04129151|Sarcoma|sarcoma
4978053|NCT04129151|Ewing sarcoma|ewing sarcoma
4978054|NCT04129086|Multimodal Pain Therapy|multimodal pain therapy
4978055|NCT04129086|Ketamine|ketamine
4978056|NCT04129086|Trauma|trauma
4978057|NCT04129073|Comparative Effectiveness Research|comparative effectiveness research
4978058|NCT04129034|chronic low back pain|chronic low back pain
4978059|NCT04129034|zygapophyseal joint syndrome|zygapophyseal joint syndrome
4978060|NCT04129034|Facet syndrome|facet syndrome
4978061|NCT04129008|coronary heart disease|coronary heart disease
4978062|NCT04129008|gastroesophageal reflux disease|gastroesophageal reflux disease
4978063|NCT04129008|indobufen|indobufen
4978064|NCT04129008|aspirin|aspirin
4978073|NCT04128943|app utilization|app utilization
4978142|NCT04128566|articular cartilage|articular cartilage
4978143|NCT04128566|mechanosensitive blood markers of articular cartilage|mechanosensitive blood markers of articular cartilage
4978144|NCT04128566|walking stress test|walking stress test
4978145|NCT04128566|ambulatory load|ambulatory load
4978146|NCT04128566|articular cartilage thinning|articular cartilage thinning
4978443|NCT04126759|Raman spectroscopy|raman spectroscopy
4978444|NCT04126746|Lung transplantation|lung transplantation
4978445|NCT04126746|Chronic lung allograft dysfunction|chronic lung allograft dysfunction
4978446|NCT04126707|Chronic Myeloid Leukemia|chronic myeloid leukemia
4978448|NCT04126681|Chronic Myeloid Leukemia|chronic myeloid leukemia
4978449|NCT04126681|HQP1351|hqp1351
4978451|NCT04126681|CML-CP|cml-cp
4978452|NCT04126655|Colorectal cancer,|colorectal cancer,
4978453|NCT04126655|Liver metastases|liver metastases
4978547|NCT04126005|Canavan Disease|canavan disease
4978548|NCT04126005|leukodystrophy|leukodystrophy
4978549|NCT04126005|natural history|natural history
4978550|NCT04126005|non-interventional|non-interventional
4978643|NCT04125576|cerebral blood volume|cerebral blood volume
4978644|NCT04125563|Cough hypersensitivity syndrome|cough hypersensitivity syndrome
4978645|NCT04125563|Capsaicin cough sensitivity|capsaicin cough sensitivity
4978646|NCT04125563|Cough monitor|cough monitor
4978647|NCT04125537|Shared-Decision Making|shared-decision making
4978648|NCT04125537|Supportive Kidney Care|supportive kidney care
4978657|NCT04125498|adhesions|adhesions
4978737|NCT04124978|thermoplastic|thermoplastic
4978739|NCT04124978|MyTAP|mytap
4978743|NCT04124952|Panoptix, trifocal IOL, multifocal IOL|panoptix, trifocal iol, multifocal iol
4978744|NCT04124939|Overactive Bladder|overactive bladder
4978746|NCT04124939|Pain|pain
4978932|NCT04123808|Brain-Computer Interfaces|brain-computer interfaces
4978939|NCT04123730|Long Term Oxygen Treatment|long term oxygen treatment
4978940|NCT04123730|Dyspnea|dyspnea
4978941|NCT04123730|Physiotherapy|physiotherapy
4978942|NCT04123704|triple negative|triple negative
4978943|NCT04123704|metastatic breast cancer|metastatic breast cancer
4978944|NCT04123704|sitravatinib|sitravatinib
4978945|NCT04123691|cardio-respiratory events|cardio-respiratory events
4978946|NCT04123691|preterm infants|preterm infants
4978948|NCT04123691|desaturation|desaturation
4979033|NCT04123132|kinesiophobia|kinesiophobia
4979034|NCT04123132|metabolic syndrome|metabolic syndrome
4979035|NCT04123132|exercise|exercise
4979232|NCT04122040|Bronchiectasis|bronchiectasis
4979233|NCT04122040|quality of life|quality of life
4979234|NCT04122040|pulmonary function tests|pulmonary function tests
4979235|NCT04122001|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4979236|NCT04122001|Alzheimer's Disease (AD)|alzheimer's disease (ad)
4979237|NCT04122001|verbal learning treatment|verbal learning treatment
4979238|NCT04122001|word list learning|word list learning
4979239|NCT04122001|logopenic Progressive Aphasia|logopenic progressive aphasia
4979240|NCT04122001|episodic memory|episodic memory
4979241|NCT04121962|Black MSM|black msm
4979242|NCT04121962|Social network|social network
4979332|NCT04121494|Inhaled vaccine|inhaled vaccine
4979333|NCT04121481|Prodovite VMP35; RCT; Athletic Performance|prodovite vmp35; rct; athletic performance
4979334|NCT04121468|remyelination|remyelination
4979427|NCT04120922|chronic kidney disease stage 4-5|chronic kidney disease stage 4-5
4979523|NCT04120311|Central Serous Retinopathy with Pit of Optic Disc|central serous retinopathy with pit of optic disc
4979730|NCT04119375|mobile health|mobile health
4979731|NCT04119375|mhealth|mhealth
4979732|NCT04119375|behavioral interventions|behavioral interventions
4979733|NCT04119375|patient-centered care|patient-centered care
4979734|NCT04119362|pancreas|pancreas
4979735|NCT04119362|quality of life|quality of life
4979736|NCT04119362|PRO|pro
4979737|NCT04119362|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4979740|NCT04119297|Cold application|cold application
4979741|NCT04119297|Craniotomy|craniotomy
4979742|NCT04119297|Heparinoid|heparinoid
4979743|NCT04119297|Periorbital edema|periorbital edema
4979744|NCT04119297|Periorbital ecchymosis|periorbital ecchymosis
4979745|NCT04119284|scoliosis|scoliosis
4979836|NCT04118699|L-105|l-105
4979933|NCT04118218|rhizolysis|rhizolysis
4979934|NCT04118192|breast cancer|breast cancer
4979936|NCT04118192|ER negative|er negative
4980031|NCT04117620|Pediatric vestibular symptom|pediatric vestibular symptom
4980032|NCT04117620|Pediatric vestibular symptom questionnaire in french|pediatric vestibular symptom questionnaire in french
4980033|NCT04117607|Adults|adults
4980034|NCT04117607|CD101|cd101
4980035|NCT04117607|Healthy|healthy
4980332|NCT04115891|dental anxiety|dental anxiety
4980333|NCT04115891|anaesthesia|anaesthesia
4980334|NCT04115878|atomoxetine|atomoxetine
4980335|NCT04115878|oxybutynin|oxybutynin
4980336|NCT04115852|fmri|fmri
4980337|NCT04115852|interoceptive food processing|interoceptive food processing
4980343|NCT04115813|Adolescents|adolescents
4980344|NCT04115813|Young Adults|young adults
4980345|NCT04115813|Antiretroviral Therapy|antiretroviral therapy
4980346|NCT04115813|Caregivers|caregivers
4980369|NCT04115527|RCT|rct
4980425|NCT04115137|Chronic pelvic pain|chronic pelvic pain
4980724|NCT04113239|FFQ|ffq
4980524|NCT04114565|major depressive disorder|major depressive disorder
4980525|NCT04114565|service use|service use
4980526|NCT04114565|migration health|migration health
4980527|NCT04114565|global mental health|global mental health
4980528|NCT04114552|inversion trauma|inversion trauma
4980531|NCT04114552|therapy|therapy
4980726|NCT04113226|chemotherapy|chemotherapy
4980727|NCT04113226|Diffuse large B cell lymphoma (DLBCL)|diffuse large b cell lymphoma (dlbcl)
4980728|NCT04113226|Relapse|relapse
4980830|NCT04112602|lung cathepsins|lung cathepsins
4980924|NCT04111939|Buprenorphine|buprenorphine
4980925|NCT04111939|methadone|methadone
4980926|NCT04111939|evidence based practices|evidence based practices
4980927|NCT04111939|community engagement|community engagement
4980928|NCT04111926|Elderly patients|elderly patients
4980929|NCT04111926|Major non-cardiac surgery|major non-cardiac surgery
4980930|NCT04111926|Dexmedetomidine|dexmedetomidine
4980931|NCT04111926|long-term survival|long-term survival
4980932|NCT04111913|anlotinib|anlotinib
4980937|NCT04111835|cervical cancer|cervical cancer
4980938|NCT04111835|cervical screening|cervical screening
4980939|NCT04111835|HPV testing|hpv testing
4980940|NCT04111809|Multiple Myeloma|multiple myeloma
4980941|NCT04111809|intravenous bisphosphonate|intravenous bisphosphonate
4980942|NCT04111809|bone markers|bone markers
4980943|NCT04111783|anesthesia|anesthesia
4980946|NCT04111770|IVUS|ivus
4981024|NCT04111315|Non-opioid pain medications|non-opioid pain medications
4981025|NCT04111315|Educational intervention|educational intervention
4981037|NCT04111250|Dental implants|dental implants
4981038|NCT04111250|Maxillary sinus augmentation|maxillary sinus augmentation
5676241|NCT00595855|cataract|cataract
4981045|NCT04111198|Coronary Artery disease|coronary artery disease
4981184|NCT04110327|CLI|cli
4981224|NCT04110054|S-600918|s-600918
4981225|NCT04110041|Transitional-aged youth|transitional-aged youth
4981226|NCT04110041|Exercise therapy|exercise therapy
4981227|NCT04110041|Neurocognition|neurocognition
4981229|NCT04110041|EEG|eeg
4981230|NCT04110028|Nicotinamide riboside|nicotinamide riboside
4981231|NCT04110028|NAD+|nad+
4981232|NCT04110028|Epigenetics|epigenetics
4981233|NCT04110028|Aging|aging
4981234|NCT04110028|PARP|parp
4981235|NCT04110002|injury prevention program; professional ballet|injury prevention program; professional ballet
4981240|NCT04109963|vascular cognitive impairment, cerebral small vessel diseases, remote ischemic conditioning|vascular cognitive impairment, cerebral small vessel diseases, remote ischemic conditioning
4981242|NCT04109898|airway management|airway management
4981243|NCT04109898|I-gel|i-gel
4981321|NCT04109365|Electrical Epidural Stimulation Test|electrical epidural stimulation test
4981322|NCT04109339|Oxytocin|oxytocin
4981323|NCT04109339|Hemodynamic|hemodynamic
4981324|NCT04109339|Myomectomy|myomectomy
4981325|NCT04109326|Physical activity|physical activity
4981326|NCT04109326|Nutrition|nutrition
4981327|NCT04109326|Therapeutic education|therapeutic education
4981328|NCT04109326|Breast cancer|breast cancer
5667134|NCT00632359|CLL|cll
4981330|NCT04109313|BTK Inhibitor|btk inhibitor
4981331|NCT04109313|Long term safety|long term safety
4981332|NCT04109313|Urticaria activity score|urticaria activity score
4981422|NCT04108936|cellular immune response|cellular immune response
4981423|NCT04108936|microbiomes|microbiomes
4981424|NCT04108923|Thyroidectomy|thyroidectomy
4981425|NCT04108923|Ligasure|ligasure
4981427|NCT04108910|UTI|uti
4981524|NCT04108377|Phosphodiesterase 4 Inhibitor|phosphodiesterase 4 inhibitor
4981525|NCT04108364|aphasia|aphasia
4981526|NCT04108364|anomia|anomia
4981527|NCT04108364|rehabilitation|rehabilitation
4981528|NCT04108364|speech-language pathology|speech-language pathology
4981529|NCT04108364|mobile applications|mobile applications
4981530|NCT04108364|language therapy|language therapy
4981623|NCT04107740|Spinocerebellar degeneration|spinocerebellar degeneration
4981624|NCT04107740|Ataxia|ataxia
4981625|NCT04107727|Quizartinib|quizartinib
4981626|NCT04107714|Stigma|stigma
4981725|NCT04107337|Straw|straw
4981726|NCT04107337|Estimated subglottal pressure|estimated subglottal pressure
4981727|NCT04107337|Aerodynamic measurements|aerodynamic measurements
4981728|NCT04107337|Oral airflow|oral airflow
4981729|NCT04107311|solid tumor|solid tumor
4981730|NCT04107311|immunooncology|immunooncology
4981731|NCT04107285|Neurocognitive Evaluations|neurocognitive evaluations
4981820|NCT04106648|primary percutaneous coronary intervention|primary percutaneous coronary intervention
4981922|NCT04105829|tooth color change|tooth color change
4981923|NCT04105816|rectus femoris|rectus femoris
4982028|NCT04105075|copd|copd
4982128|NCT04104113|Breast Cancer|breast cancer
4982131|NCT04104113|Survivorship|survivorship
4982223|NCT04103554|sacubitril/valsartan|sacubitril/valsartan
4982224|NCT04103554|heart failure|heart failure
4982225|NCT04103528|Postoperative sleep disturbances|postoperative sleep disturbances
4982226|NCT04103528|Postoperative recovery|postoperative recovery
4982227|NCT04103528|General anesthesia|general anesthesia
4982233|NCT04103463|memory|memory
4982320|NCT04102813|sympathetic nervous system|sympathetic nervous system
4982321|NCT04102813|parasympathetic nervous system|parasympathetic nervous system
4982322|NCT04102813|inflammatory cytokines|inflammatory cytokines
4982323|NCT04102813|Functional psychotherapy|functional psychotherapy
4982324|NCT04102800|benralizumab|benralizumab
4982325|NCT04102800|exacerbation|exacerbation
4982326|NCT04102800|eosinophilic|eosinophilic
4982327|NCT04102787|coronary artery disease, educational program, patient satisfaction, patient knowledge.|coronary artery disease, educational program, patient satisfaction, patient knowledge.
4982329|NCT04102774|exacerbation|exacerbation
4982416|NCT04102345|aromatherapy|aromatherapy
4982417|NCT04102345|diagnostic sleep study|diagnostic sleep study
4982418|NCT04102345|zolpidem|zolpidem
4982419|NCT04102332|Antineoplastic Agents|antineoplastic agents
4982420|NCT04102332|Cancer|cancer
4982421|NCT04102332|Drug administration|drug administration
4982422|NCT04102332|Infusion device|infusion device
4982513|NCT04101669|Type 2 Diabetes|type 2 diabetes
4982514|NCT04101669|Obesity|obesity
4982612|NCT04100850|hydrotherapy|hydrotherapy
4982613|NCT04100850|depression|depression
4982676|NCT04100291|FMT|fmt
4982710|NCT04099953|Hemodialysis|hemodialysis
4982711|NCT04099953|chronic renal failure|chronic renal failure
4982712|NCT04099953|upper extremity|upper extremity
4982713|NCT04099953|physical activity|physical activity
4982810|NCT04099511|Rehabilitation|rehabilitation
4982811|NCT04099511|Participation|participation
4982812|NCT04099498|Self-regulation|self-regulation
4982813|NCT04099498|Healthy eating|healthy eating
4982909|NCT04099017|manual therapy|manual therapy
4982910|NCT04099017|kinesiotape|kinesiotape
4982911|NCT04099017|Excercise therapies|excercise therapies
4982912|NCT04099017|isometric contraction|isometric contraction
4983012|NCT04098432|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
4983014|NCT04098406|Nanocrystal|nanocrystal
4983015|NCT04098406|electromyography|electromyography
4983016|NCT04098393|Busulfan|busulfan
4983017|NCT04098393|Melphalan|melphalan
4983018|NCT04098393|Fludarabine|fludarabine
4983019|NCT04098393|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
4983020|NCT04098393|19-245|19-245
4983022|NCT04098315|AIDS|aids
4983023|NCT04098315|DRUG RESISTANCE|drug resistance
4983024|NCT04098289|Hysteroscopy|hysteroscopy
4983111|NCT04097704|Hepatic impairment|hepatic impairment
4983112|NCT04097704|CC-90007-CP-003|cc-90007-cp-003
4983113|NCT04097704|Healthy Subject|healthy subject
4983114|NCT04097691|diabetes mellitus|diabetes mellitus
4983115|NCT04097691|diabetic neuropathy|diabetic neuropathy
4983116|NCT04097691|pain|pain
4983117|NCT04097691|glucose 10%|glucose 10%
4983216|NCT04096989|prediabetes|prediabetes
4983218|NCT04096989|body constitution|body constitution
4983219|NCT04096989|meridian energy|meridian energy
4983220|NCT04096989|APP|app
4983221|NCT04096937|Resilience|resilience
4983222|NCT04096937|Appalachian youth|appalachian youth
4983312|NCT04096300|Integrative Medicine|integrative medicine
4983313|NCT04096300|Ethnomedicine|ethnomedicine
4983314|NCT04096300|Hirudotherapy|hirudotherapy
4983316|NCT04096300|Medical Cupping Therapy|medical cupping therapy
4983317|NCT04096300|Traditional and Complementary Medicine|traditional and complementary medicine
4983398|NCT04095793|PD|pd
4983408|NCT04095793|blacking out|blacking out
4983409|NCT04095793|lightheadedness|lightheadedness
4983410|NCT04095793|norepinephrine|norepinephrine
4983411|NCT04095793|hypotension|hypotension
4983502|NCT04095208|immunotherapy|immunotherapy
4983503|NCT04095208|oncology|oncology
4983504|NCT04095208|metastatic|metastatic
4983505|NCT04095195|Familial Pancreatic Cancer|familial pancreatic cancer
4983506|NCT04095195|BRCA Mutation|brca mutation
4983507|NCT04095195|Lynch Syndrome|lynch syndrome
4983508|NCT04095195|Screening pancreatic cancer|screening pancreatic cancer
4983511|NCT04095156|B cells|b cells
4983603|NCT04094610|Primary CNS tumor|primary cns tumor
4983604|NCT04094610|anaplastic large cell lymphoma|anaplastic large cell lymphoma
4983605|NCT04094610|metastatic solid tumor|metastatic solid tumor
4983606|NCT04094610|advanced solid tumor|advanced solid tumor
4983607|NCT04094610|sarcoma|sarcoma
4983608|NCT04094610|infantile fibrosarcoma|infantile fibrosarcoma
4983700|NCT04094012|isoniazid|isoniazid
4983701|NCT04094012|latent tuberculosis infection|latent tuberculosis infection
4983702|NCT04094012|preventive therapy|preventive therapy
4983703|NCT04094012|rifapentine|rifapentine
4983704|NCT04094012|systemic drug reaction|systemic drug reaction
4983705|NCT04094012|therapeutic drug monitoring|therapeutic drug monitoring
4983706|NCT04093999|Breast reconstruction|breast reconstruction
4983707|NCT04093999|DIEP flap|diep flap
4983708|NCT04093999|Sensory recovery|sensory recovery
4983709|NCT04093999|Breast sensation|breast sensation
4983710|NCT04093999|Nerve coaptation|nerve coaptation
4983711|NCT04093986|Hydroxyurea|hydroxyurea
4983712|NCT04093960|psychobiotics|psychobiotics
4983713|NCT04093960|major depressive disorder|major depressive disorder
4983714|NCT04093960|escitalopram|escitalopram
4983802|NCT04093388|self-collection|self-collection
4983803|NCT04093388|cervical cancer screening|cervical cancer screening
4983804|NCT04093362|Futibatinib|futibatinib
4983806|NCT04093362|FGFR2|fgfr2
4983901|NCT04092829|Endometrial preparation|endometrial preparation
4983904|NCT04092777|Medicaid|medicaid
4983905|NCT04092777|Racial|racial
4984003|NCT04092153|robotic surgery|robotic surgery
4984092|NCT04091477|Neuropsychology|neuropsychology
4984093|NCT04091477|neurocognition|neurocognition
4984094|NCT04091477|Daily functioning|daily functioning
4984095|NCT04091464|Backward Walking|backward walking
4984096|NCT04091464|Neurorehabilitation|neurorehabilitation
4984189|NCT04090905|abdominal surgery|abdominal surgery
4984190|NCT04090879|Biomarkers of Exposure|biomarkers of exposure
4984191|NCT04090879|Compensatory Smoking|compensatory smoking
4984192|NCT04090879|Nicotine Dependence|nicotine dependence
4984193|NCT04090879|Reduced Nicotine Cigarettes|reduced nicotine cigarettes
4984194|NCT04090879|Affective Disorders|affective disorders
4984195|NCT04090879|Tobacco Withdrawal|tobacco withdrawal
4984196|NCT04090879|Vulnerable Populations|vulnerable populations
4984296|NCT04090268|quality of life|quality of life
4984297|NCT04090203|Peanut|peanut
4984298|NCT04090203|Allergy|allergy
4984299|NCT04090190|Urinary Incontinence|urinary incontinence
4984300|NCT04090190|Urgency Urinary|urgency urinary
4984301|NCT04090190|Anticholinergic Treatment|anticholinergic treatment
4984302|NCT04090190|Urinary Microbiome|urinary microbiome
4984303|NCT04090164|Breast cancer|breast cancer
4984305|NCT04090164|Prognosis|prognosis
4984399|NCT04089514|Biologics|biologics
4984400|NCT04089514|Non-interventional|non-interventional
4984401|NCT04089514|Real-world|real-world
4984402|NCT04089514|Adalimumab|adalimumab
4984403|NCT04089514|Europe|europe
4984404|NCT04089462|Exercise|exercise
4984405|NCT04089462|Insulin pump|insulin pump
4984406|NCT04089462|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
4984407|NCT04089462|Guidelines|guidelines
4984408|NCT04089436|Encephalitis|encephalitis
4984409|NCT04089436|Southeast Asia|southeast asia
4984410|NCT04089436|Japanese encephalitis|japanese encephalitis
4984411|NCT04089436|Next Generation sequencing|next generation sequencing
4984421|NCT04089410|Irisin|irisin
4984494|NCT04089085|Educational and Behavioral Intervention for Children|educational and behavioral intervention for children
4984495|NCT04089072|Methylene Blue|methylene blue
4984496|NCT04089072|Vasopressors|vasopressors
4984497|NCT04089072|Septic Shock|septic shock
4984498|NCT04089072|Provay Blue®|provay blue®
4984507|NCT04088994|Hemiplegic Cerebral Palsy|hemiplegic cerebral palsy
4984508|NCT04088994|Mirror neuron System|mirror neuron system
4984509|NCT04088994|Action Observation|action observation
4984598|NCT04088461|Prediabetes|prediabetes
4984599|NCT04088461|Insulin resistance|insulin resistance
4984600|NCT04088461|hyperglucemia|hyperglucemia
4984606|NCT04088357|Healthy Participants|healthy participants
4984608|NCT04088357|Dermal|dermal
4984609|NCT04088357|Biopsy|biopsy
4984610|NCT04088305|pneumonia|pneumonia
4984611|NCT04088305|vancomycin|vancomycin
4984614|NCT04088279|MRI|mri
4984702|NCT04087603|Adolescence|adolescence
4984703|NCT04087590|long acting bronchodilator|long acting bronchodilator
4984704|NCT04087590|tidal breathing|tidal breathing
4984705|NCT04087590|variability|variability
4984706|NCT04087590|impulse oscillometry spirometry|impulse oscillometry spirometry
4984797|NCT04086992|Infantile Spasms|infantile spasms
4984798|NCT04086992|parental stress|parental stress
4984799|NCT04086992|ACTH|acth
4984800|NCT04086992|remote monitoring|remote monitoring
4984801|NCT04086979|friendship|friendship
4984807|NCT04086940|role|role
4984808|NCT04086940|INTRAOPERATIVE|intraoperative
4984809|NCT04086940|beta blocker|beta blocker
4984810|NCT04086940|bariatric surgery|bariatric surgery
4984811|NCT04086940|morbid obese|morbid obese
4984899|NCT04086277|cesarean section|cesarean section
4984900|NCT04086277|Continuous intrapartum support|continuous intrapartum support
4984901|NCT04086277|nulliparous|nulliparous
4984999|NCT04085679|Mobile specialist team|mobile specialist team
4985000|NCT04085679|Personalization of care|personalization of care
4985001|NCT04085679|Nursing home|nursing home
4985096|NCT04084847|Berberis vulgaris|berberis vulgaris
4985097|NCT04084847|Blood pressure|blood pressure
4985098|NCT04084847|Lipids|lipids
4985099|NCT04084847|Inflammation|inflammation
4985100|NCT04084834|Exercise|exercise
4985101|NCT04084795|Fibromyalgia|fibromyalgia
4985102|NCT04084795|Psychological trauma|psychological trauma
4985103|NCT04084795|Posttraumatic stress disorder|posttraumatic stress disorder
4985105|NCT04084795|Anxiety disorder|anxiety disorder
4985193|NCT04084314|episodic migraine|episodic migraine
4985194|NCT04084314|headache|headache
4985195|NCT04084314|erenumab|erenumab
4985196|NCT04084314|AMG334|amg334
4985197|NCT04084314|aimovig|aimovig
4985198|NCT04084314|monoclonal antibody|monoclonal antibody
4985199|NCT04084314|CGRP-receptor antibody|cgrp-receptor antibody
4985200|NCT04084301|renal oxygenation|renal oxygenation
4985201|NCT04084301|renal blood flow|renal blood flow
4985202|NCT04084301|cardiopulmonary bypass|cardiopulmonary bypass
4985203|NCT04084301|tubular cell injury|tubular cell injury
4985204|NCT04084301|N-acetyl-beta-D-glucosaminidase|n-acetyl-beta-d-glucosaminidase
4985205|NCT04084301|nephrocheck|nephrocheck
4985206|NCT04084301|inflammation|inflammation
4985207|NCT04084301|hemolysis|hemolysis
4985209|NCT04084275|nursing care|nursing care
4985222|NCT04084223|Ultrasound|ultrasound
4985291|NCT04083885|virtual reality|virtual reality
4985292|NCT04083885|telerehabilitation|telerehabilitation
4985293|NCT04083885|technology|technology
4985298|NCT04083833|TQT TTX Halneuron cardiac safety|tqt ttx halneuron cardiac safety
4985318|NCT04083755|PAD|pad
4985388|NCT04083131|Salutogenesis|salutogenesis
4985389|NCT04083131|Teenagers|teenagers
4985390|NCT04083118|positron emission tomography|positron emission tomography
4985391|NCT04083118|sodium fluoride|sodium fluoride
4985392|NCT04083118|bicuspid aortic valve|bicuspid aortic valve
4985393|NCT04083118|thoracic aortic aneurysm|thoracic aortic aneurysm
4985394|NCT04083118|aortopathy|aortopathy
4985395|NCT04083105|nitrous oxide|nitrous oxide
4985489|NCT04082546|Coronary abnormalities|coronary abnormalities
4985490|NCT04082546|Angina|angina
4985491|NCT04082546|Global longitudinal strain|global longitudinal strain
4985494|NCT04082533|total knee replacement|total knee replacement
4985507|NCT04082364|PD-1|pd-1
4985788|NCT04080232|Bronchiolitis Obliterans syndrome|bronchiolitis obliterans syndrome
4985789|NCT04080232|allogeneic stem cell transplantation|allogeneic stem cell transplantation
4985790|NCT04080219|valvular heart surgery|valvular heart surgery
4985890|NCT04079348|Donor Site Wound|donor site wound
4985891|NCT04079309|Perioperative Anxiety|perioperative anxiety
4986085|NCT04078334|Frail older adults|frail older adults
4986086|NCT04078334|Physical activity|physical activity
4986087|NCT04078334|exercise|exercise
4986088|NCT04078334|Hospitalization|hospitalization
4986191|NCT04077814|Cerebrovascular Accident|cerebrovascular accident
4986192|NCT04077814|Cerebrovascular Stroke|cerebrovascular stroke
4986193|NCT04077814|Cerebral Stroke|cerebral stroke
4986194|NCT04077736|Relapsing polychondritis，IL-2|relapsing polychondritis，il-2
4986195|NCT04077710|radioactive iodine-125 seeds implantation|radioactive iodine-125 seeds implantation
4986196|NCT04077710|3D-printing template|3d-printing template
4986197|NCT04077710|chest wall malignancies|chest wall malignancies
4986198|NCT04077697|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis
4986199|NCT04077697|Invasive TracheoBronchial Aspergillosis|invasive tracheobronchial aspergillosis
4986200|NCT04077697|galactomannan|galactomannan
4986201|NCT04077697|1,3-β-D-Glucan|1,3-β-d-glucan
4986202|NCT04077697|influenza|influenza
4986379|NCT04076748|vaso-occlusive crisis|vaso-occlusive crisis
4986380|NCT04076748|sufentanil|sufentanil
4986381|NCT04076748|intra-nasal|intra-nasal
4986382|NCT04076735|Distal Femur Fracture; Geriatric fracture|distal femur fracture; geriatric fracture
4986384|NCT04076722|Weight Loss|weight loss
4986404|NCT04076644|TMS|tms
4986585|NCT04075630|prostaglandin|prostaglandin
4986586|NCT04075630|cervical ripening balloon|cervical ripening balloon
4986593|NCT04075578|idiopathic overactive bladder|idiopathic overactive bladder
4986594|NCT04075578|Botox|botox
4986595|NCT04075578|Onabotulinum toxinA|onabotulinum toxina
4986596|NCT04075578|50 units|50 units
4986597|NCT04075565|hypoxia|hypoxia
4986598|NCT04075565|altitude|altitude
4986599|NCT04075565|physiology|physiology
4986779|NCT04074278|handgrip strength|handgrip strength
4986780|NCT04074278|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
4986781|NCT04074265|cerebral palsy|cerebral palsy
4986782|NCT04074265|randomized controlled trial|randomized controlled trial
4986783|NCT04074265|pediatric|pediatric
4986784|NCT04074265|pain management|pain management
4986785|NCT04074265|perioperative medicine|perioperative medicine
4986786|NCT04074239|telemedicine|telemedicine
4986787|NCT04074239|Triage|triage
4986788|NCT04074239|Call centers|call centers
4986977|NCT04072796|socioeconomic factors|socioeconomic factors
4986978|NCT04072796|stroke rehabilitation|stroke rehabilitation
4987076|NCT04072120|Geographical proximity|geographical proximity
4987077|NCT04072120|Family|family
4987078|NCT04072120|Relatives|relatives
4987079|NCT04072120|Survival analysis|survival analysis
4987170|NCT04071392|hysterosalpingogram (HSG)|hysterosalpingogram (hsg)
4987171|NCT04071392|permanent contraception|permanent contraception
4987172|NCT04071392|tubal occlusion|tubal occlusion
4987173|NCT04071392|tubal patency|tubal patency
4987174|NCT04071366|Cytokine release syndrome|cytokine release syndrome
4987175|NCT04071366|immune effector cell-associated neurotoxicity syndrome|immune effector cell-associated neurotoxicity syndrome
4987271|NCT04070677|Acute Esophagitis|acute esophagitis
4987272|NCT04070677|Radiotherapy|radiotherapy
4987273|NCT04070677|Ziverel|ziverel
4987274|NCT04070677|Chondroitin sulfate|chondroitin sulfate
4987275|NCT04070677|Hyaluronic acid|hyaluronic acid
4987276|NCT04070677|Poloxamer 407|poloxamer 407
4987277|NCT04070677|Chemoradiotherapy|chemoradiotherapy
4987278|NCT04070677|Chemotherapy|chemotherapy
4987279|NCT04070664|Vertigo|vertigo
4987280|NCT04070664|Central vertigo|central vertigo
4987281|NCT04070664|Peripheral vertigo|peripheral vertigo
4987285|NCT04070651|Sleep|sleep
4987370|NCT04070131|Physical Therapy Modalities|physical therapy modalities
4987371|NCT04070131|Physical Therapy Specialty|physical therapy specialty
4987375|NCT04070092|Elderly|elderly
4987581|NCT04069013|Percutaneous Nephrolithotomy|percutaneous nephrolithotomy
4987582|NCT04069013|PCNL|pcnl
4987583|NCT04069000|Social-Emotional Learning|social-emotional learning
4987584|NCT04069000|Classroom Climate|classroom climate
4987585|NCT04069000|Self-concept|self-concept
4987586|NCT04069000|Academic Skills|academic skills
4987587|NCT04068987|magnetic resonance imaging|magnetic resonance imaging
4987588|NCT04068987|parametric mapping|parametric mapping
4987589|NCT04068974|Ovarian Cancer|ovarian cancer
4987590|NCT04068974|Recurrent Platinum-resistant|recurrent platinum-resistant
4987591|NCT04068961|CGH array chip|cgh array chip
4987592|NCT04068961|Homozygosity mapping|homozygosity mapping
4987593|NCT04068922|aging|aging
4987594|NCT04068922|resilience|resilience
4987595|NCT04068922|low back pain|low back pain
4987596|NCT04068922|positive affect|positive affect
4987597|NCT04068922|hope|hope
4987605|NCT04068857|schizophrenia|schizophrenia
4987671|NCT04068311|Consolidated Framework for Implementation Research|consolidated framework for implementation research
4987673|NCT04068298|temperature gradient|temperature gradient
4987674|NCT04068298|microcirculation|microcirculation
4987675|NCT04068285|Type 2 diabetes mellitus|type 2 diabetes mellitus
4987676|NCT04068285|exercise|exercise
4987677|NCT04068285|aerobic|aerobic
4987678|NCT04068285|interval|interval
4987679|NCT04068285|continuous|continuous
4987680|NCT04068285|gait|gait
4987681|NCT04068272|Diabetes|diabetes
4987686|NCT04068220|chiasmal, prechiasmal, lesion, endoscopic skull base surgery|chiasmal, prechiasmal, lesion, endoscopic skull base surgery
4987699|NCT04068155|Squamous Cell Carcinoma|squamous cell carcinoma
4987700|NCT04068155|Basal Cell Carcinoma|basal cell carcinoma
4987701|NCT04068155|Skin Cancer|skin cancer
4987702|NCT04068155|Skin Metastasis|skin metastasis
4987703|NCT04068155|Superficial Sarcoma|superficial sarcoma
4987704|NCT04068155|Alpha Radiation|alpha radiation
4987705|NCT04068155|Cutaneous Lesion|cutaneous lesion
4987777|NCT04067726|Prevention|prevention
4987778|NCT04067726|Premenopausal|premenopausal
4987779|NCT04067687|palliative|palliative
4987780|NCT04067687|cancer|cancer
4987781|NCT04067687|pediatric|pediatric
4987878|NCT04067167|whole-body electromyostimulation|whole-body electromyostimulation
4987879|NCT04067089|aortic stenosis|aortic stenosis
4987887|NCT04067063|Mass Screening|mass screening
4987888|NCT04067063|Health Surveys|health surveys
4987889|NCT04067063|Mental Health|mental health
4987890|NCT04067063|Suicidal Ideation|suicidal ideation
4987891|NCT04067037|Classical Hodgkin Lymphoma|classical hodgkin lymphoma
4987892|NCT04067037|PD-1/PD-L1 Signaling Pathway|pd-1/pd-l1 signaling pathway
4987978|NCT04066491|Programmed death-ligand 1|programmed death-ligand 1
4987980|NCT04066465|Brain Tumor|brain tumor
4987981|NCT04066465|children and adolescents|children and adolescents
4987982|NCT04066465|neurocognitive function|neurocognitive function
4987983|NCT04066465|neurocognitive or neuropsychological outcome|neurocognitive or neuropsychological outcome
4987984|NCT04066465|quality of life, LOQ|quality of life, loq
4987985|NCT04066465|EEG|eeg
4987986|NCT04066465|Neuropsychological Tests|neuropsychological tests
4987987|NCT04066465|Proton Therapy|proton therapy
4988170|NCT04065360|Cognitive behavioural therapy|cognitive behavioural therapy
4988172|NCT04065347|Adherence|adherence
4988173|NCT04065347|Dried Blood Spots|dried blood spots
4988174|NCT04065347|Tenofovir-diphosphate|tenofovir-diphosphate
4988175|NCT04065347|Antiretroviral therapy|antiretroviral therapy
4988270|NCT04064814|Adolescent Migraine|adolescent migraine
4988272|NCT04064814|Alpha Lipoic Acid|alpha lipoic acid
4988273|NCT04064814|Thiol Level|thiol level
4988274|NCT04064814|Calcitonin gene regulated peptide|calcitonin gene regulated peptide
4988275|NCT04064775|Social influence|social influence
4988276|NCT04064775|Peer influence|peer influence
4988281|NCT04064736|Menstrual Health|menstrual health
4988282|NCT04064736|School attendance|school attendance
4988283|NCT04064736|Adolescent health|adolescent health
4988284|NCT04064723|Osteoarthritis|osteoarthritis
4988285|NCT04064723|Total hip arthroplasty|total hip arthroplasty
4988294|NCT04064684|PARDS|pards
4988769|NCT04061785|Physical training|physical training
4988770|NCT04061785|judo|judo
4988869|NCT04060940|Depression|depression
4988870|NCT04060914|ticagrelor|ticagrelor
4988871|NCT04060914|clopidogrel|clopidogrel
4988872|NCT04060914|Percutaneous Coronary Intervention|percutaneous coronary intervention
4988873|NCT04060914|Coronary Artery Disease|coronary artery disease
4988874|NCT04060914|Adenosine|adenosine
4988875|NCT04060901|Spiritual health clinician|spiritual health clinician
4988876|NCT04060784|Immediate implant placement and provisionalization|immediate implant placement and provisionalization
4988877|NCT04060784|Socket shield technique|socket shield technique
4988878|NCT04060784|Root shield|root shield
4988879|NCT04060784|Soft tissue level change|soft tissue level change
4988880|NCT04060784|Soft tissue volume change|soft tissue volume change
4988881|NCT04060784|IIPP|iipp
4988882|NCT04060784|SST|sst
4989057|NCT04059692|manual therapy|manual therapy
4989058|NCT04059692|movement|movement
4989059|NCT04059653|neuromuscular electrical stimulation|neuromuscular electrical stimulation
4989061|NCT04059640|Inguinal Hernia|inguinal hernia
4989062|NCT04059640|Mesh Fixation|mesh fixation
4989063|NCT04059640|Surgical Site Wound Closure|surgical site wound closure
4989064|NCT04059627|Cardiac Rehab|cardiac rehab
4989066|NCT04059614|conventional oxygen|conventional oxygen
4989068|NCT04059614|diaphragm thickness|diaphragm thickness
4989069|NCT04059601|common bile duct stones|common bile duct stones
4989070|NCT04059601|cholecystectomy|cholecystectomy
4989159|NCT04059120|Overtraining|overtraining
4989160|NCT04059120|BDNF|bdnf
4989161|NCT04059120|Stretching|stretching
4989162|NCT04059068|macrophage|macrophage
4989163|NCT04059068|adipose tissue|adipose tissue
4989164|NCT04059068|fibroblast|fibroblast
4989264|NCT04058431|cognitive decline|cognitive decline
4989265|NCT04058431|pain|pain
4989266|NCT04058431|osteopathic manipulative treatment|osteopathic manipulative treatment
4989267|NCT04058327|neurophysiological/psychological tests|neurophysiological/psychological tests
4989268|NCT04058327|blood ammonia|blood ammonia
4989269|NCT04058327|early Diagnosis|early diagnosis
4989270|NCT04058327|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
4989271|NCT04058327|Hepatic Encephalopathy|hepatic encephalopathy
4989272|NCT04058327|Liver Diseases|liver diseases
4989273|NCT04058327|Cirrhosis, Liver|cirrhosis, liver
4989461|NCT04057339|Glucose Homeostasis|glucose homeostasis
4989462|NCT04057339|Mitochondrial Function|mitochondrial function
4989464|NCT04057313|Coffee|coffee
4989465|NCT04057313|Headache|headache
4989469|NCT04057300|Stroke|stroke
4989563|NCT04056676|Postoperative pain|postoperative pain
4989564|NCT04056676|Thoracic paravertebral block|thoracic paravertebral block
4989565|NCT04056676|Modified PEC block|modified pec block
4989566|NCT04056676|Breast cancer|breast cancer
4989567|NCT04056676|Total mastectomy with sentinel lymph node clearance|total mastectomy with sentinel lymph node clearance
4989568|NCT04056663|Artificial Intelligence|artificial intelligence
4989569|NCT04056663|Continuity of Patient Care|continuity of patient care
4989577|NCT04056637|multi-level pregnancy test|multi-level pregnancy test
4989578|NCT04056637|medication abortion|medication abortion
4989579|NCT04056637|first trimester abortion|first trimester abortion
4989580|NCT04056637|abortion follow-up|abortion follow-up
4989581|NCT04056598|P. acnes|p. acnes
4989582|NCT04056598|acne vulgaris|acne vulgaris
4989583|NCT04056598|humoral immune response|humoral immune response
4989604|NCT04056481|EAP|eap
4989658|NCT04056169|positron emission tomography|positron emission tomography
4989659|NCT04056156|HIV|hiv
4989660|NCT04056156|HIV-testing|hiv-testing
4989756|NCT04055311|patient focused intervention|patient focused intervention
4989757|NCT04055311|caregiver|caregiver
4989758|NCT04055311|Internet based information|internet based information
4989860|NCT04054869|manual therapy|manual therapy
4989861|NCT04054869|joint mobilization|joint mobilization
4989862|NCT04054830|Trabeculectomy|trabeculectomy
4989863|NCT04054830|NSAID|nsaid
4989864|NCT04054830|Steroid|steroid
4989865|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents
4989866|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
4989867|NCT04054830|Eye Diseases|eye diseases
4989888|NCT04054739|stroke|stroke
4989955|NCT04054414|Neurogenesis|neurogenesis
4989956|NCT04054388|LINE|line
4989957|NCT04054388|Colonoscopy|colonoscopy
4989958|NCT04054388|Bowel cleansing|bowel cleansing
4989959|NCT04054375|Steroids, Prednisone|steroids, prednisone
4989960|NCT04054336|Approach and Avoidance Task, Inhibition|approach and avoidance task, inhibition
4989961|NCT04054323|Exercise|exercise
4989962|NCT04054323|CKD|ckd
4989963|NCT04054323|Graft Survival|graft survival
4990057|NCT04053751|endotracheal suctioning|endotracheal suctioning
4990058|NCT04053751|open suctioning system|open suctioning system
4990059|NCT04053751|closed suctioning system|closed suctioning system
4990060|NCT04053751|nursing|nursing
4990157|NCT04053361|Atrial Fibrillation|atrial fibrillation
4990158|NCT04053361|Pulmonary Hypertension|pulmonary hypertension
4990159|NCT04053361|Catheter Ablation|catheter ablation
4990164|NCT04053283|metastatic; epithelial; virus; advanced|metastatic; epithelial; virus; advanced
4990165|NCT04053270|Erythropoietic Protoporphyria|erythropoietic protoporphyria
4990166|NCT04053270|EPP|epp
4990167|NCT04053270|Afamelanotide|afamelanotide
4990168|NCT04053244|iCBT|icbt
4990169|NCT04053244|cardiac event|cardiac event
4990170|NCT04053244|cognitive behavioural therapy|cognitive behavioural therapy
4990171|NCT04053244|depression|depression
4990172|NCT04053231|liver|liver
4990173|NCT04053231|hcc|hcc
4990174|NCT04053231|hepatocarcinoma|hepatocarcinoma
4990175|NCT04053231|surgery|surgery
4990176|NCT04053231|redo surgery|redo surgery
4990177|NCT04053231|recurrence|recurrence
4990178|NCT04053231|cirrhosis|cirrhosis
4990179|NCT04053218|Adult survivors of severe acute malnutrition|adult survivors of severe acute malnutrition
4990180|NCT04053218|Cognition|cognition
4990181|NCT04053192|Balloon Aortic Valvuloplasty|balloon aortic valvuloplasty
4990253|NCT04052776|Pharmacology|pharmacology
4990350|NCT04052100|Physical activity|physical activity
4990351|NCT04052100|Nutrition|nutrition
4990352|NCT04052100|Cognitive behavioural therapy|cognitive behavioural therapy
4990353|NCT04052100|Smoking cessation|smoking cessation
4990354|NCT04052087|Brain Damage Acquired|brain damage acquired
4990355|NCT04052087|BDA in subacute and chronic stage|bda in subacute and chronic stage
4990356|NCT04052087|BESTest|bestest
4990449|NCT04051437|Acute on chronic liver failure|acute on chronic liver failure
4990450|NCT04051411|mitral regurgitation|mitral regurgitation
4990547|NCT04050917|hand function|hand function
4990548|NCT04050917|occupational therapy|occupational therapy
4990549|NCT04050917|physical therapy|physical therapy
4990550|NCT04050904|heart failure|heart failure
4990551|NCT04050904|algorithm|algorithm
4990552|NCT04050878|Imaging, Three-Dimensional|imaging, three-dimensional
4990553|NCT04050878|Technology, Dental|technology, dental
4990554|NCT04050878|accuracy|accuracy
4990555|NCT04050878|extra-oral scanner|extra-oral scanner
4990647|NCT04050371|daily observed therapy|daily observed therapy
4990648|NCT04050332|Radio Frequency Identification Device|radio frequency identification device
4990649|NCT04050319|concussions|concussions
4990751|NCT04049682|School|school
4990752|NCT04049669|IDO|ido
4990753|NCT04049669|indoleamine 2,3-dioxygenase|indoleamine 2,3-dioxygenase
4990754|NCT04049669|indoximod|indoximod
4990755|NCT04049669|pediatric|pediatric
4990756|NCT04049669|childhood|childhood
4990757|NCT04049669|brain tumor|brain tumor
4990758|NCT04049669|glioblastoma|glioblastoma
4990759|NCT04049669|medulloblastoma|medulloblastoma
4990760|NCT04049669|ependymoma|ependymoma
4990761|NCT04049669|diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
4990762|NCT04049669|DIPG|dipg
4990763|NCT04049669|radiation|radiation
4990764|NCT04049669|temozolomide|temozolomide
4990765|NCT04049669|cyclophosphamide|cyclophosphamide
4990766|NCT04049669|etoposide|etoposide
4990767|NCT04049669|lomustine|lomustine
4990768|NCT04049669|immunotherapy|immunotherapy
4990769|NCT04049669|immune|immune
4990770|NCT04049669|central nervous system|central nervous system
4990771|NCT04049669|CNS|cns
4990781|NCT04049526|Music|music
4990782|NCT04049526|Preterm infants|preterm infants
4990783|NCT04049526|Heart Rate Variability|heart rate variability
4990786|NCT04049500|Physicians|physicians
4990787|NCT04049500|Nurses|nurses
4990948|NCT04048720|Multiple Family Group Intervention|multiple family group intervention
4990949|NCT04048681|artificial sweeteners|artificial sweeteners
4990951|NCT04048668|non-invasive brain stimulation|non-invasive brain stimulation
4990952|NCT04048668|tDCS|tdcs
4990953|NCT04048655|neuromuscular blockade|neuromuscular blockade
4990954|NCT04048655|neostigmine|neostigmine
4991053|NCT04048135|Metabolic diseases|metabolic diseases
4991054|NCT04048122|occupational therapy|occupational therapy
4991055|NCT04048122|cognition|cognition
4991056|NCT04048083|bilateral upper limb congenital transverse deficiency|bilateral upper limb congenital transverse deficiency
4991063|NCT04048031|Women|women
4991150|NCT04047511|psychotherapy|psychotherapy
4991151|NCT04047511|rehabilitation|rehabilitation
4991152|NCT04047485|Cataract|cataract
4991153|NCT04047485|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
4991154|NCT04047485|Cataract Surgery|cataract surgery
4991155|NCT04047485|BMICS (Bi-Manual Microincisional Cataract Surgery)|bmics (bi-manual microincisional cataract surgery)
4991156|NCT04047485|Post-operative Delirium|post-operative delirium
4991158|NCT04047459|Microfluidics|microfluidics
4991243|NCT04046991|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
4991341|NCT04046640|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4991445|NCT04046094|Intravenous (IV) Ascorbic Acid (Vitamin C)|intravenous (iv) ascorbic acid (vitamin c)
4991446|NCT04046081|Endometriosis|endometriosis
4991447|NCT04046081|Dichloroacetate|dichloroacetate
4991448|NCT04046055|transcranial direct current stimulation|transcranial direct current stimulation
4991449|NCT04046055|walking|walking
4991450|NCT04046055|balance|balance
4991451|NCT04046042|Exercise|exercise
4991458|NCT04046029|Elderly|elderly
4991539|NCT04045522|real-world study|real-world study
4991540|NCT04045509|corneal sensation|corneal sensation
4991541|NCT04045509|subbasal nerve plexus|subbasal nerve plexus
4991542|NCT04045496|Src homology phosphatase 2 (SHP2)|src homology phosphatase 2 (shp2)
4991543|NCT04045496|PTPN11|ptpn11
4991544|NCT04045496|Kirsten rat sarcoma (KRAS) proto-oncogene, GTPase|kirsten rat sarcoma (kras) proto-oncogene, gtpase
4991545|NCT04045496|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
4991552|NCT04045444|elderly|elderly
4991640|NCT04044911|Activity of daily living|activity of daily living
4991641|NCT04044911|Stroke|stroke
4991642|NCT04044911|Apraxia|apraxia
4991643|NCT04044911|Action of daily living|action of daily living
4991645|NCT04044898|Acne vulgaris|acne vulgaris
4991646|NCT04044885|Nap|nap
4991647|NCT04044885|Recovery sleep|recovery sleep
4991648|NCT04044885|Cognitive functions|cognitive functions
4991649|NCT04044885|Neurobehavioural functions|neurobehavioural functions
4991650|NCT04044885|Mood|mood
4991651|NCT04044885|Subjective sleepiness|subjective sleepiness
4991652|NCT04044872|Cardiotoxicity|cardiotoxicity
4991653|NCT04044872|Cardiac injury|cardiac injury
4991654|NCT04044872|Radiation induced heart disease (RIHD)|radiation induced heart disease (rihd)
4991671|NCT04044794|weight management|weight management
4991672|NCT04044794|body weight|body weight
4991673|NCT04044794|behavioral|behavioral
4991674|NCT04044794|weighing|weighing
4991678|NCT04044716|auricular acupressure|auricular acupressure
4991679|NCT04044716|anesthesia|anesthesia
4991680|NCT04044651|Hepatocellular Carcinoma|hepatocellular carcinoma
4991681|NCT04044651|Lenvatinib|lenvatinib
4991682|NCT04044651|Nivolumab|nivolumab
4991683|NCT04044651|Hepatitis B virus|hepatitis b virus
4991684|NCT04044586|HIV|hiv
4991685|NCT04044586|HCV|hcv
4991743|NCT04044339|0177|0177
4991744|NCT04044339|single ascending dose|single ascending dose
4991745|NCT04044339|SAD|sad
4991746|NCT04044339|multiple ascending dose|multiple ascending dose
4991747|NCT04044339|MAD|mad
4991748|NCT04044339|first-in-human|first-in-human
4991749|NCT04044339|Phase 1|phase 1
4991750|NCT04044326|消融|消融
4991751|NCT04044313|Hepatocellular Carcinoma|hepatocellular carcinoma
4991752|NCT04044313|Hepatic artery infusion chemotherapy|hepatic artery infusion chemotherapy
4991754|NCT04044313|Lenvatinib|lenvatinib
4991843|NCT04043793|Immunocompromised Host|immunocompromised host
4991844|NCT04043793|Critical care|critical care
4991845|NCT04043793|Drug Resistance, Multiple|drug resistance, multiple
4991846|NCT04043767|predictors, difficult intubation, pediatric patient|predictors, difficult intubation, pediatric patient
4992034|NCT04042675|exercise capacity|exercise capacity
4992035|NCT04042649|intensive care unit|intensive care unit
4992036|NCT04042649|critically ill patients|critically ill patients
4992037|NCT04042649|environmental intervention|environmental intervention
4992038|NCT04042636|trauma|trauma
4992140|NCT04042116|antineoplastic agents immunological|antineoplastic agents immunological
4992141|NCT04042116|antineoplastic agents|antineoplastic agents
4992149|NCT04042064|CGA|cga
4992242|NCT04041466|Arrhythmias, Cardiac|arrhythmias, cardiac
4992343|NCT04041050|navitoclax|navitoclax
4992344|NCT04041050|ruxolitinib|ruxolitinib
4992349|NCT04041024|computational psychiatry|computational psychiatry
4992350|NCT04041024|decision making|decision making
4992351|NCT04041024|risk|risk
4992352|NCT04041024|food|food
4992353|NCT04041024|monetary|monetary
4992354|NCT04041024|eating disorder|eating disorder
4992355|NCT04040998|schizophrenia|schizophrenia
4992356|NCT04040998|compensatory cognitive training|compensatory cognitive training
4992357|NCT04040998|generalized estimating equation|generalized estimating equation
4992358|NCT04040998|psychosocial correlates|psychosocial correlates
4992441|NCT04040517|Hearing Loss|hearing loss
4992442|NCT04040491|PD-1|pd-1
4992443|NCT04040491|chidamide|chidamide
4992444|NCT04040491|lenalidomide|lenalidomide
4992445|NCT04040491|etoposide|etoposide
4992446|NCT04040491|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
4992447|NCT04040452|pain control|pain control
4992448|NCT04040452|cardiac surgery|cardiac surgery
4992449|NCT04040452|pediatric|pediatric
4992450|NCT04040452|opioid|opioid
4992451|NCT04040452|NSAID|nsaid
4992452|NCT04040452|congenital heart disease|congenital heart disease
4992547|NCT04039971|ACL Rupture|acl rupture
4992548|NCT04039971|Anterior Cruciate Ligament Tear|anterior cruciate ligament tear
4992549|NCT04039971|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
4992642|NCT04039503|GIP/GLP-1 dual receptor agonist|gip/glp-1 dual receptor agonist
4992643|NCT04039503|T2DM|t2dm
4992644|NCT04039490|pediatrics|pediatrics
4992645|NCT04039490|vessel cannulations|vessel cannulations
4992646|NCT04039490|ultrasound-guided|ultrasound-guided
4992658|NCT04039412|Helicobacter Pylori Infection|helicobacter pylori infection
4992659|NCT04039412|Quadruple Therapy|quadruple therapy
4992660|NCT04039412|Egypt|egypt
4992661|NCT04039386|Hip Pain|hip pain
4992662|NCT04039386|Hip Instability|hip instability
4992663|NCT04039386|Hip Impingement|hip impingement
4992664|NCT04039386|Cognitive Based Therapy|cognitive based therapy
4992665|NCT04039386|Psychosocial Conditions|psychosocial conditions
4992666|NCT04039360|Left-sided colonic tumor|left-sided colonic tumor
4992667|NCT04039360|Intestinal obstruction|intestinal obstruction
4992668|NCT04039360|Self-expanding metallic stent|self-expanding metallic stent
4992670|NCT04039360|Stoma|stoma
4992940|NCT04037800|Sustainable functional urethral reconstruction|sustainable functional urethral reconstruction
4993040|NCT04037137|Caregiver Diffuculties Scale|caregiver diffuculties scale
4993042|NCT04037137|validity|validity
4993043|NCT04037137|Turkish version|turkish version
4993044|NCT04037124|Cervical cancer|cervical cancer
4993045|NCT04037124|Lymph node involvement|lymph node involvement
4993046|NCT04037124|Radical hysterectomy|radical hysterectomy
4993435|NCT04034758|Fecal microbiota transplantation|fecal microbiota transplantation
4993436|NCT04034758|SQIMC-md|sqimc-md
4993437|NCT04034758|Ulcerative colitis|ulcerative colitis
4993438|NCT04034732|Mindfulness-based intervention|mindfulness-based intervention
4993439|NCT04034732|Mindfulness|mindfulness
4993440|NCT04034732|Relapse prevention|relapse prevention
4993441|NCT04034719|Newborn|newborn
4993442|NCT04034719|Parents|parents
4993544|NCT04034238|Advanced Cancer|advanced cancer
4993546|NCT04034238|Antibody Based Therapeutics|antibody based therapeutics
4993547|NCT04034238|Mesothelin|mesothelin
4993548|NCT04034212|COPD|copd
4993549|NCT04034199|denosumab|denosumab
4993550|NCT04034199|zoledronic acid|zoledronic acid
4993551|NCT04034186|low back pain|low back pain
4993552|NCT04034186|rehabilitation|rehabilitation
4993553|NCT04034186|assessment|assessment
4993554|NCT04034186|quality|quality
4993555|NCT04034173|colorectal cancer|colorectal cancer
4993557|NCT04034173|low-RAS|low-ras
4993558|NCT04034173|mCRC|mcrc
4993559|NCT04034173|Panitumumab|panitumumab
4993560|NCT04034147|subjective cognition|subjective cognition
4993561|NCT04034147|metacognition|metacognition
4993562|NCT04034147|functioning|functioning
4993636|NCT04033822|feasibility study|feasibility study
4993637|NCT04033809|Rheumatoid Arthritis|rheumatoid arthritis
4993730|NCT04033185|stroke|stroke
4993731|NCT04033185|virtual reality|virtual reality
4993732|NCT04033185|robot assisted gait training|robot assisted gait training
4993930|NCT04032145|Prevention, museum, art|prevention, museum, art
4993931|NCT04032132|curcumin|curcumin
4993932|NCT04032132|CBCT|cbct
4993933|NCT04032132|HPLC|hplc
4994129|NCT04030819|schema therapy|schema therapy
4994130|NCT04030806|stroke|stroke
4994131|NCT04030806|mirror therapy|mirror therapy
4994132|NCT04030806|upper extremity|upper extremity
4994133|NCT04030793|Brain Stimulation|brain stimulation
4994134|NCT04030793|Transcranial direct current stimulation|transcranial direct current stimulation
4994135|NCT04030793|Motor function|motor function
4994220|NCT04030156|Size|size
4994221|NCT04030156|tonsil|tonsil
4994222|NCT04030156|tonsillectomy|tonsillectomy
4994223|NCT04030156|ultrasonography|ultrasonography
4994224|NCT04030143|Aripiprazole|aripiprazole
4994225|NCT04030143|Aripiprazole Intramuscular Depot|aripiprazole intramuscular depot
4994324|NCT04029454|Infectious Disease Transmission, Vertical|infectious disease transmission, vertical
4994337|NCT04029389|Tibial Nerve|tibial nerve
4994513|NCT04028297|undifferentiated|undifferentiated
4994514|NCT04028297|ultrasound|ultrasound
4994515|NCT04028284|epidural|epidural
4994516|NCT04028284|analgesia|analgesia
4994517|NCT04028284|Virtual reality|virtual reality
4994518|NCT04028271|needle-free injection|needle-free injection
4994519|NCT04028271|pain|pain
4994520|NCT04028258|Constipation|constipation
4994521|NCT04028258|Fiber|fiber
4994612|NCT04027634|schizophrenia|schizophrenia
5654931|NCT00682474|Youth|youth
4994709|NCT04026802|deconditioning of elderly inpatients|deconditioning of elderly inpatients
4994710|NCT04026802|loss of functionality|loss of functionality
4994734|NCT04026607|Muscle|muscle
4994809|NCT04026243|ultrasound guided regional blocks|ultrasound guided regional blocks
4994810|NCT04026243|Transversalis Fascia Plane Block|transversalis fascia plane block
4994811|NCT04026243|Quadratus Lumborum Block|quadratus lumborum block
4994812|NCT04026243|inguinal herniorrhaphy|inguinal herniorrhaphy
4994907|NCT04025658|Cesarean delivery|cesarean delivery
4994908|NCT04025645|Cholelithiasis|cholelithiasis
4994911|NCT04025645|Amylase|amylase
4995006|NCT04025099|weight management|weight management
4995007|NCT04025099|cardiovascular fitness|cardiovascular fitness
4995019|NCT04025060|obesity|obesity
4995105|NCT04024592|strength testing|strength testing
4995209|NCT04023786|PEEP test preload dependancy fluid responsiveness|peep test preload dependancy fluid responsiveness
4995218|NCT04023734|Medication non-adherence|medication non-adherence
4995219|NCT04023734|Type 2 diabetes|type 2 diabetes
4995220|NCT04023734|Antihypertensive agents|antihypertensive agents
4995222|NCT04023682|Provodine|provodine
4995223|NCT04023682|Hand contamination|hand contamination
4995224|NCT04023669|Brain Tumors in Adolescents|brain tumors in adolescents
4995225|NCT04023669|Brain Tumors in Children|brain tumors in children
4995226|NCT04023669|Brain Tumors in Young Adults|brain tumors in young adults
4995401|NCT04022577|Adherence Therapy|adherence therapy
4995402|NCT04022577|Insight|insight
4995403|NCT04022577|Medication Adherence|medication adherence
4995502|NCT04021914|Enchroma glasses|enchroma glasses
4995503|NCT04021901|benign ureteral stricture|benign ureteral stricture
4995504|NCT04021901|balloon dilatation|balloon dilatation
4995505|NCT04021849|Sexual Harassment|sexual harassment
4995506|NCT04021849|Virtual Course|virtual course
4995507|NCT04021849|Training|training
4995508|NCT04021823|Treatment Resistant Depression|treatment resistant depression
4995509|NCT04021823|Neurobiological correlates of treatment resistant depression|neurobiological correlates of treatment resistant depression
4995511|NCT04021810|Sleep Apnea|sleep apnea
4995594|NCT04021264|epidural|epidural
4995595|NCT04021264|environmental footprint|environmental footprint
4995596|NCT04021225|According to section 23b Medical Devices Act|according to section 23b medical devices act
4995597|NCT04021225|environmental disorder eye|environmental disorder eye
4995598|NCT04021225|allergen exposure|allergen exposure
4995626|NCT04021082|TFL|tfl
4995696|NCT04020640|exclusive breastfeeding|exclusive breastfeeding
4995697|NCT04020640|predominant breastfeeding|predominant breastfeeding
4995698|NCT04020640|partial breastfeeding|partial breastfeeding
4995699|NCT04020627|Respiratory failure|respiratory failure
4995700|NCT04020627|BiPap|bipap
4995701|NCT04020627|CPap|cpap
4995702|NCT04020627|Respiratory Parameters|respiratory parameters
4995705|NCT04020614|Awareness|awareness
4995797|NCT04020081|Lung function|lung function
4995798|NCT04020068|Diabete|diabete
4995799|NCT04020068|French Guiana|french guiana
4995800|NCT04020016|nalbuphine|nalbuphine
4995801|NCT04020016|Pharmacokinetic|pharmacokinetic
4995810|NCT04019964|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
4995811|NCT04019964|non-castrating therapy|non-castrating therapy
4995812|NCT04019964|Nivolumab|nivolumab
4995898|NCT04019535|Physiologic assessment|physiologic assessment
4995899|NCT04019496|blink reflex|blink reflex
4995903|NCT04019483|Recurrence|recurrence
4996201|NCT04017741|Chronic migraine, GON blocks|chronic migraine, gon blocks
4996202|NCT04017715|cricket injury prevention program,sports injuries,|cricket injury prevention program,sports injuries,
4996203|NCT04017663|Rehabilitation|rehabilitation
4996204|NCT04017663|Surveys and Questionnaires|surveys and questionnaires
4996205|NCT04017663|Treatment Adherence and Compliance|treatment adherence and compliance
4996206|NCT04017663|Patient Compliance|patient compliance
4996207|NCT04017637|Inflammatory Bowel Disease|inflammatory bowel disease
4996303|NCT04017260|pilonidal sinus, combined, sutures, drain|pilonidal sinus, combined, sutures, drain
4996304|NCT04017221|Sodium-glucose cotransporter 2 inhibitors|sodium-glucose cotransporter 2 inhibitors
4996305|NCT04017221|Diabetes mellitus, type 2|diabetes mellitus, type 2
4996306|NCT04017221|Urosepsis|urosepsis
4996307|NCT04017221|Diabetic ketoacidosis|diabetic ketoacidosis
4996308|NCT04017221|Lower extremity amputation|lower extremity amputation
4996309|NCT04017182|central venous oxygen saturation|central venous oxygen saturation
4996310|NCT04017182|external jugular venous oxygen saturation|external jugular venous oxygen saturation
4996315|NCT04017130|Drug therapy|drug therapy
4996402|NCT04016402|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4996403|NCT04016402|Magnetic Resonance Imaging|magnetic resonance imaging
4996404|NCT04016376|Mastectomy|mastectomy
4996405|NCT04016376|Double Mastectomy|double mastectomy
4996609|NCT04015206|Major Depressive Disorder|major depressive disorder
4996610|NCT04015206|Group Interpersonal Psychotherapy (IPT-G)|group interpersonal psychotherapy (ipt-g)
4996611|NCT04015141|Partial-onset seizures|partial-onset seizures
4996613|NCT04015141|Epilepsy|epilepsy
4996705|NCT04014517|Crohn's Disease|crohn's disease
4996706|NCT04014517|Immunonutrition|immunonutrition
4996707|NCT04014504|Newborn Hearing Screening|newborn hearing screening
4996708|NCT04014504|Otoacoustic emissions|otoacoustic emissions
4996709|NCT04014504|Pethidine|pethidine
4996710|NCT04014504|False positive|false positive
4996716|NCT04014478|Cancer； Pain|cancer； pain
4996717|NCT04014465|lung cancer|lung cancer
4996801|NCT04014062|Pharmacokinetics|pharmacokinetics
4996802|NCT04014062|Pharmacodynamics|pharmacodynamics
4996803|NCT04014062|Safety|safety
4996804|NCT04014062|Healthy Volunteers|healthy volunteers
4996805|NCT04014049|Temporary Hebergement (TH)|temporary hebergement (th)
4996806|NCT04014049|Retirement Home (EHPAD)|retirement home (ehpad)
4996807|NCT04014049|Discharge at home|discharge at home
4996810|NCT04014010|Perioperative|perioperative
4996899|NCT04013438|Frozen embryo transfer|frozen embryo transfer
4996900|NCT04013438|Luteal phase support|luteal phase support
4996901|NCT04013425|Socket preservation|socket preservation
4996902|NCT04013425|Alveolar Ridge Preservation|alveolar ridge preservation
4996903|NCT04013425|Ridge Preservation|ridge preservation
4996904|NCT04013360|Cardiac Surgery|cardiac surgery
5667984|NCT00629135|Moxifloxacine|moxifloxacine
4996906|NCT04013360|Physical Therapy Techniques|physical therapy techniques
4996907|NCT04013360|Pulmonary Funtcion|pulmonary funtcion
4996908|NCT04013308|Iontophoresis|iontophoresis
4997003|NCT04012775|diabetes mellitus|diabetes mellitus
4997101|NCT04012203|Delayed Onset Muscle Soreness|delayed onset muscle soreness
4997102|NCT04012203|Pain mechanisms|pain mechanisms
4997103|NCT04012203|Pressure Pain Threshold|pressure pain threshold
4997104|NCT04012203|Myotonometer|myotonometer
4997105|NCT04012203|Maximal isometric strength|maximal isometric strength
4997106|NCT04012203|Manual dexterity|manual dexterity
4997107|NCT04012190|Severe infection|severe infection
4997109|NCT04012190|Microbiome|microbiome
4997110|NCT04012190|Bangladesh|bangladesh
4997196|NCT04011722|Heart Valve Disease|heart valve disease
4997197|NCT04011722|High surgical risk|high surgical risk
4997198|NCT04011722|Portico NG|portico ng
4997199|NCT04011709|Nebulizer|nebulizer
4997200|NCT04011709|Pediatric|pediatric
4997297|NCT04011202|Virtual reality|virtual reality
4997298|NCT04011202|Depressive symptoms|depressive symptoms
4997299|NCT04011202|Sedentary behaviour|sedentary behaviour
4997312|NCT04011137|high-intensity interval training|high-intensity interval training
4997313|NCT04011137|postprandial metabolism|postprandial metabolism
4997314|NCT04011111|voice|voice
4997315|NCT04011111|intubation|intubation
4997316|NCT04011111|subjective|subjective
4997317|NCT04011111|objective|objective
4997318|NCT04011098|Epidural|epidural
4997319|NCT04011098|Opioids|opioids
4997506|NCT04009707|MoCA|moca
4997596|NCT04009265|adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
4997597|NCT04009265|surgery|surgery
4997598|NCT04009239|Weight loss|weight loss
4997599|NCT04009239|Diet|diet
4997600|NCT04009226|Distal Myopathies|distal myopathies
4997697|NCT04008693|Exercise performance|exercise performance
4997698|NCT04008680|consistency|consistency
4997699|NCT04008680|reliability|reliability
4997800|NCT04008004|Multiple Ascending Dose|multiple ascending dose
4997801|NCT04008004|hepatitis B virus|hepatitis b virus
4997803|NCT04007965|PCO|pco
4997804|NCT04007952|paraesophageal hernia|paraesophageal hernia
4997805|NCT04007952|gastropexy|gastropexy
4997806|NCT04007952|minimally invasive surgery|minimally invasive surgery
4997807|NCT04007939|wellness|wellness
4997808|NCT04007939|personalized medicine|personalized medicine
4997897|NCT04007549|Couple intervention|couple intervention
4997898|NCT04007549|Screening|screening
4997899|NCT04007549|Brief intervention|brief intervention
4997900|NCT04007549|Referral to treatment|referral to treatment
4997901|NCT04007549|Randomized Trial|randomized trial
4997905|NCT04007523|Caregivers|caregivers
4997906|NCT04007523|Clinical Decision Support Systems|clinical decision support systems
4997907|NCT04007523|Cognitive Dysfunction|cognitive dysfunction
4997908|NCT04007523|Confusion|confusion
4997909|NCT04007523|Delirium|delirium
4997910|NCT04007523|Feasibility Studies|feasibility studies
4997911|NCT04007523|Geriatric Assessment|geriatric assessment
4998198|NCT04005469|delayed graft function|delayed graft function
4998199|NCT04005456|wellness|wellness
4998295|NCT04005079|Vision|vision
4998296|NCT04005079|Glaucoma Surgery|glaucoma surgery
4998299|NCT04005027|Continuous Exercise|continuous exercise
4998393|NCT04004442|urinary bladder cancer|urinary bladder cancer
4998394|NCT04004442|urethra cancer|urethra cancer
4998395|NCT04004390|Pre- and post-therapeutic evaluation carried out|pre- and post-therapeutic evaluation carried out
4998491|NCT04003948|Drug dependence|drug dependence
4998492|NCT04003948|Addiction|addiction
4998493|NCT04003935|low-grade inflammation|low-grade inflammation
4998495|NCT04003935|CVD prevention|cvd prevention
4998498|NCT04003883|ST segment|st segment
4998499|NCT04003883|preclinical emergency medicine|preclinical emergency medicine
4998500|NCT04003883|stress|stress
4998501|NCT04003883|occupational health|occupational health
4998502|NCT04003883|emergency medicine|emergency medicine
4998503|NCT04003883|24h ECG|24h ecg
4998504|NCT04003857|Human Umbilical Cord Blood Derived Mesenchymal Stem Cells|human umbilical cord blood derived mesenchymal stem cells
4998505|NCT04003857|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5655121|NCT00681798|ZD6474|zd6474
4998506|NCT04003857|Premature infants|premature infants
4998507|NCT04003766|percutaneous biopsy|percutaneous biopsy
4998508|NCT04003766|endoscopic guided biopsy|endoscopic guided biopsy
4998509|NCT04003766|liver|liver
4998510|NCT04003766|hepatic conditions|hepatic conditions
4998514|NCT04003701|children|children
4998515|NCT04003701|cancer|cancer
4998516|NCT04003701|humanoid robot|humanoid robot
4998518|NCT04003701|pain|pain
4998590|NCT04003402|Healthy Volunteer|healthy volunteer
4998591|NCT04003402|ASP8062|asp8062
4998596|NCT04003376|fractional carbon dioxide laser|fractional carbon dioxide laser
4998597|NCT04003363|Myotonic Dystrophy|myotonic dystrophy
4998598|NCT04003363|Myotonic Dystrophy Type 1|myotonic dystrophy type 1
4998599|NCT04003363|Myotonic Dystrophy Type 2|myotonic dystrophy type 2
4998600|NCT04003363|DM|dm
4998601|NCT04003363|DM1|dm1
4998602|NCT04003363|DM2|dm2
5668081|NCT00628771|Group Care|group care
4998603|NCT04003285|Brain Injuries, Traumatic|brain injuries, traumatic
4998604|NCT04003285|Depression|depression
4998606|NCT04003259|Diet|diet
4998607|NCT04003259|Exercise|exercise
4998663|NCT04002934|MS|ms
4998698|NCT04002713|head and neck cancer|head and neck cancer
4998699|NCT04002713|outcomes|outcomes
4998703|NCT04002635|frozen embryo transfer|frozen embryo transfer
4998704|NCT04002609|bronchoscopy, NIRS|bronchoscopy, nirs
4998705|NCT04002570|breast cancer|breast cancer
4998798|NCT04001972|combined brief intervention|combined brief intervention
4998799|NCT04001972|AWARD advice|award advice
4998800|NCT04001972|active referral|active referral
4998889|NCT04001491|Elderly patients|elderly patients
4998890|NCT04001491|Internal medicine|internal medicine
4998891|NCT04001491|Pet-Scan|pet-scan
4998892|NCT04001478|Oesophageal Cancer|oesophageal cancer
4998893|NCT04001478|Barretts Esophagus with Dysplasia|barretts esophagus with dysplasia
4998894|NCT04001426|Overactive Bladder|overactive bladder
4998895|NCT04001426|Women|women
4998896|NCT04001426|Neuromodulation|neuromodulation
4998897|NCT04001426|Bioelectronic Medicine|bioelectronic medicine
4998903|NCT04001348|safety lancets|safety lancets
4998990|NCT04000932|Platelet rich plasma|platelet rich plasma
4998991|NCT04000906|pancreatic cancer|pancreatic cancer
4998992|NCT04000906|oeso-gastric cancer|oeso-gastric cancer
4998993|NCT04000906|epithelial ovarian cancer|epithelial ovarian cancer
4999185|NCT03999905|Adverse drug reaction|adverse drug reaction
4999186|NCT03999905|Nigeria|nigeria
4999187|NCT03999905|Community pharmacists|community pharmacists
4999285|NCT03999268|Diabetes self-management|diabetes self-management
4999286|NCT03999268|Mobile application|mobile application
4999287|NCT03999242|nasal polyposis|nasal polyposis
4999288|NCT03999242|rhinosinusitis|rhinosinusitis
4999385|NCT03998553|hMG-HP|hmg-hp
4999386|NCT03998540|titine|titine
4999387|NCT03998540|western blot|western blot
4999388|NCT03998527|Respiration|respiration
4999389|NCT03998527|Motor control|motor control
4999390|NCT03998514|Fatty Liver Disease|fatty liver disease
4999391|NCT03998514|Liver Disease|liver disease
4999392|NCT03998514|Fatty Liver|fatty liver
4999393|NCT03998514|Nonalcoholic Liver|nonalcoholic liver
4999394|NCT03998488|FMT|fmt
4999395|NCT03998488|Fecal Microbiota Transplantation|fecal microbiota transplantation
4999396|NCT03998488|Inflammatory Bowel Diseases|inflammatory bowel diseases
4999397|NCT03998475|Transition|transition
4999398|NCT03998475|Young Adult|young adult
4999399|NCT03998462|Mindfulness|mindfulness
4999400|NCT03998462|Parkinson's disease|parkinson's disease
4999401|NCT03998462|Intervention|intervention
4999402|NCT03998410|ADHF Dyspnea ED|adhf dyspnea ed
4999403|NCT03998397|blood alcohol concentration|blood alcohol concentration
4999404|NCT03998397|Emergency Department|emergency department
4999405|NCT03998397|Alcohol use disorders|alcohol use disorders
4999406|NCT03998371|Urothelial Carcinoma|urothelial carcinoma
4999493|NCT03998046|dyslipidemia|dyslipidemia
4999494|NCT03998046|cardiovascular risk factor|cardiovascular risk factor
4999495|NCT03998046|adult|adult
4999496|NCT03998046|primary care|primary care
4999595|NCT03997318|Urinary Incontinence|urinary incontinence
4999596|NCT03997318|Urinary Stress Incontinence|urinary stress incontinence
4999597|NCT03997318|Lower Urinary Tract Symptoms|lower urinary tract symptoms
4999598|NCT03997318|Urinary Bladder|urinary bladder
4999600|NCT03997318|Bladder|bladder
4999692|NCT03996837|Infertility|infertility
4999693|NCT03996837|Assisted reproduction technology|assisted reproduction technology
4999694|NCT03996798|vocational rehabilitation|vocational rehabilitation
4999695|NCT03996798|back-to-work|back-to-work
4999696|NCT03996798|social participation|social participation
4999788|NCT03996525|facial nerve palsy|facial nerve palsy
4999789|NCT03996525|facial palsy|facial palsy
4999790|NCT03996525|facial paralysis|facial paralysis
4999791|NCT03996525|cross facial nerve graft|cross facial nerve graft
4999792|NCT03996525|CFNG|cfng
4999793|NCT03996525|peripheral nerve stimulation|peripheral nerve stimulation
4999891|NCT03995654|Prevalence|prevalence
4999892|NCT03995602|vascular function|vascular function
4999893|NCT03995602|endothelial function|endothelial function
4999991|NCT03994835|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4999992|NCT03994835|Cardiovascular disease|cardiovascular disease
4999993|NCT03994835|Omics data|omics data
4999994|NCT03994835|Inflammation|inflammation
4999995|NCT03994822|Brain|brain
5000005|NCT03994822|phenox|phenox
5000094|NCT03994367|Diet|diet
5000095|NCT03994341|Neonates|neonates
5000096|NCT03994341|Thermography imaging|thermography imaging
5000097|NCT03994328|Parkinson's|parkinson's
5000098|NCT03994328|PD|pd
5000099|NCT03994328|Safinamide|safinamide
5000208|NCT03993873|SRC|src
5000394|NCT03992755|Idiopathic Pulmonary Arterial Hypertension|idiopathic pulmonary arterial hypertension
5000395|NCT03992755|Heritable Pulmonary Arterial Hypertension|heritable pulmonary arterial hypertension
5000396|NCT03992755|Drug Induced Pulmonary Arterial Hypertension|drug induced pulmonary arterial hypertension
5000397|NCT03992755|Toxin Induced Pulmonary Arterial Hypertension|toxin induced pulmonary arterial hypertension
5000398|NCT03992755|Connective tissue disease|connective tissue disease
5000493|NCT03992066|Erythropoiesis-stimulating agent|erythropoiesis-stimulating agent
5000494|NCT03992053|2-dimensional (2-D) fluoroscopy|2-dimensional (2-d) fluoroscopy
5000495|NCT03992053|3-dimensional (3-D) Computed Tomography (CT) guidance|3-dimensional (3-d) computed tomography (ct) guidance
5000496|NCT03992053|sacroiliac joint injection|sacroiliac joint injection
5000497|NCT03992040|Regional Public Health authorities (ARS) score|regional public health authorities (ars) score
5000498|NCT03992040|Reinforced Home Nursing Care Services (SSIADR)|reinforced home nursing care services (ssiadr)
5000503|NCT03992014|[14C]-linerixibat|[14c]-linerixibat
5000591|NCT03991585|Emotion regulation|emotion regulation
5000592|NCT03991559|anti-PD-1 antibody|anti-pd-1 antibody
5000593|NCT03991559|Manganese|manganese
5000594|NCT03991559|unresectable|unresectable
5000595|NCT03991559|metastatic|metastatic
5000597|NCT03991546|PROMIS|promis
5000690|NCT03990987|postoperative pain|postoperative pain
5000691|NCT03990987|postoperative sleep quality|postoperative sleep quality
5000702|NCT03990831|Burn|burn
5000792|NCT03990233|Checkpoint inhibitor (ICI)|checkpoint inhibitor (ici)
5000793|NCT03990233|SIRPα|sirpα
5000794|NCT03990233|Advanced solid tumors|advanced solid tumors
5000795|NCT03990233|Anti-PD-1|anti-pd-1
5000796|NCT03990220|probiotics|probiotics
5000894|NCT03989557|light transmittance platelet aggregometry|light transmittance platelet aggregometry
5000895|NCT03989544|Pharmacokinetics|pharmacokinetics
5000896|NCT03989544|Human monoclonal antibody|human monoclonal antibody
5000897|NCT03989544|Tezepelumab|tezepelumab
5000898|NCT03989544|Accessorized Pre-filled Syringe|accessorized pre-filled syringe
5000900|NCT03989531|Cardiogenic Shock|cardiogenic shock
5000901|NCT03989531|Adrecizumab|adrecizumab
5000902|NCT03989531|Vascular integrity|vascular integrity
5000994|NCT03989115|NSCLC|nsclc
5000995|NCT03989115|KRAS G12|kras g12
5000996|NCT03989115|BRAF Class 3|braf class 3
5000997|NCT03989115|NF1 LOF|nf1 lof
5000998|NCT03989115|KRAS amplification|kras amplification
5001090|NCT03988634|NT-proBNP|nt-probnp
5001091|NCT03988634|Acute decompensated heart failure|acute decompensated heart failure
5001092|NCT03988634|Sacubitril/valsartan|sacubitril/valsartan
5001192|NCT03987997|Critical Illness|critical illness
5001193|NCT03987997|Rehabilitation|rehabilitation
5001194|NCT03987997|Muscle atrophy|muscle atrophy
5001195|NCT03987997|Muscle weakness|muscle weakness
5001196|NCT03987997|Cyclo-ergometer|cyclo-ergometer
5001197|NCT03987997|Electrical muscle stimulation|electrical muscle stimulation
5001198|NCT03987984|Sensory Feeding Problems|sensory feeding problems
5001199|NCT03987958|Acute Myeloid Leukemia|acute myeloid leukemia
5001200|NCT03987958|Venetoclax|venetoclax
5001207|NCT03987906|Palliative Care|palliative care
5001384|NCT03986619|Food preferences|food preferences
5001385|NCT03986619|Food reward|food reward
5001386|NCT03986606|neoplasm|neoplasm
5001387|NCT03986606|checkpoint inhibitor|checkpoint inhibitor
5001388|NCT03986606|combination|combination
5001389|NCT03986606|immunotherapy|immunotherapy
5001390|NCT03986567|Mobile Applications|mobile applications
5001483|NCT03986112|inferior vena cava sonography|inferior vena cava sonography
5001484|NCT03986112|hypertension|hypertension
5001485|NCT03986112|general anesthesia|general anesthesia
5001486|NCT03986112|predictive power|predictive power
5001487|NCT03986099|Children and adolescents|children and adolescents
5001488|NCT03986099|HIV therapy|hiv therapy
5001595|NCT03985449|Implementation|implementation
5001596|NCT03985449|Shared decision making|shared decision making
5001597|NCT03985449|Patient Decision Aids|patient decision aids
5001598|NCT03985449|Decision Support Intervention|decision support intervention
5001786|NCT03984461|Bone Marrow Aspirate (BMA)|bone marrow aspirate (bma)
5001787|NCT03984435|Radiotherapy|radiotherapy
5001788|NCT03984435|Experiences|experiences
5001789|NCT03984435|Comfort management|comfort management
5001790|NCT03984435|Patients|patients
5001791|NCT03984435|Radiographers|radiographers
5001792|NCT03984422|smartphone application|smartphone application
5001882|NCT03984032|LMA Supreme|lma supreme
5001883|NCT03984032|Clinical Performance|clinical performance
5001884|NCT03984006|Exosome|exosome
5001885|NCT03984006|Urine|urine
5001886|NCT03984006|Biological marker|biological marker
5001887|NCT03983980|Tapinarof|tapinarof
5001888|NCT03983980|plaque psoriasis|plaque psoriasis
5001889|NCT03983980|adult|adult
5002395|NCT03980912|Liver Biopsy|liver biopsy
5002396|NCT03980912|Algorithm|algorithm
5002397|NCT03980912|LiverFASt select|liverfast select
5002398|NCT03980912|Liver Disease|liver disease
5002399|NCT03980873|minority stress|minority stress
5002400|NCT03980873|LGB|lgb
5002401|NCT03980873|stigma|stigma
5002402|NCT03980873|cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5002497|NCT03980210|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5002498|NCT03980210|Normobaric oxygen therapy|normobaric oxygen therapy
5002499|NCT03980210|Hyperoxia|hyperoxia
5002500|NCT03980210|Sidestream dark field videomicroscopy|sidestream dark field videomicroscopy
5002501|NCT03980210|Microcirculation|microcirculation
5002521|NCT03980028|surgery|surgery
5002591|NCT03979560|Adapted physical activity|adapted physical activity
5002592|NCT03979560|Undernutrition|undernutrition
5002593|NCT03979560|Older people|older people
5002595|NCT03979560|Under-nutrition|under-nutrition
5002596|NCT03979547|liver cancer|liver cancer
5002621|NCT03979443|Protocol|protocol
5002785|NCT03978429|Pre-eclampsia|pre-eclampsia
5002787|NCT03978429|mHealth|mhealth
5002788|NCT03978429|mobile health|mobile health
5002789|NCT03978429|Gestosis|gestosis
5002790|NCT03978429|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
5002892|NCT03977987|immunoprophylaxis|immunoprophylaxis
5002893|NCT03977948|cardiac surgery pediatric|cardiac surgery pediatric
5002894|NCT03977948|preoperative anxiety|preoperative anxiety
5002895|NCT03977935|SG-MCCG|sg-mccg
5002896|NCT03977935|Z-line visualization|z-line visualization
5002897|NCT03977935|Image quality|image quality
5002898|NCT03977935|Gastric examination time|gastric examination time
5002899|NCT03977935|Manipulation performance|manipulation performance
5002991|NCT03977376|anxiety|anxiety
5002992|NCT03977376|Urogical|urogical
5002993|NCT03977376|Guide of Hosting|guide of hosting
5003090|NCT03976843|PSMA|psma
5003091|NCT03976843|PET agent|pet agent
5003092|NCT03976843|Prostatectomy|prostatectomy
5003093|NCT03976843|Progression Free Survival|progression free survival
5003094|NCT03976830|Malnutrition|malnutrition
5003095|NCT03976830|Childhood Cancer|childhood cancer
5003096|NCT03976830|Central America|central america
5003097|NCT03976817|bioprosthesis|bioprosthesis
5003099|NCT03976817|supra-annular|supra-annular
5003100|NCT03976804|Cancer|cancer
5003101|NCT03976804|Tobacco|tobacco
5003182|NCT03976258|cardiovascular|cardiovascular
5003185|NCT03976193|active treatment|active treatment
5003283|NCT03975751|severe brain injuries|severe brain injuries
5003284|NCT03975751|sedation and analgesia|sedation and analgesia
5003286|NCT03975751|survey|survey
5003394|NCT03974893|Diet|diet
5003480|NCT03974438|post-herpetic neuralgia|post-herpetic neuralgia
5003481|NCT03974438|pain|pain
5003483|NCT03974438|shingles|shingles
5003581|NCT03973905|Tdap|tdap
5003583|NCT03973905|pregnancy|pregnancy
5003682|NCT03973268|AMPA Antagonist|ampa antagonist
5003783|NCT03972540|Weight management|weight management
5003992|NCT03971162|Pathologic myopia|pathologic myopia
5003993|NCT03971162|anti-VEGF|anti-vegf
5003994|NCT03971097|Substance abuse|substance abuse
5004092|NCT03970551|Lower Body Muscle Tensing|lower body muscle tensing
5004101|NCT03970512|contact lens|contact lens
5004102|NCT03970512|soft contact lens|soft contact lens
5004103|NCT03970499|glioma|glioma
5004104|NCT03970473|gynecologic laparoscopic surgery|gynecologic laparoscopic surgery
5004105|NCT03970473|post-laparoscopic shoulder pain|post-laparoscopic shoulder pain
5004106|NCT03970473|pulmonary recruitment manoeuvre|pulmonary recruitment manoeuvre
5004119|NCT03970408|Median nerve,|median nerve,
5004120|NCT03970408|Carpal tunnel syndrome|carpal tunnel syndrome
5004121|NCT03970408|Neurodynamic mobilization|neurodynamic mobilization
5004122|NCT03970395|Positional Plagiocephaly, Deformational Plagiocephaly,|positional plagiocephaly, deformational plagiocephaly,
5004123|NCT03970382|melanoma|melanoma
5004124|NCT03970382|HR+ breast cancer|hr+ breast cancer
5004125|NCT03970382|ovarian cancer|ovarian cancer
5004126|NCT03970382|prostate cancer|prostate cancer
5004127|NCT03970382|colorectal cancer|colorectal cancer
5004128|NCT03970382|urothelial carcinoma|urothelial carcinoma
5004129|NCT03970382|adoptive cell therapy|adoptive cell therapy
5004130|NCT03970382|neoantigen|neoantigen
5004131|NCT03970382|T cell receptor|t cell receptor
5004132|NCT03970382|T lymphocyte|t lymphocyte
5004133|NCT03970382|TCR-engineered T cells|tcr-engineered t cells
5004134|NCT03970382|personalized cell therapy|personalized cell therapy
5004135|NCT03970382|cell therapy|cell therapy
5004136|NCT03970382|immunotherapy|immunotherapy
5004137|NCT03970382|gene therapy|gene therapy
5004138|NCT03970382|PD-1|pd-1
5004139|NCT03970356|cluster randomized trial|cluster randomized trial
5004140|NCT03970356|antibiotic stewardship|antibiotic stewardship
5004141|NCT03970356|frail elderly|frail elderly
5004187|NCT03970122|diabetes complications|diabetes complications
5004188|NCT03970083|Gynecologic Cancer|gynecologic cancer
5004189|NCT03970083|Cervical Cancer|cervical cancer
5004190|NCT03970057|Psychological outcomes|psychological outcomes
5004191|NCT03970057|Internet-based cognitive behavioural therapy|internet-based cognitive behavioural therapy
5004192|NCT03970057|Perinatal women|perinatal women
5004193|NCT03970031|Diabetes|diabetes
5004194|NCT03970031|NASH|nash
5004195|NCT03970018|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5004196|NCT03970018|peritoneal dialysis|peritoneal dialysis
5004197|NCT03970018|peritoneal pressure|peritoneal pressure
5004198|NCT03970005|psychosis|psychosis
5004199|NCT03970005|treatment|treatment
5004286|NCT03969459|persistent organic pollutants|persistent organic pollutants
5004287|NCT03969459|breast milk|breast milk
5004288|NCT03969459|meconium|meconium
5004289|NCT03969459|stool|stool
5004290|NCT03969459|microbiota|microbiota
5004386|NCT03968991|Diagnostic tool|diagnostic tool
5004387|NCT03968978|Asthma, Severe Uncontrolled Asthma|asthma, severe uncontrolled asthma
5004388|NCT03968965|Image guided surgery|image guided surgery
5004489|NCT03968393|Transient Atrial Fibrillation|transient atrial fibrillation
5004504|NCT03968354|NAFLD|nafld
5004583|NCT03967782|appetite control|appetite control
5004584|NCT03967782|obesity|obesity
5004585|NCT03967782|adolescents|adolescents
5004586|NCT03967782|exercise timing|exercise timing
5004678|NCT03967288|Anesthesia, Obstetrical|anesthesia, obstetrical
5004688|NCT03967197|manometry|manometry
5004689|NCT03967197|pH monitoring|ph monitoring
5004690|NCT03967197|lidocaine|lidocaine
5004691|NCT03967171|Oxytocin|oxytocin
5004692|NCT03967171|cesarean section|cesarean section
5004693|NCT03967171|uterine atony|uterine atony
5004694|NCT03967171|Postpartum Hemorrhage|postpartum hemorrhage
5004695|NCT03967158|Xience Sierra|xience sierra
5004696|NCT03967158|Drug Eluting Stent|drug eluting stent
5004701|NCT03967106|fatigue|fatigue
5004875|NCT03966092|Quo R 40 score|quo r 40 score
5004876|NCT03966092|Post operative pain|post operative pain
5004877|NCT03966079|Acute Pulmonary Embolism|acute pulmonary embolism
5004878|NCT03966066|Bronchiectasis children|bronchiectasis children
5004973|NCT03965377|effectiveness of gaming technology|effectiveness of gaming technology
5004974|NCT03965377|knowledge of childhood injury prevention|knowledge of childhood injury prevention
5004975|NCT03965325|Value-Based Health Care|value-based health care
5004976|NCT03965325|VBHC|vbhc
5004977|NCT03965325|Patient reported outcomes measure|patient reported outcomes measure
5004978|NCT03965325|PROMs|proms
5004979|NCT03965325|PROs|pros
5004980|NCT03965325|Colorectal Cancer|colorectal cancer
5004981|NCT03965325|Patient reported outcomes|patient reported outcomes
5004982|NCT03965299|randomized, sham-controlled, double-blind trial|randomized, sham-controlled, double-blind trial
5004983|NCT03965299|transcutaneous tibial nerve stimulation|transcutaneous tibial nerve stimulation
5004984|NCT03965299|spinal cord injury|spinal cord injury
5004989|NCT03965299|urodynamics|urodynamics
5005071|NCT03964662|home rehabilitation|home rehabilitation
5005072|NCT03964662|technology|technology
5005074|NCT03964662|biofeedback|biofeedback
5005075|NCT03964662|games|games
5005076|NCT03964636|OCT-A|oct-a
5005077|NCT03964636|combined oral contraceptives|combined oral contraceptives
5005078|NCT03964623|OCT-A|oct-a
5005079|NCT03964623|smokers|smokers
5005080|NCT03964623|vapers|vapers
5005081|NCT03964623|non-smokers/non-vapers|non-smokers/non-vapers
5005082|NCT03964623|nicotine|nicotine
5005083|NCT03964623|retinal micro-vascularization|retinal micro-vascularization
5005088|NCT03964597|Cataract|cataract
5005089|NCT03964597|objective scatter index (OSI)|objective scatter index (osi)
5005090|NCT03964597|average lens density (ALD)|average lens density (ald)
5005267|NCT03963622|Esophageal manometry|esophageal manometry
5005268|NCT03963622|Airway closure|airway closure
5005269|NCT03963622|Lung recruitment|lung recruitment
5005369|NCT03963050|Cognitive Impairment|cognitive impairment
5005370|NCT03963050|Sarcopenia|sarcopenia
5005371|NCT03963050|Exercise|exercise
5005380|NCT03963011|Necrotizing Enterocolitis|necrotizing enterocolitis
5005381|NCT03963011|Premature Infant|premature infant
5005382|NCT03963011|Calprotectin|calprotectin
5005467|NCT03962413|Endoscopic Approaches To Maxillary Sinus|endoscopic approaches to maxillary sinus
5005468|NCT03962400|warfarin|warfarin
5005469|NCT03962361|Cardiac Sudden Death|cardiac sudden death
5005470|NCT03962361|Hypoxia Brain|hypoxia brain
5005559|NCT03961958|Anesthesia, General|anesthesia, general
5005560|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous
5005561|NCT03961958|pharmacokinetics|pharmacokinetics
5005562|NCT03961945|Barrett's Esophagus|barrett's esophagus
5005758|NCT03960736|Thoracic epidural analgesia|thoracic epidural analgesia
5005760|NCT03960697|early mobilization|early mobilization
5005762|NCT03960567|Intubation|intubation
5005866|NCT03960034|Physical Functional Performance|physical functional performance
5005867|NCT03960034|Prognosis|prognosis
5005868|NCT03960021|Colo-rectal cancer|colo-rectal cancer
5005869|NCT03960021|Lung metastasis|lung metastasis
5005870|NCT03960021|Radiofrequency ablation|radiofrequency ablation
5005871|NCT03960021|Tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
5005872|NCT03960021|Circulating tumor cells|circulating tumor cells
5005873|NCT03960021|Circulating DNA|circulating dna
5005879|NCT03959956|Digital auscultation|digital auscultation
5005966|NCT03959475|GP medicine|gp medicine
5006066|NCT03958656|B-cell Maturation Antigen|b-cell maturation antigen
5006067|NCT03958656|Immunotherapy|immunotherapy
5006068|NCT03958656|Adoptive T Cell Therapy|adoptive t cell therapy
5006069|NCT03958643|Sickle Nephropathy|sickle nephropathy
5006070|NCT03958643|Iothalamate|iothalamate
5006071|NCT03958643|Cystatin-C|cystatin-c
5006072|NCT03958630|Fronto Temporal Dementia|fronto temporal dementia
5006165|NCT03958045|SCLC|sclc
5006466|NCT03956147|Cultural adaptation|cultural adaptation
5006467|NCT03956147|validation|validation
5006468|NCT03956147|responsibility|responsibility
5006469|NCT03956147|shoulder|shoulder
5006470|NCT03956121|Prematurity|prematurity
5006471|NCT03956121|magnesium sulfate|magnesium sulfate
5006472|NCT03956121|fetal heart rate|fetal heart rate
5006473|NCT03956121|short-term variability|short-term variability
5006474|NCT03956121|fetal neuroprotection|fetal neuroprotection
5006476|NCT03956095|Nutritional Supplement Shakes|nutritional supplement shakes
5006477|NCT03956095|19-108|19-108
5006674|NCT03954795|TAP OSTAP Postoperative pain|tap ostap postoperative pain
5006675|NCT03954782|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5006676|NCT03954782|antiangiogenic therapy|antiangiogenic therapy
5006760|NCT03954366|Drug-drug Interaction|drug-drug interaction
5006761|NCT03954340|MCI|mci
5006762|NCT03954340|Early AD|early ad
5006763|NCT03954314|Tranexamic Acid|tranexamic acid
5006764|NCT03954314|On-pump Cardiac Surgery|on-pump cardiac surgery
5006765|NCT03954301|Foot deformities|foot deformities
5006766|NCT03954301|Cluster method|cluster method
5006767|NCT03954301|Kinematic analysis|kinematic analysis
5006768|NCT03954288|otitis media chronic|otitis media chronic
5006769|NCT03954288|cholesteatoma|cholesteatoma
5006859|NCT03953547|antiplatelet resistance|antiplatelet resistance
5006860|NCT03953547|peripheral arterial revascularization|peripheral arterial revascularization
5006861|NCT03953534|Opioids|opioids
5006862|NCT03953534|Acute Pain|acute pain
5006960|NCT03952858|telerehabilitation|telerehabilitation
5006961|NCT03952845|Capsaicin|capsaicin
5006962|NCT03952845|Rhinitis|rhinitis
5006963|NCT03952819|Diabetes Mellitus|diabetes mellitus
5006964|NCT03952819|Renal Failure|renal failure
5006965|NCT03952819|Hemodialysis Access Failure|hemodialysis access failure
5006966|NCT03952819|Sclerostin|sclerostin
5006968|NCT03952780|abdominal aortic aneurysm|abdominal aortic aneurysm
5006969|NCT03952780|endovascular repair|endovascular repair
5006972|NCT03952754|Health|health
5685577|NCT00555529|exhaled breath condensate|exhaled breath condensate
5007056|NCT03952325|Central nervous system (CNS) metastases|central nervous system (cns) metastases
5007057|NCT03952312|eHealth|ehealth
5007058|NCT03952312|Adherence|adherence
5007059|NCT03952312|Symptom Burden|symptom burden
5007060|NCT03952312|Health Related Quality of Life|health related quality of life
5007062|NCT03952273|Drug eluting stent|drug eluting stent
5007063|NCT03952273|Stent|stent
5007064|NCT03952260|Clear fluid fasting|clear fluid fasting
5007065|NCT03952260|residual gastric volume|residual gastric volume
5007066|NCT03952260|paediatric anaesthesia|paediatric anaesthesia
5007067|NCT03952247|tracheotomy|tracheotomy
5007068|NCT03952247|bronchoscopy|bronchoscopy
5007069|NCT03952247|critical care|critical care
5007070|NCT03952234|Mitochondrial|mitochondrial
5007081|NCT03952195|IBD|ibd
5007158|NCT03951649|Occipital nerve block|occipital nerve block
5007159|NCT03951636|peri-implant mucositis|peri-implant mucositis
5007160|NCT03951636|non surgical therapy|non surgical therapy
5007161|NCT03951636|laser|laser
5007162|NCT03951636|air powder|air powder
5007163|NCT03951636|chlorhexidine|chlorhexidine
5007164|NCT03951623|syk inhibitor|syk inhibitor
5007255|NCT03951077|Polycystic Ovary Syndrome|polycystic ovary syndrome
5007448|NCT03949972|Nephrotic Syndrome|nephrotic syndrome
5007449|NCT03949959|Physiotherapy|physiotherapy
5007450|NCT03949946|lipid composition|lipid composition
5007451|NCT03949946|MRI|mri
5007452|NCT03949933|proton and carbon ion radiotherapy|proton and carbon ion radiotherapy
5007453|NCT03949920|Fabry|fabry
5007454|NCT03949920|Anderson-Fabry|anderson-fabry
5007455|NCT03949920|Migalastat|migalastat
5007456|NCT03949907|Parenteral Nutrition (PN)|parenteral nutrition (pn)
5007457|NCT03949907|Cancer|cancer
5007460|NCT03949881|FEMJA graft|femja graft
5007548|NCT03949322|physical activity|physical activity
5007549|NCT03949322|cancer Related Cognitive Impairment|cancer related cognitive impairment
5007555|NCT03949257|transendoscopic enteral tubing|transendoscopic enteral tubing
5007556|NCT03949257|gut microbiota|gut microbiota
5007557|NCT03949257|ulcerative colitis|ulcerative colitis
5007558|NCT03949244|Nailfold capillary imaging|nailfold capillary imaging
5007559|NCT03949244|Latanoprost bunod|latanoprost bunod
5007560|NCT03949244|Latanoprost|latanoprost
5007561|NCT03949231|Liver Cancer|liver cancer
5007562|NCT03949231|PD1 antibody|pd1 antibody
5007563|NCT03949231|Artery infusion|artery infusion
5007570|NCT03949166|labor|labor
5007649|NCT03948633|school vaccinations|school vaccinations
5007650|NCT03948633|pain management|pain management
5007656|NCT03948594|resource|resource
5007751|NCT03947827|Neuroinflammation|neuroinflammation
5007752|NCT03947827|Microglial Activation|microglial activation
5007753|NCT03947827|Biomarker|biomarker
5007754|NCT03947814|Pimodivir,|pimodivir,
5007790|NCT03947593|ECE|ece
5007854|NCT03947242|Trastuzumab-refractory|trastuzumab-refractory
5007975|NCT03946475|Anemia|anemia
5008141|NCT03945513|oral contraceptive|oral contraceptive
5008142|NCT03945487|liver cirrhosis|liver cirrhosis
5008143|NCT03945487|mesenchymal stem cells|mesenchymal stem cells
5008242|NCT03944850|opioid use disorder|opioid use disorder
5008243|NCT03944850|intervention|intervention
5008244|NCT03944837|Acute maternal hyperoxygenation|acute maternal hyperoxygenation
5008245|NCT03944837|Echocardiography|echocardiography
5008246|NCT03944837|MRI|mri
5008247|NCT03944824|Intra-Dialytic Exercise|intra-dialytic exercise
5008248|NCT03944824|End Stage Renal Disease|end stage renal disease
5008249|NCT03944824|Hemodialysis|hemodialysis
5008250|NCT03944824|Therabands|therabands
5008251|NCT03944824|Exercise Physiologist|exercise physiologist
5008280|NCT03944746|Emergency Department Education|emergency department education
5008281|NCT03944733|iron deficiency anemia (IDA)|iron deficiency anemia (ida)
5008282|NCT03944733|iron status|iron status
5008283|NCT03944733|mother-infant interactions|mother-infant interactions
5008284|NCT03944733|intervention study|intervention study
5008285|NCT03944733|postpartum depressive symptoms|postpartum depressive symptoms
5008286|NCT03944694|delirium|delirium
5008287|NCT03944694|stroke|stroke
5008288|NCT03944694|neutrophil-to-lymphocyte ratio|neutrophil-to-lymphocyte ratio
5008289|NCT03944694|NLR|nlr
5008290|NCT03944694|mortality|mortality
5008291|NCT03944681|postoperative nausea and vomiting|postoperative nausea and vomiting
5008292|NCT03944681|torsadogenic action|torsadogenic action
5008640|NCT03942510|heart rate|heart rate
5008641|NCT03942510|recovery of physiological function|recovery of physiological function
5008642|NCT03942497|metastatic|metastatic
5008643|NCT03942497|recurrent|recurrent
5008644|NCT03942497|urothelial cancers|urothelial cancers
5008645|NCT03942497|renal pelvis|renal pelvis
5008646|NCT03942497|ureter|ureter
5008647|NCT03942497|bladder|bladder
5008648|NCT03942497|urethra|urethra
5008649|NCT03942445|Muscle ischemia|muscle ischemia
5008650|NCT03942445|Satellite cells|satellite cells
5008651|NCT03942445|Chronic limb ischemia|chronic limb ischemia
5008652|NCT03942445|Endothelial cells|endothelial cells
5008653|NCT03942406|pertussis|pertussis
5008736|NCT03941951|Tedizolid|tedizolid
5008737|NCT03941951|Dalbavancin|dalbavancin
5008738|NCT03941951|Ceftazidime-avibactam|ceftazidime-avibactam
5008739|NCT03941951|Ceftolozane-tazobactam|ceftolozane-tazobactam
5008740|NCT03941951|Isavuconazole|isavuconazole
5008741|NCT03941938|colorectal anastomosis|colorectal anastomosis
5008742|NCT03941938|leakage|leakage
5008743|NCT03941925|prebiotic|prebiotic
5008744|NCT03941899|Pain, radical prostatectomy, QLB II type|pain, radical prostatectomy, qlb ii type
5008745|NCT03941886|Pre-Eclampsia|pre-eclampsia
5008746|NCT03941886|Aspirin|aspirin
5008747|NCT03941873|Carcinoma|carcinoma
5008749|NCT03941873|G/GEJ Cancer|g/gej cancer
5008750|NCT03941834|Trigeminal Neuralgia, Pain|trigeminal neuralgia, pain
5008751|NCT03941795|PD-1 monoclonal antibody|pd-1 monoclonal antibody
5008753|NCT03941795|Axitinib|axitinib
5008837|NCT03941132|diabetes|diabetes
5008838|NCT03941119|Virtual Reality|virtual reality
5008839|NCT03941119|Biomedical Technology|biomedical technology
5008840|NCT03941119|Non-pharmacological Intervention|non-pharmacological intervention
5008841|NCT03941119|Behavioral Symptoms|behavioral symptoms
5008842|NCT03941119|Quality of Life|quality of life
5008931|NCT03940677|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5008932|NCT03940625|breast cancer|breast cancer
5008933|NCT03940625|antracyclines|antracyclines
5008934|NCT03940625|cardiotoxity|cardiotoxity
5008935|NCT03940625|myocardial damage|myocardial damage
5008937|NCT03940625|T2 mapping|t2 mapping
5008938|NCT03940625|diastolic function|diastolic function
5008940|NCT03940625|early detection|early detection
5009035|NCT03939949|mindfulness|mindfulness
5009036|NCT03939949|awareness|awareness
5009037|NCT03939949|attention to variability|attention to variability
5009038|NCT03939949|quality of life|quality of life
5009039|NCT03939949|wellbeing|wellbeing
5009040|NCT03939936|Psoriasis|psoriasis
5009041|NCT03939923|Coronary Artery Bypass Grafting Surgery|coronary artery bypass grafting surgery
5009042|NCT03939923|Sugammadex|sugammadex
5009043|NCT03939884|Analgesia|analgesia
5009044|NCT03939884|Myofascial Pain|myofascial pain
5009045|NCT03939884|MuscleCare|musclecare
5009046|NCT03939884|Voltaren|voltaren
5009047|NCT03939884|NSAID|nsaid
5009048|NCT03939819|weight loss surgery|weight loss surgery
5009049|NCT03939819|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5009161|NCT03939052|PKU|pku
5009237|NCT03938636|HC|hc
5009238|NCT03938636|tilmanocept|tilmanocept
5009239|NCT03938623|colorectal cancer|colorectal cancer
5009240|NCT03938623|general practitioners|general practitioners
5009241|NCT03938623|the patient-centered approach|the patient-centered approach
5009332|NCT03938103|organizational readiness|organizational readiness
5009333|NCT03938103|behavior change|behavior change
5009334|NCT03938103|cost-effectiveness|cost-effectiveness
5009335|NCT03938103|implementation|implementation
5009429|NCT03937570|functional capacity|functional capacity
5009430|NCT03937570|cardiopulmonary exercise test|cardiopulmonary exercise test
5009431|NCT03937531|Postoperative voiding dysfunction|postoperative voiding dysfunction
5009432|NCT03937531|Postoperative void trial|postoperative void trial
5009433|NCT03937531|Retrograde fill void trial|retrograde fill void trial
5009627|NCT03936439|stroke|stroke
5009628|NCT03936413|imaging|imaging
5009629|NCT03936413|echocardiography|echocardiography
5009630|NCT03936413|artificial intelligence|artificial intelligence
5009631|NCT03936400|cancer|cancer
5009632|NCT03936400|females|females
5009633|NCT03936400|partners|partners
5009634|NCT03936387|erector spinae block|erector spinae block
5009635|NCT03936387|regional anesthesia|regional anesthesia
5009636|NCT03936387|sternotomy|sternotomy
5009637|NCT03936387|ropivacaine|ropivacaine
5009639|NCT03936348|Medical device|medical device
5009818|NCT03935165|invisible endometriosis|invisible endometriosis
5009819|NCT03935139|microdialysis|microdialysis
5009820|NCT03935139|bone free flap|bone free flap
5009821|NCT03935139|fibula|fibula
5009822|NCT03935139|iliac crest|iliac crest
5009823|NCT03935074|enucleation|enucleation
5009824|NCT03935074|globe salvage|globe salvage
5009825|NCT03935074|superselective intra-arterial chemotherapy|superselective intra-arterial chemotherapy
5009826|NCT03935061|Anthocyanin|anthocyanin
5009827|NCT03935061|Anxiety Disorders|anxiety disorders
5009828|NCT03935061|Inflammation|inflammation
5009829|NCT03935061|interleukin-17A|interleukin-17a
5009830|NCT03935035|adolescents|adolescents
5009831|NCT03935035|internet-delivered|internet-delivered
5009832|NCT03935035|online|online
5009979|NCT03934294|ICU|icu
5010022|NCT03933904|idiopathic Castleman's disease|idiopathic castleman's disease
5010023|NCT03933904|CD|cd
5010024|NCT03933904|MCD|mcd
5010025|NCT03933904|Castleman Disease|castleman disease
5010119|NCT03933410|N-acetyl Glutamate Synthetase (NAGS)|n-acetyl glutamate synthetase (nags)
5010120|NCT03933410|Ornithine Translocase (ORNT1)|ornithine translocase (ornt1)
5010121|NCT03933410|Microbiome Metabolic Therapy (MMT)|microbiome metabolic therapy (mmt)
5010123|NCT03933410|Nitrogen Binding Therapy (NBT)|nitrogen binding therapy (nbt)
5010124|NCT03933410|Quality of Life|quality of life
5010321|NCT03932292|Ectoin|ectoin
5010614|NCT03930420|implementation science|implementation science
5010615|NCT03930420|public health practice|public health practice
5010616|NCT03930407|Cesarean section|cesarean section
5010617|NCT03930407|Uterine atony|uterine atony
5010619|NCT03930407|Follicle-stimulating hormone|follicle-stimulating hormone
5010720|NCT03929666|5-FU|5-fu
5010722|NCT03929666|Oxaliplatin|oxaliplatin
5010815|NCT03928912|nonunion|nonunion
5010816|NCT03928912|tibial shaft fracture|tibial shaft fracture
5010817|NCT03928912|path analysis model|path analysis model
5010818|NCT03928899|induction|induction
5010819|NCT03928899|caesarean section|caesarean section
5010820|NCT03928899|fetal weight|fetal weight
5010821|NCT03928899|Bishop score|bishop score
5010822|NCT03928886|discomfort|discomfort
5010823|NCT03928886|patient-assisted compression|patient-assisted compression
5010824|NCT03928886|breast cancer|breast cancer
5010825|NCT03928886|screening|screening
5010826|NCT03928886|mammography|mammography
5010827|NCT03928886|Senographe Pristina|senographe pristina
5010828|NCT03928873|shock wave|shock wave
5010829|NCT03928873|trigger finger|trigger finger
5011009|NCT03927599|VEGFR|vegfr
5011010|NCT03927599|Solid tumor|solid tumor
5011011|NCT03927586|Mild Cognitive Impairment|mild cognitive impairment
5011012|NCT03927586|exercise|exercise
5011013|NCT03927586|Cognitive training|cognitive training
5011014|NCT03927534|Obesity|obesity
5011015|NCT03927534|Overweight|overweight
5011016|NCT03927534|Mindful Eating|mindful eating
5011017|NCT03927534|Primary Care|primary care
5011018|NCT03927534|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5011019|NCT03927521|Prostate cancer|prostate cancer
5011020|NCT03927521|Post-Radiotherapy|post-radiotherapy
5011215|NCT03926169|Hidradenitis Suppurativa|hidradenitis suppurativa
5011217|NCT03926169|Placebo|placebo
5011218|NCT03926143|Solid tumors|solid tumors
5011318|NCT03925415|Severe Asthma|severe asthma
5011319|NCT03925415|Eosinophilic Asthma|eosinophilic asthma
5011320|NCT03925415|Eosinophilic Phenotype|eosinophilic phenotype
5011321|NCT03925389|Nasal function|nasal function
5011322|NCT03925389|Septorhinoplasty|septorhinoplasty
5011323|NCT03925389|Patient-reported outcome|patient-reported outcome
5011324|NCT03925389|Rhinomanometry|rhinomanometry
5011325|NCT03925389|Acoustic Rhinometry|acoustic rhinometry
5011419|NCT03924830|dentin bonding agents|dentin bonding agents
5011420|NCT03924830|tooth sensitivity|tooth sensitivity
5011421|NCT03924830|composite resin restoration|composite resin restoration
5011422|NCT03924791|Sciatica|sciatica
5011423|NCT03924791|Acute sciatica|acute sciatica
5011424|NCT03924791|Transforaminal epidural injection|transforaminal epidural injection
5011425|NCT03924791|Leg pain|leg pain
5011426|NCT03924791|Lumbar spine|lumbar spine
5011427|NCT03924791|Back pain|back pain
5011428|NCT03924791|Lumbar surgery|lumbar surgery
5011513|NCT03924336|open flap debridement|open flap debridement
5011618|NCT03923712|mild cognitive impairment|mild cognitive impairment
5011625|NCT03923686|Walled off necrosis|walled off necrosis
5011627|NCT03923686|Necrotizing pancreatitis|necrotizing pancreatitis
5011628|NCT03923686|Endoscopic drainage|endoscopic drainage
5011629|NCT03923686|Lumen apposing metal stents|lumen apposing metal stents
5011630|NCT03923686|Double pigtail plastic stent|double pigtail plastic stent
5011632|NCT03923660|breathing pattern|breathing pattern
5011633|NCT03923660|exercise|exercise
5011718|NCT03923140|Cryopyrin-Associated Periodic Syndromes|cryopyrin-associated periodic syndromes
5011719|NCT03923140|Tranilast|tranilast
5011720|NCT03923140|Efficacy|efficacy
5011721|NCT03923140|Safety|safety
5011822|NCT03922568|Sperm Selection|sperm selection
5011823|NCT03922555|Neurological Cancer|neurological cancer
5011824|NCT03922503|Stage III periodontitis|stage iii periodontitis
5011915|NCT03921801|Triceps surae|triceps surae
5011917|NCT03921801|Electromyography|electromyography
5011918|NCT03921801|Biofeedback|biofeedback
5011919|NCT03921801|Strength training|strength training
5011920|NCT03921801|Gait|gait
5011921|NCT03921801|Walking|walking
5011922|NCT03921788|venous pelvic pain|venous pelvic pain
5011923|NCT03921788|pelvic congestion syndrome|pelvic congestion syndrome
5011924|NCT03921788|calcitonin gene-related peptide|calcitonin gene-related peptide
5012013|NCT03921177|preconceptional multiple micronutrient supplementation|preconceptional multiple micronutrient supplementation
5012014|NCT03921177|periconceptional multiple micronutrient supplementation|periconceptional multiple micronutrient supplementation
5012015|NCT03921177|pregnancy outcomes|pregnancy outcomes
5012017|NCT03921177|Bangladesh|bangladesh
5012214|NCT03919760|Mental Health|mental health
5012215|NCT03919760|Psychiatric Services|psychiatric services
5012216|NCT03919760|NAVIGATE|navigate
5012217|NCT03919747|oral contraceptives|oral contraceptives
5012218|NCT03919747|knowledge|knowledge
5012219|NCT03919721|applied behavioral analysis|applied behavioral analysis
5012220|NCT03919721|data collection software|data collection software
5012221|NCT03919682|early detection, Rwanda|early detection, rwanda
5012222|NCT03919656|Metabolomics|metabolomics
5012223|NCT03919656|Dapagliflozin|dapagliflozin
5012224|NCT03919604|cystic fibrosis|cystic fibrosis
5012225|NCT03919604|lung transplantation|lung transplantation
5012226|NCT03919604|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5012227|NCT03919565|hepatitis b virus|hepatitis b virus
5012413|NCT03918798|Flat Foot|flat foot
5012510|NCT03918161|Tubular atrophy Renal transplantation|tubular atrophy renal transplantation
5012511|NCT03918161|Renal allograft|renal allograft
5012512|NCT03918161|Magnetic Resonance Imaging|magnetic resonance imaging
5012582|NCT03917719|DMD|dmd
5012909|NCT03915925|functional outcomes|functional outcomes
5012910|NCT03915912|Malignant Glioma|malignant glioma
5012911|NCT03915912|Mindfulness|mindfulness
5012912|NCT03915912|Dina Randazzo|dina randazzo
5012913|NCT03915912|Meditation|meditation
5012914|NCT03915873|von willebrand|von willebrand
5013012|NCT03915327|Intravenous iron dextran|intravenous iron dextran
5013013|NCT03915327|Preoperative|preoperative
5013015|NCT03915314|blood biomakers|blood biomakers
5013016|NCT03915314|endothelial dysfunction|endothelial dysfunction
5013017|NCT03915314|blood brain barrier (BBB)|blood brain barrier (bbb)
5013110|NCT03914794|FGFR inhibitor|fgfr inhibitor
5013111|NCT03914781|Scleroderma|scleroderma
5013112|NCT03914781|Systemic Sclerosis|systemic sclerosis
5013113|NCT03914781|Self-management|self-management
5013114|NCT03914781|E-health|e-health
5013115|NCT03914781|Intervention|intervention
5013117|NCT03914768|DIPG|dipg
5013214|NCT03914001|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
5013215|NCT03914001|multiparametric magnetic resonance imaging|multiparametric magnetic resonance imaging
5013216|NCT03914001|second resection|second resection
5013313|NCT03913468|septic shock|septic shock
5013314|NCT03913468|severe sepsis|severe sepsis
5013317|NCT03913416|pulmonary malformation|pulmonary malformation
5013318|NCT03913416|3D printed models|3d printed models
5013319|NCT03913416|thoracotomy|thoracotomy
5013320|NCT03913416|thoracoscopy children|thoracoscopy children
5013321|NCT03913403|Fluid Management|fluid management
5013322|NCT03913403|Sepsis-Induced Hypotension|sepsis-induced hypotension
5013323|NCT03913403|Vasopressors|vasopressors
5013324|NCT03913403|Cardiac Contractility|cardiac contractility
5013416|NCT03913013|Family Therapy|family therapy
5013417|NCT03912948|regional analgesia techniques|regional analgesia techniques
5013418|NCT03912948|breast cancer surgery|breast cancer surgery
5013419|NCT03912948|conservative surgery|conservative surgery
5013613|NCT03911726|D2/3 receptor availability|d2/3 receptor availability
5013614|NCT03911687|Early warning system|early warning system
5013615|NCT03911687|Clinical decision support|clinical decision support
5013616|NCT03911687|Predictive analysis|predictive analysis
5013617|NCT03911687|Failure to rescue|failure to rescue
5013618|NCT03911687|Inter-professional situational awareness|inter-professional situational awareness
5013619|NCT03911687|Nursing surveillance|nursing surveillance
5013620|NCT03911687|Healthcare process models of clinical concern (HPM-CC)|healthcare process models of clinical concern (hpm-cc)
5013621|NCT03911648|Bupivacaine|bupivacaine
5013622|NCT03911648|Lidocaine|lidocaine
5013623|NCT03911648|Caudal block|caudal block
5013624|NCT03911648|Pediatric urologic surgery|pediatric urologic surgery
5013625|NCT03911596|Presbyopia, accommodation, smart eyeglasses|presbyopia, accommodation, smart eyeglasses
5013626|NCT03911557|mutational burden|mutational burden
5013628|NCT03911557|PD-1|pd-1
5013629|NCT03911557|CTLA-4|ctla-4
5013630|NCT03911557|MEDI4736|medi4736
5013631|NCT03911557|durvalumab|durvalumab
5013632|NCT03911557|tremelimumab|tremelimumab
5013633|NCT03911557|immune therapy|immune therapy
5013634|NCT03911557|refractory|refractory
5013635|NCT03911544|Neuromuscular Agents|neuromuscular agents
5013636|NCT03911544|Bispectral Index|bispectral index
5013637|NCT03911531|hydrops|hydrops
5013638|NCT03911531|prenatal diagnosis|prenatal diagnosis
5013639|NCT03911531|amniocentesis|amniocentesis
5013640|NCT03911531|whole genome sequencing|whole genome sequencing
5013733|NCT03911128|ALL|all
5013813|NCT03910608|Frontoparietal Pathway|frontoparietal pathway
5013814|NCT03910608|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5013815|NCT03910608|Cognitive Function|cognitive function
5013816|NCT03910595|Barrier Film|barrier film
5013817|NCT03910595|Mepitel|mepitel
5013915|NCT03909958|spinal cord injury|spinal cord injury
5013916|NCT03909958|electroacupuncture|electroacupuncture
5013917|NCT03909958|Brain Structure and Function|brain structure and function
5013918|NCT03909958|Multi-mode Magnetic Resonance Imaging|multi-mode magnetic resonance imaging
5014113|NCT03908684|Spectroscopy|spectroscopy
5014114|NCT03908671|mRNA cancer vaccine|mrna cancer vaccine
5014115|NCT03908671|cancer vaccine|cancer vaccine
5014116|NCT03908671|tumor vaccine|tumor vaccine
5014117|NCT03908671|NSCLC|nsclc
5014118|NCT03908671|Esophageal Cancer|esophageal cancer
5014119|NCT03908658|inspiratory muscle training|inspiratory muscle training
5014120|NCT03908658|Nasal High Flow|nasal high flow
5014208|NCT03908112|vision therapy|vision therapy
5014209|NCT03908112|vision rehabilitation|vision rehabilitation
5014210|NCT03908099|Lifestyle intervention|lifestyle intervention
5014211|NCT03908099|Weight loss|weight loss
5014212|NCT03908099|Obesity|obesity
5014213|NCT03908099|Infertility|infertility
5014214|NCT03908099|Interdisciplinary program|interdisciplinary program
5014215|NCT03908073|Ulcerative Colitis|ulcerative colitis
5014216|NCT03908073|Vagal Nerve Stimulation|vagal nerve stimulation
5014230|NCT03907969|Safety,|safety,
5014309|NCT03907462|college|college
5014310|NCT03907462|university|university
5014311|NCT03907462|technology|technology
5014413|NCT03906669|early stage breast cancer|early stage breast cancer
5014415|NCT03906669|progesterone|progesterone
5014416|NCT03906669|post-menopausal|post-menopausal
5014417|NCT03906669|endocrine therapy|endocrine therapy
5014418|NCT03906643|tumor|tumor
5014419|NCT03906643|verteporfin|verteporfin
5014420|NCT03906643|HSP90 inhibitor|hsp90 inhibitor
5014513|NCT03906110|Fecal Immunochemical Test|fecal immunochemical test
5014514|NCT03906097|Dyslexia|dyslexia
5014515|NCT03906097|Executive function|executive function
5014516|NCT03906097|Cognitive control|cognitive control
5014517|NCT03906097|Inhibition|inhibition
5014518|NCT03906097|Working memory|working memory
5014519|NCT03906097|Prefrontal Cortex|prefrontal cortex
5014531|NCT03906032|Timed up and go|timed up and go
5014532|NCT03906032|mobility|mobility
5014533|NCT03906032|functional outcome|functional outcome
5014534|NCT03906019|erector spinae plane block|erector spinae plane block
5014535|NCT03906019|postoperative pain|postoperative pain
5014536|NCT03906019|pediatric patients|pediatric patients
5014537|NCT03906006|gout|gout
5014618|NCT03905551|physical activity|physical activity
5014627|NCT03905499|Massive rotator cuff tear|massive rotator cuff tear
5014628|NCT03905499|Pseudoparalysis|pseudoparalysis
5014629|NCT03905499|Robotic mediated therapy|robotic mediated therapy
5014630|NCT03905473|Survey|survey
5014631|NCT03905473|Physical Activity|physical activity
5014632|NCT03905473|Fatigue|fatigue
5014633|NCT03905434|Large vessel occlusion|large vessel occlusion
5014634|NCT03905434|Acute ischemic stroke|acute ischemic stroke
5014635|NCT03905434|microRNA|microrna
5014636|NCT03905408|glucose|glucose
5014638|NCT03905408|air leak|air leak
5014720|NCT03904836|Pharmacokinetics|pharmacokinetics
5014721|NCT03904836|Infection|infection
5014722|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents
5014723|NCT03904836|Antibiotics|antibiotics
5014724|NCT03904836|Renal Insufficiency, Chronic|renal insufficiency, chronic
5014725|NCT03904810|HIIT|hiit
5014726|NCT03904810|Exercise frequency|exercise frequency
5014727|NCT03904810|Exercise intensity|exercise intensity
5014728|NCT03904797|patient-reported outcome|patient-reported outcome
5014729|NCT03904797|electronic|electronic
5014730|NCT03904797|participation|participation
5014817|NCT03904186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5014915|NCT03903614|Ambidexterity|ambidexterity
5015111|NCT03902080|β3-AR agonist|β3-ar agonist
5015112|NCT03902067|AMI|ami
5015113|NCT03902028|Heart failure|heart failure
5015118|NCT03902002|RTA 408|rta 408
5015210|NCT03901404|Fundus Incision|fundus incision
5015211|NCT03901404|Energy Modalities|energy modalities
5015212|NCT03901404|Methods of Extraction|methods of extraction
5015310|NCT03900845|lower limb prosthesis|lower limb prosthesis
5015313|NCT03900845|adherence|adherence
5015408|NCT03900273|Prevention|prevention
5015409|NCT03900273|Clinical Trial|clinical trial
5015410|NCT03900247|brain computer interface|brain computer interface
5015621|NCT03899766|anxiety|anxiety
5015622|NCT03899753|prino|prino
5015623|NCT03899753|total shoulder arthroplasty|total shoulder arthroplasty
5015624|NCT03899753|wound closure|wound closure
5015625|NCT03899714|Postural Stability|postural stability
5015626|NCT03899714|Public Health|public health
5015627|NCT03899714|Balance|balance
5015628|NCT03899688|antrostomy|antrostomy
5015629|NCT03899688|Maxillary sinus augmentation|maxillary sinus augmentation
5015720|NCT03899194|biomarker|biomarker
5015721|NCT03899168|Depression|depression
5015722|NCT03899168|Mood Disorder|mood disorder
5015828|NCT03898362|scooter|scooter
5015829|NCT03898349|Automated Text Messaging System|automated text messaging system
5015830|NCT03898349|Implementation science|implementation science
5015831|NCT03898349|Hepatitis C|hepatitis c
5015832|NCT03898323|human laboratory|human laboratory
5015833|NCT03898323|alcohol approach bias modification|alcohol approach bias modification
5015834|NCT03898323|alcohol use disorder|alcohol use disorder
5015835|NCT03898323|non-treatment seeking|non-treatment seeking
5015836|NCT03898297|Depression|depression
5015837|NCT03898297|Bipolar|bipolar
5015838|NCT03898297|Mood disorder|mood disorder
5015839|NCT03898297|PET|pet
5015840|NCT03898297|mGluR5|mglur5
5015841|NCT03898297|glutamate system|glutamate system
5015842|NCT03898297|MRI|mri
5015846|NCT03898271|PTSD|ptsd
5015847|NCT03898271|Motivational Interviewing|motivational interviewing
5015848|NCT03898271|veterans|veterans
5015849|NCT03898271|military|military
5015850|NCT03898271|virtual world|virtual world
5016028|NCT03896971|thrombopoietin mimetic|thrombopoietin mimetic
5016029|NCT03896971|Egyptian|egyptian
5016030|NCT03896971|Aplastic|aplastic
5016031|NCT03896945|Negative Symptoms|negative symptoms
5016032|NCT03896945|Schizophrenia|schizophrenia
5016034|NCT03896906|preoxygenation|preoxygenation
5016035|NCT03896906|high-flow nasal cannula|high-flow nasal cannula
5016036|NCT03896867|Temperature management|temperature management
5016037|NCT03896867|Perioperative temperature management|perioperative temperature management
5016038|NCT03896867|Pediatric temperature management|pediatric temperature management
5016045|NCT03896763|child|child
5016130|NCT03896217|Multiple sclerosis|multiple sclerosis
5016131|NCT03896191|Total knee replacement|total knee replacement
5016132|NCT03896191|Revision knee surgery|revision knee surgery
5016133|NCT03896191|Knee instability|knee instability
5016134|NCT03896191|Gait analysis|gait analysis
5016135|NCT03896191|Patient reported outcome|patient reported outcome
5016231|NCT03895502|Venous Thrombosis|venous thrombosis
5016232|NCT03895502|Neoplasms|neoplasms
5016233|NCT03895502|Anticoagulant|anticoagulant
5016335|NCT03894865|screening, Egypt|screening, egypt
5016336|NCT03894839|Prothesis stomatitis, disinfection methods|prothesis stomatitis, disinfection methods
5016436|NCT03894059|agonal breathing|agonal breathing
5016642|NCT03892486|healthy people aged 18-50|healthy people aged 18-50
5016738|NCT03891849|microcirculation|microcirculation
5016739|NCT03891849|octreotide|octreotide
5016740|NCT03891849|norepinephrine|norepinephrine
5016741|NCT03891849|Variceal Hemorrhage|variceal hemorrhage
5016743|NCT03891771|Elderly|elderly
5016835|NCT03891238|urotelian metastatic cancer|urotelian metastatic cancer
5016836|NCT03891212|Prone Position|prone position
5016837|NCT03891212|Treatment Outcome|treatment outcome
5016838|NCT03891212|Respiration, Artificial|respiration, artificial
5016935|NCT03890484|Risk-taking|risk-taking
5016936|NCT03890484|Anxiety|anxiety
5016937|NCT03890484|Motives|motives
5017135|NCT03889223|neuraxial anesthesia positioning technique|neuraxial anesthesia positioning technique
5017136|NCT03889223|sitting cross-legged fetal position|sitting cross-legged fetal position
5017137|NCT03889223|lateral decubitus fetal position|lateral decubitus fetal position
5017138|NCT03889223|ultrasonography|ultrasonography
5017139|NCT03889210|Ketones|ketones
5017140|NCT03889210|Prediabetes|prediabetes
5017146|NCT03889171|genes BRCA1|genes brca1
5017229|NCT03888612|Castrate-Resistant|castrate-resistant
5017230|NCT03888612|Prostate Cancer|prostate cancer
5017231|NCT03888612|mCRPC|mcrpc
5017232|NCT03888612|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5017233|NCT03888586|Dry needling, subacromial joint, night pain|dry needling, subacromial joint, night pain
5017239|NCT03888547|health|health
5017334|NCT03888079|Otosclerosis|otosclerosis
5017335|NCT03888079|otosclerosis surgery|otosclerosis surgery
5017336|NCT03888079|local anesthesia|local anesthesia
5017337|NCT03888079|general anesthesia|general anesthesia
5017338|NCT03888079|comfort assessment|comfort assessment
5017339|NCT03888079|Glasgow Benefit Inventory questionnaire|glasgow benefit inventory questionnaire
5017340|NCT03888079|hearing results|hearing results
5017341|NCT03888066|treatment of hyperkalemia|treatment of hyperkalemia
5017342|NCT03888066|chronic kidney disease|chronic kidney disease
5017343|NCT03888066|hypertension|hypertension
5017344|NCT03888066|hyperkalemia|hyperkalemia
5017430|NCT03887624|Depressive Disorder, Treatment-Resistant|depressive disorder, treatment-resistant
5017431|NCT03887624|ethosuximide|ethosuximide
5017432|NCT03887611|Artificial Intelligence; Ultrasound;Thyroid nodule; ECI|artificial intelligence; ultrasound;thyroid nodule; eci
5017434|NCT03887559|Psychotherapy|psychotherapy
5017436|NCT03887546|Rehabilitation|rehabilitation
5017522|NCT03887169|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
5017524|NCT03887169|methionine|methionine
5017525|NCT03887143|Ischemic stroke|ischemic stroke
5017531|NCT03887117|IQOS|iqos
5017617|NCT03886597|Olea europaea|olea europaea
5017618|NCT03886597|Table Olives|table olives
5017619|NCT03886597|Pharmacokinetics|pharmacokinetics
5017620|NCT03886597|Functional Food|functional food
5017621|NCT03886597|Antioxidant|antioxidant
5017716|NCT03886090|cardiovascular exercise|cardiovascular exercise
5017718|NCT03886090|postural instability|postural instability
5017719|NCT03886090|motor memory|motor memory
5017720|NCT03886090|consolidation|consolidation
5017819|NCT03885362|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5017820|NCT03885362|Chronic Kidney Diseases|chronic kidney diseases
5017821|NCT03885349|Intimate partner violence|intimate partner violence
5017822|NCT03885349|Alcohol|alcohol
5017823|NCT03885349|Drug|drug
5017824|NCT03885349|Batterer intervention programs|batterer intervention programs
5017825|NCT03885297|obesity|obesity
5017917|NCT03884673|DTG + 3TC Simplified Therapy|dtg + 3tc simplified therapy
5017918|NCT03884673|Simplified Therapy Regimen|simplified therapy regimen
5017919|NCT03884673|Real World Study|real world study
5018108|NCT03883607|Pharmacokinetics|pharmacokinetics
5018109|NCT03883581|bulbar dysfunction|bulbar dysfunction
5018110|NCT03883568|phenotypes|phenotypes
5018111|NCT03883568|(bio)markers|(bio)markers
5018112|NCT03883555|Acute cardiogenic pulmonary|acute cardiogenic pulmonary
5018315|NCT03882411|Implementation science|implementation science
5018319|NCT03882398|balance|balance
5018426|NCT03881605|MRI|mri
5018715|NCT03879993|CD4|cd4
5018815|NCT03879382|POMES Syndrome|pomes syndrome
5018816|NCT03879382|Relapsed and Refractory|relapsed and refractory
5018817|NCT03879356|Aluminum phosphide|aluminum phosphide
5018910|NCT03878602|Newborn|newborn
5018911|NCT03878602|Elective Caesaren Section|elective caesaren section
5018912|NCT03878602|Cord Clamping|cord clamping
5018913|NCT03878576|Glycemic Index|glycemic index
5019012|NCT03877900|post mortem Magnetic Resonance Imaging|post mortem magnetic resonance imaging
5019013|NCT03877900|stillbirth|stillbirth
5019209|NCT03876860|Vaginal stenosis|vaginal stenosis
5019229|NCT03876769|CTL019|ctl019
5019312|NCT03876366|online Decision Aid tool|online decision aid tool
5019313|NCT03876340|Burns|burns
5019314|NCT03876340|Cost-effectiveness|cost-effectiveness
5019318|NCT03876301|Factor VIII|factor viii
5019408|NCT03875703|Active Immune Response|active immune response
5019409|NCT03875664|liposomal bupivacaine|liposomal bupivacaine
5019410|NCT03875664|posterior repair|posterior repair
5019412|NCT03875625|MRI|mri
5019508|NCT03875144|Surgical oncology|surgical oncology
5019509|NCT03875144|Peritoneal Carcinomatosis|peritoneal carcinomatosis
5019510|NCT03875118|Oral cancer|oral cancer
5019511|NCT03875118|Trismus|trismus
5019512|NCT03875118|Mouth-opening training|mouth-opening training
5019513|NCT03875118|Jaw exercise|jaw exercise
5019516|NCT03875092|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5019517|NCT03875092|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5019518|NCT03875066|Rehabilitation|rehabilitation
5019707|NCT03873857|Cancer|cancer
5019822|NCT03873064|BMI|bmi
5019903|NCT03872544|Treatment Outcome|treatment outcome
5019920|NCT03872479|CEP290|cep290
5020007|NCT03872037|dental caries|dental caries
5020008|NCT03872037|dentine|dentine
5020009|NCT03872011|septic shock|septic shock
5020010|NCT03872011|vitamin C|vitamin c
5020011|NCT03872011|thiamine|thiamine
5020317|NCT03870256|misoprostol|misoprostol
5020318|NCT03870243|Bubble CPAP|bubble cpap
5020319|NCT03870243|Young Children|young children
5020320|NCT03870243|Severe Pneumonia|severe pneumonia
5020321|NCT03870204|Schistosoma japonicum|schistosoma japonicum
5020322|NCT03870126|cognitive|cognitive
5020419|NCT03869671|Syringe exchange program (SEP)|syringe exchange program (sep)
5020420|NCT03869671|HIV-related risk behaviors|hiv-related risk behaviors
5020518|NCT03868956|Colour doppler ultrasound|colour doppler ultrasound
5020519|NCT03868956|D-dimer|d-dimer
5020520|NCT03868930|Mental health|mental health
5020521|NCT03868930|Veterans health|veterans health
5020522|NCT03868891|Otitis media|otitis media
5020720|NCT03867266|Ablation index|ablation index
5020721|NCT03867266|Interlesion distance|interlesion distance
5020722|NCT03867253|Alzheimer's Disease, ORY-2001|alzheimer's disease, ory-2001
5020723|NCT03867240|Gabapentin|gabapentin
5020724|NCT03867240|Pain medication|pain medication
5020725|NCT03867240|Chronic postsurgical pain|chronic postsurgical pain
5020726|NCT03867240|Pediatric|pediatric
5020732|NCT03867201|AMG334|amg334
5020818|NCT03866785|Sports medicine|sports medicine
5020819|NCT03866772|induction of labor|induction of labor
5020820|NCT03866772|unfavorable cervix|unfavorable cervix
5020821|NCT03866772|misoprostol|misoprostol
5020822|NCT03866772|cytotec|cytotec
5020823|NCT03866772|double balloon device|double balloon device
5020824|NCT03866772|cervical ripening|cervical ripening
5020828|NCT03866746|Aflibercept|aflibercept
5020829|NCT03866746|Anti-VEGFs|anti-vegfs
5020830|NCT03866746|micropulsed diode laser|micropulsed diode laser
5020836|NCT03866694|parenting|parenting
5021011|NCT03865628|Ductus venous|ductus venous
5021012|NCT03865628|Aortic isthmus|aortic isthmus
5021013|NCT03865628|Amniotic fluid|amniotic fluid
5021014|NCT03865628|Intrauterine Growth Restriction|intrauterine growth restriction
5021023|NCT03865576|ICP|icp
5021116|NCT03865069|Volume guarantee|volume guarantee
5021117|NCT03865069|preterm|preterm
5021118|NCT03865069|ventilated infants|ventilated infants
5021223|NCT03864198|Male infertility|male infertility
5021224|NCT03864198|Reveratrol|reveratrol
5021225|NCT03864198|Vitamin B12|vitamin b12
5021226|NCT03864198|Vitamin B6|vitamin b6
5021227|NCT03864198|Folic acid|folic acid
5021228|NCT03864185|IgG4 autoantibody|igg4 autoantibody
5021229|NCT03864185|Neurofascin-155|neurofascin-155
5021230|NCT03864185|Contactin-1|contactin-1
5021231|NCT03864185|Rituximab|rituximab
5021232|NCT03864159|Cupping therapy|cupping therapy
5021233|NCT03864159|Foam roller|foam roller
5021234|NCT03864159|Basketball|basketball
5021235|NCT03864159|Flexibility|flexibility
5021417|NCT03863210|patient education|patient education
5021418|NCT03863210|hope|hope
5021419|NCT03863210|decisional conflict|decisional conflict
5021420|NCT03863210|women|women
5021421|NCT03863197|Cerebral Palsy|cerebral palsy
5021422|NCT03863197|Spastic Cerebral Palsy|spastic cerebral palsy
5021423|NCT03863197|Progressive Strength Training|progressive strength training
5021424|NCT03863197|Muscle morphology|muscle morphology
5021521|NCT03862651|DAPT|dapt
5021522|NCT03862625|cerebral palsy|cerebral palsy
5021523|NCT03862625|scoliosis|scoliosis
5021524|NCT03862625|adaptive seating system|adaptive seating system
5021525|NCT03862625|sagittal balance|sagittal balance
5021526|NCT03862625|pelvic obliquity|pelvic obliquity
5021527|NCT03862625|coronal balance|coronal balance
5021528|NCT03862599|erectile dysfunction|erectile dysfunction
5021529|NCT03862599|shockwave|shockwave
5021530|NCT03862599|treatment|treatment
5021620|NCT03862196|retention|retention
5021621|NCT03862196|mHealth|mhealth
5021622|NCT03862170|HDR Brachytherapy|hdr brachytherapy
5021722|NCT03861468|obesity hypoventilation syndrome|obesity hypoventilation syndrome
5656326|NCT00677118|Clinical trial|clinical trial
5021723|NCT03861468|obstructive sleep apnea|obstructive sleep apnea
5021724|NCT03861468|bicarbonates|bicarbonates
5021725|NCT03861468|STOP-BANG|stop-bang
5021815|NCT03860974|paravertebral|paravertebral
5021816|NCT03860974|erector spinae|erector spinae
5021817|NCT03860974|nerve block|nerve block
5021823|NCT03860896|Inflammatory Bowel Disease|inflammatory bowel disease
5021919|NCT03860454|Lamin A/C Cardiomyopathy|lamin a/c cardiomyopathy
5021920|NCT03860454|Heart failure|heart failure
5021921|NCT03860441|cognition|cognition
5021922|NCT03860441|mobility|mobility
5022122|NCT03859141|Children|children
5022123|NCT03859115|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5022124|NCT03859115|sevoflurane|sevoflurane
5022314|NCT03858088|primary non-function|primary non-function
5022315|NCT03858088|retransplant|retransplant
5022316|NCT03858062|Artificial pancreas|artificial pancreas
5022317|NCT03858062|Glucose control|glucose control
5022510|NCT03856840|Bullous Pemphigoid|bullous pemphigoid
5022511|NCT03856840|Blister Fluid|blister fluid
5022512|NCT03856840|Eosinophil Cationic Protein|eosinophil cationic protein
5022513|NCT03856840|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5022514|NCT03856840|Anti-BP180|anti-bp180
5022515|NCT03856840|Disease activity|disease activity
5022516|NCT03856840|Disease severity|disease severity
5022517|NCT03856801|neuromuscular disease|neuromuscular disease
5022518|NCT03856801|whole-body vibration|whole-body vibration
5022812|NCT03855046|Anal fissure|anal fissure
5022813|NCT03855046|Chronic anal fissure|chronic anal fissure
5022814|NCT03855046|botulinum toxin A|botulinum toxin a
5022852|NCT03854903|HR+|hr+
5023012|NCT03853759|Gait Parameters, Heart Failure,Balance,Gait,Cognition,Functional Capacity,Muscle Strength|gait parameters, heart failure,balance,gait,cognition,functional capacity,muscle strength
5023013|NCT03853733|palliative radiotherapy|palliative radiotherapy
5023014|NCT03853733|rectal bleeding|rectal bleeding
5023015|NCT03853733|hypofractionated radiotherapy|hypofractionated radiotherapy
5023016|NCT03853694|bupivacaine|bupivacaine
5023017|NCT03853694|EXPAREL|exparel
5023018|NCT03853694|analgesic|analgesic
5023019|NCT03853694|TAP Block|tap block
5023020|NCT03853694|C-Section|c-section
5023021|NCT03853694|Cesarean Section|cesarean section
5023114|NCT03853122|physiotherapy|physiotherapy
5023115|NCT03853057|volumetric capnography|volumetric capnography
5023116|NCT03853057|gravity|gravity
5023117|NCT03853057|mechanical ventilation|mechanical ventilation
5023118|NCT03853057|EIT|eit
5023119|NCT03853031|TEE|tee
5023120|NCT03853031|LVEDA|lveda
5023121|NCT03853031|CVP|cvp
5023122|NCT03853031|GDFT|gdft
5023123|NCT03852992|Male Pattern Hair Loss|male pattern hair loss
5023124|NCT03852992|Androgenetic Alopecia|androgenetic alopecia
5023125|NCT03852992|Male Baldness|male baldness
5023126|NCT03852992|Bald|bald
5023128|NCT03852953|Screening|screening
5023412|NCT03851198|Reliability|reliability
5023413|NCT03851172|Cataract surgery|cataract surgery
5023414|NCT03851172|Intraoperative Miosis|intraoperative miosis
5023415|NCT03851172|Ketorolac eye drops|ketorolac eye drops
5023517|NCT03850509|digestive tract|digestive tract
5023518|NCT03850509|abdominal pain|abdominal pain
5023519|NCT03850509|diarrhea|diarrhea
5023520|NCT03850496|Venous|venous
5023523|NCT03850470|Diagnostic accuracy|diagnostic accuracy
5023524|NCT03850470|Clinical examination|clinical examination
5023525|NCT03850470|neck|neck
5023526|NCT03850470|back|back
5023527|NCT03850470|shoulder|shoulder
5023528|NCT03850470|hip|hip
5023529|NCT03850470|knee|knee
5023616|NCT03849937|Behavioral and Psychological Symptoms of Dementia|behavioral and psychological symptoms of dementia
5023617|NCT03849937|Psychotropic Medication|psychotropic medication
5023618|NCT03849937|Elderspeak|elderspeak
5023619|NCT03849937|Staff Training|staff training
5023622|NCT03849924|well-being|well-being
5023712|NCT03849469|Hepatocellular/Liver Cancer|hepatocellular/liver cancer
5023713|NCT03849469|Urothelial Cancer|urothelial cancer
5023718|NCT03849469|Gastric Cancer|gastric cancer
5023803|NCT03849040|deep neural network|deep neural network
5023804|NCT03849040|segmentation|segmentation
5023805|NCT03849027|altitude|altitude
5023806|NCT03849027|analgesia|analgesia
5023807|NCT03849027|methoxyflurane|methoxyflurane
5023808|NCT03849027|wilderness medicine|wilderness medicine
5023809|NCT03849014|Hip fractures|hip fractures
5023810|NCT03849014|Inflammatory response|inflammatory response
5023811|NCT03849014|Interleukin-6|interleukin-6
5023833|NCT03848897|Ageing|ageing
5024106|NCT03847233|Proximal Popliteal Artery|proximal popliteal artery
5024107|NCT03847233|Endovascular therapy|endovascular therapy
5024120|NCT03847181|Safety|safety
5024205|NCT03846713|airway exchange catheter|airway exchange catheter
5024306|NCT03846050|decision making|decision making
5024307|NCT03846050|drunk driving|drunk driving
5024308|NCT03846050|ambulatory assessment|ambulatory assessment
5024309|NCT03846037|Proprioception|proprioception
5024310|NCT03846037|Balance|balance
5024311|NCT03846037|Whole-body Vibation|whole-body vibation
5024312|NCT03846037|One-foot Stance|one-foot stance
5024313|NCT03846024|RibFx|ribfx
5024498|NCT03844919|TMS|tms
5024513|NCT03844841|Propofol|propofol
5024514|NCT03844841|Dexmedetomidine|dexmedetomidine
5024515|NCT03844828|Intraocular Lens|intraocular lens
5024516|NCT03844828|Trifocal|trifocal
5024517|NCT03844828|Toric Lens|toric lens
5024518|NCT03844802|neck pain|neck pain
5024519|NCT03844802|randomized control trial|randomized control trial
5024711|NCT03843593|Decline Adjuvant Immunotherapy|decline adjuvant immunotherapy
5024712|NCT03843593|Agree To Adjuvant Immunotherapy|agree to adjuvant immunotherapy
5024713|NCT03843593|19-012|19-012
5024714|NCT03843580|Time of apnea|time of apnea
5024715|NCT03843580|Optiflow|optiflow
5024716|NCT03843580|Thrive|thrive
5024721|NCT03843567|Colonic polyps|colonic polyps
5024903|NCT03842319|Mediterranean diet|mediterranean diet
5024904|NCT03842319|microbiota|microbiota
5024905|NCT03842319|immune system|immune system
5024906|NCT03842319|metabolome|metabolome
5024907|NCT03842319|proteome|proteome
5024908|NCT03842306|End tidal oxygen|end tidal oxygen
5024909|NCT03842306|Preoxygenation|preoxygenation
5024910|NCT03842306|Arterial oxygen|arterial oxygen
5024911|NCT03842280|Prolonged mechanical ventilation|prolonged mechanical ventilation
5024912|NCT03842280|Esophageal pressure|esophageal pressure
5024913|NCT03842280|Pleural pressure|pleural pressure
5024914|NCT03842215|smart physical examination system|smart physical examination system
5024915|NCT03842215|health management|health management
5024916|NCT03842215|elderly|elderly
5024934|NCT03842176|Breast Cancer|breast cancer
5024936|NCT03842176|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5024937|NCT03842176|Adjuvant chemotherapy|adjuvant chemotherapy
5024938|NCT03842163|Scintigraphy|scintigraphy
5024939|NCT03842163|Gammagraphy|gammagraphy
5024940|NCT03842163|TTR|ttr
5024941|NCT03842163|ATTR|attr
5025003|NCT03841838|QT prolongation|qt prolongation
5025004|NCT03841838|Blood pressure|blood pressure
5025006|NCT03841799|Microenvironment colorectal tissue|microenvironment colorectal tissue
5025007|NCT03841799|Immune infiltrate|immune infiltrate
5025008|NCT03841786|Metabolome|metabolome
5025009|NCT03841786|Phosphorus|phosphorus
5025010|NCT03841786|Nutrition|nutrition
5025105|NCT03841292|Cue reactivity|cue reactivity
5025106|NCT03841292|Reward Anticipation|reward anticipation
5025107|NCT03841292|Diffusion Tensor Imaging|diffusion tensor imaging
5025108|NCT03841292|Resting State Functional Connectivity|resting state functional connectivity
5025109|NCT03841292|BOLD fMRI|bold fmri
5025110|NCT03841292|Quantitative T1|quantitative t1
5025111|NCT03841253|Trans-epithelial phototherapeutic keratectomy|trans-epithelial phototherapeutic keratectomy
5025112|NCT03841253|PTK|ptk
5025113|NCT03841253|TE-PTK|te-ptk
5025114|NCT03841253|Corneal epithelium|corneal epithelium
5025208|NCT03840837|cholinesterase inhibitor|cholinesterase inhibitor
5025209|NCT03840824|healthy|healthy
5025211|NCT03840824|postmenarchal|postmenarchal
5025212|NCT03840824|chemotherapy|chemotherapy
5025213|NCT03840824|alkylating agent|alkylating agent
5025214|NCT03840824|alkylator|alkylator
5025215|NCT03840824|high dose cancer therapy|high dose cancer therapy
5025216|NCT03840824|low dose cancer therapy|low dose cancer therapy
5025217|NCT03840811|ceftriaxone|ceftriaxone
5025218|NCT03840811|challenge|challenge
5025306|NCT03840213|nutrition|nutrition
5025307|NCT03840213|self-care|self-care
5025308|NCT03840213|care/caregiver relationship|care/caregiver relationship
5025309|NCT03840213|fasting|fasting
5025506|NCT03838939|therapeutic education|therapeutic education
5025507|NCT03838939|safety skills|safety skills
5025508|NCT03838926|Hematologic|hematologic
5025509|NCT03838926|Malignancies|malignancies
5025608|NCT03838406|Stomach cancer|stomach cancer
5025609|NCT03838406|Chemotherapy|chemotherapy
5025610|NCT03838406|FOLFOX|folfox
5025807|NCT03837327|Mass Spectrometry|mass spectrometry
5025808|NCT03837327|Adnexal Mass/ Pelvic Mass|adnexal mass/ pelvic mass
5025809|NCT03837327|Venn Biosciences|venn biosciences
5025810|NCT03837327|VOCAL Study|vocal study
5025811|NCT03837314|Parkinson's disease|parkinson's disease
5025812|NCT03837314|Deep Brain Stimulation|deep brain stimulation
5025813|NCT03837314|Neuromodulation|neuromodulation
5025906|NCT03836664|Headache|headache
5025907|NCT03836664|Acute migraine headache|acute migraine headache
5025908|NCT03836651|oxidative stress|oxidative stress
5025910|NCT03836651|inflammation|inflammation
5026003|NCT03836144|Inflammation|inflammation
5026004|NCT03836144|Nephrolithiasis|nephrolithiasis
5026206|NCT03834818|surgery|surgery
5026207|NCT03834818|orthopedic surgery|orthopedic surgery
5026208|NCT03834818|orthopedic|orthopedic
5026209|NCT03834792|Sleep disorders|sleep disorders
5026210|NCT03834792|Health outcomes|health outcomes
5026211|NCT03834792|Predictive model|predictive model
5026212|NCT03834792|Health care utilization|health care utilization
5026213|NCT03834792|Validation|validation
5026214|NCT03834779|HIV|hiv
5026215|NCT03834779|AIDS|aids
5026216|NCT03834779|Substance Use|substance use
5026218|NCT03834740|recurrent GBM|recurrent gbm
5026219|NCT03834740|brain tumor|brain tumor
5026220|NCT03834740|GBM|gbm
5026221|NCT03834740|glioma|glioma
5026222|NCT03834714|Noise induced hearing loss|noise induced hearing loss
5026223|NCT03834714|Near infrared energy|near infrared energy
5026224|NCT03834714|Hering test|hering test
5026229|NCT03834675|PICC|picc
5026230|NCT03834675|shock|shock
5026407|NCT03833531|PTSD|ptsd
5026409|NCT03833531|Imagination and rescripting therapy (ImRs)|imagination and rescripting therapy (imrs)
5026410|NCT03833531|Schema-Focused Therapy (SFT)|schema-focused therapy (sft)
5026411|NCT03833531|Integrated treatment|integrated treatment
5026412|NCT03833531|Prediction|prediction
5026413|NCT03833518|hand|hand
5026414|NCT03833518|rehabilitation|rehabilitation
5026415|NCT03833518|motor cortex|motor cortex
5026416|NCT03833479|TSR-042|tsr-042
5026417|NCT03833479|Anti-PD1|anti-pd1
5026418|NCT03833479|advanced cervical cancer|advanced cervical cancer
5026419|NCT03833466|Advanced Esophageal Squamous Cell Carcinoma|advanced esophageal squamous cell carcinoma
5026420|NCT03833466|Neoadjuvant Therapy|neoadjuvant therapy
5026421|NCT03833466|Metformin|metformin
5026422|NCT03833466|Cisplatin|cisplatin
5026423|NCT03833466|Paclitaxel|paclitaxel
5026424|NCT03833453|PTSD|ptsd
5026425|NCT03833453|BPD|bpd
5026426|NCT03833453|Eye Movement Desensitisation and Reprocessing (EMDR)|eye movement desensitisation and reprocessing (emdr)
5026427|NCT03833453|Dialectical Behavior Therapy (DBT)|dialectical behavior therapy (dbt)
5026428|NCT03833453|Integrated treatment|integrated treatment
5026429|NCT03833453|Prediction|prediction
5026508|NCT03833102|Staphylococcus aureus|staphylococcus aureus
5026510|NCT03833063|botox|botox
5026511|NCT03833063|depression|depression
5026512|NCT03833063|geriatric depression|geriatric depression
5026513|NCT03833063|depression in older adults|depression in older adults
5026514|NCT03833063|depression in the elderly|depression in the elderly
5026515|NCT03833063|old age depression|old age depression
5026516|NCT03833050|heart transplant|heart transplant
5026518|NCT03833024|deep vein thrombosis|deep vein thrombosis
5026609|NCT03832556|neurogenic myositis ossificans|neurogenic myositis ossificans
5026610|NCT03832556|para-osteo-arthropathy|para-osteo-arthropathy
5026611|NCT03832556|preoperative evaluation|preoperative evaluation
5026612|NCT03832556|CT scan|ct scan
5026613|NCT03832556|MRI|mri
5026614|NCT03832543|Vaginal Hysterectomy|vaginal hysterectomy
5026615|NCT03832530|PrEP|prep
5026715|NCT03831945|HIV Therapy|hiv therapy
5026716|NCT03831945|HIV Neutralizing Antibodies|hiv neutralizing antibodies
5026717|NCT03831919|ocular accommodation|ocular accommodation
5026718|NCT03831867|spine|spine
5026719|NCT03831867|extensibility|extensibility
5026812|NCT03831308|New tools for evaluating breast Cancer patients|new tools for evaluating breast cancer patients
5026813|NCT03831256|Real life comparative effectiveness|real life comparative effectiveness
5026814|NCT03831256|Non-invasive prenatal screening|non-invasive prenatal screening
5026815|NCT03831256|Fetal aneuploidy|fetal aneuploidy
5026817|NCT03831243|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5026818|NCT03831243|Spinal metastases|spinal metastases
5027007|NCT03829956|hypopnoea|hypopnoea
5027008|NCT03829930|Castration resistant prostate cancer|castration resistant prostate cancer
5027009|NCT03829904|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5027010|NCT03829904|Traditional Chinese medicine|traditional chinese medicine
5027011|NCT03829891|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5027012|NCT03829891|Beinaglutide|beinaglutide
5027013|NCT03829891|glycemic variability|glycemic variability
5027014|NCT03829839|Amygdala, anxiety, benzodiazepines, fear, fMRI, lorazepam, oxytocin, 7 Tesla|amygdala, anxiety, benzodiazepines, fear, fmri, lorazepam, oxytocin, 7 tesla
5027015|NCT03829800|Glycemic Index|glycemic index
5027016|NCT03829800|Insulin|insulin
5027017|NCT03829800|Incretins|incretins
5027018|NCT03829800|Diabetes Mellitus type 2|diabetes mellitus type 2
5027019|NCT03829800|Subjective appetite|subjective appetite
5027020|NCT03829800|Nutritional formula|nutritional formula
5027022|NCT03829748|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5027023|NCT03829748|Endoscopic ultrasound|endoscopic ultrasound
5027024|NCT03829748|Fine-needle aspiration|fine-needle aspiration
5027053|NCT03829605|Hydrogen sulfide|hydrogen sulfide
5027054|NCT03829605|Nitric oxide|nitric oxide
5027055|NCT03829605|Stress hyperglycemia|stress hyperglycemia
5027056|NCT03829605|Acute coronary syndrome|acute coronary syndrome
5027057|NCT03829566|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5027058|NCT03829566|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5027059|NCT03829553|regional nodal irradiation|regional nodal irradiation
5027103|NCT03829293|sedation|sedation
5027104|NCT03829293|hypoxia|hypoxia
5027105|NCT03829280|Schizophrenia|schizophrenia
5027106|NCT03829280|Cognitive Adaptation Training|cognitive adaptation training
5027107|NCT03829280|Functional Outcome|functional outcome
5027108|NCT03829267|exercise|exercise
5027109|NCT03829267|physical activity|physical activity
5027110|NCT03829254|Solid tumors|solid tumors
5027111|NCT03829254|Lymphoma|lymphoma
5027206|NCT03828669|digital|digital
5027207|NCT03828656|PTSD|ptsd
5027208|NCT03828656|Nightmare Disorder|nightmare disorder
5027209|NCT03828656|Post-traumatic stress disorder|post-traumatic stress disorder
5027210|NCT03828656|Veteran|veteran
5027211|NCT03828656|Digital therapeutic|digital therapeutic
5027212|NCT03828656|Digital medicine|digital medicine
5027304|NCT03828045|Apremilast|apremilast
5027305|NCT03828045|CC-10004|cc-10004
5027306|NCT03828045|Biologic Treatments|biologic treatments
5027307|NCT03828032|Brain edema|brain edema
5027308|NCT03828032|dehydration|dehydration
5027309|NCT03828032|Noninvasive optical method|noninvasive optical method
5027310|NCT03827980|Acute Haematogenous Osteomyelitis|acute haematogenous osteomyelitis
5027311|NCT03827980|Septic Arthritis|septic arthritis
5027404|NCT03827369|Arterial pulse|arterial pulse
5027405|NCT03827369|Coefficient of variation of harmonic magnitude|coefficient of variation of harmonic magnitude
5027500|NCT03826979|Modified Radical Mastectomy|modified radical mastectomy
5027501|NCT03826953|nurse led allergy clinic|nurse led allergy clinic
5027502|NCT03826940|Inhibition|inhibition
5027503|NCT03826940|GABA|gaba
5027504|NCT03826940|molecular imaging|molecular imaging
5027505|NCT03826940|functional magnetic resonance imaging|functional magnetic resonance imaging
5027595|NCT03826290|Decision Support Systems, Clinical|decision support systems, clinical
5027596|NCT03826290|Machine Learning|machine learning
5027597|NCT03826290|Data Visualization|data visualization
5027598|NCT03826264|TAVR|tavr
5027695|NCT03825601|Multiple Sclerosis,|multiple sclerosis,
5027696|NCT03825601|Relapsing-Remitting|relapsing-remitting
5027699|NCT03825562|type 1 diabetes|type 1 diabetes
5027701|NCT03825562|adolescents|adolescents
5027702|NCT03825562|value based methods|value based methods
5027703|NCT03825562|acceptance|acceptance
5027704|NCT03825549|Opioids|opioids
5027705|NCT03825549|Nudges|nudges
5027709|NCT03825536|HIV|hiv
5027909|NCT03824574|skeletal class II|skeletal class ii
5028010|NCT03823924|body composition|body composition
5028011|NCT03823924|bone mineral density|bone mineral density
5028012|NCT03823924|adiposity|adiposity
5028013|NCT03823911|Cardiovascular Disease|cardiovascular disease
5028014|NCT03823898|obesity|obesity
5028015|NCT03823898|body composition|body composition
5028016|NCT03823898|weight management|weight management
5028018|NCT03823898|Behavioral change|behavioral change
5028109|NCT03823313|Spiritual Care|spiritual care
5028110|NCT03823313|Religion|religion
5028111|NCT03823313|Spirituality|spirituality
5028112|NCT03823313|Caregiver|caregiver
5028121|NCT03823222|Duckweed protein|duckweed protein
5028123|NCT03823222|degree of digestibility|degree of digestibility
5028124|NCT03823222|whey protein|whey protein
5028125|NCT03823209|Pre-exposure prophylaxis (PrEP)|pre-exposure prophylaxis (prep)
5028126|NCT03823183|Aging, geriatrics & gerontology|aging, geriatrics & gerontology
5028205|NCT03822871|metastatic castration resistant prostate cancer|metastatic castration resistant prostate cancer
5669491|NCT00623285|Postoperative.|postoperative.
5028207|NCT03822871|mCRPC|mcrpc
5028208|NCT03822871|PSMA|psma
5028209|NCT03822871|positron emission tomography|positron emission tomography
5028210|NCT03822871|PET|pet
5028211|NCT03822871|radiotherapy|radiotherapy
5028212|NCT03822871|targeted therapy|targeted therapy
5028213|NCT03822871|lutetium|lutetium
5028214|NCT03822871|177Lu|177lu
5028215|NCT03822858|Mesenchymal Stem Cells|mesenchymal stem cells
5028216|NCT03822858|Neural Progenitors|neural progenitors
5028217|NCT03822858|Autologous|autologous
5028218|NCT03822858|Bone Marrow|bone marrow
5028219|NCT03822858|Multiple Sclerosis|multiple sclerosis
5028220|NCT03822845|Nuclear scans|nuclear scans
5028307|NCT03822338|Pneumoperitoneum preconditioning|pneumoperitoneum preconditioning
5028308|NCT03822338|Laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
5028399|NCT03821922|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
5028400|NCT03821922|FGF23|fgf23
5028401|NCT03821909|Pancreatic cancer|pancreatic cancer
5028402|NCT03821909|Portal venous blood|portal venous blood
5028403|NCT03821909|Circulating tumor cells|circulating tumor cells
5028404|NCT03821909|Exosome|exosome
5028405|NCT03821896|Adolescents; Obesity; Lifestyle; Goals; Communication|adolescents; obesity; lifestyle; goals; communication
5028501|NCT03821363|Solid Tumors|solid tumors
5028502|NCT03821363|Lymphoma|lymphoma
5028503|NCT03821363|PD-1|pd-1
5028504|NCT03821363|SCT-I10A|sct-i10a
5028505|NCT03821350|Transforaminal epidural steroid injection|transforaminal epidural steroid injection
5028507|NCT03821337|Opioid use disorder|opioid use disorder
5028508|NCT03821324|acne scarring|acne scarring
5028509|NCT03821324|acne scar|acne scar
5028510|NCT03821324|fractional radiofrequency|fractional radiofrequency
5028511|NCT03821324|fractional RF|fractional rf
5028512|NCT03821298|pain|pain
5028513|NCT03821298|osteoarthritis|osteoarthritis
5028514|NCT03821298|function|function
5028515|NCT03821285|TB|tb
5028516|NCT03821285|Pulmonary rehabilitation|pulmonary rehabilitation
5028517|NCT03821285|Lung function|lung function
5028531|NCT03821220|Activity tracker; Arab population; Physical Activity|activity tracker; arab population; physical activity
5028532|NCT03821207|Abdominal massage|abdominal massage
5028533|NCT03821207|Exercise|exercise
5028534|NCT03821207|Primary Dysmenorrhea|primary dysmenorrhea
5028535|NCT03821194|pain relief|pain relief
5028536|NCT03821194|complementary and alternative therapy|complementary and alternative therapy
5028537|NCT03821181|pediatric moyamoya disease|pediatric moyamoya disease
5028538|NCT03821181|TIA|tia
5028539|NCT03821181|Stroke|stroke
5028540|NCT03821181|Remote ischemic conditioning|remote ischemic conditioning
5028541|NCT03821155|Vestibular Neuritis|vestibular neuritis
5028549|NCT03821142|mesh|mesh
5028595|NCT03820934|Methotrexate|methotrexate
5028596|NCT03820934|FibroScan|fibroscan
5028597|NCT03820934|FibroSure|fibrosure
5028598|NCT03820934|Cirrhosis|cirrhosis
5028692|NCT03820180|ADVAIR|advair
5028986|NCT03818113|St. Thomas solution|st. thomas solution
5028987|NCT03818113|cardiac biomarker|cardiac biomarker
5028988|NCT03818087|Breast Cancer|breast cancer
5028989|NCT03818074|High Frequency spinal cord stimulation|high frequency spinal cord stimulation
5028990|NCT03818061|Atezolizumab|atezolizumab
5028991|NCT03818061|Bevacizumab|bevacizumab
5028992|NCT03818048|sedation|sedation
5028993|NCT03818048|colonoscopy|colonoscopy
5029086|NCT03817554|Pramipexole,|pramipexole,
5029087|NCT03817554|Restless Leg Syndrome|restless leg syndrome
5029088|NCT03817554|Peritoneal Dialysis|peritoneal dialysis
5029089|NCT03817489|Colorectal Cancer Survivors|colorectal cancer survivors
5029191|NCT03816852|Premature Ovarian Insufficiency|premature ovarian insufficiency
5029192|NCT03816852|mesenchymal stem cell|mesenchymal stem cell
5029194|NCT03816800|iron-deficiency|iron-deficiency
5029195|NCT03816800|birch|birch
5029196|NCT03816800|grass|grass
5029197|NCT03816787|Cupping Therapy|cupping therapy
5029198|NCT03816787|Near Infrared Spectroscopy|near infrared spectroscopy
5029199|NCT03816774|screening colonoscopy|screening colonoscopy
5029200|NCT03816774|colo-rectal cancer|colo-rectal cancer
5029201|NCT03816774|simethicone|simethicone
5029202|NCT03816774|split-dose polyethylene glycol|split-dose polyethylene glycol
5029209|NCT03816683|Registry|registry
5029288|NCT03816059|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5029289|NCT03816059|Cerebrovascular disease|cerebrovascular disease
5029290|NCT03816046|botulinum toxim|botulinum toxim
5029291|NCT03816046|abobotulinum|abobotulinum
5029292|NCT03816046|hyperhydrosis|hyperhydrosis
5029386|NCT03815513|Intracerebral hemorrhage|intracerebral hemorrhage
5029387|NCT03815513|MRI|mri
5029388|NCT03815513|human|human
5029389|NCT03815487|pediatrics|pediatrics
5029390|NCT03815487|type 1 diabetes|type 1 diabetes
5029391|NCT03815487|insulin pump|insulin pump
5029392|NCT03815487|closed loop|closed loop
5029393|NCT03815448|Methotrexate|methotrexate
5029486|NCT03814915|Prediabetes|prediabetes
5029487|NCT03814915|Proteome|proteome
5029488|NCT03814915|Type 2 diabetes|type 2 diabetes
5029489|NCT03814889|spasticity|spasticity
5029490|NCT03814889|tone|tone
5029491|NCT03814889|hemiplegia|hemiplegia
5029492|NCT03814889|hemiparesis|hemiparesis
5029494|NCT03814889|hand|hand
5029495|NCT03814889|vibration|vibration
5029496|NCT03814863|red eye|red eye
5029497|NCT03814863|conjunctival congestion|conjunctival congestion
5029498|NCT03814863|ophthalmology clinic|ophthalmology clinic
5029499|NCT03814850|brain aneurysm|brain aneurysm
5029585|NCT03814343|onychomycosis|onychomycosis
5029586|NCT03814343|amphotericin B|amphotericin b
5029587|NCT03814343|Dimethylsulphoxide|dimethylsulphoxide
5029588|NCT03814343|non-dermatophyte|non-dermatophyte
5029682|NCT03813667|Terminal Care|terminal care
5029684|NCT03813654|attention|attention
5029685|NCT03813654|vigilance|vigilance
5029686|NCT03813654|aging|aging
5029687|NCT03813654|shift work|shift work
5029688|NCT03813641|Raltitrexed|raltitrexed
5029689|NCT03813641|First-line therapy|first-line therapy
5029690|NCT03813641|Bevacizumab|bevacizumab
5029691|NCT03813641|Colorectal Cancer|colorectal cancer
5029692|NCT03813628|celtra press|celtra press
5029693|NCT03813615|Aerobic Training|aerobic training
5029882|NCT03812276|Dental Implants|dental implants
5029883|NCT03812263|Leukocyte Adhesion Deficiency- Type I|leukocyte adhesion deficiency- type i
5029884|NCT03812263|LAD-I|lad-i
5029885|NCT03812237|Lapidus Arthrodesis|lapidus arthrodesis
5029886|NCT03812237|Early Weight Bearing|early weight bearing
5029887|NCT03812237|First Tarsometatarsal Arthrodesis|first tarsometatarsal arthrodesis
5029888|NCT03812198|healthy|healthy
5029979|NCT03811652|prostate cancer|prostate cancer
5030075|NCT03810963|High intensity interval training|high intensity interval training
5030076|NCT03810963|functional electrical stimulation cycling|functional electrical stimulation cycling
5030079|NCT03810963|body composition|body composition
5030273|NCT03809988|estrogen receptor|estrogen receptor
5030274|NCT03809975|Knee|knee
5030275|NCT03809975|Osteoarthritis|osteoarthritis
5030276|NCT03809975|Model of care|model of care
5030277|NCT03809975|Multi-disciplinary|multi-disciplinary
5030278|NCT03809936|tDCS|tdcs
5030279|NCT03809936|EEG|eeg
5030280|NCT03809923|Lidocaine|lidocaine
5030281|NCT03809923|Dexmedetomidine|dexmedetomidine
5030282|NCT03809923|Postoperative nausea and vomiting|postoperative nausea and vomiting
5030283|NCT03809923|laparoscopic hysterectomy|laparoscopic hysterectomy
5030284|NCT03809910|Oral Health, Dental care, Lifestyle|oral health, dental care, lifestyle
5030285|NCT03809884|High blood pressure|high blood pressure
5030286|NCT03809884|Potassium|potassium
5030287|NCT03809884|Potassium Citrate|potassium citrate
5030288|NCT03809884|Dietary Counselling|dietary counselling
5656821|NCT00675207|glaucoma|glaucoma
5030372|NCT03809416|fractional lasers|fractional lasers
5030374|NCT03809403|Colorectal cancer|colorectal cancer
5030375|NCT03809403|Surgical Technic|surgical technic
5030379|NCT03809390|Body mass index|body mass index
5030472|NCT03808831|Fall detection|fall detection
5030473|NCT03808831|Fall prevention|fall prevention
5030474|NCT03808831|Accelerometer|accelerometer
5030475|NCT03808831|Elderly|elderly
5030476|NCT03808792|Ovarian cancer|ovarian cancer
5030477|NCT03808792|Ultrasound|ultrasound
5030478|NCT03808792|CT|ct
5030479|NCT03808792|WB-DW/MRI|wb-dw/mri
5030480|NCT03808792|Imaging|imaging
5030572|NCT03808129|erector spinae plane block|erector spinae plane block
5030574|NCT03808129|RSO2|rso2
5030666|NCT03807518|Oesophageal Cancer|oesophageal cancer
5030667|NCT03807518|Gastric Cancer|gastric cancer
5030668|NCT03807518|Physical Fitness|physical fitness
5030669|NCT03807479|CP-CML|cp-cml
5030670|NCT03807479|CML in chronic phase|cml in chronic phase
5030675|NCT03807453|Scalp|scalp
5030766|NCT03806920|postprandial inflammation|postprandial inflammation
5030767|NCT03806907|INSITIGATE|insitigate
5030772|NCT03806868|COPD|copd
5031060|NCT03805087|Embolization, Therapeutic|embolization, therapeutic
5031061|NCT03805061|Multiple sclerosis|multiple sclerosis
5031062|NCT03805061|aerobic|aerobic
5031063|NCT03805061|isokinetic|isokinetic
5031064|NCT03805061|exercise|exercise
5031069|NCT03805035|Electroacupuncture (EA)|electroacupuncture (ea)
5031070|NCT03805035|Antihistamine|antihistamine
5031071|NCT03805035|Pain|pain
5031072|NCT03805022|Solid tumor|solid tumor
5031073|NCT03805022|Phase III trial|phase iii trial
5031159|NCT03804476|cerebral edema|cerebral edema
5031160|NCT03804463|Preservation of fertility surger|preservation of fertility surger
5031161|NCT03804463|ovarian preservation|ovarian preservation
5031259|NCT03803865|Inflammation|inflammation
5031260|NCT03803865|Neuroimaging|neuroimaging
5031262|NCT03803839|DXA|dxa
5031263|NCT03803839|Bisphosphonates|bisphosphonates
5031264|NCT03803839|Migration of stem|migration of stem
5031265|NCT03803839|Aseptic loosening of prosthesis|aseptic loosening of prosthesis
5031266|NCT03803826|cardiac resynchronization therapy|cardiac resynchronization therapy
5031267|NCT03803826|non-responders|non-responders
5031273|NCT03803800|Rehabilitation|rehabilitation
5031274|NCT03803800|Periodized exercise therapy|periodized exercise therapy
5031275|NCT03803800|Ergogenic supplementation|ergogenic supplementation
5031276|NCT03803787|Non-Small Cell Lung Cancer|non-small cell lung cancer
5031277|NCT03803787|Radiation Pneumonia|radiation pneumonia
5031361|NCT03803293|Pharmacogenomics|pharmacogenomics
5031362|NCT03803293|Personalized Medicine|personalized medicine
5031363|NCT03803293|Pharmacogenomic Varients|pharmacogenomic varients
5031364|NCT03803254|Hepatocellular Carcinoma|hepatocellular carcinoma
5031366|NCT03803254|PD-1 Antibody|pd-1 antibody
5031369|NCT03803215|theophylline|theophylline
5031557|NCT03801863|Erector Spinae Plane Block|erector spinae plane block
5031558|NCT03801863|Ropivacaine|ropivacaine
5031559|NCT03801863|Ultrasound guided nerve block|ultrasound guided nerve block
5031560|NCT03801850|volume variation|volume variation
5031561|NCT03801850|deformation|deformation
5031663|NCT03801330|electronic health|electronic health
5031664|NCT03801304|immunotherapy|immunotherapy
5031665|NCT03801304|second line of chemotherapy|second line of chemotherapy
5031666|NCT03801278|Single patient|single patient
5031667|NCT03801265|lumbar plexus block|lumbar plexus block
5031668|NCT03801265|quadratus lumborum block|quadratus lumborum block
5031669|NCT03801265|total hip arthroplasty|total hip arthroplasty
5031670|NCT03801226|Peritoneal dialysis|peritoneal dialysis
5031766|NCT03800667|Vitamin C, CAUTI|vitamin c, cauti
5031767|NCT03800654|Chronic Pain|chronic pain
5031768|NCT03800654|Psychological Flexibility|psychological flexibility
5031771|NCT03800628|survivor|survivor
5031971|NCT03799315|Incarceration|incarceration
5032068|NCT03798730|Mucoadhesion|mucoadhesion
5032069|NCT03798730|Mouthdrying|mouthdrying
5032070|NCT03798704|Lyme disease|lyme disease
5032074|NCT03798704|Slovenia|slovenia
5032170|NCT03798132|Ovarian Neoplasms, Laparoscopy, Cytoreduction Surgical Procedures.|ovarian neoplasms, laparoscopy, cytoreduction surgical procedures.
5032171|NCT03798119|Hepatitis B|hepatitis b
5032268|NCT03797404|Bronchial biopsies|bronchial biopsies
5032269|NCT03797404|Mepolizumab|mepolizumab
5032271|NCT03797391|Human Bispecific antibody,|human bispecific antibody,
5032272|NCT03797391|Epidermal Growth Factor Receptor (EGFR),|epidermal growth factor receptor (egfr),
5032273|NCT03797391|c-Mesenchymal-Epithelial Transition (cMet),|c-mesenchymal-epithelial transition (cmet),
5032274|NCT03797391|Neoplasms, Neoplasm Metastasis,|neoplasms, neoplasm metastasis,
5032275|NCT03797391|Non-Small-Cell Lung Cancer (NSCLC), First-in-human,|non-small-cell lung cancer (nsclc), first-in-human,
5032277|NCT03797352|Bone Health|bone health
5032311|NCT03797209|PPC|ppc
5032463|NCT03796065|parental self-efficacy|parental self-efficacy
5032464|NCT03796065|family communication|family communication
5032465|NCT03796065|family connectedness|family connectedness
5032466|NCT03796065|refugee youth|refugee youth
5032467|NCT03796065|youth functioning|youth functioning
5032468|NCT03796065|integration|integration
5032566|NCT03795545|High density stones|high density stones
5032567|NCT03795545|Ultraslow SWL|ultraslow swl
5032568|NCT03795545|Slow SWL|slow swl
5032569|NCT03795545|Ramping|ramping
5032570|NCT03795545|Pause|pause
5032571|NCT03795532|renal stones|renal stones
5032572|NCT03795532|SWL|swl
5032573|NCT03795532|High density stones|high density stones
5032574|NCT03795532|Ultraslow SWL|ultraslow swl
5032575|NCT03795532|Slow SWL|slow swl
5032576|NCT03795532|Ramping|ramping
5032577|NCT03795532|Pause|pause
5032579|NCT03795493|Exercise|exercise
5032672|NCT03794973|Type 1 Diabetes|type 1 diabetes
5032772|NCT03794531|Cardiovascular disease|cardiovascular disease
5032773|NCT03794531|Cardiometabolic health|cardiometabolic health
5032774|NCT03794531|Chronic disease risk factors|chronic disease risk factors
5032775|NCT03794531|Disaster research|disaster research
5032777|NCT03794531|Population health|population health
5032966|NCT03792854|chemoradiation|chemoradiation
5033062|NCT03792308|Tolerability|tolerability
5033063|NCT03792308|Pharmacokinetics|pharmacokinetics
5033064|NCT03792308|SPR206|spr206
5033256|NCT03791073|microenvironment|microenvironment
5033257|NCT03791073|proteomics|proteomics
5033362|NCT03790579|Dietary acid load|dietary acid load
5033363|NCT03790579|Pregnancy|pregnancy
5033364|NCT03790566|ESP block|esp block
5033365|NCT03790566|TAP block|tap block
5033366|NCT03790566|pyeloplasty|pyeloplasty
5033367|NCT03790566|erector spina plane block|erector spina plane block
5033458|NCT03790085|Molecular genetics|molecular genetics
5033459|NCT03790085|Neurobiochemical|neurobiochemical
5033460|NCT03790085|Early diagnosis|early diagnosis
5033461|NCT03790085|Early prediction|early prediction
5033462|NCT03790072|Gamma Delta T Lymphocytes|gamma delta t lymphocytes
5033463|NCT03790059|radiofrequency ablation|radiofrequency ablation
5033557|NCT03789357|Adrenal vein sampling|adrenal vein sampling
5033558|NCT03789357|Mineralocorticoid-receptor Antagonists|mineralocorticoid-receptor antagonists
5033559|NCT03789344|acupuncture, PCI|acupuncture, pci
5033560|NCT03789331|transgender males|transgender males
5033748|NCT03788083|immune therapy|immune therapy
5033749|NCT03788083|dendritic cells|dendritic cells
5033750|NCT03788083|immune priming|immune priming
5033751|NCT03788044|Education|education
5033945|NCT03786874|task interruptions|task interruptions
5033947|NCT03786861|aberration free|aberration free
5033948|NCT03786861|corneal wavefront guided|corneal wavefront guided
5033949|NCT03786861|higher order aberrations|higher order aberrations
5033951|NCT03786848|Prostate Cancer|prostate cancer
5034041|NCT03786315|Multimorbidity|multimorbidity
5034042|NCT03786315|Shared decision-making|shared decision-making
5034043|NCT03786315|Patient involvement|patient involvement
5034048|NCT03786289|Recombinant human erythropoietin|recombinant human erythropoietin
5034049|NCT03786276|Alcohol Use Disorder|alcohol use disorder
5034050|NCT03786276|Traumatic Brain Injury|traumatic brain injury
5034051|NCT03786276|Working Memory Training|working memory training
5034052|NCT03786276|Virtual Reality|virtual reality
5034053|NCT03786276|Physical Exercise|physical exercise
5034344|NCT03784690|Intraoperative blood pressure|intraoperative blood pressure
5034345|NCT03784690|Cardiopulmonary bypass|cardiopulmonary bypass
5034346|NCT03784690|Myocardial infarction|myocardial infarction
5034347|NCT03784690|Acute kidney injury|acute kidney injury
5034443|NCT03784014|Next generation sequencing exome|next generation sequencing exome
5034444|NCT03784001|Gratitude, Expectations|gratitude, expectations
5034445|NCT03783975|Cascade|cascade
5034446|NCT03783975|Screening|screening
5034447|NCT03783975|Ethical|ethical
5034448|NCT03783975|Legal|legal
5034450|NCT03783962|behavioral weight loss intervention, obesity|behavioral weight loss intervention, obesity
5034451|NCT03783949|Ganetespib|ganetespib
5034452|NCT03783949|Niraparib|niraparib
5034546|NCT03783286|CF transmembrane conductance regulator|cf transmembrane conductance regulator
5034547|NCT03783286|CFTR|cftr
5034548|NCT03783286|Gating Mutations|gating mutations
5034556|NCT03783234|Emergency triage|emergency triage
5034557|NCT03783221|meal ingestion|meal ingestion
5034646|NCT03782714|Low-level laser therapy, pulpotomy, formocresol|low-level laser therapy, pulpotomy, formocresol
5034647|NCT03782675|Total shoulder replacement|total shoulder replacement
5034747|NCT03782012|Knowledge Availability and Accessibility|knowledge availability and accessibility
5034748|NCT03782012|Inference Making|inference making
5034750|NCT03781999|Polyphenols|polyphenols
5034751|NCT03781999|Nutrition|nutrition
5034752|NCT03781999|Sports|sports
5034943|NCT03780868|External DCR, canalicular silicone intubation, Mitomycin C|external dcr, canalicular silicone intubation, mitomycin c
5034945|NCT03780855|Peripheral nerve injures|peripheral nerve injures
5035041|NCT03780322|physical therapy|physical therapy
5035042|NCT03780309|antihypertensive lifestyle therapy|antihypertensive lifestyle therapy
5035043|NCT03780309|positive outcome expectations|positive outcome expectations
5035044|NCT03780309|postexercise hypotension|postexercise hypotension
5035045|NCT03780309|self-efficacy|self-efficacy
5035046|NCT03780309|self-management|self-management
5035047|NCT03780296|Kinect|kinect
5035048|NCT03780296|Rehabilitation|rehabilitation
5035049|NCT03780296|Virtual reality|virtual reality
5035050|NCT03780296|Mirror therapy|mirror therapy
5035051|NCT03780283|SCLC|sclc
5035052|NCT03780283|maintenance|maintenance
5035053|NCT03780283|Anlotinib|anlotinib
5035054|NCT03780257|Retinitis Pigmentosa|retinitis pigmentosa
5035140|NCT03779646|Duchenne muscular dystrophy|duchenne muscular dystrophy
5035141|NCT03779646|Early cardiomyopathy|early cardiomyopathy
5035142|NCT03779646|bisoprolol|bisoprolol
5035143|NCT03779633|Local Oestrogen|local oestrogen
5035144|NCT03779620|symptomatic|symptomatic
5035241|NCT03779048|Appetitive Behavior|appetitive behavior
5035242|NCT03779048|Appetite Depressants|appetite depressants
5035243|NCT03779048|Anti-Obesity Agents|anti-obesity agents
5035244|NCT03779048|Weight Loss|weight loss
5035340|NCT03778593|biliary tract carcinoma|biliary tract carcinoma
5035342|NCT03778593|Irinotecan|irinotecan
5035343|NCT03778593|oxaliplatin|oxaliplatin
5035344|NCT03778580|Vitamin B6|vitamin b6
5035345|NCT03778580|Diabetes|diabetes
5035346|NCT03778567|chronic hepatitis B infection|chronic hepatitis b infection
5035347|NCT03778567|telbivudine|telbivudine
5035348|NCT03778567|chronic kidney disease|chronic kidney disease
5035349|NCT03778567|nucleotide analogue|nucleotide analogue
5035350|NCT03778515|Axial|axial
5035351|NCT03778515|Spondyloarthritis|spondyloarthritis
5035353|NCT03778515|Ankylosing Spondylitis|ankylosing spondylitis
5035354|NCT03778489|Pannexin-1 channel|pannexin-1 channel
5035355|NCT03778476|Exercise|exercise
5035356|NCT03778476|pain sensitivity|pain sensitivity
5035439|NCT03777800|Nervous System Diseases|nervous system diseases
5035440|NCT03777800|Body Therapy|body therapy
5035441|NCT03777800|Mind-Body Therapies|mind-body therapies
5035442|NCT03777800|Coping Skills|coping skills
5035443|NCT03777800|Breathing techniques|breathing techniques
5035444|NCT03777800|Body awareness|body awareness
5035445|NCT03777800|Emotional regulation|emotional regulation
5035446|NCT03777800|Randomized Controlled Trial|randomized controlled trial
5035447|NCT03777800|Qualitative study|qualitative study
5035448|NCT03777800|Mixed-methods|mixed-methods
5035449|NCT03777787|Bitter|bitter
5035541|NCT03776929|Trauma|trauma
5035734|NCT03775577|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5035735|NCT03775577|HFpEF|hfpef
5035736|NCT03775551|quality improvement|quality improvement
5035737|NCT03775551|collaborative|collaborative
5035739|NCT03775538|Parkinson|parkinson
5035740|NCT03775538|CDNF|cdnf
5035741|NCT03775538|Drug Delivery System|drug delivery system
5035742|NCT03775538|Intracerebral|intracerebral
5035743|NCT03775486|NSCLC|nsclc
5035744|NCT03775486|Durvalumab|durvalumab
5035745|NCT03775486|Olaparib|olaparib
5035746|NCT03775486|Maintenance|maintenance
5035747|NCT03775486|Homologous Recombination Repair (HRR)|homologous recombination repair (hrr)
5035834|NCT03774979|Metastatic or locally advanced solid tumors|metastatic or locally advanced solid tumors
5035837|NCT03774953|pneumonia|pneumonia
5035838|NCT03774953|community acquired pneumonia|community acquired pneumonia
5035839|NCT03774953|protein|protein
5035840|NCT03774953|lean body mass|lean body mass
5035936|NCT03774433|ecological momentary assessment|ecological momentary assessment
5035937|NCT03774433|mobile sensing|mobile sensing
5035938|NCT03774433|mHealth|mhealth
5035939|NCT03774420|Infusion pumps|infusion pumps
5035940|NCT03774420|Intraoperative brain monitoring|intraoperative brain monitoring
5035944|NCT03774394|pharmacodynamics (PD)|pharmacodynamics (pd)
5035945|NCT03774394|pharmacokinetic (PK)|pharmacokinetic (pk)
5035946|NCT03774394|clopidogrel|clopidogrel
5035947|NCT03774342|Coronary artery bypass grafting|coronary artery bypass grafting
5035948|NCT03774342|Quality of life|quality of life
5035949|NCT03774342|Cognitive dysfunction|cognitive dysfunction
5035950|NCT03774342|Sarcopenia|sarcopenia
5035951|NCT03774329|inflammatory bowel disease|inflammatory bowel disease
5035952|NCT03774329|physical activity|physical activity
5035953|NCT03774329|bone mineral density|bone mineral density
5035954|NCT03774329|pediatric|pediatric
5035955|NCT03774316|De-escalation|de-escalation
5035956|NCT03774316|Antifungal treatment|antifungal treatment
5035957|NCT03774316|Mortality|mortality
5035958|NCT03774316|Immunocompromised|immunocompromised
5035962|NCT03774277|DASH-Diet|dash-diet
5036127|NCT03773432|postprandial responses|postprandial responses
5036128|NCT03773432|hedonic sensations|hedonic sensations
5036129|NCT03773432|homeostatic sensations|homeostatic sensations
5036130|NCT03773419|Stroke-related aphasia|stroke-related aphasia
5036131|NCT03773419|Rehabilitation|rehabilitation
5036132|NCT03773419|Writing|writing
5036133|NCT03773419|Texting|texting
5036134|NCT03773406|Aphasia, tDCS, Script training, Functional language, Naming|aphasia, tdcs, script training, functional language, naming
5036135|NCT03773367|Gastric adenocarcinoma|gastric adenocarcinoma
5036224|NCT03772600|Dexcom G6|dexcom g6
5036225|NCT03772600|FreeStyle Libre|freestyle libre
5036226|NCT03772600|time in range|time in range
5036227|NCT03772600|continuous glucose monitoring|continuous glucose monitoring
5036228|NCT03772600|flash glucose monitoring|flash glucose monitoring
5036231|NCT03772561|AZD5363|azd5363
5036232|NCT03772561|Olaparib|olaparib
5036326|NCT03772015|magnetic resonance imaging|magnetic resonance imaging
5036327|NCT03771976|Older women (>35 years of age)|older women (>35 years of age)
5036431|NCT03771339|continuous epidural|continuous epidural
5036432|NCT03771339|postoperative analgesia|postoperative analgesia
5036433|NCT03771339|kidney transplant|kidney transplant
5036434|NCT03771300|Wellness|wellness
5036532|NCT03770754|Primary Root canal|primary root canal
5036635|NCT03769974|motor learning|motor learning
5036636|NCT03769961|essential tremor|essential tremor
5036637|NCT03769961|dbs|dbs
5036638|NCT03769909|PTOA|ptoa
5036639|NCT03769909|Osteoarthritis|osteoarthritis
5036640|NCT03769909|Intra-Articular Fractures|intra-articular fractures
5036641|NCT03769909|Ankle Fractures|ankle fractures
5036642|NCT03769909|Cytokines|cytokines
5036643|NCT03769909|Biomarkers|biomarkers
5036663|NCT03769857|CTX-II|ctx-ii
5037032|NCT03767764|Hepatocellular carcinoma|hepatocellular carcinoma
5037033|NCT03767764|Tumor associated antigen|tumor associated antigen
5037034|NCT03767764|Early diagnosis|early diagnosis
5037035|NCT03767764|Autoantibodies|autoantibodies
5037227|NCT03766568|upper respiratory tract infection|upper respiratory tract infection
5037228|NCT03766568|antibiotic|antibiotic
5037229|NCT03766568|endoscopy|endoscopy
5037230|NCT03766568|Otolaryngology|otolaryngology
5037231|NCT03766568|primary care|primary care
5037232|NCT03766555|Hepatocellular carcinoma|hepatocellular carcinoma
5037233|NCT03766555|Hepatectomy|hepatectomy
5037234|NCT03766555|Microwave Ablation|microwave ablation
5037235|NCT03766555|Local Ablation|local ablation
5037236|NCT03766503|Medication adherence|medication adherence
5037237|NCT03766503|Severe and persistent mental illness|severe and persistent mental illness
5037238|NCT03766477|Sleep bruxism|sleep bruxism
5037239|NCT03766477|Sleep|sleep
5037428|NCT03765177|Chimeric Antigen Receptor T cells|chimeric antigen receptor t cells
5037429|NCT03765177|CLIC-1901|clic-1901
5037430|NCT03765177|anti-CD19 CAR-T cells|anti-cd19 car-t cells
5037431|NCT03765151|low-level laser therapy|low-level laser therapy
5037432|NCT03765151|orthodontic retention|orthodontic retention
5037433|NCT03765151|periodontal disease|periodontal disease
5037459|NCT03764956|MAD|mad
5037530|NCT03764280|pediatrics|pediatrics
5037531|NCT03764280|optimization algorithm|optimization algorithm
5037532|NCT03764241|STEMI|stemi
5037622|NCT03763539|Slow SWL|slow swl
5037623|NCT03763539|Ramping|ramping
5037625|NCT03763526|Perioperative Nutritional Status|perioperative nutritional status
5037626|NCT03763526|Surgical Outcome in Digestive System Cancer|surgical outcome in digestive system cancer
5037720|NCT03762902|Henry Ford Health System|henry ford health system
5037722|NCT03762902|Lifegraph|lifegraph
5037823|NCT03762382|Pregnancy Prevention|pregnancy prevention
5037824|NCT03762369|Primary Open-angle Glaucoma|primary open-angle glaucoma
5037825|NCT03762369|Ocular Hypertension|ocular hypertension
5037827|NCT03762356|Insight|insight
5037828|NCT03762356|Awareness|awareness
5037829|NCT03762356|Violence|violence
5037830|NCT03762356|Professional views|professional views
5037831|NCT03762356|Risk to others|risk to others
5037832|NCT03762343|greater occipital nerve block|greater occipital nerve block
5037833|NCT03762343|posterior fossa|posterior fossa
5037834|NCT03762343|ultrasound|ultrasound
5037835|NCT03762343|pain|pain
5037836|NCT03762343|craniotomy|craniotomy
5037837|NCT03762330|quality of life|quality of life
5037838|NCT03762330|self-management,|self-management,
5037930|NCT03761901|locally advanced|locally advanced
5037931|NCT03761901|metastatic|metastatic
5037932|NCT03761901|lung cancer|lung cancer
5037933|NCT03761875|Hepatitis B Virus - Natural Killer|hepatitis b virus - natural killer
5037935|NCT03761823|Flexible endoscopic evaluation of swallowing|flexible endoscopic evaluation of swallowing
5037936|NCT03761823|High resolution impedance manometry|high resolution impedance manometry
5037940|NCT03761745|Rotation|rotation
5038221|NCT03760393|Work Performance|work performance
5038222|NCT03760393|Health Outcomes|health outcomes
5038223|NCT03760380|osteoarthritis (OA)|osteoarthritis (oa)
5038224|NCT03760380|gait modifying shoe|gait modifying shoe
5038225|NCT03760367|blue covarine|blue covarine
5038226|NCT03760367|numeric analogue scale|numeric analogue scale
5038227|NCT03760367|spectrophotometry|spectrophotometry
5038320|NCT03759626|para-social connection|para-social connection
5038321|NCT03759613|Burn Injury|burn injury
5038322|NCT03759613|Gait Symmetry|gait symmetry
5038323|NCT03759613|Arm Swing|arm swing
5038324|NCT03759574|Orthostatic Intolerance|orthostatic intolerance
5038416|NCT03758833|preimplantation genetic diagnosis|preimplantation genetic diagnosis
5038417|NCT03758833|clinical pregnancy|clinical pregnancy
5038418|NCT03758807|Low back pain|low back pain
5038419|NCT03758807|Manual Therapy|manual therapy
5038516|NCT03758131|Motivational Interviewing|motivational interviewing
5038517|NCT03758118|Citicoline|citicoline
5038518|NCT03758118|Non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
5038519|NCT03758118|Neuroprotection|neuroprotection
5038520|NCT03758118|Neuroenhancement|neuroenhancement
5038521|NCT03758105|Depression|depression
5038522|NCT03758105|psychiatry|psychiatry
5038523|NCT03758105|health economics|health economics
5038618|NCT03757273|Mandibular tumors resection/reconstruction|mandibular tumors resection/reconstruction
5038621|NCT03757273|Aesthetic|aesthetic
5038714|NCT03756662|Suprachoroidal pressure sensor|suprachoroidal pressure sensor
5038715|NCT03756662|ARGOS-SC|argos-sc
5038719|NCT03756610|tACS|tacs
5038720|NCT03756610|schizophrenia|schizophrenia
5038721|NCT03756610|cognition|cognition
5003068|NCT03976960|tumor|tumor
5038722|NCT03756610|fMRI|fmri
5038817|NCT03755869|Anlotinib|anlotinib
5038818|NCT03755843|passive leg risging|passive leg risging
5038819|NCT03755843|Fluid challenge|fluid challenge
5038820|NCT03755843|Preeclampsia|preeclampsia
5038821|NCT03755817|Spinal pain|spinal pain
5038822|NCT03755804|Hodgkin Lymphoma|hodgkin lymphoma
5038823|NCT03755804|Pediatric Cancer|pediatric cancer
5038824|NCT03755804|Frontline Therapy|frontline therapy
5038825|NCT03755804|Response Adapted Therapy|response adapted therapy
5038826|NCT03755804|Risk Adapted Therapy|risk adapted therapy
5038831|NCT03755778|drug-drug interaction|drug-drug interaction
5038837|NCT03755713|ASP0892|asp0892
5038838|NCT03755713|Peanut Allergy|peanut allergy
5038839|NCT03755687|Art Therapy|art therapy
5038912|NCT03755349|Complications|complications
5038913|NCT03755349|Patient satisfaction|patient satisfaction
5038914|NCT03755349|Burr hole plate|burr hole plate
5038915|NCT03755349|Scar|scar
5038916|NCT03755349|Skin depression|skin depression
5038917|NCT03755323|Obesity|obesity
5038918|NCT03755323|Nutrition Disorders|nutrition disorders
5039303|NCT03752788|Gait velocity|gait velocity
5039304|NCT03752788|Stride length|stride length
5039404|NCT03752320|Thoracic surgery|thoracic surgery
5039405|NCT03752320|Multiplex PCR|multiplex pcr
5039406|NCT03752320|Bacterial and pulmonary colonization|bacterial and pulmonary colonization
5039407|NCT03752320|Diagnosis|diagnosis
5039408|NCT03752320|Mortality|mortality
5039409|NCT03752294|MCI|mci
5039410|NCT03752294|Mild AD|mild ad
5039411|NCT03752294|Dabigatran|dabigatran
5039412|NCT03752281|Health, activity, function and long-term social assistance|health, activity, function and long-term social assistance
5039413|NCT03752268|Other Cancer|other cancer
5039502|NCT03751605|unipulmonary ventilation, complications, respiratory quotient.|unipulmonary ventilation, complications, respiratory quotient.
5039503|NCT03751579|coelioscopic|coelioscopic
5039504|NCT03751579|surgery complications|surgery complications
5039505|NCT03751579|respiratory quotient|respiratory quotient
5039507|NCT03751488|Schizophrenia|schizophrenia
5039508|NCT03751475|Acute Malnutrition|acute malnutrition
5039509|NCT03751475|Severe Acute Malnutrition|severe acute malnutrition
5039510|NCT03751475|Moderate Acute Malnutrition|moderate acute malnutrition
5039602|NCT03751137|Metabolome|metabolome
5039607|NCT03751111|arsenic exposure|arsenic exposure
5039608|NCT03751111|naloxone|naloxone
5039703|NCT03750552|169|169
5039704|NCT03750552|0169|0169
5039705|NCT03750552|TD9855|td9855
5039708|NCT03750526|stroke|stroke
5039807|NCT03749863|presbylarynx|presbylarynx
5039808|NCT03749863|vocal fold atrophy|vocal fold atrophy
5039809|NCT03749863|dysphonia|dysphonia
5039811|NCT03749863|PRP|prp
5039900|NCT03749408|long-acting local anesthesia|long-acting local anesthesia
5039901|NCT03749408|bupivacaine|bupivacaine
5039902|NCT03749408|mannitol|mannitol
5039998|NCT03748784|AAV.7m8|aav.7m8
5039999|NCT03748784|Anti-VEGF therapy|anti-vegf therapy
5040000|NCT03748784|Blindness|blindness
5040001|NCT03748784|Gene therapy|gene therapy
5040002|NCT03748784|Aflibercept (Eylea)|aflibercept (eylea)
5040003|NCT03748784|Age-Related Macular Degeneration|age-related macular degeneration
5040004|NCT03748784|Wet Macular Degeneration|wet macular degeneration
5040005|NCT03748784|Retinal Degeneration|retinal degeneration
5040006|NCT03748784|Retinal Diseases|retinal diseases
5040007|NCT03748784|Eye Diseases|eye diseases
5040008|NCT03748784|AAV Vector|aav vector
5040009|NCT03748784|Adverum|adverum
5040010|NCT03748784|wAMD|wamd
5040011|NCT03748784|AMD|amd
5040012|NCT03748784|wet AMD|wet amd
5040013|NCT03748745|HCV|hcv
5040014|NCT03748745|SH229|sh229
5040095|NCT03748238|Recurrent implantation failure|recurrent implantation failure
5040096|NCT03748238|Endometrial injury|endometrial injury
5040097|NCT03748238|Implantation|implantation
5040098|NCT03748238|Hysteroscopy|hysteroscopy
5040099|NCT03748212|Hypertension|hypertension
5040100|NCT03748212|Chronic stable angina|chronic stable angina
5040101|NCT03748212|Congestive Heart Failure|congestive heart failure
5040103|NCT03748199|cystic fibrosis|cystic fibrosis
5040104|NCT03748199|POL6014|pol6014
5040105|NCT03748199|neutrophil elastase inhibitor|neutrophil elastase inhibitor
5040106|NCT03748199|anti-inflammatory|anti-inflammatory
5040115|NCT03748108|lidocaine|lidocaine
5040116|NCT03748108|Postoperative Pain|postoperative pain
5040117|NCT03748108|hysterectomy|hysterectomy
5040195|NCT03747497|ABSSI|abssi
5040196|NCT03747497|Acute bacterial skin and skin structure infection|acute bacterial skin and skin structure infection
5040197|NCT03747484|Clinical Stage III Merkel Cell Carcinoma AJCC v8|clinical stage iii merkel cell carcinoma ajcc v8
5040203|NCT03747484|Merkel cell carcinoma, metastatic|merkel cell carcinoma, metastatic
5040284|NCT03747120|Neoadjuvant her2 targeted therapy|neoadjuvant her2 targeted therapy
5040286|NCT03747120|Pertuzumab|pertuzumab
5040287|NCT03747120|Paclitaxel|paclitaxel
5040288|NCT03747107|primary care|primary care
5040289|NCT03747107|prescribing safety|prescribing safety
5040290|NCT03747107|adverse drug event|adverse drug event
5040291|NCT03747107|drug therapy risk|drug therapy risk
5040292|NCT03747107|pharmacist|pharmacist
5040293|NCT03747107|general practice|general practice
5040391|NCT03746444|total knee arthroplasty|total knee arthroplasty
5040392|NCT03746444|general anesthesia|general anesthesia
5040393|NCT03746444|neuraxial anesthesia|neuraxial anesthesia
5040394|NCT03746444|complications|complications
5040395|NCT03746418|erector spinae|erector spinae
5040396|NCT03746418|dexmedetomidine|dexmedetomidine
5040397|NCT03746418|ultrasound|ultrasound
5040398|NCT03746418|lumbar interbody fusion|lumbar interbody fusion
5040399|NCT03746418|spondylolisthesis|spondylolisthesis
5040400|NCT03746379|kinezyhophobia|kinezyhophobia
5040432|NCT03746197|SLE|sle
5040489|NCT03745963|Assessment|assessment
5040588|NCT03745209|Peripheral IV|peripheral iv
5040589|NCT03745209|Difficult|difficult
5040590|NCT03745209|Ultrasound-guided|ultrasound-guided
5040591|NCT03745183|tinea imbricata|tinea imbricata
5040689|NCT03744507|Uterine leiomyoma|uterine leiomyoma
5040690|NCT03744507|Uterine fibroids|uterine fibroids
5040691|NCT03744507|Heavy menstrual bleeding|heavy menstrual bleeding
5040692|NCT03744507|Menorrhagia|menorrhagia
5040893|NCT03743441|Placebo-controlled|placebo-controlled
5040904|NCT03743363|balance|balance
5040994|NCT03742700|health effects|health effects
5040995|NCT03742700|cigarette smoking|cigarette smoking
5040996|NCT03742700|exhaled nitric oxide|exhaled nitric oxide
5040997|NCT03742700|pulmonary function tests|pulmonary function tests
5040998|NCT03742687|Locally advanced NSCLC|locally advanced nsclc
5040999|NCT03742687|Radiotherapy|radiotherapy
5041000|NCT03742687|Hypofractionation|hypofractionation
5041001|NCT03742648|pO2|po2
5041002|NCT03742648|pCO2|pco2
5041003|NCT03742648|pH|ph
5041192|NCT03741296|two-stage revision|two-stage revision
5041193|NCT03741283|Medicines optimisation|medicines optimisation
5041194|NCT03741283|Multimodal interventions|multimodal interventions
5041195|NCT03741283|Inflammation|inflammation
5041196|NCT03741283|Emergency Service, Hospital|emergency service, hospital
5041197|NCT03741283|Pharmacogenetics|pharmacogenetics
5670169|NCT00620711|HIE|hie
5041198|NCT03741283|Renal function|renal function
5041199|NCT03741283|Food intake|food intake
5041200|NCT03741283|Quality of life|quality of life
5041201|NCT03741283|Polypharmacy|polypharmacy
5041202|NCT03741244|glioma|glioma
5041203|NCT03741244|Apatinib|apatinib
5041204|NCT03741244|VEGFR-2|vegfr-2
5041205|NCT03741244|temozolomide|temozolomide
5041206|NCT03741231|melanoma|melanoma
5041207|NCT03741231|NSCLC|nsclc
5041208|NCT03741231|FDG|fdg
5041209|NCT03741231|PET|pet
5041210|NCT03741231|immunotherapy|immunotherapy
5041234|NCT03741062|Palate|palate
5041293|NCT03740763|Electric Stimulation Therapy|electric stimulation therapy
5041294|NCT03740763|Physiotherapy|physiotherapy
5041296|NCT03740750|hot temperature|hot temperature
5041297|NCT03740750|cutaneous electrostimulation|cutaneous electrostimulation
5041298|NCT03740724|Morphea|morphea
5041315|NCT03740529|BTK|btk
5041392|NCT03740282|early weight-bearing|early weight-bearing
5041393|NCT03740282|lapidus|lapidus
5041404|NCT03740269|KAP|kap
5041492|NCT03739905|Alzheimer's Disease|alzheimer's disease
5041581|NCT03739424|Egg|egg
5041591|NCT03739359|Nasal cannula|nasal cannula
5041592|NCT03739359|Aerosol therapy|aerosol therapy
5041687|NCT03738683|Renal function|renal function
5041688|NCT03738683|Intensive Care Unit|intensive care unit
5041689|NCT03738683|Cystatin C|cystatin c
5041691|NCT03738670|Extra-spinal|extra-spinal
5041692|NCT03738670|RFA|rfa
5041693|NCT03738670|Radiofrequency ablation|radiofrequency ablation
5041700|NCT03738592|child|child
5041895|NCT03737526|loop electrosurgical excision procedure|loop electrosurgical excision procedure
5041896|NCT03737513|Rhabdomyolysis|rhabdomyolysis
5041897|NCT03737513|Military Training|military training
5041898|NCT03737487|geriatric assessment|geriatric assessment
5041899|NCT03737487|fear of falling|fear of falling
5041900|NCT03737487|injuries|injuries
5041901|NCT03737461|BM-MSCs|bm-mscs
5041902|NCT03737461|Low back pain|low back pain
5041903|NCT03737461|Lumbar degenerative disc disease (DDD)|lumbar degenerative disc disease (ddd)
5041906|NCT03737370|Prostate Cancer|prostate cancer
5041907|NCT03737357|dental implants|dental implants
5041909|NCT03737357|biomarkers|biomarkers
5041997|NCT03736746|Other Cancer|other cancer
5041998|NCT03736733|sedentary time|sedentary time
5041999|NCT03736694|Insomnia|insomnia
5042000|NCT03736694|Cognitive behavioural therapy for insomnia|cognitive behavioural therapy for insomnia
5042001|NCT03736694|Sleep hygiene education|sleep hygiene education
5042098|NCT03736135|Mechanical ventilated patients|mechanical ventilated patients
5042099|NCT03736109|Copper-Albumin Complex|copper-albumin complex
5042100|NCT03736109|Osteoarthritis|osteoarthritis
5042101|NCT03736109|Syndecan 4|syndecan 4
5042102|NCT03736109|Substance P|substance p
5042193|NCT03735446|Myelodysplastic Syndromes|myelodysplastic syndromes
5042396|NCT03734107|adolescents and young adults|adolescents and young adults
5042397|NCT03734107|health communication|health communication
5042399|NCT03734107|type 1 diabetes|type 1 diabetes
5042400|NCT03734068|Hepatocellular carcinoma|hepatocellular carcinoma
5042414|NCT03734016|CLL|cll
5042493|NCT03733379|Metronidazole|metronidazole
5042494|NCT03733379|Amoxicillin|amoxicillin
5042495|NCT03733379|Scaling and root planing|scaling and root planing
5042496|NCT03733379|Periodontal treatment|periodontal treatment
5042497|NCT03733366|desk surface|desk surface
5042498|NCT03733366|thermal comfort|thermal comfort
5042499|NCT03733366|ergonomics|ergonomics
5042500|NCT03733366|attention|attention
5042501|NCT03733314|Crohn's Disease|crohn's disease
5042502|NCT03733314|E6011|e6011
5042503|NCT03733314|Inflammatory Bowel Diseases|inflammatory bowel diseases
5042504|NCT03733314|Gastroenteritis|gastroenteritis
5042505|NCT03733314|Gastrointestinal tract|gastrointestinal tract
5042506|NCT03733301|eczema|eczema
5042507|NCT03733301|atopic eczema|atopic eczema
5042697|NCT03732235|Liver Metastases|liver metastases
5042698|NCT03732235|Transarterial chemoembolization|transarterial chemoembolization
5042699|NCT03732235|Bevacizumab|bevacizumab
5042700|NCT03732235|Anti-angiogenesis|anti-angiogenesis
5042701|NCT03732235|Irinotecan|irinotecan
5042894|NCT03731104|Catecholamines|catecholamines
5042895|NCT03731078|Conversion Disorder|conversion disorder
5042896|NCT03731078|Functional Limb Weakness|functional limb weakness
5042897|NCT03731078|Functional Movement Disorder|functional movement disorder
5042898|NCT03731039|Postoperative pain|postoperative pain
5042899|NCT03731039|Anxiety|anxiety
5042900|NCT03731039|Depression|depression
5042993|NCT03730545|enteral immunonutrition|enteral immunonutrition
5042994|NCT03730545|immune function|immune function
5042995|NCT03730545|inflammation response|inflammation response
5042996|NCT03730532|Guided self help|guided self help
5042997|NCT03730532|Cognitive Analytic Therapy|cognitive analytic therapy
5043004|NCT03730467|health|health
5043090|NCT03729739|Angiography derived fractional flow reserve|angiography derived fractional flow reserve
5043091|NCT03729687|rectal cancer|rectal cancer
5043190|NCT03729167|periodontal debridement|periodontal debridement
5043191|NCT03729167|non-surgical therapy|non-surgical therapy
5043192|NCT03729167|periodontal disease|periodontal disease
5043193|NCT03729167|dental scaling|dental scaling
5043387|NCT03727984|Retrospective|retrospective
5043388|NCT03727984|Cohort study|cohort study
5043392|NCT03727919|stroke|stroke
5043484|NCT03727438|Self-Management|self-management
5043485|NCT03727438|Telehealth|telehealth
5043486|NCT03727425|Bronchoscopy|bronchoscopy
5043581|NCT03726983|gestational diabetes mellitus|gestational diabetes mellitus
5043582|NCT03726983|pregnant women|pregnant women
5043684|NCT03726385|neurodevelopmental therapy|neurodevelopmental therapy
5043685|NCT03726385|physiotherapy and rehabilitation|physiotherapy and rehabilitation
5043686|NCT03726385|visual feedback device|visual feedback device
5043687|NCT03726372|robotic surgery|robotic surgery
5043688|NCT03726372|laparoscopic surgery|laparoscopic surgery
5043783|NCT03725813|Satisfaction of care|satisfaction of care
5043784|NCT03725813|quasi-experimental|quasi-experimental
5043785|NCT03725813|internal medicine|internal medicine
5043881|NCT03725020|Fluoride varnish|fluoride varnish
5043882|NCT03725007|Upadacitinib|upadacitinib
5043883|NCT03725007|ABT-494|abt-494
5798785|NCT00111085|digital subtraction angiography (DSA)|digital subtraction angiography (dsa)
5043884|NCT03725007|Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA)|polyarticular course juvenile idiopathic arthritis (pcjia)
5043885|NCT03724994|chemotherapy|chemotherapy
5043886|NCT03724994|adjuvant|adjuvant
5043887|NCT03724994|palliative|palliative
5043978|NCT03724409|peptide receptor radiotherapy|peptide receptor radiotherapy
5043981|NCT03724383|Non-permanent atrial fibrillation|non-permanent atrial fibrillation
5043982|NCT03724383|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5043984|NCT03724383|Diet|diet
5043985|NCT03724383|Exercise|exercise
5043986|NCT03724383|Physical Activity|physical activity
5043987|NCT03724383|Sleep Apnea|sleep apnea
5043988|NCT03724383|Cardiovascular Risk|cardiovascular risk
5043989|NCT03724383|Obesity|obesity
5043990|NCT03724383|Hypertension|hypertension
5043991|NCT03724383|Diabetes|diabetes
5043992|NCT03724383|Risk Factor Management|risk factor management
5044056|NCT03724097|NGS|ngs
5044174|NCT03723330|Endothelial function|endothelial function
5044175|NCT03723330|Blood pressure|blood pressure
5044176|NCT03723330|healthy diet|healthy diet
5044177|NCT03723291|Head and Neck|head and neck
5044179|NCT03723252|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5044274|NCT03722355|Glioblastoma multiforme|glioblastoma multiforme
5044276|NCT03722303|carpal|carpal
5044277|NCT03722303|tunnel|tunnel
5044278|NCT03722303|injection|injection
5044369|NCT03721835|Femoral Neck Fracture|femoral neck fracture
5044371|NCT03721835|Broken hip|broken hip
5044372|NCT03721835|CONQUEST FN|conquest fn
5044373|NCT03721835|Hip Fracture|hip fracture
5044374|NCT03721783|cryoablation|cryoablation
5044375|NCT03721783|pediatric|pediatric
5044376|NCT03721783|registry|registry
5044377|NCT03721770|organ donation|organ donation
5044378|NCT03721770|family|family
5044380|NCT03721770|Bereavement|bereavement
5044568|NCT03720574|Overweight or Obesity Management|overweight or obesity management
5044569|NCT03720574|Behavioral Modification|behavioral modification
5044571|NCT03720496|TriCAR-T|tricar-t
5044572|NCT03720496|CD19-TriCAR-T|cd19-tricar-t
5044573|NCT03720496|Non-hodgkin Lymphoma|non-hodgkin lymphoma
5044668|NCT03719976|Health care navigation|health care navigation
5044669|NCT03719937|prone positioning|prone positioning
5044670|NCT03719937|chest wall mechanics|chest wall mechanics
5044671|NCT03719937|alveolar recruitment|alveolar recruitment
5044672|NCT03719937|acute respiratory distress syndrome|acute respiratory distress syndrome
5044674|NCT03719872|laparoscopic surgery|laparoscopic surgery
5044675|NCT03719872|transabdominal ultrasound|transabdominal ultrasound
5044676|NCT03719872|Free air|free air
5044767|NCT03719404|chlorhexidine|chlorhexidine
5044772|NCT03719365|PSV|psv
5044867|NCT03718702|Working population|working population
5044868|NCT03718702|Online learning|online learning
5044869|NCT03718676|pulpotomy|pulpotomy
5044870|NCT03718637|Tennis Elbow|tennis elbow
5044871|NCT03718637|Tendinopathy|tendinopathy
5044872|NCT03718637|Lateral Epicondylitis|lateral epicondylitis
5044873|NCT03718637|Bioinductive|bioinductive
5044874|NCT03718611|Generic|generic
5044875|NCT03718598|Carpal tunnel syndrome|carpal tunnel syndrome
5044876|NCT03718598|home exercise|home exercise
5044877|NCT03718598|pregnant women|pregnant women
5044878|NCT03718585|Nocturnal Hypertension|nocturnal hypertension
5045068|NCT03717389|soft tissue calcification in head and neck|soft tissue calcification in head and neck
5045069|NCT03717376|Functional Movement Disorder|functional movement disorder
5045070|NCT03717376|Functional Neurological Disorder|functional neurological disorder
5045163|NCT03716921|short antibiotic treatment|short antibiotic treatment
5045165|NCT03716921|septic arthritis|septic arthritis
5045166|NCT03716895|Severe Septic Shock|severe septic shock
5045172|NCT03716882|Infants|infants
5045356|NCT03715517|Postoperative Period|postoperative period
5045455|NCT03714789|Kidney Failure|kidney failure
5045456|NCT03714789|Pharmacokinetics|pharmacokinetics
5045457|NCT03714789|Antibiotics|antibiotics
5045458|NCT03714776|Hypertension|hypertension
5045459|NCT03714776|Hypertensive|hypertensive
5045460|NCT03714776|AGT|agt
5045461|NCT03714776|Angiotensinogen|angiotensinogen
5045551|NCT03714139|Dental Implants|dental implants
5045552|NCT03714139|bone healing|bone healing
5045553|NCT03714139|clinical trial|clinical trial
5045555|NCT03714113|Donor-specific antibodies|donor-specific antibodies
5045556|NCT03714087|Finishing protocol|finishing protocol
5045557|NCT03714087|Aligner|aligner
5045558|NCT03714048|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5045559|NCT03714048|ECMO|ecmo
5045560|NCT03714048|VA-ECMO|va-ecmo
5045561|NCT03714009|Infertility|infertility
5045562|NCT03714009|Poor ovarian reserve|poor ovarian reserve
5045563|NCT03714009|Intracytoplasmic sperm injection|intracytoplasmic sperm injection
5045935|NCT03711851|Psychological flexibility|psychological flexibility
5045936|NCT03711838|Pax7|pax7
5045937|NCT03711838|MyoD|myod
5045938|NCT03711838|Antioxidants|antioxidants
5045939|NCT03711838|Myogenic potential|myogenic potential
5045940|NCT03711838|Skeletal muscle healing|skeletal muscle healing
5045941|NCT03711812|regional anaesthesia|regional anaesthesia
5045942|NCT03711812|rib fractures|rib fractures
5046038|NCT03711331|Ventilator-associated pneumonia Hospital-acquired pneumonia Antimicrobial therapy Polymerase chain reaction Antibiotics stewardship|ventilator-associated pneumonia hospital-acquired pneumonia antimicrobial therapy polymerase chain reaction antibiotics stewardship
5046039|NCT03711331|Polymerase chain reaction|polymerase chain reaction
5046042|NCT03711292|Urgent Care Center|urgent care center
5046134|NCT03710889|Fracture|fracture
5046135|NCT03710889|Bone loss|bone loss
5046136|NCT03710850|Insulin resistance|insulin resistance
5046237|NCT03710265|Metastatic or locally advanced solid tumors|metastatic or locally advanced solid tumors
5046238|NCT03710226|mean platelet volume|mean platelet volume
5046241|NCT03710161|dialysis|dialysis
5046331|NCT03709667|exercise|exercise
5046332|NCT03709667|methamphetamine|methamphetamine
5046333|NCT03709654|acne|acne
5046334|NCT03709654|pimple|pimple
5046335|NCT03709654|black head|black head
5046336|NCT03709654|white head|white head
5046533|NCT03708458|endoscopic retrograde cholangiopancreatography (ERCP)|endoscopic retrograde cholangiopancreatography (ercp)
5046534|NCT03708458|post-ERCP pancreatitis (PEP)|post-ercp pancreatitis (pep)
5046535|NCT03708458|Nonsteroidal anti-inflammatory drugs (NSAID's)|nonsteroidal anti-inflammatory drugs (nsaid's)
5046536|NCT03708458|acetylcysteine (ACC)|acetylcysteine (acc)
5046537|NCT03708445|bile duct obstruction, extrahepatic|bile duct obstruction, extrahepatic
5046633|NCT03707691|Cochlear Implants|cochlear implants
5046634|NCT03707691|Congenital Amusia|congenital amusia
5046635|NCT03707691|Pitch|pitch
5046636|NCT03707691|Audio-visual interactions|audio-visual interactions
5046637|NCT03707678|GSK2245035|gsk2245035
5046638|NCT03707678|Allergic asthma|allergic asthma
5046729|NCT03707106|cue exposure|cue exposure
5046730|NCT03707106|progressive muscle relaxation|progressive muscle relaxation
5046731|NCT03707093|Solid tumor|solid tumor
5046732|NCT03707093|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5046733|NCT03707067|exercise induced muscle damage|exercise induced muscle damage
5046735|NCT03707067|recovery|recovery
5046831|NCT03706417|Hospitals, Community|hospitals, community
5046832|NCT03706404|Renal Colic|renal colic
5046833|NCT03706404|Point-of-Care ultrasound|point-of-care ultrasound
5046834|NCT03706404|Point-of-Care testing|point-of-care testing
5046929|NCT03705741|exercise|exercise
5046930|NCT03705741|public health|public health
5047127|NCT03704779|Student|student
5047128|NCT03704766|synovial biomarkers|synovial biomarkers
5047129|NCT03704766|alpha-defensin|alpha-defensin
5047130|NCT03704766|diagnostics|diagnostics
5047131|NCT03704766|pediatric|pediatric
5047323|NCT03703635|Intracranial Artery Stenosis|intracranial artery stenosis
5047326|NCT03703635|Angioplasty|angioplasty
5047327|NCT03703635|Aggressive Medical Care|aggressive medical care
5047329|NCT03703622|Video-debriefing|video-debriefing
5047429|NCT03702972|Flir One Thermal Imager|flir one thermal imager
5047529|NCT03702309|Circulating Tumor DNA|circulating tumor dna
5047530|NCT03702309|Blood|blood
5047531|NCT03702309|Molecular Profiling|molecular profiling
5047532|NCT03702309|Next Generation Sequencing|next generation sequencing
5047533|NCT03702309|Solid Tumors|solid tumors
5047534|NCT03702309|Hematological|hematological
5047535|NCT03702244|suspected coronary artery disease|suspected coronary artery disease
5047536|NCT03702231|Ibrutinib|ibrutinib
5047629|NCT03701542|metamorphopsia|metamorphopsia
5047630|NCT03701477|Migraine|migraine
5047631|NCT03701477|trans-diagnostic approach|trans-diagnostic approach
5047632|NCT03701477|headache|headache
5047633|NCT03701464|ERCP|ercp
5047634|NCT03701464|PTGBD|ptgbd
5047635|NCT03701464|ENGBD|engbd
5047636|NCT03701464|Gallbladder drainage|gallbladder drainage
5047730|NCT03700710|lifestyle modification|lifestyle modification
5047732|NCT03700710|weight loss|weight loss
5047733|NCT03700710|exercise|exercise
5047734|NCT03700645|Diabetes Mellitus|diabetes mellitus
5047735|NCT03700645|Uric asid|uric asid
5047736|NCT03700645|Multi Vessel Coronary Artery Disease|multi vessel coronary artery disease
5047737|NCT03700606|high flow nasal cannula|high flow nasal cannula
5047738|NCT03700606|nasal cpap|nasal cpap
5047743|NCT03700580|diabetes type 2|diabetes type 2
5047744|NCT03700580|wound healing|wound healing
5047745|NCT03700580|peripheral neuropathy|peripheral neuropathy
5047746|NCT03700580|P1G10|p1g10
5047823|NCT03700008|Technical measurements of mental state|technical measurements of mental state
5047824|NCT03700008|Course-prediction of Mental Illness|course-prediction of mental illness
5047825|NCT03699982|Cystic Fibrosis|cystic fibrosis
5047826|NCT03699969|Hypofractionation|hypofractionation
5047827|NCT03699969|VMAT|vmat
5047828|NCT03699969|head and neck cancer|head and neck cancer
5047836|NCT03699917|Fluid therapy|fluid therapy
5047922|NCT03699436|Central Sensitization|central sensitization
5047923|NCT03699436|Pain catastrophizing.|pain catastrophizing.
5047924|NCT03699436|Number of attacks|number of attacks
5047925|NCT03699423|myopia control|myopia control
5047926|NCT03699423|low concentration atropine eye drops|low concentration atropine eye drops
5047927|NCT03699423|anti-muscarinic receptors|anti-muscarinic receptors
5047928|NCT03699423|pupil size|pupil size
5047929|NCT03699423|accommodative amplitude|accommodative amplitude
5047930|NCT03699384|Azacitidine|azacitidine
5048228|NCT03697564|Stand Up to Cancer|stand up to cancer
5048429|NCT03696225|Cognitive Function|cognitive function
5048431|NCT03696186|Cancer Subtype|cancer subtype
5048520|NCT03695484|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5048521|NCT03695484|Catheter Ablation|catheter ablation
5048522|NCT03695484|Cryoballoon|cryoballoon
5048523|NCT03695484|Radiofrequency ablation|radiofrequency ablation
5048524|NCT03695484|Remote Magnetic Navigation|remote magnetic navigation
5048525|NCT03695458|phototherapy|phototherapy
5048526|NCT03695458|systemic effect|systemic effect
5048527|NCT03695458|recovery|recovery
5048528|NCT03695458|performance|performance
5048529|NCT03695458|photobiomodulation|photobiomodulation
5048530|NCT03695432|Influenza|influenza
5048531|NCT03695432|Vaccine|vaccine
5048532|NCT03695432|Probiotic|probiotic
5048533|NCT03695432|Influenza-like Illness|influenza-like illness
5048534|NCT03695393|Injection drug use|injection drug use
5048535|NCT03695393|Stigma|stigma
5048537|NCT03695367|inguinal hernia|inguinal hernia
5048538|NCT03695367|hernia|hernia
5048539|NCT03695367|hernia surgery|hernia surgery
5048540|NCT03695367|postoperative pain|postoperative pain
5048541|NCT03695367|herniorrhaphy|herniorrhaphy
5048542|NCT03695354|sarcopenia|sarcopenia
5048543|NCT03695354|vibration|vibration
5048621|NCT03694912|renal cell cancer|renal cell cancer
5048622|NCT03694912|high risk group|high risk group
5048623|NCT03694912|bio-marker|bio-marker
5048827|NCT03693729|transcranial direct current stimulation|transcranial direct current stimulation
5048828|NCT03693716|Transsubscapular|transsubscapular
5048829|NCT03693716|Long head of the biceps tendon|long head of the biceps tendon
5048831|NCT03693716|Anterior Shoulder Dislocation|anterior shoulder dislocation
5048832|NCT03693716|Bankart|bankart
5048833|NCT03693716|HillSachs|hillsachs
5048834|NCT03693716|Arthroscopic Anterior Dynamic Stabilization|arthroscopic anterior dynamic stabilization
5048835|NCT03693703|magnetic resonance imaging|magnetic resonance imaging
5048836|NCT03693703|prostate biopsy|prostate biopsy
5048837|NCT03693703|microRNA|microrna
5048838|NCT03693664|Asthma|asthma
5048839|NCT03693664|Daily Living Activities|daily living activities
5048840|NCT03693664|6 Minute Pegboard and Ring Test|6 minute pegboard and ring test
5048863|NCT03693534|IVF|ivf
5049018|NCT03692364|aseptic loosening|aseptic loosening
5049019|NCT03692351|uncemented hip arthroplasty|uncemented hip arthroplasty
5049020|NCT03692351|osteolysis|osteolysis
5049021|NCT03692351|polyethylene wear|polyethylene wear
5049022|NCT03692351|implant design|implant design
5049023|NCT03692338|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5049024|NCT03692338|ipilimumab|ipilimumab
5049025|NCT03692338|nivolumab|nivolumab
5049026|NCT03692338|exercise|exercise
5049038|NCT03692299|Systemic Sclerosis|systemic sclerosis
5049039|NCT03692299|Small Intestinal Bacterial Overgrowth|small intestinal bacterial overgrowth
5049120|NCT03691870|cardiovascular abnormalities|cardiovascular abnormalities
5049123|NCT03691844|AMZ001|amz001
5049221|NCT03690960|immature teeth|immature teeth
5049319|NCT03690414|Accommodative responses|accommodative responses
5049320|NCT03690401|Cancer|cancer
5049321|NCT03690401|Post-Treatment|post-treatment
5049322|NCT03690401|Body Composition|body composition
5049323|NCT03690401|SOZO|sozo
5049324|NCT03690401|Impedimed|impedimed
5049333|NCT03690375|skin atrophy|skin atrophy
5049334|NCT03690375|broad band bight|broad band bight
5049335|NCT03690375|ecchymosis|ecchymosis
5049336|NCT03690375|collagen|collagen
5049420|NCT03689660|virtual reality|virtual reality
5049529|NCT03688893|Bleaching|bleaching
5049530|NCT03688893|Laser|laser
5049531|NCT03688893|CIELCH|cielch
5049532|NCT03688880|Wounds|wounds
5049533|NCT03688880|Injuries|injuries
5049534|NCT03688880|Surgery|surgery
5049535|NCT03688880|Lacerations|lacerations
5049536|NCT03688880|Wound healing|wound healing
5049545|NCT03688763|anxiety|anxiety
5049624|NCT03688204|Polygenic Risk Score|polygenic risk score
5049625|NCT03688204|Personalized Risk Score|personalized risk score
5049626|NCT03688191|Sirolimus|sirolimus
5049627|NCT03688191|connective tissue disease|connective tissue disease
5049628|NCT03688191|thrombocytopenia|thrombocytopenia
5049717|NCT03687541|antithrombotic-related bleeding|antithrombotic-related bleeding
5049719|NCT03687528|platelet inhibitors|platelet inhibitors
5049720|NCT03687528|minor head injury trauma|minor head injury trauma
5049721|NCT03687528|CT-scan|ct-scan
5049723|NCT03687463|HSCT|hsct
5049724|NCT03687463|PT/Cy|pt/cy
5049818|NCT03686761|Periodontium|periodontium
5049820|NCT03686696|Myocardial infarction|myocardial infarction
5049828|NCT03686657|Obesity|obesity
5049917|NCT03685825|Surgeon experience|surgeon experience
5049918|NCT03685825|Endothelial cell loss|endothelial cell loss
5049920|NCT03685812|Autocad software|autocad software
5050020|NCT03685344|Loncastuximab Tesirine in Combination with Durvalumab|loncastuximab tesirine in combination with durvalumab
5050021|NCT03685331|HER2-negative|her2-negative
5050022|NCT03685305|Weight loss|weight loss
5050023|NCT03685305|Cognitive function|cognitive function
5050024|NCT03685305|Weight maintenance|weight maintenance
5050025|NCT03685253|diabetes|diabetes
5050322|NCT03683212|Pulmonary edema|pulmonary edema
5050323|NCT03683199|Secondary|secondary
5050324|NCT03683199|Cleft|cleft
5050325|NCT03683199|Lip|lip
5050326|NCT03683199|Nose|nose
5050327|NCT03683199|Deformity|deformity
5050423|NCT03682757|Platelets|platelets
5050424|NCT03682757|Coagulopathy|coagulopathy
5050425|NCT03682718|misoprostol , intracervical Foley catheter , induction of labor , term pregnancy.|misoprostol , intracervical foley catheter , induction of labor , term pregnancy.
5050426|NCT03682705|ABBV-105|abbv-105
5050427|NCT03682705|Upadacitinib|upadacitinib
5050428|NCT03682705|ABBV-599|abbv-599
5050429|NCT03682705|Rheumatoid Arthritis|rheumatoid arthritis
5050434|NCT03682666|stroke|stroke
5050435|NCT03682666|Kinesiotaping|kinesiotaping
5050519|NCT03682237|Flash glucose monitoring|flash glucose monitoring
5050521|NCT03682224|bupivacaine-epinephrine|bupivacaine-epinephrine
5050522|NCT03682224|bupivacaine liposome|bupivacaine liposome
5050523|NCT03682224|pain|pain
5050524|NCT03682224|Morphine equivalent dose|morphine equivalent dose
5050525|NCT03682224|lobectomy|lobectomy
5050526|NCT03682224|Laproscopic lobectomy|laproscopic lobectomy
5050527|NCT03682224|VATS lobectomy|vats lobectomy
5050528|NCT03682224|opioid medications|opioid medications
5050529|NCT03682211|Sickle cell disease|sickle cell disease
5050530|NCT03682211|Paediatric|paediatric
5050531|NCT03682211|Pain|pain
5050532|NCT03682211|Analgesia|analgesia
5050533|NCT03682211|Intranasal|intranasal
5050534|NCT03682211|Fentanyl|fentanyl
5050535|NCT03682185|Neuropsychiatric Behaviors|neuropsychiatric behaviors
5050536|NCT03682185|Agitation|agitation
5050537|NCT03682185|Alzheimer's Disease|alzheimer's disease
5050538|NCT03682185|Dementia|dementia
5050542|NCT03682146|DaVinci|davinci
5050623|NCT03681847|normal saline|normal saline
5050624|NCT03681821|ostomy|ostomy
5050625|NCT03681821|self-management|self-management
5050626|NCT03681821|self-efficacy|self-efficacy
5050627|NCT03681821|health-promoting behavior|health-promoting behavior
5050628|NCT03681795|Gilles de la Tourette syndrome|gilles de la tourette syndrome
5050722|NCT03681145|Telehealth|telehealth
5050723|NCT03681145|Health Disparity|health disparity
5050724|NCT03681106|Knee Osteoarthritis|knee osteoarthritis
5050729|NCT03681093|Asthma|asthma
5051028|NCT03679572|ischemia|ischemia
5051029|NCT03679533|Cognition|cognition
5051030|NCT03679533|Ageing|ageing
5051225|NCT03678142|antibiotic drug monitoring in sweat|antibiotic drug monitoring in sweat
5051226|NCT03678129|Autism Spectrum Disorder|autism spectrum disorder
5051227|NCT03678129|E-I balance|e-i balance
5051228|NCT03678129|AZD7325|azd7325
5051229|NCT03678129|pharmacological imaging|pharmacological imaging
5051230|NCT03678129|GABA|gaba
5051234|NCT03678064|gait|gait
5051517|NCT03676140|Neglected Tropical Diseases|neglected tropical diseases
5051518|NCT03676127|assessment|assessment
5051519|NCT03676127|breast cancer|breast cancer
5051520|NCT03676127|diagnosis|diagnosis
5051521|NCT03676127|lymphedema|lymphedema
5051522|NCT03676127|measurement|measurement
5051523|NCT03676127|ultrasound|ultrasound
5051524|NCT03676114|Ketamine|ketamine
5051525|NCT03676114|Breast Cancer Surgery|breast cancer surgery
5051526|NCT03676114|Postoperative Recovery|postoperative recovery
5051557|NCT03675893|ER+|er+
5051615|NCT03675451|Nuclear Medicine|nuclear medicine
5051616|NCT03675425|Chest shielding|chest shielding
5051617|NCT03675425|Patent Ductus Arteriosus|patent ductus arteriosus
5051716|NCT03674944|Body Mass Index|body mass index
5051717|NCT03674944|Intervention|intervention
5051815|NCT03674398|cognitive training|cognitive training
5051816|NCT03674398|brain training|brain training
5051817|NCT03674398|home-based intervention|home-based intervention
5051818|NCT03674398|social cognitive neuroscience|social cognitive neuroscience
5051819|NCT03674385|Vitamin E|vitamin e
5051820|NCT03674385|Polycystic ovary|polycystic ovary
5051824|NCT03674359|1, 3-β-D-glucan, Candidemia, Intensive Care Unit|1, 3-β-d-glucan, candidemia, intensive care unit
5051825|NCT03674346|hypnoanalgesia|hypnoanalgesia
5051826|NCT03674346|cutaneous angioma|cutaneous angioma
5051827|NCT03674346|sclerosis treatment|sclerosis treatment
5051828|NCT03674333|Folic Acid|folic acid
5051829|NCT03674333|Dyslipidemias|dyslipidemias
5051830|NCT03674333|Hyperlipidemia|hyperlipidemia
5051831|NCT03674281|Closed-Loop Control (CLC)|closed-loop control (clc)
5052013|NCT03673163|inguinal herniotomy|inguinal herniotomy
5052014|NCT03673137|gemcitabine|gemcitabine
5052018|NCT03673124|ovary|ovary
5052124|NCT03672591|Renal clearance technique|renal clearance technique
5052125|NCT03672591|Preserved ejection fraction|preserved ejection fraction
5052126|NCT03672578|Diet|diet
5052127|NCT03672578|Young Adults|young adults
5052128|NCT03672578|Health messaging|health messaging
5052219|NCT03672045|pregnancy|pregnancy
5052220|NCT03672045|postpartum hemorrhage|postpartum hemorrhage
5052221|NCT03672045|Cesarean delivery|cesarean delivery
5052222|NCT03672045|carbetocin|carbetocin
5052223|NCT03672019|Percutaneous Biliary Drainage|percutaneous biliary drainage
5052224|NCT03672019|Quality of life|quality of life
5052225|NCT03672019|18-366|18-366
5052226|NCT03671993|urethral pain syndrome|urethral pain syndrome
5052316|NCT03671434|Knowledge Translation|knowledge translation
5052317|NCT03671434|Knowledge Management|knowledge management
5052318|NCT03671434|Health Policy|health policy
5052319|NCT03671434|Social Policy|social policy
5052320|NCT03671434|Public Policy|public policy
5052321|NCT03671434|Policy Makers|policy makers
5052322|NCT03671434|Legislation as Topic|legislation as topic
5052323|NCT03671434|Evidence-based Policy|evidence-based policy
5052324|NCT03671434|Use of Research Evidence|use of research evidence
5052421|NCT03671083|Non-Sport Related Concussion|non-sport related concussion
5052422|NCT03671057|serious game, preoperative anxiety reduction|serious game, preoperative anxiety reduction
5052423|NCT03671044|Triple Negative Breast Cancer|triple negative breast cancer
5052425|NCT03671031|pancreatic fistula|pancreatic fistula
5052426|NCT03671031|pancreatic leak|pancreatic leak
5052427|NCT03671031|whipple operation|whipple operation
5052428|NCT03671031|roux-en-y|roux-en-y
5052429|NCT03670992|renal cell carcinoma|renal cell carcinoma
5052430|NCT03670992|pancreatic resection|pancreatic resection
5052519|NCT03670472|nonsense mutation readthrough|nonsense mutation readthrough
5052520|NCT03670433|Medication reconciliation|medication reconciliation
5052522|NCT03670433|Prevention|prevention
5052523|NCT03670407|Premature Ovarian Failure|premature ovarian failure
5052524|NCT03670407|Infertility, Female|infertility, female
5052525|NCT03670407|Ovarian tissue fragmentation|ovarian tissue fragmentation
5052531|NCT03670251|HCV Viral Load, Dried Blood Spot, HCV Core Ag|hcv viral load, dried blood spot, hcv core ag
5052532|NCT03670238|Nasogastric intubation|nasogastric intubation
5052533|NCT03670238|Orogastric intubation|orogastric intubation
5052534|NCT03670238|Feeding tubes|feeding tubes
5052535|NCT03670212|cigarette smoking|cigarette smoking
5052536|NCT03670212|acute stress|acute stress
5052537|NCT03670212|executive function|executive function
5052538|NCT03670212|craving|craving
5052673|NCT03669341|MRI|mri
5053121|NCT03666559|Glioma|glioma
5053122|NCT03666559|IDH1/2|idh1/2
5053123|NCT03666559|Azacitidine|azacitidine
5053124|NCT03666559|PFS|pfs
5053125|NCT03666546|Blood glucose|blood glucose
5053209|NCT03666013|Muscle function|muscle function
5053210|NCT03666013|Aging|aging
5053212|NCT03665961|gastrointestinal microbiome|gastrointestinal microbiome
5053412|NCT03664843|surveillance|surveillance
5053413|NCT03664843|longitudinal monitoring|longitudinal monitoring
5053414|NCT03664843|lead time|lead time
5053415|NCT03664830|plerixafor|plerixafor
5053416|NCT03664830|sickle cell disease|sickle cell disease
5053417|NCT03664830|mobilization|mobilization
5053418|NCT03664830|hematopoietic stem cell|hematopoietic stem cell
5053419|NCT03664830|gene therapy|gene therapy
5053420|NCT03664817|MSM: Men who have sex with Men|msm: men who have sex with men
5053511|NCT03664141|Cannabis oil|cannabis oil
5053512|NCT03664115|Non small cell lung cancer|non small cell lung cancer
5053513|NCT03664115|itraconazole|itraconazole
5053514|NCT03664115|mtor inhibition|mtor inhibition
5053515|NCT03664115|antiangiogensis|antiangiogensis
5053815|NCT03661983|Aripiprazole|aripiprazole
5053816|NCT03661983|Tourette's Disorder|tourette's disorder
5053817|NCT03661983|Pediatric|pediatric
5053818|NCT03661944|sports|sports
5053819|NCT03661944|physical therapy|physical therapy
5053911|NCT03661385|Arterial switch operation|arterial switch operation
5053913|NCT03661294|Energy, spinal cord injury|energy, spinal cord injury
5053915|NCT03661255|Alaska Native|alaska native
5053916|NCT03661255|Community Intervention|community intervention
5053917|NCT03661242|Physical activity|physical activity
5053918|NCT03661242|Exercise|exercise
5053919|NCT03661242|Adjuvant chemotherapy|adjuvant chemotherapy
5053920|NCT03661229|CVInsight|cvinsight
5053921|NCT03661229|Hemodialysis|hemodialysis
5053922|NCT03661229|Cardiovascular stress|cardiovascular stress
5053923|NCT03661203|MSM population|msm population
5054315|NCT03658811|meibomian gland dysfunction|meibomian gland dysfunction
5054316|NCT03658798|Functional Electrical Stimulation|functional electrical stimulation
5054318|NCT03658798|Rehabilitation|rehabilitation
5054319|NCT03658785|TIL|til
5054410|NCT03658213|Pre-menopausal|pre-menopausal
5054411|NCT03658213|Zoladex|zoladex
5054412|NCT03658200|Chest CT|chest ct
5054413|NCT03658200|Bolus tracking|bolus tracking
5670693|NCT00618904|Probiotics|probiotics
5054615|NCT03656627|Rheumatoid Arthritis|rheumatoid arthritis
5054616|NCT03656627|Nivolumab|nivolumab
5054617|NCT03656627|Opdivo|opdivo
5054621|NCT03656601|delivery|delivery
5054715|NCT03656133|Proliferation Saturation Index|proliferation saturation index
5054716|NCT03656133|Larynx|larynx
5054717|NCT03656133|Pharynx|pharynx
5054718|NCT03656120|opioid dependence|opioid dependence
5054847|NCT03655184|Neuropsychology|neuropsychology
5054819|NCT03655340|Blood Coagulation Disorder|blood coagulation disorder
5054820|NCT03655340|Hematologic Diseases|hematologic diseases
5054821|NCT03655340|Coagulation Protein Disorder|coagulation protein disorder
5054825|NCT03655314|formula|formula
5054924|NCT03654716|Leukemia|leukemia
5054925|NCT03654716|Solid Tumor|solid tumor
5054926|NCT03654716|Brain Tumor|brain tumor
5055029|NCT03654079|Childbirth|childbirth
5055030|NCT03654053|cirrhosis|cirrhosis
5055031|NCT03654053|hepatic decompensation|hepatic decompensation
5055032|NCT03654040|alloantigen-reactive Tregs ( arTreg)|alloantigen-reactive tregs ( artreg)
5055033|NCT03654040|immunosuppression|immunosuppression
5055034|NCT03654040|operational tolerance|operational tolerance
5055035|NCT03654014|Pulsed Electromagnetic Field therapy|pulsed electromagnetic field therapy
5055036|NCT03654014|Traumatic Brain Injury|traumatic brain injury
5055127|NCT03653585|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5055128|NCT03653585|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5055129|NCT03653585|Functional Neuroimaging|functional neuroimaging
5055130|NCT03653585|Cortical Lesion|cortical lesion
5055131|NCT03653585|Sensorimotor cortex|sensorimotor cortex
5055134|NCT03653572|Ultrasound|ultrasound
5055135|NCT03653572|Emergency care|emergency care
5055161|NCT03653481|IBD|ibd
5055226|NCT03653273|multiple sclerosis|multiple sclerosis
5055227|NCT03653273|secondary progressive|secondary progressive
5055324|NCT03652688|clubs|clubs
5055328|NCT03652649|type 2 diabetes|type 2 diabetes
5055329|NCT03652649|diabetes|diabetes
5055330|NCT03652649|ketogenic diet|ketogenic diet
5055331|NCT03652649|low carb diet|low carb diet
5055332|NCT03652649|weight loss|weight loss
5055333|NCT03652649|obesity|obesity
5055334|NCT03652649|diet treatment|diet treatment
5055335|NCT03652649|nutrition|nutrition
5055423|NCT03652103|Truncal Nerve Blocks, Ultrasound Guided Nerve Blocks|truncal nerve blocks, ultrasound guided nerve blocks
5055424|NCT03652090|biomarker|biomarker
5055428|NCT03652038|Single ascending dose|single ascending dose
5055429|NCT03652038|SAD|sad
5055523|NCT03651505|XLH|xlh
5055524|NCT03651505|Hypophosphatemia|hypophosphatemia
5055525|NCT03651505|Familial Hypophosphatemic Rickets|familial hypophosphatemic rickets
5055526|NCT03651505|FGF23|fgf23
5055527|NCT03651505|Crysvita|crysvita
5055530|NCT03651492|sleep quality|sleep quality
5055654|NCT03650829|ART|art
5055723|NCT03650517|Intracorporeal|intracorporeal
5055724|NCT03650517|Extracorporeal|extracorporeal
5055725|NCT03650478|Intensive Care|intensive care
5055726|NCT03650478|mechanical ventilation|mechanical ventilation
5055727|NCT03650478|noninvasive ventilation|noninvasive ventilation
5055728|NCT03650465|generalized anxiety|generalized anxiety
5055730|NCT03650465|worry|worry
5055731|NCT03650465|CBT|cbt
5055732|NCT03650465|REBT|rebt
5055733|NCT03650465|ACT|act
5055755|NCT03650400|Fevipiprant,|fevipiprant,
5055756|NCT03650400|GINA 2018,|gina 2018,
5055757|NCT03650400|Pediatrics|pediatrics
5055758|NCT03650374|Meniscus root tear|meniscus root tear
5055759|NCT03650348|HER2-positive breast cancer|her2-positive breast cancer
5055760|NCT03650348|HER2-positive gastric cancer|her2-positive gastric cancer
5055761|NCT03650348|HER2-positive bladder cancer|her2-positive bladder cancer
5055762|NCT03650348|Pieris|pieris
5055763|NCT03650348|PRS-343|prs-343
5055764|NCT03650348|Anticalin|anticalin
5055765|NCT03650348|Bispecific|bispecific
5055766|NCT03650348|4-1BB|4-1bb
5055824|NCT03649958|headache|headache
5055825|NCT03649958|insomnia|insomnia
5055826|NCT03649958|PTS|pts
5056234|NCT03647488|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
5056235|NCT03647488|Non-small-cell lung cancer|non-small-cell lung cancer
5056236|NCT03647488|NSCLC|nsclc
5056237|NCT03647488|epidermal growth factor receptor wild type|epidermal growth factor receptor wild type
5056239|NCT03647488|Anaplastic lymphoma kinase negative|anaplastic lymphoma kinase negative
5056241|NCT03647488|INC280|inc280
5056242|NCT03647488|capmatinib and spartalizumab|capmatinib and spartalizumab
5056243|NCT03647488|combination therapy|combination therapy
5056331|NCT03646994|Non-small Cell Lung Cancer|non-small cell lung cancer
5056332|NCT03646994|Crizotinib|crizotinib
5056333|NCT03646994|ROS1 Rearranged|ros1 rearranged
5056334|NCT03646981|visceral leishmaniasis|visceral leishmaniasis
5056335|NCT03646981|diagnostics|diagnostics
5056437|NCT03646097|OCT|oct
5056531|NCT03645694|Technology|technology
5056532|NCT03645694|Social support|social support
5056533|NCT03645681|Vascular Access|vascular access
5056534|NCT03645681|Hemodialysis Access|hemodialysis access
5056535|NCT03645681|End Stage Renal Disease|end stage renal disease
5056536|NCT03645681|Kidney Failure|kidney failure
5056537|NCT03645681|Hemodialysis|hemodialysis
5056538|NCT03645681|Arteriovenous Graft|arteriovenous graft
5056539|NCT03645681|AVG|avg
5056628|NCT03645213|distraction|distraction
5056629|NCT03645200|TP53|tp53
5056630|NCT03645200|Solid tumor|solid tumor
5056631|NCT03645200|Fluzoparib|fluzoparib
5056632|NCT03645200|Apatinib|apatinib
5056633|NCT03645174|intubation|intubation
5056634|NCT03645174|Aintree|aintree
5056726|NCT03644641|Visual loss|visual loss
5056727|NCT03644615|Osteoarthritis|osteoarthritis
5056822|NCT03644134|Type 2 Diabetes, Physiological Stress, Sleep Pattern|type 2 diabetes, physiological stress, sleep pattern
5056823|NCT03644056|IMC-001|imc-001
5056824|NCT03644030|FFM index|ffm index
5056825|NCT03644030|tissue edema index [extracellular / total water - ECW / TBW]|tissue edema index [extracellular / total water - ecw / tbw]
5056826|NCT03644030|phase angle|phase angle
5056917|NCT03643328|Staphylococcus Aureus|staphylococcus aureus
5056918|NCT03643328|haemodialysis|haemodialysis
5056920|NCT03643328|immune response|immune response
5056921|NCT03643315|Appetite regulation|appetite regulation
5056922|NCT03643315|Eating behaviour|eating behaviour
5056923|NCT03643315|Exercise|exercise
5056924|NCT03643315|HIIT|hiit
5056925|NCT03643276|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5056926|NCT03643276|Childhood|childhood
5056927|NCT03643276|Pediatric|pediatric
5057022|NCT03642535|Actinic Keratoses|actinic keratoses
5057023|NCT03642522|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5057024|NCT03642522|rTMS|rtms
5057025|NCT03642522|neurostimulation|neurostimulation
5057120|NCT03642002|music therapy|music therapy
5057122|NCT03642002|music medicine|music medicine
5057129|NCT03641950|Essential Blepharospasm|essential blepharospasm
5057131|NCT03641924|Psychotherapy|psychotherapy
5057217|NCT03641417|Bariatric surgery|bariatric surgery
5057218|NCT03641417|Appetite|appetite
5057219|NCT03641417|Ghrelin|ghrelin
5057220|NCT03641417|Energy intake|energy intake
5057230|NCT03641391|Glioma|glioma
5057321|NCT03640767|Peripheral artery disease|peripheral artery disease
5057322|NCT03640767|Mobile phone text message|mobile phone text message
5057326|NCT03640741|intra-abdominal pressure|intra-abdominal pressure
5057327|NCT03640741|intra-cerebral pressure|intra-cerebral pressure
5057328|NCT03640741|laparoscopy|laparoscopy
5057329|NCT03640741|brain perfusion|brain perfusion
5057330|NCT03640741|brain oxygenation|brain oxygenation
5057331|NCT03640741|time-resolved near infrared spectroscopy|time-resolved near infrared spectroscopy
5057332|NCT03640728|Hepatitis B, Acute-on-Chronic liver failure|hepatitis b, acute-on-chronic liver failure
5057378|NCT03640364|POP|pop
5057421|NCT03640117|geriatric assessment|geriatric assessment
5057422|NCT03640117|chemotherapy toxicity|chemotherapy toxicity
5057423|NCT03640117|overall survival|overall survival
5057424|NCT03640104|Food-based intervention|food-based intervention
5057425|NCT03640104|postpartum weight management|postpartum weight management
5057426|NCT03640104|hepatic retinol|hepatic retinol
5057427|NCT03640039|3d strut plate|3d strut plate
5057428|NCT03640039|mandibular angle fracture|mandibular angle fracture
5057429|NCT03639987|Aducanumab|aducanumab
5057528|NCT03639402|Cardiovascular disease|cardiovascular disease
5057529|NCT03639402|Mothers|mothers
5057530|NCT03639402|Peer education|peer education
5057536|NCT03639376|Children|children
5057537|NCT03639376|Cotinine|cotinine
5057538|NCT03639376|LL-37|ll-37
5057625|NCT03638817|Platelet concentrates (PC)|platelet concentrates (pc)
5057626|NCT03638817|Eltrombopag|eltrombopag
5057627|NCT03638817|Surgery|surgery
5057628|NCT03638817|Invasive acts|invasive acts
5057629|NCT03638817|Perioperative|perioperative
5057728|NCT03638141|DEB-TACE|deb-tace
5057729|NCT03638128|OI|oi
5057730|NCT03638128|Bone.|bone.
5057731|NCT03638102|sleep duration|sleep duration
5057732|NCT03638102|glucose metabolism|glucose metabolism
5057733|NCT03638063|Adenosine triphosphate|adenosine triphosphate
5057933|NCT03636633|Robotic Heart Surgery|robotic heart surgery
5057934|NCT03636633|Inspiratory Muscle Training|inspiratory muscle training
5057935|NCT03636633|Pulmonary Function Test|pulmonary function test
5057936|NCT03636633|6-Minute Walk Test|6-minute walk test
5057937|NCT03636633|Respiratory Muscle Strength|respiratory muscle strength
5057938|NCT03636633|Functional Capacity|functional capacity
5057940|NCT03636594|COPD|copd
5057941|NCT03636594|Maintenance program|maintenance program
5057942|NCT03636594|Pulmonary rehabilitation|pulmonary rehabilitation
5057943|NCT03636568|hyponatremia|hyponatremia
5057944|NCT03636568|hyponatremic|hyponatremic
5057945|NCT03636568|pituitary tumor|pituitary tumor
5057946|NCT03636568|transsphenoidal resection|transsphenoidal resection
5057952|NCT03636529|obese|obese
5058034|NCT03636256|BCG-refractory bladder cancer|bcg-refractory bladder cancer
5058035|NCT03636256|BCG-resistant bladder cancer|bcg-resistant bladder cancer
5058036|NCT03636256|NMIBC|nmibc
5058037|NCT03636256|MIBC|mibc
5058038|NCT03636217|Appetite|appetite
5058039|NCT03636217|Probiotic|probiotic
5058040|NCT03636217|Glycemic index|glycemic index
5058041|NCT03636178|alar base|alar base
5058042|NCT03636178|le fort I osteotomy|le fort i osteotomy
5058043|NCT03636165|Postoperative Pain|postoperative pain
5058044|NCT03636165|Post-Craniotomy Headache|post-craniotomy headache
5058045|NCT03636165|Methylprednisolone|methylprednisolone
5058431|NCT03633721|WIHS|wihs
5058436|NCT03633695|Intraocular lens|intraocular lens
5058437|NCT03633643|Greenlight Laser Vaporisation of the Prostate|greenlight laser vaporisation of the prostate
5058438|NCT03633643|Transurethral resection of the prostate|transurethral resection of the prostate
5058439|NCT03633643|Cotrimoxazole Prophylaxis|cotrimoxazole prophylaxis
5058440|NCT03633630|Amla|amla
5058737|NCT03631862|targeted therapy|targeted therapy
5058739|NCT03631862|PFS|pfs
5058740|NCT03631810|Acute pulmonary embolism|acute pulmonary embolism
5058741|NCT03631810|International guidelines|international guidelines
5058742|NCT03631797|Thoracic Surgery|thoracic surgery
5058743|NCT03631797|Microcirculation|microcirculation
5058744|NCT03631797|Endothelium, vascular|endothelium, vascular
5058745|NCT03631797|Microvascular reactivity|microvascular reactivity
5058746|NCT03631797|Laser Speckle|laser speckle
5058747|NCT03631784|PD1|pd1
5058748|NCT03631784|PD-1|pd-1
5058833|NCT03631212|youth|youth
5058834|NCT03631212|digital intervention|digital intervention
5058930|NCT03630653|Axillary lymph node dissection|axillary lymph node dissection
5058931|NCT03630653|Conservative surgery|conservative surgery
5058932|NCT03630640|nivolumab; neoadjuvant; electroporation,adjuvant|nivolumab; neoadjuvant; electroporation,adjuvant
5058933|NCT03630614|smokers|smokers
5059130|NCT03629301|Randomized controlled Trial|randomized controlled trial
5059131|NCT03629301|Internet delivered|internet delivered
5059133|NCT03629301|Weight loss|weight loss
5059134|NCT03629288|Azithromycin|azithromycin
5059135|NCT03629288|Periodontal debridement|periodontal debridement
5059136|NCT03629288|Antibiotics|antibiotics
5059137|NCT03629288|Periodontitis|periodontitis
5059145|NCT03629262|Elderly|elderly
5059146|NCT03629262|Orthopedic Surgery|orthopedic surgery
5059147|NCT03629262|Analgesia|analgesia
5059148|NCT03629262|Dexmedetomidine|dexmedetomidine
5059149|NCT03629262|Postoperative Delirium|postoperative delirium
5059226|NCT03628560|Healthy volunteer|healthy volunteer
5059228|NCT03628560|Pulse oximeter|pulse oximeter
5059229|NCT03628560|Hypoxia|hypoxia
5059230|NCT03628547|musculoskeletal system pain|musculoskeletal system pain
5059231|NCT03628547|athlete|athlete
5059233|NCT03628547|algometer|algometer
5059329|NCT03628092|Early breast cancer|early breast cancer
5059330|NCT03628092|Vulvovaginal atrophy|vulvovaginal atrophy
5059331|NCT03628092|Vaginal dryness|vaginal dryness
5059430|NCT03627611|Triiodothyronine|triiodothyronine
5059431|NCT03627598|high flow oxygen|high flow oxygen
5059432|NCT03627598|non invasive ventilation|non invasive ventilation
5059433|NCT03627598|hypercapnic respiratory failure|hypercapnic respiratory failure
5059434|NCT03627585|pacemaker|pacemaker
5059435|NCT03627585|heart failure|heart failure
5059525|NCT03626935|customized guide|customized guide
5059526|NCT03626922|NSABP|nsabp
5059527|NCT03626922|Merck & Co|merck & co
5059528|NCT03626922|Eli Lilly and Company|eli lilly and company
5059529|NCT03626922|Pembrolizumab|pembrolizumab
5059530|NCT03626922|Pemetrexed|pemetrexed
5059531|NCT03626922|Oxaliplatin|oxaliplatin
5059532|NCT03626922|MSS mCRC|mss mcrc
5059533|NCT03626896|BBB disruption|bbb disruption
5059534|NCT03626896|NaviFUS System|navifus system
5059630|NCT03626428|fMRI|fmri
5059631|NCT03626428|correlation clinical data|correlation clinical data
5059632|NCT03626428|effective connectivity|effective connectivity
5059642|NCT03626324|Stroke|stroke
5060021|NCT03623698|adolescents|adolescents
5060022|NCT03623698|respiratory|respiratory
5060023|NCT03623685|uterocervical angle|uterocervical angle
5060120|NCT03623165|NYHA Class III|nyha class iii
5060121|NCT03623139|carbohydrates|carbohydrates
5060122|NCT03623139|basic carbohydrate counting|basic carbohydrate counting
5060420|NCT03621137|Atopic Dermatitis|atopic dermatitis
5060421|NCT03621137|Registries|registries
5060422|NCT03621137|Systemic therapies|systemic therapies
5060423|NCT03621137|Off-label use|off-label use
5060424|NCT03621137|Phototherapy|phototherapy
5060426|NCT03621137|Adult|adult
5060428|NCT03621111|Medication Adherence|medication adherence
5060429|NCT03621111|Community Pharmacist|community pharmacist
5060430|NCT03621111|Patient counseling|patient counseling
5060432|NCT03621111|Hospital re-admission|hospital re-admission
5060434|NCT03621111|Beta-blockers|beta-blockers
5060518|NCT03620578|DLBCL|dlbcl
5060519|NCT03620578|HGBL|hgbl
5060520|NCT03620578|BCL-2|bcl-2
5060521|NCT03620578|BCL-6|bcl-6
5060522|NCT03620578|double-hit|double-hit
5060523|NCT03620578|triple-hit|triple-hit
5060524|NCT03620578|R-CHOP|r-chop
5060525|NCT03620578|DA-EPOCH-R|da-epoch-r
5060526|NCT03620578|Nivolumab|nivolumab
5060527|NCT03620578|PD1/PDL1 expression|pd1/pdl1 expression
5060528|NCT03620565|Pelvic floor reconstructive surgery|pelvic floor reconstructive surgery
5060529|NCT03620565|Mesh|mesh
5060725|NCT03619421|food|food
5060726|NCT03619408|Esophageal Atresia|esophageal atresia
5060727|NCT03619408|Esophagitis|esophagitis
5060728|NCT03619408|GER|ger
5060729|NCT03619408|Gastroesopheal reflux|gastroesopheal reflux
5060829|NCT03618823|opioids|opioids
5060830|NCT03618823|post-operative pain|post-operative pain
5060831|NCT03618810|breast cancer|breast cancer
5060832|NCT03618810|chemotherapy|chemotherapy
5060834|NCT03618810|prophylactic|prophylactic
5060934|NCT03618082|multicenter|multicenter
5060935|NCT03618082|randomized|randomized
5060936|NCT03618082|controlled|controlled
5060937|NCT03618082|Analgesia Nociception Index (ANI)|analgesia nociception index (ani)
5060938|NCT03618082|Postoperative pain|postoperative pain
5060939|NCT03618017|Breast cancer|breast cancer
5060940|NCT03618017|Survivors|survivors
5060941|NCT03618017|Survivorship plan|survivorship plan
5060942|NCT03618017|Transitional cancer care|transitional cancer care
5060943|NCT03618004|Restriction of blood flow|restriction of blood flow
5060944|NCT03618004|Anaerobic capacity|anaerobic capacity
5060945|NCT03618004|Subjective perception of effort|subjective perception of effort
5060946|NCT03618004|Wingate|wingate
5060947|NCT03618004|Isometric strength|isometric strength
5060948|NCT03617991|rehabilitation|rehabilitation
5060950|NCT03617978|hemodynamic|hemodynamic
5061038|NCT03617458|PAH|pah
5061039|NCT03617406|Low - flow|low - flow
5061040|NCT03617406|Low - gradient|low - gradient
5061041|NCT03617406|Low - dose dobutamine|low - dose dobutamine
5061042|NCT03617406|Volume challenge|volume challenge
5061043|NCT03617406|Echocardiography|echocardiography
5061044|NCT03617393|Early Warning Model|early warning model
5061138|NCT03616886|Previously untreated|previously untreated
5061139|NCT03616886|Locally Recurrent Inoperable|locally recurrent inoperable
5061140|NCT03616847|Randomised controlled trial|randomised controlled trial
5061141|NCT03616847|Hallux valgus correction|hallux valgus correction
5061142|NCT03616847|Hallux rigidus correction|hallux rigidus correction
5061234|NCT03616197|free gingival graft|free gingival graft
5061235|NCT03616197|shrinkage of graft|shrinkage of graft
5061337|NCT03615625|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5061338|NCT03615625|Power Exercise|power exercise
5061339|NCT03615599|Seventh-day Adventists|seventh-day adventists
5061341|NCT03615599|mortality|mortality
5061342|NCT03615599|cancer|cancer
5061343|NCT03615599|dietary pattern|dietary pattern
5061344|NCT03615599|soy consumption|soy consumption
5061345|NCT03615599|dairy consumption|dairy consumption
5061346|NCT03615599|plant-based|plant-based
5061347|NCT03615560|Medical staff|medical staff
5061348|NCT03615560|preeclampsia|preeclampsia
5061349|NCT03615560|cohort study|cohort study
5061350|NCT03615560|further effect|further effect
5061351|NCT03615547|azoospermia|azoospermia
5061352|NCT03615547|clominophene|clominophene
5061353|NCT03615534|Extended Release Niacin|extended release niacin
5061439|NCT03615105|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5061440|NCT03615105|α/β+ T-lymphocyte|α/β+ t-lymphocyte
5061441|NCT03615105|18-224|18-224
5061443|NCT03615092|Clinical Trial|clinical trial
5061540|NCT03614559|chronic total occlusion|chronic total occlusion
5061541|NCT03614546|primary hepatocellular carcinoma|primary hepatocellular carcinoma
5061638|NCT03613649|Healthy|healthy
5061639|NCT03613649|Moxifloxacin|moxifloxacin
5061640|NCT03613649|Repolarization|repolarization
5061641|NCT03613649|Study|study
5061643|NCT03613649|Volunteers|volunteers
5061644|NCT03613649|Zoliflodacin|zoliflodacin
5061645|NCT03613610|Genicular nerve radio-frequency ablation|genicular nerve radio-frequency ablation
5061646|NCT03613558|Dexmedetomidine|dexmedetomidine
5061932|NCT03611998|Activity-based programming|activity-based programming
5061933|NCT03611998|Brain trauma|brain trauma
5061934|NCT03611985|breast cancer|breast cancer
5061935|NCT03611985|Epidiferphane|epidiferphane
5061936|NCT03611985|taxane|taxane
5061937|NCT03611946|Zika virus|zika virus
5061938|NCT03611946|Vaccine|vaccine
5061939|NCT03611933|Back pain|back pain
5061940|NCT03611933|patient positioning|patient positioning
5062127|NCT03610802|Functional Assays|functional assays
5062232|NCT03610256|Obesity|obesity
5062233|NCT03610256|Bariatric surgery|bariatric surgery
5062234|NCT03610256|Single-anastomosis duodeno ileal bypass (SADI)|single-anastomosis duodeno ileal bypass (sadi)
5062235|NCT03610256|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5062236|NCT03610204|Alternative therapy|alternative therapy
5062237|NCT03610204|Massage|massage
5062241|NCT03610191|MD2|md2
5062327|NCT03609684|gymnastics|gymnastics
5062428|NCT03608969|Cerebral palsy|cerebral palsy
5062429|NCT03608969|Orofacial dysfunction|orofacial dysfunction
5062430|NCT03608969|Oral Health|oral health
5062528|NCT03608280|autologous bone graft|autologous bone graft
5062633|NCT03607721|gait analysis|gait analysis
5062634|NCT03607695|gait|gait
5062635|NCT03607695|exercise|exercise
5062734|NCT03607006|Autogenous bone shell|autogenous bone shell
5062735|NCT03607006|PEEK|peek
5062736|NCT03607006|Ridge augmentation|ridge augmentation
5062737|NCT03606993|Iron-deficiency|iron-deficiency
5062738|NCT03606993|Iron Deficiency Anemia|iron deficiency anemia
5062789|NCT03606655|NNK|nnk
5062839|NCT03606369|Antiemetics|antiemetics
5062840|NCT03606369|Quality of Life|quality of life
5062841|NCT03606369|Palonosetron|palonosetron
5062936|NCT03605823|Express Mini shunt; Pars plana; Vitrectomized eye|express mini shunt; pars plana; vitrectomized eye
5063039|NCT03605121|body mass index|body mass index
5063040|NCT03605121|cardiac surgery|cardiac surgery
5063041|NCT03605121|mortality|mortality
5063043|NCT03605095|gingival microcirculation|gingival microcirculation
5063044|NCT03605082|UCB0107|ucb0107
5063045|NCT03605082|Phase 1|phase 1
5063057|NCT03605043|Integrated|integrated
5063058|NCT03605043|Care cascade|care cascade
5063059|NCT03605043|Uganda|uganda
5063060|NCT03605030|Cardiac Catheterization|cardiac catheterization
5063140|NCT03604731|Immunology, Suppression, Inflammation, Cardiac, Surgery|immunology, suppression, inflammation, cardiac, surgery
5063233|NCT03603990|Macular Edema|macular edema
5063234|NCT03603990|Diabetic Retinopathy|diabetic retinopathy
5063235|NCT03603990|Macular Degeneration|macular degeneration
5063236|NCT03603990|Diabetic Angiopathies|diabetic angiopathies
5063237|NCT03603990|Retinal Disease|retinal disease
5063238|NCT03603990|Signs and Symptoms|signs and symptoms
5063239|NCT03603990|Vitrectomy|vitrectomy
5063240|NCT03603977|Simplified Therapy Regimen|simplified therapy regimen
5063334|NCT03603405|GBM, AA, Glioblastoma, Astrocytoma|gbm, aa, glioblastoma, astrocytoma
5063335|NCT03603379|anti- EGFR- immunoliposomes|anti- egfr- immunoliposomes
5063336|NCT03603288|respiratory function in DMD|respiratory function in dmd
5063337|NCT03603249|platelet inhibition|platelet inhibition
5063338|NCT03603249|platelet reactivity|platelet reactivity
5063339|NCT03603249|clopidogrel|clopidogrel
5063340|NCT03603249|trimetazidine|trimetazidine
5063341|NCT03603210|Ischaemic heart disease|ischaemic heart disease
5063342|NCT03603210|coronary angioplasty|coronary angioplasty
5063538|NCT03602326|Rehabilitation|rehabilitation
5063539|NCT03602313|Body Weight Support|body weight support
5063540|NCT03602287|anterior nasal pack|anterior nasal pack
5063541|NCT03602287|nasal pack removal|nasal pack removal
5063542|NCT03602287|2% lignocaine|2% lignocaine
5063543|NCT03602274|Paracetamol|paracetamol
5063646|NCT03601819|CTCL|ctcl
5063647|NCT03601819|PTCL|ptcl
5063648|NCT03601767|sepsis|sepsis
5063649|NCT03601767|score|score
5063650|NCT03601728|elective|elective
5063662|NCT03601689|ypT0N0|ypt0n0
5063744|NCT03601078|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5063745|NCT03601078|High Risk Multiple Myeloma|high risk multiple myeloma
5064033|NCT03599024|total hip replacement|total hip replacement
5064035|NCT03598985|Balance|balance
5064036|NCT03598985|Smartphone|smartphone
5064037|NCT03598985|Validity|validity
5064038|NCT03598985|Reliability|reliability
5064039|NCT03598985|chronic ankle instability|chronic ankle instability
5064040|NCT03598933|Upper Esophageal Sphincter|upper esophageal sphincter
5064133|NCT03598309|Lung cancer risk|lung cancer risk
5064134|NCT03598309|Chemoprevention|chemoprevention
5064135|NCT03598296|ERAS(Enhanced Recovery After Surgery)|eras(enhanced recovery after surgery)
5064234|NCT03597789|Tantrums|tantrums
5064235|NCT03597789|Inattentive|inattentive
5064236|NCT03597789|Noncompliance|noncompliance
5064237|NCT03597776|intravenous lidocaine|intravenous lidocaine
5064238|NCT03597776|pain|pain
5064239|NCT03597776|total knee replacement|total knee replacement
5064240|NCT03597776|spinal anaesthesia|spinal anaesthesia
5064241|NCT03597763|persistent fatigue|persistent fatigue
5064242|NCT03597763|traumatic brain injury|traumatic brain injury
5064243|NCT03597750|Static air support devices|static air support devices
5064245|NCT03597750|High risk population|high risk population
5064329|NCT03597243|Tanzania|tanzania
5064427|NCT03596593|China|china
5064428|NCT03596593|MSI|msi
5064429|NCT03596593|ctDNA|ctdna
5064430|NCT03596580|Screening tool|screening tool
5064531|NCT03595917|B-cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
5064532|NCT03595917|Chronic Myeloid Leukemia (CML) in lymphoid blast crisis|chronic myeloid leukemia (cml) in lymphoid blast crisis
5064534|NCT03595904|colorectal neoplasms|colorectal neoplasms
5680532|NCT00577681|HIV|hiv
5064628|NCT03595046|thoracic paravertebral block|thoracic paravertebral block
5064629|NCT03595046|erector spinae plane block|erector spinae plane block
5064630|NCT03595046|thoracic postherpetic neuralgia|thoracic postherpetic neuralgia
5064727|NCT03594253|emotion regulation|emotion regulation
5064819|NCT03593824|Phenotypic plasticity|phenotypic plasticity
5064824|NCT03593772|chronic pain|chronic pain
5064825|NCT03593772|PTSD|ptsd
5064921|NCT03593317|Heart Failure|heart failure
5065022|NCT03592667|ABPM|abpm
5065023|NCT03592615|prevalence|prevalence
5065024|NCT03592615|binocular vision disorders|binocular vision disorders
5065025|NCT03592615|accommodative disorders|accommodative disorders
5065026|NCT03592615|cataract surgery|cataract surgery
5065027|NCT03592615|corneal refractive surgery|corneal refractive surgery
5065028|NCT03592576|Expanded Access|expanded access
5065124|NCT03592056|continuous plexus block|continuous plexus block
5065125|NCT03592056|interscalene plexus block|interscalene plexus block
5065321|NCT03590717|animal sourced foods|animal sourced foods
5065322|NCT03590704|Taping|taping
5065323|NCT03590704|Seroma|seroma
5065324|NCT03590704|Safety|safety
5065325|NCT03590704|Breast Cancer|breast cancer
5065326|NCT03590704|Physiotherapy|physiotherapy
5065327|NCT03590691|storytelling|storytelling
5065328|NCT03590665|exercise, blood flow, strength, blood pressure, heart rate,|exercise, blood flow, strength, blood pressure, heart rate,
5065329|NCT03590652|multiple myeloma|multiple myeloma
5065330|NCT03590652|relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
5065331|NCT03590652|Daratumumab|daratumumab
5065335|NCT03590652|cancer|cancer
5065422|NCT03590145|Adductor-related|adductor-related
5065423|NCT03590145|Inguinal-related|inguinal-related
5065424|NCT03590145|Pubic-related|pubic-related
5065425|NCT03590145|Iliopsoas-related|iliopsoas-related
5065427|NCT03590132|adolescent|adolescent
5065428|NCT03590132|alcohol|alcohol
5065429|NCT03590132|family-centered prevention|family-centered prevention
5065430|NCT03590132|African American|african american
5065431|NCT03590119|LUTIA|lutia
5065432|NCT03590119|neuroendocrine tumor|neuroendocrine tumor
5065433|NCT03590119|lutetium-177-dotatate|lutetium-177-dotatate
5065434|NCT03590119|intra-arterial|intra-arterial
5065435|NCT03590119|liver metastases|liver metastases
5065436|NCT03590080|Graves' Disease|graves' disease
5065523|NCT03589703|Chronic Low Back Pain|chronic low back pain
5065524|NCT03589703|cLBP|clbp
5065525|NCT03589703|pain|pain
5065526|NCT03589703|acupressure|acupressure
5065627|NCT03589092|Genetic testing|genetic testing
5065628|NCT03589092|Next Generation Sequencing|next generation sequencing
5065630|NCT03589079|Monogenic Disorder|monogenic disorder
5065631|NCT03589079|Mendelian Disease|mendelian disease
5065632|NCT03589079|Single Gene Disorder|single gene disorder
5065633|NCT03589079|Next Generation Sequencing|next generation sequencing
5065634|NCT03589079|Genetic testing|genetic testing
5065729|NCT03588507|modified papilla preservation|modified papilla preservation
5065730|NCT03588507|simplified papilla preservation|simplified papilla preservation
5065828|NCT03587779|desflurane|desflurane
5065829|NCT03587779|minimum alveolar concentration|minimum alveolar concentration
5065831|NCT03587766|Chagas' Disease|chagas' disease
5065924|NCT03586739|Mesenteric Ischemia Chronic|mesenteric ischemia chronic
5065925|NCT03586739|Atherosclerosis|atherosclerosis
5065926|NCT03586739|Restenosis|restenosis
5065927|NCT03586739|Primary endovascular treatment|primary endovascular treatment
5065928|NCT03586739|Covered stents|covered stents
5065929|NCT03586739|Bare metal stents|bare metal stents
5065930|NCT03586700|Knee Osteoarthritis|knee osteoarthritis
5065931|NCT03586700|Synovium effusion|synovium effusion
5066521|NCT03583151|Corticosteroid|corticosteroid
5066522|NCT03583138|HIV|hiv
5066523|NCT03583138|AIDS|aids
5066524|NCT03583138|Opiate Addiction|opiate addiction
5066525|NCT03583138|Drug Dependence|drug dependence
5066526|NCT03583138|Buprenorphine|buprenorphine
5066527|NCT03583125|bladder cancer|bladder cancer
5066528|NCT03583125|cholangiocarcinoma|cholangiocarcinoma
5066529|NCT03583125|gastric cancer|gastric cancer
5066530|NCT03583125|breast cancer|breast cancer
5066532|NCT03583073|psychosis|psychosis
5066731|NCT03581877|Alteplase|alteplase
5066732|NCT03581877|submassive pulmonary embolism|submassive pulmonary embolism
5066733|NCT03581877|Thrombolysis|thrombolysis
5066734|NCT03581877|pulmonary catheter|pulmonary catheter
5685490|NCT00555867|hormone-receptor positive primary breast cancer|hormone-receptor positive primary breast cancer
5685491|NCT00555867|compliance|compliance
5066929|NCT03580356|Anti-IgE, CSU (Chronic Spontaneous Urticaria), hives severity score, itch severity score, urticaria activity score|anti-ige, csu (chronic spontaneous urticaria), hives severity score, itch severity score, urticaria activity score
5066930|NCT03580330|noncommunicable diseases|noncommunicable diseases
5066931|NCT03580330|hypertension|hypertension
5067086|NCT03579576|HCV|hcv
5067236|NCT03578536|Stroke|stroke
5067629|NCT03576326|Behavioral Economics|behavioral economics
5067630|NCT03576313|transmission|transmission
5067632|NCT03576300|ocular surface|ocular surface
5067633|NCT03576287|apremilast|apremilast
5067634|NCT03576274|cancer related fatigue|cancer related fatigue
5067729|NCT03575819|castration-resistant|castration-resistant
5067730|NCT03575819|androgen-signaling blockade progression|androgen-signaling blockade progression
5067835|NCT03575169|Sedation|sedation
5067836|NCT03575169|Traumatic Brain Injury|traumatic brain injury
5067837|NCT03575156|Systemic Lupus Erythematosus|systemic lupus erythematosus
5067838|NCT03575156|Systemic Scleroderma|systemic scleroderma
5067839|NCT03575156|autoimmunity|autoimmunity
5067840|NCT03575156|microparticles|microparticles
5067841|NCT03575156|platelets|platelets
5067842|NCT03575143|HIV|hiv
5067843|NCT03575143|OSA|osa
5067844|NCT03575143|PLWH|plwh
5067845|NCT03575143|Sleep|sleep
5067897|NCT03574701|CRS|crs
5067942|NCT03574467|brain neoplasms|brain neoplasms
5067944|NCT03574467|rehabilitation|rehabilitation
5068038|NCT03573804|Breast Cancer Locator|breast cancer locator
5068039|NCT03573778|health|health
5068040|NCT03573778|quality of life|quality of life
5068041|NCT03573778|safety|safety
5068045|NCT03573778|confidence|confidence
5068239|NCT03572634|Previously treated Chronic Lymphocytic Leukemia (CLL)|previously treated chronic lymphocytic leukemia (cll)
5068341|NCT03572127|Sustainability|sustainability
5068342|NCT03572101|colorectal cancer|colorectal cancer
5068343|NCT03572101|palliative care|palliative care
5068441|NCT03571451|end stage renal disease|end stage renal disease
5068442|NCT03571412|Depression|depression
5068443|NCT03571412|Major Depressive Disorder|major depressive disorder
5068444|NCT03571386|Mindfulness|mindfulness
5068445|NCT03571386|Depression|depression
5068446|NCT03571386|Anxiety|anxiety
5068447|NCT03571386|stress|stress
5068448|NCT03571360|Immunotherapy|immunotherapy
5068450|NCT03571347|post-traumatic stress disorder|post-traumatic stress disorder
5068451|NCT03571347|prevention|prevention
5068533|NCT03570697|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5068534|NCT03570697|Intravascular ultrasound (IVUS)|intravascular ultrasound (ivus)
5068535|NCT03570697|Coronary angiography|coronary angiography
5068536|NCT03570697|Coronary artery disease|coronary artery disease
5068635|NCT03570047|Non-valvular atrial fibrillation, NVAF|non-valvular atrial fibrillation, nvaf
5068636|NCT03570008|prevention|prevention
5068637|NCT03570008|bone|bone
5068638|NCT03570008|physical activity|physical activity
5068736|NCT03569553|Anthrax|anthrax
5068737|NCT03569553|Bacillus anthracis|bacillus anthracis
5068738|NCT03569553|Inhalational anthrax|inhalational anthrax
5068740|NCT03569553|AIGIV|aigiv
5068833|NCT03569059|Stroke|stroke
5068837|NCT03569059|Hand|hand
5068936|NCT03568591|Salivary Cortisol|salivary cortisol
5068937|NCT03568591|Blood Pressure|blood pressure
5068938|NCT03568591|Havening Techniques|havening techniques
5068939|NCT03568578|Fibrosis|fibrosis
5068940|NCT03568578|Liver Cirrhosis|liver cirrhosis
5068941|NCT03568578|non-invasive biopsy|non-invasive biopsy
5068942|NCT03568578|hepatitis B virus|hepatitis b virus
5068943|NCT03568552|Opioid Use Disorder (OUD)|opioid use disorder (oud)
5068944|NCT03568552|Medication Assisted Therapy (MAT)|medication assisted therapy (mat)
5068972|NCT03568344|iCCM|iccm
5069234|NCT03566186|Autonomic nervous system|autonomic nervous system
5069235|NCT03566186|Heart rate variability|heart rate variability
5069236|NCT03566186|Recovery of function|recovery of function
5069237|NCT03566186|Super-pulsed laser|super-pulsed laser
5069238|NCT03566186|Led light|led light
5069240|NCT03566160|EGD|egd
5069339|NCT03565614|older people|older people
5069340|NCT03565614|personal care services|personal care services
5069341|NCT03565614|rehabilitation|rehabilitation
5069342|NCT03565614|multimorbidity|multimorbidity
5069343|NCT03565614|disability|disability
5069344|NCT03565588|Voluntary medical male circumcision|voluntary medical male circumcision
5069345|NCT03565588|HIV prevention|hiv prevention
5069346|NCT03565588|Risk perception|risk perception
5069347|NCT03565575|Pre-Exposure Prophylaxis (PrEP) for HIV|pre-exposure prophylaxis (prep) for hiv
5069348|NCT03565575|Risk perception|risk perception
5069737|NCT03563209|Stroke|stroke
5069819|NCT03562715|mesenchymal stem cells|mesenchymal stem cells
5069820|NCT03562702|vomiting|vomiting
5069822|NCT03562689|Sepsis|sepsis
5070023|NCT03561298|Healthy subjects|healthy subjects
5070024|NCT03561259|Iobenguane Avid High-risk Neuroblastoma|iobenguane avid high-risk neuroblastoma
5070025|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine
5070026|NCT03561259|Radiopharmaceutical|radiopharmaceutical
5070027|NCT03561246|Stroke|stroke
5070028|NCT03561246|Rehabilitation|rehabilitation
5070029|NCT03561246|Walking|walking
5070030|NCT03561246|Biomechanics|biomechanics
5070035|NCT03561168|Pediatric|pediatric
5070036|NCT03561168|MRI Indications|mri indications
5070124|NCT03560661|Kennedy's disease|kennedy's disease
5070125|NCT03560648|muscle aging|muscle aging
5070126|NCT03560648|sarcopenia|sarcopenia
5070127|NCT03560648|neuromuscular dysfunction|neuromuscular dysfunction
5070128|NCT03560635|weight loss maintenance|weight loss maintenance
5070129|NCT03560635|reverse diet|reverse diet
5070326|NCT03559543|Nutritional supplement|nutritional supplement
5070327|NCT03559543|Metastatic colorectal Cancer|metastatic colorectal cancer
5070328|NCT03559543|Oxidative Stress|oxidative stress
5070329|NCT03559543|Ocoxin Viusid|ocoxin viusid
5070330|NCT03559543|Antioxidant|antioxidant
5070331|NCT03559530|osteomyelitis|osteomyelitis
5070336|NCT03559504|sevoflurane|sevoflurane
5070634|NCT03557762|Mindfulness|mindfulness
5070635|NCT03557723|Community-dwellers,older adults, museum, art|community-dwellers,older adults, museum, art
5070637|NCT03557710|overweight|overweight
5070638|NCT03557710|obesity|obesity
5070834|NCT03556436|Non-Small Cell Lung Cancer|non-small cell lung cancer
5070835|NCT03556423|Arthritis|arthritis
5070836|NCT03556423|Chronic pain|chronic pain
5071036|NCT03555266|Pain Therapy|pain therapy
5071037|NCT03555266|Auricular Therapy|auricular therapy
5071038|NCT03555253|Resilience|resilience
5071039|NCT03555253|Telehealth|telehealth
5071040|NCT03555253|Well-being|well-being
5071041|NCT03555253|Support|support
5071042|NCT03555253|Caregiving|caregiving
5071043|NCT03555240|Rheumatoid Arthritis|rheumatoid arthritis
5071044|NCT03555227|breast cancer analgesia|breast cancer analgesia
5071046|NCT03555227|ultrasound|ultrasound
5071136|NCT03554499|Facial aging|facial aging
5071137|NCT03554499|Buccal fat pad|buccal fat pad
5071138|NCT03554473|Chemosensitivity|chemosensitivity
5071139|NCT03554473|DNA Damage and Replication|dna damage and replication
5071140|NCT03554473|PD-1/PD-L1|pd-1/pd-l1
5071141|NCT03554473|Solid Tumors|solid tumors
5071237|NCT03553888|Vibrational spectroscopies|vibrational spectroscopies
5071238|NCT03553888|Salivary biomarkers|salivary biomarkers
5071239|NCT03553875|Autism|autism
5071240|NCT03553875|Massachusetts General Hospital|massachusetts general hospital
5071247|NCT03553823|Psoriasis|psoriasis
5071248|NCT03553784|Cancer|cancer
5071433|NCT03552679|Right Heart Failure|right heart failure
5071434|NCT03552679|Ventricular Assist Device|ventricular assist device
5071435|NCT03552679|Mortality|mortality
5071436|NCT03552679|ICU Stay|icu stay
5071437|NCT03552679|Acute Kidney Injury|acute kidney injury
5071438|NCT03552666|Vitamin D|vitamin d
5071439|NCT03552640|Orthodontics|orthodontics
5071440|NCT03552640|Digitized Models|digitized models
5071441|NCT03552640|Root Position|root position
5071443|NCT03552627|oxygen|oxygen
5071534|NCT03551990|Whole-body electromyostimulation|whole-body electromyostimulation
5071827|NCT03550144|Positive emotions|positive emotions
5071829|NCT03550131|LGBT|lgbt
5071830|NCT03550118|Prosthetic Socket|prosthetic socket
5071831|NCT03550118|Amputee|amputee
5071832|NCT03550118|Adjustable Socket|adjustable socket
5071834|NCT03550105|Diabetes|diabetes
5071835|NCT03550105|Physical Activity|physical activity
5071836|NCT03550105|Passive Exercise|passive exercise
5071837|NCT03550105|Blood Pressure|blood pressure
5071931|NCT03549585|criSTAL|cristal
5071932|NCT03549546|Lymphopenia|lymphopenia
5071933|NCT03549546|Lung cancer surgery|lung cancer surgery
5071934|NCT03549546|TIM-3|tim-3
5071935|NCT03549546|PD-1|pd-1
5071936|NCT03549546|CTLA-4|ctla-4
5071937|NCT03549546|lymphocytes|lymphocytes
5071939|NCT03549546|CD8|cd8
5072035|NCT03549169|Intervention|intervention
5072036|NCT03549169|Heart Failure|heart failure
5072037|NCT03549169|Symptoms management|symptoms management
5072038|NCT03549169|Selft-care|selft-care
5072138|NCT03548493|chronic subdural haematoma|chronic subdural haematoma
5072139|NCT03548493|Propofol|propofol
5072140|NCT03548493|Burr hole|burr hole
5072141|NCT03548467|melanoma|melanoma
5072142|NCT03548467|NSCLC|nsclc
5072143|NCT03548467|clear renal cell carcinoma|clear renal cell carcinoma
5072144|NCT03548467|urothelial cancer or SCCHN|urothelial cancer or scchn
5072145|NCT03548428|Atezolizumab|atezolizumab
5072146|NCT03548428|Oligometastatic Sarcomas|oligometastatic sarcomas
5072147|NCT03548428|stereotactic body radiation therapy|stereotactic body radiation therapy
5072148|NCT03548415|Acromegaly, IONIS-GHR-LRx|acromegaly, ionis-ghr-lrx
5072149|NCT03548376|rehabilitation|rehabilitation
5072150|NCT03548376|cerebral palsy|cerebral palsy
5072152|NCT03548376|balance|balance
5072532|NCT03545932|Gerontomotricity|gerontomotricity
5072533|NCT03545919|respiratory viral infections|respiratory viral infections
5072534|NCT03545919|chronic lung allograft dysfunction|chronic lung allograft dysfunction
5072535|NCT03545919|lung microbiome|lung microbiome
5072536|NCT03545867|postprandial|postprandial
5072537|NCT03545867|glycemia|glycemia
5072538|NCT03545867|lipemia|lipemia
5072539|NCT03545867|macronutrient metabolism|macronutrient metabolism
5072540|NCT03545867|physical activity|physical activity
5072541|NCT03545815|mesothelin, CRISPR-Cas9, PD-1, TCR|mesothelin, crispr-cas9, pd-1, tcr
5072545|NCT03545763|Hypertension|hypertension
5072552|NCT03545750|Citrate|citrate
5072632|NCT03545256|head neck cancer|head neck cancer
5072633|NCT03545256|Lymph node metastasis|lymph node metastasis
5072634|NCT03545256|surgery|surgery
5072635|NCT03545256|Quality of life|quality of life
5072636|NCT03545256|economical study|economical study
5072637|NCT03545243|duodenum|duodenum
5072638|NCT03545243|microbiome|microbiome
5072639|NCT03545243|proton pump inhibitor|proton pump inhibitor
5072641|NCT03545178|white coat adherence|white coat adherence
5072829|NCT03543865|Native American|native american
5072830|NCT03543852|Cancer survivor|cancer survivor
5072837|NCT03543826|neostigmine|neostigmine
5073028|NCT03542656|amyoid PET|amyoid pet
5073029|NCT03542656|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5073030|NCT03542643|ADHD|adhd
5073031|NCT03542643|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5073032|NCT03542643|children|children
5073033|NCT03542643|adolescents|adolescents
5073040|NCT03542487|Self Monitoring of Blood Glucose|self monitoring of blood glucose
5073041|NCT03542487|Electronic Medical Records|electronic medical records
5073042|NCT03542487|Nudge|nudge
5073043|NCT03542487|Secure Messaging|secure messaging
5073044|NCT03542487|Behavioral Economics|behavioral economics
5073045|NCT03542461|Squamous NSCLC|squamous nsclc
5073046|NCT03542461|Nivolumab|nivolumab
5073047|NCT03542396|Behaviour change techniques|behaviour change techniques
5073048|NCT03542396|Aerobic exercise|aerobic exercise
5073123|NCT03541876|children|children
5073125|NCT03541876|observatory|observatory
5073126|NCT03541863|Fulvestrant|fulvestrant
5073625|NCT03538795|upper-extremity|upper-extremity
5073626|NCT03538795|motor impairment|motor impairment
5073627|NCT03538795|TMS|tms
5073628|NCT03538795|brain stimulation|brain stimulation
5073629|NCT03538795|neuroplasticity|neuroplasticity
5073630|NCT03538782|percutaneous biliary drainage|percutaneous biliary drainage
5073631|NCT03538782|radiation exposure|radiation exposure
5073632|NCT03538756|Balance|balance
5073633|NCT03538756|Peripheral Neuropathy|peripheral neuropathy
5073647|NCT03538691|MDD|mdd
5073813|NCT03537729|Environment design|environment design
5073814|NCT03537729|Long term care|long term care
5073815|NCT03537729|Dementia|dementia
5073816|NCT03537716|Abdominal Fat|abdominal fat
5073817|NCT03537703|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5073818|NCT03537703|tDCS|tdcs
5073819|NCT03537703|Auditory Processing|auditory processing
5073820|NCT03537703|tone matching|tone matching
5073912|NCT03537196|Viral hepatitis C|viral hepatitis c
5073913|NCT03537183|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5073914|NCT03537183|exercise training|exercise training
5073916|NCT03537157|Crohn Disease recurrence|crohn disease recurrence
5073917|NCT03537144|Patent ductus arteriosus|patent ductus arteriosus
5073918|NCT03537144|acetaminophen|acetaminophen
5074014|NCT03536520|cognition|cognition
5074015|NCT03536520|visuo-motor learning performance|visuo-motor learning performance
5074115|NCT03535844|Endothelial function|endothelial function
5074116|NCT03535844|Lipidomics|lipidomics
5074117|NCT03535844|Middle-aged and older adults|middle-aged and older adults
5074118|NCT03535844|Oxidative stress|oxidative stress
5074119|NCT03535844|Inflammation|inflammation
5074120|NCT03535805|Cognitive and Behavioral Therapies|cognitive and behavioral therapies
5074121|NCT03535805|Children and Adolescents|children and adolescents
5074213|NCT03535090|Blood Coagulation|blood coagulation
5074214|NCT03535090|Venous Thromboembolism|venous thromboembolism
5074215|NCT03535090|Methylprednisolone|methylprednisolone
5074216|NCT03535077|Melanoma|melanoma
5074217|NCT03535077|Nevus|nevus
5074218|NCT03535077|Mole|mole
5074221|NCT03535051|vitiligo|vitiligo
5074313|NCT03534440|Anesthesia|anesthesia
5074314|NCT03534440|Preoperative assessment|preoperative assessment
5074512|NCT03533023|Firefighters|firefighters
5074513|NCT03533023|San Diego Fire and Rescue|san diego fire and rescue
5074514|NCT03533023|Cardiometabolic Health|cardiometabolic health
5074515|NCT03533023|First Responder|first responder
5074531|NCT03532893|EBC|ebc
5074614|NCT03532386|vaginal hydrocele|vaginal hydrocele
5074615|NCT03532334|19F MRI gas Ventilation|19f mri gas ventilation
5074616|NCT03532334|133 XE ventilation Scintigraphy|133 xe ventilation scintigraphy
5074813|NCT03531047|cross-linking|cross-linking
5074814|NCT03531047|customised|customised
5074815|NCT03531047|refractive|refractive
5074816|NCT03531034|Blood Pressure Variability|blood pressure variability
5074817|NCT03531034|Ambulatorial Blood Pressure Monitoring|ambulatorial blood pressure monitoring
5074818|NCT03531034|Combined Exercise|combined exercise
5074819|NCT03531021|type 1 diabetes|type 1 diabetes
5074820|NCT03531021|cardiovascular risk factor|cardiovascular risk factor
5074821|NCT03531021|teenager|teenager
5074822|NCT03531008|focal;|focal;
5074823|NCT03530956|AMPfoot|ampfoot
5074824|NCT03530956|dual-task|dual-task
5074825|NCT03530956|cognitive performance|cognitive performance
5074826|NCT03530956|physical performance|physical performance
5658810|NCT00667446|CPP|cpp
5074827|NCT03530956|lower-limb prosthesis|lower-limb prosthesis
5074828|NCT03530891|anterior mandible fracture|anterior mandible fracture
5074901|NCT03530358|MRI|mri
5074972|NCT03529968|CT|ct
5075015|NCT03529838|Heart rate variability|heart rate variability
5075016|NCT03529825|Rifaximin|rifaximin
5075024|NCT03529799|TBI|tbi
5075113|NCT03529383|Exercise|exercise
5075114|NCT03529383|Adapted physical activity|adapted physical activity
5075115|NCT03529383|Sedentary|sedentary
5075116|NCT03529383|Connected device|connected device
5075117|NCT03529383|Activity trackers|activity trackers
5075213|NCT03528655|patient decision aid|patient decision aid
5075214|NCT03528629|zolbetuximab|zolbetuximab
5075215|NCT03528629|IMAB362|imab362
5075216|NCT03528629|pharmacokinetics|pharmacokinetics
5075217|NCT03528629|tolerability|tolerability
5075419|NCT03527420|Cardiovascular|cardiovascular
5075420|NCT03527394|Obesity|obesity
5075421|NCT03527394|Pediatric|pediatric
5075422|NCT03527394|Parent|parent
5075423|NCT03527394|Family|family
5075424|NCT03527394|Motivational Interviewing|motivational interviewing
5075425|NCT03527394|Lifestyle|lifestyle
5075434|NCT03527355|Typhoid|typhoid
5075527|NCT03526978|Inactivated poliovirus vaccine|inactivated poliovirus vaccine
5075529|NCT03526978|safety|safety
5075530|NCT03526978|immunogenicity|immunogenicity
5075531|NCT03526978|infant|infant
5075532|NCT03526939|Persons who inject drugs|persons who inject drugs
5075533|NCT03526939|HIV|hiv
5075828|NCT03525054|Automated Language Analysis|automated language analysis
5075829|NCT03525054|Semantic Coherence|semantic coherence
5075830|NCT03525054|Syntaxic Complexity|syntaxic complexity
5075831|NCT03524989|hbot|hbot
5075832|NCT03524989|hyperbaric oxygen|hyperbaric oxygen
5075833|NCT03524989|sport|sport
5075834|NCT03524989|mitochondria|mitochondria
5075835|NCT03524989|athletes|athletes
5075836|NCT03524989|aerobic|aerobic
5075839|NCT03524950|stress|stress
5075929|NCT03524560|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio|comprehensive geriatric assesment, polypharmacy,geriatric depression scale,neutrophil/lymphocyte ratio
5076025|NCT03523949|Pain Neuroscience Education|pain neuroscience education
5076026|NCT03523949|Elderly|elderly
5076027|NCT03523949|Pain Education|pain education
5076028|NCT03523936|antibiotics, prebiotics, dysbiosis|antibiotics, prebiotics, dysbiosis
5076029|NCT03523923|Collaborative Care|collaborative care
5076030|NCT03523923|Effectiveness Study|effectiveness study
5076031|NCT03523845|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"|"early apical peri-implantitis; implant periapical lesion; retrograde peri-implantitis; implant failure"
5076032|NCT03523819|Solid Tumors|solid tumors
5076033|NCT03523793|Outpatient Physical Therapy|outpatient physical therapy
5076034|NCT03523754|Induction of labor|induction of labor
5076223|NCT03522519|Observational Cohort Study|observational cohort study
5076225|NCT03522480|cystic fibrosis|cystic fibrosis
5076226|NCT03522480|autogenic drainage|autogenic drainage
5076227|NCT03522480|respiratory therapy|respiratory therapy
5076228|NCT03522480|videogaming therapy|videogaming therapy
5076229|NCT03522467|Cannabis oil|cannabis oil
5076230|NCT03522467|Cannabis|cannabis
5076424|NCT03521414|intracranial pathology|intracranial pathology
5076425|NCT03521401|Adverse Childhood Experiences|adverse childhood experiences
5076426|NCT03521401|Exercise Intervention|exercise intervention
5076530|NCT03520933|Spent culture medium|spent culture medium
5076531|NCT03520933|Trophectoderm biopsy|trophectoderm biopsy
5076532|NCT03520907|transversalis fascia|transversalis fascia
5076533|NCT03520907|ilioinguinal/iliohypogastric nerve|ilioinguinal/iliohypogastric nerve
5076534|NCT03520907|inguinal hernia repair|inguinal hernia repair
5076536|NCT03520881|asthma|asthma
5076537|NCT03520855|Type 1 Diabetes|type 1 diabetes
5076538|NCT03520855|Paediatrics patients|paediatrics patients
5076600|NCT03520517|ALS|als
5076630|NCT03520413|Diabetes|diabetes
5076924|NCT03518372|Near-infrared Spectroscopy (NIRS)|near-infrared spectroscopy (nirs)
5076925|NCT03518359|Residents|residents
5076926|NCT03518359|Stress|stress
5076927|NCT03518359|Well-being|well-being
5076928|NCT03518320|Bladder Cancer|bladder cancer
5076929|NCT03518320|Urothelial Carcinoma|urothelial carcinoma
5076930|NCT03518320|Cystectomy|cystectomy
5076931|NCT03518320|Radical Cystectomy|radical cystectomy
5076932|NCT03518307|Merkel carcinoma|merkel carcinoma
5076935|NCT03518268|probiotics|probiotics
5076936|NCT03518268|aromatase inhibitors|aromatase inhibitors
5076937|NCT03518268|bone mass|bone mass
5076938|NCT03518268|postmenopausal|postmenopausal
5076939|NCT03518255|Nursing Care|nursing care
5076940|NCT03518255|Complementary therapies|complementary therapies
5076944|NCT03518229|sunburn|sunburn
5077020|NCT03517839|Inspiratory Muscle Training|inspiratory muscle training
5077021|NCT03517839|Kinesiophobia|kinesiophobia
5077023|NCT03517826|Dyspnea|dyspnea
5077024|NCT03517826|Kinesiophobia|kinesiophobia
5077025|NCT03517800|Embolization|embolization
5077026|NCT03517800|surgery|surgery
5077027|NCT03517800|hysterectomy|hysterectomy
5077028|NCT03517800|arterial ligation|arterial ligation
5077029|NCT03517761|CCJ|ccj
5077030|NCT03517761|Bone Marrow Concentrate|bone marrow concentrate
5077031|NCT03517761|Stem Cell Therapy|stem cell therapy
5077032|NCT03517761|Alar Ligament|alar ligament
5077033|NCT03517761|Transverse Ligament|transverse ligament
5077034|NCT03517670|Cerebral vasospasm|cerebral vasospasm
5077035|NCT03517670|Subarachnoid hemorrhage|subarachnoid hemorrhage
5077036|NCT03517670|Milrinone|milrinone
5077037|NCT03517670|Hemodynamic tolerance|hemodynamic tolerance
5077038|NCT03517657|upper limb|upper limb
5077039|NCT03517657|occupational therapy|occupational therapy
5077040|NCT03517657|bilateral priming|bilateral priming
5077047|NCT03517618|A phase II study|a phase ii study
5077048|NCT03517618|Heavily pre-treated metastatic colorectal cancer|heavily pre-treated metastatic colorectal cancer
5077050|NCT03517618|oral leucovrin|oral leucovrin
5077051|NCT03517605|Cardiac Rehabilitation|cardiac rehabilitation
5077052|NCT03517605|Quality of Life|quality of life
5077053|NCT03517605|Rehabilitation Nursing|rehabilitation nursing
5077054|NCT03517566|atopic dermatitis, AD, eczema, atopic eczema, itch, pruritus, histamine 4 receptor|atopic dermatitis, ad, eczema, atopic eczema, itch, pruritus, histamine 4 receptor
5077055|NCT03517566|antagonist, H4R, ZPL389, ZPL389A2203, dermatitis|antagonist, h4r, zpl389, zpl389a2203, dermatitis
5077057|NCT03517540|Steatohepatitis|steatohepatitis
5077115|NCT03517410|Mechanical Low Back Pain|mechanical low back pain
5077117|NCT03517410|Low Back Pain|low back pain
5077118|NCT03517410|Chronic Mechanical Low Back Pain|chronic mechanical low back pain
5077119|NCT03517410|CLBP|clbp
5077120|NCT03517397|Smoking Cessation|smoking cessation
5077308|NCT03516266|Postmenopausal|postmenopausal
5077309|NCT03516214|acquired resistance|acquired resistance
5077314|NCT03516201|Periodontitis|periodontitis
5077417|NCT03515525|Breast surgery|breast surgery
5077615|NCT03514264|Biomaterials|biomaterials
5077616|NCT03514264|Dental pulp cavity|dental pulp cavity
5077617|NCT03514264|Periapical abscess|periapical abscess
5077618|NCT03514264|Root canal therapy|root canal therapy
5077707|NCT03513809|Spontaneous breathing|spontaneous breathing
5077708|NCT03513809|Ventilation induced-lung injury|ventilation induced-lung injury
5077709|NCT03513809|Patient self-inflicted lung injury|patient self-inflicted lung injury
5077806|NCT03513211|Biochemically recurrent prostate cancer|biochemically recurrent prostate cancer
5077807|NCT03513211|Hormone sensitive prostate cancer|hormone sensitive prostate cancer
5077808|NCT03513198|contrast-enhanced endoscopic ultrasound|contrast-enhanced endoscopic ultrasound
5077809|NCT03513198|endoscopic ultrasound elastography|endoscopic ultrasound elastography
5077810|NCT03513198|tumor vascularity|tumor vascularity
5077811|NCT03513198|prognostic|prognostic
5077812|NCT03513185|somatic symptom disorder|somatic symptom disorder
5077813|NCT03513185|the Somatic Symptom Scale-China|the somatic symptom scale-china
5077814|NCT03513185|mental disorders management|mental disorders management
5077815|NCT03513172|Intraocular Pressure|intraocular pressure
5077899|NCT03512769|jaw support device, third molars, wisdom teeth, partially erupted or impacted|jaw support device, third molars, wisdom teeth, partially erupted or impacted
5077900|NCT03512756|Pancreatic cancer|pancreatic cancer
5077901|NCT03512756|Pancreas cancer|pancreas cancer
5077914|NCT03512756|MPS|mps
5078004|NCT03512340|efficacy|efficacy
5078005|NCT03512340|hematologic malignancies|hematologic malignancies
5078006|NCT03512340|SRF231|srf231
5078008|NCT03512262|BA058|ba058
5078295|NCT03510455|Hypophosphatemia|hypophosphatemia
5078399|NCT03509662|Cardiac Arrest|cardiac arrest
5078400|NCT03509662|Post-cardiac arrest syndrome|post-cardiac arrest syndrome
5078401|NCT03509662|Oxidative stress|oxidative stress
5078402|NCT03509623|neovascular age-related macular degeneration|neovascular age-related macular degeneration
5078403|NCT03509623|aflibercept|aflibercept
5078404|NCT03509623|intravitreal anti-VEGF|intravitreal anti-vegf
5078405|NCT03509623|coagulation|coagulation
5078406|NCT03509623|platelet count|platelet count
5078407|NCT03509623|D-Dimer|d-dimer
5078501|NCT03509064|Medico-economic impact|medico-economic impact
5078601|NCT03508219|Left Main Bifurcation|left main bifurcation
5078602|NCT03508206|Students, cognitive functions, memory|students, cognitive functions, memory
5078603|NCT03508193|EEN|een
5078604|NCT03508193|Nutrition|nutrition
5078605|NCT03508193|Diet|diet
5078606|NCT03508193|IBD|ibd
5078607|NCT03508180|Supportive care|supportive care
5078608|NCT03508180|cancer|cancer
5078609|NCT03508180|foot reflexology|foot reflexology
5078703|NCT03507491|Rhabdomyosarcoma|rhabdomyosarcoma
5078704|NCT03507491|Wilms tumor|wilms tumor
5078705|NCT03507491|Hepatoblastoma|hepatoblastoma
5078706|NCT03507491|Adolescent and young adult|adolescent and young adult
5078708|NCT03507465|letrozole|letrozole
5078998|NCT03505697|exercise|exercise
5078999|NCT03505697|maximal inspiratory pressure|maximal inspiratory pressure
5079000|NCT03505697|6-minute walk test|6-minute walk test
5079001|NCT03505619|home care service|home care service
5079002|NCT03505619|reablement service|reablement service
5079003|NCT03505619|rehabilitation|rehabilitation
5079004|NCT03505606|Amblyopia|amblyopia
5079005|NCT03505606|Visual Acuity|visual acuity
5079006|NCT03505606|Crowding|crowding
5079098|NCT03504956|MRI technique|mri technique
5079099|NCT03504956|High Resolution MRI Technique|high resolution mri technique
5079100|NCT03504943|Exercise|exercise
5079101|NCT03504943|Hemodialysis|hemodialysis
5079102|NCT03504943|Intradialytic hypotension|intradialytic hypotension
5079103|NCT03504930|Surgical|surgical
5079104|NCT03504930|Ileal pouch-anal anastomosis|ileal pouch-anal anastomosis
5079106|NCT03504904|Self-criticism|self-criticism
5079107|NCT03504904|Internet-based treatment|internet-based treatment
5079108|NCT03504904|ACT|act
5079109|NCT03504904|CFT|cft
5079110|NCT03504904|Guided self-help|guided self-help
5079111|NCT03504904|Acceptance|acceptance
5079199|NCT03504358|homogeneity and discriminatory ability|homogeneity and discriminatory ability
5079201|NCT03504332|immature teeth, revascularization|immature teeth, revascularization
5079295|NCT03503812|Asthma in children|asthma in children
5079296|NCT03503812|Atrial Fibrillation|atrial fibrillation
5079297|NCT03503812|Air pollution|air pollution
5079298|NCT03503799|breast cancer|breast cancer
5079394|NCT03503214|Acid-base equilibrium|acid-base equilibrium
5079395|NCT03503214|Stewart's approach|stewart's approach
5079396|NCT03503214|In vitro study|in vitro study
5079397|NCT03503214|Respiratory acid-base derangements|respiratory acid-base derangements
5079398|NCT03503162|bowel prepartion|bowel prepartion
5079399|NCT03503136|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5079400|NCT03503136|Induction chemotherapy|induction chemotherapy
5079693|NCT03501160|First episode psychosis|first episode psychosis
5079694|NCT03501160|Caregiving experience|caregiving experience
5079696|NCT03501134|Pro000888900|pro000888900
5079789|NCT03500601|Metagenomics|metagenomics
5079790|NCT03500601|Metabolomics|metabolomics
5079791|NCT03500575|induction therapy, photopheresis|induction therapy, photopheresis
5079792|NCT03500497|reticulocyte hemoglobin content (RetHe)|reticulocyte hemoglobin content (rethe)
5079793|NCT03500497|perioperative|perioperative
5079794|NCT03500497|colorectal surgery|colorectal surgery
5079795|NCT03500497|anemia|anemia
5079796|NCT03500471|Laparoscopic|laparoscopic
5079797|NCT03500471|Robotic|robotic
5079798|NCT03500471|Total Gastrectomy|total gastrectomy
5079799|NCT03500471|AGC|agc
5079800|NCT03500432|transperineal prostate biopsy|transperineal prostate biopsy
5079888|NCT03499912|Prognosis|prognosis
5079891|NCT03499899|checkpoint inhibition|checkpoint inhibition
5079985|NCT03499262|Early Intervention|early intervention
5080087|NCT03498599|neuroimaging|neuroimaging
5080088|NCT03498599|fear conditioning|fear conditioning
5080184|NCT03497819|Pancreatic Cancer|pancreatic cancer
5080185|NCT03497819|artery infusion|artery infusion
5080186|NCT03497806|Clostridium Difficile Infection|clostridium difficile infection
5080187|NCT03497806|CP101|cp101
5080188|NCT03497806|Crestovo|crestovo
5080384|NCT03496688|Bone regeneration|bone regeneration
5080385|NCT03496688|Histology|histology
5080485|NCT03496025|facial paralysis|facial paralysis
5080486|NCT03496025|functional electrical stimulation|functional electrical stimulation
5080496|NCT03495999|Hyperuricemia|hyperuricemia
5080497|NCT03495999|Metabolic syndrome|metabolic syndrome
5080498|NCT03495999|Left ventricular diastolic dysfunction|left ventricular diastolic dysfunction
5080499|NCT03495999|Inflammation|inflammation
5080690|NCT03494920|Brain Ischemia|brain ischemia
5080691|NCT03494920|Tissue Plasminogen Activator|tissue plasminogen activator
5080692|NCT03494920|Plasminogen|plasminogen
5080789|NCT03494244|breast reconstruction|breast reconstruction
5080790|NCT03494244|efficacy|efficacy
5080791|NCT03494231|Metastatic|metastatic
5080792|NCT03494231|Refractory|refractory
5080793|NCT03494231|Cancer|cancer
5080794|NCT03494231|Solid|solid
5080795|NCT03494231|Tumor|tumor
5080796|NCT03494218|disorders of consciousness|disorders of consciousness
5080805|NCT03494192|pain|pain
5080889|NCT03493490|placebo-controlled|placebo-controlled
5080890|NCT03493490|parallel-group|parallel-group
5080891|NCT03493490|single-centre|single-centre
5080892|NCT03493490|exploratory clinical study|exploratory clinical study
5080893|NCT03493451|T/NK-cell|t/nk-cell
5080894|NCT03493451|NK/T-cell|nk/t-cell
5080895|NCT03493451|extranodal|extranodal
5080896|NCT03493451|nasal|nasal
5080897|NCT03493451|NK-cell|nk-cell
5080898|NCT03493451|ENKTL|enktl
5080991|NCT03492541|evaporative dry eye|evaporative dry eye
5081090|NCT03492060|HNRNPC2|hnrnpc2
5081091|NCT03492060|HNRNPD|hnrnpd
5081092|NCT03492060|HNRNPE1|hnrnpe1
5081093|NCT03492060|HNRNPE2|hnrnpe2
5081094|NCT03492060|HNRNPE3|hnrnpe3
5081095|NCT03492060|HNRNPE4|hnrnpe4
5081096|NCT03492060|HNRNPG|hnrnpg
5081097|NCT03492060|HNRNPH1|hnrnph1
5081098|NCT03492060|HNRNPH2|hnrnph2
5081099|NCT03492060|HNRNPI|hnrnpi
5081100|NCT03492060|HNRNPK|hnrnpk
5081101|NCT03492060|HNRNPL|hnrnpl
5081102|NCT03492060|HNRNPM|hnrnpm
5081194|NCT03491488|executive function|executive function
5081195|NCT03491488|Early childhood education|early childhood education
5081196|NCT03491488|self regulation|self regulation
5081197|NCT03491475|Ajmaline test|ajmaline test
5081200|NCT03491449|Brain ischemia|brain ischemia
5081201|NCT03491449|Cerebral ischemia|cerebral ischemia
5081202|NCT03491410|Metastatic|metastatic
5081203|NCT03491410|Active Surveillance|active surveillance
5081204|NCT03491397|Microspheres|microspheres
5081205|NCT03491397|Artery Embolization|artery embolization
5081206|NCT03491397|Knee Osteoarthritis|knee osteoarthritis
5659117|NCT00666211|pain|pain
5081494|NCT03489811|Aromatherapy|aromatherapy
5081495|NCT03489811|Anxiety|anxiety
5081496|NCT03489811|Autism Spectrum Disorder|autism spectrum disorder
5081497|NCT03489798|Induction of labor|induction of labor
5081498|NCT03489798|Misoprostol|misoprostol
5081611|NCT03489291|FIX|fix
5081695|NCT03488771|infection|infection
5081696|NCT03488771|immunosuppression|immunosuppression
5081887|NCT03487107|Chronic Genotype 1 HCV Infection|chronic genotype 1 hcv infection
5081888|NCT03487029|diabetes|diabetes
5081891|NCT03487016|Pancreatic Cancer|pancreatic cancer
5081984|NCT03486171|risk factors|risk factors
5081985|NCT03486158|Leukocyte L1 Antigen Complex|leukocyte l1 antigen complex
5081986|NCT03486158|Feces|feces
5081987|NCT03486158|Cell Phone|cell phone
5081988|NCT03486158|Biomarkers|biomarkers
5082039|NCT03485898|UCC|ucc
5082083|NCT03485586|cataract, higher order aberration,vitrectomy,diabetic retinopathy|cataract, higher order aberration,vitrectomy,diabetic retinopathy
5082084|NCT03485560|chronic skin disease|chronic skin disease
5082085|NCT03485560|psoriasis|psoriasis
5082086|NCT03485560|Eczema|eczema
5082087|NCT03485560|atopic dermatitis|atopic dermatitis
5082088|NCT03485547|Blastic Plasmacytoid Dendritic Cell Neoplasm|blastic plasmacytoid dendritic cell neoplasm
5082089|NCT03485547|BPDCN|bpdcn
5082188|NCT03484988|Gut Microbiota|gut microbiota
5082189|NCT03484962|activated CIK|activated cik
5082190|NCT03484962|MUC1|muc1
5082191|NCT03484962|bispecific antibody|bispecific antibody
5082192|NCT03484962|liver cancer|liver cancer
5082193|NCT03484949|Gastric cancer|gastric cancer
5082194|NCT03484949|Screening|screening
5082195|NCT03484949|Risk assessment|risk assessment
5082196|NCT03484936|Intracranial Hemorrhages|intracranial hemorrhages
5082197|NCT03484936|remote ischemic conditioning|remote ischemic conditioning
5082213|NCT03484884|nodal metastases|nodal metastases
5082214|NCT03484884|17-538|17-538
5082215|NCT03484884|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5082216|NCT03484793|AESOP Model|aesop model
5082217|NCT03484793|Big data|big data
5082218|NCT03484793|medication error|medication error
5082219|NCT03484793|data mining|data mining
5082220|NCT03484793|patient safety|patient safety
5082221|NCT03484793|CPOE|cpoe
5082222|NCT03484793|CDSS|cdss
5082223|NCT03484793|alarm fatigue|alarm fatigue
5082224|NCT03484793|association rule mining.|association rule mining.
5082225|NCT03484780|Implantable Heart Failure Device Therapy|implantable heart failure device therapy
5082226|NCT03484780|Asymptomatic Diaphragmatic Stimulation|asymptomatic diaphragmatic stimulation
5082228|NCT03484767|MMA|mma
5082393|NCT03483662|implementation|implementation
5082395|NCT03483636|Lemborexant|lemborexant
5082396|NCT03483636|E2006|e2006
5082397|NCT03483636|Postural stability|postural stability
5082398|NCT03483636|Cognitive performance|cognitive performance
5082399|NCT03483623|NATO Litter|nato litter
5082491|NCT03482960|imaging|imaging
5082492|NCT03482960|hyperpolarized|hyperpolarized
5082494|NCT03482960|MRI|mri
5082590|NCT03482258|Stress|stress
5082604|NCT03482245|sepsis|sepsis
5082699|NCT03481621|Vulvodynia|vulvodynia
5082700|NCT03481608|fatty acid|fatty acid
5082701|NCT03481608|nutrition|nutrition
5082702|NCT03481608|metabolism|metabolism
5082703|NCT03481608|lauric acid|lauric acid
5082704|NCT03481608|dilauroylphosphatidylcholine|dilauroylphosphatidylcholine
5082705|NCT03481608|lrh-1|lrh-1
5082734|NCT03481452|NBO|nbo
5082785|NCT03481036|Direct acting antiviral agents (DAA)|direct acting antiviral agents (daa)
5082786|NCT03481036|Chronic Hepatitis C|chronic hepatitis c
5082787|NCT03481036|Pediatric population|pediatric population
5082788|NCT03481036|Adolescent Chronic Hepatitis C|adolescent chronic hepatitis c
5082789|NCT03481023|Atrial Fibrillation|atrial fibrillation
5082790|NCT03481023|Esophageal Cooling Device|esophageal cooling device
5082791|NCT03481023|Radiofrequency Ablation|radiofrequency ablation
5082792|NCT03481023|Arrhythmia|arrhythmia
5082793|NCT03480971|cisplatin toxicity|cisplatin toxicity
5082796|NCT03480958|breast surgery|breast surgery
5082881|NCT03480282|Primary care|primary care
5082882|NCT03480282|Cancer screening|cancer screening
5082883|NCT03480256|SHR6390|shr6390
5082884|NCT03480256|Pyrotinib|pyrotinib
5082885|NCT03480256|gastric cancer|gastric cancer
5082886|NCT03480256|Her-2 positive|her-2 positive
5082983|NCT03479606|Cognitive-behavioral therapy|cognitive-behavioral therapy
5082984|NCT03479606|Online Therapy|online therapy
5082985|NCT03479606|GroupTherapy|grouptherapy
5082986|NCT03479606|Group videoconference|group videoconference
5082987|NCT03479606|Telehealth|telehealth
5082988|NCT03479606|Telerehabilitation|telerehabilitation
5082989|NCT03479593|NSTEMI|nstemi
5082990|NCT03479593|Culprit|culprit
5082991|NCT03479593|Cardiac magnetic resonance|cardiac magnetic resonance
5083088|NCT03478891|Ebola Virus|ebola virus
5083089|NCT03478891|Immune Response|immune response
5083090|NCT03478891|Filovirus|filovirus
5083091|NCT03478891|Ebola Hemorrhagic Fever|ebola hemorrhagic fever
5083092|NCT03478891|First in Human|first in human
5083103|NCT03478839|Generalized Arterial Calcification of Infancy|generalized arterial calcification of infancy
5083104|NCT03478839|Autosomal Recessive Hypophosphatemic Rickets|autosomal recessive hypophosphatemic rickets
5083105|NCT03478839|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
5083106|NCT03478839|Idiopathic Infantile Arterial Calcification|idiopathic infantile arterial calcification
5083108|NCT03478813|Intervention|intervention
5083109|NCT03478813|Implementation|implementation
5083110|NCT03478813|Children|children
5083111|NCT03478813|Urotherapy|urotherapy
5083112|NCT03478787|Plaque Psoriasis|plaque psoriasis
5083113|NCT03478761|CYP24A1 mutation|cyp24a1 mutation
5083205|NCT03478436|pharmacokinetics|pharmacokinetics
5083206|NCT03478436|microdialysis|microdialysis
5083207|NCT03478436|healthy volunteers|healthy volunteers
5083283|NCT03477656|ABO incompatible kidney transplantation|abo incompatible kidney transplantation
5083284|NCT03477656|Desensitization|desensitization
5083285|NCT03477656|Double Filtration PlasmaPherisis (DFPP)|double filtration plasmapherisis (dfpp)
5083286|NCT03477656|Specific immunoadsorption|specific immunoadsorption
5083289|NCT03477604|Below the knee|below the knee
5083672|NCT03475433|Prostatic Neoplasms [MeSH]|prostatic neoplasms [mesh]
5083673|NCT03475433|Sleep Hygiene [MeSH]|sleep hygiene [mesh]
5083674|NCT03475433|Neoplasms [MeSH]|neoplasms [mesh]
5083675|NCT03475407|Diabetic macular edema|diabetic macular edema
5083677|NCT03475407|dexamethasone|dexamethasone
5083678|NCT03475394|Chlorhexidine gluconate|chlorhexidine gluconate
5083679|NCT03475394|Morus alba|morus alba
5083680|NCT03475394|Microbiology|microbiology
5083682|NCT03475394|Root planing|root planing
5083683|NCT03475381|Cystic Fibrosis|cystic fibrosis
5083684|NCT03475381|ivacaftor|ivacaftor
5083685|NCT03475381|lumacaftor|lumacaftor
5083689|NCT03475355|home-based|home-based
5083769|NCT03474848|rehabilitation|rehabilitation
5083770|NCT03474848|hand function|hand function
5083771|NCT03474848|daily functioning|daily functioning
5083772|NCT03474848|hand-arm bimanual intensive training|hand-arm bimanual intensive training
5083773|NCT03474835|atherosclerosis|atherosclerosis
5083774|NCT03474835|angiogenesis|angiogenesis
5083775|NCT03474835|cardiooncology|cardiooncology
5083776|NCT03474822|Advanced breast cancer|advanced breast cancer
5083777|NCT03474822|advanced liver cancer|advanced liver cancer
5083778|NCT03474822|Plasmodium immunotherapy|plasmodium immunotherapy
5083779|NCT03474822|Plasmodiun vivax|plasmodiun vivax
5083780|NCT03474809|Sepsis, PSP, Abionic|sepsis, psp, abionic
5083781|NCT03474744|Copanlisib|copanlisib
5083782|NCT03474744|Rituximab|rituximab
5083865|NCT03474315|Cardiac resynchronization therapy|cardiac resynchronization therapy
5083866|NCT03474315|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5083868|NCT03474315|Mobile application|mobile application
5083869|NCT03474315|Patient's assistance|patient's assistance
5083870|NCT03474302|African American|african american
5083871|NCT03474302|Aging|aging
5083872|NCT03474302|Physical activity|physical activity
5083967|NCT03473834|Parkinson's disease|parkinson's disease
5083968|NCT03473834|Exercise|exercise
5083969|NCT03473834|Rigidity|rigidity
5083971|NCT03473821|ACL Injury|acl injury
5084067|NCT03473262|Insulin glargine|insulin glargine
5084068|NCT03473171|nasal non-invasive ventilation|nasal non-invasive ventilation
5084069|NCT03473171|RAM Cannula|ram cannula
5084070|NCT03473171|Pediatric Complex Care|pediatric complex care
5084071|NCT03473171|Tracheostomy Avoidance|tracheostomy avoidance
5084072|NCT03473158|fetal reduction|fetal reduction
5084073|NCT03473158|embryo reduction|embryo reduction
5084074|NCT03473158|feticide|feticide
5084075|NCT03473158|potassium chloride|potassium chloride
5084076|NCT03473158|multiple pregnancy|multiple pregnancy
5084081|NCT03473080|OCD|ocd
5084170|NCT03472664|ketogenic|ketogenic
5084171|NCT03472612|OSA|osa
5084278|NCT03472079|Acute kidney injury|acute kidney injury
5084279|NCT03472079|Septic shock|septic shock
5084280|NCT03472079|TIMP2*IGFBP7|timp2*igfbp7
5084281|NCT03472053|Lung cancer|lung cancer
5084282|NCT03472053|non small cell|non small cell
5084287|NCT03471988|deep mycosis|deep mycosis
5084288|NCT03471988|aspergillosis|aspergillosis
5084289|NCT03471988|mucormycosis|mucormycosis
5084290|NCT03471988|cryptococcosis|cryptococcosis
5084291|NCT03471988|isavuconazonium sulfate|isavuconazonium sulfate
5084292|NCT03471988|isavuconazole|isavuconazole
5084367|NCT03471624|Tenofovir alafenamide (TAF)|tenofovir alafenamide (taf)
5084368|NCT03471585|THC|thc
5084369|NCT03471585|adult|adult
5084370|NCT03471572|BRCA, ovarian cancer, fallopian tube cancer|brca, ovarian cancer, fallopian tube cancer
5084371|NCT03471546|Palliative Care|palliative care
5084372|NCT03471546|Pro00091481|pro00091481
5084373|NCT03471546|Malignant Glioma|malignant glioma
5084374|NCT03471546|Katherine Peters|katherine peters
5084375|NCT03471546|David Casarett|david casarett
5084468|NCT03470857|4-Hydroxynonenal|4-hydroxynonenal
5084571|NCT03470298|Endometrial Scratching|endometrial scratching
5084572|NCT03470298|Unexplained infertility|unexplained infertility
5084573|NCT03470298|ICSI|icsi
5084574|NCT03470285|Mulitparametric MR Imaging|mulitparametric mr imaging
5084622|NCT03469947|TXA|txa
5084785|NCT03468907|flare|flare
5084967|NCT03467750|Adenotonsillectomy|adenotonsillectomy
5084968|NCT03467750|Opioids|opioids
5084969|NCT03467750|Post-surgical pain|post-surgical pain
5084970|NCT03467750|Anesthesiology|anesthesiology
5084971|NCT03467750|Pediatrics|pediatrics
5084972|NCT03467724|Fractional Radiofrequency|fractional radiofrequency
5084973|NCT03467698|Aging|aging
5084974|NCT03467698|Memory|memory
5084975|NCT03467698|Associative learning|associative learning
5084977|NCT03467581|gastric sleeve|gastric sleeve
5085068|NCT03466892|Attentional Bias|attentional bias
5085467|NCT03464422|HIV|hiv
5085559|NCT03463967|children|children
5085560|NCT03463967|adolescents|adolescents
5085564|NCT03463941|Dyads|dyads
5085757|NCT03462511|Community health worker (CHW)|community health worker (chw)
5085758|NCT03462511|Text messages|text messages
5085759|NCT03462511|Medication adherence|medication adherence
5085812|NCT03461939|PRO|pro
5085860|NCT03461705|Volcano Verrata Pressure Wire|volcano verrata pressure wire
5085862|NCT03461666|Behavioral treatment of primary insomnia|behavioral treatment of primary insomnia
5085863|NCT03461666|Focus of attention|focus of attention
5085864|NCT03461666|cognitive behavioral therapy for insomnia|cognitive behavioral therapy for insomnia
5085865|NCT03461627|randomized|randomized
5085866|NCT03461627|double-blind|double-blind
5085867|NCT03461627|double-dummy|double-dummy
5085881|NCT03461510|MRI|mri
5085964|NCT03460964|Glucose|glucose
5085965|NCT03460964|Sweat|sweat
5085966|NCT03460951|Feasibility and reproductibility|feasibility and reproductibility
5085968|NCT03460951|MRI morphological parameters (T1, STIR)|mri morphological parameters (t1, stir)
5086057|NCT03460314|Biological availability|biological availability
5086156|NCT03459677|Behavioral problems|behavioral problems
5086157|NCT03459677|CBT|cbt
5086165|NCT03459651|numeracy|numeracy
5086166|NCT03459651|number sense|number sense
5086167|NCT03459638|Screening|screening
5086168|NCT03459599|Antibiotic|antibiotic
5086169|NCT03459599|Endometritis|endometritis
5086170|NCT03459599|Placental membranes|placental membranes
5086257|NCT03459066|Quality of life|quality of life
5086258|NCT03459027|exercise hyperemia|exercise hyperemia
5086259|NCT03459027|vasodilation|vasodilation
5086260|NCT03459027|nitric oxide|nitric oxide
5086261|NCT03459027|dietary nitrate|dietary nitrate
5086455|NCT03457987|cardiac surgery|cardiac surgery
5086456|NCT03457974|saliva composition|saliva composition
5086457|NCT03457974|antioxidant activity|antioxidant activity
5086458|NCT03457974|caries risk factors|caries risk factors
5086459|NCT03457974|congenital cardiac disease|congenital cardiac disease
5086460|NCT03457961|Perampanel|perampanel
5086461|NCT03457961|focal onset seizure|focal onset seizure
5086462|NCT03457961|epilepsy|epilepsy
5086463|NCT03457909|string|string
5086464|NCT03457909|capsule endoscopy|capsule endoscopy
5086465|NCT03457896|NSABP|nsabp
5086466|NCT03457896|PUMA|puma
5086467|NCT03457896|Neratinib|neratinib
5086468|NCT03457896|Trastuzumab|trastuzumab
5086469|NCT03457896|Cetuximab|cetuximab
5086470|NCT03457896|RAS|ras
5086471|NCT03457896|NRAS|nras
5086753|NCT03455686|hyperpolarized xenon-129|hyperpolarized xenon-129
5086754|NCT03455686|lung function|lung function
5086755|NCT03455686|lung structure|lung structure
5086756|NCT03455660|Cesarean|cesarean
5086757|NCT03455660|C-Section|c-section
5086758|NCT03455647|stunting|stunting
5086759|NCT03455647|underweight|underweight
5086760|NCT03455647|wasting|wasting
5086856|NCT03454932|Inflammation|inflammation
5086857|NCT03454932|Autoimmune diseases|autoimmune diseases
5086858|NCT03454932|Osteoimmunology|osteoimmunology
5086859|NCT03454906|hemodialysis|hemodialysis
5086860|NCT03454906|hemoglobin variability|hemoglobin variability
5086861|NCT03454906|mortality|mortality
5086862|NCT03454906|nutrition|nutrition
5086863|NCT03454906|inflammation|inflammation
5086864|NCT03454880|Accelerometry|accelerometry
5086865|NCT03454880|Wearable electronic devices|wearable electronic devices
5086866|NCT03454854|risk evaluation|risk evaluation
5086867|NCT03454854|individualized treatment|individualized treatment
5086868|NCT03454854|coronary artery disease|coronary artery disease
5086869|NCT03454854|antithrombotic therapy|antithrombotic therapy
5086870|NCT03454854|Chinese people|chinese people
5086871|NCT03454854|Application|application
5086885|NCT03454789|onset time|onset time
5086954|NCT03454438|Referral|referral
5086955|NCT03454438|Primary care|primary care
5086956|NCT03454438|Rheumatologist|rheumatologist
5087154|NCT03453658|Primary Teeth|primary teeth
5087155|NCT03453658|Reciprocating instrumentation|reciprocating instrumentation
5087255|NCT03453073|chocolate consumption|chocolate consumption
5087256|NCT03453073|postmenopausal women|postmenopausal women
5087257|NCT03453073|nutrition|nutrition
5087258|NCT03453073|dietary intake|dietary intake
5087259|NCT03453073|epidemiology|epidemiology
5087260|NCT03453047|S100β|s100β
5087263|NCT03453034|TQ-B3233|tq-b3233
5087453|NCT03451981|non surgical therapy|non surgical therapy
5087454|NCT03451981|laser|laser
5087455|NCT03451981|air powder|air powder
5087456|NCT03451981|chlorhexidine|chlorhexidine
5087457|NCT03451968|amino acid|amino acid
5087458|NCT03451968|stable isotope|stable isotope
5087459|NCT03451968|critical care|critical care
5087460|NCT03451955|gluten|gluten
5087461|NCT03451955|gluten free diet|gluten free diet
5087462|NCT03451955|blood brain barrier permeability|blood brain barrier permeability
5087561|NCT03451331|nivolumab|nivolumab
5087562|NCT03451331|oxaliplatin|oxaliplatin
5087563|NCT03451305|Compression fracture, postural reduction, vertebroplasty|compression fracture, postural reduction, vertebroplasty
5087564|NCT03451266|preeclampsia|preeclampsia
5087565|NCT03451266|vitamin C|vitamin c
5087566|NCT03451266|lung ultrasound|lung ultrasound
5087567|NCT03451240|Stress|stress
5087655|NCT03450382|health promotion|health promotion
5087656|NCT03450304|Multidetector Computed Tomography|multidetector computed tomography
5087659|NCT03450291|Computational|computational
5087756|NCT03449524|Hypertension, Pulmonary|hypertension, pulmonary
5087856|NCT03448796|High tibial osteotomy|high tibial osteotomy
5087857|NCT03448796|Osteoarthrosis|osteoarthrosis
5087859|NCT03448796|Randomized controlled trial|randomized controlled trial
5087953|NCT03448198|computer-aided surgery|computer-aided surgery
5087954|NCT03448159|Stroke|stroke
5087955|NCT03448159|Exercise|exercise
5087956|NCT03448159|Fluoxetine|fluoxetine
5087957|NCT03448159|Randomized Control Trial|randomized control trial
5087958|NCT03448159|Rehabilitation|rehabilitation
5087961|NCT03448120|Acupuncture|acupuncture
5087962|NCT03448120|Dry needling|dry needling
5088152|NCT03446989|Generalized Estimating Equations|generalized estimating equations
5088158|NCT03446937|Antenal corticosteroids|antenal corticosteroids
5088159|NCT03446937|Late preterm delivery|late preterm delivery
5088160|NCT03446937|Neonatal morbidity|neonatal morbidity
5088161|NCT03446924|Nutraceuticals|nutraceuticals
5088349|NCT03445676|Hand Hygiene|hand hygiene
5088350|NCT03445676|WHO 5-moments|who 5-moments
5088355|NCT03445650|ADX-102, Sjögren-Larsson Syndrome|adx-102, sjögren-larsson syndrome
5088357|NCT03445598|depression|depression
5088359|NCT03445598|CBT|cbt
5088653|NCT03443908|obstructive sleep apnea|obstructive sleep apnea
5088654|NCT03443830|Zika virus|zika virus
5088655|NCT03443830|Tyzivumab|tyzivumab
5088656|NCT03443830|Monoclonal antibody|monoclonal antibody
5088657|NCT03443830|Infectious diseases|infectious diseases
5088658|NCT03443830|Phase 1A first in human study|phase 1a first in human study
5088659|NCT03443830|Singapore|singapore
5088660|NCT03443817|Feasibility|feasibility
5088661|NCT03443817|tele-rehabilitation|tele-rehabilitation
5088662|NCT03443817|follow-up|follow-up
5088663|NCT03443817|COPD|copd
5088766|NCT03443323|Schools|schools
5089051|NCT03441581|IBS-D|ibs-d
5089052|NCT03441581|BAM|bam
5089053|NCT03441555|Cancer|cancer
5089054|NCT03441555|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5089055|NCT03441555|relapsed Acute Myeloid Leukemia|relapsed acute myeloid leukemia
5089056|NCT03441555|refractory Acute Myeloid Leukemia|refractory acute myeloid leukemia
5089057|NCT03441542|Care cascade|care cascade
5089058|NCT03441542|Patient navigation services|patient navigation services
5089059|NCT03441542|Injection drug users|injection drug users
5089060|NCT03441542|Opioid substitution therapy|opioid substitution therapy
5089061|NCT03441490|Learning Support|learning support
5089062|NCT03441490|Chat|chat
5089151|NCT03440827|low-flow vascular malformations, scale of life's quality|low-flow vascular malformations, scale of life's quality
5089153|NCT03440814|Prader-Willi Syndrome|prader-willi syndrome
5089154|NCT03440762|Screening|screening
5089155|NCT03440762|Education|education
5089156|NCT03440762|AFib Awareness|afib awareness
5089256|NCT03440359|PCOS, crinone, vaginal progesterone, ovulation induction|pcos, crinone, vaginal progesterone, ovulation induction
5089257|NCT03440346|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5089259|NCT03440346|child|child
5089260|NCT03440346|human|human
5089261|NCT03440346|diet|diet
5089262|NCT03440346|few-foods diet|few-foods diet
5089263|NCT03440346|brain|brain
5089356|NCT03439839|Complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,|complement, alternative pathway, paroxysmal nocturnal hemoglobinuria,
5089357|NCT03439839|hemolysis|hemolysis
5089358|NCT03439813|stroke|stroke
5089454|NCT03439202|Concentration performance|concentration performance
5089461|NCT03439059|Older adults|older adults
5089657|NCT03437902|Vitamin C|vitamin c
5089658|NCT03437902|oxidative stress|oxidative stress
5089659|NCT03437902|Insulin resistance|insulin resistance
5089660|NCT03437902|lipid profile|lipid profile
5089661|NCT03437889|epidural|epidural
5089856|NCT03436771|JCARH125|jcarh125
5089857|NCT03436758|uterine fluids|uterine fluids
5089858|NCT03436758|Biobank|biobank
5089859|NCT03436758|culture medium|culture medium
5089865|NCT03436732|Immunotoxin|immunotoxin
5089956|NCT03436277|Body weight|body weight
5089957|NCT03436277|Body fat percentage|body fat percentage
5089961|NCT03436238|Perioperative|perioperative
5089962|NCT03436238|Biomarkers|biomarkers
5089963|NCT03436238|Troponin|troponin
5089964|NCT03436238|Prodrenomedullin|prodrenomedullin
5089965|NCT03436238|Endothelin|endothelin
5089966|NCT03436238|Perioperative Complications|perioperative complications
5089967|NCT03436225|steroid therapy.|steroid therapy.
5090056|NCT03435640|Nivolumab|nivolumab
5090057|NCT03435640|Opdivo®|opdivo®
5090058|NCT03435640|Metastatic|metastatic
5090059|NCT03435640|Locally advanced|locally advanced
5090060|NCT03435640|Relapsed/Refractory|relapsed/refractory
5659452|NCT00665353|HCV|hcv
5090158|NCT03435029|aging|aging
5090159|NCT03435029|cognitive rehabilitation|cognitive rehabilitation
5090259|NCT03434366|dexmedetomidine|dexmedetomidine
5090260|NCT03434340|peppermint oil|peppermint oil
5090261|NCT03434340|intrathecal morphine|intrathecal morphine
5090262|NCT03434340|PONV|ponv
5090263|NCT03434340|lower segment cesarean section|lower segment cesarean section
5090264|NCT03434340|dexamethasone|dexamethasone
5090265|NCT03434340|granisetron|granisetron
5090266|NCT03434314|Paraplegia|paraplegia
5090267|NCT03434314|Aortic Aneurysm Repair|aortic aneurysm repair
5090268|NCT03434314|Staging|staging
5090269|NCT03434314|Embolization|embolization
5090270|NCT03434314|TAAA|taaa
5090271|NCT03434314|Thoracoabdominal aortic aneurysm|thoracoabdominal aortic aneurysm
5090272|NCT03434314|MISACE|misace
5090273|NCT03434314|Spinal cord ischemia|spinal cord ischemia
5090274|NCT03434314|Spinal cord ischaemia|spinal cord ischaemia
5090275|NCT03434314|Spinal cord injury|spinal cord injury
5090276|NCT03434314|Spinal cord ischemic injury|spinal cord ischemic injury
5090277|NCT03434314|Spinal cord ischaemic injury|spinal cord ischaemic injury
5090278|NCT03434314|Permanent paraplegia|permanent paraplegia
5090279|NCT03434314|Temporary paraplegia|temporary paraplegia
5090280|NCT03434314|Paraparesis|paraparesis
5090281|NCT03434314|SCI|sci
5090282|NCT03434314|TAAA repair|taaa repair
5090283|NCT03434314|Open TAAA repair|open taaa repair
5090284|NCT03434314|Open surgical TAAA repair|open surgical taaa repair
5090285|NCT03434314|Endovascular TAAA repair|endovascular taaa repair
5090286|NCT03434314|TEVAR|tevar
5090287|NCT03434314|Aortic surgery|aortic surgery
5090288|NCT03434314|Thoracoabdominal aortic surgery|thoracoabdominal aortic surgery
5090289|NCT03434314|Type B aortic dissection|type b aortic dissection
5090290|NCT03434314|Chronic type B aortic dissection|chronic type b aortic dissection
5090291|NCT03434314|Stanford type B aortic dissection|stanford type b aortic dissection
5090292|NCT03434314|Collateral network|collateral network
5090359|NCT03434184|spinal surgery|spinal surgery
5090360|NCT03434184|scoliosis|scoliosis
5090361|NCT03434184|pelvic fixation|pelvic fixation
5090362|NCT03434158|Metastatic Prostate Cancer Resistant to Castration|metastatic prostate cancer resistant to castration
5090557|NCT03432871|Niagen|niagen
5090656|NCT03432234|Microbiome|microbiome
5090657|NCT03432234|Exacerbation|exacerbation
5090658|NCT03432221|Cognition, antidepressants drugs, SNRI, hot cognition, functioning|cognition, antidepressants drugs, snri, hot cognition, functioning
5090659|NCT03432182|Premature infant|premature infant
5090660|NCT03432182|sleep state|sleep state
5090682|NCT03431987|THC|thc
5090757|NCT03431298|Knee osteoarthritis|knee osteoarthritis
5090758|NCT03431298|Physical activity|physical activity
5090759|NCT03431298|Exercise|exercise
5090760|NCT03431272|contact lens, discomfort, dry eye|contact lens, discomfort, dry eye
5090761|NCT03431233|protein-enriched bar|protein-enriched bar
5090762|NCT03431233|food intake|food intake
5090763|NCT03431233|appetite|appetite
5090766|NCT03431194|midodrine|midodrine
5090856|NCT03430518|Ovarian cancer|ovarian cancer
5090860|NCT03430492|Biomarkers|biomarkers
5090963|NCT03429907|Surveys|surveys
5091055|NCT03429348|Post-Fire Rehabilitation|post-fire rehabilitation
5091056|NCT03429348|Sauna|sauna
5091057|NCT03429335|Transition|transition
5091058|NCT03429335|Adolescents|adolescents
5091059|NCT03429335|Smart phone|smart phone
5091064|NCT03429309|telomere|telomere
5091065|NCT03429309|propofol|propofol
5091066|NCT03429309|anesthesia-induction|anesthesia-induction
5091067|NCT03429296|Cancer|cancer
5091068|NCT03429296|Autohypnosis|autohypnosis
5091069|NCT03429296|Quality of life|quality of life
5091070|NCT03429283|Epidemiology,|epidemiology,
5091071|NCT03429283|Achromobacter xylosoxidans,|achromobacter xylosoxidans,
5091072|NCT03429283|antibiotic resistance|antibiotic resistance
5091073|NCT03429257|Aflatoxin B1|aflatoxin b1
5091074|NCT03429257|Environmental Enteric Dysfunction|environmental enteric dysfunction
5091075|NCT03429257|L:M Test|l:m test
5091076|NCT03429257|Pregnancy|pregnancy
5091360|NCT03427580|Schizophrenia|schizophrenia
5091361|NCT03427580|Psychotherapy|psychotherapy
5091455|NCT03427008|medication adherence|medication adherence
5091456|NCT03427008|video directly observed therapy|video directly observed therapy
5091457|NCT03426956|Glucagon-like Peptide-1|glucagon-like peptide-1
5091458|NCT03426956|Glucose|glucose
5091459|NCT03426956|Gastric bypass|gastric bypass
5091460|NCT03426956|Bariatric surgery|bariatric surgery
5091461|NCT03426956|Obesity|obesity
5091462|NCT03426956|Diabetes|diabetes
5091463|NCT03426891|Immunotherapy|immunotherapy
5091464|NCT03426891|Radiotherapy|radiotherapy
5091465|NCT03426891|Glioblastoma|glioblastoma
5091475|NCT03426852|Biomechanical Phenomenon|biomechanical phenomenon
5091653|NCT03425903|Fibromyalgia, Whole body cryotherapy|fibromyalgia, whole body cryotherapy
5091655|NCT03425890|Self-exercise|self-exercise
5091656|NCT03425877|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation|arousal, valence, emotion, heart rate variability, electrodermal activity, u-shape curve, performance, neurorehabilitation
5091657|NCT03425864|immediate implant|immediate implant
5091659|NCT03425851|Diaper need|diaper need
5659538|NCT00665002|Myeloid|myeloid
5091843|NCT03424616|Nucleus accumbens|nucleus accumbens
5091844|NCT03424577|H3B-6527|h3b-6527
5091845|NCT03424577|Healthy Participants|healthy participants
5091846|NCT03424577|Pharmacokinetics|pharmacokinetics
5091847|NCT03424564|Perampanel|perampanel
5091848|NCT03424564|Pharmacokinetics|pharmacokinetics
5091849|NCT03424564|E2007|e2007
5091850|NCT03424564|Chinese|chinese
5091851|NCT03424551|vibration|vibration
5091852|NCT03424551|muscle spindle|muscle spindle
5091853|NCT03424551|H reflex|h reflex
5091854|NCT03424551|tonic vibration reflex|tonic vibration reflex
5091855|NCT03424538|multiple sclerosis|multiple sclerosis
5091857|NCT03424538|neurorehabilitation|neurorehabilitation
5091858|NCT03424538|balance|balance
5091859|NCT03424499|neurogenic bladder|neurogenic bladder
5091860|NCT03424499|intermittent urethral catheterization|intermittent urethral catheterization
5091861|NCT03424499|Clean intermittent catheterization|clean intermittent catheterization
5091862|NCT03424486|Cystic fibrosis|cystic fibrosis
5091863|NCT03424486|Anxiety|anxiety
5091865|NCT03424486|Adolescence|adolescence
5091939|NCT03424057|Karydakis modification|karydakis modification
5091940|NCT03424057|pilonidal sinus|pilonidal sinus
5091941|NCT03424057|seroma|seroma
5091942|NCT03424044|glucagon|glucagon
5091943|NCT03424044|closed-loop|closed-loop
5091944|NCT03424044|Omnipod|omnipod
5091945|NCT03424044|exercise|exercise
5091946|NCT03424018|ACH|ach
5091947|NCT03424018|Achondroplasia|achondroplasia
5091948|NCT03424018|Bone Diseases|bone diseases
5091950|NCT03424018|Dwarfism|dwarfism
5092039|NCT03423498|hallux valgus,|hallux valgus,
5092040|NCT03423498|toe-spread-out exercise|toe-spread-out exercise
5092141|NCT03422939|portion sizes|portion sizes
5092142|NCT03422939|time frame|time frame
5092143|NCT03422939|visual references|visual references
5092144|NCT03422887|postoperative pain|postoperative pain
5092145|NCT03422887|general anesthesia|general anesthesia
5092146|NCT03422887|postoperative discomfort|postoperative discomfort
5092147|NCT03422874|Advanced Solid Tumors|advanced solid tumors
5092148|NCT03422874|Lymphoma|lymphoma
5092149|NCT03422874|Nelfinavir|nelfinavir
5092150|NCT03422874|MLN9708|mln9708
5092151|NCT03422874|proteasome inhibitor|proteasome inhibitor
5092155|NCT03422848|hydration|hydration
5092245|NCT03422406|Pregnancy|pregnancy
5092246|NCT03422406|Urinary iodine concentration|urinary iodine concentration
5092247|NCT03422406|Serum iodine concentration|serum iodine concentration
5092248|NCT03422406|Breast milk iodine concentration|breast milk iodine concentration
5092521|NCT03420495|OCD|ocd
5092547|NCT03420300|Hepatitis C virus|hepatitis c virus
5092548|NCT03420300|Hemodialysis|hemodialysis
5092549|NCT03420300|Direct acting antiviral agent|direct acting antiviral agent
5092550|NCT03420274|Shared decision-making|shared decision-making
5092944|NCT03417765|autologous transplantation|autologous transplantation
5092945|NCT03417739|Uveal Melanoma|uveal melanoma
5092946|NCT03417726|Cerebral Palsy|cerebral palsy
5092948|NCT03417700|vitamin D|vitamin d
5092949|NCT03417700|exercise|exercise
5092950|NCT03417700|training|training
5092951|NCT03417700|aging|aging
5092952|NCT03417648|Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian|rheumatoid arthritis, diet, fat-restricted, diet, vegetarian
5092953|NCT03417635|Meditation|meditation
5092954|NCT03417635|Cognitive assessment|cognitive assessment
5092955|NCT03417635|Executive function|executive function
5092956|NCT03417635|Older adults|older adults
5092957|NCT03417635|Randomized control trial|randomized control trial
5092958|NCT03417635|Mobility|mobility
5092959|NCT03417622|resection margin|resection margin
5092960|NCT03417622|neoadjuvant therapy|neoadjuvant therapy
5092961|NCT03417622|breast conservative surgery|breast conservative surgery
5092970|NCT03417531|Seniors|seniors
5093041|NCT03417206|Spectral Entropy (SE)|spectral entropy (se)
5093042|NCT03417206|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5093043|NCT03417206|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
5093044|NCT03417206|Sevoflurane|sevoflurane
5093045|NCT03417206|Desflurane|desflurane
5093046|NCT03417193|Lidocaine|lidocaine
5093047|NCT03417193|Dexmedetomidine|dexmedetomidine
5093048|NCT03417193|Opioid-free|opioid-free
5093049|NCT03417180|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5093050|NCT03417180|Intraoperative Blood Loss (IBL)|intraoperative blood loss (ibl)
5093051|NCT03417180|Boezaart Bleeding Scale (BBS)|boezaart bleeding scale (bbs)
5093052|NCT03417180|Spectral Entropy (SE)|spectral entropy (se)
5093053|NCT03417180|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5093054|NCT03417180|Total Intravenous Anaesthesia (TIVA)|total intravenous anaesthesia (tiva)
5093055|NCT03417180|Sevoflurane|sevoflurane
5093056|NCT03417180|Desflurane|desflurane
5093139|NCT03416647|Duodenojejunostomy|duodenojejunostomy
5093140|NCT03416647|Wilkie's syndrome|wilkie's syndrome
5093147|NCT03416608|ultrasound|ultrasound
5093148|NCT03416608|patient experience|patient experience
5093149|NCT03416608|diagnostic test|diagnostic test
5093150|NCT03416608|general practice|general practice
5093151|NCT03416608|family medicine|family medicine
5093152|NCT03416595|probiotic|probiotic
5093162|NCT03416504|OCD|ocd
5093239|NCT03416049|leg ulcer treatment|leg ulcer treatment
5093240|NCT03416049|venous stasis treatment|venous stasis treatment
5093241|NCT03416049|non invasive treatment|non invasive treatment
5093242|NCT03416049|pulsed electromagnetic|pulsed electromagnetic
5093333|NCT03415555|mitral valve replacement|mitral valve replacement
5093334|NCT03415542|Attitudes|attitudes
5093335|NCT03415542|Ecological momentary assessment|ecological momentary assessment
5093336|NCT03415529|Lung|lung
5093337|NCT03415529|ARDS|ards
5093338|NCT03415529|Acute Respiratory Syndrome|acute respiratory syndrome
5093339|NCT03415529|Prognosis|prognosis
5093421|NCT03414775|gastrointestinal microbiome|gastrointestinal microbiome
5093422|NCT03414775|pediatrics|pediatrics
5093519|NCT03414125|Colorectal Cancer|colorectal cancer
5093520|NCT03414125|Colon Cancer|colon cancer
5093521|NCT03414125|FIT Screening Strategy|fit screening strategy
5093522|NCT03414125|Colon Screening Strategy|colon screening strategy
5093719|NCT03412903|Acute geriatric treatment|acute geriatric treatment
5094115|NCT03410706|Anticoagulation|anticoagulation
5094116|NCT03410706|Rivaroxaban|rivaroxaban
5094120|NCT03410680|Adherence|adherence
5094212|NCT03409809|Dissemination|dissemination
5094213|NCT03409809|Prevention|prevention
5094214|NCT03409809|Peer Leader|peer leader
5094215|NCT03409796|Gluten Challenge|gluten challenge
5094216|NCT03409757|microbiome|microbiome
5094218|NCT03409731|Drug eluting Bio-resolvable Scaffold (BRS)|drug eluting bio-resolvable scaffold (brs)
5094316|NCT03409302|digital intervention|digital intervention
5094317|NCT03409302|web-based|web-based
5094318|NCT03409302|adherence|adherence
5094319|NCT03409289|Spontaneous Circulation (ROSC)|spontaneous circulation (rosc)
5094320|NCT03409289|Shock and Hypotension (RUSH) exam|shock and hypotension (rush) exam
5094321|NCT03409263|Cirrhosis|cirrhosis
5094322|NCT03409263|Advanced chronic liver disease|advanced chronic liver disease
5094324|NCT03409263|Variceal hemorrhage|variceal hemorrhage
5094327|NCT03409198|Neoplasms|neoplasms
5094412|NCT03408678|body composition|body composition
5094413|NCT03408678|glucocorticoids|glucocorticoids
5094414|NCT03408678|inflammation|inflammation
5094415|NCT03408678|black African|black african
5094416|NCT03408678|sex|sex
5094417|NCT03408678|gonadal steroid hormones|gonadal steroid hormones
5094418|NCT03408652|Bone Metastases|bone metastases
5094425|NCT03408587|CVA21|cva21
5094514|NCT03408093|Relapsing-remitting MS (RRMS)|relapsing-remitting ms (rrms)
5094515|NCT03408093|Secondary progressive MS (SPMS)|secondary progressive ms (spms)
5094614|NCT03407469|Questionnaires|questionnaires
5094615|NCT03407469|Surveys|surveys
5094616|NCT03407469|Cancer-related Venous Thromboembolism|cancer-related venous thromboembolism
5094617|NCT03407469|VTE|vte
5094652|NCT03407196|HbA1c|hba1c
5094710|NCT03406923|Beliefs about diabetes|beliefs about diabetes
5094711|NCT03406923|Beliefs in medicines|beliefs in medicines
5094712|NCT03406910|egg|egg
5094814|NCT03406182|under-weight|under-weight
5094815|NCT03406182|Pakistan|pakistan
5094816|NCT03406182|infant|infant
5094817|NCT03406182|time-use|time-use
5095413|NCT03402100|eye drops|eye drops
5095414|NCT03402100|outdoor|outdoor
5095415|NCT03402100|near work|near work
5095416|NCT03402048|Lung Cancer|lung cancer
5095417|NCT03402048|Elderly|elderly
5095418|NCT03402048|First line|first line
5095419|NCT03402048|Customized chemotherapy|customized chemotherapy
5095420|NCT03402048|Pharmacogenomic-driven|pharmacogenomic-driven
5095421|NCT03402048|NSCLC|nsclc
5095422|NCT03402035|Whole Blood Resuscitation|whole blood resuscitation
5095423|NCT03402022|Sport|sport
5095424|NCT03402022|competition|competition
5095425|NCT03402022|ultra-endurance|ultra-endurance
5095511|NCT03401372|Organ response|organ response
5095517|NCT03401268|hypogammaglobulinemia|hypogammaglobulinemia
5095518|NCT03401268|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5095519|NCT03401255|Placental alpha microglobulin-1|placental alpha microglobulin-1
5095520|NCT03401255|PAMG-1|pamg-1
5095521|NCT03401255|preterm labor|preterm labor
5095522|NCT03401255|preterm delivery|preterm delivery
5095523|NCT03401255|preterm birth|preterm birth
5095524|NCT03401255|cervical length|cervical length
5095526|NCT03401255|corticosteroid|corticosteroid
5095707|NCT03400176|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5095709|NCT03400176|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5095713|NCT03400085|mHealth|mhealth
5095801|NCT03399383|Standardized patient education|standardized patient education
5095802|NCT03399370|Inclisiran sodium|inclisiran sodium
5095803|NCT03399370|ASCVD|ascvd
5095804|NCT03399370|LDL-C|ldl-c
5095899|NCT03398707|PICs|pics
5095900|NCT03398707|diagnosis|diagnosis
5095901|NCT03398707|prevention|prevention
5095902|NCT03398707|outcome|outcome
5095903|NCT03398681|Heart failure|heart failure
5095904|NCT03398681|Iron deficiency|iron deficiency
5095905|NCT03398681|Cardiac magnetic resonance|cardiac magnetic resonance
5095906|NCT03398681|Ferric carboxymaltose|ferric carboxymaltose
5095907|NCT03398681|Myocardial iron|myocardial iron
5095914|NCT03398642|Occupational therapy|occupational therapy
5096182|NCT03396796|Delayed gastric emptying|delayed gastric emptying
5096183|NCT03396796|Cirrhosis|cirrhosis
5096185|NCT03396796|laparoscopy|laparoscopy
5096186|NCT03396770|Urinary biomarkers|urinary biomarkers
5096187|NCT03396770|Intensive Care Unit|intensive care unit
5096192|NCT03396731|Venous Leg Ulcer|venous leg ulcer
5096193|NCT03396731|Leg Ulcer|leg ulcer
5096194|NCT03396731|Leg Wound|leg wound
5096195|NCT03396718|Head and neck cancer|head and neck cancer
5096196|NCT03396718|Oropharyngeal cancer|oropharyngeal cancer
5096198|NCT03396718|radiotherapy|radiotherapy
5096199|NCT03396718|radiochemotherapy|radiochemotherapy
5096200|NCT03396718|de-intensification|de-intensification
5096201|NCT03396718|HPV|hpv
5096202|NCT03396679|Psoriatic arthritis|psoriatic arthritis
5096203|NCT03396679|remission|remission
5096204|NCT03396679|ultrasound|ultrasound
5096205|NCT03396653|weight loss|weight loss
5096206|NCT03396653|weight maintenance|weight maintenance
5096207|NCT03396653|weight control|weight control
5096208|NCT03396653|peer support|peer support
5096209|NCT03396653|patient-provided care|patient-provided care
5096210|NCT03396640|anteromedial|anteromedial
5096211|NCT03396627|eyelid|eyelid
5096212|NCT03396627|Muller|muller
5096237|NCT03396575|Autologous G-CSF mobilized HSCs|autologous g-csf mobilized hscs
5096384|NCT03395925|Thyroid Nodule|thyroid nodule
5096385|NCT03395925|Bipolar coagulation electrode|bipolar coagulation electrode
5096386|NCT03395925|radiofrequency ablation|radiofrequency ablation
5096387|NCT03395912|local anesthetics infiltration|local anesthetics infiltration
5096388|NCT03395912|cesarean section pain relief|cesarean section pain relief
5096395|NCT03395886|noninvasive ventilation|noninvasive ventilation
5096396|NCT03395886|remifentanil|remifentanil
5096397|NCT03395886|dexmedetomidine|dexmedetomidine
5096398|NCT03395886|cardiac surgery|cardiac surgery
5096399|NCT03395860|GVHD|gvhd
5096401|NCT03395860|PTCy|ptcy
5096402|NCT03395860|halo-HSCT|halo-hsct
5096403|NCT03395821|competency-based education|competency-based education
5096484|NCT03395301|fiber platinum coil|fiber platinum coil
5096485|NCT03395301|tubal occlusion|tubal occlusion
5096486|NCT03395288|UTI|uti
5096487|NCT03395288|recurrent UTI|recurrent uti
5096488|NCT03395249|safety|safety
5096491|NCT03395249|SPR994|spr994
5096682|NCT03394235|hairline|hairline
5096683|NCT03394235|laser hair removal|laser hair removal
5096684|NCT03394209|Favipiravir, Influenza, Human, Critical Illness, Pharmacokinetics|favipiravir, influenza, human, critical illness, pharmacokinetics
5096685|NCT03394183|cardiac rehabilitation|cardiac rehabilitation
5096686|NCT03394183|cardiorespiratory fitness|cardiorespiratory fitness
5096878|NCT03393039|Negative Affect|negative affect
5096879|NCT03393013|immunoproteasome inhibition|immunoproteasome inhibition
5096880|NCT03393013|selective proteasome inhibition|selective proteasome inhibition
5096881|NCT03393013|proteasome|proteasome
5096882|NCT03393013|lupus nephritis|lupus nephritis
5096971|NCT03392454|Thumb Carpometacarpal Joint|thumb carpometacarpal joint
5096972|NCT03392441|dementia|dementia
5096973|NCT03392441|cognition|cognition
5096974|NCT03392441|insulin|insulin
5096975|NCT03392441|adolescent|adolescent
5096976|NCT03392415|chronic total occlusion|chronic total occlusion
5097064|NCT03391934|Metastatic Colorectal Cancer|metastatic colorectal cancer
5097065|NCT03391921|vaccine|vaccine
5097066|NCT03391921|woman|woman
5097067|NCT03391908|vulnerable plaque, ACS, NSTEMI, vulnerable patient|vulnerable plaque, acs, nstemi, vulnerable patient
5097068|NCT03391895|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5097069|NCT03391895|Scoliosis|scoliosis
5097070|NCT03391895|Inspiratory Muscle Training|inspiratory muscle training
5097071|NCT03391895|Exercise Training|exercise training
5097072|NCT03391895|Respiratory Exercise Training|respiratory exercise training
5097073|NCT03391895|Pulmonary Function Test|pulmonary function test
5097075|NCT03391895|Respiratory Muscle Strength|respiratory muscle strength
5097080|NCT03391843|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5097161|NCT03391362|SRS|srs
5097551|NCT03388645|Upper Respiratory Tract Infection|upper respiratory tract infection
5097552|NCT03388632|Immunotherapy|immunotherapy
5097553|NCT03388632|T Cells|t cells
5097554|NCT03388632|Checkpoint Inhibitor|checkpoint inhibitor
5097555|NCT03388632|IL-15|il-15
5097556|NCT03388632|Combination Therapy|combination therapy
5097557|NCT03388619|Rising PSA|rising psa
5097558|NCT03388619|No evidence of metastatic disease|no evidence of metastatic disease
5097559|NCT03388619|Entire Prostate Bed|entire prostate bed
5097560|NCT03388619|Quality of Life|quality of life
5097561|NCT03388619|Irradiation|irradiation
5097562|NCT03388606|Cognitive Behavior Therapy|cognitive behavior therapy
5097649|NCT03388060|Kidney stone|kidney stone
5097650|NCT03388060|ESWL|eswl
5097651|NCT03388047|Barrett Esophagus|barrett esophagus
5097652|NCT03388047|Endoscopy|endoscopy
5097653|NCT03388047|Adenocarcinoma|adenocarcinoma
5097841|NCT03386786|Total Knee Arthroplasty|total knee arthroplasty
5097842|NCT03386786|Total Hip Arthroplasty|total hip arthroplasty
5097843|NCT03386786|Total Knee Replacement|total knee replacement
5097844|NCT03386786|Total Hip Replacement|total hip replacement
5097845|NCT03386786|Hospital Care Plan|hospital care plan
5097938|NCT03386097|Cholesterol|cholesterol
5097939|NCT03386097|Interstitial fluid|interstitial fluid
5098031|NCT03385668|Interstitial lung disease|interstitial lung disease
5098032|NCT03385629|Dental Care|dental care
5098033|NCT03385629|Dental Caries|dental caries
5098034|NCT03385629|Common Sense Model of Self-Regulation|common sense model of self-regulation
5098036|NCT03385577|Gastrointestinal (GI)|gastrointestinal (gi)
5098037|NCT03385577|Fear of Cancer Recurrence (FCR)|fear of cancer recurrence (fcr)
5098038|NCT03385551|Vulvovaginal Atrophy|vulvovaginal atrophy
5098039|NCT03385525|Healthy Volunteer|healthy volunteer
5098040|NCT03385512|Virtual standardized patient coaching|virtual standardized patient coaching
5098041|NCT03385512|Standardized patient instructor coaching|standardized patient instructor coaching
5098042|NCT03385512|Patient centered communication|patient centered communication
5098043|NCT03385499|Congenital toxoplasmosis|congenital toxoplasmosis
5098127|NCT03385005|Healthy Volunteer|healthy volunteer
5098128|NCT03385005|Spinal Cord Injury|spinal cord injury
5098129|NCT03385005|Biomedical Engineering|biomedical engineering
5098328|NCT03383718|Acute Myocardial Infarction|acute myocardial infarction
5098329|NCT03383705|Photoaged Skin|photoaged skin
5098330|NCT03383692|Unresectable or metastatic solid malignant tumors|unresectable or metastatic solid malignant tumors
5098331|NCT03383692|Solid malignant tumors|solid malignant tumors
5098722|NCT03381261|nerve decompression|nerve decompression
5098723|NCT03381248|randomized clinical trial|randomized clinical trial
5098724|NCT03381248|osteoarthritis|osteoarthritis
5098726|NCT03381248|knee|knee
5098919|NCT03380013|hypothermia treatment|hypothermia treatment
5098920|NCT03380013|OMT in infants|omt in infants
5098921|NCT03380000|Dietary nitrate supplementation|dietary nitrate supplementation
5098922|NCT03380000|Beetroot juice|beetroot juice
5098923|NCT03379961|social categorization|social categorization
5098924|NCT03379961|nurse sorting|nurse sorting
5098925|NCT03379961|emergencies units|emergencies units
5098926|NCT03379909|metformin|metformin
5098927|NCT03379909|marker lesion|marker lesion
5098930|NCT03379870|EAS|eas
5099118|NCT03378518|In-hospital Cardiac Arrest, mortality|in-hospital cardiac arrest, mortality
5099119|NCT03378479|Influenza|influenza
5099120|NCT03378453|Narcolepsy|narcolepsy
5099121|NCT03378453|Alzheimer|alzheimer
5099122|NCT03378453|Orexin|orexin
5099123|NCT03378453|Amyloid|amyloid
5099124|NCT03378453|PET-amyloid imaging|pet-amyloid imaging
5099125|NCT03378427|Tedizolid|tedizolid
5099126|NCT03378427|Adverse effects|adverse effects
5099127|NCT03378427|Efficacy|efficacy
5099128|NCT03378427|prosthetic joint infection|prosthetic joint infection
5099129|NCT03378414|Spinocerebellar Ataxia,Mesenchymal Stem Cells|spinocerebellar ataxia,mesenchymal stem cells
5099219|NCT03377829|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
5099220|NCT03377829|Percutaneous Laser Ablation|percutaneous laser ablation
5099221|NCT03377829|thyroidectomy|thyroidectomy
5099222|NCT03377829|ultrasonography|ultrasonography
5099223|NCT03377829|double-blind|double-blind
5099228|NCT03377803|Molluscum|molluscum
5099229|NCT03377803|Skin Diseases|skin diseases
5099230|NCT03377803|Poxviridae Infections|poxviridae infections
5099231|NCT03377803|Skin Diseases; Infectious|skin diseases; infectious
5099232|NCT03377803|Skin Diseases; Viral|skin diseases; viral
5099233|NCT03377803|DNA Poxvirus|dna poxvirus
5099234|NCT03377790|Molluscum|molluscum
5099235|NCT03377790|Skin Diseases|skin diseases
5099236|NCT03377790|Poxviridae Infections|poxviridae infections
5099620|NCT03375684|Balance|balance
5099713|NCT03375008|Nonalcoholic fatty liver disease(NAFLD)|nonalcoholic fatty liver disease(nafld)
5099714|NCT03375008|Imaging diagnostic|imaging diagnostic
5099715|NCT03374956|Pharmacological|pharmacological
5099716|NCT03374956|Obesity Management|obesity management
5099809|NCT03374306|Multifocal Electroretinogram|multifocal electroretinogram
5099810|NCT03374293|pancreatic cancer|pancreatic cancer
5099811|NCT03374293|Radiation|radiation
5099814|NCT03374280|Gefitinib|gefitinib
5099909|NCT03373591|liposomal bupivacaine|liposomal bupivacaine
5099910|NCT03373578|sleep;|sleep;
5099911|NCT03373578|Infant, Premature;|infant, premature;
5099912|NCT03373578|Polysomnography;|polysomnography;
5099913|NCT03373578|Ear Protective Devices|ear protective devices
5099914|NCT03373552|Coronary Artery Disease; Clopidogrel; Polymorphism, genetic|coronary artery disease; clopidogrel; polymorphism, genetic
5099915|NCT03373539|Biomarkers|biomarkers
5099916|NCT03373539|Neurotrophins|neurotrophins
5099917|NCT03373526|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5099931|NCT03373396|alcohol|alcohol
5100102|NCT03372174|postoperative infections|postoperative infections
5100106|NCT03372135|POCD|pocd
5100107|NCT03372135|RARC|rarc
5100204|NCT03371550|Concurrent 3-D chemoradiotherapy,Docetaxel,Cisplatin,Chemotherapy ·|concurrent 3-d chemoradiotherapy,docetaxel,cisplatin,chemotherapy ·
5100303|NCT03370991|Polyphenols|polyphenols
5100305|NCT03370991|Atherosclerosis|atherosclerosis
5100404|NCT03370549|Sexual risk behaviors|sexual risk behaviors
5100405|NCT03370536|Atrial Fibrillation|atrial fibrillation
5100406|NCT03370536|Persistent Atrial Fibrillation|persistent atrial fibrillation
5100407|NCT03370536|AFIB|afib
5100698|NCT03368768|Antimicrobial-resistant bacterial infection|antimicrobial-resistant bacterial infection
5100699|NCT03368768|Questionaire|questionaire
5100700|NCT03368729|metastatic breast cancer|metastatic breast cancer
5100701|NCT03368729|HER2 positive|her2 positive
5100702|NCT03368729|Poly (ADP-Ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
5100703|NCT03368729|Niraparib|niraparib
5100704|NCT03368729|Trastuzumab|trastuzumab
5100705|NCT03368716|Pediatric Obesity|pediatric obesity
5100706|NCT03368716|Executive Function|executive function
5100708|NCT03368703|COPD|copd
5100793|NCT03368248|Medico-caring staff of the NICUs|medico-caring staff of the nicus
5100887|NCT03367650|environmental factor|environmental factor
5100888|NCT03367637|Cancer Pain, Palliative care, Mobile Applications, Rwanda|cancer pain, palliative care, mobile applications, rwanda
5100889|NCT03367624|influenza|influenza
5100986|NCT03366935|dural puncture epidural (DPE)|dural puncture epidural (dpe)
5100990|NCT03366909|mindfulness|mindfulness
5101081|NCT03366363|sham acupuncture|sham acupuncture
5101082|NCT03366337|IgA Nephropathy|iga nephropathy
5101083|NCT03366337|CKD associated with type 1 diabetes|ckd associated with type 1 diabetes
5101084|NCT03366337|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5101085|NCT03366337|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5101087|NCT03366337|FSGS|fsgs
5101088|NCT03366337|ADPKD|adpkd
5101089|NCT03366337|Bardoxolone methyl|bardoxolone methyl
5101090|NCT03366337|CDDO-ME|cddo-me
5101091|NCT03366337|RTA 402|rta 402
5101092|NCT03366311|intubation|intubation
5101093|NCT03366311|epiglottis lift|epiglottis lift
5101094|NCT03366311|hold high position|hold high position
5101186|NCT03365778|educational intervention|educational intervention
5101188|NCT03365778|selective laser trabeculoplasty|selective laser trabeculoplasty
5101189|NCT03365778|POAG|poag
5101190|NCT03365778|eye drops|eye drops
5101191|NCT03365778|Primary Open Angle Glaucoma|primary open angle glaucoma
5101192|NCT03365739|Mango|mango
5101195|NCT03365713|COPD|copd
5101380|NCT03364621|Metastasis|metastasis
5101381|NCT03364621|Molecular profiling|molecular profiling
5101382|NCT03364621|Epigenetic analysis|epigenetic analysis
5101685|NCT03362580|Diabetes|diabetes
5101686|NCT03362567|Cervical Radiculopathy|cervical radiculopathy
5101687|NCT03362567|Sustained Natural Apophyseal Glides|sustained natural apophyseal glides
5101688|NCT03362567|Mechanical Cervical Traction|mechanical cervical traction
5101689|NCT03362567|Pain Intensity|pain intensity
5101690|NCT03362567|Neck Disability|neck disability
5101878|NCT03361319|Non-Small Cell Lung Cancer|non-small cell lung cancer
5101880|NCT03361306|Relapsed|relapsed
5101881|NCT03361280|hemodialysis|hemodialysis
5101882|NCT03361280|dialytic clearance|dialytic clearance
5101883|NCT03361280|pharmacokinetics|pharmacokinetics
5102067|NCT03360201|Program evaluation|program evaluation
5102068|NCT03360201|Family Conflict|family conflict
5102069|NCT03360201|Marital Conflict|marital conflict
5102162|NCT03359577|Inflammation|inflammation
5102163|NCT03359577|Cardiovascular diseases|cardiovascular diseases
5102164|NCT03359564|Lumbar Disc Herniation|lumbar disc herniation
5102165|NCT03359564|Micro Endoscopic Discectomy|micro endoscopic discectomy
5102172|NCT03359538|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5102173|NCT03359538|Motor Neuron Disease|motor neuron disease
5102174|NCT03359538|Rapamycin|rapamycin
5102175|NCT03359512|anesthesia monitoring|anesthesia monitoring
5102177|NCT03359473|COPD|copd
5102178|NCT03359473|muscle weakness|muscle weakness
5102265|NCT03358992|survival|survival
5102266|NCT03358992|osteosarcoma|osteosarcoma
5102267|NCT03358992|Ewing sarcoma|ewing sarcoma
5102268|NCT03358979|Conjunctival Diseases|conjunctival diseases
5102269|NCT03358979|Dry Eye Syndromes|dry eye syndromes
5102270|NCT03358979|Antigens|antigens
5102753|NCT03355677|complex case management|complex case management
5102754|NCT03355664|Malaria, Falciparum|malaria, falciparum
5102855|NCT03355040|shoulder dystocia|shoulder dystocia
5102856|NCT03355040|maternal and neonatal morbidity|maternal and neonatal morbidity
5102857|NCT03355027|Low Density Lipoprotein Cholesterol (LDL)|low density lipoprotein cholesterol (ldl)
5102858|NCT03355027|PCSK9|pcsk9
5103052|NCT03353441|Verbal Learning and Memory Test (VLMT)|verbal learning and memory test (vlmt)
5103053|NCT03353441|Stroop Test|stroop test
5103054|NCT03353441|Attention|attention
5103055|NCT03353441|Working Memory|working memory
5103185|NCT03352609|TMS|tms
5103253|NCT03352154|Evoked Potential P300|evoked potential p300
5103254|NCT03352102|Electric Stimulation|electric stimulation
5103255|NCT03352102|Intensive Care Units|intensive care units
5103354|NCT03351426|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5103547|NCT03349814|yersinia|yersinia
5103548|NCT03349801|iAMD|iamd
5103549|NCT03349801|biomarker|biomarker
5103550|NCT03349801|clinical endpoint|clinical endpoint
5103945|NCT03347643|transcranial direct current stimulation|transcranial direct current stimulation
5103947|NCT03347643|craving|craving
5104144|NCT03346369|Lanthanum Carbonate|lanthanum carbonate
5104145|NCT03346369|Phosphate Binder|phosphate binder
5104146|NCT03346330|Chronic pain|chronic pain
5104147|NCT03346330|Neuropathic pain|neuropathic pain
5104148|NCT03346317|Asherman syndrome|asherman syndrome
5104149|NCT03346317|hysteroscopy|hysteroscopy
5104150|NCT03346317|Uterine stent|uterine stent
5104152|NCT03346317|Amnion|amnion
5104243|NCT03345615|atrial fibrillation|atrial fibrillation
5104244|NCT03345615|myocardial infarction|myocardial infarction
5104245|NCT03345615|intensive monitoring|intensive monitoring
5104340|NCT03345069|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5104342|NCT03345043|H7N9 antigen mRNA|h7n9 antigen mrna
5104343|NCT03345043|Influenza vaccine|influenza vaccine
5104547|NCT03343938|Low oxygen tension|low oxygen tension
5104548|NCT03343938|Closed station|closed station
5104549|NCT03343938|Embryo handling|embryo handling
5104644|NCT03343301|gastrointestinal cancer|gastrointestinal cancer
5104645|NCT03343288|Silver Hydroxiapatite Coating|silver hydroxiapatite coating
5104743|NCT03342560|Liver Fibrosis|liver fibrosis
5104744|NCT03342560|Ultrasound Elastography|ultrasound elastography
5104745|NCT03342560|Shear wave speed|shear wave speed
5104746|NCT03342560|Stiffness|stiffness
5104747|NCT03342560|Liver Biopsy|liver biopsy
5104748|NCT03342547|Norovirus|norovirus
5104937|NCT03341247|Reward Processing|reward processing
5104938|NCT03341247|Working Memory|working memory
5104939|NCT03341234|Superficial Serratus Plane Block|superficial serratus plane block
5104940|NCT03341234|Modified Radical Mastectomy|modified radical mastectomy
5104941|NCT03341234|Axillary Lymph Node Disection|axillary lymph node disection
5104942|NCT03341234|bupivacaine|bupivacaine
5104944|NCT03341195|Automated calls|automated calls
5104945|NCT03341195|Routine immunization|routine immunization
5105034|NCT03340571|Alzheimer's Disease|alzheimer's disease
5105035|NCT03340571|biomarkers|biomarkers
5105036|NCT03340571|blood|blood
5105057|NCT03340493|Stroke|stroke
5105058|NCT03340493|Ischemia|ischemia
5105059|NCT03340493|Cerebral Infarction|cerebral infarction
5105060|NCT03340493|Cerebrovascular Disorders|cerebrovascular disorders
5105061|NCT03340493|Brain Diseases|brain diseases
5105062|NCT03340493|Central Nervous System Diseases|central nervous system diseases
5105063|NCT03340493|Nervous System Diseases|nervous system diseases
5105064|NCT03340493|Vascular Diseases|vascular diseases
5105065|NCT03340493|Cardiovascular Diseases|cardiovascular diseases
5105066|NCT03340493|Pathologic Processes|pathologic processes
5105067|NCT03340493|Brain Infarction|brain infarction
5105068|NCT03340493|Brain Ischemia|brain ischemia
5105069|NCT03340493|Tenecteplase|tenecteplase
5105070|NCT03340493|Fibrinolytic agents|fibrinolytic agents
5105071|NCT03340493|Fibrin Modulating agents|fibrin modulating agents
5105072|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5105073|NCT03340493|Plasminogen|plasminogen
5105074|NCT03340493|Tissue Plasminogen Activator|tissue plasminogen activator
5105075|NCT03340454|H. pylori|h. pylori
5105076|NCT03340454|H. pylori infection|h. pylori infection
5105077|NCT03340428|incarceration|incarceration
5105078|NCT03340428|linkage to care|linkage to care
5105079|NCT03340428|retention in care|retention in care
5105085|NCT03340402|Breast Cancer|breast cancer
5105087|NCT03340350|PTSD|ptsd
5105134|NCT03340064|Monotherapy|monotherapy
5105135|NCT03340064|Adjunctive Treatment|adjunctive treatment
5105136|NCT03340038|Free Flap Reconstructive Surgery|free flap reconstructive surgery
5105137|NCT03340038|Head and Neck|head and neck
5105138|NCT03340025|negative pressure wound therapy|negative pressure wound therapy
5105139|NCT03340025|split thickness skin graft|split thickness skin graft
5105140|NCT03339986|Portion Size|portion size
5105231|NCT03339310|2-Lead|2-lead
5105232|NCT03339310|FIX-HF-5C2|fix-hf-5c2
5105233|NCT03339310|Optimizer|optimizer
5105234|NCT03339258|Posttraumatic Stress Disorder|posttraumatic stress disorder
5105235|NCT03339258|Post-traumatic Stress Disorder|post-traumatic stress disorder
5105336|NCT03338764|Transient insomnia|transient insomnia
5105337|NCT03338764|Insomnia|insomnia
5105338|NCT03338764|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
5105344|NCT03338686|Keratinized tissue|keratinized tissue
5105345|NCT03338686|Keratinized mucosa|keratinized mucosa
5105346|NCT03338686|Attached mucosa|attached mucosa
5105347|NCT03338686|Dental implants|dental implants
5105348|NCT03338686|Free gingival graft|free gingival graft
5105349|NCT03338686|Connective tissue graft|connective tissue graft
5105433|NCT03338270|MRI|mri
5105435|NCT03338270|minute-MRI|minute-mri
5105436|NCT03338270|multi EPI-mix|multi epi-mix
5105437|NCT03338270|Clinical Validation|clinical validation
5105630|NCT03337009|Naloxone|naloxone
5105631|NCT03337009|Opioids|opioids
5105632|NCT03337009|Web-based intervention|web-based intervention
5105832|NCT03335904|breath-holding|breath-holding
5105833|NCT03335891|asthma education program|asthma education program
5106032|NCT03334799|stability|stability
5106035|NCT03334786|ALS|als
5106234|NCT03333668|Guanfacine|guanfacine
5106235|NCT03333668|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5106236|NCT03333668|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5106331|NCT03333200|Longitudinal|longitudinal
5106333|NCT03333200|Motor|motor
5106432|NCT03332563|internet-delivered|internet-delivered
5106433|NCT03332550|laparoscopic lavage|laparoscopic lavage
5106434|NCT03332537|Young Adults|young adults
5106436|NCT03332537|Self Management|self management
5106437|NCT03332537|Pain|pain
5106442|NCT03332498|colon|colon
5106534|NCT03332017|Relapsed/Refractory Follicular non-Hodgkin Lymphoma|relapsed/refractory follicular non-hodgkin lymphoma
5106535|NCT03332004|Indocyanine Green|indocyanine green
5106536|NCT03332004|Deep Infiltrating Endometriosis|deep infiltrating endometriosis
5106537|NCT03332004|Near-Infrared Vision|near-infrared vision
5106538|NCT03332004|Occult endometriosis|occult endometriosis
5106539|NCT03332004|Invisible endometriosis|invisible endometriosis
5106540|NCT03331978|Adherence|adherence
5106541|NCT03331978|Antiretroviral treatment|antiretroviral treatment
5106542|NCT03331978|Black/ AfricanAmerican|black/ africanamerican
5106544|NCT03331965|Metoclopramide|metoclopramide
5106632|NCT03331354|distance learning|distance learning
5106633|NCT03331354|incarceration|incarceration
5106634|NCT03331328|MonaLisa|monalisa
5106635|NCT03331328|Genitourinary syndrome of menopause (GSM)|genitourinary syndrome of menopause (gsm)
5106639|NCT03331198|JCAR017|jcar017
5106724|NCT03330756|Type 2 diabetes mellitus|type 2 diabetes mellitus
5106925|NCT03329573|Mississauga|mississauga
5106926|NCT03329573|Healthy|healthy
5106927|NCT03329573|Bioequivalence|bioequivalence
5106928|NCT03329573|Paroxetine|paroxetine
5106929|NCT03329547|Bioequivalence|bioequivalence
5106930|NCT03329547|Pharmacokinetics|pharmacokinetics
5106931|NCT03329547|SKF101804|skf101804
5106932|NCT03329547|Crossover|crossover
5106933|NCT03329547|Cefixime|cefixime
5106938|NCT03329508|Parkinson disease|parkinson disease
5106939|NCT03329495|right colon cancer|right colon cancer
5106940|NCT03329495|superior mesenteric artery|superior mesenteric artery
5107021|NCT03329040|multiparity|multiparity
5107022|NCT03329001|PARP inhibitor|parp inhibitor
5107023|NCT03329001|niraparib|niraparib
5107024|NCT03329001|Zejula|zejula
5107030|NCT03328923|post-prandial cognition|post-prandial cognition
5107031|NCT03328923|brown seaweed|brown seaweed
5107032|NCT03328910|Emergence Delirium|emergence delirium
5107033|NCT03328910|pulse oximetry|pulse oximetry
5107034|NCT03328910|Children, Preschool|children, preschool
5107035|NCT03328897|Chronic spontaneous urticarial|chronic spontaneous urticarial
5107036|NCT03328897|ISS7|iss7
5107037|NCT03328897|UAS7|uas7
5107038|NCT03328897|omalizumab|omalizumab
5107121|NCT03328325|Influenza Vaccine|influenza vaccine
5107122|NCT03328221|Heart rate variability|heart rate variability
5107123|NCT03328221|Observational study|observational study
5107124|NCT03328221|Physical activity|physical activity
5107418|NCT03326401|dietary total antioxidant activity|dietary total antioxidant activity
5107419|NCT03326401|nutritional status|nutritional status
5107420|NCT03326401|macular degeneration|macular degeneration
5107517|NCT03325933|vascular function|vascular function
5107518|NCT03325933|arterial stiffness|arterial stiffness
5107519|NCT03325933|glucose tolerance|glucose tolerance
5107628|NCT03325413|POCD|pocd
5107713|NCT03324880|rhPTH[1-84)|rhpth[1-84)
5107714|NCT03324880|Parathyroid hormone|parathyroid hormone
5107715|NCT03324880|Hypocalcemia|hypocalcemia
5107716|NCT03324880|Hypoparathyroidism|hypoparathyroidism
5107717|NCT03324854|Mosquito net|mosquito net
5107915|NCT03323541|multiple myeloma|multiple myeloma
5107917|NCT03323528|Tyrothricin|tyrothricin
5107918|NCT03323528|Benzalkonium chloride|benzalkonium chloride
5107926|NCT03323528|lozenge|lozenge
4967597|NCT04192396|ART|art
5108010|NCT03323138|Ex-PRESS|ex-press
5108011|NCT03323138|glaucoma|glaucoma
5108408|NCT03320421|hypofractionated radiation|hypofractionated radiation
5108409|NCT03320421|breast cancer|breast cancer
5108412|NCT03320408|biobank|biobank
5108600|NCT03319173|High Reduction Potential|high reduction potential
5108602|NCT03319173|Exergonic|exergonic
5108603|NCT03319173|Endergonic|endergonic
5108604|NCT03319173|Epigenetic Histone Modification|epigenetic histone modification
5108605|NCT03319173|Montreal Cognitive Assessment (MoCA)|montreal cognitive assessment (moca)
5108606|NCT03319173|Brief Visual Memory Test-Revised (BVMT-R)|brief visual memory test-revised (bvmt-r)
5108607|NCT03319173|Rey Auditory Verbal Learning Task (RAVLT)|rey auditory verbal learning task (ravlt)
5108608|NCT03319173|HOMA-IR|homa-ir
5108609|NCT03319147|exercise|exercise
5108610|NCT03319147|recovery|recovery
5108696|NCT03318666|Online systems|online systems
5108698|NCT03318666|Social media|social media
5108792|NCT03318094|insulin resistance|insulin resistance
5108793|NCT03318094|phentolamine|phentolamine
5108794|NCT03318094|microvascular recruitment|microvascular recruitment
5108795|NCT03318094|autonomic nervous system|autonomic nervous system
5108799|NCT03318068|Cancer|cancer
5108887|NCT03317184|Physical Activity|physical activity
5108891|NCT03317171|flavonoids|flavonoids
5108987|NCT03316664|schizoaffective disorder|schizoaffective disorder
5109088|NCT03315910|Lung CT|lung ct
5109184|NCT03315468|cohort|cohort
5109378|NCT03314519|Lung collapse|lung collapse
5109379|NCT03314519|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5109381|NCT03314519|compare|compare
5109671|NCT03312452|Intravenous fluid|intravenous fluid
5660187|NCT00662220|SVR|svr
5109672|NCT03312439|Myocardial infarction|myocardial infarction
5109673|NCT03312439|Stroke|stroke
5109674|NCT03312439|Diabetes|diabetes
5109675|NCT03312439|Depression|depression
5109884|NCT03311087|acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5109886|NCT03311087|intensive care unit|intensive care unit
5109894|NCT03311061|Teen Pregnancy|teen pregnancy
5109895|NCT03311061|Prevention|prevention
5109896|NCT03311061|Positive Youth Development|positive youth development
5109897|NCT03311061|Financial Literacy|financial literacy
5110183|NCT03309150|M6620|m6620
5110184|NCT03309150|Solid tumors|solid tumors
5110385|NCT03307798|dental implant,bone quality,tactile sensation|dental implant,bone quality,tactile sensation
5110386|NCT03307772|lactobacillus|lactobacillus
5110387|NCT03307772|Herpes Labialis|herpes labialis
5110388|NCT03307772|immune response|immune response
5110389|NCT03307720|agonist trigger|agonist trigger
5110390|NCT03307720|Ovulation induction|ovulation induction
5110487|NCT03307096|Randomized Controlled Trial|randomized controlled trial
5110488|NCT03307096|Retrograde Intrarenal Surgery|retrograde intrarenal surgery
5110489|NCT03307057|Pediatrics|pediatrics
5110490|NCT03307057|Behavioral Research|behavioral research
5110492|NCT03307031|elderly|elderly
5110603|NCT03306394|cancer|cancer
5110695|NCT03305874|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5110794|NCT03305224|castration-resistant prostate cancer|castration-resistant prostate cancer
5110795|NCT03305224|bone metastasis|bone metastasis
5110797|NCT03305107|Child|child
5110798|NCT03305107|Exercise|exercise
5110799|NCT03305107|Chocolate milk|chocolate milk
5110800|NCT03305107|Blood glucose|blood glucose
5110801|NCT03305107|Cognition|cognition
5110802|NCT03305107|Appetite|appetite
5110803|NCT03305107|Emotions|emotions
5110804|NCT03305107|Cortisol|cortisol
5110805|NCT03305094|Remote ischemic preconditioning|remote ischemic preconditioning
5110806|NCT03305094|Myocardial infarction|myocardial infarction
5110807|NCT03305094|Cardiac surgery|cardiac surgery
5110808|NCT03305055|opioid|opioid
5110809|NCT03305055|ketamine|ketamine
5110810|NCT03305042|aging|aging
5110811|NCT03305042|alpha-retinol|alpha-retinol
5110896|NCT03304535|Social Worker|social worker
5110897|NCT03304496|Nitroglycerin|nitroglycerin
5110898|NCT03304496|Vasodilator Agents|vasodilator agents
5110899|NCT03304496|Subcutaneous Injection|subcutaneous injection
5110900|NCT03304496|Radial Artery|radial artery
5110901|NCT03304496|Coronary Angiography|coronary angiography
5110902|NCT03304496|Cardiac Catheterization|cardiac catheterization
5110903|NCT03304496|Coronary Angioplasty|coronary angioplasty
5110905|NCT03304457|Lurasidone|lurasidone
5111067|NCT03303547|MRI|mri
5111097|NCT03303326|sexual health|sexual health
5111098|NCT03303313|RNAi therapeutic|rnai therapeutic
5111100|NCT03303313|Hemolysis|hemolysis
5111292|NCT03301922|Work focused therapy|work focused therapy
5111293|NCT03301922|Sick leave|sick leave
5111294|NCT03301896|Phase I|phase i
5111295|NCT03301896|LHC165|lhc165
5111491|NCT03300765|Intensity modulated radiation therapy|intensity modulated radiation therapy
5111492|NCT03300726|Synaptic injury|synaptic injury
5111493|NCT03300713|Mass screening|mass screening
5111693|NCT03299374|Older people|older people
5111694|NCT03299361|Carpal tunnel syndrome|carpal tunnel syndrome
5111695|NCT03299361|Corticosteroid|corticosteroid
5111696|NCT03299361|Diffusion tensor imaging|diffusion tensor imaging
5111698|NCT03299361|Magnetic resonance image|magnetic resonance image
5111699|NCT03299361|Ultrasound|ultrasound
5111700|NCT03299348|Psychological Mechanisms|psychological mechanisms
5111701|NCT03299348|Social-Cognitive Mechanisms|social-cognitive mechanisms
5111797|NCT03298867|Autoimmune Thyroid Disease|autoimmune thyroid disease
5111799|NCT03298802|triage visit for pregnancy related hypertension|triage visit for pregnancy related hypertension
5111998|NCT03297164|acute myocardial infarction|acute myocardial infarction
5111999|NCT03297164|heart failure|heart failure
5112000|NCT03297164|optimized treatment|optimized treatment
5112001|NCT03297151|Resistance Training|resistance training
5112002|NCT03297151|Muscle Function|muscle function
5112386|NCT03294590|Child oral health behaviors|child oral health behaviors
5112387|NCT03294590|Text messages|text messages
5112388|NCT03294590|Motivation|motivation
5112389|NCT03294590|Self efficacy|self efficacy
5112584|NCT03293524|Neurodegenerative Disease|neurodegenerative disease
5112682|NCT03292939|doppler indices|doppler indices
5112684|NCT03292887|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5112685|NCT03292887|Hunter Syndrome|hunter syndrome
5112686|NCT03292887|Enzyme Replacement Therapy|enzyme replacement therapy
5112687|NCT03292887|Lysosomal|lysosomal
5112688|NCT03292887|Glycosaminoglycans|glycosaminoglycans
5112689|NCT03292874|prostate cancer|prostate cancer
5112691|NCT03292848|CNS Disorders|cns disorders
5112692|NCT03292848|Brexpiprazole|brexpiprazole
5112693|NCT03292835|complex|complex
5112694|NCT03292835|zoonotic|zoonotic
5112695|NCT03292835|medical device|medical device
5112696|NCT03292796|Open Angle Glaucoma|open angle glaucoma
5112782|NCT03292250|Biomarker Driven Umbrella Trial|biomarker driven umbrella trial
5112783|NCT03292250|BYL719,poziotinib, abemaciclib, nintedanib|byl719,poziotinib, abemaciclib, nintedanib
5112784|NCT03292250|Durvalumab + Tremelimumab Combination Treatment|durvalumab + tremelimumab combination treatment
5112785|NCT03292237|Energy|energy
5112881|NCT03291548|Cardiovascular disease|cardiovascular disease
5112882|NCT03291548|Cholesterol|cholesterol
5112883|NCT03291548|Lipid profile|lipid profile
5112886|NCT03291509|weight loss|weight loss
5112979|NCT03290638|Guided Bone Regeneration|guided bone regeneration
5112980|NCT03290638|Dehydrated Human Amnion Chorion Membrane|dehydrated human amnion chorion membrane
5112981|NCT03290638|Type I Bovine Collagen Membrane|type i bovine collagen membrane
5112983|NCT03290638|Ridge Healing|ridge healing
5112984|NCT03290638|Teeth Extraction|teeth extraction
5112985|NCT03290612|Sleep|sleep
5112986|NCT03290612|Vitamin C|vitamin c
5113083|NCT03290066|Primary Dysmenorrhea|primary dysmenorrhea
5113182|NCT03289429|Atorvastatin|atorvastatin
5113183|NCT03289429|Magnesium sulfate|magnesium sulfate
5113280|NCT03288701|heart failure|heart failure
5113383|NCT03288233|Hemoglobin A1c|hemoglobin a1c
5113384|NCT03288233|HbA1c|hba1c
5113385|NCT03288233|End tidal carbon monoxide|end tidal carbon monoxide
5113387|NCT03288207|Community-Based Participatory Research|community-based participatory research
5113388|NCT03288207|Obesity|obesity
5113389|NCT03288207|Cardiovascular Disease Risk|cardiovascular disease risk
5113390|NCT03288207|Social Determinants of Health|social determinants of health
5113391|NCT03288168|Observation|observation
5113392|NCT03288168|Molecular Subgroup|molecular subgroup
5113393|NCT03288168|NanoString|nanostring
5113394|NCT03288155|Parkinson's|parkinson's
5113395|NCT03288155|Fatigue|fatigue
5113396|NCT03288155|Flavonoid|flavonoid
5113397|NCT03288155|Cocoa|cocoa
5113398|NCT03288129|monotherapy|monotherapy
5113399|NCT03288129|adjunctive therapy|adjunctive therapy
5113400|NCT03288129|open-label|open-label
5113401|NCT03288129|multicenter|multicenter
5113402|NCT03288064|raisins|raisins
5113403|NCT03288064|carbohydrates|carbohydrates
5113404|NCT03288064|antioxidant capacity|antioxidant capacity
5113405|NCT03288064|substrate oxidation|substrate oxidation
5113406|NCT03288064|prolonged cycling|prolonged cycling
5113407|NCT03288025|Insulin Resistance|insulin resistance
5113408|NCT03288025|Inflammation|inflammation
5113409|NCT03288025|Right Ventricular Function|right ventricular function
5113410|NCT03288025|Metabolism|metabolism
5113411|NCT03288025|Glucose|glucose
5113412|NCT03287986|Elderly|elderly
5113413|NCT03287986|MRI|mri
5113434|NCT03287895|CPR|cpr
5113483|NCT03287726|Appetite Regulation|appetite regulation
5113485|NCT03287726|Caloric Restriction|caloric restriction
5113678|NCT03286465|blood transfusion|blood transfusion
5113679|NCT03286452|Antimicrobial|antimicrobial
5113680|NCT03286452|Collagen|collagen
5113681|NCT03286452|Bioburden|bioburden
5113682|NCT03286452|Biofilm|biofilm
5113683|NCT03286452|PHMB|phmb
5113878|NCT03284879|Psoriasis vulgaris|psoriasis vulgaris
5113981|NCT03284255|Percutaneous Coronary Intervention|percutaneous coronary intervention
5113984|NCT03284242|Kidney|kidney
5114201|NCT03282890|HIV|hiv
5114284|NCT03282409|Acute Kidney Injury|acute kidney injury
5114285|NCT03282383|biomarkers pneumonia severity|biomarkers pneumonia severity
5114286|NCT03282370|Japanese Encephalitis|japanese encephalitis
5114287|NCT03282370|JECEVAX|jecevax
5114288|NCT03282370|Vietnam|vietnam
5114292|NCT03282331|Preoxygenation|preoxygenation
5114293|NCT03282331|Intubation|intubation
5114294|NCT03282331|Electrical Impedance Tomography|electrical impedance tomography
5114386|NCT03281733|adult|adult
4971346|NCT04169867|Cancer|cancer
5114389|NCT03281733|communication|communication
5114390|NCT03281733|discharge|discharge
5114391|NCT03281733|nutrition|nutrition
5114392|NCT03281707|NIRS|nirs
5114393|NCT03281707|DO2|do2
5114394|NCT03281694|nicotine|nicotine
5114395|NCT03281694|positive allosteric modulator|positive allosteric modulator
5114396|NCT03281694|attention|attention
5114397|NCT03281694|cognition|cognition
5114398|NCT03281681|adenocarcinoma of the ovary|adenocarcinoma of the ovary
5114399|NCT03281681|ovarian adenocarcinoma|ovarian adenocarcinoma
5114691|NCT03280030|acute myeloid leukemia|acute myeloid leukemia
5114692|NCT03280030|combination treatment|combination treatment
5114694|NCT03280030|acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5114695|NCT03280030|acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5114696|NCT03280017|anesthesia|anesthesia
5114790|NCT03279354|Smartphone application|smartphone application
5114791|NCT03279341|laxatives|laxatives
5114792|NCT03279341|constipation|constipation
5114793|NCT03279315|Iodine|iodine
5114794|NCT03279315|Balance experiment|balance experiment
5114795|NCT03279315|EAR|ear
5115081|NCT03277339|Thermal cure|thermal cure
5115179|NCT03276637|Genome Sequencing|genome sequencing
5115195|NCT03276611|air|air
5115683|NCT03272958|Pruritus|pruritus
5115782|NCT03272321|oxytocin|oxytocin
5115783|NCT03272321|EEG|eeg
5115784|NCT03272321|skin conductance response|skin conductance response
5115785|NCT03272321|heart rate|heart rate
5115786|NCT03272321|gaze direction|gaze direction
5115787|NCT03272321|eye contact|eye contact
5115983|NCT03271138|IgA TTG|iga ttg
5115984|NCT03271138|IgA DGP|iga dgp
5115985|NCT03271125|Intervention|intervention
5115986|NCT03271125|Multiple sclerosis|multiple sclerosis
5115987|NCT03271125|Treadmill|treadmill
5115988|NCT03271125|Mobility|mobility
5115989|NCT03271099|survivorship; navigation|survivorship; navigation
5115990|NCT03271086|Relaxation training|relaxation training
5115991|NCT03271086|Pediatric clinic|pediatric clinic
5115992|NCT03271086|Children 6-11 years|children 6-11 years
5115993|NCT03271086|Text messaging|text messaging
5115994|NCT03271073|gastric cancer|gastric cancer
5116081|NCT03270449|multidisciplinary|multidisciplinary
5116082|NCT03270410|neonates|neonates
5116083|NCT03270410|non invasive monitoring|non invasive monitoring
5116091|NCT03270345|Ulcer|ulcer
5116282|NCT03269136|bispecific|bispecific
5116284|NCT03269136|BCMA- CD3 bispecific|bcma- cd3 bispecific
5116385|NCT03268616|neural respiratory drive|neural respiratory drive
5116386|NCT03268616|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5116387|NCT03268616|electromyography|electromyography
5116389|NCT03268590|Hypoxia, Brain|hypoxia, brain
5116390|NCT03268512|leucocyte- and platelet rich fibrin|leucocyte- and platelet rich fibrin
5116391|NCT03268512|ridge preservation|ridge preservation
5116484|NCT03267966|periampullary cancer|periampullary cancer
5116485|NCT03267966|margin status|margin status
5116486|NCT03267966|R1 resection|r1 resection
5116487|NCT03267966|clearance margin|clearance margin
5116488|NCT03267953|Stress management, e-Health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing|stress management, e-health, cardiovascular disease, adaptive design, lay coaching, motivational interviewing
5116620|NCT03266965|Histamine|histamine
5116686|NCT03266588|migraine|migraine
5116687|NCT03266588|acute|acute
5116788|NCT03265938|Cancer of oral cavity|cancer of oral cavity
5116789|NCT03265938|Ear, Nose and Throat|ear, nose and throat
5116790|NCT03265938|Indirect laryngoscopy|indirect laryngoscopy
5116791|NCT03265938|Awake intubation|awake intubation
5116792|NCT03265938|Expected difficult intubation|expected difficult intubation
5116793|NCT03265847|intimate partner violence|intimate partner violence
5116794|NCT03265847|safety planning|safety planning
5116795|NCT03265847|immigrant, refugee|immigrant, refugee
5116796|NCT03265847|Native American|native american
5116799|NCT03265821|Smoking|smoking
5116885|NCT03265028|communication skills|communication skills
5116886|NCT03265028|general practice|general practice
5116887|NCT03265028|outpatient|outpatient
5117089|NCT03263806|fractional flow reserve CT|fractional flow reserve ct
5117090|NCT03263806|emergency department|emergency department
5117091|NCT03263793|singing|singing
5117097|NCT03263767|Peripheral haemopoietic stem cell transplant|peripheral haemopoietic stem cell transplant
5117098|NCT03263767|High dose cyclophosphamide|high dose cyclophosphamide
5117099|NCT03263767|acute GVHD|acute gvhd
5117100|NCT03263767|allogenic transplantation|allogenic transplantation
5117101|NCT03263767|RIC (reduced-intensity conditioning)|ric (reduced-intensity conditioning)
5117102|NCT03263741|Paclitaxel|paclitaxel
5117103|NCT03263741|S-1|s-1
5117104|NCT03263741|Oxaliplatin|oxaliplatin
5117184|NCT03263273|Minocycline|minocycline
5117185|NCT03263273|Topical|topical
5117186|NCT03263273|Tetracycline|tetracycline
5117187|NCT03263273|Doxycycline|doxycycline
5117188|NCT03263273|Rosacea|rosacea
5117189|NCT03263273|Skin Disease|skin disease
5117190|NCT03263273|Anti-Bacterial Agent|anti-bacterial agent
5117191|NCT03263273|Anti-Inflammatory Agent|anti-inflammatory agent
5117387|NCT03261869|Ice pack therapy, third molar surgery, swelling, pain, trismus|ice pack therapy, third molar surgery, swelling, pain, trismus
5117488|NCT03261167|post-stroke upper limb spasticity|post-stroke upper limb spasticity
5117489|NCT03261167|Efficacy|efficacy
5117491|NCT03261167|double blind|double blind
5117492|NCT03261154|Serum iPTH|serum ipth
5117493|NCT03261154|Calcium|calcium
5117591|NCT03260478|Traumatic Brain Injury (TBI)|traumatic brain injury (tbi)
5117592|NCT03260478|Red Blood Cells (RBC) Transfusion|red blood cells (rbc) transfusion
5117593|NCT03260478|Intensive Care Unit (ICU)|intensive care unit (icu)
5117594|NCT03260478|Transfusion Threshold|transfusion threshold
5117596|NCT03260478|Oxygen Delivery|oxygen delivery
5117597|NCT03260478|Neurocritical Care|neurocritical care
5117598|NCT03260478|Critical Care Neurology and Trauma|critical care neurology and trauma
5117599|NCT03260465|total hip replacement|total hip replacement
5117600|NCT03260465|roentgen stereophotogrammetric analysis|roentgen stereophotogrammetric analysis
5117601|NCT03260452|Type 2 diabetes|type 2 diabetes
5117602|NCT03260452|Adipose tissue|adipose tissue
5117603|NCT03260452|Hematopoiesis|hematopoiesis
5117604|NCT03260452|Inflammation|inflammation
5117605|NCT03260452|Macrophages|macrophages
5117606|NCT03260439|tramadol-penile block -circumcision surgery-anesthesia-child|tramadol-penile block -circumcision surgery-anesthesia-child
5117607|NCT03260426|Tolerability diet after surgery|tolerability diet after surgery
5117608|NCT03260400|RPNI|rpni
5117710|NCT03259763|Cancer|cancer
5117866|NCT03258853|cystic fibrosis|cystic fibrosis
5117867|NCT03258853|insulin|insulin
5117868|NCT03258853|glucagon|glucagon
5117869|NCT03258853|continuous glucose monitor|continuous glucose monitor
5117870|NCT03258853|bionic pancreas|bionic pancreas
5117873|NCT03258840|Paraoxonase 2|paraoxonase 2
5117874|NCT03258840|Type 2 diabetes|type 2 diabetes
5117875|NCT03258827|elderly|elderly
5117886|NCT03258814|pain|pain
5117975|NCT03258073|newborn|newborn
5118166|NCT03257241|acute myeloid leukemia|acute myeloid leukemia
5118168|NCT03257241|DA-90|da-90
5118169|NCT03257241|FLAG-IDA|flag-ida
5118170|NCT03257241|CLAG-M|clag-m
5118171|NCT03257241|Ara-C|ara-c
5118172|NCT03257241|HiDAC|hidac
5118173|NCT03257215|Vitamin D|vitamin d
5118174|NCT03257202|Propionibacterium Acnes|propionibacterium acnes
5118176|NCT03257202|Shoulder|shoulder
5118268|NCT03256643|chronic brain injury|chronic brain injury
5118269|NCT03256643|environment impact|environment impact
5118270|NCT03256643|cognitive therapy|cognitive therapy
5118271|NCT03256643|health facility environment|health facility environment
5118655|NCT03254329|micronutrients|micronutrients
5118656|NCT03254329|lactation|lactation
5118657|NCT03254329|milk volume|milk volume
5118750|NCT03253744|Image Guidance|image guidance
5118846|NCT03253107|gastric cancer|gastric cancer
5118847|NCT03253107|RNA sequencing|rna sequencing
5118848|NCT03253107|chemotherapy response|chemotherapy response
5118849|NCT03253107|miRNA sequencing|mirna sequencing
5118850|NCT03253055|Physical Performance|physical performance
5118852|NCT03253055|Illness|illness
5119037|NCT03251716|Schizophrenia|schizophrenia
5119038|NCT03251716|Efficacy|efficacy
5119137|NCT03250910|hepatitis C virus|hepatitis c virus
5119332|NCT03249883|prosthetic components comparison|prosthetic components comparison
5119333|NCT03249857|Bipolar affective disorders|bipolar affective disorders
5119530|NCT03248544|craniotomy|craniotomy
5119531|NCT03248544|Immune System|immune system
5119532|NCT03248531|Hidradenitis Suppurativa|hidradenitis suppurativa
5119533|NCT03248531|Bimekizumab|bimekizumab
5119535|NCT03248531|Moderate to Severe HS|moderate to severe hs
5119536|NCT03248518|Inflammatory Rheumatic Disease|inflammatory rheumatic disease
5119537|NCT03248518|Fatigue|fatigue
5119538|NCT03248518|Exercise|exercise
5119539|NCT03248518|Behavioural Intervention|behavioural intervention
5119540|NCT03248518|Rheumatoid Arthritis|rheumatoid arthritis
5119730|NCT03247231|Submucosal tumors|submucosal tumors
5119731|NCT03247231|Endoscopic band ligation|endoscopic band ligation
5119732|NCT03247205|hip fracture|hip fracture
5119734|NCT03247205|physical therapy|physical therapy
5120021|NCT03245164|physiotherapy|physiotherapy
5120022|NCT03245164|basketball|basketball
5120023|NCT03245151|pediatrics|pediatrics
5120024|NCT03245151|central nervous system tumors|central nervous system tumors
5120025|NCT03245151|lenvatinib|lenvatinib
5120026|NCT03245151|E7080|e7080
5120027|NCT03245151|everolimus|everolimus
5120028|NCT03245151|Ewing sarcoma/peripheral primitive neuroectodermal tumor|ewing sarcoma/peripheral primitive neuroectodermal tumor
5120029|NCT03245151|rhabdomyosarcoma|rhabdomyosarcoma
5120030|NCT03245151|high grade glioma|high grade glioma
5120031|NCT03245151|solid tumors|solid tumors
5120032|NCT03245138|endoscopic third ventriculostomy|endoscopic third ventriculostomy
5120033|NCT03245138|ventricular peritoneal shunt|ventricular peritoneal shunt
5120034|NCT03245138|communicating hydrocephalus|communicating hydrocephalus
5120038|NCT03245034|Well-Being|well-being
5120217|NCT03243734|esophageal malignancies|esophageal malignancies
5120315|NCT03243058|Type 1 Diabetes|type 1 diabetes
5120316|NCT03243058|Autoimmune|autoimmune
5120417|NCT03242395|Severe burns|severe burns
5120450|NCT03241992|IBD|ibd
5120610|NCT03240991|quality of life|quality of life
5120611|NCT03240939|Dutasteride|dutasteride
5120612|NCT03240939|Tadalafil|tadalafil
5120613|NCT03240926|COPD|copd
5120614|NCT03240926|COPD Exacerbation|copd exacerbation
5120615|NCT03240926|COPD Asthma|copd asthma
5120616|NCT03240926|COPD Bronchitis|copd bronchitis
5120621|NCT03240861|T cells|t cells
5120706|NCT03240393|treatment of lung cancer after first metastasis|treatment of lung cancer after first metastasis
5120707|NCT03240393|lung cancer|lung cancer
5120714|NCT03240393|MET mutation|met mutation
5120804|NCT03239938|chronic pain|chronic pain
5120805|NCT03239938|functionality|functionality
5120902|NCT03239431|exacerbation|exacerbation
5120903|NCT03239418|NMES|nmes
5120904|NCT03239405|laparoscopic|laparoscopic
5120905|NCT03239405|sleeve|sleeve
5120906|NCT03239405|gastrectomy|gastrectomy
5120907|NCT03239392|BNZ-1|bnz-1
5120908|NCT03239392|Cytokine|cytokine
5120909|NCT03239392|IL-2|il-2
5120910|NCT03239392|IL-15|il-15
5120911|NCT03239379|cytokine inhibitor|cytokine inhibitor
5120912|NCT03239379|IL-2|il-2
5120913|NCT03239379|IL-9|il-9
5120914|NCT03239379|IL-15|il-15
5120915|NCT03239366|T2D|t2d
5120916|NCT03239340|EGFR, NSCLC, Lung Cancer, Biopsy, Molecular Profiling|egfr, nsclc, lung cancer, biopsy, molecular profiling
5121004|NCT03238833|Antagonist protocol|antagonist protocol
5121005|NCT03238833|Cumulus cells|cumulus cells
5121006|NCT03238820|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5121007|NCT03238820|Robot|robot
5121008|NCT03238820|manual suture|manual suture
5121203|NCT03237676|neuropsychology|neuropsychology
5121204|NCT03237676|functional outcome|functional outcome
5121205|NCT03237650|Painful cutaneous electrical stimulation|painful cutaneous electrical stimulation
5121206|NCT03237650|Conditioned Pain Modulation|conditioned pain modulation
5121207|NCT03237624|gingivitis|gingivitis
5121208|NCT03237611|emesis|emesis
5121209|NCT03237611|aprepitant|aprepitant
5121210|NCT03237611|carboplatin|carboplatin
5121211|NCT03237611|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5121212|NCT03237585|gender based violence|gender based violence
5121213|NCT03237585|violence against women|violence against women
5121214|NCT03237585|intimate partner violence|intimate partner violence
5121218|NCT03237572|breast cancer|breast cancer
5121494|NCT03235843|Primary Prevention ICD Therapy|primary prevention icd therapy
5121496|NCT03235843|Heart Failure|heart failure
5121595|NCT03235427|Radiation Therapy|radiation therapy
5121596|NCT03235427|Coronary Artery Disease|coronary artery disease
5121597|NCT03235427|CAD|cad
5121598|NCT03235427|RT|rt
5121599|NCT03235427|CT|ct
5121739|NCT03234452|IgA|iga
5121879|NCT03233802|Cognitive-Behavioral Treatment|cognitive-behavioral treatment
5121880|NCT03233802|Individualized Treatment|individualized treatment
5121881|NCT03233776|Anakinra|anakinra
5121882|NCT03233776|Mucositis|mucositis
5121883|NCT03233776|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5122462|NCT03229850|Diabetes|diabetes
5122464|NCT03229850|Lipohypertrophy|lipohypertrophy
5122465|NCT03229850|Euglycemic Clamp|euglycemic clamp
5122466|NCT03229837|Construct validity|construct validity
5122467|NCT03229837|Minimally important differences|minimally important differences
5122471|NCT03229824|Drain antisepsis|drain antisepsis
5122659|NCT03228485|Application|application
5122660|NCT03228485|Pilot|pilot
5122759|NCT03227809|College student risk behavior prevention|college student risk behavior prevention
5122760|NCT03227809|Substance use|substance use
5122761|NCT03227809|Alcohol|alcohol
5122784|NCT03227718|VOR|vor
5122860|NCT03227328|endocrine therapy|endocrine therapy
5122861|NCT03227328|chemotherapy|chemotherapy
5122862|NCT03227328|randomized phase III trial|randomized phase iii trial
5122863|NCT03227328|aromatase inhibitor|aromatase inhibitor
5123156|NCT03225547|HER-2 negative breast cancer|her-2 negative breast cancer
5123157|NCT03225547|breast cancer|breast cancer
5123158|NCT03225547|pembrolizumab|pembrolizumab
5123159|NCT03225547|mifepristone|mifepristone
5123160|NCT03225534|Asthma|asthma
5123161|NCT03225534|Allergy|allergy
5123162|NCT03225534|Epidemiology|epidemiology
5123163|NCT03225534|Environment|environment
5123164|NCT03225534|Exposures|exposures
5123458|NCT03223831|unresectable malignant gastric outlet obstruction|unresectable malignant gastric outlet obstruction
5123703|NCT03222284|smartphone application|smartphone application
5123555|NCT03223155|nivolumab|nivolumab
5123556|NCT03223155|stereotactic body radiotherapy|stereotactic body radiotherapy
5123558|NCT03223129|Impaired glucose tolerance|impaired glucose tolerance
5123559|NCT03223129|Metabolomics|metabolomics
5123560|NCT03223116|heartburn|heartburn
5123561|NCT03223116|regurgitation|regurgitation
5123562|NCT03223103|Brain cancer|brain cancer
5123563|NCT03223103|Glioblastoma|glioblastoma
5123564|NCT03223103|Personalized vaccine|personalized vaccine
5123565|NCT03223103|Poly-ICLC|poly-iclc
5123566|NCT03223103|Immunotherapy|immunotherapy
5123567|NCT03223103|Cancer|cancer
5123568|NCT03223103|NovoTTF-200A|novottf-200a
5123569|NCT03223103|Optune|optune
5123571|NCT03223103|immunogenicity|immunogenicity
5123572|NCT03223090|Language|language
5123573|NCT03223090|learning|learning
5123574|NCT03223090|plasticity|plasticity
5123575|NCT03223077|Post infectious|post infectious
5123576|NCT03223051|Spinal Muscular Atrophy|spinal muscular atrophy
5123577|NCT03223051|Children|children
5123580|NCT03223051|Upper limbs|upper limbs
5123746|NCT03222128|Transaortic|transaortic
5123747|NCT03222128|NovaFlex|novaflex
5123844|NCT03221413|transcranial alternating current stimulation|transcranial alternating current stimulation
5123944|NCT03220594|ovarian reserve|ovarian reserve
5123945|NCT03220594|postpartum|postpartum
5123946|NCT03220555|Buzzy|buzzy
5123947|NCT03220555|anesthetic cream|anesthetic cream
5123948|NCT03220555|pediatric|pediatric
5123949|NCT03220555|pain|pain
5123950|NCT03220555|venipuncture|venipuncture
5123951|NCT03220555|vaccination|vaccination
5123952|NCT03220555|vibration|vibration
5123953|NCT03220555|cold|cold
5123954|NCT03220555|distraction|distraction
5123955|NCT03220555|vaccination center|vaccination center
5123956|NCT03220542|Helicobacter Pylori|helicobacter pylori
5123957|NCT03220542|Probiotics|probiotics
5123958|NCT03220542|Sulforaphane|sulforaphane
5123959|NCT03220477|Pembrolizumab|pembrolizumab
5123960|NCT03220477|guadecitabine|guadecitabine
5124052|NCT03219749|obstructive sleep apnea|obstructive sleep apnea
5124053|NCT03219749|exercise training|exercise training
5124054|NCT03219749|vascular function|vascular function
5124055|NCT03219710|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5124056|NCT03219710|olanzapine|olanzapine
5124057|NCT03219697|Childhood obesity prevention;|childhood obesity prevention;
5124058|NCT03219658|Parenting|parenting
5124059|NCT03219658|Home visiting|home visiting
5124060|NCT03219658|Childhood obesity treatment|childhood obesity treatment
5124061|NCT03219606|Systemic sclerosis|systemic sclerosis
5124062|NCT03219606|Education|education
5124076|NCT03219476|HR+|hr+
5124245|NCT03218696|cough|cough
5124246|NCT03218696|children|children
5124247|NCT03218696|Acute Upper Respiratory Tract Infection|acute upper respiratory tract infection
5124260|NCT03218657|Aplastic Anemia|aplastic anemia
5124261|NCT03218657|levamisole hydrochloride|levamisole hydrochloride
5124262|NCT03218657|clinical study|clinical study
5124264|NCT03218631|oxandrolone, cardiac|oxandrolone, cardiac
5124265|NCT03218605|Achilles tendon|achilles tendon
5124266|NCT03218605|Warming-up|warming-up
5124267|NCT03218605|Vascularisation|vascularisation
5124268|NCT03218605|Physical activity|physical activity
5124269|NCT03218605|Oxygen-to-See (O2C)|oxygen-to-see (o2c)
5124270|NCT03218592|Adherence|adherence
5124271|NCT03218592|Hair|hair
5124272|NCT03218579|microbiome|microbiome
5124273|NCT03218579|intestinal bacteria|intestinal bacteria
5124300|NCT03218397|ICU|icu
5124342|NCT03218137|Subjects|subjects
5124343|NCT03218137|diagnosed|diagnosed
5124344|NCT03218124|Thyroidectomy|thyroidectomy
5124345|NCT03218124|Remifentanil|remifentanil
5124346|NCT03218124|Extubation|extubation
5124347|NCT03218124|Cough|cough
5124348|NCT03218124|Target controlled infusion|target controlled infusion
5124349|NCT03218111|Glymphatic network|glymphatic network
5124350|NCT03218111|healthy|healthy
5124351|NCT03218111|central nervous system|central nervous system
5124352|NCT03218085|tenofovir|tenofovir
5124539|NCT03216434|post-traumatic stress disorder|post-traumatic stress disorder
5124540|NCT03216434|dopamine|dopamine
5124541|NCT03216434|biomarker|biomarker
5124542|NCT03216421|DCIS|dcis
5124544|NCT03216421|Lumpectomy|lumpectomy
5124643|NCT03215732|food security|food security
5124644|NCT03215732|treatment needs|treatment needs
5124645|NCT03215732|decentralized care|decentralized care
5124646|NCT03215732|health costs|health costs
5124647|NCT03215732|caregivers training|caregivers training
5124743|NCT03215212|intensive care unit|intensive care unit
5124844|NCT03214419|Preoperative MRI|preoperative mri
5124845|NCT03214419|Tumor localization|tumor localization
5124846|NCT03214354|sickle cell disease|sickle cell disease
5124847|NCT03214354|stem cell transplant|stem cell transplant
5124936|NCT03213847|Superb microvascular imaging|superb microvascular imaging
5124937|NCT03213847|Doppler ultrasound|doppler ultrasound
5124938|NCT03213847|Ultrasound|ultrasound
5124939|NCT03213847|Median Nerve Entrapment|median nerve entrapment
5124940|NCT03213847|Diagnoses Disease|diagnoses disease
5124941|NCT03213808|Allergic diseases|allergic diseases
5125427|NCT03210753|Subcutaneous injection|subcutaneous injection
5125430|NCT03210701|pharmacy|pharmacy
5125522|NCT03210090|Stem cells transplantation|stem cells transplantation
5125527|NCT03210090|Interferon-gamma|interferon-gamma
5125715|NCT03208725|Nested case control|nested case control
5125716|NCT03208725|Antimicrobial resistance|antimicrobial resistance
5125717|NCT03208725|Antibiotic|antibiotic
5125718|NCT03208725|Feeding|feeding
5125719|NCT03208725|Undernutrition|undernutrition
5125720|NCT03208699|anorexia|anorexia
5125721|NCT03208699|bulimia|bulimia
5125722|NCT03208686|Gender|gender
5125818|NCT03207971|Gingival recession|gingival recession
5125819|NCT03207971|Laser-Doppler Flowmetry|laser-doppler flowmetry
5125820|NCT03207971|Periodontics|periodontics
5126018|NCT03206827|animal protein|animal protein
5126019|NCT03206814|Hypertension|hypertension
5126020|NCT03206814|Ambulatory Systolic Blood Pressure|ambulatory systolic blood pressure
5126021|NCT03206814|Home Blood Pressure|home blood pressure
5126022|NCT03206814|ESH-CARE APP|esh-care app
5126119|NCT03206112|Healthy Volunteers|healthy volunteers
5126120|NCT03206112|Paired Associative Stimulation (PAS)|paired associative stimulation (pas)
5126121|NCT03206099|Phenotyping|phenotyping
5126122|NCT03206099|Genetics|genetics
5126123|NCT03206099|Sequencing|sequencing
5126124|NCT03206099|Inborn Errors of Immunity|inborn errors of immunity
5126139|NCT03206034|Memory|memory
5126315|NCT03204825|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5126316|NCT03204825|Physical activity|physical activity
5126317|NCT03204825|Feasibility|feasibility
5126318|NCT03204786|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5126320|NCT03204747|Gait speed|gait speed
5126321|NCT03204747|multiple sclerosis|multiple sclerosis
5126322|NCT03204747|lower urinary tract symptoms|lower urinary tract symptoms
5126324|NCT03204734|therapy|therapy
5126414|NCT03204188|NOTCH1 mutation|notch1 mutation
5126416|NCT03204123|prostate cancer|prostate cancer
5126417|NCT03204123|prostatectomy|prostatectomy
5126419|NCT03204123|Ga-HBED-iPSMA|ga-hbed-ipsma
5126715|NCT03202485|astigmatism|astigmatism
5126919|NCT03201003|CPNA (Characterized Peanut Allergen)|cpna (characterized peanut allergen)
5126920|NCT03201003|OIT (oral immunotherapy)|oit (oral immunotherapy)
5126921|NCT03201003|Peanut Allergy|peanut allergy
5126922|NCT03201003|Peanut-Allergic Children|peanut-allergic children
5126923|NCT03201003|Desensitization|desensitization
5126925|NCT03201003|Allergy|allergy
5126926|NCT03200990|pressure-volume loops|pressure-volume loops
5126927|NCT03200990|cardiac mechanics|cardiac mechanics
5126928|NCT03200990|high-risk PCI|high-risk pci
5126929|NCT03200938|pulpotomy|pulpotomy
5126930|NCT03200938|Biological cement|biological cement
5126931|NCT03200938|Deciduous tooth|deciduous tooth
5126932|NCT03200925|video|video
5126933|NCT03200925|skin-to-skin|skin-to-skin
5126934|NCT03200925|kangaroo care|kangaroo care
5126935|NCT03200925|prenatal education|prenatal education
5126936|NCT03200899|cognitive rehabilitation|cognitive rehabilitation
5126937|NCT03200886|hyaluronic acid|hyaluronic acid
5126938|NCT03200886|intra-articular injections|intra-articular injections
5127020|NCT03200483|Autonomic Nervous System|autonomic nervous system
5127021|NCT03200483|Aerobic exercise|aerobic exercise
5127022|NCT03200483|Recuperation|recuperation
5127023|NCT03200483|Music|music
5127026|NCT03200457|MRI|mri
5127123|NCT03199781|Motorized power massage|motorized power massage
5127124|NCT03199781|massage|massage
5127125|NCT03199768|architecture|architecture
5127126|NCT03199768|delirium|delirium
5127127|NCT03199768|environment|environment
5127128|NCT03199768|hospital design and construction|hospital design and construction
5127225|NCT03199170|Caesarean Section|caesarean section
5127226|NCT03199170|Spinal anesthesia|spinal anesthesia
5127227|NCT03199170|Quadratus lumborum block|quadratus lumborum block
5127228|NCT03199170|Postoperative pain|postoperative pain
5127233|NCT03199144|Chemotherapy|chemotherapy
5127320|NCT03198481|midurethral sling|midurethral sling
5127321|NCT03198481|movie|movie
5127326|NCT03198468|Lung Cancer|lung cancer
5127421|NCT03197792|Strain|strain
5127514|NCT03197285|propioception|propioception
5127515|NCT03197285|range of motion|range of motion
5127517|NCT03197272|Myopia|myopia
5127518|NCT03197272|corneal Crosslinking|corneal crosslinking
5127519|NCT03197259|CLL, del(17p)|cll, del(17p)
5127520|NCT03197246|PICC line|picc line
5127521|NCT03197246|ECG|ecg
5127522|NCT03197246|chest x-ray|chest x-ray
5127523|NCT03197246|IVECG|ivecg
5127617|NCT03196687|diastolic dysfunction|diastolic dysfunction
5127618|NCT03196661|safety investigation|safety investigation
5127619|NCT03196648|Gingivitis|gingivitis
5127620|NCT03196648|Periodontal disease|periodontal disease
5127621|NCT03196648|Inflammation|inflammation
5127622|NCT03196648|Teeth whitening|teeth whitening
5127623|NCT03196648|Breath freshening|breath freshening
5127624|NCT03196648|Periodontal pathogens|periodontal pathogens
5127625|NCT03196648|Bleeding on probing|bleeding on probing
5127626|NCT03196622|Sarcopenia|sarcopenia
5127627|NCT03196622|Elderly people|elderly people
5127628|NCT03196622|Hospitalization|hospitalization
5127630|NCT03196596|TAVI|tavi
4977548|NCT04132960|ADC|adc
5128114|NCT03193632|lean body mass|lean body mass
5128122|NCT03193580|tDCS|tdcs
5128314|NCT03192202|Cutaneous Lymphoma|cutaneous lymphoma
5128315|NCT03192202|cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
5128316|NCT03192202|CD30-Positive Cutaneous Lymphoma|cd30-positive cutaneous lymphoma
5128317|NCT03192202|T-cell lymphoma|t-cell lymphoma
5128318|NCT03192202|PTCL|ptcl
5128319|NCT03192202|CTCL|ctcl
5128322|NCT03192176|Vasomotor symptoms|vasomotor symptoms
5128323|NCT03192176|Menopause|menopause
5128324|NCT03192176|Hot flashes|hot flashes
5128325|NCT03192176|Perimenopause|perimenopause
5128326|NCT03192124|primary total knee|primary total knee
5128327|NCT03192124|infection|infection
5128328|NCT03192111|Healthy Volunteers|healthy volunteers
5128329|NCT03192111|Mild Renal Impairment|mild renal impairment
5128418|NCT03191695|Family|family
5128514|NCT03191240|Out-of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5128515|NCT03191240|Vasopressin|vasopressin
5128516|NCT03191214|Infra-red thermography|infra-red thermography
5128517|NCT03191201|Metabolomics, Transcriptomics, Ironomics|metabolomics, transcriptomics, ironomics
5128841|NCT03189095|SCI|sci
5128918|NCT03188601|Graft vs Host Disease|graft vs host disease
5129013|NCT03187990|Guided Biopsy|guided biopsy
5129014|NCT03187990|Prostate Cancer|prostate cancer
5129015|NCT03187977|Cognitive intervention|cognitive intervention
5129016|NCT03187977|Survivors|survivors
5129017|NCT03187977|Childhood ALL|childhood all
5129018|NCT03187964|People Living with HIV (PLHIV)|people living with hiv (plhiv)
5129019|NCT03187964|Xpert HIV-1 Viral Load (Xpert VL)|xpert hiv-1 viral load (xpert vl)
5129209|NCT03187015|HDAC|hdac
5660804|NCT00660101|ovarian cancer|ovarian cancer
5129210|NCT03186989|Mild Alzheimer's Disease|mild alzheimer's disease
5129211|NCT03186989|ISIS 814907|isis 814907
5129212|NCT03186989|Memory Loss|memory loss
5129213|NCT03186989|Alzheimers|alzheimers
5129214|NCT03186989|MAPT|mapt
5129215|NCT03186976|Risk Factor Modification|risk factor modification
5129216|NCT03186976|Catheter ablation|catheter ablation
5129217|NCT03186963|distal radius fracture|distal radius fracture
5129218|NCT03186963|volar plate|volar plate
5129219|NCT03186963|immobilization|immobilization
5129225|NCT03186859|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5129226|NCT03186859|bariatric surgery|bariatric surgery
5129227|NCT03186846|cognitive decline|cognitive decline
5129306|NCT03186326|immunotherapy|immunotherapy
5129307|NCT03186326|second line|second line
5129308|NCT03186313|HCV|hcv
5129309|NCT03186313|Sofosbuvir|sofosbuvir
5129310|NCT03186313|Ribavirin|ribavirin
5129311|NCT03186300|bolus advisor|bolus advisor
5129708|NCT03183843|Mitral Valve Stenosis|mitral valve stenosis
5129709|NCT03183843|Mitral Valve Insufficiency|mitral valve insufficiency
5129710|NCT03183843|Dabigatran|dabigatran
5129711|NCT03183843|Biological Prosthesis|biological prosthesis
5129712|NCT03183843|Mitral Valve Replacement|mitral valve replacement
5130007|NCT03182218|Anticoagulation|anticoagulation
5130008|NCT03182218|Dabigatran|dabigatran
5130009|NCT03182218|Rivaroxaban|rivaroxaban
5130010|NCT03182218|Apixaban|apixaban
5130011|NCT03182218|Edoxaban|edoxaban
5130012|NCT03182218|Direct oral anticoagulant|direct oral anticoagulant
5130013|NCT03182218|Surgery|surgery
5130014|NCT03182218|Anaesthesia|anaesthesia
5130015|NCT03182218|Novel oral anticoagulant|novel oral anticoagulant
5130204|NCT03181113|HBeAg seroconversion|hbeag seroconversion
5130205|NCT03181113|immune control|immune control
5130209|NCT03181035|Oral Tongue Cancer|oral tongue cancer
5130210|NCT03181035|Tumor Hypoxia|tumor hypoxia
5130211|NCT03181022|Patient-Provider Communication|patient-provider communication
5130212|NCT03181022|Motivational Interviewing|motivational interviewing
5130213|NCT03181022|Medication Adherence|medication adherence
5130214|NCT03181009|Oral Immunotherapy|oral immunotherapy
5130506|NCT03179007|chimeric antigen receptor T cells|chimeric antigen receptor t cells
5130604|NCT03178123|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5130605|NCT03178123|Mucosal Melanoma|mucosal melanoma
5130606|NCT03178123|Interferons|interferons
5130607|NCT03178110|physical therapy|physical therapy
5130608|NCT03178110|cancer rehabilitation|cancer rehabilitation
5130609|NCT03178097|limitation in conventional monitoring|limitation in conventional monitoring
5130611|NCT03178084|CD4/CD8 ratio|cd4/cd8 ratio
5130612|NCT03178084|immune recovery|immune recovery
5130613|NCT03178084|maraviroc|maraviroc
5130614|NCT03178084|efavirenz|efavirenz
5131191|NCT03174054|multi parametric MRI|multi parametric mri
5131192|NCT03174015|Sanitation|sanitation
5131193|NCT03174015|Demand|demand
5131194|NCT03174015|Peri-urban|peri-urban
5131195|NCT03174015|Behavior Change|behavior change
5131196|NCT03174015|Lusaka|lusaka
5131197|NCT03174015|Zambia|zambia
5131198|NCT03174002|Oxygenation|oxygenation
4979036|NCT04123106|Analgesia, Patient-Controlled|analgesia, patient-controlled
5131590|NCT03171220|Advanced Solid Tumor|advanced solid tumor
5131591|NCT03171220|Adoptive Cell Therapy(ACT)|adoptive cell therapy(act)
5131594|NCT03171207|Gait Therapy|gait therapy
5131595|NCT03171194|Lupus|lupus
5131596|NCT03171194|Stem Cell|stem cell
5131597|NCT03171194|Systemic Lupus Erythematosus|systemic lupus erythematosus
5683076|NCT00566423|PAH|pah
5131598|NCT03171181|Spatial cognition, vestibular system, motor control|spatial cognition, vestibular system, motor control
5131599|NCT03171168|Gait Analysis|gait analysis
5131600|NCT03171168|WOMAC|womac
5131601|NCT03171168|SF-36|sf-36
5131602|NCT03171142|Heliox|heliox
5131603|NCT03171129|Respiratory Distress|respiratory distress
5131604|NCT03171129|Nasal CPAP|nasal cpap
5131606|NCT03171116|ghrelin|ghrelin
5131881|NCT03169179|Wearable fitness technology|wearable fitness technology
5131905|NCT03169101|HIV|hiv
5131984|NCT03168685|weight|weight
5131985|NCT03168685|actigraph|actigraph
5131986|NCT03168685|tracking|tracking
5131987|NCT03168685|hemophilia|hemophilia
5131988|NCT03168633|: Type 2 Diabetes Mellitus|: type 2 diabetes mellitus
5131989|NCT03168633|Web-based intervention|web-based intervention
5131992|NCT03168607|ORR|orr
5132192|NCT03167125|colorectal cancer screening|colorectal cancer screening
5132193|NCT03167125|cancer screening|cancer screening
5132194|NCT03167125|pragmatic trial|pragmatic trial
5132195|NCT03167125|boot camp translation|boot camp translation
5132196|NCT03167112|Potentially Curable|potentially curable
5132197|NCT03167112|Preoperative|preoperative
5132281|NCT03166293|Physical Therapy|physical therapy
5132282|NCT03166293|Rehabilitation|rehabilitation
5132283|NCT03166280|hepatitis C|hepatitis c
5132284|NCT03166280|vitamin D|vitamin d
5132285|NCT03166280|iron|iron
5132286|NCT03166280|hepcidin|hepcidin
5132287|NCT03166215|Drug therapy|drug therapy
5132288|NCT03166202|age-related macular degeneration|age-related macular degeneration
5132289|NCT03166189|Repeated IVF failure|repeated ivf failure
5132290|NCT03166189|Stem cell|stem cell
5132291|NCT03166163|bleeding on brushing|bleeding on brushing
5132292|NCT03166150|Urinary Incontinence|urinary incontinence
5132386|NCT03165708|Epidural technique|epidural technique
5132387|NCT03165695|Delirium|delirium
5132388|NCT03165695|Insomnia|insomnia
5132389|NCT03165695|Ramelteon|ramelteon
5132390|NCT03165682|fatigue|fatigue
5132391|NCT03165682|depression|depression
5132392|NCT03165682|cortical excitability|cortical excitability
5132393|NCT03165669|education|education
5132394|NCT03165669|sleep|sleep
5132478|NCT03165019|disease progression|disease progression
5132479|NCT03165019|hypoxia|hypoxia
5132480|NCT03165006|Breast cancer, screening, survival|breast cancer, screening, survival
5132481|NCT03164993|Neoplasms|neoplasms
5132482|NCT03164980|Quality of life|quality of life
5132483|NCT03164980|ovarian cancer|ovarian cancer
5132773|NCT03163108|cerebral oxygenation|cerebral oxygenation
5132774|NCT03163095|sepsis|sepsis
5132775|NCT03163095|abdominal infection|abdominal infection
5132776|NCT03163095|open abdomen management|open abdomen management
5132777|NCT03163095|Negative pressure peritoneal therapy|negative pressure peritoneal therapy
5132779|NCT03163082|Corrosive Couple Coercion|corrosive couple coercion
5132780|NCT03163069|tooth bleaching|tooth bleaching
5132781|NCT03163069|dentifrice|dentifrice
5132782|NCT03163056|Smoking cessation|smoking cessation
5132783|NCT03163056|Depression|depression
5132784|NCT03163056|Clinical trial|clinical trial
5132785|NCT03163030|Heart Failure|heart failure
5132787|NCT03163030|VNS|vns
5132875|NCT03162536|Cardiovascular Diseases|cardiovascular diseases
5132876|NCT03162536|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5132878|NCT03162536|GS-4059|gs-4059
5132973|NCT03162081|neuropsychology|neuropsychology
5132974|NCT03162081|prescription drug misuse|prescription drug misuse
5132975|NCT03162081|dependence|dependence
5133016|NCT03161834|DNA|dna
5133071|NCT03161392|ductal ectasia|ductal ectasia
5133072|NCT03161392|breast neoplasm/diagnostic imaging|breast neoplasm/diagnostic imaging
5133073|NCT03161392|mammary Glands, Human/pathology|mammary glands, human/pathology
5133074|NCT03161392|female|female
5133088|NCT03161366|Ebola Zaire Outbreak|ebola zaire outbreak
5133210|NCT03160495|PET/MR|pet/mr
5133089|NCT03161366|Safety of rVSVΔG-ZEBOV-GP vaccine|safety of rvsvδg-zebov-gp vaccine
5133090|NCT03161366|Effectiveness of rVSVΔG-ZEBOV-GP vaccine|effectiveness of rvsvδg-zebov-gp vaccine
5133091|NCT03161340|Recurrent Implantation Failure|recurrent implantation failure
5133092|NCT03161340|Rapamycin|rapamycin
5133093|NCT03161340|Pregnancy Rate|pregnancy rate
5133094|NCT03161327|ankle brachial index|ankle brachial index
5133095|NCT03161327|peripheral arterial disease|peripheral arterial disease
5133096|NCT03161314|Plantar Fasciitis|plantar fasciitis
5133097|NCT03161314|Plantar Heel Pain|plantar heel pain
5133098|NCT03161314|Multisegment Foot Motion|multisegment foot motion
5133100|NCT03161314|Gait|gait
5133101|NCT03161314|treatment|treatment
5133102|NCT03161314|strengthening|strengthening
5133103|NCT03161314|stretching|stretching
5133104|NCT03161314|exercise|exercise
5133163|NCT03160872|Donor sperm insemination|donor sperm insemination
5133164|NCT03160872|Anti Mullerian Hormone|anti mullerian hormone
5133165|NCT03160872|Ovarian reserve|ovarian reserve
5133166|NCT03160872|Antral follicle count|antral follicle count
5133167|NCT03160859|unsedated colonoscopy|unsedated colonoscopy
5133362|NCT03159572|Homologous Recombination Deficiency (HRD)|homologous recombination deficiency (hrd)
5133463|NCT03158935|tumor-infiltrating lymphocytes (TILs)|tumor-infiltrating lymphocytes (tils)
5133464|NCT03158935|pembrolizumab|pembrolizumab
5133979|NCT03156478|Physical activity|physical activity
5133980|NCT03156478|Healthy diet|healthy diet
5134080|NCT03155594|Freestyle Libre|freestyle libre
5134081|NCT03155555|Fluid Responsiveness|fluid responsiveness
5134082|NCT03155555|Pediatric surgery|pediatric surgery
5134084|NCT03155542|alcohol|alcohol
5134273|NCT03154242|Platinum|platinum
5134274|NCT03154151|PTSD|ptsd
5134275|NCT03154151|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5134276|NCT03154151|Post-Traumatic Stress Disorder symptoms|post-traumatic stress disorder symptoms
5134277|NCT03154151|World Trade Center|world trade center
5134278|NCT03154151|9/11|9/11
5134279|NCT03154151|first responder|first responder
5134280|NCT03154151|rescue/recovery/clean-up worker|rescue/recovery/clean-up worker
5134281|NCT03154151|trauma|trauma
5134283|NCT03154138|Stroke|stroke
5134376|NCT03153709|initiating the Levonorgestrel Implant|initiating the levonorgestrel implant
5134377|NCT03153709|initiating the Depot Medroxyprogesterone Acetate Injectable|initiating the depot medroxyprogesterone acetate injectable
5134386|NCT03153657|Tooth Bleaching|tooth bleaching
5134387|NCT03153644|Qualitative Research|qualitative research
5134476|NCT03153085|Unresectable melanoma|unresectable melanoma
5134477|NCT03153085|Metastatic melanoma|metastatic melanoma
5134479|NCT03153085|TBI-1401(HF10)|tbi-1401(hf10)
5134674|NCT03152019|Hemorrhagic Hereditary Telangiectasia (HHT)|hemorrhagic hereditary telangiectasia (hht)
5134675|NCT03152019|Antiangiogenic therapy|antiangiogenic therapy
5134676|NCT03152019|Tacrolimus|tacrolimus
5134677|NCT03152006|Healthcare transition|healthcare transition
5134678|NCT03152006|Adolescents|adolescents
5134679|NCT03152006|Nigeria|nigeria
5134680|NCT03151993|Ischemic Stroke|ischemic stroke
5134681|NCT03151993|Fibrinolysis|fibrinolysis
5134682|NCT03151993|Fortelyzin|fortelyzin
5134685|NCT03151954|proliferation|proliferation
5134971|NCT03150160|safety|safety
5134972|NCT03150147|Organ preservation|organ preservation
5134973|NCT03150147|Survival|survival
5134974|NCT03150147|Graft function|graft function
5135172|NCT03148951|MPV|mpv
5135380|NCT03147352|sTM|stm
5135557|NCT03145987|Neuropsychological status|neuropsychological status
5135755|NCT03144674|indolent (slow-growing) non-Hodgkin lymphoma B-cell lymphoma|indolent (slow-growing) non-hodgkin lymphoma b-cell lymphoma
5136059|NCT03142503|diet therapy|diet therapy
5136060|NCT03142503|adipose tissue|adipose tissue
5136061|NCT03142490|Acupuncture|acupuncture
5136062|NCT03142490|Infertility|infertility
5136063|NCT03142490|In vitro fertilization|in vitro fertilization
5136064|NCT03142490|Quality of life|quality of life
5136066|NCT03142490|Anxiety|anxiety
5136067|NCT03142477|Therapeutic touch|therapeutic touch
5136460|NCT03139838|Electronic Health Records|electronic health records
5136461|NCT03139838|Economics, Behavioral|economics, behavioral
5136462|NCT03139812|continuous contact lens wear|continuous contact lens wear
5136463|NCT03139812|silicone hydrogel contact lenses|silicone hydrogel contact lenses
5136464|NCT03139812|irrigation|irrigation
5136468|NCT03139708|Mydriasis|mydriasis
5136555|NCT03138967|Glycopyrrolate|glycopyrrolate
5136556|NCT03138928|glaucoma|glaucoma
5136557|NCT03138928|trabeculectomy|trabeculectomy
5136562|NCT03138915|radiomics|radiomics
5136747|NCT03137498|ketorolac|ketorolac
5136748|NCT03137498|acute pain|acute pain
5136749|NCT03137485|lumbar disc herniation|lumbar disc herniation
5136849|NCT03136952|NIRS|nirs
5136850|NCT03136952|Monitoring|monitoring
5136851|NCT03136952|Pediatric|pediatric
5136852|NCT03136874|donors|donors
5136853|NCT03136874|gametes|gametes
5136854|NCT03136874|motivation|motivation
5136855|NCT03136874|psychological|psychological
5136863|NCT03136848|perfusion|perfusion
5136864|NCT03136822|Diabetic Foot|diabetic foot
5136868|NCT03136731|Celiac disease, Gluten, Microbiome, Genetic|celiac disease, gluten, microbiome, genetic
5136869|NCT03136718|mHealth|mhealth
5136870|NCT03136718|Hearing aids|hearing aids
5136871|NCT03136718|Auditory rehabilitation|auditory rehabilitation
5136872|NCT03136718|Adult|adult
5136873|NCT03136718|Reusable Learning Object|reusable learning object
5136874|NCT03136718|Education|education
4983013|NCT04098406|Gold|gold
5136875|NCT03136718|Personalised|personalised
5136876|NCT03136718|Telehealth|telehealth
5136877|NCT03136718|Teleaudiology|teleaudiology
5136878|NCT03136705|Phosphorus Homeostasis|phosphorus homeostasis
5136879|NCT03136705|FGF23|fgf23
5136880|NCT03136705|Vitamin D|vitamin d
5136882|NCT03136692|weight loss|weight loss
5136883|NCT03136692|diet|diet
5136884|NCT03136692|behavior|behavior
5136890|NCT03136627|RCC, Tivozanib, Nivolumab, Metastatic Renal Cell Cancer|rcc, tivozanib, nivolumab, metastatic renal cell cancer
5136955|NCT03136185|LSD1|lsd1
5136956|NCT03136159|pregnancy|pregnancy
5136957|NCT03136159|delivery|delivery
5137158|NCT03134755|Puerto Rican|puerto rican
5137159|NCT03134755|Health disparities|health disparities
5137160|NCT03134755|Treatment response|treatment response
5137161|NCT03134742|soft tissue sarcoma extremities|soft tissue sarcoma extremities
5137164|NCT03134677|Spinal anesthesia|spinal anesthesia
5137355|NCT03133325|Hyaluronic Acid, Lidocaine|hyaluronic acid, lidocaine
5137356|NCT03133286|Anal Cancer|anal cancer
5137357|NCT03133286|Bladder|bladder
5137358|NCT03133286|Cervical|cervical
5137359|NCT03133286|Colorectal|colorectal
5137360|NCT03133286|Esophageal|esophageal
5137361|NCT03133286|Gallbladder|gallbladder
5137362|NCT03133286|Liver|liver
5137457|NCT03132779|Intralipid|intralipid
5137458|NCT03132779|NK cells|nk cells
5137459|NCT03132779|Recurrent miscarriage|recurrent miscarriage
5137460|NCT03132740|Hepatic Carcinoma,Three-dimensional Visualization|hepatic carcinoma,three-dimensional visualization
5137462|NCT03132714|Clarithromycin|clarithromycin
5137554|NCT03132129|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
5137555|NCT03132116|Cat Scratch Disease's lymphadenitis|cat scratch disease's lymphadenitis
5137556|NCT03132116|Infectious Diseases|infectious diseases
5137557|NCT03132103|Vitamin D deficiency|vitamin d deficiency
5137558|NCT03132103|Simulated sunlight radiation|simulated sunlight radiation
5137657|NCT03131427|Wilson's Disease|wilson's disease
5137658|NCT03131427|Hereditary Hemochromatosis|hereditary hemochromatosis
5137659|NCT03131427|Hereditary Hyperbilirubinemias|hereditary hyperbilirubinemias
5137660|NCT03131427|Inherited Cholestatic Liver Disease|inherited cholestatic liver disease
5137751|NCT03130673|epidemiology|epidemiology
5137752|NCT03130660|central line|central line
5137950|NCT03129178|Nitric oxide|nitric oxide
5137951|NCT03129178|Microvascular|microvascular
5137952|NCT03129165|Cardiovascular diseases|cardiovascular diseases
5138249|NCT03127072|target therapy|target therapy
5138250|NCT03127059|Dysfunctional Breathing|dysfunctional breathing
5138251|NCT03127059|Uncontrolled Asthma|uncontrolled asthma
5138252|NCT03127059|Breathing Exercises|breathing exercises
5138253|NCT03127059|Adults|adults
5138254|NCT03127007|immunotherapy|immunotherapy
5138255|NCT03127007|anti-PD-L1|anti-pd-l1
5138256|NCT03126955|microvascular decompression, Xth nerve|microvascular decompression, xth nerve
5138257|NCT03126942|Aged patients|aged patients
5138347|NCT03126500|Sarcopenia|sarcopenia
5138348|NCT03126500|Hospital discharge|hospital discharge
5138349|NCT03126500|Geriatrics|geriatrics
5138350|NCT03126461|metastatic melanoma|metastatic melanoma
5138351|NCT03126448|Infection|infection
5138352|NCT03126448|Nonunion|nonunion
5138353|NCT03126448|Fracture healing|fracture healing
5138354|NCT03126435|FOLFIRINOX|folfirinox
5138355|NCT03126435|5-Fluorouracil|5-fluorouracil
5138356|NCT03126435|folinic acid|folinic acid
5138357|NCT03126435|irinotecan|irinotecan
5138358|NCT03126435|oxaliplatin|oxaliplatin
5138359|NCT03126435|Gemcitabine|gemcitabine
5138360|NCT03126409|coronary artery disease|coronary artery disease
5138361|NCT03126409|coronary artery bypass graft|coronary artery bypass graft
5138362|NCT03126344|King Vision|king vision
5138363|NCT03126331|Kidney Cancer|kidney cancer
5138364|NCT03126331|Metastatic|metastatic
5138365|NCT03126331|Nivolumab|nivolumab
5138366|NCT03126305|exposure|exposure
5138367|NCT03126305|response prevention|response prevention
5138368|NCT03126305|web-based application|web-based application
5138369|NCT03126292|Medical home|medical home
5138438|NCT03125889|Image-guided|image-guided
5138440|NCT03125889|Aquablation|aquablation
5138441|NCT03125889|AQUABEAM|aquabeam
5138442|NCT03125889|LUTS|luts
5138444|NCT03125889|Robotics|robotics
5138735|NCT03123783|PD-1|pd-1
5138736|NCT03123770|Breast cancer|breast cancer
5138737|NCT03123770|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5138739|NCT03123770|PLD|pld
5139236|NCT03120442|dexmedetomidine|dexmedetomidine
5139237|NCT03120442|fentanyl|fentanyl
5139240|NCT03120442|CAM-ICU|cam-icu
5139341|NCT03119805|patient reported outcomes|patient reported outcomes
5139342|NCT03119805|patient perpective|patient perpective
5139343|NCT03119805|physician perspective|physician perspective
5139344|NCT03119805|cut-off values|cut-off values
5139345|NCT03119805|flare|flare
5139346|NCT03119805|remission|remission
5139347|NCT03119805|minimal disease activity|minimal disease activity
5139348|NCT03119805|low disease activity|low disease activity
5139349|NCT03119792|Behavioral Modification|behavioral modification
5139350|NCT03119792|Health Community|health community
5139438|NCT03119285|BRCA1|brca1
5139635|NCT03118024|deep inferior epigastric perforator flap|deep inferior epigastric perforator flap
5139837|NCT03116776|randomized controlled trial|randomized controlled trial
5139988|NCT03115736|HIV|hiv
5140138|NCT03114553|family health history|family health history
5140139|NCT03114553|prevention|prevention
5140140|NCT03114553|genetic risk|genetic risk
5140149|NCT03114501|Yoga|yoga
5140443|NCT03112889|Sodium Valproate|sodium valproate
5140444|NCT03112889|Valproic Acid|valproic acid
5140445|NCT03112889|Myophosphorylase Deficiency|myophosphorylase deficiency
5140446|NCT03112889|Muscle Phosphorylase Deficiency|muscle phosphorylase deficiency
5140447|NCT03112889|Glycogenosis|glycogenosis
5140449|NCT03112876|younger age|younger age
5140536|NCT03112343|Joint Electronic-institutional review board (eIRB)|joint electronic-institutional review board (eirb)
5140537|NCT03112343|Centralized monitoring|centralized monitoring
5140538|NCT03112330|atrophic rhinitis|atrophic rhinitis
5140546|NCT03112304|youth|youth
5798786|NCT00111085|endothelin A receptor|endothelin a receptor
5140641|NCT03111979|Carnosine|carnosine
5140642|NCT03111979|Neuromuscular|neuromuscular
5140643|NCT03111979|Stimulation|stimulation
5140644|NCT03111979|Skeletal muscle|skeletal muscle
5140645|NCT03111966|Hepatitis C|hepatitis c
5140646|NCT03111953|Bariatric Surgery|bariatric surgery
5140935|NCT03110302|Video teleconferencing|video teleconferencing
5140941|NCT03110250|Turkey|turkey
5141033|NCT03109613|Ventilator Induced Lung Injury|ventilator induced lung injury
5141034|NCT03109613|V/Q mismatch|v/q mismatch
5141041|NCT03109496|OME|ome
5141042|NCT03109496|Otitis Media with Effusion|otitis media with effusion
5141043|NCT03109496|Microbiota|microbiota
5141044|NCT03109496|Microbiome|microbiome
5141045|NCT03109496|URT|urt
5141046|NCT03109496|Upper Respiratory Tract|upper respiratory tract
5141047|NCT03109496|Healthy URT microbiota|healthy urt microbiota
5141048|NCT03109483|geriatric patients|geriatric patients
5141049|NCT03109483|elderly|elderly
5141050|NCT03109483|multicomponent physical therapy|multicomponent physical therapy
5141133|NCT03109041|IORT|iort
5141338|NCT03107728|functional performance|functional performance
5141339|NCT03107728|performance assessment|performance assessment
5141340|NCT03107715|exclusive breastfeeding|exclusive breastfeeding
5141341|NCT03107715|health disparity|health disparity
5141342|NCT03107715|prenatal intervention|prenatal intervention
5141343|NCT03107689|ILE|ile
5141344|NCT03107689|lipid|lipid
5141345|NCT03107689|overdose|overdose
5141346|NCT03107689|resuscitation|resuscitation
5141347|NCT03107676|trunk extensors; endurance, peak torque, power, work|trunk extensors; endurance, peak torque, power, work
5141435|NCT03106935|recurrent pregnancy loss|recurrent pregnancy loss
5141436|NCT03106935|Clinical hypothyroidism|clinical hypothyroidism
5141437|NCT03106935|Subclinical hypothyroidism|subclinical hypothyroidism
5141438|NCT03106935|thyroid stimulating hormone|thyroid stimulating hormone
5141439|NCT03106935|thyroid peroxidase antibody|thyroid peroxidase antibody
5141440|NCT03106935|Levothyroxine|levothyroxine
5141441|NCT03106922|Polyethylene glycol|polyethylene glycol
5141442|NCT03106922|Bowel cleansing|bowel cleansing
5141443|NCT03106922|Colonoscopy|colonoscopy
5141444|NCT03106909|stroke|stroke
5141445|NCT03106909|pneumonia|pneumonia
5141446|NCT03106909|biomarkers|biomarkers
5141447|NCT03106909|pulmonary CT|pulmonary ct
5141448|NCT03106883|Attention bias modification|attention bias modification
5141449|NCT03106883|Cognitive bias modification|cognitive bias modification
5141450|NCT03106883|Eye-tracking|eye-tracking
5141451|NCT03106883|Treatment|treatment
5141452|NCT03106844|FMT|fmt
5141453|NCT03106844|IBD|ibd
5141454|NCT03106805|intrauterine device|intrauterine device
5141468|NCT03106753|External Cephalic Version|external cephalic version
5141469|NCT03106753|neuraxial analgesia|neuraxial analgesia
5141479|NCT03106727|Community Health Workers|community health workers
5141483|NCT03106727|NCD|ncd
5141535|NCT03106480|ART|art
5141536|NCT03106480|Body composition|body composition
5141537|NCT03106480|Inflammation|inflammation
5141538|NCT03106480|Insulin resistance|insulin resistance
5141539|NCT03106480|Beta-cell function|beta-cell function
5141541|NCT03106480|Hypertension|hypertension
5141637|NCT03105778|IVD|ivd
5141638|NCT03105765|Neuropathic Pain|neuropathic pain
5141639|NCT03105765|Chronic Pain|chronic pain
5141640|NCT03105765|Posterolateral thoracotomy|posterolateral thoracotomy
5141641|NCT03105752|Outcome Assessments (Health Care)|outcome assessments (health care)
5141843|NCT03104530|Ferritin|ferritin
5141943|NCT03104127|Balance|balance
5141944|NCT03104127|Pressure|pressure
5141945|NCT03104127|Chronic stroke|chronic stroke
5142046|NCT03103269|Physical activity|physical activity
5142047|NCT03103269|Depression|depression
5142048|NCT03103269|Anxiety|anxiety
5142049|NCT03103269|Stages of change|stages of change
5142147|NCT03102437|Cardiac Contractility Modulation|cardiac contractility modulation
5142149|NCT03102437|FIX-HF-5CA|fix-hf-5ca
5142150|NCT03102437|Continued Access|continued access
5142151|NCT03102398|Erectile Dysfunction|erectile dysfunction
5142152|NCT03102398|PDE5 inhibitor|pde5 inhibitor
5143047|NCT03097172|Atherosclerosis|atherosclerosis
5143048|NCT03097172|Hydrostatic Pressure|hydrostatic pressure
5143049|NCT03097159|costoclavicular block|costoclavicular block
5143050|NCT03097146|Stroke|stroke
5143051|NCT03097146|Aftercare|aftercare
5143052|NCT03097146|Comprehensive Care|comprehensive care
5143053|NCT03097107|hypertriglyceridemia|hypertriglyceridemia
5143054|NCT03097107|dyslipidemia|dyslipidemia
5143056|NCT03097107|lipid disorder|lipid disorder
5143150|NCT03096730|Remifentanil|remifentanil
5143151|NCT03096730|Opioid-induced hyperalgesia|opioid-induced hyperalgesia
5143152|NCT03096730|Postoperative pain|postoperative pain
5143153|NCT03096730|pain intensity|pain intensity
5143187|NCT03096496|ATO|ato
5143346|NCT03095677|muscle oxygenation|muscle oxygenation
5143347|NCT03095677|physical performance|physical performance
5143348|NCT03095664|lifestyle intervention|lifestyle intervention
5143349|NCT03095664|endometrial cancer|endometrial cancer
5143350|NCT03095664|survival|survival
5143351|NCT03095638|Dispersible tablets|dispersible tablets
5143352|NCT03095638|Bioavailability|bioavailability
5143353|NCT03095638|Dolutegravir|dolutegravir
5143731|NCT03093337|Cognitive disorders|cognitive disorders
5143732|NCT03093337|Cerebral development|cerebral development
5143733|NCT03093337|Psychomotoricity|psychomotoricity
5143734|NCT03093337|Postural management|postural management
5143735|NCT03093337|Motor coordination|motor coordination
5143737|NCT03093324|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5143738|NCT03093324|RRMS|rrms
5143739|NCT03093324|Multiple Sclerosis|multiple sclerosis
5143740|NCT03093324|MS|ms
5143741|NCT03093324|Alkermes|alkermes
5143742|NCT03093324|ALKS 8700|alks 8700
5143743|NCT03093324|Dimethyl Fumarate|dimethyl fumarate
5143745|NCT03093324|Tecfidera|tecfidera
5143746|NCT03093311|Near-Infrared Spectroscopy|near-infrared spectroscopy
5143747|NCT03093311|Neurosurgical Procedures|neurosurgical procedures
5143748|NCT03093311|Cognitive Dysfunction|cognitive dysfunction
5143749|NCT03093272|Prostate Cancer|prostate cancer
5143750|NCT03093259|ABX464|abx464
5143751|NCT03093259|Ulcerative Colitis|ulcerative colitis
5143752|NCT03093259|Refractory|refractory
5143753|NCT03093246|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
5143754|NCT03093246|Aspirin|aspirin
5143755|NCT03093246|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5143756|NCT03093246|Non-surgical therapy|non-surgical therapy
5143757|NCT03093207|Aggressive periodontitis|aggressive periodontitis
5143758|NCT03093207|Aspirin|aspirin
5143759|NCT03093207|Omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5143760|NCT03093207|Surgical therapy|surgical therapy
5143761|NCT03093142|transcranial direct current stimulation (tDCs)|transcranial direct current stimulation (tdcs)
5143762|NCT03093142|neurofeedback|neurofeedback
5143808|NCT03093103|empagliflozin|empagliflozin
5143809|NCT03093103|kidney|kidney
5143810|NCT03093103|BOLD-MRI|bold-mri
5143811|NCT03093090|furosemide|furosemide
5143812|NCT03093051|Termination|termination
5143813|NCT03093051|Unpinning|unpinning
5143814|NCT03093051|Therapy|therapy
5143815|NCT03093025|Major Depressive Disorder|major depressive disorder
5143816|NCT03093025|Adjunctive Treatment|adjunctive treatment
5143817|NCT03092999|Pharmacokinetics|pharmacokinetics
5143818|NCT03092960|Latino|latino
5143819|NCT03092960|Male|male
5143834|NCT03092830|epidermal growth factor receptor|epidermal growth factor receptor
5143835|NCT03092817|Tuberculosis|tuberculosis
5143836|NCT03092817|tuberculous meningitis|tuberculous meningitis
5143837|NCT03092817|drug induced liver injury|drug induced liver injury
5143839|NCT03092817|IRIS|iris
5143840|NCT03092817|randomized controlled trial|randomized controlled trial
5144330|NCT03089632|diabetes mellitus, type 1|diabetes mellitus, type 1
5144331|NCT03089632|gastroparesis|gastroparesis
5144332|NCT03089632|motility|motility
5144338|NCT03089593|Ginger|ginger
5144525|NCT03088449|Crohns disease|crohns disease
5144526|NCT03088449|primary non response|primary non response
5144527|NCT03088449|lose of response|lose of response
5144528|NCT03088449|personalising anti-TNF therapy|personalising anti-tnf therapy
5144622|NCT03087851|Bone turnover markers|bone turnover markers
5144623|NCT03087851|Bone mineral density|bone mineral density
5144624|NCT03087812|Microbiological burden|microbiological burden
5145114|NCT03084614|Passive Cellular Immunity|passive cellular immunity
4987598|NCT04068922|self-efficacy|self-efficacy
4987599|NCT04068922|acceptance|acceptance
5145115|NCT03084575|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency|neuroaxial rhizolysis -selective rhizolysis-thermal radiofrequency
5145116|NCT03084510|High risk for surgical valve replacement|high risk for surgical valve replacement
5145117|NCT03084510|transcatheter aortic valve replacement|transcatheter aortic valve replacement
5145210|NCT03083873|IL-2|il-2
5145211|NCT03083873|LN-145-S1|ln-145-s1
5145212|NCT03083847|Malaria|malaria
5145213|NCT03083847|Parasitemia|parasitemia
5145214|NCT03083847|Immune|immune
5145215|NCT03083847|Responses|responses
5145216|NCT03083847|Sporozoites|sporozoites
5145217|NCT03083834|cosyntropin|cosyntropin
5145218|NCT03083834|salivary free cortisol|salivary free cortisol
5145219|NCT03083834|mitotane|mitotane
5145509|NCT03082196|varnish|varnish
5145510|NCT03082170|sleep apnea|sleep apnea
5145713|NCT03080870|Family caregivers|family caregivers
5146012|NCT03079310|Parkinson's disease|parkinson's disease
5146013|NCT03079310|Neuromodulation|neuromodulation
5146014|NCT03079310|Feature extraction|feature extraction
5146015|NCT03079297|Antidepressant|antidepressant
5146016|NCT03079297|Inflammation|inflammation
5146017|NCT03079297|Biomarker|biomarker
5146018|NCT03079297|Depression|depression
5146019|NCT03079297|Treatment Resistant Depression|treatment resistant depression
5146020|NCT03079297|Leucine|leucine
5146021|NCT03079258|vascular structure|vascular structure
5146022|NCT03079258|vascular function|vascular function
5146024|NCT03079258|physical activity|physical activity
5146025|NCT03079258|sedentary behaviour|sedentary behaviour
5146036|NCT03079206|food|food
5146113|NCT03078712|Septic Shock|septic shock
5146114|NCT03078712|Lactate|lactate
5146118|NCT03078699|Thymoma|thymoma
5146313|NCT03077698|Progesterone Receptor Negative|progesterone receptor negative
5146314|NCT03077698|Sodium Cridanimod|sodium cridanimod
5146315|NCT03077685|pancreatic neoplasms|pancreatic neoplasms
5146316|NCT03077685|digestive system neoplasms|digestive system neoplasms
5146317|NCT03077685|pancreatic diseases|pancreatic diseases
5146318|NCT03077685|digestive system diseases|digestive system diseases
5146411|NCT03077191|hypofractionated whole breast radiotherapy|hypofractionated whole breast radiotherapy
5146412|NCT03077191|breast cancer|breast cancer
5146413|NCT03077191|conservative treatment|conservative treatment
5146414|NCT03077191|quality of life|quality of life
5146415|NCT03077178|Soft Tissue Sarcoma|soft tissue sarcoma
5146416|NCT03077178|Surgery|surgery
5146611|NCT03076099|brain arteriovenous malformation|brain arteriovenous malformation
5146612|NCT03076099|embolization|embolization
5146614|NCT03076073|Ultrasound|ultrasound
5146909|NCT03074110|Anaesthesia Recovery Period|anaesthesia recovery period
5146910|NCT03074110|Ventilators|ventilators
5146912|NCT03074084|abdominal pain|abdominal pain
5147009|NCT03073447|Primary PCI|primary pci
5147010|NCT03073447|Hormone|hormone
5147011|NCT03073408|Propofol|propofol
5147012|NCT03073408|Bispectral index (BIS)|bispectral index (bis)
5147013|NCT03073408|Closed loop|closed loop
5147014|NCT03073356|Myocardial metabolism|myocardial metabolism
5147312|NCT03071627|Spin|spin
5147313|NCT03071627|Misleading reporting|misleading reporting
5147314|NCT03071627|Misleading interpretation|misleading interpretation
5147315|NCT03071627|Misleading extrapolation|misleading extrapolation
5147316|NCT03071627|Animal studies|animal studies
5147317|NCT03071627|Cell culture studies|cell culture studies
5147318|NCT03071627|Pre-clinical studies|pre-clinical studies
5147319|NCT03071614|Spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies|spin, misleading reporting, misleading interpretation, misleading extrapolation, animal studies, cell culture studies, pre-clinical studies
5147507|NCT03070691|Gorlin-Goltz Syndrome|gorlin-goltz syndrome
5147508|NCT03070691|Basal Cell Nevus Syndrome|basal cell nevus syndrome
5147509|NCT03070691|BCNS, Hedgehog pathway inhibitor|bcns, hedgehog pathway inhibitor
5147510|NCT03070691|topical|topical
5147511|NCT03070691|Smoothened|smoothened
5147512|NCT03070665|endoscopic submucosal dissection|endoscopic submucosal dissection
5147513|NCT03070665|postoperation bleeding|postoperation bleeding
5147609|NCT03069989|Double-blind|double-blind
5147610|NCT03069950|Hepatic Arterial Infusion|hepatic arterial infusion
5147611|NCT03069950|Floxuridine (FUDR)|floxuridine (fudr)
5147612|NCT03069950|Irinotecan (CPT-11)|irinotecan (cpt-11)
5147613|NCT03069950|FLUOROURACIL|fluorouracil
5147614|NCT03069950|PANITUMUMAB|panitumumab
5147615|NCT03069950|16-1341|16-1341
5147616|NCT03069911|Parkinson Disease|parkinson disease
5147717|NCT03069365|Chronic Hepatitis C Virus|chronic hepatitis c virus
5147718|NCT03069365|Chronic Kidney Disease|chronic kidney disease
5147719|NCT03069365|Glecaprevir|glecaprevir
5147810|NCT03068767|HBV DNA, qHBsAg|hbv dna, qhbsag
5147908|NCT03068117|Symptom Control|symptom control
5147909|NCT03068117|Early Referral|early referral
5147910|NCT03068117|Quality of Life|quality of life
5147911|NCT03068117|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5148101|NCT03066973|VAS|vas
5148209|NCT03066427|Clear Cell Renal Carcinoma|clear cell renal carcinoma
5148210|NCT03066427|Sunitinib|sunitinib
5148211|NCT03066414|hemochromatosis|hemochromatosis
5148212|NCT03066414|blood withdrawal|blood withdrawal
5148213|NCT03066414|respiratory variations|respiratory variations
5148214|NCT03066414|inferior vena cava|inferior vena cava
5148521|NCT03064789|Vaginal Infections|vaginal infections
5148522|NCT03064776|telemedicine|telemedicine
5148523|NCT03064763|Unresectable Stage IIIB-IV Malignant Melanoma|unresectable stage iiib-iv malignant melanoma
5148524|NCT03064750|Exercise Therapy|exercise therapy
5148525|NCT03064750|Pelvic Floor|pelvic floor
5148921|NCT03062241|cryoablation|cryoablation
5148922|NCT03062241|conventional treatment of heart failure|conventional treatment of heart failure
5148923|NCT03062228|stillbirth|stillbirth
5148924|NCT03062228|sleep|sleep
5148925|NCT03062228|low birth weight|low birth weight
5149019|NCT03061513|Parkinson Disease|parkinson disease
5149020|NCT03061513|ubiquinol|ubiquinol
5149021|NCT03061513|CoQ10|coq10
5149022|NCT03061513|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5149116|NCT03060759|Fatigue|fatigue
5149117|NCT03060759|Light Therapy|light therapy
5149118|NCT03060720|Pancreatic Cancer|pancreatic cancer
5149119|NCT03060694|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5149218|NCT03059940|Anti-Smoking Drug|anti-smoking drug
5149220|NCT03059940|NRT|nrt
5149617|NCT03057340|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5149624|NCT03057249|Surgery|surgery
5149719|NCT03056638|Androgen Deprivation Therapy|androgen deprivation therapy
5149721|NCT03056638|16-1686|16-1686
5149722|NCT03056625|fortified rice|fortified rice
5149815|NCT03056079|neovascular age related macular degeneration|neovascular age related macular degeneration
5149816|NCT03056079|diabetic macular edema|diabetic macular edema
5149817|NCT03056079|retinal vein occlusion|retinal vein occlusion
5149819|NCT03056079|aqueous humor cytokine|aqueous humor cytokine
5149843|NCT03055806|Sex|sex
5149914|NCT03055377|adolescent|adolescent
5149915|NCT03055377|pharmacotherapy|pharmacotherapy
5149916|NCT03055377|medication|medication
5149917|NCT03055377|n-acetylcysteine|n-acetylcysteine
5149918|NCT03055377|trial|trial
5150013|NCT03054701|PFPS|pfps
5150014|NCT03054675|lung resection|lung resection
5150015|NCT03054675|lung function|lung function
5150016|NCT03054675|VATS|vats
5150017|NCT03054675|Thoracotomy|thoracotomy
5150018|NCT03054662|Haemophilia|haemophilia
5150213|NCT03053557|mental health consumers|mental health consumers
5150214|NCT03053544|rectal cancer|rectal cancer
5150215|NCT03053544|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5150216|NCT03053544|node positive rectal tumors|node positive rectal tumors
5150310|NCT03053102|PNH|pnh
5150311|NCT03053102|Paroxysmal|paroxysmal
5150312|NCT03053102|Hemoglobinuria|hemoglobinuria
5150315|NCT03053076|safety|safety
5150604|NCT03050944|Mediterranean diet|mediterranean diet
5150606|NCT03050944|Follistatin|follistatin
5150706|NCT03050398|femara|femara
5150708|NCT03050398|CDK4|cdk4
5150709|NCT03050398|CDK6|cdk6
5150710|NCT03050398|CDK4/6|cdk4/6
5150808|NCT03049787|physical therapy|physical therapy
5150908|NCT03049085|ASA|asa
5151004|NCT03048617|Stealth|stealth
5151198|NCT03047317|pharmacokinetics|pharmacokinetics
5151199|NCT03047291|mucositis, periimplantitis, probiotic|mucositis, periimplantitis, probiotic
5151200|NCT03047226|Lynch Syndrome|lynch syndrome
5151294|NCT03046524|Parathyroid Neoplasm|parathyroid neoplasm
5151295|NCT03046524|Chart Review|chart review
5151296|NCT03046485|AMD|amd
5151297|NCT03046485|vision loss|vision loss
5151594|NCT03044431|Shortness of breath|shortness of breath
5151596|NCT03044431|Stem cells|stem cells
5151597|NCT03044431|Platelet rich plasma|platelet rich plasma
5151598|NCT03044431|Quality of life|quality of life
5151599|NCT03044431|Pulmonary Function|pulmonary function
5151600|NCT03044418|laser|laser
5151601|NCT03044418|endotracheal tube|endotracheal tube
5151602|NCT03044418|total intravenous anesthesia|total intravenous anesthesia
5151603|NCT03044418|side effect|side effect
5151604|NCT03044418|endolaryngeal surgery|endolaryngeal surgery
5151693|NCT03043924|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5151694|NCT03043911|early detection|early detection
5151695|NCT03043911|respiratory events|respiratory events
5151794|NCT03043378|Chronic non-malignant pain|chronic non-malignant pain
5151795|NCT03043365|Fish Oils|fish oils
5151796|NCT03043365|Long Chain Monounsaturated Fatty Acids|long chain monounsaturated fatty acids
5151797|NCT03043365|Lipoproteins|lipoproteins
5151798|NCT03043365|Cardiovascular Disease|cardiovascular disease
5151799|NCT03043352|SAM|sam
5151800|NCT03043352|Malnutrition|malnutrition
5152091|NCT03041805|radiofrequency ablation|radiofrequency ablation
5152092|NCT03041805|ultrasound-guided foam sclerotherapy|ultrasound-guided foam sclerotherapy
5152093|NCT03041805|register|register
5152094|NCT03041805|anticoagulation|anticoagulation
5152192|NCT03041116|PKAN|pkan
5152193|NCT03041090|infiltration|infiltration
5152194|NCT03041090|extravasation|extravasation
5152195|NCT03041090|PET/CT|pet/ct
5152196|NCT03041090|PET|pet
5152197|NCT03041090|PET-CT|pet-ct
5152199|NCT03041025|Repeat-dose|repeat-dose
5152295|NCT03040518|Financial Incentive|financial incentive
5152296|NCT03040518|Endowment incentive|endowment incentive
5152303|NCT03040427|Amyvid|amyvid
5152688|NCT03037502|Men's Health|men's health
5152689|NCT03037502|weight loss|weight loss
5152690|NCT03037502|African American men|african american men
5152895|NCT03036384|spinal anesthesia|spinal anesthesia
5152896|NCT03036384|local anesthesia|local anesthesia
5152897|NCT03036371|Neurogenesis|neurogenesis
5152899|NCT03036371|Spatial Processing|spatial processing
5152900|NCT03036371|Hippocampus|hippocampus
5152901|NCT03036371|Cognition|cognition
5152993|NCT03035773|Survivorship|survivorship
5152994|NCT03035760|Helminths|helminths
5152995|NCT03035760|Oxfendazole|oxfendazole
5152996|NCT03035760|Pharmacokinetics|pharmacokinetics
5152997|NCT03035760|Safety|safety
5152998|NCT03035747|registry|registry
5152999|NCT03035747|varicose veins|varicose veins
5153000|NCT03035747|conventional surgery|conventional surgery
5153001|NCT03035747|thermal ablation|thermal ablation
5153002|NCT03035747|radiofrequency|radiofrequency
5153003|NCT03035747|laser|laser
5153004|NCT03035747|sclerotherapy|sclerotherapy
5153005|NCT03035721|Full term healthy infants|full term healthy infants
5153006|NCT03035721|Low protein content formula|low protein content formula
5153007|NCT03035721|Safety|safety
5153008|NCT03035721|Growth|growth
5153291|NCT03034109|Cerebrovascular disease|cerebrovascular disease
5153292|NCT03034083|healthy marriage|healthy marriage
5153293|NCT03034083|healthy relationships|healthy relationships
5153294|NCT03034083|parenting|parenting
5153595|NCT03032237|Readymade meals|readymade meals
5153596|NCT03032224|Body composition|body composition
5153792|NCT03030794|Gulf War Illness|gulf war illness
5153793|NCT03030794|Headache|headache
5153794|NCT03030794|Muscle Pain|muscle pain
5153795|NCT03030794|Joint Pain|joint pain
5153796|NCT03030794|TMS|tms
5153797|NCT03030768|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5153889|NCT03030235|heart failure|heart failure
5153890|NCT03030235|dapagliflozin|dapagliflozin
5153891|NCT03030235|SGLT-2 inhibitors|sglt-2 inhibitors
5153892|NCT03030222|heart failure|heart failure
5153893|NCT03030222|empagliflozin|empagliflozin
5153992|NCT03029637|Randomized controlled trial|randomized controlled trial
5153994|NCT03029585|ovarian cancer|ovarian cancer
5154390|NCT03027466|Quitting Smoking|quitting smoking
5154489|NCT03026855|Point-of-care|point-of-care
5154490|NCT03026829|Sound therapy|sound therapy
5154491|NCT03026829|Tinnitus relief|tinnitus relief
5154495|NCT03026790|Opioid analgesics|opioid analgesics
5154592|NCT03026231|Fecal microbiota transplantation|fecal microbiota transplantation
5154593|NCT03026166|Cancer|cancer
5154594|NCT03026166|Extensive-Stage Small Cell Lung Cancer|extensive-stage small cell lung cancer
5154595|NCT03026166|Nivolumab|nivolumab
5154596|NCT03026166|Ipilimumab|ipilimumab
5155095|NCT03022669|veterans|veterans
5155096|NCT03022669|cardiovascular disease|cardiovascular disease
5155097|NCT03022669|medication adherence|medication adherence
5155098|NCT03022656|Orthotic treatment, Ultrasound Imaging|orthotic treatment, ultrasound imaging
5155383|NCT03021070|Ante natal visit|ante natal visit
5155384|NCT03021070|Facility delivery|facility delivery
5155385|NCT03021070|Post natal visit|post natal visit
5155386|NCT03021070|Continuum of care|continuum of care
5155487|NCT03020394|severe|severe
5155586|NCT03019588|PD-L1|pd-l1
5155685|NCT03018912|Subjective Sleep Vital Sign (VS)|subjective sleep vital sign (vs)
5155686|NCT03018912|Primary Care|primary care
5155687|NCT03018912|Sleep Medicine|sleep medicine
5155688|NCT03018912|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5155786|NCT03018223|GVHD|gvhd
5155877|NCT03017534|Neurodynamics|neurodynamics
5155878|NCT03017534|Sham|sham
5155880|NCT03017521|AKT inhibitor|akt inhibitor
5155978|NCT03016845|ciprofloxacin|ciprofloxacin
5155979|NCT03016845|pharmacokinetics|pharmacokinetics
5155980|NCT03016845|Intensive Care Unit|intensive care unit
5155981|NCT03016845|Cystatin C|cystatin c
5155982|NCT03016845|CKD-EPI|ckd-epi
5155983|NCT03016845|renal function|renal function
5155984|NCT03016780|Ulcerative Colitis|ulcerative colitis
5155985|NCT03016780|Intestinal Bacteria Flora Disturbance|intestinal bacteria flora disturbance
5155986|NCT03016780|Fecal Microbiota Transplantation|fecal microbiota transplantation
5155987|NCT03016780|Intestinal Mucosal Immunity|intestinal mucosal immunity
5155988|NCT03016767|oral feeding|oral feeding
5155989|NCT03016767|oral stimulation|oral stimulation
5155990|NCT03016767|physiotherapy intervention|physiotherapy intervention
5155991|NCT03016754|sudden cardiac death|sudden cardiac death
5155993|NCT03016754|sudden cardiac arrest|sudden cardiac arrest
5155994|NCT03016754|SCA|sca
5155995|NCT03016754|heart failure|heart failure
5155996|NCT03016754|HF|hf
5156076|NCT03016260|Rheumatoid Arthritis|rheumatoid arthritis
5156180|NCT03015597|Smoking|smoking
5156181|NCT03015597|Tobacco Smoking|tobacco smoking
5156283|NCT03015129|MEDI4736|medi4736
5156284|NCT03015129|Tremelimumab|tremelimumab
5156285|NCT03015129|anti-PD-L1 Antibody|anti-pd-l1 antibody
5156286|NCT03015129|anti-CTLA-4 antibody|anti-ctla-4 antibody
5156984|NCT03010761|clinical trial|clinical trial
5156985|NCT03010748|corneal morphology|corneal morphology
5157274|NCT03009006|Calcium hydroxide intracanal medication|calcium hydroxide intracanal medication
5157369|NCT03008252|cow's milk protein allergy|cow's milk protein allergy
5157371|NCT03008187|Relapsed/Refractory Acute Myeloid Leukemia|relapsed/refractory acute myeloid leukemia
5157468|NCT03007524|rosuvastatin|rosuvastatin
5157568|NCT03006835|Clopidogrel; Platelet Inhibition Ratio|clopidogrel; platelet inhibition ratio
5157573|NCT03006809|FMT|fmt
5158374|NCT03001986|safety|safety
5158375|NCT03001986|hand, foot and mouth disease (HFMD)|hand, foot and mouth disease (hfmd)
5158376|NCT03001986|Enterovirus A, Human|enterovirus a, human
5158377|NCT03001986|vaccine|vaccine
5158472|NCT03001180|Vascular Anomaly|vascular anomaly
5158473|NCT03001180|Kaposiform Hemangioendothelioma|kaposiform hemangioendothelioma
5158674|NCT03000257|Hepatocellular carcinoma|hepatocellular carcinoma
5158675|NCT03000257|Gastric cancer|gastric cancer
5158677|NCT03000257|Mesothelioma|mesothelioma
5158773|NCT02999789|Medication Adherence/statistics & numerical data|medication adherence/statistics & numerical data
5158774|NCT02999789|Reminder Systems|reminder systems
5158777|NCT02999776|Topical|topical
5159372|NCT02995954|ACE inhibitor Calcium Antagonist|ace inhibitor calcium antagonist
5159373|NCT02995941|reliability|reliability
5159374|NCT02995941|validity|validity
5159377|NCT02995941|symptom|symptom
5159474|NCT02995057|Biocompatibility|biocompatibility
5159475|NCT02995057|Allergy|allergy
5159476|NCT02995057|Metal|metal
5159477|NCT02995057|Nickel|nickel
5159478|NCT02995057|Contact dermatitis|contact dermatitis
5159479|NCT02995005|mother to child transmission|mother to child transmission
5159681|NCT02993575|Intensive Care Unit|intensive care unit
5159682|NCT02993562|Food intake|food intake
5159684|NCT02993562|Gall Bladder emptying|gall bladder emptying
5159782|NCT02992808|IVF|ivf
5159878|NCT02992067|lymph node metastasis|lymph node metastasis
5159880|NCT02992067|CK19|ck19
5159881|NCT02992067|contrast-enhanced ultrasonography|contrast-enhanced ultrasonography
5160069|NCT02991053|Transversus Abdominis Plane Block|transversus abdominis plane block
5160070|NCT02991053|ilioinguinal / iliohypogastric nerve block|ilioinguinal / iliohypogastric nerve block
5160080|NCT02990988|Transfusion|transfusion
5160168|NCT02990377|Motivational Enhancement|motivational enhancement
5160169|NCT02990377|Interactive Voice Response|interactive voice response
5160170|NCT02990377|Reinforcement Learning|reinforcement learning
5160299|NCT02989285|HIV|hiv
5160467|NCT02988466|Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma|relapsed large-cell lymphoma, mantle-cell lymphoma and hodgkin lymphoma
5160469|NCT02988466|Relapsed T-cell lymphoma|relapsed t-cell lymphoma
5160470|NCT02988466|Natural Killer cell malignancies|natural killer cell malignancies
5160471|NCT02988466|Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell lymphoma, follicular lymphoma|relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll), marginal zone b-cell lymphoma, follicular lymphoma
5160472|NCT02988466|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5160473|NCT02988466|Relapsed multiple myeloma|relapsed multiple myeloma
5160474|NCT02988466|Bone marrow failure syndromes|bone marrow failure syndromes
5160663|NCT02987400|refractory DLBCL|refractory dlbcl
5160665|NCT02987400|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5160666|NCT02987400|window of opportunity|window of opportunity
5160667|NCT02987387|Tetralogy of Fallot|tetralogy of fallot
5160671|NCT02987387|Pulmonary Atresia|pulmonary atresia
5160755|NCT02986854|Booster vaccination|booster vaccination
5160756|NCT02986854|Meningitis|meningitis
5160757|NCT02986854|Antibody persistence|antibody persistence
5160758|NCT02986828|platelet rich plasma|platelet rich plasma
5160964|NCT02985645|DIVA|diva
5160965|NCT02985645|Platelet-Rich Plasma|platelet-rich plasma
5160966|NCT02985554|hematologic malignancies|hematologic malignancies
5160967|NCT02985554|allogeneic stem cell transplantation (allo-SCT)|allogeneic stem cell transplantation (allo-sct)
5160970|NCT02985515|Anosmia|anosmia
5160971|NCT02985515|Hyposmia|hyposmia
5161053|NCT02984943|Rheumatoid Arthritis|rheumatoid arthritis
5161054|NCT02984943|Hyperbaric Oxygen|hyperbaric oxygen
5161058|NCT02984904|Spain|spain
5161350|NCT02983071|HR+|hr+
5161505|NCT02982395|BCG|bcg
5161752|NCT02980718|Smell|smell
5161845|NCT02980302|Mutation|mutation
5161846|NCT02980302|Gene MYT1L|gene myt1l
5161847|NCT02980276|Gestational Diabetes|gestational diabetes
5162137|NCT02978443|Melanoma|melanoma
5162138|NCT02978443|Mucosal|mucosal
5162139|NCT02978443|Acral Lentiginous|acral lentiginous
5162140|NCT02978443|Ipilimumab|ipilimumab
5162141|NCT02978443|Nivolumab|nivolumab
5162142|NCT02978443|Anti-tumor|anti-tumor
5162143|NCT02978443|Potential Predictors|potential predictors
5162144|NCT02978443|Opdivo|opdivo
5162238|NCT02977923|Virtual reality|virtual reality
5162340|NCT02977468|tumor microenvironment|tumor microenvironment
5162341|NCT02977442|Mitochondrial Dynamics|mitochondrial dynamics
5162342|NCT02977442|Insulin Resistance|insulin resistance
5162343|NCT02977442|Exercise and Diabetes|exercise and diabetes
5162756|NCT02975258|HIV|hiv
5162842|NCT02974868|safety|safety
5162843|NCT02974868|efficacy|efficacy
5162844|NCT02974868|JAK|jak
5162941|NCT02974257|cardiac arrest|cardiac arrest
5162942|NCT02974257|thiamine|thiamine
5162943|NCT02974257|oxygen consumption|oxygen consumption
5162944|NCT02974257|lactate|lactate
5162945|NCT02974257|shock|shock
5162946|NCT02974244|Type 2 diabetes|type 2 diabetes
5162947|NCT02974192|Ischemic stroke|ischemic stroke
5163039|NCT02973633|Myocardial Infarction|myocardial infarction
5163040|NCT02973633|Left Ventricular Hypertrophy|left ventricular hypertrophy
5163041|NCT02973633|Diffusion Tensor MRI|diffusion tensor mri
5163042|NCT02973594|left ventricular reverse remodeling|left ventricular reverse remodeling
5163134|NCT02972983|Staphylococcus aureus|staphylococcus aureus
5163136|NCT02972983|Daptomycin|daptomycin
5163147|NCT02972905|safety|safety
5163234|NCT02972372|chemoradiation|chemoradiation
5163235|NCT02972372|esophagectomy|esophagectomy
5163236|NCT02972359|Neridronic Acid|neridronic acid
5163237|NCT02972359|Neridronate|neridronate
5163238|NCT02972359|CRPS|crps
5163336|NCT02971566|preterm infants|preterm infants
5163337|NCT02971566|near infrared spectroscopy|near infrared spectroscopy
5163338|NCT02971566|abnormal antenatal Doppler|abnormal antenatal doppler
5163345|NCT02971488|Hepatitis C|hepatitis c
5163441|NCT02971072|motor|motor
5163535|NCT02970669|acute heart failure|acute heart failure
5163536|NCT02970669|chronic heart failure|chronic heart failure
5163636|NCT02970136|Community Health Worker|community health worker
5163637|NCT02970136|Medically Underserved|medically underserved
5163643|NCT02970071|Spatio-Temporal Image Correlation|spatio-temporal image correlation
5163644|NCT02970071|Complicated congenital heart disease|complicated congenital heart disease
5163649|NCT02969980|MDS|mds
5163828|NCT02968771|Metabolomics|metabolomics
5163829|NCT02968745|Rheumatoid arthritis|rheumatoid arthritis
5163830|NCT02968745|human activity|human activity
5163853|NCT02968537|EEG|eeg
5163927|NCT02967874|Adipose -Derived Stromal Vascular Fraction Cells|adipose -derived stromal vascular fraction cells
5164026|NCT02967198|Shear wave elastography|shear wave elastography
5164027|NCT02967159|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5164028|NCT02967159|asthma|asthma
5164029|NCT02967107|adenoma|adenoma
5164627|NCT02963194|self-processing|self-processing
5164628|NCT02963194|endowment effect|endowment effect
5164629|NCT02963194|neuroimage|neuroimage
5164630|NCT02963181|Melatonin|melatonin
5164631|NCT02963181|Yohimbine|yohimbine
5164731|NCT02962544|Small incision lenticule extraction|small incision lenticule extraction
5164732|NCT02962544|Lenticule extraction|lenticule extraction
5164733|NCT02962544|LASIK|lasik
5164734|NCT02962544|Myopia|myopia
5164735|NCT02962518|Pressure Device|pressure device
5164736|NCT02962518|Clip|clip
5164737|NCT02962518|Triamcinolone|triamcinolone
5164738|NCT02962518|Fillet Technique|fillet technique
5164739|NCT02962492|Dapagliflozin|dapagliflozin
5164742|NCT02962492|DKA|dka
5165132|NCT02959944|PCYC1140|pcyc1140
5165226|NCT02959567|cervical dilation|cervical dilation
5165227|NCT02959567|balloon catheter|balloon catheter
5165228|NCT02959554|Advanced|advanced
5165429|NCT02958111|Adjuvant chemotherapy|adjuvant chemotherapy
5165721|NCT02956551|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5165722|NCT02956551|cell based therapy|cell based therapy
5165723|NCT02956551|safety|safety
5165724|NCT02956551|clinical efficacy|clinical efficacy
5165923|NCT02955303|Cognitive training|cognitive training
5165924|NCT02955303|Tablet computers|tablet computers
5165925|NCT02955277|Cognitive training|cognitive training
5165926|NCT02955277|Tablet computers|tablet computers
5165927|NCT02955264|Glycosylation|glycosylation
5165928|NCT02955264|Glucose Metabolic Disorder|glucose metabolic disorder
5165929|NCT02955264|Galactose|galactose
5165930|NCT02955251|Cancer|cancer
5165931|NCT02955251|Neoplasm|neoplasm
5166024|NCT02954679|Drug abuse|drug abuse
5166025|NCT02954679|Methylphenidate|methylphenidate
5166026|NCT02954679|Addictovigilance|addictovigilance
5166027|NCT02954679|CEIP|ceip
5166028|NCT02954666|cardio-neuromodulation|cardio-neuromodulation
5166029|NCT02954666|cardio-neuroablation|cardio-neuroablation
5166030|NCT02954666|ablation|ablation
5166125|NCT02954055|ER-positive|er-positive
5166126|NCT02954055|HER2-negative|her2-negative
5166127|NCT02954055|Stage IV|stage iv
5166128|NCT02954042|Incontinence|incontinence
5166129|NCT02954016|Obesity|obesity
5166130|NCT02954016|Weight Loss|weight loss
5166131|NCT02954016|Hypertension|hypertension
5166132|NCT02954016|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5166133|NCT02954016|Hyperlipidemia|hyperlipidemia
5166134|NCT02954003|Obesity|obesity
5166135|NCT02954003|Weight Loss|weight loss
5166225|NCT02953626|waitlist-controlled RCT|waitlist-controlled rct
5166226|NCT02953626|postpartum depression|postpartum depression
5166227|NCT02953613|Cardiac Catheterization|cardiac catheterization
5166228|NCT02953613|Cardiac intervention|cardiac intervention
4995817|NCT04019886|Preterm|preterm
5166229|NCT02953613|coronary angiogram|coronary angiogram
5166248|NCT02953496|PAD|pad
5166432|NCT02952300|single file|single file
5166530|NCT02951338|Behaviour change|behaviour change
5166531|NCT02951338|Rehabilitation|rehabilitation
5166532|NCT02951338|Self-management|self-management
5166533|NCT02951338|Education|education
5166534|NCT02951325|adjuvant RT|adjuvant rt
5166535|NCT02951312|Emphysema|emphysema
5166536|NCT02951312|Chronic bronchitis|chronic bronchitis
5166537|NCT02951312|COPD|copd
5166538|NCT02951312|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5166539|NCT02951286|Skeletal openbite|skeletal openbite
5166540|NCT02951286|Molar intrusion|molar intrusion
5166541|NCT02951286|high pull headgear|high pull headgear
5166542|NCT02951273|abdominal surgery|abdominal surgery
5166543|NCT02951273|blood pressure|blood pressure
5166544|NCT02951273|cardiac output|cardiac output
5166558|NCT02951130|CDH|cdh
5166625|NCT02950818|health education|health education
5166626|NCT02950818|chronic disease|chronic disease
5166627|NCT02950818|heart diseases|heart diseases
5166830|NCT02949635|Aged|aged
5167081|NCT02948062|ALD|ald
5167124|NCT02947724|surgicel|surgicel
5167125|NCT02947711|E2027|e2027
5167126|NCT02947711|Healthy participants|healthy participants
5167127|NCT02947711|Pharmacokinetics|pharmacokinetics
5167128|NCT02947698|acute kidney injury|acute kidney injury
5167129|NCT02947698|weekend admission|weekend admission
5167130|NCT02947698|mortality|mortality
5167327|NCT02946385|antibody persistence|antibody persistence
5167328|NCT02946372|retina surgery|retina surgery
5167329|NCT02946372|macula|macula
5167330|NCT02946372|macular hole|macular hole
5167429|NCT02945748|cardiac output|cardiac output
5167430|NCT02945748|fluid responsiveness|fluid responsiveness
5167431|NCT02945748|critically ill|critically ill
5167432|NCT02945748|hemodynamic monitoring|hemodynamic monitoring
5167433|NCT02945735|depression|depression
5167434|NCT02945735|cognitive bias modification|cognitive bias modification
5167732|NCT02943889|Mesenchymal stem cells|mesenchymal stem cells
5167733|NCT02943889|Liver cirrhosis|liver cirrhosis
5167734|NCT02943889|Stem cell therapy|stem cell therapy
5167735|NCT02943876|risk prediction|risk prediction
5167833|NCT02943252|advanced head and neck cancer|advanced head and neck cancer
5167834|NCT02943252|non-squamous|non-squamous
5167968|NCT02942251|MDD|mdd
5168038|NCT02941926|ER-positive|er-positive
5168039|NCT02941926|PR-positive|pr-positive
5168040|NCT02941926|premenopausal|premenopausal
5168041|NCT02941926|postmenopausal|postmenopausal
5168045|NCT02941887|Social behavior|social behavior
5168136|NCT02941302|imaging border|imaging border
5168137|NCT02941302|operation|operation
5168139|NCT02941237|Pulse oximetry|pulse oximetry
5168140|NCT02941237|Children|children
5168141|NCT02941211|cervix|cervix
5168234|NCT02940600|reconditioning|reconditioning
5168335|NCT02939820|FAP|fap
5168434|NCT02939404|Eating Behavior|eating behavior
5168512|NCT02938741|ATG|atg
5168530|NCT02938520|Triumeq|triumeq
5168531|NCT02938520|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5168532|NCT02938520|once monthly, every 4 weeks, once daily|once monthly, every 4 weeks, once daily
5168533|NCT02938520|GSK1265744|gsk1265744
5168534|NCT02938520|CAB|cab
5168535|NCT02938520|Tivicay|tivicay
5168536|NCT02938520|Long-Acting Intramuscular rilpivirine|long-acting intramuscular rilpivirine
5168537|NCT02938520|lamivudine|lamivudine
5168538|NCT02938520|integrase inhibitor|integrase inhibitor
5168540|NCT02938520|ART naïve|art naïve
5168623|NCT02937675|immunomodulator|immunomodulator
5168624|NCT02937675|phase 1 dose escalation|phase 1 dose escalation
5168823|NCT02936414|Berberine|berberine
5168824|NCT02936414|Cytokine|cytokine
5168825|NCT02936414|CRP|crp
5168826|NCT02936414|Metabolism|metabolism
5168827|NCT02936414|Schizophrenia|schizophrenia
5168832|NCT02936375|lupus|lupus
5168926|NCT02935777|memory|memory
5169345|NCT02933008|ACL|acl
5169643|NCT02931422|HIV|hiv
5172905|NCT02911597|TRD|trd
5173519|NCT02907788|PMN|pmn
5175971|NCT02891616|18F-FLT|18f-flt
5177578|NCT02881086|BCR-ABL|bcr-abl
5179168|NCT02870322|obesity|obesity
5179746|NCT02866227|Vaginal|vaginal
5180155|NCT02864368|Ashley|ashley
5180261|NCT02863718|CLL|cll
5180346|NCT02863107|Surveys|surveys
5180763|NCT02860273|COPD|copd
5180892|NCT02859337|BMI|bmi
5181040|NCT02858453|SHIP1|ship1
5181947|NCT02852772|HIV|hiv
5182566|NCT02848586|HIV|hiv
5184852|NCT02834338|ERAS|eras
5185786|NCT02829164|IgA|iga
5186361|NCT02825290|IVF|ivf
5187739|NCT02816814|Diet|diet
5188700|NCT02811380|CVC|cvc
5188752|NCT02810951|RDEB|rdeb
5188861|NCT02810327|MZ|mz
5189552|NCT02806193|cardiac|cardiac
5190566|NCT02799862|NSCLC|nsclc
5191038|NCT02797821|HPP|hpp
5191340|NCT02796248|stigma|stigma
5191626|NCT02794415|HIV|hiv
5193237|NCT02785068|Nal-IRI|nal-iri
5196369|NCT02766608|COPD|copd
5196448|NCT02766114|Surgery|surgery
5197316|NCT02761174|IPL|ipl
5198966|NCT02750891|HGG|hgg
5199777|NCT02745483|RFA|rfa
5201469|NCT02734875|NOACs|noacs
5201977|NCT02731872|COPD|copd
5202910|NCT02725970|BMI|bmi
5203046|NCT02725229|TENS|tens
5205049|NCT02713516|OCD|ocd
5206364|NCT02705105|HCC|hcc
5207331|NCT02698956|TAVI|tavi
5208547|NCT02692183|ET|et
5208825|NCT02690441|GAD|gad
5209153|NCT02688556|KCS|kcs
5209458|NCT02686411|PCU|pcu
5209842|NCT02684084|Ozurdex|ozurdex
5210139|NCT02682186|Pain|pain
5210278|NCT02681172|CSF|csf
5210464|NCT02680067|ICG|icg
5211554|NCT02672748|garden|garden
5212548|NCT02666092|IgE|ige
5213132|NCT02662803|GAD|gad
5213234|NCT02662270|fMRI|fmri
5213603|NCT02660268|Hip|hip
5214251|NCT02656940|obesity|obesity
5214739|NCT02653872|Safety|safety
5215640|NCT02648529|DTI|dti
5215750|NCT02647905|CGM|cgm
5216033|NCT02645981|Phase 3|phase 3
5216127|NCT02645383|Pain|pain
5219807|NCT02625077|GERD|gerd
5221645|NCT02613390|MRI|mri
5222476|NCT02608268|RCC|rcc
5222738|NCT02606305|IMGN853|imgn853
5223315|NCT02602938|aspirin|aspirin
5225912|NCT02587832|RDS|rds
5228994|NCT02570373|Healthy|healthy
5229702|NCT02566369|Safety|safety
5230100|NCT02563899|PRO|pro
5230861|NCT02559505|infants|infants
5231274|NCT02556814|ITP|itp
5231661|NCT02554474|SLE|sle
5231951|NCT02552758|PET|pet
5232053|NCT02552160|Inhaler|inhaler
5233624|NCT02542618|CBT|cbt
5235021|NCT02533375|safety|safety
5235837|NCT02528643|MDV3100|mdv3100
5236485|NCT02524340|JIA|jia
5237383|NCT02518685|TPS|tps
5237415|NCT02518464|chronic|chronic
5238521|NCT02511795|AZD1775|azd1775
5240325|NCT02501421|vaccine|vaccine
5240918|NCT02497976|Bladder|bladder
5242029|NCT02491879|gel|gel
5242640|NCT02487771|DHA|dha
5243746|NCT02481596|family|family
5243878|NCT02480972|MRI|mri
5244951|NCT02474537|INC280,|inc280,
5245130|NCT02473497|ALK|alk
5245227|NCT02473042|PONV|ponv
5245521|NCT02471703|Non-Inflammatory Joint Disease|non-inflammatory joint disease
5245523|NCT02471677|Ovarian stimulation|ovarian stimulation
5245524|NCT02471677|corifollitropin alfa|corifollitropin alfa
5245525|NCT02471677|GnRH antagonist protocol|gnrh antagonist protocol
5245526|NCT02471677|high responders|high responders
5245527|NCT02471677|follitropin beta|follitropin beta
5245625|NCT02471001|Heart|heart
5245826|NCT02469779|Surveys|surveys
5245827|NCT02469779|Questionnaires|questionnaires
5246028|NCT02468778|Mechanical circulatory support device|mechanical circulatory support device
5246030|NCT02468778|Abbott|abbott
5246031|NCT02468713|Omega-3|omega-3
5246032|NCT02468713|Blood lipid profiles|blood lipid profiles
5246033|NCT02468713|DHA|dha
5246034|NCT02468713|EPA|epa
5246035|NCT02468713|Triglyceride|triglyceride
5246036|NCT02468713|Glucose|glucose
5246037|NCT02468713|Insulin|insulin
5246038|NCT02468713|LDL|ldl
5246128|NCT02468271|Lung function|lung function
5246129|NCT02468271|Lung clearance index|lung clearance index
5246130|NCT02468258|Assisted Reproduction|assisted reproduction
5246131|NCT02468245|Nursing intervention|nursing intervention
5246132|NCT02468245|compliance|compliance
5246133|NCT02468232|chronic heart failure|chronic heart failure
5246134|NCT02468232|cardiovascular death|cardiovascular death
5246135|NCT02468232|hospitalization|hospitalization
5246136|NCT02468232|outcome study|outcome study
5246137|NCT02468232|worsening heart failure|worsening heart failure
5246138|NCT02468232|NT-proBNP|nt-probnp
5246139|NCT02468232|NYHA|nyha
5246140|NCT02468232|KCCQ|kccq
5246430|NCT02466867|Ringworm|ringworm
5246629|NCT02465528|glioblastoma|glioblastoma
5246630|NCT02465528|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5246632|NCT02465528|inflammatory myofibroblastic tumor|inflammatory myofibroblastic tumor
5246633|NCT02465515|cardiovascular events /outcomes|cardiovascular events /outcomes
5246634|NCT02465515|Type 2 diabetes mellitus|type 2 diabetes mellitus
5246635|NCT02465515|albiglutide|albiglutide
5246636|NCT02465515|glucagon-like peptide-1 receptor agonist|glucagon-like peptide-1 receptor agonist
5246637|NCT02465502|Colorectal cancer|colorectal cancer
5246638|NCT02465502|Regorafenib|regorafenib
5246639|NCT02465489|deferiprone|deferiprone
5246730|NCT02464865|obese children|obese children
5247139|NCT02462759|EMBRACE|embrace
5247343|NCT02461459|ID|id
5247439|NCT02461004|Dyslipidemia|dyslipidemia
5247442|NCT02461004|Ezetimibe|ezetimibe
5247909|NCT02458157|ICU|icu
5247941|NCT02457884|Chinese|chinese
5247942|NCT02457884|Hong Kong|hong kong
5247943|NCT02457858|Type 1 Diabetes|type 1 diabetes
5247944|NCT02457858|Islet Transplant|islet transplant
5247970|NCT02457832|Magnetic Resonance Imaging|magnetic resonance imaging
5247971|NCT02457832|Neurology|neurology
5247972|NCT02457832|Neurosciences|neurosciences
5247973|NCT02457832|Physical Medicine|physical medicine
5247974|NCT02457832|Parkinson Disease|parkinson disease
5247975|NCT02457832|Rehabilitation|rehabilitation
5247976|NCT02457806|Dental Anesthesia|dental anesthesia
5247977|NCT02457780|PTSD|ptsd
5247978|NCT02457780|Trauma|trauma
5247979|NCT02457780|World Trade Center|world trade center
5247980|NCT02457780|Respiratory|respiratory
5247982|NCT02457741|Mechanical ventilation|mechanical ventilation
5247984|NCT02457741|Respiratory mechanics|respiratory mechanics
5247985|NCT02457741|End-expiratory lung volume|end-expiratory lung volume
5247986|NCT02457689|Human Immunodeficiency Virus|human immunodeficiency virus
5247987|NCT02457689|Immunodeficiency Virus, Human|immunodeficiency virus, human
5247988|NCT02457676|Self-Regulation Training|self-regulation training
5248143|NCT02456779|diagnostic|diagnostic
5248144|NCT02456766|FibroTouch|fibrotouch
5248145|NCT02456766|acoustic attenuation parameter|acoustic attenuation parameter
5248146|NCT02456766|liver biopsy|liver biopsy
5248147|NCT02456766|hepatic steatosis|hepatic steatosis
5248148|NCT02456753|in labor|in labor
5248149|NCT02456753|Ultrasonography|ultrasonography
5248150|NCT02456753|clinical examination|clinical examination
5248151|NCT02456753|Prenatal|prenatal
5248152|NCT02456740|Migraine|migraine
5248153|NCT02456740|Headache|headache
5248938|NCT02451540|Functional Respiratory Imaging|functional respiratory imaging
5248940|NCT02451540|Roflumilast|roflumilast
5249044|NCT02450955|spinal manipulation|spinal manipulation
5249162|NCT02450110|BNP|bnp
5249433|NCT02448641|fixed motor deficits|fixed motor deficits
5249434|NCT02448628|Hypertension|hypertension
5249435|NCT02448628|moderate renal impairment|moderate renal impairment
5249436|NCT02448628|mineralocorticoid receptor antagonist|mineralocorticoid receptor antagonist
5249588|NCT02447536|BCG|bcg
5249627|NCT02447185|25-Gauge Vitrectomy|25-gauge vitrectomy
5249628|NCT02447159|Nigeria|nigeria
5249629|NCT02447159|Developing Countries|developing countries
5250036|NCT02444819|HM61713|hm61713
5250227|NCT02443597|trisomy screening|trisomy screening
5250228|NCT02443597|obesity|obesity
5250229|NCT02443584|depression|depression
5250230|NCT02443584|pharmacogenetics|pharmacogenetics
5250231|NCT02443584|pharmacogenomics|pharmacogenomics
5250232|NCT02443584|major depressive disorder|major depressive disorder
5250233|NCT02443584|genetics|genetics
5250234|NCT02443584|anti-depressants|anti-depressants
5250235|NCT02443571|observational study|observational study
5250242|NCT02443545|Iron overload|iron overload
5250243|NCT02443545|Sickle cell disease|sickle cell disease
5250244|NCT02443545|Deferiprone|deferiprone
5250245|NCT02443545|Ferriprox|ferriprox
5250246|NCT02443545|Iron chelation|iron chelation
5250247|NCT02443519|Mindfulness|mindfulness
5250248|NCT02443519|MBCT|mbct
5250268|NCT02443259|NAPI|napi
5251632|NCT02435888|Predictive equations|predictive equations
5251633|NCT02435888|Overweight|overweight
5251634|NCT02435875|hypertension|hypertension
5251635|NCT02435875|perioperative|perioperative
5251755|NCT02435030|NP-C|np-c
5251834|NCT02434575|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5251840|NCT02434549|Placebo Controlled|placebo controlled
5252030|NCT02433431|wellness programs|wellness programs
5252031|NCT02433431|mobile applications|mobile applications
5252032|NCT02433431|cortisol|cortisol
5252033|NCT02433405|Serum Amyloid A|serum amyloid a
5252034|NCT02433405|Fetuin-A|fetuin-a
5252035|NCT02433405|gingival crevicular fluid|gingival crevicular fluid
5252036|NCT02433405|serum|serum
5252037|NCT02433405|periodontal diseases|periodontal diseases
5252833|NCT02429310|Lower Limb Arterial Disease|lower limb arterial disease
5252834|NCT02429310|Supervised Exercise Therapy|supervised exercise therapy
5252835|NCT02429310|Supervised Exercise Programme|supervised exercise programme
5252836|NCT02429310|Exercise Therapy|exercise therapy
5252837|NCT02429297|Hypertension|hypertension
5253131|NCT02427867|myocardial ischemia|myocardial ischemia
5253132|NCT02427854|Major delivery complications|major delivery complications
5253133|NCT02427854|Perineal injuries|perineal injuries
5253134|NCT02427854|episiotomy|episiotomy
5253229|NCT02427204|Hepatitis C infection|hepatitis c infection
5253230|NCT02427204|Hepatitis C treatment|hepatitis c treatment
5253231|NCT02427191|Chronic plantar fasciitis|chronic plantar fasciitis
5253232|NCT02427191|Heel pain|heel pain
5253233|NCT02427178|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5253327|NCT02426645|Multi organ dysfunction|multi organ dysfunction
5253328|NCT02426645|Immunomonitoring|immunomonitoring
5253329|NCT02426645|CEUS|ceus
5253330|NCT02426632|Healthy|healthy
5253341|NCT02426593|CHF|chf
5253731|NCT02424292|Physcial activity/exercise|physcial activity/exercise
5253732|NCT02424292|anti-hormonal treatment|anti-hormonal treatment
5253733|NCT02424279|pancreatic cancer|pancreatic cancer
5253834|NCT02423733|secondary mental health care|secondary mental health care
5253835|NCT02423733|mental health|mental health
5253836|NCT02423733|e-therapy|e-therapy
5253837|NCT02423733|computerized therapy|computerized therapy
5253838|NCT02423668|cataract surgery|cataract surgery
5253839|NCT02423668|biometry|biometry
5253843|NCT02423616|MIP|mip
5253935|NCT02423213|ophthalmic surgery|ophthalmic surgery
5253936|NCT02423187|Stomach ulcer|stomach ulcer
5253937|NCT02423187|Duodenal ulcer|duodenal ulcer
5253939|NCT02423187|Recurrence|recurrence
5253940|NCT02423161|OCT|oct
5253941|NCT02423161|image-guided surgery|image-guided surgery
5253943|NCT02423161|corneal surgery|corneal surgery
5253944|NCT02423148|Lung Cancer|lung cancer
5253945|NCT02423096|biomarker|biomarker
5253946|NCT02423096|neuroendocrine|neuroendocrine
5253947|NCT02423096|metabolite|metabolite
5253948|NCT02423096|cognitive functioning|cognitive functioning
5253949|NCT02423096|clinical symptoms|clinical symptoms
5254032|NCT02422784|Vitamin D insufficient|vitamin d insufficient
5254033|NCT02422784|rooibos tea|rooibos tea
5254035|NCT02422758|hypothermia|hypothermia
5254036|NCT02422758|perioperative nursing|perioperative nursing
5254037|NCT02422758|prewarming|prewarming
5254340|NCT02421211|Hepatitis C, Chronic|hepatitis c, chronic
5254341|NCT02421211|Simeprevir|simeprevir
5254342|NCT02421211|Ledipasvir|ledipasvir
5254343|NCT02421211|Sofosbuvir|sofosbuvir
5254344|NCT02421198|Intervention Studies|intervention studies
5254676|NCT02419469|ALL|all
5254846|NCT02418637|feasibility|feasibility
5254847|NCT02418624|breast cancer 1, early onset (BRCA1)|breast cancer 1, early onset (brca1)
5254848|NCT02418624|breast cancer 2, early onset (BRCA2)|breast cancer 2, early onset (brca2)
5254849|NCT02418624|homologous recombination deficiency|homologous recombination deficiency
5254850|NCT02418624|carboplatin|carboplatin
5255111|NCT02417233|SMS|sms
5684285|NCT00561288|Affect|affect
5255348|NCT02416297|accelerated tooth movement|accelerated tooth movement
5255350|NCT02416297|Extraction|extraction
5255351|NCT02416258|Psoriasis|psoriasis
5255646|NCT02414412|Ulmus macrocarpa water extract|ulmus macrocarpa water extract
5255647|NCT02414412|immunity|immunity
5255648|NCT02414399|post-discharge mortality|post-discharge mortality
5255649|NCT02414399|morbidity and mortality prevention|morbidity and mortality prevention
5255650|NCT02414399|azithromycin|azithromycin
5255651|NCT02414399|linear growth|linear growth
5255652|NCT02414386|Vitamin D|vitamin d
5255653|NCT02414386|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5255654|NCT02414386|Multi Organ Failure|multi organ failure
5255655|NCT02414386|Acute Kidney Injury|acute kidney injury
5255656|NCT02414386|Critical Care|critical care
5255657|NCT02414386|Citrate anticoagulation|citrate anticoagulation
5255659|NCT02414373|analgesia, epidural|analgesia, epidural
5255660|NCT02414373|local anesthetics|local anesthetics
5255661|NCT02414360|Review Literature as Topic|review literature as topic
5255662|NCT02414347|Dementia|dementia
5255663|NCT02414347|Tauopathies|tauopathies
5255664|NCT02414347|Brain Diseases|brain diseases
5255665|NCT02414347|Central Nervous System Diseases|central nervous system diseases
5255666|NCT02414347|Mild Cognitive Impairment|mild cognitive impairment
5255667|NCT02414347|Nervous System Diseases|nervous system diseases
5255668|NCT02414347|Neurodegenerative Disease|neurodegenerative disease
5255669|NCT02414334|Oligometastases|oligometastases
5255670|NCT02414334|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
5255671|NCT02414334|Metastatic tumours|metastatic tumours
5255672|NCT02414308|Erectile dysfunction, Peyronie's disease, stem cell|erectile dysfunction, peyronie's disease, stem cell
5255673|NCT02414295|Stem cell|stem cell
5255674|NCT02414295|Kleinfelter syndrome|kleinfelter syndrome
5255675|NCT02414295|Azoospermia|azoospermia
5255676|NCT02414295|Sterility|sterility
5255677|NCT02414295|Infertility|infertility
5255761|NCT02413970|OSA|osa
5255939|NCT02412748|Non-Resident|non-resident
5255940|NCT02412748|Fathers|fathers
5255941|NCT02412748|African American|african american
5255943|NCT02412735|Low back pain|low back pain
5256339|NCT02410551|Polycythemia vera|polycythemia vera
5256340|NCT02410551|PV|pv
5256359|NCT02410434|gay|gay
5256570|NCT02409225|ICD|icd
5256736|NCT02408159|Zostavax|zostavax
5256737|NCT02408159|herpes zoster|herpes zoster
5256842|NCT02407626|cardiac surgery|cardiac surgery
5256843|NCT02407626|volatile anesthetic|volatile anesthetic
5257163|NCT02405533|HPV|hpv
5257841|NCT02401867|transgender|transgender
5257842|NCT02401867|female-to-male|female-to-male
5257843|NCT02401867|cervical cancer|cervical cancer
5257844|NCT02401867|HPV|hpv
5257845|NCT02401867|sexual health|sexual health
5257846|NCT02401854|atrial fibrillation|atrial fibrillation
5257847|NCT02401854|hypertension|hypertension
5257848|NCT02401854|risk factors|risk factors
5257849|NCT02401854|primary care|primary care
5257850|NCT02401854|elderly|elderly
5257851|NCT02401815|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5257852|NCT02401815|KIT|kit
5257853|NCT02401815|Biomarkers|biomarkers
5257854|NCT02401815|PLX9486|plx9486
5257855|NCT02401815|PLX3397|plx3397
5257856|NCT02401815|Sunitinib|sunitinib
5257857|NCT02401802|Colonoscopy|colonoscopy
5257942|NCT02401516|Arterial Systemic Hypertension|arterial systemic hypertension
5257943|NCT02401503|CLL|cll
5257944|NCT02401477|helicobacter pylori|helicobacter pylori
5257945|NCT02401477|ilaprazole|ilaprazole
5257946|NCT02401477|eradication|eradication
5257947|NCT02401477|dual therapy|dual therapy
5257948|NCT02401477|high dose therapy|high dose therapy
5258334|NCT02398825|Chronic myeloid leukemia|chronic myeloid leukemia
5258335|NCT02398825|Chronic phase|chronic phase
5258336|NCT02398825|Adults|adults
5258337|NCT02398825|Ponatinib|ponatinib
5258343|NCT02398734|sonolysis|sonolysis
5258541|NCT02397655|ischemia|ischemia
5258543|NCT02397655|ultrasonography|ultrasonography
5258545|NCT02397564|scar|scar
5258642|NCT02396823|Blood pressure regulation|blood pressure regulation
5258933|NCT02395107|Heart Valve Diseases|heart valve diseases
5258934|NCT02395107|Atrial Fibrillation|atrial fibrillation
5258935|NCT02395107|Hypertrophy|hypertrophy
5258936|NCT02395107|Hypertrophy, Left Ventricular|hypertrophy, left ventricular
5258937|NCT02395107|Diastology|diastology
5258938|NCT02395081|pregnancy|pregnancy
5259326|NCT02392572|Cytosar|cytosar
5259327|NCT02392572|DepoCyt|depocyt
5259533|NCT02391272|recombinant human thrombopoietin|recombinant human thrombopoietin
5259534|NCT02391272|immune thrombocytopenia|immune thrombocytopenia
5259535|NCT02391272|pregnancy|pregnancy
5259536|NCT02391246|central nervous system tumours|central nervous system tumours
5259832|NCT02389348|Induced blood stage malaria|induced blood stage malaria
5259934|NCT02388711|Dementia|dementia
5259935|NCT02388711|Transitional Care|transitional care
5259936|NCT02388711|Caregiver|caregiver
5259937|NCT02388698|HPV DNA|hpv dna
5259938|NCT02388698|PET-CT|pet-ct
5259939|NCT02388698|Recurrent cervical cancer|recurrent cervical cancer
5259940|NCT02388698|chemoradiation|chemoradiation
5260036|NCT02388139|acute myocardial infarction|acute myocardial infarction
5260037|NCT02388139|renal artery stenosis|renal artery stenosis
5260038|NCT02388113|Exercise therapy|exercise therapy
5260039|NCT02388113|Time factors|time factors
5260040|NCT02388074|Lung Cancer|lung cancer
5260041|NCT02388074|Porphyrin|porphyrin
5260042|NCT02388074|Fluorescence|fluorescence
5260136|NCT02387658|claudication|claudication
5260137|NCT02387658|translesional pressure gradient|translesional pressure gradient
5260138|NCT02387658|pressure wire|pressure wire
5260139|NCT02387658|six minute walk|six minute walk
5260140|NCT02387658|superficial femoral artery|superficial femoral artery
5260638|NCT02385006|Thromboelastography|thromboelastography
5260641|NCT02384993|Dementia|dementia
5260736|NCT02384538|Osteoarthritis, Hand|osteoarthritis, hand
5260737|NCT02384525|Septic AKI|septic aki
5260739|NCT02384525|BIA|bia
5260740|NCT02384512|Parkinson's disease|parkinson's disease
5260741|NCT02384512|akinesia|akinesia
5260742|NCT02384512|Azilect®|azilect®
5260951|NCT02383147|Adult|adult
5261454|NCT02380547|Extubation after 24 hours of invasive ventilation|extubation after 24 hours of invasive ventilation
5261455|NCT02380534|High level of Lp(a)|high level of lp(a)
5261656|NCT02379442|Adoptive Cellular Therapy|adoptive cellular therapy
5261661|NCT02379416|Drug Efflux|drug efflux
5261662|NCT02379416|Taxanes|taxanes
5261663|NCT02379416|Combination|combination
5261958|NCT02377791|Cytochrome P-450 CYP3A|cytochrome p-450 cyp3a
5261959|NCT02377791|Kidney transplant|kidney transplant
5262252|NCT02376296|castrate resistant prostate cancer|castrate resistant prostate cancer
5262254|NCT02376296|hormone sensitive prostate cancer|hormone sensitive prostate cancer
5262255|NCT02376283|STEMI|stemi
5262256|NCT02376283|NSTEMI|nstemi
5262656|NCT02373696|Caesarean section|caesarean section
5262657|NCT02373670|Positive deviance|positive deviance
5262658|NCT02373670|Peer mentors|peer mentors
5262659|NCT02373657|trachoma|trachoma
5262660|NCT02373657|soil transmitted helminths|soil transmitted helminths
5262721|NCT02373332|DHA|dha
5262954|NCT02372019|Social Anxiety Disorder|social anxiety disorder
5262955|NCT02372019|Social Phobia|social phobia
5262956|NCT02372019|Reconsolidation|reconsolidation
5262957|NCT02372019|Cognitive Bias Modification|cognitive bias modification
5262958|NCT02372019|Interpretation Bias|interpretation bias
5262959|NCT02371980|Drug therapy|drug therapy
5262960|NCT02371928|Shoulder|shoulder
5262961|NCT02371928|Instability|instability
5262962|NCT02371928|Neuromuscular|neuromuscular
5662247|NCT00654394|Crestor|crestor
5262963|NCT02371928|Physiotherapy|physiotherapy
5263257|NCT02370147|smoking reduction intervention|smoking reduction intervention
5263258|NCT02370147|no intention to quit|no intention to quit
5263264|NCT02370121|Central Obesity|central obesity
5263559|NCT02368288|HBsAg|hbsag
5264063|NCT02365532|prolonged QT|prolonged qt
5264065|NCT02365519|dry eye disease|dry eye disease
5264066|NCT02365519|efficacy|efficacy
5264067|NCT02365519|ocular discomfort|ocular discomfort
5264362|NCT02363699|under general anesthesia|under general anesthesia
5264363|NCT02363673|Autism Spectrum Disorder|autism spectrum disorder
5264411|NCT02363413|NIV|niv
5264556|NCT02362555|Ossification of nuchal ligament|ossification of nuchal ligament
5264557|NCT02362490|chronic hepatitis B|chronic hepatitis b
5264558|NCT02362490|interferon|interferon
5264559|NCT02362490|Nucleotide analogues|nucleotide analogues
5264561|NCT02362464|Multi-epitope|multi-epitope
5264562|NCT02362464|Tarp Peptide|tarp peptide
5264563|NCT02362464|Dendritic Cell Vaccine|dendritic cell vaccine
5264564|NCT02362464|D0 Prostate Cancer|d0 prostate cancer
5264576|NCT02362425|Clinical Trial|clinical trial
5264762|NCT02361424|mild AD|mild ad
5265035|NCT02359812|Arm|arm
5265264|NCT02358655|Oral anticoagulant|oral anticoagulant
5265265|NCT02358655|Knowledge translation|knowledge translation
5265266|NCT02358655|Emergency department|emergency department
5265267|NCT02358642|Rate of Pneumonia|rate of pneumonia
5265268|NCT02358642|Mortality rate|mortality rate
5265269|NCT02358603|Chronotropic Incompetence|chronotropic incompetence
5265270|NCT02358603|Heart Failure|heart failure
5265271|NCT02358564|IBS|ibs
5265272|NCT02358564|Irritable Bowel Syndrome|irritable bowel syndrome
5265273|NCT02358564|Visceral Hypersensitivity|visceral hypersensitivity
5265274|NCT02358564|Permeability|permeability
5265275|NCT02358564|Small Bowel|small bowel
5265364|NCT02358161|nab paclitaxel|nab paclitaxel
5265365|NCT02358148|Acute Coronary Syndrome|acute coronary syndrome
5265366|NCT02358148|Chest Pain|chest pain
5265367|NCT02358148|ACS|acs
5265368|NCT02358148|Risk Stratification Score|risk stratification score
5265369|NCT02358148|HEART Score|heart score
5265370|NCT02358148|Modified TIMI|modified timi
5265374|NCT02358135|Pragmatic|pragmatic
5265560|NCT02356952|Metabolic Syndrome X|metabolic syndrome x
5265561|NCT02356952|Low Glycemic Index Mediterranean Diet|low glycemic index mediterranean diet
5265562|NCT02356952|Low Glycemic Index Diet|low glycemic index diet
5265564|NCT02356926|Adverse events|adverse events
5265955|NCT02354508|GH|gh
5265956|NCT02354508|IGF-1|igf-1
5265957|NCT02354508|pasireotide LAR|pasireotide lar
5265958|NCT02354508|SOM230|som230
5265959|NCT02354508|first generation|first generation
5266163|NCT02353416|Low-Glycemic Index|low-glycemic index
5266164|NCT02353416|AGEs|ages
5266165|NCT02353403|Fructo-oligosaccharides|fructo-oligosaccharides
5266166|NCT02353403|Sugar-reduced foods|sugar-reduced foods
5266167|NCT02353403|Postprandial glucose response|postprandial glucose response
5266168|NCT02353390|presyncope|presyncope
5266169|NCT02353390|syncope|syncope
5266170|NCT02353390|adolescent|adolescent
5266171|NCT02353390|young adult|young adult
5266172|NCT02353390|immunization|immunization
5266173|NCT02353390|vaccination|vaccination
5266174|NCT02353390|water consumption|water consumption
5266175|NCT02353364|Advanced maternal age|advanced maternal age
5266176|NCT02353364|Aneuploidy|aneuploidy
5266177|NCT02353325|Iron deficiency|iron deficiency
5266178|NCT02353325|Iron fortification|iron fortification
5266358|NCT02352168|allergic rhinitis；airway inflammation；hyperreactivity|allergic rhinitis；airway inflammation；hyperreactivity
5266359|NCT02352155|haemostasis|haemostasis
5266381|NCT02352090|Dienogest|dienogest
5266550|NCT02350920|Crohn's disease|crohn's disease
5266551|NCT02350920|ulcerative colitis|ulcerative colitis
5266553|NCT02350907|antimicrobial resistance|antimicrobial resistance
5267350|NCT02346383|postlaminectomy pain syndrome|postlaminectomy pain syndrome
5267351|NCT02346370|Recurrent, previously treated, locally advanced or metastatic NSCLC (non small cell lung cancer)|recurrent, previously treated, locally advanced or metastatic nsclc (non small cell lung cancer)
5267352|NCT02346357|hip arthroscopy|hip arthroscopy
5267449|NCT02345928|Safety|safety
5267450|NCT02345928|Efficacy|efficacy
5267451|NCT02345928|CNTO 7160|cnto 7160
5267452|NCT02345928|Healthy|healthy
5267453|NCT02345928|Asthma|asthma
5267454|NCT02345928|Atopic Dermatitis|atopic dermatitis
5267456|NCT02345863|CLL|cll
5267461|NCT02345824|CDK4/6 Inhibitor|cdk4/6 inhibitor
5267752|NCT02344368|Injections, Intravenous|injections, intravenous
5267757|NCT02344290|HIV|hiv
5267851|NCT02343536|Oral Azacitidine (CC-486)|oral azacitidine (cc-486)
5268169|NCT02341872|QLF|qlf
5268348|NCT02341040|food allergy|food allergy
5268349|NCT02341040|pediatric|pediatric
5268356|NCT02341014|Carfilzomib|carfilzomib
5268357|NCT02341014|Romidepsin|romidepsin
5268358|NCT02341014|Lenalidomide|lenalidomide
5268359|NCT02341014|Lymphomas|lymphomas
5268360|NCT02341014|14-179|14-179
5268652|NCT02339090|Long Acting Recombinant Growth Hormone|long acting recombinant growth hormone
5268653|NCT02339090|Long Acting Growth Hormone|long acting growth hormone
5268654|NCT02339090|Pediatric Growth Hormone Deficiency|pediatric growth hormone deficiency
5268655|NCT02339090|Growth Hormone Replacement Therapy|growth hormone replacement therapy
5268747|NCT02338687|Hypertension, Pregnancy-Induced|hypertension, pregnancy-induced
5268748|NCT02338687|Pre-Eclampsia|pre-eclampsia
5268749|NCT02338687|Nutritional education|nutritional education
5268750|NCT02338687|Diet therapy|diet therapy
5268751|NCT02338687|Diet records|diet records
5268867|NCT02337829|SLL|sll
5268947|NCT02337322|AIDS|aids
5269046|NCT02336724|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5269047|NCT02336724|famitinib|famitinib
5269048|NCT02336698|Osteoarthritis|osteoarthritis
5269049|NCT02336698|Pain|pain
5269050|NCT02336698|Fulranumab|fulranumab
5269051|NCT02336698|JNJ-42160443|jnj-42160443
5269052|NCT02336698|Monotherapy|monotherapy
5269053|NCT02336698|Hip|hip
5269054|NCT02336698|Knee|knee
5269055|NCT02336698|Joint replacement surgery|joint replacement surgery
5269056|NCT02336685|Osteoarthritis|osteoarthritis
5269144|NCT02336074|Primary infection|primary infection
5269145|NCT02336074|Reservoir|reservoir
5269146|NCT02336074|Vorinostat|vorinostat
5269147|NCT02336074|HDAC|hdac
5269148|NCT02336022|general anesthesia|general anesthesia
5269215|NCT02335424|PD1|pd1
5269251|NCT02335294|Pain|pain
5269850|NCT02331719|ICH|ich
5270341|NCT02328664|Endoscopic resection|endoscopic resection
5270342|NCT02328664|Pathology|pathology
5270343|NCT02328664|Rescue surgery|rescue surgery
5270346|NCT02328625|Scleroderma|scleroderma
5270440|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide
5270441|NCT02328118|Vitrectomy|vitrectomy
5270443|NCT02328079|Facial Palsy (acute), Acyclovir, Prednisolone|facial palsy (acute), acyclovir, prednisolone
5270444|NCT02328066|NBI|nbi
5270458|NCT02328014|Btk|btk
5270638|NCT02327182|Dementia|dementia
5270639|NCT02327182|Central Nervous System Agents|central nervous system agents
5270641|NCT02327156|Dexmedetomidine|dexmedetomidine
5270642|NCT02327104|mindfulness|mindfulness
5270643|NCT02327104|tobacco dependence|tobacco dependence
5270644|NCT02327104|relapse prevention|relapse prevention
5270645|NCT02327091|Alfacalcidol|alfacalcidol
5270646|NCT02327091|Falls|falls
5270647|NCT02327091|Handgrip|handgrip
5270832|NCT02325999|Endoscopic Submucosal Dissection|endoscopic submucosal dissection
5270833|NCT02325999|Laparoscopic Regional Lymph node Dissection|laparoscopic regional lymph node dissection
5270836|NCT02325986|radiotherapy|radiotherapy
5271124|NCT02324660|respiratory health screening questionnaire|respiratory health screening questionnaire
5271125|NCT02324647|Urinary steroid profiling|urinary steroid profiling
5271126|NCT02324647|Adrenal incidentaloma|adrenal incidentaloma
5271127|NCT02324647|Adrenocortical carcinoma|adrenocortical carcinoma
5271128|NCT02324647|cost-effectiveness|cost-effectiveness
5271129|NCT02324621|protocol specific|protocol specific
5271130|NCT02324595|Ovarian Cancer|ovarian cancer
5271131|NCT02324595|Laparoscopy|laparoscopy
5271334|NCT02323438|tobacco|tobacco
5271517|NCT02322489|pain|pain
5271518|NCT02322489|flexibility|flexibility
5271519|NCT02322463|patients who were admitted to the pediatric ED|patients who were admitted to the pediatric ed
5271520|NCT02322411|Stroke|stroke
5271829|NCT02321072|oxygen|oxygen
5272034|NCT02319850|muscle|muscle
5272131|NCT02319343|Glucocorticoid|glucocorticoid
5272427|NCT02317614|Mobile intervention|mobile intervention
5272429|NCT02317614|Adherence reinforcement|adherence reinforcement
5272430|NCT02317614|Drug users|drug users
5272631|NCT02316600|elderly|elderly
5272729|NCT02316054|type 2 diabetes mellitus|type 2 diabetes mellitus
5272730|NCT02316054|coronary microvascular disease|coronary microvascular disease
5272731|NCT02316054|coronary artery disease|coronary artery disease
5272928|NCT02315066|gastric cancer|gastric cancer
5272931|NCT02315066|NSCLC|nsclc
5273346|NCT02312739|anxiety|anxiety
5273512|NCT02311686|Ethyl sulphate|ethyl sulphate
5273513|NCT02311686|Pharmacokinetics|pharmacokinetics
5273602|NCT02311166|Hip|hip
5273812|NCT02309996|Administration|administration
5273813|NCT02309996|Return to Work|return to work
5273814|NCT02309996|Industrial Psychology|industrial psychology
5273815|NCT02309996|Human Engineering|human engineering
5274014|NCT02308865|Early palliative care|early palliative care
5274015|NCT02308865|Lung cancer|lung cancer
5274016|NCT02308865|Quality of life|quality of life
5274019|NCT02308839|Aorta|aorta
5274109|NCT02308228|Aging|aging
5274110|NCT02308228|Hypertrophy|hypertrophy
5274111|NCT02308228|Metformin|metformin
5274614|NCT02305732|pathogen inactivation|pathogen inactivation
5274615|NCT02305732|platelets|platelets
5274616|NCT02305732|Puerto Rico|puerto rico
5274617|NCT02305706|insertion|insertion
5274618|NCT02305706|patient comfort|patient comfort
5274619|NCT02305667|Laryngoscope|laryngoscope
5274620|NCT02305667|Macintosh|macintosh
5274621|NCT02305667|Glidescope®|glidescope®
5274622|NCT02305667|King Vision™|king vision™
5274623|NCT02305667|Airtraq®|airtraq®
5274624|NCT02305667|intubation|intubation
5274625|NCT02305667|double lumen tube|double lumen tube
5274626|NCT02305654|Penis cancer|penis cancer
5274627|NCT02305654|Chemotherapy|chemotherapy
5274715|NCT02304978|colorectal cancer|colorectal cancer
5274716|NCT02304978|Tissular factor|tissular factor
5274820|NCT02304328|WFNS|wfns
5274821|NCT02304328|hWFNS|hwfns
5274822|NCT02304328|grading|grading
5274823|NCT02304315|HBV-related liver transplantation|hbv-related liver transplantation
5274830|NCT02304263|tenofovir|tenofovir
5274922|NCT02303626|Hereditary Angioedema|hereditary angioedema
5274923|NCT02303600|Sub-acute cough|sub-acute cough
5274924|NCT02303587|Severe mycoplasma pneumoniae|severe mycoplasma pneumoniae
5274925|NCT02303587|pneumonia|pneumonia
5275212|NCT02302157|AST-OPC1|ast-opc1
5275309|NCT02301624|Myasthenia Gravis|myasthenia gravis
5275310|NCT02301624|safety|safety
5275311|NCT02301624|efficacy|efficacy
5275312|NCT02301598|femtosecond laser|femtosecond laser
5275313|NCT02301598|anterior lamellar keratoplasty|anterior lamellar keratoplasty
5275610|NCT02299739|Complementary Therapies|complementary therapies
5275611|NCT02299739|Liver Function Tests|liver function tests
5275612|NCT02299739|Risk Factors|risk factors
5275613|NCT02299726|acute heart failure|acute heart failure
5275614|NCT02299726|MRA|mra
5275707|NCT02299193|sleep hygiene|sleep hygiene
5275708|NCT02299180|Advanced care planning|advanced care planning
5275709|NCT02299180|End of life care|end of life care
5275710|NCT02299167|Perianal surgery|perianal surgery
5275711|NCT02299167|hyperbaric bupivacaine|hyperbaric bupivacaine
5275712|NCT02299167|saddle block|saddle block
5275713|NCT02299115|Vigabatrin|vigabatrin
5275714|NCT02299115|Prednisolone|prednisolone
5275715|NCT02299102|Aspiration Procedures|aspiration procedures
5275717|NCT02299102|To compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures|to compare powered ported bone marrow aspiration procedures to manual standard bone marrow aspiration procedures
5275718|NCT02299089|acromegaly|acromegaly
5275720|NCT02299089|carcinoid syndrome|carcinoid syndrome
5275994|NCT02297880|low calorie sweetener satiety, intake, hunger|low calorie sweetener satiety, intake, hunger
5276002|NCT02297776|circRNA|circrna
5276185|NCT02296424|Systemic Juvenile Rheumatoid arthritis (SJRA)|systemic juvenile rheumatoid arthritis (sjra)
5276186|NCT02296411|Asthma, Anticholinergics|asthma, anticholinergics
5276188|NCT02296333|Acetaminophen, ondansetron|acetaminophen, ondansetron
5276214|NCT02296294|Bioimpedance Spectroscopy, Body Composition Monitor, Fluid Therapy|bioimpedance spectroscopy, body composition monitor, fluid therapy
5276215|NCT02296268|stroke|stroke
5276216|NCT02296268|aerobic exercise|aerobic exercise
5276217|NCT02296268|screening|screening
5276218|NCT02296268|prescription|prescription
5276219|NCT02296255|cervical cancer screening|cervical cancer screening
5276220|NCT02296255|young women vaccination|young women vaccination
5684674|NCT00559338|Dyspnea|dyspnea
5276221|NCT02296255|impact of HPV vaccination on screening|impact of hpv vaccination on screening
5276222|NCT02296216|have been treated or not treated by Gamma Knife Radiosurgery|have been treated or not treated by gamma knife radiosurgery
5276223|NCT02296203|cetuximab rechallenge|cetuximab rechallenge
5276224|NCT02296177|evidence-based intervention|evidence-based intervention
5276225|NCT02296177|mammography|mammography
5276226|NCT02296177|underserved population|underserved population
5276228|NCT02296164|CTCL|ctcl
5276229|NCT02296164|Mechlorethamine|mechlorethamine
5276230|NCT02296164|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5276231|NCT02296164|Mycosis fungoides cutaneous T-cell lymphoma|mycosis fungoides cutaneous t-cell lymphoma
5276686|NCT02293733|TKI|tki
5276983|NCT02292368|MD Anderson Symptom Inventory - Head & Neck|md anderson symptom inventory - head & neck
5276985|NCT02292368|Questionnaires|questionnaires
5276986|NCT02292368|Surveys|surveys
5276987|NCT02292355|Temporomandibular Joint Disorders|temporomandibular joint disorders
5276988|NCT02292355|posture|posture
5276989|NCT02292355|pain|pain
5276990|NCT02292355|clinical trial|clinical trial
5276991|NCT02292355|Pilates|pilates
5277659|NCT02288754|Solid tumors|solid tumors
5277660|NCT02288741|high-dose chemotherapy|high-dose chemotherapy
5277661|NCT02288741|autologous blood stem-cell transplantation|autologous blood stem-cell transplantation
5277662|NCT02288741|induction chemotherapy|induction chemotherapy
5277663|NCT02288741|elderly patients|elderly patients
5277665|NCT02288728|quality of life|quality of life
5277909|NCT02287116|BPD|bpd
5277951|NCT02286843|PET/CT|pet/ct
5277952|NCT02286843|14-156|14-156
5278456|NCT02283541|Gait|gait
5279050|NCT02280265|ADVATE|advate
5279754|NCT02276768|visceral pain|visceral pain
5279755|NCT02276768|pain intensity|pain intensity
5279757|NCT02276768|distender|distender
5279758|NCT02276768|VAS (Visual Analog Scale)|vas (visual analog scale)
5279759|NCT02276768|rectal sensory threshold|rectal sensory threshold
5279760|NCT02276768|analgesia|analgesia
5279761|NCT02276768|trimebutine|trimebutine
5279763|NCT02276768|peripheral|peripheral
5279850|NCT02275897|Speed of Injection|speed of injection
5279851|NCT02275897|Spinal Anaesthesia|spinal anaesthesia
5280001|NCT02274974|cs|cs
5280244|NCT02273648|national|national
5280834|NCT02270125|Raman microspectroscopy|raman microspectroscopy
5280835|NCT02270125|nasal polyposis|nasal polyposis
5280836|NCT02270112|atrial fibrillation|atrial fibrillation
5662533|NCT00653380|fasting|fasting
5280837|NCT02270112|atrial electrophysiology|atrial electrophysiology
5280838|NCT02270112|stroke|stroke
5280842|NCT02270073|Mindfulness|mindfulness
5280995|NCT02269306|AMH|amh
5281139|NCT02268617|Walking|walking
5281709|NCT02265237|Hepatitis C Genotype 4|hepatitis c genotype 4
5281710|NCT02265237|Chronic Hepatitis C|chronic hepatitis c
5281711|NCT02265198|Pulmonary Contusion|pulmonary contusion
5281713|NCT02265198|Respiratory Failure|respiratory failure
5281714|NCT02265172|Physiotherapy|physiotherapy
5281715|NCT02265172|Orthopaedic|orthopaedic
5281716|NCT02265172|Primary care|primary care
5281717|NCT02265146|Lipid Core Plaques (LCPs)|lipid core plaques (lcps)
5281802|NCT02264704|Neurotrophin|neurotrophin
5282829|NCT02258191|NIV|niv
5282994|NCT02257398|TQTc|tqtc
5282995|NCT02257398|Moxifloxacin|moxifloxacin
5282996|NCT02257398|GSK2140944|gsk2140944
5283992|NCT02251834|diet|diet
5284087|NCT02251405|Melamine tableware|melamine tableware
5284106|NCT02251275|ADPKD|adpkd
5284568|NCT02248688|Obesity|obesity
5284669|NCT02248285|PCR|pcr
5284875|NCT02247401|HCV|hcv
5285414|NCT02245061|TMS|tms
5285450|NCT02244892|Corneal haze|corneal haze
5285451|NCT02244892|Scheimpflug densitometry|scheimpflug densitometry
5285452|NCT02244892|Contrast sensitivity|contrast sensitivity
5285453|NCT02244879|resveratrol|resveratrol
5285454|NCT02244879|type 2 diabetes mellitus|type 2 diabetes mellitus
5285455|NCT02244879|inflammation|inflammation
5285456|NCT02244879|insulin resistance|insulin resistance
5285457|NCT02244879|body composition|body composition
5285458|NCT02244879|bone mass|bone mass
5010122|NCT03933410|Glycan|glycan
5285460|NCT02244866|LH supplementation|lh supplementation
5285461|NCT02244866|ovarian stimulation|ovarian stimulation
5285462|NCT02244866|poor responder|poor responder
5286051|NCT02241837|myocardial infarction|myocardial infarction
5286052|NCT02241824|Lumbar Orthosis|lumbar orthosis
5286053|NCT02241824|Lumbar brace|lumbar brace
5286245|NCT02240979|echocardiography|echocardiography
5286246|NCT02240979|intrinsic frequency measures of cardiac function|intrinsic frequency measures of cardiac function
5286247|NCT02240966|Testicular Neoplasms|testicular neoplasms
5286249|NCT02240966|Metabolic Syndrome|metabolic syndrome
5286250|NCT02240966|Treatment related late effects|treatment related late effects
5286641|NCT02239016|Sickle cell disease|sickle cell disease
5286642|NCT02239016|Hgb SS|hgb ss
5286643|NCT02239016|Hgb SC|hgb sc
5286644|NCT02239016|Sβ-Thalassemia|sβ-thalassemia
5286645|NCT02238977|depression|depression
5287651|NCT02234466|Clinically significant Nausea and Vomiting|clinically significant nausea and vomiting
5287652|NCT02234466|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5287654|NCT02234453|chemotherapy|chemotherapy
5287655|NCT02234453|home|home
5287656|NCT02234453|blood count|blood count
5287752|NCT02233946|Drugs|drugs
5287753|NCT02233933|radiation proctitis|radiation proctitis
5287754|NCT02233933|bleeding|bleeding
5287755|NCT02233933|therapy|therapy
5288062|NCT02232451|loop|loop
5288150|NCT02232074|Healthcare Disparities|healthcare disparities
5288151|NCT02232061|multiple sclerosis, fingolimod,|multiple sclerosis, fingolimod,
5288152|NCT02232035|diazepam|diazepam
5288153|NCT02232035|active phase|active phase
5288657|NCT02229981|Epstein-Barr Virus|epstein-barr virus
5288658|NCT02229981|EBV|ebv
5288955|NCT02228759|Postoperative pain|postoperative pain
5288956|NCT02228759|total knee arthroplasty|total knee arthroplasty
5288958|NCT02228759|Fast track arthroplasty|fast track arthroplasty
5289550|NCT02226055|North Central Province|north central province
5289551|NCT02226029|MRI, fat fraction, stomach, lipid emulsion|mri, fat fraction, stomach, lipid emulsion
5289553|NCT02226016|blepharochalasis|blepharochalasis
5290054|NCT02223988|Patients|patients
5290055|NCT02223988|mechanical|mechanical
5290056|NCT02223988|ventilation|ventilation
5290057|NCT02223988|tracheostomy|tracheostomy
5290058|NCT02223975|Spectrum Analysis, vibrational|spectrum analysis, vibrational
5290059|NCT02223975|Spectrum Analysis, infrared|spectrum analysis, infrared
5290063|NCT02223975|Raman probe|raman probe
5290152|NCT02223533|wound catheter infusion|wound catheter infusion
5290153|NCT02223533|laparoscopic colon surgery|laparoscopic colon surgery
5290154|NCT02223520|Staphylococcus aureus|staphylococcus aureus
5290661|NCT02221232|Zurex Pharma|zurex pharma
5290662|NCT02221232|Surgical/Patient preoperative skin preparation|surgical/patient preoperative skin preparation
5290767|NCT02220829|symptomatic urinary problems|symptomatic urinary problems
5290768|NCT02220829|radiation therapy|radiation therapy
5290769|NCT02220829|prostate cancer|prostate cancer
5290770|NCT02220816|Attention|attention
5290771|NCT02220816|Competitive|competitive
5290970|NCT02219984|dabigatran|dabigatran
5291069|NCT02219503|Interferon-Free|interferon-free
5291070|NCT02219503|Child Pugh A|child pugh a
5291071|NCT02219503|Ribavirin-Free|ribavirin-free
5291363|NCT02218294|ADME|adme
5291664|NCT02216929|cancer|cancer
5291665|NCT02216929|terminal care|terminal care
5291666|NCT02216929|APACHE|apache
5291667|NCT02216903|Atrial fibrillation, sleep apnea|atrial fibrillation, sleep apnea
5291673|NCT02216890|CD70 Antigen|cd70 antigen
5291868|NCT02216110|Survival|survival
5292058|NCT02214810|exparel|exparel
5292202|NCT02214212|TBI|tbi
5292253|NCT02214030|arterial hemostasis|arterial hemostasis
5292256|NCT02214017|diabetes|diabetes
5292449|NCT02213341|Milk Allergy|milk allergy
5292450|NCT02213341|Egg Allergy|egg allergy
5293165|NCT02209597|MDD|mdd
5293442|NCT02208388|Fractional flow reserve|fractional flow reserve
5293444|NCT02208362|glioblastoma|glioblastoma
5293537|NCT02207972|Epidural|epidural
5293538|NCT02207959|Gastric cancer|gastric cancer
5293637|NCT02207478|Transbronchial lung biopsy|transbronchial lung biopsy
5293638|NCT02207478|Peripheral lung lesions|peripheral lung lesions
5294142|NCT02205203|Social Anxiety|social anxiety
5294143|NCT02205203|Social Phobia|social phobia
5294144|NCT02205203|Separation Anxiety|separation anxiety
5294145|NCT02205203|Generalized Anxiety|generalized anxiety
5294146|NCT02205203|GAD|gad
5294151|NCT02205203|OCD|ocd
5294441|NCT02203799|Peanut Allergy|peanut allergy
5294442|NCT02203799|Anaphylaxis|anaphylaxis
5294443|NCT02203799|Desensitization|desensitization
5294444|NCT02203799|Food Allergy|food allergy
5294445|NCT02203799|Oral Immunotherapy|oral immunotherapy
5294845|NCT02201940|Velpatasvir|velpatasvir
5294846|NCT02201940|Hepatitis C|hepatitis c
5295046|NCT02201264|Stent|stent
5295051|NCT02201212|TSC1|tsc1
5295052|NCT02201212|TSC2|tsc2
5295054|NCT02201212|MTOR|mtor
5295141|NCT02200731|Childhood cancer survivors|childhood cancer survivors
5295142|NCT02200731|Cogntive Behavioural|cogntive behavioural
5295143|NCT02200731|Manualized|manualized
5295154|NCT02200679|Screen|screen
5295241|NCT02200289|Oxidative stress|oxidative stress
5295242|NCT02200289|Lung development|lung development
5295244|NCT02200263|oculocutaneous albinism (OCA)|oculocutaneous albinism (oca)
5296313|NCT02195024|pacemaker leads|pacemaker leads
5296314|NCT02195011|Regorafenib|regorafenib
5296315|NCT02195011|90Y|90y
5296316|NCT02195011|Radioembolization|radioembolization
5296612|NCT02193776|Multi Drug-Resistant Tuberculosis|multi drug-resistant tuberculosis
5296613|NCT02193776|Drug-Sensitive Tuberculosis|drug-sensitive tuberculosis
5296649|NCT02193646|ADR|adr
5296706|NCT02193399|Physiotherapy|physiotherapy
5296707|NCT02193399|Quality of Life|quality of life
5296708|NCT02193399|Cancer|cancer
5296721|NCT02193360|PBC|pbc
5296909|NCT02192450|Hypoglycaemia|hypoglycaemia
5296910|NCT02192450|Glucose Metabolism Disorders|glucose metabolism disorders
5296914|NCT02192450|Insulin|insulin
5297123|NCT02191423|empathy|empathy
5297124|NCT02191410|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
5297125|NCT02191410|one-lung ventilation|one-lung ventilation
5297326|NCT02190604|FEV1- Forced Expiratory volume|fev1- forced expiratory volume
5297327|NCT02190604|LCI - Lung Clearance Index|lci - lung clearance index
5297329|NCT02190604|cystic fibrosis|cystic fibrosis
5297331|NCT02190591|epidural|epidural
5297629|NCT02189486|Prostate biopsy|prostate biopsy
5297630|NCT02189486|Upgrading|upgrading
5297631|NCT02189486|Upgrading Reference set|upgrading reference set
5297640|NCT02189460|Cognition|cognition
5297641|NCT02189447|Keratoconus|keratoconus
5297643|NCT02189447|Corneal Cross-linking|corneal cross-linking
5297644|NCT02189421|peroral cholangioscopy|peroral cholangioscopy
5297730|NCT02189083|Leiomyoma|leiomyoma
5297731|NCT02189083|Medicine, Chinese Traditional|medicine, chinese traditional
5297733|NCT02189070|Follow-up|follow-up
5297832|NCT02188810|TH1 immune response|th1 immune response
5297833|NCT02188797|homeless|homeless
5297834|NCT02188797|young adults|young adults
5297835|NCT02188797|substance use|substance use
5297836|NCT02188797|HIV risk|hiv risk
5298230|NCT02187042|metastatic renal carcinoma|metastatic renal carcinoma
5298231|NCT02187029|Hyperuricemia|hyperuricemia
5298233|NCT02187029|serum uric acid|serum uric acid
5298530|NCT02185846|Fed condition|fed condition
5298531|NCT02185833|Fasting condition|fasting condition
5298532|NCT02185820|Multiple myeloma|multiple myeloma
5298629|NCT02185547|women|women
5298630|NCT02185534|Clopidogrel, Zyllt, Plavix, Phase I, Healthy Subjects, Pharmacokinetics, Bioequivalence|clopidogrel, zyllt, plavix, phase i, healthy subjects, pharmacokinetics, bioequivalence
5298631|NCT02185521|Hemodynamics|hemodynamics
5298632|NCT02185521|Medical Informatics|medical informatics
5298633|NCT02185508|IONM|ionm
5298634|NCT02185508|Lumbar Disk Disease|lumbar disk disease
5298635|NCT02185508|Degenerative Spine Disease|degenerative spine disease
5298636|NCT02185508|Radiculopathy|radiculopathy
5298727|NCT02185157|elderly|elderly
5299021|NCT02183727|ACL|acl
5299118|NCT02181751|Post Traumatic Stress Disorder|post traumatic stress disorder
5299119|NCT02181751|Depression|depression
5299120|NCT02181751|Anxiety|anxiety
5299121|NCT02181751|Quality of Life|quality of life
5299226|NCT02181244|egg|egg
5299227|NCT02181244|oatmeal|oatmeal
5299228|NCT02181244|atherogenic dyslipidemia|atherogenic dyslipidemia
5299229|NCT02181244|glycosylated hemoglobin|glycosylated hemoglobin
5299230|NCT02181244|inflammatory markers|inflammatory markers
5299531|NCT02180204|Cerebral Infarction|cerebral infarction
5299727|NCT02179242|cardiac rehab|cardiac rehab
5299728|NCT02179242|heart failure|heart failure
5299825|NCT02178774|cesarean section|cesarean section
5299826|NCT02178761|Erectile dysfunction|erectile dysfunction
5300240|NCT02176135|HIV|hiv
5300334|NCT02175628|Breast|breast
5301193|NCT02170285|constraint-induced movement therapy|constraint-induced movement therapy
5301588|NCT02168621|Scaling and root planing|scaling and root planing
5301589|NCT02168608|hepatic ischemia reperfusion injury|hepatic ischemia reperfusion injury
5302011|NCT02166502|HIV|hiv
5302168|NCT02165605|breast cancer|breast cancer
5302169|NCT02165592|Hemophilia|hemophilia
5302170|NCT02165592|Arthropathy|arthropathy
5302171|NCT02165592|Range of Motion|range of motion
5302172|NCT02165592|Strength|strength
5302173|NCT02165592|Proprioception|proprioception
5302174|NCT02165592|Gait|gait
5302175|NCT02165592|Quality of Life|quality of life
5302176|NCT02165579|procalcitonin|procalcitonin
5302177|NCT02165579|biomarkers|biomarkers
5302178|NCT02165579|Osteomyelitis|osteomyelitis
5302179|NCT02165579|diabetes|diabetes
5302180|NCT02165579|foot ulcer(s)|foot ulcer(s)
5302181|NCT02165579|Infectious Disease Society of America stage 3 infection|infectious disease society of america stage 3 infection
5302182|NCT02165566|intensive insulin therapy|intensive insulin therapy
5302183|NCT02165566|critical care patients|critical care patients
5302274|NCT02165124|Obesity|obesity
5302275|NCT02165124|Morbid Obesity|morbid obesity
5302276|NCT02165124|Bariatric Surgery|bariatric surgery
5302277|NCT02165124|Embolization|embolization
5302278|NCT02165124|Minimally Invasive|minimally invasive
5302279|NCT02165124|Weight Loss|weight loss
5302332|NCT02164786|NMR|nmr
5302673|NCT02163382|Non Invasive Ventilation|non invasive ventilation
5302674|NCT02163356|neuroblastoma|neuroblastoma
5302783|NCT02162875|adults|adults
5302879|NCT02162550|Endothelial function|endothelial function
5302881|NCT02162550|Atherosclerosis|atherosclerosis
5302882|NCT02162537|Strategy|strategy
5302883|NCT02162537|Radiotherapy|radiotherapy
5302884|NCT02162537|Chemotherapy|chemotherapy
5302885|NCT02162537|Cisplatin|cisplatin
5302886|NCT02162524|aerobic exercise|aerobic exercise
5303477|NCT02159872|MDS|mds
5303478|NCT02159872|Omacetaxine|omacetaxine
5303479|NCT02159872|Synribo|synribo
5303480|NCT02159872|Homoharringtonine|homoharringtonine
5303667|NCT02158936|MDS|mds
5303768|NCT02158533|Major Depressive Disorder|major depressive disorder
5303770|NCT02158533|Alkermes|alkermes
5303771|NCT02158533|ALKS 5461|alks 5461
5303772|NCT02158533|Samidorphan|samidorphan
5303773|NCT02158507|metastatic|metastatic
5303774|NCT02158507|triple negative breast cancer (TNBC)|triple negative breast cancer (tnbc)
5303775|NCT02158507|Veliparib|veliparib
5303776|NCT02158507|Lapatinib|lapatinib
5304062|NCT02157103|GBM|gbm
5304148|NCT02156635|Acute Stroke|acute stroke
5304150|NCT02156622|Depression|depression
5304151|NCT02156622|Measurement-based care|measurement-based care
5304253|NCT02156089|Reward Processing|reward processing
5304254|NCT02156089|Nutrition|nutrition
5304255|NCT02156089|Omega-3 Fatty Acids|omega-3 fatty acids
5304256|NCT02156089|ADHD|adhd
5304259|NCT02156063|Miscarriage|miscarriage
5304442|NCT02155270|Corneal|corneal
5304443|NCT02155270|OCT|oct
5304444|NCT02155270|Intraoperative OCT|intraoperative oct
5304653|NCT02154230|sulphate-bicarbonate-calcium water|sulphate-bicarbonate-calcium water
5304654|NCT02154230|gut microbiota|gut microbiota
5304655|NCT02154230|body composition|body composition
5304656|NCT02154230|bile salts|bile salts
5304657|NCT02154191|Lumbosacral Region|lumbosacral region
5304658|NCT02154191|Sedentary Lifestyle|sedentary lifestyle
5304659|NCT02154191|Surgical Procedure, Operative|surgical procedure, operative
5304660|NCT02154178|empiric antifungal therapy|empiric antifungal therapy
5304661|NCT02154178|biomarkers|biomarkers
5305059|NCT02152319|Tremor|tremor
5305060|NCT02152319|Bradykinesia|bradykinesia
5305069|NCT02152241|IBD|ibd
5305161|NCT02151747|breast neoplasms, BRCA1, Sanger, NGS, Next generation sequencing|breast neoplasms, brca1, sanger, ngs, next generation sequencing
5305650|NCT02149498|EEG|eeg
5305849|NCT02148471|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5305850|NCT02148458|Intermittent fasting|intermittent fasting
5305851|NCT02148458|Mediterranean diet|mediterranean diet
5305860|NCT02148419|neglect|neglect
5305946|NCT02148094|India|india
5306048|NCT02147834|deferred percutaneous coronary intervention|deferred percutaneous coronary intervention
5306049|NCT02147834|fractional flow reserve|fractional flow reserve
5306256|NCT02146833|KPT-330|kpt-330
5306343|NCT02146300|exposure|exposure
5306344|NCT02146287|cycled light|cycled light
5306345|NCT02146287|preterm infants|preterm infants
5306346|NCT02146287|infant neurodevelopment|infant neurodevelopment
5306347|NCT02146287|infant sleep|infant sleep
5306348|NCT02146274|PROSPER|prosper
5306536|NCT02145455|Arthroplasty, Replacement, Knee/methods|arthroplasty, replacement, knee/methods
5306537|NCT02145455|Knee Joint/physiopathology|knee joint/physiopathology
5306933|NCT02143817|whole body vibration training|whole body vibration training
5306934|NCT02143817|L-citrulline|l-citrulline
5306935|NCT02143817|hypertension|hypertension
5306937|NCT02143817|arterial function|arterial function
5306938|NCT02143817|arterial stiffness|arterial stiffness
5306939|NCT02143817|autonomic function|autonomic function
5306940|NCT02143817|endothelial function|endothelial function
5306941|NCT02143804|Oncolytic virus|oncolytic virus
5306942|NCT02143804|GMCSF|gmcsf
5306943|NCT02143804|pRb|prb
5306944|NCT02143804|PDL1|pdl1
5306945|NCT02143804|Immunotherapy|immunotherapy
5306946|NCT02143804|Adenovirus|adenovirus
5307038|NCT02143453|exercise|exercise
5307144|NCT02142894|TB|tb
5307337|NCT02141932|Ultrasound|ultrasound
5307533|NCT02140905|Fluids|fluids
5307633|NCT02140450|intraocular pressure, intravitreal injection, short term|intraocular pressure, intravitreal injection, short term
5307634|NCT02140437|Fulvestrant|fulvestrant
5307934|NCT02138981|Hepatocellular Carcinoma|hepatocellular carcinoma
5307935|NCT02138981|Milan Criteria|milan criteria
5307936|NCT02138968|Pre-frailty|pre-frailty
5307937|NCT02138968|Frail|frail
5307938|NCT02138968|Exercise|exercise
5307939|NCT02138968|Nutritional assessment|nutritional assessment
5307940|NCT02138968|Functional capacity|functional capacity
5307941|NCT02138942|automated vascular filling|automated vascular filling
5307942|NCT02138942|Learning Intravenous Resuscitator (LIR)|learning intravenous resuscitator (lir)
5307943|NCT02138942|General Surgery|general surgery
5307944|NCT02138942|Fluid Therapy|fluid therapy
5307945|NCT02138929|Esophageal Cancer|esophageal cancer
5307948|NCT02138929|GEJ|gej
5307966|NCT02138890|APS|aps
5308228|NCT02137785|Actinic Keratosis|actinic keratosis
5308324|NCT02137317|Developing countries|developing countries
5308326|NCT02137304|cough help|cough help
5308327|NCT02137304|in-exsufflation|in-exsufflation
5308328|NCT02137304|neuromuscular disease|neuromuscular disease
5308920|NCT02134275|whole body vibration training|whole body vibration training
5308922|NCT02134275|weight gain|weight gain
5308923|NCT02134275|obesity|obesity
5308924|NCT02134275|randomized clinical trial|randomized clinical trial
5308931|NCT02134262|Lymphoma|lymphoma
5309018|NCT02133989|Clopidogrel resistance|clopidogrel resistance
5309019|NCT02133989|Stroke, ischemic|stroke, ischemic
5309114|NCT02133573|cardiac surgery|cardiac surgery
5309115|NCT02133573|neurodevelopmental disability|neurodevelopmental disability
5309116|NCT02133573|fetus|fetus
5309117|NCT02133573|fetal neuroprotection|fetal neuroprotection
5309216|NCT02133092|Respiratory syncytial virus|respiratory syncytial virus
5309218|NCT02133092|Lower respiratory tract infection|lower respiratory tract infection
5309219|NCT02133092|LRTI|lrti
5310110|NCT02129309|agonist|agonist
5310111|NCT02129309|antagonist|antagonist
5310112|NCT02129296|Morbid obesity|morbid obesity
5310309|NCT02128399|antimicrobial stewardship|antimicrobial stewardship
5310310|NCT02128360|Low ovarian reserve|low ovarian reserve
5310312|NCT02128360|Infertility|infertility
5310402|NCT02127918|Antiepileptic drugs|antiepileptic drugs
5310403|NCT02127918|Clobazam|clobazam
5310404|NCT02127918|Seizures|seizures
5310407|NCT02127905|BMT|bmt
5311477|NCT02122835|exercise|exercise
5311478|NCT02122835|aerobic exercise|aerobic exercise
5311982|NCT02120521|Sepsis and SIRS, ICU|sepsis and sirs, icu
5311983|NCT02120508|stroke|stroke
5311984|NCT02120508|aphasia|aphasia
5311985|NCT02120508|rTMS|rtms
5311986|NCT02120508|Functional MRI|functional mri
5311987|NCT02120508|Speech training|speech training
5311988|NCT02120495|condylectomy|condylectomy
5311989|NCT02120495|TMJ function|tmj function
5311990|NCT02120495|intraoral approach|intraoral approach
5311991|NCT02120482|ABO isoagglutinins|abo isoagglutinins
5311992|NCT02120482|ABO incompatible transplantation|abo incompatible transplantation
5311993|NCT02120482|immunoadsorption|immunoadsorption
5311994|NCT02120482|membrane filtration|membrane filtration
5311995|NCT02120482|plasmapheresis|plasmapheresis
5311996|NCT02120443|infiltration|infiltration
5311997|NCT02120443|extravasation|extravasation
5311998|NCT02120443|peripheral intravenous therapy|peripheral intravenous therapy
5311999|NCT02120430|Early childhood|early childhood
5312000|NCT02120430|Audiovisual materials|audiovisual materials
5312003|NCT02120430|Timing|timing
5312174|NCT02119832|Hemodialysis|hemodialysis
5312175|NCT02119832|Vascular access|vascular access
5312176|NCT02119819|Weight loss|weight loss
5312177|NCT02119806|cardiac surgery, benzodiazepines, delirium|cardiac surgery, benzodiazepines, delirium
5312573|NCT02118038|Emotional impact|emotional impact
5312577|NCT02118012|Chlorcyclizine HCL|chlorcyclizine hcl
5312879|NCT02116699|ventilator-associated pneumonia|ventilator-associated pneumonia
5312880|NCT02116699|breastmilk|breastmilk
5312881|NCT02116699|human milk|human milk
5312882|NCT02116699|late-onset sepsis|late-onset sepsis
5312883|NCT02116699|microbiome|microbiome
5312884|NCT02116699|antioxidant|antioxidant
5313360|NCT02114593|Parent support program|parent support program
5313361|NCT02114593|Somali families|somali families
5313362|NCT02114593|Sweden|sweden
5313383|NCT02114502|MM|mm
5313470|NCT02114281|Saliva|saliva
5313858|NCT02112877|venous|venous
5314048|NCT02112071|vascular function|vascular function
5314049|NCT02112071|physical function|physical function
5314050|NCT02112032|melanoma|melanoma
5314051|NCT02112032|advanced|advanced
5314189|NCT02111551|P50|p50
5314250|NCT02111278|Lumbar|lumbar
5314893|NCT02108392|PXE|pxe
5314945|NCT02108132|mesenchymal stem cells|mesenchymal stem cells
5314946|NCT02108132|in-vitro transdifferentiation|in-vitro transdifferentiation
5315329|NCT02106702|HIV|hiv
5315361|NCT02106598|13-249|13-249
5315362|NCT02106585|Safety|safety
5315363|NCT02106585|Tolerability|tolerability
5315364|NCT02106585|Pharmacokinetics|pharmacokinetics
5315365|NCT02106585|Food-effect|food-effect
5315366|NCT02106585|Diabetes|diabetes
5315367|NCT02106572|superficial bladder cancer|superficial bladder cancer
5315368|NCT02106572|viscum album extract|viscum album extract
5315369|NCT02106572|mistletoe extract|mistletoe extract
5315370|NCT02106572|abnobaVISCUM|abnobaviscum
5315371|NCT02106572|recurrence rate|recurrence rate
5315372|NCT02106559|Pleural Photodynamic Therapy|pleural photodynamic therapy
5315461|NCT02106130|oral administration|oral administration
5315462|NCT02106130|healthy male subjects|healthy male subjects
5315463|NCT02106104|Type 2 diabetes mellitus|type 2 diabetes mellitus
5315464|NCT02106104|Diabetic kidney disease|diabetic kidney disease
5315854|NCT02104492|quality of life|quality of life
5315855|NCT02104492|qualitative research|qualitative research
5315856|NCT02104466|acupuncture|acupuncture
5316267|NCT02102529|pain|pain
5317092|NCT02098837|HIV|hiv
5317564|NCT02096588|Statin|statin
5318452|NCT02092480|Process evaluation|process evaluation
5318453|NCT02092480|Economic costing|economic costing
5318454|NCT02092467|Post-marketing|post-marketing
5318455|NCT02092467|Phase 4|phase 4
5318456|NCT02092467|Open-label|open-label
5318457|NCT02092467|Safety Surveillance|safety surveillance
5018119|NCT03883542|serous|serous
5318555|NCT02091986|asthma, children, budesonide pMDI|asthma, children, budesonide pmdi
5318556|NCT02091973|everolimus|everolimus
5318557|NCT02091973|tacrolimus|tacrolimus
5318558|NCT02091973|kidney transplantation|kidney transplantation
5318840|NCT02090699|magnetic resonance imaging|magnetic resonance imaging
5319236|NCT02088723|Patient Positioning|patient positioning
5319237|NCT02088710|Patients´ Expectations|patients´ expectations
5319240|NCT02088710|Nocebo|nocebo
5319333|NCT02088177|Cannabis Dependence|cannabis dependence
5319334|NCT02088177|Cannabis Use Disorder|cannabis use disorder
5319335|NCT02088177|Marijuana|marijuana
5319336|NCT02088177|Naltrexone|naltrexone
5319434|NCT02087618|Non-Pharmacological Intervention|non-pharmacological intervention
5319554|NCT02086890|microcurrent|microcurrent
5319827|NCT02085538|AUC|auc
5320047|NCT02084576|OCT|oct
5320209|NCT02083861|ultrasound|ultrasound
5320210|NCT02083861|pain|pain
5320211|NCT02083861|mobility|mobility
5320212|NCT02083861|heat|heat
5320214|NCT02083861|ZetrOZ|zetroz
5320307|NCT02083445|Traumatic brain injury|traumatic brain injury
5320308|NCT02083445|Exercise|exercise
5320309|NCT02083445|Psychology|psychology
5320310|NCT02083445|Physiology|physiology
5320311|NCT02083445|Progenitor cells|progenitor cells
5320312|NCT02083445|Hypoxia|hypoxia
5320313|NCT02083432|intra-oral injections|intra-oral injections
5320314|NCT02083432|CBT|cbt
5320315|NCT02083432|Blood-Injury-Injection-phobia|blood-injury-injection-phobia
5320316|NCT02083432|DSM-IV. 300.29|dsm-iv. 300.29
5320507|NCT02082587|brain metastases|brain metastases
5320508|NCT02082587|brain mets|brain mets
5320509|NCT02082587|WBRT|wbrt
5320510|NCT02082561|transdiagnostic treatment|transdiagnostic treatment
5320511|NCT02082561|cognitive behavior therapy|cognitive behavior therapy
5320606|NCT02082184|Sensing Technology|sensing technology
5320607|NCT02082184|Type 2 Diabetes,|type 2 diabetes,
5320609|NCT02082171|physical disability|physical disability
5321010|NCT02080364|Alzheimer's disease|alzheimer's disease
5321011|NCT02080364|RAGE|rage
5321012|NCT02080364|ADAS-cog|adas-cog
5321129|NCT02079727|Knee OA|knee oa
5321310|NCT02078882|Primary Biliary Cirrhosis|primary biliary cirrhosis
5321311|NCT02078882|Ursodeoxycholic acid|ursodeoxycholic acid
5321312|NCT02078882|Abatacept|abatacept
5321313|NCT02078882|Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4)|cytotoxic t-lymphocyte antigen 4 (ctla-4)
5321707|NCT02077010|inhaled|inhaled
5321799|NCT02076698|Anterior Nucleus of thalamus|anterior nucleus of thalamus
5321800|NCT02076698|Treatment refractory|treatment refractory
5321801|NCT02076698|Pharmacoresistant partial epilepsy|pharmacoresistant partial epilepsy
5321811|NCT02076659|F8|f8
5321900|NCT02076282|MRI|mri
5322098|NCT02075489|EMG|emg
5322099|NCT02075489|fatigue relief|fatigue relief
5322100|NCT02075489|veterans|veterans
5322101|NCT02075476|Fracture-luxation|fracture-luxation
5322103|NCT02075476|Hemiarthroplasty|hemiarthroplasty
5322194|NCT02075086|plasma cytokines|plasma cytokines
5322195|NCT02075086|Colon cancer|colon cancer
5322196|NCT02075073|Pharmacokinetics|pharmacokinetics
5322292|NCT02074761|SI joint|si joint
5322293|NCT02074761|SIJ|sij
5322294|NCT02074748|Bunion|bunion
5322295|NCT02074748|Foot Arch|foot arch
5322296|NCT02074748|Instability|instability
5322297|NCT02074735|alcohol dependence|alcohol dependence
5322298|NCT02074735|alcohol abuse|alcohol abuse
5322415|NCT02074176|mRNA|mrna
5322882|NCT02071849|Aortic Insufficiency|aortic insufficiency
5322883|NCT02071849|Aortic Regurgitation|aortic regurgitation
5322884|NCT02071836|web application|web application
5323185|NCT02070328|Proton Therapy|proton therapy
5323186|NCT02070328|Registry|registry
5323190|NCT02070289|Multiple dose|multiple dose
5323978|NCT02066558|Headache|headache
5323979|NCT02066558|Migraine|migraine
5324176|NCT02065674|type II Diabetes mellitus|type ii diabetes mellitus
5324385|NCT02064842|TMC435|tmc435
5324386|NCT02064842|Simeprevir|simeprevir
5324690|NCT02063464|Monocytes|monocytes
5324691|NCT02063464|Interferons Alpha and Gamma|interferons alpha and gamma
5324692|NCT02063451|Obesity [C18.654.726.500]|obesity [c18.654.726.500]
5324720|NCT02063334|men|men
5324789|NCT02062931|Primary Amenorrhea|primary amenorrhea
5324790|NCT02062931|Sex Steroid Deficiency|sex steroid deficiency
5324791|NCT02062931|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
5325085|NCT02061709|Allergy|allergy
5325086|NCT02061696|Coronary Artery Disease|coronary artery disease
5325087|NCT02061696|Coronary Disease|coronary disease
5325088|NCT02061696|Heart disease|heart disease
5325089|NCT02061696|Cardiovascular Diseases|cardiovascular diseases
5325090|NCT02061696|Arteriosclerosis|arteriosclerosis
5325187|NCT02061254|Dermis|dermis
5325188|NCT02061254|Hypodermis|hypodermis
5325189|NCT02061254|Skin|skin
5325190|NCT02061241|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5325191|NCT02061241|Pacing|pacing
5325192|NCT02061215|CYTOF|cytof
5325193|NCT02061215|CMV|cmv
5325194|NCT02061215|PCR|pcr
5325195|NCT02061215|HLA|hla
5325196|NCT02061202|Sickle Cell Disease|sickle cell disease
5685492|NCT00555867|Postmenopausal women|postmenopausal women
5325282|NCT02060812|ultrasound guided suprascapular nerve block|ultrasound guided suprascapular nerve block
5325283|NCT02060812|rebound phenomenon of pain|rebound phenomenon of pain
5325285|NCT02060799|Emergency Service, Hospital|emergency service, hospital
5325287|NCT02060799|Fatal Outcome|fatal outcome
5325288|NCT02060799|Epidemiology|epidemiology
5325289|NCT02060786|Antiplatelet; clopidogrel; acute coronary syndrome|antiplatelet; clopidogrel; acute coronary syndrome
5325290|NCT02060773|Septic shock|septic shock
5325291|NCT02060773|Early goal directed therapy|early goal directed therapy
5325292|NCT02060773|Fluid resuscitation|fluid resuscitation
5325293|NCT02060773|Hepatic perfusion|hepatic perfusion
5325294|NCT02060773|Indocyanine Green|indocyanine green
5325349|NCT02060513|KPC|kpc
5325576|NCT02059551|magnetic resonance imaging|magnetic resonance imaging
5325577|NCT02059551|venous ultrasonography of the legs|venous ultrasonography of the legs
5325578|NCT02059551|diagnostic performances|diagnostic performances
5326065|NCT02057185|job|job
5326464|NCT02055573|Early Literacy|early literacy
5326465|NCT02055573|Parental Education|parental education
5326467|NCT02055560|colorectal|colorectal
5326468|NCT02055560|OnDose|ondose
5326570|NCT02055118|iduronate sulfatase|iduronate sulfatase
5326571|NCT02055118|MPS society|mps society
5327157|NCT02052414|safety|safety
5327349|NCT02051634|Inflammation|inflammation
5327350|NCT02051634|Phytochemicals|phytochemicals
5327351|NCT02051634|Physical function|physical function
5327352|NCT02051634|Quality of life|quality of life
5327353|NCT02051634|Fatigue|fatigue
5327354|NCT02051634|Health|health
5327355|NCT02051621|pulmonary vein isolation|pulmonary vein isolation
5327452|NCT02051140|Learning|learning
5327453|NCT02051140|Memory|memory
5327454|NCT02051140|Antioxidants|antioxidants
5327455|NCT02051140|Anti-Inflammatory Agents|anti-inflammatory agents
5327456|NCT02051140|Brain|brain
5327748|NCT02049892|2-5 years after surgery|2-5 years after surgery
5327749|NCT02049892|Asymptomatic|asymptomatic
5327750|NCT02049866|osteoporosis|osteoporosis
5327751|NCT02049866|premenopausal|premenopausal
5327971|NCT02048930|DPI|dpi
5328145|NCT02048098|Labor, Induced|labor, induced
5328146|NCT02048098|Pregnancy Trimester, Second|pregnancy trimester, second
5328147|NCT02048098|Abortion, Induced|abortion, induced
5328148|NCT02048085|ACS|acs
5328149|NCT02048085|STEMI|stemi
5328150|NCT02048085|Fibrinolysis|fibrinolysis
5328151|NCT02048085|Pharmacodynamics|pharmacodynamics
5328152|NCT02048085|Pharmacokinetics|pharmacokinetics
5328153|NCT02048085|Plavix|plavix
5328154|NCT02048085|Brilinta|brilinta
5328155|NCT02048085|Ticagrelor|ticagrelor
5328156|NCT02048085|Clopidogrel|clopidogrel
5328157|NCT02048072|relapsing remitting|relapsing remitting
5328158|NCT02048072|multiple sclerosis|multiple sclerosis
5328159|NCT02048072|fingolimod|fingolimod
5328160|NCT02048072|Gilenya|gilenya
5328161|NCT02048072|autonomic nervous system|autonomic nervous system
5328180|NCT02048046|ECMO|ecmo
5328181|NCT02048046|Nutrition therapy|nutrition therapy
5328182|NCT02048033|Obesity|obesity
5328183|NCT02048033|Endogastric suturing|endogastric suturing
5328184|NCT02048033|Jujenal anastomosis|jujenal anastomosis
5328185|NCT02048033|weight regain|weight regain
5328186|NCT02048007|Childhood mortality|childhood mortality
5328187|NCT02048007|Azithromycin|azithromycin
5328188|NCT02048007|Mass treatment|mass treatment
5328247|NCT02047864|Creatine|creatine
5328248|NCT02047825|Multiple sclerosis|multiple sclerosis
5328352|NCT02047279|Atrial fibrillation|atrial fibrillation
5328353|NCT02047279|Mitral valve|mitral valve
5328354|NCT02047266|MICS CABG OPCABG ONCABG CAD|mics cabg opcabg oncabg cad
5328355|NCT02047253|carfilzomib|carfilzomib
5663134|NCT00651066|HIV|hiv
5328356|NCT02047253|prostate cancer|prostate cancer
5328357|NCT02047253|PSA (prostate-specific antigen)|psa (prostate-specific antigen)
5328358|NCT02047253|CRPC (castration-resistant prostate cancer)|crpc (castration-resistant prostate cancer)
5328359|NCT02047240|liver cirrhosis|liver cirrhosis
5328550|NCT02046408|Mobile health|mobile health
5328551|NCT02046408|behavioral health|behavioral health
5328552|NCT02046395|Type 2 Diabetes|type 2 diabetes
5328553|NCT02046395|Hypertension|hypertension
5328554|NCT02046382|IV Acetaminophen|iv acetaminophen
5328860|NCT02045225|social anxiety in sexual situations|social anxiety in sexual situations
5328861|NCT02045212|Ischemic Optic Neuropathy|ischemic optic neuropathy
5328862|NCT02045212|Traumatic Neuropathy|traumatic neuropathy
5328864|NCT02045199|Diabetic Neuropathies|diabetic neuropathies
5328959|NCT02044731|Family|family
5329267|NCT02043431|Biobank|biobank
5329451|NCT02042781|solid tumours|solid tumours
5329452|NCT02042781|tumor microenvironment|tumor microenvironment
5329458|NCT02042755|cataract|cataract
5329459|NCT02042755|IOL|iol
5329460|NCT02042755|trifocal|trifocal
5329461|NCT02042755|FineVision|finevision
5329462|NCT02042742|Cross-over studies|cross-over studies
5329463|NCT02042742|Antioxidants|antioxidants
5329465|NCT02042742|Punicalagin|punicalagin
5330156|NCT02039609|vegan|vegan
5330157|NCT02039609|omnivore|omnivore
5330158|NCT02039609|Habitual diet|habitual diet
5330159|NCT02039583|live birth|live birth
5330160|NCT02039583|infant|infant
5330161|NCT02039583|infant, newborn|infant, newborn
5330162|NCT02039583|second-hand smoke|second-hand smoke
5330164|NCT02039583|smoke-free|smoke-free
5330165|NCT02039583|smoke-free policy|smoke-free policy
5330166|NCT02039570|haemorrhoids|haemorrhoids
5330167|NCT02039570|pelvic reflux|pelvic reflux
5330168|NCT02039531|Knee|knee
5330169|NCT02039531|osteoarthritis|osteoarthritis
5330362|NCT02038686|Hip fracture|hip fracture
5330467|NCT02038140|Primary Ankle Replacement|primary ankle replacement
5330468|NCT02038140|Total Ankle Arthroplasty|total ankle arthroplasty
5330469|NCT02038140|Total Ankle Replacement|total ankle replacement
5330470|NCT02038140|Trabecular Metal Total Ankle|trabecular metal total ankle
5330471|NCT02038114|Odette Cancer Centre at Sunnybrook Health Sciences Centre|odette cancer centre at sunnybrook health sciences centre
5330472|NCT02038114|Toronto|toronto
5330501|NCT02037997|PFS|pfs
5330671|NCT02037282|Hemagglutination Inhibition Assays|hemagglutination inhibition assays
5330672|NCT02037282|Immunogenicity|immunogenicity
5331155|NCT02034955|Prostatectomy|prostatectomy
5331156|NCT02034955|Patients who had a prostatectomy|patients who had a prostatectomy
5331157|NCT02034942|non-sedation|non-sedation
5331158|NCT02034929|colon cancer|colon cancer
5332231|NCT02029872|MRSA|mrsa
5332328|NCT02029430|HIV positive|hiv positive
5332329|NCT02029430|AIDS|aids
5332538|NCT02028455|CD19|cd19
5332830|NCT02027376|LDE225|lde225
5332926|NCT02026739|minimally invasive esophagectomy; pulmonary function|minimally invasive esophagectomy; pulmonary function
5332927|NCT02026674|urineflow|urineflow
5332928|NCT02026674|luts|luts
5332929|NCT02026674|urine flow|urine flow
5332930|NCT02026674|uroflometry|uroflometry
5332931|NCT02026674|bph|bph
5332932|NCT02026635|heart failure|heart failure
5332933|NCT02026635|Optivol® cardiac device|optivol® cardiac device
5332934|NCT02026635|Medtronic CareLink|medtronic carelink
5332935|NCT02026622|major depressive disorder|major depressive disorder
5332936|NCT02026622|cerebrovascular reactivity|cerebrovascular reactivity
5332937|NCT02026622|emotional reactivity|emotional reactivity
5332938|NCT02026609|TIPS|tips
5332939|NCT02026609|Hepatic encephalopathy|hepatic encephalopathy
5332940|NCT02026609|Oral glutamine challenge|oral glutamine challenge
5332941|NCT02026609|Psychometric tests|psychometric tests
5332942|NCT02026609|Portal hypertension|portal hypertension
5332943|NCT02026609|Cirrhosis|cirrhosis
5333244|NCT02025400|eRehab|erehab
5333432|NCT02024581|East Indian sandalwood oil|east indian sandalwood oil
5333433|NCT02024581|pox virus|pox virus
5333434|NCT02024568|Pregabalin|pregabalin
5333435|NCT02024568|Arthralgia Myalgia Syndrome|arthralgia myalgia syndrome
5333436|NCT02024568|Paclitaxel|paclitaxel
5333437|NCT02024568|Pain management|pain management
5333438|NCT02024568|Breast cancer|breast cancer
5333439|NCT02024542|Bariatric Surgery|bariatric surgery
5333440|NCT02024542|Obesity|obesity
5333441|NCT02024542|Metabolic syndrome|metabolic syndrome
5333442|NCT02024542|Diabetes|diabetes
5333443|NCT02024516|Type 2 diabetes|type 2 diabetes
5333444|NCT02024516|Pomegranate|pomegranate
5333445|NCT02024516|Inflammation|inflammation
5333446|NCT02024516|lipid profiles|lipid profiles
5333540|NCT02024165|FSE|fse
5333737|NCT02023138|Feasibility|feasibility
5333738|NCT02023138|Effectiveness|effectiveness
5333931|NCT02022228|Gonadotropin Releasing Hormone Agonist|gonadotropin releasing hormone agonist
5333932|NCT02022228|Human Chorionic Gonadotropin|human chorionic gonadotropin
5333933|NCT02022189|Dent|dent
5333934|NCT02022189|Dents|dents
5333935|NCT02022189|Dent Disease|dent disease
5333936|NCT02022189|Renal Biopsy|renal biopsy
5333937|NCT02022189|Kidney Biopsy|kidney biopsy
5334231|NCT02020642|leg fluid shift|leg fluid shift
5334232|NCT02020642|neck circumference|neck circumference
5334233|NCT02020642|Sleep Apnea Syndromes|sleep apnea syndromes
5334234|NCT02020642|Sleep Apnea, Obstructive|sleep apnea, obstructive
5334236|NCT02020642|Sleep Disorders|sleep disorders
5334331|NCT02020174|Premature|premature
5334332|NCT02020174|High Blood Pressure|high blood pressure
5334333|NCT02020174|Hypertension|hypertension
5334334|NCT02020148|pregnancy|pregnancy
5334335|NCT02020148|oxytocin|oxytocin
5334336|NCT02020148|postpartum depression|postpartum depression
5334337|NCT02020148|depression|depression
5334436|NCT02019680|Endothelial Function|endothelial function
5334437|NCT02019680|Biomarkers|biomarkers
5334438|NCT02019680|Atherosclerosis|atherosclerosis
5334439|NCT02019680|Blood Flow|blood flow
5334440|NCT02019680|Blood Pressure|blood pressure
5334451|NCT02019628|NK cells cytotoxicity, dietary supplementation|nk cells cytotoxicity, dietary supplementation
5334452|NCT02019615|disorders of consciousness|disorders of consciousness
5334453|NCT02019615|minimally conscious state|minimally conscious state
5334454|NCT02019615|traumatic brain injury|traumatic brain injury
5334455|NCT02019615|stroke|stroke
5334457|NCT02019602|Cimzia®|cimzia®
5334927|NCT02017444|Pseudotumor Cerebri|pseudotumor cerebri
5334928|NCT02017444|Benign Intracranial Hypertension|benign intracranial hypertension
5334929|NCT02017444|Headaches|headaches
5334930|NCT02017444|Tinnitus|tinnitus
5334931|NCT02017444|Papilledema|papilledema
5334932|NCT02017444|Blindness|blindness
5334933|NCT02017444|Optic Disk|optic disk
5334934|NCT02017444|Intracranial Hypertension|intracranial hypertension
5334935|NCT02017444|Clinical Trial, Phase 2|clinical trial, phase 2
5334936|NCT02017444|11beta-Hydroxysteroid Dehydrogenase Type 1|11beta-hydroxysteroid dehydrogenase type 1
5334938|NCT02017431|Diesel exhaust|diesel exhaust
5334940|NCT02017431|Air pollution|air pollution
5335231|NCT02016105|safety and immunogenicity|safety and immunogenicity
5335232|NCT02016105|GP2017|gp2017
5335233|NCT02016105|Humira®|humira®
5335447|NCT02015208|elderly|elderly
5335938|NCT02013063|SPN|spn
5336206|NCT02011906|CAD|cad
5336523|NCT02010489|Bariatric Surgery|bariatric surgery
5336524|NCT02010489|Exercise|exercise
5336525|NCT02010489|Physical Fitness|physical fitness
5680423|NCT00577798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5336526|NCT02010476|Alzheimer's disease, CSF biomarkers, Insulin resistance|alzheimer's disease, csf biomarkers, insulin resistance
5336527|NCT02010463|reward processing|reward processing
5336528|NCT02010463|impulse control|impulse control
5337327|NCT02007122|HD|hd
5338041|NCT02003742|LUTS|luts
5338219|NCT02002793|pancreatitis|pancreatitis
5338220|NCT02002793|early stage|early stage
5338221|NCT02002793|mini-invasive abdominal drainage|mini-invasive abdominal drainage
5338222|NCT02002780|pediatrics|pediatrics
5338224|NCT02002780|cardiac surgery|cardiac surgery
5338225|NCT02002754|eosinophilic bronchitis|eosinophilic bronchitis
5338248|NCT02002689|PTCH1,|ptch1,
5338711|NCT02000674|pre hospital emergency|pre hospital emergency
5338712|NCT02000661|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5338713|NCT02000661|FFR guided coronary interventions|ffr guided coronary interventions
5338714|NCT02000661|Percutaneous Coronary Intervention|percutaneous coronary intervention
5339046|NCT01999114|ECG|ecg
5339301|NCT01998022|hypertension|hypertension
5339302|NCT01998022|knowledge|knowledge
5339303|NCT01998022|blood pressure control|blood pressure control
5339304|NCT01998009|colorectal cancer|colorectal cancer
5339305|NCT01998009|mass screening|mass screening
5339306|NCT01998009|fecal occult blood|fecal occult blood
5339307|NCT01997996|Pelvic Organ Prolapse|pelvic organ prolapse
5339308|NCT01997996|PROLIFT+M|prolift+m
5339309|NCT01997996|Vita sexualis|vita sexualis
5339311|NCT01997983|PBS/IC|pbs/ic
5339501|NCT01997281|diabetes mellitus|diabetes mellitus
5339502|NCT01997281|gut hormone|gut hormone
5339503|NCT01997268|Dyslipidemia|dyslipidemia
5339504|NCT01997268|Hyperlipidemia|hyperlipidemia
5339591|NCT01996852|ED|ed
5340014|NCT01995032|DMD|dmd
5340789|NCT01990989|platelet aggregation|platelet aggregation
5340887|NCT01990547|Traumatic Event|traumatic event
5341281|NCT01988740|Ischemia-modified albumin|ischemia-modified albumin
5341283|NCT01988740|Abnormal placenta|abnormal placenta
5341382|NCT01988220|stroke|stroke
5341896|NCT01985724|Axillary node positive|axillary node positive
5341998|NCT01985412|Biopsy|biopsy
5341999|NCT01985412|Non-Invasive|non-invasive
5342000|NCT01985399|HIV|hiv
5342001|NCT01985399|AIDS|aids
5342002|NCT01985399|Aging|aging
5342003|NCT01985386|Iron absorption|iron absorption
5342508|NCT01983254|intensive care unit|intensive care unit
5342509|NCT01983241|Pulmonary Emphysema|pulmonary emphysema
5342510|NCT01983241|Alpha-1 Antitrypsin Deficiency|alpha-1 antitrypsin deficiency
5342511|NCT01983241|AATD|aatd
5342512|NCT01983241|Alpha-1 PI Deficiency|alpha-1 pi deficiency
5342513|NCT01983241|Alpha-1 Protienase Inhibitor|alpha-1 protienase inhibitor
5342812|NCT01981876|Dysplasia|dysplasia
5342913|NCT01981499|PF-05180999|pf-05180999
5342914|NCT01981499|safety|safety
5342915|NCT01981499|tolerability|tolerability
5342916|NCT01981499|pharmacokinetics|pharmacokinetics
5342917|NCT01981499|histamine|histamine
5343050|NCT01980901|AAA|aaa
5343235|NCT01979900|Cavity|cavity
5343311|NCT01979419|neuroimaging|neuroimaging
5343325|NCT01979380|KD101|kd101
5343407|NCT01978821|Cerebral Palsy|cerebral palsy
5343408|NCT01978821|autologous bone marrow mononuclear cells|autologous bone marrow mononuclear cells
5343905|NCT01977001|Primary headache|primary headache
5343906|NCT01977001|Headache|headache
5343907|NCT01977001|MigraineBox|migrainebox
5344120|NCT01976091|LGMD2D|lgmd2d
5344211|NCT01975701|recurrent GBM,|recurrent gbm,
5344212|NCT01975701|FGFR,|fgfr,
5344244|NCT01975519|STS|sts
5344817|NCT01972789|Subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
5344818|NCT01972789|wet age-related macular degeneration(AMD)|wet age-related macular degeneration(amd)
5345325|NCT01970501|ARCA|arca
5345809|NCT01968317|Endometrial Atypical Hyperplasia|endometrial atypical hyperplasia
5345810|NCT01968317|Endometrial Adenocarcinoma|endometrial adenocarcinoma
5345811|NCT01968317|Conservative Medication|conservative medication
5345812|NCT01968304|Iron Status, Cancer|iron status, cancer
5345813|NCT01968291|Health Literacy|health literacy
5345814|NCT01968291|Teach-back|teach-back
5345815|NCT01968291|Emergency|emergency
5345816|NCT01968265|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5345817|NCT01968265|T2DM|t2dm
5345818|NCT01968252|Speckle-tracking echocardiography|speckle-tracking echocardiography
5345819|NCT01968252|Transthoracic echocardiography|transthoracic echocardiography
5027102|NCT03829293|colonoscopy|colonoscopy
5345820|NCT01968252|Transesophageal echocardiography|transesophageal echocardiography
5345822|NCT01968239|Macular edema|macular edema
5345823|NCT01968239|Ranibizumab|ranibizumab
5345824|NCT01968239|re-treatment|re-treatment
5345911|NCT01967836|Ambulatory Care|ambulatory care
5345912|NCT01967823|Metastatic Cancer|metastatic cancer
5345913|NCT01967823|Gene Therapy|gene therapy
5345914|NCT01967823|Immunotherapy|immunotherapy
5346700|NCT01964664|Mindfulness|mindfulness
5346701|NCT01964664|Meditation|meditation
5346702|NCT01964664|acute lateral sclerosis|acute lateral sclerosis
5346703|NCT01964664|Cerebral Palsy|cerebral palsy
5346704|NCT01964664|Cerebral Ataxia|cerebral ataxia
5346706|NCT01964651|Healthy|healthy
5347150|NCT01962675|SCI|sci
5347477|NCT01961427|exercise performance|exercise performance
5347478|NCT01961427|oxygen consumption|oxygen consumption
5347480|NCT01961414|AMD|amd
5347481|NCT01961414|Macular|macular
5347482|NCT01961414|Degeneration|degeneration
5347483|NCT01961414|Aflibercept|aflibercept
5347484|NCT01961414|Eylea|eylea
5347485|NCT01961414|Intravitreal|intravitreal
5347486|NCT01961401|exercise|exercise
5347539|NCT01961167|PAD|pad
5347577|NCT01961037|Rural|rural
5347578|NCT01961037|West Virginia|west virginia
5347579|NCT01961024|VLDL-TG kinetics|vldl-tg kinetics
5347580|NCT01961024|Postprandial state|postprandial state
5347581|NCT01961024|Obesity|obesity
5347582|NCT01961011|nerve compression, carpal tunnel, clinical decision making|nerve compression, carpal tunnel, clinical decision making
5347583|NCT01960998|radical prostatectomy|radical prostatectomy
5347585|NCT01960998|prostate cancer|prostate cancer
5348251|NCT01957605|hemodynamic variation|hemodynamic variation
5348252|NCT01957605|mean systemic pressure|mean systemic pressure
5348253|NCT01957579|Phase I|phase i
5348254|NCT01957579|advanced|advanced
5348255|NCT01957579|B cell malignancies|b cell malignancies
5348256|NCT01957579|dose escalation|dose escalation
5348549|NCT01955941|choroid|choroid
5349040|NCT01953822|United Kingdom|united kingdom
5349042|NCT01953809|oral contraceptive|oral contraceptive
5349043|NCT01953809|pharmacokinetics|pharmacokinetics
5349044|NCT01953809|drug interaction|drug interaction
5349045|NCT01953809|pharmacodynamics|pharmacodynamics
5349046|NCT01953809|GSK1322322|gsk1322322
5349047|NCT01953809|antibiotic|antibiotic
5349048|NCT01953809|safety|safety
5349049|NCT01953796|Polycystic Ovarian Syndrome stair step traditional protocol|polycystic ovarian syndrome stair step traditional protocol
5349050|NCT01953770|Acute lymphoblastic leukemia, children, adolescents, L-asparaginase, methotrexate|acute lymphoblastic leukemia, children, adolescents, l-asparaginase, methotrexate
5349051|NCT01953757|diabetic neuropathy, diet, vegan, vegetarian|diabetic neuropathy, diet, vegan, vegetarian
5349130|NCT01953302|ventral hernia|ventral hernia
5349131|NCT01953302|infection|infection
5349132|NCT01953302|hematoma|hematoma
5349133|NCT01953302|seroma|seroma
5349134|NCT01953302|recurrence|recurrence
5349135|NCT01953302|mesh technique|mesh technique
5349136|NCT01953289|Appendicitis|appendicitis
5349137|NCT01953289|Free fluid|free fluid
5349138|NCT01953276|Acute Coronary Syndrome|acute coronary syndrome
5349139|NCT01953276|Chest pain|chest pain
5349140|NCT01953276|Electrocardiograms|electrocardiograms
5349141|NCT01953276|Risk Stratification|risk stratification
5349142|NCT01953276|Emergency Department|emergency department
5349143|NCT01953263|urinary incontinence, muscle fibers|urinary incontinence, muscle fibers
5349144|NCT01953250|Deep infiltrating endometriosis|deep infiltrating endometriosis
5349145|NCT01953250|Laparoscopic sigmoid resection|laparoscopic sigmoid resection
5349146|NCT01953250|laparoscopic rectum resection|laparoscopic rectum resection
5349147|NCT01953250|Colorectal surgery|colorectal surgery
5349148|NCT01953237|Schizophrenia|schizophrenia
5349335|NCT01952223|Radiotherapy|radiotherapy
5349336|NCT01952223|Androgen Deprivation Therapy|androgen deprivation therapy
5349364|NCT01952080|SBS|sbs
5349447|NCT01951729|GIP|gip
5349643|NCT01950715|Irritable Bowel Syndrome|irritable bowel syndrome
5349644|NCT01950715|Sacral Nerve Stimulation|sacral nerve stimulation
5349645|NCT01950715|Gastro-colic response|gastro-colic response
5349646|NCT01950715|Multimodal Stimulation|multimodal stimulation
5349647|NCT01950663|Diagnostic Equipment|diagnostic equipment
5350118|NCT01948453|CAD|cad
5350241|NCT01947959|Hematologic Agents|hematologic agents
5350348|NCT01947335|Stent|stent
5351908|NCT01940120|Mitral Valve Insufficiency|mitral valve insufficiency
5351909|NCT01940120|Mitral Valve Regurgitation|mitral valve regurgitation
5351910|NCT01940120|Mitral Valve Incompetence|mitral valve incompetence
5351911|NCT01940120|Mitral Regurgitation|mitral regurgitation
5351912|NCT01940120|Mitral Insufficiency|mitral insufficiency
5351913|NCT01940120|Mitral Valve|mitral valve
5351914|NCT01940120|MR|mr
5351915|NCT01940120|Mitral Valve Prolapse|mitral valve prolapse
5351916|NCT01940120|Edge to Edge (E2E)|edge to edge (e2e)
5351917|NCT01940120|Alfieri Technique|alfieri technique
5351918|NCT01940120|MitraClip|mitraclip
5351919|NCT01940120|Functional MR|functional mr
5351920|NCT01940120|Degenerative MR|degenerative mr
5351921|NCT01940120|Echocardiogram|echocardiogram
5351922|NCT01940120|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5351923|NCT01940120|Heart Failure|heart failure
5352410|NCT01938079|Lung failure|lung failure
5352411|NCT01938079|Extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5352412|NCT01938079|Mechanical ventilation|mechanical ventilation
5352413|NCT01938079|Sedation|sedation
5352597|NCT01937013|emotion|emotion
5353101|NCT01934465|NSCLC|nsclc
5353201|NCT01934075|Obstetric fistula|obstetric fistula
5353202|NCT01934075|Mental health|mental health
5353203|NCT01934075|Tanzania|tanzania
5353204|NCT01934036|Weight loss|weight loss
5353205|NCT01934036|Nutritional supplement|nutritional supplement
5353206|NCT01934036|Waist|waist
5353207|NCT01934036|Body composition|body composition
5353297|NCT01933724|Lung diseases|lung diseases
5353298|NCT01933724|Respiratory Tract Diseases|respiratory tract diseases
5353398|NCT01933334|systemic sclerosis|systemic sclerosis
5353399|NCT01933334|interstitial lung disease|interstitial lung disease
5353679|NCT01931956|Mitral Valve|mitral valve
5353680|NCT01931956|Mitral Regurgitation (MR)|mitral regurgitation (mr)
5353681|NCT01931956|Mitral Valve Prolapse|mitral valve prolapse
5353682|NCT01931956|Edge to Edge (E2E)|edge to edge (e2e)
5353683|NCT01931956|Alfieri Technique|alfieri technique
5353684|NCT01931956|MitraClip|mitraclip
5353685|NCT01931956|Functional MR|functional mr
5353686|NCT01931956|Degenerative MR|degenerative mr
5353800|NCT01931644|Rosacea|rosacea
5353872|NCT01931241|hypercholesteremia|hypercholesteremia
5353873|NCT01931241|atherosclerotic plaque|atherosclerotic plaque
5354874|NCT01926444|oral|oral
5355977|NCT01921361|Spinal anesthesia|spinal anesthesia
5355978|NCT01921348|Hay Fever|hay fever
5355979|NCT01921348|Hayfever|hayfever
5355980|NCT01921348|Pollen Allergy|pollen allergy
5355981|NCT01921348|Pollinosis|pollinosis
5356476|NCT01919476|Lipids|lipids
5356477|NCT01919476|Satiety|satiety
5356478|NCT01919476|Almonds|almonds
5356479|NCT01919463|Colonoscopy|colonoscopy
5356480|NCT01919463|Lower Gastrointestinal Tract|lower gastrointestinal tract
5356481|NCT01919463|Magnetic Endoscopic Imaging|magnetic endoscopic imaging
5356482|NCT01919463|Abdominal Compression|abdominal compression
5357357|NCT01915420|Stents|stents
5357358|NCT01915420|Angioplasty|angioplasty
5357359|NCT01915420|Coronary Artery Disease|coronary artery disease
5357951|NCT01912352|Methylphenidate|methylphenidate
5357952|NCT01912352|Response|response
5357956|NCT01912326|pacemaker|pacemaker
5358943|NCT01907607|Efficacy and safety|efficacy and safety
5358944|NCT01907607|Adult patients|adult patients
5358945|NCT01907607|Refractory|refractory
5358946|NCT01907607|Imatinib|imatinib
5358947|NCT01907607|Sunitinib|sunitinib
5358948|NCT01907490|Topical treatment of Head Lice Infestation|topical treatment of head lice infestation
5358949|NCT01907464|Anorexia nervosa|anorexia nervosa
5358950|NCT01907464|Bone mineral density|bone mineral density
5358953|NCT01907438|BRCA|brca
5359246|NCT01905891|Non melanoma skin cancer|non melanoma skin cancer
5359247|NCT01905891|Field of cancerization|field of cancerization
5359248|NCT01905891|Skin carcinogenesis|skin carcinogenesis
5359249|NCT01905865|Undiagnosed Medical Conditions|undiagnosed medical conditions
5359251|NCT01905852|Ejection Fraction|ejection fraction
5359445|NCT01904851|Stents|stents
5359724|NCT01903603|MRI|mri
5359900|NCT01902797|PCR|pcr
5360119|NCT01901796|CBT|cbt
5360213|NCT01901341|Opioid|opioid
5360315|NCT01900951|Small cell lung cancer|small cell lung cancer
5360316|NCT01900951|temozolomide|temozolomide
5360317|NCT01900951|Maintenance chemotherapy|maintenance chemotherapy
5360318|NCT01900938|Cholangiopancreatography|cholangiopancreatography
5360319|NCT01900938|Endoscopic Retrograde|endoscopic retrograde
5360320|NCT01900925|Low back pain, non-specific low back pain|low back pain, non-specific low back pain
5360321|NCT01900912|sanitation|sanitation
5360322|NCT01900912|diarrhea prevalence|diarrhea prevalence
5360521|NCT01899976|covered biliary stent|covered biliary stent
5360522|NCT01899976|X-Suit NIR Covered Biliary Stent|x-suit nir covered biliary stent
5360523|NCT01899976|malignant strictures in biliary tree|malignant strictures in biliary tree
5360524|NCT01899963|wet Age Related Macular Degeneration|wet age related macular degeneration
5361214|NCT01896271|kidney cancer|kidney cancer
5361215|NCT01896271|metastatic cancer|metastatic cancer
5361217|NCT01896245|sore throat|sore throat
5361218|NCT01896245|intubating conditions|intubating conditions
5361707|NCT01894243|moderate hepatic impairment|moderate hepatic impairment
5361708|NCT01894230|high cholesterol|high cholesterol
5361709|NCT01894230|genetic testing|genetic testing
5361710|NCT01894230|medication adherence|medication adherence
5361711|NCT01894230|statins|statins
5361712|NCT01894230|Adverse Effects|adverse effects
5361805|NCT01893827|XR-NTX|xr-ntx
5361910|NCT01893385|immunocompetente cells, immune system|immunocompetente cells, immune system
5361911|NCT01893385|influenza vaccine|influenza vaccine
5361912|NCT01893385|elderly|elderly
5361921|NCT01893359|hyperopia|hyperopia
5361922|NCT01893359|hyperopic astigmatism|hyperopic astigmatism
5361923|NCT01893359|cross-linking|cross-linking
5362009|NCT01892917|STEMI|stemi
5362509|NCT01890980|GM-CSF|gm-csf
5362889|NCT01889316|ECG|ecg
5363405|NCT01886833|HIV|hiv
5363689|NCT01885481|betamethasone|betamethasone
5363690|NCT01885481|epidural steroid injection|epidural steroid injection
5363691|NCT01885481|comparative effectiveness research|comparative effectiveness research
5363692|NCT01885468|Hydrocephalus shunt|hydrocephalus shunt
5363693|NCT01885468|proGAV|progav
5363695|NCT01885442|mechanical ventilation|mechanical ventilation
5363697|NCT01885442|intensive care unit|intensive care unit
5363698|NCT01885442|rehabilitation|rehabilitation
5363790|NCT01885026|Randomized Controlled Trial|randomized controlled trial
5363791|NCT01885026|Alcohol|alcohol
5363792|NCT01885026|Drugs|drugs
5363822|NCT01884779|HIV|hiv
5364083|NCT01883778|Medical economics|medical economics
5364084|NCT01883778|Policy|policy
5364085|NCT01883778|Questionnaires|questionnaires
5364480|NCT01882088|GERD|gerd
5364781|NCT01881048|Surgery|surgery
5365286|NCT01878786|kidney failure|kidney failure
5365287|NCT01878773|Prostate Cancer|prostate cancer
5365288|NCT01878773|MRI scan|mri scan
5365289|NCT01878773|External beam radiotherapy|external beam radiotherapy
5365290|NCT01878760|APRICOT|apricot
5365291|NCT01878760|Anaesthesia|anaesthesia
5365292|NCT01878760|Children|children
5365293|NCT01878760|kids|kids
5365294|NCT01878760|Paediatric Anaesthesia|paediatric anaesthesia
5365295|NCT01878760|Observational Trial|observational trial
5365296|NCT01878760|epidemiology|epidemiology
5365297|NCT01878760|severe critical events in|severe critical events in
5365298|NCT01878760|European Society of Anaesthesiology|european society of anaesthesiology
5365299|NCT01878760|Europe|europe
5365300|NCT01878747|Pediatric|pediatric
5365301|NCT01878747|Pain|pain
5365302|NCT01878747|Postoperative|postoperative
5365303|NCT01878747|General Anesthesia|general anesthesia
5365304|NCT01878747|Anesthesia Recovery Period|anesthesia recovery period
5365305|NCT01878747|Infant Behavior|infant behavior
5365306|NCT01878747|Adolescent Behavior|adolescent behavior
5365307|NCT01878747|Patient Satisfaction|patient satisfaction
5365308|NCT01878721|PET/CT|pet/ct
5365309|NCT01878721|infection|infection
5365310|NCT01878721|vasculitis|vasculitis
5365311|NCT01878708|T-Cell Lymphoma|t-cell lymphoma
5365312|NCT01878708|Relapsed T-Cell Lymphoma|relapsed t-cell lymphoma
5365313|NCT01878708|Refractory T-Cell Lymphoma|refractory t-cell lymphoma
5365314|NCT01878708|Oncaspar®|oncaspar®
5365315|NCT01878708|PEG-L-asparaginase and dexamethasone|peg-l-asparaginase and dexamethasone
5365316|NCT01878695|Integrative Medicine|integrative medicine
5365317|NCT01878695|Breast Cancer|breast cancer
5365318|NCT01878695|Stage 0|stage 0
5365319|NCT01878695|Stage 1|stage 1
5365320|NCT01878669|n-acetyl cysteine|n-acetyl cysteine
5365321|NCT01878669|percutaneous coronary intervention|percutaneous coronary intervention
5365322|NCT01878643|aerosolized antibiotic|aerosolized antibiotic
5365385|NCT01878500|Bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
5365386|NCT01878500|Pelvic floor musculature|pelvic floor musculature
5365387|NCT01878500|Intraoperative stereotactic imaging|intraoperative stereotactic imaging
5365391|NCT01878474|MT-8995|mt-8995
5365982|NCT01875679|Deliberate practice|deliberate practice
5365983|NCT01875679|Debriefing|debriefing
5365984|NCT01875679|Behaviour modelling|behaviour modelling
5365985|NCT01875666|breast cancer|breast cancer
5366195|NCT01874847|placebo|placebo
5366377|NCT01873989|Symptomatic hypogonadism|symptomatic hypogonadism
5366378|NCT01873989|Testosterone replacement|testosterone replacement
5366380|NCT01873989|Methadone|methadone
5663522|NCT00647452|VLDL|vldl
5366773|NCT01872338|safety planning|safety planning
5366774|NCT01872325|cardiac arrest|cardiac arrest
5366775|NCT01872325|bystander cardiopulmonary resuscitation CPR|bystander cardiopulmonary resuscitation cpr
5366776|NCT01872325|dispatch-assisted CPR instructions|dispatch-assisted cpr instructions
5366777|NCT01872325|agonal breathing|agonal breathing
5366778|NCT01872312|BPF(Bronchopleural fistulae)|bpf(bronchopleural fistulae)
5366871|NCT01871740|Randomized controlled trial|randomized controlled trial
5366874|NCT01871714|XLHED|xlhed
5366881|NCT01871688|neuromodulation|neuromodulation
5367559|NCT01868399|dengue virus|dengue virus
5367560|NCT01868386|Radiotherapy, hypofractionated|radiotherapy, hypofractionated
5367561|NCT01868386|Salvage therapy|salvage therapy
5367562|NCT01868386|Radiotherapy, adjuvant|radiotherapy, adjuvant
5367563|NCT01868373|commensal microbiota bacteroides colitis pseudomembranous|commensal microbiota bacteroides colitis pseudomembranous
5367565|NCT01868360|transplant|transplant
5367755|NCT01867450|Deisel Exhaust|deisel exhaust
5367756|NCT01867450|Occupational Exposure|occupational exposure
5367757|NCT01867450|Cross-Sectional Study|cross-sectional study
5367758|NCT01867437|24 Hour Energy Expenditure|24 hour energy expenditure
5367759|NCT01867437|Resting Energy Expenditure|resting energy expenditure
5367760|NCT01867437|Obesity|obesity
5367761|NCT01867437|Healthy Volunteers|healthy volunteers
5367762|NCT01867424|Testosterone Membrane Transporter|testosterone membrane transporter
5367763|NCT01867424|OATP1B3|oatp1b3
5032071|NCT03798704|IFA|ifa
5032072|NCT03798704|LIAISON|liaison
5367764|NCT01867424|Castration Resistant Prostate Cancer|castration resistant prostate cancer
5367855|NCT01866943|Tranexamic Acid|tranexamic acid
5367856|NCT01866943|Total Hip Arthroplasty|total hip arthroplasty
5368250|NCT01864967|Improvement granulation tissue in chronic wounds|improvement granulation tissue in chronic wounds
5368252|NCT01864954|Postpartum|postpartum
5368253|NCT01864954|Pregnancy|pregnancy
5368460|NCT01864291|ABI|abi
5368753|NCT01863030|Resorbable mesh|resorbable mesh
5368754|NCT01863030|Phasix mesh|phasix mesh
5368755|NCT01863017|Obesity|obesity
5368756|NCT01863017|Over weight|over weight
5368757|NCT01862991|Induced Abortion|induced abortion
5368856|NCT01862510|Celiac Disease|celiac disease
5368857|NCT01862510|Hypothyroidism|hypothyroidism
5368858|NCT01862510|Celiac Sprue|celiac sprue
5368859|NCT01862510|Malabsorption|malabsorption
5368860|NCT01862497|Intradialytic Hypertension|intradialytic hypertension
5369245|NCT01860677|BOLD (Blood Oxygenation Level Dependent)|bold (blood oxygenation level dependent)
5369246|NCT01860677|fMRI (Functional Magnetic Resonance Imaging)|fmri (functional magnetic resonance imaging)
5369247|NCT01860677|spectroscopy|spectroscopy
5369248|NCT01860664|allergy|allergy
5369249|NCT01860664|allergic|allergic
5369250|NCT01860664|conjunctivitis|conjunctivitis
5369251|NCT01860664|corticosteroid|corticosteroid
5369267|NCT01860586|pvr|pvr
5369653|NCT01858922|DECA|deca
5370054|NCT01857245|Health Care Costs|health care costs
5370659|NCT01854788|Airway clearance techniques|airway clearance techniques
5370660|NCT01854788|Mucus clearance|mucus clearance
5370661|NCT01854788|Chest physiotherapy|chest physiotherapy
5370662|NCT01854788|Autogenic drainage|autogenic drainage
5370948|NCT01853904|BAL|bal
5371370|NCT01852214|ticagrelor|ticagrelor
5371371|NCT01852188|Intrapartum|intrapartum
5371372|NCT01852188|Glove|glove
5371471|NCT01851642|Cystic Fibrosis|cystic fibrosis
5371472|NCT01851629|Locomotor training|locomotor training
5371473|NCT01851629|Walking recovery|walking recovery
5371474|NCT01851629|Neuroplasticity|neuroplasticity
5371475|NCT01851616|glucose, blood|glucose, blood
5371476|NCT01851603|Schizophrenia|schizophrenia
5371477|NCT01851590|Dermatophyte onychomycosis|dermatophyte onychomycosis
5371478|NCT01851590|Fungal nail infection|fungal nail infection
5371586|NCT01851304|Bitter|bitter
5371965|NCT01849575|Risk assessment|risk assessment
5371966|NCT01849575|Behavioral change|behavioral change
5372879|NCT01845389|TURP|turp
5373003|NCT01844804|PK|pk
5373461|NCT01842581|Rifaximin|rifaximin
5373462|NCT01842581|Cirrhosis|cirrhosis
5373463|NCT01842568|Cardiac surgery|cardiac surgery
5373464|NCT01842568|Troponin|troponin
5373465|NCT01842568|Vascular events|vascular events
5373466|NCT01842568|Myocardial injury|myocardial injury
5373467|NCT01842568|Observational cohort study|observational cohort study
5373468|NCT01842568|Public health|public health
5373469|NCT01842555|PDT|pdt
5373516|NCT01842269|MMF|mmf
5373964|NCT01840124|Radiofrequency ablation|radiofrequency ablation
5373965|NCT01840111|smoking environment|smoking environment
5373966|NCT01840111|cue-exposure|cue-exposure
5373967|NCT01840111|cigarettes|cigarettes
5374262|NCT01838902|Sexual stage|sexual stage
5374263|NCT01838902|Primaquine|primaquine
5374264|NCT01838902|Dihydroartemisinin|dihydroartemisinin
5374265|NCT01838902|Piperaquine|piperaquine
5374762|NCT01836783|Amnion Allograft|amnion allograft
5374763|NCT01836770|Transforaminal Epidural Steroid Injections|transforaminal epidural steroid injections
5374764|NCT01836757|osteoarthritis|osteoarthritis
5374765|NCT01836757|CAM treatments|cam treatments
5374866|NCT01836094|PVT|pvt
5374958|NCT01835639|Membranous Nephropathy|membranous nephropathy
5375056|NCT01835054|Mitral regurgitation|mitral regurgitation
5376441|NCT01828827|PK|pk
5377383|NCT01824654|Endovascular Procedures|endovascular procedures
5377384|NCT01824654|Radiography, Interventional|radiography, interventional
5377385|NCT01824641|Acute myocardial infarction|acute myocardial infarction
5377388|NCT01824615|Sunitinib|sunitinib
5377780|NCT01822769|adult congenital heart disease|adult congenital heart disease
5377781|NCT01822769|cardiac rehabilitation|cardiac rehabilitation
5377782|NCT01822769|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
5377783|NCT01822769|exercise|exercise
5377784|NCT01822769|cardiopulmonary exercise testing|cardiopulmonary exercise testing
5377785|NCT01822769|peak vO2|peak vo2
5377787|NCT01822743|Osteopathy|osteopathy
5377985|NCT01821885|tobacco|tobacco
5378426|NCT01819727|PKU|pku
5378580|NCT01818973|Rectal Cancer|rectal cancer
5378581|NCT01818973|Bevacizumab|bevacizumab
5378582|NCT01818973|capecitabine|capecitabine
5378583|NCT01818973|oxaliplatin|oxaliplatin
5378584|NCT01818973|preoporative IMRT|preoporative imrt
5378585|NCT01818960|Stent, Myocardial Infarction, Coronary Intervention|stent, myocardial infarction, coronary intervention
5378586|NCT01818947|Lung cancer|lung cancer
5378587|NCT01818947|epidermal growth factor receptor mutation|epidermal growth factor receptor mutation
5378589|NCT01818947|Iressa|iressa
5378738|NCT01818258|HIV|hiv
5378773|NCT01817985|Severe Hepatic Impairment|severe hepatic impairment
5378774|NCT01817972|Crohn's Disease|crohn's disease
5378775|NCT01817972|Crohn's colitis|crohn's colitis
5034449|NCT03783975|Social|social
5378776|NCT01817972|Crohn's ileocolitis|crohn's ileocolitis
5379379|NCT01815411|symptom score|symptom score
5379381|NCT01815411|life quality|life quality
5379382|NCT01815411|cytokines|cytokines
5379383|NCT01815411|mRNA expression|mrna expression
5379384|NCT01815411|Quality of Life|quality of life
5379385|NCT01815411|Signs and Symptoms|signs and symptoms
5379387|NCT01815385|Term gestation|term gestation
5379389|NCT01815385|Benzo(a)pyrene|benzo(a)pyrene
5380066|NCT01812317|thrombosis|thrombosis
5380067|NCT01812291|Major Depression|major depression
5380068|NCT01812291|Minor Depression|minor depression
5380069|NCT01812291|Sub-Threshold Depression|sub-threshold depression
5380070|NCT01812291|Affective Condition|affective condition
5380071|NCT01812291|Mood Disorder|mood disorder
5380085|NCT01812239|twins|twins
5380163|NCT01811758|Culturally Specific Cognitive Behavioral Therapy|culturally specific cognitive behavioral therapy
5380164|NCT01811758|Standard Cognitive Behavioral Therapy|standard cognitive behavioral therapy
5380166|NCT01811745|Cognition|cognition
5380167|NCT01811745|Exercise|exercise
5380168|NCT01811745|Falls|falls
5380169|NCT01811745|Gait|gait
5380170|NCT01811745|Physical function|physical function
5380171|NCT01811745|Dual-task|dual-task
5380172|NCT01811745|Music|music
5380177|NCT01811732|infection|infection
5380468|NCT01810354|obese|obese
5380667|NCT01809431|infants|infants
5380668|NCT01809431|blood glucose|blood glucose
5380669|NCT01809431|weight|weight
5380670|NCT01809431|adiposity|adiposity
5380671|NCT01809431|health behaviors|health behaviors
5380766|NCT01808911|Acquired haemophilia|acquired haemophilia
5380767|NCT01808911|Comparative and randomized study|comparative and randomized study
5380768|NCT01808911|Cyclophosphamide|cyclophosphamide
5380770|NCT01808898|Ablation|ablation
5380771|NCT01808898|Outpatient|outpatient
5380772|NCT01808885|safety|safety
5380773|NCT01808885|multiple sclerosis|multiple sclerosis
5380774|NCT01808885|olesoxime|olesoxime
5380775|NCT01808885|double-blind|double-blind
5380776|NCT01808885|randomized|randomized
5380777|NCT01808859|Total Knee Arthroplasty|total knee arthroplasty
5380778|NCT01808859|Thigh Tourniquet|thigh tourniquet
5380779|NCT01808846|Obesity|obesity
5380780|NCT01808846|Insulin Resistance|insulin resistance
5380782|NCT01808846|glucose|glucose
5380957|NCT01808170|Laparoscopy|laparoscopy
5380958|NCT01808170|AMH|amh
5380959|NCT01808170|AFC|afc
5380966|NCT01808144|Gout|gout
5381158|NCT01807130|ICD|icd
5381264|NCT01806649|BKM120|bkm120
5381354|NCT01806103|physician prescribing|physician prescribing
5382053|NCT01803529|hot temperature|hot temperature
5382054|NCT01803516|Quality of Life|quality of life
5382055|NCT01803516|Assessments|assessments
5382082|NCT01803399|QTc|qtc
5382152|NCT01803165|Vasodilation/drug effects|vasodilation/drug effects
5382153|NCT01803152|Metastatic Sarcoma|metastatic sarcoma
5382154|NCT01803152|Relapsed Sarcoma|relapsed sarcoma
5382155|NCT01803152|Dendritic Cell|dendritic cell
5382156|NCT01803152|Myeloid Derived Suppressor Cells|myeloid derived suppressor cells
5382157|NCT01803152|MDSC|mdsc
5383353|NCT01797562|Contact dermatitis|contact dermatitis
5383355|NCT01797549|Traumatic brain injury|traumatic brain injury
5383562|NCT01796704|functional capacity|functional capacity
5383670|NCT01796249|Analgesia Nociception Index|analgesia nociception index
5383671|NCT01796249|ANI|ani
5383672|NCT01796236|Bone anchored hearing aid|bone anchored hearing aid
5383673|NCT01796236|Bone anchored implant|bone anchored implant
5383674|NCT01796236|Abbreviated Profile of Hearing Aid Benefit (APHAB)|abbreviated profile of hearing aid benefit (aphab)
5383965|NCT01794923|topical|topical
5384062|NCT01794598|depression|depression
5384063|NCT01794598|depression care education|depression care education
5384064|NCT01794585|traumatic brain injury|traumatic brain injury
5384065|NCT01794585|balance deficits|balance deficits
5384069|NCT01794572|Relapse|relapse
5385046|NCT01789684|breast cancer|breast cancer
5385047|NCT01789684|HBOC|hboc
5385350|NCT01788423|hearing aids|hearing aids
5385351|NCT01788410|Cryoablation|cryoablation
5385352|NCT01788410|Nerves|nerves
5385546|NCT01787617|African American Men|african american men
5385547|NCT01787617|Insulin Resistance|insulin resistance
5385548|NCT01787604|Valve-sparing|valve-sparing
5385549|NCT01787604|Valve repair|valve repair
5386453|NCT01783314|MRI|mri
5386635|NCT01782573|hepatectomy|hepatectomy
5386636|NCT01782573|chlorhexidine gluconate|chlorhexidine gluconate
5386637|NCT01782560|Laryngomalacia|laryngomalacia
5386643|NCT01782521|Primer|primer
5387029|NCT01780597|Ev Vivo Perfusion|ev vivo perfusion
5387030|NCT01780597|Cardiac function|cardiac function
5387031|NCT01780584|congenital heart surgery, thyroid hormones|congenital heart surgery, thyroid hormones
5387032|NCT01780571|Obesity|obesity
5387033|NCT01780571|general anaesthesia|general anaesthesia
5387034|NCT01780571|preoxygenation|preoxygenation
5387035|NCT01780571|atelectasis|atelectasis
5387036|NCT01780558|endometrium preparation protocols|endometrium preparation protocols
5387037|NCT01780558|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5387038|NCT01780558|natural cycles|natural cycles
5387137|NCT01780116|schizophrenia|schizophrenia
5387138|NCT01780116|adherence therapy|adherence therapy
5387139|NCT01780116|medication|medication
5387140|NCT01780116|randomized controlled trial|randomized controlled trial
5387428|NCT01778894|Echocardiography|echocardiography
5387430|NCT01778881|Physical therapy modalities|physical therapy modalities
5387431|NCT01778881|Massage|massage
5387432|NCT01778881|Muscle stretching exercises|muscle stretching exercises
5387433|NCT01778881|Relaxation therapy|relaxation therapy
5387434|NCT01778881|Imagination|imagination
5387435|NCT01778855|stroke|stroke
5387436|NCT01778855|hypothermia|hypothermia
5387437|NCT01778855|thrombolysis|thrombolysis
5387440|NCT01778855|recanalization|recanalization
5388237|NCT01775371|Analgesia|analgesia
5388238|NCT01775371|ED patients|ed patients
5388239|NCT01775371|acute pain|acute pain
5388240|NCT01775371|IV opioid|iv opioid
5388241|NCT01775345|Partial meniscectomy|partial meniscectomy
5388439|NCT01774448|Spouse Caregiver|spouse caregiver
5388502|NCT01774136|HIV|hiv
5388550|NCT01773993|Lyrica|lyrica
5388738|NCT01773187|MPN-SAF|mpn-saf
5390023|NCT01767584|Cephalexin|cephalexin
5390024|NCT01767571|Mexico|mexico
5390025|NCT01767571|Respiratory infections|respiratory infections
5390026|NCT01767571|Bioequivalence|bioequivalence
5390027|NCT01767571|Cepphalexin|cepphalexin
5390028|NCT01767532|Cephalexin|cephalexin
5390029|NCT01767532|Respiratory infections|respiratory infections
5390030|NCT01767532|Mexico|mexico
5390031|NCT01767532|Bioequivalence|bioequivalence
5390671|NCT01764594|SLE|sle
5390719|NCT01764334|Coronary angiogram|coronary angiogram
5390720|NCT01764334|Diagnosis|diagnosis
5390721|NCT01764334|Coronary revascularization|coronary revascularization
5390722|NCT01764334|Prognosis|prognosis
5390723|NCT01764334|Health economics|health economics
5391302|NCT01761708|primary ventral hernia repair with mesh|primary ventral hernia repair with mesh
5391303|NCT01761708|umbilical hernia repair|umbilical hernia repair
5391304|NCT01761708|epigastric hernia repair|epigastric hernia repair
5391984|NCT01758406|Cardiac stem ce heart failure cardiac function intracoronary transplantation|cardiac stem ce heart failure cardiac function intracoronary transplantation
5391985|NCT01758393|IgG4-related disease|igg4-related disease
5391986|NCT01758393|IgG4-RD|igg4-rd
5391987|NCT01758380|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5391988|NCT01758380|Ramadan|ramadan
5391989|NCT01758380|Vildagliptin|vildagliptin
5391990|NCT01758380|Hypoglycemia|hypoglycemia
5391991|NCT01758367|demethylating agent|demethylating agent
5392101|NCT01757964|IBD|ibd
5392181|NCT01757535|best supportive care|best supportive care
5392587|NCT01755572|Type 2 Diabetes|type 2 diabetes
5392588|NCT01755572|Hypertension|hypertension
5392589|NCT01755572|Liraglutide|liraglutide
5392590|NCT01755572|GLP-1|glp-1
5392591|NCT01755559|malaria|malaria
5392592|NCT01755559|artemisinin|artemisinin
5392601|NCT01755546|OA|oa
5392692|NCT01755052|Aging|aging
5392783|NCT01754662|Insulin resistance|insulin resistance
5392784|NCT01754662|Soy|soy
5392785|NCT01754662|Isoflavones|isoflavones
5392786|NCT01754662|Cocoa|cocoa
5392903|NCT01754155|Zimmer|zimmer
5392987|NCT01753687|visual acuity|visual acuity
5392988|NCT01753687|fluorescein staining|fluorescein staining
5392990|NCT01753661|Hearing loss|hearing loss
5392991|NCT01753661|Language|language
5393189|NCT01752751|Lung cancer|lung cancer
5393190|NCT01752725|supracervical hysterectomy|supracervical hysterectomy
5393191|NCT01752725|vessel sealing|vessel sealing
5393192|NCT01752725|bipolar electrocoagulation|bipolar electrocoagulation
5393193|NCT01752712|Oxytocin|oxytocin
5393194|NCT01752712|Social function|social function
5393196|NCT01752699|neuropathic pain,|neuropathic pain,
5393334|NCT01752062|CML|cml
5393999|NCT01748578|Healthy|healthy
5394226|NCT01747733|PCS|pcs
5394400|NCT01746927|cricoid pressure, glidescope|cricoid pressure, glidescope
5394401|NCT01746901|Relative abuse potential study; oxycodone; nalteone; Opioid-related disorders; drug abusers|relative abuse potential study; oxycodone; nalteone; opioid-related disorders; drug abusers
5394403|NCT01746875|Angiogenesis inhibitors|angiogenesis inhibitors
5394500|NCT01746394|pregnant women|pregnant women
5394501|NCT01746394|nutrition assessment|nutrition assessment
5394502|NCT01746394|health behavior|health behavior
5394508|NCT01746368|advance directives|advance directives
5394509|NCT01746355|atypical facial pain|atypical facial pain
5394705|NCT01745367|mBC|mbc
5394818|NCT01744899|Sitting|sitting
5394908|NCT01744457|tear film osmolarity|tear film osmolarity
5394909|NCT01744457|objective scattering index|objective scattering index
5394910|NCT01744457|tear break up time|tear break up time
5394911|NCT01744457|Schirmer I test|schirmer i test
5394920|NCT01744405|Chagas disease|chagas disease
5394921|NCT01744405|lactation|lactation
5394922|NCT01744405|breastmilk|breastmilk
5394923|NCT01744405|postpartum period|postpartum period
5394924|NCT01744405|infants|infants
5394925|NCT01744405|pediatric clinical pharmacology|pediatric clinical pharmacology
5394926|NCT01744405|developmental clinical pharmacology|developmental clinical pharmacology
5394927|NCT01744405|parasitology|parasitology
5037929|NCT03761901|NSCLC|nsclc
5394928|NCT01744405|trypanosoma cruzi|trypanosoma cruzi
5394938|NCT01744301|Seizure|seizure
5395004|NCT01744067|Fatty acids|fatty acids
5395005|NCT01744067|Gas chromatography|gas chromatography
5395006|NCT01744067|Interstitial fibrosis|interstitial fibrosis
5395396|NCT01742455|Pathologic Processes|pathologic processes
5395398|NCT01742442|elderly OR older|elderly or older
5395399|NCT01742442|chemotherapy|chemotherapy
5395713|NCT01741051|IQ|iq
5395804|NCT01740674|internet data collection|internet data collection
5395805|NCT01740674|longitudinal research|longitudinal research
5395806|NCT01740674|cohort retention|cohort retention
5395808|NCT01740648|Trametinib|trametinib
5396598|NCT01737450|Progressive head and neck cancer|progressive head and neck cancer
5396600|NCT01737411|surgery, solifenacin, urge urinary incontinence|surgery, solifenacin, urge urinary incontinence
5396601|NCT01737398|FAP|fap
5396602|NCT01737398|Familial Amyloid Polyneuropathy|familial amyloid polyneuropathy
5396804|NCT01736631|social phobia|social phobia
5396897|NCT01736189|Rheumatoid arthritis|rheumatoid arthritis
5396898|NCT01736189|Methotrexate|methotrexate
5396899|NCT01736176|Safety and efficacy|safety and efficacy
5396900|NCT01736176|Advanced Parkinson's disease|advanced parkinson's disease
5396901|NCT01736176|levodopa-carbidopa intestinal gel,|levodopa-carbidopa intestinal gel,
5396902|NCT01736176|carbidopa|carbidopa
5396903|NCT01736176|levodopa|levodopa
5396904|NCT01736176|Non-Motor Symptom Scale|non-motor symptom scale
5396905|NCT01736150|Hemodialysis|hemodialysis
5397007|NCT01735708|HIV|hiv
5397097|NCT01735435|geriatric patients|geriatric patients
5397098|NCT01735435|nutritional support|nutritional support
5397099|NCT01735422|Infertility|infertility
5397100|NCT01735422|Ovulation induction|ovulation induction
5397101|NCT01735422|Recombinant human Luteinizing Hormone (r-hLH)|recombinant human luteinizing hormone (r-hlh)
5397102|NCT01735422|Urinary human Chorionic Gonadotrophin (u-hCG)|urinary human chorionic gonadotrophin (u-hcg)
5397107|NCT01735409|Dose|dose
5397191|NCT01734967|CHRONIC PANCREATITIS|chronic pancreatitis
5397192|NCT01734967|Endoscopic ultrasound|endoscopic ultrasound
5397193|NCT01734954|Nerve block|nerve block
5397293|NCT01734421|Primary health care|primary health care
5397294|NCT01734421|Young people|young people
5397295|NCT01734421|Cellular phone|cellular phone
5397296|NCT01734408|immunogenicity|immunogenicity
5397297|NCT01734408|safety|safety
5398282|NCT01729507|Smoking cessation|smoking cessation
5398283|NCT01729507|Add on and smoking cessation|add on and smoking cessation
5398284|NCT01729507|Therapy for tobacco dependence|therapy for tobacco dependence
5398285|NCT01729507|Transcranial direct current stimulation|transcranial direct current stimulation
5398286|NCT01729494|belatacept|belatacept
5398287|NCT01729494|rabbit antithymocyte globulin|rabbit antithymocyte globulin
5398288|NCT01729494|alemtuzumab|alemtuzumab
5398289|NCT01729494|corticosteroid withdrawal|corticosteroid withdrawal
5398290|NCT01729468|Low Dose Acetylsalicylic Acid|low dose acetylsalicylic acid
5398291|NCT01729468|Prevention|prevention
5398292|NCT01729468|Pre-eclampsia|pre-eclampsia
5398497|NCT01728688|HBV|hbv
5398926|NCT01726712|HIV|hiv
5399530|NCT01723865|ICD|icd
5399708|NCT01723085|Laparotomy|laparotomy
5399709|NCT01723072|Chronic spontanous urticaria, refractory CSU, Angioedema|chronic spontanous urticaria, refractory csu, angioedema
5399710|NCT01723046|Upper extremity|upper extremity
5399711|NCT01723046|Rehabilitation|rehabilitation
5399713|NCT01723046|Robotics|robotics
5399921|NCT01721915|women|women
5400237|NCT01720654|MSM|msm
5400912|NCT01717729|HCC, RFA, Iodine-125, Recurrence|hcc, rfa, iodine-125, recurrence
5400913|NCT01717716|boys|boys
5400914|NCT01717716|obesity|obesity
5400922|NCT01717664|MAP|map
5401124|NCT01716793|Primary AML|primary aml
5663905|NCT00646022|PET|pet
5401125|NCT01716793|Risk-adapted treatment|risk-adapted treatment
5401126|NCT01716793|Hematopoietic transplantation|hematopoietic transplantation
5401127|NCT01716793|CD34+ cell selection|cd34+ cell selection
5401128|NCT01716767|Carpal tunnel syndrome|carpal tunnel syndrome
5401129|NCT01716767|hand pain|hand pain
5401130|NCT01716767|wrist pain|wrist pain
5401131|NCT01716767|arm pain|arm pain
5401132|NCT01716767|topical menthol|topical menthol
5401217|NCT01716481|Stroke|stroke
5401218|NCT01716481|Mesenchymal stem cells|mesenchymal stem cells
5401315|NCT01715857|Economics, Pharmaceutical|economics, pharmaceutical
5401316|NCT01715857|Physician's Practice Patterns|physician's practice patterns
5401318|NCT01715857|Sevoflurane|sevoflurane
5401530|NCT01715051|cocaine|cocaine
5402014|NCT01712919|Locoregionally advanced nasopharyngeal carcinoma|locoregionally advanced nasopharyngeal carcinoma
5402015|NCT01712919|cetuximab|cetuximab
5402016|NCT01712919|chemoradiation|chemoradiation
5402017|NCT01712893|breast cancer|breast cancer
5403635|NCT01705769|severe acute malnutrition|severe acute malnutrition
5403636|NCT01705756|Colchicine|colchicine
5403637|NCT01705756|Anakinra|anakinra
5403737|NCT01705353|functional recovery|functional recovery
5403738|NCT01705353|inflammation|inflammation
5404150|NCT01703650|CT|ct
5404331|NCT01702922|Dyadic Coping|dyadic coping
5404332|NCT01702922|Mother|mother
5404333|NCT01702922|Father|father
5404334|NCT01702909|Metastatic Renal Cell|metastatic renal cell
5404335|NCT01702909|Metastatic Kidney Cancer|metastatic kidney cancer
5404336|NCT01702896|Metastatic Melanoma|metastatic melanoma
5404337|NCT01702883|prescriptions|prescriptions
5404338|NCT01702883|hypertension|hypertension
5404339|NCT01702883|high cholesterol|high cholesterol
5404340|NCT01702883|diabetes|diabetes
5404341|NCT01702883|depression|depression
5404342|NCT01702883|adherence|adherence
5404343|NCT01702870|Magnetic resonance imaging|magnetic resonance imaging
5404344|NCT01702857|Dengue|dengue
5404345|NCT01702857|Dengue fever|dengue fever
5404346|NCT01702857|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5404347|NCT01702857|Flavivirus|flavivirus
5404348|NCT01702844|Nab paclitaxel|nab paclitaxel
5404349|NCT01702844|Abraxane|abraxane
5404350|NCT01702844|First Line|first line
5404351|NCT01702844|Non small cell lung cancer|non small cell lung cancer
5404352|NCT01702844|NSCLC|nsclc
5404752|NCT01701206|HIV|hiv
5405291|NCT01698762|OA|oa
5406330|NCT01693718|oral cavity|oral cavity
5406331|NCT01693718|larynx|larynx
5406332|NCT01693705|Tracheostomy|tracheostomy
5406333|NCT01693692|Fibromyalgia|fibromyalgia
5406334|NCT01693679|Tebivudine eGFR non-Tebivudine|tebivudine egfr non-tebivudine
5406335|NCT01693666|Pregnancy|pregnancy
5406336|NCT01693666|Obesity|obesity
5406337|NCT01693666|Weight gain|weight gain
5406338|NCT01693666|Obstetric complications|obstetric complications
5406339|NCT01693666|Lifestyle intervention|lifestyle intervention
5406340|NCT01693653|Behcet's syndrome|behcet's syndrome
5406341|NCT01693653|oral ulcers|oral ulcers
5406342|NCT01693640|Behcet's|behcet's
5406432|NCT01693354|inflammation|inflammation
5406433|NCT01693354|quality of life|quality of life
5406434|NCT01693341|Chronic stroke patients|chronic stroke patients
5406435|NCT01693341|Stroke rehabilitation|stroke rehabilitation
5406436|NCT01693341|Caregiver|caregiver
5406723|NCT01692197|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
5406724|NCT01692197|HRMDS|hrmds
5406725|NCT01692197|E7070|e7070
5406726|NCT01692197|Idarubicin|idarubicin
5406730|NCT01692197|Cytosar|cytosar
5406925|NCT01691313|a-fib|a-fib
5407133|NCT01690325|PET|pet
5407739|NCT01687712|Finox|finox
5407740|NCT01687699|cardiovascular event|cardiovascular event
5408041|NCT01686282|Postmenopausal|postmenopausal
5408042|NCT01686282|Pulse Wave Velocity|pulse wave velocity
5408045|NCT01686256|Ovarian Cancer|ovarian cancer
5408142|NCT01685762|Uterus|uterus
5409734|NCT01678859|cervical|cervical
5409735|NCT01678859|mucus|mucus
5409837|NCT01678456|Resuscitation|resuscitation
5409838|NCT01678430|Chronic Lymphocytic Leukaemia|chronic lymphocytic leukaemia
5409839|NCT01678430|Less fit|less fit
5410626|NCT01674881|Potential mediators and moderators|potential mediators and moderators
5410627|NCT01674881|Effectiveness of MBCT on psychological symptoms|effectiveness of mbct on psychological symptoms
5410628|NCT01674868|stroke|stroke
5410629|NCT01674868|recovery|recovery
5410630|NCT01674868|fluoxetine|fluoxetine
5410631|NCT01674868|aphasia|aphasia
5410632|NCT01674868|neglect|neglect
5410633|NCT01674868|motor|motor
5410634|NCT01674855|PEG-G-CSF|peg-g-csf
5410736|NCT01674452|Stroke|stroke
5411042|NCT01673048|femur|femur
5411443|NCT01671501|Substance-Related Disorders|substance-related disorders
5411444|NCT01671501|Intervention Studies|intervention studies
5411445|NCT01671501|Primary Health Care|primary health care
5411446|NCT01671501|therapy|therapy
5411447|NCT01671501|prevention & control|prevention & control
5411756|NCT01670097|Hematologic Disorder|hematologic disorder
5411757|NCT01670097|Solid Tumors|solid tumors
5411758|NCT01670097|Dyspnea|dyspnea
5663948|NCT00645879|hyperammonemia|hyperammonemia
5411759|NCT01670097|Difficulty breathing|difficulty breathing
5412408|NCT01667263|danazol|danazol
5412763|NCT01665586|dexmedetomidine|dexmedetomidine
5413362|NCT01662700|P. vivax infection|p. vivax infection
5413363|NCT01662700|Artesunate|artesunate
5413364|NCT01662700|Chloroquine|chloroquine
5413365|NCT01662700|Primaquine|primaquine
5413563|NCT01661777|Nasal steroid|nasal steroid
5413564|NCT01661777|Antihistamine|antihistamine
5413565|NCT01661764|Colorectal Neoplasm|colorectal neoplasm
5413566|NCT01661751|Group ACYW135 Meninigococcal Polysaccharide Vaccine|group acyw135 meninigococcal polysaccharide vaccine
5413945|NCT01659762|inflammatory bowel disease|inflammatory bowel disease
5413947|NCT01659749|Genetics|genetics
5413948|NCT01659749|Metabolic|metabolic
5413949|NCT01659749|Nutrition|nutrition
5413950|NCT01659749|Maternal PKU|maternal pku
5413951|NCT01659749|Phenylketonuria (PKU)|phenylketonuria (pku)
5413952|NCT01659723|Radio therapy|radio therapy
5413953|NCT01659723|STRI|stri
5414555|NCT01656863|Dehydration|dehydration
5414556|NCT01656850|hyperglycemia|hyperglycemia
5414557|NCT01656850|hyperinsulinemia|hyperinsulinemia
5414558|NCT01656837|Substance Abuse|substance abuse
5414559|NCT01656837|Child Maltreatment|child maltreatment
5414661|NCT01656317|SAH|sah
5415353|NCT01653327|pain|pain
5415751|NCT01651403|HBV|hbv
5416049|NCT01649986|Hyperlipidemia|hyperlipidemia
5416050|NCT01649986|Non-pharmacologic prevention|non-pharmacologic prevention
5416051|NCT01649960|Aging|aging
5416052|NCT01649960|Biomarkers|biomarkers
5416053|NCT01649960|CAD|cad
5416054|NCT01649947|Lung cancer|lung cancer
5416055|NCT01649947|Non-small cell lung cancer|non-small cell lung cancer
5416056|NCT01649947|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5416057|NCT01649947|Recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5416058|NCT01649934|Appointments and Schedules|appointments and schedules
5416070|NCT01649869|CMV|cmv
5416254|NCT01649050|Multiple Sclerosis|multiple sclerosis
5416255|NCT01649024|Tremelimumab|tremelimumab
5416354|NCT01648478|insulin sensitivity marker|insulin sensitivity marker
5416355|NCT01648465|metastatic|metastatic
5416356|NCT01648465|unresectable|unresectable
5416357|NCT01648465|well or moderately differentiated|well or moderately differentiated
5416665|NCT01646645|12-086|12-086
5416666|NCT01646632|institutionalized ADL fitness care-dependency|institutionalized adl fitness care-dependency
5416667|NCT01646619|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5416668|NCT01646619|Therapeutic Hypothermia|therapeutic hypothermia
5416669|NCT01646619|Therapeutic Hypothermia plus Adjuvant Therapy|therapeutic hypothermia plus adjuvant therapy
5416670|NCT01646619|Cooling|cooling
5416671|NCT01646606|Bronchiolitis|bronchiolitis
5416672|NCT01646606|Length of stay|length of stay
5416673|NCT01646606|Pilot Projects|pilot projects
5416674|NCT01646606|Oxygen saturation monitoring|oxygen saturation monitoring
5416676|NCT01646567|psoriasis|psoriasis
5416698|NCT01646502|Esp|esp
5416771|NCT01646294|Phase I|phase i
5417396|NCT01643577|nausea|nausea
5417507|NCT01643005|HIV|hiv
5417897|NCT01641185|IPI|ipi
5419073|NCT01635738|Asthma|asthma
5419267|NCT01634802|HIV|hiv
5419458|NCT01633697|emphysema|emphysema
5419459|NCT01633697|chronic bronchitis|chronic bronchitis
5419460|NCT01633684|diabetes mellitus|diabetes mellitus
5419461|NCT01633684|bone|bone
5419462|NCT01633671|Misadventures to Patients During Surgical and Medical Care|misadventures to patients during surgical and medical care
5419463|NCT01633671|Pulmonary Embolism Without Acute Cor Pulmonale|pulmonary embolism without acute cor pulmonale
5419556|NCT01633177|vitamin D|vitamin d
5419557|NCT01633177|omega-3 fatty acids|omega-3 fatty acids
5420265|NCT01629966|GAD|gad
5420338|NCT01629459|strength|strength
5420642|NCT01627938|cranial MRI|cranial mri
5420643|NCT01627938|LVEF|lvef
5420644|NCT01627938|neurological outcome|neurological outcome
5420645|NCT01627925|nasal positive airway pressure|nasal positive airway pressure
5420842|NCT01627067|Metformin|metformin
5420843|NCT01627028|Thai traditional massage|thai traditional massage
5420844|NCT01627028|Bone formation|bone formation
5420847|NCT01627002|Phase 1|phase 1
5421240|NCT01625299|diet|diet
5421532|NCT01624090|Metastatic Lung Tumors|metastatic lung tumors
5421533|NCT01624077|Regulatory T cells|regulatory t cells
5421534|NCT01624077|Liver Transplantation|liver transplantation
5422053|NCT01621555|shoulder surgery|shoulder surgery
5422054|NCT01621555|Pain sensitivity|pain sensitivity
5422055|NCT01621555|Rowe score|rowe score
5422056|NCT01621555|Constant Score|constant score
5422057|NCT01621555|Surgical Outcome|surgical outcome
5422058|NCT01621555|Postoperative pain|postoperative pain
5422059|NCT01621542|Cancer|cancer
5422060|NCT01621542|Vaccine|vaccine
5423035|NCT01617447|Aripiprazole|aripiprazole
5423036|NCT01617447|Double-blind|double-blind
5423037|NCT01617447|Randomized|randomized
5423038|NCT01617447|children and adolescents|children and adolescents
5423039|NCT01617421|Yoga|yoga
5423241|NCT01616563|cardiovascular disease|cardiovascular disease
5423242|NCT01616563|high cholesterol|high cholesterol
5423243|NCT01616563|high triglycerides|high triglycerides
5664061|NCT00645385|MRS|mrs
5424447|NCT01610960|Work of breathing|work of breathing
5424448|NCT01610960|Intensive care|intensive care
5424449|NCT01610947|Spondyloarthritis|spondyloarthritis
5424450|NCT01610947|Anti-TNF|anti-tnf
5424454|NCT01610934|MODY|mody
5424926|NCT01609465|CAD|cad
5426025|NCT01604590|MRI|mri
5426181|NCT01603992|Drug Use|drug use
5426283|NCT01603680|Ultrasonography|ultrasonography
5426394|NCT01603030|LASIK|lasik
5426900|NCT01600872|TAS|tas
5427097|NCT01600053|Chronic|chronic
5427878|NCT01596946|cluster randomisation|cluster randomisation
5427879|NCT01596933|head and neck cancer|head and neck cancer
5427880|NCT01596933|omega-3 fatty acid supplementation|omega-3 fatty acid supplementation
5427977|NCT01596608|Open-label trial|open-label trial
5427978|NCT01596608|Treatment resistant depression|treatment resistant depression
5428370|NCT01594905|CHB|chb
5429962|NCT01587703|BRD3|brd3
5431258|NCT01582399|Healthy Volunteers|healthy volunteers
5431259|NCT01582399|CD40 receptor occupancy|cd40 receptor occupancy
5431260|NCT01582399|Co-stimulation blockade|co-stimulation blockade
5431261|NCT01582399|CD40 antigen|cd40 antigen
5431262|NCT01582399|Anti-CD40|anti-cd40
5431766|NCT01580202|lamivudine|lamivudine
5431767|NCT01580202|entecavir|entecavir
5431768|NCT01580202|prophylaxis|prophylaxis
5431769|NCT01580189|Lean tissue|lean tissue
5431770|NCT01580189|Strength condition|strength condition
5431771|NCT01580189|Protein|protein
5431772|NCT01580189|Amino Acid|amino acid
5431774|NCT01580163|community|community
5431866|NCT01579760|radiation|radiation
5431867|NCT01579760|retinopathy|retinopathy
5431868|NCT01579760|macular edema|macular edema
5432957|NCT01575067|BP|bp
5433132|NCT01574222|Lung Neoplasms|lung neoplasms
5433133|NCT01574222|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5433134|NCT01574222|Thoracic Neoplasms|thoracic neoplasms
5433135|NCT01574222|Neoplasms by Site|neoplasms by site
5433136|NCT01574222|Neoplasms|neoplasms
5433422|NCT01573169|prevention|prevention
5433514|NCT01572792|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5433515|NCT01572792|Chronic Bronchitis|chronic bronchitis
5433516|NCT01572792|Emphysema|emphysema
5433517|NCT01572792|Airflow Obstruction, Chronic|airflow obstruction, chronic
5433518|NCT01572792|Chronic Airflow Obstruction|chronic airflow obstruction
5433519|NCT01572792|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5433521|NCT01572779|dorsavi|dorsavi
5434119|NCT01570426|imaging|imaging
5434120|NCT01570426|Healthy controls|healthy controls
5434121|NCT01570426|typical development|typical development
5434122|NCT01570400|social phobia|social phobia
5434518|NCT01568710|Nitric Oxide|nitric oxide
5434519|NCT01568710|Oximetry|oximetry
5434520|NCT01568710|Laser Doppler|laser doppler
5434521|NCT01568710|Sickle Cell Disease|sickle cell disease
5434531|NCT01568684|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5434532|NCT01568684|Depression|depression
5434533|NCT01568684|Depression Treatment|depression treatment
5434536|NCT01568671|Adult|adult
5434720|NCT01567826|YELLO|yello
5434998|NCT01566604|NVA237|nva237
5435226|NCT01565616|HLA|hla
5435452|NCT01564628|CAD|cad
5435540|NCT01564160|EPA|epa
5435607|NCT01563887|Driving safety|driving safety
5435608|NCT01563887|Internet|internet
5435609|NCT01563887|Web|web
5435610|NCT01563887|Treatment|treatment
5435611|NCT01563887|Intervention|intervention
5435622|NCT01563835|Termination of pregnancy|termination of pregnancy
5435707|NCT01563419|Insulin|insulin
5435708|NCT01563419|Diabetes|diabetes
5435709|NCT01563419|Low vision|low vision
5436717|NCT01558986|modified radical mastectomy|modified radical mastectomy
5437122|NCT01557387|Pseudopolyp|pseudopolyp
5437123|NCT01557387|Inflammatory bowel disease|inflammatory bowel disease
5437124|NCT01557374|Rheumatoid arthritis|rheumatoid arthritis
5437125|NCT01557374|Disease activity|disease activity
5437126|NCT01557374|Remission|remission
5437728|NCT01554813|Influenza Vaccine, Vaccination,|influenza vaccine, vaccination,
5437729|NCT01554800|Lecithin Cholesterol Acyl Transferase|lecithin cholesterol acyl transferase
5437739|NCT01554774|PVR|pvr
5438039|NCT01553526|Diabetes|diabetes
5438040|NCT01553526|Small Vessels|small vessels
5438041|NCT01553526|Chronic Total Occlusion (CTO)|chronic total occlusion (cto)
5438042|NCT01553513|PET|pet
5438043|NCT01553513|Coronary Artery Disease|coronary artery disease
5438044|NCT01553513|Inflammation|inflammation
5438045|NCT01553513|Plaque|plaque
5438046|NCT01553513|Atherosclerosis|atherosclerosis
5438047|NCT01553500|NAFLD|nafld
5438048|NCT01553500|insulin resistance|insulin resistance
5438049|NCT01553500|children|children
5440388|NCT01543945|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5440389|NCT01543945|Ambulatory|ambulatory
5440392|NCT01543932|antiplatelet effect|antiplatelet effect
5440791|NCT01542268|intestinal epithelial barrier|intestinal epithelial barrier
5440792|NCT01542268|irritable bowel syndrome|irritable bowel syndrome
5440793|NCT01542255|Metronomic Therapy|metronomic therapy
5441785|NCT01538056|AAA|aaa
5442464|NCT01534949|DLBCL, Biosimilar|dlbcl, biosimilar
5442465|NCT01534936|schizophrenia|schizophrenia
5442466|NCT01534936|atypical antipsychotics|atypical antipsychotics
5442467|NCT01534936|depressive symptoms|depressive symptoms
5442468|NCT01534923|Doctor-Patient Communication|doctor-patient communication
5442564|NCT01534494|clinical trial|clinical trial
5442565|NCT01534494|motivational enhancement therapy|motivational enhancement therapy
5442568|NCT01534481|Prematurity|prematurity
5443018|NCT01532284|IVF|ivf
5443969|NCT01528462|Sleep Disorders|sleep disorders
5443970|NCT01528462|Sleep Apnea Syndromes|sleep apnea syndromes
5443971|NCT01528462|Restless Legs Syndrome|restless legs syndrome
5444675|NCT01525160|vascular cell adhesion molecule-1|vascular cell adhesion molecule-1
5444775|NCT01524653|Systemic therapy|systemic therapy
5444776|NCT01524653|statin|statin
5444777|NCT01524653|biomarkers|biomarkers
5444778|NCT01524640|oral cholera vaccine|oral cholera vaccine
5445528|NCT01521377|QTc|qtc
5445868|NCT01520025|Myocardial blood flow|myocardial blood flow
5445869|NCT01520025|Myocardial blood flow reserve|myocardial blood flow reserve
5445870|NCT01519999|Shared decision making|shared decision making
5445871|NCT01519999|Ambulatory Care|ambulatory care
5445876|NCT01519986|Vitamin D|vitamin d
5446561|NCT01517204|Left sided double lumen endobronchial tube|left sided double lumen endobronchial tube
5446562|NCT01517204|Efficacy|efficacy
5446563|NCT01517204|Intubation complication|intubation complication
5446564|NCT01517191|Influenza|influenza
5446565|NCT01517191|Respiratory Infection|respiratory infection
5446566|NCT01517165|Opioid Dependence|opioid dependence
5446567|NCT01517165|Pioglitazone|pioglitazone
5446568|NCT01517165|Buprenorphine|buprenorphine
5447056|NCT01515124|Cost Effectiveness|cost effectiveness
5447057|NCT01515111|Non-communicable diseases|non-communicable diseases
5447058|NCT01515111|Preventive services|preventive services
5447474|NCT01513096|PEG|peg
5447763|NCT01512069|diet|diet
5447963|NCT01511354|ICU|icu
5448152|NCT01510483|preteen|preteen
5449004|NCT01506765|NAC|nac
5449448|NCT01505036|Diabetes Mellitus|diabetes mellitus
5449450|NCT01505036|U-health care|u-health care
5449454|NCT01504997|DaVinci|davinci
5449651|NCT01504360|sarcoma|sarcoma
5449834|NCT01503528|arthroplasty|arthroplasty
5449922|NCT01503099|ITB|itb
5450518|NCT01500668|catocholamine|catocholamine
5450519|NCT01500668|shock|shock
5450520|NCT01500668|vasomotor|vasomotor
5450521|NCT01500668|Vasopressin|vasopressin
5450522|NCT01500668|botulinum toxin|botulinum toxin
5450523|NCT01500655|burn|burn
5451008|NCT01498458|German Breast Group|german breast group
5451009|NCT01498458|GBG Forschungs GmbH|gbg forschungs gmbh
5451011|NCT01498458|GBG 62|gbg 62
5451012|NCT01498458|PazoX|pazox
5451013|NCT01498458|Breast Cancer|breast cancer
5451014|NCT01498458|Metastatic Breast Cancer|metastatic breast cancer
5451015|NCT01498458|Pazopanib|pazopanib
5451016|NCT01498458|Abraxane|abraxane
5451017|NCT01498458|Capecitabine|capecitabine
5451018|NCT01498458|Xeloda|xeloda
5451019|NCT01498445|Leukemia|leukemia
5451020|NCT01498445|Chronic myelogenous leukemia|chronic myelogenous leukemia
5451021|NCT01498445|Chronic myeloid leukemia|chronic myeloid leukemia
5451022|NCT01498445|CML|cml
5451023|NCT01498445|Accelerated phase|accelerated phase
5451409|NCT01496898|Levonorgestrel|levonorgestrel
5451410|NCT01496885|stroke|stroke
5451411|NCT01496872|Newborn cranial somatic dysfunction|newborn cranial somatic dysfunction
5451412|NCT01496872|Newborn observational study|newborn observational study
5451413|NCT01496872|Somatic dysfunction|somatic dysfunction
5451423|NCT01496846|Molar|molar
5451706|NCT01495624|rotator cuff repair|rotator cuff repair
5451707|NCT01495624|capsular shift|capsular shift
5451708|NCT01495624|shoulder arthroplasty|shoulder arthroplasty
5451709|NCT01495624|subacromial decompression|subacromial decompression
5451908|NCT01494766|RLS|rls
5452304|NCT01492829|HIV/STI educational video|hiv/sti educational video
5452305|NCT01492829|substance use|substance use
5452306|NCT01492829|women's health|women's health
5452307|NCT01492816|HIV prevention|hiv prevention
5452308|NCT01492816|HIV positive communities|hiv positive communities
5452309|NCT01492803|HIV infection|hiv infection
5452310|NCT01492803|Probiotics|probiotics
5452312|NCT01492764|Ablation|ablation
5452513|NCT01492088|Refractory|refractory
5452514|NCT01492088|Drug therapy|drug therapy
5452515|NCT01492075|Postoperative pain|postoperative pain
5452516|NCT01492075|Anesthetics: Local anesthetics|anesthetics: local anesthetics
5452517|NCT01492075|Surgery: Hysterectomy|surgery: hysterectomy
5452814|NCT01490957|NHL|nhl
5452815|NCT01490931|acute pain|acute pain
5452816|NCT01490931|dental pain|dental pain
5452817|NCT01490931|intranasal ketorolac|intranasal ketorolac
5452831|NCT01490879|DFU|dfu
5453222|NCT01489345|Safety|safety
5453556|NCT01487876|HBV|hbv
5453662|NCT01487694|MENQOL|menqol
5454142|NCT01485575|ICG|icg
5454495|NCT01484093|Iodine|iodine
5664255|NCT00644163|Couples|couples
5454593|NCT01483599|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5454606|NCT01483560|HbA1c|hba1c
5454912|NCT01482156|mTOR|mtor
5455129|NCT01481376|TAPP|tapp
5455382|NCT01480258|tetanus|tetanus
5456609|NCT01475292|COPD|copd
5456610|NCT01475279|Warfarin|warfarin
5456611|NCT01475279|Dantonic|dantonic
5456612|NCT01475279|Pharmacodynamics|pharmacodynamics
5456613|NCT01475279|Pharmacokinetics|pharmacokinetics
5456614|NCT01475279|Interaction|interaction
5456615|NCT01475266|Bladder Cancer|bladder cancer
5456616|NCT01475266|NMIBC|nmibc
5456617|NCT01475266|TURBT|turbt
5457718|NCT01470833|rupture|rupture
5457719|NCT01470833|non-operative|non-operative
5457720|NCT01470833|treatment|treatment
5458021|NCT01469494|DIEP flap|diep flap
5458032|NCT01469481|ADME|adme
5458119|NCT01469130|MEK, Advanced solid tumor|mek, advanced solid tumor
5458120|NCT01469117|Developmental disabilities|developmental disabilities
5458121|NCT01469117|Enteral Nutrition|enteral nutrition
5458122|NCT01469117|Tube feeding|tube feeding
5458123|NCT01469117|Nutrition support|nutrition support
5458124|NCT01469104|Diabetes|diabetes
5458125|NCT01469091|Acute admittance|acute admittance
5458126|NCT01469091|Current smoker|current smoker
5458127|NCT01469078|Chronic Kidney Disease|chronic kidney disease
5458128|NCT01469078|CKD stage 5|ckd stage 5
5458129|NCT01469078|Iron deficiency|iron deficiency
5458130|NCT01469065|inpatient|inpatient
5458131|NCT01469065|diabetes|diabetes
5458132|NCT01469065|phase 1|phase 1
5458133|NCT01469039|Alkermes|alkermes
5458856|NCT01466218|OSA|osa
5458892|NCT01466088|AD|ad
5458989|NCT01465672|SIADH|siadh
5459279|NCT01464411|Phase II|phase ii
5459280|NCT01464411|dasatinib|dasatinib
5459281|NCT01464398|Polycystic Ovary Syndrome|polycystic ovary syndrome
5459283|NCT01464398|mindfulness|mindfulness
5459284|NCT01464398|meditation|meditation
5459487|NCT01463475|Allogeneic|allogeneic
5459980|NCT01461473|Syndrome, Obstructive Sleep Apnea|syndrome, obstructive sleep apnea
5459981|NCT01461473|Syndrome, Sleep Apnea, Obstructive|syndrome, sleep apnea, obstructive
5460098|NCT01460914|ECP|ecp
5460796|NCT01458028|age|age
5460897|NCT01457755|LDV|ldv
5462682|NCT01450150|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
5463003|NCT01448785|obesity|obesity
5463290|NCT01447602|Depressive Disorder Not Otherwise Specified (DDNOS)|depressive disorder not otherwise specified (ddnos)
5463291|NCT01447589|Radiosensitiser|radiosensitiser
5463776|NCT01445691|Glioblastoma|glioblastoma
5463778|NCT01445691|5-ALA|5-ala
5463779|NCT01445691|Aminolevulinic acid|aminolevulinic acid
5463780|NCT01445691|Fluorescence|fluorescence
5463781|NCT01445678|cIAI|ciai
5463782|NCT01445639|dexmedetomidine|dexmedetomidine
5463783|NCT01445639|sedation|sedation
5463784|NCT01445639|neurosurgery|neurosurgery
5463785|NCT01445639|postoperative care|postoperative care
5463786|NCT01445613|Carotid|carotid
5463787|NCT01445613|Stent|stent
5463788|NCT01445613|Carotid Endarterectomy|carotid endarterectomy
5463789|NCT01445600|Impetigo|impetigo
5463790|NCT01445600|secondarily-infected traumatic lesions|secondarily-infected traumatic lesions
5463791|NCT01445600|retapamulin|retapamulin
5463792|NCT01445587|bortezomib|bortezomib
5463881|NCT01445327|Gastrointestinal Cancer|gastrointestinal cancer
5463882|NCT01445327|Esophageal Cancer|esophageal cancer
5463883|NCT01445327|Stomach|stomach
5463884|NCT01445327|Pancreatic Cancer|pancreatic cancer
5463889|NCT01445301|twice daily|twice daily
5463890|NCT01445301|once daily|once daily
5463891|NCT01445301|CLDM 1%-BPO 3% gel|cldm 1%-bpo 3% gel
5463892|NCT01445301|Clindamycin (CLDM)|clindamycin (cldm)
5463893|NCT01445301|benzoyl peroxide (BPO)|benzoyl peroxide (bpo)
5463894|NCT01445301|inflammatory lesion|inflammatory lesion
5463895|NCT01445301|non-inflammatory lesion|non-inflammatory lesion
5464678|NCT01441999|prevent kyphosis|prevent kyphosis
5464679|NCT01441999|long constructs|long constructs
5464680|NCT01441986|dextromethorphan|dextromethorphan
5464681|NCT01441986|amantadine|amantadine
5464682|NCT01441986|blood glucose lowering effect|blood glucose lowering effect
5465443|NCT01439139|DXA|dxa
5465594|NCT01438528|Pediatric subject|pediatric subject
5465602|NCT01438502|cardiac surgery|cardiac surgery
5465603|NCT01438502|cardio-pulmonary-bypass|cardio-pulmonary-bypass
5465604|NCT01438489|MEDI-546|medi-546
5465605|NCT01438489|Anifrolumab|anifrolumab
5465606|NCT01438489|Systemic Lupus Erythematosus|systemic lupus erythematosus
5465607|NCT01438476|Liver Cancer|liver cancer
5465608|NCT01438476|Pancreatic Cancer|pancreatic cancer
5465609|NCT01438476|Thoracic epidural analgesia|thoracic epidural analgesia
5465610|NCT01438476|TEA|tea
5465785|NCT01437813|DM2|dm2
5465786|NCT01437813|glimepiride|glimepiride
5465787|NCT01437813|metformin extended release|metformin extended release
5465788|NCT01437800|DM2|dm2
5465789|NCT01437800|glimepiride|glimepiride
5466486|NCT01434836|Anti-depressant effects|anti-depressant effects
5466487|NCT01434823|nocturnal staffing|nocturnal staffing
5466488|NCT01434823|intensivist staffing|intensivist staffing
5466777|NCT01433718|Anterior Cruciate Ligament Risk Factors|anterior cruciate ligament risk factors
5466815|NCT01433523|HDM|hdm
5466976|NCT01433003|Improve treatment response|improve treatment response
5466977|NCT01433003|TTP/HUS|ttp/hus
5466978|NCT01432990|SCI|sci
5466980|NCT01432990|rehabilitation|rehabilitation
5466982|NCT01432964|Orbital Fractures|orbital fractures
5467282|NCT01431677|Biopsy|biopsy
5468063|NCT01428908|safety|safety
5468475|NCT01427140|Palm oil|palm oil
5468476|NCT01427140|Sunflower oil|sunflower oil
5468477|NCT01427114|extranodal marginal zone lymphoma|extranodal marginal zone lymphoma
5468661|NCT01426256|cystic fibrosis|cystic fibrosis
5468662|NCT01426256|respiratory tract infection|respiratory tract infection
5468664|NCT01426256|intervention studies|intervention studies
5468665|NCT01426256|inflammation|inflammation
5469152|NCT01424202|Post extubation failure|post extubation failure
5469153|NCT01424202|Mechanical Insufflation-Exsufflation|mechanical insufflation-exsufflation
5469154|NCT01424202|Noninvasive Ventilation|noninvasive ventilation
5469155|NCT01424202|Weaning|weaning
5469156|NCT01424189|Cataract surgery|cataract surgery
5469157|NCT01424189|Intraocular lens|intraocular lens
5469158|NCT01424150|Postoperative fluid|postoperative fluid
5469159|NCT01424150|surgery|surgery
5469160|NCT01424150|anaesthesia|anaesthesia
5469262|NCT01423838|Solifenacin|solifenacin
5469263|NCT01423838|Oxybutynin|oxybutynin
5469265|NCT01423812|treatment-experienced|treatment-experienced
5469266|NCT01423812|protease inhibitor|protease inhibitor
5469267|NCT01423812|adherence|adherence
5469268|NCT01423812|lipids|lipids
5469269|NCT01423799|Quality of life|quality of life
5469460|NCT01423006|Radio Frequency|radio frequency
5469461|NCT01423006|RFA|rfa
5469462|NCT01423006|minimally invasive|minimally invasive
5469463|NCT01423006|prostate gland|prostate gland
5469464|NCT01422993|Oxaliplatin Induced|oxaliplatin induced
5469588|NCT01422460|PRP|prp
5470168|NCT01420367|Simple|simple
5470368|NCT01419600|Phase 1|phase 1
5470648|NCT01418378|fixed|fixed
5470649|NCT01418378|primary|primary
5470650|NCT01418378|total|total
5470651|NCT01418378|knee|knee
5470652|NCT01418378|arthroplasty|arthroplasty
5470653|NCT01418378|cemented|cemented
5470654|NCT01418378|osteoarthritis|osteoarthritis
5470655|NCT01418352|Tourette's Disorder|tourette's disorder
5470661|NCT01418326|skin|skin
5470753|NCT01417884|molecular cardiology|molecular cardiology
5471432|NCT01415089|Family caregiver|family caregiver
5472161|NCT01412164|DES|des
5472341|NCT01411488|Focus: anal erosion|focus: anal erosion
5472342|NCT01411449|Primovist|primovist
5472343|NCT01411449|MRI agent|mri agent
5472344|NCT01411436|Nexavar|nexavar
5472345|NCT01411436|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5472346|NCT01411423|Nexavar|nexavar
5472347|NCT01411423|Unresectable or advanced renal cell carcinoma|unresectable or advanced renal cell carcinoma
5472547|NCT01410578|PCT|pct
5473153|NCT01408290|vaccine|vaccine
5473428|NCT01407302|internal jugular vein cannulation|internal jugular vein cannulation
5473433|NCT01407237|HIV-infection|hiv-infection
5473434|NCT01407237|renin|renin
5473435|NCT01407237|aldosterone|aldosterone
5473454|NCT01407172|PAD|pad
5473940|NCT01405170|bioequivalence study|bioequivalence study
5473941|NCT01405170|methylprednisolone|methylprednisolone
5473943|NCT01405170|tablets|tablets
5473944|NCT01405170|fed|fed
5473947|NCT01405157|suspension|suspension
5474049|NCT01404871|pharmacogenetics|pharmacogenetics
5474050|NCT01404871|cortical inhibition|cortical inhibition
5474052|NCT01404858|IVF|ivf
5474447|NCT01403090|Deep Vein Thrombosis|deep vein thrombosis
5474448|NCT01403090|Venous Thromboembolism|venous thromboembolism
5474449|NCT01403090|Central Line Catheter|central line catheter
5474450|NCT01403090|Vena Cava Filters|vena cava filters
5474645|NCT01402284|Decreased Peripheral Neuropathy|decreased peripheral neuropathy
5474646|NCT01402284|Auto Stem Cell Transplant|auto stem cell transplant
5475046|NCT01400542|Cognitive functions|cognitive functions
5475240|NCT01399606|Excessive Daytime Sleepiness (EDS)|excessive daytime sleepiness (eds)
5475241|NCT01399606|Narcolepsy|narcolepsy
5475242|NCT01399593|Antibody Mediated Rejection|antibody mediated rejection
5475245|NCT01399593|AHR|ahr
5477641|NCT01389011|PVI|pvi
5478246|NCT01386580|Neoplasm Metastasis|neoplasm metastasis
5478247|NCT01386580|Neoplasms|neoplasms
5478248|NCT01386580|Central Nervous System Neoplasms|central nervous system neoplasms
5478258|NCT01386567|low T|low t
5478816|NCT01383993|Voriconazole|voriconazole
5478817|NCT01383993|Immunocompromise|immunocompromise
5478818|NCT01383993|Children|children
5478820|NCT01383980|Enteral Nutrition|enteral nutrition
5479015|NCT01383044|Banding ligation with Carvedilol|banding ligation with carvedilol
5479016|NCT01383044|the efficacy & safety of combining EVL and carvedilol in prevention of first variceal bleeding|the efficacy & safety of combining evl and carvedilol in prevention of first variceal bleeding
5479605|NCT01380652|COPD III/IV|copd iii/iv
5479606|NCT01380652|Activity Monitoring|activity monitoring
5479607|NCT01380652|SenseWear|sensewear
5479608|NCT01380652|Vibration training|vibration training
5479609|NCT01380652|Galileo|galileo
5479610|NCT01380652|Pulmonary rehabilitation|pulmonary rehabilitation
5479611|NCT01380639|COPD III/IV|copd iii/iv
5479620|NCT01380613|HIV|hiv
5480735|NCT01376076|QTc|qtc
5480820|NCT01375764|Elevated Cholesterol|elevated cholesterol
5480821|NCT01375764|Statin intolerant|statin intolerant
5480822|NCT01375764|Hypercholesterolemia|hypercholesterolemia
5480823|NCT01375751|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5480824|NCT01375751|Proprotein convertase subtilisin/kexin type 9 (PCSK9)|proprotein convertase subtilisin/kexin type 9 (pcsk9)
5481025|NCT01374906|SOM230|som230
5481518|NCT01372657|refraction|refraction
5481519|NCT01372657|iol|iol
5481520|NCT01372657|calculation|calculation
5481521|NCT01372657|formula|formula
5481528|NCT01372605|Depression|depression
5481529|NCT01372605|HIV|hiv
5481530|NCT01372605|Adherence|adherence
5481533|NCT01372553|Primary care|primary care
5483031|NCT01366196|Orthopedic Procedures|orthopedic procedures
5483032|NCT01366196|Spinal Fusions|spinal fusions
5483033|NCT01366196|Pregabalin|pregabalin
5483034|NCT01366196|Gamma-Aminobutyric Acid|gamma-aminobutyric acid
5483461|NCT01364415|MTD|mtd
5483824|NCT01362920|Procalcitonin|procalcitonin
5483826|NCT01362881|Early|early
5483827|NCT01362881|Onset|onset
5483828|NCT01362881|Scoliosis|scoliosis
5484032|NCT01362166|Chinese medicine|chinese medicine
5484033|NCT01362166|channel|channel
5484034|NCT01362166|acupuncture|acupuncture
5484035|NCT01362166|ZuSanLi|zusanli
5484135|NCT01361789|Coxib|coxib
5484283|NCT01361191|PET|pet
5484331|NCT01360970|hepatitis A vaccine|hepatitis a vaccine
5484332|NCT01360970|TNF-alfa inhibitory drugs|tnf-alfa inhibitory drugs
5484333|NCT01360970|Rheumatoid arthritis|rheumatoid arthritis
5484334|NCT01360970|methotrexate|methotrexate
5484335|NCT01360957|Obesity|obesity
5484608|NCT01359982|Contrast Enhanced Ultrasound (CEUS)|contrast enhanced ultrasound (ceus)
5484609|NCT01359969|Hereditary Angioedema|hereditary angioedema
5484610|NCT01359969|HAE|hae
5484994|NCT01358175|AS|as
5485097|NCT01357811|digoxin|digoxin
5485400|NCT01356277|renal|renal
5485401|NCT01356277|allograft|allograft
5485402|NCT01356277|immunosuppressive|immunosuppressive
5485403|NCT01356277|immunosuppression|immunosuppression
5485404|NCT01356277|adherence|adherence
5485405|NCT01356277|medication|medication
5485406|NCT01356277|compliance|compliance
5485407|NCT01356264|colorectal cancer|colorectal cancer
5485408|NCT01356264|colorectal surgery|colorectal surgery
5485409|NCT01356264|prehabilitation|prehabilitation
5485411|NCT01356264|exercise|exercise
5485914|NCT01354067|Single Limb|single limb
5486026|NCT01353599|Spinal Cord Injury|spinal cord injury
5486027|NCT01353599|Tetraplegia|tetraplegia
5486028|NCT01353599|Pulmonary Function|pulmonary function
5486029|NCT01353573|Brain Neoplasms|brain neoplasms
5486030|NCT01353573|Neoplasm Metastasis|neoplasm metastasis
5486031|NCT01353573|Neoplasms|neoplasms
5486032|NCT01353560|integrative medicine|integrative medicine
5486033|NCT01353560|barriers to utilization|barriers to utilization
5486034|NCT01353560|communication|communication
5486035|NCT01353534|Immunogenicity and Safety|immunogenicity and safety
5486036|NCT01353521|complex renal cysts|complex renal cysts
5486037|NCT01353521|Contrast enhanced ultrasound|contrast enhanced ultrasound
5486038|NCT01353508|Sodium excretion,|sodium excretion,
5486039|NCT01353508|LCZ696|lcz696
5486040|NCT01353495|Diabetic Foot Ulcers|diabetic foot ulcers
5486041|NCT01353482|mesothelioma|mesothelioma
5486042|NCT01353482|vorinostat|vorinostat
5486111|NCT01353222|Bladder cancer|bladder cancer
5486112|NCT01353222|Renal pelvis cancer|renal pelvis cancer
5486113|NCT01353222|Ureteral cancer|ureteral cancer
5486114|NCT01353222|Urethral cancer|urethral cancer
5486116|NCT01353222|Renal pelvis|renal pelvis
5486117|NCT01353222|Ureter|ureter
5486118|NCT01353222|Urethra|urethra
5486119|NCT01353222|Immune therapy|immune therapy
5486120|NCT01353222|Immunotherapy|immunotherapy
5486121|NCT01353222|Vaccine|vaccine
5486122|NCT01353222|Dendritic cells|dendritic cells
5486123|NCT01353222|Antigen-presenting cells|antigen-presenting cells
5486124|NCT01353222|Antigen presenting cells|antigen presenting cells
5486512|NCT01351610|Mesenchymal Stem Cells|mesenchymal stem cells
5486513|NCT01351597|recurrent breast cancer|recurrent breast cancer
5486514|NCT01351597|metastatic breast cancer|metastatic breast cancer
5486515|NCT01351597|docetaxel|docetaxel
5486516|NCT01351597|oxaliplatin|oxaliplatin
5486527|NCT01351519|Glioma|glioma
5486528|NCT01351519|Glioblastoma|glioblastoma
5486529|NCT01351519|Glioblastoma Multiforme|glioblastoma multiforme
5486530|NCT01351519|Astrocytoma|astrocytoma
5486531|NCT01351519|Brain Tumor|brain tumor
5486532|NCT01351506|Body weight|body weight
5486612|NCT01351103|melanoma|melanoma
5486613|NCT01351103|triple negative breast cancer|triple negative breast cancer
5486614|NCT01351103|PDR001|pdr001
5486615|NCT01351103|immunotherapy|immunotherapy
5486616|NCT01351103|head and neck scc|head and neck scc
5486619|NCT01351103|lung scc|lung scc
5486835|NCT01350141|LDL|ldl
5487018|NCT01349465|Virus Infection|virus infection
5487019|NCT01349452|Conjunctivitis, Viral|conjunctivitis, viral
5487020|NCT01349452|Adenoviridae Infections|adenoviridae infections
5487117|NCT01349088|metastatic breast cancer|metastatic breast cancer
5487218|NCT01348711|Pre-eclampsia|pre-eclampsia
5487219|NCT01348698|Adrenal Cancer|adrenal cancer
5487220|NCT01348698|Pheochromocytoma|pheochromocytoma
5487221|NCT01348698|Functioning Tumor|functioning tumor
5487222|NCT01348698|Nonfunctioning Tumor|nonfunctioning tumor
5488004|NCT01345591|BTI|bti
5488109|NCT01345214|Thrombocytopenia|thrombocytopenia
5488110|NCT01345201|Phase 1|phase 1
5488111|NCT01345201|dose escalation|dose escalation
5488112|NCT01345201|histologically confirmed|histologically confirmed
5488113|NCT01345201|malignancy metastatic|malignancy metastatic
5488229|NCT01344759|MRI|mri
5488316|NCT01344382|Parent|parent
5488592|NCT01343134|Retina|retina
5488996|NCT01341210|Informed Consent|informed consent
5488997|NCT01341197|Fecal immunochemical test|fecal immunochemical test
5488998|NCT01341197|Guaiac fecal occult blood test|guaiac fecal occult blood test
5489678|NCT01338506|Alcohol Abuse|alcohol abuse
5489679|NCT01338506|Alcohol Dependence|alcohol dependence
5489680|NCT01338506|Substance Use Disorders|substance use disorders
5489681|NCT01338506|Alcoholism|alcoholism
5489682|NCT01338480|trauma|trauma
5489683|NCT01338480|surgery|surgery
5489684|NCT01338480|informed consent|informed consent
5489685|NCT01338467|Glaucoma|glaucoma
5489686|NCT01338467|Refractory glaucoma|refractory glaucoma
5489733|NCT01338129|rds|rds
5489782|NCT01337960|Stroke|stroke
5490193|NCT01336426|PAD|pad
5490394|NCT01335607|HCV|hcv
5490605|NCT01334697|CT-1|ct-1
5490978|NCT01333059|Cycling|cycling
5491491|NCT01330888|war|war
5491703|NCT01329887|SDF|sdf
5492294|NCT01327430|sphingomyelins|sphingomyelins
5492295|NCT01327417|Depression|depression
5492296|NCT01327404|Depression|depression
5492297|NCT01327404|Diabetes Mellitus|diabetes mellitus
5492520|NCT01326572|HIV|hiv
5492605|NCT01326234|Smoking|smoking
5492606|NCT01326234|Motivation|motivation
5492607|NCT01326234|Cessation|cessation
5492608|NCT01326221|Truvada|truvada
5492796|NCT01325415|NKTR-118|nktr-118
5492797|NCT01325402|Radioligand|radioligand
5492798|NCT01325402|Alzheimers disease|alzheimers disease
5492799|NCT01325402|Maximum Diagnostic Mass|maximum diagnostic mass
5492800|NCT01325402|Beta amyloid|beta amyloid
5492801|NCT01325376|overweight|overweight
5493026|NCT01324362|FP|fp
5493190|NCT01323556|fear augmentation|fear augmentation
5493191|NCT01323556|in vivo exposure|in vivo exposure
5493192|NCT01323543|Back Pain,|back pain,
5493438|NCT01322698|ICU|icu
5494688|NCT01317355|Pain|pain
5494689|NCT01317355|Fatigue|fatigue
5494690|NCT01317355|Sleep disorder|sleep disorder
5494691|NCT01317355|HRQoL|hrqol
5494692|NCT01317342|liver transplantation|liver transplantation
5494693|NCT01317342|machine liver perfusion|machine liver perfusion
5494784|NCT01316913|long-acting muscarinic antagonist|long-acting muscarinic antagonist
5494786|NCT01316913|long-acting beta agonist|long-acting beta agonist
5494788|NCT01316900|tiotropium|tiotropium
5495781|NCT01313442|Gut Microbiota|gut microbiota
5495782|NCT01313442|Analysis of immune subsets with regard to their function|analysis of immune subsets with regard to their function
5495783|NCT01313442|Samples|samples
5495784|NCT01313442|Gastrointestinal Cancer|gastrointestinal cancer
5495785|NCT01313442|Gastrointestinal Tract Cancer|gastrointestinal tract cancer
5495795|NCT01313416|Adjuvant Therapy|adjuvant therapy
5495798|NCT01313416|Vaccination|vaccination
5495953|NCT01312740|fat mass|fat mass
5495954|NCT01312740|systemic inflammatory markers|systemic inflammatory markers
5495955|NCT01312740|improvement of complications|improvement of complications
5495968|NCT01312714|Calcium|calcium
5496100|NCT01312116|GAD|gad
5496146|NCT01311856|Internet interventions|internet interventions
5496153|NCT01311765|Surgery|surgery
5497237|NCT01307202|knee|knee
5497354|NCT01306812|Alcohol|alcohol
5497531|NCT01306136|Posttraumatic stress disorder|posttraumatic stress disorder
5497532|NCT01306136|Prolonged exposure|prolonged exposure
5497533|NCT01306136|Cognitive behavior therapy|cognitive behavior therapy
5497553|NCT01306058|TRC105|trc105
5497747|NCT01305317|Statin|statin
5498665|NCT01301690|FNA|fna
5498731|NCT01301261|blood pressure|blood pressure
5498732|NCT01301261|heart rate|heart rate
5498733|NCT01301261|oxygenation|oxygenation
5498764|NCT01301118|Burns|burns
5499033|NCT01300013|Omecamtiv mecarbil|omecamtiv mecarbil
5499034|NCT01300013|Double-blind|double-blind
5499035|NCT01300013|Randomized|randomized
5499036|NCT01300013|Placebo-controlled|placebo-controlled
5499037|NCT01299987|Keywords provided by University Hospital Mannheim:|keywords provided by university hospital mannheim:
5499048|NCT01299948|HIV|hiv
5500021|NCT01295710|US-ATG-F (Anti-human-T-lymphocyte Immune Globulin, Rabbit)|us-atg-f (anti-human-t-lymphocyte immune globulin, rabbit)
5500022|NCT01295697|Patients with non-CNS or CNS tumors|patients with non-cns or cns tumors
5500023|NCT01295697|Pediatric patients with Relapsed/Refractory Solid Tumors|pediatric patients with relapsed/refractory solid tumors
5500025|NCT01295684|cardiovascular|cardiovascular
5500026|NCT01295684|adhesion|adhesion
5500027|NCT01295684|polyphenol|polyphenol
5500143|NCT01295359|Walking|walking
5500302|NCT01294748|Drug-eluting Stent|drug-eluting stent
5500303|NCT01294748|Sirolimus|sirolimus
5500304|NCT01294735|Temozolomide|temozolomide
5500305|NCT01294735|glioblastoma multiforme|glioblastoma multiforme
5500306|NCT01294735|melanoma|melanoma
5500307|NCT01294735|advanced neoplasm|advanced neoplasm
5500308|NCT01294722|Rheumatoid Arthritis|rheumatoid arthritis
5500309|NCT01294722|anti-TNF α|anti-tnf α
5500400|NCT01294358|Selective Arterial Infusion|selective arterial infusion
5500401|NCT01294358|Locally Advanced Disease|locally advanced disease
5500406|NCT01294332|Cognition|cognition
5500961|NCT01292031|VAP|vap
5501611|NCT01289470|NIRS Technology|nirs technology
5501612|NCT01289470|Cardiovascular surgery|cardiovascular surgery
5501613|NCT01289470|valvular surgery with cardiopulmonary bypass|valvular surgery with cardiopulmonary bypass
5501630|NCT01289444|palliative care|palliative care
5501631|NCT01289444|AIDS|aids
5501632|NCT01289444|adolescents|adolescents
5501633|NCT01289444|quality of life|quality of life
5501634|NCT01289444|adherence|adherence
5501635|NCT01289444|spiritual|spiritual
5501636|NCT01289444|threat appraisal|threat appraisal
5501637|NCT01289444|treatment congruence|treatment congruence
5501638|NCT01289444|treatment preferences|treatment preferences
5501639|NCT01289444|dialysis|dialysis
5502793|NCT01284465|Minority women|minority women
5503008|NCT01283360|MSM|msm
5503278|NCT01281995|Glucocorticoids|glucocorticoids
5503279|NCT01281995|Immune Modulation|immune modulation
5503280|NCT01281995|Healthy Volunteer|healthy volunteer
5503282|NCT01281982|Imaging|imaging
5504192|NCT01277952|DBS|dbs
5504933|NCT01274910|Knee|knee
5505147|NCT01274078|lipids|lipids
5505237|NCT01273727|dexamethasone|dexamethasone
5505238|NCT01273727|intravitreal implant|intravitreal implant
5505239|NCT01273714|benign thyroid disease|benign thyroid disease
5505240|NCT01273714|incidental thyroid cancer|incidental thyroid cancer
5505241|NCT01273714|recurrent goiter|recurrent goiter
5505242|NCT01273714|revision thyroid surgery|revision thyroid surgery
5505243|NCT01273701|amphetamine|amphetamine
5505244|NCT01273701|methamphetamine|methamphetamine
5505331|NCT01273402|IMP288 (DOTA-di-HSG hapten-peptide for 111In/90Y labeling)|imp288 (dota-di-hsg hapten-peptide for 111in/90y labeling)
5505332|NCT01273389|Lupus nephritis|lupus nephritis
5505333|NCT01273389|CNTO 136|cnto 136
5505334|NCT01273389|Sirukumab|sirukumab
5505335|NCT01273389|Kidney diseases|kidney diseases
5505336|NCT01273389|Proteinuria|proteinuria
5505337|NCT01273389|Glomerulonephritis|glomerulonephritis
5505338|NCT01273376|MDD|mdd
5505339|NCT01273376|Depression|depression
5505340|NCT01273376|Major Depression|major depression
5505341|NCT01273363|Asthma|asthma
5505342|NCT01273363|Asthma in Children|asthma in children
5505343|NCT01273350|internal carotid artery|internal carotid artery
5505344|NCT01273350|common carotid artery|common carotid artery
5505345|NCT01273350|bruit|bruit
5505346|NCT01273350|tia|tia
5505347|NCT01273337|Stroke|stroke
5505691|NCT01272141|Estrogen receptor (ER)/progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2)-negative breast cancer|estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer
5505692|NCT01272115|Climacteric stage|climacteric stage
5505693|NCT01272115|Integrative health care model|integrative health care model
5505900|NCT01271270|AMD|amd
5505996|NCT01270854|Fluid resuscitation|fluid resuscitation
5505998|NCT01270815|pregabalin|pregabalin
5506188|NCT01269944|knee|knee
5506314|NCT01269528|EBC|ebc
5506605|NCT01268163|Phase I|phase i
5506891|NCT01266889|preterm infant,cerebral oxygenation, intracranial haemorrhagia|preterm infant,cerebral oxygenation, intracranial haemorrhagia
5506892|NCT01266863|Hospital-acquired pneumonia|hospital-acquired pneumonia
5506894|NCT01266863|Antibiogram|antibiogram
5506895|NCT01266863|Bronchoalveolar lavage|bronchoalveolar lavage
5506896|NCT01266850|vaccine, rotavirus, gastroenteritis, infants|vaccine, rotavirus, gastroenteritis, infants
5506897|NCT01266837|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5506898|NCT01266837|biomarker|biomarker
5506899|NCT01266837|Everolimus|everolimus
5506900|NCT01266824|Pain|pain
5506901|NCT01266824|Retinopathy of Prematurity|retinopathy of prematurity
5506902|NCT01266824|Neonates|neonates
5506903|NCT01266811|dexamethasone|dexamethasone
5506904|NCT01266811|Siltuximab|siltuximab
5506905|NCT01266811|CNTO 328|cnto 328
5506906|NCT01266811|IL-6|il-6
5506907|NCT01266811|Monoclonal Antibody|monoclonal antibody
5506908|NCT01266811|Multiple Myeloma|multiple myeloma
5506909|NCT01266811|Relapsed or Refractory|relapsed or refractory
5506910|NCT01266811|Velcade|velcade
5506911|NCT01266811|bortezomib|bortezomib
5506912|NCT01266798|Health literacy, participation|health literacy, participation
5507190|NCT01265680|HRE|hre
5507191|NCT01265667|Psoriasis|psoriasis
5507192|NCT01265667|Plaque psoriasis|plaque psoriasis
5507193|NCT01265654|Advanced Breast Cancer|advanced breast cancer
5507488|NCT01264250|Tolerability|tolerability
5507489|NCT01264250|pharmacokinetics|pharmacokinetics
5507490|NCT01264250|drug metabolism|drug metabolism
5507491|NCT01264237|Postherpetic neuralgia|postherpetic neuralgia
5507492|NCT01264237|Neuropathic pain|neuropathic pain
5507542|NCT01263938|HIV|hiv
5507977|NCT01262183|panitumumab|panitumumab
5508859|NCT01258114|Obesity|obesity
5509058|NCT01257269|Hemolytic anemia|hemolytic anemia
5509059|NCT01257256|infertile patients|infertile patients
5509060|NCT01257243|cough|cough
5509254|NCT01256346|heart rate|heart rate
5509255|NCT01256346|resuscitation|resuscitation
5509257|NCT01256307|Exercise training program|exercise training program
5509452|NCT01255462|C5,|c5,
5510246|NCT01251965|Ruxolitinib|ruxolitinib
5510247|NCT01251965|Jakafi|jakafi
5510248|NCT01251965|INC424|inc424
5510832|NCT01249209|effect after two years treatment for lifestyle change - morbid obesity adults|effect after two years treatment for lifestyle change - morbid obesity adults
5510833|NCT01249183|Diphtheria|diphtheria
5510834|NCT01249183|Tetanus|tetanus
5510835|NCT01249183|Pertussis (acellular, component)|pertussis (acellular, component)
5510839|NCT01249157|MRI|mri
5510937|NCT01248754|Neuronavigation|neuronavigation
5510938|NCT01248754|Positron emission tomography|positron emission tomography
5510940|NCT01248741|prostate cancer|prostate cancer
5511127|NCT01247844|circumcision|circumcision
5511128|NCT01247844|HIV prevention|hiv prevention
5511129|NCT01247844|device|device
5511130|NCT01247831|glaucoma, selective laser trabeculoplasty, ocular rigidity|glaucoma, selective laser trabeculoplasty, ocular rigidity
5511131|NCT01247805|Bioequivalence|bioequivalence
5511902|NCT01244295|Bereavement|bereavement
5511903|NCT01244295|Psychotherapy|psychotherapy
5511904|NCT01244295|Randomized controlled trial|randomized controlled trial
5511911|NCT01244243|stroke|stroke
5511992|NCT01243749|Target Lesion Revascularization (TLR)|target lesion revascularization (tlr)
5511993|NCT01243749|Myocardial Infarction (MI)|myocardial infarction (mi)
5511994|NCT01243749|Target Vessel Failure (TVF)|target vessel failure (tvf)
5512000|NCT01243736|anemic|anemic
5512976|NCT01239693|LNS|lns
5513268|NCT01238354|Social support|social support
5513269|NCT01238341|Pancreatobiliary disease in patients with altered gastric anatomy.|pancreatobiliary disease in patients with altered gastric anatomy.
5513270|NCT01238328|Mucopolysaccharidosis|mucopolysaccharidosis
5513271|NCT01238328|HSCT|hsct
5513272|NCT01238315|Batten's disease|batten's disease
5513273|NCT01238315|INCL|incl
5513274|NCT01238315|LINCL|lincl
5513275|NCT01238315|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
5513276|NCT01238315|NCL|ncl
5513277|NCT01238289|peer education|peer education
5513278|NCT01238289|diabetes|diabetes
5513279|NCT01238289|randomized|randomized
5513280|NCT01238289|trial|trial
5513281|NCT01238276|soft tissue infection|soft tissue infection
5513282|NCT01238276|wound infection|wound infection
5513283|NCT01238276|cellulitis|cellulitis
5513284|NCT01238276|foot ulcer|foot ulcer
5513285|NCT01238276|Diabetes|diabetes
5513286|NCT01238276|antibiotics|antibiotics
5513287|NCT01238276|cefazolin|cefazolin
5513288|NCT01238276|cephazolin|cephazolin
5513289|NCT01238276|Ancef|ancef
5513290|NCT01238276|Kefzol|kefzol
5513291|NCT01238276|subcutaneous fluid administration|subcutaneous fluid administration
5513292|NCT01238276|ultrasound|ultrasound
5513293|NCT01238276|MRSA|mrsa
5513294|NCT01238276|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5513295|NCT01238263|Atopic dermatitis, autologous serum skin testing, IgE autoantibodies|atopic dermatitis, autologous serum skin testing, ige autoantibodies
5513377|NCT01238237|Glioblastoma Multiforme|glioblastoma multiforme
5513378|NCT01238237|Anaplastic Astrocytoma|anaplastic astrocytoma
5513379|NCT01238237|High Grade Glial Neoplasms|high grade glial neoplasms
5513380|NCT01238237|Brain Tumor|brain tumor
5513381|NCT01238237|EGFR|egfr
5513382|NCT01238237|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5513383|NCT01238237|EGFRvIII|egfrviii
5513487|NCT01237743|Embolism|embolism
5514577|NCT01233063|web|web
5514770|NCT01232140|exacerbation|exacerbation
5514771|NCT01232140|antibiotic treatment|antibiotic treatment
5514773|NCT01232140|sputum|sputum
5514774|NCT01232140|inflammation|inflammation
5514776|NCT01232088|drug labelling|drug labelling
5515072|NCT01230788|ALL|all
5516028|NCT01226212|Immune|immune
5516119|NCT01225640|EBA|eba
5516732|NCT01222767|EFT|eft
5516838|NCT01222338|HIV|hiv
5516910|NCT01222052|uPA|upa
5517154|NCT01221090|PDA|pda
5517290|NCT01220531|Athymia|athymia
5517680|NCT01218958|Alcoholism|alcoholism
5517681|NCT01218932|primaquine|primaquine
5517682|NCT01218932|chloroquine|chloroquine
5517683|NCT01218932|pharmacokinetic|pharmacokinetic
5517995|NCT01217528|ICD|icd
5519056|NCT01212887|stage IIIB colon cancer|stage iiib colon cancer
5519057|NCT01212887|stage IIIC colon cancer|stage iiic colon cancer
5519058|NCT01212887|stage IV colon cancer|stage iv colon cancer
5519059|NCT01212887|stage IVB colon cancer|stage ivb colon cancer
5519060|NCT01212887|recurrent rectal cancer|recurrent rectal cancer
5519092|NCT01212835|Obesity|obesity
5519249|NCT01212146|Probiotics|probiotics
5519250|NCT01212120|Diabetic foot|diabetic foot
5519251|NCT01212107|Advanced cancer|advanced cancer
5519252|NCT01212107|Metastatic cancer|metastatic cancer
5519253|NCT01212107|Oncology|oncology
5519254|NCT01212094|Rituximab|rituximab
5519255|NCT01212094|Multiple Sclerosis|multiple sclerosis
5519256|NCT01212094|Intrathecal|intrathecal
5520448|NCT01206933|HCV|hcv
5521026|NCT01204515|IBS|ibs
5521511|NCT01202812|Omega-3 Fatty Acids|omega-3 fatty acids
5521512|NCT01202812|Eicosapentaenoic Acid|eicosapentaenoic acid
5521513|NCT01202812|Docosahexaenoic Acid|docosahexaenoic acid
5521514|NCT01202812|Fish Oils|fish oils
5521515|NCT01202812|Drug: Placebo|drug: placebo
5521516|NCT01202812|Drug: LOVAZA|drug: lovaza
5521517|NCT01202799|Pharmacokinetics|pharmacokinetics
5521518|NCT01202799|Healthy volunteers|healthy volunteers
5521519|NCT01202799|PENNSAID|pennsaid
5521612|NCT01202396|pouch|pouch
5521613|NCT01202396|pouchitis|pouchitis
5522891|NCT01197079|HPV|hpv
5523408|NCT01194713|Sleep|sleep
5680424|NCT00577798|cardiac toxicity|cardiac toxicity
5523891|NCT01192750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5524082|NCT01192087|adenoid cystic carcinoma|adenoid cystic carcinoma
5524083|NCT01192087|carbon ion therapy|carbon ion therapy
5524084|NCT01192087|IMRT (intensity-modulated therapy)|imrt (intensity-modulated therapy)
5524085|NCT01192087|radioimmunotherapy|radioimmunotherapy
5525948|NCT01184443|Olanzapine|olanzapine
5525978|NCT01184313|CPB|cpb
5526341|NCT01182831|endosonography guided celiac plexus neurolysis|endosonography guided celiac plexus neurolysis
5526342|NCT01182818|Cerebrovascular Accident|cerebrovascular accident
5526343|NCT01182818|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5526439|NCT01182389|Ventricular Tachycardia|ventricular tachycardia
5526440|NCT01182389|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5526442|NCT01182389|Robotic|robotic
5526443|NCT01182376|Multaq|multaq
5526444|NCT01182376|dronedarone|dronedarone
5526445|NCT01182376|Atrial Fibrillation|atrial fibrillation
5526735|NCT01181206|Surgical site infections|surgical site infections
5526737|NCT01181193|glioblastoma multiforme|glioblastoma multiforme
5526841|NCT01180868|imaging probe|imaging probe
5527033|NCT01180101|Obesity|obesity
5527444|NCT01178268|Stents|stents
5527915|NCT01176292|TKA|tka
5528015|NCT01176032|Essential hypertension with concentric left ventricle hypertrophy|essential hypertension with concentric left ventricle hypertrophy
5528016|NCT01176019|Amniocentesis|amniocentesis
5528416|NCT01174381|community based study|community based study
5528417|NCT01174342|Intraocular pressure|intraocular pressure
5528418|NCT01174342|Ocular tonometry|ocular tonometry
5528419|NCT01174342|Obstetric delivery|obstetric delivery
5528420|NCT01174316|Acute exacerbation|acute exacerbation
5528421|NCT01174316|Respiratory insufficiency|respiratory insufficiency
5530546|NCT01165814|Pain control after cesarean section|pain control after cesarean section
5530547|NCT01165801|AMD|amd
5530548|NCT01165801|Cataract surgery|cataract surgery
5530549|NCT01165801|Size of AMD|size of amd
5530551|NCT01165788|Blood and Marrow Transplant (BMT)|blood and marrow transplant (bmt)
5531001|NCT01163903|Doxorubicin|doxorubicin
5531693|NCT01160744|Lung neoplasms|lung neoplasms
5531694|NCT01160744|Lung cancer|lung cancer
5531695|NCT01160744|Non-small Cell Lung Cancer|non-small cell lung cancer
5531696|NCT01160744|pemetrexed|pemetrexed
5531697|NCT01160744|squamous|squamous
5531698|NCT01160744|nonsquamous|nonsquamous
5531713|NCT01160705|bone metastases|bone metastases
5532269|NCT01158235|MRSA|mrsa
5533664|NCT01152346|MDS|mds
5533814|NCT01151800|ACS|acs
5533876|NCT01151514|Impact|impact
5533956|NCT01150916|liver cirrhosis|liver cirrhosis
5534061|NCT01150695|vaccine, Francisella tularensis, Tularemia, rabbit fever, parent protocol|vaccine, francisella tularensis, tularemia, rabbit fever, parent protocol
5534062|NCT01150682|endometrial adenocarcinoma|endometrial adenocarcinoma
5534063|NCT01150682|stage II endometrial carcinoma|stage ii endometrial carcinoma
5534064|NCT01150682|stage III endometrial carcinoma|stage iii endometrial carcinoma
5534065|NCT01150682|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5534074|NCT01150630|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5534349|NCT01149629|TID|tid
5534441|NCT01149174|early single instillation|early single instillation
5534442|NCT01149174|mitomycin-C|mitomycin-c
5534444|NCT01149161|neck dissection|neck dissection
5534526|NCT01148797|FMF, Colchicine resistant|fmf, colchicine resistant
5534527|NCT01148797|Colchicine intolerant|colchicine intolerant
5534528|NCT01148797|Flare rate|flare rate
5535322|NCT01145625|Female Pattern Baldness|female pattern baldness
5535323|NCT01145612|Aortic dilation|aortic dilation
5535704|NCT01143896|Hepatitis C|hepatitis c
5535705|NCT01143896|Depression|depression
5535706|NCT01143896|Collaborative care|collaborative care
5535707|NCT01143896|Antiviral treatment|antiviral treatment
5535708|NCT01143883|All patients undergoing a colorectal resection|all patients undergoing a colorectal resection
5535709|NCT01143883|surgical site infections|surgical site infections
5535710|NCT01143844|Oncofertility|oncofertility
5535711|NCT01143844|Fertility|fertility
5535806|NCT01143519|Gene Expression|gene expression
5535903|NCT01143207|mg milligram(s)|mg milligram(s)
5535904|NCT01143207|SAE serious adverse event|sae serious adverse event
5536200|NCT01141933|QOL|qol
5536489|NCT01140802|Healthy control|healthy control
5538438|NCT01133561|randomized control trial|randomized control trial
5538439|NCT01133548|testosterone, hypogonadal, males|testosterone, hypogonadal, males
5538440|NCT01133522|AMG145|amg145
5538441|NCT01133522|Multiple Dose|multiple dose
5539236|NCT01130558|insulin ordering|insulin ordering
5539237|NCT01130545|Healthy Volunteer|healthy volunteer
5539238|NCT01130545|Magnetic Resonance Imaging|magnetic resonance imaging
5539239|NCT01130545|Gadolinium|gadolinium
5539241|NCT01130532|Erectile Dysfunction|erectile dysfunction
5539351|NCT01129869|Survey|survey
5539426|NCT01129505|pregnancy|pregnancy
5539427|NCT01129505|intervention|intervention
5539428|NCT01129505|exercise|exercise
5539429|NCT01129505|nutrition|nutrition
5539430|NCT01129505|infants|infants
5539538|NCT01129024|ITP|itp
5539950|NCT01127321|SLE|sle
5540698|NCT01124188|Aged|aged
5540794|NCT01123759|nursing mother|nursing mother
5687298|NCT00548041|HIV|hiv
5540795|NCT01123759|dietary recommendations|dietary recommendations
5540796|NCT01123759|Hair mercury|hair mercury
5540797|NCT01123759|Blood mercury|blood mercury
5540799|NCT01123759|Infant brain health|infant brain health
5541309|NCT01121588|ALK|alk
5541610|NCT01120015|OA|oa
5542105|NCT01118234|Maintenance|maintenance
5542106|NCT01118221|oxidant stress|oxidant stress
5542107|NCT01118221|exercise|exercise
5542108|NCT01118208|Medication adherence|medication adherence
5542109|NCT01118208|Accidental overdose|accidental overdose
5542110|NCT01118208|Deliberate overdose|deliberate overdose
5542111|NCT01118208|Suicide, attempted|suicide, attempted
5542112|NCT01118182|Traumatic Brain Injury|traumatic brain injury
5542113|NCT01118182|Veterans|veterans
5542114|NCT01118182|Psychiatric Disorders|psychiatric disorders
5542115|NCT01118182|Suicide|suicide
5542116|NCT01118169|Personal values|personal values
5542119|NCT01118130|Genetics|genetics
5543054|NCT01115127|pre-menopause|pre-menopause
5543055|NCT01115127|melatonin|melatonin
5543056|NCT01115127|myo-inositol|myo-inositol
5543057|NCT01115101|pain after cesarean|pain after cesarean
5543058|NCT01115101|visual analog scale|visual analog scale
5543059|NCT01115101|oxycodon|oxycodon
5543060|NCT01115101|piritramid|piritramid
5543061|NCT01115075|Leptin|leptin
5543064|NCT01115062|Pain|pain
5543752|NCT01112527|PF-00299804|pf-00299804
5543753|NCT01112514|ICG|icg
5543754|NCT01112514|indocyanine green|indocyanine green
5543755|NCT01112501|Diagnosis|diagnosis
5544277|NCT01110161|DXA|dxa
5544631|NCT01108770|HED|hed
5544818|NCT01107834|HIV|hiv
5545154|NCT01106482|TBE|tbe
5545990|NCT01102790|HIT|hit
5546441|NCT01101399|Anemia|anemia
5546909|NCT01099345|OAB|oab
5547169|NCT01098409|coronary artery bypass surgery|coronary artery bypass surgery
5547170|NCT01098409|cardioprotection|cardioprotection
5547268|NCT01097941|H1N1|h1n1
5547359|NCT01097512|Cancer treatable with gemcitabine|cancer treatable with gemcitabine
5547360|NCT01097499|Dental implant initial stability|dental implant initial stability
5547805|NCT01095913|ICG|icg
5548088|NCT01094964|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5548495|NCT01093339|GERD|gerd
5549069|NCT01090817|ileitis|ileitis
5549943|NCT01087307|Urine Collection|urine collection
5549944|NCT01087307|Saliva|saliva
5549945|NCT01087307|Specimen Collection|specimen collection
5549951|NCT01087281|Visual Attention|visual attention
5549952|NCT01087281|Visual Cortex|visual cortex
5549953|NCT01087281|Focal Lesions|focal lesions
5549954|NCT01087281|Neurological Disorder|neurological disorder
5549955|NCT01087281|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5549956|NCT01087281|Focal Brain Lesion|focal brain lesion
5549957|NCT01087281|Healthy Volunteer|healthy volunteer
5549958|NCT01087281|HV|hv
5549959|NCT01087268|gastrointestinal complications|gastrointestinal complications
5549960|NCT01087268|radiation toxicity|radiation toxicity
5549961|NCT01087268|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5549962|NCT01087268|stage I rectal cancer|stage i rectal cancer
5550214|NCT01086449|safety|safety
5550509|NCT01085110|QST|qst
5550974|NCT01083199|Radical Prostatectomy|radical prostatectomy
5550975|NCT01083199|Vesico-Urethral Anastomosis|vesico-urethral anastomosis
5550976|NCT01083186|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5550977|NCT01083186|Chronic Kidney Failure|chronic kidney failure
5550978|NCT01083173|Postmarketing Drug Surveillance|postmarketing drug surveillance
5551660|NCT01080690|endosonography, right side abdominal pain|endosonography, right side abdominal pain
5551661|NCT01080690|Endosonography (diagnostic value in right side abdominal pain)|endosonography (diagnostic value in right side abdominal pain)
5551662|NCT01080664|AS703569|as703569
5552585|NCT01077102|COPD|copd
5552666|NCT01076504|Carboplatin|carboplatin
5552667|NCT01076504|Pegfilgrastim|pegfilgrastim
5552668|NCT01076504|Neulasta|neulasta
5552669|NCT01076478|Symmetric Diabetic Polyneuropathy|symmetric diabetic polyneuropathy
5554167|NCT01070186|T1b|t1b
5554353|NCT01069432|CLL|cll
5555297|NCT01065558|Lesch-Nyhan Disease|lesch-nyhan disease
5558818|NCT01050972|Cervical Pain|cervical pain
5562158|NCT01039311|coherence|coherence
5562160|NCT01039298|Oral cancer|oral cancer
5562161|NCT01039298|fluorescence visualization|fluorescence visualization
5562169|NCT01039272|EBV|ebv
5562261|NCT01038791|COPD|copd
5562363|NCT01038401|HAART|haart
5562660|NCT01037231|PH|ph
5563585|NCT01032603|IXT|ixt
5563827|NCT01031862|RCT|rct
5563828|NCT01031862|3H|3h
5563829|NCT01031849|HIV 1 patients|hiv 1 patients
5563830|NCT01031836|Systemic Lupus Erythematosus|systemic lupus erythematosus
5563831|NCT01031836|Japanese|japanese
5563832|NCT01031836|phase 2|phase 2
5564025|NCT01031212|neoplasms|neoplasms
5564026|NCT01031212|adult solid tumor|adult solid tumor
5564027|NCT01031212|antineoplastic agents|antineoplastic agents
5564028|NCT01031199|Multiple sclerosis|multiple sclerosis
5564029|NCT01031199|Diagnostic imaging|diagnostic imaging
5564124|NCT01030861|relatives of people with type 1 diabetes|relatives of people with type 1 diabetes
5564125|NCT01030835|Screening Protocol|screening protocol
5564218|NCT01030471|adolescents|adolescents
5564622|NCT01028898|IBS|ibs
5565010|NCT01027052|MDA|mda
5565495|NCT01025063|PDT|pdt
5566461|NCT01021085|Assisted Reproductive Technology|assisted reproductive technology
5566462|NCT01021085|circulating cell free fetal DNA|circulating cell free fetal dna
5566860|NCT01019343|PD|pd
5568073|NCT01014429|PLK 1 inhibitor|plk 1 inhibitor
5568074|NCT01014429|Adult patients|adult patients
5568075|NCT01014416|Healthy Korean male|healthy korean male
5568653|NCT01011816|intervertebral disk|intervertebral disk
5568654|NCT01011803|Deglutition|deglutition
5568655|NCT01011803|Phonation|phonation
5568656|NCT01011790|Healing Rhythms™|healing rhythms™
5568657|NCT01011790|Meditation|meditation
5568658|NCT01011790|Biofeedback|biofeedback
5568659|NCT01011790|Stress|stress
5568660|NCT01011777|bladder exstrophy epispadias complex|bladder exstrophy epispadias complex
5568661|NCT01011777|urinary incontinence|urinary incontinence
5568662|NCT01011777|muscle derive cell therapy|muscle derive cell therapy
5568692|NCT01011660|sign|sign
5568766|NCT01011283|MDS|mds
5569054|NCT01010087|patients admitted to ICU|patients admitted to icu
5569439|NCT01008670|Cardiac resynchronization therapy|cardiac resynchronization therapy
5569440|NCT01008657|Radiofrequency-Extranodular-Multipolar ablation|radiofrequency-extranodular-multipolar ablation
5569441|NCT01008657|Recurrence|recurrence
5569442|NCT01008644|carbon dioxide|carbon dioxide
5569443|NCT01008644|ventilation|ventilation
5569444|NCT01008644|gender|gender
5569445|NCT01008644|osmolality|osmolality
5569446|NCT01008644|menstruation cycle|menstruation cycle
5569447|NCT01008631|renal failure|renal failure
5570025|NCT01006447|tai chi|tai chi
5570116|NCT01006044|Glioblastoma multiforme, vaccine, dendritic cells, glioma|glioblastoma multiforme, vaccine, dendritic cells, glioma
5570117|NCT01006031|Liver cirrhosis|liver cirrhosis
5570118|NCT01006031|Hepatitis C virus|hepatitis c virus
5571047|NCT01002326|BDD|bdd
5571180|NCT01001741|HIV|hiv
5571587|NCT01000038|Wii-Fit|wii-fit
5572464|NCT00996593|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5572465|NCT00996580|Contraception|contraception
5572466|NCT00996580|Oral contraceptives|oral contraceptives
5572467|NCT00996567|Malignant mesothelioma|malignant mesothelioma
5572468|NCT00996554|Hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery|hand-sutured colo-colonic and ileo-colonic anastomoses in elective surgery
5572469|NCT00996541|Runaway youth|runaway youth
5572470|NCT00996541|Homeless youth|homeless youth
5572471|NCT00996541|Family intervention|family intervention
5572472|NCT00996541|Family functioning|family functioning
5572473|NCT00996541|HIV risk behavior|hiv risk behavior
5573017|NCT00994955|SRT|srt
5573715|NCT00992589|GERD|gerd
5576506|NCT00981877|rotavirus|rotavirus
5576507|NCT00981877|probiotic|probiotic
5576609|NCT00981448|zinc|zinc
5577489|NCT00978211|DOTATOC|dotatoc
5577490|NCT00978211|somatostatin|somatostatin
5578283|NCT00974961|HRV|hrv
5579397|NCT00970827|PCI|pci
5579694|NCT00969410|Liver diseases|liver diseases
5579696|NCT00969397|PWS|pws
5579697|NCT00969384|Physical health|physical health
5579698|NCT00969384|Mental illness|mental illness
5579806|NCT00968929|massive|massive
5579995|NCT00968383|Myocardial infarction|myocardial infarction
5579996|NCT00968383|Infarct Related Artery|infarct related artery
5579997|NCT00968383|Percutaneous Coronary Intervention|percutaneous coronary intervention
5579998|NCT00968383|Medical treatment|medical treatment
5579999|NCT00968383|Tissue Viability|tissue viability
5580000|NCT00968383|Magnetic Resonance|magnetic resonance
5580001|NCT00968370|Severe and very severe pneumonia|severe and very severe pneumonia
5580034|NCT00968253|ALL|all
5581465|NCT00963053|pain|pain
5581844|NCT00961441|Adults|adults
5582441|NCT00958997|FPDTBZ|fpdtbz
5582678|NCT00957840|IVH|ivh
5582931|NCT00957320|ALL|all
5583505|NCT00955370|Parents|parents
5584062|NCT00952692|overexpressing HER2|overexpressing her2
5584065|NCT00952666|Prostate Cancer|prostate cancer
5585600|NCT00948116|Acute Kidney Injury|acute kidney injury
5585601|NCT00948116|Coronary revascularisation|coronary revascularisation
5585602|NCT00948116|eGFR <60ml/min|egfr <60ml/min
5585603|NCT00948103|Nitrous Oxide|nitrous oxide
5585604|NCT00948103|Administration, Intravesical Drug|administration, intravesical drug
5585605|NCT00948103|Botulinum toxin|botulinum toxin
5585606|NCT00948090|Hodgkin Lymphoma|hodgkin lymphoma
5585607|NCT00948090|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5585608|NCT00948090|Bone marrow transplant|bone marrow transplant
5585609|NCT00948090|stem cell transplant|stem cell transplant
5585610|NCT00948090|busulfan|busulfan
5585611|NCT00948090|cyclophosphamide|cyclophosphamide
5585612|NCT00948090|etoposide|etoposide
5585802|NCT00947388|CLL|cll
5586355|NCT00945308|blush|blush
5586744|NCT00943904|unable to fully empty bladder|unable to fully empty bladder
5586745|NCT00943904|Comparison: Motor&Sensory Response to Interstim Stimulation|comparison: motor&sensory response to interstim stimulation
5586746|NCT00943878|H1N1, influenza A viruses, vaccine, elderly, TIV|h1n1, influenza a viruses, vaccine, elderly, tiv
5586752|NCT00943865|lipids|lipids
5587738|NCT00940082|TNF-α|tnf-α
5587739|NCT00940069|TS|ts
5587740|NCT00940069|polymorphism|polymorphism
5587741|NCT00940069|lung cancer|lung cancer
5587742|NCT00940069|adenocarcinoma|adenocarcinoma
5587743|NCT00940069|pemetrexed|pemetrexed
5588592|NCT00936429|Dengue fever|dengue fever
5588882|NCT00935181|COPD|copd
5590267|NCT00929617|quality of life|quality of life
5590268|NCT00929617|doubly labeled water|doubly labeled water
5590269|NCT00929604|HIV|hiv
5590270|NCT00929604|AIDS|aids
5590467|NCT00928902|vaccine|vaccine
5591248|NCT00925587|CKD|ckd
5591630|NCT00924209|Stage IIIA (N2)|stage iiia (n2)
5591631|NCT00924209|Cisplatin|cisplatin
5591828|NCT00923624|electronic medical record|electronic medical record
5591829|NCT00923624|antiretroviral medication adherence|antiretroviral medication adherence
5591830|NCT00923611|Hypertension|hypertension
5591832|NCT00923598|TKA|tka
5591929|NCT00923325|Other Sarcoma|other sarcoma
5591930|NCT00923299|stage IV pancreatic cancer|stage iv pancreatic cancer
5591931|NCT00923299|recurrent pancreatic cancer|recurrent pancreatic cancer
5591932|NCT00923299|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5591933|NCT00923273|Pemetrexed|pemetrexed
5591934|NCT00923273|Sirolimus|sirolimus
5591935|NCT00923273|Non-Small Cell Lung Cancer|non-small cell lung cancer
5591936|NCT00923273|Phase I/II|phase i/ii
5592348|NCT00921648|EEG|eeg
5592545|NCT00920946|HD|hd
5592934|NCT00919503|disease|disease
5593108|NCT00918931|SM|sm
5593603|NCT00916838|MRI|mri
5594154|NCT00914654|Urinary concentrations|urinary concentrations
5594155|NCT00914654|Beta-agonists|beta-agonists
5594156|NCT00914641|formulation; sustained release; modified release; extended release|formulation; sustained release; modified release; extended release
5594348|NCT00913796|Calcium and phosphate metabolism|calcium and phosphate metabolism
5594349|NCT00913783|Antidepressant|antidepressant
5594351|NCT00913770|buprenorphine|buprenorphine
5594352|NCT00913770|brief intervention|brief intervention
5594358|NCT00913744|AMD|amd
5594553|NCT00912808|falling|falling
5594943|NCT00911183|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5594944|NCT00911183|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5595047|NCT00910806|TMC207-TiDP13-C117|tmc207-tidp13-c117
5595050|NCT00910806|drug-drug interaction|drug-drug interaction
5595051|NCT00910806|Tuberculosis|tuberculosis
5595052|NCT00910806|HIV|hiv
5595053|NCT00910806|nevirapine|nevirapine
5595054|NCT00910806|open-label|open-label
5595055|NCT00910806|Pharmacokinetics|pharmacokinetics
5595326|NCT00909870|fibroblasts|fibroblasts
5595327|NCT00909857|Primary Dysmenorrhea|primary dysmenorrhea
5595328|NCT00909857|Oral Contraception|oral contraception
5595330|NCT00909805|dermabond glue|dermabond glue
5595435|NCT00909350|BE|be
5595741|NCT00908063|TBI|tbi
5596009|NCT00906880|HAT|hat
5596406|NCT00905151|AIDS|aids
5596487|NCT00904969|Intrinsic sphincter deficiency|intrinsic sphincter deficiency
5596488|NCT00904969|Secondary|secondary
5596489|NCT00904969|Transurethral Resection (TUR)|transurethral resection (tur)
5596490|NCT00904969|Transurethral Resection of the Prostate (TURP)|transurethral resection of the prostate (turp)
5597034|NCT00902993|MAD|mad
5597925|NCT00900289|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5597926|NCT00900289|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5597927|NCT00900289|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5598538|NCT00899951|pain|pain
5598809|NCT00899431|CLL|cll
5598949|NCT00898950|aspirin|aspirin
5599062|NCT00898742|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5599063|NCT00898742|recurrent salivary gland cancer|recurrent salivary gland cancer
5599064|NCT00898742|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5599065|NCT00898742|stage IV salivary gland cancer|stage iv salivary gland cancer
5599066|NCT00898703|breast cancer|breast cancer
5599067|NCT00898690|stage I breast cancer|stage i breast cancer
5599262|NCT00898612|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5599202|NCT00898612|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5599203|NCT00898612|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5599204|NCT00898612|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5599205|NCT00898612|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5599206|NCT00898612|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5599207|NCT00898612|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5599208|NCT00898612|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5599209|NCT00898612|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5599210|NCT00898612|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5599211|NCT00898612|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5599212|NCT00898612|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5599213|NCT00898612|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5599214|NCT00898612|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5599215|NCT00898612|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5599216|NCT00898612|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5599217|NCT00898612|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5599218|NCT00898612|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5599219|NCT00898612|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5599220|NCT00898612|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5599221|NCT00898612|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5599222|NCT00898612|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5599223|NCT00898612|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5599224|NCT00898612|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5599225|NCT00898612|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5599226|NCT00898612|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5600322|NCT00896662|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5600324|NCT00896662|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5600325|NCT00896649|breast cancer|breast cancer
5600621|NCT00895414|stage I breast cancer|stage i breast cancer
5600622|NCT00895414|stage II breast cancer|stage ii breast cancer
5600623|NCT00895414|stage IIIA breast cancer|stage iiia breast cancer
5600624|NCT00895414|stage IIIB breast cancer|stage iiib breast cancer
5600625|NCT00895414|stage IIIC breast cancer|stage iiic breast cancer
5600626|NCT00895414|stage IV breast cancer|stage iv breast cancer
5600627|NCT00895401|Nutritional supplement|nutritional supplement
5600825|NCT00894621|Shock|shock
5601217|NCT00892905|CABG|cabg
5602150|NCT00889798|NHL|nhl
5603032|NCT00886431|IVF|ivf
5603369|NCT00885040|fMRI|fmri
5603603|NCT00884104|OAB|oab
5605734|NCT00875472|food purchases|food purchases
5605735|NCT00875472|childhood obesity|childhood obesity
5605736|NCT00875472|amount of energy dense food and beverage items purchased|amount of energy dense food and beverage items purchased
5605737|NCT00875472|amount of nutrient dense food and beverage items purchased|amount of nutrient dense food and beverage items purchased
5605829|NCT00874965|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5605830|NCT00874965|Electrostimulation|electrostimulation
5605831|NCT00874965|Muscle function|muscle function
5605832|NCT00874965|Exercise ventilation|exercise ventilation
5606521|NCT00872313|Labor|labor
5606694|NCT00871650|PET|pet
5607116|NCT00870129|MRI|mri
5607493|NCT00868556|non migraine sufferers (controls)|non migraine sufferers (controls)
5607494|NCT00868543|Gastric bypass|gastric bypass
5607495|NCT00868543|obesity|obesity
5607692|NCT00867737|Electrical-equivalent respiratory system model|electrical-equivalent respiratory system model
5607694|NCT00867698|Hepatic encephalopathy|hepatic encephalopathy
5607695|NCT00867698|Mild hepatic encephalopathy|mild hepatic encephalopathy
5607790|NCT00867295|Indwelling Catheters|indwelling catheters
5607791|NCT00867295|infection|infection
5607792|NCT00867295|cefazolin sodium|cefazolin sodium
5607793|NCT00867295|prophylactic|prophylactic
5607794|NCT00867295|antibiotic|antibiotic
5607796|NCT00867295|cancer patients|cancer patients
5608997|NCT00862563|Alcohol Abuse|alcohol abuse
5608998|NCT00862563|Substance Abuse|substance abuse
5608999|NCT00862563|Alcoholic Intoxication|alcoholic intoxication
5609000|NCT00862550|Head and Neck Cancer|head and neck cancer
5609002|NCT00862550|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5609004|NCT00862550|Radiation-Induced Xerostomia|radiation-induced xerostomia
5609005|NCT00862550|Xerostomia|xerostomia
5609006|NCT00862550|Dry Mouth|dry mouth
5609007|NCT00862550|Radiation|radiation
5609008|NCT00862511|metal ion concentration|metal ion concentration
5609009|NCT00862511|total knee arthroplasty|total knee arthroplasty
5687634|NCT00546130|PSK|psk
5609010|NCT00862511|metal hypersensitivity|metal hypersensitivity
5609011|NCT00862498|PTSD|ptsd
5609012|NCT00862498|Written Disclosure|written disclosure
5609384|NCT00860925|acetyl-salicylic acid (ASA)|acetyl-salicylic acid (asa)
5609385|NCT00860925|Perioperative vascular complications|perioperative vascular complications
5609386|NCT00860925|Noncardiac surgery|noncardiac surgery
5609387|NCT00860912|Veritas|veritas
5609883|NCT00858520|COPD|copd
5610171|NCT00857376|obesity|obesity
5610752|NCT00854958|Allergy|allergy
5610753|NCT00854958|Syndrome|syndrome
5610754|NCT00854958|Food|food
5610846|NCT00854542|Telepsychiatry|telepsychiatry
5611233|NCT00853008|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5611234|NCT00853008|High-Risk (HR)|high-risk (hr)
5665318|NCT00639756|HOMA|homa
5611235|NCT00853008|Philadelphia Chromosome-Negative|philadelphia chromosome-negative
5611236|NCT00852995|Venous Leg Ulcer (VLU)|venous leg ulcer (vlu)
5611237|NCT00852995|Venous Stasis Ulcer (VSU)|venous stasis ulcer (vsu)
5611238|NCT00852995|VLU|vlu
5611239|NCT00852995|VSU|vsu
5611240|NCT00852995|Leg Ulcer|leg ulcer
5611241|NCT00852995|Leg Wound|leg wound
5611242|NCT00852982|Exercise|exercise
5611418|NCT00852332|stage IV breast cancer|stage iv breast cancer
5611419|NCT00852332|recurrent breast cancer|recurrent breast cancer
5611520|NCT00852033|substance abuse related behavior|substance abuse related behavior
5611521|NCT00852033|adolescence|adolescence
5611630|NCT00851487|ARI|ari
5611987|NCT00850304|AML|aml
5612284|NCT00849004|silicone sheet|silicone sheet
5612285|NCT00849004|silicone gel|silicone gel
5612293|NCT00848978|Falls|falls
5612790|NCT00846989|intraocular pressure (IOP)|intraocular pressure (iop)
5612968|NCT00846287|MRI|mri
5613394|NCT00844454|PEI|pei
5613462|NCT00844116|COPD|copd
5613463|NCT00844116|spirometry|spirometry
5613464|NCT00844116|Telematic spirometry|telematic spirometry
5613896|NCT00842400|Obesity|obesity
5614571|NCT00839436|ICL|icl
5614798|NCT00838656|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5614799|NCT00838656|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5614800|NCT00838656|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5614984|NCT00838006|prediction|prediction
5614985|NCT00838006|prevention|prevention
5615184|NCT00837174|lymphoblastic lymphoma|lymphoblastic lymphoma
5615275|NCT00836849|Bioequivalence|bioequivalence
5615276|NCT00836849|Healthy Subjects|healthy subjects
5615277|NCT00836836|Childhood epilepsy|childhood epilepsy
5615278|NCT00836836|ketogenic diet|ketogenic diet
5615792|NCT00834548|MRI|mri
5616258|NCT00832507|parenteral prostanoid|parenteral prostanoid
5616260|NCT00832507|pulmonary|pulmonary
5616261|NCT00832481|Repaglinide|repaglinide
5616262|NCT00832481|Metformin|metformin
5616263|NCT00832468|insomnia|insomnia
5616356|NCT00832052|elderly, multi-dose, safety, efficacy|elderly, multi-dose, safety, efficacy
5616357|NCT00832039|sepsis|sepsis
5616362|NCT00832026|snoring|snoring
5616566|NCT00831155|extinction based treatment|extinction based treatment
5616570|NCT00831116|near infrared spectroscopy|near infrared spectroscopy
5616856|NCT00829985|Asthma|asthma
5616957|NCT00829608|HPV|hpv
5617317|NCT00828282|Zocor|zocor
5617485|NCT00827580|HFS|hfs
5617869|NCT00826150|inodiftagene vixteplasmid|inodiftagene vixteplasmid
5617870|NCT00826137|prebiotics|prebiotics
5617871|NCT00826137|Antibiotic-associated diarrhea|antibiotic-associated diarrhea
5617878|NCT00826111|GABA|gaba
5618389|NCT00824278|HIV|hiv
5620371|NCT00817336|EEG|eeg
5621069|NCT00814892|stage IV prostate cancer|stage iv prostate cancer
5621070|NCT00814879|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5621072|NCT00814879|Anti-Infective Agents|anti-infective agents
5623291|NCT00806754|PAR|par
5623389|NCT00806364|HV|hv
5623858|NCT00804258|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5623859|NCT00804258|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5623880|NCT00804193|Tinea Pedis|tinea pedis
5624986|NCT00799825|HPV|hpv
5625358|NCT00798369|Triamcinolone acetonide|triamcinolone acetonide
5625359|NCT00798356|atrial fibrillation, yoga|atrial fibrillation, yoga
5625360|NCT00798343|Influenza, heterosubtypic immune responses|influenza, heterosubtypic immune responses
5625362|NCT00798330|Blood stream infections|blood stream infections
5625363|NCT00798330|Bacteremia|bacteremia
5625364|NCT00798330|Dental procedure|dental procedure
5625365|NCT00798330|Central venous catheters|central venous catheters
5625366|NCT00798330|Mediport|mediport
5626046|NCT00795470|ICU|icu
5626166|NCT00794820|CLL|cll
5626238|NCT00794560|Pharmaceutical Services|pharmaceutical services
5626239|NCT00794547|lung cancer; nsclc|lung cancer; nsclc
5626240|NCT00794508|Severe Combined Immune Deficiency|severe combined immune deficiency
5626241|NCT00794508|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5626242|NCT00794508|Gene Therapy|gene therapy
5626243|NCT00794508|Hematopoietic Stem Cells|hematopoietic stem cells
5626823|NCT00791791|Anesthetics Inhalation|anesthetics inhalation
5626824|NCT00791791|Stress measurement|stress measurement
5627327|NCT00790023|SAR|sar
5627610|NCT00788931|HDAC inhibitor|hdac inhibitor
5627611|NCT00788931|panobinostat|panobinostat
5627612|NCT00788931|metastatic breast|metastatic breast
5627613|NCT00788931|adult female patients|adult female patients
5627614|NCT00788918|Chronic Hepatitis C|chronic hepatitis c
5627615|NCT00788918|cognitive dysfunction|cognitive dysfunction
5627616|NCT00788918|MRI|mri
5628054|NCT00787748|COPD|copd
5628106|NCT00787553|cefazolin|cefazolin
5628107|NCT00787540|Coronary disease|coronary disease
5628108|NCT00787540|Psychosocial|psychosocial
5628109|NCT00787540|Nursing|nursing
5628110|NCT00787527|Lymphoma|lymphoma
5628111|NCT00787527|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5628112|NCT00787527|SAHA|saha
5629093|NCT00783757|neo-adjuvant chemotherapy|neo-adjuvant chemotherapy
5629094|NCT00783757|TOBI|tobi
5629095|NCT00783757|breast imaging|breast imaging
5629096|NCT00783757|optical imaging|optical imaging
5630166|NCT00779181|Htn|htn
5630683|NCT00776581|Combined spinal-epidural analgesia|combined spinal-epidural analgesia
5630684|NCT00776581|Patient-controlled analgesia|patient-controlled analgesia
5630685|NCT00776581|Epidural analgesia|epidural analgesia
5630686|NCT00776555|Not required|not required
5630777|NCT00776100|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5630778|NCT00776100|squamous cell lung cancer|squamous cell lung cancer
5630779|NCT00776100|large cell lung cancer|large cell lung cancer
5630780|NCT00776100|adenocarcinoma of the lung|adenocarcinoma of the lung
5630781|NCT00776100|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5630880|NCT00775632|Campath|campath
5631156|NCT00774631|Meningitis|meningitis
5631157|NCT00774631|Hypothermia|hypothermia
5631158|NCT00774631|Intensive care|intensive care
5631159|NCT00774618|Rib Fracture|rib fracture
5631614|NCT00772733|COPD|copd
5633026|NCT00767052|Safety|safety
5633768|NCT00763789|conscious sedation|conscious sedation
5634163|NCT00762125|FMS|fms
5634841|NCT00759226|5-FU|5-fu
5634842|NCT00759226|Folinic Acid|folinic acid
5635538|NCT00755950|Acute|acute
5635639|NCT00755573|Pain|pain
5637471|NCT00749450|stage II rectal cancer|stage ii rectal cancer
5637472|NCT00749450|stage III rectal cancer|stage iii rectal cancer
5638676|NCT00744588|stress|stress
5639066|NCT00743132|impact|impact
5639524|NCT00741637|HIV|hiv
5639575|NCT00741468|DDI|ddi
5640151|NCT00739388|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5640152|NCT00739388|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5640153|NCT00739388|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5640160|NCT00739375|flow|flow
5641334|NCT00735176|Nerve Root Compression|nerve root compression
5641335|NCT00735176|Disc, intervertebral|disc, intervertebral
5641337|NCT00735176|Spondylosis|spondylosis
5641600|NCT00734487|AMD|amd
5641694|NCT00734123|Cardiovascular Prevention|cardiovascular prevention
5641696|NCT00734123|Ankle-Brachial Index|ankle-brachial index
5641839|NCT00733603|IC|ic
5641899|NCT00733356|NIRS|nirs
5642184|NCT00732316|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5642185|NCT00732316|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5685493|NCT00555854|Motivational interviewing,|motivational interviewing,
5642186|NCT00732316|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5642187|NCT00732316|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5642197|NCT00732277|sepsis|sepsis
5643365|NCT00727584|spinal cord compression|spinal cord compression
5643366|NCT00727584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5643367|NCT00727571|Anemia|anemia
5643462|NCT00727207|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5643463|NCT00727181|aortic valve|aortic valve
5643464|NCT00727181|heart valve|heart valve
5643465|NCT00727181|tissue valve|tissue valve
5643466|NCT00727181|bioprosthesis|bioprosthesis
5643467|NCT00727181|valve disorder|valve disorder
5643468|NCT00727181|valve disease|valve disease
5643469|NCT00727181|cardiac surgery|cardiac surgery
5643470|NCT00727181|aortic valve stenosis|aortic valve stenosis
5643471|NCT00727181|aortic valve regurgitation|aortic valve regurgitation
5643472|NCT00727168|prevalence study|prevalence study
5643782|NCT00726323|Sporadic papillary renal cell carcinoma,|sporadic papillary renal cell carcinoma,
5643785|NCT00726310|Spondylolisthesis|spondylolisthesis
5644261|NCT00724360|HER2|her2
5645048|NCT00720967|Hemodialysis|hemodialysis
5645049|NCT00720967|Modified ultrafiltration|modified ultrafiltration
5645050|NCT00720967|Open heart surgery|open heart surgery
5645051|NCT00720954|Thoracoscopy|thoracoscopy
5645052|NCT00720954|Pleural needle biopsy|pleural needle biopsy
5646451|NCT00716664|posture|posture
5646559|NCT00716079|Stroke|stroke
5646847|NCT00715091|SpA|spa
5647042|NCT00714467|smoking cessation|smoking cessation
5647043|NCT00714467|Asian|asian
5648874|NCT00707434|ICU|icu
5649305|NCT00705445|Malnutrition|malnutrition
5649306|NCT00705445|Diarrhea|diarrhea
5649307|NCT00705445|Pneumonia|pneumonia
5649308|NCT00705445|Growth|growth
5649309|NCT00705445|Zinc Supplements|zinc supplements
5649310|NCT00705445|Microbiome|microbiome
5649311|NCT00705419|Treatment Experienced|treatment experienced
5649728|NCT00703079|GH|gh
5649803|NCT00702832|Nausea|nausea
5649884|NCT00702572|Phase I|phase i
5649885|NCT00702572|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5649886|NCT00702546|In-vitro fertilization|in-vitro fertilization
5649887|NCT00702546|Controlled Ovarian Stimulation|controlled ovarian stimulation
5649889|NCT00702546|Follow-up|follow-up
5650068|NCT00701870|CIN|cin
5650260|NCT00700973|psychotherapy, brief|psychotherapy, brief
5650261|NCT00700973|diagnosis, dual|diagnosis, dual
5650262|NCT00700947|Heart Disease|heart disease
5650263|NCT00700947|Mitral Regurgitation|mitral regurgitation
5650264|NCT00700947|Heart Valve Disease|heart valve disease
5650494|NCT00699998|ACS|acs
5650655|NCT00699270|Total Shoulder Replacement|total shoulder replacement
5650656|NCT00699270|Shoulder Arthritis|shoulder arthritis
5650657|NCT00699257|Partial Knee Arthroplasty|partial knee arthroplasty
5650658|NCT00699257|Partial Knee Replacement|partial knee replacement
5650659|NCT00699257|Arthritis of Medial Compartment of the Knee|arthritis of medial compartment of the knee
5650660|NCT00699257|Oxford Knee|oxford knee
5650661|NCT00699244|forearm|forearm
5650662|NCT00699244|hand|hand
5650663|NCT00699244|elbow|elbow
5650664|NCT00699244|wrist|wrist
5650665|NCT00699244|brachial plexus|brachial plexus
5650666|NCT00699244|infraclavicular block|infraclavicular block
5650667|NCT00699231|Hepatitis B|hepatitis b
5650670|NCT00699231|Adjuvant|adjuvant
5650847|NCT00698399|liver|liver
5651048|NCT00697606|cesarean|cesarean
5651049|NCT00697606|adhesions|adhesions
5651050|NCT00697606|primary|primary
5651051|NCT00697606|repeat|repeat
5651052|NCT00697593|Efalizumab|efalizumab
5651253|NCT00696761|LUTS|luts
5651346|NCT00696319|Rupture of the anterior cruciate ligament of the knee|rupture of the anterior cruciate ligament of the knee
5651347|NCT00696306|Acute Ischemic Stroke|acute ischemic stroke
5651348|NCT00696306|Stroke|stroke
5651349|NCT00696306|MRI|mri
5651350|NCT00696306|DTI|dti
5651351|NCT00696306|Diffusion Tensor Imaging|diffusion tensor imaging
5651352|NCT00696306|SWI|swi
5651629|NCT00695188|rheumatoid arthritis|rheumatoid arthritis
5651630|NCT00695188|MTX polyglutamates|mtx polyglutamates
5651870|NCT00694161|TTR|ttr
5652020|NCT00693511|adolescents|adolescents
5652021|NCT00693511|adiposity|adiposity
5652022|NCT00693511|insulin sensitivity|insulin sensitivity
5652023|NCT00693511|type 2 diabetes|type 2 diabetes
5652024|NCT00693511|Latino|latino
5652025|NCT00693511|circuit training|circuit training
5652026|NCT00693511|physical activity|physical activity
5652027|NCT00693511|motivational interviewing|motivational interviewing
5652028|NCT00693498|pediatrics|pediatrics
5652029|NCT00693498|congenital heart disease|congenital heart disease
5652030|NCT00693472|Antipsychotic Agents|antipsychotic agents
5652031|NCT00693459|Hemorrhoids|hemorrhoids
5652032|NCT00693446|Pancreas-kidney allograft|pancreas-kidney allograft
5652033|NCT00693446|tacrolimus|tacrolimus
5652034|NCT00693446|sirolimus|sirolimus
5652035|NCT00693446|Pancreas-kidney allograft recipients|pancreas-kidney allograft recipients
5652036|NCT00693381|Transplantation|transplantation
5652037|NCT00693381|Graft Rejection|graft rejection
5652038|NCT00693381|Renal Transplantation|renal transplantation
5652039|NCT00693355|gut health|gut health
5652070|NCT00693329|Contrast Induced Nephrophathy (CIN)|contrast induced nephrophathy (cin)
5652072|NCT00693329|NGAL|ngal
5652073|NCT00693316|Healthy volunteer study|healthy volunteer study
5652074|NCT00693303|single subject|single subject
5652075|NCT00693303|quantitative|quantitative
5652076|NCT00693290|Colonoscopy|colonoscopy
5652077|NCT00693290|Colorectal screening|colorectal screening
5652078|NCT00693290|Colon preparation|colon preparation
5652079|NCT00693264|Human Volunteers|human volunteers
5652080|NCT00693264|Hoodia|hoodia
5652081|NCT00693264|Safety|safety
5652082|NCT00693251|stent|stent
5652083|NCT00693251|bifurcation|bifurcation
5652084|NCT00693251|coronary artery stenosis|coronary artery stenosis
5652085|NCT00693251|balloon angioplasty|balloon angioplasty
5652086|NCT00693238|Prostate Cancer|prostate cancer
5652087|NCT00693238|Proton Radiation|proton radiation
5652088|NCT00693225|Erosive Esophagitis|erosive esophagitis
5652089|NCT00693225|Reflux Esophagitis|reflux esophagitis
5652090|NCT00693225|Gastroesophageal reflux disease|gastroesophageal reflux disease
5652091|NCT00693225|GERD|gerd
5652092|NCT00693225|proton pump inhibitor|proton pump inhibitor
5652108|NCT00693173|anal|anal
5652413|NCT00691990|Thyroid Neoplasms [C19.874.788]|thyroid neoplasms [c19.874.788]
5652414|NCT00691977|Radiation Therapy|radiation therapy
5652415|NCT00691938|LBH589|lbh589
5652416|NCT00691938|Decitabine|decitabine
5652417|NCT00691938|panobinostat|panobinostat
5652589|NCT00691301|stage III cervical cancer|stage iii cervical cancer
5652590|NCT00691301|stage IVA cervical cancer|stage iva cervical cancer
5652591|NCT00691301|stage IVB cervical cancer|stage ivb cervical cancer
5652856|NCT00690508|use|use
5653550|NCT00688168|Interactive Voice Response|interactive voice response
5653551|NCT00688168|Symptom Production|symptom production
5653553|NCT00688168|IVR|ivr
5653554|NCT00688168|MM|mm
5653555|NCT00688129|school readiness|school readiness
5653744|NCT00687349|End-of-Life issues|end-of-life issues
5653745|NCT00687349|Talking with your doctor|talking with your doctor
5653746|NCT00687349|Coping with chronic illness|coping with chronic illness
5653747|NCT00687336|Helicobacter pylori|helicobacter pylori
5654741|NCT00683189|MLD|mld
5655361|NCT00680862|HIV|hiv
5655710|NCT00679471|MRI|mri
5655807|NCT00679003|Ulcerative colitis|ulcerative colitis
5655808|NCT00679003|Inflammatory bowel disease|inflammatory bowel disease
5655809|NCT00679003|Illness behavior|illness behavior
5655810|NCT00679003|Cognitive behavioral therapy|cognitive behavioral therapy
5656006|NCT00678314|Local|local
5656212|NCT00677534|Vitamin D|vitamin d
5656213|NCT00677534|Monocyte function|monocyte function
5656214|NCT00677508|Constipation|constipation
5656216|NCT00677508|Quality of life|quality of life
5656420|NCT00676702|PANCREASE MT|pancrease mt
5656421|NCT00676702|Cross-Over Studies|cross-over studies
5656422|NCT00676702|Duodenum|duodenum
5656423|NCT00676702|Intestine, Small|intestine, small
5656424|NCT00676702|Lipase|lipase
5656994|NCT00674596|proteinuria has any relation with the alteration|proteinuria has any relation with the alteration
5656995|NCT00674596|of PTX3 levels.|of ptx3 levels.
5656996|NCT00674583|Conjugate vaccine|conjugate vaccine
5656997|NCT00674583|Meningococcal disease|meningococcal disease
5656998|NCT00674583|Immunogenicity|immunogenicity
5656999|NCT00674583|Meningococcal vaccine|meningococcal vaccine
5657001|NCT00674570|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5657002|NCT00674570|Hydrocortisone|hydrocortisone
5657003|NCT00674570|Cycloserine|cycloserine
5657004|NCT00674570|Extinction, Psychological|extinction, psychological
5657005|NCT00674570|PTSD|ptsd
5657006|NCT00674570|San Francisco|san francisco
5657015|NCT00674544|childhood|childhood
5657106|NCT00674258|URLC10|urlc10
5657192|NCT00673803|posterior capsule opacification|posterior capsule opacification
5657193|NCT00673803|micro incision|micro incision
5657194|NCT00673803|sharp optic edge|sharp optic edge
5657206|NCT00673777|HLA-A*0201|hla-a*0201
5657207|NCT00673777|Peptide Vaccine|peptide vaccine
5657208|NCT00673777|URLC10|urlc10
5657209|NCT00673777|VEGFR1|vegfr1
5657210|NCT00673777|VEGFR2|vegfr2
5657211|NCT00673751|mesenteric blood flow|mesenteric blood flow
5657212|NCT00673751|GLP-2|glp-2
5657213|NCT00673751|short bowel syndrome|short bowel syndrome
5658360|NCT00669331|randomized clinical trial|randomized clinical trial
5658361|NCT00669331|mannitol|mannitol
5658362|NCT00669331|mucoactive|mucoactive
5658363|NCT00669318|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5658748|NCT00667641|recurrent thyroid cancer|recurrent thyroid cancer
5658749|NCT00667615|vorinostat|vorinostat
5658750|NCT00667615|rituximab|rituximab
5658751|NCT00667615|cyclophosphamide|cyclophosphamide
5658752|NCT00667615|etoposide|etoposide
5658753|NCT00667615|prednisone|prednisone
5658851|NCT00667316|low back pain|low back pain
5658852|NCT00667316|workers|workers
5658853|NCT00667316|disability|disability
5658854|NCT00667316|sick leave|sick leave
5658885|NCT00667186|HIV|hiv
5659836|NCT00663650|BCC|bcc
5660456|NCT00661661|tofacitinib|tofacitinib
5660457|NCT00661648|surgery|surgery
5080487|NCT03496025|facial pacing|facial pacing
5660458|NCT00661635|Laparoscopic Cholecystectomy Surgery, Acute Pain, Perioperative Pain|laparoscopic cholecystectomy surgery, acute pain, perioperative pain
5660460|NCT00661609|Eg5 Inhibitor|eg5 inhibitor
5660463|NCT00661609|Bladder Cancer|bladder cancer
5660553|NCT00661141|acetaldehyde|acetaldehyde
5661504|NCT00657163|Selective Serotonin Reuptake Inhibitor (SSRI)|selective serotonin reuptake inhibitor (ssri)
5661506|NCT00657163|Brain plasticity|brain plasticity
5661509|NCT00657137|HER2/neu positive|her2/neu positive
5661993|NCT00655226|Communicable Diseases|communicable diseases
5661994|NCT00655226|Liver Diseases|liver diseases
5662682|NCT00652652|Dyspnea|dyspnea
5662804|NCT00652119|Taxol|taxol
5663077|NCT00651352|NRT|nrt
5664248|NCT00644189|Clolar|clolar
5664349|NCT00643812|Suicide|suicide
5664647|NCT00642239|Sodium Glycididazole, Radiochemotherapy, Esophageal Carcinoma|sodium glycididazole, radiochemotherapy, esophageal carcinoma
5665058|NCT00640887|HIV|hiv
5665948|NCT00637273|sitagliptin|sitagliptin
5665949|NCT00637273|Januvia|januvia
5665950|NCT00637273|thiazolidinedione|thiazolidinedione
5665951|NCT00637273|Amylin|amylin
5665952|NCT00637273|Lilly|lilly
5665960|NCT00637221|Safety|safety
5667343|NCT00631449|HIV|hiv
5667726|NCT00630162|Amoeba|amoeba
5671075|NCT00617383|non-concordant|non-concordant
5671076|NCT00617383|clinically isolated syndrome - CIS|clinically isolated syndrome - cis
5671077|NCT00617383|brain MRI|brain mri
5671078|NCT00617383|proteomics|proteomics
5671079|NCT00617370|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5671080|NCT00617370|EPIRUBICIN|epirubicin
5671081|NCT00617370|PEGFILGRASTIM|pegfilgrastim
5671310|NCT00616590|recurrent salivary gland cancer|recurrent salivary gland cancer
5671788|NCT00614328|Alcohol|alcohol
5672017|NCT00613223|GBM|gbm
5672387|NCT00612079|PPI|ppi
5673929|NCT00606060|Continuous Infusion|continuous infusion
5673930|NCT00606047|femoroacetabular impingement|femoroacetabular impingement
5673931|NCT00606034|Type 2 diabetes|type 2 diabetes
5673932|NCT00606034|Insulin Resistance|insulin resistance
5673933|NCT00606034|Continuous Subcutaneous Insulin Infusion|continuous subcutaneous insulin infusion
5673934|NCT00606034|U-500 Insulin|u-500 insulin
5673935|NCT00606034|Omnipod|omnipod
5674042|NCT00605423|AMD|amd
5674241|NCT00604357|liver transplantation|liver transplantation
5674242|NCT00604331|Pyruvic Acid|pyruvic acid
5674243|NCT00604331|Shock, Cardiogenic|shock, cardiogenic
5674244|NCT00604331|Catecholamines|catecholamines
5674245|NCT00604331|Intra-Aortic Balloon Pumping|intra-aortic balloon pumping
5674246|NCT00604331|Cardiac Output|cardiac output
5675079|NCT00600938|DBA|dba
5676046|NCT00596804|MALT|malt
5676242|NCT00595842|Mineral trioxide aggregate|mineral trioxide aggregate
5676243|NCT00595829|Polycythemia Vera|polycythemia vera
5676244|NCT00595829|PV|pv
5676245|NCT00595816|low back pain|low back pain
5676873|NCT00592826|PHP|php
5677134|NCT00591643|Imaging|imaging
5677445|NCT00590408|statin|statin
5677589|NCT00589810|ISR|isr
5677638|NCT00589667|ALTIMA|altima
5679037|NCT00583791|VSD|vsd
5679147|NCT00583297|GES|ges
5679744|NCT00580658|DBS|dbs
5679942|NCT00579839|Milking the cord|milking the cord
5679943|NCT00579813|obesity|obesity
5679944|NCT00579813|inflammation|inflammation
5679945|NCT00579813|diabetes|diabetes
5679946|NCT00579800|Vibrant-DE|vibrant-de
5679947|NCT00579800|IDEAL|ideal
5679948|NCT00579800|MRI|mri
5679949|NCT00579800|Breast|breast
5679950|NCT00579800|07-091|07-091
5679951|NCT00579787|cervical cancer|cervical cancer
5679952|NCT00579787|quality of life assessment|quality of life assessment
5679953|NCT00579787|behavioral|behavioral
5679954|NCT00579774|Aging|aging
5679955|NCT00579774|oxidative stress|oxidative stress
5679956|NCT00579774|glycoxidative stress|glycoxidative stress
5679957|NCT00579774|glycation|glycation
5679958|NCT00579774|inflammation|inflammation
5679959|NCT00579774|nutrition|nutrition
5679960|NCT00579774|low AGE intake|low age intake
5680057|NCT00579332|PSA|psa
5680446|NCT00577798|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5680835|NCT00576056|TACE|tace
5680654|NCT00577161|rituximab|rituximab
5680655|NCT00577161|fludarabine|fludarabine
5680656|NCT00577148|NASH|nash
5680657|NCT00577148|chronic liver disease|chronic liver disease
5680658|NCT00577135|Loop Diuretics|loop diuretics
5680659|NCT00577135|Furosemide|furosemide
5680660|NCT00577135|Fluid Overload|fluid overload
5680661|NCT00577135|Cardio Renal Failure|cardio renal failure
5680662|NCT00577122|Medroxyprogesterone progesterone acetate (MPA)|medroxyprogesterone progesterone acetate (mpa)
5680663|NCT00577122|Cyclophosphamide plus Methotrexate|cyclophosphamide plus methotrexate
5680664|NCT00577096|multiple myeloma|multiple myeloma
5680665|NCT00577096|polysomnography|polysomnography
5680666|NCT00577096|quality of life|quality of life
5680748|NCT00576576|Atherosclerosis, vulnerable plaque, IVUS, shear stress|atherosclerosis, vulnerable plaque, ivus, shear stress
5680749|NCT00576563|rectal cancer|rectal cancer
5680750|NCT00576563|blood proteins|blood proteins
5680751|NCT00576563|irradiation|irradiation
5680753|NCT00576550|Hand eczema|hand eczema
5680754|NCT00576550|Prevention|prevention
5680755|NCT00576537|New/Recurrent Glioblastoma|new/recurrent glioblastoma
5680756|NCT00576524|Hypotension during dialysis|hypotension during dialysis
5680757|NCT00576524|End Stage Renal Disease|end stage renal disease
5681884|NCT00571350|tension free vaginal tapes|tension free vaginal tapes
5681885|NCT00571350|urinary incontinence|urinary incontinence
5681886|NCT00571337|Stop infliximab.|stop infliximab.
5681887|NCT00571324|hyperinsulinism|hyperinsulinism
5681888|NCT00571324|hypoglycemia|hypoglycemia
5681889|NCT00571324|KATP channel|katp channel
5681890|NCT00571324|Kir6.2|kir6.2
5681891|NCT00571311|Assent|assent
5681892|NCT00571311|Adolescent|adolescent
5681896|NCT00571298|Mesothelioma|mesothelioma
5681992|NCT00570999|Placebo|placebo
5682572|NCT00568828|Macular Teleangiectasia|macular teleangiectasia
5682573|NCT00568828|Macular Pigment|macular pigment
5682574|NCT00568815|DLBCL|dlbcl
5682575|NCT00568815|Rituximab|rituximab
5682602|NCT00568607|TTP|ttp
5683752|NCT00563264|obesity|obesity
5684852|NCT00558675|Allogeneic Cell Therapy|allogeneic cell therapy
5684854|NCT00558662|venous leg ulcer|venous leg ulcer
5684855|NCT00558662|sub bandage pressure|sub bandage pressure
5684856|NCT00558636|NSCLC|nsclc
5684857|NCT00558623|lead, blood|lead, blood
5685052|NCT00557921|peripheral vascular diseases|peripheral vascular diseases
5685053|NCT00557921|duodenal obstruction|duodenal obstruction
5686223|NCT00552981|rct|rct
5686519|NCT00551720|HIV|hiv
5687897|NCT00544804|bone metastases|bone metastases
5687898|NCT00544791|Mild Cognitive Impairment|mild cognitive impairment
5671268|NCT00616590|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5671269|NCT00616590|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5671270|NCT00616590|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5671271|NCT00616590|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5671272|NCT00616590|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5671273|NCT00616590|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5671274|NCT00616590|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5671275|NCT00616590|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5671276|NCT00616590|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5671277|NCT00616590|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5671278|NCT00616590|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5671279|NCT00616590|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5671280|NCT00616590|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5671281|NCT00616590|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5671282|NCT00616590|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5671283|NCT00616590|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5671284|NCT00616590|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5671285|NCT00616590|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5671286|NCT00616590|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5671287|NCT00616590|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5671288|NCT00616590|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5671289|NCT00616590|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5671290|NCT00616590|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671291|NCT00616590|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5671292|NCT00616590|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5671293|NCT00616590|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5671294|NCT00616590|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671295|NCT00616590|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5671296|NCT00616590|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5671297|NCT00616590|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5671298|NCT00616590|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671299|NCT00616590|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5671389|NCT00616213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5671300|NCT00616590|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5671301|NCT00616590|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5671302|NCT00616590|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671303|NCT00616590|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5671304|NCT00616590|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5671305|NCT00616590|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5671306|NCT00616590|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5671307|NCT00616590|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5671308|NCT00616590|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5671309|NCT00616590|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5671312|NCT00616590|stage II salivary gland cancer|stage ii salivary gland cancer
5671313|NCT00616590|stage III salivary gland cancer|stage iii salivary gland cancer
5671314|NCT00616590|stage IV salivary gland cancer|stage iv salivary gland cancer
5671315|NCT00616577|Caudal Epidural Ropivacaine|caudal epidural ropivacaine
5671318|NCT00616564|IL-2|il-2
5671319|NCT00616564|Sargrostim|sargrostim
5671321|NCT00616538|Atopic|atopic
5671322|NCT00616538|Dermatitis|dermatitis
5671323|NCT00616538|eczema|eczema
5671324|NCT00616538|skin barrier|skin barrier
5671325|NCT00616538|ceramide|ceramide
5671326|NCT00616538|topical|topical
5671327|NCT00616538|inflamation|inflamation
5671328|NCT00616538|steroid|steroid
5671329|NCT00616538|SCORAD|scorad
5671330|NCT00616538|glucocorticoids|glucocorticoids
5671331|NCT00616538|EpiCeram|epiceram
5671332|NCT00616538|Cutivate|cutivate
5671333|NCT00616538|fluticasone|fluticasone
5671334|NCT00616512|Water|water
5671335|NCT00616512|oral care|oral care
5671336|NCT00616512|oral hygiene|oral hygiene
5671337|NCT00616512|dysphagia|dysphagia
5671338|NCT00616512|thin liquid dysphagia|thin liquid dysphagia
5671339|NCT00616512|thickened liquids|thickened liquids
5671452|NCT00615979|telemedicine|telemedicine
5671351|NCT00616421|prevention of meningococcal disease serogroups ACWY|prevention of meningococcal disease serogroups acwy
5671352|NCT00616421|Menveo|menveo
5671353|NCT00616408|GH|gh
5671354|NCT00616408|IGF-I|igf-i
5671355|NCT00616408|GH-secreting tumors|gh-secreting tumors
5671356|NCT00616408|Octreotide|octreotide
5671357|NCT00616395|Infant Nutrition|infant nutrition
5671358|NCT00616395|Soy Phytochemicals|soy phytochemicals
5671359|NCT00616395|Infant Body Composition|infant body composition
5671360|NCT00616395|Brain Function|brain function
5671361|NCT00616395|Cognition and Development|cognition and development
5671362|NCT00616395|Healthy Infants|healthy infants
5671363|NCT00616382|PDA|pda
5671364|NCT00616382|indomethacin|indomethacin
5671365|NCT00616382|pentoxifylline|pentoxifylline
5671366|NCT00616382|Patent Ductus Arteriosus [PDA] resistant to therapy|patent ductus arteriosus [pda] resistant to therapy
5671367|NCT00616369|pulmonary hypertension|pulmonary hypertension
5671368|NCT00616369|hypertension|hypertension
5671369|NCT00616369|cardiomyopathy|cardiomyopathy
5671370|NCT00616369|arrhythmias|arrhythmias
5671371|NCT00616356|Yellow Fever|yellow fever
5671372|NCT00616343|ET|et
5671374|NCT00616304|severe falciparum malaria|severe falciparum malaria
5671375|NCT00616291|recurrent prostate cancer|recurrent prostate cancer
5671376|NCT00616291|stage IV prostate cancer|stage iv prostate cancer
5671377|NCT00616278|Growth Failure AND|growth failure and
5671378|NCT00616278|Chronic Renal Insufficiency OR|chronic renal insufficiency or
5671379|NCT00616278|End Stage Renal Disease|end stage renal disease
5671380|NCT00616265|Sleep apnea|sleep apnea
5671381|NCT00616265|Refractory Hypertension|refractory hypertension
5671382|NCT00616265|Difficult-to-treat hypertension|difficult-to-treat hypertension
5671383|NCT00616265|CPAP|cpap
5671384|NCT00616252|Antiretroviral|antiretroviral
5671385|NCT00616252|Pharmacokinetics|pharmacokinetics
5671386|NCT00616252|Pregnancy|pregnancy
5671387|NCT00616239|Melasma|melasma
5671683|NCT00614861|Pain|pain
5671390|NCT00616200|D-IBS (diarrhea predominant irritable bowel syndrome)|d-ibs (diarrhea predominant irritable bowel syndrome)
5671391|NCT00616174|Cesarean delivery|cesarean delivery
5671392|NCT00616174|Active Warming|active warming
5671393|NCT00616174|Neonatal Temperature|neonatal temperature
5671394|NCT00616161|Acute Heart Failure|acute heart failure
5671395|NCT00616161|Inotropes|inotropes
5671396|NCT00616161|Lusitropic agents|lusitropic agents
5671397|NCT00616161|Istaroxime|istaroxime
5671398|NCT00616161|PST2744|pst2744
5671399|NCT00616148|Epilepsy|epilepsy
5671403|NCT00616135|Adipose Derived Stem Cells|adipose derived stem cells
5671404|NCT00616135|Adipose Derived Regenerative Cells|adipose derived regenerative cells
5671406|NCT00616135|Reconstructive Breast Surgery|reconstructive breast surgery
5671407|NCT00616135|Breast Reconstruction|breast reconstruction
5671408|NCT00616135|Cancer|cancer
5671409|NCT00616135|Carcinoma|carcinoma
5671410|NCT00616135|Autologous fat transplantation|autologous fat transplantation
5671411|NCT00616135|Autologous fat|autologous fat
5671412|NCT00616135|Cosmetic breast deformities|cosmetic breast deformities
5671413|NCT00616135|Functional breast deformity|functional breast deformity
5671414|NCT00616135|Lumpectomy|lumpectomy
5671415|NCT00616135|Segmental mastectomy|segmental mastectomy
5671416|NCT00616135|Quadrantectomy|quadrantectomy
5671417|NCT00616135|breast conservation therapy|breast conservation therapy
5671418|NCT00616122|recurrent breast cancer|recurrent breast cancer
5671419|NCT00616122|stage IV breast cancer|stage iv breast cancer
5671420|NCT00616122|male breast cancer|male breast cancer
5671421|NCT00616096|Serum Immunoglobulin E above 5000 kU/l|serum immunoglobulin e above 5000 ku/l
5671422|NCT00616083|Breast Feeding|breast feeding
5671423|NCT00616083|Body Composition|body composition
5671424|NCT00616083|Body Fat|body fat
5671426|NCT00616083|Diet|diet
5671427|NCT00616083|Healthy Infants|healthy infants
5671428|NCT00616057|fructans supplementation|fructans supplementation
5671429|NCT00616044|Spinal Anesthesia|spinal anesthesia
5671430|NCT00616044|Epidural Anesthesia|epidural anesthesia
5671431|NCT00616044|Orthopedic procedures|orthopedic procedures
5671432|NCT00616031|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5671433|NCT00616031|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5671434|NCT00616018|acetaminophen|acetaminophen
5671435|NCT00616018|protein adducts|protein adducts
5671436|NCT00616018|hepatic function|hepatic function
5671437|NCT00616018|drug safety|drug safety
5671438|NCT00616018|non drinkers|non drinkers
5671439|NCT00616005|Glioblastoma|glioblastoma
5671440|NCT00616005|GBM|gbm
5671441|NCT00616005|Brain tumor|brain tumor
5671442|NCT00616005|Temodar|temodar
5671443|NCT00616005|Temozolomide|temozolomide
5671444|NCT00616005|Irinotecan|irinotecan
5671445|NCT00616005|CPT-11|cpt-11
5671446|NCT00616005|Camptosar|camptosar
5671447|NCT00616005|Malignant glioma|malignant glioma
5671448|NCT00616005|Anaplastic astrocytoma|anaplastic astrocytoma
5671449|NCT00616005|Glioblastoma multiforme|glioblastoma multiforme
5671450|NCT00615979|trauma|trauma
5671451|NCT00615979|portable ultrasound|portable ultrasound
5671487|NCT00615862|Sepsis, alcoholism, cortisol, delirium, critical care|sepsis, alcoholism, cortisol, delirium, critical care
5671488|NCT00615849|pneumothorax, thoracoscopy, pleurodesis|pneumothorax, thoracoscopy, pleurodesis
5671489|NCT00615823|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5671491|NCT00615810|HDL|hdl
5671492|NCT00615810|triglycerides|triglycerides
5671493|NCT00615810|non HDL cholesterol|non hdl cholesterol
5671494|NCT00615810|cholesterol|cholesterol
5671495|NCT00615810|HIV 1|hiv 1
5671496|NCT00615810|Metabolic parameters|metabolic parameters
5665956|NCT00637260|neuromodulation|neuromodulation
5671497|NCT00615810|treatment experienced|treatment experienced
5671498|NCT00615784|Acute Myeloid Leukemia|acute myeloid leukemia
5671499|NCT00615784|AML|aml
5671500|NCT00615784|Bexarotene|bexarotene
5671501|NCT00615758|Erlotinib|erlotinib
5671502|NCT00615758|Biological therapy|biological therapy
5671503|NCT00615758|Tyrosin Kinase Inhibitor therapy|tyrosin kinase inhibitor therapy
5671504|NCT00615745|Human Immunodeficiency Virus|human immunodeficiency virus
5671505|NCT00615745|treatment experienced|treatment experienced
5671506|NCT00615732|qigong|qigong
5671507|NCT00615732|traditional chinese medicine|traditional chinese medicine
5671508|NCT00615732|exercise therapy|exercise therapy
5671509|NCT00615732|neck pain|neck pain
5671510|NCT00615719|Chest Pain|chest pain
5671511|NCT00615719|Coronary Angiography|coronary angiography
5671512|NCT00615719|Acute Coronary Syndromes|acute coronary syndromes
5671513|NCT00615719|Computed Tomography|computed tomography
5671514|NCT00615706|asthma, inhaled corticosteroids|asthma, inhaled corticosteroids
5671515|NCT00615693|Uveitis|uveitis
5671516|NCT00615693|Macular Edema|macular edema
5671517|NCT00615667|Refractory Nephrotic syndrome|refractory nephrotic syndrome
5671518|NCT00615667|Tacrolimus|tacrolimus
5671519|NCT00615654|Hydrotherapy,|hydrotherapy,
5671520|NCT00615654|RCT,|rct,
5671521|NCT00615641|Children|children
5671522|NCT00615641|Nutrition|nutrition
5671523|NCT00615641|Body Fat|body fat
5671524|NCT00615641|Physical Activity|physical activity
5671525|NCT00615641|Diet|diet
5671526|NCT00615641|Childhood Obesity|childhood obesity
5671527|NCT00615641|Healthy Children|healthy children
5671528|NCT00615628|Inheritance of Osteosarcoma & Paget's Disease through Chromosome 18|inheritance of osteosarcoma & paget's disease through chromosome 18
5671529|NCT00615615|Levetiracetam|levetiracetam
5671530|NCT00615615|Keppra|keppra
5671531|NCT00615602|Early breast cancer|early breast cancer
5671532|NCT00615602|Axillary node positive|axillary node positive
5671533|NCT00615602|HER2 overexpression|her2 overexpression
5671534|NCT00615602|Adjuvant chemotherapy|adjuvant chemotherapy
5671535|NCT00615602|Dose dense|dose dense
5671536|NCT00615602|Docetaxel|docetaxel
5671537|NCT00615602|Trastuzumab|trastuzumab
5671539|NCT00615589|Stage II/III Multiple Myeloma(within 10 months from diagnosis)|stage ii/iii multiple myeloma(within 10 months from diagnosis)
5671540|NCT00615589|high risk|high risk
5671541|NCT00615589|relapse|relapse
5671542|NCT00615589|persistent|persistent
5671543|NCT00615576|Smoker,|smoker,
5671544|NCT00615576|Male,|male,
5671545|NCT00615576|Chronic Obstructive Lung Disease|chronic obstructive lung disease
5671546|NCT00615576|Cystic Fibrosis,|cystic fibrosis,
5671547|NCT00615576|Healthy Volunteer,|healthy volunteer,
5671548|NCT00615550|Preterm|preterm
5671549|NCT00615550|Cervix|cervix
5671550|NCT00615537|Thyroid Nodule|thyroid nodule
5671551|NCT00615537|Thyroid Cancer|thyroid cancer
5671552|NCT00615537|Laser Ablation|laser ablation
5671553|NCT00615537|LITT|litt
5671554|NCT00615537|Nodular Goiter|nodular goiter
5671555|NCT00615537|Thyroid Mass|thyroid mass
5671556|NCT00615524|Breast cancer|breast cancer
5671557|NCT00615524|Advanced|advanced
5671558|NCT00615524|Metastatic|metastatic
5671559|NCT00615524|Pazopanib|pazopanib
5671560|NCT00615524|GW786034|gw786034
5671561|NCT00615524|Exemestane|exemestane
5671562|NCT00615524|Efficacy|efficacy
5671563|NCT00615524|Tolerability|tolerability
5671564|NCT00615524|Health-Related Quality of Life|health-related quality of life
5671565|NCT00615511|schizophrenia|schizophrenia
5671566|NCT00615511|schizoaffective disorder|schizoaffective disorder
5671567|NCT00615511|negative symptoms|negative symptoms
5671568|NCT00615511|cognition|cognition
5671569|NCT00615498|Asthma, obesity, bariatric|asthma, obesity, bariatric
5671570|NCT00615485|Examine the risk of osteoporosis in survivors of solid pediatric cancers|examine the risk of osteoporosis in survivors of solid pediatric cancers
5671571|NCT00615472|Parkinson's Disease|parkinson's disease
5671572|NCT00615472|Deep brain stimulation (DBS)|deep brain stimulation (dbs)
5671573|NCT00615472|Subthalamic Nucleus|subthalamic nucleus
5671574|NCT00615472|Total Intravenous Anesthesia|total intravenous anesthesia
5671575|NCT00615472|Inhalational Anesthesia|inhalational anesthesia
5671576|NCT00615459|Chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled|chronic obstructive pulmonary disease, indacaterol, tiotropium, placebo controlled
5671577|NCT00615446|solid tumor malignancy, SU011248, sunitinib, neoplasms|solid tumor malignancy, su011248, sunitinib, neoplasms
5671578|NCT00615433|Schizophrenia|schizophrenia
5671580|NCT00615433|Lurasidone|lurasidone
5671581|NCT00615420|Mucositis|mucositis
5671582|NCT00615420|Radiation|radiation
5671583|NCT00615420|Honey|honey
5671599|NCT00615329|Create tumor specific gene profiles to improve diagnostic accuracy|create tumor specific gene profiles to improve diagnostic accuracy
5671600|NCT00615329|Perform gene set validation for diagnostic predictive power|perform gene set validation for diagnostic predictive power
5671601|NCT00615329|Define deviant gene list implicated in pathogenesis|define deviant gene list implicated in pathogenesis
5671602|NCT00615303|Bowel preparation, colonoscopy, simethicone, air bubble|bowel preparation, colonoscopy, simethicone, air bubble
5671603|NCT00615277|Young adults|young adults
5671604|NCT00615277|Long-chain polyunsaturated fatty acids|long-chain polyunsaturated fatty acids
5671605|NCT00615277|Cognitive function|cognitive function
5671606|NCT00615277|Mood|mood
5671607|NCT00615277|Supply with omega-3 fatty acids|supply with omega-3 fatty acids
5671608|NCT00615251|In vitro fertilization|in vitro fertilization
5671609|NCT00615238|overweight, physical activity, body composition, metabolic syndrome|overweight, physical activity, body composition, metabolic syndrome
5671610|NCT00615225|brain death|brain death
5671611|NCT00615225|inflammation|inflammation
5671612|NCT00615225|endotoxin|endotoxin
5671613|NCT00615225|transplantation|transplantation
5671614|NCT00615225|graft|graft
5671615|NCT00615225|apoptosis|apoptosis
5671616|NCT00615225|Systemic inflammatory response|systemic inflammatory response
5671617|NCT00615225|Apoptosis activation|apoptosis activation
5671618|NCT00615225|Graft outcome|graft outcome
5671619|NCT00615212|Healthy Subjects,|healthy subjects,
5671620|NCT00615212|Cytochrome P450 isoenzymes,|cytochrome p450 isoenzymes,
5671621|NCT00615212|Repeat Dose|repeat dose
5671622|NCT00615212|GSK376501,|gsk376501,
5671623|NCT00615186|Neuradiab|neuradiab
5671624|NCT00615186|Locoregional glioblastoma multiforme disease|locoregional glioblastoma multiforme disease
5671625|NCT00615186|Anti-tenascin|anti-tenascin
5671626|NCT00615186|Radiolabeled antibody therapy|radiolabeled antibody therapy
5671627|NCT00615186|Survival|survival
5671628|NCT00615173|Tacrolimus|tacrolimus
5671629|NCT00615173|lupus nephritis|lupus nephritis
5671630|NCT00615160|Metastatic melanoma|metastatic melanoma
5671631|NCT00615160|anti angiogenetic treatment|anti angiogenetic treatment
5671632|NCT00615147|Any cancer|any cancer
5671633|NCT00615147|suspected pulmonary embolism|suspected pulmonary embolism
5671634|NCT00615134|treatment experienced|treatment experienced
5671635|NCT00615121|Smoking|smoking
5671636|NCT00615121|Hypertension|hypertension
5671637|NCT00615121|Diabetes|diabetes
5671638|NCT00615121|Cardiovascular disease|cardiovascular disease
5671639|NCT00615121|Renal Failure|renal failure
5671640|NCT00615043|Transurethral resection of bladder tumor|transurethral resection of bladder tumor
5671642|NCT00615030|COPD, bronchodilator, long acting beta agonist, LABA|copd, bronchodilator, long acting beta agonist, laba
5671643|NCT00615017|Sepsis|sepsis
5671644|NCT00615017|septic shock|septic shock
5671645|NCT00615017|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5671646|NCT00615004|Acromegaly|acromegaly
5671648|NCT00615004|IGF-I|igf-i
5671649|NCT00615004|Octreotide-LAR|octreotide-lar
5671650|NCT00615004|Lanreotide|lanreotide
5671651|NCT00615004|Transsphenoidal surgery|transsphenoidal surgery
5671652|NCT00614991|Healthy Subjects|healthy subjects
5671653|NCT00614991|Pharmacokinetics study|pharmacokinetics study
5671654|NCT00614991|Pharmacokinetics of medications|pharmacokinetics of medications
5671655|NCT00614978|HER-2 positive; brain metastases|her-2 positive; brain metastases
5671656|NCT00614965|Cancer|cancer
5671657|NCT00614965|NSCLC|nsclc
5671658|NCT00614965|second-line chemotherapy|second-line chemotherapy
5671659|NCT00614965|irinotecan|irinotecan
5671660|NCT00614965|pemetrexed|pemetrexed
5671661|NCT00614939|DPP-4 inhibitors|dpp-4 inhibitors
5671662|NCT00614939|HbA1c|hba1c
5671663|NCT00614939|incretins|incretins
5671664|NCT00614939|Renal Impairment|renal impairment
5671665|NCT00614926|Fatigue|fatigue
5671666|NCT00614926|low energy|low energy
5671668|NCT00614926|treatment|treatment
5671669|NCT00614913|Proton|proton
5671670|NCT00614913|Radiotherapy|radiotherapy
5671671|NCT00614913|Hepatocellular carcinoma|hepatocellular carcinoma
5671672|NCT00614913|Liver Cancer|liver cancer
5671673|NCT00614900|COPD|copd
5671674|NCT00614900|pulmonary hypertension|pulmonary hypertension
5671675|NCT00614900|NT-proBNP|nt-probnp
5671676|NCT00614900|6 minutes walk test|6 minutes walk test
5671677|NCT00614887|Subarachnoid hemorrhage|subarachnoid hemorrhage
5671678|NCT00614887|Pituitary gland|pituitary gland
5671679|NCT00614887|Adrenal gland|adrenal gland
5671680|NCT00614874|Asthma|asthma
5671681|NCT00614874|Avandia|avandia
5671682|NCT00614861|Non-cancer pain|non-cancer pain
5671687|NCT00614835|uterine sarcoma|uterine sarcoma
5671688|NCT00614809|gefitinib|gefitinib
5671689|NCT00614809|brain metastasis|brain metastasis
5671690|NCT00614796|COPD|copd
5671691|NCT00614796|Lifestyle|lifestyle
5671692|NCT00614796|Pedometer|pedometer
5671693|NCT00614783|Screening|screening
5671694|NCT00614770|colonoscopy|colonoscopy
5671695|NCT00614744|NICHD Neonatal Research Network|nichd neonatal research network
5671696|NCT00614744|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5671697|NCT00614744|Hypothermia|hypothermia
5671698|NCT00614744|Neonatal depression|neonatal depression
5671735|NCT00614614|Human serum bactericidal assay|human serum bactericidal assay
5671736|NCT00614614|Safety|safety
5671737|NCT00614614|Vaccines, conjugate|vaccines, conjugate
5671738|NCT00614614|Booster vaccination|booster vaccination
5671739|NCT00614601|pancreatic cancer|pancreatic cancer
5671740|NCT00614601|vaccine therapy|vaccine therapy
5671741|NCT00614588|temperature|temperature
5671742|NCT00614588|monitor|monitor
5671743|NCT00614588|surgery|surgery
5671744|NCT00614562|critical associated illness polyneuropathy or polymyopathy (CIP/M)|critical associated illness polyneuropathy or polymyopathy (cip/m)
5671745|NCT00614549|Levetiracetam|levetiracetam
5671746|NCT00614549|Keppra|keppra
5671747|NCT00614549|Epilepsy|epilepsy
5671748|NCT00614549|Efficacy|efficacy
5671749|NCT00614549|Safety|safety
5671750|NCT00614536|Reflux Symptom Index|reflux symptom index
5671751|NCT00614536|Reflux Finding Score|reflux finding score
5671752|NCT00614536|Rabeprazole|rabeprazole
5671753|NCT00614536|LaryngoPharyngeal Reflux Disease|laryngopharyngeal reflux disease
5671754|NCT00614536|GastroEsophageal Reflux Disease|gastroesophageal reflux disease
5671755|NCT00614523|MDS|mds
5671756|NCT00614523|Low Risk MDS|low risk mds
5671757|NCT00614523|Intermediate-1 Risk MDS|intermediate-1 risk mds
5671758|NCT00614523|Thrombocytopenia|thrombocytopenia
5671759|NCT00614484|Proton|proton
5671760|NCT00614484|Radiation|radiation
5671761|NCT00614458|latent HIV|latent hiv
5671762|NCT00614458|resting CD4+ T cell|resting cd4+ t cell
5671763|NCT00614458|valproic acid (VPA)|valproic acid (vpa)
5671764|NCT00614458|Raltegravir (MK-0518) intensification|raltegravir (mk-0518) intensification
5671765|NCT00614458|HIV replication|hiv replication
5671766|NCT00614458|treatment experienced|treatment experienced
5671767|NCT00614445|Nausea|nausea
5671768|NCT00614445|Vomiting|vomiting
5671769|NCT00614445|Pregnancy|pregnancy
5671770|NCT00614445|Hyperemesis gravidarum|hyperemesis gravidarum
5671771|NCT00614445|Pregnancy complications|pregnancy complications
5671772|NCT00614432|anticoagulation|anticoagulation
5671773|NCT00614432|surgical abortion|surgical abortion
5671774|NCT00614419|Hernioplasty|hernioplasty
5671775|NCT00614419|polypropylene|polypropylene
5671776|NCT00614419|extracellular matrix|extracellular matrix
5671777|NCT00614419|xenograft|xenograft
5671778|NCT00614406|Celebrex|celebrex
5671779|NCT00614406|prostaglandin inhibitor|prostaglandin inhibitor
5671780|NCT00614406|ovulation|ovulation
5671781|NCT00614406|menstrual cycles|menstrual cycles
5091864|NCT03424486|Depression|depression
5671790|NCT00614328|Alcohol Drinking|alcohol drinking
5671791|NCT00614289|Mild to Moderate Hand Dermatitis|mild to moderate hand dermatitis
5671792|NCT00614289|Hand Eczema|hand eczema
5671793|NCT00614276|Sexual Dysfunction|sexual dysfunction
5671794|NCT00614276|Cancer-related Sexual Dysfunction|cancer-related sexual dysfunction
5671795|NCT00614276|Female Cancer Survivors|female cancer survivors
5671796|NCT00614276|Tendrils|tendrils
5671797|NCT00614276|Website program|website program
5671798|NCT00614276|Self-help tool|self-help tool
5671799|NCT00614276|Sexual counseling|sexual counseling
5671800|NCT00614276|Questionnaires|questionnaires
5671801|NCT00614263|Colonoscopy|colonoscopy
5671802|NCT00614263|Sedation levels|sedation levels
5671803|NCT00614250|Obstructive sleep apnea|obstructive sleep apnea
5671804|NCT00614211|Cervix|cervix
5671805|NCT00614211|Cervical|cervical
5671806|NCT00614211|Cancer|cancer
5671807|NCT00614211|Carcinoma|carcinoma
5671808|NCT00614211|Radical hysterectomy|radical hysterectomy
5671809|NCT00614211|Hysterectomy|hysterectomy
5671810|NCT00614211|Laparoscopy|laparoscopy
5671811|NCT00614211|Laparoscopic|laparoscopic
5671812|NCT00614211|Robotic|robotic
5671813|NCT00614211|Squamous Cell|squamous cell
5671814|NCT00614211|Adenosquamous|adenosquamous
5671815|NCT00614211|Adenocarcinoma|adenocarcinoma
5671816|NCT00614211|Lymphatic Mapping|lymphatic mapping
5671817|NCT00614211|IOLM|iolm
5671818|NCT00614211|SPECT|spect
5671819|NCT00614211|Sentinel Node|sentinel node
5671820|NCT00614211|Uterine cervix|uterine cervix
5671821|NCT00614198|autism|autism
5671822|NCT00614198|autism spectrum disorder|autism spectrum disorder
5671823|NCT00614198|diet|diet
5671824|NCT00614198|gluten|gluten
5671826|NCT00614198|intervention|intervention
5671827|NCT00614198|peptide|peptide
5671828|NCT00614198|randomised|randomised
5671829|NCT00614198|controlled|controlled
5671830|NCT00614198|adaptive design|adaptive design
5671831|NCT00614198|Autism Diagnostic Observation Schedule (ADOS)|autism diagnostic observation schedule (ados)
5671832|NCT00614198|Gilliam Autism Rating Scale (GARS)|gilliam autism rating scale (gars)
5671833|NCT00614198|Vineland Adaptive Behaviour Scale (VABS)|vineland adaptive behaviour scale (vabs)
5671834|NCT00614198|Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale|attention-deficit hyperactivity disorder (adhd)-iv scale
5671838|NCT00614159|Child age 1-10 years having a GI Endoscopy with sedation|child age 1-10 years having a gi endoscopy with sedation
5671839|NCT00614146|liver failure, albumin dialysis, liver support|liver failure, albumin dialysis, liver support
5671840|NCT00614133|protein metabolism|protein metabolism
5671841|NCT00614133|surgery|surgery
5671842|NCT00614133|parenteral nutrition|parenteral nutrition
5671843|NCT00614107|Atrial Fibrillation post open heart surgery|atrial fibrillation post open heart surgery
5671844|NCT00614094|placenta, hypoglycemia|placenta, hypoglycemia
5671845|NCT00614081|Glomerular filtration rate measurement|glomerular filtration rate measurement
5671846|NCT00614081|Contrast-enhanced dynamic MR imaging|contrast-enhanced dynamic mr imaging
5671847|NCT00614081|Renal transplant recipients|renal transplant recipients
5671848|NCT00614068|Treatment|treatment
5671849|NCT00614068|PTSD|ptsd
5671850|NCT00614042|CLL|cll
5671851|NCT00614042|NHL|nhl
5671852|NCT00614042|TRU-016|tru-016
5666257|NCT00635921|ziprasidone|ziprasidone
5671853|NCT00614042|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5671854|NCT00614042|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5671855|NCT00614029|sumatriptan|sumatriptan
5671856|NCT00614029|Injections|injections
5671857|NCT00614029|Subcutaneous|subcutaneous
5671858|NCT00614016|healthy volunteers|healthy volunteers
5671859|NCT00614003|decisional conflict;|decisional conflict;
5671860|NCT00614003|decision quality;|decision quality;
5671861|NCT00614003|place of end of life care;|place of end of life care;
5671862|NCT00614003|provider education|provider education
5671863|NCT00613977|fetal lung maturity|fetal lung maturity
5671864|NCT00613977|lamellar body count|lamellar body count
5671865|NCT00613964|Natriuretic Peptides|natriuretic peptides
5671866|NCT00613964|Heart Failure|heart failure
5671867|NCT00613964|Renal Failure|renal failure
5671868|NCT00613938|Acute pain|acute pain
5671869|NCT00613938|bunionectomy|bunionectomy
5671870|NCT00613938|tapentadol|tapentadol
5671871|NCT00613925|endometrial biopsy|endometrial biopsy
5093722|NCT03412903|Pharmacist|pharmacist
5671873|NCT00613912|Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Perfusion, brain|magnetic resonance imaging, magnetic resonance spectroscopy, perfusion, brain
5671874|NCT00613899|home care|home care
5671875|NCT00613899|home rehabilitation|home rehabilitation
5671876|NCT00613899|telemedicine|telemedicine
5671878|NCT00613886|NPH|nph
5671879|NCT00613886|Normal Pressure Hydrocephalus|normal pressure hydrocephalus
5671880|NCT00613873|colonoscopy|colonoscopy
5671881|NCT00613860|Endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy|endoscopic lung volume reduction, heterogeneous emphysema, interventional bronchoscopy
5671882|NCT00613847|PET Scan|pet scan
5671883|NCT00613847|Invasive Solid Tumors|invasive solid tumors
5671884|NCT00613834|Essure sterilization|essure sterilization
5671885|NCT00613834|pain management|pain management
5671886|NCT00613834|intrauterine lidocaine infusion|intrauterine lidocaine infusion
5671887|NCT00613821|surgical abortion|surgical abortion
5671888|NCT00613821|pain management|pain management
5671889|NCT00613808|venous|venous
5671891|NCT00613808|ulcer|ulcer
5671892|NCT00613795|pneumonia|pneumonia
5671893|NCT00613795|ventilator associated pneumonia|ventilator associated pneumonia
5671895|NCT00613795|Lactobacillus GG|lactobacillus gg
5671896|NCT00613769|Surgical site infections|surgical site infections
5671897|NCT00613717|iron deficiency anemia|iron deficiency anemia
5671898|NCT00613717|iron deficiency|iron deficiency
5671899|NCT00613717|infant|infant
5671900|NCT00613717|development|development
5671901|NCT00613717|behavior|behavior
5671902|NCT00613691|Refractory|refractory
5671903|NCT00613691|Progressive|progressive
5671904|NCT00613678|pain|pain
5671905|NCT00613678|activities of daily living|activities of daily living
5671906|NCT00613678|symptoms|symptoms
5671907|NCT00613678|self-management|self-management
5671908|NCT00613652|solid tumors|solid tumors
5671909|NCT00613652|solid malignancies|solid malignancies
5671910|NCT00613626|Extensive Stage|extensive stage
5671911|NCT00613626|Untreated|untreated
5671912|NCT00613600|Safety|safety
5671913|NCT00613600|Efficacy|efficacy
5671914|NCT00613600|Glucomannan|glucomannan
5671915|NCT00613600|Dietary fiber|dietary fiber
5671916|NCT00613600|Weight loss|weight loss
5671917|NCT00613587|Interleukin 13|interleukin 13
5671918|NCT00613587|Interleukin 4|interleukin 4
5671919|NCT00613587|Leukotrienes|leukotrienes
5671920|NCT00613587|Basophil Histamine Release|basophil histamine release
5671921|NCT00613561|Patients with the Severe Immunodeficiency diseases|patients with the severe immunodeficiency diseases
5688618|NCT00542503|Cardiac Outcomes|cardiac outcomes
5671922|NCT00613561|Severe Immunodeficiency diseases|severe immunodeficiency diseases
5671924|NCT00613548|Mitral|mitral
5671925|NCT00613548|Regurgitation|regurgitation
5671926|NCT00613548|CABG|cabg
5671927|NCT00613535|Partial Meniscectomy|partial meniscectomy
5671928|NCT00613535|Partial Thickness Knee Tear|partial thickness knee tear
5671929|NCT00613535|MR Imaging|mr imaging
5671930|NCT00613535|Mechanical Debridement|mechanical debridement
5671931|NCT00613535|Crepitus|crepitus
5671932|NCT00613535|Stability|stability
5671933|NCT00613535|Coblation|coblation
5671934|NCT00613535|Bipolar Radiofrequency|bipolar radiofrequency
5671998|NCT00613275|Racial and Ethnic Minorities|racial and ethnic minorities
5671999|NCT00613262|Narrow Band Imaging|narrow band imaging
5672000|NCT00613249|HIV-1 Infection|hiv-1 infection
5672001|NCT00613249|HIV Seronegativity|hiv seronegativity
5672002|NCT00613223|Malignant Gliomas|malignant gliomas
5672003|NCT00613223|Etopophos|etopophos
5672004|NCT00613223|Toposar|toposar
5672005|NCT00613223|VePesid|vepesid
5672006|NCT00613223|Etoposide|etoposide
5672007|NCT00613223|Vandetanib|vandetanib
5672008|NCT00613223|Zactima|zactima
5672009|NCT00613223|ZD6474|zd6474
5672010|NCT00613223|VP-16|vp-16
5672011|NCT00613223|Brain Tumor|brain tumor
5672012|NCT00613223|Recurring Malignant Brain Tumor|recurring malignant brain tumor
5672013|NCT00613223|Gliosarcoma|gliosarcoma
5672014|NCT00613223|Glioblastoma|glioblastoma
5672015|NCT00613223|Glioma|glioma
5672016|NCT00613223|Malignant Glioma|malignant glioma
5672018|NCT00613210|preterm delivery|preterm delivery
5672019|NCT00613210|shory cervix|shory cervix
5672020|NCT00613210|amniotic fluid sludge|amniotic fluid sludge
5672021|NCT00613210|uterine artery doppler|uterine artery doppler
5672022|NCT00613210|singeltone|singeltone
5672023|NCT00613210|normal amniotic fluid index|normal amniotic fluid index
5672024|NCT00613210|without rupter of membranes|without rupter of membranes
5672025|NCT00613210|24-34 weeks of gestation|24-34 weeks of gestation
5672026|NCT00613197|Crohn's Disease|crohn's disease
5672027|NCT00613184|Respiratory Syncytial virus|respiratory syncytial virus
5672028|NCT00613184|Bronchiolitis|bronchiolitis
5672029|NCT00613184|Pediatric|pediatric
5672030|NCT00613171|Systemic sclerosis, scleroderma, fibrosis, STI571, imatinib|systemic sclerosis, scleroderma, fibrosis, sti571, imatinib
5672031|NCT00613158|Subclincal Atherosclerosis|subclincal atherosclerosis
5672032|NCT00613145|Refractory Malignancy|refractory malignancy
5672033|NCT00613145|Phase I|phase i
5672034|NCT00613145|Sorafenib|sorafenib
5672038|NCT00613132|GBM|gbm
5672039|NCT00613132|Brain tumor|brain tumor
5672040|NCT00613132|RAD0001|rad0001
5672041|NCT00613132|Hydroxyurea|hydroxyurea
5672042|NCT00613132|Gleevec|gleevec
5672043|NCT00613132|Imatinib|imatinib
5672044|NCT00613132|Droxia|droxia
5672045|NCT00613132|Everolimus|everolimus
5672046|NCT00613132|Hydrea|hydrea
5672047|NCT00613132|Hydroxycarbamide|hydroxycarbamide
5672048|NCT00613132|Recurrent GBM|recurrent gbm
5672049|NCT00613132|Imatinib mesylate|imatinib mesylate
5672050|NCT00613132|Glioblastoma multiforme|glioblastoma multiforme
5672051|NCT00613119|Inflammation|inflammation
5672052|NCT00613119|Frontotemporal Dementia|frontotemporal dementia
5672053|NCT00613119|Dementia|dementia
5672054|NCT00613119|PBR28|pbr28
5672055|NCT00613119|PET Imaging|pet imaging
5672056|NCT00613093|Temodar|temodar
5672057|NCT00613093|Temozolomide|temozolomide
5672058|NCT00613093|O6-BG|o6-bg
5672059|NCT00613093|O6-Benzylguanine|o6-benzylguanine
5672060|NCT00613093|NSC 637037|nsc 637037
5672061|NCT00613093|Temodar-Resistant Malignant Glioma|temodar-resistant malignant glioma
5672062|NCT00613093|Brain tumor|brain tumor
5672063|NCT00613093|CNS tumor|cns tumor
5672064|NCT00613093|Cerebral glioblastoma|cerebral glioblastoma
5672065|NCT00613093|Anaplastic astrocytomas|anaplastic astrocytomas
5672066|NCT00613093|Glioma|glioma
5672067|NCT00613080|stage III rectal cancer|stage iii rectal cancer
5672068|NCT00613080|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5672069|NCT00613067|Generalized anxiety disorder|generalized anxiety disorder
5672070|NCT00613067|N100|n100
5672071|NCT00613067|Central serotonergic activity|central serotonergic activity
5672073|NCT00613054|Brain tumor|brain tumor
5672074|NCT00613054|Zactima|zactima
5672075|NCT00613054|Gleevec|gleevec
5672076|NCT00613054|Hydroxyurea|hydroxyurea
5672077|NCT00613054|Glioblastoma|glioblastoma
5672078|NCT00613054|Gliosarcoma|gliosarcoma
5672079|NCT00613054|Recurrent malignant glioma|recurrent malignant glioma
5672081|NCT00613054|Malignant glioma|malignant glioma
5672082|NCT00613054|Imatinib|imatinib
5672083|NCT00613054|Droxia|droxia
5672084|NCT00613054|Hydrea|hydrea
5672085|NCT00613054|Hydroxycarbamide|hydroxycarbamide
5672086|NCT00613054|Vandetanib|vandetanib
5672087|NCT00613028|Glioblastoma|glioblastoma
5672088|NCT00613028|Gliosarcoma|gliosarcoma
5672089|NCT00613028|GBM|gbm
5672090|NCT00613028|Bevacizumab|bevacizumab
5672091|NCT00613028|Avastin|avastin
5672092|NCT00613028|Etoposide|etoposide
5672093|NCT00613028|Brain tumor|brain tumor
5672094|NCT00613028|Irinotecan|irinotecan
5672095|NCT00613028|Glioblastoma multiforme|glioblastoma multiforme
5672096|NCT00613028|Temodar|temodar
5672097|NCT00613028|Temozolomide|temozolomide
5672098|NCT00613028|Etopophos|etopophos
5672099|NCT00613028|Toposar|toposar
5672100|NCT00613028|VePesid|vepesid
5672101|NCT00613028|VP-16|vp-16
5672102|NCT00613028|Camptosar|camptosar
5672103|NCT00613015|Cocaine Addiction|cocaine addiction
5672104|NCT00613015|Cocaine Dependence|cocaine dependence
5672105|NCT00613002|hypoactive sexual desire disorder|hypoactive sexual desire disorder
5672106|NCT00613002|testosterone|testosterone
5672122|NCT00612976|documentation of relevant data|documentation of relevant data
5672123|NCT00612976|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
5672124|NCT00612963|Candidiasis, Oral|candidiasis, oral
5672125|NCT00612963|Thrush|thrush
5672126|NCT00612963|Candidiasis|candidiasis
5672127|NCT00612937|Group B Streptococci|group b streptococci
5672128|NCT00612937|Respiratory Disease|respiratory disease
5672129|NCT00612937|Beta Lactam|beta lactam
5672130|NCT00612937|Newborn|newborn
5672131|NCT00612937|Respiratory Distress|respiratory distress
5672132|NCT00612898|HIV infection|hiv infection
5672133|NCT00612898|Drug resistance|drug resistance
5672134|NCT00612898|Reverse transcriptase inhibitor|reverse transcriptase inhibitor
5672135|NCT00612898|Nucleoside analogue|nucleoside analogue
5672136|NCT00612898|treatment experienced|treatment experienced
5672137|NCT00612859|Levetiracetam|levetiracetam
5672138|NCT00612859|Keppra|keppra
5672139|NCT00612846|Common Bile Duct Calculi|common bile duct calculi
5672140|NCT00612846|Choledocholithiasis|choledocholithiasis
5672141|NCT00612846|Endoscopic sphincterotomy|endoscopic sphincterotomy
5672142|NCT00612846|Cholecystectomy, laparoscopic|cholecystectomy, laparoscopic
5672143|NCT00612846|Laparoscopic bile duct exploration|laparoscopic bile duct exploration
5672144|NCT00612833|Vasectomy|vasectomy
5672145|NCT00612833|Male contraception|male contraception
5672146|NCT00612833|Contraceptive effectiveness|contraceptive effectiveness
5672147|NCT00612833|Semen analysis|semen analysis
5672148|NCT00612833|Surgical techniques|surgical techniques
5672149|NCT00612833|Fascial interposition|fascial interposition
5672150|NCT00612833|Cautery|cautery
5097846|NCT03386786|mHealth|mhealth
5097850|NCT03386773|mobile health|mobile health
5672151|NCT00612833|The relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.|the relative contraceptive effectiveness of three methods of occluding the vas, in the context of a no-scalpel vasectomy procedure.
5672153|NCT00612820|Seasonal Allergic Rhinitis,|seasonal allergic rhinitis,
5672154|NCT00612807|Older Adults|older adults
5672155|NCT00612794|exenatide|exenatide
5672156|NCT00612794|Byetta|byetta
5672157|NCT00612794|diabetes|diabetes
5672158|NCT00612794|Amylin|amylin
5672159|NCT00612794|Lilly|lilly
5672160|NCT00612781|intraocular lens|intraocular lens
5672161|NCT00612781|blue-light filtering intraocular lens|blue-light filtering intraocular lens
5672162|NCT00612781|contrast acuity|contrast acuity
5672163|NCT00612781|color vision|color vision
5672164|NCT00612768|Bioequivalence|bioequivalence
5672165|NCT00612768|Thimerosal|thimerosal
5672166|NCT00612768|Fragrance Mix|fragrance mix
5672167|NCT00612768|PVP formulation|pvp formulation
5672168|NCT00612768|Contact dermatitis|contact dermatitis
5672169|NCT00612755|chronic hepatitis C|chronic hepatitis c
5672170|NCT00612755|co-infection|co-infection
5672171|NCT00612755|extend treatment|extend treatment
5672172|NCT00612755|co-infected HIV-HCV|co-infected hiv-hcv
5672173|NCT00612742|Cardiovascular event|cardiovascular event
5672174|NCT00612742|Breast Cancer|breast cancer
5672175|NCT00612742|Testosterone|testosterone
5672177|NCT00612742|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5672178|NCT00612729|intraocular lens|intraocular lens
5672179|NCT00612729|light filtering intraocular lens|light filtering intraocular lens
5672180|NCT00612729|contrast acuity|contrast acuity
5672181|NCT00612729|color vision|color vision
5672182|NCT00612716|stage I multiple myeloma|stage i multiple myeloma
5672183|NCT00612716|stage II multiple myeloma|stage ii multiple myeloma
5672184|NCT00612716|stage III multiple myeloma|stage iii multiple myeloma
5672185|NCT00612716|refractory multiple myeloma|refractory multiple myeloma
5672186|NCT00612716|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5672187|NCT00612716|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5672188|NCT00612716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5672189|NCT00612716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5672190|NCT00612716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5672366|NCT00612222|Vaccination|vaccination
5672191|NCT00612716|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5672192|NCT00612716|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5672193|NCT00612716|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5672194|NCT00612716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5672195|NCT00612716|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5672196|NCT00612716|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5672197|NCT00612716|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5672198|NCT00612716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5672199|NCT00612716|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5672200|NCT00612716|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5672201|NCT00612716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5672202|NCT00612716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5672203|NCT00612716|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5672285|NCT00612469|dental caries|dental caries
5672204|NCT00612716|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5672205|NCT00612716|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5672206|NCT00612716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5672207|NCT00612716|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5672208|NCT00612716|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5672209|NCT00612716|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5672210|NCT00612716|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5672211|NCT00612716|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5672212|NCT00612716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5672213|NCT00612716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5672214|NCT00612716|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5672215|NCT00612716|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5672216|NCT00612716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5672217|NCT00612716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5672218|NCT00612716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5672219|NCT00612716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5672220|NCT00612716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5672221|NCT00612716|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5100216|NCT03371368|Obesity|obesity
5672224|NCT00612716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5672225|NCT00612716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5672226|NCT00612716|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5672227|NCT00612716|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5672228|NCT00612716|Burkitt lymphoma|burkitt lymphoma
5672229|NCT00612716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5672230|NCT00612716|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5672231|NCT00612716|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5672232|NCT00612716|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5672233|NCT00612716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5672234|NCT00612703|Cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1|cancer, oral, erlotinib, tarceva, solid tumor, advanced tumor, phase 1
5672236|NCT00612690|Children|children
5672237|NCT00612690|School-Based Mental Health Services|school-based mental health services
5672238|NCT00612690|Urban Poverty|urban poverty
5672240|NCT00612677|non-small cell|non-small cell
5672241|NCT00612651|GBM|gbm
5672242|NCT00612651|Malignant glioma|malignant glioma
5672243|NCT00612651|Brain tumor|brain tumor
5672244|NCT00612651|Temodar|temodar
5672245|NCT00612651|Temozolomide|temozolomide
5672246|NCT00612651|SCH 66336|sch 66336
5672247|NCT00612651|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
5672248|NCT00612651|Glioblastoma multiforme|glioblastoma multiforme
5672249|NCT00612651|Gliosarcoma|gliosarcoma
5672250|NCT00612651|Anaplastic astrocytoma|anaplastic astrocytoma
5672251|NCT00612651|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5672252|NCT00612651|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5672253|NCT00612638|Temodar|temodar
5672254|NCT00612638|Temozolomide|temozolomide
5672255|NCT00612638|O6-Benzylguanine|o6-benzylguanine
5672256|NCT00612638|O6-BG|o6-bg
5672257|NCT00612638|NSC 637037|nsc 637037
5672258|NCT00612638|Irinotecan|irinotecan
5672259|NCT00612638|CPT-11|cpt-11
5672260|NCT00612638|Recurrent cerebral anaplastic glioma|recurrent cerebral anaplastic glioma
5847701|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors
5672261|NCT00612638|Progressive cerebral anaplastic glioma|progressive cerebral anaplastic glioma
5672262|NCT00612638|Malignant glioma|malignant glioma
5672263|NCT00612560|breast neoplasms|breast neoplasms
5672264|NCT00612560|phytoestrogens|phytoestrogens
5672265|NCT00612560|tumor characteristics|tumor characteristics
5672266|NCT00612560|proliferation|proliferation
5672267|NCT00612560|apoptosis|apoptosis
5672268|NCT00612560|estrogen receptor|estrogen receptor
5672269|NCT00612560|HER2|her2
5672270|NCT00612547|Protozoan Infections|protozoan infections
5672271|NCT00612547|Communicable Diseases|communicable diseases
5672272|NCT00612547|Malaria Infection|malaria infection
5672273|NCT00612547|Malaria, falciparum|malaria, falciparum
5672274|NCT00612547|Malaria, vivax|malaria, vivax
5672275|NCT00612547|Artesunate Amodiaquine|artesunate amodiaquine
5672276|NCT00612521|Coronary artery disease|coronary artery disease
5672277|NCT00612521|Coronary artery stenting|coronary artery stenting
5672278|NCT00612521|peri-procedural myonecrosis|peri-procedural myonecrosis
5672279|NCT00612521|Adenosine|adenosine
5672280|NCT00612508|contraception|contraception
5672281|NCT00612508|NuvaRing|nuvaring
5672282|NCT00612508|Desogen|desogen
5672283|NCT00612508|vaginal biopsy|vaginal biopsy
5672284|NCT00612482|Substance abuse|substance abuse
5672292|NCT00612456|age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5672293|NCT00612456|vascular endothelial growth factor (VEGF),|vascular endothelial growth factor (vegf),
5672294|NCT00612456|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
5672295|NCT00612443|breast cancer|breast cancer
5672296|NCT00612430|Glioblastoma|glioblastoma
5672297|NCT00612430|Gliosarcoma|gliosarcoma
5672298|NCT00612430|GBM|gbm
5672299|NCT00612430|MG|mg
5672300|NCT00612430|Brain tumor|brain tumor
5672301|NCT00612430|Bevacizumab|bevacizumab
5672302|NCT00612430|Avastin|avastin
5672303|NCT00612430|Etoposide|etoposide
5672304|NCT00612430|VP-16|vp-16
5672305|NCT00612430|Etopophos|etopophos
5672306|NCT00612430|Toposar|toposar
5672307|NCT00612430|VePesid|vepesid
5672308|NCT00612430|Glioblastoma multiforme|glioblastoma multiforme
5672309|NCT00612430|Recurrent GBM|recurrent gbm
5672310|NCT00612430|Anaplastic astrocytoma|anaplastic astrocytoma
5666642|NCT00634257|Survey|survey
5672311|NCT00612430|Malignant glioma|malignant glioma
5672312|NCT00612417|Interaction with recombinant FVIII|interaction with recombinant fviii
5672313|NCT00612404|gastrointestinal disorder|gastrointestinal disorder
5672314|NCT00612404|endoscopy|endoscopy
5103355|NCT03351413|Fall Prevention|fall prevention
5672315|NCT00612404|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.|patient with gastrointestinal disorders for whom an endoscopy is performed and who is treated with esomeprazole afterwards.
5672317|NCT00612378|Glabellar Furrowing|glabellar furrowing
5672318|NCT00612365|Body Composition|body composition
5672319|NCT00612365|Abdomen|abdomen
5672320|NCT00612365|Atherosclerosis|atherosclerosis
5672321|NCT00612339|Glioma|glioma
5672322|NCT00612339|Temozolomide|temozolomide
5672323|NCT00612339|Temodar|temodar
5672324|NCT00612339|Avastin|avastin
5672325|NCT00612339|Bevacizumab|bevacizumab
5672327|NCT00612339|Gliosarcoma|gliosarcoma
5672328|NCT00612339|Multifocal GBM|multifocal gbm
5672329|NCT00612339|Brain tumor|brain tumor
5672330|NCT00612339|Unresectable GBM|unresectable gbm
5672331|NCT00612339|Glioblastoma multiforme|glioblastoma multiforme
5672332|NCT00612313|Major Depressive Disorder|major depressive disorder
5672333|NCT00612313|MDD|mdd
5672334|NCT00612313|Children|children
5672335|NCT00612313|Adolescents|adolescents
5672336|NCT00612313|Antidepressant|antidepressant
5672337|NCT00612313|CBT|cbt
5672338|NCT00612300|Ambulatory stroke patients|ambulatory stroke patients
5672339|NCT00612300|Gait training|gait training
5672340|NCT00612300|Lokomat|lokomat
5672341|NCT00612300|Physical therapy|physical therapy
5672343|NCT00612287|Chronic pain|chronic pain
5672344|NCT00612287|Buprenorphine|buprenorphine
5672345|NCT00612287|Drug addiction|drug addiction
5672346|NCT00612274|allogeneic|allogeneic
5672347|NCT00612261|Branch retinal vein occlusion; treatment|branch retinal vein occlusion; treatment
5672348|NCT00612248|Osteoarthritis|osteoarthritis
5672349|NCT00612248|Thumb|thumb
5672350|NCT00612248|Splint|splint
5672351|NCT00612248|Pain|pain
5672352|NCT00612248|Function|function
5672353|NCT00612248|Osteoarthritis of the trapeziometacarpal (TMC) joint|osteoarthritis of the trapeziometacarpal (tmc) joint
5672354|NCT00612235|epilepsy|epilepsy
5672355|NCT00612235|lamotrigine|lamotrigine
5672356|NCT00612235|levetiracetam|levetiracetam
5672357|NCT00612235|carbamazepine|carbamazepine
5672358|NCT00612235|phenytoin|phenytoin
5672359|NCT00612235|lamictal|lamictal
5672360|NCT00612235|keppra|keppra
5672361|NCT00612235|tegretol|tegretol
5672362|NCT00612235|carbatrol|carbatrol
5672363|NCT00612235|dilantin|dilantin
5672364|NCT00612222|Immunotherapy|immunotherapy
5672365|NCT00612222|Metastatic Melanoma|metastatic melanoma
5672367|NCT00612222|Tumor Regression|tumor regression
5672368|NCT00612222|Skin Cancer|skin cancer
5798787|NCT00111085|aneurysmal subarachnoid hemorrhage (aSAH)|aneurysmal subarachnoid hemorrhage (asah)
5798788|NCT00111059|obesity|obesity
5672369|NCT00612209|ARQ 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety|arq 197, advanced solid tumors, phase 1, dose escalation, pharmacodynamics, safety
5672370|NCT00612196|Safety and tolerability|safety and tolerability
5672371|NCT00612183|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5672372|NCT00612183|mantle cell lymphoma|mantle cell lymphoma
5672373|NCT00612170|Phase 3, safety and efficacy study, [S,S[-Reboxetine, Fibromyalgia|phase 3, safety and efficacy study, [s,s[-reboxetine, fibromyalgia
5672374|NCT00612157|Obstructive Sleep Apnea|obstructive sleep apnea
5672375|NCT00612157|Continuous Positive Airway Pressure|continuous positive airway pressure
5672376|NCT00612157|CPAP Compliance|cpap compliance
5672377|NCT00612157|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
5672378|NCT00612144|Type 2 DM|type 2 dm
5672379|NCT00612131|medical residents PGY 2 and 3|medical residents pgy 2 and 3
5672380|NCT00612118|Allergic rhinitis,|allergic rhinitis,
5672381|NCT00612118|Vienna Challenge Chamber|vienna challenge chamber
5672382|NCT00612105|Postherpetic Neuralgia, PHN, Shingles,|postherpetic neuralgia, phn, shingles,
5672383|NCT00612092|Coronary CT angiography|coronary ct angiography
5672384|NCT00612092|Radiation dose estimates|radiation dose estimates
5672385|NCT00612079|Sertindole|sertindole
5672386|NCT00612079|sensory gating|sensory gating
5672388|NCT00612079|P50 suppression|p50 suppression
5672389|NCT00612079|CANTAB|cantab
5672390|NCT00612079|Effect of Sertindole on sensory gating (P50 suppression)|effect of sertindole on sensory gating (p50 suppression)
5672391|NCT00612079|on sensorimotor gating (PPI)|on sensorimotor gating (ppi)
5672392|NCT00612079|and cognition (CANTAB)|and cognition (cantab)
5672393|NCT00612066|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5672394|NCT00612053|cardiovascular disease|cardiovascular disease
5672395|NCT00612053|coronary artery bypass grafting (CABG)|coronary artery bypass grafting (cabg)
5672396|NCT00612053|coronary artery disease (CAD)|coronary artery disease (cad)
5672397|NCT00612053|percutaneous transluminal coronary angioplasty (PCI)|percutaneous transluminal coronary angioplasty (pci)
5672398|NCT00612053|unprotected left main disease|unprotected left main disease
5672399|NCT00612027|gastrointestinal disorder|gastrointestinal disorder
5672400|NCT00612027|acid associated gastrointestinal symptoms.|acid associated gastrointestinal symptoms.
5672401|NCT00612027|esomeprazole therapy in patients with gastrointestinal disorders|esomeprazole therapy in patients with gastrointestinal disorders
5672402|NCT00612027|patients with acid associated gastrointestinal symptoms|patients with acid associated gastrointestinal symptoms
5672403|NCT00612014|delayed gastric emptying|delayed gastric emptying
5672404|NCT00612014|symptomatic gastroparesis|symptomatic gastroparesis
5672405|NCT00612014|diabetes mellitus|diabetes mellitus
5672406|NCT00612001|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5672407|NCT00612001|adult glioblastoma|adult glioblastoma
5672408|NCT00612001|adult giant cell glioblastoma|adult giant cell glioblastoma
5672409|NCT00612001|adult gliosarcoma|adult gliosarcoma
5672410|NCT00612001|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5672411|NCT00612001|recurrent adult brain tumor|recurrent adult brain tumor
5672412|NCT00612001|adult mixed glioma|adult mixed glioma
5672413|NCT00611988|Walking therapy|walking therapy
5672414|NCT00611988|Diabetes mellitus|diabetes mellitus
5672415|NCT00611988|Peripheral arterial disease|peripheral arterial disease
5672416|NCT00611975|Gonadal Steroid Hormones|gonadal steroid hormones
5672417|NCT00611975|Healthy Volunteers|healthy volunteers
5672418|NCT00611975|Antidepressant Side Effects|antidepressant side effects
5672419|NCT00611975|Fluoxetine|fluoxetine
5672420|NCT00611975|Bupropion|bupropion
5672421|NCT00611975|Prolactin|prolactin
5672422|NCT00611975|Testosterone|testosterone
5672423|NCT00611975|Estradiol|estradiol
5672424|NCT00611975|Progesterone|progesterone
5672425|NCT00611975|Sexual Function|sexual function
5672426|NCT00611975|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5672427|NCT00611975|17-OH Pregnenolone|17-oh pregnenolone
5672428|NCT00611949|Geranium oil|geranium oil
5672430|NCT00611949|Shingles|shingles
5672431|NCT00611949|Herpes zoster|herpes zoster
5672432|NCT00611936|Atomoxetine|atomoxetine
5672434|NCT00611936|d-amphetamine|d-amphetamine
5672435|NCT00611923|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5672436|NCT00611923|PMDD|pmdd
5672437|NCT00611923|PMS|pms
5672438|NCT00611897|NMDA|nmda
5672439|NCT00611897|glutamate|glutamate
5672440|NCT00611897|N-acetylcysteine|n-acetylcysteine
5672441|NCT00611897|P3|p3
5672442|NCT00611858|5-FU|5-fu
5672443|NCT00611858|cetuximab|cetuximab
5672444|NCT00611858|radiation|radiation
5672445|NCT00611858|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5672446|NCT00611858|neoadjuvant therapy|neoadjuvant therapy
5672447|NCT00611845|CABG surgery requiring CPB and at increased risk of bleeding and blood transfusion|cabg surgery requiring cpb and at increased risk of bleeding and blood transfusion
5672448|NCT00611832|behavior problems|behavior problems
5672449|NCT00611832|children|children
5672450|NCT00611832|prevention|prevention
5672451|NCT00611832|television|television
5672452|NCT00611832|media|media
5672453|NCT00611832|parenting|parenting
5672454|NCT00611819|hepatitis|hepatitis
5672455|NCT00611819|co-infection|co-infection
5672456|NCT00611806|Cognition|cognition
5672457|NCT00611806|Folic Acid|folic acid
5672458|NCT00611806|B12|b12
5672459|NCT00611793|Refractory Malignancy|refractory malignancy
5672460|NCT00611793|Advanced Malignancies|advanced malignancies
5672461|NCT00611793|PTK787/ZK222584|ptk787/zk222584
5672462|NCT00611793|Bevacizumab|bevacizumab
5672463|NCT00611780|Coronary CT angiography|coronary ct angiography
5672464|NCT00611780|Radiation dose estimates|radiation dose estimates
5672465|NCT00611767|Thiopental|thiopental
5672466|NCT00611767|Alcohol|alcohol
5672467|NCT00611767|Family History|family history
5672468|NCT00611767|Vulnerability|vulnerability
5672469|NCT00611767|GABA|gaba
5672470|NCT00611741|MRS, glutamate, osmolality|mrs, glutamate, osmolality
5672471|NCT00611728|Glioblastoma|glioblastoma
5672472|NCT00611728|CPT 11|cpt 11
5672473|NCT00611728|Sutent|sutent
5672474|NCT00611728|Sunitinib|sunitinib
5672475|NCT00611728|Sunitinib malate|sunitinib malate
5672476|NCT00611728|Malignant Glioma|malignant glioma
5672477|NCT00611728|GBM|gbm
5672478|NCT00611728|Irinotecan|irinotecan
5672479|NCT00611728|Camptosar|camptosar
5672480|NCT00611728|Anaplastic astrocytoma|anaplastic astrocytoma
5672481|NCT00611728|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5672482|NCT00611728|Anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5672483|NCT00611728|SU011248|su011248
5672484|NCT00611728|Brain tumor|brain tumor
5672485|NCT00611728|Recurrent malignant glioma|recurrent malignant glioma
5672505|NCT00611663|SLE as defined by the ACR classification|sle as defined by the acr classification
5672506|NCT00611663|Stable SLE|stable sle
5672507|NCT00611663|SLE treated by systemic corticosteroids|sle treated by systemic corticosteroids
5672508|NCT00611650|non-small cell lung cancer|non-small cell lung cancer
5672509|NCT00611650|squamous lung dysplasia|squamous lung dysplasia
5672510|NCT00611650|tobacco use disorder|tobacco use disorder
5672511|NCT00611637|Immunotherapy|immunotherapy
5672512|NCT00611624|MammoSite|mammosite
5672513|NCT00611624|brachytherapy|brachytherapy
5672514|NCT00611572|GABA|gaba
5672515|NCT00611572|glutamate|glutamate
5672516|NCT00611572|NMDA|nmda
5672517|NCT00611572|P300|p300
5672518|NCT00611572|MMN|mmn
5672519|NCT00611559|Infanrix hexa|infanrix hexa
5672520|NCT00611559|combined vaccine|combined vaccine
5672521|NCT00611546|preterm|preterm
5672522|NCT00611546|parenteral nutrition|parenteral nutrition
5672523|NCT00611546|TPN|tpn
5672524|NCT00611546|lipid emulsions|lipid emulsions
5672525|NCT00611546|photo-protection|photo-protection
5672528|NCT00611533|Cognition|cognition
5672529|NCT00611520|treatment of COPD|treatment of copd
5672530|NCT00611520|related to the budesonide/formoterole therapy in patients with COPD.|related to the budesonide/formoterole therapy in patients with copd.
5672531|NCT00611494|Drug tolerance|drug tolerance
5672532|NCT00611494|Quality of Life|quality of life
5672533|NCT00611429|Treatment|treatment
5672534|NCT00611429|Adherence|adherence
5672535|NCT00611429|Intervention|intervention
5672536|NCT00611429|Quality of Life|quality of life
5672537|NCT00611416|catechins|catechins
5672538|NCT00611416|caffeine|caffeine
5672539|NCT00611416|energy expenditure|energy expenditure
5672540|NCT00611416|fat oxidation|fat oxidation
5672541|NCT00611416|appetite|appetite
5672542|NCT00611403|LASIK|lasik
5672543|NCT00611390|Viral laryngitis;|viral laryngitis;
5672544|NCT00611390|Viral tracheitis;|viral tracheitis;
5672545|NCT00611390|Herbal medicine;|herbal medicine;
5672546|NCT00611390|Traditional medicine;|traditional medicine;
5672547|NCT00611390|Aromatic essential oils;|aromatic essential oils;
5672548|NCT00611377|delirium|delirium
5672549|NCT00611377|mechanical ventilation|mechanical ventilation
5672550|NCT00611377|age|age
5672551|NCT00611377|severity score|severity score
5672552|NCT00611364|Physical therapy|physical therapy
5672553|NCT00611364|hypertension|hypertension
5672554|NCT00611364|aged|aged
5672555|NCT00611364|exercise|exercise
5672556|NCT00611364|Physical exercise|physical exercise
5672557|NCT00611364|Physical activity|physical activity
5672558|NCT00611351|graft versus host disease|graft versus host disease
5672805|NCT00610571|AA|aa
5672559|NCT00611351|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5672560|NCT00611351|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5672561|NCT00611351|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5672562|NCT00611351|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5672563|NCT00611351|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5672564|NCT00611351|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5672565|NCT00611351|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5672566|NCT00611351|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5672567|NCT00611351|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5672568|NCT00611351|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5672569|NCT00611351|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5798789|NCT00111059|cardiovascular disease|cardiovascular disease
5672570|NCT00611351|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5672571|NCT00611351|stage III multiple myeloma|stage iii multiple myeloma
5672572|NCT00611351|refractory multiple myeloma|refractory multiple myeloma
5672573|NCT00611351|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5672574|NCT00611351|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5672575|NCT00611351|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5672576|NCT00611351|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5672577|NCT00611351|secondary myelofibrosis|secondary myelofibrosis
5672578|NCT00611351|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5672579|NCT00611351|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5672580|NCT00611351|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5672581|NCT00611351|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5672582|NCT00611351|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5672583|NCT00611351|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5672584|NCT00611351|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5672585|NCT00611351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5672586|NCT00611351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5672587|NCT00611351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5672588|NCT00611351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5672589|NCT00611351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5672590|NCT00611351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5672591|NCT00611351|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5672592|NCT00611351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5672593|NCT00611351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5672594|NCT00611351|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5672595|NCT00611351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5672596|NCT00611351|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5112390|NCT03294590|Outcome Expectations|outcome expectations
5672599|NCT00611351|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5672600|NCT00611351|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5672601|NCT00611351|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5672602|NCT00611351|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5672603|NCT00611351|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5672604|NCT00611351|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5672605|NCT00611351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5672606|NCT00611351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5672607|NCT00611351|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5672608|NCT00611351|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5672609|NCT00611351|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5672610|NCT00611351|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5672611|NCT00611351|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5672612|NCT00611351|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5672613|NCT00611351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5672614|NCT00611351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5672615|NCT00611351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5672616|NCT00611351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5672617|NCT00611351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5672618|NCT00611351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5672619|NCT00611351|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5672620|NCT00611351|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5672621|NCT00611351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5672622|NCT00611351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5672623|NCT00611351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5672624|NCT00611351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5672625|NCT00611351|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5672626|NCT00611351|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5672627|NCT00611351|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5672628|NCT00611351|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5672629|NCT00611351|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5672630|NCT00611351|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5672631|NCT00611351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5672632|NCT00611351|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5672633|NCT00611351|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5672634|NCT00611351|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5672635|NCT00611351|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5672636|NCT00611351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5672637|NCT00611351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5672638|NCT00611351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5672639|NCT00611351|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5672640|NCT00611351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5672641|NCT00611351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5672642|NCT00611351|refractory hairy cell leukemia|refractory hairy cell leukemia
5672643|NCT00611351|stage I multiple myeloma|stage i multiple myeloma
5672644|NCT00611351|stage II multiple myeloma|stage ii multiple myeloma
5672645|NCT00611338|Complementary Therapies|complementary therapies
5672647|NCT00611325|Gliosarcoma|gliosarcoma
5672648|NCT00611325|Glioblastoma multiforme|glioblastoma multiforme
5672649|NCT00611325|Recurrent malignant glioma|recurrent malignant glioma
5672651|NCT00611325|Recurrent GBM|recurrent gbm
5672652|NCT00611325|Malignant glioma|malignant glioma
5672653|NCT00611325|Brain tumor|brain tumor
5672669|NCT00611286|Patients with coronary artery disease|patients with coronary artery disease
5672670|NCT00611273|Glabellar Furrowing|glabellar furrowing
5672671|NCT00611260|Meditation|meditation
5672672|NCT00611260|Congestive Heart Failure|congestive heart failure
5672674|NCT00611260|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5672675|NCT00611221|massage|massage
5672676|NCT00611221|labour|labour
5672677|NCT00611195|Anesthesia|anesthesia
5672679|NCT00611195|Larynx|larynx
5672680|NCT00611182|dyspnea|dyspnea
5672681|NCT00611182|pulmonary fibrosis|pulmonary fibrosis
5672682|NCT00611182|interstitial lung disease|interstitial lung disease
5672683|NCT00611182|shortness of breath|shortness of breath
5672684|NCT00611169|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5672685|NCT00611169|tirofiban|tirofiban
5672686|NCT00611169|Magnetic Resonance Imaging|magnetic resonance imaging
5672687|NCT00611169|Myocardial Infarction|myocardial infarction
5672688|NCT00611156|Thermogenesis|thermogenesis
5672689|NCT00611156|Meal-induced thermogenesis|meal-induced thermogenesis
5672690|NCT00611156|energy expenditure|energy expenditure
5672691|NCT00611156|fat oxidation|fat oxidation
5672692|NCT00611156|bioactive ingredients|bioactive ingredients
5672693|NCT00611156|spices|spices
5672694|NCT00611156|ginger|ginger
5672695|NCT00611156|horseradish|horseradish
5672696|NCT00611156|black pepper|black pepper
5672697|NCT00611156|mustard|mustard
5672698|NCT00611143|Off-pump coronary artery bypass graft|off-pump coronary artery bypass graft
5672699|NCT00611143|Atorvastatin|atorvastatin
5672700|NCT00611143|Postoperative atrial fibrillation|postoperative atrial fibrillation
5672701|NCT00611130|Cocaine|cocaine
5672702|NCT00611130|Addiction|addiction
5672703|NCT00611130|Dependence|dependence
5672704|NCT00611130|Treatment|treatment
5672705|NCT00611117|adaptation to high fat diet|adaptation to high fat diet
5672706|NCT00611117|activity|activity
5672707|NCT00611117|exercise|exercise
5672708|NCT00611104|breast cancer|breast cancer
5672709|NCT00611078|Soft Tissue Sarcoma|soft tissue sarcoma
5672711|NCT00611078|pollutants|pollutants
5672712|NCT00611078|04-088|04-088
5672713|NCT00611052|Depressive Disorder|depressive disorder
5672714|NCT00611052|Depressive Disorder, Major|depressive disorder, major
5672715|NCT00611052|Mental Health|mental health
5672716|NCT00611052|Prevention|prevention
5672717|NCT00611039|Darunavir/ritonavir|darunavir/ritonavir
5672718|NCT00611039|virtual inhibitory quotient|virtual inhibitory quotient
5672719|NCT00611039|dose reduction|dose reduction
5672720|NCT00611026|Treatment of overactive bladder|treatment of overactive bladder
5672721|NCT00611013|Development of multi-purpose novel imaging protocols|development of multi-purpose novel imaging protocols
5672722|NCT00611000|colon cancer|colon cancer
5672723|NCT00611000|rectal cancer|rectal cancer
5672724|NCT00610987|Antibiotic Prophylaxis|antibiotic prophylaxis
5672725|NCT00610974|Spinal cord injury|spinal cord injury
5672726|NCT00610974|walking|walking
5672727|NCT00610974|gait training|gait training
5672728|NCT00610974|body-weight supported treadmill training|body-weight supported treadmill training
5672729|NCT00610974|rehabilitation|rehabilitation
5672730|NCT00610961|BK Polyomavirus|bk polyomavirus
5672731|NCT00610961|Transplantation, Kidney|transplantation, kidney
5672732|NCT00610961|Transplantation, Pancreas|transplantation, pancreas
5672733|NCT00610948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5672734|NCT00610935|Influenza|influenza
5672735|NCT00610935|Subjects with uncomplicated acute influenza|subjects with uncomplicated acute influenza
5672736|NCT00610922|Performance of motor skills|performance of motor skills
5672738|NCT00610870|Myocardial infarct size|myocardial infarct size
5672739|NCT00610870|Atorvastatin|atorvastatin
5672740|NCT00610870|SPECT|spect
5672741|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5672742|NCT00610844|lung cancer|lung cancer
5672743|NCT00610844|lung metastasis|lung metastasis
5672744|NCT00610844|radiofrequency ablation|radiofrequency ablation
5672745|NCT00610805|SLE|sle
5672746|NCT00610805|lupus|lupus
5672747|NCT00610805|cardiovascular|cardiovascular
5672748|NCT00610805|IMT|imt
5672749|NCT00610805|Systemic Lupus Erythematosus|systemic lupus erythematosus
5672750|NCT00610779|Rhino-sinusitis;|rhino-sinusitis;
5672751|NCT00610779|Herbal medicine;|herbal medicine;
5672752|NCT00610779|Traditional medicine;|traditional medicine;
5672753|NCT00610779|Aromatic essential oils;|aromatic essential oils;
5672754|NCT00610766|coronary CT angiography|coronary ct angiography
5672755|NCT00610766|radiation dose estimates|radiation dose estimates
5672756|NCT00610753|Anorexia nervosa|anorexia nervosa
5672757|NCT00610753|Adolescents|adolescents
5672758|NCT00610753|Family therapy|family therapy
5672759|NCT00610740|recurrent cervical cancer|recurrent cervical cancer
5672760|NCT00610740|cervical cancer|cervical cancer
5672761|NCT00610740|endometrial carcinoma|endometrial carcinoma
5672762|NCT00610740|ovarian epithelial cancer|ovarian epithelial cancer
5672763|NCT00610740|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5672764|NCT00610740|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5673722|NCT00607113|Everolimus|everolimus
5672765|NCT00610727|Migraine, Prochlorperazine aerosol|migraine, prochlorperazine aerosol
5672766|NCT00610714|Cancer|cancer
5672767|NCT00610714|Tumour|tumour
5672768|NCT00610714|Ovarian Neoplasms|ovarian neoplasms
5672769|NCT00610714|Ovarian Cancer|ovarian cancer
5672770|NCT00610675|Fifty two weeks|fifty two weeks
5672771|NCT00610675|Open label|open label
5672772|NCT00610675|extension|extension
5672773|NCT00610662|cervical cancer|cervical cancer
5672774|NCT00610662|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5672775|NCT00610662|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5672776|NCT00610662|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5672777|NCT00610649|randomized|randomized
5672778|NCT00610649|placebo controlled|placebo controlled
5672779|NCT00610649|maximum tolerated dose|maximum tolerated dose
5672780|NCT00610636|FOLFOX-4|folfox-4
5672781|NCT00610636|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5672782|NCT00610636|colorectal cancer|colorectal cancer
5672783|NCT00610636|liver metastasis|liver metastasis
5672784|NCT00610636|resectability|resectability
5672785|NCT00610623|Pseudomonas aeruginosa|pseudomonas aeruginosa
5672786|NCT00610623|Pneumonia|pneumonia
5672787|NCT00610623|Ventilator-Associated|ventilator-associated
5672788|NCT00610623|Quorum Sensing|quorum sensing
5672789|NCT00610610|Fibromyalgia|fibromyalgia
5672790|NCT00610610|Paroxetine|paroxetine
5672792|NCT00610597|alcohol|alcohol
5672793|NCT00610597|lymphocyte|lymphocyte
5672794|NCT00610584|seasonal allergic rhinitis|seasonal allergic rhinitis
5672795|NCT00610584|acupuncture|acupuncture
5672796|NCT00610584|RCT|rct
5672797|NCT00610584|CAM|cam
5672798|NCT00610571|Temodar|temodar
5672799|NCT00610571|Temozolomide|temozolomide
5672800|NCT00610571|Topotecan|topotecan
5672801|NCT00610571|Hycamtin|hycamtin
5672803|NCT00610571|Brain tumor|brain tumor
5672804|NCT00610571|Anaplastic astrocytoma|anaplastic astrocytoma
5672807|NCT00610571|Glioblastoma Multiform|glioblastoma multiform
5672808|NCT00610571|Gliosarcoma|gliosarcoma
5672809|NCT00610545|ATORVASTATIN|atorvastatin
5672810|NCT00610545|VASCULAR SURGERY|vascular surgery
5672811|NCT00610545|CARDIOVASCULAR OUTCOMES|cardiovascular outcomes
5672812|NCT00610532|pharmacoresistance|pharmacoresistance
5672813|NCT00610532|healthy volunteers|healthy volunteers
5672814|NCT00610519|Viral pharyngo-tonsillitis;|viral pharyngo-tonsillitis;
5672815|NCT00610519|Herbal medicine;|herbal medicine;
5672816|NCT00610519|Traditional medicine;|traditional medicine;
5672817|NCT00610519|Aromatic essential oils;|aromatic essential oils;
5672818|NCT00610506|Atypical Depression|atypical depression
5672819|NCT00610493|Advanced Cancer|advanced cancer
5672820|NCT00610493|Bevacizumab|bevacizumab
5672821|NCT00610493|Temsirolimus|temsirolimus
5672822|NCT00610493|Avastin|avastin
5672824|NCT00610493|CCI-779|cci-779
5672825|NCT00610493|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5672826|NCT00610493|rhuMAb-VEGF|rhumab-vegf
5672827|NCT00610493|dynamic contrast-enhanced magnetic resonance imaging|dynamic contrast-enhanced magnetic resonance imaging
5672829|NCT00610493|magnetic resonance imaging|magnetic resonance imaging
5672831|NCT00610480|Dry Eyes|dry eyes
5672832|NCT00610480|Tear Film Stability|tear film stability
5672833|NCT00610454|Levetiracetam|levetiracetam
5672834|NCT00610454|Keppra|keppra
5672835|NCT00610441|randomized|randomized
5672836|NCT00610441|double blind|double blind
5672837|NCT00610441|placebo controlled|placebo controlled
5672838|NCT00610428|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
5672839|NCT00610428|Migraine headache with or without aura.|migraine headache with or without aura.
5672840|NCT00610376|Handwashing|handwashing
5672841|NCT00610376|Randomized controlled trial|randomized controlled trial
5672842|NCT00610376|Cluster randomization|cluster randomization
5672843|NCT00610376|Community intervention trial|community intervention trial
5672844|NCT00610376|Disease prevention|disease prevention
5672845|NCT00610376|Pediatric communicable disease|pediatric communicable disease
5672846|NCT00610376|Preschool|preschool
5672847|NCT00610376|Illness absenteeism|illness absenteeism
5672848|NCT00610350|Levosimendan|levosimendan
5672849|NCT00610350|pre-conditioning|pre-conditioning
5672850|NCT00610350|cardiac surgery|cardiac surgery
5672851|NCT00610350|myocardial function|myocardial function
5672852|NCT00610350|contractility|contractility
5672853|NCT00610350|heart|heart
5672854|NCT00610350|ischaemia|ischaemia
5672855|NCT00610324|oropharyngeal cleansing|oropharyngeal cleansing
5672856|NCT00610324|oral decontamination|oral decontamination
5672857|NCT00610324|oropharyngeal bacterial flora|oropharyngeal bacterial flora
5672858|NCT00610324|oropharyngeal colonization|oropharyngeal colonization
5672859|NCT00610324|critical illness|critical illness
5672860|NCT00610324|mechanical ventilation|mechanical ventilation
5672861|NCT00610324|tracheal intubation|tracheal intubation
5672862|NCT00610324|prophylaxis|prophylaxis
5672863|NCT00610311|Metastatic Melanoma|metastatic melanoma
5672864|NCT00610311|Immunotherapy|immunotherapy
5672865|NCT00610311|Vaccination|vaccination
5676414|NCT00595049|remodelling|remodelling
5672868|NCT00610298|disability affecting strength, balance and coordination|disability affecting strength, balance and coordination
5672869|NCT00610272|single bone metastasis|single bone metastasis
5672870|NCT00610272|multiple bone metastasis|multiple bone metastasis
5672871|NCT00610272|pain relief|pain relief
5672872|NCT00610272|radiotherapy|radiotherapy
5672873|NCT00610259|Depressive disorder|depressive disorder
5672874|NCT00610259|Sleep initiation and maintenance disorder|sleep initiation and maintenance disorder
5672875|NCT00610259|Behavior therapy|behavior therapy
5672877|NCT00610246|Abdomen|abdomen
5672878|NCT00610246|Pelvis|pelvis
5672879|NCT00610246|Lesion|lesion
5672880|NCT00610246|Cancer|cancer
5672881|NCT00610246|Radiation|radiation
5672882|NCT00610246|Chemotherapy|chemotherapy
5672883|NCT00610246|Phase 1|phase 1
5672884|NCT00610246|Advanced Cancer|advanced cancer
5672885|NCT00610246|Sorafenib|sorafenib
5672886|NCT00610246|Nexavar|nexavar
5672887|NCT00610246|BAY43-9006|bay43-9006
5672888|NCT00610233|deep brain stimulation|deep brain stimulation
5672889|NCT00610233|urodynamics|urodynamics
5672890|NCT00610220|pediatrics|pediatrics
5672891|NCT00610220|wrist fractures|wrist fractures
5672892|NCT00610220|casting|casting
5672893|NCT00610220|wrist splint|wrist splint
5672894|NCT00610207|Anal fistula|anal fistula
5672895|NCT00610207|fistula in ano|fistula in ano
5672896|NCT00610207|anorectal fistula|anorectal fistula
5672897|NCT00610207|Crohn's Disease|crohn's disease
5672898|NCT00610181|Breast Cancer|breast cancer
5672899|NCT00610181|Breast Carcinoma|breast carcinoma
5672900|NCT00610181|Invasive Lobular Cancer|invasive lobular cancer
5672901|NCT00610181|Mixed Invasive Ductal-lobular Carcinoma|mixed invasive ductal-lobular carcinoma
5672902|NCT00610181|Magnetic Resonance Imaging|magnetic resonance imaging
5672903|NCT00610181|MRI|mri
5672904|NCT00610168|dTpa vaccine|dtpa vaccine
5672905|NCT00610168|pertussis|pertussis
5672906|NCT00610168|Tdap|tdap
5672907|NCT00610168|Boostrix|boostrix
5672910|NCT00610168|diphtheria|diphtheria
5672911|NCT00610142|atopic dermatitis|atopic dermatitis
5672912|NCT00610142|pimecrolimus|pimecrolimus
5672913|NCT00610142|hydrocortison|hydrocortison
5672914|NCT00610142|Optical Coherence Tomography|optical coherence tomography
5672915|NCT00610129|MK-0646|mk-0646
5672916|NCT00610090|UNITE|unite
5672917|NCT00610090|AAA|aaa
5672918|NCT00610090|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5672919|NCT00610090|Stent|stent
5672920|NCT00610090|Graft|graft
5672921|NCT00610077|Letrozole|letrozole
5672922|NCT00610077|Clomiphene citrate|clomiphene citrate
5672923|NCT00610077|Anovulatory infertility|anovulatory infertility
5672924|NCT00610077|Ovulation induction|ovulation induction
5672925|NCT00610064|Refractory lower urinary tract dysfunction|refractory lower urinary tract dysfunction
5672926|NCT00610064|Sacral neuromodulation|sacral neuromodulation
5672927|NCT00610064|Brain effects|brain effects
5672928|NCT00610064|Neuroimaging|neuroimaging
5672929|NCT00610064|Neuromodulation|neuromodulation
5672930|NCT00610051|severe heart failure|severe heart failure
5672931|NCT00610051|transplants|transplants
5672932|NCT00610038|neonatal|neonatal
5672933|NCT00610038|diabetes mellitus|diabetes mellitus
5672934|NCT00610038|mutation|mutation
5672935|NCT00610038|KIR6.2|kir6.2
5672936|NCT00610038|SUR1|sur1
5672937|NCT00610038|Neonatal diabetes mellitus with KIR6.2 or SUR1 mutations|neonatal diabetes mellitus with kir6.2 or sur1 mutations
5672938|NCT00610025|NOTES|notes
5672939|NCT00610025|transgastric endoscopy|transgastric endoscopy
5672940|NCT00610025|obesity surgery|obesity surgery
5672941|NCT00610025|Roux-en-Y surgery|roux-en-y surgery
5672942|NCT00610012|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5672943|NCT00610012|MRCC|mrcc
5672944|NCT00610012|Therapy-reality|therapy-reality
5672945|NCT00610012|Observation|observation
5672946|NCT00610012|Registry|registry
5672947|NCT00610012|RCC|rcc
5672948|NCT00610012|ARCC|arcc
5672949|NCT00610012|Germany|germany
5672950|NCT00610012|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5672951|NCT00610012|Renal Cell Carcinoma|renal cell carcinoma
5672952|NCT00610012|Renal Cell Cancer|renal cell cancer
5672953|NCT00610012|Sorafenib|sorafenib
5672954|NCT00610012|Sunitinib|sunitinib
5672955|NCT00610012|Interferon|interferon
5672956|NCT00610012|Interleukin|interleukin
5672957|NCT00610012|Temsirolimus|temsirolimus
5672958|NCT00610012|Pazopanib|pazopanib
5672959|NCT00610012|Cytokines|cytokines
5672960|NCT00610012|VEGF|vegf
5672961|NCT00609999|Glioblastoma|glioblastoma
5672962|NCT00609999|Gliosarcoma|gliosarcoma
5672963|NCT00609999|GBM|gbm
5672964|NCT00609999|Recurrent MG|recurrent mg
5672965|NCT00609999|Erlotinib|erlotinib
5672966|NCT00609999|Dasatinib|dasatinib
5672967|NCT00609999|Brain tumor|brain tumor
5672968|NCT00609999|Malignant glioma|malignant glioma
5672969|NCT00609999|Tarceva|tarceva
5672970|NCT00609999|Sprycel|sprycel
5672971|NCT00609986|Kidney|kidney
5672972|NCT00609986|Transplantation|transplantation
5672973|NCT00609986|Diabetes|diabetes
5672974|NCT00609986|Hyperglycemia|hyperglycemia
5676415|NCT00595049|bosentan|bosentan
5672975|NCT00609973|Postoperative recurrence, inflammatory bowel disease|postoperative recurrence, inflammatory bowel disease
5672976|NCT00609960|children anesthesia anxiety clowns|children anesthesia anxiety clowns
5672977|NCT00609934|renal cell carcinoma|renal cell carcinoma
5672978|NCT00609934|kidney cancer|kidney cancer
5672979|NCT00609934|bone metastases|bone metastases
5672980|NCT00609934|RCC|rcc
5672981|NCT00609934|bone pain|bone pain
5672982|NCT00609934|palliative radiotherapy|palliative radiotherapy
5672984|NCT00609934|radiation|radiation
5672985|NCT00609934|renal cell|renal cell
5672986|NCT00609882|Nasal CPAP|nasal cpap
5672987|NCT00609882|High flow nasal cannula|high flow nasal cannula
5672988|NCT00609882|Neonate|neonate
5672989|NCT00609843|Bladder cancer|bladder cancer
5672990|NCT00609843|Radiotherapy|radiotherapy
5672991|NCT00609843|Tumour delineation|tumour delineation
5672992|NCT00609843|Markers|markers
5672993|NCT00609830|Glucocorticoids|glucocorticoids
5672994|NCT00609830|Osteoporosis|osteoporosis
5672995|NCT00609830|Rheumatoid Arthritis|rheumatoid arthritis
5672996|NCT00609830|Prevention|prevention
5672997|NCT00609830|GIOP|giop
5672998|NCT00609830|Patient Education|patient education
5672999|NCT00609817|Relapsed Multiple Myeloma|relapsed multiple myeloma
5673000|NCT00609817|Refractory Multiple Myeloma|refractory multiple myeloma
5673001|NCT00609817|GCS 100|gcs 100
5673002|NCT00609804|Non-Small Cell Lung Cancer|non-small cell lung cancer
5673003|NCT00609804|Advanced|advanced
5673004|NCT00609804|Erlotinib|erlotinib
5673005|NCT00609804|Sorafenib|sorafenib
5673006|NCT00609804|Progressing on erlotinib|progressing on erlotinib
5673007|NCT00609791|recurrent breast cancer|recurrent breast cancer
5673008|NCT00609791|stage IV breast cancer|stage iv breast cancer
5673009|NCT00609791|male breast cancer|male breast cancer
5673011|NCT00609778|Mechanical|mechanical
5673012|NCT00609778|Manual|manual
5673013|NCT00609778|Survival|survival
5673014|NCT00609778|ROSC|rosc
5673015|NCT00609765|advanced|advanced
5673016|NCT00609765|unresectable|unresectable
5673017|NCT00609765|metastatic|metastatic
5673018|NCT00609765|endocrine|endocrine
5673019|NCT00609765|tumors|tumors
5673020|NCT00609752|Crohn Disease|crohn disease
5673021|NCT00609752|Children|children
5673022|NCT00609752|Bone Density|bone density
5673023|NCT00609752|Prednisolone|prednisolone
5673024|NCT00609752|Liquid Diet Therapy|liquid diet therapy
5673025|NCT00609752|Quality of Life|quality of life
5673026|NCT00609752|Metabolic Bone Disease|metabolic bone disease
5673027|NCT00609739|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5673028|NCT00609726|Endoscopic Ultrasonography|endoscopic ultrasonography
5673029|NCT00609726|Pancreatitis|pancreatitis
5673030|NCT00609726|EUS|eus
5673031|NCT00609713|Child|child
5673032|NCT00609713|Obesity|obesity
5673033|NCT00609700|burn injury|burn injury
5673034|NCT00609700|volume replacement|volume replacement
5673035|NCT00609700|Ringer's Lactate solution|ringer's lactate solution
5673036|NCT00609700|Ringer's Acetate solution|ringer's acetate solution
5673037|NCT00609700|volume replacement with crystalloids|volume replacement with crystalloids
5673038|NCT00609687|sarcoidosis|sarcoidosis
5673039|NCT00609687|diagnostic vitrectomy|diagnostic vitrectomy
5673040|NCT00609687|vitreous biopsy|vitreous biopsy
5673041|NCT00609687|sarcoidosis-associated ocular inflammation|sarcoidosis-associated ocular inflammation
5673042|NCT00609674|Perennial allergic rhinitis; fluticasone furoate nasal spray|perennial allergic rhinitis; fluticasone furoate nasal spray
5673043|NCT00609661|Mesenchymal Stem Cells, Burn|mesenchymal stem cells, burn
5673044|NCT00609648|Dental Anxiety|dental anxiety
5673045|NCT00609648|Dental Phobia|dental phobia
5673046|NCT00609648|Odontophobia|odontophobia
5673047|NCT00609635|Respiratory|respiratory
5673048|NCT00609635|RSV-induced respiratory illness|rsv-induced respiratory illness
5673049|NCT00609622|metastatic colorectal cancer sunitinib (Sutent) bevacizumab (Avastin) randomized study|metastatic colorectal cancer sunitinib (sutent) bevacizumab (avastin) randomized study
5673050|NCT00609609|Allogeneic stem cell grafts|allogeneic stem cell grafts
5673051|NCT00609609|Allogeneic bone marrow graft|allogeneic bone marrow graft
5673052|NCT00609609|Blood and Marrow Transplantation|blood and marrow transplantation
5673053|NCT00609609|Stem cell graft|stem cell graft
5673054|NCT00609609|Graft Versus Host Disease|graft versus host disease
5673055|NCT00609609|GVHD|gvhd
5673056|NCT00609609|Extracorporeal Photopheresis|extracorporeal photopheresis
5673058|NCT00609609|Photopheresis|photopheresis
5673059|NCT00609609|Methylprednisolone|methylprednisolone
5673060|NCT00609609|Medrol|medrol
5673061|NCT00609609|Depo-Medrol|depo-medrol
5673062|NCT00609609|Solu-Medrol|solu-medrol
5673063|NCT00609596|dutasteride|dutasteride
5673064|NCT00609596|tamsulosin|tamsulosin
5673065|NCT00609596|benign prostatic hyperplasia|benign prostatic hyperplasia
5673066|NCT00609570|hypertension|hypertension
5673067|NCT00609570|supplement|supplement
5673068|NCT00609570|HRV|hrv
5673069|NCT00609557|osteoarthritis pain|osteoarthritis pain
5673070|NCT00609557|activity limitation|activity limitation
5673071|NCT00609557|antidepressant|antidepressant
5673072|NCT00609557|depression|depression
5673073|NCT00609557|single-blind|single-blind
5673074|NCT00609544|Non Dialysis-dependent chronic kidney disease and anemia|non dialysis-dependent chronic kidney disease and anemia
5673075|NCT00609531|Restricted repetitive behaviors|restricted repetitive behaviors
5673076|NCT00609531|restricted interests|restricted interests
5673077|NCT00609531|Aspergers|aspergers
5673078|NCT00609531|Autism|autism
5673079|NCT00609505|Hereditary Breast and Ovarian Cancer syndrome|hereditary breast and ovarian cancer syndrome
5673080|NCT00609505|genetic counseling|genetic counseling
5673083|NCT00609505|telemedicine|telemedicine
5673084|NCT00609505|Cancer genetic counseling|cancer genetic counseling
5673085|NCT00609479|Distal radius fracture|distal radius fracture
5673086|NCT00609479|Colle´s fracture|colle´s fracture
5673087|NCT00609479|Internal fixation|internal fixation
5673088|NCT00609479|External fixation|external fixation
5673089|NCT00609479|DASH|dash
5673090|NCT00609479|PRWE|prwe
5673091|NCT00609466|Opioid|opioid
5673092|NCT00609466|Central acting analgesic|central acting analgesic
5673093|NCT00609466|CG5503 IR|cg5503 ir
5673094|NCT00609466|Postoperative pain|postoperative pain
5673095|NCT00609466|Bunionectomy|bunionectomy
5673096|NCT00609466|Morphine|morphine
5673097|NCT00609466|Placebo|placebo
5673098|NCT00609453|Control participants|control participants
5673099|NCT00609440|Morquio's disease; physiotherapy; results|morquio's disease; physiotherapy; results
5673100|NCT00609427|cognitive training|cognitive training
5673101|NCT00609427|cognitive rehabilitation|cognitive rehabilitation
5673102|NCT00609414|Burns|burns
5673103|NCT00609414|Albumin|albumin
5673104|NCT00609414|Fluid Resuscitation|fluid resuscitation
5673105|NCT00609401|Sorafenib|sorafenib
5673107|NCT00609401|Metastatic disease|metastatic disease
5673108|NCT00609375|Sepsis|sepsis
5673109|NCT00609375|Bacteremia|bacteremia
5673636|NCT00607399|Solid tumor|solid tumor
5673110|NCT00609375|Intravenous infusions|intravenous infusions
5673111|NCT00609375|cefepime|cefepime
5673112|NCT00609362|BMD|bmd
5673113|NCT00609362|Rosiglitazone|rosiglitazone
5673114|NCT00609362|Bone marrow fat|bone marrow fat
5673115|NCT00609349|risk factors for pulmonary arterial hypertension|risk factors for pulmonary arterial hypertension
5673116|NCT00609323|Pain|pain
5673117|NCT00609323|postherpetic neuralgia|postherpetic neuralgia
5673118|NCT00609310|clinical trial|clinical trial
5673119|NCT00609310|flavonoid treatment|flavonoid treatment
5673120|NCT00609310|neoplasia recurrence|neoplasia recurrence
5673121|NCT00609310|colorectal cancer|colorectal cancer
5673122|NCT00609310|polypectomy|polypectomy
5673123|NCT00609310|adenoma in Colon|adenoma in colon
5673124|NCT00609310|Neoplasia Recurrence Rates|neoplasia recurrence rates
5673125|NCT00609310|postpolypectomy patients|postpolypectomy patients
5798790|NCT00111059|depression|depression
5673126|NCT00609297|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673128|NCT00609284|Stage III|stage iii
5673129|NCT00609284|Stage IV|stage iv
5673130|NCT00609284|locally advanced|locally advanced
5673131|NCT00609245|epilepsy|epilepsy
5673132|NCT00609245|photosensitive|photosensitive
5673133|NCT00609245|valproic acid|valproic acid
5673134|NCT00609219|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5673135|NCT00609219|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5673136|NCT00609219|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5673137|NCT00609219|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5673138|NCT00609180|Acute Lung Injury|acute lung injury
5673139|NCT00609180|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5673140|NCT00609180|Feeding|feeding
5673141|NCT00609180|Critical Care|critical care
5673142|NCT00609180|Ventilator|ventilator
5673143|NCT00609180|Omega-3 Fatty Acid|omega-3 fatty acid
5673144|NCT00609180|Antioxidant|antioxidant
5673145|NCT00609167|stage II multiple myeloma|stage ii multiple myeloma
5673146|NCT00609167|stage III multiple myeloma|stage iii multiple myeloma
5673147|NCT00609154|Type 2 diabetes|type 2 diabetes
5673148|NCT00609154|Insulin|insulin
5673149|NCT00609154|biosynthesis|biosynthesis
5673150|NCT00609154|Non diabetic control|non diabetic control
5673151|NCT00609128|tears|tears
5673152|NCT00609128|conjunctival epithelial cells|conjunctival epithelial cells
5673153|NCT00609128|olopatadine|olopatadine
5673154|NCT00609128|eosinophils|eosinophils
5673155|NCT00609115|Sub-acute care|sub-acute care
5673156|NCT00609115|Robotics|robotics
5673157|NCT00609102|Type 2 diabetes|type 2 diabetes
5673158|NCT00609089|Family|family
5673159|NCT00609089|treatment|treatment
5673160|NCT00609089|reinforcement|reinforcement
5673161|NCT00609089|substance|substance
5673162|NCT00609089|trial|trial
5673163|NCT00609089|drug|drug
5673164|NCT00609089|abuse|abuse
5673165|NCT00609089|HIV|hiv
5673166|NCT00609089|risk|risk
5673167|NCT00609063|Statins|statins
5673168|NCT00609063|Myalgia|myalgia
5673169|NCT00609063|Muscle Cramp|muscle cramp
5673170|NCT00609050|cystic fibrosis|cystic fibrosis
5673171|NCT00609050|exercise|exercise
5673172|NCT00609050|perceived exertion|perceived exertion
5673173|NCT00609050|aerobic fitness|aerobic fitness
5673175|NCT00609050|health related quality of life|health related quality of life
5673176|NCT00609050|self-regulated exercise|self-regulated exercise
5673177|NCT00609037|Gastric Bypass|gastric bypass
5673178|NCT00609037|Body contouring|body contouring
5673179|NCT00609037|Excessive weight loss|excessive weight loss
5673180|NCT00609011|Melanoma|melanoma
5673181|NCT00609011|Metastatic|metastatic
5128320|NCT03192202|CD30|cd30
5673182|NCT00608998|Chronic renal failure|chronic renal failure
5673183|NCT00608998|Vasculopathy|vasculopathy
5673184|NCT00608998|Cardiovascular risk|cardiovascular risk
5673185|NCT00608998|Chronic renal failure patients|chronic renal failure patients
5673186|NCT00608985|sleeplessness|sleeplessness
5673187|NCT00608985|orexin receptor antagonist|orexin receptor antagonist
5673188|NCT00608985|almorexant|almorexant
5673189|NCT00608985|insomnia|insomnia
5673190|NCT00608972|negative for a protein called HER2/neu|negative for a protein called her2/neu
5673191|NCT00608972|negative for estrogen receptors (ER) and progesterone receptors (PR).|negative for estrogen receptors (er) and progesterone receptors (pr).
5673192|NCT00608972|breast cancer|breast cancer
5673193|NCT00608959|Skin colonization|skin colonization
5673194|NCT00608959|Catheter colonization|catheter colonization
5673195|NCT00608959|Catheter site infection|catheter site infection
5673196|NCT00608946|efficacy of treatment with copper in patients with mild Alzheimer´s disease|efficacy of treatment with copper in patients with mild alzheimer´s disease
5673197|NCT00608946|cognitive status over time|cognitive status over time
5673198|NCT00608946|CSF and volumetric data over time (1 year)|csf and volumetric data over time (1 year)
5673199|NCT00608933|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673200|NCT00608933|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5673202|NCT00608894|Autoimmune hepatitis|autoimmune hepatitis
5673203|NCT00608894|Chronic active hepatitis|chronic active hepatitis
5673204|NCT00608881|Huntington's disease|huntington's disease
5673205|NCT00608881|Huntington disease|huntington disease
5673206|NCT00608881|HD|hd
5673207|NCT00608881|coenzyme Q10|coenzyme q10
5673208|NCT00608881|CoQ|coq
5673209|NCT00608868|Carcinoma|carcinoma
5673210|NCT00608868|Non Small Cell Lung|non small cell lung
5673211|NCT00608868|EGFR mutation|egfr mutation
5673212|NCT00608868|Gefitinib|gefitinib
5673213|NCT00608855|bone metastases|bone metastases
5673214|NCT00608855|pain|pain
5673215|NCT00608855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673216|NCT00608816|epinephrine|epinephrine
5673217|NCT00608790|Tuberculosis, TB, Mycobacterium tuberculosis, children, South Africa|tuberculosis, tb, mycobacterium tuberculosis, children, south africa
5673218|NCT00608777|Localized mild breakthrough|localized mild breakthrough
5673219|NCT00608764|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5673220|NCT00608764|COPD|copd
5673221|NCT00608764|Emphysema|emphysema
5673222|NCT00608764|Chronic Bronchitis|chronic bronchitis
5673223|NCT00608764|Genetics|genetics
5673224|NCT00608764|Association Studies|association studies
5673225|NCT00608764|Computed Tomography|computed tomography
5673226|NCT00608751|Newly Diagnosed head and neck cancer|newly diagnosed head and neck cancer
5673227|NCT00608738|neutropenia|neutropenia
5673228|NCT00608738|infection|infection
5673229|NCT00608738|radiation toxicity|radiation toxicity
5673230|NCT00608738|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5673231|NCT00608738|malnutrition|malnutrition
5673232|NCT00608738|musculoskeletal complications|musculoskeletal complications
5673233|NCT00608738|thrombocytopenia|thrombocytopenia
5673234|NCT00608738|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673235|NCT00608725|heart rate|heart rate
5673236|NCT00608725|blood pressure|blood pressure
5673237|NCT00608725|blood volume|blood volume
5673238|NCT00608725|sympathetic nervous system|sympathetic nervous system
5673239|NCT00608725|orthostatic tachycardia|orthostatic tachycardia
5673240|NCT00608725|orthostatic intolerance|orthostatic intolerance
5673241|NCT00608725|POTS|pots
5673242|NCT00608712|bariatric surgery|bariatric surgery
5673243|NCT00608712|ulcer prevention|ulcer prevention
5673244|NCT00608699|Flushing|flushing
5673245|NCT00608699|GSK256073A,|gsk256073a,
5673246|NCT00608699|Dose Escalation,|dose escalation,
5673247|NCT00608699|Immediate Release Niacin,|immediate release niacin,
5673248|NCT00608686|NIAAA|niaaa
5673249|NCT00608686|Alcohol|alcohol
5673250|NCT00608686|Neurosteroids|neurosteroids
5673251|NCT00608686|Intoxication|intoxication
5673252|NCT00608673|discoid lupus erythematosus|discoid lupus erythematosus
5673253|NCT00608673|pimecrolimus 1% cream|pimecrolimus 1% cream
5673254|NCT00608673|betamethasone valerate 0.1% cream|betamethasone valerate 0.1% cream
5673255|NCT00608660|Peripheral Facial Paralysis|peripheral facial paralysis
5673256|NCT00608660|Acupuncture|acupuncture
5673257|NCT00608660|RCT|rct
5673258|NCT00608634|actinic keratosis|actinic keratosis
5673259|NCT00608621|physostigmine|physostigmine
5673260|NCT00608621|postoperative analgesia|postoperative analgesia
5673261|NCT00608621|pain|pain
5673262|NCT00608621|patient-controlled analgesia|patient-controlled analgesia
5673263|NCT00608621|Opioid consumption|opioid consumption
5673264|NCT00608621|Pain quality (VAS Score)|pain quality (vas score)
5673265|NCT00608621|Hemodynamics|hemodynamics
5673268|NCT00608595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5673269|NCT00608595|recurrent rectal cancer|recurrent rectal cancer
5673270|NCT00608595|stage I rectal cancer|stage i rectal cancer
5673271|NCT00608595|stage II rectal cancer|stage ii rectal cancer
5673272|NCT00608595|stage III rectal cancer|stage iii rectal cancer
5863031|NCT00001412|Gonadal Steroids|gonadal steroids
5673273|NCT00608582|Transcranial Magnetic Stimulation, Repetitive|transcranial magnetic stimulation, repetitive
5673276|NCT00608582|Aphasia|aphasia
5673277|NCT00608582|Chronic Stroke|chronic stroke
5673278|NCT00608582|Randomized, Controlled Trial|randomized, controlled trial
5673279|NCT00608569|Drug Therapy, Combination|drug therapy, combination
5673280|NCT00608569|HIV Non-Nucleoside Reverse Transcriptase Inhibitors|hiv non-nucleoside reverse transcriptase inhibitors
5673281|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors
5673282|NCT00608569|Viral Load|viral load
5673283|NCT00608569|Virologic Failure|virologic failure
5673284|NCT00608556|Heterotaxy|heterotaxy
5673285|NCT00608556|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5673286|NCT00608556|Congenital Heart Disease|congenital heart disease
5673287|NCT00608556|Genetic Study|genetic study
5673288|NCT00608556|Situs Inversus|situs inversus
5673289|NCT00608543|cognitive function|cognitive function
5673290|NCT00608543|psychosocial function|psychosocial function
5673291|NCT00608543|augmentation|augmentation
5673292|NCT00608543|treatment refractory depression|treatment refractory depression
5673293|NCT00608530|pain|pain
5673294|NCT00608530|chronic pain|chronic pain
5673295|NCT00608530|chronic back pain|chronic back pain
5673296|NCT00608530|randomized clinical trial|randomized clinical trial
5673297|NCT00608517|graft versus host disease|graft versus host disease
5673298|NCT00608517|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5673299|NCT00608517|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5673300|NCT00608517|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5673301|NCT00608517|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5673302|NCT00608517|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5673303|NCT00608517|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5673304|NCT00608517|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5673305|NCT00608517|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5673306|NCT00608517|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5673307|NCT00608517|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5673308|NCT00608517|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5673309|NCT00608517|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5673310|NCT00608517|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5673311|NCT00608517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5673312|NCT00608517|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5673313|NCT00608517|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5673314|NCT00608517|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5673315|NCT00608517|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5673316|NCT00608517|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5673317|NCT00608517|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5673318|NCT00608517|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5673319|NCT00608517|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5673320|NCT00608517|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5673321|NCT00608517|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
5673322|NCT00608517|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5673323|NCT00608517|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5673324|NCT00608517|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5673325|NCT00608517|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5673326|NCT00608517|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5673327|NCT00608517|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5673328|NCT00608517|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5673329|NCT00608517|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5673330|NCT00608517|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5673331|NCT00608517|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5673332|NCT00608517|stage I multiple myeloma|stage i multiple myeloma
5673333|NCT00608517|stage II multiple myeloma|stage ii multiple myeloma
5673334|NCT00608517|refractory multiple myeloma|refractory multiple myeloma
5673335|NCT00608517|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5673336|NCT00608517|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5673337|NCT00608517|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5673338|NCT00608517|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5134079|NCT03155594|DM-2|dm-2
5673339|NCT00608517|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5673340|NCT00608517|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5673341|NCT00608517|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5673342|NCT00608517|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5673343|NCT00608517|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5673344|NCT00608517|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5673345|NCT00608517|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5673346|NCT00608517|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5673347|NCT00608517|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5673348|NCT00608517|stage III multiple myeloma|stage iii multiple myeloma
5673349|NCT00608517|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5673350|NCT00608517|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5673351|NCT00608517|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5673352|NCT00608517|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5673353|NCT00608517|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5680425|NCT00577798|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5673354|NCT00608517|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5673355|NCT00608517|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5673356|NCT00608517|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5673357|NCT00608517|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5673358|NCT00608517|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5673359|NCT00608517|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5673360|NCT00608517|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5673361|NCT00608517|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5673362|NCT00608517|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5673363|NCT00608517|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5673364|NCT00608517|Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia|philadelphia chromosome positive adult precursor acute lymphoblastic leukemia
5673365|NCT00608517|Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia|philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
5673366|NCT00608517|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5673367|NCT00608517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5673368|NCT00608517|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5673369|NCT00608517|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5673370|NCT00608517|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5673371|NCT00608517|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5673372|NCT00608517|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5673373|NCT00608517|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5673374|NCT00608517|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5673375|NCT00608517|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5673376|NCT00608504|Behavioral Economics|behavioral economics
5673377|NCT00608504|Drug self administration|drug self administration
5673378|NCT00608504|Opioid|opioid
5673379|NCT00608491|Acute Decompensated Heart Failure|acute decompensated heart failure
5673380|NCT00608491|Acute Decompensated Heart Failure With Cardiorenal Syndrome|acute decompensated heart failure with cardiorenal syndrome
5673381|NCT00608491|Cardiorenal Syndrome|cardiorenal syndrome
5673382|NCT00608491|Persistent Congestion|persistent congestion
5673383|NCT00608491|Ultra Filtration|ultra filtration
5673384|NCT00608465|Fibrolytic Dysfunction|fibrolytic dysfunction
5673385|NCT00608465|Obesity|obesity
5673386|NCT00608465|PAI-1|pai-1
5673387|NCT00608452|Lung|lung
5673388|NCT00608452|Ovarian|ovarian
5673389|NCT00608452|Breast|breast
5673390|NCT00608452|Hodgkin's|hodgkin's
5673391|NCT00608439|CAST|cast
5673392|NCT00608439|Centella asiatica|centella asiatica
5673393|NCT00608439|Diabetes|diabetes
5673394|NCT00608439|Diabetic neuropathy|diabetic neuropathy
5673395|NCT00608426|African Americans|african americans
5673396|NCT00608426|telephone counseling|telephone counseling
5673397|NCT00608426|community health planning|community health planning
5673398|NCT00608426|ethnic groups|ethnic groups
5673400|NCT00608400|PTH|pth
5673401|NCT00608400|nutritional supplement|nutritional supplement
5673402|NCT00608374|Waldenström macroglobulinemia|waldenström macroglobulinemia
5673403|NCT00608374|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5673404|NCT00608374|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5673405|NCT00608374|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5673406|NCT00608374|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5673407|NCT00608374|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5673408|NCT00608374|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5673409|NCT00608348|exercise|exercise
5863988|NCT00001147|Normetanephrine|normetanephrine
5673428|NCT00608205|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5673429|NCT00608205|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5673430|NCT00608205|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5673431|NCT00608205|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5673432|NCT00608205|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5673433|NCT00608205|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5673434|NCT00608205|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5673435|NCT00608205|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5673437|NCT00608192|viral hepatitis|viral hepatitis
5673438|NCT00608192|methadone maintenance|methadone maintenance
5673439|NCT00608192|case management|case management
5673440|NCT00608192|costs|costs
5673441|NCT00608192|vaccination|vaccination
5673442|NCT00608192|risk reduction education|risk reduction education
5673444|NCT00608179|glucose clamp|glucose clamp
5673445|NCT00608153|essential hypertension|essential hypertension
5673446|NCT00608153|ARB|arb
5673447|NCT00608153|compliance|compliance
5673448|NCT00608153|candesartan|candesartan
5673449|NCT00608140|Advanced Heart Failure|advanced heart failure
5673450|NCT00608140|Non-Ischemic Heart Failure|non-ischemic heart failure
5673451|NCT00608140|Mitral Regurgitation|mitral regurgitation
5673452|NCT00608140|Mitral Valve Replacement|mitral valve replacement
5673453|NCT00608140|Congestive Heart Failure|congestive heart failure
5673454|NCT00608140|Surgical Mitral Valvuloplasty|surgical mitral valvuloplasty
5673455|NCT00608140|Dilated Cardiomyopathy|dilated cardiomyopathy
5673456|NCT00608140|Annular Ring|annular ring
5673457|NCT00608101|hypoglycemia|hypoglycemia
5673458|NCT00608101|exercise|exercise
5673459|NCT00608101|corticosteroids|corticosteroids
5673460|NCT00608088|Breast feeding|breast feeding
5673461|NCT00608088|breastfeeding|breastfeeding
5673462|NCT00608088|randomized clinical trial|randomized clinical trial
5673463|NCT00608088|poverty|poverty
5673464|NCT00608062|endothelial function|endothelial function
5673465|NCT00608062|women|women
5673466|NCT00608062|female|female
5673467|NCT00608062|estrogen deficiency|estrogen deficiency
5673468|NCT00608062|sex hormones|sex hormones
5673469|NCT00608062|adiposity|adiposity
5673470|NCT00608062|oxidative stress|oxidative stress
5673471|NCT00608062|antioxidants|antioxidants
5673472|NCT00608049|Blood Pressure|blood pressure
5673473|NCT00608049|Diabetes|diabetes
5673474|NCT00608049|Nutrition|nutrition
5798791|NCT00111059|stress|stress
5673475|NCT00608049|Dietary Carbohydrate|dietary carbohydrate
5673476|NCT00608049|Lipoproteins|lipoproteins
5673477|NCT00608049|Insulin Resistance|insulin resistance
5673478|NCT00608036|Adolescents|adolescents
5673479|NCT00608036|Neighborhood|neighborhood
5673480|NCT00608036|Walkability|walkability
5673481|NCT00608036|Physical Activity|physical activity
5673482|NCT00608036|Quality of Life|quality of life
5673483|NCT00608036|Ecological Analysis|ecological analysis
5673484|NCT00608036|Dietary Patterns|dietary patterns
5673485|NCT00608036|Weight Status|weight status
5673486|NCT00608036|Neighborhood Environment|neighborhood environment
5673487|NCT00608036|Food Environment|food environment
5673488|NCT00608036|Recreation Environment|recreation environment
5673490|NCT00608023|Lipodystrophy|lipodystrophy
5673491|NCT00608023|Abdominal fat accumulation|abdominal fat accumulation
5673492|NCT00608023|Growth hormone releasing hormone|growth hormone releasing hormone
5673493|NCT00608023|HIV-associated lipodystrophy|hiv-associated lipodystrophy
5673494|NCT00608023|Treatment experienced|treatment experienced
5673495|NCT00608010|Preservation of supernumerary embryos in an IVF program|preservation of supernumerary embryos in an ivf program
5673496|NCT00607997|Leukemia|leukemia
5673497|NCT00607997|Myeloid|myeloid
5673498|NCT00607997|Elderly|elderly
5673499|NCT00607997|Hematologic|hematologic
5673500|NCT00607997|Blood|blood
5673501|NCT00607997|Cancer|cancer
5673502|NCT00607997|Malignancy|malignancy
5673503|NCT00607997|SNS-595|sns-595
5673504|NCT00607997|Sunesis|sunesis
5673505|NCT00607997|Hematologic Diseases|hematologic diseases
5673506|NCT00607997|Myelodysplastic Syndromes|myelodysplastic syndromes
5673507|NCT00607997|Older|older
5673508|NCT00607997|voreloxin|voreloxin
5673509|NCT00607997|reveal-1|reveal-1
5673510|NCT00607984|thiotepa|thiotepa
5673511|NCT00607984|melphalan|melphalan
5673512|NCT00607984|brain tumor|brain tumor
5673513|NCT00607984|tumors of central nervous system and other solid tumors|tumors of central nervous system and other solid tumors
5673514|NCT00607971|Constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome
5673515|NCT00607958|Tipranavir|tipranavir
5673516|NCT00607958|ritonavir|ritonavir
5673517|NCT00607958|dose reduction|dose reduction
5673518|NCT00607958|inhibitory quotient|inhibitory quotient
5673519|NCT00607945|Type 2 diabetes mellitus|type 2 diabetes mellitus
5140640|NCT03111979|beta-alanine|beta-alanine
5673520|NCT00607945|conjugated linoleic acid|conjugated linoleic acid
5673522|NCT00607945|rosiglitazone|rosiglitazone
5673531|NCT00607880|vascular access device complications|vascular access device complications
5673532|NCT00607880|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673533|NCT00607867|Diabetes Mellitus (type 2)|diabetes mellitus (type 2)
5673534|NCT00607867|Diet|diet
5673535|NCT00607867|Glycohemoglobin|glycohemoglobin
5673536|NCT00607867|Lipids|lipids
5673537|NCT00607867|Kidney Function|kidney function
5673538|NCT00607867|Glycemic Index|glycemic index
5674033|NCT00605449|Simvastatin|simvastatin
5673539|NCT00607867|Dietary Protein|dietary protein
5673540|NCT00607867|Dietary Carbohydrate|dietary carbohydrate
5673541|NCT00607854|Zevalin|zevalin
5673542|NCT00607854|Reduced intensity conditioning|reduced intensity conditioning
5673543|NCT00607854|Allogenic stem cell transplantation|allogenic stem cell transplantation
5673544|NCT00607828|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5673545|NCT00607828|advanced adult primary liver cancer|advanced adult primary liver cancer
5673546|NCT00607828|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5673547|NCT00607828|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5673548|NCT00607815|PTSD|ptsd
5673549|NCT00607815|OEF/OIF|oef/oif
5673550|NCT00607815|Combat|combat
5673551|NCT00607815|Treatment|treatment
5673554|NCT00607815|Cognitive|cognitive
5673555|NCT00607802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673556|NCT00607802|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5673557|NCT00607776|dry, eyes|dry, eyes
5673558|NCT00607776|Amelioration of dry eye symptoms|amelioration of dry eye symptoms
5673559|NCT00607763|Antifungal|antifungal
5673560|NCT00607763|Echinocandin|echinocandin
5673561|NCT00607763|Candidiasis|candidiasis
5673562|NCT00607763|Micafungin|micafungin
5673563|NCT00607750|Wet AMD, Comentis, ATG003, mecamylamine|wet amd, comentis, atg003, mecamylamine
5673564|NCT00607724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5673565|NCT00607685|Trabeculectomy|trabeculectomy
5673566|NCT00607685|Wound healing|wound healing
5673567|NCT00607685|5 Fluorouracil|5 fluorouracil
5673568|NCT00607685|Hyaluronic acid|hyaluronic acid
5673569|NCT00607685|post-operative scarring|post-operative scarring
5673570|NCT00607672|Angiotensin Converting Enzyme|angiotensin converting enzyme
5673571|NCT00607672|Angiotensin Receptor Blockers|angiotensin receptor blockers
5673572|NCT00607672|Cardiopulmonary Bypass|cardiopulmonary bypass
5673573|NCT00607672|Fibrinolysis|fibrinolysis
5673574|NCT00607672|Inflammation|inflammation
5673575|NCT00607659|Chlamydia|chlamydia
5673576|NCT00607659|Chlamydia trachomatis|chlamydia trachomatis
5673577|NCT00607659|Adolescent Health|adolescent health
5673578|NCT00607659|Female Health|female health
5673579|NCT00607659|Sexually Transmitted Infections|sexually transmitted infections
5673580|NCT00607659|Infertility|infertility
5673581|NCT00607659|Pelvic Inflammatory Disease|pelvic inflammatory disease
5673582|NCT00607646|hypoglycemia|hypoglycemia
5673583|NCT00607646|dehydroepiandrosterone|dehydroepiandrosterone
5673584|NCT00607633|essential hypertension|essential hypertension
5673585|NCT00607633|ARB|arb
5673586|NCT00607633|left ventricular hypertrophy|left ventricular hypertrophy
5673587|NCT00607633|candesartan|candesartan
5673588|NCT00607620|Alcohol Abuse|alcohol abuse
5673589|NCT00607620|Alcohol Dependence|alcohol dependence
5673590|NCT00607620|Alcohol Use Disorder|alcohol use disorder
5673591|NCT00607620|Screening|screening
5673592|NCT00607620|Brief Intervention|brief intervention
5673593|NCT00607620|Motivational Interviewing|motivational interviewing
5673594|NCT00607607|ovarian cancer|ovarian cancer
5673595|NCT00607607|endometrial cancer|endometrial cancer
5673596|NCT00607581|amyloidosis|amyloidosis
5673597|NCT00607581|lenalidomide|lenalidomide
5673598|NCT00607581|cyclophosphamide|cyclophosphamide
5673599|NCT00607581|dexamethasone|dexamethasone
5673600|NCT00607568|physical stress|physical stress
5673601|NCT00607568|psychological stress|psychological stress
5673602|NCT00607555|Infant, premature|infant, premature
5673603|NCT00607555|Infant, very low birth weight|infant, very low birth weight
5673604|NCT00607555|Apnea|apnea
5673605|NCT00607555|Feeding methods|feeding methods
5673606|NCT00607555|Diaphragm|diaphragm
5673607|NCT00607542|spasticity|spasticity
5673608|NCT00607542|cerebral palsy|cerebral palsy
5673609|NCT00607542|baclofen|baclofen
5673610|NCT00607542|pharmacokinetics|pharmacokinetics
5673611|NCT00607542|pharmacodynamics|pharmacodynamics
5673612|NCT00607542|dosing|dosing
5673613|NCT00607542|safety|safety
5673614|NCT00607542|efficacy|efficacy
5673615|NCT00607529|Multiple Diseases|multiple diseases
5673616|NCT00607516|fracture|fracture
5673617|NCT00607516|arthroplasty|arthroplasty
5673618|NCT00607516|wear|wear
5673619|NCT00607516|osteoporosis|osteoporosis
5673620|NCT00607516|bone|bone
5673621|NCT00607490|Vulvodynia|vulvodynia
5673622|NCT00607490|Vulvar pain|vulvar pain
5673623|NCT00607490|Dyspareunia|dyspareunia
5673625|NCT00607490|Vestibulitis|vestibulitis
5673918|NCT00606125|Chemotherapy|chemotherapy
5673626|NCT00607464|Hypothermia, premature infants, Polyethylene occlusive wrap|hypothermia, premature infants, polyethylene occlusive wrap
5673627|NCT00607438|Locally Advanced or Metastatic|locally advanced or metastatic
5673628|NCT00607425|non-small cell lung cancer|non-small cell lung cancer
5673630|NCT00607425|saliva|saliva
5673631|NCT00607425|gene expression|gene expression
5673632|NCT00607425|healthy control subject|healthy control subject
5673633|NCT00607412|PTSD|ptsd
5673634|NCT00607412|substance use disorders|substance use disorders
5673635|NCT00607412|psychotherapy|psychotherapy
5673637|NCT00607399|Advanced Cancer|advanced cancer
5673638|NCT00607399|MET Inhibitor|met inhibitor
5673639|NCT00607399|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
5673640|NCT00607386|Hunter syndrome|hunter syndrome
5673641|NCT00607386|hunters syndrome|hunters syndrome
5673642|NCT00607386|hunter's syndrome|hunter's syndrome
5673643|NCT00607386|hunter disease|hunter disease
5673644|NCT00607386|hunters disease|hunters disease
5005926|NCT03959696|Continuing Medical Education|continuing medical education
5005927|NCT03959696|early detection of cancer|early detection of cancer
5005929|NCT03959696|colorectal cancer|colorectal cancer
5005930|NCT03959644|unsuccessful spinal anesthesia|unsuccessful spinal anesthesia
5005931|NCT03959631|Ischemic Heart Disease Virtual Community of Practice empowerment|ischemic heart disease virtual community of practice empowerment
5005932|NCT03959618|dietary supplements|dietary supplements
5005933|NCT03959618|Desmodium|desmodium
5005934|NCT03959618|chemotherapy|chemotherapy
5005935|NCT03959618|breast cancer|breast cancer
5005936|NCT03959566|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5005937|NCT03959566|Sutezolid|sutezolid
5005938|NCT03959566|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5005939|NCT03959566|PNU-100480|pnu-100480
5005940|NCT03959566|Tuberculosis|tuberculosis
5005941|NCT03959566|Antitubercular Agents|antitubercular agents
5005942|NCT03959566|Gram-positive Bacterial Infections|gram-positive bacterial infections
5005943|NCT03959566|Oxazolidinones|oxazolidinones
5005944|NCT03959566|Dose-finding|dose-finding
5005945|NCT03959566|Combination-evaluation|combination-evaluation
5005947|NCT03959566|Tolerability|tolerability
5005948|NCT03959566|Pharmacokinetics (PK)|pharmacokinetics (pk)
5005949|NCT03959566|Exposure-Response Relationship|exposure-response relationship
5005950|NCT03959566|Bedaquiline|bedaquiline
5005951|NCT03959566|Delamanid|delamanid
5005952|NCT03959566|Moxifloxacin|moxifloxacin
5005953|NCT03959566|Drug-sensitive TB|drug-sensitive tb
5005954|NCT03959553|Alzheimer's Disease|alzheimer's disease
5005955|NCT03959553|GV1001|gv1001
5005956|NCT03959501|Type 2 diabetes|type 2 diabetes
5005971|NCT03959410|hpv|hpv
5673645|NCT00607386|hunter's disease|hunter's disease
5673646|NCT00607386|MPS II|mps ii
5673647|NCT00607386|MPSII|mpsii
5673648|NCT00607386|MPS2|mps2
5673649|NCT00607386|MPS 2|mps 2
5673650|NCT00607386|mucopolysaccharides|mucopolysaccharides
5673651|NCT00607386|lysosomal storage disease|lysosomal storage disease
5673652|NCT00607386|lysosomal storage disorder|lysosomal storage disorder
5673653|NCT00607386|chronic ear infection|chronic ear infection
5673654|NCT00607386|enlarged adenoids|enlarged adenoids
5673655|NCT00607386|mps symptoms|mps symptoms
5673656|NCT00607386|mps diagnosis|mps diagnosis
5673657|NCT00607386|mps ii therapy|mps ii therapy
5673658|NCT00607386|MPS II treatment|mps ii treatment
5673659|NCT00607386|ert treatment|ert treatment
5673660|NCT00607386|elaprase|elaprase
5673661|NCT00607386|idursulfase|idursulfase
5673662|NCT00607386|iduronate sulfatase|iduronate sulfatase
5673663|NCT00607386|iduronate 2 sulfatase|iduronate 2 sulfatase
5673664|NCT00607386|enzyme replacement therapy|enzyme replacement therapy
5673665|NCT00607386|hunter syndrome treatment|hunter syndrome treatment
5673666|NCT00607386|hunter's syndrome treatment|hunter's syndrome treatment
5673667|NCT00607386|hunter syndrome therapy|hunter syndrome therapy
5673668|NCT00607386|hunter's disease treatment|hunter's disease treatment
5673669|NCT00607386|mps society|mps society
5673670|NCT00607373|Apolipoprotein B|apolipoprotein b
5673671|NCT00607373|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5673672|NCT00607373|LDL-receptor gene|ldl-receptor gene
5673673|NCT00607360|cocaine addiction, treatment, contingency management, employment intervention|cocaine addiction, treatment, contingency management, employment intervention
5673674|NCT00607347|Keywords by National Institute of General Medical Sciences|keywords by national institute of general medical sciences
5673675|NCT00607347|Hypertension|hypertension
5673676|NCT00607347|Adverse metabolic effects|adverse metabolic effects
5673677|NCT00607347|Beta blockers|beta blockers
5673678|NCT00607347|Dyslipidemia|dyslipidemia
5673680|NCT00607347|New onset diabetes|new onset diabetes
5673681|NCT00607347|Pharmacokinetic study|pharmacokinetic study
5673682|NCT00607347|Oral glucose tolerance test|oral glucose tolerance test
5673684|NCT00607334|Language Therapy|language therapy
5673685|NCT00607334|Vocabulary|vocabulary
5673686|NCT00607321|restenosis|restenosis
5673688|NCT00607321|Coronary Arteriosclerosis|coronary arteriosclerosis
5673689|NCT00607321|Arterial Occlusive Diseases|arterial occlusive diseases
5673690|NCT00607295|chemotherapy|chemotherapy
5673691|NCT00607295|hormonal therapy|hormonal therapy
5673692|NCT00607295|urogenital atrophy|urogenital atrophy
5673693|NCT00607269|Drug Abuse|drug abuse
5673694|NCT00607269|Contingency management|contingency management
5673695|NCT00607269|Voucher-based Reinforcement Therapy|voucher-based reinforcement therapy
5673696|NCT00607269|Homosexuality|homosexuality
5673697|NCT00607269|Homeless Persons|homeless persons
5673698|NCT00607243|Smallpox vaccine efficacy|smallpox vaccine efficacy
5673699|NCT00607230|type 1 diabetes mellitus|type 1 diabetes mellitus
5673700|NCT00607230|immune modulation|immune modulation
5673701|NCT00607230|cure|cure
5673702|NCT00607230|autoimmunity|autoimmunity
5673703|NCT00607217|Coronary artery diseases|coronary artery diseases
5673704|NCT00607217|Myocardial infarction|myocardial infarction
5673705|NCT00607217|Stable angina|stable angina
5673706|NCT00607217|Influenza|influenza
5673707|NCT00607217|Vaccine|vaccine
5673708|NCT00607204|Basic Research|basic research
5668098|NCT00628732|Phase II|phase ii
5673709|NCT00607204|Individual Sleep Duration|individual sleep duration
5673710|NCT00607204|Melatonin|melatonin
5673711|NCT00607204|Electroencephalogram|electroencephalogram
5673712|NCT00607204|Alertness|alertness
5673713|NCT00607204|Mood|mood
5673714|NCT00607191|Idiopathic talipes equinovarus (ITEV)|idiopathic talipes equinovarus (itev)
5673715|NCT00607178|Influenza|influenza
5673716|NCT00607178|Vaccine|vaccine
5673717|NCT00607126|impaired ambulation|impaired ambulation
5673718|NCT00607113|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5673719|NCT00607113|Avastin|avastin
5673720|NCT00607113|Bevacizumab|bevacizumab
5673721|NCT00607113|RAD001|rad001
5673723|NCT00607100|High-Resolution Optical Coherence Tomography|high-resolution optical coherence tomography
5673724|NCT00607100|Retinal Nerve Fiber Layer|retinal nerve fiber layer
5673726|NCT00607061|Glutathione|glutathione
5673727|NCT00607061|Cysteine|cysteine
5673728|NCT00607061|Synthesis rate|synthesis rate
5673729|NCT00607061|Newborns|newborns
5673730|NCT00607061|Low birth weight newborn babies|low birth weight newborn babies
5673731|NCT00607022|dental implant|dental implant
5673732|NCT00607022|early loading|early loading
5673733|NCT00607022|traditional loading|traditional loading
5673734|NCT00607022|anterior|anterior
5673735|NCT00607022|implant stability|implant stability
5673736|NCT00607022|Subjects presenting with one tooth missing in the anterior|subjects presenting with one tooth missing in the anterior
5673737|NCT00607022|incisor/canine) or pre-molar regions of the mandible|incisor/canine) or pre-molar regions of the mandible
5673738|NCT00607022|or maxilla with existing teeth that were healthy|or maxilla with existing teeth that were healthy
5673739|NCT00607022|or adequately restored shall be screened.|or adequately restored shall be screened.
5673740|NCT00606996|Drug Abuse|drug abuse
5673741|NCT00606996|Drug Dependence|drug dependence
5673742|NCT00606996|Alcohol Abuse|alcohol abuse
5673743|NCT00606996|Alcohol Dependence|alcohol dependence
5673744|NCT00606996|Major Depressive Disorder|major depressive disorder
5673745|NCT00606996|Dysthymic Disorder|dysthymic disorder
5673746|NCT00606996|Prisoners|prisoners
5673747|NCT00606996|Women|women
5673748|NCT00606970|Chemotherapy|chemotherapy
5673749|NCT00606970|Breast Cancer|breast cancer
5673750|NCT00606970|Colon Cancer|colon cancer
5673751|NCT00606970|Lung Cancer|lung cancer
5673752|NCT00606957|Obesity|obesity
5886510|NCT04273126|resilience, psychological|resilience, psychological
5886511|NCT04273126|homelessness|homelessness
5886512|NCT04273113|Biofeedback training, Offenders, Anxiety, Depression|biofeedback training, offenders, anxiety, depression
5886513|NCT04273100|Hepatocellular carcinoma|hepatocellular carcinoma
5886514|NCT04273100|Immune Suppression|immune suppression
5886515|NCT04273100|Angiogenesis|angiogenesis
5886516|NCT04273100|Hepatic Artery Embolism|hepatic artery embolism
5886517|NCT04273061|Genomic analysis|genomic analysis
5886518|NCT04273061|Atezolizumab|atezolizumab
5886519|NCT04273061|Whole genome and transcriptome analysis|whole genome and transcriptome analysis
5886520|NCT04273061|Immune Burden Variant score|immune burden variant score
5886521|NCT04273061|Immune checkpoint inhibition|immune checkpoint inhibition
5886522|NCT04273061|Personalized OncoGenomics|personalized oncogenomics
5886530|NCT04273035|Mask induction|mask induction
5886531|NCT04273035|Day Care Surgery|day care surgery
5886533|NCT04272996|subdural hematoma|subdural hematoma
5886534|NCT04272996|embolization|embolization
5886535|NCT04272996|middle meningeal artery|middle meningeal artery
5886536|NCT04272970|Familial thrombocytopenia|familial thrombocytopenia
5886537|NCT04272970|Molecular etiology|molecular etiology
5886545|NCT04272931|Future Liver Remnant|future liver remnant
5886546|NCT04272931|Portal and Hepatic Vein Embolization|portal and hepatic vein embolization
5886547|NCT04272931|Colorectal Liver Metastases|colorectal liver metastases
5886551|NCT04272905|Knowledge|knowledge
5886552|NCT04272905|Attitudes|attitudes
5886553|NCT04272905|Recording|recording
5886554|NCT04272905|Maternity|maternity
5886559|NCT04272866|Caries prevention|caries prevention
5886560|NCT04272866|Pit and fissure sealant|pit and fissure sealant
5886561|NCT04272866|Clinpro|clinpro
5886562|NCT04272866|Triage|triage
5886563|NCT04272866|Embrace|embrace
5886564|NCT04272853|Athlete|athlete
5886565|NCT04272853|Exercise|exercise
5886566|NCT04272853|Training Load|training load
5886632|NCT04272580|Inferior vena cava collapsibility index|inferior vena cava collapsibility index
5886633|NCT04272580|Norepinephrine|norepinephrine
5886634|NCT04272580|Cesarean section|cesarean section
5886635|NCT04272580|Dose-finding|dose-finding
5886636|NCT04272567|Norepinephrine|norepinephrine
5886637|NCT04272567|Hypotension|hypotension
5886638|NCT04272567|Cesarean section|cesarean section
5886639|NCT04272567|Dose-finding|dose-finding
5886640|NCT04272541|cardiovascular risk|cardiovascular risk
5886641|NCT04272541|metabolic syndrome|metabolic syndrome
5886642|NCT04272541|independency|independency
5886643|NCT04272541|psychopathology|psychopathology
5886644|NCT04272489|pattern recognition|pattern recognition
5886645|NCT04272489|home trial|home trial
5886646|NCT04272489|randomized cross-over trial|randomized cross-over trial
5886647|NCT04272489|prosthesis|prosthesis
5886648|NCT04272489|electromyography|electromyography
5886649|NCT04272476|Acupuncture|acupuncture
5886650|NCT04272476|Moxibustion|moxibustion
5886651|NCT04272476|Major Depressive Disorder|major depressive disorder
5886652|NCT04272476|MDD|mdd
5886653|NCT04272476|Neural Network Reconstruction|neural network reconstruction
5886731|NCT04272086|Fibroid uterus|fibroid uterus
5886732|NCT04272086|Myomectomy|myomectomy
5886733|NCT04272086|Abdominal myomectomy|abdominal myomectomy
5886734|NCT04272073|sarcopenia|sarcopenia
5886735|NCT04272073|obesity|obesity
5886736|NCT04272073|sarcopenic obesity|sarcopenic obesity
5886737|NCT04272073|body composition|body composition
5886738|NCT04272073|cardiac rehabilitation|cardiac rehabilitation
5886739|NCT04272073|cardiovascular disease|cardiovascular disease
5886740|NCT04272073|metabolic syndrome|metabolic syndrome
5886745|NCT04272047|Prevention|prevention
5886747|NCT04272008|tampon|tampon
5886748|NCT04272008|vaginal ring|vaginal ring
5886751|NCT04271982|Older|older
5886752|NCT04271982|Population|population
5886753|NCT04271982|Health services|health services
5886757|NCT04271943|DEMENTIA|dementia
5886758|NCT04271943|COMPUTER BASED EXERCISE|computer based exercise
5886810|NCT04271709|Vision Screening|vision screening
5886811|NCT04271709|Follow-up Eye Care|follow-up eye care
5886812|NCT04271709|Vulnerable Populations|vulnerable populations
5886813|NCT04271709|New York City|new york city
5886820|NCT04271683|Positive end-expiratory pressure|positive end-expiratory pressure
5886821|NCT04271683|Mechanical ventilation|mechanical ventilation
5886822|NCT04271683|Induction of anesthesia|induction of anesthesia
5886823|NCT04271670|Ginger|ginger
5886824|NCT04271670|Mustard|mustard
5886825|NCT04271670|Footbath|footbath
5886826|NCT04271670|Warmth perception|warmth perception
5886827|NCT04271670|Infrared thermography|infrared thermography
5886828|NCT04271670|Healthy volunteers|healthy volunteers
5886829|NCT04271657|Radiopathomics features|radiopathomics features
5886830|NCT04271657|Artificial intelligence|artificial intelligence
5886831|NCT04271657|Locally advanced rectal cancer|locally advanced rectal cancer
5886834|NCT04271644|Multiple Myeloma|multiple myeloma
5886882|NCT04271267|Lung Transplantation|lung transplantation
5886883|NCT04271267|Acute Rejection|acute rejection
5886884|NCT04271267|Cell-free DNA|cell-free dna
5886885|NCT04271241|Chronic passive stretching|chronic passive stretching
5886886|NCT04271241|Central and peripheral arterial stiffness|central and peripheral arterial stiffness
5886887|NCT04271241|Blood pressure|blood pressure
5886888|NCT04271241|Vasomotor response|vasomotor response
5886889|NCT04271241|Crossover effect|crossover effect
5886890|NCT04271228|Decision Support System|decision support system
5886891|NCT04271228|Type 1 Diabetes|type 1 diabetes
5886893|NCT04271215|Obesity|obesity
5886894|NCT04271215|Survival|survival
5886895|NCT04271215|Children|children
5886899|NCT04271176|Jaundice|jaundice
5886900|NCT04271176|Echinococcosis|echinococcosis
5886901|NCT04271176|Liver|liver
5886902|NCT04271176|Surgical treatment|surgical treatment
5886904|NCT04271137|3d printed onlay|3d printed onlay
5886974|NCT04270604|biobank|biobank
5886975|NCT04270604|disease modeling|disease modeling
5886976|NCT04270604|genetics|genetics
5886978|NCT04270591|MET amplification|met amplification
5886979|NCT04270591|MET over-expression|met over-expression
5886980|NCT04270591|C-Met Exon 14|c-met exon 14
5886981|NCT04270578|gestational diabetes|gestational diabetes
5886982|NCT04270578|insulin|insulin
5886983|NCT04270565|running|running
5886984|NCT04270565|gait-training|gait-training
5886985|NCT04270565|exercise-related lower leg pain|exercise-related lower leg pain
5887062|NCT04270188|: middle and / or anterior prolapse ≥ II (POP-Q classification)|: middle and / or anterior prolapse ≥ ii (pop-q classification)
5887063|NCT04270162|Inspiratory volume, expiratory volume, inspirometer.|inspiratory volume, expiratory volume, inspirometer.
5887064|NCT04270149|breast cancer|breast cancer
5887065|NCT04270149|estrogen receptor|estrogen receptor
5887066|NCT04270149|peptide vaccine|peptide vaccine
5887067|NCT04270149|immunotherapy|immunotherapy
5887068|NCT04270136|Breast Cancer|breast cancer
5887069|NCT04270136|mastectomy|mastectomy
5887070|NCT04270136|ambulatory care|ambulatory care
5887072|NCT04270123|PRO|pro
5887073|NCT04270123|PROM|prom
5887074|NCT04270123|Adverse Event|adverse event
5887075|NCT04270123|Quality of Life|quality of life
5887076|NCT04270084|cardiometabolic risk factors|cardiometabolic risk factors
5887077|NCT04270084|lifestyle modification|lifestyle modification
5887078|NCT04270084|visceral adiposity|visceral adiposity
5887079|NCT04270071|Yangxinshengmai granules|yangxinshengmai granules
5887080|NCT04270071|Stable angina pectoris|stable angina pectoris
5887081|NCT04270071|Coronary heart disease|coronary heart disease
5887085|NCT04270058|hATTR|hattr
5887152|NCT04269603|platelet functions|platelet functions
5887153|NCT04269603|von Willebrand disease|von willebrand disease
5887154|NCT04269603|quality assessment|quality assessment
5887155|NCT04269590|Neurologic rehabilitation|neurologic rehabilitation
5887156|NCT04269590|Dual tasking|dual tasking
5887157|NCT04269590|Motor learning|motor learning
5887158|NCT04269577|Neurologic rehabilitation|neurologic rehabilitation
5887159|NCT04269577|Motor learning|motor learning
5887160|NCT04269577|Disease progression|disease progression
5887161|NCT04269525|2019-nCOV infection|2019-ncov infection
5887162|NCT04269525|UC-MSCs Treatment|uc-mscs treatment
5887168|NCT04269174|organic and functiona diarrhoea|organic and functiona diarrhoea
5887169|NCT04269174|pattern|pattern
5887170|NCT04269174|utility|utility
5887171|NCT04269057|NLRP3 protein|nlrp3 protein
5887172|NCT04269057|human|human
5887236|NCT04267562|menstruation disturbances|menstruation disturbances
5887237|NCT04267484|Shared decision making|shared decision making
5887238|NCT04267484|Mild Cognitive Impairment|mild cognitive impairment
5887240|NCT04267484|aging in place|aging in place
5887241|NCT04267484|memory problem|memory problem
5887245|NCT04267081|AML|aml
5887246|NCT04267081|Venetoclax|venetoclax
5887247|NCT04267081|Azacytidine|azacytidine
5887248|NCT04267081|Drug Sensitivity Screening|drug sensitivity screening
5887249|NCT04266964|Spasticity|spasticity
5887250|NCT04266964|Spinal cord injury|spinal cord injury
5887251|NCT04266964|Validity|validity
5887252|NCT04266964|Reliability|reliability
5887259|NCT04266678|muscular strength|muscular strength
5887260|NCT04266678|functional capacity|functional capacity
5887261|NCT04266678|resistance exercise|resistance exercise
5887262|NCT04266509|PF-06651600|pf-06651600
5887263|NCT04266509|Rifampin|rifampin
5887264|NCT04266509|Drug-drug interaction study|drug-drug interaction study
5887265|NCT04266509|Pharmacokinetics|pharmacokinetics
5887266|NCT04266483|Non-small Cell Lung Cancer|non-small cell lung cancer
5887267|NCT04266483|Next-generation sequencing|next-generation sequencing
5887268|NCT04266483|High-throughput sequencing|high-throughput sequencing
5887269|NCT04266483|Gene|gene
5887273|NCT04266444|exergaming|exergaming
5887274|NCT04266444|virtual reality|virtual reality
5887275|NCT04266444|neuropsychological tests|neuropsychological tests
5887276|NCT04266444|motivation|motivation
5887282|NCT04266223|Radiation Therapy|radiation therapy
5887283|NCT04266223|Mask|mask
5887284|NCT04266223|Anxiety|anxiety
5887285|NCT04266223|Motion sickness|motion sickness
5887286|NCT04266223|Claustrophobia|claustrophobia
5887294|NCT04265989|coronary artery ectasia|coronary artery ectasia
5887295|NCT04265989|new classification|new classification
5887296|NCT04265989|interventional therapy|interventional therapy
5887297|NCT04265989|coronary artery aneurysm|coronary artery aneurysm
5887298|NCT04264975|immuno-oncology|immuno-oncology
5887299|NCT04264975|immunotherapy|immunotherapy
5887300|NCT04264975|biomarker|biomarker
5887301|NCT04264975|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
5887302|NCT04264975|microbiome|microbiome
5887303|NCT04264702|circulating tumor DNA|circulating tumor dna
5887304|NCT04264702|BESPOKE|bespoke
5887315|NCT04264442|FSHD, FSHD1|fshd, fshd1
5887316|NCT04264442|Muscular Dystrophy|muscular dystrophy
5673753|NCT00606957|Metabolism|metabolism
5887364|NCT04261803|familial hypercholesterolemia|familial hypercholesterolemia
5887416|NCT04258176|multimorbidity|multimorbidity
5887429|NCT04257422|Nursing|nursing
5887430|NCT04257357|Exercise|exercise
5887431|NCT04257357|Quality of life|quality of life
5887432|NCT04257357|Physical capacity|physical capacity
5887433|NCT04257357|Randomized trial|randomized trial
5887434|NCT04257357|Pilot study|pilot study
5887436|NCT04256473|Randomized Controlled Trial|randomized controlled trial
5887437|NCT04256473|Thrombolytic treatment|thrombolytic treatment
5887438|NCT04256473|Intracranial hemorrhage|intracranial hemorrhage
5887439|NCT04256473|Mutant pro-urokinase|mutant pro-urokinase
5887440|NCT04256473|Ischemic stroke|ischemic stroke
5887464|NCT04255615|Artificial Intelligence|artificial intelligence
5887484|NCT04255212|Sport climber|sport climber
5887485|NCT04255212|Delayed Onset Muscle Soreness|delayed onset muscle soreness
5887486|NCT04255212|Central sensitization|central sensitization
5887487|NCT04255212|Peripheral sensitization|peripheral sensitization
5887488|NCT04255212|Soft tissue treatment|soft tissue treatment
5887506|NCT04253548|Peer Support Mentorship|peer support mentorship
5887507|NCT04253548|Transplant|transplant
5887508|NCT04253548|Pediatrics|pediatrics
5887518|NCT04252638|Insomnia|insomnia
5887519|NCT04252638|Acceptance and Commitment Therapy|acceptance and commitment therapy
5887520|NCT04252638|Cognitive Behavioral Therapy|cognitive behavioral therapy
5887521|NCT04252638|Randomized Controlled Trial|randomized controlled trial
5887522|NCT04252638|Sleep|sleep
5887523|NCT04252638|Quality of life|quality of life
5887524|NCT04252209|xerostomia|xerostomia
5887525|NCT04252209|oral dryness|oral dryness
5887526|NCT04252209|dry mouth|dry mouth
5887541|NCT04250493|Multiple system atrophy|multiple system atrophy
5887597|NCT04245111|Trauma|trauma
5887604|NCT04244214|eHealth|ehealth
5887605|NCT04244214|mHealth|mhealth
5887606|NCT04244214|gamification|gamification
5887607|NCT04244214|big data|big data
5887624|NCT04242940|Bone anchored hearing systems|bone anchored hearing systems
5887625|NCT04242940|BAHS|bahs
5887626|NCT04242940|Listening effort|listening effort
5887627|NCT04242940|Pupillometry|pupillometry
5887628|NCT04242940|Ponto 4|ponto 4
5887660|NCT04240626|Bariatric Surgery,|bariatric surgery,
5887661|NCT04240626|Pain Control|pain control
5887662|NCT04240626|Gabapentinin|gabapentinin
5887666|NCT04239417|ventral hernia|ventral hernia
5887667|NCT04239417|graduated abdominal exercises|graduated abdominal exercises
5887668|NCT04239417|isokinetic dynamometer.|isokinetic dynamometer.
5673754|NCT00606944|enhanced recovery program|enhanced recovery program
5673755|NCT00606931|biopsy|biopsy
5673756|NCT00606931|PET|pet
5673757|NCT00606931|image-guidance|image-guidance
5673758|NCT00606931|breast cancer|breast cancer
5673759|NCT00606931|FDG|fdg
5673760|NCT00606931|PEM|pem
5673761|NCT00606918|Strength testing|strength testing
5673762|NCT00606918|Disease progression|disease progression
5673763|NCT00606918|ALS|als
5673764|NCT00606918|Healthy Adults|healthy adults
5673765|NCT00606905|Recurrent miscarriage|recurrent miscarriage
5673766|NCT00606905|Recurrent spontaneous abortion|recurrent spontaneous abortion
5673767|NCT00606905|Habitual abortion|habitual abortion
5673768|NCT00606905|IVIG|ivig
5673769|NCT00606905|Randomized Controlled Trial|randomized controlled trial
5673770|NCT00606892|therapeutic effects|therapeutic effects
5673771|NCT00606879|Solid tumor|solid tumor
5673772|NCT00606879|Advanced Cancer|advanced cancer
5673773|NCT00606879|MET inhibitor|met inhibitor
5673774|NCT00606879|Receptor Tyrosine Kinase Inhibitor (RTKI)|receptor tyrosine kinase inhibitor (rtki)
5673775|NCT00606866|renal, metastatic, carcinoma|renal, metastatic, carcinoma
5673776|NCT00606853|Substance abuse|substance abuse
5673777|NCT00606853|Contingency Management|contingency management
5673778|NCT00606840|overweight|overweight
5673779|NCT00606840|prevention of weight gain|prevention of weight gain
5673780|NCT00606840|young adults|young adults
5673781|NCT00606840|self-regulation|self-regulation
5673782|NCT00606840|daily weighing|daily weighing
5673783|NCT00606840|weight gain prevention|weight gain prevention
5673784|NCT00606827|Contrast-induced nephrophaty|contrast-induced nephrophaty
5673785|NCT00606827|Contrast media|contrast media
5673786|NCT00606827|Angiography|angiography
5673787|NCT00606827|Coronary percutaneous intervention|coronary percutaneous intervention
5673788|NCT00606814|Solid Tumors, IPI-504, docetaxel,cancer|solid tumors, ipi-504, docetaxel,cancer
5673789|NCT00606801|cognitive enhancers|cognitive enhancers
5673790|NCT00606801|Nootropic Agents|nootropic agents
5673791|NCT00606788|randomized clinical trials|randomized clinical trials
5673792|NCT00606788|intensive care|intensive care
5673793|NCT00606788|mechanical ventilation|mechanical ventilation
5673794|NCT00606788|ventilator weaning|ventilator weaning
5673795|NCT00606788|clinical protocols|clinical protocols
5673796|NCT00606788|therapy, computer-assisted|therapy, computer-assisted
5673797|NCT00606788|humans|humans
5673798|NCT00606788|various surgical diseases requiring mechanical ventilation over 24 hours|various surgical diseases requiring mechanical ventilation over 24 hours
5673799|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5673800|NCT00606775|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5673801|NCT00606775|Cardiomyopathies|cardiomyopathies
5673802|NCT00606775|Troponin I|troponin i
5673803|NCT00606762|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5673804|NCT00606762|low pressure pneumoperitoneum|low pressure pneumoperitoneum
5673805|NCT00606736|right ventricular outflow tract arrhythmia|right ventricular outflow tract arrhythmia
5673806|NCT00606736|sex hormone level|sex hormone level
5673807|NCT00606736|menstrual cycle|menstrual cycle
5673808|NCT00606736|Gonadal Hormones|gonadal hormones
5673809|NCT00606723|relapsed or refractory AML|relapsed or refractory aml
5673810|NCT00606723|in children, adolescents and young adults|in children, adolescents and young adults
5673811|NCT00606697|Primary Insomnia Adults|primary insomnia adults
5673812|NCT00606684|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5673813|NCT00606684|COPD|copd
5673814|NCT00606684|GW642444|gw642444
5887740|NCT04233385|breast cancer|breast cancer
5887741|NCT04233385|breast surgery|breast surgery
5887742|NCT04233385|myofascial massage|myofascial massage
5887743|NCT04233385|shoulder immobility|shoulder immobility
5887777|NCT04230967|pregnancy|pregnancy
5887778|NCT04230967|PPROM|pprom
5673815|NCT00606671|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5673816|NCT00606658|Insomnia|insomnia
5673817|NCT00606658|Ayurveda|ayurveda
5673818|NCT00606658|Shirodhara|shirodhara
5673819|NCT00606658|Quality of Life|quality of life
5673820|NCT00606632|Renal Mass|renal mass
5673821|NCT00606632|Clear Cell Renal Cell Carcinoma|clear cell renal cell carcinoma
5673822|NCT00606632|Cancer of Kidney|cancer of kidney
5673823|NCT00606632|Kidney Cancer|kidney cancer
5673824|NCT00606632|Neoplasms|neoplasms
5673825|NCT00606632|cG250|cg250
5673826|NCT00606632|antibody, monoclonal|antibody, monoclonal
5673827|NCT00606632|Iodine 124|iodine 124
5673828|NCT00606632|Positron-Emission Tomography|positron-emission tomography
5673829|NCT00606632|Kidney|kidney
5673830|NCT00606632|Renal Cancer|renal cancer
5673831|NCT00606632|Renal Neoplasms|renal neoplasms
5673832|NCT00606619|Gastrectomy|gastrectomy
5673833|NCT00606619|Oral feeding|oral feeding
5673834|NCT00606619|Nutrition|nutrition
5673835|NCT00606619|Gastric cancer|gastric cancer
5673836|NCT00606593|insomnia|insomnia
5673837|NCT00606593|elderly|elderly
5673838|NCT00606593|sleeplessness|sleeplessness
5673839|NCT00606580|cutaneous leishmaniasis, topical treatment, Tunisia|cutaneous leishmaniasis, topical treatment, tunisia
5673840|NCT00606567|Defibrillators, Implantable|defibrillators, implantable
5673841|NCT00606554|Respiratory Insufficiency|respiratory insufficiency
5673842|NCT00606554|Ventilators, Mechanical|ventilators, mechanical
5673843|NCT00606554|Ventilator Weaning|ventilator weaning
5673844|NCT00606554|Therapy, Computer-Assisted|therapy, computer-assisted
5673845|NCT00606541|Social Anxiety Disorder|social anxiety disorder
5673846|NCT00606541|Quetiapine XR|quetiapine xr
5673847|NCT00606541|Prevention|prevention
5673848|NCT00606541|tolerability|tolerability
5673849|NCT00606528|Antiviral therapy|antiviral therapy
5673850|NCT00606515|Pharmacokinetics|pharmacokinetics
5673851|NCT00606515|Liposomal paclitaxel|liposomal paclitaxel
5673852|NCT00606502|Stage IIIB/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
5673853|NCT00606502|Non-small cell lung cancer|non-small cell lung cancer
5673854|NCT00606502|NSCLC|nsclc
5673855|NCT00606502|Lung Cancer|lung cancer
5673856|NCT00606502|Pralatrexate|pralatrexate
5673857|NCT00606502|Erlotinib|erlotinib
5673860|NCT00606502|Smoking|smoking
5673861|NCT00606502|Smoker|smoker
5673862|NCT00606450|plaque psoriasis|plaque psoriasis
5798792|NCT00111046|Pain Relief|pain relief
5673863|NCT00606437|Umbilical Cord Blood Graft|umbilical cord blood graft
5673864|NCT00606437|Stem Cell Transplantation|stem cell transplantation
5673865|NCT00606424|head and neck cancer|head and neck cancer
5673866|NCT00606411|Sleep-Related Eating Disorder|sleep-related eating disorder
5673867|NCT00606411|Topiramate|topiramate
5673868|NCT00606411|Parasomnia|parasomnia
5673869|NCT00606398|colorectal metastases|colorectal metastases
5673870|NCT00606385|Recurrence|recurrence
5673871|NCT00606385|Survival|survival
5673872|NCT00606385|Immunology|immunology
5673873|NCT00606385|Laparoscopy|laparoscopy
5673874|NCT00606372|Off-pump|off-pump
5673875|NCT00606372|OPCAB|opcab
5673876|NCT00606372|EuroSCORE|euroscore
5673877|NCT00606372|high-risk patients|high-risk patients
5673878|NCT00606372|Quality of life|quality of life
5673879|NCT00606372|Validity of EuroSCORE|validity of euroscore
5673880|NCT00606359|Influenza|influenza
5673881|NCT00606359|Orthomyxoviridae Infections|orthomyxoviridae infections
5673882|NCT00606359|Renal Transplant|renal transplant
5673883|NCT00606346|Crohn's Disease|crohn's disease
5673884|NCT00606346|Ulcerative Colitis|ulcerative colitis
5673885|NCT00606346|Indeterminate Colitis|indeterminate colitis
5673886|NCT00606346|Inflammatory Bowel Diseases|inflammatory bowel diseases
5673887|NCT00606346|Immunomodulators|immunomodulators
5673888|NCT00606346|infliximab|infliximab
5673889|NCT00606346|TNF-alpha|tnf-alpha
5673890|NCT00606333|Coronary artery disease|coronary artery disease
5673891|NCT00606333|drug-eluting stents|drug-eluting stents
5673892|NCT00606333|sirolimus-eluting coronary stents|sirolimus-eluting coronary stents
5673893|NCT00606307|polycythemia vera (PV)|polycythemia vera (pv)
5673894|NCT00606307|essential thrombocythemia (ET)|essential thrombocythemia (et)
5673895|NCT00606307|myelofibrosis (MF)|myelofibrosis (mf)
5673896|NCT00606294|Head|head
5673897|NCT00606294|Neck|neck
5673898|NCT00606294|04-070|04-070
5673899|NCT00606268|Antifungal Prophylaxis|antifungal prophylaxis
5887811|NCT04226027|Mobile health|mobile health
5887812|NCT04226027|Mhealth|mhealth
5887813|NCT04226027|T2.coach|t2.coach
5887814|NCT04226027|Smartphone app|smartphone app
5887847|NCT04223154|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5887848|NCT04223154|Brain Stimulation|brain stimulation
5887849|NCT04223154|Neuroimaging|neuroimaging
5887882|NCT04222725|postoperative|postoperative
5887883|NCT04222725|postsurgical|postsurgical
5673900|NCT00606268|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5673901|NCT00606268|HSCT|hsct
5673902|NCT00606268|Micafungin|micafungin
5673903|NCT00606255|blood pressure|blood pressure
5673904|NCT00606255|compliance|compliance
5673905|NCT00606255|treatment|treatment
5673906|NCT00606216|MRI|mri
5673907|NCT00606164|Alzheimer's Disease|alzheimer's disease
5673908|NCT00606164|bryostatin 1|bryostatin 1
5673909|NCT00606164|bryostatin|bryostatin
5673910|NCT00606164|safety|safety
5673911|NCT00606164|efficacy|efficacy
5673912|NCT00606164|pharmacokinetics|pharmacokinetics
5673914|NCT00606164|protein kinase C|protein kinase c
5673915|NCT00606151|drug eluding stents|drug eluding stents
5673916|NCT00606151|perioperative bridging|perioperative bridging
5673917|NCT00606151|Stents|stents
5673924|NCT00606099|compensated chronic hepatitis B|compensated chronic hepatitis b
5673925|NCT00606099|telbivudin|telbivudin
5673926|NCT00606099|aedevofir dipivoxil|aedevofir dipivoxil
5673927|NCT00606086|Hepatitis, HCV, Liver disease, HepC|hepatitis, hcv, liver disease, hepc
5673928|NCT00606060|Hemophilia,|hemophilia,
5673936|NCT00606008|Sutent|sutent
5673937|NCT00605995|Schizophrenia|schizophrenia
5673938|NCT00605995|Randomized trial|randomized trial
5673939|NCT00605995|Statin|statin
5673940|NCT00605995|Placebo|placebo
5673941|NCT00605982|MRI|mri
5673942|NCT00605969|femoroacetabular, impingement|femoroacetabular, impingement
5673943|NCT00605956|head lice|head lice
5673944|NCT00605956|NatrOVA Creme Rinse - 1% is intended for the treatment of head lice|natrova creme rinse - 1% is intended for the treatment of head lice
5673945|NCT00605943|Retinal Disease|retinal disease
5673946|NCT00605943|Bevacizumab|bevacizumab
5673947|NCT00605943|Ranibizumab|ranibizumab
5673948|NCT00605943|Retinal Eye Disease|retinal eye disease
5673949|NCT00605943|Macular Degeneration|macular degeneration
5673950|NCT00605930|Progressive Supranuclear Palsy|progressive supranuclear palsy
5673951|NCT00605930|PSP|psp
5673952|NCT00605930|Nutriceutical|nutriceutical
5673953|NCT00605930|Pyruvate|pyruvate
5673954|NCT00605930|Creatine|creatine
5673955|NCT00605930|Niacinamide|niacinamide
5673956|NCT00605904|Chemical Stressor|chemical stressor
5673957|NCT00605904|Alcoholism|alcoholism
5673958|NCT00605904|Yohimbine|yohimbine
5673959|NCT00605904|Acamprosate|acamprosate
5673960|NCT00605904|Craving|craving
5673970|NCT00605852|Allergic rhinitis|allergic rhinitis
5673971|NCT00605852|first time in human|first time in human
5673972|NCT00605839|mobile technology|mobile technology
5673973|NCT00605839|cell phones|cell phones
5673974|NCT00605839|type 1 diabetes|type 1 diabetes
5673975|NCT00605800|Liver resection|liver resection
5673976|NCT00605774|catecholamines|catecholamines
5673977|NCT00605774|diabetes|diabetes
5673978|NCT00605774|exercise|exercise
5673979|NCT00605761|Cystic Fibrosis|cystic fibrosis
5673980|NCT00605761|Lung function|lung function
5673981|NCT00605761|Anti-Inflammatory|anti-inflammatory
5673982|NCT00605748|catheter ablation|catheter ablation
5673983|NCT00605748|atrial fibrillation|atrial fibrillation
5673984|NCT00605748|pulmonary vein|pulmonary vein
5673985|NCT00605696|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5673986|NCT00605696|Acute Lung Injury|acute lung injury
5673987|NCT00605657|ALPS|alps
5673988|NCT00605657|Valproic Acid|valproic acid
5673989|NCT00605657|Lymphadenopathy|lymphadenopathy
5673990|NCT00605657|Splenomegaly|splenomegaly
5673991|NCT00605657|Histone Deacytelase (HDAC) Inhibitor|histone deacytelase (hdac) inhibitor
5673992|NCT00605657|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5673993|NCT00605631|Pacing|pacing
5673994|NCT00605605|endothelial function|endothelial function
5673995|NCT00605605|atherosclerosis|atherosclerosis
5673996|NCT00605605|smoking|smoking
5673997|NCT00605605|inflammation|inflammation
5673998|NCT00605605|antioxidant|antioxidant
5673999|NCT00605592|Type 1 Diabetes|type 1 diabetes
5674000|NCT00605592|Kidney Transplant|kidney transplant
5674001|NCT00605592|Hypoglycemic Unawareness|hypoglycemic unawareness
5674002|NCT00605592|Islet Transplant|islet transplant
5887885|NCT04222725|inflammation|inflammation
5887886|NCT04222725|pain|pain
5887909|NCT04221906|BOS-475|bos-475
5887910|NCT04221906|antipsoriatic efficacy|antipsoriatic efficacy
5887911|NCT04221906|safety|safety
5887912|NCT04221906|psoriasis plaque test|psoriasis plaque test
5887917|NCT04220567|Fibromyalgia|fibromyalgia
5887918|NCT04220567|Exercise|exercise
5887919|NCT04220567|Patient-centred Education|patient-centred education
5887920|NCT04220567|Randomised Controlled Trial|randomised controlled trial
5887921|NCT04220281|propofol|propofol
5887922|NCT04220281|nitroglycerin|nitroglycerin
5887931|NCT04219657|spoke wheel injury|spoke wheel injury
5887932|NCT04219657|umbilical cord mesenchymal stem cells|umbilical cord mesenchymal stem cells
5887933|NCT04219657|skin grafting|skin grafting
5887934|NCT04218604|atrial fibrillation|atrial fibrillation
5887940|NCT04218110|Preventative|preventative
5887964|NCT04215406|air pollution|air pollution
5887965|NCT04215406|inflammatory cytokine|inflammatory cytokine
5887966|NCT04215406|hormone|hormone
5887967|NCT04215406|effect|effect
4957288|NCT04255784|transcranial magnetic stimulation|transcranial magnetic stimulation
4957289|NCT04255784|treatment resistance|treatment resistance
4957290|NCT04255784|theta burst stimulation|theta burst stimulation
5005997|NCT03959241|Acute GVHD|acute gvhd
5674003|NCT00605592|Pancreatic Islet Cell Transplantation|pancreatic islet cell transplantation
5674004|NCT00605592|University of Virginia|university of virginia
5674005|NCT00605592|Islet Transplantation|islet transplantation
5674006|NCT00605592|Kidney Transplantation|kidney transplantation
5674009|NCT00605566|cyclophosphamide|cyclophosphamide
5674010|NCT00605566|pharmacodynamic|pharmacodynamic
5674011|NCT00605540|COPD|copd
5674012|NCT00605540|Survival|survival
5888042|NCT04208334|Cancer cachexia|cancer cachexia
5888043|NCT04208334|Head and neck cancer|head and neck cancer
5888045|NCT04208334|Tumuric|tumuric
5888046|NCT04208334|Cancer anorexia cachexia|cancer anorexia cachexia
5888097|NCT04204993|Influenza A H3N2|influenza a h3n2
5888098|NCT04204122|GVHD|gvhd
5888099|NCT04204122|Graft-Versus-Host Disease|graft-versus-host disease
5888100|NCT04204122|Ocular Surface|ocular surface
5888101|NCT04204122|Ocular Surface Microbiome|ocular surface microbiome
5888102|NCT04204122|Vigamox|vigamox
5888129|NCT04201431|PvDBPII|pvdbpii
5674013|NCT00605540|Exacerbation|exacerbation
5674014|NCT00605540|Disease markers|disease markers
5674015|NCT00605527|Acute Lung Injury|acute lung injury
5674016|NCT00605527|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5674017|NCT00605514|Hemorrhagic Fever|hemorrhagic fever
5674018|NCT00605514|Healthy|healthy
5674019|NCT00605514|Immunity|immunity
5674020|NCT00605514|T-Cells|t-cells
5674021|NCT00605514|Filovirus|filovirus
5674022|NCT00605514|Healthy Volunteer|healthy volunteer
5674023|NCT00605514|HV|hv
5674024|NCT00605488|Pet Scan|pet scan
5674025|NCT00605475|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5674026|NCT00605475|Canakinumab|canakinumab
5674027|NCT00605475|ACZ885|acz885
5674028|NCT00605475|IL-1B antagonist|il-1b antagonist
5674029|NCT00605475|metformin|metformin
5674030|NCT00605475|glycemic control|glycemic control
5674031|NCT00605475|insulin sensitivity|insulin sensitivity
5674034|NCT00605449|Healthy Subjects|healthy subjects
5674035|NCT00605449|Repeat Dose|repeat dose
5674036|NCT00605449|Drug Interaction|drug interaction
5674037|NCT00605449|Randomized|randomized
5674038|NCT00605449|Pharmacokinetics|pharmacokinetics
5674039|NCT00605436|overweight|overweight
5674040|NCT00605436|sedentary|sedentary
5674041|NCT00605436|metabolic syndrome|metabolic syndrome
5674043|NCT00605423|Almera|almera
5674044|NCT00605423|Steroid|steroid
5674045|NCT00605423|Macular|macular
5674046|NCT00605423|ARMD|armd
5674047|NCT00605410|Methacholine bronchoprovocation|methacholine bronchoprovocation
5674048|NCT00605410|Antimuscarinic|antimuscarinic
5674049|NCT00605397|Cu-64 LABELED TRASTUZUMAB|cu-64 labeled trastuzumab
5674050|NCT00605371|Healthy volunteers|healthy volunteers
5674051|NCT00605371|Bioequivalence|bioequivalence
5674052|NCT00605371|Food Effects|food effects
5674053|NCT00605358|geriatric depression|geriatric depression
5674054|NCT00605319|BPH|bph
5674055|NCT00605319|BOO|boo
5674056|NCT00605306|Asthma|asthma
5674057|NCT00605306|spirometry|spirometry
5674058|NCT00605306|lung function|lung function
5674059|NCT00605306|serum cortisol|serum cortisol
5674060|NCT00605306|serum potassium|serum potassium
5674061|NCT00605306|plasma glucose|plasma glucose
5674062|NCT00605280|randomized sham-controlled multicenter macular edema|randomized sham-controlled multicenter macular edema
5674063|NCT00605267|Breast Cancer|breast cancer
5674064|NCT00605267|Breast Neoplasms|breast neoplasms
5674065|NCT00605267|Tumors or cancer of the human BREAST|tumors or cancer of the human breast
5674066|NCT00605267|Tumor or cancer of the human MAMMARY GLAND|tumor or cancer of the human mammary gland
5674067|NCT00605254|P-Glycoprotein|p-glycoprotein
5674068|NCT00605254|Positron Emission Tomography|positron emission tomography
5674069|NCT00605254|Blood Brain Barrier|blood brain barrier
5674070|NCT00605254|Quantitative Imaging|quantitative imaging
5674071|NCT00605254|Multi-Drug Transporter|multi-drug transporter
5674072|NCT00605254|Healthy Volunteer|healthy volunteer
5674073|NCT00605254|HV|hv
5674074|NCT00605241|pharmacodynamics,|pharmacodynamics,
5674075|NCT00605241|pharmacokinetics,|pharmacokinetics,
5674076|NCT00605241|tolerability,|tolerability,
5674077|NCT00605241|Safety,|safety,
5674078|NCT00605241|single dose,|single dose,
5674079|NCT00605241|placebo,|placebo,
5674080|NCT00605241|Nicotine reward|nicotine reward
5674081|NCT00605241|GSK598809|gsk598809
5674082|NCT00605176|Actinic keratosis|actinic keratosis
5674083|NCT00605176|Skin disease|skin disease
5674084|NCT00605163|Parkinson disease, observational, longitudinal|parkinson disease, observational, longitudinal
5674085|NCT00605150|Unresectable HCC|unresectable hcc
5674086|NCT00605124|osteoarthritis|osteoarthritis
5674087|NCT00605124|knee|knee
5674088|NCT00605124|total knee arthroplasty|total knee arthroplasty
5674089|NCT00605124|exercise|exercise
5674090|NCT00605098|HIV|hiv
5888146|NCT04200248|Edema|edema
5888147|NCT04200248|Neovascularization|neovascularization
5888192|NCT04197141|Unfavorable intermediate risk|unfavorable intermediate risk
5888193|NCT04197141|High risk|high risk
5888211|NCT04196283|Squamous Cell Carcinoma|squamous cell carcinoma
5888212|NCT04196283|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5888213|NCT04196283|Locally Advanced Head and Neck Squamous Cell Carcinoma|locally advanced head and neck squamous cell carcinoma
5888214|NCT04196283|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
5888218|NCT04195945|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5888219|NCT04195945|Other Hematopoietic|other hematopoietic
5674092|NCT00605098|Vertical disease transmission|vertical disease transmission
5674093|NCT00605098|Pharmacokinetics|pharmacokinetics
5674094|NCT00605098|HIV seronegativity|hiv seronegativity
5674095|NCT00605072|cognitive disorders|cognitive disorders
5674096|NCT00605072|angiotensin receptor blockers|angiotensin receptor blockers
5674098|NCT00605059|SPECT|spect
5674099|NCT00605046|Alzheimer|alzheimer
5674100|NCT00605046|SPECT|spect
5674101|NCT00605007|COPD|copd
5674102|NCT00605007|Diabetes|diabetes
5674103|NCT00605007|Respiratory Disorders|respiratory disorders
5674104|NCT00604994|Lymphoedema|lymphoedema
5674105|NCT00604994|Gynaecology|gynaecology
5674106|NCT00604994|Oncology|oncology
5674107|NCT00604994|Malignant|malignant
5674108|NCT00604994|Benign|benign
5674109|NCT00604994|Incidence|incidence
5674110|NCT00604955|visceral leishmaniasis|visceral leishmaniasis
5674111|NCT00604955|kala-azar|kala-azar
5674112|NCT00604955|Bihar, India|bihar, india
5674113|NCT00604942|Oesophagus|oesophagus
5674114|NCT00604942|Dysphagia|dysphagia
5674115|NCT00604942|Impedance|impedance
5674116|NCT00604942|High Resolution Manometry|high resolution manometry
5674117|NCT00604942|Peristalsis|peristalsis
5674118|NCT00604942|Contractile Pressure|contractile pressure
5674119|NCT00604942|Coordination of contraction|coordination of contraction
5674120|NCT00604942|Bolus transport|bolus transport
5674121|NCT00604929|muscle protein synthesis|muscle protein synthesis
5674122|NCT00604929|whole-body protein breakdown|whole-body protein breakdown
5674123|NCT00604929|nutrition|nutrition
5674124|NCT00604916|oral hygiene|oral hygiene
5674125|NCT00604890|Double-Blind|double-blind
5674126|NCT00604890|Placebo|placebo
5674127|NCT00604890|Topical|topical
5674128|NCT00604890|Treatment|treatment
5674129|NCT00604890|Dose-Ranging|dose-ranging
5674130|NCT00604890|sBCC|sbcc
5674131|NCT00604877|exercise|exercise
5674132|NCT00604877|glucose metabolism|glucose metabolism
5674133|NCT00604877|insulin sensitivity|insulin sensitivity
5674134|NCT00604877|Vascular Function|vascular function
5674135|NCT00604864|deep endometriosis|deep endometriosis
5674136|NCT00604864|pelvic pain|pelvic pain
5674137|NCT00604864|infliximab|infliximab
5674138|NCT00604864|anti TNFa|anti tnfa
5674139|NCT00604838|amniotic fluid leakage|amniotic fluid leakage
5674140|NCT00604838|urinary incontinence|urinary incontinence
5674141|NCT00604838|pregnancy|pregnancy
5674142|NCT00604838|home test|home test
5674143|NCT00604838|vaginal wetness|vaginal wetness
5674144|NCT00604825|menopause|menopause
5674145|NCT00604825|hormone therapy|hormone therapy
5674146|NCT00604825|hot flashes|hot flashes
5674147|NCT00604825|vasomotor symptoms|vasomotor symptoms
5674148|NCT00604786|Basophils|basophils
5674149|NCT00604786|Mast Cells|mast cells
5674162|NCT00604695|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5674163|NCT00604695|Acute Myocardial Infarction|acute myocardial infarction
5674164|NCT00604695|No Reflow|no reflow
5674165|NCT00604682|psoriasis|psoriasis
5674166|NCT00604669|Diabetes|diabetes
5674167|NCT00604669|Nutrition/Dietics|nutrition/dietics
5674168|NCT00604669|clinical outcomes|clinical outcomes
5674169|NCT00604669|total parenteral nutrition|total parenteral nutrition
5674170|NCT00604643|Abdominal Aneurysm|abdominal aneurysm
5674171|NCT00604643|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5674172|NCT00604643|Endovascular Stent Graft|endovascular stent graft
5888239|NCT04192981|GDC-0084|gdc-0084
5888240|NCT04192981|Radiation|radiation
5888241|NCT04192981|PIK3CA Mutations|pik3ca mutations
5888242|NCT04192981|19-359|19-359
5674173|NCT00604643|Endograft|endograft
5674174|NCT00604630|stroke|stroke
5674175|NCT00604630|EPO|epo
5674176|NCT00604630|erythropoietin|erythropoietin
5674177|NCT00604630|ischemia|ischemia
5674178|NCT00604630|hypoxia|hypoxia
5674179|NCT00604630|antiapoptosis|antiapoptosis
5674180|NCT00604630|neuroprotection|neuroprotection
5674181|NCT00604630|rtPA|rtpa
5674182|NCT00604630|thrombolysis|thrombolysis
5674183|NCT00604630|stroke, middle cerebral artery|stroke, middle cerebral artery
5888355|NCT04181151|latissimus dorsi|latissimus dorsi
5888356|NCT04181151|functional reach|functional reach
5888357|NCT04181151|stroke|stroke
5888358|NCT04181151|electromyography|electromyography
5888359|NCT04180904|PsA (Psoriatic Arthritis), Diet, Food, Nutrition|psa (psoriatic arthritis), diet, food, nutrition
5888360|NCT04180566|Pregnant|pregnant
5888361|NCT04180566|Pregnancy|pregnancy
5888362|NCT04180566|Ultrasound|ultrasound
5888363|NCT04180566|Antepartum testing|antepartum testing
5888364|NCT04180566|Neonatal outcome|neonatal outcome
5888365|NCT04180566|Antenatal complications|antenatal complications
4957678|NCT04253431|lancing device|lancing device
5674184|NCT00604630|Ischemic stroke in the middle cerebral artery territory|ischemic stroke in the middle cerebral artery territory
5674185|NCT00604617|Mycobacterium tuberculosis|mycobacterium tuberculosis
5674186|NCT00604617|Tuberculin Test|tuberculin test
5674187|NCT00604617|South Africa|south africa
5674188|NCT00604591|Dementia Treatment|dementia treatment
5674189|NCT00604591|Frontotemporal Dementia|frontotemporal dementia
5674190|NCT00604591|Dopamine|dopamine
5674191|NCT00604591|Frontotemporal Lobar Degeneration|frontotemporal lobar degeneration
5674192|NCT00604578|Pioglitazone|pioglitazone
5674194|NCT00604578|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
5674195|NCT00604578|Airflow Obstruction|airflow obstruction
5674196|NCT00604578|Airway Inflammation|airway inflammation
5674197|NCT00604565|Hemodialysis|hemodialysis
5674198|NCT00604552|Abdominal Aneurysm|abdominal aneurysm
5674199|NCT00604552|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5674200|NCT00604552|Endovascular Stent Graft|endovascular stent graft
5674201|NCT00604552|Endograft|endograft
5674202|NCT00604539|Chondroitin sulphate|chondroitin sulphate
5674203|NCT00604539|Synovitis|synovitis
5674204|NCT00604539|Knee osteoarthritis|knee osteoarthritis
5674205|NCT00604539|Magnetic Resonance Imaging|magnetic resonance imaging
5674206|NCT00604526|recurrent|recurrent
5674207|NCT00604487|induction|induction
5674208|NCT00604487|cervix|cervix
5674209|NCT00604487|balloon|balloon
5674210|NCT00604487|Bishop|bishop
5674211|NCT00604474|Deafness|deafness
5674212|NCT00604474|Hearing Loss|hearing loss
5674213|NCT00604474|Cochlear Implants|cochlear implants
5674214|NCT00604474|Advanced Bionics|advanced bionics
5674215|NCT00604474|HiResolution Bionic Ear System|hiresolution bionic ear system
5674216|NCT00604461|Carboplatin|carboplatin
5674217|NCT00604461|Bevacizumab|bevacizumab
5674218|NCT00604461|Avastin|avastin
5674219|NCT00604461|Pemetrexed|pemetrexed
5674220|NCT00604461|Alimta|alimta
5674221|NCT00604448|pulses|pulses
5674222|NCT00604448|beans|beans
5674223|NCT00604448|obesity|obesity
5674224|NCT00604448|overweight|overweight
5674225|NCT00604448|metabolic syndrome|metabolic syndrome
5674226|NCT00604435|breast cancer|breast cancer
5674227|NCT00604435|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5674228|NCT00604435|docetaxel|docetaxel
5674229|NCT00604435|epirubicin|epirubicin
5674230|NCT00604435|recombinant human endostatin (endostar)|recombinant human endostatin (endostar)
5674231|NCT00604435|chemotherapy|chemotherapy
5674232|NCT00604435|endostatin|endostatin
5674233|NCT00604422|Colonic disease|colonic disease
5674234|NCT00604422|Ulcerative colitis|ulcerative colitis
5674235|NCT00604422|suspected or known colonic disease|suspected or known colonic disease
5674236|NCT00604357|CNI free|cni free
5674237|NCT00604357|mTOR inhibition|mtor inhibition
5674238|NCT00604357|induction|induction
5674239|NCT00604357|IL2 receptor antibodies|il2 receptor antibodies
5674240|NCT00604357|renal function|renal function
5674247|NCT00604331|Cardiac Index|cardiac index
5674248|NCT00604331|Cardiac Function|cardiac function
5674249|NCT00604318|quality of life|quality of life
5674250|NCT00604292|Colonic Diseases|colonic diseases
5674251|NCT00604279|Schizophrenia|schizophrenia
5674252|NCT00604279|Paliperidone|paliperidone
5674253|NCT00604279|Paliperidone palmitate|paliperidone palmitate
5674254|NCT00604279|Risperidone|risperidone
5674255|NCT00604279|Risperidone long acting injection|risperidone long acting injection
5674257|NCT00604266|Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.|potentially resectable hilar cholangiocarcinoma as per initial imaging studies.
5674258|NCT00604266|Able to undergo PET/CT and MRI with Gadolinium|able to undergo pet/ct and mri with gadolinium
5674259|NCT00604240|NICU|nicu
5888427|NCT04175626|Drug eluting coronary stents|drug eluting coronary stents
5888428|NCT04175626|Sirolimus|sirolimus
5888429|NCT04175626|Bioabsorbable polymer|bioabsorbable polymer
5888430|NCT04175626|DES|des
5888437|NCT04174586|Cord blood microtransplatation|cord blood microtransplatation
5888438|NCT04174586|mobilized prepheral stem cell microtransplatation|mobilized prepheral stem cell microtransplatation
5888442|NCT04173988|Allogeneic CAR-T19|allogeneic car-t19
5888458|NCT04173104|Brain cancer|brain cancer
5888459|NCT04173104|18FPARPi|18fparpi
5888460|NCT04173104|PET scan|pet scan
5888461|NCT04173104|MRI|mri
5888462|NCT04173104|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5888463|NCT04173104|19-311|19-311
5674260|NCT00604240|caregivers|caregivers
5674261|NCT00604240|discharge instructions|discharge instructions
5674262|NCT00604227|high altitude pulmonary edema|high altitude pulmonary edema
5674263|NCT00604227|pulmonary interstitial fluid|pulmonary interstitial fluid
5674264|NCT00604227|pulmonary function testing|pulmonary function testing
5674265|NCT00604227|hypoxia|hypoxia
5675126|NCT00600717|Migraine|migraine
5674266|NCT00604227|pulmonary endothelial function|pulmonary endothelial function
5674267|NCT00604227|high altitude exposure without prior acclimatization|high altitude exposure without prior acclimatization
5674268|NCT00604214|Sepsis|sepsis
5674269|NCT00604214|Septic shock|septic shock
5674277|NCT00604175|HIV|hiv
5674278|NCT00604175|HPV 6|hpv 6
5674279|NCT00604175|HPV 11|hpv 11
5674280|NCT00604175|HPV 16|hpv 16
5674281|NCT00604175|HPV 18|hpv 18
5674282|NCT00604175|Vaccine|vaccine
5674283|NCT00604162|Suspected colonic disease|suspected colonic disease
5674284|NCT00604162|Known colonic disease|known colonic disease
5674285|NCT00604136|melanoma|melanoma
5674286|NCT00604136|tumor infiltrating lymphocytes|tumor infiltrating lymphocytes
5674287|NCT00604136|interleukin-2|interleukin-2
5674288|NCT00604123|JNJ-17166864|jnj-17166864
5674289|NCT00604123|allergic rhinitis|allergic rhinitis
5674290|NCT00604123|pharmacokinetics|pharmacokinetics
5674291|NCT00604123|biomarkers|biomarkers
5674292|NCT00604123|rhinitis symptoms|rhinitis symptoms
5674293|NCT00604123|mountain cedar pollen|mountain cedar pollen
5674294|NCT00604110|Biventricular pacing|biventricular pacing
5674295|NCT00604110|resynchronisation therapy|resynchronisation therapy
5674296|NCT00604110|cardiac surgery|cardiac surgery
5674297|NCT00604110|ejection fraction of less 45%|ejection fraction of less 45%
5674298|NCT00604097|youth suicide|youth suicide
5674299|NCT00604097|family therapy|family therapy
5674300|NCT00604097|primary care|primary care
5674301|NCT00604097|intervention|intervention
5674302|NCT00604084|Scabies|scabies
5674303|NCT00604084|Ivermectin|ivermectin
5674304|NCT00604084|Lindane|lindane
5674305|NCT00604084|Mass Eradication|mass eradication
5674306|NCT00604071|HMP, CNV, PHP, HPHP, AMD|hmp, cnv, php, hphp, amd
5674307|NCT00604058|Poliomyelitis|poliomyelitis
5674308|NCT00604058|intradermal|intradermal
5674309|NCT00604045|post traumatic stress disorder|post traumatic stress disorder
5674310|NCT00604045|cognitive bias|cognitive bias
5674311|NCT00604045|attention|attention
5674312|NCT00604045|combat|combat
5674313|NCT00604045|neuroimaging|neuroimaging
5674314|NCT00604032|Safety when exposed to sunlight|safety when exposed to sunlight
5674315|NCT00604019|sepsis|sepsis
5674316|NCT00604019|septic shock|septic shock
5847702|NCT00038480|Ritonavir|ritonavir
5674317|NCT00604006|Prevention of heart failure in individuals at high risk|prevention of heart failure in individuals at high risk
5674318|NCT00603993|Rheumatoid arthritis|rheumatoid arthritis
5674319|NCT00603967|Breast Cancer|breast cancer
5674320|NCT00603967|Postmenopausal|postmenopausal
5674321|NCT00603967|Aromatase|aromatase
5674322|NCT00603954|Nonmyeloablative conditioning.|nonmyeloablative conditioning.
5674323|NCT00603954|Hematological malignancies.|hematological malignancies.
5674324|NCT00603954|GVHD.|gvhd.
5674325|NCT00603941|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5674326|NCT00603941|Neoplasm|neoplasm
5674327|NCT00603941|Tumor|tumor
5674328|NCT00603941|Anti-neoplastic Agent|anti-neoplastic agent
5674329|NCT00603941|First-line treatment of advanced Anaplastic thyroid cancer|first-line treatment of advanced anaplastic thyroid cancer
5674330|NCT00603928|attitude|attitude
5674331|NCT00603928|attitude of health personnel|attitude of health personnel
5888508|NCT04170192|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5888509|NCT04170192|Inflammatory Bowel Disease|inflammatory bowel disease
5888510|NCT04170192|Interleukin 10 Receptor|interleukin 10 receptor
5888514|NCT04169490|Scar|scar
5888515|NCT04169490|Keloid|keloid
5888516|NCT04169490|Hypertrophic Scar|hypertrophic scar
5888517|NCT04169490|Cicatrix|cicatrix
5888522|NCT04168073|low sodium diet|low sodium diet
5888523|NCT04168073|high sodium diet|high sodium diet
5888524|NCT04168073|biomarker|biomarker
5888525|NCT04168073|aldosterone|aldosterone
5888526|NCT04168073|mineralocorticoid|mineralocorticoid
5888527|NCT04168073|mineralocorticoid receptor|mineralocorticoid receptor
5888552|NCT04166968|transcranial direct current stimulation|transcranial direct current stimulation
5888553|NCT04166968|stroke rehabilitation|stroke rehabilitation
5888625|NCT04163263|BOS-356|bos-356
5888626|NCT04163263|acne|acne
5888628|NCT04162418|peripheral arterial disease|peripheral arterial disease
5888629|NCT04162418|critical limb ischemia|critical limb ischemia
5888630|NCT04162418|infrapopliteal disease|infrapopliteal disease
5888641|NCT04161534|arm sling|arm sling
5888642|NCT04161534|Kinesiology tape|kinesiology tape
5888643|NCT04161105|Dry needling|dry needling
5888644|NCT04161105|Strength|strength
5888645|NCT04161105|Latent trigger points|latent trigger points
5888646|NCT04161066|Suboxone|suboxone
5888647|NCT04161066|Buprenorphine|buprenorphine
5888648|NCT04160468|S. aureus bloodstream infection|s. aureus bloodstream infection
5888649|NCT04160468|S. aureus bacteremia|s. aureus bacteremia
5888650|NCT04160468|S. aureus right-sided infective endocarditis|s. aureus right-sided infective endocarditis
5888651|NCT04160364|children|children
5888652|NCT04160364|adolescents|adolescents
5888653|NCT04160364|parents|parents
5888672|NCT04159857|hand forceps, cesarean section, one-hand technique, two-hand technique, fetal head extraction|hand forceps, cesarean section, one-hand technique, two-hand technique, fetal head extraction
5888689|NCT04157296|Cognitive behavioral therapy|cognitive behavioral therapy
5888690|NCT04157296|Computerized cognitive training|computerized cognitive training
5674332|NCT00603928|ethics|ethics
5674333|NCT00603928|bioethics|bioethics
5674334|NCT00603928|biomedical ethics|biomedical ethics
5674335|NCT00603928|patient care|patient care
5674336|NCT00603928|physicians|physicians
5674337|NCT00603928|placebo effect|placebo effect
5674338|NCT00603928|placebos|placebos
5674339|NCT00603928|questionnaires|questionnaires
5674340|NCT00603928|therapy|therapy
5674341|NCT00603928|general practice|general practice
5674351|NCT00603902|APD356|apd356
5674352|NCT00603902|BLOSSOM|blossom
5674353|NCT00603902|Hypertension|hypertension
5674354|NCT00603902|Dyslipidemia|dyslipidemia
5674355|NCT00603902|Sleep apnea|sleep apnea
5674356|NCT00603902|glucose tolerance|glucose tolerance
5674357|NCT00603902|cardiovascular disease|cardiovascular disease
5674358|NCT00603902|Arena|arena
5674359|NCT00603889|Hookworm|hookworm
5674360|NCT00603889|Allergy|allergy
5674361|NCT00603889|Vaccine|vaccine
5674362|NCT00603889|Skin test|skin test
5674363|NCT00603863|pancreatic cancer|pancreatic cancer
5674364|NCT00603863|hPAM4|hpam4
5674365|NCT00603863|MUC1 antibody|muc1 antibody
5674366|NCT00603863|cancer of the pancreas|cancer of the pancreas
5674367|NCT00603850|HMP, PHP, AMD, CNV, HPHP|hmp, php, amd, cnv, hphp
5674368|NCT00603837|Hypothermia|hypothermia
5674369|NCT00603837|Prevention|prevention
5674370|NCT00603837|ELGANs(Extremely low gestational age neonates)|elgans(extremely low gestational age neonates)
5674371|NCT00603837|Polyethylene Wrap|polyethylene wrap
5674372|NCT00603837|Sodium Acetate Transport Mattress|sodium acetate transport mattress
5674373|NCT00603824|heparin-Induced thrombocytopenia|heparin-induced thrombocytopenia
5674374|NCT00603824|fondaparinux|fondaparinux
5674388|NCT00603772|Safety when exposed to sunlight|safety when exposed to sunlight
5674389|NCT00603759|COX2 inhibitor|cox2 inhibitor
5674390|NCT00603759|head and neck cancer|head and neck cancer
5674391|NCT00603759|chemoradiation|chemoradiation
5674392|NCT00603746|Adolescents|adolescents
5674393|NCT00603746|Adults|adults
5674394|NCT00603746|Asthma|asthma
5674395|NCT00603746|Pharmacokinetics|pharmacokinetics
5888751|NCT04153149|ATTR|attr
5888752|NCT04153149|Cardiomyopathy|cardiomyopathy
5888753|NCT04153149|Amyloidosis|amyloidosis
5888754|NCT04153149|TTR|ttr
5888755|NCT04153149|Transthyretin|transthyretin
5888756|NCT04153149|TTR-mediated amyloidosis|ttr-mediated amyloidosis
5888757|NCT04153149|Amyloidosis, Hereditary|amyloidosis, hereditary
5888758|NCT04153149|Amyloidosis, Hereditary, Transthyretin-Related|amyloidosis, hereditary, transthyretin-related
5888759|NCT04153149|Familial Amyloidosis|familial amyloidosis
5888760|NCT04153149|RNAi therapeutic|rnai therapeutic
5888761|NCT04153149|Transthyretin amyloid cardiomyopathy|transthyretin amyloid cardiomyopathy
5888762|NCT04153149|TTR cardiomyopathy|ttr cardiomyopathy
5888763|NCT04153149|ATTR-CM|attr-cm
5888764|NCT04153149|Wild-type TTR|wild-type ttr
5888765|NCT04153149|V122I|v122i
5888766|NCT04153149|TTR amyloidosis|ttr amyloidosis
5888767|NCT04153149|Amyloidosis, Wild Type|amyloidosis, wild type
4958080|NCT04250805|Lidocaine|lidocaine
5674396|NCT00603746|Pharmacogenetics|pharmacogenetics
5674397|NCT00603746|GW685698X|gw685698x
5674398|NCT00603733|Ulcerative Colitis|ulcerative colitis
5674399|NCT00603733|5-Aminosalicylate|5-aminosalicylate
5674400|NCT00603720|PET|pet
5674401|NCT00603720|Heart metabolism|heart metabolism
5674402|NCT00603720|Nitric oxide|nitric oxide
5674403|NCT00603720|Myocardial remodeling|myocardial remodeling
5674404|NCT00603707|capsule|capsule
5674405|NCT00603707|constipation|constipation
5674406|NCT00603707|whole gut transit|whole gut transit
5674407|NCT00603707|colonic transit|colonic transit
5674408|NCT00603707|gastric emptying|gastric emptying
5674409|NCT00603707|small bowel transit|small bowel transit
5674410|NCT00603694|Hippocampus|hippocampus
5674411|NCT00603694|Memory|memory
5674412|NCT00603694|Radiation|radiation
5674413|NCT00603681|constipation|constipation
5674414|NCT00603681|aged|aged
5674415|NCT00603681|polyethylene glycol|polyethylene glycol
5674416|NCT00603668|CLL|cll
5674417|NCT00603655|Diet|diet
5674418|NCT00603655|glycemic load|glycemic load
5674419|NCT00603655|overweight|overweight
5674420|NCT00603655|obesity|obesity
5674421|NCT00603655|hyperlipidemia|hyperlipidemia
5674422|NCT00603642|AMG 531|amg 531
5674423|NCT00603642|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5674424|NCT00603642|ITP|itp
5674425|NCT00603642|Thrombocytopenia|thrombocytopenia
5674426|NCT00603642|Japan|japan
5674427|NCT00603642|Placebo controlled|placebo controlled
5674428|NCT00603642|Phase 3|phase 3
5674429|NCT00603629|Acute Asthma|acute asthma
5674430|NCT00603616|Inflammatory Bowel Disease|inflammatory bowel disease
5674431|NCT00603616|Crohn disease|crohn disease
5674432|NCT00603616|Crohn's disease|crohn's disease
5674433|NCT00603616|Rifaximin|rifaximin
5674434|NCT00603603|C-section|c-section
5674435|NCT00603603|Surg Wound Infect|surg wound infect
5674436|NCT00603590|Cardiovascular disease|cardiovascular disease
5674437|NCT00603590|primary prevention|primary prevention
5674438|NCT00603590|Polypill|polypill
5674439|NCT00603590|efficacy|efficacy
5674442|NCT00603590|Diabetes|diabetes
5674443|NCT00603590|Adherence|adherence
5674444|NCT00603590|Compliance|compliance
5674445|NCT00603564|CPAP|cpap
5674446|NCT00603564|community-acquired pneumonia|community-acquired pneumonia
5888813|NCT04150341|Asthma|asthma
5888814|NCT04150341|Proof of concept|proof of concept
5888815|NCT04150276|Oxygenation|oxygenation
5888816|NCT04150276|Positive end-expiratory pressure|positive end-expiratory pressure
5888817|NCT04150276|General anaesthesia|general anaesthesia
5888818|NCT04150276|Obesity|obesity
5888819|NCT04150276|Atelectasis|atelectasis
5888820|NCT04150276|Mechanical ventilation|mechanical ventilation
5888867|NCT04146077|prostate cancer|prostate cancer
5888868|NCT04146077|active surveillance|active surveillance
5888869|NCT04146077|low oncological risk|low oncological risk
5674447|NCT00603564|acute respiratory failure|acute respiratory failure
5674448|NCT00603564|hypoxemia|hypoxemia
5674449|NCT00603564|Continuous Positive Airway Pressure|continuous positive airway pressure
5674450|NCT00603551|Osteoporosis|osteoporosis
5674451|NCT00603551|Cancer|cancer
5674452|NCT00603551|Chemotherapy|chemotherapy
5674453|NCT00603551|Bone Density|bone density
5674454|NCT00603551|DXA Scan|dxa scan
5674455|NCT00603551|Heel Scan|heel scan
5674456|NCT00603538|CP-751,871, Non-small cell lung cancer, Phase 1|cp-751,871, non-small cell lung cancer, phase 1
5674457|NCT00603512|Phase II MTX add-on study in Japan|phase ii mtx add-on study in japan
5674458|NCT00603499|Diabetes|diabetes
5674459|NCT00603499|Hypertension|hypertension
5674460|NCT00603499|Hypomagnesemia|hypomagnesemia
5674461|NCT00603486|Non-invasive Blood Pressure (NIBP)|non-invasive blood pressure (nibp)
5674462|NCT00603486|GE Dinamap|ge dinamap
5674463|NCT00603486|SuperSTAT|superstat
5674464|NCT00603460|Ovarian Cancer|ovarian cancer
5674465|NCT00603460|Peritoneal Cancer|peritoneal cancer
5674466|NCT00603434|Methamphetamine|methamphetamine
5674467|NCT00603421|borderline personality disorder|borderline personality disorder
5674468|NCT00603421|suicide|suicide
5674469|NCT00603421|suicidality|suicidality
5674470|NCT00603421|suicide attempt|suicide attempt
5674471|NCT00603421|suicidal behavior|suicidal behavior
5674472|NCT00603421|self-injurious behavior|self-injurious behavior
5674473|NCT00603421|self-harm behavior|self-harm behavior
5674474|NCT00603421|suicide prevention center|suicide prevention center
5674475|NCT00603421|telephone intervention|telephone intervention
5674476|NCT00603408|Breast Cancer|breast cancer
5674477|NCT00603408|Locally Advanced|locally advanced
5674478|NCT00603408|Neoadjuvant|neoadjuvant
5674479|NCT00603382|Adults|adults
5674480|NCT00603382|Pharmacokinetics|pharmacokinetics
5674481|NCT00603382|Pharmacogenetics|pharmacogenetics
5674482|NCT00603382|Asthma|asthma
5674483|NCT00603382|Adolescents|adolescents
5674484|NCT00603382|GW685698X|gw685698x
5674485|NCT00603369|HIV prevention|hiv prevention
5674486|NCT00603369|HIV seronegativity|hiv seronegativity
5674487|NCT00603356|GIST|gist
5674488|NCT00603356|Ovarian Cancer|ovarian cancer
5674489|NCT00603356|Mesothelioma|mesothelioma
5674490|NCT00603356|Renal|renal
5674491|NCT00603356|Colorectal Cancer|colorectal cancer
5674492|NCT00603356|Sarcoma|sarcoma
5674493|NCT00603356|NSCLC|nsclc
5674494|NCT00603356|Cancer|cancer
5674505|NCT00603330|Hematopoietic cell transplantation recipients|hematopoietic cell transplantation recipients
5674506|NCT00603330|Low donor T-cell chimerism|low donor t-cell chimerism
5674507|NCT00603317|Warfarin|warfarin
5674508|NCT00603317|Drug interaction|drug interaction
5674509|NCT00603317|Pharmacogenetics|pharmacogenetics
5674510|NCT00603317|Amoxicillin|amoxicillin
5674511|NCT00603317|Clavulanic acid|clavulanic acid
5674512|NCT00603304|Serenoa repens|serenoa repens
5674513|NCT00603304|Urological symptoms|urological symptoms
5674514|NCT00603304|hyperplasia|hyperplasia
5674516|NCT00603291|obesity|obesity
5674517|NCT00603291|weight loss|weight loss
5674518|NCT00603291|lorcaserin|lorcaserin
5674519|NCT00603291|APD356|apd356
5674520|NCT00603291|BLOOM-DM|bloom-dm
5674521|NCT00603291|hypertension|hypertension
5674522|NCT00603291|dyslipidemia|dyslipidemia
5674523|NCT00603291|sleep apnea|sleep apnea
5674524|NCT00603291|glucose tolerance|glucose tolerance
5674525|NCT00603291|cardiovascular disease|cardiovascular disease
5674526|NCT00603291|Arena|arena
5674527|NCT00603278|Adolescents|adolescents
5674528|NCT00603278|Adults|adults
5674529|NCT00603278|Pharmacokinetics|pharmacokinetics
5674530|NCT00603278|Asthma|asthma
5674531|NCT00603278|GW685698X|gw685698x
5674532|NCT00603278|Pharmacogenetics|pharmacogenetics
5674533|NCT00603265|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5888870|NCT04145895|Post-operative activity restriction|post-operative activity restriction
5888871|NCT04145895|Pediatric inguinal hernia repair|pediatric inguinal hernia repair
5888872|NCT04145895|Pediatric laparoscopic appendectomy|pediatric laparoscopic appendectomy
5888883|NCT04145011|Randomized clinical trial|randomized clinical trial
5888944|NCT04140929|oral hygiene|oral hygiene
5888945|NCT04140929|quality of life|quality of life
5888946|NCT04140929|health services research|health services research
5888947|NCT04140656|elderly|elderly
5888948|NCT04140656|balance|balance
5888949|NCT04140656|falling|falling
5888950|NCT04140656|plantar sensitivity|plantar sensitivity
5888951|NCT04140656|insole|insole
4958276|NCT04249505|photoscreening|photoscreening
5674534|NCT00603265|Neuropathic Pain|neuropathic pain
5674535|NCT00603252|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5674536|NCT00603252|risk factors|risk factors
5674537|NCT00603239|diabetes|diabetes
5674538|NCT00603239|exenatide|exenatide
5674539|NCT00603239|metformin|metformin
5674540|NCT00603239|thiazolidinedione|thiazolidinedione
5674541|NCT00603239|Byetta|byetta
5674542|NCT00603239|Amylin|amylin
5674543|NCT00603239|Lilly|lilly
5674544|NCT00603226|Coronary slow flow phenomenon|coronary slow flow phenomenon
5674545|NCT00603226|Coronary angiography|coronary angiography
5674546|NCT00603226|Acute coronary syndrome|acute coronary syndrome
5674547|NCT00603226|Chest pain|chest pain
5674548|NCT00603226|Unstable angina|unstable angina
5674549|NCT00603213|Congestive Heart Failure|congestive heart failure
5674550|NCT00603213|Impedance|impedance
5674733|NCT00602160|Investigational new drug|investigational new drug
5674551|NCT00603213|Optivol Thoracid Fluid Status monitoring system|optivol thoracid fluid status monitoring system
5674552|NCT00603200|Quality of Life|quality of life
5674553|NCT00603187|Male Contraception|male contraception
5674555|NCT00603174|NAVA|nava
5674556|NCT00603174|mechanical ventilation|mechanical ventilation
5674557|NCT00603174|infants|infants
5674558|NCT00603174|pediatric intensive care|pediatric intensive care
5674559|NCT00603174|infant|infant
5674560|NCT00603148|Genetic Polymorphism|genetic polymorphism
5674561|NCT00603148|Integrin alpha2beta1|integrin alpha2beta1
5674562|NCT00603148|Phenotype|phenotype
5674563|NCT00603122|altitude illness|altitude illness
5674564|NCT00603122|hypoxia|hypoxia
5669213|NCT00624520|Death, Sudden Cardiac|death, sudden cardiac
5674565|NCT00603109|Body weight, fat mass, growth hormone, ghrelin|body weight, fat mass, growth hormone, ghrelin
5674566|NCT00603083|Hip Arthroplasty|hip arthroplasty
5674567|NCT00603083|Treatment Outcome|treatment outcome
5674568|NCT00603083|Local Anesthesia|local anesthesia
5674569|NCT00603070|Medication Errors|medication errors
5674570|NCT00603070|Adverse Drug Events|adverse drug events
5674571|NCT00603070|Patient Safety|patient safety
5674572|NCT00603070|Electronic Prescribing Systems|electronic prescribing systems
5674573|NCT00603070|Medication Reconciliation|medication reconciliation
5674574|NCT00603057|Non Small Cell Lung Cancer|non small cell lung cancer
5674575|NCT00603018|eating disorders|eating disorders
5674576|NCT00603018|anorexia nervosa|anorexia nervosa
5674577|NCT00603018|anorexia|anorexia
5674579|NCT00603018|brain imaging|brain imaging
5674580|NCT00603018|serotonin|serotonin
5674581|NCT00603018|fMRI|fmri
5674582|NCT00603018|Prozac|prozac
5674583|NCT00603018|fluoxetine|fluoxetine
5674584|NCT00603005|Glaucoma|glaucoma
5674585|NCT00603005|Adherence|adherence
5674586|NCT00602992|3T MRI|3t mri
5674587|NCT00602992|Gamma Knife Radiosurgery|gamma knife radiosurgery
5674588|NCT00602979|endotracheal intubation|endotracheal intubation
5674589|NCT00602979|intubation|intubation
5674590|NCT00602979|laryngoscopy|laryngoscopy
5889000|NCT04135287|GLP-1 RA|glp-1 ra
5889001|NCT04134884|Breast Cancer|breast cancer
5889002|NCT04134884|Phase 1|phase 1
5889035|NCT04132323|sclerotherapy, hypertonic glucose, sodium tetradecyl sulfate|sclerotherapy, hypertonic glucose, sodium tetradecyl sulfate
5889054|NCT04129502|Drug Therapy|drug therapy
5674591|NCT00602979|laryngoscope|laryngoscope
5674592|NCT00602979|surgery|surgery
5674593|NCT00602966|Oocyte cryopreservation|oocyte cryopreservation
5674594|NCT00602966|slow freeze|slow freeze
5674595|NCT00602966|vitrification|vitrification
5674596|NCT00602940|PCOS|pcos
5674597|NCT00602940|ovulation|ovulation
5674598|NCT00602940|hormones|hormones
5674599|NCT00602940|women|women
5674600|NCT00602927|Varenicline, Imaging, fMRI|varenicline, imaging, fmri
5674601|NCT00602914|MicronJet (microneedles)|micronjet (microneedles)
5674602|NCT00602914|Intradermal|intradermal
5674603|NCT00602862|Angiogenesis inhibitors|angiogenesis inhibitors
5674604|NCT00602836|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5674605|NCT00602836|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5674606|NCT00602836|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5674607|NCT00602836|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5674609|NCT00602836|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5674610|NCT00602836|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5674611|NCT00602836|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5674612|NCT00602836|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5674613|NCT00602836|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5674615|NCT00602758|Adherence|adherence
5674616|NCT00602758|Antiretroviral Therapy|antiretroviral therapy
5674617|NCT00602758|HIV|hiv
5674618|NCT00602745|pancreatic cancer|pancreatic cancer
5674619|NCT00602732|Partner Abuse|partner abuse
5674620|NCT00602732|Preventive Intervention|preventive intervention
5674621|NCT00602732|Postpartum Depression|postpartum depression
5674622|NCT00602732|Postpartum PTSD|postpartum ptsd
5674623|NCT00602706|refractory multiple myeloma|refractory multiple myeloma
5674624|NCT00602706|stage I multiple myeloma|stage i multiple myeloma
5674625|NCT00602706|stage II multiple myeloma|stage ii multiple myeloma
5674626|NCT00602706|stage III multiple myeloma|stage iii multiple myeloma
5674627|NCT00602693|chronic myelogenous leukemia|chronic myelogenous leukemia
5674628|NCT00602693|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5674629|NCT00602693|prolymphocytic leukemia|prolymphocytic leukemia
5674630|NCT00602693|advanced chronic lymphocytic leukemia|advanced chronic lymphocytic leukemia
5674631|NCT00602693|small lymphocytic lymphoma|small lymphocytic lymphoma
5674632|NCT00602693|B-cell lymphoma|b-cell lymphoma
5674633|NCT00602693|follicular lymphoma|follicular lymphoma
5674634|NCT00602693|diffuse large cell lymphoma|diffuse large cell lymphoma
5674635|NCT00602693|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5674636|NCT00602693|Hodgkin lymphoma|hodgkin lymphoma
5674637|NCT00602693|multiple myeloma|multiple myeloma
5674638|NCT00602680|Alzheimer|alzheimer
5674639|NCT00602680|cognitive|cognitive
5674640|NCT00602667|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5674641|NCT00602667|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5674734|NCT00602160|Herbs|herbs
5674642|NCT00602667|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5674643|NCT00602667|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5674644|NCT00602667|childhood choroid plexus tumor|childhood choroid plexus tumor
5674645|NCT00602667|childhood high grade glioma|childhood high grade glioma
5674646|NCT00602667|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5674647|NCT00602628|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5674648|NCT00602628|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5674649|NCT00602628|breast cancer in situ|breast cancer in situ
5674650|NCT00602628|stage I breast cancer|stage i breast cancer
5674651|NCT00602628|stage II breast cancer|stage ii breast cancer
5674652|NCT00602628|stage IIIA breast cancer|stage iiia breast cancer
5674653|NCT00602602|stage IV pancreatic cancer|stage iv pancreatic cancer
5674654|NCT00602602|recurrent pancreatic cancer|recurrent pancreatic cancer
5674655|NCT00602589|open-label|open-label
5674656|NCT00602589|randomized|randomized
5674657|NCT00602589|crossover|crossover
5674658|NCT00602589|bioequivalence|bioequivalence
5674659|NCT00602576|recurrent melanoma|recurrent melanoma
5674660|NCT00602576|stage III melanoma|stage iii melanoma
5674661|NCT00602576|stage IV melanoma|stage iv melanoma
5889075|NCT04128475|Cardiovascular events|cardiovascular events
5889076|NCT04128475|Coronary heart disease|coronary heart disease
5889077|NCT04128475|Cardiovascular death|cardiovascular death
5889078|NCT04128475|Low density lipoprotein cholesterol (LDL-c)|low density lipoprotein cholesterol (ldl-c)
5889079|NCT04128475|Evolocumab|evolocumab
5889080|NCT04128475|FOURIER OUTCOMES|fourier outcomes
5889091|NCT04126057|Myopia|myopia
5889093|NCT04125836|Acromegaly|acromegaly
5889094|NCT04125836|octreotide|octreotide
5889095|NCT04125836|CAM2029|cam2029
5889096|NCT04125836|phase 3|phase 3
5889102|NCT04125095|Proton therapy, Children and adolescents, Image guidance, Setup uncertainty|proton therapy, children and adolescents, image guidance, setup uncertainty
5889106|NCT04124926|Erosive Esophagitis|erosive esophagitis
5889107|NCT04124926|Vonoprazan|vonoprazan
5889108|NCT04124926|Lansoprazole|lansoprazole
5889109|NCT04124757|Laparoscopy|laparoscopy
5889144|NCT04121221|Multiple Sclerosis|multiple sclerosis
5889145|NCT04121221|RMS|rms
5889146|NCT04121221|GA Depot|ga depot
5889147|NCT04121221|Multiple Sclerosis, Relapsing-Remitting|multiple sclerosis, relapsing-remitting
5674662|NCT00602563|Generalized Anxiety Disorder|generalized anxiety disorder
5674663|NCT00602563|Information Processing|information processing
5674665|NCT00602537|Bipolar Type II Disorder|bipolar type ii disorder
5674666|NCT00602537|Hypomania|hypomania
5674667|NCT00602537|Antidepressant|antidepressant
5674668|NCT00602537|Mood Stabilizer|mood stabilizer
5674669|NCT00602537|Venlafaxine|venlafaxine
5674670|NCT00602537|Lithium Carbonate|lithium carbonate
5674671|NCT00602537|Major Depressive Episode|major depressive episode
5674672|NCT00602537|Hypomanic Episodes|hypomanic episodes
5674679|NCT00602511|Bortezomib|bortezomib
5674680|NCT00602511|Randomized clinical trial|randomized clinical trial
5674681|NCT00602485|adherence, cardiac rehabilitation|adherence, cardiac rehabilitation
5674682|NCT00602446|iron overload|iron overload
5674683|NCT00602433|advanced nonsmall cell lung cancer|advanced nonsmall cell lung cancer
5674685|NCT00602420|musculoskeletal complications|musculoskeletal complications
5674686|NCT00602420|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5674687|NCT00602368|cervical cancer|cervical cancer
5674688|NCT00602368|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5674689|NCT00602368|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5675225|NCT00600275|BGT226|bgt226
5674690|NCT00602368|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5674692|NCT00602355|Depression|depression
5674693|NCT00602355|Medication Therapy|medication therapy
5674694|NCT00602355|Zoloft|zoloft
5674695|NCT00602355|Sertraline|sertraline
5674696|NCT00602355|Interpersonal Psychotherapy|interpersonal psychotherapy
5674697|NCT00602329|recurrent colon cancer|recurrent colon cancer
5674698|NCT00602329|recurrent rectal cancer|recurrent rectal cancer
5674699|NCT00602329|stage III colon cancer|stage iii colon cancer
5674700|NCT00602329|stage III rectal cancer|stage iii rectal cancer
5674701|NCT00602329|stage IV colon cancer|stage iv colon cancer
5674702|NCT00602329|stage IV rectal cancer|stage iv rectal cancer
5674703|NCT00602329|adenocarcinoma of the colon|adenocarcinoma of the colon
5674704|NCT00602329|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5674705|NCT00602316|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5889161|NCT04119050|M281|m281
5889162|NCT04119050|wAIHA|waiha
5889163|NCT04119050|Nipocalimab|nipocalimab
5889174|NCT04118075|aGVHD, cGVHD, PT-CY|agvhd, cgvhd, pt-cy
5889193|NCT04114487|Cognitive rehabilitation|cognitive rehabilitation
5889194|NCT04114487|Dual task|dual task
5889195|NCT04114487|Balance|balance
5889196|NCT04114487|Motor skills|motor skills
5889199|NCT04112849|Heart Failure|heart failure
5889221|NCT04111302|hemorrhoidectiomy|hemorrhoidectiomy
5889222|NCT04111302|postoperative pain|postoperative pain
5889223|NCT04111302|auricular pressure|auricular pressure
5889224|NCT04111263|Microbiome|microbiome
5889225|NCT04111263|Intestinal permeability|intestinal permeability
5889226|NCT04111263|Cognition|cognition
5889227|NCT04111263|Immune|immune
5889228|NCT04111263|Fiber|fiber
5889229|NCT04111263|Military|military
5889230|NCT04111263|Altitude|altitude
5889231|NCT04111263|Polyphenol|polyphenol
5889240|NCT04109482|CD123 CAR-T|cd123 car-t
5889241|NCT04109482|AML|aml
5889242|NCT04109482|BPDCN|bpdcn
5889243|NCT04109482|high risk MDS|high risk mds
5889244|NCT04109482|blastic plasmacytoid dendridic cell neoplasm|blastic plasmacytoid dendridic cell neoplasm
5005998|NCT03959215|Knee injuries|knee injuries
5674706|NCT00602316|stage IA breast cancer|stage ia breast cancer
5674707|NCT00602316|stage IB breast cancer|stage ib breast cancer
5674708|NCT00602316|stage II breast cancer|stage ii breast cancer
5674709|NCT00602316|stage IIIA breast cancer|stage iiia breast cancer
5674710|NCT00602290|Major Depression|major depression
5674711|NCT00602290|Geriatric Major Unipolar Depression|geriatric major unipolar depression
5674712|NCT00602290|Executive Cognitive Dysfunction|executive cognitive dysfunction
5674713|NCT00602290|Elderly|elderly
5674714|NCT00602290|Geriatric|geriatric
5674715|NCT00602290|Executive Cognitive Impairment|executive cognitive impairment
5674716|NCT00602290|Quality of Life|quality of life
5674717|NCT00602290|Disability|disability
5674718|NCT00602290|Comorbidity|comorbidity
5674719|NCT00602290|Medical Burden|medical burden
5674720|NCT00602290|Safety|safety
5674721|NCT00602290|Candidate Genes|candidate genes
5674722|NCT00602264|Anorexia nervosa|anorexia nervosa
5674723|NCT00602264|Adipokines|adipokines
5674724|NCT00602264|Ghrelin|ghrelin
5674725|NCT00602264|Fat mass|fat mass
5674726|NCT00602212|generalized anxiety disorder (GAD)|generalized anxiety disorder (gad)
5674727|NCT00602199|stage IV melanoma|stage iv melanoma
5674728|NCT00602186|female voiding dysfunction|female voiding dysfunction
5674729|NCT00602186|Tamsolusin|tamsolusin
5674730|NCT00602186|prazosin|prazosin
5674731|NCT00602160|Food allergy|food allergy
5674732|NCT00602160|Chinese Herbs|chinese herbs
5675069|NCT00600964|obatoclax|obatoclax
5674735|NCT00602160|Therapeutic medicine|therapeutic medicine
5303766|NCT02158546|ALKS 5461|alks 5461
5674736|NCT00602160|Traditional Chinese medicine|traditional chinese medicine
5674738|NCT00602147|stage I multiple myeloma|stage i multiple myeloma
5674739|NCT00602147|stage II multiple myeloma|stage ii multiple myeloma
5674740|NCT00602147|stage III multiple myeloma|stage iii multiple myeloma
5674741|NCT00602147|refractory multiple myeloma|refractory multiple myeloma
5674742|NCT00602108|stage I breast cancer|stage i breast cancer
5889317|NCT04102007|Plaque Psoriasis|plaque psoriasis
5889318|NCT04102007|Risankizumab|risankizumab
5889319|NCT04102007|Secukinumab|secukinumab
5889320|NCT04102007|Ixekizumab|ixekizumab
5889321|NCT04102007|Psoriasis|psoriasis
5889322|NCT04102007|Biologic|biologic
5674743|NCT00602108|stage II breast cancer|stage ii breast cancer
5674744|NCT00602095|Labor induction|labor induction
5674745|NCT00602095|cervical ripening|cervical ripening
5674746|NCT00602095|misoprostol|misoprostol
5674747|NCT00602095|dinoprostone|dinoprostone
5674748|NCT00602095|balloon catheter|balloon catheter
5674749|NCT00602095|prostaglandin|prostaglandin
5674750|NCT00602082|pancreatic alpha cell adenoma|pancreatic alpha cell adenoma
5674751|NCT00602082|pancreatic alpha cell carcinoma|pancreatic alpha cell carcinoma
5674752|NCT00602082|pancreatic beta islet cell adenoma|pancreatic beta islet cell adenoma
5674753|NCT00602082|pancreatic beta islet cell carcinoma|pancreatic beta islet cell carcinoma
5674754|NCT00602082|pancreatic delta cell adenoma|pancreatic delta cell adenoma
5674755|NCT00602082|pancreatic delta cell carcinoma|pancreatic delta cell carcinoma
5674756|NCT00602082|pancreatic G-cell adenoma|pancreatic g-cell adenoma
5674757|NCT00602082|pancreatic G-cell carcinoma|pancreatic g-cell carcinoma
5674759|NCT00602082|insulinoma|insulinoma
5674760|NCT00602082|glucagonoma|glucagonoma
5674761|NCT00602082|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5674762|NCT00602082|somatostatinoma|somatostatinoma
5674763|NCT00602082|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5674764|NCT00602082|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5674765|NCT00602082|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5674766|NCT00602082|islet cell carcinoma|islet cell carcinoma
5674767|NCT00602082|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5674768|NCT00602069|PTSD|ptsd
5674769|NCT00602069|Intimate Partner Violence|intimate partner violence
5674770|NCT00602069|Cognitive Behavioral Therapy|cognitive behavioral therapy
5674771|NCT00602069|Empowerment|empowerment
5674772|NCT00602056|Immunization dropout|immunization dropout
5674773|NCT00602056|Immunization card|immunization card
5674774|NCT00602056|Center based education|center based education
5674775|NCT00602030|lung cancer|lung cancer
5674776|NCT00602030|NSCLC|nsclc
5674777|NCT00602030|lung neoplasms|lung neoplasms
5674778|NCT00602030|respiratory|respiratory
5674779|NCT00602004|Arteriovenous fistula|arteriovenous fistula
5674780|NCT00602004|hypertrophy|hypertrophy
5674781|NCT00602004|losartan|losartan
5674782|NCT00601991|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5674783|NCT00601991|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5674784|NCT00601978|Parkinson's disease|parkinson's disease
5674785|NCT00601978|carbidopa/levodopa/entacapone|carbidopa/levodopa/entacapone
5674786|NCT00601978|carbidopa/levodopa|carbidopa/levodopa
5674787|NCT00601978|non-motor symptoms|non-motor symptoms
5674788|NCT00601978|event-related potential|event-related potential
5674790|NCT00601978|EEG|eeg
5674791|NCT00601978|electroencephalogram|electroencephalogram
5674792|NCT00601952|post traumatic stress disorder|post traumatic stress disorder
5674793|NCT00601952|cognitive bias|cognitive bias
5674794|NCT00601952|attention|attention
5674795|NCT00601952|combat|combat
5674796|NCT00601939|Abused|abused
5674797|NCT00601939|Female|female
5674798|NCT00601939|African American|african american
5674799|NCT00601939|Group Empowerment Psychoeducational Intervention|group empowerment psychoeducational intervention
5674800|NCT00601939|Enhanced Treatment as Usual|enhanced treatment as usual
5674801|NCT00601926|papillary renal cell carcinoma|papillary renal cell carcinoma
5674802|NCT00601926|stage III renal cell cancer|stage iii renal cell cancer
5674803|NCT00601926|stage IV renal cell cancer|stage iv renal cell cancer
5674804|NCT00601913|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5674805|NCT00601913|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5674806|NCT00601913|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5674807|NCT00601913|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5674808|NCT00601913|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5674809|NCT00601913|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5674810|NCT00601913|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5674811|NCT00601913|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5674812|NCT00601913|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5798793|NCT00111046|Choroidal melanoma|choroidal melanoma
5309027|NCT02133963|sleep|sleep
5889346|NCT04098198|Inborn Error of Metabolism|inborn error of metabolism
5889362|NCT04097002|Prostate cancer|prostate cancer
5889363|NCT04097002|Intratumoral|intratumoral
5889364|NCT04097002|ORCA|orca
5889365|NCT04097002|Adenovirus|adenovirus
5889366|NCT04097002|Localized Prostate cancer|localized prostate cancer
5889367|NCT04097002|Intraprostatic|intraprostatic
5889374|NCT04096157|Cresemba|cresemba
5889375|NCT04096157|isavuconazonium sulfate|isavuconazonium sulfate
5889376|NCT04096157|isavuconazole|isavuconazole
5889379|NCT04095104|Pilot|pilot
5889380|NCT04095104|Feasibility|feasibility
5889381|NCT04095104|Initial Efficacy|initial efficacy
5889382|NCT04095104|Randomized Controlled Trial|randomized controlled trial
5889415|NCT04092816|Parenting|parenting
5889419|NCT04091984|donor-derived cfDNA|donor-derived cfdna
5889425|NCT04091295|tumor targeted gene therapy|tumor targeted gene therapy
5889426|NCT04091295|human cyclin G1 inhibitor|human cyclin g1 inhibitor
5889427|NCT04091295|cell cycle control|cell cycle control
5889428|NCT04091295|CCNG1 inhibitor|ccng1 inhibitor
5674813|NCT00601913|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5674814|NCT00601913|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5674816|NCT00601848|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5674901|NCT00601406|stage III cervical cancer|stage iii cervical cancer
5674817|NCT00601848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5674818|NCT00601848|malignant pleural effusion|malignant pleural effusion
5674819|NCT00601835|Diphtheria|diphtheria
5674820|NCT00601835|Tetanus|tetanus
5674821|NCT00601809|Gastrointestinal|gastrointestinal
5674822|NCT00601809|Adhesive Small Intestine Obstruction|adhesive small intestine obstruction
5674823|NCT00601809|Oral water soluble contrast|oral water soluble contrast
5674824|NCT00601809|Non-operative Conservative Management|non-operative conservative management
5674825|NCT00601809|Operative rate|operative rate
5674826|NCT00601809|Hospital stay|hospital stay
5674827|NCT00601796|adenocarcinoma of the lung|adenocarcinoma of the lung
5674828|NCT00601796|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5674829|NCT00601757|Preventive Intervention|preventive intervention
5674830|NCT00601757|Postpartum Depression|postpartum depression
5674831|NCT00601757|Women on Public Assistance|women on public assistance
5674832|NCT00601744|Orbital Exenteration|orbital exenteration
5674833|NCT00601744|Eye Cancer|eye cancer
5674834|NCT00601744|Social-Psychological Aspects|social-psychological aspects
5674835|NCT00601744|Quality of Life|quality of life
5674836|NCT00601744|Questionnaire|questionnaire
5674837|NCT00601744|Facial Appearance|facial appearance
5674838|NCT00601744|Survey|survey
5674839|NCT00601744|Interview|interview
5674840|NCT00601731|Prevention of Meningococcal disease|prevention of meningococcal disease
5674841|NCT00601705|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5674842|NCT00601705|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5674843|NCT00601705|stage III esophageal cancer|stage iii esophageal cancer
5674844|NCT00601705|stage IV esophageal cancer|stage iv esophageal cancer
5674845|NCT00601705|stage III gastric cancer|stage iii gastric cancer
5674846|NCT00601705|stage IV gastric cancer|stage iv gastric cancer
5674847|NCT00601705|stage II esophageal cancer|stage ii esophageal cancer
5674848|NCT00601705|stage II gastric cancer|stage ii gastric cancer
5674849|NCT00601692|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5674850|NCT00601692|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5674851|NCT00601692|stage II esophageal cancer|stage ii esophageal cancer
5674852|NCT00601692|stage III esophageal cancer|stage iii esophageal cancer
5674853|NCT00601692|stage IV esophageal cancer|stage iv esophageal cancer
5674854|NCT00601679|CHF treatment&prognosis,NT-proBNP testing.|chf treatment&prognosis,nt-probnp testing.
5674855|NCT00601653|Binge Eating Disorder|binge eating disorder
5674856|NCT00601653|BED|bed
5674857|NCT00601653|Nutrition|nutrition
5674858|NCT00601653|Energy Density|energy density
5889458|NCT04089111|Mechanical ventilation|mechanical ventilation
5889459|NCT04089111|Adaptive Support Ventilation|adaptive support ventilation
5889460|NCT04089111|Transpulmonary pressure|transpulmonary pressure
5889461|NCT04089111|Intrinsic PEEP|intrinsic peep
5889478|NCT04087811|LSS|lss
5889482|NCT04087265|transabdominal ultrasound|transabdominal ultrasound
5889483|NCT04087265|bowel preparation|bowel preparation
5889484|NCT04087265|colonoscopy|colonoscopy
5889500|NCT04085991|Radioligand therapy|radioligand therapy
5889501|NCT04085991|PSMA|psma
5889502|NCT04085991|PSMA therapy|psma therapy
5889503|NCT04085991|1095|1095
5889504|NCT04085653|adult, pediatric, BYL719,PIK3CA-Related Overgrowth Spectrum, PIK3CA, Related Overgrowth Spectrum,PROS|adult, pediatric, byl719,pik3ca-related overgrowth spectrum, pik3ca, related overgrowth spectrum,pros
5889522|NCT04083924|Preclinical medical students|preclinical medical students
5889523|NCT04083924|Handheld ultrasound|handheld ultrasound
5889524|NCT04083924|Butterfly iQ|butterfly iq
5889525|NCT04083924|Basic cardiac ultrasound|basic cardiac ultrasound
5889526|NCT04083924|Focused cardiac ultrasound|focused cardiac ultrasound
5889527|NCT04083924|Point of care|point of care
5889528|NCT04083924|Training|training
5889529|NCT04083924|Education|education
5889555|NCT04079790|Healthy adolescent|healthy adolescent
5889560|NCT04078061|Autism Spectrum Disorder|autism spectrum disorder
5889561|NCT04078061|EIBI|eibi
5889562|NCT04078061|ABA|aba
5889584|NCT04076462|Acromegaly|acromegaly
5889585|NCT04076462|octreotide|octreotide
5889586|NCT04076462|CAM2029|cam2029
5889587|NCT04076462|phase 3|phase 3
5889598|NCT04075487|Low back pain|low back pain
5674859|NCT00601653|Cognitive Behavioral Therapy|cognitive behavioral therapy
5674860|NCT00601653|CBT|cbt
5674861|NCT00601640|skin cancer|skin cancer
5674862|NCT00601627|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5674863|NCT00601627|stage II pancreatic cancer|stage ii pancreatic cancer
5674865|NCT00601614|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5674866|NCT00601601|stage 0 cervical cancer|stage 0 cervical cancer
5674867|NCT00601601|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5674868|NCT00601601|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5674869|NCT00601601|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5674870|NCT00601562|HIV|hiv
5674871|NCT00601549|Rectal cancer|rectal cancer
5674872|NCT00601549|CCRT|ccrt
5674873|NCT00601549|Laparoscopic Surgery|laparoscopic surgery
5674874|NCT00601549|rectal cancer can be resected by curative and elective surgery|rectal cancer can be resected by curative and elective surgery
5674875|NCT00601549|rectal adenocarcinoma below peritoneal reflection|rectal adenocarcinoma below peritoneal reflection
5674876|NCT00601549|American Society of Anesthesiology（ASA） classⅠ to Ⅲ lesions|american society of anesthesiology（asa） classⅰ to ⅲ lesions
5674877|NCT00601510|stage III gastric cancer|stage iii gastric cancer
5674878|NCT00601510|stage IV gastric cancer|stage iv gastric cancer
5674879|NCT00601484|Painful Bladder Syndrome, monoclonal antibody|painful bladder syndrome, monoclonal antibody
5674880|NCT00601471|ankle sprain|ankle sprain
5674881|NCT00601471|ankle injuries|ankle injuries
5674882|NCT00601471|sprains and strains|sprains and strains
5674883|NCT00601458|Primary, unilateral, first metatarsal bunionectomy with osteotomy|primary, unilateral, first metatarsal bunionectomy with osteotomy
5674884|NCT00601445|Changes in sleep with aging|changes in sleep with aging
5674885|NCT00601432|open-label|open-label
5674886|NCT00601432|randomized|randomized
5674887|NCT00601432|crossover|crossover
5674888|NCT00601432|food effect|food effect
5674889|NCT00601406|male breast cancer|male breast cancer
5674890|NCT00601406|stage IA breast cancer|stage ia breast cancer
5674891|NCT00601406|stage IB breast cancer|stage ib breast cancer
5674892|NCT00601406|stage II breast cancer|stage ii breast cancer
5674893|NCT00601406|stage I prostate cancer|stage i prostate cancer
5674894|NCT00601406|stage IIB prostate cancer|stage iib prostate cancer
5674895|NCT00601406|stage IIA prostate cancer|stage iia prostate cancer
5674896|NCT00601406|stage III prostate cancer|stage iii prostate cancer
5674897|NCT00601406|stage IA cervical cancer|stage ia cervical cancer
5674898|NCT00601406|stage IB cervical cancer|stage ib cervical cancer
5674899|NCT00601406|stage IIA cervical cancer|stage iia cervical cancer
5674900|NCT00601406|stage IIB cervical cancer|stage iib cervical cancer
5674902|NCT00601406|stage IVA cervical cancer|stage iva cervical cancer
5674903|NCT00601406|stage IVB cervical cancer|stage ivb cervical cancer
5674904|NCT00601406|stage I vaginal cancer|stage i vaginal cancer
5674905|NCT00601406|stage II vaginal cancer|stage ii vaginal cancer
5674906|NCT00601406|stage III vaginal cancer|stage iii vaginal cancer
5674907|NCT00601406|stage IVA vaginal cancer|stage iva vaginal cancer
5674908|NCT00601406|stage IVB vaginal cancer|stage ivb vaginal cancer
5674909|NCT00601406|stage IA vulvar cancer|stage ia vulvar cancer
5674910|NCT00601406|stage IB vulvar cancer|stage ib vulvar cancer
5889642|NCT04069624|MOUD|moud
5889643|NCT04069624|OUD|oud
5889644|NCT04069624|Telehealth|telehealth
5889645|NCT04069624|Navigator|navigator
5889691|NCT04067336|AML|aml
5889692|NCT04067336|Hematological malignancy|hematological malignancy
5889693|NCT04067336|KMT2A|kmt2a
5889694|NCT04067336|NPM1|npm1
5889722|NCT04065074|Osteoarthritis|osteoarthritis
5889723|NCT04065074|Hip|hip
5889724|NCT04065074|Intra-articular|intra-articular
5889725|NCT04065074|Injection|injection
5674911|NCT00601406|stage II vulvar cancer|stage ii vulvar cancer
5674912|NCT00601406|stage IIIC vulvar cancer|stage iiic vulvar cancer
5674913|NCT00601406|stage IIIA vulvar cancer|stage iiia vulvar cancer
5674914|NCT00601406|stage IIIB vulvar cancer|stage iiib vulvar cancer
5674915|NCT00601406|stage IVB vulvar cancer|stage ivb vulvar cancer
5674916|NCT00601406|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5674917|NCT00601406|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5674918|NCT00601406|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5674919|NCT00601406|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5674920|NCT00601406|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5674921|NCT00601406|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5674922|NCT00601406|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5674923|NCT00601406|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5674924|NCT00601406|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5674925|NCT00601406|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5674926|NCT00601406|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5674927|NCT00601406|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5674928|NCT00601406|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5674929|NCT00601406|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5674930|NCT00601406|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5674931|NCT00601406|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5674932|NCT00601406|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5674933|NCT00601406|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5674934|NCT00601406|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5674935|NCT00601406|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5674936|NCT00601406|stage II endometrial carcinoma|stage ii endometrial carcinoma
5674937|NCT00601406|ovarian stromal cancer|ovarian stromal cancer
5674938|NCT00601406|ovarian sarcoma|ovarian sarcoma
5674939|NCT00601406|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5674940|NCT00601406|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5674941|NCT00601406|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5674942|NCT00601406|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5675797|NCT00597610|Rectal|rectal
5674943|NCT00601406|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5674944|NCT00601406|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5674945|NCT00601406|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5674946|NCT00601406|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5674947|NCT00601406|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5674948|NCT00601406|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5674949|NCT00601406|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5674950|NCT00601406|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5674951|NCT00601406|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5674952|NCT00601406|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5674953|NCT00601406|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5674954|NCT00601406|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5674955|NCT00601406|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5674956|NCT00601406|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5674957|NCT00601406|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5674958|NCT00601406|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5674959|NCT00601406|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5674960|NCT00601406|stage IA endometrial carcinoma|stage ia endometrial carcinoma
5674961|NCT00601406|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5674962|NCT00601406|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5889739|NCT04061265|Articaine, local anaesthesia, child, pain|articaine, local anaesthesia, child, pain
5889754|NCT04059588|Solid Tumors|solid tumors
5889755|NCT04059588|Skin lesions|skin lesions
5889756|NCT04059588|Immunotherapy|immunotherapy
5889757|NCT04059588|CD40 antibody|cd40 antibody
5889759|NCT04059588|intratumoral|intratumoral
5889760|NCT04059588|intralesional|intralesional
5889762|NCT04059588|metastasis|metastasis
5889770|NCT04058600|virtual reality (VR)|virtual reality (vr)
5889771|NCT04058600|anxiety|anxiety
5889772|NCT04058600|colorectal cancer|colorectal cancer
5889773|NCT04058600|surgery|surgery
5889779|NCT04058028|Standard of Care therapies|standard of care therapies
5889780|NCT04058028|Oral Corticosteroids|oral corticosteroids
5889781|NCT04058028|Inmunosuppressants|inmunosuppressants
5889782|NCT04058028|Inmunodulators|inmunodulators
5889783|NCT04058028|Systemic Lupus Erythematosus|systemic lupus erythematosus
5889784|NCT04058028|B cell Activating Factor (BAFF)|b cell activating factor (baff)
5889785|NCT04058028|Inducible T cell costimulator ligand (ICOSL)|inducible t cell costimulator ligand (icosl)
5889786|NCT04056715|electrocardiography|electrocardiography
5889787|NCT04056715|electrocardiogram|electrocardiogram
5889788|NCT04056715|mobile cardiac monitoring|mobile cardiac monitoring
5889789|NCT04056715|ambulatory monitoring|ambulatory monitoring
5889790|NCT04056715|ECG|ecg
5889791|NCT04056715|EKG|ekg
5889810|NCT04055805|Aromatase Inhibitors|aromatase inhibitors
5889811|NCT04055805|Bone pathology|bone pathology
5889812|NCT04055805|QoL|qol
5889814|NCT04055272|indoor tanning|indoor tanning
5889815|NCT04055272|skin cancer|skin cancer
5889816|NCT04055272|mobile health|mobile health
5889817|NCT04055272|text messaging|text messaging
5674963|NCT00601406|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5674968|NCT00601406|stage IB uterine sarcoma|stage ib uterine sarcoma
5674969|NCT00601406|stage IC uterine sarcoma|stage ic uterine sarcoma
5674970|NCT00601406|stage IIA uterine sarcoma|stage iia uterine sarcoma
5674971|NCT00601406|stage IIB uterine sarcoma|stage iib uterine sarcoma
5674972|NCT00601406|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
5674973|NCT00601406|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
5674974|NCT00601406|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
5674975|NCT00601406|stage IVA uterine sarcoma|stage iva uterine sarcoma
5674976|NCT00601406|stage IVB uterine sarcoma|stage ivb uterine sarcoma
5674979|NCT00601354|Alli|alli
5674980|NCT00601354|Guided Self-Help|guided self-help
5674981|NCT00601341|arthralgia|arthralgia
5674982|NCT00601341|joint pain|joint pain
5674983|NCT00601341|knee injuries|knee injuries
5674984|NCT00601341|knee joint|knee joint
5674985|NCT00601341|low back pain|low back pain
5674986|NCT00601289|pituitary chromophobe adenoma|pituitary chromophobe adenoma
5674987|NCT00601289|recurrent pituitary tumor|recurrent pituitary tumor
5674988|NCT00601289|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5889885|NCT04050072|Adverse Events|adverse events
4959262|NCT04243720|Molecular Profiling|molecular profiling
4959263|NCT04243720|Liquid Biopsy|liquid biopsy
4959266|NCT04243720|Epigenetics|epigenetics
5674989|NCT00601289|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5674990|NCT00601289|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5674991|NCT00601289|pituitary basophilic adenoma|pituitary basophilic adenoma
5674992|NCT00601289|pituitary eosinophilic adenoma|pituitary eosinophilic adenoma
5674993|NCT00601289|prolactin secreting adenoma|prolactin secreting adenoma
5674994|NCT00601289|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5674995|NCT00601276|pedophilia|pedophilia
5674996|NCT00601276|antiandrogens|antiandrogens
5674997|NCT00601276|gonadotropin releasing hormone agonists|gonadotropin releasing hormone agonists
5674998|NCT00601263|Chinese Herbal Therapy|chinese herbal therapy
5674999|NCT00601263|Asthma|asthma
5675000|NCT00601263|Investigational new drug (IND)|investigational new drug (ind)
5675001|NCT00601263|Complementary and Alternative Medicine|complementary and alternative medicine
5675002|NCT00601237|HIV Prevention|hiv prevention
5675003|NCT00601237|Mobile Phone|mobile phone
5675004|NCT00601237|Technology-Based Intervention|technology-based intervention
5675006|NCT00601237|HIV Seronegativity|hiv seronegativity
5675007|NCT00601224|Social Cognition|social cognition
5675008|NCT00601224|Group Therapy|group therapy
5675009|NCT00601224|Psychosocial Intervention|psychosocial intervention
5675010|NCT00601198|Oxaliplatin-induced Neuropathy|oxaliplatin-induced neuropathy
5675011|NCT00601198|Colon and rectum|colon and rectum
5675012|NCT00601185|06-009|06-009
5675013|NCT00601185|Confocal reflectance microscopy|confocal reflectance microscopy
5675014|NCT00601185|shave-biopsy|shave-biopsy
5675015|NCT00601172|vomiting|vomiting
5675016|NCT00601172|colorectal cancer|colorectal cancer
5675017|NCT00601172|nausea|nausea
5675018|NCT00601172|oxaliplatin|oxaliplatin
5675019|NCT00601159|Metastatic Breast Cancer|metastatic breast cancer
5675020|NCT00601159|triple-negative Breast Cancer|triple-negative breast cancer
5675021|NCT00601159|cisplatin|cisplatin
5675022|NCT00601159|chemotherapy|chemotherapy
5675023|NCT00601146|Hodgkin's disease|hodgkin's disease
5675024|NCT00601146|CT scan|ct scan
5675025|NCT00601133|Solid Tumors|solid tumors
5675026|NCT00601133|Acute Inpatient Rehabilitation|acute inpatient rehabilitation
5675027|NCT00601133|Postural Instability|postural instability
5675028|NCT00601133|Balance|balance
5675029|NCT00601133|Function|function
5675030|NCT00601133|Walking|walking
5675031|NCT00601133|Questionnaire|questionnaire
5675032|NCT00601133|Survey|survey
5675033|NCT00601120|antiangiogenic therapy|antiangiogenic therapy
5675034|NCT00601120|RF ablation|rf ablation
5675035|NCT00601107|psoriasis|psoriasis
5675036|NCT00601107|psoriasis vulgaris|psoriasis vulgaris
5675037|NCT00601107|plaque psoriasis|plaque psoriasis
5675038|NCT00601107|chronic plaque psoriasis|chronic plaque psoriasis
5669915|NCT00621660|Cancer|cancer
5675039|NCT00601094|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5675040|NCT00601094|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5675041|NCT00601094|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5675042|NCT00601081|Very low birth weight infants|very low birth weight infants
5675043|NCT00601081|HMF|hmf
5675044|NCT00601081|immune system function|immune system function
5675045|NCT00601068|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate|osteonecrosis, jaws, bisphosphonate, fosamax, alendronate
5675046|NCT00601055|COPD|copd
5675047|NCT00601055|Geriatric Depression|geriatric depression
5675048|NCT00601055|Problem-Solving Therapy|problem-solving therapy
5675049|NCT00601055|Treatment Adherence|treatment adherence
5675050|NCT00601042|smoking reduction|smoking reduction
5675051|NCT00601042|smoking cessation|smoking cessation
5675052|NCT00601042|randomized trial|randomized trial
5675053|NCT00601042|Swedish snus|swedish snus
5675054|NCT00601042|smokeless tobacco|smokeless tobacco
5675055|NCT00601029|Exertional Rhabdomyolysis|exertional rhabdomyolysis
5675056|NCT00601016|Infantile hemangioma|infantile hemangioma
5675057|NCT00601016|Hemangioma|hemangioma
5675058|NCT00601016|Hemangioma of Infancy|hemangioma of infancy
5675059|NCT00601016|benign tumors of infancy|benign tumors of infancy
5675060|NCT00601016|Congenital hemangioma|congenital hemangioma
5889980|NCT04043819|cellular therapy|cellular therapy
5889981|NCT04043819|stromal vascular fraction|stromal vascular fraction
5889982|NCT04043819|SVF|svf
5889983|NCT04043819|KOOS|koos
5889984|NCT04043819|autologous|autologous
5889985|NCT04043819|mesenchymal stem cell|mesenchymal stem cell
5889986|NCT04043819|MSC|msc
5889987|NCT04043819|knee|knee
5889988|NCT04043819|osteoarthritis|osteoarthritis
5889989|NCT04043819|adipose-derived mesenchymal stem cells|adipose-derived mesenchymal stem cells
5889990|NCT04043819|Ad-MSC|ad-msc
5889991|NCT04043819|intraarticular|intraarticular
5675061|NCT00601016|Capillary|capillary
5675062|NCT00600990|post-operative nausea and vomiting|post-operative nausea and vomiting
5675063|NCT00600990|PONV|ponv
5675064|NCT00600977|ALL|all
5675065|NCT00600977|Chemotherapy|chemotherapy
5675066|NCT00600977|Pharmacokinetics of doxorubicin (pegylated or not)|pharmacokinetics of doxorubicin (pegylated or not)
5675067|NCT00600977|elderly ALL|elderly all
5675068|NCT00600964|CLL|cll
5675070|NCT00600938|iron overload|iron overload
5675071|NCT00600938|cardiac iron|cardiac iron
5675072|NCT00600938|haemosiderosis|haemosiderosis
5675073|NCT00600938|myocardial T2*|myocardial t2*
5675074|NCT00600938|left ventricular ejection fraction|left ventricular ejection fraction
5675076|NCT00600938|cardiac dysfunction|cardiac dysfunction
5675077|NCT00600938|thalassaemia|thalassaemia
5675078|NCT00600938|Diamond Blackfan anemia|diamond blackfan anemia
5675080|NCT00600938|sideroblastic anemia|sideroblastic anemia
5675081|NCT00600938|myelodysplastic syndromes|myelodysplastic syndromes
5675082|NCT00600938|MDS (low and INT-1 risk as per the IPSS for MDS)|mds (low and int-1 risk as per the ipss for mds)
5675083|NCT00600938|liver MRI|liver mri
5675084|NCT00600938|deferasirox|deferasirox
5675085|NCT00600938|deferoxamine|deferoxamine
5675086|NCT00600938|ICL670|icl670
5675087|NCT00600938|DFO|dfo
5675088|NCT00600938|cardiovascular magnetic resonance imaging|cardiovascular magnetic resonance imaging
5675089|NCT00600925|Colorectal surgery|colorectal surgery
5675090|NCT00600912|lipid emulsion|lipid emulsion
5675091|NCT00600912|fish oil|fish oil
5675092|NCT00600912|parenteral nutrition|parenteral nutrition
5675093|NCT00600912|leucotriene LTB5|leucotriene ltb5
5675094|NCT00600912|hepatic function|hepatic function
5675095|NCT00600899|Postoperative pain treatment|postoperative pain treatment
5675096|NCT00600886|Acromegaly,|acromegaly,
5675097|NCT00600886|adult,|adult,
5675098|NCT00600886|growth hormone,|growth hormone,
5675099|NCT00600886|insulin-like growth factor I,|insulin-like growth factor i,
5675100|NCT00600886|somatostatin analogue|somatostatin analogue
5675101|NCT00600873|neuroprotection|neuroprotection
5675102|NCT00600873|oxidative stress|oxidative stress
5675103|NCT00600860|MDS (all IPSS subtypes)|mds (all ipss subtypes)
5675104|NCT00600860|Newly diagnosed|newly diagnosed
5675105|NCT00600847|urticaria|urticaria
5675106|NCT00600847|cold urticaria|cold urticaria
5675107|NCT00600847|acquired cold urticaria|acquired cold urticaria
5675108|NCT00600808|SR-hGH, Pharmacokinetics, Pharmacodynamics|sr-hgh, pharmacokinetics, pharmacodynamics
5675109|NCT00600795|NPH|nph
5675110|NCT00600795|TGF-beta|tgf-beta
5675111|NCT00600782|Tuberculosis vaccine|tuberculosis vaccine
5675112|NCT00600769|MAC|mac
5675113|NCT00600769|NTM|ntm
5675114|NCT00600756|schizophrenia|schizophrenia
5675115|NCT00600756|SWNK|swnk
5675116|NCT00600743|Eating|eating
5675117|NCT00600743|Food Intake|food intake
5675118|NCT00600743|Appetite|appetite
5675119|NCT00600730|fMRi|fmri
5675120|NCT00600730|hypoglycemia|hypoglycemia
5675121|NCT00600717|Magnetoencephalography(MEG)|magnetoencephalography(meg)
5675122|NCT00600717|Electroencephalography (EEG)|electroencephalography (eeg)
5675123|NCT00600717|Intracranial recordings (iEEG/ECoG/SEEG)|intracranial recordings (ieeg/ecog/seeg)
5675124|NCT00600717|Functional Mapping|functional mapping
5675125|NCT00600717|Epilepsy|epilepsy
5675127|NCT00600717|High frequency oscillations (HFOs)|high frequency oscillations (hfos)
5675128|NCT00600717|ripples|ripples
5675129|NCT00600717|fast ripples|fast ripples
5675130|NCT00600717|high-gamma|high-gamma
5675131|NCT00600717|very high frequency oscillations (VHFOs)|very high frequency oscillations (vhfos)
5675132|NCT00600704|Allogenic Blood Use|allogenic blood use
5675133|NCT00600704|Total Blood Loss|total blood loss
5675134|NCT00600704|Reinfusion of Washed Shed Blood|reinfusion of washed shed blood
5675135|NCT00600691|Finasteride|finasteride
5675136|NCT00600691|hematuria|hematuria
5675138|NCT00600691|prostate biopsy|prostate biopsy
5890003|NCT04041037|ACell|acell
5890004|NCT04041037|ACell MicroMatrix®|acell micromatrix®
5890005|NCT04041037|ACell Cytal® Wound Matrix|acell cytal® wound matrix
5890006|NCT04041037|Urinary Bladder Matrix|urinary bladder matrix
5890020|NCT04040023|Red Blood Cell transfusion|red blood cell transfusion
5890021|NCT04040023|Anemia|anemia
5890022|NCT04040023|Iron deficiency|iron deficiency
5890023|NCT04040023|Extracorporeal circulation or Bypass|extracorporeal circulation or bypass
5890024|NCT04040023|Cardiac Surgery|cardiac surgery
5890054|NCT04036682|NSCLC|nsclc
5890055|NCT04036682|EGFR|egfr
5890056|NCT04036682|Exon 20 insertions|exon 20 insertions
5890057|NCT04036682|CLN-081|cln-081
5890058|NCT04036682|TAS6417|tas6417
5675139|NCT00600678|food for special medical purposes|food for special medical purposes
5675140|NCT00600665|Sickle Cell Anemia|sickle cell anemia
5675141|NCT00600665|Sickle Cell Disease|sickle cell disease
5890084|NCT04032990|pediatric-onset|pediatric-onset
5890085|NCT04032990|transcutaneous spinal stimulation|transcutaneous spinal stimulation
5890086|NCT04032990|upper extremity function|upper extremity function
5890105|NCT04028167|Resectable|resectable
5890114|NCT04026308|Suicide|suicide
5890115|NCT04026308|Suicide Prevention|suicide prevention
5890116|NCT04026308|Safety Planning|safety planning
5890117|NCT04026308|My3 App|my3 app
5890121|NCT04026113|Functional constipation in children|functional constipation in children
5890122|NCT04026113|LINZESS|linzess
5890150|NCT04021030|Cognitive Behavioral Therapy|cognitive behavioral therapy
5005999|NCT03959215|Anterior cruciate ligament injuries|anterior cruciate ligament injuries
5006000|NCT03959215|Telemedicine|telemedicine
5675142|NCT00600652|glucocorticoid-receptor|glucocorticoid-receptor
5675143|NCT00600652|flow cytometry|flow cytometry
5675144|NCT00600652|glucocorticoid-resistant|glucocorticoid-resistant
5675145|NCT00600652|prediction|prediction
5675146|NCT00600639|old patients|old patients
5675147|NCT00600639|NIV|niv
5675148|NCT00600639|Intubation|intubation
5675149|NCT00600639|COPD|copd
5675150|NCT00600613|Radiation Therapy|radiation therapy
5675151|NCT00600587|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5675152|NCT00600587|Genes, erbB-1|genes, erbb-1
5675153|NCT00600587|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5675154|NCT00600587|Neoadjuvant Therapy|neoadjuvant therapy
5675155|NCT00600574|fibromyalgia|fibromyalgia
5675156|NCT00600574|physical therapies|physical therapies
5675157|NCT00600574|stretching|stretching
5675158|NCT00600574|Ai Chi|ai chi
5675159|NCT00600561|meditation|meditation
5675160|NCT00600561|mindfulness|mindfulness
5675161|NCT00600561|HIV|hiv
5675162|NCT00600561|CD4|cd4
5675163|NCT00600561|Complementary Therapies|complementary therapies
5675164|NCT00600548|Cutaneous leishmaniasis|cutaneous leishmaniasis
5675165|NCT00600548|Miltefosine|miltefosine
5675166|NCT00600548|Meglumine antimoniate|meglumine antimoniate
5675167|NCT00600548|L. braziliensis, L. guyanensis|l. braziliensis, l. guyanensis
5675168|NCT00600535|Prostate neoplasms|prostate neoplasms
5675169|NCT00600535|Abiraterone acetate|abiraterone acetate
5675170|NCT00600535|CB7630|cb7630
5675171|NCT00600535|Prostate cancer|prostate cancer
5675172|NCT00600535|Pharmacokinetics|pharmacokinetics
5675173|NCT00600522|intraoperative ultrasonography|intraoperative ultrasonography
5675174|NCT00600522|hepatectomy|hepatectomy
5675175|NCT00600522|colorectal liver metastases|colorectal liver metastases
5675176|NCT00600522|hepatocellular carcinoma|hepatocellular carcinoma
5675177|NCT00600522|contrast enhanced intraoperative ultrasonography.|contrast enhanced intraoperative ultrasonography.
5675178|NCT00600509|Levetiracetam|levetiracetam
5675179|NCT00600509|Keppra|keppra
5675180|NCT00600496|ARRY-142886|arry-142886
5675181|NCT00600496|AZD6244|azd6244
5675182|NCT00600496|Cancer|cancer
5675183|NCT00600496|Colon Cancer|colon cancer
5675184|NCT00600496|Breast Cancer|breast cancer
5675185|NCT00600496|Lung Cancer|lung cancer
5675186|NCT00600496|Melanoma|melanoma
5675187|NCT00600496|Kidney Cancer|kidney cancer
5675188|NCT00600483|obesity|obesity
5675189|NCT00600483|diabetes|diabetes
5675190|NCT00600470|Behavior Problems|behavior problems
5675191|NCT00600470|Behavior Disorders|behavior disorders
5675192|NCT00600457|healing time|healing time
5675193|NCT00600457|pain|pain
5675194|NCT00600457|infection|infection
5675195|NCT00600444|permanent venous access|permanent venous access
5675196|NCT00600444|chemotherapy|chemotherapy
5675197|NCT00600444|parenteral nutrition|parenteral nutrition
5670069|NCT00621062|ligation|ligation
5675198|NCT00600444|Patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition|patients with a benign and/or malignant diseases which demand a safe and permanent venous access, e.g. for chemotherapy and/or parenteral nutrition
5675199|NCT00600444|benign diseases|benign diseases
5675200|NCT00600444|malignant diseases|malignant diseases
5675201|NCT00600431|nevus count|nevus count
5675202|NCT00600431|children|children
5675203|NCT00600431|chemotherapy|chemotherapy
5675204|NCT00600418|PTSD|ptsd
5675205|NCT00600418|DYADIC TREATMENT|dyadic treatment
5675206|NCT00600418|WAR AND TERROR|war and terror
5675207|NCT00600418|Posttraumatic symptoms among toddlers|posttraumatic symptoms among toddlers
5675208|NCT00600405|Nephrolithiasis|nephrolithiasis
5675209|NCT00600405|Ureteral Calculi|ureteral calculi
5890187|NCT04017312|Non Cystic Fibrosis Bronchiectasis|non cystic fibrosis bronchiectasis
5890188|NCT04017312|HFCWC|hfcwc
5890189|NCT04017312|High frequency chest wall oscillation|high frequency chest wall oscillation
5890239|NCT04012996|symptomatic cervical disc disease|symptomatic cervical disc disease
5890240|NCT04012996|SCDD|scdd
5890241|NCT04012996|neck pain|neck pain
5890242|NCT04012996|radiculopathy|radiculopathy
5890243|NCT04012996|myelopathy|myelopathy
5890244|NCT04012996|cervical spine pain|cervical spine pain
5675210|NCT00600379|stroke chronic gait deficits virtual reality training|stroke chronic gait deficits virtual reality training
5675211|NCT00600353|nausea|nausea
5675212|NCT00600353|cancer|cancer
5675213|NCT00600353|CINV|cinv
5675214|NCT00600327|Stroke|stroke
5675215|NCT00600327|thrombosis|thrombosis
5675216|NCT00600327|thromboembolic|thromboembolic
5675217|NCT00600327|Transient Ischemic Attack|transient ischemic attack
5675218|NCT00600327|TIA|tia
5675219|NCT00600314|Graft-Versus-Host Disease|graft-versus-host disease
5675220|NCT00600314|Transplantation, Allogeneic|transplantation, allogeneic
5675221|NCT00600314|Transplantation, Hematopoietic Stem Cell|transplantation, hematopoietic stem cell
5675222|NCT00600314|Calorimetry, Respiration|calorimetry, respiration
5675223|NCT00600301|Macula|macula
5675224|NCT00600301|Edema|edema
5675227|NCT00600275|Breast cancer|breast cancer
5675228|NCT00600275|Cowden Syndrome|cowden syndrome
5675229|NCT00600275|Phosphatidylinositol 3'-kinase (PI3K) inhibitor|phosphatidylinositol 3'-kinase (pi3k) inhibitor
5675230|NCT00600275|Advanced solid tumors (including sporadic and Cowden Syndrome) (Phase I part)|advanced solid tumors (including sporadic and cowden syndrome) (phase i part)
5675231|NCT00600275|Advanced breast cancer (including sporadic and Cowden Syndrome) (Phase II part)|advanced breast cancer (including sporadic and cowden syndrome) (phase ii part)
5675232|NCT00600262|severe nonproliferative|severe nonproliferative
5675233|NCT00600262|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5685494|NCT00555854|Multidisciplinary|multidisciplinary
5675234|NCT00600262|active photocoagulated diabetic retinopathy|active photocoagulated diabetic retinopathy
5675235|NCT00600262|intravitreal bevacizumab|intravitreal bevacizumab
5675236|NCT00600249|Breast cancer.|breast cancer.
5675237|NCT00600249|Triple negative.|triple negative.
5675238|NCT00600249|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5675239|NCT00600249|Targeted therapy.|targeted therapy.
5675240|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
5675241|NCT00600236|Diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy|diabetes mellitus type 2 with 10 years of diagnosis and proliferative diabetic retinopathy
5675242|NCT00600171|dose ranging|dose ranging
5675243|NCT00600171|placebo|placebo
5675244|NCT00600171|asthma|asthma
5675245|NCT00600171|safety|safety
5675246|NCT00600171|efficacy|efficacy
5675247|NCT00600171|pharmacokinetics|pharmacokinetics
5675248|NCT00600158|colectomy|colectomy
5675249|NCT00600145|Human volunteers|human volunteers
5675250|NCT00600145|amphetamine dependence|amphetamine dependence
5675251|NCT00600119|NKTR, constipation, opioid, induced, bowel, dysfunction, Naloxol, Naloxone, Narcan, PEG naloxol, OIC, OBD, Nektar|nktr, constipation, opioid, induced, bowel, dysfunction, naloxol, naloxone, narcan, peg naloxol, oic, obd, nektar
5675252|NCT00600093|Amantadine|amantadine
5675253|NCT00600067|Diabetes|diabetes
5675254|NCT00600067|Type 2 Diabetes|type 2 diabetes
5675255|NCT00600067|Diabetes Mellitus|diabetes mellitus
5675256|NCT00600067|Metabolic Diseases|metabolic diseases
5675257|NCT00600067|Glucose Metabolism Disorders|glucose metabolism disorders
5675258|NCT00600067|Glycemic Control|glycemic control
5675259|NCT00600054|Diffuse intrinsic pontine glioma|diffuse intrinsic pontine glioma
5675260|NCT00600054|Common Terminology Criteria|common terminology criteria
5675261|NCT00600054|Epidermal Growth factor receptor|epidermal growth factor receptor
5675262|NCT00600054|Human antihuman antibody|human antihuman antibody
5675263|NCT00600054|pharmacokinetics|pharmacokinetics
5675264|NCT00600054|monoclonal antibody|monoclonal antibody
5675265|NCT00600054|Informed Consent Form|informed consent form
5675266|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors
5675267|NCT00600041|pantoprazole|pantoprazole
5675268|NCT00600041|Cardiac Output|cardiac output
5675269|NCT00600041|Echocardiography|echocardiography
5890287|NCT04007666|Incarcerated|incarcerated
5890288|NCT04007666|Prisoners|prisoners
5890289|NCT04007666|Implementation Science|implementation science
5890302|NCT04005352|AMD, nAMD, wet AMD, RTH258, brolucizumab, double blind|amd, namd, wet amd, rth258, brolucizumab, double blind
5890323|NCT04003610|Urothelial carcinoma|urothelial carcinoma
5890324|NCT04003610|fibroblast growth factor receptor (FGFR) inhibitor|fibroblast growth factor receptor (fgfr) inhibitor
5890325|NCT04003610|FGFR3 mutation|fgfr3 mutation
5890326|NCT04003610|FGFR3 rearrangement|fgfr3 rearrangement
5890327|NCT04003610|metastatic|metastatic
5890328|NCT04003610|unresectable|unresectable
5890329|NCT04003610|cisplatin-ineligible|cisplatin-ineligible
5675270|NCT00600041|adverse effects|adverse effects
5675271|NCT00600028|idiopathic pulmonary fibrosis cough|idiopathic pulmonary fibrosis cough
5675273|NCT00600015|Advanced|advanced
5675274|NCT00600015|Sorafenib|sorafenib
5675275|NCT00600015|Erlotinib|erlotinib
5675276|NCT00600015|Double-blind|double-blind
5675277|NCT00600015|Placebo-controlled|placebo-controlled
5675278|NCT00600002|GM-CSF|gm-csf
5675279|NCT00600002|Leukine|leukine
5675280|NCT00599989|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5675281|NCT00599989|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5675282|NCT00599989|stage I breast cancer|stage i breast cancer
5675283|NCT00599989|stage II breast cancer|stage ii breast cancer
5675284|NCT00599989|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5675285|NCT00599989|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5675286|NCT00599989|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5675287|NCT00599989|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5675288|NCT00599989|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5675289|NCT00599989|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5675290|NCT00599989|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5675291|NCT00599989|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5675292|NCT00599989|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5675293|NCT00599989|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
5675294|NCT00599989|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5675295|NCT00599989|breast cancer in situ|breast cancer in situ
5675296|NCT00599950|Mitomycin C|mitomycin c
5675297|NCT00599950|Corneal epithelium|corneal epithelium
5675298|NCT00599950|Photorefractive keratectomy (PRK)|photorefractive keratectomy (prk)
5675299|NCT00599950|Confocal microscope|confocal microscope
5675300|NCT00599937|APL|apl
5675301|NCT00599924|advanced solid tumors,|advanced solid tumors,
5675302|NCT00599924|colorectal cancer,|colorectal cancer,
5675303|NCT00599924|sunitinib (SUTENT),|sunitinib (sutent),
5675304|NCT00599924|FOLFOX|folfox
5675305|NCT00599911|Drug therapy|drug therapy
5675306|NCT00599911|Depressive disorder|depressive disorder
5675307|NCT00599911|Antidepressive agents|antidepressive agents
5675308|NCT00599911|Depressive symptoms|depressive symptoms
5675309|NCT00599911|Affective disorders|affective disorders
5675310|NCT00599911|Randomized controlled trial|randomized controlled trial
5675311|NCT00599911|Placebo-controlled|placebo-controlled
5675312|NCT00599911|Double-blind|double-blind
5675313|NCT00599911|Active reference|active reference
5675314|NCT00599911|Multicenter study|multicenter study
5675315|NCT00599898|Preterm labor|preterm labor
5675316|NCT00599898|Atosiban|atosiban
5675317|NCT00599898|Nifedipine|nifedipine
5675318|NCT00599872|Allergy|allergy
5675319|NCT00599872|Sublingual Immunotherapy|sublingual immunotherapy
5675320|NCT00599872|Allergic Rhinitis|allergic rhinitis
5675321|NCT00599859|lactase|lactase
5675322|NCT00599859|lactose|lactose
5675323|NCT00599859|microflora|microflora
5675324|NCT00599846|age-related macular degeneration|age-related macular degeneration
5675325|NCT00599846|geographic atrophy|geographic atrophy
5675326|NCT00599833|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5890342|NCT04002947|BTK Inhibitor|btk inhibitor
5890343|NCT04002947|Calquence|calquence
5890344|NCT04002947|ACP-196|acp-196
5890345|NCT04002947|Monoclonal Antibody|monoclonal antibody
5890384|NCT03998267|mobile health|mobile health
5890385|NCT03998267|m-health|m-health
5890404|NCT03997500|Norepinephrine|norepinephrine
5890405|NCT03997500|Hypotension|hypotension
5890406|NCT03997500|Inferior Vena Cava Collapsibility Index|inferior vena cava collapsibility index
5890407|NCT03997500|Cesarean Delivery|cesarean delivery
5675327|NCT00599833|stage III pancreatic cancer|stage iii pancreatic cancer
5675328|NCT00599820|Angioid Streaks|angioid streaks
5675329|NCT00599820|Choroidal Neovascularization|choroidal neovascularization
5675330|NCT00599820|Bevacizumab|bevacizumab
5675331|NCT00599794|Sepsis|sepsis
5675332|NCT00599794|Intravascular volume|intravascular volume
5675333|NCT00599794|Ultrasound|ultrasound
5675334|NCT00599794|Noninvasive measurement|noninvasive measurement
5675335|NCT00599781|adenosine deaminase|adenosine deaminase
5675336|NCT00599781|SCID|scid
5675337|NCT00599781|gene therapy|gene therapy
5675338|NCT00599781|retroviral vector|retroviral vector
5675339|NCT00599742|Balance disorder|balance disorder
5675340|NCT00599742|Vestibular disorder|vestibular disorder
5675341|NCT00599742|Generalized anxiety disorder|generalized anxiety disorder
5675342|NCT00599742|Separation anxiety disorder|separation anxiety disorder
5675343|NCT00599742|Children|children
5675344|NCT00599742|Balance training|balance training
5675345|NCT00599716|dry eye syndrome|dry eye syndrome
5675346|NCT00599716|dry eye disease|dry eye disease
5675347|NCT00599716|Vismed|vismed
5675348|NCT00599716|dry eye|dry eye
5675349|NCT00599716|sodium hyaluronate|sodium hyaluronate
5675350|NCT00599716|hyaluronic acid|hyaluronic acid
5675351|NCT00599690|Epi-LASIK-LASIK microkeratome|epi-lasik-lasik microkeratome
5675352|NCT00599690|Corneal thickness|corneal thickness
5675353|NCT00599690|Confocal microscope|confocal microscope
5675354|NCT00599677|acupuncture|acupuncture
5675355|NCT00599677|meridian|meridian
5675356|NCT00599677|acupoint|acupoint
5675357|NCT00599664|Urinary Calculi|urinary calculi
5675358|NCT00599664|Urinary Stones|urinary stones
5675359|NCT00599664|Urinary Tract Stones|urinary tract stones
5675360|NCT00599664|Calculi|calculi
5675361|NCT00599651|Respiratory Distress Syndrome|respiratory distress syndrome
5675362|NCT00599651|Newborn RDS|newborn rds
5675363|NCT00599625|Crohn's Disease|crohn's disease
5675364|NCT00599612|GW856553,|gw856553,
5675365|NCT00599612|radiolabel|radiolabel
5675366|NCT00599612|ADME,|adme,
5675367|NCT00599599|Prolonged Exposure Therapy|prolonged exposure therapy
5675368|NCT00599599|Adherence to HIV Medications|adherence to hiv medications
5675369|NCT00599599|Complementary Therapies|complementary therapies
5675370|NCT00599586|migraine|migraine
5675371|NCT00599586|acupuncture|acupuncture
5675372|NCT00599586|efficacy|efficacy
5675373|NCT00599586|safety|safety
5675374|NCT00599586|meridian|meridian
5675375|NCT00599586|acupoint|acupoint
5675377|NCT00599573|cocaine dependence|cocaine dependence
5675378|NCT00599573|cocaine abuse|cocaine abuse
5675379|NCT00599573|cocaine addiction|cocaine addiction
5675380|NCT00599573|cocaine users|cocaine users
5675381|NCT00599573|cocaine-related disorders|cocaine-related disorders
5675382|NCT00599573|HIV Infection|hiv infection
5675383|NCT00599560|Meniere's disease|meniere's disease
5675384|NCT00599560|stress|stress
5675385|NCT00599560|vasopressin|vasopressin
5675386|NCT00599560|endolymphatic sac|endolymphatic sac
5675387|NCT00599560|V2 receptor|v2 receptor
5675388|NCT00599560|cyclic AMP|cyclic amp
5675389|NCT00599560|Plasma vasopressin level and V2R mRNA expression level in the endolymphatic sac both were significantly higher in patients with Meniere's disease.|plasma vasopressin level and v2r mrna expression level in the endolymphatic sac both were significantly higher in patients with meniere's disease.
5675390|NCT00599560|In Meniere's disease, there were significant negative co-relationships between vasopressin and V2R.|in meniere's disease, there were significant negative co-relationships between vasopressin and v2r.
5675391|NCT00599560|The cyclic AMP activity was basically up-regulated in the endolymphatic sac in Meniere's disease..|the cyclic amp activity was basically up-regulated in the endolymphatic sac in meniere's disease..
5675392|NCT00599560|The cyclic AMP sensitivity for vasopressin was significantly elevated in the endolymphatic sac in Meniere's disease.|the cyclic amp sensitivity for vasopressin was significantly elevated in the endolymphatic sac in meniere's disease.
5675393|NCT00599547|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5890455|NCT03991858|Rehabilitation|rehabilitation
5890456|NCT03991858|Telerehabilitation|telerehabilitation
5890457|NCT03991858|Waiting list|waiting list
5890458|NCT03991858|follow-up|follow-up
5890470|NCT03989999|Transcranial Doppler|transcranial doppler
5890475|NCT03989427|Gingiva|gingiva
5890476|NCT03989427|Gingivitis|gingivitis
5890477|NCT03989427|Flossing|flossing
5890478|NCT03989427|Brushing|brushing
5890479|NCT03989427|Plaque control|plaque control
5890480|NCT03989427|Gingival bleeding|gingival bleeding
5890481|NCT03989427|Bleeding point index|bleeding point index
5890482|NCT03989427|Plaque control record|plaque control record
5890483|NCT03989427|Rustogi Modified Navy Plaque Index|rustogi modified navy plaque index
5890484|NCT03989427|Dental Plaque|dental plaque
5890538|NCT03980626|physical activity|physical activity
5890539|NCT03980626|exercise|exercise
5890540|NCT03980626|cognition|cognition
5890541|NCT03980626|brain health|brain health
5890542|NCT03980626|breast cancer|breast cancer
5890560|NCT03978091|Aztreonam|aztreonam
5890561|NCT03978091|Ceftazidime-Avibactam|ceftazidime-avibactam
5890562|NCT03978091|Efficacy|efficacy
5890563|NCT03978091|Healthy|healthy
5890564|NCT03978091|Pharmacokinetics|pharmacokinetics
5890565|NCT03978091|Population|population
5890566|NCT03978091|Safety|safety
5890567|NCT03977779|biodegradable stent|biodegradable stent
5890572|NCT03977649|AMG334|amg334
5890634|NCT03970239|Parkinson's disease|parkinson's disease
5890635|NCT03970239|Impulse control disorders|impulse control disorders
5890636|NCT03970239|Serotoninergic system|serotoninergic system
5890637|NCT03970239|Positron Emission Tomography (PET)|positron emission tomography (pet)
5890659|NCT03968900|smoking|smoking
5890660|NCT03968900|sleep deficiencies|sleep deficiencies
5890661|NCT03968900|socioeconomic disadvantage|socioeconomic disadvantage
5890662|NCT03968900|Race|race
5675394|NCT00599521|Acne Vulgaris|acne vulgaris
5675395|NCT00599521|Adapalene|adapalene
5675396|NCT00599508|memory|memory
5675397|NCT00599508|aging|aging
5675398|NCT00599495|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5675399|NCT00599495|Multiple Myeloma|multiple myeloma
5675400|NCT00599482|HEMOGLOBIN SC DISEASE|hemoglobin sc disease
5675401|NCT00599482|HEMOGLOBIN C DISEASE|hemoglobin c disease
5675402|NCT00599482|SICKLE CELL TRAIT|sickle cell trait
5675403|NCT00599482|THALASSEMIA|thalassemia
5675404|NCT00599469|Acute Confusional Senile Dementia|acute confusional senile dementia
5675405|NCT00599469|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5675406|NCT00599469|SENILE PLAQUES|senile plaques
5675407|NCT00599469|NEUROFIBRILLARY TANGLES|neurofibrillary tangles
5675408|NCT00599469|NEUROPIL THREADS|neuropil threads
5675409|NCT00599456|Hot flashes|hot flashes
5675410|NCT00599456|Menopause|menopause
5675411|NCT00599456|Omega 3 fatty Acids|omega 3 fatty acids
5675412|NCT00599443|Cell-derived subunit influenza vaccine|cell-derived subunit influenza vaccine
5675414|NCT00599443|Reactogenicity|reactogenicity
5675415|NCT00599430|Probiotic|probiotic
5675416|NCT00599430|Lactobacillus|lactobacillus
5675417|NCT00599430|NCFM|ncfm
5675418|NCT00599430|Bifidobacterium|bifidobacterium
5675419|NCT00599430|Healthy children|healthy children
5675420|NCT00599404|Pharmacokinetics study|pharmacokinetics study
5675421|NCT00599391|KIDNEY FAILURE, ACUTE|kidney failure, acute
5675422|NCT00599391|KIDNEY FAILURE, CHRONIC|kidney failure, chronic
5675423|NCT00599391|RENAL INSUFFICIENCY|renal insufficiency
5675424|NCT00599365|adherence|adherence
5675425|NCT00599365|pharmacist intervention|pharmacist intervention
5675426|NCT00599365|persistence|persistence
5675427|NCT00599365|renal clinic|renal clinic
5675428|NCT00599365|pill count|pill count
5675429|NCT00599352|Hypovitaminosis|hypovitaminosis
5675430|NCT00599352|Chronic liver disease|chronic liver disease
5675431|NCT00599339|Rotigotine|rotigotine
5675432|NCT00599339|Neupro|neupro
5675433|NCT00599326|Exjade PCT Study|exjade pct study
5675434|NCT00599326|PCT Study|pct study
5675435|NCT00599326|Porphyria Cutanea Tarda|porphyria cutanea tarda
5675436|NCT00599287|ICU delirium|icu delirium
5675437|NCT00599287|Hypoactive delirium|hypoactive delirium
5675438|NCT00599287|Haloperidol|haloperidol
5675439|NCT00599287|Methylphenidate|methylphenidate
5675440|NCT00599287|Rivastigmine|rivastigmine
5675441|NCT00599287|Hypoactive ICU delirium|hypoactive icu delirium
5675442|NCT00599274|Multiple Sclerosis|multiple sclerosis
5675443|NCT00599274|Interferon beta 1a|interferon beta 1a
5675444|NCT00599274|Avonex|avonex
5675445|NCT00599261|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5675446|NCT00599248|osteoarthritis, knee|osteoarthritis, knee
5675447|NCT00599235|Hypertension|hypertension
5675448|NCT00599235|Exercise capacity|exercise capacity
5675449|NCT00599235|PDE5 inhibitors|pde5 inhibitors
5675451|NCT00599222|macular degeneration|macular degeneration
5675452|NCT00599222|anti-VEGF|anti-vegf
5675453|NCT00599222|laser treatment|laser treatment
5675454|NCT00599196|Rotigotine|rotigotine
5675455|NCT00599196|Neupro®|neupro®
5675456|NCT00599183|Cervical spine herniation|cervical spine herniation
5675457|NCT00599183|MRI cervical spine|mri cervical spine
5675458|NCT00599183|Diffusion tensor imaging cervical spine|diffusion tensor imaging cervical spine
5675459|NCT00599170|This is a standard phase II trial, in which patients with newly diagnosed diffuse large B cell lymphoma will receive R-CHOP with GM-CSF|this is a standard phase ii trial, in which patients with newly diagnosed diffuse large b cell lymphoma will receive r-chop with gm-csf
5675460|NCT00599144|Cholecystectomy|cholecystectomy
5675461|NCT00599131|Cancer of Larynx|cancer of larynx
5675462|NCT00599118|Atrial Fibrillation|atrial fibrillation
5675463|NCT00599118|Genetics|genetics
5675464|NCT00599092|pituitary tumor|pituitary tumor
5675465|NCT00599092|recurrence|recurrence
5675466|NCT00599079|MAC|mac
5675467|NCT00599066|M-Entropy|m-entropy
5675468|NCT00599053|Ureaplasma|ureaplasma
5675469|NCT00599053|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5675470|NCT00599053|very low birthweight|very low birthweight
5890727|NCT03961893|colonoscopy|colonoscopy
5890729|NCT03961893|adenomas|adenomas
5890730|NCT03961776|Diffusion weighted imaging|diffusion weighted imaging
5890731|NCT03961776|Radiation therapy|radiation therapy
5890751|NCT03958149|Cervical spine|cervical spine
5890772|NCT03954743|HRV|hrv
5890773|NCT03954743|Lyophilized formulation|lyophilized formulation
5890774|NCT03954743|Liquid formulation|liquid formulation
5890775|NCT03954743|Human rotavirus vaccine|human rotavirus vaccine
5890776|NCT03954743|Rotarix|rotarix
5890777|NCT03954743|Healthy infants|healthy infants
5890778|NCT03954743|PCV-free|pcv-free
5890779|NCT03954743|Porcine circovirus-free|porcine circovirus-free
5675471|NCT00599014|Cardiomyopathy, heart failure, DNA,|cardiomyopathy, heart failure, dna,
5675472|NCT00599014|echocardiography, messenger RNA, natural history|echocardiography, messenger rna, natural history
5675473|NCT00599001|healthy volunteer|healthy volunteer
5675474|NCT00599001|research subjects|research subjects
5675475|NCT00599001|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5675476|NCT00599001|phase 1|phase 1
5675477|NCT00598988|infectious mononucleosis, mono, acupuncture|infectious mononucleosis, mono, acupuncture
5675478|NCT00598975|Phase 2a: Multiple solid tumor types|phase 2a: multiple solid tumor types
5675479|NCT00598975|Phase 2b: Second-Line Colorectal Cancer (CRC)|phase 2b: second-line colorectal cancer (crc)
5675480|NCT00598962|MAC|mac
5675481|NCT00598949|Pituitary|pituitary
5675482|NCT00598949|Adenoma|adenoma
5675483|NCT00598949|Tumor|tumor
5675484|NCT00598949|Acromegaly|acromegaly
5675485|NCT00598949|Prolactinoma|prolactinoma
5675486|NCT00598949|Cushing's|cushing's
5675487|NCT00598936|Hypoxia|hypoxia
5675488|NCT00598936|Cerebral Hypoxia|cerebral hypoxia
5675489|NCT00598923|tbi|tbi
5675490|NCT00598923|traumatic brain injury|traumatic brain injury
5675491|NCT00598923|epilepsy|epilepsy
5675492|NCT00598910|HIV infection|hiv infection
5675497|NCT00598871|Thymosin beta 4|thymosin beta 4
5675498|NCT00598871|Corneal wound healing|corneal wound healing
5675500|NCT00598871|Diabetes|diabetes
5675501|NCT00598858|prostate cancer|prostate cancer
5675502|NCT00598858|Prostatectomy|prostatectomy
5675503|NCT00598845|Endometrial cancer|endometrial cancer
5675504|NCT00598845|Molecular markers|molecular markers
5675505|NCT00598845|Lymph node metastasis|lymph node metastasis
5675506|NCT00598845|Prospective study|prospective study
5675507|NCT00598845|Prognosis|prognosis
5675508|NCT00598845|Cancer of Endometrium|cancer of endometrium
5675509|NCT00598845|Tumor Markers, Biological|tumor markers, biological
5675510|NCT00598832|Acne Vulgaris|acne vulgaris
5675511|NCT00598832|Adapalene|adapalene
5675512|NCT00598819|Cerebral Oxygenation|cerebral oxygenation
5675513|NCT00598819|Oxygen Monitoring|oxygen monitoring
5675514|NCT00598806|Noninvasive Bladder Cancer|noninvasive bladder cancer
5675515|NCT00598780|Levocetirizine|levocetirizine
5675516|NCT00598780|Xyzal|xyzal
5675517|NCT00598780|Rhinitis allergic persistent|rhinitis allergic persistent
5675518|NCT00598780|Rhinitis nonseasonal|rhinitis nonseasonal
5675519|NCT00598767|Aortic valve insufficiency|aortic valve insufficiency
5675520|NCT00598767|Aortic valve stenosis|aortic valve stenosis
5675521|NCT00598767|3D echocardiogram|3d echocardiogram
5675522|NCT00598767|3D computed tomography|3d computed tomography
5675523|NCT00598754|Aortic valve stenosis|aortic valve stenosis
5675524|NCT00598754|Aortic valve insufficiency|aortic valve insufficiency
5675525|NCT00598754|Two dimensional echocardiography|two dimensional echocardiography
5675526|NCT00598754|Three dimensional echocardiography|three dimensional echocardiography
5675527|NCT00598741|Bone|bone
5675528|NCT00598741|Sarcoma|sarcoma
5675529|NCT00598741|04-083|04-083
5675530|NCT00598728|Survivors|survivors
5675531|NCT00598728|Quality of Life|quality of life
5675532|NCT00598715|In-stent restenosis|in-stent restenosis
5675533|NCT00598715|In-DES-restenosis|in-des-restenosis
5675534|NCT00598715|paclitaxel|paclitaxel
5675535|NCT00598715|sirolimus|sirolimus
5675536|NCT00598689|LASIK|lasik
5675537|NCT00598689|Ocular Lubricants|ocular lubricants
5675538|NCT00598689|Corneal Epithelium|corneal epithelium
5890810|NCT03953963|Mesenteric Visceral Fat|mesenteric visceral fat
5890811|NCT03953963|Insulin Resistance|insulin resistance
5890812|NCT03953963|Diabetes|diabetes
5890813|NCT03953963|Type 2 diabetes|type 2 diabetes
5890814|NCT03953963|Diabetes Mellitus|diabetes mellitus
5890815|NCT03953963|Noninsulin-Dependent Diabetes Mellitus|noninsulin-dependent diabetes mellitus
5890816|NCT03953963|Glucose Metabolism Disorder|glucose metabolism disorder
5890817|NCT03953963|Obesity|obesity
5890818|NCT03953963|Diabesity|diabesity
5890819|NCT03953963|HydraSolve T2D|hydrasolve t2d
5890830|NCT03953235|neoantigen cancer vaccine|neoantigen cancer vaccine
5890831|NCT03953235|shared neoantigen|shared neoantigen
5890832|NCT03953235|GRT-C903|grt-c903
5890833|NCT03953235|GRT-R904|grt-r904
5890834|NCT03953235|immunotherapy|immunotherapy
5890835|NCT03953235|PD-1|pd-1
5890836|NCT03953235|CTLA-4|ctla-4
5890837|NCT03953235|nivolumab|nivolumab
5890838|NCT03953235|ipilimumab|ipilimumab
5890875|NCT03949855|Primary Membranous Nephropathy|primary membranous nephropathy
5890876|NCT03949855|nephrotic syndrome|nephrotic syndrome
5890877|NCT03949855|Pharmacokinetics (PK) Analysis|pharmacokinetics (pk) analysis
5890878|NCT03949855|Double-Blind (Masked), Placebo-Controlled Clinical Trial|double-blind (masked), placebo-controlled clinical trial
5890879|NCT03949855|Co-administered belimumab and rituximab|co-administered belimumab and rituximab
5675539|NCT00598689|Wound Healing|wound healing
5675540|NCT00598663|Type 1 diabetes|type 1 diabetes
5675541|NCT00598650|Lewy Body Disease|lewy body disease
5675542|NCT00598650|Dementia|dementia
5675543|NCT00598650|Clinical Trial|clinical trial
5675544|NCT00598650|Phase II|phase ii
5675545|NCT00598650|E2020|e2020
5675546|NCT00598650|donepezil hydrochloride|donepezil hydrochloride
5675547|NCT00598637|drug eluting stent|drug eluting stent
5675548|NCT00598637|left main disease|left main disease
5675549|NCT00598611|urticaria|urticaria
5675550|NCT00598598|Aortic valve insufficiency|aortic valve insufficiency
5675551|NCT00598598|Aortic valve stenosis|aortic valve stenosis
5675552|NCT00598598|3D echocardiogram|3d echocardiogram
5675553|NCT00598572|Deferoxamine|deferoxamine
5675554|NCT00598572|Safety|safety
5675555|NCT00598572|Intracerebral hemorrhage|intracerebral hemorrhage
5675556|NCT00598559|Acute pain|acute pain
5675557|NCT00598559|Fever|fever
5675558|NCT00598559|IV Acetaminophen|iv acetaminophen
5675559|NCT00598559|Analgesic|analgesic
5675560|NCT00598546|Stomach|stomach
5675561|NCT00598546|Gastric|gastric
5675562|NCT00598546|Stomach Tumor|stomach tumor
5675563|NCT00598546|Stomach Cancer|stomach cancer
5675564|NCT00598507|ZK-EPO|zk-epo
5675566|NCT00598507|EpothiloneZK|epothilonezk
5675567|NCT00598494|effect of bedrest|effect of bedrest
5675568|NCT00598494|cardiac atrophy|cardiac atrophy
5675569|NCT00598481|SCID|scid
5675570|NCT00598481|gene therapy|gene therapy
5675571|NCT00598481|Adenosine deaminase|adenosine deaminase
5675572|NCT00598481|retroviral vector|retroviral vector
5675573|NCT00598455|angiomyolipomata|angiomyolipomata
5675574|NCT00598455|tuberous sclerosis complex|tuberous sclerosis complex
5675575|NCT00598442|anemia|anemia
5675576|NCT00598442|chronic kidney disease|chronic kidney disease
5675577|NCT00598442|CKD|ckd
5675578|NCT00598442|chronic renal failure|chronic renal failure
5675579|NCT00598442|CRF|crf
5675580|NCT00598442|erythropoietin|erythropoietin
5675581|NCT00598442|EPO|epo
5675582|NCT00598442|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5675583|NCT00598442|ESA|esa
5675584|NCT00598442|Hematide™|hematide™
5675585|NCT00598442|hemoglobin|hemoglobin
5675586|NCT00598442|Hb|hb
5675587|NCT00598442|Hgb|hgb
5675588|NCT00598442|Omontys|omontys
5675589|NCT00598442|peginesatide|peginesatide
5675590|NCT00598442|red blood cell|red blood cell
5675591|NCT00598442|red blood cell production|red blood cell production
5675592|NCT00598429|NICHD Neonatal Research Network|nichd neonatal research network
5675593|NCT00598429|Hypoxemic respiratory failure (HRF)|hypoxemic respiratory failure (hrf)
5675594|NCT00598429|Persistent pulmonary hypertension of the newborn (PPHN)|persistent pulmonary hypertension of the newborn (pphn)
5675595|NCT00598429|Prostaglandin E1 (PGE1)|prostaglandin e1 (pge1)
5675596|NCT00598429|Mechanical ventilation|mechanical ventilation
5675597|NCT00598429|Meconium, aspiration|meconium, aspiration
5675598|NCT00598416|Hepatitis C|hepatitis c
5675599|NCT00598416|Substance Abuse|substance abuse
5675600|NCT00598416|Psychoeducation|psychoeducation
5675601|NCT00598416|Psychiatric functioning|psychiatric functioning
5675602|NCT00598416|Physical Functioning|physical functioning
5675603|NCT00598416|Quality of Life|quality of life
5675604|NCT00598416|NIAAA|niaaa
5675605|NCT00598416|Alcohol|alcohol
5675606|NCT00598403|Cystitis|cystitis
5675607|NCT00598390|Cannabinoid|cannabinoid
5675608|NCT00598390|CB1 Receptor|cb1 receptor
5675609|NCT00598390|Brain Imaging|brain imaging
5675616|NCT00598377|Renal volume|renal volume
5675617|NCT00598377|Glomerular filtration rate|glomerular filtration rate
5675618|NCT00598377|Adrenal Cortex Function Tests|adrenal cortex function tests
5675620|NCT00598364|nodule|nodule
5675621|NCT00598364|genetic|genetic
5675622|NCT00598364|mutation|mutation
5675623|NCT00598364|malignancy|malignancy
5675631|NCT00598325|Nicotine|nicotine
5675632|NCT00598325|Vaccine|vaccine
5675633|NCT00598325|Immunogenicity|immunogenicity
5675634|NCT00598325|Tobacco|tobacco
5675635|NCT00598325|Habits|habits
5675636|NCT00598299|corneal epithelium|corneal epithelium
5675637|NCT00598286|CB1 Receptor|cb1 receptor
5675638|NCT00598286|PET|pet
5675639|NCT00598286|Cannabinoid|cannabinoid
5675640|NCT00598286|[18F]FMPEP-d2|[18f]fmpep-d2
5675641|NCT00598286|Brain Imaging|brain imaging
5675642|NCT00598286|Healthy Volunteer|healthy volunteer
5675643|NCT00598286|HV|hv
5675644|NCT00598273|anemia|anemia
5675645|NCT00598273|chronic kidney disease|chronic kidney disease
5675646|NCT00598273|CKD|ckd
5675647|NCT00598273|chronic renal failure|chronic renal failure
5675648|NCT00598273|CRF|crf
5675649|NCT00598273|erythropoietin|erythropoietin
5675650|NCT00598273|EPO|epo
5675651|NCT00598273|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5675652|NCT00598273|ESA|esa
5675653|NCT00598273|Hematide™|hematide™
5675654|NCT00598273|hemoglobin|hemoglobin
5891021|NCT03938545|Graves' Orbitopathy|graves' orbitopathy
5891022|NCT03938545|Thyroid Eye Disease|thyroid eye disease
5891031|NCT03937219|renal|renal
5891032|NCT03937219|cancer|cancer
5891033|NCT03937219|carcinoma|carcinoma
4960556|NCT04235582|addiction|addiction
5675655|NCT00598273|Hb|hb
5675656|NCT00598273|Hgb|hgb
5675657|NCT00598273|Omontys|omontys
5675658|NCT00598273|peginesatide|peginesatide
5675659|NCT00598273|red blood cell|red blood cell
5675660|NCT00598273|red blood cell production|red blood cell production
5675661|NCT00598260|active management|active management
5675662|NCT00598260|induction of labor|induction of labor
5675663|NCT00598260|cesarean delivery|cesarean delivery
5675664|NCT00598260|Cesarean|cesarean
5675665|NCT00598247|Colon Cancer Rectal Colorectal Women|colon cancer rectal colorectal women
5675666|NCT00598208|In-vitro fertilization|in-vitro fertilization
5675667|NCT00598195|Ketamine|ketamine
5675668|NCT00598195|Phamacokinetics|phamacokinetics
5675669|NCT00598195|Cardiopulmonary bypass (CPB)|cardiopulmonary bypass (cpb)
5675670|NCT00598195|ketamine/norketamine pharmacokinetic parameters|ketamine/norketamine pharmacokinetic parameters
5675671|NCT00598182|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5675672|NCT00598182|OROS methylphenidate|oros methylphenidate
5675673|NCT00598169|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5675674|NCT00598169|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5675680|NCT00598169|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5675681|NCT00598130|Patients undergoing elective open partial nephrectomy surgery|patients undergoing elective open partial nephrectomy surgery
5675682|NCT00598130|Excision of a kidney|excision of a kidney
5675683|NCT00598117|Esophageal|esophageal
5675684|NCT00598117|CancerEsophagus|canceresophagus
5675685|NCT00598104|Asthma, interleukin-13|asthma, interleukin-13
5675686|NCT00598091|Solid Tumors|solid tumors
5675687|NCT00598091|Phase I|phase i
5675688|NCT00598091|Expanded Cohort|expanded cohort
5675689|NCT00598091|Pancreatic Cancer|pancreatic cancer
5675690|NCT00598091|Dasatinib|dasatinib
5675691|NCT00598091|Gemcitabine|gemcitabine
5675692|NCT00598065|lung|lung
5675693|NCT00598052|Marijuana dependence withdrawal Escitalopram|marijuana dependence withdrawal escitalopram
5675694|NCT00598026|Tele medicine|tele medicine
5675695|NCT00598026|ICD follow-up|icd follow-up
5675696|NCT00598026|Cost / benefit study|cost / benefit study
5675697|NCT00598013|Kidney Transplantation|kidney transplantation
5675698|NCT00598013|Thiazolidinediones|thiazolidinediones
5675699|NCT00598013|Insulin Resistance|insulin resistance
5675700|NCT00598013|Atherosclerosis|atherosclerosis
5675701|NCT00598000|Lung cancer|lung cancer
5675702|NCT00598000|Quality of Life|quality of life
5675703|NCT00598000|VATS|vats
5675704|NCT00598000|thoracotomy|thoracotomy
5675705|NCT00598000|05-006|05-006
5675706|NCT00597987|BRCA1|brca1
5675707|NCT00597974|carotid artery stenosis|carotid artery stenosis
5675708|NCT00597974|Neuropsychological tests|neuropsychological tests
5675709|NCT00597974|Stroke|stroke
5675710|NCT00597974|Transient ischemia|transient ischemia
5675711|NCT00597974|Stenting|stenting
5675712|NCT00597961|Lung|lung
5675713|NCT00597961|skin|skin
5675714|NCT00597961|melanoma|melanoma
5675715|NCT00597948|mental retardation|mental retardation
5675716|NCT00597948|downs syndrome|downs syndrome
5675717|NCT00597948|autism|autism
5675718|NCT00597948|autism spectrum disorder|autism spectrum disorder
5675719|NCT00597948|cerebral palsy|cerebral palsy
5675720|NCT00597948|developmental disability|developmental disability
5675721|NCT00597948|developmental disabilities|developmental disabilities
5675722|NCT00597948|intellectual disability|intellectual disability
5675723|NCT00597948|intellectual disabilities|intellectual disabilities
5675724|NCT00597948|health promotion|health promotion
5675725|NCT00597948|disease prevention|disease prevention
5675726|NCT00597948|physical health|physical health
5675727|NCT00597948|emotional health|emotional health
5675728|NCT00597948|behavioral health|behavioral health
5675729|NCT00597948|mental health|mental health
5675730|NCT00597948|spiritual health|spiritual health
5675731|NCT00597948|prevention|prevention
5675732|NCT00597935|prolapse|prolapse
5891087|NCT03929211|Relapsed/refractory myelodysplastic syndrome|relapsed/refractory myelodysplastic syndrome
5891088|NCT03929211|Failed hypomethylating therapy|failed hypomethylating therapy
5891140|NCT03923842|NPC|npc
5891141|NCT03923842|EBV|ebv
5891172|NCT03920852|Atopic dermatitis|atopic dermatitis
5891173|NCT03920852|ruxolitinib cream|ruxolitinib cream
5891174|NCT03920852|maximum use|maximum use
5675733|NCT00597935|urinary incontinence|urinary incontinence
5675734|NCT00597935|uterosacral vaginal vault ligament suspension|uterosacral vaginal vault ligament suspension
5675735|NCT00597935|sacrospinous ligament fixation|sacrospinous ligament fixation
5675736|NCT00597935|behavioral therapy|behavioral therapy
5675737|NCT00597935|pelvic muscle training|pelvic muscle training
5675738|NCT00597922|Acute Myocardial Infarction|acute myocardial infarction
5675739|NCT00597922|Heart Attack|heart attack
5675740|NCT00597922|Gender Differences|gender differences
5675741|NCT00597922|Risk Factors|risk factors
5675742|NCT00597922|Quality of Care|quality of care
5675743|NCT00597909|Ammonul®|ammonul®
5675744|NCT00597909|sodium phenylacetate and sodium benzoate|sodium phenylacetate and sodium benzoate
5675745|NCT00597909|hepatic encephalopathy|hepatic encephalopathy
5675746|NCT00597909|Grade 3 or 4 Hepatic Encephalopathy|grade 3 or 4 hepatic encephalopathy
5675747|NCT00597883|carotid endarterectomy|carotid endarterectomy
5675748|NCT00597883|Neuropsychological tests|neuropsychological tests
5675749|NCT00597883|Stroke|stroke
5675750|NCT00597883|Transient ischemia|transient ischemia
5675752|NCT00597844|type I thyroplasty|type i thyroplasty
5675753|NCT00597844|unilateral vocal fold augmentation|unilateral vocal fold augmentation
5675755|NCT00597831|electroconvulsive therapy|electroconvulsive therapy
5675756|NCT00597831|Ultrasonography Doppler Transcranial|ultrasonography doppler transcranial
5675758|NCT00597792|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5675759|NCT00597792|Plicator|plicator
5675760|NCT00597792|Full-thickness Plication|full-thickness plication
5675761|NCT00597779|intertrochanteric fractures|intertrochanteric fractures
5675762|NCT00597766|CVA|cva
5675763|NCT00597766|Hemiplegia|hemiplegia
5675764|NCT00597766|Hemiplegic shoulder pain|hemiplegic shoulder pain
5675765|NCT00597766|Subacromial steroid injection|subacromial steroid injection
5675766|NCT00597753|anemia|anemia
5675767|NCT00597753|chronic kidney disease|chronic kidney disease
5675768|NCT00597753|CKD|ckd
5675769|NCT00597753|chronic renal failure|chronic renal failure
5675770|NCT00597753|CRF|crf
5675771|NCT00597753|dialysis|dialysis
5675772|NCT00597753|erythropoietin|erythropoietin
5675773|NCT00597753|EPO|epo
5675774|NCT00597753|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5675775|NCT00597753|ESA|esa
5675776|NCT00597753|Hematide™|hematide™
5675777|NCT00597753|hemodialysis|hemodialysis
5675778|NCT00597753|hemoglobin|hemoglobin
5675779|NCT00597753|Hb|hb
5675780|NCT00597753|Hgb|hgb
5675781|NCT00597753|Omontys|omontys
5675782|NCT00597753|peginesatide|peginesatide
5675783|NCT00597753|red blood cell|red blood cell
5675784|NCT00597753|red blood cell production|red blood cell production
5675785|NCT00597727|Peanut Allergy|peanut allergy
5675786|NCT00597727|Sublingual immunotherapy|sublingual immunotherapy
5675787|NCT00597714|Stem Cell Transplantation, Non-myeloablative|stem cell transplantation, non-myeloablative
5675788|NCT00597701|Alcohol withdrawal|alcohol withdrawal
5675789|NCT00597701|Delirium tremors|delirium tremors
5675790|NCT00597675|Peanut allergy|peanut allergy
5675791|NCT00597636|smokers|smokers
5675792|NCT00597623|Osteoarthritis|osteoarthritis
5675793|NCT00597623|Hand|hand
5675794|NCT00597623|Tumor Necrosis Factor-alpha inhibitors|tumor necrosis factor-alpha inhibitors
5675795|NCT00597623|Biological Therapy|biological therapy
5675796|NCT00597610|Rectum|rectum
5891223|NCT03915236|MON4STRAT|mon4strat
5891224|NCT03915236|Treatment Drug Monitoring|treatment drug monitoring
5891225|NCT03915236|Antibiotic Resistance|antibiotic resistance
5891226|NCT03915236|Beta-Lactams Resistance|beta-lactams resistance
5891227|NCT03915236|Meropenem|meropenem
5891228|NCT03915236|Health Care-Asociated Infection|health care-asociated infection
5891229|NCT03914261|Expanded Access|expanded access
5891230|NCT03914261|Pre-approval Access|pre-approval access
5891231|NCT03914261|Compassionate Use|compassionate use
5891232|NCT03914261|Special Access Program|special access program
5891233|NCT03914261|Named Patient Basis|named patient basis
5891234|NCT03914261|Special Access Scheme|special access scheme
5891291|NCT03909971|ALK positive|alk positive
5891292|NCT03909971|ALK inhibitor-treated|alk inhibitor-treated
5891303|NCT03907956|physiotherapy|physiotherapy
5891304|NCT03907956|carpal tunnel syndrome|carpal tunnel syndrome
5891305|NCT03907956|myofascial pain syndrome|myofascial pain syndrome
5891306|NCT03907956|dry needling|dry needling
5891307|NCT03907527|Platinum resistant|platinum resistant
5891308|NCT03907527|Ovarian Cancer|ovarian cancer
5891335|NCT03905694|PH1|ph1
5891336|NCT03905694|Primary Hyperoxaluria|primary hyperoxaluria
5891337|NCT03905694|Hyperoxaluria|hyperoxaluria
5891338|NCT03905694|RNAi Therapeutic|rnai therapeutic
5891339|NCT03905694|siRNA|sirna
5891340|NCT03905694|AGT|agt
5891358|NCT03904654|Parkinson's disease|parkinson's disease
5891359|NCT03904654|Mindfulness-based intervention|mindfulness-based intervention
5891360|NCT03904654|Mindfulness-based cognitive therapy (MBCT)|mindfulness-based cognitive therapy (mbct)
5891364|NCT03903822|Mild-to-Moderate Atopic Dermatitis|mild-to-moderate atopic dermatitis
5891365|NCT03903822|topical|topical
5891367|NCT03901482|dihydroergotamine|dihydroergotamine
5891368|NCT03901482|dihydroergotamine mesylate|dihydroergotamine mesylate
5891369|NCT03901482|migraine|migraine
5891379|NCT03899662|Electroencephalography|electroencephalography
5891380|NCT03899662|Cognitive training|cognitive training
5891381|NCT03899662|Physical training|physical training
5891382|NCT03899662|Resting state networks|resting state networks
5891390|NCT03898284|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5891391|NCT03898284|Impulse Oscillometry|impulse oscillometry
5891392|NCT03898284|Forced Vital Capacity|forced vital capacity
5891398|NCT03898167|Screening|screening
5891399|NCT03898167|Human Papillomavirus Infection|human papillomavirus infection
5891400|NCT03898167|Self-Testing|self-testing
5891417|NCT03896347|OLIF|olif
5891418|NCT03896347|ViBone|vibone
5891452|NCT03891966|Upper Extremity Fracture|upper extremity fracture
5891462|NCT03889912|Recurrent|recurrent
5891464|NCT03889067|Enteric fever|enteric fever
5891465|NCT03889067|Typhoid|typhoid
5891466|NCT03889067|Salmonella Typhi|salmonella typhi
5891467|NCT03889067|Typhoid fever|typhoid fever
5891468|NCT03889067|Salmonella infections|salmonella infections
5891469|NCT03889067|Gram-negative bacterial infections|gram-negative bacterial infections
5891470|NCT03889067|Human model of infection|human model of infection
5891473|NCT03888105|Refractory B-NHL|refractory b-nhl
5891474|NCT03888105|NHL|nhl
5891475|NCT03888105|FL|fl
5891476|NCT03888105|DLBCL|dlbcl
5891477|NCT03888105|MZL|mzl
5891478|NCT03888105|MCL|mcl
5891479|NCT03888105|bispecific antibody|bispecific antibody
5891480|NCT03888105|CD20|cd20
5891481|NCT03887936|diabetes mellitus|diabetes mellitus
5891482|NCT03887936|hypogonadism|hypogonadism
5891483|NCT03887936|testosterone|testosterone
5891484|NCT03887936|bone quality|bone quality
5891488|NCT03887780|Stroke;|stroke;
5891489|NCT03887780|Systemic embolism|systemic embolism
5891504|NCT03886493|high-risk prostate cancer|high-risk prostate cancer
5891505|NCT03886493|localized prostate cancer|localized prostate cancer
5891506|NCT03886493|prior to prostatectomy|prior to prostatectomy
5891507|NCT03886493|neoadjuvant|neoadjuvant
5675798|NCT00597597|Metastatic breast cancer|metastatic breast cancer
5675799|NCT00597597|ER and PR hormone receptor negative|er and pr hormone receptor negative
5675800|NCT00597597|HER2/neu negative|her2/neu negative
5675801|NCT00597597|EGFR positive|egfr positive
5675802|NCT00597584|anemia|anemia
5675803|NCT00597584|chronic kidney disease|chronic kidney disease
5675804|NCT00597584|CKD|ckd
5675805|NCT00597584|chronic renal failure|chronic renal failure
5675806|NCT00597584|CRF|crf
5675807|NCT00597584|dialysis|dialysis
5675808|NCT00597584|erythropoietin|erythropoietin
5675810|NCT00597584|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5675811|NCT00597584|ESA|esa
5675812|NCT00597584|Hematide™|hematide™
5675813|NCT00597584|hemodialysis|hemodialysis
5675814|NCT00597584|hemoglobin|hemoglobin
5675815|NCT00597584|Hb|hb
5675816|NCT00597584|Hgb|hgb
5675817|NCT00597584|Omontys|omontys
5675818|NCT00597584|peginesatide|peginesatide
5675819|NCT00597584|red blood cell|red blood cell
5675820|NCT00597584|red blood cell production|red blood cell production
5675821|NCT00597558|Egg allergy|egg allergy
5675822|NCT00597545|Carotid Endarterectomy|carotid endarterectomy
5675823|NCT00597545|Neuropsychological tests|neuropsychological tests
5675824|NCT00597545|Stroke|stroke
5675825|NCT00597545|Transient ischemia|transient ischemia
5675826|NCT00597545|Hypoperfusion|hypoperfusion
5675827|NCT00597545|Ischemia|ischemia
5675828|NCT00597532|Breast Cancer|breast cancer
5675829|NCT00597532|Soy|soy
5675830|NCT00597532|Milk|milk
5675831|NCT00597532|Supplementation|supplementation
5675832|NCT00597532|02-062|02-062
5675833|NCT00597519|Cancer|cancer
5675834|NCT00597519|Leukemia|leukemia
5675835|NCT00597519|Myelodysplastic Syndrome|myelodysplastic syndrome
5675836|NCT00597519|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5675837|NCT00597519|Total Body Irradiation|total body irradiation
5675838|NCT00597519|Umbilical Cord Blood Grafts|umbilical cord blood grafts
5675839|NCT00597519|06-014|06-014
5675840|NCT00597506|colorectal|colorectal
5675841|NCT00597506|refractory|refractory
5675842|NCT00597506|adenocarcinoma|adenocarcinoma
5675843|NCT00597506|bevacizumab|bevacizumab
5891567|NCT03875651|Drug-Eluting Stents|drug-eluting stents
5891587|NCT03871673|Hepatic Glycogen Storage Diseases|hepatic glycogen storage diseases
5891588|NCT03871673|Treatment|treatment
5891589|NCT03871673|Clinical trial|clinical trial
5891590|NCT03871673|Cornstarch|cornstarch
5891591|NCT03871673|Sweet polvilho|sweet polvilho
5891602|NCT03868241|ventilator-associated pneumonia|ventilator-associated pneumonia
5891603|NCT03868241|catheter related bloodstream infection|catheter related bloodstream infection
5891604|NCT03868241|urinary catheter-related infection|urinary catheter-related infection
5891605|NCT03867097|systemic sclerosis|systemic sclerosis
5891606|NCT03867097|raynaud phenomenon|raynaud phenomenon
5891620|NCT03866577|Immune thrombocytopenic purpura|immune thrombocytopenic purpura
5891621|NCT03866577|Healthy subjects|healthy subjects
5891622|NCT03866577|M254|m254
5891623|NCT03866577|Intravenous immunoglobulin (IVIg)|intravenous immunoglobulin (ivig)
5675844|NCT00597506|everolimus|everolimus
5675845|NCT00597493|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5675847|NCT00597493|Glioblastoma|glioblastoma
5675848|NCT00597493|Sorafenib|sorafenib
5675849|NCT00597493|Temozolomide|temozolomide
5675850|NCT00597493|Brain Tumor|brain tumor
5675851|NCT00597493|Recurrent GBM|recurrent gbm
5675852|NCT00597493|Temodar|temodar
5675853|NCT00597493|Gliosarcoma|gliosarcoma
5675854|NCT00597493|Glioma|glioma
5675855|NCT00597493|Nexavar|nexavar
5675856|NCT00597480|Growth hormone|growth hormone
5675857|NCT00597480|Child|child
5675858|NCT00597480|insulin resistance|insulin resistance
5675859|NCT00597480|metabolic syndrome X|metabolic syndrome x
5675860|NCT00597480|children born small for gestational age|children born small for gestational age
5675861|NCT00597467|myopia|myopia
5675862|NCT00597467|hyperopia|hyperopia
5675863|NCT00597467|extended wear|extended wear
5675864|NCT00597467|ametropia|ametropia
5675865|NCT00597454|Breast|breast
5675866|NCT00597441|unrelated|unrelated
5675867|NCT00597441|umbilical cord blood transplantation|umbilical cord blood transplantation
5675868|NCT00597441|thymus transplantation|thymus transplantation
5675869|NCT00597415|Osteoarthritis|osteoarthritis
5675871|NCT00597402|Avastin|avastin
5675872|NCT00597402|Bevacizumab|bevacizumab
5675873|NCT00597402|Temozolomide|temozolomide
5675874|NCT00597402|Temodar|temodar
5675875|NCT00597402|Irinotecan|irinotecan
5675876|NCT00597402|Camptosar|camptosar
5675877|NCT00597402|GBM|gbm
5675878|NCT00597402|Glioblastoma Multiforme|glioblastoma multiforme
5675879|NCT00597402|Gliosarcoma|gliosarcoma
5675880|NCT00597402|Brain tumor|brain tumor
5675881|NCT00597402|Glioma|glioma
5675882|NCT00597402|New GBM|new gbm
5675883|NCT00597402|Newly diagnosed GBM or gliosarcoma malignant brain tumor|newly diagnosed gbm or gliosarcoma malignant brain tumor
5675884|NCT00597389|posttraumatic stress disorder|posttraumatic stress disorder
5675885|NCT00597389|propranolol|propranolol
5675886|NCT00597389|inderol|inderol
5675887|NCT00597389|child|child
5675888|NCT00597389|trauma|trauma
5675889|NCT00597389|Posttraumatic stress disorders (PTSD)|posttraumatic stress disorders (ptsd)
5675890|NCT00597376|memory loss|memory loss
5675891|NCT00597363|vascular access site|vascular access site
5675892|NCT00597363|arterial puncture|arterial puncture
5675893|NCT00597363|femoral pseudoaneurysm|femoral pseudoaneurysm
5675894|NCT00597350|Fenugreek|fenugreek
5675895|NCT00597350|Trigonella foenum-graecum|trigonella foenum-graecum
5675896|NCT00597350|Diabetes mellitus|diabetes mellitus
5675897|NCT00597350|Blood sugar|blood sugar
5675898|NCT00597350|Insulin|insulin
5675899|NCT00597350|Glucose|glucose
5675900|NCT00597337|bullying|bullying
5675901|NCT00597337|victimisation|victimisation
5675902|NCT00597337|aggressive behavior|aggressive behavior
5675903|NCT00597324|Allen's test|allen's test
5675904|NCT00597324|lactate|lactate
5675905|NCT00597324|safety|safety
5675906|NCT00597324|radial intervention|radial intervention
5675907|NCT00597324|Patients with coronary artery disease|patients with coronary artery disease
5675908|NCT00597311|rectal cancer|rectal cancer
5891643|NCT03863873|Platelet-rich plasma|platelet-rich plasma
5891644|NCT03863080|IMVT-1401|imvt-1401
5891656|NCT03862313|optic neuritis|optic neuritis
5891657|NCT03862313|multiple sclerosis|multiple sclerosis
5891658|NCT03862313|repetitive transorbital alternating current stimulation|repetitive transorbital alternating current stimulation
5891659|NCT03862313|optical coherence tomography|optical coherence tomography
5891660|NCT03862313|low-contrast visual acuity|low-contrast visual acuity
5891674|NCT03860168|sleep|sleep
5891675|NCT03860168|sedation|sedation
5891676|NCT03860168|early mobilization|early mobilization
5891677|NCT03860168|acute rehabilitation|acute rehabilitation
5891678|NCT03860168|delirium|delirium
5891684|NCT03858049|Frozen-thawed embryo transfer|frozen-thawed embryo transfer
5891685|NCT03858049|Infertility|infertility
5891686|NCT03858049|Crinone|crinone
5891687|NCT03858049|Duphaston|duphaston
5891688|NCT03858049|Chinese population|chinese population
5891689|NCT03857477|Prostate Cancer|prostate cancer
5891702|NCT03854773|Erector spinae plane block|erector spinae plane block
5891703|NCT03854773|Video assisted thoracic surgery,|video assisted thoracic surgery,
5891704|NCT03854773|Postoperative analgesia|postoperative analgesia
5891746|NCT03849547|Chronic ankle instability|chronic ankle instability
5891747|NCT03849547|Smartphone|smartphone
5891764|NCT03846960|video laryngoscope|video laryngoscope
5891765|NCT03846960|minimally invasive surfactant administration|minimally invasive surfactant administration
5891769|NCT03845998|anaesthesia|anaesthesia
5891770|NCT03845998|laryngeal mask airway|laryngeal mask airway
5891771|NCT03845998|paediatric|paediatric
5891772|NCT03845504|depression|depression
5891773|NCT03845504|transcranial magnetic stimulation|transcranial magnetic stimulation
5891847|NCT03837899|Pediatric, solid tumors, hematological malignancies, durvalumab, tremelimumab, immunotherapy|pediatric, solid tumors, hematological malignancies, durvalumab, tremelimumab, immunotherapy
5891860|NCT03835754|Heart preservation|heart preservation
5891861|NCT03835754|Beating heart transplant|beating heart transplant
5891862|NCT03834753|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5891878|NCT03833180|Lymphoma|lymphoma
5891879|NCT03833180|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5891880|NCT03833180|Leukemia, B-Cell|leukemia, b-cell
5891881|NCT03833180|Leukemia, Lymphoid|leukemia, lymphoid
5891882|NCT03833180|Leukemia|leukemia
5891883|NCT03833180|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5891884|NCT03833180|Lymphoma, Follicular|lymphoma, follicular
5891885|NCT03833180|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5891886|NCT03833180|Burkitt Lymphoma|burkitt lymphoma
5891887|NCT03833180|Lymphoma, Lymphoplasmacytoid|lymphoma, lymphoplasmacytoid
5891888|NCT03833180|Waldenström Macroglobulinemia|waldenström macroglobulinemia
5891889|NCT03833180|Lymphoma, T-cell|lymphoma, t-cell
5891890|NCT03833180|Leukemia, Lymphoid, Acute|leukemia, lymphoid, acute
5891891|NCT03833180|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5675909|NCT00597311|radiotherapy|radiotherapy
5675910|NCT00597311|radiochemotherapy|radiochemotherapy
5675911|NCT00597298|diaphragmatic paralysis|diaphragmatic paralysis
5675912|NCT00597298|cardiac surgery|cardiac surgery
5675913|NCT00597298|respiratory muscle training|respiratory muscle training
5675914|NCT00597285|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
5675915|NCT00597285|Magnetic Resonance|magnetic resonance
5675916|NCT00597285|Epilepsy|epilepsy
5675918|NCT00597285|Healthy Volunteer|healthy volunteer
5675919|NCT00597285|HV|hv
5675920|NCT00597272|melanoma|melanoma
5675921|NCT00597272|resected local|resected local
5675922|NCT00597272|systemic metastasis|systemic metastasis
5675923|NCT00597259|hepatitis B, entecavir, pegylated interferon alfa-2a|hepatitis b, entecavir, pegylated interferon alfa-2a
5675924|NCT00597246|Brain|brain
5675925|NCT00597246|CNS|cns
5675926|NCT00597246|Central Nervous System|central nervous system
5675927|NCT00597207|CPR|cpr
5675928|NCT00597207|mechanical|mechanical
5675929|NCT00597207|manual|manual
5675930|NCT00597207|outcome|outcome
5675931|NCT00597207|survival|survival
5675932|NCT00597207|quality|quality
5675933|NCT00597194|inguinal hernia|inguinal hernia
5675934|NCT00597194|laparoscopic repair|laparoscopic repair
5675935|NCT00597194|open repair|open repair
5675936|NCT00597194|randomized|randomized
5675937|NCT00597181|Inflammatory response|inflammatory response
5675938|NCT00597168|Schizophrenia|schizophrenia
5675939|NCT00597168|atypical antipsychotic|atypical antipsychotic
5675940|NCT00597168|quality of life|quality of life
5675941|NCT00597168|ambulatory setting|ambulatory setting
5675942|NCT00597142|renal stent|renal stent
5675943|NCT00597142|stent|stent
5675944|NCT00597142|atherosclerosis|atherosclerosis
5675945|NCT00597142|aortorenal ostium|aortorenal ostium
5675946|NCT00597142|renal|renal
5675947|NCT00597142|renal artery|renal artery
5675948|NCT00597142|PTRA|ptra
5675949|NCT00597129|pancreatic cancer|pancreatic cancer
5675950|NCT00597129|cancer of the pancreas|cancer of the pancreas
5675951|NCT00597129|pancreas cancer|pancreas cancer
5675952|NCT00597116|Mesothelioma|mesothelioma
5675953|NCT00597116|inoperable|inoperable
5675954|NCT00597116|relapsed|relapsed
5675955|NCT00597103|Hemodialysis|hemodialysis
5675956|NCT00597103|Frequent Hemodialysis|frequent hemodialysis
5675957|NCT00597103|Sleep Apnea|sleep apnea
5675958|NCT00597103|Restless Leg Syndrome|restless leg syndrome
5675959|NCT00597103|Cognitive Function|cognitive function
5675960|NCT00597090|Infections|infections
5675961|NCT00597090|lymphoma|lymphoma
5675962|NCT00597064|asthma|asthma
5891934|NCT03829657|Symptomatic Neurogenic Orthostatic Hypotension|symptomatic neurogenic orthostatic hypotension
5891936|NCT03829657|multiple symptom atrophy|multiple symptom atrophy
5891937|NCT03829657|MSA|msa
5891938|NCT03829657|Parkinson's disease|parkinson's disease
5891939|NCT03829657|PD|pd
5891940|NCT03829657|pure autonomic failure|pure autonomic failure
5891941|NCT03829657|PAF|paf
5891942|NCT03829657|orthostatic hypotension|orthostatic hypotension
5891943|NCT03829657|OH|oh
5891944|NCT03829657|REDWOOD|redwood
5891945|NCT03829657|ampreloxetine|ampreloxetine
5891946|NCT03829657|low blood pressure|low blood pressure
5891947|NCT03829657|dizziness|dizziness
5891948|NCT03829657|fainting|fainting
5891949|NCT03829657|blacking out|blacking out
5891950|NCT03829657|lightheadedness|lightheadedness
5891951|NCT03829657|norepinephrine|norepinephrine
5891952|NCT03829657|hypotension|hypotension
5891953|NCT03829657|Neurogenic Orthostatic Hypotension|neurogenic orthostatic hypotension
5891955|NCT03829657|170|170
5891956|NCT03829657|0170|0170
5891957|NCT03829657|145|145
5891958|NCT03829657|0145|0145
5891959|NCT03829657|TD-9855|td-9855
5891960|NCT03829657|TD9855|td9855
5891961|NCT03829657|Parkinsonism|parkinsonism
5891975|NCT03828539|migraine|migraine
5891976|NCT03828539|erenumab|erenumab
5891977|NCT03828539|topiramate|topiramate
5891978|NCT03828539|CAMG 334|camg 334
5891979|NCT03828539|headache|headache
5891980|NCT03828539|CGRP receptor agonist|cgrp receptor agonist
5892035|NCT03822780|Interstitial lung disease|interstitial lung disease
5892036|NCT03822780|Hydroxychloroquine|hydroxychloroquine
5892047|NCT03822351|Locally Advanced NSCLC|locally advanced nsclc
5892048|NCT03822351|Non-small Cell Lung Cancer|non-small cell lung cancer
5892049|NCT03822351|Cancer|cancer
5892050|NCT03822351|Lung|lung
5892051|NCT03822351|Unresectable|unresectable
5892052|NCT03822351|Stage III|stage iii
5892056|NCT03821675|electrical stimulation|electrical stimulation
5892057|NCT03821675|wound healing|wound healing
5892058|NCT03821675|skin perfusion|skin perfusion
5892059|NCT03821675|home based therapy|home based therapy
5892060|NCT03821675|diabetic foot|diabetic foot
5892061|NCT03821675|Foot ulcer|foot ulcer
5892081|NCT03820947|Venous reflux|venous reflux
5892082|NCT03820947|Venous leg ulcer|venous leg ulcer
5892083|NCT03820947|Varicose Veins|varicose veins
5892084|NCT03820947|Chronic Venous Insufficiency|chronic venous insufficiency
5892085|NCT03820947|VenaSeal|venaseal
5892086|NCT03820947|Endothermal Ablation|endothermal ablation
5892087|NCT03820947|Surgical Stripping|surgical stripping
5892088|NCT03820947|Radiofrequency Ablation|radiofrequency ablation
5892089|NCT03820947|Laser Ablation|laser ablation
5892090|NCT03820947|Great Saphenous Vein|great saphenous vein
5892091|NCT03820947|Small Saphenous Vein|small saphenous vein
5892092|NCT03820947|Anterior Accessory Saphenous Vein|anterior accessory saphenous vein
5675963|NCT00597064|asthma control questionnaire|asthma control questionnaire
5675964|NCT00597064|oral corticosteroid|oral corticosteroid
5675965|NCT00597064|air trapping|air trapping
5675966|NCT00597064|AQLQ|aqlq
5675967|NCT00597064|control|control
5675968|NCT00597064|quality of life|quality of life
5675969|NCT00597038|Dasatinib|dasatinib
5675970|NCT00597038|Dacarbazine|dacarbazine
5675971|NCT00597025|Malnutrition|malnutrition
5675972|NCT00597025|Hypoalbuminemia|hypoalbuminemia
5675973|NCT00597025|Dietary Supplements|dietary supplements
5675974|NCT00597025|Hemodialysis|hemodialysis
5675975|NCT00597025|Peritoneal Dialysis|peritoneal dialysis
5675976|NCT00597012|Meniscal Tear|meniscal tear
5675977|NCT00597012|Osteoarthritis|osteoarthritis
5675978|NCT00597012|Arthroscopic Partial Meniscectomy|arthroscopic partial meniscectomy
5675979|NCT00597012|Physical Therapy|physical therapy
5675980|NCT00596999|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5675981|NCT00596999|Acute myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5675982|NCT00596999|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5675983|NCT00596999|Sickle Cell Disease (SCD)|sickle cell disease (scd)
5675984|NCT00596999|Beta Thalassemia|beta thalassemia
5675985|NCT00596999|Inborn Errors of Metabolism|inborn errors of metabolism
5675986|NCT00596999|Severe Combined Immunodeficiency Disease (SCID)|severe combined immunodeficiency disease (scid)
5675987|NCT00596986|Depression|depression
5675988|NCT00596986|Duloxetine|duloxetine
5675989|NCT00596986|Psychotherapy|psychotherapy
5675990|NCT00596986|Magnetic Resonance Imaging|magnetic resonance imaging
5675991|NCT00596960|Alcohol Abuse|alcohol abuse
5675992|NCT00596960|Alcohol Dependence|alcohol dependence
5675993|NCT00596960|Carbohydrate Deficient Transferrin|carbohydrate deficient transferrin
5675994|NCT00596960|Drug Dependence|drug dependence
5675995|NCT00596960|Hepatitis C|hepatitis c
5675996|NCT00596960|Motivation|motivation
5675997|NCT00596947|kidney transplantation|kidney transplantation
5675998|NCT00596947|tacrolimus|tacrolimus
5675999|NCT00596947|Prograf|prograf
5676000|NCT00596947|mycophenolate mofetil|mycophenolate mofetil
5676001|NCT00596947|CellCept|cellcept
5676002|NCT00596947|corticosteroid withdrawal|corticosteroid withdrawal
5676003|NCT00596947|prednisone withdrawal|prednisone withdrawal
5676004|NCT00596947|prednisone maintenance|prednisone maintenance
5892167|NCT03814187|Inclisiran sodium|inclisiran sodium
5892168|NCT03814187|ASCVD|ascvd
5892169|NCT03814187|LDL-C|ldl-c
5892170|NCT03814187|HeFH|hefh
5892171|NCT03814187|HoFH|hofh
5892178|NCT03813238|DCP|dcp
5892248|NCT03808519|n3 PUFA|n3 pufa
5892264|NCT03805048|Percutaneous Coronary Intervention|percutaneous coronary intervention
5892265|NCT03805048|Dysfunctional venous bypass graft|dysfunctional venous bypass graft
5892266|NCT03805048|Second generation DES|second generation des
5892267|NCT03805048|CABG|cabg
5892293|NCT03803332|PTSD|ptsd
5892294|NCT03803332|Military Sexual Trauma|military sexual trauma
5892295|NCT03803332|exposure therapy|exposure therapy
5892296|NCT03803332|interpersonal psychotherapy|interpersonal psychotherapy
5892297|NCT03803332|treatment|treatment
5676005|NCT00596947|rabbit antithymocyte globulin|rabbit antithymocyte globulin
5676006|NCT00596947|Thymoglobulin|thymoglobulin
5676007|NCT00596934|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5676008|NCT00596934|Insulin resistance|insulin resistance
5676009|NCT00596934|Obesity|obesity
5676010|NCT00596934|Leptin therapy|leptin therapy
5676011|NCT00596934|NASH|nash
5676012|NCT00596921|Ultrasonography|ultrasonography
5676013|NCT00596921|Central Venous Pressure|central venous pressure
5676014|NCT00596921|Noninvasive monitoring|noninvasive monitoring
5676016|NCT00596921|Resuscitation|resuscitation
5676017|NCT00596908|Essential Tremor|essential tremor
5676018|NCT00596908|Parkinsonian Tremor|parkinsonian tremor
5676019|NCT00596908|Parkinson Disease|parkinson disease
5676020|NCT00596908|Upper Extremity Tremor with duration of less than 2 years|upper extremity tremor with duration of less than 2 years
5676021|NCT00596895|Isoflavone, PSA, prostate cancer, recurrent, quality of life|isoflavone, psa, prostate cancer, recurrent, quality of life
5676022|NCT00596882|smoking cessation|smoking cessation
5676023|NCT00596882|nicotine dependence|nicotine dependence
5676024|NCT00596882|message prime|message prime
5676025|NCT00596882|recruitment|recruitment
5671170|NCT00616928|human|human
5676026|NCT00596856|Early childhood caries - ECC|early childhood caries - ecc
5676027|NCT00596856|Referral behavior|referral behavior
5676028|NCT00596856|Oral health risk assessment|oral health risk assessment
5676029|NCT00596856|Guideline development and dissemination|guideline development and dissemination
5676030|NCT00596830|IGF-1R inhibitor|igf-1r inhibitor
5676031|NCT00596830|Non-small-cell lung carcinoma|non-small-cell lung carcinoma
5676032|NCT00596830|CP-751|cp-751
5676033|NCT00596830|871|871
5676034|NCT00596817|Relapse prevention|relapse prevention
5676035|NCT00596817|Antidepressants|antidepressants
5676036|NCT00596817|Placebo-controlled|placebo-controlled
5676037|NCT00596817|Double-blind|double-blind
5676038|NCT00596817|Multicentre study|multicentre study
5676039|NCT00596804|NHL|nhl
5676040|NCT00596804|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5676041|NCT00596804|follicular lymphoma|follicular lymphoma
5676042|NCT00596804|B-cell lymphoma|b-cell lymphoma
5676043|NCT00596804|diffuse large cell lymphoma|diffuse large cell lymphoma
5676044|NCT00596804|small lymphoctytic lymphoma|small lymphoctytic lymphoma
5676045|NCT00596804|Mantle cell lymphoma|mantle cell lymphoma
5676047|NCT00596804|marginal zone lymphoma|marginal zone lymphoma
5676048|NCT00596804|High-Grade|high-grade
5676049|NCT00596804|Intermediate-Grade|intermediate-grade
5676050|NCT00596804|Low-Grade|low-grade
5676051|NCT00596804|Mixed|mixed
5676052|NCT00596778|Physical therapy specialty|physical therapy specialty
5676053|NCT00596778|Postoperative period. Abdominal surgery|postoperative period. abdominal surgery
5676054|NCT00596778|Anesthesia recovery period|anesthesia recovery period
5676055|NCT00596778|Spirometry|spirometry
5676056|NCT00596765|Brain Injury|brain injury
5676057|NCT00596765|Neuropsychology|neuropsychology
5676058|NCT00596765|Cognitive Behavioral Therapy|cognitive behavioral therapy
5676059|NCT00596765|Neuropsychological Rehabilitation|neuropsychological rehabilitation
5676060|NCT00596752|Alprostadil|alprostadil
5676061|NCT00596752|Prostavasin|prostavasin
5676062|NCT00596752|PAOD|paod
5676063|NCT00596752|Fontaine Stage IV|fontaine stage iv
5676064|NCT00596739|Bariatric surgery, weight loss surgery, male infertility, Roux-En-Y, gastric banding|bariatric surgery, weight loss surgery, male infertility, roux-en-y, gastric banding
5676065|NCT00596726|All patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.|all patients presenting for high-risk cardiac surgery and who might post-operatively meet the study inclusion criteria are potential study candidates.
5676066|NCT00596713|general population|general population
5676067|NCT00596700|Capsule endoscopy|capsule endoscopy
5676068|NCT00596700|Crohn's disease|crohn's disease
5676070|NCT00596700|Activity score|activity score
5676071|NCT00596700|Small bowel|small bowel
5676072|NCT00596700|Crohn's disease of the small bowel in any stage|crohn's disease of the small bowel in any stage
5892298|NCT03803111|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5892299|NCT03803111|Exercise Training Program|exercise training program
5892300|NCT03803111|Iron Deficiency|iron deficiency
5892314|NCT03802396|Delirium|delirium
5892315|NCT03802396|Aging|aging
5892316|NCT03802396|Elderly|elderly
5892317|NCT03802396|Postoperative|postoperative
5892318|NCT03802396|Cognitive Dysfunction|cognitive dysfunction
5892345|NCT03798418|Sarcopenia|sarcopenia
5892346|NCT03798418|stroke|stroke
5892347|NCT03798418|osteoporosis|osteoporosis
5892348|NCT03798418|chronic kidney disease|chronic kidney disease
5892349|NCT03798418|cancer|cancer
5892350|NCT03798418|balance and gait|balance and gait
5892386|NCT03793803|Palliative Care|palliative care
5892387|NCT03793803|Home-Based Care|home-based care
5892388|NCT03792555|Acromegaly|acromegaly
5892389|NCT03792555|ACROBAT|acrobat
5892390|NCT03792555|EVOLVE|evolve
5892394|NCT03790865|Prader-Willi Syndrome|prader-willi syndrome
5892395|NCT03790865|PWS|pws
5892409|NCT03789201|TMS-Evoked Potential|tms-evoked potential
5892410|NCT03789201|TMS|tms
5892411|NCT03789201|fMRI|fmri
5892412|NCT03789201|Behavior|behavior
5892413|NCT03789201|Electroencephalogram (EEG)|electroencephalogram (eeg)
5892414|NCT03787550|ECMO|ecmo
5892415|NCT03787550|Sedatives|sedatives
5892416|NCT03787550|Analgesics|analgesics
5892417|NCT03787550|Antibiotics|antibiotics
5892426|NCT03695081|Medicine review|medicine review
5892427|NCT03695081|Patient handoff|patient handoff
5892428|NCT03695081|Patient hand over|patient hand over
5892429|NCT03695081|Intertrochanteric fractures|intertrochanteric fractures
5892430|NCT03695081|Trochanteric fractures|trochanteric fractures
5892431|NCT03695081|Subtrochanteric fractures|subtrochanteric fractures
5892432|NCT03695081|Hospital readmission|hospital readmission
5892433|NCT03695081|Hospital readmissions|hospital readmissions
5892434|NCT03695081|Injuries, Hip|injuries, hip
5892435|NCT03695081|Hospitalization|hospitalization
5892436|NCT03695081|Hospitalisation|hospitalisation
5892437|NCT03695081|Hip|hip
5892438|NCT03695081|Fracture|fracture
5892439|NCT03695081|Femoral fractures|femoral fractures
5892440|NCT03695081|Femoral neck fractures|femoral neck fractures
5892441|NCT03695081|Medication errors|medication errors
5892442|NCT03695081|Medication review|medication review
5892443|NCT03695081|Medication reconciliation|medication reconciliation
5892458|NCT03693586|seroprevalence|seroprevalence
5892459|NCT03693586|viral load|viral load
5892460|NCT03693586|chronic hepatitis c|chronic hepatitis c
5892461|NCT03693586|vasculitis|vasculitis
5873408|NCT03714152|CHB|chb
5892473|NCT03691753|Fitaya|fitaya
5892474|NCT03691753|Vena cava filter|vena cava filter
5892486|NCT03688906|Liquid biopsy|liquid biopsy
5892487|NCT03688906|Blood test cancer|blood test cancer
5892488|NCT03688906|Cancer diagnostic|cancer diagnostic
5892489|NCT03688906|Genomics|genomics
5892490|NCT03688906|Genomic test|genomic test
5892491|NCT03688906|AI genomics|ai genomics
5892493|NCT03688906|Cancer screening|cancer screening
5892494|NCT03688009|mindfulness-based intervention|mindfulness-based intervention
5892495|NCT03688009|family psychoeducation|family psychoeducation
5892496|NCT03688009|Chinese family caregivers|chinese family caregivers
5892497|NCT03688009|early psychosis|early psychosis
5676073|NCT00596700|Recruiting|recruiting
5676074|NCT00596687|diabetes|diabetes
5676075|NCT00596687|post-op complications|post-op complications
5676076|NCT00596687|inpatient hyperglycemia|inpatient hyperglycemia
5676077|NCT00596674|Women|women
5676078|NCT00596674|Fibromyalgia Syndrome|fibromyalgia syndrome
5676079|NCT00596674|Health Behaviors|health behaviors
5676080|NCT00596674|Quality of Life|quality of life
5676081|NCT00596661|coronary stent|coronary stent
5676082|NCT00596648|Lung Cancer|lung cancer
5676083|NCT00596648|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5676084|NCT00596648|NSCLC|nsclc
5676085|NCT00596635|UTI|uti
5676086|NCT00596635|elderly|elderly
5676087|NCT00596635|prevention|prevention
5676088|NCT00596635|cranberry|cranberry
5676089|NCT00596635|E.Coli|e.coli
5676090|NCT00596622|Major Depressive or Manic Episodes|major depressive or manic episodes
5676091|NCT00596622|Bipolar|bipolar
5676092|NCT00596622|Mania|mania
5676093|NCT00596622|Depression|depression
5676094|NCT00596622|Lithium|lithium
5676095|NCT00596622|fMRI|fmri
5676096|NCT00596622|Pictures|pictures
5676097|NCT00596622|Brain Scan|brain scan
5676098|NCT00596609|Injections, intrathecal|injections, intrathecal
5676099|NCT00596609|Transcranial|transcranial
5676100|NCT00596609|Spinal Fusion|spinal fusion
5676101|NCT00596609|Evoked Potentials, Motor|evoked potentials, motor
5676102|NCT00596596|Constipation|constipation
5676103|NCT00596596|prucalopride|prucalopride
5676104|NCT00596570|Atrial fibrillation|atrial fibrillation
5676105|NCT00596570|Oral Anticoagulation|oral anticoagulation
5676106|NCT00596570|Percutaneous coronary intervention|percutaneous coronary intervention
5676107|NCT00596557|Renal function, heart transplant, everolimus|renal function, heart transplant, everolimus
5676108|NCT00596544|sexual dysfunction|sexual dysfunction
5676109|NCT00596531|Tinnitus|tinnitus
5676110|NCT00596531|acamprosate|acamprosate
5676111|NCT00596531|clinical trial|clinical trial
5676112|NCT00596505|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5676113|NCT00596505|bevacizumab (Avastin)|bevacizumab (avastin)
5676114|NCT00596505|vitreous hemorrhage|vitreous hemorrhage
5676115|NCT00596505|silicone oil|silicone oil
5676116|NCT00596479|CAD|cad
5676117|NCT00596479|G-CSF|g-csf
5676118|NCT00596479|Collaterals|collaterals
5676119|NCT00596479|CFI|cfi
5676120|NCT00596479|perfusion|perfusion
5676121|NCT00596466|open-label|open-label
5676122|NCT00596466|extension study|extension study
5676123|NCT00596466|pregabalin|pregabalin
5676124|NCT00596466|partial epilepsy|partial epilepsy
5676125|NCT00596453|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5676126|NCT00596453|Elevated Prostate Specific Antigen (PSA)|elevated prostate specific antigen (psa)
5676127|NCT00596440|smoking|smoking
5676128|NCT00596440|teachable moment|teachable moment
5676129|NCT00596440|cancer|cancer
5676130|NCT00596427|type two diabetes|type two diabetes
5676131|NCT00596427|gluconeogenesis|gluconeogenesis
5676132|NCT00596427|glucose|glucose
5676133|NCT00596427|lipid synthesis|lipid synthesis
5676134|NCT00596427|hepatic insulin sensitivity|hepatic insulin sensitivity
5676135|NCT00596427|colesevelam HCl|colesevelam hcl
5676136|NCT00596414|liver|liver
5676137|NCT00596414|biopsy|biopsy
5676138|NCT00596388|HMP, AMD, CNV, PHP, HPHP|hmp, amd, cnv, php, hphp
5676139|NCT00596375|Lidocaine|lidocaine
5676140|NCT00596375|Infant|infant
5676141|NCT00596375|Urinary Catheterization|urinary catheterization
5676142|NCT00596375|Emergency Medicine|emergency medicine
5676143|NCT00596375|Analgesia|analgesia
5676144|NCT00596362|Melanoma|melanoma
5676146|NCT00596362|Avastin|avastin
5676147|NCT00596349|epithelial Ovarian Cancer|epithelial ovarian cancer
5892601|NCT03675360|Diabetes|diabetes
5892602|NCT03675360|Low-Carbohydrate Diet|low-carbohydrate diet
5892623|NCT03673007|contraception|contraception
5892624|NCT03673007|financial access|financial access
5892625|NCT03673007|unwanted pregnancy|unwanted pregnancy
5892644|NCT03671330|HR+|hr+
5892645|NCT03671330|HER2-|her2-
5892646|NCT03671330|breast cancer|breast cancer
5892647|NCT03671330|ribociclib|ribociclib
5892648|NCT03671330|Advanced breast cancer|advanced breast cancer
5892649|NCT03671330|LEE011|lee011
5892650|NCT03671330|pre- and postmenopausal Chinese women|pre- and postmenopausal chinese women
5892651|NCT03671330|HR positive|hr positive
5892652|NCT03671330|HER2-negative|her2-negative
5892653|NCT03671330|Endocrine therapy|endocrine therapy
4962255|NCT04225819|IBD|ibd
5676148|NCT00596349|Quality of Life|quality of life
5676149|NCT00596349|Survivorship|survivorship
5676150|NCT00596323|antenna|antenna
5676151|NCT00596323|continuous glucose monitoring|continuous glucose monitoring
5676152|NCT00596323|electromagnetic|electromagnetic
5676153|NCT00596310|Lung cancer|lung cancer
5676154|NCT00596310|screening|screening
5676155|NCT00596297|Diabetic Retinopathy|diabetic retinopathy
5676156|NCT00596297|Vitreous Hemorrhage|vitreous hemorrhage
5676157|NCT00596297|Bevacizumab|bevacizumab
5676158|NCT00596297|pars plana vitrectomy|pars plana vitrectomy
5676159|NCT00596297|preoperative|preoperative
5502025|NCT01287884|ABG|abg
5676160|NCT00596284|Cognitive Behavior Therapy|cognitive behavior therapy
5676161|NCT00596284|Alzheimer's Disease|alzheimer's disease
5676162|NCT00596258|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5676163|NCT00596258|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
5676164|NCT00596258|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
5676165|NCT00596258|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5676166|NCT00596258|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5676167|NCT00596245|non-smoking healthy volunteers aged 18 - 35|non-smoking healthy volunteers aged 18 - 35
5676168|NCT00596219|HEAD|head
5676169|NCT00596219|NECK|neck
5676170|NCT00596219|SQUAMOUS|squamous
5676171|NCT00596219|CARCINOMA|carcinoma
5676172|NCT00596193|Hyperalgesia|hyperalgesia
5676173|NCT00596193|nociceptors|nociceptors
5676174|NCT00596193|Neurons|neurons
5676175|NCT00596180|carbon monoxide poisoning|carbon monoxide poisoning
5676176|NCT00596180|brain injury|brain injury
5676177|NCT00596167|Short-daily hemodialysis|short-daily hemodialysis
5676178|NCT00596167|pharmacokinetics|pharmacokinetics
5676179|NCT00596167|levofloxacin|levofloxacin
5676180|NCT00596167|gentamicin|gentamicin
5676181|NCT00596167|vancomycin|vancomycin
5676182|NCT00596141|oral periodontal gingival intraoral mucosal mucoperiosteal|oral periodontal gingival intraoral mucosal mucoperiosteal
5676183|NCT00596141|Surgery, Oral|surgery, oral
5676184|NCT00596128|Blood glucose|blood glucose
5676185|NCT00596128|Clinical pathways|clinical pathways
5676186|NCT00596076|Low back pain|low back pain
5676187|NCT00596063|pharmacokinetics|pharmacokinetics
5676188|NCT00596063|pharmacodynamics|pharmacodynamics
5676189|NCT00596063|recombinant human insulin|recombinant human insulin
5676190|NCT00596063|healthy volunteers|healthy volunteers
5676191|NCT00596050|procedural sedation|procedural sedation
5676192|NCT00596050|fracture reduction|fracture reduction
5676193|NCT00596050|pediatric emergency medicine|pediatric emergency medicine
5676194|NCT00596050|etomidate|etomidate
5676195|NCT00596050|ketamine|ketamine
5676196|NCT00596050|analgesia|analgesia
5676197|NCT00596037|Growth hormone Deficiency|growth hormone deficiency
5676198|NCT00596011|prostate cancer|prostate cancer
5676199|NCT00596011|PIN|pin
5676200|NCT00596011|polyphenon E|polyphenon e
5676201|NCT00596011|EGCG|egcg
5676202|NCT00595998|AMD, HMP, PHP|amd, hmp, php
5676203|NCT00595985|Time to Progression|time to progression
5676204|NCT00595985|Toxicity|toxicity
5676205|NCT00595985|Overall survival|overall survival
5676206|NCT00595985|Response rate|response rate
5676207|NCT00595985|Quality of live|quality of live
5676208|NCT00595985|Toxicities|toxicities
5676210|NCT00595972|Overall survival|overall survival
5892661|NCT03670719|manual therapy|manual therapy
5892662|NCT03670719|exercise|exercise
5892663|NCT03670719|physiotherapy|physiotherapy
5892664|NCT03670719|chronic cervical pain|chronic cervical pain
5892665|NCT03670719|upper cervical spain|upper cervical spain
5892683|NCT03669549|CAH|cah
5892684|NCT03669549|nevanimibe|nevanimibe
4962344|NCT04225403|Tobacco|tobacco
5676211|NCT00595972|Response rate|response rate
5676212|NCT00595972|Quality of Live|quality of live
5676213|NCT00595972|Toxicities|toxicities
5676214|NCT00595933|Head and Neck cancer|head and neck cancer
5676215|NCT00595933|Radiation therapy|radiation therapy
5676216|NCT00595933|Dry mouth remedies|dry mouth remedies
5676217|NCT00595933|Dry Mouth|dry mouth
5676218|NCT00595933|Xerostomia|xerostomia
5676219|NCT00595920|Tovaxin|tovaxin
5655820|NCT00678964|NSCLC|nsclc
5676220|NCT00595920|Autologous|autologous
5676221|NCT00595920|T-cell vaccine (TCV)|t-cell vaccine (tcv)
5676222|NCT00595907|tuberculosis|tuberculosis
5676223|NCT00595907|interferon gamma release assays|interferon gamma release assays
5676224|NCT00595907|treatment|treatment
5676225|NCT00595894|rheumatoid arthritis|rheumatoid arthritis
5676226|NCT00595894|African Americans|african americans
5676227|NCT00595894|osteopenia|osteopenia
5676228|NCT00595894|osteoporosis|osteoporosis
5676229|NCT00595894|bone mineral density|bone mineral density
5676230|NCT00595881|Bedside emergency ultrasound|bedside emergency ultrasound
5676231|NCT00595881|Abscess|abscess
5676232|NCT00595881|Cellulitis|cellulitis
5676233|NCT00595881|Soft tissue infection|soft tissue infection
5676234|NCT00595881|Methicillin resistant staphylococcus aureus (MRSA)|methicillin resistant staphylococcus aureus (mrsa)
5676235|NCT00595868|Nicotine|nicotine
5676236|NCT00595868|Smoking|smoking
5676237|NCT00595868|Smoking Cessation|smoking cessation
5676238|NCT00595855|glaucoma|glaucoma
5676239|NCT00595855|surgery|surgery
5676240|NCT00595855|non penetrating procedures|non penetrating procedures
5676246|NCT00595816|physical fitness|physical fitness
5676247|NCT00595816|injury|injury
5676248|NCT00595816|prevention|prevention
5676249|NCT00595816|conscripts|conscripts
5676250|NCT00595777|Institutional change|institutional change
5676251|NCT00595777|Improved pain management|improved pain management
5676252|NCT00595764|Buprenorphine|buprenorphine
5676253|NCT00595764|Buprenorphine/naloxone|buprenorphine/naloxone
5676254|NCT00595764|Counseling|counseling
5676255|NCT00595764|Primary care|primary care
5676258|NCT00595738|Cardiac biomarkers|cardiac biomarkers
5676259|NCT00595738|Hemodynamics|hemodynamics
5676260|NCT00595738|Tailored therapy|tailored therapy
5676261|NCT00595725|Cervix|cervix
5676262|NCT00595725|Endometrium|endometrium
5676263|NCT00595725|Cervical Carcinoma|cervical carcinoma
5676264|NCT00595725|Lymphatic Mapping|lymphatic mapping
5676265|NCT00595712|Genovarum|genovarum
5676266|NCT00595712|Medial opening-wedge high tibial osteotomy|medial opening-wedge high tibial osteotomy
5676267|NCT00595712|allograft|allograft
5676268|NCT00595686|Hematologic Malignancies Hsp90 Hematologic Malignancy|hematologic malignancies hsp90 hematologic malignancy
5676269|NCT00595673|Perfusion|perfusion
5676270|NCT00595673|Echocardiograpy|echocardiograpy
5676271|NCT00595673|SPECT|spect
5676272|NCT00595673|angiography|angiography
5676273|NCT00595673|Chest pain|chest pain
5676274|NCT00595660|Palpable Breast Mass|palpable breast mass
5676275|NCT00595660|FNA|fna
5676276|NCT00595660|Cytology|cytology
5676277|NCT00595660|Fine needle aspiration|fine needle aspiration
5676278|NCT00595660|Specimen Adequacy|specimen adequacy
5676279|NCT00595634|Hip|hip
5676280|NCT00595634|Fracture|fracture
5676281|NCT00595634|Intertrochanteric|intertrochanteric
5676282|NCT00595634|intramedullary|intramedullary
5676283|NCT00595608|aftercare|aftercare
5676284|NCT00595608|nasal septum|nasal septum
5676285|NCT00595608|turbinates|turbinates
5676286|NCT00595595|Dental Pulp|dental pulp
5676287|NCT00595595|Regenerative Medicine|regenerative medicine
5676288|NCT00595595|Odontoblasts|odontoblasts
5676289|NCT00595595|Stem Cells|stem cells
5676290|NCT00595595|Growth factor differentiation of stem/progenitor cells|growth factor differentiation of stem/progenitor cells
5676291|NCT00595595|Odontoblast-specific cell phenotypes|odontoblast-specific cell phenotypes
5676292|NCT00595569|flexible insulin therapy|flexible insulin therapy
5676293|NCT00595569|diabetes education|diabetes education
5676294|NCT00595569|diabetes|diabetes
5676295|NCT00595569|insulin|insulin
5676296|NCT00595569|Weekly ambulatory sessions|weekly ambulatory sessions
5892774|NCT03652857|Apatinib plus Vinorelbine|apatinib plus vinorelbine
5892782|NCT03652493|Anomaly of the Homologous Recombination (HR) pathway|anomaly of the homologous recombination (hr) pathway
5892783|NCT03652493|Carboplatin|carboplatin
5892787|NCT03651414|Outliers|outliers
5892837|NCT03645525|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5892838|NCT03645525|Mesenchymal stem cell|mesenchymal stem cell
5892850|NCT03644823|radiotherapy|radiotherapy
5676297|NCT00595556|Zonisamide|zonisamide
5676298|NCT00595556|Pharmacotherapy|pharmacotherapy
5676299|NCT00595556|Alcohol dependence|alcohol dependence
5676300|NCT00595556|anticonvulsant|anticonvulsant
5676301|NCT00595530|ketamine|ketamine
5676302|NCT00595530|vasoocclusive pain|vasoocclusive pain
5676303|NCT00595517|gastrointestinal|gastrointestinal
5676304|NCT00595517|GI|gi
5676305|NCT00595517|NSAID|nsaid
5676306|NCT00595517|Japan|japan
5676307|NCT00595517|Japanese|japanese
5676413|NCT00595049|scleroderma|scleroderma
5676308|NCT00595517|Gastric ulcer|gastric ulcer
5676309|NCT00595517|duodenal ulcer|duodenal ulcer
5676310|NCT00595504|schizophrenia|schizophrenia
5676311|NCT00595504|metabolism|metabolism
5676312|NCT00595504|antipsychotics|antipsychotics
5676313|NCT00595504|diabetes|diabetes
5904627|NCT00001456|Albinism|albinism
5676321|NCT00595439|Sensory Evoked Potentials (SEPs)|sensory evoked potentials (seps)
5676322|NCT00595439|Electromyogram|electromyogram
5676323|NCT00595439|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5676324|NCT00595439|Complex Regional Pain Syndrome|complex regional pain syndrome
5676325|NCT00595439|Focal Hand Dystonia|focal hand dystonia
5676326|NCT00595439|Focal Dystonia|focal dystonia
5676327|NCT00595439|Chronic Regional Pain Syndrome|chronic regional pain syndrome
5676329|NCT00595426|Knee Arthroplasty|knee arthroplasty
5676330|NCT00595426|Factor Xa|factor xa
5676331|NCT00595426|VTE|vte
5676332|NCT00595426|Thrombosis|thrombosis
5676333|NCT00595426|Anticoagulants|anticoagulants
5676334|NCT00595413|Rheumatoid arthritis|rheumatoid arthritis
5676335|NCT00595413|Atacicept|atacicept
5676336|NCT00595413|Adalimumab|adalimumab
5676337|NCT00595413|Humira®|humira®
5676338|NCT00595387|Cognitive Behavioral Therapy|cognitive behavioral therapy
5676339|NCT00595361|asthma|asthma
5676340|NCT00595361|exercise induced asthma|exercise induced asthma
5676341|NCT00595361|exercise induced bronchoconstriction|exercise induced bronchoconstriction
5676342|NCT00595361|long acting beta agonist|long acting beta agonist
5676343|NCT00595361|salmeterol|salmeterol
5676344|NCT00595361|exercise challenge|exercise challenge
5676345|NCT00595361|bronchoprotection|bronchoprotection
5676346|NCT00595361|beta 2 adrenergic receptor polymorphisms|beta 2 adrenergic receptor polymorphisms
5676347|NCT00595361|pharmacogenetics|pharmacogenetics
5676348|NCT00595335|Thyroid-associated ophthalmopathy|thyroid-associated ophthalmopathy
5676349|NCT00595335|Rituximab|rituximab
5676350|NCT00595335|Proptosis|proptosis
5676352|NCT00595322|Radiation Treatment|radiation treatment
5676353|NCT00595322|Brain Cancer|brain cancer
5676354|NCT00595296|BreastCancer|breastcancer
5676355|NCT00595296|Sentinel Lymph Nodes|sentinel lymph nodes
5676356|NCT00595296|Metastasis|metastasis
5676357|NCT00595283|Preschool Onset Major Depressive Disorder|preschool onset major depressive disorder
5676358|NCT00595283|Preschool Depression|preschool depression
5676359|NCT00595283|Emotion Development|emotion development
5676360|NCT00595283|Parent Child Interaction|parent child interaction
5676361|NCT00595257|PAD, CLI, Critical Limb Ischemia, bone marrow, stem cell, injection, infusion|pad, cli, critical limb ischemia, bone marrow, stem cell, injection, infusion
5676362|NCT00595244|Perfusion|perfusion
5676363|NCT00595244|Echocardiograpy|echocardiograpy
5676364|NCT00595244|SPECT|spect
5676365|NCT00595244|angiography|angiography
5676366|NCT00595244|Chest pain|chest pain
5676367|NCT00595231|GAD|gad
5676368|NCT00595218|Patient Preferences|patient preferences
5676369|NCT00595218|Patient Satisfaction|patient satisfaction
5676370|NCT00595218|Patient-Doctor Relationship|patient-doctor relationship
5676371|NCT00595205|vaccination|vaccination
5676372|NCT00595205|intussusception|intussusception
4955145|NCT04269252|CBD|cbd
5676373|NCT00595205|Rotavirus|rotavirus
5676374|NCT00595205|vaccine|vaccine
5676375|NCT00595179|Infrared|infrared
5676376|NCT00595179|Imaging Techniques|imaging techniques
5676377|NCT00595179|Kidney Reperfusion|kidney reperfusion
5676378|NCT00595179|Pneumoperitoneum|pneumoperitoneum
5676379|NCT00595179|Nephrectomy|nephrectomy
5680426|NCT00577798|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5892851|NCT03644823|PD1-inhibitor|pd1-inhibitor
5892854|NCT03643562|Niemann-Pick|niemann-pick
5892856|NCT03643562|NPC Type 1 (NPC1)|npc type 1 (npc1)
5892857|NCT03643510|Hormone Receptor Positive|hormone receptor positive
5892858|NCT03643510|Fulvestrant|fulvestrant
5892859|NCT03643510|Abemaciclib|abemaciclib
5892860|NCT03643510|18-107|18-107
5892869|NCT03642626|ALL|all
5892870|NCT03642626|CAR-T|car-t
5892871|NCT03642626|CAR19-T|car19-t
5892872|NCT03642626|chimeric antigen receptor T cells|chimeric antigen receptor t cells
5892883|NCT03640858|Hemodialysis|hemodialysis
5892884|NCT03640858|Larger middle molecules|larger middle molecules
5892950|NCT03635723|Technology|technology
5892951|NCT03635723|Rehabilitation|rehabilitation
5892952|NCT03635723|Wearables|wearables
5892953|NCT03635723|Breast surgery|breast surgery
5892954|NCT03635723|Physical activity|physical activity
5892955|NCT03635723|Enhanced recovery after surgery|enhanced recovery after surgery
5892956|NCT03633708|sHPT|shpt
5892957|NCT03633708|CKD|ckd
5892958|NCT03633708|pediatric|pediatric
5892989|NCT03628820|Stress|stress
5892990|NCT03628820|Anxiety|anxiety
5892991|NCT03628820|Cortisol|cortisol
5892992|NCT03628820|Therapy|therapy
5892993|NCT03628820|Dog|dog
5892994|NCT03628820|Coloring|coloring
5892995|NCT03628820|Mandala|mandala
5892996|NCT03628235|online survey|online survey
5892997|NCT03628235|indirect costs|indirect costs
5892998|NCT03628235|out-of-pocket costs|out-of-pocket costs
5892999|NCT03628235|HD|hd
5893000|NCT03628235|Huntington's disease|huntington's disease
5893001|NCT03628235|companions|companions
5893002|NCT03628235|Enroll-HD|enroll-hd
5893024|NCT03625986|smoking|smoking
5893025|NCT03625986|electronic cigarettes|electronic cigarettes
5893026|NCT03625986|nicotine|nicotine
5893027|NCT03625986|ecig|ecig
5676380|NCT00595166|Women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination|women with excessive vaginal tissue that obstruct the examiner's view of the cervix during a vaginal speculum examination
5676381|NCT00595140|Acromegaly,|acromegaly,
5676382|NCT00595140|growth hormone receptor antagonist,|growth hormone receptor antagonist,
5676383|NCT00595140|somatostatin analogue,|somatostatin analogue,
5676384|NCT00595140|combined medical treatment,|combined medical treatment,
5676385|NCT00595140|acute effect,|acute effect,
5676386|NCT00595140|endogenous GH|endogenous gh
5676387|NCT00595127|Fanconi|fanconi
5676388|NCT00595127|Anemia|anemia
5676389|NCT00595127|Stem Cell|stem cell
5676390|NCT00595127|Transplant|transplant
5676391|NCT00595114|COPD|copd
5676392|NCT00595114|Airway|airway
5676393|NCT00595114|Inflammation|inflammation
5676394|NCT00595114|Infection|infection
5676395|NCT00595114|Lipid Mediators|lipid mediators
5676396|NCT00595114|Oxidative Stress|oxidative stress
5676397|NCT00595088|Bladder Cancer|bladder cancer
5676398|NCT00595088|Refractory|refractory
5676399|NCT00595088|inodiftagene vixteplasmid|inodiftagene vixteplasmid
5676400|NCT00595075|sleep|sleep
5676401|NCT00595075|performance|performance
5676402|NCT00595075|night shift|night shift
5676403|NCT00595075|Ramelteon|ramelteon
5676404|NCT00595075|Healthy Individuals|healthy individuals
5676405|NCT00595062|Breast|breast
5676406|NCT00595062|Cancer|cancer
5676407|NCT00595049|pulmonary|pulmonary
5676408|NCT00595049|arterial|arterial
5676409|NCT00595049|artery|artery
5676410|NCT00595049|hypertension|hypertension
5676411|NCT00595049|systemic|systemic
5676412|NCT00595049|sclerosis|sclerosis
5676417|NCT00595049|intravascular|intravascular
5676419|NCT00595023|Metastasis|metastasis
5676420|NCT00595010|Child Maltreatment|child maltreatment
5676421|NCT00595010|Child Neglect|child neglect
5676422|NCT00595010|Child Physical Abuse|child physical abuse
5676423|NCT00595010|Evidence-Based Practice|evidence-based practice
5676424|NCT00594997|Lyme disease|lyme disease
5676425|NCT00594997|educational intervention for children|educational intervention for children
5676426|NCT00594997|tick borne illness|tick borne illness
5676427|NCT00594997|prophylactic therapy in children|prophylactic therapy in children
5676428|NCT00594997|Self-efficacy|self-efficacy
5676429|NCT00594997|tick prevention|tick prevention
5676430|NCT00594997|tick avoidance|tick avoidance
5676431|NCT00594997|health behavior modification|health behavior modification
5676432|NCT00594971|Health Services Research|health services research
5676433|NCT00594971|Family practice|family practice
5893047|NCT03620422|Bronchoconstriction|bronchoconstriction
5893048|NCT03620422|Airway nerve function|airway nerve function
5893049|NCT03620422|Cough|cough
5893050|NCT03620422|Diagnostic Test|diagnostic test
5893051|NCT03620422|Osmolarity|osmolarity
5893052|NCT03620422|Salbutamol|salbutamol
5893082|NCT03617367|DAXI|daxi
5893083|NCT03617367|Cervical Dystonia|cervical dystonia
5893084|NCT03617367|TWSTRS|twstrs
5893085|NCT03617367|Toxin|toxin
5893086|NCT03617367|multiple treatment|multiple treatment
5676434|NCT00594932|lupus, arthritis, mycophenolate, biomarkers|lupus, arthritis, mycophenolate, biomarkers
5676435|NCT00594919|acute kidney injury|acute kidney injury
5676436|NCT00594919|ngal|ngal
5676437|NCT00594919|cardiac surgery|cardiac surgery
5676438|NCT00594906|Fracture Healing|fracture healing
5676439|NCT00594906|Teriparatide|teriparatide
5676440|NCT00594906|Forteo|forteo
5676441|NCT00594906|Pelvic Fractures|pelvic fractures
5676442|NCT00594893|Hip|hip
5676443|NCT00594893|Arthroplasty|arthroplasty
5676444|NCT00594893|Minimally Invasive|minimally invasive
5676445|NCT00594880|HIV|hiv
5676446|NCT00594880|HIV-1|hiv-1
5676447|NCT00594880|Pegasys|pegasys
5676448|NCT00594880|Peg-IFN-Alpha-2A|peg-ifn-alpha-2a
5676449|NCT00594880|Viral Suppression|viral suppression
5676450|NCT00594880|ART cessation|art cessation
5676451|NCT00594880|Immune function|immune function
5676452|NCT00594880|Innate Immunity|innate immunity
5676453|NCT00594880|Toxicity|toxicity
5676454|NCT00594880|Immune-based therapy|immune-based therapy
5676455|NCT00594880|Treatment interruption|treatment interruption
5676456|NCT00594867|Healthy|healthy
5676457|NCT00594867|Volunteer|volunteer
5676458|NCT00594854|NSAID|nsaid
5893184|NCT03603639|Epilepsy|epilepsy
5893185|NCT03603639|Photosensitive|photosensitive
5893186|NCT03603639|Seizures|seizures
5893187|NCT03603639|PPR|ppr
5893188|NCT03603639|Anti-epileptic|anti-epileptic
5893196|NCT03602963|Diabetes Mellitus|diabetes mellitus
5893197|NCT03602963|Child|child
5893198|NCT03602963|Glucose sensor|glucose sensor
5893199|NCT03602963|Accuracy|accuracy
5893200|NCT03602963|Usability|usability
5893205|NCT03601949|Back Pain|back pain
5893206|NCT03601949|Low Back Pain|low back pain
5893207|NCT03601949|Sacroiliac Back Pain|sacroiliac back pain
5893224|NCT03597594|Severe Combined Immunodeficiency|severe combined immunodeficiency
5893225|NCT03597594|SCID|scid
4962920|NCT04222127|EUS|eus
5893272|NCT03589885|Plaque psoriasis, auto-injector, 2 mL injection, secukinumab|plaque psoriasis, auto-injector, 2 ml injection, secukinumab
5893308|NCT03586596|Smokers|smokers
5893309|NCT03586596|Mobile intervention|mobile intervention
5893310|NCT03586596|Latino|latino
5893311|NCT03586596|Promotores de Salud|promotores de salud
5893312|NCT03586596|Pharmacotherapy|pharmacotherapy
5893313|NCT03586596|Cultural accomodation|cultural accomodation
5893314|NCT03586596|Tobacco use|tobacco use
5893315|NCT03586596|Health Disparities|health disparities
5893316|NCT03586596|Cancer Disparities|cancer disparities
5893335|NCT03580070|Head cancers|head cancers
5893336|NCT03580070|Neck squamous cells carcinoma|neck squamous cells carcinoma
5893337|NCT03580070|HPV|hpv
5893338|NCT03580070|Immunotherapy|immunotherapy
5893456|NCT03561220|Prostate Cancer|prostate cancer
5893457|NCT03561220|Proton Radiation|proton radiation
5893458|NCT03561220|Photon Radiation|photon radiation
5893459|NCT03561220|Cancer of the Prostate|cancer of the prostate
5893476|NCT03559114|Sequential Compression Device|sequential compression device
5893477|NCT03559114|Anticoagulant Thromboprophylaxis|anticoagulant thromboprophylaxis
5893478|NCT03559114|Deep Vein Thrombosis|deep vein thrombosis
5893479|NCT03559114|Sub Cutaneous|sub cutaneous
5893511|NCT03553004|Metastatic pancreatic cancer|metastatic pancreatic cancer
5893512|NCT03553004|germline mutation|germline mutation
5893513|NCT03553004|somatic mutation|somatic mutation
5893514|NCT03553004|Niraparib|niraparib
5893515|NCT03553004|pancreas|pancreas
5893522|NCT03552029|Relapsed/Refractory|relapsed/refractory
5893523|NCT03552029|Newly Diagnosed|newly diagnosed
5893524|NCT03552029|Unfit for Chemotherapy|unfit for chemotherapy
5893525|NCT03552029|Positive for FLT3-ITD Mutation|positive for flt3-itd mutation
5676459|NCT00594854|Gastric Ulcer|gastric ulcer
5676460|NCT00594854|High risk|high risk
5676462|NCT00594854|Vimovo|vimovo
5676463|NCT00594841|Acromioclavicular Joint|acromioclavicular joint
5676464|NCT00594841|Shoulder dislocation|shoulder dislocation
5676465|NCT00594841|AC dislocation|ac dislocation
5676466|NCT00594828|Patient self-testing|patient self-testing
5676467|NCT00594828|Oral anticoagulation therapy|oral anticoagulation therapy
5676468|NCT00594828|Expert Systems|expert systems
5676469|NCT00594828|Point-of-Care Systems|point-of-care systems
5676470|NCT00594828|International Normalized Ratio|international normalized ratio
5676471|NCT00594815|Lymphoma|lymphoma
5676472|NCT00594815|Central Nervous System|central nervous system
5676473|NCT00594802|ALLERGIC REACTION|allergic reaction
5676474|NCT00594789|Osteoporosis|osteoporosis
5676475|NCT00594789|Fractures|fractures
5676476|NCT00594789|Bone densitometry|bone densitometry
5676477|NCT00594789|Dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5676478|NCT00594776|Cone Beam CT|cone beam ct
5676479|NCT00594776|CBCT|cbct
5676480|NCT00594776|Bone Tumors|bone tumors
5676481|NCT00594776|Autographs|autographs
5676482|NCT00594776|Allographs|allographs
5676483|NCT00594763|Turner syndrome|turner syndrome
5676484|NCT00594763|Thromboembolic disease|thromboembolic disease
5676485|NCT00594737|PET|pet
5676486|NCT00594737|frontotemporal dementia|frontotemporal dementia
5676487|NCT00594737|memantine|memantine
5676488|NCT00594737|Pick's disease|pick's disease
5676489|NCT00594724|Tongue|tongue
5676490|NCT00594724|Carcinoma|carcinoma
5676491|NCT00594724|Cancer|cancer
5676492|NCT00594724|02-093|02-093
5676493|NCT00594711|Psychotherapy|psychotherapy
5676494|NCT00594711|depression|depression
5676495|NCT00594698|Perfusion|perfusion
5676496|NCT00594698|Echocardiography|echocardiography
5676497|NCT00594698|Cardiac angiography|cardiac angiography
5676498|NCT00594698|SPECT|spect
5676499|NCT00594685|Heparin|heparin
5676500|NCT00594685|Thromboembolism|thromboembolism
5676501|NCT00594685|Thrombosis|thrombosis
5676502|NCT00594672|Cataract|cataract
5676503|NCT00594672|Age-Related Macular Degeneration|age-related macular degeneration
5676504|NCT00594672|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5676505|NCT00594672|Cataracts|cataracts
5676506|NCT00594672|Age Related Macular Degeneration|age related macular degeneration
5676507|NCT00594672|AMD|amd
5676508|NCT00594659|Marijuana|marijuana
5676509|NCT00594659|Treatment|treatment
5676510|NCT00594659|Behavioral|behavioral
5676511|NCT00594659|Computer|computer
5676512|NCT00594659|Internet|internet
5676513|NCT00594646|HIV Prevention|hiv prevention
5676514|NCT00594646|Non-occupational post-exposure prophylaxis|non-occupational post-exposure prophylaxis
5676515|NCT00594646|HIV seronegativity|hiv seronegativity
5676516|NCT00594633|Cognitive dysfunction|cognitive dysfunction
5676517|NCT00594607|clotting|clotting
5676518|NCT00594607|hemodialysis|hemodialysis
5893555|NCT03548051|Clinical Trial|clinical trial
5893556|NCT03548051|Clostridium difficile|clostridium difficile
5893557|NCT03548051|Clostridium difficle Associated Disease (CDAD)|clostridium difficle associated disease (cdad)
5893558|NCT03548051|Efficacy|efficacy
5893559|NCT03548051|Fecal Microbiota Transplantation (FMT)|fecal microbiota transplantation (fmt)
5893560|NCT03548051|Microbial Restoration|microbial restoration
5893561|NCT03548051|Partially-Blinded|partially-blinded
5893563|NCT03548051|Safety|safety
5893564|NCT03548051|Stool|stool
5893565|NCT03545789|HV|hv
5893566|NCT03545789|AD|ad
5893567|NCT03545789|PSP|psp
5893588|NCT03543839|lupus|lupus
5893589|NCT03543839|early lupus|early lupus
5893590|NCT03543839|belimumab|belimumab
5893591|NCT03543839|autoreactivity|autoreactivity
5676519|NCT00594607|anticoagulation|anticoagulation
5676520|NCT00594607|bleeding risk|bleeding risk
5676521|NCT00594594|spinal cord injury|spinal cord injury
5676522|NCT00594594|urinary tract infection|urinary tract infection
5676523|NCT00594594|probiotics|probiotics
5676524|NCT00594594|Lactobacilli|lactobacilli
5798794|NCT00111046|plaque radiotherapy|plaque radiotherapy
5676525|NCT00594581|cicatrix, scarring, TGF-beta3, avotermin, Juvista|cicatrix, scarring, tgf-beta3, avotermin, juvista
5676526|NCT00594555|Blood disease, bone marrow|blood disease, bone marrow
5676527|NCT00594555|AML|aml
5676528|NCT00594555|CML,Blast Crisis|cml,blast crisis
5676529|NCT00594542|lidocaine|lidocaine
5676530|NCT00594542|local anesthesia|local anesthesia
5676531|NCT00594542|Mohs micrographic surgery|mohs micrographic surgery
5676532|NCT00594529|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5676533|NCT00594529|Metastatic liver lesions from colorectal cancers|metastatic liver lesions from colorectal cancers
5676534|NCT00594516|Low Back Pain|low back pain
5676535|NCT00594516|Dose Equivalence|dose equivalence
5676536|NCT00594516|Tapentadol (CG5503)|tapentadol (cg5503)
5676537|NCT00594516|Tapentadol-IR|tapentadol-ir
5676538|NCT00594516|Tapentadol-ER|tapentadol-er
5676539|NCT00594503|traumatic brain injury|traumatic brain injury
5676540|NCT00594490|Breast, reconstruction, silicone|breast, reconstruction, silicone
5676541|NCT00594477|IMRT|imrt
5676542|NCT00594477|breast cancer with regional nodal metastasis|breast cancer with regional nodal metastasis
5676544|NCT00594464|NEUPRO®|neupro®
5676545|NCT00594464|Parkinson's Disease (PD)|parkinson's disease (pd)
5676546|NCT00594464|perioperative use|perioperative use
5676547|NCT00594464|anaesthesia,|anaesthesia,
5676548|NCT00594451|rheumatoid arthritis|rheumatoid arthritis
5676549|NCT00594451|cigarette smoking|cigarette smoking
5676550|NCT00594451|gene-environmental interactions|gene-environmental interactions
5676551|NCT00594451|autoimmunity|autoimmunity
5676552|NCT00594451|disease severity|disease severity
5676553|NCT00594438|Synthes Reamer-Irrigator-Aspirator (RIA)|synthes reamer-irrigator-aspirator (ria)
5676554|NCT00594438|Zimmer Sentinal Reamer|zimmer sentinal reamer
5676555|NCT00594438|Transesophageal Echocardiogram (TEE)|transesophageal echocardiogram (tee)
5676556|NCT00594412|1H-Magnetic Resonance Spectroscopy|1h-magnetic resonance spectroscopy
5676557|NCT00594412|Hepatic Steatosis|hepatic steatosis
5676558|NCT00594412|Liver Fat|liver fat
5676559|NCT00594412|Liver Biopsy|liver biopsy
5676560|NCT00594412|Liver|liver
5676561|NCT00594412|Hepatitis|hepatitis
5676562|NCT00594412|Fatty Liver|fatty liver
5676563|NCT00594399|Aging|aging
5676564|NCT00594399|Exercise|exercise
5676565|NCT00594399|Impaired Glucose Tolerance|impaired glucose tolerance
5676566|NCT00594399|Obesity|obesity
5676567|NCT00594399|Functional Status|functional status
5676568|NCT00594399|Disability|disability
5676569|NCT00594399|Health Services Research|health services research
5676570|NCT00594399|Randomized Controlled Trial|randomized controlled trial
5676571|NCT00594399|Diabetes|diabetes
5676572|NCT00594399|Adaptive Randomization Design|adaptive randomization design
5676573|NCT00594386|Rotigotine|rotigotine
5676574|NCT00594386|Neupro|neupro
5676575|NCT00594373|Microbicide|microbicide
5676576|NCT00594373|HIV Seronegativity|hiv seronegativity
5676577|NCT00594360|Exercise Prescription|exercise prescription
5676578|NCT00594360|Self-efficacy|self-efficacy
5893666|NCT03530397|Advanced solid tumors|advanced solid tumors
5893667|NCT03530397|NSCLC|nsclc
5893668|NCT03530397|lung cancer|lung cancer
5893669|NCT03530397|RCC|rcc
5893670|NCT03530397|renal cell carcinoma|renal cell carcinoma
5893671|NCT03530397|kidney cancer|kidney cancer
5893672|NCT03530397|MEDI5752|medi5752
5893673|NCT03530397|immuno-oncology|immuno-oncology
5893674|NCT03530397|Cancer|cancer
5893675|NCT03530397|PD-1/CTLA-4 Bispecific|pd-1/ctla-4 bispecific
5893676|NCT03530397|PD-1|pd-1
5893677|NCT03530397|CTLA-4|ctla-4
5893678|NCT03530397|Bispecific|bispecific
5893679|NCT03530397|Chemotherapy|chemotherapy
5893680|NCT03530397|Pemetrexed|pemetrexed
5893681|NCT03530397|Carboplatin|carboplatin
5893682|NCT03530397|Pembrolizumab|pembrolizumab
5893683|NCT03530332|Preterm Birth|preterm birth
5893684|NCT03530332|Prematurity Prevention Clinic|prematurity prevention clinic
5893685|NCT03530332|Maternal-Fetal Medicine|maternal-fetal medicine
5893701|NCT03527225|Music Therapy|music therapy
5893702|NCT03527225|First Radiotherapy|first radiotherapy
5893703|NCT03527225|Anxiety Reduction|anxiety reduction
5893704|NCT03527225|Psychosocial Functioning|psychosocial functioning
5893705|NCT03527225|State - Trait Anxiety Inventory (STAI)|state - trait anxiety inventory (stai)
5893706|NCT03527225|Symptom Distress Thermometer (SDT)|symptom distress thermometer (sdt)
5893707|NCT03526744|Dietary Supplements|dietary supplements
5893708|NCT03526744|Fish Proteins|fish proteins
5893709|NCT03526744|Protein Hydrolysates|protein hydrolysates
5893710|NCT03526744|Aged|aged
5893711|NCT03526718|Transmission|transmission
5893712|NCT03526718|Genotyping|genotyping
5893713|NCT03526718|Risk factors|risk factors
5893738|NCT03523221|Mild -Moderate Anaphylaxis|mild -moderate anaphylaxis
4963411|NCT04218630|Mat pilates|mat pilates
5676579|NCT00594360|Decisional Balance|decisional balance
5676580|NCT00594360|Readiness to Change|readiness to change
5676581|NCT00594360|Physical Activity|physical activity
5676582|NCT00594347|Streptococcus pneumoniae|streptococcus pneumoniae
5676583|NCT00594334|osteopenia|osteopenia
5676584|NCT00594334|periodontitis|periodontitis
5676585|NCT00594321|spinal fractures|spinal fractures
5676586|NCT00594269|Antidepressants|antidepressants
5676587|NCT00594269|Antipsychotics|antipsychotics
5676588|NCT00594269|Dementia|dementia
5676589|NCT00594269|Discontinuation study|discontinuation study
5676590|NCT00594269|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
5676591|NCT00594256|Schizophrenia|schizophrenia
5676592|NCT00594256|Sleep Architecture|sleep architecture
5676593|NCT00594256|Sodium Oxybate|sodium oxybate
5676594|NCT00594256|Insomnia|insomnia
5676595|NCT00594256|Cognition|cognition
5676596|NCT00594230|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5676597|NCT00594230|Refractory|refractory
5676598|NCT00594230|LBH589|lbh589
5676599|NCT00594217|PCOS|pcos
5676600|NCT00594191|Statins|statins
5676601|NCT00594191|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5676602|NCT00594191|Cirrhosis|cirrhosis
5676603|NCT00594191|Portal hypertension|portal hypertension
5676604|NCT00594191|Variceal bleeding|variceal bleeding
5676605|NCT00594178|spinal cord injury|spinal cord injury
5676606|NCT00594165|Rotigotine|rotigotine
5600520|NCT00895765|Child|child
5676607|NCT00594152|Diabetic autonomic neuropathy|diabetic autonomic neuropathy
5893816|NCT03516903|Anterior myocardial infarction|anterior myocardial infarction
5893817|NCT03516903|Methotrexate|methotrexate
5893818|NCT03516903|Myocardial remodeling|myocardial remodeling
5893900|NCT03504397|IMAB362|imab362
5893901|NCT03504397|leucovorin|leucovorin
5893902|NCT03504397|fluorouracil|fluorouracil
5893903|NCT03504397|Gastric cancer|gastric cancer
5893904|NCT03504397|claudiximab|claudiximab
5893905|NCT03504397|zolbetuximab|zolbetuximab
5893906|NCT03504397|oxaliplatin|oxaliplatin
5893907|NCT03504397|adenocarcinoma|adenocarcinoma
5893908|NCT03504397|Gastro-Esophageal Junction cancer|gastro-esophageal junction cancer
5893909|NCT03504397|HER2 Negative mFOLFOX6|her2 negative mfolfox6
5893913|NCT03503448|surgically assisted rapid maxillary expansion|surgically assisted rapid maxillary expansion
5893914|NCT03503448|surgically assisted rapid palatal expansion|surgically assisted rapid palatal expansion
5893915|NCT03503448|Malocclusion|malocclusion
4963605|NCT04217330|Implementation|implementation
5676608|NCT00594139|non-neurogenic over active bladder|non-neurogenic over active bladder
5676609|NCT00594139|urge predominant incontinence|urge predominant incontinence
5676610|NCT00594126|Myeloma|myeloma
5676611|NCT00594126|Multiple Myeloma|multiple myeloma
5676612|NCT00594126|Relapsed Multiple Myeloma|relapsed multiple myeloma
5676613|NCT00594126|Refractory Multiple Myeloma|refractory multiple myeloma
5676614|NCT00594126|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5676615|NCT00594100|carotid artery stenosis|carotid artery stenosis
5676616|NCT00594100|embolic protection device|embolic protection device
5676617|NCT00594100|GORE Neuro Protection System|gore neuro protection system
5676618|NCT00594100|GORE Flow Reversal System|gore flow reversal system
5676619|NCT00594100|reverse flow|reverse flow
5676620|NCT00594100|proximal occlusion device|proximal occlusion device
5676621|NCT00594100|GNPS|gnps
5676622|NCT00594100|Parodi|parodi
5676623|NCT00594100|EMPiRE|empire
5676624|NCT00594100|distal embolization|distal embolization
5676625|NCT00594100|minimizing risks of CAS|minimizing risks of cas
5676626|NCT00594100|PAES|paes
5676627|NCT00594048|high blood pressure|high blood pressure
5676628|NCT00594035|Spinal procedure|spinal procedure
5676629|NCT00594035|Dura incision|dura incision
5676630|NCT00594022|Electric Stimulation|electric stimulation
5676631|NCT00594022|Latency to Persistent Sleep (LPS)|latency to persistent sleep (lps)
5676632|NCT00594022|Transient Insomnia|transient insomnia
5676633|NCT00594022|Insomnia|insomnia
5676634|NCT00593970|influenza|influenza
5676635|NCT00593970|vaccine|vaccine
5676636|NCT00593970|pregnancy|pregnancy
5676637|NCT00593957|Rett Syndrome|rett syndrome
5676638|NCT00593957|Dextromethorphan|dextromethorphan
5676639|NCT00593944|CLL|cll
5676640|NCT00593944|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5676641|NCT00593944|B cell|b cell
5676642|NCT00593944|leukemia|leukemia
5676643|NCT00593944|lymphocyte|lymphocyte
5676644|NCT00593944|antibody|antibody
5676645|NCT00593944|monoclonal|monoclonal
5676646|NCT00593944|cancer|cancer
5676647|NCT00593944|blood|blood
5676648|NCT00593931|Brain functional MRI|brain functional mri
5676649|NCT00593918|RSV, asthma, innate immunity, gene, cytokines|rsv, asthma, innate immunity, gene, cytokines
5676650|NCT00593905|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5676651|NCT00593905|Pulmonary Hypertension|pulmonary hypertension
5676652|NCT00593905|Pharmacogenomics|pharmacogenomics
5676653|NCT00593905|DNA Testing|dna testing
5676654|NCT00593905|sitaxsentan|sitaxsentan
5676655|NCT00593905|bosentan|bosentan
5676656|NCT00593905|ambrisentan|ambrisentan
5676657|NCT00593905|elevated pulmonary artery pressures|elevated pulmonary artery pressures
5676658|NCT00593905|Letairis|letairis
5676659|NCT00593905|Tracleer|tracleer
5676660|NCT00593905|Thelin|thelin
5676661|NCT00593905|Primary Pulmonary Hypertension|primary pulmonary hypertension
5676662|NCT00593905|Pulmonary Artery|pulmonary artery
5676663|NCT00593892|Cytokine Levels|cytokine levels
5676664|NCT00593892|Traumatic Injury|traumatic injury
5676665|NCT00593892|Multisystem Organ Failure|multisystem organ failure
5676666|NCT00593879|MDD|mdd
5676667|NCT00593879|Depression|depression
5676668|NCT00593879|Mecamylamine|mecamylamine
5676669|NCT00593879|Add-on Therapy|add-on therapy
5676670|NCT00593879|Major Depressive Disorder|major depressive disorder
5680427|NCT00577798|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5893943|NCT03497767|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5893944|NCT03497767|EGFR mutation|egfr mutation
5893945|NCT03497767|Osimertinib|osimertinib
5893946|NCT03497767|Stereotactic Radiosurgery|stereotactic radiosurgery
5893961|NCT03494712|healthy volunteer|healthy volunteer
5893962|NCT03494712|antimiR|antimir
5893963|NCT03494712|single ascending dose|single ascending dose
5893964|NCT03493958|Alcohol Dependence|alcohol dependence
5893965|NCT03493958|Alcohol use Disorder|alcohol use disorder
5893966|NCT03493958|Insomnia|insomnia
5894001|NCT03490942|glucagon|glucagon
5894002|NCT03490942|hypoglycemia counter-regulation|hypoglycemia counter-regulation
5894044|NCT03484702|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5894045|NCT03484702|Aggressive B-cell non-Hodgkin lymphoma|aggressive b-cell non-hodgkin lymphoma
5894046|NCT03484702|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5894047|NCT03484702|Relapse / refractory lymphoma|relapse / refractory lymphoma
5894048|NCT03484702|Transplant not eligible|transplant not eligible
5894049|NCT03484702|High-grade B-cell lymphoma|high-grade b-cell lymphoma
5894050|NCT03484702|Primary central nervous system lymphoma|primary central nervous system lymphoma
5894051|NCT03484702|Transformed follicular lymphoma|transformed follicular lymphoma
5894157|NCT03474965|Sickle cell disease|sickle cell disease
5894158|NCT03474965|crizanlizumab|crizanlizumab
5894159|NCT03474965|pediatric|pediatric
5894160|NCT03474965|pharmacokinetic|pharmacokinetic
5894161|NCT03474965|P-selectin|p-selectin
5894165|NCT03474640|immunotherapy|immunotherapy
5894166|NCT03474640|check point inhibitor|check point inhibitor
5894167|NCT03474640|PD-1 antibody|pd-1 antibody
5894168|NCT03474640|solid tumor|solid tumor
5894169|NCT03474640|esophageal carcinoma|esophageal carcinoma
5894170|NCT03474640|gastric carcinoma|gastric carcinoma
5894171|NCT03474640|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5894172|NCT03474640|hepatocellular carcinoma|hepatocellular carcinoma
5894173|NCT03474640|soft tissue sarcoma|soft tissue sarcoma
5894174|NCT03474640|chondrosarcoma|chondrosarcoma
5894175|NCT03474640|orphan tumors|orphan tumors
5894176|NCT03474640|phase 1 trial|phase 1 trial
5676671|NCT00593866|Patients who have confirmed cancer arising from the pancreas|patients who have confirmed cancer arising from the pancreas
5676672|NCT00593853|LHRH-agonist related fatigue|lhrh-agonist related fatigue
5676673|NCT00593801|extremely low birth weight infants|extremely low birth weight infants
5676674|NCT00593801|transfusion need|transfusion need
5676675|NCT00593801|erythropoietin|erythropoietin
5676676|NCT00593801|trace elements|trace elements
5676677|NCT00593801|antioxidant enzymes|antioxidant enzymes
5676678|NCT00593801|reduction of the transfusion need by EPO treatment|reduction of the transfusion need by epo treatment
5676679|NCT00593801|trace elements and antioxidant enzymes in blood|trace elements and antioxidant enzymes in blood
5676680|NCT00593788|GIN test|gin test
5676681|NCT00593788|gap detection|gap detection
5676682|NCT00593788|temporal resolution|temporal resolution
5676683|NCT00593788|auditory perception|auditory perception
5676684|NCT00593788|psychoacoustics|psychoacoustics
5676685|NCT00593775|implantation rate|implantation rate
5676686|NCT00593762|Peripheral arterial occlusive disease|peripheral arterial occlusive disease
5676687|NCT00593762|Aspirin|aspirin
5676688|NCT00593762|Clopidogrel|clopidogrel
5676689|NCT00593762|Resistance|resistance
5676690|NCT00593762|Catheter interventional procedure|catheter interventional procedure
5676691|NCT00593762|ASA and clopidogrel resistance|asa and clopidogrel resistance
5676692|NCT00593749|obesity prevention|obesity prevention
5676693|NCT00593749|corner stores|corner stores
5676694|NCT00593749|schools|schools
5676695|NCT00593736|Delayed sleep phase syndrome; drug therapy|delayed sleep phase syndrome; drug therapy
5676696|NCT00593723|IMRT|imrt
5676697|NCT00593710|Randomized|randomized
5676698|NCT00593710|double-blind superiority trial|double-blind superiority trial
5676699|NCT00593697|breast cancer|breast cancer
5676700|NCT00593697|adjuvant therapy|adjuvant therapy
5676701|NCT00593697|trastuzumab|trastuzumab
5676702|NCT00593697|chemotherapy|chemotherapy
5676703|NCT00593684|neonate|neonate
5676704|NCT00593684|central lines|central lines
5676705|NCT00593684|very low birth weight|very low birth weight
5676706|NCT00593684|silver alginate|silver alginate
5676707|NCT00593671|aneuploidies in 7 chromosomes increased with advanced maternal age|aneuploidies in 7 chromosomes increased with advanced maternal age
5676708|NCT00593658|hypoxemia|hypoxemia
5676709|NCT00593658|liver transplantation evaluation|liver transplantation evaluation
5676710|NCT00593658|cirrhosis|cirrhosis
5676711|NCT00593645|Conditioning regimens|conditioning regimens
5676712|NCT00593645|Stem Cell Transplantation|stem cell transplantation
5676713|NCT00593645|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5798795|NCT00110981|psoriasis|psoriasis
5676714|NCT00593645|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5676715|NCT00593645|Nonmyeloablative conditioning|nonmyeloablative conditioning
5676716|NCT00593645|Clofarabine|clofarabine
5676717|NCT00593645|Cytarabine|cytarabine
5676718|NCT00593645|Anti-thymocyte globulin|anti-thymocyte globulin
5676719|NCT00593632|low HDL|low hdl
5676720|NCT00593619|Intravenous Iron|intravenous iron
5676721|NCT00593619|Safety|safety
5676722|NCT00593619|Perioperative|perioperative
5676723|NCT00593619|Iron deficiency|iron deficiency
5676724|NCT00593619|Non hemodialysis population|non hemodialysis population
5894201|NCT03472690|Inflammatory Bowel Disease 1|inflammatory bowel disease 1
5894210|NCT03471871|Elderly Healthy Subjects|elderly healthy subjects
5894211|NCT03471871|Adult Healthy Subjects|adult healthy subjects
5894213|NCT03471871|Respiratory Safety|respiratory safety
5894214|NCT03471871|Peripheral Oxygen Saturation|peripheral oxygen saturation
5894215|NCT03471871|Total Sleep Time|total sleep time
5894216|NCT03471468|Microparticles|microparticles
5894217|NCT03471468|Pancreatic cancer|pancreatic cancer
5894218|NCT03471468|Gastric cancer|gastric cancer
5894219|NCT03471468|Chemotherapy|chemotherapy
5894220|NCT03471468|Venous thromboembolism|venous thromboembolism
5894224|NCT03470922|Cancer|cancer
5894312|NCT03454451|mCRPC|mcrpc
5894314|NCT03454451|Lung Cancer|lung cancer
5894315|NCT03454451|Kidney Cancer|kidney cancer
5894316|NCT03454451|Rectal Cancer|rectal cancer
5894317|NCT03454451|Breast Cancer|breast cancer
5894318|NCT03454451|Sarcoma|sarcoma
5894319|NCT03454451|Endometrial|endometrial
5894320|NCT03454451|Pancreatic|pancreatic
5894321|NCT03454451|Ovarian|ovarian
5894322|NCT03454451|SCCHN|scchn
5894323|NCT03454451|NHL|nhl
5894350|NCT03450915|Influenza|influenza
5894351|NCT03450915|vaccine|vaccine
5894352|NCT03450915|universal|universal
5894353|NCT03450915|M-001|m-001
5894354|NCT03450915|Multimeric-001|multimeric-001
5894355|NCT03450915|Flu|flu
5894364|NCT03448393|CD-19 expressing tumor|cd-19 expressing tumor
5894365|NCT03448393|CD-22 Expressing Tumor|cd-22 expressing tumor
5894366|NCT03448393|Adoptive Immunotherapy|adoptive immunotherapy
5894367|NCT03448393|Philadelphia chromosome (Ph)+ ALL|philadelphia chromosome (ph)+ all
5894368|NCT03448393|Lymphoma|lymphoma
5676725|NCT00593619|Perioperative blood conservation|perioperative blood conservation
5676726|NCT00593606|Rotigotine|rotigotine
5676727|NCT00593606|NEUPRO|neupro
5676728|NCT00593606|Switching trial from ropinirole to rotigotine,|switching trial from ropinirole to rotigotine,
5676729|NCT00593606|safety and tolerability|safety and tolerability
5676730|NCT00593606|Parkinson disease|parkinson disease
5676731|NCT00593593|benign prostate hyperplasia|benign prostate hyperplasia
5676732|NCT00593593|Dutasteride|dutasteride
5676733|NCT00593593|pharmacovigilance|pharmacovigilance
5676734|NCT00593580|Ovarian cancer|ovarian cancer
5676831|NCT00593112|Child|child
5676735|NCT00593580|bone mineral density|bone mineral density
5676736|NCT00593580|bisphosphonates|bisphosphonates
5676737|NCT00593580|chemotherapy|chemotherapy
5676738|NCT00593567|Diabetic Foot Ulcer|diabetic foot ulcer
5676739|NCT00593541|MRI|mri
5676740|NCT00593528|Cirrhosis, STIC TIPS, Portal Hypertension, Transjugular Intrahepatic Portosystemic Shunt , Stents, PTFE|cirrhosis, stic tips, portal hypertension, transjugular intrahepatic portosystemic shunt , stents, ptfe
5676741|NCT00593528|cirrhotic HTP|cirrhotic htp
5676742|NCT00593502|influenza|influenza
5676743|NCT00593502|children|children
5676744|NCT00593502|acute otitis media|acute otitis media
5676745|NCT00593502|oseltamivir|oseltamivir
5676746|NCT00593489|Insulin|insulin
5676747|NCT00593489|Diabetes Mellitus|diabetes mellitus
5676748|NCT00593489|Practice Behaviour|practice behaviour
5676749|NCT00593489|Preceptor|preceptor
5676750|NCT00593489|Pharmacy|pharmacy
5676751|NCT00593476|Type 2 Diabetes|type 2 diabetes
5676752|NCT00593476|Glycemic Control|glycemic control
5676753|NCT00593476|Diabetes Support and Education|diabetes support and education
5676754|NCT00593476|Portion Control|portion control
5676755|NCT00593476|Prepackaged meals|prepackaged meals
5676756|NCT00593463|opioid dependence|opioid dependence
5676757|NCT00593463|methadone|methadone
5676758|NCT00593463|opioid|opioid
5676759|NCT00593450|bevacizumab|bevacizumab
5676760|NCT00593450|ranibizumab|ranibizumab
5676761|NCT00593450|choroidal neovascularization|choroidal neovascularization
5676762|NCT00593437|bone density diagnostic equipment discrepancies|bone density diagnostic equipment discrepancies
5676763|NCT00593411|MD Analyze|md analyze
5676764|NCT00593411|Central Nervous System|central nervous system
5676765|NCT00593411|Spine Disease|spine disease
5676766|NCT00593411|Peripheral Nerve|peripheral nerve
5676767|NCT00593398|Malaria|malaria
5676768|NCT00593398|pregnant women|pregnant women
5676769|NCT00593398|infants|infants
5676770|NCT00593398|Cameroon|cameroon
5680428|NCT00577798|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5680429|NCT00577798|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5894457|NCT03435250|MTAP|mtap
5894458|NCT03435250|MTAP deletion|mtap deletion
5894459|NCT03435250|CDKN2A deletion|cdkn2a deletion
5894460|NCT03435250|MAT2A inhibitor|mat2a inhibitor
5894461|NCT03435250|Advanced solid tumors|advanced solid tumors
5894462|NCT03435250|Lymphoma|lymphoma
5894463|NCT03434769|Cyclophosphamide|cyclophosphamide
5894464|NCT03434769|Fludarabine|fludarabine
5894465|NCT03434769|Chimeric antigen receptor T cells|chimeric antigen receptor t cells
5676771|NCT00593385|Symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.|symptomatic claudication or rest pain and angiographic confirmation of either de novo or restenotic lesions in the common and/or external iliac artery.
5676772|NCT00593372|Alzheimer's Disease|alzheimer's disease
5676773|NCT00593372|Memory|memory
5676774|NCT00593372|Treatment|treatment
5676775|NCT00593359|Spinal surgery|spinal surgery
5676776|NCT00593359|Prone spinal surgery|prone spinal surgery
5676777|NCT00593333|Femur Fracture|femur fracture
5676778|NCT00593333|Intramedullary Nailing|intramedullary nailing
5676779|NCT00593333|Trochanteric Nailing|trochanteric nailing
5676780|NCT00593333|Piriformis Starting Portal|piriformis starting portal
5649881|NCT00702585|Randomized|randomized
5676781|NCT00593333|Trochanteric Insertion Portal|trochanteric insertion portal
5676782|NCT00593320|SRS|srs
5676783|NCT00593307|glycemic response|glycemic response
5676784|NCT00593307|hunger|hunger
5676785|NCT00593294|PCOS|pcos
5676786|NCT00593294|oral contraceptives|oral contraceptives
5676787|NCT00593294|physical exercise|physical exercise
5676788|NCT00593294|CVR|cvr
5676789|NCT00593281|Hyaluronidase|hyaluronidase
5676790|NCT00593281|Hylenex|hylenex
5676791|NCT00593281|subcutaneous|subcutaneous
5676792|NCT00593281|morphine|morphine
5676793|NCT00593281|absorption|absorption
5676794|NCT00593281|bioavailability|bioavailability
5676795|NCT00593281|PK study of morphine in patients with pain|pk study of morphine in patients with pain
5676796|NCT00593242|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
5676797|NCT00593242|autologous cord blood cells|autologous cord blood cells
5676798|NCT00593242|newborn infants|newborn infants
5676799|NCT00593229|Thrombotic microangiopathy (TMA)|thrombotic microangiopathy (tma)
5676800|NCT00593229|Hemolytic uremic syndrome (HUS)|hemolytic uremic syndrome (hus)
5676801|NCT00593229|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5676802|NCT00593216|functional magnetic Resonance Imaging|functional magnetic resonance imaging
5676805|NCT00593177|Plaque psoriasis|plaque psoriasis
5676806|NCT00593177|Psoriasis|psoriasis
5676807|NCT00593164|Hypothermia, Induced|hypothermia, induced
5676808|NCT00593164|Death, Sudden, Cardiac|death, sudden, cardiac
5676809|NCT00593164|Resuscitation|resuscitation
5676810|NCT00593164|Coma|coma
5676811|NCT00593151|Antimetabolites|antimetabolites
5676812|NCT00593151|Virus Diseases|virus diseases
5676813|NCT00593151|Anti-Infective Agents|anti-infective agents
5676814|NCT00593151|RNA Virus Infections|rna virus infections
4964000|NCT04214366|ACC|acc
5676815|NCT00593151|Digestive System Diseases|digestive system diseases
5676816|NCT00593151|Flaviviridae Infections|flaviviridae infections
5676817|NCT00593151|Antineoplastic Agents|antineoplastic agents
5676818|NCT00593151|Therapeutic Uses|therapeutic uses
5676819|NCT00593151|Antiviral Agents|antiviral agents
5894555|NCT03426865|retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
5894556|NCT03426865|testicular cancer|testicular cancer
5894557|NCT03426865|testis cancer|testis cancer
5894558|NCT03426865|germ cell tumor|germ cell tumor
5894560|NCT03426865|Axumin|axumin
5894561|NCT03426865|teratoma|teratoma
5676820|NCT00593151|Molecular Mechanisms of Action|molecular mechanisms of action
5676821|NCT00593151|Pharmacologic Actions|pharmacologic actions
5676822|NCT00593138|Focalin XR|focalin xr
5676823|NCT00593138|Adult|adult
5676824|NCT00593138|PET scan|pet scan
5676825|NCT00593125|cocaine|cocaine
5676826|NCT00593125|opioids|opioids
5676827|NCT00593125|heroin|heroin
5676828|NCT00593125|levetiracetam|levetiracetam
5676829|NCT00593112|HMRS Scanning|hmrs scanning
5676830|NCT00593112|ADHD|adhd
5676832|NCT00593112|Adolescent|adolescent
5676833|NCT00593112|HMRS Scans|hmrs scans
5676834|NCT00593099|Bipolar Disorder|bipolar disorder
5676835|NCT00593099|Nicotine Dependence|nicotine dependence
5676836|NCT00593099|Smoking Cessation|smoking cessation
5676837|NCT00593099|Bupropion, sustained-release|bupropion, sustained-release
5676838|NCT00593086|wound care|wound care
5676839|NCT00593060|Temsirolimus|temsirolimus
5676840|NCT00593060|cetuximab|cetuximab
5676841|NCT00593060|metastatic disease|metastatic disease
5676842|NCT00593047|hypercholesterolemia|hypercholesterolemia
5676843|NCT00593034|Alcohol abuse|alcohol abuse
5676844|NCT00593034|Drug abuse|drug abuse
5676845|NCT00593021|Obscure Gastrointestinal Bleeding|obscure gastrointestinal bleeding
5676846|NCT00593021|Occult Gastrointestinal Bleeding|occult gastrointestinal bleeding
5676847|NCT00593021|Overt Gastrointestinal Bleeding|overt gastrointestinal bleeding
5676848|NCT00593021|Capsule Endoscopy|capsule endoscopy
5676849|NCT00593021|CT Enterography|ct enterography
5676850|NCT00593008|metastatic pancreatic cancer|metastatic pancreatic cancer
5676851|NCT00592943|Adults|adults
5676852|NCT00592943|Healthy Volunteers|healthy volunteers
5676853|NCT00592943|Nuvigil|nuvigil
5676854|NCT00592943|Armodafinil|armodafinil
5676855|NCT00592943|DAT occupancy in healthy volunteers|dat occupancy in healthy volunteers
5676856|NCT00592930|anorexia nervosa, treatment, adolescents, olanzapine|anorexia nervosa, treatment, adolescents, olanzapine
5676857|NCT00592917|osteoporosis|osteoporosis
5676858|NCT00592917|fractures|fractures
5676859|NCT00592917|risk of fracture|risk of fracture
5676860|NCT00592917|vitamin-D|vitamin-d
5676861|NCT00592917|calcium|calcium
5676862|NCT00592917|falls|falls
5676863|NCT00592917|bone mineral density|bone mineral density
5676864|NCT00592917|bone metabolism|bone metabolism
5676865|NCT00592904|Neuralgia|neuralgia
5676866|NCT00592904|neuropathy|neuropathy
5676867|NCT00592891|brain injury|brain injury
5676868|NCT00592891|brain disorders|brain disorders
5676869|NCT00592852|bipolar disorder|bipolar disorder
5676870|NCT00592852|obsessive compulsive disorder|obsessive compulsive disorder
5676871|NCT00592852|Prozac|prozac
5676872|NCT00592839|Nocturnal vasomotor symptoms in postmenopausal women|nocturnal vasomotor symptoms in postmenopausal women
5676874|NCT00592826|HMP|hmp
5676875|NCT00592826|HPHP|hphp
5676876|NCT00592826|AMD|amd
5676877|NCT00592826|CNV|cnv
5676878|NCT00592813|rehabilitation|rehabilitation
5676879|NCT00592813|function|function
5676880|NCT00592800|statistics|statistics
5676881|NCT00592800|probability|probability
5676882|NCT00592774|Post-Herpetic Neuralgia|post-herpetic neuralgia
5676883|NCT00592774|PHN)|phn)
5676884|NCT00592761|Deglutition Disorders|deglutition disorders
5676885|NCT00592761|Mendelsohn Maneuver|mendelsohn maneuver
5676886|NCT00592761|SEMG|semg
5676887|NCT00592748|charged particle radiation therapy|charged particle radiation therapy
5676888|NCT00592696|Adolescent depression|adolescent depression
5676889|NCT00592696|Adolescent smoking|adolescent smoking
5676890|NCT00592683|bipolar disorder|bipolar disorder
5676891|NCT00592683|fish oil|fish oil
5676892|NCT00592683|aripiprazole|aripiprazole
5676893|NCT00592683|children|children
5676894|NCT00592657|retrospective chart review|retrospective chart review
5676895|NCT00592657|Jimsonweed ingestion|jimsonweed ingestion
5676896|NCT00592644|ectasia|ectasia
5676897|NCT00592644|vascular lesions|vascular lesions
5676898|NCT00592644|vocal cords|vocal cords
5676899|NCT00592644|voice|voice
5676900|NCT00592644|pulsed dye laser|pulsed dye laser
5676901|NCT00592631|asthma|asthma
5676902|NCT00592631|sleep apnea|sleep apnea
5676903|NCT00592618|ESRD|esrd
5676904|NCT00592618|Hemodialysis|hemodialysis
5676905|NCT00592618|Sleep Apnea|sleep apnea
5894625|NCT03420209|proprioceptive neuromuscular facilitation|proprioceptive neuromuscular facilitation
5894626|NCT03420209|respiratory functions|respiratory functions
5894627|NCT03420209|elastic band|elastic band
5894629|NCT03417388|Coronary Angiography|coronary angiography
5894630|NCT03417388|Coronary CT Angiogram|coronary ct angiogram
5894631|NCT03417388|Ischemia|ischemia
5894632|NCT03417388|Non-obstructive CAD|non-obstructive cad
5894673|NCT03416179|glasdegib;|glasdegib;
5894674|NCT03416179|untreated;|untreated;
5894675|NCT03416179|Hedgehog Inhibitor|hedgehog inhibitor
5894676|NCT03415659|HWH340|hwh340
5894677|NCT03415659|pharmacokinetics|pharmacokinetics
5894678|NCT03415659|dose-escalation|dose-escalation
5894679|NCT03415659|safety|safety
5894680|NCT03415659|efficacy|efficacy
5894681|NCT03415659|dose-expansion|dose-expansion
5676906|NCT00592592|pediatric rhabdomyosarcoma|pediatric rhabdomyosarcoma
5676907|NCT00592592|proton radiation therapy|proton radiation therapy
5676908|NCT00592566|Severe leptospirosis|severe leptospirosis
5676909|NCT00592566|Pulmonary hemorrhage|pulmonary hemorrhage
5676910|NCT00592553|Duchenne muscular dystrophy|duchenne muscular dystrophy
5798796|NCT00110981|dermatology|dermatology
5676911|NCT00592553|Becker muscular dystrophy|becker muscular dystrophy
5676912|NCT00592553|Nonsense mutation|nonsense mutation
5676913|NCT00592553|Premature stop codon|premature stop codon
5676914|NCT00592553|DMD/BMD|dmd/bmd
5676915|NCT00592553|PTC124|ptc124
5676916|NCT00592514|Patients undergoing head and neck surgery that involves the upper aerodigestive tract|patients undergoing head and neck surgery that involves the upper aerodigestive tract
5676917|NCT00592501|proton radiation|proton radiation
5676918|NCT00592501|photon radiation|photon radiation
5676919|NCT00592501|5-FU|5-fu
5676920|NCT00592501|cisplatin|cisplatin
5676921|NCT00592488|Septic shock|septic shock
5676922|NCT00592488|Acetyl-L-carnitine|acetyl-l-carnitine
5676923|NCT00592475|conivaptan|conivaptan
5676924|NCT00592475|Liver Cirrhosis|liver cirrhosis
5676925|NCT00592475|Hypertension, Portal|hypertension, portal
5676926|NCT00592462|Breast Cancer|breast cancer
5676927|NCT00592462|Whole Body MRI|whole body mri
5676928|NCT00592462|Magnetic Resonance Imaging|magnetic resonance imaging
5676929|NCT00592462|Metastases|metastases
5676930|NCT00592449|Insomnia|insomnia
5676931|NCT00592449|Knee pain|knee pain
5676932|NCT00592449|Osteoarthritis|osteoarthritis
5676933|NCT00592449|Arthritis|arthritis
5676934|NCT00592449|Sleep|sleep
5676935|NCT00592436|ADHD|adhd
5676936|NCT00592436|pediatric|pediatric
5676937|NCT00592436|children|children
5676938|NCT00592423|Lateral neck rotation|lateral neck rotation
5676939|NCT00592423|Continuous Positive Airway Pressure|continuous positive airway pressure
5676940|NCT00592397|Dietary Intervention|dietary intervention
5676941|NCT00592397|Nutrigenomics|nutrigenomics
5676942|NCT00592397|Diet, Carbohydrate-Restricted|diet, carbohydrate-restricted
5676943|NCT00592397|Gene Expression|gene expression
5676944|NCT00592397|Gene Expression Profiling|gene expression profiling
5676945|NCT00592397|Oligonucleotide Array Sequence Analysis|oligonucleotide array sequence analysis
5676946|NCT00592397|Biological Markers|biological markers
5676947|NCT00592397|Food|food
5676948|NCT00592397|Obesity|obesity
5676949|NCT00592397|Blood|blood
5676950|NCT00592397|Subcutaneous Fat, Abdominal|subcutaneous fat, abdominal
5676951|NCT00592384|spinal cord injuries|spinal cord injuries
5676952|NCT00592384|major depressive disorder|major depressive disorder
5676953|NCT00592384|dysthymia|dysthymia
5676954|NCT00592384|antidepressant agents|antidepressant agents
5676955|NCT00592384|pain|pain
5676956|NCT00592384|quality of life|quality of life
5676957|NCT00592384|muscle spasticity|muscle spasticity
5676958|NCT00592384|community participation|community participation
5676959|NCT00592384|anxiety|anxiety
5676960|NCT00592358|bipolar disorder|bipolar disorder
5676962|NCT00592358|adolescents|adolescents
5676963|NCT00592358|Invega|invega
5676964|NCT00592345|sarcoma of the thoracic/lumbar/spine/sacrum|sarcoma of the thoracic/lumbar/spine/sacrum
5676965|NCT00592345|paraspinal soft tissues|paraspinal soft tissues
5676966|NCT00592345|proton radiation therapy|proton radiation therapy
5894690|NCT03413995|metastatic hormone sensitive|metastatic hormone sensitive
5894691|NCT03413930|TaTME|tatme
5894692|NCT03413930|Rectal cancer|rectal cancer
5894693|NCT03413930|Laparoscopic Surgery|laparoscopic surgery
5894725|NCT03409003|urea cycle disorder|urea cycle disorder
5676967|NCT00592345|photon radiation therapy|photon radiation therapy
5676968|NCT00592345|radiation applicator plaque|radiation applicator plaque
5676969|NCT00592319|Papilloma|papilloma
5676970|NCT00592319|pulsed dye laser|pulsed dye laser
5676971|NCT00592319|Celebrex|celebrex
5676972|NCT00592319|voice|voice
5676973|NCT00592306|ATG|atg
5676974|NCT00592306|rabbit thymoglobulin|rabbit thymoglobulin
5676975|NCT00592306|reperfusion lung injury|reperfusion lung injury
5676976|NCT00592306|primary graft dysfunction|primary graft dysfunction
5676977|NCT00592306|lung transplantation|lung transplantation
5676978|NCT00592293|proton beam radiation|proton beam radiation
5676979|NCT00592280|Pancreas transplantation|pancreas transplantation
5676980|NCT00592280|graft pancreatitis|graft pancreatitis
5676981|NCT00592280|Two-layer method|two-layer method
5676982|NCT00592280|organ preservation|organ preservation
5676983|NCT00592267|pediatric|pediatric
5676984|NCT00592267|bipolar disorder|bipolar disorder
5676985|NCT00592254|ADHD|adhd
5676986|NCT00592254|Adults|adults
5676987|NCT00592241|Insulin Pump|insulin pump
5676988|NCT00592228|intermediate lesion|intermediate lesion
5676989|NCT00592228|drug-eluting stent|drug-eluting stent
5676990|NCT00592228|fractional flow reserve|fractional flow reserve
5676991|NCT00592215|Second trimester labor induction|second trimester labor induction
5676992|NCT00592202|Morbid obesity|morbid obesity
5676993|NCT00592202|Adolescents|adolescents
5676994|NCT00592202|Gastric restrictive procedure|gastric restrictive procedure
5676995|NCT00592202|Adjustable gastric band|adjustable gastric band
5676996|NCT00592202|Treatment|treatment
5676997|NCT00592189|Burns|burns
5676998|NCT00592189|Wound healing|wound healing
5676999|NCT00592189|Amnion|amnion
5677000|NCT00592163|Cancer|cancer
5677001|NCT00592163|Arsenic|arsenic
5677002|NCT00592150|Essential Hypertension|essential hypertension
5677003|NCT00592137|calcium carbonate|calcium carbonate
5677004|NCT00592137|obesity|obesity
5677005|NCT00592137|dairy|dairy
5677006|NCT00592137|energy expenditure|energy expenditure
5677007|NCT00592124|Microbicide|microbicide
5677008|NCT00592124|HIV Seronegativity|hiv seronegativity
5677010|NCT00592111|Hodgkin's Disease|hodgkin's disease
5677011|NCT00592111|96-016|96-016
5677012|NCT00592098|Lower limb amputation at least 6 months prior to inclusion|lower limb amputation at least 6 months prior to inclusion
5677013|NCT00592098|Presenting with moderate-to-severe pain intensity|presenting with moderate-to-severe pain intensity
5677014|NCT00592098|Outpatients, aged 18 years and above|outpatients, aged 18 years and above
5677015|NCT00592085|Tobacco Use|tobacco use
5677016|NCT00592085|Smoking|smoking
5677017|NCT00592085|Alcohol Use|alcohol use
5677018|NCT00592085|Smoking Cessation|smoking cessation
5677019|NCT00592072|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5677020|NCT00592072|Medium Chain Fatty Acid|medium chain fatty acid
5677021|NCT00592072|Hypoglycemia|hypoglycemia
5677022|NCT00592046|Phase I|phase i
5677023|NCT00592046|Hematologic Cancers|hematologic cancers
5677024|NCT00592046|Blood Cancers|blood cancers
5677025|NCT00592046|Leukemia|leukemia
5677026|NCT00592046|multiple myeloma|multiple myeloma
5677027|NCT00592046|myelodysplasia (MDS)|myelodysplasia (mds)
5677028|NCT00592046|Relapsed/refractory leukemia or lymphoma|relapsed/refractory leukemia or lymphoma
5677029|NCT00592033|COPD oxygen|copd oxygen
5677030|NCT00592033|COPD rehabilitation|copd rehabilitation
5677031|NCT00592033|exercise|exercise
5677032|NCT00592020|kidney|kidney
5677033|NCT00592020|transplantation|transplantation
5677034|NCT00592020|minimal invasive|minimal invasive
5677035|NCT00592020|short transverse|short transverse
5677036|NCT00592020|hockey stick|hockey stick
5677037|NCT00592020|incision|incision
5677038|NCT00592020|quality of life|quality of life
5677039|NCT00592020|planned kidney transplantation|planned kidney transplantation
5677040|NCT00592007|Non Small Cell Lung Cancer|non small cell lung cancer
5677041|NCT00592007|Stage IIIB|stage iiib
5677042|NCT00592007|Stage IV|stage iv
5677043|NCT00592007|Stable on Erlotinib|stable on erlotinib
5677044|NCT00592007|Exhibit Positivity for Estrogen or Progesterone Receptor|exhibit positivity for estrogen or progesterone receptor
5677045|NCT00591994|tinnitus|tinnitus
5677046|NCT00591994|piribedil|piribedil
5677047|NCT00591994|acoustic otoemissions|acoustic otoemissions
5677048|NCT00591994|ECoG|ecog
5677049|NCT00591981|Geriatric|geriatric
5677050|NCT00591981|Thoracic|thoracic
5894787|NCT03396588|Opiate use during pregnancy|opiate use during pregnancy
5894788|NCT03396588|Clonidine|clonidine
5894789|NCT03396588|Morphine|morphine
5894790|NCT03396588|Prenatal opiate|prenatal opiate
5894791|NCT03396588|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5894792|NCT03396588|Infant, Newborn, Diseases|infant, newborn, diseases
5894793|NCT03396588|Substance-Related Disorders|substance-related disorders
5894794|NCT03396588|Chemically-Induced Disorders|chemically-induced disorders
5894795|NCT03396588|Opiate Alkaloids|opiate alkaloids
5894796|NCT03396588|Mental Disorders|mental disorders
5894797|NCT03396588|Narcotics|narcotics
5894798|NCT03396588|Central Nervous System Depressants|central nervous system depressants
5894799|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs
5894800|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists
5894801|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists
5894802|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5894803|NCT03396588|Antihypertensive Agents|antihypertensive agents
5894804|NCT03396588|Analgesics|analgesics
5894805|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents
5894806|NCT03396588|Sympatholytics|sympatholytics
5894807|NCT03396588|Autonomic Agents|autonomic agents
5894808|NCT03396588|Neurotransmitter Agents|neurotransmitter agents
5894824|NCT03395028|Biliary Atresia|biliary atresia
5894825|NCT03395028|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5894826|NCT03395028|GCSF|gcsf
5894827|NCT03394027|Impiridones|impiridones
5894828|NCT03394027|TNBC|tnbc
5894829|NCT03394027|Metastatic|metastatic
5894830|NCT03394027|Male Breast Cancer|male breast cancer
5894834|NCT03392987|OTL-200|otl-200
5894835|NCT03392987|Cryopreserved formulation|cryopreserved formulation
5894836|NCT03392987|Gene therapy|gene therapy
5894837|NCT03392987|Metachromatic leukodystrophy|metachromatic leukodystrophy
5894839|NCT03392987|Previously GSK2696274|previously gsk2696274
5894841|NCT03392064|AMG 119|amg 119
5894842|NCT03392064|CART|cart
5894843|NCT03392064|DLL3|dll3
4964604|NCT04210557|TMS|tms
5677051|NCT00591981|neoplasm|neoplasm
5677052|NCT00591981|(Patients over 70 years of age) Geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.|(patients over 70 years of age) geriatric oncology patients with thoracic neoplasms of the lung, esophagus, pleura and thymus.
5677053|NCT00591968|ultrasound|ultrasound
5677054|NCT00591968|telediagnosis|telediagnosis
5677055|NCT00591968|teleultrasound|teleultrasound
5677056|NCT00591968|telesonography|telesonography
5677057|NCT00591968|teleultrasonography|teleultrasonography
5677058|NCT00591968|teleradiology|teleradiology
5677059|NCT00591968|telemedicine|telemedicine
5677060|NCT00591968|dominican republic|dominican republic
5677061|NCT00591968|puntacana|puntacana
5677062|NCT00591968|veron|veron
5677063|NCT00591968|store-and-forward|store-and-forward
5677064|NCT00591968|asynchronous|asynchronous
5894882|NCT03386461|elderly|elderly
5894883|NCT03386461|exercise training|exercise training
5894884|NCT03386461|adipose tissue|adipose tissue
5894885|NCT03386461|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5894886|NCT03386461|inflammation|inflammation
5894887|NCT03386461|diferentiation of preadipocytes|diferentiation of preadipocytes
5894901|NCT03385239|AKCEA-APOCIII-LRx|akcea-apociii-lrx
5894902|NCT03385239|IONIS-APOCIII-LRx|ionis-apociii-lrx
5894903|NCT03385239|Dyslipidemia|dyslipidemia
5894904|NCT03385239|Metabolic Disease|metabolic disease
5894905|NCT03385239|Hyperlipidemia|hyperlipidemia
5894906|NCT03385239|Cardiac Disease|cardiac disease
5894907|NCT03385239|Lipid Metabolism Disorders|lipid metabolism disorders
5894908|NCT03385239|Triglycerides High|triglycerides high
5894974|NCT03373344|emotional processing|emotional processing
5894975|NCT03373344|multiple sclerosis|multiple sclerosis
5894976|NCT03373344|cognition|cognition
5895005|NCT03368443|Parkinson's disease|parkinson's disease
5895006|NCT03368443|context-dependent learning|context-dependent learning
5895007|NCT03368443|transcranial magnetic stimulation|transcranial magnetic stimulation
5895008|NCT03368443|cognitive function|cognitive function
5895009|NCT03368027|Vision Disorders; Stress, Psychological|vision disorders; stress, psychological
5677065|NCT00591955|geriatric|geriatric
5677066|NCT00591955|sepsis|sepsis
5677067|NCT00591955|outcome assessment(healthcare)|outcome assessment(healthcare)
5677068|NCT00591942|dental cement|dental cement
5677069|NCT00591942|ceramic crowns|ceramic crowns
5677070|NCT00591942|three-unit bridges|three-unit bridges
5677071|NCT00591942|sensitivity|sensitivity
5677072|NCT00591916|burn|burn
5677073|NCT00591916|donor site|donor site
5677074|NCT00591916|grafting|grafting
5677075|NCT00591916|scar|scar
5677076|NCT00591903|Diabetes and Cardiac Proteomics|diabetes and cardiac proteomics
5677077|NCT00591903|Atrial Appendage and Proteomics|atrial appendage and proteomics
5677078|NCT00591903|Diabetic Cardiomyopathy|diabetic cardiomyopathy
5677079|NCT00591903|Tissue Sample|tissue sample
5677080|NCT00591877|GERDCAM: Complementary and alternative medicine|gerdcam: complementary and alternative medicine
5677081|NCT00591877|NERD: non-erosive reflux disease|nerd: non-erosive reflux disease
5677082|NCT00591877|GERD: gastroesophageal reflux disease|gerd: gastroesophageal reflux disease
5677083|NCT00591877|AC: acupuncture|ac: acupuncture
5677084|NCT00591877|SAC: sham acupuncture|sac: sham acupuncture
5677085|NCT00591877|LES: lower esophageal sphincter pressure|les: lower esophageal sphincter pressure
5677086|NCT00591877|TLESR: transient lower esophageal sphincter relaxation|tlesr: transient lower esophageal sphincter relaxation
5677087|NCT00591877|Acupuncture|acupuncture
5677088|NCT00591877|Yoga|yoga
5677089|NCT00591864|Benign breast disease|benign breast disease
5677090|NCT00591864|Breast|breast
5677091|NCT00591864|MRI|mri
5677092|NCT00591864|Mammography|mammography
5677093|NCT00591864|Ultrasound|ultrasound
5677094|NCT00591864|Molecular Breast Imaging|molecular breast imaging
5677095|NCT00591864|Breast Cancer|breast cancer
5677096|NCT00591851|breast cancer|breast cancer
5677097|NCT00591851|adenocarcinoma of the breast|adenocarcinoma of the breast
5677098|NCT00591851|cardiac safety|cardiac safety
5677099|NCT00591851|Breast cancer patients seen at the Memorial Sloan-Kettering Cancer Center|breast cancer patients seen at the memorial sloan-kettering cancer center
5677100|NCT00591838|SBRT|sbrt
5677101|NCT00591773|Blood pressure|blood pressure
5677102|NCT00591773|Blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
5677103|NCT00591760|Heart Failure|heart failure
5677104|NCT00591760|Growth Hormone|growth hormone
5677105|NCT00591760|Anabolism|anabolism
5677106|NCT00591760|Anabolic Deficiency|anabolic deficiency
5677107|NCT00591760|Hormone replacement|hormone replacement
5677108|NCT00591747|randomized clinical trial|randomized clinical trial
5677109|NCT00591747|elderly|elderly
5677110|NCT00591747|cancer survivor|cancer survivor
5677111|NCT00591747|bone health|bone health
5677112|NCT00591747|body composition|body composition
5677113|NCT00591747|signs and symptoms|signs and symptoms
5677114|NCT00591734|Metastatic Melanoma|metastatic melanoma
5677115|NCT00591734|Everolimus|everolimus
5677116|NCT00591734|RAD001|rad001
5677117|NCT00591734|Bevacizumab|bevacizumab
5677118|NCT00591721|energy conservation education|energy conservation education
5677119|NCT00591721|occupational therapy intervention|occupational therapy intervention
5677120|NCT00591721|fatigue management|fatigue management
5677121|NCT00591721|psychoeducation|psychoeducation
5677122|NCT00591708|calcium|calcium
5677123|NCT00591708|bone|bone
5677124|NCT00591708|bone density|bone density
5677125|NCT00591708|adolescence|adolescence
5677126|NCT00591695|Malignant Colorectal Obstruction|malignant colorectal obstruction
5677127|NCT00591695|Stent Bridge to Surgery|stent bridge to surgery
5677128|NCT00591669|Inflammatory bowel disease|inflammatory bowel disease
5677129|NCT00591669|Crohn's disease|crohn's disease
5677130|NCT00591643|Adrenal tumors|adrenal tumors
5677131|NCT00591643|Adrenal malignancies|adrenal malignancies
5677132|NCT00591643|abnormal hormonal secretions|abnormal hormonal secretions
5677133|NCT00591643|electrolytes abnormalities|electrolytes abnormalities
5677135|NCT00591643|Scanning|scanning
5677136|NCT00591643|tumor localization|tumor localization
5677137|NCT00591630|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5677138|NCT00591630|Lymphoma|lymphoma
5677139|NCT00591630|Zevalin|zevalin
5895042|NCT03362177|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
5895043|NCT03362177|Gastrointestinal Cancer|gastrointestinal cancer
5895044|NCT03362177|Colorectal Cancer|colorectal cancer
5895053|NCT03359993|Endotracheal intubation|endotracheal intubation
5895054|NCT03359993|Neonatal premedication|neonatal premedication
5895055|NCT03359993|Delivery room|delivery room
5895138|NCT03340922|premature ventricular complex|premature ventricular complex
5895139|NCT03340922|catheter ablation|catheter ablation
5895140|NCT03340922|activation mapping|activation mapping
5677140|NCT00591630|Ibritumomab|ibritumomab
5677141|NCT00591630|IDEC-Y2B8|idec-y2b8
5677142|NCT00591630|Carmustine|carmustine
5677143|NCT00591630|BCNU|bcnu
5677144|NCT00591630|BiCNU|bicnu
5677145|NCT00591630|Etoposide|etoposide
5677146|NCT00591630|VePesid|vepesid
5677147|NCT00591630|Cytarabine|cytarabine
5677148|NCT00591630|Ara-C|ara-c
5677149|NCT00591630|Cytosar|cytosar
5677150|NCT00591630|DepoCyt|depocyt
5677151|NCT00591630|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5677152|NCT00591630|Melphalan|melphalan
5677153|NCT00591630|Rituximab|rituximab
5677154|NCT00591630|Rituxan|rituxan
5677155|NCT00591630|BEAM|beam
5677156|NCT00591617|Opioids|opioids
5677157|NCT00591617|drug dependence|drug dependence
5677158|NCT00591617|drug abuse|drug abuse
5677159|NCT00591617|treatment|treatment
5677160|NCT00591604|burn|burn
5677161|NCT00591604|vitamin D|vitamin d
5677162|NCT00591604|nutrition|nutrition
5677163|NCT00591604|burn recovery|burn recovery
5677164|NCT00591591|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5677165|NCT00591591|sleep disordered breathing|sleep disordered breathing
5677166|NCT00591591|polysomnography (psg)|polysomnography (psg)
5677167|NCT00591591|continuous positive airway pressure (cpap)|continuous positive airway pressure (cpap)
5677168|NCT00591591|brain vascular autoregulation|brain vascular autoregulation
5677169|NCT00591591|brain tissue oxygenation|brain tissue oxygenation
5677170|NCT00591591|near-infrared spectroscopy|near-infrared spectroscopy
5677171|NCT00591591|Obstructive Sleep Apnea|obstructive sleep apnea
5677172|NCT00591578|Blood pressure|blood pressure
5677173|NCT00591578|blood pressure monitoring, ambulatory|blood pressure monitoring, ambulatory
5677174|NCT00591565|Anxiety|anxiety
5677175|NCT00591565|SSRI|ssri
5677176|NCT00591565|SNRI|snri
5677178|NCT00591552|Lung cancer|lung cancer
5677179|NCT00591552|Lymph node dissection|lymph node dissection
5677180|NCT00591539|Carotid Artery Disease|carotid artery disease
5677181|NCT00591539|Intima-Media Thickening|intima-media thickening
5677182|NCT00591539|Carotid Ultrasound|carotid ultrasound
5677183|NCT00591539|Pediatric Cancer Survivors|pediatric cancer survivors
5677184|NCT00591539|Cancer Survivors|cancer survivors
5677185|NCT00591539|Head or Neck Cancer|head or neck cancer
5677186|NCT00591539|Radiation Therapy|radiation therapy
5677188|NCT00591500|Melanoma|melanoma
5677189|NCT00591500|Skin cancer|skin cancer
5677190|NCT00591500|Genetic Susceptibility|genetic susceptibility
5677191|NCT00591500|polymorphisms|polymorphisms
5677192|NCT00591487|suction|suction
5677193|NCT00591487|assisted|assisted
5677194|NCT00591487|lipectomy|lipectomy
5677195|NCT00591487|liposuction|liposuction
5677196|NCT00591487|contour|contour
5677197|NCT00591487|cosmetic|cosmetic
5677198|NCT00591487|plastic|plastic
5677199|NCT00591487|surgery|surgery
5677200|NCT00591487|Klein|klein
5677201|NCT00591487|tumescent|tumescent
5677202|NCT00591487|technique|technique
5677203|NCT00591487|Healthy women wanting Suction Assisted Lipectomy|healthy women wanting suction assisted lipectomy
5677204|NCT00591474|VRE|vre
5677205|NCT00591474|Probiotics|probiotics
5677206|NCT00591474|colonization|colonization
5677207|NCT00591474|gut health|gut health
5677208|NCT00591461|Barrett's Esophagus|barrett's esophagus
5677209|NCT00591461|Upper Endoscopy|upper endoscopy
5677210|NCT00591461|Esophageal biopsies|esophageal biopsies
5677211|NCT00591461|Accuracy|accuracy
5677212|NCT00591461|Interobserver Agreement|interobserver agreement
5677213|NCT00591448|Thermal injury|thermal injury
5677214|NCT00591435|Anesthesia|anesthesia
5677215|NCT00591435|Surgery|surgery
5677216|NCT00591435|Education|education
5677217|NCT00591435|Economics|economics
5677218|NCT00591422|Arsenic|arsenic
5677219|NCT00591422|Cancer|cancer
5677220|NCT00591383|Cancer|cancer
5677221|NCT00591383|Indibulin|indibulin
5895141|NCT03340922|wavefront|wavefront
5895145|NCT03340519|Crohn|crohn
5895146|NCT03340519|MRI|mri
5895213|NCT03335488|Urea|urea
5895214|NCT03335488|Hyperammonemic crisis (HAC)|hyperammonemic crisis (hac)
5895228|NCT03331562|Pembrolizumab|pembrolizumab
5895229|NCT03331562|Paricalcitol|paricalcitol
5677222|NCT00591383|Erlotinib|erlotinib
5677223|NCT00591370|Memorial Sloan-Kettering Cancer Center patients with measurable, unresectable stage|memorial sloan-kettering cancer center patients with measurable, unresectable stage
5677224|NCT00591370|III or IV melanoma|iii or iv melanoma
5677225|NCT00591357|Antibiotic associated diarrhea|antibiotic associated diarrhea
5895231|NCT03331562|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5895232|NCT03331562|Vitamin D|vitamin d
5895233|NCT03331562|Immune Checkpoint Inhibitor|immune checkpoint inhibitor
5895234|NCT03331562|VDR agonist|vdr agonist
5895235|NCT03331562|PD1 Inhibitor|pd1 inhibitor
5895259|NCT03328988|bladder cancer|bladder cancer
5895260|NCT03328988|radical cystectomy|radical cystectomy
5895261|NCT03328988|epidural analgesia|epidural analgesia
5895262|NCT03328988|quadratus lumborum block|quadratus lumborum block
5895263|NCT03328988|postoperative pain|postoperative pain
5895268|NCT03328494|Paclitaxel|paclitaxel
5895269|NCT03328494|BOS172722|bos172722
5895270|NCT03328494|triple-negative breast cancer|triple-negative breast cancer
5895277|NCT03326427|Attention Deficit Hyperactive Disorder|attention deficit hyperactive disorder
5895278|NCT03326427|Skill Training Group|skill training group
5895279|NCT03326427|Dialectical Behavior Therapy|dialectical behavior therapy
5895289|NCT03323294|Obesity|obesity
5895290|NCT03323294|Pediatric Health|pediatric health
5895291|NCT03323294|Type 2 Diabetes|type 2 diabetes
5895292|NCT03323294|Insulin Resistance|insulin resistance
5895293|NCT03323294|Metformin Therapy|metformin therapy
5895294|NCT03322865|Obinutuzumab|obinutuzumab
5895295|NCT03322865|Anti-CD20 antibody|anti-cd20 antibody
5895296|NCT03322865|Oncology|oncology
5677226|NCT00591357|Clostridium difficile|clostridium difficile
5677227|NCT00591357|loperamide|loperamide
5677228|NCT00591344|Parkinson's disease|parkinson's disease
5677229|NCT00591344|exercise|exercise
5677230|NCT00591331|Head Lice|head lice
5677231|NCT00591318|Ceftriaxone|ceftriaxone
5677232|NCT00591318|Psychosis|psychosis
5677233|NCT00591318|Schizophrenia|schizophrenia
5677234|NCT00591318|Schizoaffective Disorder|schizoaffective disorder
5677235|NCT00591305|papilloma|papilloma
5677237|NCT00591305|diindolylmethane|diindolylmethane
5677238|NCT00591305|recurrence|recurrence
5677239|NCT00591292|cancer|cancer
5677240|NCT00591292|tumor|tumor
5677241|NCT00591292|solid tumor|solid tumor
5677242|NCT00591292|advanced tumor|advanced tumor
5677243|NCT00591279|large bowel cancer|large bowel cancer
5677244|NCT00591279|polyps|polyps
5677245|NCT00591279|colorectal cancer|colorectal cancer
5677246|NCT00591266|Blood pressure|blood pressure
5677247|NCT00591266|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
5677248|NCT00591266|Drug Therapy|drug therapy
5677249|NCT00591253|Blood pressure|blood pressure
5677250|NCT00591253|blood pressure monitoring ambulatory|blood pressure monitoring ambulatory
5677251|NCT00591253|Drug Therapy|drug therapy
5677252|NCT00591240|RNA, ribosomal, 16S|rna, ribosomal, 16s
5677253|NCT00591240|Biosensing techniques|biosensing techniques
5677254|NCT00591240|Microchip analytical procedures|microchip analytical procedures
5677255|NCT00591214|Chronic Hepatitis C|chronic hepatitis c
5677256|NCT00591214|Protease Inhibitor|protease inhibitor
5677257|NCT00591201|Spondylarthritis|spondylarthritis
5677258|NCT00591201|TNF|tnf
5677259|NCT00591201|Infliximab|infliximab
5677260|NCT00591201|Ankylosing spondylitis|ankylosing spondylitis
5677261|NCT00591201|Juvenile SpA|juvenile spa
5677262|NCT00591201|Juvenile arthritis|juvenile arthritis
5677263|NCT00591188|kidney cancer, capecitabine, interferon|kidney cancer, capecitabine, interferon
5677264|NCT00591162|Bone, Dexa, Parathyroid, Diuretic, Tetracycline|bone, dexa, parathyroid, diuretic, tetracycline
5677265|NCT00591149|cancer|cancer
5677266|NCT00591149|head and neck cancer|head and neck cancer
5677267|NCT00591149|squamous cell cancer|squamous cell cancer
5677268|NCT00591123|Unresectable|unresectable
5677269|NCT00591123|Metastatic|metastatic
5677270|NCT00591123|Esophagus|esophagus
5895350|NCT03306576|composite restoration|composite restoration
5677271|NCT00591123|Gastric Cardia|gastric cardia
5677272|NCT00591097|urine|urine
5677273|NCT00591097|pediatric|pediatric
5677274|NCT00591097|Normal urine from healthy pediatric population|normal urine from healthy pediatric population
5677275|NCT00591084|randomized trial|randomized trial
5677276|NCT00591084|ischemic stroke|ischemic stroke
5677277|NCT00591084|Ginsenoside-Rd|ginsenoside-rd
5677278|NCT00591071|hyperglycemia|hyperglycemia
5677279|NCT00591071|insulin treatment|insulin treatment
5677280|NCT00591071|intensive care|intensive care
5677281|NCT00591071|hypoglycemia|hypoglycemia
5677282|NCT00591071|mechanical ventilation|mechanical ventilation
4972171|NCT04165239|MELAS|melas
5677283|NCT00591071|critically ill patients|critically ill patients
5677284|NCT00591058|recurrent glioma|recurrent glioma
5677285|NCT00591058|Phase I|phase i
5677286|NCT00591058|Multi-Center|multi-center
5677287|NCT00591058|Open label|open label
5895412|NCT03295097|pharmacogenomics|pharmacogenomics
5895490|NCT03285789|Dyslexia|dyslexia
5895491|NCT03285789|Visual Fields|visual fields
5677288|NCT00591058|Brain Cancer|brain cancer
5677289|NCT00591058|Brain tumor|brain tumor
5677290|NCT00591058|GBM|gbm
5677291|NCT00591058|Glioma|glioma
5677292|NCT00591058|Glioblastoma multiforme|glioblastoma multiforme
5677293|NCT00591045|gastric adenocarcinoma|gastric adenocarcinoma
5677294|NCT00591045|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5677295|NCT00591045|efficacy|efficacy
5677296|NCT00591045|safety|safety
5677297|NCT00591045|chemotherapy|chemotherapy
5895492|NCT03285789|visual attention span|visual attention span
5895493|NCT03285789|visual search|visual search
5895494|NCT03285789|visual attention field|visual attention field
5895498|NCT03282344|NKTR-214|nktr-214
5895499|NCT03282344|NIVOLUMAB|nivolumab
5895500|NCT03282344|17-366|17-366
5895524|NCT03281343|PrEP|prep
5895525|NCT03281343|Women|women
5895526|NCT03281343|Linkage to Care|linkage to care
5895539|NCT03277183|erythropoietin|erythropoietin
5895560|NCT03269994|pancreatoduodenectomy|pancreatoduodenectomy
5895561|NCT03269994|17-418|17-418
5895562|NCT03269994|cefoxitin|cefoxitin
5895563|NCT03269994|piperacillin-tazobactam|piperacillin-tazobactam
5895567|NCT03268421|juvenile fibromyalgia|juvenile fibromyalgia
5895568|NCT03268421|pain in children|pain in children
5895569|NCT03268421|musculoskeletal pain|musculoskeletal pain
5895570|NCT03268421|cognitive behavioral therapy|cognitive behavioral therapy
5895571|NCT03268421|coping skills training|coping skills training
5895572|NCT03268421|neuromuscular exercise|neuromuscular exercise
5895573|NCT03268421|graded aerobic exercise|graded aerobic exercise
5895616|NCT03261856|Breath test|breath test
5895618|NCT03261856|GI|gi
5895681|NCT03251378|VEGF|vegf
5895682|NCT03251378|colorectal|colorectal
5895685|NCT03248492|HER-2 positive breast cancer|her-2 positive breast cancer
4965504|NCT04205305|recanalization|recanalization
5677298|NCT00591032|Critical illness|critical illness
5677299|NCT00591032|Euthyroid sick syndromes|euthyroid sick syndromes
5677300|NCT00591032|Intensive care|intensive care
5677301|NCT00591032|Non-thyroidal illness syndrome|non-thyroidal illness syndrome
5677302|NCT00591032|Low-T3 syndrome|low-t3 syndrome
5677303|NCT00591019|P50, Psychomotor Vigilance Test (PVT), Arousal, Reaction Time|p50, psychomotor vigilance test (pvt), arousal, reaction time
5677304|NCT00591006|Phenytoin|phenytoin
5677305|NCT00591006|Dilantin|dilantin
5677306|NCT00591006|Corticosteroid|corticosteroid
5677307|NCT00591006|Neuroprotection|neuroprotection
5677308|NCT00591006|Mania|mania
5677309|NCT00591006|Cognition|cognition
5677312|NCT00591006|Hydrocortisone|hydrocortisone
5677313|NCT00591006|Healthy Controls|healthy controls
5677314|NCT00591006|MRI|mri
5677315|NCT00591006|hippocampal activation|hippocampal activation
5677316|NCT00590993|MRSI|mrsi
5677317|NCT00590993|MRI|mri
5677318|NCT00590993|Prostate Cancer|prostate cancer
5677319|NCT00590980|Stroke|stroke
5677320|NCT00590980|TIA (transient ischemic attack)|tia (transient ischemic attack)
5677321|NCT00590980|Brain|brain
5677323|NCT00590980|Quantitative magnetic resonance angiography (QMRA)|quantitative magnetic resonance angiography (qmra)
5677324|NCT00590967|para-aortic lymph nodes|para-aortic lymph nodes
5677325|NCT00590954|Malignant Gliomas|malignant gliomas
5677326|NCT00590954|CNS|cns
5677327|NCT00590954|Brain Cancer|brain cancer
5677328|NCT00590954|Cancer|cancer
5677329|NCT00590954|Perifosine|perifosine
5677330|NCT00590941|Lymphoma|lymphoma
5677331|NCT00590941|Rituximab|rituximab
5677332|NCT00590941|CHOP|chop
5677333|NCT00590915|ALL|all
5677334|NCT00590902|non small cell lung cancer|non small cell lung cancer
5677335|NCT00590889|artificial heart valve|artificial heart valve
5677336|NCT00590889|mitral heart valve|mitral heart valve
5677337|NCT00590889|aortic heart valve|aortic heart valve
5677338|NCT00590889|endocarditis|endocarditis
5677339|NCT00590889|Aortic valve disease requiring replacement|aortic valve disease requiring replacement
5677340|NCT00590889|Mitral valve disease requiring replacement|mitral valve disease requiring replacement
5677341|NCT00590876|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5677342|NCT00590876|Hypoglycemia|hypoglycemia
5677343|NCT00590876|Pancreatic Islet Cell Allotransplantation|pancreatic islet cell allotransplantation
5677344|NCT00590863|depression, medication, antidepressant, chronic, recurrent|depression, medication, antidepressant, chronic, recurrent
5677345|NCT00590837|AML|aml
5677346|NCT00590837|Chemotherapy|chemotherapy
5677347|NCT00590837|older|older
5677348|NCT00590837|De novo AML|de novo aml
5677349|NCT00590824|Melanoma|melanoma
5677350|NCT00590824|hu14.18-IL2|hu14.18-il2
5677351|NCT00590811|adolescents|adolescents
5677352|NCT00590811|young adults|young adults
5677353|NCT00590811|dysmenorrhea|dysmenorrhea
5677354|NCT00590811|pelvic pain|pelvic pain
5677355|NCT00590798|Cardiac Catheterization|cardiac catheterization
5677356|NCT00590798|Walk|walk
5677357|NCT00590798|Heart Catheterization|heart catheterization
5677358|NCT00590798|Coronary Disease|coronary disease
5677359|NCT00590798|Heart Disease|heart disease
5677360|NCT00590798|Coronary Artery Disease|coronary artery disease
5677361|NCT00590785|High Risk|high risk
5677362|NCT00590785|Breast Cancer|breast cancer
5677363|NCT00590785|Positive Nodes|positive nodes
5677364|NCT00590785|Cyclophosphamide|cyclophosphamide
5677365|NCT00590785|Doxorubicin|doxorubicin
5677366|NCT00590785|96-041|96-041
5677367|NCT00590772|sleep|sleep
5677368|NCT00590772|somnolence|somnolence
5677369|NCT00590772|allergies|allergies
5677370|NCT00590772|rhinitis|rhinitis
5677371|NCT00590772|fatigue|fatigue
5677372|NCT00590720|Asthma|asthma
5677373|NCT00590720|Bronchitis|bronchitis
5677374|NCT00590707|Hip fractures|hip fractures
5677375|NCT00590707|Femoral neck fractures|femoral neck fractures
5677376|NCT00590707|Trochanteric fractures|trochanteric fractures
5677377|NCT00590707|Intertrochanteric fractures|intertrochanteric fractures
5677378|NCT00590707|Subtrochanteric fractures|subtrochanteric fractures
5677379|NCT00590707|Delirium|delirium
5677380|NCT00590707|Confusion|confusion
5677381|NCT00590694|ranibizumab|ranibizumab
5677382|NCT00590694|Lucentis|lucentis
5677383|NCT00590694|Pigment Epithelial Detachment|pigment epithelial detachment
5677384|NCT00590694|Macular Degeneration|macular degeneration
5895686|NCT03248492|Metastatic or Unresectable|metastatic or unresectable
5895687|NCT03248492|Resistant or refractory to T-DM1|resistant or refractory to t-dm1
5895688|NCT03248492|DESTINY - Breast 01|destiny - breast 01
5895689|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan
5895690|NCT03248492|T-DXd|t-dxd
5895717|NCT03243331|Breast Cancer|breast cancer
5677385|NCT00590694|PrONTO|pronto
5677386|NCT00590668|atrial fibrillation|atrial fibrillation
5677387|NCT00590668|pulmonary vein ablation|pulmonary vein ablation
5677388|NCT00590668|pulmonary vein stenosis|pulmonary vein stenosis
5677389|NCT00590655|maintenance therapy|maintenance therapy
5677390|NCT00590642|obsessive compulsive disorder|obsessive compulsive disorder
5677392|NCT00590642|treatment-resistant|treatment-resistant
5677393|NCT00590642|SSRI|ssri
5677394|NCT00590629|Women with and without CAD|women with and without cad
5677395|NCT00590616|Aortic atheroma|aortic atheroma
5677396|NCT00590603|Multiple myeloma|multiple myeloma
5677397|NCT00590577|Schizophrenia|schizophrenia
5677398|NCT00590577|Long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5677399|NCT00590564|Hepatitis C|hepatitis c
5677400|NCT00590564|Sho-saiko-to|sho-saiko-to
5677402|NCT00590564|Interferon Therapy|interferon therapy
5677403|NCT00590551|Skin Breakdown|skin breakdown
5677404|NCT00590551|Skin Damage|skin damage
5677405|NCT00590551|Skin Integrity|skin integrity
5677406|NCT00590551|Pressure|pressure
5677407|NCT00590551|Slings|slings
5677408|NCT00590525|hsCRP|hscrp
5677409|NCT00590512|dietary salt|dietary salt
5677410|NCT00590512|sodium|sodium
5677411|NCT00590512|blood vessels|blood vessels
5677412|NCT00590512|vascular function|vascular function
5677413|NCT00590512|endothelial function|endothelial function
5677414|NCT00590512|heart disease risk|heart disease risk
5677415|NCT00590512|cardiovascular disease risk|cardiovascular disease risk
5677416|NCT00590499|agitation|agitation
5677423|NCT00590473|Neuromodulation|neuromodulation
5677424|NCT00590473|Interstim Therapy|interstim therapy
5677425|NCT00590460|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5677426|NCT00590460|Fanconi Anemia|fanconi anemia
5677427|NCT00590460|Severe Aplastic Anemia|severe aplastic anemia
5677428|NCT00590460|fludarabine|fludarabine
5677429|NCT00590460|campath|campath
5677430|NCT00590460|anti-CD45|anti-cd45
5677431|NCT00590447|1st-line therapy|1st-line therapy
5677432|NCT00590447|single agent rituximab|single agent rituximab
5677433|NCT00590447|CHOP|chop
5677434|NCT00590447|risk stratification|risk stratification
5677435|NCT00590434|CRC - Colorectal cancer|crc - colorectal cancer
5677436|NCT00590434|CVA - Cerebral Vascular Accident|cva - cerebral vascular accident
5677437|NCT00590434|MI - Myocardial Infarction|mi - myocardial infarction
5677438|NCT00590434|CAD - Coronary Artery Disease|cad - coronary artery disease
5677439|NCT00590434|DM - Diabetes Mellitus|dm - diabetes mellitus
5677440|NCT00590434|PVD - Peripheral Vascular Disease|pvd - peripheral vascular disease
5677441|NCT00590434|NSAIDS - Non-Steroidal Anti inflammatory Drugs|nsaids - non-steroidal anti inflammatory drugs
5677442|NCT00590434|screening|screening
5677443|NCT00590434|colonoscopy|colonoscopy
5677444|NCT00590408|coenzyme Q10|coenzyme q10
5677446|NCT00590408|myalgia|myalgia
5677447|NCT00590395|Cholecystitis|cholecystitis
5677448|NCT00590395|FDG PET/CT|fdg pet/ct
5677449|NCT00590395|HIDA scan|hida scan
5677450|NCT00590356|Device closure|device closure
5677451|NCT00590304|Asthma, Children, Rural Population, Morbidity, Endotoxin|asthma, children, rural population, morbidity, endotoxin
5677452|NCT00590291|Coronary Artery Disease|coronary artery disease
5677453|NCT00590291|Arteriovenous Malformations|arteriovenous malformations
5677454|NCT00590291|Myocardial Infarction|myocardial infarction
5677455|NCT00590291|CAD|cad
5677456|NCT00590291|MI|mi
5677457|NCT00590291|Heart Attack|heart attack
5677458|NCT00590291|AVM|avm
5677459|NCT00590291|genetic|genetic
5677460|NCT00590291|familial|familial
5677461|NCT00590278|Tomudex|tomudex
5677462|NCT00590278|inoperable rectal cancer|inoperable rectal cancer
5677463|NCT00590278|recurrent rectal cancer|recurrent rectal cancer
5677464|NCT00590265|bipolar type II disorder|bipolar type ii disorder
5677465|NCT00590265|depression|depression
5677466|NCT00590265|remission|remission
5677467|NCT00590265|light-therapy|light-therapy
5677468|NCT00590265|efficacy|efficacy
5677469|NCT00590265|safety|safety
5677470|NCT00590252|Magnetic Resonance|magnetic resonance
5895784|NCT03233724|PD-L1|pd-l1
5895785|NCT03233724|Demethylating Agents and Histone Deacetylase (HDAC) Inhibitors|demethylating agents and histone deacetylase (hdac) inhibitors
5895786|NCT03233724|DNA Hypomethylating Agent|dna hypomethylating agent
5895787|NCT03233724|Cytidine Deaminase|cytidine deaminase
5895788|NCT03233724|Checkpoint Inhibitor|checkpoint inhibitor
5895803|NCT03226704|CD19|cd19
5895804|NCT03226704|CD22|cd22
5895805|NCT03226704|CD19/22|cd19/22
5895806|NCT03226704|Immunotherapy|immunotherapy
5895807|NCT03226704|Apheresis|apheresis
5895827|NCT03222648|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5895828|NCT03222648|Exercise training|exercise training
5895829|NCT03222648|Health related quality of life|health related quality of life
5895830|NCT03222648|Biomarkers|biomarkers
5677471|NCT00590252|Imaging|imaging
5677472|NCT00590252|Spectroscopy|spectroscopy
5677473|NCT00590239|Barrett's Esophagus|barrett's esophagus
5677474|NCT00590239|Neoplasia|neoplasia
5677475|NCT00590239|Endoscopic mucosal resection|endoscopic mucosal resection
5677476|NCT00590239|High resolution endoscopy|high resolution endoscopy
5677477|NCT00590239|Chromoendoscopy|chromoendoscopy
5677478|NCT00590226|type 2 diabetes|type 2 diabetes
5677479|NCT00590226|inpatient hyperglycemia|inpatient hyperglycemia
5677480|NCT00590226|SQ insulin|sq insulin
5677481|NCT00590226|Hospitalized patients with type 2 diabetes|hospitalized patients with type 2 diabetes
5677482|NCT00590213|Casodex|casodex
5677483|NCT00590213|Prostate Cancer|prostate cancer
5677484|NCT00590200|CAD|cad
5677485|NCT00590200|Cardiovascular Disease|cardiovascular disease
5677486|NCT00590200|CVD|cvd
5677487|NCT00590200|MI|mi
5677488|NCT00590200|Myocardial Infarction|myocardial infarction
5677489|NCT00590200|Heart Attack|heart attack
5677490|NCT00590200|CABG|cabg
5677491|NCT00590200|Revascularization|revascularization
5677492|NCT00590200|genetic|genetic
5677493|NCT00590174|stent|stent
5677494|NCT00590174|antiplatelet therapy|antiplatelet therapy
5677495|NCT00590161|Fatty Liver|fatty liver
5677496|NCT00590161|Nonalcoholic fatty liver disease (NALFD)|nonalcoholic fatty liver disease (nalfd)
5677497|NCT00590161|NAFLD|nafld
5677498|NCT00590161|Nonalcoholic steatohepatitis (NASH)|nonalcoholic steatohepatitis (nash)
5677499|NCT00590161|NASH|nash
5688616|NCT00542516|Hetastarch|hetastarch
5677500|NCT00590161|pentoxifylline|pentoxifylline
5677501|NCT00590135|calcific aortic valve stenosis|calcific aortic valve stenosis
5677502|NCT00590135|echocardiography, transthoracic|echocardiography, transthoracic
5677503|NCT00590122|Parkinson's disease|parkinson's disease
5677504|NCT00590122|"time to on"|"time to on"
5677505|NCT00590122|delayed on|delayed on
5677506|NCT00590109|Breast Cancer|breast cancer
5677507|NCT00590109|Jewish|jewish
5677508|NCT00590109|BRCA1|brca1
5677510|NCT00590109|97-029|97-029
5677511|NCT00590096|Neuroblastoma|neuroblastoma
5677512|NCT00590096|Pheochromocytoma|pheochromocytoma
5677513|NCT00590096|MIBG|mibg
5677514|NCT00590083|stem cell transplantation|stem cell transplantation
5677515|NCT00590083|adenovirus|adenovirus
5677516|NCT00590083|Cytotoxic T-Lymphocytes|cytotoxic t-lymphocytes
5677517|NCT00590083|prophylaxis|prophylaxis
5677518|NCT00590070|myocardial infarction|myocardial infarction
5677519|NCT00590070|no reflow|no reflow
5677520|NCT00590070|primary PCI|primary pci
5677521|NCT00590070|Coronary no-reflow phenomenon|coronary no-reflow phenomenon
5677522|NCT00590070|primary percutaneous coronary intervention (primary PCI)|primary percutaneous coronary intervention (primary pci)
5677523|NCT00590044|Diabetic ketoacidosis|diabetic ketoacidosis
5677524|NCT00590044|insulin therapy|insulin therapy
5677525|NCT00590044|DKA|dka
5677526|NCT00590031|Esophageal Carcinoma|esophageal carcinoma
5677527|NCT00590031|Cisplatin|cisplatin
5677528|NCT00590031|Irinotecan|irinotecan
5677529|NCT00590031|Radiation Therapy|radiation therapy
5677530|NCT00590031|02-045|02-045
5677531|NCT00590018|Congenital heart disease.|congenital heart disease.
5677532|NCT00590018|Low cardiac output syndrome.|low cardiac output syndrome.
5677533|NCT00590018|Corticosteroids.|corticosteroids.
5677534|NCT00590018|Hydrocortisone.|hydrocortisone.
5677535|NCT00590018|Blood pressure.|blood pressure.
5677536|NCT00590018|Inotropes.|inotropes.
5677537|NCT00590005|severe asthma|severe asthma
5677538|NCT00590005|poorly controlled asthma|poorly controlled asthma
5895887|NCT03218566|pulmonary embolism|pulmonary embolism
5895888|NCT03218566|clot|clot
5895889|NCT03217838|AML|aml
5895890|NCT03217838|Acute Myeloid Leukaemia|acute myeloid leukaemia
5895891|NCT03217838|AZD2811|azd2811
5895892|NCT03217838|AZD1152|azd1152
5895893|NCT03217838|AZD1152 hQPA|azd1152 hqpa
5895894|NCT03217838|barasertib|barasertib
5895895|NCT03217838|azacitidine|azacitidine
5895896|NCT03217838|VIDAZA®|vidaza®
5895897|NCT03217838|venetoclax|venetoclax
5895898|NCT03217838|VENCLEXTA®|venclexta®
5895902|NCT03215810|Stage IV|stage iv
5895904|NCT03215810|Recurrent|recurrent
5895905|NCT03215810|TIL|til
5895906|NCT03215810|Tumor-infiltrating Lymphocyte Therapy (TIL)|tumor-infiltrating lymphocyte therapy (til)
5895907|NCT03215589|Near-infrared spectroscopy-derived cerebral oximetry|near-infrared spectroscopy-derived cerebral oximetry
5895911|NCT03214731|artesunate|artesunate
5895926|NCT03209401|Niraparib|niraparib
5895927|NCT03209401|Carboplatin|carboplatin
5895943|NCT03205670|Autologous Cells|autologous cells
5895944|NCT03205670|Buccal Mucosa|buccal mucosa
5895945|NCT03205670|Urethroplasty|urethroplasty
5895946|NCT03205670|Tissue-engineered Construct|tissue-engineered construct
5895947|NCT03205670|Hybrid matrix|hybrid matrix
5895948|NCT03205670|Collagen|collagen
5895949|NCT03205670|Polylactoglycolide Fibers|polylactoglycolide fibers
4965808|NCT04203030|aging|aging
5677539|NCT00589979|Osteoarthritis|osteoarthritis
5677540|NCT00589979|Knee|knee
5677541|NCT00589979|Lidoderm|lidoderm
5677542|NCT00589979|Lidocaine|lidocaine
5677543|NCT00589979|Topical patch|topical patch
5677544|NCT00589979|Adjunct therapy|adjunct therapy
5677545|NCT00589966|prostate cancer treatment|prostate cancer treatment
5677546|NCT00589966|treatment side-effects|treatment side-effects
5677547|NCT00589966|early diagnosis|early diagnosis
5677548|NCT00589966|African American Men|african american men
5677549|NCT00589966|coping skills training|coping skills training
5677550|NCT00589966|quality of life|quality of life
5677551|NCT00589966|Prostate cancer treatment side-effects|prostate cancer treatment side-effects
5677552|NCT00589953|Extreme Prematurity|extreme prematurity
5677553|NCT00589953|Erythropoietin|erythropoietin
5677554|NCT00589953|Perinatal Brain Injury|perinatal brain injury
5677555|NCT00589953|Intraventricular Hemorrhage|intraventricular hemorrhage
5677556|NCT00589953|Periventricular Leukomalacia|periventricular leukomalacia
5677557|NCT00589953|Neurodevelopmental Outcomes|neurodevelopmental outcomes
5677558|NCT00589953|Randomized Clinical Trial|randomized clinical trial
5677559|NCT00589927|stents|stents
5677560|NCT00589927|cilostazol|cilostazol
5677561|NCT00589914|Schizophrenia|schizophrenia
5677562|NCT00589914|long-acting injectable antipsychotic medication|long-acting injectable antipsychotic medication
5677563|NCT00589901|metastatic breast cancer|metastatic breast cancer
5677564|NCT00589901|capecitabine|capecitabine
5677565|NCT00589901|synergistic effect|synergistic effect
5677566|NCT00589901|chemotherapy|chemotherapy
5677567|NCT00589888|hypertension|hypertension
5677568|NCT00589888|metabolic syndrome|metabolic syndrome
5677569|NCT00589888|vascular reactivity|vascular reactivity
5677570|NCT00589888|Elevated blood pressure|elevated blood pressure
5677571|NCT00589888|lipid toxicity|lipid toxicity
5677572|NCT00589875|Immunotherapy|immunotherapy
5677573|NCT00589875|Cytotoxicity|cytotoxicity
5677574|NCT00589875|Tumor vaccine|tumor vaccine
5677575|NCT00589862|Drug Eluting Stents|drug eluting stents
5677576|NCT00589862|Clopidogrel Resistance|clopidogrel resistance
5677577|NCT00589862|Aspirin Resistance|aspirin resistance
5677578|NCT00589849|Myocardial Infarction|myocardial infarction
5677579|NCT00589849|Arrhythmia|arrhythmia
5895989|NCT03199898|Respiration, artificial|respiration, artificial
5895990|NCT03199898|Reproducibility of Results|reproducibility of results
5895991|NCT03199898|Observer Variation|observer variation
5896042|NCT03191812|Falls|falls
5896043|NCT03191812|transcranial Direct Current Stimulation|transcranial direct current stimulation
5896044|NCT03191812|Mobility|mobility
5896045|NCT03191812|Dual Task|dual task
5896076|NCT03186209|Asthma,|asthma,
5896077|NCT03186209|Bronchial Diseases,|bronchial diseases,
5896078|NCT03186209|Respiratory Tract Diseases,|respiratory tract diseases,
5896079|NCT03186209|Lung Diseases,|lung diseases,
5896080|NCT03186209|Obstructive Lung Diseases|obstructive lung diseases
5896081|NCT03185234|tDCS|tdcs
5896106|NCT03177772|caregivers|caregivers
5896107|NCT03177772|grief|grief
5896108|NCT03177772|dementia|dementia
5896109|NCT03177772|long-term care|long-term care
5896110|NCT03177772|psychotherapy group|psychotherapy group
5896159|NCT03167138|Shoulder pain|shoulder pain
5896160|NCT03167138|Rotator cuff disease|rotator cuff disease
5896161|NCT03167138|Spinal cord injuries|spinal cord injuries
5896162|NCT03167138|Mesenchymal stromal cells|mesenchymal stromal cells
5896163|NCT03167138|Regenerative medicine|regenerative medicine
5896164|NCT03167138|Rehabilitation|rehabilitation
5896190|NCT03162627|Malignant neoplasm of breast|malignant neoplasm of breast
5896191|NCT03162627|Malignant neoplasms of digestive organs|malignant neoplasms of digestive organs
5896192|NCT03162627|Malignant neoplasms of female genital organs|malignant neoplasms of female genital organs
5896193|NCT03162627|Malignant neoplasms of male genital organs|malignant neoplasms of male genital organs
5896194|NCT03162627|Malignant neoplasms of thyroid and other endocrine glands|malignant neoplasms of thyroid and other endocrine glands
5896195|NCT03162627|Solid tumors|solid tumors
5896196|NCT03162627|Ras Pathway Alterations|ras pathway alterations
5896197|NCT03162627|Ovarian Tumors with PARP Resistance|ovarian tumors with parp resistance
5896199|NCT03162627|AZD6244|azd6244
5896200|NCT03162627|Olaparib|olaparib
5896201|NCT03162627|Lynparza|lynparza
5896210|NCT03161379|Neoadjuvant therapy|neoadjuvant therapy
5896211|NCT03161379|immunotherapy|immunotherapy
5896212|NCT03161379|Cytoxan|cytoxan
5896213|NCT03161379|Cyclophosphamide|cyclophosphamide
5896214|NCT03161379|Pancreatic Vaccine|pancreatic vaccine
5896215|NCT03161379|SBRT|sbrt
5896216|NCT03161379|GVAX|gvax
5896217|NCT03161379|Nivolumab|nivolumab
5896218|NCT03161379|borderline resectable|borderline resectable
5896219|NCT03161379|Radioimmunotherapy|radioimmunotherapy
5896220|NCT03161379|Vaccine|vaccine
5896221|NCT03161379|Antibody|antibody
5896222|NCT03161379|Anti-PD-1|anti-pd-1
5896231|NCT03160898|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5896233|NCT03160898|CK-2127107|ck-2127107
5896234|NCT03160898|Reldesemtiv|reldesemtiv
5896242|NCT03159169|Neck Pain|neck pain
5896243|NCT03159169|Upper Limb Pain|upper limb pain
5896246|NCT03158519|Physical activity|physical activity
5896284|NCT03149679|Cyclophosphamide|cyclophosphamide
5896285|NCT03149679|Colorectal Cancer Metastatic|colorectal cancer metastatic
5896286|NCT03149679|TP53 Gene Mutation|tp53 gene mutation
5677580|NCT00589849|T-wave alternans|t-wave alternans
5677582|NCT00589836|HOCM|hocm
5677583|NCT00589836|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5677584|NCT00589836|tissue doppler echocardiography|tissue doppler echocardiography
5677585|NCT00589836|myocardial torsion|myocardial torsion
5677586|NCT00589823|Pain|pain
5677587|NCT00589823|Cancer|cancer
5677588|NCT00589823|Breakthrough|breakthrough
5677590|NCT00589810|in-stent restenosis|in-stent restenosis
5677591|NCT00589810|restenosis|restenosis
5677592|NCT00589810|BMS|bms
5896404|NCT03125356|diet soda|diet soda
5896405|NCT03125356|low-calorie sweeteners|low-calorie sweeteners
5896406|NCT03125356|obesity|obesity
5896407|NCT03123640|Medication reconciliation|medication reconciliation
5896408|NCT03123640|Medication review|medication review
5896409|NCT03123640|Drug related admission|drug related admission
5896415|NCT03119363|cancer-related fatigue|cancer-related fatigue
5896416|NCT03119363|circadian rhythms|circadian rhythms
5896417|NCT03119363|light therapy|light therapy
5896418|NCT03119363|systematic light exposure|systematic light exposure
5896419|NCT03119363|cancer survivors|cancer survivors
5896420|NCT03119363|oncology|oncology
5896421|NCT03119363|Multiple Myeloma|multiple myeloma
5896422|NCT03119363|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5896423|NCT03119363|Autologous stem cell transplantation|autologous stem cell transplantation
5896431|NCT03114527|Dedifferentiated liposarcoma|dedifferentiated liposarcoma
5896432|NCT03114527|DDL|ddl
5896433|NCT03114527|Leiomyosarcoma|leiomyosarcoma
5896434|NCT03114527|LMS|lms
5896435|NCT03114527|Ribociclib|ribociclib
5677593|NCT00589810|bare metal stent|bare metal stent
5677594|NCT00589810|revascularization|revascularization
5677596|NCT00589810|cardiac catheterization|cardiac catheterization
5677597|NCT00589797|Degenerative|degenerative
5677598|NCT00589797|Disc|disc
5677599|NCT00589784|Sunitinib|sunitinib
5677600|NCT00589784|Brain Cancer|brain cancer
5677601|NCT00589784|CNS Cancer|cns cancer
5677602|NCT00589784|meningioma|meningioma
5677603|NCT00589784|intracranial hemangiopericytoma|intracranial hemangiopericytoma
5677604|NCT00589784|hemangioblastoma|hemangioblastoma
5677605|NCT00589784|malignant meningioma|malignant meningioma
5677606|NCT00589784|neurofibromatosis|neurofibromatosis
5677607|NCT00589784|neurofibromatosis type 1|neurofibromatosis type 1
5677608|NCT00589784|neurofibromatosis type 2|neurofibromatosis type 2
5677610|NCT00589771|IBS|ibs
5677611|NCT00589771|Saccharomyces boulardii|saccharomyces boulardii
5677612|NCT00589771|probiotics|probiotics
5677613|NCT00589771|cytokine|cytokine
5677614|NCT00589771|histology|histology
5677615|NCT00589771|Efficacy|efficacy
5677616|NCT00589758|Right Ventricle|right ventricle
5677617|NCT00589758|Echocardiogram|echocardiogram
5677618|NCT00589758|Evaluation of Heart Failure|evaluation of heart failure
5677621|NCT00589732|angiotensin-converting enzyme|angiotensin-converting enzyme
5677622|NCT00589719|Asthma; minority; low-income; African American; Arkansas|asthma; minority; low-income; african american; arkansas
5677623|NCT00589706|high grade gliomas of the brain|high grade gliomas of the brain
5677624|NCT00589706|anti-body treatment|anti-body treatment
5677625|NCT00589706|survival|survival
5677626|NCT00589693|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5677627|NCT00589693|Pneumonia, hospital-acquired|pneumonia, hospital-acquired
5677628|NCT00589693|Doripenem|doripenem
5677629|NCT00589693|Imipenem-cilastatin|imipenem-cilastatin
5677630|NCT00589680|Acidosis, Diabetic|acidosis, diabetic
5677631|NCT00589680|Diabetic Acidosis|diabetic acidosis
5677632|NCT00589680|Diabetic Ketosis|diabetic ketosis
5677633|NCT00589680|Ketoacidosis, Diabetic|ketoacidosis, diabetic
5677634|NCT00589680|Ketosis, Diabetic|ketosis, diabetic
5677635|NCT00589667|Head and Neck Cancer|head and neck cancer
5677636|NCT00589667|GEMCITABINE|gemcitabine
5677637|NCT00589667|PEMETREXED|pemetrexed
5677639|NCT00589667|epidermoid/squamous cell|epidermoid/squamous cell
5677640|NCT00589667|carcinoma|carcinoma
5677641|NCT00589667|pharynx|pharynx
5677642|NCT00589667|larynx|larynx
5677643|NCT00589667|paranasal sinus|paranasal sinus
5677644|NCT00589667|head/neck squamous cell carcinoma|head/neck squamous cell carcinoma
5677645|NCT00589654|amenorrhea|amenorrhea
5677646|NCT00589654|menstrual cycle|menstrual cycle
5677647|NCT00589654|Breast cancer|breast cancer
5677648|NCT00589654|questionnaire|questionnaire
5677649|NCT00589654|97-127|97-127
5677650|NCT00589641|adolescents|adolescents
5896467|NCT03107546|Syndactyly|syndactyly
5896468|NCT03107546|Syndactyly release surgery|syndactyly release surgery
5896469|NCT03107546|Full thickness skin graft|full thickness skin graft
5896470|NCT03107546|Hyalomatrix|hyalomatrix
5896471|NCT03107546|Scar formation|scar formation
5896472|NCT03106987|polymerisation inhibitor (PARPi)|polymerisation inhibitor (parpi)
5896473|NCT03106987|PARPi re-treatment|parpi re-treatment
5896474|NCT03106987|BRCA1/2 (+ve)|brca1/2 (+ve)
5896475|NCT03106987|BRCA1/2 (-ve)|brca1/2 (-ve)
5896476|NCT03106987|Olaparib|olaparib
5896477|NCT03106987|ovarian cancer|ovarian cancer
5896478|NCT03106987|progression free survival (PFS)|progression free survival (pfs)
4966396|NCT04199741|19-292|19-292
5896519|NCT03102320|cholangiocarcinoma|cholangiocarcinoma
5896520|NCT03102320|pancreatic cancer|pancreatic cancer
5896521|NCT03102320|triple-negative breast cancer|triple-negative breast cancer
5896522|NCT03102320|non-small cell lung cancer|non-small cell lung cancer
5896523|NCT03102320|thymic carcinoma|thymic carcinoma
5896524|NCT03102320|gastric including gastroesophageal junction cancer|gastric including gastroesophageal junction cancer
5896544|NCT03095495|Heated Humidified High Flow Nasal Cannula (HHHFNC)|heated humidified high flow nasal cannula (hhhfnc)
5896545|NCT03095495|Low Flow Nasal Cannula|low flow nasal cannula
5896546|NCT03095495|Bronchiolitis|bronchiolitis
5896547|NCT03095495|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5896548|NCT03095495|Respiratory Failure|respiratory failure
5896549|NCT03095495|High Flow Nasal Cannula (HFNC)|high flow nasal cannula (hfnc)
5896550|NCT03095495|Lung Diseases, Obstructive|lung diseases, obstructive
4966495|NCT04199039|nursing|nursing
5896633|NCT03081559|transgender|transgender
5896634|NCT03081559|women|women
5896650|NCT03078205|TCM multi-channel therapy|tcm multi-channel therapy
5896651|NCT03078205|ART failure|art failure
5896664|NCT03076554|Programmed Death 1 (PD-1)|programmed death 1 (pd-1)
5896665|NCT03076554|Immune Checkpoint Blockade|immune checkpoint blockade
5677651|NCT00589641|suicidal ideation and behavior|suicidal ideation and behavior
5677652|NCT00589641|depression|depression
5677653|NCT00589641|substance abuse|substance abuse
5677654|NCT00589628|Childhood|childhood
5677655|NCT00589628|Uveitis|uveitis
5677656|NCT00589615|vitamin D|vitamin d
5677657|NCT00589615|bone density|bone density
5677658|NCT00589602|Adult leukemia|adult leukemia
5677659|NCT00589602|lymphoma|lymphoma
5677660|NCT00589602|myelodysplastic syndromes|myelodysplastic syndromes
5677661|NCT00589602|plasma cell disorders|plasma cell disorders
5677662|NCT00589589|burns|burns
5677663|NCT00589589|hypoglycemia|hypoglycemia
5677664|NCT00589589|hyperglycemia|hyperglycemia
5677665|NCT00589589|glucose monitoring|glucose monitoring
5677666|NCT00589563|graft versus host disease|graft versus host disease
5677667|NCT00589563|infection|infection
5677668|NCT00589563|adult favorable prognosis Hodgkin lymphoma|adult favorable prognosis hodgkin lymphoma
5677669|NCT00589563|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5677670|NCT00589563|childhood favorable prognosis Hodgkin lymphoma|childhood favorable prognosis hodgkin lymphoma
5677671|NCT00589563|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
5677672|NCT00589563|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5677673|NCT00589563|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5677674|NCT00589563|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5677675|NCT00589563|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5677676|NCT00589563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5677677|NCT00589563|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5677678|NCT00589563|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5677679|NCT00589563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5677680|NCT00589563|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5677681|NCT00589563|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5677682|NCT00589563|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5677683|NCT00589563|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5677684|NCT00589563|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5677685|NCT00589563|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5677686|NCT00589563|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5677687|NCT00589563|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5677688|NCT00589563|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5677689|NCT00589563|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5677690|NCT00589563|Burkitt lymphoma|burkitt lymphoma
5677691|NCT00589563|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5677692|NCT00589563|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5677693|NCT00589563|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5677694|NCT00589563|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5677695|NCT00589563|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5677696|NCT00589563|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5677697|NCT00589563|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5677698|NCT00589563|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5677699|NCT00589563|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5677700|NCT00589563|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5677701|NCT00589563|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5677702|NCT00589563|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5677703|NCT00589563|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5677704|NCT00589563|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5677705|NCT00589563|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5677706|NCT00589563|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5677707|NCT00589563|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5896756|NCT03055494|scalp psoriasis|scalp psoriasis
5896757|NCT03055494|plaque psoriasis|plaque psoriasis
5896758|NCT03055494|secukinumab|secukinumab
5896759|NCT03055494|AIN457|ain457
5896760|NCT03055494|biologic|biologic
5896761|NCT03055494|monoclonal antibod|monoclonal antibod
5896762|NCT03055494|psoriasis|psoriasis
5896763|NCT03055494|AIN457A|ain457a
5896791|NCT03047135|high-risk biochemically-recurrent|high-risk biochemically-recurrent
5896793|NCT03046121|dementia|dementia
5896794|NCT03046121|acute care|acute care
5896795|NCT03046121|post-acute recovery|post-acute recovery
5896796|NCT03046121|family caregivers|family caregivers
5677708|NCT00589563|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5677709|NCT00589563|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5677710|NCT00589563|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5677711|NCT00589563|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5677712|NCT00589563|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5677713|NCT00589563|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5677714|NCT00589563|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5677715|NCT00589563|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5677716|NCT00589563|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5677717|NCT00589563|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5677718|NCT00589563|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5677719|NCT00589563|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5677720|NCT00589563|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5677721|NCT00589563|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5677722|NCT00589563|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5677723|NCT00589563|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5677724|NCT00589563|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5677725|NCT00589563|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5677726|NCT00589563|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5677727|NCT00589563|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5677728|NCT00589563|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5677729|NCT00589563|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5677730|NCT00589563|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5677731|NCT00589563|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5677732|NCT00589563|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5677733|NCT00589563|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5677734|NCT00589563|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5677735|NCT00589563|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5677736|NCT00589563|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5677737|NCT00589563|small intestine lymphoma|small intestine lymphoma
5677738|NCT00589563|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5677739|NCT00589563|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5685495|NCT00555854|Life style changes|life style changes
5677740|NCT00589563|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5677741|NCT00589563|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5677742|NCT00589563|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5677743|NCT00589563|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5677744|NCT00589563|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5677745|NCT00589563|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5677746|NCT00589563|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5677747|NCT00589563|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5677748|NCT00589563|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5677749|NCT00589563|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5677750|NCT00589563|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5896804|NCT03043989|docetaxel|docetaxel
5896805|NCT03043989|cabazitaxel|cabazitaxel
5896806|NCT03043989|phase 1b|phase 1b
5896807|NCT03043989|castration-resistant|castration-resistant
5896808|NCT03043989|bone metastasis|bone metastasis
5896809|NCT03043664|GEP-NET|gep-net
5896810|NCT03043664|Pembrolizumab|pembrolizumab
5896811|NCT03043664|Lanreotide depot|lanreotide depot
5896812|NCT03043664|PD-1|pd-1
5896876|NCT03029429|pseudohypoparathyroidism|pseudohypoparathyroidism
5896877|NCT03029429|AHO|aho
5896878|NCT03029429|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5677751|NCT00589563|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5677752|NCT00589563|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5677753|NCT00589563|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5677754|NCT00589563|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5677755|NCT00589563|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5677756|NCT00589563|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5677757|NCT00589563|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5677758|NCT00589563|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5677759|NCT00589563|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5677760|NCT00589563|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5677761|NCT00589563|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5677762|NCT00589563|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5677763|NCT00589563|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5677764|NCT00589563|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5677765|NCT00589563|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5677766|NCT00589563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5677767|NCT00589563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5677768|NCT00589563|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5677772|NCT00589563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5677773|NCT00589563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5677774|NCT00589563|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5677775|NCT00589563|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5677776|NCT00589563|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5677777|NCT00589563|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5677778|NCT00589563|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5677779|NCT00589563|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5677780|NCT00589563|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5677781|NCT00589563|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5677782|NCT00589563|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5677783|NCT00589563|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5677784|NCT00589563|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5677785|NCT00589563|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5677786|NCT00589563|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5677787|NCT00589563|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5677788|NCT00589563|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5677789|NCT00589563|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5677790|NCT00589563|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5677791|NCT00589563|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5677792|NCT00589563|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5677793|NCT00589563|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5685496|NCT00555854|Prevention|prevention
5677794|NCT00589563|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5896949|NCT03001557|Mild to Moderate Alzheimer's Disease Dementia|mild to moderate alzheimer's disease dementia
5896951|NCT03001557|circadian rhythms|circadian rhythms
5677795|NCT00589563|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5677796|NCT00589563|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5677797|NCT00589563|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5677798|NCT00589563|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5677799|NCT00589563|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5677800|NCT00589563|stage I multiple myeloma|stage i multiple myeloma
5677801|NCT00589563|stage II multiple myeloma|stage ii multiple myeloma
5677802|NCT00589563|stage III multiple myeloma|stage iii multiple myeloma
5677803|NCT00589563|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5677804|NCT00589563|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5677805|NCT00589563|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5677806|NCT00589563|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5677807|NCT00589563|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5897254|NCT02931682|Creatine transporter|creatine transporter
5897255|NCT02931682|developmental delay|developmental delay
5897259|NCT02931682|seizure|seizure
5897506|NCT02881307|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5897507|NCT02881307|Musculoskeletal Ultrasound (MSUS)|musculoskeletal ultrasound (msus)
5898160|NCT02703571|TMT212|tmt212
5898161|NCT02703571|advanced solid tumors|advanced solid tumors
5898162|NCT02703571|pancreatic cancer|pancreatic cancer
5898167|NCT02702401|PD1|pd1
5898669|NCT02564523|Modified Vaccinia Virus Ankara - Bavarian Nordic (MVA-BN) Filo-vector|modified vaccinia virus ankara - bavarian nordic (mva-bn) filo-vector
5898670|NCT02564523|Safety|safety
5898671|NCT02564523|Immunogenicity|immunogenicity
5898672|NCT02564523|Inserm, Centre Muraz|inserm, centre muraz
5898674|NCT02564315|Smoking|smoking
5898675|NCT02564315|Cessation|cessation
5898676|NCT02564315|Tobacco|tobacco
5898677|NCT02564315|Relapse|relapse
5898686|NCT02562482|Antibody Response|antibody response
5898687|NCT02562482|Immune Response|immune response
5898688|NCT02562482|Healthy Volunteer|healthy volunteer
5898737|NCT02553642|Tumor Mutation|tumor mutation
5898738|NCT02553642|Nivolumab|nivolumab
5898739|NCT02553642|Nivolumab plus Ipilimumab|nivolumab plus ipilimumab
5898740|NCT02553642|Predicted Neo-antigen Burden|predicted neo-antigen burden
5898741|NCT02553642|15-126|15-126
5898747|NCT02547766|Ventricular Assist Device|ventricular assist device
5898776|NCT02541903|Epidermal growth factor receptor (EGFR),|epidermal growth factor receptor (egfr),
5898777|NCT02541903|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5898778|NCT02541903|Penile squamous cell carcinoma (PSCC)|penile squamous cell carcinoma (pscc)
5898779|NCT02541903|Gilotrif|gilotrif
5898780|NCT02541045|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5898781|NCT02541045|metadoxine|metadoxine
5898782|NCT02541045|efficacy|efficacy
5898783|NCT02541045|therapy|therapy
5898784|NCT02540954|Age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5898785|NCT02540954|Eylea treatment|eylea treatment
5898786|NCT02540954|Treat and Extend|treat and extend
5898787|NCT02540954|Intravitreal|intravitreal
5898788|NCT02540291|E7046|e7046
5898789|NCT02540291|Advanced malignancies|advanced malignancies
5898790|NCT02540291|malignancies|malignancies
5898793|NCT02534844|Niemann-Pick Type C1 (NPC1) Disease|niemann-pick type c1 (npc1) disease
5898794|NCT02534844|neurologic disease|neurologic disease
5898795|NCT02534844|gross motor dysfunction|gross motor dysfunction
5898796|NCT02534844|fine motor dysfunction|fine motor dysfunction
5898797|NCT02534844|dysphagia|dysphagia
5898798|NCT02534844|swallowing problems|swallowing problems
5898799|NCT02534844|cognitive dysfunction|cognitive dysfunction
5898800|NCT02534844|gait abnormalities|gait abnormalities
5898801|NCT02534844|pediatrics|pediatrics
5898820|NCT02531685|dmLT|dmlt
5898821|NCT02531685|Enteric|enteric
5898822|NCT02531685|Escherichia coli Infections|escherichia coli infections
5898823|NCT02531685|Shigella|shigella
5898824|NCT02531685|Toxin LTR192G/L211A|toxin ltr192g/l211a
5898851|NCT02526485|heparin|heparin
5898852|NCT02526485|thrombocytopenia|thrombocytopenia
5898853|NCT02526485|genomics|genomics
5898855|NCT02524171|crime|crime
5898856|NCT02524171|mental health|mental health
5898857|NCT02524171|substance abuse|substance abuse
5898858|NCT02524171|homelessness|homelessness
5898859|NCT02524171|Veterans|veterans
5898912|NCT02507544|Tumor Response|tumor response
5898913|NCT02507544|Hematology|hematology
5898914|NCT02507544|Oncology|oncology
5898920|NCT02503137|male pattern baldness|male pattern baldness
5898921|NCT02503137|SM04554|sm04554
5898930|NCT02500199|HER2 positive|her2 positive
5898983|NCT02475213|Melanoma, Non small cell lung cancer, SCCHN|melanoma, non small cell lung cancer, scchn
5685497|NCT00555854|Compliance|compliance
5898984|NCT02475213|Other B7-H3 expressing cancers|other b7-h3 expressing cancers
5898986|NCT02471365|Exposure Assessment|exposure assessment
5898987|NCT02471365|Questionnaire|questionnaire
5898988|NCT02471365|Product Use|product use
5898989|NCT02471365|Biomonitoring|biomonitoring
5898994|NCT02469389|Schizophrenia|schizophrenia
5898995|NCT02469389|Negative Symptoms|negative symptoms
5677808|NCT00589563|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5677809|NCT00589563|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5677810|NCT00589563|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5677811|NCT00589563|primary myelofibrosis|primary myelofibrosis
5677812|NCT00589563|secondary myelofibrosis|secondary myelofibrosis
5677813|NCT00589550|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5677814|NCT00589550|stage III renal cell cancer|stage iii renal cell cancer
5677815|NCT00589550|stage IV renal cell cancer|stage iv renal cell cancer
5677816|NCT00589537|testicular seminoma|testicular seminoma
5677817|NCT00589537|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5677818|NCT00589524|blocked arteries|blocked arteries
5677819|NCT00589524|narrowing arteries|narrowing arteries
5677820|NCT00589524|IVUS|ivus
5677822|NCT00589511|Bilateral severe to profound sensorineural hearing loss|bilateral severe to profound sensorineural hearing loss
5677823|NCT00589459|undiagnosed diabetes|undiagnosed diabetes
5677824|NCT00589459|undiagnosed pre-diabetes|undiagnosed pre-diabetes
5677825|NCT00589459|acute coronary syndrome|acute coronary syndrome
5677826|NCT00589459|undiagnosed pre-diabetes and undiagnosed diabetes|undiagnosed pre-diabetes and undiagnosed diabetes
5677827|NCT00589446|Embryoscopy|embryoscopy
5677828|NCT00589446|recurrent miscarriage|recurrent miscarriage
5677829|NCT00589446|missed abortion|missed abortion
5677830|NCT00589446|Structural anomalies in recurrent miscarriage|structural anomalies in recurrent miscarriage
5677831|NCT00589446|Embryoscopically directed biopsy for karyotyping|embryoscopically directed biopsy for karyotyping
5677832|NCT00589420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5677833|NCT00589420|recurrent prostate cancer|recurrent prostate cancer
5677834|NCT00589420|stage IV prostate cancer|stage iv prostate cancer
5677835|NCT00589394|pneumococcal vaccine|pneumococcal vaccine
5677836|NCT00589394|normal response|normal response
5677837|NCT00589394|immunodeficiency|immunodeficiency
5677838|NCT00589394|Healthy patients|healthy patients
5677839|NCT00589394|Healthy Volunteers|healthy volunteers
5677840|NCT00589381|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5677841|NCT00589381|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5677842|NCT00589381|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5677843|NCT00589381|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5689323|NCT00539227|NAC|nac
5677845|NCT00589381|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5677846|NCT00589381|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5677847|NCT00589381|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5677848|NCT00589381|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5677849|NCT00589381|Waldenström macroglobulinemia|waldenström macroglobulinemia
5677850|NCT00589381|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5899005|NCT02468102|Venous Thrombosis/Pulmonary Embolism|venous thrombosis/pulmonary embolism
5899006|NCT02468102|Stroke Prevention in Atrial Fibrillation|stroke prevention in atrial fibrillation
5899007|NCT02468102|Anticoagulants|anticoagulants
5899008|NCT02468102|Hematologic Agents|hematologic agents
5899009|NCT02468102|Therapeutic Uses|therapeutic uses
5899010|NCT02468102|Observational|observational
5899011|NCT02468102|Pulmonary Embolism|pulmonary embolism
5899012|NCT02468102|Venous Thrombosis|venous thrombosis
5899013|NCT02468102|Venous Thromboembolism|venous thromboembolism
5899014|NCT02468102|Intracranial Hemorrhages|intracranial hemorrhages
5899015|NCT02468102|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5899030|NCT02464540|laminate veneers|laminate veneers
5899031|NCT02464540|luting agent|luting agent
5899074|NCT02450812|mCRPC|mcrpc
5899087|NCT02443558|Robotics|robotics
5899088|NCT02443558|Cerebral cortex|cerebral cortex
5899089|NCT02443558|Brain waves|brain waves
5899090|NCT02443558|Electroencephalography|electroencephalography
5899091|NCT02443558|Rehabilitation|rehabilitation
5899092|NCT02443558|Brain-Computer Interfaces|brain-computer interfaces
5677851|NCT00589381|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5677852|NCT00589381|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5677853|NCT00589381|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5677854|NCT00589381|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5677855|NCT00589381|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5677856|NCT00589381|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5677857|NCT00589381|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5677858|NCT00589381|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5677859|NCT00589381|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5677860|NCT00589381|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5677861|NCT00589381|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
4988171|NCT04065360|CBT|cbt
5677862|NCT00589381|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5677863|NCT00589381|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5677864|NCT00589381|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5677865|NCT00589368|Brain Infarction|brain infarction
5677866|NCT00589368|pathology|pathology
5677867|NCT00589368|physiopathology|physiopathology
5677868|NCT00589368|psychology|psychology
5677870|NCT00589368|Fingers|fingers
5677871|NCT00589368|Grasp|grasp
5677872|NCT00589368|Functional Laterality|functional laterality
5677873|NCT00589368|Hand|hand
5677874|NCT00589368|Strength|strength
5677875|NCT00589368|Neuronal Plasticity|neuronal plasticity
5677876|NCT00589368|Psychomotor Performance|psychomotor performance
5677877|NCT00589368|Biomechanis|biomechanis
5677878|NCT00589368|Touch|touch
5677879|NCT00589368|Weight-Bearing|weight-bearing
5677880|NCT00589355|c-reactive protein|c-reactive protein
5677881|NCT00589355|endothelial dysfunction|endothelial dysfunction
5677882|NCT00589355|glucose intolerance|glucose intolerance
5677883|NCT00589329|Preterm birth|preterm birth
5677884|NCT00589329|antibiotics|antibiotics
5677885|NCT00589329|preterm labor|preterm labor
5677886|NCT00589329|respiratory distress|respiratory distress
5677887|NCT00589329|pergnancy|pergnancy
5677888|NCT00589303|Atrial Fibrillation|atrial fibrillation
5677889|NCT00589303|Heart Failure|heart failure
5677890|NCT00589303|AV Node ablation|av node ablation
5677891|NCT00589303|Cardiac pacemaker|cardiac pacemaker
5677892|NCT00589303|Antiarrhythmic drug|antiarrhythmic drug
5677893|NCT00589290|Histone deacetylase (HDAC) Inhibitors|histone deacetylase (hdac) inhibitors
5677894|NCT00589290|Mediastinal Neoplasm|mediastinal neoplasm
5677895|NCT00589290|Thymic Carcinoma|thymic carcinoma
5899114|NCT02433054|deep vein thrombosis|deep vein thrombosis
5899115|NCT02433054|chronic venous disease|chronic venous disease
5899116|NCT02433054|May-Thurner syndrome|may-thurner syndrome
5899117|NCT02433054|venous stent|venous stent
5899126|NCT02427503|asthma|asthma
5899127|NCT02427503|sinonasal polyposis|sinonasal polyposis
5899128|NCT02427503|eosinophilic bronchial inflammation|eosinophilic bronchial inflammation
5899129|NCT02427503|endoscopic sinus surgery|endoscopic sinus surgery
5899130|NCT02426892|Solid Tumors|solid tumors
5899131|NCT02426892|HPV-16 Positive Incurable Solid Tumors|hpv-16 positive incurable solid tumors
5899132|NCT02426892|ISA101|isa101
5899133|NCT02426892|HPV-16 vaccination|hpv-16 vaccination
5899134|NCT02426892|Nivolumab|nivolumab
5899136|NCT02426892|Opdivo|opdivo
5899137|NCT02426086|Myelofibrosis|myelofibrosis
5899138|NCT02426086|Imetelstat|imetelstat
5899139|NCT02426086|GRN163L|grn163l
5899140|NCT02426086|Relapsed/refractory to JAKi|relapsed/refractory to jaki
5899141|NCT02426086|IMbark|imbark
5899154|NCT02423070|Cell-free DNA|cell-free dna
5899155|NCT02423070|Acute Rejection|acute rejection
5899156|NCT02423070|Thoracic Organ Transplantation|thoracic organ transplantation
5899157|NCT02423070|Non-Invasive Testing|non-invasive testing
5899158|NCT02423070|Chronic Rejection|chronic rejection
5899159|NCT02422797|HIV|hiv
5899160|NCT02422797|NNRTI-sparing|nnrti-sparing
5899161|NCT02422797|two-drug regimen|two-drug regimen
5899162|NCT02422797|nucleoside reverse transcriptase inhibitors|nucleoside reverse transcriptase inhibitors
5899163|NCT02422797|protease inhibitor|protease inhibitor
5899164|NCT02422797|integrase inhibitor|integrase inhibitor
5899165|NCT02422797|non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5899166|NCT02422797|dolutegravir plus rilpivirine|dolutegravir plus rilpivirine
5899167|NCT02422797|virologically-suppressed|virologically-suppressed
4969272|NCT04181736|DLPFC|dlpfc
5677896|NCT00589290|Thymoma|thymoma
5677897|NCT00589277|Smoking|smoking
5677898|NCT00589277|Tobacco|tobacco
5677899|NCT00589277|Message Framing|message framing
5677900|NCT00589264|zinc|zinc
5677901|NCT00589264|iron|iron
5677902|NCT00589264|child development|child development
5677903|NCT00589264|visual attention|visual attention
5677904|NCT00589264|Peru|peru
5677905|NCT00589251|penicillin allergy, penicillin skin test|penicillin allergy, penicillin skin test
5677906|NCT00589238|stage II breast cancer|stage ii breast cancer
5677907|NCT00589238|stage IIIA breast cancer|stage iiia breast cancer
5677908|NCT00589238|stage IIIB breast cancer|stage iiib breast cancer
5677909|NCT00589238|stage IIIC breast cancer|stage iiic breast cancer
5677912|NCT00589225|Primary Hyperoxaluria|primary hyperoxaluria
5677913|NCT00589225|Hyperoxaluria|hyperoxaluria
5677914|NCT00589225|Primary Oxalosis|primary oxalosis
5677915|NCT00589225|PH type II|ph type ii
5677916|NCT00589225|PH type III|ph type iii
5677917|NCT00589225|Genetic testing for PH|genetic testing for ph
5677918|NCT00589225|Genetic testing for Primary Hyperoxaluria|genetic testing for primary hyperoxaluria
5677919|NCT00589225|Hereditary study for PH|hereditary study for ph
5677920|NCT00589225|Hereditary study for Primary Hyperoxaluria|hereditary study for primary hyperoxaluria
5899241|NCT02401542|UCC|ucc
5899242|NCT02401542|bladder cancer|bladder cancer
5899243|NCT02401542|vofatamab|vofatamab
5899244|NCT02401542|FGFR3|fgfr3
5899245|NCT02401542|invasive bladder cancer|invasive bladder cancer
5899246|NCT02401542|targeted therapy|targeted therapy
5899247|NCT02401542|Transitional Cell Carcinoma|transitional cell carcinoma
5899248|NCT02401542|TCC|tcc
5899249|NCT02401542|Phase 2|phase 2
5899250|NCT02401542|second line therapy|second line therapy
5899251|NCT02401542|monoclonal antibody|monoclonal antibody
5899252|NCT02401542|docetaxel|docetaxel
5899253|NCT02401542|combination therapy|combination therapy
5899254|NCT02401542|Phase 1|phase 1
5899255|NCT02401542|monotherapy|monotherapy
5899256|NCT02401542|B-701|b-701
5899267|NCT02397200|Growth|growth
5899268|NCT02397200|low weight|low weight
5899269|NCT02397200|low height|low height
5899270|NCT02397200|Nutritional Supplementation|nutritional supplementation
5677921|NCT00589212|GliaSite|gliasite
5677922|NCT00589212|Brain metastases|brain metastases
5677923|NCT00589212|1-3 METS|1-3 mets
5677924|NCT00589186|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5677925|NCT00589186|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5678019|NCT00588640|HEENT cancer|heent cancer
5677926|NCT00589186|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5677927|NCT00589186|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5677928|NCT00589173|Preventive Care|preventive care
5677929|NCT00589173|Health information technology|health information technology
5677930|NCT00589173|Personal health record|personal health record
5677931|NCT00589121|radiation fibrosis|radiation fibrosis
5677932|NCT00589121|radiation toxicity|radiation toxicity
5677933|NCT00589121|lymphedema|lymphedema
5677934|NCT00589121|musculoskeletal complications|musculoskeletal complications
5677935|NCT00589121|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5677936|NCT00589121|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5677937|NCT00589121|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5677938|NCT00589121|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5677939|NCT00589108|knee arthroplasty|knee arthroplasty
5677941|NCT00589082|elderly|elderly
5677942|NCT00589082|DaunoXome|daunoxome
5677943|NCT00589056|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5677944|NCT00589056|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5677945|NCT00589056|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5677946|NCT00589030|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5677947|NCT00589030|advanced adult primary liver cancer|advanced adult primary liver cancer
5677948|NCT00589030|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5677949|NCT00589030|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5677950|NCT00588978|c-reactive protein|c-reactive protein
5677951|NCT00588978|obesity|obesity
5677952|NCT00588978|women's cardiovascular health|women's cardiovascular health
5677953|NCT00588965|QT interval|qt interval
5677954|NCT00588965|beta-blocker|beta-blocker
5677955|NCT00588965|exercise|exercise
5677956|NCT00588965|electrocardiogram|electrocardiogram
5677957|NCT00588965|repolarizaton|repolarizaton
5677958|NCT00588939|reflux|reflux
5677959|NCT00588939|heartburn|heartburn
5677960|NCT00588926|Deep Brain Stimulation|deep brain stimulation
5677961|NCT00588926|Movement Disorders|movement disorders
5677962|NCT00588926|Remifentanil|remifentanil
5677963|NCT00588926|Sedation|sedation
5677964|NCT00588926|Basal Ganglia electrical activity|basal ganglia electrical activity
5677965|NCT00588913|recurrent renal cell cancer|recurrent renal cell cancer
5677966|NCT00588913|stage IV renal cell cancer|stage iv renal cell cancer
5677967|NCT00588913|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5677968|NCT00588913|lung metastases|lung metastases
5677969|NCT00588900|stage IV colon cancer|stage iv colon cancer
5899304|NCT02384265|Diabetes|diabetes
5899305|NCT02384265|Disparities|disparities
5899306|NCT02384265|Behavioral|behavioral
5899307|NCT02384265|Text messaging|text messaging
5899308|NCT02384265|Social networks|social networks
5899309|NCT02384265|African American|african american
5899310|NCT02384265|Female|female
5899329|NCT02373566|burns|burns
5899330|NCT02373566|dermal substitute|dermal substitute
5899331|NCT02373566|scar quality|scar quality
5899332|NCT02373566|reconstruction|reconstruction
5899333|NCT02373566|wound healing|wound healing
5899340|NCT02371668|Influenza A|influenza a
5899341|NCT02371668|H1N1|h1n1
5899342|NCT02371668|Challenge Model|challenge model
5899343|NCT02371668|Human Immunoglobulin and H1N1|human immunoglobulin and h1n1
5899344|NCT02371668|Efficacy and Safety in H1N1|efficacy and safety in h1n1
5899374|NCT02358226|Substance-Related Disorders|substance-related disorders
5677970|NCT00588900|stage IV rectal cancer|stage iv rectal cancer
5677971|NCT00588900|recurrent colon cancer|recurrent colon cancer
5677972|NCT00588900|recurrent rectal cancer|recurrent rectal cancer
5677973|NCT00588874|male osteoporosis|male osteoporosis
5677974|NCT00588874|male osteopenia|male osteopenia
5677975|NCT00588874|calciotropic hormones|calciotropic hormones
5677976|NCT00588848|Obstructive Sleep Apnea Hypopnea Syndrome|obstructive sleep apnea hypopnea syndrome
5677978|NCT00588848|Postoperative|postoperative
5677979|NCT00588848|CPAP|cpap
5677980|NCT00588835|pharmacokinetics|pharmacokinetics
5677981|NCT00588835|nausea and vomiting post chemotherapy|nausea and vomiting post chemotherapy
5677982|NCT00588822|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5677983|NCT00588796|fibrinogen|fibrinogen
5677984|NCT00588796|burns|burns
5677985|NCT00588796|trauma|trauma
5677986|NCT00588796|metabolism|metabolism
5677987|NCT00588757|IVC filters|ivc filters
5677988|NCT00588757|Trauma|trauma
5677989|NCT00588757|Dwell time|dwell time
5677990|NCT00588718|Necrotizing enterocolitis|necrotizing enterocolitis
5677991|NCT00588718|Progressive necrotizing enterocolitis|progressive necrotizing enterocolitis
5677992|NCT00588718|Proteomics in blood|proteomics in blood
5677993|NCT00588718|Genomics in blood|genomics in blood
5677994|NCT00588718|Multi-center|multi-center
5677995|NCT00588705|Daughters|daughters
5677996|NCT00588705|Communication|communication
5677997|NCT00588705|genetic risk|genetic risk
5677998|NCT00588705|Genetic Counseling|genetic counseling
5677999|NCT00588692|Heart Failure|heart failure
5678000|NCT00588692|Afterload Reduction|afterload reduction
5678001|NCT00588692|Sphygmocor|sphygmocor
5678002|NCT00588679|Prostate Cancer|prostate cancer
5678003|NCT00588679|Cancer|cancer
5678004|NCT00588679|MRI|mri
5678005|NCT00588679|Magnetic Resonance Imaging|magnetic resonance imaging
5678006|NCT00588679|06-035|06-035
5678007|NCT00588666|Myeloproliferative Disorder|myeloproliferative disorder
5678008|NCT00588666|urinary bladder|urinary bladder
5678009|NCT00588666|Cancer|cancer
5678010|NCT00588666|ureter|ureter
5678011|NCT00588666|renal pelvis|renal pelvis
5678012|NCT00588666|chemotherapy|chemotherapy
5678013|NCT00588653|Crohn's disease|crohn's disease
5678014|NCT00588653|capsule endoscopy|capsule endoscopy
5678015|NCT00588653|computed tomography enterography|computed tomography enterography
5678016|NCT00588653|colonoscopy|colonoscopy
5678017|NCT00588653|small bowel follow-through|small bowel follow-through
5678018|NCT00588640|Pain|pain
5678020|NCT00588627|Chronic cough|chronic cough
5678021|NCT00588627|Post nasal drip|post nasal drip
5678022|NCT00588588|Ventilator associated pneumonia|ventilator associated pneumonia
5678023|NCT00588588|Intensive Care|intensive care
5678024|NCT00588588|Antibiotics|antibiotics
5678025|NCT00588588|Mortality|mortality
5678026|NCT00588588|Length of stay|length of stay
5678027|NCT00588575|Barrett's Esophagus|barrett's esophagus
5678028|NCT00588562|PH|ph
5678029|NCT00588562|PH1|ph1
5678030|NCT00588562|PH2|ph2
5678031|NCT00588562|PH3|ph3
5678032|NCT00588562|PHI|phi
5678034|NCT00588562|PHIII|phiii
5678035|NCT00588562|PH NonI-NonII|ph noni-nonii
5899375|NCT02358226|Human Immunodeficiency Virus|human immunodeficiency virus
5899377|NCT02358226|South Africa|south africa
5899378|NCT02358226|Men|men
5899379|NCT02358226|Soccer|soccer
5899380|NCT02358226|Vocational Training|vocational training
5899381|NCT02358031|Programmed Cell Death-1 (PD1, PD-1),|programmed cell death-1 (pd1, pd-1),
5899382|NCT02358031|Programmed Cell Death Receptor Ligand 1 (PDL1, PD-L1)|programmed cell death receptor ligand 1 (pdl1, pd-l1)
5899383|NCT02358031|Programmed Cell Death Receptor Ligand 2 (PDL2, PD-L2)|programmed cell death receptor ligand 2 (pdl2, pd-l2)
5899384|NCT02358031|chemotherapy, 5-fluorouracil, cisplatin, carboplatin|chemotherapy, 5-fluorouracil, cisplatin, carboplatin
5899419|NCT02350764|Nivolumab|nivolumab
5899420|NCT02350764|Lung|lung
5899421|NCT02350764|ipilimumab|ipilimumab
5899422|NCT02350764|NSCLC|nsclc
5899423|NCT02350764|14-137|14-137
5899440|NCT02341027|Immediate postpartum contraception|immediate postpartum contraception
5899441|NCT02341027|Contraceptive implants|contraceptive implants
5899442|NCT02341027|Breastfeeding|breastfeeding
5899443|NCT02341027|Jadelle|jadelle
5899444|NCT02341027|Lactation|lactation
5899445|NCT02341027|Levonorgestrel|levonorgestrel
5899469|NCT02338609|TSC-associated SEGA,|tsc-associated sega,
5899470|NCT02338609|height,|height,
5899471|NCT02338609|weight,|weight,
5899472|NCT02338609|Tanner Stage,|tanner stage,
5899473|NCT02338609|growth development,|growth development,
4969574|NCT04179786|SciB018|scib018
5678036|NCT00588562|Primary Hyperoxaluria|primary hyperoxaluria
5678037|NCT00588562|Primary Oxalosis|primary oxalosis
5678038|NCT00588562|Hyperoxaluria|hyperoxaluria
5678039|NCT00588562|Oxalate|oxalate
5678040|NCT00588562|Cystinuria|cystinuria
5678041|NCT00588562|Cystine|cystine
5678042|NCT00588562|APRT|aprt
5678043|NCT00588562|Adenine phosphoribosyl transferase deficiency|adenine phosphoribosyl transferase deficiency
5678044|NCT00588562|Dent disease|dent disease
5678045|NCT00588562|Dent|dent
5678046|NCT00588536|Langerhans Cell Histiocytosis|langerhans cell histiocytosis
5678047|NCT00588536|LCH|lch
5678048|NCT00588536|6-Thioguanine|6-thioguanine
5678049|NCT00588536|6-TG|6-tg
5678050|NCT00588536|Methotrexate|methotrexate
5678051|NCT00588536|MTX|mtx
5678052|NCT00588536|94-132|94-132
5678053|NCT00588523|Brain|brain
5678054|NCT00588523|CNS|cns
5678055|NCT00588523|TEMOZOLOMIDE|temozolomide
5678056|NCT00588523|Busulfan|busulfan
5678057|NCT00588523|Thiotepa|thiotepa
5678058|NCT00588510|Sarcoma|sarcoma
5678059|NCT00588510|Bone|bone
5678060|NCT00588497|female sterilization, micro-insert, hysteroscopy|female sterilization, micro-insert, hysteroscopy
5678061|NCT00588484|Carotid artery|carotid artery
5678062|NCT00588484|Common carotid artery|common carotid artery
5678063|NCT00588484|Measurement|measurement
5678064|NCT00588484|Ultrasound|ultrasound
5678065|NCT00588458|Primary sclerosing cholangitis|primary sclerosing cholangitis
5678066|NCT00588458|Computed tomographic cholangiography|computed tomographic cholangiography
5678067|NCT00588458|MELD score|meld score
5678068|NCT00588458|Mayo risk score for PSC|mayo risk score for psc
5678069|NCT00588445|Lung Cancer|lung cancer
5678070|NCT00588445|Non-small cell lung cancer|non-small cell lung cancer
5678071|NCT00588445|Gefitnib|gefitnib
5678072|NCT00588445|Cancer|cancer
5678073|NCT00588445|NSCLC|nsclc
5678074|NCT00588445|bronchioloalveolar cancer|bronchioloalveolar cancer
5678075|NCT00588445|smoker|smoker
5678076|NCT00588432|Stroke|stroke
5678077|NCT00588432|Immobilization|immobilization
5678078|NCT00588432|Myofacial Pain|myofacial pain
5899517|NCT02324387|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5899524|NCT02319044|Head and neck cancer; SCCHN|head and neck cancer; scchn
5899529|NCT02315768|CLL|cll
5899530|NCT02315768|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5899531|NCT02315768|Ibrutinib|ibrutinib
5899532|NCT02315768|Obinutuzumab|obinutuzumab
5899533|NCT02315768|Cancer|cancer
5899534|NCT02314819|colorectal cancer|colorectal cancer
5678079|NCT00588432|Hyperthyroid Myopathy|hyperthyroid myopathy
5678080|NCT00588419|Breast Cancer|breast cancer
5678081|NCT00588419|Cancer|cancer
5678082|NCT00588419|Breast Sensation|breast sensation
5678083|NCT00588419|Postmastectomy Breast Reconstruction|postmastectomy breast reconstruction
5678084|NCT00588406|acute, emergency department|acute, emergency department
5678085|NCT00588380|GLP-1|glp-1
5678086|NCT00588380|Insulin Secretion|insulin secretion
5678087|NCT00588367|Inflammation|inflammation
5678088|NCT00588367|Pancreas|pancreas
5678089|NCT00588367|Chronic pancreatitis|chronic pancreatitis
5678090|NCT00588367|Alcoholic pancreatitis|alcoholic pancreatitis
5678091|NCT00588367|Carcinoma, pancreatic ductal|carcinoma, pancreatic ductal
5678092|NCT00588367|Pancreatic neoplasms|pancreatic neoplasms
5678093|NCT00588354|herniated disk|herniated disk
5678094|NCT00588354|radiculopathy|radiculopathy
5678095|NCT00588354|clonidine|clonidine
5678096|NCT00588354|epidural|epidural
5678097|NCT00588354|steroid|steroid
5678098|NCT00588354|corticosteroid|corticosteroid
5678099|NCT00588354|nucleus pulposus|nucleus pulposus
5673057|NCT00609609|ECP|ecp
5678100|NCT00588354|transforaminal|transforaminal
5678101|NCT00588341|Melanoma|melanoma
5678102|NCT00588341|Skin Cancer|skin cancer
5678103|NCT00588341|Cancer|cancer
5678104|NCT00588341|Temozolamide|temozolamide
5678106|NCT00588302|primary biliary cirrhosis|primary biliary cirrhosis
5678107|NCT00588302|ursodeoxycholic acid|ursodeoxycholic acid
5678108|NCT00588289|Pediatric Cancers|pediatric cancers
5678109|NCT00588289|Oncology|oncology
5678110|NCT00588276|measurable disease|measurable disease
5678111|NCT00588276|locally advanced disease|locally advanced disease
5678112|NCT00588263|Ashkenazi Jewish|ashkenazi jewish
5678114|NCT00588263|00-087|00-087
5678115|NCT00588237|ovary|ovary
5678116|NCT00588237|BEVACIZUMAB|bevacizumab
5678117|NCT00588237|CISPLATIN|cisplatin
5678118|NCT00588237|TAXOL|taxol
5678119|NCT00588224|stomach|stomach
5678120|NCT00588224|accommodation|accommodation
5678121|NCT00588224|volume|volume
5678122|NCT00588224|SPECT|spect
5678123|NCT00588224|3 dimensional ultrasonography|3 dimensional ultrasonography
5678124|NCT00588224|healthy volunteers|healthy volunteers
5678125|NCT00588211|Cancer related-Risks|cancer related-risks
5678126|NCT00588211|Risk Perception|risk perception
5678127|NCT00588211|Survey|survey
5678128|NCT00588211|Focus Group|focus group
5678129|NCT00588211|Smoking cessation|smoking cessation
5678130|NCT00588211|tobacco|tobacco
5678131|NCT00588198|histologically confirmed melanoma of any site|histologically confirmed melanoma of any site
5678132|NCT00588185|Progressive Prostate Cancer|progressive prostate cancer
5678133|NCT00588185|[18F]-Fluoro-2-Deoxy-D-Glucose|[18f]-fluoro-2-deoxy-d-glucose
5678134|NCT00588185|[18F] Dihydro-Testosterone|[18f] dihydro-testosterone
5678135|NCT00588185|Pet Imaging|pet imaging
5678136|NCT00588185|Pet scan|pet scan
5678137|NCT00588185|00-095|00-095
5678138|NCT00588172|Metformin|metformin
5678139|NCT00588172|Type 2 diabetes|type 2 diabetes
5899589|NCT02301195|Therapeutic Horseback Riding|therapeutic horseback riding
5899639|NCT02291913|ER-Positive Breast Cancer|er-positive breast cancer
5899640|NCT02291913|HER2-Negative Breast Cancer|her2-negative breast cancer
5899641|NCT02291913|everolimus|everolimus
5899642|NCT02291913|anti-estrogen therapy|anti-estrogen therapy
5899643|NCT02291913|PR-Positive Breast Cancer|pr-positive breast cancer
5899644|NCT02291913|Afinitor|afinitor
5848819|NCT00033163|Drug Resistance, Microbial|drug resistance, microbial
5899670|NCT02275351|alopecia|alopecia
5899671|NCT02275351|topical|topical
5899672|NCT02275351|Samumed|samumed
5899673|NCT02272998|FGFR, RET, KIT|fgfr, ret, kit
5899711|NCT02240784|Porphyria|porphyria
5899712|NCT02240784|AIP|aip
5899713|NCT02240784|VP|vp
5899714|NCT02240784|HCP|hcp
5899715|NCT02240784|Variegate|variegate
5899716|NCT02240784|Coproporphyria|coproporphyria
5899721|NCT02238847|Pancreatic|pancreatic
5899722|NCT02238847|Pancreatic Cancer|pancreatic cancer
5899723|NCT02238847|Preoperative Biliary Drainage|preoperative biliary drainage
5899724|NCT02238847|Neoadjuvant Therapy|neoadjuvant therapy
5899725|NCT02234375|Pulmonary embolism|pulmonary embolism
5899726|NCT02234375|Contrast|contrast
5899727|NCT02234375|Computed tomography|computed tomography
5899728|NCT02234375|Gadolinium|gadolinium
5848820|NCT00033163|Lamivudine|lamivudine
5899773|NCT02219555|Carpal tunnel|carpal tunnel
5899793|NCT02208063|Bacteremia|bacteremia
5899794|NCT02208063|Staphylococcus aureus|staphylococcus aureus
5899795|NCT02207530|Head and neck cancer; SCCHN|head and neck cancer; scchn
5899845|NCT02189473|metastatic epidural spinal cord compression|metastatic epidural spinal cord compression
5899846|NCT02189473|motor function|motor function
5899847|NCT02189473|ambulatory status|ambulatory status
5899848|NCT02189473|pain|pain
5899849|NCT02189473|quality of life|quality of life
5899850|NCT02189473|overall survival|overall survival
5899851|NCT02189473|local control|local control
5899852|NCT02189473|toxicity|toxicity
5899892|NCT02180217|LCI699|lci699
5899893|NCT02180217|Cushing's disease|cushing's disease
5899906|NCT02178709|Pancreatic|pancreatic
5899907|NCT02178709|Cancer|cancer
5899908|NCT02178709|Resectable|resectable
5899914|NCT02168283|cardiovascular disease|cardiovascular disease
5899915|NCT02168283|hypertension|hypertension
5899936|NCT02164760|burns|burns
5899937|NCT02164760|dermal substitute|dermal substitute
5678140|NCT00588172|Oct1|oct1
5678141|NCT00588159|Preoperative gabapentin|preoperative gabapentin
5678142|NCT00588159|Acute pain|acute pain
5678143|NCT00588159|Post-thoracotomy pain|post-thoracotomy pain
5678144|NCT00588159|Epidural analgesia|epidural analgesia
5678145|NCT00588146|anemia|anemia
5678146|NCT00588146|HHT|hht
5678147|NCT00588146|Liver disease|liver disease
5678148|NCT00588146|Hypoxemia|hypoxemia
5678149|NCT00588146|Iron deficiency anemia|iron deficiency anemia
5678150|NCT00588146|Liver disease with high cardiac output|liver disease with high cardiac output
5899938|NCT02164760|scar quality|scar quality
5899939|NCT02164760|reconstruction|reconstruction
5899940|NCT02164760|wound healing|wound healing
5899941|NCT02164760|wound closure|wound closure
5899945|NCT02162472|videocapillaroscopy, psoriasis, systemic agent|videocapillaroscopy, psoriasis, systemic agent
5673127|NCT00609297|pain|pain
5899954|NCT02161406|Scleroderma|scleroderma
5678151|NCT00588146|Diffuse pulmonary AVMs with hypoxemia|diffuse pulmonary avms with hypoxemia
5678152|NCT00588133|antifibrinolytic, bleeding, heart|antifibrinolytic, bleeding, heart
5678153|NCT00588120|Hyperoxaluria|hyperoxaluria
5678154|NCT00588120|Unknown Hyperoxaluria|unknown hyperoxaluria
5678155|NCT00588120|Enteric Hyperoxaluria|enteric hyperoxaluria
5678156|NCT00588120|Oxaluric|oxaluric
5678157|NCT00588120|High Oxalate|high oxalate
5678159|NCT00588120|C13|c13
5678160|NCT00588120|Oxalate Diet|oxalate diet
5678161|NCT00588107|Cancer|cancer
5678162|NCT00588107|Smoker|smoker
5678163|NCT00588107|Web based intervention|web based intervention
5678164|NCT00588107|Partnership for Health|partnership for health
5678165|NCT00588107|Cancer Survivors|cancer survivors
5678166|NCT00588094|Lymphoma|lymphoma
5678167|NCT00588094|ASCT|asct
5678168|NCT00588094|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5678169|NCT00588094|Cancer|cancer
5678170|NCT00588094|Second line therapy|second line therapy
5678171|NCT00588094|ICE|ice
5678172|NCT00588094|Stem cell transplant|stem cell transplant
5678173|NCT00588081|Vaginal Reconstruction|vaginal reconstruction
5678174|NCT00588068|Adrenal Gland|adrenal gland
5678175|NCT00588068|No stage requirement|no stage requirement
5678176|NCT00588042|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5678177|NCT00588042|Coronary Artery Disease|coronary artery disease
5678178|NCT00588042|Coronary Occlusion|coronary occlusion
5678179|NCT00588029|Family members|family members
5678180|NCT00588016|Itraconazole|itraconazole
5678181|NCT00588003|Breast|breast
5678182|NCT00588003|ANASTROZOLE|anastrozole
5678183|NCT00587990|Chronic Ischemic Left Ventricular Dysfunction|chronic ischemic left ventricular dysfunction
5678184|NCT00587977|Abdominal aortic aneurysm|abdominal aortic aneurysm
5678185|NCT00587964|Cancer|cancer
5678186|NCT00587964|Brain Metastasis|brain metastasis
5678187|NCT00587964|Radiosurgery|radiosurgery
5678188|NCT00587964|Bladder cancer|bladder cancer
5678189|NCT00587964|Breast cancer|breast cancer
5678190|NCT00587964|Cervical cancer|cervical cancer
5678191|NCT00587964|Colon cancer|colon cancer
5685498|NCT00555854|Self Care|self care
5678192|NCT00587964|HEENT cancer|heent cancer
5678193|NCT00587964|Lung cancer|lung cancer
5678194|NCT00587964|Melanoma|melanoma
5678195|NCT00587964|Pancreatic cancer|pancreatic cancer
5678196|NCT00587964|Prostate cancer|prostate cancer
5678197|NCT00587964|Rectal cancer|rectal cancer
5678199|NCT00587964|Testicular cancer|testicular cancer
5678200|NCT00587964|Radiation|radiation
5678201|NCT00587951|Clinical decision-making|clinical decision-making
5678202|NCT00587951|Ictal SPECT|ictal spect
5678203|NCT00587951|Epilepsy surgery|epilepsy surgery
5678204|NCT00587938|congestive heart failure|congestive heart failure
5678205|NCT00587938|Brain naturietic peptide|brain naturietic peptide
5678206|NCT00587938|hospital utilization cost|hospital utilization cost
5678207|NCT00587925|osteoporosis|osteoporosis
5678208|NCT00587912|Kaposi's Sarcoma AIDS Related|kaposi's sarcoma aids related
5678209|NCT00587912|Kaposi's Sarcoma Classical|kaposi's sarcoma classical
5678210|NCT00587912|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5678211|NCT00587912|HEMATOPOIETIC SYSTEM|hematopoietic system
5678212|NCT00587912|Cancer|cancer
5678213|NCT00587912|AIDS|aids
5678214|NCT00587899|Atrial Fibrillation|atrial fibrillation
5678215|NCT00587899|AF|af
5678216|NCT00587899|A fib|a fib
5678217|NCT00587899|cardiac ablation|cardiac ablation
5678218|NCT00587899|modified maze procedure|modified maze procedure
5678219|NCT00587886|Cancer|cancer
5678220|NCT00587886|Endometrial cancer|endometrial cancer
5678221|NCT00587886|Ovarian cancer|ovarian cancer
5678222|NCT00587886|Corpus Uteri|corpus uteri
5678223|NCT00587886|Endometrium|endometrium
5678224|NCT00587873|Relapsed|relapsed
5678225|NCT00587873|Hodgkin's Disease|hodgkin's disease
5678226|NCT00587873|Methotrexate|methotrexate
5678227|NCT00587873|6-Thioguanine|6-thioguanine
5678228|NCT00587873|94-030|94-030
5678229|NCT00587847|leukemia|leukemia
5678230|NCT00587821|Breast Cancer|breast cancer
5678231|NCT00587821|Breast biopsy|breast biopsy
5678232|NCT00587808|Heart Failure|heart failure
5678233|NCT00587808|Heart Failure, Diastolic|heart failure, diastolic
5678234|NCT00587808|Stroke Volume|stroke volume
5678235|NCT00587769|Smoking|smoking
5900049|NCT02137070|Effects of bariatric surgery on brain function|effects of bariatric surgery on brain function
5900050|NCT02137070|Reduced glucose insulin changes and brain function|reduced glucose insulin changes and brain function
5900070|NCT02129270|Fractures of the distal radius|fractures of the distal radius
5900071|NCT02129270|Hematoma block|hematoma block
5900072|NCT02129270|Lidocaine|lidocaine
5900110|NCT02116218|Traditional Chinese Medicine|traditional chinese medicine
5900111|NCT02116218|acupuncture|acupuncture
5900112|NCT02116218|complementary alternative medicine|complementary alternative medicine
5900113|NCT02116218|cancer pain|cancer pain
5900114|NCT02116218|emergency department|emergency department
4970275|NCT04176185|China|china
5900158|NCT02090530|Cancer Genomics|cancer genomics
5900159|NCT02090530|Tumor Sequencing|tumor sequencing
5900171|NCT02087488|primary insomnia|primary insomnia
5900172|NCT02087488|auricular acupuncture|auricular acupuncture
5900173|NCT02087306|Adenovirus Infection|adenovirus infection
5900174|NCT02083744|Congestive Heart Failure|congestive heart failure
5900175|NCT02083744|Self-care|self-care
5900196|NCT02080221|metastatic pancreatic cancer|metastatic pancreatic cancer
5900197|NCT02080221|pancreatic cancer|pancreatic cancer
5900198|NCT02080221|metastatic|metastatic
5678236|NCT00587769|Smoking cessation|smoking cessation
5900213|NCT02074644|Prostatism|prostatism
5900214|NCT02074644|Randomized Controlled Trial|randomized controlled trial
5900215|NCT02074644|Embolization, Therapeutic|embolization, therapeutic
5900216|NCT02074644|Hyperplasia|hyperplasia
5900217|NCT02074644|Prostatic Diseases|prostatic diseases
5900218|NCT02074644|Genital Diseases, Male|genital diseases, male
5900219|NCT02071862|Tumor metabolism|tumor metabolism
5900220|NCT02071862|Glutaminase|glutaminase
5900221|NCT02071862|Glutamine|glutamine
5900222|NCT02071862|Tricarboxylic acid (TCA) cycle|tricarboxylic acid (tca) cycle
5900228|NCT02065557|Ulcerative Colitis|ulcerative colitis
5900229|NCT02065557|adalimumab|adalimumab
5900230|NCT02064673|prostate cancer|prostate cancer
5900231|NCT02064673|radical prostatectomy|radical prostatectomy
5900235|NCT02063022|Non metastatic Ewing's Sarcoma|non metastatic ewing's sarcoma
5900240|NCT02061306|Celiac disease|celiac disease
5900241|NCT02061306|coeliac disease|coeliac disease
5900242|NCT02061306|microbiome|microbiome
5900243|NCT02061306|gluten|gluten
5900244|NCT02061306|infants|infants
5900245|NCT02061306|pregnancy|pregnancy
5900246|NCT02061306|genetic|genetic
5678237|NCT00587769|Bupropion|bupropion
5678238|NCT00587769|Varenicline|varenicline
5678239|NCT00587769|Tobacco use disorder|tobacco use disorder
5678240|NCT00587756|intraoperative ultrasonography|intraoperative ultrasonography
5678241|NCT00587756|colorectal liver metastases|colorectal liver metastases
5678242|NCT00587756|hepatectomy|hepatectomy
5678243|NCT00587756|portal vein embolization|portal vein embolization
5678244|NCT00587756|Liver|liver
5678245|NCT00587730|heart disease|heart disease
5678246|NCT00587730|cardiac disease|cardiac disease
5678247|NCT00587730|chest pain|chest pain
5678248|NCT00587730|myocardial infarction|myocardial infarction
5678249|NCT00587730|heart attack|heart attack
5678250|NCT00587691|Tovaxin|tovaxin
5678251|NCT00587691|TCV|tcv
5678252|NCT00587691|Autologous|autologous
5678253|NCT00587678|PAD|pad
5678254|NCT00587665|Pain|pain
5678255|NCT00587652|Barrett Esophagus|barrett esophagus
5678256|NCT00587652|Methylene blue|methylene blue
5678257|NCT00587652|Chromoendoscopy|chromoendoscopy
5678258|NCT00587639|Adolescent|adolescent
5678259|NCT00587639|Depression|depression
5678260|NCT00587639|rTMS|rtms
5678261|NCT00587626|neck pain|neck pain
5678262|NCT00587626|shoulder pain|shoulder pain
5678263|NCT00587626|cervical pain|cervical pain
5678264|NCT00587626|chronic|chronic
5678265|NCT00587626|recurrent|recurrent
5678266|NCT00587600|Barrett's Esophagus|barrett's esophagus
5678267|NCT00587600|High Grade Dysplasia|high grade dysplasia
5678268|NCT00587600|Photodynamic Therapy|photodynamic therapy
5678269|NCT00587574|chronic graft-versus-host disease|chronic graft-versus-host disease
5678270|NCT00587561|schizophrenia|schizophrenia
5678271|NCT00587561|social cognition|social cognition
5678272|NCT00587561|cognition|cognition
5678273|NCT00587561|treatment|treatment
5678274|NCT00587561|outcome|outcome
5678275|NCT00587548|locate the ureters during abdominal surgery|locate the ureters during abdominal surgery
5678276|NCT00587535|hemochromatosis|hemochromatosis
5678277|NCT00587535|liver cirrhosis|liver cirrhosis
5678278|NCT00587535|liver diseases|liver diseases
5678279|NCT00587522|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5678280|NCT00587522|NDO Full-thickness Plicator|ndo full-thickness plicator
5678281|NCT00587522|Plicator|plicator
5678282|NCT00587522|Endoluminal GERD Therapy|endoluminal gerd therapy
5678283|NCT00587496|HSV DNA|hsv dna
5678284|NCT00587496|volunteers|volunteers
5678285|NCT00587483|cardiopulmonary bypass|cardiopulmonary bypass
5678286|NCT00587483|reperfusion ventricular fibrillation|reperfusion ventricular fibrillation
5678287|NCT00587483|ventricular fibrillation|ventricular fibrillation
5678288|NCT00587483|amiodarone|amiodarone
5678289|NCT00587483|lidocaine|lidocaine
5678290|NCT00587483|cardiac surgery|cardiac surgery
5678291|NCT00587470|valve, mitral, regurgitation|valve, mitral, regurgitation
5900317|NCT02047292|Gait analysis|gait analysis
5900318|NCT02047292|3D videofluoroscopy|3d videofluoroscopy
5900319|NCT02047292|Femoroacetabular impingement|femoroacetabular impingement
5900320|NCT02047292|Neck-cup impingement|neck-cup impingement
5900321|NCT02047292|Head-neck ratio|head-neck ratio
5900322|NCT02047292|Hip scores|hip scores
5900323|NCT02047292|Functional assessment|functional assessment
5900324|NCT02047292|Cup size|cup size
5900325|NCT02047292|Range of motion|range of motion
5900326|NCT02047292|Unilateral Primary|unilateral primary
5900327|NCT02047292|Secondary|secondary
5900328|NCT02046096|Venous thrombosis|venous thrombosis
5900329|NCT02046096|pulmonary embolism|pulmonary embolism
5900330|NCT02046096|vena cava, inferior|vena cava, inferior
5900332|NCT02046096|venous thromboembolism|venous thromboembolism
5900346|NCT02039388|Ovarian Epithelial Cancer|ovarian epithelial cancer
5900347|NCT02039388|Serous Intraepithelial Carcinoma (STIC)|serous intraepithelial carcinoma (stic)
5900349|NCT02039388|BRCA2 gene|brca2 gene
5900350|NCT02039388|Mutation|mutation
5900351|NCT02039388|Neoplasms|neoplasms
5900352|NCT02039388|Glandular and Epithelial|glandular and epithelial
5900353|NCT02039388|Ovarian Neoplasms|ovarian neoplasms
5900354|NCT02039388|Ovarian cancer|ovarian cancer
5900355|NCT02039388|Carcinoma in situ|carcinoma in situ
5900356|NCT02039388|family history breast cancer|family history breast cancer
5900357|NCT02039388|family history ovarian cancer|family history ovarian cancer
5900373|NCT02029118|Acupoint Application,Stable Angina Pectoris,herbal medicine|acupoint application,stable angina pectoris,herbal medicine
5678292|NCT00587457|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5678293|NCT00587457|Prolymphocytic Leukemia|prolymphocytic leukemia
5678294|NCT00587457|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5678295|NCT00587457|Moxetumomab pasudotox|moxetumomab pasudotox
5678296|NCT00587444|heparin management|heparin management
5678297|NCT00587431|Prostate|prostate
5678298|NCT00587431|Cancer|cancer
5678299|NCT00587431|Docetaxel|docetaxel
5678300|NCT00587431|03-076|03-076
5678301|NCT00587405|Watermelon Stomach|watermelon stomach
5678302|NCT00587405|Cryotherapy|cryotherapy
5678303|NCT00587405|Argon Plasma Coagulation|argon plasma coagulation
5678304|NCT00587392|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5678305|NCT00587392|Long-term follow-up (LTFU)|long-term follow-up (ltfu)
5678306|NCT00587392|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
5678307|NCT00587392|Plicator|plicator
5678308|NCT00587379|testing for Endothelial Dysfunction and coronary angiography|testing for endothelial dysfunction and coronary angiography
5678309|NCT00587353|tobacco use cessation|tobacco use cessation
5678310|NCT00587353|radiation oncology|radiation oncology
5678311|NCT00587353|smoking|smoking
5678312|NCT00587314|Photodynamic Therapy|photodynamic therapy
5678313|NCT00587314|Barrett's Esophagus|barrett's esophagus
5685499|NCT00555854|Behaviour|behaviour
5678314|NCT00587314|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
5678315|NCT00587301|Child Obesity|child obesity
5678316|NCT00587288|Cinquil™|cinquil™
5678317|NCT00587288|Reslizumab|reslizumab
5678318|NCT00587275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5678319|NCT00587275|GERD|gerd
5678320|NCT00587262|Cochlear|cochlear
5678321|NCT00587262|Hearing|hearing
5678322|NCT00587262|High frequency hearing loss|high frequency hearing loss
5678323|NCT00587249|Malaria, Plasmodium falciparium, Hepatitis B Core Antigen, Circumsporozoite Epitopes|malaria, plasmodium falciparium, hepatitis b core antigen, circumsporozoite epitopes
5900395|NCT02024360|obesity|obesity
5900396|NCT02024360|overweight|overweight
5002067|NCT03982992|MRD|mrd
5900397|NCT02024360|children|children
5900398|NCT02024360|prevention|prevention
5900413|NCT02022033|Pancreatic Cancer|pancreatic cancer
5900414|NCT02022033|Adjuvant|adjuvant
5900415|NCT02022033|Pancreas|pancreas
5900416|NCT02022033|Resected|resected
5900417|NCT02022033|Invasive adenocarcinoma|invasive adenocarcinoma
5900418|NCT02022033|adenosquamous cancer|adenosquamous cancer
5900419|NCT02022033|Intraductal papillary mucinous neoplasm|intraductal papillary mucinous neoplasm
5900461|NCT02010203|TURBT|turbt
5900462|NCT02010203|Bladder|bladder
5900463|NCT02010203|Cancer|cancer
5900498|NCT01990222|ADHD|adhd
5900509|NCT01982955|MSC2156119J|msc2156119j
5900510|NCT01982955|Gefitinib|gefitinib
5900511|NCT01982955|Pemetrexed|pemetrexed
5900512|NCT01982955|Cisplatin|cisplatin
5900513|NCT01982955|MET positive|met positive
5900514|NCT01982955|Tepotinib|tepotinib
5900515|NCT01982955|Carboplatin|carboplatin
5900516|NCT01982955|INSIGHT|insight
5900530|NCT01975077|patients with mCRC who failed 2nd therapy or more|patients with mcrc who failed 2nd therapy or more
5342793|NCT01981967|IMOJEV®|imojev®
4970759|NCT04173234|Aerobic Training|aerobic training
5678324|NCT00587236|Autofluorescence|autofluorescence
5678325|NCT00587236|Narrow Band|narrow band
5678326|NCT00587236|High definition white light|high definition white light
5678327|NCT00587210|Crohn Disease|crohn disease
5678328|NCT00587210|Inflammatory Bowel Disease|inflammatory bowel disease
5678329|NCT00587197|esophageal varices|esophageal varices
5678330|NCT00587197|portal hypertension|portal hypertension
5678331|NCT00587197|gastric varices|gastric varices
5678332|NCT00587197|cost effectiveness|cost effectiveness
5678333|NCT00587184|Barrett's Esophagus|barrett's esophagus
5678334|NCT00587184|Confocal Microscopy|confocal microscopy
5678335|NCT00587171|Amblyopia|amblyopia
5678336|NCT00587171|Vision Therapy|vision therapy
5678337|NCT00587171|Patching|patching
5678338|NCT00587158|Paricalcitol|paricalcitol
5678339|NCT00587158|Parathyroid Hormone|parathyroid hormone
5678340|NCT00587158|Bone Alkaline Phosphatase|bone alkaline phosphatase
5678341|NCT00587158|Chronic Kidney Disease|chronic kidney disease
5678342|NCT00587158|Glomerular Filtration Rate|glomerular filtration rate
5678343|NCT00587158|Vitamin D Receptor|vitamin d receptor
5678344|NCT00587158|Interstitial Fibrosis and Tubular Atrophy|interstitial fibrosis and tubular atrophy
5678345|NCT00587158|Zemplar®|zemplar®
5678346|NCT00587145|Stomach Neoplasms|stomach neoplasms
5678347|NCT00587145|Secondary|secondary
5678351|NCT00587145|oxaliplatin|oxaliplatin
5678352|NCT00587132|Diabetes mellitus|diabetes mellitus
5678353|NCT00587132|Peutz-Jeghers syndrome|peutz-jeghers syndrome
5678354|NCT00587119|Urso|urso
5678355|NCT00587119|Budesonide|budesonide
5678356|NCT00587119|PBC|pbc
5678357|NCT00587119|overlap AIH|overlap aih
5678358|NCT00587119|PBC with overlap features of autoimmune hepatitis|pbc with overlap features of autoimmune hepatitis
5678359|NCT00587093|Newly diagnosed|newly diagnosed
5678360|NCT00587093|CA 125|ca 125
5678361|NCT00587093|CT scan|ct scan
5678362|NCT00587093|01-048|01-048
5678363|NCT00587067|FUDR|fudr
5678364|NCT00587067|FLOXORUIDINE|floxoruidine
5678365|NCT00587067|DEXAMETHASONE|dexamethasone
5678366|NCT00587067|Hepatic|hepatic
5678367|NCT00587067|Cancer|cancer
5678368|NCT00587067|02-120|02-120
5678369|NCT00587054|leukemia|leukemia
5678370|NCT00587054|non-Hodgkins|non-hodgkins
5678371|NCT00587054|lymphoblastic lymphoma|lymphoblastic lymphoma
5678372|NCT00587054|myelodysplastic syndrome|myelodysplastic syndrome
5678373|NCT00587054|paroxysmal nocturnal hemoglobinuria (PNH)|paroxysmal nocturnal hemoglobinuria (pnh)
5678374|NCT00587054|cytoreductive regimen|cytoreductive regimen
5678375|NCT00587054|allogeneic stem cell transplant|allogeneic stem cell transplant
5678376|NCT00587041|Synbiotic|synbiotic
5678377|NCT00587041|Urine Oxalate|urine oxalate
5678378|NCT00587041|Probiotic|probiotic
5678379|NCT00587041|Kidney Stone|kidney stone
5678380|NCT00587041|Gastric Bypass|gastric bypass
5678381|NCT00587041|Crohn's|crohn's
5678382|NCT00587041|Stone|stone
5678383|NCT00587041|Hyperoxaluria|hyperoxaluria
5678384|NCT00587041|Enteric Hyperoxaluria|enteric hyperoxaluria
5678385|NCT00587028|Colonography|colonography
5678386|NCT00587028|Colonoscopy|colonoscopy
5678387|NCT00587028|Virtual|virtual
5678388|NCT00587028|Computed Tomographic Colonography|computed tomographic colonography
5678389|NCT00587028|Large intestine|large intestine
5678390|NCT00587028|colon|colon
5678391|NCT00587002|Acute Coronary Syndrome|acute coronary syndrome
5678392|NCT00587002|Women|women
5678393|NCT00586989|Barrett's Esophagus|barrett's esophagus
5678394|NCT00586989|Esophageal Cancer|esophageal cancer
5678395|NCT00586989|High Grade Dysplasia|high grade dysplasia
5678396|NCT00586976|pain, ropivacaine, infusion, sternotomy|pain, ropivacaine, infusion, sternotomy
5678397|NCT00586963|Erosive Esophagitis|erosive esophagitis
5678398|NCT00586963|Reflux Esophagitis|reflux esophagitis
5678399|NCT00586963|GERD|gerd
5678400|NCT00586950|Myocardial Free Fatty Acid metabolism|myocardial free fatty acid metabolism
5678401|NCT00586950|High risk patients|high risk patients
5678402|NCT00586950|End-stage renal failure|end-stage renal failure
5678403|NCT00586950|Cardiovascular events|cardiovascular events
5678404|NCT00586950|prognosis|prognosis
5678405|NCT00586937|Lung Cancer Survivors|lung cancer survivors
5678406|NCT00586924|CAT-8015|cat-8015
5678407|NCT00586924|Moxetumomab pasudotox|moxetumomab pasudotox
5678408|NCT00586911|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5678415|NCT00586898|ANTIFUNGAL ANTIBIOTICS|antifungal antibiotics
5678416|NCT00586898|ESTROGENS|estrogens
5678417|NCT00586898|LUPRON|lupron
5678418|NCT00586898|TESTOSTERONE|testosterone
5678419|NCT00586898|ZOLADEX|zoladex
5678420|NCT00586885|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5678421|NCT00586885|NASH|nash
5678422|NCT00586885|L-Alanine|l-alanine
5678423|NCT00586872|Barrett's Esophagus|barrett's esophagus
5678424|NCT00586872|Early Esophageal Adenocarcinoma|early esophageal adenocarcinoma
5678425|NCT00586872|Endoscopic Mucosal Resection|endoscopic mucosal resection
5678426|NCT00586859|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5900658|NCT01933204|perimenopause|perimenopause
5900659|NCT01933204|hot flash|hot flash
5900660|NCT01933204|palpitation|palpitation
5900671|NCT01921179|Post Traumatic Stress Disorder,|post traumatic stress disorder,
5900672|NCT01921179|Mild Traumatic Brain Injury|mild traumatic brain injury
5900673|NCT01921179|Concussion|concussion
5900674|NCT01921179|Cognitive Rehabilitation|cognitive rehabilitation
5900679|NCT01915225|Tissue Procurement|tissue procurement
5900680|NCT01915225|Surgery|surgery
5900681|NCT01915225|Metastasectomy|metastasectomy
5900691|NCT01907048|Survey|survey
5900692|NCT01907048|Effectiveness of risk minimization measures|effectiveness of risk minimization measures
5900693|NCT01907048|Rivaroxaban|rivaroxaban
5900694|NCT01907048|Anticoagulants|anticoagulants
5900714|NCT01899781|Lacerations|lacerations
5900715|NCT01899781|Tendons|tendons
5900716|NCT01899781|Antobiotic|antobiotic
5848821|NCT00033163|DNA, Viral|dna, viral
5900750|NCT01883492|Only Female|only female
5900751|NCT01883492|Age between 20 - 75 at the time of operation|age between 20 - 75 at the time of operation
5678427|NCT00586859|NDO Full-thickness Plicator|ndo full-thickness plicator
5678428|NCT00586859|Plicator|plicator
5678429|NCT00586859|Endoluminal GERD Therapy|endoluminal gerd therapy
5678430|NCT00586846|Cisplatin|cisplatin
5678431|NCT00586846|Doxorubicin|doxorubicin
5678433|NCT00586846|Osteosarcoma|osteosarcoma
5678435|NCT00586833|Heart Failure|heart failure
5678436|NCT00586833|Heart Failure, Diastolic|heart failure, diastolic
5678437|NCT00586833|Dyspnea, Paroxysmal|dyspnea, paroxysmal
5678438|NCT00586833|Edema, Cardiac|edema, cardiac
5678439|NCT00586820|Coronary Atherosclerosis|coronary atherosclerosis
5678440|NCT00586820|Microvascular Dysfunction|microvascular dysfunction
5678441|NCT00586820|Non-ST Elevation Myocardial Infarction|non-st elevation myocardial infarction
5678442|NCT00586807|Ulcerative colitis|ulcerative colitis
5678443|NCT00586807|pediatrics|pediatrics
5678445|NCT00586807|protein metabolism|protein metabolism
5678446|NCT00586807|energy expenditure|energy expenditure
5678447|NCT00586794|Hypertension|hypertension
5678448|NCT00586794|Eisenmenger|eisenmenger
5678449|NCT00586781|ankle replacement|ankle replacement
5678450|NCT00586781|end-stage arthritis of the ankle|end-stage arthritis of the ankle
5678451|NCT00586781|degenerative ankle disease|degenerative ankle disease
5678452|NCT00586755|Intensive Induction|intensive induction
5678453|NCT00586755|High Dose Chemotherapy|high dose chemotherapy
5678454|NCT00586755|Bone Marrow Transplantation|bone marrow transplantation
5678455|NCT00586755|Mantle Cell Lymphoma|mantle cell lymphoma
5678456|NCT00586742|SLAP lesions|slap lesions
5678457|NCT00586742|labral repair|labral repair
5678458|NCT00586742|bicepstenodesis|bicepstenodesis
5678459|NCT00586742|conservative treatment|conservative treatment
5678460|NCT00586729|Burn|burn
5678461|NCT00586729|Burn wound management|burn wound management
5678462|NCT00586729|Burn graft|burn graft
5678463|NCT00586703|Stem cell transplant|stem cell transplant
5678464|NCT00586703|mismatched donor|mismatched donor
5678465|NCT00586703|NK infusion|nk infusion
5678466|NCT00586690|Stem cell transplant|stem cell transplant
5678467|NCT00586690|matched donor|matched donor
5678468|NCT00586690|NK infusion|nk infusion
5678469|NCT00586677|child abuse|child abuse
5678470|NCT00586677|child neglect|child neglect
5678471|NCT00586677|PCIT|pcit
5678472|NCT00586677|Lutzker|lutzker
5678473|NCT00586677|attachment|attachment
5678474|NCT00586677|parenting|parenting
5678475|NCT00586638|cognition|cognition
5678476|NCT00586638|cognition disorders|cognition disorders
5678477|NCT00586638|executive function|executive function
5678478|NCT00586638|cognitive control|cognitive control
5678479|NCT00586638|attentional control|attentional control
5678480|NCT00586638|biomedical enhancement|biomedical enhancement
5678481|NCT00586638|cognitive enhancement|cognitive enhancement
5678482|NCT00586638|computerized|computerized
5678483|NCT00586638|computer-based|computer-based
5678484|NCT00586638|video game|video game
5678485|NCT00586612|Conjugate vaccine|conjugate vaccine
5678486|NCT00586612|Persistence|persistence
5678487|NCT00586612|Hib vaccine|hib vaccine
5678488|NCT00586612|Combination vaccine|combination vaccine
5678489|NCT00586612|Meningococcal vaccine|meningococcal vaccine
5678490|NCT00586612|Safety|safety
5678491|NCT00586612|Preterm/full-term infants|preterm/full-term infants
5678492|NCT00586612|Immunogenicity|immunogenicity
5678493|NCT00586599|IBD|ibd
5678494|NCT00586599|CD|cd
5678495|NCT00586599|UC|uc
5678496|NCT00586599|Crohn's Disease|crohn's disease
5678497|NCT00586599|Ulcerative Colitis|ulcerative colitis
5678498|NCT00586599|Pediatric|pediatric
5678499|NCT00586599|inflammatory markers|inflammatory markers
5678500|NCT00586573|ADHD|adhd
5678501|NCT00586573|Namenda|namenda
5678502|NCT00586560|solid tumors|solid tumors
5678503|NCT00586547|Haploidentical|haploidentical
5678504|NCT00586547|Stem Cell Transplant|stem cell transplant
5678505|NCT00586547|Graft-Versus-Host disease|graft-versus-host disease
5678506|NCT00586534|crack, cocaine, addiction treatment, virtual reality|crack, cocaine, addiction treatment, virtual reality
5678507|NCT00586521|Coagulation Disorders|coagulation disorders
5678508|NCT00586495|Sorafenib|sorafenib
5678509|NCT00586495|Nexavar|nexavar
5678510|NCT00586495|Metastatic RCC|metastatic rcc
5678511|NCT00586495|Renal Cell Carcinoma|renal cell carcinoma
5678512|NCT00586495|Unresectable RCC|unresectable rcc
5678513|NCT00586482|cigarettes, surgery|cigarettes, surgery
5678514|NCT00586482|Smokers scheduled for elective surgery|smokers scheduled for elective surgery
5678516|NCT00586443|solid tumors|solid tumors
5678517|NCT00586443|avastin|avastin
5678518|NCT00586443|Phase I|phase i
5678519|NCT00586443|Phase 1|phase 1
5678520|NCT00586443|combination therapy|combination therapy
5900870|NCT01851447|Membrane Wound|membrane wound
5900871|NCT01851447|Inflammatory Cytokines|inflammatory cytokines
5900872|NCT01851447|Exercise|exercise
5900873|NCT01851447|Plasma Membrane Repair|plasma membrane repair
5900874|NCT01851447|Predictors of Outcome|predictors of outcome
5900883|NCT01842321|locally advanced|locally advanced
5900884|NCT01842321|metastatic|metastatic
5900885|NCT01842321|Breast Cancer|breast cancer
5900886|NCT01842321|Molecular Apocrine|molecular apocrine
5900887|NCT01842321|HER2-negative|her2-negative
5900888|NCT01842321|Abiraterone acetate|abiraterone acetate
5900898|NCT01836354|stroke|stroke
5900899|NCT01836354|interactive educational intervention|interactive educational intervention
5900900|NCT01836354|acute ischemic stroke|acute ischemic stroke
5900901|NCT01836354|transient ischemic attack|transient ischemic attack
5900908|NCT01822457|Peripheral vascular disease|peripheral vascular disease
5900925|NCT01817959|Pancreatic islet transplantation|pancreatic islet transplantation
5900926|NCT01817959|Diabetes Mellitus Type 1|diabetes mellitus type 1
5900927|NCT01817959|Islet transplantation graft survival & function|islet transplantation graft survival & function
4971152|NCT04171128|procalcitonin|procalcitonin
4971153|NCT04171115|botulinum toxin|botulinum toxin
4971155|NCT04171063|Braces|braces
5678521|NCT00586443|bevacizumab|bevacizumab
5678522|NCT00586443|RAD001|rad001
5678523|NCT00586443|everolimus|everolimus
5678524|NCT00586443|pantitumumab|pantitumumab
5678525|NCT00586430|apolipoprotein E e4|apolipoprotein e e4
5678526|NCT00586430|Alzheimer's disease|alzheimer's disease
5678527|NCT00586430|somnolence|somnolence
5678528|NCT00586430|Early detection|early detection
5678529|NCT00586417|angiogenesis|angiogenesis
5678530|NCT00586417|tumor angiogenesis|tumor angiogenesis
5678531|NCT00586417|biomarkers|biomarkers
5678532|NCT00586417|healthy volunteers|healthy volunteers
5678533|NCT00586404|Barrett's Esophagus|barrett's esophagus
5678534|NCT00586404|Esophageal neoplasms|esophageal neoplasms
5678535|NCT00586404|gastroesophageal reflux|gastroesophageal reflux
5678536|NCT00586404|gastrointestinal neoplasms|gastrointestinal neoplasms
5678537|NCT00586391|B cell Lymphoma|b cell lymphoma
5678538|NCT00586391|Cancer|cancer
5678539|NCT00586391|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5678540|NCT00586391|CD19 CHIMERIC RECEPTOR EXPRESSING T LYMPHOCYTES|cd19 chimeric receptor expressing t lymphocytes
5678541|NCT00586391|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5678542|NCT00586365|complex elbow trauma|complex elbow trauma
5678543|NCT00586365|prevention|prevention
5678544|NCT00586365|complication|complication
5678545|NCT00586365|naproxen|naproxen
5678546|NCT00586365|NSAIDS|nsaids
5678547|NCT00586352|Pediatric|pediatric
5678548|NCT00586352|Crohn's disease|crohn's disease
5678549|NCT00586352|Ulcerative colitis|ulcerative colitis
5678550|NCT00586339|HPV|hpv
5678551|NCT00586339|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5678552|NCT00586339|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5678553|NCT00586339|Cervical cancer|cervical cancer
5678554|NCT00586339|Papillomavirus|papillomavirus
5678555|NCT00586326|MammoSite|mammosite
5678556|NCT00586326|DCIS|dcis
5678557|NCT00586313|EUS Biopsy for Non-alcoholic Fatty Liver Disease|eus biopsy for non-alcoholic fatty liver disease
5678558|NCT00586300|Knee pain|knee pain
5006483|NCT03955991|Flu Vaccine|flu vaccine
5678559|NCT00586287|Phenprocoumon|phenprocoumon
5678560|NCT00586287|Dosing algorithm|dosing algorithm
5678561|NCT00586287|loading dose|loading dose
5678562|NCT00586274|Stem Cell Transplant|stem cell transplant
5678563|NCT00586274|Anemia|anemia
5678564|NCT00586274|Fanconi|fanconi
5678565|NCT00586261|Kidney Failure, Chronic|kidney failure, chronic
5678566|NCT00586261|Renal Insufficiency, Chronic|renal insufficiency, chronic
5678567|NCT00586261|Proteinuria|proteinuria
5901015|NCT01782209|BK virus viremia|bk virus viremia
5901016|NCT01782209|renal transplant|renal transplant
5901017|NCT01782209|other viral pathogens|other viral pathogens
4971251|NCT04170452|HBV DNA|hbv dna
5678568|NCT00586261|Albuminuria|albuminuria
5678569|NCT00586248|Peripheral nerve stimulator, cardiac pacemaker|peripheral nerve stimulator, cardiac pacemaker
5678570|NCT00586235|Fusion|fusion
5678571|NCT00586235|Ultrasound|ultrasound
5678572|NCT00586235|Computed tomography|computed tomography
5678573|NCT00586222|Omega-3 Fatty Acids|omega-3 fatty acids
5678574|NCT00586222|Pediatric Bipolar Disorder|pediatric bipolar disorder
5678575|NCT00586222|Adolescent Bipolar Disorder|adolescent bipolar disorder
5678576|NCT00586222|MRS|mrs
5678577|NCT00586209|sickle cell disease|sickle cell disease
5678578|NCT00586209|sickle cell anemia|sickle cell anemia
5678579|NCT00586209|L-glutamine|l-glutamine
5678580|NCT00586209|Sickle Cell Anemia (homozygous and heterozygous)|sickle cell anemia (homozygous and heterozygous)
5678581|NCT00586209|Sickle ß0-Thalassemia|sickle ß0-thalassemia
5678582|NCT00586196|Delirium|delirium
5678583|NCT00586196|Postoperative confusion|postoperative confusion
5678584|NCT00586196|Hip fracture|hip fracture
5678585|NCT00586196|Long bone fracture|long bone fracture
5678586|NCT00586183|Ventricular Remodeling|ventricular remodeling
5678587|NCT00586170|nonunion|nonunion
5678588|NCT00586170|fracture|fracture
5678589|NCT00586157|ADHD|adhd
5678590|NCT00586157|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5678591|NCT00586157|Daytrana|daytrana
5678592|NCT00586157|MTS Patch|mts patch
5678593|NCT00586157|Methylphenidate Transdermal System|methylphenidate transdermal system
5678594|NCT00586131|end-stage renal disease|end-stage renal disease
5678595|NCT00586131|automated peritoneal dialysis|automated peritoneal dialysis
5678596|NCT00586131|metabolic acidosis|metabolic acidosis
5678597|NCT00586131|nitrogen balances|nitrogen balances
5678598|NCT00586118|Sedation|sedation
5678599|NCT00586118|Volatile anaesthetic|volatile anaesthetic
5678600|NCT00586118|Sevoflurane|sevoflurane
5678601|NCT00586118|Propofol|propofol
5678602|NCT00586118|Recovery|recovery
5678603|NCT00586105|Sorafenib|sorafenib
5678604|NCT00586105|Nexavar|nexavar
5678605|NCT00586105|Metastatic RCC|metastatic rcc
5678606|NCT00586105|Renal Cell Carcinoma|renal cell carcinoma
5678607|NCT00586105|Unresectable RCC|unresectable rcc
5678608|NCT00586092|Phase I|phase i
5678609|NCT00586092|Phase 1|phase 1
5678610|NCT00586092|avastin|avastin
5678611|NCT00586092|bevacizumab|bevacizumab
5678612|NCT00586092|ABT-510|abt-510
5678613|NCT00586092|solid tumors|solid tumors
5678614|NCT00586092|angiogenesis|angiogenesis
5678615|NCT00586066|Bipolar disorder|bipolar disorder
5678616|NCT00586066|Cognitive dysfunction|cognitive dysfunction
5678618|NCT00586066|NMDA antagonist|nmda antagonist
5678619|NCT00586053|Colonic Polyps|colonic polyps
5678621|NCT00586053|Large Intestine|large intestine
5678622|NCT00586053|Cecum|cecum
5678623|NCT00586053|Sigmoid|sigmoid
5678624|NCT00586053|Rectum|rectum
5678625|NCT00586053|Colonoscopy|colonoscopy
5678626|NCT00586053|Virtual Colonoscopy|virtual colonoscopy
5678627|NCT00586053|CT Colonography|ct colonography
5678878|NCT00584558|Arrhythmia|arrhythmia
5678628|NCT00586053|Computed Tomographic Colonography|computed tomographic colonography
5678629|NCT00586053|Colonography|colonography
5678630|NCT00586040|skin cancer|skin cancer
5678631|NCT00586040|skin excision|skin excision
5678632|NCT00586040|laser|laser
5678633|NCT00586040|superficial sutures|superficial sutures
5678634|NCT00586040|wound healing|wound healing
5678635|NCT00586027|cardiac surgery|cardiac surgery
5678636|NCT00586027|low cardiac output|low cardiac output
5678637|NCT00586027|natriuretic peptide B|natriuretic peptide b
5678638|NCT00586027|mortality|mortality
5678639|NCT00586027|morbidity|morbidity
5678640|NCT00586014|Multiple myeloma|multiple myeloma
5678641|NCT00586014|Autologous Stem Cell Transplant|autologous stem cell transplant
5678642|NCT00586001|Anxiety|anxiety
5678643|NCT00586001|Emotional Disorders|emotional disorders
5678644|NCT00586001|Unified|unified
5678645|NCT00586001|Depression|depression
5678646|NCT00585962|proton beam radiation|proton beam radiation
5678647|NCT00585910|ADHD|adhd
5678648|NCT00585910|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5678649|NCT00585910|Strattera|strattera
5678650|NCT00585910|Concerta|concerta
5678651|NCT00585910|Atomoxetine|atomoxetine
5678652|NCT00585910|OROS Methylphenidate|oros methylphenidate
5678653|NCT00585897|Diabetes|diabetes
5678654|NCT00585897|Obesity|obesity
5678655|NCT00585884|Reconstruction, Silicone prostheses|reconstruction, silicone prostheses
5678656|NCT00585871|ICD patients with 5 VTs per 3 month period|icd patients with 5 vts per 3 month period
5678657|NCT00585845|Cancer|cancer
5678658|NCT00585845|Ovarian cancer|ovarian cancer
5678659|NCT00585845|Pancreatic cancer|pancreatic cancer
5678660|NCT00585845|Non-small cell lung cancer|non-small cell lung cancer
5678661|NCT00585845|Mesothelioma|mesothelioma
5678662|NCT00585845|Mesothelin|mesothelin
5678663|NCT00585845|Immunotherapy|immunotherapy
5678664|NCT00585832|hypertension|hypertension
5678665|NCT00585832|pre-hypertension|pre-hypertension
5678666|NCT00585832|adolescents|adolescents
5678667|NCT00585832|diet|diet
5678668|NCT00585832|vascular function|vascular function
5901118|NCT01744353|newly diagnosed|newly diagnosed
5901119|NCT01744353|advanced pancreatic cancer|advanced pancreatic cancer
5901120|NCT01744353|pancreatic cancer|pancreatic cancer
5901121|NCT01744353|metastatic pancreatic cancer|metastatic pancreatic cancer
5901122|NCT01744353|pancreas|pancreas
5901123|NCT01744340|Head and Neck|head and neck
5901124|NCT01744340|Colon|colon
5901141|NCT01737255|Li-Fraumeni Syndrome|li-fraumeni syndrome
5901142|NCT01737255|Whole Body Magnetic Resonance Imaging|whole body magnetic resonance imaging
5901143|NCT01737255|TP53|tp53
5901144|NCT01737255|Psychological Impact|psychological impact
5901145|NCT01737242|Prostate cancer|prostate cancer
5901146|NCT01737242|PSA|psa
5901150|NCT01736202|oral fat|oral fat
5901151|NCT01736202|insulin sensitivity|insulin sensitivity
5901222|NCT01705288|hysterectomy|hysterectomy
5901269|NCT01687660|acupuncture|acupuncture
5901270|NCT01687660|migraine prophylaxis|migraine prophylaxis
5901271|NCT01686230|acupuncture|acupuncture
5901272|NCT01686230|Angina|angina
5901273|NCT01686230|Stable Angina Pectoris|stable angina pectoris
5901280|NCT01674803|drug-eluting stent|drug-eluting stent
5901281|NCT01674803|zotarolimus|zotarolimus
5901282|NCT01674803|everolimus|everolimus
5901283|NCT01674803|sirolimus|sirolimus
5901284|NCT01674803|all comers population|all comers population
5901285|NCT01674803|target vessel failure|target vessel failure
5901286|NCT01674803|coronary artery disease|coronary artery disease
5901287|NCT01674803|durable polymer|durable polymer
5901288|NCT01674803|biodegradable polymer|biodegradable polymer
5901289|NCT01671488|Anal Cancer|anal cancer
5901290|NCT01671488|Mitomycin|mitomycin
5901291|NCT01671488|5-Fluorouracil|5-fluorouracil
5901292|NCT01671488|5-FU|5-fu
5901293|NCT01671488|IMRT|imrt
5901294|NCT01671488|ADXS11-001|adxs11-001
5901295|NCT01669720|Metastatic|metastatic
5901296|NCT01669720|Colorectal|colorectal
5901297|NCT01669720|Colorectal Cancer|colorectal cancer
5901298|NCT01669720|Resected or Ablated Metastatic Colorectal Cancer|resected or ablated metastatic colorectal cancer
5863989|NCT00001146|Bipolar Disorder|bipolar disorder
5678669|NCT00585806|Heart Failure with preserved ejection fraction|heart failure with preserved ejection fraction
5678671|NCT00585767|Hydronephrosis|hydronephrosis
5678672|NCT00585715|Cellulite|cellulite
5678673|NCT00585715|Nd:YAG Laser|nd:yag laser
5678674|NCT00585702|Bipolar Disorder|bipolar disorder
5678675|NCT00585702|Pregnancy|pregnancy
5678676|NCT00585702|Infant Development|infant development
5678677|NCT00585689|Locally advanced urothelial carcinoma of the bladder|locally advanced urothelial carcinoma of the bladder
5678678|NCT00585650|palmoplantar psoriasis|palmoplantar psoriasis
5678679|NCT00585650|etanercept|etanercept
5678680|NCT00585650|Enbrel|enbrel
5678681|NCT00585637|Vitamin D|vitamin d
5678682|NCT00585637|Blacks|blacks
5678683|NCT00585637|cancer|cancer
5678684|NCT00585637|hypertension|hypertension
5678685|NCT00585624|Esophagectomy|esophagectomy
5678686|NCT00585624|Pancreaticoduodenectomy|pancreaticoduodenectomy
5678687|NCT00585624|Whipple|whipple
5678688|NCT00585611|Heart Failure, Congestive|heart failure, congestive
5678689|NCT00585585|Depression|depression
5678690|NCT00585585|Betahistine Dihydrochloride|betahistine dihydrochloride
5678691|NCT00585572|Normal Tissues/Brains|normal tissues/brains
5678692|NCT00585572|Alzheimer|alzheimer
5678693|NCT00585572|Motor Neuron Disease|motor neuron disease
5678694|NCT00585572|Dementia|dementia
5678695|NCT00585572|Healthy Control Volunteers|healthy control volunteers
5678696|NCT00585572|Populations At Risk|populations at risk
5678697|NCT00585572|MCI|mci
5678698|NCT00585559|Lipid|lipid
5678699|NCT00585559|Peroxidation|peroxidation
5678700|NCT00585559|N-Acetylcysteine|n-acetylcysteine
5678701|NCT00585559|Acetaminophen|acetaminophen
5678702|NCT00585559|Vasospasm|vasospasm
5678703|NCT00585546|heart failure|heart failure
5678704|NCT00585546|dilated cardiomyopathy|dilated cardiomyopathy
5678705|NCT00585546|heart assist device|heart assist device
5678707|NCT00585546|adrenergic beta agonists|adrenergic beta agonists
5678708|NCT00585546|heart transplantation|heart transplantation
5685500|NCT00555841|breast cancer|breast cancer
5678709|NCT00585507|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5678710|NCT00585507|Fulvestrant|fulvestrant
5678711|NCT00585481|Epidemiological Study|epidemiological study
5678712|NCT00585481|Incidence of severe Respiratory Syncytial Virus|incidence of severe respiratory syncytial virus
5678713|NCT00585481|Preterm Brazilian children|preterm brazilian children
5678714|NCT00585455|vascular endothelium|vascular endothelium
5901342|NCT01648673|Coronary Artery Disease|coronary artery disease
5901343|NCT01648673|Cardiac Rehabilitation|cardiac rehabilitation
5901349|NCT01646463|stress|stress
5901350|NCT01646463|coping|coping
5901351|NCT01646463|emotion|emotion
5901352|NCT01646463|depression|depression
5901353|NCT01646463|group medical visits|group medical visits
5901354|NCT01646463|prenatal healthcare|prenatal healthcare
5901355|NCT01646463|preterm birth|preterm birth
5901356|NCT01646463|birth weight|birth weight
5901357|NCT01646463|postpartum depression|postpartum depression
5901358|NCT01646463|cortisol|cortisol
5901359|NCT01646463|neuroendocrine function|neuroendocrine function
5901360|NCT01646463|blood pressure|blood pressure
5901361|NCT01646463|health disparities|health disparities
5678715|NCT00585455|nitric oxide|nitric oxide
5678716|NCT00585455|depression|depression
5678717|NCT00585455|heart failure|heart failure
5678718|NCT00585455|vascular biology|vascular biology
5678719|NCT00585416|Prostate Cancer|prostate cancer
5901402|NCT01616303|cancer|cancer
5901403|NCT01616303|neoplasm|neoplasm
5901404|NCT01616303|adenocarcinoma|adenocarcinoma
5901405|NCT01616303|CA125|ca125
5901456|NCT01570348|Crohn's Disease|crohn's disease
5901457|NCT01570348|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5901458|NCT01570348|Hematopoietic cell transplantation|hematopoietic cell transplantation
5901474|NCT01563354|neuroendocrine carcinoma; lung; thymus; pasireotide LAR; everolimus|neuroendocrine carcinoma; lung; thymus; pasireotide lar; everolimus
5678720|NCT00585416|Hormone Refractory|hormone refractory
5678721|NCT00585416|Metastatic|metastatic
5678722|NCT00585364|Allergic Bronchopulmonary Aspergillosis|allergic bronchopulmonary aspergillosis
5678723|NCT00585364|Aspergillus fumigatus|aspergillus fumigatus
5678724|NCT00585364|cytokine expression|cytokine expression
5678725|NCT00585338|facial telangiectasia,|facial telangiectasia,
5678726|NCT00585338|leg vein telangiectasia|leg vein telangiectasia
5678727|NCT00585338|Port Wine Stain birthmarks|port wine stain birthmarks
5678729|NCT00585299|steatosis|steatosis
5678730|NCT00585299|fatty liver|fatty liver
5678731|NCT00585299|insulin sensitivity|insulin sensitivity
5678732|NCT00585299|fatty liver (steatosis)|fatty liver (steatosis)
5678733|NCT00585286|acne vulgaris|acne vulgaris
5678734|NCT00585286|scarring|scarring
5678735|NCT00585286|laser|laser
5678736|NCT00585260|asthma|asthma
5678737|NCT00585260|bronchoprovocation challenge test|bronchoprovocation challenge test
5678738|NCT00585260|mannitol|mannitol
5678739|NCT00585260|methacholine|methacholine
5678740|NCT00585247|birthmarks|birthmarks
5678741|NCT00585221|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5678742|NCT00585221|Imatinib|imatinib
5678743|NCT00585221|Peginterferon α-2b|peginterferon α-2b
5678744|NCT00585221|Immunotherapy|immunotherapy
5678745|NCT00585221|Targeted therapy|targeted therapy
5678747|NCT00585208|sleep disturbance|sleep disturbance
5678748|NCT00585208|bipolar disorder|bipolar disorder
5678749|NCT00585195|Crizotinib|crizotinib
5678750|NCT00585195|dose-finding|dose-finding
5678751|NCT00585195|drug-drug interaction|drug-drug interaction
5678752|NCT00585195|ALK rearrangements|alk rearrangements
5678879|NCT00584558|Catheter Ablation|catheter ablation
5678753|NCT00585195|c-Met mutations or amplifications|c-met mutations or amplifications
5678754|NCT00585195|c-Met dependent tumors|c-met dependent tumors
5678755|NCT00585195|ROS1 rearrangements|ros1 rearrangements
5678756|NCT00585195|c-Met exon 14 deletion|c-met exon 14 deletion
5678757|NCT00585195|c-Met exon 14 skipping|c-met exon 14 skipping
5678758|NCT00585195|c-Met exon 14 alterations|c-met exon 14 alterations
5678759|NCT00585182|Obesity|obesity
5678760|NCT00585182|venous thrombosis|venous thrombosis
5678761|NCT00585182|Anticoagulants|anticoagulants
5678762|NCT00585169|Pathological Gambling|pathological gambling
5678763|NCT00585169|Compulsive Gambling|compulsive gambling
5678764|NCT00585169|Gambling Addiction|gambling addiction
5678765|NCT00585169|Gambling|gambling
5678766|NCT00585169|Treatment|treatment
5678767|NCT00585169|Memantine|memantine
5678768|NCT00585169|Pharmacology|pharmacology
5678769|NCT00585156|Celebrex, Bone Ingrowth, Pain relief|celebrex, bone ingrowth, pain relief
5678770|NCT00585143|Dyslipidemia|dyslipidemia
5678771|NCT00585078|capecitabine|capecitabine
5678772|NCT00585078|oxaliplatin|oxaliplatin
5678773|NCT00585052|Ovarian Cancer|ovarian cancer
5678774|NCT00585052|Epithelial Ovarian Cancer|epithelial ovarian cancer
5678775|NCT00585052|Lovastatin|lovastatin
5678776|NCT00585052|Paclitaxel|paclitaxel
5678777|NCT00585039|child|child
5678778|NCT00585039|emergency department|emergency department
5678779|NCT00585026|Refractive error|refractive error
5678780|NCT00585026|Asthenopia|asthenopia
5678781|NCT00585026|Presbyopia|presbyopia
5678782|NCT00585026|Eyeglasses|eyeglasses
5678783|NCT00585026|Productivity|productivity
5678784|NCT00585026|Visual comfort|visual comfort
5678785|NCT00585026|Ergonomics|ergonomics
5678786|NCT00585013|Inhaled Nitric Oxide (NO)|inhaled nitric oxide (no)
5678787|NCT00585013|Anti-inflammatory|anti-inflammatory
5678788|NCT00585013|Anti-reperfusion agent|anti-reperfusion agent
5678789|NCT00584974|Depression|depression
5678790|NCT00584974|Mental Disorders|mental disorders
5678791|NCT00584974|Mood Disorders|mood disorders
5678792|NCT00584974|Depressive Disorder, Major|depressive disorder, major
5901512|NCT01534130|Chronic Fatigue Syndrome|chronic fatigue syndrome
5901513|NCT01534130|Sleep Disorder, Adjustment|sleep disorder, adjustment
5901514|NCT01534130|Acupuncture|acupuncture
5901545|NCT01503346|Appetite Loss|appetite loss
5901551|NCT01498328|EGFRvIII|egfrviii
5901552|NCT01498328|Glioblastoma|glioblastoma
5901553|NCT01498328|Rindopepimut|rindopepimut
5901555|NCT01498328|Small cell|small cell
5901556|NCT01498328|Giant cell|giant cell
5901557|NCT01498328|Brain Cancer|brain cancer
5901558|NCT01498328|Brain Tumor|brain tumor
5901559|NCT01498328|Gliosarcoma|gliosarcoma
5901560|NCT01498328|oligodendroglial|oligodendroglial
5901561|NCT01498328|radiotherapy|radiotherapy
5901562|NCT01498328|chemoradiation|chemoradiation
5901581|NCT01492751|Prostatic Neoplasms|prostatic neoplasms
5901582|NCT01492751|Radiotherapy conformal|radiotherapy conformal
5901584|NCT01492751|radical prostatectomy|radical prostatectomy
5901585|NCT01492751|Quality of life|quality of life
5901586|NCT01492751|biochemical relapse|biochemical relapse
5901587|NCT01492751|biochemical failure|biochemical failure
5901588|NCT01492751|survival|survival
5901589|NCT01492751|Clinically localized prostate cancer|clinically localized prostate cancer
5901598|NCT01490892|breast abnormality|breast abnormality
5901599|NCT01490892|ultrasound imaging|ultrasound imaging
5901600|NCT01490892|ultrasound contrast agent|ultrasound contrast agent
5901601|NCT01490892|subharmonic imaging|subharmonic imaging
5901602|NCT01483144|Familial Adenomatous Polyposis|familial adenomatous polyposis
5901603|NCT01483144|Eflornithine|eflornithine
5901604|NCT01483144|Sulindac|sulindac
5901693|NCT01445171|Aortic Valve Replacement|aortic valve replacement
5901700|NCT01438515|MRSA|mrsa
5901701|NCT01438515|doxycycline|doxycycline
5901702|NCT01438515|rifampin|rifampin
5901703|NCT01438515|mupirocin|mupirocin
5901704|NCT01438515|chlorhexidine gluconate|chlorhexidine gluconate
5901705|NCT01438515|decolonization|decolonization
5901706|NCT01438515|methicillin-resistant staphylococcus aureus|methicillin-resistant staphylococcus aureus
5901719|NCT01433315|sleep deprivation|sleep deprivation
5901720|NCT01433315|sleep restriction|sleep restriction
4972051|NCT04165720|Exercise|exercise
5678793|NCT00584974|Dysthymic Disorder|dysthymic disorder
5678794|NCT00584961|Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors|metabolic syndrome, bipolar disorder and cardiovascular risk factors
5678795|NCT00584948|FXTAS, Fragile X Premutation|fxtas, fragile x premutation
5678796|NCT00584935|Pemphigoid|pemphigoid
5678797|NCT00584935|Blistering Diseases|blistering diseases
5678798|NCT00584935|Blindness|blindness
5678799|NCT00584935|Autoimmune|autoimmune
5678800|NCT00584935|Rituximab|rituximab
5678802|NCT00584922|Catheter Ablation|catheter ablation
5678803|NCT00584922|Atrial Fibrillation|atrial fibrillation
5678804|NCT00584896|heart disease|heart disease
5678805|NCT00584896|coronary artery disease|coronary artery disease
5678806|NCT00584896|echocardiogram|echocardiogram
5678807|NCT00584896|ultrasound|ultrasound
5678808|NCT00584896|angiogram|angiogram
5678809|NCT00584896|SPECT|spect
5678810|NCT00584896|chest pain|chest pain
5678811|NCT00584896|perfusion|perfusion
5678812|NCT00584883|Patients who have newly diagnosed brain tumors|patients who have newly diagnosed brain tumors
5678813|NCT00584844|Live Vaccine Strain (LVS), Bacterial Infections, Ulceroglandular, Oculoglandular|live vaccine strain (lvs), bacterial infections, ulceroglandular, oculoglandular
5678814|NCT00584831|astigmatism|astigmatism
5678815|NCT00584831|visual acuity|visual acuity
5678816|NCT00584831|orientation|orientation
5678817|NCT00584831|contact lenses|contact lenses
5678818|NCT00584818|coronary artery disease|coronary artery disease
5678819|NCT00584818|chest pain|chest pain
5678820|NCT00584818|healthy volunteers|healthy volunteers
5678821|NCT00584818|SPECT|spect
5678822|NCT00584818|angiogram|angiogram
5678823|NCT00584818|ultrasound|ultrasound
5678824|NCT00584818|echocardiogram|echocardiogram
5678825|NCT00584818|perfusion|perfusion
5678827|NCT00584792|Prostate Cancer|prostate cancer
5678828|NCT00584779|Gabapentin Pharmacokinetics, renal impairment|gabapentin pharmacokinetics, renal impairment
5678829|NCT00584753|Breast cancer|breast cancer
5678830|NCT00584740|Crohn's disease, moderate, severe, active, AIN457|crohn's disease, moderate, severe, active, ain457
5678831|NCT00584727|astigmatism|astigmatism
5678832|NCT00584727|visual acuity|visual acuity
5678833|NCT00584727|fit|fit
5678834|NCT00584727|comfort|comfort
5678835|NCT00584727|satisfaction|satisfaction
5678836|NCT00584727|contact lens|contact lens
5678837|NCT00584714|ultrasound|ultrasound
5678839|NCT00584714|SPECT|spect
5678840|NCT00584714|coronary artery disease|coronary artery disease
5678841|NCT00584714|chest pain|chest pain
5678842|NCT00584714|low probability|low probability
5678843|NCT00584714|angiography|angiography
5678844|NCT00584714|clinical outcomes|clinical outcomes
5678845|NCT00584688|anorexia|anorexia
5678846|NCT00584688|nervosa|nervosa
5678847|NCT00584688|eating|eating
5678848|NCT00584688|disorder|disorder
5678849|NCT00584688|study|study
5678850|NCT00584688|research|research
5678851|NCT00584688|clinical|clinical
5678852|NCT00584688|trial|trial
5678853|NCT00584688|psychiatry|psychiatry
5678854|NCT00584688|psychiatric|psychiatric
5678855|NCT00584675|GERD|gerd
5678856|NCT00584675|laryngopharyngeal reflux disease|laryngopharyngeal reflux disease
5678857|NCT00584662|Rhinitis|rhinitis
5678858|NCT00584649|Inappropriate Sinus Tachycardia|inappropriate sinus tachycardia
5678859|NCT00584649|Inappropiate Tachycardia|inappropiate tachycardia
5678860|NCT00584649|Sinus Tachycardia|sinus tachycardia
5678861|NCT00584649|Palpitations|palpitations
5678862|NCT00584649|Fast Heart rate|fast heart rate
5678863|NCT00584636|child|child
5678864|NCT00584636|emergency department|emergency department
5678865|NCT00584623|dysphagia|dysphagia
5678866|NCT00584623|videofluoroscopy|videofluoroscopy
5678867|NCT00584623|flexible endoscopic evaluation|flexible endoscopic evaluation
5901764|NCT01417533|GNE Myopathy|gne myopathy
5901765|NCT01414985|Batten Disease|batten disease
5901790|NCT01402882|traumatic brain injury|traumatic brain injury
5901791|NCT01402882|tranexamic acid|tranexamic acid
5901792|NCT01402882|antifibrinolytic|antifibrinolytic
5901793|NCT01402882|randomised|randomised
5901794|NCT01402882|clinical trial|clinical trial
5901795|NCT01402063|Brain Tumors|brain tumors
5901796|NCT01402063|Glioblastoma Multiforme|glioblastoma multiforme
5901797|NCT01402063|GBM|gbm
5901799|NCT01399411|Self-Reported|self-reported
5901800|NCT01399411|Farming|farming
5901801|NCT01399411|Agriculture|agriculture
5901802|NCT01399411|Disease Validation|disease validation
5901803|NCT01399411|Autoimmune Disorders|autoimmune disorders
5901830|NCT01375530|Prevention|prevention
5901831|NCT01375530|Vaccine|vaccine
5901832|NCT01375530|Immunity|immunity
5901833|NCT01375530|Evaluate|evaluate
5678868|NCT00584610|Women's health|women's health
5678869|NCT00584597|Radiation-Induced Mucositis|radiation-induced mucositis
5678870|NCT00584597|Head and neck cancer|head and neck cancer
5678871|NCT00584597|TRAUMEEL|traumeel
5678872|NCT00584597|Mucositis|mucositis
5678873|NCT00584597|Radiation|radiation
5678874|NCT00584597|Oral cancer|oral cancer
5678875|NCT00584597|Inflammation of the mouth|inflammation of the mouth
5678876|NCT00584597|Homeopathic Medication|homeopathic medication
5678877|NCT00584584|Allergic rhinitis, adults, monoclonal antibody, interleukin-13.|allergic rhinitis, adults, monoclonal antibody, interleukin-13.
5678880|NCT00584545|pharyngeal manometry|pharyngeal manometry
5678881|NCT00584545|videofluoroscopy|videofluoroscopy
5678882|NCT00584532|Localized|localized
5678883|NCT00584532|Prostate|prostate
5678884|NCT00584532|Cancer|cancer
5674150|NCT00604786|IgE|ige
5678885|NCT00584519|Schizophrenia, Overweight, Cardiovascular Risk, Obesity|schizophrenia, overweight, cardiovascular risk, obesity
5678886|NCT00584506|orbital fractures|orbital fractures
5678888|NCT00584467|Arteriosclerosis|arteriosclerosis
5678889|NCT00584467|biomarkers|biomarkers
5678890|NCT00584467|Atherosclerosis|atherosclerosis
5678891|NCT00584454|Coxiella burnetti, Bacterial Infections, Rickettsia, Hepatits, Endocarditis|coxiella burnetti, bacterial infections, rickettsia, hepatits, endocarditis
5678892|NCT00584428|Breast Cancer|breast cancer
5678893|NCT00584428|Cancer Treatment|cancer treatment
5678894|NCT00584428|Breast Cancer Treatment|breast cancer treatment
5678895|NCT00584415|Catheter Ablation|catheter ablation
5678896|NCT00584415|Atrial Fibrillation|atrial fibrillation
5678897|NCT00584402|liver cancer|liver cancer
5678898|NCT00584389|Obesity|obesity
5678899|NCT00584389|Energy expenditure|energy expenditure
5678900|NCT00584389|Fatty acid|fatty acid
5678901|NCT00584389|Triglyceride|triglyceride
5678902|NCT00584376|Essential tremor|essential tremor
5678903|NCT00584376|tremor|tremor
5678904|NCT00584376|pregabalin|pregabalin
5678905|NCT00584376|lyrica|lyrica
5678906|NCT00584350|coronary angiogram|coronary angiogram
5678907|NCT00584350|percutaneous coronary intervention|percutaneous coronary intervention
5678908|NCT00584337|tomography|tomography
5678909|NCT00584337|coronary artery disease|coronary artery disease
5678910|NCT00584337|Stress Test|stress test
5678911|NCT00584337|Coronary CT Angiography|coronary ct angiography
5678912|NCT00584337|Diagnostic Accuracy|diagnostic accuracy
5678913|NCT00584337|Non invasive testing|non invasive testing
5678914|NCT00584324|elective surgery|elective surgery
5678915|NCT00584324|general anesthesia|general anesthesia
5678916|NCT00584324|implicit memory|implicit memory
5678917|NCT00584298|Barostat|barostat
5678918|NCT00584298|distention|distention
5678919|NCT00584298|IBS|ibs
5678926|NCT00584298|reproducibility|reproducibility
5678927|NCT00584272|cleft palate|cleft palate
5678928|NCT00584272|suture materials|suture materials
5678929|NCT00584259|GERD|gerd
5678930|NCT00584259|Gastro-Esophageal Disease|gastro-esophageal disease
5678931|NCT00584246|Restless legs syndrome|restless legs syndrome
5678932|NCT00584246|RLS|rls
5678933|NCT00584246|Pregabalin|pregabalin
5678934|NCT00584246|Lyrica|lyrica
5678935|NCT00584233|breast cancer|breast cancer
5678936|NCT00584220|Astigmatism|astigmatism
5678937|NCT00584220|vision|vision
5678938|NCT00584220|comfort|comfort
5678939|NCT00584220|satisfaction|satisfaction
5678940|NCT00584220|contact lenses|contact lenses
5678941|NCT00584207|uterine fibroids|uterine fibroids
5678942|NCT00584194|Hemorrhagic Fever, Viral Infections, Neurologic diseases, Arbovirus Infections, RVF|hemorrhagic fever, viral infections, neurologic diseases, arbovirus infections, rvf
5678943|NCT00584168|UPPP|uppp
5678944|NCT00584168|Dexamethasone|dexamethasone
5678945|NCT00584168|Uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
5678946|NCT00584168|Pain Management|pain management
5678947|NCT00584168|Increasing pain management in patients that have undergone UPPP surgery|increasing pain management in patients that have undergone uppp surgery
5678948|NCT00584155|Cisplatin Ototoxicity|cisplatin ototoxicity
5678949|NCT00584155|Lactated Ringer's|lactated ringer's
5678950|NCT00584155|Ear Cancer|ear cancer
5678951|NCT00584155|Hearing loss|hearing loss
5678952|NCT00584155|Hearing loss due to Cisplatin Ototoxicity|hearing loss due to cisplatin ototoxicity
5678953|NCT00584142|breast cancer|breast cancer
5678954|NCT00584142|survivors|survivors
5678955|NCT00584129|Cancer|cancer
5678956|NCT00584129|Dysphagia|dysphagia
5678957|NCT00584129|Radiation|radiation
5678958|NCT00584129|Patients with H&N cancer who will be receiving chemoradiation|patients with h&n cancer who will be receiving chemoradiation
5678959|NCT00584116|Aortic Valve Replacement|aortic valve replacement
5678960|NCT00584116|AVR|avr
5678961|NCT00584103|transradial amputation|transradial amputation
5678962|NCT00584103|prosthesis|prosthesis
5678963|NCT00584103|prefabricated prosthesis|prefabricated prosthesis
5678964|NCT00584103|inexpensive|inexpensive
5678965|NCT00584103|custom prosthesis|custom prosthesis
5678966|NCT00584103|adult transradial amputation|adult transradial amputation
5678967|NCT00584090|urinary incontinence|urinary incontinence
5678968|NCT00584090|parkinson's disease|parkinson's disease
5901951|NCT01326260|resuscitation|resuscitation
5901952|NCT01326260|trauma|trauma
5901953|NCT01326260|THAM|tham
5901954|NCT01326260|colloids|colloids
5901955|NCT01326260|crystalloids|crystalloids
5901999|NCT01299727|Recombinant Human Heparan N-Sulfatase (rhHNS)|recombinant human heparan n-sulfatase (rhhns)
5902000|NCT01299727|Sanfilippo Syndrome Type A (MPS IIIA)|sanfilippo syndrome type a (mps iiia)
5902001|NCT01299727|Lysosomal storage disease (LSD)|lysosomal storage disease (lsd)
5902002|NCT01299727|Mucopolysaccharidosis (MPS) III|mucopolysaccharidosis (mps) iii
5678969|NCT00584090|vesicare|vesicare
5678970|NCT00584090|solifenacin succinate|solifenacin succinate
5678971|NCT00584064|patent|patent
5678972|NCT00584064|foramen|foramen
5678973|NCT00584064|ovale|ovale
5678974|NCT00584064|PFO|pfo
5678975|NCT00584051|Control group|control group
5678976|NCT00584038|contraceptive compliance|contraceptive compliance
5678977|NCT00584038|educational intervention|educational intervention
5678978|NCT00584038|oral contraception|oral contraception
5678979|NCT00584025|Parkinson's disease|parkinson's disease
5678980|NCT00584025|dyskinesia|dyskinesia
5678981|NCT00584025|levetiracetam|levetiracetam
5678982|NCT00584025|keppra|keppra
5678983|NCT00584012|Any cancer|any cancer
5678984|NCT00584012|Breast cancer|breast cancer
5678985|NCT00584012|Lovastatin|lovastatin
5678986|NCT00584012|Docetaxel|docetaxel
5678987|NCT00583999|leptin, leptin receptors, adiponectin|leptin, leptin receptors, adiponectin
5678988|NCT00583986|top mounted|top mounted
5678989|NCT00583986|actuation indicator|actuation indicator
5678990|NCT00583986|Asthma|asthma
5678991|NCT00583986|COPD|copd
5678992|NCT00583986|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5678993|NCT00583960|swallowing problems|swallowing problems
5678994|NCT00583960|tracheal stenosis|tracheal stenosis
5678995|NCT00583947|Asthma|asthma
5678996|NCT00583947|Respiratory Tract Diseases|respiratory tract diseases
5678997|NCT00583934|esophageal cancer, head and neck cancer, dysplasia|esophageal cancer, head and neck cancer, dysplasia
5678998|NCT00583921|Atrial Fibrillation|atrial fibrillation
5678999|NCT00583921|ICD|icd
5679000|NCT00583921|BiV ICD|biv icd
5679001|NCT00583921|CHF|chf
5679002|NCT00583921|Congestive Heart Failure|congestive heart failure
5679003|NCT00583921|AF|af
5679004|NCT00583908|astigmatism|astigmatism
5679005|NCT00583908|orientation|orientation
5679006|NCT00583908|visual acuity|visual acuity
5679007|NCT00583908|contact lenses|contact lenses
5679008|NCT00583895|dermatitis|dermatitis
5679009|NCT00583895|atopic|atopic
5679010|NCT00583895|ImCOOH|imcooh
5679011|NCT00583895|safety|safety
5679012|NCT00583895|tolerability|tolerability
5679013|NCT00583895|efficacy|efficacy
5679014|NCT00583895|pharmacokinetics|pharmacokinetics
5679015|NCT00583882|Central Venous Catheter|central venous catheter
5679016|NCT00583882|Guidewire|guidewire
5679017|NCT00583882|Burn|burn
5679018|NCT00583869|Post-operative Pain|post-operative pain
5679019|NCT00583869|Fracture Patients|fracture patients
5679020|NCT00583869|Pregabalin|pregabalin
5679021|NCT00583869|LYRICA|lyrica
5679022|NCT00583856|computer aided design|computer aided design
5679023|NCT00583856|maxillofacial fracture|maxillofacial fracture
5679024|NCT00583856|orbital design|orbital design
5679025|NCT00583843|Lumpectomy|lumpectomy
5679026|NCT00583843|Ultrasonography|ultrasonography
5679027|NCT00583843|Radiotherapy|radiotherapy
5679029|NCT00583804|Spinal Cord Injury|spinal cord injury
5679030|NCT00583804|Tetraplegia|tetraplegia
5679031|NCT00583804|Functional Electrical Stimulation|functional electrical stimulation
5679032|NCT00583804|Neuroprosthesis|neuroprosthesis
5679033|NCT00583791|muscular|muscular
5679034|NCT00583791|ventricular|ventricular
5679035|NCT00583791|septal|septal
5679036|NCT00583791|defects|defects
5679038|NCT00583778|Asthma|asthma
5679039|NCT00583778|Bronchodilators|bronchodilators
5679040|NCT00583778|Levalbuterol|levalbuterol
5679041|NCT00583778|Ipratropium|ipratropium
5679042|NCT00583765|Kidney Failure, Acute|kidney failure, acute
5679043|NCT00583765|Hemodialysis|hemodialysis
5679044|NCT00583765|Hemofiltration|hemofiltration
5679045|NCT00583765|Anticoagulation|anticoagulation
5679046|NCT00583765|Citrate|citrate
5679047|NCT00583752|prostate cancer|prostate cancer
5679048|NCT00583752|vaccine|vaccine
5679049|NCT00583752|immunotherapy|immunotherapy
5679050|NCT00583739|Fatigue|fatigue
5679051|NCT00583739|Yoga|yoga
5679052|NCT00583739|Anxiety|anxiety
5902074|NCT01270373|neoadjuvant therapy|neoadjuvant therapy
5902075|NCT01270373|drug therapy|drug therapy
5902102|NCT01265407|Children|children
5902103|NCT01265407|Hemoglobinopathies|hemoglobinopathies
5902104|NCT01265407|Epidemiology|epidemiology
5902105|NCT01265407|Malaria|malaria
5902106|NCT01264055|Rare Diseases of Airways|rare diseases of airways
5902107|NCT01264055|Chronic Cough|chronic cough
5902108|NCT01264055|Nontuberculous Mycobacteriam Infection|nontuberculous mycobacteriam infection
5902109|NCT01264055|Bronchiectasis|bronchiectasis
5902110|NCT01264055|Idiopathic Bronchiectasis|idiopathic bronchiectasis
5679053|NCT00583739|Quality of Life|quality of life
5679054|NCT00583726|chemotherapy|chemotherapy
5679055|NCT00583726|exercise|exercise
5679056|NCT00583726|diet|diet
5679057|NCT00583726|fruit|fruit
5679058|NCT00583726|vegetables|vegetables
5679059|NCT00583726|low-fat|low-fat
5679060|NCT00583700|Breast Neoplasms|breast neoplasms
5679061|NCT00583700|Radiotherapy|radiotherapy
5679062|NCT00583687|Arterial pulse contour cardiac output|arterial pulse contour cardiac output
5679063|NCT00583687|Changing vascular tone|changing vascular tone
5679064|NCT00583687|Tissue Oxymetry|tissue oxymetry
5679065|NCT00583687|Prediction of Fluid Responsiveness|prediction of fluid responsiveness
5679066|NCT00583674|Gastric Cancer|gastric cancer
5679067|NCT00583674|Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma|metastatic gastric, gastroesophageal junction, or distal esophageal adenocarcinoma
5679068|NCT00583674|AMG 386|amg 386
5679069|NCT00583674|Cisplatin|cisplatin
5679070|NCT00583674|Capecitabine|capecitabine
5679071|NCT00583661|Ventricular Assist Device|ventricular assist device
5679072|NCT00583661|Pediatric Ventricular Assist Device|pediatric ventricular assist device
5679073|NCT00583648|urinary tract infections|urinary tract infections
5679076|NCT00583648|urine protocols|urine protocols
5679077|NCT00583648|urinalysis protocols|urinalysis protocols
5679078|NCT00583648|nursing protocols|nursing protocols
5679079|NCT00583648|Emergency Department|emergency department
5679080|NCT00583635|Preeclampsia|preeclampsia
5679081|NCT00583635|Prevention|prevention
5679082|NCT00583635|Food Supplement|food supplement
5679083|NCT00583622|Ovarian Cancer|ovarian cancer
5679084|NCT00583622|Epithelial Ovarian Cancer|epithelial ovarian cancer
5679085|NCT00583622|Bevacizumab|bevacizumab
5679086|NCT00583622|Carboplatin|carboplatin
5679087|NCT00583622|Gemcitabine|gemcitabine
5679088|NCT00583622|Docetaxel|docetaxel
5679089|NCT00583622|Melphalan|melphalan
5679090|NCT00583596|patent ductus arteriosus (PDA)|patent ductus arteriosus (pda)
5679091|NCT00583557|Rheumatoid Arthritis|rheumatoid arthritis
5679093|NCT00583544|Healthy|healthy
5679094|NCT00583544|Healthy Volunteers|healthy volunteers
5679095|NCT00583531|Antibiotic-refractory Pouchitis|antibiotic-refractory pouchitis
5679096|NCT00583531|Pouchitis|pouchitis
5679097|NCT00583531|Ulcerative Colitis|ulcerative colitis
5679098|NCT00583505|membranous|membranous
5679099|NCT00583505|ventricular|ventricular
5679100|NCT00583505|septal|septal
5679101|NCT00583505|defects|defects
5679102|NCT00583505|VSD|vsd
5679103|NCT00583492|Prostatic Neoplasms|prostatic neoplasms
5679104|NCT00583492|Prostate Cancer|prostate cancer
5679105|NCT00583492|Adenocarinomas|adenocarinomas
5679106|NCT00583492|Tumors of the Prostate|tumors of the prostate
5679107|NCT00583492|Gene Therapy|gene therapy
5679108|NCT00583492|IMRT|imrt
5679109|NCT00583466|submucosal cushion|submucosal cushion
5679110|NCT00583466|polypectomy|polypectomy
5679111|NCT00583466|endoscopic mucosal resection|endoscopic mucosal resection
5679112|NCT00583453|Tonsillectomy|tonsillectomy
5679113|NCT00583453|Analgesia|analgesia
5679114|NCT00583453|Pain measurement|pain measurement
5679115|NCT00583453|Celecoxib|celecoxib
5679116|NCT00583440|12-step|12-step
5679117|NCT00583440|mutual help|mutual help
5679118|NCT00583440|dual diagnosis|dual diagnosis
5679119|NCT00583440|serious mental illness|serious mental illness
5679121|NCT00583401|stroke|stroke
5679122|NCT00583388|cardiology|cardiology
5679123|NCT00583388|preventive medicine|preventive medicine
5679124|NCT00583388|cardiovascular physiology|cardiovascular physiology
5679125|NCT00583388|healthy subjects|healthy subjects
5679126|NCT00583375|arthritis|arthritis
5679127|NCT00583375|ankle pain|ankle pain
5679128|NCT00583375|foot pain|foot pain
5679129|NCT00583375|hindfoot fracture|hindfoot fracture
5679130|NCT00583375|ankle fracture|ankle fracture
5679132|NCT00583362|Lupus|lupus
5679133|NCT00583349|Bladder Cancer|bladder cancer
5679134|NCT00583349|Chemotherapy|chemotherapy
5679135|NCT00583349|Bladder Neoplasms|bladder neoplasms
5679136|NCT00583310|Prehypertension|prehypertension
5679137|NCT00583297|Arrhythmia|arrhythmia
5679138|NCT00583297|Heart Failure|heart failure
5679139|NCT00583297|T-wave Alternans|t-wave alternans
5679140|NCT00583297|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5679141|NCT00583297|Biological Markers|biological markers
5679142|NCT00583297|Molecular Genetics|molecular genetics
5679143|NCT00583297|Corus CAD|corus cad
5679144|NCT00583297|ASGES|asges
5679145|NCT00583297|Age/Sex/Gene Expression Score|age/sex/gene expression score
5679146|NCT00583297|Gene Expression|gene expression
5679148|NCT00583297|CVD|cvd
5679149|NCT00583297|Precision Medicine|precision medicine
5679150|NCT00583297|Sudden Cardiac Death|sudden cardiac death
5679151|NCT00583297|Electrophysiology Study|electrophysiology study
5679152|NCT00583297|Cardiovascular Disease|cardiovascular disease
5679153|NCT00583297|ICD|icd
5679154|NCT00583297|EPS|eps
5679155|NCT00583297|SCD|scd
5679156|NCT00583297|TWA|twa
5679157|NCT00583284|delayed enhancement computed tomography|delayed enhancement computed tomography
5679158|NCT00583284|ventricular tachycardia ablation|ventricular tachycardia ablation
5679159|NCT00583284|ventricular tachycardia|ventricular tachycardia
5679160|NCT00583245|Osteoarthritis|osteoarthritis
5679161|NCT00583245|Gait training|gait training
5679162|NCT00583245|Knee pain|knee pain
5679163|NCT00583245|Rehabilitation|rehabilitation
5679164|NCT00583245|Physical Therapy|physical therapy
5679165|NCT00583232|Pediatric|pediatric
5679166|NCT00583232|Crohn's disease|crohn's disease
5679167|NCT00583232|protein metabolism|protein metabolism
5679168|NCT00583232|energy metabolism|energy metabolism
5679169|NCT00583206|sepsis|sepsis
5679170|NCT00583206|atrophy|atrophy
5679171|NCT00583206|muscle|muscle
5679172|NCT00583206|weakness|weakness
5679173|NCT00583193|Post Traumatic Stress Disorder|post traumatic stress disorder
5679174|NCT00583193|Duloxetine|duloxetine
5679175|NCT00583193|Antidepressants|antidepressants
5679176|NCT00583180|Primary and/or secondary hyperalgesia|primary and/or secondary hyperalgesia
5679177|NCT00583180|hypoesthesia|hypoesthesia
5679178|NCT00583167|HIV|hiv
5679179|NCT00583167|AIDS|aids
5679180|NCT00583167|CNS|cns
5674441|NCT00603590|ADR|adr
5679182|NCT00583167|affects|affects
5679183|NCT00583154|constipation|constipation
5679184|NCT00583154|laxative|laxative
5679185|NCT00583128|IBS|ibs
5679186|NCT00583128|Irritable Bowel Syndrome|irritable bowel syndrome
5679187|NCT00583102|Acute Myeloid Leukemia|acute myeloid leukemia
5679188|NCT00583102|AML|aml
5679189|NCT00583102|Lovastatin|lovastatin
5679190|NCT00583102|Cytarabine|cytarabine
5679191|NCT00583076|Pouchitis|pouchitis
5679192|NCT00583076|Active Pouchitis|active pouchitis
5679193|NCT00583076|Safety and Efficacy of AST120|safety and efficacy of ast120
5679194|NCT00583037|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5679195|NCT00583037|Sleep quality|sleep quality
5679196|NCT00583037|Adult|adult
5679197|NCT00583037|Critical Care|critical care
5679198|NCT00583024|prostate cancer|prostate cancer
5679199|NCT00583024|vaccine|vaccine
5679200|NCT00583024|immunotherapy|immunotherapy
5679201|NCT00583011|Amniocentesis|amniocentesis
5679202|NCT00583011|Genetic amniocentesis|genetic amniocentesis
5679203|NCT00583011|Fetal lung maturity|fetal lung maturity
5679204|NCT00583011|Pain control|pain control
5679205|NCT00583011|Pregnancy|pregnancy
5679206|NCT00583011|High risk pregnancy|high risk pregnancy
5679207|NCT00582998|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5679208|NCT00582998|Calcaneus Fracture|calcaneus fracture
5679209|NCT00582998|Pilon Fracture|pilon fracture
5679210|NCT00582998|Tibial Plateau Fracture|tibial plateau fracture
5679211|NCT00582998|Open Reduction and Internal Fixation|open reduction and internal fixation
5679212|NCT00582985|Tracon|tracon
5679213|NCT00582985|CD105|cd105
5679214|NCT00582985|Anti CD105|anti cd105
5679215|NCT00582985|TRC105|trc105
5679216|NCT00582985|Phase 1|phase 1
5679217|NCT00582985|Cancer|cancer
5679218|NCT00582985|Monoclonal antibody|monoclonal antibody
5679219|NCT00582985|Solid Tumor|solid tumor
5679220|NCT00582972|Calcium Absorption|calcium absorption
5679221|NCT00582972|Fractional Calcium Absorption|fractional calcium absorption
5679222|NCT00582972|Omeprazole|omeprazole
5679223|NCT00582972|Stable Calcium Isotopes|stable calcium isotopes
5679224|NCT00582972|Proton Pump Inhibitor|proton pump inhibitor
5679225|NCT00582972|Intestinal Absorption of Calcium|intestinal absorption of calcium
5679226|NCT00582959|radiology imaging|radiology imaging
5679227|NCT00582959|malignancy|malignancy
5679228|NCT00582959|undergoing radiation therapy|undergoing radiation therapy
5902278|NCT01189851|IORT|iort
5902279|NCT01189851|electronic brachytherapy|electronic brachytherapy
5902281|NCT01182506|Cogmed Working Memory Training (CWMT)|cogmed working memory training (cwmt)
5902282|NCT01182506|cognitive|cognitive
5902283|NCT01182506|10-105|10-105
5902284|NCT01182506|Breast cancer survivor|breast cancer survivor
5902304|NCT01165827|Aortic Valve Insufficiency|aortic valve insufficiency
5902305|NCT01165827|Aortic Valve Stenosis|aortic valve stenosis
5023127|NCT03852992|Baldness|baldness
5902306|NCT01165827|Aortic Valve Valvuloplasty|aortic valve valvuloplasty
5902307|NCT01165827|Aortic valve Replacement|aortic valve replacement
5902308|NCT01165827|Aortic valve Intervention|aortic valve intervention
5902326|NCT01148849|HER2 positive|her2 positive
5902327|NCT01148849|breast cancer|breast cancer
5902328|NCT01148849|gastric cancer|gastric cancer
5679229|NCT00582946|Hearing Loss, Eardrum, Transducer, Hearing in Noise|hearing loss, eardrum, transducer, hearing in noise
5679230|NCT00582933|Cancer|cancer
5679231|NCT00582933|Donors|donors
5679232|NCT00582933|Leukemia|leukemia
5679233|NCT00582933|Myelodysplastic Syndrome|myelodysplastic syndrome
5679234|NCT00582933|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5679235|NCT00582933|Lymphoma|lymphoma
5679236|NCT00582933|AML|aml
5679237|NCT00582933|ALL|all
5679238|NCT00582933|CML|cml
5679239|NCT00582933|Allogeneic marrow transplant|allogeneic marrow transplant
5679625|NCT00581126|BENEFIX|benefix
5679240|NCT00582933|Bone marrow transplant|bone marrow transplant
5679241|NCT00582920|osseous lesions|osseous lesions
5679242|NCT00582920|breast cancer|breast cancer
5679243|NCT00582920|metastatic breast cancer|metastatic breast cancer
5679244|NCT00582907|FMF|fmf
5679245|NCT00582907|IL1 Trap (Rilonacept)|il1 trap (rilonacept)
5679246|NCT00582907|Periodic fever syndromes|periodic fever syndromes
5679247|NCT00582907|Autoinflammatory syndromes|autoinflammatory syndromes
5679248|NCT00582907|Familial Mediterranean Fever|familial mediterranean fever
5679249|NCT00582907|colchicine|colchicine
5679250|NCT00582894|Allogenic stem cell transplant|allogenic stem cell transplant
5679251|NCT00582894|Hematologic diseases|hematologic diseases
5679252|NCT00582881|Anti-RNP/Sm Autoantibody-Positive|anti-rnp/sm autoantibody-positive
5679253|NCT00582881|MCTD|mctd
5679254|NCT00582881|SLE|sle
5679255|NCT00582868|Subarachnoid hemorrhage|subarachnoid hemorrhage
5679256|NCT00582868|Cerebral Vasospasm|cerebral vasospasm
5679257|NCT00582868|Cleaved-tau protein|cleaved-tau protein
5679258|NCT00582868|Brain oxygen tension level|brain oxygen tension level
5679259|NCT00582855|AQW051|aqw051
5679260|NCT00582855|Mild Alzheimer's disease|mild alzheimer's disease
5679261|NCT00582855|Amnestic Mild Cognitive Impairment|amnestic mild cognitive impairment
5679262|NCT00582842|Early Stage|early stage
5679263|NCT00582842|Localized|localized
5679264|NCT00582829|Colorectal|colorectal
5679266|NCT00582829|Screening|screening
5679267|NCT00582829|Intervention|intervention
5679268|NCT00582829|Family|family
5679269|NCT00582816|Recurrent or Refractory Leukemia or Solid Tumors in Pediatrics|recurrent or refractory leukemia or solid tumors in pediatrics
5679270|NCT00582803|breast cancer|breast cancer
5679271|NCT00582803|germline mutation|germline mutation
5679272|NCT00582803|BRCA1|brca1
5679273|NCT00582803|BRCA2|brca2
5679274|NCT00582803|family history|family history
5679275|NCT00582803|genetic testing|genetic testing
5679276|NCT00582803|unaffected women over age 25 who are at elevated risk for|unaffected women over age 25 who are at elevated risk for
5679277|NCT00582803|breast cancer by virtue by a hereditary predisposition|breast cancer by virtue by a hereditary predisposition
5679278|NCT00582790|Renal Cell Cancer|renal cell cancer
5679279|NCT00582790|Metastatic|metastatic
5679280|NCT00582777|nocturnal blood pressure|nocturnal blood pressure
5679281|NCT00582777|chronic renal disease|chronic renal disease
5679282|NCT00582777|hypertensive renal disease|hypertensive renal disease
5679283|NCT00582777|African Americans|african americans
5679284|NCT00582777|ABPM|abpm
5679285|NCT00582764|Breast Lesion|breast lesion
5679286|NCT00582764|Lesion|lesion
5679287|NCT00582764|Breast|breast
5679288|NCT00582764|Cancer|cancer
5679289|NCT00582764|05-091|05-091
5679290|NCT00582751|Volumetric Analysis|volumetric analysis
5679291|NCT00582751|Multiple Diseases|multiple diseases
5902345|NCT01143181|CMV, ADV, HSV, VAVC, VARV|cmv, adv, hsv, vavc, varv
5902346|NCT01143181|life threatening|life threatening
5902394|NCT01097200|sacrocolpopexy|sacrocolpopexy
5902395|NCT01097200|meshes|meshes
5902396|NCT01097200|sacrospinous ligament|sacrospinous ligament
5902403|NCT01087333|Cytotoxicity Assay|cytotoxicity assay
5902404|NCT01087333|Neutralizing Antibodies|neutralizing antibodies
5902405|NCT01087333|Apheresis|apheresis
5902406|NCT01087333|Flow Cytometry|flow cytometry
5902407|NCT01087333|Hemolytic Uremic Syndrome (HUS)|hemolytic uremic syndrome (hus)
5902408|NCT01087320|Rare Disorders|rare disorders
5902409|NCT01087320|Genetic Disorders|genetic disorders
5902410|NCT01087320|Congenital Disorders|congenital disorders
5902411|NCT01087320|Inherited Diseases|inherited diseases
5902412|NCT01087294|CD19|cd19
5902413|NCT01087294|Chimeric-Antigen-Receptor|chimeric-antigen-receptor
5902414|NCT01087294|Gene Therapy|gene therapy
5902415|NCT01087294|Adoptive T Cell Therapy|adoptive t cell therapy
5902416|NCT01087294|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5679292|NCT00582738|Fibrosis progression|fibrosis progression
5679293|NCT00582738|recurrent hepatitis C|recurrent hepatitis c
5679294|NCT00582738|viral infection|viral infection
5679295|NCT00582738|liver transplant recipients|liver transplant recipients
5679296|NCT00582738|everolimus|everolimus
5679297|NCT00582738|Hepatitis C recurrence after orthotopic liver transplantation (OLT)|hepatitis c recurrence after orthotopic liver transplantation (olt)
5679298|NCT00582725|DLBCL, Elderly|dlbcl, elderly
5679299|NCT00582725|previously untreated DLBCL in the elderly|previously untreated dlbcl in the elderly
5679300|NCT00582712|medullary thyroid cancer|medullary thyroid cancer
5679301|NCT00582712|lithium|lithium
5679302|NCT00582699|Pancreatic Cancer|pancreatic cancer
5679303|NCT00582699|Pancreatic|pancreatic
5679304|NCT00582686|Calcaneus Fractures|calcaneus fractures
5679305|NCT00582686|Iliac Crest Bone Grafting|iliac crest bone grafting
5679306|NCT00582686|Open Reduction & Internal Fixation|open reduction & internal fixation
5679307|NCT00582673|Parkinson's, L-dopa, dyskinesia|parkinson's, l-dopa, dyskinesia
5679308|NCT00582634|non small cell lung cancer|non small cell lung cancer
5679309|NCT00582634|adjuvant|adjuvant
5679310|NCT00582634|cisplatin|cisplatin
5679311|NCT00582634|docetaxel|docetaxel
5679312|NCT00582621|Genetic Studies|genetic studies
5679313|NCT00582621|00-069|00-069
5679314|NCT00582621|blood|blood
5679315|NCT00582621|saliva|saliva
5679316|NCT00582621|buccal cell|buccal cell
5679317|NCT00582582|Metastatic|metastatic
5679318|NCT00582582|Hormone Refractory|hormone refractory
5679319|NCT00582582|Prostate Cancer|prostate cancer
5679320|NCT00582569|Breast lesion|breast lesion
5679321|NCT00582569|Spectroscopy|spectroscopy
5679323|NCT00582556|bone mineral density|bone mineral density
5679324|NCT00582543|Prostate Cancer|prostate cancer
5679325|NCT00582543|Prostate|prostate
5679326|NCT00582530|Prostate Cancer|prostate cancer
5679327|NCT00582530|Early Prostate Cancer|early prostate cancer
5679328|NCT00582530|Radical Prostatectomy|radical prostatectomy
5679329|NCT00582517|Orthopaedic Trauma|orthopaedic trauma
5679330|NCT00582517|Knee Dislocation|knee dislocation
5679331|NCT00582517|Compass Hinge External Fixator|compass hinge external fixator
5679332|NCT00582517|External Brace|external brace
5679333|NCT00582504|Encephalitis,VEE|encephalitis,vee
5679334|NCT00582491|Modafinil|modafinil
5679335|NCT00582491|Sleep|sleep
5679336|NCT00582491|Cognition|cognition
5679337|NCT00582491|Cocaine Dependence|cocaine dependence
5679338|NCT00582478|Breast cancer|breast cancer
5679339|NCT00582478|Quality of Life|quality of life
5679340|NCT00582452|HNPCC|hnpcc
5679341|NCT00582452|prophylactic colectomy|prophylactic colectomy
5679342|NCT00582439|Orthopaedic Trauma Fractures|orthopaedic trauma fractures
5679440|NCT00582075|Temozolomide|temozolomide
5679345|NCT00582439|Bone Graft|bone graft
5679346|NCT00582426|Colorectal cancer|colorectal cancer
5902440|NCT01057277|Head and Neck Cancer|head and neck cancer
5902441|NCT01057277|Advanced Inoperable Head & Neck Cancer|advanced inoperable head & neck cancer
5902442|NCT01057017|colorectal cancer|colorectal cancer
5902499|NCT00996528|fetal alcohol syndrome|fetal alcohol syndrome
5902500|NCT00996528|alcohol abuse|alcohol abuse
5902501|NCT00996528|HIV|hiv
5902502|NCT00996528|malnutrition|malnutrition
5902503|NCT00996528|children|children
5902504|NCT00996528|mentor mother|mentor mother
5902505|NCT00996528|behavioral intervention|behavioral intervention
5902506|NCT00996528|South Africa|south africa
5902507|NCT00996528|Maternal alcohol use|maternal alcohol use
5902508|NCT00996528|HIV-related transmission behaviors|hiv-related transmission behaviors
5902509|NCT00996528|low birth weight babies and low-weight children|low birth weight babies and low-weight children
5902510|NCT00996528|HIV Seronegativity|hiv seronegativity
4972849|NCT04161625|Smartphone|smartphone
5679347|NCT00582426|diarrhea|diarrhea
5679348|NCT00582426|drug therapy|drug therapy
5679349|NCT00582426|octreotide|octreotide
5679350|NCT00582426|fluorouracil|fluorouracil
5679351|NCT00582426|irinotecan|irinotecan
5679352|NCT00582426|capecitabine|capecitabine
5679353|NCT00582426|prevention|prevention
5679354|NCT00582413|Head and Neck Cancer|head and neck cancer
5679355|NCT00582400|livers, hepatocellular carcinoma (HCC)|livers, hepatocellular carcinoma (hcc)
5679356|NCT00582374|Periodontal Disease|periodontal disease
5679357|NCT00582374|Preterm Birth|preterm birth
5679358|NCT00582374|Low Birth Weight|low birth weight
5679359|NCT00582374|Pregnancy|pregnancy
5679360|NCT00582361|Open Fractures|open fractures
5679361|NCT00582361|Vacuum Assisted Closure (VAC) device|vacuum assisted closure (vac) device
5679362|NCT00582361|Irrigation and Debridement|irrigation and debridement
5679363|NCT00582348|Lung Cancer|lung cancer
5679364|NCT00582348|Survivor|survivor
5679366|NCT00582335|Colorectal cancer|colorectal cancer
5679367|NCT00582335|Genetic testing|genetic testing
5679368|NCT00582335|Genetic mutations|genetic mutations
5679369|NCT00582322|Breast Cancer|breast cancer
5679370|NCT00582322|Ovarian Cancer|ovarian cancer
5679371|NCT00582322|Family History|family history
5679372|NCT00582322|Genetic Studies|genetic studies
5679373|NCT00582309|Glycemic Control|glycemic control
5679374|NCT00582309|Intravenous Infusion|intravenous infusion
5679375|NCT00582309|Standard Insulin infusion algorithm|standard insulin infusion algorithm
5679376|NCT00582309|Infusion|infusion
5679377|NCT00582309|Critically Ill|critically ill
5679378|NCT00582296|Lynch syndrome|lynch syndrome
5679379|NCT00582296|04-144|04-144
5679380|NCT00582270|non-hodkin's lymphoma|non-hodkin's lymphoma
5679381|NCT00582270|follicular|follicular
5679382|NCT00582270|non-follicular|non-follicular
5679383|NCT00582270|infectious disease|infectious disease
5679384|NCT00582257|Gastric Cancer|gastric cancer
5679385|NCT00582257|Stomach Cancer|stomach cancer
5679386|NCT00582257|05-118|05-118
5679387|NCT00582244|Menopausal symptoms|menopausal symptoms
5679388|NCT00582244|Quality of Life|quality of life
5679389|NCT00582244|Breast cancer|breast cancer
5679390|NCT00582244|Multicenter trial|multicenter trial
5679391|NCT00582231|Penile injection therapy|penile injection therapy
5679392|NCT00582231|Erectile dysfunction|erectile dysfunction
5679393|NCT00582231|Radical pelvic surgery|radical pelvic surgery
5679394|NCT00582231|Penile Injection Anxiety|penile injection anxiety
5679395|NCT00582218|HIV/AIDS|hiv/aids
5679396|NCT00582218|Access to care|access to care
5679397|NCT00582205|Ovarian Cancer|ovarian cancer
5679398|NCT00582205|Fallopian Tube Cancer|fallopian tube cancer
5679399|NCT00582205|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5679400|NCT00582205|Uterine Cancer|uterine cancer
5679401|NCT00582205|Intraperitoneal Chemotherapy|intraperitoneal chemotherapy
5679402|NCT00582205|IP Chemotherapy|ip chemotherapy
5679403|NCT00582205|Gynecologic Cancer|gynecologic cancer
5902587|NCT00923065|Cancer|cancer
5902588|NCT00923065|Oncology|oncology
5902589|NCT00923065|Standard Care|standard care
5902603|NCT00913757|Hepatocellular Carcinoma|hepatocellular carcinoma
5902604|NCT00913757|Liver Cancer|liver cancer
5902605|NCT00913757|Chronic Liver Disease|chronic liver disease
5902606|NCT00913757|Genome Wide Association Study|genome wide association study
5902607|NCT00913757|Gene Expression Profiling|gene expression profiling
5679404|NCT00582205|Women's Cancer|women's cancer
5679405|NCT00582205|Cisplatin|cisplatin
5679406|NCT00582205|Paclitaxel|paclitaxel
5679407|NCT00582205|Recurrent Platinum Sensitive Ovarian Cancer|recurrent platinum sensitive ovarian cancer
5679408|NCT00582192|Phase I trial|phase i trial
5679409|NCT00582192|Oncologists' Communication Styles|oncologists' communication styles
5679410|NCT00582179|Draining Hematoma|draining hematoma
5679411|NCT00582179|Vacuum Assisted Closure (VAC)|vacuum assisted closure (vac)
5674789|NCT00601978|ERP|erp
5679413|NCT00582179|Draining Hematoma following orthopaedic surgery|draining hematoma following orthopaedic surgery
5798797|NCT00110981|plaque psoriasis|plaque psoriasis
5679414|NCT00582166|Zevalin, High Tumor Burden Indolent Non-Hodgkin's Lymphoma, Ibritumomab Tiuxetan|zevalin, high tumor burden indolent non-hodgkin's lymphoma, ibritumomab tiuxetan
5679415|NCT00582140|Prostate|prostate
5679416|NCT00582140|Cancer|cancer
5679417|NCT00582140|Stage D0|stage d0
5679418|NCT00582140|Non-Metastatic|non-metastatic
5679419|NCT00582140|Rising PSA|rising psa
5679420|NCT00582127|senile|senile
5679421|NCT00582127|dementia|dementia
5679422|NCT00582114|Hemodialysis|hemodialysis
5679423|NCT00582114|Hypertension|hypertension
5679424|NCT00582114|Left ventricular hypertrophy|left ventricular hypertrophy
5679426|NCT00582101|prevention|prevention
5679427|NCT00582101|families|families
5679428|NCT00582101|Latinos|latinos
5679429|NCT00582101|communication|communication
5679430|NCT00582101|sexuality|sexuality
5679431|NCT00582101|monitoring|monitoring
5679432|NCT00582101|health promotion|health promotion
5679433|NCT00582101|HIV Prevention|hiv prevention
5679434|NCT00582101|HIV Seronegativity|hiv seronegativity
5679728|NCT00580723|erythema|erythema
5679435|NCT00582088|Encephalitis, Viral Infections, Neurologic diseases, Alphavirus Infections, VEE|encephalitis, viral infections, neurologic diseases, alphavirus infections, vee
5679436|NCT00582075|Cancer|cancer
5679437|NCT00582075|Brain metastases|brain metastases
5679438|NCT00582075|Gamma Knife Radiosurgery|gamma knife radiosurgery
5679439|NCT00582075|Temodar|temodar
5679441|NCT00582062|Gastric Cancer|gastric cancer
5679442|NCT00582062|Pancreatic cancer|pancreatic cancer
5679443|NCT00582049|Retinoblastoma|retinoblastoma
5679444|NCT00582049|Sporadic heritable retinoblastoma|sporadic heritable retinoblastoma
5679445|NCT00582049|Paternal exposures|paternal exposures
5679446|NCT00582036|Hyperglycemia|hyperglycemia
5679447|NCT00582036|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5679448|NCT00582036|Bone marrow transplant|bone marrow transplant
5679449|NCT00582036|High blood sugar|high blood sugar
5679450|NCT00582023|HIV|hiv
5679451|NCT00582023|coping|coping
5679452|NCT00582023|emotion|emotion
5679453|NCT00582023|affect|affect
5679454|NCT00582023|HIV infection|hiv infection
5679455|NCT00582023|Complimentary therapies|complimentary therapies
5679456|NCT00582010|ischemia-reperfusion|ischemia-reperfusion
5679457|NCT00582010|nitric oxide|nitric oxide
5679458|NCT00582010|inflammation|inflammation
5679459|NCT00582010|cell-death|cell-death
5679460|NCT00582010|Liver-function post transplantation|liver-function post transplantation
5679461|NCT00581997|Pulmonary fibrosis, systemic sclerosis|pulmonary fibrosis, systemic sclerosis
5679462|NCT00581984|breast cancer|breast cancer
5679463|NCT00581984|breast reconstruction|breast reconstruction
5679464|NCT00581984|silicone implants|silicone implants
5679465|NCT00581971|Radiosensitization|radiosensitization
5679466|NCT00581971|COX-2 inhibitor|cox-2 inhibitor
5679467|NCT00581971|Celecoxib|celecoxib
5679468|NCT00581971|Head and Neck Cancer|head and neck cancer
5679469|NCT00581971|Chemoradiation|chemoradiation
5679470|NCT00581958|total body irradiation|total body irradiation
5679471|NCT00581958|Cancer|cancer
5679472|NCT00581958|Hematopoietic System|hematopoietic system
5679473|NCT00581932|clozapine, schizophrenia|clozapine, schizophrenia
5679474|NCT00581919|previously treated multiple myeloma|previously treated multiple myeloma
5679475|NCT00581906|Head and Neck Cancer|head and neck cancer
5679476|NCT00581906|Head Cancer|head cancer
5679477|NCT00581906|Neck Cancer|neck cancer
4973066|NCT04160455|HIV|hiv
5679478|NCT00581906|Dynamic Contrast Enhanced MRI|dynamic contrast enhanced mri
5679479|NCT00581906|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5679480|NCT00581906|Diffusion Weighted MRI (DW-MRI)|diffusion weighted mri (dw-mri)
5679481|NCT00581906|06-007|06-007
5679482|NCT00581893|epilepsy|epilepsy
5679483|NCT00581893|cognitive impairment|cognitive impairment
5679484|NCT00581893|driving simulation|driving simulation
5679485|NCT00581893|cross-over study|cross-over study
5679486|NCT00581880|end stage|end stage
5679487|NCT00581880|Terminally Ill|terminally ill
5679488|NCT00581854|untreated mantle cell lymphoma|untreated mantle cell lymphoma
5679489|NCT00581841|Healthy adult normals|healthy adult normals
5679490|NCT00581828|Calcium Absorption|calcium absorption
5679491|NCT00581828|Intestinal Absorption of Calcium|intestinal absorption of calcium
5679492|NCT00581828|Fractional Calcium Absorption|fractional calcium absorption
5679493|NCT00581828|Stable Calcium Isotopes|stable calcium isotopes
5679494|NCT00581828|Hypovitaminosis D|hypovitaminosis d
5679495|NCT00581828|Vitamin D|vitamin d
5679496|NCT00581828|Bone Mineral Density|bone mineral density
5679497|NCT00581828|Physical Function|physical function
5679498|NCT00581802|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5679499|NCT00581802|Treatment Naive|treatment naive
5679500|NCT00581802|Latent HIV Infections|latent hiv infections
5679501|NCT00581789|non small cell lung cancer|non small cell lung cancer
5679502|NCT00581789|sunitinib|sunitinib
5679508|NCT00581750|01-135|01-135
5679509|NCT00581724|breast cancer|breast cancer
5679510|NCT00581724|Colorectal cancer|colorectal cancer
5798799|NCT00110981|etanercept|etanercept
5679511|NCT00581724|Prostate cancer|prostate cancer
5679512|NCT00581724|Head and Neck cancer|head and neck cancer
5679513|NCT00581724|Lung cancer|lung cancer
5679514|NCT00581724|cancer survivors|cancer survivors
5679516|NCT00581724|quality of life|quality of life
5679517|NCT00581724|Pain in cancer survivors|pain in cancer survivors
5679518|NCT00581711|Electronic Health Record|electronic health record
5679519|NCT00581711|Clinical Decision Support|clinical decision support
5679520|NCT00581711|Otitis Media|otitis media
5679521|NCT00581698|Melanoma|melanoma
5679522|NCT00581698|Negative regional lymph nodes|negative regional lymph nodes
5679523|NCT00581698|Primary melanomas Clark III and Breslow thickness > 1 mm, or Clark|primary melanomas clark iii and breslow thickness > 1 mm, or clark
5679524|NCT00581698|IV-V and any Breslow thickness, and clinically negative regional nodes|iv-v and any breslow thickness, and clinically negative regional nodes
5679525|NCT00581685|Chronic pain|chronic pain
5679526|NCT00581685|Preemptive analgesia|preemptive analgesia
5679527|NCT00581685|Pregabalin|pregabalin
5679528|NCT00581685|Celecoxib|celecoxib
5679831|NCT00580294|Migraine|migraine
5679529|NCT00581685|Hip Arthroplasty|hip arthroplasty
5679530|NCT00581685|Osteoarthritis|osteoarthritis
5679531|NCT00581672|Anxiety|anxiety
5679532|NCT00581672|Black men|black men
5679533|NCT00581672|Prostate Cancer|prostate cancer
5679534|NCT00581672|07-125|07-125
5679535|NCT00581633|saline|saline
5679536|NCT00581633|sodium|sodium
5679537|NCT00581633|kidney|kidney
5679538|NCT00581633|tachycardia|tachycardia
5679539|NCT00581620|pneumococcus conjugated vaccine|pneumococcus conjugated vaccine
5679540|NCT00581607|Sarcoidosis|sarcoidosis
5679541|NCT00581594|Pelvic organ prolapse|pelvic organ prolapse
5679542|NCT00581594|Posterior wall defects|posterior wall defects
5679543|NCT00581594|Graft-augmented repair|graft-augmented repair
5679544|NCT00581594|Posterior colporrhaphy|posterior colporrhaphy
5679545|NCT00581581|neonatal encephalopathy|neonatal encephalopathy
5679546|NCT00581581|therapeutic hypothermia|therapeutic hypothermia
5679547|NCT00581581|head cooling|head cooling
5679548|NCT00581581|neonatal asphyxia|neonatal asphyxia
5679549|NCT00581568|Skin cooling during laser treatment|skin cooling during laser treatment
5679550|NCT00581555|Psoriasis|psoriasis
5679551|NCT00581529|breast|breast
5679552|NCT00581516|Prostate Cancer|prostate cancer
5679553|NCT00581516|PCA3|pca3
5679554|NCT00581503|early detection of lung and pleural cancer|early detection of lung and pleural cancer
5679555|NCT00581503|early detection of prostate cancer|early detection of prostate cancer
5679556|NCT00581490|Premature pubarche|premature pubarche
5679557|NCT00581490|Adrenal hyperandrogenism|adrenal hyperandrogenism
5679558|NCT00581490|Metabolic syndrome|metabolic syndrome
5679559|NCT00581477|autonomic nervous system diseases|autonomic nervous system diseases
5679560|NCT00581477|blood pressure|blood pressure
5679561|NCT00581477|congenital|congenital
5679562|NCT00581477|orthostasis|orthostasis
5679563|NCT00581477|catecholamines|catecholamines
5679564|NCT00581464|Smoking cessation|smoking cessation
5679565|NCT00581464|Tobacco dependence|tobacco dependence
5679566|NCT00581464|Mindfulness|mindfulness
5679567|NCT00581464|fMRI|fmri
5679568|NCT00581464|Craving|craving
5679569|NCT00581438|Approach Haemophilia A and B|approach haemophilia a and b
5679570|NCT00581425|BCC|bcc
5679571|NCT00581425|Basal Cell Carcinoma|basal cell carcinoma
5679572|NCT00581425|Intron-A|intron-a
5679573|NCT00581425|Aldara|aldara
5679574|NCT00581425|Basal Cell Carcinoma excluding scalp and face|basal cell carcinoma excluding scalp and face
5679575|NCT00581412|Pelvic organ prolapse|pelvic organ prolapse
5679576|NCT00581412|Composite biologic/synthetic graft|composite biologic/synthetic graft
5679577|NCT00581412|Abdominal sacrocolpopexy|abdominal sacrocolpopexy
5679578|NCT00581399|Open heart surgery|open heart surgery
5679579|NCT00581399|Cardiopulmonary Bypass|cardiopulmonary bypass
5679580|NCT00581399|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5679581|NCT00581399|Chest Tube|chest tube
5679582|NCT00581399|Valve Replacement|valve replacement
5679583|NCT00581399|Valve Repair|valve repair
5679584|NCT00581386|Endotracheal Intubation|endotracheal intubation
5679585|NCT00581386|Supraglottic Airway|supraglottic airway
5679586|NCT00581373|water|water
5679587|NCT00581373|orthostatic hypotension|orthostatic hypotension
5679588|NCT00581373|blood pressure|blood pressure
5679589|NCT00581360|Adenoid cystic carcinoma|adenoid cystic carcinoma
5679590|NCT00581360|bortezomib|bortezomib
5679591|NCT00581360|doxorubicin|doxorubicin
5679592|NCT00581334|Pelvic organ prolapse|pelvic organ prolapse
5679593|NCT00581334|Robotic-assisted laparoscopic sacrocolpopexy|robotic-assisted laparoscopic sacrocolpopexy
5679601|NCT00581295|internal bleeding|internal bleeding
5679602|NCT00581295|changes in tissue perfusion|changes in tissue perfusion
5695942|NCT00514605|HIV 1|hiv 1
5679603|NCT00581282|Cocaine abstinence|cocaine abstinence
5679604|NCT00581282|PET scan|pet scan
5679605|NCT00581256|left sided|left sided
5679606|NCT00581243|Safety,Tolerability, Schizophrenia|safety,tolerability, schizophrenia
5679607|NCT00581230|Endotracheal Intubation|endotracheal intubation
5679608|NCT00581230|Rapid Airway Management Positioner|rapid airway management positioner
5679609|NCT00581217|Burn injury|burn injury
5679610|NCT00581217|Skin graft|skin graft
5679611|NCT00581217|Donor site dressing|donor site dressing
5679612|NCT00581217|Outcomes|outcomes
5679613|NCT00581217|Infection rate|infection rate
5679614|NCT00581217|Healing time|healing time
5679615|NCT00581217|Cosmetic Result|cosmetic result
5679616|NCT00581217|Pain|pain
5679617|NCT00581217|Burn injured patients requiring skin grafting|burn injured patients requiring skin grafting
5679618|NCT00581204|trauma situations|trauma situations
5679619|NCT00581204|Lower Body Negative Pressure (LBNP)|lower body negative pressure (lbnp)
5679621|NCT00581191|Healthy|healthy
5679622|NCT00581178|Ureteral Stent|ureteral stent
5679623|NCT00581178|Kidney Stones|kidney stones
5679624|NCT00581152|TBX3|tbx3
5679626|NCT00581126|Hemophilia B|hemophilia b
5679627|NCT00581113|whole brain radiotherapy|whole brain radiotherapy
5679628|NCT00581113|neural stem cell|neural stem cell
5679629|NCT00581113|brain metastases|brain metastases
5679630|NCT00581113|radiosurgery|radiosurgery
5679631|NCT00581100|Nail Psoriasis|nail psoriasis
5679632|NCT00581100|Plaque Psoriasis|plaque psoriasis
5679633|NCT00581087|Hypertension, pulmonary|hypertension, pulmonary
5679634|NCT00581087|DHEA|dhea
5679635|NCT00581087|six-minute walk test|six-minute walk test
5679636|NCT00581087|pulmonary arterial pressure|pulmonary arterial pressure
5679637|NCT00581074|obesity|obesity
5679638|NCT00581074|diet|diet
5679639|NCT00581074|weight loss|weight loss
5679640|NCT00581074|metabolic syndrome|metabolic syndrome
5679641|NCT00581061|Incontinence|incontinence
5679642|NCT00581061|Robotic Prostatectomy|robotic prostatectomy
5679643|NCT00581048|Asthma|asthma
5679644|NCT00581048|Allergy|allergy
5679645|NCT00581048|Atopy|atopy
5679646|NCT00581048|Vitamin E|vitamin e
5679647|NCT00581048|GSTP1|gstp1
5679648|NCT00581048|Oxidative stress|oxidative stress
5679649|NCT00581035|Meningococcal disease|meningococcal disease
5679650|NCT00581035|pneumococcal disease|pneumococcal disease
5679651|NCT00581035|meningitis|meningitis
5679652|NCT00581022|postural tachycardia syndrome|postural tachycardia syndrome
5679653|NCT00581022|sleep|sleep
5679654|NCT00581022|insomnia|insomnia
5679655|NCT00581009|Sleep deprivation|sleep deprivation
5679656|NCT00581009|antidepressant|antidepressant
5679657|NCT00581009|depression|depression
5679658|NCT00581009|chronobiological|chronobiological
5679659|NCT00580996|water|water
5679660|NCT00580996|orthostatic hypotension|orthostatic hypotension
5679661|NCT00580996|blood pressure|blood pressure
5679662|NCT00580983|Head and Neck cancer|head and neck cancer
5679663|NCT00580970|prostate cancer|prostate cancer
5679664|NCT00580970|radiation therapy|radiation therapy
5679665|NCT00580970|lovastatin|lovastatin
5679666|NCT00580970|rectal injury|rectal injury
5679667|NCT00580957|Obesity|obesity
5679668|NCT00580957|Hypertension|hypertension
5679669|NCT00580957|Autonomic Nervous System|autonomic nervous system
5679670|NCT00580944|Port wine stain|port wine stain
5679671|NCT00580944|progressive malformation of human skin|progressive malformation of human skin
5679672|NCT00580931|nutraceutical, dementia, cognition, HDAC inhibitor|nutraceutical, dementia, cognition, hdac inhibitor
5679673|NCT00580918|Mild Traumatic Brain Injury|mild traumatic brain injury
5679674|NCT00580918|fMRI|fmri
5679675|NCT00580905|Adenosine|adenosine
5679676|NCT00580905|Cytokines|cytokines
5679677|NCT00580905|Inflammation|inflammation
5679678|NCT00580905|VEGF|vegf
5679679|NCT00580879|Anorectal sphincter laceration|anorectal sphincter laceration
5679680|NCT00580879|Pelvic floor dysfunction|pelvic floor dysfunction
5679681|NCT00580879|Sphincter tear|sphincter tear
5679682|NCT00580866|Elbow|elbow
5679683|NCT00580866|Upper Extremity Fractures|upper extremity fractures
5679684|NCT00580866|Distal Humerus|distal humerus
5679685|NCT00580866|Elbow Injuries|elbow injuries
5679686|NCT00580866|Dislocations|dislocations
5679687|NCT00580866|Peri-articular Elbow Injuries|peri-articular elbow injuries
5902807|NCT00851812|Exercise|exercise
5902808|NCT00851812|Breast cancer|breast cancer
5902809|NCT00851812|fatigue|fatigue
5902814|NCT00843921|Hyperammonemia|hyperammonemia
5902831|NCT00832156|Burns|burns
5902832|NCT00832156|Cultured autologous keratinocytes|cultured autologous keratinocytes
5902833|NCT00832156|Wound healing|wound healing
5902834|NCT00832156|Wound closure|wound closure
5902835|NCT00832156|Scar quality|scar quality
5902836|NCT00831766|Hematopoietic|hematopoietic
5902837|NCT00831766|Myeloid and Monocytic Leukemia|myeloid and monocytic leukemia
5679688|NCT00580853|smoking lapse behavior|smoking lapse behavior
5679689|NCT00580853|smoking cessation|smoking cessation
5679690|NCT00580853|varenicline|varenicline
5679691|NCT00580853|bupropion|bupropion
5679692|NCT00580853|medication effect on smoking lapse behavior|medication effect on smoking lapse behavior
5679693|NCT00580840|Rheumatoid Arthritis|rheumatoid arthritis
5679694|NCT00580840|Joint Disease|joint disease
5679695|NCT00580840|Arthritis|arthritis
5679696|NCT00580840|Certolizumab pegol|certolizumab pegol
5679697|NCT00580840|Cimzia|cimzia
5679698|NCT00580814|Brookhaven|brookhaven
5679699|NCT00580814|ADHD|adhd
5679700|NCT00580814|Dopamine|dopamine
5679701|NCT00580814|methylphenidate|methylphenidate
5679702|NCT00580814|PET|pet
5679703|NCT00580801|Hepatitis C|hepatitis c
5679704|NCT00580801|Telaprevir|telaprevir
5679705|NCT00580801|Pegylated-interferon-alfa-2a|pegylated-interferon-alfa-2a
5679706|NCT00580801|Pegasys|pegasys
5679707|NCT00580801|Ribavirin|ribavirin
5679708|NCT00580801|Copegus|copegus
5679709|NCT00580788|Endocrine System Diseases|endocrine system diseases
5679710|NCT00580788|MusculoSkeletal System Diseases|musculoskeletal system diseases
5679711|NCT00580788|Hormones|hormones
5679712|NCT00580788|Malignancy|malignancy
5679713|NCT00580788|Postmenopausal Women|postmenopausal women
5679714|NCT00580788|Bone metabolism|bone metabolism
5679715|NCT00580775|Menopause|menopause
5679716|NCT00580775|Hormone Replacement Therapy|hormone replacement therapy
5679717|NCT00580775|Sudden Cardiac Death|sudden cardiac death
5679718|NCT00580749|Pancreatitis|pancreatitis
5679719|NCT00580749|enteral feeding|enteral feeding
5679720|NCT00580749|distal jejunal feeding|distal jejunal feeding
5679721|NCT00580749|naso gastric feeding|naso gastric feeding
5679722|NCT00580749|pancreatic rest|pancreatic rest
5679723|NCT00580736|sebaceous hyperplasia|sebaceous hyperplasia
5679724|NCT00580723|acne|acne
5679725|NCT00580723|rosacea|rosacea
5679726|NCT00580723|acne rosacea|acne rosacea
5679727|NCT00580723|papulopustular rosacea|papulopustular rosacea
5679729|NCT00580723|telangiectasia|telangiectasia
5679730|NCT00580723|flushing|flushing
5679731|NCT00580710|type 1 diabetes|type 1 diabetes
5679732|NCT00580710|hypoglycemia|hypoglycemia
5679733|NCT00580710|magnetic resonance imaging|magnetic resonance imaging
5679836|NCT00580294|Scoliosis|scoliosis
5679734|NCT00580697|Lower urinary tract symptoms|lower urinary tract symptoms
5679735|NCT00580697|Gynecologic malignancy|gynecologic malignancy
5679736|NCT00580697|Urinary incontinence|urinary incontinence
5679737|NCT00580697|Fecal incontinence|fecal incontinence
5679738|NCT00580697|Frequency|frequency
5679739|NCT00580697|Voiding dysfunction|voiding dysfunction
5679740|NCT00580697|Sexual dysfunction|sexual dysfunction
5679741|NCT00580684|pneumococcus conjugated vaccine 7 valent|pneumococcus conjugated vaccine 7 valent
5679742|NCT00580671|Adolescent Marijuana Abuse|adolescent marijuana abuse
5679743|NCT00580658|Dystonia|dystonia
5679745|NCT00580645|alcohol|alcohol
5679746|NCT00580645|smoking cessation|smoking cessation
5679747|NCT00580645|varenicline|varenicline
5679748|NCT00580645|bupropion|bupropion
5679749|NCT00580645|smoking cessation medications|smoking cessation medications
5679750|NCT00580619|Chronic fatigue syndrome|chronic fatigue syndrome
5679751|NCT00580619|Postural tachycardia syndrome|postural tachycardia syndrome
5679752|NCT00580619|Autonomic nervous system|autonomic nervous system
5679753|NCT00580606|Food Allergy|food allergy
5679754|NCT00580606|Peanut Allergy|peanut allergy
5679755|NCT00580606|Sublingual Immunotherapy|sublingual immunotherapy
5679756|NCT00580593|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5679757|NCT00580593|ALS|als
5034044|NCT03786302|TAMP BG|tamp bg
5679758|NCT00580593|nocturnal noninvasive positive pressure ventilation|nocturnal noninvasive positive pressure ventilation
5679759|NCT00580593|NIPPV|nippv
5679760|NCT00580593|forced vital capacity|forced vital capacity
5902909|NCT00763750|glioblastoma multiforme or anaplastic glioma|glioblastoma multiforme or anaplastic glioma
5902934|NCT00727038|glaucoma|glaucoma
5902935|NCT00727038|neovascular glaucoma|neovascular glaucoma
5902936|NCT00727038|new onset glaucoma|new onset glaucoma
5902937|NCT00727038|retinal ischemia|retinal ischemia
5902938|NCT00727038|central retinal vein occlusion|central retinal vein occlusion
5902939|NCT00727038|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5902940|NCT00727038|ocular ischemic syndrome|ocular ischemic syndrome
5902941|NCT00727038|carotid stenosis|carotid stenosis
5902942|NCT00727038|vascular endothelial growth factor|vascular endothelial growth factor
5902947|NCT00720941|Locally advanced and/or metastatic renal cell carcinoma|locally advanced and/or metastatic renal cell carcinoma
5902976|NCT00698997|autism spectrum disorder|autism spectrum disorder
5902977|NCT00698997|intensive intervention for toddlers with autism|intensive intervention for toddlers with autism
5902978|NCT00698997|PDD NOS|pdd nos
5902979|NCT00698997|early steps study|early steps study
5902980|NCT00698997|early start denver model|early start denver model
5902981|NCT00698997|early intervention for infants and toddlers with autism|early intervention for infants and toddlers with autism
5902982|NCT00698997|toddler treatment|toddler treatment
5902983|NCT00698997|Sally Rogers|sally rogers
5902984|NCT00698997|University of California, Davis|university of california, davis
5902985|NCT00698997|University of Michigan|university of michigan
5902986|NCT00698997|MIND Institute|mind institute
5903039|NCT00687882|Venous Thromboembolism|venous thromboembolism
5903040|NCT00687882|Postthrombotic Syndrome|postthrombotic syndrome
5903041|NCT00687882|Antithrombotic Therapy|antithrombotic therapy
5903042|NCT00687882|Duration of Therapy|duration of therapy
5903043|NCT00687882|Children|children
5679761|NCT00580593|FVC|fvc
5679762|NCT00580567|Impulsivity|impulsivity
5679763|NCT00580567|Gambling|gambling
5679764|NCT00580567|Pathological Gamblers|pathological gamblers
5679765|NCT00580567|Problem Gamblers|problem gamblers
5679766|NCT00580567|Non-Pathological Gamblers|non-pathological gamblers
5679767|NCT00580567|Risk-taking|risk-taking
5679768|NCT00580567|Inhibition|inhibition
5679769|NCT00580567|Gambling Severity|gambling severity
5679770|NCT00580515|Cancer|cancer
5679771|NCT00580515|Randomized Controlled Trial|randomized controlled trial
5679772|NCT00580515|Family Therapy intervention|family therapy intervention
5679773|NCT00580502|Obesity, 50 lbs overweight|obesity, 50 lbs overweight
5679774|NCT00580489|helicopter|helicopter
5679775|NCT00580489|aeromedical|aeromedical
5679776|NCT00580489|pain relief|pain relief
5679777|NCT00580489|analgesia|analgesia
5679778|NCT00580489|fentanyl|fentanyl
5679779|NCT00580489|morphine|morphine
5679780|NCT00580489|adverse events|adverse events
5679781|NCT00580476|Breast Cancer|breast cancer
5679782|NCT00580476|Prostate Cancer|prostate cancer
5679783|NCT00580463|central nervous system (CNS) tumor|central nervous system (cns) tumor
5679784|NCT00580463|tissue collection|tissue collection
5679785|NCT00580385|BONE|bone
5679786|NCT00580359|Stomach Neoplasms|stomach neoplasms
5679787|NCT00580359|Secondary|secondary
5679788|NCT00580359|Combination chemotherapy|combination chemotherapy
5679789|NCT00580359|S-1|s-1
5679790|NCT00580359|Capecitabine|capecitabine
5679791|NCT00580346|Aspiration pneumonia|aspiration pneumonia
5679792|NCT00580346|Implanted laryngeal stimulator|implanted laryngeal stimulator
5679793|NCT00580346|Vocal cord closure|vocal cord closure
5679794|NCT00580346|Modified barium swallow|modified barium swallow
5679795|NCT00580333|ER negative|er negative
5679796|NCT00580333|PR negative|pr negative
5679797|NCT00580333|HER2 negative|her2 negative
5679798|NCT00580320|melanoma|melanoma
5679799|NCT00580320|soft tissue sarcoma|soft tissue sarcoma
5679800|NCT00580320|APUD tumor|apud tumor
5679801|NCT00580320|dacarbazine|dacarbazine
5679802|NCT00580320|bortezomib|bortezomib
5679803|NCT00580320|velcade|velcade
5679804|NCT00580307|Headache|headache
5679805|NCT00580307|Rhinogenic|rhinogenic
5679806|NCT00580307|Nose|nose
5679807|NCT00580307|Nasal septum|nasal septum
5679808|NCT00580307|Deviated septum|deviated septum
5679809|NCT00580307|Surgery|surgery
5679810|NCT00580307|Septoplasty|septoplasty
5679811|NCT00580307|Turbinoplasty|turbinoplasty
5679812|NCT00580307|Contact point|contact point
5679813|NCT00580307|HIT-6|hit-6
5679814|NCT00580294|Sciatica|sciatica
5679815|NCT00580294|Diabetic Neuropathies|diabetic neuropathies
5679816|NCT00580294|Complex Regional Pain Syndromes|complex regional pain syndromes
5679817|NCT00580294|Low Back Pain|low back pain
5679818|NCT00580294|Neck Pain|neck pain
5679819|NCT00580294|Headache|headache
5679820|NCT00580294|Back Pain|back pain
5679821|NCT00580294|Arthritis|arthritis
5679822|NCT00580294|Brachial Plexus Injury (stinger/burner)|brachial plexus injury (stinger/burner)
5903115|NCT00655096|Eye|eye
5903116|NCT00655096|Photograph|photograph
5903117|NCT00655096|Retina|retina
5903133|NCT00605878|Atopic Dermatitis (Eczema)|atopic dermatitis (eczema)
5903134|NCT00605878|Bacteria|bacteria
5903135|NCT00605878|Filaggrin|filaggrin
5903136|NCT00605878|Skin|skin
5903137|NCT00605878|Microbiome|microbiome
5903138|NCT00605878|Atopic Dermatitis|atopic dermatitis
5903139|NCT00605878|Eczema|eczema
5903140|NCT00605878|Health Volunteer|health volunteer
5903141|NCT00605878|HG|hg
5679823|NCT00580294|Chronic Pain|chronic pain
5679824|NCT00580294|Contractures|contractures
5679825|NCT00580294|Diabetes|diabetes
5679826|NCT00580294|Fibromyalgia|fibromyalgia
5679827|NCT00580294|Foot Pain|foot pain
5679828|NCT00580294|Fracture|fracture
5679829|NCT00580294|Hip|hip
5679830|NCT00580294|Herpes Zoster (shingles)|herpes zoster (shingles)
5679832|NCT00580294|Neuropathic Pain|neuropathic pain
5679833|NCT00580294|Osteoarthritis|osteoarthritis
5679834|NCT00580294|Osteoporosis|osteoporosis
5679835|NCT00580294|Rheumatoid Arthritis|rheumatoid arthritis
5679837|NCT00580294|Nerve pain|nerve pain
5679839|NCT00580294|Opioid|opioid
5679840|NCT00580294|Opioid Rotation|opioid rotation
5679841|NCT00580294|Oxymorphone|oxymorphone
5679842|NCT00580294|Morphine|morphine
5679843|NCT00580294|neuropathic|neuropathic
5679844|NCT00580294|oxycodone|oxycodone
5679845|NCT00580281|Gastric cancer|gastric cancer
5679846|NCT00580281|Leukemia|leukemia
5679847|NCT00580281|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5679848|NCT00580281|Imatinib|imatinib
5679849|NCT00580281|Gleevec|gleevec
5679851|NCT00580255|CRT|crt
5679852|NCT00580255|Atrial Arrhythmias|atrial arrhythmias
5679853|NCT00580255|Ventricular Arrhythmias|ventricular arrhythmias
5679854|NCT00580255|BioZ|bioz
5679855|NCT00580255|Optivol|optivol
5679856|NCT00580242|Myelodysplasia|myelodysplasia
5679857|NCT00580229|Rituxan|rituxan
5679858|NCT00580229|Rituximab|rituximab
5679859|NCT00580216|stroke|stroke
5679860|NCT00580216|systemic thromboembolic events|systemic thromboembolic events
5679861|NCT00580203|HEENT cancers|heent cancers
5679862|NCT00580203|larynx|larynx
5679863|NCT00580203|thyroid|thyroid
5679864|NCT00580203|sarcoma|sarcoma
5679865|NCT00580203|specimen analysis|specimen analysis
5679866|NCT00580177|Inguinal hernia|inguinal hernia
5679867|NCT00580177|Randomized controlled trial|randomized controlled trial
5679868|NCT00580177|Surgery|surgery
5679869|NCT00580177|Complications|complications
5679870|NCT00580177|Surgical mesh|surgical mesh
5679871|NCT00580151|Pain not controled by morphine|pain not controled by morphine
5679872|NCT00580151|Anxiety not controled by lorazepam|anxiety not controled by lorazepam
5679873|NCT00580138|Deglutition Disorders|deglutition disorders
5679874|NCT00580138|Evaluation|evaluation
5679875|NCT00580138|Real-time internet|real-time internet
5679876|NCT00580112|Breast Neoplasms|breast neoplasms
5679877|NCT00580112|Trabectedin|trabectedin
5679878|NCT00580112|Yondelis|yondelis
5679879|NCT00580099|premature infant, body composition, total energy expenditure|premature infant, body composition, total energy expenditure
5679880|NCT00580099|inflammatory growth mediators|inflammatory growth mediators
5679881|NCT00580086|Breast cancer|breast cancer
5679882|NCT00580086|MR spectroscopy|mr spectroscopy
5679883|NCT00580086|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5679884|NCT00580060|AJCC|ajcc
5679885|NCT00580060|stage|stage
5679886|NCT00580060|IIB|iib
5679887|NCT00580060|IIC|iic
5679888|NCT00580060|III|iii
5679889|NCT00580060|IV|iv
5679890|NCT00580060|Melanoma|melanoma
5679891|NCT00580060|HLA-A2+|hla-a2+
5679892|NCT00580060|Vaccine|vaccine
5679893|NCT00580047|bone density|bone density
5679894|NCT00580047|osteopenia|osteopenia
5679895|NCT00580047|transplant|transplant
5679896|NCT00580047|zoledronic acid|zoledronic acid
5679897|NCT00580047|alendronate|alendronate
5679898|NCT00580034|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
5679899|NCT00580021|Ashkenazi ancestry|ashkenazi ancestry
5679900|NCT00580021|mutations in BRCA1 or BRCA2|mutations in brca1 or brca2
5679901|NCT00580021|Breast Cancer|breast cancer
5679902|NCT00580021|Pancreatic Cancer|pancreatic cancer
5679903|NCT00580008|tomography|tomography
5679904|NCT00580008|coronary artery disease|coronary artery disease
5679905|NCT00580008|coronary artery bypass grafting|coronary artery bypass grafting
5903155|NCT00579527|DiGeorge Anomaly|digeorge anomaly
5903156|NCT00579527|Thymus Transplantation|thymus transplantation
5903157|NCT00579527|DiGeorge Syndrome|digeorge syndrome
5903158|NCT00579527|Athymia|athymia
5903159|NCT00579527|Parathyroid Transplantation|parathyroid transplantation
5903160|NCT00579527|Hypocalcemia|hypocalcemia
5903161|NCT00579527|Hypoparathyroidism|hypoparathyroidism
5903162|NCT00579527|Low T cell numbers|low t cell numbers
5903163|NCT00579527|Immunoreconstitution|immunoreconstitution
5903164|NCT00579527|Immunodeficiency|immunodeficiency
5903165|NCT00579527|Complete DiGeorge Anomaly|complete digeorge anomaly
5903166|NCT00579527|Complete Atypical DiGeorge Anomaly|complete atypical digeorge anomaly
5903167|NCT00579527|Complete DiGeorge Syndrome|complete digeorge syndrome
5903168|NCT00579527|Complete Atypical DiGeorge Syndrome|complete atypical digeorge syndrome
5903169|NCT00579527|Cultured Thymus Tissue Implantation (CTTI)|cultured thymus tissue implantation (ctti)
5903170|NCT00576836|Thymus Transplantation|thymus transplantation
5903171|NCT00576836|DiGeorge Syndrome|digeorge syndrome
5903172|NCT00576836|DiGeorge Anomaly|digeorge anomaly
5903173|NCT00576836|Athymia|athymia
5903174|NCT00576836|Parathyroid Transplantation|parathyroid transplantation
5903175|NCT00576836|Hypocalcemia|hypocalcemia
5903176|NCT00576836|Hypoparathyroidism|hypoparathyroidism
5903177|NCT00576836|Low T cell numbers|low t cell numbers
5903178|NCT00576836|Immunoreconstitution|immunoreconstitution
5903179|NCT00576836|Immunodeficiency|immunodeficiency
5903180|NCT00576836|Complete DiGeorge|complete digeorge
5903181|NCT00576836|Complete DiGeorge Anomaly|complete digeorge anomaly
5903182|NCT00576836|Typical DiGeorge|typical digeorge
5903183|NCT00576836|Cultured Thymus Tissue Implantation (CTTI)|cultured thymus tissue implantation (ctti)
5903184|NCT00576407|Thymus Transplantation|thymus transplantation
5903185|NCT00576407|DiGeorge Syndrome|digeorge syndrome
5903186|NCT00576407|Athymia|athymia
5903187|NCT00576407|Low T cell numbers|low t cell numbers
5903188|NCT00576407|Immunoreconstitution|immunoreconstitution
5903189|NCT00576407|Primary immunodeficiency|primary immunodeficiency
5903190|NCT00576407|DiGeorge Anomaly|digeorge anomaly
5903191|NCT00576407|Complete DiGeorge|complete digeorge
5903192|NCT00576407|Typical DiGeorge|typical digeorge
5903193|NCT00576407|Cultured Thymus Tissue Implantation (CTTI)|cultured thymus tissue implantation (ctti)
5903205|NCT00558311|Aneurysmal|aneurysmal
5903206|NCT00558311|Subarachnoid|subarachnoid
5903207|NCT00558311|Hemorrhage|hemorrhage
5903208|NCT00558311|vasospasm|vasospasm
5903209|NCT00558311|clazosentan|clazosentan
5903252|NCT00522795|Esophageal Cancer|esophageal cancer
5903276|NCT00504829|LCP-AtorFen|lcp-atorfen
5903277|NCT00504829|Non-HDL cholesterol|non-hdl cholesterol
5903278|NCT00504829|Triglycerides|triglycerides
5903279|NCT00504829|HDL cholesterol|hdl cholesterol
5903280|NCT00504829|LDL cholesterol|ldl cholesterol
5903281|NCT00504829|Atorvastatin|atorvastatin
5903282|NCT00504829|Fenofibrate|fenofibrate
5903305|NCT00494169|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5903306|NCT00494169|Kallmann Syndrome|kallmann syndrome
5903307|NCT00494169|Puberty|puberty
5903308|NCT00494169|Pituitary Abnormalities|pituitary abnormalities
5903309|NCT00494169|Hypothalamus|hypothalamus
5903310|NCT00494169|GnRH deficiency|gnrh deficiency
5903311|NCT00493961|Kallmann Syndrome|kallmann syndrome
5903312|NCT00493961|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5903313|NCT00493961|GnRH deficiency|gnrh deficiency
5679906|NCT00580008|vein graft|vein graft
5679907|NCT00579982|Mood disorder|mood disorder
5679908|NCT00579943|very low birth weight infant|very low birth weight infant
5679909|NCT00579943|cerebral autoregulation|cerebral autoregulation
5679910|NCT00579943|intraventricular hemorrhage|intraventricular hemorrhage
5679911|NCT00579943|carbon dioxide|carbon dioxide
5679912|NCT00579943|cerebral blood flow velocity|cerebral blood flow velocity
5679913|NCT00579943|ultrasonography, Doppler, transcranial|ultrasonography, doppler, transcranial
5679914|NCT00579943|cerebrovascular circulation|cerebrovascular circulation
5679915|NCT00579930|Bone|bone
5679916|NCT00579930|Soft Tissue|soft tissue
5679917|NCT00579917|Survivor|survivor
5679918|NCT00579917|Behavioral Intervention|behavioral intervention
5679919|NCT00579917|Bone Marrow|bone marrow
5679920|NCT00579917|Stem Cell Transplantation|stem cell transplantation
5679921|NCT00579904|PCOS|pcos
5679922|NCT00579904|polycystic ovary syndrome|polycystic ovary syndrome
5679923|NCT00579904|insulin resistance|insulin resistance
5679924|NCT00579904|fish oil|fish oil
5679925|NCT00579904|walnut-oil|walnut-oil
5679926|NCT00579904|walnuts|walnuts
5679927|NCT00579904|almonds|almonds
5679928|NCT00579904|monounsaturated fats|monounsaturated fats
5679929|NCT00579904|polyunsaturated fats|polyunsaturated fats
5679930|NCT00579904|MUFA|mufa
5679931|NCT00579904|PUFA|pufa
5679932|NCT00579891|colorectal cancer|colorectal cancer
5679933|NCT00579891|tissue collection|tissue collection
5679934|NCT00579865|Quality of Life|quality of life
5679935|NCT00579852|Lung|lung
5679936|NCT00579839|PreTerm Birth|preterm birth
5679937|NCT00579839|PreTerm Neonate|preterm neonate
5679938|NCT00579839|High risk pregnancy|high risk pregnancy
5679939|NCT00579839|Preterm Baby|preterm baby
5679940|NCT00579839|Premature Baby|premature baby
5679941|NCT00579839|Cord Clamping|cord clamping
5679961|NCT00579774|dietary AGEs|dietary ages
5679962|NCT00579761|Endocarditis|endocarditis
5679963|NCT00579761|neurological deficit|neurological deficit
5679964|NCT00579748|OCT imaging|oct imaging
5679965|NCT00579748|Barrett's esophagus|barrett's esophagus
5679966|NCT00579735|Breast cancer|breast cancer
5679967|NCT00579709|Thymus Transplantation|thymus transplantation
5679968|NCT00579709|DiGeorge Anomaly|digeorge anomaly
5679969|NCT00579709|DiGeorge Syndrome|digeorge syndrome
5679970|NCT00579709|Athymia|athymia
5679971|NCT00579709|Low T cell numbers|low t cell numbers
5679972|NCT00579709|Immunoreconstitution|immunoreconstitution
5679973|NCT00579709|Immunodeficiency|immunodeficiency
5679974|NCT00579709|Complete DiGeorge|complete digeorge
5679975|NCT00579709|Typical DiGeorge|typical digeorge
5679976|NCT00579709|Atypical DiGeorge|atypical digeorge
5039609|NCT03751111|placebo|placebo
5679977|NCT00579709|Complete DiGeorge Anomaly|complete digeorge anomaly
5679978|NCT00579696|Multiple Diseases|multiple diseases
5679979|NCT00579696|Queens|queens
5679980|NCT00579683|non-small cell lung cancer|non-small cell lung cancer
5679981|NCT00579683|NSCLC|nsclc
5679982|NCT00579683|metastatic disease|metastatic disease
5679983|NCT00579683|resistent disease|resistent disease
5679984|NCT00579683|RNA analysis|rna analysis
5679985|NCT00579683|04-103|04-103
5903350|NCT00455325|Insulin Resistance|insulin resistance
5903352|NCT00455325|Metabolic Syndrome|metabolic syndrome
5903381|NCT00439608|esophageal cancer|esophageal cancer
5903382|NCT00439608|gastroesophageal cancer|gastroesophageal cancer
5903383|NCT00439608|gastric cancer|gastric cancer
5903384|NCT00439179|Pancreatic Cancer|pancreatic cancer
5863990|NCT00001146|Clinical Trial|clinical trial
5342794|NCT01981967|Japanese encephalitis chimeric virus vaccine|japanese encephalitis chimeric virus vaccine
5342795|NCT01981954|Solifenacin succinate suspension|solifenacin succinate suspension
5342796|NCT01981954|Efficacy|efficacy
5342798|NCT01981941|Gabapentin|gabapentin
5342799|NCT01981941|Restless legs syndrome (RLS)|restless legs syndrome (rls)
5342800|NCT01981928|Phase 1|phase 1
5342801|NCT01981928|Healthy Subjects|healthy subjects
5342802|NCT01981928|Safety|safety
5342803|NCT01981928|Tolerability|tolerability
5342804|NCT01981928|Pharmacokinetics|pharmacokinetics
5342805|NCT01981928|Single Ascending Oral Dose|single ascending oral dose
5342806|NCT01981928|Food Effect|food effect
5342807|NCT01981915|Cough augmentation|cough augmentation
5342808|NCT01981915|Peak cough flow|peak cough flow
5342809|NCT01981915|hyperinsufflation|hyperinsufflation
5342810|NCT01981902|Dehydration|dehydration
5342811|NCT01981889|steroid, inflammatory bowel diseases|steroid, inflammatory bowel diseases
5342813|NCT01981876|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5342814|NCT01981863|cardiac surgery|cardiac surgery
5342815|NCT01981863|cardiopulmonary bypass|cardiopulmonary bypass
5342816|NCT01981863|fibrinolysis|fibrinolysis
5342817|NCT01981863|thromboelastography|thromboelastography
5342818|NCT01981863|D-Dimers|d-dimers
5679986|NCT00579670|Ziprasidone in patients with schizophrenia|ziprasidone in patients with schizophrenia
5679987|NCT00579657|parameters of metabolic syndrome|parameters of metabolic syndrome
5679988|NCT00579631|survivors|survivors
5679989|NCT00579631|adolescent|adolescent
5679990|NCT00579631|pediatric|pediatric
5679991|NCT00579618|non-cancer affected volunteers|non-cancer affected volunteers
5679992|NCT00579618|aged 60 years or older|aged 60 years or older
5679993|NCT00579605|Breastfeeding|breastfeeding
5679994|NCT00579605|Self-efficacy|self-efficacy
5679995|NCT00579605|Motivational Interviewing|motivational interviewing
5679996|NCT00579579|Bowel function|bowel function
5679997|NCT00579579|Bladder function|bladder function
5679998|NCT00579579|Sexual function|sexual function
5679999|NCT00579579|Quality of life|quality of life
5680000|NCT00579566|Biochemical Determinants|biochemical determinants
5680001|NCT00579566|Molecular Determinants|molecular determinants
5680002|NCT00579553|Pre Term|pre term
5680003|NCT00579553|Pre Term Birth|pre term birth
5680004|NCT00579553|Premature Birth|premature birth
5680005|NCT00579553|Premature baby|premature baby
5680006|NCT00579553|High risk pregnancy|high risk pregnancy
5680007|NCT00579553|Progesterone|progesterone
5680008|NCT00579553|IM Progesterone|im progesterone
5680009|NCT00579553|Vaginal Progesterone|vaginal progesterone
5680026|NCT00579501|Liposarcoma|liposarcoma
5680027|NCT00579501|Trabectedin|trabectedin
5680028|NCT00579501|Dexamethasone|dexamethasone
5680029|NCT00579475|mifepristone|mifepristone
5680031|NCT00579475|breast epithelial cell proliferation|breast epithelial cell proliferation
5680032|NCT00579462|Stage III or IV Lung Cancer|stage iii or iv lung cancer
5680033|NCT00579449|child abuse|child abuse
5680034|NCT00579449|child neglect|child neglect
5342819|NCT01981863|antifibrinolytic agents|antifibrinolytic agents
5342820|NCT01981850|fibrosis|fibrosis
5342821|NCT01981837|RNAi therapeutic|rnai therapeutic
5342822|NCT01981824|prediction IUGR FL/MTC|prediction iugr fl/mtc
5342823|NCT01981811|OPC-14597 Digital|opc-14597 digital
5342824|NCT01981811|Aripiprazole|aripiprazole
5342825|NCT01981811|Medical Information Device #1 System (MIND1)|medical information device #1 system (mind1)
5342826|NCT01981811|Treatment Adherence|treatment adherence
5342827|NCT01981811|Ingestible Event Marker|ingestible event marker
5342828|NCT01981798|outpatient intervention program|outpatient intervention program
5342829|NCT01981798|behavioral therapy approach|behavioral therapy approach
5342830|NCT01981798|unspecific back pain|unspecific back pain
5342831|NCT01981798|unspecific neck pain|unspecific neck pain
5342832|NCT01981798|chronic pain|chronic pain
5342833|NCT01981798|physiotherapy|physiotherapy
5342834|NCT01981798|occupational therapy|occupational therapy
5342835|NCT01981798|psychosocial aspects|psychosocial aspects
5342836|NCT01981798|fear avoidance beliefs|fear avoidance beliefs
5342837|NCT01981798|health-related quality of life|health-related quality of life
5342838|NCT01981785|Primary immune deficiencies|primary immune deficiencies
5342839|NCT01981785|Autoimmune diseases|autoimmune diseases
5342840|NCT01981785|Inflammatory diseases|inflammatory diseases
5872842|NCT03779308|whole body vibration therapy|whole body vibration therapy
5872844|NCT03779308|dystonia|dystonia
5872845|NCT03779308|functional abilities|functional abilities
5872846|NCT03779308|tone abnormalities|tone abnormalities
5872865|NCT03778060|Transcutaneous Nerve Stimulation|transcutaneous nerve stimulation
5872866|NCT03778060|Positron-Emission Tomography|positron-emission tomography
5683379|NCT00565045|hemiplegia|hemiplegia
4974150|NCT04153656|Physician burnout|physician burnout
5680035|NCT00579436|inflammation|inflammation
5680036|NCT00579436|obesity|obesity
5680037|NCT00579436|diabetes|diabetes
5680038|NCT00579423|prostate|prostate
5680039|NCT00579423|cancer|cancer
5680040|NCT00579423|vaccine|vaccine
5680041|NCT00579410|gastric acid|gastric acid
5680042|NCT00579410|esophageal reflux|esophageal reflux
5680043|NCT00579410|peptic ulcer|peptic ulcer
5680044|NCT00579410|heartburn|heartburn
5872930|NCT03772587|Generalized Myasthenia Gravis|generalized myasthenia gravis
5872931|NCT03772249|Chronic Hepatitis B|chronic hepatitis b
5872932|NCT03772249|DNA Virus Infections|dna virus infections
5872934|NCT03772249|HBsAg|hbsag
5872935|NCT03772249|Liver Disease|liver disease
5872936|NCT03772249|RNAi|rnai
5872945|NCT03770637|glucagon|glucagon
5872946|NCT03770637|post-bariatric hypoglycemia|post-bariatric hypoglycemia
5872962|NCT03766308|highland barley diet|highland barley diet
5872977|NCT03764566|childhood adversities|childhood adversities
5872978|NCT03764566|childhood neglect|childhood neglect
5872979|NCT03764566|childhood abuse|childhood abuse
5872980|NCT03764566|rejection sensitivity|rejection sensitivity
5872981|NCT03764566|justice sensitivity|justice sensitivity
5872982|NCT03764566|loneliness|loneliness
5680045|NCT00579397|Markers of Inflammation|markers of inflammation
5680046|NCT00579397|acute graft versus host disease|acute graft versus host disease
5680047|NCT00579397|predicting aGVHD|predicting agvhd
5680048|NCT00579384|Photosensitive epilepsy|photosensitive epilepsy
5680049|NCT00579384|Reflex epilepsy|reflex epilepsy
5680050|NCT00579384|Epilepsy|epilepsy
5680051|NCT00579384|JNJ-26489112|jnj-26489112
5680052|NCT00579371|islet transplantation|islet transplantation
5680053|NCT00579371|type 1 diabetes mellitus|type 1 diabetes mellitus
5872999|NCT03761914|immuno-oncology|immuno-oncology
5873000|NCT03761914|WT1-expressing tumors|wt1-expressing tumors
5873001|NCT03761914|galinpepimut-S|galinpepimut-s
5873002|NCT03761914|pembrolizumab|pembrolizumab
5873003|NCT03761914|PD1 inhibitor|pd1 inhibitor
5873004|NCT03761914|checkpoint inhibitor|checkpoint inhibitor
5873005|NCT03761914|combination immunotherapy|combination immunotherapy
5873006|NCT03761914|heteroclitic|heteroclitic
5873007|NCT03761914|multivalent|multivalent
5873008|NCT03761914|off-the-shelf vaccine|off-the-shelf vaccine
5873009|NCT03761914|HLA allele|hla allele
5873010|NCT03761914|WT1 vaccine|wt1 vaccine
5873011|NCT03761914|SLS-001|sls-001
5873012|NCT03761914|WT1 analog peptide vaccine|wt1 analog peptide vaccine
5683947|NCT00562601|Neutrophils|neutrophils
5873030|NCT03759041|microbiome|microbiome
5873057|NCT03755739|Solid cancers|solid cancers
5873058|NCT03755739|Check-point inhibitors|check-point inhibitors
5873059|NCT03755739|Interventional Radiology|interventional radiology
5873060|NCT03755739|Trans-artery infusion|trans-artery infusion
5873061|NCT03755739|Intra-tumor injection|intra-tumor injection
5680054|NCT00579371|steroid-free immunosuppression|steroid-free immunosuppression
5873067|NCT03755128|Hemolytic disease of the fetus and newborn (HDFN)|hemolytic disease of the fetus and newborn (hdfn)
5873068|NCT03755128|Erythroblastosis, Fetal|erythroblastosis, fetal
5873069|NCT03755128|Early onset severe hemolytic disease of the fetus and newborn (EOS-HDFN)|early onset severe hemolytic disease of the fetus and newborn (eos-hdfn)
5873070|NCT03755128|M281|m281
5873071|NCT03755128|Pregnant Women|pregnant women
5873072|NCT03752775|stroke|stroke
5873073|NCT03752775|upper limb|upper limb
5873074|NCT03752775|Joint coordination|joint coordination
5684025|NCT00562263|overweight|overweight
5873107|NCT03749044|Adverse Pregnancy Outcomes|adverse pregnancy outcomes
5873109|NCT03749044|Aspirin Adherence|aspirin adherence
5873153|NCT03746522|MC4R Pathway|mc4r pathway
5873154|NCT03746522|Obesity|obesity
5873155|NCT03746522|BBS|bbs
5873156|NCT03746522|AS|as
5873170|NCT03746028|Adverse Pregnancy Outcomes|adverse pregnancy outcomes
5873171|NCT03746028|SLE|sle
5873182|NCT03742934|Bowel preparation|bowel preparation
5684026|NCT00562263|obesity|obesity
5873220|NCT03738865|glucagon|glucagon
5873221|NCT03738865|hypoglycemia|hypoglycemia
5680055|NCT00579371|rabbit anti-thymocyte globulin|rabbit anti-thymocyte globulin
5680056|NCT00579358|Congenital heart defects|congenital heart defects
5680058|NCT00579332|biochemical failure|biochemical failure
5680059|NCT00579319|breast cancer|breast cancer
5680060|NCT00579306|hypertension|hypertension
5680061|NCT00579306|stroke|stroke
5680062|NCT00579306|cerebrovascular accident|cerebrovascular accident
5680063|NCT00579293|adult survivor of childhood cancer|adult survivor of childhood cancer
5680064|NCT00579293|computer assisted screening of survivors (CASS)|computer assisted screening of survivors (cass)
5680065|NCT00579280|Randomized|randomized
5680066|NCT00579280|Double-Blind|double-blind
5680067|NCT00579280|Placebo-Controlled|placebo-controlled
5680068|NCT00579280|Quetiapine|quetiapine
5680069|NCT00579280|DivalproexSodiumER|divalproexsodiumer
5680070|NCT00579280|Bipolar|bipolar
5680071|NCT00579280|Anxiety|anxiety
5680072|NCT00579280|Panic|panic
5680075|NCT00579267|structured diagnostic interview|structured diagnostic interview
5680076|NCT00579267|reliability and validity|reliability and validity
5680077|NCT00579267|K-SADS|k-sads
5680078|NCT00579267|Sheehan Disability Scale|sheehan disability scale
5680079|NCT00579254|Efficacy,safety & tolerability of Caduet In Patients With Cardiovascular Risk Factors|efficacy,safety & tolerability of caduet in patients with cardiovascular risk factors
5680080|NCT00579228|Diabetes|diabetes
5680081|NCT00579228|Vascular risk|vascular risk
5680082|NCT00579228|Inflammation|inflammation
5680083|NCT00579215|Cancer|cancer
5680084|NCT00579215|Enhanced Care|enhanced care
5680092|NCT00579189|ear drainage|ear drainage
5680093|NCT00579189|ear infection|ear infection
5680094|NCT00579189|ear drops|ear drops
5680095|NCT00579163|Blood|blood
5680096|NCT00579163|Salvia|salvia
5680097|NCT00579163|Tissue|tissue
5680098|NCT00579150|Birth Defects|birth defects
5680099|NCT00579150|High Risk Pregnancy|high risk pregnancy
5680100|NCT00579150|Type 2 Diabetes|type 2 diabetes
5680101|NCT00579137|Severe Combined Immunodeficiency Disease|severe combined immunodeficiency disease
5680102|NCT00579137|Severe Primary Immunodeficiency Disorder|severe primary immunodeficiency disorder
5680103|NCT00579137|Undefined T cell Deficiency Disorder|undefined t cell deficiency disorder
5680104|NCT00579137|Wiskott-Aldrick Syndrome|wiskott-aldrick syndrome
5680105|NCT00579137|Allogeneic stem cell transplant|allogeneic stem cell transplant
5680106|NCT00579137|Fludarabine|fludarabine
5680107|NCT00579137|monoclonal antibodies|monoclonal antibodies
5680108|NCT00579124|Blood and Marrow Transplant|blood and marrow transplant
5680109|NCT00579124|T cell Depletion|t cell depletion
5680110|NCT00579124|Unrelated|unrelated
5680111|NCT00579124|Related|related
5680112|NCT00579124|Donor|donor
5680113|NCT00579111|Myelodysplastic and Myeloproliferative Disorders|myelodysplastic and myeloproliferative disorders
5680114|NCT00579111|Acute Myelogenous Leukemia|acute myelogenous leukemia
5680115|NCT00579111|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5680116|NCT00579111|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5680117|NCT00579111|Multiple Myeloma|multiple myeloma
5680118|NCT00579111|Plasma Cell dyscrasia|plasma cell dyscrasia
5680119|NCT00579111|Lymphoproliferative disorders|lymphoproliferative disorders
5680120|NCT00579111|Hematologic Diseases|hematologic diseases
5680121|NCT00579111|Fludarabine|fludarabine
5680122|NCT00579111|Busulfan|busulfan
5680123|NCT00579111|Campath|campath
5680124|NCT00579111|Alemtuzumab|alemtuzumab
5680125|NCT00579111|allogeneic stem cell transplant|allogeneic stem cell transplant
5680126|NCT00579098|Atrial Fibrillation|atrial fibrillation
5680127|NCT00579098|Arrhythmia|arrhythmia
5680128|NCT00579098|Pulmonary Vein Isolation|pulmonary vein isolation
5680129|NCT00579098|Left atrial catheter ablation|left atrial catheter ablation
5680130|NCT00579098|Inflammation|inflammation
5680131|NCT00579098|Endothelial dysfunction|endothelial dysfunction
5680132|NCT00579072|Prostate|prostate
5680133|NCT00579072|cognitive effects|cognitive effects
5680134|NCT00579072|06-084|06-084
5680135|NCT00579046|Anemia|anemia
5680136|NCT00579046|Chronic obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5680137|NCT00579046|Erythropoietin|erythropoietin
4960444|NCT04236245|GSV|gsv
5873298|NCT03728699|AML|aml
5164428|NCT02964520|EEG biofeedback|eeg biofeedback
5164429|NCT02964520|randomized|randomized
5164433|NCT02964481|malignant|malignant
5164528|NCT02963974|cochlear implant|cochlear implant
5873309|NCT03725878|Birth Defects|birth defects
5873310|NCT03725878|periconception|periconception
5873311|NCT03725878|randomized controlled trial|randomized controlled trial
5873312|NCT03725878|folate|folate
5873325|NCT03724305|insomnia|insomnia
5873326|NCT03724305|nocturnal rumination|nocturnal rumination
5873327|NCT03724305|telemedicine CBTI|telemedicine cbti
5873328|NCT03724305|digital CBTI|digital cbti
4974647|NCT04150744|RFA|rfa
5798800|NCT00110981|ENBREL|enbrel
5680138|NCT00579046|6-minute walk test|6-minute walk test
5680139|NCT00579033|somatosensory|somatosensory
5680140|NCT00579033|cortex|cortex
5680141|NCT00579033|neuroimaging|neuroimaging
5680142|NCT00579033|tactile|tactile
5680143|NCT00579033|cortical plasticity|cortical plasticity
5680144|NCT00579033|dystonia|dystonia
5873365|NCT03720171|Osseointegration|osseointegration
5873366|NCT03720171|Bone-anchored prosthesis|bone-anchored prosthesis
5873367|NCT03720171|Neuro-prosthesis|neuro-prosthesis
5873409|NCT03714152|HBV|hbv
5873410|NCT03714152|hepatitis B|hepatitis b
5873411|NCT03714152|HBeAg positive|hbeag positive
5680146|NCT00579020|inflammation|inflammation
5680147|NCT00579020|blepharitis|blepharitis
5680148|NCT00579020|lid infection|lid infection
5680149|NCT00579007|Prophylactic Mastectomy|prophylactic mastectomy
5680150|NCT00579007|Prophylactic Oophorectomy|prophylactic oophorectomy
5680151|NCT00578994|Unicompartmental Knee|unicompartmental knee
5680152|NCT00578994|Partial Knee|partial knee
5680153|NCT00578994|Knee arthroplasty|knee arthroplasty
5680154|NCT00578981|Osteoporosis, age-related|osteoporosis, age-related
5045554|NCT03714139|histology|histology
5680155|NCT00578981|Osteoporosis, Postmenopausal|osteoporosis, postmenopausal
5680156|NCT00578981|Bone Loss|bone loss
5680157|NCT00578981|Low Bone Density|low bone density
5680158|NCT00578968|COPD|copd
5680159|NCT00578968|Tiotropium|tiotropium
5680160|NCT00578968|Spiriva|spiriva
5680161|NCT00578955|Blepharoconjunctivitis, Ophthalmology|blepharoconjunctivitis, ophthalmology
5680162|NCT00578942|Allogeneic Stem Cell Transplantation, Campath, HLA-Matched|allogeneic stem cell transplantation, campath, hla-matched
5680163|NCT00578929|allergic rhinitis|allergic rhinitis
5680164|NCT00578929|allergies|allergies
5680165|NCT00578929|seasonal allergies|seasonal allergies
5680166|NCT00578903|Severe Aplastic Anemia|severe aplastic anemia
5680167|NCT00578903|Severe|severe
5680168|NCT00578890|diabetic foot|diabetic foot
5680169|NCT00578890|osteomyelitis|osteomyelitis
5680170|NCT00578877|Contraception|contraception
5680270|NCT00578422|IVUS|ivus
5680171|NCT00578877|SILCS Diaphragm|silcs diaphragm
5680172|NCT00578877|Contraceptive Gel|contraceptive gel
5680173|NCT00578864|Neuroblastoma|neuroblastoma
5680174|NCT00578864|Etoposide|etoposide
5680175|NCT00578864|Cisplatin|cisplatin
5680176|NCT00578864|Adriamycin|adriamycin
5680177|NCT00578864|Cyclophosphamide|cyclophosphamide
5680178|NCT00578864|Cytoxan|cytoxan
5680179|NCT00578851|Hip Arthroplasty|hip arthroplasty
5680180|NCT00578851|Hip Arthritis|hip arthritis
5680181|NCT00578825|Severe acute respiratory syndrome|severe acute respiratory syndrome
5680182|NCT00578799|ulcerative colitis|ulcerative colitis
5680183|NCT00578773|ear tubes|ear tubes
5680184|NCT00578773|ear infection|ear infection
5680185|NCT00578773|ear drops|ear drops
5680186|NCT00578773|ear tube surgery|ear tube surgery
5680187|NCT00578773|acute otitis media|acute otitis media
5680188|NCT00578760|hearing loss|hearing loss
5680189|NCT00578760|ototoxicity|ototoxicity
5680190|NCT00578760|cisplatin|cisplatin
5680191|NCT00578747|Breast Cancer|breast cancer
5680192|NCT00578747|Breast Neoplasms|breast neoplasms
5680193|NCT00578747|Targeted Radiotherapy|targeted radiotherapy
5680194|NCT00578747|Mastectomy|mastectomy
5680195|NCT00578747|Seroma|seroma
5680196|NCT00578721|Colorectal cancer|colorectal cancer
5680197|NCT00578721|aspirin|aspirin
5680198|NCT00578708|membranous|membranous
5680199|NCT00578708|ventricular|ventricular
5680200|NCT00578708|septal|septal
5680201|NCT00578708|defect|defect
5680203|NCT00578695|Hyponatremia|hyponatremia
5680204|NCT00578695|Serum Sodium|serum sodium
5680205|NCT00578695|Fluid Overload|fluid overload
5680206|NCT00578695|Heart Failure|heart failure
5680207|NCT00578695|Acute Heart Failure|acute heart failure
5680208|NCT00578695|Vasopressin Antagonist|vasopressin antagonist
5680209|NCT00578669|Smoking Cessation|smoking cessation
5680210|NCT00578669|Tobacco Use Cessation|tobacco use cessation
5680211|NCT00578669|Antidepressants|antidepressants
5680212|NCT00578656|Food Allergy|food allergy
5680213|NCT00578656|Milk Allergy|milk allergy
5680214|NCT00578643|Stem Cell Transplant|stem cell transplant
5680215|NCT00578643|Chronic Granulomatous Disease|chronic granulomatous disease
5680216|NCT00578643|Fludarabine|fludarabine
5680217|NCT00578643|Busulfan|busulfan
5680218|NCT00578643|Cyclophosphamide|cyclophosphamide
5680219|NCT00578630|pediatric tumors|pediatric tumors
5680220|NCT00578630|genetic test development|genetic test development
5680221|NCT00578630|All Pediatric patients with a histologically proven tumor.|all pediatric patients with a histologically proven tumor.
5680222|NCT00578617|Atrial fibrillation|atrial fibrillation
5680223|NCT00578617|Left Atrial Ablation|left atrial ablation
5680224|NCT00578617|Pulmonary Vein Isolation|pulmonary vein isolation
5680225|NCT00578617|Catheter Ablation|catheter ablation
5680226|NCT00578617|Antiarrhythmic Drug Therapy|antiarrhythmic drug therapy
5680227|NCT00578591|Graft Versus Host Disease|graft versus host disease
5680228|NCT00578591|GVHD|gvhd
5680229|NCT00578591|allogeneic hematopoietic transplant|allogeneic hematopoietic transplant
5873448|NCT03708094|prognosis|prognosis
5873449|NCT03708094|pathogenic gene|pathogenic gene
5873450|NCT03708094|decision tree study|decision tree study
5873463|NCT03706495|Postural Kyphosis|postural kyphosis
5873464|NCT03706495|Exercises|exercises
5873465|NCT03706495|Balance|balance
5873466|NCT03706495|Respiratory Functions|respiratory functions
5873483|NCT03702777|Underactive Bladder|underactive bladder
5873484|NCT03702777|ASP8302|asp8302
5684027|NCT00562263|adolescent|adolescent
4992069|NCT04042506|SBRT|sbrt
4993325|NCT04035590|Drain|drain
4995302|NCT04023227|ARB|arb
4955148|NCT04269239|Rehabilitation|rehabilitation
4955149|NCT04269200|Cancer of Endometrium|cancer of endometrium
4955150|NCT04269200|Cancer of the Endometrium|cancer of the endometrium
4955151|NCT04269200|Carcinoma of Endometrium|carcinoma of endometrium
4955152|NCT04269200|Endometrial Cancer|endometrial cancer
4955153|NCT04269200|Endometrial Carcinoma|endometrial carcinoma
4955154|NCT04269200|Endometrium Cancer|endometrium cancer
4955155|NCT04269200|Neoplasms, Endometrial|neoplasms, endometrial
4955159|NCT04269135|Physical fitness|physical fitness
4955160|NCT04269135|Risk factors|risk factors
4955161|NCT04269135|Anthropometrics|anthropometrics
4955162|NCT04269135|Blood pressure|blood pressure
4955163|NCT04269135|Neuropsychological Tests|neuropsychological tests
4955164|NCT04269135|Physical activity|physical activity
4955165|NCT04269135|Motor skills|motor skills
4955166|NCT04269083|esophageal-gastric junction cancer, preoperative chemoradiotherapy, BIRC3|esophageal-gastric junction cancer, preoperative chemoradiotherapy, birc3
4955167|NCT04269070|sedentary|sedentary
4955169|NCT04269070|lifestyle modification|lifestyle modification
4955170|NCT04269070|cardiometabolic health|cardiometabolic health
4955173|NCT04269031|First-in-Human|first-in-human
4955174|NCT04269031|Randomized|randomized
4955175|NCT04269031|Single-blind|single-blind
4955176|NCT04269031|Placebo controlled|placebo controlled
4955177|NCT04269031|AZD2373|azd2373
4955178|NCT04269031|Single Ascending Dose|single ascending dose
4955179|NCT04269031|Sentinel Dosing|sentinel dosing
4955180|NCT04269005|mental health|mental health
4955181|NCT04269005|mental disorder|mental disorder
4955182|NCT04269005|mental comorbidity|mental comorbidity
4955183|NCT04269005|mental-somatic multimorbidity|mental-somatic multimorbidity
4955215|NCT04268914|anxiety|anxiety
4955299|NCT04268446|Turkish version|turkish version
4955345|NCT04268108|resistance|resistance
4955346|NCT04268108|solid tumor|solid tumor
4955347|NCT04268056|Radiation dermatitis|radiation dermatitis
4955348|NCT04268056|Radio Therapy|radio therapy
4955349|NCT04268056|Microbiome Profile|microbiome profile
4955350|NCT04268017|Gait analysis|gait analysis
4955351|NCT04268017|FeetMe®|feetme®
4955352|NCT04268017|GaitRite®|gaitrite®
4955353|NCT04268017|Healthy|healthy
4955354|NCT04268017|Validation|validation
4955355|NCT04268004|Cancer|cancer
4955356|NCT04268004|Fertility Preservation|fertility preservation
4955489|NCT04267107|Parkinsons disease|parkinsons disease
4955490|NCT04267107|Self-management|self-management
4955491|NCT04267107|Fatigue management|fatigue management
4955492|NCT04267107|Occupational therapy|occupational therapy
4955497|NCT04267042|Budesonide|budesonide
4955498|NCT04267042|MAD|mad
4955499|NCT04267042|INSI|insi
4955500|NCT04267042|CRS|crs
4955501|NCT04267042|AFRS|afrs
4955502|NCT04267042|Postoperative|postoperative
4955503|NCT04267029|TACO (transfusion associated circulatory overload)|taco (transfusion associated circulatory overload)
4955504|NCT04267029|TRALI (transfusion related acute lung injury)|trali (transfusion related acute lung injury)
4955673|NCT04266041|Dense-array EEG|dense-array eeg
4955674|NCT04266041|High-density EEG|high-density eeg
4955675|NCT04266041|HD-EEG|hd-eeg
4955676|NCT04266002|CNS Penetration Effectiveness|cns penetration effectiveness
4955767|NCT04265534|Pemetrexed|pemetrexed
4955768|NCT04265534|Carboplatin|carboplatin
4955769|NCT04265534|Randomized|randomized
4955770|NCT04265534|Placebo|placebo
4955771|NCT04265534|Chemotherapy|chemotherapy
4955772|NCT04265534|Targeted Therapy|targeted therapy
4955773|NCT04265534|Telaglenastat|telaglenastat
4955774|NCT04265534|Glutamine|glutamine
4955775|NCT04265534|Glutaminase|glutaminase
4955776|NCT04265534|Glutathione|glutathione
4955777|NCT04265534|Immunotherapy|immunotherapy
4955778|NCT04265534|Front-line|front-line
4955779|NCT04265534|First-line|first-line
4955780|NCT04265534|Non-squamous|non-squamous
5665663|NCT00638157|Staph Aureus|staph aureus
4955865|NCT04264897|5' adenosine monophosphate-activated protein kinase|5' adenosine monophosphate-activated protein kinase
4955866|NCT04264897|Healthspan|healthspan
4955867|NCT04264897|Skeletal muscle|skeletal muscle
4955868|NCT04264897|Mitochondria|mitochondria
4955869|NCT04264832|fat distribution, insulin resistance, PCOS|fat distribution, insulin resistance, pcos
4955870|NCT04264819|age-related macular degeneration, wetAMD, nAMD, neovascular, choroidal neovascularization, disease control|age-related macular degeneration, wetamd, namd, neovascular, choroidal neovascularization, disease control
4955871|NCT04264793|Emirati Adults|emirati adults
4955872|NCT04264793|United Arab Emirates|united arab emirates
4955873|NCT04264793|Lifestyle Intervention|lifestyle intervention
4955874|NCT04264793|Type 2 Diabetes|type 2 diabetes
4955984|NCT04264234|placenta previa|placenta previa
4955985|NCT04264234|placental invasion anomalies|placental invasion anomalies
4955986|NCT04264234|timing of the birth|timing of the birth
4955987|NCT04264195|Stroke|stroke
4955988|NCT04264195|Upper extremity paresis|upper extremity paresis
4956118|NCT04263337|Sub-concussive Exposure|sub-concussive exposure
4956119|NCT04263324|chronic pain|chronic pain
4956120|NCT04263324|fibromyalgia|fibromyalgia
4956121|NCT04263324|hypnosis|hypnosis
4956123|NCT04263324|EEG|eeg
4956124|NCT04263272|Endocrine-Metabolic health|endocrine-metabolic health
4956125|NCT04263272|Cardio-Metabolic health|cardio-metabolic health
4956126|NCT04263233|ESRD|esrd
4956135|NCT04263207|Tat|tat
4956231|NCT04262557|New medical device|new medical device
4956232|NCT04262557|Mandibular movement|mandibular movement
4956233|NCT04262557|Respiratory event index|respiratory event index
4956234|NCT04262557|Polysomnography|polysomnography
4956235|NCT04262544|mHealth|mhealth
4956236|NCT04262544|text messaging|text messaging
4956237|NCT04262544|smartphone|smartphone
4956238|NCT04262544|mobile apps|mobile apps
4956239|NCT04262544|wearables|wearables
4956240|NCT04262544|heart failure|heart failure
4956241|NCT04262544|self-management|self-management
4956242|NCT04262544|telehealth|telehealth
4956246|NCT04262518|Invasive Breast Cancer|invasive breast cancer
4956248|NCT04262518|NCCN Guidelines|nccn guidelines
4956341|NCT04261842|Well-being|well-being
4956342|NCT04261842|Readiness|readiness
4956343|NCT04261842|Self and Identity|self and identity
4956344|NCT04261842|Self-Schemas|self-schemas
4956348|NCT04261777|ePLND|eplnd
4956349|NCT04261777|MRI|mri
4956350|NCT04261777|USPIO|uspio
4956351|NCT04261777|MR lymphography|mr lymphography
4956352|NCT04261777|Ferrotran|ferrotran
4956353|NCT04261777|Ultra-small superparamagnetic iron oxide|ultra-small superparamagnetic iron oxide
4956354|NCT04261777|Nanoparticles|nanoparticles
4956456|NCT04260984|De Quervain Disease|de quervain disease
4956568|NCT04260126|Vaccine|vaccine
4956569|NCT04260126|Human papillomavirus 16|human papillomavirus 16
4956570|NCT04260113|chondrosarcoma|chondrosarcoma
4956571|NCT04260113|apatinib|apatinib
4956572|NCT04260113|inoperable|inoperable
4956573|NCT04260113|toxicity|toxicity
4956574|NCT04260113|prognosis|prognosis
4956575|NCT04260087|Headache|headache
4956576|NCT04260061|robotic-assisted therapy|robotic-assisted therapy
4956577|NCT04260061|Rehabilitation|rehabilitation
4956578|NCT04260022|chronic|chronic
4956579|NCT04260022|leukenmia|leukenmia
4956580|NCT04260022|myeloid|myeloid
4956581|NCT04260009|Drug Therapy|drug therapy
4956685|NCT04259411|Functional MR|functional mr
4956686|NCT04259411|Degenerative MR|degenerative mr
4956687|NCT04259398|anesthesia|anesthesia
4956688|NCT04259398|propofol|propofol
4956689|NCT04259398|cancer|cancer
4956690|NCT04259398|inhalational anesthetics|inhalational anesthetics
4956691|NCT04259385|Food labeling|food labeling
4956692|NCT04259385|Child|child
4956780|NCT04258839|Autism Spectrum Disorder|autism spectrum disorder
4956781|NCT04258839|ASD|asd
4956782|NCT04258839|Irritability|irritability
4956783|NCT04258800|colonoscopy|colonoscopy
4956784|NCT04258800|music|music
4956785|NCT04258800|relaxation|relaxation
4956786|NCT04258800|satisfaction|satisfaction
4956787|NCT04258787|Fuchs|fuchs
4956914|NCT04258085|Rwanda|rwanda
4956916|NCT04258085|screening|screening
4957037|NCT04257344|Heart Rate Variation|heart rate variation
4957038|NCT04257344|Actigraphy|actigraphy
4957039|NCT04257344|Sleep|sleep
4957040|NCT04257344|Quality of Recovery|quality of recovery
4957041|NCT04257331|Parenting Education|parenting education
4957042|NCT04257331|Quasi Experimental Design|quasi experimental design
4957043|NCT04257331|Propensity Score Weight|propensity score weight
4957134|NCT04256707|pharmacokinetics|pharmacokinetics
4957135|NCT04256694|Carrier rate|carrier rate
4957136|NCT04256694|Rapid antigen test|rapid antigen test
4957138|NCT04256668|assisted reproductive technology|assisted reproductive technology
4957139|NCT04256668|DNA fragmentation|dna fragmentation
4957141|NCT04256668|protamine|protamine
4957142|NCT04256668|blastocyst|blastocyst
4957143|NCT04256629|Randomised|randomised
4957144|NCT04256629|Double-Blind|double-blind
4957257|NCT04256031|Quality of life|quality of life
4957258|NCT04255992|Blood pressure|blood pressure
4957259|NCT04255992|Oxidative status|oxidative status
4957260|NCT04255966|Revision of the acetabular implant|revision of the acetabular implant
4957261|NCT04255966|orthopaedic surgery|orthopaedic surgery
4957413|NCT04254926|resource-based|resource-based
4957414|NCT04254926|self-esteem|self-esteem
4957415|NCT04254926|life review intervention|life review intervention
4957416|NCT04254887|EPBD|epbd
4957417|NCT04254861|Intrabony defect|intrabony defect
4957418|NCT04254861|Periodontitis|periodontitis
4957527|NCT04254198|Peer support group|peer support group
4957528|NCT04254198|Community-engaged|community-engaged
4957533|NCT04254159|Asthma|asthma
4957534|NCT04254159|Neuromuscular Electrical Stimulation|neuromuscular electrical stimulation
4957535|NCT04254159|Quadriceps Muscle Strength|quadriceps muscle strength
4957536|NCT04254159|Quality of Life|quality of life
4957537|NCT04254146|Rheumatoid Arthritis|rheumatoid arthritis
4957538|NCT04254146|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
4957539|NCT04254146|acute exercise|acute exercise
4957540|NCT04254107|NSCLC|nsclc
4957541|NCT04254107|cHL|chl
4957542|NCT04254107|DLBCL|dlbcl
4957543|NCT04254107|PTCL-NOS|ptcl-nos
4957636|NCT04253613|diabetes mellitus|diabetes mellitus
4957637|NCT04253613|periodontal treatment|periodontal treatment
4957638|NCT04253613|laser biostimulation therapy|laser biostimulation therapy
4957639|NCT04253600|Developmental Language Disorders|developmental language disorders
4957640|NCT04253600|Predictive factors|predictive factors
4957746|NCT04252820|body temperature|body temperature
4957747|NCT04252820|hypothermia|hypothermia
4957748|NCT04252820|prewarming|prewarming
4957749|NCT04252820|regional anesthesia|regional anesthesia
4957750|NCT04252781|Incident Chronic Obstructive Pulmonary Disease|incident chronic obstructive pulmonary disease
4957854|NCT04252144|oesophagitis|oesophagitis
4957855|NCT04252144|GERD|gerd
4957922|NCT04251715|HAI|hai
4957957|NCT04251546|ultrasound|ultrasound
4957959|NCT04251533|Triple Negative Breast Cancer|triple negative breast cancer
4957960|NCT04251533|alpelisib|alpelisib
4957961|NCT04251533|BYL719|byl719
4958066|NCT04250870|health|health
4958067|NCT04250870|nursing homes|nursing homes
4958068|NCT04250870|physical fitness|physical fitness
4958069|NCT04250844|Botulinum Toxin|botulinum toxin
4958070|NCT04250831|hormones|hormones
4958071|NCT04250831|microbiota|microbiota
4958073|NCT04250831|hunger|hunger
4958074|NCT04250831|weight loss|weight loss
4958185|NCT04250090|Ureter Stricture|ureter stricture
4958186|NCT04250090|Hydronephrosis|hydronephrosis
4958187|NCT04250038|Cefepime|cefepime
4958188|NCT04250038|Pharmacokinetic|pharmacokinetic
4958189|NCT04250038|Neurotoxicity|neurotoxicity
4958190|NCT04250038|Febrile neutropenia|febrile neutropenia
4958191|NCT04250038|Exposure|exposure
4958192|NCT04250012|Parents, burnout, parental distress, Internet-based, ACT|parents, burnout, parental distress, internet-based, act
4958288|NCT04249453|Spinal loads|spinal loads
4958289|NCT04249440|breast cancer|breast cancer
4958290|NCT04249440|HER2|her2
4958291|NCT04249440|preoperative systemic treatment|preoperative systemic treatment
4958292|NCT04249414|Ventilation Monitoring|ventilation monitoring
4958293|NCT04249414|Electrical Impedance Tomography|electrical impedance tomography
4958294|NCT04249414|Perfusion Monitoring|perfusion monitoring
4958295|NCT04249414|Hemodynamic Monitoring|hemodynamic monitoring
4958296|NCT04249375|Pharmacogenomics|pharmacogenomics
4958297|NCT04249375|Pediatrics|pediatrics
4958298|NCT04249375|Adverse Drug Reactions|adverse drug reactions
4958382|NCT04248842|Wireless monitoring|wireless monitoring
4958383|NCT04248829|Locally Advanced EGFR Sensitizing Mutation|locally advanced egfr sensitizing mutation
4958484|NCT04248166|Thyroid cancer|thyroid cancer
4958485|NCT04248166|Photoacoustic imaging|photoacoustic imaging
4958486|NCT04248140|radio frequency electromagnetic fields, volunteers|radio frequency electromagnetic fields, volunteers
4958594|NCT04247438|chitosan|chitosan
4958595|NCT04247438|methylcellulose|methylcellulose
4958596|NCT04247438|denture biofilm|denture biofilm
4958597|NCT04247438|denture plaque|denture plaque
4958598|NCT04247438|biofilm model|biofilm model
4958599|NCT04247412|Laryngomicrosurgery|laryngomicrosurgery
4958600|NCT04247412|Nonintubated deep paralysis|nonintubated deep paralysis
4958601|NCT04247412|Transnasal Humidified Rapid-insufflation Ventilatory Exchange|transnasal humidified rapid-insufflation ventilatory exchange
4958602|NCT04247386|bowel preparation quality|bowel preparation quality
4958603|NCT04247347|Caregiver|caregiver
4958604|NCT04247347|Biofeedback|biofeedback
4958692|NCT04246723|hepatitis|hepatitis
4958795|NCT04246125|Dosimetry|dosimetry
4958796|NCT04246125|Gafchromic film|gafchromic film
4958797|NCT04246125|Interventional radiology|interventional radiology
4958798|NCT04246125|Peak skin dose|peak skin dose
4958799|NCT04246112|Handwriting|handwriting
4958800|NCT04246112|Pediatrics|pediatrics
4958801|NCT04246099|Post-operative pain|post-operative pain
4958802|NCT04246073|Cancer|cancer
4958803|NCT04246073|Cancer Diagnosis|cancer diagnosis
4958804|NCT04246073|Thromboembolism|thromboembolism
4958805|NCT04246047|Belantamab mafodotin|belantamab mafodotin
4958806|NCT04246047|Relapsed/refractory multiple myeloma|relapsed/refractory multiple myeloma
4958807|NCT04246047|Daratumumab|daratumumab
4958808|NCT04246047|Bortezomib|bortezomib
4958809|NCT04246047|Dexamethasone|dexamethasone
4958810|NCT04246034|VLNT|vlnt
4958811|NCT04246034|breast reconstruction|breast reconstruction
4958812|NCT04246034|postmastectomy lymphedema|postmastectomy lymphedema
4958813|NCT04246034|vascularized lymph node transfer|vascularized lymph node transfer
4958814|NCT04246034|lymphedema surgery|lymphedema surgery
4958883|NCT04245605|Heart failure|heart failure
4958884|NCT04245592|nutritional intervention|nutritional intervention
4958885|NCT04245592|olive oil|olive oil
4958886|NCT04245592|nitric oxide|nitric oxide
4958887|NCT04245592|inflammation|inflammation
4958888|NCT04245592|cortisol|cortisol
4958889|NCT04245592|lipid profile|lipid profile
4959091|NCT04244721|interventions Early Start Denver Model (ESDM)|interventions early start denver model (esdm)
4959092|NCT04244721|Preschool Autism Communication Therapy (PACT)|preschool autism communication therapy (pact)
4959207|NCT04244136|residual normal renal tissue|residual normal renal tissue
4959208|NCT04244123|Growth Hormone|growth hormone
4959212|NCT04244071|nursing|nursing
4959213|NCT04244071|active heating|active heating
4959214|NCT04244071|thermal comfort|thermal comfort
4959215|NCT04244071|anxiety|anxiety
4959317|NCT04243330|prevention|prevention
4959318|NCT04243330|implementation science|implementation science
4959319|NCT04243317|sleep|sleep
4959320|NCT04243304|Parkinson Disease|parkinson disease
4959321|NCT04243304|PET|pet
4959369|NCT04242992|HIV|hiv
4959420|NCT04242680|non-invasive brain stimulation|non-invasive brain stimulation
4959421|NCT04242680|transcranial electrical stimulation|transcranial electrical stimulation
4959422|NCT04242654|Doppler ultrasound|doppler ultrasound
4959423|NCT04242654|heart rate|heart rate
4959424|NCT04242654|neonatal resuscitation|neonatal resuscitation
4959425|NCT04242628|UCLA Version 3 scale|ucla version 3 scale
4959430|NCT04242576|Neck|neck
4959552|NCT04242004|HIV-infected patients|hiv-infected patients
4959553|NCT04242004|neurocognitive impairment|neurocognitive impairment
4959554|NCT04242004|gut microbiota|gut microbiota
4959555|NCT04242004|fatty acid docosahexaenoic|fatty acid docosahexaenoic
4959556|NCT04242004|randomized controlled trial|randomized controlled trial
4959780|NCT04240704|JBH492|jbh492
4959781|NCT04240704|ADC|adc
4959782|NCT04240704|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5676015|NCT00596921|Shock|shock
4959783|NCT04240704|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
4959784|NCT04240678|Mass Screening|mass screening
4959788|NCT04240613|TVT-O|tvt-o
4959789|NCT04240613|long-term follow-up|long-term follow-up
4959790|NCT04240613|retrospective|retrospective
4959791|NCT04240600|nutrition|nutrition
4959792|NCT04240600|acute myeloid leukemia|acute myeloid leukemia
4959793|NCT04240600|body composition|body composition
4959795|NCT04240600|VEGF|vegf
4959876|NCT04239586|Type 1 diabetes|type 1 diabetes
4959877|NCT04239560|Radiodermatitis|radiodermatitis
4959878|NCT04239560|Gel|gel
4959879|NCT04239560|Boron|boron
4959880|NCT04239560|Radiotherapy|radiotherapy
4959881|NCT04239560|Breast Cancer|breast cancer
4959882|NCT04239547|recruitment|recruitment
4959986|NCT04238897|eye diseases|eye diseases
4959987|NCT04238858|Retinitis pigmentosa|retinitis pigmentosa
4959988|NCT04238858|Growth factors|growth factors
4959989|NCT04238858|Platelet rich plasma|platelet rich plasma
4959990|NCT04238858|Visual functions|visual functions
4960105|NCT04238260|Lower extremity|lower extremity
4960106|NCT04238260|Rehabilitation|rehabilitation
4960107|NCT04238260|Wearable device|wearable device
4960108|NCT04238260|Exercise|exercise
4960109|NCT04238260|Clinical Trial|clinical trial
4960110|NCT04238247|child restraint systems (car seats and booster seats)|child restraint systems (car seats and booster seats)
4960111|NCT04238247|seat belts|seat belts
4960112|NCT04238247|Motivational Interviewing|motivational interviewing
4960120|NCT04238195|TQT|tqt
4960121|NCT04238156|Postpartum|postpartum
4960122|NCT04238156|Hypopressive abdominal exercises|hypopressive abdominal exercises
4960123|NCT04238156|Pelvic floor muscles|pelvic floor muscles
4960124|NCT04238143|Arthritis|arthritis
4960224|NCT04237571|exercise|exercise
4960225|NCT04237571|community|community
4960226|NCT04237571|education|education
4960227|NCT04237558|Vaginal hysterectomy|vaginal hysterectomy
4960327|NCT04236947|Social Competence Promotion Program for Young Adolescents|social competence promotion program for young adolescents
4960329|NCT04236908|low back pain|low back pain
4960330|NCT04236895|Diabetes|diabetes
4960427|NCT04236414|Malignant cancer|malignant cancer
4960428|NCT04236414|Paediatric population|paediatric population
4960430|NCT04236401|electrosurgery|electrosurgery
4960431|NCT04236401|scalpel|scalpel
4960435|NCT04236388|blood pressure|blood pressure
4960647|NCT04235127|inverse probability weighting|inverse probability weighting
4960648|NCT04235127|public health|public health
4960649|NCT04235127|surveillance|surveillance
4960650|NCT04235127|population-attributable risk proportions|population-attributable risk proportions
5665971|NCT00637195|HPV|hpv
5260738|NCT02384525|CRRT|crrt
4960651|NCT04235114|89Zr|89zr
4960652|NCT04235114|Nimotuzumab|nimotuzumab
4960653|NCT04235114|Lung cancer|lung cancer
4960654|NCT04235114|Colorectal cancer|colorectal cancer
4960655|NCT04235114|EGFR|egfr
4960658|NCT04235114|Imaging|imaging
4960659|NCT04235114|89Zr-DFO-nimotuzumab|89zr-dfo-nimotuzumab
4960660|NCT04235101|Solid Tumor|solid tumor
4960661|NCT04235101|Anti-body Drug Conjugate|anti-body drug conjugate
4960663|NCT04235101|niraparib|niraparib
4960664|NCT04235088|somatosensory intensive intervention|somatosensory intensive intervention
4960731|NCT04234789|pletysmography|pletysmography
4960855|NCT04234113|Cervical Cancer|cervical cancer
4960951|NCT04233671|depression|depression
4960953|NCT04233671|anxiety|anxiety
4960970|NCT04233489|family nurture intervention|family nurture intervention
4960971|NCT04233489|emotional connection|emotional connection
4960973|NCT04233489|mother-infant interaction|mother-infant interaction
4961027|NCT04233125|Hip|hip
4961183|NCT04232280|CMV|cmv
4961294|NCT04231695|hemoperfusion|hemoperfusion
4961295|NCT04231695|CRRT|crrt
4961296|NCT04231695|ECMO|ecmo
4961297|NCT04231669|child migration|child migration
4961298|NCT04231669|child labor|child labor
4961299|NCT04231669|sub-Saharan Africa|sub-saharan africa
4961300|NCT04231669|female adolescents|female adolescents
4961301|NCT04231656|Non-invasive|non-invasive
4961302|NCT04231656|Stroke volume|stroke volume
4961303|NCT04231656|Cardiac preload|cardiac preload
4961304|NCT04231656|Interchangeability|interchangeability
4961401|NCT04230915|Intraoperative nerve monitoring|intraoperative nerve monitoring
4961504|NCT04230460|Alcohol|alcohol
4961505|NCT04230460|Driving|driving
4961506|NCT04230460|DUI|dui
4961507|NCT04230460|Drinking behavior|drinking behavior
4961508|NCT04230460|Substance Use|substance use
4961509|NCT04230460|Driving Impairment|driving impairment
4961510|NCT04230460|Drugs|drugs
4961710|NCT04229069|randomized placebo-controlled trial|randomized placebo-controlled trial
4961711|NCT04229056|parkinson disease|parkinson disease
4961713|NCT04229056|cardiac arrest|cardiac arrest
4961895|NCT04227899|ESPRIT™ BTK Everolimus Eluting Bioresorbable Scaffold System|esprit™ btk everolimus eluting bioresorbable scaffold system
4961896|NCT04227899|Percutaneous transluminal angioplasty (PTA)|percutaneous transluminal angioplasty (pta)
4961897|NCT04227899|ABT-CIP-10293|abt-cip-10293
4961898|NCT04227886|Neoadjuvant Chemoradiation|neoadjuvant chemoradiation
4961899|NCT04227886|Prediction Model|prediction model
4961900|NCT04227886|Treatment Response|treatment response
4961901|NCT04227886|Toxicities|toxicities
4961903|NCT04227886|Tissue RNA|tissue rna
4961904|NCT04227886|Plasma exosome|plasma exosome
4961906|NCT04227834|School-aged children|school-aged children
4961907|NCT04227834|Health hygiene|health hygiene
4961908|NCT04227834|Education|education
4961915|NCT04227795|Artificial intelligence|artificial intelligence
4961916|NCT04227795|Colonoscopy|colonoscopy
4961917|NCT04227795|Deep learning|deep learning
4962003|NCT04227327|Human-Epidermal-Growth-factor-negative (HER2-)|human-epidermal-growth-factor-negative (her2-)
4962004|NCT04227301|electrolyte disorder|electrolyte disorder
4962005|NCT04227301|Bone Metabolism|bone metabolism
4962006|NCT04227301|Sodium Levels|sodium levels
4962007|NCT04227288|Enstilar Foam|enstilar foam
4962008|NCT04227275|Chimeric Antigen Receptor (CAR)|chimeric antigen receptor (car)
4962009|NCT04227275|T-cells|t-cells
4962010|NCT04227275|Prostate-Specific Membrane Antigen (PSMA)|prostate-specific membrane antigen (psma)
4962011|NCT04227275|Prostate Cancer|prostate cancer
4962012|NCT04227262|cerebral palsy|cerebral palsy
4962013|NCT04227262|balance|balance
4962200|NCT04226157|Blood Pressure Monitor|blood pressure monitor
4962201|NCT04226157|Home Blood Pressure Monitor|home blood pressure monitor
4962202|NCT04226157|Ischemic Stroke|ischemic stroke
4962203|NCT04226157|Stroke Prevention|stroke prevention
4962204|NCT04226144|respiratory function tests|respiratory function tests
4962205|NCT04226144|deglution disorders|deglution disorders
4962207|NCT04226092|Transepidermal Water Loss|transepidermal water loss
4962208|NCT04226066|Advanced Malignant Solid Tumors|advanced malignant solid tumors
4962210|NCT04226053|Children|children
4962211|NCT04226053|Social support|social support
4962212|NCT04226053|Practical support|practical support
4962213|NCT04226040|degree-of-worry|degree-of-worry
4962214|NCT04226040|illness perception|illness perception
4962215|NCT04226040|acute illness|acute illness
4962303|NCT04225624|Obsession|obsession
4962304|NCT04225624|Worry|worry
4962305|NCT04225624|Attention|attention
4962306|NCT04225611|contact lens|contact lens
4962307|NCT04225611|drug|drug
4962308|NCT04225611|cystoid|cystoid
4962309|NCT04225611|macular edema|macular edema
4962310|NCT04225598|Opioid-use Disorder|opioid-use disorder
4962311|NCT04225546|cerebral palsy|cerebral palsy
4962312|NCT04225546|selective control|selective control
4962313|NCT04225546|trunk|trunk
4962314|NCT04225546|sit to stand|sit to stand
4962315|NCT04225520|Cardiac resynchronization therapy|cardiac resynchronization therapy
4962316|NCT04225520|Heart failure|heart failure
5266552|NCT02350920|ACT|act
4962400|NCT04225052|Pharmacokinetics|pharmacokinetics
4962401|NCT04225013|Biomarker|biomarker
4962402|NCT04225013|Contrast-Media|contrast-media
4962403|NCT04225013|Nephrotoxicity|nephrotoxicity
4962404|NCT04225013|Prevention|prevention
4962498|NCT04224207|Subtenon space|subtenon space
4962499|NCT04224207|Umbilical cord|umbilical cord
4962500|NCT04224194|auto injector pen in RA patients|auto injector pen in ra patients
4962501|NCT04224181|Women|women
4962502|NCT04224181|Arterial Inflammation|arterial inflammation
4962503|NCT04224181|Systemic Immune Activation|systemic immune activation
4962507|NCT04224142|PKU|pku
4962607|NCT04223635|Healthy subjects|healthy subjects
4962608|NCT04223635|Pexidartinib|pexidartinib
4962609|NCT04223635|Clinical pharmacology study|clinical pharmacology study
4962614|NCT04223622|ASC|asc
4962716|NCT04223050|COPD|copd
4962717|NCT04223050|Oxygen treatment|oxygen treatment
4962718|NCT04223050|Mortality|mortality
4963015|NCT04221542|mCRPC|mcrpc
4962782|NCT04222777|Fundamental Research|fundamental research
4962783|NCT04222777|Cinematographic recordings|cinematographic recordings
4962906|NCT04222205|Mechanical ventilation|mechanical ventilation
4962907|NCT04222205|Respiratory failure|respiratory failure
4963032|NCT04221373|Rehabilitation|rehabilitation
4963033|NCT04221373|Walking|walking
4963152|NCT04220489|Ketamine|ketamine
4963254|NCT04219722|Hyaluronic acid|hyaluronic acid
4963255|NCT04219722|Injection|injection
4963256|NCT04219722|Postmenopause|postmenopause
4963257|NCT04219722|Prospective|prospective
4963258|NCT04219722|2-step study|2-step study
4963259|NCT04219722|Single-blind|single-blind
4963260|NCT04219722|Randomized|randomized
4963354|NCT04219020|Self-reported and parent-reported pain|self-reported and parent-reported pain
4963355|NCT04219020|Pain predictors|pain predictors
4963356|NCT04219020|Management of pain|management of pain
4963357|NCT04219007|Dominantly Inherited Short Stature, Idiopathic, DISS|dominantly inherited short stature, idiopathic, diss
4963358|NCT04218994|flossing|flossing
4963457|NCT04218396|Dressing change|dressing change
4963459|NCT04218331|JASPER|jasper
4963460|NCT04218331|speech|speech
4963461|NCT04218331|autism|autism
4963462|NCT04218331|ELSA-T|elsa-t
4963463|NCT04218331|BOSCC|boscc
4963464|NCT04218318|Jaundice|jaundice
4963465|NCT04218318|Newborn|newborn
4963466|NCT04218318|Hyperbilirubinemia|hyperbilirubinemia
4963467|NCT04218318|Rebound hyperbilirubinemia|rebound hyperbilirubinemia
4963468|NCT04218318|Phototherapy|phototherapy
4963469|NCT04218318|Hemolysis|hemolysis
4963470|NCT04218253|Nutrition Therapy|nutrition therapy
4963544|NCT04217759|social cognitive theory|social cognitive theory
4963545|NCT04217759|Type 2 diabetes mellitus|type 2 diabetes mellitus
4963547|NCT04217759|diabetes prevention|diabetes prevention
4963548|NCT04217759|lifestyle intervention|lifestyle intervention
4963549|NCT04217746|high flow nasal cannula|high flow nasal cannula
4963646|NCT04216992|Computed tomography|computed tomography
4963647|NCT04216992|Epidurography|epidurography
4963649|NCT04216953|MEK Inhibitor|mek inhibitor
4963767|NCT04216030|Staple crops|staple crops
4963768|NCT04216030|Stable isotope studies|stable isotope studies
4963769|NCT04215978|OX40|ox40
4963892|NCT04215146|Breast Cancer Metastatic|breast cancer metastatic
4963893|NCT04215146|Locally Advanced Breast Cancer|locally advanced breast cancer
4963894|NCT04215146|Pelareorep|pelareorep
4963895|NCT04215146|Avelumab|avelumab
4963896|NCT04215146|Paclitaxel|paclitaxel
4963897|NCT04215146|Reovirus|reovirus
4963898|NCT04215146|Oncolytic virus|oncolytic virus
4963899|NCT04215146|HR+ breast cancer|hr+ breast cancer
5005727|NCT03960931|Gait|gait
4963993|NCT04214444|pneumococcal vaccination|pneumococcal vaccination
4963994|NCT04214444|prime-boost|prime-boost
4963995|NCT04214444|rituximab|rituximab
4963997|NCT04214366|carbon ion|carbon ion
4964085|NCT04213950|rabies PEP|rabies pep
4964086|NCT04213950|rabies IG|rabies ig
4964087|NCT04213937|nab-paclitaxel Topotecan|nab-paclitaxel topotecan
4964088|NCT04213924|Extracorporeal Shockwave Lithotripsy|extracorporeal shockwave lithotripsy
4964089|NCT04213924|Erector Spinae Plane Block|erector spinae plane block
4964090|NCT04213911|esophageal manometry|esophageal manometry
4964091|NCT04213911|superimposed pressure|superimposed pressure
4964188|NCT04213183|Hepatobiliary Disease|hepatobiliary disease
4964189|NCT04213183|Artificial Intelligence|artificial intelligence
4964190|NCT04213183|Eye Images|eye images
4964191|NCT04213157|laparoscopic partial nephrectomy|laparoscopic partial nephrectomy
4964192|NCT04213157|Trifecta|trifecta
4964193|NCT04213157|Pentafecta|pentafecta
4964194|NCT04213157|Outcomes|outcomes
4964195|NCT04213131|Spinal Cord Injuries|spinal cord injuries
4964196|NCT04213131|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
4964197|NCT04213131|Pain|pain
4964198|NCT04213131|Human|human
4964219|NCT04213040|Lactate|lactate
4964286|NCT04212624|Human retinal pigment epithelial (HuRPE) cell injection|human retinal pigment epithelial (hurpe) cell injection
4964287|NCT04212624|High myopia|high myopia
4964288|NCT04212624|retinal degeneration|retinal degeneration
4964289|NCT04212598|Chemoradiotherapy|chemoradiotherapy
4964290|NCT04212598|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4964291|NCT04212598|Radiotherapy Dose|radiotherapy dose
4964379|NCT04212104|randomized and controlled trail|randomized and controlled trail
4964380|NCT04212104|desire to eat|desire to eat
4964381|NCT04212078|Intracameral Cefuroxime|intracameral cefuroxime
4964382|NCT04212078|Levofloxacin|levofloxacin
4964383|NCT04212078|Corneal Endothelial Cell count|corneal endothelial cell count
4964384|NCT04212078|Corneal Morphology|corneal morphology
4964483|NCT04211220|Decision support software|decision support software
4964484|NCT04211207|Heart's respiratory quotient|heart's respiratory quotient
4964485|NCT04211207|Cardiac Arrest|cardiac arrest
4964486|NCT04211207|Non-invasive monitoring|non-invasive monitoring
4964487|NCT04211207|Poor prognosis|poor prognosis
4964488|NCT04211181|Quality improvement|quality improvement
4964489|NCT04211181|Venous Thromboembolism|venous thromboembolism
4964490|NCT04211181|Hospital Associated-VTE|hospital associated-vte
4964491|NCT04211168|Intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
4964492|NCT04211168|hilar cholangiocarcinoma|hilar cholangiocarcinoma
4964494|NCT04211168|gallbladder cancer|gallbladder cancer
4964495|NCT04211168|Toripalimab|toripalimab
4964574|NCT04210778|Cancer related cognitive impairment|cancer related cognitive impairment
4964575|NCT04210778|Telerehabilitation|telerehabilitation
4964576|NCT04210778|Computerized Cognitive training|computerized cognitive training
4964690|NCT04209946|Less Invasive Surfactant administration|less invasive surfactant administration
4964691|NCT04209946|Continuous Positive Airway Pressure (CPAP)|continuous positive airway pressure (cpap)
4964692|NCT04209920|Molar Incisor Hypomineralization|molar incisor hypomineralization
4964711|NCT04209855|IMGN853|imgn853
4964712|NCT04209855|Epithelial Ovarian Cancer|epithelial ovarian cancer
4964713|NCT04209855|Peritoneal Cancer|peritoneal cancer
4964714|NCT04209855|Fallopian Tube Cancer|fallopian tube cancer
4964723|NCT04209725|FLT3|flt3
4964816|NCT04209335|low back pain|low back pain
4964817|NCT04209335|physical activity level|physical activity level
4964818|NCT04209335|body mass index|body mass index
4964819|NCT04209335|core muscle endurance|core muscle endurance
4964820|NCT04209335|gender|gender
4964821|NCT04209335|McGill V-sit|mcgill v-sit
4964923|NCT04208841|India|india
4964924|NCT04208841|Person-Centered Care|person-centered care
4964925|NCT04208841|Quality Improvement|quality improvement
4964931|NCT04208815|Milk|milk
4964932|NCT04208815|Polar Lipids|polar lipids
4964933|NCT04208815|Phospholipids|phospholipids
4964934|NCT04208815|Cholesterol|cholesterol
4964935|NCT04208815|Microbiota|microbiota
4964936|NCT04208815|Microbiome|microbiome
4964937|NCT04208789|Artificial Neural Network|artificial neural network
4964938|NCT04208789|GeneXpert MTB/RIF|genexpert mtb/rif
5676328|NCT00595439|CRPS|crps
4964939|NCT04208789|Drug-Resistant Tb|drug-resistant tb
4964940|NCT04208789|Diagnosis|diagnosis
4964941|NCT04208711|HIV infection|hiv infection
4964942|NCT04208711|PLA2G1B|pla2g1b
4964943|NCT04208711|Lymphocyte CD4+|lymphocyte cd4+
4964949|NCT04208659|lumbago|lumbago
4965037|NCT04208178|HER2 positive|her2 positive
4965038|NCT04208178|induction|induction
4965039|NCT04208178|PI3K|pi3k
4965040|NCT04208178|Trastuzumab|trastuzumab
4965041|NCT04208178|Pertuzumab|pertuzumab
4965153|NCT04207450|Desensitizing agents|desensitizing agents
4965156|NCT04207424|Bariatric embolization|bariatric embolization
4965157|NCT04207424|Obesity|obesity
4965158|NCT04207424|Metabolic syndrome|metabolic syndrome
4965287|NCT04206735|mechanical ventilation|mechanical ventilation
4965414|NCT04205812|PD-L1|pd-l1
4965415|NCT04205799|cervical cancer|cervical cancer
4965416|NCT04205799|advanced/metastatic|advanced/metastatic
4965417|NCT04205799|Cabozantinib|cabozantinib
4965418|NCT04205799|platinum treatment failure|platinum treatment failure
4965419|NCT04205760|LVAD|lvad
4965420|NCT04205760|preoperative optimization|preoperative optimization
4965507|NCT04205279|Surefooted platform|surefooted platform
4965509|NCT04205253|ischemia-reperfusion injury|ischemia-reperfusion injury
4965510|NCT04205253|side effect|side effect
4965512|NCT04205253|suspension laryngoscopy|suspension laryngoscopy
4965513|NCT04205227|solid tumors|solid tumors
4965514|NCT04205214|Cognitive Behavioural Therapy|cognitive behavioural therapy
4965515|NCT04205214|Mindfulness|mindfulness
4965516|NCT04205214|Narrative Therapy|narrative therapy
4965597|NCT04204551|Cognitive Function|cognitive function
4965606|NCT04204525|electroencephalography|electroencephalography
4965607|NCT04204525|functionality|functionality
4965608|NCT04204525|quality of life|quality of life
4965609|NCT04204525|cross-sectional|cross-sectional
4965610|NCT04204512|ultrasound,|ultrasound,
4965611|NCT04204512|giant cell arteritis|giant cell arteritis
4965612|NCT04204499|Genomic signatures|genomic signatures
4965708|NCT04203888|Yoga|yoga
4965709|NCT04203888|Massage|massage
4965710|NCT04203888|Pain|pain
4965711|NCT04203888|Low Back Pain|low back pain
4965712|NCT04203888|Lower Back Pain|lower back pain
4965713|NCT04203888|Virtual|virtual
4965714|NCT04203888|Swedish Massage|swedish massage
5276227|NCT02296164|PROVe|prove
4965715|NCT04203888|Personalized Trial|personalized trial
4965716|NCT04203888|Personalized|personalized
4965717|NCT04203888|Feasibility|feasibility
4965718|NCT04203771|Probiotic|probiotic
4965719|NCT04203771|Molar removal surgery|molar removal surgery
4965720|NCT04203771|Oral pain|oral pain
4965721|NCT04203771|Maxillofacial surgery|maxillofacial surgery
4965793|NCT04203160|Cholangiocarcinoma|cholangiocarcinoma
4967391|NCT04193423|exercise|exercise
4965802|NCT04203095|Drug resistance in Immunotherapy|drug resistance in immunotherapy
4965804|NCT04203069|Lymphedema of upper arm|lymphedema of upper arm
4965805|NCT04203069|Auto-Adjustable MOBIDERM® Autofit Armsleeve|auto-adjustable mobiderm® autofit armsleeve
4965806|NCT04203069|Compression garments|compression garments
4965807|NCT04203069|Maintenance phase|maintenance phase
4965809|NCT04203030|physical function|physical function
4965811|NCT04203004|Cytokine filtration|cytokine filtration
4965896|NCT04202367|Postoperative analgesia|postoperative analgesia
4965897|NCT04202367|Inguinal hernia repair surgery|inguinal hernia repair surgery
4965898|NCT04202341|gMG|gmg
4965899|NCT04202341|Soliris|soliris
4965900|NCT04202341|Alexion C5 Inhibition Therapy|alexion c5 inhibition therapy
4965901|NCT04202341|Alexion C5IT|alexion c5it
4965902|NCT04202341|Patient Registry|patient registry
4965904|NCT04202341|Alexion Registry|alexion registry
4965990|NCT04201990|Apatinib|apatinib
4965991|NCT04201938|Omega-3 Fatty Acids|omega-3 fatty acids
4965993|NCT04201938|Lactobacillus|lactobacillus
4965994|NCT04201938|Bifidobacterium|bifidobacterium
4965995|NCT04201938|Propionibacterium|propionibacterium
4965996|NCT04201938|Acetobacter|acetobacter
4966108|NCT04201418|Polyneuropathies|polyneuropathies
4966109|NCT04201418|Amyloid neuropathies|amyloid neuropathies
4966110|NCT04201418|Amyloid neuropathies, familial|amyloid neuropathies, familial
4966111|NCT04201418|Amyloidosis, familial|amyloidosis, familial
4966112|NCT04201418|Peripheral nervous system diseases|peripheral nervous system diseases
4966113|NCT04201418|Nervous system diseases|nervous system diseases
4966114|NCT04201418|TTR|ttr
4966115|NCT04201418|Neuromuscular diseases|neuromuscular diseases
4966138|NCT04201288|HIV|hiv
4966214|NCT04200820|Sacculus|sacculus
4966215|NCT04200807|cardiac output; echocardiography; USCOM; neonates|cardiac output; echocardiography; uscom; neonates
4966216|NCT04200794|music-practice|music-practice
4966331|NCT04200118|Testicular cancer|testicular cancer
4966332|NCT04200066|Maprotiline|maprotiline
4966333|NCT04200066|Tamoxifen|tamoxifen
4966334|NCT04200066|Temozolomide|temozolomide
4966335|NCT04200053|burn|burn
4966336|NCT04200053|reflexology|reflexology
4966337|NCT04200053|music|music
4966338|NCT04200053|pain|pain
4966339|NCT04200053|anxiety|anxiety
4966340|NCT04200053|sleep|sleep
4966341|NCT04200014|Syncope|syncope
4966342|NCT04200014|Arrhythmia|arrhythmia
4966343|NCT04200001|breast cancer|breast cancer
4966344|NCT04200001|hormonotherapy|hormonotherapy
4966459|NCT04199273|Intensive Care Unit|intensive care unit
4966460|NCT04199273|Invasive Mechanical Ventilation|invasive mechanical ventilation
4966461|NCT04199273|Diaphragm weakness assessment|diaphragm weakness assessment
4966462|NCT04199273|Rehabilitation|rehabilitation
4966463|NCT04199221|Stress Inoculation|stress inoculation
4966464|NCT04199221|Medical Education|medical education
4966465|NCT04199221|Simulation Training|simulation training
4966466|NCT04199208|exercise therapy|exercise therapy
4966564|NCT04198636|Xgeva®|xgeva®
4966565|NCT04198636|Healthy adults|healthy adults
4966566|NCT04198571|Bacteria|bacteria
4966567|NCT04198571|Zinforo® (ceftaroline fosamil)|zinforo® (ceftaroline fosamil)
4966568|NCT04198571|CAP|cap
4966569|NCT04198571|cSSTi|cssti
4966570|NCT04198571|Hospitalized|hospitalized
4966571|NCT04198571|Infectious Disease|infectious disease
4966572|NCT04198571|Antibiotic|antibiotic
4966573|NCT04198571|Cephalosporin|cephalosporin
4966578|NCT04198545|Iron absorption|iron absorption
4966579|NCT04198545|Genetics|genetics
4966580|NCT04198519|Obesity|obesity
4966581|NCT04198519|Weight loss|weight loss
4966582|NCT04198519|Cardiovascular diseases|cardiovascular diseases
4966583|NCT04198519|Sleep Apnea Syndromes|sleep apnea syndromes
4966584|NCT04198519|Arterial stiffness|arterial stiffness
4966659|NCT04197986|FGFR3 Genetic Alterations|fgfr3 genetic alterations
4966660|NCT04197986|upper tract urothelial carcinomas|upper tract urothelial carcinomas
4966661|NCT04197986|UTUC|utuc
4966662|NCT04197986|Invasive Urothelial Carcinoma|invasive urothelial carcinoma
4966663|NCT04197986|Fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
4966664|NCT04197986|BGJ398|bgj398
4966665|NCT04197986|FGFR3|fgfr3
4966666|NCT04197986|urothelial bladder cancer|urothelial bladder cancer
4966667|NCT04197986|UBC|ubc
4966668|NCT04197986|Infigratinib phosphate|infigratinib phosphate
4966669|NCT04197986|Infigratinib|infigratinib
4966670|NCT04197986|Adjuvant|adjuvant
4966671|NCT04197973|SCCAI|sccai
4966672|NCT04197973|health-related quality of life index|health-related quality of life index
4966776|NCT04197297|Biomarkers|biomarkers
4966777|NCT04197297|Magnetic Resonance Imaging|magnetic resonance imaging
4966778|NCT04197297|Computed Tomography|computed tomography
4966779|NCT04197297|Radiosurgery|radiosurgery
4966780|NCT04197284|osteoarthritis|osteoarthritis
4966782|NCT04197284|biofeedback|biofeedback
4966783|NCT04197284|electrical stimulation|electrical stimulation
4966784|NCT04197284|kinesitherapy|kinesitherapy
4966890|NCT04196647|tele-medicine|tele-medicine
4966891|NCT04196634|Risk Assessment|risk assessment
4966892|NCT04196595|Menstruation|menstruation
4966893|NCT04196595|Menstrual Cycle|menstrual cycle
4966894|NCT04196595|Ovulation|ovulation
4966895|NCT04196595|Polycystic Ovary Syndrome|polycystic ovary syndrome
4966896|NCT04196595|Infertility|infertility
4966897|NCT04196595|Menopause|menopause
4967235|NCT04194333|Cone Beam CT|cone beam ct
4967236|NCT04194333|CT Augmented Fluoroscopy|ct augmented fluoroscopy
4967237|NCT04194333|EMN|emn
4967238|NCT04194333|Electromagnetic Navigation Bronchoscopy|electromagnetic navigation bronchoscopy
4967332|NCT04193696|anti-PD-1|anti-pd-1
4967333|NCT04193696|radiotherapy|radiotherapy
4967334|NCT04193683|Hamstring Muscle|hamstring muscle
4967335|NCT04193683|Hamstring Shortness|hamstring shortness
4967336|NCT04193683|Hamstring Stiffness|hamstring stiffness
4967337|NCT04193683|Myofascial Release Technique|myofascial release technique
4967577|NCT04192552|discontinue|discontinue
4967578|NCT04192552|elective|elective
4967579|NCT04192552|perioperative|perioperative
4967580|NCT04192526|serum cholinestrase, atropin, aluminum phosphide|serum cholinestrase, atropin, aluminum phosphide
4967680|NCT04191928|pancreaticoduodenectomy|pancreaticoduodenectomy
4967681|NCT04191928|whipple|whipple
4967682|NCT04191928|pharmacokinetic|pharmacokinetic
4967683|NCT04191915|Aged|aged
4967684|NCT04191915|Cardiac Surgical Procedures|cardiac surgical procedures
4967685|NCT04191915|Coronary Artery Disease|coronary artery disease
4967686|NCT04191915|Frail Elderly|frail elderly
4967687|NCT04191915|Frailty|frailty
4967688|NCT04191915|Heart Valve Diseases|heart valve diseases
4967689|NCT04191889|Advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
4967690|NCT04191889|hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
4967691|NCT04191889|anti-PD-1 immunotherapy|anti-pd-1 immunotherapy
4967692|NCT04191889|Camrelizumab|camrelizumab
4967886|NCT04190628|Melanoma|melanoma
4967786|NCT04191148|UTI|uti
4967907|NCT04190498|hepatitis C virus|hepatitis c virus
4967908|NCT04190485|Gingivitis|gingivitis
4967909|NCT04190485|Probiotic|probiotic
4967910|NCT04190485|Toothpaste|toothpaste
4967911|NCT04190485|Oral microbiota|oral microbiota
4967913|NCT04190472|Follow-up|follow-up
4967914|NCT04190472|LEEP|leep
4968113|NCT04189315|Asfotase Alfa|asfotase alfa
4968114|NCT04189289|Erector spinae plane (ESP) block|erector spinae plane (esp) block
4968115|NCT04189289|Laparoscopic bariatric surgery|laparoscopic bariatric surgery
4968116|NCT04189289|Obesity|obesity
4968117|NCT04189289|Postoperative pain|postoperative pain
4968118|NCT04189276|Hepatitis B Virus (HBV) infection|hepatitis b virus (hbv) infection
4968119|NCT04189263|aromatase inhibitor|aromatase inhibitor
4968120|NCT04189263|carbohydrate restricted diet|carbohydrate restricted diet
4968121|NCT04189237|electroacupuncture|electroacupuncture
4968122|NCT04189237|wrist functionality|wrist functionality
4968123|NCT04189237|distal radius fracture|distal radius fracture
4968132|NCT04189159|cerebral palsy|cerebral palsy
4968203|NCT04188678|Allogeneic blood and marrow transplantation (alloBMT)|allogeneic blood and marrow transplantation (allobmt)
4968204|NCT04188678|Resiliency|resiliency
4968205|NCT04188678|REBOUND|rebound
4968206|NCT04188678|over age 60|over age 60
4968207|NCT04188665|maackia amurensis|maackia amurensis
4968309|NCT04187885|adolescent|adolescent
4968310|NCT04187885|physical activity|physical activity
4968311|NCT04187885|academic stress|academic stress
4968312|NCT04187859|Hydration|hydration
4968313|NCT04187859|Fluid Intake|fluid intake
4968314|NCT04187859|Frailty|frailty
4968315|NCT04187859|Feasibility Study|feasibility study
4968316|NCT04187846|Cesarean section|cesarean section
4968317|NCT04187846|post spinal headache|post spinal headache
4968318|NCT04187846|Near Infrared spectroscopy|near infrared spectroscopy
4968319|NCT04187820|acupuncture|acupuncture
4968322|NCT04187768|Lung Cancer|lung cancer
4968417|NCT04187053|Laser|laser
4968418|NCT04187053|Antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
4968527|NCT04186429|precision medicine|precision medicine
4968529|NCT04186429|proteomic|proteomic
4968531|NCT04186429|recovery|recovery
4968627|NCT04185701|ametropia|ametropia
4968628|NCT04185688|Multiple Sclerosis|multiple sclerosis
4968629|NCT04185688|Functional reach test|functional reach test
4968630|NCT04185688|Reliability|reliability
4968747|NCT04184856|variability|variability
4968748|NCT04184856|ecological momentary assessment (EMA)|ecological momentary assessment (ema)
4968749|NCT04184817|Achondroplasia|achondroplasia
4968750|NCT04184817|cranio-vertebral abnormalities|cranio-vertebral abnormalities
4968755|NCT04184791|Deep Brain Stimulation|deep brain stimulation
4968756|NCT04184791|Parkinson's Disease|parkinson's disease
4968858|NCT04184219|dietary supplements|dietary supplements
5666415|NCT00635336|CTL|ctl
4968859|NCT04184219|knowledge about dietary supplements|knowledge about dietary supplements
4968860|NCT04184219|use of dietary supplements|use of dietary supplements
4968861|NCT04184219|trust in advertising dietary supplements|trust in advertising dietary supplements
4968862|NCT04184219|beliefs about medicines|beliefs about medicines
4968863|NCT04184219|diagnostic prediction model|diagnostic prediction model
4968864|NCT04184180|lung transplantation|lung transplantation
4968865|NCT04184180|pulmonary rehabilitation|pulmonary rehabilitation
4968866|NCT04184180|exercise training|exercise training
4968943|NCT04183725|randomized|randomized
4968944|NCT04183725|double blind|double blind
4968945|NCT04183725|parallel control|parallel control
4968956|NCT04183608|UC|uc
4969159|NCT04182360|Twins|twins
4969160|NCT04182360|Postpartum hemorrhage|postpartum hemorrhage
4969161|NCT04182360|carbetocin|carbetocin
4969162|NCT04182360|uterotonic|uterotonic
4969163|NCT04182360|cesarean delivery|cesarean delivery
4969164|NCT04182347|Individuals with Intellectual or Developmental Disabilities|individuals with intellectual or developmental disabilities
4969165|NCT04182347|Research|research
4969166|NCT04182347|ToolKit|toolkit
4969167|NCT04182347|Health Disparities|health disparities
4969168|NCT04182347|Engagement|engagement
4969169|NCT04182334|Delirium|delirium
4969170|NCT04182334|Music|music
4969171|NCT04182334|Pain|pain
4969175|NCT04182321|Entecavir|entecavir
4969176|NCT04182321|hepatitis B virus (HBV)|hepatitis b virus (hbv)
4969177|NCT04182295|Placebo|placebo
4969178|NCT04182295|Informed consent|informed consent
4969179|NCT04182295|Participant information leaflet|participant information leaflet
4969180|NCT04182295|Outcome|outcome
4969181|NCT04182295|Blinding|blinding
4969182|NCT04182295|Sham|sham
4969183|NCT04182295|Acupuncture|acupuncture
4969184|NCT04182295|Delayed Onset Muscle Soreness|delayed onset muscle soreness
4969185|NCT04182282|Alzheimer's Disease|alzheimer's disease
4969186|NCT04182282|Dementia|dementia
4969236|NCT04182009|COPD|copd
4969237|NCT04182009|Nebuliser|nebuliser
4969238|NCT04182009|Sputum Induction|sputum induction
4969239|NCT04182009|Safety|safety
4969240|NCT04182009|Tolerability|tolerability
4969241|NCT04182009|Quality|quality
4969242|NCT04182009|Quantity|quantity
4969243|NCT04182009|Physiotherapy|physiotherapy
4969244|NCT04181996|Imaging, PET, inflammation, Biomarkers, Colchicine|imaging, pet, inflammation, biomarkers, colchicine
4969245|NCT04181983|Home-based personalized exercise program|home-based personalized exercise program
4969246|NCT04181983|Smart phone application|smart phone application
4969247|NCT04181918|Action Observation Treatment|action observation treatment
4969248|NCT04181918|Motor Imagery|motor imagery
4969249|NCT04181918|Randomized Controlled Study|randomized controlled study
4969250|NCT04181905|Asthma, Kinesiophobia, Physical Activity, Quality of Life|asthma, kinesiophobia, physical activity, quality of life
4969251|NCT04181892|connective tissue graft|connective tissue graft
4969252|NCT04181879|Older people|older people
4969253|NCT04181879|Primary care|primary care
4969322|NCT04181242|Epidemiology, Incidence, Athletic Injuries, Racquet Sports, Badminton|epidemiology, incidence, athletic injuries, racquet sports, badminton
4969323|NCT04181203|Apalutamide|apalutamide
4969324|NCT04181203|Salvage radiotherapy|salvage radiotherapy
4969425|NCT04180579|chemotherapy induced alopecia|chemotherapy induced alopecia
4969426|NCT04180579|19-277|19-277
4969427|NCT04180579|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4969434|NCT04180553|Ultrasound|ultrasound
4969435|NCT04180553|Goal-directed resuscitation|goal-directed resuscitation
4969436|NCT04180540|Cardiology|cardiology
4969437|NCT04180540|Electrophysiology|electrophysiology
4969438|NCT04180527|preoperative|preoperative
4969439|NCT04180527|sleep|sleep
4969440|NCT04180527|anxiety|anxiety
4969441|NCT04180527|hip surgery|hip surgery
4969442|NCT04180527|knee surgery|knee surgery
4969443|NCT04180527|storytelling|storytelling
4969444|NCT04180514|intradialytic hypotension|intradialytic hypotension
4969445|NCT04180514|pulse wave analysis|pulse wave analysis
4969446|NCT04180514|heart rate variability|heart rate variability
4969518|NCT04180059|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
4969519|NCT04180059|lymphocyte infusion|lymphocyte infusion
4969520|NCT04180059|cytotoxic T lymphocyte|cytotoxic t lymphocyte
4969521|NCT04180059|HLA-DP|hla-dp
4969522|NCT04180059|T cell therapy|t cell therapy
4969523|NCT04180046|glioblastoma|glioblastoma
4969524|NCT04180046|cell|cell
4969525|NCT04180046|mutation|mutation
4969527|NCT04179981|Apnea|apnea
4969528|NCT04179981|Sleep Apnea Syndromes|sleep apnea syndromes
4969530|NCT04179981|Nervous System Diseases|nervous system diseases
4969729|NCT04179097|Photoplethysmography|photoplethysmography
4969730|NCT04179071|Famotidine|famotidine
4969731|NCT04179071|Drug-drug interaction study|drug-drug interaction study
4969732|NCT04179071|Small molecule kinase inhibitor|small molecule kinase inhibitor
4969733|NCT04179058|Connective tissue disease|connective tissue disease
4969763|NCT04178967|Eczema|eczema
4969826|NCT04178577|Hemodialysis|hemodialysis
4969827|NCT04178564|Neurocognitive Disorders|neurocognitive disorders
5304149|NCT02156622|HIV|hiv
4969828|NCT04178564|Dementia|dementia
4969829|NCT04178564|Cognitive Impairment|cognitive impairment
4969830|NCT04178564|Cognitive Decline|cognitive decline
4969831|NCT04178564|Elderly|elderly
4969832|NCT04178564|Cognitive Stimulation|cognitive stimulation
4969833|NCT04178564|Group Intervention|group intervention
4969834|NCT04178564|Cognition|cognition
4969835|NCT04178564|Depression|depression
4969836|NCT04178551|Opioid Medication Assisted Treatment|opioid medication assisted treatment
4969837|NCT04178551|Addiction, Opioid|addiction, opioid
4969839|NCT04178538|ACL|acl
4969910|NCT04178187|Proton pump inhibitors|proton pump inhibitors
4969911|NCT04178187|Saccharomyces boulardii|saccharomyces boulardii
4970006|NCT04177615|Ischemic stroke|ischemic stroke
4970010|NCT04177602|neoadjuvant|neoadjuvant
4970256|NCT04176263|Rehabilitation|rehabilitation
4970405|NCT04175561|Green prescription|green prescription
4970512|NCT04174807|predictive factors|predictive factors
4970513|NCT04174794|Acute heart failure|acute heart failure
4970514|NCT04174794|Lung ultrasound|lung ultrasound
4970515|NCT04174781|Hepatocellular carcinoma|hepatocellular carcinoma
4970516|NCT04174781|Transarterial chemoembolization|transarterial chemoembolization
4970517|NCT04174781|Immunotherapy|immunotherapy
4970518|NCT04174755|obesity|obesity
4970519|NCT04174755|HIV|hiv
4970520|NCT04174755|weight loss|weight loss
4970521|NCT04174755|GLP-1 analogue|glp-1 analogue
4970522|NCT04174755|immune activation|immune activation
4970523|NCT04174755|viral reservoir|viral reservoir
4970524|NCT04174755|gut microbiome|gut microbiome
4970525|NCT04174716|HRR|hrr
4970526|NCT04174690|Center of pressure|center of pressure
4970528|NCT04174690|Force platform|force platform
4970731|NCT04173377|Elbow|elbow
4970732|NCT04173377|Trauma|trauma
4970733|NCT04173377|Arthroplasty|arthroplasty
4970734|NCT04173377|Osteosynthesis|osteosynthesis
4970735|NCT04173364|interscalene block|interscalene block
4970736|NCT04173364|shoulder surgery|shoulder surgery
4970737|NCT04173364|local anesthesic|local anesthesic
4970738|NCT04173364|respiratory function|respiratory function
4970739|NCT04173364|diaphragmatic dysfunction|diaphragmatic dysfunction
4970740|NCT04173364|echography|echography
4970741|NCT04173364|locoregional anesthesia|locoregional anesthesia
4970742|NCT04173351|childbirth|childbirth
4970743|NCT04173351|nulliparous|nulliparous
4970849|NCT04172571|Tyrosine Kinase Inhibitor (TKI)|tyrosine kinase inhibitor (tki)
4970850|NCT04172571|Angiogenesis-related kinases|angiogenesis-related kinases
4970851|NCT04172558|Botulimium Toxin|botulimium toxin
4970941|NCT04172025|Epidemiology|epidemiology
4970942|NCT04172025|surveillance|surveillance
4970943|NCT04172025|bacterial pathogens|bacterial pathogens
4970944|NCT04172025|Database|database
4970945|NCT04172025|Genotyping|genotyping
4970946|NCT04172012|Tanzania|tanzania
4970947|NCT04172012|East Africa|east africa
4970948|NCT04172012|Antimicrobial resistance|antimicrobial resistance
4970949|NCT04172012|Probiotics|probiotics
4970950|NCT04172012|Extended Spectrum Beta-Lactamase Producing Bacteria|extended spectrum beta-lactamase producing bacteria
4970951|NCT04171999|Food Insecurity|food insecurity
4970952|NCT04171999|Caregivers|caregivers
4971187|NCT04170881|respiratory health|respiratory health
4971188|NCT04170881|young children|young children
4971189|NCT04170881|nursery workers|nursery workers
4971190|NCT04170881|nursery environment|nursery environment
4971191|NCT04170855|kidney sodium content|kidney sodium content
4971287|NCT04170231|Critically Ill Children|critically ill children
4971289|NCT04170218|knee osteoarthritis|knee osteoarthritis
4971290|NCT04170218|hip osteoarthritis|hip osteoarthritis
4971291|NCT04170218|quality of healthcare|quality of healthcare
4971292|NCT04170218|elderly|elderly
4971296|NCT04170179|Hepatocellular Carcinoma|hepatocellular carcinoma
4971297|NCT04170179|Lenvatinib|lenvatinib
4971298|NCT04170179|Toripalimab|toripalimab
4971299|NCT04170179|Systemic chemotherapy|systemic chemotherapy
4971300|NCT04170179|Oxaliplatin, leucovorin, 5-fluorouracil|oxaliplatin, leucovorin, 5-fluorouracil
4971301|NCT04170179|Extrahepatic metastasis|extrahepatic metastasis
4971302|NCT04170153|M1774|m1774
4971303|NCT04170153|ATR inhibitor|atr inhibitor
4971304|NCT04170153|Metastatic or Locally Advanced Unresectable Solid Tumors|metastatic or locally advanced unresectable solid tumors
4971306|NCT04170114|Cystic Fibrosis|cystic fibrosis
4971387|NCT04169646|neck-specific exercises|neck-specific exercises
4971388|NCT04169646|stepped wedge design|stepped wedge design
4971389|NCT04169646|productivity|productivity
4971492|NCT04168840|difficult airway|difficult airway
4971493|NCT04168840|difficult intubation|difficult intubation
4971494|NCT04168827|Severe trauma|severe trauma
4971495|NCT04168827|Post-traumatic stress|post-traumatic stress
4971496|NCT04168827|Anxiety|anxiety
4971497|NCT04168827|Depression|depression
4971498|NCT04168827|Intensive care|intensive care
4971596|NCT04168294|Automobile Driving|automobile driving
4971597|NCT04168242|Gynecologic cancer|gynecologic cancer
4971598|NCT04168242|chemotherapy-induced alopecia|chemotherapy-induced alopecia
4971600|NCT04168216|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
4971601|NCT04168203|pulmonary embolism|pulmonary embolism
4971602|NCT04168203|deep vein thrombosis|deep vein thrombosis
4971603|NCT04168203|venous thromboembolism|venous thromboembolism
5699535|NCT00502749|Lymphoma|lymphoma
4971605|NCT04168203|anticoagulation|anticoagulation
4971713|NCT04167592|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
4971715|NCT04167566|mass testing|mass testing
4971716|NCT04167566|treatment|treatment
4971717|NCT04167566|tracking|tracking
4971718|NCT04167566|Malaria prevalence|malaria prevalence
4971719|NCT04167566|Children|children
4971720|NCT04167566|Pakro Ghana|pakro ghana
4971721|NCT04167540|PD|pd
4971727|NCT04167540|AAV|aav
4971837|NCT04166851|Pre-exposure prophylaxis|pre-exposure prophylaxis
4971838|NCT04166851|Health Promotion|health promotion
4971839|NCT04166851|HIV/AIDS primary prevention|hiv/aids primary prevention
4971975|NCT04166006|Neuroendocrine Tumors|neuroendocrine tumors
4971976|NCT04166006|Soft Tissue Sarcoma|soft tissue sarcoma
4971977|NCT04166006|rare cancer|rare cancer
4971978|NCT04166006|vaccination|vaccination
4971979|NCT04166006|autologous dendritic cells|autologous dendritic cells
4971980|NCT04166006|adjuvant|adjuvant
4971981|NCT04166006|Interleukin-2|interleukin-2
4971992|NCT04165928|neonatal tetanus|neonatal tetanus
4971993|NCT04165928|tetanus immunization program|tetanus immunization program
4971994|NCT04165928|drug-induced|drug-induced
4971995|NCT04165928|tetanus antitoxin|tetanus antitoxin
4971996|NCT04165928|critical care medicine|critical care medicine
4971997|NCT04165928|artificial airway|artificial airway
4971998|NCT04165915|Aged of 60 years and more|aged of 60 years and more
4971999|NCT04165915|living in the Est-Héraultais territory|living in the est-héraultais territory
4972000|NCT04165915|seniors'health paths|seniors'health paths
4972001|NCT04165915|PAERPA|paerpa
4972002|NCT04165902|knee osteoarthritis, hyaluronic acid, steroid, dextrose|knee osteoarthritis, hyaluronic acid, steroid, dextrose
4972003|NCT04165889|hospitalized in internal medicine unit|hospitalized in internal medicine unit
4972069|NCT04165655|Wellbeing|wellbeing
4972208|NCT04165083|Programmed Cell Death Receptor 1 (PD-1, PD1)|programmed cell death receptor 1 (pd-1, pd1)
4972209|NCT04165083|Programmed Cell Death Receptor Ligand 1 (PD-L1, PDL1)|programmed cell death receptor ligand 1 (pd-l1, pdl1)
4972210|NCT04165083|Programmed Cell Death Receptor Ligand 2 (PD-L2, PDL2)|programmed cell death receptor ligand 2 (pd-l2, pdl2)
4972213|NCT04165057|Laparoscopic surgery|laparoscopic surgery
4972217|NCT04165057|Sugammadex|sugammadex
4972312|NCT04164472|Aggression|aggression
4972313|NCT04164472|Indicated intervention|indicated intervention
4972422|NCT04163900|Gemcitabine|gemcitabine
4972423|NCT04163900|Hepatobiliary|hepatobiliary
4972424|NCT04163900|Intrahepatic|intrahepatic
4972425|NCT04163900|Locally advanced|locally advanced
4972426|NCT04163900|Metastatic|metastatic
4972427|NCT04163900|Neoplasm|neoplasm
4972428|NCT04163900|NUC-1031|nuc-1031
4972429|NCT04163900|ProTides|protides
4972430|NCT04163900|Untreated|untreated
4972431|NCT04163887|Liver resection|liver resection
4972526|NCT04163406|Human milk oligosaccharides|human milk oligosaccharides
4972528|NCT04163406|Kenya|kenya
4972529|NCT04163393|Coronary Artery Disease|coronary artery disease
4972627|NCT04162964|Mind-body therapy|mind-body therapy
4972628|NCT04162964|Anxiety|anxiety
4972629|NCT04162964|Depression|depression
4972630|NCT04162951|Retrolaminar|retrolaminar
4972631|NCT04162951|Paravertebral|paravertebral
4972634|NCT04162938|HCV Linkage to Care|hcv linkage to care
4972635|NCT04162938|HCV Education|hcv education
4972636|NCT04162912|Advance Care Planning|advance care planning
4972637|NCT04162912|Motivational Interviewing|motivational interviewing
4972638|NCT04162912|Pallative Care|pallative care
4972639|NCT04162886|Exercise|exercise
4972640|NCT04162886|power|power
4972641|NCT04162886|muscle strength|muscle strength
4972642|NCT04162886|balance|balance
4972643|NCT04162808|bleeding|bleeding
4972644|NCT04162808|antithrombosis|antithrombosis
4972645|NCT04162795|Allergy|allergy
4972646|NCT04162795|Upper respiratory allergies|upper respiratory allergies
4972651|NCT04162717|Symptom triage|symptom triage
4972652|NCT04162717|Self care|self care
4972653|NCT04162717|Symptom management|symptom management
4972654|NCT04162717|Quality of life|quality of life
4972655|NCT04162626|public health nurse|public health nurse
4972831|NCT04161729|magnesium|magnesium
4972832|NCT04161729|analgesia|analgesia
4972833|NCT04161729|pain score|pain score
4972834|NCT04161729|opioid consumption|opioid consumption
4972835|NCT04161729|spine surgery|spine surgery
4972836|NCT04161716|Urodynamic|urodynamic
4972837|NCT04161716|bladder|bladder
4972838|NCT04161716|detrusor|detrusor
4972896|NCT04161391|MTC|mtc
4972932|NCT04161209|Stress induction paradigm|stress induction paradigm
4972933|NCT04161209|Healthy volunteers|healthy volunteers
4972934|NCT04161183|shock wave|shock wave
4972935|NCT04161183|detrusor underactivity|detrusor underactivity
4972936|NCT04161183|underactive bladder|underactive bladder
4972937|NCT04161170|Continuous glucose monitoring system|continuous glucose monitoring system
4972938|NCT04161170|Artificial intelligence|artificial intelligence
4972939|NCT04161170|Diabetes|diabetes
4972940|NCT04161170|Digital healthcare|digital healthcare
5320213|NCT02083861|strength|strength
4972941|NCT04161170|Education|education
4973034|NCT04160559|Non-small cell lung cancer， green tea, chemotherapy，QOL|non-small cell lung cancer， green tea, chemotherapy，qol
4973035|NCT04160546|Chronic Myeloid Leukemia|chronic myeloid leukemia
4973036|NCT04160546|Ponatinib|ponatinib
4973037|NCT04160520|morphine|morphine
4973038|NCT04160520|Pramipexole|pramipexole
4973039|NCT04160520|Renal Colic|renal colic
4973040|NCT04160520|Kidney Stone|kidney stone
4973041|NCT04160520|opioids|opioids
4973042|NCT04160520|analgesia|analgesia
4973179|NCT04159506|emotion regulation|emotion regulation
4973180|NCT04159467|Urinary Incontinence|urinary incontinence
4973288|NCT04158921|Glycemic Control|glycemic control
4973293|NCT04158921|Lifestyle|lifestyle
4973396|NCT04157920|TAVR|tavr
4973397|NCT04157920|transcatheter|transcatheter
4973398|NCT04157920|valve|valve
4973399|NCT04157894|Long-lasting insecticidal net|long-lasting insecticidal net
4973400|NCT04157894|LLIN|llin
4973401|NCT04157894|Insecticide treated net|insecticide treated net
4973402|NCT04157894|ITN|itn
4973403|NCT04157894|Malaria|malaria
4973404|NCT04157894|Epidemiology|epidemiology
4973406|NCT04157894|Durability|durability
4973510|NCT04157114|Alcohol Treatment|alcohol treatment
4973511|NCT04157114|Alcohol|alcohol
4973512|NCT04157101|Pain|pain
4973513|NCT04157101|Veteran|veteran
4973514|NCT04157101|Health Coaching|health coaching
4973515|NCT04157101|Clinical Trial|clinical trial
4973516|NCT04157101|Supportive Psychotherapy|supportive psychotherapy
4973517|NCT04157101|Illness beliefs|illness beliefs
4973518|NCT04157062|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
4973519|NCT04157049|AATTD|aattd
4973603|NCT04156555|diarrhea|diarrhea
4973604|NCT04156555|Gut microbiome|gut microbiome
4973605|NCT04156542|Behavioral nudges|behavioral nudges
4973606|NCT04156542|Food environment|food environment
4973607|NCT04156542|Choice architecture|choice architecture
4973608|NCT04156542|Lasting behavior change|lasting behavior change
4973609|NCT04156542|Child nutrition|child nutrition
4973610|NCT04156542|National School Lunch Program|national school lunch program
4973611|NCT04156529|body position|body position
4973612|NCT04156529|enteral feeding intolerance|enteral feeding intolerance
4973613|NCT04156529|nursing care|nursing care
4973614|NCT04156529|pain|pain
4973615|NCT04156529|stress|stress
4973620|NCT04156490|Ischemic stroke|ischemic stroke
4973621|NCT04156490|midline shift|midline shift
4973622|NCT04156464|lorazepam|lorazepam
4973623|NCT04156464|phenobarbital|phenobarbital
4973624|NCT04156464|ativan|ativan
4973625|NCT04156464|alcohol withdrawal syndrome|alcohol withdrawal syndrome
4973626|NCT04156464|alcohol withdrawal|alcohol withdrawal
4973627|NCT04156464|intensive care unit|intensive care unit
4973628|NCT04156464|delirium tremens|delirium tremens
4973629|NCT04156464|refractory alcohol withdrawal|refractory alcohol withdrawal
4973630|NCT04156464|benzodiazepine|benzodiazepine
4973631|NCT04156451|Deresuscitation|deresuscitation
4973686|NCT04156139|Weaning|weaning
4973687|NCT04156139|COPD|copd
4973688|NCT04156139|PIC|pic
4973689|NCT04156113|Beige fat cell|beige fat cell
4973690|NCT04156113|Fat tissue|fat tissue
4973691|NCT04156113|Athletes|athletes
4973692|NCT04156113|Sedentary people|sedentary people
4973693|NCT04156113|Irisin|irisin
4973694|NCT04156074|Vitamin D|vitamin d
4973695|NCT04156074|Bioavailability|bioavailability
4973696|NCT04156074|Aging|aging
4973697|NCT04156074|Fortified foods|fortified foods
4973698|NCT04156074|Vitamin D status|vitamin d status
4973787|NCT04155580|Cellular inhibitor of apoptosis protein|cellular inhibitor of apoptosis protein
4973788|NCT04155580|XIAP|xiap
4973789|NCT04155580|CDAi|cdai
4973790|NCT04155580|Cytidine deaminase inhibitor|cytidine deaminase inhibitor
4973791|NCT04155580|Cedazuridine|cedazuridine
4974009|NCT04154462|workforce|workforce
4974010|NCT04154462|medical records|medical records
4974011|NCT04154462|documentation|documentation
4974012|NCT04154462|efficiency|efficiency
4974013|NCT04154462|patient satisfaction|patient satisfaction
4974032|NCT04154397|Elderly|elderly
4974117|NCT04153734|Pembrolizumab|pembrolizumab
4974118|NCT04153734|Platinum doublets|platinum doublets
4974119|NCT04153734|Non-small cell lung cancer|non-small cell lung cancer
4974293|NCT04153123|peribulbar block|peribulbar block
4974447|NCT04152109|epilepsy|epilepsy
4974448|NCT04152109|complementary therapies|complementary therapies
4974449|NCT04152070|Frailty|frailty
4974450|NCT04152070|Spanish|spanish
4974451|NCT04152070|Older adults|older adults
4974452|NCT04152057|Pyrotinib Maleate Tablets|pyrotinib maleate tablets
4974453|NCT04152057|Trastuzumab|trastuzumab
4974454|NCT04152057|Albumin Paclitaxel|albumin paclitaxel
4974455|NCT04152057|Early or Locally Advanced|early or locally advanced
4974456|NCT04152057|neoadjuvant|neoadjuvant
4974457|NCT04151979|placenta accreta spectrum|placenta accreta spectrum
4974531|NCT04151485|pregnancy|pregnancy
4974532|NCT04151485|stress|stress
4974533|NCT04151485|depression|depression
4974534|NCT04151485|anxiety|anxiety
4974535|NCT04151485|quality of life|quality of life
4974536|NCT04151485|sleep quality|sleep quality
4974537|NCT04151485|circadian rhythm|circadian rhythm
4974538|NCT04151485|mind/body|mind/body
4974539|NCT04151472|Migraine Prophylaxis|migraine prophylaxis
4974540|NCT04151472|Mitochondrial Dysfunction|mitochondrial dysfunction
4974541|NCT04151472|Idebenone|idebenone
4975754|NCT04143399|LUTS|luts
4974634|NCT04150874|Hepatic Artery Embolization|hepatic artery embolization
4974635|NCT04150874|Liver Metastases|liver metastases
4974636|NCT04150874|Radioembolization|radioembolization
4974659|NCT04150666|water intake|water intake
4974771|NCT04149847|inguinal hernia|inguinal hernia
4974772|NCT04149847|quality of life|quality of life
4974773|NCT04149847|COMI-hernia|comi-hernia
4974774|NCT04149847|polypropylene mesh repair|polypropylene mesh repair
4974775|NCT04149847|nylon darn repair|nylon darn repair
4974776|NCT04149847|patient-reported outcomes|patient-reported outcomes
4974777|NCT04149834|Intraossous defects|intraossous defects
4974778|NCT04149834|Periodontitis|periodontitis
4974781|NCT04149795|Physical activity|physical activity
4974782|NCT04149795|Mental disorder|mental disorder
4974783|NCT04149795|Recommendation behaviour|recommendation behaviour
4974784|NCT04149795|Prescription Behaviour|prescription behaviour
4974785|NCT04149795|Mental health|mental health
4974786|NCT04149795|Exercise|exercise
4974787|NCT04149782|HIV|hiv
4974788|NCT04149782|South Africa|south africa
4974789|NCT04149782|Differentiated service delivery|differentiated service delivery
4974791|NCT04149730|Epinephrine|epinephrine
4974858|NCT04149470|Transnasal Esophagogastroduodenoscopy|transnasal esophagogastroduodenoscopy
4974859|NCT04149470|Transnasal Esophagoscopy|transnasal esophagoscopy
4974861|NCT04149431|Respiratory infection|respiratory infection
4974871|NCT04149314|HPI|hpi
4974983|NCT04148768|osteoarthritis,|osteoarthritis,
4975112|NCT04147702|Dancer|dancer
4975113|NCT04147702|Respiratory muscle|respiratory muscle
4975114|NCT04147702|Trunk muscle|trunk muscle
4975115|NCT04147689|hyaluronic acid|hyaluronic acid
4975116|NCT04147689|labia majora|labia majora
4975117|NCT04147689|vulvar|vulvar
4975231|NCT04146948|oxygen consumption|oxygen consumption
5700384|NCT00499889|Leukemia|leukemia
4975232|NCT04146948|minute ventilation volume|minute ventilation volume
4975233|NCT04146935|Crysvita|crysvita
4975234|NCT04146935|Burosumab|burosumab
4975236|NCT04146883|Prophylactic antibiotics|prophylactic antibiotics
4975330|NCT04146259|Hypoparathyroidism|hypoparathyroidism
4975332|NCT04146246|Neonate|neonate
4975333|NCT04146168|Venaseal|venaseal
4975405|NCT04145609|AKI|aki
4975602|NCT04144452|Quality of Life|quality of life
4975708|NCT04143633|Standard diet|standard diet
4975714|NCT04143555|endoscopic submucosal injection|endoscopic submucosal injection
4975715|NCT04143555|indocyanine green|indocyanine green
4975716|NCT04143542|quadratus lumborum block|quadratus lumborum block
4975717|NCT04143542|transversus abdominis block|transversus abdominis block
4975718|NCT04143542|postoperative analgesia|postoperative analgesia
4975835|NCT04143009|HIV|hiv
4975836|NCT04143009|Depression|depression
4975837|NCT04142970|Mild renal impairment|mild renal impairment
4975838|NCT04142970|Moderate renal impairment|moderate renal impairment
4975839|NCT04142957|COPD|copd
4975840|NCT04142957|Self-management|self-management
4975841|NCT04142957|Qualitative|qualitative
4975842|NCT04142957|Empowerment|empowerment
4975843|NCT04142957|Telehealth|telehealth
4975844|NCT04142944|Type1 diabetes|type1 diabetes
4975845|NCT04142944|device with predictive hypo alert|device with predictive hypo alert
4975846|NCT04142918|painful post-traumatic trigeminal neuropathy|painful post-traumatic trigeminal neuropathy
4975847|NCT04142918|neuropathic pain|neuropathic pain
5701154|NCT00498186|Neupro®|neupro®
4975848|NCT04142918|neuropathic odontalgia|neuropathic odontalgia
4975849|NCT04142918|gingival biopsy|gingival biopsy
4975939|NCT04142372|data mining|data mining
4975940|NCT04142372|hematology|hematology
4975941|NCT04142372|oncology|oncology
4975942|NCT04142372|pathology|pathology
4975943|NCT04142372|bioinformatics|bioinformatics
4975944|NCT04142372|real world data|real world data
4975945|NCT04142372|hematological malignancy|hematological malignancy
4975946|NCT04142372|survival|survival
4975947|NCT04142372|treatment response|treatment response
4976022|NCT04141917|Flu|flu
4976039|NCT04141813|forest-bathing|forest-bathing
4976040|NCT04141813|outdoor therapy|outdoor therapy
4976041|NCT04141813|wilderness therapy|wilderness therapy
4976042|NCT04141813|adventure therapy|adventure therapy
4976043|NCT04141800|Hyperkalemia|hyperkalemia
4976044|NCT04141800|Heart failure|heart failure
4976045|NCT04141800|Incidence|incidence
4976046|NCT04141800|Ejection fraction|ejection fraction
4976047|NCT04141787|Ceftriaxone|ceftriaxone
4976279|NCT04140552|gallbladder cancer|gallbladder cancer
4976280|NCT04140474|bronchoscopy|bronchoscopy
4976281|NCT04140474|Lung Cancer|lung cancer
4976282|NCT04140474|Solitary Pulmonary Nodule|solitary pulmonary nodule
4976283|NCT04140461|HIV infection|hiv infection
4976284|NCT04140461|Cryptococcal Meningitis|cryptococcal meningitis
4976483|NCT04139421|Forest Bathing|forest bathing
4976484|NCT04139421|Psychological Well-being|psychological well-being
4976485|NCT04139421|Natural Environment|natural environment
4976486|NCT04139408|Pulmonary Nodule|pulmonary nodule
4976487|NCT04139408|Localization|localization
4976489|NCT04139382|Telemedicine|telemedicine
4976587|NCT04138602|Fecal urgency|fecal urgency
4976588|NCT04138589|lumacaftor/ ivacaftor|lumacaftor/ ivacaftor
4976589|NCT04138589|tezacaftor/ ivacaftor|tezacaftor/ ivacaftor
4976590|NCT04138589|Multiple breath washout|multiple breath washout
4976591|NCT04138589|Lung clearance index|lung clearance index
4976592|NCT04138589|PRAGMA CF score|pragma cf score
4976593|NCT04138563|Exercise|exercise
4976602|NCT04138537|Acromegaly|acromegaly
4976695|NCT04138069|Pulmonary Function Test (PFT)|pulmonary function test (pft)
4976703|NCT04138030|Colonoscopy|colonoscopy
4976704|NCT04138030|Polypectomy|polypectomy
4976706|NCT04138030|Colorectal cancer|colorectal cancer
4976707|NCT04138017|Arthrodesis|arthrodesis
4976708|NCT04138004|colonoscopy|colonoscopy
4976711|NCT04137965|Fertility|fertility
4976901|NCT04136847|Signs of Hand Aging|signs of hand aging
4976906|NCT04136808|Locally Advanced or Metastatic Urothelial Carcinoma|locally advanced or metastatic urothelial carcinoma
4976907|NCT04136808|enfortumab vedotin (EV)|enfortumab vedotin (ev)
4976908|NCT04136808|ASG-22CE|asg-22ce
4976909|NCT04136808|Expanded Access|expanded access
4976910|NCT04136808|EV-901|ev-901
4976911|NCT04136795|esophageal atresia|esophageal atresia
4976912|NCT04136795|thoracoscopy|thoracoscopy
4976913|NCT04136795|rib fusion|rib fusion
4976914|NCT04136795|scoliosis|scoliosis
4976915|NCT04136795|Respiratory function|respiratory function
4976917|NCT04136782|paclitaxel|paclitaxel
4977124|NCT04135391|Stroke|stroke
4977125|NCT04135391|Oxygen consumption|oxygen consumption
4977126|NCT04135391|BDNF|bdnf
4977127|NCT04135391|Dendrites|dendrites
4977221|NCT04134923|radiology|radiology
4977222|NCT04134923|Nuclear medicine|nuclear medicine
4977223|NCT04134910|spine|spine
4977224|NCT04134910|intervertebral disc|intervertebral disc
4977225|NCT04134910|physical therapy|physical therapy
4977226|NCT04134910|imaging|imaging
4977316|NCT04134403|Ascorbic Acid Supplementation|ascorbic acid supplementation
4977317|NCT04134403|Septic Shock|septic shock
4977318|NCT04134403|STASIS|stasis
4977433|NCT04133519|IBS - Irritable Bowel Syndrome|ibs - irritable bowel syndrome
4977435|NCT04133519|Irritable Bowel|irritable bowel
4977568|NCT04132791|Aspirin|aspirin
4977680|NCT04131972|Bio-absorbable|bio-absorbable
4977681|NCT04131933|Predict 2.1|predict 2.1
4977682|NCT04131933|Oncotype DX|oncotype dx
4977683|NCT04131920|Joint Bleed|joint bleed
4977684|NCT04131920|Hemophilia A|hemophilia a
4977685|NCT04131920|Handheld Ultrasound|handheld ultrasound
4977686|NCT04131894|augmentation|augmentation
4977687|NCT04131894|dentin graft|dentin graft
4977688|NCT04131894|socket preservation|socket preservation
4977689|NCT04131855|self etch primers|self etch primers
4977690|NCT04131855|pumice|pumice
4977691|NCT04131855|orthodontic bracket failure|orthodontic bracket failure
4977692|NCT04131816|Cardiac Rehabilitation|cardiac rehabilitation
4977778|NCT04131179|Self Harm, adolescents, culturally adapted therapy, problem solving therapy, low and middle income countries|self harm, adolescents, culturally adapted therapy, problem solving therapy, low and middle income countries
4977781|NCT04131140|Palliative Care|palliative care
4977891|NCT04130360|online intervention|online intervention
4977892|NCT04130360|young people|young people
4977893|NCT04130360|aggressive behaviour|aggressive behaviour
4977993|NCT04129424|Diabetes mellitus|diabetes mellitus
4977994|NCT04129424|Insulin pump|insulin pump
4977995|NCT04129424|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
4977996|NCT04129411|RFA|rfa
4977997|NCT04129411|Radiofrequency|radiofrequency
4977998|NCT04129411|Thyroid Cancer|thyroid cancer
4977999|NCT04129411|Ablation techniques|ablation techniques
4978000|NCT04129411|Ultrasonography|ultrasonography
4978001|NCT04129385|laparoscopy|laparoscopy
4978002|NCT04129385|shoulder pain|shoulder pain
4978104|NCT04128761|Delay Discounting|delay discounting
4978105|NCT04128761|Behavioral Economic Demand|behavioral economic demand
4978106|NCT04128761|Scarcity Narrative|scarcity narrative
4978107|NCT04128761|Self-Administration|self-administration
4978108|NCT04128761|Functional MRI|functional mri
4978109|NCT04128761|Alcohol Craving|alcohol craving
4978113|NCT04128722|LMLM|lmlm
4978114|NCT04128722|Sirolimus|sirolimus
4978115|NCT04128709|urodynamics|urodynamics
4978116|NCT04128709|neurogenic|neurogenic
4978224|NCT04128124|weaning|weaning
4978225|NCT04128111|Bronchial Asthma|bronchial asthma
4978226|NCT04128111|TCM Syndrome|tcm syndrome
4978227|NCT04128111|Inflammation Phenotype|inflammation phenotype
4978228|NCT04128111|Biomarker|biomarker
4978229|NCT04128072|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
4978230|NCT04128072|Mogamulizumab|mogamulizumab
4978232|NCT04128059|vaccine|vaccine
4978316|NCT04127396|Transarterial chemoembolization|transarterial chemoembolization
4978317|NCT04127396|hepatocellular carcinoma|hepatocellular carcinoma
4978318|NCT04127396|portal vein tumor thrombus|portal vein tumor thrombus
4978319|NCT04127357|Pit and fissure sealants|pit and fissure sealants
4978320|NCT04127357|Pediatric dentistry|pediatric dentistry
4978321|NCT04127357|Toothbrushing|toothbrushing
4978322|NCT04127318|Sarcopenia|sarcopenia
4978323|NCT04127318|Quality of Life|quality of life
4978324|NCT04127318|Immunologic Markers|immunologic markers
4978325|NCT04127305|drug monitoring|drug monitoring
4978326|NCT04127305|antiinfectives|antiinfectives
4978327|NCT04127305|intensive care|intensive care
4978328|NCT04127305|ECMO|ecmo
4978329|NCT04127292|Suicide|suicide
4978402|NCT04126954|Hyperparathyroidism|hyperparathyroidism
4978403|NCT04126954|pathology phosphocalcic|pathology phosphocalcic
4978404|NCT04126941|Hypoparathyroidism|hypoparathyroidism
4978511|NCT04126291|education|education
4978512|NCT04126291|health care professionals|health care professionals
4978513|NCT04126291|type 2 diabetes|type 2 diabetes
4978514|NCT04126291|prevention|prevention
4978629|NCT04125654|mNGS|mngs
4978748|NCT04124939|Non-neurogenic Overactive bladder|non-neurogenic overactive bladder
4978752|NCT04124913|oral dydrogesterone|oral dydrogesterone
4978753|NCT04124913|luteal phase support|luteal phase support
4978754|NCT04124913|vaginal progesterone gel|vaginal progesterone gel
4978755|NCT04124913|frozen-thawed embryo transfer|frozen-thawed embryo transfer
4978756|NCT04124900|prostate cancer|prostate cancer
4978757|NCT04124900|prostate biopsy|prostate biopsy
4978758|NCT04124900|telomere|telomere
4978759|NCT04124900|biomarker|biomarker
4978840|NCT04124315|accelerometer|accelerometer
4978841|NCT04124315|smartphone|smartphone
4978842|NCT04124315|supervised exercise therapy|supervised exercise therapy
4978843|NCT04124302|diabetes type 1|diabetes type 1
4978844|NCT04124302|insulin bolus|insulin bolus
4978845|NCT04124302|prandial insulin requirement|prandial insulin requirement
4978846|NCT04124302|postprandial glycemia|postprandial glycemia
4978847|NCT04124302|insulin pump therapy|insulin pump therapy
4978848|NCT04124302|mixed meal|mixed meal
4978849|NCT04124276|Major Depressive Disorder|major depressive disorder
4978850|NCT04124276|Lycium barbarum polysaccharide|lycium barbarum polysaccharide
4978924|NCT04123834|implantless ACL reconstruction|implantless acl reconstruction
4978925|NCT04123834|press-fit fixation|press-fit fixation
4978926|NCT04123808|Stroke|stroke
4978927|NCT04123808|Hemiparesis|hemiparesis
4978928|NCT04123808|Rehabilitation|rehabilitation
4978929|NCT04123808|Upper Extremity|upper extremity
4979147|NCT04122547|Bronchiectasis|bronchiectasis
4979148|NCT04122547|roflumilast|roflumilast
4979149|NCT04122547|exacerbation|exacerbation
4979150|NCT04122547|lung function|lung function
4979256|NCT04121884|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
4979257|NCT04121884|Depressive Symptoms|depressive symptoms
4979258|NCT04121884|Power Spectral Density|power spectral density
4979259|NCT04121871|Candida auris|candida auris
4979260|NCT04121871|Oral Fungal Infection|oral fungal infection
4979261|NCT04121871|Candidiasis|candidiasis
4979262|NCT04121858|anticholinergic|anticholinergic
4979263|NCT04121858|cognitive function|cognitive function
4979264|NCT04121858|brain|brain
4979265|NCT04121858|aging|aging
4979266|NCT04121845|angina pectoris|angina pectoris
4979267|NCT04121845|coronary sinus reducer|coronary sinus reducer
4979268|NCT04121845|quality of life|quality of life
4979269|NCT04121845|reversible ischemia|reversible ischemia
4979363|NCT04121390|Maternal self-efficacy|maternal self-efficacy
4979364|NCT04121390|Newborn care knowledge|newborn care knowledge
4979365|NCT04121390|Developmental trajectory|developmental trajectory
4979366|NCT04121390|Positive parenting|positive parenting
4979367|NCT04121351|Lung Health|lung health
4979454|NCT04120740|Activity moitoring|activity moitoring
4979456|NCT04120727|eHealth|ehealth
4979457|NCT04120727|therapeutic education|therapeutic education
4979458|NCT04120727|Connected objects|connected objects
4979459|NCT04120675|extra virgin olive oil|extra virgin olive oil
4979460|NCT04120675|primary (PPMS) progressive multiple sclerosis|primary (ppms) progressive multiple sclerosis
4979461|NCT04120675|secondary (SPMS) progressive multiple sclerosis|secondary (spms) progressive multiple sclerosis
4979463|NCT04120675|cognition|cognition
4979548|NCT04120207|Depression|depression
4979649|NCT04119739|Ibuprofen|ibuprofen
4979650|NCT04119739|Median nerve neural mobilization|median nerve neural mobilization
4979651|NCT04119739|Waiting list control group|waiting list control group
4979652|NCT04119739|Physiotherapy|physiotherapy
4979653|NCT04119739|Pain management|pain management
4979654|NCT04119726|Mobile health|mobile health
4979655|NCT04119726|Acute myocardial infarction|acute myocardial infarction
4979656|NCT04119726|Cardioprotective medications|cardioprotective medications
4979657|NCT04119726|Randomized Controlled Trial|randomized controlled trial
4979757|NCT04119219|angioid streaks|angioid streaks
4979758|NCT04119206|hyponatremia|hyponatremia
4979759|NCT04119206|vasopressin|vasopressin
4979760|NCT04119206|anti-diuretic hormone|anti-diuretic hormone
4979761|NCT04119206|fluid restriction|fluid restriction
4979875|NCT04118478|health|health
4979876|NCT04118478|physical condition|physical condition
4979877|NCT04118478|qualilty of Life|qualilty of life
4979878|NCT04118478|Functional capacity|functional capacity
4979879|NCT04118478|physiological status|physiological status
4979880|NCT04118478|physical activity|physical activity
4979881|NCT04118478|elderly|elderly
4979882|NCT04118465|breech; ECV; version|breech; ecv; version
4979883|NCT04118452|early childhood development|early childhood development
4979884|NCT04118452|developmental screening|developmental screening
4979886|NCT04118439|Motor Imaginery|motor imaginery
4980078|NCT04117360|Tongue Ultrasound|tongue ultrasound
4980177|NCT04116684|Withings Blood Pressure Monitor|withings blood pressure monitor
4980178|NCT04116684|Heart Rate|heart rate
4980179|NCT04116684|Ambulatory Blood Pressure|ambulatory blood pressure
4980181|NCT04116671|stroke|stroke
4980271|NCT04116203|diabetes|diabetes
4980272|NCT04116203|obesity|obesity
4980273|NCT04116190|rehabilitation|rehabilitation
4980304|NCT04116047|HPV|hpv
4980382|NCT04115410|Pembrolizumab|pembrolizumab
4980383|NCT04115410|Atezolizumab|atezolizumab
4980384|NCT04115410|Immune-Related Adverse Events|immune-related adverse events
4980385|NCT04115410|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
4980386|NCT04115384|intranasal|intranasal
4980387|NCT04115384|insulin|insulin
4980388|NCT04115358|pulpotomy|pulpotomy
4980389|NCT04115332|psychiatric nurses|psychiatric nurses
4980399|NCT04115267|Cancer|cancer
4980471|NCT04114799|fluid responsiveness|fluid responsiveness
4980472|NCT04114799|haemodynamical monitoring|haemodynamical monitoring
4980474|NCT04114786|Radiation|radiation
4980475|NCT04114786|Brain Cancer|brain cancer
4980476|NCT04114786|Glioblastoma|glioblastoma
4980477|NCT04114786|3D printed mask|3d printed mask
4980478|NCT04114773|Rehabilitation|rehabilitation
4980479|NCT04114773|Fatigue|fatigue
4980480|NCT04114773|Relatives|relatives
4980481|NCT04114760|12-lead electrocardiography|12-lead electrocardiography
4980482|NCT04114760|Emergency medical technician|emergency medical technician
4980483|NCT04114760|chest pain|chest pain
4980779|NCT04112875|Myostatin|myostatin
4980780|NCT04112875|Follistatin|follistatin
4980781|NCT04112875|Type 2 diabetes mellitus|type 2 diabetes mellitus
4980782|NCT04112875|Vascular smooth muscle|vascular smooth muscle
4980783|NCT04112875|endothelial function|endothelial function
4980784|NCT04112862|GLUT1 deficiency syndrome|glut1 deficiency syndrome
4980785|NCT04112862|sodium lactate infusion|sodium lactate infusion
4980877|NCT04112147|antroquinonol, Chronic Hepatitis B|antroquinonol, chronic hepatitis b
4980878|NCT04112121|faith|faith
4980879|NCT04112121|religion|religion
4980880|NCT04112121|hospitalization|hospitalization
4981010|NCT04111406|Postoperative Pain|postoperative pain
4981011|NCT04111354|pacemaker|pacemaker
4981012|NCT04111354|implantation|implantation
4981132|NCT04110626|Addiction|addiction
4981133|NCT04110626|Primary prevention|primary prevention
4981134|NCT04110626|School-based programme|school-based programme
4981135|NCT04110600|Bowel movements|bowel movements
4981136|NCT04110600|Cesarean section|cesarean section
4981137|NCT04110600|Oral hydration|oral hydration
4981138|NCT04110587|hyaluronic acid|hyaluronic acid
4981139|NCT04110587|temporomandibular joint arthroscopy|temporomandibular joint arthroscopy
4981140|NCT04110587|internal derangements|internal derangements
4981141|NCT04110587|disc displacement|disc displacement
5693628|NCT00523887|Duragesic|duragesic
4981142|NCT04110587|temporomandibular disorders|temporomandibular disorders
4981143|NCT04110561|Spinal Cord Injuries|spinal cord injuries
4981144|NCT04110561|Paraplegia|paraplegia
4981145|NCT04110561|Paralysis, Lower Limbs|paralysis, lower limbs
4981146|NCT04110561|Lower Extremity|lower extremity
4981147|NCT04110561|Robotics|robotics
4981148|NCT04110561|Physiotherapy|physiotherapy
4981149|NCT04110561|Rehabilitation|rehabilitation
4981150|NCT04110561|Powered Exoskeleton|powered exoskeleton
4981152|NCT04110561|Ambulation|ambulation
4981154|NCT04110535|remimazolam|remimazolam
4981209|NCT04110119|Thiocolchicoside|thiocolchicoside
4981210|NCT04110093|Colorectal Cancer|colorectal cancer
4981211|NCT04110093|Immunotherapy|immunotherapy
4981212|NCT04110093|Regorafenib|regorafenib
4981213|NCT04110093|Nivoluamb|nivoluamb
4981214|NCT04110093|microsatellite stable|microsatellite stable
4981215|NCT04110080|enhanced recovery after surgery|enhanced recovery after surgery
4981216|NCT04110080|living donor kidney transplant|living donor kidney transplant
4981217|NCT04110080|multimodal analgesia|multimodal analgesia
4981218|NCT04110067|Myopia|myopia
4981219|NCT04110067|Refractive Surgery|refractive surgery
4981220|NCT04110067|Small Incision Lenticule Extraction|small incision lenticule extraction
4981221|NCT04110067|SMILE|smile
4981334|NCT04109300|Combination therapy|combination therapy
4981336|NCT04109287|Femoral-popliteal|femoral-popliteal
4981337|NCT04109287|Bypass|bypass
4981338|NCT04109287|Graft|graft
4981339|NCT04109287|PAD|pad
4981340|NCT04109287|PVD|pvd
4981346|NCT04109287|VFR|vfr
4981447|NCT04108832|Traditional Chinese Medicine|traditional chinese medicine
4981448|NCT04108832|Herbs|herbs
4981449|NCT04108832|Liu-wei-die-Huang-Wan|liu-wei-die-huang-wan
4981465|NCT04108637|allergy|allergy
4981559|NCT04108117|Immediate reconstruction|immediate reconstruction
5685501|NCT00555828|Myocardial Infarction|myocardial infarction
4981560|NCT04108091|transthyretin amyloid cardiomyopathy;|transthyretin amyloid cardiomyopathy;
4981561|NCT04108091|TTR Cardiomyopathy;|ttr cardiomyopathy;
4981562|NCT04108091|Transthyretin (TTR) Amyloid Cardiomyopathy;|transthyretin (ttr) amyloid cardiomyopathy;
4981563|NCT04108091|Vyndaqel;|vyndaqel;
4981564|NCT04108091|Tafamidis meglumine;|tafamidis meglumine;
4981565|NCT04108091|ATTR-CM|attr-cm
4981566|NCT04108078|HIV|hiv
4981567|NCT04108078|Stigma|stigma
4981572|NCT04108065|glp-1|glp-1
4981659|NCT04107597|Chronic Low-back Pain|chronic low-back pain
4981660|NCT04107597|Myofascial Trigger Point Release|myofascial trigger point release
4981661|NCT04107597|Core Stabilization Exercises|core stabilization exercises
4981663|NCT04107597|Pain Severity|pain severity
4981766|NCT04107129|Infertility|infertility
4981864|NCT04106375|recurrent depression|recurrent depression
4981865|NCT04106375|brain|brain
4981866|NCT04106323|Upper Egypt|upper egypt
4981867|NCT04106323|Factor|factor
4981967|NCT04105556|Male Circimcision|male circimcision
4981969|NCT04105517|Proliferative infantile hemangiomas|proliferative infantile hemangiomas
4981970|NCT04105517|Hemangiol|hemangiol
4981981|NCT04105374|Toca FC|toca fc
4982066|NCT04104607|Resistant Prostate Cancer|resistant prostate cancer
4982067|NCT04104607|PSMAxCD3|psmaxcd3
4982068|NCT04104607|CC-1|cc-1
4982069|NCT04104594|TNF alpha|tnf alpha
4982070|NCT04104568|Informal caregivers|informal caregivers
4982071|NCT04104568|People with Dementia|people with dementia
4982072|NCT04104568|Mental Health|mental health
4982073|NCT04104568|Online training and support|online training and support
4982074|NCT04104568|Intervention Study|intervention study
4982075|NCT04104555|Pes planus|pes planus
4982076|NCT04104555|Randomised controlled trial|randomised controlled trial
4982077|NCT04104555|Orthoses|orthoses
4982078|NCT04104555|Exercise|exercise
4982079|NCT04104555|Children|children
4982080|NCT04104529|thyroid cancer|thyroid cancer
4982081|NCT04104529|prostate cancer|prostate cancer
4982082|NCT04104529|neuroendocrine tumors|neuroendocrine tumors
4982083|NCT04104529|nuclear medecine|nuclear medecine
4982084|NCT04104516|Lifestyle modification|lifestyle modification
4982085|NCT04104516|Lung Cancer|lung cancer
4982086|NCT04104516|Preferences|preferences
4982087|NCT04104464|vascular malformation|vascular malformation
4982147|NCT04104009|delivery mode|delivery mode
4982148|NCT04104009|music therapy|music therapy
4982149|NCT04104009|breastfeeding|breastfeeding
4982150|NCT04104009|pain score|pain score
4982151|NCT04104009|postnatal mental health|postnatal mental health
4982152|NCT04104009|Apgar score|apgar score
4982153|NCT04103970|Low back pain|low back pain
4982154|NCT04103970|Back surgery|back surgery
4982155|NCT04103970|Lumbar spinal fusion|lumbar spinal fusion
4982263|NCT04103229|Indwelling urethral catheter|indwelling urethral catheter
4982264|NCT04103229|silicone catheter|silicone catheter
4982266|NCT04103229|Balloon|balloon
4982267|NCT04103229|Distilled water|distilled water
4982268|NCT04103216|Cryptosporidiosis|cryptosporidiosis
4982269|NCT04103216|Treatment|treatment
4982365|NCT04102618|Letrozole|letrozole
5703848|NCT00487851|Neoplasms|neoplasms
4982366|NCT04102618|Early Breast Cancer|early breast cancer
4982367|NCT04102618|Triple-negative breast cancer|triple-negative breast cancer
4982368|NCT04102618|HR+ breast cancer|hr+ breast cancer
4982373|NCT04102592|Malaria|malaria
4982480|NCT04101929|pancreatic adenocarcinoma|pancreatic adenocarcinoma
4982481|NCT04101929|apatinib|apatinib
4982544|NCT04101370|AUC|auc
4982569|NCT04101214|myofascial trigger point|myofascial trigger point
4982570|NCT04101188|Dietary Potassium|dietary potassium
4982571|NCT04101188|Dietary Sodium|dietary sodium
4982673|NCT04100356|Body composition|body composition
4982674|NCT04100356|Weight|weight
4982675|NCT04100317|Pridge plate|pridge plate
4982677|NCT04100291|Microbiota|microbiota
4982678|NCT04100278|Type 2 Diabetes|type 2 diabetes
4982679|NCT04100278|Diabetes Education and Management|diabetes education and management
4982680|NCT04100239|inflammatory bowel disease|inflammatory bowel disease
5703849|NCT00487851|Biliary|biliary
4982779|NCT04099654|bariatric surgery|bariatric surgery
4982780|NCT04099654|exercise|exercise
4982781|NCT04099628|monitoring|monitoring
4982782|NCT04099628|surveillance|surveillance
4982783|NCT04099628|re-emergence|re-emergence
4982786|NCT04099628|LAMP|lamp
4982938|NCT04098796|AFP|afp
4983119|NCT04097678|radiographic imaging|radiographic imaging
4983120|NCT04097665|ICGA|icga
4983121|NCT04097665|necrosis|necrosis
4983122|NCT04097665|blood supply|blood supply
4983123|NCT04097665|expanded flap|expanded flap
4983124|NCT04097652|acute ischemic stroke|acute ischemic stroke
4983125|NCT04097639|low-grade inflammation|low-grade inflammation
4983126|NCT04097639|anemia|anemia
4983127|NCT04097639|erythroferrone|erythroferrone
4983230|NCT04096898|dry eye|dry eye
4983231|NCT04096885|cohort|cohort
4983232|NCT04096885|visceral surgery|visceral surgery
4983233|NCT04096885|biobank|biobank
4983234|NCT04096859|elective surgery|elective surgery
4983235|NCT04096859|minimally invasive surgery|minimally invasive surgery
4983236|NCT04096859|cardiac valve reconstruction|cardiac valve reconstruction
4983237|NCT04096859|cardiac valve replacement|cardiac valve replacement
4983238|NCT04096807|Pulmonary wedge pressure|pulmonary wedge pressure
4983331|NCT04096222|Th17|th17
4983332|NCT04096222|IL-23|il-23
4983333|NCT04096222|IL-17|il-17
4983334|NCT04096222|autoimmune bullous disease|autoimmune bullous disease
4983338|NCT04096144|Post anesthesia care unit|post anesthesia care unit
4983429|NCT04095637|implant position|implant position
4983430|NCT04095637|mako robot|mako robot
4983431|NCT04095637|makoplasty|makoplasty
4983433|NCT04095611|Hemiarthroplasty|hemiarthroplasty
4983533|NCT04095065|College students|college students
4983534|NCT04095039|All-cause hopitalization|all-cause hopitalization
4983535|NCT04095026|Epilepsy|epilepsy
4983536|NCT04095026|Cognitive Function|cognitive function
4983642|NCT04094428|Multiple Organ Failure|multiple organ failure
4983643|NCT04094376|morning operation|morning operation
4983644|NCT04094376|evening operation|evening operation
4983645|NCT04094376|sleep quality|sleep quality
4983646|NCT04094376|general anesthesia|general anesthesia
4983647|NCT04094376|circadian rhythm|circadian rhythm
4983648|NCT04094350|Tuberculosis|tuberculosis
4983649|NCT04094350|Community health services|community health services
4983650|NCT04094350|Cambodia|cambodia
4983651|NCT04094350|Contact tracing|contact tracing
4983753|NCT04093687|Pain During Colonoscopy|pain during colonoscopy
4983754|NCT04093674|connective tissue|connective tissue
4983755|NCT04093674|randomized controlled trial|randomized controlled trial
4983756|NCT04093674|gingival recession|gingival recession
4983866|NCT04093037|Tear Meniscus (TM)|tear meniscus (tm)
4983867|NCT04093037|Non Invasive Break-Up Time (NIBUT)|non invasive break-up time (nibut)
4983868|NCT04092985|Arrhythmias, Cardiac|arrhythmias, cardiac
4983969|NCT04092465|Induction chemoradiotherapy|induction chemoradiotherapy
4983970|NCT04092465|Pulmonary Parenchyma Resection|pulmonary parenchyma resection
4983971|NCT04092465|Surgical Outcomes|surgical outcomes
4983972|NCT04092465|Survival|survival
4983973|NCT04092465|Morbidity|morbidity
4983974|NCT04092465|Thoracotomy|thoracotomy
4983975|NCT04092400|Glaucoma|glaucoma
4983976|NCT04092400|Glaucoma Surgery|glaucoma surgery
4983977|NCT04092400|Minimally Invasive Surgery|minimally invasive surgery
4983978|NCT04092387|Biomarkers of Exposure|biomarkers of exposure
4984168|NCT04091113|Hereditary Angioedema|hereditary angioedema
4984169|NCT04091113|Cleaved high-molecular weight kininogen|cleaved high-molecular weight kininogen
4984170|NCT04091100|Pain|pain
4984171|NCT04091100|Acupuncture|acupuncture
4984174|NCT04091100|Depression|depression
4984280|NCT04090281|de-escalation|de-escalation
4984281|NCT04090281|dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
4984282|NCT04090281|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
4984283|NCT04090268|exercise|exercise
4984284|NCT04090268|children|children
4984285|NCT04090268|adolescent|adolescent
4984286|NCT04090268|cancer|cancer
4984287|NCT04090268|malignant hemopathies|malignant hemopathies
4984288|NCT04090268|leukemia|leukemia
4984382|NCT04089579|Autism|autism
4984383|NCT04089579|Autism Spectrum Disorder|autism spectrum disorder
4984384|NCT04089579|Stem cell|stem cell
4984385|NCT04089579|Mesenchymal Stromal Cells|mesenchymal stromal cells
4984648|NCT04087967|Decitabine|decitabine
4984649|NCT04087967|HAAG|haag
4984651|NCT04087928|Stroke|stroke
4984652|NCT04087928|Upper limb|upper limb
4984653|NCT04087928|Rehabilitation|rehabilitation
4984654|NCT04087928|Focal Muscular Vibration|focal muscular vibration
4984655|NCT04087915|High cholesterol|high cholesterol
4984656|NCT04087915|Treatment for high cholesterol|treatment for high cholesterol
4984743|NCT04087369|digital tools|digital tools
4984744|NCT04087369|motivational interviewing|motivational interviewing
4984745|NCT04087343|homebound patients|homebound patients
4984746|NCT04087343|exercise|exercise
4984747|NCT04087343|nutrition|nutrition
4984748|NCT04087330|Cerebral Palsy|cerebral palsy
4984749|NCT04087330|Spastic|spastic
4984763|NCT04087239|CMV|cmv
4984859|NCT04086537|Iron Metabolism|iron metabolism
4985191|NCT04084353|India|india
4985325|NCT04083690|Heart Failure|heart failure
4985326|NCT04083612|Psoriasis|psoriasis
4985327|NCT04083612|Therapeutic drug monitoring|therapeutic drug monitoring
4985328|NCT04083612|Ixekizumab|ixekizumab
4985329|NCT04083521|Bowel movement regulation|bowel movement regulation
4985330|NCT04083521|Occasional constipation|occasional constipation
4985331|NCT04083521|Occasional diarrhea|occasional diarrhea
4985433|NCT04082897|Richter Transformation|richter transformation
4985434|NCT04082897|Safety|safety
4985435|NCT04082897|Efficacy|efficacy
4985436|NCT04082897|Obinutuzumab|obinutuzumab
4985437|NCT04082897|Venetoclax|venetoclax
4985438|NCT04082897|Atezolizumab|atezolizumab
4985439|NCT04082884|very low carbohydrate diet|very low carbohydrate diet
4985531|NCT04082130|Root coverage.|root coverage.
4985532|NCT04082091|mHealth|mhealth
4985533|NCT04082091|mixed method|mixed method
4985534|NCT04082091|feasibility study|feasibility study
4985535|NCT04082091|Malir district|malir district
4985536|NCT04082065|Conventional physical therapy(CPT)|conventional physical therapy(cpt)
4985542|NCT04082052|depression|depression
4985627|NCT04081428|Cell free DNA|cell free dna
4985731|NCT04080648|Therapeutic drug monitoring|therapeutic drug monitoring
4985732|NCT04080648|Psoriasis|psoriasis
4985733|NCT04080648|Guselkumab|guselkumab
4985734|NCT04080635|Psoriasis|psoriasis
4985735|NCT04080635|Therapeutic drug monitoring|therapeutic drug monitoring
4985751|NCT04080466|Hip|hip
4985830|NCT04079868|Osteoporotic fracture|osteoporotic fracture
4985831|NCT04079868|Age-Related Osteoporosis|age-related osteoporosis
4985832|NCT04079868|Bone Loss, Age-Related|bone loss, age-related
4985838|NCT04079777|Mitochondrial DNA ;mtDNA;|mitochondrial dna ;mtdna;
4985839|NCT04079777|Acute pancreatitis;SAP;severe acute pancreatitis;|acute pancreatitis;sap;severe acute pancreatitis;
4985840|NCT04079777|Acute pancreatic necrosis;|acute pancreatic necrosis;
4985933|NCT04079075|Correction of Hearing Impairment|correction of hearing impairment
4985934|NCT04079075|Cognitive Dysfunction|cognitive dysfunction
4985935|NCT04079075|Diet, Healthy|diet, healthy
4986023|NCT04078646|Postprandial absorption|postprandial absorption
4986024|NCT04078646|Area-under-curve|area-under-curve
4986025|NCT04078646|Bioavailability|bioavailability
4986026|NCT04078646|Proteins|proteins
4986027|NCT04078646|Tomato juice|tomato juice
4986028|NCT04078646|Carrot juice|carrot juice
4986029|NCT04078646|Randomized cross-over|randomized cross-over
4986030|NCT04078607|Distraction|distraction
4986031|NCT04078607|Eating behavior|eating behavior
4986032|NCT04078607|Fullness|fullness
4986033|NCT04078607|Hunger|hunger
4986036|NCT04078594|sepsis|sepsis
4986119|NCT04078165|endovascular surgery|endovascular surgery
4986120|NCT04078152|non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
4986122|NCT04078152|durvalumab|durvalumab
4986234|NCT04077515|Kasabach-Merritt Syndrome|kasabach-merritt syndrome
4986235|NCT04077515|Sirolimus|sirolimus
4986236|NCT04077515|Rapamycin|rapamycin
4986237|NCT04077502|binge eating disorder|binge eating disorder
4986238|NCT04077502|craving|craving
4986239|NCT04077502|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4986240|NCT04077489|macular thickness|macular thickness
4986247|NCT04077424|adult 65 and older|adult 65 and older
4986248|NCT04077411|Severe Traumatic Brain Injury|severe traumatic brain injury
4986249|NCT04077411|TBI|tbi
4986251|NCT04077411|Cerebrospinal fluid|cerebrospinal fluid
4986450|NCT04076436|Fosfomycin efficacy|fosfomycin efficacy
4986451|NCT04076436|Quinolones|quinolones
4986452|NCT04076436|Beta-lactams|beta-lactams
4986549|NCT04075877|Intervention|intervention
4986550|NCT04075877|Photography|photography
4986552|NCT04075877|Adolescence|adolescence
4986665|NCT04075071|teaching self-efficacy|teaching self-efficacy
4986681|NCT04075032|obesity|obesity
4986757|NCT04074421|Rifaximin|rifaximin
4986873|NCT04073524|Aesthetic Affective Theory (AAT)|aesthetic affective theory (aat)
4986975|NCT04072796|urinary bladder, neurogenic|urinary bladder, neurogenic
4986976|NCT04072796|quality of life|quality of life
4987075|NCT04072120|Post-acute stroke|post-acute stroke
4987775|NCT04067726|RANKL|rankl
4987084|NCT04072055|Unicompartmental Knee Arthroplasty|unicompartmental knee arthroplasty
4987086|NCT04072055|antomic femoral component|antomic femoral component
4987087|NCT04072055|anatomic tibial component|anatomic tibial component
4987088|NCT04072003|Left main, bifurcation, IVUS,PCI|left main, bifurcation, ivus,pci
4987089|NCT04071990|Family based intervention|family based intervention
4987090|NCT04071990|Cognitive behavioral group therapy|cognitive behavioral group therapy
4987091|NCT04071990|Exposure and response prevention|exposure and response prevention
4987092|NCT04071990|Family accommodation|family accommodation
4987093|NCT04071977|Vitreous humor|vitreous humor
4987094|NCT04071977|Vitrectomy|vitrectomy
4987095|NCT04071977|Aqueous humor|aqueous humor
4987096|NCT04071977|Antioxidant therapy|antioxidant therapy
4987097|NCT04071977|Oxidative markers|oxidative markers
4987098|NCT04071964|Microbiota|microbiota
4987099|NCT04071925|urethral stricture disease|urethral stricture disease
4987100|NCT04071925|urethral stricture|urethral stricture
4987101|NCT04071925|urethra|urethra
4987102|NCT04071925|urethroplasty|urethroplasty
4987103|NCT04071899|REM Sleep Behavior Disorder|rem sleep behavior disorder
4987104|NCT04071899|Validation scale|validation scale
4987105|NCT04071886|eye-tracking|eye-tracking
4987106|NCT04071886|eye movement|eye movement
4987107|NCT04071886|mindfulness|mindfulness
4987108|NCT04071782|Angioplasty|angioplasty
4987109|NCT04071756|Solid Tumor|solid tumor
4987110|NCT04071756|Hand-Foot Skin Reaction (HFSR)|hand-foot skin reaction (hfsr)
4987111|NCT04071730|Immulina|immulina
4987112|NCT04071730|Natural Killer Cells (NK)|natural killer cells (nk)
4987114|NCT04071717|NIRS|nirs
4987143|NCT04071561|Posterior Retroperitoneoscopic adrenalectomy|posterior retroperitoneoscopic adrenalectomy
4987144|NCT04071561|Retroperitoneal fat mass|retroperitoneal fat mass
4987145|NCT04071535|Small fiber neuropathy|small fiber neuropathy
4987146|NCT04071535|Diabetic neuropathies|diabetic neuropathies
4987147|NCT04071535|Skin biopsy|skin biopsy
4987148|NCT04071522|low back pain|low back pain
4987149|NCT04071522|turkish language|turkish language
4987150|NCT04071522|pain beliefs|pain beliefs
4987151|NCT04071522|validity|validity
4987152|NCT04071509|Lung Biopsy, pneumothorax, interventional radiology|lung biopsy, pneumothorax, interventional radiology
4987153|NCT04071444|Baduanjin program|baduanjin program
4987154|NCT04071444|constipation|constipation
4987162|NCT04071418|radiotherapy|radiotherapy
4987238|NCT04070963|HbA1C|hba1c
4987239|NCT04070911|Perioperative nursing|perioperative nursing
4987240|NCT04070911|Postanesthesia care|postanesthesia care
5903462|NCT00368446|PHA|pha
4987241|NCT04070911|Thirst|thirst
4987242|NCT04070911|Water|water
4987243|NCT04070911|Ice|ice
4987352|NCT04070196|point-of-care test|point-of-care test
4987353|NCT04070196|Peritoneal Dialysis|peritoneal dialysis
4987354|NCT04070170|Low-Level Light Therapy|low-level light therapy
4987454|NCT04069715|endothelial vasodilation|endothelial vasodilation
4987455|NCT04069715|Hyperlipidemias|hyperlipidemias
4987558|NCT04069182|Medicine students|medicine students
4987559|NCT04069156|heart failure|heart failure
4987561|NCT04069156|LVAD|lvad
4987740|NCT04067908|Biological markers|biological markers
4987745|NCT04067882|Genetic signature|genetic signature
4987746|NCT04067882|Treatment response|treatment response
4987747|NCT04067817|Goal-directed Fluid Therapy|goal-directed fluid therapy
4987748|NCT04067817|norepinephrine|norepinephrine
4987749|NCT04067817|phenylephrine|phenylephrine
4987750|NCT04067817|elderly|elderly
4987751|NCT04067804|Implementation Research|implementation research
4987752|NCT04067804|School-based research|school-based research
5032197|NCT03797950|OPV|opv
4987916|NCT04066946|arm|arm
4987977|NCT04066491|Transforming growth factor-beta|transforming growth factor-beta
4987988|NCT04066465|Neurosurgical Treatment|neurosurgical treatment
4987989|NCT04066452|Amyloidosis|amyloidosis
4987990|NCT04066426|naproxen sodium|naproxen sodium
4987993|NCT04066426|pain|pain
4988089|NCT04065750|antibiotic|antibiotic
4988090|NCT04065737|high-risk oral pre-malignant lesions|high-risk oral pre-malignant lesions
4988091|NCT04065737|history of invasive oral cancer|history of invasive oral cancer
4988092|NCT04065737|sintilimab|sintilimab
4988093|NCT04065724|diabetes mellitus|diabetes mellitus
4988094|NCT04065724|foot ulcer|foot ulcer
4988095|NCT04065724|resistance training|resistance training
4988096|NCT04065724|exercise|exercise
4988097|NCT04065672|ulcers|ulcers
4988098|NCT04065646|Food Access|food access
4988099|NCT04065646|Food Security|food security
4988100|NCT04065646|Fruits and Vegetables|fruits and vegetables
4988101|NCT04065646|Low-Income|low-income
4988102|NCT04065633|Phase 1 Bioequivalence Study|phase 1 bioequivalence study
4988103|NCT04065633|Healthy Participants|healthy participants
4988152|NCT04065399|AML|aml
4988372|NCT04064333|Aging|aging
4988176|NCT04065347|Tenofovir alafenamide|tenofovir alafenamide
4988177|NCT04065334|Resistance training|resistance training
4988178|NCT04065334|Endurance training|endurance training
4988179|NCT04065321|Circulating tumor cells|circulating tumor cells
4988180|NCT04065321|PET|pet
4988181|NCT04065269|Clear cell ovarian carcinoma|clear cell ovarian carcinoma
4988182|NCT04065269|Clear cell endometrial carcinoma|clear cell endometrial carcinoma
4988183|NCT04065269|Endometrioid carcinoma|endometrioid carcinoma
4988185|NCT04065269|Cervical carcinoma|cervical carcinoma
4988186|NCT04065269|ARID1A|arid1a
4988190|NCT04065217|Hemangioma|hemangioma
4988191|NCT04065217|Randomized within patient|randomized within patient
4988216|NCT04065048|diet|diet
4988399|NCT04064255|Mirror exposure|mirror exposure
4988400|NCT04064242|chronic pulmonary sarcoidosis|chronic pulmonary sarcoidosis
4988401|NCT04064216|Cosmesis|cosmesis
4988402|NCT04064216|Laparoscopic surgery|laparoscopic surgery
4988403|NCT04064216|Patient satisfaction|patient satisfaction
4988404|NCT04064216|Scar assessment|scar assessment
4988411|NCT04064151|eHealth|ehealth
4988498|NCT04063566|PSA|psa
4988499|NCT04063540|migraine|migraine
4988500|NCT04063540|aura|aura
4988501|NCT04063540|Amiloride|amiloride
4988502|NCT04063540|acid-sensing ion channel|acid-sensing ion channel
4988503|NCT04063527|epithelial ovarian cancer|epithelial ovarian cancer
4988504|NCT04063527|FIGO stage I|figo stage i
4988505|NCT04063527|staging surgery|staging surgery
4988506|NCT04063527|adjuvant chemotherapy|adjuvant chemotherapy
4988508|NCT04063423|clotting|clotting
4988509|NCT04063423|coagulation|coagulation
4988593|NCT04062838|tendon healing|tendon healing
4988594|NCT04062825|HIV|hiv
4988595|NCT04062825|platelets|platelets
4988596|NCT04062825|lymphocytes|lymphocytes
4988624|NCT04062695|MRI|mri
4988683|NCT04062253|Diagnosis|diagnosis
4988684|NCT04062253|Linkage to care|linkage to care
4988685|NCT04062253|Treatment|treatment
4988686|NCT04062240|BIS|bis
4988687|NCT04062240|Bispectral Index|bispectral index
4988688|NCT04062240|Paralysis|paralysis
4988776|NCT04061772|CHEP|chep
4988889|NCT04060745|individualized cooling protocol|individualized cooling protocol
4988893|NCT04060706|Radiotherapy|radiotherapy
4988894|NCT04060706|Image-guided|image-guided
4988895|NCT04060706|Head & Neck|head & neck
4988990|NCT04060121|early adverse life events|early adverse life events
5387438|NCT01778855|imaging|imaging
4988992|NCT04060121|cognitive behavioral therapy|cognitive behavioral therapy
4988993|NCT04060095|NOL index, anesthesia, β1-adrenergic antagonist|nol index, anesthesia, β1-adrenergic antagonist
4988994|NCT04060082|FTD|ftd
4988995|NCT04060082|Interview|interview
4988996|NCT04060082|Genetics|genetics
4988997|NCT04060082|Persons diagnosed|persons diagnosed
4988998|NCT04060082|Frontotemporal degeneration|frontotemporal degeneration
4989107|NCT04059380|hypoparathyroidism|hypoparathyroidism
4989209|NCT04058782|Myocardial infarction|myocardial infarction
4989214|NCT04058704|EGFR-TKI|egfr-tki
4989216|NCT04058704|Icotinib|icotinib
4989217|NCT04058704|radiotherapy|radiotherapy
4989218|NCT04058691|Aortic aneurysms|aortic aneurysms
4989219|NCT04058691|aortic dissections|aortic dissections
4989220|NCT04058691|thoracic|thoracic
4989221|NCT04058678|Ovarian reserve.|ovarian reserve.
4989222|NCT04058678|Telomeric factor|telomeric factor
4989223|NCT04058678|Blood|blood
4989224|NCT04058678|Granulosa cells|granulosa cells
4989225|NCT04058665|Lumbar spine surgery|lumbar spine surgery
4989322|NCT04058067|aflibercept|aflibercept
4989552|NCT04056741|RDS|rds
4989673|NCT04056052|Children|children
4989674|NCT04056052|Family-based intervention|family-based intervention
4989675|NCT04056039|rheumatoid arthritis|rheumatoid arthritis
4989676|NCT04056039|Troponin I|troponin i
4989677|NCT04056039|Atorvastatin|atorvastatin
4989678|NCT04056039|Colchicine|colchicine
4989679|NCT04056039|Cardiovascular disease risk|cardiovascular disease risk
4989680|NCT04056013|Traumatic lacerations|traumatic lacerations
4989681|NCT04056013|Vicryl Rapide|vicryl rapide
4989682|NCT04056013|nonabsorbable suture|nonabsorbable suture
4989683|NCT04056013|Suture|suture
4989684|NCT04055974|positive mental health|positive mental health
4989685|NCT04055974|cognitive behavioral therapy|cognitive behavioral therapy
4989686|NCT04055974|eHealth|ehealth
4989761|NCT04055311|urinary diversion|urinary diversion
4989762|NCT04055311|neobladder|neobladder
4989763|NCT04055285|arterial hypertension|arterial hypertension
4989764|NCT04055285|atrial fibrillation|atrial fibrillation
4989765|NCT04055285|renal denervation|renal denervation
4989766|NCT04055285|autonomous nervous system|autonomous nervous system
4989876|NCT04054778|Avatar Therapy|avatar therapy
4989877|NCT04054778|Virtual reality|virtual reality
4989885|NCT04054739|robot-assisted gait training|robot-assisted gait training
4989886|NCT04054739|cortical activity|cortical activity
4989887|NCT04054739|gait kinematics|gait kinematics
4989889|NCT04054726|Cerebellar ataxia|cerebellar ataxia
4989890|NCT04054726|Non-invasive stimulation|non-invasive stimulation
4989891|NCT04054726|Transcranial pulsed current stimulation|transcranial pulsed current stimulation
4989892|NCT04054713|Barrett Esophagus|barrett esophagus
4989893|NCT04054713|Dysplasia|dysplasia
4989894|NCT04054713|acetic acid|acetic acid
4989978|NCT04054180|Connected devices|connected devices
4989979|NCT04054128|Sodium bicarbonate lock|sodium bicarbonate lock
4989980|NCT04054128|Heparin lock|heparin lock
4989981|NCT04054128|Vascular access complication|vascular access complication
4989982|NCT04054102|stroke|stroke
4989983|NCT04054102|transcranial direct current stimulation|transcranial direct current stimulation
4989984|NCT04054102|upper extremity rehabilitation robot|upper extremity rehabilitation robot
4989986|NCT04054076|kinematics|kinematics
4989987|NCT04054076|kinetics|kinetics
4989990|NCT04054050|fatigue|fatigue
4990084|NCT04053621|thiamine pyrophosphate|thiamine pyrophosphate
4990085|NCT04053621|B1 vitamin|b1 vitamin
4990086|NCT04053621|type 2 diabetes mellitus|type 2 diabetes mellitus
4990087|NCT04053621|metabolic pathways|metabolic pathways
4990088|NCT04053595|Peri-operative goal-directed therapy|peri-operative goal-directed therapy
4990089|NCT04053595|Hemodynamic optimization|hemodynamic optimization
4990203|NCT04053101|TNM staging|tnm staging
4990204|NCT04053088|Surgical Aortic Valve Replacement (SAVR)|surgical aortic valve replacement (savr)
4990205|NCT04053088|INSPIRIS RESILIA|inspiris resilia
4990206|NCT04053088|Durability|durability
4990207|NCT04053088|Hemodynamics|hemodynamics
4990208|NCT04053075|Hospital Outbreak Detection|hospital outbreak detection
4990209|NCT04053075|Hospital Outbreak Response|hospital outbreak response
4990210|NCT04053075|Cluster|cluster
4990212|NCT04053075|Genetic Relatedness|genetic relatedness
4990307|NCT04052464|embryo transfer|embryo transfer
4990308|NCT04052464|endometrium|endometrium
4990310|NCT04052464|lavage|lavage
4990311|NCT04052464|liquid biopsy|liquid biopsy
4990312|NCT04052425|Vitiligo|vitiligo
4990313|NCT04052425|non-segmental|non-segmental
4990314|NCT04052425|JAK inhibitor|jak inhibitor
4990315|NCT04052334|Soft Tissue Sarcoma|soft tissue sarcoma
4990316|NCT04052334|Adoptive Cell Therapy|adoptive cell therapy
4990317|NCT04052321|Three-dimensional optical surface imaging|three-dimensional optical surface imaging
4990318|NCT04052321|Chest wall changes|chest wall changes
4990319|NCT04052308|Knee Osteoarthritis|knee osteoarthritis
4990320|NCT04052308|Blood Pressure|blood pressure
4990321|NCT04052308|HIIT|hiit
4990408|NCT04051697|Intervention|intervention
4990409|NCT04051697|Pilot Randomised Control Trial|pilot randomised control trial
4990410|NCT04051697|Behavioural intervention|behavioural intervention
4990411|NCT04051697|Quality of Life|quality of life
4990412|NCT04051645|Work of breathing|work of breathing
4990413|NCT04051645|Pressure Time Product|pressure time product
4990502|NCT04051177|China|china
4990729|NCT04049890|family functioning|family functioning
4990730|NCT04049890|chronic disease|chronic disease
4990731|NCT04049890|emotions|emotions
4990732|NCT04049864|neuroblastoma|neuroblastoma
4990733|NCT04049864|DNA vaccine|dna vaccine
4990734|NCT04049864|Salmonella vaccine|salmonella vaccine
4990735|NCT04049864|polyethylenimine|polyethylenimine
4990736|NCT04049786|bariatric surgery|bariatric surgery
4990737|NCT04049786|pharmacokinetics|pharmacokinetics
4990738|NCT04049786|carvedilol|carvedilol
4990864|NCT04049162|Exercise|exercise
4990865|NCT04049162|Cognition|cognition
4990866|NCT04049149|Young-onset type 2 diabetes|young-onset type 2 diabetes
4990867|NCT04049084|OTL-101|otl-101
4990868|NCT04049071|Tocilizumab|tocilizumab
4990869|NCT04049071|Giant Cell Arteritis|giant cell arteritis
4990870|NCT04049045|acute decompensated heart failure|acute decompensated heart failure
4990871|NCT04049045|empagliflozin|empagliflozin
4990872|NCT04049045|diuresis|diuresis
4990873|NCT04049045|renal function|renal function
4990874|NCT04049032|pregnancy|pregnancy
4990875|NCT04049032|prescription opioids|prescription opioids
4990876|NCT04049006|Quality of life|quality of life
4990961|NCT04048629|Point-of-care|point-of-care
4990962|NCT04048629|GeneXpert|genexpert
4990963|NCT04048603|REM sleep behavior disorder|rem sleep behavior disorder
4991075|NCT04047966|Intrauterine Growth restriction|intrauterine growth restriction
4991076|NCT04047966|Gastrointestinal microbiome|gastrointestinal microbiome
4991079|NCT04047953|gastric cancer|gastric cancer
4991181|NCT04047303|2nd line or relapsed|2nd line or relapsed
4991286|NCT04046874|Cost-effectiveness;|cost-effectiveness;
4991382|NCT04046445|Stage IV Rectal Cancer|stage iv rectal cancer
4991383|NCT04046445|KISIMA-01|kisima-01
4991384|NCT04046445|ATP128|atp128
4991385|NCT04046445|BI 754091|bi 754091
4991497|NCT04045808|edentulism|edentulism
4991498|NCT04045808|periodontitis|periodontitis
4991499|NCT04045808|periodontal disease|periodontal disease
4991500|NCT04045782|biologic|biologic
4991606|NCT04045119|Oily Skin|oily skin
4991607|NCT04045106|Proprioception|proprioception
4991608|NCT04045106|Proprioceptive Neuromuscular Facilitation,|proprioceptive neuromuscular facilitation,
4991609|NCT04045106|Cervical spine|cervical spine
4991610|NCT04045106|stretching|stretching
4991611|NCT04045067|Ablation|ablation
4991612|NCT04045067|Low voltage areas|low voltage areas
4991613|NCT04045041|Provoked vestibulodynia|provoked vestibulodynia
4991614|NCT04045041|Exposure treatment|exposure treatment
4991615|NCT04045041|Cognitive behaviour therapy|cognitive behaviour therapy
4991616|NCT04045041|Acceptance and commitment therapy|acceptance and commitment therapy
4991617|NCT04045041|Pain|pain
4991618|NCT04045041|Internet-based|internet-based
4991619|NCT04045041|Vulvodynia|vulvodynia
4991625|NCT04044989|photobiomodulation|photobiomodulation
4991626|NCT04044989|laser|laser
4991627|NCT04044989|LED|led
4991628|NCT04044989|resorption|resorption
4991629|NCT04044989|micro-CT|micro-ct
4991630|NCT04044976|Caffeine|caffeine
4991631|NCT04044976|delivery room|delivery room
4991632|NCT04044976|preterm infant|preterm infant
4991633|NCT04044963|Renal transplantation|renal transplantation
4991634|NCT04044963|Prehabilitation|prehabilitation
4991871|NCT04043663|pediatric surgery|pediatric surgery
4992082|NCT04042415|Immuno-metabolism|immuno-metabolism
4992083|NCT04042415|Calorie restriction|calorie restriction
4992084|NCT04042415|Treg cells|treg cells
4992085|NCT04042415|Inflammation|inflammation
4992086|NCT04042402|Primary Hyperoxaluria|primary hyperoxaluria
4992088|NCT04042402|PH2|ph2
4992089|NCT04042402|RNAi|rnai
4992090|NCT04042402|GalNAc|galnac
4992091|NCT04042402|LDHA|ldha
4992092|NCT04042402|LDH|ldh
4992093|NCT04042402|siRNA|sirna
4992094|NCT04042389|WhatsApp|whatsapp
4992095|NCT04042389|Email|email
4992096|NCT04042389|Oral hygiene|oral hygiene
4992097|NCT04042389|Compliance|compliance
4992171|NCT04041934|sleep|sleep
4992172|NCT04041934|adolescent|adolescent
4992173|NCT04041934|tryptophan|tryptophan
4992174|NCT04041934|athletes|athletes
4992175|NCT04041934|obeses|obeses
4992176|NCT04041921|CTO|cto
4992177|NCT04041921|PCI|pci
4992178|NCT04041921|CABG|cabg
4992179|NCT04041921|Medical treatment|medical treatment
4992180|NCT04041921|Decision CTO|decision cto
4992181|NCT04041895|Alzheimer's Disease|alzheimer's disease
4992182|NCT04041895|Dementia|dementia
4992183|NCT04041895|Linguistics|linguistics
4992184|NCT04041869|Older adults|older adults
4992185|NCT04041869|Walking|walking
4992186|NCT04041869|Fitbit|fitbit
4992190|NCT04041817|ICU|icu
4992191|NCT04041817|Pressure support ventilation|pressure support ventilation
4992192|NCT04041817|Spontaneous breathing|spontaneous breathing
4992193|NCT04041817|Trigger|trigger
4992263|NCT04041388|Bone-borne|bone-borne
4992264|NCT04041388|Distractor|distractor
4992265|NCT04041388|Tipping|tipping
4992266|NCT04041388|Osteotomy height|osteotomy height
4992267|NCT04041375|peer support|peer support
4992268|NCT04041375|mental health|mental health
4992269|NCT04041375|diabetes self-management|diabetes self-management
4992270|NCT04041375|community-based participatory research|community-based participatory research
4992273|NCT04041349|Cerebral Small Vessel Diseases|cerebral small vessel diseases
4992274|NCT04041349|Mouse Nerve Growth Factor|mouse nerve growth factor
4992275|NCT04041349|cognitive impairment|cognitive impairment
4992276|NCT04041336|Older|older
4992382|NCT04040842|low anterior resection|low anterior resection
4992383|NCT04040842|low anterior resection syndrome|low anterior resection syndrome
4992384|NCT04040829|Cognitive remediation therapy|cognitive remediation therapy
4992385|NCT04040829|Supported education|supported education
4992386|NCT04040829|Academic functioning|academic functioning
4992387|NCT04040829|Schizophrenia|schizophrenia
4992388|NCT04040829|Cognition|cognition
4992491|NCT04040231|Nivolumab|nivolumab
4992492|NCT04040231|Phase I|phase i
4992493|NCT04040231|17-654|17-654
4992494|NCT04040231|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
4992495|NCT04040218|dry needling|dry needling
4992496|NCT04040218|physical therapy|physical therapy
4992497|NCT04040205|Rb|rb
4992498|NCT04040205|Retinoblastoma|retinoblastoma
4992499|NCT04040205|Chondrosarcoma|chondrosarcoma
4992500|NCT04040205|Osteosarcoma|osteosarcoma
4992501|NCT04040205|Soft Tissue Sarcoma|soft tissue sarcoma
4992502|NCT04040192|Eczema|eczema
4992503|NCT04040192|Crisaborole|crisaborole
4992504|NCT04040153|Substance|substance
4992505|NCT04040153|Alcohol|alcohol
4992506|NCT04040153|Tobacco|tobacco
4992534|NCT04040010|DXA|dxa
4992720|NCT04039087|Cardiac function|cardiac function
4992726|NCT04039048|Biodex balance system|biodex balance system
4992727|NCT04039048|Posture control|posture control
4992728|NCT04039048|Ataxia' severity|ataxia' severity
4992729|NCT04039048|ctDCS|ctdcs
4992730|NCT04039035|Nutritional Risk Index|nutritional risk index
4992816|NCT04038567|cardiorespiratory failure|cardiorespiratory failure
4992817|NCT04038567|critical illness|critical illness
4992818|NCT04038567|psychological distress|psychological distress
4992819|NCT04038567|depression|depression
4992852|NCT04038372|HDV|hdv
4992913|NCT04038008|bioequivalence|bioequivalence
4992914|NCT04037956|Tubeless NOSES|tubeless noses
4992915|NCT04037956|traditional laparoscopic radical resection|traditional laparoscopic radical resection
4992916|NCT04037956|Rectosigmoid Cancers|rectosigmoid cancers
4992917|NCT04037943|Alpha linolenic acid|alpha linolenic acid
4992918|NCT04037904|Helicobacter pylori|helicobacter pylori
4992919|NCT04037904|Interleukin-1 beta|interleukin-1 beta
4993001|NCT04037475|herpes simplex|herpes simplex
4993002|NCT04037475|laser|laser
4993003|NCT04037436|Strength Training|strength training
4993004|NCT04037436|Balance Training|balance training
4993005|NCT04037436|Nutrition Education|nutrition education
4993006|NCT04037436|Older adults|older adults
4993118|NCT04036539|orthodontic treatment,|orthodontic treatment,
4993119|NCT04036539|photobiomodulation,|photobiomodulation,
4993120|NCT04036539|mini-implant,|mini-implant,
4993121|NCT04036539|verticalization of molars|verticalization of molars
4993122|NCT04036526|Bordetella pertussis|bordetella pertussis
4993123|NCT04036526|Live vaccine|live vaccine
4993124|NCT04036526|Immunological factors|immunological factors
4993125|NCT04036526|antibody response|antibody response
4993126|NCT04036526|cell immune response|cell immune response
4993127|NCT04036526|whooping cough|whooping cough
4993199|NCT04036097|infection diary|infection diary
4993296|NCT04035668|Dry Eye Syndromes|dry eye syndromes
4993297|NCT04035668|Pathological Processes|pathological processes
4993298|NCT04035668|Arthritis, Rheumatoid|arthritis, rheumatoid
4993299|NCT04035668|Arthritis|arthritis
4993300|NCT04035668|Joint Diseases|joint diseases
4993301|NCT04035668|Musculoskeletal Diseases|musculoskeletal diseases
4993302|NCT04035668|Rheumatic Diseases|rheumatic diseases
4993303|NCT04035668|Xerostomia|xerostomia
4993304|NCT04035668|Salivary Gland Diseases|salivary gland diseases
4993305|NCT04035668|Mouth Diseases|mouth diseases
4993306|NCT04035668|Stomatognathic Diseases|stomatognathic diseases
4993307|NCT04035668|Lacrimal Apparatus Diseases|lacrimal apparatus diseases
4993308|NCT04035668|Eye Diseases|eye diseases
4993309|NCT04035668|Connective Tissue Diseases|connective tissue diseases
4993383|NCT04035109|asthma|asthma
4993494|NCT04034459|Cetuximab|cetuximab
4993495|NCT04034459|Bevacizumab|bevacizumab
4993496|NCT04034446|Relapsed|relapsed
4993497|NCT04034446|Refractory|refractory
4993630|NCT04033848|Arthroscopy|arthroscopy
4993631|NCT04033848|Ankle Fracture|ankle fracture
4993632|NCT04033848|Patient rated outcome|patient rated outcome
4993633|NCT04033822|cholecystitis|cholecystitis
4993634|NCT04033822|cholecystectomy|cholecystectomy
4993635|NCT04033822|accelerated surgery|accelerated surgery
4993638|NCT04033809|Fiber|fiber
4993639|NCT04033809|Multigrain|multigrain
4993724|NCT04033237|Vulnerable populations|vulnerable populations
4993728|NCT04033198|Clinico-pathology , acute appendicitis , elderly , aging , histopathology|clinico-pathology , acute appendicitis , elderly , aging , histopathology
5667839|NCT00629655|human|human
5416599|NCT01647256|Fed|fed
4993729|NCT04033185|joint position sense|joint position sense
4993733|NCT04033172|Metastatic Breast Cancer, Pyrotinib, Fulvestrant|metastatic breast cancer, pyrotinib, fulvestrant
4993847|NCT04032587|stress|stress
4994139|NCT04030780|dyspepsia|dyspepsia
4994144|NCT04030728|patient coaching|patient coaching
4994145|NCT04030728|Advanced or metastatic breast cancer|advanced or metastatic breast cancer
4994146|NCT04030728|Abemaciclib|abemaciclib
4994147|NCT04030728|hormone receptor positive (HR+)|hormone receptor positive (hr+)
4994240|NCT04030039|nucleotide|nucleotide
4994243|NCT04030039|HBV DNA|hbv dna
4994244|NCT04030026|Nalbuphine|nalbuphine
4994343|NCT04029285|Aged, Aged 80 and Over|aged, aged 80 and over
4994344|NCT04029285|Postural Balance|postural balance
4994345|NCT04029285|Flow state experience|flow state experience
4994346|NCT04029285|Technology acceptance|technology acceptance
4994347|NCT04029285|Heart Rate|heart rate
4994348|NCT04029272|PCOS|pcos
4994349|NCT04029272|GLP-1|glp-1
4994350|NCT04029272|GLP-1RA|glp-1ra
4994351|NCT04029272|exenatide|exenatide
4994352|NCT04029272|Metformin|metformin
4994353|NCT04029272|glucagon-like peptide 1|glucagon-like peptide 1
4994354|NCT04029272|glucagon-like peptide 1 receptor agonist|glucagon-like peptide 1 receptor agonist
4994357|NCT04029155|peripheral pulmonary nodules|peripheral pulmonary nodules
4994358|NCT04029155|ultrathin bronchoscope|ultrathin bronchoscope
4994534|NCT04028193|post bariatric surgery|post bariatric surgery
4994536|NCT04028141|ketofol|ketofol
4994537|NCT04028141|propofol|propofol
4994538|NCT04028141|ketamine|ketamine
4994539|NCT04028141|emergency department|emergency department
5099717|NCT03374956|Individualized|individualized
4994540|NCT04028128|Nutritional Supplement|nutritional supplement
4994541|NCT04028128|High in flavanoids cocoa|high in flavanoids cocoa
4994542|NCT04028128|Body Fat composition|body fat composition
4994543|NCT04028128|Physical Exercise performance|physical exercise performance
4994544|NCT04028115|WH 540|wh 540
4994545|NCT04028102|sepsis|sepsis
4994546|NCT04028102|treatment|treatment
4994579|NCT04027764|s1|s1
4994726|NCT04026646|Flexibility|flexibility
4994727|NCT04026646|Proprioception|proprioception
4994728|NCT04026646|Physical Performance|physical performance
4994733|NCT04026607|Sarcopenia|sarcopenia
4994835|NCT04026152|Physical Activity|physical activity
4994836|NCT04026139|home-based exercise, resistance band, cartilage degeneration, glycated haemoglobin control, diabetes mellitus|home-based exercise, resistance band, cartilage degeneration, glycated haemoglobin control, diabetes mellitus
4994837|NCT04026126|Heat Therapy|heat therapy
4994840|NCT04026087|Renal transplantation|renal transplantation
4994841|NCT04026087|antibody-mediated rejection|antibody-mediated rejection
4994842|NCT04026087|DSA|dsa
4994932|NCT04025515|Single Nucleotide Variants (SNVs)|single nucleotide variants (snvs)
4994933|NCT04025515|Insertions/ Deletions (Indels)|insertions/ deletions (indels)
4994934|NCT04025515|Copy Number Variation (CNVs),|copy number variation (cnvs),
4994935|NCT04025515|Gene Fusions|gene fusions
4994936|NCT04025515|Formalin-Fixed|formalin-fixed
4994937|NCT04025515|Paraffin Embedded (FFPE) extracted DNA and RNA|paraffin embedded (ffpe) extracted dna and rna
4994938|NCT04025515|Ion PGM™ System|ion pgm™ system
4994940|NCT04025502|EEG|eeg
4995023|NCT04025047|the CTS(category-time-site) coding system|the cts(category-time-site) coding system
4995124|NCT04024475|Radiotherapy|radiotherapy
4995125|NCT04024475|Prostate cancer screening|prostate cancer screening
5864096|NCT00000417|Social support network|social support network
4995126|NCT04024475|Prostate-specific antigen (PSA)|prostate-specific antigen (psa)
4995127|NCT04024475|Prostate cancer (PCa)|prostate cancer (pca)
4995128|NCT04024475|Opportunistic screening|opportunistic screening
4995130|NCT04024436|Metastatic Breast Cancer|metastatic breast cancer
4995131|NCT04024436|FGFR|fgfr
4995132|NCT04024436|TAS-120|tas-120
4995235|NCT04023669|Refractory brain tumor|refractory brain tumor
4995236|NCT04023669|Sonic hedgehog|sonic hedgehog
4995237|NCT04023669|SHH Medulloblastoma|shh medulloblastoma
4995238|NCT04023669|St. Jude Brain Tumor Studies|st. jude brain tumor studies
4995239|NCT04023669|St. Jude Studies|st. jude studies
4995240|NCT04023669|St. Jude Treatment|st. jude treatment
4995326|NCT04023084|surveys|surveys
4995327|NCT04023084|questionnaires|questionnaires
4995328|NCT04023084|topical therapy|topical therapy
4995329|NCT04023071|AML|aml
4995427|NCT04022460|Mobile technology|mobile technology
4995429|NCT04022447|asthma|asthma
4995430|NCT04022447|real life|real life
4995431|NCT04022447|safety|safety
4995432|NCT04022382|Dry Eye Disease|dry eye disease
4995433|NCT04022382|Restylane-Defyne|restylane-defyne
4995434|NCT04022369|Aging|aging
4995435|NCT04022369|Randomized Controlled Trials (RCT)|randomized controlled trials (rct)
4995436|NCT04022369|Nursing|nursing
4995528|NCT04021667|Attitude|attitude
4995531|NCT04021628|cytomegalovirus|cytomegalovirus
4995532|NCT04021628|shedding|shedding
4995533|NCT04021628|excretion|excretion
4995534|NCT04021628|congenital|congenital
4995535|NCT04021628|cCMV|ccmv
4995759|NCT04020315|hypoxia|hypoxia
4995760|NCT04020315|cytokines|cytokines
4995761|NCT04020302|Shopping|shopping
4995762|NCT04020302|Activities of Daily Living|activities of daily living
4995763|NCT04020289|bipolar disorder|bipolar disorder
4995764|NCT04020289|depression|depression
4995765|NCT04020289|manic|manic
4995766|NCT04020289|illness perception|illness perception
4995767|NCT04020263|heart failure|heart failure
4995768|NCT04020263|levosimendan|levosimendan
4995769|NCT04020224|anemia|anemia
4995770|NCT04020224|transfusion|transfusion
4995771|NCT04020224|pathogen inactivation|pathogen inactivation
4995772|NCT04020224|pathogen reduction|pathogen reduction
4995773|NCT04020224|low-resource|low-resource
4995774|NCT04020224|sub-saharan africa|sub-saharan africa
4995782|NCT04020146|RXR|rxr
4995871|NCT04019704|Glutamate Modulator|glutamate modulator
4995872|NCT04019704|Axsome Therapeutics|axsome therapeutics
4995985|NCT04019015|Shock, Hemorrhagic|shock, hemorrhagic
4995986|NCT04019015|Trauma|trauma
4995987|NCT04019015|Mortality|mortality
4995989|NCT04019015|Hemorrhage|hemorrhage
4996083|NCT04018339|Bardoxolone Methyl|bardoxolone methyl
4996084|NCT04018339|Obese adult|obese adult
4996085|NCT04018339|body weight|body weight
4996086|NCT04018339|body composition|body composition
4996087|NCT04018326|loss to follow-up|loss to follow-up
4996534|NCT04015557|N-acetylcysteine|n-acetylcysteine
4996536|NCT04015557|Homocysteine|homocysteine
4996537|NCT04015544|insulin|insulin
4996538|NCT04015544|glucose|glucose
4996539|NCT04015544|cardiovascular disease|cardiovascular disease
4996540|NCT04015544|inflammation|inflammation
4996632|NCT04015115|Opioid-Related Disorders|opioid-related disorders
4996633|NCT04015115|Opioid Substitution Treatment|opioid substitution treatment
4996634|NCT04015115|Patient Compliance|patient compliance
4996637|NCT04015089|Infant formula|infant formula
4996638|NCT04015089|Partially hydrolized protein infant formula|partially hydrolized protein infant formula
4996745|NCT04014309|supportive care|supportive care
4996746|NCT04014309|survivorship|survivorship
4996747|NCT04014309|health service|health service
4996748|NCT04014309|triage|triage
4996749|NCT04014309|breast cancer|breast cancer
4996750|NCT04014309|gynecologic Cancer|gynecologic cancer
4996751|NCT04014296|weight loss|weight loss
4996859|NCT04013763|skin sensitization|skin sensitization
4996860|NCT04013763|specific IgE|specific ige
4996861|NCT04013763|wheat containing skin care|wheat containing skin care
4996862|NCT04013737|Antimicrobial Resistance|antimicrobial resistance
4996911|NCT04013295|HIV|hiv
4996981|NCT04012918|hormonal therapy|hormonal therapy
5706363|NCT00478192|edematous|edematous
4996982|NCT04012905|Giant Cell Arteritis|giant cell arteritis
4996983|NCT04012905|Horton disease|horton disease
4996984|NCT04012905|Corticosteroids treatment|corticosteroids treatment
4996985|NCT04012905|Prednisone|prednisone
4996986|NCT04012905|Relapse|relapse
4996987|NCT04012905|Side effect|side effect
4996988|NCT04012866|Cognitive Rehabilitation|cognitive rehabilitation
4996989|NCT04012866|Aerobic Exercise|aerobic exercise
4996991|NCT04012840|Frailty|frailty
4997069|NCT04012411|CSF|csf
4997070|NCT04012411|Biomarkers|biomarkers
4997071|NCT04012411|BDNF|bdnf
4997072|NCT04012411|P42|p42
4997073|NCT04012385|Lifestyle|lifestyle
4997288|NCT04011267|software|software
4997289|NCT04011267|musculoskeletal function|musculoskeletal function
4997290|NCT04011254|salt taste preference|salt taste preference
4997291|NCT04011254|salt taste sensitivity|salt taste sensitivity
4997292|NCT04011254|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
4997320|NCT04011098|Fentanyl|fentanyl
4997321|NCT04011098|Labour Induction|labour induction
4997323|NCT04011098|Obstetric Pain|obstetric pain
4997324|NCT04011098|Induction of Labour|induction of labour
4997325|NCT04011098|Anesthesia|anesthesia
4997326|NCT04011098|Obstetric Anesthesia|obstetric anesthesia
4997327|NCT04011085|HER2-positive Breast Cancer|her2-positive breast cancer
4997328|NCT04011085|work productivity|work productivity
4997329|NCT04011085|health-related quality of life|health-related quality of life
4997330|NCT04011072|Hemodialysis|hemodialysis
4997331|NCT04011072|Infrared therapy|infrared therapy
4997332|NCT04011072|Stenosis|stenosis
4997333|NCT04011072|Maturation|maturation
4997334|NCT04011072|Arteriovenous fistula survival|arteriovenous fistula survival
4997335|NCT04011059|Heart Failure|heart failure
4997336|NCT04011059|Cardiomyopathies|cardiomyopathies
4997337|NCT04011059|Coronary Artery Disease|coronary artery disease
4997338|NCT04011059|Ischemic Dilated Cardiomyopathy|ischemic dilated cardiomyopathy
4997339|NCT04010981|Pediatric Chronic Kidney Disease,|pediatric chronic kidney disease,
4997340|NCT04010981|virtual reality|virtual reality
4997341|NCT04010981|physical therapy|physical therapy
4997382|NCT04010669|Somatostatin|somatostatin
4997478|NCT04009967|Prostate Cancer|prostate cancer
4997479|NCT04009967|Pembrolizumab|pembrolizumab
4997480|NCT04009967|18FDG-PET Scanning|18fdg-pet scanning
4997481|NCT04009954|Post-operative Ileus|post-operative ileus
4997482|NCT04009954|Gut Microbiota|gut microbiota
4997577|NCT04009408|Muscular Dystrophy|muscular dystrophy
4997578|NCT04009369|Health care access|health care access
4997579|NCT04009369|Health services|health services
4997580|NCT04009369|Professional practices|professional practices
4997581|NCT04009330|hyper and hypo-inflammatory|hyper and hypo-inflammatory
4997789|NCT04008095|management|management
4997790|NCT04008082|Hepatocellular Carcinoma|hepatocellular carcinoma
4997791|NCT04008082|Lenvatinib Mesilate|lenvatinib mesilate
4997792|NCT04008082|Lenvima|lenvima
4997793|NCT04008082|LEN03T|len03t
4997794|NCT04008069|glucocorticoid-dependent|glucocorticoid-dependent
4997795|NCT04008043|Dexamethasone|dexamethasone
4997796|NCT04008043|Vicodin|vicodin
4997797|NCT04008043|Pain management|pain management
4997896|NCT04007549|Alcohol risk reduction|alcohol risk reduction
4997912|NCT04007523|Neurocognitive Disorders|neurocognitive disorders
4997913|NCT04007510|Psychosis|psychosis
4997914|NCT04007510|first episode|first episode
4997915|NCT04007510|clinical high risk|clinical high risk
4997916|NCT04007510|outcomes|outcomes
4997917|NCT04007510|mobile health|mobile health
4997918|NCT04007510|data driven care|data driven care
4997919|NCT04007510|learning healthcare network|learning healthcare network
4997920|NCT04007471|Dysmenorrhea|dysmenorrhea
4998007|NCT04006717|Intracanal cryotherapy|intracanal cryotherapy
4998009|NCT04006691|MitoGel|mitogel
4998106|NCT04005989|STROMAL CELLS|stromal cells
4998107|NCT04005989|ADIPOSE STROMAL CELLS|adipose stromal cells
4998108|NCT04005989|REVASCULARIZATION|revascularization
4998109|NCT04005989|MYOCARDIUM REVASCULARIZATION|myocardium revascularization
4998110|NCT04005989|CARDIAC SURGERY|cardiac surgery
4998111|NCT04005989|CORONARY ARTERY DISEASE|coronary artery disease
4998112|NCT04005937|muscle spindle|muscle spindle
4998202|NCT04005456|personalized medicine|personalized medicine
4998203|NCT04005456|functional medicine|functional medicine
4998204|NCT04005456|4P medicine|4p medicine
4998205|NCT04005456|lifestyle medicine|lifestyle medicine
4998206|NCT04005456|homocysteine|homocysteine
4998207|NCT04005456|dietary supplement|dietary supplement
4998208|NCT04005456|medical food|medical food
4998209|NCT04005456|behavioral change|behavioral change
4998210|NCT04005456|lifestyle modification|lifestyle modification
4998211|NCT04005456|employee wellness program|employee wellness program
4998212|NCT04005456|functional capacity|functional capacity
4998213|NCT04005456|food plan|food plan
4998214|NCT04005404|Regional Anesthesia|regional anesthesia
4998215|NCT04005404|Ultrasonography|ultrasonography
4998284|NCT04005118|postoperative complications|postoperative complications
4998285|NCT04005118|anastomotic leakage|anastomotic leakage
4998286|NCT04005092|non invasive ventilation|non invasive ventilation
4998287|NCT04005092|pulmonary edema|pulmonary edema
4998288|NCT04005092|high flow nasal cannula|high flow nasal cannula
4998289|NCT04005092|helmet CPAP|helmet cpap
4998290|NCT04005092|respiratory failure|respiratory failure
4998291|NCT04005092|hyperaemia|hyperaemia
4998292|NCT04005079|Cataract surgery|cataract surgery
4998293|NCT04005079|Trabectome|trabectome
4998298|NCT04005027|Intermittent Exercise|intermittent exercise
4998376|NCT04004494|lung cancer|lung cancer
4998377|NCT04004494|ground-glass opacity|ground-glass opacity
4998378|NCT04004481|Tramadol|tramadol
4998379|NCT04004481|CYP2D6 polymorphism|cyp2d6 polymorphism
4998380|NCT04004481|analgesia|analgesia
4998381|NCT04004481|intensive care|intensive care
4998382|NCT04004481|organ failure|organ failure
4998383|NCT04004455|children|children
4998385|NCT04004455|pressure pain threshold|pressure pain threshold
4998386|NCT04004455|energy-balance related behavior|energy-balance related behavior
4998472|NCT04004013|phytoestrogen|phytoestrogen
4998473|NCT04004013|hop|hop
4998474|NCT04004013|menopause|menopause
4998640|NCT04003090|ophthalmic solution|ophthalmic solution
4998864|NCT04001595|LGMD2I|lgmd2i
4998865|NCT04001595|LGMDR9|lgmdr9
4998866|NCT04001595|Limb Girdle Muscular Dystrophy|limb girdle muscular dystrophy
5706647|NCT00477165|IBS|ibs
4998971|NCT04001062|Metacarpal Shaft Fracture|metacarpal shaft fracture
4998972|NCT04001023|advanced ovarian cancer|advanced ovarian cancer
4998973|NCT04001023|EF5-PET/CT|ef5-pet/ct
4999072|NCT04000503|Cervical Cancer Screening|cervical cancer screening
4999074|NCT04000490|chest pain|chest pain
4999171|NCT04000022|Non-Treatment Resistant|non-treatment resistant
4999172|NCT04000022|Pharmaco-Naïve|pharmaco-naïve
4999173|NCT03999996|Vaccine|vaccine
4999176|NCT03999970|Sand Fly|sand fly
4999383|NCT03998553|OOCYTE RETRIEVAL|oocyte retrieval
4999384|NCT03998553|DONNOR|donnor
4999407|NCT03998371|diagnosis|diagnosis
4999408|NCT03998371|Chromosomal Aneuploidy Detection|chromosomal aneuploidy detection
4999409|NCT03998371|marker|marker
4999410|NCT03998371|urine|urine
4999416|NCT03998332|LCNEC-Large cell neuroendocrine carcinoma|lcnec-large cell neuroendocrine carcinoma
4999417|NCT03998332|Lung cancer|lung cancer
4999532|NCT03997773|Family Intervention|family intervention
4999533|NCT03997773|Denmark|denmark
4999642|NCT03997071|Internal Brace Ligament Augmentation|internal brace ligament augmentation
4999643|NCT03997071|ACL reconstruction|acl reconstruction
4999644|NCT03997071|Anterior Cruciate Ligament Rupture|anterior cruciate ligament rupture
4999645|NCT03997045|Pregnancy|pregnancy
4999646|NCT03997045|Physical exercise|physical exercise
4999647|NCT03997045|Urinary incontinence|urinary incontinence
4999648|NCT03997006|Aminophylline|aminophylline
4999649|NCT03997006|Atropine|atropine
4999650|NCT03997006|Neostigmine|neostigmine
4999651|NCT03997006|Post-dural puncture headache|post-dural puncture headache
4999652|NCT03997006|Spinal anesthesia|spinal anesthesia
4999653|NCT03996993|prostate cancer|prostate cancer
4999654|NCT03996993|Axumin|axumin
4999655|NCT03996980|Low back pain|low back pain
4999656|NCT03996980|custom-made foot orthoses|custom-made foot orthoses
4999657|NCT03996980|Foot|foot
4999658|NCT03996980|pronation|pronation
4999659|NCT03996980|posture|posture
4999663|NCT03996967|Children|children
4999845|NCT03996083|aging|aging
4999846|NCT03996083|nursing homes|nursing homes
4999847|NCT03996083|accidental falls|accidental falls
4999848|NCT03996083|exercise|exercise
4999849|NCT03996057|Urinary tract infection|urinary tract infection
4999851|NCT03996057|Women|women
4999852|NCT03996057|Postmenopausal women|postmenopausal women
4999853|NCT03996057|Prevention|prevention
4999854|NCT03996057|Non-antibiotic|non-antibiotic
4999855|NCT03995953|HIV prevention|hiv prevention
4999856|NCT03995953|HIV treatment|hiv treatment
4999857|NCT03995953|Zambia|zambia
4999859|NCT03995914|MACCEs|macces
4999936|NCT03995238|Rehabilitation|rehabilitation
4999937|NCT03995238|Gait Training|gait training
4999938|NCT03995238|Diabetes|diabetes
4999939|NCT03995238|Peripheral Artery Disease|peripheral artery disease
4999940|NCT03995212|Primary Biliary Cholangitis|primary biliary cholangitis
4999941|NCT03995212|Pruritus|pruritus
4999942|NCT03995212|CR845|cr845
5000042|NCT03994705|B-cell maturation antigen|b-cell maturation antigen
5000043|NCT03994705|Descartes-11|descartes-11
5000045|NCT03994679|3D virtual software|3d virtual software
5000157|NCT03994016|Sexual health|sexual health
5000158|NCT03993990|Diabetes、Foot ulcer、Self-care、glycemic control、Empowerment|diabetes、foot ulcer、self-care、glycemic control、empowerment
5000248|NCT03993678|phase Ib/IIa|phase ib/iia
5000261|NCT03993600|sweat|sweat
5000455|NCT03992430|MIS51ON|mis51on
5000456|NCT03992378|Sepsis|sepsis
5000462|NCT03992274|China|china
5000576|NCT03991650|Alcohol Use Disorder|alcohol use disorder
5000578|NCT03991624|decision making|decision making
5000579|NCT03991624|Iowa Gambling Task|iowa gambling task
5000580|NCT03991611|Critical care|critical care
5000683|NCT03991013|second line antiretroviral therapy|second line antiretroviral therapy
5000684|NCT03991013|dolutegravir|dolutegravir
5000685|NCT03991000|Iron deficiency|iron deficiency
5000686|NCT03991000|Atrial fibrillation|atrial fibrillation
5000788|NCT03990259|Sex differences|sex differences
5000789|NCT03990259|Performance|performance
5000790|NCT03990259|Genetics|genetics
5001019|NCT03989115|lung diseases|lung diseases
5001020|NCT03989115|respiratory tract diseases|respiratory tract diseases
5001026|NCT03989089|Germline APOBEC3B mutation|germline apobec3b mutation
5001027|NCT03989089|Pembrolizumab|pembrolizumab
5001028|NCT03989063|Motor Learning|motor learning
5001029|NCT03989063|Attentional Focus|attentional focus
5001030|NCT03989063|Limb Loss|limb loss
5001032|NCT03989063|Balance|balance
5001119|NCT03988543|Survivorship Care|survivorship care
5001120|NCT03988530|Anticholinergic|anticholinergic
5001121|NCT03988530|Scopolamine|scopolamine
5001123|NCT03988491|Kidney Failure, Chronic|kidney failure, chronic
5001124|NCT03988491|Mortality|mortality
5001125|NCT03988491|Survival|survival
5001228|NCT03987776|obesity|obesity
5001229|NCT03987776|low-grade inflammation|low-grade inflammation
5001230|NCT03987776|cardiometabolic|cardiometabolic
5001231|NCT03987776|immunity|immunity
5001232|NCT03987763|Plaque psoriasis|plaque psoriasis
5001233|NCT03987737|Prostatic neoplasm|prostatic neoplasm
5001234|NCT03987737|Prostate|prostate
5001235|NCT03987737|bp MRI of the prostate|bp mri of the prostate
5001236|NCT03987737|small rectal catheter placement|small rectal catheter placement
5001237|NCT03987724|Clinical trial|clinical trial
5001238|NCT03987724|Positron emission tomography|positron emission tomography
5001239|NCT03987724|Exercise|exercise
5001317|NCT03987178|bacterial keratitis|bacterial keratitis
5001318|NCT03987165|Neonatal Opioid Withdrawal Syndrome|neonatal opioid withdrawal syndrome
5001319|NCT03987152|Sirolimus|sirolimus
5001320|NCT03987152|mTor inhibitor|mtor inhibitor
5001321|NCT03987152|Quality of life|quality of life
5001322|NCT03987152|mammalian target of rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5001416|NCT03986411|athlete|athlete
5001417|NCT03986359|low-intensity extracorporeal shockwave therapy|low-intensity extracorporeal shockwave therapy
5001418|NCT03986359|Erectile Dysfunction|erectile dysfunction
5001534|NCT03985878|Dystrophy|dystrophy
5001535|NCT03985878|Dystrophin|dystrophin
5001536|NCT03985878|Exon Skipping|exon skipping
5001537|NCT03985878|Exon 51|exon 51
5001538|NCT03985878|Ambulatory|ambulatory
5001539|NCT03985878|Pediatric|pediatric
5001540|NCT03985865|Bitter|bitter
5001541|NCT03985865|Motilin|motilin
5001639|NCT03985267|psycho-oncology|psycho-oncology
5001640|NCT03985267|clinical health psychology|clinical health psychology
5001641|NCT03985267|ontology|ontology
5001644|NCT03985267|guided imagery|guided imagery
5001733|NCT03984734|Pylorus-preserving pancreatoduodenectomy|pylorus-preserving pancreatoduodenectomy
5469264|NCT01423812|HIV|hiv
5001734|NCT03984721|Mass spectrometry based proteomic analysis|mass spectrometry based proteomic analysis
5001735|NCT03984721|NanoLC-MS/MS|nanolc-ms/ms
5001736|NCT03984721|Amyloidosis typing|amyloidosis typing
5001737|NCT03984708|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5001841|NCT03984201|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5001842|NCT03984201|Accelerated Theta Burst Stimulation (aTBS)|accelerated theta burst stimulation (atbs)
5002054|NCT03983031|pediatric acute-onset neuropsychiatric syndrome|pediatric acute-onset neuropsychiatric syndrome
5002055|NCT03983018|Immunopsychiatry|immunopsychiatry
5002056|NCT03983018|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
5002057|NCT03983018|treatment-resistant|treatment-resistant
5002058|NCT03983005|Lung cancer|lung cancer
5707064|NCT00475800|Cox-2|cox-2
5002258|NCT03981549|Central Retinal Vein Occlusion|central retinal vein occlusion
5002357|NCT03981081|COPD|copd
5002577|NCT03979612|hereditary|hereditary
5002792|NCT03978416|Weight loss|weight loss
5002793|NCT03978416|Hispanic / Latino|hispanic / latino
5002794|NCT03978416|Older adults|older adults
5002795|NCT03978416|Eating habits|eating habits
5002910|NCT03977883|Paroxystic atrial fibrillation|paroxystic atrial fibrillation
5002911|NCT03977883|ICU patients|icu patients
5002912|NCT03977883|Rate control|rate control
5002913|NCT03977883|Rhythm control|rhythm control
5002984|NCT03977415|ILD|ild
5003016|NCT03977324|peri-implantitis|peri-implantitis
5003017|NCT03977324|surgical treatment|surgical treatment
5003021|NCT03977298|CTG|ctg
5003231|NCT03975959|PROMESSE|promesse
5003232|NCT03975959|PROSPECTIVE MEMORY|prospective memory
5003233|NCT03975959|RETROSPECTIVE MEMORY|retrospective memory
5003235|NCT03975933|Family Planning|family planning
5003336|NCT03975465|expiratory muscle strength training|expiratory muscle strength training
5003337|NCT03975465|long-term survivor|long-term survivor
5003339|NCT03975413|Microbiome|microbiome
5003340|NCT03975413|Gait|gait
5003341|NCT03975413|Longitudinal|longitudinal
5003425|NCT03974698|valgus/varus position|valgus/varus position
5003426|NCT03974698|Lateral approach|lateral approach
5003427|NCT03974698|Anterolateral approach|anterolateral approach
5003428|NCT03974685|99mTc-3PRGD2|99mtc-3prgd2
5003525|NCT03974191|Primary Health Care|primary health care
5003526|NCT03974178|Human African trypanosomiasis|human african trypanosomiasis
5003527|NCT03974178|neglected tropical disease|neglected tropical disease
5003528|NCT03974178|t.b. rhodesiense|t.b. rhodesiense
5003529|NCT03974165|cereal-based products fortified with legumes|cereal-based products fortified with legumes
5003530|NCT03974165|appetite regulation|appetite regulation
5003531|NCT03974165|postprandial glucose response|postprandial glucose response
5003533|NCT03974139|metformin|metformin
5003724|NCT03973047|Zofran|zofran
5003829|NCT03972241|Parkinson disease|parkinson disease
5003937|NCT03971526|Cerebrovascular disorders|cerebrovascular disorders
5003938|NCT03971526|Magnetic resonance imaging|magnetic resonance imaging
5004039|NCT03970902|Complex intervention|complex intervention
5004040|NCT03970902|Primary care|primary care
5004041|NCT03970902|Quality of Life|quality of life
5004042|NCT03970837|Rheumatoid Arthritis|rheumatoid arthritis
5004086|NCT03970551|IOH|ioh
5004445|NCT03968601|Preserved ventricular ejection fraction|preserved ventricular ejection fraction
5004446|NCT03968601|Global Longitudinal Strain|global longitudinal strain
5004447|NCT03968601|Post-operative ventricular dysfunction|post-operative ventricular dysfunction
5004448|NCT03968601|Echocardiography|echocardiography
5004450|NCT03968549|Probiotics|probiotics
5004539|NCT03968107|malrotation|malrotation
5004540|NCT03968107|intestinal structures|intestinal structures
5004541|NCT03968107|mesenteric vessels|mesenteric vessels
5004641|NCT03967522|brain metastases|brain metastases
5004642|NCT03967509|Externalizing behavior problems|externalizing behavior problems
5004643|NCT03967509|Social competence|social competence
5004644|NCT03967509|School readiness|school readiness
5004798|NCT03966586|hiv|hiv
5004847|NCT03966248|Traditional Chinese medicine|traditional chinese medicine
5004848|NCT03966248|Physical therapy|physical therapy
5004849|NCT03966248|Joint Diseases|joint diseases
5004850|NCT03966248|Musculoskeletal Diseases|musculoskeletal diseases
5004851|NCT03966248|Rheumatic Diseases|rheumatic diseases
5004852|NCT03966248|manual therapy|manual therapy
5004859|NCT03966196|COPD|copd
5004942|NCT03965507|Disc hernia|disc hernia
5004943|NCT03965507|Dysfunction|dysfunction
5004944|NCT03965507|Lumbar|lumbar
5004945|NCT03965507|Sacroiliac joint|sacroiliac joint
5004946|NCT03965494|adult glioblastoma|adult glioblastoma
5004947|NCT03965468|NSCLC|nsclc
5004948|NCT03965455|labial frenum|labial frenum
5004949|NCT03965455|laser therapy|laser therapy
5004950|NCT03965455|recurrence|recurrence
5004951|NCT03965455|oral hyigiene|oral hyigiene
5004952|NCT03965442|Post-mastectomy Pain Syndrome|post-mastectomy pain syndrome
5005205|NCT03963934|Nurse-led telephone follow-up|nurse-led telephone follow-up
5005206|NCT03963921|NASH|nash
5005207|NCT03963908|chronic pain|chronic pain
5005208|NCT03963908|stage of change|stage of change
5005210|NCT03963908|mobile applications|mobile applications
5005302|NCT03963518|meta-analysis|meta-analysis
5005303|NCT03963492|Walking|walking
5005304|NCT03963492|Gait|gait
5005331|NCT03963336|IIH|iih
5005415|NCT03962803|HIV-Infected Patients|hiv-infected patients
5005416|NCT03962803|Immunogenicity|immunogenicity
5005417|NCT03962803|Long-term Immune Response|long-term immune response
5005418|NCT03962777|gingivitis|gingivitis
5005419|NCT03962777|oil pulling|oil pulling
5005420|NCT03962725|Neuromuscular Blocker Avoidance|neuromuscular blocker avoidance
5005421|NCT03962725|Post Operative Pulmonary Complications|post operative pulmonary complications
5005422|NCT03962725|General Anesthesia Maintenance|general anesthesia maintenance
5005423|NCT03962725|Inhaled Anesthetics|inhaled anesthetics
5005424|NCT03962712|obesity|obesity
5005425|NCT03962712|overweight|overweight
5005431|NCT03962699|RNA|rna
5005509|NCT03962166|wavECG|wavecg
5005611|NCT03961659|Functional MRI|functional mri
5005612|NCT03961659|Olfactory function|olfactory function
5005613|NCT03961659|Liraglutid|liraglutid
5005614|NCT03961659|Dapagliflozin|dapagliflozin
5005615|NCT03961659|Acarbose|acarbose
5005616|NCT03961620|perioperative hypothermia|perioperative hypothermia
5005617|NCT03961620|core temperature|core temperature
5005618|NCT03961620|perioperative normothermia|perioperative normothermia
5005703|NCT03961022|Heart rate variability|heart rate variability
5005704|NCT03961022|Pain|pain
5005705|NCT03961022|Jump performance|jump performance
5005706|NCT03961009|Immunoglobulin|immunoglobulin
5005707|NCT03961009|Kedrion IVIg10%|kedrion ivig10%
5005708|NCT03961009|IgG antibodies|igg antibodies
5005709|NCT03961009|Agammaglobulinemia|agammaglobulinemia
5005710|NCT03961009|Hypogammaglobulinemia|hypogammaglobulinemia
5005711|NCT03960996|lacrimal duct obstruction|lacrimal duct obstruction
5005802|NCT03960411|STEMI|stemi
5005803|NCT03960398|iatrogenic|iatrogenic
5005804|NCT03960398|emergency|emergency
5005805|NCT03960398|incidence|incidence
5006028|NCT03958903|closed-loop brain stimulation|closed-loop brain stimulation
5006029|NCT03958864|Healthy Subjects|healthy subjects
5006030|NCT03958864|CC-90001|cc-90001
5006031|NCT03958864|Japanese|japanese
5006032|NCT03958864|Caucasian|caucasian
5006134|NCT03958227|Physiotherapy|physiotherapy
5006135|NCT03958227|Rehabilitation|rehabilitation
5006136|NCT03958188|Intestinal tumors|intestinal tumors
5006137|NCT03958188|Computerized Tomography|computerized tomography
5006233|NCT03957525|General Pediatric surgery|general pediatric surgery
5006234|NCT03957525|Pediatric orthopedics|pediatric orthopedics
5006235|NCT03957447|skin wounds|skin wounds
5006243|NCT03957395|FBSS|fbss
5006433|NCT03956329|Influenza Vaccination|influenza vaccination
5006434|NCT03956329|Positive Mood|positive mood
5006435|NCT03956329|Vaccination|vaccination
5006677|NCT03954782|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5006678|NCT03954782|Nintedanib|nintedanib
5006679|NCT03954769|Delirium,|delirium,
5006680|NCT03954769|Confusion Assessment Method|confusion assessment method
5006682|NCT03954769|DSM-V|dsm-v
5006946|NCT03952910|Chronic pain|chronic pain
5006947|NCT03952910|Working adults|working adults
5006948|NCT03952910|Pain education|pain education
5006949|NCT03952910|Internet-delivered|internet-delivered
5006950|NCT03952897|knee osteoarthritis|knee osteoarthritis
5006951|NCT03952897|rheumatoid arthritis|rheumatoid arthritis
5006952|NCT03952897|balneology|balneology
5006953|NCT03952897|hip balneology|hip balneology
5006954|NCT03952884|Metabolism|metabolism
5006955|NCT03952884|Amino Acid Peptides|amino acid peptides
5006958|NCT03952871|Shock|shock
5007194|NCT03951454|anxiety|anxiety
5007294|NCT03950934|Bronchoscopes|bronchoscopes
5007295|NCT03950934|Risk Assessment|risk assessment
5007296|NCT03950934|Surgery|surgery
5007334|NCT03950661|nature|nature
5007500|NCT03949686|Postoperative Analgesia|postoperative analgesia
5007501|NCT03949686|Ultrasound guided erector spinae plane block|ultrasound guided erector spinae plane block
5007502|NCT03949660|bowel|bowel
5007503|NCT03949660|spinal cord injury|spinal cord injury
5007504|NCT03949660|epidural stimulation|epidural stimulation
5007510|NCT03949621|Drug therapy|drug therapy
5007511|NCT03949608|e-learning|e-learning
5007512|NCT03949608|drug adherence|drug adherence
5007513|NCT03949608|health literacy|health literacy
5007514|NCT03949595|Obese|obese
5007515|NCT03949595|Food behaviour|food behaviour
5007608|NCT03948945|Fractional Laser|fractional laser
5007609|NCT03948945|Photoaging|photoaging
5007610|NCT03948945|Treatment|treatment
5007611|NCT03948945|Halo|halo
5007612|NCT03948906|Stroke , acute , observational study , rehabilitation|stroke , acute , observational study , rehabilitation
5007613|NCT03948867|Sickle Celll Anemia|sickle celll anemia
5007614|NCT03948867|Transcranial Doppler|transcranial doppler
5007615|NCT03948867|Tanzania|tanzania
5007616|NCT03948867|Hydroxyurea|hydroxyurea
5007617|NCT03948867|Stroke|stroke
5007618|NCT03948841|Neuroendocrine tumor|neuroendocrine tumor
5007619|NCT03948828|Endometriosis|endometriosis
5007620|NCT03948828|NK cell therapy|nk cell therapy
5007925|NCT03946774|mTOR|mtor
5007926|NCT03946774|Autophagy|autophagy
5007927|NCT03946774|Apoptosis|apoptosis
5007928|NCT03946774|Inflammation|inflammation
5007929|NCT03946735|Social Anxiety|social anxiety
5008024|NCT03946319|Behavioral Health|behavioral health
5008026|NCT03946319|Connected Health|connected health
5008027|NCT03946319|Introspect|introspect
5008028|NCT03946306|ENDODONTIC IRRIGATION, ENDODONTIC DISINFECTION, EDDY TIPS, APICAL EXTRUSION, ENDODONTIC PAIN|endodontic irrigation, endodontic disinfection, eddy tips, apical extrusion, endodontic pain
5008029|NCT03946280|ALARA|alara
5008030|NCT03946280|radiation exposure|radiation exposure
5008031|NCT03946280|Flutter ablation|flutter ablation
5008108|NCT03945747|Cardiometabolic function|cardiometabolic function
5008109|NCT03945747|Renal function|renal function
5008110|NCT03945721|Breast Cancer|breast cancer
5008111|NCT03945721|Triple Negative|triple negative
5008112|NCT03945721|Locally Advanced|locally advanced
5008113|NCT03945695|VMT|vmt
5008114|NCT03945695|VMA|vma
5008117|NCT03945682|physiotherapy|physiotherapy
5008208|NCT03945123|ginseng|ginseng
5008209|NCT03945123|Liver|liver
5008210|NCT03945045|venous thrombosis|venous thrombosis
5008212|NCT03945032|E-platform|e-platform
5008355|NCT03944369|VITORA|vitora
5008356|NCT03944369|KB109|kb109
5008357|NCT03944369|Microbiome Metabolic Therapy (MMT)|microbiome metabolic therapy (mmt)
5008358|NCT03944369|Oligosaccharide|oligosaccharide
5008359|NCT03944369|Glycan|glycan
5008360|NCT03944317|IPTip|iptip
5008361|NCT03944317|SP|sp
5008362|NCT03944317|AZ|az
5008363|NCT03944304|Single-center|single-center
5008364|NCT03944304|Prospective|prospective
5008365|NCT03944304|single-arm|single-arm
5008374|NCT03944213|TBS|tbs
5008450|NCT03943719|bacteremia|bacteremia
5008660|NCT03942406|Vaccine|vaccine
5008661|NCT03942406|Immunological factors|immunological factors
5008662|NCT03942406|Physiological effects of drugs|physiological effects of drugs
5008797|NCT03941470|NK ;natural killer cells|nk ;natural killer cells
5008908|NCT03940794|Verbal instructions|verbal instructions
5008909|NCT03940781|obstructive sleep apnea|obstructive sleep apnea
5008910|NCT03940781|oropharyngeal rehabilitation|oropharyngeal rehabilitation
5008911|NCT03940781|cardiopulmonary rehabilitation|cardiopulmonary rehabilitation
5008913|NCT03940768|home enteral nutrition|home enteral nutrition
5008916|NCT03940729|PWID|pwid
5009032|NCT03939975|Radiofrequency Ablation|radiofrequency ablation
5009162|NCT03939052|Phenylalanine metabolism|phenylalanine metabolism
5009163|NCT03939052|Protein requirements|protein requirements
5009164|NCT03939052|Indicator Amino acid Oxidation|indicator amino acid oxidation
5009165|NCT03939052|Stable isotopes|stable isotopes
5009166|NCT03939052|GMP|gmp
5009167|NCT03939052|Glycomacropeptide|glycomacropeptide
5009169|NCT03939013|Myanmar|myanmar
5009261|NCT03938467|Irrisept|irrisept
5009366|NCT03937895|Biliary Tract Cancer|biliary tract cancer
5009367|NCT03937895|BTC|btc
5009368|NCT03937895|Cholangiocarcinoma|cholangiocarcinoma
5009369|NCT03937882|Dry Eye|dry eye
5009370|NCT03937882|Dry Eye Syndrome|dry eye syndrome
5009371|NCT03937882|DES|des
5009372|NCT03937869|Adolescents|adolescents
5009373|NCT03937869|Vaginal fishy smell|vaginal fishy smell
5009577|NCT03936660|COORDINATE-DIABETES|coordinate-diabetes
5009578|NCT03936660|COORDINATE|coordinate
5009579|NCT03936660|T2DM|t2dm
5009580|NCT03936660|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5009581|NCT03936660|Cardiovascular Disease|cardiovascular disease
5009582|NCT03936660|Prevention|prevention
5009583|NCT03936647|intracranial aneurysm|intracranial aneurysm
5009584|NCT03936647|cerebral aneurysm|cerebral aneurysm
5009585|NCT03936647|brain aneurysm|brain aneurysm
5009586|NCT03936647|unruptured cerebral aneurysm|unruptured cerebral aneurysm
5009587|NCT03936647|ruptured cerebral aneurysm|ruptured cerebral aneurysm
5009588|NCT03936647|WEB embolization device|web embolization device
5009589|NCT03936647|embolization|embolization
5009590|NCT03936634|Observation study|observation study
5009591|NCT03936634|First degree relatives|first degree relatives
5009593|NCT03936634|C-Peptide|c-peptide
5009594|NCT03936634|Immune cells|immune cells
5009595|NCT03936634|Disease progression|disease progression
5009596|NCT03936621|Omega 3|omega 3
5009674|NCT03935997|Long-term care|long-term care
5009675|NCT03935997|Nursing home|nursing home
5009676|NCT03935958|kidney transplantation|kidney transplantation
5009677|NCT03935958|inflammation|inflammation
5009678|NCT03935958|vascular dysfunction|vascular dysfunction
5009679|NCT03935958|cognitive impairment|cognitive impairment
5009680|NCT03935958|oxidative stress|oxidative stress
5009767|NCT03935438|anthropometric parameters|anthropometric parameters
5009768|NCT03935438|physical efficiency|physical efficiency
5009769|NCT03935438|cardiovascular function|cardiovascular function
5009770|NCT03935412|Erector spinae plane block|erector spinae plane block
5009773|NCT03935412|postoperative analgesia|postoperative analgesia
5009774|NCT03935412|spinal anesthesia|spinal anesthesia
5009775|NCT03935373|Immune regulation|immune regulation
5009776|NCT03935373|Sjögren's syndrome|sjögren's syndrome
5009777|NCT03935373|Gene modulation|gene modulation
5009782|NCT03935373|Oral microbiome|oral microbiome
5009877|NCT03934905|cardiotoxicity|cardiotoxicity
5009879|NCT03934905|heart|heart
5009880|NCT03934827|Cancer|cancer
5009881|NCT03934827|Solid Tumour|solid tumour
5009882|NCT03934788|contact lens material|contact lens material
5009883|NCT03934788|silicon hydrogel|silicon hydrogel
5009884|NCT03934775|emergency department|emergency department
5009885|NCT03934775|risk prediction|risk prediction
5009886|NCT03934775|non-invasive hemodynamic|non-invasive hemodynamic
5009887|NCT03934775|Heart rate variability|heart rate variability
5009982|NCT03934190|macular edema|macular edema
5009983|NCT03934190|pseudophakic cystoid macular edema|pseudophakic cystoid macular edema
5009984|NCT03934190|macular pucker|macular pucker
5010089|NCT03933540|PROMIS|promis
5010194|NCT03933046|children|children
5010195|NCT03933033|Acne scars|acne scars
5010196|NCT03933033|Erbium-YAG laser|erbium-yag laser
5010197|NCT03933033|platelet-rich plasma|platelet-rich plasma
5010287|NCT03932500|Prognostic score|prognostic score
5010288|NCT03932487|iodine|iodine
5010289|NCT03932487|bisphenol A|bisphenol a
5010291|NCT03932474|depression|depression
5010487|NCT03931395|Honey|honey
5010488|NCT03931395|Pediatrics|pediatrics
5010489|NCT03931395|Post-Operative|post-operative
5010490|NCT03931343|Thoracolumbar interfascial block, Erector spinae plane block|thoracolumbar interfascial block, erector spinae plane block
5010491|NCT03931330|FGID|fgid
5010492|NCT03931330|Neural Stimulation|neural stimulation
5010493|NCT03931330|Functional Abdominal Pain|functional abdominal pain
5010578|NCT03930745|Double-Blind|double-blind
5010579|NCT03930745|Gardnerella vaginalis|gardnerella vaginalis
5010580|NCT03930745|Phase II|phase ii
5010581|NCT03930745|Placebo|placebo
5010582|NCT03930745|Randomized|randomized
5010678|NCT03929991|Cesarean Infection|cesarean infection
5120320|NCT03243058|IL-2|il-2
5010910|NCT03928262|Benralizumab|benralizumab
5010911|NCT03928262|Healthy Chinese subjects|healthy chinese subjects
5010912|NCT03928249|Eriocitrin|eriocitrin
5010913|NCT03928249|Citrus bioflavonoids|citrus bioflavonoids
5010914|NCT03928249|Flavanone|flavanone
5010915|NCT03928249|Pre-diabetes|pre-diabetes
5010916|NCT03928249|Blood glucose|blood glucose
5010917|NCT03928223|contagious itch|contagious itch
5010918|NCT03928223|Manchester Color Wheel|manchester color wheel
5010919|NCT03928210|cluster of circulating tumor cells (CTCs)|cluster of circulating tumor cells (ctcs)
5010920|NCT03928210|cardiac glycosides|cardiac glycosides
5010921|NCT03928210|digoxin|digoxin
5010922|NCT03928184|SM04690|sm04690
5010923|NCT03928184|Wnt pathway inhibitor|wnt pathway inhibitor
5010924|NCT03928184|osteoarthritis|osteoarthritis
5010925|NCT03928184|Samumed|samumed
5010926|NCT03928184|lorecivivint|lorecivivint
5010927|NCT03928171|Laparoscopic surgery|laparoscopic surgery
5011117|NCT03926819|CO|co
5011118|NCT03926819|Heme Oxygenase|heme oxygenase
5011119|NCT03926819|HO-1|ho-1
5011120|NCT03926806|yoghurt|yoghurt
5011121|NCT03926806|vitamins B|vitamins b
5011122|NCT03926806|body weight|body weight
5011123|NCT03926806|glycemic control|glycemic control
5011124|NCT03926780|warfarin|warfarin
5011125|NCT03926780|rivaroxaban|rivaroxaban
5011126|NCT03926780|left ventricular thrombus|left ventricular thrombus
5011127|NCT03926767|Pain Neuroscience Education|pain neuroscience education
5011128|NCT03926767|Chronic Pain|chronic pain
5011129|NCT03926767|Orofacial Manual Therapy|orofacial manual therapy
5011130|NCT03926767|Orofacial exercises|orofacial exercises
5011131|NCT03926767|Neck Motor Control Exercises|neck motor control exercises
5011132|NCT03926728|CTH522|cth522
5011133|NCT03926728|Chlamydia|chlamydia
5011134|NCT03926728|C. Trachomatis|c. trachomatis
5011135|NCT03926715|Malnutrition|malnutrition
5011136|NCT03926715|Post-operative complication|post-operative complication
5011137|NCT03926689|egg consumption|egg consumption
5011138|NCT03926689|dietary diversity|dietary diversity
5678706|NCT00585546|clenbuterol|clenbuterol
5011139|NCT03926689|complementary feeding|complementary feeding
5011140|NCT03926689|South Asia|south asia
5011141|NCT03926689|SMS|sms
5011196|NCT03926312|low physical activity|low physical activity
5011197|NCT03926312|risk factors control|risk factors control
5011198|NCT03926286|Dry Eye|dry eye
5011199|NCT03926286|Auto-Immune Disorder|auto-immune disorder
5011200|NCT03926273|epilepsy|epilepsy
5011201|NCT03926273|serum ghrelin|serum ghrelin
5011202|NCT03926273|urine ghrelin|urine ghrelin
5011203|NCT03926247|pilot study|pilot study
5011204|NCT03926247|mental health|mental health
5011205|NCT03926247|immigrant|immigrant
5011207|NCT03926208|Betadine|betadine
5011296|NCT03925636|Clostridium Difficile|clostridium difficile
5011297|NCT03925636|cDiff|cdiff
5011298|NCT03925636|Diet|diet
5011299|NCT03925610|Morbid obesity|morbid obesity
5011300|NCT03925610|Opioid-induced ventilatory depression|opioid-induced ventilatory depression
5011301|NCT03925610|Bariatric surgery|bariatric surgery
5011302|NCT03925610|Sleep apnea|sleep apnea
5011397|NCT03924947|Exocrine Pancreatic Insufficiency (EPI)|exocrine pancreatic insufficiency (epi)
5011398|NCT03924947|Modernized Process (MP)|modernized process (mp)
5011399|NCT03924934|Infection|infection
5011400|NCT03924934|Bacterial Infection|bacterial infection
5011519|NCT03924310|vibrotactile feedback|vibrotactile feedback
5011520|NCT03924310|feedback display|feedback display
5011521|NCT03924297|chilipad|chilipad
5011523|NCT03924206|Smoke|smoke
5011524|NCT03924206|Plume|plume
5011525|NCT03924206|Electrocautery|electrocautery
5011526|NCT03924206|Mass spectrometer|mass spectrometer
5011527|NCT03924180|Amino acid|amino acid
5011528|NCT03924180|GMP|gmp
5011529|NCT03924180|PKU|pku
5011537|NCT03924154|KAR5417|kar5417
5011748|NCT03922971|outpatient|outpatient
5011749|NCT03922971|infection|infection
5011750|NCT03922971|Endoscopic procedures|endoscopic procedures
5011751|NCT03922945|weight loss|weight loss
5011752|NCT03922945|obesity|obesity
5011753|NCT03922945|weight control|weight control
5011754|NCT03922932|Diabetes|diabetes
5011755|NCT03922932|OCT|oct
5011756|NCT03922932|Angiography|angiography
5011757|NCT03922932|Diabetic retinopathy|diabetic retinopathy
5011758|NCT03922893|Genetic evaluation|genetic evaluation
5011759|NCT03922893|Germline genetic variant|germline genetic variant
5011760|NCT03922893|Genetic cancer|genetic cancer
5011761|NCT03922893|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5011762|NCT03922893|19-133|19-133
5011763|NCT03922880|ADI-PEG 20|adi-peg 20
5011764|NCT03922880|nivolumab|nivolumab
5011765|NCT03922880|ipilimumab|ipilimumab
5011766|NCT03922880|19-010|19-010
5011767|NCT03922880|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5011768|NCT03922867|insomnia|insomnia
5011769|NCT03922867|fibromyalgia|fibromyalgia
5011770|NCT03922815|Surgical Pleth Index (SPI)|surgical pleth index (spi)
5011771|NCT03922815|Adequacy of Anaesthesia (AoA)|adequacy of anaesthesia (aoa)
5011772|NCT03922815|State Entropy (SE)|state entropy (se)
5123557|NCT03223129|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5011773|NCT03922815|Postoperative nausea and vomitting (PONV)|postoperative nausea and vomitting (ponv)
5011774|NCT03922815|Colonoscopy|colonoscopy
5011775|NCT03922802|Spinal Cord Injury|spinal cord injury
5011782|NCT03922776|PBMc|pbmc
5011827|NCT03922503|Demineralized freeze-dried bone allograft|demineralized freeze-dried bone allograft
5011828|NCT03922503|DFDBA|dfdba
5011829|NCT03922503|Collagen Membrane|collagen membrane
5011830|NCT03922503|non-contained intraosseous defects|non-contained intraosseous defects
5011831|NCT03922503|one wall intraosseous defects|one wall intraosseous defects
5011832|NCT03922503|combined 1- to 2-wall intraosseous defect|combined 1- to 2-wall intraosseous defect
5011833|NCT03922438|Cleft lip and palate|cleft lip and palate
5011929|NCT03921736|estrogen-progestin therapy|estrogen-progestin therapy
5011930|NCT03921736|hypertension|hypertension
5011931|NCT03921736|uric acid|uric acid
5011932|NCT03921736|xanthine|xanthine
5011933|NCT03921736|hypoxanthine|hypoxanthine
5011934|NCT03921736|menopause|menopause
5011935|NCT03921736|thiazide diuretic|thiazide diuretic
5011941|NCT03921723|Suspension|suspension
5012035|NCT03920969|HIV|hiv
5012036|NCT03920969|Self Esteem|self esteem
5012037|NCT03920943|patient transfer|patient transfer
5012038|NCT03920930|ERAS|eras
5012039|NCT03920930|pain|pain
5012040|NCT03920930|knee arthroplasty|knee arthroplasty
5012041|NCT03920930|joint pain|joint pain
5012042|NCT03920930|regional anaesthesia|regional anaesthesia
5012043|NCT03920917|Atrial fibrillation|atrial fibrillation
5012046|NCT03920891|Valvular Atrial fibrillation|valvular atrial fibrillation
5012130|NCT03920371|handheld gamma camera|handheld gamma camera
5012131|NCT03920332|Pregnancy|pregnancy
5012132|NCT03920332|obstetric|obstetric
5012244|NCT03919500|Preterm infant|preterm infant
5012245|NCT03919500|Necrotizing enterocolitis|necrotizing enterocolitis
5012246|NCT03919500|Erythropoietin|erythropoietin
5012247|NCT03919500|Neurodevelopment|neurodevelopment
5012248|NCT03919474|sudden hearing loss,|sudden hearing loss,
5012249|NCT03919474|SSNHL|ssnhl
5012267|NCT03919422|elderly|elderly
5012350|NCT03919084|ACO|aco
5012351|NCT03919058|Multiple Sclerosis|multiple sclerosis
5864097|NCT00000417|Outcomes research|outcomes research
5012352|NCT03919058|Non-exercise physical activity|non-exercise physical activity
5012353|NCT03919058|NEPA|nepa
5012354|NCT03919058|Cardiometabolic health|cardiometabolic health
5012446|NCT03918681|ACLR|aclr
5012447|NCT03918681|Loading|loading
5012448|NCT03918668|breast neoplasm|breast neoplasm
5012449|NCT03918668|cancer|cancer
5012450|NCT03918668|risk factor|risk factor
5012451|NCT03918668|nutrition|nutrition
5012452|NCT03918655|Acute Myeloid Leukemia.|acute myeloid leukemia.
5012453|NCT03918655|Macrophage migration inhibitory factor|macrophage migration inhibitory factor
5012454|NCT03918655|Hematopoietic stem cell|hematopoietic stem cell
5012563|NCT03917784|Curcumin|curcumin
5012662|NCT03917329|Acceptance and Commitment Therapy|acceptance and commitment therapy
5012754|NCT03916848|Stereoelectroencephalography|stereoelectroencephalography
5012755|NCT03916848|Single unit recording|single unit recording
5012756|NCT03916848|Single neuron recording|single neuron recording
5012757|NCT03916848|SEEG|seeg
5012758|NCT03916848|Epilepsy surgery|epilepsy surgery
5685502|NCT00555828|Myocardial infarct|myocardial infarct
5668735|NCT00626197|SLE|sle
5524112|NCT01192048|DNA|dna
5012759|NCT03916835|Pediatric Critical ill care or intensive care|pediatric critical ill care or intensive care
5012760|NCT03916835|anxiety|anxiety
5012849|NCT03916315|Obsessive Compulsive Disorder|obsessive compulsive disorder
5012850|NCT03916315|posttraumatic stress disorder|posttraumatic stress disorder
5012851|NCT03916302|acute pulmonary embolism|acute pulmonary embolism
5012852|NCT03916276|Chronic Pain|chronic pain
5012853|NCT03916276|Opioid|opioid
5012854|NCT03916276|Heterogeneous Pain|heterogeneous pain
5012855|NCT03916276|Musculoskeletal Pain|musculoskeletal pain
5012856|NCT03916276|Mindfulness Meditation|mindfulness meditation
5012858|NCT03916276|Cognitive Therapy|cognitive therapy
5012948|NCT03915691|Atrial Fibrillation|atrial fibrillation
5012949|NCT03915691|Mapping|mapping
5012950|NCT03915691|Ablation|ablation
5012951|NCT03915678|Immunotherapy|immunotherapy
5012952|NCT03915678|Radiotherapy|radiotherapy
5012953|NCT03915678|Oncology|oncology
5012954|NCT03915678|Metastatic|metastatic
5012955|NCT03915652|minority health|minority health
5012956|NCT03915652|prevention|prevention
5012957|NCT03915652|vaccine|vaccine
5012958|NCT03915652|behavior|behavior
5012959|NCT03915652|women's health|women's health
5012960|NCT03915652|autoimmune|autoimmune
5012961|NCT03915652|intervention|intervention
5012962|NCT03915652|survey|survey
5012963|NCT03915652|QI/QA|qi/qa
5012964|NCT03915652|outcomes (health services/delivery)|outcomes (health services/delivery)
5012965|NCT03915639|Post-Craniotomy Headache|post-craniotomy headache
5013051|NCT03915184|Carcinoma, Multiple Myeloma|carcinoma, multiple myeloma
5013052|NCT03915171|NGS bMSI Gastrointestinal|ngs bmsi gastrointestinal
5013157|NCT03914456|Robotic|robotic
5013158|NCT03914456|Functional magnetic resonance imaging|functional magnetic resonance imaging
5013159|NCT03914443|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5013160|NCT03914443|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5013161|NCT03914443|Nivolumab|nivolumab
5013162|NCT03914443|JCOG|jcog
5013163|NCT03914430|Breakfast|breakfast
5013164|NCT03914430|Blood glucose|blood glucose
5013259|NCT03913702|Methylprednisolone|methylprednisolone
5013260|NCT03913702|Subacromial impingement syndrome|subacromial impingement syndrome
5013265|NCT03913637|Mild Cognitive Impairment|mild cognitive impairment
5013266|NCT03913637|Cognition|cognition
5013267|NCT03913637|Disability|disability
5013268|NCT03913637|Non-pharmacological Intervention|non-pharmacological intervention
5013269|NCT03913637|Behavioral Intervention|behavioral intervention
5013270|NCT03913637|Amyloid deposition|amyloid deposition
5013271|NCT03913624|Rehabilitation|rehabilitation
5013272|NCT03913624|Electric stimulation|electric stimulation
5013273|NCT03913624|Upper limb|upper limb
5013274|NCT03913624|Aging|aging
5013275|NCT03913611|Shoulder arthroscopy|shoulder arthroscopy
5013276|NCT03913611|Rotator cuff repair|rotator cuff repair
5013277|NCT03913598|social media use|social media use
5013278|NCT03913598|online medical services|online medical services
5013279|NCT03913598|internet use|internet use
5013280|NCT03913585|Tailored lifestyle intervention|tailored lifestyle intervention
5013281|NCT03913585|Selective prevention|selective prevention
5013282|NCT03913585|Primary care|primary care
5013283|NCT03913585|Web based health risk assessment|web based health risk assessment
5013284|NCT03913585|Patient-centered health information system|patient-centered health information system
5013285|NCT03913559|B-cell Acute Lymphoblastic Leukemia|b-cell acute lymphoblastic leukemia
5013286|NCT03913546|neuromuscular properties|neuromuscular properties
5013287|NCT03913546|strength|strength
5013288|NCT03913546|power|power
5013289|NCT03913546|performance|performance
5013290|NCT03913533|Newborn|newborn
5013344|NCT03913286|neuroprosthetic|neuroprosthetic
5013345|NCT03913286|neuroprosthesis|neuroprosthesis
5013346|NCT03913286|brain-computer|brain-computer
5013464|NCT03912636|vagal nerve|vagal nerve
5013557|NCT03912038|umbilical cord|umbilical cord
5013558|NCT03912012|Diabetes mellitus type 1|diabetes mellitus type 1
5013559|NCT03912012|Type 1 diabetes|type 1 diabetes
5013560|NCT03912012|diabetes|diabetes
5013561|NCT03912012|pediatrics|pediatrics
5013562|NCT03912012|Glomerular hyperfiltration|glomerular hyperfiltration
5013563|NCT03912012|endothelial dysfunction|endothelial dysfunction
5013811|NCT03910634|Carboplatin|carboplatin
5013812|NCT03910608|Paired Associative Stimulation|paired associative stimulation
5013818|NCT03910595|Quality of Life|quality of life
5013819|NCT03910595|Radiation Dermatitis|radiation dermatitis
5013820|NCT03910595|Skin toxicity|skin toxicity
5013910|NCT03909997|morbidity|morbidity
5013911|NCT03909997|adenocarcinoma|adenocarcinoma
5013919|NCT03909945|Annona muricata|annona muricata
5013920|NCT03909945|Hypertension|hypertension
5013968|NCT03909581|PCI|pci
5014011|NCT03909204|Laparoscopic-Assisted Percutaneous Endoscopic Cecostomy|laparoscopic-assisted percutaneous endoscopic cecostomy
5014013|NCT03909191|HBsAg|hbsag
5014014|NCT03909191|cccDNA|cccdna
5014015|NCT03909191|Nucleos(t)ide analogue|nucleos(t)ide analogue
5014016|NCT03909191|virological relapse|virological relapse
5685503|NCT00555828|Infarction|infarction
5014017|NCT03909178|Acetabular Labrum Tear|acetabular labrum tear
5014018|NCT03909178|Femoro Acetabular Impingement|femoro acetabular impingement
5014020|NCT03909178|Hip Arthroscopy|hip arthroscopy
5014021|NCT03909178|Prospective|prospective
5014022|NCT03909178|PROMs|proms
5014023|NCT03909178|mHHS|mhhs
5014098|NCT03908788|Circulating DNA in patients|circulating dna in patients
5014099|NCT03908788|Treatment with anti-EGFR therapy|treatment with anti-egfr therapy
5014100|NCT03908775|Intubation|intubation
5014101|NCT03908775|Children|children
5014102|NCT03908775|Hemodynamics|hemodynamics
5014204|NCT03908138|multiple myeloma|multiple myeloma
5014205|NCT03908138|lenalidomide|lenalidomide
5014206|NCT03908112|convergence insufficiency|convergence insufficiency
5014217|NCT03908073|Transcutaneous Vagal Nerve Stimulation|transcutaneous vagal nerve stimulation
5014218|NCT03908073|Cytokines|cytokines
5014219|NCT03908073|LPS stimulated cytokine production|lps stimulated cytokine production
5014322|NCT03907462|wearable|wearable
5014323|NCT03907462|mobile application|mobile application
5014324|NCT03907462|behavior mechanism|behavior mechanism
5014325|NCT03907462|behavior|behavior
5014326|NCT03907436|nutrition|nutrition
5014327|NCT03907436|diet|diet
5014328|NCT03907436|inflammation|inflammation
5014329|NCT03907436|myeloproliferative neoplasm|myeloproliferative neoplasm
5014330|NCT03907397|allergy|allergy
5014331|NCT03907397|food|food
5014332|NCT03907397|peanut|peanut
5014333|NCT03907397|threshold|threshold
5014334|NCT03907397|immunotherapy|immunotherapy
5014423|NCT03906552|pain|pain
5014424|NCT03906552|neonate|neonate
5014425|NCT03906552|heel lancing|heel lancing
5014426|NCT03906539|Cardiometabolic parameters|cardiometabolic parameters
5014431|NCT03906526|Motolimod|motolimod
5127908|NCT03194815|Autoantibodies|autoantibodies
5014554|NCT03905902|active cellular immunotherapy|active cellular immunotherapy
5014555|NCT03905902|dendritic cells|dendritic cells
5014556|NCT03905902|platinum-sensitive|platinum-sensitive
5014557|NCT03905902|relapsed ovarian cancer|relapsed ovarian cancer
5014558|NCT03905902|biologic|biologic
5014559|NCT03905889|Renal cell carcinoma|renal cell carcinoma
5014791|NCT03904342|Consolidated Framework for Implementation Research (CFIR)|consolidated framework for implementation research (cfir)
5014796|NCT03904238|Hypersomnia|hypersomnia
5014797|NCT03904238|narcolepsy|narcolepsy
5014798|NCT03904238|idiopathic hypersomnia|idiopathic hypersomnia
5014799|NCT03904238|psychosocial|psychosocial
5014800|NCT03904238|cognitive-behavior therapy|cognitive-behavior therapy
5014880|NCT03903900|Healthy eating|healthy eating
5014985|NCT03903068|transcranial alternating current stimulation|transcranial alternating current stimulation
5014986|NCT03903055|MDS|mds
5014987|NCT03903055|RNA-seq|rna-seq
5014988|NCT03903042|Aurora fundus camera|aurora fundus camera
5015178|NCT03901638|multiple system atrophy, cerebellar ataxia, NMDA, microbiota|multiple system atrophy, cerebellar ataxia, nmda, microbiota
5015179|NCT03901547|documentation|documentation
5015180|NCT03901547|serious illness|serious illness
5015181|NCT03901534|Interstitial Lung Disease (ILD)|interstitial lung disease (ild)
5015182|NCT03901534|Idiopathic Pulmonary Fibrosis (IPF)|idiopathic pulmonary fibrosis (ipf)
5015183|NCT03901534|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5015184|NCT03901534|CPAP|cpap
5015185|NCT03901508|tDCS|tdcs
5015186|NCT03901508|Athlete|athlete
5015187|NCT03901508|Isokinetic|isokinetic
5015188|NCT03901508|Strength|strength
5015189|NCT03901508|Endurance|endurance
5015190|NCT03901495|differential diagnosis|differential diagnosis
5015191|NCT03901495|hospital outpatient clinics|hospital outpatient clinics
5015224|NCT03901339|TPC|tpc
5015269|NCT03901144|moisturiser|moisturiser
5015270|NCT03901144|emollient|emollient
5015271|NCT03901118|ovarian cancer, relapsed or refractory|ovarian cancer, relapsed or refractory
5015272|NCT03901118|chiauranib, chemotherapy|chiauranib, chemotherapy
5015368|NCT03900494|inhalation therapy|inhalation therapy
5015369|NCT03900494|children|children
5015370|NCT03900494|toddlers|toddlers
5679092|NCT00583557|RA|ra
5015371|NCT03900494|emergency room|emergency room
5015373|NCT03900468|Deep Brain Stimulation|deep brain stimulation
5015374|NCT03900468|DBS|dbs
5015375|NCT03900468|EPAS|epas
5015379|NCT03900416|Mindfulness|mindfulness
5015466|NCT03899935|Laparoscopy|laparoscopy
5015467|NCT03899922|Uvea toxicity|uvea toxicity
5015580|NCT03899792|Thyroid Neoplasms|thyroid neoplasms
5015581|NCT03899792|Cancer of the Thyroid|cancer of the thyroid
5015582|NCT03899792|Cancer of Thyroid|cancer of thyroid
5015583|NCT03899792|Neoplasms, Thyroid|neoplasms, thyroid
5015584|NCT03899792|Thyroid Adenoma|thyroid adenoma
5015585|NCT03899792|Thyroid Cancer|thyroid cancer
5015689|NCT03899337|Richter's Transformation|richter's transformation
5015690|NCT03899337|Richter's Syndrome|richter's syndrome
5015691|NCT03899337|CHOP-R|chop-r
5016047|NCT03896750|Open-Label|open-label
5016048|NCT03896750|Pretomanid|pretomanid
5016049|NCT03896750|Renal Pharmacokinetic|renal pharmacokinetic
5016050|NCT03896750|Safety|safety
5016051|NCT03896750|Single-Dose|single-dose
5016052|NCT03896737|diagnosis|diagnosis
5016053|NCT03896737|elderly|elderly
5016054|NCT03896737|autologous stem cell transplantation|autologous stem cell transplantation
5016055|NCT03896711|dementia care|dementia care
5016056|NCT03896711|community-based|community-based
5016166|NCT03895957|virtual reality|virtual reality
5016167|NCT03895957|social phobia|social phobia
5016168|NCT03895957|vret|vret
5016169|NCT03895957|virtual reality exposure therapy|virtual reality exposure therapy
5016284|NCT03895190|stress|stress
5016285|NCT03895190|positive psychology|positive psychology
5016286|NCT03895190|meditation|meditation
5016287|NCT03895190|mobile application (app)|mobile application (app)
5016288|NCT03895190|medical students|medical students
5016289|NCT03895125|dual-task training|dual-task training
5016290|NCT03895125|attention|attention
5016291|NCT03895125|Parkinson's disease|parkinson's disease
5016292|NCT03895125|walking|walking
5016294|NCT03895112|Therapeutic|therapeutic
5016295|NCT03895112|Fibrosis|fibrosis
5016296|NCT03895112|Splenomegaly|splenomegaly
5016297|NCT03895112|Myeloproliferative neoplasms research consortium|myeloproliferative neoplasms research consortium
5016298|NCT03895112|Intravenous Infusion|intravenous infusion
5016378|NCT03894566|Infant, Newborn|infant, newborn
5016379|NCT03894566|Child|child
5016380|NCT03894566|Infant|infant
5016381|NCT03894566|Health|health
5016382|NCT03894566|Public Health|public health
5016383|NCT03894566|Predictors|predictors
5016384|NCT03894527|Acute Exercise|acute exercise
5016406|NCT03894384|PG1|pg1
5016477|NCT03893695|Metastatic Hepatocellular Carcinoma|metastatic hepatocellular carcinoma
5016478|NCT03893682|Oral|oral
5016479|NCT03893682|DLBCL|dlbcl
5016480|NCT03893682|PMBCL|pmbcl
5016481|NCT03893682|BCLU|bclu
5016482|NCT03893682|GZL|gzl
5016582|NCT03892967|Sleep Disturbance|sleep disturbance
5016583|NCT03892967|Electronic Health Record|electronic health record
5016584|NCT03892967|Pain|pain
5016585|NCT03892967|Anxiety|anxiety
5016586|NCT03892967|Depression|depression
5016587|NCT03892967|Fatigue|fatigue
5016600|NCT03892824|AF|af
5016681|NCT03892213|Chagas Disease|chagas disease
5016682|NCT03892213|drug-drug interaction|drug-drug interaction
5016683|NCT03892213|benznidazole|benznidazole
5016684|NCT03892213|E1224|e1224
5016685|NCT03892213|pharmacokinetics|pharmacokinetics
5016686|NCT03892200|Mouth Care|mouth care
5016687|NCT03892187|prehabilitation|prehabilitation
5016688|NCT03892187|perioperative outcomes|perioperative outcomes
5016689|NCT03892148|Heart Failure|heart failure
5016776|NCT03891589|Micronutrient|micronutrient
5016777|NCT03891589|Growth|growth
5016778|NCT03891576|Ovarian Cancer|ovarian cancer
5016779|NCT03891576|Fallopian Tube Cancer|fallopian tube cancer
5016781|NCT03891576|Platinum Senitive|platinum senitive
5016912|NCT03890588|CKD|ckd
5016981|NCT03890224|Respiratory Support|respiratory support
5017083|NCT03889574|ICD10 for ACS, STEMI or NSTEMI, with triple therapy agents of aspirin, P2Y12 inhibitorand OAC status post-stent|icd10 for acs, stemi or nstemi, with triple therapy agents of aspirin, p2y12 inhibitorand oac status post-stent
5017084|NCT03889561|Water|water
5017085|NCT03889561|Parks|parks
5017086|NCT03889561|Public spaces|public spaces
5017089|NCT03889535|crowns|crowns
5017189|NCT03888898|N95 filtering facepiece respirators|n95 filtering facepiece respirators
5017190|NCT03888898|elastomeric respirators|elastomeric respirators
5017289|NCT03888326|Proprioception|proprioception
5017290|NCT03888326|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5017291|NCT03888326|Non-invasive Brain Stimulation|non-invasive brain stimulation
5017292|NCT03888326|Chronic Stroke|chronic stroke
5017293|NCT03888326|tDCS|tdcs
5017294|NCT03888326|Sensory Recovery|sensory recovery
5017295|NCT03888287|PICK study|pick study
5017296|NCT03888287|Impact of Watch Rx|impact of watch rx
5017297|NCT03888248|Neurofibromatosis Type 1|neurofibromatosis type 1
5017298|NCT03888248|Whole-body vibration|whole-body vibration
5017299|NCT03888248|Muscle weakness|muscle weakness
5017515|NCT03887195|empathy|empathy
5017516|NCT03887195|emotional intelligence|emotional intelligence
5017517|NCT03887195|Medical student|medical student
5017518|NCT03887195|Educational program|educational program
5017519|NCT03887195|Physician-Patient Relations|physician-patient relations
5017520|NCT03887182|auditory processing disorders|auditory processing disorders
5017612|NCT03886649|Nodal marginal zone lymphoma|nodal marginal zone lymphoma
5017613|NCT03886649|Follicular lymphoma|follicular lymphoma
5017614|NCT03886649|Diffuse large B-cell lymphoma (DLBCL), NOS|diffuse large b-cell lymphoma (dlbcl), nos
5017615|NCT03886597|Polyphenols|polyphenols
5017616|NCT03886597|Triterpenes|triterpenes
5017622|NCT03886597|Cardiovascular Disease|cardiovascular disease
5017623|NCT03886597|Anti-inflammatory|anti-inflammatory
5017624|NCT03886584|Bipolar Disorder|bipolar disorder
5017625|NCT03886584|Source-monitoring|source-monitoring
5017626|NCT03886558|exercise|exercise
5017712|NCT03886090|Parkinson's Disease|parkinson's disease
5017713|NCT03886090|motor learning|motor learning
5017723|NCT03886025|Implusivity|implusivity
5017831|NCT03885297|weight loss|weight loss
5017832|NCT03885284|Pancreas|pancreas
5017833|NCT03885284|Radiation|radiation
5017834|NCT03885284|mFOLFIRINOX|mfolfirinox
5017835|NCT03885258|melatonin|melatonin
5017836|NCT03885258|pinealectomy|pinealectomy
5018025|NCT03884192|Immune-mediated cancer therapy|immune-mediated cancer therapy
5018129|NCT03883490|Elastin Metabolites|elastin metabolites
5018130|NCT03883490|Aorta Stiffness|aorta stiffness
5018139|NCT03883438|Therapy|therapy
5018240|NCT03882879|karate|karate
5018341|NCT03882307|transforming growth factor -beta|transforming growth factor -beta
5018440|NCT03881501|Sintilimab Injection|sintilimab injection
5018441|NCT03881501|Endostar|endostar
5018442|NCT03881462|muscle function|muscle function
5018443|NCT03881462|rotator cuff|rotator cuff
5018444|NCT03881449|digital medicine|digital medicine
5018445|NCT03881436|Anatomy|anatomy
5018446|NCT03881436|Fiber tractography|fiber tractography
5018472|NCT03881267|VLU|vlu
5018544|NCT03880916|Duloxetine|duloxetine
5018545|NCT03880890|sphenoid nasalization|sphenoid nasalization
5018546|NCT03880877|metastatic colorectal cancer|metastatic colorectal cancer
5018547|NCT03880877|FOLFIRI|folfiri
5018548|NCT03880877|regorafenib|regorafenib
5018549|NCT03880864|Lung ultrasound score|lung ultrasound score
5018550|NCT03880864|Weaning|weaning
5018551|NCT03880864|Mechanical ventilation|mechanical ventilation
5018635|NCT03880435|Infertility|infertility
5018636|NCT03880435|Reproductive outcome|reproductive outcome
5018637|NCT03880435|Hysteroscopy|hysteroscopy
5018638|NCT03880435|Adhesion prophylaxis|adhesion prophylaxis
5018639|NCT03880383|brain-based developmental disorders|brain-based developmental disorders
5018837|NCT03879213|Cognitive function|cognitive function
5018838|NCT03879187|High-fat diet|high-fat diet
5018839|NCT03879187|Insulin|insulin
5133099|NCT03161314|EMG|emg
5018840|NCT03879187|Glucose|glucose
5019051|NCT03877601|Bevacizumab-800CW|bevacizumab-800cw
5019052|NCT03877549|dexamethasone|dexamethasone
5019053|NCT03877549|labor epidural|labor epidural
5019054|NCT03877549|cesarean section|cesarean section
5019055|NCT03877523|Cocarnit|cocarnit
5019056|NCT03877523|Diabetes Mellitus|diabetes mellitus
5019057|NCT03877523|Macrophages polarization|macrophages polarization
5019143|NCT03877120|Alcohol dependence|alcohol dependence
5019144|NCT03877120|Alcohol withdrawal syndrome|alcohol withdrawal syndrome
5019145|NCT03877120|Benzodiacepines|benzodiacepines
5019146|NCT03877107|lower urinary tract dysfunction|lower urinary tract dysfunction
5019147|NCT03877107|urinary incontinence|urinary incontinence
5019148|NCT03877107|normal pressure hydrocephalus|normal pressure hydrocephalus
5019149|NCT03877107|overactive bladder|overactive bladder
5019151|NCT03877094|virtual reality|virtual reality
5019152|NCT03877094|breast biopsy|breast biopsy
5019153|NCT03877094|environmental health|environmental health
5019154|NCT03877094|patient comfort|patient comfort
5019155|NCT03877094|complementary therapies|complementary therapies
5019156|NCT03877094|Nurse care|nurse care
5019343|NCT03876054|dorsal root ganglion stimulation|dorsal root ganglion stimulation
5019344|NCT03876041|SIRS|sirs
5019452|NCT03875443|implant positioning|implant positioning
5019453|NCT03875443|reduction|reduction
5019454|NCT03875443|intraoperative fluoroscopy|intraoperative fluoroscopy
5019455|NCT03875443|reduction algorithm|reduction algorithm
5019462|NCT03875417|RF|rf
5019569|NCT03874793|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5019570|NCT03874793|Muscle Relaxation|muscle relaxation
5019571|NCT03874793|fMRI|fmri
5019572|NCT03874793|Group Psychotherapy|group psychotherapy
5019573|NCT03874767|patient mobility|patient mobility
5019574|NCT03874767|ambulation|ambulation
5019575|NCT03874754|Multiple chronic conditions|multiple chronic conditions
5019576|NCT03874741|Head and Neck Cancer|head and neck cancer
5019577|NCT03874741|Epidermal growth factor receptor|epidermal growth factor receptor
5019657|NCT03874273|crizotinib|crizotinib
5019658|NCT03874273|Paediatric oncology|paediatric oncology
5019659|NCT03874234|Dose escalation phase|dose escalation phase
5019660|NCT03874234|First time in human|first time in human
5019661|NCT03874234|Single ascending dose|single ascending dose
5019662|NCT03874234|Multiple ascending dose|multiple ascending dose
5019663|NCT03874234|GSK3186899|gsk3186899
5019664|NCT03874208|Outcome prediction|outcome prediction
5019666|NCT03874208|Coma,|coma,
5019747|NCT03873662|Outcome|outcome
5019749|NCT03873662|Neurologic outcome|neurologic outcome
5019762|NCT03873519|stress|stress
5019848|NCT03872908|Colorectal cancer|colorectal cancer
5019849|NCT03872882|Newborn hearing screening|newborn hearing screening
5019850|NCT03872882|Hearing loss|hearing loss
5019851|NCT03872882|Hearing screening equipment|hearing screening equipment
5020052|NCT03871790|Neoepitopes|neoepitopes
5020053|NCT03871790|Vaccination|vaccination
5020054|NCT03871790|Tumor-specific antigens|tumor-specific antigens
5020055|NCT03871790|Personalized medicine|personalized medicine
5020155|NCT03871244|randomized controlled trial|randomized controlled trial
5020156|NCT03871244|red blood cell tranfusions|red blood cell tranfusions
5020157|NCT03871231|Termination|termination
5020158|NCT03871231|Unpinning|unpinning
5020159|NCT03871231|Therapy|therapy
5020160|NCT03871205|Neoantigen|neoantigen
5020161|NCT03871205|Dentritic cell vaccine|dentritic cell vaccine
5020162|NCT03871205|Immunotherapy|immunotherapy
5020163|NCT03871205|Refractory lung cancer|refractory lung cancer
5020164|NCT03871192|FACET JOINTS|facet joints
5020165|NCT03871192|FACET INJECTIONS|facet injections
5020166|NCT03871192|NERVE BLOCK|nerve block
5020168|NCT03871127|CABG|cabg
5020169|NCT03871127|Left main|left main
5020170|NCT03871101|Dental Anxiety|dental anxiety
5020245|NCT03870646|Mucus|mucus
5020246|NCT03870607|probiotics|probiotics
5020247|NCT03870607|prebiotics|prebiotics
5020248|NCT03870607|microbiome|microbiome
5020249|NCT03870581|Artificial intelligence|artificial intelligence
5020348|NCT03870061|Vaccinations|vaccinations
5020349|NCT03870061|Nigeria|nigeria
5020350|NCT03870061|Conditional Cash Transfers|conditional cash transfers
5020351|NCT03870061|Cash Incentives|cash incentives
5020415|NCT03869684|AMD|amd
5020456|NCT03869385|Sepsis|sepsis
5020457|NCT03869359|gluten-free diet|gluten-free diet
5020458|NCT03869359|gluten-containing diet|gluten-containing diet
5020459|NCT03869359|microbiota|microbiota
5020460|NCT03869359|metabolomics|metabolomics
5020461|NCT03869359|healthy volunteers|healthy volunteers
5020462|NCT03869333|Shigella flexneri 2a|shigella flexneri 2a
5020463|NCT03869333|Enteric|enteric
5020464|NCT03869333|Shigella|shigella
5020465|NCT03869307|Joint instability|joint instability
5020466|NCT03869307|Hypermobility|hypermobility
5020467|NCT03869307|Shoulder|shoulder
5020468|NCT03869307|Strength training|strength training
5020469|NCT03869242|Glioblastoma|glioblastoma
5020470|NCT03869242|NovoTTF-200A|novottf-200a
5020471|NCT03869242|Radiation Therapy|radiation therapy
5020472|NCT03869242|Temozolomide|temozolomide
5020544|NCT03868696|Emergency Department|emergency department
5020545|NCT03868644|Youth|youth
5020546|NCT03868644|Kenya|kenya
5020547|NCT03868644|Voluntary Counseling and Testing for HIV|voluntary counseling and testing for hiv
5020548|NCT03868644|Condoms|condoms
5020549|NCT03868644|HIV prevention|hiv prevention
5020550|NCT03868644|HSV-2|hsv-2
5020551|NCT03868514|breast reconstruction|breast reconstruction
5020552|NCT03868514|surgical mesh|surgical mesh
5020553|NCT03868475|High-risk breast lesions|high-risk breast lesions
5020554|NCT03868475|Vacuum-assisted excision|vacuum-assisted excision
5020562|NCT03868410|TMS|tms
5020638|NCT03867864|Headache|headache
5020878|NCT03866369|multiple ascending dose|multiple ascending dose
5020879|NCT03866369|supra-therapeutic dose|supra-therapeutic dose
5020881|NCT03866356|evidence-based practice|evidence-based practice
5020882|NCT03866356|Star model|star model
5020883|NCT03866356|stress incontinence|stress incontinence
5020884|NCT03866356|nursing care protocol|nursing care protocol
5020885|NCT03866356|female|female
5020886|NCT03866330|Osteoarthritis|osteoarthritis
5020887|NCT03866330|Wharton Jelly derived Mesenchymal Stem Cells|wharton jelly derived mesenchymal stem cells
5020888|NCT03866278|Opiate|opiate
5020889|NCT03866265|Platelet Sensitivity|platelet sensitivity
5020890|NCT03866265|PAF|paf
5020891|NCT03866265|Thrombin|thrombin
5020957|NCT03865888|Cyclosporine|cyclosporine
5020958|NCT03865888|Tacrolimus|tacrolimus
5020959|NCT03865875|Pancreatic Ductal Adenocarcinoma|pancreatic ductal adenocarcinoma
5020960|NCT03865875|Total Neoadjuvant Therapy|total neoadjuvant therapy
5020961|NCT03865875|Prehabilitation|prehabilitation
5021053|NCT03865420|FUS|fus
5021060|NCT03865394|foot ulcer|foot ulcer
5021061|NCT03865355|Metabolomic profile|metabolomic profile
5021062|NCT03865355|Biomarkers|biomarkers
5021063|NCT03865342|mHealth|mhealth
5021064|NCT03865342|Diabetes Prevention Program|diabetes prevention program
5021065|NCT03865342|weight loss|weight loss
5021066|NCT03865342|body weight|body weight
5021067|NCT03865342|behavioral interventions|behavioral interventions
5021068|NCT03865303|Critical Illness|critical illness
5021069|NCT03865303|Patient Safety|patient safety
5021070|NCT03865303|Delivery of Health Care|delivery of health care
5021071|NCT03865303|Electronic Health Records|electronic health records
5021072|NCT03865277|Head and neck cancer|head and neck cancer
5021073|NCT03865277|radiochemotherapy|radiochemotherapy
5021074|NCT03865277|HPV|hpv
5021075|NCT03865251|H-reflex modulation|h-reflex modulation
5021076|NCT03865251|motoneuronal excitability|motoneuronal excitability
5021077|NCT03865251|Ia afferent inputs|ia afferent inputs
5021078|NCT03865251|posture|posture
5021079|NCT03865251|Kinesiology tape|kinesiology tape
5021080|NCT03865225|Ischaemic Stroke|ischaemic stroke
5021086|NCT03865186|Cognition|cognition
5021163|NCT03864679|fed|fed
5021273|NCT03863990|PAH prognosis|pah prognosis
5021274|NCT03863990|PAH outcomes|pah outcomes
5021275|NCT03863990|PAH survival|pah survival
5021276|NCT03863990|PAH risk status|pah risk status
5021277|NCT03863977|TAP block|tap block
5021278|NCT03863977|inguinal hernia|inguinal hernia
5021284|NCT03863951|ischemic stroke|ischemic stroke
5021285|NCT03863951|depression|depression
5021286|NCT03863951|intestinal microbiota|intestinal microbiota
5021287|NCT03863925|Electroconvulsive therapy|electroconvulsive therapy
5021288|NCT03863925|Propofol|propofol
5021360|NCT03863522|Breast Cancer Diagnosis|breast cancer diagnosis
5685504|NCT00555802|Low Back Pain|low back pain
5021361|NCT03863522|Ultrasound-guided core needle biopsy|ultrasound-guided core needle biopsy
5021362|NCT03863522|Fine needle aspiration|fine needle aspiration
5021363|NCT03863522|FNA|fna
5021364|NCT03863522|Diagnostic Cartridge|diagnostic cartridge
5021365|NCT03863509|vape|vape
5021366|NCT03863509|E-Cigarette|e-cigarette
5021367|NCT03863509|E-cig|e-cig
5021464|NCT03862937|Protein Supplementation|protein supplementation
5021465|NCT03862937|Body Composition|body composition
5021466|NCT03862937|Resistance Training|resistance training
5021580|NCT03862443|Health Behavior|health behavior
5021581|NCT03862443|Behavioral Economics|behavioral economics
5021582|NCT03862443|Monetary Incentives|monetary incentives
5021583|NCT03862417|Scoliosis|scoliosis
5021584|NCT03862417|Exercise|exercise
5021689|NCT03861689|Perianal Crohn's disease|perianal crohn's disease
5021916|NCT03860467|Electroencephalogram|electroencephalogram
5021789|NCT03861104|septoplasty; nasal packing; anxiety; medical video|septoplasty; nasal packing; anxiety; medical video
5021790|NCT03861013|Stress management|stress management
5021791|NCT03861013|Intervention program|intervention program
5021792|NCT03861013|University students|university students
5021793|NCT03861013|Perceived stress|perceived stress
5021794|NCT03861013|Mental health|mental health
5021837|NCT03860857|MRI|mri
5022212|NCT03858764|Peripheral arterial disease|peripheral arterial disease
5022214|NCT03858738|breast cancer|breast cancer
5022215|NCT03858738|breast pathology|breast pathology
5022408|NCT03857451|biomechanics|biomechanics
5022409|NCT03857438|Bipolar and Related Disorders|bipolar and related disorders
5718222|NCT00438152|Saquinavir|saquinavir
5071824|NCT03550144|Awe|awe
5022410|NCT03857438|Mood Disorders|mood disorders
5022411|NCT03857438|Mental Disorders|mental disorders
5022412|NCT03857438|Behavioral Symptoms|behavioral symptoms
5022413|NCT03857438|Cognitive functions|cognitive functions
5022414|NCT03857438|Simulation|simulation
5022415|NCT03857425|Gastritis|gastritis
5022416|NCT03857425|H Pylori Infection|h pylori infection
5022417|NCT03857412|Polishing|polishing
5022418|NCT03857412|Cataract surgery|cataract surgery
5022421|NCT03857386|ultrasonography|ultrasonography
5022495|NCT03856905|Gait|gait
5022613|NCT03856190|Vegan|vegan
5022614|NCT03856190|Plant based|plant based
5022615|NCT03856190|Randomized Trial|randomized trial
5022616|NCT03856164|Tranexamic acid|tranexamic acid
5022617|NCT03856164|TXA|txa
5022618|NCT03856164|Anti-fibrinolytics|anti-fibrinolytics
5022619|NCT03856164|Postpartum hemorrhage|postpartum hemorrhage
5022621|NCT03856164|Fibrinolysis|fibrinolysis
5022704|NCT03855618|Post-Stroke.|post-stroke.
5022705|NCT03855579|Levosimendan|levosimendan
5022706|NCT03855579|Milrinone|milrinone
5022707|NCT03855579|Off-pump|off-pump
5022708|NCT03855579|Coronary|coronary
5022805|NCT03855098|dietary biomarkers|dietary biomarkers
5022806|NCT03855098|personalized nutrition|personalized nutrition
5022807|NCT03855085|Kidney transplant|kidney transplant
5022808|NCT03855085|volumetry|volumetry
5022809|NCT03855085|ultrasound|ultrasound
5022906|NCT03854643|pilates method|pilates method
5022907|NCT03854617|oral Navelbine|oral navelbine
5022908|NCT03854617|Metastasis Breast Cancer|metastasis breast cancer
5023003|NCT03853889|optic nerve sheath pressure|optic nerve sheath pressure
5023004|NCT03853889|noninvasive intracranial pressure measurement|noninvasive intracranial pressure measurement
5023005|NCT03853889|epidural anesthesia|epidural anesthesia
5023006|NCT03853889|cesarean|cesarean
5023007|NCT03853863|foot muscle strength|foot muscle strength
5023008|NCT03853863|foot muscle size|foot muscle size
5023009|NCT03853863|minimal footwear|minimal footwear
5023010|NCT03853863|preschool child|preschool child
5023011|NCT03853863|ultrasonography|ultrasonography
5023111|NCT03853122|tendinopathy|tendinopathy
5023112|NCT03853122|exercise|exercise
5023113|NCT03853122|dosage|dosage
5023022|NCT03853694|elective c-section|elective c-section
5023024|NCT03853668|sleep quality|sleep quality
5023105|NCT03853200|Microbiological root canal sampling|microbiological root canal sampling
5023106|NCT03853174|COPD|copd
5023107|NCT03853174|Inflammation|inflammation
5023108|NCT03853174|exercise training|exercise training
5023109|NCT03853135|Behçet disease|behçet disease
5023110|NCT03853135|endocan|endocan
5023129|NCT03852953|Mammography|mammography
5023130|NCT03852953|Overdiagnosis|overdiagnosis
5023132|NCT03852953|Harms and benefits|harms and benefits
5023222|NCT03852407|Prophylaxis|prophylaxis
5023424|NCT03851107|environmental barriers|environmental barriers
5023426|NCT03851107|disabilities|disabilities
5023427|NCT03851107|body functions|body functions
5023428|NCT03851055|Zinc|zinc
5023429|NCT03851055|blood glucose|blood glucose
5023430|NCT03851055|diabetes|diabetes
5023433|NCT03851029|Smoking|smoking
5023539|NCT03850444|Programmed Cell Death 1|programmed cell death 1
5023541|NCT03850444|Programmed Cell Death Ligand 1 (PD-L1)|programmed cell death ligand 1 (pd-l1)
5023542|NCT03850444|PDL1|pdl1
5023544|NCT03850431|Mental Health|mental health
5023647|NCT03849820|minimal invasive surgery|minimal invasive surgery
5023649|NCT03849820|MIS|mis
5023650|NCT03849807|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5023740|NCT03849326|Neuromuscular function|neuromuscular function
5023741|NCT03849300|arterial stiffness|arterial stiffness
5023742|NCT03849300|cardiorespiratory capacity|cardiorespiratory capacity
5023743|NCT03849300|exercise tolerance|exercise tolerance
5023744|NCT03849300|VO2max|vo2max
5023745|NCT03849274|Knee Arthropathy|knee arthropathy
5023746|NCT03849274|Hip Arthopathy|hip arthopathy
5023747|NCT03849274|Hypertrophic Scar|hypertrophic scar
5023748|NCT03849274|Smart Scar Care Pad|smart scar care pad
5023838|NCT03848845|GSK2857916, Pembrolizumab, Multiple Myeloma, RP2D|gsk2857916, pembrolizumab, multiple myeloma, rp2d
5023839|NCT03848832|Cannabidiol|cannabidiol
5023840|NCT03848832|CBD|cbd
5023947|NCT03848130|Quality of life|quality of life
5023948|NCT03848130|Traditional physiotherapy|traditional physiotherapy
5023949|NCT03848117|Patient Rated Tennis Elbow Evaluation (PRTEE)|patient rated tennis elbow evaluation (prtee)
5023950|NCT03848117|Mobilization with movement|mobilization with movement
5024042|NCT03847610|Pharmacokinetics|pharmacokinetics
5024043|NCT03847610|Penicillin V|penicillin v
5024044|NCT03847610|Penicillins|penicillins
5024045|NCT03847610|Proof of Concept Study|proof of concept study
5024046|NCT03847610|Clinical Trial, Phase I|clinical trial, phase i
5024047|NCT03847610|Microneedle array|microneedle array
5024048|NCT03847584|Low socioeconomic status population|low socioeconomic status population
5024049|NCT03847584|Web-based prospective cohort study|web-based prospective cohort study
5024050|NCT03847584|Survey|survey
5024051|NCT03847584|Recruitment|recruitment
5024052|NCT03847584|Attitude|attitude
5024053|NCT03847584|Subjective norms|subjective norms
5024054|NCT03847584|Perceived behavioural control|perceived behavioural control
5024055|NCT03847584|Intention|intention
5024132|NCT03847103|Task-specific Training|task-specific training
5024133|NCT03847103|Rehabilitation|rehabilitation
5024139|NCT03847051|MRI (magnetic resonance imaging)|mri (magnetic resonance imaging)
5024140|NCT03847051|Neuroradiology|neuroradiology
5024141|NCT03847051|EPIMix (Echo planar imaging mix)|epimix (echo planar imaging mix)
5024144|NCT03847025|Pacemaker|pacemaker
5024350|NCT03845751|hemi ablation|hemi ablation
5024567|NCT03844425|Orthodontic Retainers|orthodontic retainers
5024568|NCT03844425|Printing, Three-Dimensional|printing, three-dimensional
5024570|NCT03844412|Pelvic pain|pelvic pain
5024667|NCT03843814|Diffuse Weighted Imaging (DWI)|diffuse weighted imaging (dwi)
5024668|NCT03843801|Endoscopy|endoscopy
5024669|NCT03843801|Mini invasive|mini invasive
5024670|NCT03843788|Post-cesarean pain|post-cesarean pain
5024671|NCT03843788|Transcutaneous Electrical Nerve Stimulation|transcutaneous electrical nerve stimulation
5024672|NCT03843775|Binimetinib|binimetinib
5024673|NCT03843775|Encorafenib|encorafenib
5024674|NCT03843775|18-547|18-547
5024675|NCT03843762|Adolescents|adolescents
5024676|NCT03843762|Sleep|sleep
5024679|NCT03843749|HER2|her2
5024767|NCT03843333|Rural|rural
5024768|NCT03843333|Primary care|primary care
5024769|NCT03843320|SAVR|savr
5024770|NCT03843320|TAVR|tavr
5024771|NCT03843320|Physical function|physical function
5024772|NCT03843320|Aortic valve replacement|aortic valve replacement
5024773|NCT03843320|Wearable devices|wearable devices
5024774|NCT03843320|Smart watch|smart watch
5024775|NCT03843320|Activity tracker|activity tracker
5024776|NCT03843307|Electrical stimulation|electrical stimulation
5024777|NCT03843307|Perfusion|perfusion
5024785|NCT03843203|Pain|pain
5024857|NCT03842670|Neuroimaging|neuroimaging
5024858|NCT03842657|citrate, dialysate|citrate, dialysate
5024860|NCT03842657|coagulation|coagulation
5024994|NCT03841981|Cardiovascular risk|cardiovascular risk
5024995|NCT03841981|Microbiome|microbiome
5024996|NCT03841929|Multimodal hemodynamic assessment|multimodal hemodynamic assessment
5024997|NCT03841903|Spinal cord|spinal cord
5025117|NCT03841240|thrombosis|thrombosis
5025118|NCT03841240|infection|infection
5025119|NCT03841240|ultrasound|ultrasound
5025120|NCT03841240|risk factor|risk factor
5025241|NCT03840577|Bispectral index|bispectral index
5025242|NCT03840577|critical care patients|critical care patients
5025243|NCT03840577|delirium|delirium
5025345|NCT03839927|Geriatrics|geriatrics
5025346|NCT03839927|Physical Activity|physical activity
5025347|NCT03839914|vancomycin powder|vancomycin powder
5025348|NCT03839914|surgical site infection|surgical site infection
5025349|NCT03839914|open posterior spinal surgery|open posterior spinal surgery
5025350|NCT03839901|Scaphoid-Lunate|scaphoid-lunate
5025351|NCT03839901|instability|instability
5025353|NCT03839888|atropine|atropine
5025354|NCT03839888|cycloplegia|cycloplegia
5025355|NCT03839888|refraction|refraction
5025356|NCT03839888|axial length|axial length
5025357|NCT03839888|anterior chamber depth|anterior chamber depth
5025358|NCT03839849|periodontal pockets|periodontal pockets
5025359|NCT03839849|injectable platelet-rich fibrin|injectable platelet-rich fibrin
5025360|NCT03839849|saline|saline
5025434|NCT03839446|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5025435|NCT03839446|bone marrow|bone marrow
5025437|NCT03839381|mini BESTest|mini bestest
5025438|NCT03839381|balance defisit|balance defisit
5025439|NCT03839381|postural control|postural control
5025440|NCT03839381|Sensoriomotor impairment|sensoriomotor impairment
5025441|NCT03839368|angle fracture|angle fracture
5025442|NCT03839355|Apixaban|apixaban
5025443|NCT03839355|Warfarin|warfarin
5025444|NCT03839342|Advanced Cancer|advanced cancer
5025445|NCT03839342|Advanced Solid Tumors|advanced solid tumors
5025446|NCT03839342|Non-V600 BRAF Mutations|non-v600 braf mutations
5025447|NCT03839329|Older Adult|older adult
5025448|NCT03839329|Psychological Well-being|psychological well-being
5025455|NCT03839316|Stroke|stroke
5025522|NCT03838783|Exercise|exercise
5025523|NCT03838783|Insulin Degludec|insulin degludec
5025524|NCT03838783|Continuous glucose monitoring (CGM)|continuous glucose monitoring (cgm)
5025525|NCT03838783|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5025526|NCT03838757|Lung cancer|lung cancer
5025552|NCT03838575|SSI|ssi
5025626|NCT03838315|Cervical Radiculopathy,|cervical radiculopathy,
5025627|NCT03838315|Neural Mobilizations,|neural mobilizations,
5025628|NCT03838315|Soft Tissue Mobilization|soft tissue mobilization
5025629|NCT03838302|Sexual functioning|sexual functioning
5025630|NCT03838302|Laparoscopy|laparoscopy
5025631|NCT03838302|Colpotomy|colpotomy
5025632|NCT03838302|Specimen retrieval|specimen retrieval
5025633|NCT03838302|Transvaginal extraction|transvaginal extraction
5025634|NCT03838263|Nivolumab|nivolumab
5025635|NCT03838263|High-risk|high-risk
5025715|NCT03837795|Sensory Over-Responsivity|sensory over-responsivity
5145118|NCT03084497|Massage|massage
5025716|NCT03837782|laparoscopy,laparotomy,colorectal cancer|laparoscopy,laparotomy,colorectal cancer
5025717|NCT03837769|Blood Pressure|blood pressure
5025718|NCT03837769|OBPM|obpm
5025719|NCT03837769|Cuffless|cuffless
5025720|NCT03837730|ICU, sepsis, septic shok, arginase, citrulline|icu, sepsis, septic shok, arginase, citrulline
5025721|NCT03837717|Saliva|saliva
5025722|NCT03837717|Neonatal Encephalopathy|neonatal encephalopathy
5025723|NCT03837717|Hypoxic-Ischemic Encephalopathy|hypoxic-ischemic encephalopathy
5025724|NCT03837717|Bonding|bonding
5025920|NCT03836599|Allopurinol|allopurinol
5025923|NCT03836573|E-cigarettes|e-cigarettes
5025924|NCT03836573|Nicotine Replacement Therapy|nicotine replacement therapy
5025927|NCT03836560|quit rates|quit rates
5026019|NCT03835936|Pediatric|pediatric
5026020|NCT03835923|lifestyle intervention|lifestyle intervention
5026021|NCT03835923|chronic ischemic heart disease|chronic ischemic heart disease
5026022|NCT03835923|diabetes mellitus type 2|diabetes mellitus type 2
5026249|NCT03834558|myofascial self conditioning|myofascial self conditioning
5026353|NCT03833804|unhealthy alcohol use|unhealthy alcohol use
5026354|NCT03833804|opioid use disorder|opioid use disorder
5026355|NCT03833804|illicit drug use|illicit drug use
5026357|NCT03833791|Physical Activity|physical activity
5026358|NCT03833791|fat mass|fat mass
5026359|NCT03833791|fat free mass|fat free mass
5026360|NCT03833765|gingival recession|gingival recession
5026361|NCT03833752|rigid cystoscopy|rigid cystoscopy
5026362|NCT03833752|flexible cystosocpy|flexible cystosocpy
5026468|NCT03833258|THA|tha
5026630|NCT03832478|Postoperative pain|postoperative pain
5026631|NCT03832465|Levofloxacin|levofloxacin
5026632|NCT03832465|Amoxicillin|amoxicillin
5026633|NCT03832465|Proton pump inhibitor|proton pump inhibitor
5026634|NCT03832465|Helicobacter Pylori|helicobacter pylori
5026635|NCT03832439|Probiotic|probiotic
5026636|NCT03832439|Microbiome|microbiome
5026637|NCT03832387|Non-invasive mechanical ventilation|non-invasive mechanical ventilation
5026638|NCT03832387|Oxygen therapy|oxygen therapy
5026639|NCT03832387|Extubation failure|extubation failure
5026640|NCT03832348|PET scan imaging, pembrolizumab, response, parametric imaging|pet scan imaging, pembrolizumab, response, parametric imaging
5026641|NCT03832322|Adenoma miss rate|adenoma miss rate
5026642|NCT03832322|Adenoma detection rate|adenoma detection rate
5026643|NCT03832296|Arthritis|arthritis
5026644|NCT03832296|Knee|knee
5026645|NCT03832296|weight loss|weight loss
5026646|NCT03832270|Parenting support|parenting support
5026723|NCT03831867|exercise|exercise
5026724|NCT03831867|physical activity|physical activity
5026725|NCT03831867|physical education|physical education
5026727|NCT03831841|multicomponent exercise|multicomponent exercise
5026728|NCT03831841|body composition|body composition
5026729|NCT03831841|vitamin D|vitamin d
5026824|NCT03831217|Tension-Free Vaginal Tape|tension-free vaginal tape
5026825|NCT03831217|trans-labial ultrasound|trans-labial ultrasound
5027079|NCT03829410|Bevacizumab|bevacizumab
5027198|NCT03828669|behavioral medicine|behavioral medicine
5027199|NCT03828669|pain|pain
5027200|NCT03828669|perioperative|perioperative
5027201|NCT03828669|enhanced recovery after surgery|enhanced recovery after surgery
5027202|NCT03828669|surgery|surgery
5027203|NCT03828669|intervention|intervention
5027286|NCT03828214|EMG|emg
5027303|NCT03828045|Psoriatic Arthritis|psoriatic arthritis
5027422|NCT03827317|positron emission tomography|positron emission tomography
5027423|NCT03827304|Burns|burns
5027424|NCT03827304|Virtual Reality|virtual reality
5027426|NCT03827278|Talaromyces|talaromyces
5027427|NCT03827278|voriconazole|voriconazole
5027428|NCT03827278|Amphotericin Sequential Itraconazole therapy|amphotericin sequential itraconazole therapy
5027429|NCT03827278|anti-Interferon-γ autoantibodies|anti-interferon-γ autoantibodies
5027430|NCT03827213|shoulder surgery, post operative pain|shoulder surgery, post operative pain
5027431|NCT03827200|Cirrhosis|cirrhosis
5027432|NCT03827200|Portal Hypertension|portal hypertension
5027434|NCT03827200|N-003|n-003
5027513|NCT03826914|heart attack|heart attack
5027514|NCT03826914|stroke|stroke
5027515|NCT03826914|hypertension|hypertension
5027516|NCT03826914|amino acids|amino acids
5027517|NCT03826914|electrolytes|electrolytes
5027518|NCT03826914|antioxidants|antioxidants
5027614|NCT03826121|Sesam Esamesame Oil Cake|sesam esamesame oil cake
5027616|NCT03826095|Respiratory function|respiratory function
5027617|NCT03826095|Respiratory muscle strength|respiratory muscle strength
5027626|NCT03826030|stroke|stroke
5027725|NCT03825471|patient-controlled analgesia (PCA)|patient-controlled analgesia (pca)
5027851|NCT03824782|ROP|rop
5027942|NCT03824392|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5027943|NCT03824392|Resokine|resokine
5027944|NCT03824392|Sarcoidosis|sarcoidosis
5027945|NCT03824392|Granulomas|granulomas
5027946|NCT03824392|Inflammation|inflammation
5027947|NCT03824392|Lymphoproliferative Disorders|lymphoproliferative disorders
5028045|NCT03823599|Alcohol misuse|alcohol misuse
5028046|NCT03823599|Accident & Emergency Department|accident & emergency department
5028047|NCT03823599|AUDIT|audit
5028048|NCT03823599|instant messaging|instant messaging
5028049|NCT03823573|fast track|fast track
5028050|NCT03823573|total knee arthroplasty|total knee arthroplasty
5028051|NCT03823573|tranexamic acid|tranexamic acid
5028052|NCT03823573|drain|drain
5028053|NCT03823547|DAPT|dapt
5028054|NCT03823547|Dual Antiplatelet Therapy|dual antiplatelet therapy
5028055|NCT03823547|Myocardial infarction|myocardial infarction
5028056|NCT03823547|Acute Coronary Syndrome|acute coronary syndrome
5028057|NCT03823547|Ticagrelor|ticagrelor
5028058|NCT03823547|Prasugrel|prasugrel
5028081|NCT03823495|elderly|elderly
5028276|NCT03822481|Post-Bariatric Surgery Weight-loss Diary|post-bariatric surgery weight-loss diary
5028286|NCT03822455|cystic fibrosis|cystic fibrosis
5028287|NCT03822442|Cardiomyopathy, cardiomegaly|cardiomyopathy, cardiomegaly
5028288|NCT03822442|cardiac transplant|cardiac transplant
5028542|NCT03821155|SHIMP (suppressing head impulse paradigm)|shimp (suppressing head impulse paradigm)
5028543|NCT03821155|SVV (subjective visual vertical)|svv (subjective visual vertical)
5028544|NCT03821155|Vestibular rehabilitation|vestibular rehabilitation
5028545|NCT03821155|Prednisolone|prednisolone
5028546|NCT03821155|v-HIT (video head impulse test)|v-hit (video head impulse test)
5028556|NCT03821129|PFO|pfo
5028649|NCT03820492|Optical coherence tomography|optical coherence tomography
5028650|NCT03820492|Computed tomography angiography|computed tomography angiography
5028652|NCT03820479|PONV|ponv
5028653|NCT03820479|PDNV|pdnv
5028657|NCT03820440|End-expiratory occlusion test|end-expiratory occlusion test
5028750|NCT03819725|Infant|infant
5028751|NCT03819725|Nutrition|nutrition
5028752|NCT03819725|interstitial glucose variation|interstitial glucose variation
5028864|NCT03818854|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5028865|NCT03818828|venous stasis|venous stasis
5028866|NCT03818828|VLU|vlu
5028867|NCT03818802|NAD boosting therapy|nad boosting therapy
5028868|NCT03818802|Nicotinamide Riboside|nicotinamide riboside
5029082|NCT03817567|Esophageal Diseases|esophageal diseases
5029083|NCT03817567|Epidermal growth factor receptor|epidermal growth factor receptor
5029207|NCT03816696|GSK3640254, dolutegravir, healthy subjects, two-way interaction, HIV|gsk3640254, dolutegravir, healthy subjects, two-way interaction, hiv
5029321|NCT03815916|Parkinson's Disease|parkinson's disease
5029322|NCT03815916|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5029432|NCT03815279|Carfilzomib|carfilzomib
5029433|NCT03815279|Lenalidomide|lenalidomide
5029434|NCT03815279|Screening|screening
5029435|NCT03815266|transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5029436|NCT03815266|Computerized Mirror Therapy (CMT)|computerized mirror therapy (cmt)
5029556|NCT03814590|Reactogenicity|reactogenicity
5029557|NCT03814590|Immunogenicity|immunogenicity
5029558|NCT03814577|General anesthesia|general anesthesia
5029572|NCT03814447|MESO|meso
5029654|NCT03813784|SHR-1210|shr-1210
5029655|NCT03813771|T-cells|t-cells
5029656|NCT03813771|Treat to Target|treat to target
5029657|NCT03813771|DMARD-naive|dmard-naive
5029658|NCT03813771|Benepali|benepali
5029659|NCT03813745|embryo quality|embryo quality
5029660|NCT03813745|denudation|denudation
5029661|NCT03813745|IVF|ivf
5029662|NCT03813745|ICSI|icsi
5029781|NCT03813082|Aging|aging
5029782|NCT03813030|Dermal open flow microperfusion|dermal open flow microperfusion
5029783|NCT03813030|Dermal microdialysis|dermal microdialysis
5029784|NCT03813004|motek grail|motek grail
5029785|NCT03813004|balance|balance
5029786|NCT03813004|gait perturbation|gait perturbation
5029787|NCT03812978|"Flexor tendon rehabilitation"|"flexor tendon rehabilitation"
5029788|NCT03812978|"Smart-phone application"|"smart-phone application"
5029789|NCT03812978|"adherence"|"adherence"
5029790|NCT03812965|Botulinum Toxin|botulinum toxin
5029791|NCT03812965|Gingival Smile|gingival smile
5029792|NCT03812952|misdiagnose|misdiagnose
5029793|NCT03812952|mistreatment|mistreatment
5029794|NCT03812952|antibiotics|antibiotics
5029981|NCT03811639|ablation, atrial fibrillation, autonomic nervous system|ablation, atrial fibrillation, autonomic nervous system
5029982|NCT03811626|Mild TBI|mild tbi
5029983|NCT03811626|quality of life|quality of life
5029984|NCT03811626|coping strategies|coping strategies
5029985|NCT03811626|symptoms|symptoms
5030073|NCT03811054|slowly progress|slowly progress
5030074|NCT03810989|dermodialysis|dermodialysis
5030174|NCT03810482|fatigue|fatigue
5030077|NCT03810963|chronic spinal cord injury|chronic spinal cord injury
5030183|NCT03810404|Sports nutrition|sports nutrition
5030184|NCT03810404|Sodium bicarbonate|sodium bicarbonate
5030185|NCT03810404|Physical capacity|physical capacity
5030186|NCT03810404|Exercise performance|exercise performance
5030187|NCT03810404|Buffering potential|buffering potential
5030188|NCT03810404|Biochemical markers|biochemical markers
5030190|NCT03810391|preoperative anxiety|preoperative anxiety
5030191|NCT03810391|sedation|sedation
5030192|NCT03810391|recommend dose|recommend dose
5030431|NCT03809052|Phase 1|phase 1
5030432|NCT03809052|First Time in Human|first time in human
5030433|NCT03809052|Safety|safety
5030434|NCT03809052|Tolerability|tolerability
5030435|NCT03809052|Pharmacokinetics|pharmacokinetics
5030436|NCT03809052|Single Ascending Dose (SAD)|single ascending dose (sad)
5030438|NCT03809052|Healthy Volunteers|healthy volunteers
5030543|NCT03808441|trametinib|trametinib
5030544|NCT03808441|ipilimumab|ipilimumab
5030545|NCT03808441|nivolumab|nivolumab
5030546|NCT03808402|Surfactant|surfactant
5030547|NCT03808402|Less Invasive Surfactant Administration|less invasive surfactant administration
5030548|NCT03808402|Mechanical Ventilation|mechanical ventilation
5030549|NCT03808389|Parkinson's disease|parkinson's disease
5030550|NCT03808389|Fecal microbiota transplantation|fecal microbiota transplantation
5030551|NCT03808389|Microbiome|microbiome
5030635|NCT03807765|brain metastases|brain metastases
5030741|NCT03807128|Resistance|resistance
5030742|NCT03807128|Quality of life|quality of life
5030743|NCT03807115|Stroke|stroke
5030744|NCT03807115|Rehabilitation|rehabilitation
5030745|NCT03807115|Knowledge translation intervention|knowledge translation intervention
5030746|NCT03807115|Walking capacity|walking capacity
5030747|NCT03807102|Lung Cancer|lung cancer
5030748|NCT03807089|Colonoscopy|colonoscopy
5030749|NCT03807089|colon cancer screening|colon cancer screening
5030750|NCT03807050|Pharmacokinetics|pharmacokinetics
5030751|NCT03807037|atrial fibrillation,tocotrienol,coronary artery bypass grafting|atrial fibrillation,tocotrienol,coronary artery bypass grafting
5030764|NCT03806920|GIP|gip
5030825|NCT03806621|rotational atherectomy|rotational atherectomy
5030922|NCT03806010|Quantitative sensory testing|quantitative sensory testing
5030924|NCT03805971|pCLE|pcle
5030925|NCT03805971|confocal laser endomicroscopy|confocal laser endomicroscopy
5031019|NCT03805477|fibrotic lung disease|fibrotic lung disease
5031020|NCT03805464|biomechanics|biomechanics
5031021|NCT03805464|inertial measurement unit|inertial measurement unit
5031022|NCT03805425|Hypeorpia|hypeorpia
5031023|NCT03805425|Crosslinking|crosslinking
5031218|NCT03804034|SP|sp
5031243|NCT03803956|High-level soccer players|high-level soccer players
5031388|NCT03803033|Clinical pharmacy|clinical pharmacy
5031389|NCT03803020|coronary artery disease|coronary artery disease
5031390|NCT03803020|chronic total occlusion|chronic total occlusion
5031391|NCT03803020|fractional flow reserve|fractional flow reserve
5031392|NCT03803020|single-photon emission computed tomography|single-photon emission computed tomography
5031502|NCT03802162|CKD-355|ckd-355
5031503|NCT03802149|Ulipristal Acetate|ulipristal acetate
5031504|NCT03802149|Abortion|abortion
5031505|NCT03802149|Cervical Preparation|cervical preparation
5031506|NCT03802149|Dilation and Evacuation|dilation and evacuation
5031507|NCT03802136|AKI|aki
5031508|NCT03802136|Sepsis|sepsis
5031509|NCT03802136|Biomarker|biomarker
5031510|NCT03802136|renal function|renal function
5031512|NCT03802123|PET/CT|pet/ct
5031513|NCT03802123|⁸⁹Zr-Df-IAB22M2C|⁸⁹zr-df-iab22m2c
5031514|NCT03802123|CD8|cd8
5031515|NCT03802123|Imaging|imaging
5031516|NCT03802097|Gastric cancer|gastric cancer
5031727|NCT03800875|Insulin|insulin
5031864|NCT03800030|tACS|tacs
5031949|NCT03799406|Modified Tal score|modified tal score
5031950|NCT03799406|Randomized|randomized
5031951|NCT03799406|Controlled trial|controlled trial
5031952|NCT03799393|injury prevention|injury prevention
5031953|NCT03799393|car safety|car safety
5031954|NCT03799393|car seats|car seats
5031955|NCT03799393|booster seats|booster seats
5031956|NCT03799393|car restraints|car restraints
5031959|NCT03799354|exercise|exercise
5684853|NCT00558662|compression therapy|compression therapy
5032041|NCT03798990|Road safety|road safety
5032042|NCT03798977|Skin metastasis|skin metastasis
5032043|NCT03798977|Resistance|resistance
5032044|NCT03798977|Endoplasmic reticulum stress|endoplasmic reticulum stress
5032045|NCT03798977|Metastasis|metastasis
5032046|NCT03798951|Esophageal cancer surgery|esophageal cancer surgery
5032047|NCT03798951|Prehabilitation|prehabilitation
5032053|NCT03798873|Obesity|obesity
5032148|NCT03798275|amniotic fluid index|amniotic fluid index
5032149|NCT03798275|caffeine|caffeine
5032150|NCT03798275|coffee|coffee
5032151|NCT03798275|oligohydramnios|oligohydramnios
5032243|NCT03797521|Promentis Pharmaceuticals|promentis pharmaceuticals
5032245|NCT03797521|SXC-2023|sxc-2023
5032246|NCT03797469|Perimetry|perimetry
5032362|NCT03796845|Exercise|exercise
5032363|NCT03796832|Knee Osteoarthritis|knee osteoarthritis
5032364|NCT03796832|Exercise Therapy|exercise therapy
5032365|NCT03796832|Shoes|shoes
5032366|NCT03796832|Pain|pain
5032586|NCT03795454|preterm infant|preterm infant
5032587|NCT03795415|WLHIV|wlhiv
5032588|NCT03795415|empowerment|empowerment
5032589|NCT03795415|disclosure|disclosure
5032590|NCT03795415|Mali|mali
5032591|NCT03795389|Diabetes|diabetes
5032592|NCT03795389|Chronic Kidney Disease|chronic kidney disease
5032593|NCT03795363|CF|cf
5032594|NCT03795363|CFTR|cftr
5032694|NCT03794869|chronic low back pain|chronic low back pain
5032696|NCT03794869|randomized clinical trial|randomized clinical trial
5032697|NCT03794869|exercise program|exercise program
5032698|NCT03794856|Healthy participants|healthy participants
5032794|NCT03794375|Telehealth|telehealth
5032795|NCT03794375|Recurrence|recurrence
5032796|NCT03794362|analgesia|analgesia
5032797|NCT03794362|pain|pain
5032798|NCT03794362|nociception|nociception
5032799|NCT03794362|pupillometry|pupillometry
5032800|NCT03794362|analgesic|analgesic
5032889|NCT03793504|physical activity|physical activity
5032890|NCT03793491|continuous infusion|continuous infusion
5032891|NCT03793491|personality|personality
5032892|NCT03793478|Acute myeloid leukemia recurrent|acute myeloid leukemia recurrent
5032984|NCT03792828|serotonin-norepinephrine reuptake inhibitors|serotonin-norepinephrine reuptake inhibitors
5033183|NCT03791502|Flexibility|flexibility
5033184|NCT03791502|Pilates|pilates
5722357|NCT00423605|Stiffness|stiffness
5033185|NCT03791476|Delayed graft function|delayed graft function
5033187|NCT03791424|sedation|sedation
5033388|NCT03790449|Infertility|infertility
5033389|NCT03790449|Lifestyle|lifestyle
5033390|NCT03790449|mobile health|mobile health
5033391|NCT03790449|Diet|diet
5033392|NCT03790449|Physical Activity|physical activity
5033393|NCT03790449|Mindfulness|mindfulness
5033396|NCT03790345|Schizophrenia|schizophrenia
5033488|NCT03789955|Mid thoracic epidural space|mid thoracic epidural space
5033602|NCT03789123|Ovarian reserve|ovarian reserve
5033603|NCT03789110|Breast Cancer|breast cancer
5033604|NCT03789097|Radiation|radiation
5033605|NCT03789097|Poly-ICLC|poly-iclc
5033606|NCT03789097|Pembrolizumab|pembrolizumab
5033607|NCT03789097|Lymphoma|lymphoma
5033608|NCT03789097|Breast Cancer|breast cancer
5033609|NCT03789097|Carcinoma|carcinoma
5033610|NCT03789045|Exercise|exercise
5033690|NCT03788629|mobilization|mobilization
5033691|NCT03788616|Bioactive Restorative Material , ART|bioactive restorative material , art
5033692|NCT03788525|Screen time|screen time
5033693|NCT03788512|acute ischemic cerebrovascular disease|acute ischemic cerebrovascular disease
5033694|NCT03788512|cerebral atherosclerosis|cerebral atherosclerosis
5033695|NCT03788512|coronary atherosclerosis|coronary atherosclerosis
5033697|NCT03788499|Massage|massage
5033780|NCT03787875|chronic periodontitis|chronic periodontitis
5033781|NCT03787862|Foot ulcers|foot ulcers
5033782|NCT03787862|Foot Surgery|foot surgery
5033783|NCT03787862|Hyperspectral imaging|hyperspectral imaging
5033784|NCT03787849|Emergence delirium|emergence delirium
5033785|NCT03787849|Child|child
5033786|NCT03787849|Postoperative complications|postoperative complications
5033787|NCT03787849|DNA methylation|dna methylation
5033788|NCT03787849|Epigenetic|epigenetic
5033789|NCT03787836|Exercise Response|exercise response
5033790|NCT03787836|Interindividual Variability|interindividual variability
5033791|NCT03787797|Epicardial adipose tissue|epicardial adipose tissue
5696222|NCT00513617|Anemia|anemia
5864098|NCT00000417|Self-help|self-help
5033866|NCT03787342|Periosteal Releasing Incision, Modified Periosteal Releasing Incision, Coronally Advanced Lingual Flap, Double Flap Incision, Titanium mesh, GBR|periosteal releasing incision, modified periosteal releasing incision, coronally advanced lingual flap, double flap incision, titanium mesh, gbr
5033867|NCT03787329|Femur Head Necrosis|femur head necrosis
5033868|NCT03787329|Mesenchymal Stromal Cells|mesenchymal stromal cells
5033869|NCT03787329|Bone Marrow|bone marrow
5033870|NCT03787316|gait|gait
5033961|NCT03786770|Forehead Lines|forehead lines
5033962|NCT03786770|Glabellar Lines|glabellar lines
5033963|NCT03786770|Frown Lines|frown lines
5033965|NCT03786757|left ventricular thrombus|left ventricular thrombus
5033966|NCT03786757|rivaroxaban|rivaroxaban
5033967|NCT03786744|Autism, ASD, Cord blood|autism, asd, cord blood
5033968|NCT03786731|Major Depressive Disorder|major depressive disorder
5033969|NCT03786731|Sleep|sleep
5033971|NCT03786718|Diabetes|diabetes
5034184|NCT03785691|Hyperemesis Gravidarum (HG)|hyperemesis gravidarum (hg)
5034185|NCT03785691|Mirtazapine|mirtazapine
5034186|NCT03785691|Ondansetron|ondansetron
5034187|NCT03785691|Pregnancy|pregnancy
5034188|NCT03785691|Nausea and Vomiting of Pregnancy (NVP)|nausea and vomiting of pregnancy (nvp)
5034285|NCT03785080|thromboembolism|thromboembolism
5034399|NCT03784196|neck pain|neck pain
5034518|NCT03783481|Breast cancer survivors|breast cancer survivors
5034519|NCT03783481|mobile community|mobile community
5034520|NCT03783481|distress|distress
5034521|NCT03783455|Corticosteroid|corticosteroid
5034522|NCT03783455|Hyaluronic acid|hyaluronic acid
5034523|NCT03783455|Joint Lavage|joint lavage
5034524|NCT03783429|Heart Failure|heart failure
5034635|NCT03782805|vitamin D, type 2 diabetes, inflammation|vitamin d, type 2 diabetes, inflammation
5034636|NCT03782779|Respiratory physical therapy|respiratory physical therapy
5034637|NCT03782766|Piezocision|piezocision
5034638|NCT03782766|Temporary anchorage device|temporary anchorage device
5034639|NCT03782766|molar protraction|molar protraction
5034640|NCT03782753|Parkinson Disease|parkinson disease
5034641|NCT03782753|LRRK2|lrrk2
5034642|NCT03782727|skin cancer|skin cancer
5034643|NCT03782727|surgery|surgery
5034644|NCT03782727|ulcerated|ulcerated
5034645|NCT03782727|infection|infection
5034648|NCT03782675|operating room air|operating room air
5034649|NCT03782675|surgical site infection|surgical site infection
5034650|NCT03782675|airborne CFU|airborne cfu
5034651|NCT03782649|Non-invasive glucose monitoring|non-invasive glucose monitoring
5034652|NCT03782649|Raman spectroscopy|raman spectroscopy
5034653|NCT03782610|Patent Ductus Arteriosus|patent ductus arteriosus
5034654|NCT03782610|Preterm Infant|preterm infant
5034655|NCT03782610|Echocardiogram|echocardiogram
5034656|NCT03782610|Prospective Cohort|prospective cohort
5034657|NCT03782610|Prediction Modeling|prediction modeling
5034718|NCT03782246|pain|pain
5034719|NCT03782246|mindfulness|mindfulness
5034720|NCT03782246|cognitive behavioral therapy|cognitive behavioral therapy
5034925|NCT03781063|ER+/HER2|er+/her2
5034926|NCT03781063|ESR1 mutation|esr1 mutation
5034927|NCT03781050|Peutz-Jeghers Syndrome (PJS)|peutz-jeghers syndrome (pjs)
5034928|NCT03781050|Rapamycin (sirolimus)|rapamycin (sirolimus)
5034929|NCT03781050|Mammalian target of rapamycin (mTOR) inhibitor|mammalian target of rapamycin (mtor) inhibitor
5034930|NCT03781050|Treatment|treatment
5034931|NCT03781011|Gut microbiota|gut microbiota
5034932|NCT03781011|Trimethylamine N-oxide|trimethylamine n-oxide
5034933|NCT03781011|Oral carnitine challenge test|oral carnitine challenge test
5034934|NCT03781011|Cardiovascular disease|cardiovascular disease
5034935|NCT03780946|magnamosis; magnetic anastomosis; pancreaticojejunostomy|magnamosis; magnetic anastomosis; pancreaticojejunostomy
5034936|NCT03780907|Epilepsy|epilepsy
5034937|NCT03780907|E2007|e2007
5034938|NCT03780907|partial seizures|partial seizures
5035007|NCT03780543|hepatitis B|hepatitis b
5035138|NCT03779659|Topical anesthesia|topical anesthesia
5035139|NCT03779659|Analgesia|analgesia
5035145|NCT03779620|aortic valve|aortic valve
5035146|NCT03779620|stenosis|stenosis
5035147|NCT03779620|ultrasound|ultrasound
5035148|NCT03779620|non-invasive|non-invasive
5035149|NCT03779594|NPH|nph
5035150|NCT03779594|Acetazolamide|acetazolamide
5035151|NCT03779542|anterior chamber parameters|anterior chamber parameters
5035152|NCT03779542|phacoemulsification|phacoemulsification
5035153|NCT03779542|anterior segment swept-source optical coherence tomography|anterior segment swept-source optical coherence tomography
5035154|NCT03779529|olive oil|olive oil
5035234|NCT03779087|Rescue treatment|rescue treatment
5035235|NCT03779074|Helicobacter pylori|helicobacter pylori
5035364|NCT03778398|music therapy|music therapy
5035482|NCT03777553|Veterans|veterans
5035483|NCT03777501|proprioception|proprioception
5035484|NCT03777501|vibration|vibration
5035485|NCT03777501|balance|balance
5035487|NCT03777462|pancreatic cancer|pancreatic cancer
5035488|NCT03777462|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5035489|NCT03777462|SBRT|sbrt
5035499|NCT03777384|oropharynx|oropharynx
5035500|NCT03777384|head and neck cancer|head and neck cancer
5035502|NCT03777267|Stress|stress
5035588|NCT03776591|Colon cancer|colon cancer
5035679|NCT03775954|Fetal Anomaly|fetal anomaly
5035680|NCT03775954|Fetal Echocardiography|fetal echocardiography
5035681|NCT03775954|Non-Stress Testing|non-stress testing
5035682|NCT03775954|New Technology|new technology
5035683|NCT03775954|Birth Defects|birth defects
5035684|NCT03775954|Fetal Research|fetal research
5035685|NCT03775941|Neuroimaging|neuroimaging
5035791|NCT03775239|Hyper sexuality|hyper sexuality
5035792|NCT03775239|Mindfulness|mindfulness
5035793|NCT03775213|Ductal carcinoma in situ|ductal carcinoma in situ
5035794|NCT03775213|Decision support tool|decision support tool
5669775|NCT00622323|Byetta|byetta
5671425|NCT00616083|Infant|infant
5035795|NCT03775213|Informed decision-making|informed decision-making
5035910|NCT03774641|Lamotrigine|lamotrigine
5035911|NCT03774641|Bipolar Disorder|bipolar disorder
5035912|NCT03774641|Major Depressive Disorder|major depressive disorder
5035913|NCT03774641|Schizo Affective Disorder|schizo affective disorder
5035914|NCT03774615|Iron Deficiency|iron deficiency
5035917|NCT03774589|morbidity|morbidity
5036038|NCT03773900|Fecal Short Chain Fatty Acid (SCFA)|fecal short chain fatty acid (scfa)
5036039|NCT03773900|cardiometabolic risk|cardiometabolic risk
5036040|NCT03773900|nutritional challenge test|nutritional challenge test
5036139|NCT03773367|Oxaliplatin|oxaliplatin
5036140|NCT03773367|Irinotecan|irinotecan
5036141|NCT03773367|Preoperative chemotherapy|preoperative chemotherapy
5036142|NCT03773367|Postoperative chemotherapy|postoperative chemotherapy
5036252|NCT03772496|fine needle aspiration biopsy|fine needle aspiration biopsy
5036253|NCT03772496|Circulating tumor cells|circulating tumor cells
5036254|NCT03772496|benign|benign
5036255|NCT03772496|malignant|malignant
5036256|NCT03772483|virtual reality|virtual reality
5036257|NCT03772483|pain control|pain control
5036284|NCT03772210|fMRI|fmri
5036359|NCT03771690|Appetite|appetite
5036361|NCT03771690|Ghrelin|ghrelin
5036362|NCT03771690|Individual variability|individual variability
5036363|NCT03771690|Meal intake|meal intake
5036364|NCT03771690|Peptide YY|peptide yy
5036365|NCT03771677|Chronic Hepatitis B|chronic hepatitis b
5036366|NCT03771677|IFNA2p.Ala120Thr /ISGs|ifna2p.ala120thr /isgs
5036367|NCT03771638|Adherence|adherence
5036368|NCT03771638|PrEP|prep
5036369|NCT03771638|HIV Prevention|hiv prevention
5036370|NCT03771638|Truvada|truvada
5036455|NCT03771196|Bioactive Restorative Material|bioactive restorative material
5036564|NCT03770559|Laparoscopy|laparoscopy
5036565|NCT03770559|Open|open
5036566|NCT03770520|Quantitative Flow Ratio|quantitative flow ratio
5036567|NCT03770520|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5036568|NCT03770520|Graft patency|graft patency
5036569|NCT03770481|communication|communication
5036570|NCT03770481|end-of-life|end-of-life
5036571|NCT03770481|intensive care unit|intensive care unit
5036572|NCT03770442|ICU acquired weakness (ICU-AW)|icu acquired weakness (icu-aw)
5036576|NCT03770429|Leukemia|leukemia
5036667|NCT03769844|immunoparalysis|immunoparalysis
5036668|NCT03769844|GM-CSF|gm-csf
5036669|NCT03769818|erector spinae plane block|erector spinae plane block
5036670|NCT03769818|total abdominal hysterectomy|total abdominal hysterectomy
5036671|NCT03769818|dexamethasone|dexamethasone
5036672|NCT03769805|anlotinib|anlotinib
5036673|NCT03769805|Maintenance treatment|maintenance treatment
5036674|NCT03769792|Obstetrical anal sphincter injury|obstetrical anal sphincter injury
5036675|NCT03769792|Impedance spectroscopy|impedance spectroscopy
5036762|NCT03769467|Stomatognathic Diseases|stomatognathic diseases
5036763|NCT03769467|Otorhinolaryngologic Diseases|otorhinolaryngologic diseases
5036764|NCT03769467|Pembrolizumab|pembrolizumab
5036765|NCT03769467|Programmed death-1 (PD-1)|programmed death-1 (pd-1)
5036766|NCT03769467|Programmed death-ligand 1(PD-L1)|programmed death-ligand 1(pd-l1)
5036767|NCT03769441|Renal Transplantation|renal transplantation
5036768|NCT03769441|Kidney Transplantation|kidney transplantation
5036769|NCT03769441|Iron Deficiency|iron deficiency
5036770|NCT03769428|opioid consumption|opioid consumption
5036771|NCT03769428|erector spinae plane block|erector spinae plane block
5036772|NCT03769428|breast surgery|breast surgery
5036773|NCT03769428|analgesia|analgesia
5036774|NCT03769428|PCA morphine|pca morphine
5036775|NCT03769428|Locoregional anesthesia|locoregional anesthesia
5036776|NCT03769428|breast cancer surgery|breast cancer surgery
5036777|NCT03769376|toothlessness|toothlessness
5036778|NCT03769337|serum markers of infections|serum markers of infections
5036779|NCT03769298|Tremors|tremors
5036780|NCT03769259|suicide|suicide
5036841|NCT03769064|ADHD|adhd
5036842|NCT03769064|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5036843|NCT03769064|stimulant|stimulant
5036844|NCT03769051|Cow's Milk Protein allergy|cow's milk protein allergy
5036845|NCT03769051|Open Food Challenge test|open food challenge test
5036846|NCT03769051|Immune Tolerance|immune tolerance
5036847|NCT03769051|Amino Acid Formula|amino acid formula
5036925|NCT03768531|Biliary tract cancers (BTC)|biliary tract cancers (btc)
5036926|NCT03768531|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5036927|NCT03768531|Adjuvant chemotherapy|adjuvant chemotherapy
5037023|NCT03767803|Visual Symptoms|visual symptoms
5037024|NCT03767790|Artificial Pancreas|artificial pancreas
5037025|NCT03767790|Hyperglycemia|hyperglycemia
5037026|NCT03767790|Hypoglycemia|hypoglycemia
5037529|NCT03764280|type 1 diabetes|type 1 diabetes
5037240|NCT03766477|Sleep hygiene|sleep hygiene
5037241|NCT03766464|sleep bruxism|sleep bruxism
5864099|NCT00000416|Arthritis|arthritis
5037353|NCT03765606|Cocoa Flavan-3-ols|cocoa flavan-3-ols
5037458|NCT03764969|pavlovian instrumental transfer|pavlovian instrumental transfer
5037461|NCT03764917|NGS|ngs
5037462|NCT03764917|RNAseq|rnaseq
5037463|NCT03764865|cleavage embryo|cleavage embryo
5037464|NCT03764865|blastocyst|blastocyst
5037465|NCT03764865|embryo transfer|embryo transfer
5037467|NCT03764852|outpatient|outpatient
5037559|NCT03763942|HealthMindr|healthmindr
5037771|NCT03762642|Procedure Choice|procedure choice
5037772|NCT03762642|Surgical Outcome|surgical outcome
5037773|NCT03762616|multiparametric MRI|multiparametric mri
5037774|NCT03762616|micro-ultrasound|micro-ultrasound
5037775|NCT03762616|prostate biopsy|prostate biopsy
5037776|NCT03762603|Pneumatic|pneumatic
5037777|NCT03762603|exoskeleton|exoskeleton
5037778|NCT03762590|Candidates for Hereditary Pancreatic Cancer Testing|candidates for hereditary pancreatic cancer testing
5037779|NCT03762577|Pulmonary Hypertension|pulmonary hypertension
5037882|NCT03762083|vulvovaginitis|vulvovaginitis
5037883|NCT03762083|genital disease, female|genital disease, female
5037884|NCT03762083|vaginitis, bacterial|vaginitis, bacterial
5723666|NCT00417950|alcohol|alcohol
5037885|NCT03762057|Intraabdominal Hypertension|intraabdominal hypertension
5038006|NCT03761355|executive functions|executive functions
5038007|NCT03761355|medical simulation|medical simulation
5038063|NCT03761173|PE|pe
5038102|NCT03760887|Low back pain|low back pain
5038103|NCT03760887|Sensory|sensory
5038104|NCT03760887|Tactile|tactile
5038105|NCT03760887|Education|education
5038106|NCT03760835|congenital adrenal hyperplasia|congenital adrenal hyperplasia
5038107|NCT03760835|glucocorticoid treatment|glucocorticoid treatment
5038108|NCT03760835|dual release hydrocortisone|dual release hydrocortisone
5038109|NCT03760822|ramucirumab|ramucirumab
5038110|NCT03760822|elderly patient|elderly patient
5038111|NCT03760822|second line therapy|second line therapy
5038112|NCT03760809|dexmedetomidine|dexmedetomidine
5038113|NCT03760809|hydromophine|hydromophine
5038114|NCT03760809|tonsillectomy and adenoidectomy|tonsillectomy and adenoidectomy
5038115|NCT03760796|readmission|readmission
5038118|NCT03760796|cost-effectiveness|cost-effectiveness
5038297|NCT03759808|concussion|concussion
5038298|NCT03759808|capnometry-assisted respiratory training|capnometry-assisted respiratory training
5038399|NCT03758911|interview|interview
5038400|NCT03758898|Bariatric surgery|bariatric surgery
5202127|NCT02730884|MF|mf
5038401|NCT03758898|Chest physiotherapy|chest physiotherapy
5038402|NCT03758898|Pulmonary functions|pulmonary functions
5038403|NCT03758898|Quality of life|quality of life
5038404|NCT03758885|IVF|ivf
5038405|NCT03758885|ICSI|icsi
5038406|NCT03758885|ART|art
5038407|NCT03758885|ET|et
5038408|NCT03758859|Glaucoma|glaucoma
5038409|NCT03758846|Dual-task training|dual-task training
5038499|NCT03758235|overactive bladder syndrome|overactive bladder syndrome
5038500|NCT03758235|botulinum toxin type A|botulinum toxin type a
5038501|NCT03758235|onabotulinumtoxin/A|onabotulinumtoxin/a
5038502|NCT03758235|incobotulinumtoxin/A|incobotulinumtoxin/a
5038503|NCT03758235|treatment|treatment
5038504|NCT03758209|Morbidity, Mortality, Complication, Prehabilitation, ERAS|morbidity, mortality, complication, prehabilitation, eras
5038612|NCT03757286|maxillary tumors resection\ reconstruction|maxillary tumors resection\ reconstruction
5038613|NCT03757286|CAD\CAM|cad\cam
5038614|NCT03757286|osteotomy, cutting guide|osteotomy, cutting guide
5038615|NCT03757286|aesthetic|aesthetic
5038616|NCT03757286|operation time|operation time
5038617|NCT03757286|free scapular flap|free scapular flap
5038620|NCT03757273|Osteotomy, Cutting guide|osteotomy, cutting guide
5038622|NCT03757273|Operation time|operation time
5038623|NCT03757273|Free fibular flap|free fibular flap
5038706|NCT03756779|Diet study|diet study
5038707|NCT03756740|telerehabilitation, exercises, video, physical therapy|telerehabilitation, exercises, video, physical therapy
5038708|NCT03756675|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5038709|NCT03756675|G-CSF-mobilized peripheral blood stem cell|g-csf-mobilized peripheral blood stem cell
5038710|NCT03756675|haplotype|haplotype
5038711|NCT03756662|Non-penetrating glaucoma surgery|non-penetrating glaucoma surgery
5038712|NCT03756662|Open angle glaucoma|open angle glaucoma
5038713|NCT03756662|Intraocular pressure measurements|intraocular pressure measurements
5038805|NCT03755960|acupuncture|acupuncture
5038806|NCT03755960|peripheral neuropathy|peripheral neuropathy
5038807|NCT03755960|diabetes mellitus type II|diabetes mellitus type ii
5038808|NCT03755960|neurophysiology|neurophysiology
5038809|NCT03755960|nerve conduction velocity|nerve conduction velocity
5038810|NCT03755908|Forced oscillation technique|forced oscillation technique
5038811|NCT03755908|Airway obstruction|airway obstruction
5038813|NCT03755895|Cancer|cancer
5038814|NCT03755895|hypnosis|hypnosis
5038815|NCT03755895|care management|care management
5038840|NCT03755687|Pain Management|pain management
5038841|NCT03755687|Pediatrics|pediatrics
5038842|NCT03755687|Emergency Medicine|emergency medicine
5038843|NCT03755674|Obesity|obesity
5038844|NCT03755674|Appetite regulation|appetite regulation
5038845|NCT03755674|Chronotype|chronotype
5038920|NCT03755297|Regulatory B cells|regulatory b cells
5038957|NCT03755115|ICD|icd
5039021|NCT03754647|OCD|ocd
5680241|NCT00578552|smoking|smoking
5039434|NCT03752125|fat metabolism|fat metabolism
5039435|NCT03752112|Syphilis|syphilis
5039436|NCT03752112|Women|women
5039437|NCT03752112|Cefixime|cefixime
5039438|NCT03752112|Brazil|brazil
5039546|NCT03751358|Magnetic résonance imaging|magnetic résonance imaging
5039547|NCT03751345|Parenting skills|parenting skills
5039553|NCT03751332|Conversion|conversion
5039769|NCT03750032|acute appendicitis|acute appendicitis
5039771|NCT03750032|closure of appendicular stump|closure of appendicular stump
5039772|NCT03750032|economical and medical outcomes|economical and medical outcomes
5039773|NCT03750019|food intake|food intake
5039774|NCT03750019|memory|memory
5039775|NCT03750019|remembered satisfaction|remembered satisfaction
5039776|NCT03750019|memory for recent eating|memory for recent eating
5039785|NCT03749980|VHL|vhl
5039867|NCT03749642|Placebo|placebo
5039871|NCT03749590|MagPEP, post-ERCP pancreatitis, Magnesium Sulfate|magpep, post-ercp pancreatitis, magnesium sulfate
5039872|NCT03749577|l-citrullin|l-citrullin
5039873|NCT03749577|beetroot juice|beetroot juice
5039874|NCT03749577|Raynaud's phenomenon|raynaud's phenomenon
5039964|NCT03748966|rickets|rickets
5040091|NCT03748251|diet|diet
5040213|NCT03747432|Conscious Sedation|conscious sedation
5040214|NCT03747432|Propofol|propofol
5040215|NCT03747432|Dexmedetomidine|dexmedetomidine
5040216|NCT03747419|Bladder Cancer|bladder cancer
5040217|NCT03747419|Bladder Carcinoma|bladder carcinoma
5040218|NCT03747419|Carcinoma of Bladder|carcinoma of bladder
5040219|NCT03747419|Carcinoma of the Bladder|carcinoma of the bladder
5040220|NCT03747419|MIBC|mibc
5040242|NCT03747367|Stress|stress
5040321|NCT03746873|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5040322|NCT03746873|Health promotion tool|health promotion tool
5040323|NCT03746873|Self management|self management
5040324|NCT03746873|Evidence based care|evidence based care
5040325|NCT03746873|Implementation|implementation
5040327|NCT03746860|Allergic Rhinitis|allergic rhinitis
5040328|NCT03746860|Allergic Asthma|allergic asthma
5040329|NCT03746860|House Dust Mite|house dust mite
5040330|NCT03746860|Immunotherapy|immunotherapy
5040331|NCT03746834|Fecal incontinence|fecal incontinence
5040332|NCT03746834|Anorectal malformation|anorectal malformation
5040488|NCT03745963|EEG|eeg
5040766|NCT03744000|STEMI|stemi
5247981|NCT02457780|Mind-Body|mind-body
5040767|NCT03744000|Deferred stenting|deferred stenting
5040768|NCT03744000|Anterior wall myocardial infarction|anterior wall myocardial infarction
5040769|NCT03743974|arthroscopic shoulder surgery|arthroscopic shoulder surgery
5040770|NCT03743974|interscalene block analgesia|interscalene block analgesia
5040771|NCT03743974|supraclavicular block analgesia|supraclavicular block analgesia
5040772|NCT03743974|Ambulatory surgery for rotator cuff|ambulatory surgery for rotator cuff
5040773|NCT03743961|quality of life|quality of life
5040774|NCT03743961|elderly|elderly
5040780|NCT03743935|STEMI|stemi
5040861|NCT03743571|transcranial direct current stimulation|transcranial direct current stimulation
5040862|NCT03743571|exposure therapy|exposure therapy
5040863|NCT03743558|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5040965|NCT03742973|JAK|jak
5041077|NCT03742063|Ewing sarcoma|ewing sarcoma
5041078|NCT03742063|clinical evaluation|clinical evaluation
5041079|NCT03742063|pathological evaluation|pathological evaluation
5041173|NCT03741426|Cediranib|cediranib
5041174|NCT03741426|Durvalumab|durvalumab
5041175|NCT03741400|motor weakness|motor weakness
5041176|NCT03741400|rehabilitation|rehabilitation
5041177|NCT03741361|Female|female
5041236|NCT03741049|CVCI|cvci
5041310|NCT03740607|peripheral intravenous catheter|peripheral intravenous catheter
5041311|NCT03740581|Diabetic foot ulcer|diabetic foot ulcer
5041312|NCT03740581|Intensive glycemic control|intensive glycemic control
5041313|NCT03740529|Loxo|loxo
5041317|NCT03740529|CLL|cll
5041411|NCT03740256|Breast|breast
5041412|NCT03740256|Gastric|gastric
5041413|NCT03740256|Esophageal|esophageal
5041512|NCT03739736|Combination TB/HIV prevention interventions|combination tb/hiv prevention interventions
5041513|NCT03739736|Incidence of Tuberculosis|incidence of tuberculosis
5041514|NCT03739736|Prevalence of Tuberculosis|prevalence of tuberculosis
5041515|NCT03739736|Africa|africa
5041516|NCT03739736|Community-based|community-based
5041522|NCT03739684|Positron emission tomography|positron emission tomography
5041523|NCT03739684|biochemical recurrence|biochemical recurrence
5041524|NCT03739684|rising PSA|rising psa
5041525|NCT03739684|PET/CT|pet/ct
5041526|NCT03739684|Diagnostic|diagnostic
5041527|NCT03739684|Imaging|imaging
5041528|NCT03739684|PSMA|psma
5041529|NCT03739684|radical prostatectomy|radical prostatectomy
5041531|NCT03739658|Sports|sports
5041532|NCT03739658|Athletic Injuries|athletic injuries
5041609|NCT03739242|Cholesterol|cholesterol
5041610|NCT03739242|Triglycerides|triglycerides
5041611|NCT03739242|Dyslipidemia|dyslipidemia
5041612|NCT03739242|Low density lipoprotein cholesterol|low density lipoprotein cholesterol
5041613|NCT03739242|Dietary Fats|dietary fats
5041614|NCT03739242|Hyperlipidemias|hyperlipidemias
5041615|NCT03739242|Dietary Supplements|dietary supplements
5041616|NCT03739242|Food Supplements|food supplements
5041617|NCT03739242|Nutraceuticals|nutraceuticals
5041702|NCT03738579|biofilm|biofilm
5041703|NCT03738579|EPS matrix|eps matrix
5041704|NCT03738579|antimicrobial|antimicrobial
5041808|NCT03737864|transition to substance abuse treatment|transition to substance abuse treatment
5041810|NCT03737864|recidivism|recidivism
5041811|NCT03737864|patient navigation|patient navigation
5041812|NCT03737851|Relapsing multiple sclerosis|relapsing multiple sclerosis
5041813|NCT03737838|Paroxysmal|paroxysmal
5041814|NCT03737838|Atrial|atrial
5041815|NCT03737838|Fibrillation|fibrillation
5041920|NCT03737318|speech, articulation, motor development|speech, articulation, motor development
5041922|NCT03737305|Disc Displacement|disc displacement
5041923|NCT03737305|Temporomandibular Disorders|temporomandibular disorders
5042032|NCT03736447|Allergy|allergy
5042033|NCT03736447|Peanut Allergy|peanut allergy
5042034|NCT03736447|Characterized Peanut Allergen|characterized peanut allergen
5042035|NCT03736447|Oral Immunotherapy|oral immunotherapy
5042036|NCT03736434|Mindfulness|mindfulness
5042037|NCT03736434|Blood pressure|blood pressure
5042139|NCT03735927|Neurobehavioral Manifestations|neurobehavioral manifestations
5042140|NCT03735927|Nervous System Diseases|nervous system diseases
5042141|NCT03735927|Signs and Symptoms|signs and symptoms
5042142|NCT03735927|Neurocognitive Disorders|neurocognitive disorders
5042240|NCT03735199|3D Printed Scaffold Device|3d printed scaffold device
5042241|NCT03735186|Coronary heart disease|coronary heart disease
5042242|NCT03735186|Exercise|exercise
5042243|NCT03735186|Inflammation|inflammation
5042244|NCT03735186|Postprandial lipaemia|postprandial lipaemia
5042245|NCT03735186|Smoking|smoking
5042246|NCT03735160|Nasotracheal intubation|nasotracheal intubation
5042247|NCT03735160|nasal alar injury|nasal alar injury
5042248|NCT03735069|Vital pulp therapy|vital pulp therapy
5042249|NCT03735069|Indirect pulp treatment|indirect pulp treatment
5042250|NCT03735069|Partial (Cvek) pulpotomy|partial (cvek) pulpotomy
5042251|NCT03735069|Complete (cervical) pulpotomy|complete (cervical) pulpotomy
5042252|NCT03735069|Enamel hypomineralization defects|enamel hypomineralization defects
5042253|NCT03735069|Molar incisor hypomineralization|molar incisor hypomineralization
5042254|NCT03735069|Children|children
5042255|NCT03735056|Diagnosis|diagnosis
5042256|NCT03735056|Emotional support|emotional support
5042257|NCT03735056|Peer support|peer support
5042258|NCT03735043|Pregnancy|pregnancy
5042259|NCT03735043|ccNexfin©|ccnexfin©
5042317|NCT03734653|Feasibility Study|feasibility study
5042318|NCT03734627|Gut hormones|gut hormones
5042540|NCT03733223|t-PA/PAI-1|t-pa/pai-1
5042761|NCT03731845|chemotherapy|chemotherapy
5042762|NCT03731845|single nucleotide polymorphism|single nucleotide polymorphism
5042763|NCT03731819|MRI|mri
5042764|NCT03731806|celiac disease|celiac disease
5042765|NCT03731806|capsule endoscopy|capsule endoscopy
5042766|NCT03731793|non-animal chondroitin sulphate|non-animal chondroitin sulphate
5042767|NCT03731793|knee osteoarthritis|knee osteoarthritis
5042768|NCT03731793|overweight|overweight
5042769|NCT03731780|caries, prevention, personalized medicine|caries, prevention, personalized medicine
5042770|NCT03731767|Manipulation|manipulation
5042771|NCT03731767|Thrust|thrust
5042851|NCT03731351|acute ischemic stroke|acute ischemic stroke
5042852|NCT03731312|Iodine|iodine
5042853|NCT03731312|Urinary iodine concentration|urinary iodine concentration
5042854|NCT03731299|muscle synergies|muscle synergies
5042855|NCT03731299|gait|gait
5042959|NCT03730701|Life style|life style
5043072|NCT03729778|Streptococcus pneumoniae infection|streptococcus pneumoniae infection
5043073|NCT03729778|Prevnar-13|prevnar-13
5043074|NCT03729778|PCV-13|pcv-13
5043075|NCT03729778|Pneumococcal vaccine|pneumococcal vaccine
5043076|NCT03729778|Pneumococcal vaccines|pneumococcal vaccines
5043077|NCT03729778|Streptococcus pneumoniae colonization|streptococcus pneumoniae colonization
5043079|NCT03729765|hemoperfusion|hemoperfusion
5043164|NCT03729271|Irritable Bowel Syndrome|irritable bowel syndrome
5043165|NCT03729245|Kidney Cancer|kidney cancer
5043166|NCT03729245|Kidney Neoplasms|kidney neoplasms
5043167|NCT03729245|Renal Cancer|renal cancer
5043168|NCT03729245|Renal Neoplasms|renal neoplasms
5043169|NCT03729245|CD122|cd122
5043170|NCT03729245|CD122-Biased Agonist|cd122-biased agonist
5043171|NCT03729245|CD122-Biased Cytokine|cd122-biased cytokine
5043172|NCT03729245|IL-2 Receptor Agonist|il-2 receptor agonist
5043173|NCT03729245|Immuno-oncology therapy|immuno-oncology therapy
5043177|NCT03729245|PD-L1|pd-l1
5043264|NCT03728790|hypertensive disorders of pregnancy|hypertensive disorders of pregnancy
5043265|NCT03728790|preeclampsia|preeclampsia
5043281|NCT03728621|AIP|aip
5043363|NCT03728075|Chronic Heart Failure|chronic heart failure
5043365|NCT03728062|Physical exercise|physical exercise
5043366|NCT03728062|Salivary Immunoglobulin A|salivary immunoglobulin a
5043367|NCT03728062|Recovery strategy from stress|recovery strategy from stress
5043371|NCT03728049|Biomarker|biomarker
5043456|NCT03727672|Interleukin6|interleukin6
5043458|NCT03727659|Cannabis|cannabis
5043459|NCT03727659|CONNECT|connect
5043460|NCT03727659|Depression|depression
5043461|NCT03727659|FaceBook|facebook
5043462|NCT03727620|aggressive periodontitis|aggressive periodontitis
5043463|NCT03727620|systemic antibiotics|systemic antibiotics
5043464|NCT03727620|doxycycline|doxycycline
5043465|NCT03727581|hemodialysis|hemodialysis
5043466|NCT03727581|vascular access|vascular access
5043467|NCT03727581|dialysis catheter|dialysis catheter
5043491|NCT03727412|EVAR|evar
5043549|NCT03727165|continous infusion|continous infusion
5043550|NCT03727165|cyclic infusion|cyclic infusion
5043551|NCT03727152|generic TAF/E/D|generic taf/e/d
5043552|NCT03727152|virologically suppressed HIV-infected adults|virologically suppressed hiv-infected adults
5043649|NCT03726593|malarone|malarone
5043650|NCT03726593|atovaquone|atovaquone
5043651|NCT03726593|mefloquine|mefloquine
5043652|NCT03726593|pyramax|pyramax
5043653|NCT03726593|pyronaridine|pyronaridine
5043680|NCT03726411|GCF|gcf
5043750|NCT03725956|Nasal polyposis|nasal polyposis
5043752|NCT03725956|sinus surgery|sinus surgery
5043753|NCT03725956|polysomnography|polysomnography
5043766|NCT03725904|Saliva|saliva
5043848|NCT03725267|Melatonin|melatonin
5043849|NCT03725267|Polymixin B|polymixin b
5043850|NCT03725267|RIFLE|rifle
5043851|NCT03725267|Nephrotoxicity|nephrotoxicity
5043852|NCT03725254|Chemoradiotherapy|chemoradiotherapy
5043853|NCT03725254|retroperitoneal lymphadenectomy|retroperitoneal lymphadenectomy
5043854|NCT03725254|IMRT|imrt
5043855|NCT03725254|SBRT|sbrt
5043856|NCT03725215|Split-Belt Treadmill|split-belt treadmill
5043857|NCT03725215|Training|training
5043858|NCT03725202|Giant Cell Arteritis (GCA)|giant cell arteritis (gca)
5043954|NCT03724513|High Altitude|high altitude
5043955|NCT03724513|Gastric Antrum Perforation|gastric antrum perforation
5043956|NCT03724513|Mucosal Atrophy|mucosal atrophy
5043957|NCT03724513|Intra Luminal Pressure|intra luminal pressure
5043958|NCT03724500|Non small cell lung cancer|non small cell lung cancer
5043959|NCT03724500|Circulating tumor cell|circulating tumor cell
5043960|NCT03724474|Physical Activity|physical activity
5043961|NCT03724474|Sleep|sleep
5043962|NCT03724474|Smartphones|smartphones
5043963|NCT03724474|Wearable Activity Monitors|wearable activity monitors
5044069|NCT03724006|Diagnosis|diagnosis
5044070|NCT03724006|Parents|parents
5044071|NCT03724006|Quality of Life|quality of life
5044072|NCT03724006|Education|education
5044073|NCT03723993|Ischemic preconditioning|ischemic preconditioning
5044076|NCT03723980|Flare up|flare up
5044160|NCT03723447|pain|pain
5044161|NCT03723434|Human|human
5044162|NCT03723434|Brain|brain
5044163|NCT03723434|Connectivity|connectivity
5044164|NCT03723434|Stroke|stroke
5044165|NCT03723434|Traumatic brain injury|traumatic brain injury
5044265|NCT03722537|Arthritis|arthritis
5044268|NCT03722498|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5044269|NCT03722498|Sorafenib|sorafenib
5044270|NCT03722472|Vaccine, recombinant, adjuvant, GLA-SE, ID93|vaccine, recombinant, adjuvant, gla-se, id93
5044271|NCT03722407|CMML|cmml
5044482|NCT03720938|active video games|active video games
5044483|NCT03720938|physical fitness|physical fitness
5044484|NCT03720938|self-perception|self-perception
5044485|NCT03720938|enjoyment|enjoyment
5044486|NCT03720938|obesity|obesity
5044487|NCT03720925|oral heath|oral heath
5044488|NCT03720925|quality of life|quality of life
5044489|NCT03720925|tooth injuries|tooth injuries
5044490|NCT03720925|children|children
5044491|NCT03720925|family|family
5044492|NCT03720847|Steroid hormones|steroid hormones
5044493|NCT03720847|Estradiol|estradiol
5044494|NCT03720847|Progesterone|progesterone
5044495|NCT03720847|Depression|depression
5044496|NCT03720847|Suicide|suicide
5044497|NCT03720808|pain management|pain management
5044498|NCT03720808|pain in children|pain in children
5044567|NCT03720587|Trochanteric bursitis|trochanteric bursitis
5044865|NCT03718715|Microbiota|microbiota
5044575|NCT03720496|CD19-CAR-T|cd19-car-t
5044581|NCT03720457|CD19|cd19
5044582|NCT03720457|CAR-T|car-t
5044583|NCT03720457|Diffuse Large B-cell Lymphoma|diffuse large b-cell lymphoma
5044584|NCT03720457|Follicular Lymphoma|follicular lymphoma
5044585|NCT03720457|Relapsed /Refractory|relapsed /refractory
5044586|NCT03720418|Parkinson's disease|parkinson's disease
5044587|NCT03720418|Gene therapy|gene therapy
5044588|NCT03720418|OXB-102|oxb-102
5044589|NCT03720418|AXO-Lenti-PD|axo-lenti-pd
5044590|NCT03720405|pulmonary resection|pulmonary resection
5045013|NCT03717805|Patient information|patient information
5045014|NCT03717779|Lung ultrasound,|lung ultrasound,
5045015|NCT03717779|heart failure|heart failure
5045016|NCT03717779|diagnosis|diagnosis
5045017|NCT03717779|accuracy|accuracy
5045018|NCT03717740|preeclampsia|preeclampsia
5045019|NCT03717740|esomeprazole|esomeprazole
5045020|NCT03717740|Soluble Fms Like Tyrosine Kinase -1|soluble fms like tyrosine kinase -1
5045316|NCT03715868|Acute kidney injury|acute kidney injury
5045317|NCT03715868|Acute renal failure|acute renal failure
5045318|NCT03715868|Diet|diet
5045319|NCT03715868|Cardiothoracic surgery|cardiothoracic surgery
5045320|NCT03715868|Change of protein source|change of protein source
5045321|NCT03715816|endoscopy|endoscopy
5045322|NCT03715816|minimally invasive surgery|minimally invasive surgery
5045323|NCT03715816|passive breaks|passive breaks
5670245|NCT00620373|Breast|breast
5045324|NCT03715816|active breaks|active breaks
5045325|NCT03715816|muscle activity|muscle activity
5045326|NCT03715816|back curvature|back curvature
5045403|NCT03715127|emotion regulation|emotion regulation
5045404|NCT03715127|placebo-controlled|placebo-controlled
5045510|NCT03714399|Intensive Care Unit Acquired Weakness (ICUAW)|intensive care unit acquired weakness (icuaw)
5045511|NCT03714399|Critical Illness Polyneuromyopathy (CIPM)|critical illness polyneuromyopathy (cipm)
5045512|NCT03714399|Health Related Quality of Life (HRQoL)|health related quality of life (hrqol)
5045720|NCT03713268|OCT Angiography|oct angiography
5045721|NCT03713268|OCTA|octa
5045722|NCT03713255|Regional Anesthesia|regional anesthesia
5045723|NCT03713255|Paravertebral Block|paravertebral block
5045724|NCT03713255|Breast Cancer Surgery|breast cancer surgery
5045725|NCT03713255|MTP block|mtp block
5045726|NCT03713229|anal squamous intraepithelial lesions|anal squamous intraepithelial lesions
5045727|NCT03713229|anal squamous cell carcinoma|anal squamous cell carcinoma
5045728|NCT03713229|high-resolution anoscopy|high-resolution anoscopy
5045729|NCT03713229|liquid-based cytology|liquid-based cytology
5045730|NCT03713229|human papillomavirus|human papillomavirus
5045737|NCT03713203|Metvixia®|metvixia®
5045804|NCT03712839|Monitoring|monitoring
5045805|NCT03712839|Self Awareness|self awareness
5045806|NCT03712826|Crohn|crohn
5045807|NCT03712826|immunological profile|immunological profile
5045808|NCT03712826|ustekinumab|ustekinumab
5045809|NCT03712826|anti-TNF|anti-tnf
5045810|NCT03712813|aromatase inhibitors|aromatase inhibitors
5045811|NCT03712813|low intensity vibration|low intensity vibration
5045812|NCT03712800|Dysmenorrhea|dysmenorrhea
5045813|NCT03712800|Women Health|women health
5045814|NCT03712800|Rhythmical Massage|rhythmical massage
5045895|NCT03712085|Abdominal acupuncture|abdominal acupuncture
5045896|NCT03712085|Brain Plasticity|brain plasticity
5045899|NCT03712059|Polypectomy|polypectomy
5046004|NCT03711552|Caesarean|caesarean
5046005|NCT03711552|cesarean|cesarean
5046006|NCT03711552|ObsQoR-11|obsqor-11
5046007|NCT03711552|QoR-15|qor-15
5046008|NCT03711552|MCID|mcid
5046009|NCT03711552|minimal clinically important difference|minimal clinically important difference
5046010|NCT03711552|quality of recovery|quality of recovery
5046103|NCT03711058|Microsatellite stable|microsatellite stable
5046104|NCT03711045|eye-tracking|eye-tracking
5046105|NCT03711045|eye movement|eye movement
5046114|NCT03711019|Magnetic Seizure Therapy|magnetic seizure therapy
5046115|NCT03711019|Electroconvulsive Therapy|electroconvulsive therapy
5046116|NCT03711006|Fecal Microbiota Transplantation|fecal microbiota transplantation
5046117|NCT03710954|Evaluation of pain|evaluation of pain
5046118|NCT03710954|Fuzzy systems theory|fuzzy systems theory
5046209|NCT03710408|Adverse effects|adverse effects
5046210|NCT03710408|Subcutaneous hydration|subcutaneous hydration
5046211|NCT03710343|Cerebral Palsy|cerebral palsy
5046212|NCT03710343|Spastic|spastic
5046307|NCT03709836|Coronary angiography|coronary angiography
5046308|NCT03709836|Coronary computed tomography angiography|coronary computed tomography angiography
5046309|NCT03709836|Percutaneous coronary intervention|percutaneous coronary intervention
5046556|NCT03708263|rosacea|rosacea
5046639|NCT03707678|Inhaled corticosteroids|inhaled corticosteroids
5046640|NCT03707678|Toll-like receptors|toll-like receptors
5046642|NCT03707665|Nurse|nurse
5046743|NCT03706950|HIV-1|hiv-1
5046744|NCT03706937|Addiction|addiction
5046745|NCT03706937|Tobacco|tobacco
5046746|NCT03706937|Oncology|oncology
5046853|NCT03706287|pemetrexed|pemetrexed
5047061|NCT03705104|Cognitive Behavioral Therapy|cognitive behavioral therapy
5047062|NCT03705104|CBT|cbt
5047063|NCT03705104|Acceptance and Commitment Therapy|acceptance and commitment therapy
5047064|NCT03705104|ACT|act
5047065|NCT03705104|Psychological well-being|psychological well-being
5047066|NCT03705091|Magnetic resonance imaging|magnetic resonance imaging
5047067|NCT03705091|Biomarkers|biomarkers
5047068|NCT03705091|Arterial spin labelling|arterial spin labelling
5047069|NCT03705091|Diffusion weighted imaging|diffusion weighted imaging
5047070|NCT03705091|Renal transplantation|renal transplantation
5047071|NCT03705078|Bleeding gastric varices|bleeding gastric varices
5047072|NCT03705078|cirrhosis|cirrhosis
5047143|NCT03704662|Preoperative Fractionated Radiation Therapy|preoperative fractionated radiation therapy
5047144|NCT03704649|Nutrition|nutrition
5047145|NCT03704649|Literacy|literacy
5047146|NCT03704649|Education|education
5047147|NCT03704649|Adolescent|adolescent
5047148|NCT03704649|Girl|girl
5047149|NCT03704649|Participatory|participatory
5047150|NCT03704649|Video|video
5047151|NCT03704649|Ghana|ghana
5047157|NCT03704610|sarcoidosis|sarcoidosis
5047158|NCT03704610|extra-thoracic|extra-thoracic
5047159|NCT03704610|infliximab|infliximab
5047164|NCT03704571|adenoma|adenoma
5047338|NCT03703557|Volatile organic compounds|volatile organic compounds
5047339|NCT03703518|Mixed reality|mixed reality
5047340|NCT03703518|Exercise|exercise
5047348|NCT03703375|CC-486|cc-486
5047349|NCT03703375|Azacitidine|azacitidine
5047351|NCT03703375|T Cell Lymphoma|t cell lymphoma
5047446|NCT03702829|wild-type transthyretin amyloidosis|wild-type transthyretin amyloidosis
5047447|NCT03702829|TTR amyloidosis|ttr amyloidosis
5047448|NCT03702829|familial amyloid cardiomyopathy|familial amyloid cardiomyopathy
5047449|NCT03702829|mutant transthyretin amyloidosis|mutant transthyretin amyloidosis
5047548|NCT03702153|ventral hernia|ventral hernia
5047549|NCT03702153|mesh infection|mesh infection
5047550|NCT03702153|enteric fistula|enteric fistula
5047551|NCT03702153|polypropylene mesh|polypropylene mesh
5047552|NCT03702153|synthetic mesh|synthetic mesh
5047553|NCT03702153|abdominal wall reconstruction|abdominal wall reconstruction
5047554|NCT03702153|complex hernia|complex hernia
5047555|NCT03702114|menstrual migraine|menstrual migraine
5047556|NCT03702114|auricular point|auricular point
5047557|NCT03702114|diagnostic accuracy|diagnostic accuracy
5047558|NCT03702114|Auricular Point Detection device|auricular point detection device
5047559|NCT03702101|orofacial pain|orofacial pain
5047560|NCT03702101|auricular point|auricular point
5047561|NCT03702101|electrical impedance|electrical impedance
5047562|NCT03702088|Minimal residual disease|minimal residual disease
5047646|NCT03701373|Advanced Gastric Cancer|advanced gastric cancer
5047647|NCT03701373|Maintenance|maintenance
5047648|NCT03701373|S-1|s-1
5047649|NCT03701373|First-line treatment|first-line treatment
5047650|NCT03701347|Colposcopy|colposcopy
5047651|NCT03701347|Simulator|simulator
5047652|NCT03701347|Comparison Study|comparison study
5047692|NCT03700996|ACL|acl
5047774|NCT03700411|Colorectal Cancer|colorectal cancer
5047775|NCT03700411|Circulating Tumor Cell|circulating tumor cell
5047776|NCT03700359|extensive-stage small-cell lung cancer|extensive-stage small-cell lung cancer
5047777|NCT03700359|lobaplatin/etoposide|lobaplatin/etoposide
5047778|NCT03700359|Anlotinib maintenance therapy|anlotinib maintenance therapy
5047842|NCT03699904|EBV|ebv
5047876|NCT03699696|anesthetic dosing|anesthetic dosing
5047877|NCT03699696|induction|induction
5047878|NCT03699696|elderly|elderly
5047984|NCT03699046|Subchondroplasty|subchondroplasty
5047985|NCT03699046|Knee Function|knee function
5047986|NCT03699046|Knee Pain|knee pain
5047987|NCT03699046|Bone Quality|bone quality
5047988|NCT03699046|Bone Micro-architecture|bone micro-architecture
5047989|NCT03699033|Radiation|radiation
5047990|NCT03699033|NSCLC|nsclc
5047991|NCT03699033|Hypofractionated|hypofractionated
5047992|NCT03699033|Carboplatin|carboplatin
5047993|NCT03699033|Paclitaxel|paclitaxel
5047994|NCT03699033|IMRT|imrt
5047995|NCT03699033|Fraction|fraction
5047996|NCT03699033|Stage III|stage iii
5047997|NCT03699033|4D PET/CT|4d pet/ct
5047999|NCT03699020|Chronic Pain|chronic pain
5048000|NCT03699020|Acceptance and Commitment Therapy|acceptance and commitment therapy
5048001|NCT03699020|Behavioral Intervention|behavioral intervention
5048078|NCT03698565|Analgesia Nociception Index|analgesia nociception index
5048079|NCT03698565|Pupillary Index Pain|pupillary index pain
5048080|NCT03698539|Stuttering|stuttering
5048081|NCT03698539|Down syndrome|down syndrome
5048082|NCT03698539|Gestures|gestures
5048177|NCT03697876|sodium hyaluronate|sodium hyaluronate
5048178|NCT03697876|Chondroitin sulfate 0.18%|chondroitin sulfate 0.18%
5048180|NCT03697824|HLA-A2+|hla-a2+
5048278|NCT03697200|Ecological Momentary Assessment|ecological momentary assessment
5048279|NCT03697200|Musculoskeletal Symptoms|musculoskeletal symptoms
5048280|NCT03697187|Hereditary Angioedema|hereditary angioedema
5048281|NCT03697187|HAE|hae
5048282|NCT03697187|Ruconest|ruconest
5048283|NCT03697187|rhC1INH|rhc1inh
5048284|NCT03697187|Registry|registry
5048285|NCT03697187|Pharming|pharming
5048287|NCT03697122|Afterdrop|afterdrop
5048611|NCT03694964|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5048612|NCT03694964|Sarcopenia|sarcopenia
5048613|NCT03694964|Citrulline|citrulline
5048614|NCT03694964|Body composition|body composition
5048615|NCT03694964|Denutrition|denutrition
5048616|NCT03694951|Sedentary Behaviour|sedentary behaviour
5048617|NCT03694951|Subjective Well-Being|subjective well-being
5048618|NCT03694951|University Students|university students
5048714|NCT03694366|Child Mortality|child mortality
5048813|NCT03693794|evidence based interventions|evidence based interventions
5048818|NCT03693781|HSPB8|hspb8
5048941|NCT03692845|spine fusion|spine fusion
5048942|NCT03692845|minimally invasive surgery|minimally invasive surgery
5048943|NCT03692819|Chronic Periodontitis|chronic periodontitis
5048944|NCT03692819|Periodontal Debridement|periodontal debridement
5048945|NCT03692819|Antibiotics|antibiotics
5048946|NCT03692819|Probiotics|probiotics
5048949|NCT03692793|Exercise Test|exercise test
5049050|NCT03692182|Dementia|dementia
5049155|NCT03691519|Low OMega 3|low omega 3
5049156|NCT03691519|Preventive trial|preventive trial
5049157|NCT03691519|low RBC DHA/EPA index|low rbc dha/epa index
5049270|NCT03690674|ADHD|adhd
5049369|NCT03690076|Endocarditis|endocarditis
5049370|NCT03690050|Diabetic macular oedema|diabetic macular oedema
5049371|NCT03690050|Diabetic retinopathy|diabetic retinopathy
5049372|NCT03690037|Tranexamic Acid|tranexamic acid
5049373|NCT03690011|Autologouse CAR T cells|autologouse car t cells
5049374|NCT03690011|T-cell Acute Lymphoblastic Leukemia|t-cell acute lymphoblastic leukemia
5049375|NCT03690011|T-cell acute lymphoblastic lymphoma|t-cell acute lymphoblastic lymphoma
5049376|NCT03690011|T-non-Hodgkin lymphoma|t-non-hodgkin lymphoma
5049377|NCT03689998|immediate implant|immediate implant
5049378|NCT03689998|melatonin|melatonin
5049379|NCT03689998|atrumatic extraction|atrumatic extraction
5049380|NCT03689959|knee|knee
5049467|NCT03689309|High Flow Oxygen|high flow oxygen
5049468|NCT03689270|subluxation|subluxation
5049469|NCT03689270|Divide and conquer|divide and conquer
5049470|NCT03689257|inflammatory bowel disease|inflammatory bowel disease
5049471|NCT03689257|Ulcerative colitis|ulcerative colitis
5049583|NCT03688412|Defibrillators, Implantable|defibrillators, implantable
5049584|NCT03688399|Intraocular Lens|intraocular lens
5049585|NCT03688399|trifocal|trifocal
5049686|NCT03687853|Pancreatic ductal adenocarcinoma|pancreatic ductal adenocarcinoma
5049794|NCT03686865|regenerated bone, native bone, dental implant|regenerated bone, native bone, dental implant
5049795|NCT03686839|Neurofeedback|neurofeedback
5049796|NCT03686839|Acceptance technology|acceptance technology
5049797|NCT03686839|Electroencephalography|electroencephalography
5049798|NCT03686839|MCI|mci
5049799|NCT03686826|evoked potentials (EP)|evoked potentials (ep)
5049800|NCT03686826|motor evoked potentials (MEP)|motor evoked potentials (mep)
5049801|NCT03686826|Somato-sensory evoked potentials (SSEP)|somato-sensory evoked potentials (ssep)
5049803|NCT03686800|VLS|vls
5049890|NCT03686098|Asian|asian
5049993|NCT03685474|Special Learning Needs|special learning needs
5049994|NCT03685474|Minority Groups|minority groups
5049995|NCT03685461|Hearing Loss|hearing loss
5049996|NCT03685461|Cochlear Implant|cochlear implant
5049997|NCT03685435|Ultrasound|ultrasound
5049998|NCT03685435|Gastric content|gastric content
5049999|NCT03685435|Non-fasting|non-fasting
5050000|NCT03685435|Rapid Sequence Induction|rapid sequence induction
5050009|NCT03685396|PRF|prf
5050098|NCT03684798|Implementation Intentions|implementation intentions
5050099|NCT03684798|Abstinence|abstinence
5050100|NCT03684759|Expectoration|expectoration
5050101|NCT03684759|Cystic Fibrosis|cystic fibrosis
5050102|NCT03684759|Nasopharyngeal|nasopharyngeal
5050103|NCT03684759|Viral molecular diagnosis|viral molecular diagnosis
5050104|NCT03684733|Breast cancer|breast cancer
5050105|NCT03684733|BRCA1/2 mutation carriers|brca1/2 mutation carriers
5050106|NCT03684733|Breast screening|breast screening
5050111|NCT03684720|Basic Science|basic science
5050308|NCT03683329|critical care|critical care
5050309|NCT03683329|cancer|cancer
5275716|NCT02299102|Bone Marrow|bone marrow
5050310|NCT03683329|antimicrobial treatment|antimicrobial treatment
5050311|NCT03683329|de-escalation|de-escalation
5050312|NCT03683329|septic shock|septic shock
5050313|NCT03683329|sepsis|sepsis
5050314|NCT03683290|Oocyte|oocyte
5050442|NCT03682627|kidney transplantation|kidney transplantation
5050443|NCT03682627|Lymphatic complications|lymphatic complications
5050444|NCT03682627|preventive fenestration|preventive fenestration
5050445|NCT03682627|clipping|clipping
5050464|NCT03682523|Frailty|frailty
5050584|NCT03682029|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5050585|NCT03682029|Low-Risk Myeloid Malignancies|low-risk myeloid malignancies
5050586|NCT03682029|Vitamin C|vitamin c
5050587|NCT03682029|Epigenetics|epigenetics
5050692|NCT03681392|Nutritional Supplements|nutritional supplements
5050805|NCT03680625|Anxiety|anxiety
5050905|NCT03680248|hepatic fat content|hepatic fat content
5050906|NCT03680248|dietary fat|dietary fat
5050907|NCT03680248|glucose|glucose
5050908|NCT03680248|fructose|fructose
5050909|NCT03680248|non-esterified fatty acid|non-esterified fatty acid
5050910|NCT03680248|triglyceride|triglyceride
5050911|NCT03680248|insulin|insulin
5050912|NCT03680248|postprandial period|postprandial period
5050995|NCT03679767|renal cell carcinoma|renal cell carcinoma
5050996|NCT03679728|Zika virus|zika virus
5050997|NCT03679728|Children|children
5050998|NCT03679728|Microcephaly|microcephaly
5051098|NCT03678987|pharmacokinetics|pharmacokinetics
5051099|NCT03678987|mycophenolate mofetil|mycophenolate mofetil
5051100|NCT03678974|Cardiorespiratory Fitness|cardiorespiratory fitness
5051101|NCT03678974|Intensive Behavioral Therapy for Obesity|intensive behavioral therapy for obesity
5051102|NCT03678974|Exercise Prescription|exercise prescription
5051103|NCT03678935|Celiac disease|celiac disease
5051104|NCT03678935|Irritable bowel syndrome|irritable bowel syndrome
5051105|NCT03678922|musculoskeletal pain|musculoskeletal pain
5051106|NCT03678922|adolescents|adolescents
5051182|NCT03678454|Iclusig®|iclusig®
5051288|NCT03677713|transsphenoidal|transsphenoidal
5051289|NCT03677713|surgical resection|surgical resection
5051290|NCT03677713|pituitary tumour|pituitary tumour
5051291|NCT03677713|nasal packing|nasal packing
5051292|NCT03677713|Merocel|merocel
5051293|NCT03677700|vitrectomy|vitrectomy
5051294|NCT03677700|cryoindentation|cryoindentation
5051390|NCT03677050|Bowel preparation|bowel preparation
5051391|NCT03677050|Colonoscopy|colonoscopy
5051392|NCT03677050|Smart phone application|smart phone application
5051393|NCT03677050|Patient satisfaction|patient satisfaction
5051404|NCT03677011|sperm|sperm
5051477|NCT03676400|hair growth|hair growth
5051478|NCT03676400|androgenic alopecia|androgenic alopecia
5051479|NCT03676400|paracrine factors|paracrine factors
5051567|NCT03675789|LPS|lps
5051599|NCT03675607|Parenting|parenting
5051701|NCT03674983|Anti-Retroviral Agents|anti-retroviral agents
5051702|NCT03674983|Behavioral Economics|behavioral economics
5051703|NCT03674983|Biological Markers|biological markers
5051704|NCT03674983|Cost-effectiveness|cost-effectiveness
5051706|NCT03674983|HIV Prevention|hiv prevention
5051707|NCT03674983|PrEP|prep
5051708|NCT03674970|smoking cessation|smoking cessation
5051709|NCT03674970|nicotine film|nicotine film
5051710|NCT03674970|nicotine delivery|nicotine delivery
5051711|NCT03674970|random nicotine delivery|random nicotine delivery
5051927|NCT03673631|acute respiratory failure|acute respiratory failure
5051928|NCT03673631|withholding therapies|withholding therapies
5051929|NCT03673631|withdrawing therapies|withdrawing therapies
5051932|NCT03673592|Blastocyst biopsy|blastocyst biopsy
5051933|NCT03673592|Aneuploidy testing|aneuploidy testing
5051935|NCT03673579|NICU|nicu
5052027|NCT03673059|Quality of life|quality of life
5052028|NCT03673059|Moisturization|moisturization
5052030|NCT03673020|Vaccine|vaccine
5052254|NCT03671772|α-synucleinopathy|α-synucleinopathy
5052255|NCT03671772|Neurodegeneration|neurodegeneration
5052256|NCT03671772|Prodromal markers|prodromal markers
5730909|NCT00390962|SIADH|siadh
5052257|NCT03671772|REM sleep behavior disorder|rem sleep behavior disorder
5052265|NCT03671746|Inflammatory cytokine|inflammatory cytokine
5052266|NCT03671746|inflammation|inflammation
5052267|NCT03671746|trauma|trauma
5052268|NCT03671746|opioid|opioid
5052269|NCT03671707|tobacco dependence treatment|tobacco dependence treatment
5052270|NCT03671707|combined brief intervention|combined brief intervention
5052271|NCT03671707|AWARD advice|award advice
5052364|NCT03671317|palliative care|palliative care
5052365|NCT03671317|medical clowning|medical clowning
5052366|NCT03671317|anxiety relief|anxiety relief
5052367|NCT03671317|pain reduction|pain reduction
5052368|NCT03671317|distraction|distraction
5052369|NCT03671317|humor|humor
5052370|NCT03671317|papoose|papoose
5052371|NCT03671317|restraints|restraints
5052372|NCT03671304|renal call carcinoma|renal call carcinoma
5052373|NCT03671304|exercise|exercise
5052374|NCT03671304|physical activity|physical activity
5052375|NCT03671304|mobile intervention|mobile intervention
5052376|NCT03671304|just-in-time adaptive intervention|just-in-time adaptive intervention
5052377|NCT03671304|affective framing|affective framing
5052378|NCT03671304|intention planning|intention planning
5052470|NCT03670797|oral health status|oral health status
5052471|NCT03670797|oral findings|oral findings
5052472|NCT03670797|oral manifestations|oral manifestations
5052481|NCT03670732|Apnea|apnea
5052600|NCT03669809|biological rhythm|biological rhythm
5052601|NCT03669809|metabolism|metabolism
5052602|NCT03669809|hormone|hormone
5052603|NCT03669809|lipid|lipid
5052604|NCT03669809|bile acids|bile acids
5052605|NCT03669809|obesity|obesity
5052606|NCT03669796|Dietary Supplements|dietary supplements
5052607|NCT03669796|Fish Proteins|fish proteins
5052608|NCT03669796|Protein Hydrolysates|protein hydrolysates
5052694|NCT03669250|MMN|mmn
5052697|NCT03669250|gamma power|gamma power
5052698|NCT03669250|P300|p300
5052699|NCT03669250|auditory gating|auditory gating
5052799|NCT03668613|AIN457A|ain457a
5052800|NCT03668600|Depression|depression
5052801|NCT03668574|Back pain|back pain
5052896|NCT03667911|bowel preparation|bowel preparation
5052897|NCT03667911|colonoscopy|colonoscopy
5052898|NCT03667911|virtual reality|virtual reality
5052899|NCT03667911|patient education|patient education
5052900|NCT03667885|next generation sequencing|next generation sequencing
5052901|NCT03667885|multi planar magnetic resonance|multi planar magnetic resonance
5052902|NCT03667885|liquid biopsies|liquid biopsies
5052903|NCT03667885|non-invasive diagnostics|non-invasive diagnostics
5052985|NCT03667469|Gastric bypass|gastric bypass
5053183|NCT03666247|Behavioral Science|behavioral science
5053184|NCT03666247|Infectious Diseases|infectious diseases
5053185|NCT03666247|Health Promotion|health promotion
5053186|NCT03666247|Sexually Transmitted Diseases|sexually transmitted diseases
5053506|NCT03664141|Malnutrition|malnutrition
5053507|NCT03664141|Hemodialysis|hemodialysis
5053508|NCT03664141|Appetite|appetite
5053509|NCT03664141|Inflammation|inflammation
5053510|NCT03664141|Body composition|body composition
5053516|NCT03664115|antifungal|antifungal
5053517|NCT03664115|anticancer|anticancer
5053518|NCT03664115|platinum based chemotherapy|platinum based chemotherapy
5053519|NCT03664050|letrozol|letrozol
5053520|NCT03664050|laparoscopic ovarian drilling|laparoscopic ovarian drilling
5053705|NCT03662802|neural network|neural network
5053706|NCT03662802|cardiac arrhythmia|cardiac arrhythmia
5053707|NCT03662802|ECG|ecg
5053708|NCT03662802|EKG|ekg
5053709|NCT03662789|Heart transplant|heart transplant
5107622|NCT03325439|ENS|ens
5053804|NCT03662165|sex workers|sex workers
5053828|NCT03661892|Pain|pain
5053910|NCT03661385|Transposition of Great Arteries|transposition of great arteries
5054010|NCT03660579|Recovery|recovery
5053924|NCT03661203|Hindrances HIV screening|hindrances hiv screening
5053925|NCT03661203|Late recourse HIV test|late recourse hiv test
5053926|NCT03661203|Healt social psychology|healt social psychology
5054032|NCT03660475|dry eye|dry eye
5054234|NCT03659227|Lyell Syndrome|lyell syndrome
5054438|NCT03657966|Platinum-sensitive|platinum-sensitive
5054547|NCT03657095|Lung Diseases|lung diseases
5054548|NCT03657095|Vascular Diseases|vascular diseases
5054549|NCT03657095|Cardiovascular Diseases|cardiovascular diseases
5054593|NCT03656796|PD|pd
5054649|NCT03656458|Dynamic Stability Training|dynamic stability training
5054650|NCT03656458|Fall Risk|fall risk
5054651|NCT03656458|Berg Balance Scale|berg balance scale
5054652|NCT03656458|Physical Therapy|physical therapy
5054653|NCT03656458|Forward Reach Test|forward reach test
5054758|NCT03655704|Bromodomain-Containing Protein 4 (BRD4)|bromodomain-containing protein 4 (brd4)
5054759|NCT03655704|BRD4 inhibitor|brd4 inhibitor
5054760|NCT03655704|Feasibility pilot study|feasibility pilot study
5054761|NCT03655704|Phase 2 clinical trial|phase 2 clinical trial
5054763|NCT03655704|Two-centre|two-centre
5054764|NCT03655678|CRISPR-Cas9|crispr-cas9
5054765|NCT03655678|Beta-Thalassemia|beta-thalassemia
5054766|NCT03655678|Hemoglobinopathies|hemoglobinopathies
5054767|NCT03655652|positioning|positioning
5054768|NCT03655626|Machine Learning|machine learning
5054769|NCT03655626|Sepsis|sepsis
5054770|NCT03655626|Implementation Science|implementation science
5054771|NCT03655626|Health Information Technology|health information technology
5054772|NCT03655613|Immunotherapy|immunotherapy
5054846|NCT03655184|migraine|migraine
5054848|NCT03655171|Parkinson Disease|parkinson disease
5054849|NCT03655171|Exploratory study|exploratory study
5054850|NCT03655171|Quantitative method|quantitative method
5054851|NCT03655171|AI Video analysis|ai video analysis
5054852|NCT03655171|Motor dysfunction|motor dysfunction
5054853|NCT03655132|chronic pain|chronic pain
5054854|NCT03655132|veterans|veterans
5054856|NCT03655132|online treatment|online treatment
5054857|NCT03655119|Child|child
5054951|NCT03654482|Knotless seton|knotless seton
5054952|NCT03654482|Quality of life|quality of life
5054953|NCT03654482|Perianal Disease Activity Index|perianal disease activity index
5054954|NCT03654456|obstructive sleep apnea|obstructive sleep apnea
5054955|NCT03654456|sepsis|sepsis
5055063|NCT03653910|double-lumen tube intubation|double-lumen tube intubation
5055064|NCT03653910|remifentanil|remifentanil
5055065|NCT03653910|target controlled infusion|target controlled infusion
5055066|NCT03653897|Ingestion event marker|ingestion event marker
5055283|NCT03653026|ABT-494|abt-494
5055284|NCT03653026|Ulcerative Colitis|ulcerative colitis
5055285|NCT03653000|Regional anesthesia|regional anesthesia
5055397|NCT03652272|medication safety|medication safety
5055398|NCT03652272|adherence|adherence
5055401|NCT03652259|LGMD2E|lgmd2e
5055503|NCT03651557|cerebral performance category|cerebral performance category
5055504|NCT03651557|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5055505|NCT03651557|neuroprotection|neuroprotection
5055506|NCT03651557|glutamate|glutamate
5055507|NCT03651557|N-Methyl-D-aspartate (NMDA) receptor antagonist|n-methyl-d-aspartate (nmda) receptor antagonist
5055508|NCT03651557|Anti-oxidant|anti-oxidant
5055509|NCT03651557|free radical|free radical
5055510|NCT03651544|influenza|influenza
5055511|NCT03651544|vaccine|vaccine
5055513|NCT03651531|metformin|metformin
5055604|NCT03651141|Hamstring tightness|hamstring tightness
5055605|NCT03651141|myofascial decompression|myofascial decompression
5055606|NCT03651141|cupping|cupping
5055607|NCT03651141|neurodynamic sliding|neurodynamic sliding
5055608|NCT03651128|Multiple Myeloma|multiple myeloma
5055700|NCT03650634|supernumerary tooth|supernumerary tooth
5055701|NCT03650634|hyperdontia|hyperdontia
5055702|NCT03650634|mesiodens|mesiodens
5055703|NCT03650634|paramolar|paramolar
5055704|NCT03650595|MRI|mri
5055845|NCT03649828|Probiotics|probiotics
5055846|NCT03649828|Metabolic Syndrome|metabolic syndrome
5055847|NCT03649828|Cardiovascular Diseases|cardiovascular diseases
5055851|NCT03649815|mHealth|mhealth
5055948|NCT03649191|Evidence-based practice|evidence-based practice
5056048|NCT03648515|Tooth-size-arch-length-discrepancy|tooth-size-arch-length-discrepancy
5056050|NCT03648502|hearing loss|hearing loss
5056051|NCT03648502|auditory process|auditory process
5056052|NCT03648489|TAK228|tak228
5056053|NCT03648489|TAK-228|tak-228
5056054|NCT03648489|Paclitaxel|paclitaxel
5056055|NCT03648489|Ovarian cancer|ovarian cancer
5056056|NCT03648489|Platinum resistant|platinum resistant
5056057|NCT03648476|Anger|anger
5056058|NCT03648476|Aggression|aggression
5056059|NCT03648476|Hostility|hostility
5056247|NCT03647462|hospital readmission|hospital readmission
5056249|NCT03647397|asthma|asthma
5056301|NCT03647137|PET|pet
5056364|NCT03646630|quadratus lumborum block|quadratus lumborum block
5056365|NCT03646630|caudal block|caudal block
5056366|NCT03646604|Upadacitinib|upadacitinib
5056368|NCT03646604|Atopic Dermatitis|atopic dermatitis
5056369|NCT03646591|gastric cancer|gastric cancer
5056370|NCT03646591|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5056371|NCT03646591|FLOT regimen|flot regimen
5056372|NCT03646578|maternal anxiety|maternal anxiety
5056373|NCT03646539|Automated conversational agent|automated conversational agent
5056456|NCT03646032|Sexual education|sexual education
5056458|NCT03646032|STI|sti
5056459|NCT03646032|Consent|consent
5056460|NCT03646019|Coronary artery disease|coronary artery disease
5056461|NCT03646019|paraoxanase 1|paraoxanase 1
5864100|NCT00000416|Rheumatic disorders|rheumatic disorders
5056462|NCT03646019|Thiobarbituric Acid Reactive Substances|thiobarbituric acid reactive substances
5056463|NCT03646019|Thiol groups|thiol groups
5056464|NCT03645993|Early-Onset Alzheimer's disease|early-onset alzheimer's disease
5056465|NCT03645980|DKN-01|dkn-01
5056466|NCT03645980|Hepatocellular Carcinoma|hepatocellular carcinoma
5056467|NCT03645980|WNT signaling|wnt signaling
5056468|NCT03645954|Femoral triangle block|femoral triangle block
5056469|NCT03645954|Adductor canal block|adductor canal block
5056551|NCT03645616|Reproducibility|reproducibility
5056552|NCT03645616|Gait Speed|gait speed
5056553|NCT03645603|pediatrics|pediatrics
5056555|NCT03645603|analgesia|analgesia
5056870|NCT03643757|Thoracotomy|thoracotomy
5056871|NCT03643744|Actinic Keratosis|actinic keratosis
5056872|NCT03643744|Photodynamic Therapy|photodynamic therapy
5056873|NCT03643705|Implementation Science|implementation science
5056874|NCT03643705|Cardiovascular Disease|cardiovascular disease
5056875|NCT03643705|Prevention|prevention
5056994|NCT03642769|Normal Saline|normal saline
5056995|NCT03642743|hysterectomy|hysterectomy
5056997|NCT03642743|gynecology|gynecology
5057093|NCT03642106|Latino|latino
5057304|NCT03640936|specific IgE|specific ige
5057305|NCT03640910|Dental implants|dental implants
5057306|NCT03640910|Overdenture|overdenture
5057307|NCT03640910|Randomized controlled trial|randomized controlled trial
5057308|NCT03640897|Infant diaper rash|infant diaper rash
5057309|NCT03640897|Baby wipes|baby wipes
5057562|NCT03639272|talus;|talus;
5057563|NCT03639272|ORIF;|orif;
5057564|NCT03639272|screw fixation.|screw fixation.
5057565|NCT03639246|Ovarian cancer|ovarian cancer
5057566|NCT03639246|Platinum resistant|platinum resistant
5057567|NCT03639207|IFNL4|ifnl4
5057568|NCT03639207|Genetics|genetics
5057569|NCT03639207|Ledipasvir/Sofosbuvir Treatment|ledipasvir/sofosbuvir treatment
5057785|NCT03637660|HIV|hiv
5057875|NCT03637075|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5057876|NCT03637075|cerebral insulin resistance|cerebral insulin resistance
5057877|NCT03637075|insulin action in the human brain|insulin action in the human brain
5057879|NCT03637049|PBI-4050|pbi-4050
5058127|NCT03635684|Acetaminophen|acetaminophen
5058128|NCT03635684|Palliative Care|palliative care
5058129|NCT03635684|Infusions, Subcutaneous|infusions, subcutaneous
5058319|NCT03634644|male infertility|male infertility
5058320|NCT03634644|oligoasthenoteratospermia|oligoasthenoteratospermia
5058321|NCT03634618|carpal tunnel syndrome|carpal tunnel syndrome
5058322|NCT03634618|mirror therapy|mirror therapy
5058323|NCT03634618|postoperative rehabilitation|postoperative rehabilitation
5058324|NCT03634618|physical therapy modalities|physical therapy modalities
5058325|NCT03634618|median nerve|median nerve
5058326|NCT03634605|Tetracycline|tetracycline
5058338|NCT03634488|Nigeria|nigeria
5058407|NCT03633825|crisis referrals|crisis referrals
5058408|NCT03633825|help-seeking|help-seeking
5058409|NCT03633825|risk assessment|risk assessment
5058410|NCT03633825|treatment barrier|treatment barrier
5058411|NCT03633812|End Stage Liver Disease|end stage liver disease
5058412|NCT03633812|Acute Kidney Injury|acute kidney injury
5058518|NCT03633149|motivational interviewing|motivational interviewing
5058519|NCT03633136|video|video
5058520|NCT03633136|patient education|patient education
5058521|NCT03633123|Surgical site infection|surgical site infection
5058522|NCT03633123|Abdominal surgery|abdominal surgery
5058523|NCT03633123|Colon and small bowl surgery|colon and small bowl surgery
5058524|NCT03633110|Vaccine|vaccine
5058525|NCT03633110|Personalized|personalized
5058529|NCT03633110|Skin|skin
5058608|NCT03632772|Solifenacin|solifenacin
5058609|NCT03632694|cancer survivor|cancer survivor
5058610|NCT03632694|cancer survivorship|cancer survivorship
5058611|NCT03632694|light physical activity|light physical activity
5058612|NCT03632694|sedentary behavior|sedentary behavior
5058705|NCT03632122|function|function
5058706|NCT03632122|older adults|older adults
5058707|NCT03632122|Medicare|medicare
5058708|NCT03632109|gonorrhea|gonorrhea
5058709|NCT03632109|pharynx|pharynx
5058710|NCT03632109|treatment|treatment
5058711|NCT03632109|gentamicin|gentamicin
5058712|NCT03632031|partial and full-thickness wounds|partial and full-thickness wounds
5058713|NCT03632031|pressure ulcer|pressure ulcer
5058714|NCT03632031|venous ulcer|venous ulcer
5058715|NCT03632031|chronic vascular ulcer|chronic vascular ulcer
5058812|NCT03631303|Sudden Cardiac Death|sudden cardiac death
5058814|NCT03631290|renal dialysis|renal dialysis
5058912|NCT03630757|Pain|pain
5058913|NCT03630744|fluid theraphy|fluid theraphy
5058914|NCT03630744|surgical procedures|surgical procedures
5058915|NCT03630744|adult patients|adult patients
5058916|NCT03630744|glycocalyx|glycocalyx
5058917|NCT03630744|practice guideline|practice guideline
5058918|NCT03630718|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
5058920|NCT03630718|Cholangitis|cholangitis
5058921|NCT03630718|Hypnosis|hypnosis
5058922|NCT03630718|Psychological treatment|psychological treatment
5058923|NCT03630692|kidney cancer,|kidney cancer,
5059071|NCT03629691|PFS|pfs
5059123|NCT03629353|airway management|airway management
5059124|NCT03629353|high flow nasal cannula|high flow nasal cannula
5059125|NCT03629353|laryngeal microsurgery|laryngeal microsurgery
5059126|NCT03629314|Opioid|opioid
5059127|NCT03629301|Obesity|obesity
5059128|NCT03629301|Overweight|overweight
5059129|NCT03629301|Lifestyle Intervention|lifestyle intervention
5059150|NCT03629262|Long-term Outcome|long-term outcome
5059151|NCT03629223|Tepotinib|tepotinib
5059152|NCT03629223|Pharmacokinetics|pharmacokinetics
5059241|NCT03628508|muscle tension|muscle tension
5059242|NCT03628508|alignment|alignment
5059243|NCT03628508|knee osteoarthritis|knee osteoarthritis
5059244|NCT03628508|loading|loading
5059245|NCT03628495|insert|insert
5059246|NCT03628495|pressure therapy|pressure therapy
5059247|NCT03628495|silicone gel|silicone gel
5059345|NCT03628066|Oncotype DX Breast Recurrence Score|oncotype dx breast recurrence score
5059346|NCT03628066|Open-Label|open-label
5059347|NCT03628053|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5059449|NCT03627494|Pharmacodynamics|pharmacodynamics
5059450|NCT03627494|Dose Escalation|dose escalation
5059451|NCT03627481|endoscopic sinus surgery|endoscopic sinus surgery
5059452|NCT03627429|temporomandibular arthritis|temporomandibular arthritis
5059453|NCT03627429|temporomandibular joint|temporomandibular joint
5059454|NCT03627429|rheumatoid arthritis|rheumatoid arthritis
5059455|NCT03627429|viscosupplementation|viscosupplementation
5059456|NCT03627429|hyaluronic acid|hyaluronic acid
5059457|NCT03627416|Hereditary spastic paraplegia|hereditary spastic paraplegia
5059458|NCT03627416|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5059459|NCT03627416|disturbed gait|disturbed gait
5059460|NCT03627416|Adrenomyeloneuropthy|adrenomyeloneuropthy
5059669|NCT03626103|mhealth|mhealth
5059863|NCT03624621|Major Depressive Disorder|major depressive disorder
5059864|NCT03624621|Cognitive Remediation|cognitive remediation
5059865|NCT03624621|Functioning|functioning
5059866|NCT03624621|Full Recovery|full recovery
5059867|NCT03624621|Functional Remediation|functional remediation
5059868|NCT03624595|Cardiac Surgery|cardiac surgery
5059869|NCT03624595|Cardiopulmonary Bypass|cardiopulmonary bypass
5059870|NCT03624595|Dexmedetomidine|dexmedetomidine
5059871|NCT03624595|Delirium|delirium
5059872|NCT03624595|Survival|survival
5308921|NCT02134275|young adult|young adult
5059873|NCT03624582|Cardiorespiratory fitness|cardiorespiratory fitness
5059874|NCT03624582|Sedentary behavior|sedentary behavior
5059946|NCT03624244|Aromatase inhibitors|aromatase inhibitors
5059947|NCT03624231|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5059948|NCT03624218|PTSD|ptsd
5059950|NCT03624218|PE|pe
5059951|NCT03624218|Prolonged Exposure|prolonged exposure
5059952|NCT03624192|Pediatric, Complex Skin Deformities|pediatric, complex skin deformities
5059953|NCT03624140|major pediatric surgery|major pediatric surgery
5059954|NCT03624140|hemoglobin measurement|hemoglobin measurement
5060147|NCT03622931|romiplostim|romiplostim
5060148|NCT03622931|nplate|nplate
5060150|NCT03622892|Non Invasive Prenatal Diagnosis|non invasive prenatal diagnosis
5060159|NCT03622827|high risk|high risk
5060248|NCT03622190|music students|music students
5060345|NCT03621644|Pancreatic Cancer|pancreatic cancer
5060346|NCT03621644|Radiation Therapy|radiation therapy
5060347|NCT03621644|SBRT|sbrt
5060348|NCT03621631|knee osteoarthritis|knee osteoarthritis
5060349|NCT03621631|Tai Chi|tai chi
5060350|NCT03621631|Biofeedback|biofeedback
5060351|NCT03621631|External Knee Adduction Moment|external knee adduction moment
5060352|NCT03621618|vasoactive medication|vasoactive medication
5060353|NCT03621618|dynamic arterial elastance|dynamic arterial elastance
5060354|NCT03621579|RNFLT|rnflt
5060355|NCT03621540|transcranial direct current stimulation|transcranial direct current stimulation
5060437|NCT03621111|Renin Angiotensin System Inhibitors (RASi)|renin angiotensin system inhibitors (rasi)
5060438|NCT03621111|Mineralocorticoid/aldosterone receptor antagonists|mineralocorticoid/aldosterone receptor antagonists
5060439|NCT03621098|Exercise|exercise
5060440|NCT03621072|Fluconazole|fluconazole
5061037|NCT03617484|Relapsed|relapsed
5061045|NCT03617393|Clinical Pathway|clinical pathway
5061046|NCT03617393|Diabetes|diabetes
5061047|NCT03617393|Pulmonary Infection|pulmonary infection
5061053|NCT03617341|Breast cancer|breast cancer
5061054|NCT03617341|brain metastases|brain metastases
5061055|NCT03617341|screening|screening
5061056|NCT03617341|brain MRI|brain mri
5061057|NCT03617328|peptide|peptide
5061058|NCT03617328|vaccine|vaccine
5061059|NCT03617328|adjuvant|adjuvant
5061060|NCT03617328|6MHP|6mhp
5061251|NCT03616015|intestinal dysbiosis|intestinal dysbiosis
5061252|NCT03616015|immune reconstitution|immune reconstitution
5061254|NCT03615989|Females|females
5061255|NCT03615989|Creatine|creatine
5061256|NCT03615989|Dairy|dairy
5061257|NCT03615989|Exercise|exercise
5061258|NCT03615976|arthroscopy|arthroscopy
5061259|NCT03615976|Patellofemoral Osteoarthritis|patellofemoral osteoarthritis
5061270|NCT03615911|vaccine|vaccine
5061271|NCT03615911|clinical phase 1|clinical phase 1
5061272|NCT03615911|modified vaccinia Ankara vector|modified vaccinia ankara vector
5061273|NCT03615911|MERS-CoV|mers-cov
5061274|NCT03615898|medication incidents reporting system errors morbidity Spain|medication incidents reporting system errors morbidity spain
5061275|NCT03615885|Montmorency Tart Cherry|montmorency tart cherry
5681204|NCT00574327|Role|role
5061276|NCT03615885|Anthocyanins|anthocyanins
5061376|NCT03615404|Pro00092868|pro00092868
5061377|NCT03615404|Landi|landi
5061378|NCT03615365|Capnography|capnography
5061379|NCT03615365|Diagnosis|diagnosis
5061380|NCT03615365|Breathlessness|breathlessness
5061381|NCT03615365|Exacerbations|exacerbations
5061382|NCT03615365|Device|device
5061383|NCT03615352|Endometrioma|endometrioma
5061384|NCT03615352|laparoscopy|laparoscopy
5061481|NCT03614871|Gingiva|gingiva
5061482|NCT03614871|Oral hygiene|oral hygiene
5061483|NCT03614871|Periodontitis|periodontitis
5061585|NCT03614169|HIS-pacing|his-pacing
5061586|NCT03614169|Biventricular pacing|biventricular pacing
5061587|NCT03614156|Depression|depression
5061588|NCT03614104|Mobile health technology|mobile health technology
5061589|NCT03614091|Paravertebral block|paravertebral block
5061590|NCT03614091|Erector spinae plane block|erector spinae plane block
5061592|NCT03614091|respirometer|respirometer
5061688|NCT03613298|rectal endometriosis|rectal endometriosis
5061689|NCT03613298|safety profile|safety profile
5061690|NCT03613298|Deep invasive endometriosis|deep invasive endometriosis
5061691|NCT03613298|Endometriosis, rectum|endometriosis, rectum
5061692|NCT03613272|thymoma|thymoma
5061693|NCT03613272|thymectomy|thymectomy
5061694|NCT03613272|Myasthenia Gravis|myasthenia gravis
5061780|NCT03612882|University Students|university students
5061781|NCT03612869|MPS IIIA|mps iiia
5061807|NCT03612739|AML|aml
5061981|NCT03611595|cabozantinib|cabozantinib
5061982|NCT03611556|MEDI9447|medi9447
5061983|NCT03611556|oleclumab|oleclumab
5061984|NCT03611556|immunotherapy|immunotherapy
5062043|NCT03611205|HPV|hpv
5062083|NCT03610958|overweight|overweight
5062084|NCT03610958|obesity|obesity
5062086|NCT03610919|multiple doses|multiple doses
5062292|NCT03609866|intracranial pressure increase|intracranial pressure increase
5062293|NCT03609866|chest physiotherapy|chest physiotherapy
5062294|NCT03609866|ventilated patients|ventilated patients
5062309|NCT03609788|pain sensitivity|pain sensitivity
5062310|NCT03609762|Musculoskeletal Problems|musculoskeletal problems
5319141|NCT02089230|AML|aml
5062311|NCT03609762|Health-Related Quality of Life|health-related quality of life
5062312|NCT03609762|Routine Measurement|routine measurement
5062313|NCT03609762|Randomized Controlled Trial|randomized controlled trial
5062314|NCT03609762|Clinical Outcomes|clinical outcomes
5062315|NCT03609710|Low rectal cancer|low rectal cancer
5062316|NCT03609710|Robotic surgery|robotic surgery
5062317|NCT03609710|Anastomotic leak|anastomotic leak
5062318|NCT03609697|Diabetes prevention|diabetes prevention
5062319|NCT03609697|Pre-diabetes|pre-diabetes
5062320|NCT03609697|Weight loss|weight loss
5062322|NCT03609697|Obesity|obesity
5062383|NCT03609385|stroke|stroke
5062482|NCT03608592|refractory acuter respiratory distress syndrome|refractory acuter respiratory distress syndrome
5062483|NCT03608592|mesenchymal stem cells|mesenchymal stem cells
5062484|NCT03608592|salvage therapy|salvage therapy
5062485|NCT03608566|severe asthma|severe asthma
5062486|NCT03608553|MRgFUS|mrgfus
5062487|NCT03608553|BBB|bbb
5062584|NCT03607994|HIRREM-SOP|hirrem-sop
5062585|NCT03607994|Sleep Deprivation|sleep deprivation
5062586|NCT03607968|Pelvic organ prolapse|pelvic organ prolapse
5062587|NCT03607968|Transvaginal mesh|transvaginal mesh
5062589|NCT03607929|ARE|are
5062689|NCT03607292|Ankle surgery|ankle surgery
5062690|NCT03607279|NGAL|ngal
5062691|NCT03607279|Prostatectomy|prostatectomy
5062692|NCT03607279|Acute kidney injury|acute kidney injury
5062693|NCT03607266|ibuprofen ,|ibuprofen ,
5062698|NCT03607253|foot|foot
5062901|NCT03605992|Randomized Controlled Trial|randomized controlled trial
5062902|NCT03605992|Protocol|protocol
5062903|NCT03605979|type 1 diabetes|type 1 diabetes
5062904|NCT03605979|hypoglycemia unawareness|hypoglycemia unawareness
5062905|NCT03605979|Insulin pump|insulin pump
5062906|NCT03605979|Continuous glucose monitoring systems|continuous glucose monitoring systems
5062999|NCT03605316|quality of life|quality of life
5063000|NCT03605290|total knee replacement|total knee replacement
5063001|NCT03605290|gait analysis|gait analysis
5063002|NCT03605290|PROMS|proms
5063003|NCT03605290|mechanical aligment|mechanical aligment
5063004|NCT03605290|kinematic alignment|kinematic alignment
5063009|NCT03605238|Neuromyelitis Optica Spectrum Disorder|neuromyelitis optica spectrum disorder
5063010|NCT03605238|aquaporin4-IgG|aquaporin4-igg
5063011|NCT03605238|CAR-T therapy|car-t therapy
5063012|NCT03605225|Android application|android application
5063013|NCT03605225|Anesthesia|anesthesia
5063330|NCT03603457|Economic assessment|economic assessment
5672828|NCT00610493|DCE|dce
5063331|NCT03603431|Healthy Volunteers|healthy volunteers
5063332|NCT03603431|MicroRNAs|micrornas
5063333|NCT03603431|Angiogenesis Inducing Agents|angiogenesis inducing agents
5063343|NCT03603210|drug coated balloons (DCB)|drug coated balloons (dcb)
5063344|NCT03603197|BP-C1|bp-c1
5063346|NCT03603197|Benzene polycarboxylic acids complex with cis-diammineplatinum(II)|benzene polycarboxylic acids complex with cis-diammineplatinum(ii)
5063360|NCT03603158|HERG|herg
5063441|NCT03602755|Spain|spain
5063442|NCT03602742|Atrial Fibrillation|atrial fibrillation
5063443|NCT03602742|Arrhythmias, Cardiac|arrhythmias, cardiac
5063444|NCT03602742|EZYPRO ECG Recorder|ezypro ecg recorder
5063445|NCT03602742|ECG monitor|ecg monitor
5063447|NCT03602742|14-day ECG monitor|14-day ecg monitor
5063448|NCT03602729|Breastfeeding|breastfeeding
5063548|NCT03602274|NAPQI|napqi
5063549|NCT03602222|LGBT mental health|lgbt mental health
5063550|NCT03602222|provider training in LGBT-affirmative clinical practice|provider training in lgbt-affirmative clinical practice
5063551|NCT03602209|implant-related infections|implant-related infections
5063552|NCT03602209|orthopaedics|orthopaedics
5063553|NCT03602209|implant removal|implant removal
5063554|NCT03602209|antibiotic duration|antibiotic duration
5063555|NCT03602209|outcome|outcome
5063556|NCT03602183|difficult airway|difficult airway
5063557|NCT03602183|endotracheal intubation|endotracheal intubation
5063558|NCT03602183|chest compression|chest compression
5063559|NCT03602183|physician|physician
5063565|NCT03602157|CD30|cd30
5063758|NCT03600987|left middle cerebral artery|left middle cerebral artery
5063759|NCT03600987|cerebrovascular accident (CVA)|cerebrovascular accident (cva)
5063760|NCT03600987|stroke|stroke
5063761|NCT03600935|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5063762|NCT03600922|Osteoarthritis|osteoarthritis
5063763|NCT03600922|Patellar resurfacing|patellar resurfacing
5063764|NCT03600922|Anterior knee pain|anterior knee pain
5063846|NCT03600233|NET|net
5063944|NCT03599713|Metastatic merkel cell carcinoma|metastatic merkel cell carcinoma
5063945|NCT03599713|anti-PD-1 antibody|anti-pd-1 antibody
5063946|NCT03599713|immunoglobulin G4 (IgG4) monoclonal antibody|immunoglobulin g4 (igg4) monoclonal antibody
5064043|NCT03598933|Cricopharyngeal botulinum toxin injection|cricopharyngeal botulinum toxin injection
5064044|NCT03598920|obesity|obesity
5064045|NCT03598920|bariatric medicine|bariatric medicine
5064046|NCT03598920|endoscopy treatment|endoscopy treatment
5064047|NCT03598920|body composition|body composition
5064048|NCT03598920|Adipokines|adipokines
5064049|NCT03598920|Ghrelin|ghrelin
5064050|NCT03598920|Quality of Life|quality of life
5064051|NCT03598920|nutrition status|nutrition status
5064052|NCT03598920|vitamins|vitamins
5325286|NCT02060799|prognosis|prognosis
5064145|NCT03598218|Hypofractionated Radiation|hypofractionated radiation
5064464|NCT03596346|Rapeseed|rapeseed
5064465|NCT03596346|Ingredient|ingredient
5064466|NCT03596346|Safety|safety
5064467|NCT03596346|Tolerability|tolerability
5064468|NCT03596307|Ashwagandha|ashwagandha
5064469|NCT03596307|Endurance|endurance
5064470|NCT03596307|VO2 max|vo2 max
5064471|NCT03596307|Glycowithanolides|glycowithanolides
5064472|NCT03596307|Shoden|shoden
5064473|NCT03596242|high blood pressure|high blood pressure
5064475|NCT03596242|text messaging|text messaging
5064476|NCT03596242|monitoring|monitoring
5064477|NCT03596229|carotid endarterectomy|carotid endarterectomy
5064478|NCT03596229|adverse cardiac events|adverse cardiac events
5064479|NCT03596177|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5064480|NCT03596177|Obesity|obesity
5064559|NCT03595709|HIV Infections|hiv infections
5064560|NCT03595631|neurodynamics|neurodynamics
5064561|NCT03595631|pain|pain
5064562|NCT03595592|Unilateral, HER2 positive|unilateral, her2 positive
5064563|NCT03595579|AXS-05|axs-05
5064564|NCT03595579|Major Depressive Disorder|major depressive disorder
5064565|NCT03595579|MDD|mdd
5064566|NCT03595579|Axsome|axsome
5064567|NCT03595579|NMDA Receptor|nmda receptor
5064568|NCT03595579|Depression|depression
5064569|NCT03595579|Dextromethorphan|dextromethorphan
5064570|NCT03595579|Bupropion|bupropion
5064571|NCT03595540|fasting-mimicking diet|fasting-mimicking diet
5064572|NCT03595540|cancer|cancer
5064573|NCT03595540|nutritional status|nutritional status
5064574|NCT03595540|body composition|body composition
5064575|NCT03595540|fasting|fasting
5064576|NCT03595527|Screening|screening
5064577|NCT03595527|Linkage to care|linkage to care
5064578|NCT03595475|Prodromal markers|prodromal markers
5064579|NCT03595475|Psychiatric disorders|psychiatric disorders
5064580|NCT03595475|α-synucleinopathy|α-synucleinopathy
5064581|NCT03595475|Family study|family study
5064582|NCT03595423|long-term survival|long-term survival
5064583|NCT03595423|bioprosthesis|bioprosthesis
5064584|NCT03595410|risk of recurrence|risk of recurrence
5064585|NCT03595410|Nomograms|nomograms
5064586|NCT03595410|Laryngeal cancer|laryngeal cancer
5064587|NCT03595384|Behavioral intervention|behavioral intervention
5064588|NCT03595371|Schnitzler|schnitzler
5064589|NCT03595345|delisting|delisting
5064590|NCT03595345|tumor-specific death|tumor-specific death
5064591|NCT03595345|Milan Criteria|milan criteria
5671042|NCT00617526|HIV|hiv
5672909|NCT00610168|tetanus|tetanus
5064592|NCT03595319|Hypotension|hypotension
5064593|NCT03595319|Sevoflurane|sevoflurane
5064627|NCT03595059|small cell lung cancer (SCLC)|small cell lung cancer (sclc)
5064631|NCT03595020|major depression disorder|major depression disorder
5064632|NCT03595020|functional near-infrared spectroscopy|functional near-infrared spectroscopy
5064633|NCT03595020|facial emotion recognition|facial emotion recognition
5064634|NCT03594916|Dysmenorrhea|dysmenorrhea
5064726|NCT03594253|regulation focused psychotherapy for children|regulation focused psychotherapy for children
5064829|NCT03593746|Cardiopulmonary Exercise Test|cardiopulmonary exercise test
5064830|NCT03593746|Rehabilitation|rehabilitation
5064849|NCT03593629|HIV|hiv
5064927|NCT03593187|HIV-1|hiv-1
5064928|NCT03593187|Lymphoma|lymphoma
5064929|NCT03593187|Gene therapy|gene therapy
5064931|NCT03593161|stem cell transplantation|stem cell transplantation
5064932|NCT03593161|allogeneic|allogeneic
5064933|NCT03593161|humor therapy|humor therapy
5064934|NCT03593161|distress|distress
5065030|NCT03592576|Compassionate Use|compassionate use
5065137|NCT03591991|Reperfusion Injury|reperfusion injury
5065138|NCT03591991|Microvascular protection|microvascular protection
5065139|NCT03591991|CI-AKI|ci-aki
5065140|NCT03591991|No-Reflow Phenomenon|no-reflow phenomenon
5065141|NCT03591978|Disease progression|disease progression
5065142|NCT03591978|Circulating Pulmonary Cells|circulating pulmonary cells
5065144|NCT03591952|Thoracentesis|thoracentesis
5065145|NCT03591926|SM04646|sm04646
5065232|NCT03591484|photodynamic therapy|photodynamic therapy
5065233|NCT03591484|bronchiectasis|bronchiectasis
5065234|NCT03591471|Children，|children，
5065238|NCT03591380|Donors, Living|donors, living
5065339|NCT03590652|Ninlaro|ninlaro
5065340|NCT03590652|Decadron|decadron
5065341|NCT03590639|Inflammatory Bowel Diseases|inflammatory bowel diseases
5065342|NCT03590639|disability|disability
5065343|NCT03590639|quality of life|quality of life
5065344|NCT03590639|IBD Disk|ibd disk
5065345|NCT03590639|IBD-Disability Index|ibd-disability index
5065346|NCT03590639|Patient-Reported Outcomes|patient-reported outcomes
5065354|NCT03590613|Sentinel-dosing|sentinel-dosing
5065355|NCT03590613|GSK2982772|gsk2982772
5065356|NCT03590613|Japnese|japnese
5065357|NCT03590613|Dose-ascending|dose-ascending
5065358|NCT03590613|Crossover|crossover
5065359|NCT03590613|Healthy|healthy
5065576|NCT03589352|gynaecological aftercare|gynaecological aftercare
5065577|NCT03589352|contraception|contraception
5065896|NCT03587129|platinum-refractory|platinum-refractory
5066011|NCT03586232|Bromelain|bromelain
5066012|NCT03586232|Body healing post op|body healing post op
5330163|NCT02039583|tobacco smoke pollution|tobacco smoke pollution
5066013|NCT03586232|Rhinoplasty Outcome Evaluation|rhinoplasty outcome evaluation
5066015|NCT03586219|Patient Education|patient education
5066016|NCT03586219|Opioid|opioid
5066017|NCT03586219|Medication Storage|medication storage
5066018|NCT03586219|Medication Disposal|medication disposal
5066019|NCT03586206|Clostridium difficile|clostridium difficile
5066038|NCT03585920|Fat|fat
5066101|NCT03585634|Family health|family health
5066199|NCT03585127|Virtual reality|virtual reality
5066200|NCT03585101|Hepatitis C virus|hepatitis c virus
5066201|NCT03585101|Endothelial function|endothelial function
5066202|NCT03585101|Cardiovascular disease risk|cardiovascular disease risk
5066203|NCT03585101|Metabolic disease|metabolic disease
5066204|NCT03585101|Inflammation|inflammation
5066205|NCT03585101|Insulin resistance|insulin resistance
5066206|NCT03585062|S-1|s-1
5066207|NCT03585062|Paclitaxel-albumin|paclitaxel-albumin
5066208|NCT03585062|Unresectable Pancreatic Cancer|unresectable pancreatic cancer
5066209|NCT03585062|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5066210|NCT03585010|anxiety disorders|anxiety disorders
5066288|NCT03584542|Substance-related Disorders|substance-related disorders
5066289|NCT03584542|Health Impact Assessment|health impact assessment
5066290|NCT03584516|Graft-versus-host-disease|graft-versus-host-disease
5066291|NCT03584516|itacitinib|itacitinib
5066297|NCT03584503|rhinoplasty|rhinoplasty
5066607|NCT03582605|antibiotics|antibiotics
5066608|NCT03582605|prophylaxis|prophylaxis
5066609|NCT03582605|temporary anchorage devices|temporary anchorage devices
5066610|NCT03582605|mini-screw implants|mini-screw implants
5066612|NCT03582605|MSIs|msis
5066613|NCT03582605|failure rate|failure rate
5066614|NCT03582592|Fluid distribution timetable|fluid distribution timetable
5066615|NCT03582592|Fluid restriction adherence|fluid restriction adherence
5066616|NCT03582592|End-Stage Kidney Disease|end-stage kidney disease
5066617|NCT03582592|Hemodialysis|hemodialysis
5066618|NCT03582592|Thirst|thirst
5066619|NCT03582592|Interdialytic Weight Gain|interdialytic weight gain
5066620|NCT03582592|Nursing|nursing
5066621|NCT03582527|osteosarcoma|osteosarcoma
5066702|NCT03581968|diabetes|diabetes
5066703|NCT03581968|type 1 diabetes|type 1 diabetes
5066704|NCT03581968|diabetes mellitus|diabetes mellitus
5066705|NCT03581968|pediatrics|pediatrics
5066706|NCT03581968|diabetes camp|diabetes camp
5066707|NCT03581955|biomarkers|biomarkers
5066709|NCT03581955|banana|banana
5671140|NCT00617058|metformin|metformin
5066710|NCT03581955|tomato|tomato
5066711|NCT03581955|urine|urine
5066712|NCT03581955|plasma|plasma
5066713|NCT03581955|intake|intake
5066714|NCT03581955|exposure|exposure
5066715|NCT03581955|metabolomics|metabolomics
5066716|NCT03581942|Copanlisib|copanlisib
5066717|NCT03581942|Ibrutinib|ibrutinib
5066719|NCT03581942|PCNSL|pcnsl
5066795|NCT03581409|antiplatelet preparation|antiplatelet preparation
5066797|NCT03581409|coil embolization|coil embolization
5066798|NCT03581396|Hydrops sacculaire|hydrops sacculaire
5735649|NCT00374192|Anxiety|anxiety
5066896|NCT03580720|Diaphragm weakness|diaphragm weakness
5066897|NCT03580694|Non-Small Cell Lung Cancer|non-small cell lung cancer
5066966|NCT03580213|ADL|adl
5066992|NCT03580148|arthritis|arthritis
5066993|NCT03580148|shoulder|shoulder
5066994|NCT03580135|pulpotomy|pulpotomy
5066995|NCT03580135|primary molars|primary molars
5067392|NCT03577730|Delirium on Emergence|delirium on emergence
5067393|NCT03577730|Depression|depression
5067394|NCT03577730|Anxiety|anxiety
5067395|NCT03577730|Anxiety Disorders|anxiety disorders
5067396|NCT03577730|Affect|affect
5067397|NCT03577691|Blood Disorders|blood disorders
5067398|NCT03577691|Hydroxyurea (HU)|hydroxyurea (hu)
5067399|NCT03577691|Decision Aid|decision aid
5067400|NCT03577678|Comminuted lateral clavicle fracture , New prosthesis,|comminuted lateral clavicle fracture , new prosthesis,
5067402|NCT03577652|Ticagrelor|ticagrelor
5067480|NCT03577119|Bioactive fatty acids|bioactive fatty acids
5067481|NCT03577119|Insulin sensitivity|insulin sensitivity
5067482|NCT03577119|Diet|diet
5067573|NCT03576677|Exercise capacity|exercise capacity
5067676|NCT03576066|HBV|hbv
5067677|NCT03576066|HBeAg-positive|hbeag-positive
5067678|NCT03576066|hepatitis B|hepatitis b
5067812|NCT03575299|MDR-TB|mdr-tb
5067813|NCT03575299|Allogeneic γδT cells|allogeneic γδt cells
5067814|NCT03575299|adoptive treatment|adoptive treatment
5067815|NCT03575286|Pregnancy|pregnancy
5067816|NCT03575286|Urine Testing|urine testing
5067818|NCT03575273|methadone|methadone
5068044|NCT03573778|domestic violence|domestic violence
5068046|NCT03573778|control|control
5068047|NCT03573778|nursing intervention|nursing intervention
5068048|NCT03573765|epidemiology|epidemiology
5068148|NCT03573271|skin laxity|skin laxity
5068149|NCT03573271|sagging skin|sagging skin
5068150|NCT03573232|Parkinson Disease|parkinson disease
5068151|NCT03573232|Pisa Syndrome|pisa syndrome
5068152|NCT03573232|Camptocormia|camptocormia
5068153|NCT03573232|Antecollis|antecollis
5068154|NCT03573232|Striatal deformities|striatal deformities
5068155|NCT03573219|Short-Wave Diathermy|short-wave diathermy
5068156|NCT03573219|Transient muscle pain|transient muscle pain
5068235|NCT03572647|Anaemia|anaemia
5068348|NCT03572036|Outcomes Assessment|outcomes assessment
5068349|NCT03572036|Sickle Cell Disease|sickle cell disease
5068350|NCT03572023|Acute coronary syndrome|acute coronary syndrome
5068459|NCT03571308|R-CHOP|r-chop
5068460|NCT03571308|Molecular Profiling|molecular profiling
5068461|NCT03571308|Chemoimmunotherapy|chemoimmunotherapy
5068462|NCT03571295|pediatric airway management|pediatric airway management
5068463|NCT03571295|learning curve|learning curve
5068464|NCT03571282|conbercept|conbercept
5068465|NCT03571282|circumscribed choroidal haemangioma|circumscribed choroidal haemangioma
5068466|NCT03571282|safety|safety
5068560|NCT03570450|recovery|recovery
5068561|NCT03570450|repair|repair
5068562|NCT03570450|stroke|stroke
5068563|NCT03570450|msesenchymal stem cell|msesenchymal stem cell
5068564|NCT03570450|regenerative|regenerative
5068565|NCT03570437|Endometrial|endometrial
5068566|NCT03570437|Cancer|cancer
5068567|NCT03570437|Paclitaxel|paclitaxel
5068568|NCT03570437|Cediranib|cediranib
5068569|NCT03570437|Olaparib|olaparib
5068663|NCT03569904|Viral bacterial pulmonary dysbiosis|viral bacterial pulmonary dysbiosis
5068767|NCT03569462|Men who have sex with men|men who have sex with men
5068769|NCT03569449|Family navigation|family navigation
5068770|NCT03569449|Family partners|family partners
5068771|NCT03569449|Multiphase optimization strategy (MOST)|multiphase optimization strategy (most)
5068772|NCT03569449|Pediatric Symptom Checklist-17|pediatric symptom checklist-17
5068773|NCT03569449|Survey of Wellbeing of Young children (SWYC)|survey of wellbeing of young children (swyc)
5068776|NCT03569410|peritoneal dialysis|peritoneal dialysis
5068862|NCT03568968|Mitochondria|mitochondria
5068863|NCT03568968|Nicotinamide Riboside|nicotinamide riboside
5068864|NCT03568955|assessment|assessment
5068865|NCT03568955|validation|validation
5068866|NCT03568955|prolonged grief disorder|prolonged grief disorder
5068867|NCT03568955|cross cultural|cross cultural
5068868|NCT03568955|questionnaire|questionnaire
5068869|NCT03568942|gepotidacin|gepotidacin
5068870|NCT03568942|GSK2140944|gsk2140944
5068871|NCT03568942|acute cystitis|acute cystitis
5068872|NCT03568942|pharmacokinetics|pharmacokinetics
5068875|NCT03568916|Safety|safety
5068964|NCT03568383|Multidrug Resistance|multidrug resistance
5068965|NCT03568383|Prevention|prevention
5068966|NCT03568383|Household Contact|household contact
5069068|NCT03567616|venetoclax|venetoclax
5069167|NCT03566849|Scapular dyskinesis|scapular dyskinesis
5069168|NCT03566849|Kinetic chain|kinetic chain
5069169|NCT03566836|Smart Watch|smart watch
5069170|NCT03566836|Garmin|garmin
5069171|NCT03566836|Wearable|wearable
5069209|NCT03566511|MRI|mri
5069272|NCT03565965|Gait disorders|gait disorders
5069404|NCT03565302|Proteome|proteome
5069405|NCT03565302|VO2max|vo2max
5069604|NCT03564067|TRD|trd
5069605|NCT03564067|tDCS|tdcs
5069606|NCT03564067|cCBT|ccbt
5069607|NCT03564067|Home-based tDCS-cCBT|home-based tdcs-ccbt
5069696|NCT03563495|stem cells.|stem cells.
5069697|NCT03563495|autogenous grafts.|autogenous grafts.
5069698|NCT03563456|structured exercise|structured exercise
5069699|NCT03563456|glycemic control|glycemic control
5069700|NCT03563456|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5069744|NCT03563170|HCC|hcc
5069790|NCT03562871|PD-1|pd-1
5069791|NCT03562871|PD-L1|pd-l1
5069792|NCT03562871|Programmed Cell Death 1|programmed cell death 1
5069793|NCT03562871|Chemotherapy|chemotherapy
5069794|NCT03562871|Pemetrexed|pemetrexed
5069795|NCT03562871|Carboplatin|carboplatin
5069796|NCT03562871|Pembrolizumab|pembrolizumab
5069797|NCT03562871|Immunotherapy|immunotherapy
5069798|NCT03562871|IO102|io102
5069885|NCT03562234|Colorectal Liver Metastases|colorectal liver metastases
5069886|NCT03562234|Obesity Related Cancer|obesity related cancer
5069887|NCT03562234|Chemotherapy|chemotherapy
5069890|NCT03562208|Diabetes Mellitus|diabetes mellitus
5069891|NCT03562208|Bone Marrow|bone marrow
5069892|NCT03562208|Transplant|transplant
5069893|NCT03562195|Eosinophilic inflammation|eosinophilic inflammation
5069894|NCT03562195|Mepolizumab|mepolizumab
5069895|NCT03562195|Asthma|asthma
5069896|NCT03562143|Iron|iron
5069897|NCT03562143|Deficiency|deficiency
5069898|NCT03562143|Anemia|anemia
5069899|NCT03562143|Supplementation|supplementation
5069900|NCT03562143|Pregnancy|pregnancy
5069901|NCT03562130|Teduglutide|teduglutide
5069902|NCT03562130|Short Bowel Syndrome|short bowel syndrome
5069903|NCT03562130|Parenteral nutrition|parenteral nutrition
5069904|NCT03562130|Intestinal failure|intestinal failure
5069905|NCT03562117|Child-Pugh classification|child-pugh classification
5069906|NCT03562117|Open label|open label
5069907|NCT03562117|Hepatic Impairment|hepatic impairment
5069908|NCT03562117|Gepotidacin|gepotidacin
5069909|NCT03562078|Tai Chi Quan|tai chi quan
5069910|NCT03562078|HbA1c|hba1c
5069911|NCT03562078|quality of life|quality of life
5069912|NCT03562052|Cancer|cancer
5069913|NCT03562052|Lung|lung
5070088|NCT03560908|dasatinib|dasatinib
5070089|NCT03560882|atorvastatin|atorvastatin
5070090|NCT03560882|p53|p53
5070091|NCT03560882|tumor resection|tumor resection
5070092|NCT03560869|Dehydration|dehydration
5070093|NCT03560843|MBSR, TBI, insomnia|mbsr, tbi, insomnia
5070094|NCT03560817|QALY|qaly
5070098|NCT03560804|olmesartan|olmesartan
5070188|NCT03560453|Support Intensity|support intensity
5070189|NCT03560440|Vancomycin|vancomycin
5070293|NCT03559907|early childhood|early childhood
5070294|NCT03559907|parent training|parent training
5070399|NCT03559127|pain|pain
5070400|NCT03559127|criotherapy|criotherapy
5070401|NCT03559127|cold irrigation|cold irrigation
5070407|NCT03559101|Hydration|hydration
5070408|NCT03559101|Plasma Volume|plasma volume
5070409|NCT03559101|Amino acids|amino acids
5070410|NCT03559101|Glucose|glucose
5070411|NCT03559101|Electrolytes|electrolytes
5070412|NCT03559101|Fluid Retention|fluid retention
5070413|NCT03559101|Aging|aging
5070497|NCT03558633|Paralaryngeal pressure|paralaryngeal pressure
5070498|NCT03558633|Intubation|intubation
5070499|NCT03558620|manual ventilation|manual ventilation
5070500|NCT03558581|Nursing Process|nursing process
5070501|NCT03558581|Nephrology Nursing|nephrology nursing
5070502|NCT03558581|Education Health|education health
5070503|NCT03558568|Parkinson's Disease|parkinson's disease
5070504|NCT03558568|Deep Brain Stimulation|deep brain stimulation
5070505|NCT03558568|Subthalamic Nucleus|subthalamic nucleus
5070507|NCT03558568|STN|stn
5070508|NCT03558568|Face|face
5070510|NCT03558568|Parkinson|parkinson
5070588|NCT03558100|obesity|obesity
5070589|NCT03558100|gait|gait
5070590|NCT03558100|bariatric surgery|bariatric surgery
5070591|NCT03558100|walking|walking
5070592|NCT03558100|obstacles|obstacles
5070593|NCT03558087|muscle-invasive|muscle-invasive
5070594|NCT03558074|Refractory wAMD|refractory wamd
5070689|NCT03557476|Lipid Profiles|lipid profiles
5070690|NCT03557476|Oxidative Stress|oxidative stress
5070691|NCT03557437|Helicobacter pylori Therapy|helicobacter pylori therapy
5070692|NCT03557424|Polyglucosamine|polyglucosamine
5070693|NCT03557424|Glucomannan|glucomannan
5070694|NCT03557424|Weight reduction|weight reduction
5070695|NCT03557424|Weight loss|weight loss
5070696|NCT03557424|without change in lifestyle|without change in lifestyle
5070711|NCT03557307|Asthma|asthma
5070787|NCT03556748|whole-body electromyostimulation|whole-body electromyostimulation
5070788|NCT03556735|Depression, unipolar|depression, unipolar
5070789|NCT03556735|Treatment resistant|treatment resistant
5070790|NCT03556735|PEMF|pemf
5673201|NCT00608920|SPECT|spect
5070791|NCT03556722|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5070792|NCT03556722|Transcranial Doppler|transcranial doppler
5070793|NCT03556722|Neuromodulation|neuromodulation
5070794|NCT03556722|Randomized Controlled Trials|randomized controlled trials
5070795|NCT03556722|Pain|pain
5070796|NCT03556722|Migraine prophylaxis|migraine prophylaxis
5070797|NCT03556722|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5070798|NCT03556722|Protocol|protocol
5070799|NCT03556696|general anesthesia|general anesthesia
5070800|NCT03556696|analgesia/nociception balance monitoring|analgesia/nociception balance monitoring
5070801|NCT03556696|expert system|expert system
5070803|NCT03556657|Music Therapy|music therapy
5070868|NCT03556332|Dexamethasone|dexamethasone
5070869|NCT03556332|Daratumumab|daratumumab
5070870|NCT03556332|salvage autologous hematopoietic cell transplantation|salvage autologous hematopoietic cell transplantation
5070871|NCT03556332|17-493|17-493
5070872|NCT03556319|Multiple Dosage|multiple dosage
5070873|NCT03556280|Dementia|dementia
5070874|NCT03556280|Alzheimer's Disease|alzheimer's disease
5070875|NCT03556280|Cognitive Impairment|cognitive impairment
5070876|NCT03556254|Helicobacter pylori infection|helicobacter pylori infection
5070877|NCT03556254|Genotypic resistance|genotypic resistance
5070878|NCT03556254|Antimicrobial susceptibility|antimicrobial susceptibility
5070879|NCT03556228|TrkA|trka
5070880|NCT03556228|NTRK1|ntrk1
5070881|NCT03556228|Thymic|thymic
5070882|NCT03556228|Pancreatic|pancreatic
5070883|NCT03556228|TNBC|tnbc
5070884|NCT03556215|otitis media with effusion|otitis media with effusion
5070885|NCT03556215|balloon tuboplasty|balloon tuboplasty
5070886|NCT03556215|Eustachian tube|eustachian tube
5070887|NCT03556215|Eustachian tube dysfunction|eustachian tube dysfunction
5070891|NCT03556176|Anxiety|anxiety
5070892|NCT03556176|Mood|mood
5070944|NCT03555773|mesenchymal stromal cells|mesenchymal stromal cells
5070945|NCT03555773|complex anal fistulas|complex anal fistulas
5070946|NCT03555773|micro-fragmented adipose tissue|micro-fragmented adipose tissue
5070947|NCT03555773|regenerative medicine|regenerative medicine
5070948|NCT03555747|Canine distalization|canine distalization
5070949|NCT03555747|Gingival crevicular fluid|gingival crevicular fluid
5070950|NCT03555747|Cytokines|cytokines
5071050|NCT03555162|Tool|tool
5071051|NCT03555162|fMRI|fmri
5071395|NCT03552939|diet|diet
5071396|NCT03552926|Small subcortical infarct|small subcortical infarct
5071397|NCT03552926|Cerebrovascular disorders|cerebrovascular disorders
5071398|NCT03552926|Neurocognitive and cardiovascular disorders|neurocognitive and cardiovascular disorders
5071399|NCT03552926|Disability|disability
5071400|NCT03552926|Dementia|dementia
5071401|NCT03552926|Stroke|stroke
5071402|NCT03552913|Enhanced Recovery After Surgery|enhanced recovery after surgery
5071403|NCT03552913|Fast track|fast track
5071404|NCT03552913|Surgery|surgery
5071405|NCT03552913|Hysterectomy|hysterectomy
5071406|NCT03552913|Left colectomy|left colectomy
5071407|NCT03552913|Total knee arthroplasty|total knee arthroplasty
5071408|NCT03552887|Adverse Event|adverse event
5071493|NCT03552250|Parenting Program|parenting program
5071494|NCT03552224|Evoked auditory nerve activity|evoked auditory nerve activity
5071495|NCT03552224|Hearing Loss|hearing loss
5071496|NCT03552224|Tinnitus|tinnitus
5071497|NCT03552211|Multiple Sclerosis|multiple sclerosis
5071498|NCT03552211|Progressive Multiple Sclerosis|progressive multiple sclerosis
5071499|NCT03552211|Biotin|biotin
5071500|NCT03552211|Relapse|relapse
5071501|NCT03552198|Air quality alerts|air quality alerts
5071502|NCT03552198|Health behaviour change|health behaviour change
5071503|NCT03552198|Adherence|adherence
5071504|NCT03552185|Neurogenic Dysphagia|neurogenic dysphagia
5071505|NCT03552185|Multiple Sclerosis|multiple sclerosis
5071506|NCT03552146|sedation|sedation
5071508|NCT03552133|rebreathe|rebreathe
5071587|NCT03551509|Rotator Cuff Tear|rotator cuff tear
5071588|NCT03551509|Large Rotator Cuff Tear|large rotator cuff tear
5071589|NCT03551509|Massive Rotator Cuff Tear|massive rotator cuff tear
5071591|NCT03551509|Extracellular Matrix|extracellular matrix
5071592|NCT03551509|ArthroFLEX|arthroflex
5071593|NCT03551483|Arts-based Intervention|arts-based intervention
5071594|NCT03551483|Mobile Health|mobile health
5071596|NCT03551470|robotic|robotic
5071673|NCT03551002|Direct acting antivirals|direct acting antivirals
5071674|NCT03551002|Hepatitis C modeling|hepatitis c modeling
5071675|NCT03550989|Environmental Aerosol Exposure|environmental aerosol exposure
5071760|NCT03550430|tinnitus intensity|tinnitus intensity
5071761|NCT03550430|tinnitus loudness|tinnitus loudness
5071762|NCT03550417|disease management|disease management
5071763|NCT03550417|best practice guidelines|best practice guidelines
5071764|NCT03550378|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5071766|NCT03550378|Renal Impairment|renal impairment
5071768|NCT03550352|Cannabinoids|cannabinoids
5071769|NCT03550352|HIV reservoir|hiv reservoir
5071770|NCT03550352|Microbiome|microbiome
5071772|NCT03550352|THC|thc
5071794|NCT03550261|CAH|cah
5071864|NCT03549975|stroke|stroke
5071865|NCT03549975|hand|hand
5071985|NCT03549351|multiparameter flow cytometry|multiparameter flow cytometry
5071986|NCT03549338|Metastatic Colorectal Cancer|metastatic colorectal cancer
5071987|NCT03549338|Colorectal Cancer|colorectal cancer
5071988|NCT03549338|Carcinoma|carcinoma
5071989|NCT03549338|Sym004|sym004
5071990|NCT03549338|futuximab|futuximab
5071991|NCT03549338|modotuximab|modotuximab
5071992|NCT03549325|Neisseria lactamica|neisseria lactamica
5071993|NCT03549325|healthy volunteers|healthy volunteers
5071994|NCT03549325|nasal inoculation|nasal inoculation
5071995|NCT03549325|colonisation|colonisation
5071997|NCT03549312|Hepatitis C|hepatitis c
5071998|NCT03549312|Methadone|methadone
5071999|NCT03549312|HIV/HCV Co-Infection|hiv/hcv co-infection
5072083|NCT03548714|Alcohol|alcohol
5072084|NCT03548714|Alcoholic|alcoholic
5072085|NCT03548714|Alcoholism|alcoholism
5072086|NCT03548714|Alcohol abuse|alcohol abuse
5072087|NCT03548714|Alcohol interaction|alcohol interaction
5072088|NCT03548714|Alcohol Use Disorder|alcohol use disorder
5072089|NCT03548714|Alcohol use|alcohol use
5072090|NCT03548714|Alcohol dependence|alcohol dependence
5072091|NCT03548714|Alcohol dependent|alcohol dependent
5072092|NCT03548714|Ethanol abuse|ethanol abuse
5072208|NCT03548012|Caregivers|caregivers
5072209|NCT03548012|Support Needs|support needs
5072307|NCT03547349|videogaming therapy|videogaming therapy
5072308|NCT03547349|incentive spirometry|incentive spirometry
5072309|NCT03547349|atelectases|atelectases
5072310|NCT03547310|EMG|emg
5072311|NCT03547310|Prosthesis control|prosthesis control
5072324|NCT03547258|AML|aml
5072503|NCT03546114|Sex and gender|sex and gender
5072504|NCT03546114|Patient preference|patient preference
5072505|NCT03546114|Osteopathic medicine|osteopathic medicine
5072741|NCT03544372|concussion, rugby, self-report, concussion history, reliability|concussion, rugby, self-report, concussion history, reliability
5072742|NCT03544359|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5072743|NCT03544359|functional magnetic resonance imaging (MRI)|functional magnetic resonance imaging (mri)
5072744|NCT03544346|brain health, professional athlete, retired, neuropsychological assessment|brain health, professional athlete, retired, neuropsychological assessment
5072746|NCT03544333|brain stimulation|brain stimulation
5072827|NCT03543865|American Indian|american indian
5073266|NCT03540927|Entrepreneurs|entrepreneurs
5073361|NCT03540368|Gastrointestinal bleeding|gastrointestinal bleeding
5073362|NCT03540368|Tranexamic acid|tranexamic acid
5073363|NCT03540368|Clinical trial|clinical trial
5073558|NCT03539094|Intermittent fasting|intermittent fasting
5073559|NCT03539094|western diet|western diet
5073560|NCT03539094|microbiome|microbiome
5073561|NCT03539081|Epidural Spinal Cord Stimulation|epidural spinal cord stimulation
5073562|NCT03539081|Muscle Sympathetic Nerve Activity|muscle sympathetic nerve activity
5073670|NCT03538613|Gene Therapy|gene therapy
5073671|NCT03538600|Blood|blood
5073672|NCT03538600|Microbiome Analysis|microbiome analysis
5073673|NCT03538600|Stool|stool
5073674|NCT03538600|Saliva|saliva
5073675|NCT03538600|Skin|skin
5073676|NCT03538587|Refractory Metastic Sarcoma|refractory metastic sarcoma
5073677|NCT03538587|Diffuse Intrinsic Pontine Glioma DIPG|diffuse intrinsic pontine glioma dipg
5073678|NCT03538587|Relapsed-Refractory Leukemia|relapsed-refractory leukemia
5073679|NCT03538587|Meditation|meditation
5073755|NCT03538067|percutaneous coronary intervention|percutaneous coronary intervention
5073757|NCT03538067|stent deployment|stent deployment
5073758|NCT03538067|stent expansion|stent expansion
5073769|NCT03538015|β-blocker|β-blocker
5073855|NCT03537521|urgent surgery|urgent surgery
5073856|NCT03537521|andexanet alpha|andexanet alpha
5073860|NCT03537495|tuberculous meningitis|tuberculous meningitis
5073865|NCT03537443|Childhood|childhood
5073970|NCT03536832|Cesarean Section; Complications|cesarean section; complications
5073971|NCT03536832|suture material|suture material
5073972|NCT03536806|Pharmacological cardioversion|pharmacological cardioversion
5073973|NCT03536806|Canrenone|canrenone
5073974|NCT03536793|Early detection of pancreatic cancer|early detection of pancreatic cancer
5073975|NCT03536793|Endo180|endo180
5074063|NCT03536273|pilates exercises|pilates exercises
5074064|NCT03536273|functional movement screen|functional movement screen
5074065|NCT03536273|posture|posture
5074066|NCT03536273|quality of life|quality of life
5074067|NCT03536247|bile duct stones|bile duct stones
5074281|NCT03534713|Paclitaxel|paclitaxel
5074282|NCT03534700|sacrococcygeal pilonidal disease|sacrococcygeal pilonidal disease
5074283|NCT03534687|RAGE|rage
5074284|NCT03534687|ADAM10|adam10
5074285|NCT03534687|Exercise|exercise
5074286|NCT03534687|sRAGE|srage
5074287|NCT03534635|metastatic melanoma|metastatic melanoma
5074288|NCT03534635|tumor microenvironment|tumor microenvironment
5074289|NCT03534635|pembrolizumab|pembrolizumab
5074290|NCT03534635|PD1|pd1
5074291|NCT03534596|cohort|cohort
5074292|NCT03534596|surgery|surgery
5074293|NCT03534596|adhesive small bowel obstruction|adhesive small bowel obstruction
5074294|NCT03534557|spirometry|spirometry
5074295|NCT03534544|artificial pancreas|artificial pancreas
5074296|NCT03534544|pediatric|pediatric
5074297|NCT03534544|parents|parents
5074582|NCT03532607|Chronic|chronic
5074583|NCT03532594|Protamine|protamine
5074584|NCT03532594|Heparin Antagonists|heparin antagonists
5074585|NCT03532594|Cardiopulmonary Bypass|cardiopulmonary bypass
5074586|NCT03532555|zinc|zinc
5074593|NCT03532503|pregnancy termination|pregnancy termination
5074594|NCT03532503|second trimester|second trimester
5074603|NCT03532464|Vaginal|vaginal
5074689|NCT03531905|diabetes|diabetes
5074690|NCT03531905|cholesterolemia|cholesterolemia
5074691|NCT03531905|type 2 diabetes|type 2 diabetes
5074692|NCT03531905|LDL-C|ldl-c
5074694|NCT03531905|diabetes mellitus|diabetes mellitus
5074695|NCT03531892|Ulcerative Colitis|ulcerative colitis
5074696|NCT03531892|Inflammatory Bowel Disease, Ulcerative Colitis Type|inflammatory bowel disease, ulcerative colitis type
5074697|NCT03531892|Colitis|colitis
5074698|NCT03531892|AJM300|ajm300
5074699|NCT03531840|DNA Mismatch Repair|dna mismatch repair
5074700|NCT03531840|BAP1|bap1
5074701|NCT03531840|BRCA|brca
5074702|NCT03531827|Androgen Receptor Antagonist|androgen receptor antagonist
5074703|NCT03531827|PSA|psa
5074704|NCT03531827|Hormonal Therapy|hormonal therapy
5074705|NCT03531827|Nanoparticle Drug|nanoparticle drug
5074706|NCT03531827|Antitumor|antitumor
5074770|NCT03531385|Behcet's disease|behcet's disease
5074771|NCT03531385|Central sensitisation|central sensitisation
5074772|NCT03531385|Neuropathic pain|neuropathic pain
5075003|NCT03529877|Skin Diseases, Genetic|skin diseases, genetic
5075004|NCT03529877|Somatic Cell Therapy|somatic cell therapy
5075102|NCT03529409|Drug Use|drug use
5075103|NCT03529396|G6PD deficiency|g6pd deficiency
5075104|NCT03529396|Acute hemolytic anemia|acute hemolytic anemia
5075105|NCT03529396|Vivax malaria|vivax malaria
5075106|NCT03529396|Primaquine|primaquine
5075107|NCT03529396|Weekly primaquine|weekly primaquine
5075108|NCT03529396|Chloroquine|chloroquine
5075322|NCT03528044|Cognition|cognition
5075323|NCT03528044|Working memory|working memory
5075324|NCT03528044|Grey matter|grey matter
5075325|NCT03528044|GLP-1|glp-1
5075326|NCT03528044|Inflammation|inflammation
5075327|NCT03528044|Stress|stress
5075328|NCT03528044|Follow-up|follow-up
5075329|NCT03528044|Psychiatric|psychiatric
5075330|NCT03528018|Virtual Reality|virtual reality
5075331|NCT03528018|Rehabilitation|rehabilitation
5075334|NCT03528005|Multimorbid|multimorbid
5075409|NCT03527420|DNA methylation|dna methylation
5075410|NCT03527420|Exercise|exercise
5075411|NCT03527420|Weight loss|weight loss
5075412|NCT03527420|Bariatric|bariatric
5075413|NCT03527420|Macrovascular|macrovascular
5075414|NCT03527420|Microvascular|microvascular
5075415|NCT03527420|Epigenetics|epigenetics
5075416|NCT03527420|Adipose tissue|adipose tissue
5075523|NCT03526991|Freezing of Gait|freezing of gait
5075524|NCT03526991|Locomotion|locomotion
5367857|NCT01866943|Post Op|post op
5075525|NCT03526991|Spinal cord stimulation|spinal cord stimulation
5132858|NCT03162536|SLL|sll
5075634|NCT03526406|Flavonoid|flavonoid
5075635|NCT03526406|Grape Seed|grape seed
5075738|NCT03525795|Oncology|oncology
5075739|NCT03525795|EZH2 Inhibitor|ezh2 inhibitor
5075740|NCT03525782|CAR-T cell therapy|car-t cell therapy
5075742|NCT03525782|PD-1 Knockout|pd-1 knockout
5075826|NCT03525054|Prediction Of Psychosis|prediction of psychosis
5075827|NCT03525054|Machine Learning|machine learning
5076529|NCT03520933|Aneuploidy|aneuploidy
5075837|NCT03524976|endovascular treatment|endovascular treatment
5075838|NCT03524976|liquid embolization|liquid embolization
5075840|NCT03524950|dexmedetomidine|dexmedetomidine
5075841|NCT03524937|Delirium|delirium
5075842|NCT03524937|Mechanical ventilation|mechanical ventilation
5075843|NCT03524937|Intensive care unit|intensive care unit
5076050|NCT03523611|lung cancer|lung cancer
5076051|NCT03523611|Ventricular Failure|ventricular failure
5076052|NCT03523585|Breast Cancer|breast cancer
5076053|NCT03523585|Metastatic breast cancer|metastatic breast cancer
5076269|NCT03522272|cetylpyridinium chloride|cetylpyridinium chloride
5076270|NCT03522272|Staphylococcus aureus|staphylococcus aureus
5076271|NCT03522272|Gram negative bacilli|gram negative bacilli
5076604|NCT03520517|Lou-Gehrigs Disease|lou-gehrigs disease
5076605|NCT03520517|Lou Gehrig Disease|lou gehrig disease
5076606|NCT03520517|Riluzole|riluzole
5076607|NCT03520517|Rilutek®|rilutek®
5076608|NCT03520517|Neuroprotective Agents|neuroprotective agents
5076609|NCT03520517|Administration, Sublingual|administration, sublingual
5076610|NCT03520517|Administration, Oral|administration, oral
5076611|NCT03520517|Biological Availability|biological availability
5076612|NCT03520504|Proton Radiation|proton radiation
5076613|NCT03520504|craniospinal irradiation (CSI)|craniospinal irradiation (csi)
5076795|NCT03519334|Workplace|workplace
5076886|NCT03518606|Advanced solid tumours|advanced solid tumours
5076887|NCT03518606|Durvalumab|durvalumab
5076888|NCT03518606|Tremelimumab|tremelimumab
5076889|NCT03518606|Metronomic vinorelbine|metronomic vinorelbine
5077013|NCT03517878|Community Health Worker|community health worker
5077014|NCT03517878|Pregnancy|pregnancy
5077015|NCT03517878|Breast Feeding|breast feeding
5077016|NCT03517878|Child Development|child development
5077017|NCT03517878|Home Visits|home visits
5077018|NCT03517878|Infants|infants
5077019|NCT03517839|Dyspnea|dyspnea
5077518|NCT03515096|HSCT|hsct
5077056|NCT03517553|electrical muscle stimulation|electrical muscle stimulation
5077059|NCT03517540|NAFLD|nafld
5077060|NCT03517540|Fatty Liver Disease|fatty liver disease
5077061|NCT03517540|Liver|liver
5077062|NCT03517527|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5077168|NCT03517085|gene therapy|gene therapy
5077169|NCT03517085|von Gierke disease|von gierke disease
5077170|NCT03517085|glucose metabolism disorder|glucose metabolism disorder
5077171|NCT03517059|Levodopa|levodopa
5077172|NCT03517059|axial symptoms|axial symptoms
5077173|NCT03517046|Arthritis|arthritis
5077174|NCT03517046|Articular Cartilage|articular cartilage
5077260|NCT03516565|gingival crevicular fluid|gingival crevicular fluid
5077261|NCT03516539|Videolaryngoscopy|videolaryngoscopy
5077262|NCT03516526|natalizumab|natalizumab
5077263|NCT03516487|PKU|pku
5077264|NCT03516474|nir|nir
5077265|NCT03516474|diabetes|diabetes
5077266|NCT03516474|diabetic foot ulcer (DFU).|diabetic foot ulcer (dfu).
5077267|NCT03516474|wound|wound
5077268|NCT03516461|Gut Microbiota|gut microbiota
5077269|NCT03516461|Radiation Enteritis|radiation enteritis
5077270|NCT03516461|Selective Microbiota Transplantation|selective microbiota transplantation
5077355|NCT03516019|patient provider communication|patient provider communication
5077356|NCT03516019|smart watch|smart watch
5077357|NCT03516019|user engagement|user engagement
5077358|NCT03516019|population health data|population health data
5077359|NCT03515993|long-term survival|long-term survival
5077360|NCT03515993|gynecologic cancer|gynecologic cancer
5077471|NCT03515291|Scar|scar
5077472|NCT03515291|Fibrosis|fibrosis
5077473|NCT03515291|Cell|cell
5077574|NCT03514563|3D|3d
5077683|NCT03513926|Molecular profile|molecular profile
5077684|NCT03513913|in vitro fertilization|in vitro fertilization
5077685|NCT03513913|intracytoplasmic sperm injection|intracytoplasmic sperm injection
5077743|NCT03513601|PR|pr
5077904|NCT03512756|cancer|cancer
5077905|NCT03512756|low toxicity|low toxicity
5077906|NCT03512756|chemotherapy|chemotherapy
5077907|NCT03512756|metastatic|metastatic
5078015|NCT03512262|bone loss|bone loss
5078016|NCT03512197|Newly diagnosed FLT3-mutation negative|newly diagnosed flt3-mutation negative
5078017|NCT03512197|PKC412|pkc412
5078018|NCT03512197|midostaurin|midostaurin
5078019|NCT03512197|cytarabine|cytarabine
5078020|NCT03512197|daunorubicin|daunorubicin
5078021|NCT03512197|idarubicin|idarubicin
5078022|NCT03512197|acute myeloid leukemia|acute myeloid leukemia
5078023|NCT03512197|AML|aml
5078024|NCT03512197|FLT3-MN (SR<0.05)|flt3-mn (sr<0.05)
5078028|NCT03512197|EFS|efs
5078103|NCT03511729|outcomes|outcomes
5078104|NCT03511729|children|children
5078105|NCT03511716|Mitral Insufficiency|mitral insufficiency
5379380|NCT01815411|fatigue|fatigue
5078106|NCT03511716|Mitral Valve Incompetence|mitral valve incompetence
5078107|NCT03511690|Latinas, African Americans|latinas, african americans
5078191|NCT03511105|Pharmacodynamics|pharmacodynamics
5078192|NCT03511105|Healthy subjects|healthy subjects
5078193|NCT03511105|GSK2798745|gsk2798745
5078288|NCT03510468|Antiretrovial Therapy|antiretrovial therapy
5078289|NCT03510468|Human Immunodeficiency Virus|human immunodeficiency virus
5078290|NCT03510468|Latent Tuberculosis Infection (LTBI)|latent tuberculosis infection (ltbi)
5078291|NCT03510468|Drug-Drug Interaction|drug-drug interaction
5078292|NCT03510468|Rifamycin|rifamycin
5078294|NCT03510455|Fibroblast Growth Factor (FGF23)|fibroblast growth factor (fgf23)
5078296|NCT03510442|Inflammation|inflammation
5078297|NCT03510442|Fever|fever
5078298|NCT03510442|Arthritis|arthritis
5078299|NCT03510442|Sequencing|sequencing
5078300|NCT03510416|apatinib，TACE， hepatocellular carcinoma|apatinib，tace， hepatocellular carcinoma
5078301|NCT03510390|head and neck cancer|head and neck cancer
5078302|NCT03510390|tissue hypoxia|tissue hypoxia
5078303|NCT03510390|metformin|metformin
5078304|NCT03510364|Subjective social status|subjective social status
5078305|NCT03510364|Obesity|obesity
5078306|NCT03510364|High calorie intake|high calorie intake
5078307|NCT03510364|Energy balance|energy balance
5078308|NCT03510364|Eating behavior|eating behavior
5078309|NCT03510325|Schizophrenia; Antipsychotics；Cost-Effectiveness Analyses|schizophrenia; antipsychotics；cost-effectiveness analyses
5078310|NCT03510286|proteinuria|proteinuria
5078311|NCT03510286|preeclampsia|preeclampsia
5078312|NCT03510286|diagnostic|diagnostic
5078313|NCT03510286|dipstick|dipstick
5078314|NCT03510286|protein|protein
5078315|NCT03510286|urine|urine
5078316|NCT03510286|creatinine|creatinine
5078317|NCT03510273|Thermocoagulation|thermocoagulation
5078318|NCT03510273|Treatment|treatment
5078319|NCT03510273|Cervical precancer|cervical precancer
5078320|NCT03510260|Cesarean, Consent, Electronic, Satisfaction|cesarean, consent, electronic, satisfaction
5078321|NCT03510234|Pigmentary retinopathy|pigmentary retinopathy
5078322|NCT03510234|Argus II retinal prosthesis|argus ii retinal prosthesis
5078352|NCT03510026|arterial graft patency|arterial graft patency
5078353|NCT03510026|electrosurgery|electrosurgery
5078354|NCT03510026|arterial graft preparation|arterial graft preparation
5078355|NCT03510013|low flow anesthesia|low flow anesthesia
5078581|NCT03508336|swallowing|swallowing
5078691|NCT03507543|Advanced solid tumours|advanced solid tumours
5078692|NCT03507543|primary peritoneal Cancer|primary peritoneal cancer
5078693|NCT03507530|physiotherapy and rehabilitation|physiotherapy and rehabilitation
5078695|NCT03507530|quality of life|quality of life
5078696|NCT03507517|prevention|prevention
5078790|NCT03507140|hepatocellular carcinoma|hepatocellular carcinoma
5078791|NCT03507140|Liver transplantation|liver transplantation
5078792|NCT03507140|Microbiota|microbiota
5078793|NCT03507114|Rumination|rumination
5078794|NCT03507114|Cognitive behavioural therapy (CBT)|cognitive behavioural therapy (cbt)
5078795|NCT03507114|Depression|depression
5078796|NCT03507114|Anxiety|anxiety
5078797|NCT03507088|fulvestrant 500 mg|fulvestrant 500 mg
5078882|NCT03506477|skin diseases|skin diseases
5078883|NCT03506464|Plantar Fasciitis|plantar fasciitis
5079093|NCT03504995|Prostate Cancer|prostate cancer
5079097|NCT03504969|umbilical cord|umbilical cord
5079788|NCT03500601|Cognition|cognition
5079112|NCT03504904|Compassion|compassion
5079113|NCT03504865|Exparel|exparel
5079114|NCT03504865|Bupivacaine|bupivacaine
5079115|NCT03504852|psoriasis|psoriasis
5079116|NCT03504852|secukinumab|secukinumab
5079117|NCT03504852|immune-mediated systemic disease|immune-mediated systemic disease
5079118|NCT03504852|papules|papules
5079119|NCT03504852|plaques|plaques
5079120|NCT03504852|itching|itching
5079121|NCT03504839|defibrillator|defibrillator
5079122|NCT03504826|adaptive robotics|adaptive robotics
5079123|NCT03504826|locomotor training|locomotor training
5079124|NCT03504826|Spinal Cord diseases|spinal cord diseases
5079125|NCT03504826|walking rehabilitation|walking rehabilitation
5079126|NCT03504826|Spinal Cord Injury|spinal cord injury
5079127|NCT03504813|Elderly|elderly
5079209|NCT03504280|hypovitaminosis D|hypovitaminosis d
5079312|NCT03503747|type 1 diabetes|type 1 diabetes
5079422|NCT03503032|Total cavo-pulmonary connection|total cavo-pulmonary connection
5079423|NCT03503032|Fenestrated|fenestrated
5079424|NCT03503032|Congenital heart defects|congenital heart defects
5079425|NCT03503032|Pediatrics|pediatrics
5079426|NCT03502993|children|children
5079428|NCT03502980|Catheterization, Peripheral Venous|catheterization, peripheral venous
5079526|NCT03502109|Primary Care|primary care
5079527|NCT03502096|portion size|portion size
5079528|NCT03502096|food intake|food intake
5079529|NCT03502096|energy intake|energy intake
5079530|NCT03502096|food choice|food choice
5079531|NCT03502070|CF, Human Factors, TOBI® Podhaler™, user interface, IFU|cf, human factors, tobi® podhaler™, user interface, ifu
5079532|NCT03502044|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5079533|NCT03502044|Chronic Fatigue Syndrome|chronic fatigue syndrome
5079534|NCT03502044|Kinetic Oscillatory Stimulation in nasal cavity|kinetic oscillatory stimulation in nasal cavity
5079717|NCT03500965|pictorial warning labels|pictorial warning labels
5079718|NCT03500965|risk knowledge|risk knowledge
5079719|NCT03500965|emotion|emotion
5079720|NCT03500965|memory|memory
5079721|NCT03500965|risk perceptions|risk perceptions
5079722|NCT03500965|quit intentions|quit intentions
5079723|NCT03500913|Growth Hormone Deficiency|growth hormone deficiency
5079724|NCT03500913|Adipose Tissue|adipose tissue
5079725|NCT03500913|Inflammation|inflammation
5079933|NCT03499548|Male prisoners|male prisoners
5079934|NCT03499535|Risk Perception|risk perception
5079935|NCT03499522|Hemophilic arthropathy|hemophilic arthropathy
5079936|NCT03499522|Pain|pain
5079937|NCT03499522|Functional Disease Present|functional disease present
5079938|NCT03499522|Quality of life|quality of life
5079939|NCT03499522|Anxiety|anxiety
5079940|NCT03499522|Stress|stress
5079941|NCT03499522|Coping strategies|coping strategies
5079942|NCT03499496|plaques detection by ultrasound|plaques detection by ultrasound
5079943|NCT03499483|Post-Exposure-Prophylaxis|post-exposure-prophylaxis
5079944|NCT03499470|copd|copd
5079945|NCT03499470|exacerbation|exacerbation
5079946|NCT03499470|structured discharge|structured discharge
5079947|NCT03499470|readmission|readmission
5079948|NCT03499470|chronic respiratory failure|chronic respiratory failure
5079949|NCT03499457|Penicillin Allergy|penicillin allergy
5079950|NCT03499457|chalenge test|chalenge test
5079951|NCT03499457|primary clinic|primary clinic
5079952|NCT03499418|newborn|newborn
5079953|NCT03499418|TTN|ttn
5079954|NCT03499418|PPHN|pphn
5080012|NCT03499145|keratitis|keratitis
5080013|NCT03499145|pterygium|pterygium
5080014|NCT03499145|cataracts|cataracts
5080015|NCT03499132|anesthesia, obstructive sleep apnea|anesthesia, obstructive sleep apnea
5080016|NCT03499093|esthetics|esthetics
5080017|NCT03499093|orofacial esthetic scale|orofacial esthetic scale
5080018|NCT03499080|Medication free treatment, mental illness, outcome|medication free treatment, mental illness, outcome
5080019|NCT03499054|Breathing exercises|breathing exercises
5080107|NCT03498378|Metastatic Head and Neck Squamous Cell Carcinoma|metastatic head and neck squamous cell carcinoma
5080213|NCT03497689|treprostinil|treprostinil
5080214|NCT03497689|pulmonary arterial hypertension|pulmonary arterial hypertension
5080215|NCT03497689|PAH|pah
5080216|NCT03497689|Remodulin|remodulin
5080217|NCT03497689|Orenitram|orenitram
5005928|NCT03959696|colonoscopy|colonoscopy
5080218|NCT03497663|Familial high risk|familial high risk
5080219|NCT03497663|offspring|offspring
5080220|NCT03497663|schizophrenia|schizophrenia
5080221|NCT03497663|bipolar disorder|bipolar disorder
5080222|NCT03497663|recurrent depression|recurrent depression
5080223|NCT03497663|early intervention|early intervention
5080224|NCT03497663|parental training|parental training
5080229|NCT03497611|PPI|ppi
5080302|NCT03497156|Lercanidipine|lercanidipine
5080303|NCT03497143|Bariatric surgery|bariatric surgery
5080304|NCT03497143|Gastrointestinal tract|gastrointestinal tract
5080305|NCT03497143|Biological availability|biological availability
5080306|NCT03497143|Pharmacokinetics|pharmacokinetics
5080396|NCT03496623|6-Minute Walk Test|6-minute walk test
5080400|NCT03496571|Eosinophilic Gastritis|eosinophilic gastritis
5080403|NCT03496571|EG|eg
5080514|NCT03495921|First Relapse|first relapse
5080620|NCT03495375|Synbiotic2000Forte|synbiotic2000forte
5080621|NCT03495362|Yeast Beta-glucan|yeast beta-glucan
5080622|NCT03495362|Immune Function|immune function
5080623|NCT03495362|Prediabetes|prediabetes
5080624|NCT03495362|Gut Microbiota|gut microbiota
5080720|NCT03494751|Monitoring|monitoring
5080962|NCT03492775|GA101|ga101
5081052|NCT03492281|Urologic Diseases|urologic diseases
5081053|NCT03492281|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5081054|NCT03492281|Urological Agents|urological agents
5081055|NCT03492242|Anti-PD-1|anti-pd-1
5081056|NCT03492242|Anti-PD-L1|anti-pd-l1
5081057|NCT03492242|Anti-CTLA-4|anti-ctla-4
5081058|NCT03492242|Immune checkpoint inhibitors|immune checkpoint inhibitors
5081059|NCT03492242|Immune adverse drug reactions|immune adverse drug reactions
5081060|NCT03492229|Gait|gait
5924097|NCT04274985|Validity|validity
5924098|NCT04274985|Reliability|reliability
5924099|NCT04274985|Temporomandibular Joint Disorders|temporomandibular joint disorders
5924104|NCT04274933|Breast Cancer|breast cancer
5924105|NCT04274933|Metastatic|metastatic
5924106|NCT04274933|Locally Advanced|locally advanced
5924107|NCT04274933|Venetoclax|venetoclax
5924108|NCT04274933|Capecitabine|capecitabine
5924109|NCT04274933|Hormone Receptor Positive|hormone receptor positive
5924110|NCT04274933|HER2 Negative|her2 negative
5924111|NCT04274907|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5924112|NCT04274907|Cancer|cancer
5924113|NCT04274907|Venetoclax|venetoclax
5924114|NCT04274907|Pembrolizumab|pembrolizumab
5924115|NCT04274907|PD-L1 Expression|pd-l1 expression
5924116|NCT04274907|ABT-199|abt-199
5924117|NCT04274894|Hypogonadism|hypogonadism
5924118|NCT04274894|Testosterone Replacement Therapy|testosterone replacement therapy
5924119|NCT04274894|AndroGel|androgel
5924126|NCT04274855|Trait anxiety|trait anxiety
5924127|NCT04274855|Oral health|oral health
5924128|NCT04274855|Oral health status|oral health status
5924129|NCT04274855|Oral health outcomes|oral health outcomes
5924130|NCT04274855|Periodontal|periodontal
5924131|NCT04274855|Gingival|gingival
5924132|NCT04274855|Caries risk assessment|caries risk assessment
5924133|NCT04274855|Bruxism|bruxism
5924134|NCT04274855|Healthcare utilization|healthcare utilization
5924135|NCT04274855|Health care-seeking behavior|health care-seeking behavior
5924136|NCT04274855|Perceived oral health|perceived oral health
5924137|NCT04274842|Dynamic optical coherence tomography|dynamic optical coherence tomography
5924138|NCT04274842|facial telangiectasia|facial telangiectasia
5924139|NCT04274842|intense pulsed light|intense pulsed light
5924140|NCT04274842|blood vessel dimensions|blood vessel dimensions
5924141|NCT04274842|selective photothermolysis|selective photothermolysis
5924142|NCT04274816|Stage I-II melanoma|stage i-ii melanoma
5924143|NCT04274816|Anti-CTLA-4|anti-ctla-4
5924144|NCT04274816|Immunotherapy|immunotherapy
5924145|NCT04274816|Neoadjuvant|neoadjuvant
5924146|NCT04274777|Traumatic Brain Injury|traumatic brain injury
5924147|NCT04274777|Coagulation Disorder|coagulation disorder
5924155|NCT04274712|cfDNA|cfdna
5924163|NCT04274582|lipid profile|lipid profile
5924164|NCT04274582|aronia|aronia
5924165|NCT04274582|body composition|body composition
5924166|NCT04274569|Caries|caries
5924167|NCT04274569|Fluoride vanish|fluoride vanish
5924168|NCT04274569|Calcium phosphate|calcium phosphate
5924169|NCT04274569|Randomised clinical trial|randomised clinical trial
5924170|NCT04274569|Remineralisation|remineralisation
5924171|NCT04274543|Regenerative Medicine|regenerative medicine
5924172|NCT04274543|Knee Pain|knee pain
5924173|NCT04274543|Meniscus Tear|meniscus tear
5924174|NCT04274491|Recovery|recovery
5924263|NCT04273724|Geriatric oncology|geriatric oncology
5924264|NCT04273724|Comprehensive geriatric assessment|comprehensive geriatric assessment
5924265|NCT04273724|Patient-reported outcomes|patient-reported outcomes
5924266|NCT04273724|Muscle-invasive bladder cancer|muscle-invasive bladder cancer
5924267|NCT04273685|Early Psychosis|early psychosis
5924277|NCT04273594|permanent contraception|permanent contraception
5924278|NCT04273594|birth control|birth control
5924279|NCT04273594|pregnancy prevention|pregnancy prevention
5924280|NCT04273568|Proprioceptive Neuromuscular Facilitation|proprioceptive neuromuscular facilitation
5924281|NCT04273568|Shoulder pain|shoulder pain
5924282|NCT04273555|FDG-PET|fdg-pet
5924283|NCT04273555|MRI|mri
5924284|NCT04273555|quantitative imaging|quantitative imaging
5924285|NCT04273542|Breast cancer|breast cancer
5924286|NCT04273542|broadband spectroscopy laser|broadband spectroscopy laser
5924287|NCT04273542|liquid biospsies|liquid biospsies
5924288|NCT04273542|cancer screening|cancer screening
5924292|NCT04273477|MRI Radiomics|mri radiomics
5924293|NCT04273477|Artificial intelligence|artificial intelligence
5924294|NCT04273477|Locally advanced rectal cancer|locally advanced rectal cancer
5924295|NCT04273477|Pathologic complete response|pathologic complete response
5924296|NCT04273477|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5924297|NCT04273451|Radiopathomics features|radiopathomics features
5924298|NCT04273451|Artificial intelligence|artificial intelligence
5924299|NCT04273451|Locally advanced rectal cancer|locally advanced rectal cancer
5924300|NCT04273451|Tumor regression grading|tumor regression grading
5924301|NCT04273451|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5924305|NCT04273425|Pain|pain
5924306|NCT04273399|Crohn's Disease|crohn's disease
5924307|NCT04273399|Exercise|exercise
5924308|NCT04273399|Feasibility|feasibility
5924309|NCT04273386|Scleroderma|scleroderma
5924366|NCT04272606|Posterior Lumbar Interbody Fusion|posterior lumbar interbody fusion
5924367|NCT04272606|Transforaminal Lumbar Interbody Fusion|transforaminal lumbar interbody fusion
5924368|NCT04272606|Tranexamic Acid|tranexamic acid
5924369|NCT04272606|Neurosurgery|neurosurgery
5924386|NCT04272112|zirconia|zirconia
5924387|NCT04272112|crown|crown
5924388|NCT04272112|clinal trial|clinal trial
5924396|NCT04272060|coronary heart disease|coronary heart disease
5924397|NCT04272060|coronary angiography|coronary angiography
5924398|NCT04272060|CT angiography|ct angiography
5924399|NCT04272060|cardiac catheterization|cardiac catheterization
5924401|NCT04271995|nasogastric tube|nasogastric tube
5924402|NCT04271995|gastric lipase|gastric lipase
5924412|NCT04271722|cervical ripening|cervical ripening
5924413|NCT04271722|mifepristone|mifepristone
5924414|NCT04271722|balloon catheter|balloon catheter
5924430|NCT04271189|Type 2 diabetes|type 2 diabetes
5924431|NCT04271189|Polychemotherapy|polychemotherapy
5924432|NCT04271189|Diabetes remission|diabetes remission
5924438|NCT04270955|Subdural Hematoma|subdural hematoma
5924439|NCT04270955|Chronic Subdural Hematoma|chronic subdural hematoma
5924440|NCT04270955|Intracranial Hemorrhage|intracranial hemorrhage
5924445|NCT04270422|Pain|pain
5924446|NCT04270422|Disability|disability
5924447|NCT04270422|Pain catastrophising|pain catastrophising
5924448|NCT04270422|Quality of life|quality of life
5924449|NCT04270422|Fear of movement|fear of movement
5924450|NCT04270422|Chronic non specific low back pain|chronic non specific low back pain
5924451|NCT04270357|cholecystectomy|cholecystectomy
5924452|NCT04270357|middle income country|middle income country
5924453|NCT04270357|gallbladder|gallbladder
5924454|NCT04270357|laparoscopy|laparoscopy
5924467|NCT04269681|non invasive ventilation|non invasive ventilation
5924468|NCT04269681|high flow nasal cannula|high flow nasal cannula
5924469|NCT04269681|palliative|palliative
5924470|NCT04269681|dypnea|dypnea
5924471|NCT04269681|standard care|standard care
5924472|NCT04269681|do-not-intubate|do-not-intubate
5924473|NCT04269681|acute respiratory failure|acute respiratory failure
5924486|NCT04268732|biomarkers|biomarkers
5924487|NCT04268732|bacterial infection|bacterial infection
5924488|NCT04268732|viral infection|viral infection
5924489|NCT04268732|malarial infection|malarial infection
5924502|NCT04268121|Neoadjuvant treatment|neoadjuvant treatment
5924503|NCT04268121|Adjuvant treatment|adjuvant treatment
5924549|NCT04264624|Guided Biofilm Therapy|guided biofilm therapy
5924550|NCT04264624|Periodontitis|periodontitis
5924551|NCT04264624|Erythritol|erythritol
5924568|NCT04263922|Primary Glomerulonephritis|primary glomerulonephritis
5924569|NCT04263922|Huaiqihuang Granule|huaiqihuang granule
5924570|NCT04263922|CKD3|ckd3
5924571|NCT04263818|colonoscopy|colonoscopy
5924572|NCT04263818|tracking motion|tracking motion
5924584|NCT04262583|Chronic Heart Failure, adherence, registry|chronic heart failure, adherence, registry
5924645|NCT04256356|Newborns|newborns
5924646|NCT04256356|fermented milk|fermented milk
5924647|NCT04256356|innate immunity|innate immunity
5924693|NCT04254445|Personalized video training|personalized video training
5924694|NCT04254445|Thoracocentesis|thoracocentesis
5924695|NCT04254445|Pleural tap|pleural tap
5924709|NCT04253782|Community Healthcare|community healthcare
5924710|NCT04253782|Emergency Medicine|emergency medicine
5924711|NCT04253782|Addictions Recovery|addictions recovery
5924712|NCT04253782|Substance Abuse|substance abuse
5924713|NCT04253782|Opioid Overdose|opioid overdose
5924714|NCT04253535|Pregnancy|pregnancy
5924715|NCT04253535|Puerperium Recurrence|puerperium recurrence
5924716|NCT04253535|Cervical artery dissection|cervical artery dissection
5924717|NCT04253457|Pain VAS Score|pain vas score
5924718|NCT04253457|Corticosteroid injection|corticosteroid injection
5924719|NCT04253457|Local anaesthetic|local anaesthetic
5924720|NCT04252911|BIS|bis
5924721|NCT04252911|Intraoperative awareness|intraoperative awareness
5924748|NCT04250181|atrial fibrillation ablation|atrial fibrillation ablation
5924749|NCT04250181|high power radiofrequency ablation|high power radiofrequency ablation
5924866|NCT04239300|water birth|water birth
5924936|NCT04234451|Acupuncture|acupuncture
5924937|NCT04234451|sphenopalatine ganglion|sphenopalatine ganglion
5924938|NCT04234451|perennial allergic rhinitis|perennial allergic rhinitis
5924939|NCT04234451|neuropeptides|neuropeptides
5924940|NCT04234451|inflammatory cytokines|inflammatory cytokines
5924941|NCT04234451|neuro-immune interactions|neuro-immune interactions
5924946|NCT04233255|Ultrasound|ultrasound
5924947|NCT04233255|Muscle|muscle
5924948|NCT04233255|Electrophysiology|electrophysiology
5924949|NCT04233242|HIV-1|hiv-1
5924950|NCT04233242|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5924951|NCT04233242|drug resistance|drug resistance
5924952|NCT04233242|treatment failure|treatment failure
5924953|NCT04233242|child|child
5924954|NCT04233242|adolescent|adolescent
5924955|NCT04233242|Lesotho|lesotho
5924956|NCT04233242|Tanzania|tanzania
5925004|NCT04228094|eHealth|ehealth
5925005|NCT04228094|evidence based medicine|evidence based medicine
5925006|NCT04228094|machine learning|machine learning
5925038|NCT04225468|prevention|prevention
5925039|NCT04225468|opioid exposure|opioid exposure
5925040|NCT04225468|exposure reduction|exposure reduction
5925059|NCT04223804|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5925060|NCT04223804|HIV Infection|hiv infection
5925061|NCT04223804|HIV-1|hiv-1
5925062|NCT04223804|ABBV-181|abbv-181
5925063|NCT04223804|Analytical Treatment Interruption|analytical treatment interruption
5925064|NCT04223804|Budigalimab|budigalimab
5925065|NCT04223804|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
5925066|NCT04223804|Anti-PD-1 Antibody|anti-pd-1 antibody
5925067|NCT04223141|Robot|robot
5925075|NCT04222972|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5925076|NCT04222972|RET Lung|ret lung
5925077|NCT04222972|RET Mutation|ret mutation
5925078|NCT04222972|RET Alteration|ret alteration
5925079|NCT04222972|RET Positive|ret positive
5925080|NCT04222972|RET Inhibitor|ret inhibitor
5925081|NCT04222972|RET Altered|ret altered
5925082|NCT04222972|RET Rearrangement|ret rearrangement
5925083|NCT04222972|RET NSCLC|ret nsclc
5925084|NCT04222972|RET-Rearranged NSCLC|ret-rearranged nsclc
5925085|NCT04222972|RET Fusion|ret fusion
5925086|NCT04222972|RET Fusion Lung Cancer|ret fusion lung cancer
5925087|NCT04222972|M918T|m918t
5925088|NCT04222972|TRIM33-RET|trim33-ret
5925089|NCT04222972|Lung Cancer Mutation|lung cancer mutation
5925090|NCT04222972|BLU 667|blu 667
5925091|NCT04222972|Pralsetinib|pralsetinib
5925092|NCT04222972|RET Tyrosine Kinase|ret tyrosine kinase
5925093|NCT04222972|RET Gene Mutation|ret gene mutation
5925094|NCT04222972|RET Kinase|ret kinase
5925095|NCT04222972|Advanced Lung Cancer|advanced lung cancer
5925096|NCT04222972|Metastatic Lung Cancer|metastatic lung cancer
5925097|NCT04222972|KIF5B-RET|kif5b-ret
5925098|NCT04222972|CCDC6-RET|ccdc6-ret
5925109|NCT04222439|Deep Learning|deep learning
5925110|NCT04222439|Central Neural Networks|central neural networks
5925111|NCT04222439|Endoscopy|endoscopy
5925112|NCT04222439|Gastrointestinal Disease|gastrointestinal disease
5925121|NCT04221854|Colorectal cancer screening|colorectal cancer screening
5925122|NCT04221854|SDC2 DNA Methylation|sdc2 dna methylation
5925123|NCT04221854|Fecal immunochemical test|fecal immunochemical test
5925156|NCT04215848|asthma|asthma
5925157|NCT04215848|allergy|allergy
5925197|NCT04211337|medullary thyroid carcinoma|medullary thyroid carcinoma
5925198|NCT04211337|targeted therapy|targeted therapy
5925203|NCT04210661|word prediction|word prediction
5925204|NCT04210661|dysorthographia|dysorthographia
5925208|NCT04210115|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5925209|NCT04210115|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5925210|NCT04210115|Programmed Death-Ligand 2 (PDL2, PD-L2)|programmed death-ligand 2 (pdl2, pd-l2)
5925225|NCT04209569|SBCC|sbcc
5925226|NCT04209569|child wasting|child wasting
5925227|NCT04209569|aflatoxin|aflatoxin
5081061|NCT03492229|Brain stimulation|brain stimulation
5081062|NCT03492229|tDCS|tdcs
5081063|NCT03492229|Walking|walking
5081064|NCT03492203|Cognitive Remediation|cognitive remediation
5081065|NCT03492203|Neurocognition|neurocognition
5081066|NCT03492203|Severe mental illness|severe mental illness
5081067|NCT03492203|Remote treatment|remote treatment
5081068|NCT03492190|protein availability|protein availability
5081069|NCT03492190|beans|beans
5081070|NCT03492190|children|children
5081071|NCT03492190|elderly|elderly
5081074|NCT03492138|Multiple Myeloma|multiple myeloma
5081147|NCT03491735|glaucoma|glaucoma
5081148|NCT03491735|egypt|egypt
5081149|NCT03491735|india|india
5081150|NCT03491735|2018|2018
5081159|NCT03491683|Glioblastoma|glioblastoma
5925228|NCT04209569|coliform|coliform
5925229|NCT04209569|Uganda|uganda
5925238|NCT04208828|Gastroparesis|gastroparesis
5925239|NCT04208828|Nausea|nausea
5925240|NCT04208828|Vomiting|vomiting
5925241|NCT04208828|Abdominal Pain|abdominal pain
5925242|NCT04208828|Neuropathy|neuropathy
5925268|NCT04207086|Neoadjuvant therapy|neoadjuvant therapy
5925269|NCT04207086|Adjuvant therapy|adjuvant therapy
5925270|NCT04207086|Pembrolizumab|pembrolizumab
5925271|NCT04207086|Lenvatinib|lenvatinib
5925272|NCT04207086|Pathological response|pathological response
5925277|NCT04206826|prebiotics|prebiotics
5925380|NCT04197570|Opioid Free Anesthesia|opioid free anesthesia
5925381|NCT04197570|Cardiac Surgery|cardiac surgery
5925382|NCT04197570|Non-opioid Anesthesia|non-opioid anesthesia
5925383|NCT04197570|Dexmedetomidine|dexmedetomidine
5925384|NCT04197570|Hemodynamic|hemodynamic
5925385|NCT04197570|Opioid|opioid
5925386|NCT04197570|Fentanyl|fentanyl
5925387|NCT04197570|Cardiac Anesthesia|cardiac anesthesia
5673683|NCT00607334|Child Language|child language
5081160|NCT03491683|immunotherapy|immunotherapy
5081161|NCT03491683|DNA therapy|dna therapy
5081162|NCT03491683|checkpoint inhibitor|checkpoint inhibitor
5081163|NCT03491657|virtual reality pain|virtual reality pain
5081164|NCT03491657|opioid|opioid
5081165|NCT03491657|pediatric burn|pediatric burn
5081166|NCT03491657|wound care|wound care
5081167|NCT03491644|Traumatic accident|traumatic accident
5081168|NCT03491644|Oxygen|oxygen
5081169|NCT03491644|Intensive Care|intensive care
5081170|NCT03491644|Emergency|emergency
5081171|NCT03491618|lumbar facet joint pain|lumbar facet joint pain
5081172|NCT03491618|Lumbar Medial Branch Neurotomy|lumbar medial branch neurotomy
5081173|NCT03491618|Chronic Low Back Pain|chronic low back pain
5081262|NCT03491150|Mental Disorders|mental disorders
5925388|NCT04197570|Cardiopulmonary Bypass|cardiopulmonary bypass
5925389|NCT04197570|post sternotomy pain|post sternotomy pain
5925408|NCT04196491|Multiple Myeloma|multiple myeloma
5925409|NCT04196491|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5925411|NCT04196491|KarMMa-4|karmma-4
5925412|NCT04196491|Phase I|phase i
5925413|NCT04196491|NDMM|ndmm
5925414|NCT04196491|High Risk|high risk
5925415|NCT04196491|R-ISS III|r-iss iii
5925416|NCT04196491|KRd|krd
5925417|NCT04196491|RVd|rvd
5925418|NCT04196491|Dara-KRd|dara-krd
5925419|NCT04196491|Dara-RVd|dara-rvd
5925420|NCT04196491|CyBorD|cybord
5925421|NCT04196491|BCMA|bcma
5925430|NCT04194216|Rhinoplasty|rhinoplasty
5925431|NCT04194216|Antibiotic prophylaxis|antibiotic prophylaxis
5925432|NCT04193436|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5925433|NCT04193436|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5925450|NCT04192890|Prostate|prostate
5925495|NCT04190589|Robot|robot
5925496|NCT04190589|Hemicolectomy|hemicolectomy
5925497|NCT04190589|Cancer|cancer
5925505|NCT04189198|Articaine|articaine
5925506|NCT04189198|Bupivacaine|bupivacaine
5925507|NCT04189198|Ultrasound|ultrasound
5925508|NCT04189198|Supraclavicular block|supraclavicular block
5925522|NCT04187014|Total hip replacement|total hip replacement
5925523|NCT04187014|Oral tranexamic acid|oral tranexamic acid
5925524|NCT04187014|Oral aminocaproic acid|oral aminocaproic acid
5925525|NCT04187014|Blood loss|blood loss
5673725|NCT00607100|Band Atrophy|band atrophy
5081263|NCT03491137|Wireless monitoring, postoperative complications|wireless monitoring, postoperative complications
5081264|NCT03491111|Cerebrovascular disease|cerebrovascular disease
5081265|NCT03491111|respiratory muscle training|respiratory muscle training
5081266|NCT03491111|spirometry|spirometry
5081267|NCT03491111|peak flow|peak flow
5081269|NCT03491098|Otitis Media with Effusion|otitis media with effusion
5081352|NCT03490578|Robot-assisted gait training|robot-assisted gait training
5081354|NCT03490565|treatment tolerability|treatment tolerability
5081355|NCT03490565|treatment complications|treatment complications
5081356|NCT03490539|observational|observational
5081357|NCT03490539|comparative effectiveness|comparative effectiveness
5081358|NCT03490539|myasthenia gravis|myasthenia gravis
5081359|NCT03490500|protein S100B|protein s100b
5081360|NCT03490500|negative predictive value|negative predictive value
5081452|NCT03490071|Longstanding hip and groin pain|longstanding hip and groin pain
5081453|NCT03490071|Patient reported outcome|patient reported outcome
5081454|NCT03490058|pre-exposure prophylaxis|pre-exposure prophylaxis
5081455|NCT03490058|young women|young women
5925598|NCT04179292|Scleroderma|scleroderma
5925599|NCT04179292|Systemic sclerosis|systemic sclerosis
5925600|NCT04179292|Hand therapy|hand therapy
5925601|NCT04179032|Belimumab|belimumab
5925602|NCT04179032|Pediatric|pediatric
5925603|NCT04179032|Pharmacokinetics|pharmacokinetics
5925604|NCT04179032|Pharmacodynamics|pharmacodynamics
5925605|NCT04179032|Safety|safety
5925606|NCT04179032|Systemic lupus erythematosus|systemic lupus erythematosus
5925610|NCT04177303|Metformin|metformin
5925611|NCT04177303|Incretin hormones|incretin hormones
5925612|NCT04177303|Inflammation|inflammation
5925613|NCT04177303|Microbiome|microbiome
5081456|NCT03490058|delivery of health care|delivery of health care
5081457|NCT03490058|HIV infections/prevention|hiv infections/prevention
5081458|NCT03490045|Diaper Need|diaper need
5081459|NCT03490045|Well-Child Care|well-child care
5925673|NCT04172467|Secondary immunodeficiencies (SID)|secondary immunodeficiencies (sid)
5925674|NCT04172467|Chronic lymphocytic leukemia (CLL)|chronic lymphocytic leukemia (cll)
5925675|NCT04172467|Multiple myeloma (MM)|multiple myeloma (mm)
5925691|NCT04169854|Postoperative Pain|postoperative pain
5081460|NCT03490045|Infant Immunizations|infant immunizations
5081546|NCT03489564|Mitochondrial metabolism|mitochondrial metabolism
5081547|NCT03489564|Placenta|placenta
5081651|NCT03489057|care transition|care transition
5081652|NCT03489044|Alzheimer|alzheimer
5081653|NCT03489044|Seizure|seizure
5081654|NCT03489044|Epilepsy|epilepsy
5081655|NCT03489044|Anti-epileptic drug|anti-epileptic drug
5081745|NCT03488290|Parents|parents
5081842|NCT03487497|gait analysis|gait analysis
5081843|NCT03487497|electromyography|electromyography
5081844|NCT03487497|strength test|strength test
5081845|NCT03487497|walking|walking
5081846|NCT03487419|left atrial echocardiography|left atrial echocardiography
5081847|NCT03487419|new onset atrial fibrillation|new onset atrial fibrillation
5081848|NCT03487419|coronary artery bypass grafting|coronary artery bypass grafting
5925692|NCT04169854|Postcraniotomy Pain|postcraniotomy pain
5925693|NCT04169854|Lidocaine Patch|lidocaine patch
5925712|NCT04167501|cervical precancerous lesion|cervical precancerous lesion
5925713|NCT04167501|HPV|hpv
5925714|NCT04167501|vaccination|vaccination
5925715|NCT04167501|Impact study|impact study
5925716|NCT04167501|France|france
5925717|NCT04167475|Bifidobacterium longum 1714™|bifidobacterium longum 1714™
5925718|NCT04167475|probiotic|probiotic
5925719|NCT04167475|sleep quality|sleep quality
5925720|NCT04167475|PSQI|psqi
5925721|NCT04167475|actigraphy|actigraphy
5925722|NCT04167475|sleep latency|sleep latency
5925723|NCT04167475|sleep efficiency|sleep efficiency
5925744|NCT04125368|Maternal Nutrition|maternal nutrition
5925745|NCT04125368|Antenatal Care|antenatal care
5925746|NCT04125368|Ethiopia|ethiopia
5081849|NCT03487419|speckle tracking echocardiography|speckle tracking echocardiography
5081850|NCT03487393|facial nerve|facial nerve
5081851|NCT03487393|magnetic stimulation|magnetic stimulation
5082040|NCT03485898|mortality|mortality
5082041|NCT03485898|alzheimer's disease|alzheimer's disease
5082042|NCT03485898|longitudinal study|longitudinal study
5925773|NCT04121559|Adolescent Nutrition|adolescent nutrition
5925774|NCT04121559|Ethiopia|ethiopia
5925794|NCT04118764|focused ultrasound|focused ultrasound
5925795|NCT04118764|blood-brain barrier opening|blood-brain barrier opening
5925796|NCT04118764|non-invasive therapy|non-invasive therapy
5925816|NCT04112641|peripheral neuropathy|peripheral neuropathy
5925817|NCT04112641|chemotherapy|chemotherapy
5925818|NCT04112641|taxane|taxane
5925819|NCT04112641|platinum compound|platinum compound
5925842|NCT04111081|hemorrhoidectiomy|hemorrhoidectiomy
5925843|NCT04111081|postoperative pain|postoperative pain
5925844|NCT04111081|auricular pressure|auricular pressure
5082043|NCT03485885|anthocyanins, maqui berries, bioavailability|anthocyanins, maqui berries, bioavailability
5082058|NCT03485781|EEG|eeg
5082322|NCT03484156|Frailty|frailty
5082323|NCT03484156|Tele-monitoring|tele-monitoring
5082324|NCT03484156|Disability|disability
5082325|NCT03484143|Moderate to Severe Alzheimer's Disease,|moderate to severe alzheimer's disease,
5082326|NCT03484130|primary aldosteronism|primary aldosteronism
5082327|NCT03484104|Cardiopulmonary bypass|cardiopulmonary bypass
5082330|NCT03484091|Hyruan-One|hyruan-one
5082420|NCT03483454|exercise, fitness, sleep, children, obesity|exercise, fitness, sleep, children, obesity
5082421|NCT03483402|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
5082422|NCT03483402|Primary Open-angle Glaucoma|primary open-angle glaucoma
5082423|NCT03483402|Micropulse Laser Trabeculoplasty|micropulse laser trabeculoplasty
5082424|NCT03483402|Intraocular Pressure|intraocular pressure
5082425|NCT03483376|black stain|black stain
5082426|NCT03483376|dental plaque|dental plaque
5082427|NCT03483376|antimicrobial photodynamic therapy|antimicrobial photodynamic therapy
5082428|NCT03483376|curcumin|curcumin
5082429|NCT03483376|tooth discoloration|tooth discoloration
5886892|NCT04271215|Overweight|overweight
5082430|NCT03483337|(DW)-MRI|(dw)-mri
5082431|NCT03483337|oncological biomarkers|oncological biomarkers
5082432|NCT03483337|18-053|18-053
5082463|NCT03483103|NHL|nhl
5082521|NCT03482726|cyclist|cyclist
5082522|NCT03482726|modulation|modulation
5082523|NCT03482700|COPD; GP Surgeries|copd; gp surgeries
5082524|NCT03482687|adolescent behavior|adolescent behavior
5082525|NCT03482687|interpersonal relationships|interpersonal relationships
5082526|NCT03482687|intimate partner violence|intimate partner violence
5082527|NCT03482687|violence/prevention & control|violence/prevention & control
5082528|NCT03482687|program evaluation|program evaluation
5082529|NCT03482687|teen dating violence|teen dating violence
5082613|NCT03482128|coagulation|coagulation
5082614|NCT03482128|cardiac surgery|cardiac surgery
5082616|NCT03482115|traumatic brain injury|traumatic brain injury
5082617|NCT03482115|anoxic encephalopathy|anoxic encephalopathy
5926063|NCT04087681|Extraintestinal pathogenic Escherichia coli (ExPEC)|extraintestinal pathogenic escherichia coli (expec)
5926064|NCT04087681|Invasive ExPEC disease (IED)|invasive expec disease (ied)
5926065|NCT04087681|Pilot study|pilot study
5926091|NCT04084262|bunion|bunion
5926092|NCT04084262|supinating reduction|supinating reduction
5926093|NCT04084262|multi-plane|multi-plane
5926094|NCT04084262|lapidus|lapidus
5926095|NCT04084262|arthrodesis|arthrodesis
5926096|NCT04084262|intramedullary nail|intramedullary nail
5926097|NCT04084262|hallux valgus|hallux valgus
5886977|NCT04270591|MET|met
5926167|NCT04074044|Prevention|prevention
5926168|NCT04074044|Pregnancy|pregnancy
5926169|NCT04074044|Mobile Health App|mobile health app
5926170|NCT04074044|PEMAT questionnaire|pemat questionnaire
5082618|NCT03482115|brain connectome|brain connectome
5082619|NCT03482115|neuroinflammation|neuroinflammation
5082620|NCT03482115|prognosis|prognosis
5082621|NCT03482102|Hepatocellular Carcinoma|hepatocellular carcinoma
5082622|NCT03482102|Biliary Tract Cancer|biliary tract cancer
5082720|NCT03481491|Transcranial magnetic stimulation|transcranial magnetic stimulation
5082721|NCT03481491|Genetic dystonia|genetic dystonia
5082722|NCT03481478|occult|occult
5082820|NCT03480711|mitomycinC|mitomycinc
5082821|NCT03480698|acute ischemic stroke|acute ischemic stroke
5082822|NCT03480646|Phase 1/2|phase 1/2
5082823|NCT03480646|Oncology|oncology
5082824|NCT03480646|EZH2 Inhibitor|ezh2 inhibitor
5082938|NCT03479814|rectal cancer|rectal cancer
5082939|NCT03479814|neoadjuvant chemoradiation|neoadjuvant chemoradiation
5082943|NCT03479697|HIRREM|hirrem
5083054|NCT03479216|Injections, Intra-Articular|injections, intra-articular
5083055|NCT03479216|Magnesium|magnesium
5083056|NCT03479216|Pain, Postoperative|pain, postoperative
5083072|NCT03479060|MIDAS|midas
5083412|NCT03476902|OCD|ocd
5083441|NCT03476616|Hypertension|hypertension
5083754|NCT03474913|PSA|psa
5083755|NCT03474900|intramedullary nailing|intramedullary nailing
5083756|NCT03474900|randomised controlled trial|randomised controlled trial
5083757|NCT03474900|biodegradable|biodegradable
5083758|NCT03474900|children|children
5083759|NCT03474900|forearm shaft fractures|forearm shaft fractures
5083760|NCT03474887|Telemedicine|telemedicine
5083761|NCT03474887|Remote consultation|remote consultation
5083762|NCT03474887|Mobile health|mobile health
5083763|NCT03474887|Telehealth|telehealth
5083764|NCT03474887|mhealth|mhealth
5083765|NCT03474887|eVisits|evisits
5083877|NCT03474276|Prebiotic|prebiotic
5083878|NCT03474276|Randomized Controlled Trial|randomized controlled trial
5926279|NCT04066023|Episodic cluster headache|episodic cluster headache
5926280|NCT04066023|Chronic cluster headache|chronic cluster headache
5887239|NCT04267484|Technology|technology
5083879|NCT03474276|Pragmatic trial|pragmatic trial
5083880|NCT03474276|Azithromycin|azithromycin
5083881|NCT03474276|Cognitive impairment|cognitive impairment
5083882|NCT03474263|Motor Neurone Disease (MND)|motor neurone disease (mnd)
5083883|NCT03474263|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5083884|NCT03474237|algorithms|algorithms
5083885|NCT03474237|adrenal adenoma|adrenal adenoma
5083886|NCT03474237|cushing syndrome|cushing syndrome
5083887|NCT03474237|pheochromocytoma|pheochromocytoma
5083901|NCT03474159|stiffness|stiffness
5083979|NCT03473808|Physical Stimulation|physical stimulation
5083980|NCT03473795|Patient Outcomes|patient outcomes
5084094|NCT03473054|Cerebrovascular Accident|cerebrovascular accident
5084095|NCT03473054|Stress|stress
5084096|NCT03473054|Anxiety|anxiety
5084097|NCT03473054|Depression|depression
5084207|NCT03472482|Mild Cognitive Impairment|mild cognitive impairment
5084208|NCT03472430|Oocyte Retrieval|oocyte retrieval
5084209|NCT03472430|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5084335|NCT03471806|Magnetic Resonance|magnetic resonance
5084336|NCT03471806|Metabolic hormones|metabolic hormones
5084337|NCT03471767|Smoking cessation|smoking cessation
5084538|NCT03470389|Biofluid Mechanics|biofluid mechanics
5084542|NCT03470376|HIV|hiv
5084647|NCT03469791|Treatment|treatment
5084648|NCT03469791|Decompression alone|decompression alone
5084649|NCT03469791|Instrumented fusion|instrumented fusion
5084650|NCT03469791|Oswestry Disability Index|oswestry disability index
5084652|NCT03469778|rehabilitation|rehabilitation
5084653|NCT03469778|upper limb|upper limb
5084654|NCT03469778|motor activity|motor activity
5084655|NCT03469778|robotic|robotic
5084656|NCT03469765|AKI|aki
5084657|NCT03469752|Hispanic Latino families|hispanic latino families
5084658|NCT03469739|Intimate Partner Violence|intimate partner violence
5084659|NCT03469726|Liver metastases|liver metastases
5084660|NCT03469726|Diffusion weighted MRI|diffusion weighted mri
5084661|NCT03469674|Radiotherapy|radiotherapy
5084662|NCT03469674|Vaginal brachytherapy|vaginal brachytherapy
5084663|NCT03469674|Molecular risk factors|molecular risk factors
5084664|NCT03469622|Adenoma|adenoma
5084665|NCT03469622|Polyp|polyp
5084666|NCT03469622|EndoRings|endorings
5084667|NCT03469622|Colonoscopy|colonoscopy
5887342|NCT04262856|Non Small Cell Lung Cancer|non small cell lung cancer
5887343|NCT04262856|Lung Cancer|lung cancer
5887344|NCT04262856|NSCLC|nsclc
5887350|NCT04262531|Critical Illness|critical illness
5926320|NCT04059497|Craving|craving
5926321|NCT04059497|Smoking urge|smoking urge
5926322|NCT04059497|Withdrawal|withdrawal
5926323|NCT04059497|Nicotine|nicotine
5926324|NCT04059497|Exercise|exercise
5926325|NCT04059497|Isometric|isometric
5926326|NCT04059497|Handgrip|handgrip
5926356|NCT04055402|Alcohol|alcohol
5926393|NCT04052945|Acupuncture|acupuncture
5926394|NCT04052945|sphenopalatine ganglion|sphenopalatine ganglion
5926395|NCT04052945|seasonal allergic rhinitis|seasonal allergic rhinitis
5887351|NCT04262531|muscle|muscle
5887352|NCT04262531|mortality|mortality
5084668|NCT03469622|Endoscopic device|endoscopic device
5084669|NCT03469622|Colon cancer screening|colon cancer screening
5084670|NCT03469609|infants|infants
5084671|NCT03469609|necrotizing enterocolitis (NEC)|necrotizing enterocolitis (nec)
5084672|NCT03469609|focal intestinal perforation (FIP)|focal intestinal perforation (fip)
5084673|NCT03469609|enterostomy creation|enterostomy creation
5084681|NCT03469570|Non-Cardiac|non-cardiac
5084815|NCT03468699|liver cirrhosis|liver cirrhosis
5084817|NCT03468673|HCV|hcv
5084818|NCT03468673|Questionnaire|questionnaire
5084819|NCT03468673|Qualitative analysis|qualitative analysis
5084820|NCT03468673|Sexual Quality of Life|sexual quality of life
5084821|NCT03468673|Psychometric validation|psychometric validation
5084822|NCT03468660|Accented speech perception|accented speech perception
5084823|NCT03468647|frailty|frailty
5084824|NCT03468647|tele-monitoring|tele-monitoring
5084825|NCT03468647|self-management|self-management
5084826|NCT03468634|endoscopy|endoscopy
5084827|NCT03468634|Raman spectroscopy|raman spectroscopy
5084828|NCT03468621|woundclosure|woundclosure
5084829|NCT03468621|technique|technique
5084902|NCT03468036|critical illness|critical illness
5084903|NCT03468036|ICU|icu
5084904|NCT03468036|extubation|extubation
5084905|NCT03468036|respiratory failure|respiratory failure
5084906|NCT03468023|Cast treatment|cast treatment
5084907|NCT03468023|above-elbow cast|above-elbow cast
5084908|NCT03468023|below-elbow cast|below-elbow cast
5084909|NCT03468023|long arm cast|long arm cast
5084910|NCT03468023|short arm cast|short arm cast
5084911|NCT03467971|Metformin|metformin
5084912|NCT03467971|Bioavailability|bioavailability
5084913|NCT03467971|Food effect|food effect
5084923|NCT03467945|Metformin|metformin
5085021|NCT03467165|Hip|hip
5085119|NCT03466502|Recurrent Clostridium difficile infection|recurrent clostridium difficile infection
5085121|NCT03466476|Wearable Technology|wearable technology
5085122|NCT03466476|Total Knee Arthroplasty|total knee arthroplasty
5085123|NCT03466463|Crigler-Najjar|crigler-najjar
5085124|NCT03466463|Adeno Associated Virus|adeno associated virus
5085126|NCT03466450|glasdegib|glasdegib
5085304|NCT03465553|pain|pain
5085305|NCT03465553|quality of life|quality of life
5085306|NCT03465540|Multiple Myeloma|multiple myeloma
5085307|NCT03465540|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5085308|NCT03465540|Acute Myeloid Leukemia|acute myeloid leukemia
5085309|NCT03465540|AML|aml
5085310|NCT03465540|NHL|nhl
5085401|NCT03465085|Inhaled Anticoagulation|inhaled anticoagulation
5085402|NCT03465059|BGB-3111|bgb-3111
5085403|NCT03465059|Zanubrutinib|zanubrutinib
5085404|NCT03465059|pharmacokinetics|pharmacokinetics
5085405|NCT03465059|healthy subjects|healthy subjects
5085443|NCT03464708|HMB|hmb
5085494|NCT03464344|intracerebral hemorrhage|intracerebral hemorrhage
5085495|NCT03464344|cerebral amyloid angiopathy|cerebral amyloid angiopathy
5085496|NCT03464344|cortical superficial siderosis|cortical superficial siderosis
5085497|NCT03464344|Magnetic Resonance Imaging|magnetic resonance imaging
5085498|NCT03464318|idiopathic scoliosis|idiopathic scoliosis
5085499|NCT03464318|radiographs|radiographs
5085500|NCT03464318|low dose|low dose
5085501|NCT03464305|Colonic Neoplasms|colonic neoplasms
5085502|NCT03464305|Colorectal Neoplasms|colorectal neoplasms
5085898|NCT03461458|Degenerative Disc Disease|degenerative disc disease
5086015|NCT03460639|low-level laser|low-level laser
5086017|NCT03460626|pharmacy students|pharmacy students
5926396|NCT04052945|neuropeptides|neuropeptides
5926397|NCT04052945|inflammatory cytokines|inflammatory cytokines
5926398|NCT04052945|neuro-immune interactions|neuro-immune interactions
5926416|NCT04052035|follicle size|follicle size
5926417|NCT04052035|maturity|maturity
5926418|NCT04052035|euploid|euploid
5926465|NCT04047238|Dementia|dementia
5926466|NCT04047238|Cognitive Impairment|cognitive impairment
5887415|NCT04258176|outpatient|outpatient
5086018|NCT03460626|Saudi Arabia|saudi arabia
5086020|NCT03460561|Rectus sheath block|rectus sheath block
5086021|NCT03460561|Major abdominal cancer surgery|major abdominal cancer surgery
5086022|NCT03460535|Rythmia system|rythmia system
5086023|NCT03460496|preterm infants|preterm infants
5086024|NCT03460496|transition to home|transition to home
5086025|NCT03460496|advanced practice nurse|advanced practice nurse
5086026|NCT03460496|cost-analysis|cost-analysis
5086028|NCT03460444|Caspase 1|caspase 1
5086031|NCT03460444|MCT Oil|mct oil
5086103|NCT03460067|lumpectomy|lumpectomy
5086104|NCT03460015|COPD exacerbation|copd exacerbation
5086105|NCT03460015|Sevoflurane|sevoflurane
5086106|NCT03460015|Airway Resistance|airway resistance
5926467|NCT04047238|Cognitive Decline|cognitive decline
5926468|NCT04047238|Neurocognitive Disorders|neurocognitive disorders
5926470|NCT04047238|Reminiscence Therapy|reminiscence therapy
5926471|NCT04047238|Individual Intervention|individual intervention
5926472|NCT04047238|Cognition|cognition
5926473|NCT04047238|Depression|depression
5926474|NCT04047238|Quality of Life|quality of life
5926518|NCT04044391|Coronary Artery Disease|coronary artery disease
5926519|NCT04044391|Myocardial ischemia|myocardial ischemia
5926547|NCT04040894|Proptosis|proptosis
5926554|NCT04040335|overweight|overweight
5926555|NCT04040335|physical activity|physical activity
5926556|NCT04040335|sedentary|sedentary
5926557|NCT04040335|hispanic men|hispanic men
5086109|NCT03460002|Campaign|campaign
5086327|NCT03458676|AMRI|amri
5086328|NCT03458624|FURESTEM-AD Inj.|furestem-ad inj.
5086329|NCT03458624|Stem cells|stem cells
5086330|NCT03458585|ionising radiation|ionising radiation
5086331|NCT03458585|patient awareness|patient awareness
5086332|NCT03458585|patient knowledge|patient knowledge
5086333|NCT03458572|Caesarean section|caesarean section
5086334|NCT03458559|Bone metastases|bone metastases
5086337|NCT03458559|Survival|survival
5086420|NCT03458208|Cmax|cmax
5086421|NCT03458208|Pharmacokinetics|pharmacokinetics
5086550|NCT03457363|oxygen|oxygen
5086551|NCT03457363|nasal cannula|nasal cannula
5086552|NCT03457363|double trunk mask|double trunk mask
5086553|NCT03457363|hypoxia|hypoxia
5086554|NCT03457350|hysteroscopy|hysteroscopy
5086555|NCT03457350|cervical stenosis|cervical stenosis
5086556|NCT03457350|probing|probing
5086557|NCT03457324|JCM-16021|jcm-16021
5086558|NCT03457324|Trial|trial
5086559|NCT03457324|Irritable Bowel Syndrome|irritable bowel syndrome
5086560|NCT03457324|Chinese Medicine|chinese medicine
5086561|NCT03457311|GSP, oral galactose single point (OGSP)|gsp, oral galactose single point (ogsp)
5086562|NCT03457285|Ankylosing spondylitis; physiotherapy; Salaso|ankylosing spondylitis; physiotherapy; salaso
5086563|NCT03457272|Patient Safety|patient safety
5086564|NCT03457272|Risk Factors|risk factors
5086572|NCT03457194|Obesity|obesity
5086629|NCT03456791|Major epididymis specific protein E4|major epididymis specific protein e4
5086630|NCT03456778|Sonographic imaging|sonographic imaging
5086843|NCT03455062|Transplant, fertility|transplant, fertility
5480819|NCT01375764|Raised Cholesterol|raised cholesterol
5481256|NCT01373944|MPI|mpi
5086844|NCT03455036|whole body vibration, erythema, tryptase, unpleasantness|whole body vibration, erythema, tryptase, unpleasantness
5086845|NCT03455023|Cancer pain|cancer pain
5086846|NCT03455023|Pharmaceutical care|pharmaceutical care
5086894|NCT03454711|Obesity|obesity
5087285|NCT03452904|Restenosis|restenosis
5087287|NCT03452865|proton pump inhibitor|proton pump inhibitor
5087288|NCT03452865|esomeprazole|esomeprazole
5087501|NCT03451747|female|female
5087502|NCT03451643|colorectal cancer|colorectal cancer
5087503|NCT03451643|liver metastases|liver metastases
5087504|NCT03451643|stage IV|stage iv
5087505|NCT03451591|Cerebral Small Vessel Diseases|cerebral small vessel diseases
5087506|NCT03451591|Stroke, Lacunar|stroke, lacunar
5087507|NCT03451591|Dementia|dementia
5087508|NCT03451591|Alzheimer's disease|alzheimer's disease
5087509|NCT03451578|macular degeneration|macular degeneration
5087510|NCT03451578|blindness|blindness
5087612|NCT03450824|Anterior Knee Pain|anterior knee pain
5087721|NCT03449615|Sentinel node biopsy|sentinel node biopsy
5087722|NCT03449602|thoracoscopy|thoracoscopy
5087723|NCT03449602|pleuroscopy|pleuroscopy
5087724|NCT03449602|metastatic cancer|metastatic cancer
5087725|NCT03449602|lung cancer|lung cancer
5087726|NCT03449602|malignant pleural effusion|malignant pleural effusion
5087727|NCT03449602|tuberculosis|tuberculosis
5087728|NCT03449576|PTSD|ptsd
5087729|NCT03449576|neuroimaging|neuroimaging
5087730|NCT03449576|fMRI|fmri
5087731|NCT03449576|veterans|veterans
5087732|NCT03449576|exposure therapy|exposure therapy
5087733|NCT03449576|treatment|treatment
5087806|NCT03449082|allogeneic stem cell|allogeneic stem cell
5087808|NCT03449017|nicotine|nicotine
5087809|NCT03449017|alcohol|alcohol
5087810|NCT03449017|vape|vape
5087811|NCT03449017|electronic cigarette|electronic cigarette
5087812|NCT03449004|Validation|validation
5087813|NCT03449004|questionnaire|questionnaire
5087814|NCT03449004|satisfaction|satisfaction
5087815|NCT03449004|online information|online information
5087816|NCT03448991|NPO time|npo time
5087817|NCT03448991|Gastric content|gastric content
5087818|NCT03448991|Gastric pH|gastric ph
5087819|NCT03448978|Descartes-08|descartes-08
5087820|NCT03448978|CAR T Cell|car t cell
5087822|NCT03448978|CAR-T|car-t
5087823|NCT03448978|CAR T-Cell|car t-cell
5087905|NCT03448510|male|male
5673859|NCT00606502|PDX|pdx
5088017|NCT03447665|Infant behavioral sleep intervention|infant behavioral sleep intervention
5088019|NCT03447665|Pediatric insomnia|pediatric insomnia
5088020|NCT03447665|Infant night wakings|infant night wakings
5088021|NCT03447639|Catheter associated UTI|catheter associated uti
5088022|NCT03447639|Povidine iodine|povidine iodine
5088023|NCT03447639|Bladder Irrigation|bladder irrigation
5088024|NCT03447613|retinal nerve fiber layer|retinal nerve fiber layer
5088025|NCT03447613|cerebrospinal fluid Aβ and Tau|cerebrospinal fluid aβ and tau
5088026|NCT03447587|Randomized controlled trial|randomized controlled trial
5088027|NCT03447587|Sleep|sleep
5088119|NCT03447132|Luminal|luminal
5088548|NCT03444506|SAR|sar
5088329|NCT03445884|positron emission tomography|positron emission tomography
5088330|NCT03445884|nuclear medicine|nuclear medicine
5088331|NCT03445884|prognosis|prognosis
5088332|NCT03445871|Rheumatoid Arthritis|rheumatoid arthritis
5088333|NCT03445871|Methotrexate|methotrexate
5088334|NCT03445871|Erythrocyte polyglutamate|erythrocyte polyglutamate
5088335|NCT03445871|Compliance Questionnaire Rheumatology|compliance questionnaire rheumatology
5088336|NCT03445845|TNF blocker|tnf blocker
5088358|NCT03445598|anxiety|anxiety
5088429|NCT03445182|local anaesthesia|local anaesthesia
5088430|NCT03445182|dentalvibe|dentalvibe
5088432|NCT03445156|Violent video game|violent video game
5088521|NCT03444675|Transplantation; intestine|transplantation; intestine
5088522|NCT03444675|endoscopy|endoscopy
5088523|NCT03444675|severity score|severity score
5088524|NCT03444675|transplant rejection|transplant rejection
5088525|NCT03444675|transplant; complications|transplant; complications
5088527|NCT03444649|Epacadostat|epacadostat
5088528|NCT03444649|Idarubicin|idarubicin
5088529|NCT03444649|Cytarabine|cytarabine
5088530|NCT03444636|Multimodal analgesia|multimodal analgesia
5088531|NCT03444636|Thoracic epidural|thoracic epidural
5088532|NCT03444636|Postoperative pain|postoperative pain
5088616|NCT03444103|IL-6 blockade|il-6 blockade
5088735|NCT03443427|Non-typeable Haemophilus influenzae|non-typeable haemophilus influenzae
5088736|NCT03443427|Moraxella catarrhalis|moraxella catarrhalis
5088737|NCT03443427|Safety|safety
5088738|NCT03443427|Third vaccine dose|third vaccine dose
5088739|NCT03443427|Vaccination|vaccination
5088769|NCT03443310|DVT|dvt
5088831|NCT03442972|Duodenal biopsy|duodenal biopsy
5088832|NCT03442972|Gut Peptide|gut peptide
5088833|NCT03442972|Chylomicrons|chylomicrons
5088928|NCT03442348|Dietary intervention|dietary intervention
5088929|NCT03442348|Randomised Control Trial|randomised control trial
5089020|NCT03441867|Cognitive Behavioral Therapy|cognitive behavioral therapy
5089021|NCT03441867|Veterans|veterans
5089022|NCT03441867|Quality of Life|quality of life
5089024|NCT03441867|Convulsion, Non-Epileptic|convulsion, non-epileptic
5089141|NCT03440944|ultrasound guided IV|ultrasound guided iv
5089142|NCT03440918|Infection|infection
5089143|NCT03440892|survivin|survivin
5089144|NCT03440892|biomarker of pharmacological response|biomarker of pharmacological response
5089145|NCT03440892|antirheumatic treatment|antirheumatic treatment
5089379|NCT03439696|Thoracoscopy|thoracoscopy
5089381|NCT03439696|Needlescopy|needlescopy
5089382|NCT03439696|Uniportal|uniportal
5089383|NCT03439670|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5089384|NCT03439670|Vamorolone|vamorolone
5089385|NCT03439657|HZ|hz
5089386|NCT03439657|Safety|safety
5089387|NCT03439657|Immunogenicity|immunogenicity
5089388|NCT03439657|Shingles|shingles
5089389|NCT03439657|Adults|adults
5089390|NCT03439657|Prevenar 13|prevenar 13
5089391|NCT03439605|Troponin-T|troponin-t
5089475|NCT03439046|ER-positive|er-positive
5089476|NCT03439046|PR-positive|pr-positive
5089576|NCT03438383|bariatric surgery|bariatric surgery
5089577|NCT03438383|sham Bi-PAP|sham bi-pap
5089578|NCT03438383|sham BiPAP|sham bipap
5089579|NCT03438383|postoperative complications|postoperative complications
5089580|NCT03438331|Insomnia|insomnia
5089676|NCT03437798|Cardiovascular Risk Factor|cardiovascular risk factor
5089677|NCT03437798|Genomic|genomic
5089778|NCT03437278|Anti-IgE|anti-ige
5089779|NCT03437278|Chronic spontaneous urticaria,|chronic spontaneous urticaria,
5089780|NCT03437252|COPD|copd
5089781|NCT03437252|COPD exacerbation|copd exacerbation
5089782|NCT03437252|COPD AE|copd ae
5089783|NCT03437252|Physical activity|physical activity
5089784|NCT03437252|Wearable arm device|wearable arm device
5089785|NCT03437239|Bicep tenodesis|bicep tenodesis
5089786|NCT03437226|Heart Failure, Levosimendan|heart failure, levosimendan
5089787|NCT03437200|œsophageal cancer nivolumab ipilimumab|œsophageal cancer nivolumab ipilimumab
5089788|NCT03437174|Hypoparathyroidism|hypoparathyroidism
5089789|NCT03437174|Parathyroid Disease|parathyroid disease
5089790|NCT03437174|Burden of Illness|burden of illness
5682508|NCT00569231|Warts|warts
5089871|NCT03436719|Oral Antibiotic|oral antibiotic
5089872|NCT03436719|Antibiotic Prophylaxis|antibiotic prophylaxis
5089873|NCT03436693|Diabetic Nephropathy|diabetic nephropathy
5089874|NCT03436693|Canagliflozin|canagliflozin
5089876|NCT03436693|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5089877|NCT03436654|prostate cancer|prostate cancer
5089974|NCT03436147|pelvic organ prolapse quantification|pelvic organ prolapse quantification
5089975|NCT03436134|Donor-specific antibodies|donor-specific antibodies
5089978|NCT03436095|Bundle|bundle
5090086|NCT03435445|obesity|obesity
5090087|NCT03435445|overweight|overweight
5090088|NCT03435445|telemedicine|telemedicine
5090089|NCT03435445|ehealth|ehealth
5090196|NCT03434730|tocilizumab|tocilizumab
5090470|NCT03433534|antineoplastic agent|antineoplastic agent
5090471|NCT03433534|ELISA|elisa
5090472|NCT03433534|pharmacokinetic|pharmacokinetic
5090473|NCT03433521|Spatio-Temporal Diagnostic Pattern|spatio-temporal diagnostic pattern
5090474|NCT03433495|stroke|stroke
5090475|NCT03433495|aphasia|aphasia
5090476|NCT03433495|melodic intonation therapy|melodic intonation therapy
5090480|NCT03433456|obesity|obesity
5090564|NCT03432858|Prophylactic Antibiotics|prophylactic antibiotics
5090669|NCT03432117|respiratory rehabilitation|respiratory rehabilitation
5090670|NCT03432117|personalized mobile services|personalized mobile services
5090671|NCT03432091|melatonin|melatonin
5090672|NCT03432091|melatonin receptor agonist|melatonin receptor agonist
5090673|NCT03432091|circadian-clock-related genes|circadian-clock-related genes
5090675|NCT03432065|Anxiety|anxiety
5090889|NCT03430349|neurovirulence|neurovirulence
5090890|NCT03430349|novel polio vaccine candidates|novel polio vaccine candidates
5090891|NCT03430297|anti-PD-1 monoclonal antibody|anti-pd-1 monoclonal antibody
5090893|NCT03430297|Dacarbazine|dacarbazine
5090987|NCT03429777|Hearing Abnormalities|hearing abnormalities
5090988|NCT03429777|Tinnitus|tinnitus
5090989|NCT03429777|Hearing aids|hearing aids
5090990|NCT03429777|Cochlear implants|cochlear implants
5090991|NCT03429751|lung ultrasound, fluid, hysterectomy, B lines|lung ultrasound, fluid, hysterectomy, b lines
5090992|NCT03429738|Ibuprofen|ibuprofen
5090993|NCT03429738|phase-I-study|phase-i-study
5090994|NCT03429738|pharmacokinetic|pharmacokinetic
5090995|NCT03429738|combination therapy|combination therapy
5090996|NCT03429738|bioavailability|bioavailability
5090997|NCT03429738|bioequivalence|bioequivalence
5091099|NCT03429101|HER2 Positive|her2 positive
5091100|NCT03429101|T-DM1|t-dm1
5091111|NCT03429062|balance|balance
5091112|NCT03429062|gait|gait
5091113|NCT03429062|Multiple Sclerosis|multiple sclerosis
5091114|NCT03429036|Genomic DNA|genomic dna
5091115|NCT03429036|DNA Banking|dna banking
5091116|NCT03429036|Tissue Sample|tissue sample
5091117|NCT03429036|Saliva|saliva
5091118|NCT03429036|Blood Collection|blood collection
5091630|NCT03426046|Cariously exposed pulp|cariously exposed pulp
5091632|NCT03426046|Partial pulpotomy|partial pulpotomy
5091633|NCT03426046|Image J Software|image j software
5091634|NCT03426020|Premedication|premedication
5091635|NCT03426020|Pediatric patients|pediatric patients
5091636|NCT03426020|Emergence agitation|emergence agitation
5091637|NCT03426007|uterine lavage|uterine lavage
5091638|NCT03426007|intrauterine insemination|intrauterine insemination
5091639|NCT03426007|embryo|embryo
5091741|NCT03425214|Reward system|reward system
5091742|NCT03425214|REM sleep behaviour disorder|rem sleep behaviour disorder
5091743|NCT03425214|Narco-cataplexy|narco-cataplexy
5091744|NCT03425175|Non-relevant conversation|non-relevant conversation
5091748|NCT03425162|pain|pain
5091982|NCT03423784|oral gels|oral gels
5091983|NCT03423784|paediatric dentistry|paediatric dentistry
5091984|NCT03423758|Pseudoexfoliation Glaucoma, Angle block glaucoma, Genetic|pseudoexfoliation glaucoma, angle block glaucoma, genetic
5092088|NCT03423199|tamoxifen|tamoxifen
5092218|NCT03422536|Squamous Cell Carcinoma|squamous cell carcinoma
5092219|NCT03422536|lip carcinoma|lip carcinoma
5092220|NCT03422536|oral cavity carcinoma|oral cavity carcinoma
5092262|NCT03422367|asd|asd
5092322|NCT03421899|Mitochondria|mitochondria
5092323|NCT03421899|Mitochondrial dysfunction|mitochondrial dysfunction
5092324|NCT03421899|Parkin|parkin
5092423|NCT03421275|minor trauma|minor trauma
5092526|NCT03420417|Mechanical ventilation|mechanical ventilation
5092527|NCT03420391|phototherapy|phototherapy
5092528|NCT03420391|performance|performance
5092529|NCT03420391|muscular recovery|muscular recovery
5092530|NCT03420391|photobiomodulation therapy|photobiomodulation therapy
5926588|NCT04036968|Clinical Trial|clinical trial
5926590|NCT04036968|Phase II|phase ii
5926646|NCT04029220|Patient Navigation|patient navigation
5926647|NCT04029220|Mental Health Services|mental health services
5887884|NCT04222725|ocular|ocular
5092627|NCT03419767|melatonin|melatonin
5092929|NCT03417856|Ichthyosis|ichthyosis
5092930|NCT03417856|Netherton Syndrome|netherton syndrome
5092931|NCT03417843|ablation catheter|ablation catheter
5093212|NCT03416218|STEM Skills|stem skills
5093213|NCT03416192|Dialysis|dialysis
5093214|NCT03416192|MCO|mco
5093215|NCT03416192|Middle molecules|middle molecules
5093219|NCT03416166|Tricuspid Valve|tricuspid valve
5093220|NCT03416166|tricuspid regurgitation|tricuspid regurgitation
5093221|NCT03416166|transcatheter tricuspid regurgitation|transcatheter tricuspid regurgitation
5093222|NCT03416127|Diabetes Mellitus type 2|diabetes mellitus type 2
5926662|NCT04024826|resistance training|resistance training
5926663|NCT04024826|carbohydrate metabolism|carbohydrate metabolism
5926664|NCT04024826|fat oxidation|fat oxidation
5926681|NCT04021368|Acute Myeloid Leukemia|acute myeloid leukemia
5926682|NCT04021368|Myelodysplastic Syndrome|myelodysplastic syndrome
5926683|NCT04021368|CDK8/19 Inhibitor|cdk8/19 inhibitor
5926684|NCT04021368|SEL120|sel120
5926685|NCT04021368|Clinical Trial, Phase Ib|clinical trial, phase ib
5926692|NCT04020341|Gepotidacin, Phase 3, Urinary Tract Infection, Nitrofurantoin, Efficacy, Acute cystitis|gepotidacin, phase 3, urinary tract infection, nitrofurantoin, efficacy, acute cystitis
5926693|NCT04020328|Leflunomide|leflunomide
5926694|NCT04020328|Glucocorticoids|glucocorticoids
5926695|NCT04020328|Conservative Treatment|conservative treatment
5926696|NCT04020328|Glomerulonephritis, IGA|glomerulonephritis, iga
5926697|NCT04020328|Renal Insufficiency, Chronic|renal insufficiency, chronic
5887963|NCT04215406|pregnancy|pregnancy
5093304|NCT03415763|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
5888044|NCT04208334|Curcumin|curcumin
5093305|NCT03415750|Renal transplant|renal transplant
5093306|NCT03415698|Regenerative medicine|regenerative medicine
5093407|NCT03414853|Appendicitis, abdominal pain, free text prediction|appendicitis, abdominal pain, free text prediction
5093408|NCT03414840|coronary artery disease|coronary artery disease
5093443|NCT03414619|OCD|ocd
5093612|NCT03413579|Survival|survival
5093613|NCT03413579|Monoclonal antibody|monoclonal antibody
5093614|NCT03413579|RECIST|recist
5093615|NCT03413579|Cisplatin|cisplatin
5093705|NCT03413033|Semi-occluded vocal tract|semi-occluded vocal tract
5093707|NCT03413033|tongue trill|tongue trill
5093813|NCT03412357|pleurectomy/decortication|pleurectomy/decortication
5093814|NCT03412357|indwelling pleural catheter|indwelling pleural catheter
5093815|NCT03412344|clinical trial|clinical trial
5093816|NCT03412344|patient|patient
5093817|NCT03412344|questionnaire|questionnaire
5093834|NCT03412227|CBT|cbt
5093999|NCT03411174|hypofractionated partial breast irradiation|hypofractionated partial breast irradiation
5094000|NCT03411161|Mps1|mps1
5094001|NCT03411161|Mps1i|mps1i
5094002|NCT03411161|S81694|s81694
5094003|NCT03411161|breast cancer|breast cancer
5094004|NCT03411161|triple negative breast cancer|triple negative breast cancer
5094005|NCT03411161|phase I|phase i
5094006|NCT03411161|phase II|phase ii
5094007|NCT03411148|fear avoidance|fear avoidance
5094011|NCT03411148|fear of falling|fear of falling
5094089|NCT03410823|hip fracture|hip fracture
5094090|NCT03410823|exercise|exercise
5094091|NCT03410823|protein|protein
5094092|NCT03410810|Prematurity|prematurity
5094093|NCT03410810|Neuroimaging|neuroimaging
5094094|NCT03410797|SOVT|sovt
5094095|NCT03410797|semi occluded vocal tract|semi occluded vocal tract
5094096|NCT03410797|voice disorder|voice disorder
5094097|NCT03410797|voice therapy|voice therapy
5094098|NCT03410797|muscle tension dysphonia|muscle tension dysphonia
5094100|NCT03410797|vocal fold lesions|vocal fold lesions
5094101|NCT03410797|vocal fold atrophy|vocal fold atrophy
5094102|NCT03410784|PD-L1 Expression|pd-l1 expression
5094103|NCT03410784|prognostic factors|prognostic factors
5094104|NCT03410784|predictive factors|predictive factors
5094105|NCT03410784|Patient reported outcomes|patient reported outcomes
5094106|NCT03410771|Distribution Volume|distribution volume
5094107|NCT03410771|Antibiotics|antibiotics
5094108|NCT03410745|exercise|exercise
5094117|NCT03410706|Observation study|observation study
5094119|NCT03410680|Antiretroviral Therapy|antiretroviral therapy
5094121|NCT03410680|HIV|hiv
5094122|NCT03410680|Men who have sex with men|men who have sex with men
5094123|NCT03410680|Sexual minorities|sexual minorities
5094124|NCT03410680|habit-formation|habit-formation
5094125|NCT03410680|gamification|gamification
5094126|NCT03410641|cancer risk|cancer risk
5094127|NCT03410641|randomised trial|randomised trial
5094128|NCT03410641|intervention|intervention
5094171|NCT03410316|Epidemiology|epidemiology
5094172|NCT03410316|Etiology|etiology
5094173|NCT03410225|Pregnancy Prevention|pregnancy prevention
5094174|NCT03410225|Male Involvement|male involvement
5094175|NCT03410212|Inferior alveolar nerve block|inferior alveolar nerve block
5094176|NCT03410212|ketorolac|ketorolac
5094178|NCT03410160|adrenal crisis|adrenal crisis
5094198|NCT03409926|Diet|diet
5094289|NCT03409406|speech and language disorder|speech and language disorder
5094290|NCT03409406|mobile health technology|mobile health technology
5094398|NCT03408769|Partnership questionnaire (partnerschaftsfragebogen; PFB)|partnership questionnaire (partnerschaftsfragebogen; pfb)
5094399|NCT03408743|Multiphase optimization strategy|multiphase optimization strategy
5094400|NCT03408743|College students|college students
5094401|NCT03408730|Hepatitis B Vaccines|hepatitis b vaccines
5094407|NCT03408704|Streptococcus Pyogenes Infection|streptococcus pyogenes infection
5094408|NCT03408704|Randomized Controlled Trial|randomized controlled trial
5094409|NCT03408691|probiotic|probiotic
5094410|NCT03408691|permeability|permeability
5094411|NCT03408691|stress|stress
5094419|NCT03408639|End-Stage Renal Disease, Anemia, Erythropoietin, Hemoglobin|end-stage renal disease, anemia, erythropoietin, hemoglobin
5094420|NCT03408613|Obstructive Sleep Apnea|obstructive sleep apnea
5094502|NCT03408158|Blood disease|blood disease
5094503|NCT03408145|Stem Cell Therapy|stem cell therapy
5094505|NCT03408145|Hyaluronic Acid|hyaluronic acid
5094506|NCT03408145|Synovial Fluid|synovial fluid
5888145|NCT04200248|Fibrosis|fibrosis
5094507|NCT03408119|prune|prune
5094508|NCT03408119|dried plum|dried plum
5094509|NCT03408119|osteoporosis|osteoporosis
5094510|NCT03408119|osteopenia|osteopenia
5094597|NCT03407560|bone substitute|bone substitute
5094598|NCT03407560|spinal fusion|spinal fusion
5094599|NCT03407560|lumbar spine disease|lumbar spine disease
5094600|NCT03407547|upper limb|upper limb
5094601|NCT03407547|recovery|recovery
5094653|NCT03407196|BMI|bmi
5745047|NCT00339703|FIZZ|fizz
5094705|NCT03406962|myeloablative conditioning regimen|myeloablative conditioning regimen
5094706|NCT03406962|bone marrow transplant|bone marrow transplant
5094707|NCT03406962|mucopolysaccharidosis-1H|mucopolysaccharidosis-1h
5094708|NCT03406923|Health literacy|health literacy
5094709|NCT03406923|Self-efficacy|self-efficacy
5682742|NCT00567840|EBA|eba
5094714|NCT03406910|western diet|western diet
5094715|NCT03406910|type 2 diabetes|type 2 diabetes
5094716|NCT03406910|Adventist Health Study|adventist health study
5094798|NCT03406429|PPA|ppa
5094813|NCT03406182|stunting|stunting
5094912|NCT03405675|Medical morbidities|medical morbidities
5094913|NCT03405675|Falls|falls
5094918|NCT03405675|B12|b12
5095009|NCT03404960|DDR|ddr
5095108|NCT03404336|migraine|migraine
5095308|NCT03403049|carbon|carbon
5095309|NCT03403049|carbon ion|carbon ion
5095310|NCT03403049|ion|ion
5095313|NCT03403023|Dry Eye Disease|dry eye disease
5095314|NCT03403023|Tear Film Imager|tear film imager
5095406|NCT03402178|single ascending dose|single ascending dose
5095407|NCT03402178|multiple ascending dose|multiple ascending dose
5095540|NCT03401216|Optical coherence tomography|optical coherence tomography
5095541|NCT03401216|Healing score|healing score
5095542|NCT03401216|Neointimal coverage|neointimal coverage
5095543|NCT03401216|synergy 48|synergy 48
5095544|NCT03401216|long lesion|long lesion
5095546|NCT03401203|ROTA|rota
5095644|NCT03400592|Irinotecan|irinotecan
5095645|NCT03400592|Nimotuzumab|nimotuzumab
5095646|NCT03400592|biomarker|biomarker
5095647|NCT03400579|Emergency Medical Services|emergency medical services
5095648|NCT03400540|verbal instruction, pelvic diaphragm, muscle contraction|verbal instruction, pelvic diaphragm, muscle contraction
5095649|NCT03400514|Artificial intelligence|artificial intelligence
5095650|NCT03400514|concordance|concordance
5745048|NCT00339690|Asthma|asthma
5095651|NCT03400488|Coronary Artery Disease,|coronary artery disease,
5095652|NCT03400488|Cardiovascular disease (CAD),|cardiovascular disease (cad),
5095733|NCT03399760|i-PRF (injectable platelet rich fibrin)|i-prf (injectable platelet rich fibrin)
5095734|NCT03399760|alveolar bone height|alveolar bone height
5095735|NCT03399760|canine root resorption|canine root resorption
5095736|NCT03399760|bone density|bone density
5095741|NCT03399734|E2007|e2007
5095825|NCT03399175|Electroretinogram|electroretinogram
5095826|NCT03399149|Respiratory Insufficiency|respiratory insufficiency
5095836|NCT03399097|Obesity|obesity
5095944|NCT03398499|Light therapy|light therapy
5096032|NCT03397810|cardiac amyloidosis|cardiac amyloidosis
5096033|NCT03397810|radiotherapy|radiotherapy
5096034|NCT03397797|muscle relaxant|muscle relaxant
5096035|NCT03397784|Tidal volume challenge|tidal volume challenge
5096036|NCT03397784|Fluid responsiveness|fluid responsiveness
5096037|NCT03397784|Preload responsiveness|preload responsiveness
5096038|NCT03397784|Functional hemodynamic monitoring|functional hemodynamic monitoring
5096039|NCT03397784|Cardiac surgery|cardiac surgery
5096040|NCT03397784|inferior vena cava variation|inferior vena cava variation
5096041|NCT03397771|urinary incontinence, SSRI|urinary incontinence, ssri
5096110|NCT03397316|upper esthetic zone|upper esthetic zone
5096111|NCT03397316|marginal bone loss|marginal bone loss
5096112|NCT03397290|Chest X-ray|chest x-ray
5096113|NCT03397290|Ultrasound|ultrasound
5096114|NCT03397277|IPV|ipv
5096115|NCT03397238|myeloid cell|myeloid cell
5096116|NCT03397238|reprogramming|reprogramming
5096117|NCT03397238|monocyte|monocyte
5096118|NCT03397238|tumor-associated macrophage|tumor-associated macrophage
5096119|NCT03397212|NADA|nada
5096120|NCT03397173|Azacitidine|azacitidine
5096121|NCT03397173|Ascorbic Acid|ascorbic acid
5096122|NCT03397160|Prostate cancer|prostate cancer
5096252|NCT03396562|XYY|xyy
5926813|NCT04007770|Breast Cancer|breast cancer
5926814|NCT04007770|Colorectal Cancer|colorectal cancer
5926815|NCT04007770|Gynecologic Cancer|gynecologic cancer
5926816|NCT04007770|Acupuncture|acupuncture
5926817|NCT04007770|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5096253|NCT03396562|XXYY|xxyy
5096254|NCT03396562|XXXY|xxxy
5096255|NCT03396562|XXXXY|xxxxy
5096256|NCT03396562|sex chromosome variation|sex chromosome variation
5096595|NCT03394612|Skin|skin
5096596|NCT03394612|Wound Healing|wound healing
5096597|NCT03394612|Tissue Engineering|tissue engineering
5096598|NCT03394612|Dermis|dermis
5096690|NCT03394157|sleeve gastrectomy , MGB , type 2 diabetes , obesity , SASI|sleeve gastrectomy , mgb , type 2 diabetes , obesity , sasi
5096695|NCT03394079|OCT|oct
5096795|NCT03393520|Quinidine sulfate|quinidine sulfate
5096900|NCT03392974|Hemorrhagic Disorders|hemorrhagic disorders
5096901|NCT03392974|Genetic Diseases|genetic diseases
5096902|NCT03392974|Inborn|inborn
5096903|NCT03392974|Factor VIII|factor viii
5096904|NCT03392974|Coagulants|coagulants
5096933|NCT03392714|CSF|csf
5096991|NCT03392324|retina implant|retina implant
5096992|NCT03392324|retinal prosthesis|retinal prosthesis
5096993|NCT03392324|visual prosthesis|visual prosthesis
5096994|NCT03392324|macular degeneration|macular degeneration
5097119|NCT03391635|acupuncture|acupuncture
5097120|NCT03391635|functional constipation|functional constipation
5097121|NCT03391635|transcutaneous electric nerve stimulation|transcutaneous electric nerve stimulation
5097132|NCT03391583|Education|education
5097209|NCT03390972|Swallowing function|swallowing function
5097210|NCT03390972|Anesthetic sedation|anesthetic sedation
5097342|NCT03390114|HIV|hiv
5097612|NCT03388294|sensory|sensory
5097613|NCT03388294|early intervention|early intervention
5097614|NCT03388294|parent coaching|parent coaching
5097615|NCT03388281|Pacemaker|pacemaker
5097824|NCT03386929|axitinib|axitinib
5097825|NCT03386929|palbociclib|palbociclib
5097826|NCT03386929|dual matched normal and tumor biopsies|dual matched normal and tumor biopsies
5097827|NCT03386929|SIMS algorithm|sims algorithm
5097828|NCT03386929|Sequencing|sequencing
5097830|NCT03386916|Technology, Radiologic - Radiography, Interventional - Image-Guided Biopsy - Early Detection of Cancer - Carcinoma, Bronchogenic / diagnosis - Outpatients|technology, radiologic - radiography, interventional - image-guided biopsy - early detection of cancer - carcinoma, bronchogenic / diagnosis - outpatients
5097914|NCT03386279|healthy volunteers|healthy volunteers
5097918|NCT03386227|Assisted Reproductive Technology|assisted reproductive technology
5097919|NCT03386227|Antibiotic Prophylaxis|antibiotic prophylaxis
5097920|NCT03386227|Microbiome|microbiome
5097921|NCT03386201|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5097922|NCT03386201|Fluorescence|fluorescence
5097923|NCT03386162|Breast cancer, PI3K, alpelisib|breast cancer, pi3k, alpelisib
5098015|NCT03385733|inspiratory muscle training|inspiratory muscle training
5098016|NCT03385733|functional capacity|functional capacity
5098017|NCT03385733|physical activity|physical activity
5098018|NCT03385707|Post-bariatric hypoglycemia|post-bariatric hypoglycemia
5098020|NCT03385681|postoperative pain|postoperative pain
5098021|NCT03385681|pain assessment|pain assessment
5098022|NCT03385681|pain management|pain management
5098023|NCT03385681|knowledge|knowledge
5098139|NCT03384927|Treatment diary|treatment diary
5098140|NCT03384914|axillary nodes|axillary nodes
5098160|NCT03384810|CPR|cpr
5098239|NCT03384303|Gut hormones|gut hormones
5098240|NCT03384303|Limb lengths|limb lengths
5098241|NCT03384303|Biliopancreatic limb|biliopancreatic limb
5098446|NCT03383003|High dose Amoxicillin|high dose amoxicillin
5098451|NCT03382977|GBM|gbm
5098636|NCT03381820|Asian|asian
5098637|NCT03381820|stage-2 hypertension|stage-2 hypertension
5098641|NCT03381781|decitabine|decitabine
5098745|NCT03381066|NSCLC|nsclc
5098959|NCT03379701|chronic rhinosinusitis, nasal polyposis|chronic rhinosinusitis, nasal polyposis
5098960|NCT03379662|Autism|autism
5098961|NCT03379662|Autistic Disorder|autistic disorder
5098962|NCT03379662|Autistic Spectrum Disorder|autistic spectrum disorder
5099165|NCT03378193|Squamous cell carcinoma|squamous cell carcinoma
5099167|NCT03378193|Textural analysis|textural analysis
5099182|NCT03378154|King vision|king vision
5099183|NCT03378154|Difficult airway|difficult airway
5099184|NCT03378154|Videolaryngoscope|videolaryngoscope
5099185|NCT03378154|Paediatric intubation|paediatric intubation
5099186|NCT03378128|debulking surgery|debulking surgery
5099397|NCT03376945|Jaundice|jaundice
5099497|NCT03376399|Diabetic Gastroparesis|diabetic gastroparesis
5099498|NCT03376399|Bariatric Surgery Candidate|bariatric surgery candidate
5099689|NCT03375164|DMD|dmd
5099690|NCT03375164|dystrophin|dystrophin
5099691|NCT03375138|Healthy volunteers|healthy volunteers
5099692|NCT03375112|Total Hip Arthroplasty|total hip arthroplasty
5099693|NCT03375112|Fascia Iliaca|fascia iliaca
5099694|NCT03375112|Nerve Block|nerve block
5099695|NCT03375112|Pain Control|pain control
5099795|NCT03374371|Staphylococcus epidermidis Contamination|staphylococcus epidermidis contamination
5099797|NCT03374371|implanted material|implanted material
5099798|NCT03374345|Cold Hypersensitivity|cold hypersensitivity
5099799|NCT03374345|Korean medicine|korean medicine
5099800|NCT03374345|Sipjeondaebo-tang|sipjeondaebo-tang
5099801|NCT03374345|Cold intolerance|cold intolerance
5099802|NCT03374332|Refractory|refractory
5099803|NCT03374332|progression|progression
5099804|NCT03374332|recurrence|recurrence
5099875|NCT03373864|AKI|aki
5099894|NCT03373734|Online Cognitive Behavioural Therapy|online cognitive behavioural therapy
5099895|NCT03373734|Pregnancy|pregnancy
5099896|NCT03373734|Self-help|self-help
5100014|NCT03372941|Hospital avoidance|hospital avoidance
5100015|NCT03372941|Antibiotic therapy|antibiotic therapy
5100113|NCT03372083|Asunra|asunra
5100114|NCT03372083|Jadenu|jadenu
5100115|NCT03372083|Exjade|exjade
5100116|NCT03372083|ICL 670|icl 670
5100117|NCT03372083|Pediatric|pediatric
5100118|NCT03372070|primary snoring|primary snoring
5100119|NCT03372070|bed partner|bed partner
5100120|NCT03372070|home sleep testing|home sleep testing
5100121|NCT03372057|Lymphoma|lymphoma
5100122|NCT03372057|T-cell Lymphoma|t-cell lymphoma
5100123|NCT03372057|Relapse|relapse
5100124|NCT03372057|Refractory|refractory
5100125|NCT03372057|PI3K-δ,γ|pi3k-δ,γ
5100126|NCT03372044|Relative bioavailability|relative bioavailability
5100127|NCT03372044|Modified release|modified release
5100128|NCT03372044|Pharmacokinetics|pharmacokinetics
5100129|NCT03372031|Music Supported Therapy|music supported therapy
5100130|NCT03372031|plasticity|plasticity
5100143|NCT03371966|Nitrate|nitrate
5100203|NCT03371576|toric IOL|toric iol
5100205|NCT03371511|Microbiota|microbiota
5100206|NCT03371511|Microbiome|microbiome
5100207|NCT03371485|Non-small cell lung cancer|non-small cell lung cancer
5100208|NCT03371485|Immunotherapy|immunotherapy
5100209|NCT03371485|Cancer vaccine|cancer vaccine
5100210|NCT03371485|Dendritic cell vaccine|dendritic cell vaccine
5100211|NCT03371485|Allogeneic vaccine|allogeneic vaccine
5100212|NCT03371446|DNA Methylation. Smoking. SOCS-1 gene.|dna methylation. smoking. socs-1 gene.
5100403|NCT03370549|Suicide|suicide
5100408|NCT03370536|Arrhythmia|arrhythmia
5100409|NCT03370471|aerobic exercise|aerobic exercise
5100606|NCT03369275|Cryopreserved|cryopreserved
5100607|NCT03369275|Allogeneic|allogeneic
5100608|NCT03369275|Phase II|phase ii
5100609|NCT03369262|preterm labor|preterm labor
5100811|NCT03368105|antibiotic-associated diarrhoea|antibiotic-associated diarrhoea
5100812|NCT03368092|severe trauma|severe trauma
5100813|NCT03368092|acute respiratory distress syndrome|acute respiratory distress syndrome
5101013|NCT03366779|Lumbar disc herniation, reherniation|lumbar disc herniation, reherniation
5101014|NCT03366753|acute normovolemic hemodilution|acute normovolemic hemodilution
5101015|NCT03366753|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5101016|NCT03366753|hydroxyethyl starch|hydroxyethyl starch
5101018|NCT03366740|Persistent diarrhea|persistent diarrhea
5101019|NCT03366740|> 6 to 36 months aged children|> 6 to 36 months aged children
5101021|NCT03366740|rice suji|rice suji
5101122|NCT03366116|DNA Methylation|dna methylation
5101123|NCT03366116|Pharmacokinetics|pharmacokinetics
5101124|NCT03366116|Nucleoside Analog|nucleoside analog
5555744|NCT01063660|AML|aml
5101136|NCT03366012|GERD|gerd
5101340|NCT03364803|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5101341|NCT03364790|knee - spine syndrome|knee - spine syndrome
5101342|NCT03364790|PLIF|plif
5101343|NCT03364790|TKA|tka
5101344|NCT03364790|sagittal parameters|sagittal parameters
5101345|NCT03364790|neuroelectrophysiology|neuroelectrophysiology
5101351|NCT03364751|Smoking|smoking
5101757|NCT03362112|lipoprotein-associated phospholipase A2|lipoprotein-associated phospholipase a2
5101758|NCT03362099|varenicline|varenicline
5101759|NCT03362099|bupropion|bupropion
5101760|NCT03362086|bone tumor osteosarcoma|bone tumor osteosarcoma
5101761|NCT03362073|Ketamine|ketamine
5101764|NCT03362073|Palliative care|palliative care
5101954|NCT03360890|pembrolizumab|pembrolizumab
5101955|NCT03360890|docetaxel|docetaxel
5102001|NCT03360617|IV|iv
5102045|NCT03360292|Neonatology|neonatology
5102046|NCT03360266|remineralization|remineralization
5102047|NCT03360266|fluoride varnish|fluoride varnish
5102048|NCT03360227|syncope|syncope
5102049|NCT03360227|bradycardia|bradycardia
5102050|NCT03360227|tachycardia|tachycardia
5926867|NCT04001803|Antiretroviral therapy, HIV infections, cabotegravir, rilpivirine, long-acting intramuscular injection,|antiretroviral therapy, hiv infections, cabotegravir, rilpivirine, long-acting intramuscular injection,
5926928|NCT03996395|infant|infant
5926929|NCT03996395|biomarker|biomarker
5926930|NCT03996395|fruit|fruit
5926931|NCT03996395|vegetable|vegetable
5926932|NCT03996395|complementary feeding|complementary feeding
5926933|NCT03996395|nutrition|nutrition
5926934|NCT03996395|reflectance spectroscopy|reflectance spectroscopy
5926947|NCT03992469|Entocort EC induction|entocort ec induction
5926948|NCT03992469|double blind, controlled safety/tolerability trial|double blind, controlled safety/tolerability trial
5926949|NCT03992469|open label exploratory efficacy trial|open label exploratory efficacy trial
5926950|NCT03992469|mild-to-moderate crohn's disease|mild-to-moderate crohn's disease
5926951|NCT03992469|Chinese Herbal Therapy|chinese herbal therapy
5926961|NCT03991156|Radiotherapy|radiotherapy
5102051|NCT03360227|sudden cardiac death|sudden cardiac death
5102052|NCT03360227|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5102053|NCT03360227|ventricular tachycardia|ventricular tachycardia
5102054|NCT03360227|ventricular fibrillation|ventricular fibrillation
5102055|NCT03360227|biomarker|biomarker
5102056|NCT03360227|thyroid hormone|thyroid hormone
5102057|NCT03360214|Mastectomy|mastectomy
5102133|NCT03359772|Quality of Life|quality of life
5102134|NCT03359759|Telemedicine|telemedicine
5102135|NCT03359759|Connected watches|connected watches
5102136|NCT03359759|Patient-Reported symptom monitoring|patient-reported symptom monitoring
5102137|NCT03359759|Secure Platform|secure platform
5102138|NCT03359733|Drug therapy|drug therapy
5102251|NCT03359044|Fiberoptic bronchoscopy|fiberoptic bronchoscopy
5102252|NCT03359044|Neuropsychological Development|neuropsychological development
5102253|NCT03359044|general anesthesia|general anesthesia
5102254|NCT03359018|osteosarcoma|osteosarcoma
5102353|NCT03358446|femoral vein central catheterization|femoral vein central catheterization
5102354|NCT03358446|leg angulation|leg angulation
5102355|NCT03358407|Inflammatory Bowel disease|inflammatory bowel disease
5102356|NCT03358407|Pro-drug|pro-drug
5102357|NCT03358407|Double-blinded|double-blinded
5102358|NCT03358407|Crossover|crossover
5102359|NCT03358381|total knee arthroplasty|total knee arthroplasty
5102360|NCT03358381|CT scan|ct scan
5102361|NCT03358355|PAD|pad
5102443|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors
5102444|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
5102536|NCT03357120|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5102563|NCT03356808|CAR-T|car-t
5102637|NCT03356418|Exercise|exercise
5102638|NCT03356418|Vibration|vibration
5102732|NCT03355794|ribociclib|ribociclib
5102733|NCT03355794|everolimus|everolimus
5102734|NCT03355781|childhood trauma|childhood trauma
5102735|NCT03355781|candidate gene expression|candidate gene expression
5102736|NCT03355781|cerebral morphology|cerebral morphology
5102737|NCT03355781|schizophrenic symptomatology|schizophrenic symptomatology
5102738|NCT03355781|conceptual framework of stress vulnerability|conceptual framework of stress vulnerability
5102739|NCT03355768|Romidepsin|romidepsin
5102740|NCT03355768|Pralatrexate|pralatrexate
5102741|NCT03355768|PTCL|ptcl
5102742|NCT03355768|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5102743|NCT03355742|XIENCE|xience
5102744|NCT03355742|High bleeding risk (HBR)|high bleeding risk (hbr)
5102745|NCT03355742|Dual antiplatelet therapy (DAPT)|dual antiplatelet therapy (dapt)
5102746|NCT03355742|Coronary Artery Disease|coronary artery disease
5102747|NCT03355742|Drug eluting stent (DES)|drug eluting stent (des)
5102748|NCT03355690|thrombectomy|thrombectomy
5102749|NCT03355690|thrombolysis|thrombolysis
5102750|NCT03355690|Health-economic status|health-economic status
5102751|NCT03355690|Outcome after stroke|outcome after stroke
5102752|NCT03355677|Case finding|case finding
5102755|NCT03355664|Malaria|malaria
5102756|NCT03355664|Protozoan Infections|protozoan infections
5102757|NCT03355664|Lumefantrine|lumefantrine
5102758|NCT03355664|Artemether|artemether
5102759|NCT03355664|Amodiaquine|amodiaquine
5102760|NCT03355664|Piperaquine|piperaquine
5102761|NCT03355664|Artemether-lumefantrine combination|artemether-lumefantrine combination
5102806|NCT03355456|Medication refractory atrial fibrillation|medication refractory atrial fibrillation
5102809|NCT03355443|Colonoscopy|colonoscopy
5103016|NCT03353831|Recurrent Ovarian Cancer|recurrent ovarian cancer
5103017|NCT03353831|Atezolizumab|atezolizumab
5103018|NCT03353831|Bevacizumab|bevacizumab
5103020|NCT03353779|antiplatelet|antiplatelet
5103216|NCT03352336|Atelectasis|atelectasis
5103323|NCT03351686|tranexamic acid|tranexamic acid
5103324|NCT03351647|Crohn Disease|crohn disease
5103516|NCT03350087|stroke|stroke
5103626|NCT03349450|Immunologic Factors|immunologic factors
5103627|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs
5103628|NCT03349450|Antirheumatic Agents|antirheumatic agents
5103629|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5103630|NCT03349450|Alkylating Agents|alkylating agents
5103631|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5103634|NCT03349450|Canada|canada
5103720|NCT03349034|Microvascular|microvascular
5103721|NCT03349034|Postoperative Pain|postoperative pain
5103722|NCT03349021|esophagus|esophagus
5103723|NCT03349021|stenosis|stenosis
5103724|NCT03349021|bougienage|bougienage
5103725|NCT03349008|necro-inflammatory|necro-inflammatory
5103726|NCT03349008|glycyrrhizin|glycyrrhizin
5103727|NCT03349008|entecavir|entecavir
5103728|NCT03349008|hepatic biological parameters|hepatic biological parameters
5103729|NCT03349008|liver fibrosis|liver fibrosis
5103730|NCT03348982|Physical activity|physical activity
5103731|NCT03348982|Sleep|sleep
5103732|NCT03348982|Children|children
5103733|NCT03348982|Autism Spectrum Disorder|autism spectrum disorder
5103734|NCT03348982|Melatonin|melatonin
5103735|NCT03348969|Mitomycin C|mitomycin c
5103736|NCT03348969|Neoadjuvant|neoadjuvant
5103737|NCT03348904|Non-small cell lung cancer|non-small cell lung cancer
5104000|NCT03347344|Spinocerebellar ataxia-SCA2|spinocerebellar ataxia-sca2
5104001|NCT03347344|SARA (Scale for the Assessment and Rating of Ataxia) score|sara (scale for the assessment and rating of ataxia) score
5104002|NCT03347344|Riluzole (Rilutek)|riluzole (rilutek)
5104003|NCT03347331|PET imaging- Serotonin-Radiotracer|pet imaging- serotonin-radiotracer
5104004|NCT03347305|Energy expenditure|energy expenditure
5104005|NCT03347305|Peritoneal dialysis|peritoneal dialysis
5104007|NCT03347292|Liver cancer|liver cancer
5104095|NCT03346746|mood|mood
5104096|NCT03346746|diet|diet
5104097|NCT03346733|psyllium|psyllium
5104098|NCT03346733|viscous fibre|viscous fibre
5104099|NCT03346720|Data Sharing|data sharing
5104100|NCT03346655|Treatment|treatment
5104104|NCT03346642|Decitabine|decitabine
5104312|NCT03345264|Fertility Disorders|fertility disorders
5104314|NCT03345251|ICSI - physical - Manipulation - scratching|icsi - physical - manipulation - scratching
5104418|NCT03344679|Adenosine|adenosine
5104426|NCT03344614|apatinib|apatinib
5104523|NCT03344107|Pain|pain
5104524|NCT03344107|Renal Calculi|renal calculi
5104729|NCT03342677|HCC|hcc
5105105|NCT03340259|Newborn Infants|newborn infants
5105221|NCT03339479|differential diagnosis|differential diagnosis
5105222|NCT03339479|frozen pathological examination|frozen pathological examination
5105224|NCT03339427|cardiovascular|cardiovascular
5105225|NCT03339427|muscle power|muscle power
5105455|NCT03338179|Schizophrenia|schizophrenia
5105456|NCT03338114|ALS|als
5105457|NCT03338114|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5105458|NCT03338114|Fasciculation|fasciculation
5105459|NCT03338114|FLX-787|flx-787
5105460|NCT03338062|Radiation Treatment|radiation treatment
5105461|NCT03338036|Concussion|concussion
5105462|NCT03338036|Post-Concussion Syndrome|post-concussion syndrome
5105463|NCT03338036|Biofeedback|biofeedback
5105464|NCT03338036|Heart Rate Variability|heart rate variability
5105465|NCT03338036|Neurofeedback|neurofeedback
5105548|NCT03337568|busulfan|busulfan
5105549|NCT03337568|fludarabine|fludarabine
5105550|NCT03337568|ATG|atg
5105551|NCT03337542|AR101|ar101
5105552|NCT03337542|Characterized Peanut Allergen|characterized peanut allergen
5105753|NCT03336385|Prebiotics|prebiotics
5888812|NCT04150341|TD-8236|td-8236
5105754|NCT03336385|Intestinal permeability|intestinal permeability
5105755|NCT03336385|NSAIDS|nsaids
5105756|NCT03336359|colonoscopy|colonoscopy
5105757|NCT03336359|image enhanced endoscopy|image enhanced endoscopy
5105759|NCT03336346|Dolutegravir|dolutegravir
5105760|NCT03336346|Efavirenz|efavirenz
5105761|NCT03336346|Etonogestrel|etonogestrel
5105762|NCT03336333|zanubrutinib|zanubrutinib
5105852|NCT03335748|Cognitive training|cognitive training
5105853|NCT03335748|Intervention|intervention
5105854|NCT03335748|Youths|youths
5105855|NCT03335735|alcohol|alcohol
5105856|NCT03335735|driving|driving
5105857|NCT03335735|breathalyzers|breathalyzers
5105858|NCT03335735|smartphone|smartphone
5105859|NCT03335722|stammering|stammering
5105860|NCT03335722|speech motor disorder|speech motor disorder
5683082|NCT00566410|Phase I|phase i
5105942|NCT03335202|antibiotic therapy|antibiotic therapy
5105943|NCT03335202|cftr modifier|cftr modifier
5105945|NCT03335189|E-Health|e-health
5105946|NCT03335189|Smartphone technology|smartphone technology
5105947|NCT03335189|Real-time symptom assessment|real-time symptom assessment
5105948|NCT03335189|Self-care|self-care
5105949|NCT03335189|Symptom management|symptom management
5105950|NCT03335150|Parkinson's disease|parkinson's disease
5105951|NCT03335150|Rehabilitation|rehabilitation
5105952|NCT03335150|Cognition|cognition
5106036|NCT03334786|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5106037|NCT03334786|Fasciculation|fasciculation
5106038|NCT03334786|FLX-787|flx-787
5106039|NCT03334773|Type 2 diabetes, nutrition education programme, intervention, South Africa|type 2 diabetes, nutrition education programme, intervention, south africa
5106040|NCT03334760|Cohort study|cohort study
5106041|NCT03334760|Infant feeding|infant feeding
5106042|NCT03334760|Overweight|overweight
5106043|NCT03334760|Child BMI|child bmi
5106044|NCT03334760|Breastfeeding|breastfeeding
5106045|NCT03334760|Intake of protein|intake of protein
5106046|NCT03334747|uncomplicated Plasmodium falciparum Malaria.|uncomplicated plasmodium falciparum malaria.
5106047|NCT03334734|Tuberculosis|tuberculosis
5106048|NCT03334734|PBTZ169|pbtz169
5106049|NCT03334734|antimycobacterial|antimycobacterial
5106050|NCT03334708|17-257|17-257
5106051|NCT03334669|Childhood obesity|childhood obesity
5106052|NCT03334669|Preschool|preschool
5106140|NCT03334227|High-Flow Nasal Cannula|high-flow nasal cannula
5106141|NCT03334227|Severe Sepsis|severe sepsis
5106239|NCT03333642|metabolic surgery|metabolic surgery
5106240|NCT03333642|ileal interposition|ileal interposition
5106241|NCT03333629|Autistic Disorder|autistic disorder
5106242|NCT03333629|Early Detection|early detection
5106243|NCT03333629|Early Intervention|early intervention
5106244|NCT03333616|Genitourinary Cancer|genitourinary cancer
5106245|NCT03333603|Schizophrenia|schizophrenia
5106248|NCT03333564|Vitamin D3|vitamin d3
5106249|NCT03333564|Vitamin D deficiency|vitamin d deficiency
5106250|NCT03333564|estradiol|estradiol
5106251|NCT03333564|omega-3 fatty acids|omega-3 fatty acids
5106330|NCT03333200|NDRD|ndrd
5106631|NCT03331354|employment|employment
5106334|NCT03333200|Language|language
5106338|NCT03333174|bradycardia|bradycardia
5106438|NCT03332537|Gut microbiome|gut microbiome
5106555|NCT03331848|Levodopa-Induced Dyskinesia (LID)|levodopa-induced dyskinesia (lid)
5106556|NCT03331848|Foliglurax|foliglurax
5106557|NCT03331848|Parkinson's Disease|parkinson's disease
5106558|NCT03331848|mGlu4 PAM|mglu4 pam
5106559|NCT03331822|circadian|circadian
5106560|NCT03331822|light therapy|light therapy
5106561|NCT03331822|ICU nurse|icu nurse
5106562|NCT03331809|intubation|intubation
5106563|NCT03331809|pharyngitis|pharyngitis
5106564|NCT03331796|mild cognitive impairment|mild cognitive impairment
5106565|NCT03331796|tms|tms
5106566|NCT03331796|rtms|rtms
5106569|NCT03331796|non-pharmacological|non-pharmacological
5106659|NCT03331159|Lumbar Fusion|lumbar fusion
5106660|NCT03331159|Hydroxyapatite|hydroxyapatite
5106661|NCT03331146|Nitric Oxide|nitric oxide
5106662|NCT03331146|Sodium Nitrite|sodium nitrite
5106663|NCT03331146|Cardiopulmonary bypass|cardiopulmonary bypass
5106664|NCT03331146|cardioplegic cardiac arrest|cardioplegic cardiac arrest
5106665|NCT03331146|coronary revacularization|coronary revacularization
5106755|NCT03330548|Plant-based diet|plant-based diet
5106756|NCT03330548|Hyperlipidemia|hyperlipidemia
5106757|NCT03330548|Diabetes|diabetes
5888886|NCT04145011|Knee|knee
5106758|NCT03330548|Overweight|overweight
5106759|NCT03330548|Veterans|veterans
5106853|NCT03330015|Patient's experience|patient's experience
5106854|NCT03330015|Patient's choice|patient's choice
5106967|NCT03329326|upper limb amputation|upper limb amputation
5106968|NCT03329326|rehabilitation outcome|rehabilitation outcome
5106969|NCT03329313|Intensive care unit|intensive care unit
5106970|NCT03329313|SLEDD-f|sledd-f
5106972|NCT03329300|Pediatric Obesity|pediatric obesity
5107093|NCT03328429|marsupialisation|marsupialisation
5107095|NCT03328416|Image-Guided Biopsy|image-guided biopsy
5107096|NCT03328416|Multidetector Computed Tomography|multidetector computed tomography
5107097|NCT03328416|Diagnostic Imaging|diagnostic imaging
5107098|NCT03328416|Cryosurgery|cryosurgery
5107099|NCT03328416|Ablation Techniques|ablation techniques
5107100|NCT03328403|Endovascular therapy|endovascular therapy
5107101|NCT03328403|Mechanical thrombectomy|mechanical thrombectomy
5107102|NCT03328403|Acute ischaemic stroke treatment|acute ischaemic stroke treatment
5107103|NCT03328364|enzalutamide|enzalutamide
5107104|NCT03328364|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer
5107105|NCT03328364|Xtandi|xtandi
5107106|NCT03328364|registry based study|registry based study
5107107|NCT03328364|MDV3100|mdv3100
5107108|NCT03328364|mCRPC|mcrpc
5107109|NCT03328351|Manual therapy|manual therapy
5107110|NCT03328351|cervical radiculopathy|cervical radiculopathy
5107111|NCT03328351|pressure pain threshold|pressure pain threshold
5107116|NCT03328338|Heart.|heart.
5107175|NCT03327883|PET MRI|pet mri
5107373|NCT03326635|Elderly|elderly
5699588|NCT00502580|MDM|mdm
5107374|NCT03326622|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5107375|NCT03326622|aerobic exercise|aerobic exercise
5107376|NCT03326622|functional outcome|functional outcome
5107377|NCT03326622|non-invasive ventilation|non-invasive ventilation
5107378|NCT03326622|oxygen uptake|oxygen uptake
5107379|NCT03326596|Hemorrhage|hemorrhage
5107380|NCT03326596|Tranexamic acid (TXA)|tranexamic acid (txa)
5107381|NCT03326596|Estimated Blood Loss (EBL)|estimated blood loss (ebl)
5107675|NCT03325153|STOP-Bang questionnaire|stop-bang questionnaire
5107676|NCT03325153|Cardiopulmonary events|cardiopulmonary events
5107677|NCT03325127|Prostate Cancer, Bone metastases, Xofigo, Zytiga, Xtandi.|prostate cancer, bone metastases, xofigo, zytiga, xtandi.
5107678|NCT03325114|type 1 diabetes|type 1 diabetes
5107679|NCT03325114|hypercalciuria|hypercalciuria
5107680|NCT03325088|Severe Asthma|severe asthma
5107772|NCT03324594|functional performance|functional performance
5107773|NCT03324594|synthetic male condom|synthetic male condom
5107774|NCT03324581|ADHD|adhd
5107775|NCT03324581|ADD|add
5107776|NCT03324516|pterional incision|pterional incision
5107971|NCT03323385|Phase 3b|phase 3b
5107972|NCT03323359|Hemopatch|hemopatch
5107973|NCT03323359|Hepatic resection|hepatic resection
5107974|NCT03323359|Hemostasis|hemostasis
5107975|NCT03323359|Surgery|surgery
5107978|NCT03323346|cooper|cooper
5108179|NCT03321968|Human|human
5108180|NCT03321968|RNA Virus Infections|rna virus infections
5108181|NCT03321968|Lot Consistency|lot consistency
5108274|NCT03321227|Eggs|eggs
5108371|NCT03320590|Time lapse Primovision|time lapse primovision
5108372|NCT03320590|Spermatic nuclear quality|spermatic nuclear quality
5108373|NCT03320590|intracytoplasmic sperm injection (ICSI)|intracytoplasmic sperm injection (icsi)
5108374|NCT03320590|Embryonic kinetics|embryonic kinetics
5108375|NCT03320564|injections, intravenous|injections, intravenous
5108475|NCT03319979|Folate, DHFR|folate, dhfr
5108565|NCT03319459|Renal cancer|renal cancer
5108675|NCT03318783|Epoxyeicosatrienoic Acids|epoxyeicosatrienoic acids
5108676|NCT03318770|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5108883|NCT03317197|Vasopressin-steroid-epinephrine (VSE)|vasopressin-steroid-epinephrine (vse)
5108884|NCT03317197|Treatment Outcome|treatment outcome
5108885|NCT03317197|prognosis|prognosis
5108886|NCT03317197|Return of spontaneous circulation|return of spontaneous circulation
5110282|NCT03308500|HIIT|hiit
5109079|NCT03315975|Influenza vaccine|influenza vaccine
5110283|NCT03308500|Children|children
5109080|NCT03315923|Active secondary progressive Multiple Sclerosis|active secondary progressive multiple sclerosis
5109081|NCT03315923|Glatiramer acetate|glatiramer acetate
5109082|NCT03315923|Rituximab|rituximab
5109083|NCT03315923|Comparative study|comparative study
5109084|NCT03315923|Disability|disability
5109085|NCT03315923|Randomized clinical trial|randomized clinical trial
5109086|NCT03315923|Annualized relapse rate|annualized relapse rate
5109087|NCT03315910|Tobacco Treatment|tobacco treatment
5109264|NCT03315065|thoracic Radiation therapy|thoracic radiation therapy
5109265|NCT03315065|Lung Function|lung function
5109266|NCT03315052|Graft loss|graft loss
5109267|NCT03315052|Renal failure|renal failure
5109268|NCT03315052|Infection|infection
5109358|NCT03314584|transcranial magnetic stimulation|transcranial magnetic stimulation
5109361|NCT03314571|Labor pain|labor pain
5109560|NCT03313154|Psychiatric comorbidity|psychiatric comorbidity
5109561|NCT03313154|Cognitive impairment|cognitive impairment
5109562|NCT03313154|Chronic Hepatitis HCV-related|chronic hepatitis hcv-related
5109563|NCT03313089|micronutrient powders|micronutrient powders
5109565|NCT03313089|nutrition|nutrition
5109566|NCT03313089|food security program|food security program
5109567|NCT03313089|nutritional program|nutritional program
5109568|NCT03313089|hemoglobin|hemoglobin
5109569|NCT03313089|anemia|anemia
5109570|NCT03313076|burn injury|burn injury
5109571|NCT03313076|thermal burn injury|thermal burn injury
5109572|NCT03313076|omega 3 fatty acids|omega 3 fatty acids
5109573|NCT03313076|vitamin D|vitamin d
5109574|NCT03313076|fish oil|fish oil
5109575|NCT03313076|chronic pain|chronic pain
5109578|NCT03313063|myocard|myocard
5109643|NCT03312634|Retinoic acid receptor agonist|retinoic acid receptor agonist
5109644|NCT03312634|Retinoic acid receptor gamma agonist|retinoic acid receptor gamma agonist
5109648|NCT03312634|FOP|fop
5109752|NCT03311711|Behavioral Research|behavioral research
5109862|NCT03311204|contact lens and ocular discomfort|contact lens and ocular discomfort
5109863|NCT03311178|Shock|shock
5109864|NCT03311178|Preterm infant|preterm infant
5109865|NCT03311178|Dobutamine|dobutamine
5109866|NCT03311165|neonate|neonate
5109867|NCT03311165|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5109868|NCT03311165|prognosis|prognosis
5109869|NCT03311165|risk factor|risk factor
5109870|NCT03311165|clinical course|clinical course
5109871|NCT03311152|Hepatocellular carcinoma|hepatocellular carcinoma
5109872|NCT03311152|Cirrhosis|cirrhosis
5109873|NCT03311152|Circulating epigenetic biomarker|circulating epigenetic biomarker
5109874|NCT03311152|Plasma biomarker|plasma biomarker
5109875|NCT03311152|SEPT9|sept9
5109876|NCT03311152|Septin9|septin9
5109877|NCT03311152|DNA methylation biomarker|dna methylation biomarker
5109878|NCT03311152|Circulating DNA methylation biomarker|circulating dna methylation biomarker
5109879|NCT03311152|Alpha-fetoprotein|alpha-fetoprotein
5109968|NCT03310684|Uric acid|uric acid
5109969|NCT03310684|Left ventricular hypertrophy|left ventricular hypertrophy
5109970|NCT03310645|Refractory chronic cough|refractory chronic cough
5109971|NCT03310645|healthy volunteers|healthy volunteers
5109972|NCT03310632|Antroquinonol|antroquinonol
5109973|NCT03310632|Hocena|hocena
5109974|NCT03310632|metastatic pancreatic cancer|metastatic pancreatic cancer
5109982|NCT03310593|bipolar disorder|bipolar disorder
5110167|NCT03309410|Emergency Service, Hospital|emergency service, hospital
5110168|NCT03309410|Venous to arterial conversion|venous to arterial conversion
5110169|NCT03309410|Matched-Pair Analysis|matched-pair analysis
5110170|NCT03309397|adolescent sports|adolescent sports
5110171|NCT03309358|Cystic Fibrosis|cystic fibrosis
5110172|NCT03309358|Pulmonary exacerbation|pulmonary exacerbation
5110261|NCT03308773|T2DM|t2dm
5110262|NCT03308773|Carotid IMT/Plaque|carotid imt/plaque
5110263|NCT03308747|Low-grade systemic inflammation|low-grade systemic inflammation
5110362|NCT03307876|A2M|a2m
5110475|NCT03307200|Supportive care|supportive care
5110476|NCT03307200|Prospective observational study|prospective observational study
5110477|NCT03307161|manual therapy|manual therapy
5110478|NCT03307161|heart rate|heart rate
5110479|NCT03307148|Locally Advanced or Metastatic|locally advanced or metastatic
5110480|NCT03307135|Spasticity|spasticity
5110481|NCT03307135|electrophysiology|electrophysiology
5110482|NCT03307135|biomechanics|biomechanics
5110483|NCT03307135|objective assessment|objective assessment
5110484|NCT03307096|FURS|furs
5110491|NCT03307031|training volume|training volume
5110493|NCT03307031|lipid profile|lipid profile
5110494|NCT03307031|postmenopausal|postmenopausal
5110568|NCT03306563|TBI|tbi
5110579|NCT03306550|metabolic enzymes|metabolic enzymes
5110580|NCT03306524|mechanical ventilation|mechanical ventilation
5110581|NCT03306524|SIPPV|sippv
5110582|NCT03306524|PSV|psv
5110583|NCT03306524|Device flow|device flow
5110679|NCT03306017|left ventricular assist device|left ventricular assist device
5110680|NCT03306017|platelet-leukocyte conjugates|platelet-leukocyte conjugates
5110780|NCT03305341|Methotrexate|methotrexate
5110781|NCT03305341|Lung|lung
5110782|NCT03305341|Cancer|cancer
5110783|NCT03305328|Oscillations|oscillations
5110784|NCT03305328|Non-invasive Brain Stimulation|non-invasive brain stimulation
5110785|NCT03305328|Transcranial Alternating Current Stimulation|transcranial alternating current stimulation
5110786|NCT03305276|diet;|diet;
5110787|NCT03305276|exercise;|exercise;
5110788|NCT03305276|hypertension;|hypertension;
5110789|NCT03305276|vitamin d|vitamin d
5110790|NCT03305237|Weight loss|weight loss
5110791|NCT03305237|Chrono-nutrition|chrono-nutrition
5110792|NCT03305237|Diet|diet
5110793|NCT03305237|energy expenditure|energy expenditure
5110812|NCT03305042|hypervitaminosis A|hypervitaminosis a
5110913|NCT03304405|ASD|asd
5111126|NCT03303066|Hemoglobin (Hb)|hemoglobin (hb)
5111127|NCT03303066|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
5111220|NCT03302338|Simulated amniotic fluid like solution|simulated amniotic fluid like solution
5111221|NCT03302338|Necrotizing enterocolitis|necrotizing enterocolitis
5111222|NCT03302325|stage IV solid tumor|stage iv solid tumor
5111524|NCT03300427|acute heart failure|acute heart failure
5111525|NCT03300427|chronic heart failure|chronic heart failure
5111526|NCT03300427|congestive heart failure|congestive heart failure
5111527|NCT03300427|congestive cardiac failure|congestive cardiac failure
5111528|NCT03300388|Insulin resistance|insulin resistance
5111538|NCT03300336|Walking|walking
5111960|NCT03297372|monofocal|monofocal
5112063|NCT03296631|microbiome development|microbiome development
5112064|NCT03296618|chronic stroke|chronic stroke
5112065|NCT03296618|neural stem cell|neural stem cell
5112165|NCT03295994|arthroscopy|arthroscopy
5112166|NCT03295994|physical therapy|physical therapy
5112167|NCT03295994|rehabilitation|rehabilitation
5112169|NCT03295994|rotator cuff tear|rotator cuff tear
5112170|NCT03295929|3D model|3d model
5112171|NCT03295929|Inner ear|inner ear
5112172|NCT03295903|Vascular function|vascular function
5112255|NCT03295383|Rituximab|rituximab
5112345|NCT03294889|Stereotactic body radiation therapy|stereotactic body radiation therapy
5112346|NCT03294889|Calypso® beacon system|calypso® beacon system
5112453|NCT03294252|peritoneal metastases|peritoneal metastases
5112454|NCT03294187|Upper Extremity|upper extremity
5112455|NCT03294187|Feedback|feedback
5112456|NCT03294187|Rehabilitation|rehabilitation
5112495|NCT03293953|HIV|hiv
5112547|NCT03293628|uterine cervical neoplasm|uterine cervical neoplasm
5112548|NCT03293602|prostate cancer|prostate cancer
5112550|NCT03293602|BOLD|bold
5112551|NCT03293602|18F-MISO|18f-miso
5112884|NCT03291548|Randomised Control Trial|randomised control trial
5112885|NCT03291522|Testicular sperm extraction|testicular sperm extraction
5112887|NCT03291509|weight management|weight management
5112888|NCT03291483|Whole body vibration|whole body vibration
5112889|NCT03291483|mesh id D000072797|mesh id d000072797
5112890|NCT03291483|Plyometric exercise|plyometric exercise
5112891|NCT03291483|Muscle strength|muscle strength
5113482|NCT03287726|Probiotics|probiotics
5112987|NCT03290599|Cognitive dysfunction|cognitive dysfunction
5112989|NCT03290599|Mini mental Test,|mini mental test,
5112990|NCT03290599|Preoperative Hospitalisation|preoperative hospitalisation
5112991|NCT03290599|Spinal Anesthesia|spinal anesthesia
5112992|NCT03290534|wedge resection|wedge resection
5112993|NCT03290534|sublobar resection|sublobar resection
5112994|NCT03290534|brachytherapy|brachytherapy
5112995|NCT03290534|CivaSheet|civasheet
5889160|NCT04119050|Warm Autoimmune Hemolytic Anemia|warm autoimmune hemolytic anemia
5113210|NCT03289286|Electronic tool|electronic tool
5113211|NCT03289286|e-follow-up|e-follow-up
5113212|NCT03289273|Liver cancer|liver cancer
5113223|NCT03289143|Dementia|dementia
5113304|NCT03288584|Left ventricular function|left ventricular function
5113305|NCT03288584|Apoptosis|apoptosis
5113306|NCT03288584|Oxidative stress|oxidative stress
5113307|NCT03288571|Diabetes|diabetes
5113308|NCT03288571|nephropathy|nephropathy
5113309|NCT03288571|Kidney|kidney
5113310|NCT03288571|parenchyma|parenchyma
5113311|NCT03288571|Wharton Jelly|wharton jelly
5113312|NCT03288571|Mesenchymal stem cells|mesenchymal stem cells
5113313|NCT03288545|MIUC|miuc
5113314|NCT03288545|ASG-22ME|asg-22me
5113315|NCT03288545|ASG-22CE|asg-22ce
5113316|NCT03288545|Antibody-drug conjugate|antibody-drug conjugate
5113317|NCT03288545|Antineoplastic agents|antineoplastic agents
5113318|NCT03288545|CPI|cpi
5113319|NCT03288545|Enfortumab vedotin|enfortumab vedotin
5113320|NCT03288545|MIBC|mibc
5113321|NCT03288545|Locally advanced urothelial cancer|locally advanced urothelial cancer
5113322|NCT03288545|Cisplatin|cisplatin
5113323|NCT03288545|Drug therapy|drug therapy
5113324|NCT03288545|Carboplatin|carboplatin
5113325|NCT03288545|Metastatic urothelial cancer|metastatic urothelial cancer
5113326|NCT03288545|Nectin-4|nectin-4
5113372|NCT03288298|MTT|mtt
5113550|NCT03287271|ovary|ovary
5113551|NCT03287271|carboplatin|carboplatin
5113647|NCT03286686|multisensory integration|multisensory integration
5113648|NCT03286673|calcium carbonate|calcium carbonate
5113649|NCT03286673|calcium phosphate|calcium phosphate
5113650|NCT03286673|metabolic effects|metabolic effects
5113651|NCT03286673|human study|human study
5113653|NCT03286660|Exercise tests|exercise tests
5113744|NCT03285841|optical coherence tomography|optical coherence tomography
5113745|NCT03285841|autofluorescence imaging|autofluorescence imaging
5113746|NCT03285828|medical education, motivational interviewing, medical empathy|medical education, motivational interviewing, medical empathy
5113752|NCT03285750|GRP120|grp120
5113753|NCT03285750|Adipose tissue|adipose tissue
5113754|NCT03285750|Type 2 diabetes|type 2 diabetes
5113755|NCT03285737|Protein ingestion|protein ingestion
5113756|NCT03285737|Muscle protein synthesis|muscle protein synthesis
5113757|NCT03285724|Mitral Valve Repair|mitral valve repair
5113758|NCT03285724|Transapical|transapical
5113759|NCT03285724|artificial chordae|artificial chordae
5113760|NCT03285724|bi-leaflet prolapse|bi-leaflet prolapse
5113761|NCT03285724|anterior prolapse|anterior prolapse
5113833|NCT03285347|executive dysfunction|executive dysfunction
5113835|NCT03285347|computer-based cognitive training|computer-based cognitive training
5113836|NCT03285321|Nivolumab|nivolumab
5113837|NCT03285321|Ipilimumab|ipilimumab
5113838|NCT03285321|immunotherapy|immunotherapy
5113839|NCT03285269|shock|shock
5113840|NCT03285269|ultrasound|ultrasound
5113841|NCT03285256|Prospective memory, working memory, substance abuse|prospective memory, working memory, substance abuse
5113842|NCT03285243|Delirium, anesthesia, pediatrics|delirium, anesthesia, pediatrics
5113843|NCT03285217|HMB|hmb
5113846|NCT03285191|NRS|nrs
5113922|NCT03284658|Biomarker|biomarker
5114023|NCT03283826|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5114024|NCT03283826|EBV-associated Multiple Sclerosis|ebv-associated multiple sclerosis
5114025|NCT03283826|Inflammation|inflammation
5114026|NCT03283826|Central Nervous System|central nervous system
5114027|NCT03283826|Autoimmune Disease|autoimmune disease
5114029|NCT03283826|Demyelination|demyelination
5114030|NCT03283826|Cell Therapy|cell therapy
5114031|NCT03283826|T-cell|t-cell
5114032|NCT03283826|Allogeneic|allogeneic
5114033|NCT03283826|EBV viremia|ebv viremia
5114034|NCT03283826|Off-the-shelf (T cells)|off-the-shelf (t cells)
5114035|NCT03283813|Paediatric Obesity|paediatric obesity
5114036|NCT03283813|Insulin resistance|insulin resistance
5114037|NCT03283813|Zinc|zinc
5114038|NCT03283813|Myo-inositol|myo-inositol
5114113|NCT03283345|systemic responses to trauma|systemic responses to trauma
5114115|NCT03283332|adolescents|adolescents
5114116|NCT03283332|cohort|cohort
5114117|NCT03283332|longitudinal|longitudinal
5114118|NCT03283332|health inequalities|health inequalities
5114119|NCT03283319|Influenza|influenza
5114120|NCT03283319|human|human
5114121|NCT03283319|Influenza in Birds|influenza in birds
5114122|NCT03283319|Orthomyxoviridae Infections|orthomyxoviridae infections
5114123|NCT03283319|RNA Virus Infections|rna virus infections
5114318|NCT03282149|cytokine|cytokine
5114319|NCT03282149|anti-inflammatory|anti-inflammatory
5114320|NCT03282149|pain|pain
5114324|NCT03282071|Mental health|mental health
5114325|NCT03282071|Mental well-being|mental well-being
5114326|NCT03282071|Community-based engagement|community-based engagement
5114327|NCT03282071|Positive psychology|positive psychology
5114333|NCT03282045|lysobact|lysobact
5114453|NCT03281460|Laparoscopy|laparoscopy
5114454|NCT03281460|in-bag morcellation|in-bag morcellation
5114455|NCT03281447|Nurse navigation|nurse navigation
5114456|NCT03281447|Family|family
5114457|NCT03281447|Self Efficacy|self efficacy
5114466|NCT03281356|Pilot Study|pilot study
5114549|NCT03280849|biomaterials|biomaterials
5114553|NCT03280810|Postural|postural
5114646|NCT03280290|Lymphocytes CD4|lymphocytes cd4
5114647|NCT03280290|Lymphocytes CCR7|lymphocytes ccr7
5114648|NCT03280290|ALLOGRAFT|allograft
5114649|NCT03280290|Hematopoietic Stem Cells|hematopoietic stem cells
5114650|NCT03280251|Cognitive disorders|cognitive disorders
5114750|NCT03279588|Ultrasound diagnosis|ultrasound diagnosis
5114751|NCT03279588|Abdominal Ultrasound|abdominal ultrasound
5114752|NCT03279588|Emergency Department|emergency department
5114760|NCT03279510|auditory perception|auditory perception
5114761|NCT03279510|hearing|hearing
5114763|NCT03279471|autism spectrum disorder|autism spectrum disorder
5114854|NCT03278964|Graves Disease|graves disease
5114962|NCT03278275|neuroendocrine tumors|neuroendocrine tumors
5115253|NCT03276104|Scleral suturing|scleral suturing
5115254|NCT03276104|Verisyse|verisyse
5115255|NCT03276104|Iris-claw|iris-claw
5115352|NCT03275402|Radioimmunotherapy|radioimmunotherapy
5115353|NCT03275402|Neuroblastoma|neuroblastoma
5115454|NCT03274674|PRF|prf
5115550|NCT03273959|Physical Therapy|physical therapy
5115551|NCT03273959|Exercise|exercise
5115552|NCT03273959|Hospitalization|hospitalization
5115553|NCT03273959|Pediatric|pediatric
5115554|NCT03273959|Adolescents|adolescents
5115555|NCT03273946|CCI18781|cci18781
5115556|NCT03273946|Observational|observational
5115559|NCT03273946|Asthma|asthma
5115640|NCT03273192|adalimumab|adalimumab
5115641|NCT03273192|single dose|single dose
5115642|NCT03273192|Phase 1|phase 1
5115643|NCT03273192|PK|pk
5115851|NCT03271866|Metabolic syndrome|metabolic syndrome
5115852|NCT03271866|Metformin|metformin
5115853|NCT03271866|Cognitive impairment|cognitive impairment
5115854|NCT03271866|Clinical trial|clinical trial
5115855|NCT03271827|Apnoeic oxygenation|apnoeic oxygenation
5115856|NCT03271827|Airway management|airway management
5115857|NCT03271827|Oxygen insufflation|oxygen insufflation
5115858|NCT03271827|Paediatric general anaesthesia|paediatric general anaesthesia
5115859|NCT03271775|Dizziness|dizziness
5115944|NCT03271450|comparative safety|comparative safety
5115945|NCT03271450|comparative effectiveness|comparative effectiveness
5115946|NCT03271385|hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5115947|NCT03271385|hypertensive Heart Disease|hypertensive heart disease
5115948|NCT03271385|cardiac magnetic resonance|cardiac magnetic resonance
5115949|NCT03271307|self-test|self-test
5116167|NCT03269981|Prospective study|prospective study
5116168|NCT03269942|Intracranial Aneurysm|intracranial aneurysm
5116169|NCT03269942|Flow Diverter|flow diverter
5116170|NCT03269942|Cerebral Revascularization|cerebral revascularization
5116171|NCT03269851|neurological deficit|neurological deficit
5116172|NCT03269799|uncontrolled type 2 diabetes mellitus|uncontrolled type 2 diabetes mellitus
5116173|NCT03269799|periodontitis|periodontitis
5927108|NCT03969979|epididymo-orchitis|epididymo-orchitis
5927109|NCT03969979|shear wave elastography|shear wave elastography
5116174|NCT03269799|non surgical periodontal treatment|non surgical periodontal treatment
5116256|NCT03269331|evidence-based practice models|evidence-based practice models
5116257|NCT03269331|military nursing|military nursing
5116258|NCT03269331|clinical inquiry|clinical inquiry
5116259|NCT03269266|Scrub Typhus|scrub typhus
5116261|NCT03269253|ALSPAC|alspac
5116356|NCT03268746|Cataract|cataract
5116357|NCT03268746|Prospective|prospective
5116358|NCT03268746|Single Arm|single arm
5116588|NCT03267173|CEA|cea
5116597|NCT03267108|PF|pf
5116693|NCT03266549|infantile esotropia|infantile esotropia
5116694|NCT03266536|Gut microbiota|gut microbiota
5116809|NCT03265782|preterms|preterms
5116810|NCT03265769|Femoral approach|femoral approach
5116811|NCT03265769|Radial approach|radial approach
5116812|NCT03265769|Chronic total occlusion|chronic total occlusion
5116813|NCT03265730|Outpatient clinics|outpatient clinics
5116814|NCT03265730|oral antibiotics|oral antibiotics
5116815|NCT03265730|diarrhea|diarrhea
5116816|NCT03265717|telomerase, tert, cancer vaccine|telomerase, tert, cancer vaccine
5116817|NCT03265704|Maternal PIH|maternal pih
5116818|NCT03265704|Neonatal thrombocytopenia|neonatal thrombocytopenia
5116819|NCT03265704|Neonatal neutropenia|neonatal neutropenia
5660995|NCT00659529|pH|ph
5116820|NCT03265691|Accidental Falls|accidental falls
5116821|NCT03265691|Hyponatremia|hyponatremia
5116822|NCT03265691|Elderly|elderly
5116823|NCT03265691|Risk factors|risk factors
5116824|NCT03265691|Nurse|nurse
5116825|NCT03265665|walking|walking
5116826|NCT03265665|African American women|african american women
5116827|NCT03265665|community-based|community-based
5116831|NCT03265587|Feng Shui|feng shui
5116833|NCT03265587|Chi|chi
5116899|NCT03264989|crizanlizumab|crizanlizumab
5116900|NCT03264989|monoclonal antibody|monoclonal antibody
5116901|NCT03264989|Anemia, Sickle Cell|anemia, sickle cell
5116902|NCT03264989|HbS Disease|hbs disease
5117115|NCT03263663|adjuvant|adjuvant
5117116|NCT03263650|prostate cancer|prostate cancer
5117117|NCT03263650|genomic alterations|genomic alterations
5117118|NCT03263650|DNA damage repair|dna damage repair
5117119|NCT03263650|DDR pathway gene expression|ddr pathway gene expression
5117121|NCT03263650|small cell prostate carcinoma|small cell prostate carcinoma
5117214|NCT03263065|Bran|bran
5117215|NCT03263065|Psyllium|psyllium
5117216|NCT03263052|kidney transplant|kidney transplant
5117321|NCT03262363|Polymorphism,|polymorphism,
5117322|NCT03262363|Diabetes,|diabetes,
5117323|NCT03262363|Chronic kidney disease|chronic kidney disease
5117424|NCT03261674|Insomnia|insomnia
5117425|NCT03261674|Traumatic Brain Injury|traumatic brain injury
5117426|NCT03261674|Cognitive Behavioral Therapy|cognitive behavioral therapy
5117427|NCT03261674|Veterans|veterans
5117428|NCT03261622|Sacral Nerve Stimulation|sacral nerve stimulation
5117429|NCT03261622|Sacral Nerve Modulation|sacral nerve modulation
5117430|NCT03261609|extremely preterm|extremely preterm
5117431|NCT03261609|young adults|young adults
5117432|NCT03261609|CVD risks factors|cvd risks factors
5117433|NCT03261609|inflammation|inflammation
5117434|NCT03261609|chronic health conditions|chronic health conditions
5117435|NCT03261609|term|term
5117436|NCT03261596|Soil-transmitted helminth|soil-transmitted helminth
5117437|NCT03261596|hookworm|hookworm
5117438|NCT03261596|hookworm infections|hookworm infections
5117524|NCT03260907|Electroacupuncture|electroacupuncture
5117525|NCT03260894|Renal cell carcinoma|renal cell carcinoma
5117526|NCT03260894|programmed cell death 1 (PD-1) inhibitor|programmed cell death 1 (pd-1) inhibitor
5117527|NCT03260894|indoleamine 2|indoleamine 2
5117528|NCT03260894|3-dioxygenase 1 (IDO1) inhibitor|3-dioxygenase 1 (ido1) inhibitor
5117529|NCT03260881|Epicardial Fat|epicardial fat
5117530|NCT03260855|Lymphoma|lymphoma
5117531|NCT03260855|Cancer survivorship|cancer survivorship
5117532|NCT03260855|Fear|fear
5927132|NCT03968211|immunodeficiency|immunodeficiency
5927133|NCT03968211|IgE|ige
5889462|NCT04089111|Safety|safety
5117533|NCT03260842|early detection|early detection
5117534|NCT03260842|biomarkers|biomarkers
5117535|NCT03260842|pancreas cancer|pancreas cancer
5117642|NCT03260205|Neurobehavioral disorder|neurobehavioral disorder
5117643|NCT03260192|circulating tumor DNA|circulating tumor dna
5117645|NCT03260166|lupus-associated skin lesion|lupus-associated skin lesion
5117835|NCT03259074|ankylosing spondylitis, AS, secukinumab, GP2017, adalimumab biosimilar, mSASSS, ASAS20|ankylosing spondylitis, as, secukinumab, gp2017, adalimumab biosimilar, msasss, asas20
5117836|NCT03259009|colorectal cancer|colorectal cancer
5117837|NCT03259009|anti-EGFR therapy|anti-egfr therapy
5117838|NCT03259009|rechallenge|rechallenge
5117839|NCT03259009|circulating tumor DNA|circulating tumor dna
5118045|NCT03257839|ATUS|atus
5118046|NCT03257839|ABTUS|abtus
5118051|NCT03257839|DBT|dbt
5118155|NCT03257254|GSV|gsv
5118266|NCT03256643|craniocerebral trauma|craniocerebral trauma
5118267|NCT03256643|exercise therapy|exercise therapy
5118272|NCT03256630|Active Surveillance|active surveillance
5118273|NCT03256630|Radical Prostatectomy|radical prostatectomy
5118274|NCT03256617|low back pain|low back pain
5118275|NCT03256617|cognitive reassurance|cognitive reassurance
5927202|NCT03960541|HIV Dyslipidemias|hiv dyslipidemias
5927203|NCT03960541|CD24Fc|cd24fc
5927204|NCT03960541|HIV Chronic Inflammation|hiv chronic inflammation
5927205|NCT03960541|LDL Reduction|ldl reduction
5889551|NCT04079790|GSK2140944|gsk2140944
5118276|NCT03256617|physical therapist training|physical therapist training
5118277|NCT03256604|point of care, HGF, innate immunity|point of care, hgf, innate immunity
5118282|NCT03256461|sepsis|sepsis
5118283|NCT03256461|lactate clearance|lactate clearance
5118284|NCT03256461|protocolized resuscitation|protocolized resuscitation
5118285|NCT03256422|Controlled, virological and therapeutic success, treatment discontinution, 4 days per week|controlled, virological and therapeutic success, treatment discontinution, 4 days per week
5118286|NCT03256409|biomaterials|biomaterials
5118438|NCT03255421|reverse cystometry|reverse cystometry
5118439|NCT03255421|follow-up|follow-up
5118440|NCT03255395|MRI|mri
5118441|NCT03255395|Ultrasound|ultrasound
5118442|NCT03255395|Phantom Limb Pain|phantom limb pain
5118443|NCT03255395|Residual Limb Pain|residual limb pain
5118444|NCT03255395|Neuroma|neuroma
5118450|NCT03255369|Child|child
5118834|NCT03253211|Emergency Department Clinicians|emergency department clinicians
5118835|NCT03253211|Co-management|co-management
5680752|NCT00576563|FDG-PET-CT|fdg-pet-ct
5118943|NCT03252353|Octreotide Capsules, Acromegaly, OPTIMAL, MYCAPSSA|octreotide capsules, acromegaly, optimal, mycapssa
5118945|NCT03252301|post operative|post operative
5118946|NCT03252301|surgery|surgery
5118947|NCT03252301|objective|objective
5118948|NCT03252236|Stroke|stroke
5118949|NCT03252236|Tai Chi|tai chi
5118950|NCT03252236|Dual-tasking|dual-tasking
5119034|NCT03251742|MRI|mri
5119131|NCT03250975|Intubation injury|intubation injury
5119132|NCT03250975|Acute laryngeal injury|acute laryngeal injury
5119133|NCT03250975|Chronic Laryngeal Injury|chronic laryngeal injury
5119134|NCT03250962|Relapsed/Refractory; Hodgkin Lymphoma；Decitabine; SHR-1210|relapsed/refractory; hodgkin lymphoma；decitabine; shr-1210
5119135|NCT03250936|trampoline|trampoline
5119136|NCT03250923|Oral Candidiasis, Thrush, Oral Moniliasis|oral candidiasis, thrush, oral moniliasis
5119138|NCT03250910|human immunodeficiency virus|human immunodeficiency virus
5119139|NCT03250910|Direct acting antiviral agent|direct acting antiviral agent
5119140|NCT03250897|Alveolar macrophages|alveolar macrophages
5119141|NCT03250897|Blood monocyte-derived macrophages|blood monocyte-derived macrophages
5119142|NCT03250897|FACS analysis|facs analysis
5119213|NCT03250559|Stone disease|stone disease
5119214|NCT03250533|Wound healing|wound healing
5119215|NCT03250533|Phototherapy|phototherapy
5119216|NCT03250533|Electrotherapy|electrotherapy
5119217|NCT03250507|TAP block|tap block
5119307|NCT03249974|accuracy|accuracy
5119634|NCT03247946|infant|infant
5119635|NCT03247946|feeding position|feeding position
5119636|NCT03247946|respiratory|respiratory
5119637|NCT03247946|ear|ear
5119638|NCT03247933|COPD|copd
5184515|NCT02836405|ASD|asd
5119639|NCT03247933|RESPIRATORY REHABILITATION TELEMEDICINE|respiratory rehabilitation telemedicine
5119725|NCT03247296|Sofosbuvir|sofosbuvir
5119923|NCT03245866|Neurosurgery|neurosurgery
5119924|NCT03245866|Interventional Neuroradiology|interventional neuroradiology
5119925|NCT03245866|Neurointensive Care Medicine|neurointensive care medicine
5119926|NCT03245866|Switzerland|switzerland
5119927|NCT03245853|Keratoconus|keratoconus
5119928|NCT03245853|Corneal Crosslinking|corneal crosslinking
5119929|NCT03245853|CXL|cxl
5119930|NCT03245814|service dogs|service dogs
5119933|NCT03245801|Canada|canada
5120138|NCT03244202|Genomic Sequencing|genomic sequencing
5120139|NCT03244202|Randomized Controlled Trail|randomized controlled trail
5120140|NCT03244202|Genetic Counselling|genetic counselling
5120141|NCT03244189|Urinary Stone Disease|urinary stone disease
5120142|NCT03244189|Kidney Stone|kidney stone
5120143|NCT03244189|Urinary Calculi|urinary calculi
5120145|NCT03244163|Spyglass DS|spyglass ds
5120146|NCT03244163|Laser lithotripsy|laser lithotripsy
5120343|NCT03242967|HIF|hif
5120452|NCT03241992|Patient Portal|patient portal
5120453|NCT03241992|Quality of Life|quality of life
5120550|NCT03241290|Radiological|radiological
5120551|NCT03241277|social phobia|social phobia
5889641|NCT04069689|Clemizole|clemizole
5120552|NCT03241277|anxiety disorders|anxiety disorders
5120553|NCT03241277|DSM-IV TR|dsm-iv tr
5120554|NCT03241277|periodontal disease|periodontal disease
5120555|NCT03241277|non surgical periodontal treatment|non surgical periodontal treatment
5120556|NCT03241251|psychosocial risk|psychosocial risk
5120557|NCT03241225|Elder abuse|elder abuse
5120558|NCT03241225|Depression|depression
5120559|NCT03241225|Mental health|mental health
5120560|NCT03241212|adolescent|adolescent
5120639|NCT03240822|Amputation|amputation
5120846|NCT03239743|pre-operative anxiety|pre-operative anxiety
5121182|NCT03237858|remote monitoring|remote monitoring
5121183|NCT03237819|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5121184|NCT03237819|Intensive care|intensive care
5121185|NCT03237806|ARDS,|ards,
5121186|NCT03237806|Transpulmonary pressure,|transpulmonary pressure,
5121187|NCT03237806|Sedation|sedation
5121188|NCT03237754|migraine|migraine
5121189|NCT03237754|neurostimulation|neurostimulation
5121190|NCT03237754|neuroimaging|neuroimaging
5121191|NCT03237754|tDCS|tdcs
5121490|NCT03235882|gastric aspirate|gastric aspirate
5121499|NCT03235830|Health literacy|health literacy
5121593|NCT03235427|Coronary Vessels|coronary vessels
5121594|NCT03235427|Radiation|radiation
5121600|NCT03235427|Cardiac toxicity|cardiac toxicity
5121601|NCT03235427|Cardiac calcium score|cardiac calcium score
5121602|NCT03235427|Chest RT|chest rt
5121603|NCT03235427|Lung Cancer|lung cancer
5121604|NCT03235427|Lymphoma|lymphoma
5121605|NCT03235427|Cardiac CT Scan|cardiac ct scan
5121606|NCT03235427|Coronary Artery|coronary artery
5121607|NCT03235427|Coronary arteries|coronary arteries
5121608|NCT03235427|Cardiac Side Effect|cardiac side effect
5121609|NCT03235427|Cardiac tissue|cardiac tissue
5121610|NCT03235427|Cardiac|cardiac
5121611|NCT03235401|Questionnaire|questionnaire
5121612|NCT03235401|Disability assessment|disability assessment
5121613|NCT03235401|Bothersomeness|bothersomeness
5121614|NCT03235401|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5121777|NCT03234257|Plaque stability|plaque stability
5121866|NCT03233841|Infant, Newborn Diseases|infant, newborn diseases
5121870|NCT03233828|Immunotherapy|immunotherapy
5121975|NCT03233399|Magnetoencephalography|magnetoencephalography
5122265|NCT03230994|Complications|complications
5121976|NCT03233399|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5121977|NCT03233373|Nasal Airway Obstruction|nasal airway obstruction
5121978|NCT03233373|Devices|devices
5121979|NCT03233373|Imaging, Diagnostic|imaging, diagnostic
5121983|NCT03233321|Pain|pain
5122155|NCT03231813|irritant contact dermatitis|irritant contact dermatitis
5122156|NCT03231813|sodium lauryl sulphate|sodium lauryl sulphate
5122158|NCT03231813|transepidermal water loss|transepidermal water loss
5122159|NCT03231800|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
5122247|NCT03231085|iron intravenous|iron intravenous
5122248|NCT03231072|mechanical ventilation|mechanical ventilation
5122249|NCT03231072|pleural effusion|pleural effusion
5122251|NCT03231059|Coronary artery disease|coronary artery disease
5122252|NCT03231059|Percutaneous coronary intervention|percutaneous coronary intervention
5122253|NCT03231059|Drug-eluting stent|drug-eluting stent
5122254|NCT03231059|Antiplatelet drugs|antiplatelet drugs
5122255|NCT03231059|Clinical event committee|clinical event committee
5122256|NCT03231020|single ventricle|single ventricle
5122257|NCT03231020|pediatric cardiology|pediatric cardiology
5122336|NCT03230695|robotic therapy|robotic therapy
5122337|NCT03230695|transcranial direct current stimulation|transcranial direct current stimulation
5122338|NCT03230682|early improvement|early improvement
5122339|NCT03230682|antidepressants|antidepressants
5122340|NCT03230682|major depression diorder|major depression diorder
5122341|NCT03230682|resting-state fMRI|resting-state fmri
5122342|NCT03230669|substance abuse|substance abuse
5122423|NCT03230084|Progesterone|progesterone
5122424|NCT03230084|Urine dipstick test|urine dipstick test
5122425|NCT03230084|Feasibility study|feasibility study
5122426|NCT03230084|Fertile period|fertile period
5122427|NCT03230084|Menstrual cycle|menstrual cycle
5122430|NCT03230071|Herbal therapy|herbal therapy
5122528|NCT03229408|Anovulation|anovulation
5122529|NCT03229408|Insulin Resistance|insulin resistance
5122530|NCT03229395|skeletal muscle|skeletal muscle
5122531|NCT03229395|muscle mass|muscle mass
5122532|NCT03229395|glucocorticoids|glucocorticoids
5927234|NCT03955523|SCI|sci
5927235|NCT03955523|paraplegia|paraplegia
5927236|NCT03955523|tetraplegia|tetraplegia
5927237|NCT03955523|quadriplegia|quadriplegia
5927238|NCT03955523|spinal cord|spinal cord
5889758|NCT04059588|Cancer|cancer
5122533|NCT03229395|biomarkers|biomarkers
5122534|NCT03229382|MCL, obinutuzumab|mcl, obinutuzumab
5122535|NCT03229369|ACL|acl
5122536|NCT03229369|ALL|all
5122537|NCT03229369|Ligament injury|ligament injury
5122538|NCT03229369|Reconstruction|reconstruction
5122539|NCT03229343|idiopathic pulmonary fibrosis, palliative care|idiopathic pulmonary fibrosis, palliative care
5122540|NCT03229330|Wound Healing|wound healing
5122541|NCT03229330|Outcome Assessment (Health Care)|outcome assessment (health care)
5122637|NCT03228641|wrinkle removal|wrinkle removal
5122638|NCT03228641|skin laxity reduction|skin laxity reduction
5122639|NCT03228628|Spinal puncture|spinal puncture
5122640|NCT03228628|Pain|pain
5122641|NCT03228628|Anxiety|anxiety
5122642|NCT03228628|Nitrous oxyde|nitrous oxyde
5122643|NCT03228615|shared decision making|shared decision making
5122644|NCT03228576|Tacrolimus|tacrolimus
5122645|NCT03228576|Envarsus|envarsus
5122646|NCT03228576|Everolimus|everolimus
5122647|NCT03228576|kidney|kidney
5122730|NCT03228056|videothoracoscopic surgery|videothoracoscopic surgery
5122731|NCT03228056|thoracic epidural analgesia|thoracic epidural analgesia
5122732|NCT03228056|lung lobectomy|lung lobectomy
5122733|NCT03228043|Apatinib|apatinib
5122734|NCT03228043|Outcome, Fatal|outcome, fatal
5122735|NCT03228043|Colorectal Cancer|colorectal cancer
5122736|NCT03228043|surgery|surgery
5122737|NCT03228043|adjuvant chemotherapy|adjuvant chemotherapy
5122738|NCT03228030|thiamine|thiamine
5122739|NCT03228030|heart failure|heart failure
5122740|NCT03228030|heart failure with reduced ejection fraction|heart failure with reduced ejection fraction
5122741|NCT03228030|geriatric|geriatric
5122742|NCT03228030|thiamin|thiamin
5122743|NCT03228030|vitamin b1|vitamin b1
5122824|NCT03227510|Hepatocellular Carcinoma , MicroRNAs, Somalia|hepatocellular carcinoma , micrornas, somalia
5122825|NCT03227497|Blood Pressure|blood pressure
5122826|NCT03227497|Cholesterol|cholesterol
5122827|NCT03227497|Triglycerides|triglycerides
5122828|NCT03227497|Walnuts|walnuts
5122829|NCT03227458|areal bone mineral density|areal bone mineral density
5122923|NCT03226925|radiotherapy|radiotherapy
5122924|NCT03226925|ventilator|ventilator
5122925|NCT03226873|HIV prevention|hiv prevention
5122926|NCT03226873|PrEP|prep
5122927|NCT03226873|peer navigation|peer navigation
5122991|NCT03226574|RTX|rtx
5123023|NCT03226366|antimicrobial|antimicrobial
5123024|NCT03226366|care reorganization|care reorganization
5123025|NCT03226366|severe sepsis|severe sepsis
5123026|NCT03226366|swarming|swarming
5123027|NCT03226314|bacterial multi-resitance|bacterial multi-resitance
5123028|NCT03226288|Plantar Fascitis|plantar fascitis
5123029|NCT03226288|orthopedic|orthopedic
5123030|NCT03226288|3D surface scanning|3d surface scanning
5123031|NCT03226275|Concor AM®|concor am®
5123032|NCT03226275|Concor®|concor®
5123033|NCT03226275|Norvasc®|norvasc®
5123034|NCT03226275|Bisoprolol|bisoprolol
5123035|NCT03226275|Amlodipine|amlodipine
5123036|NCT03226275|Bisoprolol-Amlodipine fixed dose combination|bisoprolol-amlodipine fixed dose combination
5123037|NCT03226275|Chinese Participants|chinese participants
5123039|NCT03226236|vaccination|vaccination
5123040|NCT03226236|dendritic cells|dendritic cells
5123041|NCT03226236|autologous tumor homogenate|autologous tumor homogenate
5123042|NCT03226236|High Dose -IL2|high dose -il2
5123043|NCT03226236|immunomodulating radiotherapy|immunomodulating radiotherapy
5123044|NCT03226236|secondary|secondary
5123045|NCT03226210|Diabetes Mellitus|diabetes mellitus
5123097|NCT03225898|resistance exercise|resistance exercise
5123098|NCT03225885|gestational age|gestational age
5123099|NCT03225885|multi-media|multi-media
5123100|NCT03225885|mobile application|mobile application
5123101|NCT03225885|anxiety|anxiety
5123102|NCT03225885|clinical trial|clinical trial
5123134|NCT03225703|MRI|mri
5123203|NCT03225365|Ipilimumab|ipilimumab
5123204|NCT03225365|Immune modulation|immune modulation
5123205|NCT03225326|articaine|articaine
5123312|NCT03224676|Perceived sleep distractors|perceived sleep distractors
5123313|NCT03224676|Adult patients|adult patients
5123314|NCT03224663|Effectiveness|effectiveness
5123315|NCT03224663|Module based learning|module based learning
5123316|NCT03224663|Mobile application based learning|mobile application based learning
5123317|NCT03224663|Facility based newborn care|facility based newborn care
5123414|NCT03224000|Squamous cell carcinoma of the tonsil|squamous cell carcinoma of the tonsil
5123420|NCT03224000|Radiation Therapy|radiation therapy
5123650|NCT03222596|Pain|pain
5123651|NCT03222596|Motivation|motivation
5123652|NCT03222596|Multiple sclerosis|multiple sclerosis
5123974|NCT03220412|media|media
5123975|NCT03220386|staphylococcus aureus|staphylococcus aureus
5123976|NCT03220386|nosocomial infection|nosocomial infection
5123977|NCT03220386|decolonization|decolonization
5123978|NCT03220386|emergency department|emergency department
5123979|NCT03220373|Neuropsychology|neuropsychology
5123980|NCT03220373|Cognition|cognition
5124096|NCT03219385|uterine myoma|uterine myoma
5124097|NCT03219385|abnormal menstrual bleeding|abnormal menstrual bleeding
5124098|NCT03219385|heavy menstrual bleeding|heavy menstrual bleeding
5124099|NCT03219385|menorrhagia|menorrhagia
5124102|NCT03219359|IBD|ibd
5124197|NCT03218995|dystrophin|dystrophin
5124327|NCT03218267|total hip replacement|total hip replacement
5124328|NCT03218267|static disbalance|static disbalance
5124329|NCT03218254|hematological cancer, fatigue, quality of life|hematological cancer, fatigue, quality of life
5124330|NCT03218241|Healthy Volunteers|healthy volunteers
5124331|NCT03218228|aggressive periodontitis|aggressive periodontitis
5124332|NCT03218215|cough assits|cough assits
5124333|NCT03218202|Inflammatory Bowel Disease|inflammatory bowel disease
5124334|NCT03218202|Crohn Disease|crohn disease
5124335|NCT03218202|Ulcerative Colitis|ulcerative colitis
5124437|NCT03217513|osteoarthritis|osteoarthritis
5124438|NCT03217513|knee|knee
5124440|NCT03217396|synaptic plasticity|synaptic plasticity
5124441|NCT03217396|neuroinflammation|neuroinflammation
5124442|NCT03217396|neurodegeneration|neurodegeneration
5124443|NCT03217383|Oral appliance therapy|oral appliance therapy
5124453|NCT03217201|Oncology|oncology
5124528|NCT03216590|Soft Tissue Swelling|soft tissue swelling
5124529|NCT03216590|Rotator Cuff Repair|rotator cuff repair
5124530|NCT03216590|Shoulder Arthroscopy Complications|shoulder arthroscopy complications
5124747|NCT03215160|Mobilization|mobilization
5124748|NCT03215160|Manual Therapies|manual therapies
5124749|NCT03215160|Exercise|exercise
5124750|NCT03215147|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5124751|NCT03215147|Airway Disease|airway disease
5124752|NCT03215134|Improving Access to Psychological Therapies (IAPT)|improving access to psychological therapies (iapt)
5124753|NCT03215134|Primary mental health service|primary mental health service
5124754|NCT03215134|Compassion Focused Therapy (CFT)|compassion focused therapy (cft)
5124839|NCT03214432|Sickness absence|sickness absence
5124946|NCT03213782|Agitation|agitation
5125047|NCT03213145|drug-drug interaction|drug-drug interaction
5125049|NCT03213132|insomnia|insomnia
5125050|NCT03213132|CBT|cbt
5125057|NCT03213106|TMS|tms
5125264|NCT03211845|Ehealth|ehealth
5125540|NCT03209947|Ulnar Neuropathies|ulnar neuropathies
5125635|NCT03209206|Intravesical Chemotherapy|intravesical chemotherapy
5125636|NCT03209206|Docetaxel|docetaxel
5125849|NCT03207737|Mindfulness|mindfulness
5125850|NCT03207737|Nutrition|nutrition
5125851|NCT03207737|Exercise|exercise
5125852|NCT03207724|advanced pancreatic cancer|advanced pancreatic cancer
5125853|NCT03207724|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5125854|NCT03207724|recurrent diagnosis|recurrent diagnosis
5126060|NCT03206580|strength training|strength training
5126062|NCT03206567|Hair thinning, Hair loss, Women, Nutraceutical supplement|hair thinning, hair loss, women, nutraceutical supplement
5126065|NCT03206515|Renal Pelvic Pressure|renal pelvic pressure
5126169|NCT03205813|Pain, Postoperative|pain, postoperative
5126170|NCT03205813|Cesarean delivery|cesarean delivery
5126171|NCT03205813|Intrathecal morphine|intrathecal morphine
5126172|NCT03205761|Advanced Breast Cancer|advanced breast cancer
5126173|NCT03205761|Triple Negative|triple negative
5126174|NCT03205761|olaparib|olaparib
5126175|NCT03205761|lynparza|lynparza
5126368|NCT03204487|OCT|oct
5126484|NCT03203707|early intervention|early intervention
5126592|NCT03203369|Natural Killer (NK) cell blastic lymphoma|natural killer (nk) cell blastic lymphoma
5126593|NCT03203369|Hematologic malignancies|hematologic malignancies
5126594|NCT03203369|Cluster of differentiation (CD) CD4+CD56+ hematodermic tumor|cluster of differentiation (cd) cd4+cd56+ hematodermic tumor
5126595|NCT03203369|Acute leukemia and myeloid neoplasms|acute leukemia and myeloid neoplasms
5126597|NCT03203369|Allogeneic|allogeneic
5126680|NCT03202719|Inactivated polio vaccine|inactivated polio vaccine
5126681|NCT03202719|Polio|polio
5126682|NCT03202719|oral polio vaccine|oral polio vaccine
5126686|NCT03202641|ARDS|ards
5126879|NCT03201341|Multisensory|multisensory
5126880|NCT03201341|Plasticity|plasticity
5126881|NCT03201341|Body|body
5126882|NCT03201341|Space|space
5126883|NCT03201341|MRI|mri
5128815|NCT03189316|Human|human
5127024|NCT03200457|Liver iron|liver iron
5127025|NCT03200457|Liver steatosis|liver steatosis
5127027|NCT03200405|umbilical hernia|umbilical hernia
5127028|NCT03200405|mesh repair|mesh repair
5127029|NCT03200405|MRI-visibility|mri-visibility
5127030|NCT03200405|underlay|underlay
5127031|NCT03200405|NANEP|nanep
5127032|NCT03200405|DynaMeshCICAT|dynameshcicat
5127033|NCT03200405|DynaMeshVisible|dynameshvisible
5127034|NCT03200405|preperitoneal|preperitoneal
5127035|NCT03200392|Er,Cr:YSGG laser|er,cr:ysgg laser
5127036|NCT03200392|connective tissue graft|connective tissue graft
5127037|NCT03200392|root coverage|root coverage
5127038|NCT03200392|mucogingival surgery|mucogingival surgery
5127039|NCT03200392|gingival recession|gingival recession
5127040|NCT03200366|Cancer Screening Tests|cancer screening tests
5127041|NCT03200366|Colonoscopy|colonoscopy
5127042|NCT03200275|Legionella urine antigen test|legionella urine antigen test
5127043|NCT03200249|dose escalation, chemo-radiation, rectum cancer, phase 2|dose escalation, chemo-radiation, rectum cancer, phase 2
5127044|NCT03200236|Lung Cancer Screening|lung cancer screening
5127045|NCT03200236|Smoking Cessation|smoking cessation
5127046|NCT03200236|Tobacco Use|tobacco use
5127048|NCT03200210|Hyperuricemia|hyperuricemia
5127053|NCT03200197|Saliva|saliva
5127099|NCT03199924|acute pain|acute pain
5127100|NCT03199924|Renal colic|renal colic
5127219|NCT03199196|Surveys|surveys
5127324|NCT03198468|Non Small Cell Lung Cancer|non small cell lung cancer
5127325|NCT03198468|Metastatic Lung Cancer|metastatic lung cancer
5127327|NCT03198468|Vapor Ablation|vapor ablation
5127328|NCT03198468|BTVA|btva
5127329|NCT03198429|domestic violence|domestic violence
5127331|NCT03198429|fathers|fathers
5127420|NCT03197792|Venous congestion|venous congestion
5127425|NCT03197766|Achondroplasia|achondroplasia
5127532|NCT03197168|low-and-middle income countries|low-and-middle income countries
5127533|NCT03197142|cardiac arrest|cardiac arrest
5127534|NCT03197142|resuscitation|resuscitation
5127535|NCT03197142|Out-Of-Hospital Cardiac Arrest|out-of-hospital cardiac arrest
5127536|NCT03197142|CPR|cpr
5127642|NCT03196505|Bupivacaine|bupivacaine
5127643|NCT03196505|Postoperative Complications|postoperative complications
5127644|NCT03196505|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
5127645|NCT03196505|Sleeve Gastrectomy|sleeve gastrectomy
5127742|NCT03195673|Silent embolism|silent embolism
5127743|NCT03195673|Terazosin|terazosin
5127744|NCT03195660|adaptive servo-ventilation|adaptive servo-ventilation
5127745|NCT03195660|ASV|asv
5127746|NCT03195660|HFpEF|hfpef
5127747|NCT03195647|cardiovascular|cardiovascular
5127748|NCT03195647|potassium supplementation|potassium supplementation
5127835|NCT03195114|cardiac MRI|cardiac mri
5127836|NCT03195114|echocardiography|echocardiography
5127837|NCT03195114|biomarkers|biomarkers
5127838|NCT03195101|orbital tumors|orbital tumors
5927331|NCT03947112|Physical activity level|physical activity level
5127839|NCT03195101|transconjunctival approach|transconjunctival approach
5127840|NCT03195062|Fructose|fructose
5127932|NCT03194659|Nutrition|nutrition
5127933|NCT03194659|choline|choline
5127934|NCT03194659|pregnancy|pregnancy
5127935|NCT03194659|docosahexaenoic acid|docosahexaenoic acid
5127936|NCT03194659|DHA|dha
5127937|NCT03194659|fatty acids|fatty acids
5127939|NCT03194620|Flavanols|flavanols
5127940|NCT03194620|Cocoa Flavanols|cocoa flavanols
5127941|NCT03194620|Epicatechins|epicatechins
5127942|NCT03194620|Polyphenols|polyphenols
5127943|NCT03194620|Procyanidins|procyanidins
5127944|NCT03194620|EGCG|egcg
5127945|NCT03194620|EGC|egc
5128140|NCT03193333|primary open-angle glaucoma|primary open-angle glaucoma
5128141|NCT03193333|Ophthalmic antihypertensives|ophthalmic antihypertensives
5128147|NCT03193320|PVI|pvi
5128240|NCT03192800|clinical outcome|clinical outcome
5128241|NCT03192800|prognositic factor|prognositic factor
5128242|NCT03192800|spinal dural arteriovenous fistula|spinal dural arteriovenous fistula
5128473|NCT03191383|Maternal immunization|maternal immunization
5128474|NCT03191383|Immunogenicity|immunogenicity
5128475|NCT03191383|Vaccines|vaccines
5128476|NCT03191383|Safety|safety
5128477|NCT03191383|Reactogenicity|reactogenicity
5128478|NCT03191383|Respiratory Syncytial Virus|respiratory syncytial virus
5128479|NCT03191370|pain during laryngoscopy, Flexible nasal endoscopy|pain during laryngoscopy, flexible nasal endoscopy
5128480|NCT03191357|traumatic brain injury,posttraumatic stress,service member|traumatic brain injury,posttraumatic stress,service member
5128568|NCT03190967|Preventing the Formation of a Metastasis|preventing the formation of a metastasis
5128570|NCT03190954|[11C] NNC-112|[11c] nnc-112
5128571|NCT03190954|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5128572|NCT03190954|Dopamine D1 Receptor|dopamine d1 receptor
5128573|NCT03190954|D2 Receptors|d2 receptors
5128575|NCT03190941|HRAS|hras
5128576|NCT03190941|NRAS|nras
5128577|NCT03190941|Cell Therapy|cell therapy
5128578|NCT03190941|Immunotherapy|immunotherapy
5128584|NCT03190889|ACL Reconstruction|acl reconstruction
5128585|NCT03190889|Rehabilitation|rehabilitation
5128586|NCT03190889|Sports Injury|sports injury
5128587|NCT03190889|Neuromuscular Intervention|neuromuscular intervention
5128588|NCT03190889|Knee Injury|knee injury
5128589|NCT03190876|Drain usage|drain usage
5128590|NCT03190863|Tenodesis grasp|tenodesis grasp
5128591|NCT03190863|Neurofeedback|neurofeedback
5128592|NCT03190863|Motor imagery|motor imagery
5128593|NCT03190863|Reach-to-grasp|reach-to-grasp
5128594|NCT03190863|Rehabilitation|rehabilitation
5128651|NCT03190486|Baby cries|baby cries
5128652|NCT03190486|pain|pain
5128653|NCT03190486|brain responses|brain responses
5128654|NCT03190486|neuroimaging|neuroimaging
5128655|NCT03190486|fMRI|fmri
5128662|NCT03190317|Veteran|veteran
5128873|NCT03188887|GFR|gfr
5128951|NCT03188354|Positron-Emission Tomography|positron-emission tomography
5128952|NCT03188354|Magnetic Resonance Imaging|magnetic resonance imaging
5128961|NCT03188289|chitosan|chitosan
5129050|NCT03187873|Kenya|kenya
5129157|NCT03187314|Radiation|radiation
5129302|NCT03186339|QoL|qol
5129491|NCT03185169|postmenopausal|postmenopausal
5129492|NCT03185169|dysuria|dysuria
5129493|NCT03185169|dyspareunia|dyspareunia
5129494|NCT03185169|vaginal dryness|vaginal dryness
5757908|NCT00291512|MSM|msm
5129590|NCT03184480|asthma|asthma
5129591|NCT03184480|Post-marketing surveillance|post-marketing surveillance
5129592|NCT03184480|ARNUITY ELLIPTA|arnuity ellipta
5129593|NCT03184467|GV1001|gv1001
5129594|NCT03184467|Alzheimer Disease|alzheimer disease
5129595|NCT03184454|OCD|ocd
5129596|NCT03184454|deep brain stimulation|deep brain stimulation
5129597|NCT03184454|treatment-resistant OCD|treatment-resistant ocd
5129598|NCT03184428|YAG-Laser Capsulotomy|yag-laser capsulotomy
5129599|NCT03184389|Behavioral Counseling|behavioral counseling
5129600|NCT03184389|Cigarette Smoking|cigarette smoking
5129622|NCT03184337|Women|women
5129883|NCT03182790|Incentives|incentives
5129884|NCT03182790|AWARD model|award model
5129885|NCT03182790|Smoking Cessation Intervention|smoking cessation intervention
5130089|NCT03181815|ACUTE MYELOID LEUKEMIA|acute myeloid leukemia
5130090|NCT03181789|HIV vaccine|hiv vaccine
5130091|NCT03181789|DNA vaccine|dna vaccine
5130093|NCT03181789|Electroporation|electroporation
5130094|NCT03181789|p24|p24
5130095|NCT03181789|Gag|gag
5130096|NCT03181789|Adjuvant|adjuvant
5130097|NCT03181789|Healthy|healthy
5130102|NCT03181750|Palliative Care|palliative care
5130104|NCT03181750|Patient Navigation|patient navigation
5130192|NCT03181165|Low-carbohydrate|low-carbohydrate
5130406|NCT03179579|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5130407|NCT03179579|Systemic Chemotherapy|systemic chemotherapy
5130408|NCT03179579|Cytoreductive Surgery|cytoreductive surgery
5130409|NCT03179566|drug disposal|drug disposal
5130410|NCT03179540|Low Rectal Cancer|low rectal cancer
5130411|NCT03179540|Complete Clinical Response|complete clinical response
5130412|NCT03179540|Non-operative Management|non-operative management
5130413|NCT03179527|Unstable Angina|unstable angina
5927381|NCT03941717|pain management|pain management
5927382|NCT03941717|children|children
5927383|NCT03941717|parents|parents
5927384|NCT03941717|mindfulness|mindfulness
5890183|NCT04017312|HFCWO|hfcwo
5130414|NCT03179527|Shuanghe Decoction|shuanghe decoction
5130415|NCT03179514|Unstable Angina|unstable angina
5130420|NCT03179475|Targin®|targin®
5130498|NCT03179033|Passive leg raising|passive leg raising
5130499|NCT03179020|Intensive Care Units|intensive care units
5130500|NCT03179020|Brain Death|brain death
5130501|NCT03179020|Organ Donation|organ donation
5130502|NCT03179020|Family interview|family interview
5130724|NCT03177447|Heart Failure, Congestive|heart failure, congestive
5130725|NCT03177434|constipation|constipation
5130726|NCT03177434|children|children
5130727|NCT03177434|polyethylene glycols (PEG)|polyethylene glycols (peg)
5130728|NCT03177434|lactulose|lactulose
5130729|NCT03177408|Diastolic Dysfunction|diastolic dysfunction
5130814|NCT03176732|Hypertension|hypertension
5130815|NCT03176732|Positive Airway Pressure|positive airway pressure
5130816|NCT03176732|Blood Pressure|blood pressure
5130819|NCT03176641|Platelet-Rich Plasma|platelet-rich plasma
5130908|NCT03176264|ElevatION;CRC-101|elevation;crc-101
5130909|NCT03176238|post menopausal|post menopausal
5130910|NCT03176238|advanced breast cancer|advanced breast cancer
5130911|NCT03176238|metastatic breast cancer|metastatic breast cancer
5130913|NCT03176238|exemestane|exemestane
5130914|NCT03176238|mTor inhibitor|mtor inhibitor
5130917|NCT03176212|Cytokine|cytokine
5131001|NCT03175601|Gait speed|gait speed
5131185|NCT03174093|Mobile Health|mobile health
5131307|NCT03173287|IVIM|ivim
5131308|NCT03173287|1.5T MRI|1.5t mri
5131309|NCT03173248|Acute Myeloid Leukemia|acute myeloid leukemia
5131310|NCT03173248|Leukemia|leukemia
5131311|NCT03173248|Azacitidine|azacitidine
5131312|NCT03173248|AG-120|ag-120
5131313|NCT03173248|ivosidenib|ivosidenib
5131314|NCT03173209|school|school
5131315|NCT03173196|severe sepsis|severe sepsis
5131316|NCT03173196|encephalopathy|encephalopathy
5131317|NCT03173170|Drug Therapy|drug therapy
5131318|NCT03173144|Life Style|life style
5131319|NCT03173144|Diet|diet
5131392|NCT03172624|17-219|17-219
5131588|NCT03171220|Neoantigen Reactive T cells (NRTs)|neoantigen reactive t cells (nrts)
5131605|NCT03171129|high flow nasal canula|high flow nasal canula
5131608|NCT03171116|children|children
5131609|NCT03171064|Exercise|exercise
5131610|NCT03171064|Cancer|cancer
5131611|NCT03171064|Melanoma|melanoma
5131612|NCT03171064|Feasibility|feasibility
5131613|NCT03171064|PD-1 antibodies|pd-1 antibodies
5131614|NCT03171064|Checkpoint inhibitors|checkpoint inhibitors
5131615|NCT03171064|Immune system|immune system
5131716|NCT03170362|Depression|depression
5131717|NCT03170271|Asthma, Bronchial Diseases, Respiratory Tract Diseases, Lung Diseases, Obstructive Lung Diseases|asthma, bronchial diseases, respiratory tract diseases, lung diseases, obstructive lung diseases
5131838|NCT03169491|Adenotonsillectomy|adenotonsillectomy
5131718|NCT03170271|Additional relevant MeSH terms:|additional relevant mesh terms:
5131719|NCT03170271|Asthma|asthma
5131720|NCT03170271|Inflammation|inflammation
5131721|NCT03170271|Bronchial Diseases|bronchial diseases
5131722|NCT03170271|Respiratory Tract Diseases|respiratory tract diseases
5131723|NCT03170271|Lung Diseases, Obstructive|lung diseases, obstructive
5131724|NCT03170271|Lung Diseases Respiratory Hypersensitivity|lung diseases respiratory hypersensitivity
5131725|NCT03170271|Hypersensitivity, Immediate|hypersensitivity, immediate
5131726|NCT03170271|Hypersensitivity|hypersensitivity
5131727|NCT03170271|Immune System Diseases|immune system diseases
5131728|NCT03170271|Pathologic Processes|pathologic processes
5131729|NCT03170258|real-time fMRI|real-time fmri
5131730|NCT03170258|reward|reward
5131731|NCT03170258|motivation|motivation
5131732|NCT03170258|dopamine|dopamine
5131734|NCT03170232|HRQoL|hrqol
5131735|NCT03170232|Disease Progression|disease progression
5131783|NCT03169868|medication therapy management|medication therapy management
5131784|NCT03169855|Traffic Ophthalmology|traffic ophthalmology
5131785|NCT03169855|Glare|glare
5131786|NCT03169855|Cataract|cataract
5133460|NCT03158935|ovarian|ovarian
5131787|NCT03169855|Nighttime driving|nighttime driving
5131871|NCT03169218|Entrapment neuropathy. Carpal tunnel|entrapment neuropathy. carpal tunnel
5131872|NCT03169218|Exercise therapy|exercise therapy
5927386|NCT03941652|Continuous Glucose Values|continuous glucose values
5927387|NCT03941652|Physical Activity|physical activity
5927388|NCT03941652|Nutrition|nutrition
5927389|NCT03941652|Behaviour Change|behaviour change
5927390|NCT03941652|Stress|stress
5927391|NCT03941652|Recovery|recovery
5927392|NCT03941652|Human-Computer Interaction (HCI)|human-computer interaction (hci)
5927393|NCT03941652|Mobile Application|mobile application
5927394|NCT03941652|Diet|diet
5927395|NCT03941652|Self-tracking|self-tracking
5927396|NCT03941197|child development|child development
5927397|NCT03941197|family literacy program|family literacy program
5927398|NCT03941197|primary care|primary care
5131874|NCT03169218|Neuronal plasticity|neuronal plasticity
5131875|NCT03169218|Mirror neurons|mirror neurons
5131968|NCT03168711|ALS|als
5131969|NCT03168711|Inosine|inosine
5131970|NCT03168711|Uric acid|uric acid
5131971|NCT03168711|Urate|urate
5132090|NCT03167827|climateric|climateric
5132185|NCT03167151|Non-muscle invasive bladder cancer (NMIBC)|non-muscle invasive bladder cancer (nmibc)
5132198|NCT03167112|FOLFIRINOX|folfirinox
5132302|NCT03166150|Physical Therapy|physical therapy
5132303|NCT03166150|Multi-modal Rehabilitation|multi-modal rehabilitation
5132304|NCT03166150|Stress Urinary Incontinence|stress urinary incontinence
5132424|NCT03165474|childhood obesity|childhood obesity
5132425|NCT03165474|mhealth|mhealth
5132426|NCT03165474|digital health|digital health
5132427|NCT03165474|nutrition|nutrition
5132428|NCT03165474|intervention|intervention
5132429|NCT03165461|intubation to supraglottic devices|intubation to supraglottic devices
5132430|NCT03165461|intubating laryngeal tube|intubating laryngeal tube
5132431|NCT03165448|oral surgery|oral surgery
5132432|NCT03165448|psychology|psychology
5132433|NCT03165448|fear|fear
5132434|NCT03165448|pain|pain
5132435|NCT03165448|dentistry|dentistry
5132436|NCT03165396|mild cognitive impairment|mild cognitive impairment
5132444|NCT03165318|Muscle|muscle
5132527|NCT03164551|TICON|ticon
5132716|NCT03163368|neoadjuvant|neoadjuvant
5132834|NCT03162653|childbirth outcome|childbirth outcome
5132951|NCT03162224|PD-L1 inhibitor|pd-l1 inhibitor
5133308|NCT03159871|Cesarean section|cesarean section
5133403|NCT03159273|Cardiovascular activity|cardiovascular activity
5133404|NCT03159260|night-time leg cramps|night-time leg cramps
5133405|NCT03159260|topical|topical
5133406|NCT03159260|spasm|spasm
5133407|NCT03159247|education|education
5133408|NCT03159247|counseling|counseling
5133409|NCT03159247|motivational interviewing|motivational interviewing
5133410|NCT03159247|tailoring|tailoring
5133411|NCT03159221|type 2 diabetes in adolescents|type 2 diabetes in adolescents
5133412|NCT03159221|obesity in adolescents|obesity in adolescents
5133413|NCT03159221|behavioral family systems therapy|behavioral family systems therapy
5133414|NCT03159208|Prognosis|prognosis
5758754|NCT00288964|ARDS|ards
5133496|NCT03158766|spine|spine
5133497|NCT03158727|intensive care|intensive care
5133498|NCT03158701|evaluation|evaluation
5684176|NCT00561639|sepsis|sepsis
5133499|NCT03158675|fractional co2 laser, topical steroid,UVB narrow band|fractional co2 laser, topical steroid,uvb narrow band
5133500|NCT03158662|Epidermolysis Bullosa|epidermolysis bullosa
5133501|NCT03158662|Recessive Dystrophic|recessive dystrophic
5133502|NCT03158662|Simplex|simplex
5133504|NCT03158649|Pregnancy|pregnancy
5133699|NCT03157349|Acute Neck Pain|acute neck pain
5133700|NCT03157349|Placebo|placebo
5133701|NCT03157349|chiropractic|chiropractic
5133702|NCT03157336|Cassava|cassava
5133703|NCT03157336|Konzo|konzo
5133704|NCT03157336|Cyanide|cyanide
5133705|NCT03157336|Cyanate|cyanate
5133706|NCT03157336|Thiocyanate|thiocyanate
5133707|NCT03157336|Carbamoylation|carbamoylation
5133708|NCT03157336|Isoprostanes|isoprostanes
5133710|NCT03157323|Glycemic Index|glycemic index
5133803|NCT03157128|C634Y|c634y
5133804|NCT03157128|K666E|k666e
5134105|NCT03155503|tolerability|tolerability
5134106|NCT03155490|Hospital medical emergency team|hospital medical emergency team
5134107|NCT03155490|Leadership|leadership
5134108|NCT03155490|Simulation training|simulation training
5134109|NCT03155477|SLE, vitamin D, SLEDAI, IL-6, TGF- β1|sle, vitamin d, sledai, il-6, tgf- β1
5927405|NCT03940365|Labor|labor
5927406|NCT03940365|Uterine contraction|uterine contraction
5134110|NCT03155464|indocyanine-green|indocyanine-green
5134111|NCT03155464|systemic scerlosis|systemic scerlosis
5134112|NCT03155438|Oxidative stress|oxidative stress
5134113|NCT03155438|Cumulus cell|cumulus cell
5134114|NCT03155438|Controlled ovarian hyperstimulation|controlled ovarian hyperstimulation
5134115|NCT03155438|In vitro fertilization|in vitro fertilization
5134116|NCT03155438|Low responder|low responder
5134117|NCT03155412|Type 2 Diabetes|type 2 diabetes
5134118|NCT03155412|adipose tissue|adipose tissue
5134119|NCT03155412|preadipocytes|preadipocytes
5134120|NCT03155412|expandability|expandability
5134121|NCT03155412|hypertrophy|hypertrophy
5134122|NCT03155412|hyperplasia|hyperplasia
5134123|NCT03155412|lipogenesis|lipogenesis
5134124|NCT03155412|adipogenesis|adipogenesis
5134125|NCT03155412|insulin sensitivity|insulin sensitivity
5134127|NCT03155399|Neurorehabilitation|neurorehabilitation
5134128|NCT03155399|Proprioceptive Training|proprioceptive training
5134129|NCT03155399|Bilateral Arm Training|bilateral arm training
5134130|NCT03155399|Intracortical Inhibition|intracortical inhibition
5134131|NCT03155373|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5134132|NCT03155360|Colics|colics
5134133|NCT03155360|infant colics|infant colics
5134134|NCT03155360|Migraine equivalent|migraine equivalent
5134135|NCT03155360|Migraine|migraine
5758755|NCT00288964|COPD|copd
5134136|NCT03155360|Episodic symptoms associated to migraine|episodic symptoms associated to migraine
5134137|NCT03155360|Colic|colic
5134138|NCT03155334|Multiple Sclerosis; Patient Information Sheet; User Testing|multiple sclerosis; patient information sheet; user testing
5134139|NCT03155256|EUS, cyanoacrylate, coils, gastric varices|eus, cyanoacrylate, coils, gastric varices
5134144|NCT03155230|Inguinal hernia|inguinal hernia
5134145|NCT03155217|melanoma|melanoma
5134146|NCT03155217|elderly|elderly
5134147|NCT03155217|tolerance|tolerance
5134148|NCT03155217|adverse effects|adverse effects
5134149|NCT03155217|targeted therapies|targeted therapies
5134159|NCT03155191|Adoptive Immunotherapy|adoptive immunotherapy
5134160|NCT03155191|Genetically Engineered Lymphocyte Therapy|genetically engineered lymphocyte therapy
5134161|NCT03155191|Retroviral Vector|retroviral vector
5134162|NCT03155191|Neoplasms by Histologic Type|neoplasms by histologic type
5134163|NCT03155191|Neoplasms|neoplasms
5134164|NCT03155191|Neoplasms, Experimental|neoplasms, experimental
5134165|NCT03155191|Immune System Diseases|immune system diseases
5134166|NCT03155191|Chimeric antigen receptor|chimeric antigen receptor
5134167|NCT03155165|Colonoscopy, Retroview™ colonoscope, retrofex colonoscopy|colonoscopy, retroview™ colonoscope, retrofex colonoscopy
5134183|NCT03155035|STH|sth
5134591|NCT03152461|Coagulation|coagulation
5134701|NCT03151837|Bitter melon(Momordica charantia)|bitter melon(momordica charantia)
5134702|NCT03151837|Insulin sensitivity|insulin sensitivity
5134708|NCT03151798|Nonalcoholic fatty liver|nonalcoholic fatty liver
5134711|NCT03151785|CPR|cpr
5134847|NCT03150953|MRI|mri
5134904|NCT03150680|Genetic Risk Score|genetic risk score
5134905|NCT03150680|Precision Medicine|precision medicine
5134906|NCT03150654|macular pigment|macular pigment
5134907|NCT03150654|macular pigment optical density|macular pigment optical density
5135000|NCT03150004|phase II|phase ii
5135001|NCT03150004|pharmacogenomics|pharmacogenomics
5135002|NCT03149991|treatment resistant|treatment resistant
5135003|NCT03149991|inadequate response|inadequate response
5135006|NCT03149978|metabonomics|metabonomics
5135094|NCT03149510|mobile application|mobile application
5135095|NCT03149510|mHealth|mhealth
5135096|NCT03149458|stroke|stroke
5135097|NCT03149458|balance|balance
5135295|NCT03147768|Laser Tissue Welding|laser tissue welding
5135400|NCT03147274|Adolescence|adolescence
5135484|NCT03146520|Methylation biomarker|methylation biomarker
5135485|NCT03146520|Colorectal cancer|colorectal cancer
5135486|NCT03146520|EarlyTect Colon Cancer test|earlytect colon cancer test
5135487|NCT03146481|Anesthetic efficacy, Irriversible pulpitis, Aceclofenac|anesthetic efficacy, irriversible pulpitis, aceclofenac
5135488|NCT03146455|Thrombelastograghy|thrombelastograghy
5135489|NCT03146455|reference ranges|reference ranges
5864101|NCT00000416|Work-related disability|work-related disability
5135589|NCT03145844|Hepatitis|hepatitis
5135590|NCT03145831|Pediatrics|pediatrics
5135591|NCT03145818|dissemination|dissemination
5135592|NCT03145805|blood chemical analysis|blood chemical analysis
5135593|NCT03145805|bupivacaine|bupivacaine
5135594|NCT03145805|local anesthetic toxicity|local anesthetic toxicity
5135876|NCT03143920|bacterial infection|bacterial infection
5135877|NCT03143907|Mindfulness|mindfulness
5135993|NCT03142919|MDD|mdd
5136086|NCT03142386|quality of life|quality of life
5136300|NCT03140722|DD-CKD|dd-ckd
5136396|NCT03140280|chemopreventive agent|chemopreventive agent
5136397|NCT03140280|BRB|brb
5136398|NCT03140280|pharmokinetics|pharmokinetics
5136399|NCT03140267|Ventilated induced diaphragmatic dysfunction|ventilated induced diaphragmatic dysfunction
5136400|NCT03140267|Weaning|weaning
5136401|NCT03140267|Inspiratory muscle training|inspiratory muscle training
5136402|NCT03140215|Baska|baska
5136403|NCT03140215|seal pressure|seal pressure
5136404|NCT03140215|I-Gel|i-gel
5927508|NCT03927157|Asthma|asthma
5927509|NCT03927157|Uncontrolled Asthma|uncontrolled asthma
5927510|NCT03927157|Severe Uncontrolled Asthma|severe uncontrolled asthma
5927511|NCT03927144|Erenumab|erenumab
5927512|NCT03927144|AMG334|amg334
5927513|NCT03927144|Migraine|migraine
5927514|NCT03927144|Episodic|episodic
5927515|NCT03927144|Headache|headache
5927516|NCT03927144|CGRP|cgrp
5136405|NCT03140215|Supraglottic airway device|supraglottic airway device
5136406|NCT03140189|Esophageal cancer|esophageal cancer
5136407|NCT03140189|Robotic|robotic
5136408|NCT03140189|Ivor-Lewis esophagectomy|ivor-lewis esophagectomy
5136409|NCT03140176|Sunitinib|sunitinib
5136411|NCT03140176|Africa Middle East|africa middle east
5136487|NCT03139565|Infection|infection
5136488|NCT03139565|Vaccine|vaccine
5136489|NCT03139565|Immunogenicity|immunogenicity
5136490|NCT03139552|Taste Test|taste test
5136491|NCT03139552|Spices|spices
5136492|NCT03139552|Reduced sugar|reduced sugar
5136493|NCT03139552|Food liking|food liking
5136684|NCT03137940|Unilateral Cerebral Palsy|unilateral cerebral palsy
5136686|NCT03137940|Safety|safety
5136687|NCT03137940|Upper Limb functions|upper limb functions
5136688|NCT03137927|bordetella pertussis|bordetella pertussis
5136689|NCT03137927|vaccine|vaccine
5136690|NCT03137927|Immunologic Factors|immunologic factors
5136693|NCT03137914|TMJ|tmj
5136778|NCT03137342|PrEP|prep
5136779|NCT03137342|Adherence|adherence
5136780|NCT03137342|Risk Reduction|risk reduction
5136781|NCT03137342|Stimulant Use|stimulant use
5136782|NCT03137290|Paediatric general anaesthesia|paediatric general anaesthesia
5136783|NCT03137290|Rocuronium|rocuronium
5136784|NCT03137290|Neostigmine|neostigmine
5136920|NCT03136367|disparities|disparities
5136921|NCT03136367|decision quality|decision quality
5136925|NCT03136315|Renal failure|renal failure
5137042|NCT03135600|Knee|knee
5137043|NCT03135600|ACL Injury|acl injury
5137044|NCT03135600|Kinematics|kinematics
5137343|NCT03133468|food effect study|food effect study
5137344|NCT03133468|pharmacodynamics|pharmacodynamics
5137345|NCT03133455|Rumination|rumination
5137447|NCT03132922|Ovarian|ovarian
5137448|NCT03132818|Procreation with donation|procreation with donation
5137461|NCT03132714|Full-mouth ultrasonic debridement|full-mouth ultrasonic debridement
5137463|NCT03132714|Amoxicillin|amoxicillin
5137464|NCT03132714|Metronidazole|metronidazole
5137778|NCT03130478|persistence|persistence
5137779|NCT03130465|adherence|adherence
5137780|NCT03130465|long-acting injectable antipsychotic|long-acting injectable antipsychotic
5137781|NCT03130465|all-cause treatment discontinuation|all-cause treatment discontinuation
5137782|NCT03130465|recent-onset schizophrenia|recent-onset schizophrenia
5137783|NCT03130465|daily oral atypical antipsychotic|daily oral atypical antipsychotic
5137784|NCT03130439|Breast Cancer|breast cancer
5137785|NCT03130426|Diabetes|diabetes
5137786|NCT03130426|iGlarLixi|iglarlixi
5137787|NCT03130426|Metformin|metformin
5137788|NCT03130426|Insulin|insulin
5137972|NCT03128905|CPPD|cppd
5137973|NCT03128905|Calcium Pyrophosphate Deposition Disease|calcium pyrophosphate deposition disease
5137974|NCT03128814|Tennis|tennis
5137975|NCT03128814|Asymmetry|asymmetry
5137976|NCT03128814|Structural|structural
5137977|NCT03128814|Functional|functional
5137978|NCT03128801|Low Back Pain|low back pain
5137979|NCT03128801|Back Pain|back pain
5137980|NCT03128801|Muscle Stretching Exercises|muscle stretching exercises
5138067|NCT03128203|Functional connectivity|functional connectivity
5138068|NCT03128203|BOLD|bold
5138069|NCT03128190|high-risk surgery|high-risk surgery
5138070|NCT03128190|pulse-pressure variation|pulse-pressure variation
5138071|NCT03128190|monitoring|monitoring
5138072|NCT03128190|Postoperative Complications|postoperative complications
5138073|NCT03128177|nocturnal hypertension|nocturnal hypertension
5138156|NCT03127800|Oximetry|oximetry
5138157|NCT03127800|Respiratory Polygraphy|respiratory polygraphy
5138158|NCT03127800|Polysomnography|polysomnography
5138159|NCT03127774|Cisplatin|cisplatin
5138260|NCT03126942|Dental Economics|dental economics
5138386|NCT03126214|atrial fibrillation|atrial fibrillation
5138387|NCT03126214|stroke|stroke
5138388|NCT03126214|oral anticoagulation therapy|oral anticoagulation therapy
5138389|NCT03126214|pharmacist case management|pharmacist case management
5138497|NCT03125577|CD123|cd123
5138699|NCT03123939|relapsed/refractory pediatric/young adult|relapsed/refractory pediatric/young adult
5138700|NCT03123926|spontaneous preterm birth|spontaneous preterm birth
5138701|NCT03123926|lipids|lipids
5138702|NCT03123926|biomarkers|biomarkers
5138703|NCT03123874|human milk|human milk
5138704|NCT03123874|breast milk|breast milk
5138904|NCT03122626|community-based exercise program|community-based exercise program
5138905|NCT03122626|task-oriented exercise|task-oriented exercise
5138906|NCT03122626|group exercise program|group exercise program
5138910|NCT03122587|tACS|tacs
5139005|NCT03121924|oocyte donation|oocyte donation
5139006|NCT03121911|Recent Myocardial Infarction|recent myocardial infarction
5139007|NCT03121911|Interval Physical Training|interval physical training
5139008|NCT03121911|Inspiratory Muscle Training|inspiratory muscle training
5139013|NCT03121859|TENS|tens
5890728|NCT03961893|g-eye|g-eye
5139096|NCT03121157|African Americans|african americans
5139097|NCT03121157|Emerging adults|emerging adults
5139413|NCT03119402|Developmental Dyslexia|developmental dyslexia
5139414|NCT03119402|Music|music
5139415|NCT03119402|Rhythm|rhythm
5139416|NCT03119402|transcranial electrical stimulation|transcranial electrical stimulation
5139418|NCT03119389|Hand Hygiene|hand hygiene
5139516|NCT03118648|activities of daily living|activities of daily living
5139518|NCT03118635|Diet|diet
5139519|NCT03118635|Physical Activity|physical activity
5139614|NCT03118167|Water-soluble antioxidant of bamboo leaves|water-soluble antioxidant of bamboo leaves
5139615|NCT03118154|endometriosis|endometriosis
5139616|NCT03118154|pelvic pain|pelvic pain
5139617|NCT03118154|dysmenorrhea|dysmenorrhea
5139718|NCT03117491|Gow-Gates nerve block|gow-gates nerve block
5140020|NCT03115489|Ketamine|ketamine
5140121|NCT03114709|Behavior change|behavior change
5140122|NCT03114709|Aging|aging
5140123|NCT03114709|Randomized controlled trial|randomized controlled trial
5140231|NCT03114137|pulse wave velocity|pulse wave velocity
5140232|NCT03114137|blood viscosity|blood viscosity
5140233|NCT03114124|ablation|ablation
5140234|NCT03114124|atrioventricular node|atrioventricular node
5140235|NCT03114124|microfidelity|microfidelity
5140331|NCT03113435|oxygen consumption|oxygen consumption
5140332|NCT03113435|Stroke volume optimization|stroke volume optimization
5140333|NCT03113422|High Tumor Burden Follicular Lymphoma|high tumor burden follicular lymphoma
5140334|NCT03113422|Venetoclax|venetoclax
5140335|NCT03113422|Obinutuzumab|obinutuzumab
5140336|NCT03113422|Bendamustine|bendamustine
5140421|NCT03113032|sensorimotor function|sensorimotor function
5140423|NCT03113019|dendritic cell, IL-12, IL-18, сytotoxicity|dendritic cell, il-12, il-18, сytotoxicity
5140460|NCT03112785|Hip|hip
5140523|NCT03112408|eye movements|eye movements
5140524|NCT03112369|American Indian / Alaska Native|american indian / alaska native
5140525|NCT03112369|HIV Prevention|hiv prevention
5140526|NCT03112369|Sexual Risk Behavior|sexual risk behavior
5140527|NCT03112369|Trauma|trauma
5140596|NCT03112187|IDA|ida
5140629|NCT03112031|Human immunodeficiency virus|human immunodeficiency virus
5140630|NCT03112018|premature birth|premature birth
5140631|NCT03112018|neonatal mortality|neonatal mortality
5140632|NCT03112018|premature infant|premature infant
5140633|NCT03112005|Diabetic Eye Disease|diabetic eye disease
5140741|NCT03111329|Necrotizing Enterocolitis of Newborn|necrotizing enterocolitis of newborn
5140742|NCT03111329|Sepsis Newborn|sepsis newborn
5140743|NCT03111329|Nutrition of newborn|nutrition of newborn
5140744|NCT03111329|feeding tolerance of newborn|feeding tolerance of newborn
5140830|NCT03110991|Prevention|prevention
5140934|NCT03110302|Telehealth|telehealth
5140831|NCT03110991|Non-professional caregivers|non-professional caregivers
5140833|NCT03110913|Healthy|healthy
5140834|NCT03110913|Men|men
5140835|NCT03110913|Adults|adults
5140836|NCT03110913|Methionine|methionine
5140842|NCT03110809|obesity|obesity
5141051|NCT03109470|Tocilizumab|tocilizumab
5141156|NCT03108794|hepatitis B，registry,cirrhosis, HCC|hepatitis b，registry,cirrhosis, hcc
5141157|NCT03108781|Dementia|dementia
5141257|NCT03108144|smoking cessation|smoking cessation
5141258|NCT03108144|alcohol|alcohol
5141259|NCT03108144|primary care|primary care
5141260|NCT03108144|screening|screening
5141363|NCT03107559|perfüsion index|perfüsion index
5141518|NCT03106610|BMS-936558|bms-936558
5141519|NCT03106610|Opdivo|opdivo
5141520|NCT03106610|Questionnaires|questionnaires
5141521|NCT03106610|Surveys|surveys
5141522|NCT03106597|Peripheral Edema|peripheral edema
5141523|NCT03106597|Bioimpedance Analysis|bioimpedance analysis
5141524|NCT03106584|Knee pain|knee pain
5141653|NCT03105713|Surgery|surgery
5141743|NCT03105206|flexible ureteroscopy|flexible ureteroscopy
5141744|NCT03105193|Colon surgery|colon surgery
5141745|NCT03105193|Lignocaine|lignocaine
5141746|NCT03105193|Lidocaine|lidocaine
5141747|NCT03105193|Analgesia|analgesia
5141748|NCT03105193|Local anaesthetic|local anaesthetic
5141749|NCT03105167|CBT|cbt
5141750|NCT03105167|RCT|rct
5141859|NCT03104504|Suicide Screening|suicide screening
5141860|NCT03104504|Safety Planning|safety planning
5927623|NCT03913650|peripheral nerve block|peripheral nerve block
5927625|NCT03913650|post-operative pain|post-operative pain
5927626|NCT03913650|limb surgery|limb surgery
5927671|NCT03910244|Epistaxis|epistaxis
5927672|NCT03910244|pomalidomide|pomalidomide
5927673|NCT03910244|blood transfusion|blood transfusion
5141861|NCT03104491|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5141862|NCT03104491|donor chimerism|donor chimerism
5141864|NCT03104478|Real time molecular characterization|real time molecular characterization
5141865|NCT03104465|Chronic Pain|chronic pain
5141866|NCT03104465|Mindfulness|mindfulness
5141867|NCT03104465|Behavioral Health|behavioral health
5141868|NCT03104465|Quality of Life|quality of life
5141869|NCT03104439|Pancreatic Cancer|pancreatic cancer
5141870|NCT03104439|Microsatellite Stable Colorectal Cancer|microsatellite stable colorectal cancer
5141871|NCT03104426|Hemolytic disease of the fetus and newborn|hemolytic disease of the fetus and newborn
5141872|NCT03104426|HDFN|hdfn
5141873|NCT03104426|Red blood cell alloimmunization|red blood cell alloimmunization
5141953|NCT03104101|Trospium chloride|trospium chloride
5141954|NCT03104075|Genomics|genomics
5141955|NCT03104075|Epigenomics|epigenomics
5141956|NCT03104075|Pneumococcal vaccine|pneumococcal vaccine
5685505|NCT00555802|Motor Control Exercise|motor control exercise
5142271|NCT03101631|Chemotherapy in elderly population|chemotherapy in elderly population
5142274|NCT03101618|pet|pet
5142275|NCT03101592|antiretroviral therapy|antiretroviral therapy
5142276|NCT03101592|retention|retention
5142277|NCT03101592|ART|art
5142278|NCT03101592|cost-effectiveness|cost-effectiveness
5142279|NCT03101592|virologic suppression|virologic suppression
5142280|NCT03101579|Leptomeningeal metastasis|leptomeningeal metastasis
5142281|NCT03101579|Recurrence|recurrence
5142282|NCT03101579|Intrathecal chemotherapy|intrathecal chemotherapy
5142361|NCT03101124|Administration, Topical|administration, topical
5142362|NCT03101072|Gram-negative bacteremia|gram-negative bacteremia
5142363|NCT03101072|antibiotic durations|antibiotic durations
5142456|NCT03100578|WALLED OFF PANCREATIC NECROSIS|walled off pancreatic necrosis
5142457|NCT03100565|colposcopy|colposcopy
5142458|NCT03100565|pain|pain
5142459|NCT03100565|coughing|coughing
5142460|NCT03100565|anesthetic spray|anesthetic spray
5142461|NCT03100552|Colonoscopy|colonoscopy
5142462|NCT03100552|Endoscopic resection|endoscopic resection
5142463|NCT03100552|Sessile serrated adenoma|sessile serrated adenoma
5142464|NCT03100539|Massage|massage
5142465|NCT03100539|Fascia|fascia
5142466|NCT03100526|High-Risk Patients|high-risk patients
5142467|NCT03100500|QVM149,|qvm149,
5142468|NCT03100500|Asthma,|asthma,
5142469|NCT03100500|Japanese,|japanese,
5142470|NCT03100500|Allergic asthma,|allergic asthma,
5142471|NCT03100500|Allergy triggered asthma,|allergy triggered asthma,
5142472|NCT03100500|Reactive asthma,|reactive asthma,
5142473|NCT03100500|Asthma attack,|asthma attack,
5142474|NCT03100500|Difficulty breathing|difficulty breathing
5142513|NCT03100136|PET|pet
5142573|NCT03099707|ART|art
5142750|NCT03098784|administrative employees|administrative employees
5142751|NCT03098758|Polymerase Chain Reaction|polymerase chain reaction
5142752|NCT03098758|gastric cancer|gastric cancer
5142753|NCT03098758|citology|citology
5142845|NCT03098459|Dementia|dementia
5143833|NCT03092830|HEDGE HOG|hedge hog
5142846|NCT03098459|Critical Care|critical care
5142847|NCT03098459|Subdural hemorrhage|subdural hemorrhage
5142848|NCT03098459|Cognition|cognition
5142849|NCT03098459|Neuropsychological Outcomes|neuropsychological outcomes
5142940|NCT03097744|Lateral Meniscus Tear|lateral meniscus tear
5142941|NCT03097744|Medial Meniscus Tear|medial meniscus tear
5143167|NCT03096639|Diaphragm atrophy|diaphragm atrophy
5143375|NCT03095521|Angal|angal
5143376|NCT03095521|ANTI-ANGIN® FORMULA|anti-angin® formula
5143377|NCT03095521|sore throat|sore throat
5143379|NCT03095508|Angal S|angal s
5143571|NCT03094273|Saucerization biopsy|saucerization biopsy
5143572|NCT03094273|Skin lesion|skin lesion
5143573|NCT03094247|Malnutrition|malnutrition
5143574|NCT03094247|Micronutrients|micronutrients
5143575|NCT03094247|Polyunsaturated fatty acids|polyunsaturated fatty acids
5143578|NCT03094247|Peanuts|peanuts
5143661|NCT03093870|Biliary Tract Neoplasms|biliary tract neoplasms
5143662|NCT03093870|Bile Duct Neoplasms|bile duct neoplasms
5143663|NCT03093870|Gallbladder Neoplasms|gallbladder neoplasms
5143664|NCT03093844|Stem Cell Transplant|stem cell transplant
5143665|NCT03093844|Umbilical Cord Blood Transplant|umbilical cord blood transplant
5772347|NCT00234962|Ritonavir|ritonavir
5143666|NCT03093844|Haploidentical CD34+ Selected Cells|haploidentical cd34+ selected cells
5143667|NCT03093805|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5143668|NCT03093805|Graft Versus Host Disease|graft versus host disease
5143669|NCT03093779|Hearing Loss|hearing loss
5143670|NCT03093779|Deaf|deaf
5143671|NCT03093779|Health Literacy|health literacy
5143672|NCT03093779|Health Information|health information
5143714|NCT03093415|HCV|hcv
5143841|NCT03092817|dexamethasone|dexamethasone
5143842|NCT03092804|Shunting|shunting
5143843|NCT03092804|Brain constructure|brain constructure
5143844|NCT03092804|Neural network|neural network
5144042|NCT03091309|Counselling|counselling
5144043|NCT03091309|Patient Education|patient education
5144044|NCT03091283|time management, anaesthesia training program|time management, anaesthesia training program
5144343|NCT03089528|Direct laryngoscopy|direct laryngoscopy
5144344|NCT03089528|Videolaryngoscopy|videolaryngoscopy
5144380|NCT03089359|Lactate|lactate
5144544|NCT03088319|postnatal depression stress mindfulness allostatic load|postnatal depression stress mindfulness allostatic load
5144545|NCT03088293|idiopathic refractory scleritis|idiopathic refractory scleritis
5144546|NCT03088293|infliximab|infliximab
5144547|NCT03088293|cyclophosphamide|cyclophosphamide
5144580|NCT03088150|RFA|rfa
5144643|NCT03087669|Left Ventricular Assist Device|left ventricular assist device
5144644|NCT03087669|Hemodynamic monitoring|hemodynamic monitoring
5144645|NCT03087656|levofloxacin|levofloxacin
5144647|NCT03087656|Cholangitis|cholangitis
5144736|NCT03086980|health related quality of life|health related quality of life
5144737|NCT03086980|utility|utility
5144738|NCT03086980|regression|regression
5144828|NCT03086473|functional echocardiography|functional echocardiography
5144829|NCT03086434|Culturally tailored intervention|culturally tailored intervention
5144830|NCT03086434|American Indian early adolescents|american indian early adolescents
5144936|NCT03085797|SB240563|sb240563
5145138|NCT03084406|Evidence-based Practices|evidence-based practices
5145145|NCT03084354|labour|labour
5145249|NCT03083743|Antineoplastic Agents, Cytokines|antineoplastic agents, cytokines
5145250|NCT03083743|Antineoplastic Agents|antineoplastic agents
5145251|NCT03083743|Biological activity factor|biological activity factor
5145252|NCT03083743|Genetic Engineering|genetic engineering
5145349|NCT03082950|survival|survival
5145350|NCT03082924|surface EMGdi|surface emgdi
5145351|NCT03082924|pulmonary rehabilitation|pulmonary rehabilitation
5145352|NCT03082924|inspiratory muscle training|inspiratory muscle training
5145353|NCT03082924|exercise training|exercise training
5145354|NCT03082911|screening|screening
5145444|NCT03082456|mammography|mammography
5145445|NCT03082456|sonography|sonography
5145846|NCT03080103|Antibiotic-first Treatment|antibiotic-first treatment
5145847|NCT03080103|Recurrent Appendicitis|recurrent appendicitis
5145848|NCT03080103|Prospective Study|prospective study
5145849|NCT03080051|PSP|psp
5145850|NCT03080051|AD|ad
5145851|NCT03080051|HV|hv
5146057|NCT03079024|Recent Onset Psychosis|recent onset psychosis
5146058|NCT03079011|ESR1 mutation detection, ctDNA|esr1 mutation detection, ctdna
5146059|NCT03078998|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5146060|NCT03078998|Cerebral Palsy|cerebral palsy
5146074|NCT03078933|DFU|dfu
5146176|NCT03078335|Non sterile gloves|non sterile gloves
5146177|NCT03078335|infection control|infection control
5146178|NCT03078309|retinitis pigmentosa|retinitis pigmentosa
5146179|NCT03078309|retinal degeneration|retinal degeneration
5146272|NCT03077880|soft tissue|soft tissue
5146379|NCT03077373|smoking|smoking
5146490|NCT03076632|transcranial magnetic stimulation|transcranial magnetic stimulation
5146491|NCT03076632|neurostimulation|neurostimulation
5146492|NCT03076632|non-invasive stimulation|non-invasive stimulation
5146493|NCT03076632|closed-loop stimulation|closed-loop stimulation
5146589|NCT03076190|catastrophizing|catastrophizing
5146590|NCT03076190|cancer|cancer
5146594|NCT03076164|15-098|15-098
5146693|NCT03075436|Behavior change|behavior change
5146694|NCT03075436|Neglected tropical diseases|neglected tropical diseases
5146703|NCT03075410|FTIH|ftih
5146792|NCT03074955|Propofol|propofol
5146793|NCT03074955|Trendelenburg|trendelenburg
5146794|NCT03074955|leg wrapping|leg wrapping
5146795|NCT03074929|risk communication|risk communication
5146796|NCT03074903|intrauterine device|intrauterine device
5146797|NCT03074903|bleeding|bleeding
5146798|NCT03074877|Substance Use|substance use
5146799|NCT03074864|Activating mutations,lung cancer,radiotherapy|activating mutations,lung cancer,radiotherapy
5146800|NCT03074851|low sodium salt|low sodium salt
5146801|NCT03074851|blood pressure|blood pressure
5146802|NCT03074851|reporter|reporter
5146803|NCT03074838|Cardiac surgery|cardiac surgery
5146804|NCT03074838|TAVI|tavi
5146805|NCT03074825|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5146806|NCT03074825|Relapsed/Refractory|relapsed/refractory
5146807|NCT03074825|Aurora kinase B|aurora kinase b
5146808|NCT03074734|secondhand smoke|secondhand smoke
5146809|NCT03074734|passive smoking|passive smoking
5146810|NCT03074734|respiratory diseases|respiratory diseases
5146872|NCT03074422|Parkinson disease|parkinson disease
5146974|NCT03073746|Symptoms|symptoms
5146976|NCT03073746|Diagnosis|diagnosis
5147084|NCT03072849|Chronic graft-vs-host disease|chronic graft-vs-host disease
5147085|NCT03072849|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5147086|NCT03072823|CVDs|cvds
5147087|NCT03072823|cardiovascular diseases|cardiovascular diseases
5147308|NCT03071640|old|old
5147497|NCT03070743|atlantoaxial dislocation|atlantoaxial dislocation
5147619|NCT03069911|OnabotulinumtoxinA|onabotulinumtoxina
5147620|NCT03069911|BOTOX|botox
5147621|NCT03069898|Marital relationship|marital relationship
5147622|NCT03069872|Transvaginal ultrasound|transvaginal ultrasound
5147623|NCT03069872|General practice|general practice
5147624|NCT03069872|Early diagnosis|early diagnosis
5147625|NCT03069872|Symptoms|symptoms
5147630|NCT03069846|skin cancer|skin cancer
5147631|NCT03069846|laser spectroscopy|laser spectroscopy
5147646|NCT03069729|screen|screen
5147739|NCT03069313|Arthralgia|arthralgia
5147741|NCT03069313|Joint pain|joint pain
5147837|NCT03068520|BRAIN PRIMARY TUMOR|brain primary tumor
5147838|NCT03068520|RESPONSE TO TREATMENT|response to treatment
5147950|NCT03067961|Typhoid|typhoid
5927690|NCT03907293|Cardiac Rehabilitation|cardiac rehabilitation
5927692|NCT03907293|Coronary Artery Disease|coronary artery disease
5148144|NCT03066778|Programmed cell death protein-1 (PD-1)|programmed cell death protein-1 (pd-1)
5148247|NCT03066375|Spontaneous breathing|spontaneous breathing
5148248|NCT03066362|Spontaneous ventilation|spontaneous ventilation
5148249|NCT03066323|Blood glucose|blood glucose
5148250|NCT03066310|Bladder cancer|bladder cancer
5148456|NCT03065192|AAV2|aav2
5148457|NCT03065192|Viral Vector|viral vector
5148560|NCT03064581|Pap Test|pap test
5148666|NCT03063801|Congenital Heart Disease|congenital heart disease
5148798|NCT03063164|Visumax|visumax
5148865|NCT03062592|appetite|appetite
5148866|NCT03062592|ghrelin|ghrelin
5149077|NCT03061019|child|child
5149288|NCT03059472|nutrition|nutrition
5149289|NCT03059472|social network|social network
5149290|NCT03059472|civic engagement|civic engagement
5149291|NCT03059459|Lung Diseases, Obstructive|lung diseases, obstructive
5149378|NCT03058926|Pancreatic Cancer|pancreatic cancer
5149379|NCT03058926|Data Management|data management
5149380|NCT03058926|Protocol compliance|protocol compliance
5149382|NCT03058926|Consortium studies|consortium studies
5149477|NCT03058289|PD-1|pd-1
5149576|NCT03057691|Major Adverse Cardiovascular Events|major adverse cardiovascular events
5149577|NCT03057613|radiation|radiation
5149578|NCT03057613|resected|resected
5149675|NCT03056885|broncho-alveolar lavage|broncho-alveolar lavage
5149676|NCT03056885|protective ventilation|protective ventilation
5149677|NCT03056885|cytokines|cytokines
5150321|NCT03053037|pulp necrosis|pulp necrosis
5150322|NCT03052985|medical devices (meshes)|medical devices (meshes)
5150323|NCT03052985|surgery|surgery
5150325|NCT03052933|copanlisib|copanlisib
5150418|NCT03052127|Eye cancer|eye cancer
5150419|NCT03052127|Ocular melanoma|ocular melanoma
5150420|NCT03052127|Choroidal melanoma|choroidal melanoma
5150421|NCT03052114|Electrical Impedance Tomography|electrical impedance tomography
5150423|NCT03052114|Stroke|stroke
5150425|NCT03052114|Head Injury|head injury
5150609|NCT03050944|Semen quality|semen quality
5150610|NCT03050944|Diet|diet
5150613|NCT03050931|EIT|eit
5150716|NCT03050398|Postmenopausal|postmenopausal
5150717|NCT03050398|Premenopausal|premenopausal
5150814|NCT03049709|oscillometric radial pulse wave analysis|oscillometric radial pulse wave analysis
5150815|NCT03049696|Roux-En-Y Gastric Bypass|roux-en-y gastric bypass
5150816|NCT03049696|Bariatric Surgery|bariatric surgery
5672526|NCT00611546|oxidative stress|oxidative stress
5150817|NCT03049696|Pre-Operative Physical Activity and Education Program|pre-operative physical activity and education program
5150818|NCT03049696|Obesity|obesity
5150819|NCT03049696|Exercise|exercise
5150842|NCT03049566|Aspirin|aspirin
5150906|NCT03049098|Visual Perception|visual perception
5151008|NCT03048617|Mitochondrial Myopathy|mitochondrial myopathy
5151009|NCT03048617|Primary Mitochondrial Myopathy|primary mitochondrial myopathy
5151010|NCT03048578|Roux-en-Y gastric bypass (RYGB)|roux-en-y gastric bypass (rygb)
5151011|NCT03048565|mindfulness|mindfulness
5151012|NCT03048565|caregivers|caregivers
5151013|NCT03048552|drug use|drug use
5151014|NCT03048552|drug addiction|drug addiction
5151015|NCT03048552|drug habituation|drug habituation
5151016|NCT03048552|drug use disorders|drug use disorders
5151017|NCT03048552|organic mental disorders|organic mental disorders
5151104|NCT03047980|Cognitive impairment|cognitive impairment
5151105|NCT03047980|sirolimus|sirolimus
5151106|NCT03047915|Anxiety|anxiety
5151107|NCT03047915|Music intervention|music intervention
5151196|NCT03047330|weight gain|weight gain
5151406|NCT03045653|endocrine therapy|endocrine therapy
5151407|NCT03045653|Hormone Receptor Positive Malignant Neoplasm of Breast|hormone receptor positive malignant neoplasm of breast
5151408|NCT03045653|Tamoxifen|tamoxifen
5151409|NCT03045653|Breast Cancer Metastatic|breast cancer metastatic
5151411|NCT03045640|parenting program|parenting program
5151412|NCT03045640|home visiting|home visiting
5151413|NCT03045627|Acute Myeloid Leukemia|acute myeloid leukemia
5151414|NCT03045627|PEG-G-CSF|peg-g-csf
5151415|NCT03045601|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
5151416|NCT03045601|Coronary Angiography|coronary angiography
5685506|NCT00555802|General exercise|general exercise
5151417|NCT03045601|Fractional Flow Reserve, Myocardial|fractional flow reserve, myocardial
5151592|NCT03044444|nutrition|nutrition
5151593|NCT03044444|sports|sports
5151605|NCT03044405|fluid responsiveness|fluid responsiveness
5151606|NCT03044405|focused echocardiography|focused echocardiography
5151607|NCT03044405|major surgery|major surgery
5151609|NCT03044392|Labour Analgesia|labour analgesia
5151709|NCT03043807|prostatectomy|prostatectomy
5151710|NCT03043807|androgen deprivation|androgen deprivation
5151711|NCT03043807|chemotherapy|chemotherapy
5151712|NCT03043807|radiation|radiation
5151713|NCT03043794|early stage|early stage
5927793|NCT03890510|pulse pressure variation|pulse pressure variation
5927794|NCT03890510|intraocular pressure|intraocular pressure
5927795|NCT03890510|optic sheath diameter|optic sheath diameter
5927796|NCT03890510|spine surgery|spine surgery
5927797|NCT03890510|prone position|prone position
5927806|NCT03887312|Phone-delivered therapy|phone-delivered therapy
5927807|NCT03887312|Cognitive behavioral therapy (CBT)|cognitive behavioral therapy (cbt)
5927808|NCT03887312|Telephone-delivered therapy|telephone-delivered therapy
5927809|NCT03887312|Children|children
5927810|NCT03887312|Adolescents|adolescents
5927811|NCT03887312|Syrian refugees|syrian refugees
5927824|NCT03884959|Urea Cycle Disorder|urea cycle disorder
5927825|NCT03884959|Hyperammonemia|hyperammonemia
5927826|NCT03884959|Metabolic Decompensation|metabolic decompensation
5927833|NCT03883620|Dengue|dengue
5151714|NCT03043794|low risk|low risk
5151715|NCT03043768|Parkinson's disease|parkinson's disease
5151733|NCT03043651|HFpEF|hfpef
5151925|NCT03042754|treatment outcome|treatment outcome
5151926|NCT03042754|Microbacterial tuberculosis|microbacterial tuberculosis
5927870|NCT03875937|tranexamic acid|tranexamic acid
5927871|NCT03875937|pharmacokinetic|pharmacokinetic
5927872|NCT03875937|intramuscular|intramuscular
5927878|NCT03875339|Infant Hearing Screening|infant hearing screening
5927879|NCT03875339|Patient Navigator|patient navigator
5927880|NCT03875105|exercise capacity|exercise capacity
5927881|NCT03875105|activities of daily living|activities of daily living
5927900|NCT03869099|Childhood pneumonia|childhood pneumonia
5927901|NCT03869099|acute respiratory illness|acute respiratory illness
5927902|NCT03869099|Pakistan|pakistan
5927920|NCT03864393|walking economy|walking economy
5927921|NCT03864393|fatigability|fatigability
5927922|NCT03864393|propulsion|propulsion
5151927|NCT03042715|Supportive Care|supportive care
5151928|NCT03042689|AML|aml
5151929|NCT03042676|anti-T lymphocytic globulin (ATG)|anti-t lymphocytic globulin (atg)
5151930|NCT03042676|allogeneic stem cell transplant|allogeneic stem cell transplant
5891463|NCT03889912|CSCC|cscc
5152013|NCT03042195|Supplementary Parenteral Nutrition|supplementary parenteral nutrition
5152014|NCT03042195|Postoperative Nutrition|postoperative nutrition
5152015|NCT03042195|Postoperative complications|postoperative complications
5152016|NCT03042169|Stage IV gastric cancer|stage iv gastric cancer
5152017|NCT03042169|palliative surgery|palliative surgery
5152018|NCT03042169|chemotherapy|chemotherapy
5152116|NCT03041701|YES|yes
5152117|NCT03041701|RMS|rms
5152118|NCT03041675|Lacer Acupuncture|lacer acupuncture
5152119|NCT03041675|Paralytic ileus|paralytic ileus
5152120|NCT03041649|Gastroesophageal Reflux|gastroesophageal reflux
5152121|NCT03041649|Feeding Disorder|feeding disorder
5152122|NCT03041649|Gastrostomy tube|gastrostomy tube
5152123|NCT03041649|Family Satisfaction|family satisfaction
5152124|NCT03041649|GT button|gt button
5152125|NCT03041649|Enteral nutrition|enteral nutrition
5152126|NCT03041649|Gastrostomy button|gastrostomy button
5152239|NCT03040804|HS|hs
5152431|NCT03039283|Moderate to profound sensorineural hearing loss|moderate to profound sensorineural hearing loss
5152432|NCT03039270|Tooth Sensitivity|tooth sensitivity
5152433|NCT03039270|Tooth Bleaching|tooth bleaching
5152434|NCT03039270|Desensitizing agent|desensitizing agent
5152435|NCT03039270|Sonic vibration|sonic vibration
5152436|NCT03039257|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5152467|NCT03039049|IVF|ivf
5152737|NCT03037385|lung cancer RET inhibitor|lung cancer ret inhibitor
5152841|NCT03036696|Clinical Research Studies|clinical research studies
5152842|NCT03036696|BEACH|beach
5152843|NCT03036657|Acupuncture|acupuncture
5152844|NCT03036657|Electroacupuncture|electroacupuncture
5152845|NCT03036657|Nerve Conduction Studies|nerve conduction studies
5152846|NCT03036657|Quantitative Sensory Testing|quantitative sensory testing
5152847|NCT03036644|electronic cigarette|electronic cigarette
5152848|NCT03036644|e-cigarette|e-cigarette
5152849|NCT03036644|oxidative stress|oxidative stress
5152850|NCT03036644|tobacco smoking|tobacco smoking
5152851|NCT03036618|BMI|bmi
5152852|NCT03036618|Blood Cholesterol|blood cholesterol
5152853|NCT03036618|Glucose|glucose
5152854|NCT03036618|Insulin|insulin
5152855|NCT03036618|Gut health|gut health
5152948|NCT03036085|analgesia|analgesia
5152949|NCT03036085|local anesthetics|local anesthetics
5152950|NCT03036072|Therapeutic Hypothermia|therapeutic hypothermia
5152954|NCT03036007|Spine, Disc, Neck pain, Rehabilitation, Exercise Therapy, Internet|spine, disc, neck pain, rehabilitation, exercise therapy, internet
5152955|NCT03035968|Vojta therapy|vojta therapy
5152956|NCT03035968|reflex locomotion|reflex locomotion
5152957|NCT03035968|stroke rehabilitation|stroke rehabilitation
5152958|NCT03035968|stroke|stroke
5153179|NCT03034733|Knee Replacement|knee replacement
5153180|NCT03034733|Pain, Postoperative|pain, postoperative
5153181|NCT03034733|Glucocorticoids|glucocorticoids
5153182|NCT03034733|Dexamethasone|dexamethasone
5153183|NCT03034720|Concussion|concussion
5153184|NCT03034720|persistent post-concussive symptoms|persistent post-concussive symptoms
5153185|NCT03034720|CBT|cbt
5153186|NCT03034720|collaborative care|collaborative care
5153270|NCT03034187|Quality of Life since 2011(set-up SFP-prostate)|quality of life since 2011(set-up sfp-prostate)
5153374|NCT03033511|Extensive-Stage Small Cell Lung Cancer (ED SCLC)|extensive-stage small cell lung cancer (ed sclc)
5153376|NCT03033511|Platinum-Based Chemotherapy|platinum-based chemotherapy
5153377|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine
5153470|NCT03032952|Computerised interventions|computerised interventions
5153471|NCT03032952|Mobile applications|mobile applications
5153472|NCT03032952|Stress, Psychological|stress, psychological
5891601|NCT03868241|sepsis|sepsis
5153578|NCT03032354|probiotics|probiotics
5153579|NCT03032354|children|children
5153580|NCT03032354|remission|remission
5153581|NCT03032341|mobility assessment tool|mobility assessment tool
5153583|NCT03032289|active transport|active transport
5153584|NCT03032289|cycling|cycling
5153585|NCT03032289|walking|walking
5153737|NCT03031132|PYY|pyy
5153881|NCT03030300|type 2 diabetes|type 2 diabetes
5153882|NCT03030300|remission|remission
5153883|NCT03030300|short-term intensive insulin therapy|short-term intensive insulin therapy
5153884|NCT03030248|microbiome|microbiome
5153885|NCT03030248|bone marrow transplantation|bone marrow transplantation
5153988|NCT03029663|postoperative complications|postoperative complications
5153989|NCT03029650|Peer Review|peer review
5153990|NCT03029650|Research|research
5153991|NCT03029637|Resin bonded bridges|resin bonded bridges
5153995|NCT03029585|ovarian neoplasms|ovarian neoplasms
5153996|NCT03029585|ovarian diseases|ovarian diseases
5153997|NCT03029559|Inspiratory threshold loading|inspiratory threshold loading
5153998|NCT03029520|Endodontic Postoperative Pain|endodontic postoperative pain
5153999|NCT03029520|iRoot SP Sealer|iroot sp sealer
5154000|NCT03029520|Randomized Clinical Trial|randomized clinical trial
5154010|NCT03029494|saliva|saliva
5154083|NCT03029130|catheter extension|catheter extension
5154084|NCT03029117|rheumatic pregnancy|rheumatic pregnancy
5154085|NCT03029104|Keratoconus|keratoconus
5154086|NCT03029104|Forme fruste keratoconus|forme fruste keratoconus
5701220|NCT00497991|AML|aml
5154087|NCT03029104|Post-LASIK ectasia|post-lasik ectasia
5154290|NCT03027947|Pain|pain
5154176|NCT03028558|E-Cigarettes|e-cigarettes
5154177|NCT03028545|schizophrenia|schizophrenia
5154178|NCT03028545|anorexia|anorexia
5154182|NCT03028532|Sports Medicine|sports medicine
5154272|NCT03028025|time to hemostasis|time to hemostasis
5154273|NCT03028025|radial artery|radial artery
5154274|NCT03028025|transradial catheterization|transradial catheterization
5154275|NCT03028025|TR band|tr band
5154276|NCT03028025|Statseal|statseal
5154368|NCT03027557|Bone Mineral Density|bone mineral density
5154369|NCT03027557|Calcium|calcium
5154370|NCT03027544|multiple brain metastases|multiple brain metastases
5154371|NCT03027544|large brain metastases|large brain metastases
5154372|NCT03027544|meningeal metastases|meningeal metastases
5154373|NCT03027544|tomotherapy|tomotherapy
5154375|NCT03027505|MUAC|muac
5154376|NCT03027505|Acute malnutrition|acute malnutrition
5154464|NCT03026998|hereditary retinoblastoma,|hereditary retinoblastoma,
5154469|NCT03026972|Safety|safety
5154571|NCT03026374|Quality of Life|quality of life
5154573|NCT03026335|Positive Youth Development|positive youth development
5154583|NCT03026270|Physiotherapy|physiotherapy
5154584|NCT03026270|Paraffin|paraffin
5154585|NCT03026270|Burn|burn
5154586|NCT03026270|Contracture|contracture
5154587|NCT03026244|Immunity|immunity
5154588|NCT03026244|Elderly|elderly
5154589|NCT03026244|Inflammation|inflammation
5154590|NCT03026244|Milk protein|milk protein
5154597|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine
5154685|NCT03025620|Alphalinolenic acid|alphalinolenic acid
5154686|NCT03025620|Lipid cardiovascular risk factors|lipid cardiovascular risk factors
5154687|NCT03025620|Inflammation|inflammation
5154688|NCT03025607|Prevention|prevention
5154689|NCT03025607|Mobile health|mobile health
5154690|NCT03025607|Autonomous motivation|autonomous motivation
5154878|NCT03024359|Monounsaturated fatty acids|monounsaturated fatty acids
5154879|NCT03024359|Hypothalamic inflammation|hypothalamic inflammation
5154970|NCT03023553|Young adults|young adults
5154971|NCT03023540|Charcot Marie Tooth Type 1A|charcot marie tooth type 1a
5155070|NCT03022994|lymphocytes|lymphocytes
5155071|NCT03022994|duodenal biopsies|duodenal biopsies
5155072|NCT03022994|rectal biopsies|rectal biopsies
5155073|NCT03022916|toenail polish|toenail polish
5155270|NCT03021785|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5155271|NCT03021785|Anti-VEGF|anti-vegf
5155272|NCT03021785|CNV|cnv
5155364|NCT03021239|LVAD Hemodynamics|lvad hemodynamics
5927993|NCT03852498|Adrenoleukodystrophy|adrenoleukodystrophy
5927994|NCT03852498|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
5927995|NCT03852498|Gene therapy|gene therapy
5927996|NCT03852498|Hematopoietic stem cell|hematopoietic stem cell
5928044|NCT03843359|GSK3745417, pembrolizumab, solid tumor, first time in human, Stimulator of Interferon Genes, STING|gsk3745417, pembrolizumab, solid tumor, first time in human, stimulator of interferon genes, sting
5891642|NCT03863873|Carpal Tunnel Syndrome|carpal tunnel syndrome
5155471|NCT03020433|stroke therapy|stroke therapy
5155473|NCT03020433|cerebrovascular accident|cerebrovascular accident
5155474|NCT03020433|brain diseases|brain diseases
5155568|NCT03019718|Inpatient rehabilitation|inpatient rehabilitation
5155569|NCT03019718|Internet-based intervention|internet-based intervention
5155570|NCT03019718|Aftercare|aftercare
5155571|NCT03019718|Return to work|return to work
5155572|NCT03019718|Psychodynamic|psychodynamic
5155573|NCT03019705|Cyberchondria|cyberchondria
5155672|NCT03019068|Clinical Trial Recruitment Support Systems (CTRSS)|clinical trial recruitment support systems (ctrss)
5155673|NCT03019042|Hou Gu Mi Xi|hou gu mi xi
5155674|NCT03019042|Shen Ling Bai Zhu San|shen ling bai zhu san
5155690|NCT03018912|Insomnia|insomnia
5928080|NCT03838458|hypospadias|hypospadias
5928081|NCT03838458|prepuce|prepuce
5928082|NCT03838458|HOXA13|hoxa13
5928083|NCT03838458|FGFR2|fgfr2
5928084|NCT03838458|TGF beta|tgf beta
5928091|NCT03836716|Arimoclomol|arimoclomol
5928093|NCT03836586|catastrophizing|catastrophizing
5928094|NCT03836586|cognitive-behavior therapy|cognitive-behavior therapy
5928133|NCT03832491|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5928134|NCT03832491|Kartegener Syndrome|kartegener syndrome
5928135|NCT03832491|Immotile Cilia Syndrome|immotile cilia syndrome
5155767|NCT03018275|Lyophilized Biotherapeutic, Microbiome, Probiotic|lyophilized biotherapeutic, microbiome, probiotic
5155768|NCT03018275|Commensal Gram-negative Bacteria|commensal gram-negative bacteria
5155769|NCT03018275|Staphylococcus Aureus|staphylococcus aureus
5155770|NCT03018275|Transepidermal Water Loss|transepidermal water loss
5155771|NCT03018275|Allergic Diseases|allergic diseases
5155776|NCT03018236|cocaine|cocaine
5155777|NCT03018236|alcohol|alcohol
5155779|NCT03018236|addiction|addiction
5156205|NCT03015519|GSK716155|gsk716155
5156206|NCT03015519|Type 2 diabetes mellitus|type 2 diabetes mellitus
5156316|NCT03014999|Humans|humans
5156317|NCT03014986|HCV|hcv
5156318|NCT03014947|MSB11022|msb11022
5156515|NCT03013842|pregnancy|pregnancy
5156516|NCT03013842|fetal monitoring|fetal monitoring
5156719|NCT03012529|Rifampin|rifampin
5156817|NCT03011775|Pioglitazone, Insulin Resistance|pioglitazone, insulin resistance
5156818|NCT03011775|Atherosclerosis, Coronary Heart Disease|atherosclerosis, coronary heart disease
5156819|NCT03011749|Radium-223 therapy|radium-223 therapy
5156820|NCT03011710|e-cigarette|e-cigarette
5156821|NCT03011710|blood flow|blood flow
5156822|NCT03011710|oral effects|oral effects
5156823|NCT03011710|oral pH|oral ph
5156825|NCT03011684|Breast Cancer|breast cancer
5157003|NCT03010683|Arterial stiffness|arterial stiffness
5157004|NCT03010683|Endothelial glycocalyx|endothelial glycocalyx
5157005|NCT03010683|Coronary flow reserve|coronary flow reserve
5157006|NCT03010670|Oxytocin|oxytocin
5157007|NCT03010670|Gaze processing|gaze processing
5157008|NCT03010670|Interpersonal motor resonance|interpersonal motor resonance
5157009|NCT03010618|hall technique|hall technique
5157010|NCT03010618|stainless steel crowns|stainless steel crowns
5157092|NCT03010098|closed-loop of target controlled infusion|closed-loop of target controlled infusion
5157093|NCT03010033|pulmonary rehabilitation|pulmonary rehabilitation
5157094|NCT03010033|lobectomy|lobectomy
5157095|NCT03010033|smoker|smoker
5157096|NCT03010020|HIV Prevention|hiv prevention
5157097|NCT03010020|MSM|msm
5157098|NCT03010020|Rectal Gonorrhea|rectal gonorrhea
5157104|NCT03009981|PSA|psa
5157195|NCT03009526|Pregnancy|pregnancy
5157196|NCT03009526|Malawi|malawi
5157197|NCT03009526|Intermittent preventive treatment|intermittent preventive treatment
5157198|NCT03009526|dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5157199|NCT03009526|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5157200|NCT03009461|Hepatocellular carcinoma|hepatocellular carcinoma
5157201|NCT03009461|Portal vein tumor thrombosis|portal vein tumor thrombosis
5157202|NCT03009461|Hepatic arterial infusion chemotherapy|hepatic arterial infusion chemotherapy
5157203|NCT03009461|Sorafenib|sorafenib
5157204|NCT03009396|Crohn's Disease,|crohn's disease,
5157205|NCT03009396|moderate to severe|moderate to severe
5157206|NCT03009396|remission|remission
5157207|NCT03009396|Mycobacterium avium paratuberculosis|mycobacterium avium paratuberculosis
5157208|NCT03009396|antibiotic|antibiotic
5157209|NCT03009370|Ovarian reserve, pregnancy loss|ovarian reserve, pregnancy loss
5157210|NCT03009357|wearable activity tracker|wearable activity tracker
5157211|NCT03009357|thyrotoxicosis|thyrotoxicosis
5157212|NCT03009344|relapsed or refractory B-cell non-Hodgkin's lymphoma|relapsed or refractory b-cell non-hodgkin's lymphoma
5157213|NCT03009344|tazemetostat|tazemetostat
5157272|NCT03009032|probiotics|probiotics
5157273|NCT03009032|synbiotics|synbiotics
5157368|NCT03008252|lactose intolerance|lactose intolerance
5157275|NCT03009006|Ca(OH)2 intracanal medication|ca(oh)2 intracanal medication
5157276|NCT03009006|Chlorhexidene gel|chlorhexidene gel
5157277|NCT03009006|CHX gel|chx gel
5157469|NCT03007524|optical coherence tomography|optical coherence tomography
5157470|NCT03007524|acute coronary syndrome|acute coronary syndrome
5157471|NCT03007511|Percutaneous Endoscopic Gastrostomy|percutaneous endoscopic gastrostomy
5928188|NCT03826589|Cervical cancer|cervical cancer
5928189|NCT03826589|Avelumab|avelumab
5928197|NCT03825172|Caudal block|caudal block
5928198|NCT03825172|Ultrasound|ultrasound
5928199|NCT03825172|Children|children
5928200|NCT03825172|Regional block anatomy|regional block anatomy
5928203|NCT03824457|Intoxication|intoxication
5928210|NCT03823391|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5928211|NCT03823391|ABBV-3373|abbv-3373
5928212|NCT03823391|Adalimumab|adalimumab
5891935|NCT03829657|snOH|snoh
5157472|NCT03007511|Feeding tube|feeding tube
5157473|NCT03007511|Enteral nutrition|enteral nutrition
5157474|NCT03007511|Endoscopy|endoscopy
5157475|NCT03007511|Gastrointestinal|gastrointestinal
5157476|NCT03007472|cochlear implant, sound processor|cochlear implant, sound processor
5157477|NCT03007459|Body composition|body composition
5157478|NCT03007459|Bone mineral density|bone mineral density
5157479|NCT03007459|Binge Eating|binge eating
5157480|NCT03007459|Eating Disorder|eating disorder
5157481|NCT03007459|Exercise Dependency|exercise dependency
5157482|NCT03007459|Depression|depression
5157483|NCT03007459|Perfectionism|perfectionism
5157484|NCT03007459|Body building|body building
5157485|NCT03007459|Drive for Muscularity|drive for muscularity
5157487|NCT03007446|Apatinib|apatinib
5157569|NCT03006822|Myofascial Trigger Points|myofascial trigger points
5157570|NCT03006822|Liberation for Pression|liberation for pression
5157571|NCT03006822|Therapy Soft Tissue|therapy soft tissue
5157572|NCT03006809|Ulcerative colitis|ulcerative colitis
5157574|NCT03006809|fecal transplant|fecal transplant
5157575|NCT03006796|Obesity|obesity
5157576|NCT03006705|ONO-4538,BMS-936558,Nivolumab,gastric,adjuvant,S-1,CapeOX|ono-4538,bms-936558,nivolumab,gastric,adjuvant,s-1,capeox
5157577|NCT03006614|Breast Cancer Model|breast cancer model
5157578|NCT03006614|Effects of Chemotherapy|effects of chemotherapy
5157579|NCT03006614|breast cancer|breast cancer
5157580|NCT03006588|FNA,EUS,retropharyngeal lymph node (RPLN),NPC|fna,eus,retropharyngeal lymph node (rpln),npc
5157581|NCT03006575|Non-small cell lung cancer|non-small cell lung cancer
5157582|NCT03006575|Split-course Chemoradiotherapy|split-course chemoradiotherapy
5157652|NCT03006107|Single dose piroxicam|single dose piroxicam
5157653|NCT03006107|Intraligamentary piroxicam|intraligamentary piroxicam
5157654|NCT03006107|Intraligamentary mepecaine|intraligamentary mepecaine
5157848|NCT03004742|polyphenols|polyphenols
5157949|NCT03004196|Probiotics|probiotics
5158046|NCT03003585|direct laryngoscopy|direct laryngoscopy
5158145|NCT03003286|Flexible|flexible
5158146|NCT03003286|Unstuck|unstuck
5158147|NCT03003286|Low Income|low income
5158148|NCT03003286|Behavior|behavior
5158149|NCT03003286|Coping|coping
5158150|NCT03003286|Disparity|disparity
5158151|NCT03003286|Problem Solving|problem solving
5158152|NCT03003286|Self-Control|self-control
5158153|NCT03003286|impulsive|impulsive
5158345|NCT03002090|iron deficiency|iron deficiency
5158347|NCT03002090|exercise training|exercise training
5158348|NCT03002090|aerobic|aerobic
5158349|NCT03002090|performance|performance
5158369|NCT03002012|HIV|hiv
5158448|NCT03001388|Pancreatic insufficiency|pancreatic insufficiency
5158449|NCT03001388|Cystic Fibrosis|cystic fibrosis
5158450|NCT03001388|Transient Elastography|transient elastography
5158451|NCT03001375|Laparoscopic colectomy.|laparoscopic colectomy.
5158452|NCT03001375|Splenic flexure mobilization.|splenic flexure mobilization.
5158453|NCT03001375|Anastomotic leakage.|anastomotic leakage.
5158750|NCT02999945|neurodevelopmental outcome|neurodevelopmental outcome
5158752|NCT02999906|Oral Treprostinil|oral treprostinil
5158753|NCT02999906|dual therapy|dual therapy
5158754|NCT02999906|6 Minute Walk Test|6 minute walk test
5158762|NCT02999854|Overall survival|overall survival
5158847|NCT02999256|Tart Cherry Juice|tart cherry juice
5158848|NCT02999256|Fat Oxidation|fat oxidation
5158849|NCT02999256|Lipid Profile|lipid profile
5158952|NCT02998762|major depressive disorder|major depressive disorder
5158954|NCT02998762|MDD|mdd
5159051|NCT02998008|Exercise Therapy|exercise therapy
5159052|NCT02998008|Heart Function Tests|heart function tests
5159053|NCT02998008|Heart/physiology|heart/physiology
5159054|NCT02998008|Echocardiography|echocardiography
5159055|NCT02997995|T2-T4 Breast cancer|t2-t4 breast cancer
5159143|NCT02997449|Stereotactic ablative radiotherapy (SABR)|stereotactic ablative radiotherapy (sabr)
5159144|NCT02997449|Intrathoracic nodal staging|intrathoracic nodal staging
5159216|NCT02997033|Men|men
5159331|NCT02996448|AD-HIES|ad-hies
5159332|NCT02996448|Anti-rAls3 Antibody|anti-rals3 antibody
5159439|NCT02995434|Cancer Pain Management|cancer pain management
5159443|NCT02995408|parenting|parenting
5159553|NCT02994602|Nestorone|nestorone
5159554|NCT02994602|Testosterone|testosterone
5159555|NCT02994550|FSH|fsh
5159556|NCT02994550|LH|lh
5159557|NCT02994550|IVF|ivf
5159558|NCT02994511|Circulating tumour DNA|circulating tumour dna
5159559|NCT02994511|ctDNA|ctdna
5159560|NCT02994420|Obesity|obesity
5159561|NCT02994420|Menstrual Cycle|menstrual cycle
5159562|NCT02994420|Gonadal Steroid Hormones|gonadal steroid hormones
5159563|NCT02994420|Satiety Response|satiety response
5159564|NCT02994420|Glucagon-Like Peptide 1|glucagon-like peptide 1
5159645|NCT02993744|inflammatory parameters|inflammatory parameters
5928289|NCT03816228|Dementia|dementia
5928290|NCT03816228|Taupathies|taupathies
5928291|NCT03816228|Brain Disease|brain disease
5928292|NCT03816228|Mild Cognitive Impairment|mild cognitive impairment
5928293|NCT03816228|Neurodegenerative Disease|neurodegenerative disease
5928294|NCT03816163|metastatic pancreatic cancer|metastatic pancreatic cancer
5928295|NCT03816163|IMAB362|imab362
5928296|NCT03816163|nab-paclitaxel|nab-paclitaxel
5928297|NCT03816163|gemcitabine|gemcitabine
5928298|NCT03816163|zolbetuximab|zolbetuximab
5928299|NCT03816163|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5928300|NCT03816163|pancreatic cancer|pancreatic cancer
5928301|NCT03816163|CLDN 18.2|cldn 18.2
5928333|NCT03813186|MDS|mds
5928334|NCT03813186|CMML|cmml
5928335|NCT03813186|ASTX727|astx727
5928336|NCT03813186|decitabine|decitabine
5928337|NCT03813186|AML|aml
5159646|NCT02993744|betamethasone|betamethasone
5159647|NCT02993744|leukocytes|leukocytes
5159648|NCT02993731|Neoplasms|neoplasms
5159649|NCT02993731|Neoplasms by Site|neoplasms by site
5159846|NCT02992288|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5159848|NCT02992275|Muscle|muscle
5159849|NCT02992275|Skeletal/physiopathology|skeletal/physiopathology
5159948|NCT02991703|pOpmètre|popmètre
5160353|NCT02989064|Cell Therapy|cell therapy
5160577|NCT02987985|Opioid-free|opioid-free
5160779|NCT02986633|Echocardiography|echocardiography
5160890|NCT02986100|rucaparib|rucaparib
5160995|NCT02985320|safety|safety
5161211|NCT02983838|Amyloid|amyloid
5161398|NCT02982967|EPCs|epcs
5161403|NCT02982941|Wilms Tumor|wilms tumor
5161497|NCT02982447|blue laser imaging,detection,randomized trial|blue laser imaging,detection,randomized trial
5161888|NCT02979990|education|education
5162449|NCT02976922|RAS|ras
5163259|NCT02972125|Lacosamide|lacosamide
5163363|NCT02971345|stent|stent
5164391|NCT02964767|HIV|hiv
5164600|NCT02963467|smoking|smoking
5164717|NCT02962674|BPH|bph
5165127|NCT02960022|MDV3100|mdv3100
5165851|NCT02955719|Anxiety|anxiety
5166070|NCT02954432|Transcranial Ultrasound|transcranial ultrasound
5166190|NCT02953743|Lenvatinib|lenvatinib
5166560|NCT02951130|HRF|hrf
5167154|NCT02947555|AGE|age
5167367|NCT02946138|GM-CSF|gm-csf
5167832|NCT02943252|S1|s1
5167688|NCT02944123|Half dose|half dose
5167798|NCT02943486|Diabetes|diabetes
5168239|NCT02940548|young|young
5168738|NCT02936908|weaning|weaning
5168948|NCT02935517|Eye diseases|eye diseases
5169055|NCT02934815|psychological intervention|psychological intervention
5169216|NCT02934087|AAA|aaa
5169728|NCT02931019|posture|posture
5169927|NCT02929472|Physical Activity|physical activity
5170401|NCT02926677|CCT|cct
5170502|NCT02926144|McGrath MAC|mcgrath mac
5170830|NCT02924116|Biomobie|biomobie
5171375|NCT02921230|atherosclerosis|atherosclerosis
5171473|NCT02920658|Topical treatment|topical treatment
5171568|NCT02920112|Bariatrics|bariatrics
5171812|NCT02918656|Infographics|infographics
5171945|NCT02917915|COPD|copd
5172053|NCT02917291|ATMP|atmp
5172260|NCT02915939|Coping|coping
5172644|NCT02913859|prostate cancer|prostate cancer
5172769|NCT02912923|Hemiplegia|hemiplegia
5779264|NCT00200863|performance|performance
5173066|NCT02910531|Cystinuria|cystinuria
5173266|NCT02909400|MELAS|melas
5173565|NCT02907580|influenza|influenza
5173695|NCT02906657|Elderly|elderly
5174076|NCT02904304|Flu|flu
5174927|NCT02898233|LLLT|lllt
5176749|NCT02886520|Transobturator tape|transobturator tape
5176875|NCT02885753|metastasis|metastasis
5177285|NCT02882815|IrisFIT PFO|irisfit pfo
5178025|NCT02878161|predictive|predictive
5178540|NCT02874495|Remission|remission
5178828|NCT02872493|obesity|obesity
5178931|NCT02871869|CHOP protocol|chop protocol
5179335|NCT02869035|PET|pet
5179431|NCT02868528|PGS|pgs
5179728|NCT02866344|Surgery|surgery
5180068|NCT02864797|cohort|cohort
5180365|NCT02862990|Fertility|fertility
5180790|NCT02860104|breast|breast
5180909|NCT02859285|Estradiol|estradiol
5181058|NCT02858362|DMD|dmd
5181462|NCT02855515|AHI|ahi
5181767|NCT02853929|Hepatitis B|hepatitis b
5181972|NCT02852590|Pediatric|pediatric
5182398|NCT02849613|graft|graft
5182683|NCT02847962|Food assistance|food assistance
5182784|NCT02847611|Dynamometer mechanic|dynamometer mechanic
5182986|NCT02846441|SPECT|spect
5183509|NCT02843490|biomarker|biomarker
5183618|NCT02842853|Licensed MCV4 vaccine|licensed mcv4 vaccine
5183815|NCT02841410|Food|food
5183928|NCT02840526|PVB|pvb
5184053|NCT02839798|TMS|tms
5185351|NCT02831452|pelvic floor muscles|pelvic floor muscles
5185558|NCT02830087|pain, postoperative|pain, postoperative
5185861|NCT02828748|cannabinoids|cannabinoids
5186171|NCT02826395|imaging|imaging
5186265|NCT02825758|acceptability|acceptability
5186371|NCT02825264|STARflo|starflo
5186695|NCT02823288|rape|rape
5186909|NCT02821728|ATP|atp
5187095|NCT02820545|hospital|hospital
5187320|NCT02819336|complications|complications
5187668|NCT02817373|IVF|ivf
5188595|NCT02811952|bladder cancer|bladder cancer
5188696|NCT02811432|Preterm infant|preterm infant
5188804|NCT02810691|Nutrition|nutrition
5188916|NCT02810093|Big Data|big data
5189134|NCT02808702|Neuroimaging|neuroimaging
5189226|NCT02807987|Hypertension|hypertension
5189725|NCT02804945|Placebo|placebo
5189934|NCT02803593|Asian American|asian american
5190249|NCT02801838|Electromyogram|electromyogram
5190780|NCT02798796|MRI|mri
5191265|NCT02796560|Drugs, Generic|drugs, generic
5191479|NCT02795325|PH1|ph1
5191631|NCT02794376|IBS|ibs
5800998|NCT00104156|Qi|qi
5192302|NCT02790541|aging|aging
5193067|NCT02786173|PAD|pad
5193362|NCT02784249|Glaucoma|glaucoma
5193495|NCT02783625|16-042|16-042
5194032|NCT02780791|Estradiol|estradiol
5194133|NCT02780310|15-327|15-327
5194235|NCT02779972|Physiology|physiology
5194635|NCT02777333|Simulation|simulation
5195394|NCT02772835|RDS|rds
5195592|NCT02771756|Safety|safety
5195797|NCT02770599|IBD nurse|ibd nurse
5195974|NCT02769338|TIA|tia
5196149|NCT02768324|sepsis|sepsis
5196657|NCT02765048|PTSD|ptsd
5197075|NCT02762370|pain|pain
5197283|NCT02761317|bisacodyl|bisacodyl
5197484|NCT02760238|registry|registry
5197882|NCT02757872|Vitamin D|vitamin d
5198710|NCT02752529|Polymorphism|polymorphism
5199526|NCT02747264|PRO|pro
5199632|NCT02746445|Autism|autism
5199844|NCT02745145|Abituzumab|abituzumab
5200255|NCT02743143|Risk|risk
5200880|NCT02738723|Chemotherapy|chemotherapy
5802768|NCT00097396|plague|plague
5201705|NCT02733471|Lidocaine|lidocaine
5202446|NCT02729025|Dyslipidemia|dyslipidemia
5202829|NCT02726425|Medical group visits|medical group visits
5203144|NCT02724709|Aortic Valve|aortic valve
5203858|NCT02720380|Child|child
5204596|NCT02715895|Infant|infant
5204811|NCT02714725|On Pump|on pump
5205356|NCT02711605|fat|fat
5205666|NCT02709551|hrv|hrv
5205873|NCT02708173|vaccine|vaccine
5206288|NCT02705469|ZEN003694|zen003694
5206387|NCT02704949|Ureteroscopy|ureteroscopy
5207210|NCT02699736|HIV|hiv
5207310|NCT02699047|Inflammation|inflammation
5207405|NCT02698501|Asthma|asthma
5207626|NCT02697214|ECG|ecg
5207712|NCT02696759|Cancer|cancer
5207914|NCT02695797|Immunotherapy|immunotherapy
5208750|NCT02690766|Type 2 Diabetes|type 2 diabetes
5208852|NCT02690220|prolapse|prolapse
5209079|NCT02689128|nausea|nausea
5209181|NCT02688400|Canada|canada
5209295|NCT02687516|Treatment|treatment
5209400|NCT02686788|contrast enhancing lesions|contrast enhancing lesions
5209796|NCT02684487|ICU|icu
5210840|NCT02677402|temperature|temperature
5210970|NCT02676544|PAE|pae
5211583|NCT02672540|VOC|voc
5211660|NCT02671968|CGM|cgm
5211747|NCT02671292|Obesity|obesity
5211878|NCT02670356|EPA|epa
5212135|NCT02668653|AML|aml
5212192|NCT02668367|Aviragen|aviragen
5212291|NCT02667652|T2DM|t2dm
5212709|NCT02665065|AML|aml
5212941|NCT02663752|MDS|mds
5213212|NCT02662465|Treatment|treatment
5213453|NCT02661035|AML|aml
5214016|NCT02658188|XP13512|xp13512
5214839|NCT02653326|Telerehabilitation|telerehabilitation
5215030|NCT02652208|stable angina|stable angina
5215662|NCT02648425|ASLAN001|aslan001
5215779|NCT02647723|docosahexaenoic|docosahexaenoic
5216179|NCT02645071|health|health
5216819|NCT02641041|Japanese|japanese
5217457|NCT02637505|Debridement|debridement
5217654|NCT02636348|Calcium|calcium
5218254|NCT02633163|Lupus|lupus
5219439|NCT02627144|Avastin|avastin
5219545|NCT02626585|postoperative edema|postoperative edema
5219848|NCT02624726|FOLFIRI|folfiri
5220176|NCT02622815|Thrombosis|thrombosis
5220485|NCT02620878|SAP therapy|sap therapy
5222412|NCT02608658|SBP|sbp
5223237|NCT02603419|PK|pk
5223308|NCT02602990|Cerebral|cerebral
5223506|NCT02601924|Anesthesia|anesthesia
5223914|NCT02599480|HFpEF|hfpef
5224368|NCT02596711|NRT|nrt
5224542|NCT02595671|Sustainable weight loss|sustainable weight loss
5224670|NCT02594943|Biopsy|biopsy
5224732|NCT02594592|Asians|asians
5225039|NCT02592837|EBUS|ebus
5928467|NCT03801083|Biliary Tract Cancer|biliary tract cancer
5928468|NCT03801083|Cholangiocarcinoma|cholangiocarcinoma
5928476|NCT03800576|tacrolimus|tacrolimus
5928477|NCT03800576|liver transplant|liver transplant
5928478|NCT03800576|gene polymorphism|gene polymorphism
5928479|NCT03800576|immunosuppressant|immunosuppressant
5928491|NCT03795298|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5928492|NCT03795298|Left atrial appendage|left atrial appendage
5928493|NCT03795298|Ablation|ablation
5225740|NCT02588963|infant|infant
5225828|NCT02588326|Pharmacokinetics|pharmacokinetics
5225926|NCT02587728|Amyloidosis|amyloidosis
5226342|NCT02584933|ALK|alk
5226660|NCT02582853|AIDP|aidp
5226848|NCT02581592|Hepatitis|hepatitis
5227287|NCT02579460|Barrett's esophagus|barrett's esophagus
5227417|NCT02578706|HIV|hiv
5227606|NCT02577575|Oxytocin|oxytocin
5227822|NCT02576626|DPI|dpi
5227923|NCT02576184|Incisional hernia|incisional hernia
5228239|NCT02574390|ALS|als
5228323|NCT02573974|skeletal muscle|skeletal muscle
5228431|NCT02573467|muscle wasting,|muscle wasting,
5228925|NCT02570919|MRI|mri
5229029|NCT02570165|efficacy|efficacy
5229447|NCT02567877|cognitive function|cognitive function
5229686|NCT02566512|weaning|weaning
5229787|NCT02565875|Simulation|simulation
5229889|NCT02565173|adenosine agonist|adenosine agonist
5230346|NCT02562495|thickness of the quadriceps|thickness of the quadriceps
5230354|NCT02562456|Composite Resins|composite resins
5230546|NCT02561247|Acute Kidney Injury|acute kidney injury
5230753|NCT02560168|iECG|iecg
5230988|NCT02558686|disability|disability
5231304|NCT02556684|BSGI|bsgi
5231399|NCT02556229|inflammatory choroidal neovascularization|inflammatory choroidal neovascularization
5231400|NCT02556229|young patient|young patient
5231505|NCT02555553|Binge Eating|binge eating
5231924|NCT02552901|fluorescence|fluorescence
5232247|NCT02550977|Safety|safety
5232628|NCT02548858|Body image|body image
5892492|NCT03688906|CRC|crc
5232722|NCT02548247|Orafti® Inulin|orafti® inulin
5232846|NCT02547519|T1D|t1d
5233030|NCT02546414|China|china
5233370|NCT02544269|Hemodynamics|hemodynamics
5233371|NCT02544256|Microcirculation|microcirculation
5233372|NCT02544256|Mild Hypothermia, Induced|mild hypothermia, induced
5233373|NCT02544256|Subarachnoid Hemorrhage, Aneurysmal|subarachnoid hemorrhage, aneurysmal
5234499|NCT02537054|aflibercept|aflibercept
5234596|NCT02536352|Pregnancy Nutrition|pregnancy nutrition
5234929|NCT02533817|Insulin|insulin
5235244|NCT02532179|mouse specific IgE|mouse specific ige
5236431|NCT02524860|Imaging|imaging
5236935|NCT02521623|Breast Implant|breast implant
5237356|NCT02518867|Cerebral palsy|cerebral palsy
5237357|NCT02518867|Transcranial magnetic stimulation|transcranial magnetic stimulation
5237358|NCT02518841|ThermaWedge TM|thermawedge tm
5237359|NCT02518841|stretches|stretches
5237564|NCT02517502|DHA|dha
5238023|NCT02514356|SMS|sms
5238192|NCT02513511|awake intubation|awake intubation
5238298|NCT02512913|Smoking Cessation|smoking cessation
5238615|NCT02511249|motor abilities|motor abilities
5238724|NCT02510287|labor pain|labor pain
5239029|NCT02508701|HPV|hpv
5239239|NCT02507492|POMC, LEPR, PCSK1|pomc, lepr, pcsk1
5239240|NCT02507466|locomotion|locomotion
5239241|NCT02507453|volunteers|volunteers
5239242|NCT02507427|Prostate cancer, robot, nerve mapping and monitoring|prostate cancer, robot, nerve mapping and monitoring
5239634|NCT02505165|Brain Tumor|brain tumor
5239635|NCT02505165|Randomized clinical trial|randomized clinical trial
5239637|NCT02505165|Parent|parent
5239736|NCT02504710|Inertial Sensor|inertial sensor
5240032|NCT02503085|Ibuprofen|ibuprofen
5240033|NCT02503072|ARV adherence|arv adherence
5240034|NCT02503020|Arachidonic acid|arachidonic acid
5240035|NCT02503020|Omega-6/omega-3 ratio|omega-6/omega-3 ratio
5240036|NCT02503020|Preterm infants nutrition|preterm infants nutrition
5240037|NCT02502981|CKD|ckd
5240038|NCT02502981|left ventricle|left ventricle
5240039|NCT02502981|aldosterone|aldosterone
5240133|NCT02502539|miRNA|mirna
5240321|NCT02501434|delayed ischemic neurological deficits|delayed ischemic neurological deficits
5240537|NCT02500420|T1 mapping|t1 mapping
5240538|NCT02500420|2D strain|2d strain
5240539|NCT02500394|renal replacement therapy|renal replacement therapy
5240540|NCT02500381|Duchenne muscular dystrophy|duchenne muscular dystrophy
5240541|NCT02500381|Exon Skipping|exon skipping
5240542|NCT02500381|DMD|dmd
5240543|NCT02500381|Exon 53|exon 53
5240544|NCT02500381|Exon 45|exon 45
5240545|NCT02500381|Ambulatory|ambulatory
5240546|NCT02500381|Pediatric|pediatric
5240632|NCT02499770|Small Cell Lung Cancer|small cell lung cancer
5240633|NCT02499770|CDK 4/6 Inhibitor|cdk 4/6 inhibitor
5240634|NCT02499757|Perception|perception
5240635|NCT02499757|brain response|brain response
5240636|NCT02499757|nicotine|nicotine
5240637|NCT02499757|taste|taste
5240638|NCT02499744|NIPPV|nippv
5240639|NCT02499744|HHFNC|hhfnc
5240640|NCT02499744|RDS|rds
5240641|NCT02499744|neonate|neonate
5240642|NCT02499731|physical activity|physical activity
5240643|NCT02499731|nutrition|nutrition
5240644|NCT02499731|social network|social network
5240645|NCT02499718|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5240662|NCT02499627|Hodgkin|hodgkin
5240925|NCT02497937|GSK2798745|gsk2798745
5241122|NCT02496741|isocitrate dehydrogenase 1/2 mutation|isocitrate dehydrogenase 1/2 mutation
5241123|NCT02496741|metformin|metformin
5241124|NCT02496741|chloroquine|chloroquine
5241125|NCT02496728|Mobile Health|mobile health
5241126|NCT02496728|Smartphone|smartphone
5241127|NCT02496728|Cardiovascular health|cardiovascular health
5241128|NCT02496728|College students|college students
5241129|NCT02496728|Smoking|smoking
5241130|NCT02496728|Physical activity|physical activity
5241131|NCT02496728|Diet|diet
5241132|NCT02496728|BMI|bmi
5241133|NCT02496728|Blood pressure|blood pressure
5241134|NCT02496728|Cholesterol|cholesterol
5241223|NCT02496390|Gut microbiome|gut microbiome
5242428|NCT02488915|Cerebral Ischemia|cerebral ischemia
5242429|NCT02488915|Cerebrovascular Disorders|cerebrovascular disorders
5242430|NCT02488915|EmboTrap® Revascularization Device|embotrap® revascularization device
5242431|NCT02488915|EmboTrap|embotrap
5242432|NCT02488915|Ischemia|ischemia
5242433|NCT02488915|Ischemic|ischemic
5892600|NCT03675360|Prediabetes|prediabetes
5242434|NCT02488915|Ischemic Stroke|ischemic stroke
5242435|NCT02488915|Mechanical Thrombectomy|mechanical thrombectomy
5242436|NCT02488915|Neurovascular Intervention|neurovascular intervention
5242437|NCT02488915|Revascularization|revascularization
5242438|NCT02488915|Stent Retriever|stent retriever
5242439|NCT02488915|Stroke|stroke
5242440|NCT02488915|Vascular Diseases|vascular diseases
5242441|NCT02488915|Neuravi|neuravi
5242442|NCT02488889|Chantix|chantix
5242443|NCT02488876|Cardiac surgery|cardiac surgery
5242444|NCT02488876|Tissue sample database|tissue sample database
5242445|NCT02488876|Inflammatory responds|inflammatory responds
5242446|NCT02488863|Older adults|older adults
5242447|NCT02488863|Chronic Pain|chronic pain
5242448|NCT02488863|Musculoskeletal|musculoskeletal
5242449|NCT02488850|immune monitoring|immune monitoring
5242598|NCT02488109|refeeding|refeeding
5242599|NCT02488109|adolescent medicine|adolescent medicine
5242600|NCT02488109|nutritional rehabilitation|nutritional rehabilitation
5242601|NCT02488083|non-invasive|non-invasive
5242602|NCT02488031|SCA, dysmetria|sca, dysmetria
5242603|NCT02488018|Glycemic index|glycemic index
5242604|NCT02488018|honey|honey
5242605|NCT02488018|reference glucose|reference glucose
5242606|NCT02488005|Inflammatory Bowel Disease|inflammatory bowel disease
5242607|NCT02488005|Small Bowel|small bowel
5242730|NCT02487290|AAA|aaa
5242801|NCT02487030|GS-5885|gs-5885
5242908|NCT02486458|Topical|topical
5243020|NCT02485743|satiation|satiation
5243252|NCT02484417|RSV|rsv
5243431|NCT02483611|Magnesium sulfate|magnesium sulfate
5243432|NCT02483611|Isotonic solution|isotonic solution
5243529|NCT02483013|color alteration|color alteration
5243530|NCT02483013|tooth sensitivity|tooth sensitivity
5243531|NCT02482987|dental|dental
5243532|NCT02482987|extraction|extraction
5243537|NCT02482974|Everolimus|everolimus
5243648|NCT02482311|AZD1775|azd1775
5243747|NCT02481596|support|support
5243948|NCT02480439|Drug Therapy|drug therapy
5243949|NCT02480413|Broselow Tape|broselow tape
5243950|NCT02480413|Weight estimation|weight estimation
5243951|NCT02480413|Patient safety|patient safety
5243953|NCT02480400|Escitalopram|escitalopram
5244041|NCT02479737|heart surgery|heart surgery
5244140|NCT02479243|MRI|mri
5244141|NCT02479243|Atherosclerotic Stenosis|atherosclerotic stenosis
5244142|NCT02479243|Collateral Circulation|collateral circulation
5244546|NCT02476955|AKT2|akt2
5244743|NCT02475785|anchorage|anchorage
5244744|NCT02475785|FFRD|ffrd
5244745|NCT02475785|mini plates|mini plates
5244746|NCT02475785|fixed functional appliance|fixed functional appliance
5244747|NCT02475772|ovarian cancer|ovarian cancer
5244748|NCT02475772|recurrent|recurrent
5244749|NCT02475772|chemotherapy|chemotherapy
5244750|NCT02475772|intraperitoneal|intraperitoneal
5244751|NCT02475772|cisplatin|cisplatin
5244752|NCT02475772|doxorubicin|doxorubicin
5244753|NCT02475746|drug interaction, PF-06372865, itraconazole|drug interaction, pf-06372865, itraconazole
5244759|NCT02475590|Sleeve gastrectomy|sleeve gastrectomy
5244760|NCT02475590|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5244761|NCT02475590|Excess weight loss|excess weight loss
5244762|NCT02475590|Quality of life|quality of life
5244763|NCT02475577|telemedicine|telemedicine
5245508|NCT02471755|RCT|rct
5245538|NCT02471573|frozen embryo transfer|frozen embryo transfer
5245539|NCT02471573|fresh transfer|fresh transfer
5245540|NCT02471560|Microbiota|microbiota
5245542|NCT02471560|Gastro intestinal|gastro intestinal
5245649|NCT02470793|Descemet Membrane Endothelial Keratoplasty|descemet membrane endothelial keratoplasty
5245650|NCT02470793|Minimal Surgical Procedure|minimal surgical procedure
5245651|NCT02470728|patient readmission|patient readmission
5245652|NCT02470728|pain relief units|pain relief units
5245752|NCT02470104|autologous|autologous
5246199|NCT02467959|emergency ultrasound|emergency ultrasound
5246200|NCT02467959|acute appendicitis|acute appendicitis
5246201|NCT02467959|bedside ultrasound|bedside ultrasound
5246231|NCT02467764|Hip|hip
5246300|NCT02467374|OCD|ocd
5246393|NCT02467036|behavioral treatment|behavioral treatment
5246394|NCT02467036|family based treatment|family based treatment
5246421|NCT02466958|MDD|mdd
5246597|NCT02465814|Uterine fibroids|uterine fibroids
5246598|NCT02465814|Heavy Menstrual Bleeding|heavy menstrual bleeding
5246599|NCT02465788|Helos|helos
5246600|NCT02465788|Hair Removal|hair removal
5246601|NCT02465788|Hair Reduction|hair reduction
5246602|NCT02465775|non-invasive|non-invasive
5246918|NCT02464059|vitamin D|vitamin d
5247124|NCT02462824|PAD|pad
5247221|NCT02462317|Botulinum toxin|botulinum toxin
5247419|NCT02461108|Nutrition labeling|nutrition labeling
5247420|NCT02461108|Fat tax|fat tax
5247421|NCT02461108|Vegetable subsidy|vegetable subsidy
5247422|NCT02461108|Behavioral economics|behavioral economics
5247423|NCT02461108|Health behavior|health behavior
5247519|NCT02460549|empowerment|empowerment
5247520|NCT02460549|prostate cancer|prostate cancer
5247521|NCT02460549|oral endocrine therapy|oral endocrine therapy
5247522|NCT02460549|side effects|side effects
5247523|NCT02460536|attention bias modification treatment|attention bias modification treatment
5247524|NCT02460536|attention training|attention training
5247525|NCT02460536|anxiety disorders|anxiety disorders
5247526|NCT02460536|clinical trials|clinical trials
5247527|NCT02460471|Radiotherapy|radiotherapy
5247528|NCT02460471|Palliative Care|palliative care
5247529|NCT02460471|IMRT|imrt
5247722|NCT02459457|cisplatin|cisplatin
5247723|NCT02459457|carboplatin|carboplatin
5247724|NCT02459457|fluorouracil|fluorouracil
5247725|NCT02459444|Respiratory Muscles|respiratory muscles
5247726|NCT02459444|Muscle Weakness|muscle weakness
5247727|NCT02459444|Hospitalization|hospitalization
5247728|NCT02459444|Length of Stay|length of stay
5247729|NCT02459444|Mortality|mortality
5247817|NCT02458937|Hip Core Decompression|hip core decompression
5247818|NCT02458937|Function Outcomes|function outcomes
5247819|NCT02458885|myocardial infarction|myocardial infarction
5247820|NCT02458885|observational registry|observational registry
5247821|NCT02458885|mortality|mortality
5247822|NCT02458872|Clinical Alarms|clinical alarms
5247910|NCT02458157|Intensive|intensive
5247912|NCT02458157|Fluid Removal|fluid removal
5247913|NCT02458157|AKI|aki
5247914|NCT02458157|Critical Care|critical care
5248166|NCT02456714|FOLFIRINOX|folfirinox
5248379|NCT02455115|Postoperative care|postoperative care
5248380|NCT02455115|Glomerular filtration rate|glomerular filtration rate
5248381|NCT02455115|Renal blood flow|renal blood flow
5248472|NCT02454634|immunotherapy|immunotherapy
5248473|NCT02454634|IDH1R132H-mutated glioma|idh1r132h-mutated glioma
5248474|NCT02454556|Assisted reproduction technologies|assisted reproduction technologies
5248475|NCT02454556|Follicle stimulating hormone (FSH).|follicle stimulating hormone (fsh).
5248476|NCT02454543|metastatic|metastatic
5248477|NCT02454543|prostatectomy|prostatectomy
5248560|NCT02454062|Pharmacokinetics|pharmacokinetics
5248561|NCT02454062|Pharmacodynamics|pharmacodynamics
5248562|NCT02454062|MTD|mtd
5248563|NCT02454023|Stroke|stroke
5248564|NCT02454023|Transient ischemic attack|transient ischemic attack
5248565|NCT02454023|Obstructive sleep apnea|obstructive sleep apnea
5248566|NCT02454023|Portable sleep monitor|portable sleep monitor
5248567|NCT02454023|Screening|screening
5248568|NCT02453997|lupus nephritis|lupus nephritis
5248569|NCT02453997|mycophenolic acid|mycophenolic acid
5248570|NCT02453997|pharmacokinetics|pharmacokinetics
5248571|NCT02453997|pharmacogenomics|pharmacogenomics
5248572|NCT02453984|89Zr-MPLD3280A-PET|89zr-mpld3280a-pet
5248573|NCT02453971|alcohol consumption|alcohol consumption
5248645|NCT02453737|3D Conformal Photon|3d conformal photon
5248646|NCT02453724|Ultrasonography|ultrasonography
5248647|NCT02453724|Lung|lung
5248648|NCT02453724|Hemorrhage|hemorrhage
5248649|NCT02453724|Point of care ultrasound|point of care ultrasound
5248656|NCT02453633|No-show|no-show
5248933|NCT02451566|Aneurysm|aneurysm
5248934|NCT02451540|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5248935|NCT02451540|dynamics hyperinflation|dynamics hyperinflation
5248937|NCT02451540|CT scan|ct scan
5249235|NCT02449785|MRI|mri
5249429|NCT02448693|Narrow Band Imaging|narrow band imaging
5249430|NCT02448693|chromoendoscopy|chromoendoscopy
5249431|NCT02448641|ischemic stroke|ischemic stroke
5249438|NCT02448628|Japanese|japanese
5249439|NCT02448615|Kenya|kenya
5249480|NCT02448381|MF|mf
5249632|NCT02447159|HIV|hiv
5249740|NCT02446483|Idiazole 20mg|idiazole 20mg
5249938|NCT02445339|Narcotic Antagonists|narcotic antagonists
5249939|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents
5249940|NCT02445339|Pharmacologic Actions|pharmacologic actions
5250253|NCT02443389|nephrotoxic|nephrotoxic
5928548|NCT03783598|Diabetes Mellitus|diabetes mellitus
5928549|NCT03783598|Problem Solving|problem solving
5928550|NCT03783598|Occupational Therapy|occupational therapy
5928551|NCT03783598|Healthy Lifestyle|healthy lifestyle
5928552|NCT03783598|Occupational Performance|occupational performance
5892775|NCT03652857|NSCLC|nsclc
5250254|NCT02443389|Fluid overload|fluid overload
5250255|NCT02443389|Acute renal failure|acute renal failure
5250256|NCT02443389|Prematurity|prematurity
5250257|NCT02443389|Risk factors|risk factors
5250258|NCT02443389|Epidemiology|epidemiology
5250269|NCT02443259|late preterm|late preterm
5250270|NCT02443207|Toothache|toothache
5250271|NCT02443207|Quality of life|quality of life
5250272|NCT02443207|Oral Health|oral health
5250273|NCT02443207|Children|children
5250274|NCT02443194|depression|depression
5250275|NCT02443194|glioblastoma|glioblastoma
5250276|NCT02443181|Essential tremor; closed-loop DBS|essential tremor; closed-loop dbs
5250279|NCT02443168|Male|male
5250280|NCT02443168|AG-221|ag-221
5250281|NCT02443168|[14C]|[14c]
5250282|NCT02443168|Single dose|single dose
5250283|NCT02443168|Oral|oral
5250284|NCT02443168|Intravenous|intravenous
5250285|NCT02443142|mild TBI|mild tbi
5250286|NCT02443142|concussion|concussion
5250287|NCT02443142|post-concussion syndrome|post-concussion syndrome
5250288|NCT02443103|pilot study|pilot study
5250289|NCT02443103|guanabenz acetate|guanabenz acetate
5250290|NCT02443090|secondary hypogonadism|secondary hypogonadism
5250291|NCT02443090|sexual dysfunction|sexual dysfunction
5250292|NCT02443090|erectile dysfunction|erectile dysfunction
5250293|NCT02443064|Pharmacokinetics/pharmacodynamics|pharmacokinetics/pharmacodynamics
5250294|NCT02443064|vancomycin|vancomycin
5250295|NCT02443064|blood stream infections|blood stream infections
5250296|NCT02443064|Chinese patients|chinese patients
5250297|NCT02443064|MRSA|mrsa
5250298|NCT02443038|patient fall|patient fall
5250299|NCT02443038|yoga|yoga
5250300|NCT02443038|balance|balance
5250301|NCT02443012|Diabetic Macular Edema|diabetic macular edema
5250434|NCT02442375|dose de-escalation|dose de-escalation
5250529|NCT02442037|phase 1/2 clinical study|phase 1/2 clinical study
5250530|NCT02442037|human umbilical cord mesenchymal stem cell|human umbilical cord mesenchymal stem cell
5250532|NCT02442037|UC|uc
5250926|NCT02440100|Multiple doses of PF-06648671|multiple doses of pf-06648671
5250932|NCT02440061|Ghrelin|ghrelin
5251115|NCT02439086|response|response
5251225|NCT02438215|PD|pd
5251317|NCT02437656|Rectal cancer|rectal cancer
5251318|NCT02437617|Advanced cancers|advanced cancers
5251418|NCT02437032|Apoptosis rate|apoptosis rate
5251419|NCT02437032|Endocrinology|endocrinology
5251420|NCT02437019|PCI-32765|pci-32765
5251935|NCT02434081|NSCLC|nsclc
5252040|NCT02433353|PTSD|ptsd
5252146|NCT02432729|one year|one year
5252281|NCT02432079|Cilia|cilia
5252451|NCT02431286|nausea and vomiting, postoperative|nausea and vomiting, postoperative
5252452|NCT02431286|emesis, postoperative|emesis, postoperative
5252453|NCT02431273|TDF|tdf
5252454|NCT02431273|FTC|ftc
5252455|NCT02431273|MVC|mvc
5252456|NCT02431273|TDF-FTC|tdf-ftc
5252457|NCT02431273|TDF-FTC-MVC|tdf-ftc-mvc
5252458|NCT02431273|IVR|ivr
5252459|NCT02431273|ARV|arv
5252460|NCT02431260|solid tumor|solid tumor
5252461|NCT02431260|lymphoma|lymphoma
5252462|NCT02431260|BET bromodomain inhibitor|bet bromodomain inhibitor
5252463|NCT02431260|BRD|brd
5252464|NCT02431260|Diffuse large B-cell lymphoma (DLBCL)|diffuse large b-cell lymphoma (dlbcl)
5252465|NCT02431260|Burkitt's lymphoma|burkitt's lymphoma
5252466|NCT02431260|c-MYC|c-myc
5252467|NCT02431260|colorectal cancer|colorectal cancer
5252534|NCT02430883|pain, RIRS, kidney|pain, rirs, kidney
5252535|NCT02430870|Drug therapy|drug therapy
5252536|NCT02430844|acute kidney injury|acute kidney injury
5252537|NCT02430844|radiographic contrast|radiographic contrast
5252538|NCT02430844|critically ill|critically ill
5252540|NCT02430818|ketamine|ketamine
5252541|NCT02430818|emergency medicine|emergency medicine
5252935|NCT02428829|arthroplasty|arthroplasty
5252936|NCT02428829|total|total
5252937|NCT02428829|orthopaedic|orthopaedic
5252938|NCT02428829|rehabiliation|rehabiliation
5252939|NCT02428829|physiotherapy|physiotherapy
5253130|NCT02427867|non cardiac surgery|non cardiac surgery
5253135|NCT02427789|Physical exercise|physical exercise
5253136|NCT02427789|Biomarkers|biomarkers
5253157|NCT02427659|VRD|vrd
5253239|NCT02427113|Music Medicine|music medicine
5928553|NCT03783598|Person-Centered|person-centered
5928554|NCT03783598|Occupation Based|occupation based
5928560|NCT03783273|Vitamin D Insufficiency|vitamin d insufficiency
5928561|NCT03783273|Vitamin D Supplementation|vitamin d supplementation
5928562|NCT03783273|Food Fortification|food fortification
5928590|NCT03778424|Central Nervous System|central nervous system
5928591|NCT03778424|E2080|e2080
5928592|NCT03778424|Rufinamide|rufinamide
5928593|NCT03778424|Epilepsy|epilepsy
5928594|NCT03778424|Seizures|seizures
5928595|NCT03778424|Brain Diseases|brain diseases
5928596|NCT03778229|Non Small Cell Lung Cancer|non small cell lung cancer
5928660|NCT03772743|older adults|older adults
5928661|NCT03772743|multivessel coronary disease|multivessel coronary disease
5253544|NCT02425332|Spinal Cord Injury|spinal cord injury
5253545|NCT02425332|adaptive control|adaptive control
5253546|NCT02425332|assessment|assessment
5253547|NCT02425332|assist-as-needed|assist-as-needed
5253548|NCT02425332|walking ability|walking ability
5253549|NCT02425332|Lokomat|lokomat
5253650|NCT02424825|diet|diet
5253873|NCT02423525|low grade gliomas|low grade gliomas
5253992|NCT02422888|Endothelial function|endothelial function
5254214|NCT02421978|Decreased motivation|decreased motivation
5254215|NCT02421965|Schizophrenia|schizophrenia
5254216|NCT02421965|Schizoaffective Disorder|schizoaffective disorder
5254217|NCT02421965|Bipolar Disorder|bipolar disorder
5254220|NCT02421965|Smartphone|smartphone
5254309|NCT02421419|trigger thumb|trigger thumb
5254520|NCT02420405|Small biopsies|small biopsies
5254621|NCT02419807|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
5254622|NCT02419807|Indocyanine Green|indocyanine green
5254623|NCT02419807|axillary lymph node mapping|axillary lymph node mapping
5254624|NCT02419807|Mastectomy, Segmental|mastectomy, segmental
5254625|NCT02419807|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5254713|NCT02419469|Rubex|rubex
5254714|NCT02419469|Dexamethasone|dexamethasone
5254715|NCT02419469|Decadron|decadron
5254716|NCT02419469|Thioguanine|thioguanine
5254717|NCT02419469|6-thioguanine|6-thioguanine
5254718|NCT02419443|inguinal hernia repair, chronic pain|inguinal hernia repair, chronic pain
5254719|NCT02419430|well-being|well-being
5254806|NCT02418871|presbyopia|presbyopia
5254807|NCT02418858|Essential tremor|essential tremor
5254808|NCT02418858|DBS|dbs
5254811|NCT02418832|TEFNA|tefna
5254909|NCT02418312|peptic ulcer|peptic ulcer
5255315|NCT02416453|Modified Vaccinia Virus Ankara - Bavarian Nordic Filo-vector (MVA-BN Filo)|modified vaccinia virus ankara - bavarian nordic filo-vector (mva-bn filo)
5255423|NCT02415933|Child Labor|child labor
5255424|NCT02415933|Child Maltreatment|child maltreatment
5255425|NCT02415920|Investigating oxytocin's effects|investigating oxytocin's effects
5255426|NCT02415920|human communication|human communication
5255429|NCT02415868|Vaginal Microbiota|vaginal microbiota
5255558|NCT02415036|HCC|hcc
5255613|NCT02414685|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline|poor-prognosis germ cell cancer, paclitaxel, ifosfamid and cisplatin regimen, tumor marker decline
5255614|NCT02414672|psychosocial intervention|psychosocial intervention
5255615|NCT02414672|advanced lung cancer|advanced lung cancer
5255782|NCT02413801|PDUS|pdus
5256183|NCT02411331|Intravenous Drug Delivery Systems|intravenous drug delivery systems
5256184|NCT02411331|Coagulase-negative staphylococci infection|coagulase-negative staphylococci infection
5256379|NCT02410330|Angiographic recanalization rate|angiographic recanalization rate
5256380|NCT02410330|Salvagability index|salvagability index
5256381|NCT02410330|Sonothrombolysis|sonothrombolysis
5256678|NCT02408536|serous ovarian cancer|serous ovarian cancer
5256679|NCT02408523|Lacosamide|lacosamide
5256699|NCT02408445|XXY|xxy
5256888|NCT02407353|Parallel Design|parallel design
5256889|NCT02407353|CSF Aβ Concentrations|csf aβ concentrations
5256890|NCT02407353|PF-06648671|pf-06648671
5256891|NCT02407340|Alcohol Withdrawal Delirium|alcohol withdrawal delirium
5256892|NCT02407327|Circulating tumour cells in Advanced Non Small Cell Lung Cancer|circulating tumour cells in advanced non small cell lung cancer
5256893|NCT02407314|Peripheral Arterial Disease|peripheral arterial disease
5256899|NCT02407288|OCD|ocd
5256992|NCT02406677|Acute Coronary Syndromes, ACS, Myocardial Infarction, STEMI, NSTEMI, MI, Co-Payments, Copay, Cost Sharing|acute coronary syndromes, acs, myocardial infarction, stemi, nstemi, mi, co-payments, copay, cost sharing
5256993|NCT02406638|3D Pelvic floor USG|3d pelvic floor usg
5256995|NCT02406638|TVT|tvt
5257085|NCT02405910|advanced|advanced
5928662|NCT03772743|intracoronary physiology|intracoronary physiology
5928663|NCT03772743|functional assessment|functional assessment
5928674|NCT03769766|prostate cancer|prostate cancer
5928675|NCT03769766|active surveillance|active surveillance
5928676|NCT03769766|curcumin|curcumin
5928693|NCT03766126|refractory|refractory
5928694|NCT03766126|relapsed|relapsed
5928695|NCT03766126|Acute|acute
5928696|NCT03766126|Myeloid|myeloid
5928697|NCT03766126|leukemia|leukemia
5928698|NCT03766126|AML|aml
5893046|NCT03620422|Mannitol|mannitol
5257292|NCT02404831|Pulmonary Rehabilitation|pulmonary rehabilitation
5257293|NCT02404831|Exercise|exercise
5257294|NCT02404831|Telerehab|telerehab
5257386|NCT02404376|Acute Coronary Syndrome|acute coronary syndrome
5257387|NCT02404376|Cardioprotection|cardioprotection
5257388|NCT02404363|Clopidogrel|clopidogrel
5257389|NCT02404363|Pancreatic Cancer|pancreatic cancer
5257390|NCT02404363|Efficacy|efficacy
5257391|NCT02404363|Chemotherapy|chemotherapy
5257600|NCT02403297|Saliva|saliva
5257686|NCT02402985|isocaloric diet|isocaloric diet
5257687|NCT02402972|adjuvant chemotherapy|adjuvant chemotherapy
5257688|NCT02402972|intraportal chemotherapy|intraportal chemotherapy
5257689|NCT02402972|prevention|prevention
5257690|NCT02402959|Insomnia|insomnia
5257691|NCT02402959|Traditional Chinese Medicine|traditional chinese medicine
5257692|NCT02402959|herbal medicine|herbal medicine
5257693|NCT02402959|cohort study|cohort study
5257694|NCT02402959|individualized treatment|individualized treatment
5257772|NCT02402426|Dementia|dementia
5258004|NCT02400944|MSK Tobacco Cessation Program|msk tobacco cessation program
5258005|NCT02400944|smoking exposure|smoking exposure
5258007|NCT02400905|PAD|pad
5893120|NCT03614637|Cannabis Abstinence Sperm Cells|cannabis abstinence sperm cells
5893149|NCT03608397|Cervical Dystonia|cervical dystonia
5893150|NCT03608397|TWSTRS|twstrs
5893151|NCT03608397|Toxin|toxin
5928764|NCT03756129|Refractory Depression; Therapy-Resistant Depression; Treatment Resistant Depression; MDE; MDD|refractory depression; therapy-resistant depression; treatment resistant depression; mde; mdd
5928775|NCT03751709|Haplo-Mismatched Cellular Therapy|haplo-mismatched cellular therapy
5928776|NCT03751709|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5928777|NCT03751709|ALL|all
5928778|NCT03751709|B-ALL|b-all
5928779|NCT03751709|donor lymphocyte|donor lymphocyte
5928780|NCT03751709|DLI|dli
5928781|NCT03751709|blinatumomab|blinatumomab
5928782|NCT03751709|bispecific|bispecific
5928783|NCT03751709|microtransplantation|microtransplantation
5928784|NCT03751709|microtransplant|microtransplant
5893153|NCT03607422|Atopic Dermatitis|atopic dermatitis
5893154|NCT03607422|Upadacitinib|upadacitinib
5893155|NCT03607422|ABT-494|abt-494
5258296|NCT02399137|Nab-paclitaxel|nab-paclitaxel
5258407|NCT02398370|ED|ed
5258821|NCT02395731|dual eligible|dual eligible
5258822|NCT02395731|care coordination|care coordination
5258823|NCT02395731|community-based|community-based
5258824|NCT02395731|care quality|care quality
5258909|NCT02395224|Medical futility|medical futility
5258910|NCT02395224|Survival rate|survival rate
5259116|NCT02393794|BRCA1|brca1
5259117|NCT02393794|BRCA2|brca2
5259118|NCT02393794|TNBC|tnbc
5259119|NCT02393781|severe sepsis|severe sepsis
5259124|NCT02393703|15-015|15-015
5259309|NCT02392611|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
5259310|NCT02392585|Leiomyoma of uterus|leiomyoma of uterus
5259311|NCT02392585|Hemostasis, Surgical|hemostasis, surgical
5259312|NCT02392585|Prevention of Surgical Blood Loss|prevention of surgical blood loss
5259313|NCT02392585|mechanical uterine tourniquet|mechanical uterine tourniquet
5259314|NCT02392572|Leukemia|leukemia
5259315|NCT02392572|Acute myelogenous leukemia|acute myelogenous leukemia
5259316|NCT02392572|AML|aml
5259318|NCT02392572|MDS|mds
5260044|NCT02388074|Sputum Cytology|sputum cytology
5260045|NCT02388074|Early Detection|early detection
5260046|NCT02388048|Leukemia|leukemia
5260047|NCT02388048|Chronic|chronic
5260048|NCT02388048|High-risk|high-risk
5260049|NCT02388048|ofatumumab|ofatumumab
5260050|NCT02388048|ibrutinib|ibrutinib
5260051|NCT02388048|Lymphoblastic|lymphoblastic
5260052|NCT02388035|profiles changes|profiles changes
5260053|NCT02388035|microorganisms|microorganisms
5260054|NCT02388035|cefotaxime|cefotaxime
5260055|NCT02388035|SBP|sbp
5260056|NCT02388035|Egyptian|egyptian
5260057|NCT02388035|effective antibiotics|effective antibiotics
5260059|NCT02388009|safety|safety
5260339|NCT02386462|laryngeal mask airway|laryngeal mask airway
5260341|NCT02386436|GSK2330811|gsk2330811
5260438|NCT02385812|Asbestos|asbestos
5260746|NCT02384512|Quality of life|quality of life
5260747|NCT02384512|Daily practice|daily practice
5260748|NCT02384460|Amicus Therapeutics|amicus therapeutics
5260749|NCT02384460|Scioderm, Inc.|scioderm, inc.
5260958|NCT02383147|Humans|humans
5260959|NCT02383147|Male|male
5260960|NCT02383147|Neurofeedback|neurofeedback
5260961|NCT02383147|Prospective Studies|prospective studies
5260962|NCT02383147|Questionnaires|questionnaires
5260963|NCT02383147|Tinnitus|tinnitus
5260964|NCT02383147|Treatment Outcome|treatment outcome
5260965|NCT02383095|Schizophrenia|schizophrenia
5260966|NCT02383095|Art-therapy|art-therapy
5260967|NCT02383095|Visual organization|visual organization
5260968|NCT02383069|Pulmonary rehabilitation|pulmonary rehabilitation
5260969|NCT02383069|Asthma|asthma
5260970|NCT02383069|Children|children
5260971|NCT02383069|Teenager|teenager
5260972|NCT02383069|Physical capacity|physical capacity
5260973|NCT02383056|wound|wound
5260975|NCT02383056|lower extremity|lower extremity
5928836|NCT03747861|R-R intervals|r-r intervals
5928837|NCT03747861|Heart rate|heart rate
5928838|NCT03747861|HRV|hrv
5673629|NCT00607425|screening|screening
5928860|NCT03746041|Myelodysplastic syndromes|myelodysplastic syndromes
5928861|NCT03746041|MDS|mds
5928862|NCT03746041|Chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5928863|NCT03746041|CMML|cmml
5928864|NCT03746041|abaloparatide|abaloparatide
5928865|NCT03746041|bevacizumab|bevacizumab
5928866|NCT03746041|phase 1|phase 1
5893183|NCT03603639|E2730|e2730
5261144|NCT02382042|Substance Abuse|substance abuse
5261145|NCT02382003|Anxiety|anxiety
5261146|NCT02382003|Cognitive bias|cognitive bias
5261147|NCT02382003|Telemedicine|telemedicine
5261248|NCT02381431|imaging|imaging
5261347|NCT02381015|Genomic testing|genomic testing
5928907|NCT03740880|ICSI|icsi
5928908|NCT03740880|early trigger|early trigger
5928909|NCT03740880|poor ovarian responders|poor ovarian responders
5928910|NCT03740880|low AMH|low amh
5928935|NCT03737149|Knee Replacement|knee replacement
5928936|NCT03737149|Knee Arthroplasty|knee arthroplasty
5928937|NCT03737149|Hip Replacement|hip replacement
5928938|NCT03737149|Hip Arthroplasty|hip arthroplasty
5928939|NCT03737149|Joint Replacement|joint replacement
5928940|NCT03737149|Physical Therapy|physical therapy
5928941|NCT03737149|Partial Knee Replacement|partial knee replacement
5928942|NCT03737149|Hip Pain, Chronic|hip pain, chronic
5928943|NCT03737149|Knee Pain, Chronic|knee pain, chronic
5261348|NCT02381015|Chemoprevention|chemoprevention
5893365|NCT03574571|Radium-223|radium-223
5893366|NCT03574571|Docetaxel|docetaxel
5893367|NCT03574571|18-150|18-150
5893368|NCT03574571|C16-174|c16-174
5893369|NCT03574571|DORA Trial|dora trial
5893421|NCT03568084|elderly|elderly
5929041|NCT03723278|nitric oxide|nitric oxide
5929042|NCT03722719|Urinary Incontinence, Stress|urinary incontinence, stress
5929043|NCT03722719|Physical Therapy Modalities|physical therapy modalities
5893423|NCT03568084|exercise|exercise
5261349|NCT02381015|Prostate Specific Antigen|prostate specific antigen
5261350|NCT02381015|Prostate Cancer|prostate cancer
5261740|NCT02378883|AVM|avm
5262170|NCT02376712|Differential diagnosis|differential diagnosis
5262172|NCT02376712|Renal Blood Flow|renal blood flow
5262173|NCT02376712|Transesophageal Echocardiography|transesophageal echocardiography
5262188|NCT02376686|sleep Quality|sleep quality
5262189|NCT02376686|Depression|depression
5262190|NCT02376686|Music|music
5262191|NCT02376686|quality of life|quality of life
5262192|NCT02376673|Pediatric Health Literacy|pediatric health literacy
5262193|NCT02376673|Home Literacy Orientation|home literacy orientation
5262194|NCT02376673|safe sleep|safe sleep
5262195|NCT02376647|Patients|patients
5262196|NCT02376647|ARDS diagnosis|ards diagnosis
5262197|NCT02376621|omega-3 based dietary supplements|omega-3 based dietary supplements
5262198|NCT02376621|Bioavailability|bioavailability
5262199|NCT02376595|Rocuronium|rocuronium
5262200|NCT02376595|Pharmacokinetics|pharmacokinetics
5262201|NCT02376595|Pharmacodynamics|pharmacodynamics
5262206|NCT02376556|Blepharoplasty|blepharoplasty
5262261|NCT02376244|High intensity Interval Exercise training|high intensity interval exercise training
5262262|NCT02376244|Cardiac rehabilitation|cardiac rehabilitation
5262263|NCT02376244|cardiac revascularisation|cardiac revascularisation
5262264|NCT02376244|Percutaneous coronary interventions|percutaneous coronary interventions
5262265|NCT02376244|Cardiac surgery|cardiac surgery
5262562|NCT02374398|TKA|tka
5262563|NCT02374372|hemodialysis|hemodialysis
5262667|NCT02373592|Telemedicine|telemedicine
5262979|NCT02371824|Lumbar Vertebrae|lumbar vertebrae
5263187|NCT02370680|Antiplatelet therapy|antiplatelet therapy
5263188|NCT02370680|platelet turnover|platelet turnover
5263189|NCT02370680|high platelet turnover|high platelet turnover
5263190|NCT02370680|platelet aggregation|platelet aggregation
5263191|NCT02370680|cardiovascular disease|cardiovascular disease
5263196|NCT02370654|COPD|copd
5263385|NCT02369341|Southern Hemisphere influenza vaccine|southern hemisphere influenza vaccine
5263386|NCT02369341|Elderly|elderly
5263489|NCT02368782|transient evoked otoacoustic emissions|transient evoked otoacoustic emissions
5263490|NCT02368782|distortion product otoacoustic emissions|distortion product otoacoustic emissions
5263491|NCT02368782|ketamine|ketamine
5263492|NCT02368782|propofol|propofol
5263493|NCT02368782|child|child
5263494|NCT02368704|Endoplasmic Reticulum|endoplasmic reticulum
5263501|NCT02368600|Chinese|chinese
5263579|NCT02368184|acute decompensated heart failure (ADHF)|acute decompensated heart failure (adhf)
5263580|NCT02368158|myocard infarction|myocard infarction
5263581|NCT02368158|arrhythmia|arrhythmia
5263582|NCT02368158|fitness of driving|fitness of driving
5263583|NCT02368145|stroke|stroke
5263677|NCT02367690|Diabetes|diabetes
5263778|NCT02367235|robotic|robotic
5263876|NCT02366663|Lymphatic Diseases|lymphatic diseases
5263877|NCT02366663|Lymphoma, B-Cell|lymphoma, b-cell
5263878|NCT02366663|Lymphoproliferative Disorders|lymphoproliferative disorders
5263879|NCT02366663|Neoplasms|neoplasms
5263880|NCT02366663|Neoplasms by Histologic Type|neoplasms by histologic type
5263881|NCT02366663|Antibodies, Monoclonal|antibodies, monoclonal
5263882|NCT02366663|Immunologic Factors|immunologic factors
5263883|NCT02366663|Pharmacologic Actions|pharmacologic actions
5673687|NCT00607321|Coronary Disease|coronary disease
5263884|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs
5263968|NCT02366130|Radium-223 chloride|radium-223 chloride
5263969|NCT02366130|Radium-223 dichloride|radium-223 dichloride
5263970|NCT02366130|Alpharadin|alpharadin
5263971|NCT02366130|Denosumab|denosumab
5263972|NCT02366130|AMG 162|amg 162
5264268|NCT02364206|p38 MAPK inhibitor|p38 mapk inhibitor
5264793|NCT02361268|yoga|yoga
5264989|NCT02360072|nitric oxide|nitric oxide
5265090|NCT02359461|Vascular function|vascular function
5265192|NCT02358993|Catheter-Related Infections|catheter-related infections
5265193|NCT02358993|Pelvic Reconstructive Surgery|pelvic reconstructive surgery
5265194|NCT02358993|Urogynecology|urogynecology
5265202|NCT02358980|HFR|hfr
5265305|NCT02358473|NSCLC|nsclc
5893480|NCT03559114|VTE|vte
5265306|NCT02358473|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5265307|NCT02358473|Carcinoma, Non-Small Cell Lung|carcinoma, non-small cell lung
5265308|NCT02358473|KW-0761|kw-0761
5265309|NCT02358473|Mogamulizumab|mogamulizumab
5265517|NCT02357290|irritability|irritability
5265519|NCT02357290|bipolar|bipolar
5265520|NCT02357277|Osteoporosis|osteoporosis
5265521|NCT02357277|Glucocorticoids|glucocorticoids
5265522|NCT02357277|Postmenopausal|postmenopausal
5265523|NCT02357238|Uveitis|uveitis
5265524|NCT02357238|Infectious|infectious
5265525|NCT02357225|Pompe disease|pompe disease
5265526|NCT02357225|Pyridostigmine|pyridostigmine
5265713|NCT02355977|Surface and root planning|surface and root planning
5265714|NCT02355977|Pocket depth|pocket depth
5265715|NCT02355977|Sulcus bleeding index|sulcus bleeding index
5265716|NCT02355977|Prevotella intermedia|prevotella intermedia
5266014|NCT02354235|MT-2412|mt-2412
5266015|NCT02354235|MP-513|mp-513
5266016|NCT02354235|TA-7284|ta-7284
5266017|NCT02354235|Teneligliptin|teneligliptin
5266018|NCT02354235|Canagliflozin|canagliflozin
5266019|NCT02354222|MT-2412|mt-2412
5266020|NCT02354222|MP-513|mp-513
5266021|NCT02354222|TA-7284|ta-7284
5266022|NCT02354222|Teneligliptin|teneligliptin
5266023|NCT02354222|Canagliflozin|canagliflozin
5266389|NCT02352025|S-equol|s-equol
5266437|NCT02351674|Heart Rate|heart rate
5266438|NCT02351674|Percutaneous coronary intervention|percutaneous coronary intervention
5266440|NCT02351648|readmission|readmission
5266467|NCT02351466|MRI|mri
5266546|NCT02350959|Plaque|plaque
5266750|NCT02349997|obstructive sleep apnea|obstructive sleep apnea
5266752|NCT02349997|fluid shift|fluid shift
5266954|NCT02348645|Foraminotomy|foraminotomy
5267251|NCT02346825|Children|children
5267345|NCT02346396|tDCS|tdcs
5267346|NCT02346383|back pain|back pain
5267347|NCT02346383|neuromodulation|neuromodulation
5267349|NCT02346383|spinal cord stimulation|spinal cord stimulation
5267666|NCT02344706|Electroencephalography|electroencephalography
5267667|NCT02344693|Electroencephalography|electroencephalography
5267668|NCT02344654|Fluorescence|fluorescence
5267861|NCT02343510|Fallopian tubal cancer, high grade serous , ovarian cancer|fallopian tubal cancer, high grade serous , ovarian cancer
5267862|NCT02343484|pulsed radiofrequency|pulsed radiofrequency
5267863|NCT02343484|gelified ethanol|gelified ethanol
5267864|NCT02343471|Whey proteins|whey proteins
5267960|NCT02343094|ELISA|elisa
5268008|NCT02342938|MEG|meg
5268257|NCT02341586|Iron|iron
5268258|NCT02341586|Childbearing Age|childbearing age
5268259|NCT02341586|Women|women
5268260|NCT02341586|Home Fortification|home fortification
5268261|NCT02341573|Traditional Chinese Medicine|traditional chinese medicine
5268263|NCT02341560|NAION|naion
5268373|NCT02340923|DMD|dmd
5268471|NCT02340299|Prematurity|prematurity
5268472|NCT02340273|tendinopathy|tendinopathy
5268473|NCT02340273|ultrasound|ultrasound
5370133|NCT01857193|ER+|er+
5268818|NCT02338128|cardiovascular|cardiovascular
5268819|NCT02338128|Febuxostat|febuxostat
5268820|NCT02338089|Uterine contraction|uterine contraction
5268821|NCT02338089|Oxytocin desensitization|oxytocin desensitization
5269011|NCT02336893|Total Communication Methods|total communication methods
5269012|NCT02336893|Quality Improvement|quality improvement
5269013|NCT02336893|Quality of Health Care|quality of health care
5269124|NCT02336243|preeclampsia|preeclampsia
5269125|NCT02336243|fetal growth|fetal growth
5269126|NCT02336230|GVHD|gvhd
5269132|NCT02336165|T Cell|t cell
5269238|NCT02335372|Acetic acid|acetic acid
5269630|NCT02333071|Female Sexual Desire Disorder|female sexual desire disorder
5269633|NCT02333058|MDS|mds
5269634|NCT02333058|JMML|jmml
5269635|NCT02333045|HIV-negative|hiv-negative
5269636|NCT02333045|Women|women
5269637|NCT02333045|At-risk|at-risk
5269638|NCT02333019|risk|risk
5269639|NCT02333006|Anosognosia|anosognosia
5269640|NCT02332993|FPP (Fermented Papaya Preparation)|fpp (fermented papaya preparation)
5929094|NCT03717051|nicotine replacement sample|nicotine replacement sample
5929095|NCT03717051|smoking cessation|smoking cessation
5929096|NCT03717051|smoking hotspots|smoking hotspots
5269641|NCT02332993|Negative Pressure Therapy|negative pressure therapy
5269642|NCT02332993|Wound Vac|wound vac
5269643|NCT02332993|Wound|wound
5269742|NCT02332395|pain|pain
5269691|NCT02332668|PD1|pd1
5269719|NCT02332538|VAPORIZATION|vaporization
5269720|NCT02332525|Oral Vibrational Stimulation|oral vibrational stimulation
5269815|NCT02332057|IUD,Diclofenac , Lidocaine|iud,diclofenac , lidocaine
5269816|NCT02332031|Sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer|sorafenib, levothyroxine, drug interaction, pharmacokinetics, healthy volunteer
5269820|NCT02331966|RECURRENCES|recurrences
5269905|NCT02331355|amputation, hand, forearm, arm, traumatic, transplantation|amputation, hand, forearm, arm, traumatic, transplantation
5269906|NCT02331342|Agreement of NICOM and Innocor|agreement of nicom and innocor
5269907|NCT02331329|Accuracy of NICOM|accuracy of nicom
5269997|NCT02330887|Nepal|nepal
5270129|NCT02330094|SAH|sah
5270207|NCT02329561|Opioid|opioid
5270299|NCT02328885|UCBT|ucbt
5270300|NCT02328872|screening|screening
5270301|NCT02328872|cervical screening|cervical screening
5270302|NCT02328872|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5270303|NCT02328872|cancer prevention|cancer prevention
5270511|NCT02327728|injection pattern|injection pattern
5270611|NCT02327377|National Institute of Child Health & Human Development (US.)|national institute of child health & human development (us.)
5270612|NCT02327377|Telemedicine|telemedicine
5270613|NCT02327377|E-Health|e-health
5270615|NCT02327377|Parenting education|parenting education
5270715|NCT02326740|Pyoderma Gangrenosum|pyoderma gangrenosum
5270716|NCT02326740|Classic Pyoderma Gangrenosum|classic pyoderma gangrenosum
5270717|NCT02326727|Epidural Analgesia|epidural analgesia
5270718|NCT02326727|Natural Killer Cells|natural killer cells
5270719|NCT02326675|Etoposide|etoposide
5270720|NCT02326675|Cryotherapy|cryotherapy
5270721|NCT02326662|spinal cord injury|spinal cord injury
5270722|NCT02326662|neural stem cells|neural stem cells
5270723|NCT02326662|paraplegia|paraplegia
5270724|NCT02326662|transplantation|transplantation
5270725|NCT02326649|cardiac output|cardiac output
5270726|NCT02326610|Small for gestational age (SGA)|small for gestational age (sga)
5270727|NCT02326610|Human growth hormone (hGH)|human growth hormone (hgh)
5270728|NCT02326597|Hydroxyurea|hydroxyurea
5270729|NCT02326597|Bone marrow transplant|bone marrow transplant
5270799|NCT02326259|Diabetic Retinopathy|diabetic retinopathy
5270901|NCT02325674|Lipodystrophy|lipodystrophy
5270994|NCT02325310|Postpartum vaccination|postpartum vaccination
5270995|NCT02325310|Breastfeeding women|breastfeeding women
5271106|NCT02324725|naltrexone|naltrexone
5271211|NCT02324049|Mucopolysaccharidosis|mucopolysaccharidosis
5271212|NCT02324049|Mucopolysaccharidosis type IIIB|mucopolysaccharidosis type iiib
5271213|NCT02324049|Sanfilippo Syndrome|sanfilippo syndrome
5271214|NCT02324049|Metabolism, Inborn Errors|metabolism, inborn errors
5271215|NCT02324049|Metabolic Diseases|metabolic diseases
5271216|NCT02324049|Genetic Diseases, Inborn|genetic diseases, inborn
5271217|NCT02324049|Carbohydrate Metabolism, Inborn Errors|carbohydrate metabolism, inborn errors
5271218|NCT02324049|Connective Tissue Diseases|connective tissue diseases
5271219|NCT02324049|Lysosomal Storage Diseases|lysosomal storage diseases
5271221|NCT02324049|Mucopolysaccharidoses|mucopolysaccharidoses
5271222|NCT02324049|Pathologic Processes|pathologic processes
5271223|NCT02324023|ultrasound|ultrasound
5271224|NCT02324023|perfusion|perfusion
5271225|NCT02324023|endoscopic|endoscopic
5271226|NCT02324010|gastric emptying|gastric emptying
5271227|NCT02324010|glycemia|glycemia
5271228|NCT02324010|appetite|appetite
5271229|NCT02324010|incretin hormones|incretin hormones
5271230|NCT02323997|HPV|hpv
5271231|NCT02323997|cervical cancer|cervical cancer
5271232|NCT02323997|human papillomavirus|human papillomavirus
5271233|NCT02323997|cervical pre-cancer|cervical pre-cancer
5271234|NCT02323997|cervical neoplasia|cervical neoplasia
5271235|NCT02323945|acute intermittent hypoxia|acute intermittent hypoxia
5271585|NCT02322255|FOP|fop
5271739|NCT02321527|SLN|sln
5929101|NCT03716414|Sentinel lymph node|sentinel lymph node
5271993|NCT02320110|Insulin resistance|insulin resistance
5271994|NCT02320110|Body Mass Index|body mass index
5271996|NCT02320110|Metabolic Syndrome|metabolic syndrome
5271997|NCT02320110|Lipid Profile|lipid profile
5271998|NCT02320110|Diabetes Mellitus|diabetes mellitus
5272000|NCT02320084|Hereditary Tyrosinemia, Type I|hereditary tyrosinemia, type i
5272196|NCT02319005|FAC|fac
5272285|NCT02318433|DRF|drf
5272603|NCT02316847|Seizures|seizures
5272691|NCT02316223|community health worker|community health worker
5272692|NCT02316223|electronic medical record|electronic medical record
5272693|NCT02316197|DNA-PK Inhibitor|dna-pk inhibitor
5272694|NCT02316197|Advanced solid tumors|advanced solid tumors
5272695|NCT02316197|Chronic lymphocytic Leukemia|chronic lymphocytic leukemia
5272696|NCT02316197|Phase I, first-in-human|phase i, first-in-human
5272994|NCT02314793|ASP2205|asp2205
5272995|NCT02314741|poem|poem
5273048|NCT02314481|RET|ret
5273193|NCT02313649|liver|liver
5274085|NCT02308306|Chronic pain|chronic pain
5274199|NCT02307682|CNV|cnv
5274403|NCT02306577|HIV|hiv
5274841|NCT02304211|Microdosing|microdosing
5274842|NCT02304211|Phase 0|phase 0
5274843|NCT02304211|Exploratory Investigational New Drug (IND)|exploratory investigational new drug (ind)
5274844|NCT02304211|Intra-Arterial|intra-arterial
5274845|NCT02304211|PET Imaging|pet imaging
5274846|NCT02304185|Healthy|healthy
5274847|NCT02304185|Acquired Immuno-Deficiency Syndrome|acquired immuno-deficiency syndrome
5274849|NCT02304185|Glycoprotein|glycoprotein
5274931|NCT02303535|Specific Procedure Definitions|specific procedure definitions
5274932|NCT02303535|OPCS|opcs
5674386|NCT00603772|exposure to UV light|exposure to uv light
5275351|NCT02301286|Survival|survival
5275661|NCT02299440|treatment of acute suicidal ideation|treatment of acute suicidal ideation
5275662|NCT02299440|ketamine|ketamine
5275663|NCT02299440|low-dose ketamine|low-dose ketamine
5275666|NCT02299401|Medical abortion|medical abortion
5275667|NCT02299401|Induced abortion|induced abortion
5275678|NCT02299375|losmapimod|losmapimod
5275978|NCT02298036|Medically Unexplained|medically unexplained
5275979|NCT02298023|adipose derived mesenchymal stem cell|adipose derived mesenchymal stem cell
5275980|NCT02298023|allogeneic stem cell|allogeneic stem cell
5275981|NCT02298023|Rotator cuff tear|rotator cuff tear
5275982|NCT02297997|sarcopenia|sarcopenia
5275984|NCT02297984|Neuroglobin|neuroglobin
5276068|NCT02297334|CytoSorb(TM)|cytosorb(tm)
5276317|NCT02295761|adherence|adherence
5276915|NCT02292602|health disparities|health disparities
5276916|NCT02292602|intervention|intervention
5276917|NCT02292589|Traumatic Brain Injury|traumatic brain injury
5276918|NCT02292589|Post concussion syndrome|post concussion syndrome
5276919|NCT02292589|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5276920|NCT02292589|Neuromodulation|neuromodulation
5276921|NCT02292576|volunteers|volunteers
5276923|NCT02292550|Non-small cell lung cancer|non-small cell lung cancer
5277017|NCT02292186|Heart Failure|heart failure
5277499|NCT02289612|Postprandial Insulin|postprandial insulin
5277500|NCT02289612|Postprandial Acetaminophen|postprandial acetaminophen
5277501|NCT02289612|Satiety|satiety
5277503|NCT02289599|E2307|e2307
5277657|NCT02288754|WGS|wgs
5929221|NCT03696121|intracerebral haemorrhage|intracerebral haemorrhage
5278197|NCT02285400|Central Drive|central drive
5278198|NCT02285348|Ataxia Telangiectasia|ataxia telangiectasia
5278199|NCT02285348|cerebrospinal fluid|cerebrospinal fluid
5278804|NCT02280850|Angina|angina
5279103|NCT02280070|SOX|sox
5279199|NCT02279615|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5279299|NCT02279095|Palovarotene|palovarotene
5279300|NCT02279095|Retinoic acid receptor agonist|retinoic acid receptor agonist
5279416|NCT02278536|XXX|xxx
5279820|NCT02276079|Mild Traumatic Brain Injury|mild traumatic brain injury
5279821|NCT02276079|Aerobic Exercise|aerobic exercise
5279822|NCT02276079|Brain-Derived Neurotrophic Factor|brain-derived neurotrophic factor
5280122|NCT02274233|Chelation|chelation
5280606|NCT02271542|Propofol|propofol
5280705|NCT02270853|sleep apnea screening|sleep apnea screening
5280706|NCT02270840|cardiac resynchronization therapy|cardiac resynchronization therapy
5280707|NCT02270801|recombinant human thrombopoietin|recombinant human thrombopoietin
5280708|NCT02270801|immune thrombocytopenia|immune thrombocytopenia
5280709|NCT02270801|pregnancy|pregnancy
5280710|NCT02270775|Questionnaire|questionnaire
5280711|NCT02270775|Translation|translation
5280712|NCT02270762|Early Physical Exercise|early physical exercise
5280713|NCT02270762|Early Passive Exercise|early passive exercise
5280714|NCT02270762|Alveolar Recruitment|alveolar recruitment
5280715|NCT02270762|Electrical Impedance Tomography|electrical impedance tomography
5280764|NCT02270359|CAD|cad
5281296|NCT02267707|Pancreatic Cancer|pancreatic cancer
5281297|NCT02267668|concussion|concussion
5281298|NCT02267668|sports concussion|sports concussion
5281305|NCT02267629|OCD|ocd
5281476|NCT02266771|Negative Pressure Wound Therapy, Wound VAC, Instillation|negative pressure wound therapy, wound vac, instillation
5281477|NCT02266758|Gestational Diabetes|gestational diabetes
5281479|NCT02266758|Pregnancy|pregnancy
5281480|NCT02266719|Aortic Aneurysm, Abdominal [C14.907.055.239.075]|aortic aneurysm, abdominal [c14.907.055.239.075]
5281481|NCT02266693|Cognitive Behavioural Therapy|cognitive behavioural therapy
5281482|NCT02266693|Internet Based|internet based
5281483|NCT02266693|CBT|cbt
5281484|NCT02266693|Transdiagnostic|transdiagnostic
5281485|NCT02266693|MDD|mdd
5281571|NCT02266199|interview|interview
5281867|NCT02264275|Inflammatory Bowel Disease|inflammatory bowel disease
5281868|NCT02264275|Children|children
5281869|NCT02264275|Adolescents|adolescents
5281870|NCT02264275|Pediatric|pediatric
5281874|NCT02264223|Plasma|plasma
5282164|NCT02262065|implant|implant
5282391|NCT02260609|DFU|dfu
5282469|NCT02260193|CKD|ckd
5282557|NCT02259491|Honey|honey
5282783|NCT02258529|FL|fl
5282851|NCT02257996|HIPAA|hipaa
5282852|NCT02257983|hearing|hearing
5282853|NCT02257983|noise|noise
5282854|NCT02257983|oxidative stress|oxidative stress
5282855|NCT02257970|Lymphedema|lymphedema
5282856|NCT02257970|edema|edema
5282857|NCT02257970|swelling|swelling
5282858|NCT02257931|infection|infection
5282859|NCT02257931|bacteria|bacteria
5282860|NCT02257931|gram-negative|gram-negative
5282861|NCT02257931|HSCT|hsct
5282862|NCT02257931|allogeneic|allogeneic
5282942|NCT02257710|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5282943|NCT02257710|Small Vessels|small vessels
5282944|NCT02257710|Chronic Total Occlusion|chronic total occlusion
5283238|NCT02255799|memory|memory
5283335|NCT02255253|high sodium intake|high sodium intake
5283336|NCT02255240|breast cancer|breast cancer
5283337|NCT02255240|cancer|cancer
5283338|NCT02255240|survivorship|survivorship
5283719|NCT02253225|Rumination|rumination
5283819|NCT02252679|Calcium Isotopes|calcium isotopes
5283821|NCT02252666|balance|balance
5284128|NCT02251041|Ischemia-reperfusion|ischemia-reperfusion
5284129|NCT02251041|Effectiveness|effectiveness
5284130|NCT02251028|whiplash, prevention, pain, cognitive-behavioural therapy|whiplash, prevention, pain, cognitive-behavioural therapy
5284690|NCT02248233|optimal therapeutic time window|optimal therapeutic time window
5284691|NCT02248233|optimal dose|optimal dose
5284692|NCT02248233|multi-center|multi-center
5284693|NCT02248194|Dysfunction uterine bleeding|dysfunction uterine bleeding
5284980|NCT02247050|Antibiotics|antibiotics
5284981|NCT02247050|Humans|humans
5284982|NCT02247050|Overuse of Low-Value Services|overuse of low-value services
5284983|NCT02247050|Pragmatic Trial|pragmatic trial
5284984|NCT02247050|Stepped Wedge Design|stepped wedge design
5284985|NCT02247050|Cluster Randomized Trial|cluster randomized trial
5284986|NCT02247050|Choosing Wisely|choosing wisely
5284987|NCT02247037|Triple Negative Breast Cancer|triple negative breast cancer
5284988|NCT02247037|Patient Derived Xenograft|patient derived xenograft
5284989|NCT02247037|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5284990|NCT02247037|Therapeutic Resistance|therapeutic resistance
5284991|NCT02247011|bone mineral density|bone mineral density
5284992|NCT02247011|25(OH)D|25(oh)d
5929228|NCT03694821|Osteoarthritis|osteoarthritis
5929229|NCT03694821|Knee|knee
5929230|NCT03694821|Injection|injection
5929231|NCT03694821|Ketorolac|ketorolac
5893899|NCT03504397|HER2|her2
5284993|NCT02246985|Processed foods|processed foods
5285000|NCT02246985|Bread|bread
5285180|NCT02246283|elderly|elderly
5285181|NCT02246283|lifelong|lifelong
5285182|NCT02246283|quality of life|quality of life
5285183|NCT02246283|register|register
5285184|NCT02246283|questionaire|questionaire
5285185|NCT02246218|Urea Cycle Disorder|urea cycle disorder
5285186|NCT02246218|UCD|ucd
5285187|NCT02246218|Buphenyl|buphenyl
5285274|NCT02245802|Prediction model|prediction model
5285277|NCT02245776|Incurable Neurological Disorders|incurable neurological disorders
5285780|NCT02243306|GSK1278863|gsk1278863
5285781|NCT02243306|Prolyl hydroxylase inhibitor|prolyl hydroxylase inhibitor
5285878|NCT02242929|Surgery|surgery
5285879|NCT02242916|reccurent Head and Neck tumors|reccurent head and neck tumors
5285880|NCT02242916|re-irradiation|re-irradiation
5285881|NCT02242916|photon|photon
5285882|NCT02242916|proton|proton
5285883|NCT02242916|carbon-ion|carbon-ion
5285978|NCT02242474|Anti-TNF|anti-tnf
5286074|NCT02241668|3'-Deoxy-3'-18f-Fluorothymidine|3'-deoxy-3'-18f-fluorothymidine
5286075|NCT02241668|Fluoro-L-Thymidine Positron Emission Tomography|fluoro-l-thymidine positron emission tomography
5286077|NCT02241668|Magnetic resonance imaging|magnetic resonance imaging
5286078|NCT02241668|MRI|mri
5286079|NCT02241655|Anesthesia|anesthesia
5286080|NCT02241655|Electroencephalography|electroencephalography
5286081|NCT02241655|Burst suppression|burst suppression
5286082|NCT02241655|Surgery|surgery
5286083|NCT02241655|Delirium|delirium
5286084|NCT02241655|Falls|falls
5286098|NCT02241551|Borderline|borderline
5286166|NCT02241330|wheat|wheat
5286167|NCT02241317|Diabetes mellitus|diabetes mellitus
5286168|NCT02241317|Hypoglycaemia|hypoglycaemia
5286477|NCT02239783|ankylosis|ankylosis
5286573|NCT02239328|esophageal cancer|esophageal cancer
5286574|NCT02239315|Breast cancers|breast cancers
5286775|NCT02238509|HER2 Positive|her2 positive
5286776|NCT02238509|HER2+|her2+
5286777|NCT02238509|MBC|mbc
5286778|NCT02238509|Metastatic|metastatic
5286779|NCT02238509|Metastatic breast cancer|metastatic breast cancer
5286780|NCT02238509|Chemotherapy|chemotherapy
5286977|NCT02237365|safety|safety
5287176|NCT02236546|melanoma|melanoma
5287377|NCT02235740|multiple myeloma|multiple myeloma
5287378|NCT02235714|Airway inflammation|airway inflammation
5287579|NCT02234752|Cognition|cognition
5287580|NCT02234752|Cognitive Impairment|cognitive impairment
5287689|NCT02234297|Tumor Paint|tumor paint
5287811|NCT02233673|Obesity|obesity
5288322|NCT02231242|brain|brain
5288622|NCT02230111|Stress|stress
5288623|NCT02230111|Weight management|weight management
5288721|NCT02229617|Subcutaneous testosterone|subcutaneous testosterone
5288826|NCT02229240|Type 2 diabetes mellitus|type 2 diabetes mellitus
5288827|NCT02229227|switch study|switch study
5288828|NCT02229227|albiglutide|albiglutide
5288830|NCT02229227|Type 2 diabetes mellitus|type 2 diabetes mellitus
5288926|NCT02228863|Stroke|stroke
5288927|NCT02228863|Spasticity|spasticity
5288928|NCT02228850|Secondary Raynaud's Phenomenon|secondary raynaud's phenomenon
5288929|NCT02228850|Secondary Raynaud's Disease|secondary raynaud's disease
5288930|NCT02228850|Scleroderma|scleroderma
5289127|NCT02228057|anastomosis|anastomosis
5289128|NCT02228057|sensibility|sensibility
5289324|NCT02227082|locally advanced breast cancer|locally advanced breast cancer
5289325|NCT02227056|Acquired pediatric brain injury|acquired pediatric brain injury
5289326|NCT02227056|Methylphenidate|methylphenidate
5289630|NCT02225574|Advanced phase chronic myeloid leukemia|advanced phase chronic myeloid leukemia
5289631|NCT02225574|refractory chronic phase chronic myeloid leukemia|refractory chronic phase chronic myeloid leukemia
5290010|NCT02224235|PCI|pci
5290026|NCT02224183|back pain|back pain
5290027|NCT02224170|Dexamethasone|dexamethasone
5290118|NCT02223767|TMS|tms
5290244|NCT02223143|Lipid lowering therapy|lipid lowering therapy
5290245|NCT02223130|HIV|hiv
5290345|NCT02222805|Hyperbilirubinemia|hyperbilirubinemia
5290346|NCT02222805|Jaundice|jaundice
5929243|NCT03692312|AMO-02-MD-2-003|amo-02-md-2-003
5929244|NCT03692312|Congenital Myotonic Dystrophy|congenital myotonic dystrophy
5929245|NCT03692312|Myotonic Dystrophy|myotonic dystrophy
5929246|NCT03692312|Dystrophia Myotonica|dystrophia myotonica
5929247|NCT03692312|Myotonia Atrophica|myotonia atrophica
5929248|NCT03692312|Myotonia Dystrophica|myotonia dystrophica
5929249|NCT03692312|Myotonic Dystrophy, Congenital|myotonic dystrophy, congenital
5929250|NCT03692312|Steinert Disease|steinert disease
5929251|NCT03692312|Steinert Myotonic Dystrophy|steinert myotonic dystrophy
5929252|NCT03692312|Steinert's Disease|steinert's disease
5929320|NCT03682679|magnetic resonance imaging|magnetic resonance imaging
5290347|NCT02222805|Neurodevelopment|neurodevelopment
5290348|NCT02222792|Staphylococci, Streptococci, P acnes and Gram-negative bacteria|staphylococci, streptococci, p acnes and gram-negative bacteria
5290353|NCT02222714|stroke|stroke
5290443|NCT02222363|Safety and tolerability|safety and tolerability
5290444|NCT02222363|Tumor response by RECIST 1.1|tumor response by recist 1.1
5290445|NCT02222363|Progression-free survival|progression-free survival
5290446|NCT02222363|Overall survival Pharmacokinetics|overall survival pharmacokinetics
5290637|NCT02221310|MDS|mds
5290750|NCT02220933|MS|ms
5291456|NCT02217917|Double-blind|double-blind
5291457|NCT02217917|Single ascending dose|single ascending dose
5291458|NCT02217917|Multiple ascending dose|multiple ascending dose
5291462|NCT02217878|morphine|morphine
5291555|NCT02217358|white light endoscopy|white light endoscopy
5291556|NCT02217358|magnifying endoscopy|magnifying endoscopy
5291557|NCT02217358|direct laryngoscopy|direct laryngoscopy
5291764|NCT02216487|mCRC|mcrc
5291866|NCT02216110|Endoscopic submucosal dissection|endoscopic submucosal dissection
5291867|NCT02216110|Gastrectomy|gastrectomy
5291869|NCT02216110|Outcome|outcome
5291873|NCT02216006|Atelectasis|atelectasis
5291959|NCT02215447|Gastrointestinal Neuroendocrine Carcinomas|gastrointestinal neuroendocrine carcinomas
5291961|NCT02215447|carboplatin|carboplatin
5292145|NCT02214472|Regurgitation|regurgitation
5292146|NCT02214472|Vomiting|vomiting
5292147|NCT02214472|Biofeedback|biofeedback
5292150|NCT02214459|mHealth|mhealth
5292347|NCT02213783|Imipenem|imipenem
5292348|NCT02213783|Febrile neutropenia|febrile neutropenia
5292349|NCT02213783|Gram-negative infection|gram-negative infection
5292539|NCT02213016|Stimulation magnetic transcranial, major depression, cognitive impairment|stimulation magnetic transcranial, major depression, cognitive impairment
5292540|NCT02213003|islet transplantation|islet transplantation
5292541|NCT02212990|Fever|fever
5292659|NCT02212366|EEG|eeg
5292843|NCT02211261|single dose|single dose
5292844|NCT02211261|multiple dose|multiple dose
5292845|NCT02211261|escalation|escalation
5292846|NCT02211261|safety study|safety study
5292847|NCT02211261|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5292848|NCT02211248|Cardiac Frequency Variability|cardiac frequency variability
5292931|NCT02210884|Breast feeding|breast feeding
5292932|NCT02210845|Diabetes|diabetes
5292933|NCT02210845|Supervised Exercise|supervised exercise
5292934|NCT02210845|Weight loss|weight loss
5292939|NCT02210819|Thromboembolism|thromboembolism
5292940|NCT02210819|Embolism and Thrombosis|embolism and thrombosis
5292943|NCT02210819|Thrombosis|thrombosis
5293028|NCT02210442|primary health care|primary health care
5293029|NCT02210442|cluster clinical trial|cluster clinical trial
5293030|NCT02210429|Supraclavicular Block|supraclavicular block
5293031|NCT02210429|Supraclavicular Catheter|supraclavicular catheter
5293123|NCT02209935|outcome|outcome
5293422|NCT02208492|Levetiracetam, Carabamazepine|levetiracetam, carabamazepine
5293423|NCT02208479|cardiac surgery|cardiac surgery
5293424|NCT02208479|diaphragm dysfunction|diaphragm dysfunction
5293517|NCT02208050|Mobility|mobility
5293617|NCT02207621|Glaucoma|glaucoma
5293715|NCT02207088|Renal impairment|renal impairment
5293716|NCT02207088|dialysis|dialysis
5293717|NCT02207088|Hepatitis C Virus|hepatitis c virus
5293819|NCT02206529|behavioral|behavioral
5293820|NCT02206529|social networks|social networks
5293821|NCT02206529|social support|social support
5293822|NCT02206503|LENALIDOMIDE|lenalidomide
5293823|NCT02206503|BIOCHEMICAL PROGRESSION|biochemical progression
5293824|NCT02206503|RELAPSED/REFRACTORY MM|relapsed/refractory mm
5293825|NCT02206503|WITHOUT CRAB|without crab
5293826|NCT02206490|Gulf War Illness|gulf war illness
5293827|NCT02206490|treatment|treatment
5293828|NCT02206490|dextromethorphan|dextromethorphan
5294008|NCT02205645|repair|repair
5294009|NCT02205645|tear|tear
5294010|NCT02205645|injury|injury
5294011|NCT02205619|Residual cementum|residual cementum
5294012|NCT02205619|root surface instrumentation|root surface instrumentation
5294414|NCT02203968|Clinical trials|clinical trials
5294415|NCT02203942|Bacterial Vaginosis|bacterial vaginosis
5294416|NCT02203942|Vulvovaginal Candidiasis|vulvovaginal candidiasis
5294417|NCT02203942|Trichomoniasis|trichomoniasis
5294418|NCT02203929|Macular Holes|macular holes
5294718|NCT02202564|hepatocellular carcinoma|hepatocellular carcinoma
5294719|NCT02202564|liver transplantation|liver transplantation
5294819|NCT02202057|magnitude estimation|magnitude estimation
5294820|NCT02202044|Bladder Cancer|bladder cancer
5294821|NCT02202018|Knowledge Translation|knowledge translation
5894212|NCT03471871|Lemborexant|lemborexant
5294922|NCT02201641|reversible pulpitis|reversible pulpitis
5295021|NCT02201342|Myocardial performance|myocardial performance
5295023|NCT02201316|Mosapride citrate anhydrous|mosapride citrate anhydrous
5295125|NCT02200796|Thermic Effect of Food|thermic effect of food
5295129|NCT02200783|Radial artery|radial artery
5295435|NCT02199210|Forethought|forethought
5295532|NCT02198768|prospective|prospective
5295732|NCT02197767|rituximab|rituximab
5295968|NCT02196688|013|013
5296305|NCT02195063|Scar care|scar care
5296306|NCT02195063|Wound care|wound care
5296307|NCT02195063|UDT|udt
5296308|NCT02195063|Urinary drug testing|urinary drug testing
5296309|NCT02195037|Delayed Cord Clamping|delayed cord clamping
5929525|NCT03654248|Time management|time management
5929526|NCT03654248|Group intervention|group intervention
5929527|NCT03654248|Executive function|executive function
5296310|NCT02195024|pacemaker|pacemaker
5296311|NCT02195024|magnetic resonance imaging|magnetic resonance imaging
5296312|NCT02195024|MRI conditional|mri conditional
5296317|NCT02195011|SIR-Spheres Microspheres|sir-spheres microspheres
5296360|NCT02194816|PD|pd
5296410|NCT02194504|Metabolic health|metabolic health
5296411|NCT02194504|Phenotyping|phenotyping
5296718|NCT02193373|Rib-Raising|rib-raising
5296817|NCT02192840|provisional T stenting|provisional t stenting
5296818|NCT02192840|dedicated bifurcation stent|dedicated bifurcation stent
5296923|NCT02192411|lidocaine|lidocaine
5297245|NCT02191059|Wild Type EGFR|wild type egfr
5297451|NCT02190136|resistance training|resistance training
5297452|NCT02190136|stretching/yoga training|stretching/yoga training
5297454|NCT02190136|mood state|mood state
5297455|NCT02190123|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5297456|NCT02190123|Oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (OAP)|oral antiplatelets (ticagrelor, prasugrel, clopidogrel) (oap)
5297457|NCT02190123|Treatment persistence.|treatment persistence.
5297458|NCT02190110|Pulmonary embolism|pulmonary embolism
5297459|NCT02190110|diagnosis|diagnosis
5297460|NCT02190110|emergency medicine|emergency medicine
5297461|NCT02190110|ultrasonography|ultrasonography
5297462|NCT02190097|PCOS|pcos
5297463|NCT02190097|insulin sensitivity|insulin sensitivity
5297464|NCT02190097|paleolithic diet|paleolithic diet
5297465|NCT02190084|apathy|apathy
5297536|NCT02189798|Cochlear Implant|cochlear implant
5297537|NCT02189798|HiRes™ 90K Advantage implant|hires™ 90k advantage implant
5297538|NCT02189798|Cochlear Implantation|cochlear implantation
5297539|NCT02189798|HiFocus™ Mid-Scala electrode|hifocus™ mid-scala electrode
5297540|NCT02189798|Listening Benefits|listening benefits
5297759|NCT02188992|Sepsis|sepsis
5297956|NCT02188251|Activamp|activamp
5298050|NCT02187822|Brain lesions|brain lesions
5298155|NCT02187393|Epithelial cell function of cells from individuals with various genotypes|epithelial cell function of cells from individuals with various genotypes
5298156|NCT02187302|nanopharmaceutical,|nanopharmaceutical,
5298157|NCT02187289|NCSG|ncsg
5298158|NCT02187289|Compression bandages|compression bandages
5298159|NCT02187289|devices|devices
5298160|NCT02187289|Night time compression|night time compression
5298162|NCT02187289|Compression therapy|compression therapy
5298462|NCT02186093|Angina, Stable|angina, stable
5298564|NCT02185794|Antimetabolites|antimetabolites
5298664|NCT02185352|Brain Metastases|brain metastases
5298769|NCT02184845|supported restoration(s)|supported restoration(s)
5298770|NCT02184845|maxillary lateral incisor|maxillary lateral incisor
5298772|NCT02184845|lateral incisor|lateral incisor
5298878|NCT02184468|Police|police
5299073|NCT02182687|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5299074|NCT02182687|Orthotopic liver transplant|orthotopic liver transplant
5299076|NCT02182687|stereotactic body radiation therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5299077|NCT02182687|trans-arterial chemoembolization (TACE)|trans-arterial chemoembolization (tace)
5299078|NCT02182596|Acute Myeloid Leukemia|acute myeloid leukemia
5299079|NCT02182596|First relapsing AML|first relapsing aml
5299080|NCT02182466|Colon capsule endoscopy|colon capsule endoscopy
5299083|NCT02182440|SA-AKI|sa-aki
5299487|NCT02180412|Hemin|hemin
5299488|NCT02180399|Sepsis|sepsis
5299489|NCT02180399|Capillary blood lactate|capillary blood lactate
5299494|NCT02180360|Range of motion|range of motion
5299587|NCT02179957|fractional flow reserve (FFR)|fractional flow reserve (ffr)
5299588|NCT02179957|computed tomography (CT)|computed tomography (ct)
5299590|NCT02179944|medication abortion|medication abortion
5299591|NCT02179944|serum hCG|serum hcg
5299799|NCT02178904|Coronary Artery Stenosis|coronary artery stenosis
5299800|NCT02178891|short implants|short implants
5894411|NCT03441022|Cardioversion|cardioversion
5894412|NCT03441022|BodyGuardian|bodyguardian
5894413|NCT03441022|Amiigo Wristband|amiigo wristband
5894437|NCT03439072|glucagon|glucagon
5894438|NCT03439072|hypoglycemia|hypoglycemia
5929555|NCT03652077|Advanced malignancies|advanced malignancies
5929556|NCT03652077|immunoglobulin (Ig)G1k monoclonal antibody|immunoglobulin (ig)g1k monoclonal antibody
5929557|NCT03652077|T-cell immunoglobulin and mucin domain 3 (TIM-3)|t-cell immunoglobulin and mucin domain 3 (tim-3)
5894439|NCT03437668|Schizophrenia|schizophrenia
5894440|NCT03437668|Withania Somnifera|withania somnifera
5299997|NCT02177760|severe combined immunodeficiency|severe combined immunodeficiency
5299998|NCT02177760|maternal engraftment|maternal engraftment
5300003|NCT02177734|Influenza|influenza
5300004|NCT02177734|H7N9|h7n9
5300005|NCT02177734|Immunogenicity|immunogenicity
5300006|NCT02177734|Adults|adults
5300007|NCT02177721|Raxibacumab|raxibacumab
5300008|NCT02177721|anthrax|anthrax
5300009|NCT02177721|anti-toxin|anti-toxin
5300010|NCT02177695|Bladder Cancer|bladder cancer
5300011|NCT02177695|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5300098|NCT02177058|Hospitalizations|hospitalizations
5300403|NCT02175381|Platinum-based treatment|platinum-based treatment
5300404|NCT02175368|total etch protocol|total etch protocol
5300497|NCT02174848|Ferriprox|ferriprox
5300498|NCT02174835|Pharmacokinetics|pharmacokinetics
5300692|NCT02173847|femtosecond laser|femtosecond laser
5300964|NCT02171936|CETD|cetd
5301159|NCT02170441|Microscopic Observation Drug Susceptibility Assay|microscopic observation drug susceptibility assay
5301160|NCT02170441|Pyrosequencing|pyrosequencing
5301161|NCT02170428|growth,|growth,
5301162|NCT02170428|infancy,|infancy,
5301253|NCT02170025|Cystic fibrosis|cystic fibrosis
5301350|NCT02169531|Autologous|autologous
5301351|NCT02169518|PON1 activity|pon1 activity
5301352|NCT02169518|HDL functionality|hdl functionality
5301652|NCT02168205|Healthy volunteer|healthy volunteer
5301653|NCT02168205|Pharmacokinetics|pharmacokinetics
5301654|NCT02168205|Pomalyst|pomalyst
5301655|NCT02168205|Pomalidomide|pomalidomide
5301656|NCT02168205|Food effect|food effect
5301657|NCT02168205|smoker|smoker
5301658|NCT02168192|Breaking bad news skills|breaking bad news skills
5301659|NCT02168192|Communications skills|communications skills
5301660|NCT02168192|Medical education|medical education
5301661|NCT02168192|Obstetrics|obstetrics
5301662|NCT02168192|Simulation|simulation
5301746|NCT02167828|AIDS|aids
5301835|NCT02167269|spontaneous breathing|spontaneous breathing
5301836|NCT02167269|pediatric anesthesia|pediatric anesthesia
5301837|NCT02167230|Coronary Artery Disease|coronary artery disease
5302130|NCT02165865|hand amputation|hand amputation
5302252|NCT02165202|biomedical HIV prevention research|biomedical hiv prevention research
5302253|NCT02165189|Simeprevir|simeprevir
5302254|NCT02165189|Sofosbuvir|sofosbuvir
5302255|NCT02165189|Ribavirin|ribavirin
5302256|NCT02165189|Hepatitits C|hepatitits c
5302257|NCT02165189|Hepatitis C virus ribonucleic acid|hepatitis c virus ribonucleic acid
5302258|NCT02165176|cannabis|cannabis
5302259|NCT02165176|toxicology|toxicology
5302260|NCT02165176|intoxication|intoxication
5302261|NCT02165150|Elastic Band|elastic band
5302262|NCT02165150|Institutional Elders|institutional elders
5302263|NCT02165150|Functional Fitness|functional fitness
5302264|NCT02165150|Sleep Quality|sleep quality
5302353|NCT02164695|Remote ischemic perconditioning|remote ischemic perconditioning
5302653|NCT02163460|drainage|drainage
5302809|NCT02162797|HIV|hiv
5894559|NCT03426865|PET scan|pet scan
5302887|NCT02162524|obesity|obesity
5302984|NCT02162095|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5302985|NCT02162095|Coronary artery disease|coronary artery disease
5302986|NCT02162095|Coronary calcium score|coronary calcium score
5302987|NCT02162043|Glaucoma|glaucoma
5302988|NCT02162043|Perimetry|perimetry
5302990|NCT02162043|Screening|screening
5303273|NCT02160769|Tear Lipid Thickness|tear lipid thickness
5303274|NCT02160769|Pterygium surgery|pterygium surgery
5303275|NCT02160756|Healthy|healthy
5303276|NCT02160756|JNJ-56021927|jnj-56021927
5303277|NCT02160756|JNJ-56142060|jnj-56142060
5303278|NCT02160756|ARN-509|arn-509
5303279|NCT02160730|Cushings disease|cushings disease
5303280|NCT02160730|R-roscovitine|r-roscovitine
5303281|NCT02160717|Turner Syndrome|turner syndrome
5303282|NCT02160717|Diabetes|diabetes
5303283|NCT02160704|Sperm density|sperm density
5303284|NCT02160704|Testosterone|testosterone
5303285|NCT02160704|Hypogonadism|hypogonadism
5303286|NCT02160652|Ureteral Obstruction|ureteral obstruction
5303287|NCT02160652|HYDRONEPHROSIS|hydronephrosis
5303570|NCT02159378|Gestational Diabetes|gestational diabetes
5303659|NCT02158962|Partner abuse|partner abuse
5303660|NCT02158962|Abuse African Caribbean women|abuse african caribbean women
5303661|NCT02158962|Intimate Partner Violence|intimate partner violence
5303662|NCT02158949|alcohol|alcohol
5303663|NCT02158949|mHealth|mhealth
5303789|NCT02158455|CABG|cabg
5304160|NCT02156596|renal colic|renal colic
5304270|NCT02156011|In vivo knee joint loading|in vivo knee joint loading
5304271|NCT02156011|Video-fluoroscopy|video-fluoroscopy
5888215|NCT04196283|Cancer|cancer
5304272|NCT02156011|Instrumented implants|instrumented implants
5304273|NCT02156011|Optical motion capture|optical motion capture
5702984|NCT00491192|ICU|icu
5304274|NCT02156011|Ground reaction forces|ground reaction forces
5304277|NCT02155972|Bipolar|bipolar
5304358|NCT02155725|PPH|pph
5304359|NCT02155725|fibrinogen|fibrinogen
5304360|NCT02155725|vaginal delivery|vaginal delivery
5304362|NCT02155686|Elderly|elderly
5304455|NCT02155231|Male with history of anal sex with men or previous participants of the MSM VCT study|male with history of anal sex with men or previous participants of the msm vct study
5304456|NCT02155218|Magnetic Resonance Angiography|magnetic resonance angiography
5304558|NCT02154763|Bariatric surgery|bariatric surgery
5304559|NCT02154763|Bariatrics|bariatrics
5304560|NCT02154763|Local anesthetic|local anesthetic
5304561|NCT02154763|Ropivacaine|ropivacaine
5305293|NCT02151006|IVF|ivf
5305486|NCT02150122|Serum 25-hydroxyvitamin D (25OHD)|serum 25-hydroxyvitamin d (25ohd)
5305487|NCT02150122|Adolescents|adolescents
5305489|NCT02150096|clinical trial|clinical trial
5305672|NCT02149394|Thirst|thirst
5305673|NCT02149394|Ice|ice
5305674|NCT02149394|Water|water
5305675|NCT02149394|Perioperative Nursing|perioperative nursing
5305773|NCT02148835|Bioavailability|bioavailability
5305774|NCT02148835|Eicosapentaenoic acid|eicosapentaenoic acid
5305799|NCT02148757|DVT|dvt
5305978|NCT02147990|cancer|cancer
5306685|NCT02144831|TIA|tia
5343008|NCT01981161|Zoster infection|zoster infection
5306882|NCT02143986|sepsis|sepsis
5307314|NCT02141997|safety|safety
5307413|NCT02141490|Imaging Agent|imaging agent
5307414|NCT02141477|Leukemia|leukemia
5307415|NCT02141477|Acute Myelogenous Leukemia|acute myelogenous leukemia
5307416|NCT02141477|AML|aml
5307417|NCT02141477|High Risk Myelodysplastic Syndrome|high risk myelodysplastic syndrome
5307418|NCT02141477|MDS|mds
5307419|NCT02141477|Omacetaxine|omacetaxine
5307420|NCT02141477|Synribo|synribo
5307421|NCT02141477|Homoharringtonine|homoharringtonine
5307422|NCT02141477|Decitabine|decitabine
5307423|NCT02141477|Dacogen|dacogen
5307429|NCT02141425|Healthy volunteers|healthy volunteers
5307430|NCT02141425|ASP015K|asp015k
5307431|NCT02141412|optimal dose of dexmedetomidine|optimal dose of dexmedetomidine
5307432|NCT02141412|prevent shivering|prevent shivering
5307433|NCT02141412|improve quality of emergence|improve quality of emergence
5307434|NCT02141412|anesthesia|anesthesia
5307435|NCT02141412|without delay|without delay
5307436|NCT02141412|recovery|recovery
5307441|NCT02141373|seroma|seroma
5307548|NCT02140814|PKD|pkd
5307594|NCT02140671|compliance|compliance
5307595|NCT02140671|hospital admission|hospital admission
5307596|NCT02140671|educations|educations
5307597|NCT02140671|self-management|self-management
5307604|NCT02140658|outcome|outcome
5308004|NCT02138760|prostate biopsy|prostate biopsy
5308006|NCT02138760|detection rates|detection rates
5308121|NCT02138357|Neupro|neupro
5693243|NCT00525239|HDL|hdl
5308309|NCT02137356|capecitabine|capecitabine
5308310|NCT02137356|chemoradiation|chemoradiation
5308311|NCT02137356|radiation|radiation
5308312|NCT02137356|radiotherapy|radiotherapy
5308313|NCT02137356|neoadjuvant|neoadjuvant
5308315|NCT02137343|Gastric Cancer|gastric cancer
5308617|NCT02135692|Safety|safety
5308807|NCT02134678|cognitive therapy|cognitive therapy
5308809|NCT02134678|psychotherapy|psychotherapy
5308810|NCT02134678|mechanisms of action|mechanisms of action
5308904|NCT02134314|ECD|ecd
5309122|NCT02133547|Nose|nose
5309234|NCT02133014|pancreatitis|pancreatitis
5309477|NCT02131805|skin|skin
5309532|NCT02131558|Sentinel lymph node|sentinel lymph node
5309533|NCT02131558|Indocyanine green|indocyanine green
5309534|NCT02131558|Near infrared imaging|near infrared imaging
5309535|NCT02131545|quetiapine|quetiapine
5309631|NCT02130986|acute bronchitis|acute bronchitis
5309729|NCT02130674|metabolism|metabolism
5309927|NCT02129920|Brain Ischemia|brain ischemia
5310023|NCT02129556|Breast|breast
5310282|NCT02128568|War|war
5310429|NCT02127879|Schizophrenia|schizophrenia
5310430|NCT02127879|Negative symptoms|negative symptoms
5310434|NCT02127853|serial cataract surgery|serial cataract surgery
5310717|NCT02126436|acupuncture|acupuncture
5310812|NCT02125981|limaprost alfadex|limaprost alfadex
5310813|NCT02125981|cervical myelopathy|cervical myelopathy
5310814|NCT02125981|surgery|surgery
5310815|NCT02125968|chronic low back pain|chronic low back pain
5310816|NCT02125968|video game|video game
5310817|NCT02125968|therapeutic effects|therapeutic effects
5310818|NCT02125955|Pediatric|pediatric
5310819|NCT02125955|Overweight|overweight
5310820|NCT02125955|Obesity|obesity
5310821|NCT02125955|Gut microbiota|gut microbiota
5310822|NCT02125955|Adiposity|adiposity
5310823|NCT02125955|Prebiotic|prebiotic
5310824|NCT02125955|Dietary fiber|dietary fiber
5310901|NCT02125526|No reflow|no reflow
5310902|NCT02125526|Intra-aortic balloon pump|intra-aortic balloon pump
5310903|NCT02125526|Exhausted autoregulation|exhausted autoregulation
5310904|NCT02125513|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5310921|NCT02125487|Cultural|cultural
5311093|NCT02124616|Muscle diseases|muscle diseases
5674193|NCT00604578|Asthma|asthma
5311184|NCT02124161|flu vaccine|flu vaccine
5311281|NCT02123615|Subdermal bloodless space|subdermal bloodless space
5311282|NCT02123615|Subdermal injection|subdermal injection
5311283|NCT02123615|Subcutaneous injection|subcutaneous injection
5311378|NCT02123212|Screening|screening
5312547|NCT02118168|HIV|hiv
5313039|NCT02115932|Gait|gait
5313129|NCT02115620|Remote Consultation|remote consultation
5313431|NCT02114437|Closed-Loop TCI|closed-loop tci
5313920|NCT02112630|End Stage Renal Disease|end stage renal disease
5313921|NCT02112630|ESRD|esrd
5313922|NCT02112630|Boceprevir|boceprevir
5313923|NCT02112630|Pegylated Interferon|pegylated interferon
5313924|NCT02112630|Ribavirin|ribavirin
5313925|NCT02112617|Neuroblastoma|neuroblastoma
5314008|NCT02112253|Stereotactic surgery|stereotactic surgery
5314009|NCT02112253|Globus pallidus interna|globus pallidus interna
5314010|NCT02112253|Tics|tics
5314024|NCT02112175|MPV|mpv
5314235|NCT02111330|Cancer|cancer
5314311|NCT02110966|Symptomatic irreversible pulpitis.|symptomatic irreversible pulpitis.
5314709|NCT02109081|delirium|delirium
5314710|NCT02109081|postoperative cognitive dysfunction|postoperative cognitive dysfunction
5314711|NCT02109081|postoperative|postoperative
5314796|NCT02108847|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5314797|NCT02108847|Pain, Postoperative|pain, postoperative
5314803|NCT02108834|acute pain|acute pain
5314895|NCT02108392|eye|eye
5314896|NCT02108392|biomarkers|biomarkers
5314897|NCT02108366|severe|severe
5314898|NCT02108366|influenza A|influenza a
5314899|NCT02108366|celecoxib|celecoxib
5314900|NCT02108353|Type 2 Diabetes|type 2 diabetes
5314901|NCT02108353|metabolic control|metabolic control
5314902|NCT02108353|Metabolomics|metabolomics
5315002|NCT02107859|PTC124|ptc124
5315108|NCT02107521|ICSI|icsi
5315441|NCT02106260|CLS003|cls003
5315539|NCT02105922|Protein supplementation|protein supplementation
5315739|NCT02105155|Liver transplantation,|liver transplantation,
4964550|NCT04210856|EEG|eeg
5315740|NCT02105155|Conversion (Prograf® to Advagraf®),|conversion (prograf® to advagraf®),
5315742|NCT02105155|Advagraf® ,|advagraf® ,
5315743|NCT02105155|acute rejection,|acute rejection,
5315835|NCT02104570|Proprioception|proprioception
5315836|NCT02104570|Shoulder|shoulder
5315838|NCT02104557|Pregnancy|pregnancy
5315839|NCT02104557|Contraception|contraception
5315840|NCT02104557|Endometriosis-associated pain|endometriosis-associated pain
5315841|NCT02104557|PMS|pms
5315842|NCT02104557|Post Marketing Surveillance|post marketing surveillance
5315843|NCT02104544|DHA intake;|dha intake;
5315844|NCT02104544|Plasma;|plasma;
5315862|NCT02104414|Exparel|exparel
5316032|NCT02103660|contraceptive implant|contraceptive implant
5316033|NCT02103660|Depo-Medroxyprogesterone Acetate|depo-medroxyprogesterone acetate
5316034|NCT02103660|Hormonal Contraception|hormonal contraception
5316035|NCT02103660|progestin|progestin
5316040|NCT02103634|MRI|mri
5316133|NCT02103075|Neuromuscular electrical stimulation (NMES)|neuromuscular electrical stimulation (nmes)
5316134|NCT02103075|silent period|silent period
5316135|NCT02103075|cerebellum|cerebellum
5316142|NCT02103062|RAS|ras
5316523|NCT02101463|aneurysms|aneurysms
5316524|NCT02101463|fenestrated|fenestrated
5316525|NCT02101463|stent-grafts|stent-grafts
5316526|NCT02101463|Vascular|vascular
5316527|NCT02101463|Endovascular|endovascular
5316528|NCT02101450|extra-abdominal|extra-abdominal
5316529|NCT02101450|intra-abdominal|intra-abdominal
5316530|NCT02101450|removal of placenta|removal of placenta
5316730|NCT02100436|unadjuvanted|unadjuvanted
5316830|NCT02099903|Chagas Cardiomyopathy|chagas cardiomyopathy
5316831|NCT02099903|Renal Denervation|renal denervation
5316832|NCT02099903|Irrigated Radiofrequency Catheter|irrigated radiofrequency catheter
5316833|NCT02099890|Chronic Inflammation|chronic inflammation
5316837|NCT02099890|Depression|depression
5317022|NCT02099214|congestive heart failure|congestive heart failure
5317224|NCT02098252|Aneurysm|aneurysm
5317327|NCT02097797|fecal transplantation|fecal transplantation
5317328|NCT02097784|cirrhosis|cirrhosis
5317329|NCT02097784|hepatorenal syndrome|hepatorenal syndrome
5317330|NCT02097784|acute kidney injury|acute kidney injury
5317336|NCT02097732|Immune therapy|immune therapy
5317422|NCT02097329|antacid|antacid
5317521|NCT02096874|Bevacizumab|bevacizumab
5317612|NCT02096406|Surgical valve repair|surgical valve repair
5317613|NCT02096406|Valve Replacement|valve replacement
5317614|NCT02096380|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5317615|NCT02096380|cycle|cycle
5317617|NCT02096380|docetaxel|docetaxel
5317711|NCT02096029|nicotine replacement therapy|nicotine replacement therapy
5317712|NCT02096029|primary care|primary care
5317713|NCT02096029|comparative effectiveness|comparative effectiveness
5317804|NCT02095431|patients undergoing the liver transplantation|patients undergoing the liver transplantation
5317805|NCT02095431|acute kidney injury|acute kidney injury
5317806|NCT02095418|New-onset diabetes after transplantation (NODAT)|new-onset diabetes after transplantation (nodat)
5317807|NCT02095418|Liver transplantation|liver transplantation
5317904|NCT02095015|MPS|mps
5318196|NCT02093676|type 1|type 1
5318383|NCT02092870|Diabetic Foot|diabetic foot
5318384|NCT02092857|nutrient|nutrient
5318385|NCT02092857|nutrition|nutrition
5318386|NCT02092857|arachidonic acid|arachidonic acid
5318486|NCT02092311|varicocele|varicocele
5318606|NCT02091765|Internet-based|internet-based
5318703|NCT02091336|capillar glucose|capillar glucose
5318704|NCT02091323|T2DM, gastric bypass surgery, BMI<35, obesity|t2dm, gastric bypass surgery, bmi<35, obesity
5318789|NCT02090959|Duchenne muscular dystrophy|duchenne muscular dystrophy
5318790|NCT02090959|Dystrophinopathy|dystrophinopathy
5318791|NCT02090959|Nonsense mutation|nonsense mutation
5319037|NCT02089802|RCC|rcc
5323780|NCT02067559|ICU|icu
5319488|NCT02087384|Anal intraepithelial neoplasia|anal intraepithelial neoplasia
5319685|NCT02086227|Bioequivalence|bioequivalence
5319686|NCT02086214|Upper limb|upper limb
5319876|NCT02085317|Microcirculation|microcirculation
5319883|NCT02085304|GBM|gbm
5319982|NCT02084940|IVF|ivf
5320170|NCT02084030|Susceptibility gene|susceptibility gene
5320171|NCT02084017|Surgical Site Infection|surgical site infection
5320172|NCT02084017|Vascular Surgery|vascular surgery
5320272|NCT02083627|Fidaxomicin|fidaxomicin
5320273|NCT02083627|Rosuvastatin|rosuvastatin
5320274|NCT02083627|Multiple Doses|multiple doses
5320275|NCT02083627|Single Doses|single doses
5320597|NCT02082249|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5320598|NCT02082249|levodopa|levodopa
5320599|NCT02082249|carbidopa|carbidopa
5685507|NCT00555802|Ultrasonography, Multifidus|ultrasonography, multifidus
5894838|NCT03392987|MLD|mld
5320600|NCT02082249|Advanced Parkinson's Disease|advanced parkinson's disease
5435055|NCT01566318|Anxiety|anxiety
5320601|NCT02082236|Plasma concentrations|plasma concentrations
5320693|NCT02081690|PAH-SYMPACT|pah-sympact
5320694|NCT02081690|psychometric instrument|psychometric instrument
5320695|NCT02081664|Amalgam attributed health complaints|amalgam attributed health complaints
5320696|NCT02081664|feasibility pilot study|feasibility pilot study
5320697|NCT02081664|integrated medical care program|integrated medical care program
5320698|NCT02081664|lifestyle|lifestyle
5320699|NCT02081638|Treated Progressors|treated progressors
5320789|NCT02081300|Testosterone undecanoate|testosterone undecanoate
5320790|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate
5320791|NCT02081300|Methyltestosterone|methyltestosterone
5320792|NCT02081300|Androgens|androgens
5320793|NCT02081300|Hormones|hormones
5320794|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists
5320795|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs
5320796|NCT02081300|Pharmacologic Actions|pharmacologic actions
5320797|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal
5320798|NCT02081300|Antineoplastic Agents|antineoplastic agents
5320799|NCT02081300|Anabolic Agents|anabolic agents
5320800|NCT02081287|Bipolar Disorder|bipolar disorder
5320801|NCT02081287|Depression|depression
5321079|NCT02079987|Healthcare Coach|healthcare coach
5321080|NCT02079987|Care Transition Intervention|care transition intervention
5321081|NCT02079987|Emergency Department Population|emergency department population
5321084|NCT02079974|pain|pain
5321281|NCT02079012|Anxiety|anxiety
5321595|NCT02077491|Aged|aged
5321679|NCT02077088|atopic|atopic
5321984|NCT02075983|Vaccine|vaccine
5321985|NCT02075983|Immunisation|immunisation
5321986|NCT02075983|DNA|dna
5321987|NCT02075983|Adverse events|adverse events
5321988|NCT02075983|Electroporation|electroporation
5322077|NCT02075541|Reactogenicity|reactogenicity
5322097|NCT02075489|EEG|eeg
5322180|NCT02075125|Korea|korea
5322287|NCT02074800|Safety|safety
5322491|NCT02073760|Sepsis|sepsis
5322680|NCT02072824|Pregabalin|pregabalin
5322885|NCT02071836|DWI intervention|dwi intervention
5322886|NCT02071836|DUI intervention|dui intervention
5322887|NCT02071836|Experimental group: Right Turns + treatment as usual|experimental group: right turns + treatment as usual
5322888|NCT02071836|Control group: Treatment as usual|control group: treatment as usual
5322889|NCT02071823|Opicapone,|opicapone,
5322980|NCT02071342|percutaneous coronary intervention|percutaneous coronary intervention
5322981|NCT02071329|FP-01.1|fp-01.1
5322982|NCT02071329|Influenza A|influenza a
5322983|NCT02071329|Flu|flu
5322984|NCT02071329|Vaccine|vaccine
5323281|NCT02069847|Endoscopic submucosal dissection|endoscopic submucosal dissection
5323283|NCT02069847|Radical endoscopic mucosal resection|radical endoscopic mucosal resection
5323490|NCT02068937|Therapy|therapy
5929697|NCT03633227|Primary Biliary Cholangitis|primary biliary cholangitis
5929698|NCT03633227|Primary Biliary Cirrhosis|primary biliary cirrhosis
5929699|NCT03633227|PBC|pbc
5929700|NCT03633227|Hepatic Impairment|hepatic impairment
5929701|NCT03633227|Cirrhosis|cirrhosis
5929702|NCT03633227|Liver|liver
5323681|NCT02068040|with preserved ejection fraction of >55%|with preserved ejection fraction of >55%
5323682|NCT02068027|Diabetes Mellitus|diabetes mellitus
5323683|NCT02068027|Pain|pain
5323684|NCT02068027|Foot pain|foot pain
5323685|NCT02068027|Neuropathy|neuropathy
5323686|NCT02068014|stapplers- obesity- stomach|stapplers- obesity- stomach
5323687|NCT02067988|Radioembolization|radioembolization
5323688|NCT02067988|Somatostatin receptor treatment|somatostatin receptor treatment
5929714|NCT03630549|HIV|hiv
5929715|NCT03630549|Village Health Worker|village health worker
5929716|NCT03630549|Differentiated Care|differentiated care
5929717|NCT03630549|Lesotho|lesotho
5929718|NCT03630549|Africa|africa
5929719|NCT03630549|antiretroviral therapy|antiretroviral therapy
5323689|NCT02067988|Neuroendocrine tumors|neuroendocrine tumors
5323690|NCT02067988|Liver metastases|liver metastases
5323691|NCT02067975|tryptophan|tryptophan
5323692|NCT02067975|kynurenic acid|kynurenic acid
5323693|NCT02067975|schizophrenia|schizophrenia
5323694|NCT02067962|Juvenile idiopathic arhtritis|juvenile idiopathic arhtritis
5323696|NCT02067962|Gene identification|gene identification
5323697|NCT02067962|Whole exome sequencing|whole exome sequencing
5323698|NCT02067962|Next generation sequencing|next generation sequencing
5323699|NCT02067962|Identification of molecular basis|identification of molecular basis
5864194|NCT00000405|Ossification|ossification
5323700|NCT02067962|Acceptation of both parents to participate to the study|acceptation of both parents to participate to the study
5323702|NCT02067923|type 1 diabetes|type 1 diabetes
5323740|NCT02067806|TNS|tns
5323753|NCT02067741|topical application CR1447|topical application cr1447
5323756|NCT02067728|obesity prevention|obesity prevention
5323846|NCT02067117|influenza|influenza
5323847|NCT02067091|STEMI|stemi
5323848|NCT02067091|Coronary|coronary
5323849|NCT02067091|Bioresorbable scaffold|bioresorbable scaffold
5323850|NCT02067091|Drug eluting stent|drug eluting stent
5323851|NCT02067091|Optical coherence tomography|optical coherence tomography
5323852|NCT02067091|Multislice computed tomography|multislice computed tomography
5323853|NCT02067078|nerve block|nerve block
5323857|NCT02067078|pain|pain
5324036|NCT02066337|Superoxide dismutase|superoxide dismutase
5324039|NCT02066298|Asthma|asthma
5324040|NCT02066298|Mometasone|mometasone
5324041|NCT02066298|Tiotropium|tiotropium
5324042|NCT02066285|Solitary fibrous tumor|solitary fibrous tumor
5324047|NCT02066272|IBD|ibd
5324344|NCT02064998|Brief intervention|brief intervention
5324345|NCT02064972|Graft vs Host Disease|graft vs host disease
5324346|NCT02064972|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5324347|NCT02064972|Biological Marker|biological marker
5324447|NCT02064608|Neoadjuvant treatment|neoadjuvant treatment
5324862|NCT02062619|tDCS|tdcs
5324964|NCT02062203|chronic kidney disease|chronic kidney disease
5324965|NCT02062203|CKD|ckd
5324966|NCT02062203|chronic renal insufficiency|chronic renal insufficiency
5324967|NCT02062203|renal impairment|renal impairment
5324968|NCT02062203|safety|safety
5324969|NCT02062164|psychosocial, healthcare, co-morbidities, extremely obese adolescents|psychosocial, healthcare, co-morbidities, extremely obese adolescents
5324970|NCT02062151|Acupuncture|acupuncture
5325163|NCT02061332|DCIS|dcis
5325271|NCT02060877|suspected lung cancer|suspected lung cancer
5325272|NCT02060877|diagnostic work-up|diagnostic work-up
5325273|NCT02060864|enzyme|enzyme
5325274|NCT02060864|gluten|gluten
5325275|NCT02060864|food intolerance|food intolerance
5325280|NCT02060812|ultrasound guided axillary nerve block|ultrasound guided axillary nerve block
5325281|NCT02060812|arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5325379|NCT02060409|myelodysplastic syndrome|myelodysplastic syndrome
5325447|NCT02060123|RCT|rct
5325701|NCT02058914|endocrine|endocrine
5325703|NCT02058914|blood glucose|blood glucose
5325704|NCT02058901|sunitinib|sunitinib
5325705|NCT02058901|solid tumors|solid tumors
5325706|NCT02058888|metagenomics|metagenomics
5325707|NCT02058888|antimicrobial resistance|antimicrobial resistance
5325708|NCT02058888|multidrug resistance|multidrug resistance
5325709|NCT02058849|Mucositis|mucositis
5325710|NCT02058849|Beetroot|beetroot
5325711|NCT02058849|Head and neck cancer|head and neck cancer
5325712|NCT02058836|Chronic testicular pain|chronic testicular pain
5325713|NCT02058836|Orchialgia|orchialgia
5325797|NCT02058563|Safety|safety
5325877|NCT02058056|Early prophylactic|early prophylactic
5325972|NCT02057484|kidney transplant|kidney transplant
5325973|NCT02057484|Advagraf|advagraf
5325974|NCT02057484|Tacrolimus|tacrolimus
5325975|NCT02057471|Adenocarcinoma|adenocarcinoma
5325976|NCT02057471|Anemia|anemia
5325977|NCT02057471|Blood Transfusion|blood transfusion
5325978|NCT02057471|Colorectal surgery|colorectal surgery
5325979|NCT02057471|Preoperative care|preoperative care
5325980|NCT02057471|Perioperative care|perioperative care
5326163|NCT02056938|kidney|kidney
5326164|NCT02056938|delayed graft function|delayed graft function
5326171|NCT02056912|gene|gene
5326461|NCT02055599|Chronic Wounds|chronic wounds
5326462|NCT02055599|Clinical Decision Support|clinical decision support
5326470|NCT02055560|5-FU|5-fu
5326679|NCT02054676|reliability|reliability
5326680|NCT02054676|validity|validity
5326681|NCT02054663|Acute coronary syndrome|acute coronary syndrome
5326682|NCT02054663|Coronary artery disease|coronary artery disease
5327057|NCT02052882|13-132|13-132
5327058|NCT02052869|endotracheal intubation|endotracheal intubation
5327059|NCT02052869|esophageal intubation|esophageal intubation
5327060|NCT02052856|Tunnel Widening|tunnel widening
5327061|NCT02052856|All-Inside Suspensory Method|all-inside suspensory method
5327062|NCT02052856|Biointerference Screw Fixation|biointerference screw fixation
5327064|NCT02052791|SMA|sma
5327261|NCT02052037|Egg|egg
5327368|NCT02051530|mood|mood
5327777|NCT02049697|TPI 1062|tpi 1062
5327891|NCT02049216|osteoarthritis|osteoarthritis
5327892|NCT02049216|tape|tape
5328078|NCT02048306|Family|family
5328331|NCT02047357|Child|child
5328444|NCT02046863|Tremor|tremor
5328549|NCT02046408|Patient-facing information technology|patient-facing information technology
5328555|NCT02046382|Cesarean Section|cesarean section
5328556|NCT02046382|Pain, Postoperative|pain, postoperative
5328557|NCT02046369|Lurasidone, Latuda, Bipolar Depression|lurasidone, latuda, bipolar depression
5328558|NCT02046356|hepatocellular carcinoma|hepatocellular carcinoma
5328559|NCT02046356|radiofrequency ablation|radiofrequency ablation
5328560|NCT02046356|Milan Criteria|milan criteria
5328561|NCT02046356|recurrence|recurrence
5328562|NCT02046356|risk factor|risk factor
5328563|NCT02046343|physical activity|physical activity
5328564|NCT02046343|prevention|prevention
5328565|NCT02046343|health disparities|health disparities
5328566|NCT02046343|behavior|behavior
5328567|NCT02046343|community based intervention|community based intervention
5328568|NCT02046330|Deep Brain Stimulation|deep brain stimulation
5328569|NCT02046330|Treatment Resistant Depression|treatment resistant depression
5328570|NCT02046330|Major Depressive Disorder|major depressive disorder
5328989|NCT02044601|XRT|xrt
5329056|NCT02044302|breast reconstruction|breast reconstruction
5329057|NCT02044289|depression|depression
5329058|NCT02044289|electroconvulsive therapy (ECT)|electroconvulsive therapy (ect)
5329059|NCT02044289|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5329060|NCT02044276|Neutropenia|neutropenia
5329061|NCT02044276|NHL|nhl
5329062|NCT02044276|Non-Hodgkin lymphomas|non-hodgkin lymphomas
5329063|NCT02044276|R-CHOP-21|r-chop-21
5329064|NCT02044263|Cognitive therapy|cognitive therapy
5329065|NCT02044263|Behavior therapy|behavior therapy
5329066|NCT02044263|Waiting lists|waiting lists
5329067|NCT02044263|Therapy, computer-assisted|therapy, computer-assisted
5329068|NCT02044263|Internet|internet
5329069|NCT02044250|Aspirin|aspirin
5329339|NCT02043158|Long term survivors|long term survivors
5329553|NCT02042274|genetic variation|genetic variation
5329554|NCT02042274|gene expression|gene expression
5329555|NCT02042248|HIV|hiv
5329556|NCT02042248|Acute HIV Infection|acute hiv infection
5329557|NCT02042248|Chronic HIV Infection|chronic hiv infection
5329558|NCT02042248|AGS-004|ags-004
5329559|NCT02042248|Phase 1|phase 1
5329560|NCT02042248|Antiretroviral Therapy|antiretroviral therapy
5329746|NCT02041624|grass mix|grass mix
5329840|NCT02041104|Real-Time Polymerase Chain Reaction|real-time polymerase chain reaction
5329841|NCT02041104|Denaturating Gradient Gel Electrophoresis|denaturating gradient gel electrophoresis
5329842|NCT02041078|Liver surgery|liver surgery
5329843|NCT02041078|Blood loss|blood loss
5329939|NCT02040610|Image Guided Proton Therapy|image guided proton therapy
5329940|NCT02040584|De Novo Liver Transplant, Tacrolimus Minimisation, Everolimus, Renal Function, Liver transplant, allograft rejection, xenograft rejection, host vs graft disease|de novo liver transplant, tacrolimus minimisation, everolimus, renal function, liver transplant, allograft rejection, xenograft rejection, host vs graft disease
5330028|NCT02040025|peripheral vascular resistance|peripheral vascular resistance
5330029|NCT02040025|EECP|eecp
5330030|NCT02040025|Blood pressure|blood pressure
5330031|NCT02040025|angiogenesis|angiogenesis
5330032|NCT02040025|Coronary Artery Disease|coronary artery disease
5330033|NCT02040025|Coronary Disease|coronary disease
5330034|NCT02040025|Heart Diseases|heart diseases
5330035|NCT02040025|Cardiovascular Diseases|cardiovascular diseases
5330036|NCT02040012|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5330037|NCT02039999|chronic|chronic
5330038|NCT02039999|cough|cough
5330039|NCT02039999|challenge|challenge
5929760|NCT03623243|Multiple Sclerosis; Advancing Multiple Sclerosis; conversion; siponimod;|multiple sclerosis; advancing multiple sclerosis; conversion; siponimod;
5929762|NCT03622632|uric acid|uric acid
5929763|NCT03622632|organ failure|organ failure
5929786|NCT03618264|Postoperative Pain|postoperative pain
5929787|NCT03618264|Post-Craniotomy Headache|post-craniotomy headache
5929788|NCT03618264|Dexamethasone|dexamethasone
5929789|NCT03618264|Ropivacaine|ropivacaine
5929790|NCT03618264|Pre-emptive Scalp Infiltration|pre-emptive scalp infiltration
5330579|NCT02037672|roflumilast|roflumilast
5330580|NCT02037672|metformin|metformin
5330582|NCT02037646|Colorectal cancer|colorectal cancer
5895230|NCT03331562|Pancreatic cancer|pancreatic cancer
5330583|NCT02037646|Screening|screening
5330584|NCT02037646|Fecal occult blood|fecal occult blood
5330585|NCT02037646|Fecal immunochemical test|fecal immunochemical test
5330586|NCT02037646|Qualitative|qualitative
5330587|NCT02037646|Quantitative|quantitative
5330588|NCT02037620|Epidural Stimulation|epidural stimulation
5330589|NCT02037607|Deep vein thrombosis|deep vein thrombosis
5330590|NCT02037607|Children|children
5330591|NCT02037607|Pediatric|pediatric
5330863|NCT02036450|atrial fibrillation|atrial fibrillation
5330864|NCT02036450|cardiac arrhythmia|cardiac arrhythmia
5330865|NCT02036450|stroke|stroke
5330866|NCT02036450|implantable loop recorder|implantable loop recorder
5331446|NCT02033681|hand|hand
5331539|NCT02033356|MRI|mri
5331633|NCT02032953|anabolism|anabolism
5331734|NCT02032316|UURS|uurs
5331831|NCT02031874|HIV|hiv
5332117|NCT02030249|Diet - reducing|diet - reducing
5332118|NCT02030249|Appetite|appetite
5332119|NCT02030249|Visual analogue scale|visual analogue scale
5332120|NCT02030249|Ghrelin|ghrelin
5332121|NCT02030249|Peptide YY|peptide yy
5332122|NCT02030249|Bone mass|bone mass
5332123|NCT02030249|Bone turnover|bone turnover
5332124|NCT02030249|Muscle strength|muscle strength
5332126|NCT02030236|rewarming|rewarming
5332212|NCT02029989|MTM|mtm
5333158|NCT02025660|Mycobacterium w|mycobacterium w
5333684|NCT02023372|NuCel|nucel
5333881|NCT02022449|Maternal psychosocial stress and distress|maternal psychosocial stress and distress
5333882|NCT02022449|Maternal health outcomes|maternal health outcomes
5333884|NCT02022449|Pediatric cancer|pediatric cancer
5333885|NCT02022410|CAS|cas
5333886|NCT02022410|Length of stay|length of stay
5333888|NCT02022410|TKA|tka
5334086|NCT02021526|Glucose Transporter Type I Deficiency|glucose transporter type i deficiency
5334087|NCT02021513|SLE|sle
5334088|NCT02021513|Fish Oil|fish oil
5334090|NCT02021448|OHS|ohs
5334294|NCT02020304|labor pain|labor pain
5334409|NCT02019745|Live attenuated influenza virus (LAIV)|live attenuated influenza virus (laiv)
5334410|NCT02019745|Flu vaccine|flu vaccine
5334411|NCT02019745|FluMist|flumist
5334412|NCT02019745|Smokers|smokers
5334413|NCT02019745|New and emerging tobacco products|new and emerging tobacco products
5334527|NCT02019225|dialysis|dialysis
5334726|NCT02018302|G1D|g1d
5335041|NCT02016963|HGS1021|hgs1021
5335042|NCT02016963|Immunogenicity|immunogenicity
5335043|NCT02016937|Anesthesia , lactation, birth|anesthesia , lactation, birth
5335044|NCT02016924|Pediatrics|pediatrics
5335045|NCT02016924|Adolescents|adolescents
5335046|NCT02016924|HIV|hiv
5335047|NCT02016924|HIV-1|hiv-1
5335048|NCT02016924|Treatment experienced|treatment experienced
5335049|NCT02016898|Primary open angle glaucoma|primary open angle glaucoma
5335050|NCT02016898|trabeculectomy|trabeculectomy
5335243|NCT02016079|nutrition|nutrition
5335244|NCT02016079|behavior problems|behavior problems
5335245|NCT02016079|externalizing|externalizing
5335246|NCT02016079|internalizing|internalizing
5335247|NCT02016079|antisocial|antisocial
5335347|NCT02015611|Falls|falls
5335451|NCT02015195|Humans|humans
5335653|NCT02014493|Infant, premature|infant, premature
5335654|NCT02014493|Electromyography|electromyography
5335655|NCT02014493|Diaphragm|diaphragm
5335656|NCT02014480|Long-acting beta-agonist|long-acting beta-agonist
5335753|NCT02014103|tacrolimus|tacrolimus
5335883|NCT02013466|Elderly|elderly
5335965|NCT02012985|oxalate|oxalate
5336040|NCT02012699|Healthy Control|healthy control
5336344|NCT02011217|Bread|bread
5336535|NCT02010437|Superficial Venous Insufficiency|superficial venous insufficiency
5336637|NCT02010034|Liver Function|liver function
5929893|NCT03606941|electroacupuncture; delirium; the elderly; surgery, major|electroacupuncture; delirium; the elderly; surgery, major
5337037|NCT02008240|Infertility|infertility
5337038|NCT02008240|Hydrosalpinx|hydrosalpinx
5337131|NCT02007915|Pamidronate|pamidronate
5337628|NCT02005757|European League Against Rheumatism|european league against rheumatism
5337725|NCT02005289|Prolymphocytic Leukemia|prolymphocytic leukemia
5337726|NCT02005289|MOR00208|mor00208
5337727|NCT02005289|MOR208|mor208
5337728|NCT02005276|Sedentary|sedentary
5337730|NCT02005276|Team Studies|team studies
5338227|NCT02002754|bronchodilator|bronchodilator
5338237|NCT02002715|eosinophilic bronchitis|eosinophilic bronchitis
5338238|NCT02002715|inhaled corticosteroids|inhaled corticosteroids
5338239|NCT02002715|therapeutic effect|therapeutic effect
5338240|NCT02002702|Acute heart failure (AHF),|acute heart failure (ahf),
5338520|NCT02001532|Stroke|stroke
5929946|NCT03598608|programmed cell death 1 (PD-1, PD1)|programmed cell death 1 (pd-1, pd1)
5929947|NCT03598608|programmed cell death ligand 1 (PD-L1, PDL1)|programmed cell death ligand 1 (pd-l1, pdl1)
5929948|NCT03598608|programmed cell death ligand 2 (PD-L2, PDL2)|programmed cell death ligand 2 (pd-l2, pdl2)
5929958|NCT03595176|Intravascular Lithotripsy|intravascular lithotripsy
5929959|NCT03595176|Percutaneous Coronary Intervention|percutaneous coronary intervention
5929965|NCT03593785|Cholesterol|cholesterol
5929966|NCT03593785|Biomarkers|biomarkers
5338620|NCT02001051|Diabetes, Hypertension, Hypercholesterolemia, Obesity, and Osteoporosis.|diabetes, hypertension, hypercholesterolemia, obesity, and osteoporosis.
5930020|NCT03588546|Fasenra Benralizumab Bronchial asthma|fasenra benralizumab bronchial asthma
5930021|NCT03588299|Severe hemophilia A (<1% FVIII activity)|severe hemophilia a (<1% fviii activity)
5930022|NCT03588299|Factor VIII gene therapy|factor viii gene therapy
5930029|NCT03582826|systemic malodor|systemic malodor
5930030|NCT03582826|body odor|body odor
5930031|NCT03582826|bad breath|bad breath
5930032|NCT03582826|PATM|patm
5930033|NCT03582826|microbiome|microbiome
5930034|NCT03582826|TMAU|tmau
5930035|NCT03582826|Malabsorption|malabsorption
5930036|NCT03582826|Dysbiosis|dysbiosis
5930053|NCT03580083|MPS I , gene therapy, Hurler, Hurler- Scheie|mps i , gene therapy, hurler, hurler- scheie
5930060|NCT03575611|Malignant neoplasms of urinary tract|malignant neoplasms of urinary tract
5930061|NCT03575611|Oligometastatic renal cell carcinoma|oligometastatic renal cell carcinoma
5930063|NCT03575611|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5930064|NCT03575611|SBRT|sbrt
5930065|NCT03575611|XRT|xrt
5930066|NCT03575611|Radiation therapy|radiation therapy
5930067|NCT03575390|Pomegranate|pomegranate
5895617|NCT03261856|SIBO|sibo
5338621|NCT02001051|Nonoperative and Operative Management|nonoperative and operative management
5338717|NCT02000648|Chronic urticaria|chronic urticaria
5338914|NCT01999868|ustekinumab|ustekinumab
5339017|NCT01999244|Self-monitoring|self-monitoring
5339114|NCT01998789|Liver Transplantation|liver transplantation
5339115|NCT01998789|Everolimus|everolimus
5339117|NCT01998776|ulcer|ulcer
5339626|NCT01996579|Critically Ill|critically ill
5339627|NCT01996579|Intensive care|intensive care
5339629|NCT01996579|Orogastric tube|orogastric tube
5339823|NCT01995942|EMVI|emvi
5339925|NCT01995422|Anxiety|anxiety
5339939|NCT01995370|Aspirin|aspirin
5340247|NCT01993849|Anxiety|anxiety
5340515|NCT01992419|cardiac arrest phone detection|cardiac arrest phone detection
5340517|NCT01992393|Schizophrenia|schizophrenia
5340909|NCT01990534|Neoplasms|neoplasms
5341003|NCT01990066|Physical Function|physical function
5341300|NCT01988610|cognition|cognition
5341301|NCT01988610|prediabetes|prediabetes
5341302|NCT01988610|mood|mood
5341303|NCT01988597|Dry Eyes|dry eyes
5341304|NCT01988597|Quality of life|quality of life
5341305|NCT01988597|Utility assessment|utility assessment
5341306|NCT01988584|Cerebral Palsy|cerebral palsy
5341307|NCT01988584|Brain Injury|brain injury
5341308|NCT01988584|Stem Cells|stem cells
5341309|NCT01988584|Mononuclear Cells|mononuclear cells
5341310|NCT01988584|Bone Marrow|bone marrow
5341491|NCT01987817|OIT|oit
5341515|NCT01987661|Ventimotion2|ventimotion2
5341516|NCT01987648|Craniotomy|craniotomy
5341517|NCT01987648|Postoperative complications|postoperative complications
5341518|NCT01987648|Perioperative care|perioperative care
5341519|NCT01987648|Postoperative intracerebral hemorrhage|postoperative intracerebral hemorrhage
5341520|NCT01987648|Postoperative seizure|postoperative seizure
5341521|NCT01987635|Mitral valve disease|mitral valve disease
5341522|NCT01987635|primarily regurgitation|primarily regurgitation
5341523|NCT01987635|necessitating surgical repair|necessitating surgical repair
5341524|NCT01987622|lumbar spinal stenosis|lumbar spinal stenosis
5341525|NCT01987622|claudication|claudication
5341526|NCT01987622|low back pain|low back pain
5341527|NCT01987622|radiculopathy|radiculopathy
5341528|NCT01987622|acupuncture|acupuncture
5341529|NCT01987622|Korean medicine|korean medicine
5341594|NCT01987271|noninvasive ventilation|noninvasive ventilation
5341596|NCT01987258|excess post-exercise oxygen consumption|excess post-exercise oxygen consumption
5342417|NCT01983592|Cancer|cancer
5342418|NCT01983553|Dengue Virus|dengue virus
5342419|NCT01983553|Dengue Fever|dengue fever
5342420|NCT01983553|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5342421|NCT01983553|CYD Dengue Vaccine|cyd dengue vaccine
5342422|NCT01983540|Diphtheria|diphtheria
5343054|NCT01980836|Tocilizumab|tocilizumab
5343462|NCT01978522|postal questionnaires|postal questionnaires
5343463|NCT01978522|return rates|return rates
5343466|NCT01978483|Adult|adult
5343467|NCT01978483|skin|skin
5343468|NCT01978483|metabolism|metabolism
5343469|NCT01978483|radiation effects|radiation effects
5343470|NCT01978483|Ultraviolet Rays|ultraviolet rays
5343471|NCT01978483|RANKL|rankl
5343472|NCT01978483|RANK Ligand|rank ligand
5343522|NCT01978327|Lp-PLA2|lp-pla2
5343555|NCT01978262|cytokines|cytokines
5343556|NCT01978262|hormones|hormones
5343557|NCT01978262|progesterone|progesterone
5343558|NCT01978249|Colorectal cancer|colorectal cancer
5343559|NCT01978249|Primary tumor resection|primary tumor resection
5343560|NCT01978249|Chemotherapy|chemotherapy
5343561|NCT01978249|Overall survival|overall survival
5343562|NCT01978249|Quality of life|quality of life
5343567|NCT01978236|BRAF inhibitor|braf inhibitor
5343960|NCT01976819|HME|hme
5344256|NCT01975493|Neonatology|neonatology
5344257|NCT01975493|Pharmacokinetics|pharmacokinetics
5344258|NCT01975493|Antimicrobials|antimicrobials
5344259|NCT01975467|midshaft clavicle fracture|midshaft clavicle fracture
5344260|NCT01975467|intramedullary nail|intramedullary nail
5344261|NCT01975467|sling|sling
5345061|NCT01971684|health-related quality of life|health-related quality of life
5345062|NCT01971684|HRQL|hrql
5345063|NCT01971684|Purpura|purpura
5345064|NCT01971684|Purpura, Thrombocytopenic|purpura, thrombocytopenic
5345065|NCT01971684|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5345066|NCT01971684|Blood Coagulation Disorders|blood coagulation disorders
5345067|NCT01971684|Hematologic Diseases|hematologic diseases
5345068|NCT01971684|Hemorrhage|hemorrhage
5345069|NCT01971684|Skin Manifestations|skin manifestations
5345070|NCT01971684|Thrombocytopenia|thrombocytopenia
5345071|NCT01971684|Blood Platelet Disorders|blood platelet disorders
5345072|NCT01971684|Immune System Diseases|immune system diseases
5345142|NCT01971398|Attitudes|attitudes
5345143|NCT01971359|Stroke, Intracerebral Hemorrhage, ICH|stroke, intracerebral hemorrhage, ich
5345144|NCT01971346|Psoriasis|psoriasis
5345145|NCT01971346|ENBREL|enbrel
5345146|NCT01971346|etanercept|etanercept
5345147|NCT01971346|anti-TNF|anti-tnf
5345148|NCT01971333|pulse pressure variation|pulse pressure variation
5345149|NCT01971333|stroke volume variation|stroke volume variation
5345150|NCT01971333|plethysmographic variation index|plethysmographic variation index
5345151|NCT01971333|fluid responsiveness|fluid responsiveness
5345152|NCT01971294|Urinary symptoms|urinary symptoms
5345153|NCT01971294|Systemic sclerosis|systemic sclerosis
5345154|NCT01971294|Severity index|severity index
5345155|NCT01971294|Urinary tract infection|urinary tract infection
5345156|NCT01971294|mortality|mortality
5345157|NCT01971294|Quality of life|quality of life
5345158|NCT01971281|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5345159|NCT01971281|Pancreas tumor|pancreas tumor
5345328|NCT01970501|Metoprolol|metoprolol
5345329|NCT01970501|Metoprolol succinate|metoprolol succinate
5345421|NCT01970072|Remimazolam Tosylate|remimazolam tosylate
5345524|NCT01969669|Refractory|refractory
5345525|NCT01969669|ABT-199|abt-199
5345526|NCT01969669|Pharmacokinetics|pharmacokinetics
5345527|NCT01969669|Cancer|cancer
5345528|NCT01969656|vitamin D analog|vitamin d analog
5345538|NCT01969630|femoropopliteal lesions|femoropopliteal lesions
5345539|NCT01969604|Rheumatoid Arthritis|rheumatoid arthritis
5345540|NCT01969604|Sedentary Behaviour|sedentary behaviour
5345541|NCT01969604|Motivational Counselling|motivational counselling
5345622|NCT01969279|Side effect|side effect
5345623|NCT01969266|Healthy volunteer|healthy volunteer
5345624|NCT01969266|PCI-32765|pci-32765
5345625|NCT01969266|PCI 45227|pci 45227
5345626|NCT01969266|JNJ-54179060|jnj-54179060
5345627|NCT01969266|Pharmacokinetic|pharmacokinetic
5345828|NCT01968226|RDG-K5|rdg-k5
5346251|NCT01966796|drug-resistant bacteria|drug-resistant bacteria
5346344|NCT01966367|Histiocytic Syndrome|histiocytic syndrome
5346470|NCT01965704|NAS|nas
5346656|NCT01964833|PDT|pdt
5346749|NCT01964443|Alexithymia|alexithymia
5346863|NCT01964014|once|once
5347005|NCT01963429|RFA|rfa
5347054|NCT01963156|Quality improvement|quality improvement
5347055|NCT01963130|Vildagliptin|vildagliptin
5347056|NCT01963130|Portal Vein Pressure|portal vein pressure
5347057|NCT01963130|Hepatosteatosis|hepatosteatosis
5347437|NCT01961648|Apnea|apnea
5347752|NCT01960192|primary CNS lymphoma;chemotherapy;|primary cns lymphoma;chemotherapy;
5347753|NCT01960192|RR;PFS;OS|rr;pfs;os
5347754|NCT01960153|Heart failure|heart failure
5347943|NCT01959126|Telomere length|telomere length
5347944|NCT01959126|Psychological Sress|psychological sress
5347945|NCT01959126|Mindfulness|mindfulness
5347946|NCT01959113|Microbiome|microbiome
5347947|NCT01959113|Bacteria transplant|bacteria transplant
5347948|NCT01959113|Atopic dermatitis treatments|atopic dermatitis treatments
5347949|NCT01959100|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5347950|NCT01959100|pulmonary non-infectious complications|pulmonary non-infectious complications
5347951|NCT01959100|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5347953|NCT01959087|Colonic surgery|colonic surgery
5347954|NCT01959087|Postoperative morbidity|postoperative morbidity
5347955|NCT01959087|Postoperative outcomes|postoperative outcomes
5347956|NCT01959061|Advanced colorectal cancer of liver metastatic|advanced colorectal cancer of liver metastatic
5347961|NCT01959022|PTSD|ptsd
5352254|NCT01938716|PK|pk
5348423|NCT01956591|Tachyphylaxis|tachyphylaxis
5348424|NCT01956591|Undesirable effects|undesirable effects
5348425|NCT01956591|Side effects|side effects
5348426|NCT01956591|Self-assessment|self-assessment
5348441|NCT01956513|ADC|adc
5348619|NCT01955525|mortality|mortality
5348915|NCT01954277|TNF|tnf
5349060|NCT01953705|MRI|mri
5349127|NCT01953341|Migraine|migraine
5349265|NCT01952652|day case surgery|day case surgery
5349266|NCT01952626|intrathecal|intrathecal
5349267|NCT01952626|morphine|morphine
5349268|NCT01952626|ondansetron|ondansetron
5349269|NCT01952626|palonosetron|palonosetron
5349270|NCT01952626|pruritus|pruritus
5349271|NCT01952613|Foot drop|foot drop
5349369|NCT01952067|cements|cements
5349370|NCT01952067|Radiostereometric Analysis|radiostereometric analysis
5349471|NCT01951638|Worsening Heart Failure|worsening heart failure
5349525|NCT01951404|MRI|mri
5349676|NCT01950533|Egg allergy|egg allergy
5349776|NCT01950104|Blastocyst stage|blastocyst stage
5349777|NCT01950104|Day 3|day 3
5349778|NCT01950104|Preimplantation genetic screening|preimplantation genetic screening
5349779|NCT01950091|low back pain|low back pain
5349780|NCT01950091|internet|internet
5349782|NCT01950091|prevention|prevention
5349783|NCT01950091|treatment|treatment
5349968|NCT01949181|Lung cancer|lung cancer
5350120|NCT01948453|FMD|fmd
5350176|NCT01948193|Tetanus|tetanus
5350469|NCT01946919|Safety|safety
5354787|NCT01926769|5FU|5fu
5350946|NCT01944501|tinnitus|tinnitus
5351040|NCT01944150|Hypnosis|hypnosis
5351041|NCT01944150|chronic pain|chronic pain
5351042|NCT01944150|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5351043|NCT01944150|nociceptive pain|nociceptive pain
5351044|NCT01944150|neuropathic pain|neuropathic pain
5351045|NCT01944150|complementary therapies|complementary therapies
5351046|NCT01944137|colonic neoplasms|colonic neoplasms
5351239|NCT01943409|length of stay|length of stay
5352054|NCT01939613|multiple organ dysfunction|multiple organ dysfunction
5352055|NCT01939613|intra-abdominal pressure|intra-abdominal pressure
5352056|NCT01939600|Resistant starch|resistant starch
5352066|NCT01939574|PFS|pfs
5352196|NCT01938989|IOL|iol
5352557|NCT01937208|Esophageal Carcinoma|esophageal carcinoma
5352558|NCT01937208|chemoradiation|chemoradiation
5352559|NCT01937208|radiation dose|radiation dose
5352560|NCT01937195|IV Catheter comparison|iv catheter comparison
5352561|NCT01937195|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
5352562|NCT01937195|IV Catheter Study|iv catheter study
5352751|NCT01936207|syndrome|syndrome
5353469|NCT01932957|Laparoscopy|laparoscopy
5353470|NCT01932957|Ruptured ectopic pregnancy|ruptured ectopic pregnancy
5353471|NCT01932931|Vitamin D|vitamin d
5353634|NCT01932138|HIV|hiv
5353649|NCT01932086|Bread|bread
5353881|NCT01931150|rash|rash
5354052|NCT01930409|Femoral Fractures|femoral fractures
5354066|NCT01930357|Rabies|rabies
5354468|NCT01928238|NIV|niv
5354772|NCT01926860|Epaxal|epaxal
5354960|NCT01925950|BDP|bdp
5355056|NCT01925573|Brain Tumor|brain tumor
5355057|NCT01925534|Optiflow|optiflow
5355058|NCT01925534|Humidified high-flow oxygen therapy|humidified high-flow oxygen therapy
5355059|NCT01925534|Noninvasive ventilation|noninvasive ventilation
5355060|NCT01925534|Acute respiratory failure|acute respiratory failure
5355061|NCT01925534|Standard oxygen therapy|standard oxygen therapy
5355062|NCT01925521|Intestinal Infection|intestinal infection
5355063|NCT01925495|otitis media|otitis media
5355147|NCT01925209|controlled clinical trial,|controlled clinical trial,
5355148|NCT01925209|randomized,|randomized,
5355149|NCT01925209|body mass,|body mass,
5355150|NCT01925209|muscle function,|muscle function,
5355151|NCT01925209|strength,|strength,
5355152|NCT01925209|performance,|performance,
5355153|NCT01925209|physical function|physical function
5355154|NCT01925196|Motor Neuron Disease|motor neuron disease
5355155|NCT01925196|Frontotemporal Dementia|frontotemporal dementia
5355156|NCT01925196|Cognitive Testing|cognitive testing
5355159|NCT01925183|Boceprevir|boceprevir
5355259|NCT01924780|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5355260|NCT01924754|HPV|hpv
5355261|NCT01924754|Gardasil|gardasil
5355262|NCT01924754|seroconversion|seroconversion
5355263|NCT01924741|Liver neoplasms|liver neoplasms
5355264|NCT01924741|Liver regeneration|liver regeneration
5355265|NCT01924715|somatoform disorder|somatoform disorder
5355266|NCT01924715|psychotherapy|psychotherapy
5355267|NCT01924715|depression|depression
5355268|NCT01924715|anxiety|anxiety
5355357|NCT01924390|Tooth extraction|tooth extraction
5355358|NCT01924377|AF|af
5681134|NCT00574587|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5355359|NCT01924364|Craniomaxillofacial (CMF) Battle-injured (BI)|craniomaxillofacial (cmf) battle-injured (bi)
5355360|NCT01924364|Facial Trauma|facial trauma
5355361|NCT01924364|Fat Grafts|fat grafts
5355363|NCT01924364|Wounded warriors|wounded warriors
5355549|NCT01923467|internet|internet
5355798|NCT01922284|HIV|hiv
5355852|NCT01922063|randomized|randomized
5356353|NCT01919944|itch|itch
5356456|NCT01919554|House Dust Mite Allergen Extract|house dust mite allergen extract
5356457|NCT01919541|Colorectal Surgery|colorectal surgery
5356459|NCT01919528|catheterization|catheterization
5356460|NCT01919528|central line|central line
5356461|NCT01919528|mechanical ventilation|mechanical ventilation
5356462|NCT01919528|intensive care|intensive care
5356463|NCT01919528|axillary vein|axillary vein
5356464|NCT01919515|pediatric|pediatric
5356483|NCT01919450|PET|pet
5356561|NCT01919008|FK949E|fk949e
5356654|NCT01918553|risk factors|risk factors
5356655|NCT01918553|cohort study|cohort study
5356656|NCT01918540|Radiostereometry|radiostereometry
5356657|NCT01918540|Total Hip Arthroplasty|total hip arthroplasty
5356658|NCT01918540|Stem design|stem design
5356662|NCT01918514|epidural|epidural
5357139|NCT01916460|Interstitial cell of Cajal|interstitial cell of cajal
5357140|NCT01916447|Angiogenesis Inhibitor|angiogenesis inhibitor
5357331|NCT01915498|relapse AML|relapse aml
5357332|NCT01915498|refractory AML|refractory aml
5357333|NCT01915472|Metastatic Colorectal Cancer|metastatic colorectal cancer
5357334|NCT01915472|Colorectal Cancer|colorectal cancer
5357625|NCT01914224|Sodium|sodium
5357822|NCT01913067|HER2 negative|her2 negative
5357823|NCT01913067|NSCLC|nsclc
5357824|NCT01913054|Etomidate|etomidate
5357825|NCT01913054|Propofol|propofol
5357826|NCT01913054|Painless gastroscopy|painless gastroscopy
5357827|NCT01913041|perioperative hypothermia|perioperative hypothermia
5357914|NCT01912573|narcotics|narcotics
5358023|NCT01911988|Metastasis|metastasis
5358024|NCT01911975|Small Fiber Neuropathy|small fiber neuropathy
5358025|NCT01911975|Painful Neuropathy|painful neuropathy
5358026|NCT01911975|NAV1.7 Voltage-Gated Sodium Channel|nav1.7 voltage-gated sodium channel
5358027|NCT01911975|SCN9A|scn9a
5358028|NCT01911949|femoral nerve block|femoral nerve block
5358123|NCT01911494|eclampsia|eclampsia
5358225|NCT01910987|Velcade|velcade
5358327|NCT01910493|mhealth|mhealth
5358544|NCT01909492|MS|ms
5358616|NCT01909232|Major depression|major depression
5359526|NCT01904526|Guanfacine|guanfacine
5359704|NCT01903811|carfilzomib|carfilzomib
5359714|NCT01903733|CML|cml
5359802|NCT01903213|Bixalomer|bixalomer
5359803|NCT01903213|Chronic renal failure patients with Hyperphosphatemia|chronic renal failure patients with hyperphosphatemia
5359804|NCT01903213|Kiklin®|kiklin®
5359805|NCT01903200|Antipsychotic|antipsychotic
5359806|NCT01903200|FK949E|fk949e
5359807|NCT01903200|Quetiapine|quetiapine
5359808|NCT01903200|Elderly|elderly
5359809|NCT01903187|hypertension|hypertension
5359810|NCT01903187|resistant hypertension|resistant hypertension
5359811|NCT01903187|renal denervation|renal denervation
5359812|NCT01903174|Breast Cancer|breast cancer
5359888|NCT01902849|interleukins|interleukins
5359889|NCT01902849|colorectal surgery|colorectal surgery
5359890|NCT01902836|Dialyzable Leukocyte Extracts|dialyzable leukocyte extracts
5360089|NCT01901913|Closed loop|closed loop
5360187|NCT01901458|peripheral blood stem cells|peripheral blood stem cells
5360188|NCT01901445|Quality of life|quality of life
5360189|NCT01901445|Constipation|constipation
5360617|NCT01899586|Exercise Independence|exercise independence
5360820|NCT01898468|Intracostal Closure Technique|intracostal closure technique
5360914|NCT01898039|malignant melanoma|malignant melanoma
5361414|NCT01895530|immune function|immune function
5361415|NCT01895530|bacterial translocation|bacterial translocation
5361416|NCT01895530|gastrointestinal surgery|gastrointestinal surgery
5361417|NCT01895504|Colonoscopy|colonoscopy
5361418|NCT01895504|Colorectal cancer|colorectal cancer
5361419|NCT01895504|Adenoma|adenoma
5361420|NCT01895478|asthma|asthma
5361421|NCT01895478|pediatrics|pediatrics
5361422|NCT01895478|control|control
5361423|NCT01895478|medication adherence|medication adherence
5361424|NCT01895465|urine collection, contamination|urine collection, contamination
5361425|NCT01895452|Schizophrenia|schizophrenia
5361426|NCT01895439|Bone marrow derived Mesenchymal Stem Cells|bone marrow derived mesenchymal stem cells
5361427|NCT01895439|Multiple Sclerosis|multiple sclerosis
5361428|NCT01895439|Oligodendrocytes|oligodendrocytes
5361429|NCT01895439|Neuroimmunology|neuroimmunology
5361430|NCT01895439|Autoimmune disease|autoimmune disease
5361431|NCT01895413|Cartilage injury|cartilage injury
5361432|NCT01895413|Osteoarthritis|osteoarthritis
5361433|NCT01895413|Mesenchymal stem cells|mesenchymal stem cells
5361434|NCT01895400|Renexin for Recurrent Vestibulopathy|renexin for recurrent vestibulopathy
5361435|NCT01895374|Laser therapy|laser therapy
5361436|NCT01895374|Biological dressing|biological dressing
5361437|NCT01895374|Amniotic membrane|amniotic membrane
5361438|NCT01895374|Hydrocolloid bandages|hydrocolloid bandages
5361439|NCT01895374|wound healing|wound healing
5361440|NCT01895361|SelG1|selg1
5361441|NCT01895361|P-selectin|p-selectin
5361442|NCT01895361|monoclonal antibody|monoclonal antibody
5361443|NCT01895361|sickle cell disease|sickle cell disease
5361444|NCT01895361|sickle cell anemia|sickle cell anemia
5361445|NCT01895361|sickle cell|sickle cell
5361446|NCT01895361|pain crisis|pain crisis
5361447|NCT01895361|pain crises|pain crises
5361448|NCT01895361|vasoocclusion|vasoocclusion
5361449|NCT01895361|vaso-occlusion|vaso-occlusion
5361450|NCT01895361|priapism|priapism
5361478|NCT01895244|scleroderma|scleroderma
5361479|NCT01895244|autologous stem cell transplantation|autologous stem cell transplantation
5361480|NCT01895244|thiotepa|thiotepa
5361481|NCT01895244|cluster of differentiation (CD) 34 selection|cluster of differentiation (cd) 34 selection
5361483|NCT01895192|vacuoles|vacuoles
5361858|NCT01893671|HOA|hoa
5361931|NCT01893320|MDS|mds
5362098|NCT01892644|Ferritin|ferritin
5362099|NCT01892644|Transfusional siderosis|transfusional siderosis
5362100|NCT01892631|Text messaging|text messaging
5362101|NCT01892605|Mozart K.448|mozart k.448
5362190|NCT01892137|Actinic Keratosis|actinic keratosis
5362289|NCT01891812|Emergency department|emergency department
5362479|NCT01891097|Insomnia|insomnia
5362480|NCT01891097|Acupuncture|acupuncture
5362481|NCT01891097|Electroacupuncture|electroacupuncture
5362487|NCT01891084|Fever|fever
5362858|NCT01889420|relapse|relapse
5362859|NCT01889420|refractory|refractory
5362860|NCT01889420|relapsed|relapsed
5362861|NCT01889420|pomalidomide|pomalidomide
5362862|NCT01889420|pomalyst|pomalyst
5362863|NCT01889420|everolimus|everolimus
5362864|NCT01889420|afinitor|afinitor
5362868|NCT01889394|excision|excision
5362955|NCT01889056|Exercise|exercise
5362956|NCT01889043|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5362965|NCT01889004|EEG|eeg
5363167|NCT01887977|MRI|mri
5363254|NCT01887535|JNJ-54861911|jnj-54861911
5363654|NCT01885637|Caregivers|caregivers
5363655|NCT01885637|Home Care Services, Hospital-Based|home care services, hospital-based
5363656|NCT01885637|Psychological|psychological
5363657|NCT01885637|From Oncological Treatment to Palliative Care at Home|from oncological treatment to palliative care at home
5363658|NCT01885637|Place of death|place of death
5363659|NCT01885624|TAB08|tab08
5363660|NCT01885624|healthy volunteers|healthy volunteers
5363875|NCT01884545|type 2 diabetes|type 2 diabetes
5363876|NCT01884545|genetic testing|genetic testing
5363877|NCT01884545|health coaching|health coaching
5363878|NCT01884545|risk assessment|risk assessment
5363879|NCT01884532|Adverse Local Tissue Reaction|adverse local tissue reaction
5363880|NCT01884532|Metal Ions|metal ions
5363882|NCT01884532|Whole Blood|whole blood
5363883|NCT01884532|Metal-on-Metal|metal-on-metal
5363884|NCT01884532|Total Hip Arthroplasty|total hip arthroplasty
5363885|NCT01884532|ASR-XL Metal-on-Metal|asr-xl metal-on-metal
5363962|NCT01884220|Cholesteryl Ester Storage Disease|cholesteryl ester storage disease
5363963|NCT01884220|Enzyme deficiency|enzyme deficiency
5364189|NCT01883362|SCT|sct
5364258|NCT01883076|HLHS|hlhs
5364357|NCT01882608|ecological momentary assessment|ecological momentary assessment
5364358|NCT01882595|Nebulization aerosol nebulizer tracheostomy|nebulization aerosol nebulizer tracheostomy
5364359|NCT01882556|Early treatment of spasticity.|early treatment of spasticity.
5364551|NCT01881802|Morphine|morphine
5364853|NCT01880684|Thermodilution|thermodilution
5364854|NCT01880684|Blood Volume|blood volume
5364855|NCT01880684|Cardiac Output|cardiac output
5364857|NCT01880684|Capnography|capnography
5364858|NCT01880684|Blood Pressure|blood pressure
5364952|NCT01880281|Healthy volunteers|healthy volunteers
5364953|NCT01880255|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5364954|NCT01880255|Schizophrenia|schizophrenia
5364955|NCT01880255|Cognition|cognition
5365259|NCT01878929|pollen|pollen
5365425|NCT01878240|endovascular|endovascular
5365426|NCT01878214|Health communication|health communication
5930263|NCT03565796|Smoking cessation|smoking cessation
5930264|NCT03565796|Quit to Win|quit to win
5930265|NCT03565796|Brief intervention|brief intervention
5930266|NCT03565796|Financial incentive|financial incentive
5930267|NCT03565796|Active referral|active referral
5930268|NCT03565796|AWARD model|award model
5930315|NCT03557281|Early bactericidal activity|early bactericidal activity
5930316|NCT03557281|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5930317|NCT03557281|GSK3036656|gsk3036656
5930318|NCT03557281|Pulmonary tuberculosis|pulmonary tuberculosis
5930319|NCT03557281|Colony forming units|colony forming units
5365427|NCT01878214|Smoking cessation|smoking cessation
5365428|NCT01878214|Health behavior|health behavior
5365429|NCT01878214|Construction industry|construction industry
5365430|NCT01878214|Audience segmentation|audience segmentation
5365431|NCT01878201|Fimasartan|fimasartan
5930355|NCT03551691|pancreatic enzyme|pancreatic enzyme
5930363|NCT03549754|Registry|registry
5930364|NCT03549754|Type 2 Diabetes|type 2 diabetes
5930365|NCT03549754|T2DM|t2dm
5930366|NCT03549754|Adult population|adult population
5930375|NCT03548623|Hypertension|hypertension
5930376|NCT03548623|renal denervation|renal denervation
5930377|NCT03548623|preference|preference
5930378|NCT03548623|shared decision making|shared decision making
5896198|NCT03162627|Selumetinib|selumetinib
5365432|NCT01878201|24 hours ABP monitoring(ABPM)|24 hours abp monitoring(abpm)
5365815|NCT01876394|Arterial Stiffness|arterial stiffness
5366232|NCT01874756|schizophrenia|schizophrenia
5366235|NCT01874756|negative symptoms|negative symptoms
5366331|NCT01874132|Lipids|lipids
5366444|NCT01873703|MDS|mds
5366641|NCT01872845|BES|bes
5366836|NCT01871974|FK949E|fk949e
5366837|NCT01871974|Antipsychotic|antipsychotic
5366838|NCT01871974|Quetiapine|quetiapine
5366839|NCT01871909|Physical trauma|physical trauma
5366840|NCT01871896|Surgical Endoscopy|surgical endoscopy
5367523|NCT01868477|myelodysplastic syndrome|myelodysplastic syndrome
5367524|NCT01868477|MDS|mds
5367637|NCT01868048|Multiple Sclerosis|multiple sclerosis
5367638|NCT01868035|radioimmunotherapy|radioimmunotherapy
5367639|NCT01868035|Iodine 131 Tositumomab|iodine 131 tositumomab
5367640|NCT01868022|FGFR1|fgfr1
5367641|NCT01868022|FP1039|fp1039
5367642|NCT01868022|GSK3052230|gsk3052230
5367643|NCT01868022|docetaxel|docetaxel
5367644|NCT01868022|FGFR|fgfr
5367645|NCT01868022|carboplatin|carboplatin
5367646|NCT01868022|HGS1036|hgs1036
5367722|NCT01867645|Critical illness|critical illness
5368145|NCT01865565|neoadjuvant|neoadjuvant
5368146|NCT01865565|imatinib|imatinib
5368645|NCT01863459|ADD|add
5369066|NCT01861535|VIN|vin
5369677|NCT01858779|atrial fibrillation|atrial fibrillation
5369678|NCT01858779|secondary prevention of stroke|secondary prevention of stroke
5369679|NCT01858779|peripheral pulse measurement|peripheral pulse measurement
5369680|NCT01858766|Hepatitis|hepatitis
5369681|NCT01858766|HCV Genotype 1|hcv genotype 1
5369682|NCT01858766|HCV Genotype 2|hcv genotype 2
5369683|NCT01858766|HCV Genotype 3|hcv genotype 3
5369684|NCT01858766|HCV Genotype 4|hcv genotype 4
5369698|NCT01858714|obesity|obesity
5369871|NCT01857960|Cost|cost
5370180|NCT01856920|Calcitonin|calcitonin
5930477|NCT03534453|PARP Inhibitor|parp inhibitor
5930478|NCT03534453|Platinum sensitive|platinum sensitive
5930493|NCT03532009|Heart Failure|heart failure
5370181|NCT01856920|T-cells|t-cells
5370182|NCT01856920|Immune Response|immune response
5370183|NCT01856920|HLA Patients|hla patients
5370184|NCT01856920|Vaccine|vaccine
5370470|NCT01855607|chemotherapy induced neuropathy|chemotherapy induced neuropathy
5370471|NCT01855542|metabolic acidosis, plasmalyte solution, 0.9% normal saline|metabolic acidosis, plasmalyte solution, 0.9% normal saline
5370704|NCT01854619|PDT|pdt
5370778|NCT01854424|Serum Amyloid P|serum amyloid p
5370974|NCT01853761|aerobic exercise|aerobic exercise
5370975|NCT01853722|DCN01|dcn01
5370976|NCT01853722|Ocular Surgical Preparation|ocular surgical preparation
5370977|NCT01853722|Prophylaxis against infection|prophylaxis against infection
5370978|NCT01853722|Pre-operative prep|pre-operative prep
5370979|NCT01853683|General Surgery|general surgery
5370987|NCT01853631|chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5370988|NCT01853631|refractory|refractory
5370989|NCT01853631|recurrent|recurrent
5370990|NCT01853631|aggressive B-cell Lymphoma|aggressive b-cell lymphoma
5370991|NCT01853631|CD19|cd19
5371073|NCT01853332|Adjustment|adjustment
5371171|NCT01852955|Breast|breast
5371276|NCT01852578|Refractory|refractory
5371699|NCT01850706|uNGF|ungf
5371800|NCT01850355|Anxiety|anxiety
5371894|NCT01849913|neck pain|neck pain
5372093|NCT01848977|reperfusion|reperfusion
5372310|NCT01848106|Regado|regado
5372609|NCT01846793|BPO|bpo
5372716|NCT01846247|stroke|stroke
5373507|NCT01842295|Obesity|obesity
5373609|NCT01841814|Osteoporosis|osteoporosis
5373610|NCT01841814|Chemotherapy|chemotherapy
5373611|NCT01841814|Patient with|patient with
5373612|NCT01841775|Hepatitis C, Chronic|hepatitis c, chronic
5373613|NCT01841775|Genotype 2/3|genotype 2/3
5374016|NCT01839838|with|with
5374017|NCT01839838|that has been|that has been
5374018|NCT01839838|surgically excised|surgically excised
5374019|NCT01839825|elderly|elderly
5374020|NCT01839825|fall|fall
5374021|NCT01839825|acute illness|acute illness
5374022|NCT01839825|care giver|care giver
5374023|NCT01839812|Cardiopulmonary bypass|cardiopulmonary bypass
5374024|NCT01839812|Cortisol|cortisol
5374114|NCT01839487|PEGPH20|pegph20
5374208|NCT01839058|Non Cardiac Chest Pain|non cardiac chest pain
5374605|NCT01837329|Pemetrexed Platinum|pemetrexed platinum
5374718|NCT01836913|PET/CT|pet/ct
5374812|NCT01836419|elderly patients|elderly patients
5374813|NCT01836406|ketorolac|ketorolac
5374814|NCT01836406|remote ischemic preconditioning|remote ischemic preconditioning
5374815|NCT01836406|partial nephrectomy|partial nephrectomy
5374816|NCT01836393|Plai|plai
5374817|NCT01836393|Efficacy|efficacy
5374818|NCT01836393|OA knee|oa knee
5374819|NCT01836393|The efficacy study of Plai cream for OA knee|the efficacy study of plai cream for oa knee
5374820|NCT01836367|Actinic Keratosis|actinic keratosis
5374821|NCT01836367|Face|face
5375003|NCT01835457|Iceman|iceman
5375004|NCT01835457|LPS|lps
5375005|NCT01835457|Cortisol|cortisol
5375006|NCT01835457|Catecholamines|catecholamines
5375007|NCT01835444|Physician Assistant|physician assistant
5375494|NCT01833143|Bortezomib|bortezomib
5375495|NCT01833143|KRAS G12D|kras g12d
5375496|NCT01833143|12-222|12-222
5375497|NCT01833117|Dry eye|dry eye
5375605|NCT01832675|Endoscopy|endoscopy
5375606|NCT01832675|Anesthetics, Local|anesthetics, local
5375607|NCT01832675|Bupivacaine|bupivacaine
5375608|NCT01832675|Lidocaine|lidocaine
5375609|NCT01832649|Exercise|exercise
5375610|NCT01832649|Cocaine dependence|cocaine dependence
5375611|NCT01832636|L-Alanyl-L-Glutamine|l-alanyl-l-glutamine
5375612|NCT01832636|Environmental enteric dysfunction|environmental enteric dysfunction
5375613|NCT01832636|Tropical enteropathy|tropical enteropathy
5375614|NCT01832623|Vitamin D|vitamin d
5930494|NCT03532009|Chronic Heart Failure|chronic heart failure
5930495|NCT03532009|Hyperkalaemia|hyperkalaemia
5930526|NCT03524612|Thrombocytopenic|thrombocytopenic
5930528|NCT03524612|Platelets|platelets
5930529|NCT03524612|Bleeding|bleeding
5930530|NCT03524612|ITP|itp
5930531|NCT03524612|eltrombopag|eltrombopag
5930532|NCT03524612|ETB115|etb115
5930533|NCT03524612|induce sustained remission|induce sustained remission
5930534|NCT03524612|refractory or relapsed|refractory or relapsed
5930535|NCT03524612|first-line steroids|first-line steroids
5375615|NCT01832623|bone|bone
5375617|NCT01832623|nutritional status|nutritional status
5930659|NCT03513289|ICU delirium|icu delirium
5930660|NCT03513289|post-intensive care syndrome|post-intensive care syndrome
5930661|NCT03513289|critical illness myopathy|critical illness myopathy
5376217|NCT01829893|bioequivalence|bioequivalence
5376220|NCT01829880|Chronic heart failure|chronic heart failure
5376221|NCT01829880|Bisoprolol|bisoprolol
5376245|NCT01829802|HIV|hiv
5376320|NCT01829399|Subcutaneous axillary local anesthetic|subcutaneous axillary local anesthetic
5376321|NCT01829399|ability to tolerate tourniquet discomfort.|ability to tolerate tourniquet discomfort.
5376323|NCT01829347|liver failure|liver failure
5376324|NCT01829347|acute alcoholic hepatitis|acute alcoholic hepatitis
5376325|NCT01829347|patients failing steroid therapy|patients failing steroid therapy
5376414|NCT01828905|bone graft substitute|bone graft substitute
5376420|NCT01828892|Autologous platelet rich fibrin glue|autologous platelet rich fibrin glue
5376421|NCT01828892|Enterocutaneous fistulas|enterocutaneous fistulas
5376422|NCT01828892|Single low output GI fistulas|single low output gi fistulas
5376904|NCT01827111|Metastatic Melanoma|metastatic melanoma
5376905|NCT01827111|Advanced stage IV melanoma|advanced stage iv melanoma
5376906|NCT01827111|Unresectable stage III mucosal melanoma|unresectable stage iii mucosal melanoma
5376961|NCT01826799|ICU|icu
5376997|NCT01826630|CLn Body Wash|cln body wash
5376998|NCT01826630|CLn BodyWash|cln bodywash
5376999|NCT01826617|Prostate Disease Nomogram|prostate disease nomogram
5377000|NCT01826617|Asian Men|asian men
5377001|NCT01826604|cesarean section|cesarean section
5377002|NCT01826604|Pregnant|pregnant
5377004|NCT01826552|Orsiro hybrid stent|orsiro hybrid stent
5377005|NCT01826552|Drug-eluting stent|drug-eluting stent
5377006|NCT01826552|Zotarolimus-eluting stent|zotarolimus-eluting stent
5377007|NCT01826552|Coronary heart disease|coronary heart disease
5377008|NCT01826552|Cobalt chromium|cobalt chromium
5505148|NCT01274078|CRP|crp
5377009|NCT01826539|Dorsal digital nerve|dorsal digital nerve
5377012|NCT01826539|dorsal digital island flap|dorsal digital island flap
5377081|NCT01826227|18F-FDG|18f-fdg
5377181|NCT01825681|mindfulness|mindfulness
5377182|NCT01825681|help|help
5377183|NCT01825642|Prostate cancer|prostate cancer
5377188|NCT01825629|Pain|pain
5377482|NCT01824082|amputees|amputees
5377585|NCT01823601|Life Management Program|life management program
5377586|NCT01823601|Breathing|breathing
5377889|NCT01822353|egg allergy|egg allergy
5377890|NCT01822353|nut allergy|nut allergy
5377998|NCT01821820|Inflammation|inflammation
5377999|NCT01821820|Oxidative stress|oxidative stress
5378000|NCT01821820|Immune dysfunction|immune dysfunction
5378001|NCT01821820|Metabolites|metabolites
5378002|NCT01821807|spinal anesthesia|spinal anesthesia
5378197|NCT01821001|Menorrhagia|menorrhagia
5378293|NCT01820390|Deep Brain Stimulation (DBS)|deep brain stimulation (dbs)
5378294|NCT01820390|Parkinson's Disease|parkinson's disease
5378295|NCT01820390|Essential Tremor|essential tremor
5378392|NCT01819831|preoperative radiation|preoperative radiation
5378393|NCT01819818|Schizophrenia|schizophrenia
5378394|NCT01819818|Paliperidone palmitate|paliperidone palmitate
5378395|NCT01819818|Invega|invega
5378396|NCT01819818|Sustenna|sustenna
5378397|NCT01819818|Korea|korea
5378808|NCT01817803|kidney|kidney
5379202|NCT01816061|Goals|goals
5379525|NCT01814878|Ultracet|ultracet
5379612|NCT01814475|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5379613|NCT01814475|Progression Free Survival|progression free survival
5379806|NCT01813513|antiviral drugs|antiviral drugs
5379901|NCT01812993|Ischemic stroke, sleep apnea, non-invasive ventilatory treatment|ischemic stroke, sleep apnea, non-invasive ventilatory treatment
5379902|NCT01812980|Influenza|influenza
5379903|NCT01812980|Human Immunodeficiency Virus|human immunodeficiency virus
5379904|NCT01812954|moderate-to-severe psoriasis|moderate-to-severe psoriasis
5379994|NCT01812551|cystic fibrosis|cystic fibrosis
5380224|NCT01811576|TV-1106|tv-1106
5380321|NCT01811134|endovascular procedure; flow diverter stent|endovascular procedure; flow diverter stent
5380322|NCT01811121|Glioblastoma|glioblastoma
5380323|NCT01811121|5ALA|5ala
5380324|NCT01811121|fluorescence|fluorescence
5380325|NCT01811121|resection|resection
5381061|NCT01807650|Wound healing|wound healing
5381062|NCT01807650|Skin grafting|skin grafting
5381063|NCT01807650|Superficial wound|superficial wound
5381066|NCT01807624|Pharmacokinetic|pharmacokinetic
5381271|NCT01806610|BPS804|bps804
5381357|NCT01806077|Cardiovascular Diseases|cardiovascular diseases
5381358|NCT01806077|Vascular Diseases|vascular diseases
5381656|NCT01804777|Amiloride|amiloride
5381657|NCT01804777|Hydrochlorothiazide(HCTZ)|hydrochlorothiazide(hctz)
5381658|NCT01804777|Hypertension|hypertension
5381831|NCT01804270|TMS|tms
5381847|NCT01804257|Patient non-adherence|patient non-adherence
5381849|NCT01804257|Schizophrenia|schizophrenia
5381850|NCT01804257|Telehealth|telehealth
5381851|NCT01804257|Telemedicine|telemedicine
5381854|NCT01804244|Healthy|healthy
5382380|NCT01802177|UVB|uvb
5382673|NCT01800721|HIV|hiv
5382963|NCT01799460|the Comprehensive Treatment Regimen|the comprehensive treatment regimen
5382965|NCT01799447|Intervention study|intervention study
5382991|NCT01799265|OSA|osa
5671950|NCT00613496|hsCRP|hscrp
5383351|NCT01797575|Bipolar Depression|bipolar depression
5383352|NCT01797575|Mood Swings|mood swings
5383356|NCT01797549|functional near infrared spectroscopy|functional near infrared spectroscopy
5383357|NCT01797523|Endometrial cancer|endometrial cancer
5383358|NCT01797523|Advanced or Recurrent Endometrial Carcinoma|advanced or recurrent endometrial carcinoma
5383359|NCT01797523|Metformin|metformin
5930679|NCT03512275|Hidradenitis Suppurativa|hidradenitis suppurativa
5383360|NCT01797523|Letrozole|letrozole
5383361|NCT01797523|Femara|femara
5383362|NCT01797523|Everolimus|everolimus
5383363|NCT01797523|Afinitor|afinitor
5383364|NCT01797523|Zortress|zortress
5383387|NCT01797445|HIV|hiv
5383450|NCT01797159|Prophylactic Cranial Irradiation|prophylactic cranial irradiation
5383451|NCT01797159|PCI|pci
5383452|NCT01797159|Hippocampal-sparing irradiation|hippocampal-sparing irradiation
5383460|NCT01797120|RAD001|rad001
5383732|NCT01795989|MRI|mri
5383763|NCT01795768|Multicentre|multicentre
5383764|NCT01795768|Phase II biomarker study|phase ii biomarker study
5383765|NCT01795755|Horse Assisted Therapy (HAT)|horse assisted therapy (hat)
5383766|NCT01795755|Equine Assisted Psychotherapy (EAP)|equine assisted psychotherapy (eap)
5383767|NCT01795755|clinical trial|clinical trial
5383768|NCT01795755|Randomised Controlled Trial (RCT)|randomised controlled trial (rct)
5383769|NCT01795755|psychotherapy|psychotherapy
5383770|NCT01795742|Asthma|asthma
5383771|NCT01795742|Nebulizers|nebulizers
5383772|NCT01795742|Salbutamol|salbutamol
5384252|NCT01793623|atrial fibrillation|atrial fibrillation
5384540|NCT01792557|Complications|complications
5384541|NCT01792557|Recovery duration|recovery duration
5384542|NCT01792557|Time to return to work|time to return to work
5384543|NCT01792531|children|children
5384545|NCT01792531|treatment|treatment
5384546|NCT01792531|family|family
5384634|NCT01791985|AZD4547|azd4547
5384732|NCT01791556|ART monitoring|art monitoring
5384832|NCT01790997|Bleeding profile|bleeding profile
5385132|NCT01789320|TA|ta
5385946|NCT01785680|SAM|sam
5386134|NCT01784913|cancer|cancer
5386336|NCT01783886|VEGF Trap-Eye|vegf trap-eye
5386531|NCT01782976|Survey|survey
5386337|NCT01783886|best-corrected visual acuity (BCVA)|best-corrected visual acuity (bcva)
5386338|NCT01783860|Azithromycin|azithromycin
5386339|NCT01783860|Doxycycline|doxycycline
5386340|NCT01783860|Posterior Blepharitis|posterior blepharitis
5386341|NCT01783847|Erythropoietin|erythropoietin
5386342|NCT01783847|Traumatic Optic Neuropathy|traumatic optic neuropathy
5386626|NCT01782612|Stress|stress
5386931|NCT01780987|PE|pe
5386928|NCT01781000|MEG|meg
5387017|NCT01780636|Botox|botox
5387018|NCT01780636|Constipation|constipation
5387019|NCT01780623|fatigue|fatigue
5387020|NCT01780623|sleep|sleep
5387021|NCT01780623|quality of life|quality of life
5387022|NCT01780623|light|light
5387023|NCT01780623|cancer|cancer
5387157|NCT01780025|Hearing|hearing
5387246|NCT01779518|HCV|hcv
5387339|NCT01779271|Pelubiprofen|pelubiprofen
5387446|NCT01778816|Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS|achilles tendon, muscle volume, achilles tendon length, force, atrs, hannover, aofas
5387553|NCT01778361|fracture|fracture
5387653|NCT01777789|functional neuroimaging|functional neuroimaging
5387654|NCT01777789|Memory|memory
5387655|NCT01777776|Open-label dose escalation|open-label dose escalation
5518316|NCT01216176|PK|pk
5387657|NCT01777776|LEE011|lee011
5387852|NCT01777100|Sufentanil|sufentanil
5387947|NCT01776658|Ocular pain|ocular pain
5388053|NCT01776229|stress|stress
5388154|NCT01775748|Grape juice|grape juice
5388367|NCT01774734|Randomized trials|randomized trials
5388368|NCT01774721|first-line|first-line
5388369|NCT01774721|locally advanced or metastatic|locally advanced or metastatic
5388370|NCT01774721|non-small cell lung cancer|non-small cell lung cancer
5388371|NCT01774721|epidermal growth factor receptor|epidermal growth factor receptor
5388372|NCT01774721|EGFR|egfr
5388373|NCT01774721|ARCHER|archer
5388374|NCT01774721|mutation|mutation
5388375|NCT01774721|dacomitinib|dacomitinib
5388376|NCT01774721|SFJ|sfj
5388461|NCT01774318|sleep-wake-cycles|sleep-wake-cycles
5388565|NCT01773954|age related macular degeneration|age related macular degeneration
5388679|NCT01773252|RLS|rls
5388954|NCT01772342|Quality of Life|quality of life
5388955|NCT01772342|Air Filters|air filters
5388956|NCT01772303|Pressure Ulcers, diabetic Ulcers, post operational wounds|pressure ulcers, diabetic ulcers, post operational wounds
5388957|NCT01772277|Endoscopic dacryocystorhinostomy|endoscopic dacryocystorhinostomy
5389043|NCT01771978|troponin|troponin
5389135|NCT01771497|Breast CT|breast ct
5389136|NCT01771484|tachycardia|tachycardia
5389137|NCT01771484|pots|pots
5389138|NCT01771484|orthostatic intolerance|orthostatic intolerance
5389335|NCT01770587|Sleep|sleep
5389336|NCT01770587|Behavioral Medicine|behavioral medicine
5930691|NCT03509181|interpretation bias|interpretation bias
5930692|NCT03509181|smartphone|smartphone
5930693|NCT03509181|partial hospital|partial hospital
5389337|NCT01770587|Suicide|suicide
5389338|NCT01770587|Suicidal Ideation|suicidal ideation
5389527|NCT01769729|chronic low back pain|chronic low back pain
5389528|NCT01769716|Global developmental delay|global developmental delay
5389529|NCT01769716|Umbilical cord blood|umbilical cord blood
5389530|NCT01769716|Rehabilitation|rehabilitation
5389531|NCT01769690|PD|pd
5389532|NCT01769690|Parkinson's Disease|parkinson's disease
5389533|NCT01769690|DBS|dbs
5389614|NCT01769261|adverse effects|adverse effects
5389741|NCT01768832|fMRI|fmri
5390020|NCT01767584|Pharmacokinetics|pharmacokinetics
5390243|NCT01766648|Locking|locking
5390340|NCT01766193|Epidemiology|epidemiology
5390540|NCT01765231|Lymphoma|lymphoma
5390633|NCT01764737|SEMA4D|sema4d
5390736|NCT01764243|Alzheimer's Disease|alzheimer's disease
5390737|NCT01764243|Nicotinic Acetylcholine Receptor Agonist|nicotinic acetylcholine receptor agonist
5390738|NCT01764243|Cognitive function|cognitive function
5390739|NCT01764243|Dementia|dementia
5390740|NCT01764243|Central Nervous System Agents|central nervous system agents
5390827|NCT01763892|Neurocognitive Outcomes|neurocognitive outcomes
5390828|NCT01763892|Endothelin 1|endothelin 1
5390829|NCT01763879|Thoracic surgery|thoracic surgery
5390830|NCT01763879|one lung ventilation|one lung ventilation
5390831|NCT01763879|pressure-controlled ventilation|pressure-controlled ventilation
5391012|NCT01763099|Mesenchymal Stem Cells|mesenchymal stem cells
5391113|NCT01762657|Lanzoprazole|lanzoprazole
5391207|NCT01762111|In-Vitro fertilization|in-vitro fertilization
5391208|NCT01762098|In vitro fertilization|in vitro fertilization
5391790|NCT01759329|body weight|body weight
5391209|NCT01762098|Hysteroscopy|hysteroscopy
5391210|NCT01762098|Endometrial biopsy|endometrial biopsy
5391211|NCT01762085|neuropathic diabetic foot ulcer|neuropathic diabetic foot ulcer
5391212|NCT01762085|nerve decompression surgery|nerve decompression surgery
5391213|NCT01762072|homocysteine-vitamin B12-fish oil-ferritin|homocysteine-vitamin b12-fish oil-ferritin
5391214|NCT01762059|bionic pancreas|bionic pancreas
5391215|NCT01762059|artificial pancreas|artificial pancreas
5391217|NCT01762059|glucagon|glucagon
5391218|NCT01762059|continuous glucose monitoring|continuous glucose monitoring
5391220|NCT01762059|outpatient|outpatient
5391285|NCT01761786|Thrombosis|thrombosis
5391286|NCT01761786|Acute Coronary Syndrome|acute coronary syndrome
5391287|NCT01761786|Myocardial Ischemia|myocardial ischemia
5391317|NCT01761643|PrEP|prep
5391681|NCT01759940|cervical block|cervical block
5391682|NCT01759927|Physical activity counselor|physical activity counselor
5391683|NCT01759927|Workplace intervention|workplace intervention
5391774|NCT01759485|Vitamin-D|vitamin-d
5391977|NCT01758445|Breast|breast
5392084|NCT01758003|Physical Activity|physical activity
5392085|NCT01758003|Sedentary Behaviour|sedentary behaviour
5392086|NCT01758003|Healthy Volunteer|healthy volunteer
5392087|NCT01758003|Quality of Life|quality of life
5392088|NCT01758003|Exercise Capacity|exercise capacity
5392089|NCT01758003|Transtheoretical Model|transtheoretical model
5392090|NCT01757990|dental caries|dental caries
5392174|NCT01757561|propofol|propofol
5392373|NCT01756521|moxifloxacin|moxifloxacin
5392581|NCT01755598|Endemic region|endemic region
5392806|NCT01754623|SBRT|sbrt
5392896|NCT01754194|Laparoscopy|laparoscopy
5392897|NCT01754181|Glycemic control algorithm|glycemic control algorithm
5392898|NCT01754181|closed loop|closed loop
5392899|NCT01754181|artificial pancreas|artificial pancreas
5392900|NCT01754168|Parkinson disease|parkinson disease
5392901|NCT01754168|Cognition|cognition
5392902|NCT01754155|Vitamin E|vitamin e
5392904|NCT01754155|RSA|rsa
5392905|NCT01754155|Radiostereometric Analysis|radiostereometric analysis
5392906|NCT01754129|Caregiver|caregiver
5392940|NCT01754038|PRO|pro
5392995|NCT01753648|retinal blood flow|retinal blood flow
5393096|NCT01753024|hemodialysis|hemodialysis
5393097|NCT01753024|mechanical ventilation|mechanical ventilation
5393098|NCT01753011|Stress urinary Incontinence|stress urinary incontinence
5393206|NCT01752647|screening|screening
5393207|NCT01752647|low dose|low dose
5393208|NCT01752647|computed tomography|computed tomography
5393209|NCT01752634|Psoriatic arthritis, PsA, ACR, CASPAR, PASDAS|psoriatic arthritis, psa, acr, caspar, pasdas
5393210|NCT01752621|Acromegaly|acromegaly
5393211|NCT01752621|mortality|mortality
5393212|NCT01752621|morbidity|morbidity
5930738|NCT03504189|Fetal monitoring, Prenatal monitoring|fetal monitoring, prenatal monitoring
5930741|NCT03502824|Chronic wounds|chronic wounds
5930742|NCT03502824|PHMB|phmb
5930743|NCT03502824|Pressure Ulcer|pressure ulcer
5930744|NCT03502824|Wound Management|wound management
5930745|NCT03502824|Collagen|collagen
5930746|NCT03502824|Stage II|stage ii
5930747|NCT03502824|Stage III|stage iii
5930748|NCT03502824|Stage IV|stage iv
5890185|NCT04017312|PEP|pep
5930749|NCT03502824|Pressure Injury|pressure injury
5930766|NCT03499938|Asthma|asthma
5930767|NCT03499938|Bronchiolitis|bronchiolitis
5930768|NCT03499938|Wheezing|wheezing
5930769|NCT03499938|Structured Light Plethysmography|structured light plethysmography
5896950|NCT03001557|sleep|sleep
5393213|NCT01752621|incidence|incidence
5393214|NCT01752621|prevalence|prevalence
5393215|NCT01752608|Depression|depression
5393217|NCT01752608|iPhone|iphone
5393312|NCT01752166|Candidemia|candidemia
5393410|NCT01751633|Spinal Fusion/methods [MeSH]|spinal fusion/methods [mesh]
5393411|NCT01751633|Thoracolumbar fracture management|thoracolumbar fracture management
5393412|NCT01751633|Quality of life|quality of life
5393413|NCT01751633|Functional outcome|functional outcome
5930813|NCT03491696|Depressive disorder|depressive disorder
5930814|NCT03491696|Metyrapone|metyrapone
5930815|NCT03491696|Dexamethasone Suppression Test|dexamethasone suppression test
5930816|NCT03491696|Antidepressive association|antidepressive association
5930817|NCT03491696|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
5930818|NCT03491696|Cortisol|cortisol
5930819|NCT03491696|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5930820|NCT03491696|Serotonin and Norepinephrine Reuptake Inhibitor|serotonin and norepinephrine reuptake inhibitor
5930821|NCT03491462|arimoclomol|arimoclomol
5930822|NCT03491462|ALS|als
5930845|NCT03488329|Hospital readmissions|hospital readmissions
5930846|NCT03488329|Seniors|seniors
5896966|NCT02994953|Avelumab|avelumab
5896967|NCT02994953|M9241|m9241
5896968|NCT02994953|NHS-IL12|nhs-il12
5896969|NCT02994953|Advanced Solid Tumors|advanced solid tumors
5896977|NCT02991690|Hypothermia|hypothermia
5896978|NCT02991690|Cervical Spinal Cord Injury|cervical spinal cord injury
5896979|NCT02991690|Trauma|trauma
5393414|NCT01751607|AF, catheter ablation, non-PV triggers, SNP|af, catheter ablation, non-pv triggers, snp
5393415|NCT01751581|Obesity|obesity
5393416|NCT01751581|Resting Metabolic Rate|resting metabolic rate
5393503|NCT01751217|Telemedicine|telemedicine
5393504|NCT01751165|≥ 50 years of age|≥ 50 years of age
5393505|NCT01751165|Herpes zoster|herpes zoster
5393599|NCT01750671|Morbidity|morbidity
5393600|NCT01750658|Biomarkers|biomarkers
5393601|NCT01750658|Exacerbations|exacerbations
5393602|NCT01750658|COPD|copd
5393603|NCT01750593|radiofrequency|radiofrequency
5393604|NCT01750593|thyroid|thyroid
5394526|NCT01746264|Obesity|obesity
5394623|NCT01745705|Proprioception|proprioception
5394624|NCT01745679|Ceftriaxone|ceftriaxone
5394625|NCT01745679|Adverse drug effects|adverse drug effects
5394626|NCT01745679|Therapeutic monitoring|therapeutic monitoring
5394627|NCT01745679|Meningitis|meningitis
5394628|NCT01745666|Long QT syndrome, stress tests|long qt syndrome, stress tests
5394629|NCT01745640|Multiple myeloma|multiple myeloma
5394630|NCT01745640|dexamethasone|dexamethasone
5394631|NCT01745640|pomalidomide|pomalidomide
5704362|NCT00486031|IBD|ibd
5394632|NCT01745640|response|response
5394633|NCT01745640|safety|safety
5394634|NCT01745640|del 17p|del 17p
5394635|NCT01745640|t 4-14|t 4-14
5394828|NCT01744808|Healthy|healthy
5395550|NCT01741792|bispecific antibody|bispecific antibody
5395551|NCT01741792|anti-CD19|anti-cd19
5395552|NCT01741792|Immunotherapeutic treatment|immunotherapeutic treatment
5395553|NCT01741792|Immunoproliferative disorders|immunoproliferative disorders
5395554|NCT01741779|whole body vibration training|whole body vibration training
5395555|NCT01741779|hypocaloric diet|hypocaloric diet
5395556|NCT01741779|prehypertension|prehypertension
5395600|NCT01741519|PK|pk
5395655|NCT01741311|HIV|hiv
5395883|NCT01740414|pain|pain
5395984|NCT01740024|Immunotherapy|immunotherapy
5396075|NCT01739712|Neurobehavioral|neurobehavioral
5396076|NCT01739699|craniotomy|craniotomy
5396077|NCT01739699|brain surgery|brain surgery
5396078|NCT01739699|acetaminophen|acetaminophen
5396079|NCT01739699|Tylenol|tylenol
5396080|NCT01739686|Quality of Life|quality of life
5396097|NCT01739608|CRC|crc
5396275|NCT01738711|Anxiety|anxiety
5396479|NCT01737931|SPM 962|spm 962
5396480|NCT01737931|rotigotine|rotigotine
5396481|NCT01737931|application site reaction|application site reaction
5396570|NCT01737606|Cerebral pulsatility|cerebral pulsatility
5396679|NCT01737047|Ageing|ageing
5396776|NCT01736722|Magnetic Imaging|magnetic imaging
5396778|NCT01736709|immunogenicity,|immunogenicity,
5396883|NCT01736267|ABI|abi
5397331|NCT01734174|left ventricular volume|left ventricular volume
5397332|NCT01734174|ejection volume|ejection volume
5530443|NCT01166334|Web|web
5397522|NCT01733173|mass in posterior fossa|mass in posterior fossa
5397523|NCT01733173|benign|benign
5397524|NCT01733173|malignant|malignant
5397525|NCT01733173|surgical resection|surgical resection
5930878|NCT03484923|Unresectable|unresectable
5930879|NCT03484923|melanoma|melanoma
5930880|NCT03484923|metastatic melanoma|metastatic melanoma
5930881|NCT03484923|advanced melanoma|advanced melanoma
5930882|NCT03484923|spartalizumab|spartalizumab
5930883|NCT03484923|PDR001|pdr001
5930884|NCT03484923|LAG525|lag525
5930885|NCT03484923|capmatinib|capmatinib
5930886|NCT03484923|INC280|inc280
5930887|NCT03484923|canakinumab|canakinumab
5930888|NCT03484923|ACZ885|acz885
5930889|NCT03484923|ribociclib|ribociclib
5930890|NCT03484923|LEE011|lee011
5930891|NCT03484923|immunotherapy|immunotherapy
5930892|NCT03484923|platform study|platform study
5397526|NCT01733173|MRI|mri
5397527|NCT01733173|fMRI|fmri
5397528|NCT01733173|DTI|dti
5397529|NCT01733173|12-121|12-121
5397530|NCT01733160|Atrial Fibrillation|atrial fibrillation
5397531|NCT01733160|Stroke|stroke
5397532|NCT01733160|Anticoagulants|anticoagulants
5397620|NCT01732887|attention|attention
5397621|NCT01732887|rehabilitation|rehabilitation
5397706|NCT01732341|Self-expanding stent|self-expanding stent
5397707|NCT01732315|Adolescent vaccination|adolescent vaccination
5397708|NCT01732315|Immunization rates|immunization rates
5397710|NCT01732315|Attitudes|attitudes
5397911|NCT01731379|fat|fat
5398003|NCT01730859|Ankle|ankle
5398316|NCT01729416|air|air
5398419|NCT01728974|Pathophysiology|pathophysiology
5398420|NCT01728961|HIV 1|hiv 1
5398421|NCT01728961|NVP|nvp
5398422|NCT01728961|malaria|malaria
5398423|NCT01728961|Children|children
5398424|NCT01728961|Youth|youth
5399031|NCT01726348|HIV-1|hiv-1
5399526|NCT01723904|Rotigotine|rotigotine
5399644|NCT01723319|ADHD|adhd
5399747|NCT01722851|Breast Cancer|breast cancer
5399850|NCT01722344|Vocational rehabilitation|vocational rehabilitation
5399851|NCT01722344|Supported employment|supported employment
5399947|NCT01721798|mg milligram(s)|mg milligram(s)
5400041|NCT01721486|obstructed air passages|obstructed air passages
5400042|NCT01721486|swallowing difficulties|swallowing difficulties
5400139|NCT01721135|pharmacokinetics|pharmacokinetics
5400140|NCT01721135|QTc|qtc
5400141|NCT01721109|Adolescents|adolescents
5400451|NCT01719705|pregabalin|pregabalin
5400545|NCT01719198|adenoma|adenoma
5400750|NCT01718210|GM-CSF|gm-csf
5400751|NCT01718210|recurrent implantation failure|recurrent implantation failure
5400752|NCT01718210|pregnancy rate|pregnancy rate
5400753|NCT01718210|IVF|ivf
5400754|NCT01718197|Severe Asthma|severe asthma
5400755|NCT01718197|Bronchoscopy|bronchoscopy
5400756|NCT01718184|sulcoflex|sulcoflex
5400757|NCT01718184|toric|toric
5400758|NCT01718184|corneal implantation|corneal implantation
5400759|NCT01718171|Appendicitis|appendicitis
5400760|NCT01718171|SIRS|sirs
5400761|NCT01718171|C-reactive protein|c-reactive protein
5400762|NCT01718132|Quality of the anaesthetic care in a PACU|quality of the anaesthetic care in a pacu
5400763|NCT01718132|reduction of postoperative pain|reduction of postoperative pain
5400764|NCT01718132|reduction of postoperative nausea and vomiting|reduction of postoperative nausea and vomiting
5400765|NCT01718132|quality markers|quality markers
5400766|NCT01718106|coronary artery disease|coronary artery disease
5400767|NCT01718106|drug eluting stent|drug eluting stent
5400768|NCT01718106|bioabsorbable polymer|bioabsorbable polymer
5400925|NCT01717664|MS|ms
5401047|NCT01717183|Patient|patient
5401859|NCT01713673|Hyperhidrosis|hyperhidrosis
5402055|NCT01712698|spinal cord injury|spinal cord injury
5402056|NCT01712698|cervical spine|cervical spine
5402057|NCT01712685|Kidney Neoplasm|kidney neoplasm
5402058|NCT01712685|RCC|rcc
5402267|NCT01711645|women|women
5402371|NCT01711229|Ofirmev|ofirmev
5402772|NCT01709292|Biomarkers|biomarkers
5402773|NCT01709292|Papillary thyroid cancer|papillary thyroid cancer
5402775|NCT01709292|BRAF mutated|braf mutated
5402776|NCT01709292|Vemurafenib|vemurafenib
5402777|NCT01709292|PLX4032|plx4032
5402778|NCT01709292|RO5185426|ro5185426
5402779|NCT01709292|Zelboraf™|zelboraf™
5402780|NCT01709279|Ischemic heart failure|ischemic heart failure
5402781|NCT01709279|Myocardial regeneration|myocardial regeneration
5402783|NCT01709253|hpofractionation study using proton beam therapy|hpofractionation study using proton beam therapy
5402784|NCT01709240|Chitosan|chitosan
5402862|NCT01709006|Head and neck cancer|head and neck cancer
5930989|NCT03475342|prevention, postpartum haemorrhage|prevention, postpartum haemorrhage
5930990|NCT03475342|moderate anaemia|moderate anaemia
5930991|NCT03475342|severe anaemia|severe anaemia
5930992|NCT03475342|antifibrinolytic|antifibrinolytic
5930993|NCT03475342|tranexamic acid|tranexamic acid
5930994|NCT03475342|pregnancy|pregnancy
5402863|NCT01708980|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5402864|NCT01708980|Electromyography|electromyography
5402865|NCT01708980|Resistance training|resistance training
5402874|NCT01708876|plasmodium|plasmodium
5402955|NCT01708577|respiration|respiration
5403155|NCT01707758|angiogenesis|angiogenesis
5403156|NCT01707758|tissue remodeling/invasion|tissue remodeling/invasion
5403157|NCT01707732|Obesity|obesity
5403158|NCT01707732|thromboprophylaxis|thromboprophylaxis
5403354|NCT01706939|nasopharynx primary|nasopharynx primary
5403553|NCT01706146|dabigatran|dabigatran
5404164|NCT01703624|pharmacokinetics|pharmacokinetics
5404497|NCT01702168|EST|est
5404498|NCT01702168|Community|community
5404499|NCT01702168|Latino|latino
5404602|NCT01701687|Hazardous alcohol|hazardous alcohol
5405098|NCT01699555|Monoclonal antibody|monoclonal antibody
5405191|NCT01699191|Bifidobacterium breve|bifidobacterium breve
5405192|NCT01699191|Lactobacillus casei|lactobacillus casei
5405194|NCT01699165|rhinitis|rhinitis
5405499|NCT01697787|Treatment, diagnosis|treatment, diagnosis
5405500|NCT01697761|Crohn's disease,acupuncture,moxibustion,inflammation factors|crohn's disease,acupuncture,moxibustion,inflammation factors
5405501|NCT01697748|cesarean section incisions|cesarean section incisions
5405503|NCT01697748|c-section|c-section
5406003|NCT01695109|GLP1|glp1
5406185|NCT01694329|Otitis media|otitis media
5406188|NCT01694277|GIST|gist
5406281|NCT01693874|elderly|elderly
5406282|NCT01693861|Colorectal|colorectal
5406283|NCT01693861|Cancer|cancer
5406284|NCT01693861|Metastatic|metastatic
5406711|NCT01692223|12-167|12-167
5406944|NCT01691235|HCV|hcv
5407119|NCT01690429|Cardiorespiratory risk|cardiorespiratory risk
5407120|NCT01690377|Dendritic Cells|dendritic cells
5407121|NCT01690364|Motor evoked potential monitoring|motor evoked potential monitoring
5407122|NCT01690364|General Anesthesia|general anesthesia
5407123|NCT01690364|Neurosurgery|neurosurgery
5407124|NCT01690364|Cisatracurium|cisatracurium
5407125|NCT01690364|Vecuronium|vecuronium
5407126|NCT01690338|TOFr (train of four ratio)|tofr (train of four ratio)
5407139|NCT01690312|EPA|epa
5407211|NCT01690117|family caregiver|family caregiver
5407314|NCT01689584|PALB2|palb2
5407515|NCT01688557|narrow band imaging|narrow band imaging
5407620|NCT01688232|CD3|cd3
5407921|NCT01686828|obesity|obesity
5407922|NCT01686815|metabolic side effects|metabolic side effects
5407923|NCT01686815|atypical antipsychotics|atypical antipsychotics
5407924|NCT01686815|FSIVGTT|fsivgtt
5407925|NCT01686802|oral morphine|oral morphine
5407926|NCT01686802|ibuprofen|ibuprofen
5408017|NCT01686373|Treatment|treatment
5408228|NCT01685450|adults|adults
5408229|NCT01685437|Peyronie's disease, penile plaque, penile curvature|peyronie's disease, penile plaque, penile curvature
5408230|NCT01685424|Etoricoxib|etoricoxib
5408231|NCT01685424|ARCOXIA|arcoxia
5543567|NCT01113216|CF|cf
5408820|NCT01682746|Low grade Astrocytoma|low grade astrocytoma
5408918|NCT01682525|Ovarian Tissue|ovarian tissue
5409208|NCT01681199|OPG|opg
5409209|NCT01681173|Nutritional support|nutritional support
5409325|NCT01680783|shock|shock
5409714|NCT01678963|AMD|amd
5409801|NCT01678599|Chagas Disease|chagas disease
5409802|NCT01678599|PCR|pcr
5409803|NCT01678599|diagnosis|diagnosis
5409806|NCT01678573|Healthy|healthy
5409807|NCT01678573|Pharmacokinetics|pharmacokinetics
5409808|NCT01678573|Abiraterone acetate|abiraterone acetate
5409809|NCT01678573|Abiraterone|abiraterone
5409811|NCT01678573|Zytiga|zytiga
5409906|NCT01678209|Stimulant|stimulant
5410005|NCT01677728|chemotherapy|chemotherapy
5410006|NCT01677728|cetuximab|cetuximab
5410007|NCT01677728|bevacizumab|bevacizumab
5410008|NCT01677689|oral temperature|oral temperature
5410009|NCT01677689|respiratory symptom|respiratory symptom
5410395|NCT01675895|Hyperbaric Levobupivacaine|hyperbaric levobupivacaine
5410397|NCT01675895|Lidocaine|lidocaine
5410398|NCT01675895|TUR-P|tur-p
5410399|NCT01675882|Food allergy|food allergy
5410400|NCT01675882|Immediate hypersensitivity|immediate hypersensitivity
5410401|NCT01675882|Whole peanut extract|whole peanut extract
5410402|NCT01675882|Allergenic product|allergenic product
5411010|NCT01673178|safety|safety
5411011|NCT01673178|multiple dose|multiple dose
5411012|NCT01673178|intravenous|intravenous
5411013|NCT01673152|Obesity|obesity
5931053|NCT03467516|Metastatic Uveal Melanoma|metastatic uveal melanoma
5931055|NCT03467516|Melanoma|melanoma
5411014|NCT01673152|Overweight|overweight
5411015|NCT01673152|Satiety|satiety
5411016|NCT01673152|Oligofructose|oligofructose
5411100|NCT01672879|HVPG|hvpg
5411205|NCT01672502|rls|rls
5411528|NCT01671150|social cognition|social cognition
5411529|NCT01671150|neural activity|neural activity
5411535|NCT01671124|TG|tg
5411786|NCT01669993|Age|age
5411844|NCT01669746|Hair Loss|hair loss
5412053|NCT01668745|Non-specific effects|non-specific effects
5412054|NCT01668693|Endometrial receptivity|endometrial receptivity
5412055|NCT01668693|recurrent implantation failure|recurrent implantation failure
5412056|NCT01668693|predictor tool|predictor tool
5412058|NCT01668693|customized microarray|customized microarray
5412060|NCT01668680|Metronomic Chemotherapy|metronomic chemotherapy
5412153|NCT01668329|Septic shock|septic shock
5412154|NCT01668329|Inflammatory process|inflammatory process
5412155|NCT01668329|Cytokines|cytokines
5412156|NCT01668329|Hormonal response|hormonal response
5412157|NCT01668329|Oxydative stress|oxydative stress
5412158|NCT01668316|Overweight|overweight
5412159|NCT01668316|Obese|obese
5412160|NCT01668316|Postpartum|postpartum
5412161|NCT01668316|Weight loss|weight loss
5412162|NCT01668316|Inflammation|inflammation
5412164|NCT01668316|Cardiovascular|cardiovascular
5412165|NCT01668303|juvenile drug court|juvenile drug court
5412453|NCT01667068|Risk Factors|risk factors
5412548|NCT01666613|Phase I, Healthy volunteers, pharmacokinetics|phase i, healthy volunteers, pharmacokinetics
5412549|NCT01666613|Bioavailability|bioavailability
5412550|NCT01666613|AUC|auc
5412551|NCT01666548|haemolytic uraemic syndrome|haemolytic uraemic syndrome
5412552|NCT01666548|complications of HUS|complications of hus
5412553|NCT01666548|renal replacement treatment|renal replacement treatment
5412554|NCT01666548|renal function outcome|renal function outcome
5412555|NCT01666548|neuropsychological sequelae|neuropsychological sequelae
5412556|NCT01666548|psychological adjustment|psychological adjustment
5412557|NCT01666548|quality of life|quality of life
5412562|NCT01666522|sarcopenia|sarcopenia
5412630|NCT01666223|GLP-1|glp-1
5412731|NCT01665703|Fluorodeoxyglucose Positron Emission Tomography-Magnetic Resonance Imaging|fluorodeoxyglucose positron emission tomography-magnetic resonance imaging
5412831|NCT01665326|Immunomodulation|immunomodulation
5412832|NCT01665326|Anti-drug antibodies|anti-drug antibodies
5412834|NCT01665300|myocardial deformation imaging|myocardial deformation imaging
5412929|NCT01664793|influenza|influenza
5413032|NCT01664039|Glaucoma|glaucoma
5413118|NCT01663766|Chronic lymphocytic leukemia or small lymphocytic leukemia (CLL or SLL)|chronic lymphocytic leukemia or small lymphocytic leukemia (cll or sll)
5549275|NCT01089894|PET|pet
5413119|NCT01663753|2-fluoro-2-deoxy-d-glucose-positron emission tomography|2-fluoro-2-deoxy-d-glucose-positron emission tomography
5413120|NCT01663753|Positron emission tomography|positron emission tomography
5413121|NCT01663753|Magnetic resonance imaging|magnetic resonance imaging
5413122|NCT01663753|Diffusion weighted MRI|diffusion weighted mri
5413123|NCT01663753|Squamous-cell cervical carcinoma|squamous-cell cervical carcinoma
5413124|NCT01663753|Sensitivity|sensitivity
5413125|NCT01663714|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5413127|NCT01663714|Bexxar|bexxar
5413207|NCT01663324|chronic subjective Tinnitus|chronic subjective tinnitus
5413817|NCT01660477|BAL8557|bal8557
5413900|NCT01660061|Chromogenic factor X|chromogenic factor x
5414023|NCT01659307|Aspirin|aspirin
5414494|NCT01656993|ASA|asa
5414972|NCT01655095|PEG|peg
5415635|NCT01651832|Socioeconomic Factors|socioeconomic factors
5415732|NCT01651520|Disability|disability
5415829|NCT01651000|Kidney Diseases|kidney diseases
5416028|NCT01650103|chloride|chloride
5416029|NCT01650103|ScvO2|scvo2
5416030|NCT01650103|hemodynamic indexes|hemodynamic indexes
5416031|NCT01650090|Pulmonary relapse|pulmonary relapse
5416032|NCT01650090|Osteosarcoma|osteosarcoma
5416033|NCT01650090|Lung metastases|lung metastases
5416034|NCT01650090|Pediatric osteosarcoma|pediatric osteosarcoma
5416037|NCT01650077|Soft tissue sarcoma|soft tissue sarcoma
5416148|NCT01649440|biomarkers|biomarkers
5416654|NCT01646710|FBR|fbr
5416897|NCT01645865|HIV|hiv
5417003|NCT01645150|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5417206|NCT01644019|emergency medical service|emergency medical service
5417208|NCT01644006|telemedicine|telemedicine
5417209|NCT01644006|teleconsultation|teleconsultation
5417210|NCT01644006|emergency medical service|emergency medical service
5417212|NCT01643993|embryo|embryo
5417213|NCT01643967|Ozone|ozone
5417214|NCT01643967|Sunflower oil|sunflower oil
5417285|NCT01643603|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5417417|NCT01643473|Blood Pressure Control|blood pressure control
5417418|NCT01643473|Patient-centered|patient-centered
5931164|NCT03451825|Avelumab|avelumab
5931165|NCT03451825|Anti PD-L1|anti pd-l1
5931166|NCT03451825|Solid tumors|solid tumors
5931167|NCT03451825|CNS tumors|cns tumors
5931168|NCT03451825|Lymphoma|lymphoma
5931169|NCT03451825|Pediatric subjects|pediatric subjects
5931202|NCT03447821|Infectious diarrhoea|infectious diarrhoea
5931203|NCT03447821|rifamycin SV|rifamycin sv
5931204|NCT03447821|rifamycin SV MMX|rifamycin sv mmx
5931205|NCT03447821|MMX|mmx
5417419|NCT01643473|Black|black
5417421|NCT01643460|Mucinous cystadenomas [MCN])|mucinous cystadenomas [mcn])
5417815|NCT01641562|DIAGNOSTIC TOOLS,|diagnostic tools,
5897439|NCT02897167|Psychosis|psychosis
5931289|NCT03439254|Compensated Cirrhosis|compensated cirrhosis
5931290|NCT03439254|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5931291|NCT03439254|Fatty Liver Disease|fatty liver disease
5931292|NCT03439254|NASH|nash
5931312|NCT03434262|ATRT|atrt
5931313|NCT03434262|Brain Tumors in Adolescents|brain tumors in adolescents
5931314|NCT03434262|Brain Tumors in Children|brain tumors in children
5931315|NCT03434262|Brain Tumors in Young Adults|brain tumors in young adults
5931316|NCT03434262|CDK4 amplification|cdk4 amplification
5931317|NCT03434262|CDK 4/6|cdk 4/6
5931327|NCT03434262|MAPK pathway|mapk pathway
5931329|NCT03434262|MEK inhibitor|mek inhibitor
5931330|NCT03434262|MEK1|mek1
5931331|NCT03434262|MEK2|mek2
5931332|NCT03434262|Mekinist|mekinist
5931333|NCT03434262|Molecular|molecular
5931334|NCT03434262|Molecular therapy|molecular therapy
5931335|NCT03434262|MYC amplification|myc amplification
5931336|NCT03434262|PTCH1|ptch1
5931337|NCT03434262|Rare brain tumor|rare brain tumor
5931338|NCT03434262|Recurrent ATRT|recurrent atrt
5931339|NCT03434262|Recurrent brain tumor|recurrent brain tumor
5931340|NCT03434262|Recurrent ependymoma|recurrent ependymoma
5931341|NCT03434262|Recurrent high grade glioma|recurrent high grade glioma
5931342|NCT03434262|Recurrent malignant glioma|recurrent malignant glioma
5931343|NCT03434262|Recurrent medulloblastoma|recurrent medulloblastoma
5931344|NCT03434262|Refractory brain tumor|refractory brain tumor
5931345|NCT03434262|Small molecule inhibitor|small molecule inhibitor
5931346|NCT03434262|SMO antagonist|smo antagonist
5931347|NCT03434262|Smoothened protein|smoothened protein
5931348|NCT03434262|Sonic hedgehog|sonic hedgehog
5931349|NCT03434262|Combination therapy|combination therapy
5418013|NCT01640665|Breast Cancer|breast cancer
5418014|NCT01640665|GI Tumors|gi tumors
5418015|NCT01640665|Sorafenib|sorafenib
5418016|NCT01640665|Capecitabine|capecitabine
5418102|NCT01640353|si joint|si joint
5418103|NCT01640353|si joint pain|si joint pain
5418104|NCT01640353|si joint injury|si joint injury
5418105|NCT01640353|si joint treatment|si joint treatment
5418106|NCT01640353|si joint injections|si joint injections
5418392|NCT01639053|Breast Revision|breast revision
5418585|NCT01637870|Negative pressure|negative pressure
5418586|NCT01637857|foof hypersensitivity|foof hypersensitivity
5418587|NCT01637857|anal fissures|anal fissures
5418588|NCT01637857|ano-rectal manometry|ano-rectal manometry
5418589|NCT01637844|Pregnant women|pregnant women
5418590|NCT01637844|HBsAg positive|hbsag positive
5418639|NCT01637623|OSA|osa
5419181|NCT01635166|Hip|hip
5419366|NCT01634178|safety|safety
5419572|NCT01633125|Self-esteem|self-esteem
5419573|NCT01633099|decitabine|decitabine
5419574|NCT01633099|acute myeloid leukemia|acute myeloid leukemia
5419575|NCT01633099|elderly patient|elderly patient
5419576|NCT01633060|BKM120|bkm120
5419761|NCT01632241|Lupus|lupus
5419762|NCT01632215|gabapentine|gabapentine
5419763|NCT01632215|postoperative pain|postoperative pain
5419764|NCT01632202|submucosal myomas|submucosal myomas
5419962|NCT01631279|NSCLC|nsclc
5420867|NCT01626937|Out of hospital|out of hospital
5420969|NCT01626378|Behavioral Variant Frontotemporal Dementia|behavioral variant frontotemporal dementia
5420970|NCT01626378|bvFTD|bvftd
5420971|NCT01626378|Frontotemporal Dementia|frontotemporal dementia
5420972|NCT01626365|double-lumen tube|double-lumen tube
5420973|NCT01626365|intubation|intubation
5421059|NCT01626079|Functional MR|functional mr
5421161|NCT01625650|RA|ra
5421454|NCT01624324|aminoglycoside|aminoglycoside
5421562|NCT01623934|Leptin|leptin
5421769|NCT01622855|Rape|rape
5421869|NCT01622439|Valproate|valproate
5422086|NCT01621438|coronary artery|coronary artery
5422087|NCT01621438|atherosclerosis|atherosclerosis
5422088|NCT01621438|angina pectoris|angina pectoris
5422089|NCT01621425|breast cancer|breast cancer
5422090|NCT01621425|prostate carcinoma|prostate carcinoma
5422091|NCT01621425|docetaxel|docetaxel
5422191|NCT01620970|PF03446962|pf03446962
5422574|NCT01619280|adult|adult
5422769|NCT01618604|correlation|correlation
5422777|NCT01618578|CRPS|crps
5422966|NCT01617837|P6 acupressure|p6 acupressure
5423473|NCT01615601|INTELENCE|intelence
5423568|NCT01615159|Urinary sodium excretion|urinary sodium excretion
5423569|NCT01615159|Feeding study|feeding study
5423570|NCT01615159|Diet maintenance|diet maintenance
5931472|NCT03422172|GSK1265744|gsk1265744
5931473|NCT03422172|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5931474|NCT03422172|Human immunodeficiency virus|human immunodeficiency virus
5931475|NCT03422172|Cabotegravir|cabotegravir
5931476|NCT03422172|Pharmacokinetics|pharmacokinetics
5423571|NCT01615146|Myelodysplasia|myelodysplasia
5423572|NCT01615146|Leukemia|leukemia
5423573|NCT01615146|Thrombocytopenia|thrombocytopenia
5423574|NCT01615146|Platelet|platelet
5423585|NCT01615055|Prozac|prozac
5423663|NCT01614639|CLBP|clbp
5423763|NCT01614249|EPA|epa
5423865|NCT01613937|Gestational Diabetes|gestational diabetes
5424263|NCT01611792|Strength and conditioning exercise|strength and conditioning exercise
5424264|NCT01611792|Physical therapy|physical therapy
5424265|NCT01611792|Rehabilitation|rehabilitation
5424266|NCT01611779|obstructive sleep apnea|obstructive sleep apnea
5424269|NCT01611766|Ovarian Cancer|ovarian cancer
5424498|NCT01610765|HSV|hsv
5424681|NCT01610089|nitric oxide|nitric oxide
5424683|NCT01610076|Code Status|code status
5424684|NCT01610076|Do not resuscitate (DNR)|do not resuscitate (dnr)
5424686|NCT01610076|CPR|cpr
5424763|NCT01609816|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5424881|NCT01609725|Periodontitis|periodontitis
5424998|NCT01609088|endothelium|endothelium
5425102|NCT01608607|Clinical trials|clinical trials
5425295|NCT01607931|GLP-1|glp-1
5425413|NCT01607398|CAT|cat
5426200|NCT01603888|infants|infants
5426712|NCT01601639|GAVE|gave
5426807|NCT01601171|infertility|infertility
5426995|NCT01600469|NMDA|nmda
5427488|NCT01598571|Phase 1|phase 1
5427777|NCT01597362|direct|direct
5427883|NCT01596933|cancer cachexia|cancer cachexia
5427989|NCT01596569|Blast Traumatic Brain Injury|blast traumatic brain injury
5427990|NCT01596569|Cognitive Rehabilitation|cognitive rehabilitation
5427991|NCT01596569|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5427992|NCT01596569|Combined Treatment|combined treatment
5427998|NCT01596543|HTT|htt
5428177|NCT01595815|Fertilization failure, calcium ionophore, SrCl2|fertilization failure, calcium ionophore, srcl2
5428179|NCT01595789|Coronary Artery Disease|coronary artery disease
5428180|NCT01595789|Diabetes Mellitus|diabetes mellitus
5428181|NCT01595789|Left ventricular ejection fraction|left ventricular ejection fraction
5428182|NCT01595789|Beta-cell function|beta-cell function
5428183|NCT01595776|CLI, PAD, Buerger disease|cli, pad, buerger disease
5428184|NCT01595763|Deep vein thrombosis|deep vein thrombosis
5428221|NCT01595620|THC|thc
5428278|NCT01595373|Ghrelin|ghrelin
5428468|NCT01594541|mild cognitive impairment|mild cognitive impairment
5428469|NCT01594541|alzheimer's|alzheimer's
5428470|NCT01594528|schizophrenia|schizophrenia
5428471|NCT01594528|major depression|major depression
5428472|NCT01594528|pain|pain
5428473|NCT01594528|behavior|behavior
5428474|NCT01594502|prostate cancer|prostate cancer
5428475|NCT01594502|dutasteride|dutasteride
5428564|NCT01594294|wettability|wettability
5428565|NCT01594294|contamination|contamination
5428566|NCT01594294|contact lenses|contact lenses
5428567|NCT01594281|Panretinal photocoagulation|panretinal photocoagulation
5428573|NCT01594255|ECG|ecg
5428762|NCT01593397|Obesity|obesity
5429199|NCT01591668|HCV|hcv
5429651|NCT01589445|Metformin|metformin
5429847|NCT01588405|UT-15C SR|ut-15c sr
5429848|NCT01588405|PAH|pah
5429849|NCT01588392|Physical activity|physical activity
5429850|NCT01588392|preschoolers|preschoolers
5429851|NCT01588353|AK160, collagenase clostridium histolyticum|ak160, collagenase clostridium histolyticum
5430146|NCT01586793|Bipolar depression|bipolar depression
5430238|NCT01586507|Tramadol hydrochloride|tramadol hydrochloride
5430239|NCT01586507|Adolescents|adolescents
5430240|NCT01586494|Pain|pain
5430241|NCT01586494|ULTRAM ER|ultram er
5430242|NCT01586494|Tramadol hydrochloride|tramadol hydrochloride
5430243|NCT01586494|Children|children
5430244|NCT01586481|Diabetic foot ulcer|diabetic foot ulcer
5430245|NCT01586481|Off loading|off loading
5430246|NCT01586481|Compliance|compliance
5430247|NCT01586481|Healing duration|healing duration
5430248|NCT01586481|Amputation rate|amputation rate
5430258|NCT01586429|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia|comparing the analgesic efficacy of ultrasound-guided nerve block catheter compared with epidural analgesia
5430259|NCT01586416|Colonic neoplasms|colonic neoplasms
5430260|NCT01586416|Older adults|older adults
5430621|NCT01584882|Dentist|dentist
5430818|NCT01584115|MPLA (monophosphoryl lipid A).|mpla (monophosphoryl lipid a).
5430820|NCT01584115|Bordetella pertussis.|bordetella pertussis.
5430822|NCT01584102|obesity|obesity
5431013|NCT01583426|GBG 69|gbg 69
5431014|NCT01583426|GBG|gbg
5431015|NCT01583426|German Breast Group|german breast group
5931532|NCT03412851|Thrombectomy|thrombectomy
5931533|NCT03412851|Stentriever|stentriever
5931534|NCT03412851|ADAPT|adapt
5931535|NCT03412656|CUFF|cuff
5931536|NCT03412656|Soft Hand Pro|soft hand pro
5931537|NCT03412656|SHP|shp
5931538|NCT03412656|SH Pro|sh pro
5931539|NCT03412656|SoftHand|softhand
5931540|NCT03410693|Urothelial carcinoma|urothelial carcinoma
5431016|NCT01583426|neo-adjuvant|neo-adjuvant
5431017|NCT01583426|GBG Forschungs GmbH|gbg forschungs gmbh
5431018|NCT01583426|Tubular breast cancer stage II|tubular breast cancer stage ii
5431028|NCT01583387|healthy adults|healthy adults
5431120|NCT01582997|BRAF|braf
5431216|NCT01582620|Telemedicine|telemedicine
5931606|NCT03405870|cholesterol|cholesterol
5931608|NCT03405870|total parenteral nutrition|total parenteral nutrition
5931615|NCT03401632|Enteral nutrition|enteral nutrition
5931616|NCT03401632|Vasoactive Drugs|vasoactive drugs
5931617|NCT03401632|Critical Care|critical care
5931626|NCT03401294|Metastatic colorectal cancer|metastatic colorectal cancer
5931627|NCT03401294|Conversion therapy|conversion therapy
5931628|NCT03401294|Liver Metastasectomy|liver metastasectomy
5931652|NCT03396757|Acute Kidney Injury|acute kidney injury
5931653|NCT03396757|Critical Care|critical care
5931654|NCT03396757|Renal Replacement Therapy|renal replacement therapy
5931689|NCT03391778|Immuno-oncology|immuno-oncology
5931690|NCT03391778|T Cell Therapy|t cell therapy
5931691|NCT03391778|T Cell Receptor|t cell receptor
5931692|NCT03391778|Previously Treated|previously treated
5931693|NCT03391778|Cell Therapy|cell therapy
5931694|NCT03391778|SPEAR T Cell|spear t cell
5931695|NCT03391778|Metastatic|metastatic
5931696|NCT03391778|Solid and Hematological Malignancies|solid and hematological malignancies
5931697|NCT03391778|Safety|safety
5931698|NCT03391778|Long Term Follow Up|long term follow up
5431217|NCT01582620|remote consultation|remote consultation
5431218|NCT01582620|rural|rural
5431219|NCT01582620|thrombolysis therapy|thrombolysis therapy
5431220|NCT01582620|plasminogen activators|plasminogen activators
5431221|NCT01582620|stroke care|stroke care
5431222|NCT01582620|stroke management|stroke management
5431225|NCT01582581|mental health|mental health
5431424|NCT01581606|Timing|timing
5572727|NCT00996021|QTc|qtc
5431946|NCT01579461|Phase 1|phase 1
5432138|NCT01578551|Lung adenocarcinoma|lung adenocarcinoma
5432251|NCT01578057|alcohol|alcohol
5432336|NCT01577680|healthy subjects|healthy subjects
5432337|NCT01577680|pharmacokinetics|pharmacokinetics
5432338|NCT01577680|vilanterol|vilanterol
5432339|NCT01577680|tolerability|tolerability
5432340|NCT01577680|safety|safety
5432342|NCT01577680|GW642444|gw642444
5432436|NCT01577368|Continuous infusion|continuous infusion
5432437|NCT01577368|Intermittent infusion|intermittent infusion
5432471|NCT01577238|BV|bv
5432531|NCT01576874|hormones|hormones
5433100|NCT01574352|Obesity|obesity
5433395|NCT01573286|necrotising enterocolitis|necrotising enterocolitis
5433396|NCT01573286|intestinal atresia|intestinal atresia
5433490|NCT01572870|Chit1|chit1
5433618|NCT01572454|hypokalemia|hypokalemia
5433703|NCT01572090|Energy expenditure|energy expenditure
5433704|NCT01572090|Physical activity|physical activity
5433705|NCT01572064|MRI|mri
5433706|NCT01572064|liver biopsy|liver biopsy
5433707|NCT01572064|serological markers|serological markers
5433708|NCT01572051|osteoarthritis|osteoarthritis
5433803|NCT01571674|Manual therapy|manual therapy
5433804|NCT01571674|Mobilization|mobilization
5433805|NCT01571674|Physical Therapy|physical therapy
5433806|NCT01571674|Prognosis|prognosis
5433807|NCT01571674|Shoulder pain|shoulder pain
5434007|NCT01570868|CMR|cmr
5434406|NCT01569178|mortality|mortality
5434407|NCT01569165|Acidogenicity|acidogenicity
5434408|NCT01569165|Acidulated phosphate fluoride|acidulated phosphate fluoride
5434411|NCT01569139|Validation|validation
5434625|NCT01568281|Bioequivalence|bioequivalence
5434716|NCT01567852|post-anesthesia recovery|post-anesthesia recovery
5434717|NCT01567852|electroconvulsive therapy|electroconvulsive therapy
5434718|NCT01567839|degree of pulpal anesthesia obtained|degree of pulpal anesthesia obtained
5434719|NCT01567839|primary infiltration in the lower first molar|primary infiltration in the lower first molar
5434721|NCT01567826|Atorvastatin|atorvastatin
5434722|NCT01567826|Simvastatin|simvastatin
5434723|NCT01567826|Rosuvastatin|rosuvastatin
5434724|NCT01567826|lipid therapy|lipid therapy
5434745|NCT01567761|IOP|iop
5434797|NCT01567527|Aripiprazole|aripiprazole
5434894|NCT01566968|COPD|copd
5931747|NCT03383380|Activated PI3K-delta Syndrome|activated pi3k-delta syndrome
5931748|NCT03383380|Immunodeficiency Primary|immunodeficiency primary
5931749|NCT03383380|Akt/mTOR pathway|akt/mtor pathway
5931750|NCT03383380|Rapamycin Therapy|rapamycin therapy
5931751|NCT03383380|Hyperphosphorylation|hyperphosphorylation
5931752|NCT03379727|Midostaurin|midostaurin
5931753|NCT03379727|PKC412|pkc412
5931754|NCT03379727|FMS-like tyrosine kinase receptor|fms-like tyrosine kinase receptor
5931755|NCT03379727|FLT3|flt3
5931756|NCT03379727|Acute Myeloid Leukemia|acute myeloid leukemia
5931757|NCT03379727|AML|aml
5931758|NCT03379727|7+3 chemotherapy|7+3 chemotherapy
5931759|NCT03379727|5+2 chemotherapy|5+2 chemotherapy
5931760|NCT03379727|Daunorubicin|daunorubicin
5931761|NCT03379727|Idarubicin|idarubicin
5931762|NCT03379727|Cytarabine|cytarabine
5931789|NCT03374566|Epstein-Barr Virus Infections|epstein-barr virus infections
5931790|NCT03374566|Immunodeficiency|immunodeficiency
5931791|NCT03374566|Screening|screening
5931792|NCT03374566|Immunologic Function|immunologic function
5931794|NCT03374449|Major surgery|major surgery
5931795|NCT03374449|Postoperative morbidity and mortality|postoperative morbidity and mortality
5931796|NCT03374449|Renin angiotensin system inhibitors|renin angiotensin system inhibitors
5435273|NCT01565486|RFS|rfs
5435326|NCT01565265|LH|lh
5436258|NCT01560949|XRT|xrt
5436721|NCT01558947|Peri-operative chemotherapy|peri-operative chemotherapy
5437134|NCT01557361|critical illness|critical illness
5437135|NCT01557335|To evaluate adenosine diphosphate (ADP)-induced platelet aggregation|to evaluate adenosine diphosphate (adp)-induced platelet aggregation
5437544|NCT01555554|Post-traumatic stress disorder|post-traumatic stress disorder
5437546|NCT01555554|surgery|surgery
5437547|NCT01555554|anesthesia|anesthesia
5437550|NCT01555541|DLBCL|dlbcl
5437635|NCT01555281|Dexamethasone|dexamethasone
5437743|NCT01554748|thumb|thumb
5437855|NCT01554397|LDR|ldr
5437971|NCT01553760|ACM|acm
5438070|NCT01553435|analgesia|analgesia
5439070|NCT01549223|Cesarean Delivery|cesarean delivery
5439261|NCT01548456|intramedullary nailing|intramedullary nailing
5439262|NCT01548443|Wound Healing|wound healing
5439263|NCT01548443|hydrocolloid|hydrocolloid
5439264|NCT01548443|Wound Dressing|wound dressing
5439265|NCT01548443|Medifoam H|medifoam h
5439266|NCT01548443|Duoderm THIN|duoderm thin
5439355|NCT01548014|Crohn's disease|crohn's disease
5439357|NCT01548014|infliximab|infliximab
5439359|NCT01548001|Iguratimod|iguratimod
5439481|NCT01547585|Soy|soy
5439554|NCT01547299|prostate cancer|prostate cancer
5440012|NCT01545492|DNA|dna
5440723|NCT01542528|Executive function|executive function
5440724|NCT01542528|Inhibitory control|inhibitory control
5440725|NCT01542528|Computer games|computer games
5440917|NCT01541657|Balance|balance
5441012|NCT01541202|chronic heart failure|chronic heart failure
5441208|NCT01540240|HIV treatment|hiv treatment
5441402|NCT01539291|CLL|cll
5441496|NCT01539070|Childhood obesity|childhood obesity
5441497|NCT01539070|Physical activity|physical activity
5441498|NCT01539070|Feeding practices|feeding practices
5441620|NCT01538498|PCI|pci
5441803|NCT01537991|isotoxic|isotoxic
5442190|NCT01535950|wet AMD|wet amd
5442595|NCT01534390|microparticles|microparticles
5442596|NCT01534390|in-line microfilters|in-line microfilters
5442597|NCT01534390|systemic inflammation|systemic inflammation
5442598|NCT01534390|organ failure|organ failure
5442599|NCT01534390|critical illness|critical illness
5443297|NCT01531114|Insulin|insulin
5443298|NCT01531101|Transference work|transference work
5443299|NCT01531101|Psychodynamic|psychodynamic
5443300|NCT01531101|Depression|depression
5443301|NCT01531101|Treatment|treatment
5931805|NCT03373331|Emotional Processing|emotional processing
5931806|NCT03373331|Cognition|cognition
5931807|NCT03373331|Traumatic Brain Injury|traumatic brain injury
5931808|NCT03373331|Intervention|intervention
5931821|NCT03371030|distal radius fractures|distal radius fractures
5931822|NCT03371030|pronator quadratus|pronator quadratus
5931823|NCT03371030|osteosynthesis|osteosynthesis
5931873|NCT03361241|Postural Balance|postural balance
5931874|NCT03361241|Motor Function|motor function
5931875|NCT03361241|Gait|gait
5931876|NCT03361241|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5931877|NCT03361241|Physiotherapist|physiotherapist
5443302|NCT01531101|Adolescent|adolescent
5443303|NCT01531088|Nursing Home|nursing home
5443304|NCT01531075|HBV, Inflammatory bowel disease, immunosuppressor|hbv, inflammatory bowel disease, immunosuppressor
5443325|NCT01530997|p16|p16
5443785|NCT01529099|Knee|knee
5443786|NCT01529099|Knee replacement|knee replacement
5443787|NCT01529099|Knee implant|knee implant
5443890|NCT01528813|Er:YAG|er:yag
5444080|NCT01527955|Anxiety|anxiety
5444485|NCT01526161|Therapy|therapy
5444684|NCT01525134|Lipoarabinomannan|lipoarabinomannan
5444685|NCT01525121|mechanical ventilation|mechanical ventilation
5444686|NCT01525121|chest physiotherapy|chest physiotherapy
5444687|NCT01525121|critical care|critical care
5444688|NCT01525121|pneumonia|pneumonia
5444899|NCT01524146|Ablation|ablation
5445247|NCT01522612|CGA|cga
5445689|NCT01520662|wellness|wellness
5446196|NCT01518725|Cholecalciferol|cholecalciferol
5446197|NCT01518712|Healthy Volunteers|healthy volunteers
5446198|NCT01518712|Bioequivalence|bioequivalence
5446200|NCT01518712|Metformin IR|metformin ir
5446379|NCT01518023|HbA1c|hba1c
5446584|NCT01517126|Developmental Delay|developmental delay
5446688|NCT01516762|Radium 223|radium 223
5447295|NCT01514006|functional outcomes|functional outcomes
5447297|NCT01513993|Telemonitoring|telemonitoring
5447298|NCT01513980|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5447299|NCT01513980|Telemonitoring|telemonitoring
5447796|NCT01511952|entrainment|entrainment
5447797|NCT01511952|premature infants|premature infants
5447798|NCT01511952|live music intervention|live music intervention
5447799|NCT01511952|parent preferred lullabies|parent preferred lullabies
5447800|NCT01511939|Knee pain|knee pain
5447801|NCT01511939|Anticoagulant|anticoagulant
5447802|NCT01511939|Warfarin|warfarin
5447803|NCT01511939|Dabigatran|dabigatran
5447804|NCT01511939|Clopidogrel|clopidogrel
5447805|NCT01511939|Aspirin|aspirin
5447806|NCT01511939|Topical NSAID|topical nsaid
5447807|NCT01511939|Osteoarthritis|osteoarthritis
5447808|NCT01511926|Vimovo™ treated patients and prescribing patterns|vimovo™ treated patients and prescribing patterns
5447809|NCT01511926|Risk of gastrointestinal side effects|risk of gastrointestinal side effects
5447880|NCT01511588|Infertility|infertility
5448070|NCT01510834|CTI|cti
5448166|NCT01510405|Subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.|subjects undergoing or who have undergone thoracic surgery for presumed lung cancer.
5448168|NCT01510392|Optical coherence tomography|optical coherence tomography
5448169|NCT01510392|Glaucoma|glaucoma
5448170|NCT01510392|Macula|macula
5448461|NCT01509066|low calorie|low calorie
5448462|NCT01509066|infertility|infertility
5448463|NCT01509066|PCOS|pcos
5448464|NCT01509053|Schizophrenia|schizophrenia
5448466|NCT01509027|hemodialysis|hemodialysis
5448680|NCT01508156|HCV|hcv
5448856|NCT01507415|Cohort Studies|cohort studies
5449060|NCT01506583|Patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.|patients who exhibit flu-like symptoms during a flu season, including cough, myalgia, nasal obstruction, sore throat, headache, fatigue, and/or feverishness.
5449061|NCT01506557|vitamin D|vitamin d
5449062|NCT01506557|vitamin D deficiency|vitamin d deficiency
5449063|NCT01506557|breastfeeding|breastfeeding
5449064|NCT01506557|body composition|body composition
5449247|NCT01506024|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5449248|NCT01506024|Surgical Procedures, Operative|surgical procedures, operative
5891472|NCT03888105|Relapsed B-NHL|relapsed b-nhl
5449249|NCT01506024|Surgical Procedures, Minimally Invasive|surgical procedures, minimally invasive
5449250|NCT01505985|Hip fracture|hip fracture
5449251|NCT01505985|SPPB|sppb
5449334|NCT01505621|Protein damage|protein damage
5931906|NCT03353220|Obesity|obesity
5931907|NCT03353220|Weight Loss|weight loss
5931908|NCT03353220|Lorcaserin|lorcaserin
5931909|NCT03353220|Healthy Volunteers|healthy volunteers
5931929|NCT03345992|Macrolides|macrolides
5931930|NCT03345849|Upadacitinib|upadacitinib
5931931|NCT03345849|ABT-494|abt-494
5931932|NCT03345849|Efficacy|efficacy
5931933|NCT03345849|Safety|safety
5931934|NCT03345849|Crohn's Disease|crohn's disease
5931956|NCT03342937|pembrolizumab|pembrolizumab
5931957|NCT03342937|XELOX|xelox
5931958|NCT03342937|gastric cancer|gastric cancer
5931972|NCT03340506|Tafinlar|tafinlar
5931973|NCT03340506|Mekinist|mekinist
5931974|NCT03340506|Dabrafenib|dabrafenib
5931975|NCT03340506|Trametinib|trametinib
5931976|NCT03340506|Adult|adult
5931977|NCT03340506|Pediatric|pediatric
5931978|NCT03340506|Melanoma|melanoma
5931979|NCT03340506|Melanoma Stage IV|melanoma stage iv
5931980|NCT03340506|Metastatic Melanoma|metastatic melanoma
5931981|NCT03340506|Advanced Melanoma|advanced melanoma
5931982|NCT03340506|Lung Cancer|lung cancer
5931983|NCT03340506|NSLC|nslc
5931984|NCT03340506|Non Small Cell Lung Cancer|non small cell lung cancer
5931985|NCT03340506|BRAF V600 Mutation|braf v600 mutation
5931986|NCT03340506|BRAF Gene Mutation|braf gene mutation
5931987|NCT03340506|Solid tumor|solid tumor
5931988|NCT03340506|Rare cancers|rare cancers
5931989|NCT03340506|High Grade Glioma|high grade glioma
5449534|NCT01504802|deoxypyridinoline|deoxypyridinoline
5449535|NCT01504802|growth velocity|growth velocity
5449536|NCT01504802|pharmacodynamic|pharmacodynamic
5449537|NCT01504802|biomarker|biomarker
5449637|NCT01504412|Pain|pain
5449810|NCT01503671|left ventricular diastolic function|left ventricular diastolic function
5449914|NCT01503138|Immigrants|immigrants
5450201|NCT01502020|Zyclara|zyclara
5450314|NCT01501565|Safety|safety
5450613|NCT01500278|Cimzia|cimzia
5450709|NCT01499953|SVT|svt
5450811|NCT01499550|COPD|copd
5451230|NCT01497652|MoCA|moca
5451325|NCT01497197|Oocytes|oocytes
5451326|NCT01497197|Implantation|implantation
5451327|NCT01497184|Leukemia|leukemia
5451328|NCT01497184|Lymphoma|lymphoma
5451840|NCT01495000|India|india
5451939|NCT01494636|Safety|safety
5452091|NCT01493973|EPO|epo
5452133|NCT01493674|folate|folate
5452354|NCT01492621|DTI|dti
5452674|NCT01491555|EIM|eim
5453292|NCT01488981|TBI|tbi
5453387|NCT01488578|Overactive Bladder|overactive bladder
5453388|NCT01488578|Japanese|japanese
5453389|NCT01488578|Tolterodine|tolterodine
5453390|NCT01488578|Detrusitol|detrusitol
5453391|NCT01488578|Detrol|detrol
5453392|NCT01488578|Postmarketing commitment plan.|postmarketing commitment plan.
5453393|NCT01488552|pancreatic cancer|pancreatic cancer
5453394|NCT01488552|pancreatic adenocarcinoma|pancreatic adenocarcinoma
5453956|NCT01486186|Humans|humans
5454446|NCT01484327|LVEF|lvef
5454447|NCT01484314|Relapsed|relapsed
5454448|NCT01484301|Chronic pain|chronic pain
5454449|NCT01484301|Opioids|opioids
5454646|NCT01483417|Cosmetic outcome|cosmetic outcome
5454748|NCT01482832|Interpersonal psychotherapy|interpersonal psychotherapy
5454846|NCT01482416|hormone replacement therapy|hormone replacement therapy
5454847|NCT01482416|Doppler velocimetry|doppler velocimetry
5454848|NCT01482416|Flow-mediated dilation|flow-mediated dilation
5454850|NCT01482364|HOTMAN System|hotman system
5932040|NCT03336645|Seizure|seizure
5932041|NCT03336645|Midazolam hydrochloride|midazolam hydrochloride
5932042|NCT03336645|Convulsive|convulsive
5932080|NCT03333109|AMG 334, erenumab, migraine, episodic, headache, CGRP|amg 334, erenumab, migraine, episodic, headache, cgrp
5932081|NCT03332225|sepsis|sepsis
5932082|NCT03332225|macrophage activation syndrome|macrophage activation syndrome
5932083|NCT03332225|immunoparalysis|immunoparalysis
5932084|NCT03332225|anakinra|anakinra
5932085|NCT03332225|recombinant human interferon-gamma|recombinant human interferon-gamma
5932086|NCT03332225|HLA-DR|hla-dr
5898159|NCT02703571|LEE011|lee011
5454851|NCT01482364|Hemodynamic integrated management|hemodynamic integrated management
5454853|NCT01482351|cognition|cognition
5454854|NCT01482351|memory|memory
5454855|NCT01482351|function|function
5454856|NCT01482351|amnestic mild cognitive impairment|amnestic mild cognitive impairment
5454857|NCT01482351|older adults|older adults
5454858|NCT01482351|Alzheimer's Disease|alzheimer's disease
5454861|NCT01482338|COC|coc
5454866|NCT01482286|Exercise|exercise
5455233|NCT01480843|glargine|glargine
5455624|NCT01479348|Radiopharmaceutical|radiopharmaceutical
5455728|NCT01479049|cardiac surgery|cardiac surgery
5456033|NCT01477814|fecal immunochemical test|fecal immunochemical test
5456034|NCT01477814|clinical guidelines|clinical guidelines
5456035|NCT01477788|pelvic mass|pelvic mass
5456036|NCT01477788|ovarian mass|ovarian mass
5456037|NCT01477788|ultrasound|ultrasound
5456038|NCT01477788|serum markers|serum markers
5456039|NCT01477788|ovarian malignancy|ovarian malignancy
5456040|NCT01477775|myocardial infarction|myocardial infarction
5456041|NCT01477775|coronary stent|coronary stent
5456042|NCT01477775|Oral P2Y12 receptor blocker|oral p2y12 receptor blocker
5456043|NCT01477775|Platelet reactivity units (PRU)|platelet reactivity units (pru)
5456044|NCT01477762|startle response|startle response
5456045|NCT01477762|fear conditioning|fear conditioning
5456046|NCT01477762|PTSD|ptsd
5456047|NCT01477749|prostate cancer|prostate cancer
5456048|NCT01477749|prostate|prostate
5456123|NCT01477450|Oxygen|oxygen
5456221|NCT01477112|Antioxidants|antioxidants
5456222|NCT01477086|Sarcopenia|sarcopenia
5456223|NCT01477086|Hip fracture|hip fracture
5456224|NCT01477086|Frailty|frailty
5456225|NCT01477073|in-vitro fertilization|in-vitro fertilization
5456226|NCT01477073|reproductive disorder|reproductive disorder
5456227|NCT01477034|Vitamin D deficiency|vitamin d deficiency
5456626|NCT01475214|urinary nitrogen|urinary nitrogen
5456721|NCT01474850|pressure control ventilation|pressure control ventilation
5456722|NCT01474850|lung recruitment|lung recruitment
5456815|NCT01474486|congestive heart failure (CHF)|congestive heart failure (chf)
5457316|NCT01472419|prognosis|prognosis
5458265|NCT01468454|CHI|chi
5458737|NCT01466439|P50|p50
5459045|NCT01465360|MCI|mci
5459405|NCT01463852|JNK|jnk
5459458|NCT01463605|older|older
5459658|NCT01462864|Lifestyle|lifestyle
5459755|NCT01462422|Prevention|prevention
5460062|NCT01461109|Parkinson Disease|parkinson disease
5460063|NCT01461109|Alzheimer Disease|alzheimer disease
5460064|NCT01461109|[18F] CFPyPB|[18f] cfpypb
5460567|NCT01459159|Enzyme inhibitor|enzyme inhibitor
5460568|NCT01459159|non-del (5q)|non-del (5q)
5460569|NCT01459159|non-deletion 5q|non-deletion 5q
5460570|NCT01459146|IPT|ipt
5460571|NCT01459146|malaria|malaria
5460572|NCT01459146|ACT|act
5460573|NCT01459146|schistosomiasis|schistosomiasis
5460574|NCT01459146|Hemoglobin|hemoglobin
5460575|NCT01459146|Anemia|anemia
5460576|NCT01459146|Sustained attention|sustained attention
5460577|NCT01459146|Recall|recall
5460578|NCT01459146|Schoolchildren|schoolchildren
5460579|NCT01459146|Kassena-Nankana|kassena-nankana
5460580|NCT01459133|investigational|investigational
5460581|NCT01459133|inhaled insulin product|inhaled insulin product
5460582|NCT01459120|Home-based HIV-testing|home-based hiv-testing
5460583|NCT01459120|Voluntary Counseling and Testing|voluntary counseling and testing
5460651|NCT01458730|Maintenance temozolomide|maintenance temozolomide
5460652|NCT01458717|pancreas|pancreas
5460653|NCT01458717|cancer|cancer
5460654|NCT01458717|borderline resectable|borderline resectable
5460655|NCT01458717|locally advanced|locally advanced
5460656|NCT01458717|resectability|resectability
5460657|NCT01458717|chemotherapy|chemotherapy
5460658|NCT01458717|radiation|radiation
5898262|NCT02671435|Colorectal, colon, CRC, solid tumors, check point inhibitors, immunotherapy, metastatic|colorectal, colon, crc, solid tumors, check point inhibitors, immunotherapy, metastatic
5932161|NCT03316859|opioid-induced constipation (OIC)|opioid-induced constipation (oic)
5460659|NCT01458717|chemoradiation|chemoradiation
5460660|NCT01458717|neoadjuvant|neoadjuvant
5460661|NCT01458717|survival|survival
5460662|NCT01458717|prognosis|prognosis
5461165|NCT01456572|ghrelin|ghrelin
5461253|NCT01456221|Obesity|obesity
5461352|NCT01455636|hand hygiene|hand hygiene
5461446|NCT01455246|Multi drug resistant bacteria|multi drug resistant bacteria
5932176|NCT03311633|Radius Fracture Distal Therapy|radius fracture distal therapy
5932177|NCT03311633|Fracture fixation|fracture fixation
5932178|NCT03311633|Closed Fracture Reduction|closed fracture reduction
5932256|NCT03303001|subacromial infiltration|subacromial infiltration
5932257|NCT03303001|high volumen|high volumen
5932258|NCT03303001|shoulder pain|shoulder pain
5461447|NCT01455246|Sepsis|sepsis
5461448|NCT01455246|Albumin|albumin
5461449|NCT01455233|cornea|cornea
5461450|NCT01455233|ocular antibiotic|ocular antibiotic
5461451|NCT01455233|cataract surgery|cataract surgery
5462046|NCT01452633|pain|pain
5462138|NCT01452308|Gilead|gilead
5462334|NCT01451606|Pelvic Pain|pelvic pain
5462335|NCT01451593|Optic neuritis|optic neuritis
5462336|NCT01451593|Multiple sclerosis|multiple sclerosis
5462337|NCT01451593|Retinal nerve fibre layer|retinal nerve fibre layer
5462338|NCT01451593|Axonal loss|axonal loss
5462339|NCT01451593|Neuroprotection|neuroprotection
5462340|NCT01451593|Phenytoin|phenytoin
5462341|NCT01451593|MRI|mri
5462342|NCT01451593|Optical coherence tomography|optical coherence tomography
5462343|NCT01451593|Sodium Channel Blockers|sodium channel blockers
5462526|NCT01450839|Transdermal Administration|transdermal administration
5462527|NCT01450839|Japanese|japanese
5462529|NCT01450839|male|male
5462530|NCT01450839|volunteers|volunteers
5462647|NCT01450319|CRC|crc
5463228|NCT01447810|Hemiplegia|hemiplegia
5463229|NCT01447810|Brain Tumor|brain tumor
5463230|NCT01447810|Rehabilitation|rehabilitation
5463231|NCT01447797|Irbesartan|irbesartan
5463519|NCT01446757|geriatric competence|geriatric competence
5463520|NCT01446731|Prostate cancer|prostate cancer
5463711|NCT01445886|Calcipotriol|calcipotriol
5463712|NCT01445886|Nail Psoriasis Severity Index|nail psoriasis severity index
5463713|NCT01445873|Pulmonary arterial hypertension|pulmonary arterial hypertension
5463714|NCT01445873|sitaxentan sodium|sitaxentan sodium
5463716|NCT01445860|DDI|ddi
5463717|NCT01445860|pharmacokinetics|pharmacokinetics
5464064|NCT01444612|cancer surgery|cancer surgery
5464162|NCT01444183|Epilepsy|epilepsy
5464163|NCT01444183|seizures|seizures
5465267|NCT01439789|rhNRG-1|rhnrg-1
5465268|NCT01439789|NT-proBNP|nt-probnp
5465270|NCT01439776|SVR|svr
5465368|NCT01439412|Acupuncture|acupuncture
5465473|NCT01439022|Parkinson's Disease|parkinson's disease
5465474|NCT01439022|Exercise|exercise
5465475|NCT01439022|Treatment Outcome|treatment outcome
5465476|NCT01439022|Patient Adherence|patient adherence
5465477|NCT01439009|Heart failure|heart failure
5465687|NCT01438203|treatment|treatment
5465989|NCT01436903|cavatermTM|cavatermtm
5465990|NCT01436903|probe|probe
5465991|NCT01436890|Chronic Persistent Asthma|chronic persistent asthma
5465992|NCT01436877|BPH|bph
5465993|NCT01436877|bladder neck obstruction|bladder neck obstruction
5465994|NCT01436877|Bladder neck obstruction secondary to BPH|bladder neck obstruction secondary to bph
5465995|NCT01436864|Recombinant Human VEGF Receptor-Fc Fusion Protein (KH902|recombinant human vegf receptor-fc fusion protein (kh902
5465996|NCT01436864|)|)
5466008|NCT01436851|ECP|ecp
5466083|NCT01436487|ischemic stroke|ischemic stroke
5466084|NCT01436487|adult stem cells|adult stem cells
5466085|NCT01436474|Varenicline|varenicline
5466086|NCT01436474|Chantix|chantix
5466087|NCT01436474|Chronic Pain|chronic pain
5466088|NCT01436474|Opioid dependence|opioid dependence
5466089|NCT01436448|efficacy|efficacy
5466090|NCT01436448|Lactobacillus Rhamnosus|lactobacillus rhamnosus
5466269|NCT01435720|Mantle Cell Lymphoma|mantle cell lymphoma
5466270|NCT01435720|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5466271|NCT01435720|Plasma Cell Leukemia|plasma cell leukemia
5466272|NCT01435720|B cell malignancy|b cell malignancy
5466366|NCT01435278|Overweight|overweight
5466572|NCT01434550|unresectable|unresectable
5466965|NCT01433029|CAB|cab
5467391|NCT01431326|anxiety|anxiety
5467480|NCT01431144|soft tissue thickness|soft tissue thickness
5467481|NCT01431144|dental implant|dental implant
5467482|NCT01431144|soft tissue recession|soft tissue recession
5467483|NCT01431144|implant exposure|implant exposure
5467484|NCT01431131|graft placement|graft placement
5467485|NCT01431131|bone resorption|bone resorption
5467486|NCT01431118|iron metabolism|iron metabolism
5467571|NCT01430819|Fluzone® 2011-2012 Formulation|fluzone® 2011-2012 formulation
5468263|NCT01427998|blood glucose|blood glucose
5468365|NCT01427439|MDD|mdd
5468962|NCT01425034|Cast|cast
5469162|NCT01424150|mortality|mortality
5469163|NCT01424150|morbidity|morbidity
5932287|NCT03296423|BCG vaccination|bcg vaccination
5932312|NCT03292198|Subclinical lymphedema|subclinical lymphedema
5932313|NCT03292198|bioimpedance|bioimpedance
5932314|NCT03292198|breast cancer|breast cancer
5932323|NCT03290417|Active Surveillance|active surveillance
5932324|NCT03290417|Vitamin D|vitamin d
5932325|NCT03290417|Omega-3 Fatty Acid|omega-3 fatty acid
5932326|NCT03290417|tumeric curcumin|tumeric curcumin
5469164|NCT01424111|Biomarkers|biomarkers
5469165|NCT01424111|Depression|depression
5469166|NCT01424111|Major Depressive Disorder|major depressive disorder
5469167|NCT01424111|Escitalopram|escitalopram
5469168|NCT01424072|stress psychological|stress psychological
5469169|NCT01424072|coping behavior|coping behavior
5470086|NCT01420640|exercise|exercise
5470288|NCT01419899|Brief intervention|brief intervention
5470289|NCT01419899|Rapid testing|rapid testing
5470290|NCT01419873|Hyperglycaemia|hyperglycaemia
5470291|NCT01419873|Very low birthweight infants|very low birthweight infants
5470792|NCT01417676|late morbidity|late morbidity
5470794|NCT01417663|Cardiovascular disease|cardiovascular disease
5470795|NCT01417663|Endothelial function|endothelial function
5470796|NCT01417663|Physical activity|physical activity
5470884|NCT01417247|modification|modification
5470885|NCT01417247|metabolic syndrome|metabolic syndrome
5471072|NCT01416545|Child|child
5471267|NCT01415752|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5471268|NCT01415752|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5471269|NCT01415752|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5471359|NCT01415427|LSD|lsd
5471458|NCT01415011|Elderly|elderly
5471460|NCT01414972|Atherosclerosis|atherosclerosis
5471461|NCT01414972|Coronary Artery Disease|coronary artery disease
5471863|NCT01413204|TA-7284|ta-7284
5471864|NCT01413204|JNJ-28431754|jnj-28431754
5472059|NCT01412502|Tissue Donors|tissue donors
5472060|NCT01412502|Tissue and Organ Procurement|tissue and organ procurement
5472061|NCT01412502|Brain death|brain death
5472062|NCT01412502|Withdrawal of life support|withdrawal of life support
5472162|NCT01412164|CAD|cad
5472265|NCT01411774|OCD|ocd
5472488|NCT01410825|WAS|was
5472686|NCT01410136|OCD|ocd
5472977|NCT01408966|Cirrhosis|cirrhosis
5473184|NCT01408095|diabetes|diabetes
5473575|NCT01406730|blood|blood
5474212|NCT01404156|Surgery|surgery
5474508|NCT01402739|ROTEM|rotem
5475020|NCT01400607|cartilage|cartilage
5475114|NCT01400217|Metered-Dose Inhaler|metered-dose inhaler
5475115|NCT01400204|hangover|hangover
5475116|NCT01400204|next day effects|next day effects
5475117|NCT01400204|MDMA|mdma
5475118|NCT01400204|Alcohol|alcohol
5475119|NCT01400191|Metformin|metformin
5475419|NCT01398943|lung|lung
5475624|NCT01397916|CLL|cll
5475714|NCT01397474|critically ill patients|critically ill patients
5475715|NCT01397474|fluid administration|fluid administration
5475716|NCT01397448|Rabeprazole|rabeprazole
5475719|NCT01397448|Aspirin|aspirin
5475909|NCT01396642|Hospital Acquired Infection|hospital acquired infection
5475911|NCT01396603|Optical Frequency Domain Imaging|optical frequency domain imaging
5475912|NCT01396603|Optical Coherence Tomography|optical coherence tomography
5476102|NCT01395589|allergy|allergy
5476497|NCT01393860|aliskiren|aliskiren
5476498|NCT01393860|hypertension|hypertension
5476499|NCT01393860|renal impairment|renal impairment
5476500|NCT01393847|Sickle Cell|sickle cell
5476501|NCT01393847|Pain|pain
5476502|NCT01393847|Genetics|genetics
5476503|NCT01393847|Sickle Cell Disease|sickle cell disease
5476504|NCT01393847|Healthy Volunteer|healthy volunteer
5476906|NCT01392170|CCyR|ccyr
5477054|NCT01391650|ACL|acl
5477699|NCT01388777|Breast Cancer|breast cancer
5477700|NCT01388777|Breast Carcinoma|breast carcinoma
5477701|NCT01388777|Cryoablation|cryoablation
5477702|NCT01388777|The Visica 2™ Treatment System|the visica 2™ treatment system
5477703|NCT01388777|Unifocal primary invasive ductal breast carcinoma|unifocal primary invasive ductal breast carcinoma
5477704|NCT01388777|Cryoprobe|cryoprobe
5477710|NCT01388725|sTREM-1|strem-1
5477899|NCT01387932|TACE|tace
5478304|NCT01386411|Genetic testing|genetic testing
5478398|NCT01385956|epithelial cancer|epithelial cancer
5478399|NCT01385956|adenocarcinoma|adenocarcinoma
5478400|NCT01385956|exocrine pancreas|exocrine pancreas
5478401|NCT01385943|Reflectance Confocal Microscopy|reflectance confocal microscopy
5478402|NCT01385943|Dermoscopy|dermoscopy
5478403|NCT01385943|Clinical Photos|clinical photos
5479373|NCT01381562|abscess|abscess
5482837|NCT01367067|MRI|mri
5898536|NCT02598661|Relapsed/refractory to ESAs|relapsed/refractory to esas
5898537|NCT02598661|Transfusion dependent|transfusion dependent
5898538|NCT02598661|IMerge|imerge
5932381|NCT03287765|Dementia|dementia
5932382|NCT03287765|Tauopathies|tauopathies
5932383|NCT03287765|cognitive impairment|cognitive impairment
5932384|NCT03287765|CNS Diseases|cns diseases
5932385|NCT03287765|neurodegenerative disease|neurodegenerative disease
5932424|NCT03279523|Dementia|dementia
5932425|NCT03279523|HIV|hiv
5932426|NCT03279523|Brain Disease|brain disease
5932427|NCT03279523|CNS Diseases|cns diseases
5932428|NCT03279523|Mild Cognitive Impairment|mild cognitive impairment
5932429|NCT03279523|Neurodegenerative Disease|neurodegenerative disease
5932430|NCT03279523|Tauopathies|tauopathies
5932438|NCT03272165|Healthy Volunteers|healthy volunteers
5932439|NCT03272165|Safety|safety
5932441|NCT03272165|Pharmacokinetics|pharmacokinetics
5932442|NCT03272165|Pharmacodynamics|pharmacodynamics
5932443|NCT03272165|Immunogenicity|immunogenicity
5479891|NCT01379534|TKI 258|tki 258
5479892|NCT01379521|Localised|localised
5479893|NCT01379521|unresectable|unresectable
5479894|NCT01379521|chemoembolization|chemoembolization
5480185|NCT01378312|tuberculosis|tuberculosis
5480514|NCT01377142|mesh|mesh
5480587|NCT01376817|fat emulsions|fat emulsions
5480588|NCT01376817|omega 3 fatty acids|omega 3 fatty acids
5480589|NCT01376791|Periodontal disease|periodontal disease
5480590|NCT01376791|Atherosclerosis|atherosclerosis
5480600|NCT01376739|Magnevist|magnevist
5480683|NCT01376388|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5480684|NCT01376388|Pharmacogenetics|pharmacogenetics
5480685|NCT01376388|GSK573719/GW642444|gsk573719/gw642444
5480901|NCT01375439|uterine cervicitis|uterine cervicitis
5480902|NCT01375439|pregnancy outcome|pregnancy outcome
5480903|NCT01375426|Non-severe pneumonia|non-severe pneumonia
5481004|NCT01375010|HIV|hiv
5481203|NCT01374100|Qigong|qigong
5481204|NCT01374100|Complementary Medicine|complementary medicine
5481205|NCT01374100|Exercise|exercise
5481206|NCT01374100|Traditional Chinese Medicine|traditional chinese medicine
5481298|NCT01373749|Treatment|treatment
5481492|NCT01372800|adiponectin|adiponectin
5481493|NCT01372800|cardiovascular diseases|cardiovascular diseases
5481500|NCT01372761|Obese|obese
5481916|NCT01370954|NAC|nac
5481996|NCT01370564|Heart failure|heart failure
5482196|NCT01369758|morcellator|morcellator
5482293|NCT01369407|Heart Failure NYHA class III|heart failure nyha class iii
5482294|NCT01369407|Advanced heart failure|advanced heart failure
5482295|NCT01369407|Systolic Heart Failure|systolic heart failure
5482296|NCT01369394|Measles|measles
5482297|NCT01369394|Mumps|mumps
5482298|NCT01369394|Rubella|rubella
5482299|NCT01369394|MMR|mmr
5482300|NCT01369394|Prevention|prevention
5482301|NCT01369394|Tailoring|tailoring
5482302|NCT01369394|Persuasive communication|persuasive communication
5482303|NCT01369394|Children|children
5482304|NCT01369381|Cervical spine|cervical spine
5482305|NCT01369381|Endotracheal intubation|endotracheal intubation
5482384|NCT01369069|diabetes|diabetes
5482792|NCT01367223|polytraumatised|polytraumatised
5482894|NCT01366859|Immunocal|immunocal
5482895|NCT01366859|Antioxidant|antioxidant
5482896|NCT01366846|Peanut|peanut
5482897|NCT01366833|Dysphagia|dysphagia
5482898|NCT01366833|Esophagus|esophagus
5482899|NCT01366833|Cancer|cancer
5482900|NCT01366833|Esophageal Cancer|esophageal cancer
5482901|NCT01366794|Gut hormones|gut hormones
5482902|NCT01366794|Insulin secretion|insulin secretion
5482903|NCT01366781|Gut hormones|gut hormones
5482904|NCT01366781|Insulin secretion|insulin secretion
5482905|NCT01366768|Gut hormones|gut hormones
5482906|NCT01366768|Insulin secretion|insulin secretion
5482907|NCT01366768|Normal physiology|normal physiology
5482908|NCT01366729|hemiplegia|hemiplegia
5482909|NCT01366729|walking|walking
5482910|NCT01366729|canes|canes
5482911|NCT01366729|TheraTogs|theratogs
5898637|NCT02567357|intellectual disability|intellectual disability
5932460|NCT03268876|Epithelial ovarian cancer|epithelial ovarian cancer
5932461|NCT03268876|Surgery|surgery
5932462|NCT03268876|Quality of life|quality of life
5898638|NCT02567357|Prader-Willi syndrome|prader-willi syndrome
5898639|NCT02567357|Fragile X syndrome|fragile x syndrome
5898640|NCT02567357|web-based training|web-based training
5898641|NCT02567357|Down syndrome|down syndrome
5898650|NCT02566395|Stem Cell Transplantation|stem cell transplantation
5898651|NCT02566395|Haploidentical Donors|haploidentical donors
5898661|NCT02564523|Healthy|healthy
5898662|NCT02564523|Vaccine|vaccine
5898663|NCT02564523|Ebola viruses|ebola viruses
5898664|NCT02564523|Ebola virus disease (EVD)|ebola virus disease (evd)
5898665|NCT02564523|Filoviruses|filoviruses
5898666|NCT02564523|Hemorrhagic fever|hemorrhagic fever
5898667|NCT02564523|Monovalent vaccine|monovalent vaccine
5898668|NCT02564523|Human adenovirus serotype 26 (Ad26) expressing the Ebola virus Mayinga variant glycoprotein (Ad26.ZEBOV)|human adenovirus serotype 26 (ad26) expressing the ebola virus mayinga variant glycoprotein (ad26.zebov)
5482912|NCT01366729|EMG|emg
5482913|NCT01366729|balance|balance
5482984|NCT01366482|plaque excision,|plaque excision,
5482985|NCT01366482|drug-coated balloon|drug-coated balloon
5482986|NCT01366482|drug-eluting balloon|drug-eluting balloon
5482987|NCT01366469|coronary artery bypass grafting|coronary artery bypass grafting
5482988|NCT01366469|coronary artery disease|coronary artery disease
5685508|NCT00555802|Transversus abdominis|transversus abdominis
5482989|NCT01366469|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5482990|NCT01366456|Temperature Change|temperature change
5482991|NCT01366456|Moxibustion|moxibustion
5482992|NCT01366456|Warming effect|warming effect
5482993|NCT01366443|ROM PLUS|rom plus
5482994|NCT01366443|conventional clinical tests of rupture of membranes (ROM)|conventional clinical tests of rupture of membranes (rom)
5483167|NCT01365728|Nearsightedness|nearsightedness
5483371|NCT01364857|port wine stain of a limb|port wine stain of a limb
5483373|NCT01364831|athletic performance|athletic performance
5483374|NCT01364792|schizophrenia|schizophrenia
5483375|NCT01364792|treatment|treatment
5483376|NCT01364792|inflammation|inflammation
5483377|NCT01364792|neuroinflammation|neuroinflammation
5483378|NCT01364792|hippocampal|hippocampal
5483379|NCT01364779|aspirin|aspirin
5483380|NCT01364779|Chronic kidney disease|chronic kidney disease
5483381|NCT01364753|Memory|memory
5483457|NCT01364441|first in human|first in human
5483458|NCT01364441|safety|safety
5483459|NCT01364441|tolerability|tolerability
5483460|NCT01364441|pharmacokinetics|pharmacokinetics
5483462|NCT01364415|pasireotide|pasireotide
5483463|NCT01364415|LAR|lar
5483464|NCT01364415|NETs|nets
5483651|NCT01363726|southern Israel|southern israel
5483816|NCT01362933|PE|pe
5483856|NCT01362790|Immunotoxin|immunotoxin
5483857|NCT01362790|T-Cell Depletion|t-cell depletion
5483858|NCT01362790|Mesothelioma|mesothelioma
5483960|NCT01362452|Fludarabine|fludarabine
5483961|NCT01362452|Fludarabine Phosphate|fludarabine phosphate
5484067|NCT01362075|Local infiltration analgesia|local infiltration analgesia
5484068|NCT01362049|Stabilization exercise|stabilization exercise
5484069|NCT01362049|Physical therapy|physical therapy
5932599|NCT03249714|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, Japanese patients|double-blind, placebo controlled, ofatumumab, relapsing multiple sclerosis, japanese patients
5932601|NCT03248128|Efficacy|efficacy
5932602|NCT03248128|Vilanterol|vilanterol
5932603|NCT03248128|Asthma|asthma
5932604|NCT03248128|Safety|safety
5932605|NCT03248128|GW642444|gw642444
5932606|NCT03248128|GW685698|gw685698
5932610|NCT03244644|C Difficile Colitis|c difficile colitis
5932611|NCT03244644|Clostridium Difficile|clostridium difficile
5932612|NCT03244644|CDI|cdi
5898911|NCT02507544|Safety and Tolerability|safety and tolerability
5898922|NCT02503137|AGA|aga
5484651|NCT01359774|Energy|energy
5484840|NCT01358916|primary health care|primary health care
5484935|NCT01358422|non-cardiac surgery|non-cardiac surgery
5484936|NCT01358422|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5484938|NCT01358422|OBTAIN|obtain
5484940|NCT01358422|ESA|esa
5485032|NCT01358058|Proton|proton
5485142|NCT01357616|OAG|oag
5485467|NCT01355952|Obesity|obesity
5485785|NCT01354691|Anxiety|anxiety
5485876|NCT01354275|Clinical Pregnancy rates|clinical pregnancy rates
5485877|NCT01354275|GnRH Antagonist|gnrh antagonist
5485878|NCT01354275|GnRH Agonist|gnrh agonist
5485879|NCT01354262|Diabetes|diabetes
5486232|NCT01352741|low back pain|low back pain
5486555|NCT01351428|NICOM|nicom
5486659|NCT01350843|Orange Juice|orange juice
5486660|NCT01350843|Cholesterol|cholesterol
5486661|NCT01350843|Obesity|obesity
5486662|NCT01350830|inguinal hernia|inguinal hernia
5486663|NCT01350830|groin hernia|groin hernia
5486664|NCT01350830|chronic pain|chronic pain
5486665|NCT01350830|mesh repair|mesh repair
5688534|NCT00542893|SAE|sae
5486666|NCT01350804|Rheumatoid Arthritis|rheumatoid arthritis
5486669|NCT01350804|inflammatory joints|inflammatory joints
5486958|NCT01349660|GBM|gbm
5487060|NCT01349244|CT|ct
5487167|NCT01348893|Mental health|mental health
5487572|NCT01347307|stereotactic radiotherapy|stereotactic radiotherapy
5488066|NCT01345318|Crohn's Disease|crohn's disease
5488067|NCT01345318|safety|safety
5488068|NCT01345318|efficacy|efficacy
5488080|NCT01345266|HRCT|hrct
5488188|NCT01345006|SMD|smd
5488466|NCT01343667|Parodi|parodi
5488467|NCT01343667|EMPiRE|empire
5488468|NCT01343667|distal embolization|distal embolization
5488469|NCT01343667|minimizing risks of CAS|minimizing risks of cas
5488470|NCT01343667|PAES|paes
5488474|NCT01343654|rural|rural
5488561|NCT01343264|Radical Pleurectomy|radical pleurectomy
5488562|NCT01343264|Pleurectomy/decortication|pleurectomy/decortication
5488563|NCT01343264|Cisplatin|cisplatin
5488564|NCT01343264|Pemetrexed|pemetrexed
5488565|NCT01343264|Radiation|radiation
5488566|NCT01343251|dialysis|dialysis
5488567|NCT01343251|HeRO graft|hero graft
5488572|NCT01343238|obesity|obesity
5488664|NCT01342861|protein supplementation|protein supplementation
5488794|NCT01342224|cancer|cancer
5489270|NCT01340040|cancer|cancer
5489271|NCT01340040|solid tumours|solid tumours
5489273|NCT01340040|dose escalation|dose escalation
5489465|NCT01339273|TAP block|tap block
5489557|NCT01338974|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5489558|NCT01338974|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5489569|NCT01338935|CW 002|cw 002
5489760|NCT01338012|antigen presenting cells|antigen presenting cells
5489761|NCT01338012|cancer vaccine|cancer vaccine
5489762|NCT01338012|prostatic adenocarcinoma|prostatic adenocarcinoma
5489763|NCT01338012|Sipuleucel-T|sipuleucel-t
5489764|NCT01338012|castration resistant prostate cancer (CRPC)|castration resistant prostate cancer (crpc)
5489855|NCT01337713|Anxiety, GAD, Massage|anxiety, gad, massage
5489870|NCT01337661|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5489871|NCT01337661|COPD|copd
5489872|NCT01337661|Acute Exacerbation of COPD|acute exacerbation of copd
5489873|NCT01337661|AECOPD|aecopd
5489874|NCT01337648|Fecal biomarkers|fecal biomarkers
5489875|NCT01337648|Radiation biodosimetry|radiation biodosimetry
5489876|NCT01337648|Total-body irradiation (TBI)|total-body irradiation (tbi)
5489877|NCT01337648|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5489878|NCT01337648|Gene expression profiles|gene expression profiles
5489958|NCT01337349|Biomarkers|biomarkers
5899004|NCT02468102|Rivaroxaban|rivaroxaban
5490166|NCT01336556|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5490167|NCT01336556|Snore|snore
5490176|NCT01336517|Stroke|stroke
5490274|NCT01336127|Effectiveness|effectiveness
5490365|NCT01335789|marijuana dependence|marijuana dependence
5490483|NCT01335191|HIV|hiv
5490570|NCT01334827|HIV|hiv
5491044|NCT01332747|TC|tc
5491149|NCT01332292|GW685698|gw685698
5491359|NCT01331369|adherence|adherence
5491656|NCT01330108|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5491658|NCT01330108|WHO Group 1|who group 1
5491659|NCT01330095|Bifidobacterium bifidum|bifidobacterium bifidum
5491660|NCT01330095|Very low birth weight infant|very low birth weight infant
5491756|NCT01329666|Primary Hyperparathyroidism|primary hyperparathyroidism
5491757|NCT01329666|Endocrinology|endocrinology
5491758|NCT01329666|Hypercalcemia|hypercalcemia
5491759|NCT01329666|Vitamin D deficiency|vitamin d deficiency
5492161|NCT01327963|GERD|gerd
5492470|NCT01326793|college|college
5492471|NCT01326793|university|university
5492472|NCT01326780|Acne|acne
5492473|NCT01326780|Irritation|irritation
5492497|NCT01326663|TBI|tbi
5492570|NCT01326442|hypertriglyceridemia|hypertriglyceridemia
5492571|NCT01326429|Sodium|sodium
5492572|NCT01326429|Hyponatremia|hyponatremia
5492573|NCT01326429|Hypernatremia|hypernatremia
5492574|NCT01326429|Emergency department|emergency department
5492888|NCT01324999|Sarcoidosis Associated Pulmonary Hypertension|sarcoidosis associated pulmonary hypertension
5492889|NCT01324986|extraesophageal symptoms of gastroesophageal reflux disease|extraesophageal symptoms of gastroesophageal reflux disease
5492890|NCT01324973|Medical Informatics|medical informatics
5492891|NCT01324973|Therapy, Computer-Assisted|therapy, computer-assisted
5492892|NCT01324973|Health Education|health education
5492893|NCT01324973|Diet|diet
5492894|NCT01324973|Exercise|exercise
5493083|NCT01324141|Dermatitis|dermatitis
5493170|NCT01323595|sperm|sperm
5493276|NCT01323348|Diabetes Education|diabetes education
5493278|NCT01323348|HbA1c|hba1c
5493489|NCT01322490|PROSTVAC|prostvac
5493595|NCT01322009|Trauma|trauma
5493808|NCT01321151|MRI|mri
5494295|NCT01319162|PCOS|pcos
5494370|NCT01318811|Anticoagulation|anticoagulation
5494466|NCT01318265|human volunteers|human volunteers
5494669|NCT01317446|plaque index|plaque index
5494670|NCT01317446|discoloration index|discoloration index
5494671|NCT01317446|mouth rinse|mouth rinse
5494672|NCT01317446|amine fluoride/stannous fluoride|amine fluoride/stannous fluoride
5495085|NCT01316354|Arabinoxylan|arabinoxylan
5494987|NCT01316744|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5494988|NCT01316744|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5495233|NCT01315886|PID|pid
5495664|NCT01313975|Cerebral salt wasting|cerebral salt wasting
5495765|NCT01313494|China|china
5495766|NCT01313481|Older persons|older persons
5495767|NCT01313481|Exercise|exercise
5495768|NCT01313481|Balance|balance
5496055|NCT01312311|weekly docetaxel|weekly docetaxel
5496056|NCT01312311|cisplatin|cisplatin
5496057|NCT01312298|Arthritis|arthritis
5496058|NCT01312298|General anaesthesia|general anaesthesia
5496059|NCT01312298|Spinal anaesthesia|spinal anaesthesia
5496060|NCT01312285|osteoarthritis|osteoarthritis
5496061|NCT01312285|painful hips|painful hips
5496144|NCT01311856|Survey|survey
5496336|NCT01310842|SP|sp
5496756|NCT01309321|Sepsis|sepsis
5497050|NCT01307891|Tigatuzumab (CS-1008)|tigatuzumab (cs-1008)
5497051|NCT01307891|Abraxane (ABI-007)|abraxane (abi-007)
5497052|NCT01307891|HER-2-neu negative|her-2-neu negative
5497053|NCT01307891|ER negative, PR negative|er negative, pr negative
5497054|NCT01307865|midface volume loss|midface volume loss
5497055|NCT01307865|aging of midface|aging of midface
5497056|NCT01307865|sculptra|sculptra
5497135|NCT01307579|Pediatrics|pediatrics
5497320|NCT01306955|retinal vasculitis|retinal vasculitis
5497321|NCT01306955|posterior uveitis|posterior uveitis
5497322|NCT01306955|methylprednisolone|methylprednisolone
5497323|NCT01306942|HER2 positive breast cancer|her2 positive breast cancer
5497324|NCT01306942|first line treatment|first line treatment
5497325|NCT01306942|Dasatinib|dasatinib
5497326|NCT01306942|SRC kinase|src kinase
5497327|NCT01306942|Trastuzumab resistance|trastuzumab resistance
5497413|NCT01306630|capecitabine (Xeloda®)|capecitabine (xeloda®)
5497414|NCT01306604|Genetic Diseases|genetic diseases
5497415|NCT01306604|Lipidoses|lipidoses
5497421|NCT01306591|Bevacizumab|bevacizumab
5497514|NCT01306240|surfactant|surfactant
5497622|NCT01305837|multiple sclerosis|multiple sclerosis
5497933|NCT01304589|provoked vestibulodynia|provoked vestibulodynia
5498059|NCT01304043|forum|forum
5498237|NCT01303432|Mobilee|mobilee
5498426|NCT01302574|gut|gut
5498621|NCT01301937|Leishmania braziliensis|leishmania braziliensis
5498622|NCT01301937|Meglumine Antimoniate|meglumine antimoniate
5498623|NCT01301937|Treatment Effectiveness|treatment effectiveness
5498624|NCT01301937|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5498625|NCT01301924|Leishmaniasis Cutaneous|leishmaniasis cutaneous
5498626|NCT01301924|Leishmania braziliensis|leishmania braziliensis
5498627|NCT01301924|Meglumine Antimoniate|meglumine antimoniate
5498628|NCT01301924|Treatment Effectiveness|treatment effectiveness
5498629|NCT01301924|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5498630|NCT01301911|Breast cancer, Advanced|breast cancer, advanced
5498631|NCT01301911|Cipatinib|cipatinib
5499016|NCT01300026|NHL|nhl
5499402|NCT01298323|Metastatic|metastatic
5499798|NCT01296646|Alcohol|alcohol
5499799|NCT01296646|Alcoholics|alcoholics
5500001|NCT01295749|No Flow|no flow
5500122|NCT01295463|Kaposi sarcoma|kaposi sarcoma
5500299|NCT01294761|AIDS|aids
5500300|NCT01294761|Clinical Trials, Randomized|clinical trials, randomized
5500301|NCT01294748|Coronary Artery Disease|coronary artery disease
5501252|NCT01290900|OT|ot
5501320|NCT01290692|Nervous System Neoplasms|nervous system neoplasms
5501655|NCT01289392|CPAP|cpap
5501854|NCT01288638|Diet|diet
5501942|NCT01288209|Hepatitis C|hepatitis c
5502040|NCT01287780|Prostheses and Implants|prostheses and implants
5502133|NCT01287364|perennial allergic rhinitis|perennial allergic rhinitis
5502134|NCT01287364|PAR|par
5502135|NCT01287351|Real-world|real-world
5502143|NCT01287351|USA|usa
5502232|NCT01287000|Respiratory Health Outcomes|respiratory health outcomes
5502329|NCT01286480|Adolescent|adolescent
5502330|NCT01286467|PF-04449913|pf-04449913
5502331|NCT01286467|Hedgehog Inhibitor|hedgehog inhibitor
5502332|NCT01286467|Solid tumor|solid tumor
5502333|NCT01286467|Pharmacokinetics|pharmacokinetics
5502335|NCT01286467|Pharmacodynamics|pharmacodynamics
5502336|NCT01286454|BIOAVAILABILITY|bioavailability
5502337|NCT01286454|FOOD EFFECT|food effect
5502339|NCT01286428|liver|liver
5502425|NCT01286116|interventional cardiology|interventional cardiology
5502426|NCT01286116|apical remodeling|apical remodeling
5502427|NCT01286116|LV dilatation|lv dilatation
5502428|NCT01286116|akinesis|akinesis
5502429|NCT01286116|dyskinesis|dyskinesis
5899240|NCT02401542|Urothelial Cell Carcinoma|urothelial cell carcinoma
5502430|NCT01286116|myocardial infarction|myocardial infarction
5502431|NCT01286103|Canagliflozin|canagliflozin
5502432|NCT01286103|Pharmacokinetics|pharmacokinetics
5502433|NCT01286103|Pharmacodynamics|pharmacodynamics
5502434|NCT01286090|Cisapride (PREPULSID)|cisapride (prepulsid)
5502435|NCT01286090|Placebo|placebo
5502436|NCT01286090|Diabetes mellitus|diabetes mellitus
5502437|NCT01286090|Diabetic gastroparesis|diabetic gastroparesis
5502438|NCT01286077|Multiple Myeloma|multiple myeloma
5502439|NCT01286077|bortezomib|bortezomib
5502440|NCT01286077|hematology|hematology
5502519|NCT01285713|Dehydration|dehydration
5705432|NCT00481871|PDX|pdx
5502805|NCT01284387|Mild to moderate Alzheimer's disease|mild to moderate alzheimer's disease
5502806|NCT01284387|immunization|immunization
5502807|NCT01284387|amyloid imaging|amyloid imaging
5502808|NCT01284387|injection|injection
5502809|NCT01284387|vaccine|vaccine
5502810|NCT01284374|HPV Vaccines|hpv vaccines
5502899|NCT01283984|Safety|safety
5503094|NCT01282931|Progression|progression
5503096|NCT01282918|DF Test|df test
5503290|NCT01281982|Astrocytoma|astrocytoma
5503392|NCT01281436|HeartSmartKids|heartsmartkids
5503684|NCT01280006|Stroke|stroke
5503961|NCT01278849|hepatic impairment|hepatic impairment
5503962|NCT01278836|Flap|flap
5503963|NCT01278836|leg defect|leg defect
5503964|NCT01278836|reconstruction|reconstruction
5503965|NCT01278836|tissue|tissue
5503966|NCT01278823|obesity|obesity
5503967|NCT01278823|type 2 diabetes|type 2 diabetes
5503968|NCT01278810|Icaritin,|icaritin,
5503969|NCT01278810|ERa36|era36
5503970|NCT01278784|Dry eye syndromes|dry eye syndromes
5503971|NCT01278784|Chitosan-N-Acetylcysteine|chitosan-n-acetylcysteine
5503972|NCT01278771|CHD|chd
5503973|NCT01278758|Advanced or metastatic cancer,|advanced or metastatic cancer,
5503974|NCT01278758|refractory,|refractory,
5503975|NCT01278758|core phase,|core phase,
5503976|NCT01278758|extension phase,|extension phase,
5503977|NCT01278758|dose escalation,|dose escalation,
5503978|NCT01278758|standard chemotherapy,|standard chemotherapy,
5503979|NCT01278758|doctaxel,|doctaxel,
5503980|NCT01278758|paclitaxel,|paclitaxel,
5503981|NCT01278758|carboplatin,|carboplatin,
5503982|NCT01278758|safety,|safety,
5503983|NCT01278758|tolerability|tolerability
5503984|NCT01278745|cardiac allograft vasculopathy (CAV)|cardiac allograft vasculopathy (cav)
5504000|NCT01278680|Health|health
5504230|NCT01277809|Blood Pressure|blood pressure
5504231|NCT01277809|Depression|depression
5504232|NCT01277809|Behavior|behavior
5504233|NCT01277809|Dementia|dementia
5504239|NCT01277744|DSRCT|dsrct
5504515|NCT01276613|Resectable Adenocarcinoma of the Pancreas|resectable adenocarcinoma of the pancreas
5504516|NCT01276613|Gemcitabine|gemcitabine
5504517|NCT01276613|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5504518|NCT01276613|Gemzar|gemzar
5504519|NCT01276587|sickle cell disease|sickle cell disease
5505002|NCT01274663|Healthy Subjects|healthy subjects
5505003|NCT01274637|postpartum|postpartum
5505005|NCT01274637|venous thromboembolism|venous thromboembolism
5505474|NCT01273077|Rotavirus|rotavirus
5505505|NCT01272830|synovitis|synovitis
5505630|NCT01272349|air|air
5505712|NCT01272011|Respiration|respiration
5505823|NCT01271595|acupuncture|acupuncture
5505914|NCT01271179|primary non-function|primary non-function
5506116|NCT01270269|Immobility|immobility
5506118|NCT01270269|Signs and Symptoms|signs and symptoms
5506130|NCT01270256|allergy|allergy
5506318|NCT01269515|immune activation|immune activation
5506319|NCT01269515|immune modulating|immune modulating
5506729|NCT01267565|amylase|amylase
5507154|NCT01265888|PH IPF|ph ipf
5507155|NCT01265875|Chronic Pancreatitis|chronic pancreatitis
5507156|NCT01265862|Tracheal intubation|tracheal intubation
5507357|NCT01264848|venous insufficiency|venous insufficiency
5507358|NCT01264822|Rabeprazole Sodium|rabeprazole sodium
5507359|NCT01264822|Helicobacter pylori|helicobacter pylori
5507360|NCT01264822|stomach neoplasms|stomach neoplasms
5507458|NCT01264484|Advantage|advantage
5507947|NCT01262261|suboxone|suboxone
5507948|NCT01262261|opioid pain medication|opioid pain medication
5507949|NCT01262261|opioid withdrawal|opioid withdrawal
5507950|NCT01262248|small colorectal polyps|small colorectal polyps
5507951|NCT01262248|narrow band imaging|narrow band imaging
5507952|NCT01262248|vascularization|vascularization
5507953|NCT01262248|computer-based classification|computer-based classification
5508045|NCT01261949|transcranial magnetic stimulation|transcranial magnetic stimulation
5508046|NCT01261949|sensation disorders|sensation disorders
5508047|NCT01261949|hearing disorders|hearing disorders
5508048|NCT01261936|Menorrhagia|menorrhagia
5508076|NCT01261793|Lupus|lupus
5508136|NCT01261494|PPARs|ppars
5508226|NCT01261104|counseling|counseling
5508227|NCT01261091|Neurocritical Care|neurocritical care
5508228|NCT01261091|Ischemic Stroke|ischemic stroke
5508229|NCT01261091|Intracerebral Hemorrhage|intracerebral hemorrhage
5676351|NCT00595322|Bevacizumab|bevacizumab
5508230|NCT01261091|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5508622|NCT01259401|Sleep|sleep
5508730|NCT01258933|CLL|cll
5509018|NCT01257516|pharmacokinetics|pharmacokinetics
5509115|NCT01257009|sympathetic activity|sympathetic activity
5509116|NCT01257009|chronic kidney disease|chronic kidney disease
5509117|NCT01257009|atorvastatin|atorvastatin
5509118|NCT01257009|lipitor|lipitor
5509119|NCT01256983|Sleep quality|sleep quality
5509422|NCT01255670|Metronidazole|metronidazole
5509625|NCT01254825|Saphenous nerve|saphenous nerve
5510317|NCT01251614|Double-blind|double-blind
5510318|NCT01251614|Chronic plaque psoriasis|chronic plaque psoriasis
5510319|NCT01251614|Pediatric|pediatric
5510320|NCT01251588|Cartilage legions|cartilage legions
5510413|NCT01251159|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5510414|NCT01251159|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5510415|NCT01251159|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5510416|NCT01251159|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5510417|NCT01251159|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5510418|NCT01251159|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5510419|NCT01251159|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5510420|NCT01251159|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5510421|NCT01251159|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5510422|NCT01251159|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5510423|NCT01251146|Hypertension|hypertension
5510424|NCT01251146|Bisoprolol|bisoprolol
5510425|NCT01251146|Atenolol|atenolol
5510426|NCT01251133|Communicable Diseases|communicable diseases
5510427|NCT01251133|Infection|infection
5510428|NCT01251133|Influenza|influenza
5510429|NCT01251133|Orthomyxoviridae Infections|orthomyxoviridae infections
5510430|NCT01251133|RNA Virus Infections|rna virus infections
5510431|NCT01251133|Virus Diseases|virus diseases
5510432|NCT01251133|Respiratory Tract Infections|respiratory tract infections
5510433|NCT01251133|Respiratory Tract Diseases|respiratory tract diseases
5510434|NCT01251107|Hodgkin lymphoma|hodgkin lymphoma
5510436|NCT01251107|BEACOPP|beacopp
5510437|NCT01251107|Salvage high dose chemotherapy|salvage high dose chemotherapy
5510438|NCT01251094|Dementia|dementia
5510439|NCT01251094|Parkinson's|parkinson's
5510441|NCT01251094|Dementia Registry for Parkinson's Disease|dementia registry for parkinson's disease
5510442|NCT01251081|high volume hemofiltration|high volume hemofiltration
5510720|NCT01249794|NIV|niv
5510863|NCT01249027|China|china
5511181|NCT01247636|Balance|balance
5511584|NCT01245790|RA|ra
5511659|NCT01245387|prospective|prospective
5511858|NCT01244464|Poliomyelitis|poliomyelitis
5511859|NCT01244464|IMOVAX POLIO™|imovax polio™
5511860|NCT01244464|Polio|polio
5511861|NCT01244451|CLL|cll
5511862|NCT01244451|relapsed|relapsed
5511863|NCT01244451|refractory|refractory
5513969|NCT01235962|pazopanib|pazopanib
5514061|NCT01235442|Topical|topical
5932794|NCT03219957|Hepatitis C Virus|hepatitis c virus
5932795|NCT03219957|RNA Viruses|rna viruses
5932796|NCT03219957|Flavivirus|flavivirus
5932797|NCT03219957|Liver Diseases|liver diseases
5932798|NCT03219957|Hepatitis, Viral, Human|hepatitis, viral, human
5932799|NCT03219957|Flaviviridae Infections|flaviviridae infections
5899376|NCT02358226|Alcoholism|alcoholism
5514156|NCT01235000|Influenza vaccines|influenza vaccines
5514353|NCT01234116|Health Care Workers|health care workers
5514445|NCT01233648|CRT-D|crt-d
5514542|NCT01233206|PCOS|pcos
5514841|NCT01231776|acupuncture|acupuncture
5514943|NCT01231451|HIV Infection|hiv infection
5514944|NCT01231438|Renal failure stage 3B|renal failure stage 3b
5514945|NCT01231425|Back pain|back pain
5514946|NCT01231425|cervicalgia|cervicalgia
5514947|NCT01231425|dorsalgia|dorsalgia
5516268|NCT01224886|Exercise|exercise
5516269|NCT01224886|Physical activity|physical activity
5516270|NCT01224886|Oxidative capacity|oxidative capacity
5516271|NCT01224886|Diabetes|diabetes
5516272|NCT01224886|Metabolic syndrome|metabolic syndrome
5516273|NCT01224873|breast cancer|breast cancer
5516274|NCT01224873|bone metastasis|bone metastasis
5516275|NCT01224873|comparison of diagnostic methods|comparison of diagnostic methods
5516276|NCT01224873|bone scintigraphy|bone scintigraphy
5516277|NCT01224873|fluoride PET/CT|fluoride pet/ct
5516278|NCT01224873|FDG-PET/CT|fdg-pet/ct
5516458|NCT01223989|overweight|overweight
5516459|NCT01223989|obesity|obesity
5516460|NCT01223989|bread|bread
5516461|NCT01223989|hypocaloric diet|hypocaloric diet
5516462|NCT01223976|latent tuberculosis psoriasis arthritis TST QTF|latent tuberculosis psoriasis arthritis tst qtf
5516463|NCT01223976|Screening of latent tuberculosis in psoriasis|screening of latent tuberculosis in psoriasis
5516464|NCT01223963|Macrolane|macrolane
5517227|NCT01220791|progesterone|progesterone
5517425|NCT01219959|Diabetes|diabetes
5517620|NCT01219257|Synovitis|synovitis
5517825|NCT01218165|Healthy Eldery People|healthy eldery people
5518169|NCT01216735|smokers|smokers
5518211|NCT01216631|seronegative|seronegative
5518320|NCT01216176|ER+|er+
5518700|NCT01214473|Probiotics|probiotics
5518701|NCT01214473|Synbiotics|synbiotics
5518702|NCT01214460|MET|met
5518703|NCT01214447|Hemodialysis|hemodialysis
5518704|NCT01214447|Inflammation|inflammation
5518705|NCT01214447|Malnutrition|malnutrition
5518706|NCT01214447|Phase Angle|phase angle
5518707|NCT01214434|Cradle Cap|cradle cap
5518708|NCT01214434|Infantile seborrheic Dermatitis|infantile seborrheic dermatitis
5518709|NCT01214421|Kidney Disease|kidney disease
5518795|NCT01213888|macular edema|macular edema
5518990|NCT01213160|Japanese|japanese
5519091|NCT01212848|Suicidal ideation|suicidal ideation
5519320|NCT01211873|CNS|cns
5519416|NCT01211496|leg|leg
5520209|NCT01208025|Plaque|plaque
5520305|NCT01207557|flu|flu
5520397|NCT01207232|planning prompt|planning prompt
5520494|NCT01206725|Diabetes type 2|diabetes type 2
5520592|NCT01206205|Bortezomib|bortezomib
5520785|NCT01205347|Statin|statin
5520900|NCT01204905|CD4|cd4
5520976|NCT01204749|Paclitaxel|paclitaxel
5520977|NCT01204749|Ovarian Cancer|ovarian cancer
5520978|NCT01204749|TRINOVA-1|trinova-1
5521068|NCT01204372|Metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5521069|NCT01204372|First-line chemotherapy|first-line chemotherapy
5521263|NCT01203670|Amylase|amylase
5521264|NCT01203657|exercise|exercise
5521265|NCT01203657|physical activity|physical activity
5521266|NCT01203657|tai chi|tai chi
5521267|NCT01203644|Postoperative pain|postoperative pain
5899474|NCT02338609|everolimus,|everolimus,
5899475|NCT02338609|RAD001|rad001
5899513|NCT02324387|Breast Cancer|breast cancer
5899514|NCT02324387|Molecular breast imaging|molecular breast imaging
5899515|NCT02324387|MBI|mbi
5899516|NCT02324387|Tc99m sestamibi|tc99m sestamibi
5899518|NCT02324387|NAC|nac
5521268|NCT01203644|Analgesia|analgesia
5521565|NCT01202552|aged|aged
5521767|NCT01201694|Advanced malignancies|advanced malignancies
5521769|NCT01201694|Turmeric|turmeric
5521866|NCT01201252|children|children
5521867|NCT01201252|gastroenteritis|gastroenteritis
5521868|NCT01201252|Rotavirus|rotavirus
5522562|NCT01198522|L19|l19
5523151|NCT01195922|Signal Transduction Inhibitors|signal transduction inhibitors
5523444|NCT01194609|Pilot study|pilot study
5523535|NCT01194180|Mycobacterium tuberculosis|mycobacterium tuberculosis
5523536|NCT01194180|BCG|bcg
5523537|NCT01194180|MVA85A|mva85a
5523538|NCT01194167|Platelet refractory thrombocytopenia|platelet refractory thrombocytopenia
5523570|NCT01194076|OCD|ocd
5523631|NCT01193738|osteopathy|osteopathy
5523632|NCT01193725|Combat Disorders|combat disorders
5523633|NCT01193725|Exposure Therapy|exposure therapy
5523634|NCT01193725|Army Personnel|army personnel
5523635|NCT01193712|Electrophysiologic Techniques, Cardiac|electrophysiologic techniques, cardiac
5523636|NCT01193660|umbilical cord blood|umbilical cord blood
5523913|NCT01192724|Antiplatelet|antiplatelet
5523914|NCT01192724|Coronary artery diseae|coronary artery diseae
5523916|NCT01192711|diabetes|diabetes
5524013|NCT01192308|Pharmacogenetics|pharmacogenetics
5524221|NCT01191645|Esophageal motility|esophageal motility
5524326|NCT01191242|genetic|genetic
5524449|NCT01190696|TEN|ten
5524606|NCT01190059|Lung|lung
5525099|NCT01187732|cost effectiveness|cost effectiveness
5525195|NCT01187316|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5525198|NCT01187290|stage IIIA, N2|stage iiia, n2
5525590|NCT01185886|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5525591|NCT01185886|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5525592|NCT01185886|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5525594|NCT01185821|BAF312|baf312
5525595|NCT01185821|siponimod|siponimod
5526185|NCT01183481|nausea|nausea
5526495|NCT01182116|J pouch|j pouch
5527100|NCT01179815|Cohort Studies|cohort studies
5527190|NCT01179217|Sickle Cell Pain Crises|sickle cell pain crises
5527191|NCT01179217|Painful Crises|painful crises
5527192|NCT01179217|Sickle Cell Pain|sickle cell pain
5527193|NCT01179217|Vaso-occlusive Crises|vaso-occlusive crises
5527194|NCT01179191|chronic pain|chronic pain
5527195|NCT01179191|Embeda|embeda
5527196|NCT01179191|opioid|opioid
5527779|NCT01176734|Tinnitus, Clicking|tinnitus, clicking
5527780|NCT01176734|Tinnitus, Leudet|tinnitus, leudet
5527781|NCT01176734|Tinnitus, Leudet's|tinnitus, leudet's
5527782|NCT01176734|Tinnitus, Noise Induced|tinnitus, noise induced
5527783|NCT01176734|Tinnitus, Objective|tinnitus, objective
5527790|NCT01176721|psychosis|psychosis
5527879|NCT01176435|Vision|vision
5528274|NCT01174966|oxygen challenge test|oxygen challenge test
5528295|NCT01174888|AML|aml
5528880|NCT01172340|behavioral|behavioral
5528969|NCT01172028|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5528970|NCT01172028|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5528971|NCT01172028|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5529340|NCT01170715|Psoriasis|psoriasis
5529523|NCT01169935|MRI|mri
5529539|NCT01169857|SLE|sle
5529634|NCT01169441|Removal|removal
5529918|NCT01168557|ventilation|ventilation
5530084|NCT01167777|CT|ct
5932862|NCT03206775|cognitive training|cognitive training
5932863|NCT03206775|Self-report assessments|self-report assessments
5932864|NCT03206775|Normative Data|normative data
5932882|NCT03203993|BRCA mutation|brca mutation
5932883|NCT03203850|hereditary hemochromatosis|hereditary hemochromatosis
5932884|NCT03203850|ICL670|icl670
5932885|NCT03203850|deferasirox FCT|deferasirox fct
5932886|NCT03203850|iron overload|iron overload
5932895|NCT03200717|renal cell carcinoma|renal cell carcinoma
5932896|NCT03200717|metastatic renal cell|metastatic renal cell
5932897|NCT03200717|pazopanib|pazopanib
5932898|NCT03200717|checkpoint inhibitor therapy|checkpoint inhibitor therapy
5932900|NCT03200717|hypernephroma|hypernephroma
5932901|NCT03200717|renal adenocarcinoma|renal adenocarcinoma
5932902|NCT03200717|kidney cancer|kidney cancer
5932903|NCT03200717|renal cancer|renal cancer
5932904|NCT03200717|adult|adult
5932909|NCT03200522|Asthma, Diet|asthma, diet
5530968|NCT01164020|resistance training|resistance training
5531070|NCT01163630|single-center|single-center
5531169|NCT01163045|neurostimulation|neurostimulation
5531258|NCT01162629|missing teeth|missing teeth
5531351|NCT01162278|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5531352|NCT01162265|Tuberculosis|tuberculosis
5531353|NCT01162265|IGRA|igra
5531354|NCT01162265|latent|latent
5531355|NCT01162252|psoriasis|psoriasis
5531356|NCT01162252|mindfulness|mindfulness
5531357|NCT01162252|MBSR|mbsr
5531358|NCT01162252|stress|stress
5531359|NCT01162252|living well|living well
5904043|NCT00007813|childhood choroid plexus tumor|childhood choroid plexus tumor
5531360|NCT01162239|smoking|smoking
5531754|NCT01160562|Children|children
5531755|NCT01160562|Adults|adults
5531763|NCT01160536|Genetic Testing|genetic testing
5531863|NCT01160146|Over weight|over weight
5531864|NCT01160146|referral patterns|referral patterns
5531865|NCT01160146|Continuing Medical Education|continuing medical education
5532143|NCT01158781|TBI|tbi
5532308|NCT01158001|Telemedicine|telemedicine
5532608|NCT01156662|Thrombus aspiration|thrombus aspiration
5532610|NCT01156649|Obstructive sleep apnea|obstructive sleep apnea
5532948|NCT01155362|Human Placenta-Derived Cells for the Treatment of Moderate-to-Severe Crohn's Disease|human placenta-derived cells for the treatment of moderate-to-severe crohn's disease
5532949|NCT01155349|brain fitness|brain fitness
5532950|NCT01155349|cognitive training|cognitive training
5532951|NCT01155349|cognitive intervention|cognitive intervention
5532952|NCT01155349|speed of processing training|speed of processing training
5532953|NCT01155349|Parkinson's disease|parkinson's disease
5532955|NCT01155336|Fish Oils|fish oils
5533028|NCT01155050|obese|obese
5533133|NCT01154764|healthy male volunteers|healthy male volunteers
5533134|NCT01154751|Femoral artery stenosis|femoral artery stenosis
5533690|NCT01152268|sperm banking|sperm banking
5534396|NCT01149408|Decitabine|decitabine
5535093|NCT01146639|EVAR DynaCT|evar dynact
5535500|NCT01144845|Thoracotomy|thoracotomy
5535892|NCT01143220|Arrhythmias, Cardiac|arrhythmias, cardiac
5535894|NCT01143207|AE adverse event|ae adverse event
5535895|NCT01143207|DCF data collection forms|dcf data collection forms
5535910|NCT01143194|Memory|memory
5535990|NCT01142830|Children|children
5535991|NCT01142817|HIV|hiv
5535992|NCT01142817|Women|women
5536001|NCT01142791|MRgFUS|mrgfus
5536756|NCT01139619|Inoperable Non Small Cell Lung Cancer|inoperable non small cell lung cancer
5536757|NCT01139593|IVF|ivf
5536758|NCT01139593|ICSI|icsi
5536759|NCT01139593|gonadotropin|gonadotropin
5536760|NCT01139593|am dose|am dose
5536761|NCT01139593|pm dose|pm dose
5536942|NCT01138852|cefuroxime|cefuroxime
5536943|NCT01138852|cesarean|cesarean
5536944|NCT01138839|HELLP 1|hellp 1
5536945|NCT01138839|Dexamethasone|dexamethasone
5536946|NCT01138839|Clinical trial|clinical trial
5538633|NCT01132612|AIN457|ain457
5537387|NCT01137812|Canagliflozin|canagliflozin
5537423|NCT01137695|pramlintide|pramlintide
5537620|NCT01137539|TVT|tvt
5540426|NCT01125176|CLL|cll
5538022|NCT01135550|Headache|headache
5932919|NCT03198702|children|children
5932920|NCT03198702|shoulder deformation|shoulder deformation
5932921|NCT03198702|obstetrical brachial plexus palsy|obstetrical brachial plexus palsy
5932922|NCT03197922|Autism Spectrum Disorder|autism spectrum disorder
5932923|NCT03197922|Constipation|constipation
5932988|NCT03186898|hepatocellular carcinoma|hepatocellular carcinoma
5932990|NCT03186898|Proton Therapy|proton therapy
5932991|NCT03186898|Photon Therapy|photon therapy
5538114|NCT01135108|Pain postoperative / drug therapy|pain postoperative / drug therapy
5538115|NCT01135095|Myocardial perfusion|myocardial perfusion
5538116|NCT01135095|Low radiation dose|low radiation dose
5538117|NCT01135095|Single photon emission computed tomography|single photon emission computed tomography
5538206|NCT01134666|Erbitux|erbitux
5538431|NCT01133574|SLV354|slv354
5933012|NCT03182140|long-acting contraception,|long-acting contraception,
5933013|NCT03182140|unintended pregnancy|unintended pregnancy
5933014|NCT03182140|satisfaction|satisfaction
5933015|NCT03182140|bleeding profile|bleeding profile
5933016|NCT03182140|amenorrhea|amenorrhea
5933061|NCT03173950|Immunotherapy|immunotherapy
5933062|NCT03173950|Anti-PD-1 Antibody|anti-pd-1 antibody
5933063|NCT03173950|Brain Tumors|brain tumors
5933064|NCT03173950|MDASI-BT|mdasi-bt
5933065|NCT03173950|Spinal Cord Tumors|spinal cord tumors
5538489|NCT01133210|hypertriglyceridemia|hypertriglyceridemia
5933087|NCT03170466|Palliative care|palliative care
5933098|NCT03165734|myelofibrosis|myelofibrosis
5933099|NCT03165734|pacritinib|pacritinib
5933100|NCT03165734|Post-polycythemia Vera Myelofibrosis|post-polycythemia vera myelofibrosis
5933101|NCT03165734|Post-essential Thrombocythemia Myelofibrosis|post-essential thrombocythemia myelofibrosis
5933102|NCT03165734|Ruxolitinib|ruxolitinib
5933103|NCT03165734|Bone Marrow Disease|bone marrow disease
5933104|NCT03165734|Hematologic Diseases|hematologic diseases
5933105|NCT03165734|Blood Platelet Disorders|blood platelet disorders
5933106|NCT03165734|Hemorrhagic Disorders|hemorrhagic disorders
5933107|NCT03165734|Splenomegaly|splenomegaly
5933108|NCT03165734|Anemia|anemia
5933109|NCT03165734|Spleen volume|spleen volume
5933110|NCT03165734|Spleen|spleen
5538490|NCT01133210|triglyceride|triglyceride
5538491|NCT01133210|cholesterol|cholesterol
5538492|NCT01133210|Maraviroc|maraviroc
5538494|NCT01133197|arthritis|arthritis
5933168|NCT03154385|ITP|itp
5538495|NCT01133197|Impact of thumb arthritis on health|impact of thumb arthritis on health
5538496|NCT01133184|HBV transmission PreS1/PreS2/S HBV vaccine|hbv transmission pres1/pres2/s hbv vaccine
5538598|NCT01132690|pediatric|pediatric
5538825|NCT01132456|STENT THROMBOSIS|stent thrombosis
5539203|NCT01130662|AML|aml
5539301|NCT01130233|rectal cancer|rectal cancer
5539302|NCT01130220|Brain Tumor|brain tumor
5539303|NCT01130220|Brain Neoplasm|brain neoplasm
5539304|NCT01130207|Obesity|obesity
5539305|NCT01130207|Diabetes|diabetes
5539306|NCT01130207|Periodontal disease|periodontal disease
5539307|NCT01130194|follicular lymphoma|follicular lymphoma
5539308|NCT01130194|radioimmunotherapy|radioimmunotherapy
5539309|NCT01130194|rituximab|rituximab
5539310|NCT01130194|C-MOPP-R|c-mopp-r
5539311|NCT01130194|autologous transplant|autologous transplant
5539312|NCT01130155|Antimalarials|antimalarials
5539313|NCT01130155|Diagnosis|diagnosis
5539318|NCT01130103|PTSD|ptsd
5539412|NCT01129635|CRT|crt
5539545|NCT01128998|S1|s1
5539593|NCT01128829|diabetes|diabetes
5539808|NCT01127971|device|device
5539881|NCT01127659|hypogonadism|hypogonadism
5540379|NCT01125410|vaginal therapy|vaginal therapy
5540380|NCT01125397|bariatric surgery|bariatric surgery
5540381|NCT01125397|behavioral weight management|behavioral weight management
5540382|NCT01125397|psychosocial outcomes following bariatric surgery|psychosocial outcomes following bariatric surgery
5540383|NCT01125371|Hazardous alcohol use|hazardous alcohol use
5540388|NCT01125345|PCO|pco
5540563|NCT01124656|Actos|actos
5540858|NCT01123512|Spine|spine
5541064|NCT01122615|Sunitinib|sunitinib
5541065|NCT01122615|Sunitinib Malate|sunitinib malate
5541066|NCT01122615|Sutent|sutent
5541068|NCT01122615|Torisel|torisel
5541658|NCT01119768|GI|gi
5541877|NCT01118936|EQ-5D|eq-5d
5671974|NCT00613366|pain management|pain management
5543250|NCT01114399|Cholesterol|cholesterol
5543748|NCT01112553|fMRI|fmri
5544527|NCT01109147|Schizophrenic Disorders|schizophrenic disorders
5544528|NCT01109147|Schizophrenia|schizophrenia
5544624|NCT01108783|Sneezing|sneezing
5544722|NCT01108328|postprandial|postprandial
5544723|NCT01108328|appetite|appetite
5544725|NCT01108328|satiety|satiety
5545064|NCT01106742|AbM|abm
5545204|NCT01106209|PMNs|pmns
5545396|NCT01105442|Surgery|surgery
5545487|NCT01105052|Bibliotherapy|bibliotherapy
5545488|NCT01105039|Pain pattern|pain pattern
5545863|NCT01103323|Metastatic Colorectal Cancer|metastatic colorectal cancer
5546067|NCT01102374|Geriatrics|geriatrics
5546429|NCT01101412|polycythemia vera|polycythemia vera
5546657|NCT01100450|resistance training|resistance training
5546754|NCT01100008|severity|severity
5546955|NCT01099202|Hyper-CVAD|hyper-cvad
5546956|NCT01099202|augmented BFM|augmented bfm
5546957|NCT01099202|Epoetin alfa|epoetin alfa
5546958|NCT01099202|Epogen|epogen
5546959|NCT01099202|Erythropoietin|erythropoietin
5546960|NCT01099189|Histology|histology
5546961|NCT01099189|Compliance|compliance
5546962|NCT01099189|Dialysis|dialysis
5546963|NCT01099189|Arteriovenous access fistula|arteriovenous access fistula
5547253|NCT01098019|Hyperpigmentation|hyperpigmentation
5547256|NCT01097980|trazodone|trazodone
5547257|NCT01097980|SSRI|ssri
5547258|NCT01097980|sexual dysfunction|sexual dysfunction
5547259|NCT01097980|5-HT2A polymorphism|5-ht2a polymorphism
5547260|NCT01097967|Sleep disordered breathing|sleep disordered breathing
5547261|NCT01097967|Continuous Positive Airway Pressure|continuous positive airway pressure
5547262|NCT01097967|Sleep apnoea|sleep apnoea
5547263|NCT01097967|Markers of atherosclerosis|markers of atherosclerosis
5547264|NCT01097954|Exercise induced asthma|exercise induced asthma
5547265|NCT01097954|Exercise induced bronchospasm|exercise induced bronchospasm
5547266|NCT01097954|exhaled Nitric Oxide|exhaled nitric oxide
5547267|NCT01097941|Influenza|influenza
5547269|NCT01097915|PROP taste sensitivity|prop taste sensitivity
5547270|NCT01097915|Gustin (CAVI) polymorphism|gustin (cavi) polymorphism
5547271|NCT01097915|Salivary zinc|salivary zinc
5547527|NCT01096758|neurological outcome|neurological outcome
5547528|NCT01096758|psychological and neurological development|psychological and neurological development
5547529|NCT01096758|comparison with healthy adults|comparison with healthy adults
5547697|NCT01096316|women|women
5548265|NCT01094249|R076477BIM1004|r076477bim1004
5548266|NCT01094236|behavior management|behavior management
5548267|NCT01094236|academic performance|academic performance
5548268|NCT01094236|playground supervision|playground supervision
5548269|NCT01094236|harm reduction|harm reduction
5548270|NCT01094236|Behavioral Research|behavioral research
5933178|NCT03153683|Acute|acute
5933179|NCT03153683|Ischemic|ischemic
5933180|NCT03153683|Stroke|stroke
5933181|NCT03153683|Biomarkers|biomarkers
5933182|NCT03153683|Proteins|proteins
5933183|NCT03153683|Leukocyte|leukocyte
5933184|NCT03153683|Inflammatory Cells|inflammatory cells
5933185|NCT03153683|Acid/Base Balance|acid/base balance
5933186|NCT03152669|asthma|asthma
5933187|NCT03152669|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5933188|NCT03152669|Salford Lung Study|salford lung study
5933194|NCT03151681|Reconsolidation|reconsolidation
5933195|NCT03151681|Propranolol|propranolol
5933196|NCT03151681|Infidelity|infidelity
5933197|NCT03151681|Attachment injury|attachment injury
5933289|NCT03131453|Placebo controlled,|placebo controlled,
5933290|NCT03131453|APOE4 carriers,|apoe4 carriers,
5933291|NCT03131453|Homozygotes,|homozygotes,
5933292|NCT03131453|Heterozygotes,|heterozygotes,
5933293|NCT03131453|Brain Amyloid,|brain amyloid,
5933294|NCT03131453|Preclinical Alzheimer's Disease (AD),|preclinical alzheimer's disease (ad),
5933295|NCT03131453|Aβ lowering,|aβ lowering,
5933296|NCT03131453|BACE-1 inhibitor|bace-1 inhibitor
5933299|NCT03128528|SGLT-2 inhibitor, Chronic heart failure, tissue sodium,|sglt-2 inhibitor, chronic heart failure, tissue sodium,
5548271|NCT01094223|Stimulant|stimulant
5548756|NCT01092208|HV|hv
5933334|NCT03119974|ITP|itp
5933335|NCT03119974|TPO-RAS|tpo-ras
5933336|NCT03119974|Thrombopoietin-receptor agonists|thrombopoietin-receptor agonists
5933351|NCT03112317|Surgery|surgery
5933352|NCT03112317|Hypothermia|hypothermia
5933353|NCT03112317|Prevention|prevention
5933354|NCT03112317|Surgical Site Infection|surgical site infection
5933355|NCT03112317|Bleeding|bleeding
5548937|NCT01091506|vitamin B6|vitamin b6
5548938|NCT01091506|vitamin B12|vitamin b12
5548939|NCT01091506|psychotic symptoms|psychotic symptoms
5548940|NCT01091506|MTHFR C677T Polymorphism|mthfr c677t polymorphism
5548941|NCT01091493|COPD|copd
5549125|NCT01090492|scleroderma|scleroderma
5549504|NCT01089036|ROS|ros
5549792|NCT01087866|treatment|treatment
5549891|NCT01087489|injections, intraocular|injections, intraocular
5550010|NCT01087255|Chronic Kidney Disease|chronic kidney disease
5550011|NCT01087255|Medication Adherence|medication adherence
5550012|NCT01087242|Tang-min Lin pills|tang-min lin pills
5550013|NCT01087242|type 2 diabetes|type 2 diabetes
5550102|NCT01086852|Factor X deficiency|factor x deficiency
5550103|NCT01086852|surgery|surgery
5550104|NCT01086852|Factor X deficiency subjects requiring surgery|factor x deficiency subjects requiring surgery
5550105|NCT01086839|Cystic Fibrosis|cystic fibrosis
5550106|NCT01086839|chronic rhinosinusitis|chronic rhinosinusitis
5550564|NCT01084902|OH|oh
5550584|NCT01084824|Warts|warts
5551556|NCT01081119|prevention|prevention
5550884|NCT01083524|DCA|dca
5550973|NCT01083199|Prostate Cancer|prostate cancer
5551177|NCT01082419|ARFI|arfi
5551671|NCT01080625|epinephrine|epinephrine
5552158|NCT01078441|Dexamethasone|dexamethasone
5552586|NCT01077102|eccentric exercise training|eccentric exercise training
5552587|NCT01077102|cycle ergometer|cycle ergometer
5552621|NCT01076829|MDA|mda
5552976|NCT01075295|BMI|bmi
5553462|NCT01073436|WBC ≤ 10 x 109/L.|wbc ≤ 10 x 109/l.
5553463|NCT01073436|Platelet count < 450,000 x 109/L.|platelet count < 450,000 x 109/l.
5554345|NCT01069458|Body weight|body weight
5554442|NCT01069094|Uterine fibroids|uterine fibroids
5554443|NCT01069081|Metastasis Breast Cancer|metastasis breast cancer
5554545|NCT01068535|MetS|mets
5554729|NCT01067794|Stage IIIB-IV|stage iiib-iv
5554826|NCT01067352|Saizen|saizen
5555309|NCT01065480|Training|training
5555608|NCT01064219|hCG|hcg
5555697|NCT01063855|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5555698|NCT01063855|Sildenafil (Viagra)|sildenafil (viagra)
5555699|NCT01063855|Vardenafil (Levitra)|vardenafil (levitra)
5555700|NCT01063855|Tadalafil (Cialis)|tadalafil (cialis)
5555701|NCT01063842|Drop-out rate|drop-out rate
5555702|NCT01063842|Osteoarthritis|osteoarthritis
5555703|NCT01063842|Tolerability|tolerability
5555704|NCT01063842|Tramadol|tramadol
5555705|NCT01063842|Acetaminophen|acetaminophen
5555706|NCT01063829|HCMV|hcmv
5556095|NCT01062152|Glutathione analog|glutathione analog
5556096|NCT01062152|Glutathione Transferase|glutathione transferase
5556097|NCT01062152|Glutathione Transferase inhibitor|glutathione transferase inhibitor
5556099|NCT01062152|GSTp1-1 inhibitor|gstp1-1 inhibitor
5556392|NCT01060904|monomethyl auristatin E|monomethyl auristatin e
5556588|NCT01059968|energy availability|energy availability
5556589|NCT01059968|menstrual status|menstrual status
5556590|NCT01059968|female|female
5556591|NCT01059968|adolescent|adolescent
5556592|NCT01059955|scleritis|scleritis
5556593|NCT01059955|anterior scleritis|anterior scleritis
5556674|NCT01059656|Dermatofibrosarcoma|dermatofibrosarcoma
5556778|NCT01059279|MEFV|mefv
5556872|NCT01058980|adenosine|adenosine
5557518|NCT01056146|TBI|tbi
5557948|NCT01054430|Hepatic|hepatic
5559425|NCT01048762|radically operated|radically operated
5559426|NCT01048762|exercise training|exercise training
5559427|NCT01048762|dyspnea counseling|dyspnea counseling
5559433|NCT01048736|obesity|obesity
5559522|NCT01048372|monoclonal antibody|monoclonal antibody
5559716|NCT01047735|Cellular Physiology|cellular physiology
5933356|NCT03112317|Surgical instruments|surgical instruments
5560417|NCT01046149|postmenopause|postmenopause
5560700|NCT01044901|Coronary Disease|coronary disease
5560798|NCT01044524|Phase I|phase i
5561093|NCT01043367|Dietary supplement|dietary supplement
5561094|NCT01043367|Deprexil|deprexil
5561095|NCT01043354|cholesterol|cholesterol
5561096|NCT01043354|diabetes|diabetes
5561097|NCT01043354|adherence|adherence
5561098|NCT01043341|HPV|hpv
5561099|NCT01043341|vaccines|vaccines
5561100|NCT01043341|knowledge|knowledge
5561286|NCT01042574|intracranial monitoring|intracranial monitoring
5561287|NCT01042574|external ventricular drain (ventriculostomy)|external ventricular drain (ventriculostomy)
5561288|NCT01042574|hypertension|hypertension
5561289|NCT01042561|vitamin d|vitamin d
5561290|NCT01042561|prematurity|prematurity
5561385|NCT01042145|Treatment|treatment
5561386|NCT01042145|Croup|croup
5561393|NCT01042132|human|human
5561478|NCT01041846|Hypomethylating agent|hypomethylating agent
5561850|NCT01040442|Accidental Falls|accidental falls
5562242|NCT01038882|sedation|sedation
5562743|NCT01036685|Cognition|cognition
5562845|NCT01036061|addiction|addiction
5563721|NCT01032200|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5563722|NCT01032200|adult subependymoma|adult subependymoma
5564134|NCT01030822|Booster vaccination|booster vaccination
5564439|NCT01029652|gout|gout
5565385|NCT01025479|Korean prostate cancer|korean prostate cancer
5565386|NCT01025453|thyroid|thyroid
5565387|NCT01025453|follicular cell|follicular cell
5565393|NCT01025453|09-148|09-148
5565483|NCT01025115|Diamel|diamel
5565682|NCT01024153|children|children
5565972|NCT01023100|taste study open label investigational drug oral therapy|taste study open label investigational drug oral therapy
5565974|NCT01023074|CAP|cap
5565975|NCT01023048|preimplantation diagnosis|preimplantation diagnosis
5565976|NCT01023022|CareLink|carelink
5565977|NCT01023022|Remote Monitoring|remote monitoring
5565978|NCT01023022|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5565979|NCT01023022|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
5565980|NCT01023009|Occlusion|occlusion
5565981|NCT01023009|vitrectomy|vitrectomy
5566093|NCT01022580|BPD|bpd
5566354|NCT01021501|chronic maintenance hemodialysis|chronic maintenance hemodialysis
5566725|NCT01019967|Obsessive Compulsive Disorder|obsessive compulsive disorder
5566727|NCT01019941|CKD-810|ckd-810
5566728|NCT01019941|Taxotere inj.|taxotere inj.
5566729|NCT01019941|Advanced Solid cancer|advanced solid cancer
5566730|NCT01019941|Pharmacokinetic evaluation|pharmacokinetic evaluation
5566731|NCT01019928|GERD|gerd
5566732|NCT01019928|patient|patient
5566733|NCT01019928|esophagus|esophagus
5566738|NCT01019915|skeletal muscle|skeletal muscle
5566862|NCT01019343|TS|ts
5566917|NCT01019096|women/adolescents|women/adolescents
5567200|NCT01017744|No more in acute state|no more in acute state
5567299|NCT01017146|Ance|ance
5567388|NCT01016795|Clinical Trial|clinical trial
5567389|NCT01016782|Inflammatory Rosacea|inflammatory rosacea
5567390|NCT01016782|Rosacea|rosacea
5567391|NCT01016769|Paclitaxel|paclitaxel
5567392|NCT01016769|Carboplatin|carboplatin
5568239|NCT01013727|Volunteers|volunteers
5568747|NCT01011400|clitoris|clitoris
5568841|NCT01010971|Mountain Cedar|mountain cedar
5569141|NCT01009723|Inhibin A|inhibin a
5569744|NCT01007630|PD|pd
5569745|NCT01007630|Rasagiline|rasagiline
5569746|NCT01007630|Azilect|azilect
5933468|NCT03096847|ribociclib|ribociclib
5933470|NCT03096847|RIBECCA|ribecca
5569747|NCT01007630|Olfactory|olfactory
5569748|NCT01007630|Sense of Smell|sense of smell
5569749|NCT01007630|UPSIT|upsit
5569750|NCT01007617|Children|children
5569751|NCT01007617|Cancer|cancer
5569752|NCT01007617|Mucositis|mucositis
5569753|NCT01007617|Laser|laser
5569754|NCT01007617|Prevention|prevention
5569755|NCT01007617|Chemotherapy|chemotherapy
5569757|NCT01007604|claudication|claudication
5569758|NCT01007604|pneumatic compression device|pneumatic compression device
5569925|NCT01006863|Ephedrine|ephedrine
5933471|NCT03096847|breast cancer|breast cancer
5894309|NCT03454451|NSCLC|nsclc
5933472|NCT03096847|breast carcinoma|breast carcinoma
5933473|NCT03096847|HR-positive|hr-positive
5933474|NCT03096847|HER2-negative|her2-negative
5933475|NCT03096847|advanced breast cancer|advanced breast cancer
5933476|NCT03096847|Letrozole|letrozole
5933477|NCT03096847|CDK4/6|cdk4/6
5933482|NCT03096262|cognitive skills|cognitive skills
5933483|NCT03096262|technical|technical
5933484|NCT03096262|internet platform|internet platform
5933485|NCT03096262|Stroke|stroke
5933486|NCT03096262|Hemiparesis|hemiparesis
5571088|NCT01002170|Cycloserine|cycloserine
5571193|NCT01001689|Fitness|fitness
5571295|NCT01001260|Prostaglandins|prostaglandins
5571598|NCT00999960|Cancer|cancer
5571683|NCT00999622|infection|infection
5571981|NCT00998517|CSB++|csb++
5572104|NCT00998075|ASA|asa
5572839|NCT00995540|T1DM|t1dm
5572933|NCT00995241|HIV|hiv
5671995|NCT00613275|Activation|activation
5573742|NCT00992459|UCD|ucd
5573835|NCT00992043|exercise training|exercise training
5573836|NCT00992017|Vaccine|vaccine
5573956|NCT00991601|liver|liver
5574224|NCT00990509|MRI|mri
5574227|NCT00990509|Phase II|phase ii
5574323|NCT00990223|Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics|eplerenone aldosterone and plasma renin activity responses pharmacodynamics
5574324|NCT00990197|Pilot study|pilot study
5574510|NCT00989404|healthy subjects|healthy subjects
5574616|NCT00989040|Pain|pain
5574711|NCT00988546|Disability Evaluation|disability evaluation
5574712|NCT00988546|Joint Diseases|joint diseases
5574713|NCT00988546|Joint Disability|joint disability
5574714|NCT00988533|Head Lice|head lice
5689294|NCT00539279|Elderly|elderly
5574807|NCT00988156|Placebo-controlled|placebo-controlled
5574808|NCT00988156|Parallel-group|parallel-group
5574809|NCT00988143|Influenza|influenza
5574812|NCT00988130|sexual dysfunction|sexual dysfunction
5574901|NCT00987831|flare|flare
5575098|NCT00987155|arm crank|arm crank
5575385|NCT00986063|AIDS|aids
5575798|NCT00984360|Meth|meth
5576310|NCT00982774|PKDL|pkdl
5576304|NCT00982800|analgesic|analgesic
5576882|NCT00980382|phase I/II|phase i/ii
5576978|NCT00980070|lumbar puncture positioning device|lumbar puncture positioning device
5576979|NCT00980031|Aldosterone Blockade|aldosterone blockade
5576980|NCT00980031|Aldosterone Receptor Blockers|aldosterone receptor blockers
5577281|NCT00978848|emergency contraception use|emergency contraception use
5577283|NCT00978835|Hypertension|hypertension
5577284|NCT00978835|Physical Activity|physical activity
5577285|NCT00978835|Diet|diet
5577286|NCT00978835|Medication Adherence|medication adherence
5577287|NCT00978822|Subarachnoid hemorrhage|subarachnoid hemorrhage
5577288|NCT00978822|Hypertension|hypertension
5577289|NCT00978822|brain Aneurysm|brain aneurysm
5577290|NCT00978822|intracerebral hemorrhage|intracerebral hemorrhage
5577789|NCT00976963|UTI|uti
5578795|NCT00973375|coronary thrombosis|coronary thrombosis
5579081|NCT00972192|HIV testing|hiv testing
5579498|NCT00970398|growth|growth
5579577|NCT00969969|Hallux Rigidus|hallux rigidus
5579793|NCT00968994|Wound Infection|wound infection
5580105|NCT00968058|Intubation, Endotracheal|intubation, endotracheal
5580345|NCT00967109|Anemia|anemia
5580941|NCT00964821|aplastic anemia|aplastic anemia
5581464|NCT00963053|dysmenorrhea|dysmenorrhea
5581466|NCT00963053|pre-emptive|pre-emptive
5581564|NCT00962650|NOTES|notes
5581851|NCT00961389|delirium|delirium
5582053|NCT00960622|treatment experienced|treatment experienced
5582354|NCT00959361|HIV|hiv
5582548|NCT00958438|Joint Diseases|joint diseases
5582825|NCT00957710|neuroimaging|neuroimaging
5582879|NCT00957437|Phase 1|phase 1
5583137|NCT00956475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5583138|NCT00956475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5583139|NCT00956475|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5583140|NCT00956475|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5583141|NCT00956475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5583142|NCT00956475|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5583143|NCT00956475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5583144|NCT00956475|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5583146|NCT00956475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5583446|NCT00955643|periodontitis|periodontitis
5583838|NCT00953745|Depression|depression
5583937|NCT00953277|Continence|continence
5584210|NCT00952185|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5584211|NCT00952185|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5584212|NCT00952185|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5584213|NCT00952185|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5584214|NCT00952185|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5584422|NCT00951756|Controlled feeding experiment|controlled feeding experiment
5584957|NCT00950118|Genetic testing|genetic testing
5584958|NCT00950118|exome sequencing|exome sequencing
5584959|NCT00950118|genome sequencing|genome sequencing
5585058|NCT00949689|depression|depression
5585059|NCT00949689|sleep problems|sleep problems
5585060|NCT00949689|cognitive therapy|cognitive therapy
5585061|NCT00949663|Diabetes|diabetes
5585062|NCT00949663|Blood Sugar|blood sugar
5585232|NCT00949104|Sucrose|sucrose
5585450|NCT00948779|Adherence|adherence
5586504|NCT00944827|Catechins|catechins
5586626|NCT00944307|HIV|hiv
5586702|NCT00944034|toddler|toddler
5933625|NCT03071484|Early Stages of Psychosis|early stages of psychosis
5933626|NCT03071484|Schizophrenia|schizophrenia
5933627|NCT03071484|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5933628|NCT03071484|Cognitive Symptomatology|cognitive symptomatology
5933629|NCT03071484|Double-blind Randomized Controlled Trial|double-blind randomized controlled trial
5586903|NCT00943150|Electrosurgery|electrosurgery
5587611|NCT00940524|ALLOPURINOL|allopurinol
5587612|NCT00940524|CARMUSTINE (BCNU)|carmustine (bcnu)
5587613|NCT00940524|CYCLOPHOSPHAMIDE (CYTOXAN)|cyclophosphamide (cytoxan)
5587818|NCT00939640|Antioxidants|antioxidants
5588567|NCT00936572|Lymphocyte|lymphocyte
5588808|NCT00935545|CNS|cns
5588863|NCT00935298|Tacrolimus|tacrolimus
5588939|NCT00935090|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5588940|NCT00935090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5589059|NCT00935090|primary systemic amyloidosis|primary systemic amyloidosis
5589060|NCT00935090|refractory multiple myeloma|refractory multiple myeloma
5589061|NCT00935090|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5589143|NCT00934635|D2-receptor occupancy|d2-receptor occupancy
5589144|NCT00934635|Antipsychotic drugs|antipsychotic drugs
5589145|NCT00934635|Paliperidone ER, Oral risperidone|paliperidone er, oral risperidone
5589146|NCT00934635|Dopamine|dopamine
5589147|NCT00934635|Fallypride|fallypride
5589148|NCT00934635|Plasma concentration|plasma concentration
5706120|NCT00479128|AD|ad
5589149|NCT00934635|Therapeutic window, Healthy controls|therapeutic window, healthy controls
5589150|NCT00934622|AcrySof|acrysof
5589331|NCT00933673|DICE|dice
5589531|NCT00932802|NIS|nis
5589727|NCT00931944|ALS|als
5590004|NCT00930670|rosuvastatin|rosuvastatin
5590105|NCT00930254|pediatric nursing|pediatric nursing
5590307|NCT00929422|PET|pet
5590793|NCT00927615|myocardial perfusion|myocardial perfusion
5590989|NCT00926705|Dexmedetomidine|dexmedetomidine
5591086|NCT00926341|inflammatory markers|inflammatory markers
5591186|NCT00925847|Lithium|lithium
5591314|NCT00925366|MRI|mri
5591373|NCT00925236|macrothrombocytopenia|macrothrombocytopenia
5591374|NCT00925236|leukocyte inclusions|leukocyte inclusions
5591375|NCT00925236|cataracts deafness|cataracts deafness
5591376|NCT00925236|nephritis|nephritis
5591378|NCT00925223|IBS|ibs
5591562|NCT00924482|Perioperative medical care|perioperative medical care
5591563|NCT00924469|Prostate cancer|prostate cancer
5591564|NCT00924469|Abiraterone acetate|abiraterone acetate
5591565|NCT00924469|Leuprolide acetate|leuprolide acetate
5591566|NCT00924469|Prednisone|prednisone
5591567|NCT00924469|CB7630|cb7630
5591568|NCT00924469|Testosterone|testosterone
5591569|NCT00924456|Transcendental Meditation|transcendental meditation
5591570|NCT00924456|blood pressure|blood pressure
5591571|NCT00924456|psychological distress|psychological distress
5591572|NCT00924456|high psychological distress|high psychological distress
5591573|NCT00924443|acute myelogenous leukemia|acute myelogenous leukemia
5591574|NCT00924443|acute myeloid leukemia|acute myeloid leukemia
5591575|NCT00924443|clolar|clolar
5591768|NCT00923832|PCR Assays|pcr assays
5592201|NCT00922220|low back pain|low back pain
5592202|NCT00922220|spinal manipulation|spinal manipulation
5592203|NCT00922220|central sensitization|central sensitization
5592204|NCT00922220|manual therapy|manual therapy
5592297|NCT00921869|Cancer|cancer
5592298|NCT00921869|Gastrointestinal Cancer|gastrointestinal cancer
5592299|NCT00921856|Acetylcholine|acetylcholine
5592300|NCT00921843|Pediatric patients undergoing surgery|pediatric patients undergoing surgery
5592301|NCT00921830|ibuprofen|ibuprofen
5592302|NCT00921830|healthy volunteers|healthy volunteers
5592303|NCT00921830|bioavailability|bioavailability
5592320|NCT00921765|Pain|pain
5592584|NCT00920829|Alcohol Dependence|alcohol dependence
5592586|NCT00920829|Naltrexone|naltrexone
5592587|NCT00920829|Substance Abuse|substance abuse
5592588|NCT00920829|Genetics|genetics
5592671|NCT00920582|T1DM|t1dm
5592864|NCT00919815|Ciclosporin|ciclosporin
5593129|NCT00918879|HbA1c|hba1c
5593209|NCT00918593|Palliative|palliative
5593510|NCT00917150|COPD|copd
5593616|NCT00916799|copd|copd
5593704|NCT00916448|Sepsis|sepsis
5593705|NCT00916448|Multi organ dysfunction syndrome|multi organ dysfunction syndrome
5593706|NCT00916448|Oxidative Stress|oxidative stress
5593707|NCT00916448|Heme oxygenase|heme oxygenase
5593708|NCT00916435|Arrhythmia|arrhythmia
5593996|NCT00915252|azacitidine|azacitidine
5594199|NCT00914420|OCT|oct
5594288|NCT00914095|Noradrenaline|noradrenaline
5594993|NCT00911001|Arthroplasty|arthroplasty
5594994|NCT00911001|Antithrombotic prophylaxis treatment|antithrombotic prophylaxis treatment
5595209|NCT00910208|Pain|pain
5595304|NCT00909909|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5595305|NCT00909909|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5595308|NCT00909909|stage I breast cancer|stage i breast cancer
5595501|NCT00909090|lutein|lutein
5596182|NCT00906074|Surgical Wound Infection|surgical wound infection
5596376|NCT00905281|Quality of life|quality of life
5596928|NCT00903370|Catheter Ablation, Radiofrequency|catheter ablation, radiofrequency
5596929|NCT00903357|Atopic dermatitis|atopic dermatitis
5596930|NCT00903357|Montelukast|montelukast
5596931|NCT00903331|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5596932|NCT00903331|MUSIC|music
5596933|NCT00903318|Endocrine|endocrine
5596934|NCT00903318|Environmental Chemicals|environmental chemicals
5596935|NCT00903318|Male:Female Birth Ratio|male:female birth ratio
5596936|NCT00903318|Phthalate Exposure|phthalate exposure
5597115|NCT00902733|stage I pancreatic cancer|stage i pancreatic cancer
5933648|NCT03069703|ANCA- associated vasculitides|anca- associated vasculitides
5933649|NCT03069703|pneumovax|pneumovax
5933650|NCT03069703|prevenar|prevenar
5933651|NCT03069703|pneumovas|pneumovas
5597116|NCT00902733|stage II pancreatic cancer|stage ii pancreatic cancer
5597117|NCT00902733|stage III pancreatic cancer|stage iii pancreatic cancer
5597118|NCT00902733|stage IV pancreatic cancer|stage iv pancreatic cancer
5597120|NCT00902720|Tissue|tissue
5597121|NCT00902720|Cryopreservation|cryopreservation
5597122|NCT00902707|healthy nonsmokers|healthy nonsmokers
5597123|NCT00902694|Serious Mental Illness|serious mental illness
5597124|NCT00902694|Weight Loss|weight loss
5597125|NCT00902681|Bioequivalence, Pharmacokinetics|bioequivalence, pharmacokinetics
5597126|NCT00902668|radiation toxicity|radiation toxicity
5597127|NCT00902668|stage IA breast cancer|stage ia breast cancer
5597128|NCT00902668|stage IB breast cancer|stage ib breast cancer
5597129|NCT00902668|stage II breast cancer|stage ii breast cancer
5597130|NCT00902668|breast cancer in situ|breast cancer in situ
5597131|NCT00902655|Nocturnal polyuria|nocturnal polyuria
5597132|NCT00902655|Nocturnal bladder capacity|nocturnal bladder capacity
5597133|NCT00902642|Physical therapy,|physical therapy,
5597135|NCT00902642|psychosocial factors,|psychosocial factors,
5597136|NCT00902642|dissimilation,|dissimilation,
5597137|NCT00902642|evidence based,|evidence based,
5597138|NCT00902642|education|education
5597139|NCT00902629|Epiretinal Fibrosis|epiretinal fibrosis
5597140|NCT00902629|Macular Pucker|macular pucker
5597141|NCT00902616|Type 2 diabetes|type 2 diabetes
5597142|NCT00902616|Peripheral neuropathy|peripheral neuropathy
5597143|NCT00902616|Microcirculation|microcirculation
5597144|NCT00902603|pulmonary arterial hypertension|pulmonary arterial hypertension
5597145|NCT00902603|Ventavis®|ventavis®
5597146|NCT00902603|iloprost|iloprost
5597147|NCT00902590|renal pelvis|renal pelvis
5597148|NCT00902590|ureter|ureter
5597149|NCT00902590|bladder|bladder
5597150|NCT00902590|09-025|09-025
5597151|NCT00902590|Renal Pelvis, Ureter, Bladder Cancer|renal pelvis, ureter, bladder cancer
5597152|NCT00902564|Generalized Anxiety Disorder|generalized anxiety disorder
5597153|NCT00902564|GAD|gad
5597154|NCT00902564|Antidepressant|antidepressant
5597155|NCT00902564|Anxiolytic|anxiolytic
5597480|NCT00901342|dendritic cells|dendritic cells
5597673|NCT00900653|estriol|estriol
5671587|NCT00615381|Craniotomy|craniotomy
5598476|NCT00899951|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5598477|NCT00899951|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5598478|NCT00899951|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5671589|NCT00615381|Neuropsychology|neuropsychology
5598646|NCT00899756|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5598647|NCT00899756|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5598648|NCT00899756|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5598649|NCT00899756|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5598650|NCT00899743|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5598651|NCT00899743|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5598933|NCT00898976|stage I breast cancer|stage i breast cancer
5599072|NCT00898690|stage IV breast cancer|stage iv breast cancer
5599299|NCT00898612|recurrent neuroblastoma|recurrent neuroblastoma
5599505|NCT00898222|aspirin|aspirin
5798755|NCT00111176|stent graft|stent graft
5600412|NCT00896285|chest tube|chest tube
5600397|NCT00896363|anti-depressant|anti-depressant
5600512|NCT00895791|PCI|pci
5603253|NCT00885508|AML|aml
5600818|NCT00894725|left colon cancer|left colon cancer
5601014|NCT00893737|Migraine|migraine
5601206|NCT00892931|Brain Neoplasms|brain neoplasms
5601313|NCT00892554|Female|female
5601756|NCT00891137|refractory anemia|refractory anemia
5601833|NCT00890929|Acute myeloid leukemia|acute myeloid leukemia
5602208|NCT00889603|Aricept® Evess|aricept® evess
5602378|NCT00889083|Liver|liver
5602678|NCT00887640|cancer|cancer
5602778|NCT00887211|stent|stent
5603023|NCT00886496|stage III and IV childhood large cell lymphoma|stage iii and iv childhood large cell lymphoma
5603024|NCT00886496|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5603025|NCT00886496|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5603026|NCT00886483|Neurofeedback|neurofeedback
5603027|NCT00886470|cytokines|cytokines
5603117|NCT00886132|Adenoid Cystic Carcinoma|adenoid cystic carcinoma
5603118|NCT00886132|Salivary Glands|salivary glands
5603119|NCT00886132|Metastasis|metastasis
5603120|NCT00886106|Capsaicin|capsaicin
5603121|NCT00886106|Remifentanil|remifentanil
5603424|NCT00884858|CD4|cd4
5603512|NCT00884520|squamous cell carcinoma|squamous cell carcinoma
5603661|NCT00883896|ACR|acr
5604015|NCT00882336|Hyperlipidemia|hyperlipidemia
5604110|NCT00881959|Miller Class II|miller class ii
5604305|NCT00881010|IVR|ivr
5604789|NCT00879034|Progeria|progeria
5604791|NCT00879034|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
5604792|NCT00879034|Lonafarnib|lonafarnib
5604882|NCT00878735|Psychobiology|psychobiology
5604978|NCT00878332|Patients interested in fixed non removable dental rehabilitation by dental implants.|patients interested in fixed non removable dental rehabilitation by dental implants.
5604980|NCT00878332|Adult patients|adult patients
5604981|NCT00878319|Humeral|humeral
5605073|NCT00877903|Myocardial infarction|myocardial infarction
5605074|NCT00877903|Heart attack|heart attack
5605075|NCT00877903|Mesenchymal stem cells|mesenchymal stem cells
5605076|NCT00877903|MSC|msc
5605077|NCT00877903|Adult human stem cells|adult human stem cells
5605078|NCT00877903|Osiris|osiris
5605103|NCT00877838|NOS|nos
5605476|NCT00876512|ADAMTS13|adamts13
5605571|NCT00876122|NHL|nhl
5606175|NCT00873574|V617|v617
5606252|NCT00873301|vulvodynia|vulvodynia
5606253|NCT00873301|vestibulectomy|vestibulectomy
5606254|NCT00873301|surgery|surgery
5606255|NCT00873301|vestibulitis|vestibulitis
5606256|NCT00873288|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5606257|NCT00873288|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5606258|NCT00873288|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5606259|NCT00873288|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5606260|NCT00873275|stage IV colon cancer|stage iv colon cancer
5606261|NCT00873275|stage IV rectal cancer|stage iv rectal cancer
5606262|NCT00873275|recurrent colon cancer|recurrent colon cancer
5606263|NCT00873275|recurrent rectal cancer|recurrent rectal cancer
5606266|NCT00873262|PreMenstrual Syndrome|premenstrual syndrome
5606330|NCT00872963|RTS,S,|rts,s,
5606434|NCT00872625|recurrent breast cancer|recurrent breast cancer
5606623|NCT00871858|stage IIIA breast cancer|stage iiia breast cancer
5606624|NCT00871858|stage IIIB breast cancer|stage iiib breast cancer
5606625|NCT00871858|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5606627|NCT00871845|obesity|obesity
5606791|NCT00871377|EPA|epa
5606815|NCT00871286|Chronic sinusitis|chronic sinusitis
5607119|NCT00870116|non-operated|non-operated
5607311|NCT00869349|IFS|ifs
5607408|NCT00869024|Heart failure|heart failure
5608024|NCT00866541|flow proportional pressure support|flow proportional pressure support
5608115|NCT00866242|Vaccine|vaccine
5608116|NCT00866242|Mucosal immunity|mucosal immunity
5608523|NCT00864604|Healthy subjects|healthy subjects
5608524|NCT00864591|SPECT Imaging|spect imaging
5608525|NCT00864591|Stress adenosine CMR|stress adenosine cmr
5608526|NCT00864578|POAG|poag
5608527|NCT00864578|IOP|iop
5608528|NCT00864578|Forskolin|forskolin
5608529|NCT00864578|Food supplement|food supplement
5608530|NCT00864565|Bioequivalence|bioequivalence
5608531|NCT00864565|Fentanyl|fentanyl
5608532|NCT00864565|Healthy subjects|healthy subjects
5608533|NCT00864552|Hemophilia A|hemophilia a
5608536|NCT00864539|milk|milk
5608709|NCT00863655|Estrogen Receptor positive|estrogen receptor positive
5608711|NCT00863655|exemestane|exemestane
5608742|NCT00863538|SCD|scd
5608800|NCT00863291|Depression|depression
5608801|NCT00863291|suicidality|suicidality
5608802|NCT00863291|buprenorphine|buprenorphine
5608896|NCT00862940|Neuroimaging|neuroimaging
5609233|NCT00861510|MCL|mcl
5609336|NCT00861133|ECG|ecg
5609617|NCT00859898|Glucose Metabolism Disorders|glucose metabolism disorders
5609618|NCT00859898|Metabolic Diseases|metabolic diseases
5609619|NCT00859898|Metformin|metformin
5933714|NCT03054610|plantar fascitis|plantar fascitis
5933715|NCT03054610|Botulinum toxin A|botulinum toxin a
5933716|NCT03054610|Betamethason Sodium Phosphate|betamethason sodium phosphate
5933717|NCT03054610|infiltration|infiltration
5933718|NCT03054610|plantar fascia|plantar fascia
5933725|NCT03053128|cardiac ischemia|cardiac ischemia
5609652|NCT00859729|DNA|dna
5609812|NCT00858793|AIDS|aids
5609909|NCT00858377|Open-label|open-label
5609910|NCT00858377|Oncology|oncology
5609911|NCT00858364|darbepoetin alfa|darbepoetin alfa
5933791|NCT03039959|Renal Doppler ultrasonography|renal doppler ultrasonography
5933792|NCT03039959|Venous Congestion|venous congestion
5609912|NCT00858364|non-small cell lung cancer|non-small cell lung cancer
5609914|NCT00858364|chemotherapy|chemotherapy
5609915|NCT00858364|chemotherapy induce anemia|chemotherapy induce anemia
5609916|NCT00858364|advanced lung cancer|advanced lung cancer
5609920|NCT00858364|anemia|anemia
5610099|NCT00857610|Aged skin|aged skin
5610101|NCT00857610|Retinol|retinol
5610687|NCT00855218|Combination|combination
5610788|NCT00854841|suboptimal response|suboptimal response
5610789|NCT00854841|dasatinib|dasatinib
5610790|NCT00854841|imatinib|imatinib
5610979|NCT00853983|ADME|adme
5611075|NCT00853684|Oxaliplatin|oxaliplatin
5933845|NCT03033914|Nivolumab|nivolumab
5933846|NCT03033914|adriamycin|adriamycin
5933847|NCT03033914|bleomycin|bleomycin
5933848|NCT03033914|vinblastine|vinblastine
5933849|NCT03033914|dacarbazine|dacarbazine
5933850|NCT03033914|16-1536|16-1536
5901221|NCT01705288|laparotomy|laparotomy
5611166|NCT00853320|Healthy Subjects|healthy subjects
5611282|NCT00852839|Xerostomia|xerostomia
5611484|NCT00852137|Peplin|peplin
5611674|NCT00851318|Certolizumab Pegol|certolizumab pegol
5611840|NCT00850915|tuberculosis|tuberculosis
5612142|NCT00849654|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5612143|NCT00849654|Bruton's Tyrosine Kinase|bruton's tyrosine kinase
5612144|NCT00849641|decompensation|decompensation
5612145|NCT00849641|septic shock|septic shock
5612146|NCT00849641|tissue oxygenation|tissue oxygenation
5612338|NCT00848809|Vancomycin|vancomycin
5612339|NCT00848809|Hemofiltration|hemofiltration
5612541|NCT00847899|s-EH enzyme inhibition|s-eh enzyme inhibition
5612635|NCT00847509|lung cancer|lung cancer
5612636|NCT00847509|head and neck cancer|head and neck cancer
5612637|NCT00847509|radiotherapy|radiotherapy
5612638|NCT00847509|chemoradiotherapy|chemoradiotherapy
5612832|NCT00846859|smoking|smoking
5613233|NCT00845143|surgery|surgery
5613414|NCT00844441|adult acute basophilic leukemia|adult acute basophilic leukemia
5613418|NCT00844402|Cholestasis|cholestasis
5613601|NCT00843479|Insulin resistance|insulin resistance
5613602|NCT00843479|Aging|aging
5613603|NCT00843479|Incretins|incretins
5613604|NCT00843479|DPP-IV protein, human|dpp-iv protein, human
5613605|NCT00843479|Glucagon-Like Peptide 1|glucagon-like peptide 1
5613692|NCT00843154|Cardiac Failure|cardiac failure
5613693|NCT00843154|Congestive Heart Failure|congestive heart failure
5613783|NCT00842777|BMI|bmi
5613873|NCT00842452|stage III vaginal cancer|stage iii vaginal cancer
5613874|NCT00842452|stage IVA vaginal cancer|stage iva vaginal cancer
5614300|NCT00840788|skin adhesive|skin adhesive
5614460|NCT00839969|voiding|voiding
5614641|NCT00839189|asthma|asthma
5615123|NCT00837460|Hand|hand
5615217|NCT00837083|hypercholesterolemia|hypercholesterolemia
5615218|NCT00837083|cholesterol|cholesterol
5615219|NCT00837083|LDL-cholesterol|ldl-cholesterol
5615220|NCT00837083|rosuvastatin|rosuvastatin
5615240|NCT00837005|CAD|cad
5615428|NCT00836238|Elderly|elderly
5615727|NCT00834899|Safety|safety
5615817|NCT00834340|Bioequivalence|bioequivalence
5616921|NCT00829738|PPI therapy|ppi therapy
5617024|NCT00829348|Chronic|chronic
5617309|NCT00828308|high risk|high risk
5617724|NCT00826735|childbirth|childbirth
5618525|NCT00823732|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5618527|NCT00823719|relapsed|relapsed
5618528|NCT00823719|grade 3B follicular lymphoma|grade 3b follicular lymphoma
5618959|NCT00822471|Prevention|prevention
5619084|NCT00821938|CRT|crt
5619160|NCT00821600|Risperidone|risperidone
5619161|NCT00821600|Antipsychotic|antipsychotic
5619162|NCT00821600|Pharmacokinetic|pharmacokinetic
5619166|NCT00821561|Persistent|persistent
5619257|NCT00821132|FALS|fals
5619355|NCT00820729|biomarkers|biomarkers
5619455|NCT00820378|Vascular disease|vascular disease
5619548|NCT00820014|cataract surgery|cataract surgery
5619665|NCT00819611|Placebo|placebo
5619952|NCT00818727|Bone density|bone density
5619908|NCT00818948|Lupus|lupus
5620088|NCT00818298|raclopride|raclopride
5620387|NCT00817258|NPC|npc
5620479|NCT00816842|Villous atrophy|villous atrophy
5620722|NCT00816244|Ki67|ki67
5620823|NCT00815893|satisfaction|satisfaction
5621231|NCT00814294|Type 2|type 2
5621308|NCT00814034|Aromatase Inhibitors|aromatase inhibitors
5621309|NCT00814034|Coagulation parameters|coagulation parameters
5933873|NCT03029962|Teenage Pregnancy Prevention|teenage pregnancy prevention
5933874|NCT03029962|LGB Girls|lgb girls
5933875|NCT03029962|Text-Messaging|text-messaging
5933876|NCT03029962|Information-Motivation-Behavioral Skills(IMB)Model|information-motivation-behavioral skills(imb)model
5901348|NCT01646463|mindfulness|mindfulness
5621310|NCT00814034|Tamoxifen|tamoxifen
5621316|NCT00813969|Autologous|autologous
5621414|NCT00813514|AMD|amd
5621841|NCT00812214|insomnia|insomnia
5622127|NCT00811122|AD|ad
5622139|NCT00811096|Recurrence|recurrence
5622427|NCT00809965|ACS|acs
5622771|NCT00808743|Chemoprevention|chemoprevention
5622772|NCT00808743|Celecoxib|celecoxib
5622773|NCT00808743|Ursodeoxycholic acid|ursodeoxycholic acid
5622774|NCT00808743|Anti-Inflammatory agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5622775|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5622776|NCT00808730|Asthma, airway remodelling, smooth muscle, mitochondria|asthma, airway remodelling, smooth muscle, mitochondria
5622777|NCT00808717|Myocardial Infarction|myocardial infarction
5901401|NCT01616303|ovarian|ovarian
5622780|NCT00808704|asphyxia|asphyxia
5623290|NCT00806754|Ciclesonide|ciclesonide
5623487|NCT00805935|infertility|infertility
5623583|NCT00805480|skin disease|skin disease
5623584|NCT00805467|RA|ra
5623585|NCT00805454|Healthy Volunteers|healthy volunteers
5623586|NCT00805454|Phase I|phase i
5623587|NCT00805454|Pet Scan|pet scan
5623588|NCT00805441|Alcoholic|alcoholic
5623589|NCT00805415|Oral Contraceptive|oral contraceptive
5623590|NCT00805415|Ovulation Inhibition|ovulation inhibition
5623593|NCT00805376|Brain|brain
5623777|NCT00804674|anesthesia|anesthesia
5624154|NCT00803101|Invasive procedures|invasive procedures
5624155|NCT00803101|Vitamin K|vitamin k
5624157|NCT00803101|Kcentra|kcentra
5624611|NCT00801086|Radiation|radiation
5624878|NCT00800150|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5624879|NCT00800150|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5624880|NCT00800150|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5624881|NCT00800150|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5625054|NCT00799643|Inflammation|inflammation
5625276|NCT00798681|BSI|bsi
5625352|NCT00798421|Influenza, transmission|influenza, transmission
5625468|NCT00797914|Instrumentation|instrumentation
5625469|NCT00797914|Force Monitoring|force monitoring
5625470|NCT00797914|Quality Control|quality control
5625471|NCT00797914|Training|training
5625472|NCT00797888|diabetes|diabetes
5625473|NCT00797888|behavioral intervention|behavioral intervention
5625560|NCT00797511|Tetanus|tetanus
5626434|NCT00793702|skin test|skin test
5626451|NCT00793650|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5626452|NCT00793637|Angular stable locking system|angular stable locking system
5626454|NCT00793637|Complications|complications
5626940|NCT00791375|cancer|cancer
5627521|NCT00789282|complications|complications
5627736|NCT00788346|Health information technology|health information technology
5627737|NCT00788346|Education|education
5627738|NCT00788333|Advanced or Metastatic Her-2-positive Breast Cancer|advanced or metastatic her-2-positive breast cancer
5627739|NCT00788320|Tuberculosis|tuberculosis
5627740|NCT00788320|vitamin D|vitamin d
5627741|NCT00788320|immune system|immune system
5627742|NCT00788307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5627743|NCT00788307|recurrent prostate cancer|recurrent prostate cancer
5627744|NCT00788307|stage I prostate cancer|stage i prostate cancer
5627745|NCT00788307|stage II prostate cancer|stage ii prostate cancer
5627746|NCT00788294|Pharmacokinetics tanezumab subcutaneous bioavailability intravenous Japanese subjects|pharmacokinetics tanezumab subcutaneous bioavailability intravenous japanese subjects
5627747|NCT00788242|Cardiac surgery|cardiac surgery
5627748|NCT00788242|Cardioprotection|cardioprotection
5627749|NCT00788242|Aortocoronary bypass graft|aortocoronary bypass graft
5627750|NCT00788242|Aortic stenosis|aortic stenosis
5627751|NCT00788229|Dry Eye Syndromes|dry eye syndromes
5627752|NCT00788229|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5627753|NCT00788229|artificial tears|artificial tears
5627754|NCT00788229|carboxymethylcellulose sodium|carboxymethylcellulose sodium
5627755|NCT00788229|sodium hyaluronate|sodium hyaluronate
5627757|NCT00788216|Whole pelvic radiation|whole pelvic radiation
5627759|NCT00788216|Chemoradiation|chemoradiation
5627760|NCT00788216|Complications|complications
5627761|NCT00788216|Quality of Life|quality of life
5627762|NCT00788190|Distal Radius Fracture|distal radius fracture
5627763|NCT00788190|Elderly|elderly
5627764|NCT00788190|Prospective randomized trial|prospective randomized trial
5627765|NCT00788190|Outcomes|outcomes
5627766|NCT00788190|Pain and Function|pain and function
5627767|NCT00788190|Surgical Vs. conservative management|surgical vs. conservative management
5627768|NCT00788190|Fractures with borderline alignment|fractures with borderline alignment
5627769|NCT00788177|age-related macular degeneration|age-related macular degeneration
5627770|NCT00788177|subretinal injection|subretinal injection
5627875|NCT00788112|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5627877|NCT00788099|Plitidepsin|plitidepsin
5627878|NCT00788099|Tumors|tumors
5627879|NCT00788099|Lymphomas|lymphomas
5627880|NCT00788073|fragile X syndrome|fragile x syndrome
5627881|NCT00788073|irritability|irritability
5933959|NCT03010371|positive psychotherapy, online, breast cancer, survivors|positive psychotherapy, online, breast cancer, survivors
5933973|NCT03008811|Atrial Fibrillation|atrial fibrillation
5933974|NCT03008811|Catheter Ablation|catheter ablation
5934002|NCT03001167|Microbiome|microbiome
5934003|NCT03001167|Antibiotics|antibiotics
5934004|NCT03001167|Growth|growth
5934007|NCT02999126|Total Intravenous Anesthesia|total intravenous anesthesia
5934008|NCT02999126|Titration|titration
5934009|NCT02999126|Target Controlled Infusion|target controlled infusion
5934010|NCT02999126|Propofol|propofol
5934011|NCT02999126|Bispectral index|bispectral index
5934014|NCT02995824|Liver transplantation|liver transplantation
5934015|NCT02995824|HIV infection|hiv infection
5934017|NCT02995824|Raltegravir|raltegravir
5934054|NCT02987166|immunotherapy|immunotherapy
5934056|NCT02987166|MK-3475|mk-3475
5934057|NCT02987166|High-dose conformal radiation therapy|high-dose conformal radiation therapy
5934058|NCT02987166|HDCRT|hdcrt
5934059|NCT02987166|advanced solid tumor|advanced solid tumor
5934060|NCT02986308|Metabolomics|metabolomics
5934061|NCT02986308|Intestinal Polyps|intestinal polyps
5934062|NCT02986308|TCM Syndromes|tcm syndromes
5934063|NCT02986308|TCM Constitution Types|tcm constitution types
5934119|NCT02972177|Lung cancer|lung cancer
5934120|NCT02972177|Transbronchial ablation|transbronchial ablation
5934121|NCT02972177|Radiofrequency ablation|radiofrequency ablation
5934122|NCT02972177|Microwave ablation|microwave ablation
5627882|NCT00788073|behavior problems|behavior problems
5628039|NCT00787761|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5628040|NCT00787761|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5628041|NCT00787761|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5628042|NCT00787761|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5628046|NCT00787761|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5628132|NCT00787527|Intestinal T-cell lymphoma|intestinal t-cell lymphoma
5628133|NCT00787527|Subcutaneous panniculitic T-cell lymphoma|subcutaneous panniculitic t-cell lymphoma
5628134|NCT00787514|ovarian cancer, folate receptor, plasma|ovarian cancer, folate receptor, plasma
5628229|NCT00787163|pPROM|pprom
5628522|NCT00786019|Vessel|vessel
5628523|NCT00786019|Function|function
5628524|NCT00786019|Exercise|exercise
5628525|NCT00786019|Program|program
5629115|NCT00783588|CLL|cll
5630503|NCT00777387|slow-freeze|slow-freeze
5630716|NCT00776412|HV|hv
5630806|NCT00775944|Smoking|smoking
5630901|NCT00775567|Fructose|fructose
5631097|NCT00774813|Mild|mild
5631197|NCT00774488|fat biopsies|fat biopsies
5631547|NCT00772993|myopia|myopia
5631649|NCT00772603|Partial onset seizures|partial onset seizures
5632274|NCT00770185|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5632364|NCT00769834|uremia|uremia
5820514|NCT00077311|anemia|anemia
5633146|NCT00766571|VACTERL|vacterl
5633394|NCT00765544|MS|ms
5633482|NCT00765284|HDL|hdl
5633509|NCT00765102|Romidepsin|romidepsin
5633991|NCT00762892|Lipids|lipids
5634181|NCT00762099|Pregabalin|pregabalin
5634408|NCT00761098|SBP|sbp
5634571|NCT00760331|HNF1B|hnf1b
5634698|NCT00759876|DMD|dmd
5634968|NCT00758524|Essential hypertension|essential hypertension
5634969|NCT00758524|phase 2 study|phase 2 study
5634971|NCT00758511|cortisol|cortisol
5635068|NCT00757887|malaria|malaria
5635548|NCT00755911|Procedures|procedures
5635737|NCT00755248|outcome|outcome
5635859|NCT00755040|primary myelofibrosis|primary myelofibrosis
5635975|NCT00754351|chemotherapy|chemotherapy
5635976|NCT00754338|comfort|comfort
5635977|NCT00754338|wetability|wetability
5635978|NCT00754338|protein deposit|protein deposit
5635979|NCT00754338|lipid deposit|lipid deposit
5635980|NCT00754312|breast cancer|breast cancer
5635990|NCT00754247|HSE|hse
5636080|NCT00753805|mare's milk|mare's milk
5636381|NCT00752791|Anemia|anemia
5636481|NCT00752375|DMSA scan|dmsa scan
5636794|NCT00751465|Social Phobia|social phobia
5636895|NCT00751023|Cognitive|cognitive
5637099|NCT00750100|hCG|hcg
5671714|NCT00614666|coccidioidomycosis|coccidioidomycosis
5637363|NCT00749801|Dyslipidemic|dyslipidemic
5637364|NCT00749801|nattokinase|nattokinase
5637365|NCT00749801|fibrinolytic|fibrinolytic
5637366|NCT00749775|Eplerenone|eplerenone
5637367|NCT00749775|Selara|selara
5637368|NCT00749775|Hypertension|hypertension
5637372|NCT00749775|ESSENCE|essence
5637560|NCT00749073|Laminotomy|laminotomy
5637787|NCT00748098|PSG|psg
5637921|NCT00747617|LH|lh
5638156|NCT00746668|Reading|reading
5638560|NCT00745017|outome predictors|outome predictors
5638561|NCT00745017|personality dimensions|personality dimensions
5638562|NCT00745004|IBS D|ibs d
5638950|NCT00743600|rotator cuff|rotator cuff
5638952|NCT00743561|sleep apnea|sleep apnea
5639046|NCT00743184|BPH|bph
5639144|NCT00742833|Micturition|micturition
5639450|NCT00741832|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5639451|NCT00741832|dynamic hyperinflation|dynamic hyperinflation
5639453|NCT00741832|recovery|recovery
5639454|NCT00741832|positive expiratory pressure|positive expiratory pressure
5639455|NCT00741832|exercise|exercise
5639456|NCT00741819|pulmonary arterial hypertension|pulmonary arterial hypertension
5639751|NCT00740766|Obesity|obesity
5640516|NCT00738062|PAF|paf
5640610|NCT00737815|Randomized Controlled Trial|randomized controlled trial
5640612|NCT00737815|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5640613|NCT00737815|Inflammation|inflammation
5640708|NCT00737438|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5640709|NCT00737438|TAXOTERE (DOCETAXEL)|taxotere (docetaxel)
5640710|NCT00737438|ESOPHAGUS|esophagus
5640711|NCT00737438|STOMACH|stomach
5640712|NCT00737438|08-081|08-081
5640713|NCT00737425|laparoscopic-assisted surgery|laparoscopic-assisted surgery
5640714|NCT00737425|abdominal|abdominal
5640715|NCT00737425|pain relief|pain relief
5640716|NCT00737425|wound healing|wound healing
5934154|NCT02964507|GSK525762|gsk525762
5934155|NCT02964507|HR+/HER2- advanced or metastatic breast cancer|hr+/her2- advanced or metastatic breast cancer
5934174|NCT02957968|Breast Cancer|breast cancer
5640719|NCT00737412|Probiotics|probiotics
5640994|NCT00736619|TAXOL (PACLITAXEL)|taxol (paclitaxel)
5641094|NCT00736112|Recurrent Middle Ear Infections|recurrent middle ear infections
5641095|NCT00736112|Middle Ear Fluid|middle ear fluid
5641400|NCT00734929|PONV|ponv
5641553|NCT00734682|liposomal irinotecan|liposomal irinotecan
5642161|NCT00732420|Phase I|phase i
5642261|NCT00732043|PSA|psa
5642361|NCT00731510|Carbohydrate supplementation|carbohydrate supplementation
5642362|NCT00731510|Expedition,|expedition,
5642363|NCT00731510|Hydration,|hydration,
5642364|NCT00731510|Hypoxia|hypoxia
5642365|NCT00731510|Performance|performance
5642366|NCT00731497|SODIS|sodis
5642367|NCT00731497|Drinking Water|drinking water
5642939|NCT00729040|heart|heart
5643444|NCT00727246|FMRI|fmri
5643888|NCT00725855|Schizophrenia|schizophrenia
5643992|NCT00725400|Surgery|surgery
5644355|NCT00724022|Inhibitor|inhibitor
5644156|NCT00724919|ESBL|esbl
5644453|NCT00723489|Scarification Method|scarification method
5644950|NCT00721396|Infants|infants
5644646|NCT00722670|prevention|prevention
5644851|NCT00721799|FLT|flt
5645335|NCT00720070|tongue cancer|tongue cancer
5645447|NCT00719836|JAK2 Inhibitor|jak2 inhibitor
5645448|NCT00719823|Maraviroc Compassionate Use|maraviroc compassionate use
5645451|NCT00719797|stage IV rectal cancer|stage iv rectal cancer
5645452|NCT00719797|stage IV colon cancer|stage iv colon cancer
5645453|NCT00719797|stage III rectal cancer|stage iii rectal cancer
5645455|NCT00719784|Respiratory|respiratory
5645969|NCT00718328|Hemorrhage|hemorrhage
5646064|NCT00718003|Movement Disorders|movement disorders
5646539|NCT00716170|Glucose-dependent insulinotropic polypeptide|glucose-dependent insulinotropic polypeptide
5646540|NCT00716170|Glucagon-like peptide-1|glucagon-like peptide-1
5646541|NCT00716170|Glucagon-like peptide-2|glucagon-like peptide-2
5646542|NCT00716144|Psoriasis|psoriasis
5646543|NCT00716131|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5646578|NCT00716053|LVRS|lvrs
5647133|NCT00714025|Palliative treatment|palliative treatment
5647134|NCT00714025|advance or metastatic TCC|advance or metastatic tcc
5647135|NCT00714025|Failure after Platinum-based chemotherapy|failure after platinum-based chemotherapy
5647136|NCT00714012|Display development|display development
5647238|NCT00713570|COMT|comt
5647137|NCT00714012|Intuitive display use|intuitive display use
5647223|NCT00713622|seizures|seizures
5647224|NCT00713609|Acne|acne
5647225|NCT00713609|Acne Vulgaris|acne vulgaris
5647226|NCT00713609|Pimples|pimples
5647227|NCT00713596|Nasal Surgery|nasal surgery
5647228|NCT00713596|Septorhinoplasty|septorhinoplasty
5647507|NCT00712556|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5647508|NCT00712556|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5647509|NCT00712556|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5647686|NCT00712062|PCNSL|pcnsl
5647790|NCT00711633|infant,|infant,
5647884|NCT00711321|Alzheimer Vaccine|alzheimer vaccine
5647885|NCT00711321|A-beta immunotherapy|a-beta immunotherapy
5647886|NCT00711308|pulmonary embolism|pulmonary embolism
5647887|NCT00711308|low molecular weight heparin|low molecular weight heparin
5647888|NCT00711308|vitamin K antagonist|vitamin k antagonist
5647889|NCT00711308|Longterm|longterm
5647890|NCT00711295|Influenza (Pandemic)|influenza (pandemic)
5648011|NCT00710801|Tacrolimus|tacrolimus
5647891|NCT00711282|Replacement of non-restorable single tooth/teeth|replacement of non-restorable single tooth/teeth
5647892|NCT00711256|Sunscreen|sunscreen
5647893|NCT00711256|Application|application
5647894|NCT00711256|Vitamin D|vitamin d
5647895|NCT00711256|Sun protection factor|sun protection factor
5647965|NCT00710957|CHS|chs
5648266|NCT00709904|venous thromboprophylaxis|venous thromboprophylaxis
5648267|NCT00709904|primary prevention|primary prevention
5648268|NCT00709904|orthopedic surgery|orthopedic surgery
5648349|NCT00709618|MBC|mbc
5648466|NCT00709176|Colorectal Cancer|colorectal cancer
5648567|NCT00708747|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5648568|NCT00708747|interleukins|interleukins
5648569|NCT00708747|standardized serum-protein solution|standardized serum-protein solution
5648570|NCT00708734|exercise|exercise
5648571|NCT00708721|hypomethylating therapy|hypomethylating therapy
5648572|NCT00708721|CML|cml
5648583|NCT00708656|IBD|ibd
5648764|NCT00707941|Pneumonia|pneumonia
5648861|NCT00707460|Sandy Lake (Health & Diabetes Project)|sandy lake (health & diabetes project)
5648895|NCT00707356|male|male
5649049|NCT00706602|prediction rule|prediction rule
5649251|NCT00705705|High-Risk Behavior|high-risk behavior
5649252|NCT00705705|Men Who Have Sex With Men|men who have sex with men
5649253|NCT00705705|HIV Seronegativity|hiv seronegativity
5649254|NCT00705692|Tetanus|tetanus
5649255|NCT00705692|Vaccines|vaccines
5649256|NCT00705692|Renal Dialysis|renal dialysis
5649257|NCT00705692|Levamisole|levamisole
5649258|NCT00705679|Microbicide|microbicide
5649259|NCT00705679|HIV Seronegativity|hiv seronegativity
5649260|NCT00705653|cancer|cancer
5649261|NCT00705653|advanced cancer|advanced cancer
5649262|NCT00705653|solid tumors|solid tumors
5649263|NCT00705653|CGC-11047|cgc-11047
5649264|NCT00705653|PG-11047|pg-11047
5649265|NCT00705640|stage II melanoma|stage ii melanoma
5649266|NCT00705640|stage III melanoma|stage iii melanoma
5649267|NCT00705640|stage IV melanoma|stage iv melanoma
5649268|NCT00705640|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5649269|NCT00705640|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5649270|NCT00705640|conjunctival melanoma|conjunctival melanoma
5685578|NCT00555529|applanation tonometry|applanation tonometry
5934225|NCT02951364|observational|observational
5649271|NCT00705640|extraocular extension melanoma|extraocular extension melanoma
5649272|NCT00705640|iris melanoma|iris melanoma
5649273|NCT00705640|metastatic intraocular melanoma|metastatic intraocular melanoma
5649274|NCT00705640|recurrent intraocular melanoma|recurrent intraocular melanoma
5649275|NCT00705627|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5649276|NCT00705627|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5649277|NCT00705627|concurrent chemotherapy|concurrent chemotherapy
5649278|NCT00705627|randomized controlled clinical trials|randomized controlled clinical trials
5649279|NCT00705601|Nonrestorative Sleep, Restorative Sleep Questionnaire Refinement|nonrestorative sleep, restorative sleep questionnaire refinement
5649280|NCT00705575|Essential Hypertension|essential hypertension
5649281|NCT00705575|Stage II|stage ii
5649282|NCT00705549|Advanced|advanced
5649283|NCT00705549|NSCLC|nsclc
5649284|NCT00705549|ERCC1|ercc1
5649285|NCT00705549|RRM1|rrm1
5649286|NCT00705549|BCRA1|bcra1
5649287|NCT00705549|Alimta|alimta
5649288|NCT00705549|Gemcitabine|gemcitabine
5649289|NCT00705536|rHuPH20|rhuph20
5649290|NCT00705536|Hyaluronidase|hyaluronidase
5649291|NCT00705536|Insulin|insulin
5649604|NCT00703612|Adipose stromal vascular fraction|adipose stromal vascular fraction
5649605|NCT00703612|Autologous|autologous
5649606|NCT00703612|Hyperglycemia|hyperglycemia
5649607|NCT00703599|Diabetes Mellitus|diabetes mellitus
5649788|NCT00702858|Aromatase Inhibitors|aromatase inhibitors
5649789|NCT00702845|In vitro fertilization|in vitro fertilization
5649791|NCT00702845|Hormones|hormones
5650083|NCT00701805|Hemodialysis|hemodialysis
5650185|NCT00701350|Pregnancy|pregnancy
5650387|NCT00700362|Hyperglycemia|hyperglycemia
5650801|NCT00698581|Epilepsy; Monotherapy|epilepsy; monotherapy
5650802|NCT00698581|Partial Onset Seizures|partial onset seizures
5650803|NCT00698581|Adults and Adolescents|adults and adolescents
5650804|NCT00698568|Herpes simplex, Herpes simplex candidate vaccine|herpes simplex, herpes simplex candidate vaccine
5650998|NCT00697853|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5650999|NCT00697840|Hepatitis B|hepatitis b
5651000|NCT00697840|Engerix™-B|engerix™-b
5651001|NCT00697840|Recombinant hepatitis B vaccine|recombinant hepatitis b vaccine
5651207|NCT00696943|cell death|cell death
5651515|NCT00695552|Major depression, exercise|major depression, exercise
5651602|NCT00695318|AMD|amd
5651894|NCT00694057|Metformin|metformin
5652736|NCT00690976|gay|gay
5652818|NCT00690612|pediatric|pediatric
5653020|NCT00689988|child|child
5653114|NCT00689611|Zyban|zyban
5653115|NCT00689611|Secondary intervention post-ACS|secondary intervention post-acs
5653116|NCT00689598|Atrial fibrillation, spironolactone|atrial fibrillation, spironolactone
5653117|NCT00689585|Complex Regional Pain Syndrome|complex regional pain syndrome
5653310|NCT00689000|Refractory|refractory
5653513|NCT00688311|synbiotic|synbiotic
5653514|NCT00688311|probiotic|probiotic
5653515|NCT00688311|immune activation|immune activation
5653516|NCT00688311|blood CD4 count|blood cd4 count
5653517|NCT00688311|bacterial translocation|bacterial translocation
5653596|NCT00687960|Age|age
5653707|NCT00687570|patients with rectal cancer undergoing surgery|patients with rectal cancer undergoing surgery
5653709|NCT00687570|Bowel preparation|bowel preparation
5653710|NCT00687570|Rectal cancer|rectal cancer
5654295|NCT00685087|To determine psychological and behavioral correlates of CP disease progression and outcomes.|to determine psychological and behavioral correlates of cp disease progression and outcomes.
5654296|NCT00685074|Motivational Interview|motivational interview
5654297|NCT00685074|Computer based intervention|computer based intervention
5654298|NCT00685074|Substance abuse|substance abuse
5654299|NCT00685074|post-partum|post-partum
5654300|NCT00685061|Adult, primary deceased donor kidney transplant recipients|adult, primary deceased donor kidney transplant recipients
5654301|NCT00685048|Gambling|gambling
5654302|NCT00685048|Brief Therapies|brief therapies
5654303|NCT00685048|Substance Abuse|substance abuse
5654304|NCT00685035|high frequency chest wall oscillation, cystic fibrosis|high frequency chest wall oscillation, cystic fibrosis
5654466|NCT00684294|cancer|cancer
5654467|NCT00684294|oncology|oncology
5654469|NCT00684268|silibinin|silibinin
5654470|NCT00684268|chronic hepatitis C|chronic hepatitis c
5654471|NCT00684268|peginterferon|peginterferon
5654472|NCT00684268|ribavirin|ribavirin
5654473|NCT00684268|nonresponders|nonresponders
5654474|NCT00684268|efficacy of iv. silibinin|efficacy of iv. silibinin
5654475|NCT00684268|safety|safety
5654476|NCT00684255|Autoimmune Disease|autoimmune disease
5655244|NCT00681330|TTK|ttk
5655343|NCT00680901|HER2|her2
5655644|NCT00679757|Obstructive sleep apnea|obstructive sleep apnea
5655645|NCT00679757|Wound healing|wound healing
5655646|NCT00679757|Non-healing wounds|non-healing wounds
5655647|NCT00679744|Tay-Sachs disease.|tay-sachs disease.
5656051|NCT00678132|Cancer|cancer
5656052|NCT00678132|Solid Tumor|solid tumor
5656053|NCT00678119|Kidney cancer|kidney cancer
5656054|NCT00678119|Renal cancer|renal cancer
5656055|NCT00678119|Renal Cell Carcinoma|renal cell carcinoma
5656147|NCT00677742|hormonal contraception|hormonal contraception
5656148|NCT00677742|contraceptive behavior|contraceptive behavior
5656149|NCT00677742|patient compliance|patient compliance
5656152|NCT00677729|infants|infants
5656263|NCT00677326|VEGFR1|vegfr1
5656866|NCT00675077|Huntington Chorea|huntington chorea
5656947|NCT00674791|Histologically confirmed, TxN2-3M0 or metastatic breast cancer|histologically confirmed, txn2-3m0 or metastatic breast cancer
5656948|NCT00674778|Radial|radial
5656949|NCT00674778|Femoral|femoral
5656950|NCT00674778|artery|artery
5656951|NCT00674778|Invasive cardiology safety|invasive cardiology safety
5656952|NCT00674739|external genital warts|external genital warts
5657171|NCT00673946|hospitalization|hospitalization
5657414|NCT00673049|IGR-1R|igr-1r
5657597|NCT00672295|Paraplatin|paraplatin
5657700|NCT00671918|lymph nodes|lymph nodes
5657982|NCT00671086|Transient Insomnia|transient insomnia
5657984|NCT00671086|Sleep Disorders, Intrinsic|sleep disorders, intrinsic
5657985|NCT00671073|Airflow Obstruction, Chronic|airflow obstruction, chronic
5657986|NCT00671073|Chronic Airflow Obstruction|chronic airflow obstruction
5657987|NCT00671073|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5657990|NCT00671073|COPD|copd
5658064|NCT00670696|Topical anaesthesia for venous cannulation|topical anaesthesia for venous cannulation
5658357|NCT00669344|VCI|vci
5658460|NCT00668759|AF|af
5661077|NCT00659165|PYY|pyy
5849346|NCT00029822|AUR|aur
5659051|NCT00666497|Histone deacetylase inhibitor|histone deacetylase inhibitor
5659052|NCT00666497|DNA methyltransferase inhibitor|dna methyltransferase inhibitor
5659053|NCT00666497|Epigenetic Therapy|epigenetic therapy
5659054|NCT00666484|neurotoxicity|neurotoxicity
5659288|NCT00666107|HIV|hiv
5659438|NCT00665418|children|children
5659439|NCT00665418|Larynx|larynx
5659440|NCT00665405|Delivery, obstetric|delivery, obstetric
5659625|NCT00664703|Methylphenidate|methylphenidate
5660124|NCT00662480|peripheral arterial disease|peripheral arterial disease
5660219|NCT00662129|stage IV breast cancer|stage iv breast cancer
5660424|NCT00661830|biliary|biliary
5660682|NCT00660621|GBM|gbm
5660759|NCT00660296|CO2|co2
5661097|NCT00659048|PAR|par
5661109|NCT00659022|metabolism|metabolism
5661402|NCT00657696|organizations|organizations
5661794|NCT00656045|Dietary Intake|dietary intake
5662102|NCT00654745|blood pressure reduction|blood pressure reduction
5662103|NCT00654719|Heart failure|heart failure
5662104|NCT00654719|cachexia|cachexia
5662390|NCT00653900|Verify now|verify now
5662488|NCT00653562|polysomnography|polysomnography
5662582|NCT00653107|Stent|stent
5662877|NCT00651794|Medical Errors|medical errors
5663689|NCT00646737|conversion|conversion
5663408|NCT00648687|very low birth weight infants|very low birth weight infants
5663409|NCT00648635|Rectal Cancer|rectal cancer
5663410|NCT00648635|Recurrent Rectal Adenocarcinoma|recurrent rectal adenocarcinoma
5663926|NCT00645970|combat injuries|combat injuries
5663927|NCT00645970|pain assessment|pain assessment
5663929|NCT00645970|rehabilitation|rehabilitation
5664023|NCT00645528|insulin|insulin
5664024|NCT00645528|teaching|teaching
5664236|NCT00644267|risk score|risk score
5664848|NCT00641550|Apgar scores|apgar scores
5664934|NCT00641329|Attention Deficit|attention deficit
5665124|NCT00640601|Seroquel|seroquel
5665303|NCT00639769|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5665403|NCT00639301|Survivor|survivor
5665702|NCT00637962|HIV|hiv
5665947|NCT00637273|Byetta|byetta
5666236|NCT00636012|acupuncture|acupuncture
5666365|NCT00635505|HFA|hfa
5666434|NCT00635271|HV|hv
5666830|NCT00633633|Diet|diet
5668080|NCT00628771|Translational Research|translational research
5668541|NCT00626964|Bioimpedance|bioimpedance
5668542|NCT00626964|Morbid Obesity|morbid obesity
5668543|NCT00626964|APO A|apo a
5668545|NCT00626964|Framingham risk score|framingham risk score
5668546|NCT00626964|Prevention of Coronary Heart Disease|prevention of coronary heart disease
5668547|NCT00626964|Lifestyle Intervention|lifestyle intervention
5668819|NCT00625924|reconstruction|reconstruction
5668820|NCT00625911|thoracotomy|thoracotomy
5669013|NCT00625274|Nexium|nexium
4955131|NCT04269447|Vascular surgery|vascular surgery
4955132|NCT04269447|Vascular disease|vascular disease
4955133|NCT04269447|Cardiovascular disease|cardiovascular disease
4955134|NCT04269434|screening|screening
4955506|NCT04267029|FNHTR (febrile non-hemolytic transfusion reaction)|fnhtr (febrile non-hemolytic transfusion reaction)
4955507|NCT04267029|TAD (transfusion associated dyspnea)|tad (transfusion associated dyspnea)
4962142|NCT04226443|Analgesia|analgesia
4962927|NCT04222088|TES|tes
4964707|NCT04209855|Folate-receptor alpha expression|folate-receptor alpha expression
4964708|NCT04209855|Phase 3|phase 3
4964709|NCT04209855|Antibody-drug conjugate|antibody-drug conjugate
4964710|NCT04209855|mirvetuximab soravtansine|mirvetuximab soravtansine
4972243|NCT04164849|Photopheresis|photopheresis
4972244|NCT04164849|5-aminolevulinic acid|5-aminolevulinic acid
4974649|NCT04150744|hepatocellular carcinoma|hepatocellular carcinoma
4974650|NCT04150731|Breast cancer|breast cancer
4974651|NCT04150731|Liver metastases|liver metastases
4974652|NCT04150731|FES-PET/CT|fes-pet/ct
4974653|NCT04150731|Dynamic scan|dynamic scan
4974654|NCT04150679|bile duct injury|bile duct injury
4975766|NCT04143373|Warm Saline|warm saline
4979037|NCT04123106|Anesthetics, Local|anesthetics, local
4979048|NCT04123002|Miswak|miswak
4979231|NCT04122053|personalized nutrition|personalized nutrition
4981039|NCT04111250|Crestal approach|crestal approach
4981040|NCT04111211|Alzheimer's disease|alzheimer's disease
4981041|NCT04111211|related disorders|related disorders
4981042|NCT04111211|Mild Cognitive Impairment|mild cognitive impairment
4981043|NCT04111198|Epicardial fat tissue|epicardial fat tissue
4981044|NCT04111198|Cardiac MRI|cardiac mri
4985492|NCT04082546|Speckle-traking echocardiography|speckle-traking echocardiography
4985493|NCT04082546|Myocardial ischemia|myocardial ischemia
4987600|NCT04068909|coronary artery disease|coronary artery disease
4987601|NCT04068909|death|death
4987602|NCT04068909|gene|gene
4987603|NCT04068909|bleeding|bleeding
4987604|NCT04068909|atherosclerosis|atherosclerosis
4987672|NCT04068298|sepsis|sepsis
4989067|NCT04059614|EIT|eit
4993556|NCT04034173|FIRE|fire
4995802|NCT04020016|hepatic impairment|hepatic impairment
4995803|NCT04020003|Levosimendan|levosimendan
4995807|NCT04019977|Nurse Home Visiting|nurse home visiting
4995808|NCT04019964|Prostate cancer|prostate cancer
4995809|NCT04019964|MMR-deficient prostate cancer|mmr-deficient prostate cancer
4999188|NCT03999866|airtraq|airtraq
5000899|NCT03989544|Autoinjector|autoinjector
5003098|NCT03976817|surgery|surgery
5014818|NCT03904186|HIV|hiv
5016033|NCT03896945|AVP-786|avp-786
5021776|NCT03861273|FIX|fix
5023922|NCT03848273|EEG|eeg
5026205|NCT03834818|pain|pain
5028506|NCT03821350|Radicular pain|radicular pain
5032073|NCT03798704|children|children
5032087|NCT03798626|CRC|crc
5036438|NCT03771261|Egg|egg
5046037|NCT03711331|Antimicrobial therapy|antimicrobial therapy
5050115|NCT03684720|Instructional design|instructional design
5050116|NCT03684720|Guided Discovery Learning|guided discovery learning
5050117|NCT03684720|Retention|retention
5050119|NCT03684668|sexual behavior|sexual behavior
5050120|NCT03684668|condom use|condom use
5050121|NCT03684668|Self-Efficacy|self-efficacy
5050122|NCT03684668|educational technology|educational technology
5050123|NCT03684655|HIV infection|hiv infection
5050124|NCT03684655|Positron Emission Tomography|positron emission tomography
5050125|NCT03684655|F-AraG|f-arag
5050126|NCT03684655|Magnetic Resonance Imaging|magnetic resonance imaging
5050316|NCT03683290|Development|development
5050317|NCT03683290|Pregnancy|pregnancy
5050318|NCT03683290|Competence|competence
5050319|NCT03683212|Emergency department|emergency department
5050320|NCT03683212|Elderly|elderly
5050321|NCT03683212|Acute heart failure|acute heart failure
5051618|NCT03675425|Chest Childing|chest childing
5053914|NCT03661255|Suicide Prevention|suicide prevention
5056238|NCT03647488|EGFRwt|egfrwt
5056240|NCT03647488|ALK-|alk-
5058738|NCT03631862|RR|rr
5060427|NCT03621111|Myocardial Infarct|myocardial infarct
5060431|NCT03621111|Pill counts|pill counts
5062143|NCT03610763|tDCS|tdcs
5064821|NCT03593824|Prosperity|prosperity
5067731|NCT03575767|TCR Repertoire|tcr repertoire
5067732|NCT03575767|Next Generation Sequencing|next generation sequencing
5067733|NCT03575767|ALL|all
5067734|NCT03575767|AML|aml
5067735|NCT03575767|MDS|mds
5067736|NCT03575767|Myeloablative|myeloablative
5067737|NCT03575741|postural control|postural control
5067738|NCT03575741|rehabilitation|rehabilitation
5934245|NCT02947217|Immunology|immunology
5934246|NCT02947217|Pregnancy|pregnancy
5934247|NCT02947217|Implantation Rate|implantation rate
5934248|NCT02947217|Fertilization in Vitro|fertilization in vitro
5934249|NCT02946177|Immunology|immunology
5934250|NCT02946177|Pregnancy|pregnancy
5934251|NCT02946177|Implantation Rate|implantation rate
5934252|NCT02946177|Fertilization in Vitro|fertilization in vitro
5934253|NCT02946177|Oocyte donor egg recipient|oocyte donor egg recipient
5067739|NCT03575741|return-to-sport|return-to-sport
5067740|NCT03575741|mTBI|mtbi
5067741|NCT03575728|Mental Health|mental health
5067742|NCT03575728|Information Technology|information technology
5067743|NCT03575728|Chronic Disease Prevention and Management|chronic disease prevention and management
5067755|NCT03575689|Septoplasty|septoplasty
5069349|NCT03565575|HIV|hiv
5069350|NCT03565562|Health promotion|health promotion
5069351|NCT03565562|Local authorities involvement|local authorities involvement
5069353|NCT03565562|Primary prevention|primary prevention
5069435|NCT03565172|children|children
5069436|NCT03565107|Epigenetic|epigenetic
5069437|NCT03565107|Female age|female age
5069438|NCT03565107|Gene regulation|gene regulation
5069724|NCT03563274|Hepatocellular Carcinoma,Holmium-166,SIRT,QuiremSpheres®|hepatocellular carcinoma,holmium-166,sirt,quiremspheres®
5069725|NCT03563261|Older Adults|older adults
5071833|NCT03550105|Glucose|glucose
5082394|NCT03483636|Drug-alcohol interaction|drug-alcohol interaction
5086055|NCT03460314|Bariatric surgery|bariatric surgery
5086056|NCT03460314|Gastrointestinal tract|gastrointestinal tract
5087959|NCT03448120|Muscle fatigue|muscle fatigue
5087960|NCT03448120|Thermography|thermography
5093720|NCT03412903|Inpatient treatment team|inpatient treatment team
5093723|NCT03412903|Comprehensive pharmaceutical assessment|comprehensive pharmaceutical assessment
5093724|NCT03412903|Medication history|medication history
5094045|NCT03410992|PSO|pso
5094112|NCT03410732|immunotherapy|immunotherapy
5094113|NCT03410732|tumor cell membrane proteins|tumor cell membrane proteins
5094114|NCT03410706|Venous thromboembolism|venous thromboembolism
5094217|NCT03409744|HoFH|hofh
5096184|NCT03396796|Hypertension|hypertension
5097847|NCT03386773|patient generated health data|patient generated health data
5103456|NCT03350594|Adolescence|adolescence
5103545|NCT03349814|appendicitis|appendicitis
5103546|NCT03349814|appendectomy|appendectomy
5105434|NCT03338270|Neuroradiology|neuroradiology
5112583|NCT03293524|Nervous System Diseases|nervous system diseases
5114400|NCT03281681|ovarian cancer|ovarian cancer
5114401|NCT03281681|cancer of the ovary|cancer of the ovary
5114402|NCT03281681|ovarian neoplasm|ovarian neoplasm
5114403|NCT03281681|AO|ao
5114693|NCT03280030|FLT3|flt3
5117490|NCT03261167|GSK1358820|gsk1358820
5128321|NCT03192202|immunotherapy|immunotherapy
5143354|NCT03095638|Healthy|healthy
5146023|NCT03079258|cerebrovascular reactivity|cerebrovascular reactivity
5149720|NCT03056638|Ultra-Hypofractionated SBRT|ultra-hypofractionated sbrt
5249437|NCT02448628|CS-3150|cs-3150
5255349|NCT02416297|Tomography|tomography
5272134|NCT02319330|HIV|hiv
5287657|NCT02234453|remote|remote
5287658|NCT02234427|aspirin, atherosclerosis|aspirin, atherosclerosis
5287659|NCT02234414|vertebral fracture assessment (vfa)|vertebral fracture assessment (vfa)
5287749|NCT02233946|Prevention|prevention
5287750|NCT02233946|Youth|youth
5287751|NCT02233946|Alcohol|alcohol
5303767|NCT02158546|Samidorphan|samidorphan
5303769|NCT02158533|Depression|depression
5319238|NCT02088710|Breast Cancer|breast cancer
5335335|NCT02015663|CF|cf
5387954|NCT01776619|PK|pk
5395809|NCT01740648|Rectal Cancers|rectal cancers
5395810|NCT01740648|KRAS|kras
5395811|NCT01740648|BRAF|braf
5395812|NCT01740648|NRAS Mutant|nras mutant
5396140|NCT01739387|Asthma|asthma
5449449|NCT01505036|smart-care|smart-care
5459294|NCT01464346|CGM|cgm
5502799|NCT01284452|ARDS|ards
5524380|NCT01190904|MI|mi
5524563|NCT01190202|Plasmodium falciparum|plasmodium falciparum
5524564|NCT01190189|Serious adverse events (SAEs)|serious adverse events (saes)
5585599|NCT00948116|Renal Impairment|renal impairment
5649882|NCT00702585|Multi-center|multi-center
5649883|NCT00702585|Multi-national|multi-national
5934266|NCT02941900|Genetic Testing|genetic testing
5934267|NCT02941900|16-1243|16-1243
5671647|NCT00615004|GH|gh
5671825|NCT00614198|casein|casein
5688614|NCT00542516|Hydroxyethyl Starch|hydroxyethyl starch
5688615|NCT00542516|Hemodilution|hemodilution
5688617|NCT00542516|Colloids|colloids
5671923|NCT00613548|Moderate|moderate
5689168|NCT00539825|Plethysmography|plethysmography
5689169|NCT00539825|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5689170|NCT00539825|COPD,|copd,
5689171|NCT00539825|FTIH,|ftih,
5689172|NCT00539812|Intimate partner violence|intimate partner violence
5689173|NCT00539812|alcohol use|alcohol use
5689373|NCT00538980|PV|pv
5672737|NCT00610909|IBS|ibs
5672823|NCT00610493|Torisel|torisel
5689909|NCT00538733|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5689910|NCT00538720|Primary Hyperparathyroidism|primary hyperparathyroidism
5690334|NCT00536848|HIV|hiv
5690780|NCT00535028|late asthmatic response|late asthmatic response
5674554|NCT00603187|Acyline|acyline
5674815|NCT00601887|Anti-inflammatory|anti-inflammatory
5691203|NCT00533416|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5691204|NCT00533416|Selective Mitotic Inhibitor|selective mitotic inhibitor
5691205|NCT00533416|Targeted Therapy|targeted therapy
5691208|NCT00533390|efavirenz|efavirenz
5691304|NCT00532870|Ventral hernias are the second most common type of abdominal hernias after inguinal hernias.|ventral hernias are the second most common type of abdominal hernias after inguinal hernias.
5691305|NCT00532870|The majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo Laparotomy .|the majority of ventral hernias are incisional hernias that develop in 11% to 20% of patients who undergo laparotomy .
5691317|NCT00532818|Epigenetic therapy|epigenetic therapy
5674977|NCT00601354|Binge Eating|binge eating
5675137|NCT00600691|hematospermia|hematospermia
5691991|NCT00529828|CLA|cla
5675610|NCT00598390|PET Imaging|pet imaging
5675611|NCT00598390|[11C]MePPEP|[11c]meppep
5675612|NCT00598390|Healthy Volunteer|healthy volunteer
5675613|NCT00598390|HV|hv
5675614|NCT00598377|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5675615|NCT00598377|Adrenal functions|adrenal functions
5675809|NCT00597584|EPO|epo
5692292|NCT00528593|HIV|hiv
5676209|NCT00595972|Time to Progression|time to progression
5693624|NCT00523900|BMI under 19|bmi under 19
5693625|NCT00523900|under nourished|under nourished
5693626|NCT00523900|malnourished|malnourished
5693627|NCT00523887|Radiation pain|radiation pain
5693738|NCT00523523|stroke|stroke
5693826|NCT00523159|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5677509|NCT00590109|BRCA2|brca2
5677609|NCT00589784|07-135|07-135
5694593|NCT00520494|XLA|xla
5678198|NCT00587964|Sarcoma|sarcoma
5695012|NCT00518570|PMS|pms
5679120|NCT00583401|PFO|pfo
5695639|NCT00515723|control|control
5679322|NCT00582569|MRI|mri
5679515|NCT00581724|07-068|07-068
5679620|NCT00581191|SAD|sad
5696031|NCT00514280|Birth Weight|birth weight
5696032|NCT00514280|Gestational Age|gestational age
5696033|NCT00514280|Lead|lead
5696034|NCT00514280|Tobacco Smoke|tobacco smoke
5696036|NCT00514267|HRPC|hrpc
5696602|NCT00512551|DNA|dna
5697596|NCT00509106|CAP|cap
5680440|NCT00577798|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5680441|NCT00577798|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5680442|NCT00577798|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5680443|NCT00577798|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5680444|NCT00577798|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5680445|NCT00577798|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5697780|NCT00508612|Diastolic Blood Pressure|diastolic blood pressure
5680447|NCT00577798|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5680448|NCT00577798|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5685580|NCT00555529|smokers|smokers
5680449|NCT00577798|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5680450|NCT00577798|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5680451|NCT00577798|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5680452|NCT00577798|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5680453|NCT00577798|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5698796|NCT00505128|Endoscopic sphincterotomy|endoscopic sphincterotomy
5699256|NCT00503828|WOMAC|womac
5682897|NCT00567099|Open Label|open label
5683078|NCT00566423|MIF|mif
5683277|NCT00565669|Dry Eye|dry eye
5683472|NCT00564603|Glucocorticoid|glucocorticoid
5680454|NCT00577798|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5680455|NCT00577798|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5680456|NCT00577798|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5680521|NCT00577759|diet|diet
5680522|NCT00577759|tobacco|tobacco
5680457|NCT00577798|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5680458|NCT00577798|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5683860|NCT00562874|HIV|hiv
5683936|NCT00562640|06-155|06-155
5684101|NCT00561912|RCC|rcc
5680459|NCT00577798|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5680460|NCT00577798|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5680461|NCT00577798|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5685161|NCT00557388|aging|aging
5685383|NCT00556348|AMD|amd
5680462|NCT00577798|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5680463|NCT00577798|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5680464|NCT00577798|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5685698|NCT00555061|SID|sid
5702186|NCT00494299|HCC|hcc
5680465|NCT00577798|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5680466|NCT00577798|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5680467|NCT00577798|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5680468|NCT00577798|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5681130|NCT00574613|skin fibrosis in systemic sclerosis|skin fibrosis in systemic sclerosis
5681131|NCT00574600|HIV Seronegativity|hiv seronegativity
5702643|NCT00492609|Surgery|surgery
5680469|NCT00577798|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5680470|NCT00577798|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5681132|NCT00574600|HIV Preventive Vaccine|hiv preventive vaccine
5680471|NCT00577798|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5680472|NCT00577798|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5680473|NCT00577798|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5681133|NCT00574587|Vorinostat|vorinostat
5687007|NCT00549523|HIV|hiv
5703654|NCT00488592|MDS|mds
5680474|NCT00577798|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5680475|NCT00577798|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5680476|NCT00577798|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5687918|NCT00544726|Rehabilitation|rehabilitation
5704959|NCT00483652|MS|ms
5705322|NCT00482313|Prison|prison
5689091|NCT00540202|Coartem|coartem
5706583|NCT00477399|QOL|qol
5689927|NCT00538655|treatment study|treatment study
5680477|NCT00577798|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5680478|NCT00577798|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5707012|NCT00475956|Choriocarcinoma|choriocarcinoma
5681972|NCT00571038|Hypertension|hypertension
5681973|NCT00571038|Self-help groups|self-help groups
5681974|NCT00571038|Community health networks|community health networks
5681975|NCT00571038|Health knowledge, attitudes, practice|health knowledge, attitudes, practice
5681976|NCT00571038|Patient participation|patient participation
5681977|NCT00571038|Randomized clinical trial|randomized clinical trial
5681978|NCT00571025|Mild Cognitive Impairment|mild cognitive impairment
5681979|NCT00571025|disease/disorder proneness/risk|disease/disorder proneness/risk
5681980|NCT00571025|family genetics|family genetics
5681981|NCT00571025|genetic counseling|genetic counseling
5681982|NCT00571025|genetic marker|genetic marker
5681983|NCT00571025|genetic polymorphism|genetic polymorphism
5846409|NCT00044590|Pesticides|pesticides
5681984|NCT00571025|genetic susceptibility|genetic susceptibility
5681986|NCT00571012|outflow facility|outflow facility
5681987|NCT00571012|Healthy eye function|healthy eye function
5681988|NCT00570999|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5681989|NCT00570999|Palifermin|palifermin
5681990|NCT00570999|Kepivance|kepivance
5681991|NCT00570999|Prevenar|prevenar
5681993|NCT00570986|Plaque Psoriasis|plaque psoriasis
5681994|NCT00570973|Variceal Bleeding|variceal bleeding
5681995|NCT00570973|Cirrhosis|cirrhosis
5681996|NCT00570973|Encephalopathy|encephalopathy
5681997|NCT00570973|Endoscopic band ligation|endoscopic band ligation
5681998|NCT00570973|TIPS|tips
5681999|NCT00570960|Peritonitis|peritonitis
5682000|NCT00570947|CPR Anytime|cpr anytime
5682001|NCT00570921|Breast cancer|breast cancer
5682002|NCT00570921|Fulvestrant|fulvestrant
5682003|NCT00570921|Everolimus|everolimus
5682004|NCT00570908|brain metastasis|brain metastasis
5682005|NCT00570908|breast cancer|breast cancer
5682006|NCT00570908|metastatic breast cancer|metastatic breast cancer
5682007|NCT00570895|Iron|iron
5682008|NCT00570895|Absorption|absorption
5682009|NCT00570895|Ascorbic Acid|ascorbic acid
5682010|NCT00570895|Ferrous Fumarate|ferrous fumarate
5682011|NCT00570882|Renal cell carcinoma|renal cell carcinoma
5682012|NCT00570882|Sunitinib|sunitinib
5682013|NCT00570882|phase II study|phase ii study
5682014|NCT00570882|Randomized study|randomized study
5682015|NCT00570869|Infant CPR|infant cpr
5682016|NCT00570856|Folic Acid|folic acid
5682017|NCT00570856|Homocysteine|homocysteine
5682018|NCT00570856|intima-media thickness|intima-media thickness
5682019|NCT00570817|Methotrexate|methotrexate
5682020|NCT00570817|Nephrotoxicity|nephrotoxicity
5682021|NCT00570817|Hydration|hydration
5682022|NCT00570817|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5682023|NCT00570817|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5682024|NCT00570817|Medulloblastoma|medulloblastoma
5682025|NCT00570817|Ependymoma|ependymoma
5682026|NCT00570817|Prolonged elimination time of methotrexate|prolonged elimination time of methotrexate
5682027|NCT00570804|Smoking Cessation|smoking cessation
5682028|NCT00570804|Puerto Rico Quitline|puerto rico quitline
5682029|NCT00570804|Motivational Relapse Prevention|motivational relapse prevention
5682030|NCT00570804|Oral Cancer|oral cancer
5682031|NCT00570804|Risk Reduction|risk reduction
5682032|NCT00570804|Tobacco Use|tobacco use
5682033|NCT00570804|Alcohol Use|alcohol use
5682035|NCT00570804|Motivation and Problem-Solving|motivation and problem-solving
5682036|NCT00570804|Telephone Interview|telephone interview
5682037|NCT00570804|Counseling|counseling
5682038|NCT00570791|Cornea|cornea
5682039|NCT00570791|Tonometers|tonometers
5682040|NCT00570791|Goldmann applanation|goldmann applanation
5682041|NCT00570791|Tonopen|tonopen
5682042|NCT00570791|Shiotz|shiotz
5682043|NCT00570791|Pneumatonometer|pneumatonometer
5682166|NCT00570154|Macrophages and Diabetes or Insulin Resistance|macrophages and diabetes or insulin resistance
5682044|NCT00570778|QVA, Indacaterol, Glycopyrrolate, Concept1, COPD, cross over study, safety and efficacy, trough FEV1|qva, indacaterol, glycopyrrolate, concept1, copd, cross over study, safety and efficacy, trough fev1
5682045|NCT00570739|Colesevelam|colesevelam
5682046|NCT00570739|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5682047|NCT00570739|Pre-diabetes|pre-diabetes
5682048|NCT00570739|Metformin|metformin
5682049|NCT00570700|prostate|prostate
5682050|NCT00570687|Inhaled Insulin|inhaled insulin
5682051|NCT00570674|SSCHN|sschn
5682052|NCT00570674|Abraxane|abraxane
5682053|NCT00570674|IMRT|imrt
5682054|NCT00570648|Corneal transplantation|corneal transplantation
5682055|NCT00570635|GIST|gist
5682056|NCT00570635|Gastrointestinal Cancer|gastrointestinal cancer
5682057|NCT00570622|Cirrhosis|cirrhosis
5934328|NCT02932501|Bisphosphonate|bisphosphonate
5934329|NCT02932501|Jaw|jaw
5934330|NCT02932501|Osteonecrosis|osteonecrosis
5934331|NCT02932501|Antiresorptive drugs|antiresorptive drugs
5934332|NCT02932501|Denosumab|denosumab
5682058|NCT00570622|oxidative stress|oxidative stress
5682059|NCT00570622|pioglitazone|pioglitazone
5682060|NCT00570609|CPR|cpr
5682061|NCT00570583|Depression|depression
5682062|NCT00570583|Cognitive impairment|cognitive impairment
5682063|NCT00570583|Dementia|dementia
5682064|NCT00570583|Neuroimaging|neuroimaging
5682065|NCT00570583|Genetics|genetics
5682066|NCT00570570|stroke|stroke
5682067|NCT00570570|hemiplegia|hemiplegia
5682068|NCT00570570|gait|gait
5682069|NCT00570570|Strengthening|strengthening
5682070|NCT00570570|Physiotherapy|physiotherapy
5682071|NCT00570557|Skill Maintenance|skill maintenance
5682072|NCT00570557|Skill Decay|skill decay
5682073|NCT00570557|Screening|screening
5682074|NCT00570544|copd|copd
5682075|NCT00570544|emphysema|emphysema
5682076|NCT00570544|tiotropium|tiotropium
5682077|NCT00570544|lung function|lung function
5682078|NCT00570544|dynamic hyperinflation|dynamic hyperinflation
5682079|NCT00570518|driving under the influence|driving under the influence
5682080|NCT00570518|psychoactive substances|psychoactive substances
5682081|NCT00570518|roadside surveys|roadside surveys
5682082|NCT00570518|hospital surveys|hospital surveys
5682083|NCT00570518|accident involvement risk estimation|accident involvement risk estimation
5682084|NCT00570492|allergic rhinitis|allergic rhinitis
5682085|NCT00570492|fluticasone furoate nasal spray|fluticasone furoate nasal spray
5682086|NCT00570492|growth|growth
5682087|NCT00570479|Retisert|retisert
5682088|NCT00570479|Uveitis|uveitis
5682089|NCT00570479|glaucoma|glaucoma
5682090|NCT00570466|Type 2 Diabetes|type 2 diabetes
5682091|NCT00570466|Prevention|prevention
5682092|NCT00570466|Children|children
5682093|NCT00570466|Diet|diet
5682094|NCT00570466|Physical Activity|physical activity
5682095|NCT00570440|AE adverse event|ae adverse event
5682096|NCT00570440|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5682097|NCT00570440|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5682098|NCT00570440|ART antiretroviral therapy|art antiretroviral therapy
5682099|NCT00570440|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5682100|NCT00570440|DCF data collection forms|dcf data collection forms
5682101|NCT00570440|DMC Data Monitoring Committee|dmc data monitoring committee
5682102|NCT00570440|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5682103|NCT00570440|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5682104|NCT00570440|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5682105|NCT00570440|ICH International Conference of Harmonisation|ich international conference of harmonisation
5682106|NCT00570440|IND Investigational New Drug Application|ind investigational new drug application
5682107|NCT00570440|IRB Institutional Review Board|irb institutional review board
5682108|NCT00570440|IU international units|iu international units
5682109|NCT00570440|mg milligram(s)|mg milligram(s)
5682110|NCT00570440|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5682111|NCT00570440|PCR polymerase chain reaction|pcr polymerase chain reaction
5682112|NCT00570440|SAE serious adverse event|sae serious adverse event
5682113|NCT00570440|µg microgram|µg microgram
5682114|NCT00570440|ULN upper limit of the normal range|uln upper limit of the normal range
5682115|NCT00570440|WB Western Blot|wb western blot
5682116|NCT00570427|psychotherapy|psychotherapy
5682117|NCT00570427|behavior therapy|behavior therapy
5682118|NCT00570427|counseling|counseling
5682119|NCT00570427|aging|aging
5682120|NCT00570427|medically underserved population|medically underserved population
5682121|NCT00570401|adenocarcinoma of the lung|adenocarcinoma of the lung
5682122|NCT00570401|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5682123|NCT00570401|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5682124|NCT00570401|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5682125|NCT00570401|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5682126|NCT00570388|Neurocognitive|neurocognitive
5682127|NCT00570388|Alcohol Dependence|alcohol dependence
5682128|NCT00570388|Prometa|prometa
5682129|NCT00570388|Prometa Protocol|prometa protocol
5682130|NCT00570388|Starosta|starosta
5682131|NCT00570375|Blood disease, bone marrow|blood disease, bone marrow
5682132|NCT00570362|Normal tension glaucoma|normal tension glaucoma
5682133|NCT00570362|Glutathione|glutathione
5682134|NCT00570362|Antioxidant|antioxidant
5682135|NCT00570349|Inhaled Nitric oxide|inhaled nitric oxide
5682136|NCT00570349|Cystic Fibrosis|cystic fibrosis
5682137|NCT00570336|HCV|hcv
5682138|NCT00570336|HCV treatment failure|hcv treatment failure
5682139|NCT00570336|Elevated aminotransferases|elevated aminotransferases
5682140|NCT00570323|Breast Cancer|breast cancer
5682141|NCT00570323|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
5682142|NCT00570297|Pediatric|pediatric
5682143|NCT00570297|Polymorphism, Genetic|polymorphism, genetic
5682144|NCT00570297|Adrenergic beta-Agonists|adrenergic beta-agonists
5682145|NCT00570284|Cancer|cancer
5682146|NCT00570284|solid tumor|solid tumor
5682147|NCT00570284|food effect|food effect
5682148|NCT00570284|HDAC inhibitor|hdac inhibitor
5682149|NCT00570284|oral|oral
5682150|NCT00570284|LBH589|lbh589
5682151|NCT00570271|placebo effect|placebo effect
5682152|NCT00570271|blood pressure|blood pressure
5682153|NCT00570271|autonomic nervous system|autonomic nervous system
5682154|NCT00570271|prestige|prestige
5682155|NCT00570271|basic research on physiological placebo effects|basic research on physiological placebo effects
5682156|NCT00570245|Lung transplantation|lung transplantation
5682157|NCT00570232|Resectable, recurrent head and neck cancer|resectable, recurrent head and neck cancer
5682158|NCT00570206|Probation|probation
5682159|NCT00570206|Motivational|motivational
5682160|NCT00570180|newly diagnosed|newly diagnosed
5682161|NCT00570167|Osteoarthritis|osteoarthritis
5682162|NCT00570167|Hip|hip
5682163|NCT00570167|Artroplasty|artroplasty
5682165|NCT00570154|Mitochondrial Function in Monocytes|mitochondrial function in monocytes
5682167|NCT00570154|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5682168|NCT00570154|Diabetes|diabetes
5682169|NCT00570154|Monocyte|monocyte
5682170|NCT00570154|Macrophages|macrophages
5682171|NCT00570154|Proteome|proteome
5682172|NCT00570154|Type 2 Diabetes|type 2 diabetes
5682173|NCT00570154|Insulin Resistance|insulin resistance
5682174|NCT00570154|Insulin Sensitivity|insulin sensitivity
5682175|NCT00570154|Pre-Diabetes|pre-diabetes
5682176|NCT00570154|Healthy Volunteer|healthy volunteer
5682177|NCT00570154|HV|hv
5682178|NCT00570128|Down Syndrome|down syndrome
5682179|NCT00570128|trisomy 21|trisomy 21
5682180|NCT00570115|Sleep Apnea Syndromes diastolic disfunction left atrium|sleep apnea syndromes diastolic disfunction left atrium
5682181|NCT00570102|dietary manipulation|dietary manipulation
5682182|NCT00570102|infants|infants
5682183|NCT00570102|feasibility|feasibility
5682184|NCT00570102|Type 1 Diabetes Mellitus, Beta-cell Autoimmunity|type 1 diabetes mellitus, beta-cell autoimmunity
5682185|NCT00570089|Ranolazine|ranolazine
5682186|NCT00570089|Myocardial ischemia|myocardial ischemia
5682187|NCT00570089|Double blinded|double blinded
5682188|NCT00570089|Placebo controlled|placebo controlled
5682189|NCT00570063|Schizophrenia|schizophrenia
5682190|NCT00570063|acute exacerbation|acute exacerbation
5682191|NCT00570063|and PF-02545920|and pf-02545920
5682192|NCT00570050|Major Depressive Disorder, Memory, Executive function|major depressive disorder, memory, executive function
5682193|NCT00570037|Influenza|influenza
5682194|NCT00570037|Vaccine|vaccine
5682195|NCT00570037|Children|children
5682196|NCT00570024|Acupuncture|acupuncture
5682197|NCT00570024|Coronary Artery Disease|coronary artery disease
5682198|NCT00569985|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5682199|NCT00569985|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5682200|NCT00569985|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5682201|NCT00569985|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5848029|NCT00036595|Motor Control|motor control
5682202|NCT00569985|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5682203|NCT00569985|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5682204|NCT00569985|Treatment Experienced|treatment experienced
5682205|NCT00569959|fasting lipid measures|fasting lipid measures
5682206|NCT00569959|non-fasting lipid measures|non-fasting lipid measures
5682207|NCT00569959|clinical decision-making|clinical decision-making
5682208|NCT00569959|LDL-Cholesterol|ldl-cholesterol
5682209|NCT00569946|AG-013736|ag-013736
5682211|NCT00569946|Phase 2|phase 2
5682212|NCT00569933|Hip Surgery|hip surgery
5682213|NCT00569933|Perioperative|perioperative
5682214|NCT00569933|suggestions/imagery|suggestions/imagery
5682215|NCT00569907|type 2 diabetes|type 2 diabetes
5682216|NCT00569907|continuous glucose monitoring|continuous glucose monitoring
5682217|NCT00569907|exenatide|exenatide
5682218|NCT00569907|exenatide use|exenatide use
5682219|NCT00569881|Epithelium|epithelium
5682220|NCT00569881|Wound Healing|wound healing
5682221|NCT00569881|PRK|prk
5682222|NCT00569868|PLASMACYTOMA|plasmacytoma
5682223|NCT00569829|cognitive behavioral therapy|cognitive behavioral therapy
5682224|NCT00569829|anxiety disorders|anxiety disorders
5682225|NCT00569829|school-based intervention|school-based intervention
5682226|NCT00569829|randomized, controlled trial|randomized, controlled trial
5682227|NCT00569816|myocardial protection|myocardial protection
5682228|NCT00569816|pharmacological preconditioning|pharmacological preconditioning
5682229|NCT00569816|volatile anesthetics|volatile anesthetics
5682230|NCT00569816|myocardial injury following CABG surgery|myocardial injury following cabg surgery
5682231|NCT00569790|S-1|s-1
5682232|NCT00569790|Irinotecan|irinotecan
5682233|NCT00569790|Bevacizumab|bevacizumab
5682234|NCT00569764|schizophrenia|schizophrenia
5682235|NCT00569764|metabolic syndrome|metabolic syndrome
5682236|NCT00569764|aripiprazole|aripiprazole
5682237|NCT00569751|de novo|de novo
5682238|NCT00569751|coronary|coronary
5682239|NCT00569751|coronary artery disease|coronary artery disease
5682240|NCT00569751|coronary disease|coronary disease
5682241|NCT00569738|neuroendocrine tumor|neuroendocrine tumor
5682242|NCT00569738|somatostatin analog|somatostatin analog
5682243|NCT00569738|Gallium 68|gallium 68
5682244|NCT00569738|PET|pet
5682245|NCT00569712|non-small cell lung cancer|non-small cell lung cancer
5682246|NCT00569712|precancerous condition|precancerous condition
5682247|NCT00569699|S-1|s-1
5682248|NCT00569699|Bevacizumab|bevacizumab
5682249|NCT00569686|PAD|pad
5682250|NCT00569686|peripheral artery disease|peripheral artery disease
5682251|NCT00569673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5682252|NCT00569673|fallopian tube cancer|fallopian tube cancer
5682253|NCT00569673|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5682254|NCT00569660|Myelofibrosis|myelofibrosis
5682255|NCT00569660|MF|mf
5682256|NCT00569660|Leukemia|leukemia
5682257|NCT00569660|Azacitidine|azacitidine
5682258|NCT00569660|Vidaza|vidaza
5682259|NCT00569647|preoperative anxiety|preoperative anxiety
5682260|NCT00569647|burn reconstruction|burn reconstruction
5682261|NCT00569634|Venous blood gas|venous blood gas
5682262|NCT00569634|Arterial blood gas|arterial blood gas
5682263|NCT00569634|pH|ph
5682264|NCT00569634|pCO2|pco2
5682265|NCT00569634|Bicarbonate|bicarbonate
5682266|NCT00569608|Parental stress|parental stress
5682267|NCT00569608|Early discharge|early discharge
5682268|NCT00569608|Anxiety|anxiety
5682269|NCT00569608|Depression|depression
5682270|NCT00569608|Neonatal Intensive Care Unit|neonatal intensive care unit
5682271|NCT00569595|Prevention of Diabetes and other chronic diseases|prevention of diabetes and other chronic diseases
5682272|NCT00569582|Cushing's Disease|cushing's disease
5682273|NCT00569582|Cushing's Syndrome|cushing's syndrome
5682274|NCT00569582|Cushings|cushings
5682275|NCT00569582|Pituitary|pituitary
5682277|NCT00569582|Adrenocorticotropic hormone|adrenocorticotropic hormone
5682278|NCT00569582|Ectopic|ectopic
5682279|NCT00569582|Adrenal adenoma|adrenal adenoma
5682280|NCT00569582|Adrenal carcinoma|adrenal carcinoma
5682281|NCT00569582|Adrenal autonomy|adrenal autonomy
5682282|NCT00569582|Cortisol|cortisol
5682283|NCT00569582|Hypercortisolemia|hypercortisolemia
5682284|NCT00569582|Cushingoid|cushingoid
5682285|NCT00569582|Moon facies|moon facies
5682286|NCT00569582|Dorsocervical fat|dorsocervical fat
5682287|NCT00569582|Plethora|plethora
5682288|NCT00569582|Hirsutism|hirsutism
5682289|NCT00569582|Violaceous striae|violaceous striae
5682290|NCT00569582|Hormone|hormone
5682291|NCT00569582|Contraceptive|contraceptive
5682292|NCT00569582|Endocrine|endocrine
5682293|NCT00569582|Cushing Syndrome|cushing syndrome
5682294|NCT00569582|Ectopic ACTH Secretion|ectopic acth secretion
5682295|NCT00569556|Diabetes Mellitus|diabetes mellitus
5682296|NCT00569556|Chronic Care Model|chronic care model
5682297|NCT00569556|Case Management|case management
5682298|NCT00569543|breast cancer in situ|breast cancer in situ
5682299|NCT00569543|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5682300|NCT00569543|stage I breast cancer|stage i breast cancer
5682301|NCT00569543|stage II breast cancer|stage ii breast cancer
5682302|NCT00569543|stage IIIA breast cancer|stage iiia breast cancer
5682303|NCT00569543|stage IIIB breast cancer|stage iiib breast cancer
5682304|NCT00569543|stage IIIC breast cancer|stage iiic breast cancer
5682305|NCT00569543|stage IV breast cancer|stage iv breast cancer
5682306|NCT00569530|nitric oxide|nitric oxide
5682307|NCT00569530|surfactant|surfactant
5682308|NCT00569530|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5682309|NCT00569530|prematurity|prematurity
5682310|NCT00569530|neonates|neonates
5682311|NCT00569530|iNO|ino
5682312|NCT00569530|Infasurf|infasurf
5682313|NCT00569530|lung function|lung function
5682314|NCT00569530|ventilated infants|ventilated infants
5682315|NCT00569517|obesity|obesity
5682316|NCT00569517|CBT|cbt
5682317|NCT00569517|Atypical antipsychotics|atypical antipsychotics
5682318|NCT00569517|metabolic syndrome|metabolic syndrome
5682319|NCT00569504|schizophrenia|schizophrenia
5682320|NCT00569504|antipsychotics|antipsychotics
5682321|NCT00569504|metabolic syndrome|metabolic syndrome
5682322|NCT00569504|prevalence|prevalence
5682323|NCT00569478|ICD|icd
5682324|NCT00569478|Rehabilitation|rehabilitation
5682325|NCT00569465|nitric oxide|nitric oxide
5682326|NCT00569465|oxidative stress|oxidative stress
5682327|NCT00569465|diabetes|diabetes
5682328|NCT00569465|hypertension|hypertension
5682329|NCT00569465|endothelial dysfunction|endothelial dysfunction
5682330|NCT00569439|Labor|labor
5682331|NCT00569439|Carbohydrate|carbohydrate
5682332|NCT00569439|Dystocia|dystocia
5682333|NCT00569413|Sex|sex
5682334|NCT00569413|brain imaging|brain imaging
5682335|NCT00569413|dopamine|dopamine
5682336|NCT00569413|sexual disorder|sexual disorder
5682337|NCT00569387|pancreatic cancer|pancreatic cancer
5682338|NCT00569387|vaccine|vaccine
5682339|NCT00569361|allergic rhinitis to dust mite|allergic rhinitis to dust mite
5682340|NCT00569361|allergic rhinitis associated with bronchial hyperreactivity|allergic rhinitis associated with bronchial hyperreactivity
5682341|NCT00569361|allergic rhinitis associated with asthma|allergic rhinitis associated with asthma
5682342|NCT00569335|S-1, Bevacizumab, Irinotecan|s-1, bevacizumab, irinotecan
5682343|NCT00569322|ICU|icu
5682344|NCT00569322|Admission|admission
5682345|NCT00569322|BG|bg
5682346|NCT00569309|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5682347|NCT00569309|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5682348|NCT00569309|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5934405|NCT02922049|Probe Based Confocal Laser Endomicroscopy (pCLE)|probe based confocal laser endomicroscopy (pcle)
5934406|NCT02922049|Barrett's esophagus|barrett's esophagus
5934408|NCT02922049|Intestinal metaplasia|intestinal metaplasia
5934458|NCT02916862|fiber|fiber
5934459|NCT02916862|calcium absorption|calcium absorption
5934460|NCT02916862|bone mass|bone mass
5934461|NCT02916862|adolescents|adolescents
5682349|NCT00569309|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5682350|NCT00569309|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5682351|NCT00569309|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5682352|NCT00569309|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5682353|NCT00569309|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5934466|NCT02913261|GvHD (Graft versus Host Disease)|gvhd (graft versus host disease)
5934467|NCT02913261|INC424|inc424
5934468|NCT02913261|ruxolitinib|ruxolitinib
5934469|NCT02913261|best available therapy (BAT)|best available therapy (bat)
5934470|NCT02913261|corticosteroid-refractory acute graft vs. host disease|corticosteroid-refractory acute graft vs. host disease
5934471|NCT02913261|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5934472|NCT02913261|steroid refractory acute graft vs. host disease|steroid refractory acute graft vs. host disease
5934473|NCT02913261|Janus Kinase (JAK) inhibitor|janus kinase (jak) inhibitor
5902975|NCT00698997|autism|autism
5682354|NCT00569309|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5682355|NCT00569309|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5682356|NCT00569309|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5682357|NCT00569309|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5682358|NCT00569309|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5682359|NCT00569309|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5682360|NCT00569309|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5682361|NCT00569309|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5682583|NCT00568763|stage IV melanoma|stage iv melanoma
5682362|NCT00569309|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5682363|NCT00569309|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5682364|NCT00569309|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5682365|NCT00569309|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5682366|NCT00569309|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5682367|NCT00569309|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5682368|NCT00569309|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5682369|NCT00569309|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5682370|NCT00569309|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5682371|NCT00569309|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5682372|NCT00569309|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5682373|NCT00569309|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5682374|NCT00569309|stage I multiple myeloma|stage i multiple myeloma
5682375|NCT00569309|stage II multiple myeloma|stage ii multiple myeloma
5682376|NCT00569309|stage III multiple myeloma|stage iii multiple myeloma
5682377|NCT00569309|refractory multiple myeloma|refractory multiple myeloma
5682378|NCT00569309|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5682379|NCT00569309|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5682380|NCT00569309|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5682381|NCT00569309|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5698698|NCT00505479|Congenital Hypothyroidism|congenital hypothyroidism
5698700|NCT00505479|iodine|iodine
5698701|NCT00505479|deficiency|deficiency
5698702|NCT00505466|Human Genetics|human genetics
5698703|NCT00505466|Genetic Counseling|genetic counseling
5682382|NCT00569309|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5682383|NCT00569309|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5682384|NCT00569309|small intestine lymphoma|small intestine lymphoma
5682385|NCT00569296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5682386|NCT00569296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5682387|NCT00569283|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5682388|NCT00569283|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5682389|NCT00569283|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5682390|NCT00569283|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5685581|NCT00555529|healthy control|healthy control
5682391|NCT00569283|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5682392|NCT00569283|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5682393|NCT00569283|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5682394|NCT00569283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5682395|NCT00569283|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5682396|NCT00569283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5682397|NCT00569283|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5682398|NCT00569283|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5682399|NCT00569283|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5682400|NCT00569283|primary myelofibrosis|primary myelofibrosis
5682401|NCT00569283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5682402|NCT00569283|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5682403|NCT00569283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5682404|NCT00569283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5682405|NCT00569283|disseminated neuroblastoma|disseminated neuroblastoma
5682406|NCT00569283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5682407|NCT00569283|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5682408|NCT00569283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5682409|NCT00569283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5682410|NCT00569283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5682411|NCT00569283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5682412|NCT00569283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5682413|NCT00569283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5682414|NCT00569283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5682415|NCT00569283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5682416|NCT00569283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5682417|NCT00569283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5682418|NCT00569283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5682875|NCT00567190|Herceptin|herceptin
5682419|NCT00569283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5682420|NCT00569283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5682421|NCT00569283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5682486|NCT00569283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5682422|NCT00569283|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5682423|NCT00569283|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5682424|NCT00569283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5682425|NCT00569283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5682426|NCT00569283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5682427|NCT00569283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5682428|NCT00569283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5682429|NCT00569283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5682430|NCT00569283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5682431|NCT00569283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5698795|NCT00505128|EUS Endoscopic UltraSonography|eus endoscopic ultrasonography
5698798|NCT00505102|Kidney Diseases|kidney diseases
5698799|NCT00505102|Heart Transplantation|heart transplantation
5698800|NCT00505102|Everolimus|everolimus
5682432|NCT00569283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5682433|NCT00569283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5682434|NCT00569283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5682435|NCT00569283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5682436|NCT00569283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5682437|NCT00569283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5682438|NCT00569283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5682439|NCT00569283|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5682440|NCT00569283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5682441|NCT00569283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5682442|NCT00569283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5682443|NCT00569283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5682444|NCT00569283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5682445|NCT00569283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5682446|NCT00569283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5682447|NCT00569283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5682448|NCT00569283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5682449|NCT00569283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5682450|NCT00569283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5682451|NCT00569283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5682452|NCT00569283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5682453|NCT00569283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5682454|NCT00569283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5682455|NCT00569283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5682456|NCT00569283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5682457|NCT00569283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5682458|NCT00569283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5682459|NCT00569283|recurrent neuroblastoma|recurrent neuroblastoma
5682460|NCT00569283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5682461|NCT00569283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5682462|NCT00569283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5682463|NCT00569283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5682464|NCT00569283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5682465|NCT00569283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5682466|NCT00569283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5934546|NCT02890459|HIV|hiv
5934547|NCT02890459|incentives|incentives
5934548|NCT02890459|behavioral economics|behavioral economics
5682467|NCT00569283|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5682468|NCT00569283|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5682469|NCT00569283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5682470|NCT00569283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5682471|NCT00569283|refractory hairy cell leukemia|refractory hairy cell leukemia
5682472|NCT00569283|refractory multiple myeloma|refractory multiple myeloma
5682473|NCT00569283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5682474|NCT00569283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5682475|NCT00569283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5682476|NCT00569283|stage I multiple myeloma|stage i multiple myeloma
5682477|NCT00569283|stage II multiple myeloma|stage ii multiple myeloma
5682478|NCT00569283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5682479|NCT00569283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5682480|NCT00569283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5682481|NCT00569283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5682482|NCT00569283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5682973|NCT00566826|Function|function
5682483|NCT00569283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5682484|NCT00569283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5682485|NCT00569283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5682487|NCT00569283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5682488|NCT00569283|stage III multiple myeloma|stage iii multiple myeloma
5682489|NCT00569283|stage IIIA breast cancer|stage iiia breast cancer
5682490|NCT00569283|stage IIIB breast cancer|stage iiib breast cancer
5682491|NCT00569283|stage IIIC breast cancer|stage iiic breast cancer
5682492|NCT00569283|stage IV breast cancer|stage iv breast cancer
5682493|NCT00569283|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5682494|NCT00569283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5682495|NCT00569283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5682496|NCT00569283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5682497|NCT00569283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5682498|NCT00569283|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5682499|NCT00569283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5682500|NCT00569283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5682501|NCT00569283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5682502|NCT00569257|LHRH receptor|lhrh receptor
5682503|NCT00569257|receptor positive tumors|receptor positive tumors
5682504|NCT00569257|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5682505|NCT00569244|Primary Dysmenorrhea|primary dysmenorrhea
5682506|NCT00569244|Menstrual Pain|menstrual pain
5682507|NCT00569244|Oral Contraception|oral contraception
5682510|NCT00569231|HPV|hpv
5682511|NCT00569231|Injections, Intralesional|injections, intralesional
5682512|NCT00569231|Immune System|immune system
5682513|NCT00569192|asthmatic children|asthmatic children
5682514|NCT00569179|Myeloid Malignancies|myeloid malignancies
5682515|NCT00569179|Bone Marrow Transplant|bone marrow transplant
5682516|NCT00569179|AML|aml
5682517|NCT00569179|ALL|all
5682518|NCT00569179|MDS|mds
5682519|NCT00569179|CML|cml
5682520|NCT00569166|fatigue|fatigue
5682521|NCT00569166|sleep disorders|sleep disorders
5682522|NCT00569166|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5682523|NCT00569166|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5682524|NCT00569166|breast cancer|breast cancer
5682525|NCT00569166|hot flashes|hot flashes
5682526|NCT00569153|Androgen-independent prostate cancer, metastatic|androgen-independent prostate cancer, metastatic
5682527|NCT00569088|hemorrhagic stroke|hemorrhagic stroke
5682528|NCT00569088|Chinese Medicine|chinese medicine
5682529|NCT00569088|pathogenesis|pathogenesis
5682530|NCT00569088|YURE|yure
5682531|NCT00569075|Apoptic biomarkers|apoptic biomarkers
5682532|NCT00569075|Early detection periodontitis|early detection periodontitis
5682533|NCT00569075|Gingival crevicular fluid|gingival crevicular fluid
5682534|NCT00569075|Healthy subjects|healthy subjects
5682535|NCT00569062|Psychomotor retardation|psychomotor retardation
5682536|NCT00569062|cytokines|cytokines
5682537|NCT00569062|GW856553|gw856553
5682538|NCT00569062|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5682539|NCT00569036|Advanced or Metastatic Solid Tumors or Neoplasms|advanced or metastatic solid tumors or neoplasms
5682540|NCT00569023|Beta Carotene|beta carotene
5682541|NCT00569023|visual functions|visual functions
5682542|NCT00569023|Fundus albipunctatus|fundus albipunctatus
5682543|NCT00569023|Night Blindness|night blindness
5682544|NCT00569010|Acute Myelogenous Leukemia|acute myelogenous leukemia
5682545|NCT00569010|AML|aml
5682546|NCT00569010|Myelodysplastic Syndrome|myelodysplastic syndrome
5682547|NCT00569010|MDS|mds
5682548|NCT00569010|Leukemia|leukemia
5682549|NCT00568997|Atopic dermatitis eczema pediatric pimecrolimus malignancy|atopic dermatitis eczema pediatric pimecrolimus malignancy
5682550|NCT00568971|DCF|dcf
5682551|NCT00568971|Advanced gastric cancer|advanced gastric cancer
5682552|NCT00568971|Phase II study|phase ii study
5682553|NCT00568971|Efficacy|efficacy
5682554|NCT00568971|Toxicity|toxicity
5682555|NCT00568958|heavy episodic drinking|heavy episodic drinking
5682556|NCT00568958|young adults|young adults
5682557|NCT00568958|naltrexone|naltrexone
5682558|NCT00568958|BASICS counseling|basics counseling
5682559|NCT00568958|alcohol-related consequences|alcohol-related consequences
5682560|NCT00568958|double-blind trial|double-blind trial
5682561|NCT00568958|randomized clinical trial|randomized clinical trial
5682562|NCT00568945|Atrial Fibrillation|atrial fibrillation
5682563|NCT00568945|Capadenoson|capadenoson
5682564|NCT00568880|stage I multiple myeloma|stage i multiple myeloma
5682565|NCT00568880|stage II multiple myeloma|stage ii multiple myeloma
5682566|NCT00568880|stage III multiple myeloma|stage iii multiple myeloma
5682567|NCT00568880|refractory multiple myeloma|refractory multiple myeloma
5682568|NCT00568841|advanced Non-Small-Cell Lung Cancer|advanced non-small-cell lung cancer
5682570|NCT00568841|FDG-PET|fdg-pet
5682571|NCT00568841|FLT-PET|flt-pet
5682576|NCT00568815|ESHAP|eshap
5682577|NCT00568815|Efficacy|efficacy
5682578|NCT00568815|Toxicity|toxicity
5682579|NCT00568789|Insomnia|insomnia
5682580|NCT00568789|Aged|aged
5682581|NCT00568789|Postural Balance|postural balance
5682582|NCT00568789|Drug Therapy|drug therapy
5682891|NCT00567125|VEGF-A|vegf-a
5682584|NCT00568763|recurrent melanoma|recurrent melanoma
5682585|NCT00568750|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5682586|NCT00568737|Severe Sepsis|severe sepsis
5682587|NCT00568724|Hydronephrosis|hydronephrosis
5682588|NCT00568724|Ureteral obstruction|ureteral obstruction
5682589|NCT00568711|Doxycycline,|doxycycline,
5682590|NCT00568711|Rifampin|rifampin
5682591|NCT00568711|Scrub typhus.|scrub typhus.
5682592|NCT00568672|Major Depression|major depression
5934647|NCT02869659|pre-diabetes|pre-diabetes
5934648|NCT02869659|overweight|overweight
5934649|NCT02869659|lifestyle change|lifestyle change
5934650|NCT02869659|glucose|glucose
5682593|NCT00568672|Olanzapine|olanzapine
5682594|NCT00568672|add-on therapy|add-on therapy
5682595|NCT00568672|antidepressant|antidepressant
5682596|NCT00568672|atypical antipsychotic|atypical antipsychotic
5682597|NCT00568659|Gas exchange|gas exchange
5682598|NCT00568659|Respiratory mechanics|respiratory mechanics
5682599|NCT00568659|Ventilator Induced Lung Injury|ventilator induced lung injury
5682600|NCT00568607|NK/T cell lymphoma|nk/t cell lymphoma
5682601|NCT00568607|Response Rate|response rate
5682603|NCT00568607|OS|os
5682604|NCT00568607|Toxicities|toxicities
5682605|NCT00568594|Apolipoprotein A-I,|apolipoprotein a-i,
5682606|NCT00568594|Atherosclerosis,|atherosclerosis,
5682607|NCT00568594|HDL,|hdl,
5682608|NCT00568594|Inflammation,|inflammation,
5682609|NCT00568568|Growth Hormone|growth hormone
5682610|NCT00568568|GH signaling|gh signaling
5682611|NCT00568568|Insulin resistance|insulin resistance
5682612|NCT00568568|Insulin Signaling|insulin signaling
5682613|NCT00568542|cardiomyopathy|cardiomyopathy
5682614|NCT00568542|ischemia|ischemia
5934656|NCT02864953|Stroke|stroke
5934657|NCT02864953|Infarction|infarction
5934658|NCT02864953|Cerebrovascular Disorders|cerebrovascular disorders
5934659|NCT02864953|Brain Diseases|brain diseases
5934660|NCT02864953|Brain Edema Ischemia|brain edema ischemia
5934661|NCT02864953|Pathological Processes Necrosis|pathological processes necrosis
5934662|NCT02864953|Central Nervous System Diseases|central nervous system diseases
5934663|NCT02864953|Vascular Diseases|vascular diseases
5934664|NCT02864953|Cardiovascular Diseases|cardiovascular diseases
5934665|NCT02864953|Glyburide|glyburide
5934666|NCT02864953|Hypoglycemic Agents|hypoglycemic agents
5934667|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs
5934682|NCT02860572|fluid therapy|fluid therapy
5934683|NCT02860572|oliguria|oliguria
5934684|NCT02860572|endothelial injury|endothelial injury
5872843|NCT03779308|cerebral palsy|cerebral palsy
5682615|NCT00568542|percutaneous coronary intervention|percutaneous coronary intervention
5934739|NCT02844946|Acceptance and Commitment Therapy|acceptance and commitment therapy
5934740|NCT02844946|mild Traumatic Brain Injury|mild traumatic brain injury
5934741|NCT02844946|Veterans|veterans
5934742|NCT02844946|Post Traumatic Stress Disorder|post traumatic stress disorder
5934748|NCT02842866|Meningitis|meningitis
5934749|NCT02842866|Meningococcal Meningitis|meningococcal meningitis
5934750|NCT02842866|Meningococcal Infections|meningococcal infections
5934751|NCT02842866|MenACYW conjugate vaccine|menacyw conjugate vaccine
5934752|NCT02842866|Menomune® - A/C/Y/W-135|menomune® - a/c/y/w-135
5934757|NCT02841033|Daratumumab|daratumumab
5934786|NCT02825160|Iloprost|iloprost
5934787|NCT02825160|Ventavis|ventavis
5934788|NCT02825160|Prostacycline analogue|prostacycline analogue
5934789|NCT02825160|Pulmonary arterial hypertension|pulmonary arterial hypertension
5934790|NCT02825160|Japan|japan
5934791|NCT02825160|Post-marketing surveillance|post-marketing surveillance
5872929|NCT03772587|M281|m281
5682616|NCT00568542|remodeling|remodeling
5682617|NCT00568529|Advanced gastric cancer|advanced gastric cancer
5682618|NCT00568529|Response rate|response rate
5682619|NCT00568529|Side effects|side effects
5682620|NCT00568529|time to progression|time to progression
5682621|NCT00568529|overall survival|overall survival
5682622|NCT00568516|ASP3550|asp3550
5682623|NCT00568516|Degarelix|degarelix
5934822|NCT02818920|Pembrolizumab|pembrolizumab
5934823|NCT02818920|Neoadjuvant|neoadjuvant
5934824|NCT02818920|Tumor Infiltrating Lymphocytes (TILs)|tumor infiltrating lymphocytes (tils)
5934838|NCT02815033|Hormono-Sensitive prostate cancer|hormono-sensitive prostate cancer
5934839|NCT02815033|Enzalutamide|enzalutamide
5934840|NCT02815033|Imaging|imaging
5934841|NCT02815033|PET/CT|pet/ct
5934842|NCT02815033|Whole body MRI|whole body mri
5934843|NCT02815033|Circulating tumour cells|circulating tumour cells
5934844|NCT02815033|Cell-free tumour DNA|cell-free tumour dna
5934845|NCT02814968|Castration-resistant prostate cancer|castration-resistant prostate cancer
5934846|NCT02814968|Enzalutamide|enzalutamide
5934847|NCT02814968|Imaging|imaging
5934848|NCT02814968|PET/CT|pet/ct
5934849|NCT02814968|Whole body MRI|whole body mri
5934850|NCT02814968|Circulating tumour cells|circulating tumour cells
5934851|NCT02814968|Cell-free tumour DNA|cell-free tumour dna
5872998|NCT03761914|peptide vaccine|peptide vaccine
5682624|NCT00568516|Prostate cancer|prostate cancer
5682625|NCT00568516|Prostatic neoplasms|prostatic neoplasms
5682626|NCT00568503|COPD/TIOTROPIUM/QAX028|copd/tiotropium/qax028
5682627|NCT00568477|Rituximab, Heemannn|rituximab, heemannn
5682628|NCT00568464|ESFT (Ewing's sarcoma family of tumors)|esft (ewing's sarcoma family of tumors)
5682629|NCT00568464|Response rate|response rate
5682630|NCT00568464|TTP|ttp
5682631|NCT00568464|OS|os
5682632|NCT00568464|Toxicity|toxicity
5682633|NCT00568451|stage IV melanoma|stage iv melanoma
5682634|NCT00568451|recurrent melanoma|recurrent melanoma
5682635|NCT00568412|atopic dermatitis|atopic dermatitis
5682636|NCT00568399|Coronary|coronary
5682637|NCT00568399|Calcification|calcification
5682638|NCT00568399|Dialysis|dialysis
5682639|NCT00568399|Thiosulfate|thiosulfate
5682640|NCT00568399|Cardiovascular|cardiovascular
5682641|NCT00568386|Dry eye|dry eye
5682642|NCT00568373|Gastroparesis|gastroparesis
5682643|NCT00568373|Gastric electrical stimulator|gastric electrical stimulator
5682644|NCT00568347|chronic airflow obstruction|chronic airflow obstruction
5682645|NCT00568334|chickenpox|chickenpox
5682646|NCT00568334|varicella|varicella
5682647|NCT00568334|two-dose schedule|two-dose schedule
5682648|NCT00568334|second year of life|second year of life
5682649|NCT00568321|monoclonal antibody|monoclonal antibody
5682650|NCT00568308|Hepatocellular Carcinoma|hepatocellular carcinoma
5682651|NCT00568308|PI-88|pi-88
5682652|NCT00568308|Phase III|phase iii
5682653|NCT00568308|Adjuvant Therapy|adjuvant therapy
5682654|NCT00568308|Hepatoma|hepatoma
5682655|NCT00568308|Liver Cancer|liver cancer
5678158|NCT00588120|Oxalate|oxalate
5682656|NCT00568269|Recurrence rate after inguinal hernia repair on primary inguinal herina.|recurrence rate after inguinal hernia repair on primary inguinal herina.
5682657|NCT00568256|Ulcerative Colitis|ulcerative colitis
5682658|NCT00568256|IBD Flare-Up|ibd flare-up
5682659|NCT00568256|Stress|stress
5682664|NCT00568230|heart failure|heart failure
5682665|NCT00568230|mitral regurgitation|mitral regurgitation
5682666|NCT00568204|pruritus, itching, mexyn-a, clearitch, magicool-plus|pruritus, itching, mexyn-a, clearitch, magicool-plus
5682667|NCT00568191|Age-related macular degeneration|age-related macular degeneration
5682668|NCT00568191|choroidal neovascularization|choroidal neovascularization
5682669|NCT00568191|Stratus OCT|stratus oct
5682670|NCT00568191|Cirrus OCT|cirrus oct
5682671|NCT00568165|Heart failure, congestive|heart failure, congestive
5682672|NCT00568165|Echocardiography|echocardiography
5682673|NCT00568165|Patient care team|patient care team
5682674|NCT00568152|Apples|apples
5682675|NCT00568152|Dietary intervention|dietary intervention
5682676|NCT00568152|Procyanidins|procyanidins
5682677|NCT00568139|adrenal cancer|adrenal cancer
5682678|NCT00568139|mitotane (Lysodren)|mitotane (lysodren)
5682679|NCT00568139|adverse events|adverse events
5682680|NCT00568126|Antidepressant Induced Sexual Dysfunction|antidepressant induced sexual dysfunction
5682681|NCT00568126|Depression|depression
5682682|NCT00568126|Sexual Dysfunction|sexual dysfunction
5682683|NCT00568113|preterm labour|preterm labour
5682684|NCT00568113|n acetyl cysteine|n acetyl cysteine
5682685|NCT00568113|bacterial vaginosis|bacterial vaginosis
5682686|NCT00568100|gas exchange|gas exchange
5682687|NCT00568100|pressure support ventilation|pressure support ventilation
5682688|NCT00568100|respiratory mechanics|respiratory mechanics
5682689|NCT00568100|COPD|copd
5682690|NCT00568100|NAVA|nava
5682691|NCT00568087|N-acetylcysteine|n-acetylcysteine
5682692|NCT00568087|Alcoholism|alcoholism
5682693|NCT00568087|Treatment|treatment
5682694|NCT00568061|INOT44|inot44
5682695|NCT00568061|NOMI|nomi
5682696|NCT00568048|stage IV melanoma|stage iv melanoma
5682697|NCT00568048|recurrent melanoma|recurrent melanoma
5682698|NCT00568035|diabetic|diabetic
5682699|NCT00568035|peripheral|peripheral
5682700|NCT00568035|neuropathy|neuropathy
5682701|NCT00568009|Congestive Heart Failure|congestive heart failure
5682702|NCT00568009|Impaired Renal Function|impaired renal function
5682703|NCT00567996|Chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled|chronic obstructive pulmonary disease, indacaterol, salmeterol, placebo controlled
5682704|NCT00567970|liver metastases|liver metastases
5682705|NCT00567957|pre-eclampsia|pre-eclampsia
5682706|NCT00567957|remifentanil|remifentanil
5682707|NCT00567957|anesthesia, general|anesthesia, general
5682708|NCT00567957|analgesics, opioid|analgesics, opioid
5682709|NCT00567957|anesthetics, intravenous|anesthetics, intravenous
5682710|NCT00567957|Cesarean section|cesarean section
5682711|NCT00567957|newborn|newborn
5682712|NCT00567957|maternal haemodynamic|maternal haemodynamic
5682713|NCT00567944|Physical Therapy Modalities|physical therapy modalities
5682714|NCT00567944|Electric Stimulation|electric stimulation
5682715|NCT00567944|Postural Balance|postural balance
5682716|NCT00567918|Keratoconjunctivitis|keratoconjunctivitis
5682717|NCT00567918|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5682718|NCT00567918|FK506|fk506
5682719|NCT00567918|Tacrolimus|tacrolimus
5682720|NCT00567905|Type 2 Diabetes|type 2 diabetes
5682721|NCT00567905|Green tea extract|green tea extract
5682722|NCT00567905|overweight|overweight
5682723|NCT00567892|tinnitus|tinnitus
5682724|NCT00567892|subjective tinnitus|subjective tinnitus
5682725|NCT00567892|therapy|therapy
5682726|NCT00567892|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5682727|NCT00567892|clinical trial|clinical trial
5682728|NCT00567879|Breast Cancer|breast cancer
5682729|NCT00567879|HER2 positive|her2 positive
5682730|NCT00567879|adult-female|adult-female
5682731|NCT00567879|LBH589|lbh589
5682732|NCT00567879|HDAC inhibitor|hdac inhibitor
5682733|NCT00567879|panobinostat|panobinostat
5682734|NCT00567853|mitral valve regurgitation|mitral valve regurgitation
5682735|NCT00567853|mitral valve disease|mitral valve disease
5935018|NCT02767427|Preoperative Care|preoperative care
5935019|NCT02767427|Chlorhexidine|chlorhexidine
5935020|NCT02767427|Pre-Surgical Wash|pre-surgical wash
5935021|NCT02767427|Spine Surgery|spine surgery
5935022|NCT02767427|Surgical site infections|surgical site infections
5935023|NCT02767427|Cutaneous bacterial load on skin|cutaneous bacterial load on skin
5682736|NCT00567853|mitral valve repair|mitral valve repair
5682737|NCT00567853|mitral valve dysfunction|mitral valve dysfunction
5682738|NCT00567853|heart valve|heart valve
5682739|NCT00567853|valve disease|valve disease
5682740|NCT00567853|cardiac surgery|cardiac surgery
5682741|NCT00567840|Early Bactericidal Activity|early bactericidal activity
5682743|NCT00567840|pulmonary tuberculosis|pulmonary tuberculosis
5682744|NCT00567840|PA-824|pa-824
5682745|NCT00567840|Pretomanid|pretomanid
5682746|NCT00567840|CL-007|cl-007
5682747|NCT00567827|Pneumonia|pneumonia
5682748|NCT00567814|Cocaine|cocaine
5682749|NCT00567814|Dependence|dependence
5682750|NCT00567814|Addiction|addiction
5682751|NCT00567814|Cortisol|cortisol
5682752|NCT00567814|GABA|gaba
5682753|NCT00567801|Lower Extremity|lower extremity
5682754|NCT00567801|Ischemia|ischemia
5682755|NCT00567788|Glaucoma, angle-closure|glaucoma, angle-closure
5682756|NCT00567762|Keratoconjunctivitis|keratoconjunctivitis
5682757|NCT00567762|vernal keratoconjunctivitis|vernal keratoconjunctivitis
5682758|NCT00567762|FK506|fk506
5682759|NCT00567762|Tacrolimus|tacrolimus
5682760|NCT00567749|HIV-1 Infections|hiv-1 infections
5682761|NCT00567736|low back pain|low back pain
5682762|NCT00567736|complementary therapies|complementary therapies
5682763|NCT00567697|ranibizumab|ranibizumab
5682764|NCT00567697|CRVO|crvo
5682765|NCT00567697|macular edema|macular edema
5682766|NCT00567697|sham|sham
5682767|NCT00567684|Transitional Cell Carcinoma|transitional cell carcinoma
5682768|NCT00567684|Urothelial Cancer|urothelial cancer
5682769|NCT00567684|Bladder Cancer|bladder cancer
5682770|NCT00567684|Computed Tomography Urography|computed tomography urography
5682771|NCT00567684|CTU|ctu
5682772|NCT00567684|Intravenous Urography|intravenous urography
5682773|NCT00567684|IVU|ivu
5682774|NCT00567684|TCC|tcc
5682775|NCT00567684|transitional cell carcinomas|transitional cell carcinomas
5682776|NCT00567671|keratoconus|keratoconus
5682777|NCT00567671|ectasia|ectasia
5682778|NCT00567671|cross-linking|cross-linking
5682779|NCT00567671|riboflavin|riboflavin
5682780|NCT00567671|UVA light|uva light
5682781|NCT00567671|cornea|cornea
5682782|NCT00567632|Pneumococci|pneumococci
5682783|NCT00567632|Antibody|antibody
5682784|NCT00567632|Standard laboratory values|standard laboratory values
5682785|NCT00567619|GERD|gerd
5682786|NCT00567619|NIS|nis
5682787|NCT00567580|stage IIB prostate cancer|stage iib prostate cancer
5682788|NCT00567580|stage IIA prostate cancer|stage iia prostate cancer
5682789|NCT00567580|stage III prostate cancer|stage iii prostate cancer
5682790|NCT00567580|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5682791|NCT00567554|breast cancer|breast cancer
5682792|NCT00567554|primary systemic therapy|primary systemic therapy
5682793|NCT00567554|pCR Rates|pcr rates
5682794|NCT00567554|Bevacizumab|bevacizumab
5682795|NCT00567554|Trastuzumab|trastuzumab
5682796|NCT00567554|Lapatinib|lapatinib
5682797|NCT00567554|Everolimus|everolimus
5682798|NCT00567541|shoulder|shoulder
5682799|NCT00567541|pain|pain
5682800|NCT00567541|stroke|stroke
5682801|NCT00567541|subluxation|subluxation
5682802|NCT00567528|Soft tissue injuries|soft tissue injuries
5682803|NCT00567528|Topical ibuprofen|topical ibuprofen
5682804|NCT00567528|Adolescent athletes|adolescent athletes
5682805|NCT00567489|ESRD|esrd
5682806|NCT00567489|Diabetes|diabetes
5682807|NCT00567489|CAPD|capd
5682808|NCT00567489|APD|apd
5682809|NCT00567476|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
5682810|NCT00567463|Asthma|asthma
5682811|NCT00567463|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5682812|NCT00567463|Methacholine|methacholine
5682813|NCT00567463|Induced sputum|induced sputum
5682814|NCT00567463|bronchial biopsies|bronchial biopsies
5682815|NCT00567450|sciatic block|sciatic block
5682816|NCT00567450|ropivacaine|ropivacaine
5682817|NCT00567450|mepivacaine|mepivacaine
5682818|NCT00567450|locoregional anesthesia|locoregional anesthesia
5682819|NCT00567437|aortic stenosis|aortic stenosis
5682820|NCT00567437|prognosis|prognosis
5682821|NCT00567437|brain natriuretic peptide|brain natriuretic peptide
5682822|NCT00567424|epilepsy|epilepsy
5682823|NCT00567424|refractory|refractory
5682824|NCT00567424|seizure|seizure
5682825|NCT00567424|drug interactions|drug interactions
5682826|NCT00567424|pharmacokinetics|pharmacokinetics
5682827|NCT00567411|Glaucoma|glaucoma
5682828|NCT00567411|Laser|laser
5682829|NCT00567411|laser trabeculoplasty|laser trabeculoplasty
5682830|NCT00567411|selective laser trabeculoplasty|selective laser trabeculoplasty
5682831|NCT00567411|intraocular pressure|intraocular pressure
5682832|NCT00567398|ESRD|esrd
5682833|NCT00567398|Diabetes|diabetes
5682834|NCT00567398|CAPD|capd
5682835|NCT00567398|APD|apd
5682836|NCT00567372|Diffuse diabetic macular edema|diffuse diabetic macular edema
5682837|NCT00567372|sub-tenon|sub-tenon
5682838|NCT00567372|Bevacizumab|bevacizumab
5682839|NCT00567359|NSCLC|nsclc
5682840|NCT00567359|erlotinib|erlotinib
5682841|NCT00567359|epidermal growth factor receptor|epidermal growth factor receptor
5682842|NCT00567359|EGFR|egfr
5935081|NCT02743949|Drug therapy|drug therapy
5935107|NCT02738086|Amputation|amputation
5935108|NCT02738086|Physical Activity|physical activity
5935109|NCT02738086|Rehabilitation|rehabilitation
5682843|NCT00567346|randomised|randomised
5682844|NCT00567346|double-blind|double-blind
5682845|NCT00567346|placebo-controlled|placebo-controlled
5682846|NCT00567346|efficacy and safety|efficacy and safety
5682847|NCT00567346|Oralgen® Grass Pollen|oralgen® grass pollen
5682848|NCT00567346|allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5682849|NCT00567346|Allergy|allergy
5682850|NCT00567346|Rhinoconjunctivitis|rhinoconjunctivitis
5682851|NCT00567346|Immunotherapy|immunotherapy
5682852|NCT00567346|Grass pollen extract|grass pollen extract
5682853|NCT00567320|varenicline|varenicline
5682854|NCT00567294|Osteoporosis|osteoporosis
5682855|NCT00567294|Medication adherence|medication adherence
5682856|NCT00567294|Telephonic education|telephonic education
5682857|NCT00567294|Motivational interviewing|motivational interviewing
5682858|NCT00567281|Schizoaffective disorder|schizoaffective disorder
5682859|NCT00567281|Auditory Hallucinations|auditory hallucinations
5682860|NCT00567281|Voices|voices
5682861|NCT00567281|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5682862|NCT00567281|rTMS|rtms
5682863|NCT00567281|Wernicke's Area|wernicke's area
5682864|NCT00567281|Middle Temporal Cortex|middle temporal cortex
5682988|NCT00566787|bipolar|bipolar
5682865|NCT00567281|Persistent Auditory Hallucinations|persistent auditory hallucinations
5682866|NCT00567281|"Previously Participated in Parent rTMS Protocol"|"previously participated in parent rtms protocol"
5682867|NCT00567268|Post-Marketing surveillance|post-marketing surveillance
5935148|NCT02729337|technology|technology
5935149|NCT02729337|adolescent|adolescent
5935150|NCT02729337|developing country|developing country
5935151|NCT02729337|hiv prevention|hiv prevention
5935152|NCT02729337|mHealth|mhealth
5935184|NCT02721251|exercise|exercise
5935185|NCT02721251|weight loss|weight loss
5935186|NCT02721251|sleep apnea|sleep apnea
5682868|NCT00567255|Obesity|obesity
5682869|NCT00567242|aphasia|aphasia
5682870|NCT00567242|therapies, investigational|therapies, investigational
5682871|NCT00567242|rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5682872|NCT00567242|magnetic resonance imaging, functional|magnetic resonance imaging, functional
5682874|NCT00567229|refractory multiple myeloma|refractory multiple myeloma
5682876|NCT00567190|Breast cancer|breast cancer
5682877|NCT00567190|MBC|mbc
5682878|NCT00567190|Taxotere|taxotere
5682879|NCT00567190|HER2|her2
5682880|NCT00567190|HER2 positive breast cancer|her2 positive breast cancer
5682881|NCT00567190|HER2 + breast cancer|her2 + breast cancer
5682883|NCT00567190|HER2-positive metastatic breast cancer|her2-positive metastatic breast cancer
5682884|NCT00567164|Oral Contraception|oral contraception
5935310|NCT02689193|Proteomics|proteomics
5935311|NCT02689193|Rapid Diagnostic Test|rapid diagnostic test
5935312|NCT02689193|Salmonellosis|salmonellosis
5935381|NCT02668575|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5682885|NCT00567164|Birth Control pill|birth control pill
5682886|NCT00567164|Healthy women requesting oral contraception|healthy women requesting oral contraception
5682887|NCT00567164|Contraceptive efficacy|contraceptive efficacy
5682888|NCT00567125|low-pressure pneumoperitoneum|low-pressure pneumoperitoneum
5682889|NCT00567125|laparoscopy|laparoscopy
5682890|NCT00567125|cytokines|cytokines
5682894|NCT00567099|Antipsychotic|antipsychotic
5935457|NCT02641626|cardiac arrest|cardiac arrest
5935458|NCT02641626|survival|survival
5935459|NCT02641626|neurologic prognosis|neurologic prognosis
5935460|NCT02641626|coronariography|coronariography
5935461|NCT02641626|hypothermia|hypothermia
5682895|NCT00567099|Psychopharmacology|psychopharmacology
5682896|NCT00567099|Clinical Trial|clinical trial
5682898|NCT00567099|Schizophrenia|schizophrenia
5682899|NCT00567099|Sensory Gating|sensory gating
5682900|NCT00567099|Attention|attention
5682902|NCT00567086|Migraine|migraine
5682903|NCT00567073|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5682904|NCT00567073|GSD-II|gsd-ii
5682905|NCT00567073|Pompe Disease|pompe disease
5682906|NCT00567073|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5682907|NCT00567073|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5682908|NCT00567073|Glycogenosis II|glycogenosis ii
5682909|NCT00567060|Piracetam|piracetam
5682910|NCT00567060|Nootropil|nootropil
5682911|NCT00567034|Zyprexa|zyprexa
5682912|NCT00567034|naltrexone|naltrexone
5682913|NCT00567034|schizophrenia|schizophrenia
5682914|NCT00567034|Metabolic Syndrome|metabolic syndrome
5682915|NCT00567034|pain|pain
5682916|NCT00567021|reflux|reflux
5682917|NCT00567021|NSAR treatment|nsar treatment
5682918|NCT00567021|Patients with reflux symptoms or gastrointestinal symptoms after NSAR Treatment|patients with reflux symptoms or gastrointestinal symptoms after nsar treatment
5682919|NCT00567008|cocaine|cocaine
5682920|NCT00567008|crack cocaine|crack cocaine
5682921|NCT00567008|cocaine-related disorders|cocaine-related disorders
5682922|NCT00567008|substance-related disorders|substance-related disorders
5682923|NCT00567008|alpha4beta2 nicotinic acetylcholine receptor|alpha4beta2 nicotinic acetylcholine receptor
5682924|NCT00566995|Kidney Tumors|kidney tumors
5682925|NCT00566995|Clear Cell Renal Cancer|clear cell renal cancer
5682926|NCT00566995|VEGFR Inhibitor|vegfr inhibitor
5682927|NCT00566995|EGFR Inhibitor|egfr inhibitor
5682928|NCT00566995|VHL|vhl
5682929|NCT00566995|Von Hippel Lindau|von hippel lindau
5682930|NCT00566995|Kidney Tumor|kidney tumor
5682931|NCT00566982|Urogenital atrophy|urogenital atrophy
5682932|NCT00566982|Menopausal symptoms|menopausal symptoms
5682933|NCT00566982|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5678349|NCT00587145|S-1|s-1
5682934|NCT00566982|Vaginal atrophy|vaginal atrophy
5682935|NCT00566969|cocaine, opiate, methadone, carvedilol|cocaine, opiate, methadone, carvedilol
5682936|NCT00566956|Hydrosalpinx/IVF/Reproductive outcome.|hydrosalpinx/ivf/reproductive outcome.
5682937|NCT00566956|Hydrosalpinx|hydrosalpinx
5682938|NCT00566943|Staple Line Reinforcement, Buttress|staple line reinforcement, buttress
5682939|NCT00566917|Vagina|vagina
5682940|NCT00566917|Prolapse|prolapse
5682941|NCT00566917|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
5682942|NCT00566904|Post-herpetic Neuralgia|post-herpetic neuralgia
5682943|NCT00566904|Pain after Shingles|pain after shingles
5682944|NCT00566904|Shingles|shingles
5682945|NCT00566904|PHN|phn
5682946|NCT00566891|percutaneous coronary angioplasty|percutaneous coronary angioplasty
5682947|NCT00566891|pci|pci
5682948|NCT00566891|tirofiban|tirofiban
5682949|NCT00566891|side effects|side effects
5682950|NCT00566878|Glycogen Storage Disease|glycogen storage disease
5682951|NCT00566878|GSD-II|gsd-ii
5682952|NCT00566878|Pompe Disease|pompe disease
5682953|NCT00566878|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5682954|NCT00566878|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5682955|NCT00566878|Glycogenosis II|glycogenosis ii
5682956|NCT00566852|cognitive/functional effects|cognitive/functional effects
5682957|NCT00566852|neurotoxicity|neurotoxicity
5682958|NCT00566852|tumors metastatic to brain|tumors metastatic to brain
5682959|NCT00566852|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5682960|NCT00566839|COPD|copd
5682961|NCT00566839|LVRS|lvrs
5682962|NCT00566839|Awake surgery|awake surgery
5682963|NCT00566839|Thoracic epidural anesthesia|thoracic epidural anesthesia
5682964|NCT00566839|One-lung ventilation|one-lung ventilation
5682965|NCT00566839|Emphysema|emphysema
5682966|NCT00566839|VATS|vats
5682967|NCT00566839|Lung surgery|lung surgery
5682968|NCT00566826|Physical Function|physical function
5682969|NCT00566826|Total Knee Replacement|total knee replacement
5682970|NCT00566826|Physical Activity|physical activity
5682971|NCT00566826|Behavioral Support|behavioral support
5682972|NCT00566826|Arthroplasty|arthroplasty
5682974|NCT00566826|Self-Care|self-care
5682975|NCT00566813|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5682976|NCT00566813|Islets of Langerhans Transplantation|islets of langerhans transplantation
5682977|NCT00566813|Exenatide|exenatide
5682978|NCT00566813|Soluble tumor necrosis factor receptor|soluble tumor necrosis factor receptor
5935533|NCT02628067|Programmed Cell Death-1 (PD1, PD-1)|programmed cell death-1 (pd1, pd-1)
5935534|NCT02628067|Programmed Death-Ligand 1 (PDL1, PD-L1)|programmed death-ligand 1 (pdl1, pd-l1)
5935535|NCT02628067|microsatellite instability (MSI)|microsatellite instability (msi)
5935536|NCT02628067|mismatch repair (MMR)|mismatch repair (mmr)
5935537|NCT02628067|anal carcinoma|anal carcinoma
5935538|NCT02628067|anal cancer|anal cancer
5935539|NCT02628067|biliary adenocarcinoma|biliary adenocarcinoma
5935540|NCT02628067|biliary cancer|biliary cancer
5935541|NCT02628067|cholangiocarcinoma|cholangiocarcinoma
5935542|NCT02628067|bile duct cancer|bile duct cancer
5935544|NCT02628067|carcinoid tumor|carcinoid tumor
5682980|NCT00566800|Barrett esophagus|barrett esophagus
5682981|NCT00566787|AF|af
5682982|NCT00566787|Atrial Fibrillation|atrial fibrillation
5682983|NCT00566787|afib|afib
5682984|NCT00566787|racing heart|racing heart
5682985|NCT00566787|cabg|cabg
5682986|NCT00566787|valve|valve
5682987|NCT00566787|ablation|ablation
5682989|NCT00566787|radiofrequency|radiofrequency
5682990|NCT00566787|rf|rf
5682991|NCT00566774|myocardial infarction|myocardial infarction
5682992|NCT00566774|secondary prevention|secondary prevention
5682993|NCT00566774|health insurance|health insurance
5682994|NCT00566774|cost-sharing|cost-sharing
5682995|NCT00566761|Macular edema|macular edema
5935693|NCT02598752|functional performance testing|functional performance testing
5935694|NCT02598752|exercise fitness testing|exercise fitness testing
5935726|NCT02583360|Infant|infant
5935727|NCT02583360|Feeding difficulties|feeding difficulties
5935728|NCT02583360|Dysphagia|dysphagia
5682996|NCT00566761|central retinal vein occlusion|central retinal vein occlusion
5682997|NCT00566761|bevacizumab|bevacizumab
5682998|NCT00566761|triamcinolone|triamcinolone
5682999|NCT00566709|transfusion|transfusion
5683000|NCT00566709|NIRS|nirs
5683001|NCT00566709|cerebral oxygenation|cerebral oxygenation
5683002|NCT00566709|red blood cell|red blood cell
5683003|NCT00566709|near infrared spectroscopy|near infrared spectroscopy
5683004|NCT00566696|Haploidentical stem cell transplant|haploidentical stem cell transplant
5683005|NCT00566696|Allogeneic stem cell transplant|allogeneic stem cell transplant
5683006|NCT00566696|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5683007|NCT00566696|Bone marrow transplant|bone marrow transplant
5683008|NCT00566696|High risk hematologic malignancies|high risk hematologic malignancies
5683009|NCT00566696|T cell depletion methodology|t cell depletion methodology
5683010|NCT00566696|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5683011|NCT00566696|Campath-1H intravenous|campath-1h intravenous
5683012|NCT00566683|Propofol|propofol
5683013|NCT00566683|colonoscopy|colonoscopy
5683014|NCT00566683|sedation|sedation
5683015|NCT00566683|pain|pain
5683016|NCT00566683|compare NAPS versus diazemuls in outpatient colonoscopy|compare naps versus diazemuls in outpatient colonoscopy
5683017|NCT00566670|Hemodialysis|hemodialysis
5683018|NCT00566657|Critical Limb Ischemia|critical limb ischemia
5683019|NCT00566657|Peripheral Artery Disease|peripheral artery disease
5683020|NCT00566657|Plasmid based gene therapy|plasmid based gene therapy
5683021|NCT00566644|endometrial cancer|endometrial cancer
5683022|NCT00566644|hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)|hereditary non-polyposis colon cancer (hmsh2, hmlh1, hpms1, hpms2)
5683023|NCT00566631|Schizophrenia|schizophrenia
5683024|NCT00566631|Paliperidone Extended Release (ER)|paliperidone extended release (er)
5683025|NCT00566631|Invega|invega
5683026|NCT00566618|Breast Cancer|breast cancer
5683027|NCT00566618|Bone Metastases|bone metastases
5683028|NCT00566618|Breast Cancer with Bone Metastases|breast cancer with bone metastases
5683029|NCT00566618|Breast Cancer with Metastases to Bone|breast cancer with metastases to bone
5683030|NCT00566618|Dasatinib|dasatinib
5683031|NCT00566618|Zometa|zometa
5683032|NCT00566618|Zoledronic Acid|zoledronic acid
5683033|NCT00566618|Zoledronate|zoledronate
5683034|NCT00566618|BMS-345825|bms-345825
5683035|NCT00566618|Sprycel®|sprycel®
5683036|NCT00566579|Human papillomavirus|human papillomavirus
5683037|NCT00566579|Clearance|clearance
5683038|NCT00566579|Cryotherapy|cryotherapy
5683039|NCT00566566|adipocytokines|adipocytokines
5683040|NCT00566566|inflammatory markers|inflammatory markers
5683041|NCT00566566|cardiovascular disease|cardiovascular disease
5683042|NCT00566566|diabetes mellitus|diabetes mellitus
5683043|NCT00566566|Leptin|leptin
5683044|NCT00566553|Grape Seed Extract|grape seed extract
5683045|NCT00566553|Breast Cancer|breast cancer
5683046|NCT00566553|Estrogen Levels|estrogen levels
5683047|NCT00566553|Aromatase Inhibitor|aromatase inhibitor
5683048|NCT00566540|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5683049|NCT00566540|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5683050|NCT00566540|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5683051|NCT00566540|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5683052|NCT00566540|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5683053|NCT00566540|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5683054|NCT00566540|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5683055|NCT00566514|fibromyalgia|fibromyalgia
5683056|NCT00566514|ribose|ribose
5683057|NCT00566514|d-ribose|d-ribose
5683058|NCT00566514|dextrose|dextrose
5683059|NCT00566501|Moderate-to-severe|moderate-to-severe
5683060|NCT00566501|Alzheimer's|alzheimer's
5683061|NCT00566501|Disease|disease
5683062|NCT00566488|Thymus Transplantation|thymus transplantation
5683063|NCT00566488|Parathyroid Transplantation|parathyroid transplantation
5683064|NCT00566488|DiGeorge Syndrome|digeorge syndrome
5683065|NCT00566488|Hypoparathyroidism|hypoparathyroidism
5683066|NCT00566488|Athymia|athymia
5683067|NCT00566449|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5935798|NCT02568943|multiple myelome, MM, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, LBH589|multiple myelome, mm, expanded treatment, panobinostat, bortezomib, dexamethasone, relapsed, refractory, lbh589
5935810|NCT02565511|Randomization, Placebo controlled, Parallel-group, APOE4 Homozygotes, Preclinical Alzheimer's Disease (AD), Aβ lowering|randomization, placebo controlled, parallel-group, apoe4 homozygotes, preclinical alzheimer's disease (ad), aβ lowering
4956122|NCT04263324|fMRI|fmri
5683068|NCT00566449|ADHD|adhd
5683069|NCT00566449|JNJ-31001074|jnj-31001074
5683070|NCT00566436|Peripheral Arterial Occlusive Disease|peripheral arterial occlusive disease
5683071|NCT00566436|Superficial Femoral Artery|superficial femoral artery
5683072|NCT00566436|Remote Endarterectomy|remote endarterectomy
5683073|NCT00566436|Suprageniculate Bypass Surgery|suprageniculate bypass surgery
5683074|NCT00566436|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5683075|NCT00566436|Vascular Patency|vascular patency
5683077|NCT00566423|Biomarkers|biomarkers
5683080|NCT00566423|6 Minute Walk (6MW)|6 minute walk (6mw)
5683081|NCT00566410|DCA|dca
5683083|NCT00566410|Dose Escalation|dose escalation
5683084|NCT00566410|Solid Tumours|solid tumours
5683085|NCT00566410|Dichloroacetate|dichloroacetate
5683086|NCT00566410|Pharmacokinetic|pharmacokinetic
5683087|NCT00566397|RI RI Study Rage Inhibitors|ri ri study rage inhibitors
5683088|NCT00566384|Loss of libido|loss of libido
5683089|NCT00566384|Acquired, oral contraceptive -associated female sexual dysfunction|acquired, oral contraceptive -associated female sexual dysfunction
5683090|NCT00566371|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5683092|NCT00566371|atomoxetine|atomoxetine
5683093|NCT00566358|diabetes mellitus, type 2|diabetes mellitus, type 2
5683094|NCT00566358|duodenal exclusion|duodenal exclusion
5683095|NCT00566358|bariatric surgery|bariatric surgery
5683096|NCT00566358|Glucagon-Like Peptide 1|glucagon-like peptide 1
5683097|NCT00566358|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5683098|NCT00566358|insulin|insulin
5683099|NCT00566358|glucagon|glucagon
5683100|NCT00566358|ghrelin|ghrelin
5683101|NCT00566332|Waldenström Macroglobulinemia|waldenström macroglobulinemia
5683102|NCT00566332|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5683103|NCT00566332|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
5683104|NCT00566332|Fludarabine|fludarabine
5683105|NCT00566332|Chlorambucil|chlorambucil
5683106|NCT00566319|Exercise|exercise
5683107|NCT00566306|Clostridium difficile|clostridium difficile
5683108|NCT00566306|disinfectant|disinfectant
5683109|NCT00566280|MBI|mbi
5683110|NCT00566280|Mammogram|mammogram
5683111|NCT00566280|Breast Cancer|breast cancer
5683112|NCT00566280|Breast Ultrasound|breast ultrasound
5683113|NCT00566280|Bloody Nipple Discharge|bloody nipple discharge
5683114|NCT00566280|Molecular Breast Imaging|molecular breast imaging
5683115|NCT00566254|Epilepsy|epilepsy
5683116|NCT00566254|paediatric|paediatric
5683117|NCT00566254|partial onset seizures|partial onset seizures
5683118|NCT00566241|Body weight|body weight
5683119|NCT00566241|Body composition|body composition
5683120|NCT00566241|Pulmonary function|pulmonary function
5683121|NCT00566241|Carbohydrate tolerance|carbohydrate tolerance
5683122|NCT00566228|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5683123|NCT00566228|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5683124|NCT00566228|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5683125|NCT00566228|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5683126|NCT00566215|diabetes mellitus, type 2|diabetes mellitus, type 2
5683127|NCT00566215|Insulin resistance|insulin resistance
5683128|NCT00566215|Intra-Abdominal Fat|intra-abdominal fat
5683129|NCT00566215|Omentum|omentum
5683130|NCT00566215|duodenal exclusion|duodenal exclusion
5683131|NCT00566215|bariatric surgery|bariatric surgery
5683132|NCT00566215|Glucagon-Like Peptide 1|glucagon-like peptide 1
5683133|NCT00566215|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5683134|NCT00566215|insulin|insulin
5683135|NCT00566215|glucagon|glucagon
5683136|NCT00566215|ghrelin|ghrelin
5683137|NCT00566215|adiponectin|adiponectin
5683138|NCT00566215|Cytokines|cytokines
5683139|NCT00566202|Major Depressive Disorder|major depressive disorder
5683140|NCT00566202|Depression|depression
5683141|NCT00566202|JNJ-18038683|jnj-18038683
5683142|NCT00566202|Escitalopram|escitalopram
5683143|NCT00566189|diabetes mellitus, type 2|diabetes mellitus, type 2
5683144|NCT00566189|Insulin resistance|insulin resistance
5683145|NCT00566189|Intra-Abdominal Fat|intra-abdominal fat
5683146|NCT00566189|Omentum|omentum
5683147|NCT00566189|duodenal exclusion|duodenal exclusion
5935850|NCT02559687|Programmed Cell Death-1 (PD-1, PD1)|programmed cell death-1 (pd-1, pd1)
5935851|NCT02559687|Programmed Cell Death-Ligand 1 (PD-L1, PDL1)|programmed cell death-ligand 1 (pd-l1, pdl1)
5935852|NCT02559687|Programmed Cell Death-Ligand 2 (PD-L2, PDL2)|programmed cell death-ligand 2 (pd-l2, pdl2)
5935883|NCT02548351|Non Alcoholic Steatohepatitis, fatty liver disease, NASH|non alcoholic steatohepatitis, fatty liver disease, nash
5683148|NCT00566189|bariatric surgery|bariatric surgery
5683149|NCT00566189|Glucagon-Like Peptide 1|glucagon-like peptide 1
5683150|NCT00566189|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5683151|NCT00566189|insulin|insulin
5683152|NCT00566189|glucagon|glucagon
5683153|NCT00566189|ghrelin|ghrelin
5935962|NCT02527434|Urothelial bladder cancer, Triple-negative breast cancer, Pancreatic ductal adenocarcinoma, Advanced Solid Tumors, Tremelimumab, MEDI4736, ORR|urothelial bladder cancer, triple-negative breast cancer, pancreatic ductal adenocarcinoma, advanced solid tumors, tremelimumab, medi4736, orr
5935963|NCT02526277|RLS|rls
5935975|NCT02518906|Psychotherapy|psychotherapy
5935976|NCT02518906|psychotherapy process|psychotherapy process
5935977|NCT02518906|therapeutic alliance|therapeutic alliance
5935978|NCT02518906|psychotherapeutic change|psychotherapeutic change
5935979|NCT02518906|psychophysiology|psychophysiology
4956340|NCT04261842|Active Duty|active duty
5936019|NCT02511002|Influenza Like Infection (ILI)|influenza like infection (ili)
5936020|NCT02511002|Longitudinal Observation|longitudinal observation
5936021|NCT02511002|Flu|flu
5936022|NCT02511002|Immunity|immunity
5936023|NCT02511002|Natural History|natural history
5683154|NCT00566189|adiponectin|adiponectin
5683155|NCT00566189|Cytokines|cytokines
5683156|NCT00566176|Atrial Fibrillation|atrial fibrillation
5683157|NCT00566176|AF|af
5683158|NCT00566176|AFIB|afib
5683159|NCT00566176|racing heart|racing heart
5683160|NCT00566176|pulmonary vein isolation|pulmonary vein isolation
5683161|NCT00566176|pvi|pvi
5683162|NCT00566176|mini maze|mini maze
5683163|NCT00566176|maze|maze
5683164|NCT00566150|Keppra|keppra
5683165|NCT00566150|Levetiracetam|levetiracetam
5683166|NCT00566150|Anticonvulsant|anticonvulsant
5683167|NCT00566150|Depression|depression
5683168|NCT00566150|Bipolar Disorder|bipolar disorder
5683169|NCT00566150|Affective Disorders|affective disorders
5683170|NCT00566150|Mood Disorders|mood disorders
5683171|NCT00566150|Double Blind|double blind
5683172|NCT00566150|Acute Antidepressant Effects|acute antidepressant effects
5683173|NCT00566137|Scleroderma|scleroderma
5683174|NCT00566137|Pulmonary Hypertension|pulmonary hypertension
5683175|NCT00566124|Levemir, Lantus, Insulatard, Pharmacodynamics, Healthy humans|levemir, lantus, insulatard, pharmacodynamics, healthy humans
5683176|NCT00566111|Ceftriaxone|ceftriaxone
5683177|NCT00566111|Acute Antidepressant Effects|acute antidepressant effects
5683178|NCT00566111|Glutamatergic System|glutamatergic system
5683179|NCT00566111|Double-Blind|double-blind
5683180|NCT00566111|Mood Disorders|mood disorders
5683181|NCT00566111|Bipolar Disorder|bipolar disorder
5683182|NCT00566111|Depression|depression
5683183|NCT00566111|Affective Disorders|affective disorders
5683184|NCT00566098|stage II multiple myeloma|stage ii multiple myeloma
5683185|NCT00566098|stage III multiple myeloma|stage iii multiple myeloma
5683187|NCT00566085|Breast Cancer|breast cancer
5683188|NCT00566085|Neoadjuvant Therapy|neoadjuvant therapy
5683189|NCT00566085|Molecular Breast Imaging|molecular breast imaging
5683190|NCT00566072|the effect of information on compliance of medication|the effect of information on compliance of medication
5683191|NCT00566059|therapeutic advice|therapeutic advice
5683192|NCT00566033|AUDIT|audit
5683193|NCT00566033|Chronic kidney disease|chronic kidney disease
5683194|NCT00566033|Clinical trial|clinical trial
5683195|NCT00566033|Creatinine|creatinine
5683196|NCT00566033|Multiple intervents|multiple intervents
5683197|NCT00566033|Nephrology guidelines.|nephrology guidelines.
5683198|NCT00566020|Open-label extension|open-label extension
5683199|NCT00566020|Tolerability|tolerability
5683200|NCT00566020|Lamotrigine|lamotrigine
5683201|NCT00566020|Safety|safety
5683202|NCT00566020|Bipolar I disorder|bipolar i disorder
5683203|NCT00566007|disc herniation|disc herniation
5683204|NCT00566007|lumbar|lumbar
5683205|NCT00566007|ozone therapy|ozone therapy
5683206|NCT00565994|hemodialysis|hemodialysis
5683207|NCT00565994|Vascular access|vascular access
5683208|NCT00565994|arteriovenous fistula|arteriovenous fistula
5683209|NCT00565994|indwelling percutaneous catheters|indwelling percutaneous catheters
5683210|NCT00565994|arteriovenous grafts|arteriovenous grafts
5683211|NCT00565981|B-CLL|b-cll
5683212|NCT00565981|refractory|refractory
5683213|NCT00565981|molecular profiling|molecular profiling
5683214|NCT00565981|alemtuzumab|alemtuzumab
5683215|NCT00565981|fludarabinephosphate|fludarabinephosphate
5683216|NCT00565968|stage IIIB melanoma|stage iiib melanoma
5683217|NCT00565968|stage IIIC melanoma|stage iiic melanoma
5683218|NCT00565968|recurrent melanoma|recurrent melanoma
5683219|NCT00565955|Montelukast|montelukast
5683220|NCT00565955|Acute Asthma|acute asthma
5683221|NCT00565942|Integrative medicine|integrative medicine
5683222|NCT00565942|Primary care|primary care
5683223|NCT00565942|Swedish massage therapy|swedish massage therapy
5683224|NCT00565942|Manual therapy|manual therapy
5683225|NCT00565942|Naprapathy|naprapathy
5683226|NCT00565942|Shiatsu|shiatsu
5683227|NCT00565942|Acupuncture/TCM|acupuncture/tcm
5683228|NCT00565942|Qigong|qigong
5683229|NCT00565942|Pragmatic RCT|pragmatic rct
5683230|NCT00565942|Health services research|health services research
5683356|NCT00565240|folliculogenesis|folliculogenesis
5683231|NCT00565929|Variola major, smallpox, vaccine, hematopoietic stem cell transplant|variola major, smallpox, vaccine, hematopoietic stem cell transplant
5683232|NCT00565916|Post-Menopausal|post-menopausal
5683233|NCT00565916|PET|pet
5683234|NCT00565916|Estrogen|estrogen
5683235|NCT00565916|Progesterone|progesterone
5683236|NCT00565916|Heart Metabolism|heart metabolism
5683237|NCT00565916|Cardiovascular Disease|cardiovascular disease
5683238|NCT00565903|pleuropulmonary blastoma|pleuropulmonary blastoma
5683239|NCT00565903|PPB|ppb
5683240|NCT00565903|cystic nephroma|cystic nephroma
5683241|NCT00565903|DICER1|dicer1
5683242|NCT00565903|miRNA|mirna
5683243|NCT00565890|very low birth weight infant|very low birth weight infant
5683244|NCT00565890|hypothyroxinemia|hypothyroxinemia
5683245|NCT00565890|outcomes|outcomes
5683246|NCT00565877|Catheter|catheter
5683247|NCT00565877|Peripherally inserted central catheter|peripherally inserted central catheter
5683248|NCT00565877|ultrasound|ultrasound
5683249|NCT00565877|malposition|malposition
5683250|NCT00565864|Hypothyroidism|hypothyroidism
5683251|NCT00565864|Cognition|cognition
5936224|NCT02447003|PD1|pd1
5936225|NCT02447003|PD-1|pd-1
5936226|NCT02447003|PDL1|pdl1
5936227|NCT02447003|PD-L1|pd-l1
5936294|NCT02421185|Carcinoma, Hepatocellular|carcinoma, hepatocellular
4956684|NCT04259411|DMR|dmr
5683252|NCT00565864|Metabolism|metabolism
5683253|NCT00565838|Randomized study|randomized study
5683254|NCT00565838|surgical treatment|surgical treatment
5683255|NCT00565838|autologous fascial sling|autologous fascial sling
5683256|NCT00565838|TVT|tvt
5683257|NCT00565838|stress urinary incontinence.|stress urinary incontinence.
5683258|NCT00565812|knee Osteoarthritis Disease Modifying Osteoarthritis Drug|knee osteoarthritis disease modifying osteoarthritis drug
5683259|NCT00565799|DM|dm
5683260|NCT00565760|Acute|acute
5683261|NCT00565760|Pain|pain
5683262|NCT00565747|GM-CSF|gm-csf
5683263|NCT00565747|infertility|infertility
5683264|NCT00565721|Static PET imaging|static pet imaging
5683265|NCT00565721|Dynamic PET imaging|dynamic pet imaging
5683266|NCT00565721|Angiogenesis|angiogenesis
5683267|NCT00565721|αvβ3 integrins|αvβ3 integrins
5683268|NCT00565721|oncology imaging|oncology imaging
5683269|NCT00565708|stage II colon cancer|stage ii colon cancer
5683270|NCT00565708|stage III colon cancer|stage iii colon cancer
5683271|NCT00565708|stage II rectal cancer|stage ii rectal cancer
5683272|NCT00565708|stage III rectal cancer|stage iii rectal cancer
5683273|NCT00565695|Visual Outcomes|visual outcomes
5683274|NCT00565695|Patient Satisfaction|patient satisfaction
5683275|NCT00565695|Cataract Extraction|cataract extraction
5683276|NCT00565669|Treatment|treatment
5683377|NCT00565045|hand|hand
5683278|NCT00565656|Myelodysplastic syndromes (int-1, int-2 and high risk according to IPSS) with excess of marrow blasts including CMML with leucocytes<10 000/mm3|myelodysplastic syndromes (int-1, int-2 and high risk according to ipss) with excess of marrow blasts including cmml with leucocytes<10 000/mm3
5683279|NCT00565643|Adhesion|adhesion
5683280|NCT00565643|Seprafilm|seprafilm
5708713|NCT00469911|MRS|mrs
5683281|NCT00565643|Cesarean section|cesarean section
5683282|NCT00565617|depression|depression
5683283|NCT00565617|epidural|epidural
5683284|NCT00565617|cortical stimulation|cortical stimulation
5683285|NCT00565617|brain stimulation|brain stimulation
5683286|NCT00565617|treatment-resistant|treatment-resistant
5683287|NCT00565617|deep brain stimulation|deep brain stimulation
5683288|NCT00565617|TMS|tms
5683289|NCT00565617|DBS|dbs
5683290|NCT00565617|ECS|ecs
5683291|NCT00565604|Perforator Veins|perforator veins
5683292|NCT00565604|Incompetent Veins|incompetent veins
5683293|NCT00565604|Varicose Veins|varicose veins
5683294|NCT00565591|asthma|asthma
5683295|NCT00565591|inhaler device|inhaler device
5683296|NCT00565591|albuterol sulfate|albuterol sulfate
5683297|NCT00565565|Biventriular chronic heart failure, Pulmonary hypertension|biventriular chronic heart failure, pulmonary hypertension
5683298|NCT00565552|silicone gel|silicone gel
5683299|NCT00565552|cicatrix|cicatrix
5683300|NCT00565552|wound healing|wound healing
5683301|NCT00565552|scar|scar
5683302|NCT00565552|keloid|keloid
5683303|NCT00565539|PEGylated recombinant interleukin 29|pegylated recombinant interleukin 29
5683304|NCT00565539|interferon lambda|interferon lambda
5683305|NCT00565539|interleukin 29|interleukin 29
5683306|NCT00565539|hepatitis C|hepatitis c
5683307|NCT00565539|virus|virus
5683308|NCT00565539|infection|infection
5683309|NCT00565539|liver|liver
5683310|NCT00565526|Autonomic Nervous System|autonomic nervous system
5683311|NCT00565526|Sjogren's Syndrome|sjogren's syndrome
5683312|NCT00565526|Pathogenesis|pathogenesis
5683313|NCT00565526|Cholinergic|cholinergic
5683314|NCT00565526|Parasympathetic|parasympathetic
5683315|NCT00565526|Sjogren Syndrome|sjogren syndrome
5683316|NCT00565487|Radiotherapy|radiotherapy
5683317|NCT00565487|Non-operable pancreatic cancer|non-operable pancreatic cancer
5683318|NCT00565487|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5683319|NCT00565474|Renal transplantation|renal transplantation
5683320|NCT00565474|fluvastatin|fluvastatin
5683321|NCT00565448|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5683322|NCT00565422|Internet addiction|internet addiction
5683323|NCT00565422|Problematic internet use|problematic internet use
5683324|NCT00565422|Escitalopram|escitalopram
5683325|NCT00565422|Lexapro|lexapro
5683326|NCT00565409|Active Rheumatoid Arthritis|active rheumatoid arthritis
5683327|NCT00565383|Pregnancy|pregnancy
5683328|NCT00565383|37 Weeks Gestation|37 weeks gestation
5683329|NCT00565383|Breech Presentation|breech presentation
5683330|NCT00565383|Version Procedure|version procedure
5683331|NCT00565383|Pain Control|pain control
5683332|NCT00565383|Neuraxial analgesia|neuraxial analgesia
5683333|NCT00565370|Gastric cancer|gastric cancer
5683334|NCT00565370|capecitabine|capecitabine
5936295|NCT02421185|JNJ 42756493|jnj 42756493
5936296|NCT02421185|a pan-Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor|a pan-fibroblast growth factor receptor tyrosine kinase inhibitor
5936297|NCT02418182|Analgesic|analgesic
5936298|NCT02418182|Pain Control|pain control
5936299|NCT02418182|IVF|ivf
5936300|NCT02418182|Tylenol|tylenol
5936301|NCT02418182|Acetaminophen|acetaminophen
5936302|NCT02418182|Egg Retrieval|egg retrieval
5936303|NCT02418182|iv vitro Fertilization|iv vitro fertilization
5936322|NCT02414230|fronto-temporal dementia|fronto-temporal dementia
5936323|NCT02414230|Tauopathies|tauopathies
5936324|NCT02414230|Nervous System Diseases|nervous system diseases
5936325|NCT02414230|Neurodegenerative Diseases|neurodegenerative diseases
5936357|NCT02410304|Rheumatoid arthritis / ultrasonography / synovitis|rheumatoid arthritis / ultrasonography / synovitis
5936358|NCT02408120|Hyperglycemia|hyperglycemia
5936359|NCT02408120|Hypoglycemia|hypoglycemia
5683335|NCT00565370|cisplatin|cisplatin
5683336|NCT00565370|sorafenib|sorafenib
5683337|NCT00565370|phase I|phase i
5683338|NCT00565370|phase II|phase ii
5683339|NCT00565357|Postnatal Growth|postnatal growth
5683340|NCT00565357|Postnatal Development|postnatal development
5683341|NCT00565357|Noise|noise
5683342|NCT00565357|Neonatal Intensive Care Unit|neonatal intensive care unit
5683343|NCT00565344|Medicaid|medicaid
5683344|NCT00565344|Disenrollment|disenrollment
5683345|NCT00565318|Benfotiamine|benfotiamine
5683346|NCT00565318|Diabetes|diabetes
5683347|NCT00565318|Nephropathy|nephropathy
5683348|NCT00565305|Healing Touch|healing touch
5683349|NCT00565305|NK cytotoxicity|nk cytotoxicity
5683350|NCT00565305|cytokines|cytokines
5683351|NCT00565305|fatigue|fatigue
5683352|NCT00565279|Seborrhoeic dermatitis|seborrhoeic dermatitis
5683353|NCT00565253|pulmonary embolism|pulmonary embolism
5683354|NCT00565253|inhaled nitric oxide|inhaled nitric oxide
5683355|NCT00565240|ovarian synchronization|ovarian synchronization
5683357|NCT00565214|vitamin supplements|vitamin supplements
5683358|NCT00565214|healthy smokers|healthy smokers
5683359|NCT00565214|epithelial lung tissue|epithelial lung tissue
5683360|NCT00565214|bronchoscopy|bronchoscopy
5683361|NCT00565214|antioxidant levels|antioxidant levels
5683362|NCT00565201|Stroke, Cerebrovascular accident, Spasticity, Arm, Hand|stroke, cerebrovascular accident, spasticity, arm, hand
5683363|NCT00565175|Treatment resistant|treatment resistant
5683364|NCT00565175|Chronic|chronic
5683365|NCT00565136|Device study|device study
5683366|NCT00565136|Pelvic floor weakness|pelvic floor weakness
5683367|NCT00565136|Fecal incontinence|fecal incontinence
5683368|NCT00565123|bacterial conjunctivitis levofloxacin fluoroquinolone|bacterial conjunctivitis levofloxacin fluoroquinolone
5683369|NCT00565097|Polycystic Liver Disease|polycystic liver disease
5683370|NCT00565097|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5683371|NCT00565097|Liver cyst|liver cyst
5683372|NCT00565097|Lanreotide|lanreotide
5683373|NCT00565071|Cost-effectiveness|cost-effectiveness
5683374|NCT00565071|Diagnosis|diagnosis
5683375|NCT00565071|Treatment|treatment
5683380|NCT00565045|electrical stimulation|electrical stimulation
5683381|NCT00565045|recovery|recovery
5683382|NCT00565032|postpartum depression|postpartum depression
5683383|NCT00565032|thyroxine|thyroxine
5683384|NCT00565032|thyroid antibodies|thyroid antibodies
5683385|NCT00565032|thyroid stimulating hormone|thyroid stimulating hormone
5683386|NCT00565032|Edinburgh Postnatal Depression Scale (EPDS)|edinburgh postnatal depression scale (epds)
5683387|NCT00564980|Randomized|randomized
5683388|NCT00564980|Prospective|prospective
5683389|NCT00564980|Procedure / Surgery|procedure / surgery
5683390|NCT00564954|ADHD|adhd
5683391|NCT00564954|children|children
5683392|NCT00564954|laboratory classroom|laboratory classroom
5683393|NCT00564954|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5683394|NCT00564941|Myelodysplastic Syndromes|myelodysplastic syndromes
5683395|NCT00564941|beta-Thalassemia|beta-thalassemia
5683396|NCT00564941|Iron Overload|iron overload
5683397|NCT00564941|Iron Chelating Agents|iron chelating agents
5683398|NCT00564941|deferasirox|deferasirox
5936391|NCT02396342|Hemophilia B, gene therapy|hemophilia b, gene therapy
5936416|NCT02387970|Dental implants|dental implants
5936417|NCT02387970|Partial edentulism|partial edentulism
5936418|NCT02387970|Immediate/delayed provisionalization|immediate/delayed provisionalization
5936437|NCT02380352|antibiotic stewardship|antibiotic stewardship
5936438|NCT02380352|non-inferiority|non-inferiority
5936439|NCT02380352|randomized controlled trial|randomized controlled trial
5936443|NCT02379429|Specimen Collection|specimen collection
5936444|NCT02379429|Urine|urine
5936445|NCT02379429|Blood|blood
5936446|NCT02379429|Saliva|saliva
5936505|NCT02358499|triazoles|triazoles
5936506|NCT02358499|fungi|fungi
5936507|NCT02358499|transplantation, hematopoietic stem cell|transplantation, hematopoietic stem cell
5936508|NCT02358499|leukemia|leukemia
5936509|NCT02358499|pediatrics|pediatrics
5936510|NCT02358499|pharmacokinetics|pharmacokinetics
5936511|NCT02358499|bone marrow failure syndrome|bone marrow failure syndrome
5936564|NCT02343302|Pancreatic Fistula|pancreatic fistula
5683399|NCT00564928|Hormone resistant prostate cancer|hormone resistant prostate cancer
5683400|NCT00564928|castrate resistant prostate cancer|castrate resistant prostate cancer
5683401|NCT00564928|HRPC|hrpc
5683402|NCT00564928|CRPC|crpc
5683403|NCT00564915|Epilepsy|epilepsy
5683404|NCT00564902|Macular Pigment Optical Density|macular pigment optical density
5683405|NCT00564902|Skin Carotenoids|skin carotenoids
5683406|NCT00564902|Lipofuscin|lipofuscin
5683407|NCT00564902|Photostress (Glare Recovery)|photostress (glare recovery)
5683408|NCT00564902|Visual Field Progression|visual field progression
5683409|NCT00564902|Contrast Sensitivity|contrast sensitivity
5683410|NCT00564902|Color Vision|color vision
5683411|NCT00564902|Cognitive Function|cognitive function
5683412|NCT00564889|primary systemic amyloidosis|primary systemic amyloidosis
5683413|NCT00564876|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5683414|NCT00564876|carcinoma|carcinoma
5683415|NCT00564876|dasatinib|dasatinib
5683416|NCT00564876|neoadjuvant|neoadjuvant
5683417|NCT00564876|adjuvant|adjuvant
5683418|NCT00564876|resection|resection
5683419|NCT00564876|genomic signature|genomic signature
5683420|NCT00564876|predictor|predictor
5683421|NCT00564876|microarray|microarray
5683422|NCT00564863|Diarrhea|diarrhea
5683423|NCT00564863|ETEC|etec
5683424|NCT00564837|Anterior cruciate ligament|anterior cruciate ligament
5683425|NCT00564837|Reconstruction|reconstruction
5683426|NCT00564837|Rehabilitation|rehabilitation
5683427|NCT00564837|Home-based|home-based
5678826|NCT00584805|EEE|eee
5683428|NCT00564824|coronary disease|coronary disease
5683429|NCT00564824|atherosclerosis|atherosclerosis
5683430|NCT00564824|endothelial function|endothelial function
5683431|NCT00564824|caffeine|caffeine
5683432|NCT00564824|cerebrovascular disease|cerebrovascular disease
5683433|NCT00564824|prevention|prevention
5683434|NCT00564811|Agaricus blazei (Murrill) ss. Heinemann,|agaricus blazei (murrill) ss. heinemann,
5683435|NCT00564811|Hepatitis C|hepatitis c
5683436|NCT00564811|Nutritional status|nutritional status
5683437|NCT00564811|Liver Function Tests|liver function tests
5683438|NCT00564811|Antiviral Agents|antiviral agents
5683439|NCT00564798|protocoladolescents|protocoladolescents
5683440|NCT00564798|children|children
5683441|NCT00564798|health behaviours/attitudes|health behaviours/attitudes
5683442|NCT00564798|weight loss/management|weight loss/management
5683443|NCT00564798|program evaluation|program evaluation
5683444|NCT00564772|raltegravir|raltegravir
5683445|NCT00564772|lopinavir|lopinavir
5683446|NCT00564772|ritonavir|ritonavir
5683447|NCT00564772|pharmacokinetics|pharmacokinetics
5683448|NCT00564759|CGD|cgd
5683449|NCT00564746|SB-681323,|sb-681323,
5683450|NCT00564746|ADME,|adme,
5683451|NCT00564746|radiolabel|radiolabel
5683452|NCT00564694|adenocarcinoma of the colon|adenocarcinoma of the colon
5683453|NCT00564694|recurrent colon cancer|recurrent colon cancer
5683454|NCT00564694|stage I colon cancer|stage i colon cancer
5683455|NCT00564694|stage II colon cancer|stage ii colon cancer
5683456|NCT00564694|stage III colon cancer|stage iii colon cancer
5683457|NCT00564694|stage IV colon cancer|stage iv colon cancer
5683651|NCT00563784|Carboplatin|carboplatin
5683458|NCT00564694|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5683459|NCT00564694|recurrent rectal cancer|recurrent rectal cancer
5683460|NCT00564694|stage I rectal cancer|stage i rectal cancer
5683461|NCT00564694|stage II rectal cancer|stage ii rectal cancer
5683462|NCT00564694|stage III rectal cancer|stage iii rectal cancer
5683463|NCT00564694|stage IV rectal cancer|stage iv rectal cancer
5683464|NCT00564655|pediatrics|pediatrics
5683465|NCT00564655|Gastric Tube Insertion|gastric tube insertion
5683467|NCT00564655|Regional Anesthetic|regional anesthetic
5683468|NCT00564655|Transversus Abdominal Plane|transversus abdominal plane
5683469|NCT00564616|cardiac arrest|cardiac arrest
5683470|NCT00564616|video cell phone|video cell phone
5683471|NCT00564616|dispatcher-assisted CPR|dispatcher-assisted cpr
5683473|NCT00564603|Opioids|opioids
5683474|NCT00564603|Balanced analgesia|balanced analgesia
5683475|NCT00564577|Diarrhea ETEC|diarrhea etec
5683476|NCT00564564|obsessive compulsive disorder|obsessive compulsive disorder
5936651|NCT02324504|Peripherally Inserted Central Catheter (PICC)|peripherally inserted central catheter (picc)
5936652|NCT02324504|Electrocardiographic guidance|electrocardiographic guidance
5936653|NCT02324504|Reposition|reposition
4957140|NCT04256668|histone|histone
5683477|NCT00564564|pharmacological treatment|pharmacological treatment
5683478|NCT00564564|quetiapine|quetiapine
5683479|NCT00564564|clomipramine|clomipramine
5683480|NCT00564564|SSRI|ssri
5683481|NCT00564551|Prediabetes|prediabetes
5683482|NCT00564551|Type 2 diabetes|type 2 diabetes
5683483|NCT00564551|Metabolic syndrome|metabolic syndrome
5683484|NCT00564551|Insulin resistance syndrome|insulin resistance syndrome
5683485|NCT00564551|Weight loss|weight loss
5683486|NCT00564551|Milk products|milk products
5683487|NCT00564551|Calcium|calcium
5683488|NCT00564538|liver transplant|liver transplant
5683489|NCT00564525|children|children
5683490|NCT00564525|abdominal pain|abdominal pain
5683491|NCT00564525|amitriptyline|amitriptyline
5683492|NCT00564512|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5683493|NCT00564512|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5683494|NCT00564512|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5683495|NCT00564512|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5683496|NCT00564512|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5683497|NCT00564499|COPD|copd
5683498|NCT00564499|Symbicort|symbicort
5683499|NCT00564499|General Practitioners|general practitioners
5683500|NCT00564486|Abdominal Laparoscopic Surgery|abdominal laparoscopic surgery
5683501|NCT00564473|internal medicine|internal medicine
5683502|NCT00564473|herbal medicine|herbal medicine
5683503|NCT00564473|prevalence|prevalence
5683504|NCT00564473|attitudes|attitudes
5683505|NCT00564473|herb-drug interaction|herb-drug interaction
5683506|NCT00564434|delirium|delirium
5683507|NCT00564434|pathophysiology|pathophysiology
5683508|NCT00564434|risk factors|risk factors
5683509|NCT00564434|pain|pain
5683510|NCT00564434|dementia|dementia
5683511|NCT00564395|blood sugar|blood sugar
5683512|NCT00564395|glycemic|glycemic
5683513|NCT00564382|Acute coronary syndrome|acute coronary syndrome
5683514|NCT00564382|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5683515|NCT00564382|Contrast agents|contrast agents
5683516|NCT00564382|Gadolinium|gadolinium
5683517|NCT00564369|HIV testing|hiv testing
5683518|NCT00564369|HIV Seronegativity|hiv seronegativity
5683519|NCT00564356|cataract, phacoemulsification, coumadin, antiaggregants|cataract, phacoemulsification, coumadin, antiaggregants
5683520|NCT00564343|Balance|balance
5683521|NCT00564343|Water based training|water based training
5683522|NCT00564343|Physical functioning|physical functioning
5683523|NCT00564343|stepping behavior|stepping behavior
5683524|NCT00564330|dental erosion|dental erosion
5683525|NCT00564330|OCT|oct
5683526|NCT00564330|proton pump inhibitor|proton pump inhibitor
5683527|NCT00564317|PTSD|ptsd
5683528|NCT00564317|Depression|depression
5683529|NCT00564317|Suicidality|suicidality
5683530|NCT00564317|trauma-focussed treatment|trauma-focussed treatment
5683531|NCT00564317|KIDNET|kidnet
5683532|NCT00564317|Narrative Exposure Therapy for Children|narrative exposure therapy for children
5683533|NCT00564317|Meditation|meditation
5683534|NCT00564317|Relaxation|relaxation
5683535|NCT00564317|War|war
5683536|NCT00564304|Nasal Potential Difference|nasal potential difference
5683537|NCT00564291|OCT|oct
5683538|NCT00564278|Hispanic Americans|hispanic americans
5683539|NCT00564278|Major Depressive Disorder|major depressive disorder
5683540|NCT00564278|Antidepressant Therapy|antidepressant therapy
5683541|NCT00564278|Motivational Interviewing|motivational interviewing
5683542|NCT00564278|Treatment Retention|treatment retention
5683543|NCT00564278|Treatment Adherence|treatment adherence
5683544|NCT00564265|GIST|gist
5683545|NCT00564226|urge urinary incontinence|urge urinary incontinence
5683546|NCT00564213|Myopia|myopia
5683547|NCT00564213|Mitomycin|mitomycin
5683548|NCT00564200|Multiple Myeloma, transplant|multiple myeloma, transplant
5683549|NCT00564174|recurrent pregnancy loss|recurrent pregnancy loss
5683550|NCT00564174|lupus anticoagulant|lupus anticoagulant
5683551|NCT00564174|anti cardiolipin antibodies|anti cardiolipin antibodies
5683552|NCT00564174|thrombophilia|thrombophilia
5683553|NCT00564174|low molecular weight heparin|low molecular weight heparin
5683554|NCT00564174|aspirin|aspirin
5683652|NCT00563784|Paraplatin|paraplatin
5683555|NCT00564174|randomized clinical trial|randomized clinical trial
5683556|NCT00564148|antiVEGF therapy|antivegf therapy
5683557|NCT00564135|hysterectomy|hysterectomy
5683558|NCT00564135|laparoscopy|laparoscopy
5683559|NCT00564135|urinary retention|urinary retention
5683560|NCT00564135|urinary tract infection|urinary tract infection
5936688|NCT02308111|Primary Biliary Cirrhosis|primary biliary cirrhosis
5936690|NCT02308111|Cirrhosis|cirrhosis
5936691|NCT02308111|Liver|liver
5936714|NCT02303431|Pediatric|pediatric
5936715|NCT02303431|Pharmacokinetics (PK)|pharmacokinetics (pk)
5936716|NCT02303431|Pharmacodynamics (PDy)|pharmacodynamics (pdy)
5936717|NCT02303431|Anticoagulant|anticoagulant
5936718|NCT02303431|Safety|safety
5683561|NCT00564135|catheterization|catheterization
5683562|NCT00564122|Murmur|murmur
5683564|NCT00564122|Stethoscope|stethoscope
5683565|NCT00564122|Congenital Heart Disease|congenital heart disease
5683566|NCT00564122|Structural Heart Disease|structural heart disease
5798801|NCT00110981|NB-UVB, narrow-band UVB, phototherapy|nb-uvb, narrow-band uvb, phototherapy
5683567|NCT00564083|Compare the relative differences between the organic and sythentic materials for sacryl colpopexy.|compare the relative differences between the organic and sythentic materials for sacryl colpopexy.
5683568|NCT00564070|Depression|depression
5683569|NCT00564070|Diabetes|diabetes
5683570|NCT00564070|Adherence|adherence
5683571|NCT00564057|HIV|hiv
5683572|NCT00564057|blood pressure|blood pressure
5683573|NCT00564057|left ventricle|left ventricle
5683574|NCT00564057|metabolic profile|metabolic profile
5683575|NCT00564057|treatment experienced|treatment experienced
5683576|NCT00564044|biofilm-infection-related immune hyperreactivity|biofilm-infection-related immune hyperreactivity
5683577|NCT00564044|mesh extrusion|mesh extrusion
5683578|NCT00564044|mid-urethral sling|mid-urethral sling
5683579|NCT00564044|determine the immune reactivity of biofilms in mesh erosion|determine the immune reactivity of biofilms in mesh erosion
5683580|NCT00564031|hormone replacement therapy; endothelial function;|hormone replacement therapy; endothelial function;
5683581|NCT00564018|type 1 diabetes, basal-bolus, honeymoon, C-peptide|type 1 diabetes, basal-bolus, honeymoon, c-peptide
5683582|NCT00564005|stroke rehabilitation|stroke rehabilitation
5683583|NCT00564005|cortical reorganization|cortical reorganization
5683584|NCT00564005|kinematic analysis|kinematic analysis
5683585|NCT00563979|age related macular degeneration|age related macular degeneration
5683586|NCT00563979|supplementation|supplementation
5683587|NCT00563979|macular pigment|macular pigment
5683588|NCT00563966|smoking pregnancy behaviour polymorphisms|smoking pregnancy behaviour polymorphisms
5683589|NCT00563953|Breast|breast
5683590|NCT00563953|Cancer|cancer
5683591|NCT00563953|Anthracyclines|anthracyclines
5683592|NCT00563953|Cardiopathy|cardiopathy
5683593|NCT00563940|diabetic macular edema|diabetic macular edema
5683594|NCT00563940|OCT|oct
5683595|NCT00563927|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5683596|NCT00563927|T1-4N2-3M0|t1-4n2-3m0
5683597|NCT00563914|Malaria|malaria
5683598|NCT00563901|CHD|chd
5683599|NCT00563901|Combined CHD|combined chd
5683600|NCT00563901|Stroke|stroke
5683601|NCT00563901|Combined Cardiovascular Disease (CVD)|combined cardiovascular disease (cvd)
5683602|NCT00563901|Pharmacogenetics|pharmacogenetics
5683603|NCT00563901|End-Stage Renal Disease|end-stage renal disease
5683604|NCT00563901|Heart Failure|heart failure
5683605|NCT00563901|Hospitalized/Fatal Heart Failure|hospitalized/fatal heart failure
5683606|NCT00563901|Angina|angina
5683607|NCT00563901|Coronary Revascularizations|coronary revascularizations
5683608|NCT00563901|CHD Mortality|chd mortality
5683609|NCT00563901|Lisinopril|lisinopril
5683610|NCT00563901|Chlorthalidone|chlorthalidone
5683611|NCT00563901|Amlodipine|amlodipine
5683612|NCT00563901|Doxazosin|doxazosin
5683613|NCT00563888|PTSD|ptsd
5683614|NCT00563888|torture survivors|torture survivors
5683615|NCT00563888|Narrative Exposure Therapy|narrative exposure therapy
5683616|NCT00563888|trauma-related memory processes|trauma-related memory processes
5683617|NCT00563888|steady state visual evoked fields|steady state visual evoked fields
5683618|NCT00563875|Platelets|platelets
5683619|NCT00563875|Platelet aggregation|platelet aggregation
5683620|NCT00563875|Drug resistance|drug resistance
5683621|NCT00563875|Aspirin|aspirin
5683622|NCT00563875|Diabetes mellitus|diabetes mellitus
5683623|NCT00563862|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5683624|NCT00563862|T3-4N0-1M0|t3-4n0-1m0
5683625|NCT00563836|ovarian cancer|ovarian cancer
5683626|NCT00563836|catumaxomab|catumaxomab
5683627|NCT00563836|phase II|phase ii
5683628|NCT00563836|intraoperative|intraoperative
5683629|NCT00563836|adjuvant|adjuvant
5683630|NCT00563836|trifunctional antibody|trifunctional antibody
5683631|NCT00563823|stage IV melanoma|stage iv melanoma
5683632|NCT00563823|recurrent melanoma|recurrent melanoma
5683633|NCT00563810|Adult|adult
5683634|NCT00563810|Aged|aged
5683635|NCT00563797|treatment|treatment
5936784|NCT02296125|Advanced Non-Small Cell Lung Cancer; EGFRm+; AZD9291; TKI; Phase III|advanced non-small cell lung cancer; egfrm+; azd9291; tki; phase iii
5936799|NCT02286375|health-social partnership|health-social partnership
5936800|NCT02286375|self-efficacy|self-efficacy
5936820|NCT02269917|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5936821|NCT02269917|Emerald|emerald
5936822|NCT02269917|Darunavir|darunavir
5936823|NCT02269917|Cobicistat|cobicistat
5936824|NCT02269917|Emtricitabine|emtricitabine
5936825|NCT02269917|Tenofovir Alafenamide|tenofovir alafenamide
5683636|NCT00563797|alcohol dependence|alcohol dependence
5683637|NCT00563797|depression|depression
5683638|NCT00563797|mecamylamine|mecamylamine
5683639|NCT00563784|Non-Small Cell Lung Cancer|non-small cell lung cancer
5683640|NCT00563784|Lung Cancer|lung cancer
5683641|NCT00563784|Squamous Cell Carcinoma|squamous cell carcinoma
5683642|NCT00563784|Adenocarcinoma|adenocarcinoma
5683643|NCT00563784|Bronchoalveolar Cell Carcinoma|bronchoalveolar cell carcinoma
5683644|NCT00563784|Large Cell Anaplastic Carcinoma|large cell anaplastic carcinoma
5683645|NCT00563784|Giant Cell Carcinoma|giant cell carcinoma
5683646|NCT00563784|Clear Cell Carcinoma|clear cell carcinoma
5683647|NCT00563784|Erlotinib|erlotinib
5683648|NCT00563784|Erlotinib Hydrocholoride|erlotinib hydrocholoride
5683649|NCT00563784|OSI-774|osi-774
5683650|NCT00563784|Tarceva|tarceva
5683653|NCT00563784|Paclitaxel|paclitaxel
5683654|NCT00563784|Taxol|taxol
5683655|NCT00563784|NSCLC|nsclc
5683656|NCT00563758|Chronic constipation|chronic constipation
5683657|NCT00563745|COPD|copd
5683658|NCT00563745|ALS|als
5683660|NCT00563745|mechanical ventilation|mechanical ventilation
5683661|NCT00563745|Integrated care|integrated care
5683662|NCT00563745|strict follow up|strict follow up
5683663|NCT00563745|impact and costs on health care resources|impact and costs on health care resources
5683664|NCT00563745|telemedicine programme|telemedicine programme
5700041|NCT00501059|Stroke and cardiovascular death|stroke and cardiovascular death
5700042|NCT00501059|Aspirin|aspirin
5700043|NCT00501046|Kidney Diseases|kidney diseases
5700044|NCT00501033|Induction of labor|induction of labor
5700045|NCT00501033|Cesarean|cesarean
5700046|NCT00501033|Endometritis|endometritis
5700047|NCT00501033|Foley|foley
5700048|NCT00501033|Infections|infections
5700049|NCT00501020|Type 2 Diabetes|type 2 diabetes
5700050|NCT00501020|metformin|metformin
5700051|NCT00501020|rosiglitazone|rosiglitazone
5683665|NCT00563745|home mechanical ventilation (HMV)|home mechanical ventilation (hmv)
5683666|NCT00563745|frail patients|frail patients
5683667|NCT00563745|chronic respiratory failure (CRF)|chronic respiratory failure (crf)
5683668|NCT00563693|heart failure|heart failure
5683669|NCT00563693|cheyne stokes respiration|cheyne stokes respiration
5683670|NCT00563693|adaptive servo ventilator|adaptive servo ventilator
5683671|NCT00563680|AMG 479|amg 479
5683672|NCT00563680|IGF-1R|igf-1r
5683673|NCT00563680|Insulin-like growth factor|insulin-like growth factor
5683674|NCT00563680|Insulin-like growth factor receptor|insulin-like growth factor receptor
5683675|NCT00563680|Ewing's|ewing's
5683676|NCT00563680|Sarcoma|sarcoma
5683677|NCT00563667|Pterygium|pterygium
5683678|NCT00563667|Cataract|cataract
5683679|NCT00563667|Astigmatism|astigmatism
5683680|NCT00563654|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5683681|NCT00563654|Acute Retention of Urine (AUR)|acute retention of urine (aur)
5683682|NCT00563641|NCPAP|ncpap
5683683|NCT00563641|Very early surfactant|very early surfactant
5683684|NCT00563628|Pattern Scan Laser.|pattern scan laser.
5683685|NCT00563628|Photocoagulation.|photocoagulation.
5679074|NCT00583648|urine|urine
5683686|NCT00563628|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
5683687|NCT00563628|Laser treatment|laser treatment
5683688|NCT00563615|Constipation (idiopathic)|constipation (idiopathic)
5683689|NCT00563602|Portal hypertension|portal hypertension
5683690|NCT00563602|Prevention of rebleeding|prevention of rebleeding
5683691|NCT00563602|Complications of cirrhosis|complications of cirrhosis
5683692|NCT00563602|Portal hemodynamic|portal hemodynamic
5683693|NCT00563602|Prazosine|prazosine
5683694|NCT00563602|Nadolol|nadolol
5683695|NCT00563602|isosorbide mononitrate|isosorbide mononitrate
5683696|NCT00563589|Acute graft-versus-host disease post high risk allogeneic stem cell transplantation|acute graft-versus-host disease post high risk allogeneic stem cell transplantation
5683697|NCT00563576|Depo-Provera|depo-provera
5683698|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate
5683699|NCT00563576|Metrorrhagia|metrorrhagia
5683700|NCT00563576|Irregular Bleeding|irregular bleeding
5936873|NCT02241512|post-ERCP pancreatitis|post-ercp pancreatitis
5936874|NCT02241512|pediatric|pediatric
5936875|NCT02241512|ibuprofen|ibuprofen
4957526|NCT04254198|Women|women
5683701|NCT00563563|Nicotine-dependence in overweight and obese subjects|nicotine-dependence in overweight and obese subjects
5683702|NCT00563537|neurology|neurology
5683703|NCT00563537|sclerosis|sclerosis
5683704|NCT00563537|imaging|imaging
5683705|NCT00563537|tomography|tomography
5683706|NCT00563511|smoking cessation|smoking cessation
5683707|NCT00563498|Veno-occlusive disease|veno-occlusive disease
5683708|NCT00563498|Mucositis|mucositis
5683709|NCT00563485|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5683710|NCT00563485|Acute Retention of Urine (AUR)|acute retention of urine (aur)
5683711|NCT00563472|Healthy female volunteers will participate in this study|healthy female volunteers will participate in this study
5683712|NCT00563459|Epilepsy, seizures|epilepsy, seizures
5683713|NCT00563459|partial onset seizures|partial onset seizures
5683714|NCT00563459|anti-epileptic drugs (AED)|anti-epileptic drugs (aed)
5683715|NCT00563459|carisbamate|carisbamate
5683716|NCT00563459|topiramate|topiramate
5683717|NCT00563459|levetiracetam|levetiracetam
5683718|NCT00563446|Anemia|anemia
5683719|NCT00563446|End-stage renal failure|end-stage renal failure
5683720|NCT00563446|Continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
5683721|NCT00563433|diabetic|diabetic
5683722|NCT00563433|diabetes mellitus|diabetes mellitus
5683723|NCT00563433|foot|foot
5683724|NCT00563433|ulcers|ulcers
5683726|NCT00563433|oral antibiotic|oral antibiotic
5683727|NCT00563433|topical cream|topical cream
5683728|NCT00563420|Lung cancer|lung cancer
5683729|NCT00563407|skin toxicity prediction|skin toxicity prediction
5683730|NCT00563407|cardiac toxicity prediction|cardiac toxicity prediction
5683731|NCT00563394|diabetic|diabetic
5683732|NCT00563394|diabetes mellitus|diabetes mellitus
5683733|NCT00563394|foot|foot
5683734|NCT00563394|ulcers|ulcers
5683735|NCT00563394|Floxin|floxin
5683736|NCT00563394|oral antibiotic|oral antibiotic
5683737|NCT00563394|topical cream|topical cream
5683738|NCT00563355|chronic kidney disease|chronic kidney disease
5683739|NCT00563355|cardiovascular disease|cardiovascular disease
5683740|NCT00563342|Ethanol, lock solution, infection|ethanol, lock solution, infection
5683741|NCT00563329|Smokers who are not willing to quit in the near future but intend to reduce smoking|smokers who are not willing to quit in the near future but intend to reduce smoking
5683743|NCT00563316|chemotherapy|chemotherapy
5683744|NCT00563316|cancer|cancer
5683745|NCT00563316|metastatic|metastatic
5683746|NCT00563316|irinotecan|irinotecan
5683747|NCT00563316|EGFr|egfr
5684184|NCT00561613|nonoxynol-9|nonoxynol-9
5683748|NCT00563316|epidermal growth factor|epidermal growth factor
5683749|NCT00563277|Pterygium|pterygium
5683750|NCT00563277|Cataract|cataract
5683751|NCT00563277|Intraocular lens power calculation accuracy|intraocular lens power calculation accuracy
5683753|NCT00563264|parenting|parenting
5683754|NCT00563264|postpartum period|postpartum period
5683755|NCT00563264|family research|family research
5683756|NCT00563251|Bronchiolitis obliterans in bone marrow transplant recipients|bronchiolitis obliterans in bone marrow transplant recipients
5683758|NCT00563212|Lung Diseases, Interstitial|lung diseases, interstitial
5683759|NCT00563212|Fibrosis|fibrosis
5683760|NCT00563212|Interferons|interferons
5683761|NCT00563212|Pulmonary Fibrosis|pulmonary fibrosis
5683762|NCT00563212|Pathologic Processes|pathologic processes
5683763|NCT00563212|Lung Diseases|lung diseases
5683764|NCT00563212|Fibrosing alveolitis|fibrosing alveolitis
5683765|NCT00563212|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5683766|NCT00563212|Aerosols|aerosols
5683767|NCT00563199|smoking cessation|smoking cessation
5683768|NCT00563199|smoking behaviors|smoking behaviors
5683769|NCT00563186|infection control|infection control
5683770|NCT00563186|nosocomial infection|nosocomial infection
5683771|NCT00563186|hospital design|hospital design
5683772|NCT00563186|physical plant design|physical plant design
5683773|NCT00563186|antibiotic resistant organisms|antibiotic resistant organisms
5683774|NCT00563186|MRSA|mrsa
5683775|NCT00563186|VRE|vre
5683776|NCT00563186|CDI|cdi
5683777|NCT00563160|lung cancer|lung cancer
5683778|NCT00563147|tivozanib|tivozanib
5683779|NCT00563147|AV-951|av-951
5683780|NCT00563134|Suspected or confirmed severe Gram-negative sepsis|suspected or confirmed severe gram-negative sepsis
5683781|NCT00563121|Retinopathy of Prematurity|retinopathy of prematurity
5683782|NCT00563121|ROP|rop
5683783|NCT00563121|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5683784|NCT00563121|VEGF|vegf
5683785|NCT00563121|Vitreous|vitreous
5683786|NCT00563121|Subretinal Fluid|subretinal fluid
5683787|NCT00563121|ELISA|elisa
5683788|NCT00563121|VEGF levels in Aqueous, Vitreous and subretinal Fluid|vegf levels in aqueous, vitreous and subretinal fluid
5683789|NCT00563108|Acute graft-versus-host disease post allogeneic stem cell transplantation|acute graft-versus-host disease post allogeneic stem cell transplantation
5683790|NCT00563095|Hepatocellular carcinoma|hepatocellular carcinoma
5683791|NCT00563082|SLE|sle
5683792|NCT00563082|Genetics|genetics
5683793|NCT00563069|diagnostic and therapeutic rigid cystoscopy|diagnostic and therapeutic rigid cystoscopy
5683794|NCT00563056|Formoterol|formoterol
5683795|NCT00563056|Fluticasone|fluticasone
5683796|NCT00563056|Asthma|asthma
5683797|NCT00563043|Pattern Scan Laser.|pattern scan laser.
5683798|NCT00563043|Photocoagulation.|photocoagulation.
5683799|NCT00563043|Diabetic retinopathy treatment.|diabetic retinopathy treatment.
5683800|NCT00563043|Laser treatment.|laser treatment.
5683801|NCT00563043|Electroretinogram.|electroretinogram.
5683802|NCT00563043|a wave.|a wave.
5683803|NCT00563043|b wave.|b wave.
5937028|NCT02193152|NSCLC|nsclc
5937029|NCT02193152|Pazopanib|pazopanib
5937088|NCT02179255|DOR|dor
5937089|NCT02179255|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
5937090|NCT02179255|Ovarian Failure|ovarian failure
5937091|NCT02179255|Human Growth Hormone|human growth hormone
5683804|NCT00563043|Implicit time.|implicit time.
5683805|NCT00563030|Cardiopulmonary bypass|cardiopulmonary bypass
5683806|NCT00563030|Neutrophils|neutrophils
5683807|NCT00563030|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5683808|NCT00563017|Catatonic Schizophrenia|catatonic schizophrenia
5683809|NCT00563017|Disorganized Schizophrenia|disorganized schizophrenia
5683810|NCT00563017|Paranoid Schizophrenia|paranoid schizophrenia
5683811|NCT00563017|Undifferentiated Schizophrenia|undifferentiated schizophrenia
5683812|NCT00563017|Schizo-affective disorders|schizo-affective disorders
5683813|NCT00563004|Diabetes mellitus|diabetes mellitus
5683814|NCT00563004|Herbal treatment|herbal treatment
5683815|NCT00563004|Food supplement|food supplement
5683816|NCT00562991|exhaled NO|exhaled no
5683817|NCT00562991|asthma|asthma
5683818|NCT00562991|child|child
5683819|NCT00562978|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5683820|NCT00562978|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5683821|NCT00562978|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5683822|NCT00562978|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5683823|NCT00562978|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5683824|NCT00562978|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5683825|NCT00562978|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5683826|NCT00562978|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5683827|NCT00562978|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5683828|NCT00562978|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5683829|NCT00562978|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5683830|NCT00562978|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5673274|NCT00608582|TMS|tms
5683831|NCT00562978|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5683832|NCT00562978|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5683833|NCT00562978|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5683834|NCT00562978|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5683835|NCT00562978|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5683836|NCT00562978|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5683837|NCT00562978|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5683838|NCT00562978|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5683839|NCT00562978|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5683840|NCT00562978|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5683841|NCT00562978|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5683842|NCT00562978|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5683843|NCT00562952|Natriuretic peptide|natriuretic peptide
5683844|NCT00562952|Prognosis|prognosis
5683845|NCT00562952|Diabetes|diabetes
5683846|NCT00562952|Heart failure|heart failure
5683847|NCT00562952|Heart disease|heart disease
5683848|NCT00562939|Antibody Formation|antibody formation
5683849|NCT00562939|Antibody Affinity|antibody affinity
5683850|NCT00562939|Immunity|immunity
5683851|NCT00562939|Pneumococcal Vaccines|pneumococcal vaccines
5683852|NCT00562939|Oligodeoxyribonucleotides|oligodeoxyribonucleotides
5683853|NCT00562926|Schizophrenia|schizophrenia
5683854|NCT00562926|Schizophrenia spectrum disorder|schizophrenia spectrum disorder
5683856|NCT00562913|Sorafenib|sorafenib
5683857|NCT00562913|Cyclophosphamide|cyclophosphamide
5683858|NCT00562913|Doxorubicin|doxorubicin
5683859|NCT00562887|Crohn's Disease|crohn's disease
5683861|NCT00562874|AIDS|aids
5683862|NCT00562874|WOMEN|women
5683863|NCT00562874|KENYA|kenya
5683864|NCT00562874|NUTRITION|nutrition
5683865|NCT00562874|HIV/AIDS|hiv/aids
5683866|NCT00562874|treatment naive|treatment naive
5683867|NCT00562861|Bipolar Disorder|bipolar disorder
5683868|NCT00562861|Bipolar Depression|bipolar depression
5683869|NCT00562861|Clinical Trials, Phase II|clinical trials, phase ii
5683870|NCT00562861|Clinical Pharmacology|clinical pharmacology
5683871|NCT00562848|gastric emptying|gastric emptying
5683872|NCT00562848|pharmacokinetic|pharmacokinetic
5937139|NCT02159521|post-thrombotic syndrome|post-thrombotic syndrome
5937140|NCT02159521|chronic deep vein thrombosis|chronic deep vein thrombosis
5937174|NCT02151981|Advanced Non-Small Cell Lung Cancer; T790M Mutation Positive|advanced non-small cell lung cancer; t790m mutation positive
5683873|NCT00562848|tolerability|tolerability
5683875|NCT00562848|GSK962040|gsk962040
5683876|NCT00562848|gut motility|gut motility
5683877|NCT00562848|First Time in Human|first time in human
5683878|NCT00562835|ARDS|ards
5683879|NCT00562835|Adult|adult
5683880|NCT00562835|Methylprednisolone|methylprednisolone
5683881|NCT00562796|Growth Hormone Deficiency|growth hormone deficiency
5683882|NCT00562796|Cardiovascular Disease|cardiovascular disease
5683883|NCT00562796|Intra-abdominal Fat|intra-abdominal fat
5683884|NCT00562796|Insulin Resistance|insulin resistance
5683885|NCT00562783|HBV|hbv
5683886|NCT00562783|HCV|hcv
5683887|NCT00562783|Liver cirrhosis|liver cirrhosis
5683888|NCT00562770|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5683889|NCT00562770|CLL|cll
5683890|NCT00562770|Leukemia|leukemia
5683891|NCT00562757|Wedensky modulation|wedensky modulation
5683892|NCT00562757|Risk stratification|risk stratification
5683893|NCT00562757|Electrophysiology|electrophysiology
5683894|NCT00562757|Noninvasive|noninvasive
5683895|NCT00562757|Ischemic heart disease|ischemic heart disease
5683896|NCT00562757|ICD guidelines|icd guidelines
5683897|NCT00562757|Myocardial infarction|myocardial infarction
5683898|NCT00562718|stage II breast cancer|stage ii breast cancer
5683899|NCT00562718|stage IIIA breast cancer|stage iiia breast cancer
5683900|NCT00562718|stage IIIB breast cancer|stage iiib breast cancer
5683901|NCT00562718|male breast cancer|male breast cancer
5683902|NCT00562718|recurrent breast cancer|recurrent breast cancer
5683903|NCT00562705|growth hormone|growth hormone
5683904|NCT00562705|eating regulation|eating regulation
5683905|NCT00562705|nutritional intervention|nutritional intervention
5683906|NCT00562705|short stature|short stature
5683907|NCT00562705|ISS|iss
5683908|NCT00562705|SGA|sga
5683909|NCT00562705|IGHD|ighd
5683910|NCT00562705|MPHD|mphd
5683911|NCT00562692|Heart failure|heart failure
5683912|NCT00562692|OAD|oad
5683913|NCT00562692|BNP|bnp
5683914|NCT00562692|Heart Failure patients who present to the emergency department|heart failure patients who present to the emergency department
5683915|NCT00562679|Patients with coronary artery disease|patients with coronary artery disease
5683916|NCT00562666|cell therapy|cell therapy
5683917|NCT00562666|T lymphocytes|t lymphocytes
5683918|NCT00562666|hepatic intra-arterial injection|hepatic intra-arterial injection
5683919|NCT00562653|profile autoantibodies|profile autoantibodies
5683920|NCT00562653|clinical symptoms|clinical symptoms
5683921|NCT00562640|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5683922|NCT00562640|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5683923|NCT00562640|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5683924|NCT00562640|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5683925|NCT00562640|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5683926|NCT00562640|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5683927|NCT00562640|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5683928|NCT00562640|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5683929|NCT00562640|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5683930|NCT00562640|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5683931|NCT00562640|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5683932|NCT00562640|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5683933|NCT00562640|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5683934|NCT00562640|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5683935|NCT00562640|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5683939|NCT00562627|local infiltration analgesia|local infiltration analgesia
5683940|NCT00562627|TKA|tka
5683941|NCT00562627|epidural analgesia|epidural analgesia
5683942|NCT00562627|operation|operation
5683943|NCT00562627|surgery|surgery
5683944|NCT00562601|Leukapheresis|leukapheresis
5683945|NCT00562601|Plasmapheresis|plasmapheresis
5683946|NCT00562601|Lymphocytes|lymphocytes
5683948|NCT00562536|Umbilical cord clamping|umbilical cord clamping
5683949|NCT00562536|Preterm infants|preterm infants
5683950|NCT00562536|Randomized controlled trial|randomized controlled trial
5683951|NCT00562536|For women giving birth to singleton infants 32 weeks gestational age or less|for women giving birth to singleton infants 32 weeks gestational age or less
5683952|NCT00562523|Cancer|cancer
5937221|NCT02138734|antitumor|antitumor
5937222|NCT02138734|BCG|bcg
5937223|NCT02138734|bladder cancer|bladder cancer
5937224|NCT02138734|cancer|cancer
5937225|NCT02138734|immunotherapy|immunotherapy
5937226|NCT02138734|instillation|instillation
5937227|NCT02138734|interleukin-15|interleukin-15
5937228|NCT02138734|intravesical|intravesical
5937229|NCT02138734|naive|naive
5937230|NCT02138734|non-muscle invasive|non-muscle invasive
5937231|NCT02138734|transitional cell carcinoma|transitional cell carcinoma
5937232|NCT02138734|ALT-803|alt-803
5937233|NCT02138734|N-803|n-803
4957958|NCT04251546|TPV|tpv
5683953|NCT00562523|Docetaxel|docetaxel
5683954|NCT00562523|Sorafenib|sorafenib
5683955|NCT00562510|HIV-1 infection|hiv-1 infection
5683956|NCT00562510|raltegravir|raltegravir
5683957|NCT00562510|immune discordance|immune discordance
5683958|NCT00562510|treatment experienced|treatment experienced
5683959|NCT00562497|Acute GVHD|acute gvhd
5683960|NCT00562497|Acute Graft Versus Host Disease|acute graft versus host disease
5683961|NCT00562471|adhesions|adhesions
5683962|NCT00562471|gynecologic surgery|gynecologic surgery
5683963|NCT00562471|laparoscopy|laparoscopy
5683964|NCT00562471|laparotomy|laparotomy
5683965|NCT00562471|polyethylene glycol|polyethylene glycol
5683966|NCT00562471|hydrogel|hydrogel
5683967|NCT00562471|Adhesions following gynecologic surgery to remove myomas|adhesions following gynecologic surgery to remove myomas
5683968|NCT00562458|Advanced breast cancer|advanced breast cancer
5683969|NCT00562458|Advanced breast cancer in postmenopausal women|advanced breast cancer in postmenopausal women
5683970|NCT00562445|Adrenal insufficiency|adrenal insufficiency
5683971|NCT00562445|GI bleeding|gi bleeding
5683972|NCT00562445|Portal hypertension|portal hypertension
5683973|NCT00562445|Acute pancreatitis|acute pancreatitis
5683974|NCT00562445|Critical emergencies in digestive diseases|critical emergencies in digestive diseases
5683975|NCT00562445|Severe acute pancreatitis|severe acute pancreatitis
5683976|NCT00562432|atrial fibrillation|atrial fibrillation
5683977|NCT00562432|CABG|cabg
5683978|NCT00562432|ganglionated plexi|ganglionated plexi
5683979|NCT00562406|Macular edema secondary to branch retinal vein occlusion|macular edema secondary to branch retinal vein occlusion
5683980|NCT00562380|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5683981|NCT00562380|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5683982|NCT00562380|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5683983|NCT00562380|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5683984|NCT00562380|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5683985|NCT00562380|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5683986|NCT00562380|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5683987|NCT00562380|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5683988|NCT00562380|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5683989|NCT00562380|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5683990|NCT00562380|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5683991|NCT00562380|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5683992|NCT00562380|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5683993|NCT00562380|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5683994|NCT00562380|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5683995|NCT00562380|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5683996|NCT00562380|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5683997|NCT00562380|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5683998|NCT00562380|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5683999|NCT00562380|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5684000|NCT00562380|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5684001|NCT00562380|small intestine lymphoma|small intestine lymphoma
5684002|NCT00562380|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5684003|NCT00562380|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5684004|NCT00562380|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5684185|NCT00561600|Hip arthroplasty|hip arthroplasty
5937372|NCT02082340|Tuberculosis|tuberculosis
5937373|NCT02082340|Armenia|armenia
5937374|NCT02082340|Clinical trial|clinical trial
5937375|NCT02082340|Directly Observed Therapy (DOT)|directly observed therapy (dot)
5937376|NCT02082340|Self-administered drug intake|self-administered drug intake
4958065|NCT04250870|community dwelling|community dwelling
5684005|NCT00562380|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5684006|NCT00562380|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5684007|NCT00562380|recurrent prostate cancer|recurrent prostate cancer
5684008|NCT00562354|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5684009|NCT00562341|obesity|obesity
5684011|NCT00562341|prostate cancer|prostate cancer
5684012|NCT00562328|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5684013|NCT00562328|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5684014|NCT00562328|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5684015|NCT00562302|lung biopsy|lung biopsy
5684016|NCT00562289|Stroke|stroke
5684017|NCT00562289|Patent Foramen Ovale|patent foramen ovale
5684018|NCT00562289|Atrial septal aneurysm|atrial septal aneurysm
5684019|NCT00562289|Antiplatelet therapy|antiplatelet therapy
5684020|NCT00562289|Oral anticoagulants|oral anticoagulants
5684021|NCT00562289|Transcatheter closure|transcatheter closure
5684022|NCT00562289|Migraine|migraine
5684023|NCT00562276|IUD|iud
5684024|NCT00562276|insertion timing|insertion timing
5684028|NCT00562263|insulin resistance|insulin resistance
5684029|NCT00562263|treatment|treatment
5684030|NCT00562237|immunogenicity|immunogenicity
5684031|NCT00562237|safety|safety
5684032|NCT00562237|adjuvanted pandemic vaccine|adjuvanted pandemic vaccine
5684033|NCT00562224|PCI-24781|pci-24781
5684034|NCT00562224|Neoplasms by site|neoplasms by site
5684035|NCT00562224|Lymphoma, non-hodgkin|lymphoma, non-hodgkin
5684036|NCT00562224|Hodgkin disease|hodgkin disease
5684037|NCT00562224|Multiple myeloma|multiple myeloma
5684038|NCT00562224|Leukemia, lymphocytic, chronic|leukemia, lymphocytic, chronic
5684039|NCT00562211|children|children
5684040|NCT00562185|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5684041|NCT00562185|ovarian sarcoma|ovarian sarcoma
5684042|NCT00562185|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5684043|NCT00562185|ovarian stromal cancer|ovarian stromal cancer
5684044|NCT00562159|rhinoconjunctivitis|rhinoconjunctivitis
5684045|NCT00562159|rhinitis|rhinitis
5684046|NCT00562159|conjunctivitis|conjunctivitis
5684047|NCT00562159|allergy|allergy
5684048|NCT00562159|allergen|allergen
5684049|NCT00562159|immunotherapy|immunotherapy
5684050|NCT00562146|nutrition|nutrition
5684051|NCT00562146|enteral access|enteral access
5684052|NCT00562107|Minimized ventricular pacing, clinical outcome, SafeR, AAIsafeR, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic AF|minimized ventricular pacing, clinical outcome, safer, aaisafer, dual chamber pacemaker therapy, % of ventricular pacing, hospitalizations, symptomatic af
5684053|NCT00562094|Pantoprazole|pantoprazole
5684054|NCT00562094|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
5684055|NCT00562094|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5684056|NCT00562094|sleep disorders|sleep disorders
5684057|NCT00562081|asthma|asthma
5684058|NCT00562081|Virtual Asthma Clinic|virtual asthma clinic
5684059|NCT00562081|metabolites|metabolites
5684060|NCT00562081|asthma education|asthma education
5684061|NCT00562068|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5684062|NCT00562068|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5684063|NCT00562068|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5684064|NCT00562068|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5684065|NCT00562068|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5684066|NCT00562068|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5684067|NCT00562068|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5684068|NCT00562068|small intestine lymphoma|small intestine lymphoma
5684069|NCT00562068|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5684070|NCT00562042|pulmonary embolism|pulmonary embolism
5684071|NCT00562042|risk stratification|risk stratification
5684072|NCT00562042|prognosis|prognosis
5684073|NCT00562042|troponin|troponin
5684074|NCT00562042|Brain natriuretic peptide|brain natriuretic peptide
5684075|NCT00562042|echocardiogram|echocardiogram
5684076|NCT00562029|Diabetes Mellitus|diabetes mellitus
5684077|NCT00562029|Surgery|surgery
5684078|NCT00562029|Duodenal Bypass|duodenal bypass
5684079|NCT00562029|Resolution|resolution
5684080|NCT00562029|Surgical Procedures|surgical procedures
5937412|NCT02061189|neuromuscular disease, Spinal Muscular Atrophy, Infantile,|neuromuscular disease, spinal muscular atrophy, infantile,
5937413|NCT02061189|motor function measure, Hammersmith scale,|motor function measure, hammersmith scale,
5937414|NCT02061189|rehabilitation program, physical exercise|rehabilitation program, physical exercise
5684081|NCT00562016|Patient undergoing scheduled PCI|patient undergoing scheduled pci
5684082|NCT00562003|Ovarian cancer study|ovarian cancer study
5684083|NCT00561990|pancreatic cancer|pancreatic cancer
5684084|NCT00561977|Nutrition|nutrition
5684085|NCT00561977|Dietary Quality|dietary quality
5684086|NCT00561977|Weight loss|weight loss
5684087|NCT00561938|Confocal laser endomicroscopy|confocal laser endomicroscopy
5679503|NCT00581789|erlotinib|erlotinib
5684088|NCT00561938|cancerous and non-cancerous conditions|cancerous and non-cancerous conditions
5684089|NCT00561938|tolerance|tolerance
5684090|NCT00561938|intravenous fluorescein|intravenous fluorescein
5684186|NCT00561600|Acetabular cup replacement|acetabular cup replacement
5684187|NCT00561600|Acetabulum arthroplasty|acetabulum arthroplasty
5684188|NCT00561587|novel antipsychotic|novel antipsychotic
5684091|NCT00561938|Digestive symptoms or disease requiring an endoscopy procedure (upper GI endoscopy or colonoscopy) performed under general anaesthesia|digestive symptoms or disease requiring an endoscopy procedure (upper gi endoscopy or colonoscopy) performed under general anaesthesia
5684092|NCT00561912|Renal Cell Carcinoma|renal cell carcinoma
5684093|NCT00561912|Renal Cell Cancer|renal cell cancer
5684094|NCT00561912|Clear Cell|clear cell
5684095|NCT00561912|Kidney|kidney
5684096|NCT00561912|Decitabine|decitabine
5684097|NCT00561912|Dacogen|dacogen
5684098|NCT00561912|5-Aza-Deoxycytidine|5-aza-deoxycytidine
5684099|NCT00561912|Interferon Alfa-2b|interferon alfa-2b
5684100|NCT00561912|Intron A®|intron a®
5684102|NCT00561899|safety|safety
5684103|NCT00561899|tolerability|tolerability
5684104|NCT00561899|efficacy|efficacy
5684105|NCT00561899|intermittent prevetive treatment|intermittent prevetive treatment
5684106|NCT00561899|children|children
5684107|NCT00561886|COPD|copd
5684108|NCT00561886|lung function|lung function
5684109|NCT00561886|dysnpea|dysnpea
5684110|NCT00561873|astrocytoma, glioblastoma, intrinsic pontine glioma|astrocytoma, glioblastoma, intrinsic pontine glioma
5684111|NCT00561860|Obstructive sleep apnea-hypopnea|obstructive sleep apnea-hypopnea
5684112|NCT00561860|Telemedicine|telemedicine
5684215|NCT00561483|biomarker|biomarker
5684113|NCT00561834|non-arteritic ischemic optic neuropathy|non-arteritic ischemic optic neuropathy
5684114|NCT00561834|ranibizumab|ranibizumab
5684116|NCT00561821|elderly|elderly
5684117|NCT00561821|randomized|randomized
5684118|NCT00561821|placebo controlled|placebo controlled
5684119|NCT00561808|PCO/PCOD|pco/pcod
5684121|NCT00561808|Immature Oocytes|immature oocytes
5684122|NCT00561795|AGO|ago
5684123|NCT00561795|Advanced,|advanced,
5684124|NCT00561795|Gynaecologic cancer(s),|gynaecologic cancer(s),
5684125|NCT00561795|Genetics|genetics
5684126|NCT00561795|GW786034,|gw786034,
5684127|NCT00561795|Pazopanib,|pazopanib,
5684128|NCT00561782|Spinal Cord Injury Pain|spinal cord injury pain
5684129|NCT00561782|Chronic Neuropathic Pain|chronic neuropathic pain
5684130|NCT00561782|SCI Pain|sci pain
5684131|NCT00561782|Pain, Chronic Neuropathic|pain, chronic neuropathic
5684132|NCT00561782|Spectroscopy, Magnetic Resonance|spectroscopy, magnetic resonance
5684133|NCT00561782|MRS|mrs
5684134|NCT00561782|Traumatic Brain Injury Pain|traumatic brain injury pain
5684135|NCT00561769|poor responder|poor responder
5684136|NCT00561769|growth hormone|growth hormone
5684137|NCT00561769|luteal|luteal
5684138|NCT00561756|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5684139|NCT00561756|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5684140|NCT00561756|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5684141|NCT00561756|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5684142|NCT00561756|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5684143|NCT00561756|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5684144|NCT00561756|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5684145|NCT00561756|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5684146|NCT00561756|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5684147|NCT00561743|Multiple myeloma|multiple myeloma
5684148|NCT00561743|response rate|response rate
5684149|NCT00561743|peripheral stem cell transplant|peripheral stem cell transplant
5684150|NCT00561743|safety|safety
5684151|NCT00561743|tolerability|tolerability
5684152|NCT00561730|PPI (Proton Pump Inhibitor) therapy|ppi (proton pump inhibitor) therapy
5684153|NCT00561730|Pantoprazole|pantoprazole
5684154|NCT00561730|eGERD (Erosive Gastroesophageal Reflux Disease)|egerd (erosive gastroesophageal reflux disease)
4958287|NCT04249453|Biomechanics|biomechanics
5684155|NCT00561730|NERD (Non-Erosive Reflux Disease)|nerd (non-erosive reflux disease)
5684156|NCT00561717|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5684157|NCT00561717|Ragweed|ragweed
5684158|NCT00561717|Pollen|pollen
5684159|NCT00561717|Allergy|allergy
5684160|NCT00561704|obese female|obese female
5684161|NCT00561704|Type 2 Diabetes|type 2 diabetes
5684162|NCT00561704|Diabetic Nephropathy|diabetic nephropathy
5684163|NCT00561704|Glucose Metabolism|glucose metabolism
5684164|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5684165|NCT00561704|Adiponectin|adiponectin
5937617|NCT02002741|PDA|pda
5937618|NCT02002741|Preterm|preterm
5937619|NCT02002741|Infant|infant
5937620|NCT02002741|Electrocardiography|electrocardiography
5937621|NCT02002741|Paracetamol|paracetamol
5937622|NCT02002741|Acamol|acamol
5937623|NCT02002741|ibuprofen|ibuprofen
5937624|NCT02002741|Placebo|placebo
5937659|NCT01985022|autism|autism
5937660|NCT01985022|autism spectrum disorders|autism spectrum disorders
5937661|NCT01985022|pervasive developmental disorders|pervasive developmental disorders
5937662|NCT01985022|toddlers|toddlers
5937663|NCT01985022|intervention|intervention
4958385|NCT04248829|EGFR TKI|egfr tki
5684166|NCT00561691|diffuse instrinsic ponitine glioma, brainstem|diffuse instrinsic ponitine glioma, brainstem
5684167|NCT00561678|Postoperative Confusion|postoperative confusion
5684168|NCT00561678|Postoperative Delirium|postoperative delirium
5684169|NCT00561678|PD|pd
5684170|NCT00561678|Postoperative Cognitive Dysfunction|postoperative cognitive dysfunction
5684171|NCT00561678|POCD|pocd
5684172|NCT00561652|Low back pain|low back pain
5684173|NCT00561652|Chiropractic|chiropractic
5684174|NCT00561652|Exercise|exercise
5684175|NCT00561652|Veterans|veterans
5684177|NCT00561639|immunosuppressed|immunosuppressed
5684178|NCT00561639|multiplex PCR|multiplex pcr
5684179|NCT00561639|diagnosis|diagnosis
5684180|NCT00561639|therapeutic|therapeutic
5684181|NCT00561613|Diaphragm|diaphragm
5684182|NCT00561613|postcoital test|postcoital test
5684189|NCT00561587|quetiapine|quetiapine
5684190|NCT00561587|depression|depression
5684191|NCT00561587|psychopathology|psychopathology
5684192|NCT00561574|elderly|elderly
5684193|NCT00561574|randomized|randomized
5684194|NCT00561574|double blind|double blind
5684195|NCT00561561|Schizophrenia|schizophrenia
5684196|NCT00561561|Prepulse Inhibition|prepulse inhibition
5684197|NCT00561561|Acoustic Startle|acoustic startle
5684198|NCT00561535|IBS|ibs
5684199|NCT00561535|Diarrhea|diarrhea
5684200|NCT00561535|Rome III|rome iii
5684201|NCT00561522|Recurrence|recurrence
5684202|NCT00561522|Metastasis|metastasis
5684203|NCT00561522|Hepatocellular Carcinoma|hepatocellular carcinoma
5684204|NCT00561522|Radical Hepatic Resection|radical hepatic resection
5684205|NCT00561522|Drug Prevention|drug prevention
5684206|NCT00561522|Capecitabine|capecitabine
5684207|NCT00561522|Surgery|surgery
5684208|NCT00561496|HIV prevention|hiv prevention
5684209|NCT00561496|Microbicides|microbicides
5684210|NCT00561496|Pharmacokinetics|pharmacokinetics
5684211|NCT00561496|vaginal biopsies|vaginal biopsies
5684212|NCT00561483|Acute heart failure|acute heart failure
5684213|NCT00561483|cystatin C|cystatin c
5684214|NCT00561483|renal failure|renal failure
5684216|NCT00561470|colorectal cancer|colorectal cancer
5684217|NCT00561470|metastatic|metastatic
5684218|NCT00561470|anti-angiogenic|anti-angiogenic
5684219|NCT00561470|irinotecan|irinotecan
5684220|NCT00561470|5-FU|5-fu
5684221|NCT00561470|FOLFIRI|folfiri
5684222|NCT00561457|Iliac|iliac
5684223|NCT00561457|Artery|artery
5684224|NCT00561457|Occlusive|occlusive
5684225|NCT00561457|Stenosis|stenosis
5684226|NCT00561444|Prostate Cancer|prostate cancer
5684227|NCT00561444|Radical retropubic prostatectomy|radical retropubic prostatectomy
5684228|NCT00561444|Robotic prostatectomy|robotic prostatectomy
5684229|NCT00561444|Photon external beam radiation|photon external beam radiation
5684230|NCT00561444|Photon external beam radiation with hormone therapy|photon external beam radiation with hormone therapy
5684231|NCT00561444|Proton radiation|proton radiation
5684232|NCT00561444|Radioisotopic implant|radioisotopic implant
5684233|NCT00561444|Cryotherapy|cryotherapy
5684234|NCT00561444|Quality of Life|quality of life
5684235|NCT00561444|Questionnaire|questionnaire
5684236|NCT00561444|Survey|survey
5684238|NCT00561431|CVVHDF Dose Study|cvvhdf dose study
5684239|NCT00561418|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5684240|NCT00561418|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5684241|NCT00561418|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5684242|NCT00561418|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5684243|NCT00561418|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5684244|NCT00561418|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5684245|NCT00561418|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5684246|NCT00561418|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5684247|NCT00561418|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5684248|NCT00561418|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5684249|NCT00561418|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5684250|NCT00561418|small intestine lymphoma|small intestine lymphoma
5684251|NCT00561418|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5684252|NCT00561405|Stroke|stroke
5684253|NCT00561405|Walking|walking
5684254|NCT00561405|Motor learning|motor learning
5684255|NCT00561405|Skill acquisition|skill acquisition
5684256|NCT00561392|Alzheimer's Disease|alzheimer's disease
5684257|NCT00561392|Rivastigmine|rivastigmine
5684258|NCT00561392|Patch|patch
5684259|NCT00561379|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5684260|NCT00561379|not previously treated|not previously treated
5684261|NCT00561366|ALS|als
5684262|NCT00561366|Lou Gehrig's disease|lou gehrig's disease
5684263|NCT00561353|Hepatitis C, Chronic|hepatitis c, chronic
5684264|NCT00561353|Tibotec|tibotec
5684265|NCT00561353|TMC435350-TiDP16-C201|tmc435350-tidp16-c201
5684266|NCT00561353|TMC435350-C201|tmc435350-c201
5684267|NCT00561353|TMC435|tmc435
5684268|NCT00561353|PEGASYS (peginterferon alpha-2a, PegIFNα-2a)|pegasys (peginterferon alpha-2a, pegifnα-2a)
5684269|NCT00561353|COPEGUS (ribavirin)|copegus (ribavirin)
5684270|NCT00561340|ADHD|adhd
5684271|NCT00561340|Growth|growth
5684272|NCT00561340|Atomoxetine|atomoxetine
5684273|NCT00561340|Pediasure|pediasure
5684274|NCT00561327|hypertension|hypertension
5684275|NCT00561327|angiotensin receptor blockers|angiotensin receptor blockers
5684276|NCT00561327|peroxisome proliferator activated receptor gamma|peroxisome proliferator activated receptor gamma
5684277|NCT00561314|sexual dysfunction|sexual dysfunction
5684278|NCT00561314|urinary incontinence|urinary incontinence
5684279|NCT00561314|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5684280|NCT00561314|stage I prostate cancer|stage i prostate cancer
5684281|NCT00561314|stage IIB prostate cancer|stage iib prostate cancer
5684282|NCT00561314|stage IIA prostate cancer|stage iia prostate cancer
5684283|NCT00561288|Acetaminophen|acetaminophen
5684284|NCT00561288|Social Psychology|social psychology
5684286|NCT00561288|Interpersonal Rejection|interpersonal rejection
5684287|NCT00561262|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5684288|NCT00561262|stage I prostate cancer|stage i prostate cancer
5684289|NCT00561262|stage IIB prostate cancer|stage iib prostate cancer
5684290|NCT00561262|stage IIA prostate cancer|stage iia prostate cancer
5684291|NCT00561262|stage III prostate cancer|stage iii prostate cancer
5684292|NCT00561223|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5684293|NCT00561223|pulmonary hypertension|pulmonary hypertension
5684294|NCT00561210|infections|infections
5684295|NCT00561184|H5N1 Pandemic|h5n1 pandemic
5684296|NCT00561145|Anorexia of ageing|anorexia of ageing
5684297|NCT00561145|Anorexia of aging|anorexia of aging
5684298|NCT00561145|Energy balance|energy balance
5684299|NCT00561145|Elderly|elderly
5684300|NCT00561132|vanadium|vanadium
5684301|NCT00561132|insulin sensitivity|insulin sensitivity
5684302|NCT00561132|impaired glucose tolerance|impaired glucose tolerance
5684303|NCT00561132|triglycerides|triglycerides
5684304|NCT00561119|maintenance chemotherapy|maintenance chemotherapy
5684305|NCT00561119|metastatic or recurrent breast cancer|metastatic or recurrent breast cancer
5684306|NCT00561119|gemcitabine|gemcitabine
5684307|NCT00561119|paclitaxel(GP)|paclitaxel(gp)
5684308|NCT00561106|Bell´s palsy|bell´s palsy
5684309|NCT00561106|prednisone|prednisone
5684310|NCT00561106|valacyclovir|valacyclovir
5684311|NCT00561093|Hypoalbuminemia|hypoalbuminemia
5684312|NCT00561093|Protein-energy malnutrition|protein-energy malnutrition
5684313|NCT00561093|Inflammation|inflammation
5684314|NCT00561093|Oxidative stress|oxidative stress
5684315|NCT00561093|Chronic Kidney disease (CKD) stage 5|chronic kidney disease (ckd) stage 5
5684316|NCT00561093|maintenance hemodialysis|maintenance hemodialysis
5684317|NCT00561067|Spinal cord injury|spinal cord injury
5684318|NCT00561067|spinal shock|spinal shock
5684319|NCT00561067|erythropoietin|erythropoietin
5684320|NCT00561054|Coimbra|coimbra
5684321|NCT00561054|NSCLC|nsclc
5684322|NCT00561054|CETUXIMAB|cetuximab
5684323|NCT00561041|alcohol|alcohol
5684324|NCT00561041|alcohol use disorder|alcohol use disorder
5684325|NCT00561041|cognitive-behavioral therapy|cognitive-behavioral therapy
5684326|NCT00561041|brief phone aftercare intervention|brief phone aftercare intervention
5684327|NCT00561041|individual aftercare therapy|individual aftercare therapy
5684328|NCT00561028|Atherosclerosis|atherosclerosis
5684329|NCT00561028|Coronary artery disease|coronary artery disease
5684330|NCT00561028|Chlamydia pneumoniae|chlamydia pneumoniae
5937782|NCT01950572|Samples|samples
5937783|NCT01950572|Biobank|biobank
5937784|NCT01950572|Lung Neoplasms|lung neoplasms
5937785|NCT01950572|Ovarian Neoplasms|ovarian neoplasms
5684331|NCT00561028|Mycoplasma pneumoniae|mycoplasma pneumoniae
5684332|NCT00561015|Hepatitis C, Chronic|hepatitis c, chronic
5684333|NCT00561015|Genotype 2|genotype 2
5684334|NCT00561015|Genotype 3|genotype 3
5684335|NCT00561015|Telaprevir|telaprevir
5684336|NCT00561002|Influenza Vaccine|influenza vaccine
5684337|NCT00561002|Influenza Virus|influenza virus
5684338|NCT00561002|Orthomyxoviridae Infections|orthomyxoviridae infections
5937903|NCT01893372|Leukemia|leukemia
5937904|NCT01893372|Myelodysplastic syndrome|myelodysplastic syndrome
5937906|NCT01893372|Overall response rate|overall response rate
5937907|NCT01893372|ORR|orr
5937908|NCT01893372|Eltrombopag|eltrombopag
5937909|NCT01893372|Promacta|promacta
5937910|NCT01893372|Hypomethylating Agent|hypomethylating agent
5937926|NCT01878617|SJMB12|sjmb12
5937927|NCT01878617|Brain Cancer|brain cancer
5937928|NCT01878617|Brain Tumors in Children|brain tumors in children
5937929|NCT01878617|Cisplatin|cisplatin
5937930|NCT01878617|Cyclophosphamide|cyclophosphamide
5902943|NCT00727038|neovascular|neovascular
5937931|NCT01878617|Embryonal Tumors of CNS|embryonal tumors of cns
5937932|NCT01878617|GDC-0449|gdc-0449
5937933|NCT01878617|Gemcitabine|gemcitabine
5937934|NCT01878617|Hedgehog Pathway Inhibitor|hedgehog pathway inhibitor
5937935|NCT01878617|Infratentorial|infratentorial
5937936|NCT01878617|Mass in Brain|mass in brain
5937937|NCT01878617|Medulloblastoma|medulloblastoma
5937938|NCT01878617|Medulloblastoma Brain Tumor|medulloblastoma brain tumor
5937939|NCT01878617|Medulloblastoma Tumor|medulloblastoma tumor
5937940|NCT01878617|Molecular|molecular
5937941|NCT01878617|Neuroectodermal Tumor, Primitive|neuroectodermal tumor, primitive
5937942|NCT01878617|Newly Diagnosed Childhood Medulloblastoma|newly diagnosed childhood medulloblastoma
5937943|NCT01878617|Non-SHH Non-WNT|non-shh non-wnt
5937944|NCT01878617|Pediatric Brain Tumor|pediatric brain tumor
5937945|NCT01878617|Pemetrexed|pemetrexed
5937946|NCT01878617|Posterior Fossa Tumor|posterior fossa tumor
5937947|NCT01878617|Proton Beam Therapy|proton beam therapy
5937948|NCT01878617|Radiation Therapy|radiation therapy
5937949|NCT01878617|Rare Brain Tumor|rare brain tumor
5937950|NCT01878617|Risk|risk
5937951|NCT01878617|SHH|shh
5937952|NCT01878617|Sonic Hedgehog Pathway|sonic hedgehog pathway
5684339|NCT00561002|Fluzone®|fluzone®
5684340|NCT00560989|Chronic Beryllium Disease|chronic beryllium disease
5684341|NCT00560989|CBD|cbd
5684342|NCT00560989|Beryllium|beryllium
5684343|NCT00560989|Genetic|genetic
5684344|NCT00560989|Environmental|environmental
5684345|NCT00560976|neutrophil gelatinase associated lipocalin|neutrophil gelatinase associated lipocalin
5684346|NCT00560976|hemodialysis|hemodialysis
5684347|NCT00560976|iron|iron
5684348|NCT00560976|inflammation|inflammation
5684349|NCT00560976|Oxidative Stress|oxidative stress
5684350|NCT00560963|Advanced or metastatic pancreas carcinoma|advanced or metastatic pancreas carcinoma
5684351|NCT00560963|gemcitabine|gemcitabine
5684352|NCT00560963|everolimus|everolimus
5684353|NCT00560937|Schizophrenia|schizophrenia
5684354|NCT00560937|Pregnenolone|pregnenolone
5684355|NCT00560937|Cognition|cognition
5684356|NCT00560937|Negative Symptoms|negative symptoms
5684357|NCT00560911|oral anticoagulation|oral anticoagulation
5684358|NCT00560911|self-management|self-management
5684359|NCT00560911|elderly patients|elderly patients
5684360|NCT00560911|randomised controlled trial|randomised controlled trial
5684361|NCT00560898|staining|staining
5684362|NCT00560898|epithelial barrier function|epithelial barrier function
5684363|NCT00560885|atrial fibrillation|atrial fibrillation
5684364|NCT00560885|af|af
5684365|NCT00560885|ablation|ablation
5684366|NCT00560885|arrhythmia|arrhythmia
5684367|NCT00560885|racing heart|racing heart
5684368|NCT00560885|afib|afib
5937953|NCT01878617|St Jude Medullo|st jude medullo
5937954|NCT01878617|St. Jude Brain Tumor Studies|st. jude brain tumor studies
5937955|NCT01878617|St. Jude Medullo|st. jude medullo
5937956|NCT01878617|St. Jude Studies|st. jude studies
5937957|NCT01878617|St. Jude Treatment|st. jude treatment
5937958|NCT01878617|Treatment for Brain Tumors in Children|treatment for brain tumors in children
5937959|NCT01878617|Untreated Childhood Medulloblastoma|untreated childhood medulloblastoma
5937960|NCT01878617|Vincristine|vincristine
5937961|NCT01878617|Vismodegib|vismodegib
5937962|NCT01878617|WNT|wnt
5937963|NCT01878084|Tissue regeneration|tissue regeneration
5937964|NCT01878084|sol gel bioglass|sol gel bioglass
5937965|NCT01878084|alveolar ridge preservation|alveolar ridge preservation
5937966|NCT01878084|children|children
5937967|NCT01878084|Egyptian|egyptian
5937968|NCT01878084|class II orthodontic cases|class ii orthodontic cases
5937974|NCT01873924|Batten disease|batten disease
5937975|NCT01873924|NCL|ncl
5937976|NCT01873924|Neuronal Ceroid Lipofuscinosis|neuronal ceroid lipofuscinosis
5684369|NCT00560885|surgical ablation|surgical ablation
5938047|NCT01851577|Coparenting|coparenting
5938048|NCT01851577|Problem solving|problem solving
5938049|NCT01851577|Child development|child development
5938050|NCT01851577|Father involvement|father involvement
5684370|NCT00560872|atrial flutter|atrial flutter
5684371|NCT00560872|ablation|ablation
5684372|NCT00560872|navigation|navigation
5684373|NCT00560859|Sleep disordered breathing|sleep disordered breathing
5684374|NCT00560859|Sleep apnea|sleep apnea
5684375|NCT00560859|Tonsillectomy|tonsillectomy
5700749|NCT00499343|Isophosphamide|isophosphamide
5700750|NCT00499343|Rituximab|rituximab
5700751|NCT00499343|Ifosfamide|ifosfamide
5700752|NCT00499343|Sargramostim|sargramostim
5700753|NCT00499343|Leukine|leukine
5700754|NCT00499343|Filgrastim|filgrastim
5684376|NCT00560859|Adenoidectomy|adenoidectomy
5684377|NCT00560859|Snoring|snoring
5684378|NCT00560859|Neurobehavioral Manifestations|neurobehavioral manifestations
5684379|NCT00560859|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5684380|NCT00560846|Gastric cancer|gastric cancer
5684381|NCT00560846|Esophageal cancer|esophageal cancer
5684382|NCT00560846|Surgical complications|surgical complications
5684383|NCT00560846|Immunonutrition|immunonutrition
5684384|NCT00560820|β-thalassemia|β-thalassemia
5684385|NCT00560820|transfusional iron overload|transfusional iron overload
5684386|NCT00560820|renal function|renal function
5684387|NCT00560820|renal biomarkers|renal biomarkers
5684388|NCT00560820|deferasirox|deferasirox
5684389|NCT00560807|WAD II|wad ii
5684391|NCT00560807|mobilization|mobilization
5684392|NCT00560807|dosage|dosage
5684393|NCT00560807|acute whiplash associated disorders (WAD) II and III (113) with a symptom duration of less than 30 days|acute whiplash associated disorders (wad) ii and iii (113) with a symptom duration of less than 30 days
5684394|NCT00560807|neck pain|neck pain
5684395|NCT00560794|Minimal Residual Disease|minimal residual disease
5684396|NCT00560794|adult ALL|adult all
5684397|NCT00560794|immunotherapeutic treatment|immunotherapeutic treatment
5684398|NCT00560794|anti-CD19 bispecific antibody derivative|anti-cd19 bispecific antibody derivative
5684399|NCT00560794|Blinatumomab|blinatumomab
5684400|NCT00560794|MT103|mt103
5684401|NCT00560781|PTSD|ptsd
5684402|NCT00560781|Pregnenolone|pregnenolone
5684403|NCT00560781|Cognition|cognition
5684496|NCT00560222|randomized controlled trial|randomized controlled trial
5684497|NCT00560222|lactoferrin|lactoferrin
5684404|NCT00560768|Risk stratification method, negative predictive value, fast ventricular arrhythmias, ICD|risk stratification method, negative predictive value, fast ventricular arrhythmias, icd
5684405|NCT00560768|The negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.|the negative predictive value of the t amplitude variance as a method for risk stratification for patients with an increased risk for scd.
5684406|NCT00560755|Prevention of: measles, mumps, rubella and varicella|prevention of: measles, mumps, rubella and varicella
5684407|NCT00560729|elderly people|elderly people
5684408|NCT00560690|Hepatitis C|hepatitis c
5684409|NCT00560690|metformin|metformin
5684410|NCT00560690|Insulin Resistance|insulin resistance
5684411|NCT00560677|Schizophrenia|schizophrenia
5684412|NCT00560677|PTSD|ptsd
5684413|NCT00560677|Cognition|cognition
5684414|NCT00560664|knee|knee
5684415|NCT00560664|chondral defect|chondral defect
5684416|NCT00560664|osteochondral defect|osteochondral defect
5684417|NCT00560651|keratoconus|keratoconus
5684418|NCT00560651|cornea|cornea
5684419|NCT00560651|cross linking|cross linking
5684420|NCT00560651|UV-light|uv-light
5684421|NCT00560651|riboflavin|riboflavin
5684422|NCT00560612|PTSD|ptsd
5684423|NCT00560612|Paroxetine|paroxetine
5684424|NCT00560612|Subthreshold|subthreshold
5684425|NCT00560599|MRSA|mrsa
5684426|NCT00560599|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5684427|NCT00560599|Staphylococcus aureus|staphylococcus aureus
5684428|NCT00560599|Skin Infections|skin infections
5684429|NCT00560599|Body Decolonization|body decolonization
5684430|NCT00560599|Environmental Decolonization|environmental decolonization
5684431|NCT00560586|sleep fragmentation|sleep fragmentation
5684432|NCT00560586|apnea|apnea
5684433|NCT00560586|hypoxia|hypoxia
5684434|NCT00560560|Refractory Colorectal|refractory colorectal
5684435|NCT00560560|Single arm|single arm
5684436|NCT00560560|Phase 2|phase 2
5684437|NCT00560534|Magnetic resonance|magnetic resonance
5684438|NCT00560534|whole body|whole body
5684439|NCT00560534|angiography|angiography
5684440|NCT00560534|venous compression|venous compression
5684441|NCT00560534|MRI|mri
5684442|NCT00560521|CPAP|cpap
5684443|NCT00560521|Tuberculosis|tuberculosis
5684444|NCT00560521|Pleural effusion|pleural effusion
5684445|NCT00560521|Physiotherapy|physiotherapy
5684446|NCT00560495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5938137|NCT01808820|Malignant Glioma|malignant glioma
5938138|NCT01808820|Glioblastoma Multiforme|glioblastoma multiforme
5938139|NCT01808820|Anaplastic Astrocytoma|anaplastic astrocytoma
5938140|NCT01808820|High Grade Glioma|high grade glioma
5938142|NCT01808820|Dendritic Cell Vaccine|dendritic cell vaccine
5938143|NCT01808820|DC Vaccine|dc vaccine
5938144|NCT01808820|Leukapheresis|leukapheresis
5938166|NCT01802788|Aortic Stenosis|aortic stenosis
5938167|NCT01802788|Heart Valve Prosthesis|heart valve prosthesis
5938168|NCT01802788|Trans Catheter Aortic Valve Replacement|trans catheter aortic valve replacement
5938169|NCT01802788|TAVR|tavr
5938170|NCT01802788|Trans Catheter Aortic Valve Implant|trans catheter aortic valve implant
5938171|NCT01802788|TAVI|tavi
5938188|NCT01789281|Neoplasms, Carcinoid tumor, Neuroendocrine tumor|neoplasms, carcinoid tumor, neuroendocrine tumor
5938223|NCT01775085|Interventions|interventions
5938224|NCT01775085|Meaning-Centered Group (MCG)|meaning-centered group (mcg)
4958993|NCT04245163|education*|education*
5938225|NCT01775085|Discussion Group (DG)|discussion group (dg)
5938226|NCT01775085|Modules|modules
5938227|NCT01775085|Sessions|sessions
5938228|NCT01775085|12-291|12-291
5938313|NCT01742182|Parkinson's Disease|parkinson's disease
5938314|NCT01742182|Excessive Daytime Sleepiness|excessive daytime sleepiness
5938315|NCT01742182|Circadian Rhythms|circadian rhythms
5938316|NCT01742182|Light Therapy|light therapy
5684447|NCT00560495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5684448|NCT00560495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5684449|NCT00560495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5684450|NCT00560495|adenocarcinoma of the lung|adenocarcinoma of the lung
5684451|NCT00560495|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5684452|NCT00560495|large cell lung cancer|large cell lung cancer
5684453|NCT00560495|squamous cell lung cancer|squamous cell lung cancer
5684454|NCT00560482|prostate|prostate
5684455|NCT00560482|cancer|cancer
5684456|NCT00560482|prostatic cancer|prostatic cancer
5684457|NCT00560482|castrate-resistant prostate cancer (CRPC)|castrate-resistant prostate cancer (crpc)
5684458|NCT00560469|Adipokines|adipokines
5684459|NCT00560469|Inflammation|inflammation
5684460|NCT00560469|Metabolic syndrome|metabolic syndrome
5684461|NCT00560456|Age, Snoring, Driving simulator, Sleep deprivation, chronic sleep restriction, objective and subjective sleepiness|age, snoring, driving simulator, sleep deprivation, chronic sleep restriction, objective and subjective sleepiness
5684462|NCT00560443|bone fracture|bone fracture
5684463|NCT00560443|ketorolac|ketorolac
5684464|NCT00560443|tramadol|tramadol
5684465|NCT00560378|Tacrolimus|tacrolimus
5684466|NCT00560378|Administration, topical|administration, topical
5684467|NCT00560378|Drug safety|drug safety
5684468|NCT00560378|Adults|adults
5684469|NCT00560378|Children|children
5684470|NCT00560365|stage I colon cancer|stage i colon cancer
5684471|NCT00560365|stage II colon cancer|stage ii colon cancer
5684472|NCT00560365|stage III colon cancer|stage iii colon cancer
5684473|NCT00560365|stage I rectal cancer|stage i rectal cancer
5684474|NCT00560365|stage II rectal cancer|stage ii rectal cancer
5684475|NCT00560365|stage III rectal cancer|stage iii rectal cancer
5684476|NCT00560339|Congestive Heart Failure|congestive heart failure
5684477|NCT00560339|Implantable Defibrillators|implantable defibrillators
5684478|NCT00560339|Intrathoracic Impedance|intrathoracic impedance
5684479|NCT00560326|Paediatric patients|paediatric patients
5684480|NCT00560326|Tacrolimus|tacrolimus
5684481|NCT00560326|Dermatitis, Atopic|dermatitis, atopic
5684482|NCT00560313|Meningococcal disease|meningococcal disease
5684483|NCT00560313|prevention|prevention
5684484|NCT00560313|vaccination|vaccination
5684485|NCT00560287|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5684486|NCT00560287|Non-invasive ventilation|non-invasive ventilation
5684487|NCT00560287|Chronic Respiratory Failure|chronic respiratory failure
5684488|NCT00560261|Sickle cell disease;|sickle cell disease;
5684489|NCT00560261|Lung capillary blood volume;|lung capillary blood volume;
5684490|NCT00560261|Children|children
5684491|NCT00560248|Chest Pain|chest pain
5684492|NCT00560248|STEMI|stemi
5684493|NCT00560248|UA/NSTEMI|ua/nstemi
5684495|NCT00560248|Emergency Department|emergency department
5684500|NCT00560222|malnutrition|malnutrition
5684501|NCT00560222|growth|growth
5684502|NCT00560209|ONO-1101|ono-1101
5684503|NCT00560209|Coronary Artery Disease|coronary artery disease
5684504|NCT00560209|Multi-slice CT|multi-slice ct
5684505|NCT00560196|Neuropathic pain|neuropathic pain
5684506|NCT00560196|Chronic pain|chronic pain
5684507|NCT00560196|Depression|depression
5684508|NCT00560196|Anxiety|anxiety
5684509|NCT00560183|Acute|acute
5684510|NCT00560183|Bunionectomy|bunionectomy
5684511|NCT00560170|HMG-CoA Reductase Inhibitors|hmg-coa reductase inhibitors
5684512|NCT00560170|endothelial function|endothelial function
5684513|NCT00560170|HMG-CoA Reductase Inhibitors on vascular protection|hmg-coa reductase inhibitors on vascular protection
5684514|NCT00560157|ICU patients|icu patients
5684515|NCT00560118|recurrent melanoma|recurrent melanoma
5684516|NCT00560118|stage IV melanoma|stage iv melanoma
5684517|NCT00560105|COPD|copd
5684518|NCT00560092|Magnesium|magnesium
5684519|NCT00560092|Pain|pain
5684520|NCT00560092|Morphine|morphine
5684521|NCT00560092|Intrathecal|intrathecal
5684522|NCT00560092|NMDA|nmda
5684523|NCT00560092|Elective total hip replacement under intrathecal anesthesia|elective total hip replacement under intrathecal anesthesia
5684524|NCT00560066|influenza|influenza
5684525|NCT00560066|vaccine|vaccine
5684526|NCT00560053|Multiple Myeloma|multiple myeloma
4959205|NCT04244162|brain imaging|brain imaging
4959206|NCT04244162|neurocognitive testing|neurocognitive testing
5938367|NCT01729455|Belimumab|belimumab
5938368|NCT01729455|Connective Tissue Diseases|connective tissue diseases
5938370|NCT01729455|Additional relevant MeSH terms:|additional relevant mesh terms:
5938371|NCT01729455|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5938372|NCT01729455|Autoimmune Diseases|autoimmune diseases
5938373|NCT01729455|SLE|sle
5938374|NCT01729455|Systemic Lupus Erythematosus|systemic lupus erythematosus
5938375|NCT01729455|Autoimmune Disease|autoimmune disease
5938376|NCT01729455|Antibodies|antibodies
5938377|NCT01729455|Immune System Diseases|immune system diseases
5684527|NCT00560053|Alternating chemotherapy|alternating chemotherapy
5684528|NCT00560053|Transplantation|transplantation
5684529|NCT00560040|Troponin|troponin
5684530|NCT00560040|Natriuretic Peptide, Brain|natriuretic peptide, brain
5684531|NCT00560040|Exercise|exercise
5684532|NCT00560040|Echocardiography|echocardiography
5684533|NCT00560027|postpartum depression|postpartum depression
5684534|NCT00560027|intimate partner violence|intimate partner violence
5684535|NCT00560001|frail elderly|frail elderly
5684536|NCT00560001|medication errors|medication errors
5684537|NCT00560001|patient compliance & attitudes|patient compliance & attitudes
5684538|NCT00560001|guideline adherence|guideline adherence
5684539|NCT00559988|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5684540|NCT00559988|Cardiac Resynchronization Therapy Defibrillator|cardiac resynchronization therapy defibrillator
5684541|NCT00559988|Home Monitoring|home monitoring
5684542|NCT00559988|Oral Anticoagulation|oral anticoagulation
5684543|NCT00559975|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5684544|NCT00559962|LDL|ldl
5684545|NCT00559962|hepatic fat|hepatic fat
5684546|NCT00559897|bone metastases|bone metastases
5684547|NCT00559897|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5684548|NCT00559897|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5684549|NCT00559897|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5684550|NCT00559884|pharmacokinetics,|pharmacokinetics,
5684551|NCT00559884|healthy male and females,|healthy male and females,
5684552|NCT00559884|pharmacodynamics|pharmacodynamics
5684553|NCT00559871|dyskinesia|dyskinesia
5684554|NCT00559871|movement disorders|movement disorders
5684555|NCT00559871|basal ganglia diseases|basal ganglia diseases
5684556|NCT00559871|JP-1730|jp-1730
5684557|NCT00559871|Parkinson|parkinson
5684558|NCT00559871|end-of-dose wearing off|end-of-dose wearing off
5684559|NCT00559871|fluctuations|fluctuations
5684560|NCT00559858|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5684561|NCT00559858|breast cancer|breast cancer
5684562|NCT00559858|male breast cancer|male breast cancer
5684563|NCT00559858|colon cancer|colon cancer
5684564|NCT00559858|rectal cancer|rectal cancer
5684565|NCT00559832|acute mountain sickness|acute mountain sickness
5684566|NCT00559832|intermittent hypoxia|intermittent hypoxia
5684567|NCT00559832|acclimatization|acclimatization
5684568|NCT00559819|Alcohol|alcohol
5684569|NCT00559819|Driving|driving
5684570|NCT00559819|Impairment|impairment
5684571|NCT00559806|immobilisation|immobilisation
5684572|NCT00559806|aging|aging
5684573|NCT00559806|resistance training|resistance training
5684574|NCT00559806|atrophy|atrophy
5684575|NCT00559806|The effect of immobilisation in elderly compared to young individuals|the effect of immobilisation in elderly compared to young individuals
5684576|NCT00559780|Resistance training|resistance training
5684577|NCT00559780|Aging|aging
5684578|NCT00559780|hip-surgery|hip-surgery
5684579|NCT00559767|Kidney Function|kidney function
5684580|NCT00559767|Genes|genes
5684581|NCT00559767|Association Analysis|association analysis
5684582|NCT00559767|Polymorphisms|polymorphisms
5684583|NCT00559767|Diabetes|diabetes
5684584|NCT00559741|stage IV colon cancer|stage iv colon cancer
5684585|NCT00559741|recurrent colon cancer|recurrent colon cancer
5684586|NCT00559741|stage IV rectal cancer|stage iv rectal cancer
5684587|NCT00559741|recurrent rectal cancer|recurrent rectal cancer
5684588|NCT00559715|bevacizumab|bevacizumab
5684589|NCT00559715|ranibizumab|ranibizumab
5684590|NCT00559715|macular degeneration|macular degeneration
5684591|NCT00559715|age-related|age-related
5684592|NCT00559715|neovascular|neovascular
5938416|NCT01705509|The Effects of Ranolazine on CPET Parameters in Ischemic|the effects of ranolazine on cpet parameters in ischemic
5938417|NCT01705509|Cardiomyopathy Patients|cardiomyopathy patients
5684593|NCT00559715|intravitreal injection|intravitreal injection
5684594|NCT00559715|vision loss|vision loss
5684595|NCT00559715|outpatient setting|outpatient setting
5684596|NCT00559702|natalizumab|natalizumab
5684597|NCT00559702|multiple sclerosis|multiple sclerosis
5684599|NCT00559689|asthma patients|asthma patients
5684600|NCT00559689|well-controlled|well-controlled
5684601|NCT00559676|recurrent colon cancer|recurrent colon cancer
5684602|NCT00559676|stage IV colon cancer|stage iv colon cancer
5684603|NCT00559676|recurrent rectal cancer|recurrent rectal cancer
5684604|NCT00559676|stage IV rectal cancer|stage iv rectal cancer
5684605|NCT00559663|Flavonoid|flavonoid
5684609|NCT00559663|platelet reactivity|platelet reactivity
5684610|NCT00559650|Acute decompensated heart failure|acute decompensated heart failure
5684611|NCT00559650|Double blind study,|double blind study,
5684612|NCT00559650|BAY58-2667|bay58-2667
5684613|NCT00559650|Soluble guanylate cyclase activator|soluble guanylate cyclase activator
5684614|NCT00559624|safety|safety
5684615|NCT00559624|tolerability|tolerability
5684616|NCT00559624|dose-escalation|dose-escalation
5684617|NCT00559611|Non-Small Lung Cancer|non-small lung cancer
5684618|NCT00559611|Lung Cancer|lung cancer
5684619|NCT00559611|Endobronchial Ultrasound|endobronchial ultrasound
5684620|NCT00559611|Fine Needle Aspiration|fine needle aspiration
5684621|NCT00559611|Mediastinoscopy|mediastinoscopy
5684622|NCT00559611|EBUS-FNA|ebus-fna
5684623|NCT00559611|EBUS|ebus
5684624|NCT00559611|Needle Biopsy|needle biopsy
5684625|NCT00559611|NSCLC|nsclc
5684626|NCT00559598|pancreatic cancer|pancreatic cancer
5684627|NCT00559598|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5684628|NCT00559572|Exercise|exercise
5684629|NCT00559572|Group Counseling|group counseling
5684630|NCT00559572|Obesity|obesity
5684631|NCT00559559|Primary and secondary prevention for ventricular tachycardia|primary and secondary prevention for ventricular tachycardia
5684632|NCT00559520|Patients|patients
5684633|NCT00559520|Suffering|suffering
5684634|NCT00559520|Undernutrition|undernutrition
5684635|NCT00559520|Requiring|requiring
5684636|NCT00559520|Vascular|vascular
5684637|NCT00559520|Surgery|surgery
5872933|NCT03772249|CHB|chb
5684638|NCT00559494|complete spinal cord injury|complete spinal cord injury
5684639|NCT00559494|incomplete spinal cord injury|incomplete spinal cord injury
5684640|NCT00559494|central cord spinal cord injury|central cord spinal cord injury
5684641|NCT00559494|traumatic|traumatic
5684642|NCT00559481|recurrent prostate cancer|recurrent prostate cancer
5684643|NCT00559442|high altitude pulmonary edema|high altitude pulmonary edema
5684644|NCT00559442|hypoxic pulmonary vasoconstriction|hypoxic pulmonary vasoconstriction
5684645|NCT00559442|right ventricular function|right ventricular function
5684646|NCT00559442|hypoxia|hypoxia
5684647|NCT00559429|Prostate Cancer|prostate cancer
5684648|NCT00559416|HIV/AIDS|hiv/aids
5684649|NCT00559416|HLA-B*57|hla-b*57
5684650|NCT00559416|Cell Transfer|cell transfer
5684651|NCT00559416|HIV|hiv
5684652|NCT00559416|treatment experienced|treatment experienced
5684653|NCT00559403|Human immunodeficiency virus|human immunodeficiency virus
5684654|NCT00559403|South Africa|south africa
5684655|NCT00559403|Intervention Studies|intervention studies
5684656|NCT00559403|Sexual Behavior|sexual behavior
5684657|NCT00559403|Adolescents|adolescents
5684658|NCT00559403|STD|std
5684659|NCT00559403|HIV Seronegativity|hiv seronegativity
5684660|NCT00559390|Polycystic Ovary Syndrome|polycystic ovary syndrome
5684661|NCT00559390|Metabolic Syndrome|metabolic syndrome
5684662|NCT00559390|PCOS|pcos
5684663|NCT00559390|children|children
5684664|NCT00559390|girls|girls
5684665|NCT00559390|daughters|daughters
5684666|NCT00559390|sisters|sisters
5684667|NCT00559390|irregular periods|irregular periods
5684668|NCT00559351|esophagectomy|esophagectomy
5684669|NCT00559351|chemotherapy|chemotherapy
5684670|NCT00559351|chemoradiotherapy|chemoradiotherapy
5684671|NCT00559351|combined modality therapy|combined modality therapy
5684673|NCT00559338|Heart Failure|heart failure
5684675|NCT00559338|Cardiomyopathy|cardiomyopathy
5684676|NCT00559312|mild COPD|mild copd
5684677|NCT00559312|dyspnea|dyspnea
5684678|NCT00559312|exercise|exercise
5684679|NCT00559312|combination therapy|combination therapy
5684680|NCT00559299|163090|163090
5684681|NCT00559299|placebo-controlled|placebo-controlled
5684682|NCT00559299|MDD|mdd
5684683|NCT00559299|Depression|depression
5684684|NCT00559299|Tolerability|tolerability
5684685|NCT00559299|MDE|mde
5684686|NCT00559286|perfusion|perfusion
5684687|NCT00559286|microcirculation|microcirculation
5684688|NCT00559286|RBC function|rbc function
5938508|NCT01662466|testosterone|testosterone
5938510|NCT01662466|IVF|ivf
5938511|NCT01662466|egg quality|egg quality
5938512|NCT01662466|pregnancy rates|pregnancy rates
5684689|NCT00559286|NO metabolism|no metabolism
5684690|NCT00559286|AT receptor blocker|at receptor blocker
5684691|NCT00559234|Optic Nerve|optic nerve
5684692|NCT00559234|Retina|retina
5684693|NCT00559234|Cornea|cornea
5684694|NCT00559234|Lens|lens
5684695|NCT00559234|Ocular Genetic Diseases|ocular genetic diseases
5684696|NCT00559234|Inherited Eye Disease|inherited eye disease
5684697|NCT00559234|Genetic Eye Disease|genetic eye disease
5684698|NCT00559221|AML|aml
5684699|NCT00559208|Children and Youth|children and youth
5684700|NCT00559208|Families|families
5684701|NCT00559208|Differential Response|differential response
5684702|NCT00559195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5684703|NCT00559195|anemia|anemia
5684707|NCT00559169|menstrual cycle|menstrual cycle
5684708|NCT00559156|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5684709|NCT00559156|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5684710|NCT00559156|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5684711|NCT00559156|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5684712|NCT00559156|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5684713|NCT00559156|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5684714|NCT00559156|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5684715|NCT00559156|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5684716|NCT00559156|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5684717|NCT00559156|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5684718|NCT00559156|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5684719|NCT00559156|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5684720|NCT00559156|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5680085|NCT00579215|Decision-Making|decision-making
5684721|NCT00559156|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5684722|NCT00559156|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5684723|NCT00559156|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5684724|NCT00559156|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5684725|NCT00559156|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5684726|NCT00559156|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5684727|NCT00559156|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5684728|NCT00559156|recurrent salivary gland cancer|recurrent salivary gland cancer
5684729|NCT00559156|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5684730|NCT00559156|stage III salivary gland cancer|stage iii salivary gland cancer
5684731|NCT00559156|stage IV salivary gland cancer|stage iv salivary gland cancer
5684732|NCT00559143|AV conduction disturbances|av conduction disturbances
5684733|NCT00559143|LV function|lv function
5684734|NCT00559143|Biventricular Pacing|biventricular pacing
5684735|NCT00559143|Conductance Catheters|conductance catheters
5684736|NCT00559130|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5684737|NCT00559130|Acute Lung Injury|acute lung injury
5684738|NCT00559130|Sepsis|sepsis
5684739|NCT00559130|Hemoperfusion|hemoperfusion
5684740|NCT00559104|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5684741|NCT00559104|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5684742|NCT00559104|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5684743|NCT00559104|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5684744|NCT00559104|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5684745|NCT00559104|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5684746|NCT00559104|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5684747|NCT00559104|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5684748|NCT00559104|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5684749|NCT00559104|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5684750|NCT00559091|AML|aml
5684751|NCT00559091|Acute myelocytic leukemia|acute myelocytic leukemia
5684752|NCT00559091|leukemia|leukemia
5684753|NCT00559091|relapsed|relapsed
5684754|NCT00559091|refractory|refractory
5684755|NCT00559091|M4|m4
5684756|NCT00559091|M5|m5
5684757|NCT00559078|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
5684758|NCT00559078|Psychosexual Development|psychosexual development
5684759|NCT00559078|Sexual Development|sexual development
5684760|NCT00559078|Intersex|intersex
5684761|NCT00559078|Qualitative|qualitative
5684763|NCT00559078|Interview|interview
5684764|NCT00559078|Disorder of Sex Development|disorder of sex development
5684765|NCT00559078|Telephone|telephone
5684766|NCT00559078|Quality of Life|quality of life
5684767|NCT00559078|Mental Health|mental health
5684768|NCT00559078|Counseling|counseling
5684769|NCT00559065|Case-Cohort Study|case-cohort study
5684770|NCT00559065|Leukemia|leukemia
5684771|NCT00559065|Lymphoma|lymphoma
5684772|NCT00559065|Benzene|benzene
5684773|NCT00559065|Blood Disorders|blood disorders
5684774|NCT00559065|Solvent Exposure|solvent exposure
5684775|NCT00559065|Cancer Risk|cancer risk
5684776|NCT00559052|Enzymes|enzymes
5684777|NCT00559052|VIOKASE|viokase
5684778|NCT00559052|Bioavailability|bioavailability
5684779|NCT00559039|breast cancer|breast cancer
5684780|NCT00559039|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5684781|NCT00559013|Staple line reinforcement|staple line reinforcement
5684782|NCT00559013|Staple line buttress|staple line buttress
5684783|NCT00559013|Anastomotic reinforcement|anastomotic reinforcement
5684784|NCT00559000|PTSD|ptsd
5684785|NCT00559000|Children|children
5684786|NCT00559000|trauma-focused Treatment|trauma-focused treatment
5684787|NCT00559000|KIDNET|kidnet
5684788|NCT00559000|Narrative Exposure Therapy for Children|narrative exposure therapy for children
5684789|NCT00558987|Discipline|discipline
5684790|NCT00558987|Parenting|parenting
5684791|NCT00558987|Primary Care|primary care
5684792|NCT00558987|Videos|videos
5684793|NCT00558961|CLL|cll
5684794|NCT00558961|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5684795|NCT00558961|leukemia|leukemia
5684796|NCT00558961|gleevec|gleevec
5684797|NCT00558961|chlorambucil|chlorambucil
5684798|NCT00558948|Bone Marrow Transplant|bone marrow transplant
5684799|NCT00558948|Bone Mineral Density|bone mineral density
5684800|NCT00558948|Survivors|survivors
5684801|NCT00558948|Muscle Strength|muscle strength
5684802|NCT00558922|Lung|lung
5684803|NCT00558922|Non small cell|non small cell
5684804|NCT00558922|antisense|antisense
5684805|NCT00558922|oligonucleotide|oligonucleotide
5684806|NCT00558922|paclitaxel|paclitaxel
5684807|NCT00558922|carboplatin|carboplatin
5684808|NCT00558896|stage II multiple myeloma|stage ii multiple myeloma
5684809|NCT00558896|stage III multiple myeloma|stage iii multiple myeloma
5684810|NCT00558896|refractory multiple myeloma|refractory multiple myeloma
5684811|NCT00558870|Solid Tumors|solid tumors
5684812|NCT00558870|Morphine|morphine
5684813|NCT00558870|Methadone|methadone
5684814|NCT00558870|Co-Opioid Analgesic|co-opioid analgesic
5684815|NCT00558870|Pain|pain
5684816|NCT00558844|Cystic Fibrosis|cystic fibrosis
5684817|NCT00558844|Respiratory Infections|respiratory infections
5684818|NCT00558844|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5684819|NCT00558844|CFTR|cftr
5684820|NCT00558831|Acne|acne
5684821|NCT00558779|Coronary artery bypass|coronary artery bypass
5684822|NCT00558779|off pump coronary artery bypass grafting (OPCAB)|off pump coronary artery bypass grafting (opcab)
5684823|NCT00558766|Disruptive Behavior Disorders|disruptive behavior disorders
5684824|NCT00558766|Behavior|behavior
5684825|NCT00558766|Gambling|gambling
5684826|NCT00558766|Dopaminergic Mechanisms|dopaminergic mechanisms
5684827|NCT00558766|Dopamine|dopamine
5684828|NCT00558766|Parkinson Disease|parkinson disease
5684829|NCT00558766|PD|pd
5684830|NCT00558740|Dietary protein|dietary protein
5684831|NCT00558740|Fructose|fructose
5684832|NCT00558740|VLDL-triglycerides|vldl-triglycerides
5684833|NCT00558740|Hepatic de novo lipogenesis|hepatic de novo lipogenesis
5684834|NCT00558740|Lipid oxidation|lipid oxidation
5684835|NCT00558727|Advanced Solid Tumors|advanced solid tumors
5684836|NCT00558727|Solid Tumors|solid tumors
5684837|NCT00558727|Tumor|tumor
5684838|NCT00558727|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5684839|NCT00558727|Chemotherapy|chemotherapy
5684840|NCT00558727|Benzoquinone|benzoquinone
5684841|NCT00558701|burns|burns
5684842|NCT00558701|donor site|donor site
5684843|NCT00558701|healing|healing
5684844|NCT00558701|microcurrent|microcurrent
5684845|NCT00558675|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5684846|NCT00558675|Hodgkins Lymphoma|hodgkins lymphoma
5684847|NCT00558675|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5684848|NCT00558675|Chronic Myeloid Leukemia|chronic myeloid leukemia
5684849|NCT00558675|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5684850|NCT00558675|Multiple Myeloma|multiple myeloma
5684851|NCT00558675|Immunotherapy|immunotherapy
5938762|NCT01524679|chronic hepatitis B|chronic hepatitis b
5684858|NCT00558623|pregnancy|pregnancy
5684860|NCT00558623|randomized trial|randomized trial
5684861|NCT00558623|dietary supplementation|dietary supplementation
5684862|NCT00558623|bone resorption|bone resorption
5684863|NCT00558597|Proteomics|proteomics
5684864|NCT00558597|Lung Transplantation|lung transplantation
5684865|NCT00558584|dilated cardiomyopathy|dilated cardiomyopathy
5684866|NCT00558584|immunoadsorption|immunoadsorption
5684867|NCT00558584|immunoglobulin G|immunoglobulin g
5684868|NCT00558558|Solid Tumors|solid tumors
5684869|NCT00558558|Cancer-Associated Anorexia|cancer-associated anorexia
5938975|NCT01405079|Lung cancer|lung cancer
5938976|NCT01405079|II-IIIA(N1-N2)|ii-iiia(n1-n2)
5938977|NCT01405079|Adjuvant treatment|adjuvant treatment
5938978|NCT01405079|EGFR mutations|egfr mutations
5938979|NCT01405079|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5684870|NCT00558558|Weight Loss|weight loss
5684872|NCT00558558|Fermented Soy Product|fermented soy product
5684873|NCT00558558|Nutrition|nutrition
5684874|NCT00558558|Cachexia|cachexia
5684875|NCT00558545|Breast|breast
5684876|NCT00558545|paclitaxel|paclitaxel
5684877|NCT00558545|antisense|antisense
5684878|NCT00558545|oligonucleotide|oligonucleotide
5684879|NCT00558532|Morbid obesity|morbid obesity
5684880|NCT00558532|Omega-3 fatty acid levels|omega-3 fatty acid levels
5684881|NCT00558519|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5684882|NCT00558519|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5684883|NCT00558519|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5684884|NCT00558506|Ankylosing spondylitis|ankylosing spondylitis
5684885|NCT00558506|activity|activity
5684886|NCT00558506|treatment|treatment
5684887|NCT00558506|clinical trial|clinical trial
5684994|NCT00558077|Anovulation|anovulation
5684888|NCT00558454|Iron supplements|iron supplements
5684889|NCT00558454|Infant|infant
5684890|NCT00558454|Low birth weight|low birth weight
5684891|NCT00558454|Prevention of iron deficiency and its physiological consequences|prevention of iron deficiency and its physiological consequences
5684892|NCT00558454|Safety|safety
5684893|NCT00558376|Colonoscopy|colonoscopy
5684894|NCT00558363|Prostate Cancer|prostate cancer
5684895|NCT00558363|AVODART|avodart
5684897|NCT00558363|dutasteride|dutasteride
5684898|NCT00558363|PSADT|psadt
5684899|NCT00558363|Prostate specific antigen|prostate specific antigen
5684900|NCT00558363|radical therapy|radical therapy
5684901|NCT00558363|doubling time|doubling time
5684902|NCT00558350|lobectomy|lobectomy
5684903|NCT00558350|inflammatory reaction|inflammatory reaction
5684904|NCT00558350|intrapulmonary|intrapulmonary
5684905|NCT00558350|intrapleural|intrapleural
5684906|NCT00558337|Treatment of Parkinson's Disease|treatment of parkinson's disease
5684907|NCT00558324|LASIK|lasik
4955168|NCT04269070|prediabetes|prediabetes
5684908|NCT00558324|Confocal microscopy|confocal microscopy
5684909|NCT00558324|Flap|flap
5684917|NCT00558298|schizophrenia|schizophrenia
5684918|NCT00558298|schizoaffective disorder|schizoaffective disorder
5684919|NCT00558298|risperidone|risperidone
5684920|NCT00558298|intramuscular injection|intramuscular injection
5684921|NCT00558298|long-acting injectable|long-acting injectable
5684922|NCT00558285|COPD|copd
5684923|NCT00558285|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5684924|NCT00558285|Indacaterol|indacaterol
5684925|NCT00558285|QVA149|qva149
5684926|NCT00558272|breast cancer|breast cancer
5684927|NCT00558272|prostate cancer|prostate cancer
5684928|NCT00558272|metastatic bone disease|metastatic bone disease
5684929|NCT00558272|Subjects with breast cancer or prostate cancer with metastatic bone disease|subjects with breast cancer or prostate cancer with metastatic bone disease
5684930|NCT00558246|Breast Lift|breast lift
5684931|NCT00558246|Breast Reduction|breast reduction
5684932|NCT00558246|Breast Reconstruction|breast reconstruction
5684933|NCT00558246|Plastic Surgery|plastic surgery
5684934|NCT00558246|Skin Closure|skin closure
5684935|NCT00558246|Wound Healing|wound healing
5684936|NCT00558246|Dermabond|dermabond
5684937|NCT00558233|Colorectal cancer|colorectal cancer
5684938|NCT00558233|Screening|screening
5684939|NCT00558233|Health literacy|health literacy
5684940|NCT00558233|Patient education|patient education
5684941|NCT00558233|Computer assisted instruction|computer assisted instruction
5684942|NCT00558220|Lymphoma, B-cell|lymphoma, b-cell
5684943|NCT00558220|Immunotherapy, passive|immunotherapy, passive
5684944|NCT00558220|Remission induction|remission induction
5684945|NCT00558220|Autologous transplantation|autologous transplantation
5684946|NCT00558207|Pancreatic cancer|pancreatic cancer
5684947|NCT00558207|pancreas cancer|pancreas cancer
5684948|NCT00558207|Locally advanced or metastatic pancreatic adenocarcioma|locally advanced or metastatic pancreatic adenocarcioma
5684949|NCT00558194|Weight loss|weight loss
5684950|NCT00558181|B CLL|b cll
5684951|NCT00558181|Chronic B Lymphocytic Leukemia|chronic b lymphocytic leukemia
5684952|NCT00558181|Methylprednisolone|methylprednisolone
5684953|NCT00558181|Rituximab|rituximab
5684954|NCT00558168|Anastrazole|anastrazole
5684955|NCT00558168|safety|safety
5684956|NCT00558168|early breast cancer|early breast cancer
5684957|NCT00558155|immunonutrition|immunonutrition
5684958|NCT00558155|enteral nutrition|enteral nutrition
5684959|NCT00558155|parenteral nutrition|parenteral nutrition
5684960|NCT00558155|surgery|surgery
5938997|NCT01383018|Erectile Dysfunction (ED)|erectile dysfunction (ed)
5938998|NCT01383018|Penile Implant|penile implant
5938999|NCT01383018|Impotence|impotence
5939000|NCT01383018|Penile Prosthesis|penile prosthesis
5939001|NCT01383018|Registry|registry
5939034|NCT01362595|leucine administration|leucine administration
5939035|NCT01362595|red blood cell transfusion|red blood cell transfusion
5939036|NCT01362595|Diamond Blackfan anemia|diamond blackfan anemia
5684961|NCT00558142|contrast nephropathy|contrast nephropathy
5684962|NCT00558142|radiocontrast-induced nephropathy|radiocontrast-induced nephropathy
5684963|NCT00558142|chronic kidney disease|chronic kidney disease
5684964|NCT00558142|acetylcysteine|acetylcysteine
5684965|NCT00558142|clinical study|clinical study
5684966|NCT00558129|Lumbar Spinal Stenosis|lumbar spinal stenosis
5684967|NCT00558129|X-STOP® IPD|x-stop® ipd
5684968|NCT00558129|Interspinous process decompression|interspinous process decompression
5684969|NCT00558129|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5684970|NCT00558116|Carpal Tunnel Syndrome|carpal tunnel syndrome
5684971|NCT00558116|Dynamic Splinting|dynamic splinting
5684972|NCT00558116|Nerve Conduction Studies|nerve conduction studies
5684973|NCT00558116|Splinting|splinting
5684974|NCT00558116|Levine Katz Survey|levine katz survey
5684975|NCT00558103|GW572016|gw572016
5684976|NCT00558103|Breast Cancer|breast cancer
5684977|NCT00558103|RECIST|recist
5684978|NCT00558103|Inflammatory Breast Cancer|inflammatory breast cancer
5684979|NCT00558103|Pazopanib|pazopanib
5684980|NCT00558103|ErbB2|erbb2
5684981|NCT00558103|Cutaneous Disease|cutaneous disease
5684982|NCT00558103|Tykerb|tykerb
5684983|NCT00558103|Inflammatory|inflammatory
5684984|NCT00558103|Skin|skin
5684985|NCT00558103|Her2|her2
5684986|NCT00558103|Lapatinib|lapatinib
5684987|NCT00558103|GW786034|gw786034
5684988|NCT00558090|pain|pain
5684989|NCT00558090|Intensive Care Unit|intensive care unit
5684990|NCT00558090|morphine|morphine
5684991|NCT00558090|pKpD|pkpd
5684992|NCT00558090|numerical rating scale|numerical rating scale
5684993|NCT00558090|critically ill patients|critically ill patients
5684995|NCT00558077|Clomiphene citrate|clomiphene citrate
5684996|NCT00558077|Fertility|fertility
5684997|NCT00558077|Metformin|metformin
5684998|NCT00558077|Ovulation induction|ovulation induction
5684999|NCT00558077|PCOS|pcos
5685000|NCT00558077|Sterility|sterility
5685001|NCT00558077|Treatment|treatment
5685002|NCT00558077|Clomiphene citrate-resistance|clomiphene citrate-resistance
5685003|NCT00558051|Colorectal Cancer|colorectal cancer
5685004|NCT00558051|Colorectal Carcinoma|colorectal carcinoma
4956347|NCT04261777|SPL-01-001|spl-01-001
5685005|NCT00558051|Colorectal Tumors|colorectal tumors
5685006|NCT00558051|Neoplasms, Colorectal|neoplasms, colorectal
5685007|NCT00558038|Hepatic|hepatic
5685008|NCT00558038|Encephalopathy|encephalopathy
5685009|NCT00558038|Liver|liver
5685010|NCT00558038|Liver Disease|liver disease
5685011|NCT00558038|Liver Failure|liver failure
5685012|NCT00558038|Lactulose|lactulose
5685013|NCT00558038|AST-120|ast-120
5685014|NCT00558012|Osteoporosis|osteoporosis
5685015|NCT00558012|Bone loss|bone loss
5685016|NCT00558012|Frail Geriatric Women|frail geriatric women
5685017|NCT00558012|Nursing Home Patients|nursing home patients
5685018|NCT00558012|Fragility Fractures|fragility fractures
5685019|NCT00557999|Cardiology|cardiology
5685020|NCT00557999|Mechanical ventilation|mechanical ventilation
5685021|NCT00557999|Intensive care|intensive care
5685022|NCT00557986|1-Metastatic breast cancer|1-metastatic breast cancer
5685023|NCT00557986|2-Surgery|2-surgery
5685024|NCT00557986|3-Survival|3-survival
5685025|NCT00557947|Abdominoplasty|abdominoplasty
5685026|NCT00557947|Body Lift|body lift
5685027|NCT00557947|Plastic Surgery|plastic surgery
5685028|NCT00557947|Skin Closure|skin closure
5685029|NCT00557947|Wound Healing|wound healing
5685030|NCT00557947|Dermabond|dermabond
5685031|NCT00557934|tetralogy of Fallot|tetralogy of fallot
5685032|NCT00557934|right ventricular dysfunction|right ventricular dysfunction
5685033|NCT00557934|pulmonary insufficiency|pulmonary insufficiency
5685034|NCT00557934|pulmonary valve replacement|pulmonary valve replacement
5685035|NCT00557934|pressure-volume loops|pressure-volume loops
5685036|NCT00557934|long-term follow-up in tetralogy of Fallot|long-term follow-up in tetralogy of fallot
5685037|NCT00557921|ACS|acs
5685038|NCT00557921|CAD|cad
5685039|NCT00557921|MI|mi
5685040|NCT00557921|PCI|pci
5685041|NCT00557921|PTCA|ptca
5685042|NCT00557921|NSTEMI|nstemi
5685043|NCT00557921|STEMI|stemi
5939140|NCT01338415|pediatric|pediatric
5939141|NCT01338415|pulmonary arterial hypertension|pulmonary arterial hypertension
5939142|NCT01338415|bosentan|bosentan
5939143|NCT01338415|Tracleer|tracleer
5901583|NCT01492751|brachytherapy|brachytherapy
5356696|NCT01918397|Optimized background regimen|optimized background regimen
5685044|NCT00557921|acute coronary syndrome|acute coronary syndrome
5685045|NCT00557921|cerebrovascular disorders|cerebrovascular disorders
5685046|NCT00557921|coronary artery stent placement|coronary artery stent placement
5685047|NCT00557921|coronary thrombosis|coronary thrombosis
5685048|NCT00557921|myocardial infarction|myocardial infarction
5685049|NCT00557921|myocardial ischemia|myocardial ischemia
5356697|NCT01918384|Duchenne muscular dystrophy|duchenne muscular dystrophy
5356699|NCT01918384|Arbekacin|arbekacin
5356700|NCT01918384|nonsense|nonsense
5356701|NCT01918384|readthrough|readthrough
5356702|NCT01918345|Diabetes|diabetes
5356703|NCT01918345|Diabetes Mellitus|diabetes mellitus
5356704|NCT01918345|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5356705|NCT01918345|Diabetes, gestational|diabetes, gestational
5356706|NCT01918345|Prevention & control|prevention & control
5356707|NCT01918345|Postpartum Period|postpartum period
5356708|NCT01918345|Mothers|mothers
5356709|NCT01918345|Diet|diet
5356710|NCT01918345|Diabetic Diet|diabetic diet
5356711|NCT01918345|Exercise|exercise
5356712|NCT01918345|Life Style|life style
5356713|NCT01918345|Motivation|motivation
5356714|NCT01918345|Health Behavior|health behavior
5356715|NCT01918345|Insulin-Secreting Cells|insulin-secreting cells
5356716|NCT01918345|Randomized Controlled Trial|randomized controlled trial
5356717|NCT01918345|Clinical Trial|clinical trial
5356718|NCT01918345|Pilot Projects|pilot projects
5356719|NCT01918345|Feasibility Studies|feasibility studies
5356720|NCT01918306|Triple Negative Breast Cancer|triple negative breast cancer
5356721|NCT01918306|Estrogen receptor negative breast cancer|estrogen receptor negative breast cancer
5356722|NCT01918306|Metastatic breast cancer|metastatic breast cancer
5356723|NCT01918306|Stage IV breast cancer|stage iv breast cancer
5356724|NCT01918306|HER2 negative breast cancer|her2 negative breast cancer
5356725|NCT01918293|ASTHMA|asthma
5356726|NCT01918293|SMARTPHONE APPLICATION|smartphone application
5356727|NCT01918280|Klinefelter Syndrome|klinefelter syndrome
5356728|NCT01918280|Azoospermia|azoospermia
5356729|NCT01918280|Seminal analyses|seminal analyses
5356730|NCT01918280|Testicular biopsy|testicular biopsy
5356731|NCT01918241|Pegylation|pegylation
5356732|NCT01918241|G-CSF|g-csf
5908721|NCT04163380|Estrogen|estrogen
5908722|NCT04163380|Progesterone|progesterone
5908723|NCT04163380|Menstrual Cycle|menstrual cycle
5908724|NCT04163380|Resistance Training|resistance training
5908725|NCT04162470|PNH|pnh
5908771|NCT04159454|Pacing|pacing
5908772|NCT04159454|Heart failure|heart failure
5908773|NCT04159454|Dyssynchrony|dyssynchrony
5908786|NCT04157179|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4960328|NCT04236908|acupuncture|acupuncture
5685050|NCT00557921|percutaneous coronary intervention|percutaneous coronary intervention
5685051|NCT00557921|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5685155|NCT00557440|Mometasone|mometasone
5685054|NCT00557921|duodenal ulcer|duodenal ulcer
5685055|NCT00557921|dyspepsia|dyspepsia
5685056|NCT00557921|esophagitis, peptic|esophagitis, peptic
5685057|NCT00557921|gastric outlet obstruction|gastric outlet obstruction
5685058|NCT00557921|gastroduodenal ulcer|gastroduodenal ulcer
5685059|NCT00557921|gastroesophageal reflux disease|gastroesophageal reflux disease
5685060|NCT00557921|gastrointestinal hemorrhage|gastrointestinal hemorrhage
5685061|NCT00557921|peptic ulcer|peptic ulcer
5685062|NCT00557921|peptic ulcer perforation|peptic ulcer perforation
5685063|NCT00557908|Von Willebrand Disease|von willebrand disease
5685064|NCT00557908|VWD|vwd
5685065|NCT00557908|prophylaxis|prophylaxis
5685066|NCT00557895|Asthma|asthma
5685067|NCT00557895|Hypersensitivity|hypersensitivity
5685068|NCT00557895|Peanut Allergy|peanut allergy
5685069|NCT00557895|Eosinophilic Esophagitis|eosinophilic esophagitis
5685070|NCT00557895|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5685071|NCT00557882|prolapse|prolapse
5685072|NCT00557882|uterus|uterus
5685073|NCT00557882|mesh|mesh
5685074|NCT00557882|bladder|bladder
5685075|NCT00557856|Solid Tumors Transforming Growth Factor Beta Activin Receptor-like Kinase 1|solid tumors transforming growth factor beta activin receptor-like kinase 1
5685076|NCT00557843|Bupivacaine|bupivacaine
5685077|NCT00557843|Colon|colon
5685078|NCT00557843|Surgery|surgery
5685079|NCT00557843|Oxygenation|oxygenation
5685080|NCT00557830|Renal Cell Carcinoma|renal cell carcinoma
5685081|NCT00557830|Kidney Cancer|kidney cancer
5685082|NCT00557817|HCT|hct
5685083|NCT00557817|autologous|autologous
5685084|NCT00557817|erythropoiesis|erythropoiesis
5685085|NCT00557817|iron saccharate|iron saccharate
5685086|NCT00557817|erythropoietin|erythropoietin
5685087|NCT00557817|darbepoetin alpha|darbepoetin alpha
5685088|NCT00557804|Congestive Heart Failure|congestive heart failure
5685089|NCT00557791|AMD|amd
5685090|NCT00557791|ARMD|armd
5685091|NCT00557791|Exudative Macular Degeneration|exudative macular degeneration
5685092|NCT00557791|Bevasiranib|bevasiranib
5685093|NCT00557791|siRNA|sirna
5685094|NCT00557778|prevention|prevention
5685095|NCT00557778|dyslipidemia|dyslipidemia
5685096|NCT00557765|Tuberculosis|tuberculosis
5685097|NCT00557765|Latent tuberculosis infection|latent tuberculosis infection
5685098|NCT00557765|Interferon gamma release assay|interferon gamma release assay
5685099|NCT00557765|Contact tracing|contact tracing
5685100|NCT00557739|CRx-191|crx-191
5685101|NCT00557739|Plaque|plaque
5685102|NCT00557739|Psoriasis|psoriasis
5685103|NCT00557739|nortriptyline hydrochloride|nortriptyline hydrochloride
5685104|NCT00557739|mometasone furoate|mometasone furoate
5685105|NCT00557739|psoriatic infiltrate|psoriatic infiltrate
5685109|NCT00557700|Mild to moderate asthma|mild to moderate asthma
5685110|NCT00557687|IVF|ivf
5685111|NCT00557687|ovarian reserve|ovarian reserve
5685112|NCT00557687|poor response|poor response
5685113|NCT00557661|Heart failure|heart failure
5685114|NCT00557661|CD-NP|cd-np
5685115|NCT00557648|Anxiety|anxiety
5685116|NCT00557648|Children|children
5685117|NCT00557648|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5685118|NCT00557648|School-Based Interventions|school-based interventions
5685119|NCT00557635|pseudo-arthrosis, osseous matrix, cell therapy|pseudo-arthrosis, osseous matrix, cell therapy
5685120|NCT00557622|PTSD (Posttraumatic Stress Disorder)|ptsd (posttraumatic stress disorder)
5685121|NCT00557622|CAPS|caps
5685122|NCT00557622|fMRI|fmri
5685123|NCT00557622|Paroxetine|paroxetine
5685124|NCT00557609|Microphthalmia transcription (MiT) factor associated tumors|microphthalmia transcription (mit) factor associated tumors
5685125|NCT00557609|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
5685126|NCT00557609|Clear cell sarcoma (CCS)|clear cell sarcoma (ccs)
5685127|NCT00557609|Renal cell carcinoma (RCC)|renal cell carcinoma (rcc)
5685128|NCT00557596|Pancreatic|pancreatic
5685129|NCT00557596|antisense|antisense
5908801|NCT04155437|maternal nutrition|maternal nutrition
5908802|NCT04155437|antenatal care|antenatal care
5908803|NCT04155437|Burkina Faso|burkina faso
5908848|NCT04152551|hearing loss|hearing loss
5908849|NCT04152551|bisphosphonate|bisphosphonate
5908850|NCT04152551|skeletal dysplasia|skeletal dysplasia
5908851|NCT04152551|brittle bone disorder|brittle bone disorder
5908852|NCT04152551|osteogenesis imperfecta|osteogenesis imperfecta
5342882|NCT01981681|PF-06263276|pf-06263276
5908862|NCT04152200|PH1|ph1
5908863|NCT04152200|Primary Hyperoxaluria|primary hyperoxaluria
5908864|NCT04152200|Hyperoxaluria|hyperoxaluria
5908865|NCT04152200|RNAi Therapeutic|rnai therapeutic
5908866|NCT04152200|siRNA|sirna
5908867|NCT04152200|AGT|agt
5908868|NCT04152200|Systemic Oxalosis|systemic oxalosis
4960429|NCT04236414|Olaparib|olaparib
5685130|NCT00557596|oligonucleotide|oligonucleotide
5685131|NCT00557596|gemcitabine|gemcitabine
5685132|NCT00557583|VBY-376 Hepatitis C pharmacokinetics safety|vby-376 hepatitis c pharmacokinetics safety
5685133|NCT00557570|Antiretroviral|antiretroviral
5685134|NCT00557570|Opportunistic Infection|opportunistic infection
5685135|NCT00557570|treatment experienced|treatment experienced
5685136|NCT00557570|treatment naive|treatment naive
5685137|NCT00557557|Colorectal|colorectal
5685138|NCT00557557|liver|liver
5685139|NCT00557557|cancer|cancer
5685140|NCT00557557|metastases|metastases
5685141|NCT00557544|migraine|migraine
5685142|NCT00557544|metoclopramide|metoclopramide
5685143|NCT00557544|ketoprofen|ketoprofen
5685144|NCT00557544|child|child
5685145|NCT00557492|pancreas|pancreas
5685146|NCT00557492|pancreatic|pancreatic
5685147|NCT00557492|cancer|cancer
5685148|NCT00557492|resectable|resectable
5685149|NCT00557466|QMF|qmf
5685150|NCT00557466|indacaterol|indacaterol
5685151|NCT00557466|TWISTHALER® device|twisthaler® device
5685152|NCT00557440|Asthma|asthma
5685153|NCT00557440|QMF|qmf
5685156|NCT00557427|mild to moderate depression according to the DSM-IV scale|mild to moderate depression according to the dsm-iv scale
5685157|NCT00557414|acute respiratory distress syndrome|acute respiratory distress syndrome
5848030|NCT00036582|Psychophysiology|psychophysiology
5685158|NCT00557414|soluble triggering receptor expressed on myeloid cells-1|soluble triggering receptor expressed on myeloid cells-1
5685159|NCT00557414|prognosis|prognosis
5685160|NCT00557388|muscle loss|muscle loss
5685162|NCT00557388|protein|protein
5685163|NCT00557388|amino acids|amino acids
5685164|NCT00557388|exercise|exercise
5685165|NCT00557388|protein synthesis|protein synthesis
5685166|NCT00557375|Brain Tumors|brain tumors
5685167|NCT00557375|Survey|survey
5685168|NCT00557362|Keratitis|keratitis
5685169|NCT00557362|Eye Infection, Fungal|eye infection, fungal
5685170|NCT00557362|Fungal Eye Infection|fungal eye infection
5685171|NCT00557362|Ocular Infection, Fungal|ocular infection, fungal
5685172|NCT00557362|Fungal Keratitis|fungal keratitis
5685173|NCT00557362|Mycotic Infections, Ocular|mycotic infections, ocular
5685174|NCT00557362|Voriconazole|voriconazole
5685176|NCT00557349|gastric bypass surgery|gastric bypass surgery
5685177|NCT00557349|anastomosis, Roux-en-Y|anastomosis, roux-en-y
5685178|NCT00557349|Complication, Postoperative|complication, postoperative
5685179|NCT00557310|osteoporosis, teriparatide, postmenopausal, MRI, finite element analysis|osteoporosis, teriparatide, postmenopausal, mri, finite element analysis
5685180|NCT00557297|asthma|asthma
5685181|NCT00557297|SMART|smart
5685182|NCT00557297|inhaled|inhaled
5685183|NCT00557297|glucocorticosteroid|glucocorticosteroid
5685184|NCT00557297|reliever|reliever
5685185|NCT00557297|maintenance|maintenance
5685186|NCT00557297|single inhaler|single inhaler
5685187|NCT00557284|Atopic Dermatitis (Eczema) associated with food allergies|atopic dermatitis (eczema) associated with food allergies
5685188|NCT00557245|HIV infection|hiv infection
5685189|NCT00557245|HIV uninfected partners|hiv uninfected partners
5685190|NCT00557245|Double Blind|double blind
5685191|NCT00557245|Placebo|placebo
5685192|NCT00557245|Seroconversion|seroconversion
5685193|NCT00557245|TDF|tdf
5685194|NCT00557245|FTC TDF|ftc tdf
5685195|NCT00557245|Safety|safety
5685196|NCT00557245|HIV Seronegativity|hiv seronegativity
5908891|NCT04149821|CLL|cll
5908892|NCT04149821|progression|progression
5908960|NCT04145752|femoral nerve block|femoral nerve block
5908961|NCT04145752|Ultrasound guided|ultrasound guided
5908962|NCT04145752|Nurse-led|nurse-led
5908992|NCT04143243|Acceptance and Commitment Therapy|acceptance and commitment therapy
5908993|NCT04143243|Veterans|veterans
5908994|NCT04143243|polytrauma|polytrauma
5908995|NCT04143243|traumatic brain injury|traumatic brain injury
5908996|NCT04143243|chronic pain|chronic pain
5908997|NCT04143243|Post Traumatic Stress Disorder|post traumatic stress disorder
5908998|NCT04143243|depression|depression
5908999|NCT04143243|Anxiety|anxiety
5356762|NCT01918059|suture|suture
5356763|NCT01918059|cosmetic|cosmetic
4960662|NCT04235101|ADC|adc
5685197|NCT00557232|bevacizumab|bevacizumab
5685198|NCT00557232|rubeosis iridis|rubeosis iridis
5685199|NCT00557232|glaucoma|glaucoma
5685200|NCT00557219|cardiac surgery|cardiac surgery
5685201|NCT00557219|fenoldopam|fenoldopam
5685202|NCT00557219|ketanserin|ketanserin
5909095|NCT04134052|ketamine|ketamine
5909096|NCT04134052|midazolam|midazolam
5909097|NCT04134052|cognitive dysfunction|cognitive dysfunction
5909104|NCT04133363|L-PRF|l-prf
5909105|NCT04133363|Bone Allograft|bone allograft
5909106|NCT04133363|Ridge Preservation|ridge preservation
5909107|NCT04133363|Socket grafting|socket grafting
5909108|NCT04133363|Bone regeneration|bone regeneration
5684705|NCT00559169|epilepsy|epilepsy
5684706|NCT00559169|seizures|seizures
5342895|NCT01981603|Hemodialysis|hemodialysis
5687657|NCT00546065|ablation|ablation
5692650|NCT00527228|steroids|steroids
4968042|NCT04189627|Maviret|maviret
5685203|NCT00557219|renal replacement therapy|renal replacement therapy
5685204|NCT00557206|Recurrent Disease|recurrent disease
5685205|NCT00557206|Metastatic Disease|metastatic disease
5685206|NCT00557206|Squamous Cell Carcinoma|squamous cell carcinoma
5685207|NCT00557206|Multicenter|multicenter
5685208|NCT00557206|Phase II|phase ii
5685209|NCT00557180|Steroid Resistance|steroid resistance
5685210|NCT00557180|Inflammation|inflammation
5685211|NCT00557154|Pediatrics|pediatrics
5685212|NCT00557154|Venous access|venous access
5685213|NCT00557154|Emergency|emergency
5685214|NCT00557141|Single arm observational retrospective and prospective study|single arm observational retrospective and prospective study
5685215|NCT00557128|COREG CR,|coreg cr,
5685216|NCT00557128|lisinopril,|lisinopril,
5685217|NCT00557128|hypertension,|hypertension,
5685218|NCT00557128|dose proportionality,|dose proportionality,
5685219|NCT00557128|fixed dose combination (FDC)|fixed dose combination (fdc)
5685220|NCT00557115|Quality of life|quality of life
5685221|NCT00557115|Quadriceps|quadriceps
5685222|NCT00557115|Muscle|muscle
5685223|NCT00557115|Exacerbation|exacerbation
5685224|NCT00557102|liver metastases|liver metastases
5685225|NCT00557102|lung metastases|lung metastases
5685226|NCT00557102|recurrent rectal cancer|recurrent rectal cancer
5685227|NCT00557102|stage IV rectal cancer|stage iv rectal cancer
5685228|NCT00557102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5685229|NCT00557102|adenocarcinoma of the colon|adenocarcinoma of the colon
5685230|NCT00557102|recurrent colon cancer|recurrent colon cancer
5685231|NCT00557102|stage IV colon cancer|stage iv colon cancer
5685232|NCT00557089|Pediatrics|pediatrics
5685233|NCT00557089|Cystic Fibrosis|cystic fibrosis
5685234|NCT00557089|Lung Clearance Index|lung clearance index
5685235|NCT00557089|rhDNAse|rhdnase
5685236|NCT00557076|Randomized Clinical Trial|randomized clinical trial
5685237|NCT00557076|Auditory Stimulation|auditory stimulation
5685238|NCT00557050|Hamstring|hamstring
5685239|NCT00557050|Muscle|muscle
5685240|NCT00557050|Injury|injury
5685241|NCT00557050|Prevention|prevention
5685242|NCT00557050|Muscles|muscles
5685243|NCT00557037|Castrate and Non-Castrate Prostate Cancer|castrate and non-castrate prostate cancer
5685244|NCT00557024|hepatocellular carcinoma|hepatocellular carcinoma
5685245|NCT00557024|liver cancer|liver cancer
5685246|NCT00557024|radiofrequency ablation|radiofrequency ablation
5685247|NCT00557024|radiotherapy|radiotherapy
5685248|NCT00557024|adjuvant therapy|adjuvant therapy
5685249|NCT00556998|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents|pharmacokinetics and safety data of voriconazole in immunocompromised adolescents
5685250|NCT00556959|ADHD|adhd
5685251|NCT00556959|Clonidine|clonidine
5685355|NCT00556439|Vasculitis|vasculitis
5685252|NCT00556959|Attention Deficit|attention deficit
5685253|NCT00556959|Hyperactivity|hyperactivity
5685254|NCT00556959|CLONICEL|clonicel
5685255|NCT00556959|Addrenex|addrenex
5685256|NCT00556946|Vascular Malformation|vascular malformation
5685257|NCT00556933|Induction|induction
5685258|NCT00556933|rATG|ratg
5685259|NCT00556933|Calcineurin-inhibitor withdrawal|calcineurin-inhibitor withdrawal
5685260|NCT00556920|Coreg CR|coreg cr
5685261|NCT00556907|DCIS|dcis
5685262|NCT00556907|To evaluate Preoperative mammagraphy and MRI to select candiates with DCIS for IORT|to evaluate preoperative mammagraphy and mri to select candiates with dcis for iort
5685263|NCT00556868|High school students|high school students
5685264|NCT00556868|Boarding school|boarding school
5685266|NCT00556868|Fasting|fasting
5685267|NCT00556868|Memory|memory
5685268|NCT00556868|Attention|attention
5685269|NCT00556868|Mood|mood
5005957|NCT03959501|Sodium glucose co-transporter 2 inhibitors|sodium glucose co-transporter 2 inhibitors
5005958|NCT03959501|Ketones|ketones
5005962|NCT03959475|Elderly subject|elderly subject
5886655|NCT04272476|functional near infrared spectroscopy (fNIRS) imaging|functional near infrared spectroscopy (fnirs) imaging
5886656|NCT04272450|respiratory muscle|respiratory muscle
5886657|NCT04272450|mouth pressure|mouth pressure
5886658|NCT04272450|normative data|normative data
5886659|NCT04272450|predicted value|predicted value
5886801|NCT04271748|CD|cd
5887133|NCT04269655|Blood Glucose|blood glucose
5887134|NCT04269655|Cost-Effectiveness|cost-effectiveness
5887135|NCT04269655|Hospital|hospital
5887136|NCT04269655|Diabetes Management|diabetes management
5887137|NCT04269655|Technology|technology
5887138|NCT04269655|Remote Monitoring|remote monitoring
5887139|NCT04269655|Digital Dashboard|digital dashboard
5887140|NCT04269655|Cloud-Based|cloud-based
5887141|NCT04269655|Hypoglycemia|hypoglycemia
5887142|NCT04269655|Hyperglycemia|hyperglycemia
5887143|NCT04269655|Real-Time|real-time
5887936|NCT04218604|radiofrequency ablation|radiofrequency ablation
5887937|NCT04218604|pulmonary vein isolation|pulmonary vein isolation
5887938|NCT04218604|left atrial wall thickness|left atrial wall thickness
5887939|NCT04218604|multidetector cardiac tomography|multidetector cardiac tomography
5901835|NCT01375530|Healthy Volunteer|healthy volunteer
5902948|NCT00720941|Pazopanib|pazopanib
5902949|NCT00720941|Sunitinib|sunitinib
5902950|NCT00720941|GW786034|gw786034
5902951|NCT00720941|Renal cell carcinoma|renal cell carcinoma
4955484|NCT04267198|rehabilitation|rehabilitation
4955485|NCT04267198|speech-language pathology|speech-language pathology
4955486|NCT04267185|Exercise|exercise
4955487|NCT04267185|Caregiver|caregiver
4955694|NCT04265794|Boys and Girls Clubs|boys and girls clubs
4955806|NCT04265365|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
4955807|NCT04265365|Repetitive peripheral magnetic stimulation|repetitive peripheral magnetic stimulation
4955808|NCT04265365|stroke|stroke
4955809|NCT04265365|novel treatment|novel treatment
4955810|NCT04265352|cardiac echogenic focus|cardiac echogenic focus
4955811|NCT04265339|Sleep|sleep
4955812|NCT04265339|Tobacco Smoking|tobacco smoking
4955813|NCT04265339|Smoking cessation|smoking cessation
4955814|NCT04265287|severe pneumonia|severe pneumonia
4955815|NCT04265274|metastatic breast cancer, vinorelbin, cisplatin, disulfiram|metastatic breast cancer, vinorelbin, cisplatin, disulfiram
4955816|NCT04265248|Virtual reality|virtual reality
4955817|NCT04265248|Chronic pain|chronic pain
4955818|NCT04265248|Neck pain|neck pain
4955819|NCT04265248|Physiotherapy|physiotherapy
4955820|NCT04265248|Exercise|exercise
4955821|NCT04265235|Exercise|exercise
4955931|NCT04264468|prognosis|prognosis
4955933|NCT04264455|Life Vest|life vest
4955934|NCT04264455|BioMonitor|biomonitor
4955935|NCT04264455|Myocarditis|myocarditis
4955936|NCT04264455|Ventricular Arrythmia|ventricular arrythmia
4955943|NCT04264429|Patellofemoral Pain Syndrome|patellofemoral pain syndrome
4955944|NCT04264429|Physiotherapy|physiotherapy
4955945|NCT04264429|Knee|knee
4955946|NCT04264429|Orthoses|orthoses
4955947|NCT04264403|Chronic Kidney Disease|chronic kidney disease
4955948|NCT04264403|Renal Denervation|renal denervation
4955949|NCT04264403|Uncontrolled Hypertension|uncontrolled hypertension
4955950|NCT04264390|exercise|exercise
4956059|NCT04263779|Choice Architecture|choice architecture
4956183|NCT04262947|Difficult Venous Access|difficult venous access
4956184|NCT04262934|25 OH-VITAmin D supplementation|25 oh-vitamin d supplementation
4956185|NCT04262934|muscle strength|muscle strength
4956186|NCT04262921|Coronavirus|coronavirus
4956187|NCT04262921|2019-nCoV|2019-ncov
4956188|NCT04262895|cognition|cognition
4956189|NCT04262895|neurobehavioral symptoms|neurobehavioral symptoms
4956190|NCT04262895|psychiatric symptoms|psychiatric symptoms
4956204|NCT04262765|ramiprilat|ramiprilat
4956205|NCT04262765|ramipril|ramipril
4956206|NCT04262765|amlodipine|amlodipine
4956207|NCT04262765|atorvastatin|atorvastatin
4956208|NCT04262765|drug interaction|drug interaction
4956209|NCT04262765|multiple-dose|multiple-dose
4956210|NCT04262765|pharmacokinetic|pharmacokinetic
4956211|NCT04262739|solid tumors|solid tumors
4956320|NCT04261972|Circulating tumour DNA|circulating tumour dna
4956321|NCT04261972|Cell-free DNA (cfDNA)|cell-free dna (cfdna)
4956322|NCT04261972|Hereditary cancer syndrome|hereditary cancer syndrome
4956323|NCT04261972|Cancer|cancer
4956324|NCT04261972|BRCA1|brca1
4956325|NCT04261972|Lynch syndrome|lynch syndrome
4956326|NCT04261972|Hereditary breast and ovarian cancer|hereditary breast and ovarian cancer
4956327|NCT04261972|Liquid biopsies|liquid biopsies
4956328|NCT04261972|BRCA2|brca2
4956329|NCT04261920|Oxaliplatin induced peripheral neurotoxicity|oxaliplatin induced peripheral neurotoxicity
4956330|NCT04261920|Clinical curative effect|clinical curative effect
4956331|NCT04261855|radiotherapy|radiotherapy
4956436|NCT04261140|bulkfill composite|bulkfill composite
4956437|NCT04261140|flowable composite|flowable composite
4956438|NCT04261140|nanohybrid composite|nanohybrid composite
4956439|NCT04261140|cervical lesion|cervical lesion
4956441|NCT04261127|algorithm|algorithm
4956552|NCT04260165|Scapholunate Advanced Collapse|scapholunate advanced collapse
4956553|NCT04260165|Scaphoid Non-union Advanced Collapse|scaphoid non-union advanced collapse
4956554|NCT04260165|Wrist arthrodesis|wrist arthrodesis
4956555|NCT04260165|Proximal Row Carpectomy|proximal row carpectomy
4956556|NCT04260152|Gingival Recession|gingival recession
4956558|NCT04260152|CAF|caf
4956559|NCT04260152|CTG|ctg
4956560|NCT04260152|Geistlich|geistlich
4956561|NCT04260139|ileocolic pedicle|ileocolic pedicle
4956669|NCT04259502|Postoperative Analgesia|postoperative analgesia
4956670|NCT04259502|Peroperative Analgesia|peroperative analgesia
4956671|NCT04259502|Ultrasound|ultrasound
4956672|NCT04259502|Rhomboid intercostal block|rhomboid intercostal block
4956673|NCT04259502|Erector spinae plane block|erector spinae plane block
4956674|NCT04259502|Mastectomy|mastectomy
4956675|NCT04259489|Type 2 Diabetes|type 2 diabetes
4956676|NCT04259489|Diabetes Education and Management|diabetes education and management
4956677|NCT04259489|Share Care|share care
4956678|NCT04259476|post-operative analgesia, ketamine, multi-modal therapy|post-operative analgesia, ketamine, multi-modal therapy
4956679|NCT04259424|Rehabilitation|rehabilitation
4956680|NCT04259424|Upper Extremity|upper extremity
4956681|NCT04259424|Aerobic Exercise|aerobic exercise
4956682|NCT04259424|Motor Function|motor function
4956683|NCT04259411|FMR|fmr
4956693|NCT04259385|Sugar-sweetened beverages|sugar-sweetened beverages
4956694|NCT04259385|Eating|eating
4956695|NCT04259385|Drinking|drinking
4956696|NCT04259385|Choice behavior|choice behavior
4956697|NCT04259333|opioid|opioid
4956698|NCT04259333|rhinoplasty|rhinoplasty
4956699|NCT04259333|pain, postoperative|pain, postoperative
4956758|NCT04259047|Health Disparities|health disparities
4956759|NCT04259047|Retinal Imaging|retinal imaging
4956760|NCT04259021|difficult air way, pre-anesthetic evaluation, voice analysis|difficult air way, pre-anesthetic evaluation, voice analysis
4956761|NCT04259008|manganese, parenteral nutrition, neonate, preterm, safety|manganese, parenteral nutrition, neonate, preterm, safety
4956762|NCT04258969|Pedaling|pedaling
4956871|NCT04258306|Pharmacokinetics of resveratrol. Plasma profile of a new formulation based on resveratrol|pharmacokinetics of resveratrol. plasma profile of a new formulation based on resveratrol
4956872|NCT04258267|"Influencing factors"|"influencing factors"
4956873|NCT04258267|Rehabilitation|rehabilitation
4956874|NCT04258267|"Anatomical shoulder arthroplasty"|"anatomical shoulder arthroplasty"
4956875|NCT04258267|"Reverse shoulder arthroplasty"|"reverse shoulder arthroplasty"
4956876|NCT04258254|Movement|movement
4956877|NCT04258254|Play|play
4956884|NCT04258241|Postoperative recovery|postoperative recovery
4956885|NCT04258241|Adductor canal block|adductor canal block
4956990|NCT04257630|quality of life|quality of life
4956995|NCT04257604|Partial seizures|partial seizures
4957112|NCT04256837|Stimulation|stimulation
4957267|NCT04255901|primary insomnia|primary insomnia
4957268|NCT04255875|safety|safety
4957269|NCT04255875|tolerability|tolerability
4957270|NCT04255875|single ascending dose|single ascending dose
4957271|NCT04255875|multiple dose|multiple dose
4957272|NCT04255875|pharmacokinetics|pharmacokinetics
4957273|NCT04255875|Phase 1|phase 1
4957287|NCT04255784|depression|depression
4957426|NCT04254796|Meditation Healthy teens, MRI|meditation healthy teens, mri
4957433|NCT04254731|Racemic methadone|racemic methadone
4957434|NCT04254731|R-methadone|r-methadone
4957435|NCT04254731|QTc interval|qtc interval
4957436|NCT04254731|Methadone maintenance treatment patients|methadone maintenance treatment patients
4957437|NCT04254718|NICU|nicu
4957561|NCT04254029|Stevia rebaudiana bertoni|stevia rebaudiana bertoni
4957562|NCT04254029|Diabetes mellitus|diabetes mellitus
4957563|NCT04254016|Diastolic function|diastolic function
4957564|NCT04254016|Blood pressure|blood pressure
4957565|NCT04254016|Diabetes mellitus|diabetes mellitus
4957566|NCT04254016|Hibiscus Sabdariffa|hibiscus sabdariffa
4957567|NCT04254016|Stevia Rebaudiana|stevia rebaudiana
4957568|NCT04254003|toric contact lens|toric contact lens
4957569|NCT04254003|daily disposable|daily disposable
4957570|NCT04254003|silicone hydrogel contact lens|silicone hydrogel contact lens
4957571|NCT04254003|axis orientation|axis orientation
4957677|NCT04253444|reflux hypersensitivity|reflux hypersensitivity
4957683|NCT04253327|low malignant potential|low malignant potential
4957684|NCT04253327|sexual health|sexual health
4957686|NCT04253327|distress|distress
4957687|NCT04253327|surgery|surgery
4957688|NCT04253314|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4957689|NCT04253314|Venetoclax|venetoclax
4957796|NCT04252534|Electromagnetic stimulation|electromagnetic stimulation
4957797|NCT04252534|Platelet rich plasma|platelet rich plasma
4957912|NCT04251741|Rheumatoid arthritis|rheumatoid arthritis
4957913|NCT04251741|Therapeutic Drug Monitoring|therapeutic drug monitoring
4957916|NCT04251741|Failure|failure
4958021|NCT04251208|Postpartum|postpartum
4958022|NCT04251208|Mental health|mental health
4958024|NCT04251143|Cornea|cornea
4958025|NCT04251143|Ectasia|ectasia
4958026|NCT04251143|Keratoconus|keratoconus
4958027|NCT04251143|Cross-Linking|cross-linking
4958028|NCT04251143|Keratoplasty|keratoplasty
4958029|NCT04251104|Images|images
4958030|NCT04251104|personal relevance|personal relevance
4958031|NCT04251091|exoskeleton|exoskeleton
4958032|NCT04251091|ambulation|ambulation
4958148|NCT04250350|Skin Diseases|skin diseases
4958149|NCT04250337|Eczema|eczema
4958150|NCT04250337|Dermatitis|dermatitis
4958151|NCT04250337|Dermatitis, Atopic|dermatitis, atopic
4958152|NCT04250337|Skin Diseases|skin diseases
4958269|NCT04249570|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
4958270|NCT04249570|Povidone-iodine|povidone-iodine
4958271|NCT04249570|peristomal infection|peristomal infection
4958272|NCT04249544|Impulsive behavior|impulsive behavior
4958273|NCT04249544|Social decision making|social decision making
4958274|NCT04249544|Moral decision making|moral decision making
4956878|NCT04258254|Social|social
4956879|NCT04258254|Communication|communication
4956880|NCT04258254|Motor|motor
4956881|NCT04258241|Local infiltration analgesia|local infiltration analgesia
4956882|NCT04258241|Primary knee arthroplasty|primary knee arthroplasty
4956883|NCT04258241|Postoperative pain management|postoperative pain management
4958389|NCT04248829|YH25448|yh25448
4958390|NCT04248829|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
4958391|NCT04248829|Adenocarcinoma of lung|adenocarcinoma of lung
4958392|NCT04248829|Non-squamous carcinoma of lung|non-squamous carcinoma of lung
4958393|NCT04248829|Phase III|phase iii
4958407|NCT04248725|pain|pain
4958477|NCT04248205|hemorrhoidectomy|hemorrhoidectomy
4958479|NCT04248205|post operative pain|post operative pain
4958480|NCT04248179|Postoperative Pain|postoperative pain
4958481|NCT04248179|Opioid Consumption|opioid consumption
4958482|NCT04248179|Ultrasound guided nerve block|ultrasound guided nerve block
4958483|NCT04248179|Paravertebral Block by proxy|paravertebral block by proxy
4977697|NCT04131764|MS|ms
4958487|NCT04248127|Phenolic|phenolic
4958488|NCT04248127|Honey|honey
4958489|NCT04248127|Inflammation|inflammation
4958490|NCT04248127|Yogurt|yogurt
4958491|NCT04248127|Microbiome|microbiome
4958492|NCT04248101|Double Ligation, Topical Silver Nitrate|double ligation, topical silver nitrate
4958493|NCT04248088|stretching|stretching
4958495|NCT04248088|yoga|yoga
4958566|NCT04247607|multidisciplinary team|multidisciplinary team
4958567|NCT04247607|intensive care rehabilitation|intensive care rehabilitation
4958579|NCT04247490|prevalence|prevalence
4958580|NCT04247490|immunosuppressive treatmen|immunosuppressive treatmen
4958581|NCT04247490|liver transplantation|liver transplantation
4958582|NCT04247477|ARDS|ards
4958693|NCT04246723|HCV|hcv
4958694|NCT04246723|antiviral|antiviral
4958695|NCT04246710|pancreatic cancer|pancreatic cancer
4958696|NCT04246710|EUS|eus
4958697|NCT04246710|molecular subtyping|molecular subtyping
4958698|NCT04246710|personalized medicine|personalized medicine
4958699|NCT04246671|HER2-expressing tumors, HER2 antibodies, PD-1 inhibitor|her2-expressing tumors, her2 antibodies, pd-1 inhibitor
4958700|NCT04246606|IHC4|ihc4
4958701|NCT04246606|IHC4+C|ihc4+c
4958702|NCT04246606|Endopredict|endopredict
4958703|NCT04246580|Indocyanine green|indocyanine green
4958704|NCT04246580|Pelvic lymphadenectomy|pelvic lymphadenectomy
4958705|NCT04246567|hypotensive anesthesia|hypotensive anesthesia
4958706|NCT04246567|HIF 1a|hif 1a
4958781|NCT04246294|Pain Detect|pain detect
4958782|NCT04246294|Longitudinal, follow-up|longitudinal, follow-up
4958783|NCT04246281|Electrical Stimulation|electrical stimulation
4958784|NCT04246281|Neuromodulation|neuromodulation
4958785|NCT04246255|Local Anesthesia, Cannula Site Pain, Lidocaine Hydrocloride|local anesthesia, cannula site pain, lidocaine hydrocloride
4958786|NCT04246229|transcutaneous bilirubinometry|transcutaneous bilirubinometry
4958787|NCT04246229|phototherapy|phototherapy
4958907|NCT04245540|menstrual distress|menstrual distress
4958908|NCT04245540|herbal medicine|herbal medicine
4958909|NCT04245540|phytomedicine|phytomedicine
4958910|NCT04245540|complementary therapy|complementary therapy
4958911|NCT04245540|complementary medicine|complementary medicine
4958912|NCT04245540|alternative therapy|alternative therapy
4958913|NCT04245540|alternative medicine|alternative medicine
4958914|NCT04245540|traditional medicine|traditional medicine
4958916|NCT04245540|supplement|supplement
4959006|NCT04245072|central chorioretinitis|central chorioretinitis
4959007|NCT04245059|transcranial electrical stimulation|transcranial electrical stimulation
4959008|NCT04245059|transcranial direct current stimulation|transcranial direct current stimulation
4959009|NCT04245059|motor cortex|motor cortex
4959010|NCT04245059|motor performance|motor performance
4959011|NCT04245059|secondary effects|secondary effects
4959012|NCT04245046|Candesartan|candesartan
4959013|NCT04245046|Amlodipine|amlodipine
4959014|NCT04245046|Atorvastatin|atorvastatin
4959015|NCT04245046|drug interaction|drug interaction
4959016|NCT04245046|multiple-dose|multiple-dose
4959017|NCT04245046|pharmacokinetic|pharmacokinetic
4959093|NCT04244708|Temozolomide; radiotherapy; refractory pituitary adenomas|temozolomide; radiotherapy; refractory pituitary adenomas
4959094|NCT04244695|oral corticosteroid|oral corticosteroid
4959095|NCT04244695|postoperative pain|postoperative pain
4959096|NCT04244695|dexamethasone|dexamethasone
4959097|NCT04244695|total knee arthroplasty|total knee arthroplasty
4959098|NCT04244682|Imaging|imaging
4959099|NCT04244682|Neuroanatomy|neuroanatomy
4959100|NCT04244682|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
4959101|NCT04244682|Neuroscience|neuroscience
4959102|NCT04244669|FBSS|fbss
4959105|NCT04244669|Quality of life|quality of life
4959106|NCT04244669|Pain|pain
4959107|NCT04244669|Activity monitoring|activity monitoring
4959112|NCT04244643|contact lenses|contact lenses
4959113|NCT04244617|iCBT|icbt
4959217|NCT04244058|18F-FPEB|18f-fpeb
4959218|NCT04244058|NMDA|nmda
4959219|NCT04244058|Dopamine|dopamine
4959220|NCT04244058|mGlu5-R|mglu5-r
4959221|NCT04244058|Molecular neuroimaging|molecular neuroimaging
4959233|NCT04243967|TLH|tlh
4959344|NCT04243161|Quality of Life|quality of life
4959345|NCT04243148|Falls|falls
4959346|NCT04243148|Hospitalizations|hospitalizations
4959347|NCT04243148|Mortality|mortality
4959348|NCT04243148|Phase angle|phase angle
4959349|NCT04243148|Body Composition|body composition
5000717|NCT03990766|Anosmia|anosmia
4959350|NCT04243135|r-ESWT|r-eswt
4959351|NCT04243135|knee osteoarthritis|knee osteoarthritis
4959352|NCT04243135|pain|pain
4959353|NCT04243135|function|function
4959354|NCT04243109|Multiple Myeloma|multiple myeloma
4959448|NCT04242498|Hidradenitis Suppurativa|hidradenitis suppurativa
4959449|NCT04242498|Acne inversa|acne inversa
4959598|NCT04241822|vestibular disease|vestibular disease
4959599|NCT04241822|musculoskeletal pain|musculoskeletal pain
4959600|NCT04241822|prognosis|prognosis
4959601|NCT04241822|vestibular rehabilitation|vestibular rehabilitation
4959602|NCT04241770|Acute Myocardial Infarction|acute myocardial infarction
4959603|NCT04241770|Mortality|mortality
4959604|NCT04241770|Registry|registry
4959605|NCT04241770|Turkey|turkey
4959606|NCT04241757|ElectroCardioGram|electrocardiogram
4959607|NCT04241757|General practice|general practice
4959608|NCT04241757|Diagnosis|diagnosis
4959689|NCT04241237|Liquid Biopsy|liquid biopsy
4959690|NCT04241237|Tissue biopsy|tissue biopsy
4959691|NCT04241237|Concordance|concordance
4959692|NCT04241224|lower extremity Peripheral Arterial Disease (PAD)|lower extremity peripheral arterial disease (pad)
4959693|NCT04241172|Proprioceprion|proprioceprion
4959694|NCT04241172|Balance|balance
4959695|NCT04241172|Total Knee Replacement|total knee replacement
4959696|NCT04241159|Frailty|frailty
4959697|NCT04241159|Aging|aging
4959698|NCT04241159|Heart failure|heart failure
4959699|NCT04241159|Plasma|plasma
4959700|NCT04241159|Infusion|infusion
4959706|NCT04241120|Hair Pulling Disorder|hair pulling disorder
4959707|NCT04241120|Body-Focused Repetitive Behaviors|body-focused repetitive behaviors
4959708|NCT04241120|Trichotillomania|trichotillomania
4959714|NCT04241016|adult|adult
4959805|NCT04240483|sterile water injection|sterile water injection
4959806|NCT04240483|emergency department|emergency department
4959807|NCT04240483|sterile water|sterile water
4959808|NCT04240483|acute low back pain|acute low back pain
4959809|NCT04240470|acute ischemic stroke|acute ischemic stroke
4959810|NCT04240470|endovascular treatment|endovascular treatment
4959811|NCT04240470|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
4959907|NCT04239456|cognitive rehabilitation|cognitive rehabilitation
4959908|NCT04239443|immunotherapy|immunotherapy
4959909|NCT04239443|PD-1 checkpoint inhibitor|pd-1 checkpoint inhibitor
4959910|NCT04239443|circulating blood tumor cells (CTC)|circulating blood tumor cells (ctc)
4959914|NCT04239391|dialysis|dialysis
4959915|NCT04239391|pediatric|pediatric
4959916|NCT04239391|chronic kidney disease|chronic kidney disease
4959917|NCT04239391|anemia|anemia
4959918|NCT04239365|recurrence|recurrence
4959919|NCT04239365|endoscopic mucosal resection|endoscopic mucosal resection
4959920|NCT04239365|colorectal lesions|colorectal lesions
4959921|NCT04239365|advanced endoscopic imaging|advanced endoscopic imaging
4959928|NCT04239339|Emotion|emotion
4960031|NCT04238637|Intrahepatic Biliary Tract Carcinoma|intrahepatic biliary tract carcinoma
4960032|NCT04238637|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
4960033|NCT04238637|BTC|btc
4960034|NCT04238637|iBTC|ibtc
4960035|NCT04238637|iCCA|icca
4960036|NCT04238624|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
4960037|NCT04238624|Thyroid Cancer|thyroid cancer
4960038|NCT04238624|Cemiplimab|cemiplimab
4960039|NCT04238624|BRAF-Mutant Anaplastic Thyroid Cancer|braf-mutant anaplastic thyroid cancer
4960041|NCT04238624|BRAF Gene Mutation|braf gene mutation
4960150|NCT04238000|step variability|step variability
4960151|NCT04238000|gait variability|gait variability
4960152|NCT04238000|gait speed|gait speed
4960163|NCT04237948|physical therapy|physical therapy
4960164|NCT04237896|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4960165|NCT04237896|Acute exacerbation|acute exacerbation
4958583|NCT04247477|EIT|eit
4960166|NCT04237896|Inpatients|inpatients
4960267|NCT04237311|Nutrition|nutrition
4960268|NCT04237298|Space Maintenance|space maintenance
4960269|NCT04237298|Palatal Expansion Technique|palatal expansion technique
4960270|NCT04237298|Recurrence|recurrence
4960271|NCT04237285|pediatric|pediatric
4960371|NCT04236674|Distraction|distraction
4960372|NCT04236674|Thermomechanical analgesia|thermomechanical analgesia
4960373|NCT04236674|Music|music
4960374|NCT04236674|Anxiety|anxiety
4960375|NCT04236674|Pain|pain
4960376|NCT04236674|Analgesia|analgesia
4960377|NCT04236674|Buzzy|buzzy
4960378|NCT04236674|Interventional radiology|interventional radiology
4960379|NCT04236674|IR|ir
4960380|NCT04236674|Picc|picc
4960482|NCT04236011|Multiple Myeloma|multiple myeloma
4960483|NCT04235972|orthopaedic surgery|orthopaedic surgery
4960484|NCT04235972|Staples|staples
4960591|NCT04235413|nutrition|nutrition
4960592|NCT04235413|health disparities|health disparities
4960593|NCT04235413|food purchases|food purchases
4960594|NCT04235400|dry eye|dry eye
4960595|NCT04235400|TBUT|tbut
4960596|NCT04235400|NIBUT|nibut
4960597|NCT04235387|robotic surgical procedures|robotic surgical procedures
4960598|NCT04235387|laparoscopic surgical procedures|laparoscopic surgical procedures
4960599|NCT04235387|prostatectomy|prostatectomy
4960600|NCT04235387|haemodynamic changes|haemodynamic changes
4960601|NCT04235387|ventilatory changes|ventilatory changes
4960602|NCT04235348|Colonic mucus|colonic mucus
4960697|NCT04234906|Magnesium Sulfate|magnesium sulfate
4960698|NCT04234906|Dexedetomidine|dexedetomidine
4960699|NCT04234906|anti-arrhythmic medications|anti-arrhythmic medications
4960700|NCT04234893|Coronary Stenosis|coronary stenosis
4960701|NCT04234893|Percutaneous Coronary Intervention|percutaneous coronary intervention
4960702|NCT04234893|Drug-coated Balloon|drug-coated balloon
4960703|NCT04234893|Drug eluting Balloon|drug eluting balloon
4960704|NCT04234893|Paclitaxel|paclitaxel
4960812|NCT04234308|absorbable sutures|absorbable sutures
4960813|NCT04234308|non-absorbable sutures|non-absorbable sutures
4960814|NCT04234308|histological properties|histological properties
4960815|NCT04234256|Y Balance Test|y balance test
4960816|NCT04234256|Stretching|stretching
4960817|NCT04234256|Dynamic balance|dynamic balance
4960818|NCT04234243|HIPEC|hipec
4960819|NCT04234230|Ventricular Assist Device|ventricular assist device
4960820|NCT04234230|Self-management|self-management
4960821|NCT04234230|Psychosocial Factors|psychosocial factors
4960822|NCT04234217|Sleep|sleep
4960827|NCT04234191|Buprenorphine/naloxone|buprenorphine/naloxone
4960828|NCT04234191|Suboxone|suboxone
4960829|NCT04234191|Opioid agonist treatment|opioid agonist treatment
4960830|NCT04234191|Micro-induction|micro-induction
4960831|NCT04234191|Microdosing|microdosing
4960898|NCT04233970|Multiple Sclerosis|multiple sclerosis
4960899|NCT04233970|Relapsing Remitting|relapsing remitting
4960900|NCT04233970|Relapse Management|relapse management
4960901|NCT04233970|Steroids|steroids
4960902|NCT04233970|Autonomy|autonomy
4960903|NCT04233957|endothelium|endothelium
4960904|NCT04233957|oxidative stress|oxidative stress
4960905|NCT04233957|physical activity|physical activity
4960906|NCT04233957|ventricular-vascular coupling|ventricular-vascular coupling
4960907|NCT04233957|pulsatile load|pulsatile load
4960908|NCT04233944|Birth Outcomes|birth outcomes
4960909|NCT04233944|Pregnancy|pregnancy
4960910|NCT04233944|Aflatoxin|aflatoxin
4960911|NCT04233944|Environmental Enteric Dysfunction (EED)|environmental enteric dysfunction (eed)
4960913|NCT04233944|Stunting|stunting
4961020|NCT04233177|Blood flow|blood flow
4961026|NCT04233125|Femoral Head|femoral head
4961028|NCT04233125|Core Decompression|core decompression
4961029|NCT04233125|Polymethlymethacrylate|polymethlymethacrylate
4961030|NCT04233125|Cement|cement
4961031|NCT04233125|Progression|progression
4961032|NCT04233125|Survival|survival
4961033|NCT04233099|Raman Spectroscopy|raman spectroscopy
4961035|NCT04233099|Biomarker|biomarker
4961125|NCT04232670|ductal stone|ductal stone
4961126|NCT04232670|duct stricture|duct stricture
4961127|NCT04232670|ERCP|ercp
4961128|NCT04232670|pancreatic duct obstruction|pancreatic duct obstruction
4961129|NCT04232670|duct calcification|duct calcification
4961130|NCT04232657|Spinal Cord Injury|spinal cord injury
4961131|NCT04232657|Veterans Affairs RR&D|veterans affairs rr&d
4961132|NCT04232657|Sublesional Bone Loss|sublesional bone loss
4961249|NCT04231929|HCC|hcc
4961471|NCT04230577|mild-moderate traumatic brain injury|mild-moderate traumatic brain injury
4961472|NCT04230577|TBI|tbi
4961473|NCT04230577|Cognition|cognition
4961474|NCT04230577|Executive Function|executive function
4961581|NCT04229836|Tildrakizumab|tildrakizumab
4961582|NCT04229836|Moderate-to-Severe Chronic Plaque Psoriasis|moderate-to-severe chronic plaque psoriasis
4961583|NCT04229836|Quality of Life (QoL)|quality of life (qol)
4961584|NCT04229823|Machado-Joseph Disease|machado-joseph disease
4961585|NCT04229823|Spinocerebellar Ataxia Type 3|spinocerebellar ataxia type 3
4961777|NCT04228653|Basal Ganglia Diseases|basal ganglia diseases
4961778|NCT04228653|Central Nervous System Diseases|central nervous system diseases
4961779|NCT04228653|Dopamine|dopamine
4961780|NCT04228653|Cardiotonic Agents|cardiotonic agents
4961869|NCT04228133|PTSD|ptsd
4961870|NCT04228133|attention training|attention training
4961871|NCT04228133|cognitive bias modification|cognitive bias modification
4961872|NCT04228133|home-delivered intervention|home-delivered intervention
4961873|NCT04228120|Self-care behaviour|self-care behaviour
4961874|NCT04228120|Self-regulation|self-regulation
4961875|NCT04228120|Heart Failure|heart failure
4961879|NCT04228055|Low Carbohydrate, Keto, Androgen Deprivation Therapy|low carbohydrate, keto, androgen deprivation therapy
4961880|NCT04227964|periodontitis|periodontitis
4961881|NCT04227964|periodontal regeneration|periodontal regeneration
4961882|NCT04227964|tooth extraction|tooth extraction
4961883|NCT04227964|dental implant|dental implant
4961884|NCT04227964|fixed partial denture|fixed partial denture
4962112|NCT04226638|dynamic ultrasound|dynamic ultrasound
4962113|NCT04226625|Anesthesia|anesthesia
4962114|NCT04226612|Blood Pressure|blood pressure
4962115|NCT04226612|Inpatient|inpatient
4962116|NCT04226612|Adverse Events|adverse events
4962117|NCT04226612|All-cause mortality|all-cause mortality
4962120|NCT04226586|short stature|short stature
4962236|NCT04225962|Mucociscidosis|mucociscidosis
4962374|NCT04225247|Gingival Recession|gingival recession
4962375|NCT04225247|Bonding Agents|bonding agents
4962376|NCT04225234|Financial incentive|financial incentive
4962377|NCT04225234|Behavioral economics|behavioral economics
4962378|NCT04225234|Attrition|attrition
4962379|NCT04225234|Reach|reach
4962380|NCT04225234|Participation|participation
4962381|NCT04225234|Retention|retention
4962382|NCT04225234|Weight loss|weight loss
4962387|NCT04225169|Pain|pain
4962388|NCT04225169|Anxiety|anxiety
4962389|NCT04225169|Depression|depression
4962390|NCT04225117|Squamous NSCLC|squamous nsclc
4962392|NCT04225117|ASG-22CE|asg-22ce
4962469|NCT04224363|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4962470|NCT04224363|Effectiveness|effectiveness
4962471|NCT04224363|Safety|safety
5342900|NCT01981577|Functional connectivity|functional connectivity
4962473|NCT04224285|sleep|sleep
4962478|NCT04224285|mobile health|mobile health
4962591|NCT04223713|Biological aortic valve prosthesis|biological aortic valve prosthesis
4962592|NCT04223713|aortic flow patterns|aortic flow patterns
4962593|NCT04223713|MRI|mri
4962594|NCT04223700|Ultrasound guided intervention|ultrasound guided intervention
4962595|NCT04223700|Rhomboid muscle|rhomboid muscle
4962596|NCT04223700|Thoracic spine|thoracic spine
4962597|NCT04223687|Food and beverage purchases|food and beverage purchases
4962598|NCT04223687|Sugar-sweetened beverages|sugar-sweetened beverages
4962599|NCT04223687|Beverages|beverages
4960952|NCT04233671|stress|stress
4962600|NCT04223674|serology|serology
4962689|NCT04223245|automaticity|automaticity
4962690|NCT04223245|gait|gait
4962691|NCT04223245|balance|balance
4962692|NCT04223206|uremic toxins|uremic toxins
4962897|NCT04222231|Blood flow restriction training|blood flow restriction training
4962898|NCT04222231|Muscle hypertrophy|muscle hypertrophy
4962899|NCT04222231|Muscle Strength|muscle strength
4963022|NCT04221542|Immunotherapy|immunotherapy
4963023|NCT04221542|Immuno-oncology|immuno-oncology
4963024|NCT04221542|Immunooncology|immunooncology
4963025|NCT04221542|Bispecific T-Cell engager®|bispecific t-cell engager®
4963130|NCT04220788|pharmacist service|pharmacist service
4963131|NCT04220749|Radiotherapy|radiotherapy
4963132|NCT04220749|Trans-Oral Surgery|trans-oral surgery
4963133|NCT04220749|HPV-Negative|hpv-negative
4963135|NCT04220736|STEMI|stemi
4963136|NCT04220736|Cardiac magnetic resonance|cardiac magnetic resonance
4963139|NCT04220723|frailty|frailty
4963237|NCT04219813|Non-celiac Gluten/Wheat Sensitivity|non-celiac gluten/wheat sensitivity
4963238|NCT04219813|Gluten Immunogenic Peptides|gluten immunogenic peptides
4963239|NCT04219813|Celiac Disease|celiac disease
4963240|NCT04219787|Roux-en-Y Gastric Bypass|roux-en-y gastric bypass
4963241|NCT04219787|Biliopancreatic Limb Length|biliopancreatic limb length
4963244|NCT04219761|MI|mi
4963245|NCT04219748|alcohol-related disorders|alcohol-related disorders
4963246|NCT04219748|emergency department|emergency department
4963247|NCT04219748|frequent users|frequent users
4963248|NCT04219748|case management|case management
4963339|NCT04219059|cancer|cancer
4963340|NCT04219059|prostate|prostate
4963341|NCT04219059|radiomics|radiomics
4963343|NCT04219059|prognostic factors|prognostic factors
4963450|NCT04218396|Acute Pain|acute pain
4963571|NCT04217616|Total Tenderness Score|total tenderness score
4963572|NCT04217616|Cold Pressor Test|cold pressor test
4963573|NCT04217616|Headache Resistant|headache resistant
4963574|NCT04217603|Continuous Positive Airway Pressure|continuous positive airway pressure
4963575|NCT04217603|Tracheobronchomalacia|tracheobronchomalacia
4963576|NCT04217603|Excessive Dynamic Airway Collapse|excessive dynamic airway collapse
4963577|NCT04217603|Excessive Central Airway Collapse|excessive central airway collapse
4963578|NCT04217551|Bayesian Adaptive Clinical Trial|bayesian adaptive clinical trial
4963579|NCT04217551|Hypothermia, therapeutic|hypothermia, therapeutic
4963580|NCT04217551|Coma|coma
4963584|NCT04217447|atrial fibrillation|atrial fibrillation
4963585|NCT04217447|oral anticoagulation|oral anticoagulation
4963586|NCT04217447|antithrombotic therapy|antithrombotic therapy
4963587|NCT04217421|Congenital Heart Disease|congenital heart disease
4963588|NCT04217421|Neuroprotection|neuroprotection
4963589|NCT04217421|Allopurinol|allopurinol
4963590|NCT04217421|Brain injury|brain injury
4963591|NCT04217421|Cardiopulmonary bypass|cardiopulmonary bypass
4963592|NCT04217421|Brain function|brain function
4963593|NCT04217421|Brain oxygenation|brain oxygenation
4963594|NCT04217421|Cardiac function|cardiac function
4963659|NCT04216849|human umbilical cord mesenchymal stem cells|human umbilical cord mesenchymal stem cells
4963660|NCT04216849|type 2 diabetic nephropathy|type 2 diabetic nephropathy
4963661|NCT04216836|Magnesium|magnesium
4963662|NCT04216836|Supplementation|supplementation
4963663|NCT04216836|Interleukin-6|interleukin-6
4963664|NCT04216836|Soluble interleukin-6 receptor|soluble interleukin-6 receptor
4963666|NCT04216836|Pain|pain
4963667|NCT04216836|Exercise performance|exercise performance
4963668|NCT04216836|Exercise recovery|exercise recovery
4963669|NCT04216836|Downhill running|downhill running
4963670|NCT04216823|perfusion index|perfusion index
4963671|NCT04216823|supraclavicular brachial plexus block|supraclavicular brachial plexus block
4963672|NCT04216823|children|children
4963673|NCT04216706|cardiac output|cardiac output
4963674|NCT04216706|total peripheral vascular resistance|total peripheral vascular resistance
4963675|NCT04216706|hemodynamic parameters|hemodynamic parameters
4963676|NCT04216706|adaptation to pregnancy|adaptation to pregnancy
4963677|NCT04216706|tailored treatment|tailored treatment
4963763|NCT04216095|Magnetic seizure therapy|magnetic seizure therapy
4963764|NCT04216095|Electroconvulsive Therapy|electroconvulsive therapy
4963765|NCT04216095|Treatment Resistant Depression (TRD)|treatment resistant depression (trd)
4963770|NCT04215978|PD-1|pd-1
4963888|NCT04215159|Trastuzumab biosimilar|trastuzumab biosimilar
4963889|NCT04215159|samfenet|samfenet
4963890|NCT04215146|Breast|breast
4963891|NCT04215146|Breast Cancer|breast cancer
4982611|NCT04100889|Microbiome|microbiome
4963900|NCT04215146|HER2- breast cancer|her2- breast cancer
4963901|NCT04215146|Breast malignancy|breast malignancy
4963902|NCT04215133|venous insufficiency|venous insufficiency
4963903|NCT04215133|exercise therapy|exercise therapy
4963904|NCT04215133|inspiratory muscle|inspiratory muscle
4963905|NCT04215133|kalf muscle|kalf muscle
4963906|NCT04215133|venous return|venous return
4963907|NCT04215042|Contrast-Induced Acute Kidney Injury|contrast-induced acute kidney injury
4963911|NCT04215042|Angiography|angiography
4963912|NCT04215042|Coronary percutaneous intervention|coronary percutaneous intervention
4963913|NCT04215003|breast cancer|breast cancer
4963921|NCT04214977|prone|prone
4963988|NCT04214457|Leiomyoma (LM)|leiomyoma (lm)
4963989|NCT04214457|Leiomyosarcoma (LMS)|leiomyosarcoma (lms)
4963990|NCT04214457|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
4963991|NCT04214457|Circulating tumor DNA (ctDNA)|circulating tumor dna (ctdna)
4963996|NCT04214431|fear of childbirth, pregnancy, childbirth education,|fear of childbirth, pregnancy, childbirth education,
4963998|NCT04214366|heavy ion|heavy ion
4963999|NCT04214366|salivary gland tumor|salivary gland tumor
4964001|NCT04214366|Radiation therapy|radiation therapy
4964003|NCT04214353|68Ga-PSMA-PET/CT|68ga-psma-pet/ct
4964083|NCT04213950|rabies vaccine|rabies vaccine
4964210|NCT04213066|Contrast sensitivity|contrast sensitivity
4964212|NCT04213066|Stochastic resonance|stochastic resonance
4964213|NCT04213066|Visual acuity|visual acuity
4964214|NCT04213066|Visual evoked potential|visual evoked potential
4964215|NCT04213040|Open heart surgery|open heart surgery
4964220|NCT04213040|Outcome|outcome
4964320|NCT04212442|dementia|dementia
4964321|NCT04212442|affordable housing|affordable housing
4964322|NCT04212442|subsidized housing|subsidized housing
4964323|NCT04212442|functional impairment|functional impairment
4964324|NCT04212429|Clinical Safety|clinical safety
4964325|NCT04212429|Levofloxacin 1.5%|levofloxacin 1.5%
4964329|NCT04212390|Personalized medicine|personalized medicine
4964330|NCT04212390|Gene mutations|gene mutations
4964331|NCT04212390|Real-world evidence (RWE)|real-world evidence (rwe)
4964332|NCT04212390|Real world data (RWD)|real world data (rwd)
4964333|NCT04212377|Endometrial Cancer|endometrial cancer
4964334|NCT04212364|peer education|peer education
4964345|NCT04212286|EOB-MRI|eob-mri
4964421|NCT04211753|Mobile app|mobile app
4964422|NCT04211753|Crisis intervention|crisis intervention
4964423|NCT04211753|Effectiveness|effectiveness
4964424|NCT04211727|Oncology|oncology
4964536|NCT04210947|muscle biomechanical properties|muscle biomechanical properties
4964537|NCT04210934|Microbiota|microbiota
4964660|NCT04210128|19-315|19-315
4964804|NCT04209374|hemispherical dual-mobility acetabular cup|hemispherical dual-mobility acetabular cup
4964945|NCT04208659|auricular acupuncture|auricular acupuncture
4964946|NCT04208659|chronic pain|chronic pain
4965043|NCT04208165|PVB|pvb
4965080|NCT04207905|Work Requirement|work requirement
4965081|NCT04207905|Community Engagement Requirement|community engagement requirement
4965082|NCT04207879|modified Atkins Diet|modified atkins diet
4965083|NCT04207879|Overweight|overweight
4965084|NCT04207879|Obesity|obesity
4965085|NCT04207879|Gut Microbiome|gut microbiome
4965086|NCT04207879|Body composition|body composition
4965087|NCT04207866|Auditory Training|auditory training
4965088|NCT04207866|Teleconferencing|teleconferencing
4965089|NCT04207853|Diabetes Mellitus|diabetes mellitus
4965090|NCT04207853|Skin Temperature|skin temperature
4965091|NCT04207853|Circulation|circulation
4965092|NCT04207853|Peripheral Sensitivity|peripheral sensitivity
4965093|NCT04207853|Plantar Pressure|plantar pressure
4965094|NCT04207853|Vibration|vibration
4965189|NCT04207294|Vitamin D|vitamin d
4965190|NCT04207294|Pork|pork
4965348|NCT04206280|return of bowel function|return of bowel function
4965349|NCT04206280|post-operative narcotic use|post-operative narcotic use
4965350|NCT04206267|Tooth movement|tooth movement
4965351|NCT04206267|AcceleDent|acceledent
4965352|NCT04206267|distalizing|distalizing
4965353|NCT04206241|HIV|hiv
4965354|NCT04206241|POC|poc
4965355|NCT04206241|EID|eid
4965356|NCT04206228|Severe Aortic Stenosis|severe aortic stenosis
4965357|NCT04206228|Iron-deficiency|iron-deficiency
4965358|NCT04206228|Iron Isomaltoside|iron isomaltoside
4965359|NCT04206228|Exercise Capacity|exercise capacity
4965360|NCT04206215|transcranial Direct Current Stimulation|transcranial direct current stimulation
4965447|NCT04205695|continuous nerve block|continuous nerve block
4965448|NCT04205695|Catheter tips configurations|catheter tips configurations
4965449|NCT04205656|bone marrow concentrate (BMC)|bone marrow concentrate (bmc)
4965450|NCT04205656|stem cell|stem cell
4965454|NCT04205617|Food insecurity|food insecurity
4965551|NCT04204915|Hospitalisation for heart failure|hospitalisation for heart failure
4965552|NCT04204915|Cardiovascular death|cardiovascular death
4965553|NCT04204902|Tepotinib|tepotinib
4965554|NCT04204902|Bioequivalence|bioequivalence
4965555|NCT04204902|Pharmacokinetics|pharmacokinetics
4965556|NCT04204876|magnet resonance imaging (MRI)|magnet resonance imaging (mri)
4965557|NCT04204876|Positron emission tomography/computer tomography (PET/CT)|positron emission tomography/computer tomography (pet/ct)
4965558|NCT04204876|GCA relapse|gca relapse
4965559|NCT04204863|Status epilepticus|status epilepticus
4965560|NCT04204863|Electroencephalogram|electroencephalogram
4965778|NCT04203290|General anesthesia combined with TEA|general anesthesia combined with tea
4965779|NCT04203277|vaccine uptake, timely vaccination|vaccine uptake, timely vaccination
4965780|NCT04203264|artificial intelligence|artificial intelligence
4965781|NCT04203264|magnetically controlled capsule endoscopy|magnetically controlled capsule endoscopy
4965895|NCT04202367|Concentration|concentration
4965903|NCT04202341|Generalized Myasthenia Gravis|generalized myasthenia gravis
4965905|NCT04202289|Burns|burns
4965906|NCT04202289|Nile tilapia|nile tilapia
4965907|NCT04202289|Xenograft|xenograft
4965908|NCT04202289|Oreochromis niloticus|oreochromis niloticus
4965909|NCT04202289|Biocompatible materials|biocompatible materials
4965910|NCT04202289|Wound healing|wound healing
4974458|NCT04151979|MRI|mri
4965911|NCT04202276|gastroesophageal reflux|gastroesophageal reflux
4965912|NCT04202276|weight|weight
4965916|NCT04202276|esophageal pH-impedance|esophageal ph-impedance
4965917|NCT04202276|food frequency questionnair|food frequency questionnair
4965918|NCT04202250|femoral nerve catheter|femoral nerve catheter
4965919|NCT04202250|Total Knee Arthroplasty|total knee arthroplasty
4965920|NCT04202250|Catheter tips configurations|catheter tips configurations
4965926|NCT04202211|IBD|ibd
4965987|NCT04202016|Piezocision|piezocision
4965989|NCT04201990|Camrelizumab|camrelizumab
4984607|NCT04088357|Skin|skin
4966119|NCT04201418|Neurodegenerative diseases|neurodegenerative diseases
4966120|NCT04201418|Genetic diseases, inborn|genetic diseases, inborn
4966121|NCT04201418|Metabolism, inborn errors|metabolism, inborn errors
4966122|NCT04201418|hATTR|hattr
4966123|NCT04201392|Psychiatric inpatient care|psychiatric inpatient care
4966124|NCT04201379|chronic|chronic
4966125|NCT04201379|neckpain|neckpain
4966232|NCT04200768|Tumour Microenvironment|tumour microenvironment
4966233|NCT04200755|Morphea|morphea
4966234|NCT04200716|Arterial function|arterial function
4966235|NCT04200716|Physical exercise|physical exercise
4966236|NCT04200716|Arterial stiffness|arterial stiffness
4966237|NCT04200716|Ambulatory Measurement of Blood Pressure|ambulatory measurement of blood pressure
4966248|NCT04200651|MIGS, Minimally invasive glaucoma surgery|migs, minimally invasive glaucoma surgery
4966254|NCT04200599|primigravida|primigravida
4966255|NCT04200599|amniotomy,|amniotomy,
4966256|NCT04200599|immediate oxytocin|immediate oxytocin
4966358|NCT04199897|Salivary microbiota|salivary microbiota
4964326|NCT04212429|Moxifloxacin 0.5%|moxifloxacin 0.5%
4966359|NCT04199897|Probiotics|probiotics
4966360|NCT04199884|Intolerance of Uncertainty|intolerance of uncertainty
4966362|NCT04199858|Pain|pain
4966363|NCT04199858|Nocebo|nocebo
4966364|NCT04199858|Hyperalgesia|hyperalgesia
4966365|NCT04199858|Electroencephalography|electroencephalography
4966366|NCT04199858|EEG|eeg
4966367|NCT04199858|Conditioning|conditioning
4971835|NCT04166864|Depression|depression
4971836|NCT04166864|TMS|tms
4966503|NCT04198974|Personality-targeted Interventions|personality-targeted interventions
4966504|NCT04198974|Adolescence|adolescence
4966505|NCT04198909|hidden hearing loss|hidden hearing loss
4966506|NCT04198909|questionnaire|questionnaire
4966507|NCT04198909|hearing screening|hearing screening
4966625|NCT04198220|Cryptogenic stroke|cryptogenic stroke
4966626|NCT04198220|Atrial Fibrillation|atrial fibrillation
4966627|NCT04198207|tuberous sclerosis complex|tuberous sclerosis complex
4966628|NCT04198207|epilepsy|epilepsy
4966629|NCT04198207|vagus nerve stimulation|vagus nerve stimulation
4966630|NCT04198181|tuberous sclerosis complex|tuberous sclerosis complex
4966631|NCT04198181|epilepsy|epilepsy
4966632|NCT04198181|resective epilepsy surgery|resective epilepsy surgery
4966633|NCT04198168|Ultrasound|ultrasound
4966634|NCT04198168|Renal perfusion|renal perfusion
4966635|NCT04198168|Fluid treatment|fluid treatment
4966636|NCT04198168|Venous congestion|venous congestion
4966637|NCT04198168|Renal function|renal function
4966638|NCT04198142|Psychiatric inpatient care|psychiatric inpatient care
4966639|NCT04198129|Infection|infection
4966640|NCT04198129|Jaw fracture|jaw fracture
4966642|NCT04198103|LUTS|luts
4966643|NCT04198077|Mechanical Ventilation|mechanical ventilation
4966644|NCT04198077|Critically ill patient|critically ill patient
4966645|NCT04198077|Oxygenation|oxygenation
4966646|NCT04198077|ICU|icu
4966649|NCT04198038|pediatrics|pediatrics
4966881|NCT04196816|Stage IV|stage iv
4966882|NCT04196777|anti-bacterial|anti-bacterial
4966883|NCT04196751|clinical supervision, work related stress, sense of coherence, cultural sensitivity, mental health nursing|clinical supervision, work related stress, sense of coherence, cultural sensitivity, mental health nursing
4966884|NCT04196686|Virtual Reality|virtual reality
4966885|NCT04196686|Augmented Reality|augmented reality
4966886|NCT04196686|Ice Immersion|ice immersion
4966887|NCT04196647|Parkinson disease|parkinson disease
4966888|NCT04196647|duodopa|duodopa
4966889|NCT04196647|pump|pump
4967020|NCT04195698|Atopic Dermatitis|atopic dermatitis
4967021|NCT04195698|Upadacitinib|upadacitinib
4967022|NCT04195698|ABT-494|abt-494
4967125|NCT04195152|Body mass index|body mass index
4967126|NCT04195139|GBM|gbm
4967127|NCT04195139|Astrocytoma WHO grade IV|astrocytoma who grade iv
4967128|NCT04195139|Elderly|elderly
4967129|NCT04195139|Nivolumab|nivolumab
4967130|NCT04195139|Temozolomide|temozolomide
4967131|NCT04195113|anticoagulant|anticoagulant
4967132|NCT04195113|atrial fibrillation|atrial fibrillation
4967135|NCT04195113|surgery|surgery
4967223|NCT04194372|CardioVascular Disease|cardiovascular disease
4967224|NCT04194372|morbi-mortality|morbi-mortality
4967225|NCT04194372|Hospital Cohort|hospital cohort
4967319|NCT04193839|Bar code medication administration|bar code medication administration
4967320|NCT04193839|Neonates|neonates
4967321|NCT04193774|Ocular surface microbiome|ocular surface microbiome
4967322|NCT04193774|Anesthesia|anesthesia
4967323|NCT04193774|Extraction protocol|extraction protocol
4967324|NCT04193748|pomegranate, seeds, peel, topical, Oral lichen planus, pain, OHIP-14.|pomegranate, seeds, peel, topical, oral lichen planus, pain, ohip-14.
4967325|NCT04193722|Breast cancer|breast cancer
4967326|NCT04193722|Radiotherapy|radiotherapy
4967327|NCT04193722|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
4967328|NCT04193722|Late toxicity|late toxicity
4967329|NCT04193722|Trials within cohorts|trials within cohorts
4967330|NCT04193722|Patient reported outcomes|patient reported outcomes
4967338|NCT04193683|Respiratory Functions|respiratory functions
4967339|NCT04193683|Respiratory Muscle Strength|respiratory muscle strength
4967340|NCT04193683|Respiratory Muscle Endurance|respiratory muscle endurance
4967341|NCT04193670|nociceptors- immune response|nociceptors- immune response
4967342|NCT04193670|atopic prurigo|atopic prurigo
4967343|NCT04193657|Metastatic Prostate Cancer|metastatic prostate cancer
4967344|NCT04193657|Older men|older men
4967345|NCT04193657|Supportive care|supportive care
4967346|NCT04193657|Frailty|frailty
4967350|NCT04193631|CBD|cbd
4967387|NCT04193449|outcome|outcome
4967390|NCT04193423|neck pain|neck pain
4967541|NCT04192721|cognitive behavioral therapy|cognitive behavioral therapy
4967542|NCT04192721|group counseling|group counseling
4967543|NCT04192721|nursing students|nursing students
4967544|NCT04192708|intercostal nerve blocks|intercostal nerve blocks
4967545|NCT04192708|ultrasound guidance|ultrasound guidance
4967546|NCT04192708|thoracic paravertebral block|thoracic paravertebral block
4967549|NCT04192682|Anlotinib|anlotinib
4967648|NCT04192097|Family patient meeting|family patient meeting
4967649|NCT04192071|Nutrition|nutrition
4967650|NCT04192058|polymorphism Taq1A|polymorphism taq1a
4967651|NCT04192058|tDCS|tdcs
4967652|NCT04192058|dopamine|dopamine
4967653|NCT04192058|eating behavior|eating behavior
4967654|NCT04192019|type 1 diabetes|type 1 diabetes
4967655|NCT04192019|glucagon|glucagon
4967656|NCT04192019|hypoglycemia|hypoglycemia
4967657|NCT04192019|exercise|exercise
4967658|NCT04192019|glycogen|glycogen
4967659|NCT04192006|biomechanical|biomechanical
4967775|NCT04191200|Schizophrenic disorder|schizophrenic disorder
4967776|NCT04191200|Oral Health|oral health
4967783|NCT04191161|Modic type I|modic type i
4967784|NCT04191161|Chronic low back pain|chronic low back pain
4967785|NCT04191161|Rigid brace|rigid brace
4967787|NCT04191148|Bacteriophage|bacteriophage
4967788|NCT04191148|Phage|phage
4968378|NCT04187222|Mucositis|mucositis
4967808|NCT04191018|portal hypertension|portal hypertension
4967809|NCT04191018|cirrhosis|cirrhosis
4967811|NCT04190992|Decision aid|decision aid
4967899|NCT04190602|Mitral Valve Repair|mitral valve repair
4967915|NCT04190420|Hypertension|hypertension
4968013|NCT04189744|Pregnancy Malaria|pregnancy malaria
4968014|NCT04189744|Bacterial Vaginoses|bacterial vaginoses
4968133|NCT04189159|dysartria|dysartria
4968134|NCT04189159|motor speech treatment|motor speech treatment
4968135|NCT04189159|prompt|prompt
4968136|NCT04189133|luteinising hormone|luteinising hormone
4968137|NCT04189133|male infertility|male infertility
4968138|NCT04189133|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
4968139|NCT04189133|human menopausal gonadotropin|human menopausal gonadotropin
4968140|NCT04189120|post thoracotomy pain|post thoracotomy pain
4968141|NCT04189120|thoracic epidural|thoracic epidural
4968142|NCT04189120|serratus anterior plane block|serratus anterior plane block
4968143|NCT04189120|ultrasound|ultrasound
4968144|NCT04189094|radiotherapy|radiotherapy
4968145|NCT04189094|chemotherapy|chemotherapy
4966025|NCT04201704|Intensive Care Units, Pediatric|intensive care units, pediatric
4968217|NCT04188639|Emicizumab|emicizumab
4968218|NCT04188626|Automated driving|automated driving
4968219|NCT04188626|Conditional automation|conditional automation
4968220|NCT04188626|Driver distraction|driver distraction
4968221|NCT04188626|Driver take-over quality|driver take-over quality
4968222|NCT04188626|Biomarkers|biomarkers
4968223|NCT04188587|177Lu-PSMA-I&T|177lu-psma-i&t
4968224|NCT04188587|Prostate cancer|prostate cancer
4968225|NCT04188574|DSO|dso
4968226|NCT04188574|Fungual Infection|fungual infection
4968227|NCT04188574|Fungus, Nail|fungus, nail
4968228|NCT04188535|Glioblastoma|glioblastoma
4968229|NCT04188535|Esophageal Cancer|esophageal cancer
4968230|NCT04188535|Radiotherapy|radiotherapy
4968231|NCT04188535|Magnetic Resonance Imaging|magnetic resonance imaging
4968232|NCT04188535|MRI|mri
4968233|NCT04188496|Pulmonary Functions|pulmonary functions
4968234|NCT04188496|Stroke|stroke
4968235|NCT04188470|Polypharmacy|polypharmacy
4968254|NCT04188353|ICP|icp
4968305|NCT04187898|Early Stage Breast Cancer|early stage breast cancer
4968306|NCT04187898|Long-acting Myeloid Growth Factor|long-acting myeloid growth factor
4968307|NCT04187898|Docetaxel + Cyclophosphamide (TC) Chemotherapy|docetaxel + cyclophosphamide (tc) chemotherapy
4968308|NCT04187885|sleep|sleep
4968320|NCT04187820|Crohn's disease|crohn's disease
4968321|NCT04187768|Blood Donation|blood donation
4968323|NCT04187768|Non Small Cell Lung Cancer|non small cell lung cancer
4968324|NCT04187755|fever|fever
4968325|NCT04187755|neutropenia|neutropenia
4968326|NCT04187755|temperature|temperature
4968327|NCT04187755|absolute neutrophil count|absolute neutrophil count
4968328|NCT04187755|antibiotic|antibiotic
4968329|NCT04187690|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
4968330|NCT04187690|traditional Chinese medicine|traditional chinese medicine
4968331|NCT04187690|randomized controlled trial|randomized controlled trial
4968332|NCT04187677|sensory|sensory
4968333|NCT04187677|carpal tunnel syndrome|carpal tunnel syndrome
4968334|NCT04187664|failure to rescue|failure to rescue
4968335|NCT04187664|high-risk surgical patient|high-risk surgical patient
4968336|NCT04187612|pregnancy|pregnancy
4968337|NCT04187586|burns|burns
4968338|NCT04187586|rehabilitation|rehabilitation
4968339|NCT04187586|extracorporeal shock wave therapy|extracorporeal shock wave therapy
4973662|NCT04156269|CS1|cs1
4968406|NCT04187144|Urinary Tract Infection|urinary tract infection
4968407|NCT04187118|Lymphoma|lymphoma
4968408|NCT04187118|Quality Of Life|quality of life
4968409|NCT04187118|Cancer Care Pathway|cancer care pathway
4968410|NCT04187118|Post-Chemotherapy|post-chemotherapy
4968411|NCT04187092|knee osteoarthritis|knee osteoarthritis
4968412|NCT04187092|video-game based interventions|video-game based interventions
4968413|NCT04187092|strength|strength
4968414|NCT04187092|Balance|balance
4968415|NCT04187092|Precision|precision
4968416|NCT04187053|Dental implants|dental implants
4968508|NCT04186494|Continuous positive airway pressure|continuous positive airway pressure
4968509|NCT04186494|Insulin resistance|insulin resistance
4968510|NCT04186494|Vascular inflammation|vascular inflammation
4968511|NCT04186468|PICS|pics
4968513|NCT04186468|Intensive Care Unit|intensive care unit
4968610|NCT04185727|supervised exercise|supervised exercise
4968723|NCT04185012|Eosinophils|eosinophils
4968724|NCT04184986|Fabry Disease, gastrointestinal, GI symptoms, screening|fabry disease, gastrointestinal, gi symptoms, screening
4968725|NCT04184960|Gastric cancer|gastric cancer
4968726|NCT04184960|Gastroscopy|gastroscopy
4968727|NCT04184960|Atrophic gastritis|atrophic gastritis
4968728|NCT04184960|Intestinal metaplasia|intestinal metaplasia
4968729|NCT04184934|Liver cirrhosis|liver cirrhosis
4968730|NCT04184934|Gastrointestinal hemorrhage|gastrointestinal hemorrhage
4968731|NCT04184934|Acute Kidney injury|acute kidney injury
4968850|NCT04184245|non-invasive cardiac output monitoring|non-invasive cardiac output monitoring
4968851|NCT04184245|near infrared spectroscopy|near infrared spectroscopy
5699532|NCT00502762|refractory|refractory
4968957|NCT04183595|Exposure to mercury|exposure to mercury
4969001|NCT04183374|DFI|dfi
4969059|NCT04183036|Choledocholithiasis|choledocholithiasis
4969060|NCT04183036|sphincterotomy;sphincter of Oddi|sphincterotomy;sphincter of oddi
4969061|NCT04183023|Whole Genome Sequencing (WGS)|whole genome sequencing (wgs)
4969062|NCT04183023|SNP-chip|snp-chip
4969063|NCT04183023|Genetic variants|genetic variants
4969064|NCT04183023|Salivary DNA|salivary dna
4969065|NCT04183023|General population|general population
4969066|NCT04182984|Ocular myasthenia gravis|ocular myasthenia gravis
4969067|NCT04182971|Juice|juice
4969068|NCT04182971|Fiber|fiber
4969069|NCT04182919|Zingiber cassumunar|zingiber cassumunar
4969190|NCT04182282|Person-Centered Care|person-centered care
4969192|NCT04182269|Multiple sclerosis|multiple sclerosis
4969193|NCT04182269|Glittre ADL test|glittre adl test
4969194|NCT04182269|Functional capacity assesment|functional capacity assesment
4969200|NCT04182230|Sexually transmitted infections|sexually transmitted infections
4969204|NCT04182152|Electromagnetic navigation bronchoscopy (ENB)|electromagnetic navigation bronchoscopy (enb)
4969205|NCT04182152|localization|localization
4969206|NCT04182152|Lung cancer|lung cancer
4969210|NCT04182139|Stiffness|stiffness
4969305|NCT04181385|olanzapine|olanzapine
4969306|NCT04181372|Stage III Non-small-cell Lung Cancer|stage iii non-small-cell lung cancer
4969307|NCT04181372|Anlotinib Hydrochloride|anlotinib hydrochloride
4969308|NCT04181372|Neoadjuvant|neoadjuvant
4969416|NCT04180605|Stroke prevention|stroke prevention
4969417|NCT04180605|Computed tomography|computed tomography
4969418|NCT04180605|Computational simulation|computational simulation
4969419|NCT04180605|Preoperative planning|preoperative planning
4969421|NCT04180592|Prostate Biopsy|prostate biopsy
4969422|NCT04180579|alopecia|alopecia
4969423|NCT04180579|breast cancer|breast cancer
4969447|NCT04180514|Constitution in Chinese Medicine Questionnaire|constitution in chinese medicine questionnaire
4969448|NCT04180475|Remote monitoring|remote monitoring
4969449|NCT04180462|Implementation Strategy|implementation strategy
4969450|NCT04180462|Quality Improvement|quality improvement
4969451|NCT04180436|sleeve gastrectomy|sleeve gastrectomy
4969452|NCT04180436|gastric bypass|gastric bypass
4969453|NCT04180436|morbid obesity|morbid obesity
4969454|NCT04180397|Fluid overload|fluid overload
4969455|NCT04180397|Fluid removal|fluid removal
4969456|NCT04180397|Oedema|oedema
4969458|NCT04180371|EphA2|epha2
4969548|NCT04179929|Ph-negative|ph-negative
4969549|NCT04179929|minimal residual disease|minimal residual disease
4969550|NCT04179929|transplantation|transplantation
4969551|NCT04179916|virtual reality|virtual reality
4969552|NCT04179916|VR|vr
4969553|NCT04179916|COPD|copd
4969554|NCT04179916|coronary heart disease|coronary heart disease
4969651|NCT04179487|negative predictive value|negative predictive value
4969775|NCT04178876|endometrioma|endometrioma
4969776|NCT04178876|ethanol|ethanol
4969777|NCT04178876|sclerotherapy|sclerotherapy
4969778|NCT04178876|aspiration|aspiration
4969779|NCT04178876|ovarian reserve|ovarian reserve
4969780|NCT04178876|endometriosis|endometriosis
4969781|NCT04178876|AMH|amh
4969882|NCT04178291|debridement|debridement
4969883|NCT04178265|electroacupuncture|electroacupuncture
4969884|NCT04178265|triangular fibrocartilage complex tears|triangular fibrocartilage complex tears
4969885|NCT04178265|TFCC tears|tfcc tears
4969886|NCT04178265|pain|pain
4969887|NCT04178265|wrist functionality|wrist functionality
4969888|NCT04178239|Fatigue|fatigue
4969974|NCT04177810|PD-L1 (receptor blocking antibody)|pd-l1 (receptor blocking antibody)
4969976|NCT04177810|CXCR4 (chemokine receptor)|cxcr4 (chemokine receptor)
4969977|NCT04177810|Antibodies|antibodies
4969980|NCT04177797|Toripalimab|toripalimab
4970081|NCT04177342|post-operative pain|post-operative pain
4970082|NCT04177316|VTRNA2-1 promoter|vtrna2-1 promoter
4970213|NCT04176445|Critical Care|critical care
4970345|NCT04175756|colorectal cancer|colorectal cancer
4970346|NCT04175756|laparoscopic surgery|laparoscopic surgery
4970347|NCT04175756|Seal & Cut|seal & cut
4970348|NCT04175756|Total Mesorectal Excision (TME)|total mesorectal excision (tme)
4970349|NCT04175756|Partial Mesorectal Excision (PME)|partial mesorectal excision (pme)
4970350|NCT04175756|Complete Mesocolic Excision (CME)|complete mesocolic excision (cme)
4970351|NCT04175743|Safety|safety
4970472|NCT04175041|Transcranial Direct Current Stimulation|transcranial direct current stimulation
4970473|NCT04175028|Executive Function|executive function
4970474|NCT04175015|Education|education
4970475|NCT04175015|Randomised trial|randomised trial
4970476|NCT04175015|Children|children
4970478|NCT04175002|heparin-binding epidermal growth factor|heparin-binding epidermal growth factor
4970479|NCT04175002|polycystic ovarian syndrome|polycystic ovarian syndrome
4970480|NCT04175002|implantation window|implantation window
4970481|NCT04175002|obese|obese
4970482|NCT04174989|Acute Upper Gastrointestinal Hemorrhage|acute upper gastrointestinal hemorrhage
4970483|NCT04174989|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
4970484|NCT04174989|Gastrointestinal Bleeding|gastrointestinal bleeding
4970485|NCT04174989|Acute Upper Gastrointestinal Bleeding|acute upper gastrointestinal bleeding
4970490|NCT04174950|hope level|hope level
4970571|NCT04174417|hypotensive anesthesia|hypotensive anesthesia
4970573|NCT04174417|Brain Hypoxia|brain hypoxia
4970574|NCT04174417|tissue hypoxia|tissue hypoxia
4970575|NCT04174404|Pediatric Surgery Care|pediatric surgery care
4970576|NCT04174404|Circumcision|circumcision
4970577|NCT04174404|Children|children
4970578|NCT04174404|Parent|parent
4970579|NCT04174404|perioperative care|perioperative care
4970580|NCT04174404|randomised controlled trial|randomised controlled trial
4970673|NCT04173741|Internal Jugular Vein|internal jugular vein
4970674|NCT04173741|Interobserver Variability|interobserver variability
4970675|NCT04173741|Ultrasound|ultrasound
4970676|NCT04173728|Healthy|healthy
4970677|NCT04173728|Mets|mets
4970678|NCT04173728|Homeostasis|homeostasis
4970679|NCT04173715|Cut-Points|cut-points
4970680|NCT04173715|Accelerometry|accelerometry
4970681|NCT04173715|Physical Activity Quantification|physical activity quantification
4970927|NCT04172129|MBRSA|mbrsa
4970928|NCT04172116|metabolic surgery|metabolic surgery
4970929|NCT04172103|acute kidney injury|acute kidney injury
4970930|NCT04172103|chronic kidney disease|chronic kidney disease
4970931|NCT04172103|cardiac surgery|cardiac surgery
4970932|NCT04172103|thoracic aortic surgery|thoracic aortic surgery
4971041|NCT04171700|somatic|somatic
4971180|NCT04170907|pharmacokinetics|pharmacokinetics
4971181|NCT04170907|pharmacodynamics|pharmacodynamics
4971186|NCT04170881|cleaning products|cleaning products
4971192|NCT04170855|Sodium MRI|sodium mri
4971193|NCT04170842|Wound dressing|wound dressing
4971196|NCT04170816|Dry needling|dry needling
4971197|NCT04170816|Kinesiotape|kinesiotape
4971198|NCT04170816|Low-back pain|low-back pain
4971199|NCT04170803|Chronic Pain|chronic pain
4971200|NCT04170803|Musculoskeletal Injury|musculoskeletal injury
4971201|NCT04170803|Functional near-infrared spectroscopy|functional near-infrared spectroscopy
4971202|NCT04170803|Structural health monitoring|structural health monitoring
4971203|NCT04170803|Dry needling|dry needling
4971204|NCT04170777|Advanced cancer|advanced cancer
4971205|NCT04170777|Imaging study|imaging study
4971280|NCT04170283|Bruton's tyrosine kinase (BTK) inhibitor|bruton's tyrosine kinase (btk) inhibitor
4971281|NCT04170283|long-term extension|long-term extension
4971282|NCT04170257|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
4971283|NCT04170257|Population-level screening|population-level screening
4971284|NCT04170257|Narrow Band Imaging|narrow band imaging
4971285|NCT04170257|Iodine Staining|iodine staining
4971286|NCT04170257|Sensitivity and Specificity|sensitivity and specificity
4971404|NCT04169555|renal colic|renal colic
4971405|NCT04169555|emergency room|emergency room
4971406|NCT04169555|point of care|point of care
4971408|NCT04169516|microcirculation|microcirculation
4971413|NCT04169477|TENS|tens
4971415|NCT04169464|DAAs|daas
4971416|NCT04169464|Egyptian patients|egyptian patients
4971417|NCT04169464|creatinine|creatinine
4981151|NCT04110561|Walking|walking
4971507|NCT04168775|peak inspiratory flow rate|peak inspiratory flow rate
4971508|NCT04168762|Ultrasound|ultrasound
4971509|NCT04168762|Neuromodulation|neuromodulation
4971513|NCT04168736|cascade|cascade
4971627|NCT04168060|sleeve gastrectomy|sleeve gastrectomy
4971628|NCT04168060|crura dissection|crura dissection
4971629|NCT04168060|bariatric surgery|bariatric surgery
4971630|NCT04168047|visceral hypersensitivity|visceral hypersensitivity
4971631|NCT04168047|Insomnia|insomnia
4971632|NCT04167995|Hyperactivity|hyperactivity
4971633|NCT04167995|Inattention|inattention
4971634|NCT04167995|Probiotics|probiotics
4971636|NCT04167982|low-dose isotretinoin|low-dose isotretinoin
4971637|NCT04167982|Photodynamic Therapy|photodynamic therapy
4971638|NCT04167982|Painless|painless
4971639|NCT04167969|Molecular Phenotyping|molecular phenotyping
4971780|NCT04167293|Hepatocellular carcinoma|hepatocellular carcinoma
4971804|NCT04167085|HHT|hht
4971922|NCT04166305|Epilepsy, genetic and drug resistant|epilepsy, genetic and drug resistant
4971923|NCT04166292|augmentation|augmentation
4971924|NCT04166292|restoration|restoration
4971925|NCT04166292|dermal filler|dermal filler
4972076|NCT04165642|paroxysmal AF|paroxysmal af
4972077|NCT04165642|persistent AF|persistent af
4972078|NCT04165642|AF ablation|af ablation
4972079|NCT04165590|advanced malignant solid tumor|advanced malignant solid tumor
4972080|NCT04165590|Plasmodium immunotherapy|plasmodium immunotherapy
4972089|NCT04165538|Clopidogrel|clopidogrel
4972215|NCT04165057|Neuromuscular monitoring|neuromuscular monitoring
4972216|NCT04165057|Neuromuscular blockade|neuromuscular blockade
4972222|NCT04165005|elderly|elderly
4972335|NCT04164407|Corneal dystrophies|corneal dystrophies
4972337|NCT04164394|Probiotic|probiotic
4972447|NCT04163848|Environment|environment
4972448|NCT04163835|Wenxin Granules|wenxin granules
4972569|NCT04163146|Children|children
4972570|NCT04163146|Adolescents|adolescents
4972571|NCT04163133|delay of trigger, ovarian stimulation, antagonist protocol, in vitro fertilization|delay of trigger, ovarian stimulation, antagonist protocol, in vitro fertilization
4972572|NCT04163107|Drug Therapy|drug therapy
4972573|NCT04163107|Administration and Dosage|administration and dosage
4972574|NCT04163107|Hydroxychloroquine|hydroxychloroquine
4972575|NCT04163107|Carfilzomib|carfilzomib
4972576|NCT04163107|Dexamethasone|dexamethasone
4972577|NCT04163107|Drug Therapy, Combination|drug therapy, combination
4972578|NCT04163081|Nicotine Replacement Therapy|nicotine replacement therapy
4972684|NCT04162522|proteomics|proteomics
4972685|NCT04162522|metabolomics|metabolomics
4972686|NCT04162496|Hyaluronic Acid Filler|hyaluronic acid filler
4972687|NCT04162496|Neck Rhytides|neck rhytides
4972688|NCT04162496|Transverse Neck Lines|transverse neck lines
4972801|NCT04161898|Upadacitinib|upadacitinib
4972802|NCT04161898|Placebo|placebo
4972803|NCT04161898|Corticosteroid|corticosteroid
4972804|NCT04161898|Prednisolone|prednisolone
4972805|NCT04161885|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
4972806|NCT04161885|Venetoclax|venetoclax
4972807|NCT04161885|Azacitidine|azacitidine
4972808|NCT04161885|Stem Cell Transplantation (SCT)|stem cell transplantation (sct)
4972809|NCT04161885|Best Support Care (BSC)|best support care (bsc)
4972912|NCT04161365|Direct Visual Urethrotomy|direct visual urethrotomy
4972913|NCT04161313|respiratory functions|respiratory functions
4972914|NCT04161313|exercise capacity|exercise capacity
4972915|NCT04161313|muscle strength|muscle strength
4972916|NCT04161287|CyberKnife|cyberknife
4972917|NCT04161287|SBRT|sbrt
4972918|NCT04161287|TACE|tace
4972919|NCT04161287|prognosis|prognosis
4972920|NCT04161274|minor surgery procedures|minor surgery procedures
4972921|NCT04161274|wounds and injuries|wounds and injuries
4973027|NCT04160637|postoperative|postoperative
4973028|NCT04160637|predictive factor|predictive factor
4973030|NCT04160611|stress|stress
4973031|NCT04160611|midazolam|midazolam
4973032|NCT04160611|premedication|premedication
4973033|NCT04160598|Neuraxial opioids, post-operative itching, intrathecal Fentanyl pruritus, Spinal anesthesia|neuraxial opioids, post-operative itching, intrathecal fentanyl pruritus, spinal anesthesia
4973043|NCT04160520|pain relief|pain relief
4973045|NCT04160507|APOL 1 gene|apol 1 gene
4973046|NCT04160507|Kidney Disease|kidney disease
4973088|NCT04160208|DNA fragmentation Index|dna fragmentation index
4973095|NCT04160182|Breast cancer|breast cancer
4973096|NCT04160182|fatigue|fatigue
4973097|NCT04160182|Intervention|intervention
4973098|NCT04160169|Counseling|counseling
4973099|NCT04160169|Tanzania|tanzania
4973100|NCT04160156|Continuous glucose monitoring|continuous glucose monitoring
4973101|NCT04160156|sensor|sensor
4973102|NCT04160156|glycated hemoglobin|glycated hemoglobin
4973103|NCT04160156|Time in range|time in range
4973187|NCT04159441|Hepatotoxicity of Antituberculosis Therapy|hepatotoxicity of antituberculosis therapy
4973188|NCT04159441|DILI|dili
4973189|NCT04159428|hearing loss|hearing loss
4973190|NCT04159428|screening|screening
4973191|NCT04159428|elderly|elderly
4973192|NCT04159428|hidden hearing loss|hidden hearing loss
4982478|NCT04101968|Parkinson|parkinson
4973193|NCT04159428|speech in noise audiometry|speech in noise audiometry
4973194|NCT04159428|HHIE-S survey|hhie-s survey
4973287|NCT04158921|Insulin Therapy|insulin therapy
4973289|NCT04158921|Hyperglycemia|hyperglycemia
4973290|NCT04158921|Hypoglycemia|hypoglycemia
4973291|NCT04158921|Health Education|health education
4973292|NCT04158921|Self-Management|self-management
4973294|NCT04158895|HIV|hiv
4973295|NCT04158895|Malawi|malawi
4973296|NCT04158895|Differentiated service delivery|differentiated service delivery
4973297|NCT04158895|Antiretroviral therapy|antiretroviral therapy
4973298|NCT04158882|HIV|hiv
4973299|NCT04158882|Zambia|zambia
4973300|NCT04158882|Differentiated service delivery|differentiated service delivery
4973301|NCT04158882|Antiretroviral therapy|antiretroviral therapy
4973302|NCT04158869|n-3 fatty acids|n-3 fatty acids
4973306|NCT04158843|Humerus|humerus
4973383|NCT04158115|Spine Mobilization|spine mobilization
4973384|NCT04158037|mHealth App|mhealth app
4973385|NCT04158024|Erector Spinae Plane Blockade|erector spinae plane blockade
4973522|NCT04157049|AAT|aat
4973523|NCT04157049|ZZ|zz
4973524|NCT04157049|MZ|mz
4973525|NCT04157049|CARRIER|carrier
4973526|NCT04157049|MM|mm
4973527|NCT04157049|MS|ms
4973650|NCT04156386|Muscle Strength|muscle strength
4973651|NCT04156386|Musculoskeletal Physiology|musculoskeletal physiology
4973652|NCT04156386|Muscle, Skeletal|muscle, skeletal
4973776|NCT04155606|Unruptured Intracranial Aneurysm|unruptured intracranial aneurysm
4973777|NCT04155606|Endovascular treatment|endovascular treatment
4973778|NCT04155606|Surgical treatment|surgical treatment
4973779|NCT04155606|Conservative management|conservative management
4973780|NCT04155580|AML|aml
4973781|NCT04155580|Bone marrow|bone marrow
4973782|NCT04155580|CMML|cmml
4973783|NCT04155580|MDS|mds
4973784|NCT04155580|ASTX727|astx727
4973785|NCT04155580|ASTX660|astx660
4973786|NCT04155580|cIAP1|ciap1
4991742|NCT04044339|TD-5202|td-5202
4973792|NCT04155580|Decitabine|decitabine
4973793|NCT04155580|Acute myeloid leukemia|acute myeloid leukemia
4973796|NCT04155554|HIV|hiv
4973874|NCT04155242|Radiofrequency ablation|radiofrequency ablation
4973875|NCT04155242|Early Oesophageal Neoplasia|early oesophageal neoplasia
4973892|NCT04155177|Caesarean|caesarean
4973893|NCT04155177|surgery|surgery
4973894|NCT04155177|training|training
4973895|NCT04155177|obstetrics|obstetrics
4973896|NCT04155164|Primary Open Angle Glaucoma|primary open angle glaucoma
4973897|NCT04155164|Metformin|metformin
4973898|NCT04155164|Visual function|visual function
4973899|NCT04155138|cochlear implant|cochlear implant
4973900|NCT04155138|hearing aid|hearing aid
4973901|NCT04155138|cros device|cros device
4973902|NCT04155138|bimodal|bimodal
4973943|NCT04154787|Idiopathic membranous nephropathy, MN.|idiopathic membranous nephropathy, mn.
4973944|NCT04154761|Inferior vena cava|inferior vena cava
4973945|NCT04154761|radical resection|radical resection
4973946|NCT04154761|Vascular reconstruction|vascular reconstruction
4973947|NCT04154748|Barretts Esophagus|barretts esophagus
4973948|NCT04154748|Dysplasia|dysplasia
4974197|NCT04153396|Pain, Postoperative|pain, postoperative
4974198|NCT04153396|Betamethasone;|betamethasone;
4974199|NCT04153396|Ropivacaine;|ropivacaine;
4974200|NCT04153396|Wound Infiltration|wound infiltration
4974225|NCT04153305|update|update
4974385|NCT04152408|continuous glucose monitoring|continuous glucose monitoring
4974386|NCT04152395|Metabolic Syndrome|metabolic syndrome
4974390|NCT04152343|Radiofrequency Ablation|radiofrequency ablation
4974391|NCT04152330|Congenital heart disease|congenital heart disease
4974392|NCT04152330|Children developmental|children developmental
4974393|NCT04152330|Parents training|parents training
4974394|NCT04152317|Operative Hysteroscopy|operative hysteroscopy
4974395|NCT04152317|Misoprostol|misoprostol
4974396|NCT04152304|shoulder instability|shoulder instability
4974397|NCT04152304|feasibility studies|feasibility studies
5700275|NCT00500292|cancer|cancer
4974398|NCT04152304|neuromuscular exercise|neuromuscular exercise
4974399|NCT04152291|Atherosclerosis|atherosclerosis
4974495|NCT04151758|Gut microbiota|gut microbiota
4974496|NCT04151758|Nutrition|nutrition
4974497|NCT04151758|PUFA supplementation|pufa supplementation
4974498|NCT04151693|Psychological intervention|psychological intervention
4974499|NCT04151693|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
4974500|NCT04151693|Accept and Commitment Therapy (ACT)|accept and commitment therapy (act)
4974501|NCT04151693|Cognitive functioning|cognitive functioning
4974502|NCT04151693|Fatigue|fatigue
4974505|NCT04151693|Deep breathing|deep breathing
4974599|NCT04150991|Gut microbiome|gut microbiome
4974600|NCT04150991|Hyperphagia|hyperphagia
4974601|NCT04150991|Prader-Willi Syndrome|prader-willi syndrome
4974602|NCT04150978|High Protein Polymeric Feeding|high protein polymeric feeding
4974603|NCT04150978|APACHE II Score|apache ii score
4974604|NCT04150978|SOFA Score|sofa score
4974605|NCT04150978|NUTRIC Score|nutric score
4974606|NCT04150978|Critical Illness|critical illness
4974607|NCT04150978|Intensive Care Unit|intensive care unit
4974608|NCT04150978|Oligomeric Protein Feeding|oligomeric protein feeding
4974609|NCT04150965|Multiple Myeloma|multiple myeloma
4974729|NCT04150042|pancreatic cancer|pancreatic cancer
4974730|NCT04150042|BRCA|brca
4974764|NCT04149899|OHT|oht
4974884|NCT04149249|smoking cessation tool|smoking cessation tool
4974885|NCT04149249|smoking cessation|smoking cessation
4974886|NCT04149249|quit smoking|quit smoking
4974887|NCT04149249|smoking cessation resources|smoking cessation resources
4974888|NCT04149249|smoking cessation barriers|smoking cessation barriers
4974889|NCT04149249|smoking cessation intervention tool|smoking cessation intervention tool
4974890|NCT04149236|Culture|culture
4974891|NCT04149210|fluorometholone 0.1%|fluorometholone 0.1%
4974892|NCT04149210|trachomatous trichiasis|trachomatous trichiasis
4974896|NCT04149210|trichiasis|trichiasis
4974996|NCT04148690|Tanzania|tanzania
4974997|NCT04148690|Malaria in Pregnancy|malaria in pregnancy
4974998|NCT04148664|Atrial Fibrillation|atrial fibrillation
4974999|NCT04148651|vulvar dystrophy|vulvar dystrophy
4975126|NCT04147650|Dry Eye Disease|dry eye disease
4975127|NCT04147637|Hytpoglycemia|hytpoglycemia
4975128|NCT04147637|FreeStyle Libre|freestyle libre
4975129|NCT04147637|Flash Glucose Monitoring|flash glucose monitoring
4975130|NCT04147637|MiaoMiao|miaomiao
4975131|NCT04147637|Time in Range|time in range
4975133|NCT04147624|Cognitive Aging|cognitive aging
4975134|NCT04147598|Inflammatory bowel disease|inflammatory bowel disease
4975135|NCT04147598|diet|diet
4975136|NCT04147598|low fat|low fat
4975137|NCT04147598|UC|uc
4975138|NCT04147598|IBD|ibd
4975238|NCT04146857|Hypoxia|hypoxia
4975373|NCT04145817|Related women to index case|related women to index case
4975374|NCT04145817|Risk estimation|risk estimation
4975498|NCT04145180|Quality of Life|quality of life
4975499|NCT04145180|Head and Neck Cancer|head and neck cancer
4975500|NCT04145167|chronic total occlusion|chronic total occlusion
4975501|NCT04145167|coronary percutaneous intervention|coronary percutaneous intervention
4975618|NCT04144296|Arterial blood gas analysis|arterial blood gas analysis
4975619|NCT04144296|Capillary blood gas analysis|capillary blood gas analysis
4975620|NCT04144283|Parkinson's disease|parkinson's disease
4975621|NCT04144283|Ageing|ageing
4975622|NCT04144283|Rehabilitation|rehabilitation
4975623|NCT04144283|Sleep|sleep
4975624|NCT04144283|Motor learning|motor learning
4975637|NCT04144140|E7766|e7766
4975734|NCT04143490|Inflammatory markers|inflammatory markers
4975735|NCT04143490|Gastrointestinal integrity|gastrointestinal integrity
4975736|NCT04143477|peficitinib|peficitinib
4975737|NCT04143477|ASP015K|asp015k
4975738|NCT04143477|pharmacokinetics|pharmacokinetics
4975739|NCT04143464|Thoracic Hyperkyphosis|thoracic hyperkyphosis
4975740|NCT04143464|Exercise|exercise
4975741|NCT04143464|Older Adults|older adults
4975742|NCT04143451|influenza, intradermal, imiquimod, high-dose, vaccine|influenza, intradermal, imiquimod, high-dose, vaccine
4975743|NCT04143438|patella|patella
4975744|NCT04143438|EOS 3D imaging|eos 3d imaging
4975889|NCT04142684|Phrenic Nerve|phrenic nerve
4975890|NCT04142645|Medication Reconciliation|medication reconciliation
4975892|NCT04142619|Multiple Myeloma|multiple myeloma
4975893|NCT04142619|Chimeric Antigen Receptor T-Cell (CART-T) therapy|chimeric antigen receptor t-cell (cart-t) therapy
4975894|NCT04142619|Transcription Activator-Like Effector Nuclease (TALEN)|transcription activator-like effector nuclease (talen)
4975895|NCT04142619|Allogeneic|allogeneic
4975896|NCT04142593|Metabolic Syndrome（MetS）|metabolic syndrome（mets）
4975897|NCT04142593|Classification|classification
4975898|NCT04142593|Decision Tree|decision tree
4975900|NCT04142580|discopathy|discopathy
4975985|NCT04142177|physical therapy|physical therapy
4976129|NCT04141410|Levosimendan|levosimendan
4976130|NCT04141397|precision medicine|precision medicine
4976131|NCT04141397|genomic sequencing|genomic sequencing
4976132|NCT04141397|administrative data|administrative data
4976133|NCT04141397|quasi-experimental methods|quasi-experimental methods
4976239|NCT04140721|POTS|pots
4976240|NCT04140708|Exercise|exercise
4976241|NCT04140708|Parkinson's|parkinson's
4976242|NCT04140708|Glymphatic System|glymphatic system
4976243|NCT04140695|Chronic Pruritus|chronic pruritus
4976244|NCT04140695|Eczema|eczema
4976245|NCT04140682|Proportional assist ventilation|proportional assist ventilation
4976246|NCT04140682|Pressure support ventilation|pressure support ventilation
4976247|NCT04140682|Weaning|weaning
4976350|NCT04140084|Head computed tomography|head computed tomography
4976351|NCT04140071|Eating habits|eating habits
4976352|NCT04140071|Web-based prospective cohort study|web-based prospective cohort study
4976443|NCT04139603|ergonomic education|ergonomic education
4976444|NCT04139603|pelvic girdle questionnaire|pelvic girdle questionnaire
4976445|NCT04139603|five times sit to stand test|five times sit to stand test
4976561|NCT04138771|Posterior capsule opacification|posterior capsule opacification
4976562|NCT04138771|Pupil malformation|pupil malformation
4976563|NCT04138771|Suppurative endophthalmitis|suppurative endophthalmitis
4976564|NCT04138732|Community|community
4976565|NCT04138732|Health|health
4976566|NCT04138732|Hospital|hospital
4976567|NCT04138719|Triple-negative Breast Cancer|triple-negative breast cancer
4976568|NCT04138719|Nab-paclitaxel|nab-paclitaxel
4976569|NCT04138719|Carboplatin|carboplatin
4976570|NCT04138719|Epirubicin|epirubicin
4976571|NCT04138693|Blood/Urine/Hair lead|blood/urine/hair lead
4987085|NCT04072055|UKA|uka
4976572|NCT04138693|Lead uptake & Lead bioavailability|lead uptake & lead bioavailability
4976573|NCT04138680|Brain Imaging|brain imaging
4976574|NCT04138680|Biofeedback|biofeedback
4976575|NCT04138667|breast cancer related lymphedema|breast cancer related lymphedema
4976576|NCT04138667|lymphedema|lymphedema
4976577|NCT04138667|outcome measurement|outcome measurement
4976578|NCT04138667|responsiveness|responsiveness
4976585|NCT04138602|Fecal smearing|fecal smearing
4976586|NCT04138602|Incomplete defecation|incomplete defecation
4976594|NCT04138563|Magnetic Resonance Imaging|magnetic resonance imaging
4976667|NCT04138186|Gastrointestinal function disorder|gastrointestinal function disorder
4976668|NCT04138173|physical activity|physical activity
4976669|NCT04138173|tele coaching|tele coaching
4976670|NCT04138160|obesity dietary restriction|obesity dietary restriction
4976671|NCT04138147|Cervical plexus,|cervical plexus,
4976672|NCT04138147|Retrolaminar,|retrolaminar,
4976673|NCT04138147|Auriculotemporal,|auriculotemporal,
4976674|NCT04138147|Parotid|parotid
4976675|NCT04138134|autophagy|autophagy
4976676|NCT04138134|spermidine|spermidine
4976677|NCT04138121|cricothyroid membrane|cricothyroid membrane
4976678|NCT04138121|pregnancy|pregnancy
4976679|NCT04138121|ultrasound|ultrasound
4976681|NCT04138108|Stress|stress
4976768|NCT04137575|Breast Cancer|breast cancer
4976769|NCT04137575|Distress|distress
4976770|NCT04137575|Emotion Regulation|emotion regulation
4976771|NCT04137562|Adipose Derived Mesenchymal Stem cell|adipose derived mesenchymal stem cell
4976772|NCT04137562|ADMSC|admsc
4976870|NCT04137003|Anterior cruciate ligament|anterior cruciate ligament
4976871|NCT04137003|Post surgery|post surgery
4976872|NCT04136990|Anterior Cruciate Ligament Reconstruction|anterior cruciate ligament reconstruction
4977003|NCT04136314|Prospect Theory|prospect theory
4977004|NCT04136314|Medication Preferences|medication preferences
4977009|NCT04136262|rheumatoid arthritis|rheumatoid arthritis
4977010|NCT04136262|Tripterygium wilfordii Hook F|tripterygium wilfordii hook f
4977011|NCT04136262|methotrexate|methotrexate
4977012|NCT04136262|postmenopausal women|postmenopausal women
4977013|NCT04136262|randomized controlled trial|randomized controlled trial
4977014|NCT04136249|cancer|cancer
4977015|NCT04136249|cachexia|cachexia
4977016|NCT04136249|nutrition|nutrition
4977102|NCT04135651|Pentax|pentax
4977103|NCT04135586|exercise|exercise
4977104|NCT04135586|high interval training|high interval training
4977105|NCT04135586|resistance exercise|resistance exercise
4977106|NCT04135573|Atuoimmune thyroid disease|atuoimmune thyroid disease
4977311|NCT04134416|Non-invasive brain stimulation|non-invasive brain stimulation
4977312|NCT04134416|Cognitive enhancing drug|cognitive enhancing drug
4977314|NCT04134403|Steroids|steroids
4977430|NCT04133532|Left ventricular outflow tract obstruction|left ventricular outflow tract obstruction
4977431|NCT04133532|Quality of life|quality of life
4977432|NCT04133532|Diastolic dysfunction|diastolic dysfunction
4977436|NCT04133493|fish skin graft|fish skin graft
4977437|NCT04133493|omega3 fatty acids|omega3 fatty acids
4977563|NCT04132856|oncology|oncology
4977564|NCT04132830|HIV-exposed Uninfected|hiv-exposed uninfected
4977565|NCT04132830|In Utero Exposure|in utero exposure
4977566|NCT04132830|Metabolic|metabolic
4977567|NCT04132830|Immune|immune
4977569|NCT04132791|Chronotherapy|chronotherapy
4977570|NCT04132778|Asthma|asthma
4977571|NCT04132778|AsthmaTuner|asthmatuner
4977572|NCT04132778|Management|management
4977573|NCT04132765|cerebral palsy|cerebral palsy
4977574|NCT04132765|drooling impact scale|drooling impact scale
4977575|NCT04132765|hypersalivation|hypersalivation
4977576|NCT04132765|validity|validity
4977577|NCT04132752|obstetric paralysis|obstetric paralysis
4977578|NCT04132752|home exercise|home exercise
4977579|NCT04132752|motivation|motivation
4977580|NCT04132752|rehabilitation|rehabilitation
4977581|NCT04132752|parents|parents
4977582|NCT04132726|Massage|massage
4977583|NCT04132713|skin microbiota|skin microbiota
4977584|NCT04132713|16S rRNA gene|16s rrna gene
4977585|NCT04132713|hand foot sysdom|hand foot sysdom
4977586|NCT04132713|breast cancer chemotherapy|breast cancer chemotherapy
4977592|NCT04132648|CKD|ckd
4977655|NCT04132154|Spinal Anesthesia|spinal anesthesia
4977656|NCT04132154|caesarean section|caesarean section
4977657|NCT04132154|zero heat flux technology|zero heat flux technology
4977658|NCT04132154|active warming|active warming
4977659|NCT04132115|Intracerebral Hemorrhage|intracerebral hemorrhage
4977660|NCT04132115|Subarachnoid Hemorrhage|subarachnoid hemorrhage
4977661|NCT04132115|Therapeutic Drug Monitoring|therapeutic drug monitoring
4977663|NCT04132102|EGFR mutation|egfr mutation
4977769|NCT04131257|Continuum of care|continuum of care
4977770|NCT04131257|Diabetes|diabetes
4977771|NCT04131257|Pre-diabetes|pre-diabetes
4977772|NCT04131231|microparticles packaging chemotherapeutic drugs|microparticles packaging chemotherapeutic drugs
4977773|NCT04131231|MPCD|mpcd
4977774|NCT04131231|malignant pleural effusion|malignant pleural effusion
4977882|NCT04130399|neoadjuvent chemotherapy|neoadjuvent chemotherapy
4977883|NCT04130399|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
4977884|NCT04130373|Autologous fat grafting|autologous fat grafting
4977885|NCT04130373|Lipofilling|lipofilling
4977886|NCT04130373|Breast cancer|breast cancer
4977887|NCT04130373|Breast reconstruction|breast reconstruction
4977888|NCT04130360|problem-solving|problem-solving
4977889|NCT04130360|youth|youth
4977890|NCT04130360|brief intervention|brief intervention
4977894|NCT04130282|Pfs25|pfs25
4977895|NCT04130256|Medication adherence|medication adherence
4977896|NCT04130243|Biomarker|biomarker
4977897|NCT04130243|Congenital Heart Disease|congenital heart disease
4977982|NCT04129515|Melanoma Brain Metastasis|melanoma brain metastasis
4977983|NCT04129515|Metastatic Melanoma|metastatic melanoma
4977985|NCT04129463|Buphthalmous|buphthalmous
4977986|NCT04129463|Iris incarceration|iris incarceration
4977988|NCT04129463|IOP|iop
4977989|NCT04129463|AXL|axl
4978004|NCT04129372|fruits|fruits
4978129|NCT04128670|muscle pain|muscle pain
4978134|NCT04128644|depression|depression
4978135|NCT04128644|prevention|prevention
4978248|NCT04127812|mindfullness|mindfullness
4978250|NCT04127812|snacking|snacking
4978251|NCT04127812|obesity|obesity
4978252|NCT04127812|children|children
4978253|NCT04127773|VLBW - Very Low Birth Weight Infant|vlbw - very low birth weight infant
4978254|NCT04127773|Gastric tube|gastric tube
4978255|NCT04127773|Enteral nutrition|enteral nutrition
4978256|NCT04127773|Prematurity|prematurity
4978257|NCT04127773|Nursing|nursing
4978355|NCT04127175|Breast density|breast density
4978356|NCT04127175|Volpara|volpara
4978357|NCT04127175|Quantra|quantra
4978358|NCT04127175|BI-RADS|bi-rads
4978359|NCT04127175|Digital Mammography|digital mammography
4978360|NCT04127175|Digital Breast Tomosynthesis|digital breast tomosynthesis
4978703|NCT04125238|Alcohol Craving|alcohol craving
4978704|NCT04125186|Bladder diary|bladder diary
4978705|NCT04125134|Dry Eye|dry eye
4978706|NCT04125134|artifical tear|artifical tear
4978707|NCT04125121|Neuroplasticity|neuroplasticity
4978708|NCT04125121|Neuroplastic changes|neuroplastic changes
4978709|NCT04125121|General anaesthesia|general anaesthesia
4978710|NCT04125121|Magnetic resonance imaging|magnetic resonance imaging
4978711|NCT04125121|Sevoflurane|sevoflurane
4978816|NCT04124549|Physical Fitness|physical fitness
4978817|NCT04124536|Self Testing|self testing
4978818|NCT04124536|Partner notification|partner notification
4978819|NCT04124536|Secondary Distribution|secondary distribution
4978820|NCT04124523|skull base surger|skull base surger
4978821|NCT04124523|CSF leaks|csf leaks
4978822|NCT04124523|intracranial pressure|intracranial pressure
4978823|NCT04124523|endoscopic skull base surgery|endoscopic skull base surgery
4978829|NCT04124484|DBPR108|dbpr108
4978917|NCT04123860|hydrodynamic ultrasonic|hydrodynamic ultrasonic
4978918|NCT04123860|buccal pad fat|buccal pad fat
4978919|NCT04123860|platelet rich fibrin|platelet rich fibrin
4978920|NCT04123860|immediate dental implant|immediate dental implant
4978921|NCT04123847|epidural stimulation|epidural stimulation
4979044|NCT04123041|Electronic Nicotine Delivery System|electronic nicotine delivery system
4979045|NCT04123041|Combustible Cigarettes|combustible cigarettes
4979046|NCT04123041|Nicotine|nicotine
4979047|NCT04123002|P.gingivalis|p.gingivalis
4979055|NCT04122937|peritoneal carcinomatosis|peritoneal carcinomatosis
4979056|NCT04122937|colon cancer|colon cancer
4979057|NCT04122937|ovarian cancer|ovarian cancer
4979139|NCT04122573|Risk stratification|risk stratification
4979140|NCT04122573|Prognosis|prognosis
4979141|NCT04122573|Biomarkers|biomarkers
4979142|NCT04122560|fluconazole|fluconazole
4979143|NCT04122560|candidiasis|candidiasis
4979253|NCT04121884|Alcohol Abuse|alcohol abuse
4979254|NCT04121884|Prolonged Grief Disorder|prolonged grief disorder
4979255|NCT04121884|Stress Disorder, Acute|stress disorder, acute
4979270|NCT04121845|exercise testing|exercise testing
4979271|NCT04121845|oxygen consumption|oxygen consumption
4979272|NCT04121819|Langerhans cell histiocytosis|langerhans cell histiocytosis
4979273|NCT04121819|adult|adult
4979274|NCT04121819|newly diagnosed|newly diagnosed
4979275|NCT04121780|TBI|tbi
4979276|NCT04121780|GHD|ghd
4979277|NCT04121780|Growth Hormone|growth hormone
4979278|NCT04121780|Norditropin Flexpro|norditropin flexpro
4979382|NCT04121247|sickle cell disease|sickle cell disease
4979383|NCT04121247|nonpharmacological approaches|nonpharmacological approaches
4979385|NCT04121247|parent|parent
4979386|NCT04121247|nurse|nurse
4979484|NCT04120519|Langerhans cell histiocytosis|langerhans cell histiocytosis
4979485|NCT04120519|adult|adult
4979486|NCT04120519|recurrent/refractory|recurrent/refractory
4979487|NCT04120493|Gene therapy|gene therapy
4979597|NCT04119999|remodeling|remodeling
4979598|NCT04119999|blood pressure|blood pressure
4979599|NCT04119999|trial|trial
4979600|NCT04119986|Quantitative flow ratio|quantitative flow ratio
4979601|NCT04119986|drug coated balloon|drug coated balloon
4979602|NCT04119986|Drug eluted stent|drug eluted stent
4979603|NCT04119986|In-stent restenosis|in-stent restenosis
4979604|NCT04119973|Thrombelastography|thrombelastography
4979605|NCT04119973|Acute on Chronic Liver Failure|acute on chronic liver failure
4979606|NCT04119973|Platelet|platelet
4979607|NCT04119973|Multicenter Prospective Study|multicenter prospective study
4979608|NCT04119934|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
4979609|NCT04119934|COPD|copd
4979610|NCT04119934|smoking cessation|smoking cessation
4979611|NCT04119934|smoking|smoking
4979612|NCT04119908|constitutional haemorrhagic diseases, Videomicroscopy, prediction, bleeding|constitutional haemorrhagic diseases, videomicroscopy, prediction, bleeding
4979613|NCT04119908|Videomicroscopy|videomicroscopy
4979614|NCT04119908|prediction|prediction
4979840|NCT04118699|systemic scleroderma|systemic scleroderma
4979841|NCT04118686|Neurodegenerative disease|neurodegenerative disease
4979842|NCT04118686|Cognitive decline|cognitive decline
4979843|NCT04118686|Non-pharmacological treatments|non-pharmacological treatments
4979844|NCT04118686|Cognitive training|cognitive training
4979845|NCT04118686|Non-invasive brain stimulation|non-invasive brain stimulation
4979943|NCT04118140|symptom cluster|symptom cluster
4979944|NCT04118127|Schizophrenia,brexpiprazole,open-label,linical pharmacology|schizophrenia,brexpiprazole,open-label,linical pharmacology
4979947|NCT04118049|Pessary use|pessary use
4979948|NCT04118049|Probiotics|probiotics
4979949|NCT04118049|Cytokines|cytokines
4979950|NCT04118049|Microenvironment|microenvironment
4979951|NCT04118036|Glioblastoma|glioblastoma
4979952|NCT04118023|7T Magnetic Resonance Imaging|7t magnetic resonance imaging
4979953|NCT04118023|Clinical|clinical
4979954|NCT04118023|Cartilaginous Lesion|cartilaginous lesion
4980029|NCT04117633|Rectopexy|rectopexy
4980030|NCT04117633|pediatrics|pediatrics
4980036|NCT04117607|Intravenous|intravenous
4980037|NCT04117607|Rezafungin|rezafungin
4980038|NCT04117607|Subcutaneous|subcutaneous
4980065|NCT04117399|IMT|imt
4980248|NCT04116281|Heart hate variability|heart hate variability
4980249|NCT04116281|Physical therapy|physical therapy
4980250|NCT04116281|Breast neoplasms|breast neoplasms
4980251|NCT04116281|Pressure pain threshold|pressure pain threshold
4980252|NCT04116281|Perceived pain|perceived pain
4980253|NCT04116255|Temporomandibular joint disorders|temporomandibular joint disorders
4980353|NCT04115774|Genotype-Phenotype Correlation|genotype-phenotype correlation
4980355|NCT04115709|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
4980356|NCT04115709|Intensive Care|intensive care
4980357|NCT04115709|Device|device
4980358|NCT04115709|Beacon Caresystem©|beacon caresystem©
4980452|NCT04114955|Brazil|brazil
4980453|NCT04114942|young adult|young adult
4980580|NCT04114253|Coagulation|coagulation
4980680|NCT04113577|MCI|mci
4980793|NCT04112836|chemotherapy|chemotherapy
4980900|NCT04112056|Infant formula|infant formula
4980901|NCT04112056|Infant gastrointestinal symptoms questionnaire|infant gastrointestinal symptoms questionnaire
4980902|NCT04112043|systolic blood pressure (SBP)|systolic blood pressure (sbp)
4980903|NCT04112043|cardiovascular (CV) disease|cardiovascular (cv) disease
4980904|NCT04112017|Hyalunic acid|hyalunic acid
4980905|NCT04112017|Filler|filler
4980906|NCT04112017|Dorsal hand|dorsal hand
4981053|NCT04111133|Ivabradine|ivabradine
4981054|NCT04111120|thromboelastography|thromboelastography
4981055|NCT04111120|variceal bleeding|variceal bleeding
4981059|NCT04111068|Macular Degeneration|macular degeneration
4981060|NCT04111068|Brain Stimulation|brain stimulation
4981061|NCT04111068|Psychophysics|psychophysics
4981062|NCT04111068|Reading|reading
4981063|NCT04111068|tDCS|tdcs
4981064|NCT04111068|RSVP|rsvp
4981170|NCT04110379|salivary cortisol|salivary cortisol
4981171|NCT04110366|influenza|influenza
4981172|NCT04110366|vaccine|vaccine
4981173|NCT04110366|virus|virus
4981174|NCT04110366|antibody|antibody
4981175|NCT04110366|cytokine|cytokine
4981176|NCT04110366|respiratory|respiratory
4981182|NCT04110327|MicroStent|microstent
4981294|NCT04109521|child|child
4981295|NCT04109521|nutrition|nutrition
4981442|NCT04108884|Vascular disease|vascular disease
4981443|NCT04108871|Biopsy|biopsy
4981444|NCT04108871|Transperineal Prostate Biopsy|transperineal prostate biopsy
4981445|NCT04108871|Prostate Cancer Detection|prostate cancer detection
4981446|NCT04108871|Transrectal Prostate Biopsy|transrectal prostate biopsy
4981554|NCT04108117|Postoperative complications|postoperative complications
4981556|NCT04108117|Prognosis|prognosis
4981557|NCT04108117|Survivals|survivals
4981558|NCT04108117|Nipple sparing mastectomy|nipple sparing mastectomy
4981568|NCT04108078|Intersectional Stigma|intersectional stigma
4981569|NCT04108078|Men who have sex with men|men who have sex with men
4981570|NCT04108065|gestational diabetes mellitus|gestational diabetes mellitus
4981669|NCT04107558|Virtual reality , hypnosis, pain, anxiety, anesthesia|virtual reality , hypnosis, pain, anxiety, anesthesia
4981671|NCT04107545|sport|sport
5021795|NCT03861013|Anxiety|anxiety
4981775|NCT04107064|Neurodiversity|neurodiversity
4981777|NCT04107064|Employment|employment
4981778|NCT04107064|Neurodiverse|neurodiverse
4981779|NCT04107038|Anesthesia, TAVR, Cardiothoracic, Cardiology|anesthesia, tavr, cardiothoracic, cardiology
4981780|NCT04107012|White spot lesion|white spot lesion
4981781|NCT04107012|QLF|qlf
4981782|NCT04107012|Clear aligners|clear aligners
4981783|NCT04106986|Knee osteoarthritis|knee osteoarthritis
4981784|NCT04106986|Pulsed Electromagnetic Field|pulsed electromagnetic field
4981785|NCT04106986|Progressive Resistance Exercise|progressive resistance exercise
4981868|NCT04106323|Inhibitor|inhibitor
4981869|NCT04106271|Chronic Pain|chronic pain
4981870|NCT04106271|dyadic pain management program|dyadic pain management program
4981975|NCT04105465|groin node dissection|groin node dissection
4981976|NCT04105465|bilateral groin node dissection|bilateral groin node dissection
4981977|NCT04105465|lymphedema|lymphedema
4981978|NCT04105465|lymphocyst|lymphocyst
4981979|NCT04105465|lymphorrea|lymphorrea
4981980|NCT04105374|Toca 511|toca 511
4981982|NCT04105335|Oligonucleotide|oligonucleotide
4981983|NCT04105335|saRNA|sarna
4981984|NCT04105335|Pembrolizumab|pembrolizumab
4981985|NCT04105335|Tumour microenvironment|tumour microenvironment
4981986|NCT04105335|Myeloid-derived suppressor cells|myeloid-derived suppressor cells
4981987|NCT04105335|C/EBP-a|c/ebp-a
4982093|NCT04104347|insight|insight
4982207|NCT04103697|rectal cancer|rectal cancer
4982208|NCT04103697|neoadjuvant chemotherapy|neoadjuvant chemotherapy
4982209|NCT04103697|mesorectal excision|mesorectal excision
4982336|NCT04102722|mammogram|mammogram
4982338|NCT04102696|Coronary Artery Bypass Grafting|coronary artery bypass grafting
4982343|NCT04102683|Game|game
4982454|NCT04102137|aP vaccine|ap vaccine
4982455|NCT04102124|Castration-resistant Prostate Cancer|castration-resistant prostate cancer
4982456|NCT04102124|SHR3680|shr3680
4982457|NCT04102124|SHR3162|shr3162
4982458|NCT04102072|pulmonary artery catheter|pulmonary artery catheter
4982459|NCT04102072|echocardiography|echocardiography
4982460|NCT04102072|fluid responsiveness|fluid responsiveness
4982461|NCT04102072|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
4982562|NCT04101279|patient reported outcome|patient reported outcome
4982671|NCT04100356|Glucose tolerance (GT)|glucose tolerance (gt)
4982795|NCT04099615|Acute Cerebrovascular Accident|acute cerebrovascular accident
4982796|NCT04099615|Endovascular Procedures|endovascular procedures
4982896|NCT04099160|low back pain|low back pain
4982897|NCT04099147|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
4982898|NCT04099147|NAFLD|nafld
4982899|NCT04099147|Artificial Intelligence|artificial intelligence
4982900|NCT04099147|Deep Learning System|deep learning system
4982901|NCT04099095|Wait-list|wait-list
4982902|NCT04099069|Transbronchial Cryobiopsy|transbronchial cryobiopsy
4982903|NCT04099069|anesthesia|anesthesia
4982904|NCT04099069|tracheal intubation|tracheal intubation
4982905|NCT04099069|rigid bronchoscopy|rigid bronchoscopy
4982906|NCT04099069|safety|safety
4982907|NCT04099069|interstitial lung disease|interstitial lung disease
4982908|NCT04099030|drug shortage|drug shortage
4982913|NCT04099017|muscle strength|muscle strength
4982914|NCT04098991|neuroimaging|neuroimaging
4982915|NCT04098991|thyroid|thyroid
4982916|NCT04098991|white matter|white matter
4982917|NCT04098978|Children|children
4982918|NCT04098978|Adolescents|adolescents
4982919|NCT04098978|Young Adults|young adults
4982920|NCT04098978|Pediatric Hypertension|pediatric hypertension
4982921|NCT04098978|Pharmacoeconomics|pharmacoeconomics
4982922|NCT04098978|Pharmacist|pharmacist
4982927|NCT04098926|Older women|older women
4982928|NCT04098926|Accelerated radiotherapy|accelerated radiotherapy
4982929|NCT04098926|Dose-integrated radiotherapy|dose-integrated radiotherapy
4982930|NCT04098913|screen time|screen time
4982931|NCT04098913|physical activity|physical activity
4982932|NCT04098913|sleep|sleep
4982933|NCT04098913|stress|stress
4982934|NCT04098822|Urinary Incontinence, Stress|urinary incontinence, stress
4982935|NCT04098822|Suburethral Slings|suburethral slings
4982936|NCT04098822|Prostatectomy|prostatectomy
4982939|NCT04098796|PD-1|pd-1
4982973|NCT04098679|Type 1 diabetes|type 1 diabetes
4982974|NCT04098679|Offspring|offspring
4982975|NCT04098679|Continuous glucose monitoring|continuous glucose monitoring
4982976|NCT04098640|Young patient|young patient
4982977|NCT04098640|Asian|asian
4982978|NCT04098627|laughter|laughter
4982979|NCT04098627|depression|depression
4982980|NCT04098627|hemodialysis|hemodialysis
4982981|NCT04098614|recovery coaching|recovery coaching
4982982|NCT04098614|risk factors|risk factors
4982983|NCT04098614|substance abuse|substance abuse
4982984|NCT04098614|EEG|eeg
4982985|NCT04098601|recovery coaching|recovery coaching
4982986|NCT04098601|substance abuse|substance abuse
4982987|NCT04098549|Type 1 Diabetes|type 1 diabetes
4982988|NCT04098549|Glucose Metabolism|glucose metabolism
4983075|NCT04098029|CP|cp
4983076|NCT04098029|Cord Blood|cord blood
4983077|NCT04098029|Stem cells|stem cells
4983078|NCT04098029|HLA|hla
4983079|NCT04098003|gut microbiome|gut microbiome
4983080|NCT04098003|statins|statins
4983081|NCT04098003|cholesterol|cholesterol
4983082|NCT04097977|User involvement|user involvement
4983197|NCT04097067|Lymphatic Diseases|lymphatic diseases
4983198|NCT04097067|Immunoproliferative Disorders|immunoproliferative disorders
4983199|NCT04097067|Immune System Diseases|immune system diseases
4983320|NCT04096274|evidence-based practice|evidence-based practice
4983321|NCT04096274|behavioral health|behavioral health
4983322|NCT04096274|youth mental health|youth mental health
4983435|NCT04095611|Modified Muscle Sparing Posterior Technique (SPAIRE)|modified muscle sparing posterior technique (spaire)
4983436|NCT04095611|Displaced Intracapsular Hip Fracture|displaced intracapsular hip fracture
4983437|NCT04095598|High ankle sprain|high ankle sprain
4983542|NCT04095013|bupivacaine-fentanyl|bupivacaine-fentanyl
4983543|NCT04095013|bupivacaine-dexmedetomidine|bupivacaine-dexmedetomidine
4983545|NCT04095013|complications|complications
4983546|NCT04095013|hemodynamics|hemodynamics
4983550|NCT04094961|Multiple Myeloma|multiple myeloma
4983551|NCT04094961|Multiple Myeloma in Relapse|multiple myeloma in relapse
4983552|NCT04094948|Pompe disease|pompe disease
4983553|NCT04094948|LOPD|lopd
4983554|NCT04094948|Late-onset Pompe Disease|late-onset pompe disease
4983654|NCT04094350|Peer group|peer group
4983780|NCT04093531|Sjogren|sjogren
4983781|NCT04093531|Ustekinumab|ustekinumab
4983782|NCT04093531|SS|ss
4983792|NCT04093453|Short Chain Fatty Acids|short chain fatty acids
4983793|NCT04093453|Propionate|propionate
4983794|NCT04093453|Energy Expenditure|energy expenditure
4983795|NCT04093453|Lipid Oxidation|lipid oxidation
4983896|NCT04092842|Breast Neoplasms|breast neoplasms
4983897|NCT04092842|Breast Conserving Surgery|breast conserving surgery
4983898|NCT04092829|Pre-Eclampsia|pre-eclampsia
4983899|NCT04092829|Corpus Luteum|corpus luteum
4983900|NCT04092829|Frozen embryo transfer|frozen embryo transfer
4983907|NCT04092777|Linguistic|linguistic
4983908|NCT04092777|Minorities|minorities
4983909|NCT04092764|Numbness|numbness
4983910|NCT04092764|Pain|pain
4983911|NCT04092764|Tingling|tingling
4983912|NCT04092764|Reduced sense of touch|reduced sense of touch
4983913|NCT04092764|Reduced proprioception|reduced proprioception
4983914|NCT04092764|Sensory Neuropathy|sensory neuropathy
4983915|NCT04092751|SCY-078|scy-078
4983916|NCT04092751|Ibrexafungerp|ibrexafungerp
4983917|NCT04092751|Pravastatin|pravastatin
4983995|NCT04092218|child behavior|child behavior
4983996|NCT04092218|first dental visit|first dental visit
4983997|NCT04092218|caries experience|caries experience
4983998|NCT04092192|IVC filter, filter removal, filter retrieval|ivc filter, filter removal, filter retrieval
4983999|NCT04092153|total knee arthroplasty|total knee arthroplasty
4984000|NCT04092153|total knee replacement|total knee replacement
4984001|NCT04092153|functional alignment|functional alignment
4984002|NCT04092153|kinematic alignment|kinematic alignment
4984004|NCT04092153|mako robot|mako robot
4984005|NCT04092153|makoplasty|makoplasty
4984006|NCT04092153|patient outcomes|patient outcomes
4984007|NCT04092127|RetCam|retcam
4984008|NCT04092127|Pain evaluation|pain evaluation
4984009|NCT04092127|PIPP (Premature Infant Pain Profile) Score|pipp (premature infant pain profile) score
4984071|NCT04091607|lower back pain|lower back pain
4984072|NCT04091607|lumbar spondylosis|lumbar spondylosis
4984073|NCT04091568|Awake fibre-optic tracheal intubation|awake fibre-optic tracheal intubation
4984074|NCT04091568|Asleep fibre-optic tracheal intubation|asleep fibre-optic tracheal intubation
4984075|NCT04091568|Patient experience|patient experience
4984084|NCT04091503|TMZ|tmz
4984197|NCT04090879|E-Cigarettes|e-cigarettes
4984198|NCT04090866|pulmonary arterial hypertension|pulmonary arterial hypertension
4984199|NCT04090866|right-sided heart failure|right-sided heart failure
4984200|NCT04090866|metabolism|metabolism
4984201|NCT04090866|PET/MRI|pet/mri
4984202|NCT04090840|obesity|obesity
4984203|NCT04090840|fasting|fasting
4984204|NCT04090840|diet|diet
4984205|NCT04090827|transition|transition
4984206|NCT04090827|Congenital heart disease|congenital heart disease
4984228|NCT04090671|MDP|mdp
4984325|NCT04089969|CTA, FFRct, CAD|cta, ffrct, cad
4984326|NCT04089969|End Stage Liver DIsease|end stage liver disease
4984327|NCT04089969|Liver failure, Liver transplant|liver failure, liver transplant
4984328|NCT04089956|spinal cord injury|spinal cord injury
4984329|NCT04089956|weaning|weaning
4984330|NCT04089943|peripheral artery disease|peripheral artery disease
4984331|NCT04089943|microRNA|microrna
4984332|NCT04089930|herpes zoster|herpes zoster
4984333|NCT04089930|vaccine|vaccine
4984334|NCT04089930|lupus|lupus
4984451|NCT04089280|probiotics|probiotics
4984452|NCT04089280|metformin intolerance|metformin intolerance
4984453|NCT04089254|Suicide|suicide
4984454|NCT04089254|Suicidal|suicidal
4984455|NCT04089254|Adolescent|adolescent
4984569|NCT04088669|home-based pulmonary rehabilitation|home-based pulmonary rehabilitation
4984570|NCT04088669|home-based rehabilitation|home-based rehabilitation
4984571|NCT04088630|Fingolimod|fingolimod
4984572|NCT04088630|Neurologic Deficits|neurologic deficits
4984573|NCT04088630|Brain Injury|brain injury
4984695|NCT04087629|StrataXRT|strataxrt
4984818|NCT04086862|adult female|adult female
4984819|NCT04086849|radiomics|radiomics
4984820|NCT04086849|pathomics|pathomics
4984821|NCT04086849|head and neck cancer|head and neck cancer
4984822|NCT04086849|biomarkers|biomarkers
4984823|NCT04086849|machine learning|machine learning
4984924|NCT04086108|GABA|gaba
4984925|NCT04086108|Glutamate|glutamate
4984926|NCT04086108|Tomato|tomato
4984927|NCT04086108|Plasmakinetics|plasmakinetics
4984928|NCT04086108|Bioavailability|bioavailability
4984929|NCT04086095|Respiratory Distress Syndrome|respiratory distress syndrome
4984930|NCT04086095|Less Invasive Surfactant Administration|less invasive surfactant administration
4984931|NCT04086095|Neofact|neofact
4984932|NCT04086095|Preterm babies|preterm babies
4984933|NCT04086082|Lung cancer|lung cancer
4985022|NCT04085419|primary hyperparathyroidism|primary hyperparathyroidism
4985125|NCT04084587|Biofeedback|biofeedback
4985126|NCT04084587|Retimax Vision Trainer|retimax vision trainer
4985127|NCT04084587|Age-Related Macular Degeneration|age-related macular degeneration
4985128|NCT04084587|Age-Related Maculopathy|age-related maculopathy
4985129|NCT04084587|Maculopathies, Age-Related|maculopathies, age-related
4985130|NCT04084587|Retinal Degeneration|retinal degeneration
4985131|NCT04084587|Evoked Potentials, Visual|evoked potentials, visual
4985132|NCT04084574|Racial disparities|racial disparities
4985133|NCT04084574|Hypertension|hypertension
4985134|NCT04084574|Diet|diet
4985365|NCT04083313|Endostapler|endostapler
4985366|NCT04083313|Endoclip|endoclip
4985600|NCT04081545|Opioid Free Anesthesia|opioid free anesthesia
4985601|NCT04081545|Bariatric Surgery|bariatric surgery
4985602|NCT04081545|Non-Opioid Anesthesia|non-opioid anesthesia
4985603|NCT04081545|Ketamine|ketamine
4985604|NCT04081545|Dexmedetomidine|dexmedetomidine
4985605|NCT04081545|Lidocaine|lidocaine
4985606|NCT04081532|endometriosis|endometriosis
4985607|NCT04081532|laparoscopy|laparoscopy
4985608|NCT04081532|pelvic pain|pelvic pain
4985609|NCT04081519|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
4985610|NCT04081519|Theta Burst Stimulation|theta burst stimulation
4985612|NCT04081519|TBS|tbs
4985613|NCT04081519|resting-state fMRI|resting-state fmri
4985616|NCT04081493|Preconditioning|preconditioning
4985690|NCT04080921|meningitis|meningitis
4985817|NCT04080050|Cardiovascular Disease|cardiovascular disease
4985691|NCT04080921|neurological sequelae due|neurological sequelae due
4985692|NCT04080895|Artemether-lumefantrine|artemether-lumefantrine
4985693|NCT04080895|Amodiaquine|amodiaquine
4985694|NCT04080869|acne vulgaris|acne vulgaris
4985695|NCT04080869|retinoids|retinoids
4985696|NCT04080869|retinyl palmitate|retinyl palmitate
4985697|NCT04080869|ethosomes|ethosomes
4985699|NCT04080856|Elagolix|elagolix
4985794|NCT04080193|Obesity|obesity
4985795|NCT04080193|Intervention|intervention
4985796|NCT04080193|Smartphone-App|smartphone-app
4985797|NCT04080180|opioid use disorder|opioid use disorder
4985798|NCT04080180|buprenorphine|buprenorphine
4985799|NCT04080180|treatment adherence|treatment adherence
4985800|NCT04080167|implementation science|implementation science
4985801|NCT04080167|sickle cell anemia|sickle cell anemia
4985802|NCT04080167|digital medicine|digital medicine
4985803|NCT04080167|adherence|adherence
4985804|NCT04080167|hydroxycarbamide|hydroxycarbamide
4985810|NCT04080141|Depression|depression
4985902|NCT04079283|Radiomics|radiomics
4985903|NCT04079283|Immunotherapy|immunotherapy
4985904|NCT04079270|Weight gain|weight gain
4985905|NCT04079270|Endocrine treatment|endocrine treatment
4985906|NCT04079244|Preoperative anxiety|preoperative anxiety
4985907|NCT04079244|Distractions|distractions
4985908|NCT04079244|Flow|flow
4985909|NCT04079244|Child|child
4985910|NCT04079231|Diabetic Macula Edema|diabetic macula edema
4985911|NCT04079231|Intravitreal injection|intravitreal injection
4985912|NCT04079231|brolucizumab|brolucizumab
4985913|NCT04079231|aflibercept|aflibercept
4985991|NCT04078815|Nonmaleficence|nonmaleficence
4985992|NCT04078815|Dignity|dignity
4985993|NCT04078815|Honesty|honesty
4985994|NCT04078789|sex offenses|sex offenses
4985995|NCT04078789|sexually transmitted diseases|sexually transmitted diseases
4985996|NCT04078789|traumatic injury|traumatic injury
4985999|NCT04078763|virtual reality|virtual reality
4986101|NCT04078269|dendritic cell|dendritic cell
4986103|NCT04078269|immunotherapy|immunotherapy
4986104|NCT04078256|proprioception|proprioception
4986105|NCT04078256|running|running
4986106|NCT04078256|prevention|prevention
4986107|NCT04078256|injuries|injuries
4986108|NCT04078217|home-based exercise program|home-based exercise program
4986109|NCT04078217|gait|gait
4986110|NCT04078217|mobility|mobility
4986111|NCT04078204|Butylphthalide|butylphthalide
4986216|NCT04077593|Telemedicine|telemedicine
4986217|NCT04077593|Dyspnea|dyspnea
4986218|NCT04077593|Emergencies|emergencies
4986219|NCT04077580|blinded randomized trial|blinded randomized trial
4986220|NCT04077580|frail elderly women|frail elderly women
4986221|NCT04077580|prevention|prevention
4986222|NCT04077567|RA|ra
4986223|NCT04077554|VEGF gene expression|vegf gene expression
4986224|NCT04077554|VEGF gene polymorphism|vegf gene polymorphism
4986225|NCT04077554|leptin|leptin
4986226|NCT04077541|trauma care bundles|trauma care bundles
4986227|NCT04077541|internet paltform|internet paltform
4986228|NCT04077541|patients with extremity injuries|patients with extremity injuries
5003190|NCT03976180|ACS|acs
4986323|NCT04076995|vasopressin|vasopressin
4986324|NCT04076995|copeptin|copeptin
4986325|NCT04076982|vegetarian|vegetarian
4986326|NCT04076982|vegan|vegan
4986327|NCT04076982|plant-based|plant-based
4986328|NCT04076982|protein|protein
4986329|NCT04076982|strength|strength
4986432|NCT04076488|Feasibility|feasibility
4986539|NCT04075929|Cycling|cycling
4986660|NCT04075071|Teacher-Child Interaction Training|teacher-child interaction training
4986661|NCT04075071|teacher-child relationships|teacher-child relationships
4986662|NCT04075071|child behavior|child behavior
4986663|NCT04075071|child social-emotional skills|child social-emotional skills
4986664|NCT04075071|preschool|preschool
5003580|NCT03973905|Boostrix|boostrix
4986666|NCT04075071|teacher behavior|teacher behavior
4986667|NCT04075058|Breast cancer|breast cancer
4986668|NCT04075058|hypofractionated radiotherapy|hypofractionated radiotherapy
4986745|NCT04074538|colorectal cancer|colorectal cancer
4986746|NCT04074538|cohort study|cohort study
4986747|NCT04074538|CRC screening|crc screening
4986748|NCT04074525|Decisional regret|decisional regret
4986749|NCT04074525|Comfort care|comfort care
4986750|NCT04074525|Palliative care|palliative care
4986751|NCT04074525|Infant resuscitation|infant resuscitation
4986752|NCT04074486|Concussion|concussion
4986753|NCT04074486|Mild Traumatic Brain Injury|mild traumatic brain injury
4986754|NCT04074486|Automated/Electronic Near Point Convergence|automated/electronic near point convergence
5003681|NCT03973268|Biomarker|biomarker
4986756|NCT04074460|major surgeries lasting >2 hours|major surgeries lasting >2 hours
4986850|NCT04073784|recurrent NPC|recurrent npc
4986851|NCT04073784|metastatic NPC|metastatic npc
4986852|NCT04073771|Septic shock, AKI, CRRT|septic shock, aki, crrt
4986951|NCT04072952|Malignant Neoplasm of the Breast|malignant neoplasm of the breast
4986952|NCT04072952|mBC|mbc
4986953|NCT04072952|ER+/HER2-|er+/her2-
4986954|NCT04072952|Locally Advanced Breast Cancer|locally advanced breast cancer
4987049|NCT04072289|small incision lenticule extraction|small incision lenticule extraction
4987208|NCT04071119|alcohol use disorder|alcohol use disorder
4987326|NCT04070456|Mini-Z|mini-z
4987327|NCT04070443|Clinical Trial, Phase II|clinical trial, phase ii
4987328|NCT04070443|Tyrosine Kinase Inhibitors|tyrosine kinase inhibitors
4987437|NCT04069767|Stroke|stroke
4987438|NCT04069767|Sub-acute|sub-acute
4987439|NCT04069767|Innovative|innovative
4987440|NCT04069767|Randomized controlled trial|randomized controlled trial
4987442|NCT04069767|Gait|gait
4987541|NCT04069247|insomnia|insomnia
4987542|NCT04069247|depression|depression
4987543|NCT04069247|suicide|suicide
4987544|NCT04069247|youth|youth
4987545|NCT04069234|myocardial infarction|myocardial infarction
4987546|NCT04069234|percutaneous coronary invervention|percutaneous coronary invervention
4987547|NCT04069234|coronary flow velocity reserve (CFR)|coronary flow velocity reserve (cfr)
4987548|NCT04069208|Acute Myeloid Leukemia|acute myeloid leukemia
4987549|NCT04069208|ultra-high dose idarubicin|ultra-high dose idarubicin
4987550|NCT04069208|induction|induction
4987551|NCT04069195|Inflammation|inflammation
4987552|NCT04069195|DHA|dha
4987553|NCT04069195|Pregnancy|pregnancy
4987554|NCT04069195|preterm|preterm
4987555|NCT04069195|overweight|overweight
4987556|NCT04069182|Depression|depression
4987560|NCT04069156|ventricular assist device|ventricular assist device
4987562|NCT04069156|aspirin|aspirin
4987563|NCT04069104|Melanoma identification|melanoma identification
4987564|NCT04069052|Dyspnea|dyspnea
4987565|NCT04069052|Exertional Dyspnea|exertional dyspnea
4987566|NCT04069052|Dead Space|dead space
4987567|NCT04069052|Exercise|exercise
4987568|NCT04069052|Inspiratory Neural Drive|inspiratory neural drive
4987569|NCT04069039|Stroke|stroke
4987618|NCT04068701|ACL|acl
4987667|NCT04068337|selective cerebral perfusion|selective cerebral perfusion
4987713|NCT04068155|SCC|scc
4987835|NCT04067297|Primary Prevention|primary prevention
4987836|NCT04067297|Cardiovascular disease|cardiovascular disease
4987837|NCT04067297|Lipids|lipids
4987838|NCT04067297|Statins|statins
4987839|NCT04067297|Lipid management|lipid management
4987840|NCT04067297|Lipid screening|lipid screening
4987851|NCT04067219|Alterations|alterations
4988082|NCT04065815|whole-body electromyostimulation|whole-body electromyostimulation
4988083|NCT04065789|multiple myeloma (MM)|multiple myeloma (mm)
4988084|NCT04065789|Myeloma|myeloma
4988085|NCT04065789|NDMM|ndmm
4988086|NCT04065789|RRMM|rrmm
4988087|NCT04065750|bacteremia|bacteremia
4988088|NCT04065750|resistant bacteria|resistant bacteria
4988104|NCT04065633|Estimation of the Effect of Food|estimation of the effect of food
4988105|NCT04065633|Relative Bioavailability|relative bioavailability
4988106|NCT04065620|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
4988107|NCT04065607|Laparotomy|laparotomy
4988108|NCT04065607|Laparostomy|laparostomy
4988203|NCT04065165|carcinoid syndrome|carcinoid syndrome
4988204|NCT04065165|somatostatin analogues|somatostatin analogues
4988205|NCT04065165|tryptophan hydroxylase inhibitor|tryptophan hydroxylase inhibitor
4988206|NCT04065139|pressurized intraperitoneal aerosol chemotherapy (PIPAC)|pressurized intraperitoneal aerosol chemotherapy (pipac)
4988207|NCT04065139|gastric adenocarcinoma|gastric adenocarcinoma
4988208|NCT04065139|metastasis|metastasis
4988209|NCT04065126|Mental health|mental health
4988210|NCT04065126|Physical activity|physical activity
4988215|NCT04065061|Erinacine A, supplement, Alzheimer's disease|erinacine a, supplement, alzheimer's disease
4988217|NCT04065048|inflammatory bowel disease|inflammatory bowel disease
4988218|NCT04065048|gut microbiome|gut microbiome
4988219|NCT04065035|Body|body
4988220|NCT04065035|moisturizer|moisturizer
4988221|NCT04065035|Firming|firming
4988224|NCT04065009|ovarian cancer|ovarian cancer
4998670|NCT04002934|BZA|bza
4988313|NCT04064632|Dual ART|dual art
4988314|NCT04064632|Rilpivirine|rilpivirine
4988315|NCT04064632|Darunavir/cobicistat|darunavir/cobicistat
4988316|NCT04064632|NNRTI|nnrti
4988318|NCT04064632|virologically suppressed patients|virologically suppressed patients
4988320|NCT04064593|Acute Myocardial Infarction|acute myocardial infarction
4988321|NCT04064593|Sleep Apnea|sleep apnea
4988322|NCT04064593|Outcomes|outcomes
4988323|NCT04064580|capnography|capnography
4988324|NCT04064567|PrEP|prep
4988325|NCT04064567|Community Health Worker|community health worker
4988326|NCT04064567|Criminal Justice|criminal justice
4988421|NCT04064086|Chronic kidney disease|chronic kidney disease
4988422|NCT04064086|Pre-dialysis education|pre-dialysis education
4988423|NCT04064086|Kidney Disease Education|kidney disease education
4988424|NCT04064086|Patient Education|patient education
4988425|NCT04064086|Decision Making|decision making
4988431|NCT04064021|Acupunture|acupunture
4988432|NCT04063995|Spasticity|spasticity
4988433|NCT04063995|Stroke|stroke
4988527|NCT04063280|Endoscopic mucosal resection|endoscopic mucosal resection
4988528|NCT04063228|non-progressive central neurological injury|non-progressive central neurological injury
4988529|NCT04063215|severe|severe
4988530|NCT04063215|hypoxic-ischemic encephalopathy|hypoxic-ischemic encephalopathy
4988531|NCT04063215|stroke|stroke
4988532|NCT04063215|intracranial hemorrhage|intracranial hemorrhage
4988533|NCT04063215|cerebral palsy|cerebral palsy
4988534|NCT04063215|chronic|chronic
4988535|NCT04063215|neurological injury|neurological injury
4988536|NCT04063202|Adolescent|adolescent
4988537|NCT04063202|Depression|depression
4988538|NCT04063202|Stress|stress
4988539|NCT04063202|Resilience|resilience
4988540|NCT04063189|Clarithromycin Lenalidomide Dexamethasone Regimen|clarithromycin lenalidomide dexamethasone regimen
4988622|NCT04062695|Sacroiliitis|sacroiliitis
4988716|NCT04062110|distal radius fractures|distal radius fractures
4988717|NCT04062110|above-elbow cast|above-elbow cast
4988718|NCT04062110|below-elbow cast|below-elbow cast
4988719|NCT04062110|conservative treatment|conservative treatment
4988720|NCT04062110|extra-articular fractures|extra-articular fractures
5903464|NCT00368446|HV|hv
4988811|NCT04061486|Sperm selection|sperm selection
4988812|NCT04061473|Pancreatectomy|pancreatectomy
4988813|NCT04061473|Diabetes|diabetes
4988814|NCT04061473|SGLT-2 inhibitor|sglt-2 inhibitor
4988815|NCT04061473|DPP4 inhibitor|dpp4 inhibitor
4988934|NCT04060485|Myeloproliferative Neoplasm|myeloproliferative neoplasm
4988935|NCT04060485|Aplastic Anemia|aplastic anemia
4988936|NCT04060485|Genetic mutation|genetic mutation
4988937|NCT04060485|Prognosis|prognosis
4988938|NCT04060459|Bladder cancer；Paclitaxel-binding albumin；Cisplatin；Neoadjuvant Chemotherapy|bladder cancer；paclitaxel-binding albumin；cisplatin；neoadjuvant chemotherapy
4988945|NCT04060381|Infants|infants
4989025|NCT04059861|depth of invasion|depth of invasion
4989026|NCT04059861|tongue cancer|tongue cancer
4989027|NCT04059861|floor of the mouth cancer|floor of the mouth cancer
4989028|NCT04059861|resection margin|resection margin
4989029|NCT04059861|thickness|thickness
4989030|NCT04059861|tongue carcinoma|tongue carcinoma
4989031|NCT04059861|tongue neoplasm|tongue neoplasm
4989032|NCT04059861|cancer of the tongue|cancer of the tongue
4989035|NCT04059848|Stroke|stroke
4989150|NCT04059211|emergency department|emergency department
4989151|NCT04059185|Child abuse|child abuse
4989152|NCT04059185|Child maltreatment|child maltreatment
4989153|NCT04059159|catheter|catheter
4989154|NCT04059133|low intensity extracorporeal low energy shock wave therapy|low intensity extracorporeal low energy shock wave therapy
4989155|NCT04059133|stress urinary incontinence|stress urinary incontinence
4989156|NCT04059133|overactive bladder|overactive bladder
4989157|NCT04059133|urine leakage|urine leakage
4989158|NCT04059120|Exercise|exercise
4989165|NCT04059068|liver disease|liver disease
4989285|NCT04058236|Glycocalyx levels|glycocalyx levels
4989286|NCT04058236|pancreatectomy|pancreatectomy
4989287|NCT04058236|human albumin 5%|human albumin 5%
4989392|NCT04057755|treatment|treatment
4989393|NCT04057742|Chronic Active Antibody Mediated Rejection|chronic active antibody mediated rejection
4989394|NCT04057742|cAMR|camr
4989395|NCT04057703|CEREVANCE|cerevance
4989396|NCT04057703|Pediatrics|pediatrics
4989397|NCT04057703|Cohort|cohort
4989398|NCT04057690|Malignant Brain Edema|malignant brain edema
4989399|NCT04057690|Stroke, Acute|stroke, acute
4989400|NCT04057690|Prediction|prediction
4989406|NCT04057638|Transplants|transplants
4989407|NCT04057638|Transplantation|transplantation
4989408|NCT04057638|Craniomaxillofacial Transplantation|craniomaxillofacial transplantation
4989409|NCT04057638|Upper Extremity Transplantation|upper extremity transplantation
4989410|NCT04057638|Vascularized Composite Allotransplantation (VCA)|vascularized composite allotransplantation (vca)
4989491|NCT04057209|surgery|surgery
4989605|NCT04056468|Drug Therapy|drug therapy
4989606|NCT04056455|Drug Therapy|drug therapy
4989607|NCT04056403|labor epidural|labor epidural
4989608|NCT04056403|ultrasound|ultrasound
4989611|NCT04056377|Retinopathy|retinopathy
4989735|NCT04055454|Lassa Fever|lassa fever
4989740|NCT04055415|Pulmonary hypertension（PH）mesenchymal stem cells(MSC)|pulmonary hypertension（ph）mesenchymal stem cells(msc)
4989742|NCT04055376|Alzheimer Disease|alzheimer disease
4989743|NCT04055376|Cognitive Impairment|cognitive impairment
4989744|NCT04055376|Non-invasive Sensory Stimulation|non-invasive sensory stimulation
4989745|NCT04055376|Light and Sound Stimulation|light and sound stimulation
4989746|NCT04055376|Gamma|gamma
4989747|NCT04055363|Growth|growth
4989748|NCT04055363|Tolerance|tolerance
4989749|NCT04055363|Adverse Event|adverse event
4989750|NCT04055363|Gastrointestinal disorder|gastrointestinal disorder
4989840|NCT04054973|Treatment resistant|treatment resistant
4989841|NCT04054973|L-arginine|l-arginine
4989843|NCT04054960|Parkinson disease OFF state, Noninvasive stimulation|parkinson disease off state, noninvasive stimulation
4989844|NCT04054947|Suicidal and Self-injurious Behavior|suicidal and self-injurious behavior
4989845|NCT04054934|T1DM|t1dm
4989846|NCT04054934|Hypothalamus|hypothalamus
4989973|NCT04054271|Blood types, Dental implant, Marginal Bone Resorption, Implant Survival|blood types, dental implant, marginal bone resorption, implant survival
4989974|NCT04054258|coronary heart disease|coronary heart disease
4989975|NCT04054258|e-health|e-health
4989976|NCT04054258|self-efficacy|self-efficacy
4989977|NCT04054180|Continuous positive airway pressure|continuous positive airway pressure
5006663|NCT03954847|Image|image
4989989|NCT04054050|insomnia|insomnia
4990386|NCT04051944|Chronic inflammatory demyelinating polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
4990387|NCT04051944|CIDP|cidp
4990388|NCT04051944|UCB7665|ucb7665
4990389|NCT04051944|rozanolixizumab|rozanolixizumab
4990390|NCT04051918|cognitive training|cognitive training
4990392|NCT04051918|music learning|music learning
4990488|NCT04051268|Typhoid Conjugate Vaccine|typhoid conjugate vaccine
4990489|NCT04051229|Metabolic Flexibility|metabolic flexibility
4990494|NCT04051203|GON|gon
4990596|NCT04050566|Endothelial cell activation|endothelial cell activation
4990597|NCT04050566|Poverty|poverty
4990598|NCT04050540|Sexually Transmitted Infections|sexually transmitted infections
4990599|NCT04050514|side effects|side effects
4990600|NCT04050514|mandibular advancement device|mandibular advancement device
4990601|NCT04050514|clinical intervention|clinical intervention
4990602|NCT04050514|snoring|snoring
4990603|NCT04050514|treatment|treatment
4990604|NCT04050501|Brain infarction|brain infarction
4990605|NCT04050501|Brain ischemia|brain ischemia
4990606|NCT04050501|Vagus nerve stimulation|vagus nerve stimulation
4990607|NCT04050501|Penumbra|penumbra
4990608|NCT04050475|Depression|depression
4990609|NCT04050475|Fasting Mimicking Diet|fasting mimicking diet
4990854|NCT04049240|Moderate sedation|moderate sedation
4990855|NCT04049240|Adult|adult
4990856|NCT04049240|High-flow nasal oxygenation|high-flow nasal oxygenation
4990857|NCT04049240|Vitrectomy|vitrectomy
4990858|NCT04049240|Airway management|airway management
4990859|NCT04049188|Cancer Patients Hospice Care|cancer patients hospice care
4990860|NCT04049188|Palliative Radiation Therapy|palliative radiation therapy
4990861|NCT04049162|Blueberries|blueberries
4990862|NCT04049162|Pulse Wave Velocity|pulse wave velocity
4990863|NCT04049162|Aging|aging
4990877|NCT04049006|randomized Controlled trials|randomized controlled trials
4991093|NCT04047875|progestogen-only contraceptives|progestogen-only contraceptives
4991094|NCT04047875|etonogestrel-releasing implant|etonogestrel-releasing implant
4991095|NCT04047862|BGB-A1217|bgb-a1217
4991213|NCT04047173|Radiofrequency Ablation|radiofrequency ablation
4991214|NCT04047173|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
4991215|NCT04047160|Primary Biliary Cholangitis (PBC)|primary biliary cholangitis (pbc)
4991216|NCT04047160|Liver Cirrhosis, Biliary|liver cirrhosis, biliary
4991217|NCT04047160|Cholangitis, Chronic Nonsuppurative Destructive|cholangitis, chronic nonsuppurative destructive
4991218|NCT04047160|Liver Cirrhosis, Obstructive|liver cirrhosis, obstructive
4991300|NCT04046835|Three-dimensional optical surface scanning|three-dimensional optical surface scanning
4991301|NCT04046835|Patient position|patient position
4991302|NCT04046822|obesity|obesity
4991303|NCT04046822|liraglutide|liraglutide
4991304|NCT04046822|gut microbiome|gut microbiome
4991305|NCT04046796|Rare Diseases|rare diseases
4991306|NCT04046796|Genetic Predisposition|genetic predisposition
4991307|NCT04046796|Omics Technology|omics technology
4991308|NCT04046796|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
4991394|NCT04046367|nutrition|nutrition
4991513|NCT04045678|LY03003|ly03003
4991517|NCT04045652|HPV|hpv
4991518|NCT04045652|HIV|hiv
4991519|NCT04045613|metastatic urothelial cancer|metastatic urothelial cancer
4991520|NCT04045613|bladder cancer|bladder cancer
4991521|NCT04045613|Fibroblast Growth Factor Receptor|fibroblast growth factor receptor
4991522|NCT04045613|FGFR genetic aberration|fgfr genetic aberration
4991523|NCT04045613|targeted therapy|targeted therapy
4991524|NCT04045613|derazantinib|derazantinib
4991525|NCT04045613|checkpoint inhibitor|checkpoint inhibitor
4991532|NCT04045574|PICN|picn
4991691|NCT04044560|acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant|acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant
4991692|NCT04044547|Parkinson disease|parkinson disease
4991693|NCT04044547|LY03003|ly03003
4991694|NCT04044534|Intranasal insulin|intranasal insulin
4991695|NCT04044534|PTSD|ptsd
4991799|NCT04044001|Tolerability|tolerability
4991800|NCT04044001|Bactericidal Activity|bactericidal activity
4991801|NCT04043962|chronic pain|chronic pain
4991917|NCT04043390|C Reactive Protein|c reactive protein
4991918|NCT04043390|Xpert HIV-1 VL|xpert hiv-1 vl
4991919|NCT04043390|Truenat HIV-1 VL|truenat hiv-1 vl
4991920|NCT04043390|C Reactive Protein QUBE|c reactive protein qube
4991921|NCT04043377|Coronary atherosclerosis|coronary atherosclerosis
4991922|NCT04043377|68Ga-DOTATATE|68ga-dotatate
4991923|NCT04043377|PET-CTA imaging|pet-cta imaging
4991924|NCT04043377|No significant myocardial ischemia|no significant myocardial ischemia
4992006|NCT04042792|peak ADA concentration|peak ada concentration
4992007|NCT04042792|Pediatric inflammatory rheumatic diseases|pediatric inflammatory rheumatic diseases
4992008|NCT04042779|Multiple task training|multiple task training
4992009|NCT04042779|Single task training|single task training
4992253|NCT04041401|paediatric intensive care unit|paediatric intensive care unit
4992255|NCT04041401|PTSD|ptsd
4992256|NCT04041401|storybook|storybook
4992257|NCT04041401|Narrative|narrative
4992258|NCT04041401|Feasibility|feasibility
4992259|NCT04041401|Case-series|case-series
4992260|NCT04041388|Transpalatal|transpalatal
4992261|NCT04041388|Maxillary expansion|maxillary expansion
4992262|NCT04041388|Tooth-borne|tooth-borne
4992277|NCT04041336|Hip fracture surgery|hip fracture surgery
4992278|NCT04041336|Optical coherence tomography|optical coherence tomography
4992279|NCT04041323|AKI|aki
4992281|NCT04041323|ICU|icu
4992282|NCT04041323|postoperative|postoperative
4992283|NCT04041297|Non Small Cell Lung Cancer|non small cell lung cancer
4992390|NCT04040829|Mixed qualitative and quantitative methodology|mixed qualitative and quantitative methodology
4992391|NCT04040803|transcranial alternating current stimulation|transcranial alternating current stimulation
4992392|NCT04040803|transcranial random noise stimulation|transcranial random noise stimulation
4992394|NCT04040803|full spectrum|full spectrum
4992395|NCT04040790|visual acuity|visual acuity
4992531|NCT04040010|Postmenopausal women|postmenopausal women
4992532|NCT04040010|bone markers|bone markers
4992632|NCT04039568|Health Enhancement Program|health enhancement program
4992633|NCT04039542|Feasibility|feasibility
4992634|NCT04039542|Compassion Focussed Therapy|compassion focussed therapy
4992635|NCT04039542|Older adults|older adults
4992636|NCT04039529|lung biopsy|lung biopsy
4993110|NCT04036578|pelvic floor dysfunction|pelvic floor dysfunction
4993111|NCT04036578|pelvic floor muscle training|pelvic floor muscle training
4993112|NCT04036578|pelvic organ prolapse|pelvic organ prolapse
4993113|NCT04036578|surface electromyographic program|surface electromyographic program
4993114|NCT04036565|Sunlight|sunlight
4993204|NCT04036058|Barrier Precautions|barrier precautions
4993205|NCT04036045|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
4993206|NCT04036019|B cell lymphoma received prior CD19 CAR-T therapy|b cell lymphoma received prior cd19 car-t therapy
4993207|NCT04036006|Behavioral intervention|behavioral intervention
4993208|NCT04036006|Lifestyle|lifestyle
4993250|NCT04035811|ACH|ach
4993311|NCT04035668|Immune System Diseases|immune system diseases
4993312|NCT04035655|Disorders of consciousness|disorders of consciousness
4993313|NCT04035655|Transcranial direct current stimulation|transcranial direct current stimulation
4993314|NCT04035655|Electroencephalography|electroencephalography
4993316|NCT04035655|Coma Recovery Scale - Revised|coma recovery scale - revised
4993407|NCT04034979|shared-decision making|shared-decision making
4993408|NCT04034966|peritoneal dialysis|peritoneal dialysis
4993409|NCT04034966|Claria|claria
4993410|NCT04034966|telemedicine|telemedicine
4993411|NCT04034953|Cancer Screening|cancer screening
4993412|NCT04034953|Colorectal Cancer|colorectal cancer
4993413|NCT04034953|Breast Cancer|breast cancer
4993522|NCT04034316|Mesenchymal Stromal Cells|mesenchymal stromal cells
4993523|NCT04034316|Steroid Dependent Nephrotic Syndrome in Children|steroid dependent nephrotic syndrome in children
4993524|NCT04034316|Proteinuria|proteinuria
4993525|NCT04034316|Immunosuppressive treatment|immunosuppressive treatment
4993526|NCT04034290|influenza|influenza
4993527|NCT04034290|vaccine|vaccine
4993528|NCT04034290|Immunologic Factors|immunologic factors
4993529|NCT04034290|Respiratory Tract Infections|respiratory tract infections
4993656|NCT04033705|Continuous glucose monitoring|continuous glucose monitoring
4993657|NCT04033705|CGM|cgm
4993658|NCT04033679|Magnetic resonance imaging|magnetic resonance imaging
4993659|NCT04033679|Brain stimulation|brain stimulation
4993871|NCT04032366|Hypoxemia|hypoxemia
4993872|NCT04032366|Type A acute aortic dissection|type a acute aortic dissection
4993873|NCT04032366|inhaled nitric oxide|inhaled nitric oxide
4993874|NCT04032301|ketamine|ketamine
4993875|NCT04032301|stress disorders, post-traumatic|stress disorders, post-traumatic
4993876|NCT04032301|stress disorders, traumatic|stress disorders, traumatic
4993877|NCT04032301|anxiety disorders|anxiety disorders
4993878|NCT04032301|mental disorders|mental disorders
4993879|NCT04032301|adjuvants, anesthesia|adjuvants, anesthesia
4993880|NCT04032301|analgesics|analgesics
4993881|NCT04032301|anesthetics|anesthetics
4993882|NCT04032301|anesthetics, dissociative|anesthetics, dissociative
4993883|NCT04032301|anesthetics, general|anesthetics, general
4993884|NCT04032301|anesthetics, intravenous|anesthetics, intravenous
4993885|NCT04032301|excitatory amino acid agents|excitatory amino acid agents
4993886|NCT04032301|excitatory amino acid antagonists|excitatory amino acid antagonists
4993887|NCT04032301|hypnotics and sedatives|hypnotics and sedatives
4993888|NCT04032301|molecular mechanisms of pharmacological action|molecular mechanisms of pharmacological action
4993889|NCT04032301|neurotransmitter agents|neurotransmitter agents
4993890|NCT04032301|peripheral nervous system agents|peripheral nervous system agents
4993891|NCT04032301|pharmacologic actions|pharmacologic actions
4993892|NCT04032301|physiological effects of drugs|physiological effects of drugs
4993893|NCT04032301|psychotropic drugs|psychotropic drugs
4993894|NCT04032301|sensory system agents|sensory system agents
4993903|NCT04032288|ARDS|ards
4993941|NCT04032093|Respiratory Syncytial Virus|respiratory syncytial virus
4993942|NCT04032093|RSV|rsv
4993943|NCT04032093|Vaccine|vaccine
4993944|NCT04032067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
4993945|NCT04032067|GV1001|gv1001
4994039|NCT04031443|antibiotic resistance|antibiotic resistance
4994040|NCT04031430|remote monitoring|remote monitoring
4994041|NCT04031430|gestational hypertensive disorders|gestational hypertensive disorders
4994042|NCT04031430|pregnancy outcomes|pregnancy outcomes
4994043|NCT04031391|physical activity|physical activity
4994150|NCT04030715|Eradication Rate|eradication rate
4994151|NCT04030689|HIV Testing|hiv testing
4994152|NCT04030689|Combined HIV prevention|combined hiv prevention
4994153|NCT04030689|Linkage to care|linkage to care
4994154|NCT04030689|Implementation plan|implementation plan
4994262|NCT04029896|spastic|spastic
4994374|NCT04029103|health technology|health technology
4994375|NCT04029103|mobile application|mobile application
4994376|NCT04029064|right aortic arch|right aortic arch
4994377|NCT04029064|congenital heart disease|congenital heart disease
4994378|NCT04029064|pediatrics|pediatrics
4994379|NCT04029064|cardiology|cardiology
4994380|NCT04029064|prenatal diagnosis|prenatal diagnosis
4994382|NCT04029025|Dentalwings DWOS Intraoral Scan|dentalwings dwos intraoral scan
4994462|NCT04028505|Continuous Infusion|continuous infusion
4994463|NCT04028505|Bolus Form|bolus form
4994464|NCT04028492|gastroparesis|gastroparesis
4994465|NCT04028492|idiopathic|idiopathic
4994466|NCT04028492|diabetic|diabetic
4994467|NCT04028492|tradipitant|tradipitant
4994468|NCT04028492|nausea|nausea
4994469|NCT04028492|vomiting|vomiting
4994470|NCT04028492|stomach|stomach
4994471|NCT04028492|motility|motility
4994472|NCT04028492|functional|functional
4994473|NCT04028492|NK-1 antagonist|nk-1 antagonist
4994574|NCT04027790|plasma|plasma
4994575|NCT04027790|cell-free DNA|cell-free dna
4994676|NCT04027010|juvenile justice|juvenile justice
4994677|NCT04027010|male-focused intervention|male-focused intervention
4994678|NCT04027010|unplanned teen fatherhood|unplanned teen fatherhood
4994679|NCT04027010|technology-based intervention|technology-based intervention
4994680|NCT04026971|obesity|obesity
4994681|NCT04026971|phone application|phone application
4994682|NCT04026971|nutrition education|nutrition education
4994771|NCT04026425|cardiopulmonary exercise test (CPET)|cardiopulmonary exercise test (cpet)
4994772|NCT04026425|post-exertional malaise (PEM)|post-exertional malaise (pem)
4994773|NCT04026399|physical stimulation|physical stimulation
4994774|NCT04026399|Subliminal stimulation|subliminal stimulation
4994775|NCT04026399|stroke rehabilitation|stroke rehabilitation
4994776|NCT04026399|upper extremity|upper extremity
4994777|NCT04026399|paresis|paresis
4994778|NCT04026399|hand function|hand function
4994779|NCT04026399|occupational therapy|occupational therapy
4994780|NCT04026399|physical therapy|physical therapy
4994781|NCT04026360|Infants|infants
4994782|NCT04026360|Cystic Fibrosis|cystic fibrosis
4994783|NCT04026360|Inflammation|inflammation
4994784|NCT04026360|Microbiome|microbiome
4994875|NCT04025892|pregnancy|pregnancy
4994876|NCT04025892|digital health|digital health
4994877|NCT04025892|daily weighing|daily weighing
4994878|NCT04025866|conventional rehabilitation|conventional rehabilitation
4994879|NCT04025866|arm ergometer|arm ergometer
4994880|NCT04025866|aerobic exercise|aerobic exercise
4994881|NCT04025866|intertrochanteric fractures|intertrochanteric fractures
4994882|NCT04025840|Pancreatic cancer|pancreatic cancer
4994883|NCT04025840|Radical resection|radical resection
4994884|NCT04025840|Epidural block|epidural block
4994885|NCT04025840|Dexamethasone|dexamethasone
4994904|NCT04025658|twin|twin
4994980|NCT04025190|collaborative care|collaborative care
4994981|NCT04025190|psycho-oncology|psycho-oncology
4994982|NCT04025190|bone marrow transplant|bone marrow transplant
4994983|NCT04025177|Indomethacin|indomethacin
4994984|NCT04025177|Pharmacokinetics|pharmacokinetics
4994985|NCT04025177|Preterm birth|preterm birth
4994986|NCT04025177|Pharmacodynamics|pharmacodynamics
4994987|NCT04025164|Hypofractionated radiotherapy|hypofractionated radiotherapy
4994988|NCT04025164|Breast Conserving Surery|breast conserving surery
4995072|NCT04024813|Cholangitis|cholangitis
4995073|NCT04024813|Bile Duct Diseases|bile duct diseases
4995088|NCT04024709|POP|pop
4995183|NCT04023916|PD-L1|pd-l1
4995184|NCT04023903|Bardoxolone Methyl|bardoxolone methyl
4995307|NCT04023188|deep learning|deep learning
4995308|NCT04023188|diagnosis|diagnosis
4995412|NCT04022538|Vertical bone augmentation|vertical bone augmentation
4995413|NCT04022538|Inlay bone graft|inlay bone graft
4995414|NCT04022538|Dental Implants|dental implants
4995420|NCT04022486|Infant|infant
4995536|NCT04021628|seropositive|seropositive
4995537|NCT04021628|maternal|maternal
4995538|NCT04021615|rehabilitation|rehabilitation
4995539|NCT04021615|general surgery|general surgery
4995646|NCT04020939|SPY imaging|spy imaging
4995647|NCT04020939|indocyanine green|indocyanine green
4995648|NCT04020939|pediatric surgery|pediatric surgery
4995649|NCT04020939|ICG|icg
4995650|NCT04020939|intestinal resections|intestinal resections
4995651|NCT04020939|intestinal perfusion|intestinal perfusion
4995652|NCT04020926|hyponatremia|hyponatremia
4995653|NCT04020913|GH|gh
4995778|NCT04020172|tissue flap oxygenation|tissue flap oxygenation
4995779|NCT04020172|DIEP flap breast reconstruction surgery|diep flap breast reconstruction surgery
4995780|NCT04020146|periodontitis|periodontitis
4995781|NCT04020146|periimplantitis|periimplantitis
4995909|NCT04019444|Adults|adults
4996020|NCT04018846|Peripheral Artery Disease|peripheral artery disease
4996021|NCT04018846|Revascularization|revascularization
4996022|NCT04018846|Graft|graft
4996023|NCT04018846|Vein|vein
4996024|NCT04018846|Artery|artery
4996025|NCT04018846|Limb|limb
4996026|NCT04018846|Amputation|amputation
4996027|NCT04018833|Diabetic Macular Edema|diabetic macular edema
4996028|NCT04018833|Bevacizumab|bevacizumab
4996032|NCT04018833|OCT|oct
4996118|NCT04018183|non-small cell lung cancer|non-small cell lung cancer
4996120|NCT04018157|ketodex, ketofol , agitation , nasal surgery|ketodex, ketofol , agitation , nasal surgery
4996220|NCT04017624|Fruit and vegetable consumption|fruit and vegetable consumption
4996221|NCT04017598|anemia|anemia
4996222|NCT04017598|gut inflammation|gut inflammation
4996223|NCT04017598|iron deficiency|iron deficiency
4996224|NCT04017598|iron|iron
4996225|NCT04017598|iron supplementation|iron supplementation
4996226|NCT04017585|gluten free diet|gluten free diet
4996227|NCT04017585|FODMAPs|fodmaps
4996228|NCT04017585|gastrointestinal symptoms|gastrointestinal symptoms
4996229|NCT04017572|dialysis|dialysis
4996230|NCT04017572|peritoneal dialysis|peritoneal dialysis
4996231|NCT04017546|CYC065|cyc065
4996232|NCT04017546|CDK2/9|cdk2/9
4996233|NCT04017546|venetoclax|venetoclax
4996234|NCT04017546|BCL-2|bcl-2
4996235|NCT04017546|MCL-1|mcl-1
4996236|NCT04017546|Relapsed|relapsed
4996237|NCT04017546|Refractory|refractory
4996238|NCT04017546|acute myeloid leukemia|acute myeloid leukemia
4996239|NCT04017546|myelodysplastic syndromes|myelodysplastic syndromes
4996240|NCT04017546|AML|aml
4996444|NCT04016246|premature infant|premature infant
4996446|NCT04016233|Tenofovir|tenofovir
4996447|NCT04016233|Tenofovir douche|tenofovir douche
4996448|NCT04016220|asthma|asthma
4996449|NCT04016220|budesonide|budesonide
4996450|NCT04016220|nebulized|nebulized
4996451|NCT04016220|adult|adult
4996452|NCT04016194|Multiple-breath washout, MBW|multiple-breath washout, mbw
4996453|NCT04016194|Lung clearance index, LCI|lung clearance index, lci
4996454|NCT04016194|Prediction|prediction
4996455|NCT04016194|Survival|survival
4996456|NCT04016194|Cystic Fibrosis, CF|cystic fibrosis, cf
4996543|NCT04015544|L-arginine|l-arginine
4996544|NCT04015531|breast cancer|breast cancer
4996545|NCT04015531|radiotherapy|radiotherapy
4996546|NCT04015531|hypofractionated therapy|hypofractionated therapy
4996547|NCT04015531|nodal irradiation|nodal irradiation
4996548|NCT04015479|muscle protein synthesis|muscle protein synthesis
4996549|NCT04015479|resistance training|resistance training
4996550|NCT04015479|protein supplementation|protein supplementation
4996646|NCT04014998|proprioception|proprioception
4996647|NCT04014998|balance|balance
4996648|NCT04014959|depression|depression
4996649|NCT04014959|TMS|tms
4996650|NCT04014959|fMRI|fmri
4996771|NCT04014218|ARDS|ards
4996772|NCT04014218|sepsis|sepsis
4996773|NCT04014218|outcome|outcome
4996774|NCT04014192|Sodium and Glucose Synergistic Transporter 2 Inhibitor|sodium and glucose synergistic transporter 2 inhibitor
4996775|NCT04014192|Beta Cell Function|beta cell function
4996776|NCT04014192|Alpha Cell Function|alpha cell function
4996777|NCT04014192|Insulin Sensitivity|insulin sensitivity
4996890|NCT04013451|kindness|kindness
4996891|NCT04013451|social interaction anxiety|social interaction anxiety
4997149|NCT04012021|cirrhosis|cirrhosis
4997150|NCT04012021|steatosis|steatosis
4997153|NCT04012021|7 tesla|7 tesla
4997243|NCT04011436|patellofemoral pain AND physiotherapy|patellofemoral pain and physiotherapy
4997244|NCT04011423|Unstable Shoes|unstable shoes
4997245|NCT04011423|Whole Body Vibration|whole body vibration
4997250|NCT04011397|Diabetes|diabetes
4997395|NCT04010591|Pediatric patients|pediatric patients
4997396|NCT04010591|Voiding Dysfunction|voiding dysfunction
4997397|NCT04010591|urodynamic study|urodynamic study
4997398|NCT04010578|Vitamin K2|vitamin k2
4997399|NCT04010578|18F-NaF|18f-naf
4997492|NCT04009837|hip pain|hip pain
4997493|NCT04009811|Randomized controlled trial|randomized controlled trial
4997494|NCT04009811|Palatal obturators|palatal obturators
4997495|NCT04009798|heart failure|heart failure
4997496|NCT04009798|risk prediction|risk prediction
4997497|NCT04009798|prognosis|prognosis
4997498|NCT04009772|Cefepime, Cefuroxime, Metronidazole, Cesarean, Intrapartum|cefepime, cefuroxime, metronidazole, cesarean, intrapartum
4997499|NCT04009759|cardiac arrest|cardiac arrest
4997500|NCT04009759|Morphine|morphine
4997602|NCT04009226|Muscular Dystrophies|muscular dystrophies
4997604|NCT04009226|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
4997712|NCT04008628|children|children
4997713|NCT04008628|infants|infants
4997714|NCT04008628|analgesia|analgesia
4997715|NCT04008628|nitrous oxide|nitrous oxide
4997716|NCT04008602|Cooling|cooling
4997717|NCT04008602|Criotherapy|criotherapy
4997718|NCT04008602|Strenght|strenght
4997719|NCT04008602|Plyometric exercise|plyometric exercise
4997720|NCT04008576|Transdiagnostic CBT|transdiagnostic cbt
4997827|NCT04007822|therapeutic alliance|therapeutic alliance
4997828|NCT04007822|communication|communication
4997829|NCT04007809|type 1 diabetes|type 1 diabetes
4997830|NCT04007809|children|children
4997831|NCT04007809|biomarkers|biomarkers
4997839|NCT04007796|PTSD|ptsd
4997951|NCT04007250|Magnetic Anal Sphincter|magnetic anal sphincter
4997952|NCT04007237|mycological efficacy|mycological efficacy
4997953|NCT04007237|ketoconazole|ketoconazole
4997954|NCT04007237|selenium disulfide 1,8%|selenium disulfide 1,8%
4997955|NCT04007237|Pityriasis versicolor|pityriasis versicolor
4997956|NCT04007198|moderate-to-severe asthma|moderate-to-severe asthma
4997957|NCT04007185|quality of life|quality of life
4997958|NCT04007185|cognitive function|cognitive function
4997959|NCT04007185|visual function|visual function
4997961|NCT04007172|neural therapy|neural therapy
4997962|NCT04007172|physical theraphy|physical theraphy
4998050|NCT04006561|Neurocognitive Function (NCF)|neurocognitive function (ncf)
4998051|NCT04006561|Whole-Brain Radiation Therapy (WBRT)|whole-brain radiation therapy (wbrt)
4998052|NCT04006561|Simultaneous Integrated Boost (SIB)|simultaneous integrated boost (sib)
4998053|NCT04006561|Hyperfractionation|hyperfractionation
4998054|NCT04006561|Radiotherapy|radiotherapy
4998055|NCT04006561|Chemotherapy|chemotherapy
4998056|NCT04006561|Neurotoxicity|neurotoxicity
4998057|NCT04006535|Vasculitis|vasculitis
4998058|NCT04006522|renal cell carcinoma|renal cell carcinoma
4998059|NCT04006522|atezolizumab|atezolizumab
4998060|NCT04006522|PET/CT|pet/ct
4998061|NCT04006509|preterm breast milk|preterm breast milk
4998071|NCT04006366|bariatrics|bariatrics
4998072|NCT04006314|platelet rich plasma; neural prolotherapy|platelet rich plasma; neural prolotherapy
4998154|NCT04005729|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
4998155|NCT04005729|induced hypothermia|induced hypothermia
4998157|NCT04005703|Malignant lymphoma|malignant lymphoma
4998263|NCT04005183|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
4998264|NCT04005183|Neoplasms by Histologic Type|neoplasms by histologic type
4998265|NCT04005183|Kidney Neoplasms|kidney neoplasms
4998266|NCT04005183|Urologic Neoplasms|urologic neoplasms
4998267|NCT04005183|Urogenital Neoplasms|urogenital neoplasms
4998268|NCT04005183|Neoplasms by Site|neoplasms by site
4998269|NCT04005183|Kidney Diseases|kidney diseases
4998270|NCT04005183|Urologic Diseases|urologic diseases
4998271|NCT04005170|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
4998368|NCT04004507|Night Vision Disturbances|night vision disturbances
4998369|NCT04004507|NVD|nvd
4998370|NCT04004507|Glare|glare
4998371|NCT04004507|Halos|halos
4998372|NCT04004507|Starbursts|starbursts
4998373|NCT04004507|Nyxol|nyxol
4998374|NCT04004494|segmentectomy|segmentectomy
5342924|NCT01981486|tolerability|tolerability
4998375|NCT04004494|Video-assisted thoracoscopic surgery|video-assisted thoracoscopic surgery
4998478|NCT04004000|Atrophic Muscular Diseases|atrophic muscular diseases
4998479|NCT04004000|Musculoskeletal Diseases|musculoskeletal diseases
4998480|NCT04004000|Neuromuscular Diseases|neuromuscular diseases
4998482|NCT04003974|Muscular Dystrophies|muscular dystrophies
4998483|NCT04003974|Muscular Dystrophy|muscular dystrophy
4998484|NCT04003974|Facioscapulohumeral Muscular Disorders|facioscapulohumeral muscular disorders
4998641|NCT04003090|glaucoma|glaucoma
4998642|NCT04003090|retinal ganglion cells|retinal ganglion cells
4998643|NCT04003090|neuroprotective effect|neuroprotective effect
4998644|NCT04003077|Laser meridian massage|laser meridian massage
4998645|NCT04003077|heroin addicts|heroin addicts
4998861|NCT04001647|Aging|aging
4998862|NCT04001647|Obesity|obesity
4998863|NCT04001647|TUDCA|tudca
4998867|NCT04001595|Congenital Muscular Dystrophy|congenital muscular dystrophy
4998868|NCT04001595|Muscle-Eye-Brain Disease|muscle-eye-brain disease
4998869|NCT04001595|Walker-Warburg Syndrome|walker-warburg syndrome
4998870|NCT04001595|FKRP gene mutation|fkrp gene mutation
4998871|NCT04001582|FSHD|fshd
4999077|NCT04000477|Endocervical curettage|endocervical curettage
4999078|NCT04000477|Kevorkian|kevorkian
4999181|NCT03999905|Mystery patient|mystery patient
4999182|NCT03999905|Oral anticoagulant|oral anticoagulant
4999293|NCT03999229|Anemia-induced tissue hypoxia|anemia-induced tissue hypoxia
4999294|NCT03999229|Red blood cell Transfusion|red blood cell transfusion
4999295|NCT03999216|diuretics|diuretics
4999302|NCT03999151|Exercise|exercise
4999304|NCT03999151|Lifestyle|lifestyle
4999433|NCT03998241|movement analysis|movement analysis
4999435|NCT03998202|Myopenia|myopenia
4999562|NCT03997643|Randomized Trial|randomized trial
4999697|NCT03996798|disability case manager|disability case manager
4999698|NCT03996785|Clinical depression|clinical depression
4999700|NCT03996785|Group-walking|group-walking
4999800|NCT03996486|Anti-tissue factor pathway inhibitor (aTFPI)|anti-tissue factor pathway inhibitor (atfpi)
4999801|NCT03996486|Human monoclonal immunoglobulin G2 antibody|human monoclonal immunoglobulin g2 antibody
4999804|NCT03996421|Prebiotics|prebiotics
4999815|NCT03996369|APD334|apd334
4999919|NCT03995407|Wound healing|wound healing
4999920|NCT03995381|Haemostasis|haemostasis
4999921|NCT03995368|Schizophrenia|schizophrenia
5000038|NCT03994705|CAR T-Cell|car t-cell
5000161|NCT03993977|blood transfusion|blood transfusion
5000162|NCT03993977|cancer|cancer
5000163|NCT03993977|surgery|surgery
5000164|NCT03993977|abdominal|abdominal
5000220|NCT03993847|SpA|spa
5000254|NCT03993678|abscopal effect|abscopal effect
5000255|NCT03993678|T cell stimulation|t cell stimulation
5000256|NCT03993639|Hematopoietic Stem Cells Mobilization|hematopoietic stem cells mobilization
5000257|NCT03993639|Healthy Volunteer (HV)|healthy volunteer (hv)
5000258|NCT03993639|filgrastim|filgrastim
5000350|NCT03993171|nanocrystal|nanocrystal
5000351|NCT03993171|NADH|nadh
5000355|NCT03993093|HIV|hiv
5000356|NCT03993093|Opportunistic infection|opportunistic infection
5000357|NCT03993093|CD4+ T cells|cd4+ t cells
5000358|NCT03993093|AIDS defining condition|aids defining condition
5000359|NCT03993080|dental anxiety|dental anxiety
5000360|NCT03993080|virtual reality|virtual reality
5000453|NCT03992430|Duchenne|duchenne
5000454|NCT03992430|EXONDYS|exondys
5000457|NCT03992365|non-inferiority|non-inferiority
5000458|NCT03992274|HIV prevention|hiv prevention
5000459|NCT03992274|Implementation science|implementation science
5000460|NCT03992274|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5000461|NCT03992274|Men who have sex with men|men who have sex with men
5000463|NCT03992248|TRF; hepatic glycogen; type 2 diabetes; insulin sensitivity|trf; hepatic glycogen; type 2 diabetes; insulin sensitivity
5000689|NCT03991000|Anemia|anemia
5000805|NCT03990129|Basel Cocktail|basel cocktail
5000931|NCT03989414|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
4996519|NCT04015609|Spanish|spanish
5001043|NCT03988959|salivary gland tumor|salivary gland tumor
5001044|NCT03988933|Latent Tuberculosis|latent tuberculosis
5001045|NCT03988933|Rifampin|rifampin
5001046|NCT03988933|Short Treatment for Latent Tuberculosis|short treatment for latent tuberculosis
5001047|NCT03988933|High dose rifampin|high dose rifampin
5001152|NCT03988218|Body awareness|body awareness
5001275|NCT03987412|Behavioral intervention|behavioral intervention
5001283|NCT03987399|children|children
5001376|NCT03986658|Major Depressive Disorder|major depressive disorder
5001377|NCT03986658|Repetitive Transcranial Magnetic Stimulation (rTMS)|repetitive transcranial magnetic stimulation (rtms)
5001378|NCT03986658|Treatment-Resistant Depression|treatment-resistant depression
5001379|NCT03986658|Adolescents|adolescents
5001380|NCT03986645|4DFlow|4dflow
5001432|NCT03986294|S1|s1
5001495|NCT03986047|Thermal therapy|thermal therapy
5001496|NCT03986047|Exercises|exercises
5001497|NCT03986047|Pain|pain
5001618|NCT03985397|compliance to diet|compliance to diet
5001619|NCT03985397|CARRF-KL.|carrf-kl.
5001620|NCT03985371|Band Keratopathy|band keratopathy
5001621|NCT03985358|opioid counseling|opioid counseling
5001625|NCT03985306|Diabetic foot ulcer|diabetic foot ulcer
5001830|NCT03984214|THC|thc
5001840|NCT03984201|Chronic Pain|chronic pain
5006009|NCT03959124|magnetic resonance image|magnetic resonance image
5001972|NCT03983590|palliative care|palliative care
5001843|NCT03984201|Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)|stanford accelerated intelligent neuromodulation therapy (saint)
5001844|NCT03984188|Biomass Associated COPD|biomass associated copd
5001845|NCT03984188|Low-dose Theophylline|low-dose theophylline
5001946|NCT03983720|Multiple sclerosis|multiple sclerosis
5001947|NCT03983720|Chronic fatigue|chronic fatigue
5001948|NCT03983707|Purastat|purastat
5001949|NCT03983681|Multiple Sclerosis|multiple sclerosis
5001950|NCT03983681|MS|ms
5001951|NCT03983681|Relapsing-Remitting MS|relapsing-remitting ms
5001952|NCT03983681|Progressive MS|progressive ms
5001953|NCT03983681|RRMS|rrms
5001954|NCT03983681|PPMS|ppms
5001955|NCT03983681|SPMS|spms
5001956|NCT03983681|Primary Progressive|primary progressive
5001958|NCT03983642|Dynamic balance|dynamic balance
5002069|NCT03982992|MC|mc
5002148|NCT03982394|Biologics|biologics
5002149|NCT03982394|Psoriasis Vulgaris|psoriasis vulgaris
5002150|NCT03982355|Cancer|cancer
5018107|NCT03883607|Pediatric|pediatric
5002151|NCT03982342|catheter closure|catheter closure
5002154|NCT03982290|autism|autism
5002247|NCT03981679|cfDNA|cfdna
5002248|NCT03981679|Intplex|intplex
5002249|NCT03981679|colorectal cancer|colorectal cancer
5002250|NCT03981640|Exercise|exercise
5002346|NCT03981133|sudden unexpected infant death|sudden unexpected infant death
5002347|NCT03981120|In-vitro fertilization|in-vitro fertilization
5002348|NCT03981120|acupuncture|acupuncture
5002349|NCT03981120|preimplantation genetic screening|preimplantation genetic screening
5002350|NCT03981120|pregnancy|pregnancy
5002351|NCT03981120|laser|laser
5002352|NCT03981120|miscarriage|miscarriage
5006010|NCT03959098|Korean Medicine|korean medicine
5002353|NCT03981107|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5002354|NCT03981107|Chest compressions only CPR|chest compressions only cpr
5002355|NCT03981107|Dispatcher assisted CPR|dispatcher assisted cpr
5002359|NCT03981081|Steroids|steroids
5002557|NCT03979872|MC1R Genetic Testing|mc1r genetic testing
5002558|NCT03979742|Spinal Cord Injury|spinal cord injury
5002559|NCT03979742|Umbilical Cord Blood|umbilical cord blood
5002560|NCT03979742|Injured Spinal Cord|injured spinal cord
5002561|NCT03979742|Lithium Carbonate|lithium carbonate
5002562|NCT03979703|fibrosing interstitial lung disease|fibrosing interstitial lung disease
5002563|NCT03979703|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5002659|NCT03979300|Medical|medical
5002660|NCT03979300|Psychology|psychology
5002661|NCT03979300|Educational|educational
5002662|NCT03979300|Learning|learning
5002663|NCT03979287|Chronic Neck Pain|chronic neck pain
5002664|NCT03979287|Interferential Current Electrotherapy|interferential current electrotherapy
5002665|NCT03979287|Therapeutic Exercise|therapeutic exercise
5002666|NCT03979287|Physical Therapy|physical therapy
5002667|NCT03979274|Eutirox|eutirox
5002752|NCT03978663|immune priming|immune priming
5002753|NCT03978663|radiation therapy|radiation therapy
5002754|NCT03978663|neoadjuvant radiation|neoadjuvant radiation
5003110|NCT03976739|gastric cancer; helicobacter pylori; precancerous lesion; bile reflux|gastric cancer; helicobacter pylori; precancerous lesion; bile reflux
5003111|NCT03976726|Laryngel Mask|laryngel mask
5003112|NCT03976713|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5003113|NCT03976713|Bufei Yishen Granule|bufei yishen granule
5003114|NCT03976713|Randomized Controlled Trial|randomized controlled trial
5003120|NCT03976674|Obesity|obesity
5003206|NCT03976063|Nifedipine|nifedipine
5003207|NCT03976063|Latency|latency
5003208|NCT03976063|Neonatal outcome|neonatal outcome
5003209|NCT03976063|Preterm birth|preterm birth
5003210|NCT03976063|Randomized controlled trial|randomized controlled trial
5003312|NCT03975543|Inherited Eye Diseases|inherited eye diseases
5003313|NCT03975543|Vision Disorders|vision disorders
5003314|NCT03975543|Inherited Retinal Disorders|inherited retinal disorders
5003315|NCT03975543|Rod-Cone Dystrophy|rod-cone dystrophy
5003317|NCT03975530|American Indian|american indian
5003515|NCT03974230|chromosome 18|chromosome 18
5003516|NCT03974230|genetic|genetic
5003517|NCT03974217|Leukemia|leukemia
5003733|NCT03973021|very small embryonic-like stem cell|very small embryonic-like stem cell
5003734|NCT03973008|Gastric Adenocarcinoma|gastric adenocarcinoma
5003735|NCT03973008|Adjuvant Radiotherapy|adjuvant radiotherapy
5003736|NCT03972969|Parkinson's disease|parkinson's disease
5003945|NCT03971513|Post operative pain|post operative pain
5003946|NCT03971487|schizo-affective psychosis|schizo-affective psychosis
5003947|NCT03971487|schizophrenia|schizophrenia
5003949|NCT03971448|Removable device/boot|removable device/boot
5003950|NCT03971448|Immobilization strategy|immobilization strategy
5003951|NCT03971448|Emergency Department|emergency department
5003952|NCT03971435|child care|child care
5003953|NCT03971435|child development|child development
5003954|NCT03971435|child health|child health
5003955|NCT03971435|child nutrition|child nutrition
5003957|NCT03971435|children|children
5019904|NCT03872505|breast cancer|breast cancer
5004043|NCT03970837|GSK3196165|gsk3196165
5004044|NCT03970837|Tofacitinib|tofacitinib
5004218|NCT03969836|cerebral oxygenation|cerebral oxygenation
5004228|NCT03969732|Stroke|stroke
5004342|NCT03969199|Cirrhosis, Liver|cirrhosis, liver
5004343|NCT03969199|Liver Diseases|liver diseases
5004344|NCT03969199|Dietary compliance|dietary compliance
5004345|NCT03969199|Low sodium diet|low sodium diet
5004486|NCT03968419|CD8|cd8
5004557|NCT03967990|dietary fiber|dietary fiber
5004558|NCT03967990|whole grain|whole grain
5004559|NCT03967964|Gynaecology|gynaecology
5004560|NCT03967964|Obstetrics|obstetrics
5004561|NCT03967951|Radiomics|radiomics
5004562|NCT03967951|Pancretic neuroendocrine neoplasms (panNEN)|pancretic neuroendocrine neoplasms (pannen)
5004563|NCT03967925|proteinase 3|proteinase 3
5004564|NCT03967860|CT Scan|ct scan
5004565|NCT03967847|Rotator Cuff Tear|rotator cuff tear
5004566|NCT03967847|Postoperative Pain|postoperative pain
5004567|NCT03967834|Soft Tissue Sarcoma|soft tissue sarcoma
5004577|NCT03967808|Registry|registry
5004653|NCT03967418|sexual addiction|sexual addiction
5004654|NCT03967418|internet gaming disorder|internet gaming disorder
5004655|NCT03967418|eating disorders|eating disorders
5004656|NCT03967405|Wound|wound
5004657|NCT03967405|Imaging|imaging
5004658|NCT03967392|Bupivacaine,dexamethasone,Analgesia,Skin Graft ,Donor|bupivacaine,dexamethasone,analgesia,skin graft ,donor
5004659|NCT03967379|Other Cancer|other cancer
5004660|NCT03967366|Melatonin|melatonin
5004661|NCT03967366|coronary artery calcification|coronary artery calcification
5004662|NCT03967366|relation|relation
5004663|NCT03967353|Tuberculosis|tuberculosis
5004664|NCT03967353|Home Treatment Management|home treatment management
5004704|NCT03967093|DIPG|dipg
5004755|NCT03966846|kefir|kefir
5004860|NCT03966131|Speech|speech
5004987|NCT03965299|electrical stimulation|electrical stimulation
5004988|NCT03965299|paraplegia; tetraplegia|paraplegia; tetraplegia
5004990|NCT03965273|Child marriage|child marriage
5004991|NCT03965273|Tipping Point|tipping point
5005142|NCT03964363|preoperative period|preoperative period
5005143|NCT03964363|surgery|surgery
5005144|NCT03964363|breathing exercise|breathing exercise
5005145|NCT03964363|postoperative complications|postoperative complications
5005146|NCT03964363|resistance training|resistance training
5005147|NCT03964363|endurance training|endurance training
5005148|NCT03964363|anaesthesia|anaesthesia
5005149|NCT03964363|activities of daily living|activities of daily living
5005150|NCT03964363|patient reported outcome|patient reported outcome
5005151|NCT03964363|prehabilitation|prehabilitation
5005231|NCT03963752|Rapid Progressive|rapid progressive
5005232|NCT03963752|Integrative Chinese and Western Medicine|integrative chinese and western medicine
5005233|NCT03963752|Evidence-based Medicine|evidence-based medicine
5005234|NCT03963739|Prostate|prostate
5005235|NCT03963739|Adenocarcinoma|adenocarcinoma
5005236|NCT03963726|Radiotherapy|radiotherapy
5005253|NCT03963661|Stroke|stroke
5005333|NCT03963336|microthrombi|microthrombi
5005334|NCT03963336|anticoagulation|anticoagulation
5005335|NCT03963271|idiopathic ventricular fibrillation|idiopathic ventricular fibrillation
5005455|NCT03962452|Mitochondrial disease|mitochondrial disease
5005456|NCT03962452|Next Generation Sequencing (NGS)|next generation sequencing (ngs)
5005458|NCT03962439|Cognition|cognition
5005459|NCT03962439|Alzheimer's Disease|alzheimer's disease
5005460|NCT03962439|Memory|memory
5005461|NCT03962439|Engagement|engagement
5005462|NCT03962439|Digital Photography|digital photography
5005463|NCT03962439|Older Adults|older adults
5005464|NCT03962439|Neural Function|neural function
5005465|NCT03962439|Neuroimaging|neuroimaging
5005546|NCT03961997|Modafinil/adverse effects|modafinil/adverse effects
5005777|NCT03960528|postoperative opioid requirement|postoperative opioid requirement
5005778|NCT03960515|Rheumatoid Arthritis|rheumatoid arthritis
5005902|NCT03959839|Recurrence|recurrence
5005903|NCT03959839|R0|r0
5005904|NCT03959839|Safety|safety
5006121|NCT03958292|Microbiological evaluation|microbiological evaluation
5006122|NCT03958279|postvoiding residual volume|postvoiding residual volume
5006123|NCT03958279|early postpartum period|early postpartum period
5006124|NCT03958240|Head and Neck Cancer|head and neck cancer
5006125|NCT03958240|Ovarian Cancer|ovarian cancer
5006126|NCT03958240|Cervical Cancer|cervical cancer
5006127|NCT03958240|Cervical Intraepithelial Neoplasia 3|cervical intraepithelial neoplasia 3
5006128|NCT03958240|Glioblastoma Multiforme of Brain Stem|glioblastoma multiforme of brain stem
5006219|NCT03957564|Radical gastrectomy|radical gastrectomy
5006319|NCT03956940|intplex|intplex
5006320|NCT03956862|GB001|gb001
5006321|NCT03956862|Gossamer Bio|gossamer bio
5006322|NCT03956862|Gossamer|gossamer
5006323|NCT03956862|Nasal Polyposis|nasal polyposis
5006324|NCT03956862|CRSwNP|crswnp
5006325|NCT03956862|CRSsNP|crssnp
5006326|NCT03956849|overweight|overweight
5006327|NCT03956849|obesity|obesity
5006328|NCT03956849|pediatric obesity|pediatric obesity
5006329|NCT03956823|hypertension|hypertension
5006410|NCT03956420|Coronary Artery Bypass Surgery/Grafting, ERAS|coronary artery bypass surgery/grafting, eras
5006411|NCT03956407|Rehabilitation|rehabilitation
5006412|NCT03956407|Neuromodulation|neuromodulation
5006532|NCT03955549|Research on Schizophrenia in Egypt|research on schizophrenia in egypt
5006536|NCT03955536|Open Heart Surgery|open heart surgery
5006542|NCT03955497|Knee Osteoarthritis|knee osteoarthritis
5006543|NCT03955497|Stem Cell|stem cell
5006544|NCT03955497|Cartilage repair|cartilage repair
5006545|NCT03955484|Prostatic Hyperplasia|prostatic hyperplasia
5006546|NCT03955484|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5006774|NCT03954236|18-412|18-412
5006775|NCT03954210|Cognitive Behavioral Therapy for Insomnia|cognitive behavioral therapy for insomnia
5006776|NCT03954210|CBT-I|cbt-i
5006777|NCT03954210|Alzheimer's|alzheimer's
5006778|NCT03954210|Alzheimer's Disease|alzheimer's disease
5006779|NCT03954171|Epithelial Ovarian Cancer|epithelial ovarian cancer
5006780|NCT03954171|Platinum based-chemotherapy|platinum based-chemotherapy
5006781|NCT03954119|blood pressure|blood pressure
5006782|NCT03954119|emergency department|emergency department
5006783|NCT03954119|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease
5006784|NCT03954119|myocardial infarction|myocardial infarction
5006785|NCT03954119|stroke|stroke
5006786|NCT03954119|long-term prognosis|long-term prognosis
5006787|NCT03954106|CAR-T|car-t
5006796|NCT03954002|Transthoracic Echocardiography (TTE)|transthoracic echocardiography (tte)
5006797|NCT03954002|Transoesophageal Echocardiography (TOE)|transoesophageal echocardiography (toe)
5006808|NCT03953950|Peritoneal Dialysis|peritoneal dialysis
5006809|NCT03953950|Peritoneal Membrane|peritoneal membrane
5006821|NCT03953833|DLT|dlt
5006873|NCT03953469|heart rate|heart rate
5006874|NCT03953469|blood pressure|blood pressure
5006875|NCT03953456|Hepatic lipid composition|hepatic lipid composition
5006876|NCT03953456|Elafibranor|elafibranor
5006877|NCT03953456|Hepatic Glucose Production|hepatic glucose production
5006885|NCT03953365|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5006886|NCT03953365|cytoreduction surgery|cytoreduction surgery
5006887|NCT03953365|prophylactic mesh|prophylactic mesh
5006888|NCT03953352|Adaptive radiotherapy|adaptive radiotherapy
5006909|NCT03953222|Parkinson's disease|parkinson's disease
5007016|NCT03952520|Systems navigation|systems navigation
5007017|NCT03952520|Psychosocial counseling|psychosocial counseling
5007018|NCT03952520|Vietnam|vietnam
5007022|NCT03952468|suicide prevention|suicide prevention
5007023|NCT03952468|Veterans|veterans
5007024|NCT03952455|Nucleus Accumbens|nucleus accumbens
5007025|NCT03952455|Deep brain stimulation|deep brain stimulation
5007026|NCT03952455|Methadone|methadone
5007027|NCT03952442|gastric cancer|gastric cancer
5007028|NCT03952442|nutrition|nutrition
5007029|NCT03952442|health education|health education
5007031|NCT03952429|alcohol abuse|alcohol abuse
5007130|NCT03951870|fMRI Neurofeedback|fmri neurofeedback
5007132|NCT03951857|Obesity|obesity
5007133|NCT03951857|Single muscle fiber contractile properties|single muscle fiber contractile properties
5007134|NCT03951857|Intramyocellular lipids|intramyocellular lipids
5007135|NCT03951857|Resistance exercise|resistance exercise
5007136|NCT03951844|Exoskeleton|exoskeleton
5007137|NCT03951844|Upper limb|upper limb
5007138|NCT03951844|Assistive device|assistive device
5007139|NCT03951831|Cancer|cancer
5007140|NCT03951831|Chemoimmunotherapy|chemoimmunotherapy
5007150|NCT03951740|Mio Slice|mio slice
5007238|NCT03951246|eye tracking|eye tracking
5007239|NCT03951246|pediatric cancer|pediatric cancer
5707746|NCT00473304|Safety|safety
5007240|NCT03951246|posterior fossa tumors|posterior fossa tumors
5007340|NCT03950661|anxiety|anxiety
5007435|NCT03950063|Bone Infections|bone infections
5007436|NCT03950024|arthrogenic muscle inhibition|arthrogenic muscle inhibition
5007437|NCT03950024|anterior cruciate ligament|anterior cruciate ligament
5007447|NCT03949972|MCD|mcd
5007579|NCT03949088|Intradialytic hypotension (IDH)|intradialytic hypotension (idh)
5007580|NCT03949088|Ultrafiltration (UF) profiling|ultrafiltration (uf) profiling
5007582|NCT03949088|Hemodialysis|hemodialysis
5007809|NCT03947463|Pectoral Nerves I & II block, Serratus Plane Block, General Anesthesia, opioid analgesia, breast cancer and modified radical mastectomy|pectoral nerves i & ii block, serratus plane block, general anesthesia, opioid analgesia, breast cancer and modified radical mastectomy
5007810|NCT03947450|amputation|amputation
5007811|NCT03947450|stem cells|stem cells
5007812|NCT03947450|autologous fibroblast|autologous fibroblast
5007813|NCT03947450|skin wound|skin wound
5007905|NCT03946943|Anlotinib|anlotinib
5007906|NCT03946917|Regorafenib|regorafenib
5007907|NCT03946917|JS001|js001
5007908|NCT03946917|Colorectal cancer|colorectal cancer
5007909|NCT03946917|Microsatellite stability|microsatellite stability
5008008|NCT03946358|Human PapillomaVirus (HPV)|human papillomavirus (hpv)
5010798|NCT03929068|ALS|als
5008227|NCT03944928|Pleural irregularity|pleural irregularity
5008231|NCT03944889|MUAP- Motor Unit Action Potential|muap- motor unit action potential
5008232|NCT03944889|RMS- Root Mean Square|rms- root mean square
5008233|NCT03944889|US-Ultrasound|us-ultrasound
5008234|NCT03944876|Botulinum Toxin Type A|botulinum toxin type a
5008235|NCT03944876|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5008236|NCT03944876|Autonomic Nerve Block|autonomic nerve block
5008237|NCT03944876|Injections|injections
5008238|NCT03944863|antibiotic prophylaxis|antibiotic prophylaxis
5008239|NCT03944863|per oral endoscopic myotomy|per oral endoscopic myotomy
5008240|NCT03944850|veterans|veterans
5008241|NCT03944850|anxiety sensitivity|anxiety sensitivity
5008293|NCT03944681|transmural dispersion of repolarisation|transmural dispersion of repolarisation
5008294|NCT03944681|corrected QT interval|corrected qt interval
5008295|NCT03944655|Post operative sore throat|post operative sore throat
5008298|NCT03944642|Complex Intervention|complex intervention
5008367|NCT03944304|phase II|phase ii
5008397|NCT03944005|LIA|lia
5008469|NCT03943654|Diarrhoea|diarrhoea
5008470|NCT03943654|mHealth|mhealth
5008471|NCT03943654|Healthline|healthline
5008472|NCT03943628|prevention|prevention
5008473|NCT03943628|Hispanic adolescents|hispanic adolescents
5008474|NCT03943628|obesity and overweightness|obesity and overweightness
5008475|NCT03943628|family functioning|family functioning
5008476|NCT03943628|sexual risk behavior|sexual risk behavior
5008477|NCT03943537|Psychosis|psychosis
5008478|NCT03943537|Insulin|insulin
5008479|NCT03943537|Brain Metabolism|brain metabolism
5008480|NCT03943537|Cognition|cognition
5008481|NCT03943524|Polypharmacy|polypharmacy
5008482|NCT03943524|Outpatient|outpatient
5008483|NCT03943524|Drug Interaction|drug interaction
5008484|NCT03943524|Adverse Drug Reaction|adverse drug reaction
5008485|NCT03943524|DrApp|drapp
5008486|NCT03943524|Interax-AI|interax-ai
5008487|NCT03943485|abdominal hysterectomy|abdominal hysterectomy
5008488|NCT03943485|uterine manipulator|uterine manipulator
5008489|NCT03943485|vaginal length|vaginal length
5008490|NCT03943485|sexual function|sexual function
5008491|NCT03943485|surgeons' satisfaction|surgeons' satisfaction
5008492|NCT03943472|BCMA|bcma
5008493|NCT03943472|CAR-T|car-t
5019748|NCT03873662|Prognostication|prognostication
5008548|NCT03943030|Pulmonary rehabilitation|pulmonary rehabilitation
5008549|NCT03943030|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5008550|NCT03943030|Cardiovascular effects|cardiovascular effects
5008551|NCT03943030|Endothelial dysfunction|endothelial dysfunction
5008552|NCT03943017|safety dysfunctions|safety dysfunctions
5008553|NCT03943004|advanced solid tumors|advanced solid tumors
5008554|NCT03943004|refractory or relapsed tumors|refractory or relapsed tumors
5008555|NCT03942952|Multiple Sclerosis|multiple sclerosis
5008556|NCT03942952|NMO|nmo
5008633|NCT03942562|Gait analysis|gait analysis
5008634|NCT03942549|microbiome|microbiome
5008635|NCT03942549|cytokine|cytokine
5008636|NCT03942510|resistance training|resistance training
5008637|NCT03942510|vascular occlusion|vascular occlusion
5008638|NCT03942510|hemodynamics, cardiovascular system|hemodynamics, cardiovascular system
5008639|NCT03942510|autonomic nervous system|autonomic nervous system
5008781|NCT03941561|Gastric Cancer|gastric cancer
5008783|NCT03941535|Vitamin K|vitamin k
5008784|NCT03941522|loop ileostomy|loop ileostomy
5008785|NCT03941522|diversion ileostomy|diversion ileostomy
5008895|NCT03940872|Parkinson Disease|parkinson disease
5008896|NCT03940872|Parkinsonian central pain|parkinsonian central pain
5008897|NCT03940872|Diagnosis|diagnosis
5008898|NCT03940872|Primary Parkinsonian Pain Diagnostic Questionnaire|primary parkinsonian pain diagnostic questionnaire
5008899|NCT03940859|contrast-enhanced magnetic resonance imaging|contrast-enhanced magnetic resonance imaging
5008900|NCT03940859|intracranial dissecting aneurysm|intracranial dissecting aneurysm
5008901|NCT03940859|intramural hematoma|intramural hematoma
5004263|NCT03969576|Drug-eluting bead transarterial chemoembolization|drug-eluting bead transarterial chemoembolization
5009149|NCT03939091|Pyeloplasty|pyeloplasty
5009150|NCT03939091|Renogram|renogram
5009151|NCT03939091|Follow up|follow up
5009152|NCT03939078|menopause|menopause
5009153|NCT03939078|vaginal atrophy|vaginal atrophy
5009154|NCT03939078|urinary incontinence|urinary incontinence
5009155|NCT03939078|CO2 laser|co2 laser
5009156|NCT03939078|fractional laser|fractional laser
5009157|NCT03939078|dyspareunia|dyspareunia
5009158|NCT03939078|vaginal dryness|vaginal dryness
5009159|NCT03939078|vaginal lubrication|vaginal lubrication
5009160|NCT03939052|Phenylketonuria|phenylketonuria
5009168|NCT03939013|hepatitis C|hepatitis c
5009170|NCT03939013|primary care|primary care
5009171|NCT03939013|direct acting antivirals|direct acting antivirals
5009172|NCT03939000|clinical profile|clinical profile
5009173|NCT03939000|diabetic foot ulcer|diabetic foot ulcer
5009174|NCT03939000|laboratory finding|laboratory finding
5009175|NCT03939000|tertiary hospital|tertiary hospital
5009176|NCT03938974|self-management|self-management
5009177|NCT03938974|social ecology|social ecology
5009178|NCT03938974|biopsychosocial|biopsychosocial
5009179|NCT03938974|social participation|social participation
5009180|NCT03938974|everyday living|everyday living
5009181|NCT03938974|person-centered|person-centered
5009182|NCT03938974|longitudinal|longitudinal
5009184|NCT03938922|PDD|pdd
5009187|NCT03938870|Alzheimer's Disease|alzheimer's disease
5009224|NCT03938701|Fluorescence|fluorescence
5009225|NCT03938701|OTL38|otl38
5009226|NCT03938701|Folate receptor|folate receptor
5009227|NCT03938701|Disease activity|disease activity
5009228|NCT03938688|ventral hernia repair|ventral hernia repair
5009229|NCT03938688|mesh|mesh
5009230|NCT03938688|pain|pain
5009231|NCT03938688|incisional hernia|incisional hernia
5009232|NCT03938662|alcoholic liver diseases|alcoholic liver diseases
5009233|NCT03938662|S-Adenosyl methionine|s-adenosyl methionine
5009234|NCT03938662|choline|choline
5009235|NCT03938636|RA|ra
5009242|NCT03938597|yellow fever vaccine|yellow fever vaccine
5009243|NCT03938597|genetic factors|genetic factors
5009247|NCT03938558|fatigue|fatigue
5009319|NCT03938181|cardiac surgery patients|cardiac surgery patients
5009320|NCT03938181|acute renal failure|acute renal failure
5009321|NCT03938181|intensive care|intensive care
5009322|NCT03938155|Frailty|frailty
5009323|NCT03938155|Women|women
5009324|NCT03938155|Early detection|early detection
5009325|NCT03938155|Screening Program|screening program
5009328|NCT03938103|preschool|preschool
5009426|NCT03937583|Extended screening|extended screening
5009427|NCT03937570|left ventricular assist device|left ventricular assist device
5009428|NCT03937570|echo-optimization|echo-optimization
5009434|NCT03937531|Spontaneous void trial|spontaneous void trial
5009435|NCT03937531|Midurethral sling|midurethral sling
5009436|NCT03937505|robotic-assisted surgery|robotic-assisted surgery
5009437|NCT03937505|minimally invasive surgery|minimally invasive surgery
5009439|NCT03937492|CRPS|crps
5009441|NCT03937466|hot flashes|hot flashes
5009528|NCT03937115|Endurance performance|endurance performance
5009529|NCT03937115|Cognitive performance|cognitive performance
5009530|NCT03937102|cardiac output|cardiac output
5009664|NCT03936127|Transrectal|transrectal
5009665|NCT03936127|Fusion Biopsy|fusion biopsy
5009666|NCT03936075|receptive music therapy|receptive music therapy
5009667|NCT03936075|Guided Imagery & Music (GIM)|guided imagery & music (gim)
5009668|NCT03936075|chemotherapy|chemotherapy
5009683|NCT03935945|Alcohol|alcohol
5009765|NCT03935438|cardiac rehabilitation|cardiac rehabilitation
5009766|NCT03935438|acute coronary syndrome|acute coronary syndrome
5009778|NCT03935373|Traditional Chinese Medicine pattern|traditional chinese medicine pattern
5009784|NCT03935360|external validation|external validation
5009902|NCT03934723|Visceral fat|visceral fat
5009903|NCT03934697|Eating Disorder|eating disorder
5009904|NCT03934697|Anorexia Nervosa|anorexia nervosa
5009905|NCT03934697|Bulimia Nervosa|bulimia nervosa
5009906|NCT03934697|Imaginal Exposure Therapy|imaginal exposure therapy
5009919|NCT03934645|delirium|delirium
5009920|NCT03934645|Intensive Care Delirium Screening Checklist (ICDSC)|intensive care delirium screening checklist (icdsc)
5009921|NCT03934645|intensive care unit (ICU)|intensive care unit (icu)
5010004|NCT03934034|NTM|ntm
5010005|NCT03934034|Registry|registry
5010006|NCT03934034|Pulmonary infection|pulmonary infection
5010007|NCT03934021|Stroke|stroke
5010008|NCT03934021|Ischemic stroke|ischemic stroke
5010009|NCT03934021|microbiome|microbiome
5010010|NCT03934021|atherosclerotic|atherosclerotic
5010011|NCT03934008|Motivational Interviewing|motivational interviewing
5010095|NCT03933514|Cytokines|cytokines
5010096|NCT03933514|Aggressive Periodontitis|aggressive periodontitis
5010214|NCT03932942|Pediatrics|pediatrics
5010215|NCT03932942|Pediatric emergency medicine|pediatric emergency medicine
5010216|NCT03932942|Cost-benefit analysis|cost-benefit analysis
5010318|NCT03932318|Azacitidine|azacitidine
5010217|NCT03932942|Antimicrobial stewardship|antimicrobial stewardship
5010218|NCT03932929|Non-Carious Cervical Lesions|non-carious cervical lesions
5010219|NCT03932929|Universal adhesive|universal adhesive
5010307|NCT03932396|addictive behaviours|addictive behaviours
5010308|NCT03932396|Mental disease|mental disease
5010309|NCT03932396|Navigator|navigator
5010310|NCT03932396|screening|screening
5010312|NCT03932344|SJIA|sjia
5010313|NCT03932344|Kineret|kineret
5010314|NCT03932344|Anakinra|anakinra
5010315|NCT03932344|Long term safety|long term safety
5010316|NCT03932318|Lintuzumab-Ac225|lintuzumab-ac225
5010319|NCT03932318|Lintuzumab|lintuzumab
5010320|NCT03932318|Refractory AML|refractory aml
5010333|NCT03932240|FC|fc
5010399|NCT03931928|adjuvant therapy|adjuvant therapy
5010400|NCT03931902|pediatric airway management|pediatric airway management
5010401|NCT03931863|ondansetron|ondansetron
5010402|NCT03931850|Pudendal nerve|pudendal nerve
5010403|NCT03931850|circumcision|circumcision
5010404|NCT03931850|pediatric|pediatric
5010405|NCT03931837|Tourniquet|tourniquet
5010406|NCT03931837|Total knee arthroplasty|total knee arthroplasty
5010407|NCT03931837|Postoperative pain|postoperative pain
5010408|NCT03931837|Range of motion|range of motion
5010409|NCT03931837|Wound complication|wound complication
5010410|NCT03931824|Shoulder Pain|shoulder pain
5010411|NCT03931824|Hemiplegia|hemiplegia
5010412|NCT03931824|Shoulder Subluxation|shoulder subluxation
5010413|NCT03931824|Spasticity|spasticity
5010414|NCT03931824|Stroke|stroke
5010415|NCT03931811|Knee Osteoarthritis|knee osteoarthritis
5010480|NCT03931512|transcranial direct current stimulation|transcranial direct current stimulation
5010481|NCT03931512|motor learning|motor learning
5010538|NCT03930992|HIV|hiv
5010589|NCT03930693|hypertension|hypertension
5010590|NCT03930693|nitrate|nitrate
5010591|NCT03930693|beetroot juice|beetroot juice
5010592|NCT03930667|Appendicitis; Laparoscopic Surgery; Cost Effectiveness|appendicitis; laparoscopic surgery; cost effectiveness
5010593|NCT03930654|African American women, HIV risk, substance use, sexual risk|african american women, hiv risk, substance use, sexual risk
5010594|NCT03930641|brolucizumab 6 mg prefilled syringe PFS|brolucizumab 6 mg prefilled syringe pfs
5010595|NCT03930641|open label study|open label study
5010689|NCT03929900|Mortality|mortality
5010690|NCT03929900|Complications|complications
5010691|NCT03929900|Risk factors|risk factors
5010692|NCT03929887|Glomerular disease|glomerular disease
5010693|NCT03929887|sample repository|sample repository
5010694|NCT03929887|clinical data|clinical data
5010695|NCT03929887|digital pathology repository|digital pathology repository
5010696|NCT03929887|web-based database|web-based database
5010697|NCT03929861|Fluconazole|fluconazole
5010698|NCT03929861|bioequivalence|bioequivalence
5010699|NCT03929861|capsule|capsule
5010700|NCT03929848|cuff pressure, laryngomicrosurgery|cuff pressure, laryngomicrosurgery
5010701|NCT03929835|Cannabis|cannabis
5010702|NCT03929822|Mammography|mammography
5010703|NCT03929822|Contrast-Enhanced Spectral Mammography|contrast-enhanced spectral mammography
5010704|NCT03929822|19-116|19-116
5010705|NCT03929770|Swan-Ganz catheter|swan-ganz catheter
5010708|NCT03929666|Bispecific antibody|bispecific antibody
5010709|NCT03929666|Biparatopic antibody|biparatopic antibody
5010710|NCT03929666|Immunotherapy|immunotherapy
5010711|NCT03929666|Gastric cancers|gastric cancers
5010712|NCT03929666|Esophageal cancers|esophageal cancers
5010713|NCT03929666|Gastroesophageal junction (GEJ) cancers|gastroesophageal junction (gej) cancers
5010714|NCT03929666|Chemotherapy|chemotherapy
5010716|NCT03929666|FP|fp
5010721|NCT03929666|Leucovorin (folinic acid)|leucovorin (folinic acid)
5010723|NCT03929666|XELOX|xelox
5010724|NCT03929653|Next Generation Sequencing|next generation sequencing
5010725|NCT03929653|Personalized Therapy|personalized therapy
5010726|NCT03929653|Molecular Tumor Board|molecular tumor board
5010765|NCT03929380|Muscular power|muscular power
5010766|NCT03929354|Asymptomatic Carotid Artery Stenosis|asymptomatic carotid artery stenosis
5010769|NCT03929341|angina|angina
5010887|NCT03928457|radiofrequency exposure|radiofrequency exposure
5011000|NCT03927612|virtual reality|virtual reality
5011001|NCT03927612|perspective taking|perspective taking
5011002|NCT03927612|conduct disorder|conduct disorder
5011003|NCT03927612|oppositional defiant disorder|oppositional defiant disorder
5011004|NCT03927612|functional magnetic resonance imaging|functional magnetic resonance imaging
5011005|NCT03927612|child|child
5011006|NCT03927612|adolescent|adolescent
5011007|NCT03927599|TP53|tp53
5011021|NCT03927521|Focal HIFU|focal hifu
5011022|NCT03927521|PSMA|psma
5011023|NCT03927521|PET-MRI|pet-mri
5011143|NCT03926611|BTK inhibitor|btk inhibitor
5011144|NCT03926611|Urticaria Activity Score|urticaria activity score
5011262|NCT03925844|FRESCO risk function|fresco risk function
5011263|NCT03925844|risk function|risk function
5011264|NCT03925844|cognitive aging|cognitive aging
5011265|NCT03925844|prevention|prevention
5011266|NCT03925818|Lactobacillus reuteri; Bismuth; Helicobacter pylori;|lactobacillus reuteri; bismuth; helicobacter pylori;
5011267|NCT03925792|lifestyle Medicine|lifestyle medicine
5011268|NCT03925792|police|police
5011269|NCT03925792|mood|mood
5011270|NCT03925792|psychological being|psychological being
5011271|NCT03925792|mental health|mental health
5011288|NCT03925649|SCI|sci
5011367|NCT03925168|heart rate|heart rate
5011369|NCT03925168|energy|energy
5011370|NCT03925168|mood|mood
5011371|NCT03925168|medication compliance|medication compliance
5011372|NCT03925168|music|music
5011491|NCT03924414|Parkinson's Disease|parkinson's disease
5011492|NCT03924414|Osteoporosis|osteoporosis
5011493|NCT03924414|Zoledronic acid|zoledronic acid
5011494|NCT03924414|Neurology|neurology
5011496|NCT03924414|Fracture|fracture
5011497|NCT03924401|Pediatrics|pediatrics
5011498|NCT03924401|Non-malignant hematologic diseases|non-malignant hematologic diseases
5011499|NCT03924401|Severe aplastic anemia|severe aplastic anemia
5011500|NCT03924401|Fanconi anemia|fanconi anemia
5011501|NCT03924401|Sickle cell disease|sickle cell disease
5011502|NCT03924401|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5011503|NCT03924401|Thalassemia|thalassemia
5011596|NCT03923829|Non-surgical Periodontal Therapy|non-surgical periodontal therapy
5011597|NCT03923829|stage II periodontitis|stage ii periodontitis
5011598|NCT03923829|stage III periodontitis|stage iii periodontitis
5011599|NCT03923829|gingival crevicular fluid|gingival crevicular fluid
5011600|NCT03923829|total oxidant capacity|total oxidant capacity
5011601|NCT03923829|Type 2 diabetic patients|type 2 diabetic patients
5011602|NCT03923777|Active Surveillance|active surveillance
5011603|NCT03923725|Artemether|artemether
5011604|NCT03923725|Lumefantrine|lumefantrine
5011706|NCT03923218|Vitamin D|vitamin d
5011708|NCT03923218|Serum|serum
5011709|NCT03923218|periodontitis|periodontitis
5011710|NCT03923205|buckwheat|buckwheat
5011711|NCT03923205|postprandial glycemia|postprandial glycemia
5011712|NCT03923205|Type 2 diabetes|type 2 diabetes
5011713|NCT03923153|inspiratory muscle trainig|inspiratory muscle trainig
5006770|NCT03954288|sclerostin|sclerostin
5011849|NCT03922360|Smartphone|smartphone
5011850|NCT03922321|IMVT-1401|imvt-1401
5011851|NCT03922321|Graves' Orbitopathy|graves' orbitopathy
5011852|NCT03922321|Thyroid Eye Disease|thyroid eye disease
5011853|NCT03922282|Gasless|gasless
5011854|NCT03922282|Bilateral axillo-breast approach|bilateral axillo-breast approach
5011855|NCT03922282|Da Vinci|da vinci
5011856|NCT03922282|Robot-assisted thyroid surgery|robot-assisted thyroid surgery
5011857|NCT03922243|students|students
5011858|NCT03922243|dental treatment|dental treatment
5006878|NCT03953430|Tibialis anterior tendon transfer|tibialis anterior tendon transfer
5006879|NCT03953430|Oxford foot model|oxford foot model
5006880|NCT03953430|gait analysis|gait analysis
5006881|NCT03953417|Bipolar Disorder|bipolar disorder
5006882|NCT03953417|Treatment Resistant Depression|treatment resistant depression
5006883|NCT03953417|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5006884|NCT03953417|Theta Burst|theta burst
5006911|NCT03953222|Gait|gait
5011948|NCT03921684|Anti-PD-1 antibody|anti-pd-1 antibody
5011949|NCT03921671|metastatic or relapsed non-pre-treated disease|metastatic or relapsed non-pre-treated disease
5939695|NCT01050855|Non-malignant diseases|non-malignant diseases
5939696|NCT01050855|Immune deficiencies|immune deficiencies
5939697|NCT01050855|Hemoglobinopathies|hemoglobinopathies
5939698|NCT01050855|Reduced Intensity Conditioning(RIC)|reduced intensity conditioning(ric)
5012050|NCT03920878|pre-existing DME|pre-existing dme
5012051|NCT03920878|cataract surgery|cataract surgery
5012055|NCT03920839|solid tumors|solid tumors
5012056|NCT03920839|non-small cell lung cancer|non-small cell lung cancer
5012057|NCT03920839|malignant pleural mesothelioma|malignant pleural mesothelioma
5012058|NCT03920839|chemotherapy|chemotherapy
5342934|NCT01981473|etanercept|etanercept
5012059|NCT03920839|programmed cell death protein 1 (PD-1) inhibitor|programmed cell death protein 1 (pd-1) inhibitor
5012060|NCT03920787|inositol|inositol
5012061|NCT03920787|insulin resistance|insulin resistance
5012062|NCT03920787|overweight|overweight
5012138|NCT03920254|JAK inhibitor|jak inhibitor
5012265|NCT03919422|thoracic paravertebral block|thoracic paravertebral block
5012266|NCT03919422|regional anesthesia|regional anesthesia
5012268|NCT03919422|proximal humeral fracture|proximal humeral fracture
5012269|NCT03919422|brachial plexus block|brachial plexus block
5012270|NCT03919422|cervical plexus block|cervical plexus block
5012271|NCT03919422|intercostobrachial nerve|intercostobrachial nerve
5012276|NCT03919396|Myopia Control|myopia control
5012277|NCT03919396|Orthokeratology|orthokeratology
5012278|NCT03919396|Electroretinogram|electroretinogram
5012304|NCT03919279|pain|pain
5012367|NCT03918993|lymphocyte to monocyte ratio|lymphocyte to monocyte ratio
5012475|NCT03918512|LSS specific activity limitation|lss specific activity limitation
5012476|NCT03918512|development and validation of new questionaire|development and validation of new questionaire
5012477|NCT03918473|Functional Performance|functional performance
5012478|NCT03918473|Manual Therapy|manual therapy
5012480|NCT03918447|RTA 402|rta 402
5012694|NCT03917121|Needle-free anesthesia|needle-free anesthesia
5012695|NCT03917121|Needle-less anesthesia|needle-less anesthesia
5012696|NCT03917121|Needle-free injection|needle-free injection
5012697|NCT03917121|Jet injection|jet injection
5012698|NCT03917121|Needle-less local anesthesia|needle-less local anesthesia
5012699|NCT03917121|Needle-less syringe|needle-less syringe
5012700|NCT03917121|Needle infiltration anesthesia|needle infiltration anesthesia
5012701|NCT03917121|Needle injection|needle injection
5012702|NCT03917121|Local infiltration anesthesia|local infiltration anesthesia
5012703|NCT03917121|Local anesthesia|local anesthesia
5012705|NCT03917121|Vital pulp therapy|vital pulp therapy
5012706|NCT03917121|Primary molars|primary molars
5012707|NCT03917121|Child patients|child patients
5012708|NCT03917121|Pediatric patients|pediatric patients
5012746|NCT03916900|Mature|mature
5012781|NCT03916783|Uganda|uganda
5012782|NCT03916770|muscle|muscle
5012783|NCT03916770|vibration|vibration
5012784|NCT03916770|H reflex|h reflex
5012785|NCT03916770|H/M ratio|h/m ratio
5012786|NCT03916770|spasticity|spasticity
5012787|NCT03916757|Brain cancer|brain cancer
5012887|NCT03916055|ERP|erp
5012888|NCT03916055|Internet|internet
5012889|NCT03916055|Self-help|self-help
5012890|NCT03916029|primary health care|primary health care
5012891|NCT03916029|workforce|workforce
5012892|NCT03916029|Aboriginal or Torres Strait Islander|aboriginal or torres strait islander
5012893|NCT03916029|facilitator|facilitator
5012894|NCT03916029|education|education
5012895|NCT03916016|Integrated Behavioral Health|integrated behavioral health
5012896|NCT03916016|Integrated Care|integrated care
5013010|NCT03915340|Rytmonorm|rytmonorm
5013011|NCT03915327|Iron-deficiency anemia|iron-deficiency anemia
5013125|NCT03914716|Radiogenomics|radiogenomics
5013127|NCT03914677|Spinal Cord Injuries|spinal cord injuries
5013128|NCT03914677|autonomic dysreflexia|autonomic dysreflexia
5013129|NCT03914677|mecamylamine|mecamylamine
5013130|NCT03914586|Sepsis|sepsis
5013131|NCT03914586|Acute Renal Failure|acute renal failure
5013132|NCT03914586|Extra Corporeal Therapy|extra corporeal therapy
5013133|NCT03914573|health|health
5013135|NCT03914573|pain|pain
5013236|NCT03913897|children|children
5013237|NCT03913897|distraction|distraction
5013238|NCT03913884|Impacted third molar surgery|impacted third molar surgery
5013393|NCT03913117|HPV16|hpv16
5013394|NCT03913091|Total Shoulder Arthroplasty (TSA)|total shoulder arthroplasty (tsa)
5013605|NCT03911752|Subacute Stage|subacute stage
5013606|NCT03911752|Qualitative Study|qualitative study
5013607|NCT03911739|CTN-0080|ctn-0080
5013608|NCT03911739|clinical trials network|clinical trials network
5013609|NCT03911739|medication assisted treatment|medication assisted treatment
5013610|NCT03911739|pharmacokinetics|pharmacokinetics
5013611|NCT03911726|PET/MR|pet/mr
5013612|NCT03911726|Dopaminergic supersensitivity|dopaminergic supersensitivity
5014308|NCT03907462|obesity|obesity
5013641|NCT03911518|incision and drainage|incision and drainage
5013753|NCT03910998|anesthesia|anesthesia
5013754|NCT03910985|COPD|copd
5013755|NCT03910933|Warfarin|warfarin
5013756|NCT03910933|Child|child
5013757|NCT03910907|mycoplasma genitalium|mycoplasma genitalium
5013758|NCT03910907|urethritis|urethritis
5013759|NCT03910907|NGU|ngu
5013760|NCT03910907|treatment|treatment
5013859|NCT03910296|Cancer|cancer
5013863|NCT03910231|vasopressin receptor|vasopressin receptor
5013864|NCT03910231|renal sodium excretion|renal sodium excretion
5013865|NCT03910218|HIV prevention|hiv prevention
5013866|NCT03910218|homeless|homeless
5013867|NCT03910205|interleukin-18|interleukin-18
5013868|NCT03910205|gingival crevicular fluid|gingival crevicular fluid
5013869|NCT03910205|tumor necrosis factor alpha|tumor necrosis factor alpha
5013870|NCT03910166|drug eluting balloon catheter|drug eluting balloon catheter
5013871|NCT03910166|stenting|stenting
5013872|NCT03910153|Prebiotic|prebiotic
5013873|NCT03910153|Potato Starch|potato starch
5013874|NCT03910153|Resistant Starch|resistant starch
5013875|NCT03910153|MSPrebiotic|msprebiotic
5013971|NCT03909555|chronic complications|chronic complications
5013972|NCT03909542|inflammatory bowel disease|inflammatory bowel disease
5013973|NCT03909542|ileostomy|ileostomy
5013974|NCT03909542|ileostomy reversal|ileostomy reversal
5013975|NCT03909542|stoma reversal|stoma reversal
5013976|NCT03909464|chemotherapy|chemotherapy
5013977|NCT03909464|neurosensory|neurosensory
5014065|NCT03909035|inappropriate prescribing|inappropriate prescribing
5014066|NCT03909035|collaboration|collaboration
5014067|NCT03909009|Fibromyalgia, transcranial magnetic stimulation, pain|fibromyalgia, transcranial magnetic stimulation, pain
5014068|NCT03908983|Mitral Regurgitation|mitral regurgitation
5014069|NCT03908983|Mitral valve repair|mitral valve repair
5014070|NCT03908983|Mitral annuloplasty|mitral annuloplasty
5014071|NCT03908983|Adjustable annuloplasty|adjustable annuloplasty
5014072|NCT03908905|Pain|pain
5014073|NCT03908905|Sleep|sleep
5014074|NCT03908905|Neuropsychology|neuropsychology
5014075|NCT03908905|Fatigue|fatigue
5014076|NCT03908905|Activity level|activity level
5014077|NCT03908905|Attention|attention
5014078|NCT03908905|Executive function|executive function
5014079|NCT03908905|Memory|memory
5014161|NCT03908424|PDPH - Post Dural Puncture Headache|pdph - post dural puncture headache
5014163|NCT03908424|chronic backache|chronic backache
5014164|NCT03908411|Paratracheal pressure|paratracheal pressure
5014165|NCT03908398|ATP bioluminescence|atp bioluminescence
5014279|NCT03907631|Infliximab|infliximab
5014280|NCT03907631|Outcomes|outcomes
5014281|NCT03907631|Risk Stratification|risk stratification
5014282|NCT03907618|Antral follicle count|antral follicle count
5014283|NCT03907618|Anti müllerian hormone|anti müllerian hormone
5014284|NCT03907618|Ovarian reserve|ovarian reserve
5014285|NCT03907618|HbA1c|hba1c
5014286|NCT03907618|type 1 diabetes mellitus|type 1 diabetes mellitus
5014400|NCT03906851|Physical activity|physical activity
5014401|NCT03906825|Endothelium|endothelium
5014402|NCT03906799|Atrial Fibrillation|atrial fibrillation
5014403|NCT03906799|Electrical Cardioversion|electrical cardioversion
5014617|NCT03905551|fatigue|fatigue
5014539|NCT03905993|Immune System|immune system
5014675|NCT03905239|algorithm|algorithm
5014676|NCT03905239|procalcitonin|procalcitonin
5014768|NCT03904537|TIL|til
5014804|NCT03904199|High Blood Glucose|high blood glucose
5014805|NCT03904186|Tobacco Use|tobacco use
5014806|NCT03904186|Tobacco Use Disorder|tobacco use disorder
5014807|NCT03904186|Substance-Related Disorders|substance-related disorders
5014808|NCT03904186|Nicotine|nicotine
5014809|NCT03904186|Ganglionic Stimulants|ganglionic stimulants
5014810|NCT03904186|Autonomic Agents|autonomic agents
5014811|NCT03904186|Peripheral Nervous System Agents|peripheral nervous system agents
5014812|NCT03904186|Physiological Effects of Drugs|physiological effects of drugs
5014813|NCT03904186|Nicotinic Agonists|nicotinic agonists
5014891|NCT03903757|Personalized therapy|personalized therapy
5014892|NCT03903744|syncope|syncope
5014893|NCT03903744|cardioneuroablation|cardioneuroablation
5014894|NCT03903744|cardioneuromodulation|cardioneuromodulation
5014993|NCT03903029|Rosuvastatin|rosuvastatin
5014995|NCT03903003|high flow nasal oxygen (POİNT)|high flow nasal oxygen (point)
5014996|NCT03902990|dual task, treadmill, cognitive rehabilitation|dual task, treadmill, cognitive rehabilitation
5014997|NCT03902925|vitrectomy|vitrectomy
5014998|NCT03902925|anesthesia|anesthesia
5014999|NCT03902925|retinal disease|retinal disease
5015000|NCT03902925|Pain|pain
5015001|NCT03902925|diabetic retinopathy|diabetic retinopathy
5015002|NCT03902925|maculopathy|maculopathy
5015003|NCT03902912|recurrent miscarriage|recurrent miscarriage
5015005|NCT03902886|toddlers, gait|toddlers, gait
5015075|NCT03902275|algorithm based therapy|algorithm based therapy
5015076|NCT03902249|Intravenous Dexamethasone|intravenous dexamethasone
5015077|NCT03902249|Pudendal nerve block|pudendal nerve block
5015172|NCT03901690|Clearance|clearance
5015173|NCT03901690|Human papillomavirus|human papillomavirus
5015174|NCT03901677|exercise|exercise
5015175|NCT03901677|Awareness|awareness
5015176|NCT03901677|posture|posture
5015177|NCT03901651|colonic polyps|colonic polyps
5423185|NCT01616784|Administration and Dosage|administration and dosage
5015192|NCT03901495|clinical applications software|clinical applications software
5015196|NCT03901469|TNBC|tnbc
5015197|NCT03901469|ZEN003694|zen003694
5015198|NCT03901469|ZEN-3694|zen-3694
5015199|NCT03901469|Talazoparib|talazoparib
5015200|NCT03901469|Breast Cancer|breast cancer
5015201|NCT03901469|PARPi|parpi
5015231|NCT03901339|ADC|adc
5015293|NCT03901001|cytokines|cytokines
5015294|NCT03901001|chemokines|chemokines
5015295|NCT03900988|respiratory, mortality, cytokines, chemokines, N-acetylcysteine (NAC)|respiratory, mortality, cytokines, chemokines, n-acetylcysteine (nac)
5015296|NCT03900962|Severe obesity|severe obesity
5015297|NCT03900962|Exercise|exercise
5015298|NCT03900962|Weight management|weight management
5015299|NCT03900962|Resistance training|resistance training
5015300|NCT03900962|Power training|power training
5015301|NCT03900962|Physical function|physical function
5029468|NCT03814967|EEG|eeg
5015302|NCT03900949|Acute Myeloid Leukemia|acute myeloid leukemia
5015394|NCT03900312|Native American|native american
5015395|NCT03900312|Youth|youth
5015396|NCT03900312|Young Adult|young adult
5015503|NCT03899792|SPECC1L-RET|specc1l-ret
5015504|NCT03899792|TBL1XR1-RET|tbl1xr1-ret
5015505|NCT03899792|BCR-RET|bcr-ret
5015506|NCT03899792|FGRF1OP-RET|fgrf1op-ret
5015507|NCT03899792|RFG8-RET|rfg8-ret
5015508|NCT03899792|RET-PTC9|ret-ptc9
5015509|NCT03899792|ACBD5-RET|acbd5-ret
5015664|NCT03899519|OSA|osa
5015735|NCT03898999|Balance|balance
5015736|NCT03898999|Falls|falls
5015737|NCT03898999|Older Adult|older adult
5015875|NCT03898050|transcutaneous cardiac pacing|transcutaneous cardiac pacing
5015876|NCT03898011|Bioequivalence|bioequivalence
5016107|NCT03896425|non-invasive brain stimulation|non-invasive brain stimulation
5016240|NCT03895398|underfive children|underfive children
5016241|NCT03895398|post-disaster recovery|post-disaster recovery
5016242|NCT03895398|optimized food based recommendation|optimized food based recommendation
5016243|NCT03895398|growth|growth
5016244|NCT03895398|development|development
5016245|NCT03895398|psycho-social stimulation|psycho-social stimulation
5016246|NCT03895385|BKZ|bkz
5016366|NCT03894670|Gastrointestinal transit|gastrointestinal transit
5016367|NCT03894670|Food reward|food reward
5016368|NCT03894670|Food preferences|food preferences
5016369|NCT03894657|CYSTIC FIBROSIS|cystic fibrosis
5016370|NCT03894657|ORKAMBI|orkambi
5016371|NCT03894631|Kahook dual blade|kahook dual blade
5016372|NCT03894631|Trabectome|trabectome
5016469|NCT03893760|dilated cardiomyopathy|dilated cardiomyopathy
5016470|NCT03893760|right heart systolic function|right heart systolic function
5016471|NCT03893760|right ventriculo-arterial coupling|right ventriculo-arterial coupling
5016475|NCT03893695|Phase Ib/II|phase ib/ii
5016700|NCT03892122|Drug-induced sleep endoscopy|drug-induced sleep endoscopy
5016701|NCT03892122|Dexmedetomidine|dexmedetomidine
5016702|NCT03892122|Airway collapsibility|airway collapsibility
5016806|NCT03891433|Comparative Study|comparative study
5016830|NCT03891277|TIA|tia
5016898|NCT03890835|Mineral Trioxide Aggregate (MTA)|mineral trioxide aggregate (mta)
5016899|NCT03890835|Biodentine|biodentine
5016900|NCT03890835|Vital pulp therapy|vital pulp therapy
5016901|NCT03890835|Postoperative pain|postoperative pain
5016902|NCT03890835|Overall success|overall success
5016903|NCT03890731|Metastatic colorectal cancer (mCRC)|metastatic colorectal cancer (mcrc)
5016904|NCT03890731|Renal cell cancer|renal cell cancer
5016905|NCT03890731|Gastro-intestinal stromal tumor|gastro-intestinal stromal tumor
5016906|NCT03890731|Hepatocellular carcinoma|hepatocellular carcinoma
5016907|NCT03890640|Ultrasound|ultrasound
5016909|NCT03890640|Fluoroscopy|fluoroscopy
5016998|NCT03890107|Ear tubes|ear tubes
5016999|NCT03890107|Myringotomy|myringotomy
5017000|NCT03890107|Otitis Media|otitis media
5017001|NCT03890107|Tympanostomy|tympanostomy
5017002|NCT03890094|Sufentanil|sufentanil
5017003|NCT03890094|Bronchoscopy|bronchoscopy
5017004|NCT03890094|Conscious sedation|conscious sedation
5017005|NCT03890094|midazolam|midazolam
5017006|NCT03890081|Coping Strategies Questionnaire|coping strategies questionnaire
5017007|NCT03890081|Cross-cultural adaptation|cross-cultural adaptation
5017008|NCT03890081|Reliability|reliability
5017009|NCT03890081|Validity|validity
5017010|NCT03890029|PTSD|ptsd
5017011|NCT03890029|Elevated Cardiovascular Disease risk|elevated cardiovascular disease risk
5017030|NCT03889899|CMN|cmn
5017201|NCT03888885|Physical Activity|physical activity
5017202|NCT03888885|University Students|university students
5017203|NCT03888807|Knee Osteoarthritis|knee osteoarthritis
5017206|NCT03888768|iron deficiency|iron deficiency
5017311|NCT03888196|Running|running
5017312|NCT03888196|Ginseng|ginseng
5017313|NCT03888183|hyaluronic acid|hyaluronic acid
5017314|NCT03888183|salt solution|salt solution
5017315|NCT03888183|dry eye disease|dry eye disease
5017316|NCT03888183|ocular surface disease|ocular surface disease
5017440|NCT03887533|2-Hydroxypropyl-Beta-Cyclodextrin|2-hydroxypropyl-beta-cyclodextrin
5017442|NCT03887507|Vojta therapy|vojta therapy
5017443|NCT03887507|core stability|core stability
5017444|NCT03887507|postural balance|postural balance
5017445|NCT03887494|Implantable device, Hip fractures|implantable device, hip fractures
5017446|NCT03887481|transcranial direct current stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5017447|NCT03887481|neurodegeneration|neurodegeneration
5017448|NCT03887481|verbal short-term memory|verbal short-term memory
5017543|NCT03887039|oral habits|oral habits
5017544|NCT03887039|dental trauma|dental trauma
5939750|NCT01005745|lymphodepletion|lymphodepletion
5017546|NCT03887039|children|children
5017547|NCT03887000|Fibromyalgia|fibromyalgia
5017548|NCT03887000|Stress|stress
5017549|NCT03887000|Magnesium|magnesium
5017550|NCT03887000|Sleep disorders|sleep disorders
5017551|NCT03886987|Modified Draize-95 Test|modified draize-95 test
5017562|NCT03886896|nalbuphine|nalbuphine
5017649|NCT03886389|Estrogen receptor positive|estrogen receptor positive
5017650|NCT03886389|Proliferation|proliferation
5017651|NCT03886389|Insulin resistance|insulin resistance
5017652|NCT03886389|PROMs|proms
5017653|NCT03886389|NMRI|nmri
5017764|NCT03885830|Chronic Myeloid Leukemia|chronic myeloid leukemia
5017765|NCT03885830|CML|cml
5017766|NCT03885830|Pharmacokinetics|pharmacokinetics
5017767|NCT03885817|Exercise therapy|exercise therapy
5017768|NCT03885817|Fatigue|fatigue
5017789|NCT03885622|NIDJD|nidjd
5017971|NCT03884465|Pulmonary arterial hypertension|pulmonary arterial hypertension
5017972|NCT03884465|Pulmonary hypertension|pulmonary hypertension
5017974|NCT03884465|PH|ph
5017975|NCT03884465|WHO Group 1 pulmonary arterial hypertension|who group 1 pulmonary arterial hypertension
5017976|NCT03884465|WHO Group 1 pulmonary hypertension|who group 1 pulmonary hypertension
5017977|NCT03884465|WHO Group 1 PAH|who group 1 pah
5017978|NCT03884465|WHO Group 1 PH|who group 1 ph
5017979|NCT03884465|WHO Group 1|who group 1
5017980|NCT03884465|Group 1 PAH|group 1 pah
5017981|NCT03884465|Group 1 PH|group 1 ph
5017982|NCT03884465|Idiopathic PAH|idiopathic pah
5017983|NCT03884465|Heritable PAH|heritable pah
5017984|NCT03884465|Drug induced PAH|drug induced pah
5017985|NCT03884465|Toxin induced PAH|toxin induced pah
5017986|NCT03884465|Pulmonary shunt|pulmonary shunt
5017987|NCT03884465|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
5017988|NCT03884465|Heritable pulmonary arterial hypertension|heritable pulmonary arterial hypertension
5018042|NCT03884153|Ischemic Stroke|ischemic stroke
5018043|NCT03884153|CRP apheresis|crp apheresis
5018044|NCT03884140|Thyroid nodules|thyroid nodules
5018045|NCT03884140|T.S.H|t.s.h
5018046|NCT03884140|Thyroid US|thyroid us
5018047|NCT03884140|FNAC|fnac
5018048|NCT03884127|orlistat|orlistat
5018049|NCT03884127|Ezetimibe|ezetimibe
5018050|NCT03884127|Gastrointestinal Microbiome|gastrointestinal microbiome
5018051|NCT03884114|technology-enhanced simulation|technology-enhanced simulation
5018052|NCT03884114|serious games|serious games
5018053|NCT03884114|multiple choice questionnaires|multiple choice questionnaires
5018054|NCT03884114|medical education|medical education
5018055|NCT03884088|Balance|balance
5018056|NCT03884088|Limits of Stability|limits of stability
5018137|NCT03883464|Postoperative|postoperative
5018138|NCT03883438|Gingival recession|gingival recession
5018142|NCT03883438|Surgical flaps|surgical flaps
5018143|NCT03883438|Acellular dermis|acellular dermis
5018245|NCT03882879|randomized trial|randomized trial
5018246|NCT03882879|camaraderie|camaraderie
5018247|NCT03882879|depression|depression
5018248|NCT03882879|anxiety|anxiety
5018249|NCT03882879|quality of life|quality of life
5018343|NCT03882294|probiotics|probiotics
5018344|NCT03882294|aflatoxin biomarkers|aflatoxin biomarkers
5018345|NCT03882294|healthy subjects|healthy subjects
5018346|NCT03882294|intervention|intervention
5018347|NCT03882281|Chronic Myeloid Leukemia, Chronic Phase|chronic myeloid leukemia, chronic phase
5018349|NCT03882268|Urban|urban
5018350|NCT03882268|Maternal Nutrition|maternal nutrition
5018351|NCT03882268|Nutrition Counseling|nutrition counseling
5018352|NCT03882268|Behavior change|behavior change
5018353|NCT03882268|Infant and young child feeding|infant and young child feeding
5018356|NCT03882164|Liver transplant;|liver transplant;
5018357|NCT03882164|Immunosuppression;|immunosuppression;
5018358|NCT03882164|Transplant rejection;|transplant rejection;
5018359|NCT03882151|epilepsy|epilepsy
5018428|NCT03881605|Quality of life|quality of life
5018429|NCT03881605|Surveillance|surveillance
5018430|NCT03881553|Prematurity|prematurity
5018431|NCT03881553|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5018432|NCT03881553|Autonomic Function|autonomic function
5018433|NCT03881553|Sleep|sleep
5018434|NCT03881553|Stochastic Resonance|stochastic resonance
5018435|NCT03881553|Newborn/Infant|newborn/infant
5018436|NCT03881514|Newborn Hearing Screening|newborn hearing screening
5018437|NCT03881514|Automated Auditory Brainstem Response|automated auditory brainstem response
5018438|NCT03881514|Mode Of Delivery|mode of delivery
5018532|NCT03880994|Fertility concerns|fertility concerns
5018533|NCT03880994|Sleep Quality|sleep quality
5018745|NCT03879811|Temozolomide|temozolomide
5018746|NCT03879811|Nivolumab|nivolumab
5018747|NCT03879811|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5018748|NCT03879811|18-545|18-545
5018749|NCT03879798|DS-3201b|ds-3201b
5018750|NCT03879798|Irinotecan|irinotecan
5018751|NCT03879798|18-553|18-553
5018752|NCT03879785|Tobacco|tobacco
5018753|NCT03879785|Alcohol|alcohol
5018754|NCT03879785|Prescription Drug|prescription drug
5018755|NCT03879785|Illicit Substance Use|illicit substance use
5018756|NCT03879785|Screening|screening
5018757|NCT03879785|Spanish|spanish
5018758|NCT03879785|Hispanic|hispanic
5018759|NCT03879733|childcare|childcare
5018833|NCT03879226|Aerobic Endurance|aerobic endurance
5018834|NCT03879213|Raspberry|raspberry
5018835|NCT03879213|Metabolic responses|metabolic responses
5018836|NCT03879213|Endothelial function|endothelial function
5018841|NCT03879187|Muscle|muscle
5018842|NCT03879187|eNOS|enos
5018843|NCT03879187|Isotopes|isotopes
5018936|NCT03878394|cognitive exercises|cognitive exercises
5018938|NCT03878368|Sulforaphane|sulforaphane
5018939|NCT03878303|SLE|sle
5018940|NCT03878251|Intellectual disability|intellectual disability
5018941|NCT03878251|Attention evaluation criteria|attention evaluation criteria
5018942|NCT03878251|Games on touchscreen|games on touchscreen
5018943|NCT03878251|Eye tracking|eye tracking
5018944|NCT03878238|Probiotic|probiotic
5018947|NCT03878186|HIV|hiv
5018948|NCT03878186|Threat appraisal|threat appraisal
5018949|NCT03878186|Cognitive behavioral therapy|cognitive behavioral therapy
5018950|NCT03878186|Antiretroviral-naïve|antiretroviral-naïve
5018951|NCT03878186|Challenge appraisal|challenge appraisal
5018952|NCT03878186|Affect|affect
5018953|NCT03878186|Adherence|adherence
5018954|NCT03878186|Quality of life|quality of life
5018955|NCT03878186|Anxiety|anxiety
5018956|NCT03878186|Depression|depression
5018957|NCT03878186|Viral load|viral load
5018958|NCT03878186|Loss to follow-up|loss to follow-up
5018959|NCT03878173|temporary tooth|temporary tooth
5018960|NCT03878173|pain|pain
5019023|NCT03877783|mediterranean diet|mediterranean diet
5019024|NCT03877783|physical fitness|physical fitness
5019131|NCT03877146|Breast Pain|breast pain
5019132|NCT03877146|Body Pain|body pain
5019133|NCT03877146|Anticipatory Pain|anticipatory pain
5019135|NCT03877146|Coping Skills|coping skills
5019136|NCT03877146|Self Efficacy|self efficacy
5019137|NCT03877133|Near-infrared spectroscopy|near-infrared spectroscopy
5019138|NCT03877133|Renal regional oxygen saturation|renal regional oxygen saturation
5019139|NCT03877133|Living donor liver transplantation|living donor liver transplantation
5019140|NCT03877133|Acute kidney injury|acute kidney injury
5019159|NCT03877081|Sepsis|sepsis
5019233|NCT03876769|tisagenlecleucel|tisagenlecleucel
5019234|NCT03876769|HR B-ALL EOC MRD|hr b-all eoc mrd
5019235|NCT03876769|Minimal Residual Disease (MRD)|minimal residual disease (mrd)
5019236|NCT03876769|Positive at the End of Consolidation (EOC)|positive at the end of consolidation (eoc)
5019237|NCT03876730|Cerebral Palsy|cerebral palsy
5019238|NCT03876730|Lower Extremity Orthosis|lower extremity orthosis
5019239|NCT03876730|ICF Core Set|icf core set
5019339|NCT03876119|Mechanical Thrombectomy|mechanical thrombectomy
5019340|NCT03876119|Recanalization|recanalization
5019341|NCT03876119|Reperfusion|reperfusion
5019342|NCT03876054|spinal cord stimulation|spinal cord stimulation
5019345|NCT03876041|MiRNA-155|mirna-155
5019346|NCT03876041|Treg|treg
5019347|NCT03876028|Lymphoma|lymphoma
5019446|NCT03875456|Cephalohematoma|cephalohematoma
5019447|NCT03875456|Infant, Newborn|infant, newborn
5019448|NCT03875456|Perinatal Care|perinatal care
5019449|NCT03875456|Plagiocephaly|plagiocephaly
5019450|NCT03875456|Nonsynostotic|nonsynostotic
5019451|NCT03875456|Skull/pathology|skull/pathology
5019457|NCT03875417|HCC in elderly|hcc in elderly
5019458|NCT03875417|recurrent HCC|recurrent hcc
5019459|NCT03875417|Liver resection|liver resection
5019460|NCT03875417|Quality of Life|quality of life
5019461|NCT03875417|intervention radiology|intervention radiology
5423189|NCT01616784|Insulin Infusion Systems|insulin infusion systems
5019578|NCT03874741|SCT200|sct200
5019683|NCT03874000|second line|second line
5019684|NCT03874000|cancer|cancer
5019685|NCT03874000|NSCLC|nsclc
5019686|NCT03873974|Lyme Borreliosis|lyme borreliosis
5019687|NCT03873974|Lyme disease|lyme disease
5019688|NCT03873974|In Vitro Diagnostics System|in vitro diagnostics system
5019689|NCT03873974|Dark Field Microscopy|dark field microscopy
5019690|NCT03873961|High-Intensity Laser Therapy|high-intensity laser therapy
5019694|NCT03873922|Ketosis|ketosis
5020110|NCT03871491|Bangladesh|bangladesh
5020111|NCT03871491|India|india
5020112|NCT03871491|Pakistan|pakistan
5020113|NCT03871491|Kenya|kenya
5020116|NCT03871465|corticosteroid|corticosteroid
5020337|NCT03870113|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5020338|NCT03870113|Human Papillomavirus|human papillomavirus
5020339|NCT03870113|Dentritic Vaccine|dentritic vaccine
5020341|NCT03870074|heart failure|heart failure
5020342|NCT03870074|cardiac resynchronization therapy|cardiac resynchronization therapy
5020343|NCT03870074|cardiopulmonary exercise test|cardiopulmonary exercise test
5020344|NCT03870074|responders to CRT|responders to crt
5020345|NCT03870074|non-responders to CRT|non-responders to crt
5020346|NCT03870074|survival prognosis after CRT|survival prognosis after crt
5020347|NCT03870061|Randomized Controlled Trial|randomized controlled trial
5020439|NCT03869567|dual energy computed tomography|dual energy computed tomography
5020573|NCT03868319|low tidal volume|low tidal volume
5020574|NCT03868319|positive end-expiratory pressure|positive end-expiratory pressure
5020575|NCT03868319|Lung ultrasound|lung ultrasound
5020576|NCT03868319|postoperative pulmonary complications|postoperative pulmonary complications
5020577|NCT03868267|Quality of Life|quality of life
5020578|NCT03868267|Anxiety|anxiety
5020589|NCT03868228|PIPAC|pipac
5020672|NCT03867656|Bone turnover|bone turnover
5020673|NCT03867656|Bone remodeling|bone remodeling
5020674|NCT03867643|Hepatitis B Vaccine|hepatitis b vaccine
5020675|NCT03867643|booster|booster
5020676|NCT03867643|Immune response|immune response
5020782|NCT03866954|thymidine phosphorylase|thymidine phosphorylase
5020783|NCT03866954|enyme replacement|enyme replacement
5020784|NCT03866941|synthetic cannabinoids, Assiut, violence,acute,chronic|synthetic cannabinoids, assiut, violence,acute,chronic
5020785|NCT03866902|overweight|overweight
5020911|NCT03866148|High sensitivity C-Reactive Protein|high sensitivity c-reactive protein
5020912|NCT03866148|High sensitivity Troponin-T|high sensitivity troponin-t
5020913|NCT03866148|Fibroblast Growth Factor-23|fibroblast growth factor-23
5021009|NCT03865628|Ombilical artery|ombilical artery
5717548|NCT00440362|Influenza|influenza
5021010|NCT03865628|Middel cerebral artery|middel cerebral artery
5021015|NCT03865628|Small-for-gestational Age|small-for-gestational age
5021016|NCT03865628|Prognosis|prognosis
5021017|NCT03865602|evidence based medicine|evidence based medicine
5021018|NCT03865602|continuity of patient care|continuity of patient care
5021019|NCT03865602|patient navigator|patient navigator
5021020|NCT03865602|health services|health services
5021021|NCT03865602|pragmatic clinical trial|pragmatic clinical trial
5021022|NCT03865589|Ultrasound Elastography|ultrasound elastography
5021024|NCT03865576|Papilledema|papilledema
5021025|NCT03865576|Neurological Intensive Care|neurological intensive care
5021027|NCT03865563|chemotherapy|chemotherapy
5021133|NCT03864952|Infection|infection
5021134|NCT03864952|genomic|genomic
5021135|NCT03864952|dental calculus|dental calculus
5021136|NCT03864926|Kidney Transplant|kidney transplant
5021137|NCT03864913|Gender affirming care|gender affirming care
5021138|NCT03864900|Anticoagulants|anticoagulants
5021139|NCT03864900|Atrial fibrillation|atrial fibrillation
5021140|NCT03864900|Adherence|adherence
5021141|NCT03864900|Health belief model|health belief model
5021142|NCT03864887|Brain death|brain death
5021143|NCT03864887|Oxygen metabolism|oxygen metabolism
5021147|NCT03864874|Thoracoscopy|thoracoscopy
5021243|NCT03864107|Metabolic Endotoxemia|metabolic endotoxemia
5021379|NCT03863379|sci|sci
5021480|NCT03862872|Vitamin D|vitamin d
5021481|NCT03862872|Zeaxanthin|zeaxanthin
5021482|NCT03862872|Lutein|lutein
5021483|NCT03862872|Omega-3 Index|omega-3 index
5021484|NCT03862872|Chronic Inflammation Test|chronic inflammation test
5021485|NCT03862872|11-dehydrothromboxane B2|11-dehydrothromboxane b2
5021590|NCT03862391|general anesthesia|general anesthesia
5021591|NCT03862391|low-flow anesthesia|low-flow anesthesia
5021592|NCT03862365|reliability|reliability
5021593|NCT03862365|validity|validity
5021597|NCT03862339|Catheter Ablation|catheter ablation
5021603|NCT03862235|anabolic steroid|anabolic steroid
5021604|NCT03862235|T1-mapping|t1-mapping
5021605|NCT03862235|cardiac structure|cardiac structure
5021606|NCT03862222|retina|retina
5021607|NCT03862222|Alzheimer|alzheimer
5021608|NCT03862222|cognitive aging|cognitive aging
5021609|NCT03862222|biomarker|biomarker
5021611|NCT03862222|ophthalmology|ophthalmology
5021693|NCT03861676|PSMA|psma
5021694|NCT03861676|DCF-Pyl|dcf-pyl
5021695|NCT03861650|bone marrow aspirate concentrate|bone marrow aspirate concentrate
5021796|NCT03861013|Depression|depression
5021797|NCT03861013|Quality of life|quality of life
5016398|NCT03894462|Interpersonal Theory|interpersonal theory
5016400|NCT03894410|HER2|her2
5021798|NCT03861013|Sense of coherence|sense of coherence
5021799|NCT03861013|Self-efficacy|self-efficacy
5021800|NCT03861013|Social support|social support
5021801|NCT03861013|Resilience|resilience
5021802|NCT03861013|Psychological resources|psychological resources
5021803|NCT03861013|Reward|reward
5021804|NCT03861013|Cortisol|cortisol
5021805|NCT03861013|Ambulatory assessment|ambulatory assessment
5021810|NCT03860987|Imaging|imaging
5021811|NCT03860987|Prostatectomy|prostatectomy
5021812|NCT03860987|Anti-androgen Therapy|anti-androgen therapy
5021813|NCT03860987|18F-DCFPyL-PSMA|18f-dcfpyl-psma
5021814|NCT03860974|regional anesthesia|regional anesthesia
5021901|NCT03860519|uncontrolled asthma|uncontrolled asthma
5021902|NCT03860519|asthma medication adherence|asthma medication adherence
5021903|NCT03860519|Propeller Health|propeller health
5021904|NCT03860519|Connected Inhaler System|connected inhaler system
5022003|NCT03859960|Body composition|body composition
5022004|NCT03859960|glucose|glucose
5022005|NCT03859960|spasticity|spasticity
5022006|NCT03859960|spinal cord injury|spinal cord injury
5022007|NCT03859947|Bronchiolitis|bronchiolitis
5022008|NCT03859947|Emergency department|emergency department
5022009|NCT03859947|High‑flow nasal cannula|high‑flow nasal cannula
5022010|NCT03859947|Flow rate|flow rate
5022011|NCT03859908|surgery|surgery
5022012|NCT03859908|infection|infection
5022013|NCT03859908|antisepsis|antisepsis
5022096|NCT03859297|rumination focused cognitive behavioral therapy|rumination focused cognitive behavioral therapy
5022097|NCT03859297|default mode network|default mode network
5022098|NCT03859297|rumination induction|rumination induction
5022099|NCT03859271|Physical activity|physical activity
5022100|NCT03859245|Photobiomodulation|photobiomodulation
5022101|NCT03859245|Diabetic Retinopathy (DR)|diabetic retinopathy (dr)
5022102|NCT03859245|Age-related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5022103|NCT03859245|Mid-peripheral Drusen|mid-peripheral drusen
5022104|NCT03859245|Alzheimer's disease (AD)|alzheimer's disease (ad)
5022105|NCT03859245|Ketogenic Diet (KD)|ketogenic diet (kd)
5022106|NCT03859219|Rozanolixizumab|rozanolixizumab
5022107|NCT03859219|Caucasian healthy-volunteers|caucasian healthy-volunteers
5022185|NCT03858868|built environment|built environment
5022186|NCT03858868|faith-based organizations|faith-based organizations
5022187|NCT03858855|aromatherapy|aromatherapy
5022188|NCT03858855|essential oils|essential oils
5022189|NCT03858855|Gastrointestinal Cancer|gastrointestinal cancer
5022190|NCT03858855|Neuroendocrine Cancer|neuroendocrine cancer
5022204|NCT03858803|HIV|hiv
5022278|NCT03858309|Sleep|sleep
5022407|NCT03857451|gait|gait
5022541|NCT03856684|HPV|hpv
5022611|NCT03856229|Steroids for PCP|steroids for pcp
5022620|NCT03856164|Obstetric hemorrhage|obstetric hemorrhage
5022622|NCT03856151|hemodialysis|hemodialysis
5022719|NCT03855540|quality of sleep|quality of sleep
5022720|NCT03855540|plasmatic biomarkers|plasmatic biomarkers
5022721|NCT03855527|Atraumatic Restorative Treatment|atraumatic restorative treatment
5072297|NCT03547388|PET|pet
5022722|NCT03855527|Chlorhexidine|chlorhexidine
5022723|NCT03855527|Silver Diamine Fluoride|silver diamine fluoride
5022724|NCT03855527|Primary Teeth|primary teeth
5022725|NCT03855514|DFU|dfu
5022726|NCT03855514|Chronic Diabetic Foot Ulcer|chronic diabetic foot ulcer
5022819|NCT03855046|Spasm of the internal sphincter|spasm of the internal sphincter
5022820|NCT03855046|Anal sphincter insufficiency|anal sphincter insufficiency
5022821|NCT03855046|randomized|randomized
5022822|NCT03855020|plasma EBV DNA|plasma ebv dna
5022823|NCT03855020|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5022824|NCT03855020|longitudinal surveillance|longitudinal surveillance
5022825|NCT03855007|Iguratimod|iguratimod
5718223|NCT00438152|Lipids|lipids
5022826|NCT03854981|Insulin Resistance|insulin resistance
5022827|NCT03854981|Cardiovascular Risk|cardiovascular risk
5022915|NCT03854565|Endothelial Dysfunction|endothelial dysfunction
5022916|NCT03854565|mechanical ventilation|mechanical ventilation
5022917|NCT03854565|Glycocalyx|glycocalyx
5023032|NCT03853655|Adjuvant Radiotherapy|adjuvant radiotherapy
5023033|NCT03853655|Depth of Invasion|depth of invasion
5023034|NCT03853603|lipid profile|lipid profile
5023035|NCT03853603|12,13-diHOME|12,13-dihome
5023046|NCT03853538|Dermal spray|dermal spray
5023047|NCT03853538|Ablative lasering|ablative lasering
5023068|NCT03853486|VWD|vwd
5023164|NCT03852680|wide necked intracranial aneurysms|wide necked intracranial aneurysms
5023165|NCT03852667|low back pain|low back pain
5023166|NCT03852667|recurrent|recurrent
5023167|NCT03852667|non-specific|non-specific
5023168|NCT03852667|secondary prevention|secondary prevention
5718224|NCT00438152|HIV-1|hiv-1
5023169|NCT03852667|pain neuroscience education|pain neuroscience education
5023263|NCT03852199|proprioception|proprioception
5023264|NCT03852199|sphygmomanometer|sphygmomanometer
5023265|NCT03852199|surface EMG|surface emg
5023358|NCT03851653|OSA|osa
5023359|NCT03851653|CPAP|cpap
5023360|NCT03851588|Antiretroviral therapy|antiretroviral therapy
5023361|NCT03851588|Dolutegravir|dolutegravir
5023362|NCT03851588|Rifampicin|rifampicin
5023363|NCT03851588|Tuberculosis|tuberculosis
5023364|NCT03851588|Drug-drug interaction|drug-drug interaction
5023365|NCT03851536|Embryo Transfer|embryo transfer
5023366|NCT03851536|ICSI|icsi
5023367|NCT03851536|Transvaginal Ultrasound|transvaginal ultrasound
5023368|NCT03851484|Tourette syndrome|tourette syndrome
5023369|NCT03851484|premonitory urge|premonitory urge
5023370|NCT03851484|sensory dysregulation|sensory dysregulation
5023371|NCT03851484|hypersensitivity|hypersensitivity
5023372|NCT03851458|Focus Groups|focus groups
5023453|NCT03850860|prosthetic joint infection|prosthetic joint infection
5023454|NCT03850860|empirical antibiotherapy|empirical antibiotherapy
5023455|NCT03850847|Neurological Determination of Death|neurological determination of death
5023456|NCT03850847|Organ Donation|organ donation
5023457|NCT03850847|Determination of Death|determination of death
5023458|NCT03850847|Understanding Decision Making|understanding decision making
5023459|NCT03850847|Substitute Decision Maker|substitute decision maker
5023460|NCT03850821|Physical Activity|physical activity
5023461|NCT03850821|Community-based Intervention|community-based intervention
5023462|NCT03850821|Social Motivational Theories|social motivational theories
5023463|NCT03850821|Behavioral Change|behavioral change
5023464|NCT03850821|Social Mechanisms|social mechanisms
5023465|NCT03850808|heart failure|heart failure
5023562|NCT03850236|morbidity|morbidity
5023563|NCT03850236|risk factors|risk factors
5023564|NCT03850236|Benign or malign pathology|benign or malign pathology
5023565|NCT03850197|Tubomanometry|tubomanometry
5023566|NCT03850197|EarPopper|earpopper
5023567|NCT03850197|Eustachian tube function test|eustachian tube function test
5023580|NCT03850132|Caregivers|caregivers
5023675|NCT03849638|gait training|gait training
5023676|NCT03849638|biofeedback|biofeedback
5023677|NCT03849599|Ulcerative Colitis|ulcerative colitis
5023678|NCT03849586|penile prosthesis implant|penile prosthesis implant
5023679|NCT03849573|eHealth|ehealth
5023680|NCT03849573|Adherence|adherence
5023681|NCT03849573|Health Related Quality of Life|health related quality of life
5023682|NCT03849573|Symptom Burden|symptom burden
5023683|NCT03849573|Breast Cancer|breast cancer
5023686|NCT03849534|Children|children
5023773|NCT03849170|stress inoculation technique|stress inoculation technique
5023774|NCT03849170|competitive anxiety|competitive anxiety
5023775|NCT03849170|psychological intervention|psychological intervention
5039433|NCT03752125|flavonoids|flavonoids
5023776|NCT03849131|monoclonal anti-PD-1 immunotherapy|monoclonal anti-pd-1 immunotherapy
5023777|NCT03849131|monoclonal anti-CTLA-4 immunotherapy|monoclonal anti-ctla-4 immunotherapy
5023778|NCT03849131|checkpoint inhibitors|checkpoint inhibitors
5023779|NCT03849131|autoimmune manifestations|autoimmune manifestations
5018306|NCT03882489|Effective Dose (ED95)|effective dose (ed95)
5023876|NCT03848546|perceived wellbeing|perceived wellbeing
5023877|NCT03848533|Melatonin|melatonin
5023878|NCT03848533|Metformin|metformin
5023983|NCT03847935|occupational therapy|occupational therapy
5023984|NCT03847909|PH1|ph1
5023985|NCT03847909|PH2|ph2
5023986|NCT03847909|Primary Hyperoxaluria|primary hyperoxaluria
5023987|NCT03847909|RNAi|rnai
5024090|NCT03847428|Liver Cancer|liver cancer
5024091|NCT03847376|Rilpivirine|rilpivirine
5024092|NCT03847376|Long Acting Rilpivirine Injection|long acting rilpivirine injection
5024093|NCT03847376|HIV|hiv
5024094|NCT03847376|Rilpivirine Expanded Access|rilpivirine expanded access
5024095|NCT03847376|Rilpivirine Single Patient Request|rilpivirine single patient request
5024096|NCT03847337|telemedicine|telemedicine
5024097|NCT03847298|pediatric|pediatric
5024098|NCT03847298|pacemaker|pacemaker
5024198|NCT03846739|dose|dose
5024199|NCT03846739|emotion processing|emotion processing
5024200|NCT03846739|sex differences|sex differences
5024299|NCT03846102|Numerical Rating scale|numerical rating scale
5024300|NCT03846063|Total hip arthroplasty|total hip arthroplasty
5024301|NCT03846063|Physiotherapy|physiotherapy
5024302|NCT03846063|Osteoarthritis|osteoarthritis
5024303|NCT03846063|Usual care|usual care
5024316|NCT03846024|Trauma|trauma
5024415|NCT03845361|Cardiac Surgery|cardiac surgery
5024416|NCT03845361|Radial artery cannulation|radial artery cannulation
5024417|NCT03845322|curcumin|curcumin
5024418|NCT03845322|chronic|chronic
5024419|NCT03845322|recurrence|recurrence
5024420|NCT03845322|hematoma|hematoma
5024421|NCT03845322|subdural|subdural
5024422|NCT03845322|turmeric|turmeric
5024423|NCT03845309|Heart failure|heart failure
5024425|NCT03845309|Quality of Life|quality of life
5024581|NCT03844386|ART|art
5024622|NCT03844152|gut health|gut health
5024623|NCT03844152|butyrate|butyrate
5024624|NCT03844113|carnosine|carnosine
5024625|NCT03844113|peripheral arterial disease|peripheral arterial disease
5024626|NCT03844100|Refractory Functional Dyspepsia|refractory functional dyspepsia
5024627|NCT03844087|multiplanar, plyometric, neck strength|multiplanar, plyometric, neck strength
5024628|NCT03844074|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5024629|NCT03844061|Systemic Sclerosis|systemic sclerosis
5024630|NCT03844048|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5024631|NCT03844048|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5024632|NCT03844048|Multiple Myeloma (MM)|multiple myeloma (mm)
5024633|NCT03844048|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5024634|NCT03844048|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5024635|NCT03844048|Cancer|cancer
5024636|NCT03844048|Venetoclax|venetoclax
5024722|NCT03843567|Virtual chromoendoscopy|virtual chromoendoscopy
5024723|NCT03843567|Training|training
5024724|NCT03843567|Polyp characterisation|polyp characterisation
5024725|NCT03843554|Head Cancer|head cancer
5024726|NCT03843554|Neck Cancer|neck cancer
5024727|NCT03843554|Oral Mucositis|oral mucositis
5024728|NCT03843554|Oral Health|oral health
5024729|NCT03843554|Radiation|radiation
5024730|NCT03843554|Chemoradiation|chemoradiation
5024731|NCT03843541|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
5024826|NCT03842956|Fix-Ex|fix-ex
5024827|NCT03842956|Pin Side|pin side
5024828|NCT03842956|Trauma|trauma
5024962|NCT03842111|school readiness|school readiness
5024963|NCT03842111|teachers|teachers
5024964|NCT03842098|Korean Medicine Patient Registry|korean medicine patient registry
5024965|NCT03842098|Post-operative Therapy|post-operative therapy
5024966|NCT03842098|Musculoskeletal Disorders|musculoskeletal disorders
5024967|NCT03842085|HER2-positive|her2-positive
5025074|NCT03841357|abatacept|abatacept
5025075|NCT03841357|uveitis|uveitis
5025076|NCT03841357|prevention|prevention
5025077|NCT03841331|Pruritus|pruritus
5025078|NCT03841318|lymphoid cells|lymphoid cells
5025079|NCT03841318|gut-derived lymphocytes|gut-derived lymphocytes
5025080|NCT03841305|Liver|liver
5025196|NCT03840876|Supraglottic|supraglottic
5025197|NCT03840876|Intranasal|intranasal
5025198|NCT03840876|Microlaryngeal Surgery|microlaryngeal surgery
5025199|NCT03840863|Energy Drink|energy drink
5025200|NCT03840863|Blood Pressure|blood pressure
5025201|NCT03840863|Arrhythmia|arrhythmia
5025202|NCT03840850|Type 2 diabetes mellitus|type 2 diabetes mellitus
5025203|NCT03840837|cognitive impairment|cognitive impairment
5025313|NCT03840161|Diabetes mellitus Type 2|diabetes mellitus type 2
5025430|NCT03839459|Denosumab|denosumab
5025431|NCT03839446|cytogenetic status|cytogenetic status
5025432|NCT03839446|mitoxantrone|mitoxantrone
5025433|NCT03839446|etoposide|etoposide
5025449|NCT03839329|Acceptance and Commitment Therapy|acceptance and commitment therapy
5025450|NCT03839329|Brief interventions|brief interventions
5025451|NCT03839329|Psychological flexibility|psychological flexibility
5041623|NCT03739203|MDD|mdd
5025452|NCT03839316|Cortical stimulation|cortical stimulation
5025453|NCT03839316|Motor function|motor function
5025454|NCT03839316|Rehabilitation|rehabilitation
5025456|NCT03839290|bilateral cleft lip and palate|bilateral cleft lip and palate
5025457|NCT03839290|unilateral cleft lip and palate|unilateral cleft lip and palate
5025540|NCT03838718|Sarcoma|sarcoma
5025541|NCT03838718|Surgery|surgery
5025542|NCT03838718|Multivisceral resection|multivisceral resection
5025543|NCT03838718|Chemotherapy|chemotherapy
5025544|NCT03838718|Radiation Therapy|radiation therapy
5025545|NCT03838718|Patients' Registry|patients' registry
5025560|NCT03838575|RCT|rct
5025656|NCT03838185|Neurodegenerative Disease|neurodegenerative disease
5025657|NCT03838172|Burn Injury|burn injury
5025658|NCT03838172|quality of life|quality of life
5025659|NCT03838172|scar|scar
5025660|NCT03838120|Ultrasound|ultrasound
5025661|NCT03838120|Minimum|minimum
5025760|NCT03837522|Deceased kidney donation|deceased kidney donation
5025868|NCT03836976|EEG|eeg
5025869|NCT03836976|neuroplasticity|neuroplasticity
5025870|NCT03836976|gamma oscillation|gamma oscillation
5025988|NCT03836196|PSMA PET/CT|psma pet/ct
5075976|NCT03524235|CLL|cll
5025989|NCT03836196|multi-parametric MRI|multi-parametric mri
5025990|NCT03836196|multi-parametric TRUS|multi-parametric trus
5025991|NCT03836196|Transperineal mapping biopsy|transperineal mapping biopsy
5025992|NCT03836196|LDR Brachytherapy|ldr brachytherapy
5025993|NCT03836196|External Beam Radiation Treatment|external beam radiation treatment
5025994|NCT03836183|bronchoscopy|bronchoscopy
5025995|NCT03836183|ultrasound|ultrasound
5025996|NCT03836183|thorax|thorax
5025997|NCT03836170|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5025998|NCT03836170|gut microbiota|gut microbiota
5025999|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine
5026012|NCT03836014|Relapse|relapse
5026079|NCT03835611|Gait|gait
5026080|NCT03835611|Dual Task walking|dual task walking
5026081|NCT03835611|Feasibility|feasibility
5026082|NCT03835572|Circadian Rhythm|circadian rhythm
5026083|NCT03835572|Education|education
5026084|NCT03835572|Student burnout|student burnout
5026085|NCT03835572|Sleep Hygiene|sleep hygiene
5026086|NCT03835559|varicose vein|varicose vein
5026087|NCT03835559|stripping|stripping
5026088|NCT03835559|endovenous|endovenous
5026089|NCT03835559|ablation|ablation
5026090|NCT03835559|Occlusion|occlusion
5026091|NCT03835559|quality of life|quality of life
5026092|NCT03835546|Brain|brain
5026093|NCT03835546|HIV-1 Infection|hiv-1 infection
5026095|NCT03835533|Immunotherapy|immunotherapy
5026099|NCT03835533|CDX-301|cdx-301
5026306|NCT03834207|Depression|depression
5026307|NCT03834207|Renal Failure|renal failure
5026308|NCT03834207|Kidney Failure|kidney failure
5026309|NCT03834207|Ageing|ageing
5026310|NCT03834207|Computer System|computer system
5026311|NCT03834207|Information Technology|information technology
5026312|NCT03834207|Patient Empowerment|patient empowerment
5026313|NCT03834207|Guideline Reconciliation|guideline reconciliation
5026559|NCT03832816|ACTH|acth
5026577|NCT03832712|Randomized Controlled Trial|randomized controlled trial
5026578|NCT03832673|bladder|bladder
5026579|NCT03832673|cancer|cancer
5026580|NCT03832660|Lifestyle|lifestyle
5026581|NCT03832660|ARNI|arni
5026582|NCT03832660|Exercise tolerance|exercise tolerance
5026583|NCT03832621|nivolumab|nivolumab
5026584|NCT03832621|ipilimumab|ipilimumab
5026702|NCT03831984|bromfenac|bromfenac
5026703|NCT03831984|NSAID|nsaid
5026704|NCT03831984|pupil|pupil
5026705|NCT03831971|Reward Pathway|reward pathway
5026706|NCT03831971|Pharmacokinetics|pharmacokinetics
5026707|NCT03831971|Dopamine|dopamine
5026708|NCT03831971|Opioid Use|opioid use
5026709|NCT03831971|Addiction|addiction
5026720|NCT03831867|children|children
5026721|NCT03831867|health|health
5026722|NCT03831867|pilates|pilates
5026730|NCT03831841|fitness|fitness
5026731|NCT03831802|epilepsy|epilepsy
5026811|NCT03831308|Physical activity and quality of life of cancer patients|physical activity and quality of life of cancer patients
5026819|NCT03831243|Bone metastases|bone metastases
5026820|NCT03831230|ex vivo|ex vivo
5026924|NCT03830541|tooth loss|tooth loss
5026925|NCT03830515|Lacerations|lacerations
5026926|NCT03830515|Wounds|wounds
5026927|NCT03830502|Prophylactic salpingectomy|prophylactic salpingectomy
5026928|NCT03830502|Opportunistic salpingectomy|opportunistic salpingectomy
5718615|NCT00436501|Taxotere|taxotere
5027069|NCT03829423|magnetic resonance imaging|magnetic resonance imaging
5027070|NCT03829423|breast cancer|breast cancer
5027071|NCT03829410|Kras mutation|kras mutation
5027072|NCT03829410|PCM-075|pcm-075
5027073|NCT03829410|Onvansertib|onvansertib
5027074|NCT03829410|FOLFIRI|folfiri
5027075|NCT03829410|Irinotecan|irinotecan
5027076|NCT03829410|5-Fluorouracil|5-fluorouracil
5027080|NCT03829397|Demoralization Scale-Mandarin Version|demoralization scale-mandarin version
5027081|NCT03829397|Demoralization syndrome|demoralization syndrome
5027082|NCT03829384|Chikungunya fever|chikungunya fever
5027083|NCT03829384|Alphavirus infections|alphavirus infections
5027084|NCT03829384|Togavirus|togavirus
5027085|NCT03829384|Viral diseases|viral diseases
5027086|NCT03829371|TRANSPLANT INELIGIBLE|transplant ineligible
5027091|NCT03829358|PAC-QOL|pac-qol
5027195|NCT03828682|kidney transplantation|kidney transplantation
5027196|NCT03828682|steroid withdrawal|steroid withdrawal
5027322|NCT03827928|Depression|depression
5027323|NCT03827915|Atrial fibrillation|atrial fibrillation
5027324|NCT03827915|Refractory atrial fibrillation|refractory atrial fibrillation
5027325|NCT03827915|Double sequential external defibrillation|double sequential external defibrillation
5027326|NCT03827889|dental caries|dental caries
5027327|NCT03827889|Tooth, Deciduous|tooth, deciduous
5027328|NCT03827889|Fluorides, Topical|fluorides, topical
5027442|NCT03827200|Non-Alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5027443|NCT03827200|Non-alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5027550|NCT03826706|One-lung ventilation|one-lung ventilation
5027552|NCT03826693|nitrous oxide|nitrous oxide
5027553|NCT03826654|vitamin D|vitamin d
5027554|NCT03826654|fortified oil|fortified oil
5027558|NCT03826576|mediterranean diet|mediterranean diet
5027559|NCT03826576|Food allergen|food allergen
5027657|NCT03825835|Resuscitation|resuscitation
5027658|NCT03825835|Premature Infant|premature infant
5027659|NCT03825835|Oxygen|oxygen
5027660|NCT03825822|Pain|pain
5027662|NCT03825822|Infants|infants
5027776|NCT03825120|health|health
5027777|NCT03825120|cardiovascular disease|cardiovascular disease
5027778|NCT03825120|cardiovascular disease risk|cardiovascular disease risk
5027779|NCT03825055|disease-specific variables|disease-specific variables
5027780|NCT03825055|biopsychosocial characteristics|biopsychosocial characteristics
5027781|NCT03825055|resilience|resilience
5027782|NCT03825055|adjustment|adjustment
5027874|NCT03824717|Infraclavicular block|infraclavicular block
5027875|NCT03824704|PARP|parp
5027876|NCT03824704|PARPi|parpi
5027877|NCT03824704|PARP inhibitor|parp inhibitor
5027878|NCT03824704|ARIES|aries
5027879|NCT03824704|Opdivo|opdivo
5027880|NCT03824704|Rucaparib|rucaparib
5027881|NCT03824704|Nivolumab|nivolumab
5027882|NCT03824704|PD-1|pd-1
5027883|NCT03824704|BRCA|brca
5027884|NCT03824704|LOH|loh
5027885|NCT03824704|CO-338|co-338
5027886|NCT03824704|Immunotherapy|immunotherapy
5027887|NCT03824704|BMS-936558|bms-936558
5027888|NCT03824704|Clovis|clovis
5027889|NCT03824704|Clovis Oncology|clovis oncology
5027890|NCT03824704|Rubraca|rubraca
5027970|NCT03824236|Sporozoite challenge|sporozoite challenge
5028099|NCT03823417|Periacetabular Osteotomy|periacetabular osteotomy
5028104|NCT03823378|ABBV-105|abbv-105
5028105|NCT03823378|Upadacitinib|upadacitinib
5028106|NCT03823378|ABBV-599|abbv-599
5028107|NCT03823378|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5028231|NCT03822767|poliomyelitis|poliomyelitis
5028232|NCT03822767|safety|safety
5028233|NCT03822767|immunogenicity|immunogenicity
5028234|NCT03822767|infant|infant
5028235|NCT03822767|sequential schedule|sequential schedule
5028346|NCT03822104|Bovine Colostrum|bovine colostrum
5028347|NCT03822104|Enteral Feeding|enteral feeding
5028348|NCT03822104|Nutrition|nutrition
5028349|NCT03822104|Human milk|human milk
5028350|NCT03822078|Postmenopausal|postmenopausal
5028351|NCT03822078|Denosumab|denosumab
5028352|NCT03822065|Depressive Disorder, Major|depressive disorder, major
5028353|NCT03822065|Depressive Disorder|depressive disorder
5028354|NCT03822065|Mood Disorders|mood disorders
5028355|NCT03822065|Mental Disorders|mental disorders
5028617|NCT03820765|Hemodialyis, Peritonealdialysis, Qualitiy assurance dialysis|hemodialyis, peritonealdialysis, qualitiy assurance dialysis
5028618|NCT03820700|Virtual Reality|virtual reality
5028619|NCT03820700|Hypnosis|hypnosis
5028620|NCT03820700|Intensive care units|intensive care units
5028621|NCT03820700|Cardiac surgery|cardiac surgery
5028719|NCT03819868|Pit and Fissure Sealants|pit and fissure sealants
5028720|NCT03819842|cataract surgery|cataract surgery
5028721|NCT03819842|cataract|cataract
5028722|NCT03819842|toric IOL|toric iol
5028723|NCT03819816|informal caregivers|informal caregivers
5028724|NCT03819816|person with dementia|person with dementia
5028725|NCT03819816|e-health solution|e-health solution
5028726|NCT03819790|Diabetes, type 2|diabetes, type 2
5028727|NCT03819790|GLP-1 RA|glp-1 ra
5028826|NCT03819244|Diode Laser|diode laser
5028827|NCT03819244|Erbium Laser|erbium laser
5028828|NCT03819244|Second-stage Implant Surgery|second-stage implant surgery
5028934|NCT03818360|Emergency departments|emergency departments
5028935|NCT03818347|Solid tumor|solid tumor
5028936|NCT03818347|Hydrogen gas|hydrogen gas
5028937|NCT03818334|Bone Marrow Transplantation|bone marrow transplantation
5028938|NCT03818334|Hematological Malignancies|hematological malignancies
5028939|NCT03818334|Post-Cy|post-cy
5028940|NCT03818308|Acute hepatitis C virus (HCV) infection|acute hepatitis c virus (hcv) infection
5028941|NCT03818256|Antipsychotic-induced weight gain (AIWG)|antipsychotic-induced weight gain (aiwg)
5028942|NCT03818256|Obesity|obesity
5028943|NCT03818256|Weight Gain|weight gain
5028944|NCT03818256|Mental disorders|mental disorders
5028969|NCT03818165|CEA|cea
5029041|NCT03817762|pediatric respiratory polygraphy|pediatric respiratory polygraphy
5029159|NCT03817034|ketorolac|ketorolac
5029160|NCT03817034|pain management|pain management
5029161|NCT03817034|opioid sparing|opioid sparing
5029162|NCT03817034|analgesia|analgesia
5029163|NCT03817021|Responsive parenting|responsive parenting
5029282|NCT03816085|muscles|muscles
5029283|NCT03816059|Respiratory virus infection|respiratory virus infection
5029284|NCT03816059|Extrapulmonary complications|extrapulmonary complications
5029285|NCT03816059|Myocardial infarction|myocardial infarction
5029286|NCT03816059|Asthma|asthma
5029287|NCT03816059|Bronchiectasis|bronchiectasis
5029293|NCT03816046|injection|injection
5029406|NCT03815396|AAT|aat
5029535|NCT03814707|platelet rich fibrin in wound healing|platelet rich fibrin in wound healing
5029638|NCT03814005|Drug therapy|drug therapy
5029639|NCT03813979|pharmacokinetics|pharmacokinetics
5029640|NCT03813979|dolutegravir|dolutegravir
5029641|NCT03813940|human papillomavirus vaccine|human papillomavirus vaccine
5029642|NCT03813914|insulin resistance, blood pressure,|insulin resistance, blood pressure,
5029643|NCT03813849|remnants of conception|remnants of conception
5029772|NCT03813095|Opioids: Harmful Use|opioids: harmful use
5029773|NCT03813095|Cocaine|cocaine
5029774|NCT03813095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors
5029775|NCT03813095|Analgesics|analgesics
5029776|NCT03813095|Mental Disorders|mental disorders
5029777|NCT03813095|Narcotics|narcotics
5029778|NCT03813095|Cannabidiol|cannabidiol
5029779|NCT03813082|Positron emission tomography|positron emission tomography
5029780|NCT03813082|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5029795|NCT03812913|Turner syndrome|turner syndrome
5029796|NCT03812913|Cognitive Functions|cognitive functions
5029797|NCT03812913|Social Cognition|social cognition
5029798|NCT03812913|Pediatrics|pediatrics
5029875|NCT03812328|P-selectin|p-selectin
5029989|NCT03811626|Cognitive dimension|cognitive dimension
5030223|NCT03810300|Gender|gender
5030224|NCT03810248|sleep bruxism|sleep bruxism
5030225|NCT03810248|polisomnography|polisomnography
5030226|NCT03810235|lidocaine|lidocaine
5030227|NCT03810235|patch|patch
5030228|NCT03810222|TBI moderate, TBI severe, GOSE|tbi moderate, tbi severe, gose
5030229|NCT03810183|QAW039,|qaw039,
5030230|NCT03810183|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5030231|NCT03810183|COPD, sputum,|copd, sputum,
5030232|NCT03810183|eosinophillic,|eosinophillic,
5030267|NCT03809988|HR|hr
5030358|NCT03809572|MBCT|mbct
5030359|NCT03809572|Mindfulness Based Cognitive Therapy|mindfulness based cognitive therapy
5030360|NCT03809572|emotion regulation|emotion regulation
5030361|NCT03809559|Magnetic Resonance Cholangiopancreatography (MRCP)|magnetic resonance cholangiopancreatography (mrcp)
5030362|NCT03809507|opioids|opioids
5030363|NCT03809494|lower extremity|lower extremity
5030364|NCT03809494|Peripheral Arterial Disease|peripheral arterial disease
5030365|NCT03809494|Ischemia|ischemia
5030452|NCT03808948|congestive heart failure|congestive heart failure
5030453|NCT03808948|glomerular filtration rate|glomerular filtration rate
5030454|NCT03808948|plasma volume|plasma volume
5030455|NCT03808935|epilepsy|epilepsy
5030456|NCT03808935|drug resistant|drug resistant
5030457|NCT03808935|refractory|refractory
5030458|NCT03808935|seizures|seizures
5030459|NCT03808935|cannabidiol|cannabidiol
5030461|NCT03808935|cannabis|cannabis
5030467|NCT03808883|Barriers to Healthcare Access|barriers to healthcare access
5030468|NCT03808883|Participatory Action Research|participatory action research
5030469|NCT03808883|Cultural Competency|cultural competency
5030470|NCT03808857|recurrent Metastatic Cervical Cancer|recurrent metastatic cervical cancer
5030471|NCT03808857|platinum|platinum
5030481|NCT03808779|Papillary Thyroid Microcarcinoma|papillary thyroid microcarcinoma
5030482|NCT03808779|Radiofrequency Ablation|radiofrequency ablation
5030483|NCT03808779|Surgery|surgery
5030484|NCT03808753|Mini Fluid Challenge|mini fluid challenge
5030485|NCT03808753|End-expiratory occlusion test|end-expiratory occlusion test
5030486|NCT03808753|Fluid responsiveness|fluid responsiveness
5030489|NCT03808727|CPT|cpt
5030569|NCT03808207|gas chromatography|gas chromatography
5031662|NCT03801330|software|software
5030573|NCT03808129|postoperative analgesia|postoperative analgesia
5030575|NCT03808116|breast biopsy|breast biopsy
5030576|NCT03808103|Phage|phage
5030577|NCT03808103|Bacteriophage|bacteriophage
5030578|NCT03808103|AIEC|aiec
5030579|NCT03808090|oxalate|oxalate
5030580|NCT03808090|obesity|obesity
5030581|NCT03808090|kidney stones|kidney stones
5030582|NCT03808090|diabetes|diabetes
5030665|NCT03807544|TENS|tens
5030671|NCT03807479|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5030672|NCT03807479|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5030673|NCT03807453|Psoriasis Vulgaris|psoriasis vulgaris
5030886|NCT03806270|Oculocardiac reflex|oculocardiac reflex
5030887|NCT03806270|Hydroxyzine dihydrochloride|hydroxyzine dihydrochloride
5030889|NCT03806270|Premedication|premedication
5030890|NCT03806270|The Ramsay Scale|the ramsay scale
5030891|NCT03806244|stereotactic navigation|stereotactic navigation
5030892|NCT03806244|colorectal cancer|colorectal cancer
5030975|NCT03805672|enoxaparin|enoxaparin
5030976|NCT03805672|DVT|dvt
5030977|NCT03805659|Adult|adult
5030978|NCT03805659|Primary Progressive Aphasia|primary progressive aphasia
5030979|NCT03805659|High-definition Transcranial Direct Current Stimulation|high-definition transcranial direct current stimulation
5030980|NCT03805659|HD-tDCS|hd-tdcs
5030981|NCT03805659|Language|language
5030982|NCT03805659|Logopenic|logopenic
5030983|NCT03805659|Magnetic Resonance Imaging|magnetic resonance imaging
5030984|NCT03805659|MRI|mri
5030985|NCT03805659|Magnetoencephalography|magnetoencephalography
5030986|NCT03805659|MEG|meg
5030987|NCT03805659|Brain|brain
5031084|NCT03804996|relapsed or refractory|relapsed or refractory
5031085|NCT03804983|Artificial Pancreas (AP)|artificial pancreas (ap)
5031086|NCT03804983|Insulin Pump|insulin pump
5031087|NCT03804983|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5031088|NCT03804983|MyTDI|mytdi
5031091|NCT03804970|Diabetes|diabetes
5031190|NCT03804307|Symptomatic thoracic lesions|symptomatic thoracic lesions
5031191|NCT03804242|positive youth development|positive youth development
5031192|NCT03804242|school-to-prison pipeline|school-to-prison pipeline
5031193|NCT03804242|mental health stigma|mental health stigma
5031312|NCT03803605|Resting|resting
5031313|NCT03803579|Atrial Fibrillation|atrial fibrillation
5031322|NCT03803540|NAFLD|nafld
5031587|NCT03801785|Dental problems|dental problems
5031588|NCT03801785|Theta Rhythm|theta rhythm
5031589|NCT03801772|Aquatic Therapy|aquatic therapy
5031590|NCT03801772|Hydrotherapy|hydrotherapy
5031591|NCT03801772|Pool Therapy|pool therapy
5031826|NCT03800303|parents|parents
5031827|NCT03800290|Beta-2 adrenergic agonist|beta-2 adrenergic agonist
5031828|NCT03800290|Glucose homeostasis|glucose homeostasis
5031829|NCT03800290|Skeletal muscle|skeletal muscle
5031830|NCT03800290|Human|human
5031831|NCT03800264|Bisoprolol,|bisoprolol,
5031923|NCT03799536|Bioequivalence|bioequivalence
5031924|NCT03799536|Sotalol|sotalol
5031925|NCT03799536|Sotalex|sotalex
5031926|NCT03799510|Schistosomiasis|schistosomiasis
5031927|NCT03799510|Recombinant vaccine|recombinant vaccine
5031928|NCT03799510|rSm14|rsm14
5032032|NCT03799003|squamous cell carcinoma of the head and neck (SCCHN)|squamous cell carcinoma of the head and neck (scchn)
5032033|NCT03799003|metastatic castration-resistant prostate cancer (mCRPC)|metastatic castration-resistant prostate cancer (mcrpc)
5032035|NCT03799003|Tumors|tumors
5032036|NCT03799003|pembrolizumab|pembrolizumab
5032037|NCT03799003|colorectal cancer|colorectal cancer
5032039|NCT03799003|Advanced solid tumors|advanced solid tumors
5032143|NCT03798301|Hematopoietic stem cell transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5032145|NCT03798288|Digital Decision Support System|digital decision support system
5032146|NCT03798288|App|app
5032147|NCT03798288|Self-management|self-management
5032152|NCT03798236|Adenosine A3 receptor antagonist|adenosine a3 receptor antagonist
5032153|NCT03798236|autoimmune diseases|autoimmune diseases
5032174|NCT03798119|Switch|switch
5032238|NCT03797573|vegetative state|vegetative state
5032239|NCT03797573|minimally conscious state|minimally conscious state
5032240|NCT03797560|Eight Brocades; Ba-Duan-Jin; Baduanjin; Qigong; Pain|eight brocades; ba-duan-jin; baduanjin; qigong; pain
5032241|NCT03797534|warfarin|warfarin
5046133|NCT03710889|Osteoporosis|osteoporosis
5032247|NCT03797469|Vitamins|vitamins
5032248|NCT03797469|Glaucoma|glaucoma
5032249|NCT03797469|Supplements|supplements
5032250|NCT03797469|Vitamin B3|vitamin b3
5032251|NCT03797469|Nicotinamide|nicotinamide
5032252|NCT03797443|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5032253|NCT03797443|Cancer|cancer
5032350|NCT03796936|virtual reality|virtual reality
5032351|NCT03796936|eye movement desensitization and reprocessing|eye movement desensitization and reprocessing
5032353|NCT03796923|Hospital at home|hospital at home
5032354|NCT03796923|Readmission|readmission
5032355|NCT03796923|Transitional care|transitional care
5032356|NCT03796923|Frailty|frailty
5032357|NCT03796923|Patient Related Outcome Measures|patient related outcome measures
5032358|NCT03796910|safety|safety
5032359|NCT03796910|tolerability|tolerability
5032360|NCT03796910|pharmacokinetics|pharmacokinetics
5032361|NCT03796910|SPR720|spr720
5032367|NCT03796819|intrahepatic cholangiocarcinoma|intrahepatic cholangiocarcinoma
5032368|NCT03796819|surgery|surgery
5032369|NCT03796819|lymphadenectomy|lymphadenectomy
5032370|NCT03796819|lymph node metastasis|lymph node metastasis
5032446|NCT03796208|Pregnancy|pregnancy
5032447|NCT03796208|tobacco|tobacco
5032448|NCT03796195|Stelate Ganglion Block|stelate ganglion block
5032449|NCT03796182|Phase 1|phase 1
5032450|NCT03796182|Metformin|metformin
5032451|NCT03796182|Atopic dermatitis|atopic dermatitis
5032452|NCT03796117|Muscle Strength|muscle strength
5032453|NCT03796117|Fatigue|fatigue
5032454|NCT03796117|Neuromuscular efficiency|neuromuscular efficiency
5032455|NCT03796117|Discomfort level|discomfort level
5032688|NCT03794908|Pain|pain
5032689|NCT03794908|Light|light
5032690|NCT03794882|Hernia, Ventral|hernia, ventral
5032691|NCT03794882|Pain, Postoperative|pain, postoperative
5032692|NCT03794882|Opioid Use|opioid use
5032693|NCT03794882|Pain|pain
5032699|NCT03794856|Asthma|asthma
5032802|NCT03794245|Testing and Diagnosis|testing and diagnosis
5032803|NCT03794245|Treatment|treatment
5026450|NCT03833323|PAH|pah
5032903|NCT03793413|infant feeding|infant feeding
5032904|NCT03793413|bottle feeding|bottle feeding
5032905|NCT03793400|punctate inner choroidopathy|punctate inner choroidopathy
5033000|NCT03792763|smoldering multiple myeloma|smoldering multiple myeloma
5033002|NCT03792763|denosumab|denosumab
5033003|NCT03792763|Austrian Study Group of Medical Tumour Therapy (AGMT)|austrian study group of medical tumour therapy (agmt)
5033004|NCT03792763|high risk smoldering myeloma|high risk smoldering myeloma
5033006|NCT03792698|Frailty|frailty
5033098|NCT03791996|Cognitive impairment|cognitive impairment
5033099|NCT03791996|Syndrome of the trephined|syndrome of the trephined
5033100|NCT03791944|nasopharynx cancer|nasopharynx cancer
5033101|NCT03791944|Radiotherapy|radiotherapy
5033102|NCT03791918|Hepatocellular Carcinoma|hepatocellular carcinoma
5033103|NCT03791918|Lenvatinib|lenvatinib
5033104|NCT03791918|PD-1 Antibody|pd-1 antibody
5033106|NCT03791905|Esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5033108|NCT03791905|Definitive chemoradiotherapy|definitive chemoradiotherapy
5033109|NCT03791905|Induction chemotherapy|induction chemotherapy
5033110|NCT03791892|Adhesive capsulitis|adhesive capsulitis
5033111|NCT03791892|suprascapular nerve|suprascapular nerve
5033112|NCT03791892|shoulder mobilization|shoulder mobilization
5033113|NCT03791879|Caudal|caudal
5033114|NCT03791879|Dexmedetomidine|dexmedetomidine
5033115|NCT03791879|Levobupivacaine|levobupivacaine
5033116|NCT03791879|hypospadias|hypospadias
5033117|NCT03791853|Breast Neoplasms|breast neoplasms
5033118|NCT03791853|Optical Coherence Tomogram|optical coherence tomogram
5033119|NCT03791853|Sentinel lymph node|sentinel lymph node
5033176|NCT03791541|Survey|survey
5033177|NCT03791528|Sacroiliac Joint Dysfunction|sacroiliac joint dysfunction
5033180|NCT03791502|Elderly|elderly
5033387|NCT03790462|Stress, Electroencephalogram,Indian Music, Electrocardiogram|stress, electroencephalogram,indian music, electrocardiogram
5033394|NCT03790410|COPD Postural Control IMT|copd postural control imt
5033395|NCT03790397|Lung Cancer, EGFR positive, NSCLC, Osimertinib|lung cancer, egfr positive, nsclc, osimertinib
5033397|NCT03790345|Cobalamin|cobalamin
5033398|NCT03790345|Pyridoxine|pyridoxine
5033399|NCT03790345|Drug-induced movement disorder|drug-induced movement disorder
5033400|NCT03790332|cGVHD|cgvhd
5033401|NCT03790332|chronic graft versus host disease|chronic graft versus host disease
5033402|NCT03790332|PCYC1146IM|pcyc1146im
5033403|NCT03790332|Pediatric|pediatric
5033404|NCT03790332|GVHD|gvhd
5033405|NCT03790332|chronic|chronic
5033406|NCT03790332|1146|1146
5033407|NCT03790332|Pharmacyclics|pharmacyclics
5033408|NCT03790332|PCYC|pcyc
5033481|NCT03789981|AML|aml
5033595|NCT03789162|Blood Draw|blood draw
5033596|NCT03789162|Sample Collection|sample collection
5033597|NCT03789162|Stool DNA|stool dna
5033598|NCT03789149|Intraoperative Radiotherapy|intraoperative radiotherapy
5033599|NCT03789123|Endometrioma|endometrioma
5033600|NCT03789123|Estradiol valerate + dienogest|estradiol valerate + dienogest
5033611|NCT03789045|Metabolic thresholds|metabolic thresholds
5033612|NCT03789045|Fat oxidation|fat oxidation
5033613|NCT03789032|Vadadustat|vadadustat
5033614|NCT03789032|Rabeprazole|rabeprazole
5033615|NCT03789032|Pharmacokinetics|pharmacokinetics
5033616|NCT03789019|BP-C1|bp-c1
5033659|NCT03788811|ERG|erg
5033688|NCT03788629|hemiplegia|hemiplegia
5033689|NCT03788629|foot|foot
5033696|NCT03788512|coexistence|coexistence
5033708|NCT03788434|CDI|cdi
5033802|NCT03787719|End Stage Renal Disease|end stage renal disease
5033803|NCT03787706|Neck Pain|neck pain
5033902|NCT03787056|PROGASTRIN|progastrin
5033903|NCT03787043|Food Effect|food effect
5033904|NCT03787004|Chronic Pain|chronic pain
5033905|NCT03787004|Nociceptive Pain|nociceptive pain
5033906|NCT03787004|Mixed Pain|mixed pain
5033907|NCT03786978|Diabetes mellitus|diabetes mellitus
5033908|NCT03786978|Pharmaceutical care|pharmaceutical care
5033909|NCT03786978|Educational intervention|educational intervention
5033910|NCT03786978|Pharmacoeconomic evaluation|pharmacoeconomic evaluation
5033911|NCT03786965|Ischemic Heart Disease|ischemic heart disease
5034012|NCT03786471|cost-effectiveness|cost-effectiveness
5034143|NCT03785925|Bladder Cancer|bladder cancer
5034144|NCT03785925|CD122|cd122
5034145|NCT03785925|Cisplatin Ineligible|cisplatin ineligible
5034146|NCT03785925|Immuno-oncology|immuno-oncology
5034147|NCT03785925|Immunotherapy|immunotherapy
5034148|NCT03785925|Locally Advanced Urothelial Cancer|locally advanced urothelial cancer
5034149|NCT03785925|Metastatic Urothelial Cancer|metastatic urothelial cancer
5034245|NCT03785353|Pain Neuroscience Education|pain neuroscience education
5034246|NCT03785353|Spanish-speaking|spanish-speaking
5034247|NCT03785340|Dry Eye Disease|dry eye disease
5034249|NCT03785275|Glycemic control|glycemic control
5034250|NCT03785249|KRAS|kras
5034251|NCT03785249|NSCLC|nsclc
5034350|NCT03784638|edema|edema
5034351|NCT03784638|flap design|flap design
5034352|NCT03784625|metastatic melanoma|metastatic melanoma
5034353|NCT03784625|targeted radionuclide therapy|targeted radionuclide therapy
5034358|NCT03784586|Arrhythmias|arrhythmias
5034359|NCT03784586|electrophisiological study|electrophisiological study
5723663|NCT00417963|Stenosis|stenosis
5034456|NCT03783884|Diaphragm Atrophy|diaphragm atrophy
5034457|NCT03783884|Weaning Failure|weaning failure
5034459|NCT03783884|SBT|sbt
5034460|NCT03783884|VILI|vili
5034463|NCT03783871|HCC|hcc
5034590|NCT03783078|anti-PD-1|anti-pd-1
5034591|NCT03783078|anti-PD-L1|anti-pd-l1
5034592|NCT03783078|Merkel cell carcinoma|merkel cell carcinoma
5028372|NCT03822000|trauma|trauma
5034593|NCT03783065|Variceal Rebleeding|variceal rebleeding
5034594|NCT03783065|Hepatic venous pressure gradient|hepatic venous pressure gradient
5034597|NCT03783039|bleeding|bleeding
5034714|NCT03782285|apical prolapse|apical prolapse
5034715|NCT03782285|sacrospinous Ligament Fixation|sacrospinous ligament fixation
5034716|NCT03782246|chronic pain|chronic pain
5034717|NCT03782246|multiple sclerosis|multiple sclerosis
5048536|NCT03695393|HIV|hiv
5034721|NCT03782233|Neuromuscular Blockade|neuromuscular blockade
5034724|NCT03782220|neck pain|neck pain
5034820|NCT03781661|Coronar Computed Tomography Angiography|coronar computed tomography angiography
5034822|NCT03781661|Calcium score|calcium score
5034823|NCT03781661|Diagnostic Examination|diagnostic examination
5034824|NCT03781661|Patient Satisfaction|patient satisfaction
5034825|NCT03781661|Normal Coronary Arteries|normal coronary arteries
5034826|NCT03781635|Ketamine|ketamine
5034827|NCT03781635|anesthesia|anesthesia
5034828|NCT03781635|BIS monitoring|bis monitoring
5034829|NCT03781635|epidural|epidural
5034830|NCT03781635|intraoperative|intraoperative
5034908|NCT03781128|lysergic acid diethylamide (LSD)|lysergic acid diethylamide (lsd)
5035020|NCT03780439|gastric cancer|gastric cancer
5035021|NCT03780439|gastrectomy|gastrectomy
5035022|NCT03780400|Osteoarthritis|osteoarthritis
5035023|NCT03780400|Knee Osteoarthritis|knee osteoarthritis
5035024|NCT03780400|Hip Osteoarthritis|hip osteoarthritis
5035025|NCT03780387|Felis Catus (cat)|felis catus (cat)
5035026|NCT03780361|soluble CD14|soluble cd14
5035027|NCT03780361|MCP-1|mcp-1
5035028|NCT03780361|IL-6|il-6
5035029|NCT03780361|ICAM-1|icam-1
5035030|NCT03780361|cytokine|cytokine
5035036|NCT03780348|Assessment|assessment
5035132|NCT03779672|Memantine|memantine
5035133|NCT03779672|N-methyl-D-aspartate receptor|n-methyl-d-aspartate receptor
5035134|NCT03779672|Serum inflammatory|serum inflammatory
5035135|NCT03779672|Seizure|seizure
5035136|NCT03779659|Electronic dental anesthesia|electronic dental anesthesia
5035137|NCT03779659|Transcutaneous Electronic Nerve Stimulation (TENS)|transcutaneous electronic nerve stimulation (tens)
5048924|NCT03693014|18-359|18-359
5035155|NCT03779529|hemodialysis|hemodialysis
5035156|NCT03779529|lipids|lipids
5035158|NCT03779490|Annuloplasty|annuloplasty
5035246|NCT03779048|Body Weight Changes|body weight changes
5035247|NCT03779048|Signs and Symptoms|signs and symptoms
5035248|NCT03779035|adjuvant chemotherapy|adjuvant chemotherapy
5035249|NCT03779035|cholangiocarcinoma|cholangiocarcinoma
5035250|NCT03779035|invasive gall bladder carcinoma|invasive gall bladder carcinoma
5035251|NCT03779035|overall survival|overall survival
5035252|NCT03779035|disease free survival|disease free survival
5035253|NCT03779035|Gemcitabine|gemcitabine
5035254|NCT03779035|Capecitabine|capecitabine
5035255|NCT03779022|breast cancer|breast cancer
5035256|NCT03779022|biomarker|biomarker
5035257|NCT03779022|neoadjuvant treatment|neoadjuvant treatment
5035258|NCT03779022|microRNA|microrna
5035259|NCT03779022|response|response
5035260|NCT03778996|Ewing's Sarcoma|ewing's sarcoma
5035261|NCT03778996|Locally advanced sarcoma|locally advanced sarcoma
5035262|NCT03778996|Metastatic sarcoma|metastatic sarcoma
5035264|NCT03778996|D.L-alpha-metyrosine|d.l-alpha-metyrosine
5035265|NCT03778983|Cognitive Development|cognitive development
5035319|NCT03778749|intensive care unit|intensive care unit
5035320|NCT03778710|Lymph node metastasis, Gastric cancer|lymph node metastasis, gastric cancer
5035321|NCT03778671|transversus abdominis plane block|transversus abdominis plane block
5035322|NCT03778671|Dexmedetomidine|dexmedetomidine
5035323|NCT03778671|Fentanyl|fentanyl
5035328|NCT03778645|Adrenal venous sampling|adrenal venous sampling
5035329|NCT03778645|Hyperaldosteronism|hyperaldosteronism
5035330|NCT03778645|Angiography|angiography
5035331|NCT03778645|Antecubital approach|antecubital approach
5035332|NCT03778632|Stuttering|stuttering
5035333|NCT03778632|School-age|school-age
5035334|NCT03778632|Emotional reactivity|emotional reactivity
5035335|NCT03778632|Wearable technology|wearable technology
5035452|NCT03777774|Decompressive craniectomy|decompressive craniectomy
5035453|NCT03777774|subgaleal drain|subgaleal drain
5035454|NCT03777774|subgaleal hematoma|subgaleal hematoma
5035456|NCT03777774|surgical site infection|surgical site infection
5035569|NCT03776669|Morbid obesity|morbid obesity
5035570|NCT03776669|Hiatal hernia|hiatal hernia
5035571|NCT03776669|Gastroesophageal reflux disease|gastroesophageal reflux disease
5035580|NCT03776630|miR|mir
5035786|NCT03775252|Ketogenic Diet|ketogenic diet
5035787|NCT03775239|Desire dysfunction|desire dysfunction
5035790|NCT03775239|Sexual pain|sexual pain
5035919|NCT03774563|sleep|sleep
5035920|NCT03774550|Atrial Fibrillation|atrial fibrillation
5036055|NCT03773783|Myofunctional appliance|myofunctional appliance
5036056|NCT03773770|Expanded Access|expanded access
5036057|NCT03773770|Compassionate Use|compassionate use
5036058|NCT03773770|Carnitine Palmitoyltransferase Deficiency|carnitine palmitoyltransferase deficiency
5036059|NCT03773770|CPT I|cpt i
5036060|NCT03773770|CPT II|cpt ii
5036061|NCT03773770|Very Long Chain acyl-CoA Dehydrogenase Deficiency|very long chain acyl-coa dehydrogenase deficiency
5036062|NCT03773770|VLCAD|vlcad
5036312|NCT03772054|Syndecan-1|syndecan-1
5036064|NCT03773770|LHCAD|lhcad
5036149|NCT03773302|unresectable cholangiocarcinoma|unresectable cholangiocarcinoma
5036150|NCT03773302|metastatic cholangiocarcinoma|metastatic cholangiocarcinoma
5036151|NCT03773302|fibroblast growth factor receptor inhibitor|fibroblast growth factor receptor inhibitor
5036152|NCT03773302|FGFR2|fgfr2
5036153|NCT03773302|FGFR2 gene fusions/translocations|fgfr2 gene fusions/translocations
5036393|NCT03771495|hip external rotators|hip external rotators
5036394|NCT03771469|OSA|osa
5036395|NCT03771469|obstructive sleep apnea|obstructive sleep apnea
5036396|NCT03771469|Down syndrome|down syndrome
5036397|NCT03771469|sleep questionnaires|sleep questionnaires
5036398|NCT03771469|sleep study|sleep study
5036399|NCT03771443|Gluten-free toothpaste,celiac disease, GFD, children|gluten-free toothpaste,celiac disease, gfd, children
5036400|NCT03771430|Total knee arthroplasty|total knee arthroplasty
5036401|NCT03771430|Physiotherapy|physiotherapy
5030146|NCT03810599|Cardiac rehabilitation adherence|cardiac rehabilitation adherence
5030147|NCT03810599|Patient-reported outcomes|patient-reported outcomes
5030148|NCT03810599|Post-traumatic growth|post-traumatic growth
5030149|NCT03810599|Anxiety|anxiety
5030150|NCT03810599|Depression|depression
5030151|NCT03810599|Adherence|adherence
5036487|NCT03771040|Eosinophil|eosinophil
5036488|NCT03771040|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5036489|NCT03771027|low FODMAP diet|low fodmap diet
5036490|NCT03771027|functional abdominal pain|functional abdominal pain
5036491|NCT03771027|children|children
5036492|NCT03771014|intensive care|intensive care
5036493|NCT03771014|physiotherapy|physiotherapy
5036592|NCT03770273|Monoclonal Therapy|monoclonal therapy
5030245|NCT03810105|Durvalumab|durvalumab
5030246|NCT03810105|Castration Sensitive Biochemically Recurrent Non-Metastatic Prostate Cancer|castration sensitive biochemically recurrent non-metastatic prostate cancer
5030247|NCT03810105|18-480|18-480
5030248|NCT03810105|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5030249|NCT03810079|transcranial direct current stimulation|transcranial direct current stimulation
5030253|NCT03810079|neuromodulation|neuromodulation
5036593|NCT03770273|Interleukin-6|interleukin-6
5036594|NCT03770273|Mast Cell|mast cell
5036698|NCT03769636|All day life activities|all day life activities
5036699|NCT03769636|Walking capacity|walking capacity
5036700|NCT03769636|Fatigue|fatigue
5036702|NCT03769610|Foley|foley
5036703|NCT03769610|Transcervical|transcervical
5036704|NCT03769597|Cirrhosis Renal|cirrhosis renal
5036705|NCT03769597|GFR|gfr
5036706|NCT03769597|renal function|renal function
5036707|NCT03769597|Bayesian model|bayesian model
5036708|NCT03769597|plasma clearance|plasma clearance
5036709|NCT03769597|iohexol|iohexol
5036710|NCT03769584|quality of life|quality of life
5036711|NCT03769584|treatment outcome|treatment outcome
5036712|NCT03769584|sexuality|sexuality
5036713|NCT03769584|partnership|partnership
5036714|NCT03769584|surgery of endometriosis|surgery of endometriosis
5036722|NCT03769519|adult|adult
5036798|NCT03769233|Mindfulness|mindfulness
5036899|NCT03768648|Demyelinating Diseases|demyelinating diseases
5036900|NCT03768648|Immune System Diseases|immune system diseases
5036905|NCT03768648|brain MRI|brain mri
5037001|NCT03767907|online treatment|online treatment
5037002|NCT03767894|Hand orthosis|hand orthosis
5037003|NCT03767894|Stroke|stroke
5037004|NCT03767881|AXIOS|axios
5037005|NCT03767881|Acute Cholecystitis|acute cholecystitis
5037006|NCT03767881|Percutaneous Gallbladder Drainage|percutaneous gallbladder drainage
5037007|NCT03767881|Cholecystitis|cholecystitis
5037008|NCT03767881|Gallbladder Drainage|gallbladder drainage
5037009|NCT03767855|CK-3773274|ck-3773274
5037010|NCT03767855|CK-274|ck-274
5037011|NCT03767855|obstructive hypertrophic cardiomyopathy|obstructive hypertrophic cardiomyopathy
5037012|NCT03767855|oHCM|ohcm
5037013|NCT03767816|laparoscopic cholecystectomy|laparoscopic cholecystectomy
5037100|NCT03767452|Recurrence|recurrence
5037101|NCT03767452|Incomplete Response|incomplete response
5037102|NCT03767452|Worsening|worsening
5037103|NCT03767452|Curvature|curvature
5037104|NCT03767439|Nivolumab|nivolumab
5037105|NCT03767439|Vismodegib|vismodegib
5037106|NCT03767439|Basal Cell|basal cell
5037107|NCT03767439|Basal Cell Nevus Syndrome (BCNS)|basal cell nevus syndrome (bcns)
5037195|NCT03766828|Dialysis access|dialysis access
5037196|NCT03766802|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5037197|NCT03766802|Physical activity|physical activity
5037198|NCT03766802|exercise behavior|exercise behavior
5037199|NCT03766802|exercise|exercise
5037200|NCT03766802|smart phone|smart phone
5037201|NCT03766802|wearable technology|wearable technology
5037202|NCT03766802|self-management|self-management
5037203|NCT03766802|glycated hemoglobin (HbA1c)|glycated hemoglobin (hba1c)
5037205|NCT03766737|Vision Disorders|vision disorders
5037308|NCT03765970|TESS|tess
5037309|NCT03765970|Soft tissue and bone|soft tissue and bone
5037310|NCT03765970|Questionnaires|questionnaires
5037311|NCT03765957|Mesenchymal Stem Cells|mesenchymal stem cells
5037320|NCT03765905|PCOS|pcos
5037321|NCT03765905|SCUBE|scube
5037322|NCT03765905|Cardiovascular disease|cardiovascular disease
5037323|NCT03765866|rotational thromboelastometry|rotational thromboelastometry
5037324|NCT03765866|viscoelastic test|viscoelastic test
5037325|NCT03765866|coagulopathy|coagulopathy
5037326|NCT03765866|trauma|trauma
5037327|NCT03765866|hemorrhage|hemorrhage
5037403|NCT03765398|Dual-task training|dual-task training
5037404|NCT03765398|Virtual-reality exergaming|virtual-reality exergaming
5037405|NCT03765398|Cognitive-motor-balance training|cognitive-motor-balance training
5037406|NCT03765398|Mild cognitive impairment|mild cognitive impairment
5037407|NCT03765398|Older adults|older adults
5037408|NCT03765385|Aged|aged
5037409|NCT03765385|Aged, 80 and over|aged, 80 and over
5037410|NCT03765385|Exercise|exercise
5037411|NCT03765372|perioperative outcome|perioperative outcome
5037412|NCT03765372|clavien-dindo classification|clavien-dindo classification
5037413|NCT03765372|IPF|ipf
5037414|NCT03765372|hsTnT|hstnt
5037415|NCT03765372|proBNP|probnp
5037416|NCT03765359|insulin need|insulin need
5037417|NCT03765359|diabetic pregnancy|diabetic pregnancy
5037418|NCT03765359|insulin resistance|insulin resistance
5037504|NCT03764527|Artemether-Lumefantrine|artemether-lumefantrine
5037506|NCT03764527|Artesunate|artesunate
5037507|NCT03764527|Amodiaquine|amodiaquine
5037508|NCT03764527|Zanzibar|zanzibar
5037509|NCT03764436|Early Child Development|early child development
5037510|NCT03764436|School Readiness|school readiness
5037519|NCT03764384|PaCO2|paco2
5037610|NCT03763656|Xromi|xromi
5037699|NCT03762967|Autologous Stem Cell|autologous stem cell
5037700|NCT03762967|Male infertility|male infertility
5037701|NCT03762967|Adipose-Derived stem cell|adipose-derived stem cell
5037702|NCT03762967|Azoospermia|azoospermia
5037808|NCT03762434|metabolic sydrome|metabolic sydrome
5037809|NCT03762434|booklet|booklet
5037810|NCT03762434|RCT|rct
5037811|NCT03762408|Osteoarthritis|osteoarthritis
5037812|NCT03762408|Knee|knee
5037813|NCT03762408|Chondroitin Sulfate|chondroitin sulfate
5037814|NCT03762408|Hyaluronic Acid|hyaluronic acid
5037815|NCT03762408|Intra-articular Injection|intra-articular injection
5037816|NCT03762408|Viscosupplementation|viscosupplementation
5037817|NCT03762408|Pain Relief|pain relief
5038056|NCT03761199|whole body cryostimulation|whole body cryostimulation
5038057|NCT03761186|type 1 diabetes|type 1 diabetes
5038058|NCT03761186|low carbohydrate diet|low carbohydrate diet
5038059|NCT03761186|randomized trial|randomized trial
5038169|NCT03760588|Echocardiography|echocardiography
5038170|NCT03760588|Cardio-oncology|cardio-oncology
5038171|NCT03760588|Circulating biomarkers|circulating biomarkers
5038277|NCT03759873|Case management|case management
5038278|NCT03759873|Socioeconomic status|socioeconomic status
5038279|NCT03759847|hemodialysis|hemodialysis
5038280|NCT03759847|fluid intake|fluid intake
5038281|NCT03759847|Interdialytic weight gain|interdialytic weight gain
5038282|NCT03759821|Infant and young child feeding|infant and young child feeding
5038283|NCT03759821|nutrition|nutrition
5038284|NCT03759821|Stimulation|stimulation
5038379|NCT03759067|maintenance dose|maintenance dose
5038380|NCT03759067|periprocedural MI|periprocedural mi
5038382|NCT03759028|closed reduction percutaneous pinning|closed reduction percutaneous pinning
5038383|NCT03759028|post-operative pain control|post-operative pain control
5038384|NCT03759028|opiod|opiod
5038385|NCT03759028|pediatric|pediatric
5038386|NCT03759028|elbow fracture|elbow fracture
5038391|NCT03758950|Sickle Cell|sickle cell
5038392|NCT03758950|Inhaled Steroids|inhaled steroids
5038393|NCT03758937|bariatric surgery|bariatric surgery
5038394|NCT03758937|volume-controlled ventilation|volume-controlled ventilation
5038395|NCT03758937|pressure-controlled ventilation|pressure-controlled ventilation
5038398|NCT03758911|donor|donor
5038487|NCT03758378|dietary modification|dietary modification
5038491|NCT03758326|Body image|body image
5038492|NCT03758261|VATS|vats
5038493|NCT03758261|Regional Anesthesia|regional anesthesia
5038494|NCT03758261|Paravertebral nerve block|paravertebral nerve block
5052123|NCT03672591|Heart failure|heart failure
5038611|NCT03757312|cardiopulmonary bypass|cardiopulmonary bypass
5038627|NCT03757195|sticky bone|sticky bone
5038739|NCT03756363|Debris extrusion|debris extrusion
5038740|NCT03756363|Filling removal|filling removal
5038741|NCT03756363|solvent|solvent
5038880|NCT03755557|glucocorticosteroids|glucocorticosteroids
5038881|NCT03755557|nasal congestion|nasal congestion
5038882|NCT03755557|Vienna Challenge Chamber|vienna challenge chamber
5038883|NCT03755531|Oxytocin|oxytocin
5038884|NCT03755531|Carbetocin|carbetocin
5038885|NCT03755531|Emergency Caesarean Section|emergency caesarean section
5038891|NCT03755505|Emphysema|emphysema
5038986|NCT03754855|vaccination coverage|vaccination coverage
5038987|NCT03754855|electronic health tools|electronic health tools
5038988|NCT03754855|diet|diet
5038989|NCT03754829|Randomized Controlled trial|randomized controlled trial
5038990|NCT03754829|Mobile Application|mobile application
5038991|NCT03754829|Problem-Solving Therapy|problem-solving therapy
5038992|NCT03754829|Online Guided Intervention|online guided intervention
5038993|NCT03754816|PECS II block, parasternal block, analgesia|pecs ii block, parasternal block, analgesia
5059949|NCT03624218|SCI|sci
5038994|NCT03754803|Dolutegravir|dolutegravir
5038995|NCT03754803|Two-drug regimen|two-drug regimen
5038998|NCT03754803|Lamivudine|lamivudine
5039105|NCT03754023|AKI|aki
5039371|NCT03752398|Pancreatic Cancer|pancreatic cancer
5039372|NCT03752398|Triple Negative Breast Cancer|triple negative breast cancer
5039373|NCT03752398|Hepatocellular/Liver Cancer|hepatocellular/liver cancer
5039374|NCT03752398|Urothelial Cancer|urothelial cancer
5039375|NCT03752398|Bladder Cancer|bladder cancer
5039376|NCT03752398|Renal Cell Cancer|renal cell cancer
5039377|NCT03752398|Head and Neck Cancer|head and neck cancer
5039378|NCT03752398|Colorectal Cancer|colorectal cancer
5039379|NCT03752398|Endometrial Cancer|endometrial cancer
5039381|NCT03752398|Small Cell Lung Cancer|small cell lung cancer
5039477|NCT03751735|efficacy|efficacy
5039478|NCT03751722|Crohn disease|crohn disease
5039479|NCT03751722|Ulcerative colitis|ulcerative colitis
5039480|NCT03751722|genetic makers|genetic makers
5039613|NCT03751085|stereotactic|stereotactic
5039716|NCT03750448|Randomized controlled trial|randomized controlled trial
5039717|NCT03750448|No intervention|no intervention
5039718|NCT03750448|Telerehabilitation|telerehabilitation
5039738|NCT03750279|RCT|rct
5039833|NCT03749798|Wavefront measurement|wavefront measurement
5039834|NCT03749772|obesity, cognitive therapy, executive function|obesity, cognitive therapy, executive function
5039835|NCT03749759|Cataract|cataract
5039836|NCT03749759|Cataract surgery|cataract surgery
5039931|NCT03749200|Motivational therapy|motivational therapy
5039933|NCT03749174|Anesthetic|anesthetic
5039934|NCT03749174|Plaster|plaster
5039935|NCT03749174|Ortotic|ortotic
5039936|NCT03749161|Cataract Surgery|cataract surgery
5040047|NCT03748498|pain|pain
5040048|NCT03748485|local advanced colorectal cancer|local advanced colorectal cancer
5040123|NCT03748069|IPA|ipa
5040184|NCT03747588|pancreatic cancer|pancreatic cancer
5040185|NCT03747562|Gabapentin|gabapentin
5040186|NCT03747536|Ipratropium bromide|ipratropium bromide
5040187|NCT03747536|Sialorrhea|sialorrhea
5040188|NCT03747536|Pediatric|pediatric
5040189|NCT03747523|Vitamin D Deficiency|vitamin d deficiency
5040190|NCT03747523|Drisdol|drisdol
5040191|NCT03747523|Rickets|rickets
5040192|NCT03747523|Plasma|plasma
5040193|NCT03747523|Healthy Subjects|healthy subjects
5040194|NCT03747523|Autosomal Dominant Tubulo Interstitial Kidney Disease|autosomal dominant tubulo interstitial kidney disease
5040198|NCT03747484|Clinical Stage IV Merkel Cell Carcinoma AJCC v8|clinical stage iv merkel cell carcinoma ajcc v8
5040199|NCT03747484|Pathologic Stage III Merkel Cell Carcinoma AJCC v8|pathologic stage iii merkel cell carcinoma ajcc v8
5040279|NCT03747133|RCC|rcc
5040280|NCT03747120|her2-positive breast cancer|her2-positive breast cancer
5040281|NCT03747120|Breast Cancer|breast cancer
5040282|NCT03747120|Pembrolizumab|pembrolizumab
5040283|NCT03747120|Immunotherapy|immunotherapy
5040294|NCT03747055|Nepal|nepal
5040295|NCT03747055|Psychological treatment|psychological treatment
5040296|NCT03747055|Task shifting|task shifting
5040297|NCT03747055|Humanitarian crisis|humanitarian crisis
5040298|NCT03747042|ER-positive|er-positive
5040299|NCT03747042|HER2-negative|her2-negative
5040417|NCT03746275|Embolism|embolism
5040418|NCT03746275|Thromboembolism|thromboembolism
5040420|NCT03746262|Cancer|cancer
5040528|NCT03745651|eczema|eczema
5040529|NCT03745651|topical therapy|topical therapy
5040530|NCT03745651|JAK inhibitor|jak inhibitor
5040531|NCT03745638|Atopic dermatitis|atopic dermatitis
5040532|NCT03745638|pruritus|pruritus
5040533|NCT03745638|eczema|eczema
5040534|NCT03745638|topical therapy|topical therapy
5040535|NCT03745638|JAK inhibitor|jak inhibitor
5040536|NCT03745599|Pericoronitis|pericoronitis
5040545|NCT03745469|Age|age
5040629|NCT03744832|Emergency Department|emergency department
5040630|NCT03744832|Point of Care Testing|point of care testing
5040631|NCT03744832|Group A Strep|group a strep
5040632|NCT03744754|Fertility Preservation|fertility preservation
5040734|NCT03744208|Head and Neck Cancer|head and neck cancer
5040735|NCT03744208|Epidermal growth factor receptor|epidermal growth factor receptor
5040736|NCT03744208|EGFR|egfr
5040737|NCT03744208|SCT200|sct200
5040738|NCT03744195|Supraspinatus|supraspinatus
5040739|NCT03744195|Tendinitis|tendinitis
5040842|NCT03743675|Weight Loss|weight loss
5040843|NCT03743662|WHO grade IV|who grade iv
5040844|NCT03743662|IDH wildtype|idh wildtype
5040845|NCT03743662|MGMT hypermethylation|mgmt hypermethylation
5040847|NCT03743662|nivolumab|nivolumab
5040946|NCT03743207|Feeding tolerance|feeding tolerance
5040947|NCT03743207|Temperature|temperature
5040948|NCT03743116|Orthostatic Intolerance|orthostatic intolerance
5040949|NCT03743116|Orthostatic Hypotension|orthostatic hypotension
5040950|NCT03743116|Knee arthroplasty|knee arthroplasty
5040951|NCT03743090|coronary artery disease|coronary artery disease
5040952|NCT03743090|obstructive sleep apnea|obstructive sleep apnea
5040953|NCT03743077|Exercise|exercise
5040954|NCT03743077|Respiratory training|respiratory training
5040955|NCT03743025|Coronary Artery Bypass Surgery (CABG)|coronary artery bypass surgery (cabg)
5040956|NCT03743025|Post Operative|post operative
5040957|NCT03743025|Obesity|obesity
5040958|NCT03743012|rehabilitation|rehabilitation
5040959|NCT03743012|metabolomics|metabolomics
5040960|NCT03742999|Biofeedback|biofeedback
5040961|NCT03742999|eye-hand coordination|eye-hand coordination
5040962|NCT03742999|Peabody|peabody
5040963|NCT03742986|Nivolumab|nivolumab
5040964|NCT03742973|Janus kinase inhibitor|janus kinase inhibitor
5040966|NCT03742947|ancillary biologic study|ancillary biologic study
5040967|NCT03742947|fibrinolysis|fibrinolysis
5041039|NCT03742427|ultrasonography|ultrasonography
5041040|NCT03742427|optic nerve sheath|optic nerve sheath
5041041|NCT03742427|head trauma|head trauma
5041143|NCT03741634|adolescent health|adolescent health
5041144|NCT03741634|sexual health|sexual health
5041145|NCT03741634|reproductive health|reproductive health
5041146|NCT03741634|food security|food security
5041147|NCT03741621|dietary fibre|dietary fibre
5041148|NCT03741621|Viscosity|viscosity
5041149|NCT03741621|lipids|lipids
5041150|NCT03741621|Healthy|healthy
5041151|NCT03741582|Transportation|transportation
5041152|NCT03741582|Urban Health|urban health
5041153|NCT03741582|Quality of Life|quality of life
5041154|NCT03741582|Social Capital|social capital
5041155|NCT03741582|Crime|crime
5041281|NCT03740854|pressure controlled ventilation|pressure controlled ventilation
5041282|NCT03740854|volume controlled ventilation|volume controlled ventilation
5041396|NCT03740269|oral health promotion|oral health promotion
5041397|NCT03740269|oral health education program|oral health education program
5041398|NCT03740269|oral hygiene status|oral hygiene status
5041499|NCT03739879|6-minute Walking Test|6-minute walking test
5041502|NCT03739827|Service to the Patients|service to the patients
5041503|NCT03739827|Knowledge about the Nature of Cancer|knowledge about the nature of cancer
5041504|NCT03739827|Cancer Evaluations|cancer evaluations
5041505|NCT03739775|HPV positive pelvic cancer|hpv positive pelvic cancer
5041506|NCT03739775|Circulating tumor biomarker|circulating tumor biomarker
5041507|NCT03739749|Arthroscopic Superior Capsular Reconstruction|arthroscopic superior capsular reconstruction
5041508|NCT03739749|Irreparable rotator cuff tear|irreparable rotator cuff tear
5041509|NCT03739749|Allograft|allograft
5041625|NCT03739151|overweight and obesity|overweight and obesity
5041626|NCT03739151|eating behavior|eating behavior
5041627|NCT03739151|nonadherence, patient|nonadherence, patient
5041628|NCT03739151|ecological momentary assessment|ecological momentary assessment
5041729|NCT03738410|HIV stigma|hiv stigma
5041844|NCT03737734|CMN|cmn
5041845|NCT03737734|Basal cell carcinoma|basal cell carcinoma
5041846|NCT03737734|Superficial sarcoma|superficial sarcoma
5041847|NCT03737734|Kaposi sarcoma|kaposi sarcoma
5041848|NCT03737734|Alpha radiation|alpha radiation
5041849|NCT03737734|Cutaneous lesion|cutaneous lesion
5041850|NCT03737734|Tongue cancer|tongue cancer
5041851|NCT03737734|Lip cancer|lip cancer
5041852|NCT03737708|tacrolimus|tacrolimus
5041967|NCT03736967|Severe|severe
5041968|NCT03736915|hand; injections; pain; syringes; anesthesia, local|hand; injections; pain; syringes; anesthesia, local
5041969|NCT03736902|Physical activity|physical activity
5041970|NCT03736902|Exercise|exercise
5041971|NCT03736902|Relapse|relapse
5041972|NCT03736902|Exacerbation|exacerbation
5041973|NCT03736902|Attack|attack
5041974|NCT03736889|MSI-H/dMMR|msi-h/dmmr
5041975|NCT03736889|Solid tumors|solid tumors
5041976|NCT03736889|PD-1|pd-1
5041977|NCT03736876|Youth|youth
5041978|NCT03736876|Adolescents|adolescents
5042071|NCT03736252|Orthosis|orthosis
5042072|NCT03736252|Pain|pain
5042073|NCT03736252|Function|function
5042074|NCT03736239|ECMO|ecmo
5042075|NCT03736239|Intensive Care Units|intensive care units
5042076|NCT03736239|Shock, Cardiogenic|shock, cardiogenic
5042179|NCT03735550|thermography|thermography
5042180|NCT03735550|liquid crystal contact thermography|liquid crystal contact thermography
5042181|NCT03735550|efficacy|efficacy
5042182|NCT03735550|breast neoplasm|breast neoplasm
5042183|NCT03735537|Fracture|fracture
5042184|NCT03735537|Teriparatide|teriparatide
5042190|NCT03735485|pnf|pnf
5042301|NCT03734718|Glucose Metabolism Disorders|glucose metabolism disorders
5042302|NCT03734718|Metabolic Diseases|metabolic diseases
5042303|NCT03734718|Endocrine System Diseases|endocrine system diseases
5042304|NCT03734718|Glucagon|glucagon
5042305|NCT03734718|Incretin|incretin
5042306|NCT03734705|hoarding disorder|hoarding disorder
5042307|NCT03734705|intolerance of uncertainty|intolerance of uncertainty
5042308|NCT03734705|experiential avoidance|experiential avoidance
5042309|NCT03734705|imaginal exposure|imaginal exposure
5042310|NCT03734705|clutter|clutter
5042375|NCT03734328|VAS|vas
5042394|NCT03734120|Spermatic nuclear quality|spermatic nuclear quality
5042395|NCT03734107|transition to adult medical care|transition to adult medical care
5042401|NCT03734068|Transarterial chemoembolization|transarterial chemoembolization
5042511|NCT03733288|Physical activity|physical activity
5042512|NCT03733288|Adults|adults
5042513|NCT03733288|Economic|economic
5042514|NCT03733288|Evaluation|evaluation
5042515|NCT03733262|deprescribing|deprescribing
5042516|NCT03733262|hemodialysis|hemodialysis
5042517|NCT03733262|medication optimization|medication optimization
5042518|NCT03733262|medication prescribing patterns|medication prescribing patterns
5042519|NCT03733262|patient safety|patient safety
5042520|NCT03733262|polypharmacy|polypharmacy
5042521|NCT03733262|pill burden|pill burden
5042522|NCT03733262|quality improvement activity|quality improvement activity
5042527|NCT03733249|ALL|all
5042624|NCT03732716|blood pressure|blood pressure
5042625|NCT03732716|elderly|elderly
5042626|NCT03732716|sarcopenia|sarcopenia
5042627|NCT03732716|fall|fall
5042628|NCT03732703|Multiple Myeloma|multiple myeloma
5042726|NCT03732092|vegetative state|vegetative state
5042727|NCT03732092|olfactory stimulation|olfactory stimulation
5042728|NCT03732079|Inferior Vena Cava Diameter|inferior vena cava diameter
5042729|NCT03732066|Dual antiplatelet therapy|dual antiplatelet therapy
5042730|NCT03732066|Mobile health|mobile health
5042731|NCT03732066|Discontinuation rate|discontinuation rate
5042732|NCT03732066|Drug-eluting stent implantation|drug-eluting stent implantation
5042733|NCT03732066|Randomized controlled trial|randomized controlled trial
5042734|NCT03732014|Bronchial wash|bronchial wash
5042735|NCT03732014|Xpert MTB/RIF|xpert mtb/rif
5042828|NCT03731494|Short-Form 36-Item Health Survey|short-form 36-item health survey
5042829|NCT03731494|Psychological General Well Being Index|psychological general well being index
5042830|NCT03731494|Minnesota Multiphasic Personality Inventory|minnesota multiphasic personality inventory
5042831|NCT03731455|Cortical strip|cortical strip
5042833|NCT03731442|Salvage therapy|salvage therapy
5042834|NCT03731442|Recurrence|recurrence
5042835|NCT03731442|Chemoradiation|chemoradiation
5042836|NCT03731429|Cough|cough
5042837|NCT03731429|Sore throat|sore throat
5042929|NCT03730831|Posttraumatic Stress Disorder|posttraumatic stress disorder
5042930|NCT03730831|Narrative Exposure Therapy|narrative exposure therapy
5042931|NCT03730818|Exercise Therapy|exercise therapy
5042932|NCT03730818|Aquatic Therapy|aquatic therapy
5042933|NCT03730818|Health-Related Quality of Life|health-related quality of life
5043034|NCT03730168|Circuit weight training|circuit weight training
5043035|NCT03730142|phosphoinositide-3 kinase (PI3K)|phosphoinositide-3 kinase (pi3k)
5043036|NCT03730142|mammalian target of rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5043038|NCT03730064|Inflammation|inflammation
5043142|NCT03729388|Buprenorphine|buprenorphine
5043143|NCT03729388|Prognosis|prognosis
5043144|NCT03729362|Pompe|pompe
5043145|NCT03729362|rhGAA|rhgaa
5043146|NCT03729336|urine specimen|urine specimen
5043147|NCT03729336|contamination|contamination
5043148|NCT03729323|Motivational Interviewing|motivational interviewing
5043149|NCT03729323|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5043150|NCT03729323|Systemic Arterial Hypertension|systemic arterial hypertension
5729414|NCT00396669|Addiction|addiction
5043151|NCT03729323|Chronic Diseases|chronic diseases
5043152|NCT03729323|Self-care|self-care
5043156|NCT03729297|salivary gland cancer|salivary gland cancer
5043368|NCT03728049|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5043369|NCT03728049|Paravalvular regurgitation|paravalvular regurgitation
5043372|NCT03728049|Aortic stenosis|aortic stenosis
5043373|NCT03728049|Von willebrand Factor|von willebrand factor
5043374|NCT03728036|walking|walking
5043375|NCT03728036|recovery|recovery
5043376|NCT03728036|compensation|compensation
5043377|NCT03728010|Electrical impedance tomography|electrical impedance tomography
5043378|NCT03728010|One-lung ventilation|one-lung ventilation
5043379|NCT03728010|Protective ventilation|protective ventilation
5043380|NCT03728010|Ventilator- Induce Lung injury|ventilator- induce lung injury
5043381|NCT03727997|Acute kidney injury|acute kidney injury
5043382|NCT03727997|Renal replacement therapy|renal replacement therapy
5043452|NCT03727685|Advance care planning|advance care planning
5043453|NCT03727672|Primary headaches|primary headaches
5043455|NCT03727672|Interleukin1β|interleukin1β
5043468|NCT03727555|X-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy
5043469|NCT03727555|Lentiviral vector|lentiviral vector
5043470|NCT03727529|Parkinson's Disease|parkinson's disease
5043471|NCT03727529|Virtual reality|virtual reality
5043472|NCT03727529|Long range autocorrelations|long range autocorrelations
5043473|NCT03727477|lorlatinib|lorlatinib
5043474|NCT03727477|Non-small Cell Lung Cancer|non-small cell lung cancer
5043475|NCT03727464|Memory priming|memory priming
5043908|NCT03724825|Adropin|adropin
5043909|NCT03724825|adiponectin|adiponectin
5043910|NCT03724825|testosterone|testosterone
5043911|NCT03724825|obese men|obese men
5043912|NCT03724812|Aortic Stenosis|aortic stenosis
5043913|NCT03724812|FlexNav™ Delivery System|flexnav™ delivery system
5043914|NCT03724812|Portico Delivery System|portico delivery system
5043915|NCT03724812|Transcatheter Aortic Valve Replacement|transcatheter aortic valve replacement
5044142|NCT03723473|Peripheral Arterial Occlusive Disease (PAOD)|peripheral arterial occlusive disease (paod)
5044143|NCT03723473|Phosphorus-31|phosphorus-31
5044256|NCT03722602|BMI|bmi
5044257|NCT03722602|body composition|body composition
5044258|NCT03722602|functional scales|functional scales
5044259|NCT03722563|lateral suspension|lateral suspension
5044260|NCT03722563|laparoscopic hysterectomy|laparoscopic hysterectomy
5044261|NCT03722563|pelvic organ prolapse|pelvic organ prolapse
5044262|NCT03722563|sacrocolpopexy|sacrocolpopexy
5044263|NCT03722537|Allograft|allograft
5044264|NCT03722537|Osteochondral Allograft|osteochondral allograft
5044272|NCT03722355|Glioma|glioma
5044273|NCT03722355|Glioblastoma|glioblastoma
5044279|NCT03722303|steroid|steroid
5044354|NCT03721913|community participation|community participation
5044355|NCT03721913|family empowerment|family empowerment
5044427|NCT03721328|Hip|hip
5044471|NCT03721029|Urinary incontinence|urinary incontinence
5044472|NCT03721029|Prostate cancer|prostate cancer
5044473|NCT03721029|Erectile dysfunction|erectile dysfunction
5044474|NCT03721029|Functional outcome|functional outcome
5044476|NCT03721029|Prostatectomy|prostatectomy
5044714|NCT03719612|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5044715|NCT03719612|DEFINITY®|definity®
5044716|NCT03719612|Enhanced Echocardiogram|enhanced echocardiogram
5044717|NCT03719612|Cardiac Magnetic Resonance|cardiac magnetic resonance
5044723|NCT03719586|EBOV|ebov
5044724|NCT03719586|Viral Hemorrhagic Fever|viral hemorrhagic fever
5044725|NCT03719586|Ebola Treatment Center|ebola treatment center
5044726|NCT03719586|Filovirus|filovirus
5044727|NCT03719586|Zaire Ebola Virus|zaire ebola virus
5044728|NCT03719573|Colon Cancer|colon cancer
5044729|NCT03719573|Frailty|frailty
5044730|NCT03719573|Geriatric assessment|geriatric assessment
5044753|NCT03719456|Calculi|calculi
5044814|NCT03719066|cholera|cholera
5044815|NCT03719066|oral cholera vaccine|oral cholera vaccine
5044816|NCT03719066|vibriocidal titer|vibriocidal titer
5044817|NCT03719066|ELISA antibodies|elisa antibodies
5044818|NCT03719066|Adverse event following immunization|adverse event following immunization
5044819|NCT03719027|Prevalence and incidence of CTEPH after pulmonary embolism|prevalence and incidence of cteph after pulmonary embolism
5044820|NCT03719027|history of diagnosis|history of diagnosis
5044821|NCT03718949|pre-operative fasting|pre-operative fasting
5044922|NCT03718260|Radical Prostatectomy|radical prostatectomy
5044923|NCT03718260|Radiation Therapy|radiation therapy
5044928|NCT03718234|hyperplasia|hyperplasia
5045035|NCT03717584|metabolome|metabolome
5045036|NCT03717584|lipidome|lipidome
5045037|NCT03717519|platelets|platelets
5045038|NCT03717519|thrombocytosis|thrombocytosis
5045039|NCT03717519|prognosis|prognosis
5045040|NCT03717506|zits|zits
5045041|NCT03717506|pimples|pimples
5045042|NCT03717506|blackheads|blackheads
5045131|NCT03717116|hypocalcemia, parathormone, bone density|hypocalcemia, parathormone, bone density
5045132|NCT03717090|mass spectrometry, diagnosis, prosthetic joint infection, matrix-assisted laser desorption ionization|mass spectrometry, diagnosis, prosthetic joint infection, matrix-assisted laser desorption ionization
5045137|NCT03717038|Metastatic Colorectal Cancer|metastatic colorectal cancer
5045138|NCT03717038|Colorectal Cancer Metastatic|colorectal cancer metastatic
5045139|NCT03717038|Carcinoma|carcinoma
5045140|NCT03717038|Sym004|sym004
5045141|NCT03717038|futuximab|futuximab
5045143|NCT03717038|TAS-102|tas-102
5045225|NCT03716505|Prevention|prevention
5045226|NCT03716505|Episodic|episodic
5045227|NCT03716505|Chronic|chronic
5045229|NCT03716401|Magnetic Resonance Imaging|magnetic resonance imaging
5045336|NCT03715751|Adaptive Support Ventilation|adaptive support ventilation
5045337|NCT03715751|ARDS|ards
5045338|NCT03715751|Esophageal Pressure|esophageal pressure
5045339|NCT03715751|Mechanical Ventilation|mechanical ventilation
5045544|NCT03714204|TM|tm
5045658|NCT03713541|barriers|barriers
5045659|NCT03713541|factors|factors
5045660|NCT03713541|treatment|treatment
5045661|NCT03713541|first treatment initiation|first treatment initiation
5045662|NCT03713502|Pre-diabetes|pre-diabetes
5045664|NCT03713502|HIV|hiv
5045765|NCT03713047|Neuropathy|neuropathy
5045766|NCT03713047|Inflammation|inflammation
5045767|NCT03713047|Chronic pain|chronic pain
5045787|NCT03712943|MMR|mmr
5045867|NCT03712423|Neoplasms|neoplasms
5046098|NCT03711058|Antibody|antibody
5046099|NCT03711058|Solid Tumors|solid tumors
5046100|NCT03711058|Colon Cancer|colon cancer
5046101|NCT03711058|MSS|mss
5046102|NCT03711058|Mismatch-repair proficient|mismatch-repair proficient
5046119|NCT03710928|very low carbohydrate diet|very low carbohydrate diet
5046120|NCT03710928|nutrition|nutrition
5046121|NCT03710928|ketogenic diet|ketogenic diet
5046122|NCT03710928|ketosis|ketosis
5046123|NCT03710928|nutritional ketosis|nutritional ketosis
5046124|NCT03710928|metabolism|metabolism
5046125|NCT03710928|metabolic health|metabolic health
5046126|NCT03710915|HDAC inhibitor|hdac inhibitor
5046214|NCT03710343|Motor Function|motor function
5046215|NCT03710343|GMFCS|gmfcs
5046216|NCT03710343|Cognitive Function|cognitive function
5046217|NCT03710343|Glucophage|glucophage
5046218|NCT03710343|Metformin|metformin
5046219|NCT03710330|cesarean section|cesarean section
5046220|NCT03710330|tranexamic acid|tranexamic acid
5046221|NCT03710330|postpartum hemorrhage|postpartum hemorrhage
5046222|NCT03710317|cesarean section|cesarean section
5046223|NCT03710317|tranexamic acid|tranexamic acid
5046224|NCT03710317|postpartum hemorrhage|postpartum hemorrhage
5046225|NCT03710317|buccal misoprostol|buccal misoprostol
5046420|NCT03709108|Continuous Glucose Monitor|continuous glucose monitor
5046421|NCT03709108|Insulin Sensitivity|insulin sensitivity
5046423|NCT03709095|Inpatient Rehabilitation|inpatient rehabilitation
5046425|NCT03709095|Exercise|exercise
5046516|NCT03708549|Schizophrenia|schizophrenia
5046517|NCT03708536|bevacizumab|bevacizumab
5046518|NCT03708536|s-1|s-1
5046519|NCT03708536|capecitabin|capecitabin
5046520|NCT03708536|maintenance|maintenance
5046521|NCT03708523|Hypopituitarism,Pituitary function|hypopituitarism,pituitary function
5046522|NCT03708497|carbetocin|carbetocin
5046623|NCT03707756|COCh|coch
5046624|NCT03707756|Mutation|mutation
5046625|NCT03707756|Genotype-phenotype|genotype-phenotype
5046626|NCT03707717|BKZ|bkz
5046627|NCT03707717|UCB4940|ucb4940
5046628|NCT03707717|Auto-Injector|auto-injector
5046629|NCT03707717|Healthy Participants|healthy participants
5046630|NCT03707704|Exercise|exercise
5046631|NCT03707704|Rehabilitation|rehabilitation
5046641|NCT03707665|Compression Ultrasound testing|compression ultrasound testing
5046643|NCT03707626|wellens sign|wellens sign
5046644|NCT03707626|coronary collateral circulation|coronary collateral circulation
5046645|NCT03707626|acute myocardial infarction|acute myocardial infarction
5046646|NCT03707626|left anterior descending artery|left anterior descending artery
5046647|NCT03707613|ERCP|ercp
5046649|NCT03707613|learning curve|learning curve
5046721|NCT03707145|gait|gait
5046722|NCT03707132|Tourniquet|tourniquet
5046723|NCT03707132|low uterus segment|low uterus segment
5046724|NCT03707132|placenta accreta|placenta accreta
5046725|NCT03707132|hysterectomy|hysterectomy
5046726|NCT03707132|massive blood loss management|massive blood loss management
5046727|NCT03707119|educational programme; EBP competencies; training;|educational programme; ebp competencies; training;
5046736|NCT03707041|malaria|malaria
5046828|NCT03706469|Drug Therapy|drug therapy
5046829|NCT03706417|Hypothermia, Induced|hypothermia, induced
5046830|NCT03706417|Telemedicine|telemedicine
5046835|NCT03706391|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5046836|NCT03706391|progressive muscular atrophy|progressive muscular atrophy
5046837|NCT03706391|motor neuron disease|motor neuron disease
5046855|NCT03706261|Tau|tau
5046928|NCT03705741|pregnancy|pregnancy
5046935|NCT03705728|elderly|elderly
5047039|NCT03705169|pharmacodynamics|pharmacodynamics
5047040|NCT03705169|broadly neutralizing antibody|broadly neutralizing antibody
5047041|NCT03705169|antiretroviral|antiretroviral
5047042|NCT03705169|Phase 1|phase 1
5047043|NCT03705143|Disease|disease
5047044|NCT03705143|Depressive Disorder|depressive disorder
5047045|NCT03705143|Depression|depression
5047046|NCT03705143|Mood Disorders|mood disorders
5047047|NCT03705143|Mental Disorders|mental disorders
5047048|NCT03705143|Substance use Disorders|substance use disorders
5047049|NCT03705143|Chinese heroin user|chinese heroin user
5047050|NCT03705143|Culture|culture
5047051|NCT03705130|Multifocal Contact Lens|multifocal contact lens
5047052|NCT03705130|Myopia|myopia
5047053|NCT03705130|Visual Performance|visual performance
5047054|NCT03705104|Pain|pain
5047057|NCT03705104|E-health|e-health
5047137|NCT03704688|KRAS Mutant Advanced Non-Small Cell Lung Cancer|kras mutant advanced non-small cell lung cancer
5047138|NCT03704688|17-297|17-297
5047139|NCT03704688|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5060425|NCT03621137|Child|child
5047243|NCT03704038|Mechanical ventialtion|mechanical ventialtion
5047244|NCT03704025|Exercise tolerance|exercise tolerance
5047248|NCT03704012|Massage|massage
5047358|NCT03703349|Randomized controlled trial|randomized controlled trial
5047359|NCT03703336|ROTAVIN|rotavin
5047360|NCT03703336|Rotavirus vaccine|rotavirus vaccine
5047361|NCT03703336|Rotavirus|rotavirus
5047362|NCT03703336|Diarrhea|diarrhea
5047363|NCT03703310|Gorlin syndrome|gorlin syndrome
5047364|NCT03703310|Basal cell nevus syndrome BCNS|basal cell nevus syndrome bcns
5047366|NCT03703310|Basal cell carcinoma|basal cell carcinoma
5048387|NCT03696498|RCT|rct
5047713|NCT03700827|Visceral Adipose Tissue|visceral adipose tissue
5047714|NCT03700827|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
5047715|NCT03700827|Exercise|exercise
5047716|NCT03700827|Intervention|intervention
5047717|NCT03700801|Triple Combination Therapy|triple combination therapy
5047718|NCT03700801|Premixed Insulin|premixed insulin
5047719|NCT03700801|Hypoglycemic efficacy|hypoglycemic efficacy
5047960|NCT03699202|RSV,AK0529,Chinese|rsv,ak0529,chinese
5047961|NCT03699189|type 1 diabetes|type 1 diabetes
5048090|NCT03698435|pharmacokinetics|pharmacokinetics
5048091|NCT03698409|Migraine|migraine
5048092|NCT03698409|Onabotulinumtoxin A|onabotulinumtoxin a
5048093|NCT03698409|Botox|botox
5048094|NCT03698409|Reconstitution|reconstitution
5048095|NCT03698409|Saline|saline
5048096|NCT03698383|Herzuma|herzuma
5048097|NCT03698383|Gedatolisib|gedatolisib
5048189|NCT03697785|intensive care|intensive care
5048300|NCT03697109|Dorsocervical Fat Pad|dorsocervical fat pad
5048301|NCT03697109|Adrenal Adenoma|adrenal adenoma
5048302|NCT03697109|Adrenal Autonomy|adrenal autonomy
5048400|NCT03696381|cognitive impairment|cognitive impairment
5048491|NCT03695640|magnesium sulphate|magnesium sulphate
5048492|NCT03695627|Stress, health, meditation, mindfulness, employees, job strain, burnout, work, help, mood, affect|stress, health, meditation, mindfulness, employees, job strain, burnout, work, help, mood, affect
5048493|NCT03695588|pain relief|pain relief
5048494|NCT03695588|Caesarean|caesarean
5048495|NCT03695588|Cesarean|cesarean
5048496|NCT03695588|c-section|c-section
5048497|NCT03695588|intrathecal morphine|intrathecal morphine
5048498|NCT03695588|analgesia|analgesia
5048500|NCT03695588|QL|ql
5048501|NCT03695588|QLB2|qlb2
5048502|NCT03695588|QL2|ql2
5048503|NCT03695575|Bone Conduction|bone conduction
5048504|NCT03695575|Assistive Listening Devices|assistive listening devices
5048640|NCT03694782|physical activity|physical activity
5048642|NCT03694782|well being|well being
5048643|NCT03694782|natural experiment|natural experiment
5048644|NCT03694782|loneliness|loneliness
5048645|NCT03694782|accelerometry|accelerometry
5048737|NCT03694275|Cyclin-dependent kinase-like 5 deficiency disorder|cyclin-dependent kinase-like 5 deficiency disorder
5048738|NCT03694275|RETT syndrome|rett syndrome
5048739|NCT03694275|Chromosome 15q|chromosome 15q
5048865|NCT03693469|Pain|pain
5048866|NCT03693469|Anxiety|anxiety
5048872|NCT03693417|heat|heat
5048967|NCT03692624|cancer survivors|cancer survivors
5048968|NCT03692624|heart rate variability|heart rate variability
5048969|NCT03692624|biofeedback|biofeedback
5048970|NCT03692611|chronic pain|chronic pain
5048971|NCT03692611|hiv|hiv
5048972|NCT03692611|opioid prescribing|opioid prescribing
5048973|NCT03692611|behavioral clinical trial|behavioral clinical trial
5048974|NCT03692585|Ethnography|ethnography
5048975|NCT03692585|Health Informatics|health informatics
5048976|NCT03692585|Healthy Lifestyle|healthy lifestyle
5049004|NCT03692442|NGS|ngs
5049887|NCT03686098|Diet|diet
5049078|NCT03692000|Healthy Lifestyle|healthy lifestyle
5049185|NCT03691298|shoulder instability|shoulder instability
5049186|NCT03691285|Overdenture|overdenture
5049187|NCT03691285|Dental implant|dental implant
5049188|NCT03691285|Cost analysis|cost analysis
5049189|NCT03691259|Dance|dance
5049190|NCT03691259|Postural stability|postural stability
5049191|NCT03691259|Ballet|ballet
5049192|NCT03691246|Myocardial Infarction|myocardial infarction
5049193|NCT03691246|Dyslipidemia|dyslipidemia
5049281|NCT03690635|VISTA technique|vista technique
5342949|NCT01981395|allodynia|allodynia
5049282|NCT03690635|sub epithelial connective tissue graft|sub epithelial connective tissue graft
5049283|NCT03690635|recession treatment|recession treatment
5049284|NCT03690583|Pneumonia|pneumonia
5049285|NCT03690583|Zinc supplementation|zinc supplementation
5049286|NCT03690583|Cytokines|cytokines
5049287|NCT03690583|Lymphoproliferation|lymphoproliferation
5049288|NCT03690583|Viruses|viruses
5049817|NCT03686761|Distraction|distraction
5049537|NCT03688880|Surgical Wounds|surgical wounds
5049538|NCT03688841|Varicose ulcer|varicose ulcer
5049539|NCT03688841|Compression Therapy|compression therapy
5049540|NCT03688841|Negative Pressure|negative pressure
5049541|NCT03688841|Vacuum Assisted Closure|vacuum assisted closure
5049640|NCT03688165|Functional Gait Recovery|functional gait recovery
5049641|NCT03688165|Hemiparesis|hemiparesis
5049642|NCT03688165|Treadmill-based robotic systems|treadmill-based robotic systems
5049643|NCT03688152|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5049739|NCT03687424|"Colonoscopy[Mesh]"|"colonoscopy[mesh]"
5049743|NCT03687398|genetic analysis|genetic analysis
5049744|NCT03687398|endometriosis|endometriosis
5049745|NCT03687398|nanoclonal|nanoclonal
5049857|NCT03686410|Pain|pain
5049858|NCT03686410|Poor Sleep Quality|poor sleep quality
5049859|NCT03686345|Midostaurin|midostaurin
5049878|NCT03686215|lumpectomy|lumpectomy
5049979|NCT03685591|advanced|advanced
5050109|NCT03684733|Background Parenchymal Enhancement (BPE)|background parenchymal enhancement (bpe)
5050110|NCT03684720|Medical education|medical education
5050112|NCT03684720|Procedural skills|procedural skills
5050113|NCT03684720|Simulation|simulation
5050114|NCT03684720|Transfer|transfer
5050128|NCT03684603|Acoustic Cueing|acoustic cueing
5050223|NCT03683979|Cognitive bias modification|cognitive bias modification
5050224|NCT03683979|Interpretation bias modification|interpretation bias modification
5050225|NCT03683966|Fabry|fabry
5050356|NCT03683030|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5050357|NCT03683017|Malocclusion|malocclusion
5050358|NCT03683017|Photobiomodulation|photobiomodulation
5050359|NCT03683017|Biolux|biolux
5050360|NCT03683017|OrthoPulse|orthopulse
5050361|NCT03683017|Low-level laser therapy|low-level laser therapy
5050362|NCT03683017|Orthodontics|orthodontics
5050363|NCT03682978|Arbaclofen|arbaclofen
5050364|NCT03682978|Placebo-Controlled|placebo-controlled
5050365|NCT03682978|Randomized|randomized
5050366|NCT03682978|Double-Blind|double-blind
5050368|NCT03682978|Efficacy|efficacy
5050475|NCT03682484|Pharmacokinetics|pharmacokinetics
5050619|NCT03681860|Tuberculosis|tuberculosis
5050620|NCT03681860|Vaccination|vaccination
5050621|NCT03681847|hypertonic saline|hypertonic saline
5050629|NCT03681795|glutamaergic system|glutamaergic system
5050630|NCT03681795|PET-scan|pet-scan
5050631|NCT03681795|physiopathology|physiopathology
5050632|NCT03681782|premature infant, abdominal massage|premature infant, abdominal massage
5050731|NCT03681093|Nasal polyps score|nasal polyps score
5050732|NCT03681093|nasal endoscopy|nasal endoscopy
5050733|NCT03681093|nasal congestion score|nasal congestion score
5050734|NCT03681093|quality of life|quality of life
5050735|NCT03681093|smell|smell
5050836|NCT03680560|adenoid cystic carcinoma|adenoid cystic carcinoma
5050837|NCT03680534|root canal preparation|root canal preparation
5050838|NCT03680534|single-file preparation techniques|single-file preparation techniques
5050937|NCT03680092|stem cell transplantation|stem cell transplantation
5051041|NCT03679429|Adenoma detection rate|adenoma detection rate
5051042|NCT03679429|Narrow band imaging|narrow band imaging
5051043|NCT03679429|Optical biopsy|optical biopsy
5051044|NCT03679429|Accuracy|accuracy
5051045|NCT03679377|Orthognathic surgical procedures|orthognathic surgical procedures
5051046|NCT03679377|Osteosynthesis|osteosynthesis
5051047|NCT03679364|Panax notoginseng|panax notoginseng
5051048|NCT03679364|acute ischemic stroke|acute ischemic stroke
5051049|NCT03679364|Vietnam|vietnam
5051050|NCT03679364|observational registry study|observational registry study
5051141|NCT03678766|Binge Eating|binge eating
5051142|NCT03678766|Overeating|overeating
5051143|NCT03678766|Body Mass Index|body mass index
5051243|NCT03677947|treatment resistance|treatment resistance
5051244|NCT03677947|treatment satisfaction|treatment satisfaction
5051246|NCT03677947|cognitive therapy|cognitive therapy
5051247|NCT03677947|inference based cognitive therapy|inference based cognitive therapy
5051248|NCT03677947|exposure and response prevention|exposure and response prevention
5051349|NCT03677258|cosmetology|cosmetology
5051350|NCT03677258|lifting|lifting
5051443|NCT03676582|respiratory changes|respiratory changes
5051444|NCT03676569|autoimmune epilepsy|autoimmune epilepsy
5051446|NCT03676569|ADRC|adrc
5051555|NCT03675893|Endometrial Cancer|endometrial cancer
5051556|NCT03675893|CDK4/6|cdk4/6
5051558|NCT03675893|Estrogen Receptor|estrogen receptor
5051559|NCT03675854|end stage renal disease|end stage renal disease
5051560|NCT03675854|infection|infection
5051561|NCT03675854|antibiotic|antibiotic
5051562|NCT03675841|Pazufloxacin Mesilate ear drops|pazufloxacin mesilate ear drops
5051563|NCT03675828|Heart Failure|heart failure
5051564|NCT03675828|Distance Health|distance health
5051565|NCT03675828|Virtual Health|virtual health
5051566|NCT03675789|Thrombi|thrombi
5051568|NCT03675789|Platelet Thrombus|platelet thrombus
5051569|NCT03675776|Depression|depression
5051663|NCT03675152|pediatric|pediatric
5051664|NCT03675126|Duchenne muscular dystrophy|duchenne muscular dystrophy
5051665|NCT03675126|Exon Skipping|exon skipping
5051666|NCT03675126|DMD|dmd
5051667|NCT03675126|Exon 51|exon 51
5051668|NCT03675126|Ambulatory|ambulatory
5051669|NCT03675126|Pediatric|pediatric
5051670|NCT03675126|Nonambulatory|nonambulatory
5051671|NCT03675126|Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO)|peptide-conjugated phosphorodiamidate morpholino oligomer (ppmo)
5051672|NCT03675126|Duchenne|duchenne
5051673|NCT03675113|upper extremity aerobic exercise|upper extremity aerobic exercise
5051674|NCT03675113|functional exercise capacity|functional exercise capacity
5051676|NCT03675113|respiratory endurance|respiratory endurance
5051759|NCT03674671|genomics|genomics
5051760|NCT03674671|proteomic|proteomic
5051761|NCT03674671|BP|bp
5051762|NCT03674645|Healthy volunteers|healthy volunteers
5051763|NCT03674645|Test|test
5051893|NCT03673852|Serious Mental Illness (SMI)|serious mental illness (smi)
5051894|NCT03673813|Hypothalamic obesity|hypothalamic obesity
5051895|NCT03673813|Prader-willi syndrome|prader-willi syndrome
5051896|NCT03673813|Physical activity|physical activity
5051897|NCT03673800|gambling disorder|gambling disorder
5051898|NCT03673800|pathological gambling|pathological gambling
5051899|NCT03673800|problem gambling|problem gambling
5051994|NCT03673293|Postoperative mobility|postoperative mobility
5051995|NCT03673293|Gait symmetry|gait symmetry
5051996|NCT03673293|Feedback|feedback
5052102|NCT03672734|laparoscopic surgery|laparoscopic surgery
5052103|NCT03672734|pH stomach|ph stomach
5052104|NCT03672734|volume gastric content|volume gastric content
5052211|NCT03672097|Unstable angina (UA)|unstable angina (ua)
5052212|NCT03672097|Prasugrel|prasugrel
5052213|NCT03672097|ACS-PCI|acs-pci
5052214|NCT03672071|ephedrine|ephedrine
5052215|NCT03672071|norepinephrine|norepinephrine
5052216|NCT03672071|maternal hemodynamics|maternal hemodynamics
5052217|NCT03672071|spinal anesthesia|spinal anesthesia
5052227|NCT03671993|electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
5052229|NCT03671980|Calprotectin|calprotectin
5052343|NCT03671369|Human Papillomavirus Vaccine|human papillomavirus vaccine
5052640|NCT03669627|Fluzone|fluzone
5052641|NCT03669601|solid tumour|solid tumour
5052642|NCT03669601|locally advanced|locally advanced
5052643|NCT03669601|metastatic|metastatic
5052647|NCT03669536|dementia|dementia
5052882|NCT03667989|CZT|czt
5052956|NCT03667664|Prevention|prevention
5052957|NCT03667638|Platelet-Rich Plasma|platelet-rich plasma
5052958|NCT03667638|Laser Doppler Imaging|laser doppler imaging
5052959|NCT03667638|Growth Factors|growth factors
5052960|NCT03667638|Wound Healing|wound healing
5052961|NCT03667638|Chronic wound healing disorder|chronic wound healing disorder
5052962|NCT03667638|Wound quality of life|wound quality of life
5052963|NCT03667625|aquatherapy|aquatherapy
5052964|NCT03667625|stretching exercises|stretching exercises
5053149|NCT03666403|airway expansion|airway expansion
5053150|NCT03666403|noninvasive ventilation|noninvasive ventilation
5053151|NCT03666390|treatment refractory depression|treatment refractory depression
5053153|NCT03666390|ketamine|ketamine
5053154|NCT03666351|Aortic Stenosis|aortic stenosis
5053247|NCT03665688|Hygroscopic|hygroscopic
5053248|NCT03665649|Asherman Syndrome|asherman syndrome
5053357|NCT03665246|Ghana|ghana
5053358|NCT03665246|ASQ|asq
5053359|NCT03665246|SRQ20|srq20
5053360|NCT03665246|Integrated Mothers and Babies Course|integrated mothers and babies course
5053361|NCT03665246|maternal and child health|maternal and child health
5053362|NCT03665194|QT/QTc Interval|qt/qtc interval
5053474|NCT03664453|RTA 408|rta 408
5053687|NCT03662906|Electroacupuncture|electroacupuncture
5053904|NCT03661398|Degenerative Mitral Valve Disease|degenerative mitral valve disease
5054033|NCT03660475|diabetic subjects|diabetic subjects
5054034|NCT03660449|Esophageal Squamous Cell Carcinoma|esophageal squamous cell carcinoma
5054129|NCT03659812|Artificial insemination with donor sperm (AID)|artificial insemination with donor sperm (aid)
5054131|NCT03659812|Sperm|sperm
5054132|NCT03659773|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5054135|NCT03659773|vaccination|vaccination
5054228|NCT03659279|Time management|time management
5054229|NCT03659279|Group intervention|group intervention
5054230|NCT03659279|Executive function|executive function
5054231|NCT03659227|Drug reactions|drug reactions
5054232|NCT03659227|severe cutaneous adverse reactions (SCARs|severe cutaneous adverse reactions (scars
5054233|NCT03659227|Stevens-Johnson syndrome|stevens-johnson syndrome
5054235|NCT03659227|(generalized bullous) fixed drug reaction|(generalized bullous) fixed drug reaction
5054236|NCT03659227|AGEP|agep
5054237|NCT03659227|DRESS|dress
5054238|NCT03659227|drug induced IgA bullous dermatosis|drug induced iga bullous dermatosis
5054239|NCT03659227|maculopapular exanthema|maculopapular exanthema
5054240|NCT03659227|erythema multiforme|erythema multiforme
5054244|NCT03659214|Orkambi|orkambi
5054309|NCT03658850|Critical care|critical care
5054310|NCT03658824|Behavioural Activation|behavioural activation
5054311|NCT03658824|Bipolar Disorder|bipolar disorder
5054312|NCT03658824|Bipolar Depression|bipolar depression
5054313|NCT03658824|Multiple Baseline|multiple baseline
5054314|NCT03658824|Case Series|case series
5054320|NCT03658785|neo-antigen|neo-antigen
5054321|NCT03658772|Keynote-878|keynote-878
5054322|NCT03658772|ARY-007|ary-007
5054323|NCT03658772|Immuno-Oncology|immuno-oncology
5054333|NCT03658746|Rescue Therapy|rescue therapy
5054403|NCT03658226|Case Series|case series
5054404|NCT03658226|Acceptability|acceptability
5054405|NCT03658226|Feasibility|feasibility
5054406|NCT03658226|Psychodynamic Interpersonal Therapy|psychodynamic interpersonal therapy
5054407|NCT03658213|Early breast cancer|early breast cancer
5054511|NCT03657264|Gadolinium-based contrast agent|gadolinium-based contrast agent
5054512|NCT03657264|Cardiac safety|cardiac safety
5054513|NCT03657264|ECG|ecg
5054514|NCT03657264|Gadopiclenol|gadopiclenol
5054517|NCT03657186|Probiotics|probiotics
5054732|NCT03655912|Binocular therapy|binocular therapy
5054733|NCT03655912|Videogames|videogames
5054734|NCT03655899|metabolomics|metabolomics
5054875|NCT03654989|Wound Healing|wound healing
5054883|NCT03654924|LMA|lma
5055006|NCT03654209|Recurrence rates|recurrence rates
5055007|NCT03654196|Acute Bronchitis|acute bronchitis
5055008|NCT03654118|Arthroscopy|arthroscopy
5055009|NCT03654118|Bankart|bankart
5055010|NCT03654118|Shoulder|shoulder
5055011|NCT03654118|ISIS|isis
5055012|NCT03654105|Inflammation|inflammation
5055013|NCT03654105|Primary Prevention|primary prevention
5055014|NCT03654105|Multiple Prevention|multiple prevention
5055015|NCT03654105|Lung Cancer Screening|lung cancer screening
5055016|NCT03654105|Smoking Cessation|smoking cessation
5055114|NCT03653676|Inflammation|inflammation
5055115|NCT03653650|Platelet-Rich Plasma|platelet-rich plasma
5055116|NCT03653650|Persistent Epithelial Defect|persistent epithelial defect
5055121|NCT03653611|COPD|copd
5055122|NCT03653611|CAPTURE|capture
5055138|NCT03653546|EGFR|egfr
5055233|NCT03653247|Biological: Plerixafor|biological: plerixafor
5055234|NCT03653247|Phase: Phase 1/2|phase: phase 1/2
5055237|NCT03653234|telecare|telecare
5055343|NCT03652623|Behavior Change|behavior change
5055344|NCT03652623|Gender Affirmation|gender affirmation
5055348|NCT03652597|Target engagement|target engagement
5055349|NCT03652597|TMS|tms
5055451|NCT03651843|occupational risk|occupational risk
5055572|NCT03651297|Harness Assist|harness assist
5055573|NCT03651297|Balance training|balance training
5055574|NCT03651297|Types of harness assist|types of harness assist
5055575|NCT03651297|Fall-arrest harness|fall-arrest harness
5055576|NCT03651297|Adjustable harness|adjustable harness
5055577|NCT03651284|obesity|obesity
5055578|NCT03651284|physical activity|physical activity
5055579|NCT03651284|nutrition|nutrition
5055580|NCT03651284|adolescents|adolescents
5055581|NCT03651284|gamification|gamification
5055670|NCT03650803|Quantitative MR Imaging|quantitative mr imaging
5055816|NCT03650023|impaired fasting glucose|impaired fasting glucose
5055817|NCT03650023|Impaired Glucose Tolerance|impaired glucose tolerance
5055931|NCT03649308|split-thickness skin graft|split-thickness skin graft
5055932|NCT03649282|NCPAP|ncpap
5055933|NCT03649282|HFNC|hfnc
5055934|NCT03649282|Preterm infants|preterm infants
5055935|NCT03649282|Cardiorespiratory behaviour|cardiorespiratory behaviour
5055936|NCT03649282|Non-invasive respiratory support|non-invasive respiratory support
5055937|NCT03649269|Eryngium heterophyllum|eryngium heterophyllum
5055938|NCT03649269|Amphipterygium adstringens|amphipterygium adstringens
5055939|NCT03649269|tea|tea
5056020|NCT03648645|Hypertension|hypertension
5056021|NCT03648645|telemonitoring|telemonitoring
5056022|NCT03648632|Stereotactic Radiotherapy|stereotactic radiotherapy
5056023|NCT03648606|infant|infant
5056024|NCT03648606|thermoregulation|thermoregulation
5056025|NCT03648606|wakefulness episode|wakefulness episode
5056026|NCT03648593|microenterpreneur|microenterpreneur
5056027|NCT03648593|work ability|work ability
5056028|NCT03648593|work recovery|work recovery
5056029|NCT03648593|native mobile app|native mobile app
5056030|NCT03648593|health behaviour|health behaviour
5056031|NCT03648593|work|work
5056032|NCT03648593|stress|stress
5056033|NCT03648593|work performance|work performance
5056034|NCT03648567|GLILD|glild
5056122|NCT03648164|rest|rest
5056123|NCT03648164|environment|environment
5056124|NCT03648164|activity|activity
5056125|NCT03648164|trust|trust
5056127|NCT03648164|outlook|outlook
5056303|NCT03647137|MRI|mri
5056495|NCT03645889|Traditional Chinese Medicine|traditional chinese medicine
5056496|NCT03645876|SHR-1210|shr-1210
5056497|NCT03645876|BP102|bp102
5056498|NCT03645876|Phase II|phase ii
5056499|NCT03645824|Hemato-Oncology|hemato-oncology
5056500|NCT03645824|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5056604|NCT03645382|obersity|obersity
5056605|NCT03645382|diabetes mellitus|diabetes mellitus
5056718|NCT03644667|immunosuppression (IS)|immunosuppression (is)
5057208|NCT03641482|NBF gingival gel|nbf gingival gel
5057209|NCT03641482|post-surgical complications|post-surgical complications
5057210|NCT03641482|clinica trial|clinica trial
5057216|NCT03641417|Obesity|obesity
5057420|NCT03640117|aging|aging
5056818|NCT03644173|cancer patients|cancer patients
5056931|NCT03643276|Bispecific antibody|bispecific antibody
5056932|NCT03643276|Bortezomib|bortezomib
5056933|NCT03643276|Chemotherapy|chemotherapy
5056934|NCT03643276|Randomized trial|randomized trial
5056935|NCT03643237|video game|video game
5056936|NCT03643237|older adults|older adults
5056940|NCT03643224|ablation|ablation
5057159|NCT03641742|Interstitial Lung Disease|interstitial lung disease
5057160|NCT03641742|Pulmonary Fibrosis|pulmonary fibrosis
5057161|NCT03641729|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5057162|NCT03641729|exercise training|exercise training
5057163|NCT03641729|feasibility|feasibility
5057164|NCT03641729|safety|safety
5057166|NCT03641690|pandemic influenza|pandemic influenza
5057524|NCT03639402|Physical activity|physical activity
5057525|NCT03639402|Attitude|attitude
5057526|NCT03639402|Knowledge|knowledge
5057539|NCT03639376|Passive smoking|passive smoking
5057540|NCT03639376|Periodontal health|periodontal health
5057760|NCT03637868|brain metastases|brain metastases
5057761|NCT03637842|cannabis|cannabis
5057762|NCT03637842|impulsivity|impulsivity
5057897|NCT03636893|SOX|sox
5057990|NCT03636334|Staged cluster randomized controlled trial|staged cluster randomized controlled trial
5057991|NCT03636321|living donor liver transplantation|living donor liver transplantation
5057992|NCT03636321|intraductal stent|intraductal stent
5057993|NCT03636321|biliary complications after liver transplantation|biliary complications after liver transplantation
5057994|NCT03636308|advanced pancreatic cancer|advanced pancreatic cancer
5057995|NCT03636308|nanoparticle albumin-bound paclitaxel|nanoparticle albumin-bound paclitaxel
5057996|NCT03636308|S-1|s-1
5058010|NCT03636282|Hockey|hockey
5058110|NCT03635749|Symptomatic Extracranial or Intracranial Arterial Stenosis|symptomatic extracranial or intracranial arterial stenosis
5058111|NCT03635749|Statin Therapy|statin therapy
5058112|NCT03635749|Clinical Trial|clinical trial
5058113|NCT03635736|brain damage|brain damage
5058114|NCT03635736|sonography|sonography
5058121|NCT03635697|Pregnancy|pregnancy
5058213|NCT03635112|IBD|ibd
5058214|NCT03635112|Crohn's Disease|crohn's disease
5058215|NCT03635112|Intestinal restriction|intestinal restriction
5058216|NCT03635086|Chikungunya virus|chikungunya virus
5058217|NCT03635086|mosquito-borne pathogen|mosquito-borne pathogen
5058218|NCT03635086|chikungunya fever|chikungunya fever
5058219|NCT03635086|Phase II|phase ii
5058220|NCT03635034|urinary catheter|urinary catheter
5058221|NCT03635034|catheter ablation procedures|catheter ablation procedures
5058300|NCT03634761|Program Quality|program quality
5058301|NCT03634761|Intervention Setting|intervention setting
5058302|NCT03634761|Autism|autism
5058303|NCT03634735|Inflammatory Bowel Disease|inflammatory bowel disease
5058304|NCT03634735|Fatigue|fatigue
5058402|NCT03633903|Resilience|resilience
5058403|NCT03633864|IgA nephropathy|iga nephropathy
5058404|NCT03633864|fecal microbiota transplantation|fecal microbiota transplantation
5058405|NCT03633825|suicide|suicide
5058406|NCT03633825|mental health crisis|mental health crisis
5058413|NCT03633812|Beta blocker|beta blocker
5058414|NCT03633786|endometriosis|endometriosis
5058415|NCT03633786|robot-assisted surgery|robot-assisted surgery
5058416|NCT03633786|standard laparoscopic surgery|standard laparoscopic surgery
5058417|NCT03633773|ICC|icc
5058418|NCT03633773|Mucin-1|mucin-1
5058514|NCT03633149|smoking cessation|smoking cessation
5058515|NCT03633149|computer-delivered intervention|computer-delivered intervention
5058516|NCT03633149|contraception|contraception
5058517|NCT03633149|behavioral intervention|behavioral intervention
5058623|NCT03632616|chronic pancreatitis|chronic pancreatitis
5058624|NCT03632616|quality of life|quality of life
5058625|NCT03632590|Magnesium|magnesium
5058626|NCT03632590|Supplements|supplements
5058627|NCT03632577|High Flow Oxygen|high flow oxygen
5058628|NCT03632577|Non Invasive Ventilation|non invasive ventilation
5058629|NCT03632577|Automated Flow Oxygen Titration|automated flow oxygen titration
5058630|NCT03632577|respiratory risk|respiratory risk
5058631|NCT03632551|Mismatch negativity|mismatch negativity
5058632|NCT03632551|EEG|eeg
5058633|NCT03632551|Single sided deafness|single sided deafness
5058725|NCT03631992|Mothers|mothers
5058848|NCT03631199|non-squamous|non-squamous
5058849|NCT03631199|hsCRP|hscrp
5058850|NCT03631199|IL-1β|il-1β
5058851|NCT03631199|PD-L1|pd-l1
5058852|NCT03631199|CANOPY|canopy
5058853|NCT03631199|CANOPY-1|canopy-1
5058854|NCT03631199|platinum-based doublet chemotherapy|platinum-based doublet chemotherapy
5058855|NCT03631199|first line therapy|first line therapy
5058856|NCT03631199|locally advanced|locally advanced
5058857|NCT03631199|metastatic|metastatic
5058878|NCT03631030|MRI|mri
5058957|NCT03630497|Acute Optic Neuritis (AON)|acute optic neuritis (aon)
5058958|NCT03630497|Demyelination|demyelination
5058959|NCT03630497|Optic Neuritis|optic neuritis
5058960|NCT03630484|Ventilator Hyperinflation|ventilator hyperinflation
5058961|NCT03630484|Expiratory Rib Cage Compression|expiratory rib cage compression
5051473|NCT03676413|salmeterol|salmeterol
5058976|NCT03630328|AGN|agn
5059058|NCT03629808|metabolic surgery|metabolic surgery
5059059|NCT03629808|laparoscopic sleeve gastrectomy|laparoscopic sleeve gastrectomy
5059060|NCT03629769|Prostate inflammation|prostate inflammation
5059061|NCT03629769|CPS/CPPS|cps/cpps
5059062|NCT03629769|Prostatitis|prostatitis
5059182|NCT03628950|Postoperative analgesia|postoperative analgesia
5059183|NCT03628950|Suprascapular nerve block|suprascapular nerve block
5059184|NCT03628950|Infraclavicular nerve block|infraclavicular nerve block
5059185|NCT03628950|Arthroscopic rotator cuff repair|arthroscopic rotator cuff repair
5059186|NCT03628950|Hemi-diaphragmatic paralysis|hemi-diaphragmatic paralysis
5059187|NCT03628937|Green tea polyphenols|green tea polyphenols
5059188|NCT03628937|Children obesity|children obesity
5059189|NCT03628937|Precocious puberty|precocious puberty
5059190|NCT03628937|Prevention|prevention
5059191|NCT03628872|Scaling and root planing|scaling and root planing
5059192|NCT03628872|Laser scaling|laser scaling
5059193|NCT03628859|Renal cancer metastatic|renal cancer metastatic
5059194|NCT03628859|Immunotherapy|immunotherapy
5059391|NCT03627871|interest in exercising more|interest in exercising more
5059536|NCT03626896|GBM|gbm
5059648|NCT03626259|losartan/amlodipine|losartan/amlodipine
5059649|NCT03626259|arterial stiffness|arterial stiffness
5059650|NCT03626246|Bone loss|bone loss
5059651|NCT03626246|Bone fracture|bone fracture
5059652|NCT03626246|Bone biopsy|bone biopsy
5059653|NCT03626246|Kidney|kidney
5059654|NCT03626220|acupuncture|acupuncture
5059655|NCT03626220|chemotherapy-induced peripheral neuropathy|chemotherapy-induced peripheral neuropathy
5059656|NCT03626207|Retinitis pigmentosa|retinitis pigmentosa
5059657|NCT03626207|Visual function evaluation|visual function evaluation
5059658|NCT03626155|Walking|walking
5059659|NCT03626155|type 2 diabetes|type 2 diabetes
5059678|NCT03626090|MSC|msc
5059741|NCT03625570|treadmill training|treadmill training
5059742|NCT03625557|Guardant Health|guardant health
5059743|NCT03625557|GRECO|greco
5059744|NCT03625544|bone graft|bone graft
5059745|NCT03625544|ceramic|ceramic
5059746|NCT03625544|spinal fusion|spinal fusion
5059747|NCT03625544|RCT|rct
5059748|NCT03625531|Acupuncture|acupuncture
5059749|NCT03625531|Polycystic Ovary Syndrome|polycystic ovary syndrome
5059750|NCT03625531|Personalized protocol|personalized protocol
5059783|NCT03625336|MRI|mri
5059936|NCT03624322|POD® device|pod® device
5059937|NCT03624270|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
5059938|NCT03624270|Oral arsenic trioxide|oral arsenic trioxide
5060026|NCT03623672|REM|rem
5060053|NCT03623568|CKD|ckd
5060341|NCT03621670|Neisseria meningitides|neisseria meningitides
5060342|NCT03621670|Bexsero|bexsero
5060163|NCT03622814|respite care|respite care
5060164|NCT03622814|train-the-trainer|train-the-trainer
5060165|NCT03622762|Green tea extract|green tea extract
5060166|NCT03622762|Kidney damage|kidney damage
5060167|NCT03622762|type 2 diabetes mellitus|type 2 diabetes mellitus
5060168|NCT03622736|Rhizarthrosis|rhizarthrosis
5060169|NCT03622736|basal thumb arthritis|basal thumb arthritis
5060170|NCT03622736|Osteoarthritis Thumb|osteoarthritis thumb
5060171|NCT03622736|viscosupplementation|viscosupplementation
5060172|NCT03622736|hyaluronic acid|hyaluronic acid
5060174|NCT03622723|hallux rigidus|hallux rigidus
5060247|NCT03622190|playing-related musculoskeletal disorder (PRMD)|playing-related musculoskeletal disorder (prmd)
5060249|NCT03622190|pain|pain
5060250|NCT03622190|musculoskeletal (MSK) disorder|musculoskeletal (msk) disorder
5060251|NCT03622164|radiotherapy|radiotherapy
5060252|NCT03622151|mental health|mental health
5072929|NCT03543293|surgery|surgery
5060711|NCT03619473|chinstrap|chinstrap
5060824|NCT03618836|Next generation sequencing|next generation sequencing
5060825|NCT03618823|analgesia|analgesia
5060826|NCT03618823|pain control|pain control
5060827|NCT03618823|adenotonsillectomy|adenotonsillectomy
5060828|NCT03618823|tonsillectomy|tonsillectomy
5060835|NCT03618810|febrile neutropenia|febrile neutropenia
5060836|NCT03618784|FURESTEM-RA Inj.|furestem-ra inj.
5060837|NCT03618784|Rheumatoid Arthritis|rheumatoid arthritis
5060838|NCT03618784|Cell therapy|cell therapy
5060839|NCT03618771|Total Knee Arthroplasty|total knee arthroplasty
5061091|NCT03617159|magnetic resonance imaging|magnetic resonance imaging
5061092|NCT03617159|diffusion weighted imaging|diffusion weighted imaging
5061093|NCT03617146|Diabetes Distress|diabetes distress
5061094|NCT03617146|Diabetes Mellitus|diabetes mellitus
5061095|NCT03617146|Diabetes Control|diabetes control
5061096|NCT03617146|Health Coaching|health coaching
5061097|NCT03617146|Diabetes Self-management|diabetes self-management
5061098|NCT03617120|Scoliosis brace|scoliosis brace
5061099|NCT03617120|Conventional treatment for Adolescent Idiopathic Scoliosis|conventional treatment for adolescent idiopathic scoliosis
5061100|NCT03617120|In-brace correction|in-brace correction
5061101|NCT03617120|Trunk listing|trunk listing
5061102|NCT03617120|Vertebral rotation|vertebral rotation
5733872|NCT00379327|Pregnancy|pregnancy
5061103|NCT03617120|Interface pressure|interface pressure
5061106|NCT03617120|Trunk asymmetry|trunk asymmetry
5061185|NCT03616587|Advanced Breast Cancer|advanced breast cancer
5061186|NCT03616561|Nail psoriasis|nail psoriasis
5061187|NCT03616561|apremilast|apremilast
5061188|NCT03616561|ultrasound|ultrasound
5061189|NCT03616548|intestinal transplantation|intestinal transplantation
5061190|NCT03616548|graft rejection|graft rejection
5061191|NCT03616548|image enhanced endoscopy|image enhanced endoscopy
5061193|NCT03616509|Growth Hormone|growth hormone
5061309|NCT03615742|Asthma|asthma
5061310|NCT03615742|Controlled Human Exposure Study|controlled human exposure study
5061314|NCT03615729|T helper 17|t helper 17
5061465|NCT03614962|Memory|memory
5061466|NCT03614949|persistent cervical cancer|persistent cervical cancer
5061467|NCT03614923|ANB020|anb020
5061468|NCT03614923|Etikomab|etikomab
5061469|NCT03614923|CRSwNP|crswnp
5061470|NCT03614910|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5061471|NCT03614910|irreversible electroporation|irreversible electroporation
5061571|NCT03614247|retrograde intrarenal surgery|retrograde intrarenal surgery
5061572|NCT03614234|Glomerular filtration rate|glomerular filtration rate
5061573|NCT03614234|Proteinuria|proteinuria
5061574|NCT03614234|PRX-102|prx-102
5061575|NCT03614234|pegunigalsidase alfa|pegunigalsidase alfa
5061576|NCT03614234|Fabry disease|fabry disease
5061577|NCT03614221|Atopic Dermatitis|atopic dermatitis
5061695|NCT03613272|VATS|vats
5061696|NCT03613272|subxiphoid|subxiphoid
5061699|NCT03613246|TAVI|tavi
5061898|NCT03612141|Brain Death|brain death
5061899|NCT03612141|organ donation|organ donation
5061900|NCT03612128|cerebral palsy|cerebral palsy
5061901|NCT03612128|mirror therapy|mirror therapy
5061902|NCT03612128|cerebral re-organization|cerebral re-organization
5062010|NCT03611400|Intestinal Permeability|intestinal permeability
5062011|NCT03611400|Leaky Gut|leaky gut
5062012|NCT03611387|Primary Angle-Closure Glaucoma|primary angle-closure glaucoma
5062205|NCT03610386|Atopic|atopic
5062206|NCT03610386|Dermatitis|dermatitis
5062207|NCT03610386|TRPM8|trpm8
5062208|NCT03610386|menthol|menthol
5062209|NCT03610373|anxiety|anxiety
5062210|NCT03610373|depression|depression
5062211|NCT03610373|childhood|childhood
5062212|NCT03610373|therapy|therapy
5062213|NCT03610373|treatment|treatment
5062214|NCT03610373|medical decision making|medical decision making
5062215|NCT03610360|DENIM|denim
5062216|NCT03610334|First-In-Human|first-in-human
5062217|NCT03610295|congenital cataract|congenital cataract
5062218|NCT03610295|prophylactic peripheral iridectomy|prophylactic peripheral iridectomy
5062219|NCT03610295|aphakic angle-closure glaucoma|aphakic angle-closure glaucoma
5062220|NCT03610295|aphakic open-angle glaucoma|aphakic open-angle glaucoma
5062221|NCT03610295|iris posterior synechia|iris posterior synechia
5062222|NCT03610295|visual axis opacity|visual axis opacity
5062340|NCT03609632|Insulin|insulin
5062441|NCT03608904|Music|music
5062442|NCT03608904|Ischemic Stroke|ischemic stroke
5062443|NCT03608904|fMRI|fmri
5062444|NCT03608904|functional MRI|functional mri
5062445|NCT03608839|Diabetic macular edema|diabetic macular edema
5062448|NCT03608813|Metabolomics|metabolomics
5062546|NCT03608189|ACL injury|acl injury
5062547|NCT03608189|Knee trauma|knee trauma
5062548|NCT03608189|Meniscus tear|meniscus tear
5062549|NCT03608176|Obesity|obesity
5062550|NCT03608176|Randomized Controlled Trial|randomized controlled trial
5062570|NCT03608059|ATG|atg
5062656|NCT03607552|Dense Breasts|dense breasts
5062657|NCT03607552|Diffusion Weighted Imaging|diffusion weighted imaging
5062658|NCT03607526|Vegetable Intake|vegetable intake
5062659|NCT03607500|Caloric Intake Reduction|caloric intake reduction
5062660|NCT03607500|Dietician|dietician
5062876|NCT03606174|PD-L1|pd-l1
5062877|NCT03606135|Pneumonia|pneumonia
5062878|NCT03606135|Streptococcus pneumoniae|streptococcus pneumoniae
5062879|NCT03606135|Incidence|incidence
5062880|NCT03606135|Ethiology|ethiology
5062881|NCT03606135|Serotype|serotype
5062882|NCT03606122|Actinic keratosis on the upper extremities|actinic keratosis on the upper extremities
5062980|NCT03605394|sinus septum|sinus septum
5062981|NCT03605394|CBCT|cbct
5062982|NCT03605381|Stroke|stroke
5062983|NCT03605381|PROMs|proms
5062984|NCT03605381|Cohort|cohort
5062985|NCT03605368|Intervention|intervention
5062986|NCT03605368|Technology|technology
5062987|NCT03605355|minor stroke|minor stroke
5062988|NCT03605355|cost-effectiveness|cost-effectiveness
5062989|NCT03605355|feasibility|feasibility
5062990|NCT03605355|day clinic|day clinic
5062991|NCT03605342|PTSD|ptsd
5062992|NCT03605342|Opiate Use Disorder|opiate use disorder
5063206|NCT03604198|Cortisol|cortisol
5063323|NCT03603496|Interactive Voice Response|interactive voice response
5063324|NCT03603496|Tobacco Quitline|tobacco quitline
5063325|NCT03603483|patients- prosthesis mismatching|patients- prosthesis mismatching
5063326|NCT03603457|Epidemiology|epidemiology
5063327|NCT03603457|Prognostic factors|prognostic factors
5063328|NCT03603457|Stratified medicine|stratified medicine
5063329|NCT03603457|Quality of life|quality of life
5356796|NCT01917968|Transvaginal|transvaginal
5356797|NCT01917968|Native Tissue Repair|native tissue repair
5063439|NCT03602755|Transplant|transplant
5063440|NCT03602755|Multiple Myeloma|multiple myeloma
5063449|NCT03602729|Teaching|teaching
5063450|NCT03602729|Intervention|intervention
5063451|NCT03602729|NICU|nicu
5063452|NCT03602716|schizophrenia|schizophrenia
5063453|NCT03602716|HD-tDCS|hd-tdcs
5063454|NCT03602716|negative symptoms|negative symptoms
5063457|NCT03602690|Dolutegravir|dolutegravir
5063567|NCT03602157|Lymphoma|lymphoma
5063568|NCT03602157|T lymphocytes|t lymphocytes
5063569|NCT03602131|Chidamide|chidamide
5063570|NCT03602131|autologous stem cell transplantation|autologous stem cell transplantation
5063571|NCT03602118|clinical seizures,|clinical seizures,
5063572|NCT03602105|exercise|exercise
5063573|NCT03602105|prehabilitation|prehabilitation
5063574|NCT03602105|arthritis|arthritis
5063575|NCT03602105|quality of life|quality of life
5063576|NCT03602105|osteoarthritis|osteoarthritis
5063577|NCT03602105|rehabilitation|rehabilitation
5063582|NCT03602014|Hypotension|hypotension
5063583|NCT03602014|Spinal Cord Injury|spinal cord injury
5063584|NCT03602014|Droxidopa|droxidopa
5063815|NCT03600467|Androgen Receptor Positive|androgen receptor positive
5063816|NCT03600467|Seviteronel|seviteronel
5063817|NCT03600467|Advanced Cancers|advanced cancers
5063818|NCT03600441|cancer|cancer
5063819|NCT03600428|asthma|asthma
5063820|NCT03600428|influenza vaccine|influenza vaccine
5063821|NCT03600428|inactivated influenza vaccine|inactivated influenza vaccine
5063900|NCT03599908|IgE|ige
5064002|NCT03599219|platelets|platelets
5064003|NCT03599219|bleeding|bleeding
5064004|NCT03599206|genetic: CXCR3 polymorphism rs2280964|genetic: cxcr3 polymorphism rs2280964
5064005|NCT03599180|Knee Osteoarthritis|knee osteoarthritis
5064007|NCT03599180|Microdialysis|microdialysis
5064121|NCT03598387|intermittent hemodialysis|intermittent hemodialysis
5064122|NCT03598387|renal recovery|renal recovery
5064123|NCT03598374|Inositol|inositol
5064124|NCT03598374|Polycystic ovarian syndrome|polycystic ovarian syndrome
5064125|NCT03598374|Fertility|fertility
5064126|NCT03598374|Clinical pregnancy rate|clinical pregnancy rate
5064127|NCT03598374|Miscarriage rate|miscarriage rate
5064128|NCT03598374|Live birth rate|live birth rate
5064129|NCT03598361|pregnancy outcomes, minerals|pregnancy outcomes, minerals
5064131|NCT03598309|Lung RADS 3|lung rads 3
5064215|NCT03597867|non steroidal antinflammatory drugs|non steroidal antinflammatory drugs
5064438|NCT03596541|Wireless|wireless
5064596|NCT03595293|Alcohol Use Disorder|alcohol use disorder
5064597|NCT03595293|Functional Near-infrared Spectroscopy|functional near-infrared spectroscopy
5064599|NCT03595293|Resisting Craving|resisting craving
5064600|NCT03595267|Indigenous Canadians|indigenous canadians
5064601|NCT03595267|Screening Study|screening study
5064602|NCT03595215|TENS|tens
5064605|NCT03595163|Sevoflurane|sevoflurane
5064606|NCT03595163|Propofol|propofol
5064607|NCT03595163|Folic Acid Concentrations|folic acid concentrations
5064608|NCT03595163|Homocysteine Concentrations|homocysteine concentrations
5064609|NCT03595163|Cochlear Implant Surgery|cochlear implant surgery
5064610|NCT03595150|Endoscopic Retrograde Cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5064692|NCT03594526|Mothers|mothers
5064693|NCT03594526|Research|research
5064694|NCT03594526|Support|support
5064695|NCT03594513|Gingival Recession|gingival recession
5064696|NCT03594513|Tooth Abrasion|tooth abrasion
5064697|NCT03594513|Mucoderm|mucoderm
5064698|NCT03594500|Emergency service|emergency service
5064699|NCT03594500|Hearing loss|hearing loss
5064700|NCT03594500|Patient readmission|patient readmission
5064701|NCT03594500|Communication|communication
5064702|NCT03594487|Multiple Sclerosis|multiple sclerosis
5064703|NCT03594487|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5064704|NCT03594487|Fecal Microbiota Transplantation|fecal microbiota transplantation
5064705|NCT03594474|intravenous fat emulsions|intravenous fat emulsions
5064706|NCT03594474|preterm infants|preterm infants
5064707|NCT03594435|ibudilast, treatment, medication development|ibudilast, treatment, medication development
5064708|NCT03594383|Lung|lung
5064709|NCT03594383|POCUS|pocus
5064710|NCT03594383|Pneumonia|pneumonia
5064711|NCT03594383|ARI|ari
5064712|NCT03594383|CHWs|chws
5064713|NCT03594357|Multiple sclerosis|multiple sclerosis
5064714|NCT03594357|Balance|balance
5064715|NCT03594357|Cognition|cognition
5064716|NCT03594357|Functional exercise capacity|functional exercise capacity
5064717|NCT03594357|Fatigue|fatigue
5064718|NCT03594357|Sleep quality|sleep quality
5064719|NCT03594344|Diabetic foot|diabetic foot
5064720|NCT03594344|Diabetes|diabetes
5064721|NCT03594344|Lower extremity amputation|lower extremity amputation
5064722|NCT03594344|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5064723|NCT03594344|HBOT|hbot
5064724|NCT03594292|hallux valgus and Bunion|hallux valgus and bunion
5064761|NCT03594058|urinary conditions|urinary conditions
5064762|NCT03594058|urgency urinary incontinence|urgency urinary incontinence
5064764|NCT03594058|micturitions|micturitions
5064766|NCT03594032|bronchiectasis|bronchiectasis
5064767|NCT03594032|NTM infections|ntm infections
5064768|NCT03594032|Middle-aged and old women|middle-aged and old women
5064862|NCT03593577|saccular dilatation|saccular dilatation
5064865|NCT03593577|vertigo|vertigo
5064972|NCT03592966|Cognitive function|cognitive function
5064973|NCT03592966|Vascular function|vascular function
5065077|NCT03592342|OLPClinROM|olpclinrom
5065078|NCT03592342|OLPSSM|olpssm
5065079|NCT03592303|Post-partum haemorrhage|post-partum haemorrhage
5065080|NCT03592303|Thromboelastography|thromboelastography
5065081|NCT03592303|Coagulopathy|coagulopathy
5065082|NCT03592303|Fibrinogenemia|fibrinogenemia
5065083|NCT03592277|Sepsis|sepsis
5065187|NCT03591757|Leptomeningeal|leptomeningeal
5065189|NCT03591731|IFCT|ifct
5065146|NCT03591926|IPF|ipf
5065289|NCT03590977|chlorohexidine|chlorohexidine
5065290|NCT03590977|caries index|caries index
5065291|NCT03590964|Implant, Bone ring, Sinus lift.|implant, bone ring, sinus lift.
5065292|NCT03590847|Intermittent fasting|intermittent fasting
5065293|NCT03590847|Inflammation|inflammation
5065294|NCT03590847|Diet|diet
5065295|NCT03590847|Lifestyle|lifestyle
5065296|NCT03590847|Eating habits|eating habits
5065443|NCT03590067|Haemodialysis|haemodialysis
5065444|NCT03590067|Renal transplantation|renal transplantation
5065446|NCT03590067|chronic kidney disease|chronic kidney disease
5065580|NCT03589352|cervical screening|cervical screening
5065581|NCT03589352|breast self examination|breast self examination
5065582|NCT03589352|mammography|mammography
5065584|NCT03589352|body knowledge|body knowledge
5065585|NCT03589352|prevention|prevention
5065586|NCT03589352|self care|self care
5065587|NCT03589339|Oral Cavity Cancer|oral cavity cancer
5065588|NCT03589339|Oropharynx Cancer|oropharynx cancer
5065589|NCT03589339|Lung Metastasis|lung metastasis
5065590|NCT03589339|Liver Metastasis|liver metastasis
5065591|NCT03589326|Ponatinib|ponatinib
5065592|NCT03589326|Imatinib mesylate|imatinib mesylate
5065593|NCT03589326|Bcr-Abl Tyrosine Kinase|bcr-abl tyrosine kinase
5065453|NCT03590015|Schizophrenia|schizophrenia
5065472|NCT03589898|GABA|gaba
5065678|NCT03588728|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5065790|NCT03588065|public health|public health
5065791|NCT03588065|Soccer|soccer
5065794|NCT03587935|Colon Polyp|colon polyp
5065890|NCT03587142|stomach|stomach
5066112|NCT03585504|Bleeding Acceptability|bleeding acceptability
5066158|NCT03585335|BMI|bmi
5066221|NCT03584932|Sexual/gender minorities|sexual/gender minorities
5066222|NCT03584932|Navigation|navigation
5066223|NCT03584893|Juvenile Cataract|juvenile cataract
5066225|NCT03584893|Diarrhea|diarrhea
5066226|NCT03584893|Neonatal Jaundice|neonatal jaundice
5066227|NCT03584893|Xanthoma|xanthoma
5084328|NCT03471819|serotonin|serotonin
5066228|NCT03584880|postoperative pain|postoperative pain
5066229|NCT03584880|Diode laser|diode laser
5066230|NCT03584880|retreatment|retreatment
5066319|NCT03584386|Technology|technology
5066327|NCT03584373|Opioids|opioids
5066417|NCT03583749|elderly|elderly
5066418|NCT03583723|Adaptive radiotherapy|adaptive radiotherapy
5066419|NCT03583697|Dwarfism|dwarfism
5066420|NCT03583697|Bone Diseases|bone diseases
5066421|NCT03583697|Bone Diseases, Developmental|bone diseases, developmental
5066422|NCT03583697|ACH|ach
5066423|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type
5066424|NCT03583697|Musculoskeletal Diseases|musculoskeletal diseases
5066425|NCT03583697|Natriuretic Agents|natriuretic agents
5066426|NCT03583697|Physiological Effect of Drugs|physiological effect of drugs
5066427|NCT03583697|Skeletal Dysplasias|skeletal dysplasias
5066502|NCT03583268|Hypoglycemia|hypoglycemia
5066503|NCT03583268|Glucose variability|glucose variability
5066504|NCT03583229|Heart Transplantation|heart transplantation
5066505|NCT03583229|Cardiac Allograft Vasculopathy|cardiac allograft vasculopathy
5066506|NCT03583216|Diabetic pregnancies, Factor XII|diabetic pregnancies, factor xii
5066879|NCT03580850|T2 weighted gradient echo|t2 weighted gradient echo
5066880|NCT03580837|Breast Cancer|breast cancer
5066881|NCT03580837|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5066883|NCT03580811|Dental Implants|dental implants
5066884|NCT03580811|Alveolar bone grafting|alveolar bone grafting
5066885|NCT03580772|Total knee replacement|total knee replacement
5066890|NCT03580733|candidiasis|candidiasis
5066891|NCT03580733|ß-D-glucan|ß-d-glucan
5066892|NCT03580733|caspofungin|caspofungin
5066893|NCT03580720|Monitoring|monitoring
5066894|NCT03580720|Breathing effort|breathing effort
5079200|NCT03504358|survival|survival
5066898|NCT03580694|NSCLC|nsclc
5066899|NCT03580694|Anti-PD-1|anti-pd-1
5066977|NCT03580200|Trigger Point Dry Needling|trigger point dry needling
5066978|NCT03580200|Deep Dry Needling|deep dry needling
5066979|NCT03580200|Muscle Strength|muscle strength
5066980|NCT03580200|Gluteus Medius|gluteus medius
5066981|NCT03580174|Physical therapy|physical therapy
5066983|NCT03580174|Botulinum toxin|botulinum toxin
5066984|NCT03580174|Activity|activity
5066985|NCT03580174|Function|function
5066986|NCT03580161|Absorbed Radiation Dose|absorbed radiation dose
5066987|NCT03580161|Radiation Risks|radiation risks
5066988|NCT03580161|Radiation Protection|radiation protection
5066989|NCT03580161|Dosimetry|dosimetry
5066990|NCT03580148|osteoarthritis|osteoarthritis
5067075|NCT03579602|tozuleristide|tozuleristide
5067076|NCT03579602|Canvas imaging system|canvas imaging system
5067078|NCT03579602|CNS tumor|cns tumor
5067176|NCT03578900|Hyposalivation|hyposalivation
5067177|NCT03578900|Quality of Life|quality of life
5067178|NCT03578900|Sjogren's Syndrome|sjogren's syndrome
5067180|NCT03578848|blood pressure monitoring|blood pressure monitoring
5067199|NCT03578731|APP|app
5067273|NCT03578367|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5067274|NCT03578367|leukemia, myeloid chronic|leukemia, myeloid chronic
5067275|NCT03578367|Hematologic Diseases|hematologic diseases
5067276|NCT03578367|Asciminib|asciminib
5067277|NCT03578367|ABL001|abl001
5067278|NCT03578367|Imatinib|imatinib
5067279|NCT03578367|Nilotinib|nilotinib
5067281|NCT03578367|DMR|dmr
5067372|NCT03577769|Bacteriuria|bacteriuria
5067582|NCT03576625|vegetable oil|vegetable oil
5067583|NCT03576625|omega-3 fatty acids|omega-3 fatty acids
5067584|NCT03576625|participants|participants
5067586|NCT03576573|Osteoarthritis|osteoarthritis
5067588|NCT03576573|Ankylosis|ankylosis
5067687|NCT03576014|DNA Vaccine|dna vaccine
5067688|NCT03576014|Kidney transplant|kidney transplant
5067689|NCT03576014|Cytomegalovirus|cytomegalovirus
5067690|NCT03576014|BK virus|bk virus
5067691|NCT03575988|Type 2 diabetes|type 2 diabetes
5067692|NCT03575988|Pulmonary function|pulmonary function
5067693|NCT03575988|Vascular endothelial function|vascular endothelial function
5067694|NCT03575988|Ultrasound|ultrasound
5067695|NCT03575975|x-ray motion analysis|x-ray motion analysis
5067696|NCT03575975|joint kinematics|joint kinematics
5067697|NCT03575975|functional range of motion|functional range of motion
5067811|NCT03575325|B-cell acute lymphoblastic leukemia|b-cell acute lymphoblastic leukemia
5067817|NCT03575286|Medical Diagnostics|medical diagnostics
5067947|NCT03574454|Machine Learning|machine learning
5067952|NCT03574402|NSCLC|nsclc
5068054|NCT03573765|outcomes|outcomes
5068055|NCT03573765|complications|complications
5068072|NCT03573700|CAR|car
5068177|NCT03573089|Randomised controlled trial|randomised controlled trial
5068178|NCT03573089|Bone markers|bone markers
5068179|NCT03573089|Cardiovascular risk factors|cardiovascular risk factors
5068180|NCT03573089|Phosphate lowering agent|phosphate lowering agent
5068181|NCT03573089|End stage kidney disease|end stage kidney disease
5068387|NCT03571737|acute pain|acute pain
5068388|NCT03571737|muscle strain|muscle strain
5068389|NCT03571737|muscle sprain|muscle sprain
5068390|NCT03571737|injury|injury
5068393|NCT03571724|Cigarette|cigarette
5068499|NCT03570931|Infantile Neuroaxonal Dystrophy|infantile neuroaxonal dystrophy
5068500|NCT03570918|HIV, Latent HIV-1 infection, HIV therapy, antibody-based therapy|hiv, latent hiv-1 infection, hiv therapy, antibody-based therapy
5068501|NCT03570905|acute, displaced distal radius fracture|acute, displaced distal radius fracture
5068513|NCT03570879|Laparoscopy|laparoscopy
5068514|NCT03570879|Power morcellation|power morcellation
5068515|NCT03570879|Transvaginal extraction|transvaginal extraction
5068518|NCT03570853|Resiliency|resiliency
5068735|NCT03569566|Elite endurance athletes|elite endurance athletes
5068739|NCT03569553|Bacterial infection|bacterial infection
5068850|NCT03569020|Cholesterol|cholesterol
5068851|NCT03569020|Weight|weight
5068852|NCT03569020|Arthritis|arthritis
5068854|NCT03569020|Body mass index|body mass index
5068855|NCT03569020|Fruit|fruit
5068856|NCT03569020|Vegetable|vegetable
5068857|NCT03569020|Low fat dairy|low fat dairy
5068858|NCT03569020|Lean meat|lean meat
5068859|NCT03569020|Fiber|fiber
5068973|NCT03568344|Community based treatment|community based treatment
5068974|NCT03568331|Chronic Pruritus|chronic pruritus
5068975|NCT03568331|Eczema|eczema
5068978|NCT03568305|asthma|asthma
5068979|NCT03568305|occupational asthma|occupational asthma
5068980|NCT03568253|Bulk composite|bulk composite
5068981|NCT03568253|High viscisity glassionomer|high viscisity glassionomer
5068983|NCT03568253|E-dentistry|e-dentistry
5068984|NCT03568227|Hypnosis|hypnosis
5069069|NCT03567616|pomalidomide|pomalidomide
5069070|NCT03567616|dexamethasone|dexamethasone
5069173|NCT03566810|Diabetes Mellitus|diabetes mellitus
5069174|NCT03566810|Glucophage Extended Release (GXR)|glucophage extended release (gxr)
5069175|NCT03566810|Bioequivalence Study|bioequivalence study
5069176|NCT03566784|inguinal hernia repair|inguinal hernia repair
5069177|NCT03566784|electrocoagulation|electrocoagulation
5069178|NCT03566784|postoperative pain|postoperative pain
5069179|NCT03566784|thermal injury|thermal injury
5069180|NCT03566784|neuralgia|neuralgia
5069181|NCT03566771|Mobile Health|mobile health
5069270|NCT03565965|Randomized clinical trial|randomized clinical trial
5069271|NCT03565965|Parkinson's disease|parkinson's disease
5069273|NCT03565965|Locomotor imagery training|locomotor imagery training
5069274|NCT03565952|Menopausal women|menopausal women
5069275|NCT03565952|Insomnia|insomnia
5069276|NCT03565939|Ulcerative Colitis|ulcerative colitis
5069277|NCT03565939|Trichuris suis|trichuris suis
5069278|NCT03565939|Trichuris suis ova|trichuris suis ova
5069279|NCT03565939|Probiotic|probiotic
5069280|NCT03565939|IBD|ibd
5069281|NCT03565939|Inflammatory bowel diseases|inflammatory bowel diseases
5069396|NCT03565328|Mitochondrial oxidative phosphorylation in sceletal muscles|mitochondrial oxidative phosphorylation in sceletal muscles
5069498|NCT03564795|Wound Dressing|wound dressing
5069518|NCT03564613|HIV|hiv
5069595|NCT03564093|emergency room sedation|emergency room sedation
5069596|NCT03564093|intranasal sedation|intranasal sedation
5069597|NCT03564093|dexmedetomidine|dexmedetomidine
5069598|NCT03564093|intranasal dexmedetomidine|intranasal dexmedetomidine
5069599|NCT03564093|children|children
5069694|NCT03563508|Egyptian population|egyptian population
5061911|NCT03612102|CBT|cbt
5069806|NCT03562793|healthcare disparities|healthcare disparities
5069807|NCT03562793|communication|communication
5069808|NCT03562767|Culturally-Tailored Cognitive Behavior intervention (CT-CB)|culturally-tailored cognitive behavior intervention (ct-cb)
5070053|NCT03561077|Adolescents|adolescents
5070054|NCT03561064|cancer|cancer
5070055|NCT03561064|insomnia|insomnia
5070169|NCT03560479|Cancer|cancer
5070170|NCT03560479|Bladder cancer|bladder cancer
5070171|NCT03560479|Clinical trial|clinical trial
5070172|NCT03560479|Anti-cancer|anti-cancer
5070173|NCT03560479|Antineoplastic|antineoplastic
5070174|NCT03560479|alpha1H|alpha1h
5070175|NCT03560479|HAMLET|hamlet
5070274|NCT03560050|food environment|food environment
5070275|NCT03559998|Simulation training|simulation training
5070276|NCT03559998|role-play|role-play
5070277|NCT03559998|psychiatry|psychiatry
5070278|NCT03559998|students|students
5070279|NCT03559998|medical|medical
5070280|NCT03559998|psychology|psychology
5070281|NCT03559998|educational|educational
5070282|NCT03559998|learning|learning
5070283|NCT03559985|Paracetamol|paracetamol
5070375|NCT03559257|treatment-resistant|treatment-resistant
5070376|NCT03559257|treatment resistant|treatment resistant
5070377|NCT03559244|exercise|exercise
5070378|NCT03559244|pectus carinatum|pectus carinatum
5070379|NCT03559244|orthosis|orthosis
5070380|NCT03559244|dynamic compression brace|dynamic compression brace
5070381|NCT03559231|duodenal adenoma|duodenal adenoma
5070382|NCT03559231|FTRD|ftrd
5070383|NCT03559231|dFTRD|dftrd
5070384|NCT03559231|EMR|emr
5070385|NCT03559231|endoscopic mucosal resection|endoscopic mucosal resection
5070388|NCT03559179|CDS|cds
5070389|NCT03559179|Medication Assisted Therapy|medication assisted therapy
5070390|NCT03559153|Office workers|office workers
5070391|NCT03559153|Worker health|worker health
5070392|NCT03559153|Work ability|work ability
5070393|NCT03559153|Musculoskeletal disease|musculoskeletal disease
5070394|NCT03559140|post-endodontic pain|post-endodontic pain
5070395|NCT03559140|pain|pain
5070396|NCT03559140|root canal treatment|root canal treatment
5070397|NCT03559140|cryotherapy|cryotherapy
5070398|NCT03559127|post-endodontic pain|post-endodontic pain
5070414|NCT03559101|Beverage Hydration Index|beverage hydration index
5070415|NCT03559101|Dehydration|dehydration
5070416|NCT03559101|Oral Rehydration|oral rehydration
5070418|NCT03559075|eczema|eczema
5070472|NCT03558763|Monitoring|monitoring
5070580|NCT03558217|direct anterior approach|direct anterior approach
5070581|NCT03558217|direct lateral approach|direct lateral approach
5070582|NCT03558191|Recurrent/Metastatic Nasopharyngeal Carcinoma|recurrent/metastatic nasopharyngeal carcinoma
5070584|NCT03558126|silicone tube|silicone tube
5070585|NCT03558126|miniature drainage device|miniature drainage device
5070587|NCT03558126|IOP|iop
5070686|NCT03557502|Arterial Stiffness|arterial stiffness
5070687|NCT03557476|Octacosanol|octacosanol
5070816|NCT03556553|occlusal caries|occlusal caries
5070818|NCT03556540|Hemodialysis|hemodialysis
5070942|NCT03555812|Hip, Arthroplasty, pelvic inclination, ultrasound|hip, arthroplasty, pelvic inclination, ultrasound
5070943|NCT03555773|perianal Crohn's disease|perianal crohn's disease
5070951|NCT03555747|Orthodontic force|orthodontic force
5070952|NCT03555747|Periodontium|periodontium
5070953|NCT03555747|Gingivitis|gingivitis
5070954|NCT03555734|Pulses (beans, chickpeas, lentils, dry peas)|pulses (beans, chickpeas, lentils, dry peas)
5070975|NCT03555643|TIA|tia
5071056|NCT03555110|Obesity|obesity
5071057|NCT03555097|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5071058|NCT03555097|Non-invasive Positive Pressure Ventilation|non-invasive positive pressure ventilation
5071059|NCT03555097|Respiratory Mechanics|respiratory mechanics
5071060|NCT03555097|Neural Respiratory Drive|neural respiratory drive
5071061|NCT03555071|live attenuated varicella vaccine|live attenuated varicella vaccine
5071062|NCT03555071|consistency|consistency
5071063|NCT03555071|immunogenicity|immunogenicity
5071064|NCT03555071|safety|safety
5071065|NCT03555071|children|children
5071159|NCT03554369|Dose-Limiting Toxicity|dose-limiting toxicity
5071160|NCT03554369|Maximum Tolerated Dose|maximum tolerated dose
5071161|NCT03554369|Stereotactic Body Radiation Therapy (SBRT)|stereotactic body radiation therapy (sbrt)
5071162|NCT03554343|newborn screening|newborn screening
5071164|NCT03554330|balloon atrial septostomy|balloon atrial septostomy
5071274|NCT03553641|competence|competence
5071275|NCT03553628|dental caries|dental caries
5071276|NCT03553628|propolis|propolis
5071277|NCT03553628|chlorhexidine|chlorhexidine
5071278|NCT03553628|clove oil|clove oil
5071279|NCT03553628|bee wax|bee wax
5071280|NCT03553602|Prostate Cancer|prostate cancer
5071281|NCT03553602|HDR brachytherapy|hdr brachytherapy
5071282|NCT03553602|Recurrent Prostate Cancer|recurrent prostate cancer
5071283|NCT03553602|Oligometastasis|oligometastasis
5071284|NCT03553602|Salvage Brachytherapy|salvage brachytherapy
5071367|NCT03553121|walking|walking
5071368|NCT03553121|debulking|debulking
5071369|NCT03553108|Solid Tumor|solid tumor
5071370|NCT03553056|alcohol|alcohol
5071371|NCT03553056|hazardous drinking|hazardous drinking
5071372|NCT03553056|mobile phone app|mobile phone app
5071373|NCT03553056|clinical trial|clinical trial
5071374|NCT03553043|consumer behaviour|consumer behaviour
5071375|NCT03553043|alcohol labelling|alcohol labelling
5071376|NCT03553043|energy labelling|energy labelling
5071377|NCT03553017|Optical Coherence Tomography|optical coherence tomography
5071378|NCT03553017|Automated|automated
5071379|NCT03553017|Binocular|binocular
5071385|NCT03552991|Dietary Fiber|dietary fiber
5071386|NCT03552991|Microbiota|microbiota
5071387|NCT03552991|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5071388|NCT03552991|Metformin|metformin
5071389|NCT03552991|Sulfonylurea Compounds|sulfonylurea compounds
5071390|NCT03552965|xerostomia|xerostomia
5071482|NCT03552341|Pregnancy|pregnancy
5071483|NCT03552302|Yoga|yoga
5071484|NCT03552302|Tinnitus|tinnitus
5071485|NCT03552302|Sleep|sleep
5071486|NCT03552289|Dialysis|dialysis
5071487|NCT03552289|Renal|renal
5071488|NCT03552289|Hemodialysis|hemodialysis
5071489|NCT03552289|Stenosis(es)|stenosis(es)
5071490|NCT03552289|Transluminal|transluminal
5071491|NCT03552289|Percutaneous Transluminal Angioplasty|percutaneous transluminal angioplasty
5071492|NCT03552263|Acute mountain sickness|acute mountain sickness
5738263|NCT00364494|Hematocrit|hematocrit
5083676|NCT03475407|cytokine|cytokine
5071507|NCT03552133|variable deadspace|variable deadspace
5071509|NCT03552133|hypercapnic side-effects|hypercapnic side-effects
5071510|NCT03552107|Lorcaserin|lorcaserin
5071511|NCT03552107|Belviq|belviq
5071512|NCT03552094|Arbovirus|arbovirus
5071513|NCT03552081|spermatogenesis|spermatogenesis
5071514|NCT03552081|tobacco|tobacco
5071515|NCT03552081|DNA Fragmentation Index|dna fragmentation index
5071516|NCT03552068|Parkinson's disease|parkinson's disease
5071517|NCT03552068|Impulse control disorder|impulse control disorder
5089875|NCT03436693|Canaglu|canaglu
5071582|NCT03551561|Surgical Procedures.|surgical procedures.
5071583|NCT03551535|Wearable technology|wearable technology
5071584|NCT03551535|Pregnancy|pregnancy
5071585|NCT03551535|Exercise|exercise
5071586|NCT03551535|Mobile Health|mobile health
5071595|NCT03551483|Online Recreation|online recreation
5071597|NCT03551470|laparoscopy|laparoscopy
5071598|NCT03551470|liver surgery|liver surgery
5071633|NCT03551275|BCD-132|bcd-132
5071796|NCT03550261|LC-MSMS|lc-msms
5071913|NCT03549650|LUTS|luts
5072046|NCT03549039|quality of life|quality of life
5072048|NCT03549039|cleft palate|cleft palate
5072049|NCT03549013|Tumor-related Trigeminal Neuralgia|tumor-related trigeminal neuralgia
5072050|NCT03549013|Percutaneous Radiofrequency Thermocoagulation|percutaneous radiofrequency thermocoagulation
5072051|NCT03549013|Three‐dimensional Computed Tomography|three‐dimensional computed tomography
5072052|NCT03549000|NZV930|nzv930
5072053|NCT03549000|PDR001|pdr001
5072054|NCT03549000|NIR178|nir178
5072055|NCT03549000|Immune checkpoint inhibitor|immune checkpoint inhibitor
5072056|NCT03549000|immunotherapy|immunotherapy
5072057|NCT03549000|CD73|cd73
5072058|NCT03549000|PD-1|pd-1
5072059|NCT03549000|PD-L1|pd-l1
5072164|NCT03548324|Very Low Birth Weight Infant|very low birth weight infant
5072165|NCT03548311|ALS|als
5072166|NCT03548311|motor neuron disease|motor neuron disease
5072167|NCT03548311|Lou Gehrig's disease|lou gehrig's disease
5072168|NCT03548298|GERD, Hybrid-APC, efficacy, safety|gerd, hybrid-apc, efficacy, safety
5072169|NCT03548298|ARAT|arat
5072170|NCT03548272|dedicated bifurcation stent|dedicated bifurcation stent
5072171|NCT03548272|non-LM bifurcation|non-lm bifurcation
5072172|NCT03548272|sirolimus-eluting stent|sirolimus-eluting stent
5072173|NCT03548259|Carpal Tunnel Syndrome|carpal tunnel syndrome
5072174|NCT03548259|Platelet-rich plasma|platelet-rich plasma
5072175|NCT03548259|Surgery|surgery
5072176|NCT03548181|Tele-rehabilitation|tele-rehabilitation
5072178|NCT03548142|Palliative Care|palliative care
5072261|NCT03547557|Bone Tumors|bone tumors
5072262|NCT03547544|helicobacter pylori|helicobacter pylori
5072263|NCT03547544|urease test|urease test
5072264|NCT03547544|helicotec|helicotec
5072265|NCT03547518|Urinary Urgency|urinary urgency
5072266|NCT03547518|Urinary Frequency|urinary frequency
5072267|NCT03547518|Urge Incontinence|urge incontinence
5072268|NCT03547505|Glide path|glide path
5072269|NCT03547505|postoperative pain|postoperative pain
5072270|NCT03547505|R-Pilot|r-pilot
5072356|NCT03547076|Pocket sized imaging device|pocket sized imaging device
5072357|NCT03547076|Handheld ultrasound device|handheld ultrasound device
5072358|NCT03547076|General practitioner|general practitioner
5072458|NCT03546413|prevention|prevention
5072459|NCT03546387|18-126|18-126
5072460|NCT03546387|Memorial Sloan Kettering Cancer Center|memorial sloan kettering cancer center
5072461|NCT03546322|head and neck cancer|head and neck cancer
5072462|NCT03546322|health information technology|health information technology
5072463|NCT03546322|patient safety|patient safety
5072464|NCT03546322|adherence|adherence
5072465|NCT03546322|ambulatory|ambulatory
5072466|NCT03546322|outpatient|outpatient
5072467|NCT03546322|human factors|human factors
5072468|NCT03546322|vulnerable populations|vulnerable populations
5072557|NCT03545646|Abdominal tissues|abdominal tissues
5072573|NCT03545581|Fructose|fructose
5072685|NCT03544853|Prosthetic socket|prosthetic socket
5072686|NCT03544853|Biomechanics|biomechanics
5072688|NCT03544788|mobile compression device|mobile compression device
5072689|NCT03544762|breast cancer|breast cancer
5072690|NCT03544762|PET|pet
5072691|NCT03544762|[18F]FES|[18f]fes
5072692|NCT03544762|estrogen receptor|estrogen receptor
5072693|NCT03544762|hormone treatment|hormone treatment
5072694|NCT03544762|personalized cancer care|personalized cancer care
5072695|NCT03544736|Nivolumab|nivolumab
5072696|NCT03544736|Immunotherapy|immunotherapy
5072703|NCT03544710|surgical site infection|surgical site infection
5072704|NCT03544671|Vitamin D|vitamin d
5072708|NCT03544671|Mexico|mexico
5072786|NCT03544203|intraabdominal infections|intraabdominal infections
5072787|NCT03544203|peritonitis|peritonitis
5072788|NCT03544203|critically ill|critically ill
5072789|NCT03544177|mobility|mobility
5072790|NCT03544177|exercise therapy|exercise therapy
5072791|NCT03544177|blood flow restricted exercise|blood flow restricted exercise
5072792|NCT03544177|rehabilitation|rehabilitation
5072793|NCT03544099|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5072882|NCT03543592|postmenopausal bleeding|postmenopausal bleeding
5072980|NCT03543098|Knee Dislocation|knee dislocation
5072981|NCT03543098|Multiple Ligament Knee Injury|multiple ligament knee injury
5072982|NCT03543033|lumbar radiculopathy|lumbar radiculopathy
5072983|NCT03543033|corticosteroid epidural injection|corticosteroid epidural injection
5073107|NCT03541954|pain thresholds|pain thresholds
5073219|NCT03541317|Coaching|coaching
5073220|NCT03541317|Facilitation|facilitation
5073311|NCT03540719|open reduction|open reduction
5073312|NCT03540719|internal fixation|internal fixation
5073411|NCT03540017|Fallopian Tube Cancer|fallopian tube cancer
5073412|NCT03540017|Primary Peritoneal Cancer|primary peritoneal cancer
5073413|NCT03539965|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5073414|NCT03539965|Predictive Biomarkers|predictive biomarkers
5073415|NCT03539965|Prognostic Biomarkers|prognostic biomarkers
5073416|NCT03539965|Complete Pathological Response|complete pathological response
5073417|NCT03539965|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5073434|NCT03539848|TBI|tbi
5073508|NCT03539445|recovery of dysfunction|recovery of dysfunction
5073509|NCT03539419|Psoriasis|psoriasis
5073611|NCT03538873|Elderly|elderly
5073959|NCT03536910|spinal anesthesia|spinal anesthesia
5073976|NCT03536793|Urinary tissue factor|urinary tissue factor
5074081|NCT03536143|RDEB|rdeb
5074082|NCT03536143|Krystal|krystal
5074083|NCT03536143|epidermolysis|epidermolysis
5074084|NCT03536143|bercolagene|bercolagene
5074330|NCT03534401|Contraception|contraception
5074331|NCT03534401|Clinic-based screening for IPV|clinic-based screening for ipv
5074332|NCT03534401|Clinic-based counseling|clinic-based counseling
5074333|NCT03534362|Propel Stent|propel stent
5074334|NCT03534362|Nasopore|nasopore
5074337|NCT03534349|performance|performance
5074429|NCT03533816|Graft versus host disease (GVHD)|graft versus host disease (gvhd)
5074430|NCT03533816|haploidentical|haploidentical
5074431|NCT03533764|Asthma Self-Management for Adolescents (ASMA)|asthma self-management for adolescents (asma)
5074432|NCT03533764|Community Health Workers (CHW)|community health workers (chw)
5074433|NCT03533751|ANB020|anb020
5074434|NCT03533751|etokimab|etokimab
5074435|NCT03533751|eczema|eczema
5074436|NCT03533751|moderate to severe|moderate to severe
5074437|NCT03533725|Initiation, Exclusivity, Duration|initiation, exclusivity, duration
5074522|NCT03533010|Vitamin D|vitamin d
5074523|NCT03533010|Calcium|calcium
5074524|NCT03532971|BK virus|bk virus
5074525|NCT03532971|BK polyomavirus|bk polyomavirus
5074526|NCT03532971|hematopoietic-cell transplantation|hematopoietic-cell transplantation
5074624|NCT03532269|app|app
5074634|NCT03532230|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5074635|NCT03532204|Oligometastatis|oligometastatis
5074637|NCT03532191|Quality Improvement|quality improvement
5074638|NCT03532191|Healthcare Providers|healthcare providers
5074639|NCT03532191|Health Disparity|health disparity
5074747|NCT03531554|Fatty acid Oxidation Disorders|fatty acid oxidation disorders
5074748|NCT03531554|ketone ester|ketone ester
5074749|NCT03531554|VLCAD deficiency|vlcad deficiency
5074750|NCT03531541|TENS|tens
5074751|NCT03531541|cervical manipulation|cervical manipulation
5074752|NCT03531541|pressure pain|pressure pain
5074760|NCT03531476|Online|online
5074858|NCT03530696|Metastatic Breast Cancer|metastatic breast cancer
5074859|NCT03530683|Neoplasms|neoplasms
5074860|NCT03530683|Lymphoma|lymphoma
5074861|NCT03530683|Myeloma|myeloma
5074862|NCT03530644|Non-invasive glucose monitoring|non-invasive glucose monitoring
5074863|NCT03530605|PCNSL, primary central nervous system lymphoma|pcnsl, primary central nervous system lymphoma
5075075|NCT03529461|complications|complications
5075076|NCT03529448|Glioblastoma|glioblastoma
5075077|NCT03529435|Posttraumatic Stress Disorder|posttraumatic stress disorder
5075079|NCT03529435|Post-Traumatic Stress|post-traumatic stress
5075080|NCT03529435|Trauma and Stressor Related Disorders|trauma and stressor related disorders
5075081|NCT03529435|Trauma|trauma
5075082|NCT03529435|Combat|combat
5075083|NCT03529435|Military|military
5075084|NCT03529435|Veterans|veterans
5075085|NCT03529435|Prolonged Exposure|prolonged exposure
5075086|NCT03529435|Exposure Therapy|exposure therapy
5075087|NCT03529435|Behavior Therapy|behavior therapy
5075088|NCT03529435|Psychological Treatment|psychological treatment
5075089|NCT03529435|Psychotherapy|psychotherapy
5075173|NCT03528980|fertility|fertility
5075283|NCT03528265|validation|validation
5075405|NCT03527433|Incisional hernia|incisional hernia
5075406|NCT03527433|Wound infection|wound infection
5075407|NCT03527433|Midline laparotomy|midline laparotomy
5075417|NCT03527420|Adipocytokines|adipocytokines
5075418|NCT03527420|Inflammation|inflammation
5075426|NCT03527394|Health Behavior|health behavior
5075427|NCT03527381|Cardiopulmonary Bypass|cardiopulmonary bypass
5075555|NCT03526835|Cytokines|cytokines
5075556|NCT03526835|EGFR|egfr
5075557|NCT03526835|LGR5|lgr5
5075558|NCT03526809|Magnetic resonance imaging|magnetic resonance imaging
5075559|NCT03526796|Pouchitis|pouchitis
5075560|NCT03526796|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5075561|NCT03526783|Obesity Surgery|obesity surgery
5075562|NCT03526783|Failed Sleeve Gastrectomy|failed sleeve gastrectomy
5075563|NCT03526783|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5075564|NCT03526783|Mini/One anastomosis gastric bypass|mini/one anastomosis gastric bypass
5075565|NCT03526770|pH of saliva|ph of saliva
5075566|NCT03526770|carbonated drink|carbonated drink
5075567|NCT03526770|buffering agent|buffering agent
5075568|NCT03526770|oral hygiene|oral hygiene
5075569|NCT03526757|Postural balance|postural balance
5075570|NCT03526757|Pilates method|pilates method
5075646|NCT03526354|Substance Use Disorders|substance use disorders
5075647|NCT03526354|Alcohol Use Disorder|alcohol use disorder
5075648|NCT03526354|Cannabis Use Disorder|cannabis use disorder
5075871|NCT03524859|Gait Speed|gait speed
5075872|NCT03524859|Chair rise|chair rise
5075873|NCT03524846|Ascorbic acid|ascorbic acid
5075980|NCT03524235|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5075981|NCT03524235|Natural Killer Cell|natural killer cell
5075982|NCT03524235|CliniMACS|clinimacs
5075983|NCT03524235|Post-transplantation cyclophosphamide|post-transplantation cyclophosphamide
5075984|NCT03524235|Donor Lymphocyte Infusion|donor lymphocyte infusion
5076210|NCT03522597|Infant Growth|infant growth
5076211|NCT03522545|treatment-resistant bipolar depression|treatment-resistant bipolar depression
5076212|NCT03522545|bipolar disorder|bipolar disorder
5076213|NCT03522545|manic depression|manic depression
5076214|NCT03522532|dental restorations|dental restorations
5076215|NCT03522532|gingival crevicular fluid|gingival crevicular fluid
5076216|NCT03522532|glutathione|glutathione
5076217|NCT03522532|lipid peroxidation|lipid peroxidation
5076218|NCT03522532|superoxide dismutase|superoxide dismutase
5076219|NCT03522519|Physical Activity|physical activity
5076248|NCT03522350|IVF|ivf
5076322|NCT03522038|coronary chronic total occlusion|coronary chronic total occlusion
5076323|NCT03522038|functional evaluation|functional evaluation
5076324|NCT03522012|Pharmacokinetics|pharmacokinetics
5076325|NCT03522012|Tocilizumab|tocilizumab
5076326|NCT03521999|PTSD|ptsd
5076327|NCT03521999|peer resource|peer resource
5076328|NCT03521999|Veterans|veterans
5076329|NCT03521999|web-based intervention|web-based intervention
5076409|NCT03521505|bronchoscopy|bronchoscopy
5076410|NCT03521492|Early childhood caries, Vitamin D deficiency, Parathyroid hormone, Calcium|early childhood caries, vitamin d deficiency, parathyroid hormone, calcium
5076516|NCT03520959|NY-ESO-1|ny-eso-1
5076517|NCT03520959|cancer vaccine|cancer vaccine
5075737|NCT03525795|Phase 1/2|phase 1/2
5076650|NCT03520335|prehospital|prehospital
5076651|NCT03520335|stroke scale|stroke scale
5076652|NCT03520335|large vessel occlusion|large vessel occlusion
5076653|NCT03520309|Diagnosis|diagnosis
5076662|NCT03520244|Fatigue|fatigue
5076744|NCT03519607|Coping|coping
5076745|NCT03519607|Men|men
5076746|NCT03519594|angioembolization|angioembolization
5076747|NCT03519594|computed tomography|computed tomography
5076748|NCT03519581|DME|dme
5076749|NCT03519581|micropulse laser|micropulse laser
5076750|NCT03519529|sex hormone-binding globulin|sex hormone-binding globulin
5076751|NCT03519516|ocular antibiotic|ocular antibiotic
5076752|NCT03519516|quinolone|quinolone
5076753|NCT03519516|levofloxacin|levofloxacin
5076828|NCT03519035|borderline|borderline
5076950|NCT03518151|public health|public health
5076951|NCT03518151|dietary inequalities|dietary inequalities
5076952|NCT03518151|environment design|environment design
5076953|NCT03518125|Anthrax|anthrax
5068623|NCT03570177|QCT|qct
5076958|NCT03518125|BioThrax|biothrax
5077137|NCT03517306|lung cancer, FDG, PET/CT, radiomics|lung cancer, fdg, pet/ct, radiomics
5077138|NCT03517280|Malnutrition|malnutrition
5077241|NCT03516747|parathyroid hormone level|parathyroid hormone level
5077242|NCT03516734|Iron deficiency|iron deficiency
5077243|NCT03516734|Food-based dietary intervention|food-based dietary intervention
5077244|NCT03516695|Registry|registry
5077350|NCT03516032|rehabilitation|rehabilitation
5077398|NCT03515694|TOF|tof
5077583|NCT03514420|Lipodystrophy|lipodystrophy
5077584|NCT03514420|Lipodystrophy, Familial Partial|lipodystrophy, familial partial
5077585|NCT03514420|Lipid Metabolism Disorders|lipid metabolism disorders
5077586|NCT03514420|Dyslipidemias|dyslipidemias
5077587|NCT03514420|Kobberling-Dunnigan syndrome (type 1 and 2)|kobberling-dunnigan syndrome (type 1 and 2)
5077588|NCT03514420|Lipoatrophic Diabetes|lipoatrophic diabetes
5077589|NCT03514407|Relapsed Ewing sarcoma|relapsed ewing sarcoma
5356804|NCT01917929|[E04.555.110.110.110]|[e04.555.110.110.110]
5077795|NCT03513315|heatwave|heatwave
5077922|NCT03512730|regenera|regenera
5077923|NCT03512704|Heart failure|heart failure
5077924|NCT03512704|clinical prediction rules|clinical prediction rules
5078040|NCT03512080|International Normalised Ratio|international normalised ratio
5078041|NCT03512080|Uganda|uganda
5078042|NCT03512080|Cape Town|cape town
5078043|NCT03512080|Cardiovascular Disease|cardiovascular disease
5078044|NCT03512080|Genome-wide Association Study|genome-wide association study
5078045|NCT03512080|Stratified Medicine|stratified medicine
5078046|NCT03512080|Pharmacogenetics|pharmacogenetics
5078047|NCT03512067|Mechanical Ventilation|mechanical ventilation
5078048|NCT03512067|Respiratory Support|respiratory support
5078049|NCT03512054|Tracheostomy|tracheostomy
5078050|NCT03512054|Decannulation|decannulation
5078051|NCT03512054|Rehabilitation|rehabilitation
5078131|NCT03511508|chronic disease|chronic disease
5078132|NCT03511508|interdisciplinary|interdisciplinary
5078133|NCT03511508|midwifery|midwifery
5078134|NCT03511469|Kontralateral Education, Bankart, Rehabilitation, Shoulder,|kontralateral education, bankart, rehabilitation, shoulder,
5078135|NCT03511456|leg pain|leg pain
5078136|NCT03511456|waist pain|waist pain
5078137|NCT03511456|life quality|life quality
5078238|NCT03510793|microcirculation; aortic aneurysm; anesthesia|microcirculation; aortic aneurysm; anesthesia
5078239|NCT03510780|Platlet rich fibrin|platlet rich fibrin
5078240|NCT03510780|Enamel Matrix Derivative|enamel matrix derivative
5078241|NCT03510780|Bone graft|bone graft
5078242|NCT03510780|Non-inferiority study|non-inferiority study
5078243|NCT03510754|Endoscopic ultrasound|endoscopic ultrasound
5078244|NCT03510754|Biliary drainage|biliary drainage
5078245|NCT03510754|Endoscopic ultrasound guided biliary drainage|endoscopic ultrasound guided biliary drainage
5078246|NCT03510741|Schizophrenia|schizophrenia
5078363|NCT03510000|carbohydrate counting|carbohydrate counting
5078364|NCT03509935|ultrasound,|ultrasound,
5078365|NCT03509935|high-risk surgery|high-risk surgery
5078366|NCT03509935|intensive care|intensive care
5078367|NCT03509909|yoga|yoga
5078368|NCT03509909|exercise|exercise
5078369|NCT03509909|randomized controlled trial|randomized controlled trial
5078471|NCT03509220|Bowel cleansing|bowel cleansing
5078472|NCT03509207|Uterine sarcoma|uterine sarcoma
5078474|NCT03509194|liver|liver
5078584|NCT03508336|vegetative state|vegetative state
5078710|NCT03507465|capecitabine|capecitabine
5078711|NCT03507465|neoadjuvant|neoadjuvant
5078712|NCT03507465|chemotherapy|chemotherapy
5078713|NCT03507465|ER+/HER2-|er+/her2-
5078719|NCT03507426|Retrobulbar block|retrobulbar block
5078937|NCT03506113|Gram staining|gram staining
5078938|NCT03506113|Antimicrobial therapy|antimicrobial therapy
5078939|NCT03506113|Empirical therapy|empirical therapy
5078940|NCT03506113|Nosocomial infection|nosocomial infection
5079041|NCT03505411|Glutathione peroxidase|glutathione peroxidase
5079042|NCT03505411|Malondialdehyde|malondialdehyde
5079043|NCT03505411|Isoprostanes|isoprostanes
5079044|NCT03505411|anti-ox-LDL|anti-ox-ldl
5079045|NCT03505411|Superoxide dismutase|superoxide dismutase
5079046|NCT03505411|Glutathione reductase|glutathione reductase
5079047|NCT03505411|Interleukin-6|interleukin-6
5079048|NCT03505411|C-reactive protein|c-reactive protein
5079049|NCT03505411|Autonomic nervous system|autonomic nervous system
5079050|NCT03505385|Co-creation|co-creation
5079177|NCT03504501|RASopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation|rasopathies, neurofibromatosis type 1, noonan syndrome, synaptic plasticity, transcranial magnetic stimulation
5079178|NCT03504462|Foot surgery|foot surgery
5079285|NCT03503864|Children|children
5079286|NCT03503851|Mitral Regurgitation|mitral regurgitation
5079288|NCT03503851|MitraClip|mitraclip
5079388|NCT03503292|Granisetron|granisetron
5079389|NCT03503292|Bariatric surgery|bariatric surgery
5079390|NCT03503266|Mass Balance Study with MT-7117|mass balance study with mt-7117
5079391|NCT03503240|Quality of Life|quality of life
5079392|NCT03503240|survey|survey
5079393|NCT03503240|18-168|18-168
5079401|NCT03503136|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5079402|NCT03503136|Nedaplatin|nedaplatin
5079403|NCT03503136|Capecitabine|capecitabine
5079404|NCT03503097|Prostate cancer|prostate cancer
5079405|NCT03503097|metastatic|metastatic
5079406|NCT03503097|genetic testing|genetic testing
5079407|NCT03503097|cancer risk|cancer risk
5079408|NCT03503097|BRCA1|brca1
5079409|NCT03503097|BRCA2|brca2
5079410|NCT03503084|Tai Chi Chuan|tai chi chuan
5079411|NCT03503084|insulin resistance|insulin resistance
5079412|NCT03503084|cholesterol|cholesterol
5079413|NCT03503084|endothelin-1|endothelin-1
5079414|NCT03503058|Plasmodium falciparum|plasmodium falciparum
5079415|NCT03503058|Sporozoites|sporozoites
5079416|NCT03503058|PfSPZ|pfspz
5079417|NCT03503045|Diabetes Mellitus|diabetes mellitus
5079418|NCT03503045|Polypharmacy|polypharmacy
5079419|NCT03503045|Overtreatment|overtreatment
5079420|NCT03503045|Undertreatment|undertreatment
5079421|NCT03503032|Extracardiac Fontan|extracardiac fontan
5091264|NCT03428152|hysterectomy|hysterectomy
5079427|NCT03502980|Peripherally Inserted Central Catheter Line Insertion|peripherally inserted central catheter line insertion
5079429|NCT03502967|Traumatic Brain Injury|traumatic brain injury
5079430|NCT03502967|TBI|tbi
5079431|NCT03502928|Dry Needling|dry needling
5079432|NCT03502928|Manual Therapy|manual therapy
5079433|NCT03502928|Motor Control|motor control
5079434|NCT03502928|Whiplash|whiplash
5079435|NCT03502915|breech presentation|breech presentation
5079473|NCT03502642|intrathecal morphine|intrathecal morphine
5079474|NCT03502642|randomized controlled trial|randomized controlled trial
5079475|NCT03502564|Posttraumatic stress disorder|posttraumatic stress disorder
5079683|NCT03501290|Oral Nutritional Supplements|oral nutritional supplements
5079802|NCT03500432|prostate cancer diagnosis|prostate cancer diagnosis
5079803|NCT03500367|mammilian target of rapamycin inhibitor|mammilian target of rapamycin inhibitor
5079804|NCT03500367|Rapamycin (sirolimus)|rapamycin (sirolimus)
5079805|NCT03500367|Treatment|treatment
5079806|NCT03500367|Complications|complications
5079807|NCT03500354|malnutrition|malnutrition
5079808|NCT03500276|yoga|yoga
5079810|NCT03500276|proinflammatory genes|proinflammatory genes
5079905|NCT03499795|Peri-anal intraepithelial neoplasia 3 (PAIN3)|peri-anal intraepithelial neoplasia 3 (pain3)
5079906|NCT03499782|Prognosis|prognosis
5079907|NCT03499782|Surgery options|surgery options
5079908|NCT03499782|Bayesian networks|bayesian networks
5079909|NCT03499756|Postnatal depression, interpersonal psychotherapy|postnatal depression, interpersonal psychotherapy
5079910|NCT03499730|Midazolam|midazolam
5079911|NCT03499730|Inguinal hernia|inguinal hernia
5100410|NCT03370471|learning|learning
5080031|NCT03498937|Noninvasive brain stimulation|noninvasive brain stimulation
5080032|NCT03498924|tumor marker|tumor marker
5080033|NCT03498924|HE4|he4
5080034|NCT03498924|CA125|ca125
5080142|NCT03498196|MIBC|mibc
5080256|NCT03497468|exercise training|exercise training
5080257|NCT03497468|mobility|mobility
5080258|NCT03497468|balance|balance
5080259|NCT03497468|fatigue|fatigue
5080260|NCT03497468|quality of life|quality of life
5080261|NCT03497416|Preoperative Anemia|preoperative anemia
5080262|NCT03497416|elderly|elderly
5080263|NCT03497416|healthcare outcomes|healthcare outcomes
5080264|NCT03497390|Type 2 diabetes|type 2 diabetes
5080265|NCT03497390|Obesity|obesity
5080266|NCT03497364|Cesarean Section|cesarean section
5080267|NCT03497364|Hypotension|hypotension
5080268|NCT03497364|Combined spinal-epidural anesthesia|combined spinal-epidural anesthesia
5080269|NCT03497312|Rehabilitation|rehabilitation
5080270|NCT03497312|children with disabilities|children with disabilities
5080271|NCT03497312|general anesthesia|general anesthesia
5080272|NCT03497312|Children with special healthcare need|children with special healthcare need
5080342|NCT03497000|photodynamic therapy|photodynamic therapy
5080449|NCT03496363|Children|children
5080570|NCT03495635|prevention|prevention
5080571|NCT03495622|Text messaging|text messaging
5080572|NCT03495622|Community health worker|community health worker
5080573|NCT03495622|Smoking cessation|smoking cessation
5080574|NCT03495622|India|india
5080575|NCT03495622|Cardiovascular mortality|cardiovascular mortality
5739306|NCT00360568|levodopa|levodopa
5080670|NCT03495011|MRI|mri
5080671|NCT03495011|Oncotype Dx|oncotype dx
5080672|NCT03494959|Pentaglobin|pentaglobin
5080673|NCT03494959|Carbapenem-resistant Klebsiella pneumoniae|carbapenem-resistant klebsiella pneumoniae
5080674|NCT03494959|Pseudomonas aeruginosa|pseudomonas aeruginosa
5080675|NCT03494959|febrile neutropenia|febrile neutropenia
5080676|NCT03494959|infection-related mortality|infection-related mortality
5080677|NCT03494946|Liver metastasis|liver metastasis
5080678|NCT03494946|Colorectal cancer|colorectal cancer
5080679|NCT03494920|Stroke|stroke
5080680|NCT03494920|Ischemia|ischemia
5080886|NCT03493516|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5080887|NCT03493516|Risk Prediction|risk prediction
5080888|NCT03493490|Double-Blind Method|double-blind method
5080899|NCT03493451|peripheral T-cell|peripheral t-cell
5080900|NCT03493451|anaplastic large cell|anaplastic large cell
5080901|NCT03493451|ALCL|alcl
5080902|NCT03493451|angioimmunoblastic|angioimmunoblastic
5080903|NCT03493451|PTCL-NOS|ptcl-nos
5080904|NCT03493451|Relapsed|relapsed
5081135|NCT03491761|WOMAC|womac
5081136|NCT03491761|KOOS|koos
5081137|NCT03491761|Euflexxa|euflexxa
5081138|NCT03491748|Pharmacokinetics|pharmacokinetics
5081139|NCT03491748|ETX0282|etx0282
5081140|NCT03491748|Single Ascending Dose|single ascending dose
5081141|NCT03491748|Multiple Ascending Doses|multiple ascending doses
5081142|NCT03491748|ETX1317|etx1317
5081143|NCT03491748|Cefpodoxime Proxetil|cefpodoxime proxetil
5081144|NCT03491748|Cefpodoxime|cefpodoxime
5081145|NCT03491748|Enterobacteriaceae Infections|enterobacteriaceae infections
5081146|NCT03491735|patterns|patterns
5092947|NCT03417726|Balance|balance
5081174|NCT03491605|chronic EBV infection, hemophagocytic lymphohistiocytosis|chronic ebv infection, hemophagocytic lymphohistiocytosis
5081175|NCT03491592|Physical Activity|physical activity
5081176|NCT03491592|Latinas|latinas
5081177|NCT03491592|Spanish-language|spanish-language
5081178|NCT03491592|Text-Message|text-message
5081179|NCT03491592|Exercise|exercise
5081180|NCT03491592|Web-based|web-based
5081182|NCT03491579|Epacadostat|epacadostat
5081183|NCT03491579|Cladribine|cladribine
5081184|NCT03491579|Cytarabine|cytarabine
5081268|NCT03491111|maximal inspiratory pressure, maximal expiratory pressure|maximal inspiratory pressure, maximal expiratory pressure
5081270|NCT03491072|extracorporeal shock-wave Lithotripsy,|extracorporeal shock-wave lithotripsy,
5081271|NCT03491072|pain relief during extracorporeal shock-wave Lithotripsy|pain relief during extracorporeal shock-wave lithotripsy
5081272|NCT03491072|fentanyl|fentanyl
5081273|NCT03491072|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5081276|NCT03491033|residual disease|residual disease
5081369|NCT03490448|body composition|body composition
5081370|NCT03490448|glucose metabolism|glucose metabolism
5081371|NCT03490448|lipid metabolism|lipid metabolism
5081403|NCT03490331|JEB|jeb
5081485|NCT03489876|Metatarsophalangeal Joint|metatarsophalangeal joint
5081486|NCT03489876|Arthritis|arthritis
5081487|NCT03489876|Synthetic Cartilage Implant|synthetic cartilage implant
5081488|NCT03489876|Cartiva|cartiva
5081489|NCT03489876|Osteochondral Autograft Transfer|osteochondral autograft transfer
5081490|NCT03489863|clopidogrel|clopidogrel
5081491|NCT03489863|prasugrel|prasugrel
5081492|NCT03489863|ticagrelor|ticagrelor
5081493|NCT03489811|Essential Oils|essential oils
5081499|NCT03489798|Failed induction|failed induction
5081500|NCT03489785|Predicted factor|predicted factor
5081501|NCT03489785|Motor Evoked Potentials|motor evoked potentials
5081584|NCT03489369|Anti-LAG-3|anti-lag-3
5081585|NCT03489369|LAG-3|lag-3
5081586|NCT03489369|LAG3|lag3
5103322|NCT03351712|RCT|rct
5081587|NCT03489356|Addressing Behavior Change (ABC)|addressing behavior change (abc)
5081588|NCT03489356|Addressing Behavior Change (ABC) Intervention|addressing behavior change (abc) intervention
5081683|NCT03488927|Sexual Assault|sexual assault
5081684|NCT03488927|Disclosure|disclosure
5081685|NCT03488927|Social Reactions|social reactions
5081686|NCT03488927|Coping|coping
5081780|NCT03487965|dicarbonyl compounds|dicarbonyl compounds
5081893|NCT03487016|Metastatic|metastatic
5081894|NCT03487003|laryngeal mask airway|laryngeal mask airway
5081895|NCT03487003|children, preschool|children, preschool
5081896|NCT03487003|muscle relaxant|muscle relaxant
5081897|NCT03486990|safety|safety
5081994|NCT03486119|Non -small cell lung cancer|non -small cell lung cancer
5082283|NCT03484468|flap_thickness|flap_thickness
5082402|NCT03483623|Laser doppler pressure monitor|laser doppler pressure monitor
5082403|NCT03483623|Transcutanous oxygenation|transcutanous oxygenation
5082405|NCT03483571|asymptomatic|asymptomatic
5082406|NCT03483571|submicroscopic|submicroscopic
5082407|NCT03483571|PCR|pcr
5082408|NCT03483558|vegetable metabolite signature|vegetable metabolite signature
5082409|NCT03483558|human serum/urinary metabolite|human serum/urinary metabolite
5082410|NCT03483558|liquid chromatography mass spectrometry|liquid chromatography mass spectrometry
5082411|NCT03483545|Ovarian Response|ovarian response
5082412|NCT03483545|In vitro fertilization|in vitro fertilization
5082413|NCT03483545|Controlled ovarian stimulation|controlled ovarian stimulation
5082414|NCT03483532|lithiasis|lithiasis
5082415|NCT03483532|uric acid|uric acid
5082416|NCT03483532|crystallization|crystallization
5082417|NCT03483493|Tic disorders|tic disorders
5082418|NCT03483493|Tourette Syndrome|tourette syndrome
5082419|NCT03483493|Online delivered therapy|online delivered therapy
5094111|NCT03410732|dendritic cell|dendritic cell
5082504|NCT03482869|walking impairment|walking impairment
5082505|NCT03482869|disability|disability
5082506|NCT03482869|diabetes mellitus|diabetes mellitus
5082507|NCT03482830|Inflammation|inflammation
5082508|NCT03482830|Insulin-glucose homeostasis|insulin-glucose homeostasis
5082509|NCT03482830|Hypothalamic-pituitary-adrenal axis|hypothalamic-pituitary-adrenal axis
5082510|NCT03482830|Endothelial function and damage|endothelial function and damage
5082511|NCT03482830|Thyroid hormones|thyroid hormones
5082519|NCT03482726|bicycle|bicycle
5082530|NCT03482674|Health literacy|health literacy
5082531|NCT03482674|Innovation Fund|innovation fund
5082532|NCT03482674|lifestyle intervention|lifestyle intervention
5082533|NCT03482674|risk screening|risk screening
5082534|NCT03482674|type 2 diabetes mellitus|type 2 diabetes mellitus
5082535|NCT03482674|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5082536|NCT03482661|Magnetic steering|magnetic steering
5082607|NCT03482232|overuse|overuse
5082612|NCT03482128|transfusion|transfusion
5094323|NCT03409263|Ascites|ascites
5082623|NCT03482063|B vitamin|b vitamin
5082624|NCT03482063|herbal supplement|herbal supplement
5082625|NCT03482063|attention|attention
5082626|NCT03482011|Psoriasis|psoriasis
5082627|NCT03482011|IL-23|il-23
5082628|NCT03481998|CDK4/6 inhibitor|cdk4/6 inhibitor
5082738|NCT03481439|Orthopaedic surgery|orthopaedic surgery
5082739|NCT03481439|Traumatology|traumatology
5082740|NCT03481426|musculoskelelal disorder|musculoskelelal disorder
5082741|NCT03481426|occupational health service|occupational health service
5082742|NCT03481400|Calcitonin gene-related peptide|calcitonin gene-related peptide
5082743|NCT03481361|Obstructive sleep apnoea (OSA)|obstructive sleep apnoea (osa)
5082744|NCT03481361|Type 1 diabetes (T1D)|type 1 diabetes (t1d)
5082745|NCT03481361|Type 2 diabetes (T2D)|type 2 diabetes (t2d)
5082843|NCT03480516|Silver Diamine Fluoride|silver diamine fluoride
5082844|NCT03480516|Sodium Fluoride Varnish|sodium fluoride varnish
5082845|NCT03480516|Arrest caries|arrest caries
5082846|NCT03480516|Caries prevention|caries prevention
5082847|NCT03480516|Cost Effectiveness|cost effectiveness
5082848|NCT03480516|Oral Health|oral health
5082849|NCT03480516|Quality of Life|quality of life
5082850|NCT03480503|Apelin12|apelin12
5082852|NCT03480412|Luteal Phase Stimulation|luteal phase stimulation
5082853|NCT03480412|Poor Ovarian Response|poor ovarian response
5082877|NCT03480321|PMR|pmr
5082949|NCT03479697|Hyperarousal|hyperarousal
5082951|NCT03479697|Acoustic Stimulation|acoustic stimulation
5083067|NCT03479099|Circulating Tumor Cell|circulating tumor cell
5083068|NCT03479099|Cell-Free Tumor DNA|cell-free tumor dna
5083069|NCT03479099|Liquid Biopsy|liquid biopsy
5083070|NCT03479060|Wet cupping therapy|wet cupping therapy
5083255|NCT03477877|Rwanda|rwanda
5083357|NCT03477266|Postoperative ileus|postoperative ileus
5083358|NCT03477266|mosapride|mosapride
5083359|NCT03477266|mouth dissolving tablets|mouth dissolving tablets
5083360|NCT03477266|Intraoperative vomiting|intraoperative vomiting
5083361|NCT03477240|Cervical Cancer|cervical cancer
5083362|NCT03477240|TELEPHONIC QUESTIONNAIRE|telephonic questionnaire
5083363|NCT03477240|Follow up|follow up
5083364|NCT03477227|compression stocking|compression stocking
5083365|NCT03477227|elastic stocking|elastic stocking
5083366|NCT03477227|endovenous radiofrequency ablation|endovenous radiofrequency ablation
5083367|NCT03477227|compression therapy|compression therapy
5083541|NCT03476122|CTCs|ctcs
5083542|NCT03476122|Early detection|early detection
5083543|NCT03476122|Automated|automated
5083544|NCT03476096|pregnancy|pregnancy
5083545|NCT03476096|microcirculation|microcirculation
5083547|NCT03476083|Hepatitis B Infection|hepatitis b infection
5083753|NCT03474913|prostate imaging|prostate imaging
5083766|NCT03474887|eConsultation|econsultation
5083767|NCT03474887|ehealth|ehealth
5083768|NCT03474848|cerebral palsy|cerebral palsy
5083783|NCT03474744|Oncology|oncology
5083784|NCT03474718|scalp|scalp
5083785|NCT03474718|hair loss|hair loss
5083787|NCT03474705|Clinical Pain|clinical pain
5083909|NCT03474133|relapsed|relapsed
5083910|NCT03474133|refractory|refractory
5083911|NCT03474133|brentuximab vedotin|brentuximab vedotin
5083912|NCT03474133|autologous stem cell transplantation|autologous stem cell transplantation
5083913|NCT03474120|Genetic causes|genetic causes
5083914|NCT03474120|etiology|etiology
5083915|NCT03474120|POI|poi
5083916|NCT03474120|DOR|dor
5083922|NCT03474094|Clinical Trial|clinical trial
5083923|NCT03474094|randomized|randomized
5083924|NCT03474094|phase II|phase ii
5083925|NCT03474094|atezolizumab|atezolizumab
5083926|NCT03474094|PD-L1|pd-l1
5083927|NCT03474081|Umeclidinium|umeclidinium
5083928|NCT03474081|Lung function|lung function
5083929|NCT03474081|RESPIMAT|respimat
5083931|NCT03474081|Triple Therapy|triple therapy
5084014|NCT03473496|CD38-CART|cd38-cart
5084015|NCT03473483|nicotine|nicotine
5084016|NCT03473483|tobacco|tobacco
5084017|NCT03473483|research electronic cigarette|research electronic cigarette
5084018|NCT03473483|e-cigarette|e-cigarette
5084019|NCT03473483|SREC|srec
5084020|NCT03473470|Maternal and Neonatal Hypothermia, cesarean delivery|maternal and neonatal hypothermia, cesarean delivery
5084021|NCT03473457|CD38-CART|cd38-cart
5084022|NCT03473457|CD33-CART|cd33-cart
5084023|NCT03473457|CD56-CART|cd56-cart
5084115|NCT03472989|high-load strength training|high-load strength training
5084116|NCT03472989|foot orthosis|foot orthosis
5084124|NCT03472963|Post-Exposure Prophylaxis|post-exposure prophylaxis
5084125|NCT03472963|Anti-Retroviral|anti-retroviral
5084126|NCT03472963|Pharmacokinetics|pharmacokinetics
5084127|NCT03472937|Mechanical cervical ripening|mechanical cervical ripening
5084128|NCT03472937|Transcervical catheter|transcervical catheter
5084129|NCT03472937|Foley catheter for labor induction|foley catheter for labor induction
5084132|NCT03472924|AMI|ami
5084228|NCT03472261|cerebral palsy|cerebral palsy
5084229|NCT03472261|botulinum toxin-A|botulinum toxin-a
5084230|NCT03472261|pronator deformity|pronator deformity
5084231|NCT03472248|Adolescents|adolescents
5084357|NCT03471689|Pain perception|pain perception
5084358|NCT03471689|Regulation|regulation
5084359|NCT03471689|Mindfulness|mindfulness
5084360|NCT03471650|J17149|j17149
5084473|NCT03470844|Intensive Care Medicine|intensive care medicine
5084474|NCT03470844|Neurocognitive dysfunction|neurocognitive dysfunction
5084480|NCT03470818|Anxiety|anxiety
5084580|NCT03470246|Coronary artery disease|coronary artery disease
5084581|NCT03470246|eHealth|ehealth
5084582|NCT03470246|Interactive guidance|interactive guidance
5084583|NCT03470246|Mitral valve insufficiency|mitral valve insufficiency
5084807|NCT03468712|mortality|mortality
5084940|NCT03467880|Asthma|asthma
5085169|NCT03466177|Alzheimer's disease|alzheimer's disease
5085260|NCT03465722|GIST tyrosine kinase inhibitor treatment|gist tyrosine kinase inhibitor treatment
5085261|NCT03465722|GIST TKI|gist tki
5085262|NCT03465722|GIST tyrosine kinase inhibitor|gist tyrosine kinase inhibitor
5085263|NCT03465722|Advanced GIST|advanced gist
5085264|NCT03465722|GIST mutations|gist mutations
5085265|NCT03465722|GIST treatments|gist treatments
5085266|NCT03465722|Blueprint GIST|blueprint gist
5085267|NCT03465722|Relapsed GIST clinical trial|relapsed gist clinical trial
5085268|NCT03465722|Refractory GIST clinical trial|refractory gist clinical trial
5085270|NCT03465722|cancer gist|cancer gist
5085356|NCT03465280|Recurrent respiratory papillomatosis|recurrent respiratory papillomatosis
5085357|NCT03465267|stroke|stroke
5085358|NCT03465267|upper extremity rehabilitation robot|upper extremity rehabilitation robot
5085359|NCT03465267|stroke rehabilitation|stroke rehabilitation
5085360|NCT03465241|Non-Small Cell Lung Cancer|non-small cell lung cancer
5085361|NCT03465241|stage II to IIIA|stage ii to iiia
5085362|NCT03465241|circulating tumor DNA|circulating tumor dna
5085363|NCT03465241|The next generation of high-throughput gene sequencing|the next generation of high-throughput gene sequencing
5085364|NCT03465228|Low Back Pain|low back pain
5085449|NCT03464656|semen|semen
5085450|NCT03464656|male infertility|male infertility
5085585|NCT03463785|cone beam computed tomography|cone beam computed tomography
5085586|NCT03463772|in vitro maturation|in vitro maturation
5085587|NCT03463772|polycystic ovarian syndrome|polycystic ovarian syndrome
5085588|NCT03463772|oocyte|oocyte
5085589|NCT03463733|Glioma|glioma
5085593|NCT03463733|Hydroxyurea|hydroxyurea
5085681|NCT03463018|Echinacea, Subthreshold Anxiety|echinacea, subthreshold anxiety
5085683|NCT03462979|Urine|urine
5085684|NCT03462979|Stool|stool
5085685|NCT03462979|home testing|home testing
5085686|NCT03462966|Rifaximin|rifaximin
5085687|NCT03462966|Xifaxan|xifaxan
5107471|NCT03326193|BRCA|brca
5085692|NCT03462888|Rhabdomyosarcoma|rhabdomyosarcoma
5085779|NCT03462329|Post-Lyme symptoms|post-lyme symptoms
5085780|NCT03462329|Pretreatment expectations|pretreatment expectations
5085781|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a
5085782|NCT03462290|Injections|injections
5085783|NCT03462290|Sphenopalatine Ganglion Block|sphenopalatine ganglion block
5085784|NCT03462277|methylation|methylation
5085785|NCT03462277|hydroxymethylation|hydroxymethylation
5085786|NCT03462277|atherosclerosis|atherosclerosis
5085787|NCT03462277|coronary heart disease|coronary heart disease
5086004|NCT03460691|quality of life|quality of life
5086005|NCT03460678|Generic Erlotinib|generic erlotinib
5086007|NCT03460678|NSCLC|nsclc
5086121|NCT03459937|mindfulness|mindfulness
5086122|NCT03459937|weight loss|weight loss
5086123|NCT03459937|physical activity|physical activity
5086124|NCT03459924|Right ventricular function|right ventricular function
5086125|NCT03459924|Liver transplantation|liver transplantation
5086126|NCT03459924|Transesophageal echocardiography|transesophageal echocardiography
5086127|NCT03459911|Bioequivalence|bioequivalence
5086128|NCT03459872|acupuncture|acupuncture
5086129|NCT03459872|quantitative data|quantitative data
5086130|NCT03459872|outcomes based rehabilitation|outcomes based rehabilitation
5086131|NCT03459872|fine motor control|fine motor control
5086132|NCT03459846|Urinary Bladder Neoplasms|urinary bladder neoplasms
5086133|NCT03459833|premature ejaculation|premature ejaculation
5086134|NCT03459833|IELT|ielt
5086135|NCT03459833|hyaluronic acid|hyaluronic acid
5086136|NCT03459833|glans penis augmentation|glans penis augmentation
5086137|NCT03459807|Blood pressure|blood pressure
5086138|NCT03459807|Hemodialysis|hemodialysis
5086139|NCT03459807|End-stage-renal-disease|end-stage-renal-disease
5086140|NCT03459807|Chronic kidney disease|chronic kidney disease
5086141|NCT03459742|Obesity|obesity
5086142|NCT03459742|Gamification|gamification
5086143|NCT03459742|Schools|schools
5086144|NCT03459742|Cluster Randomized Trial|cluster randomized trial
5086148|NCT03459716|Biomarkers|biomarkers
5086149|NCT03459716|Endothelial microparticles|endothelial microparticles
5086152|NCT03459677|Truancy|truancy
5086317|NCT03458754|Respiratory muscle strength|respiratory muscle strength
5086318|NCT03458754|Peripheric muscle strength|peripheric muscle strength
5086321|NCT03458715|SGLT2 inhibitor|sglt2 inhibitor
5086322|NCT03458715|DPP4 inhibitor|dpp4 inhibitor
5086323|NCT03458702|autonomic function|autonomic function
5086324|NCT03458702|emotion|emotion
5086325|NCT03458702|heart rate variability|heart rate variability
5086326|NCT03458676|Advanced magnetic resonance imaging|advanced magnetic resonance imaging
5086335|NCT03458559|Rhenium-188-HEDP|rhenium-188-hedp
5086336|NCT03458559|Radium 223-chloride|radium 223-chloride
5086338|NCT03458559|Prostate cancer|prostate cancer
5086339|NCT03458533|Pituitary|pituitary
5086340|NCT03458533|Obesity|obesity
5086341|NCT03458533|Overweight|overweight
5086412|NCT03458234|Focal therapy|focal therapy
5086413|NCT03458234|Prostate cancer|prostate cancer
5086415|NCT03458234|Intra-urethral transponder|intra-urethral transponder
5086416|NCT03458221|ovarian carcinoma|ovarian carcinoma
5086417|NCT03458221|Signal Transduction Pathway|signal transduction pathway
5086418|NCT03458221|therapy|therapy
5086422|NCT03458208|metformin|metformin
5086423|NCT03458208|fed|fed
5086424|NCT03458208|fasting|fasting
5086425|NCT03458195|ileo-caecal resection; post-operative recurrence|ileo-caecal resection; post-operative recurrence
5086426|NCT03458143|ketamine|ketamine
5086534|NCT03457480|Surveys|surveys
5086651|NCT03456596|RE-AIM|re-aim
5086652|NCT03456583|Breast Biopsy|breast biopsy
5086653|NCT03456583|Breast Biopsy Imaging|breast biopsy imaging
5086654|NCT03456583|Stereotactic Imaging|stereotactic imaging
5086655|NCT03456414|exercise|exercise
5086656|NCT03456414|physical function|physical function
5086657|NCT03456414|health related quality of life|health related quality of life
5086658|NCT03456375|progesterone|progesterone
5086886|NCT03454789|duration action local anesthetic|duration action local anesthetic
5086887|NCT03454789|postoperative analgesia|postoperative analgesia
5086888|NCT03454763|sst2-positive tumors|sst2-positive tumors
5086889|NCT03454763|Neuroendocrine Tumors|neuroendocrine tumors
5086890|NCT03454763|radiolabelled somatostatin analogues (PRRT)|radiolabelled somatostatin analogues (prrt)
5086995|NCT03454269|Illusions|illusions
5086996|NCT03454269|Retina|retina
5086997|NCT03454256|Virtual Reality|virtual reality
5086998|NCT03454256|Total Knee Replacement|total knee replacement
5086999|NCT03454256|Proprioception|proprioception
5087000|NCT03454256|Balance|balance
5087089|NCT03453918|Dysmetabolic iron overload syndrome|dysmetabolic iron overload syndrome
5087090|NCT03453918|Metabolic syndrome X|metabolic syndrome x
5087091|NCT03453918|Genetic Hemochromatosis|genetic hemochromatosis
5087092|NCT03453918|Oxylipin|oxylipin
5087093|NCT03453918|Lipidomic analysis|lipidomic analysis
5087094|NCT03453905|CT-based Finite Element Analysis|ct-based finite element analysis
5087095|NCT03453905|Randomized Controlled Study|randomized controlled study
5087096|NCT03453905|Preventive bone fixation|preventive bone fixation
5087097|NCT03453905|Randomized Controlled Trial|randomized controlled trial
5087098|NCT03453892|Metastatic cancer|metastatic cancer
5087099|NCT03453892|Radiotherapy|radiotherapy
5087100|NCT03453892|Immunotherapy|immunotherapy
5087101|NCT03453892|radioimmuno therapy|radioimmuno therapy
5087179|NCT03453554|everyday functioning|everyday functioning
5087290|NCT03452865|septic shock|septic shock
5087519|NCT03451526|NSCLC|nsclc
5087520|NCT03451526|surgeries|surgeries
5087521|NCT03451513|Prevention|prevention
5087640|NCT03450486|star excursion balance test|star excursion balance test
5087641|NCT03450486|exercise|exercise
5087642|NCT03450473|Mesh|mesh
5087643|NCT03450460|peer support|peer support
5087644|NCT03450460|feasibility trial|feasibility trial
5087645|NCT03450460|mixed methods|mixed methods
5087646|NCT03450447|Head and Neck Cancer|head and neck cancer
5087647|NCT03450447|Esophageal Cancer|esophageal cancer
5087648|NCT03450447|endoscopic submucosal dissection|endoscopic submucosal dissection
5087649|NCT03450447|quality of life|quality of life
5087650|NCT03450447|median survival time|median survival time
5087651|NCT03450382|community health|community health
5087748|NCT03449524|Pulmonary Vascular Resistance|pulmonary vascular resistance
5087749|NCT03449524|Cardiac MRI|cardiac mri
5087750|NCT03449524|Right Ventricular Function|right ventricular function
5087791|NCT03449303|QOL|qol
5087878|NCT03448666|ECT|ect
5087993|NCT03447886|Breast Cancer|breast cancer
5087994|NCT03447873|Antiretroviral treatment|antiretroviral treatment
5087995|NCT03447873|Treatment simplification|treatment simplification
5087996|NCT03447873|Dual therapy|dual therapy
5087997|NCT03447873|Immune recovery|immune recovery
5088003|NCT03447782|New Daily Persistent Headache|new daily persistent headache
5088004|NCT03447782|Chronic Headache|chronic headache
5088118|NCT03447132|Breast Cancer|breast cancer
5088120|NCT03447132|Neoadjuvant|neoadjuvant
5088121|NCT03447132|pCR|pcr
5088234|NCT03446495|ovarian cancer, trabectedin, recurrent ovarian cancer|ovarian cancer, trabectedin, recurrent ovarian cancer
5088235|NCT03446469|Chronic ankle instability|chronic ankle instability
5088236|NCT03446469|Functional instability|functional instability
5088237|NCT03446469|Ankle sprain|ankle sprain
5088238|NCT03446469|postural sway|postural sway
5088239|NCT03446469|Fascial Manipulation|fascial manipulation
5088240|NCT03446456|Magnetic Resonance Imaging|magnetic resonance imaging
5088241|NCT03446456|Healthy Volunteers|healthy volunteers
5088242|NCT03446430|arterial stiffness|arterial stiffness
5088243|NCT03446430|pulse wave velocity|pulse wave velocity
5088244|NCT03446430|laser Doppler vibrometry|laser doppler vibrometry
5088245|NCT03446365|Asthma|asthma
5088246|NCT03446365|Latino children|latino children
5088247|NCT03446365|middle school|middle school
5088315|NCT03445962|Physical Activity|physical activity
5088316|NCT03445962|exercise|exercise
5088317|NCT03445962|biological parameters|biological parameters
5088445|NCT03445104|Huperzine A|huperzine a
5088551|NCT03444454|Quality of life|quality of life
5147771|NCT03069066|Stent|stent
5088552|NCT03444441|Foot|foot
5088553|NCT03444441|Ankle|ankle
5088554|NCT03444441|Finnish|finnish
5088555|NCT03444441|Validation|validation
5088983|NCT03442075|Cancer of Prostate|cancer of prostate
5088984|NCT03442075|Analgesic method|analgesic method
5088985|NCT03442062|quality improvement|quality improvement
5088986|NCT03442062|HPV vaccine|hpv vaccine
5089098|NCT03441204|Mortality|mortality
5089215|NCT03440502|spinal anaesthesia|spinal anaesthesia
5089216|NCT03440502|cesarean section|cesarean section
5089217|NCT03440502|diabetes mellitus|diabetes mellitus
5089218|NCT03440450|Liposomal gemcitabine|liposomal gemcitabine
5089220|NCT03440437|Immuno-oncology|immuno-oncology
5089221|NCT03440437|bispecific antibody|bispecific antibody
5089222|NCT03440437|check-point inhibitor|check-point inhibitor
5089223|NCT03440437|dose escalation|dose escalation
5089224|NCT03440437|cohort expansion|cohort expansion
5089342|NCT03440021|Behavioral Symptoms|behavioral symptoms
5089457|NCT03439150|Left ventricular function|left ventricular function
5089458|NCT03439111|Lycium chinense fruit|lycium chinense fruit
5089462|NCT03439059|Sedentary behaviour|sedentary behaviour
5089463|NCT03439059|Assisted living facility|assisted living facility
5089464|NCT03439059|cognitive function|cognitive function
5089465|NCT03439046|HR-positive HER2-negative|hr-positive her2-negative
5089466|NCT03439046|advanced breast cancer|advanced breast cancer
5089467|NCT03439046|LEE011|lee011
5089468|NCT03439046|ribociclib|ribociclib
5089469|NCT03439046|letrozole|letrozole
5089471|NCT03439046|CDK4|cdk4
5089551|NCT03438617|China|china
5089552|NCT03438617|Urban|urban
5089553|NCT03438591|cerclage pacing|cerclage pacing
5089554|NCT03438591|cerclage-CRT|cerclage-crt
5089556|NCT03438578|Patient safety|patient safety
5089557|NCT03438578|Postoperative care|postoperative care
5089558|NCT03438578|Monitoring, physiologic|monitoring, physiologic
5089559|NCT03438578|Safety management|safety management
5089560|NCT03438565|Asahi Chikai Black 18 Neurovascular Guidewire|asahi chikai black 18 neurovascular guidewire
5089561|NCT03438565|Prospective|prospective
5089562|NCT03438565|Retrospective|retrospective
5089563|NCT03438513|Caregivers|caregivers
5089564|NCT03438513|Burden|burden
5089565|NCT03438513|Coping|coping
5089566|NCT03438513|Quality of life|quality of life
5089640|NCT03437993|game|game
5089756|NCT03437408|Pacing|pacing
5089757|NCT03437395|Lumpectomy|lumpectomy
5089758|NCT03437395|Unifocal Disease|unifocal disease
5089759|NCT03437395|Stage 0 or 1 Disease|stage 0 or 1 disease
5089855|NCT03436771|JCAR017|jcar017
5089760|NCT03437382|Hepatocellular carcinoma|hepatocellular carcinoma
5089761|NCT03437382|Radiofrequency ablation (RFA)|radiofrequency ablation (rfa)
5089762|NCT03437382|Radioembolization|radioembolization
5089763|NCT03437382|Quirem Spheres|quirem spheres
5089887|NCT03436576|Concentration|concentration
5089764|NCT03437382|Selective internal radiation therapy|selective internal radiation therapy
5089767|NCT03437356|pulmonary vein isolation|pulmonary vein isolation
5090102|NCT03435354|Activity motivation|activity motivation
5090103|NCT03435354|Children|children
5090104|NCT03435354|Adolescents|adolescents
5090105|NCT03435354|Cluster-randomized trial|cluster-randomized trial
5090106|NCT03435341|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5090107|NCT03435341|Observational|observational
5090108|NCT03435341|Standard Clinical Practice|standard clinical practice
5090109|NCT03435341|Survival|survival
5090110|NCT03435341|Tolerability|tolerability
5090111|NCT03435341|Spain|spain
5090204|NCT03434665|Bariatric embolization|bariatric embolization
5090205|NCT03434665|Gastric artery|gastric artery
5090206|NCT03434665|Obesity|obesity
5090207|NCT03434665|Transradial|transradial
5090208|NCT03434639|Gut permeability|gut permeability
5090209|NCT03434639|Fluorescence|fluorescence
5090371|NCT03434093|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5090372|NCT03434093|Electrical Field Modeling|electrical field modeling
5090373|NCT03434093|Working Memory|working memory
5090379|NCT03434067|hyperthyroidism|hyperthyroidism
5090380|NCT03434067|thyroidectomy|thyroidectomy
5090382|NCT03434067|immunochromatographic assay|immunochromatographic assay
5090383|NCT03434054|losartan|losartan
5090384|NCT03434054|emotional processing|emotional processing
5090385|NCT03434054|anxiety|anxiety
5090386|NCT03434054|magnet resonance imaging|magnet resonance imaging
5090387|NCT03434054|MRI|mri
5090460|NCT03433560|febrile neutropenia|febrile neutropenia
5090569|NCT03432793|Itraconazole|itraconazole
5090570|NCT03432793|Fluvoxamine|fluvoxamine
5090571|NCT03432793|TD-9855|td-9855
5090572|NCT03432793|Smoking|smoking
5090573|NCT03432793|Caffeine|caffeine
5090574|NCT03432793|CYP1A2|cyp1a2
5090575|NCT03432793|CYP3A4|cyp3a4
5090681|NCT03431987|Alcohol|alcohol
5090683|NCT03431987|fMRI|fmri
5090684|NCT03431987|MRI|mri
5090794|NCT03430947|MEK inhibitor|mek inhibitor
5090795|NCT03430947|Vemurafenib|vemurafenib
5090800|NCT03430908|17-653|17-653
5090905|NCT03430206|laryngoscopy|laryngoscopy
5090906|NCT03430206|otolaryngology|otolaryngology
5090908|NCT03430206|desaturation|desaturation
5090909|NCT03430206|anesthesia|anesthesia
5091015|NCT03429582|Cryotherapy|cryotherapy
5091016|NCT03429582|Cervica Pre-cancer|cervica pre-cancer
5091017|NCT03429582|Low and Middle Income Countries (LMICs)|low and middle income countries (lmics)
5091018|NCT03429569|Keratoconus|keratoconus
5091019|NCT03429569|Cross-linking|cross-linking
5091259|NCT03428178|onset between 6 to 12 months|onset between 6 to 12 months
5091260|NCT03428178|onset between 12 to 24 months|onset between 12 to 24 months
5091261|NCT03428178|onset between 24 to 60 months|onset between 24 to 60 months
5091262|NCT03428178|onset over 60 months|onset over 60 months
5091263|NCT03428152|superior hypogastric plexus block|superior hypogastric plexus block
5091265|NCT03428152|postoperative pain|postoperative pain
5091266|NCT03428139|lumbosacral radicular pain|lumbosacral radicular pain
5091267|NCT03428139|pulsed radiofrequency|pulsed radiofrequency
5091271|NCT03428126|Colon Cancer|colon cancer
5091346|NCT03427684|Hypo-fractionated radiotherapy|hypo-fractionated radiotherapy
5091448|NCT03427034|Urine|urine
5091449|NCT03427034|Haematuria|haematuria
5091450|NCT03427034|Flexible cystoscopy|flexible cystoscopy
5091451|NCT03427034|Recurrence|recurrence
5091452|NCT03427034|Cytology|cytology
5091566|NCT03426384|Digital Therapeutics|digital therapeutics
5091567|NCT03426384|Health Coaching|health coaching
5091691|NCT03425682|Transforaminal Lumbar Interbody Fusion (TLIF)|transforaminal lumbar interbody fusion (tlif)
5091692|NCT03425682|Posterior Lumbar Interbody Fusion (PLIF)|posterior lumbar interbody fusion (plif)
5091693|NCT03425669|Acoustic and vestibular noise stimulation|acoustic and vestibular noise stimulation
5091694|NCT03425656|breast cancer|breast cancer
5091695|NCT03425656|AryoTrust™|aryotrust™
5091696|NCT03425656|Herceptin®|herceptin®
5091697|NCT03425656|non-Inferiority|non-inferiority
5091698|NCT03425578|Monosodium glutamate|monosodium glutamate
5091699|NCT03425578|Amino acids|amino acids
5091700|NCT03425578|Glucose tolerance|glucose tolerance
5091701|NCT03425513|Belgium|belgium
5091702|NCT03425513|Prevalence|prevalence
5091780|NCT03425019|Osteoarthritis|osteoarthritis
5091781|NCT03425019|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5091782|NCT03425019|tDCS|tdcs
5091783|NCT03424993|Endothelium, vascular|endothelium, vascular
5091784|NCT03424993|Cardiovascular Disease|cardiovascular disease
5091785|NCT03424993|Hemodynamics|hemodynamics
5091786|NCT03424993|Oxidative Stress|oxidative stress
5091906|NCT03424395|dietary and wellness coaching/advice|dietary and wellness coaching/advice
5091907|NCT03424395|liquid meal challenge test|liquid meal challenge test
5091958|NCT03423979|BPH|bph
5092017|NCT03423602|Percutaneous vascular closure device|percutaneous vascular closure device
5092018|NCT03423602|Large hole closure device|large hole closure device
5092128|NCT03422991|Vascular Diseases|vascular diseases
5092379|NCT03421457|Transperineal ultrasound|transperineal ultrasound
5092380|NCT03421457|Lateral Mesh Suspension|lateral mesh suspension
5092381|NCT03421457|Descensus uteri|descensus uteri
5092382|NCT03421457|Laparoscopic pelvic organ prolapse repair|laparoscopic pelvic organ prolapse repair
5092383|NCT03421457|Uterus preserving|uterus preserving
5092384|NCT03421457|hysteropexy|hysteropexy
5092385|NCT03421457|uterine-preserving|uterine-preserving
5092483|NCT03420820|betadine|betadine
5092485|NCT03420781|vomiting|vomiting
5092591|NCT03420131|Quantitative Flow Ratio|quantitative flow ratio
5092592|NCT03420131|Fractional Flow Reserve|fractional flow reserve
5092593|NCT03420092|vasoactive leukotrienes by leukocytes|vasoactive leukotrienes by leukocytes
5092594|NCT03420092|bioavailability|bioavailability
5092595|NCT03420053|PfSPZ Vaccine|pfspz vaccine
5092604|NCT03419988|Nrf2|nrf2
5092688|NCT03419455|Diet|diet
5092790|NCT03418831|cognitive function|cognitive function
5092791|NCT03418818|hypoxia|hypoxia
5092792|NCT03418818|sarcoma|sarcoma
5092793|NCT03418818|FAZA|faza
5092794|NCT03418818|PET Imaging|pet imaging
5092795|NCT03418805|Ibuprofen|ibuprofen
5092889|NCT03418220|Cytokines|cytokines
5092890|NCT03418220|test LUMINEX®|test luminex®
5092891|NCT03418207|TPS system|tps system
5092892|NCT03418207|trans-perineal template-guided mapping biopsy|trans-perineal template-guided mapping biopsy
5092893|NCT03418207|prostate cancer|prostate cancer
5092894|NCT03418207|spatial distribution|spatial distribution
5092895|NCT03418207|large tissue slice|large tissue slice
5092896|NCT03418194|Anesthesia, General|anesthesia, general
5092897|NCT03418181|Residual Kidney Function|residual kidney function
5092898|NCT03418181|Haemodialysis|haemodialysis
5092993|NCT03417427|complete remission|complete remission
5092999|NCT03417362|audiovisual|audiovisual
5093000|NCT03417362|information|information
5093001|NCT03417362|acceptability|acceptability
5093002|NCT03417349|Acute Ischemic Stroke|acute ischemic stroke
5093003|NCT03417349|Thrombectomy|thrombectomy
5093004|NCT03417349|Aspiration Thrombectomy|aspiration thrombectomy
5093008|NCT03417258|phytoestrogens|phytoestrogens
5093375|NCT03415126|KRAS mutant|kras mutant
5093586|NCT03413696|Hepatitis C knowledge|hepatitis c knowledge
5093587|NCT03413696|HIV knowledge|hiv knowledge
5093588|NCT03413696|Hepatitis C treatment|hepatitis c treatment
5093589|NCT03413644|Hematological diseases|hematological diseases
5093590|NCT03413631|prenatal substance abuse|prenatal substance abuse
5093591|NCT03413631|mentalization|mentalization
5093592|NCT03413631|prenatal depression|prenatal depression
5093593|NCT03413631|prenatal anxiety|prenatal anxiety
5093594|NCT03413631|maternal-fetal attachment|maternal-fetal attachment
5093679|NCT03413254|Diagnostic laparoscopy|diagnostic laparoscopy
5093680|NCT03413254|Second look surgery|second look surgery
5093681|NCT03413254|Third look surgery|third look surgery
5093682|NCT03413241|autism spectrum disorder|autism spectrum disorder
5093683|NCT03413202|butylphthalide(NBP)|butylphthalide(nbp)
5093851|NCT03412110|SMT|smt
5093887|NCT03411798|ankylosing spondylitis(AS)|ankylosing spondylitis(as)
5093888|NCT03411798|TNFi|tnfi
5093889|NCT03411798|Yisaipu®|yisaipu®
5093890|NCT03411798|Disease modifying anti-rheumatic drugs (DMARDs)|disease modifying anti-rheumatic drugs (dmards)
5093976|NCT03411278|deep oscillation|deep oscillation
5094086|NCT03410836|inflammation|inflammation
5094087|NCT03410836|cytokine|cytokine
5094088|NCT03410836|post-operative immunosuppression|post-operative immunosuppression
5094129|NCT03410641|smoking cessation|smoking cessation
5094253|NCT03409601|Obesity, eating behavior, food, nutrition|obesity, eating behavior, food, nutrition
5094379|NCT03408873|Medication Non-Adherence|medication non-adherence
5094520|NCT03408041|Alzheimer Disease|alzheimer disease
5094521|NCT03408041|Objective parameters|objective parameters
5094522|NCT03408041|Scheltens index|scheltens index
5094523|NCT03408028|Therapeutic code|therapeutic code
5094524|NCT03408028|Geriatry|geriatry
5094628|NCT03407391|Nutrition|nutrition
5094765|NCT03406650|immunotherapy|immunotherapy
5094766|NCT03406650|durvalumab|durvalumab
5094767|NCT03406650|MEDI4736|medi4736
5094977|NCT03405246|Diet intervention|diet intervention
5094978|NCT03405233|ESRD|esrd
5094979|NCT03405233|ePTFE|eptfe
5094980|NCT03405233|neointemal hyperplasia|neointemal hyperplasia
5094981|NCT03405220|smoking|smoking
5095067|NCT03404648|high risk|high risk
5095173|NCT03403972|pharmacokinetics|pharmacokinetics
5095174|NCT03403972|simvastatin|simvastatin
5095175|NCT03403972|vancomycin|vancomycin
5095177|NCT03403959|pupillometry|pupillometry
5095178|NCT03403959|light therapy|light therapy
5095179|NCT03403959|visual impairment|visual impairment
5095180|NCT03403959|melatonin|melatonin
5095181|NCT03403959|ipRGC|iprgc
5095182|NCT03403946|difficult airway|difficult airway
5095271|NCT03403231|Motivation|motivation
5095272|NCT03403218|balance, risk of falling|balance, risk of falling
5095273|NCT03403192|EZ Blocker|ez blocker
5095274|NCT03403192|DLT|dlt
5095341|NCT03402815|HIV|hiv
5095374|NCT03402568|acylcarnitines|acylcarnitines
5095375|NCT03402529|Contrast Enhanced Spectral Mammography|contrast enhanced spectral mammography
5095376|NCT03402516|hysteroscopic myomectomy|hysteroscopic myomectomy
5095377|NCT03402516|26Fr resector|26fr resector
5095625|NCT03400748|Endobronchial ultrasound|endobronchial ultrasound
5095626|NCT03400748|EBUS|ebus
5095627|NCT03400722|Suboptimal ovarian response|suboptimal ovarian response
5095628|NCT03400722|Ovarian Stimulation|ovarian stimulation
5095730|NCT03399838|midazolam|midazolam
5095731|NCT03399838|anxiety relief|anxiety relief
5095732|NCT03399786|HoFH|hofh
5095831|NCT03399136|Aerobic capacity|aerobic capacity
5095832|NCT03399123|Laparoscopic hepatectomy|laparoscopic hepatectomy
5095833|NCT03399123|Low tidal volume|low tidal volume
5095834|NCT03399123|Blood loss|blood loss
5095835|NCT03399110|Gastric cancer,Adjuvant chemtherapy|gastric cancer,adjuvant chemtherapy
5096046|NCT03397732|Tissue inhibitor of matrix metalloproteinase|tissue inhibitor of matrix metalloproteinase
5096047|NCT03397732|Vascular surgery|vascular surgery
5096048|NCT03397732|Aorta stent implantation|aorta stent implantation
5096049|NCT03397732|Aorto-bifemoral bypass surgery|aorto-bifemoral bypass surgery
5096050|NCT03397719|Autism Spectrum Disorder|autism spectrum disorder
5096051|NCT03397719|Early Intervention|early intervention
5096052|NCT03397719|Parent-Mediated Intervention|parent-mediated intervention
5096098|NCT03397394|HRD|hrd
5096142|NCT03397082|Paracervical blockade|paracervical blockade
5096143|NCT03397082|Lidocaine gel|lidocaine gel
5096144|NCT03397069|peribubar block - midazolam|peribubar block - midazolam
5096145|NCT03397056|Patient willingness|patient willingness
5096146|NCT03397056|Participation|participation
5096147|NCT03397030|Prostate Cancer|prostate cancer
5096149|NCT03397030|Exercise|exercise
5096150|NCT03397004|Hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5096152|NCT03397004|Doxycycline|doxycycline
5096153|NCT03396991|Analgesia technique|analgesia technique
5096154|NCT03396991|Pain control|pain control
5096155|NCT03396939|Stroke|stroke
5096156|NCT03396939|Rehabilitation|rehabilitation
5096157|NCT03396939|Task oriented training|task oriented training
5096158|NCT03396939|Motor recovery|motor recovery
5096159|NCT03396939|Hand function|hand function
5096160|NCT03396939|Arm function|arm function
5096161|NCT03396913|Intense Pulsed Light|intense pulsed light
5096162|NCT03396913|Meibomian Gland Dysfunction|meibomian gland dysfunction
5096163|NCT03396913|Dry Eye Disease|dry eye disease
5096164|NCT03396887|Alcohol Use Disorder|alcohol use disorder
5096165|NCT03396887|Smartphone Application|smartphone application
5096166|NCT03396861|macular edema|macular edema
5096167|NCT03396861|pseudophakia|pseudophakia
5096168|NCT03396861|pseudophakic macular edema|pseudophakic macular edema
5096169|NCT03396861|retinal swelling|retinal swelling
5096170|NCT03396861|aflibercept|aflibercept
5096272|NCT03396549|food intake|food intake
5096274|NCT03396536|oral hygiene|oral hygiene
5096275|NCT03396536|discomfort|discomfort
5096276|NCT03396523|Losartan|losartan
5096277|NCT03396523|Fear extinction|fear extinction
5096278|NCT03396510|Cancer Care|cancer care
5096279|NCT03396484|TrialNet|trialnet
5096280|NCT03396458|Hepatitis B|hepatitis b
5096282|NCT03396458|Screening|screening
5096372|NCT03395951|Mean Systemic Filling Pressure|mean systemic filling pressure
5094288|NCT03409406|developmental disability|developmental disability
5096373|NCT03395951|Diuretics|diuretics
5096374|NCT03395951|Pressure for venous return|pressure for venous return
5096503|NCT03395080|epithelial histology|epithelial histology
5096504|NCT03395080|Wnt pathway|wnt pathway
5096505|NCT03395080|DKK1|dkk1
5096506|NCT03395080|endometrial|endometrial
5096507|NCT03395080|uterine|uterine
5096508|NCT03395080|ovarian|ovarian
5096509|NCT03395080|carcinosarcoma|carcinosarcoma
5096510|NCT03395067|Obesity|obesity
5096511|NCT03395067|Infertility|infertility
5096512|NCT03395067|In vitro fertilization|in vitro fertilization
5096513|NCT03395054|neck pain|neck pain
5096514|NCT03395054|pulmonary function test|pulmonary function test
5096515|NCT03395054|respiratory muscle strength|respiratory muscle strength
5096522|NCT03395015|Therapy, soft tissue|therapy, soft tissue
5096599|NCT03394612|Epidermis|epidermis
5096600|NCT03394599|Physical Activity|physical activity
5096601|NCT03394599|Rehabilitation|rehabilitation
5096602|NCT03394599|Exercise|exercise
5096603|NCT03394599|Engagement|engagement
5096604|NCT03394599|Older Adults|older adults
5096605|NCT03394586|Golimumab|golimumab
5096606|NCT03394586|TNF-inhibitors|tnf-inhibitors
5096614|NCT03394560|gait|gait
5096688|NCT03394183|acute exercise response|acute exercise response
5096689|NCT03394183|quality of life|quality of life
5096692|NCT03394118|Liquid biopsy|liquid biopsy
5096693|NCT03394105|Pleurodesis|pleurodesis
5096694|NCT03394092|immunoglobulin G|immunoglobulin g
5096696|NCT03394079|IVUS|ivus
5096794|NCT03393520|Deudextromethorphan hydrobromide|deudextromethorphan hydrobromide
5096796|NCT03393507|ovarian cancer|ovarian cancer
5096797|NCT03393481|biologic,|biologic,
5096798|NCT03393481|venous thromboembolism,|venous thromboembolism,
5096799|NCT03393481|unilateral knee arthroplasty|unilateral knee arthroplasty
5096800|NCT03393455|Fetal pathology|fetal pathology
5096801|NCT03393455|Obstetrical outcome|obstetrical outcome
5096802|NCT03393455|Pediatric outcome|pediatric outcome
5096804|NCT03393442|Gd-based contrast media|gd-based contrast media
5096885|NCT03393013|active proliferative lupus nephritis|active proliferative lupus nephritis
5096892|NCT03392974|Hemophilia A|hemophilia a
5096906|NCT03392961|Dosing time|dosing time
5096988|NCT03392376|Haloperidol|haloperidol
5096989|NCT03392324|atrophic macular degeneration|atrophic macular degeneration
5097223|NCT03390907|Colon polyp|colon polyp
5097224|NCT03390907|EMR|emr
5097225|NCT03390907|Hybrid-APC|hybrid-apc
5097319|NCT03390257|Endoscopy, BSD|endoscopy, bsd
5097411|NCT03389555|Metabolic Resuscitation|metabolic resuscitation
5097412|NCT03389503|Access site|access site
5097413|NCT03389503|Transradial access|transradial access
5097414|NCT03389503|Coronary artery disease|coronary artery disease
5097504|NCT03388853|Acetylcysteine/Doxofylline|acetylcysteine/doxofylline
5097505|NCT03388853|Acetylcysteine|acetylcysteine
5097620|NCT03388268|Diarrhea|diarrhea
5097621|NCT03388255|Polydeoxyribonucletide|polydeoxyribonucletide
5097622|NCT03388255|Placentex|placentex
5097624|NCT03388229|Dietary pattern|dietary pattern
5097625|NCT03388229|glycemic control|glycemic control
5097626|NCT03388229|type 2 diabetes|type 2 diabetes
5097727|NCT03387475|efficacy|efficacy
5097728|NCT03387475|safety|safety
5097735|NCT03387436|Palliative care|palliative care
5097736|NCT03387436|Advance care planning|advance care planning
5097737|NCT03387436|psychological intervention|psychological intervention
5097738|NCT03387410|Laparoscopic surgery|laparoscopic surgery
5097739|NCT03387410|Fluorescence|fluorescence
5097740|NCT03387397|Co-morbidities|co-morbidities
5097741|NCT03387371|chronic periodontitis, laser|chronic periodontitis, laser
5097742|NCT03387358|intensive care unit|intensive care unit
5097743|NCT03387358|nasal bridle securement device|nasal bridle securement device
5097817|NCT03386955|non-small cell lung cancer|non-small cell lung cancer
5097818|NCT03386955|NSCLC|nsclc
5097819|NCT03386942|Solid Tumors|solid tumors
5097820|NCT03386942|Folate Receptor α (FRA)-Positive platinum-resistant ovarian carcinoma|folate receptor α (fra)-positive platinum-resistant ovarian carcinoma
5097936|NCT03386110|HIV|hiv
5097940|NCT03386084|capacitive resistive diathermy|capacitive resistive diathermy
5097941|NCT03386084|motor control|motor control
5098057|NCT03385369|Safety|safety
5098102|NCT03385161|BPH|bph
5098186|NCT03384719|Milk protein|milk protein
5098187|NCT03384719|Plant protein|plant protein
5098188|NCT03384719|Insulin-like growth factor-1 (IGF-1)|insulin-like growth factor-1 (igf-1)
5098189|NCT03384719|Insulin|insulin
5098190|NCT03384719|Insulin-like growth factor-binding protein-3 (IGFBP-3)|insulin-like growth factor-binding protein-3 (igfbp-3)
5098191|NCT03384706|posttraumatic stress disorder (PTSD)|posttraumatic stress disorder (ptsd)
5098192|NCT03384706|Clinical Trial|clinical trial
5098193|NCT03384706|Psychotherapy|psychotherapy
5098194|NCT03384706|Assessment|assessment
5098195|NCT03384706|Effectiveness|effectiveness
5158938|NCT02998853|FFR|ffr
5098278|NCT03384160|Articaine|articaine
5098279|NCT03384160|Mepivacaine|mepivacaine
5098280|NCT03384134|cancer|cancer
5098281|NCT03384134|cognitive and behavioral skills training intervention|cognitive and behavioral skills training intervention
5098282|NCT03384134|pain|pain
5098283|NCT03384134|symptoms|symptoms
5098284|NCT03384134|quality of life|quality of life
5098285|NCT03384121|CYP24A1|cyp24a1
5098286|NCT03384121|Nephrocalcinosis|nephrocalcinosis
5098287|NCT03384121|Hypercalcemia|hypercalcemia
5098288|NCT03384121|Hypercalcuria|hypercalcuria
5098289|NCT03384095|Aromatase Inhibitors|aromatase inhibitors
5098373|NCT03383367|high risk patients|high risk patients
5098374|NCT03383341|gut microbiota|gut microbiota
5098375|NCT03383341|cricket powder|cricket powder
5098376|NCT03383341|prebiotic fiber|prebiotic fiber
5098667|NCT03381664|tolerability|tolerability
5098668|NCT03381664|AVP-923|avp-923
5098669|NCT03381664|dextromethorphan|dextromethorphan
5098670|NCT03381664|quinidine|quinidine
5098766|NCT03380962|Donor Specific Antibody|donor specific antibody
5098767|NCT03380949|Analgesia|analgesia
5098768|NCT03380949|Monitoring|monitoring
5098769|NCT03380949|Opioid|opioid
5098862|NCT03380286|Drug Eluting Stent|drug eluting stent
5098988|NCT03379480|Yoga|yoga
5098989|NCT03379480|fMRI|fmri
5098990|NCT03379467|SMS Reminder|sms reminder
5098991|NCT03379467|Two-way Reminder|two-way reminder
5098992|NCT03379428|Breast Cancer|breast cancer
5098996|NCT03379415|Meniscectomy|meniscectomy
5099079|NCT03378882|Angiostrongylus cantonensis|angiostrongylus cantonensis
5099080|NCT03378882|Angiostrongylus costaricensis|angiostrongylus costaricensis
5099081|NCT03378843|Polyamine, cardiovascular disease, cancer|polyamine, cardiovascular disease, cancer
5099211|NCT03377933|Helicobacter pylori|helicobacter pylori
5099212|NCT03377933|Probiotics|probiotics
5099213|NCT03377933|Efficacy|efficacy
5099214|NCT03377933|Safety|safety
5099215|NCT03377933|gastromicroecology|gastromicroecology
5099336|NCT03377231|Pregnancy, Striae gravidarum, Striae distensae, Women's health|pregnancy, striae gravidarum, striae distensae, women's health
5099345|NCT03377179|Single arm|single arm
5099430|NCT03376750|RCT|rct
5099655|NCT03375437|ALK|alk
5099746|NCT03374683|Outdoor play|outdoor play
5099747|NCT03374670|Zimura|zimura
5099748|NCT03374670|ARC1905|arc1905
5099749|NCT03374670|Eylea|eylea
5099751|NCT03374670|IPCV|ipcv
5099992|NCT03373071|CD19-LNH|cd19-lnh
5099993|NCT03373058|Hyperthermic Intraperitoneal Chemotherapy|hyperthermic intraperitoneal chemotherapy
5099994|NCT03373058|Advanced-Stage Epithelial Ovarian Cancer|advanced-stage epithelial ovarian cancer
5099995|NCT03373058|Cytoreductive surgery|cytoreductive surgery
5099996|NCT03373058|Postoperative Chemotherapy|postoperative chemotherapy
5100001|NCT03373032|Physical Activity|physical activity
5100002|NCT03373032|Sensory Neuropathy|sensory neuropathy
5100003|NCT03373032|Acupuncture|acupuncture
5100004|NCT03373019|chidamide|chidamide
5100005|NCT03373019|R-GDP|r-gdp
5745544|NCT00338026|Breast|breast
5100075|NCT03372369|online survey|online survey
5100076|NCT03372356|DT|dt
5100077|NCT03372356|HADS|hads
5100078|NCT03372356|SPBS|spbs
5100079|NCT03372356|CD-RISC|cd-risc
5100080|NCT03372356|Psychosocial Screening|psychosocial screening
5100081|NCT03372330|peripheral artery disease|peripheral artery disease
5100082|NCT03372330|sepsis|sepsis
5100083|NCT03372317|Tau|tau
5100084|NCT03372317|MK-6240|mk-6240
5100199|NCT03371641|Biomarker|biomarker
5100200|NCT03371641|PlGF|plgf
5100201|NCT03371641|Cognitive development|cognitive development
5100202|NCT03371641|Behavior troubles|behavior troubles
5100213|NCT03371433|Osteoporosis|osteoporosis
5100214|NCT03371433|Hip Fractures|hip fractures
5100215|NCT03371433|Soft Drinks|soft drinks
5100217|NCT03371368|Insulin Resistance|insulin resistance
5100218|NCT03371368|Bariatric Surgery|bariatric surgery
5100306|NCT03370991|Oxidative Stress|oxidative stress
5100307|NCT03370991|Inflammmation|inflammmation
5100417|NCT03370432|prospective case-cohort study|prospective case-cohort study
5100418|NCT03370432|single nucleotide polymorphisms|single nucleotide polymorphisms
5100524|NCT03369821|neonatal diabetes|neonatal diabetes
5100619|NCT03369236|complement mediated disease|complement mediated disease
5100724|NCT03368586|Children|children
5100727|NCT03368573|Cognitive Assessment|cognitive assessment
5100728|NCT03368573|QbTest|qbtest
5100823|NCT03368053|gp120-NefTat/AS01B vaccine candidate|gp120-neftat/as01b vaccine candidate
5100824|NCT03368053|V1V2|v1v2
5100827|NCT03368014|Sharing|sharing
5100927|NCT03367429|stroke|stroke
5101161|NCT03365895|Magnetic Resonance Imaging|magnetic resonance imaging
5101162|NCT03365895|Diffusion Tensor Imaging|diffusion tensor imaging
5101163|NCT03365843|Cardiac surgery|cardiac surgery
5101164|NCT03365843|Sternal closure|sternal closure
5101388|NCT03364582|Dietary patterns|dietary patterns
5101389|NCT03364582|Metabolomics|metabolomics
5101390|NCT03364582|Mortaltiy|mortaltiy
5101391|NCT03364582|Colorectal cancer|colorectal cancer
5101392|NCT03364569|Drainage|drainage
5101393|NCT03364569|Breast augmentation|breast augmentation
5101394|NCT03364569|Tranexamic acid|tranexamic acid
5101395|NCT03364517|Medical regulation|medical regulation
5101490|NCT03363958|cardiac surgery|cardiac surgery
5101594|NCT03363399|Myeloperoxidase|myeloperoxidase
5101700|NCT03362489|Intra-Uterine Insemination|intra-uterine insemination
5101701|NCT03362489|Poor responders|poor responders
5101703|NCT03362476|Hepatitis C|hepatitis c
5101905|NCT03361163|Streptococcus pyogenes pharyngitis|streptococcus pyogenes pharyngitis
5101906|NCT03361163|Streptococcus Pharyngitis|streptococcus pharyngitis
5101907|NCT03361163|Strep Throat|strep throat
5101908|NCT03361163|Streptococcus pyogenes Infection|streptococcus pyogenes infection
5101909|NCT03361163|Group A Streptococcus: B Hemolytic Pharyngitis|group a streptococcus: b hemolytic pharyngitis
5101910|NCT03361163|Group A Streptococcal Infection|group a streptococcal infection
5101994|NCT03360695|Major Depression|major depression
5101995|NCT03360669|hypertension, blood pressure, systolic, diastolic, AOBP, Omron HEM-907, research, clinical|hypertension, blood pressure, systolic, diastolic, aobp, omron hem-907, research, clinical
5101996|NCT03360656|shivering, fever, normothermia|shivering, fever, normothermia
5101997|NCT03360643|Point-of-care ultrasound|point-of-care ultrasound
5101998|NCT03360643|Intussusception|intussusception
5101999|NCT03360643|Pediatric Emergency Medicine|pediatric emergency medicine
5102000|NCT03360643|Ultrasound|ultrasound
5102002|NCT03360617|Intravenous|intravenous
5102003|NCT03360617|IV Push|iv push
5102094|NCT03360032|Cardiopulmonary exercise test|cardiopulmonary exercise test
5102095|NCT03360032|VO2 peak|vo2 peak
5102098|NCT03360006|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5102222|NCT03359239|personalized neoantigen vaccine|personalized neoantigen vaccine
5102224|NCT03359187|Head and Neck Cancer|head and neck cancer
5102327|NCT03358654|stem cells|stem cells
5102328|NCT03358641|exercise|exercise
5102329|NCT03358641|physical activity|physical activity
5102330|NCT03358641|radiographic osteoarthritis|radiographic osteoarthritis
5102331|NCT03358628|Osteosarcoma|osteosarcoma
5102332|NCT03358628|Patient-derived xenograft|patient-derived xenograft
5102333|NCT03358615|robson classification|robson classification
5102334|NCT03358615|Egypt|egypt
5102335|NCT03358602|Supraglottic cancer|supraglottic cancer
5102336|NCT03358602|Laryngeal cancer|laryngeal cancer
5102337|NCT03358602|Cervical lymph node|cervical lymph node
5102338|NCT03358602|Neck dissection|neck dissection
5102344|NCT03358550|accommodation|accommodation
5102345|NCT03358550|dark focus|dark focus
5102346|NCT03358550|night myopia|night myopia
5102347|NCT03358537|Dietary fiber|dietary fiber
5102348|NCT03358472|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5102421|NCT03357939|pharmacokinetics|pharmacokinetics
5102422|NCT03357939|biosimilar|biosimilar
5102423|NCT03357900|Consciousness Monitor|consciousness monitor
5102424|NCT03357900|Clinical Pharmacology|clinical pharmacology
5102425|NCT03357861|cancer|cancer
5102426|NCT03357861|intensive care unit|intensive care unit
5102427|NCT03357861|checkpoint inhibitors|checkpoint inhibitors
5102428|NCT03357861|adverse event|adverse event
5102429|NCT03357835|trauma|trauma
5102430|NCT03357835|triage|triage
5102509|NCT03357406|implant|implant
5102612|NCT03356652|Electrical dyssynchrony|electrical dyssynchrony
5102613|NCT03356639|Schizophrenia|schizophrenia
5102614|NCT03356639|ASP6981|asp6981
5102615|NCT03356639|Safety|safety
5102846|NCT03355157|Chemotherapy|chemotherapy
5102847|NCT03355157|Real world setting|real world setting
5102848|NCT03355157|Electronic patient-reported outcome|electronic patient-reported outcome
5103059|NCT03353428|Cytotoxic lymphocyte|cytotoxic lymphocyte
5103060|NCT03353428|LC-CTL|lc-ctl
5103061|NCT03353428|NSCLC|nsclc
5103063|NCT03353402|Melanoma|melanoma
5103161|NCT03352765|17-373|17-373
5103263|NCT03352024|lumbar puncture|lumbar puncture
5103264|NCT03352024|CSF|csf
5103265|NCT03352024|hypno analgesia|hypno analgesia
5103266|NCT03352024|no drug care|no drug care
5103267|NCT03352024|pain|pain
5103268|NCT03352024|anxiety|anxiety
5103269|NCT03352024|counseling|counseling
5103270|NCT03351998|insulin sensitivity|insulin sensitivity
5103271|NCT03351998|cardiorespiratory fitness|cardiorespiratory fitness
5103301|NCT03351764|EEG|eeg
5103361|NCT03351387|high risk lower extremity wound|high risk lower extremity wound
5103362|NCT03351374|behavioral health|behavioral health
5103363|NCT03351374|software|software
5103364|NCT03351374|integration|integration
5103563|NCT03349762|open-label|open-label
5103564|NCT03349762|prospective|prospective
5103565|NCT03349749|intensive care units|intensive care units
5103566|NCT03349749|resuscitation|resuscitation
5103567|NCT03349749|fluid therapy|fluid therapy
5103568|NCT03349749|Vascular Access Devices|vascular access devices
5103569|NCT03349749|cardiac output|cardiac output
5103570|NCT03349749|monitoring, physiologic|monitoring, physiologic
5103891|NCT03347942|Obesity|obesity
5103980|NCT03347461|Ear drops|ear drops
5103981|NCT03347461|Middle ear|middle ear
5103982|NCT03347448|Psychology|psychology
5103983|NCT03347448|Skin|skin
5103984|NCT03347435|clopidogrel|clopidogrel
5103985|NCT03347435|pharmacogenetics|pharmacogenetics
5103986|NCT03347435|antiplatelet therapy|antiplatelet therapy
5104196|NCT03345914|Eczema|eczema
5104197|NCT03345901|pemafibrate|pemafibrate
5104198|NCT03345875|human papillomavirus|human papillomavirus
5104311|NCT03345264|Sexual Dysfunction|sexual dysfunction
5104315|NCT03345238|Dry Needling|dry needling
5104316|NCT03345238|Myofascial Pain Syndrome|myofascial pain syndrome
5104317|NCT03345238|Neurophysiological effects|neurophysiological effects
5104318|NCT03345238|Autonomic Nervous System|autonomic nervous system
5104319|NCT03345225|Chemoembolization (TACE)|chemoembolization (tace)
5104321|NCT03345225|Liver Cancer|liver cancer
5104322|NCT03345199|Multiple Sclerosis, Inspiratory Muscle Training|multiple sclerosis, inspiratory muscle training
5104323|NCT03345186|Outcome|outcome
5104324|NCT03345186|Gout|gout
5104325|NCT03345147|Vitamin A|vitamin a
5104326|NCT03345147|Isotopic dilution|isotopic dilution
5104404|NCT03344809|generation|generation
5104405|NCT03344809|sequencing|sequencing
5104410|NCT03344757|prostate cancer|prostate cancer
5104411|NCT03344757|localized prostate cancer|localized prostate cancer
5104412|NCT03344757|spanish|spanish
5104413|NCT03344757|latino|latino
5104414|NCT03344757|hispanic|hispanic
5104510|NCT03344159|Positron Emissions Tomography|positron emissions tomography
5104511|NCT03344146|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy|ischemic stroke, direct oral anticoagulants, adherence, electronic monitoring, adherence-improving intervention, polypharmacy
5104608|NCT03343483|Volunteerism|volunteerism
5104609|NCT03343483|Aged|aged
5104610|NCT03343483|Loneliness|loneliness
5104611|NCT03343483|Quality of Life|quality of life
5104612|NCT03343470|Cushing Syndrome|cushing syndrome
5104613|NCT03343470|Adrenal Insufficiency|adrenal insufficiency
5104614|NCT03343470|Peripheral blood mononuclear cells|peripheral blood mononuclear cells
5104615|NCT03343470|Melatonin|melatonin
5104616|NCT03343470|Cortisol|cortisol
5104704|NCT03342898|Drug Therapy|drug therapy
5104705|NCT03342885|Low Back Pain|low back pain
5104706|NCT03342885|Sleep ergonomics|sleep ergonomics
5104707|NCT03342872|Adolescents|adolescents
5104807|NCT03342235|Anisometropic Amblyopia|anisometropic amblyopia
5104808|NCT03342235|Visual Acuity|visual acuity
5104905|NCT03341403|severe asthma|severe asthma
5105015|NCT03340766|Antibodies|antibodies
5105016|NCT03340766|Bispecific in combination with PD-1/PD-L1 inhibitor|bispecific in combination with pd-1/pd-l1 inhibitor
5105017|NCT03340727|Moderate preterm infant|moderate preterm infant
5105018|NCT03340727|Caffeine citrate|caffeine citrate
5105022|NCT03340662|Healthy Volunteer|healthy volunteer
5105023|NCT03340662|CC-122|cc-122
5105024|NCT03340662|Adult|adult
5105025|NCT03340662|Phase 1|phase 1
5105026|NCT03340662|CYTOCHROME P450|cytochrome p450
5105027|NCT03340623|DIEP|diep
5105028|NCT03340623|Venous coupler|venous coupler
5105029|NCT03340584|Total Knee Replacement|total knee replacement
5105030|NCT03340584|Taping|taping
5105031|NCT03340584|Rehabilitation|rehabilitation
5105032|NCT03340584|Edema|edema
5105033|NCT03340584|Pain|pain
5105086|NCT03340350|Minocycline|minocycline
5105088|NCT03340337|electrical stimulation|electrical stimulation
5105089|NCT03340337|Muscle Strength|muscle strength
5105090|NCT03340337|Fatigue|fatigue
5105091|NCT03340337|assessments, pain|assessments, pain
5105092|NCT03340324|inflammation|inflammation
5105093|NCT03340324|autoimmunity|autoimmunity
5105094|NCT03340324|immunotherapy|immunotherapy
5105095|NCT03340324|infertility|infertility
5105096|NCT03340324|pelvic pain|pelvic pain
5105097|NCT03340311|M-Health, GDM, Bluetooth, SMBG|m-health, gdm, bluetooth, smbg
5105098|NCT03340272|prostate cancer|prostate cancer
5105099|NCT03340272|pelvic irradiation|pelvic irradiation
5105100|NCT03340272|hormonal treatment|hormonal treatment
5105102|NCT03340259|Enterostomy|enterostomy
5105103|NCT03340259|Microbiota|microbiota
5105161|NCT03339882|LHRH-a|lhrh-a
5105162|NCT03339882|breast cancer|breast cancer
5105163|NCT03339843|cancer|cancer
5105164|NCT03339830|SMA|sma
5105396|NCT03338530|Psychosocial treatment|psychosocial treatment
5105398|NCT03338530|Autism Spectrum Disorder|autism spectrum disorder
5105399|NCT03338504|type 2 myocardial infarction|type 2 myocardial infarction
5105505|NCT03337776|screening update rate|screening update rate
5105726|NCT03336541|Postpartum depression|postpartum depression
5105727|NCT03336528|Long-acting insulin analog|long-acting insulin analog
5105959|NCT03335124|Hemodynamics|hemodynamics
5106101|NCT03334487|Remitting Small Cell Lung Cancer|remitting small cell lung cancer
5106102|NCT03334487|Delta-like protein 3 (DLL3)|delta-like protein 3 (dll3)
5106103|NCT03334487|DLL3 Expressing Small Cell Lung Cancer|dll3 expressing small cell lung cancer
5106104|NCT03334487|Rovalpituzumab Tesirine|rovalpituzumab tesirine
5106105|NCT03334461|Oral antiseptics|oral antiseptics
5106106|NCT03334461|remineralisation agents|remineralisation agents
5106110|NCT03334422|atopic eczema|atopic eczema
5106200|NCT03333837|Caregivers|caregivers
5106201|NCT03333837|Quality of Life|quality of life
5106202|NCT03333837|Dance|dance
5106203|NCT03333837|Social Group|social group
5106204|NCT03333837|MRI|mri
5106205|NCT03333837|mild cognitive impairment|mild cognitive impairment
5106206|NCT03333837|MCI|mci
5106207|NCT03333837|Social engagement|social engagement
5356823|NCT01917864|Speech treatment|speech treatment
5106208|NCT03333824|Pharmacokinetics, Cardiac Conduction, Mitotic Checkpoint inhibitor, QTc interval|pharmacokinetics, cardiac conduction, mitotic checkpoint inhibitor, qtc interval
5106209|NCT03333798|Intimate Partner Violence|intimate partner violence
5106210|NCT03333798|Domestic Violence|domestic violence
5106211|NCT03333798|Mental Health|mental health
5106212|NCT03333798|Cognitive- Behavioral Therapy|cognitive- behavioral therapy
5106213|NCT03333798|Community Lay Workers|community lay workers
5106214|NCT03333785|Primary Care|primary care
5106516|NCT03332069|Hyperthermia|hyperthermia
5106518|NCT03332069|HIV|hiv
5106519|NCT03332056|Ureteral stent pain|ureteral stent pain
5106520|NCT03332056|nephrolithiasis|nephrolithiasis
5106521|NCT03332056|kidney stone|kidney stone
5106522|NCT03332043|HIRREM|hirrem
5106523|NCT03332043|Neurotechnology|neurotechnology
5106524|NCT03332043|Closed-loop|closed-loop
5106525|NCT03332043|Acoustic stimulation|acoustic stimulation
5356825|NCT01917851|Hb|hb
5106646|NCT03331198|CAR T cells|car t cells
5106647|NCT03331198|autologous T cell therapy|autologous t cell therapy
5106648|NCT03331198|immunotherapy|immunotherapy
5106649|NCT03331185|Extraction|extraction
5106650|NCT03331185|Alveolar Ridge Augmentation|alveolar ridge augmentation
5106651|NCT03331185|Freeze Dried Bone Allograft|freeze dried bone allograft
5106859|NCT03329950|Liver Cancer|liver cancer
5106860|NCT03329950|GI Cancer|gi cancer
5106861|NCT03329950|Kidney Cancer|kidney cancer
5106862|NCT03329950|Celldex|celldex
5106863|NCT03329950|Monoclonal|monoclonal
5106864|NCT03329950|Antibody|antibody
5106865|NCT03329950|CD40|cd40
5106974|NCT03329300|Behavioral Intervention|behavioral intervention
5106977|NCT03329287|Depression|depression
5128569|NCT03190954|Raclopride|raclopride
5107129|NCT03328143|Craniotomy, anxiety, malignant, cancer, brain tumor|craniotomy, anxiety, malignant, cancer, brain tumor
5107322|NCT03326843|ITP|itp
5107328|NCT03326804|H1|h1
5107552|NCT03325803|ablative depth|ablative depth
5107651|NCT03325283|stroke prevention|stroke prevention
5107763|NCT03324620|physiotherapy|physiotherapy
5107764|NCT03324620|nurse|nurse
5107765|NCT03324620|Cost effectiveness|cost effectiveness
5107766|NCT03324620|Activities of Daily Living|activities of daily living
5107767|NCT03324620|exercise tolerance|exercise tolerance
5107966|NCT03323398|Moderna|moderna
5107967|NCT03323385|Colorectal surgery|colorectal surgery
5107968|NCT03323385|Pain|pain
5107969|NCT03323385|Analgesia|analgesia
5107970|NCT03323385|N1539|n1539
5107976|NCT03323346|metastatic breast cancer|metastatic breast cancer
5107977|NCT03323346|disulfiram|disulfiram
5107984|NCT03323281|Diabetic foot|diabetic foot
5107985|NCT03323281|Cognitive functions|cognitive functions
5107986|NCT03323281|Psychiatric disorders|psychiatric disorders
5107987|NCT03323281|Neurology|neurology
5107988|NCT03323281|Psychiatry|psychiatry
5108076|NCT03322761|Early treatment|early treatment
5108077|NCT03322683|Neck Pain|neck pain
5108078|NCT03322683|Physical Therapy Modalities|physical therapy modalities
5108079|NCT03322683|Massage|massage
5108080|NCT03322683|Manual Therapy|manual therapy
5108170|NCT03322046|Firefighters|firefighters
5108270|NCT03321240|Epiletogenicity index|epiletogenicity index
5108271|NCT03321240|SEEG|seeg
5108272|NCT03321227|Children|children
5108273|NCT03321227|Nutrition|nutrition
5118673|NCT03254199|CMT|cmt
5108275|NCT03321227|Cognitive performance|cognitive performance
5108276|NCT03321227|Glycemic response|glycemic response
5108277|NCT03321227|Appetite|appetite
5108278|NCT03321227|Emotion|emotion
5108279|NCT03321214|Gluten Free diet|gluten free diet
5108361|NCT03320642|chronic myelogenous leukemia|chronic myelogenous leukemia
5108362|NCT03320642|myelodysplasia|myelodysplasia
5108363|NCT03320642|chronic lymphocytic leukemia/small lymphocytic lymphoma|chronic lymphocytic leukemia/small lymphocytic lymphoma
5108364|NCT03320642|follicular|follicular
5108365|NCT03320642|marginal zone|marginal zone
5108366|NCT03320642|diffuse large B-cell|diffuse large b-cell
5108463|NCT03320031|glycemic variability|glycemic variability
5108464|NCT03320018|neuroprotection|neuroprotection
5108465|NCT03320018|antioxidant|antioxidant
5108466|NCT03320005|respiratory performance|respiratory performance
5108467|NCT03320005|quality of life|quality of life
5108468|NCT03320005|physical performance|physical performance
5108469|NCT03319992|Robotics [H01.671.293.643]|robotics [h01.671.293.643]
5118851|NCT03253055|Bone|bone
5108470|NCT03319992|Exoskeleton Device [E07.341]|exoskeleton device [e07.341]
5108473|NCT03319992|Exercise Therapy [E02.779.483]|exercise therapy [e02.779.483]
5108548|NCT03319459|EGFR|egfr
5108549|NCT03319459|Advanced Solid Tumor|advanced solid tumor
5108550|NCT03319459|Breast Cancer|breast cancer
5108551|NCT03319459|Head and Neck Cancer|head and neck cancer
5108552|NCT03319459|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5108553|NCT03319459|Colorectal Cancer|colorectal cancer
5108554|NCT03319459|Gastric Cancer|gastric cancer
5108555|NCT03319459|HER2 Positive|her2 positive
5108556|NCT03319459|EGFR Positive|egfr positive
5108557|NCT03319459|EGFR+|egfr+
5108558|NCT03319459|HER2+|her2+
5108559|NCT03319459|Immunotherapy|immunotherapy
5108560|NCT03319459|NK cell therapy|nk cell therapy
5108561|NCT03319459|Natural killer cell therapy|natural killer cell therapy
5108562|NCT03319459|antibody-dependent cell-mediated cytotoxicity|antibody-dependent cell-mediated cytotoxicity
5108563|NCT03319459|ADCC|adcc
5118972|NCT03252171|GD2|gd2
5108566|NCT03319433|spinal hypotension|spinal hypotension
5108567|NCT03319433|perfusion index|perfusion index
5108637|NCT03318978|Accelerator Mass Spectrometry|accelerator mass spectrometry
5108638|NCT03318978|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
5108748|NCT03318432|Cerebral Ischemia|cerebral ischemia
5108749|NCT03318432|Cerebral Infarction|cerebral infarction
5108750|NCT03318432|Cerebral Stroke|cerebral stroke
5108751|NCT03318432|Cerebral Vascular Accident|cerebral vascular accident
5108752|NCT03318432|Stroke Recovery|stroke recovery
5108753|NCT03318406|registry|registry
5108754|NCT03318406|vapor ablation|vapor ablation
5108755|NCT03318406|InterVapor|intervapor
5108756|NCT03318406|BTVA|btva
5108757|NCT03318341|physical stimulation|physical stimulation
5108758|NCT03318341|Subliminal stimulation|subliminal stimulation
5108761|NCT03318341|paresis|paresis
5108843|NCT03317665|prosthetic|prosthetic
5108844|NCT03317665|mesh|mesh
5108845|NCT03317613|Neuropathic Pain|neuropathic pain
5108846|NCT03317613|Qutenza|qutenza
5108947|NCT03316807|HIV|hiv
5109044|NCT03316183|neurocognitive outcomes|neurocognitive outcomes
5109045|NCT03316183|Cerebral protection|cerebral protection
5109046|NCT03316144|immunotherapy|immunotherapy
5109047|NCT03316144|check point inhibitor|check point inhibitor
5109048|NCT03316144|PD-1 antibody|pd-1 antibody
5109049|NCT03316144|phase 1 trial|phase 1 trial
5109050|NCT03316144|Malignant Lymphoma|malignant lymphoma
5109051|NCT03316131|Gout|gout
5109052|NCT03316131|Uric acid|uric acid
5109053|NCT03316131|Hyperuricemia|hyperuricemia
5109054|NCT03316131|Asymptomatic gout|asymptomatic gout
5109055|NCT03316131|Febuxostat|febuxostat
5109140|NCT03315728|Indigenous|indigenous
5109141|NCT03315728|First Nation|first nation
5109142|NCT03315728|Participatory|participatory
5109143|NCT03315728|Diabetes|diabetes
5109144|NCT03315728|Chronic Disease|chronic disease
5109145|NCT03315702|R-spondin proteins, mechanical ventilation, lung injury|r-spondin proteins, mechanical ventilation, lung injury
5109146|NCT03315663|Mobile Health|mobile health
5109231|NCT03315234|Coronary Artery Disease|coronary artery disease
5109232|NCT03315234|SNPs|snps
5109233|NCT03315234|Genetics|genetics
5109234|NCT03315234|Genetic Risk Score|genetic risk score
5109235|NCT03315234|Personalized Medicine|personalized medicine
5109331|NCT03314818|plaque progression|plaque progression
5109332|NCT03314818|Framingham Risk Score|framingham risk score
5109437|NCT03314181|t(11,14) positive relapsed/refractory (R/R) multiple myeloma|t(11,14) positive relapsed/refractory (r/r) multiple myeloma
5109438|NCT03314181|Non-refractory Relapsed Multiple Myeloma|non-refractory relapsed multiple myeloma
5109439|NCT03314181|Non-refractory Refractory Multiple Myeloma|non-refractory refractory multiple myeloma
5109442|NCT03314181|Multiple Myeloma|multiple myeloma
5109530|NCT03313349|ADHD, Behavioral Problems, Children and Adolescents|adhd, behavioral problems, children and adolescents
5109531|NCT03313336|Dermal anesthesia.|dermal anesthesia.
5109532|NCT03313336|Venipuncture and intravenous cannulation.|venipuncture and intravenous cannulation.
5109533|NCT03313336|Skin blanching or erythema.|skin blanching or erythema.
5109534|NCT03313336|Phase I.|phase i.
5109535|NCT03313336|Therapeutic equivalence.|therapeutic equivalence.
5109536|NCT03313336|Eutectic Mixture of Local anaesthetics (EMLA)|eutectic mixture of local anaesthetics (emla)
5109537|NCT03313323|Immuno-PET|immuno-pet
5109538|NCT03313323|Ipilimumab|ipilimumab
5109539|NCT03313323|Immunotherapy|immunotherapy
5109540|NCT03313310|Youth Empowerment|youth empowerment
5109541|NCT03313310|Employment Intervention|employment intervention
5109542|NCT03313310|Young Men Who Have Sex With Men|young men who have sex with men
5109543|NCT03313310|Young Transgender Women|young transgender women
5109545|NCT03313297|wound healing|wound healing
5109546|NCT03313297|11 beta-hydroxysteroid dehydrogenase type 1|11 beta-hydroxysteroid dehydrogenase type 1
5109548|NCT03313271|CLAP|clap
5109631|NCT03312686|endoflip|endoflip
5109850|NCT03311282|breastfeeding|breastfeeding
5109851|NCT03311282|infants|infants
5109852|NCT03311282|squeezing|squeezing
5109853|NCT03311282|breathing|breathing
5109854|NCT03311256|Tissue Transit Time|tissue transit time
5109855|NCT03311243|cytokines|cytokines
5109856|NCT03311243|scaling root planing|scaling root planing
5109857|NCT03311243|oral hygiene|oral hygiene
5109858|NCT03311243|systemic inflammation|systemic inflammation
5109859|NCT03311204|Eyelid margin|eyelid margin
5109923|NCT03310918|AML|aml
5110001|NCT03310502|liver|liver
5110206|NCT03309033|Immune Response|immune response
5110207|NCT03309033|Long-Term Protection|long-term protection
5110209|NCT03309020|Cataracts|cataracts
5110210|NCT03309020|Visual Acuity|visual acuity
5110211|NCT03309007|Autophagy|autophagy
5110212|NCT03308994|Multiple sclerosis|multiple sclerosis
5110213|NCT03308994|Epidemiology|epidemiology
5110214|NCT03308994|Oral disease modifying treatments|oral disease modifying treatments
5110307|NCT03308318|Deep layer of the deep temporal fascia|deep layer of the deep temporal fascia
5110308|NCT03308318|Superficial layer of the deep temporal fascia|superficial layer of the deep temporal fascia
5110309|NCT03308318|Temporal fascial layers|temporal fascial layers
5110539|NCT03306732|Thiamine Supplementation|thiamine supplementation
5110540|NCT03306732|Vasoplegia Syndrome|vasoplegia syndrome
5110541|NCT03306732|Inotropic support|inotropic support
5110542|NCT03306732|Cardiac surgery|cardiac surgery
5110543|NCT03306732|Renal Failure|renal failure
5110656|NCT03306147|Pain education|pain education
5110757|NCT03305445|Refractory Diffuse Large B-Cell Lymphoma|refractory diffuse large b-cell lymphoma
5110758|NCT03305445|Nivolumab|nivolumab
5110931|NCT03304314|ICP|icp
5111033|NCT03303794|Total Knee arthroplasty|total knee arthroplasty
5111034|NCT03303794|bupivacaine|bupivacaine
5111035|NCT03303794|anesthesia|anesthesia
5111036|NCT03303729|Carbohydrate|carbohydrate
5111037|NCT03303729|Cluster Dextrin|cluster dextrin
5111038|NCT03303729|Exercise training|exercise training
5111039|NCT03303729|Protein supplement|protein supplement
5111132|NCT03303040|Diaphragm stimulation|diaphragm stimulation
5111234|NCT03302273|stem cell therapy|stem cell therapy
5111235|NCT03302273|dry eye disease|dry eye disease
5111338|NCT03301662|health-related quality of life|health-related quality of life
5111339|NCT03301662|Short Form-36|short form-36
5111546|NCT03300297|Temporomandibular joint|temporomandibular joint
5111547|NCT03300297|Physical Therapy|physical therapy
5111548|NCT03300297|Cervical spine thrust joint manipulation|cervical spine thrust joint manipulation
5111549|NCT03300297|therapy, exercise|therapy, exercise
5111556|NCT03300219|rct|rct
5111654|NCT03299556|iPhone|iphone
5111767|NCT03299010|Mortality|mortality
5111768|NCT03299010|Cardiovascular Diseases|cardiovascular diseases
5111769|NCT03299010|Chinese|chinese
5111770|NCT03299010|Prediction|prediction
5111776|NCT03298945|colonoscopy|colonoscopy
5111777|NCT03298945|colorectal cancer|colorectal cancer
5111778|NCT03298945|bowel preparation regimen|bowel preparation regimen
5111779|NCT03298945|pragmatic trial|pragmatic trial
5111780|NCT03298932|Transesophageal echography|transesophageal echography
5111781|NCT03298932|Perioperative cardiac surgery|perioperative cardiac surgery
5111785|NCT03298893|nivolumab|nivolumab
5111971|NCT03297333|Exercise|exercise
5111972|NCT03297333|Cardiac Fat|cardiac fat
5111973|NCT03297333|Cardiac Magnetic Resonance|cardiac magnetic resonance
5111974|NCT03297333|Vascular Health|vascular health
5111977|NCT03297294|Neuropathic pain|neuropathic pain
5112077|NCT03296501|ADRC|adrc
5112078|NCT03296501|adipose derived regenerative cells|adipose derived regenerative cells
5112080|NCT03296501|mesenchymal cells|mesenchymal cells
5112188|NCT03295838|Alexithymia|alexithymia
5112277|NCT03295279|Quantitative computerized tomography|quantitative computerized tomography
5112278|NCT03295279|Qualitative computerized tomography of the chest|qualitative computerized tomography of the chest
5112279|NCT03295279|Chronic airway disease|chronic airway disease
5112280|NCT03295279|Interstitial lung disease|interstitial lung disease
5112281|NCT03295279|Occupational pulmonology|occupational pulmonology
5112282|NCT03295253|urinary incontinence|urinary incontinence
5112283|NCT03295253|stress urinary incontinence|stress urinary incontinence
5112284|NCT03295253|stress incontinence|stress incontinence
5112285|NCT03295240|Mantle Cell Lymphoma|mantle cell lymphoma
5112286|NCT03295240|MCL|mcl
5112287|NCT03295240|Lymphoma|lymphoma
5112288|NCT03295240|Venetoclax|venetoclax
5112289|NCT03295240|17-216|17-216
5112292|NCT03295227|Pembrolizumab|pembrolizumab
5112294|NCT03295227|MK-3475|mk-3475
5112358|NCT03294824|Allogeneic transplantation|allogeneic transplantation
5112359|NCT03294772|Respiratory Tract Infections|respiratory tract infections
5112360|NCT03294772|gastroenteritis|gastroenteritis
5112361|NCT03294772|hand sanitizer|hand sanitizer
5112469|NCT03294135|Long term immunogenicity|long term immunogenicity
5112570|NCT03293537|Heart rate|heart rate
5112571|NCT03293524|Heredity Optic Atrophy|heredity optic atrophy
5112572|NCT03293524|Leber Hereditary Optic Atrophy|leber hereditary optic atrophy
5112573|NCT03293524|Leber Hereditary Optic Neuropathy|leber hereditary optic neuropathy
5112574|NCT03293524|LHON|lhon
5112575|NCT03293524|Eye Diseases|eye diseases
5112576|NCT03293524|Hereditary Eye Diseases|hereditary eye diseases
5112577|NCT03293524|Inherited retinal dystrophies or degeneration|inherited retinal dystrophies or degeneration
5112578|NCT03293524|Inborn Genetic Disease|inborn genetic disease
5112579|NCT03293524|Gene Therapy|gene therapy
5112580|NCT03293524|Intravitreal Injections|intravitreal injections
5112581|NCT03293524|Mitochondrial Disease|mitochondrial disease
5112582|NCT03293524|AAV2 Vectors|aav2 vectors
5112585|NCT03293524|Heredodegenerative Disorders of the Nervous System|heredodegenerative disorders of the nervous system
5112586|NCT03293524|Atrophy|atrophy
5112587|NCT03293524|Pathological Conditions, Anatomical|pathological conditions, anatomical
5112651|NCT03293147|Biomarker|biomarker
5112652|NCT03293147|Urine|urine
5112653|NCT03293147|HPLC-MS/MS|hplc-ms/ms
5112654|NCT03293134|Fowler syndrome|fowler syndrome
5112655|NCT03293121|running related injuries|running related injuries
5112656|NCT03293108|Osteoporosis|osteoporosis
5112657|NCT03293108|Denosumab|denosumab
5112658|NCT03293095|musculoskeletal pathology|musculoskeletal pathology
5112659|NCT03293095|motion sensor|motion sensor
5112893|NCT03291483|Balance|balance
5112894|NCT03291470|knee|knee
5112895|NCT03291431|alcohol use disorder|alcohol use disorder
5112896|NCT03291431|intermittent theta burst|intermittent theta burst
5112897|NCT03291431|Veterans|veterans
5112898|NCT03291431|depressive disorder|depressive disorder
5112899|NCT03291431|cigarette smoking|cigarette smoking
5113009|NCT03290495|electroencephalography|electroencephalography
5113010|NCT03290495|maintenance|maintenance
5113135|NCT03289728|ischemia imaging|ischemia imaging
5113139|NCT03289663|vectors|vectors
5113241|NCT03289026|Aripiprazole; Acute schizophrenia episode; positive symptoms|aripiprazole; acute schizophrenia episode; positive symptoms
5113242|NCT03289000|osteoarthritis|osteoarthritis
5113243|NCT03289000|knee arthroplasty|knee arthroplasty
5113244|NCT03289000|knee replacement|knee replacement
5113245|NCT03289000|patient specific|patient specific
5113246|NCT03288974|Multiple Myeloma|multiple myeloma
5113247|NCT03288974|POMALYST®|pomalyst®
5113248|NCT03288974|Pomalidomide|pomalidomide
5113249|NCT03288974|Observational|observational
5113250|NCT03288974|Korea|korea
5113251|NCT03288974|Post Marketing Surveillance[PMS]|post marketing surveillance[pms]
5113252|NCT03288974|Relapsed and Refractory Multiple Myeloma|relapsed and refractory multiple myeloma
5113345|NCT03288441|Thrombocytopenia|thrombocytopenia
5113346|NCT03288441|Anticoagulants|anticoagulants
5113347|NCT03288441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5113348|NCT03288415|Integrated prognostic model|integrated prognostic model
5113357|NCT03288363|tDCS|tdcs
5113513|NCT03287466|oxygen concentration|oxygen concentration
5113514|NCT03287440|Health Disparities|health disparities
5113611|NCT03286998|ultrasonography|ultrasonography
5113612|NCT03286933|yoga therapy|yoga therapy
5113614|NCT03286933|quality of life|quality of life
5113615|NCT03286933|pain management|pain management
5113616|NCT03286920|home nutrition|home nutrition
5113617|NCT03286920|BMI|bmi
5113618|NCT03286920|postoperative|postoperative
5113619|NCT03286920|body weight|body weight
5113620|NCT03286907|Uptake of HPV vaccination|uptake of hpv vaccination
5113621|NCT03286881|Common Mental Disorders|common mental disorders
5113622|NCT03286881|Brief Psychological Treatments|brief psychological treatments
5113623|NCT03286881|Primary Care|primary care
5113624|NCT03286881|Randomized Clinical Trial|randomized clinical trial
5113626|NCT03286842|Germline BRCA1/2 mutations|germline brca1/2 mutations
5113705|NCT03286270|mRUS|mrus
5113943|NCT03284554|Amino acid|amino acid
5113944|NCT03284554|Probiotic bacteria|probiotic bacteria
5113945|NCT03284489|Pancreatitis|pancreatitis
5114059|NCT03283683|survival|survival
5114060|NCT03283683|actigraphy|actigraphy
5114063|NCT03283644|gastric bypass|gastric bypass
5114064|NCT03283644|Obesity|obesity
5114065|NCT03283644|Morbid obesity|morbid obesity
5114170|NCT03283046|Newly diagnosed|newly diagnosed
5114337|NCT03282019|HOT|hot
5114419|NCT03281590|investigation|investigation
5114420|NCT03281590|prevalence|prevalence
5114421|NCT03281590|incidence|incidence
5114422|NCT03281590|quality of care|quality of care
5114423|NCT03281590|hospitalization|hospitalization
5114424|NCT03281590|morbidity|morbidity
5114425|NCT03281590|disability|disability
5114446|NCT03281512|CHNS|chns
5114874|NCT03278899|Adrenoleukodystropy|adrenoleukodystropy
5114976|NCT03278093|Physical therapy|physical therapy
5114977|NCT03278093|Balance|balance
5114978|NCT03278093|Posturography|posturography
5114979|NCT03278067|England|england
5115065|NCT03277352|esophageal cancer|esophageal cancer
5115066|NCT03277352|hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5115067|NCT03277352|melanoma (mucosal or cutaneous)|melanoma (mucosal or cutaneous)
5115068|NCT03277352|Merkel cell carcinoma|merkel cell carcinoma
5115069|NCT03277352|mesothelioma|mesothelioma
5115071|NCT03277352|solid tumors|solid tumors
5115153|NCT03276806|CT low dose|ct low dose
5115261|NCT03276052|COPD, Pharmacokinetics|copd, pharmacokinetics
5115262|NCT03276026|sugammadex|sugammadex
5115263|NCT03276026|post anesthesia care unit recovery|post anesthesia care unit recovery
5115361|NCT03275363|Subjective cognitive decline|subjective cognitive decline
5115362|NCT03275363|Mild Cognitive Impairment|mild cognitive impairment
5115364|NCT03275363|Cerebral aging|cerebral aging
5115456|NCT03274674|Microneedle|microneedle
5115457|NCT03274674|Gingival Thickness|gingival thickness
5115458|NCT03274674|Injectable-Platelet-Rich-Fibrin|injectable-platelet-rich-fibrin
5115459|NCT03274674|Platelet Rich Fibrin|platelet rich fibrin
5115762|NCT03272490|polyaxial|polyaxial
5115763|NCT03272490|outcome|outcome
5115764|NCT03272477|hormone receptor positive|hormone receptor positive
5115765|NCT03272477|human epidermal growth factor receptor 2 positive|human epidermal growth factor receptor 2 positive
5115766|NCT03272477|Early breast cancer|early breast cancer
5115767|NCT03272477|HR+/HER2+|hr+/her2+
5115768|NCT03272464|Melanoma|melanoma
5115876|NCT03271723|observational studies|observational studies
5115877|NCT03271723|epidemiology|epidemiology
5115878|NCT03271723|maternal health|maternal health
5115879|NCT03271710|Distal embolization|distal embolization
5115880|NCT03271710|Percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5115881|NCT03271710|Integrated embolic protection|integrated embolic protection
5115882|NCT03271684|stroke, self-management, Bridges, participation, function, self-efficacy|stroke, self-management, bridges, participation, function, self-efficacy
5115886|NCT03271671|niv|niv
5116099|NCT03270241|Vitiligo|vitiligo
5116100|NCT03270241|Dermatology|dermatology
5116101|NCT03270241|Johns Hopkins|johns hopkins
5116102|NCT03270241|Compensation|compensation
5116212|NCT03269604|Urological Surgery|urological surgery
5116213|NCT03269604|Bacterial resistance|bacterial resistance
5116214|NCT03269591|Dysmenorrhea|dysmenorrhea
5116215|NCT03269591|Pulsed electromagnetic field|pulsed electromagnetic field
5116216|NCT03269591|Diclofenac|diclofenac
5116217|NCT03269578|Pharmacodynamics|pharmacodynamics
5116218|NCT03269578|Tissue Collection|tissue collection
5116219|NCT03269578|Tissue Biopsies|tissue biopsies
5116220|NCT03269578|Biospecimen|biospecimen
5116221|NCT03269578|Assay Development|assay development
5116222|NCT03269526|Pancreatic Cancer|pancreatic cancer
5116223|NCT03269526|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5116224|NCT03269526|Adoptive cell therapy|adoptive cell therapy
5116225|NCT03269526|Armed activated T-cells|armed activated t-cells
5116226|NCT03269526|Bispecific antibody|bispecific antibody
5116227|NCT03269526|Immunotherapy|immunotherapy
5116228|NCT03269474|epidermolysis bullosa simplex|epidermolysis bullosa simplex
5116229|NCT03269474|genetic expression|genetic expression
5116230|NCT03269474|drug repurposing|drug repurposing
5116231|NCT03269474|computational approaches|computational approaches
5116232|NCT03269474|drug discovery|drug discovery
5116416|NCT03268382|Recurrent Cancer|recurrent cancer
5116420|NCT03268304|Virtual Reality|virtual reality
5116529|NCT03267641|Precision Medicine|precision medicine
5116530|NCT03267628|intrathecal morphine|intrathecal morphine
5116531|NCT03267628|quadratus lumborum type 2 block|quadratus lumborum type 2 block
5116532|NCT03267628|cesarean section|cesarean section
5116533|NCT03267628|pain|pain
5116534|NCT03267615|Liver Cirrhosis|liver cirrhosis
5116630|NCT03266835|Chronic Total Occlusion|chronic total occlusion
5116631|NCT03266835|Peripheral|peripheral
5116632|NCT03266835|SoundBite™ Crossing System|soundbite™ crossing system
5116633|NCT03266835|CTO|cto
5116634|NCT03266835|intra-luminal|intra-luminal
5116635|NCT03266835|Active wire|active wire
5116636|NCT03266835|Device|device
5116637|NCT03266835|Procedure|procedure
5116638|NCT03266809|Cardiac function|cardiac function
5116639|NCT03266809|Cardio-toxicity|cardio-toxicity
5116640|NCT03266770|ureteral stent|ureteral stent
5116641|NCT03266744|Metastatic Breast Cancer|metastatic breast cancer
5116642|NCT03266744|Whole Body MRI|whole body mri
5116643|NCT03266744|Computerised Tomography|computerised tomography
5116722|NCT03266393|Tacrolimus|tacrolimus
5116723|NCT03266393|Rejection|rejection
5116724|NCT03266393|Adherence|adherence
5116725|NCT03266393|Quality of Life|quality of life
5116726|NCT03266393|post-transplant immunosuppression|post-transplant immunosuppression
5116727|NCT03266354|Artisan|artisan
5116728|NCT03266302|vasodilatory shock|vasodilatory shock
5116729|NCT03266302|hemoadsorption|hemoadsorption
5116730|NCT03266302|cardiac surgery|cardiac surgery
5116731|NCT03266302|cytokines|cytokines
5116732|NCT03266250|inferior vena caca ultrasound|inferior vena caca ultrasound
5116847|NCT03265405|immunosuppression|immunosuppression
5116961|NCT03264638|Diane-35|diane-35
5116962|NCT03264625|Cholecalciferol|cholecalciferol
5116963|NCT03264625|Peritoneal dialysis|peritoneal dialysis
5116964|NCT03264625|Peritonitis|peritonitis
5116965|NCT03264573|Atrophic scar|atrophic scar
5116966|NCT03264573|PRP|prp
5116967|NCT03264573|ADSCs|adscs
5116968|NCT03264560|Telepsychiatry|telepsychiatry
5116969|NCT03264560|Synchronous|synchronous
5116970|NCT03264560|Asynchronous|asynchronous
5116971|NCT03264560|SNF|snf
5116972|NCT03264521|Crowdsourcing|crowdsourcing
5116973|NCT03264521|Patient Engagement|patient engagement
5116974|NCT03264521|Chiropractic|chiropractic
5116975|NCT03264508|endothelial function|endothelial function
5116976|NCT03264508|arterial stiffness|arterial stiffness
5116977|NCT03264508|heat|heat
5117057|NCT03263988|intraoperative monitoring|intraoperative monitoring
5117059|NCT03263962|Canrenone|canrenone
5117060|NCT03263949|risk prediction|risk prediction
5117061|NCT03263949|ventricular arrhythmia|ventricular arrhythmia
5117062|NCT03263949|myocardial infarction|myocardial infarction
5117063|NCT03263936|Relapse|relapse
5117064|NCT03263936|Myelogenous|myelogenous
5117065|NCT03263936|Leukemia|leukemia
5117066|NCT03263936|Refractory|refractory
5117067|NCT03263936|Acute|acute
5117068|NCT03263936|Pediatric|pediatric
5117297|NCT03262441|Reservoir|reservoir
5117298|NCT03262441|CD4 T cell|cd4 t cell
5117299|NCT03262441|Anti-proliferation|anti-proliferation
5117300|NCT03262415|LabPatch Continuous Glucose Monitoring (CGM)|labpatch continuous glucose monitoring (cgm)
5117301|NCT03262402|Chronic periodontitis|chronic periodontitis
5117302|NCT03262402|Candida spp|candida spp
5117310|NCT03262376|Stress|stress
5117394|NCT03261817|web|web
5117395|NCT03261817|brain imaging|brain imaging
5117396|NCT03261817|heart rate variability|heart rate variability
5117397|NCT03261817|circadian cycles|circadian cycles
5117398|NCT03261817|cognition|cognition
5117399|NCT03261817|well-being|well-being
5117498|NCT03261102|IBD|ibd
5117537|NCT03260829|palatally impacted canines|palatally impacted canines
5117677|NCT03260023|Anti PD-L1|anti pd-l1
5117678|NCT03260023|Therapeutic Vaccine|therapeutic vaccine
5117679|NCT03259971|Rett syndrome|rett syndrome
5117680|NCT03259971|Tourette syndrome|tourette syndrome
5117681|NCT03259971|Probiotic|probiotic
5117682|NCT03259919|Metformin|metformin
5117768|NCT03259438|Neuroimmune Interactions|neuroimmune interactions
5117769|NCT03259438|Complex Systems Analysis|complex systems analysis
5117770|NCT03259438|Female|female
5117865|NCT03258866|purpura|purpura
5117771|NCT03259425|Resectable Stage IIIB, IIIC, and IVM1a|resectable stage iiib, iiic, and ivm1a
5117772|NCT03259373|AF|af
5117773|NCT03259373|AFib|afib
5117861|NCT03258905|Seeking Safety|seeking safety
5117985|NCT03258034|Conversion therapy|conversion therapy
5117987|NCT03258021|GBM|gbm
5118329|NCT03256123|Iron Deficiency|iron deficiency
5118330|NCT03256123|Parasite|parasite
5118331|NCT03256123|Gut Microbiota|gut microbiota
5118417|NCT03255590|transcranial magnetic stimulation|transcranial magnetic stimulation
5118418|NCT03255590|motor learning|motor learning
5118621|NCT03254446|Diabetes|diabetes
5118622|NCT03254446|Hypertension|hypertension
5118623|NCT03254446|Dyslipidemia|dyslipidemia
5118624|NCT03254446|Cardiovascular Risk|cardiovascular risk
5118625|NCT03254433|Neuroimaging|neuroimaging
5118626|NCT03254433|Smoking Cessation|smoking cessation
5118627|NCT03254433|Weight Loss|weight loss
5118722|NCT03253874|Health Service Research|health service research
5118723|NCT03253874|Low-Value Care|low-value care
5118724|NCT03253874|Safety-Net Hospital|safety-net hospital
5673267|NCT00608621|Side effects|side effects
5118931|NCT03252470|laparoscopic roux-en-y gastric bypass|laparoscopic roux-en-y gastric bypass
5118932|NCT03252457|Purpura|purpura
5118933|NCT03252457|Thrombocytopenia|thrombocytopenia
5118934|NCT03252457|immune throbocytopenia|immune throbocytopenia
5118935|NCT03252444|Shoulder dyskinesis|shoulder dyskinesis
5118936|NCT03252444|EMG biofeedback training|emg biofeedback training
5118937|NCT03252444|Intensive Scapula-focused intervention|intensive scapula-focused intervention
5118973|NCT03252171|glioma|glioma
5119017|NCT03251820|cognition|cognition
5119018|NCT03251820|continuous spikes and waves during sleep|continuous spikes and waves during sleep
5119019|NCT03251807|Low-intensity pulsed ultrasound|low-intensity pulsed ultrasound
5119020|NCT03251807|Twin-block|twin-block
5119021|NCT03251807|Functional treatment|functional treatment
5119023|NCT03251781|Exercise Test|exercise test
5119114|NCT03251118|Crohn's Disease|crohn's disease
5119226|NCT03250377|Partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
5119227|NCT03250377|Briviact|briviact
5119228|NCT03250325|Adoptive cell transfer|adoptive cell transfer
5119229|NCT03250325|Cell therapy|cell therapy
5119232|NCT03250325|T cell receptor gene therapy|t cell receptor gene therapy
5119233|NCT03250325|Synovial sarcoma|synovial sarcoma
5119234|NCT03250312|Osteopathic manipulation|osteopathic manipulation
5119235|NCT03250312|low back pain|low back pain
5119318|NCT03249935|Symptoms|symptoms
5119319|NCT03249935|Urethral|urethral
5119320|NCT03249935|Urogenital|urogenital
5119322|NCT03249922|spinal cord stimulation|spinal cord stimulation
5119324|NCT03249896|RCT|rct
5119414|NCT03249415|Autologous treatment|autologous treatment
5119415|NCT03249415|Paracrine factors|paracrine factors
5119515|NCT03248622|Incidence|incidence
5119642|NCT03247894|Multiple sclerosis, anesthesia|multiple sclerosis, anesthesia
5119742|NCT03247127|neurocognitive function|neurocognitive function
5119743|NCT03247075|Social anxiety disorder|social anxiety disorder
5119840|NCT03246321|Aerosols|aerosols
5119841|NCT03246321|Chemotherapy, Cancer, Regional Perfusion|chemotherapy, cancer, regional perfusion
5119842|NCT03246321|Antineoplastic Agents|antineoplastic agents
5119843|NCT03246321|Leucovorin|leucovorin
5356830|NCT01917812|exercise|exercise
5119844|NCT03246321|Fluorouracil|fluorouracil
5119845|NCT03246321|Platinum|platinum
5119846|NCT03246321|Intraoperative Complications|intraoperative complications
5119847|NCT03246321|Postoperative Complications|postoperative complications
5119848|NCT03246321|Drug-Related Side Effects and Adverse Reactions|drug-related side effects and adverse reactions
5119849|NCT03246321|Disease-free survival|disease-free survival
5119850|NCT03246321|Survival|survival
5119851|NCT03246321|Mortality|mortality
5119852|NCT03246321|Quality of Life|quality of life
5119853|NCT03246321|Costs and Cost Analysis|costs and cost analysis
5119854|NCT03246321|Translational Medical Research|translational medical research
5119855|NCT03246321|Clinical Trials, Phase II as topic|clinical trials, phase ii as topic
5119856|NCT03246321|PIPAC|pipac
5119882|NCT03246139|MEG|meg
5119914|NCT03245944|immature AVF|immature avf
5119915|NCT03245944|percutaneous intervention|percutaneous intervention
5119916|NCT03245892|Nivolumab|nivolumab
5119917|NCT03245892|Paclitaxel|paclitaxel
5119918|NCT03245892|Carboplatin|carboplatin
5120015|NCT03245216|balance|balance
5120016|NCT03245216|postural instability|postural instability
5120017|NCT03245216|motor skill|motor skill
5120018|NCT03245203|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5120019|NCT03245164|obese children|obese children
5120020|NCT03245164|motor skills|motor skills
5120035|NCT03245060|psychosocial well-being|psychosocial well-being
5120133|NCT03244215|High performance liquid chromatography,|high performance liquid chromatography,
5120134|NCT03244215|Inflammatory biomarkers|inflammatory biomarkers
5120135|NCT03244215|modified Rankin scale ( mRS)|modified rankin scale ( mrs)
5120136|NCT03244202|Incidental Findings|incidental findings
5120137|NCT03244202|Decision Aids|decision aids
5120147|NCT03244163|Endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography
5120148|NCT03244150|Physical activity|physical activity
5120237|NCT03243565|Adenoid Hyperplasia|adenoid hyperplasia
5120238|NCT03243565|children|children
5120239|NCT03243565|respiratory tract infection|respiratory tract infection
5120342|NCT03242967|hypoxia-inducible factor|hypoxia-inducible factor
5120344|NCT03242967|dialysis-dependent chronic kidney disease|dialysis-dependent chronic kidney disease
5120454|NCT03241966|Parkinson's Disease|parkinson's disease
5120455|NCT03241966|Online Study|online study
5120456|NCT03241966|Quality of Life|quality of life
5120457|NCT03241966|Activities of Daily Living|activities of daily living
5120458|NCT03241966|Perception|perception
5120459|NCT03241966|Cognition|cognition
5120460|NCT03241966|Gait|gait
5120461|NCT03241927|Pembrolizumab|pembrolizumab
5120462|NCT03241927|NK Cell Exhaustion|nk cell exhaustion
5120463|NCT03241927|PD-1|pd-1
5120464|NCT03241927|Unresectable|unresectable
5120465|NCT03241927|Stage III|stage iii
5120466|NCT03241927|Stage IV|stage iv
5120467|NCT03241901|Artemether-Lumefantrine, Primaquine|artemether-lumefantrine, primaquine
5120468|NCT03241888|Levonorgestrel-releasing intrauterine system|levonorgestrel-releasing intrauterine system
5120469|NCT03241888|megestrol acetate|megestrol acetate
5120535|NCT03241368|Irritable Bowel Disease|irritable bowel disease
5120536|NCT03241368|IBD|ibd
5120537|NCT03241368|Mucosal Disease|mucosal disease
5120538|NCT03241329|Endometriosis|endometriosis
5120539|NCT03241329|Metabolomics|metabolomics
5120540|NCT03241329|Transcriptomics|transcriptomics
5120541|NCT03241329|Follicular fluid|follicular fluid
5120542|NCT03241329|Cumulus cells|cumulus cells
5120543|NCT03241329|Oocyte quality|oocyte quality
5120544|NCT03241316|qualitative and survey research|qualitative and survey research
5120545|NCT03241303|Glp-1|glp-1
5120546|NCT03241303|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
5120548|NCT03241290|C-arm|c-arm
5120634|NCT03240822|Allotransplantation|allotransplantation
5120635|NCT03240822|Vascularized Composite Allotransplantation|vascularized composite allotransplantation
5120636|NCT03240822|VCA|vca
5120637|NCT03240822|Genital Trauma|genital trauma
5120746|NCT03240198|cohort|cohort
5120836|NCT03239795|Primary Health Care|primary health care
5120837|NCT03239795|Health Facilities|health facilities
5120838|NCT03239769|Thyroid surgery|thyroid surgery
5120839|NCT03239769|Thyroidectomy|thyroidectomy
5120840|NCT03239769|Minimally invasive access|minimally invasive access
5120841|NCT03239769|Aesthetic principle|aesthetic principle
5120842|NCT03239769|POSAS|posas
5120843|NCT03239743|virtual reality|virtual reality
5120844|NCT03239743|adenoidectomy|adenoidectomy
5120847|NCT03239730|dyspnea|dyspnea
5121075|NCT03238430|Intrathecal morphine, continuous wound infiltration|intrathecal morphine, continuous wound infiltration
5121076|NCT03238417|women's health|women's health
5121297|NCT03237039|fall-risk|fall-risk
5121298|NCT03237039|gait cycle analysis|gait cycle analysis
5121397|NCT03236363|Cardiorespiratory fitness|cardiorespiratory fitness
5121299|NCT03237026|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine|prostate cancer, prostatectomy, prostate radiotherapy, chemotherapy, immunotherapy, biomarkers, metabolomics, urine
5121300|NCT03237013|Sunbathing|sunbathing
5121301|NCT03237013|Indoor Tanning|indoor tanning
5121302|NCT03237013|Facial Morphing|facial morphing
5121303|NCT03237013|Skin Cancer Risk|skin cancer risk
5121304|NCT03237000|Preeclampsia|preeclampsia
5121305|NCT03237000|MgSO4|mgso4
5121306|NCT03236987|MAC|mac
5121307|NCT03236987|Clarithromycin|clarithromycin
5121308|NCT03236987|Azithromycin|azithromycin
5121309|NCT03236987|Efficacy|efficacy
5121310|NCT03236987|Safety|safety
5121375|NCT03236454|cognition|cognition
5121472|NCT03235973|refractory myelodysplastic syndrome|refractory myelodysplastic syndrome
5121473|NCT03235973|cladribine dose escalation|cladribine dose escalation
5121474|NCT03235947|Renal transplant|renal transplant
5121475|NCT03235947|Antimicrobian prophylaxis|antimicrobian prophylaxis
5121476|NCT03235947|Fosfomycin|fosfomycin
5121479|NCT03235934|glucose monitoring|glucose monitoring
5121788|NCT03234153|Durvalumab|durvalumab
5121895|NCT03233685|Visual training|visual training
5121896|NCT03233672|adjuvant|adjuvant
5121997|NCT03233191|Digital Mammography|digital mammography
5121998|NCT03233191|Breast Tomography|breast tomography
5121999|NCT03233191|Screening Mammography|screening mammography
5122000|NCT03233191|TMIST|tmist
5122001|NCT03233165|laser therapy|laser therapy
5122002|NCT03233165|recurrence|recurrence
5122003|NCT03233165|leukoplakia|leukoplakia
5122004|NCT03233165|precancerous lesion|precancerous lesion
5122078|NCT03232515|Dialysis|dialysis
5122183|NCT03231540|Critical care|critical care
5122184|NCT03231540|nutrition|nutrition
5122185|NCT03231540|whey protein|whey protein
5122186|NCT03231540|mechanical ventilation|mechanical ventilation
5122187|NCT03231540|muscle function|muscle function
5122188|NCT03231514|body composition|body composition
5122189|NCT03231514|exercise performance|exercise performance
5122190|NCT03231514|keto-adaptation|keto-adaptation
5122192|NCT03231475|EGFR-TKI|egfr-tki
5122193|NCT03231449|routine care, evaluation, Africa, observatory|routine care, evaluation, africa, observatory
5122194|NCT03231436|intrathecal bupivacaine|intrathecal bupivacaine
5122195|NCT03231436|hyperbaric bupivacaine|hyperbaric bupivacaine
5122196|NCT03231436|failed spinal|failed spinal
5122197|NCT03231423|Obesity|obesity
5122198|NCT03231423|VAS|vas
5122281|NCT03230929|EMG, BIS, phase lag entropy|emg, bis, phase lag entropy
5122282|NCT03230903|Multiple Sclerosis|multiple sclerosis
5122283|NCT03230903|Telerehabilitation|telerehabilitation
5122284|NCT03230903|Physical rehabilitation|physical rehabilitation
5122379|NCT03230318|liver cancer|liver cancer
5122765|NCT03227809|Risky sexual behaviors|risky sexual behaviors
5122771|NCT03227770|Hemoperfusion|hemoperfusion
5122772|NCT03227770|Hemodialysis|hemodialysis
5122773|NCT03227770|Mortality|mortality
5122774|NCT03227757|TRILUMINATE|triluminate
5122775|NCT03227757|Percutaneous transcatheter intervention|percutaneous transcatheter intervention
5122776|NCT03227757|Tricuspid regurgitation|tricuspid regurgitation
5122777|NCT03227757|Tricuspid Valve Repair System|tricuspid valve repair system
5122877|NCT03227211|Readmission|readmission
5123109|NCT03225820|pharmacogenomic information|pharmacogenomic information
5123110|NCT03225807|Intubated|intubated
5123111|NCT03225807|Intubation|intubation
5123112|NCT03225807|Ventilator|ventilator
5123113|NCT03225807|Ventilator-free days|ventilator-free days
5123114|NCT03225807|Ventilator free days|ventilator free days
5123115|NCT03225807|Mechanical Ventilation|mechanical ventilation
5123116|NCT03225807|Meta-Analysis|meta-analysis
5123117|NCT03225807|Tidal Volume|tidal volume
5123336|NCT03224507|Daratumumab|daratumumab
5123337|NCT03224507|Carfilzomib|carfilzomib
5123338|NCT03224507|Lenalidomide|lenalidomide
5123339|NCT03224468|medical marijuana|medical marijuana
5123340|NCT03224468|cannabis|cannabis
5123341|NCT03224468|pain|pain
5123342|NCT03224468|insomnia|insomnia
5123343|NCT03224468|depression|depression
5123344|NCT03224468|anxiety|anxiety
5123345|NCT03224468|addiction|addiction
5123674|NCT03222453|stem cell|stem cell
5123675|NCT03222388|IIEF|iief
5123691|NCT03222362|trauma|trauma
5123775|NCT03221959|malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
5123776|NCT03221920|Very Low Carbohydrate Diet|very low carbohydrate diet
5123777|NCT03221920|Colorectal Adenocarcinoma|colorectal adenocarcinoma
5123778|NCT03221894|Complementary therapies|complementary therapies
5123779|NCT03221868|motor activity|motor activity
5123781|NCT03221842|Antibody-mediated kidney transplant rejection|antibody-mediated kidney transplant rejection
5123782|NCT03221842|Renal|renal
5123783|NCT03221829|spinal anaesthesia|spinal anaesthesia
5123865|NCT03221244|Virtual Reality|virtual reality
5124138|NCT03219229|Pre-pubertal|pre-pubertal
5124238|NCT03218748|stigma|stigma
5124501|NCT03216759|Comprehensive intestinal protection strategy|comprehensive intestinal protection strategy
5124502|NCT03216759|Intestinal complications|intestinal complications
5124504|NCT03216746|oral health|oral health
5124505|NCT03216746|knowledge|knowledge
5124506|NCT03216746|adolescent|adolescent
5124507|NCT03216733|DES|des
5124508|NCT03216733|Angina pectoris|angina pectoris
5124509|NCT03216733|Stent|stent
5124510|NCT03216720|Coronary artery bypass grafting|coronary artery bypass grafting
5124829|NCT03214497|Supreme|supreme
5124830|NCT03214497|Protector|protector
5124833|NCT03214458|Therapy|therapy
5124924|NCT03213899|Hospital Mortality|hospital mortality
5124925|NCT03213899|Length of Stay|length of stay
5124926|NCT03213899|Malnutrition|malnutrition
5124927|NCT03213886|hip fracture|hip fracture
5124929|NCT03213886|vitamin D|vitamin d
5124930|NCT03213886|rehabilitation|rehabilitation
5124935|NCT03213847|Carpal Tunnel Syndrome|carpal tunnel syndrome
5124942|NCT03213808|hypersensitivity|hypersensitivity
5124943|NCT03213808|International Classification of Diseases (ICD)|international classification of diseases (icd)
5124944|NCT03213808|World Health Organization (WHO)|world health organization (who)
5124945|NCT03213782|Nature Based Sounds|nature based sounds
5124947|NCT03213782|Anxiety|anxiety
5124948|NCT03213782|Patients|patients
5124949|NCT03213782|Intensive Care Units|intensive care units
5124950|NCT03213769|oral minor aphthous ulcer|oral minor aphthous ulcer
5125127|NCT03212560|Physical activity|physical activity
5125225|NCT03212118|Occupational Health|occupational health
5125240|NCT03212053|ROTEM|rotem
5125323|NCT03211533|general movements|general movements
5125324|NCT03211520|Cancer treatment|cancer treatment
5125325|NCT03211520|Anthracyclines|anthracyclines
5125326|NCT03211520|Cardiac MRI|cardiac mri
5125327|NCT03211507|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5125328|NCT03211494|Mechanical ventilation|mechanical ventilation
5125358|NCT03211221|OCD|ocd
5125432|NCT03210701|POCT|poct
5125507|NCT03210155|Post Partum|post partum
5125508|NCT03210155|Anxiety|anxiety
5125509|NCT03210155|Depression|depression
5125510|NCT03210155|Insomnia|insomnia
5125511|NCT03210155|Sleep Quality|sleep quality
5125512|NCT03210155|Maternal Functioning|maternal functioning
5125514|NCT03210129|Motivation|motivation
5125601|NCT03209414|Arterial stiffness|arterial stiffness
5125602|NCT03209414|Applanation tonometry|applanation tonometry
5125603|NCT03209414|Lean body mass|lean body mass
5125604|NCT03209414|ST2 biomarker|st2 biomarker
5125607|NCT03209375|triage|triage
5125608|NCT03209375|early warning system|early warning system
5125609|NCT03209362|Knee|knee
5125610|NCT03209362|Osteoarthritis|osteoarthritis
5125611|NCT03209362|Intra-articular injection|intra-articular injection
5125612|NCT03209349|Sigmoidoscopy|sigmoidoscopy
5125613|NCT03209336|Ultra-low rectal cancer|ultra-low rectal cancer
5125615|NCT03209336|IORT|iort
5125689|NCT03208972|low dose hCG|low dose hcg
5125690|NCT03208972|hp-FSH|hp-fsh
5125691|NCT03208972|Corifollitropin Alfa|corifollitropin alfa
5125692|NCT03208972|costs of IVF|costs of ivf
5125693|NCT03208946|Advanced glycation end products|advanced glycation end products
5125694|NCT03208946|Absorption|absorption
5125695|NCT03208946|Excretion|excretion
5125696|NCT03208933|Pirfenidone, UIP, IPF, FVC|pirfenidone, uip, ipf, fvc
5125791|NCT03208114|breastfeeding, support, promotion|breastfeeding, support, promotion
5125792|NCT03208075|phosphorus,diet|phosphorus,diet
5125793|NCT03208075|phosphorus|phosphorus
5125794|NCT03208075|healthy subject|healthy subject
5125795|NCT03208062|Biobank|biobank
5125903|NCT03207386|Sexual Violence|sexual violence
5125904|NCT03207386|Prevention|prevention
5125905|NCT03207386|Mixed-Methods|mixed-methods
5125906|NCT03207386|Outcome Evaluation|outcome evaluation
5125907|NCT03207386|Process Evaluation|process evaluation
5125908|NCT03207386|Adolescence|adolescence
5125909|NCT03207347|BAP1|bap1
5125910|NCT03207347|niraparib|niraparib
5125911|NCT03207347|DNA repair|dna repair
5125912|NCT03207347|PARP inhibitor|parp inhibitor
5125913|NCT03207347|homologous repair deficiency|homologous repair deficiency
5125914|NCT03207347|renal cell carcinoma|renal cell carcinoma
5125915|NCT03207347|cholangiocarcinoma|cholangiocarcinoma
5125916|NCT03207347|mesothelioma|mesothelioma
5125917|NCT03207347|uveal melanoma|uveal melanoma
5125923|NCT03207334|PKC412|pkc412
5125988|NCT03206931|Neurotrophic tyrosine receptor kinase (NTRK)|neurotrophic tyrosine receptor kinase (ntrk)
5125991|NCT03206931|NTRK3|ntrk3
5125992|NCT03206931|Fusion Positive|fusion positive
5125993|NCT03206931|Children|children
5125994|NCT03206931|Loxo-195|loxo-195
5125995|NCT03206892|LESS surgery|less surgery
5125996|NCT03206892|conventional multi-port laparoscopy|conventional multi-port laparoscopy
5125997|NCT03206892|SILS|sils
5125998|NCT03206892|Single-site surgery|single-site surgery
5125999|NCT03206892|Covidien|covidien
5126094|NCT03206255|Human Papilloma Virus 16|human papilloma virus 16
5126095|NCT03206255|Human Papilloma Virus 18|human papilloma virus 18
5126096|NCT03206255|adolescent girl|adolescent girl
5126097|NCT03206255|non-inferiority|non-inferiority
5126098|NCT03206255|immuno-persistence|immuno-persistence
5126099|NCT03206242|Rehabilitation|rehabilitation
5126100|NCT03206242|Physiotherapy|physiotherapy
5126101|NCT03206242|Trismus|trismus
5126102|NCT03206242|Pain|pain
5126103|NCT03206242|Return to work|return to work
5126104|NCT03206242|Quality of life|quality of life
5126105|NCT03206190|SPG4|spg4
5126106|NCT03206190|presymptomatic|presymptomatic
5126108|NCT03206190|mutation carriers|mutation carriers
5126109|NCT03206190|biomarkers|biomarkers
5126212|NCT03205462|nosocomial infection|nosocomial infection
5126213|NCT03205462|factors of pathogenicity of bacteria|factors of pathogenicity of bacteria
5126214|NCT03205462|the system of secretion of type III pathogenic bacteria|the system of secretion of type iii pathogenic bacteria
5192477|NCT02789332|pCR|pcr
5126297|NCT03204994|Fluorescence guided surgery|fluorescence guided surgery
5126298|NCT03204981|intramural needle ablation|intramural needle ablation
5126299|NCT03204981|ventricular arrhythmia|ventricular arrhythmia
5126408|NCT03204227|Vietnam|vietnam
5126409|NCT03204214|binge drinking|binge drinking
5126410|NCT03204201|Fluorescence|fluorescence
5126411|NCT03204188|Deletion 17p|deletion 17p
5126412|NCT03204188|Bruton's Tyrosine Kinase Inhibitor|bruton's tyrosine kinase inhibitor
5126413|NCT03204188|TP53 Mutation|tp53 mutation
5126418|NCT03204123|biochemical recurrence|biochemical recurrence
5126420|NCT03204123|16-306|16-306
5126421|NCT03204110|Reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome
5126422|NCT03204110|Anatomic and morphological retinal network analysis|anatomic and morphological retinal network analysis
5126423|NCT03204110|Retinal vessel analyser|retinal vessel analyser
5126424|NCT03204110|retinography|retinography
5126425|NCT03204110|Prospective analysis|prospective analysis
5126426|NCT03204084|pterygium,Low temperature plasma|pterygium,low temperature plasma
5126427|NCT03204045|oxycodone, fentanyl, tracheal extubation|oxycodone, fentanyl, tracheal extubation
5126428|NCT03204032|Tegafur|tegafur
5126429|NCT03204032|Temozolomide|temozolomide
5126430|NCT03204032|Thalidomide|thalidomide
5126431|NCT03204032|Extrapancreatic Neuroendocrine Tumor|extrapancreatic neuroendocrine tumor
5126432|NCT03204019|Tegafur|tegafur
5126433|NCT03204019|Temozolomide|temozolomide
5126494|NCT03203655|Obesity|obesity
5126495|NCT03203655|Hispanic|hispanic
5126496|NCT03203655|Women|women
5126497|NCT03203642|ADPKD|adpkd
5126498|NCT03203642|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5126599|NCT03203369|Cluster of differentiation 56 (CD56)|cluster of differentiation 56 (cd56)
5126600|NCT03203356|growth hormone|growth hormone
5126601|NCT03203356|children|children
5126696|NCT03202602|Continuous positive airway pressure|continuous positive airway pressure
5126697|NCT03202602|Telemoedicine|telemoedicine
5126698|NCT03202589|Preoperative assessement for geriatric patients|preoperative assessement for geriatric patients
5126699|NCT03202589|FOCUS Echocardiography|focus echocardiography
5126700|NCT03202589|Orthopedic|orthopedic
5126797|NCT03201848|Huaiqihuang granule|huaiqihuang granule
5126798|NCT03201848|immune thrombocytopenia|immune thrombocytopenia
5126901|NCT03201211|Safety|safety
5127067|NCT03200158|interleukin (IL)|interleukin (il)
5127068|NCT03200093|Clostridium difficile|clostridium difficile
5127406|NCT03197857|Muscle|muscle
5127407|NCT03197857|6-minute walking test|6-minute walking test
5127408|NCT03197857|Protein supplementation|protein supplementation
5127409|NCT03197857|Physical activity program|physical activity program
5127410|NCT03197831|Medicaid Expansion, Affordable Care Act, Health Care Reform|medicaid expansion, affordable care act, health care reform
5127411|NCT03197818|COPD|copd
5127498|NCT03197350|Prognosis|prognosis
5127499|NCT03197337|Vulvodynia|vulvodynia
5127500|NCT03197337|Localized Provoked Vulvodynia (LPV)|localized provoked vulvodynia (lpv)
5127501|NCT03197337|Referred pain|referred pain
5127503|NCT03197311|Oral surgery|oral surgery
5127631|NCT03196596|Computer simulation|computer simulation
5127749|NCT03195647|coronary artery by pass surgery|coronary artery by pass surgery
5127751|NCT03195634|Portal Hypertension|portal hypertension
5127752|NCT03195621|Coronary Artery Disease|coronary artery disease
5127753|NCT03195621|Critical lesion|critical lesion
5127754|NCT03195608|In-vehicle technologies|in-vehicle technologies
5127755|NCT03195608|Parkinson's disease|parkinson's disease
5127756|NCT03195608|Driving performance|driving performance
5127757|NCT03195569|QL1101 Avastin® Non Small Cell Lung Cancer|ql1101 avastin® non small cell lung cancer
5127759|NCT03195543|Platelets|platelets
5127843|NCT03195062|Post-prandial kinetics|post-prandial kinetics
5127844|NCT03195049|hyperbilirubinemia|hyperbilirubinemia
5127845|NCT03195049|kernicterus|kernicterus
5127846|NCT03195036|HIV-exposed|hiv-exposed
5127847|NCT03195036|Early Childhood Development|early childhood development
5127848|NCT03195036|Cameroon|cameroon
5127913|NCT03194776|PAD|pad
5127951|NCT03194568|Idiopathic Scoliosis|idiopathic scoliosis
5127952|NCT03194568|Adolescent Idiopathic Scoliosis|adolescent idiopathic scoliosis
5127953|NCT03194555|Innate Immune System|innate immune system
5128057|NCT03193970|Registry|registry
5128165|NCT03193151|Liver transplant|liver transplant
5128166|NCT03193151|global gene expression|global gene expression
5128167|NCT03193151|molecular diagnostics|molecular diagnostics
5128168|NCT03193138|Cardiotoxicity|cardiotoxicity
5128169|NCT03193138|Androgens|androgens
5128170|NCT03193138|Hormone Replacement Therapy|hormone replacement therapy
5128171|NCT03193138|Testosterone|testosterone
5128172|NCT03193138|Androgen Antagonists|androgen antagonists
5128173|NCT03193112|Agomelatine|agomelatine
5128267|NCT03192501|advanced cancers|advanced cancers
5128395|NCT03191747|Gender|gender
5128503|NCT03191266|alcohol use disorder|alcohol use disorder
5128505|NCT03191266|relapse|relapse
5128506|NCT03191266|Veterans|veterans
5128740|NCT03189810|Schizophrenia|schizophrenia
5128945|NCT03188380|preterm|preterm
5129051|NCT03187860|Bronchial epithelial cell|bronchial epithelial cell
5129155|NCT03187327|ovarian cancers|ovarian cancers
5129156|NCT03187314|Esophageal cancer|esophageal cancer
5129387|NCT03185832|Sudden Cardiac Death|sudden cardiac death
5129389|NCT03185832|Implanted device|implanted device
5129391|NCT03185832|CRT|crt
5129392|NCT03185806|severe acute pancreatitis|severe acute pancreatitis
5129393|NCT03185806|sterile acute peripancreatic fluid collections|sterile acute peripancreatic fluid collections
5129449|NCT03185442|PRF|prf
5129605|NCT03184389|Physiological Monitoring|physiological monitoring
5129606|NCT03184389|Respiratory Pattern Monitoring|respiratory pattern monitoring
5129607|NCT03184389|Stress-Management Interventions|stress-management interventions
5130306|NCT03180320|Baduanjin|baduanjin
5129698|NCT03183934|Stem cell|stem cell
5129699|NCT03183908|influenza vaccine|influenza vaccine
5129700|NCT03183908|fever following vaccination|fever following vaccination
5129701|NCT03183908|pain following vaccination|pain following vaccination
5129702|NCT03183908|quality of life|quality of life
5129703|NCT03183869|microbiome|microbiome
5129704|NCT03183869|multiple sclerosis|multiple sclerosis
5129800|NCT03183193|Transcriptomics|transcriptomics
5129902|NCT03182699|FGF 23|fgf 23
5130002|NCT03182244|ASP2215|asp2215
5130003|NCT03182231|exendin|exendin
5130121|NCT03181633|Hemoglobinuria|hemoglobinuria
5130122|NCT03181633|ACH-0144471|ach-0144471
5130123|NCT03181594|Cryotherapy|cryotherapy
5130124|NCT03181594|Cryoablation|cryoablation
5130125|NCT03181581|ultrasonography|ultrasonography
5130126|NCT03181581|ultrasonics|ultrasonics
5130127|NCT03181581|brain|brain
5130128|NCT03181581|surgery|surgery
5130129|NCT03181555|Pregnant|pregnant
5130233|NCT03180944|mucosal irritation|mucosal irritation
5130234|NCT03180944|image quality|image quality
5130235|NCT03180892|Iodine|iodine
5130236|NCT03180892|thyroid peroxidase antibody|thyroid peroxidase antibody
5130335|NCT03180060|SPECT|spect
5130447|NCT03179306|Costa Rica|costa rica
5130448|NCT03179280|Type 1 diabetes|type 1 diabetes
5130449|NCT03179280|Dual-wave bolus|dual-wave bolus
5130450|NCT03179280|Postprandial euglycaemia|postprandial euglycaemia
5130558|NCT03178487|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
5130559|NCT03178487|Safety|safety
5130560|NCT03178487|Efficacy|efficacy
5130561|NCT03178474|infant formula|infant formula
5130562|NCT03178474|Clinical trial|clinical trial
5130563|NCT03178474|Chinese infant|chinese infant
5130564|NCT03178474|body growth|body growth
5130565|NCT03178474|gut microbiota|gut microbiota
5130566|NCT03178474|Stool characteristics|stool characteristics
5130567|NCT03178461|Caesarean Section|caesarean section
5130568|NCT03178461|Delivery|delivery
5130569|NCT03178435|risk score|risk score
5130570|NCT03178435|Acute kidney injury|acute kidney injury
5130571|NCT03178435|critical care|critical care
5130572|NCT03178422|tobacco use cessation|tobacco use cessation
5130573|NCT03178422|smoking prevention|smoking prevention
5130575|NCT03178370|Gastroparesis|gastroparesis
5130576|NCT03178370|Nausea and Vomiting|nausea and vomiting
5130577|NCT03178370|Abdominal Pain|abdominal pain
5130578|NCT03178370|Gastric Emptying|gastric emptying
5130579|NCT03178370|Electrophysiology|electrophysiology
5130580|NCT03178370|Hormones|hormones
5130581|NCT03178370|Inflammation|inflammation
5130582|NCT03178370|Enteric Nervous System|enteric nervous system
5130583|NCT03178370|Autonomic Nervous System|autonomic nervous system
5130642|NCT03177850|acetazolamide|acetazolamide
5130643|NCT03177850|altitude|altitude
5130644|NCT03177850|nocturnal pulse oxymetry|nocturnal pulse oxymetry
5130855|NCT03176485|colon|colon
5130856|NCT03176485|thyroid|thyroid
5130857|NCT03176485|Differentiated|differentiated
5130858|NCT03176485|Hepatocellular Carcinoma|hepatocellular carcinoma
5130860|NCT03176485|RCC|rcc
5130864|NCT03176472|HDAC6|hdac6
5342963|NCT01981356|Schizophrenia|schizophrenia
5198108|NCT02756559|sepsis|sepsis
5130963|NCT03175887|TMS|tms
5131057|NCT03175081|Intraperitoneal local anesthetic|intraperitoneal local anesthetic
5131059|NCT03175081|Postoperative pain|postoperative pain
5131060|NCT03175081|Bariatric surgery|bariatric surgery
5131061|NCT03175068|Functional magnetic resonance imaging|functional magnetic resonance imaging
5131138|NCT03174522|Tissue-engineered Medicinal Product|tissue-engineered medicinal product
5131139|NCT03174522|Revascularization|revascularization
5131141|NCT03174522|Vasculogenesis|vasculogenesis
5131142|NCT03174522|Arteriogenesis|arteriogenesis
5131252|NCT03173638|acute non arteritic anterior ischemic optic neuropathy|acute non arteritic anterior ischemic optic neuropathy
5131253|NCT03173638|mesenchymal stem cells|mesenchymal stem cells
5131254|NCT03173638|intravitreal injection|intravitreal injection
5131256|NCT03173599|Chronic Hepatitis B|chronic hepatitis b
5131360|NCT03172897|Adult|adult
5131361|NCT03172897|Intensive care unit|intensive care unit
5131362|NCT03172897|Mechanical ventilation|mechanical ventilation
5131363|NCT03172897|Delirium|delirium
5131364|NCT03172897|Dexmedetomidine|dexmedetomidine
5131365|NCT03172884|Renal Impairment|renal impairment
5131450|NCT03172312|hypoparathyroidism|hypoparathyroidism
5131451|NCT03172312|prediction|prediction
5131452|NCT03172273|Liver Cirrhosis|liver cirrhosis
5131453|NCT03172273|Transjugular Intrahepatic Portosystemic shunt|transjugular intrahepatic portosystemic shunt
5131454|NCT03172273|Refractory ascites|refractory ascites
5131455|NCT03172247|cardiology diabetes|cardiology diabetes
5342964|NCT01981356|Acute psychiatric disorder|acute psychiatric disorder
5131456|NCT03172234|β-endorphins,laryngoscopy and tracheal intubation|β-endorphins,laryngoscopy and tracheal intubation
5131686|NCT03170531|MRI|mri
5131687|NCT03170531|MR imaging|mr imaging
5131688|NCT03170531|17-267|17-267
5131689|NCT03170505|cleft palate|cleft palate
5131805|NCT03169621|Chronic Endometritis|chronic endometritis
5131806|NCT03169621|Endometrial pathogens|endometrial pathogens
5131807|NCT03169621|Microbiological diagnosis|microbiological diagnosis
5132020|NCT03168399|Phenylketonuria|phenylketonuria
5132021|NCT03168399|PKU|pku
5132022|NCT03168399|Metabolism|metabolism
5132023|NCT03168399|Metabolic|metabolic
5132024|NCT03168399|Control|control
5132025|NCT03168399|Acceptability|acceptability
5132026|NCT03168347|Decision making|decision making
5132027|NCT03168269|CCTA interpretation|ccta interpretation
5132028|NCT03168269|technicians|technicians
5132029|NCT03168269|experts|experts
5132030|NCT03168269|comparison|comparison
5132032|NCT03168217|Periodontitis|periodontitis
5132122|NCT03167528|Quality of life|quality of life
5132124|NCT03167476|biomarker|biomarker
5132125|NCT03167450|CRISPR|crispr
5132126|NCT03167450|Gene Editing|gene editing
5132127|NCT03167450|Qualitative|qualitative
5132128|NCT03167450|Participation Clinical Trials|participation clinical trials
5132129|NCT03167450|Genetic Literacy|genetic literacy
5132130|NCT03167437|Reduce Symptoms of Crohn's Disease|reduce symptoms of crohn's disease
5132131|NCT03167437|HDAC Inhibitors|hdac inhibitors
5132132|NCT03167424|In-stent restenosis|in-stent restenosis
5132133|NCT03167424|Bioresorbable vascular scaffold|bioresorbable vascular scaffold
5132134|NCT03167424|Coronary angiography|coronary angiography
5132135|NCT03167398|fecal microbiota transplantation|fecal microbiota transplantation
5132136|NCT03167398|carbapenem-resistant enterobacteriaceae|carbapenem-resistant enterobacteriaceae
5132137|NCT03167398|multidrug resistant bacteria|multidrug resistant bacteria
5132138|NCT03167398|carrier|carrier
5132139|NCT03167385|locally advanced differentiated thyroid carcinoma|locally advanced differentiated thyroid carcinoma
5132141|NCT03167372|Light Therapy|light therapy
5132159|NCT03167294|BPH|bph
5132210|NCT03167034|acetazolamide|acetazolamide
5132211|NCT03167034|altitude|altitude
5132212|NCT03167021|Cannabis|cannabis
5132213|NCT03167021|Community pharmacy|community pharmacy
5132214|NCT03167021|Prevention|prevention
5132319|NCT03166033|etiology|etiology
5132454|NCT03165175|education|education
5132567|NCT03164317|Hypertension|hypertension
5132568|NCT03164317|High blood pressure|high blood pressure
5132569|NCT03164317|Task shifting|task shifting
5132571|NCT03164291|MAC and NTM|mac and ntm
5132662|NCT03163667|RCC|rcc
5132663|NCT03163667|CB-839|cb-839
5132916|NCT03162445|Autism|autism
5133133|NCT03161067|Intracortical Microstimulation|intracortical microstimulation
5133134|NCT03161067|Upper extremity prosthetics|upper extremity prosthetics
5158953|NCT02998762|biomarkers|biomarkers
5133135|NCT03161054|Metronomic Chemotherapy|metronomic chemotherapy
5133150|NCT03160963|elderly|elderly
5133251|NCT03160274|oncogene|oncogene
5133252|NCT03160274|mutation|mutation
5133253|NCT03160274|susceptibility gene|susceptibility gene
5133254|NCT03160222|reliability|reliability
5356847|NCT01917747|Infant hearing screening|infant hearing screening
5133255|NCT03160222|bioelectrical impedance analysis|bioelectrical impedance analysis
5133256|NCT03160222|computed tomography|computed tomography
5133257|NCT03160222|strength|strength
5133258|NCT03160222|mobility|mobility
5133259|NCT03160209|risk factors|risk factors
5133260|NCT03160209|case-control study|case-control study
5133263|NCT03160183|initiating chemotherapy|initiating chemotherapy
5133569|NCT03158194|Asthma|asthma
5133570|NCT03158181|Behavior; Operational block; Monitoring; Social Sciences ; New technologies|behavior; operational block; monitoring; social sciences ; new technologies
5133787|NCT03157128|C611Y|c611y
5133788|NCT03157128|C611W|c611w
5133789|NCT03157128|C618F|c618f
5133790|NCT03157128|C618R|c618r
5133791|NCT03157128|C618S|c618s
5133792|NCT03157128|C620F|c620f
5133793|NCT03157128|C620R|c620r
5133794|NCT03157128|C620S|c620s
5133795|NCT03157128|C630R|c630r
5133796|NCT03157128|C630Y|c630y
5133797|NCT03157128|D631Y|d631y
5133798|NCT03157128|C634F|c634f
5134087|NCT03155529|cervical cancer|cervical cancer
5134088|NCT03155529|radical hysterectomy|radical hysterectomy
5134089|NCT03155529|Postoperative pelvic floor dysfunction|postoperative pelvic floor dysfunction
5134090|NCT03155529|the injure of pelvic floor|the injure of pelvic floor
5134091|NCT03155529|Three-dimensional reconstruction|three-dimensional reconstruction
5134092|NCT03155529|structural destruction of pelvic organs|structural destruction of pelvic organs
5134093|NCT03155529|structural destruction of pelvoic floor|structural destruction of pelvoic floor
5134094|NCT03155516|Cancer pain|cancer pain
5134095|NCT03155516|GPM|gpm
5134096|NCT03155516|pain assessment|pain assessment
5134229|NCT03154671|integrated care|integrated care
5134230|NCT03154671|randomized controlled trial|randomized controlled trial
5134231|NCT03154632|Myofascial trigger point|myofascial trigger point
5134232|NCT03154632|Trapezius Muscle|trapezius muscle
5134233|NCT03154632|Diathermy|diathermy
5134465|NCT03153150|Vitamin K antagonist|vitamin k antagonist
5134466|NCT03153150|Antiplatelet drug|antiplatelet drug
5134467|NCT03153124|Respiratory muscle strength|respiratory muscle strength
5134468|NCT03153124|Renal insufficiency|renal insufficiency
5134469|NCT03153124|Respiratory muscle training|respiratory muscle training
5134475|NCT03153098|well-being|well-being
5134561|NCT03152617|malnutrition|malnutrition
5134562|NCT03152617|bone disease|bone disease
5134563|NCT03152617|oral health|oral health
5134564|NCT03152591|Polycystic ovary syndrome|polycystic ovary syndrome
5134565|NCT03152591|PCOS|pcos
5134568|NCT03152591|overweight|overweight
5134659|NCT03152149|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5134660|NCT03152110|High Intensity Interval Training|high intensity interval training
5134661|NCT03152110|HIIT|hiit
5134662|NCT03152110|Physical Activity|physical activity
5134663|NCT03152071|thoracoscopic surgery|thoracoscopic surgery
5134664|NCT03152071|RATS|rats
5134665|NCT03152071|VATS|vats
5134775|NCT03151265|Wearable Sensors|wearable sensors
5134975|NCT03150147|Reperfusion injury|reperfusion injury
5134976|NCT03150147|Heart transplantation|heart transplantation
5135079|NCT03149549|Antibody drug conjugate|antibody drug conjugate
5135080|NCT03149549|CD166|cd166
5135081|NCT03149536|pharmacogenetic|pharmacogenetic
5135082|NCT03149536|pharmacogenomic|pharmacogenomic
5135083|NCT03149536|polymorphism|polymorphism
5135084|NCT03149536|individualized controlled ovarian stimulation|individualized controlled ovarian stimulation
5135085|NCT03149536|algorithm|algorithm
5135086|NCT03149536|assisted reproduction|assisted reproduction
5135087|NCT03149523|exhaustive genetic and immunological analyses|exhaustive genetic and immunological analyses
5135088|NCT03149523|targeted therapies|targeted therapies
5135089|NCT03149523|colon cancer|colon cancer
5135170|NCT03148990|Safety Efficacy Imunogenicity|safety efficacy imunogenicity
5135361|NCT03147352|Flesh eating bacteria|flesh eating bacteria
5135362|NCT03147352|Meleneys ulcer|meleneys ulcer
5135363|NCT03147352|Wounds and Injuries|wounds and injuries
5135364|NCT03147352|Streptococcus pyogenes|streptococcus pyogenes
5135365|NCT03147352|Staphylococcus aureus|staphylococcus aureus
5135366|NCT03147352|Soft Tissue Infections/blood|soft tissue infections/blood
5135367|NCT03147352|Necrosis/blood|necrosis/blood
5135368|NCT03147352|Necrosis/diagnosis|necrosis/diagnosis
5135369|NCT03147352|Necrosis/mortality|necrosis/mortality
5135371|NCT03147352|Prognosis|prognosis
5135446|NCT03146819|total knee replacement|total knee replacement
5135447|NCT03146819|patient specific|patient specific
5135448|NCT03146819|total knee arthroplasty|total knee arthroplasty
5135449|NCT03146819|orthopedics|orthopedics
5135450|NCT03146806|Cancer pain|cancer pain
5135451|NCT03146806|Anesthesiology|anesthesiology
5135452|NCT03146806|Opiates|opiates
5135453|NCT03146806|Intranasal ketamine|intranasal ketamine
5135454|NCT03146793|Calciphylaxis/complications|calciphylaxis/complications
5135455|NCT03146793|Kidney Failure, Chronic/complications|kidney failure, chronic/complications
5135457|NCT03146793|Thiosulfates/therapeutic use|thiosulfates/therapeutic use
5135458|NCT03146793|Time Factors|time factors
5135460|NCT03146702|Quality of Life|quality of life
5135461|NCT03146689|osteoarthritis|osteoarthritis
5135462|NCT03146689|n-of-1|n-of-1
5135463|NCT03146689|ibuprofen|ibuprofen
5135464|NCT03146689|capsaicin|capsaicin
5135465|NCT03146689|NSAID|nsaid
5135466|NCT03146689|topical|topical
5135467|NCT03146663|Platinum-resistant|platinum-resistant
5135468|NCT03146663|ovarian neoplasm|ovarian neoplasm
5135469|NCT03146663|antineoplastic agents|antineoplastic agents
5135470|NCT03146663|ovarian diseases|ovarian diseases
5135490|NCT03146455|racial|racial
5135534|NCT03146195|pelvic organ prolapse|pelvic organ prolapse
5135535|NCT03146195|dynamic magnetic resonance imaging|dynamic magnetic resonance imaging
5135536|NCT03146195|three-dimensional reconstruction|three-dimensional reconstruction
5135537|NCT03146195|space coordinates|space coordinates
5135539|NCT03146182|Procalcitonin|procalcitonin
5135649|NCT03145415|caudal block|caudal block
5135650|NCT03145376|TAVI|tavi
5135651|NCT03145376|MitraClip|mitraclip
5135652|NCT03145376|geriatric assessment|geriatric assessment
5135653|NCT03145376|heart rate variability|heart rate variability
5765614|NCT00260988|INR|inr
5135739|NCT03144817|dialysis disequilibrium|dialysis disequilibrium
5135740|NCT03144817|intra-dialytic hypotension|intra-dialytic hypotension
5135742|NCT03144804|Colorectal Cancer|colorectal cancer
5135839|NCT03144089|Morbid obesity|morbid obesity
5135843|NCT03144076|healthcare|healthcare
5135939|NCT03143517|Indeterminate Colitis|indeterminate colitis
5135940|NCT03143426|3D laparoscopic cholecystectomy|3d laparoscopic cholecystectomy
5135995|NCT03142919|MRI|mri
5136039|NCT03142620|Drug resistant H.pylori infection|drug resistant h.pylori infection
5136040|NCT03142620|vitamin D|vitamin d
5136041|NCT03142620|gastritis|gastritis
5136042|NCT03142529|Non dialysis|non dialysis
5136149|NCT03141905|self-management|self-management
5136150|NCT03141905|remote monitoring|remote monitoring
5136151|NCT03141879|Frailty|frailty
5136152|NCT03141879|Physical Activity|physical activity
5136153|NCT03141879|Resistance training|resistance training
5136154|NCT03141853|Randomized Controlled Trial|randomized controlled trial
5136155|NCT03141853|Intervention Study|intervention study
5136157|NCT03141827|Apolipoprotein|apolipoprotein
5136158|NCT03141827|Pancreatic clamp|pancreatic clamp
5136159|NCT03141827|Insulin|insulin
5136160|NCT03141827|Nasal|nasal
5136161|NCT03141801|ACL|acl
5136162|NCT03141801|Knee|knee
5136163|NCT03141801|Muscle|muscle
5136164|NCT03141788|Aligners|aligners
5136244|NCT03141229|School|school
5136245|NCT03141229|Burnout|burnout
5136344|NCT03140488|Induction of labor|induction of labor
5136451|NCT03139864|Substrate utilization|substrate utilization
5136571|NCT03138889|HCC|hcc
5136670|NCT03138044|Hepatocellular Carcinoma|hepatocellular carcinoma
5136964|NCT03136120|IPF|ipf
5137066|NCT03135392|Neurotization|neurotization
5137166|NCT03134677|P wave dispersion|p wave dispersion
5137168|NCT03134651|Oocyte retrieval|oocyte retrieval
5137169|NCT03134651|Monitoring of brain function|monitoring of brain function
5137170|NCT03134625|metabolomics|metabolomics
5137171|NCT03134625|biomarker|biomarker
5137172|NCT03134625|acute rejection|acute rejection
5137173|NCT03134612|lidocain|lidocain
5137174|NCT03134612|ondansetron|ondansetron
5137175|NCT03134612|pain|pain
5137176|NCT03134612|propofol|propofol
5137177|NCT03134586|Capsule endoscopy|capsule endoscopy
5137178|NCT03134586|Crohn's disease|crohn's disease
5137179|NCT03134586|Magnetic resonance enterography|magnetic resonance enterography
5137259|NCT03133975|high dose vitamin D|high dose vitamin d
5137260|NCT03133975|dyslipidemia|dyslipidemia
5137261|NCT03133975|premenopausal women|premenopausal women
5137262|NCT03133923|Attenuated Mumps Vaccine(F-genotype，Human Diploid Cell, KMB-17), safety, immunogenecity|attenuated mumps vaccine(f-genotype，human diploid cell, kmb-17), safety, immunogenecity
5137263|NCT03133910|Pharmacokinetics|pharmacokinetics
5137264|NCT03133910|Ceftazidime|ceftazidime
5137266|NCT03133897|prednisone|prednisone
5137484|NCT03132519|Cough|cough
5137485|NCT03132519|Hypertension|hypertension
5137486|NCT03132519|Remifentanil|remifentanil
5137487|NCT03132519|Sevoflurane|sevoflurane
5137488|NCT03132519|Desflurane|desflurane
5137489|NCT03132441|advanced heart failure|advanced heart failure
5137490|NCT03132441|NYHA Class III-IV|nyha class iii-iv
5137491|NCT03132441|frailty|frailty
5137492|NCT03132441|cardiac rehabilitation|cardiac rehabilitation
5137506|NCT03132389|HIV|hiv
5137580|NCT03131882|trigger thumb|trigger thumb
5137631|NCT03131544|BPH|bph
5137722|NCT03130829|QoL|qol
5137803|NCT03130374|cell therapy|cell therapy
5137900|NCT03129555|Direct-acting Oral Anticoagulants|direct-acting oral anticoagulants
5137901|NCT03129555|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
5137902|NCT03129516|imaginary|imaginary
5137903|NCT03129516|Turkish version|turkish version
5137904|NCT03129516|motor imagery|motor imagery
5137905|NCT03129516|reliability|reliability
5137906|NCT03129503|Optical coherence tomography (OCT)|optical coherence tomography (oct)
5137907|NCT03129490|Atrial Fibrillation|atrial fibrillation
5137908|NCT03129490|Non-vitamin K antagonist oral anticoagulation|non-vitamin k antagonist oral anticoagulation
5137909|NCT03129490|Direct-acting oral anticoagulants|direct-acting oral anticoagulants
5137910|NCT03129490|Novel oral anticoagulant drugs|novel oral anticoagulant drugs
5137911|NCT03129490|Non-vitamin K antagonist oral anticoagulants|non-vitamin k antagonist oral anticoagulants
5137912|NCT03129477|Non invasive ventilation in COPD|non invasive ventilation in copd
5137913|NCT03129477|Noninvasive ventilation|noninvasive ventilation
5137914|NCT03129477|Tele-monitoring|tele-monitoring
5137915|NCT03129438|continuous EEG|continuous eeg
5137916|NCT03129438|routine EEG|routine eeg
5137917|NCT03129438|prognosis|prognosis
5137918|NCT03129425|Patient|patient
5137919|NCT03129425|Caregiver|caregiver
5137920|NCT03129425|Coping|coping
5137921|NCT03129425|Psychosocial adaptation|psychosocial adaptation
5137922|NCT03129399|anesthesia|anesthesia
5137923|NCT03129399|King Vision|king vision
5137924|NCT03129399|videolaryngoscope|videolaryngoscope
5137925|NCT03129399|nasotracheal|nasotracheal
5137926|NCT03129360|Early Psychosis|early psychosis
5137927|NCT03129360|Levetiracetam|levetiracetam
5137928|NCT03129308|HIV|hiv
5137929|NCT03129308|Cutaneous Autoantibodies|cutaneous autoantibodies
5137930|NCT03129308|Indirect Immunofluorescence|indirect immunofluorescence
5137931|NCT03129269|Cognitive decline|cognitive decline
5137932|NCT03129269|frailty|frailty
5137933|NCT03129269|mild cognitive impairment|mild cognitive impairment
5137934|NCT03129269|Positron Emission Tomography, PET|positron emission tomography, pet
5137935|NCT03129269|Alzheimer disease|alzheimer disease
5137936|NCT03129269|amyloid load|amyloid load
5137937|NCT03129269|Magnetic resonance imaging, MRI|magnetic resonance imaging, mri
5137938|NCT03129256|non-small cell lung cancer|non-small cell lung cancer
5137939|NCT03129256|Apatinib|apatinib
5137940|NCT03129256|S1|s1
5137953|NCT03129165|Public Health|public health
5137954|NCT03129165|Hypertension|hypertension
5137955|NCT03129165|Smoking|smoking
5137956|NCT03129165|Hypercholesterolemia|hypercholesterolemia
5137957|NCT03129165|Food Habits|food habits
5137958|NCT03129165|Exercise|exercise
5137959|NCT03129165|Anxiety|anxiety
5137960|NCT03129165|Depression|depression
5137961|NCT03129165|Obesity|obesity
5137962|NCT03129165|Diabetes|diabetes
5137963|NCT03129139|Metastatic|metastatic
5137964|NCT03128996|Bone marrow transplant|bone marrow transplant
5137965|NCT03128996|Transplant|transplant
5137966|NCT03128996|Transplantation|transplantation
5138278|NCT03126890|Linezolid|linezolid
5138422|NCT03126045|Lumbar puncture|lumbar puncture
5138525|NCT03125447|Mobility|mobility
5138529|NCT03125343|radiotherapy|radiotherapy
5138530|NCT03125343|chemotherapy|chemotherapy
5138531|NCT03125343|complete response|complete response
5138624|NCT03124368|MCGN|mcgn
5138728|NCT03123809|Idiopathic -unknown etiology|idiopathic -unknown etiology
5138729|NCT03123796|chronic rejection|chronic rejection
5138730|NCT03123796|transplant outcome|transplant outcome
5138731|NCT03123783|CD40|cd40
5138732|NCT03123783|Immunotherapy|immunotherapy
5138832|NCT03123055|Urothelial Cell Carcinoma|urothelial cell carcinoma
5138833|NCT03123055|UCC|ucc
5138834|NCT03123055|bladder cancer|bladder cancer
5138835|NCT03123055|B-701|b-701
5138836|NCT03123055|FGFR3|fgfr3
5138843|NCT03123055|Phase 1b|phase 1b
5138931|NCT03122522|Ipilimumab|ipilimumab
5138932|NCT03122522|Nivolumab|nivolumab
5138933|NCT03122522|17-162|17-162
5138942|NCT03122496|17-108|17-108
5139242|NCT03120429|weight loss|weight loss
5139338|NCT03119818|ATP|atp
5139360|NCT03119753|Rapid Prototyping technique|rapid prototyping technique
5139361|NCT03119753|complete denture|complete denture
5139362|NCT03119714|bronchoprovocation|bronchoprovocation
5139363|NCT03119714|early-late asthmatic reaction|early-late asthmatic reaction
5139364|NCT03119714|mast cell stabilizer|mast cell stabilizer
5139365|NCT03119714|mast cell mediators|mast cell mediators
5139369|NCT03119675|Myopia|myopia
5139467|NCT03119038|degenerative joint disease|degenerative joint disease
5139468|NCT03119038|osteoarthritis|osteoarthritis
5139469|NCT03119025|Dendritic Cells|dendritic cells
5139470|NCT03119025|DC-based Vaccines|dc-based vaccines
5139471|NCT03119025|Chronic HCV Infection|chronic hcv infection
5139472|NCT03119025|Antigen-Specific T cell response|antigen-specific t cell response
5139473|NCT03119025|Recombinant HCV-Core antigen|recombinant hcv-core antigen
5139474|NCT03119025|Recombinant HCV-NS3 antigen|recombinant hcv-ns3 antigen
5139475|NCT03119012|Bioresorbable scaffold|bioresorbable scaffold
5139479|NCT03118986|olanzapine|olanzapine
5139773|NCT03117231|transcranial direct current stimulation|transcranial direct current stimulation
5139880|NCT03116529|Durvalumab|durvalumab
5241225|NCT02496390|Obesity|obesity
5140305|NCT03113695|Chronic Lumphocytic Leukemia|chronic lumphocytic leukemia
5140306|NCT03113695|obinutuzumab|obinutuzumab
5140307|NCT03113695|HDMP|hdmp
5140308|NCT03113695|lenalidomide|lenalidomide
5140309|NCT03113695|cancer|cancer
5140310|NCT03113695|methylprednisolone|methylprednisolone
5140311|NCT03113643|Acute Myeloid Leukemia|acute myeloid leukemia
5140312|NCT03113643|Myelodysplastic Syndrome|myelodysplastic syndrome
5140313|NCT03113630|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5140314|NCT03113630|Virtual Reality Exposure Therapy|virtual reality exposure therapy
5140315|NCT03113630|User-Computer Interface|user-computer interface
5140316|NCT03113630|Rehabilitation|rehabilitation
5140317|NCT03113630|Motor Activity|motor activity
5140393|NCT03113175|Anxiety|anxiety
5140394|NCT03113175|Collaborative care|collaborative care
5140395|NCT03113175|Consultation-liaison|consultation-liaison
5140396|NCT03113175|General practitioner|general practitioner
5140397|NCT03113175|Psychiatry|psychiatry
5140398|NCT03113162|multiple sclerosis|multiple sclerosis
5140498|NCT03112525|transporter|transporter
5140613|NCT03112083|krill powder|krill powder
5140614|NCT03112083|krill oil|krill oil
5140615|NCT03112083|safety|safety
5140616|NCT03112083|tolerability|tolerability
5140617|NCT03112083|adverse event|adverse event
5140618|NCT03112083|omega-3 fatty acids|omega-3 fatty acids
5140619|NCT03112083|eicosapentaenoic acid|eicosapentaenoic acid
5140621|NCT03112044|Lung|lung
5140727|NCT03111368|pancreatic neoplasm|pancreatic neoplasm
5140728|NCT03111368|slow-pull|slow-pull
5140729|NCT03111368|negative pressure|negative pressure
5140730|NCT03111355|nuts|nuts
5140731|NCT03111355|micronutrients|micronutrients
5140732|NCT03111355|nutrigenomics|nutrigenomics
5140733|NCT03111355|nutrigenetics|nutrigenetics
5140820|NCT03111017|peak oxygen uptake|peak oxygen uptake
5140821|NCT03111004|information technology|information technology
5140822|NCT03111004|telemedicine|telemedicine
5140930|NCT03110315|Belsomra|belsomra
5140931|NCT03110315|Sleep disorder|sleep disorder
5140932|NCT03110315|Sleep|sleep
5140933|NCT03110302|Posttraumatic Stress Disorder|posttraumatic stress disorder
5141153|NCT03108807|NEWS|news
5141262|NCT03108144|referral to treatment|referral to treatment
5141263|NCT03108144|cancer risk|cancer risk
5141264|NCT03108118|Diaphragm dysfunction|diaphragm dysfunction
5141374|NCT03107520|avascular necrosis|avascular necrosis
5141375|NCT03107507|EEG with Periodic Abnormalities|eeg with periodic abnormalities
5141376|NCT03107507|Levetiracetam|levetiracetam
5141377|NCT03107507|Phenobarbitone|phenobarbitone
5141378|NCT03107507|neonatal seizures|neonatal seizures
5141770|NCT03105024|extinction|extinction
5141771|NCT03105024|self-efficacy|self-efficacy
5141772|NCT03105011|Type 2 diabetes|type 2 diabetes
5141773|NCT03104998|Idiopathic|idiopathic
5141774|NCT03104998|Infertility|infertility
5141775|NCT03104998|coenzyme q10|coenzyme q10
5141776|NCT03104998|Pakistan|pakistan
5141777|NCT03104985|Trophic ulcer; low level laser therapy; Chronic Venous Insufficiency|trophic ulcer; low level laser therapy; chronic venous insufficiency
5141778|NCT03104972|ADHD|adhd
5141779|NCT03104972|TRANS CRANIAL ELECTRIC STIMULATION|trans cranial electric stimulation
5141780|NCT03104959|hangovers|hangovers
5141898|NCT03104348|COPD|copd
5142012|NCT03103685|Dual antiplatelet therapy|dual antiplatelet therapy
5142014|NCT03103672|quality of anesthesia|quality of anesthesia
5142015|NCT03103672|reduce recovery time|reduce recovery time
5142016|NCT03103633|oxygen dynamics|oxygen dynamics
5142017|NCT03103633|Prognosis|prognosis
5142018|NCT03103555|Anti-interferon gamma autoantibody|anti-interferon gamma autoantibody
5142020|NCT03103542|rFVIIIFc|rfviiifc
5142113|NCT03102736|nitroprusside|nitroprusside
5142114|NCT03102723|STEMI|stemi
5142115|NCT03102723|primary percutaneous coronary intervention (PPCI)|primary percutaneous coronary intervention (ppci)
5142116|NCT03102723|cangrelor|cangrelor
5142117|NCT03102723|reperfusion|reperfusion
5142118|NCT03102697|Intragastric balloon|intragastric balloon
5142119|NCT03102697|obesity|obesity
5142120|NCT03102697|metabolic syndrome|metabolic syndrome
5142217|NCT03101852|severe acute malnutrition|severe acute malnutrition
5142218|NCT03101852|moderate acute malnutrition|moderate acute malnutrition
5142219|NCT03101852|HIV-infection|hiv-infection
5142220|NCT03101852|adolescents|adolescents
5142324|NCT03101358|cutaneous metastasis|cutaneous metastasis
5142325|NCT03101358|skin metastases|skin metastases
5142425|NCT03100773|dental atraumatic restorative treatment|dental atraumatic restorative treatment
5142426|NCT03100773|health education|health education
5142427|NCT03100773|microbiota|microbiota
5142428|NCT03100773|oral hygiene|oral hygiene
5142549|NCT03099993|kinematics|kinematics
5142758|NCT03098732|Stroke|stroke
5142759|NCT03098732|Ischemic|ischemic
5142760|NCT03098732|Tissue Plasminogen Activator|tissue plasminogen activator
5142761|NCT03098732|Thrombolysis|thrombolysis
5142762|NCT03098732|Vascular Diseases|vascular diseases
5142763|NCT03098732|Cerebrovascular Disorders|cerebrovascular disorders
5142959|NCT03097562|Cataract|cataract
5142960|NCT03097562|Femtosecond laser|femtosecond laser
5142961|NCT03097562|Cornea|cornea
5142962|NCT03097562|Anatomy|anatomy
5143066|NCT03097029|pancreatic enzymes|pancreatic enzymes
5143067|NCT03097016|Renal Impairment|renal impairment
5143068|NCT03097016|Pharmacokinetics|pharmacokinetics
5143070|NCT03097016|Mild|mild
5143071|NCT03097016|Moderate|moderate
5143183|NCT03096548|Skin Cancer|skin cancer
5143197|NCT03096379|TB|tb
5143493|NCT03094676|Recovery of Physiological Function|recovery of physiological function
5143494|NCT03094676|Heart Rate|heart rate
5143495|NCT03094663|IPACK|ipack
5143497|NCT03094650|stroke|stroke
5143498|NCT03094650|neurorehabilitation|neurorehabilitation
5143506|NCT03094624|EEG|eeg
5143593|NCT03094117|Misleading extrapolation|misleading extrapolation
5143594|NCT03094117|phase I/II trials|phase i/ii trials
5143595|NCT03094117|non-randomized trials|non-randomized trials
5143698|NCT03093532|emergency department|emergency department
5143699|NCT03093532|stage 2 hypertension|stage 2 hypertension
5143700|NCT03093532|minorities|minorities
5143701|NCT03093506|Erythropoietin|erythropoietin
5143718|NCT03093415|MAT|mat
5143910|NCT03092362|quality of life|quality of life
5143913|NCT03092271|suicide|suicide
5144004|NCT03091686|Intentions|intentions
5144205|NCT03090269|pharmacokinetics|pharmacokinetics
5144304|NCT03089736|Pain|pain
5144305|NCT03089736|Head and neck cancer|head and neck cancer
5144406|NCT03089177|Community Gardening|community gardening
5144407|NCT03089177|Health Behavior Change|health behavior change
5144408|NCT03089177|Physical Activity|physical activity
5144409|NCT03089177|Diet|diet
5144410|NCT03089177|Obesity|obesity
5144500|NCT03088592|Deep Brain Stimulation|deep brain stimulation
5144501|NCT03088579|radiation shielding|radiation shielding
5144503|NCT03088553|trough concentrations|trough concentrations
5144504|NCT03088553|CMV viral load|cmv viral load
5144505|NCT03088553|safety|safety
5144507|NCT03088540|Previous Smoker|previous smoker
5144607|NCT03088007|regular and special schools|regular and special schools
5144608|NCT03087942|end stage renal disase ESRD|end stage renal disase esrd
5144609|NCT03087942|dialysis effect on pharmacokinetics PK|dialysis effect on pharmacokinetics pk
5144707|NCT03087240|Intestinal Microbiome|intestinal microbiome
5144709|NCT03087227|febrile neutropenia|febrile neutropenia
5144710|NCT03087227|neutropenia/chemically induced/*complications|neutropenia/chemically induced/*complications
5144712|NCT03087227|Patient readmission|patient readmission
5144800|NCT03086564|immuno therapy|immuno therapy
5144801|NCT03086551|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5144802|NCT03086551|Motor Impairment|motor impairment
5144803|NCT03086551|Rehabilitation|rehabilitation
5144804|NCT03086551|Motor Learning|motor learning
5144898|NCT03086057|PrEP|prep
5144899|NCT03086057|Prevention|prevention
5144900|NCT03086057|Male Sex Workers (MSW)|male sex workers (msw)
5144901|NCT03086031|Traumatic brain injury, Vocational rehabilitation, Caregiver intervention,|traumatic brain injury, vocational rehabilitation, caregiver intervention,
5144992|NCT03085511|Glucagon-Like Peptide 1|glucagon-like peptide 1
5144996|NCT03085511|Protein quality|protein quality
5144997|NCT03085498|retinal vessels|retinal vessels
5144998|NCT03085498|physical activity|physical activity
5144999|NCT03085498|children|children
5145000|NCT03085498|psychosocial health|psychosocial health
5145209|NCT03083873|TIL|til
5145325|NCT03083184|hemodiafiltration|hemodiafiltration
5145326|NCT03083184|tunnelled dialysis catheter|tunnelled dialysis catheter
5145332|NCT03083171|LPS|lps
5145429|NCT03082495|Symptom management|symptom management
5145431|NCT03082495|presurgical|presurgical
5145432|NCT03082495|chemoradiotherapy|chemoradiotherapy
5145528|NCT03082066|intraosseus needle|intraosseus needle
5145632|NCT03081468|Binocular|binocular
5145633|NCT03081455|Screening|screening
5145634|NCT03081455|Hereditary Cancer|hereditary cancer
5145635|NCT03081403|Sensitive skin|sensitive skin
5145636|NCT03081403|Quantitative Sensory Testing|quantitative sensory testing
5145637|NCT03081364|Cardiac Implanted Device|cardiac implanted device
5145726|NCT03080714|no known ocular pathology|no known ocular pathology
5145822|NCT03080194|schizophrenia|schizophrenia
5145823|NCT03080194|violence risk|violence risk
5145824|NCT03080194|long-acting antipsychotics|long-acting antipsychotics
5145825|NCT03080194|community-based|community-based
5145826|NCT03080168|suicidal ideation|suicidal ideation
5145827|NCT03080168|suicidal behavior|suicidal behavior
5145828|NCT03080168|Veterans|veterans
5145923|NCT03079830|postoperative pain|postoperative pain
5145925|NCT03079791|cardiac allograft vasculopathy|cardiac allograft vasculopathy
5145926|NCT03079791|CAV|cav
5145927|NCT03079791|intravascular imaging|intravascular imaging
5145928|NCT03079765|Telehealth|telehealth
5145929|NCT03079765|Functional behavior assessment|functional behavior assessment
5145930|NCT03079713|pain|pain
5145931|NCT03079713|anesthesia|anesthesia
5145932|NCT03079713|vibrator|vibrator
5145933|NCT03079713|intravitreal|intravitreal
5145934|NCT03079713|injection|injection
5145935|NCT03079687|Ovarian cancer|ovarian cancer
5145936|NCT03079687|gynaecological cancer|gynaecological cancer
5145937|NCT03079687|platinum-sensitive disease|platinum-sensitive disease
5145938|NCT03079687|platinum-sensitive relapsed|platinum-sensitive relapsed
5145939|NCT03079687|Olaparib|olaparib
5145941|NCT03079687|Neoplasms|neoplasms
5146005|NCT03079323|External beam radiotherapy|external beam radiotherapy
5146006|NCT03079323|Prostate cancer|prostate cancer
5146007|NCT03079323|Elective para-aortic radiation therapy|elective para-aortic radiation therapy
5146008|NCT03079323|PART|part
5146144|NCT03078556|HIV|hiv
5146357|NCT03077503|Fentanyl|fentanyl
5146358|NCT03077490|Pelvic organ prolapse|pelvic organ prolapse
5146359|NCT03077490|transvaginal mesh|transvaginal mesh
5146360|NCT03077490|complications|complications
5146361|NCT03077464|nutrition education|nutrition education
5146362|NCT03077464|Vegetables|vegetables
5146363|NCT03077464|Fruit|fruit
5146364|NCT03077438|Meningitis|meningitis
5146365|NCT03077438|Meningococcal Meningitis|meningococcal meningitis
5146366|NCT03077438|MenACYW conjugate vaccine|menacyw conjugate vaccine
5146367|NCT03077438|MENVEO®|menveo®
5146369|NCT03077399|stroke|stroke
5146458|NCT03076801|Cardiac Rehabilitation|cardiac rehabilitation
5146459|NCT03076788|echocardiography|echocardiography
5146460|NCT03076788|intraventricular pressure gradients|intraventricular pressure gradients
5146564|NCT03076320|Adapalene + Benzoyl peroxide (A-BPO)|adapalene + benzoyl peroxide (a-bpo)
5146565|NCT03076294|knee ostearthritis|knee ostearthritis
5146566|NCT03076294|transcranial magnetic stimulation|transcranial magnetic stimulation
5146567|NCT03076294|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5146568|NCT03076294|chronic pain|chronic pain
5146569|NCT03076294|musculoskeletal manipulations|musculoskeletal manipulations
5146570|NCT03076216|Pancreatic Cancer|pancreatic cancer
5146571|NCT03076216|Pancreas|pancreas
5146572|NCT03076216|metastases|metastases
5146573|NCT03076216|pancreatic tumour|pancreatic tumour
5146574|NCT03076216|unresectable|unresectable
5146575|NCT03076216|locally advanced|locally advanced
5146576|NCT03076216|implantable|implantable
5146577|NCT03076216|radiographic|radiographic
5146578|NCT03076216|device|device
5146579|NCT03076216|Phosphorous-32 (P32)|phosphorous-32 (p32)
5146580|NCT03076216|OncoSil™|oncosil™
5146651|NCT03075748|Stent|stent
5146878|NCT03074344|artificial tear|artificial tear
5146880|NCT03074344|Hyaluronic acid|hyaluronic acid
5146881|NCT03074305|In-bioresorbable vascular scaffold restenosis|in-bioresorbable vascular scaffold restenosis
5146978|NCT03073707|Non-Typhoid Salmonella|non-typhoid salmonella
5146979|NCT03073707|Invasive blood stream infections|invasive blood stream infections
5146980|NCT03073707|Reservoir|reservoir
5146981|NCT03073707|Household environment|household environment
5146982|NCT03073707|Children|children
5147083|NCT03072849|Airflow obstruction|airflow obstruction
5147088|NCT03072823|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5147198|NCT03072212|HIV|hiv
5147288|NCT03071731|Glittre|glittre
5147502|NCT03070730|autonomic reflex|autonomic reflex
5147503|NCT03070717|High myopia, shortsightedness, retinal changes|high myopia, shortsightedness, retinal changes
5147504|NCT03070691|Basal cell carcinoma|basal cell carcinoma
5147653|NCT03069677|midazolam|midazolam
5147760|NCT03069131|primary prophylaxis|primary prophylaxis
5147761|NCT03069131|rifaximin|rifaximin
5147762|NCT03069118|Telemedicine|telemedicine
5147763|NCT03069118|Online Treatment|online treatment
5147764|NCT03069118|Digital Intervention|digital intervention
5147765|NCT03069079|primary immunodeficiency|primary immunodeficiency
5147857|NCT03068403|Radiochemotherapy|radiochemotherapy
5147858|NCT03068377|lycopene|lycopene
5147859|NCT03068377|eye|eye
5147860|NCT03068377|vessel function|vessel function
5147861|NCT03068364|Mortality|mortality
5147862|NCT03068364|Hypertension|hypertension
5147863|NCT03068364|Left ventricular hypertrophy|left ventricular hypertrophy
5147864|NCT03068364|NT-proBNP|nt-probnp
5147865|NCT03068364|ECG|ecg
5147866|NCT03068364|Transthoracic echocardiography|transthoracic echocardiography
5147867|NCT03068299|Prevention|prevention
5147868|NCT03068299|Cognition|cognition
5147869|NCT03068299|Aged care|aged care
5147870|NCT03068299|Caregivers|caregivers
5147871|NCT03068299|Frail elderly|frail elderly
5147872|NCT03068299|Dancing therapy|dancing therapy
5147883|NCT03068195|laparoscopy|laparoscopy
5147951|NCT03067961|Salmonella Typhi|salmonella typhi
5147952|NCT03067961|Challenge study|challenge study
5147953|NCT03067961|Human model of infection|human model of infection
5148146|NCT03066778|PD1|pd1
5148149|NCT03066726|Cesarean section|cesarean section
5148150|NCT03066726|Estimated fetal weight|estimated fetal weight
5148151|NCT03066726|Middle cerebral artery|middle cerebral artery
5148152|NCT03066726|Umbilical artery|umbilical artery
5148364|NCT03065686|CL/P|cl/p
5148471|NCT03065088|Mobile Applications|mobile applications
5148472|NCT03065062|Lung Cancer Squamous Cell|lung cancer squamous cell
5148473|NCT03065062|Head & Neck Cancer|head & neck cancer
5148583|NCT03064347|Obesity|obesity
5148680|NCT03063671|postmastectomy pain|postmastectomy pain
5148681|NCT03063658|Ibuprofen|ibuprofen
5148682|NCT03063658|Paracetamol|paracetamol
5148683|NCT03063658|Laparoscopic cholecystectomy|laparoscopic cholecystectomy
5148684|NCT03063658|Morphine|morphine
5148685|NCT03063658|Visual analog scale|visual analog scale
5148779|NCT03063281|anti-ficolin-3 antibodies|anti-ficolin-3 antibodies
5148780|NCT03063268|Electronic Consent|electronic consent
5148781|NCT03063268|Human Behavior|human behavior
5148782|NCT03063268|Bioethics|bioethics
5148783|NCT03063268|Research Ethics|research ethics
5148872|NCT03062527|Training support|training support
5148873|NCT03062527|Low Glycemic Index|low glycemic index
5148875|NCT03062527|Endurance|endurance
5148971|NCT03061890|preterm birth|preterm birth
5148972|NCT03061890|phthalates|phthalates
5148973|NCT03061890|NICU|nicu
5148974|NCT03061890|stress|stress
5148975|NCT03061890|lung health|lung health
5148977|NCT03061890|growth|growth
5149075|NCT03061071|Obstructive Sleep Apnea|obstructive sleep apnea
5149293|NCT03059459|Particulate Matter|particulate matter
5149294|NCT03059433|Substance use|substance use
5149389|NCT03058887|High Intensity Interval Training|high intensity interval training
5149391|NCT03058887|Microcirculation|microcirculation
5149392|NCT03058874|Chronic Kidney Disease|chronic kidney disease
5149393|NCT03058874|Hemodialysis|hemodialysis
5149488|NCT03058224|Immunoglobulin IgY|immunoglobulin igy
5149489|NCT03058224|Fibromyalgia|fibromyalgia
5149490|NCT03058224|Widespread Pain Index|widespread pain index
5149491|NCT03058224|Eggyolk|eggyolk
5149492|NCT03058224|FIQ-R|fiq-r
5149493|NCT03058224|SF-36v2TM|sf-36v2tm
5149494|NCT03058224|MOS-SS|mos-ss
5149584|NCT03057600|TNBC|tnbc
5149585|NCT03057600|Tumor Metabolism|tumor metabolism
5149794|NCT03056274|Metformin|metformin
5150024|NCT03054558|Junctional zone|junctional zone
5150025|NCT03054558|recurrent pregnancy loss|recurrent pregnancy loss
5150026|NCT03054558|3D power Doppler|3d power doppler
5150027|NCT03054480|Fractional Micro-Needle Radiofrequency|fractional micro-needle radiofrequency
5150123|NCT03054051|Feasibility|feasibility
5150222|NCT03053505|fecal microbiota transplantation (FMT)|fecal microbiota transplantation (fmt)
5150223|NCT03053505|Clostridium difficile infection|clostridium difficile infection
5150224|NCT03053505|gut flora|gut flora
5150225|NCT03053505|human microbiome|human microbiome
5150226|NCT03053505|colitis|colitis
5150326|NCT03052933|gemcitabine|gemcitabine
5150327|NCT03052933|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5150328|NCT03052933|extranodal NK/T-cell lymphoma|extranodal nk/t-cell lymphoma
5150331|NCT03052894|anesthesiology|anesthesiology
5150334|NCT03052855|Psychiatry|psychiatry
5150430|NCT03052075|Primary Hyperparathyroidism|primary hyperparathyroidism
5150526|NCT03051399|Gut microbiome|gut microbiome
5150630|NCT03050788|Smartphone confocal microscopy|smartphone confocal microscopy
5150632|NCT03050788|Point of care diagnosis|point of care diagnosis
5150633|NCT03050762|Endocrine Disease|endocrine disease
5150642|NCT03050736|GBM|gbm
5150735|NCT03050346|Myocardial Oxygenation|myocardial oxygenation
5150736|NCT03050320|Resilience|resilience
5150738|NCT03050307|Drug therapy|drug therapy
5150836|NCT03049592|Diabetes|diabetes
5150837|NCT03049592|Contraception|contraception
5150838|NCT03049592|Prenatal Counseling|prenatal counseling
5150939|NCT03047798|mouthrinse|mouthrinse
5150940|NCT03047733|Vitiligo|vitiligo
5150941|NCT03047733|308 nm excimer laser|308 nm excimer laser
5150942|NCT03047681|TAVR|tavr
5150943|NCT03047681|tryptse|tryptse
5150944|NCT03047681|mast|mast
5150945|NCT03047408|REM Sleep Behavior Disorder|rem sleep behavior disorder
5150946|NCT03047408|Parkinson's Disease|parkinson's disease
5150947|NCT03047408|REM sleep without Atonia|rem sleep without atonia
5150948|NCT03049189|non-functional and functional P-NET|non-functional and functional p-net
5150949|NCT03049189|non-functional GE-NET|non-functional ge-net
5150950|NCT03049176|HIV-discordant couple|hiv-discordant couple
5150951|NCT03049176|ART|art
5150952|NCT03049176|PrEP|prep
5150953|NCT03049176|semen washing|semen washing
5150954|NCT03049176|artificial vaginal insemination|artificial vaginal insemination
5150955|NCT03049176|safer conception|safer conception
5150956|NCT03049176|pregnancy|pregnancy
5150957|NCT03049124|Exercise|exercise
5150959|NCT03049124|Cancer|cancer
5151030|NCT03048448|Hepatic impairment,|hepatic impairment,
5151140|NCT03047603|Differential diagnosis|differential diagnosis
5151142|NCT03047603|Alpha-fetoprotein|alpha-fetoprotein
5151237|NCT03046901|Vancomycin|vancomycin
5151238|NCT03046901|Primary Sclerosing cholangitis|primary sclerosing cholangitis
5151239|NCT03046901|Post-liver transplantation|post-liver transplantation
5151240|NCT03046849|Lynch Syndrome|lynch syndrome
5151243|NCT03046836|Couples|couples
5151675|NCT03044041|Tranexamic acid|tranexamic acid
5151801|NCT03043352|LHW|lhw
5151802|NCT03043352|CMAM|cmam
5151803|NCT03043339|Microbiota composition|microbiota composition
5151804|NCT03043339|Kidney transplant recipient|kidney transplant recipient
5151805|NCT03043339|Kidney transplant donor|kidney transplant donor
5265466|NCT02357589|3D|3d
5151806|NCT03043339|Antibiotics|antibiotics
5151807|NCT03043339|Drug resistance|drug resistance
5151808|NCT03043339|Transplantation surgery|transplantation surgery
5151809|NCT03043326|Pre-exposure Prophylaxis|pre-exposure prophylaxis
5151902|NCT03042858|patent processus vaginalis|patent processus vaginalis
5151912|NCT03042793|myeloma|myeloma
5152003|NCT03042286|pharmacokinetics and pharmacogenetics|pharmacokinetics and pharmacogenetics
5152004|NCT03042273|recurrent|recurrent
5152130|NCT03041558|domestic violence|domestic violence
5152357|NCT03040180|Neoplastic processes|neoplastic processes
5152461|NCT03039101|neutrophils|neutrophils
5152462|NCT03039101|allergy|allergy
5152463|NCT03039062|Serum miR-122|serum mir-122
5152464|NCT03039062|drug-induced liver injury by chemotherapy|drug-induced liver injury by chemotherapy
5152473|NCT03039023|TMAO|tmao
5152566|NCT03038295|propranolol|propranolol
5152660|NCT03037645|lymphoplasmacytoid lymphoma|lymphoplasmacytoid lymphoma
5152773|NCT03037229|Heart Diseases|heart diseases
5152891|NCT03036397|Anxiety|anxiety
5152892|NCT03036397|Vasopressin|vasopressin
5153160|NCT03034824|Er,Cr:YSGG laser|er,cr:ysgg laser
5153165|NCT03034811|Osteoarthritis|osteoarthritis
5775241|NCT00221377|trachea|trachea
5153478|NCT03032913|Pancreas|pancreas
5153600|NCT03032224|Quality of Life|quality of life
5153601|NCT03032224|Morbidity|morbidity
5153602|NCT03032185|menopause|menopause
5153603|NCT03032185|post-menopause|post-menopause
5153604|NCT03032185|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5153695|NCT03031327|Ocular Discomfort Following Refractive Surgery|ocular discomfort following refractive surgery
5153696|NCT03031327|Refractive Surgery|refractive surgery
5153697|NCT03031314|Joint Replacement|joint replacement
5153698|NCT03031314|Knee Replacement|knee replacement
5153788|NCT03030820|Periodontitis|periodontitis
5153910|NCT03030105|Scopolamine|scopolamine
5153911|NCT03030105|Donepezil|donepezil
5153916|NCT03030053|Flavanols|flavanols
5153917|NCT03030053|Flavonoids|flavonoids
5154039|NCT03029364|Intra-individual variability|intra-individual variability
5154040|NCT03029364|Determinants|determinants
5154041|NCT03029364|Whole-body fat oxidation|whole-body fat oxidation
5154251|NCT03028168|Yôga|yôga
5154347|NCT03027622|quality of life|quality of life
5154715|NCT03025451|exercise|exercise
5154716|NCT03025451|stress|stress
5154717|NCT03025451|gender|gender
5154718|NCT03025451|age|age
5154721|NCT03025451|diabetes|diabetes
5154814|NCT03024775|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
5154815|NCT03024775|ancient wheats|ancient wheats
5154816|NCT03024775|modern wheats|modern wheats
5154817|NCT03024775|ATIs|atis
5154818|NCT03024749|Spinal Arteriovenous Malformation|spinal arteriovenous malformation
5154852|NCT03024554|MFM|mfm
5155005|NCT03023345|microwave trans rectal focal treatment|microwave trans rectal focal treatment
5155006|NCT03023332|Caregiver|caregiver
5155115|NCT03022526|Combined spinal epidural|combined spinal epidural
5155116|NCT03022513|Non-celiac Wheat Sensitivity|non-celiac wheat sensitivity
5155209|NCT03022136|epidural block|epidural block
5155210|NCT03022136|dermatome|dermatome
5155211|NCT03022136|human|human
5155212|NCT03022136|spinal nerve|spinal nerve
5155213|NCT03022136|thoracic|thoracic
5155214|NCT03022071|Cognitive behavior therapy|cognitive behavior therapy
5155215|NCT03022071|Psychodynamic therapy|psychodynamic therapy
5155216|NCT03022071|Mediators|mediators
5155217|NCT03022071|Moderators|moderators
5155302|NCT03021603|low-intensity intervention|low-intensity intervention
5155408|NCT03020849|prediction score|prediction score
5155409|NCT03020849|severe trauma|severe trauma
5155410|NCT03020823|SCB01A|scb01a
5155411|NCT03020823|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5155412|NCT03020784|acute neuroinflammatory|acute neuroinflammatory
5155413|NCT03020771|Crimean-congo hemorrhagic fever|crimean-congo hemorrhagic fever
5155414|NCT03020771|vaccine|vaccine
5155415|NCT03020771|human|human
5155416|NCT03020771|phase I|phase i
5155417|NCT03020745|Pharmacokinetics|pharmacokinetics
5155418|NCT03020745|Safety|safety
5155502|NCT03020264|Hypoglycemia|hypoglycemia
5155503|NCT03020264|Elderly|elderly
5155504|NCT03020264|Insulinotherapy|insulinotherapy
5155506|NCT03020251|chest physiotherapy|chest physiotherapy
5155609|NCT03019484|Clinical Trial|clinical trial
5155827|NCT03018041|Kidney biopsy|kidney biopsy
5155828|NCT03018015|Bioequivalence|bioequivalence
5155829|NCT03018015|Healthy|healthy
5155830|NCT03018015|Bioavailability|bioavailability
5155831|NCT03018015|Ibuprofen|ibuprofen
5155832|NCT03018002|HIV, PMTCT|hiv, pmtct
5155833|NCT03017989|Near Infrared Fluorescence Imaging|near infrared fluorescence imaging
5155834|NCT03017989|Indocyanine green (ICG)|indocyanine green (icg)
5155835|NCT03017963|acute coronary syndrome|acute coronary syndrome
5155836|NCT03017963|sodium thiosulfate|sodium thiosulfate
5155837|NCT03017963|maximum tolerable dose|maximum tolerable dose
5155838|NCT03017963|dose-limiting toxicity|dose-limiting toxicity
5155839|NCT03017911|PICC Line|picc line
5155841|NCT03017911|Thrombosis|thrombosis
5156043|NCT03016468|6 Minute Walk Test|6 minute walk test
5156044|NCT03016455|Kidney Transplant|kidney transplant
5156046|NCT03016442|Double balloon catheter|double balloon catheter
5156047|NCT03016442|Dinoprostone|dinoprostone
5156048|NCT03016442|Labor induction|labor induction
5156148|NCT03015766|insomnia|insomnia
5156149|NCT03015766|hemodialysis|hemodialysis
5156150|NCT03015766|auricular acupressure|auricular acupressure
5156151|NCT03015766|randomized controlled trial|randomized controlled trial
5156152|NCT03015753|Migraine|migraine
5156153|NCT03015753|Tai Chi|tai chi
5156154|NCT03015753|Prophylaxis|prophylaxis
5156158|NCT03015727|radiotherapy|radiotherapy
5156248|NCT03015363|Telemonitoring|telemonitoring
5156363|NCT03014687|transsphenoidal surgery|transsphenoidal surgery
5156364|NCT03014674|SB-240563|sb-240563
5156365|NCT03014674|subcutaneous|subcutaneous
5156366|NCT03014674|lyophilized drug product|lyophilized drug product
5156367|NCT03014674|Mepolizumab|mepolizumab
5156368|NCT03014674|liquid drug product|liquid drug product
5156369|NCT03014674|safety syringe|safety syringe
5156370|NCT03014674|auto injector|auto injector
5156457|NCT03014167|intestinal nematodes|intestinal nematodes
5156458|NCT03014167|soil-transmitted helminths|soil-transmitted helminths
5156459|NCT03014167|mass drug administration|mass drug administration
5156460|NCT03014167|Benin|benin
5156461|NCT03014167|India|india
5156462|NCT03014167|Malawi|malawi
5156463|NCT03014154|video games|video games
5156478|NCT03014063|AVP|avp
5156552|NCT03013608|Fingertip injury|fingertip injury
5156553|NCT03013595|Mental health|mental health
5156554|NCT03013595|Youth mental health|youth mental health
5156555|NCT03013595|Adolescent|adolescent
5156556|NCT03013595|Health services|health services
5156557|NCT03013595|Transition|transition
5156558|NCT03013595|Longitudinal cohort study|longitudinal cohort study
5156559|NCT03013595|Cluster randomised controlled trial|cluster randomised controlled trial
5156560|NCT03013595|Young adult|young adult
5156561|NCT03013556|HBeAg positive|hbeag positive
5156572|NCT03013517|Allergy|allergy
5156651|NCT03013127|Osteosarcoma|osteosarcoma
5156750|NCT03012360|Pneumology|pneumology
5156854|NCT03011541|Retinal Dystrophy|retinal dystrophy
5156855|NCT03011541|Hereditary Retinal Dystrophy|hereditary retinal dystrophy
5156856|NCT03011541|Malattia Leventinese|malattia leventinese
5156857|NCT03011541|Retinitis Pigmentosa|retinitis pigmentosa
5156858|NCT03011541|Stargardt Disease|stargardt disease
5156859|NCT03011541|Cone Dystrophy|cone dystrophy
5156860|NCT03011541|Rod-Cone Dystrophy|rod-cone dystrophy
5156942|NCT03011060|pathological complete response|pathological complete response
5156943|NCT03011060|Neoadjuvant Therapy|neoadjuvant therapy
5157156|NCT03009656|Emergency|emergency
5157294|NCT03008889|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
5157296|NCT03008876|acetaminophen|acetaminophen
5157297|NCT03008850|Shivering|shivering
5157298|NCT03008850|Intrathecal|intrathecal
5157299|NCT03008850|Magnesium Sulfate|magnesium sulfate
5157302|NCT03008798|Intracranial Artery|intracranial artery
5157303|NCT03008798|in-stent restenosis|in-stent restenosis
5157304|NCT03008798|Herbal Medicine|herbal medicine
5157305|NCT03008785|isoflavone|isoflavone
5157306|NCT03008785|blood pressure|blood pressure
5157307|NCT03008785|climateric symptoms|climateric symptoms
5157308|NCT03008785|exercise|exercise
5157309|NCT03008759|Fluoride|fluoride
5157310|NCT03008759|Dental caries|dental caries
5157316|NCT03008707|D004238|d004238
5157388|NCT03008109|Recombinant human endostatin|recombinant human endostatin
5157389|NCT03008070|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5157390|NCT03008070|NASH|nash
5157391|NCT03008070|peroxisome proliferator-activated receptor (PPAR)|peroxisome proliferator-activated receptor (ppar)
5157392|NCT03008070|Liver Diseases|liver diseases
5157393|NCT03008070|Fibrosis|fibrosis
5157394|NCT03008070|Fatty Liver|fatty liver
5157395|NCT03008070|Non-alcoholic Fatty Liver Disease|non-alcoholic fatty liver disease
5157631|NCT03006289|Metabolic Syndrome|metabolic syndrome
5157632|NCT03006289|fasting plasma glucose|fasting plasma glucose
5157633|NCT03006263|Stomach Neoplasms|stomach neoplasms
5157634|NCT03006263|Totally Laparoscopic Total Gastrectomy|totally laparoscopic total gastrectomy
5157635|NCT03006263|Laparoscopy Assisted Total Gastrectomy|laparoscopy assisted total gastrectomy
5157637|NCT03006250|Sevoflurane|sevoflurane
5157722|NCT03005717|LIPO-202|lipo-202
5157723|NCT03005717|bulge|bulge
5157724|NCT03005704|Ticagrelor|ticagrelor
5157816|NCT03004963|Volume Status|volume status
5157817|NCT03004963|Body Composition Monitor|body composition monitor
5157818|NCT03004911|fibromyalgia|fibromyalgia
5157819|NCT03004911|mobile application|mobile application
5157820|NCT03004911|self-care|self-care
5157910|NCT03004521|Augmentation|augmentation
5157911|NCT03004508|Ginkgo Biloba Extract|ginkgo biloba extract
5157912|NCT03004508|Safety|safety
5157913|NCT03004508|Genomic Stability|genomic stability
5158012|NCT03003897|Dietary Fiber|dietary fiber
5158013|NCT03003897|Soluble Fiber|soluble fiber
5158014|NCT03003897|Body Mass Index|body mass index
5158015|NCT03003897|Body Weight|body weight
5158016|NCT03003897|Blood Glucose|blood glucose
5158017|NCT03003897|Insulin|insulin
5158018|NCT03003871|stroke|stroke
5158021|NCT03003858|gingivitis|gingivitis
5158104|NCT03003429|anxiety|anxiety
5158216|NCT03002896|Cancer|cancer
5158317|NCT03002350|Cell sorting|cell sorting
5158318|NCT03002350|Next-generation sequencing (NGS)|next-generation sequencing (ngs)
5158319|NCT03002350|disruptive mutation|disruptive mutation
5158320|NCT03002337|aromatherapy massage, yoga|aromatherapy massage, yoga
5158321|NCT03002324|Vaccines|vaccines
5158323|NCT03002324|Decision Making|decision making
5158423|NCT03001596|Neoadjuvant Chemoradiotherapy|neoadjuvant chemoradiotherapy
5158424|NCT03001596|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5158425|NCT03001596|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5158426|NCT03001596|Esophageal Squamous Cell Carcinoma（cT3-4aN0-1M0）|esophageal squamous cell carcinoma（ct3-4an0-1m0）
5158427|NCT03001583|Mediterranean diet|mediterranean diet
5158428|NCT03001583|weight loss|weight loss
5158429|NCT03001583|type 2 diabetes|type 2 diabetes
5158430|NCT03001583|education program|education program
5158431|NCT03001583|cooking|cooking
5158435|NCT03001531|Complete paraplegia|complete paraplegia
5158525|NCT03000946|Octreotide|octreotide
5158526|NCT03000946|Pancreatic fistula|pancreatic fistula
5158527|NCT03000920|short message service (SMS)|short message service (sms)
5158528|NCT03000920|screening|screening
5158529|NCT03000920|cost-effectiveness|cost-effectiveness
5158530|NCT03000907|prevention|prevention
5158531|NCT03000907|frailty|frailty
5158617|NCT03000517|pharmacokinetics|pharmacokinetics
5158618|NCT03000465|pneumoperitoneum pressure|pneumoperitoneum pressure
5158619|NCT03000465|laparoscopic pressure|laparoscopic pressure
5158624|NCT03000452|Daratumumab|daratumumab
5158719|NCT03000049|anti-infective therapy|anti-infective therapy
5158720|NCT03000036|Breast cancer|breast cancer
5158721|NCT03000036|Doxorubicin|doxorubicin
5158722|NCT03000036|Cardiovascular Magnetic Resonance|cardiovascular magnetic resonance
5158723|NCT03000036|T1 mapping|t1 mapping
5158822|NCT02999373|prevention, infection, preterm, cord blood mononuclear cells|prevention, infection, preterm, cord blood mononuclear cells
5158824|NCT02999360|Speech Therapy|speech therapy
5158825|NCT02999360|Aerobic Exercise (AE)|aerobic exercise (ae)
5158826|NCT02999347|Treatment Outcome|treatment outcome
5158827|NCT02999347|Mid-urethral slings|mid-urethral slings
5158830|NCT02999334|Antenatal care|antenatal care
5158923|NCT02998918|polyphenol|polyphenol
5158924|NCT02998918|V-cam|v-cam
5159025|NCT02998281|inspiratory muscle training|inspiratory muscle training
5159026|NCT02998255|PEG|peg
5159027|NCT02998255|Bowel preparation|bowel preparation
5159028|NCT02998255|Colonoscopy|colonoscopy
5159029|NCT02998203|organic diet|organic diet
5159030|NCT02998203|health|health
5159031|NCT02998203|pesticides|pesticides
5159032|NCT02998203|inflammation biomarkers|inflammation biomarkers
5159033|NCT02998203|oxidative stress biomarkers|oxidative stress biomarkers
5159034|NCT02998177|Postoperative pain|postoperative pain
5159035|NCT02998177|Rebound pain|rebound pain
5159120|NCT02997566|Sympathetic Nervous System|sympathetic nervous system
5159122|NCT02997553|Indocyanine green (ICG)|indocyanine green (icg)
5159123|NCT02997553|Sentinel lymph node biopsy|sentinel lymph node biopsy
5159124|NCT02997553|Technetium99|technetium99
5159125|NCT02997553|Tumors|tumors
5159313|NCT02996565|Home blood pressure monitoring|home blood pressure monitoring
5159314|NCT02996565|Pharmacist|pharmacist
5159318|NCT02996513|Vitamin A status|vitamin a status
5159418|NCT02995564|Young adults|young adults
5159419|NCT02995551|Menisci, Tibial|menisci, tibial
5159531|NCT02994680|Behavioral Intervention|behavioral intervention
5159532|NCT02994680|Propane Stove|propane stove
5159533|NCT02994667|Electrophysiology|electrophysiology
5159534|NCT02994641|critical care|critical care
5159756|NCT02992925|Haemophilus influenza type b|haemophilus influenza type b
5159759|NCT02992925|DPT-IPV|dpt-ipv
5159857|NCT02992223|Recurrent|recurrent
5159968|NCT02991560|taping|taping
5159969|NCT02991560|conservative treatment|conservative treatment
5159970|NCT02991534|Patient Participation [N05.300.150.600.620]|patient participation [n05.300.150.600.620]
5160054|NCT02991105|Cancer|cancer
5160055|NCT02991105|Organ Transplantation|organ transplantation
5160056|NCT02991092|colon carcinoma|colon carcinoma
5160057|NCT02991092|liquid treatment|liquid treatment
5160058|NCT02991092|fast-track surgery|fast-track surgery
5160059|NCT02991079|Food Habits|food habits
5160066|NCT02991066|Mechanism|mechanism
5160146|NCT02990507|mobility impairment|mobility impairment
5160147|NCT02990507|virtual environment|virtual environment
5160148|NCT02990507|exercise|exercise
5160149|NCT02990507|physical activity|physical activity
5160150|NCT02990468|Mucositis|mucositis
5160257|NCT02989584|bladder cancer|bladder cancer
5160258|NCT02989584|metastatic bladder cancer|metastatic bladder cancer
5160259|NCT02989584|atezolizumab|atezolizumab
5160260|NCT02989584|urothelial carcinoma|urothelial carcinoma
5160261|NCT02989519|preterm labor|preterm labor
5160262|NCT02989519|progesterone efficacy|progesterone efficacy
5160263|NCT02989519|threatened preterm labor|threatened preterm labor
5160264|NCT02989493|Alcoholism|alcoholism
5160346|NCT02989103|Radiation|radiation
5160670|NCT02987387|Transcatheter pulmonary valve replacement|transcatheter pulmonary valve replacement
5160674|NCT02987348|type 2 diabetes|type 2 diabetes
5160777|NCT02986672|learning difficulties|learning difficulties
5160778|NCT02986633|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5160782|NCT02986568|TMMR|tmmr
5160998|NCT02985294|Neuropathic pain|neuropathic pain
5161303|NCT02983188|Metabolic Syndrome|metabolic syndrome
5161304|NCT02983188|Chinese medicine|chinese medicine
5161305|NCT02983188|Herbal medicine|herbal medicine
5161306|NCT02983175|ultrasonogaphy|ultrasonogaphy
5161307|NCT02983175|full stomach|full stomach
5161308|NCT02983175|pulmonary aspiration|pulmonary aspiration
5161309|NCT02983175|anaesthesia|anaesthesia
5161310|NCT02983136|Hand Hygiene|hand hygiene
5161312|NCT02983136|Partnership|partnership
5161501|NCT02982395|Nanoxel M|nanoxel m
5161502|NCT02982395|Docetaxel PM|docetaxel pm
5161503|NCT02982395|Docetaxel|docetaxel
5161504|NCT02982395|Mitomycin C|mitomycin c
5161506|NCT02982395|BCG refractory|bcg refractory
5161507|NCT02982395|Non muscle invasive bladder cancer|non muscle invasive bladder cancer
5161508|NCT02982395|intravesical|intravesical
5161510|NCT02982395|Urothelial carcinoma|urothelial carcinoma
5161591|NCT02981797|castration resistant|castration resistant
5161592|NCT02981784|chronic myeloid leukemia (CML)|chronic myeloid leukemia (cml)
5161593|NCT02981784|Philadelphia-positive (Ph+)|philadelphia-positive (ph+)
5161594|NCT02981784|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5161595|NCT02981732|Osteoporosis|osteoporosis
5161596|NCT02981732|kidney yin deficiency syndrome|kidney yin deficiency syndrome
5161597|NCT02981732|liuwei dihuang pill|liuwei dihuang pill
5161677|NCT02981251|Health education|health education
5161678|NCT02981251|Community based|community based
5161679|NCT02981199|microtransplantation|microtransplantation
5161680|NCT02981199|multiple myeloma|multiple myeloma
5161681|NCT02981186|Intraocular Lens|intraocular lens
5161682|NCT02981186|trifocal|trifocal
5161683|NCT02981186|cataract|cataract
5161684|NCT02981186|PhysIOL|physiol
5161685|NCT02981147|cough|cough
5161686|NCT02981147|thyme|thyme
5161687|NCT02981147|Cisti|cisti
5161688|NCT02981147|Ivy Leaves|ivy leaves
5161689|NCT02981134|bioabsorbable scaffold|bioabsorbable scaffold
5161690|NCT02981134|computed tomography|computed tomography
5161691|NCT02981121|Diabetes Prevention|diabetes prevention
5161692|NCT02981082|Systemic Sclerosis, Scleroderma, PAH, Pulmonary Hypertension|systemic sclerosis, scleroderma, pah, pulmonary hypertension
5161693|NCT02981056|Skincare regimens|skincare regimens
5161694|NCT02981056|Skin moisturization|skin moisturization
5161695|NCT02981056|Skin barrier|skin barrier
5161696|NCT02981056|Skin development|skin development
5161697|NCT02981017|Chronic sinusitis|chronic sinusitis
5161698|NCT02981017|Frontal sinusitis|frontal sinusitis
5161699|NCT02981017|Skull base neoplasm|skull base neoplasm
5161749|NCT02980731|Progression-free survival (PFS)|progression-free survival (pfs)
5161750|NCT02980731|Overall survival (OS)|overall survival (os)
5161751|NCT02980718|Olfaction training|olfaction training
5161753|NCT02980653|Phase II study|phase ii study
5161754|NCT02980653|Critical body weight loss|critical body weight loss
5161756|NCT02980653|Megestrol acetate|megestrol acetate
5161844|NCT02980302|IQ|iq
5161942|NCT02979782|minimal invasive coronary artery bypass graft (Endo-CABG)|minimal invasive coronary artery bypass graft (endo-cabg)
5161943|NCT02979769|Open-label extension study|open-label extension study
5161944|NCT02979769|Clinical trial Phase 2|clinical trial phase 2
5161945|NCT02979769|Efficacy and safety|efficacy and safety
5161946|NCT02979769|Heterotopic ossification|heterotopic ossification
5161947|NCT02979769|Flare-up|flare-up
5161948|NCT02979769|Palovarotene|palovarotene
5161949|NCT02979769|Retinoic acide receptor agonist|retinoic acide receptor agonist
5161950|NCT02979769|Retinoic acide receptor gamma agonist|retinoic acide receptor gamma agonist
5161951|NCT02979769|Clementia|clementia
5161952|NCT02979769|Myositis Ossificans|myositis ossificans
5161953|NCT02979769|Munchmeyer's Disease|munchmeyer's disease
5161954|NCT02979769|FOP|fop
5161955|NCT02979717|satiety|satiety
5161956|NCT02979717|protein|protein
5161957|NCT02979717|fiber|fiber
5161958|NCT02979678|Breast cancer, quality of life|breast cancer, quality of life
5162017|NCT02979119|Congenital|congenital
5162018|NCT02979093|maternal drug addiction|maternal drug addiction
5162019|NCT02979093|mother-infant attachment|mother-infant attachment
5162020|NCT02979093|intranasal oxytocin|intranasal oxytocin
5162021|NCT02979093|unresolved trauma|unresolved trauma
5162022|NCT02979093|maternal brain responses|maternal brain responses
5162023|NCT02979093|mother-infant synchrony|mother-infant synchrony
5162024|NCT02979067|Apnoea time, preoxygenation, difficult airway, emergency|apnoea time, preoxygenation, difficult airway, emergency
5162025|NCT02979041|neck pain|neck pain
5162026|NCT02979041|Virtual reality|virtual reality
5162027|NCT02979041|Range of motion|range of motion
5162028|NCT02979041|physiotherapy|physiotherapy
5162029|NCT02979041|Air force|air force
5162030|NCT02979041|kinematics|kinematics
5162031|NCT02979028|TEAS|teas
5162101|NCT02978664|colonoscopy|colonoscopy
5162102|NCT02978664|water exchange|water exchange
5162103|NCT02978664|adenoma detection rate|adenoma detection rate
5162104|NCT02978664|distraction|distraction
5162106|NCT02978651|OSA|osa
5162332|NCT02977546|Noninvasive|noninvasive
5162436|NCT02977052|Ipilimumab|ipilimumab
5162534|NCT02976558|EBV|ebv
5162628|NCT02976064|collaborative self-management|collaborative self-management
5162629|NCT02976038|Primary Mitochondrial Disease|primary mitochondrial disease
5162630|NCT02976038|Stealth|stealth
5162631|NCT02976038|elamipretide|elamipretide
5162632|NCT02976012|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5162633|NCT02976012|Aflibercept|aflibercept
5162634|NCT02976012|Vitreous Hemorrhage|vitreous hemorrhage
5162728|NCT02975427|Diet|diet
5162823|NCT02974985|Facelift|facelift
5162824|NCT02974985|HA Filler|ha filler
5162825|NCT02974985|Hyaluronic acid|hyaluronic acid
5162826|NCT02974985|Facial Rejuvenation|facial rejuvenation
5162827|NCT02974985|Aging Face|aging face
5162926|NCT02974465|recovery of function|recovery of function
5162927|NCT02974400|internet-based intervention|internet-based intervention
5162928|NCT02974400|e-mental health|e-mental health
5162929|NCT02974400|cognitive behavioural intervention|cognitive behavioural intervention
5162930|NCT02974322|Crohn's Disease|crohn's disease
5162931|NCT02974322|GED-0301|ged-0301
5163077|NCT02973399|CLL|cll
5163263|NCT02972073|Neuromuscular control|neuromuscular control
5163264|NCT02972060|Hormone Naive Prostate Cancer|hormone naive prostate cancer
5163265|NCT02972047|Reflux|reflux
5163266|NCT02972021|respiratory insufficiency|respiratory insufficiency
5163267|NCT02972021|High-flow nasal cannula|high-flow nasal cannula
5163359|NCT02971423|gram-negative bacterium|gram-negative bacterium
5163364|NCT02971345|chemoembolization|chemoembolization
5163468|NCT02971072|treatment strategy|treatment strategy
5163469|NCT02971072|United States|united states
5163470|NCT02971072|work|work
5163562|NCT02970552|HIV|hiv
5163563|NCT02970552|Vaginal Progesterone|vaginal progesterone
5163564|NCT02970552|ART|art
5163565|NCT02970552|Adherence|adherence
5163566|NCT02970552|Feasibility|feasibility
5163567|NCT02970526|Colorectal cancer survivors|colorectal cancer survivors
5163678|NCT02969837|Multiple Myeloma|multiple myeloma
5163679|NCT02969837|Elotuzumab|elotuzumab
5163680|NCT02969837|Carfilzomib (Kyprolis)|carfilzomib (kyprolis)
5163681|NCT02969837|Lenalidomide (Revlimid)|lenalidomide (revlimid)
5163873|NCT02968446|Healthy Volunteer|healthy volunteer
5163874|NCT02968433|Young Male Plasma|young male plasma
5163969|NCT02967640|Shoulder|shoulder
5673423|NCT00608244|Liver Transplantation|liver transplantation
5164079|NCT02966782|Relapsed/refractory|relapsed/refractory
5164080|NCT02966782|Venetoclax|venetoclax
5164081|NCT02966782|Azacitidine|azacitidine
5164082|NCT02966756|Relapsed chronic lymphocytic leukemia (CLL)|relapsed chronic lymphocytic leukemia (cll)
5164083|NCT02966756|Refractory chronic lymphocytic leukemia (CLL)|refractory chronic lymphocytic leukemia (cll)
5164084|NCT02966756|17p deletion|17p deletion
5164085|NCT02966756|venetoclax|venetoclax
5164086|NCT02966756|Leukemia|leukemia
5164087|NCT02966756|Lymphoproliferative Disorders|lymphoproliferative disorders
5164089|NCT02966730|Ibrutinib|ibrutinib
5164171|NCT02966145|Nonfluent Variant Primary Progressive Aphasia|nonfluent variant primary progressive aphasia
5164172|NCT02966145|Oligosymptomatic Progressive Supranuclear Palsy|oligosymptomatic progressive supranuclear palsy
5164173|NCT02966145|Variant Progressive Supranuclear Palsy|variant progressive supranuclear palsy
5164174|NCT02966145|Biomarker|biomarker
5164365|NCT02964923|Metabolic side effects of drugs|metabolic side effects of drugs
5164366|NCT02964923|schizophrenia|schizophrenia
5164367|NCT02964923|Second-Generation Antipsychotic|second-generation antipsychotic
5164369|NCT02964910|Hepatitis E|hepatitis e
5164468|NCT02964325|pathogen reduction therapy|pathogen reduction therapy
5164857|NCT02961803|ALD|ald
5164906|NCT02961465|Slow-transit constipation|slow-transit constipation
5165006|NCT02960724|oral cancer|oral cancer
5165104|NCT02960074|Allergy, Peanut|allergy, peanut
5165196|NCT02959749|Osimertinib|osimertinib
5165302|NCT02958904|Erectile dysfunction|erectile dysfunction
5165414|NCT02958202|DMD|dmd
5165511|NCT02957591|Brain-Gut interactions|brain-gut interactions
5165709|NCT02956616|Enhanced Recovery|enhanced recovery
5165941|NCT02955238|Latinos|latinos
5165942|NCT02955238|CIMT|cimt
5166055|NCT02954536|esophagogastric cancer|esophagogastric cancer
5166056|NCT02954536|16-937|16-937
5166080|NCT02954354|Flu|flu
5166186|NCT02953756|Fatigue|fatigue
5166501|NCT02951650|vagus nerve stimulation|vagus nerve stimulation
5166502|NCT02951637|Adenocarcinoma, EGFR, Gefitinib, Pemetrexed, Carboplatin|adenocarcinoma, egfr, gefitinib, pemetrexed, carboplatin
5166736|NCT02950142|order sets|order sets
5167228|NCT02947152|ADC|adc
5167255|NCT02947022|GBCA|gbca
5167553|NCT02944825|UTI|uti
5167905|NCT02942823|physical activity|physical activity
5168003|NCT02942095|OSI-774|osi-774
5168559|NCT02938286|CO2 laser|co2 laser
5168667|NCT02937415|waterpipe smoking|waterpipe smoking
5673426|NCT00608218|inhaled steroids|inhaled steroids
5169102|NCT02934607|Spacer device|spacer device
5169354|NCT02932956|GPC3-CAR T cells|gpc3-car t cells
5169468|NCT02932332|shortness of breath|shortness of breath
5169566|NCT02931799|Inflammatory Bowel Diseases|inflammatory bowel diseases
5169786|NCT02930486|Syndesmosis|syndesmosis
5169883|NCT02929953|prevalence|prevalence
5170232|NCT02927782|Lumbar|lumbar
5170235|NCT02927756|Composite Lymphomas|composite lymphomas
5170469|NCT02926313|RCT|rct
5170713|NCT02924636|Macrosomia|macrosomia
5170802|NCT02924324|16-1417|16-1417
5170907|NCT02923687|Premedication|premedication
5171019|NCT02922998|Interleukin-4|interleukin-4
5171342|NCT02921477|bosulif|bosulif
5171577|NCT02920060|RSE|rse
5172026|NCT02917460|Rady|rady
5172133|NCT02916849|Exercise therapy/methods*|exercise therapy/methods*
5172233|NCT02916017|Adalimumab|adalimumab
5172334|NCT02915484|Emotions|emotions
5172528|NCT02914652|Surgery|surgery
5172627|NCT02914041|Kyphosis|kyphosis
5172752|NCT02912949|NRG1|nrg1
5173075|NCT02910427|stroke|stroke
5173162|NCT02910050|letrozole|letrozole
5173356|NCT02908867|Spinal cord injuries|spinal cord injuries
5173559|NCT02907606|urine|urine
5173664|NCT02906878|Haematology|haematology
5173760|NCT02906215|digital health|digital health
5173862|NCT02905604|dorsomedial prefrontal cortex|dorsomedial prefrontal cortex
5173970|NCT02905097|Gait|gait
5174097|NCT02904226|ICOS|icos
5174319|NCT02902822|melanoma|melanoma
5174535|NCT02901275|Analgesia|analgesia
5174666|NCT02900365|cataract|cataract
5174895|NCT02898415|HCC|hcc
5175202|NCT02896244|microbiome|microbiome
5175298|NCT02895568|Antimalarial drug|antimalarial drug
5175393|NCT02894996|pediatric|pediatric
5175593|NCT02893865|Oxidative stress|oxidative stress
5175983|NCT02891551|Non-interventional|non-interventional
5176078|NCT02891031|Medicine, Traditional|medicine, traditional
5176088|NCT02890901|Score|score
5176197|NCT02890290|nutrition|nutrition
5176198|NCT02890290|frail|frail
5176295|NCT02889835|restoration|restoration
5176308|NCT02889744|Brain|brain
5176425|NCT02889016|PANS|pans
5176508|NCT02888366|Mammography|mammography
5176612|NCT02887560|Right ventricle|right ventricle
5176715|NCT02886806|closed loop|closed loop
5176925|NCT02885324|GBM|gbm
5177148|NCT02883764|EPA|epa
5177246|NCT02883127|Diet|diet
5177419|NCT02882178|prescription|prescription
5177523|NCT02881502|HDAC2|hdac2
5177668|NCT02880683|Sympathetic Fibers|sympathetic fibers
5177762|NCT02879968|tumor volume|tumor volume
5177892|NCT02879188|degenerative joint disease|degenerative joint disease
5178106|NCT02877732|Vision|vision
5178318|NCT02876211|Selective vitamin D receptor activation|selective vitamin d receptor activation
5178412|NCT02875353|Post-Polypectomy|post-polypectomy
5178413|NCT02875353|Colon bleeding|colon bleeding
5178477|NCT02874885|CRC|crc
5178510|NCT02874729|Biomarkers, Tumor|biomarkers, tumor
5178610|NCT02873975|Advanced Cancers|advanced cancers
5178705|NCT02873351|L-DOPA|l-dopa
5178800|NCT02872675|Prebiotics|prebiotics
5179525|NCT02867891|AML|aml
5179701|NCT02866591|quality of life|quality of life
5179803|NCT02865863|Mood|mood
5179911|NCT02865447|DXA|dxa
5180174|NCT02864290|AML|aml
5180241|NCT02863874|Labor|labor
5180339|NCT02863120|Joint Diseases|joint diseases
5180561|NCT02861794|RSA|rsa
5181012|NCT02858700|procalcitonin|procalcitonin
5181119|NCT02858011|cash transfer|cash transfer
5181224|NCT02857036|antidepressant treatment|antidepressant treatment
5181225|NCT02857023|Neurocognitive|neurocognitive
5169080|NCT02934711|Exercise coordinated groups (GECO)|exercise coordinated groups (geco)
5169082|NCT02934685|Prostatic Neoplasms|prostatic neoplasms
5169182|NCT02934178|Enterobacteriaceae Infections|enterobacteriaceae infections
5169183|NCT02934178|Gram-Negative Bacterial Infections|gram-negative bacterial infections
5169184|NCT02934178|Bacterial Infections|bacterial infections
5169188|NCT02934178|Intestinal Diseases|intestinal diseases
5181412|NCT02855671|thermal|thermal
5181413|NCT02855671|temperature|temperature
5181414|NCT02855658|Sjögren's syndrome|sjögren's syndrome
5181415|NCT02855658|Gan-Lu-Yin|gan-lu-yin
5181416|NCT02855658|Sang-Ju-Yin|sang-ju-yin
5181417|NCT02855658|Xuefu-Zhuyu-Decoction|xuefu-zhuyu-decoction
5181509|NCT02855359|Antineoplastic Agents|antineoplastic agents
5169279|NCT02933463|children with high caries risk|children with high caries risk
5169280|NCT02933437|Brugada syndrome|brugada syndrome
5169281|NCT02933437|SCN5A|scn5a
5169282|NCT02933437|SCN10A|scn10a
5169283|NCT02933437|Ajmaline|ajmaline
5169284|NCT02933411|Bleeding Disorders|bleeding disorders
5169285|NCT02933411|Heavy Menstrual Bleeding|heavy menstrual bleeding
5169286|NCT02933359|cranial vault|cranial vault
5169287|NCT02933359|calvarial trauma|calvarial trauma
5169288|NCT02933359|calvarial reconstruction|calvarial reconstruction
5169289|NCT02933320|Indolent B-cell Lymphoma|indolent b-cell lymphoma
5169384|NCT02932826|Cell Therapy|cell therapy
5169385|NCT02932800|Catheters|catheters
5169386|NCT02932800|Vascular Access Devices|vascular access devices
5169387|NCT02932800|Suture Techniques|suture techniques
5295833|NCT02197169|CNS|cns
5181593|NCT02854787|Spinal anesthesia|spinal anesthesia
5181594|NCT02854787|cesarean|cesarean
5181595|NCT02854787|blood pressure|blood pressure
5181596|NCT02854787|Norepinephrine|norepinephrine
5181597|NCT02854787|Phenylephrine|phenylephrine
5181598|NCT02854735|Head and Neck Neoplasms|head and neck neoplasms
5181599|NCT02854735|Total body composition|total body composition
5181601|NCT02854735|Malnutrition|malnutrition
5181671|NCT02854384|Epilepsy|epilepsy
5181672|NCT02854384|Mobile phone|mobile phone
5181673|NCT02854371|gadoxetic acid|gadoxetic acid
5181674|NCT02854371|T1 map|t1 map
5181675|NCT02854371|MRI|mri
5181676|NCT02854345|CZT camera|czt camera
5181677|NCT02854345|pinhole|pinhole
5181678|NCT02854332|Pain|pain
5181679|NCT02854332|Analgesic|analgesic
5181774|NCT02853864|Gender|gender
5181775|NCT02853864|Propofol|propofol
5181776|NCT02853864|Dexmedetomidine|dexmedetomidine
5181777|NCT02853864|Interaction|interaction
5181778|NCT02853851|Stress factors,|stress factors,
5181779|NCT02853851|intensive care units,|intensive care units,
5181780|NCT02853851|scale,|scale,
5181781|NCT02853851|quality of care|quality of care
5181871|NCT02853240|Cerebral palsy|cerebral palsy
5181872|NCT02853240|children|children
5181873|NCT02853240|muscle spasticity|muscle spasticity
5181961|NCT02852642|power training|power training
5181962|NCT02852642|plyometric training|plyometric training
5181963|NCT02852642|functional capacity|functional capacity
5181964|NCT02852629|decision-support sheet|decision-support sheet
5181966|NCT02852616|Posttraumatic Stress Disorder|posttraumatic stress disorder
5181967|NCT02852616|Narrative Exposure Therapy|narrative exposure therapy
5182055|NCT02852096|gastric cancer|gastric cancer
5182152|NCT02851251|multicenter|multicenter
5182153|NCT02851134|genetic|genetic
5182243|NCT02850523|Cognitive-behavioural therapy (CBT)|cognitive-behavioural therapy (cbt)
5182244|NCT02850510|Harsh discipline|harsh discipline
5182245|NCT02850510|parental competence|parental competence
5182246|NCT02850510|positive parenting|positive parenting
5182247|NCT02850497|optical coherence tomography|optical coherence tomography
5182248|NCT02850497|malapposition|malapposition
5182249|NCT02850497|endothelization|endothelization
5182252|NCT02850471|pulmonary protection|pulmonary protection
5182337|NCT02849938|children with medical complexity|children with medical complexity
5182338|NCT02849938|Telemedicine|telemedicine
5182339|NCT02849938|Tracheostomy|tracheostomy
5182340|NCT02849925|Pit and Fissure Sealants|pit and fissure sealants
5245536|NCT02471573|IVF|ivf
5170259|NCT02927613|Mortality|mortality
5170260|NCT02927613|Complications|complications
5170261|NCT02927613|Developing country|developing country
5170262|NCT02927600|Glycemic response|glycemic response
5170263|NCT02927600|Glycemic index|glycemic index
5170264|NCT02927600|Meal intervention|meal intervention
5170265|NCT02927600|Chinese population|chinese population
5170267|NCT02927587|fiberoptic bronchoscopy|fiberoptic bronchoscopy
5170268|NCT02927587|sedation|sedation
5170269|NCT02927574|drug-coated balloon angioplasty|drug-coated balloon angioplasty
5170270|NCT02927574|angioplasty|angioplasty
5170271|NCT02927574|plain old balloon angioplasty|plain old balloon angioplasty
5170272|NCT02927574|peripheral arterial disease|peripheral arterial disease
5170273|NCT02927574|intermittent claudication|intermittent claudication
5170315|NCT02927262|AML|aml
5182423|NCT02849522|Quality of Life|quality of life
5182424|NCT02849483|PONV|ponv
5182425|NCT02849483|digestive signs and symptoms|digestive signs and symptoms
5182426|NCT02849483|vomiting|vomiting
5182427|NCT02849483|antiemetics|antiemetics
5182494|NCT02849119|Surgical Procedures, Robotic|surgical procedures, robotic
5182495|NCT02849119|Nephrectomy|nephrectomy
5182496|NCT02849106|3D culture|3d culture
5182497|NCT02849106|chemogram|chemogram
5182498|NCT02849106|FOLFOX|folfox
5182499|NCT02849106|FOLFIRI|folfiri
5182500|NCT02849093|Optical coherence tomography|optical coherence tomography
5182501|NCT02849093|imaging of ocular structures|imaging of ocular structures
5182502|NCT02849067|ischaemic heart disease|ischaemic heart disease
5182503|NCT02849067|comedy session|comedy session
5182506|NCT02849041|Lung|lung
5182582|NCT02848521|quality of life|quality of life
5182673|NCT02847962|Anemia, Iron-Deficiency|anemia, iron-deficiency
5182674|NCT02847962|Deficiency, Vitamin A|deficiency, vitamin a
5182675|NCT02847962|Growth Velocity|growth velocity
5182676|NCT02847962|Stunting|stunting
5182677|NCT02847962|Wasting|wasting
5170554|NCT02925702|Biomarkers|biomarkers
5170555|NCT02925663|executive functioning|executive functioning
5170556|NCT02925650|Alzheimer's Disease|alzheimer's disease
5170557|NCT02925650|SILK™|silk™
5170558|NCT02925650|Pharmacodynamics|pharmacodynamics
5170559|NCT02925650|Safety|safety
5170560|NCT02925650|Pharmacokinetics|pharmacokinetics
5170581|NCT02925559|MAGE|mage
5182755|NCT02847767|Hepatocellular Carcinoma|hepatocellular carcinoma
5182756|NCT02847767|Dynamic Contrast-Enhanced Computed Tomography|dynamic contrast-enhanced computed tomography
5182757|NCT02847754|bony metastases|bony metastases
5182758|NCT02847754|physical exercise|physical exercise
5182759|NCT02847741|Depression|depression
5182760|NCT02847741|Cholesterol|cholesterol
5299589|NCT02179957|cardiac|cardiac
5182761|NCT02847741|Suicidal behavior|suicidal behavior
5170652|NCT02925143|E-learning|e-learning
5170653|NCT02925143|Web based learning|web based learning
5170654|NCT02925117|ABT-494|abt-494
5182837|NCT02847299|neuromuscular diseases|neuromuscular diseases
5182838|NCT02847299|peak cough flow|peak cough flow
5182839|NCT02847273|NIRS|nirs
5182840|NCT02847273|Regional oxygen saturation|regional oxygen saturation
5182841|NCT02847273|cardiac surgery with bypass|cardiac surgery with bypass
5182842|NCT02847247|healthy|healthy
5182843|NCT02847234|Cervical necrotizing fasciitis|cervical necrotizing fasciitis
5182844|NCT02847234|mediastinitis|mediastinitis
5182845|NCT02847221|cough peak flow|cough peak flow
5182846|NCT02847221|scheduled weaning trial|scheduled weaning trial
5182848|NCT02847221|prognosis|prognosis
5182930|NCT02846766|FGF|fgf
5183028|NCT02846207|Buyanghuanwu decoction|buyanghuanwu decoction
5183029|NCT02846207|clinical effects and mechanisms|clinical effects and mechanisms
5183030|NCT02846194|Fibromyalgia|fibromyalgia
5183031|NCT02846194|Guided Imagery|guided imagery
5183032|NCT02846194|chronic pain|chronic pain
5183033|NCT02846155|preparation|preparation
5183117|NCT02845648|anticholinergics|anticholinergics
5183118|NCT02845648|awakener|awakener
5183119|NCT02845622|Hazelnut|hazelnut
5183120|NCT02845622|Cocoa|cocoa
5183121|NCT02845622|Flavonoid|flavonoid
5183122|NCT02845622|Lipids|lipids
5183123|NCT02845622|Vascular Reactivity|vascular reactivity
5183125|NCT02845609|Sialic acid|sialic acid
5183208|NCT02845076|Noninvasive ventilation|noninvasive ventilation
5183209|NCT02845076|Respiratory insufficiency|respiratory insufficiency
5183210|NCT02845076|Hypercapnia|hypercapnia
5183211|NCT02845076|ventilator weaning|ventilator weaning
5183212|NCT02845063|muscle plasticity|muscle plasticity
5183213|NCT02845063|exercise|exercise
5183214|NCT02845063|rehabilitation|rehabilitation
5183215|NCT02845063|perfusion|perfusion
5183216|NCT02845063|ACE|ace
5183217|NCT02845063|genotype|genotype
5171137|NCT02922504|Pain|pain
5183297|NCT02844608|Oncology clinical practice|oncology clinical practice
5183391|NCT02844075|PD-1|pd-1
5183392|NCT02844075|neoadjuvant|neoadjuvant
5183393|NCT02844075|chemoradiation|chemoradiation
5183394|NCT02844049|Deep Brain Stimulation|deep brain stimulation
5183395|NCT02844049|Quality of Life|quality of life
5183396|NCT02844036|Distal Lesions|distal lesions
5183397|NCT02844036|Post-embolic HTP|post-embolic htp
5183398|NCT02844036|Angioplasty|angioplasty
5183399|NCT02844023|Arteritis|arteritis
5183400|NCT02844023|Biomarker|biomarker
5183601|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists
5183705|NCT02842203|colorectal cancer|colorectal cancer
5183706|NCT02842190|Neonatal|neonatal
5183707|NCT02842190|NIPPV|nippv
5183708|NCT02842190|BIPAP|bipap
5183709|NCT02842190|Extubation failure|extubation failure
5183710|NCT02842151|Intraocular Lens (IOL)|intraocular lens (iol)
5183711|NCT02842125|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
5183712|NCT02842125|solid tumors|solid tumors
5183713|NCT02842125|nivolumab|nivolumab
5183714|NCT02842125|Ad-P53|ad-p53
5183715|NCT02842125|metastatic|metastatic
5183716|NCT02842125|capecitabine|capecitabine
5183717|NCT02842125|pembrolizumab|pembrolizumab
5183718|NCT02842112|Acute myeloid leukemia|acute myeloid leukemia
5183719|NCT02842112|prognosis|prognosis
5183720|NCT02842112|stem cell harvest|stem cell harvest
5183721|NCT02842112|autologous transplant|autologous transplant
5183759|NCT02841930|Primary Prevention|primary prevention
5183760|NCT02841800|radiofrequency ablation|radiofrequency ablation
5183761|NCT02841800|malignant biliary stenosis|malignant biliary stenosis
5183762|NCT02841787|Depression|depression
5183763|NCT02841787|Web-based intervention|web-based intervention
5183764|NCT02841787|Aging|aging
5183765|NCT02841787|Geriatrics|geriatrics
5183766|NCT02841787|Social network|social network
5183767|NCT02841787|Older adults|older adults
5183768|NCT02841748|Pembrolizumab|pembrolizumab
5183769|NCT02841748|HNSCC|hnscc
5183770|NCT02841735|brief intervention|brief intervention
5183771|NCT02841735|web-based interventions|web-based interventions
5183772|NCT02841735|harm reduction|harm reduction
5183773|NCT02841735|young adult|young adult
5183774|NCT02841735|college student|college student
5183775|NCT02841709|insomnia|insomnia
5183776|NCT02841709|elderly|elderly
5183777|NCT02841709|Polysomnography|polysomnography
5183778|NCT02841696|Heart failure|heart failure
5183779|NCT02841696|Systolic dysfunction|systolic dysfunction
5183780|NCT02841696|GLS|gls
5183781|NCT02841696|Arterial stiffness|arterial stiffness
5183782|NCT02841696|Left ventricular hypertrophy|left ventricular hypertrophy
5183793|NCT02841540|CMML|cmml
5183834|NCT02841345|action|action
5183945|NCT02840474|HIV-1 Infection|hiv-1 infection
5184154|NCT02839122|Dutasteride|dutasteride
5183946|NCT02840474|Broadly Neutralizing Antibody|broadly neutralizing antibody
5184027|NCT02840006|Vasodilator Agents|vasodilator agents
5184029|NCT02839993|associative learning|associative learning
5184030|NCT02839980|oropharyngeal colonization|oropharyngeal colonization
5184031|NCT02839915|Language Impairment|language impairment
5184032|NCT02839850|Arthroplasty|arthroplasty
5171995|NCT02917707|liver metastasis|liver metastasis
5171996|NCT02917681|ALS|als
5171997|NCT02917681|mesenchymal stem cells|mesenchymal stem cells
5171999|NCT02917668|Obesity|obesity
5184033|NCT02839850|replacement|replacement
5184034|NCT02839850|Knee|knee
5184035|NCT02839850|function|function
5184036|NCT02839850|radiographic|radiographic
5184037|NCT02839850|survivorship|survivorship
5184038|NCT02839837|Depression|depression
5184039|NCT02839837|Depressive Disorder|depressive disorder
5184040|NCT02839837|Exercise|exercise
5184041|NCT02839837|Neuroplasticity|neuroplasticity
5184042|NCT02839837|Non-invasive brain stimulation|non-invasive brain stimulation
5184043|NCT02839837|Healthy Control|healthy control
5184044|NCT02839824|bowel cleansing|bowel cleansing
5184108|NCT02839499|normal texture food|normal texture food
5184109|NCT02839486|antibiotic prophylaxis|antibiotic prophylaxis
5184110|NCT02839486|pharmacokinetics|pharmacokinetics
5184111|NCT02839486|cardiopulmonary bypass|cardiopulmonary bypass
5184112|NCT02839447|semen|semen
5184113|NCT02839447|sperm|sperm
5184119|NCT02839408|probiotic|probiotic
5184203|NCT02838823|triple negative breast cancer|triple negative breast cancer
5184204|NCT02838823|safety|safety
5184205|NCT02838810|peginterferon alfa|peginterferon alfa
5184206|NCT02838810|Chronic Hepatitis B|chronic hepatitis b
5184207|NCT02838797|Parkinson's disease|parkinson's disease
5184208|NCT02838797|Gastroparesis|gastroparesis
5184209|NCT02838797|Constipation|constipation
5184210|NCT02838797|Prokinetic|prokinetic
5184396|NCT02837328|Arrhythmia|arrhythmia
5184710|NCT02835378|epidemiology|epidemiology
5184799|NCT02834715|Sweetener|sweetener
5184800|NCT02834702|sinew acupuncture|sinew acupuncture
5184801|NCT02834702|neck pain|neck pain
5184802|NCT02834702|chronic pain|chronic pain
5184803|NCT02834676|DiscoGel(R)|discogel(r)
5184804|NCT02834676|gelified ethanol|gelified ethanol
5184805|NCT02834676|percutaneous treatment|percutaneous treatment
5184806|NCT02834676|Oswestry Disability Index (ODI)|oswestry disability index (odi)
5184807|NCT02834676|Visual analog Scale (VAS)|visual analog scale (vas)
5184808|NCT02834676|Neuropathic Pain Questionnaire (DN-4)|neuropathic pain questionnaire (dn-4)
5184809|NCT02834676|cervical|cervical
5248939|NCT02451540|FRI|fri
5184810|NCT02834637|HPV|hpv
5184811|NCT02834637|cervical cancer|cervical cancer
5184812|NCT02834637|vaccines|vaccines
5184813|NCT02834637|HPV vaccine|hpv vaccine
5184814|NCT02834637|dose reduction|dose reduction
5184815|NCT02834637|Human papilloma virus vaccine schedules|human papilloma virus vaccine schedules
5184816|NCT02834624|surfactant|surfactant
5184817|NCT02834624|respiratory distress syndrome|respiratory distress syndrome
5184879|NCT02834169|psammocarcinoma|psammocarcinoma
5184891|NCT02834078|HbA1c|hba1c
5185080|NCT02832986|Frailty consultation|frailty consultation
5185084|NCT02832973|Bisoprolol|bisoprolol
5185173|NCT02832492|pupil near response|pupil near response
5185275|NCT02831894|insomnia|insomnia
5185614|NCT02829879|Arginin|arginin
5185702|NCT02829619|Weight loss|weight loss
5185703|NCT02829606|Age-related Macular Degeneration|age-related macular degeneration
5185789|NCT02829164|kidney failure|kidney failure
5185790|NCT02829151|Peripheral artery disease|peripheral artery disease
5185791|NCT02829151|Critical limb ischemia|critical limb ischemia
5185792|NCT02829151|Angioplasty|angioplasty
5185793|NCT02829151|Antiplatelet therapy|antiplatelet therapy
5185794|NCT02829125|Early rehabilitation|early rehabilitation
5185795|NCT02829125|abdominal surgery|abdominal surgery
5185796|NCT02829125|ERAS|eras
5185797|NCT02829112|Shulman|shulman
5185891|NCT02828410|IPAA|ipaa
5185982|NCT02827552|radiotherapy|radiotherapy
5185983|NCT02827552|radiosensitivity|radiosensitivity
5186183|NCT02826343|COPD|copd
5186184|NCT02826330|Crohn's Disease|crohn's disease
5186185|NCT02826330|Healthy relatives|healthy relatives
5186186|NCT02826330|Dysbiosis|dysbiosis
5186187|NCT02826330|Biomarkers|biomarkers
5174152|NCT02903862|Case Management|case management
5174153|NCT02903862|Alzheimer's Disease|alzheimer's disease
5186188|NCT02826304|Vaginal Hysterectomy|vaginal hysterectomy
5186189|NCT02826304|Laparoscopic assisted vaginal hysterectomy|laparoscopic assisted vaginal hysterectomy
5186272|NCT02825732|Behavioral disorders|behavioral disorders
5186273|NCT02825732|Functional dependency|functional dependency
5186274|NCT02825719|Fibroid|fibroid
5186377|NCT02825225|Biopsy|biopsy
5186476|NCT02824640|Intervention|intervention
5186478|NCT02824588|Pain|pain
5186573|NCT02824042|PK DDI|pk ddi
5186574|NCT02824042|ECG thorough QTC|ecg thorough qtc
5186576|NCT02823977|dexmedetomidine|dexmedetomidine
5186577|NCT02823977|alcohol|alcohol
5186578|NCT02823964|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency
5186589|NCT02823886|MRI|mri
5186783|NCT02822664|Brain, pedophilia, neuroimaging|brain, pedophilia, neuroimaging
5186784|NCT02822638|Myocardial infarction|myocardial infarction
5186785|NCT02822638|biomarkers|biomarkers
5186786|NCT02822638|STEMI|stemi
5186787|NCT02822625|Capsaicin|capsaicin
5186788|NCT02822625|QUTENZA®|qutenza®
5186789|NCT02822625|Hypnosis|hypnosis
5311674|NCT02121756|Dipyridamole|dipyridamole
5186790|NCT02822625|Peripheral Neuropathic|peripheral neuropathic
5186791|NCT02822612|optical coherence tomography|optical coherence tomography
5186792|NCT02822612|optical imaging|optical imaging
5186793|NCT02822612|retinal imaging|retinal imaging
5186797|NCT02822573|Donepezil|donepezil
5186865|NCT02822040|Root Resorption|root resorption
5186971|NCT02821299|Swallowing|swallowing
5186972|NCT02821299|Voice production|voice production
5186973|NCT02821299|Respiration|respiration
5186974|NCT02821299|Quality of life|quality of life
5186975|NCT02821247|Treatment Naïve Patients|treatment naïve patients
5186976|NCT02821234|Insomnia|insomnia
5186977|NCT02821234|Hyperarousal|hyperarousal
5187058|NCT02820779|Intracranial aneurysms|intracranial aneurysms
5187059|NCT02820766|Posterior Stabilized Knee|posterior stabilized knee
5187060|NCT02820766|Total Knee Arthroscopy|total knee arthroscopy
5187061|NCT02820766|Journey II BCS|journey ii bcs
5187063|NCT02820753|Health Literacy|health literacy
5187148|NCT02820272|Cold water|cold water
5187149|NCT02820272|Negative pressure wound therapy|negative pressure wound therapy
5187150|NCT02820272|pain|pain
5187151|NCT02820246|nutrition assessment|nutrition assessment
5187152|NCT02820246|nutrition therapy|nutrition therapy
5187153|NCT02820246|nutrition surveys|nutrition surveys
5187154|NCT02820246|patient outcome assessment|patient outcome assessment
5187155|NCT02820246|outcome and process assessment|outcome and process assessment
5187253|NCT02819752|squamous cell carcinoma|squamous cell carcinoma
5187254|NCT02819752|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5187256|NCT02819713|Prostate Biopsy|prostate biopsy
5187257|NCT02819713|NRS-score|nrs-score
5187280|NCT02819570|EOS|eos
5187407|NCT02818790|mHealth|mhealth
5187595|NCT02817685|ultrasound|ultrasound
5187693|NCT02817126|Rectal Cancer|rectal cancer
5187795|NCT02816528|Stewardship|stewardship
5188013|NCT02815176|Choroid|choroid
5188122|NCT02814656|dry powder inhaler|dry powder inhaler
5176106|NCT02890823|Asian|asian
5176107|NCT02890810|Acupuncture|acupuncture
5176108|NCT02890810|Back Pain|back pain
5176109|NCT02890810|Chronic Pain|chronic pain
5176110|NCT02890797|bronchiolitis|bronchiolitis
5176111|NCT02890797|parenchymal condensation|parenchymal condensation
5176112|NCT02890797|chest X-ray|chest x-ray
5188223|NCT02813980|Sleep|sleep
5188224|NCT02813980|Polysomnography|polysomnography
5188225|NCT02813980|Autonomic|autonomic
5188226|NCT02813980|Cardiovascular|cardiovascular
5188227|NCT02813941|Randomized controlled trial|randomized controlled trial
5188228|NCT02813941|Systematic review|systematic review
5188229|NCT02813941|Summary of finding tables|summary of finding tables
5188420|NCT02812927|Glycemic lability index|glycemic lability index
5188421|NCT02812927|Continuous glucose monitoring system|continuous glucose monitoring system
5188422|NCT02812927|intensive care|intensive care
5188423|NCT02812927|Insulin|insulin
5188424|NCT02812888|Hyperthyroidism|hyperthyroidism
5188621|NCT02811874|diabetes education|diabetes education
5188622|NCT02811874|community health workers|community health workers
5188623|NCT02811874|diabetes control|diabetes control
5188927|NCT02810028|ACT|act
5188932|NCT02809937|dexmedetomidine|dexmedetomidine
5188933|NCT02809937|long-term outcome|long-term outcome
5188934|NCT02809924|endotracheal intubation|endotracheal intubation
5188935|NCT02809924|teaching|teaching
5188936|NCT02809924|just-in-time|just-in-time
5188937|NCT02809898|Biomarkers, Neoplasms|biomarkers, neoplasms
5188938|NCT02809885|Hepatitis E|hepatitis e
5188939|NCT02809885|Pediatric|pediatric
5188940|NCT02809885|Transplantation|transplantation
5188941|NCT02809885|Prevalence|prevalence
5188942|NCT02809820|ACS|acs
5188943|NCT02809820|Beta Blockers|beta blockers
5188944|NCT02809820|platelet aggregation|platelet aggregation
5188945|NCT02809820|light transmission aggregometry|light transmission aggregometry
5189048|NCT02809066|calcium|calcium
5189141|NCT02808637|vaccination|vaccination
5189237|NCT02807896|pancreatic cancer|pancreatic cancer
5189238|NCT02807896|bile duct cancer|bile duct cancer
5189239|NCT02807896|miRNA|mirna
5189241|NCT02807883|ALL|all
5177334|NCT02882607|Prevention|prevention
5189405|NCT02807090|Physical Therapy|physical therapy
5189406|NCT02807077|Healthy subjects|healthy subjects
5189407|NCT02807038|Respiratory Function Tests|respiratory function tests
5189408|NCT02807038|Air pollution|air pollution
5189409|NCT02807038|Pregnancy|pregnancy
5189410|NCT02807038|Spirometry|spirometry
5189411|NCT02807012|Home care services|home care services
5189412|NCT02807012|Nursing|nursing
5189413|NCT02807012|Clinical trial|clinical trial
5189414|NCT02807012|Geriatric nursing|geriatric nursing
5189415|NCT02807012|Family caregiver|family caregiver
5189416|NCT02807012|Aged|aged
5189417|NCT02806999|Heart disease|heart disease
5189418|NCT02806999|Postoperative period|postoperative period
5189419|NCT02806999|Hyperglycemia|hyperglycemia
5189420|NCT02806999|Berberine|berberine
5189421|NCT02806999|Insulin|insulin
5189422|NCT02806999|Clinical trials as topic|clinical trials as topic
5189423|NCT02806947|Acute GVHD|acute gvhd
5189424|NCT02806947|Standard-Risk|standard-risk
5189425|NCT02806947|Sirolimus|sirolimus
5189426|NCT02806947|Refined Minnesota Risk Criteria|refined minnesota risk criteria
5189427|NCT02806947|Ann Arbor|ann arbor
5189428|NCT02806947|Biomarker|biomarker
5189429|NCT02806947|Steroid-Free|steroid-free
5189430|NCT02806921|Scleral Contact Lens|scleral contact lens
5189431|NCT02806921|Tear Proteases|tear proteases
5189432|NCT02806921|Tear Cytokines|tear cytokines
5189433|NCT02806908|Driving|driving
5189434|NCT02806895|Driving|driving
5189435|NCT02806856|Middle Cerebral Artery Stroke|middle cerebral artery stroke
5189436|NCT02806856|tDCS|tdcs
5189437|NCT02806856|Acute|acute
5189438|NCT02806843|stroke|stroke
5189439|NCT02806843|hemiplegia|hemiplegia
5189440|NCT02806843|healthy|healthy
5189441|NCT02806843|robotics|robotics
5189442|NCT02806843|rehabilitation|rehabilitation
5189443|NCT02806843|therapy|therapy
5189444|NCT02806830|Intravitreal injection|intravitreal injection
5189445|NCT02806830|AMD|amd
5189446|NCT02806830|Diabetic Retinopathy|diabetic retinopathy
5189447|NCT02806830|Retinal Artery Occlusion|retinal artery occlusion
5189448|NCT02806830|Myopia, Degenerative|myopia, degenerative
5189449|NCT02806830|eye drops|eye drops
5189450|NCT02806804|vaccine|vaccine
5189451|NCT02806804|safety|safety
5189452|NCT02806804|immunogenicity|immunogenicity
5189453|NCT02806791|Patients|patients
5189454|NCT02806778|cardiac arrest|cardiac arrest
5189455|NCT02806778|jugular venous oximetry|jugular venous oximetry
5189459|NCT02806765|Gait Speed|gait speed
5189548|NCT02806219|Bioequivalence|bioequivalence
5189549|NCT02806219|Certolizumab pegol|certolizumab pegol
5189550|NCT02806219|Human Volunteers|human volunteers
5189551|NCT02806193|cardiovascular|cardiovascular
5189633|NCT02805673|Quality of Life|quality of life
5189634|NCT02805660|MGCD0103|mgcd0103
5189635|NCT02805660|MEDI4736|medi4736
5189636|NCT02805660|Mocetinostat|mocetinostat
5189637|NCT02805660|Durvalumab|durvalumab
5189638|NCT02805660|HDAC Inhibitor|hdac inhibitor
5189639|NCT02805660|PD-L1 Inhibitor|pd-l1 inhibitor
5189640|NCT02805660|Phase 1|phase 1
5189641|NCT02805660|Phase 2|phase 2
5189642|NCT02805660|Metastatic Solid Tumor|metastatic solid tumor
5189643|NCT02805660|Non-small cell lung cancer|non-small cell lung cancer
5189644|NCT02805660|immunotherapy|immunotherapy
5189645|NCT02805660|checkpoint inhibitor|checkpoint inhibitor
5189646|NCT02805647|25-Hydroxy-vitamin D, children, bone fractures, vitamin D receptor polymorphism|25-hydroxy-vitamin d, children, bone fractures, vitamin d receptor polymorphism
5189647|NCT02805634|nine holes peg|nine holes peg
5189648|NCT02805634|triple stimulation|triple stimulation
5189649|NCT02805634|multiple sclerosis|multiple sclerosis
5189650|NCT02805582|Peripheral Nerve Block|peripheral nerve block
5189651|NCT02805569|videolaryngoscope|videolaryngoscope
5189652|NCT02805569|intubation stylet|intubation stylet
5189653|NCT02805569|articulating stylet|articulating stylet
5189654|NCT02805569|difficult airway|difficult airway
5189655|NCT02805530|oligometastatic disease, radical treatment|oligometastatic disease, radical treatment
5189656|NCT02805517|Minimally Invasive Surgical Procedures|minimally invasive surgical procedures
5189657|NCT02805517|Transplant Donors|transplant donors
5189658|NCT02805504|Bupivacaine|bupivacaine
5189703|NCT02805127|Asthma|asthma
5189704|NCT02805127|COPD|copd
5189790|NCT02804607|graft|graft
5189791|NCT02804607|development|development
5189792|NCT02804607|complications|complications
5189793|NCT02804607|autonomy|autonomy
5189794|NCT02804568|Schizophrenia|schizophrenia
5189795|NCT02804568|Alkermes|alkermes
5189796|NCT02804568|ALK 3831|alk 3831
5189797|NCT02804568|Samidorphan|samidorphan
5189798|NCT02804555|reactive oxygen species|reactive oxygen species
5189799|NCT02804555|elective cesarean section|elective cesarean section
5189800|NCT02804555|oxygen therapy|oxygen therapy
5189801|NCT02804555|newborn|newborn
5189802|NCT02804542|fascia iliaca blocks|fascia iliaca blocks
5189803|NCT02804529|Laparoscopic entry|laparoscopic entry
5189804|NCT02804529|Meng's point|meng's point
5189805|NCT02804529|Veress needle|veress needle
5189806|NCT02804477|adherence|adherence
5189807|NCT02804477|opioid|opioid
5189871|NCT02804100|Plasma DNA|plasma dna
5189872|NCT02804061|nutrition|nutrition
5189873|NCT02804061|exercise|exercise
5189874|NCT02804061|behavior change|behavior change
5189875|NCT02804061|adherence|adherence
5189876|NCT02804048|Dyspareunia|dyspareunia
5189877|NCT02804048|Pelvic floor muscles|pelvic floor muscles
5189878|NCT02804048|Women|women
5189880|NCT02804009|anxiety|anxiety
5189881|NCT02804009|coronary angiography|coronary angiography
5189882|NCT02803957|Degenerative|degenerative
5189883|NCT02803957|Mitral Regurgitation|mitral regurgitation
5189884|NCT02803944|azithromycin|azithromycin
5189949|NCT02803476|PCO|pco
5190171|NCT02802150|Zanthoxylum schinifolium seed Oil|zanthoxylum schinifolium seed oil
5190172|NCT02802150|soy bean oil|soy bean oil
5190173|NCT02802150|omega-3 fatty acid|omega-3 fatty acid
5190174|NCT02802150|dry eye disease|dry eye disease
5190175|NCT02802137|tafluprost|tafluprost
5190176|NCT02802137|dorzolamide|dorzolamide
5190177|NCT02802137|timolol|timolol
5190178|NCT02802137|FC|fc
5190179|NCT02802124|hepatocellular carcinoma|hepatocellular carcinoma
5190180|NCT02802124|carbon-ion radiotherapy|carbon-ion radiotherapy
5190275|NCT02801760|PrEP|prep
5190276|NCT02801760|Autonomous Research Consent|autonomous research consent
5190277|NCT02801760|Participation-associated Outcomes|participation-associated outcomes
5190278|NCT02801747|HIV care continuum|hiv care continuum
5190279|NCT02801747|antiretroviral therapy|antiretroviral therapy
5190379|NCT02801084|Reduced|reduced
5190380|NCT02801084|Environmental|environmental
5190587|NCT02799745|Pathological Cancer Progression|pathological cancer progression
5190588|NCT02799745|Enzalutamide|enzalutamide
5190681|NCT02799225|carbapenems|carbapenems
5190872|NCT02798406|Alcyone|alcyone
5190978|NCT02797964|BRCA1|brca1
5190979|NCT02797964|BRCA2|brca2
5190980|NCT02797964|MYC|myc
5190981|NCT02797964|RAD50|rad50
5190982|NCT02797964|Fanconi anemia|fanconi anemia
5191083|NCT02797457|Bilateral allograft|bilateral allograft
5191084|NCT02797457|Prosthetic forehands|prosthetic forehands
5191273|NCT02796508|Healthy aging|healthy aging
5191274|NCT02796508|Cognitive training|cognitive training
5191275|NCT02796508|Video-games|video-games
5191276|NCT02796508|Attention|attention
5191368|NCT02796118|Safety|safety
5191569|NCT02794831|NSAIDs|nsaids
5191864|NCT02793076|Survivors|survivors
5192062|NCT02791945|Veterans|veterans
5192063|NCT02791945|co-occurring disorders|co-occurring disorders
5192064|NCT02791945|pharmacotherapy|pharmacotherapy
5192065|NCT02791932|Pregnancy|pregnancy
5192066|NCT02791932|Postpartum period|postpartum period
5192067|NCT02791932|Depression|depression
5192068|NCT02791906|Chronic Kidney Diseases|chronic kidney diseases
5192069|NCT02791906|Chronic Kidney Insufficiency|chronic kidney insufficiency
5192070|NCT02791906|Chronic Renal Diseases|chronic renal diseases
5192071|NCT02791906|Chronic Renal Insufficiency|chronic renal insufficiency
5192072|NCT02791906|Kidney Insufficiency, Chronic|kidney insufficiency, chronic
5192073|NCT02791906|Cardiac Failure|cardiac failure
5192276|NCT02790658|Subjects|subjects
5192277|NCT02790645|Type 1 diabetes|type 1 diabetes
5192284|NCT02790645|Depression|depression
5192474|NCT02789345|epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5192481|NCT02789332|BRCA1/2|brca1/2
5192558|NCT02788968|Conflict detection|conflict detection
5192559|NCT02788968|Reasoning|reasoning
5192560|NCT02788955|Protein|protein
5192561|NCT02788955|Diet intervention|diet intervention
5192562|NCT02788955|Muscle|muscle
5192563|NCT02788955|Colorectal cancer|colorectal cancer
5192564|NCT02788942|Port|port
5192565|NCT02788942|Infection|infection
5192566|NCT02788942|cholecystectomy|cholecystectomy
5192570|NCT02788916|Drug Therapy|drug therapy
5192659|NCT02788292|autologous fat grafting|autologous fat grafting
5192660|NCT02788279|Locally advanced or Metastatic colorectal adenocarcinoma|locally advanced or metastatic colorectal adenocarcinoma
5192759|NCT02787642|Advanced soft-tissue sarcoma|advanced soft-tissue sarcoma
5192760|NCT02787642|Unresectable Soft-tissue Sarcoma|unresectable soft-tissue sarcoma
5192761|NCT02787629|D007440|d007440
5192762|NCT02787590|Neurology|neurology
5192763|NCT02787577|Sleep Duration|sleep duration
5192764|NCT02787577|Sleep Quality|sleep quality
5192765|NCT02787577|Body Composition|body composition
5192842|NCT02787213|proteomics|proteomics
5192843|NCT02787213|pregnancy|pregnancy
5192844|NCT02787213|biomarkers|biomarkers
5192845|NCT02787213|preterm birth|preterm birth
5192846|NCT02787200|electroencephalogram (EEG),Human brain,Brain-Computer Interface|electroencephalogram (eeg),human brain,brain-computer interface
5192847|NCT02787187|Standard lymphadenectomy|standard lymphadenectomy
5192848|NCT02787187|extended lymphadenectomy|extended lymphadenectomy
5192849|NCT02787187|pancreaticoduodenectomy|pancreaticoduodenectomy
5192850|NCT02787174|Asthma|asthma
5192919|NCT02786953|Diabetes Management|diabetes management
5192921|NCT02786940|remote|remote
5192922|NCT02786940|cardiac monitoring|cardiac monitoring
5192923|NCT02786940|mortality|mortality
5192924|NCT02786927|HANDIHALER|handihaler
5192925|NCT02786927|Dry Powder Inhaler|dry powder inhaler
5192926|NCT02786927|COPD|copd
5192927|NCT02786927|ELLIPTA|ellipta
5192928|NCT02786927|Inhaler preference attributes|inhaler preference attributes
5192929|NCT02786875|lifestyle|lifestyle
5192930|NCT02786875|low glycemic index diet|low glycemic index diet
5192931|NCT02786875|exercise|exercise
5192932|NCT02786875|vitamin D|vitamin d
5192933|NCT02786875|breast cancer|breast cancer
5192934|NCT02786875|Mediterranean diet|mediterranean diet
5192935|NCT02786862|mechanical ventilation|mechanical ventilation
5192936|NCT02786862|independent ventilation|independent ventilation
5193008|NCT02786498|Fracture Healing|fracture healing
5193009|NCT02786485|BPX-501|bpx-501
5193010|NCT02786485|Rimiducid|rimiducid
5193011|NCT02786485|AP1903|ap1903
5193012|NCT02786485|Hematological malignancies|hematological malignancies
5193013|NCT02786485|Hematologic diseases|hematologic diseases
5193014|NCT02786485|Leukemias and Myelodysplastic Syndromes|leukemias and myelodysplastic syndromes
5193015|NCT02786485|Lymphomas|lymphomas
5193016|NCT02786485|Multiple myeloma|multiple myeloma
5193113|NCT02785809|AMH|amh
5193214|NCT02785146|Prevention of recurrence and metastasis|prevention of recurrence and metastasis
5193215|NCT02785146|Efficacy and safety|efficacy and safety
5193218|NCT02785120|Safety|safety
5193322|NCT02784561|allogeneic peripheral blood stem cell transplantation|allogeneic peripheral blood stem cell transplantation
5193323|NCT02784561|conditioning regimen|conditioning regimen
5193450|NCT02783820|malaria, single ascending dose,|malaria, single ascending dose,
5193451|NCT02783794|BP-C1|bp-c1
5193534|NCT02783456|calculated intra glomerular pressure|calculated intra glomerular pressure
5193535|NCT02783443|Anesthesia, glycocalyx, perfused boundary region|anesthesia, glycocalyx, perfused boundary region
5193536|NCT02783430|Ketamine|ketamine
5193537|NCT02783430|Palliative care|palliative care
5193538|NCT02783430|Supportive care|supportive care
5193539|NCT02783430|Early palliative care|early palliative care
5193540|NCT02783430|Fast acting antidepressant|fast acting antidepressant
5193541|NCT02783430|End of life care|end of life care
5193543|NCT02783430|psychological distress|psychological distress
5193544|NCT02783430|antidepressant|antidepressant
5193546|NCT02783417|Visceral fat|visceral fat
5193579|NCT02783235|VIA|via
5193741|NCT02782273|morphine|morphine
5193742|NCT02782221|lipolysis|lipolysis
5193971|NCT02781012|Healthy|healthy
5194064|NCT02780726|Peritoneal dialysis|peritoneal dialysis
5194166|NCT02780245|Ecbolics|ecbolics
5194370|NCT02779101|Pembrolizumab|pembrolizumab
5194371|NCT02779088|physical fitness,body composition,sarcopenia|physical fitness,body composition,sarcopenia
5194372|NCT02779075|Sleeve Gastrectomy|sleeve gastrectomy
5194458|NCT02778425|partial splenic embolization|partial splenic embolization
5194459|NCT02778412|Thyroid cancer|thyroid cancer
5194460|NCT02778412|Thyroid nodules|thyroid nodules
5194461|NCT02778412|Thyroid neoplasia|thyroid neoplasia
5194462|NCT02778412|Thyroiditis|thyroiditis
5194463|NCT02778399|Pelvic Pain|pelvic pain
5194550|NCT02777801|hepatitis B carrier|hepatitis b carrier
5194551|NCT02777801|entecavir|entecavir
5194552|NCT02777788|Chinese Traditional Medicine|chinese traditional medicine
5194554|NCT02777775|CNF|cnf
5194555|NCT02777775|PNF|pnf
5194556|NCT02777775|Skin Tumors|skin tumors
5261556|NCT02380027|MRI|mri
5194648|NCT02777281|Wheelchair|wheelchair
5194755|NCT02776748|Pharmacokinetics|pharmacokinetics
5194865|NCT02776085|ultrasound|ultrasound
5195073|NCT02775032|general practice|general practice
5195172|NCT02774369|RCT|rct
5195271|NCT02773550|Multiple Myeloma|multiple myeloma
5195272|NCT02773524|Metastatic|metastatic
5195273|NCT02773524|Locally recurrent|locally recurrent
5195274|NCT02773524|Oesophago-gastric junction|oesophago-gastric junction
5195468|NCT02772497|DME|dme
5195576|NCT02771795|HER2|her2
5195577|NCT02771795|Trastuzumab|trastuzumab
5195578|NCT02771795|Biosimilar|biosimilar
5195579|NCT02771795|Cancer|cancer
5195586|NCT02771769|copy number instability|copy number instability
5195588|NCT02771769|cancer|cancer
5195672|NCT02771275|Mitral Valve Repair|mitral valve repair
5195673|NCT02771275|Transapical|transapical
5195674|NCT02771275|Artificial Chordae|artificial chordae
5195680|NCT02771236|Inherited Eye Disease|inherited eye disease
5802243|NCT00099463|Virus|virus
5195681|NCT02771210|Active psoriatic arthritis|active psoriatic arthritis
5195682|NCT02771210|Axial spondyloarthritides|axial spondyloarthritides
5195683|NCT02771210|Subcutaneous|subcutaneous
5195684|NCT02771210|Secukinumab in prefilled syringe|secukinumab in prefilled syringe
5195764|NCT02770638|Sport|sport
5195765|NCT02770638|Athlete|athlete
5195766|NCT02770638|Male|male
5195865|NCT02770027|Colon Surgery|colon surgery
5195990|NCT02769247|intrauterine device|intrauterine device
5195992|NCT02769247|pain|pain
5195998|NCT02769208|Air Pollution|air pollution
5195999|NCT02769208|Air Filtration|air filtration
5196000|NCT02769208|Exposure Assessment|exposure assessment
5196006|NCT02769182|falls|falls
5196098|NCT02768545|Hepatitis C|hepatitis c
5196199|NCT02767869|insulin sensitivity|insulin sensitivity
5196200|NCT02767804|ALK-positive NSCLC|alk-positive nsclc
5196403|NCT02766296|trauma|trauma
5196497|NCT02765906|pregnancy|pregnancy
5196498|NCT02765906|patient education|patient education
5196499|NCT02765906|graphic card|graphic card
5196501|NCT02765906|HELLP|hellp
5196582|NCT02765477|Modified Sgarbossa Criteria|modified sgarbossa criteria
5196585|NCT02765451|development|development
5196586|NCT02765451|clinical research|clinical research
5196587|NCT02765451|cancer|cancer
5196588|NCT02765451|private hospital|private hospital
5196589|NCT02765451|public hospital|public hospital
5196590|NCT02765451|northwestern france|northwestern france
5196591|NCT02765451|france|france
5196592|NCT02765451|hospitals|hospitals
5196593|NCT02765412|decision support|decision support
5196601|NCT02765360|EIT|eit
5196674|NCT02764866|Lung cancer|lung cancer
5196675|NCT02764866|Sleep apnea|sleep apnea
5196676|NCT02764866|Sleep disordered breathing|sleep disordered breathing
5196780|NCT02764164|TDCS|tdcs
5184953|NCT02833805|ATG|atg
5197098|NCT02762279|Children|children
5197099|NCT02762279|Esophageal Pressure|esophageal pressure
5280055|NCT02274506|ALL|all
5197205|NCT02761681|Focused Interviews|focused interviews
5197206|NCT02761681|RCT Control Condition|rct control condition
5197207|NCT02761681|RCT ACT-CL Condition|rct act-cl condition
5197208|NCT02761668|Pathological tooth migration|pathological tooth migration
5197209|NCT02761668|periodontal regenerative surgery|periodontal regenerative surgery
5334414|NCT02019732|Mild outcomes|mild outcomes
5197210|NCT02761668|vertical infrabony defects|vertical infrabony defects
5197399|NCT02760667|Oropharyngeal cancer|oropharyngeal cancer
5197497|NCT02760147|Pressure Support Ventilation|pressure support ventilation
5197602|NCT02759588|fallopian cancer|fallopian cancer
5197604|NCT02759588|abdominal cancer|abdominal cancer
5197605|NCT02759588|imaging|imaging
5197606|NCT02759588|carcinoma|carcinoma
5197607|NCT02759588|DNA virus|dna virus
5197702|NCT02758860|Colonoscopy|colonoscopy
5197800|NCT02758353|Nigeria|nigeria
5197904|NCT02757742|cardiopathy|cardiopathy
5198015|NCT02757066|NPC-15|npc-15
5186023|NCT02827240|Female sex workers|female sex workers
5198177|NCT02756013|BSA|bsa
5198430|NCT02754297|177Lu-octreotate|177lu-octreotate
5198431|NCT02754245|multicenter study|multicenter study
5198432|NCT02754245|emergency department|emergency department
5198433|NCT02754245|overcrowding status|overcrowding status
5198434|NCT02754245|estimation tool|estimation tool
5198435|NCT02754245|validation|validation
5198436|NCT02754232|Physical training|physical training
5198437|NCT02754232|Telemedicine|telemedicine
5198438|NCT02754232|Daily activities|daily activities
5198439|NCT02754232|Cross sectoral|cross sectoral
5198521|NCT02753569|PET/CT|pet/ct
5198704|NCT02752581|knee pain|knee pain
5198705|NCT02752555|Oligoasthenoteratozoospermia|oligoasthenoteratozoospermia
5198706|NCT02752555|Male factor managment|male factor managment
5198707|NCT02752555|Intacytoplasmic sperm injection|intacytoplasmic sperm injection
5198708|NCT02752529|Liver Transplantation|liver transplantation
5198709|NCT02752529|Individualized Therapy|individualized therapy
5198711|NCT02752477|Opioid-sparing|opioid-sparing
5198712|NCT02752464|Weight Loss|weight loss
5198713|NCT02752464|Health Status Disparities|health status disparities
5198790|NCT02751970|Dental adhesive|dental adhesive
5198791|NCT02751970|adhesive systems|adhesive systems
5198792|NCT02751970|Dental Restoration Failure|dental restoration failure
5198793|NCT02751944|exercise-induced|exercise-induced
5198886|NCT02751281|pneumatic|pneumatic
5198887|NCT02751281|ultra-sonic|ultra-sonic
5198888|NCT02751281|percutaneous nephrolithotomy|percutaneous nephrolithotomy
5198889|NCT02751268|infraorbital nerve block|infraorbital nerve block
5198890|NCT02751268|infratrochlear nerve block|infratrochlear nerve block
5198975|NCT02750800|Crohn's disease|crohn's disease
5198976|NCT02750800|Ulcerative colitis|ulcerative colitis
5198977|NCT02750800|Patient support program|patient support program
5198978|NCT02750800|Quality of life|quality of life
5198979|NCT02750800|Patient related outcomes|patient related outcomes
5198980|NCT02750800|Observational study|observational study
5198981|NCT02750800|Adalimumab|adalimumab
5199189|NCT02749461|contextual factors|contextual factors
5199270|NCT02748941|GSM|gsm
5199294|NCT02748850|apheresis patients|apheresis patients
5199295|NCT02748824|Age- Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Cataract|age- related macular degeneration; diabetic retinopathy; glaucoma; cataract
5199296|NCT02748811|elderly|elderly
5199297|NCT02748811|intervention study|intervention study
5199298|NCT02748811|geriatrics|geriatrics
5199299|NCT02748811|chemotherapy|chemotherapy
5199300|NCT02748772|Anti-angiogenesis Drugs|anti-angiogenesis drugs
5199301|NCT02748772|Advanced Colorectal Cancer|advanced colorectal cancer
5199373|NCT02748291|Walking|walking
5199374|NCT02748291|Pedometer|pedometer
5199375|NCT02748291|Physical Activity|physical activity
5199376|NCT02748291|Activities of Daily Function|activities of daily function
5199377|NCT02748291|Department of Health Physical Activity Guidelines|department of health physical activity guidelines
5199378|NCT02748291|Improve pain|improve pain
5199379|NCT02748291|Decrease pain|decrease pain
5199380|NCT02748291|Improve function|improve function
5199388|NCT02748174|Migraine|migraine
5199457|NCT02747771|hair pulling|hair pulling
5199458|NCT02747771|habit reversal training|habit reversal training
5199459|NCT02747771|acceptance and commitment therapy|acceptance and commitment therapy
5199460|NCT02747771|cognitive behavioral therapy|cognitive behavioral therapy
5199461|NCT02747758|neuropathic pain|neuropathic pain
5199462|NCT02747758|neuralgia|neuralgia
5199463|NCT02747758|tDCS|tdcs
5199465|NCT02747745|Caregivers|caregivers
5199479|NCT02747667|Eye|eye
5199540|NCT02747225|in vivo|in vivo
5199541|NCT02747212|electrical properties|electrical properties
5199542|NCT02747212|malignant tissues|malignant tissues
5199543|NCT02747212|ex vivo|ex vivo
5199544|NCT02747199|SYNERGY|synergy
5199545|NCT02747199|Neointimal formation|neointimal formation
5199644|NCT02746237|Serotonin|serotonin
5199754|NCT02745600|RFA|rfa
5199847|NCT02745132|Chronic, Cognition Disorders|chronic, cognition disorders
5199848|NCT02745132|Neurocognition Disorders|neurocognition disorders
5199849|NCT02745132|Cognitive Impairments|cognitive impairments
5199850|NCT02745132|Diffusion Magnetic Resonance Imaging|diffusion magnetic resonance imaging
5199852|NCT02745132|Verbal fluency|verbal fluency
5200018|NCT02744261|Drug Delivery Systems|drug delivery systems
5200019|NCT02744248|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5200020|NCT02744196|rheumatoid arthritis|rheumatoid arthritis
5200021|NCT02744196|rheumatism|rheumatism
5200022|NCT02744196|Acellbia|acellbia
5200023|NCT02744196|methotrexate|methotrexate
5200024|NCT02744196|biologic therapy|biologic therapy
5200025|NCT02744196|monoclonal antibody|monoclonal antibody
5200026|NCT02744196|rituximab|rituximab
5200027|NCT02744183|Exercise|exercise
5200028|NCT02744183|Fasted|fasted
5200029|NCT02744183|Glucose|glucose
5200030|NCT02744183|Energy Balance|energy balance
5200031|NCT02744170|COPD|copd
5200032|NCT02744170|Incremental Shuttle Walk Test|incremental shuttle walk test
5200033|NCT02744170|Endurance Shuttle Walk Test|endurance shuttle walk test
5200034|NCT02744170|oxygen therapy|oxygen therapy
5200105|NCT02743741|Somatostatin Receptor Positive Neuroendocrine Tumors|somatostatin receptor positive neuroendocrine tumors
5200212|NCT02743351|CML|cml
5200213|NCT02743351|Stem Cell Transplant|stem cell transplant
5200214|NCT02743351|Transplant|transplant
5200215|NCT02743351|aGvHD|agvhd
5200330|NCT02742766|Dose escalation study|dose escalation study
5200331|NCT02742766|Safety|safety
5200332|NCT02742766|Pharmacodynamics|pharmacodynamics
5200534|NCT02741011|Mentally Handicapped|mentally handicapped
5200635|NCT02740309|adolescent anxiety|adolescent anxiety
5200732|NCT02739867|tumor-educated platelets|tumor-educated platelets
5200733|NCT02739867|platelet RNA profiling|platelet rna profiling
5200769|NCT02739568|EDS|eds
5200828|NCT02739152|Infections|infections
5200829|NCT02739152|Worsening|worsening
5200830|NCT02739126|Diagnosis|diagnosis
5200831|NCT02739100|pharmacokinetics|pharmacokinetics
5200832|NCT02739100|bioequivalence|bioequivalence
5200833|NCT02739087|radiation free cardiac catheterization|radiation free cardiac catheterization
5200834|NCT02739061|pathogenesis|pathogenesis
5201025|NCT02737683|depression|depression
5201115|NCT02737189|Mechanical Embolectomy|mechanical embolectomy
5201116|NCT02737176|Smoking Cessation|smoking cessation
5201117|NCT02737176|Mouth Diseases|mouth diseases
5201118|NCT02737176|Periodontal Diseases|periodontal diseases
5201119|NCT02737176|Leukoplakia|leukoplakia
5201120|NCT02737176|Keratosis|keratosis
5201121|NCT02737176|Implant|implant
5201122|NCT02737176|Lichen Planus|lichen planus
5201123|NCT02737163|Programmable shunts|programmable shunts
5201124|NCT02737163|Strata valve|strata valve
5201125|NCT02737124|Acetaminophen|acetaminophen
5201126|NCT02737124|Surgery|surgery
5201127|NCT02737124|Meniscectomy|meniscectomy
5201128|NCT02737098|PTSD|ptsd
5201138|NCT02737046|ATLL|atll
5201413|NCT02735239|Immunotherapy|immunotherapy
5201414|NCT02735239|Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)|cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
5201846|NCT02732782|tendinosis|tendinosis
5201847|NCT02732782|intervention|intervention
5201848|NCT02732782|training load|training load
5201849|NCT02732782|high performance sports|high performance sports
5201850|NCT02732756|ADHD|adhd
5201934|NCT02732145|Lichen Simplex Chronicus|lichen simplex chronicus
5202147|NCT02730793|Cystic Fibrosis|cystic fibrosis
5202148|NCT02730793|P. aeruginosa (PA)|p. aeruginosa (pa)
5202153|NCT02730741|diarrhoea|diarrhoea
5202248|NCT02730143|Altitude|altitude
5202338|NCT02729558|radiotherapy|radiotherapy
5202551|NCT02728154|pre-clinical diastolic dysfunction (pre-HFpEF)|pre-clinical diastolic dysfunction (pre-hfpef)
5202552|NCT02728128|Milrinone|milrinone
5202553|NCT02728115|Huntington's Disease|huntington's disease
5202554|NCT02728115|Stem Cell|stem cell
5202555|NCT02728115|Dental Pulp Stem Cells|dental pulp stem cells
5202560|NCT02728102|Vaccine|vaccine
5202648|NCT02727504|low flow|low flow
5199442|NCT02747862|FAP|fap
5202938|NCT02725814|Sucrose|sucrose
5202939|NCT02725814|Effectiveness|effectiveness
5202940|NCT02725814|Healthcare Delivery|healthcare delivery
5202943|NCT02725775|Orange Juice, Polyphenol, Cognition|orange juice, polyphenol, cognition
5202944|NCT02725762|Dry AMD|dry amd
5202945|NCT02725762|Vision Loss|vision loss
5202946|NCT02725762|AMD|amd
5202947|NCT02725749|shoulder|shoulder
5202948|NCT02725749|low level laser therapy|low level laser therapy
5202949|NCT02725749|exercises|exercises
5202950|NCT02725710|uterine aspiration|uterine aspiration
5202951|NCT02725658|Neoadjuvant Therapy|neoadjuvant therapy
5202952|NCT02725658|Diffuse Optical Spectroscopic Imaging|diffuse optical spectroscopic imaging
5202953|NCT02725658|DOSI|dosi
5202954|NCT02725658|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5202955|NCT02725645|Surface electromyography|surface electromyography
5203040|NCT02725294|access to care|access to care
5203147|NCT02724683|catheter|catheter
5203193|NCT02724449|IAD|iad
5203247|NCT02724163|Children|children
5203248|NCT02724163|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5203346|NCT02723734|African-American men|african-american men
5203441|NCT02723253|radiotherapy|radiotherapy
5203442|NCT02723253|chemotherapy|chemotherapy
5203443|NCT02723253|Raltitrexed|raltitrexed
5203647|NCT02721797|collagen|collagen
5203649|NCT02721797|hyperflexation|hyperflexation
5203746|NCT02721160|malnutrition|malnutrition
5203874|NCT02720237|HIV|hiv
5192121|NCT02791659|prone|prone
5192126|NCT02791607|P16Ink4A|p16ink4a
5204152|NCT02718586|Myokines|myokines
5204153|NCT02718586|Protein Energy Wasting|protein energy wasting
5204154|NCT02718586|Hemodialysis|hemodialysis
5204155|NCT02718573|Hepatitis C|hepatitis c
5204156|NCT02718573|Interferon-free|interferon-free
5204157|NCT02718573|DDA's|dda's
5204158|NCT02718547|Diabetes mellitus|diabetes mellitus
5204159|NCT02718547|Diabetic macular edema|diabetic macular edema
5204160|NCT02718547|Intra ocular pressure|intra ocular pressure
5204161|NCT02718547|Ocular perfusion pressure|ocular perfusion pressure
5204162|NCT02718547|Retinal perfusion|retinal perfusion
5211057|NCT02675907|Bunion|bunion
5204163|NCT02718521|contrast-induced nephropathy|contrast-induced nephropathy
5204164|NCT02718521|hydration therapy combined with intravenous infusion of isosorbide|hydration therapy combined with intravenous infusion of isosorbide
5204166|NCT02718469|Ebola|ebola
5204231|NCT02718027|Alport Syndrome|alport syndrome
5204335|NCT02717624|Mantle Cell Lymphoma|mantle cell lymphoma
5204336|NCT02717624|MCL|mcl
5204337|NCT02717624|Acalabrutinib|acalabrutinib
5204338|NCT02717624|ACE-LY-106|ace-ly-106
5204443|NCT02716870|Cholesterol|cholesterol
5204655|NCT02715661|blood flow|blood flow
5204656|NCT02715661|brain health|brain health
5204658|NCT02715661|endothelial activation|endothelial activation
5204659|NCT02715596|head and neck|head and neck
5204660|NCT02715596|eicosapentanoic acid|eicosapentanoic acid
5204661|NCT02715596|body composition|body composition
5204662|NCT02715570|Aspergillus species|aspergillus species
5204663|NCT02715570|Filamentous fungi|filamentous fungi
5204664|NCT02715570|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors
5204665|NCT02715570|Anti-Infective Agents|anti-infective agents
5204666|NCT02715570|Antifungal Agents|antifungal agents
5204667|NCT02715570|Enzyme Inhibitors|enzyme inhibitors
5204668|NCT02715570|Aspergillosis|aspergillosis
5204670|NCT02715570|Asthma|asthma
5204742|NCT02715102|lung nodules|lung nodules
5204832|NCT02714595|Hospital acquired pneumonia (HAP)|hospital acquired pneumonia (hap)
5204833|NCT02714595|Sepsis|sepsis
5204835|NCT02714595|S-649266|s-649266
5204924|NCT02714127|Self-sampling|self-sampling
5205008|NCT02713750|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5205009|NCT02713750|Hormonal Contraception|hormonal contraception
5205010|NCT02713750|Human Immunodeficiency Virus|human immunodeficiency virus
5205011|NCT02713750|Intrauterine Device|intrauterine device
5205012|NCT02713750|Pharmacokinetic|pharmacokinetic
5205013|NCT02713750|Sexually Transmitted Diseases|sexually transmitted diseases
5205014|NCT02713750|Reproductive Health|reproductive health
5205015|NCT02713737|hypoxemia|hypoxemia
5205016|NCT02713737|high-flow|high-flow
5205017|NCT02713737|atrial fibrillation|atrial fibrillation
5205018|NCT02713737|sleep|sleep
5205019|NCT02713711|Psoriasis|psoriasis
5205020|NCT02713711|balneotherapy|balneotherapy
5205021|NCT02713711|phototherapy|phototherapy
5205022|NCT02713711|balneophototherapy|balneophototherapy
5205023|NCT02713698|Anaesthetics|anaesthetics
5205024|NCT02713698|Intravenous|intravenous
5205025|NCT02713698|Propofol|propofol
5205094|NCT02713282|R092670|r092670
5205285|NCT02712034|Medication-assisted treatment (MAT)|medication-assisted treatment (mat)
5205286|NCT02712034|Buprenorphine|buprenorphine
5205288|NCT02712034|Naltrexone|naltrexone
5205289|NCT02712021|Cerebral Palsy|cerebral palsy
5205290|NCT02712021|Lycra|lycra
5205291|NCT02712021|Motor Function|motor function
5205297|NCT02711956|Phase 1b/2a|phase 1b/2a
5205382|NCT02711189|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5205383|NCT02711189|Alcohol|alcohol
5205384|NCT02711189|Cue Reactivity|cue reactivity
5205417|NCT02711059|insulin resistance|insulin resistance
5205418|NCT02711020|Depressive symptoms|depressive symptoms
5205419|NCT02711020|Fibromyalgia|fibromyalgia
5205420|NCT02711020|Cognitive Behavioral Therapy|cognitive behavioral therapy
5205421|NCT02711020|Personal Constructs Therapy|personal constructs therapy
5205422|NCT02711020|Differential Efficacy|differential efficacy
5205423|NCT02711007|osteosarcoma|osteosarcoma
5205424|NCT02711007|metastasis|metastasis
5205425|NCT02711007|advanced|advanced
5205426|NCT02711007|apatinib|apatinib
5205427|NCT02710994|Immediate release omeprazole|immediate release omeprazole
5205428|NCT02710994|Integrated gastric acidity|integrated gastric acidity
5205429|NCT02710981|Sildenafil vaginal gel|sildenafil vaginal gel
5205430|NCT02710981|endometrium|endometrium
5205431|NCT02710981|clomiphene|clomiphene
5205432|NCT02710981|anovulation|anovulation
5205583|NCT02710370|Diabetes Mellitus, Experimental/metabolism|diabetes mellitus, experimental/metabolism
5205584|NCT02710370|Energy Metabolism|energy metabolism
5205585|NCT02710370|Glucose/metabolism|glucose/metabolism
5205586|NCT02710370|Jejunum/metabolism|jejunum/metabolism
5205587|NCT02710370|Metabolomics|metabolomics
5205588|NCT02710370|Gene Expression|gene expression
5205589|NCT02710357|Mandibular Prosthesis Implantation|mandibular prosthesis implantation
5205590|NCT02710357|Prostheses and Implants|prostheses and implants
5857581|NCT00022867|Children|children
5205674|NCT02709473|propofol|propofol
5205779|NCT02708810|radiosurgery (RS)|radiosurgery (rs)
5205780|NCT02708810|trigeminal neuralgia (TGN)|trigeminal neuralgia (tgn)
5205781|NCT02708797|Cerebral autoregulation|cerebral autoregulation
5205784|NCT02708797|Doppler Transcranial|doppler transcranial
5205785|NCT02708784|Glykogen storage disease type 2)|glykogen storage disease type 2)
5205786|NCT02708784|Dystrophia Myotonica|dystrophia myotonica
5205787|NCT02708784|Muscular disorders|muscular disorders
5205788|NCT02708784|MR-imaging|mr-imaging
5205789|NCT02708784|Muscle strength|muscle strength
5205790|NCT02708784|Myopathies|myopathies
5205868|NCT02708199|Serology|serology
5205966|NCT02707575|Keratin|keratin
5205967|NCT02707575|Ranibizumab|ranibizumab
5206108|NCT02706678|Renal transplant recipients|renal transplant recipients
5206313|NCT02705378|Constipation|constipation
5206314|NCT02705365|Lung Screening|lung screening
5206419|NCT02704702|Fimasartan|fimasartan
5206524|NCT02703805|Wellness|wellness
5206728|NCT02702557|Frail Elderly|frail elderly
5206729|NCT02702557|Elastic Band Exercises|elastic band exercises
5206730|NCT02702557|Unsupervised Exercises|unsupervised exercises
5206731|NCT02702557|Monitoring Technology|monitoring technology
5206732|NCT02702557|Bandcizer|bandcizer
5206746|NCT02702492|NHL|nhl
5207022|NCT02701244|Breast Neoplasms|breast neoplasms
5207023|NCT02701244|Breast Diseases|breast diseases
5207024|NCT02701244|Neoplasms|neoplasms
5207025|NCT02701244|Neoplasms by Site|neoplasms by site
5207026|NCT02701231|lung cancer|lung cancer
5207027|NCT02701231|Low-frequency rotating magnetic therapy system|low-frequency rotating magnetic therapy system
5207028|NCT02701231|systemic anti-tumor therapy|systemic anti-tumor therapy
5207029|NCT02701218|Canalith repositioning procedure (CRP)|canalith repositioning procedure (crp)
5207030|NCT02701218|BPPV|bppv
5207031|NCT02701205|Plaque Psoriasis|plaque psoriasis
5207032|NCT02701205|Skin Disease|skin disease
5207033|NCT02701192|coccygodynia|coccygodynia
5207034|NCT02701192|coccygectomy|coccygectomy
5207035|NCT02701192|coccyx|coccyx
5207036|NCT02701179|Lignocaine|lignocaine
5207037|NCT02701166|Pruritus|pruritus
5207038|NCT02701166|itch|itch
5207100|NCT02700672|Executive Function|executive function
5207213|NCT02699736|HCV|hcv
5207322|NCT02698982|elderly|elderly
5207517|NCT02697721|Chronic Disease Self-Management Program|chronic disease self-management program
5207518|NCT02697695|chronic inflammation|chronic inflammation
5207519|NCT02697695|fatty liver index|fatty liver index
5207520|NCT02697669|Heart failure|heart failure
5207605|NCT02697305|Isoleucine|isoleucine
5207606|NCT02697305|Branched chain amino acids|branched chain amino acids
5207607|NCT02697292|Intravenous Immunoglobulin|intravenous immunoglobulin
5207608|NCT02697292|VGKC|vgkc
5214357|NCT02656238|BPA|bpa
5207609|NCT02697292|Autoimmune epilepsy|autoimmune epilepsy
5207610|NCT02697292|Gamumex-C|gamumex-c
5207611|NCT02697279|Abscess|abscess
5207702|NCT02696850|sinusitis|sinusitis
5207803|NCT02696278|gut microbiota|gut microbiota
5207886|NCT02695992|NT-proBNP|nt-probnp
5207887|NCT02695992|Biomarkers|biomarkers
5207889|NCT02695953|biomarker|biomarker
5207890|NCT02695953|Cognitive Processing Therapy|cognitive processing therapy
5207891|NCT02695914|Inflammatory markers|inflammatory markers
5207892|NCT02695901|Plaque index|plaque index
5207893|NCT02695901|Melaleuca alternifolia oil.|melaleuca alternifolia oil.
5207894|NCT02695901|Nanoparticles|nanoparticles
5207895|NCT02695875|Fibromyalgia|fibromyalgia
5207896|NCT02695875|Pain|pain
5207897|NCT02695875|Postural balance|postural balance
5207898|NCT02695875|Physical therapy|physical therapy
5207899|NCT02695875|Aquatic therapy|aquatic therapy
5207900|NCT02695849|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5207901|NCT02695836|Audit and Feedback|audit and feedback
5207902|NCT02695836|Nursing Homes|nursing homes
5207966|NCT02695407|haemodynamic monitoring|haemodynamic monitoring
5207971|NCT02695329|navigation system|navigation system
5207972|NCT02695329|palm-sized|palm-sized
5207973|NCT02695329|total knee arthroplasty|total knee arthroplasty
5207974|NCT02695316|Migrants|migrants
5207975|NCT02695316|Communication Barriers|communication barriers
5208062|NCT02694627|gender, caregiving, MNCH, violence, sexual and reproductive health, parenting|gender, caregiving, mnch, violence, sexual and reproductive health, parenting
5208063|NCT02694614|weight loss|weight loss
5208157|NCT02694068|Genetic|genetic
5208158|NCT02694068|Peritoneal Membrane|peritoneal membrane
5208159|NCT02694068|Peritoneal Equilibrium Test|peritoneal equilibrium test
5208160|NCT02694068|Ultrafiltration Capacity|ultrafiltration capacity
5208161|NCT02694068|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5208162|NCT02694055|Community Health Workers|community health workers
5208163|NCT02694055|Community Case Management|community case management
5208164|NCT02694055|Proactive Case Detection|proactive case detection
5208165|NCT02694055|Under-five Child Mortality|under-five child mortality
5208186|NCT02693977|AT|at
5208257|NCT02693665|pediatric advance care planning|pediatric advance care planning
5208258|NCT02693665|adolescent|adolescent
5208259|NCT02693665|family|family
5208260|NCT02693665|palliative care|palliative care
5208261|NCT02693665|end of life|end of life
5208380|NCT02692911|Inflammation|inflammation
5208399|NCT02692820|Preterm|preterm
5208482|NCT02692417|sexual|sexual
5208681|NCT02691130|vaccine|vaccine
5208682|NCT02691130|universal|universal
5208683|NCT02691130|peptide|peptide
5208786|NCT02690571|Air Pollution|air pollution
5208877|NCT02690103|HCV|hcv
5208878|NCT02690103|Viremia|viremia
5208879|NCT02690103|Biobran|biobran
5208880|NCT02690103|PEG interferon|peg interferon
5208881|NCT02690090|Deep Vein Thrombosis|deep vein thrombosis
5208882|NCT02690090|Prophylaxis|prophylaxis
5208883|NCT02690090|Critically ill adults|critically ill adults
5208884|NCT02690077|Patient Satisfaction|patient satisfaction
5208885|NCT02690077|Earlier Family Bond Initiation|earlier family bond initiation
5208886|NCT02690077|Maternal and Neonatal Outcomes|maternal and neonatal outcomes
5208887|NCT02690064|Endothelial Function|endothelial function
5208888|NCT02690064|Maximal Exercise Capacity|maximal exercise capacity
5208889|NCT02690064|Flow Mediated Dilation|flow mediated dilation
5208890|NCT02690064|Antioxidant|antioxidant
5208891|NCT02690064|FEV1|fev1
5208964|NCT02689622|Hematology|hematology
5209193|NCT02688322|Acinetobacter infections|acinetobacter infections
5209321|NCT02687308|Prostatic cancer|prostatic cancer
5209322|NCT02687308|Radical prostatectomy|radical prostatectomy
5209426|NCT02686632|Denture Stomatitis|denture stomatitis
5209427|NCT02686632|Denture Erythematous Stomatitis|denture erythematous stomatitis
5197456|NCT02760342|Pharmacokinetics|pharmacokinetics
5197457|NCT02760342|Metformin|metformin
5197458|NCT02760342|Drug-drug interaction|drug-drug interaction
5197459|NCT02760342|ASP015K|asp015k
5197460|NCT02760329|asthma|asthma
5197461|NCT02760329|COPD|copd
5197463|NCT02760329|lung disease|lung disease
5209507|NCT02686151|OHSS|ohss
5209508|NCT02686099|Rigid Fixation|rigid fixation
5197551|NCT02759783|SBRT|sbrt
5209601|NCT02685449|prandial insulin requirement|prandial insulin requirement
5209602|NCT02685449|pure protein meal|pure protein meal
5209805|NCT02684370|BI 655066|bi 655066
5197839|NCT02758080|Personalized medicine|personalized medicine
5197840|NCT02758080|Next generation sequencing|next generation sequencing
5197841|NCT02758041|Acne|acne
5209900|NCT02683746|Albiglutide|albiglutide
5209901|NCT02683746|Tolerability|tolerability
5198142|NCT02756221|symptoms|symptoms
5198143|NCT02756208|vaccine|vaccine
5198144|NCT02756208|healthy volunteer|healthy volunteer
5198145|NCT02756195|Patient safety|patient safety
5198146|NCT02756195|adverse events|adverse events
5198147|NCT02756195|pediatric surgery|pediatric surgery
5210095|NCT02682394|Cancer of pancreas|cancer of pancreas
5210096|NCT02682394|steatosis|steatosis
5198240|NCT02755636|Cluster-Randomized Trial|cluster-randomized trial
5198241|NCT02755636|Mobile Health|mobile health
5198242|NCT02755610|Peritoneal Dialysis|peritoneal dialysis
5198243|NCT02755610|Checklist|checklist
5198248|NCT02755584|Aging|aging
5198267|NCT02755415|Robotic|robotic
5210194|NCT02681861|ASP6294|asp6294
5210285|NCT02681133|Knee osteoarthritis|knee osteoarthritis
5210287|NCT02681133|Survey|survey
5210400|NCT02680496|Robot-Assistance|robot-assistance
5210401|NCT02680496|Gait [MeSH]|gait [mesh]
5210408|NCT02680483|Jordan|jordan
5210500|NCT02679846|monitoring VEEG|monitoring veeg
5210501|NCT02679846|safety|safety
5210596|NCT02679157|ADL|adl
5210600|NCT02679131|beleodaq|beleodaq
5210703|NCT02678364|RCT|rct
5210811|NCT02677610|Steroid|steroid
5210866|NCT02677168|OSA|osa
5210919|NCT02676882|Vitamins|vitamins
5211006|NCT02676232|Recurrent Abdominal Pain|recurrent abdominal pain
5211007|NCT02676232|Children|children
5211008|NCT02676193|Tobacco Smoking|tobacco smoking
5211009|NCT02676193|Cigarettes|cigarettes
5211010|NCT02676193|Packaging|packaging
5211011|NCT02676193|Text messaging|text messaging
5211012|NCT02676193|Graphic Images|graphic images
5211013|NCT02676193|Sensor-Based Assessments|sensor-based assessments
5211014|NCT02676167|HIV prevention|hiv prevention
5211015|NCT02676167|men who have sex with men|men who have sex with men
5211016|NCT02676167|pre-exposure prophylaxis|pre-exposure prophylaxis
5211017|NCT02676167|PrEP|prep
5211018|NCT02676167|Greece|greece
5211094|NCT02675751|myopia|myopia
5211095|NCT02675673|Enteral Feeding|enteral feeding
5211204|NCT02675062|Sedentary behaviour|sedentary behaviour
5297936|NCT02188355|DES|des
5211205|NCT02675062|Knee arthroplasty|knee arthroplasty
5211206|NCT02675049|Intranasal|intranasal
5211207|NCT02675049|Dexmedetomidine|dexmedetomidine
5211208|NCT02675049|Anaesthesia|anaesthesia
5211209|NCT02675049|Breast Lumpectomy|breast lumpectomy
5211298|NCT02674516|associated risk factors|associated risk factors
5211299|NCT02674503|Walking|walking
5211300|NCT02674503|Hospitalization|hospitalization
5211499|NCT02673112|Concussion|concussion
5211584|NCT02672540|Vaso occlusive crisis|vaso occlusive crisis
5211585|NCT02672501|immunotherapy|immunotherapy
5211587|NCT02672501|leukemia|leukemia
5211588|NCT02672449|Prostate cancer|prostate cancer
5211589|NCT02672449|Carbon ions|carbon ions
5211590|NCT02672449|Radiobiology|radiobiology
5211591|NCT02672449|Radiotherapy|radiotherapy
5211592|NCT02672436|Diabetic Foot Ulcer|diabetic foot ulcer
5211593|NCT02672436|Diabetes Mellitus|diabetes mellitus
5211594|NCT02672436|Wound Healing|wound healing
5211595|NCT02672397|Epidural|epidural
5298453|NCT02186158|Elderly|elderly
5211668|NCT02671864|Angiogenesis Inflammation|angiogenesis inflammation
5211767|NCT02671188|Humanized Immunoglobulin G|humanized immunoglobulin g
5211873|NCT02670395|JNJ-54416076|jnj-54416076
5211974|NCT02669758|Schizophrenia|schizophrenia
5211975|NCT02669758|Safety|safety
5211986|NCT02669667|Safety|safety
5212088|NCT02668900|Cardiovascular disease|cardiovascular disease
5212089|NCT02668900|Decision Support|decision support
5212090|NCT02668900|Patient Decision Aid|patient decision aid
5212091|NCT02668900|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5212092|NCT02668900|implantable cardioverter defibrillator replacement|implantable cardioverter defibrillator replacement
5212093|NCT02668874|Pit and Fissure sealants|pit and fissure sealants
5212094|NCT02668874|Isolation|isolation
5212095|NCT02668874|permanent teeth|permanent teeth
5212096|NCT02668874|children|children
5212097|NCT02668874|Isolite®|isolite®
5212099|NCT02668848|Stroke|stroke
5212188|NCT02668367|RSV|rsv
5200302|NCT02742922|self harm|self harm
5200325|NCT02742818|blanket|blanket
5212279|NCT02667782|Community care|community care
5212280|NCT02667756|biomarker|biomarker
5212281|NCT02667756|inflammation|inflammation
5212282|NCT02667756|prognosis|prognosis
5212283|NCT02667756|knee|knee
5212284|NCT02667743|NSCLC|nsclc
5212285|NCT02667743|Paclitaxel Micelles for Injection|paclitaxel micelles for injection
5212286|NCT02667691|superoxyde dismutase|superoxyde dismutase
5212287|NCT02667691|melon concentrate|melon concentrate
5212288|NCT02667691|oxydative stress|oxydative stress
5212289|NCT02667691|overweight women|overweight women
5212290|NCT02667665|Alzheimer's Disease Dementia|alzheimer's disease dementia
5212292|NCT02667652|RYGB|rygb
5212384|NCT02667093|AML|aml
5200589|NCT02740634|LPA|lpa
5212578|NCT02665767|Telesonography, Appendix|telesonography, appendix
5212782|NCT02664662|Rehabilitation|rehabilitation
5212784|NCT02664649|TAVR|tavr
5212874|NCT02664155|Renal insufficiency|renal insufficiency
5212875|NCT02664155|Direct oral anticoagulants (DOA)|direct oral anticoagulants (doa)
5212876|NCT02664155|Deep Vein Thrombosis (DVT)|deep vein thrombosis (dvt)
5213069|NCT02663219|RDS|rds
5213070|NCT02663206|spastic esophageal disorders|spastic esophageal disorders
5213369|NCT02661399|CIPN|cipn
5213467|NCT02660957|Smoking cessation|smoking cessation
5213468|NCT02660931|Pediatrics|pediatrics
5213469|NCT02660905|HIV-HCV co-infected|hiv-hcv co-infected
5213470|NCT02660905|HCV|hcv
5213471|NCT02660905|HIV|hiv
5213472|NCT02660905|Hep C|hep c
5213473|NCT02660905|Hepatitis C|hepatitis c
5213474|NCT02660905|HCV positive|hcv positive
5213475|NCT02660892|IAAO|iaao
5213714|NCT02659631|CRC|crc
5213771|NCT02659358|Fitbit|fitbit
5213772|NCT02659358|Patient Reported Outcomes (PRO)|patient reported outcomes (pro)
5213773|NCT02659358|Stage 3/4 cancer|stage 3/4 cancer
5213776|NCT02659345|Art Therapy|art therapy
5213865|NCT02658968|DLBCL|dlbcl
5213961|NCT02658396|Multiple Myeloma|multiple myeloma
5213962|NCT02658396|Relapsed Multiple Myeloma|relapsed multiple myeloma
5213963|NCT02658396|Refractory Multiple Myeloma|refractory multiple myeloma
5213964|NCT02658370|physical exercises|physical exercises
5213965|NCT02658370|physical therapy|physical therapy
5213966|NCT02658370|Wii game console|wii game console
5213967|NCT02658370|patients perspective|patients perspective
5213968|NCT02658344|Stem cell|stem cell
5214150|NCT02657447|Follicular Lymphoma|follicular lymphoma
5214151|NCT02657447|Marginal Zone Lymphoma|marginal zone lymphoma
5214248|NCT02656953|VDU lenses|vdu lenses
5214334|NCT02656355|Gait Initiation|gait initiation
5214335|NCT02656355|Freezing of gait|freezing of gait
5214336|NCT02656355|Balance training|balance training
5214337|NCT02656355|Anticipatory postural adjustments|anticipatory postural adjustments
5214338|NCT02656342|OCD|ocd
5214339|NCT02656329|Heart Failure (HF)|heart failure (hf)
5214340|NCT02656329|Single photon emission computer tomography scan (SPECT)|single photon emission computer tomography scan (spect)
5214341|NCT02656329|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5214342|NCT02656329|Left Ventricular ejection fraction (LVEF)|left ventricular ejection fraction (lvef)
5214343|NCT02656329|New York Health Association (NYHA)|new york health association (nyha)
5214344|NCT02656329|Metaiodobenzylguanidine (mIBG)|metaiodobenzylguanidine (mibg)
5214345|NCT02656329|123I-iobenguane|123i-iobenguane
5214346|NCT02656329|Heart-to-mediastinal ratio (H/M)|heart-to-mediastinal ratio (h/m)
5214347|NCT02656329|ADMIRE-ICD (AdreView Myocardial Imaging for Risk Evaluation - Implantable Cardioverter Defibrillator|admire-icd (adreview myocardial imaging for risk evaluation - implantable cardioverter defibrillator
5214348|NCT02656329|All-cause mortality|all-cause mortality
5214349|NCT02656329|Cardiac mortality|cardiac mortality
5214350|NCT02656251|biofilms|biofilms
5214351|NCT02656251|cross over trial|cross over trial
5214352|NCT02656251|chlorhexidine|chlorhexidine
5214403|NCT02655913|Immune function|immune function
5214512|NCT02655159|Retrospective|retrospective
5214616|NCT02654535|Body weight|body weight
5214715|NCT02653911|Acupuncture|acupuncture
5214716|NCT02653898|Malaria|malaria
5214818|NCT02653430|obesity|obesity
5214917|NCT02652819|Chronic Kidney Disease|chronic kidney disease
5215003|NCT02652442|postural balance|postural balance
5215004|NCT02652442|rehabilitation|rehabilitation
5215005|NCT02652429|PAH|pah
5376415|NCT01828905|Cerament|cerament
5215006|NCT02652429|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5215008|NCT02652429|iNO|ino
5215118|NCT02651519|bispectral index|bispectral index
5215222|NCT02650830|bile acids profile|bile acids profile
5215223|NCT02650830|GLP-1|glp-1
5215224|NCT02650830|FGF-19|fgf-19
5215324|NCT02650297|Lymphedema secondary to breast cancer|lymphedema secondary to breast cancer
5215429|NCT02649660|Lipidomics|lipidomics
5215430|NCT02649660|Sphingolipids|sphingolipids
5215433|NCT02649660|Gb3|gb3
5215523|NCT02649140|24-hour urine|24-hour urine
5215524|NCT02649140|Calcium oxalate|calcium oxalate
5215632|NCT02648568|Sleepwalking|sleepwalking
5215633|NCT02648568|sleep terrors|sleep terrors
5215634|NCT02648568|arousal disorders|arousal disorders
5215635|NCT02648568|F513 (CIM-10)|f513 (cim-10)
5215636|NCT02648568|F514 (CIM-10)|f514 (cim-10)
5215739|NCT02648048|Vismodegib|vismodegib
5215847|NCT02647385|inflammatory cytokines|inflammatory cytokines
5215848|NCT02647372|parkinson|parkinson
5215850|NCT02647372|globus pallidus|globus pallidus
5215939|NCT02646774|Aspergillosis|aspergillosis
5215940|NCT02646774|Antifungal|antifungal
5215941|NCT02646774|Micafungin|micafungin
5215942|NCT02646748|Advanced|advanced
5216029|NCT02645994|Closed Loop Anesthesia Delivery System|closed loop anesthesia delivery system
5216039|NCT02645968|ILD|ild
5216126|NCT02645383|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5216129|NCT02645370|Danzhen|danzhen
5216130|NCT02645370|Topiramate|topiramate
5216131|NCT02645370|Headache diary APP|headache diary app
5216132|NCT02645370|preventive treatment|preventive treatment
5216133|NCT02645357|Oncology Patients|oncology patients
5216227|NCT02644811|mini-implants|mini-implants
5216334|NCT02644096|User Involvement|user involvement
5216432|NCT02643459|Acute care|acute care
5216526|NCT02642926|monopolar energy|monopolar energy
5216527|NCT02642913|Enzalutamide|enzalutamide
5216528|NCT02642913|Sorafenib|sorafenib
5216529|NCT02642913|15-279|15-279
5216530|NCT02642900|Complete denture|complete denture
5216531|NCT02642900|Candida spp|candida spp
5216532|NCT02642900|Photodynamic therapy|photodynamic therapy
5216533|NCT02642887|gingival recession|gingival recession
5216534|NCT02642887|tunnel technique|tunnel technique
5216535|NCT02642887|Miller Class I and II|miller class i and ii
5216536|NCT02642835|mesh|mesh
5216537|NCT02642835|pelvic organ prolapse|pelvic organ prolapse
5216538|NCT02642822|Cytomegalovirus|cytomegalovirus
5216615|NCT02642380|ITP|itp
5216616|NCT02642380|high-dose dexamethasone|high-dose dexamethasone
5216617|NCT02642328|VO2Max|vo2max
5216620|NCT02642302|VO2Max|vo2max
5216731|NCT02641522|Type 1 diabetes|type 1 diabetes
5216733|NCT02641496|PTSD|ptsd
5216838|NCT02640976|poor ovarian response|poor ovarian response
5217187|NCT02639052|Itch|itch
5217188|NCT02639052|Botox|botox
5217283|NCT02638402|receptor tyrosin kinases|receptor tyrosin kinases
5217359|NCT02637869|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5217360|NCT02637843|radial|radial
5217361|NCT02637843|angiography|angiography
5217362|NCT02637843|angioplasty|angioplasty
5217363|NCT02637843|randomized|randomized
5217364|NCT02637843|sheath|sheath
5217365|NCT02637843|slender|slender
5217366|NCT02637791|Stroke|stroke
5217367|NCT02637791|Rehabilitation|rehabilitation
5217368|NCT02637791|Virtual Reality|virtual reality
5217369|NCT02637778|nutrient profiles|nutrient profiles
5217370|NCT02637778|menu plans|menu plans
5217371|NCT02637778|n-3 LC-PUFA|n-3 lc-pufa
5217372|NCT02637778|SFA|sfa
5217373|NCT02637778|MUFA|mufa
5217374|NCT02637778|PUFA|pufa
5217375|NCT02637778|cardiovascular risk|cardiovascular risk
5217376|NCT02637765|Breast Cancer|breast cancer
5217377|NCT02637765|Physical Activity|physical activity
5217378|NCT02637765|Quality of life|quality of life
5217379|NCT02637752|Pediatric Obesity|pediatric obesity
5217380|NCT02637752|Body Mass Index|body mass index
5217381|NCT02637752|Dentistry|dentistry
5217382|NCT02637739|hysteroscope|hysteroscope
5217427|NCT02637609|community-based participatory research (CBPR)|community-based participatory research (cbpr)
5217428|NCT02637609|patient priority|patient priority
5217429|NCT02637609|diabetes|diabetes
5217430|NCT02637583|conjugate vaccine|conjugate vaccine
5217431|NCT02637583|polysaccharide vaccine|polysaccharide vaccine
5217432|NCT02637570|healthy male athletes|healthy male athletes
5217433|NCT02637570|18-35 years old|18-35 years old
5217434|NCT02637531|IPI-549|ipi-549
5217435|NCT02637531|Phase 1|phase 1
5217436|NCT02637531|Advanced Solid Tumor|advanced solid tumor
5217437|NCT02637531|Non-small cell lung cancer|non-small cell lung cancer
5217512|NCT02637141|celiac|celiac
5217612|NCT02636634|brain metastases|brain metastases
5217613|NCT02636634|radiation necrosis|radiation necrosis
5217703|NCT02635958|BMI|bmi
5217704|NCT02635958|InBody|inbody
5217705|NCT02635958|iDXA|idxa
5217706|NCT02635958|validation|validation
5217707|NCT02635945|adenosine A1 receptor antagonist|adenosine a1 receptor antagonist
5217708|NCT02635945|adenosine receptor modulator|adenosine receptor modulator
5217709|NCT02635945|COPD|copd
5217710|NCT02635945|asthma|asthma
5217711|NCT02635919|Nicotine addiction|nicotine addiction
5217712|NCT02635919|Cigarette smoking|cigarette smoking
5217715|NCT02635906|BED REST|bed rest
5217791|NCT02635412|Morbidly|morbidly
5217792|NCT02635412|Adherent Placenta|adherent placenta
5217901|NCT02634957|benign vocal fold lesions|benign vocal fold lesions
5218001|NCT02634489|Tamsulosin hydrochloride|tamsulosin hydrochloride
5218002|NCT02634489|Solifenacin succinate|solifenacin succinate
5218003|NCT02634476|Alcohol|alcohol
5218004|NCT02634476|Substance use disorder|substance use disorder
5218005|NCT02634476|cognitive bias|cognitive bias
5218006|NCT02634476|behavioral intervention|behavioral intervention
5218007|NCT02634476|computerised training|computerised training
5218008|NCT02634463|Immunoassay|immunoassay
5218009|NCT02634463|Antipsychotic|antipsychotic
5218010|NCT02634463|Aripiprazole|aripiprazole
5218011|NCT02634463|Olanzapine|olanzapine
5218012|NCT02634463|Paliperidone|paliperidone
5206095|NCT02706834|Drug therapy|drug therapy
5206096|NCT02706821|prediabetes|prediabetes
5206097|NCT02706821|blood glucose|blood glucose
5218074|NCT02634203|Chronic Thromboembolic Pulmonary Hypertension|chronic thromboembolic pulmonary hypertension
5218075|NCT02634203|Balloon Pulmonary Angioplasty|balloon pulmonary angioplasty
5218077|NCT02634190|Cervical cancer screening|cervical cancer screening
5218078|NCT02634190|High risk Human Papillomavirus|high risk human papillomavirus
5218079|NCT02634190|Aptima HPV Assay|aptima hpv assay
5218080|NCT02634177|Genotyping|genotyping
5218081|NCT02634177|Genecept Assay™|genecept assay™
5218082|NCT02634164|leucine|leucine
5218083|NCT02634164|isoleucine|isoleucine
5218084|NCT02634151|LDL‐C|ldl‐c
5218085|NCT02634151|Lipid Regulator|lipid regulator
5218086|NCT02634138|Peripheral Vascular Disease|peripheral vascular disease
5218152|NCT02633735|Clinical Decision Support|clinical decision support
5218153|NCT02633696|Clinical trial|clinical trial
5218155|NCT02633696|Healthy volunteers|healthy volunteers
5218256|NCT02633150|insulinoresistant|insulinoresistant
5218257|NCT02633150|menopausal women|menopausal women
5218258|NCT02633150|polyphenol|polyphenol
5218259|NCT02633137|Lenalidomide|lenalidomide
5218268|NCT02633111|15-180|15-180
5218362|NCT02632565|osteoarthritis|osteoarthritis
5218442|NCT02632279|Tryptophan depletion|tryptophan depletion
5218443|NCT02632279|Serotonin|serotonin
5218444|NCT02632266|prematurity|prematurity
5218445|NCT02632266|growth|growth
5218446|NCT02632266|nutrition|nutrition
5218447|NCT02632266|human milk fortifier|human milk fortifier
5218448|NCT02632253|exercise therapy|exercise therapy
5218449|NCT02632253|GUCH|guch
5218450|NCT02632253|ventricular ejection fraction|ventricular ejection fraction
5218451|NCT02632253|HIIT|hiit
5218452|NCT02632253|MICE|mice
5218453|NCT02632240|gingival recession|gingival recession
5218527|NCT02631876|IMGN853|imgn853
5218529|NCT02631876|Antibody drug conjugate|antibody drug conjugate
5218530|NCT02631876|ImmunoGen|immunogen
5218534|NCT02631876|Phase 3|phase 3
5218633|NCT02631252|AML|aml
5218726|NCT02630836|mesenchymal stromal cells|mesenchymal stromal cells
5218727|NCT02630836|stem cells|stem cells
5218728|NCT02630836|elderly|elderly
5218734|NCT02630797|Calcium|calcium
5218834|NCT02630264|randomized|randomized
5218835|NCT02630251|Cancer|cancer
5218937|NCT02629484|echocardiography|echocardiography
5218938|NCT02629484|hip fracture|hip fracture
5218939|NCT02629484|surgery|surgery
5219039|NCT02629068|Stigma|stigma
5219165|NCT02628379|Genomic Testing|genomic testing
5219166|NCT02628379|Cancer of Unknown Primary|cancer of unknown primary
5219306|NCT02627781|negative appendectomy|negative appendectomy
5219413|NCT02627352|Intraocular Pressure|intraocular pressure
5219513|NCT02626793|Observational|observational
5219514|NCT02626793|CC-10004|cc-10004
5219515|NCT02626793|non-interventional|non-interventional
5219516|NCT02626793|Germany|germany
5219517|NCT02626767|high-intensity interval training|high-intensity interval training
5219518|NCT02626767|adolescents|adolescents
5219519|NCT02626767|school-based exercise|school-based exercise
5219520|NCT02626767|cardiometabolic health|cardiometabolic health
5219532|NCT02626689|SF36v2|sf36v2
5219812|NCT02625064|proteomic|proteomic
5219814|NCT02625012|Vitiligo|vitiligo
5219911|NCT02624388|Genistein|genistein
5219912|NCT02624388|Soy|soy
5219913|NCT02624388|Chemotherapy side-effects|chemotherapy side-effects
5220028|NCT02623842|urinary incontinence|urinary incontinence
5220029|NCT02623842|woman|woman
5220030|NCT02623842|radiofrequency|radiofrequency
5208136|NCT02694172|cereal bar|cereal bar
5208137|NCT02694146|platelet-rich plasma (PRP)|platelet-rich plasma (prp)
5208138|NCT02694146|hyaluronic acid (Hylan G-F 20).|hyaluronic acid (hylan g-f 20).
5208139|NCT02694146|NSAIDs|nsaids
5220324|NCT02621905|Bioavailability|bioavailability
5220940|NCT02618226|Intracranial pressure|intracranial pressure
5221223|NCT02616315|Drug therapy|drug therapy
5221476|NCT02614560|AML|aml
5221478|NCT02614534|HIPEC|hipec
5221580|NCT02613988|MRI|mri
5221682|NCT02613143|zonulo-hyaloido-vitrectomy|zonulo-hyaloido-vitrectomy
5221905|NCT02611713|OFF time|off time
5222009|NCT02611037|Transarterial|transarterial
5222012|NCT02611024|PM01183|pm01183
5222120|NCT02610257|Handwriting|handwriting
5222231|NCT02609646|Anti-Infective Agents|anti-infective agents
5222535|NCT02607878|Prognosis|prognosis
5222739|NCT02606305|ADC|adc
5222832|NCT02605811|temozolomide|temozolomide
5222927|NCT02605200|Pediatrics|pediatrics
5223116|NCT02604004|3TC|3tc
5223117|NCT02604004|LC-MS/MS|lc-ms/ms
5223339|NCT02602795|HIV|hiv
5223435|NCT02602379|Nociception Level|nociception level
5223677|NCT02600871|Abscess|abscess
5223753|NCT02600390|Leg Ulcer|leg ulcer
5223854|NCT02599779|SBRT|sbrt
5224069|NCT02598635|Phosphorus|phosphorus
5224157|NCT02598089|Trivalent Vaccine|trivalent vaccine
5224761|NCT02594436|topical|topical
5224965|NCT02593240|Obesity|obesity
5225270|NCT02591667|5-Fluorouracil|5-fluorouracil
5225366|NCT02591030|Modified folfirinox|modified folfirinox
5225367|NCT02591030|Gemcis|gemcis
5225556|NCT02589886|Education|education
5225557|NCT02589886|e-Health|e-health
5225654|NCT02589236|N91115|n91115
5225755|NCT02588872|hyaluronic acid|hyaluronic acid
5225756|NCT02588859|T2DM, Diabetes|t2dm, diabetes
5225853|NCT02588157|Glidescope|glidescope
5225958|NCT02587520|Tetanus|tetanus
5226052|NCT02587000|adenomyosis|adenomyosis
5226267|NCT02585583|DBS|dbs
5226441|NCT02584153|Incisional|incisional
5226565|NCT02583399|Pain|pain
5226772|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil
5226870|NCT02581501|Phase I|phase i
5226978|NCT02581020|Hepatitis C|hepatitis c
5227009|NCT02580981|RNA|rna
5227102|NCT02580383|Multifidus twitching|multifidus twitching
5215331|NCT02650245|breath|breath
5227410|NCT02578797|Neoplasms|neoplasms
5227519|NCT02578225|MI|mi
5227614|NCT02577536|Pregnancy outcome|pregnancy outcome
5227856|NCT02576470|stroke|stroke
5227962|NCT02575755|Piperaquine|piperaquine
5228064|NCT02575300|gastroenteropancreatic NETs|gastroenteropancreatic nets
5228158|NCT02574754|bioequivalence|bioequivalence
5228344|NCT02573870|COPD|copd
5228449|NCT02573376|pharmacokinetics|pharmacokinetics
5228452|NCT02573324|Temozolomide|temozolomide
5228552|NCT02572869|Quality of Life|quality of life
5228651|NCT02572245|Single Dose|single dose
5228927|NCT02570867|glaucoma|glaucoma
5229131|NCT02569528|anticoagulation|anticoagulation
5229246|NCT02568917|Composite Resins|composite resins
5229451|NCT02567851|PET scans|pet scans
5229452|NCT02567851|Lymphoma|lymphoma
5229574|NCT02567162|Stroke|stroke
5229680|NCT02566538|prediction algorithm|prediction algorithm
5229892|NCT02565173|trabecular meshwork|trabecular meshwork
5230024|NCT02564354|F508del|f508del
5230129|NCT02563743|Anxiety disorders|anxiety disorders
5230250|NCT02563132|colonoscopy|colonoscopy
5230359|NCT02562443|MDS|mds
5230481|NCT02561715|DBS|dbs
5230551|NCT02561221|primary care|primary care
5230990|NCT02558686|eccentric exercise|eccentric exercise
5231085|NCT02558010|Gabapentin|gabapentin
5231580|NCT02554929|CBT|cbt
5231671|NCT02554409|Influenza|influenza
5232070|NCT02552121|esophagus cancer|esophagus cancer
5232266|NCT02550847|MR/PET|mr/pet
5232470|NCT02549664|Long QT Syndrome (LQTS)|long qt syndrome (lqts)
5232871|NCT02547259|schizophrenia|schizophrenia
5232872|NCT02547259|memory|memory
5232873|NCT02547259|pain|pain
5232959|NCT02546817|Treatment|treatment
5233061|NCT02546154|Kidney Diseases|kidney diseases
5233289|NCT02544685|Probiotic|probiotic
5233426|NCT02543879|BET Inhibitor|bet inhibitor
5233499|NCT02543385|S Ketamine|s ketamine
5233784|NCT02541552|ropivacaine|ropivacaine
5233900|NCT02540824|Apatinib|apatinib
5233901|NCT02540824|RET|ret
5233902|NCT02540824|gene fusion|gene fusion
5233930|NCT02540733|MRI|mri
5234001|NCT02540226|Tranexamic Acid|tranexamic acid
5234092|NCT02539550|first-in-human|first-in-human
5234425|NCT02537496|PAS|pas
5234677|NCT02535767|Primaquine|primaquine
5235020|NCT02533375|efficacy|efficacy
5235223|NCT02532192|Belinostat|belinostat
5235350|NCT02531672|11C-choline|11c-choline
5235351|NCT02531672|Positron Emission Tomography|positron emission tomography
5235569|NCT02530203|CABG|cabg
5235785|NCT02528981|GBS|gbs
5235877|NCT02528370|COPD exacerbation|copd exacerbation
5235878|NCT02528370|Telemedicine|telemedicine
5235904|NCT02528279|artemether-lumefantrine|artemether-lumefantrine
5235905|NCT02528279|mixed species malaria|mixed species malaria
5235909|NCT02528240|platelets|platelets
5236499|NCT02524210|volunteers|volunteers
5236500|NCT02524197|Hip|hip
5236699|NCT02522975|efficacy|efficacy
5236700|NCT02522975|safety|safety
5236899|NCT02521792|Clementia|clementia
5236900|NCT02521792|Myositis Ossificans Progressiva|myositis ossificans progressiva
5237002|NCT02520947|desflurane|desflurane
5237099|NCT02520232|executive functions|executive functions
5237115|NCT02520063|neoadjuvant|neoadjuvant
5237431|NCT02518412|Neuromodulation|neuromodulation
5237432|NCT02518412|Neuropsychology|neuropsychology
5237531|NCT02517775|healthy|healthy
5237536|NCT02517684|Crohn's disease|crohn's disease
5237635|NCT02516982|Prenatal Care|prenatal care
5237749|NCT02516150|Artificial Pancreas|artificial pancreas
5237770|NCT02516020|IVF|ivf
5238166|NCT02513628|outcome|outcome
5238382|NCT02512497|T-LGL|t-lgl
5238505|NCT02511873|SFN|sfn
5238704|NCT02510508|alcohol|alcohol
5238899|NCT02509390|Trauma|trauma
5239400|NCT02506244|Wristband|wristband
5239496|NCT02505711|Agriculture|agriculture
5239796|NCT02504320|Drug therapy|drug therapy
5239797|NCT02504255|Crohn disease|crohn disease
5239798|NCT02504255|inflammatory biomarkers|inflammatory biomarkers
5239799|NCT02504255|immunologic markers|immunologic markers
5239800|NCT02504255|calprotectin|calprotectin
5239801|NCT02504216|Rivaroxaban|rivaroxaban
5239889|NCT02503696|Colorectal Neoplasm|colorectal neoplasm
5239988|NCT02503254|Carbon Heated Tobacco Product|carbon heated tobacco product
5240401|NCT02501057|Human Immunodeficiency Virus|human immunodeficiency virus
5240621|NCT02499822|Organ damage|organ damage
5240622|NCT02499822|Nifedipine GITS|nifedipine gits
5241041|NCT02497261|Prospective cohort|prospective cohort
5241151|NCT02496676|Lymphoma|lymphoma
5241561|NCT02494544|knee implant|knee implant
5241658|NCT02494089|in situ simulation|in situ simulation
5241659|NCT02494089|in hospital cardiac arrest|in hospital cardiac arrest
5241661|NCT02494089|education|education
5241662|NCT02494089|patient simulation|patient simulation
5241842|NCT02493010|Computerized Cognitive Behavioral Therapy|computerized cognitive behavioral therapy
5241941|NCT02492503|recurrent or metastatic carcinoma cervix chemotherapy|recurrent or metastatic carcinoma cervix chemotherapy
5242026|NCT02491879|mechanical low back pain|mechanical low back pain
5242027|NCT02491879|emergency department|emergency department
5242105|NCT02491424|Osseointegration|osseointegration
5242110|NCT02491333|acupuncture|acupuncture
5242386|NCT02489175|Parastomal hernia|parastomal hernia
5242388|NCT02489175|stomaplasty|stomaplasty
5242389|NCT02489175|ring|ring
5242390|NCT02489149|food insecurity|food insecurity
5242391|NCT02489136|spiritist passe|spiritist passe
5242392|NCT02489136|laying of hands|laying of hands
5242393|NCT02489136|newborn|newborn
5242394|NCT02489136|adult|adult
5242395|NCT02489136|conditions|conditions
5242498|NCT02488668|Sensory Feedback|sensory feedback
5242501|NCT02488642|nitric oxide donors|nitric oxide donors
5242728|NCT02487303|Analgesia, Obstetrical|analgesia, obstetrical
5242729|NCT02487303|Cesarean Section|cesarean section
5242913|NCT02486406|Hepatitis C Genotype 4|hepatitis c genotype 4
5242914|NCT02486406|Pediatric|pediatric
5242915|NCT02486341|continuous glucose monitoring system|continuous glucose monitoring system
5242916|NCT02486341|basal insulin|basal insulin
5242917|NCT02486341|diabetes mellitus|diabetes mellitus
5242919|NCT02486328|Cognitive dysfunction|cognitive dysfunction
5242920|NCT02486328|Colonoscopy|colonoscopy
5242921|NCT02486328|Sedation|sedation
5243008|NCT02485821|Bishop score|bishop score
5243009|NCT02485808|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5243010|NCT02485808|Bladder Symptoms|bladder symptoms
5243011|NCT02485808|Overactive Bladder|overactive bladder
5243012|NCT02485808|Urinary Urgency|urinary urgency
5243013|NCT02485808|Lower Urinary Tract Dysfunction|lower urinary tract dysfunction
5243014|NCT02485795|Pain Management|pain management
5243015|NCT02485795|Genetic Variation|genetic variation
5243016|NCT02485795|Genetic Polymorphism|genetic polymorphism
5243017|NCT02485795|Polymorphism, Single Nucleotide Genetic Association Studies|polymorphism, single nucleotide genetic association studies
5243018|NCT02485795|Healthcare Utilization|healthcare utilization
5243021|NCT02485743|satiety|satiety
5243300|NCT02484209|aged|aged
5243504|NCT02483104|BRCA|brca
5243505|NCT02483104|Primary peritoneal cancer|primary peritoneal cancer
5243506|NCT02483104|carboplatin|carboplatin
5243507|NCT02483104|Fallopian tube|fallopian tube
5243508|NCT02483104|Poly (ADP-ribose) polymerase (PARP)|poly (adp-ribose) polymerase (parp)
5243509|NCT02483104|paclitaxel|paclitaxel
5243510|NCT02483104|Ovarian cancer|ovarian cancer
5243511|NCT02483104|veliparib|veliparib
5243512|NCT02483091|Knowledge translation|knowledge translation
5243513|NCT02483091|Clinical practice guidelines|clinical practice guidelines
5243514|NCT02483091|Multimodal care|multimodal care
5243515|NCT02483091|Brief Action Planning|brief action planning
5243597|NCT02482636|pneumococcal|pneumococcal
5243599|NCT02482623|Dementia|dementia
5243696|NCT02481973|Grant Bentley Method|grant bentley method
5243807|NCT02481297|Untreated with high-risk molecular features|untreated with high-risk molecular features
5244014|NCT02479919|Social Cognition|social cognition
5244015|NCT02479919|Schizophrenia|schizophrenia
5244214|NCT02478697|employment|employment
5244314|NCT02478255|Xenon gas|xenon gas
5244416|NCT02477553|numeracy|numeracy
5244514|NCT02476994|Intralipid|intralipid
5244713|NCT02475967|telerehabilitation|telerehabilitation
5244841|NCT02475109|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5244843|NCT02475083|Virtual reality|virtual reality
5244844|NCT02475083|Balance|balance
5244845|NCT02475083|Falls|falls
5244846|NCT02475057|Prostate Cancer|prostate cancer
5244847|NCT02475057|Cardiovascular disease|cardiovascular disease
5244848|NCT02475057|Degarelix|degarelix
5244849|NCT02475044|post-concussion|post-concussion
5244850|NCT02475044|Cognitive-Behavioral Theray|cognitive-behavioral theray
5244851|NCT02475044|parenting|parenting
5244852|NCT02475031|transversus abdominis plane block|transversus abdominis plane block
5244853|NCT02475018|Shuhua Milk|shuhua milk
5244854|NCT02475018|plant sterol esters|plant sterol esters
5244855|NCT02475018|serum cholesterol|serum cholesterol
5244856|NCT02475018|human|human
5244857|NCT02475005|self management app|self management app
5244858|NCT02475005|headache|headache
5244859|NCT02475005|adolescent|adolescent
5244861|NCT02474992|Social network|social network
5244862|NCT02474992|Social support|social support
5244863|NCT02474992|Disclosure|disclosure
5244864|NCT02474992|Stigma|stigma
5244865|NCT02474992|Kenya|kenya
5244867|NCT02474979|Prevention|prevention
5245017|NCT02474186|radiation therapy|radiation therapy
5245018|NCT02474186|abscopal|abscopal
5245019|NCT02474186|abscopal effect|abscopal effect
5245020|NCT02474186|T-cell|t-cell
5245021|NCT02474186|GM-CSF|gm-csf
5245022|NCT02474186|anti-tumor|anti-tumor
5245023|NCT02474186|immune|immune
5245024|NCT02474186|immune response|immune response
5245025|NCT02474186|capecitabine|capecitabine
5245026|NCT02474186|xeloda|xeloda
5245027|NCT02474186|taxol|taxol
5245099|NCT02473679|AED|aed
5245109|NCT02473562|Parkinson's disease|parkinson's disease
5245206|NCT02473094|Rectal Cancer|rectal cancer
5245315|NCT02472691|MDS|mds
5245316|NCT02472691|AML|aml
5245392|NCT02472262|Environmental|environmental
5245393|NCT02472262|Enteric|enteric
5245480|NCT02471885|cardio-oncology|cardio-oncology
5245481|NCT02471885|anthracycline|anthracycline
5245618|NCT02471014|Obesity|obesity
5245715|NCT02470312|CRT|crt
5245816|NCT02469818|glenohumeral dislocation|glenohumeral dislocation
5245817|NCT02469792|Anterior cruciate ligament|anterior cruciate ligament
5245907|NCT02469415|Azacytidine|azacytidine
5245908|NCT02469415|Decitabine|decitabine
5245909|NCT02469415|Dacogen|dacogen
5245910|NCT02469402|reduced|reduced
5245911|NCT02469402|protein|protein
5245912|NCT02469402|formula|formula
5246003|NCT02468869|Satisfaction|satisfaction
5246253|NCT02467582|Aspirin|aspirin
5246347|NCT02467179|Arrhythmia|arrhythmia
5246348|NCT02467179|cavo-tricuspid isthmus|cavo-tricuspid isthmus
5246349|NCT02467179|atrial fibrillation|atrial fibrillation
5246350|NCT02467179|atrial fibrillation ablation|atrial fibrillation ablation
5246351|NCT02467166|esophagoscopy|esophagoscopy
5246449|NCT02466698|Colectomy|colectomy
5246548|NCT02466009|metastatic colorectal cancer|metastatic colorectal cancer
5246549|NCT02466009|colorectal adenocarcinoma|colorectal adenocarcinoma
5246555|NCT02465983|CAR / CART|car / cart
5246974|NCT02463838|Emergency Department|emergency department
5247069|NCT02463318|SIRT1|sirt1
5247169|NCT02462590|Ventilator Associated Pneumonia|ventilator associated pneumonia
5247171|NCT02462590|C-Difficile|c-difficile
5247172|NCT02462590|Antibiotic-associated Diarrhea|antibiotic-associated diarrhea
5247173|NCT02462590|Diarrhea|diarrhea
5247174|NCT02462577|Local morphine|local morphine
5247175|NCT02462577|Postmastectomy pain|postmastectomy pain
5247176|NCT02462564|peritoneal surface malignancies|peritoneal surface malignancies
5247177|NCT02462564|Post operative cognitive dysfunction|post operative cognitive dysfunction
5247178|NCT02462551|Depression|depression
5247179|NCT02462551|Treatment Resistant Depression|treatment resistant depression
5247180|NCT02462525|relapsed multiple myeloma|relapsed multiple myeloma
5247181|NCT02462525|antibody drug conjugate|antibody drug conjugate
5247182|NCT02462525|refractory multiple myeloma|refractory multiple myeloma
5247254|NCT02462148|Saphenous|saphenous
5247359|NCT02461420|PMS|pms
5247445|NCT02460978|Safety|safety
5247773|NCT02459197|Pain|pain
5248028|NCT02457416|Oral immunotherapy|oral immunotherapy
5248029|NCT02457390|contrast enhanced laparoscopic ultrasound|contrast enhanced laparoscopic ultrasound
5248030|NCT02457390|CE-LUS|ce-lus
5248031|NCT02457390|LUS|lus
5248032|NCT02457390|robot assisted CRC resection|robot assisted crc resection
5235980|NCT02527720|Mindfulness|mindfulness
5235981|NCT02527720|Therapy|therapy
5235982|NCT02527720|Problem Drinking|problem drinking
5248105|NCT02457000|Circadian Rhythm|circadian rhythm
5248106|NCT02456961|Collagen crosslinking (CXL)|collagen crosslinking (cxl)
5248219|NCT02456272|Surgical treatment|surgical treatment
5248524|NCT02454270|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5248634|NCT02453763|Diffusion tensor imaging|diffusion tensor imaging
5248635|NCT02453763|Functional magnetic imaging|functional magnetic imaging
5248636|NCT02453763|Rehabilitation|rehabilitation
5248637|NCT02453750|Congenital Diaphragmatic Hernia|congenital diaphragmatic hernia
5248737|NCT02453022|Omeprazole|omeprazole
5248833|NCT02452320|intravenous acetaminophen|intravenous acetaminophen
5248834|NCT02452294|Brain|brain
5248835|NCT02452281|Therapeutically Unresectable|therapeutically unresectable
5248839|NCT02452203|floating|floating
5248925|NCT02451592|Fungemia|fungemia
5249046|NCT02450929|pneumonia|pneumonia
5249047|NCT02450929|vascular|vascular
5249048|NCT02450929|orthopedic|orthopedic
5249049|NCT02450929|urologic|urologic
5249050|NCT02450929|neurologic|neurologic
5249051|NCT02450916|work-related injury|work-related injury
5249052|NCT02450916|occupational disease|occupational disease
5249053|NCT02450916|workers' compensation|workers' compensation
5423253|NCT01616472|osteoporosis|osteoporosis
5249236|NCT02449785|UTE|ute
5412057|NCT01668693|ERA|era
5249322|NCT02449265|limited-stage DLBCL|limited-stage dlbcl
5249529|NCT02448004|Healthy|healthy
5249617|NCT02447237|liquid diet|liquid diet
5249828|NCT02445950|Cost-Effectiveness|cost-effectiveness
5249829|NCT02445950|Guideline Adherence|guideline adherence
5249830|NCT02445937|decision making for incapacitated patients|decision making for incapacitated patients
5249831|NCT02445937|intensive care|intensive care
5249834|NCT02445937|palliative care|palliative care
5249918|NCT02445339|Emergency Care Services|emergency care services
5249919|NCT02445339|Emergency Department|emergency department
5249921|NCT02445339|Extended-release naltrexone|extended-release naltrexone
5249922|NCT02445339|Frequent Users|frequent users
5249923|NCT02445339|Health Care Utilization|health care utilization
5249924|NCT02445339|Medical Management|medical management
5249925|NCT02445339|Naltrexone|naltrexone
5249926|NCT02445339|Population Health|population health
5249927|NCT02445339|Public Health|public health
5249928|NCT02445339|Vivitrol|vivitrol
5250016|NCT02444923|Traumatic irregular cornea|traumatic irregular cornea
5250113|NCT02444390|Failed non steroidal aromatases inhibitors|failed non steroidal aromatases inhibitors
5250114|NCT02444390|Eligible for everolimus+exemestane|eligible for everolimus+exemestane
5250115|NCT02444364|diabetes|diabetes
5250116|NCT02444364|bone loss|bone loss
5250117|NCT02444364|Bone Density|bone density
5250118|NCT02444325|group prenatal care|group prenatal care
5250198|NCT02443766|Complementary Medicine|complementary medicine
5250199|NCT02443766|Meditation Retreat|meditation retreat
5250200|NCT02443766|Ignatian Retreat|ignatian retreat
5250201|NCT02443766|Single Photon Emission Computed Tomography (SPECT)|single photon emission computed tomography (spect)
5250203|NCT02443766|Wellbeing|wellbeing
5250365|NCT02442622|de Quervain's disease|de quervain's disease
5250366|NCT02442622|de Quervain's tenosynovitis.|de quervain's tenosynovitis.
5250367|NCT02442622|ASTYM|astym
5250369|NCT02442609|internet|internet
5250554|NCT02441881|Venefit|venefit
5250555|NCT02441842|β-blocker|β-blocker
5250663|NCT02441413|HRCT|hrct
5250755|NCT02440919|Capnography|capnography
5250756|NCT02440919|Pulmonary Ventilation|pulmonary ventilation
5250758|NCT02440906|Cerebrovascular Disease|cerebrovascular disease
5250840|NCT02440646|Coronary artery disease|coronary artery disease
5250841|NCT02440646|Natural history of atherosclerosis|natural history of atherosclerosis
5250842|NCT02440646|Radiocontrast-induced thyroid dysfunction|radiocontrast-induced thyroid dysfunction
5250843|NCT02440646|Contrast-induced nephropathy|contrast-induced nephropathy
5250844|NCT02440646|Plaque burden|plaque burden
5250852|NCT02440607|aids|aids
5250934|NCT02440048|extraction|extraction
5250935|NCT02440048|Bond Apatite|bond apatite
5250936|NCT02440035|Healthy Participants|healthy participants
5250937|NCT02440035|Ad35.RSV.FA2|ad35.rsv.fa2
5250938|NCT02440035|JNJ-61187191|jnj-61187191
5250939|NCT02439996|Kawasaki disease IVIG|kawasaki disease ivig
5250940|NCT02439970|kidney transplant allograft|kidney transplant allograft
5250941|NCT02439970|recipients|recipients
5250942|NCT02439944|Nicotine Patch|nicotine patch
5250943|NCT02439944|Nicotine Mouth Spray|nicotine mouth spray
5250944|NCT02439944|Smoking Cessation|smoking cessation
5250945|NCT02439944|Quit Smoking|quit smoking
5250946|NCT02439944|Abstinence|abstinence
5250947|NCT02439944|Dependence|dependence
5251019|NCT02439593|hyperthermia|hyperthermia
5251020|NCT02439580|Patients|patients
5251021|NCT02439580|After Surgery|after surgery
5251022|NCT02439567|Cirrhosis|cirrhosis
5251023|NCT02439567|Chronic hepatitis C|chronic hepatitis c
5251025|NCT02439567|Portal hypertension|portal hypertension
5251308|NCT02437695|Trendelenburg Position|trendelenburg position
5251309|NCT02437682|Gastro-esophageal Reflux Disease|gastro-esophageal reflux disease
5251310|NCT02437682|Proton pump inhibitor|proton pump inhibitor
5251311|NCT02437669|Intranasal|intranasal
5251494|NCT02436616|EEG|eeg
5251813|NCT02434692|Primary Open Angle Glaucoma|primary open angle glaucoma
5251814|NCT02434692|POAG|poag
5251815|NCT02434692|Glaucoma|glaucoma
5251816|NCT02434692|Cataract|cataract
5251817|NCT02434692|Surgery|surgery
5251818|NCT02434692|Ocular Pressure|ocular pressure
5252011|NCT02433522|Rituximab|rituximab
5252126|NCT02432976|Exenatide|exenatide
5252127|NCT02432937|Corever|corever
5252335|NCT02431819|Peripheral Arterial Disease|peripheral arterial disease
5252539|NCT02430844|biomarker|biomarker
5252336|NCT02431819|Progressive compressive stockings|progressive compressive stockings
5252337|NCT02431793|Opioids|opioids
5252338|NCT02431780|Neonatal Seizures|neonatal seizures
5252431|NCT02431364|Adult Subjects|adult subjects
5252559|NCT02430753|Lung Neoplasms|lung neoplasms
5252649|NCT02430155|condom-loaded Foley's catheter|condom-loaded foley's catheter
5252650|NCT02430155|Bakri balloon|bakri balloon
5252651|NCT02430155|primary atonic postpartum hemorrhage|primary atonic postpartum hemorrhage
5252652|NCT02430142|microcirculation|microcirculation
5252653|NCT02430142|oxygen uptake|oxygen uptake
5252654|NCT02430142|hypoxia|hypoxia
5252655|NCT02430142|adenosine|adenosine
5252656|NCT02430142|central venous saturation|central venous saturation
5252657|NCT02430142|hypoxanthine|hypoxanthine
5252658|NCT02430142|laserdoppler|laserdoppler
5252659|NCT02430103|Breast Cancer|breast cancer
5252660|NCT02430103|Preservation of Ovarian Reserve Function|preservation of ovarian reserve function
5252661|NCT02430103|Goserelin|goserelin
5252662|NCT02430103|AMH|amh
5252663|NCT02430090|regionel anesthesia|regionel anesthesia
5252664|NCT02430090|levobupivacaine|levobupivacaine
5252665|NCT02430090|ceserean section|ceserean section
5252666|NCT02430077|Hepatic Steatosis|hepatic steatosis
5252667|NCT02430051|sensory processing|sensory processing
5252668|NCT02430051|oral care|oral care
5252669|NCT02430051|electrodermal activity|electrodermal activity
5252670|NCT02430051|cooperation|cooperation
5252671|NCT02430051|anxiety|anxiety
5252672|NCT02430051|distress|distress
5252673|NCT02430051|stress|stress
5252674|NCT02430051|behavior|behavior
5252675|NCT02430051|occupational therapy|occupational therapy
5252676|NCT02430038|transperineal ultrasound|transperineal ultrasound
5252677|NCT02430038|labour|labour
5252678|NCT02430038|sonopartogram|sonopartogram
5252679|NCT02430038|prediction model|prediction model
5252680|NCT02430025|Cardiovascular Diseases|cardiovascular diseases
5252681|NCT02430025|Vascular Diseases|vascular diseases
5252682|NCT02430025|Acute Coronary Syndrome|acute coronary syndrome
5252683|NCT02430025|Chest Pain|chest pain
5252684|NCT02430025|Heart Diseases|heart diseases
5252699|NCT02429960|Analgesia|analgesia
5252796|NCT02429466|ovarian germ cell tumor|ovarian germ cell tumor
5252810|NCT02429414|FOB|fob
5252903|NCT02428946|Insulin Sensitivity|insulin sensitivity
5252904|NCT02428946|obesity|obesity
5252905|NCT02428946|dopamine|dopamine
5252906|NCT02428933|Brown Adipose Tissue|brown adipose tissue
5253006|NCT02428465|Parenting stress|parenting stress
5253332|NCT02426606|Lentils|lentils
5253333|NCT02426606|Post-prandial|post-prandial
5253359|NCT02426437|COPD|copd
5253524|NCT02425345|Physical Activity|physical activity
5253671|NCT02424695|RLS|rls
5253746|NCT02424175|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5253750|NCT02424097|Prevention|prevention
5253856|NCT02423590|Squamous|squamous
5253857|NCT02423590|Lung|lung
5253858|NCT02423590|Apatorsen|apatorsen
5253881|NCT02423512|MADCAM1|madcam1
5254206|NCT02422017|wound|wound
5254316|NCT02421393|Falls|falls
5254523|NCT02420379|eteplirsen|eteplirsen
5254628|NCT02419768|Variability|variability
5254631|NCT02419768|ICF|icf
5254735|NCT02419313|Xeomin|xeomin
5254950|NCT02418091|patients with moderate DKD and uncontrolled HTN|patients with moderate dkd and uncontrolled htn
5254951|NCT02418065|Physical exercises|physical exercises
5254952|NCT02418065|Oral nutritional supplementation|oral nutritional supplementation
5254953|NCT02418065|Multimodal|multimodal
5254954|NCT02418065|Hemodialysis|hemodialysis
5254955|NCT02418065|Protein-Energy Wasting|protein-energy wasting
5254956|NCT02418052|esophageal cancer|esophageal cancer
5254957|NCT02418052|minimally invasive esophagectomy|minimally invasive esophagectomy
5254958|NCT02418052|anastomotic leak|anastomotic leak
5254959|NCT02418052|neck flexion|neck flexion
5254960|NCT02418039|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5254961|NCT02418039|Nutrition|nutrition
5254962|NCT02418013|Frailty|frailty
5254964|NCT02418013|Plasma|plasma
5255026|NCT02417610|Polynucleotide|polynucleotide
5255027|NCT02417610|Hyaluronic acid|hyaluronic acid
5255028|NCT02417610|Intra articular injection|intra articular injection
5255029|NCT02417597|hepatitis E|hepatitis e
5255030|NCT02417571|Chronic kidney disease|chronic kidney disease
5255031|NCT02417571|Blood pressure|blood pressure
5255034|NCT02417519|Coffee|coffee
5255421|NCT02415933|Child and Family Well-being|child and family well-being
5255422|NCT02415933|Child Separation|child separation
5255430|NCT02415842|Supra-seasonal influenza vaccine|supra-seasonal influenza vaccine
5255431|NCT02415842|Pandemic|pandemic
5255623|NCT02414620|Dental Anesthetic Injection|dental anesthetic injection
5255624|NCT02414607|Elderberry juice|elderberry juice
5255625|NCT02414607|Alzheimer's|alzheimer's
5255795|NCT02413658|Wound model|wound model
5255798|NCT02413632|screening|screening
5255892|NCT02413073|kidney disease|kidney disease
5255996|NCT02412462|EMT and Stem Cell Biomarkers|emt and stem cell biomarkers
5256092|NCT02411890|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5256093|NCT02411877|Acute ischemic stroke|acute ischemic stroke
5256095|NCT02411877|Stroke|stroke
5256096|NCT02411877|Hypothermia|hypothermia
5256186|NCT02411331|Vancomycin lock solution|vancomycin lock solution
5256284|NCT02410811|Cardiomyopathy|cardiomyopathy
5256387|NCT02410317|Emergency cesarean section|emergency cesarean section
5256491|NCT02409745|randomized controlled study|randomized controlled study
5256688|NCT02408471|Rheumatoid Arthritis|rheumatoid arthritis
5256689|NCT02408471|Systemic Lupus Erythematosus|systemic lupus erythematosus
5256690|NCT02408471|Osteoarthritis|osteoarthritis
5256691|NCT02408471|Autoimmune Diseases|autoimmune diseases
5256692|NCT02408471|Connective Tissue Diseases|connective tissue diseases
5256784|NCT02407860|infant physiology|infant physiology
5340342|NCT01993316|EEG|eeg
5340482|NCT01992575|OCT|oct
5257010|NCT02406339|Physical Therapy|physical therapy
5429868|NCT01588275|MRA|mra
5257111|NCT02405767|Diabetic foot ulcer|diabetic foot ulcer
5257112|NCT02405754|Corus CAD|corus cad
5257113|NCT02405754|Personalized Medicine|personalized medicine
5257114|NCT02405754|CAD|cad
5257115|NCT02405754|ASGES|asges
5257116|NCT02405754|Age/Sex/Gene Expression Score|age/sex/gene expression score
5257117|NCT02405754|GES|ges
5257118|NCT02405754|CVD|cvd
5257199|NCT02405364|Patient up to 65 years|patient up to 65 years
5257200|NCT02405364|initial management|initial management
5257201|NCT02405351|Telemedicine, Stroke, Working Memory, Cognitive Training|telemedicine, stroke, working memory, cognitive training
5257203|NCT02405325|physical activity|physical activity
5257204|NCT02405325|multilevel|multilevel
5257302|NCT02404792|Frail Elderly|frail elderly
5257303|NCT02404792|IGF-1|igf-1
5257304|NCT02404779|ICU|icu
5257305|NCT02404779|Deep sedation|deep sedation
5257306|NCT02404779|Mechanical ventilation|mechanical ventilation
5257307|NCT02404779|Traumatic brain injury|traumatic brain injury
5257396|NCT02404311|HIV|hiv
5257606|NCT02403271|PCYC|pcyc
5257801|NCT02402205|Implementation; TF-CBT; adjudicated youth; RTF; trauma|implementation; tf-cbt; adjudicated youth; rtf; trauma
5257802|NCT02402192|corifollitropin alfa|corifollitropin alfa
5257930|NCT02401529|Pain, Postoperative|pain, postoperative
5257931|NCT02401529|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5257932|NCT02401529|Randomized controlled trial|randomized controlled trial
5257933|NCT02401529|Post-tonsillectomy pain|post-tonsillectomy pain
5257934|NCT02401529|delayed feeding|delayed feeding
5257935|NCT02401516|Postural Reprogramming Insole|postural reprogramming insole
5258036|NCT02400658|IORT|iort
5258134|NCT02400203|hemp oil,|hemp oil,
5258135|NCT02400203|hemp|hemp
5258136|NCT02400203|fatty acids|fatty acids
5258137|NCT02400203|omega-6|omega-6
5258139|NCT02400203|blood pressure|blood pressure
5258140|NCT02400203|blood lipids|blood lipids
5258141|NCT02400190|radiation|radiation
5258229|NCT02399475|Aging|aging
5258347|NCT02398721|FNAC|fnac
5258660|NCT02396732|Trauma|trauma
5258661|NCT02396732|Venous thromboembolism|venous thromboembolism
5258662|NCT02396693|Newborn|newborn
5258664|NCT02396680|Ragweed Allergy|ragweed allergy
5258859|NCT02395458|Sequential therapy|sequential therapy
5258860|NCT02395458|Triple therapy|triple therapy
5258862|NCT02395393|Acute rejection|acute rejection
5259166|NCT02393300|tranexamic acid|tranexamic acid
5259167|NCT02393300|blood loss|blood loss
5259168|NCT02393300|topical administration|topical administration
5259266|NCT02392806|CPAP|cpap
5259373|NCT02392195|Plagiocephaly|plagiocephaly
5259374|NCT02392182|lung|lung
5259375|NCT02392169|neuroendocrine|neuroendocrine
5259376|NCT02392169|ADHD|adhd
5259377|NCT02392169|heredity|heredity
5259378|NCT02392169|cognitive function|cognitive function
5259379|NCT02392143|colorectal cancer screening|colorectal cancer screening
5259380|NCT02392104|International Normalized Ratio|international normalized ratio
5259381|NCT02392104|Warfarin|warfarin
5259466|NCT02391636|oxytocin|oxytocin
5259467|NCT02391623|Multiple Ascending Dose|multiple ascending dose
5259468|NCT02391623|Healthy Subjects|healthy subjects
5259469|NCT02391623|Hyperlipidemia|hyperlipidemia
5259470|NCT02391623|Lipid Metabolism Disorders|lipid metabolism disorders
5259572|NCT02391064|impairment prediction|impairment prediction
5259779|NCT02389660|Depression, Blended Cognitive Behavioural Therapy, Internet intervention|depression, blended cognitive behavioural therapy, internet intervention
5259877|NCT02389088|Granulosa Cell|granulosa cell
5259878|NCT02389088|Androgens|androgens
5259879|NCT02389088|FSH|fsh
5259880|NCT02389088|Ovary|ovary
5259881|NCT02389075|intraepithelial lymphocytes (IEL)|intraepithelial lymphocytes (iel)
5259882|NCT02389075|microbiome|microbiome
5259883|NCT02389075|colon mucosa|colon mucosa
5260117|NCT02387749|mesenchymal stem cells|mesenchymal stem cells
5260236|NCT02387151|Rejection|rejection
5260237|NCT02387112|End stage heart disease|end stage heart disease
5262453|NCT02374918|Concussion|concussion
5260238|NCT02387112|Ventricular assist device|ventricular assist device
5260239|NCT02387099|Stage IIIB|stage iiib
5260240|NCT02387099|Stage IV|stage iv
5260241|NCT02387099|Recurrent|recurrent
5260242|NCT02387099|Metastatic|metastatic
5260243|NCT02387086|gefitinib|gefitinib
5260244|NCT02387086|thalidomide|thalidomide
5260245|NCT02387086|NSCLC|nsclc
5260323|NCT02386618|colorectal cancer|colorectal cancer
5260529|NCT02385513|Immunogenicity|immunogenicity
5260530|NCT02385487|Myocardial Infarction|myocardial infarction
5260531|NCT02385487|Inflammation|inflammation
5260534|NCT02385487|Sepsis|sepsis
5423265|NCT01616446|pharmacokinetics|pharmacokinetics
5260750|NCT02384460|Simplex|simplex
5260981|NCT02383030|fulvestrant|fulvestrant
5261189|NCT02381886|Astrocytoma|astrocytoma
5261190|NCT02381886|Glioblastoma|glioblastoma
5261334|NCT02381067|NuCel|nucel
5261401|NCT02380755|Cardiovascular risk|cardiovascular risk
5261402|NCT02380755|Endocrine System Diseases|endocrine system diseases
5261403|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators
5261405|NCT02380755|Infertility, Male|infertility, male
5261507|NCT02380287|interleukin-17|interleukin-17
5261515|NCT02380209|breast cancer|breast cancer
5261608|NCT02379741|Therapeutic uses|therapeutic uses
5261714|NCT02379078|Medical informatics|medical informatics
5261715|NCT02379078|Toolkit development|toolkit development
5261716|NCT02379078|Study protocol|study protocol
5261717|NCT02379078|User-centred design|user-centred design
5261912|NCT02377973|growth,|growth,
5261913|NCT02377973|infancy,|infancy,
5261914|NCT02377973|children,|children,
5261915|NCT02377973|diet,|diet,
5261916|NCT02377973|breastfeeding|breastfeeding
5261917|NCT02377973|complementary feeding|complementary feeding
5261918|NCT02377973|early life programming|early life programming
5261919|NCT02377973|tracking|tracking
5261920|NCT02377973|physical activity|physical activity
5261922|NCT02377960|text message|text message
5261924|NCT02377960|IMB|imb
5262120|NCT02376907|endoscopic ultrasound|endoscopic ultrasound
5262400|NCT02375321|OSA|osa
5262662|NCT02373657|hand washing|hand washing
5262663|NCT02373592|Diabetic Neuropathies|diabetic neuropathies
5262664|NCT02373592|Thermometry|thermometry
5262665|NCT02373592|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5262666|NCT02373592|Foot Ulcer|foot ulcer
5262668|NCT02373579|omega-3 fatty acids|omega-3 fatty acids
5262669|NCT02373579|methotrexate|methotrexate
5262670|NCT02373579|hepatotoxicity|hepatotoxicity
5262677|NCT02373553|posture|posture
5262678|NCT02373553|postural|postural
5262679|NCT02373553|kinetics|kinetics
5262680|NCT02373540|spinal cord stimulation|spinal cord stimulation
5262681|NCT02373540|chronic pain|chronic pain
5262683|NCT02373501|caesarean delivery|caesarean delivery
5262757|NCT02373072|Pakinson's Disease, Movement Disorders|pakinson's disease, movement disorders
5262758|NCT02373033|Folate|folate
5250278|NCT02443168|Healthy|healthy
5262759|NCT02373033|folic acid|folic acid
5262760|NCT02373033|intervention trial|intervention trial
5262761|NCT02373033|folate status|folate status
5262844|NCT02372604|Efficacy|efficacy
5262845|NCT02372604|Tolerance|tolerance
5262941|NCT02372162|Metabolomics|metabolomics
5262942|NCT02372123|Dysmenorrhea|dysmenorrhea
5262943|NCT02372123|Primary dysmenorrhea|primary dysmenorrhea
5262944|NCT02372123|physiotherapy|physiotherapy
5262945|NCT02372123|massage|massage
5263056|NCT02371447|VPM1002BC|vpm1002bc
5263079|NCT02371265|HIV|hiv
5263155|NCT02370732|Bariatric Surgery|bariatric surgery
5263370|NCT02369419|Heart failure|heart failure
5263371|NCT02369419|cardiac resynchronization therapy|cardiac resynchronization therapy
5263372|NCT02369406|Botswana|botswana
5263373|NCT02369406|Immunology|immunology
5268651|NCT02339090|Growth Hormone Deficiency|growth hormone deficiency
5263584|NCT02368145|acute stroke|acute stroke
5263585|NCT02368145|post stroke depression|post stroke depression
5263587|NCT02368132|Dementia|dementia
5263588|NCT02368106|patient registry|patient registry
5263589|NCT02368106|radiation oncology|radiation oncology
5263590|NCT02368106|technology assessment|technology assessment
5263591|NCT02368093|Rheumatoid arthritis|rheumatoid arthritis
5263592|NCT02368080|Lung Clearance Index|lung clearance index
5263593|NCT02368080|Cystic Fibrosis|cystic fibrosis
5263594|NCT02368080|Multiple Breath Nitrogen Washout|multiple breath nitrogen washout
5263595|NCT02368054|Epinephrine|epinephrine
5263596|NCT02368054|Bupivacaine|bupivacaine
5263597|NCT02368054|Stroke Volume|stroke volume
5263598|NCT02368054|Cardiac Output|cardiac output
5263669|NCT02367755|electroencephalography|electroencephalography
5263772|NCT02367287|Nutritional Physiological Phenomena|nutritional physiological phenomena
5263773|NCT02367248|Brain hemorrhage|brain hemorrhage
5263774|NCT02367248|Cerebral Hemorrhage|cerebral hemorrhage
5263798|NCT02367183|IBD|ibd
5263869|NCT02366663|radioimmunotherapy|radioimmunotherapy
5263987|NCT02366000|Parent-child communication|parent-child communication
5263988|NCT02366000|Health risk behaviors|health risk behaviors
5263989|NCT02366000|Randomized controlled trial|randomized controlled trial
5263990|NCT02365987|interesterified|interesterified
5264134|NCT02364934|sex|sex
5264191|NCT02364674|High Resolution Computed Tomography scans|high resolution computed tomography scans
5264288|NCT02364089|Cardiovascular Risk Factors|cardiovascular risk factors
5264331|NCT02363907|CGM|cgm
5264821|NCT02361008|TEE-guided|tee-guided
5264822|NCT02361008|asymmetric occluder|asymmetric occluder
5264823|NCT02361008|surgical repair|surgical repair
5264824|NCT02360982|Delirium|delirium
5264825|NCT02360982|regional anesthesia|regional anesthesia
5350020|NCT01948921|EGD|egd
5264826|NCT02360982|general anesthesia|general anesthesia
5264827|NCT02360969|strabismus|strabismus
5264828|NCT02360969|surgical procedure|surgical procedure
5264829|NCT02360969|anesthesia|anesthesia
5264830|NCT02360969|squint|squint
5264831|NCT02360969|child|child
5264832|NCT02360956|Olmesartan medoxomil|olmesartan medoxomil
5264833|NCT02360956|Epicardial adipose tissue|epicardial adipose tissue
5264834|NCT02360956|Multidetector Computed Tomography|multidetector computed tomography
5264835|NCT02360943|elderly patients|elderly patients
5264836|NCT02360943|Pulmonary embolism|pulmonary embolism
5264837|NCT02360943|Anticoagulant treatments|anticoagulant treatments
5264840|NCT02360930|Vincristine|vincristine
5264896|NCT02360605|colorectal cancer screening|colorectal cancer screening
5264897|NCT02360605|low literacy|low literacy
5264898|NCT02360605|community clinics|community clinics
5264899|NCT02360605|Fecal Immunochemical Test|fecal immunochemical test
5264900|NCT02360579|Autologous Adoptive Cell Transfer|autologous adoptive cell transfer
5264992|NCT02360059|Neuropathy|neuropathy
5265200|NCT02358980|Acute kidney injury|acute kidney injury
5265201|NCT02358980|KIDNEY THERAPY|kidney therapy
5265321|NCT02358356|midgut|midgut
5265358|NCT02358174|MMP|mmp
5265437|NCT02357784|CPT Testing|cpt testing
5265546|NCT02357095|treatment|treatment
5265652|NCT02356354|molecular factors|molecular factors
5265656|NCT02356315|Brain|brain
5265853|NCT02355067|postpartum depression|postpartum depression
5265854|NCT02355067|mothers|mothers
5265855|NCT02355067|infants|infants
5265856|NCT02355067|depression|depression
5265857|NCT02355054|Recurrent|recurrent
5265858|NCT02355041|diet|diet
5265859|NCT02355041|body weight|body weight
5265860|NCT02355041|eating|eating
5266069|NCT02354027|SHR3824 metformin drug-drug interaction|shr3824 metformin drug-drug interaction
5266187|NCT02353286|Biodegradable stents, ERCP|biodegradable stents, ercp
5266188|NCT02353273|WH-1,Diabetic Foot,Ulcer|wh-1,diabetic foot,ulcer
5266189|NCT02353234|Phenolics|phenolics
5266190|NCT02353234|Aleurone|aleurone
5266191|NCT02353234|Bioavailability|bioavailability
5266192|NCT02353234|Pharmacokinetics|pharmacokinetics
5266195|NCT02353182|abdominal|abdominal
5266291|NCT02352597|Phytoestrogens|phytoestrogens
5266292|NCT02352597|ovulation induction|ovulation induction
5266294|NCT02352584|Quadrivalent Influenza Vaccine|quadrivalent influenza vaccine
5266295|NCT02352584|Influenza vaccine|influenza vaccine
5266296|NCT02352584|Vaccination|vaccination
5266379|NCT02352090|Ethinyl Estradiol|ethinyl estradiol
5266503|NCT02351297|volunteers|volunteers
5266603|NCT02350569|hepatitis C|hepatitis c
5266604|NCT02350569|Gilead|gilead
5266605|NCT02350569|Communicable Diseases|communicable diseases
5266606|NCT02350569|Infection|infection
5266607|NCT02350569|Liver Diseases|liver diseases
5266608|NCT02350569|RNA Virus Infections|rna virus infections
5266609|NCT02350543|Aspirin usage|aspirin usage
5266610|NCT02350543|Transurethral resection of bladder tumor (TURBT)|transurethral resection of bladder tumor (turbt)
5266611|NCT02350530|Colorectal cancer|colorectal cancer
5266612|NCT02350530|Metastatic colorectal cancer|metastatic colorectal cancer
5266692|NCT02350231|Twin pregnancy|twin pregnancy
5266693|NCT02350231|progesterone|progesterone
5266694|NCT02350218|Transplantation|transplantation
5266695|NCT02350218|Living donor|living donor
5266696|NCT02350218|Eglandin|eglandin
5266714|NCT02350140|HIV|hiv
5266791|NCT02349698|Lymphoma|lymphoma
5266892|NCT02349087|EEG|eeg
5266992|NCT02348437|Volar plating|volar plating
5267094|NCT02347826|patient|patient
5267506|NCT02345577|Physical Therapy Modalities|physical therapy modalities
5267717|NCT02344576|palliative care|palliative care
5267728|NCT02344472|MBC|mbc
5267819|NCT02343809|Physiotherapy|physiotherapy
5267918|NCT02343341|family-based|family-based
5267919|NCT02343341|prevention|prevention
5267920|NCT02343315|low back pain|low back pain
5267921|NCT02343315|home exercises|home exercises
5267922|NCT02343315|chronic pain|chronic pain
5268019|NCT02342886|HR|hr
5268020|NCT02342886|Pretomanid|pretomanid
5268021|NCT02342886|NC-006|nc-006
5268022|NCT02342886|STAND|stand
5268023|NCT02342873|ultrasound|ultrasound
5268024|NCT02342873|nerve stimulator|nerve stimulator
5268121|NCT02342041|safety|safety
5268215|NCT02341677|Image Fusion|image fusion
5268216|NCT02341664|Mobile Tablet Device|mobile tablet device
5268217|NCT02341664|Outpatient Clinic|outpatient clinic
5268218|NCT02341664|Tobacco|tobacco
5268219|NCT02341664|Health|health
5268220|NCT02341664|Barriers|barriers
5268221|NCT02341664|Prevention|prevention
5268222|NCT02341664|Prescribing Practices|prescribing practices
5268223|NCT02341664|Informed Consent|informed consent
5268431|NCT02340663|grinding|grinding
5268432|NCT02340650|suspicious bladder lesion, normal bladder tissue|suspicious bladder lesion, normal bladder tissue
5268433|NCT02340585|Next Generation Neuroform Stent System|next generation neuroform stent system
5268650|NCT02339090|VRS-317|vrs-317
5268776|NCT02338453|Attention Modification|attention modification
5268777|NCT02338453|Dot-Probe|dot-probe
5268778|NCT02338453|GCBT|gcbt
5268779|NCT02338362|Corticosteroids|corticosteroids
5268780|NCT02338362|Bronchodilator Agents|bronchodilator agents
5268781|NCT02338362|Intraocular Pressure|intraocular pressure
5268782|NCT02338323|Hyperuricemia|hyperuricemia
5268783|NCT02338323|Renal Function|renal function
5268785|NCT02338323|Febuxostat|febuxostat
5268871|NCT02337829|Leukemia|leukemia
5268969|NCT02337140|TAVI|tavi
5269137|NCT02336165|GBM|gbm
5269228|NCT02335398|chronic pain|chronic pain
5269229|NCT02335398|noncancer pain|noncancer pain
5269230|NCT02335398|cancer pain|cancer pain
5269231|NCT02335398|QTc prolongation|qtc prolongation
5269325|NCT02334878|Stem Cells|stem cells
5269517|NCT02333799|TMC-207|tmc-207
5269518|NCT02333799|NiX-TB|nix-tb
5269531|NCT02333669|SCNN1A|scnn1a
5269758|NCT02332291|MRI|mri
5269828|NCT02331927|marker-driven|marker-driven
5269829|NCT02331927|bevacizumab|bevacizumab
5269928|NCT02331134|Tissue|tissue
5270125|NCT02330120|airway resistance|airway resistance
5270126|NCT02330120|sedation|sedation
5270127|NCT02330120|intensive care|intensive care
5270128|NCT02330094|aSAH|asah
5270135|NCT02330042|OCT|oct
5270333|NCT02328690|military|military
5270434|NCT02328170|immunoglobulin E, food hypersensitivities, child, allergens|immunoglobulin e, food hypersensitivities, child, allergens
5270435|NCT02328144|Hemorrhoidectomy|hemorrhoidectomy
5270452|NCT02328040|Closed loop|closed loop
5270656|NCT02327026|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5270657|NCT02327026|Bag-valve-mask ventilation|bag-valve-mask ventilation
5270658|NCT02327026|Tracheal intubation|tracheal intubation
5270659|NCT02326961|osteoarthritis|osteoarthritis
5270660|NCT02326961|knee|knee
5270768|NCT02326441|advanced malignancies|advanced malignancies
5271071|NCT02324972|AD|ad
5271072|NCT02324972|AQX-1125|aqx-1125
5271073|NCT02324972|SHIP1|ship1
5271074|NCT02324946|Sleep Apnea Syndromes|sleep apnea syndromes
5271075|NCT02324946|Perioperative Period|perioperative period
5271076|NCT02324946|Mass Screening|mass screening
5271307|NCT02323555|chemotherapy|chemotherapy
5271308|NCT02323555|Targeted therapy|targeted therapy
5271310|NCT02323542|Starch|starch
5271501|NCT02322554|USWR|uswr
5271614|NCT02322125|walking|walking
5271615|NCT02322125|locomotion|locomotion
5271616|NCT02322125|rehabilitation|rehabilitation
5271617|NCT02322112|Dietary Fiber|dietary fiber
5271682|NCT02321761|TBI|tbi
5271721|NCT02321553|glucose|glucose
5271747|NCT02321527|FNA|fna
5271824|NCT02321111|TLR4 signaling and inflammatory gene expression|tlr4 signaling and inflammatory gene expression
5271825|NCT02321111|Plasma cytokine concentration|plasma cytokine concentration
5271917|NCT02320617|Lung Neoplasms|lung neoplasms
5271918|NCT02320617|diffusion weighted MRI|diffusion weighted mri
5271919|NCT02320617|ADC value|adc value
5271920|NCT02320617|treatment effect|treatment effect
5272030|NCT02319863|prognosis|prognosis
5272135|NCT02319330|Adherence|adherence
5272232|NCT02318823|alcohol|alcohol
5272435|NCT02317562|Disimmune disease|disimmune disease
5272436|NCT02317562|Neurology chronic disease|neurology chronic disease
5272437|NCT02317562|Rare disease|rare disease
5272438|NCT02317549|sepsis|sepsis
5272439|NCT02317549|septic shock|septic shock
5272440|NCT02317549|vasodilatory shock|vasodilatory shock
5272441|NCT02317549|circulatory shock|circulatory shock
5272442|NCT02317549|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5272443|NCT02317549|SIRS|sirs
5272444|NCT02317549|infection|infection
5272445|NCT02317549|toxemia|toxemia
5272446|NCT02317549|gut barrier breakdown|gut barrier breakdown
5272447|NCT02317549|autodigestion|autodigestion
5272528|NCT02317250|amyloid|amyloid
5272529|NCT02317250|amyloid imaging|amyloid imaging
5272530|NCT02317250|CMS|cms
5272532|NCT02317250|CED|ced
5272623|NCT02316665|Sleep apnea syndrome|sleep apnea syndrome
5272624|NCT02316665|Nocturnal glycemia|nocturnal glycemia
5272625|NCT02316665|Continuous glucose monitoring system|continuous glucose monitoring system
5272626|NCT02316665|Continuous positive airway pressure|continuous positive airway pressure
5272724|NCT02316080|dentin sensitivity|dentin sensitivity
5272725|NCT02316080|biomaterials|biomaterials
5272726|NCT02316067|Spinal cord|spinal cord
5272727|NCT02316067|Wounds and Injuries|wounds and injuries
5272728|NCT02316067|Rehabilitation|rehabilitation
5272829|NCT02315573|Bupivacaine|bupivacaine
5272929|NCT02315066|stomach cancer|stomach cancer
5273134|NCT02314013|uncomplicated diverticulitis, economic cost, hospital stay|uncomplicated diverticulitis, economic cost, hospital stay
5273135|NCT02313974|Lupus Nephritis Treatment|lupus nephritis treatment
5273136|NCT02313974|Renal Biopsy in Lupus|renal biopsy in lupus
5273137|NCT02313974|Lupus Flare|lupus flare
5375641|NCT01832519|MRI|mri
5273233|NCT02313337|Preanesthetic medication|preanesthetic medication
5273324|NCT02312869|Burn patients|burn patients
5273419|NCT02312219|Atherosclerosis|atherosclerosis
5273420|NCT02312219|Positron-Emission Tomography|positron-emission tomography
5273421|NCT02312219|Imaging|imaging
5273422|NCT02312219|fluorodeoxyglucose|fluorodeoxyglucose
5273423|NCT02312193|hypertension|hypertension
5273441|NCT02312128|outcome|outcome
5273508|NCT02311699|Intimate Partner Violence|intimate partner violence
5273510|NCT02311686|Fatty acid ethyl esters|fatty acid ethyl esters
5273511|NCT02311686|Ethyl glucoronide|ethyl glucoronide
5273514|NCT02311673|Prader-Willi Syndrome|prader-willi syndrome
5273515|NCT02311673|obesity|obesity
5273516|NCT02311673|hyperphagia|hyperphagia
5273517|NCT02311647|Tamoxifen|tamoxifen
5273518|NCT02311647|Uterine cavity|uterine cavity
5273519|NCT02311647|endometrium|endometrium
5273520|NCT02311634|Electrical pudendal nerve stimulation|electrical pudendal nerve stimulation
5273521|NCT02311634|Transvaginal electrical stimulation|transvaginal electrical stimulation
5273522|NCT02311634|Urge urinary incontinence|urge urinary incontinence
5273523|NCT02311634|Comparative study|comparative study
5273524|NCT02311621|CAR T cell|car t cell
5273595|NCT02311192|Ocular ultrasound|ocular ultrasound
5273804|NCT02309996|Randomized Controlled Trial|randomized controlled trial
5470904|NCT01417104|MI|mi
5273805|NCT02309996|Intervention Studies|intervention studies
5273909|NCT02309476|Laser|laser
5273912|NCT02309437|Pain|pain
5274009|NCT02308878|Opioid abuse|opioid abuse
5274010|NCT02308878|Cognitive Therapy|cognitive therapy
5274011|NCT02308878|Executive Function|executive function
5274012|NCT02308878|Mobile Health|mobile health
5274013|NCT02308878|Rehabilitation|rehabilitation
5274017|NCT02308852|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot|bi-manual , motor skill learning , stroke , chronic patients,neuro-rehabilitative robot
5274018|NCT02308839|Aneurysm|aneurysm
5274020|NCT02308839|Abdominal|abdominal
5274021|NCT02308800|diabetic foot ulcer|diabetic foot ulcer
5274022|NCT02308787|platelet depletion|platelet depletion
5274023|NCT02308787|apheresis|apheresis
5274024|NCT02308774|osteomyelitis, diabetic foot infection|osteomyelitis, diabetic foot infection
5274025|NCT02308735|gestation|gestation
5274026|NCT02308735|diabetes|diabetes
5274027|NCT02308735|ethanol|ethanol
5274028|NCT02308722|Borderline resectable|borderline resectable
5274029|NCT02308709|Radiotherapy|radiotherapy
5274030|NCT02308709|Pulmonary Functional Imaging|pulmonary functional imaging
5274031|NCT02308709|Computed Tomography (CT)|computed tomography (ct)
5274032|NCT02308709|Image Registration|image registration
5274033|NCT02308709|Functional Image-guided Radiotherapy|functional image-guided radiotherapy
5274034|NCT02308696|Older Adults|older adults
5274035|NCT02308696|Aging in Place|aging in place
5274036|NCT02308683|hscrp|hscrp
5274194|NCT02307695|Saxagliptin|saxagliptin
5274398|NCT02306590|survival time|survival time
5274836|NCT02304237|progesterone|progesterone
5274837|NCT02304224|sepsis|sepsis
5274838|NCT02304224|melatonin|melatonin
5274839|NCT02304224|Human Leukocyte Antigen-DR|human leukocyte antigen-dr
5274840|NCT02304224|outcome|outcome
5274848|NCT02304185|Acquired Immunodeficiency Syndrome Virus|acquired immunodeficiency syndrome virus
5274850|NCT02304185|Adjuvant|adjuvant
5274851|NCT02304185|Vaccine|vaccine
5274852|NCT02304185|Placebo|placebo
5275031|NCT02302950|raltegravir use|raltegravir use
5275249|NCT02301975|Vilanterol|vilanterol
5275466|NCT02300779|Personal satisfaction|personal satisfaction
5275562|NCT02300077|fentanyl, morphine|fentanyl, morphine
5275563|NCT02300077|methadone|methadone
5275564|NCT02300051|Compulsive sexual behavior|compulsive sexual behavior
5275565|NCT02300051|Intervention|intervention
5275566|NCT02300051|Short term psychodynamic group psychotherapy|short term psychodynamic group psychotherapy
5275567|NCT02300051|Sexual addiction|sexual addiction
5275683|NCT02299362|EOS|eos
5275794|NCT02298712|MPS I|mps i
5275889|NCT02298361|Longitudinal Studies|longitudinal studies
5275890|NCT02298361|Male|male
5275921|NCT02298309|TB|tb
5276091|NCT02297152|Sexual dysfunction|sexual dysfunction
5276339|NCT02295501|ebola|ebola
5276533|NCT02294487|HIB|hib
5276948|NCT02292485|LCS|lcs
5277061|NCT02291965|hematopoietic cell transplant|hematopoietic cell transplant
5277157|NCT02291263|Polio|polio
5277158|NCT02291263|Inactivated polio vaccine|inactivated polio vaccine
5277258|NCT02290782|outcome|outcome
5277350|NCT02290405|primary insomnia|primary insomnia
5277754|NCT02288104|Liver|liver
5277755|NCT02288104|Kidney|kidney
5277756|NCT02288104|Confocal endomicroscopy|confocal endomicroscopy
5277757|NCT02288104|Optical Biopsy|optical biopsy
5277758|NCT02288104|Scanner|scanner
5277759|NCT02288104|Fluoroscopy|fluoroscopy
5277760|NCT02288104|CT|ct
5277761|NCT02288104|Computed Tomography|computed tomography
5277762|NCT02288104|Radiofrequency Ablation|radiofrequency ablation
5277764|NCT02288091|ALS|als
5277847|NCT02287649|autoreactive B and T cells|autoreactive b and t cells
5277849|NCT02287610|RA|ra
5277939|NCT02286895|rotavirus|rotavirus
5277940|NCT02286895|rotavirus vaccine|rotavirus vaccine
5277941|NCT02286895|Mali|mali
5278237|NCT02285114|tenofovir|tenofovir
5278432|NCT02283710|Pentoxifylline|pentoxifylline
5278534|NCT02283138|FLV, VOCAL, PA-RI, preterm fetuses, RDS|flv, vocal, pa-ri, preterm fetuses, rds
5278535|NCT02283099|Ebola virus, vaccination, phase I, healthy volunteers|ebola virus, vaccination, phase i, healthy volunteers
5278536|NCT02283086|Quality Improvement|quality improvement
5278537|NCT02283086|Physician Feedback|physician feedback
5278538|NCT02283073|Diagnosis|diagnosis
5278539|NCT02283060|Atripla|atripla
5278551|NCT02282969|Smokers|smokers
5278789|NCT02281461|HIV|hiv
5278838|NCT02281409|Mogamulizumab (KW-0761)|mogamulizumab (kw-0761)
5278839|NCT02281409|14-135|14-135
5278840|NCT02281396|safety|safety
5278841|NCT02281396|rabies vaccine|rabies vaccine
5278842|NCT02281396|MRC-5 cell|mrc-5 cell
5278843|NCT02281383|Bacillus Calmette-Guérin (BCG)|bacillus calmette-guérin (bcg)
5278844|NCT02281383|14-174|14-174
5279126|NCT02279992|Brain Neoplasms, Malignant|brain neoplasms, malignant
5279128|NCT02279979|PHP|php
5279327|NCT02278926|Ultrasound|ultrasound
5279450|NCT02278419|Healthy|healthy
5279735|NCT02276807|Behavioral Symptoms|behavioral symptoms
5279736|NCT02276807|Mental Disorders|mental disorders
5279737|NCT02276807|Depressive Disorder|depressive disorder
5279738|NCT02276807|suicidal ideation|suicidal ideation
5383815|NCT01795573|GVHD|gvhd
5481207|NCT01374100|Meditation|meditation
5279739|NCT02276807|primary health care|primary health care
5279740|NCT02276807|Veterans|veterans
5279741|NCT02276794|Low back pain|low back pain
5279742|NCT02276794|Thrust manipulation|thrust manipulation
5279844|NCT02275949|Acupuncture|acupuncture
5279845|NCT02275936|N91115|n91115
5279846|NCT02275936|Cavosonstat|cavosonstat
5280339|NCT02272959|Anxiety/Anxiety disorders, Clinical trials, treatment, cognition, computer/Internet technology|anxiety/anxiety disorders, clinical trials, treatment, cognition, computer/internet technology
5280340|NCT02272907|Bariatric Surgery|bariatric surgery
5280341|NCT02272907|Laparoscopy|laparoscopy
5280428|NCT02272504|Surveillance|surveillance
5280526|NCT02272049|Respiratory|respiratory
5280949|NCT02269579|Relapsed/Refractory ALL|relapsed/refractory all
5281056|NCT02269046|hyperlipidemias|hyperlipidemias
5281057|NCT02269046|effectiveness|effectiveness
5281058|NCT02269033|Breast cancer|breast cancer
5281061|NCT02269033|Latinas|latinas
5281150|NCT02268539|pilot study|pilot study
5268680|NCT02339038|Ledipasvir/Sofosbuvir|ledipasvir/sofosbuvir
5281581|NCT02266121|MS|ms
5281628|NCT02265848|Spinal cord stimulation|spinal cord stimulation
5281826|NCT02264496|Exercise, Aerobic|exercise, aerobic
5281933|NCT02263612|Long-term|long-term
5282034|NCT02262936|Randomized Controlled Trial|randomized controlled trial
5282036|NCT02262910|CRPC|crpc
5282131|NCT02262273|platinum sensitive|platinum sensitive
5282132|NCT02262273|recurrent|recurrent
5282171|NCT02262052|MRI|mri
5282223|NCT02261844|Hepatocellular carcinoma|hepatocellular carcinoma
5282225|NCT02261844|Metabolism|metabolism
5282322|NCT02261220|advanced solid tumors|advanced solid tumors
5282522|NCT02259595|NAC|nac
5282623|NCT02259231|Melanoma|melanoma
5282624|NCT02259231|Checkpoint inhibitor|checkpoint inhibitor
5282625|NCT02259231|omaveloxolone|omaveloxolone
5282626|NCT02259218|Biomarker|biomarker
5282627|NCT02259218|Radiation|radiation
5282721|NCT02258893|Parts per billion|parts per billion
5282921|NCT02257736|Prostatic neoplasms|prostatic neoplasms
5283133|NCT02256384|Respiratory Acoustic Monitor|respiratory acoustic monitor
5283236|NCT02255799|TBI|tbi
5283327|NCT02255305|CDI|cdi
5283534|NCT02254421|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5283535|NCT02254421|Antiviral|antiviral
5283536|NCT02254421|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
5283537|NCT02254421|Lower respiratory tract infection|lower respiratory tract infection
5283538|NCT02254408|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5283539|NCT02254408|Antiviral|antiviral
5283540|NCT02254408|Hematopoietic Cell Transplant (HCT)|hematopoietic cell transplant (hct)
5283541|NCT02254408|Upper respiratory tract infection|upper respiratory tract infection
5283542|NCT02254382|diastolic heart failure|diastolic heart failure
5283544|NCT02254343|stroke rehabilitation|stroke rehabilitation
5283552|NCT02254304|RMS|rms
5284123|NCT02251054|Overactive Bladder|overactive bladder
5284124|NCT02251054|Multimedia|multimedia
5284125|NCT02251054|Behavioral Therapy|behavioral therapy
5284126|NCT02251041|Liver|liver
5284127|NCT02251041|Transplantation|transplantation
5284309|NCT02250209|Trastuzumab|trastuzumab
5284310|NCT02250209|XELOX|xelox
5284311|NCT02250209|Stage III|stage iii
5284312|NCT02250209|D2 Gastrectomy|d2 gastrectomy
5284313|NCT02250196|Bowel preparation|bowel preparation
5284314|NCT02250196|Polyethylene glycol with ascorbic acid|polyethylene glycol with ascorbic acid
5284315|NCT02250196|Sodium picosulfate with magnesium citrate|sodium picosulfate with magnesium citrate
5284316|NCT02250183|Medihoney|medihoney
5284317|NCT02250183|Santyl|santyl
5284318|NCT02250183|Burns|burns
5284320|NCT02250144|Feet orthoses|feet orthoses
5284678|NCT02248272|Type 2 Diabetes|type 2 diabetes
5284679|NCT02248272|Hyperinsulinemia|hyperinsulinemia
5284680|NCT02248272|Meal frequency|meal frequency
5284699|NCT02248090|Phase 1|phase 1
5284974|NCT02247050|Over Prescribing|over prescribing
5285212|NCT02246101|cardiac disease|cardiac disease
5285405|NCT02245087|revascularization|revascularization
5285585|NCT02244164|RMN|rmn
5285628|NCT02243995|Fatigue|fatigue
5285719|NCT02243644|parenchymal neurocysticercosis upto five lesions|parenchymal neurocysticercosis upto five lesions
5285721|NCT02243631|Probenecid|probenecid
5285722|NCT02243631|Chondrocalcinosis|chondrocalcinosis
5285723|NCT02243527|Exercise|exercise
5285724|NCT02243514|Hypertension|hypertension
5285725|NCT02243514|Heart failure|heart failure
5285726|NCT02243514|Sympathetic hyperactivity|sympathetic hyperactivity
5285727|NCT02243514|Renal nerve|renal nerve
5285728|NCT02243514|Remodeling|remodeling
5285815|NCT02243267|Colon Cancer Colon Cancer Prevention|colon cancer colon cancer prevention
5285816|NCT02243241|Healthy volunteers|healthy volunteers
5285817|NCT02243241|Opioid|opioid
5285818|NCT02243241|ECG|ecg
5285819|NCT02243241|QTcI|qtci
5285822|NCT02243215|Laparoscopy|laparoscopy
5286016|NCT02241993|glucose sensor|glucose sensor
5286139|NCT02241447|referral|referral
5286140|NCT02241434|Duchenne muscular dystrophy|duchenne muscular dystrophy
5286237|NCT02241005|Antimicrobial resistance|antimicrobial resistance
5286238|NCT02240992|Poor Graft Function|poor graft function
5286239|NCT02240992|Delayed platelet engraftment|delayed platelet engraftment
5486667|NCT01350804|RA|ra
5286241|NCT02240992|Mesenchymal Stem Cells|mesenchymal stem cells
5286366|NCT02240329|cough|cough
5286654|NCT02238925|Secondary AML|secondary aml
5286749|NCT02238613|Biliary obstruction|biliary obstruction
5286750|NCT02238613|Intrahepatic Cholangiocarcinoma|intrahepatic cholangiocarcinoma
5286956|NCT02237456|PCI|pci
5287054|NCT02237118|Visual analoge scale|visual analoge scale
5287056|NCT02237066|PTA|pta
5287057|NCT02237066|Balloon|balloon
5287058|NCT02237053|Energy expenditure|energy expenditure
5287259|NCT02236117|children|children
5287345|NCT02235870|BMI|bmi
5287466|NCT02235363|tensiometer|tensiometer
5287565|NCT02234804|OCT|oct
5287666|NCT02234388|connective tissue disease|connective tissue disease
5287667|NCT02234388|registry|registry
5287668|NCT02234388|hospital for special surgery|hospital for special surgery
5287673|NCT02234349|bile acids|bile acids
5287675|NCT02234349|incretins|incretins
5287992|NCT02232893|Gastrointestinal Quality of Life Index (GIQLI)|gastrointestinal quality of life index (giqli)
5287993|NCT02232893|Abdominal Discomfort|abdominal discomfort
5287994|NCT02232893|Abdominal Bloating|abdominal bloating
5287995|NCT02232893|Laparoscopic colectomy|laparoscopic colectomy
5287996|NCT02232893|Postoperative ileus (POI)|postoperative ileus (poi)
5287997|NCT02232880|hypertension|hypertension
5287998|NCT02232880|inflammation|inflammation
5287999|NCT02232867|rehabilitation|rehabilitation
5288000|NCT02232867|stroke|stroke
5288001|NCT02232867|walking|walking
5288002|NCT02232867|interlimb connections|interlimb connections
5288003|NCT02232854|Depression|depression
5288004|NCT02232841|Electrical impedance tomography|electrical impedance tomography
5288005|NCT02232841|lung imaging|lung imaging
5288006|NCT02232789|Mephedrone|mephedrone
5288180|NCT02231853|BK Virus|bk virus
5288181|NCT02231853|Cytotoxic T Cells|cytotoxic t cells
5288183|NCT02231853|Adenovirus|adenovirus
5288185|NCT02231840|Phenotypes|phenotypes
5288186|NCT02231840|Alcohol Use|alcohol use
5288187|NCT02231840|Alcohol|alcohol
5288188|NCT02231840|Alcohol Dependence|alcohol dependence
5288189|NCT02231840|Genetics|genetics
5288277|NCT02231541|Magnetic Fields|magnetic fields
5288278|NCT02231541|Pain|pain
5288279|NCT02231541|Visual Analogue scale|visual analogue scale
5288784|NCT02229396|Treatment efficacy|treatment efficacy
5288785|NCT02229396|Placebo|placebo
5288786|NCT02229396|Metabolism|metabolism
5288885|NCT02229058|Gastric Cancer|gastric cancer
5288886|NCT02229058|Albumin Bound Paclitaxel|albumin bound paclitaxel
5288887|NCT02229058|S-1|s-1
5288888|NCT02229058|First Line|first line
5288889|NCT02229045|gastric caner|gastric caner
5288891|NCT02229045|5-FU/CF|5-fu/cf
5288996|NCT02228551|non-critically ill|non-critically ill
5289098|NCT02228174|Heavy menstrual bleeding|heavy menstrual bleeding
5289099|NCT02228174|HMB|hmb
5289100|NCT02228174|Myoma|myoma
5289101|NCT02228174|Menorrhagia|menorrhagia
5289102|NCT02228161|Yoga|yoga
5289103|NCT02228161|Work-related Stress,|work-related stress,
5289104|NCT02228161|Stress Adaptation.|stress adaptation.
5289105|NCT02228148|Post linguistically deafness, severe to profound deafness|post linguistically deafness, severe to profound deafness
5289106|NCT02228122|Chronic wounds|chronic wounds
5289107|NCT02228122|Biofilms|biofilms
5289108|NCT02228122|Bacteria|bacteria
5289115|NCT02228083|dental|dental
5289200|NCT02227589|adolescent,|adolescent,
5289201|NCT02227589|alcohol abuse|alcohol abuse
5289202|NCT02227589|depression,|depression,
5289286|NCT02227277|HIV|hiv
5289492|NCT02226224|in vitro|in vitro
5289602|NCT02225756|Prevention and control|prevention and control
5289627|NCT02225600|BPD|bpd
5289805|NCT02225028|toning|toning
5289806|NCT02225028|SCI|sci
5289807|NCT02225028|spinal cord injury|spinal cord injury
5289808|NCT02225028|home-based|home-based
5289809|NCT02225028|home exercise|home exercise
5289810|NCT02225015|Cancer|cancer
5289822|NCT02224963|Aging,|aging,
5289905|NCT02224677|lateral cleft|lateral cleft
5290006|NCT02224248|motivation|motivation
5290229|NCT02223221|SNP array|snp array
5290330|NCT02222857|Vitrectomy|vitrectomy
5290441|NCT02222363|Refractory advanced solid tumors|refractory advanced solid tumors
5290643|NCT02221258|Stem cell|stem cell
5290651|NCT02221245|CSC|csc
5290751|NCT02220933|EDSS|edss
5290863|NCT02220439|rotavirus|rotavirus
5290961|NCT02219997|Intraocular lens (IOL)|intraocular lens (iol)
5291104|NCT02219399|DHA|dha
5291165|NCT02219061|waning|waning
5291351|NCT02218320|HIV|hiv
5291353|NCT02218320|raltegravir|raltegravir
5291566|NCT02217332|Asthma|asthma
5291671|NCT02216890|Follicular Lymphoma, Grade 3|follicular lymphoma, grade 3
5291674|NCT02216890|Drug Therapy|drug therapy
5291775|NCT02216396|dementia|dementia
5291776|NCT02216396|care home|care home
5291882|NCT02215980|Multiple myeloma|multiple myeloma
5291883|NCT02215980|Diagnosis|diagnosis
5291884|NCT02215980|Elderly and unfit patients|elderly and unfit patients
5291885|NCT02215980|Lenalidomide plus steroids|lenalidomide plus steroids
5291975|NCT02215382|changes in IOP|changes in iop
5291976|NCT02215382|heart rate|heart rate
5291977|NCT02215382|blood pressure|blood pressure
5291978|NCT02215382|tracheal extubation|tracheal extubation
5291979|NCT02215330|Central serous chorioretinopathy|central serous chorioretinopathy
5292165|NCT02214433|Antibiotic|antibiotic
5292166|NCT02214433|Antibiotic Resistant Bacterial Infection|antibiotic resistant bacterial infection
5292167|NCT02214381|breast cancer|breast cancer
5292168|NCT02214381|elderly|elderly
5292369|NCT02213731|Cryoablation|cryoablation
5292371|NCT02213731|Pulmonary Vein Isolation|pulmonary vein isolation
5292372|NCT02213718|Desflurane|desflurane
5292373|NCT02213718|myocardial function|myocardial function
5292374|NCT02213718|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5292376|NCT02213705|TRANSPLANTATION|transplantation
5292662|NCT02212340|quality of recovery|quality of recovery
5292664|NCT02212327|Na+ MRI|na+ mri
5292665|NCT02212327|salt stores|salt stores
5292666|NCT02212314|Response Inhibition, Williams Syndrome|response inhibition, williams syndrome
5292667|NCT02212275|ASD|asd
5292668|NCT02212275|autism|autism
5292780|NCT02211599|protein|protein
5292869|NCT02211092|Self Care|self care
5292980|NCT02210637|Hospitalization|hospitalization
5293076|NCT02210104|Advanced|advanced
5293077|NCT02210104|Metastatic|metastatic
5293078|NCT02210104|Immunotherapy|immunotherapy
5293182|NCT02209493|Prevention|prevention
5293280|NCT02209025|Theobromine|theobromine
5293281|NCT02209012|Actinic Keratosis|actinic keratosis
5293374|NCT02208674|cluster randomized trial|cluster randomized trial
5293375|NCT02208661|Morquio A syndrome|morquio a syndrome
5293376|NCT02208661|Mucopolysaccharidosis IV A|mucopolysaccharidosis iv a
5293377|NCT02208661|Psychological health|psychological health
5293378|NCT02208648|coronary calcification|coronary calcification
5293465|NCT02208219|Neurorehabilitation|neurorehabilitation
5293466|NCT02208206|Neuropathic pain|neuropathic pain
5293467|NCT02208206|Phenotype|phenotype
5293468|NCT02208206|Genotype|genotype
5293469|NCT02208206|Biomarkers|biomarkers
5293471|NCT02208206|Diabetes mellitus|diabetes mellitus
5293562|NCT02207816|Plasmodium falciparum|plasmodium falciparum
5293663|NCT02207257|PER977|per977
5294313|NCT02204462|PET|pet
5294527|NCT02203396|ATG|atg
5294528|NCT02203396|Cyclosporine|cyclosporine
5294529|NCT02203396|Levamisole|levamisole
5294530|NCT02203383|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5294619|NCT02203032|Psoriasis|psoriasis
5294620|NCT02203032|Plaque-type psoriasis|plaque-type psoriasis
5294621|NCT02203032|Guselkumab|guselkumab
5294622|NCT02203032|Ustekinumab|ustekinumab
5294723|NCT02202551|LID|lid
5294825|NCT02202018|Cluster randomized trial|cluster randomized trial
5294932|NCT02201628|Intubation, endotracheal|intubation, endotracheal
5294933|NCT02201628|Pediatric|pediatric
5294934|NCT02201628|Anesthesia|anesthesia
5294960|NCT02201524|JAK|jak
5295033|NCT02201290|Chronic immune thrombocytopenic purpura, ITP, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics|chronic immune thrombocytopenic purpura, itp, eltrombopag olamine, thrombopoietin receptor agonist, pediatrics
5295245|NCT02200263|macular pigment|macular pigment
5295246|NCT02200263|visual function|visual function
5295247|NCT02200237|EV71 Vaccine|ev71 vaccine
5295248|NCT02200211|Amblyopia|amblyopia
5295346|NCT02199691|Adacel®|adacel®
5295441|NCT02199171|cytoreductive surgery|cytoreductive surgery
5295442|NCT02199158|iridoplasty|iridoplasty
5295444|NCT02199158|glaucoma|glaucoma
5295546|NCT02198664|OIT|oit
5295637|NCT02198209|GLP-1|glp-1
5295638|NCT02198209|liver glucokinase|liver glucokinase
5295639|NCT02198170|Healthy Volunteers|healthy volunteers
5295640|NCT02198157|duration of second stage|duration of second stage
5295646|NCT02198144|Black Men|black men
5295867|NCT02197065|hip|hip
5295916|NCT02196857|AZA-CR|aza-cr
5295917|NCT02196857|Ladakamycin|ladakamycin
5295918|NCT02196857|NSC-102816|nsc-102816
5295919|NCT02196857|Sorafenib|sorafenib
5295920|NCT02196857|Nexavar|nexavar
5295921|NCT02196857|BAY 43-9006|bay 43-9006
5295922|NCT02196844|Lung cancer|lung cancer
5295923|NCT02196844|Hatha Yoga|hatha yoga
5295924|NCT02196844|Questionnaires|questionnaires
5295925|NCT02196844|Surveys|surveys
5296007|NCT02196441|implantable contact lens procedure|implantable contact lens procedure
5296008|NCT02196428|Ambient Assisted Living (AAL)|ambient assisted living (aal)
5296009|NCT02196428|Telemonitoring|telemonitoring
5296010|NCT02196428|Teleconsultation|teleconsultation
5296011|NCT02196415|Hindfoot Alignment|hindfoot alignment
5296012|NCT02196415|Rearfoot|rearfoot
5296098|NCT02195947|Poor responder|poor responder
5296099|NCT02195947|Antagonist protocol|antagonist protocol
5296100|NCT02195934|Cardiovascular disease, blood orange juice, anthocyanins|cardiovascular disease, blood orange juice, anthocyanins
5296154|NCT02195778|UAE|uae
5296193|NCT02195531|Adherence|adherence
5296522|NCT02194101|proximal femoral fracture|proximal femoral fracture
5296525|NCT02194062|Nasal steroids|nasal steroids
5296611|NCT02193776|Tuberculosis|tuberculosis
5296822|NCT02192827|Dexamethasone|dexamethasone
5296823|NCT02192814|Lacosamide|lacosamide
5296824|NCT02192814|LCM|lcm
5296825|NCT02192814|Epilepsy|epilepsy
5296929|NCT02192398|Pain management|pain management
5296931|NCT02192398|Back|back
5296932|NCT02192372|creatinine|creatinine
5296933|NCT02192372|glomerular filtration rate|glomerular filtration rate
5296934|NCT02192372|metabolic syndrome|metabolic syndrome
5296935|NCT02192346|metastatic|metastatic
5296936|NCT02192346|refractory|refractory
5296937|NCT02192346|progressive|progressive
5296938|NCT02192320|Atorvastatin|atorvastatin
5297024|NCT02191969|Elderly|elderly
5297136|NCT02191371|one-lung ventilation|one-lung ventilation
5297137|NCT02191371|thoracic surgery|thoracic surgery
5297138|NCT02191358|Cytochrome drug interactions|cytochrome drug interactions
5297139|NCT02191358|Drug-drug interaction|drug-drug interaction
5297233|NCT02191111|Pharmacist|pharmacist
5297337|NCT02190552|Brain|brain
5297442|NCT02190188|knee brace,|knee brace,
5297443|NCT02190188|orthotic device|orthotic device
5297446|NCT02190149|Factor VIII Deficiency|factor viii deficiency
5297563|NCT02189746|Kangaroo mother care|kangaroo mother care
5297564|NCT02189720|Amifampridine Phosphate|amifampridine phosphate
5297565|NCT02189720|Amifampridine|amifampridine
5297566|NCT02189720|3,4-Diaminopyridine Phosphate|3,4-diaminopyridine phosphate
5297569|NCT02189720|CMS|cms
5297792|NCT02188901|Sonazoid|sonazoid
5297887|NCT02188576|tranexamic acid|tranexamic acid
5297888|NCT02188576|Antifibrinolytic|antifibrinolytic
5297983|NCT02188160|Corticosteroid|corticosteroid
5297984|NCT02188160|Dry Eye|dry eye
5297985|NCT02188160|Hyperemia|hyperemia
5297986|NCT02188160|Ocular Discomfort|ocular discomfort
5298079|NCT02187757|Dyslipidemia|dyslipidemia
5298080|NCT02187757|High cholesterol|high cholesterol
5298187|NCT02187224|Post-Traumatic stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5298188|NCT02187224|Progesterone|progesterone
5298295|NCT02186743|Irritable Bowel Syndrome|irritable bowel syndrome
5298296|NCT02186743|IBS|ibs
5298418|NCT02186262|MRI|mri
5298714|NCT02185222|Preventive therapy|preventive therapy
5298921|NCT02184169|hemodynamics|hemodynamics
5299138|NCT02181673|Simponi|simponi
5299418|NCT02180750|HIV|hiv
5299565|NCT02180035|HAART|haart
5299566|NCT02180022|Quercetin|quercetin
5299567|NCT02180022|Endothelial function|endothelial function
5299568|NCT02180022|Onion peel extract|onion peel extract
5299569|NCT02180022|volunteers|volunteers
5299570|NCT02179996|Vaccination|vaccination
5299571|NCT02179996|Very preterm-born infants|very preterm-born infants
5299572|NCT02179996|Hib immunisation|hib immunisation
5299573|NCT02179996|Pertussis immunisation|pertussis immunisation
5299574|NCT02179983|Bronchiectasis|bronchiectasis
5299670|NCT02179567|Elderly|elderly
5299671|NCT02179567|1st Line|1st line
5299680|NCT02179489|HIPEC|hipec
5299894|NCT02178345|MRI|mri
5299973|NCT02177903|opioid usage|opioid usage
5300096|NCT02177071|anti-metabolites|anti-metabolites
5300097|NCT02177058|Nursing homes|nursing homes
5300099|NCT02177032|Rabies vaccines|rabies vaccines
5300196|NCT02176330|Economic Analysis|economic analysis
5300419|NCT02175251|GAF|gaf
5300496|NCT02174848|Deferiprone|deferiprone
5300599|NCT02174367|Transient elastography|transient elastography
5300689|NCT02173860|Coronary graft failure or patency|coronary graft failure or patency
5300690|NCT02173847|anvil-shaped corneal graft|anvil-shaped corneal graft
5300691|NCT02173847|penetrating keratoplasty|penetrating keratoplasty
5300693|NCT02173847|laser welding|laser welding
5300694|NCT02173834|Brown Adipose Tissue|brown adipose tissue
5300695|NCT02173834|Weight|weight
5300696|NCT02173834|Sympathetic Nervous System|sympathetic nervous system
5300697|NCT02173756|chemotherapy|chemotherapy
5300698|NCT02173756|mucositis|mucositis
5300699|NCT02173756|systemic opioids|systemic opioids
5300700|NCT02173756|morphine|morphine
5300701|NCT02173743|plasma, calcific tendinitis, rotator cuff, PRP|plasma, calcific tendinitis, rotator cuff, prp
5300702|NCT02173704|Meningitis|meningitis
5300703|NCT02173704|Infants|infants
5300705|NCT02173626|Mindfulness|mindfulness
5300764|NCT02173379|Coronary artery stenosis|coronary artery stenosis
5300765|NCT02173379|Coronary scaffold|coronary scaffold
5300766|NCT02173379|Coronary Stent|coronary stent
5300767|NCT02173379|Drug eluting stents|drug eluting stents
5300768|NCT02173379|Everolimus|everolimus
5300769|NCT02173379|Myocardial ischemia|myocardial ischemia
5301144|NCT02170493|Optimial Limb Loading|optimial limb loading
5301145|NCT02170493|42IIIB|42iiib
5301239|NCT02170090|muscle invasive gall bladder carcinoma|muscle invasive gall bladder carcinoma
5301337|NCT02169596|Antiplatelet agents|antiplatelet agents
5301338|NCT02169596|Endothelial function|endothelial function
5301339|NCT02169583|GSK1325756|gsk1325756
5301341|NCT02169583|Bioavailability|bioavailability
5301342|NCT02169583|Pharmacokinetics|pharmacokinetics
5301343|NCT02169570|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5301344|NCT02169570|Pulmonary Tuberculosis|pulmonary tuberculosis
5301345|NCT02169570|Vitamin D|vitamin d
5301547|NCT02168712|Safety|safety
5301632|NCT02168296|Pharmacokinetics|pharmacokinetics
5301751|NCT02167763|contraception|contraception
5301844|NCT02167217|Young Children|young children
5301845|NCT02167217|Toddlers|toddlers
5301942|NCT02166801|Communication|communication
5301943|NCT02166801|Gross motor function|gross motor function
5301944|NCT02166801|Hand function|hand function
5302032|NCT02166359|Icodextrin|icodextrin
5302129|NCT02165865|upper extremity amputation|upper extremity amputation
5302284|NCT02165085|Ehlers-Danlos syndrome, vascular type|ehlers-danlos syndrome, vascular type
5302285|NCT02165085|Pathophysiology|pathophysiology
5302286|NCT02165072|Inferior vena cava|inferior vena cava
5302287|NCT02165072|Kidney injury|kidney injury
5302288|NCT02165072|Ultrasound|ultrasound
5302289|NCT02165059|Nausea|nausea
5302290|NCT02165059|Vomiting|vomiting
5302291|NCT02165059|Functional dyspepsia|functional dyspepsia
5302292|NCT02165059|Bloating|bloating
5302293|NCT02165059|Regurgitation|regurgitation
5302294|NCT02165059|Retching|retching
5302680|NCT02163291|advanced gastric cancer|advanced gastric cancer
5302681|NCT02163291|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5302683|NCT02163291|feasibility|feasibility
5302787|NCT02162849|Tobacco Use Cessation|tobacco use cessation
5302788|NCT02162849|Smoking Cessation|smoking cessation
5302789|NCT02162849|Cancer Prevention|cancer prevention
5302790|NCT02162849|Behavioral Counseling|behavioral counseling
5302791|NCT02162849|Nicotine Replacement Therapy|nicotine replacement therapy
5303007|NCT02161978|antiangiogenic|antiangiogenic
5303008|NCT02161978|cancer|cancer
5303199|NCT02161120|IBS, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, FODMAP, microbiota|ibs, irritable bowel syndrome, functional gastrointestinal disorder, diet, bread, rye, fodmap, microbiota
5303200|NCT02161107|Grass|grass
5303201|NCT02161107|Allergy|allergy
5303202|NCT02161107|rhinoconjunctivitis|rhinoconjunctivitis
5303203|NCT02161107|rhinitis|rhinitis
5303204|NCT02161107|asthma|asthma
5303205|NCT02161094|Community management incentives|community management incentives
5303206|NCT02161081|Myocardial ischemia|myocardial ischemia
5303211|NCT02161081|Radiation dose|radiation dose
5303305|NCT02160535|Concussion|concussion
5303403|NCT02160106|TGF-β|tgf-β
5303513|NCT02159677|EIM|eim
5303609|NCT02159131|ethinyl estradiol|ethinyl estradiol
5303610|NCT02159131|GSK1265744|gsk1265744
5303611|NCT02159131|pharmacokinetics|pharmacokinetics
5303706|NCT02158806|Venous ulcer, varicose ulcer, gravitational ulcer, aspirin|venous ulcer, varicose ulcer, gravitational ulcer, aspirin
5303806|NCT02158416|thrombocytopenic|thrombocytopenic
5303909|NCT02157857|NSCLC, SCLC, lung cancer, EBUS-TBNA|nsclc, sclc, lung cancer, ebus-tbna
5304204|NCT02156401|Outcome|outcome
5304414|NCT02155413|Acute pain|acute pain
5304415|NCT02155413|Audit|audit
5304416|NCT02155413|Safety|safety
5304417|NCT02155413|Tolerability|tolerability
5304418|NCT02155400|perioperative hypothermia|perioperative hypothermia
5304520|NCT02154893|Osteoarthritis|osteoarthritis
5304521|NCT02154880|HIV|hiv
5304630|NCT02154347|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5304631|NCT02154347|HbA1c|hba1c
5304632|NCT02154334|Allergic Rhinitis|allergic rhinitis
5304943|NCT02152813|Electrical stimulation, exercise, stroke , rehabilitation|electrical stimulation, exercise, stroke , rehabilitation
5304944|NCT02152787|emergence agitation|emergence agitation
5304945|NCT02152787|propofol|propofol
5304946|NCT02152787|strabismus surgery|strabismus surgery
5304947|NCT02152787|children|children
5304948|NCT02152787|elective strabismus surgery|elective strabismus surgery
5304949|NCT02152761|bimagrumab|bimagrumab
5304952|NCT02152761|elderly|elderly
5304953|NCT02152761|controlled clinical trial|controlled clinical trial
5305036|NCT02152358|ventilator-free days|ventilator-free days
5305145|NCT02151825|Probiotics|probiotics
5305146|NCT02151825|Prebiotics|prebiotics
5305147|NCT02151825|Synbiotic|synbiotic
5305148|NCT02151825|Bifidobacterium lactis BB-12|bifidobacterium lactis bb-12
5305327|NCT02150876|DES|des
5305440|NCT02150330|DHEAS|dheas
5305540|NCT02149901|Pure Autonomic Failure|pure autonomic failure
5305541|NCT02149901|Multiple System Atrophy|multiple system atrophy
5305542|NCT02149901|Pseudoephedrine|pseudoephedrine
5305543|NCT02149901|Water|water
5305544|NCT02149901|Osmopressor|osmopressor
5305545|NCT02149888|HIV|hiv
5305546|NCT02149888|Pre-Exposure Prophylaxis|pre-exposure prophylaxis
5305547|NCT02149888|PrEP|prep
5305548|NCT02149888|Human Immunodeficiency Virus|human immunodeficiency virus
5305549|NCT02149875|Acute ischemic stroke|acute ischemic stroke
5305550|NCT02149875|Dl-3-n-butylphthalide|dl-3-n-butylphthalide
5305551|NCT02149875|Cerebrolysin|cerebrolysin
5305553|NCT02149862|Diagnostic|diagnostic
5305618|NCT02149667|revision procedures|revision procedures
5305626|NCT02149615|isotretinoin|isotretinoin
5305929|NCT02148159|adults|adults
5306131|NCT02147379|Cognition|cognition
5306227|NCT02146911|Smoking Treatment|smoking treatment
5306228|NCT02146911|Tobacco Treatment|tobacco treatment
5306229|NCT02146911|Quitting Smoking|quitting smoking
5306230|NCT02146911|Bupropion|bupropion
5306231|NCT02146911|Varenicline|varenicline
5306232|NCT02146911|Efficacy|efficacy
5306234|NCT02146911|Genetics analysis|genetics analysis
5306508|NCT02145533|MMP|mmp
5306527|NCT02145481|cardiology|cardiology
5306528|NCT02145481|heart disease|heart disease
5306529|NCT02145468|Myocardial infarction|myocardial infarction
5306530|NCT02145468|Acute coronary syndrome|acute coronary syndrome
5306531|NCT02145468|Cardiovascular disease|cardiovascular disease
5306532|NCT02145468|p38 mitogen-activated protein kinase (MAPK) inhibitor|p38 mitogen-activated protein kinase (mapk) inhibitor
5306533|NCT02145468|NSTEMI|nstemi
5306534|NCT02145468|Losmapimod|losmapimod
5306535|NCT02145468|STEMI|stemi
5306538|NCT02145455|Knee Joint/radiography|knee joint/radiography
5306539|NCT02145455|Knee Joint/surgery|knee joint/surgery
5306540|NCT02145455|Knee Prosthesis|knee prosthesis
5306568|NCT02145390|TCC|tcc
5306813|NCT02144233|Occlusal adjustment|occlusal adjustment
5306911|NCT02143908|immune status|immune status
5306913|NCT02143908|Bangladesh|bangladesh
5306914|NCT02143908|aged 18-45 years|aged 18-45 years
5306915|NCT02143908|urban community|urban community
5306929|NCT02143830|AML|aml
5307054|NCT02143349|obesity|obesity
5307466|NCT02141204|Lyophilized formulation|lyophilized formulation
5307566|NCT02140749|Bifidobacteria|bifidobacteria
5307567|NCT02140749|Bristol Stool Scale|bristol stool scale
5307568|NCT02140749|Constipation|constipation
5307569|NCT02140749|Diet|diet
5307570|NCT02140749|Fructooligosacchardes|fructooligosacchardes
5307571|NCT02140749|Microbiota|microbiota
5307578|NCT02140723|TP53|tp53
5307666|NCT02140255|HIV Remission|hiv remission
5307667|NCT02140242|AML|aml
5307671|NCT02140242|7+3|7+3
5307770|NCT02139787|Hypertension, obesity|hypertension, obesity
5307771|NCT02139787|Dietary behaviors|dietary behaviors
5307772|NCT02139787|Physical activity behaviors|physical activity behaviors
5307787|NCT02139774|Men|men
5307862|NCT02139345|Rheumatoid arthritis|rheumatoid arthritis
5307863|NCT02139345|Post-traumatic arthritis|post-traumatic arthritis
5307864|NCT02139345|Avascular necrosis|avascular necrosis
5307873|NCT02139280|Stem Cell|stem cell
5308593|NCT02135861|MRI|mri
5308787|NCT02134769|catheter-related bloodstream infections|catheter-related bloodstream infections
5308788|NCT02134756|Supplement impact|supplement impact
5308789|NCT02134756|Performance|performance
5308886|NCT02134392|FMT|fmt
5308997|NCT02134041|Alzheimer disease|alzheimer disease
5308998|NCT02134015|Carcinoma|carcinoma
5308999|NCT02134015|Non-Small-Cell Lung|non-small-cell lung
5309006|NCT02134015|Neoplasms|neoplasms
5309094|NCT02133638|Hypoxic Brain Damage|hypoxic brain damage
5309096|NCT02133638|S100b protein|s100b protein
5309106|NCT02133586|Ozone|ozone
5309311|NCT02132507|epilepsy|epilepsy
5309512|NCT02131675|C-peptide|c-peptide
5309720|NCT02130687|Hypertension|hypertension
5310011|NCT02129595|Antineoplastic Agents|antineoplastic agents
5310121|NCT02129244|MDR-TB|mdr-tb
5310219|NCT02128841|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5310220|NCT02128841|anticoagulants|anticoagulants
5310523|NCT02127411|Mindfulness|mindfulness
5310616|NCT02126982|clopidogrel besylate|clopidogrel besylate
5674504|NCT00603330|Chimerism|chimerism
5310712|NCT02126462|Neglected Tropical Disease|neglected tropical disease
5310713|NCT02126462|Na-APR-1|na-apr-1
5310714|NCT02126462|Na-GST-1|na-gst-1
5310715|NCT02126436|phantom limb pain|phantom limb pain
5310716|NCT02126436|phantom limb sensation|phantom limb sensation
5310718|NCT02126436|randomised controlled trial|randomised controlled trial
5310719|NCT02126423|Drug Resistance, Microbial|drug resistance, microbial
5310720|NCT02126410|sarcopenia|sarcopenia
5310721|NCT02126410|sleep duration|sleep duration
5310722|NCT02126410|body composition|body composition
5310723|NCT02126410|skeletal muscle|skeletal muscle
5310724|NCT02126397|endometrial polyp|endometrial polyp
5310725|NCT02126397|resection of endometrial polyps|resection of endometrial polyps
5310726|NCT02126397|hysteroscopy|hysteroscopy
5310727|NCT02126397|bipolar electrode Versapoint|bipolar electrode versapoint
5310728|NCT02126397|Laser Diode|laser diode
5310729|NCT02126384|Immunology|immunology
5310730|NCT02126384|human|human
5310763|NCT02126202|PCI|pci
5310788|NCT02126072|Ethanol|ethanol
5310899|NCT02125526|Acute myocardial infarction|acute myocardial infarction
5310900|NCT02125526|Persisting ischemia|persisting ischemia
5310905|NCT02125513|ovarian cancer|ovarian cancer
5310907|NCT02125513|peritoneal carcinoma|peritoneal carcinoma
5311190|NCT02124096|Zoonotic|zoonotic
5311291|NCT02123576|Pentoxyfylline|pentoxyfylline
5311390|NCT02123160|Cortisol|cortisol
5311585|NCT02122198|Hormone therapy|hormone therapy
5311586|NCT02122198|functional MRI|functional mri
5311587|NCT02122159|safety|safety
5311588|NCT02122159|tolerability|tolerability
5311589|NCT02122159|RPE cellular therapy|rpe cellular therapy
5311590|NCT02122159|MMD|mmd
5312114|NCT02120001|Ventilator-Associated Pneumonia (VAP)|ventilator-associated pneumonia (vap)
5312115|NCT02120001|Ventilator-Associated Events (VAE)|ventilator-associated events (vae)
5312218|NCT02119598|Telemedicine|telemedicine
5312423|NCT02118779|DM1|dm1
5312525|NCT02118285|Ovarian cancer|ovarian cancer
5299597|NCT02179892|surgery|surgery
5299598|NCT02179892|pain|pain
5312810|NCT02116998|Strep pneumoniae|strep pneumoniae
5312811|NCT02116998|Pneumonia|pneumonia
5312812|NCT02116985|Dual-Loop TCI|dual-loop tci
5312814|NCT02116985|Laparoscopic Cholecystectomy|laparoscopic cholecystectomy
5312828|NCT02116920|CIN|cin
5312917|NCT02116543|Hepatitis C|hepatitis c
5300049|NCT02177526|CT|ct
5313015|NCT02116049|HIV|hiv
5313102|NCT02115711|Smoking|smoking
5313201|NCT02115360|Later Complication|later complication
5313297|NCT02114905|Tic Disorder|tic disorder
5313507|NCT02114138|pAKI|paki
5313700|NCT02113410|Fatigue|fatigue
5313701|NCT02113410|Depression|depression
5313702|NCT02113410|Life Satisfaction|life satisfaction
5313896|NCT02112682|Completion axillary lymph node dissection|completion axillary lymph node dissection
5313991|NCT02112331|Preterm newborns|preterm newborns
5314099|NCT02111863|Immunotherapy|immunotherapy
5314100|NCT02111863|Clinical Response|clinical response
5314105|NCT02111824|Lung Cancer|lung cancer
5314106|NCT02111824|Peripheral lung lesions|peripheral lung lesions
5314107|NCT02111824|Lung biopsy|lung biopsy
5314108|NCT02111824|Minimally invasive|minimally invasive
5314109|NCT02111824|multimodality image-guided intervention system|multimodality image-guided intervention system
5314110|NCT02111824|MIMIG|mimig
5314111|NCT02111824|Indocyanine green|indocyanine green
5314113|NCT02111811|Depression|depression
5314114|NCT02111811|Treatment Outcome|treatment outcome
5314134|NCT02111720|HIV|hiv
5314191|NCT02111499|psoriasis plaque test|psoriasis plaque test
5314192|NCT02111499|topical application|topical application
5314194|NCT02111486|Breakfast|breakfast
5314195|NCT02111486|Satiety|satiety
5314196|NCT02111486|Fibre|fibre
5314390|NCT02110628|roux-en-y|roux-en-y
5314492|NCT02110069|Tufted angioma|tufted angioma
5314592|NCT02109718|Dressings|dressings
5314593|NCT02109718|Outpatient Management|outpatient management
5314594|NCT02109718|Petrolatum Jelly|petrolatum jelly
5314597|NCT02109692|muscle dystrophies|muscle dystrophies
5314807|NCT02108808|FFR|ffr
5315005|NCT02107820|Percutaneous Tibial nerve stimulation|percutaneous tibial nerve stimulation
5315453|NCT02106182|Thrupas|thrupas
5315866|NCT02104375|arterial stiffness|arterial stiffness
5316017|NCT02103751|CVD|cvd
5316080|NCT02103361|Tremfya|tremfya
5316293|NCT02102412|crc|crc
5316374|NCT02102126|Blood pressure variability|blood pressure variability
5316475|NCT02101671|Confusion|confusion
5316476|NCT02101671|Disorientation|disorientation
5316795|NCT02100020|physical activity|physical activity
5316805|NCT02099994|HIV|hiv
5316900|NCT02099591|Colonic Inertia|colonic inertia
5317309|NCT02097862|adipose stem cells|adipose stem cells
5317311|NCT02097849|vaccine|vaccine
5317312|NCT02097849|pneumococcal|pneumococcal
5317313|NCT02097849|meningococcal|meningococcal
5317314|NCT02097849|tetanus diphtheria|tetanus diphtheria
5317315|NCT02097849|immune response|immune response
5317397|NCT02097381|GUT|gut
5317406|NCT02097368|Tongue strength|tongue strength
5317407|NCT02097368|neuromuscular|neuromuscular
5317408|NCT02097368|swallowing|swallowing
5317409|NCT02097355|chronic disease|chronic disease
5317503|NCT02096952|ASD|asd
5317595|NCT02096445|rehabilitation|rehabilitation
5317701|NCT02096042|Azacytidine|azacytidine
5317702|NCT02096042|Azacitidine|azacitidine
5317703|NCT02096042|5-aza|5-aza
5317704|NCT02096042|Vidaza|vidaza
5317833|NCT02095353|MRI|mri
5317909|NCT02095015|ENT|ent
5318004|NCT02094573|Drug Therapy|drug therapy
5318101|NCT02094131|flow-oriented spirometer|flow-oriented spirometer
5318102|NCT02094131|volume-oriented spirometer|volume-oriented spirometer
5318103|NCT02094131|physical therapy|physical therapy
5318201|NCT02093650|Menopausal symptoms|menopausal symptoms
5318202|NCT02093650|menopause related quality of life|menopause related quality of life
5318203|NCT02093650|black cohosh|black cohosh
5318205|NCT02093650|MENQOL|menqol
5318289|NCT02093195|Treatment, COPD, bosentan|treatment, copd, bosentan
5318290|NCT02093156|bowel preparation|bowel preparation
5318291|NCT02093156|Ottawa Score|ottawa score
5318292|NCT02093143|Diagnostic panendoscopy of the upper airway|diagnostic panendoscopy of the upper airway
5318293|NCT02093143|Total intravenous general anesthesia|total intravenous general anesthesia
5318376|NCT02092883|Neuroinflammation|neuroinflammation
5318487|NCT02092311|varicocelectomy|varicocelectomy
5318611|NCT02091752|INC424|inc424
5318708|NCT02091310|Pharmacokinetic|pharmacokinetic
5318798|NCT02090946|home activity programs|home activity programs
5318902|NCT02090361|loss of cutaneous substance|loss of cutaneous substance
5318998|NCT02090049|Satiety|satiety
5318999|NCT02090049|Bread|bread
5319095|NCT02089477|Type 2 diabetes, InterWalk, Individual Support, Motivation|type 2 diabetes, interwalk, individual support, motivation
5319096|NCT02089412|Healthy Subjects|healthy subjects
5319098|NCT02089412|High-Fat Meal|high-fat meal
5319187|NCT02089035|Vascular function|vascular function
5319188|NCT02089035|Blood pressure|blood pressure
5319189|NCT02089022|Ice|ice
5319190|NCT02089022|Heat|heat
5319191|NCT02089022|Ground reaction forces|ground reaction forces
5319192|NCT02089022|Electromyography|electromyography
5319193|NCT02089022|Lower Limb|lower limb
5319194|NCT02089022|Center of pressure|center of pressure
5319195|NCT02088970|Infectious keratitis|infectious keratitis
5319383|NCT02087917|placebo-controlled trial|placebo-controlled trial
5319384|NCT02087904|Osteoarthritis|osteoarthritis
5319385|NCT02087904|Synovitis|synovitis
5319387|NCT02087904|Pain|pain
5319388|NCT02087878|Hepatosplenic T-Cell Lymphoma|hepatosplenic t-cell lymphoma
5319477|NCT02087501|Abdominal Aortoiliac Aneurysm|abdominal aortoiliac aneurysm
5319478|NCT02087501|Endovascular Aortic Repair|endovascular aortic repair
5319479|NCT02087501|EVAR|evar
5319482|NCT02087462|Sciatica|sciatica
5319648|NCT02086370|PBS|pbs
5319776|NCT02085759|Healthy|healthy
5319865|NCT02085356|HIV|hiv
5319866|NCT02085356|PMTCT|pmtct
5319867|NCT02085356|South Africa|south africa
5319868|NCT02085356|Couples|couples
5319869|NCT02085356|Male involvement|male involvement
5319870|NCT02085343|Exposure therapy|exposure therapy
5319871|NCT02085343|Specific phobia|specific phobia
5319963|NCT02085031|Roux-en-Y Anastomosis|roux-en-y anastomosis
5320059|NCT02084563|Essential Thrombocythemia (ET)|essential thrombocythemia (et)
5320154|NCT02084108|Frail and dependent older adults|frail and dependent older adults
5320155|NCT02084108|Integrated care|integrated care
5320156|NCT02084108|Home care|home care
5320157|NCT02084108|Multidimensional geriatric assessment|multidimensional geriatric assessment
5320158|NCT02084108|RAI-HC (resident assessment instrument- Home care)|rai-hc (resident assessment instrument- home care)
5320370|NCT02083107|Misoprostol|misoprostol
5320376|NCT02083042|CMV|cmv
5320586|NCT02082327|migalastat HCl|migalastat hcl
5320705|NCT02081599|insulin resistance|insulin resistance
5320706|NCT02081586|CBT|cbt
5320707|NCT02081586|Type 2 Diabetes|type 2 diabetes
5320708|NCT02081586|Diabetes Distress|diabetes distress
5320709|NCT02081586|Adherence|adherence
5320710|NCT02081586|Smartphone App|smartphone app
5320815|NCT02081235|congenital heart disease|congenital heart disease
5320918|NCT02080871|VBX|vbx
5321019|NCT02080325|soy|soy
5321020|NCT02080312|Meniere's disease|meniere's disease
5321021|NCT02080312|endolymphatic hydrops|endolymphatic hydrops
5321022|NCT02080286|spatial neglect|spatial neglect
5321023|NCT02080286|rehabilitation|rehabilitation
5321096|NCT02079935|BN|bn
5321121|NCT02079792|Head Position|head position
5321122|NCT02079779|Robotic-assisted therapy|robotic-assisted therapy
5321123|NCT02079779|Acute Stroke|acute stroke
5321126|NCT02079727|Condrosulf|condrosulf
5321224|NCT02079311|Patient warming|patient warming
5321225|NCT02079311|Active warming|active warming
5321226|NCT02079311|Forced Air Warming|forced air warming
5321227|NCT02079311|Warming blanket|warming blanket
5321229|NCT02079272|Breast Cancer|breast cancer
5321295|NCT02078960|CML|cml
5321319|NCT02078843|GEP-NET|gep-net
5321434|NCT02078297|IL-23|il-23
5321615|NCT02077387|executive functioning|executive functioning
5321823|NCT02076646|metastatic|metastatic
5321824|NCT02076646|melanoma|melanoma
5321825|NCT02076646|tumor targeting|tumor targeting
5321826|NCT02076646|Dose definition|dose definition
5321922|NCT02076204|Pregnancy|pregnancy
5322022|NCT02075710|Diet|diet
5322023|NCT02075710|Sugar|sugar
5322127|NCT02075411|nerve block|nerve block
5322128|NCT02075411|pain|pain
5322129|NCT02075398|Portable pulse oximeter|portable pulse oximeter
5322137|NCT02075372|Hybrid|hybrid
5322228|NCT02074956|BCG Vaccinated|bcg vaccinated
5322229|NCT02074956|HIV Negative|hiv negative
5322230|NCT02074943|Androgenetic Alopecia|androgenetic alopecia
5322232|NCT02074917|ACL|acl
5322434|NCT02074111|high-resolution MRI|high-resolution mri
5322532|NCT02073578|achalasia|achalasia
5322533|NCT02073578|POEM|poem
5322723|NCT02072629|Antibiotics|antibiotics
5322831|NCT02072161|Statin|statin
5322936|NCT02071498|Pillbox|pillbox
5322937|NCT02071498|Non-adherence|non-adherence
5323145|NCT02070575|PSA|psa
5323244|NCT02070042|Oxybutynin|oxybutynin
5323250|NCT02069977|Autism|autism
5323349|NCT02069470|Early cancer diagnosis|early cancer diagnosis
5323355|NCT02069392|cognition|cognition
5323522|NCT02068820|SLN|sln
5323551|NCT02068729|L2-S1|l2-s1
5323651|NCT02068196|Malignant Melanoma|malignant melanoma
5323652|NCT02068196|Ipilimumab|ipilimumab
5323653|NCT02068183|World Trade Center exposure|world trade center exposure
5323663|NCT02068131|Novaferon|novaferon
5323770|NCT02067598|Scapular exercises|scapular exercises
5323771|NCT02067572|oral health|oral health
5323772|NCT02067572|mouthwash|mouthwash
5323773|NCT02067572|salvia|salvia
5324085|NCT02066064|Colorectal Cancer|colorectal cancer
5324087|NCT02066064|Standard Colonoscopy|standard colonoscopy
5324088|NCT02066064|G-EYE(TM) Colonoscopy|g-eye(tm) colonoscopy
5324089|NCT02066038|chemotherapy|chemotherapy
5324090|NCT02066038|maintenance therapy|maintenance therapy
5324102|NCT02065986|HIV|hiv
5324181|NCT02065648|Syngo Native|syngo native
5324182|NCT02065648|Gadolinium|gadolinium
5324183|NCT02065648|Non contrast|non contrast
5324184|NCT02065622|Ulcerative Colitis|ulcerative colitis
5324185|NCT02065609|Trastuzumab|trastuzumab
5324186|NCT02065596|Sickle Cell Disease|sickle cell disease
5324187|NCT02065596|Sickle Cell Anemia|sickle cell anemia
5324188|NCT02065596|GvHD|gvhd
5324216|NCT02065492|T2*|t2*
5324276|NCT02065206|Clinical Research Careers|clinical research careers
5324277|NCT02065167|avascular necrosis of femoral head|avascular necrosis of femoral head
5324278|NCT02065167|cell therapy|cell therapy
5324279|NCT02065167|Mesenchymal stem cells|mesenchymal stem cells
5324280|NCT02065154|acute myeloid leukemia|acute myeloid leukemia
5324282|NCT02065154|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5324283|NCT02065154|ALL|all
5324284|NCT02065154|chronic myeloid leukemia|chronic myeloid leukemia
5324285|NCT02065154|CML|cml
5324286|NCT02065154|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5324287|NCT02065154|CLL|cll
5324288|NCT02065154|non-Hodgkin lymphoma|non-hodgkin lymphoma
5324289|NCT02065154|NHL|nhl
5324291|NCT02065154|HL|hl
5324574|NCT02064023|type 2 diabetes|type 2 diabetes
5324575|NCT02064023|pregnancy|pregnancy
5324576|NCT02063971|Skin aging|skin aging
5324577|NCT02063971|Soothing activity|soothing activity
5324578|NCT02063971|Hyaluronic acid injections|hyaluronic acid injections
5324854|NCT02062658|OCD|ocd
5324897|NCT02062437|Ceramic|ceramic
5325106|NCT02061553|TBI|tbi
5325222|NCT02061098|Cardiovascular|cardiovascular
5325482|NCT02059980|OCD|ocd
5325566|NCT02059577|carnitine|carnitine
5325567|NCT02059577|digestive enzymes|digestive enzymes
5325568|NCT02059577|gluten-free casein-free diet|gluten-free casein-free diet
5325569|NCT02059564|Diabetes Mellitus|diabetes mellitus
5325570|NCT02059564|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5325579|NCT02059538|Obesity|obesity
5325662|NCT02059096|Chronic neuropathic pain|chronic neuropathic pain
5325663|NCT02059096|Cortical excitability|cortical excitability
5325664|NCT02059083|adolescent|adolescent
5325774|NCT02058602|HRCT|hrct
5325869|NCT02058199|pharmacodynamics|pharmacodynamics
5326077|NCT02057172|blood sugar levels|blood sugar levels
5326170|NCT02056912|lipodystrophy|lipodystrophy
5326177|NCT02056873|tourette|tourette
5326370|NCT02055963|Surveys|surveys
5326480|NCT02055508|Physical Activity|physical activity
5326481|NCT02055508|Palliative Care|palliative care
5326482|NCT02055508|Lung Cancer|lung cancer
5326483|NCT02055508|NSCLC|nsclc
5326484|NCT02055495|Painful flatfeet|painful flatfeet
5326485|NCT02055495|Planovagus feet|planovagus feet
5326589|NCT02055118|hunter's disease treatment|hunter's disease treatment
5326592|NCT02055092|Young onset dementia|young onset dementia
5326593|NCT02055092|Quality of life|quality of life
5326791|NCT02054130|Asthma|asthma
5326878|NCT02053766|Dexmedetomidine (Precedex®)|dexmedetomidine (precedex®)
5326879|NCT02053766|Propofol|propofol
5326882|NCT02053727|Hepatitis B|hepatitis b
5326966|NCT02053311|orteronel|orteronel
5327081|NCT02052739|Refractory status epilepticus|refractory status epilepticus
5327180|NCT02052349|healthy volunteers|healthy volunteers
5327280|NCT02051998|Scanning laser ophthalmoscopy|scanning laser ophthalmoscopy
5327281|NCT02051985|Chronic heart failure|chronic heart failure
5327282|NCT02051985|Heart decompensation|heart decompensation
5327283|NCT02051985|Aerobic exercise training|aerobic exercise training
5327284|NCT02051985|Functional capacity|functional capacity
5327285|NCT02051985|Dyspnea|dyspnea
5327286|NCT02051985|Beta-adrenergic receptor signaling|beta-adrenergic receptor signaling
5327287|NCT02051959|Phantom Limb Pain|phantom limb pain
5327288|NCT02051959|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5327289|NCT02051959|Amputation|amputation
5327290|NCT02051959|Diabetes Mellitus|diabetes mellitus
5327291|NCT02051946|novel drug delivery technique for glaucoma patients|novel drug delivery technique for glaucoma patients
5327292|NCT02051933|pilon|pilon
5327293|NCT02051933|tibial plafond|tibial plafond
5327294|NCT02051933|botox|botox
5327295|NCT02051933|ankle dorsiflexion|ankle dorsiflexion
5327296|NCT02051933|ankle functionality|ankle functionality
5327297|NCT02051933|ankle range of motion|ankle range of motion
5327298|NCT02051920|Elastography|elastography
5327299|NCT02051894|Neonates|neonates
5327300|NCT02051894|Dobutamine|dobutamine
5327301|NCT02051894|Superior Vena Cana Flow|superior vena cana flow
5327305|NCT02051868|Anal cancer|anal cancer
5327356|NCT02051621|isthmus ablation|isthmus ablation
5327357|NCT02051621|recurrence|recurrence
5327359|NCT02051595|blood pump|blood pump
5327468|NCT02051088|Intermittent claudication|intermittent claudication
5327469|NCT02051088|endovascular treatment|endovascular treatment
5327471|NCT02051075|IVF|ivf
5327472|NCT02051075|ICSI|icsi
5327473|NCT02051075|Asthenospermia|asthenospermia
5327474|NCT02051075|pentoxyphylline|pentoxyphylline
5327475|NCT02051075|Spermatozoa|spermatozoa
5327476|NCT02051062|Pharmacokinetics|pharmacokinetics
5327478|NCT02051062|Pediatric|pediatric
5327559|NCT02050672|ART|art
5327658|NCT02050256|General practitioner|general practitioner
5327659|NCT02050256|Electronic decision support|electronic decision support
5327660|NCT02050243|pediatrics|pediatrics
5327661|NCT02050243|brain tumor|brain tumor
5327662|NCT02050243|CNS|cns
5327757|NCT02049853|diagnostics|diagnostics
5327973|NCT02048917|Cessation|cessation
5327974|NCT02048917|Bupropion|bupropion
5327975|NCT02048917|Varenicline|varenicline
5327976|NCT02048917|Nicotine|nicotine
5327977|NCT02048917|Counseling|counseling
5327978|NCT02048917|Tobacco|tobacco
5327983|NCT02048852|menthol|menthol
5328064|NCT02048332|Epstein-Barr Virus (EBV)|epstein-barr virus (ebv)
5328423|NCT02046967|quality of life|quality of life
5328661|NCT02046018|Rural Uganda|rural uganda
5328662|NCT02046005|Family History|family history
5328663|NCT02046005|RA|ra
5328664|NCT02046005|Rheumatoid Arthritis|rheumatoid arthritis
5328665|NCT02046005|Genetics|genetics
5328666|NCT02046005|Rheumatoid Factor|rheumatoid factor
5328667|NCT02046005|Shared Epitope|shared epitope
5328668|NCT02046005|Anti-CCP|anti-ccp
5328674|NCT02045940|FTIH|ftih
5328955|NCT02044731|Obesity|obesity
5328964|NCT02044705|Primary Health Care|primary health care
5328965|NCT02044705|Pediatrics|pediatrics
5328966|NCT02044705|Obesity|obesity
5328967|NCT02044705|Overweight|overweight
5328968|NCT02044705|Clinical trial|clinical trial
5328969|NCT02044705|Hispanic Americans|hispanic americans
5328970|NCT02044705|Family|family
5328971|NCT02044705|Body mass index|body mass index
5328972|NCT02044692|Hunter syndrome|hunter syndrome
5328974|NCT02044692|Hunterase|hunterase
5329074|NCT02044237|online therapy|online therapy
5329171|NCT02043691|Aortic|aortic
5329369|NCT02043093|Universal school-based prevention|universal school-based prevention
5329370|NCT02043080|Tuberculosis|tuberculosis
5329372|NCT02043080|Xpert MTB/RIF|xpert mtb/rif
5329373|NCT02043080|Determine TB-LAM|determine tb-lam
5329375|NCT02043080|Zambia|zambia
5329376|NCT02043080|Cost Effectiveness Analysis Curve|cost effectiveness analysis curve
5329377|NCT02043080|Centre for Infectious Disease Research in Zambia|centre for infectious disease research in zambia
5329378|NCT02043067|TB|tb
5329379|NCT02043067|HIV|hiv
5329380|NCT02043067|Extensively resistant TB|extensively resistant tb
5329387|NCT02043054|Obesity|obesity
5329469|NCT02042742|Humans|humans
5329582|NCT02042196|estrogen deficiency|estrogen deficiency
5329679|NCT02041871|Liver Surgery|liver surgery
5329680|NCT02041871|Hepatectomy|hepatectomy
5329681|NCT02041871|Immunonutrition|immunonutrition
5329682|NCT02041871|Cancer|cancer
5329683|NCT02041871|Morbidity|morbidity
5329684|NCT02041871|Postoperative complication|postoperative complication
5329685|NCT02041858|Alarms|alarms
5329686|NCT02041858|Physiologic Monitoring|physiologic monitoring
5329687|NCT02041858|Critical Care|critical care
5329688|NCT02041858|Alarm fatigue|alarm fatigue
5329694|NCT02041845|Thorax|thorax
5329875|NCT02040909|quality of intubation|quality of intubation
5329877|NCT02040909|pharmacodynamics|pharmacodynamics
5330096|NCT02039830|female|female
5330216|NCT02039375|Monitoring|monitoring
5330217|NCT02039349|Alcoholism|alcoholism
5330218|NCT02039349|Ghrelin|ghrelin
5330313|NCT02038894|Anesthetic|anesthetic
5330418|NCT02038413|NSCLC|nsclc
5330419|NCT02038413|cT1/cT2aN0M0|ct1/ct2an0m0
5330420|NCT02038413|Stereotactic lung treatment|stereotactic lung treatment
5330653|NCT02037386|Side branch stent|side branch stent
5330849|NCT02036541|Pseudoexfoliation Glaucoma|pseudoexfoliation glaucoma
5330850|NCT02036541|Pigmentary Glaucoma|pigmentary glaucoma
5330851|NCT02036528|Foot Ulcer|foot ulcer
5330852|NCT02036528|Diabetic Foot|diabetic foot
5330853|NCT02036528|Gentamicins|gentamicins
5330854|NCT02036528|infection|infection
5330855|NCT02036502|PD1|pd1
5330856|NCT02036502|PD-1|pd-1
5331136|NCT02035059|Cortisol|cortisol
5331251|NCT02034448|AKI|aki
5343010|NCT01981135|Air Pollution|air pollution
5331621|NCT02032966|malleolus|malleolus
5331747|NCT02032199|SF-36|sf-36
5331809|NCT02031991|Oncology|oncology
5331912|NCT02031302|Lotus|lotus
5332012|NCT02030756|constipation|constipation
5332107|NCT02030288|alcohol|alcohol
5332218|NCT02029989|Point of Care Testing|point of care testing
5332219|NCT02029989|Chronic Persistent Mental Illness|chronic persistent mental illness
5332220|NCT02029937|Squamous cell neoplasia|squamous cell neoplasia
5332221|NCT02029937|Proflavine|proflavine
5332222|NCT02029937|Lugol's chromoendoscopy|lugol's chromoendoscopy
5332223|NCT02029911|Menorrhagia|menorrhagia
5332224|NCT02029911|Excessive uterine bleeding|excessive uterine bleeding
5332225|NCT02029911|Endometrial Ablation|endometrial ablation
5332226|NCT02029898|cesarean section|cesarean section
5332227|NCT02029898|anesthesia|anesthesia
5332228|NCT02029898|children|children
5332229|NCT02029885|Hypertension|hypertension
5332230|NCT02029885|Renal Denervation|renal denervation
5332232|NCT02029872|colonization|colonization
5332233|NCT02029872|decolonization|decolonization
5332234|NCT02029859|pregnancy (after 30 weeks of amenorhea)|pregnancy (after 30 weeks of amenorhea)
5332235|NCT02029859|obesity (BMI>35)|obesity (bmi>35)
5332236|NCT02029859|sleep apnea syndrom|sleep apnea syndrom
5332409|NCT02029014|LAmbre|lambre
5332498|NCT02028585|low-fat milk|low-fat milk
5332595|NCT02028208|Patch Test|patch test
5332692|NCT02027857|traumatic brain injury;|traumatic brain injury;
5332693|NCT02027857|brain edema;|brain edema;
5332694|NCT02027857|intracranial pressure|intracranial pressure
5332695|NCT02027831|lymph nodes|lymph nodes
5332696|NCT02027818|margins|margins
5332697|NCT02027818|tumorectomy|tumorectomy
5332698|NCT02027805|Steroid-resistant|steroid-resistant
5332699|NCT02027805|Graft vs Host Disease|graft vs host disease
5332700|NCT02027805|Refractory acute Graft vs Host Disease|refractory acute graft vs host disease
5332701|NCT02027805|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5332702|NCT02027805|Stem Cell Transplantation|stem cell transplantation
5332703|NCT02027805|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5332783|NCT02027506|T WAVE|t wave
5332801|NCT02027454|HIV|hiv
5333024|NCT02026245|swelling|swelling
5333025|NCT02026245|measurement|measurement
5333231|NCT02025452|diarrhoea|diarrhoea
5333232|NCT02025452|gastroenteritis|gastroenteritis
5333233|NCT02025452|rapid diagnostics|rapid diagnostics
5333234|NCT02025452|probiotics|probiotics
5333235|NCT02025452|sub-Saharan Africa|sub-saharan africa
5333533|NCT02024191|glutamine|glutamine
5333236|NCT02025439|Traumatic Brain Injury|traumatic brain injury
5333238|NCT02025439|Amantadine|amantadine
5333420|NCT02024646|AMG 827|amg 827
5333554|NCT02024113|positron emission tomography|positron emission tomography
5333555|NCT02024061|Adolescents|adolescents
5333556|NCT02024061|Obesity|obesity
5333557|NCT02024061|Physical activity|physical activity
5333560|NCT02024048|Pregnancy|pregnancy
5333643|NCT02023658|HIV|hiv
5333644|NCT02023658|pMTCT|pmtct
5333645|NCT02023645|lutein|lutein
5333646|NCT02023645|cognition|cognition
5333647|NCT02023645|neural efficiency|neural efficiency
5333648|NCT02023645|aging|aging
5333649|NCT02023632|older adults|older adults
5333744|NCT02023112|Ombitasvir|ombitasvir
5333745|NCT02023112|Paritaprevir|paritaprevir
5333746|NCT02023112|Ritonavir|ritonavir
5333747|NCT02023112|Ribavirin|ribavirin
5333748|NCT02023112|VIEKIRAX Combination Tablets|viekirax combination tablets
5333749|NCT02023099|Hepatitis C|hepatitis c
5333750|NCT02023099|Genotype 1b|genotype 1b
5333751|NCT02023099|Cirrhotic|cirrhotic
5333752|NCT02023099|Treatment Experienced|treatment experienced
5333753|NCT02023099|Treatment Naive|treatment naive
5333754|NCT02023099|Japanese|japanese
5333755|NCT02023099|ombitasvir|ombitasvir
5333940|NCT02022176|Nitrite|nitrite
5334060|NCT02021604|HI|hi
5334261|NCT02020551|Scores During IUD insertion.|scores during iud insertion.
5334262|NCT02020538|Thoracic surgery|thoracic surgery
5334264|NCT02020538|acute kidney injury|acute kidney injury
5334265|NCT02020538|hyperchloremia|hyperchloremia
5334266|NCT02020538|intravenous fluid|intravenous fluid
5334267|NCT02020486|Healthy|healthy
5334268|NCT02020473|Informed consents|informed consents
5334269|NCT02020473|Withholding/withdrawing life support (WLS)|withholding/withdrawing life support (wls)
5334270|NCT02020473|Intensive care unit (ICU)|intensive care unit (icu)
5334271|NCT02020460|post-laminectomy pain syndrome,|post-laminectomy pain syndrome,
5334272|NCT02020460|refractory,|refractory,
5334589|NCT02018900|Immune response|immune response
5334590|NCT02018848|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5334591|NCT02018848|Attention Training|attention training
5334592|NCT02018848|Attention Bias Modification|attention bias modification
5334689|NCT02018497|Stress|stress
5334792|NCT02017990|Mortality|mortality
5678617|NCT00586066|Memantine|memantine
5335216|NCT02016170|platelet reactivity|platelet reactivity
5335438|NCT02015234|long term safety|long term safety
5335646|NCT02014506|Malignant disease|malignant disease
5335750|NCT02014181|enterolactone|enterolactone
5335946|NCT02013063|Dynamic contrast enhanced CT scan|dynamic contrast enhanced ct scan
5335947|NCT02013063|soft tissue solitary dominant|soft tissue solitary dominant
5335948|NCT02013063|≥ 8mm and ≤30mm|≥ 8mm and ≤30mm
5335949|NCT02013037|cardiac transplantation|cardiac transplantation
5335950|NCT02013037|immunosuppression|immunosuppression
5335951|NCT02013037|acute cellular rejection|acute cellular rejection
5335952|NCT02013037|antibody mediated rejection|antibody mediated rejection
5336031|NCT02012699|Pancreatic tumor|pancreatic tumor
5336429|NCT02010762|Crohn's disease|crohn's disease
5336430|NCT02010762|Vitamin D|vitamin d
5336522|NCT02010502|cyclists|cyclists
5336642|NCT02010021|RAD001|rad001
5336734|NCT02009618|IBS|ibs
5336929|NCT02008721|epigallocatechin gallate|epigallocatechin gallate
5337431|NCT02006628|Cannabinoids|cannabinoids
5337630|NCT02005731|Low Intensity Shockwave|low intensity shockwave
5337631|NCT02005731|Extracorporeal shockwave therapy|extracorporeal shockwave therapy
5337632|NCT02005731|Erectile dysfunction|erectile dysfunction
5337633|NCT02005692|pressure ulcers|pressure ulcers
5337634|NCT02005692|bed sores|bed sores
5337635|NCT02005692|patient turn protocol|patient turn protocol
5337824|NCT02004873|pacemaker|pacemaker
5337825|NCT02004873|leadless|leadless
5337826|NCT02004873|single chamber|single chamber
5337827|NCT02004860|local immunosuppressive|local immunosuppressive
5338028|NCT02003781|cardiovascular disease|cardiovascular disease
5338124|NCT02003352|Saccadometry|saccadometry
5338125|NCT02003313|safety, immunogenicity, Meningococcal Polysaccharide Vaccine|safety, immunogenicity, meningococcal polysaccharide vaccine
5338126|NCT02003300|Oxygen uptake|oxygen uptake
5338127|NCT02003300|Anesthetic gas uptake|anesthetic gas uptake
5338128|NCT02003287|Deglutition Disorders|deglutition disorders
5338217|NCT02002806|Pancreatic cancer|pancreatic cancer
5338651|NCT02000934|CLL|cll
5338746|NCT02000544|Extracorporeal Circulation|extracorporeal circulation
5338747|NCT02000544|Cardiopulmonary Bypass|cardiopulmonary bypass
5338748|NCT02000544|Cardiac surgery|cardiac surgery
5338749|NCT02000531|Non-small-cell lung cancer (NSCLC)|non-small-cell lung cancer (nsclc)
5338750|NCT02000518|emergency radiotherapy|emergency radiotherapy
5338751|NCT02000518|MSCC|mscc
5338752|NCT02000518|spine|spine
5338753|NCT02000518|neurological outcome|neurological outcome
5338754|NCT02000466|Women|women
5338929|NCT01999777|seizure clusters|seizure clusters
5338930|NCT01999777|acute repetitive seizures|acute repetitive seizures
5338931|NCT01999777|rescue treatment|rescue treatment
5338932|NCT01999751|Magnetic Resonance Imaging|magnetic resonance imaging
5339029|NCT01999205|physical activity|physical activity
5339330|NCT01997905|Left Atrial Appendage|left atrial appendage
5339331|NCT01997905|LAA|laa
5339332|NCT01997905|Atrial Fibrillation|atrial fibrillation
5339333|NCT01997905|AFib|afib
5339334|NCT01997905|AF|af
5339436|NCT01997554|TSH Testing|tsh testing
5339439|NCT01997515|Pain|pain
5339545|NCT01997060|Body weight|body weight
5339637|NCT01996566|non-esterified fatty acids|non-esterified fatty acids
5339638|NCT01996566|threshold|threshold
5339729|NCT01996306|Fluorouracil|fluorouracil
5339865|NCT01995747|IgE|ige
5340044|NCT01994941|Platelet Reactivity|platelet reactivity
5340238|NCT01993953|Body composition|body composition
5340250|NCT01993849|ADHD|adhd
5340335|NCT01993355|cognitive-behavioral therapy,|cognitive-behavioral therapy,
5340435|NCT01992809|omega 3|omega 3
5340635|NCT01991795|Outcome|outcome
5340729|NCT01991301|proteosmoe inhibitor|proteosmoe inhibitor
5340730|NCT01991301|carfilzumib|carfilzumib
5340828|NCT01990872|Vitamin D3|vitamin d3
5340946|NCT01990313|DBS|dbs
5341123|NCT01989273|Shock|shock
5341342|NCT01988441|children|children
5341344|NCT01988428|sepsis|sepsis
5341449|NCT01988038|Disease Progression|disease progression
5341450|NCT01987986|cellulite|cellulite
5341452|NCT01987986|orange peel|orange peel
5341453|NCT01987986|cottage cheese|cottage cheese
5341882|NCT01985763|FOLFOX|folfox
5341978|NCT01985464|stem cells|stem cells
5341979|NCT01985451|Lymphoma|lymphoma
5341980|NCT01985438|Head and Neck Neoplasms|head and neck neoplasms
5341981|NCT01985438|Nutritional Support|nutritional support
5341982|NCT01985438|Randomized Controlled Trial|randomized controlled trial
5341984|NCT01985438|Nasogastric tube|nasogastric tube
5342280|NCT01984034|Academic detailing|academic detailing
5342390|NCT01983735|Stage 2 Hypertension|stage 2 hypertension
5342391|NCT01983735|S-Amlodipine|s-amlodipine
5342392|NCT01983735|Telmisartan|telmisartan
5342394|NCT01983696|embryo quality|embryo quality
5342490|NCT01983306|Constipation|constipation
5342491|NCT01983306|Opioid|opioid
5342617|NCT01982760|Edema|edema
5342709|NCT01982279|Preschool children|preschool children
5343029|NCT01981070|empowerment|empowerment
5343031|NCT01981070|parental stress|parental stress
5343131|NCT01980420|Oesogastric junction - GEJ|oesogastric junction - gej
5343132|NCT01980420|Dynamic MRI Imaging|dynamic mri imaging
5343647|NCT01977937|Analgesics, Nonopioid|analgesics, nonopioid
5343648|NCT01977924|sleep apnea|sleep apnea
5343649|NCT01977924|polyphenols|polyphenols
5343846|NCT01977196|Infants|infants
5343944|NCT01976871|Willis-Ekbom Disease|willis-ekbom disease
5343945|NCT01976871|Rotigotine|rotigotine
5344265|NCT01975454|Teng-Long-Bu-Zhong-Tang|teng-long-bu-zhong-tang
5344567|NCT01973764|Ventricular System|ventricular system
5344568|NCT01973764|Puncture|puncture
5344569|NCT01973764|Ventricular catheter|ventricular catheter
5344764|NCT01973101|Chemo-induction|chemo-induction
5344870|NCT01972503|Liver|liver
5344972|NCT01972022|Drug Eluting Stents|drug eluting stents
5345083|NCT01971645|Adjuvant|adjuvant
5345302|NCT01970592|rehabilitation|rehabilitation
5345410|NCT01970124|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5345411|NCT01970124|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5345412|NCT01970124|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
5345413|NCT01970111|Spinocerebellar degeneration (SCD)|spinocerebellar degeneration (scd)
5345414|NCT01970111|Thyrotropin-Releasing Hormone (TRH)|thyrotropin-releasing hormone (trh)
5345415|NCT01970111|Spinocerebellar Ataxia (SCA)|spinocerebellar ataxia (sca)
5345416|NCT01970111|Cortical Cerebellar Atrophy (CCA)|cortical cerebellar atrophy (cca)
5345505|NCT01969695|ABT-199|abt-199
5345615|NCT01969305|Multi-media intervention|multi-media intervention
5345616|NCT01969305|Drug use|drug use
5345617|NCT01969292|colonoscopy|colonoscopy
5345618|NCT01969292|quality assurance|quality assurance
5345619|NCT01969279|Osteoporosis|osteoporosis
5345620|NCT01969279|Bisphosphonate|bisphosphonate
5345621|NCT01969279|Atypical femoral fracture|atypical femoral fracture
5345751|NCT01968668|Japanese patients|japanese patients
5345628|NCT01969253|Breast Cancer, Axillary Lymph Node Dissection, Lymphedema|breast cancer, axillary lymph node dissection, lymphedema
5345629|NCT01969240|Chest Pain|chest pain
5345630|NCT01969240|Decision Aid|decision aid
5345631|NCT01969240|Acute Coronary Syndrome|acute coronary syndrome
5345633|NCT01969240|Emergency Department|emergency department
5345634|NCT01969240|Cardiac Testing|cardiac testing
5345635|NCT01969240|Healthcare Utilization|healthcare utilization
5345643|NCT01969227|Extubation|extubation
5345695|NCT01968954|high risk of cardiovascular events|high risk of cardiovascular events
5345696|NCT01968941|stereotactic body radiotherapy|stereotactic body radiotherapy
5345699|NCT01968941|local control|local control
5346334|NCT01966367|CD34+ selection|cd34+ selection
5346520|NCT01965457|obstructive sleep apnea|obstructive sleep apnea
5346521|NCT01965457|pediatric|pediatric
5346522|NCT01965457|adenoid hypertrophy|adenoid hypertrophy
5346523|NCT01965444|Sub-epidermal moisture|sub-epidermal moisture
5346524|NCT01965444|Pressure Ulcers|pressure ulcers
5346526|NCT01965405|AIDS|aids
5346617|NCT01965028|tRNS|trns
5346834|NCT01964131|Japanese|japanese
5346936|NCT01963715|Squamous cell carcinoma|squamous cell carcinoma
5350972|NCT01944410|PRP|prp
5347148|NCT01962675|tDCS|tdcs
5347321|NCT01962246|Preoperative Concurrent Chemoradiotherapy|preoperative concurrent chemoradiotherapy
5347322|NCT01962246|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5347323|NCT01962220|HIV/AIDS|hiv/aids
5347325|NCT01962220|Pregnant Women|pregnant women
5347326|NCT01962220|Kenya|kenya
5347327|NCT01962220|Maternal Health|maternal health
5347328|NCT01962207|10 years Meningitec|10 years meningitec
5347330|NCT01962207|booster response|booster response
5347411|NCT01961882|Antigen specific cancer immunotherapeutic|antigen specific cancer immunotherapeutic
5347412|NCT01961869|black raspberry|black raspberry
5347413|NCT01961869|chemoprevention|chemoprevention
5347414|NCT01961869|oral delivery|oral delivery
5347415|NCT01961856|platelet reactivity|platelet reactivity
5347416|NCT01961856|ticagrelor loading dose|ticagrelor loading dose
5347417|NCT01961856|clopidogrel loading dose|clopidogrel loading dose
5347515|NCT01961271|chronic pain|chronic pain
5347742|NCT01960244|FH|fh
5347833|NCT01959763|ICT intervention|ict intervention
5348130|NCT01958125|non invasive|non invasive
5348131|NCT01958125|gammacore|gammacore
5348132|NCT01958112|Cervical Cancer|cervical cancer
5348133|NCT01958112|Cervical|cervical
5348134|NCT01958112|Cervix|cervix
5348135|NCT01958099|Injury Prevention|injury prevention
5348435|NCT01956552|Metastatic breast cancer|metastatic breast cancer
5348633|NCT01955408|bladder cancer|bladder cancer
5348920|NCT01954264|Burden of Disease Study|burden of disease study
5348921|NCT01954251|FLU-D-QIV|flu-d-qiv
5348922|NCT01954251|Adults|adults
5348923|NCT01954251|Safety|safety
5348924|NCT01954251|Immunogenicity|immunogenicity
5348925|NCT01954251|co-administration|co-administration
5348926|NCT01954251|Herpes zoster|herpes zoster
5348927|NCT01954238|Anti-coagulant|anti-coagulant
5348928|NCT01954238|Coagulation factor Xa inhibitor|coagulation factor xa inhibitor
5348929|NCT01954225|Fistula in ano|fistula in ano
5348930|NCT01954225|Bhagandara|bhagandara
5348931|NCT01954225|Udumbara sutra|udumbara sutra
5348932|NCT01954212|Oral health|oral health
5348933|NCT01954199|Sciatica|sciatica
5348934|NCT01954199|Nerve pain|nerve pain
5349008|NCT01953874|chronic heart failure|chronic heart failure
5349009|NCT01953874|left-sided heart failure|left-sided heart failure
5349010|NCT01953874|heart failure decompensation|heart failure decompensation
5349011|NCT01953874|sleep apnea|sleep apnea
5349012|NCT01953874|sleep disordered breathing|sleep disordered breathing
5349013|NCT01953874|central sleep apnea|central sleep apnea
5349014|NCT01953874|obstructive sleep apnea|obstructive sleep apnea
5349015|NCT01953874|cheyne-stokes respiration|cheyne-stokes respiration
5349016|NCT01953861|Phase I|phase i
5349017|NCT01953861|Combination tablet EC905|combination tablet ec905
5349018|NCT01953861|Omnic OCAS®|omnic ocas®
5349019|NCT01953861|Vesicare®|vesicare®
5349020|NCT01953861|Food effect|food effect
5349021|NCT01953861|Vesomni|vesomni
5349022|NCT01953861|VesiFlow|vesiflow
5349023|NCT01953861|Urizia|urizia
5349024|NCT01953848|Phase I|phase i
5349025|NCT01953848|Combination tablet EC905|combination tablet ec905
5349026|NCT01953848|Steady-state|steady-state
5349248|NCT01952756|vasculogenesis|vasculogenesis
5349249|NCT01952756|angiogenesis|angiogenesis
5349251|NCT01952756|biomarkers|biomarkers
5349359|NCT01952093|Mother-child interaction|mother-child interaction
5349360|NCT01952093|Neurodevelopment|neurodevelopment
5349376|NCT01952054|AMG 162|amg 162
5349467|NCT01951677|vaccine|vaccine
5349468|NCT01951677|adjuvant|adjuvant
5349469|NCT01951677|prophylaxis|prophylaxis
5353351|NCT01933503|MAD|mad
5349472|NCT01951638|Heart Failure with Preserved Ejection Fraction|heart failure with preserved ejection fraction
5349473|NCT01951625|Worsening Heart Failure|worsening heart failure
5349474|NCT01951625|Heart Failure with Reduced Ejection Fraction|heart failure with reduced ejection fraction
5349475|NCT01951612|cognitive impairment|cognitive impairment
5349559|NCT01951222|Asthma, COPD, broncodilator, airway, lung, inhalation, antimuscarinic|asthma, copd, broncodilator, airway, lung, inhalation, antimuscarinic
5349561|NCT01951209|Hepatitis C|hepatitis c
5349562|NCT01951209|Cirrhosis|cirrhosis
5349563|NCT01951209|B-cell|b-cell
5349660|NCT01950585|CD34 + Cells|cd34 + cells
5349764|NCT01950143|global gene expression|global gene expression
5349766|NCT01950130|IABP|iabp
5350175|NCT01948193|Diphtheria|diphtheria
5350273|NCT01947803|Safety|safety
5350660|NCT01946022|GnRH agonist and antagonist|gnrh agonist and antagonist
5350760|NCT01945515|robotic rehabilitation|robotic rehabilitation
5350858|NCT01945021|Xalkori|xalkori
5350953|NCT01944475|Premature thelarche|premature thelarche
5350954|NCT01944475|Tanner-stage|tanner-stage
5350955|NCT01944475|GnRH-test|gnrh-test
5350956|NCT01944462|pneumococcal vaccine|pneumococcal vaccine
5351165|NCT01943604|Neuropsychology|neuropsychology
5351365|NCT01942746|blueberry|blueberry
5351659|NCT01941329|Proliferative Retinopathy|proliferative retinopathy
5351660|NCT01941329|Ranibizumab|ranibizumab
5351681|NCT01941290|STEMI|stemi
5351753|NCT01940978|ADHD|adhd
5351852|NCT01940367|Overactive Bladder|overactive bladder
5351853|NCT01940367|TENS|tens
5351854|NCT01940367|PTNS|ptns
5618031|NCT00825630|HP|hp
5351855|NCT01940367|Electrical Nerve Stimulation|electrical nerve stimulation
5351856|NCT01940367|Urge Urinary Incontinence|urge urinary incontinence
5351857|NCT01940354|IV Catheter comparison|iv catheter comparison
5351858|NCT01940354|AccuCath versus Conventional IV Catheters|accucath versus conventional iv catheters
5351859|NCT01940354|IV Catheter Study|iv catheter study
5351860|NCT01940354|IV Catheter User Preference Comparison|iv catheter user preference comparison
5351861|NCT01940354|First Attempt Success Rate for IV Catheters|first attempt success rate for iv catheters
5351862|NCT01940354|AccuCath Device Performance|accucath device performance
5351863|NCT01940354|Patient Satisfaction with IV Catheters|patient satisfaction with iv catheters
5351865|NCT01940341|Hepatitis|hepatitis
5351867|NCT01940341|Viread|viread
5352376|NCT01938196|Chronic Constipation|chronic constipation
5352377|NCT01938196|Constipation|constipation
5352378|NCT01938196|Functional gastrointestinal disorders|functional gastrointestinal disorders
5352379|NCT01938183|chronic periodontitis|chronic periodontitis
5352576|NCT01937182|Platelet|platelet
5352783|NCT01936064|Breast Cancer|breast cancer
5353077|NCT01934660|Inflammation|inflammation
5353175|NCT01934153|GSK573719|gsk573719
5353176|NCT01934153|axilla|axilla
5353177|NCT01934153|Umeclidinium|umeclidinium
5353178|NCT01934140|Healthy|healthy
5353179|NCT01934140|Adults|adults
5353180|NCT01934140|Safety|safety
5353181|NCT01934140|Neisseria meningitidis|neisseria meningitidis
5353184|NCT01934140|Adolescents|adolescents
5353280|NCT01933737|elderly;|elderly;
5353281|NCT01933737|proprioception;|proprioception;
5353282|NCT01933737|prevention;|prevention;
5353382|NCT01933399|Lumbosacral orthoses|lumbosacral orthoses
5353383|NCT01933399|Low back pain treatment|low back pain treatment
5353480|NCT01932905|neuropathic pain|neuropathic pain
5353577|NCT01932333|Healthy|healthy
5353578|NCT01932333|Safety|safety
5353667|NCT01932008|Coronary artery bypass grafting|coronary artery bypass grafting
5353668|NCT01932008|Chronic kidney disease|chronic kidney disease
5353669|NCT01932008|Body composition|body composition
5353670|NCT01932008|Physical activity|physical activity
5353671|NCT01932008|Physical function|physical function
5353672|NCT01931982|diabetes, GLP-1, Victoza, CFR, microvascular dysfunction|diabetes, glp-1, victoza, cfr, microvascular dysfunction
5353691|NCT01931956|EVEREST|everest
5353869|NCT01931280|Gestational diabetes|gestational diabetes
5353963|NCT01930773|peri-procedural MI|peri-procedural mi
5354072|NCT01930344|OCHRA|ochra
5354366|NCT01928706|OHIP EDENT|ohip edent
5354469|NCT01928238|NAVA|nava
5354571|NCT01927744|SCCHN|scchn
5354721|NCT01927159|TB|tb
5354770|NCT01926860|Prevenar13|prevenar13
5354869|NCT01926444|analgesia|analgesia
5354968|NCT01925950|marrow transplant|marrow transplant
5354969|NCT01925950|SCT|sct
5354970|NCT01925950|beclomethasone 17,21-dipropionate|beclomethasone 17,21-dipropionate
5354971|NCT01925937|Coenzyme Q10|coenzyme q10
5354972|NCT01925937|Atorvastatin|atorvastatin
5354973|NCT01925937|clinical trial|clinical trial
5354974|NCT01925937|congestive heart failure|congestive heart failure
5354981|NCT01925911|DDI|ddi
5355180|NCT01925027|Nano+ DES|nano+ des
5355181|NCT01925027|OCT|oct
5355316|NCT01924546|cognition|cognition
5355426|NCT01924039|Psychosis|psychosis
5355830|NCT01922219|fMRI|fmri
5355929|NCT01921530|Lumbar|lumbar
5356032|NCT01921062|Motor imagery|motor imagery
5356033|NCT01921062|Immobilisation|immobilisation
5356034|NCT01921062|Effectivity|effectivity
5356035|NCT01921023|Blood Gas analysis|blood gas analysis
5356036|NCT01920997|Healthy|healthy
5356037|NCT01920997|normal menstrual cycles|normal menstrual cycles
5356060|NCT01920867|MSC|msc
5356126|NCT01920698|Heart failure|heart failure
5356325|NCT01920009|adherence|adherence
5356433|NCT01919645|Sleep Disorders|sleep disorders
5356550|NCT01919099|Post-Transplant Virus|post-transplant virus
5356551|NCT01919086|Bortezomib|bortezomib
5356552|NCT01919086|Dexamethasone|dexamethasone
5356553|NCT01919086|Lenalidomide|lenalidomide
5356554|NCT01919086|13-064|13-064
5356556|NCT01919047|overactive bladder|overactive bladder
5356557|NCT01919047|mirabegron|mirabegron
5423310|NCT01616251|Meat|meat
5356645|NCT01918605|spacer|spacer
5356953|NCT01917344|Neurological functioning|neurological functioning
5357047|NCT01916967|Histamine Agents|histamine agents
5357368|NCT01915381|App|app
5357646|NCT01914133|Acarbose|acarbose
5357647|NCT01914133|PPH (Post Prandial Hypotension)|pph (post prandial hypotension)
5357648|NCT01914133|Falls|falls
5357742|NCT01913535|Antidepressant|antidepressant
5357844|NCT01912950|hair removal|hair removal
5357845|NCT01912950|epilation|epilation
5357857|NCT01912846|RCT|rct
5357949|NCT01912352|ADHD|adhd
5358061|NCT01911832|Quality of life|quality of life
5358267|NCT01910805|diabetes risk|diabetes risk
5358268|NCT01910805|diabetes risk awareness|diabetes risk awareness
5358403|NCT01910129|VNS|vns
5358561|NCT01909453|vemurafenib|vemurafenib
5358755|NCT01908543|Nosebleeds|nosebleeds
5358848|NCT01908075|Real-world|real-world
5359077|NCT01906775|ICD|icd
5359164|NCT01906372|polymyositis|polymyositis
5359277|NCT01905670|cardiac pacing|cardiac pacing
5359278|NCT01905670|electrical stimulation|electrical stimulation
5359279|NCT01905670|bi-ventricular pacing|bi-ventricular pacing
5359280|NCT01905657|PD1|pd1
5359281|NCT01905657|PD-1|pd-1
5359282|NCT01905657|PDL1|pdl1
5359283|NCT01905657|PD-L1|pd-l1
5359284|NCT01905644|Vaginal delivery|vaginal delivery
5359285|NCT01905644|Perineal lesions|perineal lesions
5359286|NCT01905644|Anal sphincter rupture|anal sphincter rupture
5359287|NCT01905644|Ultrasound|ultrasound
5359362|NCT01905228|Metastatic Advance Solid Neoplasms|metastatic advance solid neoplasms
5359363|NCT01905228|Unresectable Advance Solid Neoplasms|unresectable advance solid neoplasms
5359364|NCT01905215|Immunogenicity|immunogenicity
5359365|NCT01905215|Respiratory Syncytial Virus|respiratory syncytial virus
5359366|NCT01905215|Reactogenicity|reactogenicity
5359367|NCT01905215|Vaccination|vaccination
5359369|NCT01905202|Proton Pump Inhibitor|proton pump inhibitor
5359371|NCT01905202|Tolerability|tolerability
5359372|NCT01905202|pH control|ph control
5359447|NCT01904851|Angioplasty|angioplasty
5359448|NCT01904851|Endovascular Procedures|endovascular procedures
5359449|NCT01904786|Hypoxic Ischemic Encephalopathy|hypoxic ischemic encephalopathy
5359450|NCT01904786|Newborn|newborn
5359451|NCT01904786|Outcomes|outcomes
5359452|NCT01904786|Melatonin|melatonin
5359453|NCT01904773|Combined Multiple Motor and Vocal Tic Disorder; Tourette Disorder; Gilles de la Tourette Syndrome; Tourette Disease|combined multiple motor and vocal tic disorder; tourette disorder; gilles de la tourette syndrome; tourette disease
5359454|NCT01904760|agitation|agitation
5359539|NCT01904461|tonsillectomy|tonsillectomy
5359540|NCT01904461|children|children
5359541|NCT01904461|vacuum|vacuum
5359542|NCT01904461|medical device|medical device
5359543|NCT01904461|pain|pain
5359544|NCT01904461|hemorrhage|hemorrhage
5359545|NCT01904461|post-surgical complications|post-surgical complications
5359626|NCT01904006|embryo density|embryo density
5359627|NCT01904006|low oxygen|low oxygen
5359711|NCT01903785|cycling|cycling
5359922|NCT01902693|HAART|haart
5359923|NCT01902693|Malignancy|malignancy
5360025|NCT01902134|Postoperative pain|postoperative pain
5356007|NCT01921205|UCB|ucb
5360230|NCT01901302|Opioid|opioid
5360335|NCT01900873|COPD|copd
5360443|NCT01900327|neoadjuvant treatment|neoadjuvant treatment
5360550|NCT01899846|17P|17p
5360659|NCT01899417|economics|economics
5360660|NCT01899404|Cervical Cancer|cervical cancer
5360661|NCT01899404|PET Scan for cervix|pet scan for cervix
5360662|NCT01899404|MRI for cervix|mri for cervix
5360663|NCT01899391|Prostate cancer|prostate cancer
5360664|NCT01899378|probiotics|probiotics
5360665|NCT01899365|anti-pneumococcal vaccination|anti-pneumococcal vaccination
5360666|NCT01899365|information|information
5360667|NCT01899365|emergency department|emergency department
5360673|NCT01899313|texting|texting
5360847|NCT01898351|Macronutrients metabolism|macronutrients metabolism
5360848|NCT01898351|Health effects of plant proteins vs. meat proteins|health effects of plant proteins vs. meat proteins
5360849|NCT01898351|Partial meat proteins replacement with plant proteins|partial meat proteins replacement with plant proteins
5360960|NCT01897766|SGA|sga
5361246|NCT01896128|armodafinil|armodafinil
5361263|NCT01896037|HDL-c|hdl-c
5361343|NCT01895712|Multicenter|multicenter
5361344|NCT01895712|Observational registry|observational registry
5361346|NCT01895712|Stenting|stenting
5361578|NCT01894789|myocardial blood flow|myocardial blood flow
5361579|NCT01894789|myocardial perfusion imaging|myocardial perfusion imaging
5361580|NCT01894789|myocardial blood flow reserve|myocardial blood flow reserve
5362002|NCT01892917|Multicenter|multicenter
5362110|NCT01892592|Cardiovascular Disease|cardiovascular disease
5362111|NCT01892579|Agitation|agitation
5362113|NCT01892579|Alzheimer's Disease|alzheimer's disease
5362114|NCT01892579|Neuropsychiatric Behaviors|neuropsychiatric behaviors
5362116|NCT01892566|mobile health|mobile health
5362117|NCT01892566|spirometry|spirometry
5362303|NCT01891734|Psychotherapy|psychotherapy
5362304|NCT01891721|cognitive training|cognitive training
5362305|NCT01891721|schizophrenia|schizophrenia
5362306|NCT01891721|mismatch negativity|mismatch negativity
5362307|NCT01891721|cognition|cognition
5362308|NCT01891721|functional capacity|functional capacity
5362392|NCT01891409|Shang Ring|shang ring
5362495|NCT01891045|OQ-45.2|oq-45.2
5362579|NCT01890746|sAML/MDS|saml/mds
5362768|NCT01889862|Pegvaliase|pegvaliase
5362874|NCT01889381|Facial Deformity|facial deformity
5362882|NCT01889355|glucose|glucose
5362983|NCT01888939|Child|child
5363287|NCT01887405|Jext|jext
5363484|NCT01886443|Liver|liver
5363815|NCT01884805|Wavefront aberrometer|wavefront aberrometer
5364024|NCT01883921|PI|pi
5364122|NCT01883609|Plasmodium Falciparum|plasmodium falciparum
5364123|NCT01883609|Malaria|malaria
5364124|NCT01883609|Vaccine|vaccine
5364125|NCT01883609|Plasmodium|plasmodium
5364126|NCT01883609|Falciparum|falciparum
5364127|NCT01883583|Ultrasound|ultrasound
5364128|NCT01883583|Perfusion Imaging|perfusion imaging
5364129|NCT01883583|Elasticity Imaging Techniques|elasticity imaging techniques
5364130|NCT01883583|Kidney Transplantation|kidney transplantation
5364131|NCT01883583|Graft Rejection|graft rejection
5364132|NCT01883583|Chronic allograft nephropathy|chronic allograft nephropathy
5364215|NCT01883297|Low-Dose Interleukin-2|low-dose interleukin-2
5364216|NCT01883297|Autologous dendritic cells|autologous dendritic cells
5364217|NCT01883297|Anti-CD3 monoclonal antibody|anti-cd3 monoclonal antibody
5364407|NCT01882374|Mucositis|mucositis
5364510|NCT01881984|ACADM deficiency|acadm deficiency
5364511|NCT01881984|MCADH deficiency|mcadh deficiency
5364512|NCT01881984|985A>G mutation|985a>g mutation
5364514|NCT01881984|Ravicti|ravicti
5364914|NCT01880385|bevacizumab|bevacizumab
5365128|NCT01879514|Therapy of Chinese medicine|therapy of chinese medicine
5365129|NCT01879501|Low vision|low vision
5365130|NCT01879501|Self management|self management
5365226|NCT01879059|endothelial function|endothelial function
5365400|NCT01878435|mHealth|mhealth
5365401|NCT01878409|Sexuality|sexuality
5365561|NCT01877551|HIV|hiv
5365610|NCT01877356|ambulatory surgery|ambulatory surgery
5369357|NCT01860261|HIV|hiv
5365704|NCT01876940|children|children
5365802|NCT01876524|Bipolar disorder|bipolar disorder
5365803|NCT01876524|Personality disorder|personality disorder
5365804|NCT01876511|microsatellite unstable (MSI)|microsatellite unstable (msi)
5365805|NCT01876511|microsatellite stable (MSS)|microsatellite stable (mss)
5365806|NCT01876511|MLH 1|mlh 1
5365807|NCT01876511|MSH 2|msh 2
5365808|NCT01876511|MSH 6|msh 6
5365809|NCT01876511|PMS2|pms2
5365810|NCT01876485|Diabetes Mellitus|diabetes mellitus
5365811|NCT01876485|health literacy|health literacy
5365812|NCT01876485|patient activation|patient activation
5365813|NCT01876485|goals of care|goals of care
5365814|NCT01876394|Healthy|healthy
5423317|NCT01616212|Teens|teens
5365816|NCT01876394|Blood Pressure|blood pressure
5365817|NCT01876394|Blood Glucose|blood glucose
5365818|NCT01876394|Vascular Function|vascular function
5365819|NCT01876368|hypertension,|hypertension,
5365820|NCT01876368|LCZ696,|lcz696,
5365821|NCT01876368|olmesartan|olmesartan
5365822|NCT01876355|Delirium, clonidine, ICU, sedation|delirium, clonidine, icu, sedation
5365823|NCT01876342|sports hernia|sports hernia
5365824|NCT01876342|sportsman's hernia|sportsman's hernia
5365825|NCT01876342|chronic groin pain|chronic groin pain
5365826|NCT01876342|open minimal repair|open minimal repair
5365827|NCT01876342|totally extraperitoneal endoscopic technique|totally extraperitoneal endoscopic technique
5365828|NCT01876329|Rheumatoid Arthritis|rheumatoid arthritis
5365829|NCT01876329|Vitamin B12 deficiency|vitamin b12 deficiency
5365830|NCT01876329|Autoimmune Thyroid Disease|autoimmune thyroid disease
5365831|NCT01876329|Autoantibodies|autoantibodies
5365832|NCT01876316|Moxifloxacin|moxifloxacin
5365833|NCT01876316|QT interval prolongation|qt interval prolongation
5365834|NCT01876316|Korean|korean
5365835|NCT01876316|Japanese|japanese
5365836|NCT01876290|Anesthesiology|anesthesiology
5365837|NCT01876290|Complications|complications
5365838|NCT01876290|Closed-loop|closed-loop
5365839|NCT01876277|Cancer|cancer
5365866|NCT01876186|nerve growth factor|nerve growth factor
5365867|NCT01876173|Sudden cardiac death|sudden cardiac death
5365868|NCT01876173|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5365869|NCT01876173|decision aid|decision aid
5365870|NCT01876147|Low vision|low vision
5366212|NCT01874821|ROM|rom
5366278|NCT01874548|Autophagy|autophagy
5366480|NCT01873521|Neurally Adjusted Ventilatory Assist|neurally adjusted ventilatory assist
5366481|NCT01873521|Patient/ventilator Asynchrony|patient/ventilator asynchrony
5366482|NCT01873521|Pediatric patient|pediatric patient
5366574|NCT01873092|Physical Activity|physical activity
5366672|NCT01872702|Chemotherapy|chemotherapy
5366888|NCT01871675|Bendamustine|bendamustine
5366889|NCT01871675|Hematologic Malignancy|hematologic malignancy
5366890|NCT01871675|Relapsed|relapsed
5366891|NCT01871675|Refractory|refractory
5367088|NCT01870622|Infant,|infant,
5367183|NCT01870180|EyeBag|eyebag
5367274|NCT01869634|systemic immune activation|systemic immune activation
5367275|NCT01869608|postpartum screening|postpartum screening
5367276|NCT01869608|type 2 diabetes|type 2 diabetes
5367277|NCT01869595|2000 MSM and TG sites in Bangkok,Lampang,Ubonratchathani|2000 msm and tg sites in bangkok,lampang,ubonratchathani
5367278|NCT01869582|Fetal hypoxia|fetal hypoxia
5367279|NCT01869582|Birth asphyxia|birth asphyxia
5367363|NCT01869270|hexosaminidase A activity|hexosaminidase a activity
5367364|NCT01869270|GM2-ganglioside|gm2-ganglioside
5367365|NCT01869270|gangliosidoses|gangliosidoses
5367470|NCT01868841|SPECT|spect
5367575|NCT01868334|PPSV|ppsv
5367683|NCT01867801|Ischemia|ischemia
5367685|NCT01867775|Sleep disorders|sleep disorders
5367811|NCT01867255|venlafaxine|venlafaxine
5368104|NCT01865734|Physical Therapy|physical therapy
5368105|NCT01865734|Podiatry|podiatry
5368106|NCT01865734|Musculoskeletal Manipulations|musculoskeletal manipulations
5368107|NCT01865734|Exercise Therapy|exercise therapy
5368108|NCT01865721|Bowel cancer screening|bowel cancer screening
5368109|NCT01865721|Analgesia|analgesia
5368110|NCT01865721|Entonox|entonox
5368111|NCT01865721|Pain|pain
5368303|NCT01864772|Recurrent|recurrent
5368304|NCT01864772|Elderly|elderly
5368305|NCT01864772|Geriatry|geriatry
5649615|NCT00703560|HCV|hcv
5368306|NCT01864759|melanoma|melanoma
5368307|NCT01864759|oncolytic|oncolytic
5368308|NCT01864759|adenovirus|adenovirus
5368309|NCT01864759|virotherapy|virotherapy
5368310|NCT01864759|locally advanced|locally advanced
5368311|NCT01864759|metastatic|metastatic
5368312|NCT01864733|Chronic heart failure|chronic heart failure
5368313|NCT01864733|Undernutrition|undernutrition
5368314|NCT01864733|Rehabilitation|rehabilitation
5368401|NCT01864395|IV fluids|iv fluids
5368402|NCT01864395|blood pressure|blood pressure
5368404|NCT01864395|hemofilter|hemofilter
5368499|NCT01864070|Neuroendocrine tumors|neuroendocrine tumors
5368589|NCT01863745|nilotinib|nilotinib
5368687|NCT01863303|colorectal cancer|colorectal cancer
5368794|NCT01862809|Tobacco- Related Cancer|tobacco- related cancer
5368795|NCT01862796|Food Intake|food intake
5368796|NCT01862796|Weight Loss|weight loss
5368797|NCT01862796|Compliance|compliance
5368798|NCT01862783|Erythrocytes|erythrocytes
5368904|NCT01862315|13-066|13-066
5369007|NCT01861938|failed|failed
5369186|NCT01860937|13-052|13-052
5369300|NCT01860456|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5369301|NCT01860456|Pharmacokinetics|pharmacokinetics
5369302|NCT01860456|ATP-Binding Cassette Transporters|atp-binding cassette transporters
5369305|NCT01860456|Toxicity|toxicity
5369406|NCT01860131|bariatrics, lifestyle and behavioral modification programs|bariatrics, lifestyle and behavioral modification programs
5369407|NCT01860079|Early discharge|early discharge
5369408|NCT01860079|STEMI|stemi
5369409|NCT01860079|PPCI|ppci
5369817|NCT01858207|liver cancer|liver cancer
5369818|NCT01858194|Tachycardia, Renal Sympathetic Denervation|tachycardia, renal sympathetic denervation
5369819|NCT01858194|Catheter Ablation|catheter ablation
5369820|NCT01858194|Cardioverter-Defibrillator|cardioverter-defibrillator
5369821|NCT01858142|Pediatric anesthesia|pediatric anesthesia
5369822|NCT01858142|Pre-operative anxiety|pre-operative anxiety
5369823|NCT01858142|parental presence|parental presence
5369940|NCT01857622|DU-176b|du-176b
5370219|NCT01856738|Cost-effectiveness analysis|cost-effectiveness analysis
5370417|NCT01855867|PEP|pep
5370611|NCT01855009|Drinking|drinking
5370612|NCT01854983|fluorescence colposcopy|fluorescence colposcopy
5370720|NCT01854567|Lymphoma|lymphoma
5370827|NCT01854294|protein|protein
5371060|NCT01853384|vlu|vlu
5371251|NCT01852695|Family centered care|family centered care
5371252|NCT01852695|NICU family centered care|nicu family centered care
5371253|NCT01852695|NICU parent program|nicu parent program
5371254|NCT01852682|Peritoneal Dialysis|peritoneal dialysis
5371348|NCT01852318|pregabalin|pregabalin
5371673|NCT01850875|EMDR|emdr
5371778|NCT01850433|BDD|bdd
5371969|NCT01849562|Hepatitis C|hepatitis c
5371970|NCT01849562|Liver Diseases|liver diseases
5371971|NCT01849562|Hepatitis, viral, human|hepatitis, viral, human
5372065|NCT01849029|Substance Use Disorders|substance use disorders
5372066|NCT01849029|Alcohol-Related Disorders|alcohol-related disorders
5372067|NCT01849029|Binge Drinking|binge drinking
5372068|NCT01849029|Sexual Partners|sexual partners
5372069|NCT01849029|Sexual Behavior|sexual behavior
5372070|NCT01849029|Unsafe Sex|unsafe sex
5372071|NCT01849016|Sickle Cell Disease|sickle cell disease
5372072|NCT01849016|Sickle Cell Anemia|sickle cell anemia
5372073|NCT01849016|Pain|pain
5372164|NCT01848769|Inhalation|inhalation
5372165|NCT01848769|pMDI|pmdi
5372266|NCT01848262|InSurE|insure
5372476|NCT01847365|Okustim|okustim
5372568|NCT01847001|Neoadjuvant|neoadjuvant
5372569|NCT01847001|Experimental|experimental
5372603|NCT01846793|BPH|bph
5372666|NCT01846455|Suboxone|suboxone
5373062|NCT01844596|CHWs|chws
5373160|NCT01844232|spasticity|spasticity
5373261|NCT01843569|IVM|ivm
5373450|NCT01842607|eosinophils|eosinophils
5373873|NCT01840657|motor function|motor function
5373993|NCT01839929|FK506|fk506
5374097|NCT01839565|Osteosynthesis|osteosynthesis
5374098|NCT01839565|Quality of life|quality of life
5374099|NCT01839552|Fentanyl Citrate Nasal Spray (FCNS)|fentanyl citrate nasal spray (fcns)
5374100|NCT01839552|Lazanda|lazanda
5374101|NCT01839552|Breakthrough pain in cancer patients|breakthrough pain in cancer patients
5374102|NCT01839539|colorectal cancer|colorectal cancer
5374103|NCT01839539|DC-CIK|dc-cik
5374104|NCT01839539|CRC|crc
5374105|NCT01839526|Fabry disease|fabry disease
5374107|NCT01839513|Desflurane|desflurane
5374289|NCT01838798|Intensive care|intensive care
5374582|NCT01837433|safety|safety
5374583|NCT01837433|short|short
5374584|NCT01837433|term|term
5374585|NCT01837433|subacute thyroiditis|subacute thyroiditis
5374586|NCT01837407|Soft tissue loss|soft tissue loss
5374789|NCT01836575|Advanced NSCLC|advanced nsclc
5374901|NCT01835977|Unilateral prostate cancer|unilateral prostate cancer
5374902|NCT01835964|Glucose Variability (GV)|glucose variability (gv)
5374903|NCT01835964|Continuous Glucose Monitor (CGM)|continuous glucose monitor (cgm)
5374995|NCT01835496|pharmacokinetics|pharmacokinetics
5375101|NCT01834859|diet|diet
5375193|NCT01834404|Incretin|incretin
5375194|NCT01834404|Satiety|satiety
5375290|NCT01833988|camp|camp
5375390|NCT01833520|recurrent or metastatic|recurrent or metastatic
5375391|NCT01833520|Ra-223 dichloride|ra-223 dichloride
5375392|NCT01833520|Radium-223 chloride|radium-223 chloride
5375393|NCT01833520|Alpharadin|alpharadin
5375394|NCT01833507|increased activity|increased activity
5375395|NCT01833507|weight loss|weight loss
5375397|NCT01833494|Hemodialysis|hemodialysis
5375398|NCT01833494|Hyperphosphatemia|hyperphosphatemia
5375399|NCT01833481|Surgical approach|surgical approach
5375400|NCT01833481|Direct-anterior|direct-anterior
5375401|NCT01833481|Anterior-lateral|anterior-lateral
5375403|NCT01833481|Hip implant|hip implant
5375592|NCT01832714|NOTC|notc
5375593|NCT01832714|VNG|vng
5375711|NCT01832220|Microflora|microflora
5376347|NCT01829243|Neurocognition|neurocognition
5376462|NCT01828762|DC|dc
5376555|NCT01828372|concomitant diseases|concomitant diseases
5376887|NCT01827137|GPS|gps
5376959|NCT01826799|sleep|sleep
5377073|NCT01826266|Study treatment|study treatment
5377074|NCT01826266|Thromboelastography-reaction time|thromboelastography-reaction time
5377374|NCT01824680|Obesity|obesity
5377583|NCT01823614|X4-tropic variant|x4-tropic variant
5377681|NCT01823185|Ticagrelor|ticagrelor
5377891|NCT01822340|AGHD|aghd
5378006|NCT01821807|backache|backache
5378106|NCT01821300|Cardiovascular|cardiovascular
5378107|NCT01821261|Gums|gums
5378108|NCT01821261|Gingiva|gingiva
5378109|NCT01821261|Gingival Inflammation|gingival inflammation
5378110|NCT01821261|Gingival Bleeding|gingival bleeding
5378305|NCT01820364|MAPK1/2 inhibitor|mapk1/2 inhibitor
5378306|NCT01820364|Pi3K inhibitor|pi3k inhibitor
5378508|NCT01819402|visceral fat metabolism; FDG-PET/CT; pioglitazone; glimepiride; adiponectin|visceral fat metabolism; fdg-pet/ct; pioglitazone; glimepiride; adiponectin
5378509|NCT01819389|Chronic myeloid leukemia|chronic myeloid leukemia
5378510|NCT01819389|suboptimal response|suboptimal response
5378512|NCT01819389|nilotinib|nilotinib
5378514|NCT01819376|Overweight|overweight
5378525|NCT01819350|Sucrose|sucrose
5378717|NCT01818310|ischemia|ischemia
5378718|NCT01818310|diabetes mellitus|diabetes mellitus
5378834|NCT01817712|PTSD|ptsd
5379117|NCT01816451|aerobic capacity|aerobic capacity
5379120|NCT01816451|heart rate|heart rate
5379220|NCT01815970|dyspnea|dyspnea
5379317|NCT01815606|Pancreas|pancreas
5379318|NCT01815606|cancer|cancer
5379319|NCT01815606|EUS-FNA|eus-fna
5379320|NCT01815606|19Gauge|19gauge
5379321|NCT01815606|25Gauge|25gauge
5379322|NCT01815606|35mm mass|35mm mass
5379323|NCT01815593|Erectile Dysfunction|erectile dysfunction
5379324|NCT01815593|Vascular Endothelium|vascular endothelium
5379325|NCT01815593|Counterpulsation, External|counterpulsation, external
5379326|NCT01815580|HIV|hiv
5379327|NCT01815580|Treatment as Prevention|treatment as prevention
5379332|NCT01815554|Tetraplegia|tetraplegia
5379425|NCT01815294|Breast cancer|breast cancer
5379429|NCT01815294|DOXIL/CAELYX|doxil/caelyx
5379520|NCT01814891|Focus: feeding orange maize to children for 90 days.|focus: feeding orange maize to children for 90 days.
5379521|NCT01814891|Focus: total body reserves of vitamin A.|focus: total body reserves of vitamin a.
5379527|NCT01814865|ER+|er+
5380015|NCT01812499|incident reporting|incident reporting
5380016|NCT01812473|protein binding|protein binding
5380017|NCT01812473|voriconazole|voriconazole
5380018|NCT01812473|pediatrics|pediatrics
5380115|NCT01812057|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5380116|NCT01812057|Dexamethasone|dexamethasone
5380117|NCT01812057|Injections, Spinal|injections, spinal
5380118|NCT01812057|morphine|morphine
5380119|NCT01812031|PET/CT|pet/ct
5380120|NCT01812031|18F-fluoro-2-deoxyglucose|18f-fluoro-2-deoxyglucose
5380121|NCT01812031|lung neoplasms|lung neoplasms
5380122|NCT01812031|respiratory motion|respiratory motion
5380123|NCT01812018|Soft Tissue Sarcoma|soft tissue sarcoma
5380124|NCT01812018|Pulmonary metastases|pulmonary metastases
5380125|NCT01812005|MLN8237|mln8237
5380127|NCT01812005|Rituximab|rituximab
5380232|NCT01811524|Glioma|glioma
5669288|NCT00624130|Contraception,|contraception,
5669660|NCT00622791|propofol|propofol
5380748|NCT01809054|Hip, Knee, Arthroplasty, venous thromboembolic events, blood loss|hip, knee, arthroplasty, venous thromboembolic events, blood loss
5380749|NCT01809028|cell block, number of passes|cell block, number of passes
5380760|NCT01808989|tcpo2|tcpo2
5380875|NCT01808391|Myocardial ischemia|myocardial ischemia
5380876|NCT01808391|Cardiovascular disease|cardiovascular disease
5380877|NCT01808391|Arteriosclerosis|arteriosclerosis
5380878|NCT01808391|Vascular disease|vascular disease
5380879|NCT01808378|Bilateral limbic associated keratopathy|bilateral limbic associated keratopathy
5509850|NCT01253746|NTD|ntd
5380914|NCT01808248|HCV|hcv
5380954|NCT01808183|NIRS|nirs
5380955|NCT01808183|near Infrared spectroscopy|near infrared spectroscopy
5380956|NCT01808183|compartment perfusion|compartment perfusion
5380960|NCT01808170|Endometrioma|endometrioma
5380961|NCT01808170|ovarian reserve|ovarian reserve
5380962|NCT01808170|Ovarian cystectomy|ovarian cystectomy
5380963|NCT01808170|ovarian cyst deroofing|ovarian cyst deroofing
5380964|NCT01808157|atopic dermatitis|atopic dermatitis
5380965|NCT01808157|pruritus|pruritus
5380967|NCT01808131|Gout|gout
5380968|NCT01808118|Spondylitis|spondylitis
5381159|NCT01807130|CRT|crt
5381261|NCT01806662|Eczema|eczema
5381365|NCT01806064|RCC|rcc
5381454|NCT01805726|tolerance|tolerance
5381456|NCT01805726|dexmedetomidine|dexmedetomidine
5381457|NCT01805726|alfentanil|alfentanil
5381458|NCT01805713|Biomarkers|biomarkers
5381459|NCT01805700|type 1|type 1
5381551|NCT01805440|Neuroimaging|neuroimaging
5381552|NCT01805440|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5381553|NCT01805440|Uridine|uridine
5381554|NCT01805440|Pyrimidines|pyrimidines
5381555|NCT01805427|trough concentration|trough concentration
5381556|NCT01805427|weight|weight
5381558|NCT01805427|virological failure|virological failure
5381559|NCT01805414|inpatient diabetes|inpatient diabetes
5423331|NCT01616160|Nasal polyps|nasal polyps
5381560|NCT01805414|inpatient diabetes nutrition|inpatient diabetes nutrition
5381561|NCT01805401|Decision-making|decision-making
5381562|NCT01805401|Impulse control|impulse control
5381563|NCT01805401|Transcranial direct current stimulation|transcranial direct current stimulation
5381564|NCT01805401|Brain stimulation|brain stimulation
5381727|NCT01804530|Tenosynovial giant cell tumor|tenosynovial giant cell tumor
5381728|NCT01804530|TGCT|tgct
5381729|NCT01804517|migraine|migraine
5381734|NCT01804465|prostate|prostate
5382029|NCT01803685|Stereotaxic radiosurgery|stereotaxic radiosurgery
5382138|NCT01803178|plant sterols|plant sterols
5382139|NCT01803178|blood lipids|blood lipids
5382162|NCT01803113|hCG|hcg
5382446|NCT01801891|Surface neuromuscular electrical stimulation|surface neuromuscular electrical stimulation
5382541|NCT01801423|sickle cell anemia|sickle cell anemia
5382542|NCT01801423|Nigeria|nigeria
5382543|NCT01801423|hydroxyurea|hydroxyurea
5382544|NCT01801423|low income country|low income country
5382545|NCT01801410|pre-eclampsia|pre-eclampsia
5382546|NCT01801410|labor induction|labor induction
5382740|NCT01800344|LMA|lma
5382839|NCT01799889|WM|wm
5382840|NCT01799889|Waldenström's macroglobulinemia|waldenström's macroglobulinemia
5382841|NCT01799876|knee|knee
5382842|NCT01799876|cartilage|cartilage
5382937|NCT01799499|Urinary Bladder Neoplasms|urinary bladder neoplasms
5382938|NCT01799499|Carcinoma|carcinoma
5382939|NCT01799499|Urologic Neoplasms|urologic neoplasms
5382940|NCT01799499|Urogenital Neoplasms|urogenital neoplasms
5382941|NCT01799499|Neoplasms by Site|neoplasms by site
5382942|NCT01799499|Neoplasms|neoplasms
5383130|NCT01798745|Auto antibodies|auto antibodies
5383326|NCT01797718|Puberty|puberty
5383446|NCT01797172|herniated disc|herniated disc
5383494|NCT01796977|NSM|nsm
5383776|NCT01795729|Allograft vascular disease|allograft vascular disease
5383977|NCT01794884|Recovery|recovery
5384086|NCT01794507|multiple myeloma|multiple myeloma
5384176|NCT01794078|Acute Mountain Sickness|acute mountain sickness
5384177|NCT01794078|High altitude induced fatigue|high altitude induced fatigue
5496435|NCT01310478|DLT|dlt
5384459|NCT01792973|Antiretrovirals|antiretrovirals
5384460|NCT01792973|Cervical cancer|cervical cancer
5384461|NCT01792934|Debulking, cytoreduction, RFA, SABR, palliative chemotherapy|debulking, cytoreduction, rfa, sabr, palliative chemotherapy
5384462|NCT01792921|Age 7-10 years old|age 7-10 years old
5384472|NCT01792856|coaching|coaching
5384559|NCT01792401|Dietary supplements|dietary supplements
5384857|NCT01790763|Second-degree|second-degree
5384858|NCT01790750|PDA|pda
5384859|NCT01790750|Echo|echo
5384860|NCT01790750|PES|pes
5384861|NCT01790750|Handheld echo system|handheld echo system
5385365|NCT01788358|Nifedipine GITS|nifedipine gits
5385568|NCT01787552|Dose escalation|dose escalation
5385569|NCT01787552|Maximum Tolerated Dose|maximum tolerated dose
5385570|NCT01787552|MTD|mtd
5385571|NCT01787552|Safety Expansion|safety expansion
5385572|NCT01787552|Safety|safety
5385860|NCT01786122|breast neoplasms|breast neoplasms
5385861|NCT01786109|anandamide|anandamide
5385862|NCT01786109|cannabinoid|cannabinoid
5386151|NCT01784822|Graft repair|graft repair
5386152|NCT01784809|HIV|hiv
5386153|NCT01784809|STIs|stis
5386161|NCT01784796|stroke|stroke
5386265|NCT01784263|Autism|autism
5386357|NCT01783795|Dent genetic testing|dent genetic testing
5386358|NCT01783795|CLCN5|clcn5
5386359|NCT01783795|OCRL1|ocrl1
5386360|NCT01783795|Genetic testing for Dent Disease|genetic testing for dent disease
5386362|NCT01783782|Capsule Endoscopy|capsule endoscopy
5386549|NCT01782807|Hysterectomy|hysterectomy
5386650|NCT01782495|Liver Transplant|liver transplant
5386654|NCT01782482|Myopia|myopia
5386846|NCT01781416|SCORE|score
5386957|NCT01780870|Obesity|obesity
5387059|NCT01780467|Dopamine|dopamine
5387060|NCT01780467|Parkinson's disease|parkinson's disease
5387066|NCT01780454|ESRD|esrd
5387192|NCT01779765|IBS|ibs
5387278|NCT01779479|Genevieve|genevieve
5387279|NCT01779479|Breast Cancer|breast cancer
5387281|NCT01779479|Cabazitaxel|cabazitaxel
5387483|NCT01778621|Acupuncture|acupuncture
5387484|NCT01778621|AMH|amh
5387485|NCT01778621|PCOS|pcos
5387486|NCT01778608|Sedation|sedation
5387487|NCT01778595|Microbiome|microbiome
5387610|NCT01778101|reflux|reflux
5387696|NCT01777646|Mesenchymal Strmal Cells (MSC)|mesenchymal strmal cells (msc)
5387797|NCT01777243|safety|safety
5387895|NCT01776931|Dietary protein|dietary protein
5387896|NCT01776918|POLG1 Mutation|polg1 mutation
5387897|NCT01776918|Phenylketonuria|phenylketonuria
5387898|NCT01776905|Melanoma|melanoma
5387899|NCT01776905|Cancer|cancer
5387900|NCT01776892|Collagenase|collagenase
5387901|NCT01776892|Needle aponeurotomy|needle aponeurotomy
5387902|NCT01776866|Coronary Angiography|coronary angiography
5387903|NCT01776866|Rotational Coronary Angiography|rotational coronary angiography
5387904|NCT01776866|Contrast Media|contrast media
5387905|NCT01776866|Radiation|radiation
5387984|NCT01776424|Coronary artery disease|coronary artery disease
5387985|NCT01776424|CAD|cad
5387986|NCT01776424|Peripheral artery disease|peripheral artery disease
5387987|NCT01776424|PAD|pad
5387988|NCT01776424|Artery disease|artery disease
5388093|NCT01776060|'omic|'omic
5388292|NCT01775111|protein supplementation|protein supplementation
5388294|NCT01775098|Gout|gout
5388295|NCT01775098|uric acid|uric acid
5388296|NCT01775098|allopurinol|allopurinol
5388303|NCT01775072|tissue|tissue
5388304|NCT01775072|blood|blood
5388305|NCT01775072|salvia|salvia
5388306|NCT01775072|buccal swab|buccal swab
5388307|NCT01775072|Genomic Profiling|genomic profiling
5388308|NCT01775072|Solid Tumors|solid tumors
5388309|NCT01775072|hematologic cancer|hematologic cancer
5388407|NCT01774591|Female|female
5388610|NCT01773694|water|water
5388712|NCT01773226|APS|aps
5388801|NCT01772914|mixed meal test|mixed meal test
5388901|NCT01772537|aneurysm|aneurysm
5389093|NCT01771783|Renin-inhibitor|renin-inhibitor
5389094|NCT01771770|retinal venous pressure (RVP)|retinal venous pressure (rvp)
5389095|NCT01771770|chronically reduced ambient pressure|chronically reduced ambient pressure
5389096|NCT01771770|oxygen partial pressure|oxygen partial pressure
5389179|NCT01771211|MCI|mci
5389196|NCT01771146|Neoadjuvant|neoadjuvant
5389293|NCT01770769|hospital cost|hospital cost
5389299|NCT01770756|Willpower|willpower
5389393|NCT01770353|Triple Negative Breast Cancer|triple negative breast cancer
5389499|NCT01769833|HBsAg|hbsag
5389618|NCT01769248|FNB|fnb
5389799|NCT01768533|guidelines|guidelines
5389997|NCT01767701|raltegravir|raltegravir
5390426|NCT01765816|Elderly|elderly
5390530|NCT01765283|UCD|ucd
5390615|NCT01764789|psychological intervention|psychological intervention
5390618|NCT01764776|LDE225|lde225
5390823|NCT01763892|apo-E|apo-e
5390917|NCT01763515|Osteoarthritis|osteoarthritis
5390918|NCT01763502|Cognitive development|cognitive development
5390919|NCT01763502|Anemia|anemia
5390920|NCT01763502|Preschool|preschool
5390921|NCT01763502|Food transfers|food transfers
5390922|NCT01763502|Cash transfers|cash transfers
5390923|NCT01763502|Early childhood|early childhood
5390924|NCT01763502|Nutrition|nutrition
5390925|NCT01763489|randomized controlled trial|randomized controlled trial
5391119|NCT01762644|Omeprazole|omeprazole
5391224|NCT01762046|Genetics|genetics
5391425|NCT01761084|Osteoporosis|osteoporosis
5391620|NCT01760148|HCV|hcv
5391624|NCT01760148|Sustained Virus Response|sustained virus response
5391626|NCT01760135|nutrition|nutrition
5391627|NCT01760135|hyperglycemia|hyperglycemia
5391628|NCT01760122|peginterferon|peginterferon
5391629|NCT01760122|HBeAg Positive|hbeag positive
5391712|NCT01759719|platinum-chromium stents|platinum-chromium stents
5391813|NCT01759199|COPD|copd
5391907|NCT01758770|bone mineral density|bone mineral density
5392012|NCT01758315|Patient Safety|patient safety
5392013|NCT01758302|taste test|taste test
5392014|NCT01758302|food consumption|food consumption
5392015|NCT01758302|hunger|hunger
5392130|NCT01757834|Elastography|elastography
5392225|NCT01757210|Aprepitant|aprepitant
5392226|NCT01757210|Pediatrics|pediatrics
5392227|NCT01757210|Chemotherapy-induced nausea/vomiting|chemotherapy-induced nausea/vomiting
5392228|NCT01757210|Survey|survey
5392430|NCT01756300|Vascular Disease|vascular disease
5392530|NCT01755806|Cardiac cycle|cardiac cycle
5392637|NCT01755338|blood brain barrier|blood brain barrier
5563173|NCT01034410|AML|aml
5392741|NCT01754896|fecal occult blood test|fecal occult blood test
5392967|NCT01753817|Transradial patency|transradial patency
5392968|NCT01753804|DMD|dmd
5392969|NCT01753804|Myopathy|myopathy
5392970|NCT01753804|Natural History|natural history
5392971|NCT01753804|Muscular dystrophy|muscular dystrophy
5392972|NCT01753804|Biomarkers|biomarkers
5392974|NCT01753778|Nerve Entrapment, Morton's neuroma, entrapment neuropathy|nerve entrapment, morton's neuroma, entrapment neuropathy
5392975|NCT01753765|occipital neuralgia|occipital neuralgia
5392977|NCT01753700|crossover|crossover
5393174|NCT01752829|Excess weight loss|excess weight loss
5393622|NCT01750450|Pressure Volume Area|pressure volume area
5393623|NCT01750450|Pressure Flow Area|pressure flow area
5393624|NCT01750450|Myocardial Work|myocardial work
5393625|NCT01750437|NERD|nerd
5393626|NCT01750424|Scar|scar
5393627|NCT01750424|Fat Grafting|fat grafting
5393720|NCT01749995|Screening tool|screening tool
5393819|NCT01749371|Alpha-Tocopherol|alpha-tocopherol
5393820|NCT01749371|Inflammation|inflammation
5393821|NCT01749371|Oxidative Stress|oxidative stress
5393822|NCT01749371|Malondialdehyde|malondialdehyde
5393916|NCT01749007|Suicide|suicide
5394013|NCT01748513|transthoracic echocardiography,|transthoracic echocardiography,
5394015|NCT01748513|rapid weight loss,|rapid weight loss,
5394016|NCT01748513|venous return,|venous return,
5394109|NCT01748110|erectile function|erectile function
5394209|NCT01747772|Shear Wave Sonoelastography|shear wave sonoelastography
5394210|NCT01747772|Metavir Liver Fibrosis Grading|metavir liver fibrosis grading
5394211|NCT01747759|• Knee osteoarthritis|• knee osteoarthritis
5394212|NCT01747759|Total knee arthroplasty|total knee arthroplasty
5394213|NCT01747759|Selfcare|selfcare
5394214|NCT01747759|Booklet|booklet
5394215|NCT01747759|Rehabilitation|rehabilitation
5394303|NCT01747343|Incontinence|incontinence
5394406|NCT01746875|Aflibercept|aflibercept
5394742|NCT01745159|Protopic|protopic
5394743|NCT01745159|pediatric|pediatric
5394747|NCT01745146|TBI|tbi
5394971|NCT01744158|dystonia|dystonia
5395276|NCT01742962|Penis|penis
5395377|NCT01742520|pain|pain
5395477|NCT01742130|Angiography|angiography
5395478|NCT01742130|Coronary percutaneous intervention|coronary percutaneous intervention
5395479|NCT01742117|percutaneous coronary intervention|percutaneous coronary intervention
5395480|NCT01742117|angioplasty|angioplasty
5395481|NCT01742104|glaucoma|glaucoma
5395486|NCT01742091|Volunteers|volunteers
5395577|NCT01741740|pain, hernia, chronic, discomfort, retrospective|pain, hernia, chronic, discomfort, retrospective
5395578|NCT01741675|Questionnaires|questionnaires
5395579|NCT01741675|Quality of Life|quality of life
5395580|NCT01741675|Response rate|response rate
5395581|NCT01741649|Surgical wound infection|surgical wound infection
5395691|NCT01741116|TKI258|tki258
5395791|NCT01740713|hereditary haemoglobinopathy|hereditary haemoglobinopathy
5395914|NCT01740310|influenza,|influenza,
5396012|NCT01739933|Markers of inflammation|markers of inflammation
5396013|NCT01739920|Povidone-Iodine|povidone-iodine
5396014|NCT01739920|Ophthalmic Solutions|ophthalmic solutions
5396015|NCT01739920|Endophthalmitis|endophthalmitis
5396016|NCT01739920|Preoperative procedures|preoperative procedures
5396017|NCT01739907|Iron deficiency|iron deficiency
5396018|NCT01739907|Menstruating women|menstruating women
5396019|NCT01739907|Vitamin D|vitamin d
5396020|NCT01739907|Functional food|functional food
5396021|NCT01739894|Advanced gastric cancer|advanced gastric cancer
5396022|NCT01739894|unresectable gastric cancer|unresectable gastric cancer
5396023|NCT01739894|recurrent gastric cancer|recurrent gastric cancer
5396024|NCT01739894|with peritoneal metastasis|with peritoneal metastasis
5396028|NCT01739881|Endobronchial Ultrasound (EBUS)|endobronchial ultrasound (ebus)
5396100|NCT01739569|Reaction time|reaction time
5396101|NCT01739569|State of moods|state of moods
5396102|NCT01739569|Working hours|working hours
5396105|NCT01739556|primary PCI|primary pci
5396196|NCT01739062|Genetic screening|genetic screening
5396407|NCT01738243|Thyroid|thyroid
5396501|NCT01737840|ranitidine|ranitidine
5396502|NCT01737840|emergency department|emergency department
5396504|NCT01737814|sickle cell disease|sickle cell disease
5396506|NCT01737801|Lung function|lung function
5396593|NCT01737476|age 18-65|age 18-65
5396603|NCT01737398|TTR|ttr
5396813|NCT01736566|Primary Care|primary care
5396933|NCT01736059|bone marrow CD34+ cells|bone marrow cd34+ cells
5396934|NCT01736059|retinal disease|retinal disease
5396935|NCT01736059|clinical trial|clinical trial
5396936|NCT01736059|autologous|autologous
5396937|NCT01736046|CT Enterography|ct enterography
5396938|NCT01736046|Crohn's Disease|crohn's disease
5396939|NCT01736046|Inflammatory Bowel Disease|inflammatory bowel disease
5396942|NCT01736033|Proscar|proscar
5397034|NCT01735643|motivation|motivation
5397246|NCT01734707|intima-media thickness|intima-media thickness
5397357|NCT01734096|white coat hypertension|white coat hypertension
5397385|NCT01733901|PCI|pci
5397459|NCT01733589|Recombinant human endostatin|recombinant human endostatin
5397463|NCT01733563|fructose|fructose
5397571|NCT01732978|Newborn|newborn
5397667|NCT01732601|Suicidal Ideation|suicidal ideation
5397762|NCT01732094|Poor ovarian responders|poor ovarian responders
5397763|NCT01732094|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
5397764|NCT01732081|Hepatitis B|hepatitis b
5397765|NCT01732068|Poor ovarian response|poor ovarian response
5397766|NCT01732068|Poor ovarian responders|poor ovarian responders
5397767|NCT01732068|Bologna criteria for poor ovarian response|bologna criteria for poor ovarian response
5397768|NCT01732055|Pregnancy|pregnancy
5397769|NCT01732055|Antenatal|antenatal
5397770|NCT01732055|Major Depressive Disorder|major depressive disorder
5397774|NCT01732055|Spouses|spouses
5397845|NCT01731769|Early Vacuum Assisted Closure|early vacuum assisted closure
5397944|NCT01731275|immunogenicity|immunogenicity
5397945|NCT01731275|anti-E6011 antibody|anti-e6011 antibody
5397946|NCT01731262|Arthritis, Rheumatoid|arthritis, rheumatoid
5397949|NCT01731262|Synovitis|synovitis
5398034|NCT01730690|Bacterial meningitis in adults|bacterial meningitis in adults
5398035|NCT01730690|determinants of in-hospital mortality|determinants of in-hospital mortality
5398036|NCT01730677|Lapatinib|lapatinib
5398037|NCT01730677|Vinorelbine|vinorelbine
5398038|NCT01730664|ertapenem|ertapenem
5398039|NCT01730664|tuberculosis|tuberculosis
5398040|NCT01730664|pharmacokinetics|pharmacokinetics
5398041|NCT01730651|cervical cancer with metastatic lymphadenopathies|cervical cancer with metastatic lymphadenopathies
5398042|NCT01730638|thyroid,|thyroid,
5398225|NCT01729728|Tonsillectomy|tonsillectomy
5398226|NCT01729728|Dental surgery|dental surgery
5398227|NCT01729728|Ear surgery|ear surgery
5398228|NCT01729728|Nose surgery|nose surgery
5398229|NCT01729728|Throat surgery|throat surgery
5398230|NCT01729715|Pediatric|pediatric
5398231|NCT01729715|Insomnia|insomnia
5398232|NCT01729702|1- Hypertrophic cardiomyopathy|1- hypertrophic cardiomyopathy
5903873|NCT00249678|methamphetamine|methamphetamine
5398341|NCT01729325|Post-traumatic Stress disorder (PTSD)|post-traumatic stress disorder (ptsd)
5398450|NCT01728896|Acute pancreatitis, nutrition|acute pancreatitis, nutrition
5398451|NCT01728883|Diabetic Retinopathy|diabetic retinopathy
5398452|NCT01728883|Diabetic Macular Edema|diabetic macular edema
5398481|NCT01728740|FDC|fdc
5399353|NCT01724879|dasatinib|dasatinib
5399455|NCT01724385|vitreous hemorrhage,|vitreous hemorrhage,
5399456|NCT01724359|Schizophrenia|schizophrenia
5399457|NCT01724359|Paliperidone extended-release (ER)|paliperidone extended-release (er)
5399458|NCT01724359|Antipsychotic agents|antipsychotic agents
5399459|NCT01724346|CLL, SLL|cll, sll
5399460|NCT01724333|EORTC QLQ-C30|eortc qlq-c30
5399461|NCT01724333|Oral health|oral health
5399462|NCT01724333|Quality of life|quality of life
5399463|NCT01724333|Questionnaires|questionnaires
5399464|NCT01724333|Patient reported|patient reported
5399465|NCT01724333|outcomes|outcomes
5399466|NCT01724320|solid tumors|solid tumors
5399490|NCT01724177|ATL|atl
5399770|NCT01722760|Neonatal|neonatal
5399771|NCT01722760|Preterm|preterm
5399772|NCT01722760|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5400073|NCT01721330|ADHD|adhd
5400281|NCT01720420|mandible|mandible
5400388|NCT01719978|Mepivacaine|mepivacaine
5400389|NCT01719978|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5400390|NCT01719978|Hemodynamic|hemodynamic
5400391|NCT01719978|Electrocardiography and Dentistry.|electrocardiography and dentistry.
5400392|NCT01719965|Community Advisory Board|community advisory board
5400393|NCT01719965|Focus Group Discussion|focus group discussion
5400394|NCT01719965|Interview|interview
5400396|NCT01719965|Thailand|thailand
5400479|NCT01719601|Nucynta IR|nucynta ir
5400482|NCT01719588|Tapentadol PR|tapentadol pr
5400676|NCT01718600|MRI|mri
5400795|NCT01718028|lipid deficiency|lipid deficiency
5400888|NCT01717768|Gonadal Disorders|gonadal disorders
5400889|NCT01717768|Endocrine System Diseases|endocrine system diseases
5400890|NCT01717768|Testosterone|testosterone
5400891|NCT01717768|Testosterone enanthate|testosterone enanthate
5400894|NCT01717768|Methyltestosterone|methyltestosterone
5401089|NCT01716949|recurrent rectal cancer|recurrent rectal cancer
5401319|NCT01715844|L-citrulline|l-citrulline
5401320|NCT01715844|ADMA|adma
5401321|NCT01715844|Asthma|asthma
5401322|NCT01715844|Obesity|obesity
5401422|NCT01715415|Partial Responder|partial responder
5401427|NCT01715415|Relapser|relapser
5401520|NCT01715103|healthy women volunteers|healthy women volunteers
5401617|NCT01714661|Cognition Impairment|cognition impairment
5401618|NCT01714661|Alpha-7 nAChR|alpha-7 nachr
5401716|NCT01714180|Obese|obese
5401717|NCT01714180|Non-obese|non-obese
5401718|NCT01714180|Weight|weight
5402130|NCT01712256|Clinical trial|clinical trial
5402131|NCT01712256|Human immunodeficiency virus-1 (HIV-1)|human immunodeficiency virus-1 (hiv-1)
5402331|NCT01711411|Kenya|kenya
5402332|NCT01711398|solid tumor|solid tumor
5402333|NCT01711398|peptide|peptide
5402334|NCT01711385|Oral Health|oral health
5402335|NCT01711385|Prediabetes|prediabetes
5402336|NCT01711385|Diabetes|diabetes
5402337|NCT01711385|Periodontitis|periodontitis
5402338|NCT01711385|Early Identification|early identification
5402339|NCT01711385|Prevention|prevention
5402340|NCT01711372|ADHD|adhd
5402341|NCT01711320|Omeprazole|omeprazole
5402425|NCT01710917|Opioid-induced constipation|opioid-induced constipation
5402426|NCT01710917|Opioid|opioid
5402428|NCT01710917|Laxative|laxative
5402524|NCT01710410|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5402525|NCT01710410|nicotine replacement therapy|nicotine replacement therapy
5402527|NCT01710410|addiction|addiction
5402529|NCT01710410|neuroplasticity|neuroplasticity
5402619|NCT01710085|Recurrence|recurrence
5402720|NCT01709695|fMRI|fmri
5402834|NCT01709084|RNA|rna
5403037|NCT01708291|mindfulness|mindfulness
5403128|NCT01707927|EOA|eoa
5403244|NCT01707446|Delirium|delirium
5403245|NCT01707446|Cerebral Oximetry|cerebral oximetry
5403246|NCT01707433|spondyloepiphyseal dysplasia|spondyloepiphyseal dysplasia
5403247|NCT01707433|multiple epiphyseal dysplasia|multiple epiphyseal dysplasia
5403528|NCT01706302|RSV|rsv
5403644|NCT01705743|nitrous oxide|nitrous oxide
5403855|NCT01704742|Kenya|kenya
5403956|NCT01704404|Emphysema|emphysema
5404152|NCT01703650|RECIST|recist
5404254|NCT01703338|early rehabilitation|early rehabilitation
5404368|NCT01702818|Childhood Maltreatment|childhood maltreatment
5404369|NCT01702818|Childhood Abuse|childhood abuse
5404599|NCT01701687|Cirrhosis|cirrhosis
5404695|NCT01701349|Stage IVC Anaplastic Thyroid Cancer|stage ivc anaplastic thyroid cancer
5404696|NCT01701349|Thyroid Cancer|thyroid cancer
5404698|NCT01701336|Hepatitis|hepatitis
5404795|NCT01700907|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5404796|NCT01700907|elderly patients|elderly patients
5404894|NCT01700543|Good Bone Stock|good bone stock
5404895|NCT01700530|mitochondria|mitochondria
5404896|NCT01700530|fitness|fitness
5404988|NCT01700062|standard calorie|standard calorie
5404989|NCT01700062|parenteral nutrition|parenteral nutrition
5405180|NCT01699217|Philadelphia positive|philadelphia positive
5405286|NCT01698788|diabetic macular edema|diabetic macular edema
5405389|NCT01698346|Pertussis|pertussis
5405489|NCT01697852|LLIN|llin
5405600|NCT01697111|Drospirenone|drospirenone
5405601|NCT01697111|Ethinylestradiol Betadex|ethinylestradiol betadex
5405602|NCT01697111|Endometriosis|endometriosis
5405603|NCT01697111|Dienogest|dienogest
5405604|NCT01697111|Japanese Patients|japanese patients
5405605|NCT01697098|Dexamethasone|dexamethasone
5405606|NCT01697098|preterm labour|preterm labour
5405607|NCT01697098|respiratory distress|respiratory distress
5405608|NCT01697085|sea buckthorn|sea buckthorn
5405609|NCT01697085|mucous membrane|mucous membrane
5405610|NCT01697085|dryness|dryness
5405611|NCT01697085|metabolic syndrome|metabolic syndrome
5405612|NCT01697085|vaginal atrophy|vaginal atrophy
5405613|NCT01697072|Gastric Cancer|gastric cancer
5405614|NCT01697072|First Line Treatment Gastroesophageal Junction (GEJ)|first line treatment gastroesophageal junction (gej)
5405615|NCT01697072|Gastroesophageal Junction Cancer (GEJ)|gastroesophageal junction cancer (gej)
5405616|NCT01697072|GEJ Cancer|gej cancer
5405617|NCT01697059|appendicitis|appendicitis
5405618|NCT01697046|peri-exposure|peri-exposure
5405619|NCT01697046|chemoprophylaxis|chemoprophylaxis
5405779|NCT01696175|ScvO2|scvo2
5405876|NCT01695668|dry eyes|dry eyes
5406071|NCT01694875|HPV|hpv
5406512|NCT01693029|CKD 5d|ckd 5d
5406614|NCT01692587|PSA|psa
5406695|NCT01692262|Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|metastatic castrate-resistant prostate cancer (mcrpc),
5406808|NCT01691807|ofatumumab|ofatumumab
5406904|NCT01691378|Traumatic Brain Injury|traumatic brain injury
5406905|NCT01691378|Hopelessness|hopelessness
5406907|NCT01691365|Antioxidant|antioxidant
5407103|NCT01690507|demethylating agent|demethylating agent
5407213|NCT01690117|intervention|intervention
5407319|NCT01689545|HIV|hiv
5407622|NCT01688232|CD45RO|cd45ro
5407623|NCT01688232|biopsy|biopsy
5407624|NCT01688232|genetic feature of the tumor|genetic feature of the tumor
5407625|NCT01688232|relapse|relapse
5407626|NCT01688232|immunohistochemistry|immunohistochemistry
5407627|NCT01688232|image analysis software|image analysis software
5407628|NCT01688219|SAPHO syndrome|sapho syndrome
5407629|NCT01688219|Innate immunity|innate immunity
5407630|NCT01688219|TNF alpha|tnf alpha
5407631|NCT01688219|Polymorphonuclear neutrophils|polymorphonuclear neutrophils
5407632|NCT01688219|Propionibacterium acnes|propionibacterium acnes
5407633|NCT01688219|Interleukin-8|interleukin-8
5407709|NCT01687790|breast biopsy|breast biopsy
5407710|NCT01687777|Supraspinatus tendon|supraspinatus tendon
5407711|NCT01687777|Mesenchymal stem cells|mesenchymal stem cells
5407712|NCT01687777|OrthADAPT|orthadapt
5407713|NCT01687777|Rotator cuff|rotator cuff
5407717|NCT01687751|feasibility studies|feasibility studies
5407812|NCT01687283|pharmacokinetics|pharmacokinetics
5407933|NCT01686750|HIV|hiv
5408011|NCT01686373|Brain|brain
5408012|NCT01686373|Stimulation|stimulation
5408013|NCT01686373|Communication|communication
5408014|NCT01686373|Stoke|stoke
5408015|NCT01686373|Post|post
5408121|NCT01685918|aged|aged
5408222|NCT01685476|intracranial pressure|intracranial pressure
5408425|NCT01684579|Breast Cancer|breast cancer
5408525|NCT01684215|Phase 1/2|phase 1/2
5408730|NCT01683188|skin cancer|skin cancer
5409020|NCT01682083|MEK inhibitor|mek inhibitor
5409021|NCT01682083|trametinib|trametinib
5409033|NCT01682070|Safety|safety
5409210|NCT01681173|Diet therapy|diet therapy
5409310|NCT01680848|Caries risk,|caries risk,
5409311|NCT01680848|Practice pattern,|practice pattern,
5409326|NCT01680770|shock|shock
5409403|NCT01680432|cheese|cheese
5409920|NCT01678209|Imaging|imaging
5409948|NCT01678118|smoking|smoking
5410024|NCT01677624|Hypervascular tumor|hypervascular tumor
5410025|NCT01677624|arteriovenous malformation|arteriovenous malformation
5410027|NCT01677611|Resveratrol|resveratrol
5410126|NCT01677195|Dietary|dietary
5410319|NCT01676337|Emergency department|emergency department
5410320|NCT01676337|Primary care|primary care
5410321|NCT01676324|Fecal Calprotectin|fecal calprotectin
5410322|NCT01676311|cognition|cognition
5410323|NCT01676311|seizures|seizures
5410324|NCT01676311|electroencephalography|electroencephalography
5410415|NCT01675817|protamine|protamine
5410612|NCT01674933|oral|oral
5410746|NCT01674413|Crohn's|crohn's
5411043|NCT01673048|treatment|treatment
5411044|NCT01673048|children|children
5411139|NCT01672814|Riboflavin|riboflavin
5411140|NCT01672814|Microwave|microwave
5411141|NCT01672814|Keraflex|keraflex
5411142|NCT01672775|Renal Cell Carcinoma|renal cell carcinoma
5411461|NCT01671449|S-1|s-1
5411682|NCT01670435|anthrax|anthrax
5411891|NCT01669486|CPOT|cpot
5411992|NCT01669031|false negative reactions|false negative reactions
5411994|NCT01669031|mean deviation|mean deviation
5411995|NCT01669031|variability|variability
5411996|NCT01669031|program|program
5411997|NCT01669031|software|software
5411998|NCT01669031|glaucoma/diagnosis|glaucoma/diagnosis
5411999|NCT01669031|visual field tests/methods|visual field tests/methods
5412000|NCT01669031|aged|aged
5412001|NCT01669031|humans|humans
5412216|NCT01668108|Packaging Sizes|packaging sizes
5412422|NCT01667224|Obesity|obesity
5412423|NCT01667224|Abdominal fat|abdominal fat
5412519|NCT01666782|Oncology|oncology
5412724|NCT01665742|Genetic susceptibility|genetic susceptibility
5412829|NCT01665326|Immune Tolerance Induction|immune tolerance induction
5412830|NCT01665326|Lumizyme|lumizyme
5412835|NCT01665300|Trastuzumab|trastuzumab
5412836|NCT01665287|Cerebral Oximetry|cerebral oximetry
5412837|NCT01665287|Near infrared spectroscopy|near infrared spectroscopy
5412927|NCT01664806|Thermal injury|thermal injury
5412928|NCT01664806|Surgical complications|surgical complications
5412930|NCT01664793|vaccination|vaccination
5413024|NCT01664156|Cold stress test|cold stress test
5413128|NCT01663714|cycolophosphamide, vacristine, and pednisone|cycolophosphamide, vacristine, and pednisone
5413130|NCT01663701|Severe sepsis|severe sepsis
5413132|NCT01663701|Bundle|bundle
5413333|NCT01662791|Weight Loss|weight loss
5413643|NCT01661361|TDM|tdm
5413739|NCT01660854|Plasmodium|plasmodium
5413740|NCT01660854|falciparum|falciparum
5413830|NCT01660412|Pain|pain
5414043|NCT01659216|Urgency-Frequency Syndrome|urgency-frequency syndrome
5414141|NCT01658670|Heart failure|heart failure
5414142|NCT01658670|exercise|exercise
5414302|NCT01657929|GLA|gla
5414679|NCT01656252|Cytarabine|cytarabine
5414758|NCT01656018|Pharmacokinetics|pharmacokinetics
5414759|NCT01656018|Ex-vivo pharmacodynamics|ex-vivo pharmacodynamics
5414760|NCT01656005|COPD|copd
5414761|NCT01656005|Beta blockers|beta blockers
5414762|NCT01656005|Cardioselective|cardioselective
5414763|NCT01656005|Non-cardioselective|non-cardioselective
5414765|NCT01655992|capecitabine|capecitabine
5414850|NCT01655602|Trichophytic closure|trichophytic closure
5414953|NCT01655147|Healthy|healthy
5414954|NCT01655147|Pharmacokinetics|pharmacokinetics
5414955|NCT01655147|Abiraterone acetate|abiraterone acetate
5414956|NCT01655147|Abiraterone|abiraterone
5414957|NCT01655147|JNJ-589485|jnj-589485
5415348|NCT01653327|head and neck|head and neck
5415349|NCT01653327|cancer|cancer
5415350|NCT01653327|radiation therapy|radiation therapy
5415351|NCT01653327|chemoradiation|chemoradiation
5415354|NCT01653275|Mediterranean Diet|mediterranean diet
5415355|NCT01653275|Bone turnover|bone turnover
5415356|NCT01653275|postmenopausal women|postmenopausal women
5415357|NCT01653262|Brivaracetam|brivaracetam
5415638|NCT01651832|Adult|adult
5415639|NCT01651832|Aged|aged
5415640|NCT01651832|Aged, 80 and over|aged, 80 and over
5415758|NCT01651377|Mirapex|mirapex
5415926|NCT01650545|aerosolized liposomal cyclosporine A|aerosolized liposomal cyclosporine a
5415927|NCT01650545|bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5415928|NCT01650545|Lung Transplantation|lung transplantation
5415930|NCT01650519|knee surgery, arthroscopy; orthopaedic, orthopedic surgery|knee surgery, arthroscopy; orthopaedic, orthopedic surgery
5416027|NCT01650103|potassium|potassium
5416164|NCT01649375|AS|as
5416482|NCT01647828|Newly diagnosed Stage IV Pancreatic Cancer|newly diagnosed stage iv pancreatic cancer
5416485|NCT01647802|standing devices|standing devices
5416582|NCT01647373|axial length|axial length
5416592|NCT01647321|SPMS|spms
5416717|NCT01646450|NSCLC|nsclc
5416816|NCT01646125|lung cancer|lung cancer
5416823|NCT01646125|NSCLC|nsclc
5416919|NCT01645748|docetaxel|docetaxel
5417019|NCT01645072|Dietary therapy|dietary therapy
5417020|NCT01645072|ketogenic diet|ketogenic diet
5417021|NCT01645072|childhood epilepsy|childhood epilepsy
5417022|NCT01645033|Cognitive Behavioral Therapy|cognitive behavioral therapy
5417023|NCT01645033|computer|computer
5417024|NCT01645020|absorbable mesh|absorbable mesh
5417025|NCT01645020|Partially absorbed Mesh|partially absorbed mesh
5417115|NCT01644682|KO TAB123|ko tab123
5417116|NCT01644682|Household|household
5417117|NCT01644682|Kala-azar endemic area|kala-azar endemic area
5417118|NCT01644656|portal hypertension|portal hypertension
5417119|NCT01644656|cirrhosis|cirrhosis
5417120|NCT01644656|ARFI|arfi
5417121|NCT01644656|diagnostic study|diagnostic study
5417122|NCT01644643|Ceftazidime,|ceftazidime,
5417123|NCT01644643|avibactam,|avibactam,
5417124|NCT01644643|metronidazone,|metronidazone,
5417125|NCT01644643|Anti-Infectives|anti-infectives
5417126|NCT01644604|Hypertension|hypertension
5417216|NCT01643954|prostatectomy|prostatectomy
5417367|NCT01643603|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5417440|NCT01643395|conservative treatment|conservative treatment
5417441|NCT01643382|diabetes|diabetes
5417442|NCT01643382|kidney transplant|kidney transplant
5417443|NCT01643382|end stage renal disease|end stage renal disease
5417444|NCT01643382|delayed draft function|delayed draft function
5417445|NCT01643369|meditation|meditation
5417446|NCT01643369|compassion|compassion
5417447|NCT01643369|inflammation|inflammation
5417448|NCT01643369|immune system|immune system
5417449|NCT01643356|weight|weight
5417450|NCT01643356|pregnancy|pregnancy
5417451|NCT01643356|behavioral intervention|behavioral intervention
5417452|NCT01643356|obesity|obesity
5417530|NCT01642914|Linaclotide|linaclotide
5417629|NCT01642485|Japanese Caucasian bridging|japanese caucasian bridging
5417634|NCT01642459|hemodialysis|hemodialysis
5417722|NCT01641900|schizophrenia|schizophrenia
5417723|NCT01641900|eszopiclone|eszopiclone
5417725|NCT01641887|Heartburn|heartburn
5417726|NCT01641887|Decision Aid|decision aid
5417821|NCT01641536|Virus Diseases|virus diseases
5417919|NCT01641120|Relapsing Remitting|relapsing remitting
5418021|NCT01640626|Trichuris|trichuris
5418022|NCT01640626|Hookworm|hookworm
5418023|NCT01640626|Prevention and control|prevention and control
5418024|NCT01640613|carotid endarterectomy|carotid endarterectomy
5418025|NCT01640613|regional anaesthesia|regional anaesthesia
5418026|NCT01640613|ultrasound guided block|ultrasound guided block
5418027|NCT01640600|To determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.|to determine whether 4-8 year-old children exposed to nicotine or antidepressants in utero have more behavioral problems.
5680251|NCT00578500|oophorectomy, in vitro maturation, ovarian cryopreservation,|oophorectomy, in vitro maturation, ovarian cryopreservation,
5418031|NCT01640587|Mefloquine-artesunate|mefloquine-artesunate
5418095|NCT01640379|Text Messaging|text messaging
5418096|NCT01640379|mobile health (mhealth)|mobile health (mhealth)
5418201|NCT01639950|Survey Scale|survey scale
5418295|NCT01639534|peripheral blood|peripheral blood
5418401|NCT01639001|1L|1l
5418690|NCT01637376|Non Small cell lung carcinoma|non small cell lung carcinoma
5418694|NCT01637376|adenocarcinoma|adenocarcinoma
5418778|NCT01636934|Symptom Burden|symptom burden
5418779|NCT01636934|Chemoradiation|chemoradiation
5418879|NCT01636557|CYP450 enzyme|cyp450 enzyme
5418883|NCT01636453|wide-neck|wide-neck
5419192|NCT01635088|Asthma|asthma
5419220|NCT01635023|AUC|auc
5419299|NCT01634659|myopia|myopia
5419598|NCT01633021|Diabetes|diabetes
5557718|NCT01055366|OAG|oag
5420091|NCT01630889|CKD|ckd
5420486|NCT01628770|Pakistan|pakistan
5420487|NCT01628731|loop diuretics|loop diuretics
5420488|NCT01628731|fluid balance|fluid balance
5420584|NCT01628133|Patent Ductus Arteriosus|patent ductus arteriosus
5420687|NCT01627795|Cancer|cancer
5420709|NCT01627717|HCV|hcv
5420806|NCT01627262|placebo|placebo
5420892|NCT01626859|Antipsychotic Agents|antipsychotic agents
5420893|NCT01626859|Mental Disorder|mental disorder
5420894|NCT01626859|Psychotropic Drugs|psychotropic drugs
5420895|NCT01626859|Dopamine Agents|dopamine agents
5420896|NCT01626859|Central Nervous System Agents|central nervous system agents
5420897|NCT01626846|Neurofibromatosis|neurofibromatosis
5420898|NCT01626833|anorexia nervosa|anorexia nervosa
5420899|NCT01626833|GH|gh
5420998|NCT01626274|Long term vital signs monitoring|long term vital signs monitoring
5421191|NCT01625533|Coronary Angiography|coronary angiography
5421417|NCT01624584|CBT|cbt
5421485|NCT01624220|Breast cancer|breast cancer
5421606|NCT01623713|iloperidone|iloperidone
5421704|NCT01623180|DES|des
5421800|NCT01622686|Prescription Labels|prescription labels
5421801|NCT01622686|Low Health Literacy|low health literacy
5421802|NCT01622686|Limited English Proficiency|limited english proficiency
5421899|NCT01622309|Oxidative Stress|oxidative stress
5422000|NCT01621776|post-prandial hyperglycemia|post-prandial hyperglycemia
5422001|NCT01621737|oxytocin|oxytocin
5422002|NCT01621724|Gene therapy|gene therapy
5422004|NCT01621724|AML|aml
5422005|NCT01621724|CML|cml
5422006|NCT01621711|substance abuse|substance abuse
5422007|NCT01621711|Substance Dependence|substance dependence
5422009|NCT01621711|Alcohol Abuse|alcohol abuse
5422112|NCT01621308|Continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
5422113|NCT01621282|journal club|journal club
5422315|NCT01620268|Renal Allograft Rejection|renal allograft rejection
5422316|NCT01620242|recurrent or metastatic head and neck cancer|recurrent or metastatic head and neck cancer
5422690|NCT01618903|Pharmacokinetics|pharmacokinetics
5422897|NCT01618149|osteoarthritis|osteoarthritis
5422898|NCT01618149|periprosthetic bone loss|periprosthetic bone loss
5422899|NCT01618149|dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5422909|NCT01618110|ADHD|adhd
5422992|NCT01617668|neoadjuvant,|neoadjuvant,
5422993|NCT01617668|triple negative breast cancer|triple negative breast cancer
5422994|NCT01617642|Porphyria|porphyria
5422995|NCT01617642|Inflammation|inflammation
5422996|NCT01617642|Diet|diet
5423397|NCT01615796|antibiotics|antibiotics
5423496|NCT01615497|alcohol abuse therapy|alcohol abuse therapy
5423606|NCT01615003|unstable angina|unstable angina
5423607|NCT01615003|blood stasis syndrome|blood stasis syndrome
5423697|NCT01614561|Target cholesterol levels guidelines for the management of high blood cholesterol|target cholesterol levels guidelines for the management of high blood cholesterol
5423698|NCT01614548|Prostatic Neoplasms|prostatic neoplasms
5423699|NCT01614548|Prostate Cancer|prostate cancer
5423700|NCT01614548|Disease Management|disease management
5423701|NCT01614548|Rural|rural
5423702|NCT01614548|Urban|urban
5424298|NCT01611610|outcome measures|outcome measures
5424299|NCT01611610|spinal muscular atrophy|spinal muscular atrophy
5424401|NCT01611194|hyperbaric oxygen|hyperbaric oxygen
5424515|NCT01610661|glucose homeostasis|glucose homeostasis
5424719|NCT01609985|Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices|cardiac resynchronization therapy defibrillator (crt-d) devices
5424720|NCT01609972|Back pain|back pain
5424721|NCT01609972|Spinal Cord Stimulation|spinal cord stimulation
5424722|NCT01609959|Hypertension|hypertension
5424789|NCT01609816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5424848|NCT01609816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5424849|NCT01609816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5424851|NCT01609816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5425036|NCT01608945|steroid|steroid
5425336|NCT01607814|isoprostanes|isoprostanes
5425431|NCT01607346|Urinary Retention|urinary retention
5425534|NCT01606891|preschooler obesity prevention|preschooler obesity prevention
5425734|NCT01605877|Cataracts|cataracts
5425928|NCT01605045|Cardiac catheterization|cardiac catheterization
5426024|NCT01604590|Bevacizumab|bevacizumab
5426026|NCT01604577|health literacy|health literacy
5426027|NCT01604577|health numeracy|health numeracy
5426028|NCT01604564|Registry|registry
5426029|NCT01604564|Colitis Ulcerosa (CU)|colitis ulcerosa (cu)
5426030|NCT01604564|Familial Adenomatous Polyposis(FAP)|familial adenomatous polyposis(fap)
5426123|NCT01604200|hypertension|hypertension
5426223|NCT01603771|Cognition|cognition
5426225|NCT01603758|Cholesterol|cholesterol
5426533|NCT01602328|Allogeneic stem cells|allogeneic stem cells
5426616|NCT01602016|ASD|asd
5426633|NCT01601912|Exercise|exercise
5426836|NCT01601054|instrumentation|instrumentation
5426930|NCT01600781|QOL|qol
5427125|NCT01599910|Electronic Documentation|electronic documentation
5427126|NCT01599897|Tuberculosis|tuberculosis
5427127|NCT01599897|TB|tb
5427128|NCT01599897|Pulmonary|pulmonary
5427129|NCT01599897|Vaccine|vaccine
5427130|NCT01599884|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5427220|NCT01599637|Xolair|xolair
5427323|NCT01599286|Carbaglu|carbaglu
5427542|NCT01598311|CDI|cdi
5427606|NCT01598077|Gastric cancer|gastric cancer
5427707|NCT01597622|PGA|pga
5427798|NCT01597206|posterior reduced dental arch|posterior reduced dental arch
5427805|NCT01597180|HIV|hiv
5427907|NCT01596881|Imaging|imaging
5428109|NCT01596127|LP|lp
5428360|NCT01594957|Pharmacokinetics|pharmacokinetics
5428452|NCT01594567|Insulin resistance|insulin resistance
5428453|NCT01594567|Body weight|body weight
5428454|NCT01594567|Uric acid|uric acid
5428455|NCT01594567|Blood pressure|blood pressure
5428456|NCT01594554|HCV viral genotypes|hcv viral genotypes
5428457|NCT01594554|host genotypes|host genotypes
5428458|NCT01594554|IL28B|il28b
5428459|NCT01594554|Outcome|outcome
5428461|NCT01594554|ITPA|itpa
5428665|NCT01593891|IVUS, CCSVI|ivus, ccsvi
5428760|NCT01593410|Chinese Subjects|chinese subjects
5428761|NCT01593410|Relapsed/Refractory Multiple Myeloma|relapsed/refractory multiple myeloma
5428763|NCT01593397|Insulin Resistance|insulin resistance
5428959|NCT01592773|Pervasive Child Development Disorder|pervasive child development disorder
5429053|NCT01592409|young drivers|young drivers
5429153|NCT01591798|Robotic surgery|robotic surgery
5429154|NCT01591798|Laparoscopic surgery|laparoscopic surgery
5429155|NCT01591785|Hand|hand
5429156|NCT01591785|Foot|foot
5429157|NCT01591785|Eczema|eczema
5429158|NCT01591785|Atopic Dermatitis|atopic dermatitis
5429549|NCT01589952|Pegalyted interferon|pegalyted interferon
5429550|NCT01589952|Entecavir|entecavir
5429551|NCT01589939|Reduced Planning Target Volume|reduced planning target volume
5429552|NCT01589939|radiation therapy|radiation therapy
5429640|NCT01589471|Quality of life|quality of life
5707803|NCT00473122|XRT|xrt
5429641|NCT01589471|Incontinence|incontinence
5429642|NCT01589471|Rectal cancer|rectal cancer
5429643|NCT01589471|Anorectal manometry|anorectal manometry
5429644|NCT01589458|toothpastes|toothpastes
5429943|NCT01587833|Benzodiazepines|benzodiazepines
5430040|NCT01587313|bidil|bidil
5430041|NCT01587313|volunteers|volunteers
5430148|NCT01586793|rTMS|rtms
5430263|NCT01586403|Melanoma|melanoma
5430356|NCT01586039|Circadian Rhythms|circadian rhythms
5430758|NCT01584284|Genelux|genelux
5430856|NCT01583998|electronic medical records|electronic medical records
5430956|NCT01583569|Biomarkers|biomarkers
5431171|NCT01582815|JNJ-40411813|jnj-40411813
5431694|NCT01580514|cardiac magnetic resonance|cardiac magnetic resonance
5431806|NCT01580020|Macular Degeneration|macular degeneration
5431914|NCT01579552|Childhood Cancer Survivor Women Post Chest Radiation|childhood cancer survivor women post chest radiation
5432014|NCT01579214|Africa south of the sahara|africa south of the sahara
5432115|NCT01578629|stroke|stroke
5432212|NCT01578291|Children|children
5432422|NCT01577407|Pain|pain
5432524|NCT01576913|exercise testing|exercise testing
5432716|NCT01576263|Anaesthesia|anaesthesia
5432735|NCT01576224|DASH|dash
5432902|NCT01575496|Tinnitus|tinnitus
5432988|NCT01574963|OPG|opg
5432989|NCT01574963|RANKL|rankl
5432990|NCT01574963|bone disease|bone disease
5432991|NCT01574950|Delirium|delirium
5432992|NCT01574937|Castration Resistant|castration resistant
5432993|NCT01574937|Post Chemotherapy|post chemotherapy
5432994|NCT01574924|Personality change|personality change
5432996|NCT01574924|Coping|coping
5433190|NCT01574092|Brainstem gliomas|brainstem gliomas
5433191|NCT01574092|Intrinsic brain stem tumor|intrinsic brain stem tumor
5433192|NCT01574092|PAEDIATRIC HIGH GRADE GLIOMA|paediatric high grade glioma
5433193|NCT01574092|Childhood brain stem glioma|childhood brain stem glioma
5433194|NCT01574066|Community-acquired pneumonia|community-acquired pneumonia
5433195|NCT01574066|Diagnosis|diagnosis
5433196|NCT01574066|Emergency medicine|emergency medicine
5433197|NCT01574066|Chest CT-scan|chest ct-scan
5433204|NCT01574040|Lifestyle|lifestyle
5433206|NCT01574040|Behavior|behavior
5433279|NCT01573728|Depression|depression
5433374|NCT01573364|Distal Airways|distal airways
5433470|NCT01572987|Barrett's Esophagus|barrett's esophagus
5433471|NCT01572987|Esophageal neoplasms|esophageal neoplasms
5433472|NCT01572987|Radiofrequency ablation|radiofrequency ablation
5433473|NCT01572987|Endoscopic mucosal resection|endoscopic mucosal resection
5433474|NCT01572974|Barrett's esophagus|barrett's esophagus
5433475|NCT01572974|Gastroesophageal reflux disease|gastroesophageal reflux disease
5433482|NCT01572922|Cancer|cancer
5433569|NCT01572662|Allogeneic Transplantation|allogeneic transplantation
5433570|NCT01572636|Hurler Syndrome|hurler syndrome
5433571|NCT01572623|Therapeutic strategies for carotid artery stenting|therapeutic strategies for carotid artery stenting
5433648|NCT01572337|NIV|niv
5433783|NCT01571739|Tuberculosis|tuberculosis
5434000|NCT01570868|CML|cml
5434116|NCT01570426|MRI|mri
5434202|NCT01570114|colon|colon
5434725|NCT01567826|Statin therapy|statin therapy
5434914|NCT01566903|arterial stenosis|arterial stenosis
5434915|NCT01566903|arteriovenous malformations|arteriovenous malformations
5434916|NCT01566903|Post-treatment follow-up|post-treatment follow-up
5434917|NCT01566890|sickle cell|sickle cell
5434918|NCT01566890|sickle cell crisis|sickle cell crisis
5434926|NCT01566890|Lexiscan|lexiscan
5435004|NCT01566539|Oxytocin|oxytocin
5435005|NCT01566539|Vasopressin|vasopressin
5435104|NCT01566110|pediatric|pediatric
5435203|NCT01565668|AC220|ac220
5435305|NCT01565330|Diagnostic imaging|diagnostic imaging
5435306|NCT01565304|Teen pregnancy|teen pregnancy
5435307|NCT01565304|Sexually transmitted infections|sexually transmitted infections
5435308|NCT01565304|Sexual risk behaviors|sexual risk behaviors
5435309|NCT01565291|Amyloid imaging|amyloid imaging
5435310|NCT01565291|Positron Emission Tomography|positron emission tomography
5435311|NCT01565291|18F-AV-45|18f-av-45
5435312|NCT01565291|florbetapir F 18|florbetapir f 18
5435313|NCT01565291|Diagnostic imaging|diagnostic imaging
5435314|NCT01565278|Parenteral nutrition|parenteral nutrition
5435315|NCT01565278|fish oil|fish oil
5435316|NCT01565278|liver disease|liver disease
5435317|NCT01565278|Omegaven|omegaven
5435318|NCT01565278|hepatic|hepatic
5435319|NCT01565278|liver biopsy|liver biopsy
5435320|NCT01565278|bilirubin|bilirubin
5435396|NCT01564849|rhinitis|rhinitis
5435596|NCT01563913|supplement|supplement
5435913|NCT01562301|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5435914|NCT01562301|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5436101|NCT01561547|sucrose|sucrose
5437118|NCT01557400|nmDBMD|nmdbmd
5436102|NCT01561547|kangaroo mother care|kangaroo mother care
5436103|NCT01561534|fibula flap|fibula flap
5436104|NCT01561534|oral implants|oral implants
5436105|NCT01561534|computer-guided|computer-guided
5436106|NCT01561508|diabetes mellitus|diabetes mellitus
5436204|NCT01561131|Weight loss|weight loss
5436302|NCT01560728|Generalized Anxiety Disorder|generalized anxiety disorder
5436303|NCT01560728|Social Phobia|social phobia
5436304|NCT01560728|Panic Disorder|panic disorder
5436305|NCT01560715|Retinitis pigmentosa|retinitis pigmentosa
5436307|NCT01560715|bone marrow|bone marrow
5436308|NCT01560715|retinal dysprophy|retinal dysprophy
5436309|NCT01560702|autologous blood|autologous blood
5436530|NCT01559805|HIV|hiv
5436606|NCT01559519|TIPS|tips
5436820|NCT01558635|AF|af
5437220|NCT01556867|Omphalitis|omphalitis
5437324|NCT01556412|cholestatic hepatopathy|cholestatic hepatopathy
5437427|NCT01556022|Ischemic heart disease|ischemic heart disease
5437428|NCT01556022|Coronary artery disease|coronary artery disease
5437429|NCT01556022|Chronic heart failure|chronic heart failure
5437430|NCT01556022|Cardiovascular disease|cardiovascular disease
5437524|NCT01555645|Randomized|randomized
5437525|NCT01555619|Left heart pacing lead|left heart pacing lead
5437527|NCT01555619|Heart Failure|heart failure
5437834|NCT01554436|Prognosis|prognosis
5437636|NCT01555255|malaria|malaria
5437730|NCT01554800|LCAT|lcat
5437945|NCT01553903|Hormonal therapy|hormonal therapy
5438067|NCT01553435|Morphine|morphine
5438262|NCT01552577|Eye-tracking|eye-tracking
5438263|NCT01552577|Neurocognitive Function|neurocognitive function
5438366|NCT01552239|Image-guided Radiation Therapy|image-guided radiation therapy
5438567|NCT01551290|Ulcerative colitis|ulcerative colitis
5438672|NCT01550796|Tinnitus|tinnitus
5438768|NCT01550510|Micronutrients|micronutrients
5424029|NCT01612936|Asthma|asthma
5438862|NCT01550120|sensitivity|sensitivity
5438863|NCT01550120|human|human
5438864|NCT01550107|Sarcopenia|sarcopenia
5438865|NCT01550107|Allopurinol|allopurinol
5438866|NCT01550107|Xanthine Oxidase|xanthine oxidase
5438958|NCT01549717|Patient monitoring|patient monitoring
5438959|NCT01549717|Wireless monitoring|wireless monitoring
5438960|NCT01549717|Wearable monitor|wearable monitor
5438961|NCT01549704|Total knee arthroplasty|total knee arthroplasty
5438963|NCT01549704|High pain responders|high pain responders
5439099|NCT01549119|HIV|hiv
5439143|NCT01548872|Cardioplegia|cardioplegia
5439549|NCT01547351|Relapse in multiple sclerosis|relapse in multiple sclerosis
5439550|NCT01547351|Psychometric properties of the patient self-report questionnaire|psychometric properties of the patient self-report questionnaire
5439746|NCT01546337|anemia|anemia
5439837|NCT01545947|Neoplasms|neoplasms
5439838|NCT01545947|Pulmonary|pulmonary
5439839|NCT01545947|Lung Cancer|lung cancer
5439840|NCT01545947|Cancer of the Lung|cancer of the lung
5439841|NCT01545947|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
5439842|NCT01545947|IV Non-Small Cell Lung Cancer|iv non-small cell lung cancer
5439843|NCT01545947|Non-Small Cell Lung Cancer|non-small cell lung cancer
5439844|NCT01545934|Overweight|overweight
5439845|NCT01545934|Obese|obese
5439846|NCT01545934|Pregnancy|pregnancy
5439914|NCT01545687|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5439988|NCT01545531|gold standard measure|gold standard measure
5440095|NCT01545193|Elderly|elderly
5564973|NCT01027182|HIV|hiv
5440804|NCT01542203|Breast Cancer|breast cancer
5441290|NCT01539785|Hyperthermic|hyperthermic
5441291|NCT01539785|ovarian cancer|ovarian cancer
5441382|NCT01539343|CRBSI|crbsi
5441792|NCT01538030|Fetal membranes, premature rupture|fetal membranes, premature rupture
5442086|NCT01536457|retrospective|retrospective
5442182|NCT01536002|Anesthetics, intravenous|anesthetics, intravenous
5442184|NCT01536002|Pharmacokinetics|pharmacokinetics
5442200|NCT01535898|MRI|mri
5442592|NCT01534403|Monoclonal antibody|monoclonal antibody
5442593|NCT01534403|B-cell immunotherapy|b-cell immunotherapy
5442594|NCT01534403|Epratuzumab|epratuzumab
5442601|NCT01534377|Depression|depression
5442697|NCT01533844|Clostridium difficile|clostridium difficile
5442794|NCT01533441|INR|inr
5442894|NCT01532895|Pain|pain
5442990|NCT01532492|Responsiveness|responsiveness
5443092|NCT01531998|Bortezomib|bortezomib
5443094|NCT01531998|LDP-341|ldp-341
5443229|NCT01531452|s1|s1
5443295|NCT01531114|ticagrelor|ticagrelor
5443296|NCT01531114|STEMI|stemi
5443305|NCT01531062|nigella sativa|nigella sativa
5443406|NCT01530672|POC|poc
5443498|NCT01530269|chemotherapy|chemotherapy
5443600|NCT01529801|Osseotite Certain Tapered|osseotite certain tapered
5443864|NCT01528878|HCC|hcc
5444103|NCT01527838|Hematologic malignancies|hematologic malignancies
5444104|NCT01527799|Sickle cell anemia|sickle cell anemia
5444307|NCT01526798|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5444308|NCT01526798|chronic Inflammation|chronic inflammation
5444309|NCT01526798|EPO Resistance|epo resistance
5444310|NCT01526798|ESA Resistance|esa resistance
5444311|NCT01526798|high cut-off dialysis|high cut-off dialysis
5444312|NCT01526798|hemodialysis|hemodialysis
5444395|NCT01526486|urethral cancer|urethral cancer
5444396|NCT01526486|scrotal cancer|scrotal cancer
5444397|NCT01526486|Paget's disease|paget's disease
5444597|NCT01525550|sunitinib|sunitinib
5444598|NCT01525550|neoplasms|neoplasms
5444926|NCT01524068|IPF|ipf
5445125|NCT01523262|preconditioning|preconditioning
5445707|NCT01520623|Graft-versus-host disease (GvHD)|graft-versus-host disease (gvhd)
5445804|NCT01520233|disseminated neuroblastoma|disseminated neuroblastoma
5445805|NCT01520233|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5446006|NCT01519440|maternal blood loss|maternal blood loss
5446007|NCT01519401|PCOS|pcos
5446110|NCT01519063|Alcoholism|alcoholism
5446111|NCT01519037|calcimimetic agent|calcimimetic agent
5446217|NCT01518647|Treatment|treatment
5446219|NCT01518634|Bodily Distress Syndrome|bodily distress syndrome
5446306|NCT01518205|heparin-induced extracorporal lipid apheresis.|heparin-induced extracorporal lipid apheresis.
5446501|NCT01517477|surgery|surgery
5446504|NCT01517477|Eye Diseases|eye diseases
5446616|NCT01517061|Genetic Susceptibility|genetic susceptibility
5446617|NCT01517061|Amputation|amputation
5446618|NCT01517048|Body Composition|body composition
5446619|NCT01517048|Obesity|obesity
5446631|NCT01517035|MDS|mds
5446808|NCT01516281|PD|pd
5446879|NCT01515956|LSD|lsd
5447103|NCT01514838|urine glucose|urine glucose
5447104|NCT01514838|ipragliflozin|ipragliflozin
5447718|NCT01512225|breastmilk|breastmilk
5447719|NCT01512225|domperidone|domperidone
5447720|NCT01512225|preterm|preterm
5447721|NCT01512212|thyroid|thyroid
5447722|NCT01512212|fine|fine
5447723|NCT01512212|needle|needle
5447724|NCT01512212|aspiration|aspiration
5447829|NCT01511835|diabetes|diabetes
5448115|NCT01510587|obesity|obesity
5448219|NCT01510210|Atrial Fibrillation|atrial fibrillation
5448424|NCT01509300|CD3 depletion|cd3 depletion
5448425|NCT01509300|Children and adolescents|children and adolescents
5448426|NCT01509300|Haploidentical hematopoietic stem cell transplantation|haploidentical hematopoietic stem cell transplantation
5448427|NCT01509287|Donnai-Barrow Syndrome (DBS)|donnai-barrow syndrome (dbs)
5448428|NCT01509287|metabolic testing|metabolic testing
5448429|NCT01509287|genes|genes
5448433|NCT01509274|PRP|prp
5448627|NCT01508273|AA|aa
5448826|NCT01507597|T1DM|t1dm
5448923|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5448924|NCT01507090|children for whom there is no scale to determine weight|children for whom there is no scale to determine weight
5449019|NCT01506726|elderly|elderly
5449223|NCT01506128|Menstrual blood|menstrual blood
5449326|NCT01505660|Care management|care management
5449510|NCT01504867|ALI|ali
5449524|NCT01504828|function|function
5449628|NCT01504490|Advanced cancer|advanced cancer
5449811|NCT01503671|inflammation|inflammation
5449812|NCT01503671|peritoneal dialysis|peritoneal dialysis
5449813|NCT01503671|LV diastolic function changes after statin intervention|lv diastolic function changes after statin intervention
5449814|NCT01503658|Clopidogrel,|clopidogrel,
5449815|NCT01503658|Aspirin,|aspirin,
5449916|NCT01503125|GAN|gan
5449989|NCT01502826|Inflammation|inflammation
5450295|NCT01501617|Hair Loss|hair loss
5450409|NCT01501149|RR|rr
5450802|NCT01499589|turnover time|turnover time
5451329|NCT01497184|Allogeneic donor lymphocyte infusion|allogeneic donor lymphocyte infusion
5451330|NCT01497184|DLI|dli
5451331|NCT01497184|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5451332|NCT01497184|HSCT|hsct
5451430|NCT01496833|Aorta Aneurysm|aorta aneurysm
5451531|NCT01496352|Colorectal surgery|colorectal surgery
5451677|NCT01495702|HIV|hiv
5451742|NCT01495481|Dexmedetomidine|dexmedetomidine
5451842|NCT01495000|bone mineral density|bone mineral density
5451980|NCT01494480|ALS|als
5452470|NCT01492322|Nicotine withdrawal condition|nicotine withdrawal condition
5452471|NCT01492309|Major Depressive Disorder|major depressive disorder
5452472|NCT01492309|Pregnancy|pregnancy
5452473|NCT01492309|Brain Derived Neurotrophic Factor|brain derived neurotrophic factor
5452679|NCT01491529|Levodopa|levodopa
5452894|NCT01490723|ATG|atg
5452988|NCT01490320|Parenting|parenting
5452989|NCT01490307|parenting intervention|parenting intervention
5452990|NCT01490307|Family Check-Up|family check-up
5452991|NCT01490307|Anxiety Disorders|anxiety disorders
5452992|NCT01490307|Depression|depression
5452993|NCT01490307|Depressive Disorder|depressive disorder
5452994|NCT01490307|Conduct Disorder|conduct disorder
5452995|NCT01490307|Mental Disorders|mental disorders
5452996|NCT01490307|Behavioral Symptoms|behavioral symptoms
5452997|NCT01490307|Mood Disorders|mood disorders
5452998|NCT01490307|Mental Disorders Diagnosed in Childhood|mental disorders diagnosed in childhood
5452999|NCT01490307|Substance-Related Disorders|substance-related disorders
5453000|NCT01490294|Cardiac MRI|cardiac mri
5453001|NCT01490294|gadobutrol|gadobutrol
5453034|NCT01490138|IFI|ifi
5453077|NCT01489982|insomnia|insomnia
5453295|NCT01488981|FES|fes
5453374|NCT01488656|Air pollution|air pollution
5453375|NCT01488643|Bronchospasm|bronchospasm
5453376|NCT01488643|Laparoscopic Gastrectomy|laparoscopic gastrectomy
5453377|NCT01488643|Obesity|obesity
5453378|NCT01488630|substance abuse|substance abuse
5453641|NCT01487733|stage IVC squamous cell carcinoma of the oropharynx|stage ivc squamous cell carcinoma of the oropharynx
5798671|NCT00111410|Amgen, Clinical Trials|amgen, clinical trials
5798672|NCT00111397|Mycobacterial|mycobacterial
5453657|NCT01487694|back cohosh|back cohosh
5453846|NCT01486784|AML|aml
5454036|NCT01486004|HCV|hcv
5454240|NCT01485159|spirometry|spirometry
5454241|NCT01485159|burden|burden
5454242|NCT01485133|colonoscopy|colonoscopy
5454243|NCT01485133|water|water
5454244|NCT01485133|surgery|surgery
5454245|NCT01485133|unsedated|unsedated
5454246|NCT01485120|Blood pressure (low, normal, high)|blood pressure (low, normal, high)
5798675|NCT00111397|Microarray|microarray
5454247|NCT01485107|Ulthera® System|ulthera® system
5454248|NCT01485107|Ultherapy™ treatment|ultherapy™ treatment
5454347|NCT01484808|PSA|psa
5454431|NCT01484418|Exposure in vivo in chronic low back pain|exposure in vivo in chronic low back pain
5454432|NCT01484405|surgical approach for total hip arthroplasty|surgical approach for total hip arthroplasty
5454433|NCT01484392|open angle glaucoma|open angle glaucoma
5454434|NCT01484392|compliance|compliance
5454435|NCT01484392|adherence|adherence
5454526|NCT01483898|critical limb ischemia|critical limb ischemia
5454734|NCT01482923|HIV/AIDS|hiv/aids
5454735|NCT01482923|Community-Based Service Organizations|community-based service organizations
5454736|NCT01482923|11-173|11-173
5454738|NCT01482897|Discal sciatica, infiltrations|discal sciatica, infiltrations
5454835|NCT01482481|Spain|spain
5455043|NCT01481675|diabetes mellitus|diabetes mellitus
5455044|NCT01481675|weight loss|weight loss
5455045|NCT01481675|ghrelin|ghrelin
5455145|NCT01481272|Salvage therapy in DLBCL|salvage therapy in dlbcl
5455242|NCT01480791|endothelial dysfunction|endothelial dysfunction
5455432|NCT01480024|oocytes|oocytes
5455531|NCT01479673|Intravenous Feeding|intravenous feeding
5455738|NCT01478984|onestage|onestage
5455843|NCT01478542|First line Therapy|first line therapy
5455959|NCT01478152|Ectoin|ectoin
5456059|NCT01477736|Urodynamic|urodynamic
5456211|NCT01477138|SSS|sss
5456466|NCT01475786|burning|burning
5903969|NCT00092222|MCD|mcd
5456574|NCT01475448|joint moment|joint moment
5456575|NCT01475409|anti-TNF|anti-tnf
5456584|NCT01475396|brain|brain
5456683|NCT01475019|Orlistat|orlistat
5456777|NCT01474642|Capecitabine|capecitabine
5456883|NCT01474213|adult|adult
5602589|NCT00888030|outcome|outcome
5457068|NCT01473368|gut microbiome|gut microbiome
5457165|NCT01473030|serum DHT|serum dht
5457687|NCT01470963|Referral|referral
5457693|NCT01470924|relapse|relapse
5457793|NCT01470560|Mindfulness|mindfulness
5457994|NCT01469663|Levels of Emotional Awareness|levels of emotional awareness
5458330|NCT01468233|boil|boil
5458635|NCT01466907|secondary prevention|secondary prevention
5458637|NCT01466894|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5458638|NCT01466894|NAFLD|nafld
5458639|NCT01466894|Fatty liver|fatty liver
5458640|NCT01466894|NASH|nash
5458641|NCT01466868|Diffuse Large B cell Lymphoma|diffuse large b cell lymphoma
5458642|NCT01466868|AKT|akt
5458643|NCT01466868|MK 2206|mk 2206
5458664|NCT01466790|HCV|hcv
5459624|NCT01463007|colloid|colloid
5459717|NCT01462591|wasted left ventricular energy|wasted left ventricular energy
5459718|NCT01462578|Neoplasms benign, malignant and unspecified|neoplasms benign, malignant and unspecified
5459922|NCT01461681|Heart failure|heart failure
5459927|NCT01461642|ACT|act
5460022|NCT01461278|Cataract surgery|cataract surgery
5460023|NCT01461278|Suprachoroidal space|suprachoroidal space
5460128|NCT01460784|Brown adipose tissue|brown adipose tissue
5460129|NCT01460784|Dyslipidemia|dyslipidemia
5460130|NCT01460771|childhood dystonia|childhood dystonia
5460131|NCT01460758|Depression|depression
5460132|NCT01460758|Transcranial magnetic stimulation|transcranial magnetic stimulation
5460133|NCT01460758|rTMS|rtms
5460134|NCT01460758|DLPFC|dlpfc
5460135|NCT01460758|medial frontal cortex|medial frontal cortex
5460136|NCT01460758|anterior cingulate complex|anterior cingulate complex
5460137|NCT01460745|Erbitux|erbitux
5460138|NCT01460745|CRC|crc
5460139|NCT01460745|mCRC|mcrc
5460140|NCT01460745|Liver|liver
5460141|NCT01460745|Metastases|metastases
5460142|NCT01460732|Hypertension|hypertension
5460146|NCT01460706|Glioma|glioma
5460367|NCT01459926|OIC|oic
5460508|NCT01459302|SALS|sals
5460631|NCT01458847|primary|primary
5460746|NCT01458301|Drug Therapy|drug therapy
5460956|NCT01457443|Pompe Disease|pompe disease
5461052|NCT01456962|CD4+ T cells|cd4+ t cells
5461356|NCT01455623|CMT|cmt
5461357|NCT01455610|Computed tomography|computed tomography
5461358|NCT01455610|Contrast enhancement|contrast enhancement
5461359|NCT01455610|Pancreas|pancreas
5461360|NCT01455610|Cancer|cancer
5461361|NCT01455610|Resectability|resectability
5461362|NCT01455597|Postmenopausal Women|postmenopausal women
5461363|NCT01455597|Vaginal Dryness|vaginal dryness
5461364|NCT01455597|Postmenopausal Vulvovaginal Atrophy|postmenopausal vulvovaginal atrophy
5461365|NCT01455584|HM781-36B|hm781-36b
5461366|NCT01455558|Pharmacokinetics|pharmacokinetics
5461367|NCT01455545|Asthma|asthma
5461368|NCT01455545|Degree of Control|degree of control
5461369|NCT01455545|Exhaled Nitric Oxide|exhaled nitric oxide
5461370|NCT01455545|Asthma Control Test|asthma control test
5461540|NCT01454804|Pazopanib|pazopanib
5461541|NCT01454804|GW786034|gw786034
5461542|NCT01454804|Lapatinib|lapatinib
5461543|NCT01454804|Tykerb|tykerb
5461544|NCT01454804|GW572016|gw572016
5461545|NCT01454804|Trastuzumab|trastuzumab
5461546|NCT01454804|Herceptin|herceptin
5461547|NCT01454791|multiple sclerosis|multiple sclerosis
5461548|NCT01454791|diclofenac|diclofenac
5461934|NCT01453153|Cancer|cancer
5462030|NCT01452737|colonoscopy|colonoscopy
5462031|NCT01452737|bowel preparation|bowel preparation
5462032|NCT01452737|Golytely|golytely
5462122|NCT01452373|Hot flush(es)|hot flush(es)
5462123|NCT01452373|Hot flash(es)|hot flash(es)
5462636|NCT01450345|ASA I-II|asa i-ii
5462848|NCT01449357|NSCLC|nsclc
5462948|NCT01449032|Patients|patients
5463146|NCT01448109|Sepsis|sepsis
5463368|NCT01447251|DM2|dm2
5463466|NCT01446965|death|death
5463540|NCT01446627|wound healing|wound healing
5463741|NCT01445769|PPV-MF|ppv-mf
5463875|NCT01445340|Mycosis Fungoides|mycosis fungoides
5464102|NCT01444456|Lung Cancer|lung cancer
5464406|NCT01443156|Diabetes|diabetes
5464407|NCT01443156|Shift work|shift work
5464413|NCT01443143|Diabetes|diabetes
5464695|NCT01441908|Multi-analyte|multi-analyte
5464800|NCT01441453|Liver resection|liver resection
5464908|NCT01441089|Cancer|cancer
5465004|NCT01440751|filtering surgery|filtering surgery
5465100|NCT01440439|hypoglycaemia|hypoglycaemia
5465410|NCT01439282|Estrogen Receptor-Positive Early Stage Breast Cancer|estrogen receptor-positive early stage breast cancer
5465411|NCT01439269|Separation stress|separation stress
5450248|NCT01501877|Smoking|smoking
5465647|NCT01438359|PA21|pa21
5465936|NCT01437111|Osteoporosis|osteoporosis
5465937|NCT01437111|Postmenopausal|postmenopausal
5465938|NCT01437098|Valvular Heart Disease|valvular heart disease
5465939|NCT01437098|Severe Aortic Stenosis|severe aortic stenosis
5465940|NCT01437098|Aortic Valve Replacement|aortic valve replacement
5465941|NCT01437085|Needle deflection|needle deflection
5465942|NCT01437085|Prostate Deformation|prostate deformation
5465943|NCT01437085|Prostate Brachytherapy|prostate brachytherapy
5465945|NCT01437046|Alcohol drinking|alcohol drinking
5465946|NCT01437046|Alcohol craving|alcohol craving
5465947|NCT01437033|Breath Tests|breath tests
5465948|NCT01437033|Human Volunteers|human volunteers
5465949|NCT01437033|Pilot Study|pilot study
5465950|NCT01437033|Breath Test|breath test
5465951|NCT01437020|IL-10|il-10
5466027|NCT01436747|Proteinuria|proteinuria
5466028|NCT01436747|Albuminuria|albuminuria
5466029|NCT01436747|Vitamin D|vitamin d
5466030|NCT01436747|Paricalcitol|paricalcitol
5466031|NCT01436721|Effectiveness|effectiveness
5466032|NCT01436721|Device success|device success
5466033|NCT01436721|Hepatectomy|hepatectomy
5466034|NCT01436708|pelvic organ prolapse|pelvic organ prolapse
5466035|NCT01436708|urinary symptoms|urinary symptoms
5466036|NCT01436708|sexual function|sexual function
5466037|NCT01436695|seizure early detection|seizure early detection
5466038|NCT01436682|Nerve Blocks|nerve blocks
5466430|NCT01435070|Colles' fracture|colles' fracture
5466533|NCT01434667|genetic counseling|genetic counseling
5466535|NCT01434654|HAND|hand
5466536|NCT01434654|HIV|hiv
5466724|NCT01434043|Quantitative perfusion|quantitative perfusion
5466825|NCT01433497|relapse-free|relapse-free
5466826|NCT01433497|secondary progressive|secondary progressive
5466827|NCT01433484|cardiovascular disease|cardiovascular disease
5466828|NCT01433484|coronary heart disease|coronary heart disease
5466829|NCT01433484|obesity|obesity
5466835|NCT01433471|Mucus|mucus
5466923|NCT01433185|Cellular Phone|cellular phone
5466925|NCT01433172|stage IV|stage iv
5467137|NCT01432249|enbrel|enbrel
5467347|NCT01431391|Vaccine|vaccine
5467439|NCT01431300|central veins|central veins
5467449|NCT01431261|Pacing|pacing
5467543|NCT01430910|pharmacokinetics|pharmacokinetics
5467729|NCT01430182|Methadone/therapeutic use|methadone/therapeutic use
5467730|NCT01430182|Morphine/therapeutic use|morphine/therapeutic use
5467731|NCT01430182|Middle Aged|middle aged
5467732|NCT01430182|Pain Measurement/drug effects|pain measurement/drug effects
5467733|NCT01430182|Pain Measurement/methods|pain measurement/methods
5467734|NCT01430182|Pain, Postoperative/prevention & control|pain, postoperative/prevention & control
5467735|NCT01430182|Prospective Studies|prospective studies
5467736|NCT01430182|Double-Blind Method|double-blind method
5467914|NCT01429363|contained herniated lumbar discs|contained herniated lumbar discs
5467915|NCT01429363|TDD|tdd
5467916|NCT01429363|Case series|case series
5467917|NCT01429363|RCT|rct
5467921|NCT01429350|rtPA|rtpa
5468111|NCT01428778|Brain MRI|brain mri
5468422|NCT01427270|Constipation|constipation
5468618|NCT01426542|brain injury|brain injury
5468619|NCT01426542|stroke|stroke
5468620|NCT01426542|cerebral palsy|cerebral palsy
5468621|NCT01426542|seizures|seizures
5468717|NCT01426061|Randomized controlled trial|randomized controlled trial
5468839|NCT01425476|breast|breast
5468916|NCT01425177|Retained CBD Stones|retained cbd stones
5468917|NCT01425177|Recurrent CBD Stones|recurrent cbd stones
5469014|NCT01424865|stage IIIA breast cancer|stage iiia breast cancer
5469110|NCT01424410|paediatric schistosomiasis morbidity immunology|paediatric schistosomiasis morbidity immunology
5469112|NCT01424384|Anxiety Disorder|anxiety disorder
5469113|NCT01424384|neuropsychological tests|neuropsychological tests
5469114|NCT01424345|Kidney Transplantation|kidney transplantation
5469119|NCT01424332|darexaban|darexaban
5469223|NCT01423955|Safety|safety
5469452|NCT01423019|Adipose Tissue|adipose tissue
5469453|NCT01423019|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5469567|NCT01422486|Revlimid refractory|revlimid refractory
5469570|NCT01422486|Telintra|telintra
5469785|NCT01421836|stent patency|stent patency
5470358|NCT01419639|meningiomas|meningiomas
5470150|NCT01420432|Ankylosing Spondylitis|ankylosing spondylitis
5470370|NCT01419600|safety|safety
5470450|NCT01419379|COPD exacerbation rate|copd exacerbation rate
5470545|NCT01419015|Aortic Stenosis|aortic stenosis
5470640|NCT01418404|Kinematics analysis|kinematics analysis
5470641|NCT01418391|minimal laparotomy|minimal laparotomy
5470642|NCT01418391|TAP block|tap block
5470645|NCT01418378|Sigma|sigma
5470754|NCT01417884|molecular epidemiology|molecular epidemiology
5470855|NCT01417442|aggressive|aggressive
5470856|NCT01417429|galantamine|galantamine
5470857|NCT01417429|subjective nicotine|subjective nicotine
5470858|NCT01417429|tobacco withdrawal symptoms|tobacco withdrawal symptoms
5470859|NCT01417429|nicotine|nicotine
5470860|NCT01417390|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5471041|NCT01416688|recurrent colon cancer|recurrent colon cancer
5471336|NCT01415492|Meat consumption|meat consumption
5471337|NCT01415479|Colon cancer|colon cancer
5471338|NCT01415479|Screening|screening
5471339|NCT01415479|Decision-making|decision-making
5471340|NCT01415453|retinitis pigmentosa|retinitis pigmentosa
5471341|NCT01415453|acoustic radiation force ultrasound|acoustic radiation force ultrasound
5471342|NCT01415453|RP|rp
5471343|NCT01415453|visual field loss|visual field loss
5471344|NCT01415453|Photoreceptor|photoreceptor
5471345|NCT01415453|Vision loss|vision loss
5471429|NCT01415115|hypertension|hypertension
5471430|NCT01415089|Cancer|cancer
5471431|NCT01415089|Quality of life|quality of life
5471433|NCT01415089|Stress and coping|stress and coping
5471434|NCT01415089|Web-based intervention|web-based intervention
5471435|NCT01415089|Communication|communication
5471436|NCT01415063|Hepatocellular Carcinoma|hepatocellular carcinoma
5471628|NCT01414140|Mirena, contraception|mirena, contraception
5471629|NCT01414114|Clinical Trial, Phase 2|clinical trial, phase 2
5471630|NCT01414114|Renal Dialysis|renal dialysis
5471631|NCT01414114|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5471635|NCT01414088|Nephrology|nephrology
5471930|NCT01412957|Chemorefractory|chemorefractory
5472233|NCT01411930|Insulin resistance|insulin resistance
5472234|NCT01411930|Antipsychotics|antipsychotics
5472365|NCT01411358|vaccine|vaccine
5472661|NCT01410214|complete resection|complete resection
5472761|NCT01409759|Perforators|perforators
5472848|NCT01409317|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5472849|NCT01409317|rTMS|rtms
5472850|NCT01409317|DTMS|dtms
5472851|NCT01409317|fMRI|fmri
5472852|NCT01409317|Randomized, Sham-Controlled Trial|randomized, sham-controlled trial
5472853|NCT01409304|Major depression|major depression
5472854|NCT01409304|Deep Transcranial Magnetic Stimulation|deep transcranial magnetic stimulation
5472945|NCT01409083|end-tidal carbon dioxide|end-tidal carbon dioxide
5473256|NCT01407835|Skin prick test|skin prick test
5473544|NCT01406821|PRP|prp
5473634|NCT01406535|angiogenesis|angiogenesis
5473738|NCT01406106|Lipids|lipids
5474074|NCT01404767|esmolol|esmolol
5474362|NCT01403311|Glioblastoma|glioblastoma
5474575|NCT01402505|sleeve gastrectomy|sleeve gastrectomy
5474576|NCT01402505|transvaginal NOTES|transvaginal notes
5474577|NCT01402492|Cocaine-Related disorders|cocaine-related disorders
5474578|NCT01402492|Cocaine|cocaine
5474579|NCT01402492|Substance-Related disorders|substance-related disorders
5474580|NCT01402492|Opioid abuse|opioid abuse
5474581|NCT01402492|Opioid dependence|opioid dependence
5474582|NCT01402492|abuse|abuse
5474775|NCT01401725|electronic order sets|electronic order sets
5474975|NCT01400815|smoking|smoking
5475178|NCT01399970|Acne|acne
5475384|NCT01399021|Drain removal|drain removal
5475486|NCT01398618|tuberculosis|tuberculosis
5475680|NCT01397721|pulmonary vasculature|pulmonary vasculature
5475681|NCT01397721|pulmonary hypertension|pulmonary hypertension
5475682|NCT01397721|atherosclerosis|atherosclerosis
5475684|NCT01397721|emphysema|emphysema
5475775|NCT01397253|Medication errors|medication errors
5475930|NCT01396525|PAD|pad
5476172|NCT01395303|death|death
5476173|NCT01395303|vitamin D|vitamin d
5476174|NCT01395303|androgens|androgens
5476175|NCT01395303|thyroid hormones|thyroid hormones
5476176|NCT01395290|staphylococcus aureus|staphylococcus aureus
5476267|NCT01394939|viral therapy|viral therapy
5476268|NCT01394939|RAS mutant|ras mutant
5476269|NCT01394939|Erbitux failure|erbitux failure
5476271|NCT01394939|FOLFOX failure|folfox failure
5476460|NCT01394081|Patient Navigation|patient navigation
5476570|NCT01393509|11-041|11-041
5476671|NCT01393067|biliary stenosis|biliary stenosis
5476672|NCT01393067|liver transplantation|liver transplantation
5476673|NCT01393054|Nigella sativa seed extract|nigella sativa seed extract
5476674|NCT01393054|hypertension|hypertension
5476874|NCT01392209|CNS|cns
5476875|NCT01392209|anti-VEGF antibody|anti-vegf antibody
5476876|NCT01392209|11-057|11-057
5477116|NCT01391377|HDL|hdl
5477268|NCT01390623|Short-term antibiotic|short-term antibiotic
5477462|NCT01389856|Persistent pulmonary hypertension, newborn|persistent pulmonary hypertension, newborn
5477463|NCT01389856|PPHN|pphn
5477464|NCT01389843|Heart failure|heart failure
5477465|NCT01389843|Registry|registry
5477662|NCT01388933|Kampo|kampo
5477875|NCT01388023|gingivitis|gingivitis
5477970|NCT01387633|Health Education|health education
5478072|NCT01387295|breast cancer|breast cancer
5478410|NCT01385917|MRI|mri
5478479|NCT01385579|vulnerable populations|vulnerable populations
5478566|NCT01385137|stage I breast cancer|stage i breast cancer
5478766|NCT01384175|OPCAB|opcab
5478858|NCT01383772|Visual field tests|visual field tests
5478974|NCT01383213|Pneumonia|pneumonia
5479163|NCT01382316|AA|aa
5479553|NCT01380899|Lewy Bodies|lewy bodies
5479878|NCT01379534|Cancer,|cancer,
5480383|NCT01377519|Fibroids|fibroids
5480384|NCT01377519|Uterine|uterine
5480385|NCT01377519|Focused Ultrasound|focused ultrasound
5480488|NCT01377233|Lu 31-310|lu 31-310
5480489|NCT01377220|Hepatocellular carcinoma|hepatocellular carcinoma
5846740|NCT00043628|Coronary Artery Disease|coronary artery disease
5480490|NCT01377220|Positron Emission Tomography/computed tomography (PET-CT)|positron emission tomography/computed tomography (pet-ct)
5480582|NCT01376830|COPD|copd
5481115|NCT01374542|Thoracoscopy|thoracoscopy
5481116|NCT01374516|Dengue Virus|dengue virus
5481117|NCT01374516|Dengue fever|dengue fever
5481118|NCT01374516|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5481317|NCT01373632|significant stenosis (>70% of lumen stenosis)|significant stenosis (>70% of lumen stenosis)
5481318|NCT01373632|epicardial coronary arteries|epicardial coronary arteries
5481322|NCT01373619|ivabradine|ivabradine
5481412|NCT01373138|crossover|crossover
5481508|NCT01372722|treatment resistant|treatment resistant
5481729|NCT01371734|MDD|mdd
5466630|NCT01434368|HV|hv
5481917|NCT01370954|oxidative stress|oxidative stress
5481918|NCT01370954|memory deficit|memory deficit
5481919|NCT01370954|antioxidant|antioxidant
5481920|NCT01370941|Chymosin|chymosin
5481921|NCT01370941|24H urine calcium excretion|24h urine calcium excretion
5481922|NCT01370941|Calcium absorption|calcium absorption
5481924|NCT01370928|Colonoscopy performance|colonoscopy performance
5482009|NCT01370460|Total knee arthroplasty|total knee arthroplasty
5482010|NCT01370447|Leigh syndrome|leigh syndrome
5482112|NCT01370083|Dysphagia|dysphagia
5482321|NCT01369342|Stelara|stelara
5482429|NCT01368887|psoriasis|psoriasis
5482533|NCT01368471|STEMI|stemi
5482638|NCT01367977|Dysautonomia|dysautonomia
5482833|NCT01367093|CARDIOVASCULAR|cardiovascular
5483067|NCT01366092|interleukin|interleukin
5483170|NCT01365715|Therapeutic angiography|therapeutic angiography
5483172|NCT01365715|Surgical blood loss|surgical blood loss
5483173|NCT01365715|Spinal metastases|spinal metastases
5483174|NCT01365715|Spinal neoplasms|spinal neoplasms
5483175|NCT01365715|Vertebral metastases|vertebral metastases
5483176|NCT01365715|metastatic spine surgery|metastatic spine surgery
5483177|NCT01365715|Spinal surgery|spinal surgery
5483186|NCT01365676|PMS|pms
5483268|NCT01365364|PLM|plm
5483783|NCT01363154|K-448|k-448
5483889|NCT01362660|post-natal monitoring|post-natal monitoring
5483890|NCT01362660|exposure in utero|exposure in utero
5483891|NCT01362647|Muscle Relaxation|muscle relaxation
5483893|NCT01362634|substance use|substance use
5483894|NCT01362634|club drugs|club drugs
5483895|NCT01362634|sexual risk|sexual risk
5484415|NCT01360658|Safety|safety
5484699|NCT01359540|Bone mineral density|bone mineral density
5484700|NCT01359540|THA|tha
5484889|NCT01358604|recurrent neuroblastoma|recurrent neuroblastoma
5469742|NCT01421901|Surgery|surgery
5485198|NCT01357291|Inmates|inmates
5485412|NCT01356264|referred for scheduled resection|referred for scheduled resection
5485413|NCT01356251|Quality of life|quality of life
5485414|NCT01356251|support group|support group
5485521|NCT01355822|preterm birth|preterm birth
5485728|NCT01354951|11-056|11-056
5485833|NCT01354444|Memory problems|memory problems
5486067|NCT01353352|Clinical Decision Rule|clinical decision rule
5486197|NCT01352936|bacteremia|bacteremia
5486198|NCT01352936|vancomycin|vancomycin
5486199|NCT01352936|teicoplanin|teicoplanin
5486200|NCT01352923|PEAR1 gene|pear1 gene
5486202|NCT01352897|Cholesterol|cholesterol
5486203|NCT01352897|rosuvastatin|rosuvastatin
5486294|NCT01352520|mycosis fungoides|mycosis fungoides
5486295|NCT01352520|MF|mf
5486296|NCT01352520|SGN-35 (brentuximab vedotin)|sgn-35 (brentuximab vedotin)
5486297|NCT01352520|skin lymphomas|skin lymphomas
5486837|NCT01350141|PCSK9|pcsk9
5486838|NCT01350141|PF-04950615|pf-04950615
5486839|NCT01350141|RN316|rn316
5486840|NCT01350128|COPD|copd
5487139|NCT01348997|cancer survivors|cancer survivors
5487140|NCT01348997|internet|internet
5487141|NCT01348997|depression|depression
5487446|NCT01347762|nabilone|nabilone
5487544|NCT01347385|Laparoscopic myomectomy|laparoscopic myomectomy
5487647|NCT01347099|OCD|ocd
5487848|NCT01346280|Patient Experiences|patient experiences
5487926|NCT01345968|anemia|anemia
5487927|NCT01345968|transfusion|transfusion
5487928|NCT01345968|intravenous ferric carboxymaltose|intravenous ferric carboxymaltose
5487929|NCT01345929|cUTI|cuti
5487930|NCT01345890|swallowing|swallowing
5487931|NCT01345890|stroke|stroke
5487932|NCT01345890|aspiration|aspiration
5487933|NCT01345890|human|human
5487934|NCT01345890|electrical stimulation|electrical stimulation
5487935|NCT01345890|post stroke dysphagia|post stroke dysphagia
5487936|NCT01345877|burn injury|burn injury
5487937|NCT01345877|cold pressor test|cold pressor test
5487938|NCT01345877|gender|gender
5487939|NCT01345877|pain|pain
5488018|NCT01345539|Oligo mets|oligo mets
5488256|NCT01344642|HIV|hiv
5488338|NCT01344304|FOLFOX|folfox
5488430|NCT01343810|Mindfulness-Based Stress Reduction|mindfulness-based stress reduction
5488527|NCT01343394|Children|children
5488528|NCT01343381|Heparin|heparin
5488529|NCT01343381|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5488530|NCT01343381|Anti-coagulation efficacy|anti-coagulation efficacy
5488531|NCT01343368|Post-menarchal|post-menarchal
5488532|NCT01343355|Tropical Spastic Paraparesis|tropical spastic paraparesis
5488533|NCT01343355|HAM|ham
5488534|NCT01343355|TSP|tsp
5488540|NCT01343329|Traumatic Brain Injury|traumatic brain injury
5488541|NCT01343329|Dysautonomia|dysautonomia
5488542|NCT01343329|Brain Injury|brain injury
5488543|NCT01343329|Sympathetic hyperactivity|sympathetic hyperactivity
5488544|NCT01343316|Enteral Feeds|enteral feeds
5488545|NCT01343316|Supplemental Feeds|supplemental feeds
5488546|NCT01343316|Transpyloric Tube|transpyloric tube
5488547|NCT01343316|Nasogastric Tube|nasogastric tube
5488548|NCT01343303|Osteoarthritis, knee|osteoarthritis, knee
5488631|NCT01343017|Pulmonary gas exchange|pulmonary gas exchange
5488632|NCT01343017|Functional residual capacity|functional residual capacity
5488633|NCT01343017|Cardiac output|cardiac output
5488634|NCT01343017|Sevoflurane|sevoflurane
5488635|NCT01343004|BA058|ba058
5488636|NCT01343004|abaloparatide|abaloparatide
5488637|NCT01343004|Abaloparatide-SC|abaloparatide-sc
5488638|NCT01343004|osteoporosis|osteoporosis
5488639|NCT01343004|postmenopausal|postmenopausal
5488640|NCT01343004|bone loss|bone loss
5488641|NCT01343004|ACTIVE|active
5488642|NCT01343004|fracture|fracture
5488643|NCT01342991|Haemorrhoids|haemorrhoids
5488649|NCT01342978|HNSCC|hnscc
5488821|NCT01342107|Multi-Purpose Solution Wettability|multi-purpose solution wettability
5488923|NCT01341626|economic costs|economic costs
5489023|NCT01341106|treatment with Entecavir|treatment with entecavir
5489024|NCT01341080|Balance|balance
5489025|NCT01341080|Postural impairment|postural impairment
5489026|NCT01341080|Falls|falls
5489027|NCT01341080|Parkinson Disease|parkinson disease
5489028|NCT01341054|mucositis|mucositis
5489029|NCT01341054|chamomilla|chamomilla
5489030|NCT01341054|therapeutics|therapeutics
5489031|NCT01341028|weight loss|weight loss
5489032|NCT01341028|appetite|appetite
5489033|NCT01341028|ghrelin|ghrelin
5489034|NCT01341028|PYY|pyy
5489113|NCT01340703|posterior vitreous detachment|posterior vitreous detachment
5489114|NCT01340690|ADHD|adhd
5489115|NCT01340690|children|children
5489116|NCT01340690|adolescents|adolescents
5489117|NCT01340690|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5489118|NCT01340690|ADHDRS - IV|adhdrs - iv
5489307|NCT01339975|Urologic Neoplasms|urologic neoplasms
5489404|NCT01339624|ketorolac|ketorolac
5489509|NCT01339130|vascular injury|vascular injury
5489510|NCT01339130|Parkinson's disease|parkinson's disease
5489512|NCT01339117|children|children
5489596|NCT01338844|IVF failure|ivf failure
5489597|NCT01338831|prostate cancer,|prostate cancer,
5489598|NCT01338831|breast cancer,|breast cancer,
5489699|NCT01338363|pharmacoepidemiology|pharmacoepidemiology
5489701|NCT01338350|safety|safety
5489702|NCT01338350|tolerability|tolerability
5489703|NCT01338350|pharmacokinetics|pharmacokinetics
5490044|NCT01337024|NDO|ndo
5490247|NCT01336192|Advanced NSCLC|advanced nsclc
5490552|NCT01334905|YM178|ym178
5490642|NCT01334528|Repeated measures|repeated measures
5490643|NCT01334502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5490644|NCT01334502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5490824|NCT01333787|constipation|constipation
5491127|NCT01332448|orlistat|orlistat
5491334|NCT01331486|Mild hypertension|mild hypertension
5491437|NCT01331057|Bilingualism|bilingualism
5491538|NCT01330667|Limited Formula|limited formula
5491539|NCT01330654|Intermediate risk of adverse cardiac event|intermediate risk of adverse cardiac event
5491541|NCT01330654|Age forty to seventy five|age forty to seventy five
5491636|NCT01330238|Efficacy|efficacy
5491847|NCT01329263|menthol cigarettes|menthol cigarettes
5491860|NCT01329198|TS|ts
5492059|NCT01328418|Lengthening|lengthening
5492150|NCT01327989|Neurovascular intervention|neurovascular intervention
5492251|NCT01327599|Open-angle glaucoma|open-angle glaucoma
5492252|NCT01327599|Ocular hypertension|ocular hypertension
5492253|NCT01327599|Pigment dispersion glaucoma|pigment dispersion glaucoma
5492254|NCT01327599|Intraocular pressure|intraocular pressure
5492255|NCT01327586|disability|disability
5492256|NCT01327586|substance abuse|substance abuse
5492257|NCT01327586|cocaine abuse|cocaine abuse
5492258|NCT01327586|dual diagnosis|dual diagnosis
5492259|NCT01327586|representative payee|representative payee
5492560|NCT01326455|angiogram|angiogram
5492688|NCT01325935|Clopidogrel|clopidogrel
5492778|NCT01325493|hyperalgesia|hyperalgesia
5492994|NCT01324544|Analgesia|analgesia
5493197|NCT01323543|Lumbago|lumbago
5493616|NCT01321879|Sepsis|sepsis
5493712|NCT01321541|Follicular Grade 3 Lymphoma|follicular grade 3 lymphoma
5493713|NCT01321502|treatment of herpes|treatment of herpes
5493714|NCT01321489|Phase III|phase iii
5493803|NCT01321151|Mild Brain Injury|mild brain injury
5494092|NCT01320033|inflammatory lesions|inflammatory lesions
5494093|NCT01320020|Cancer|cancer
5494094|NCT01320020|Neoplasm|neoplasm
5494095|NCT01320020|Carcinoma|carcinoma
5494096|NCT01320020|intravenous|intravenous
5494189|NCT01319695|IVF|ivf
5494190|NCT01319682|Pain|pain
5494191|NCT01319682|Preemptive|preemptive
5494193|NCT01319682|Intravenous|intravenous
5494194|NCT01319682|Lumbar fusion|lumbar fusion
5494195|NCT01319656|Chronic diseases|chronic diseases
5494196|NCT01319656|Primary care|primary care
5494197|NCT01319656|Rehabilitation|rehabilitation
5494284|NCT01319227|Porous Titanium Construct|porous titanium construct
5494377|NCT01318798|Clinical consequences|clinical consequences
5494576|NCT01317797|MT203|mt203
5494793|NCT01316887|nDPI|ndpi
5494879|NCT01316744|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5494880|NCT01316744|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5495010|NCT01316718|diarrhoea|diarrhoea
5495103|NCT01316289|ankle joint|ankle joint
5495104|NCT01316276|Cystic Fibrosis|cystic fibrosis
5495105|NCT01316276|Respiratory Infections|respiratory infections
5495106|NCT01316276|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5495301|NCT01315548|Contrast enhanced harmonic endoscopic ultrasound|contrast enhanced harmonic endoscopic ultrasound
5495302|NCT01315548|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5495303|NCT01315548|Chronic pancreatitis|chronic pancreatitis
5495304|NCT01315535|Mandibular Advancement|mandibular advancement
5495305|NCT01315535|Oral Appliance|oral appliance
5495307|NCT01315522|Stents|stents
5495382|NCT01315171|functional MRI|functional mri
5495383|NCT01315158|Obstructive Sleep Apnea|obstructive sleep apnea
5495384|NCT01315158|Body Mass Index|body mass index
5495385|NCT01315132|Myeloablative Hematopoietic Stem Cell Transplant|myeloablative hematopoietic stem cell transplant
5495386|NCT01315132|Cyclophosphamide tolerization|cyclophosphamide tolerization
5495387|NCT01315132|2 Step Approach|2 step approach
5495388|NCT01315132|Hematological malignancies|hematological malignancies
5495389|NCT01315132|leukemia|leukemia
5495390|NCT01315132|lymphoma|lymphoma
5495391|NCT01315132|multiple myeloma|multiple myeloma
5495394|NCT01315093|poor responders|poor responders
5495473|NCT01314755|Nutrition|nutrition
5495569|NCT01314404|Vaccine|vaccine
5495666|NCT01313975|Diabetes insipidus|diabetes insipidus
5495667|NCT01313962|antiviral|antiviral
5495668|NCT01313962|intranasal|intranasal
5495770|NCT01313468|maximal oxygen uptake|maximal oxygen uptake
5495855|NCT01313221|plaque psoriasis|plaque psoriasis
5495856|NCT01313221|moderate|moderate
5496067|NCT01312259|Interstitial Cystitis|interstitial cystitis
5496068|NCT01312259|Pelvic Floor dysfunction|pelvic floor dysfunction
5496160|NCT01311752|follow up|follow up
5496360|NCT01310803|TURBT|turbt
5496585|NCT01309854|RA|ra
5496865|NCT01308814|Menopause|menopause
5497163|NCT01307475|Depressive Syndrome|depressive syndrome
5497164|NCT01307475|Melancholia|melancholia
5497165|NCT01307475|Depressive Neurosis|depressive neurosis
5497166|NCT01307475|Unipolar Depression|unipolar depression
5497167|NCT01307475|Depressive Symptoms|depressive symptoms
5497255|NCT01307163|children and adolescents|children and adolescents
5497256|NCT01307163|after a successful liver transplantation|after a successful liver transplantation
5497258|NCT01307150|Atopic Dermatitis|atopic dermatitis
5497987|NCT01304342|satisfaction|satisfaction
5497988|NCT01304342|respiratory depression|respiratory depression
5497989|NCT01304303|solid|solid
5497990|NCT01304303|tumor|tumor
5497991|NCT01304303|taxane|taxane
5498082|NCT01303926|carboplatin paclitaxel bevacizumab|carboplatin paclitaxel bevacizumab
5498083|NCT01303926|maintenance|maintenance
5498084|NCT01303913|COPD|copd
5498085|NCT01303913|Oxygen desaturation|oxygen desaturation
5498086|NCT01303913|Walking test|walking test
5498183|NCT01303575|Youth|youth
5498371|NCT01302834|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5498372|NCT01302834|human papilloma virus infection|human papilloma virus infection
5498373|NCT01302821|breast - male|breast - male
5498374|NCT01302821|breast - female|breast - female
5498375|NCT01302821|metastatic|metastatic
5498376|NCT01302821|invasive|invasive
5498377|NCT01302808|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5498558|NCT01302119|toenail treatment|toenail treatment
5498559|NCT01302119|foot dermatoses|foot dermatoses
5498560|NCT01302119|fungal culture|fungal culture
5498583|NCT01302080|cohort|cohort
5498670|NCT01301651|Virtual Reality|virtual reality
5498757|NCT01301170|Dry Needling|dry needling
5498758|NCT01301170|Manual Therapy|manual therapy
5498957|NCT01300234|chronic hepatitis B|chronic hepatitis b
5499062|NCT01299909|Smoking cessation|smoking cessation
5499267|NCT01299090|wrinkles|wrinkles
5499752|NCT01296854|spa therapy|spa therapy
5499952|NCT01295944|Neurologic|neurologic
5499954|NCT01295931|NIR|nir
5500071|NCT01295528|heart rate|heart rate
5500151|NCT01295307|acute myeloid leukemia|acute myeloid leukemia
5500153|NCT01295307|refractory|refractory
5500154|NCT01295307|Relapsed or refractory AML|relapsed or refractory aml
5500371|NCT01294501|Health Literacy|health literacy
5500575|NCT01293708|Elderly|elderly
5500576|NCT01293695|hot flashes|hot flashes
5500577|NCT01293695|post menopausal women|post menopausal women
5500578|NCT01293695|skin conductance monitors|skin conductance monitors
5500579|NCT01293695|hypnosis|hypnosis
5500767|NCT01292850|Topical|topical
5500964|NCT01292031|meropenem|meropenem
5501165|NCT01291342|Nanomaterials|nanomaterials
5501268|NCT01290861|Cognitive Battery|cognitive battery
5501373|NCT01290432|inofolic plus|inofolic plus
5501374|NCT01290432|myoinositol|myoinositol
5501375|NCT01290432|folic acid|folic acid
5501376|NCT01290419|RSV|rsv
5501385|NCT01290393|HPV|hpv
5501701|NCT01289249|treatment evaluation|treatment evaluation
5501702|NCT01289236|Shoulder Pain|shoulder pain
5501703|NCT01289223|Indolent B-cell NHL, bendamustine, rituximab, progression-free survival|indolent b-cell nhl, bendamustine, rituximab, progression-free survival
5501704|NCT01289210|B cell|b cell
5501705|NCT01289210|lymphoma|lymphoma
5501706|NCT01289184|Occupational Health Hazards|occupational health hazards
5501930|NCT01288274|DMPA|dmpa
5501980|NCT01288079|MDD|mdd
5502076|NCT01287598|target therapy|target therapy
5502278|NCT01286740|HIV-1|hiv-1
5502392|NCT01286285|paediatric|paediatric
5502576|NCT01285479|MS|ms
5846756|NCT00043511|Injections, Intramuscular|injections, intramuscular
5502704|NCT01284946|Skin fragility and bullae lesions|skin fragility and bullae lesions
5502705|NCT01284946|non-transfusion iron overload|non-transfusion iron overload
5502706|NCT01284933|Stroke|stroke
5502707|NCT01284933|Ischemic Attack, Transient|ischemic attack, transient
5502708|NCT01284933|Magnetic Resonance Imaging|magnetic resonance imaging
5502709|NCT01284933|Carotid Arteries|carotid arteries
5502792|NCT01284465|Type 2 diabetes self-management|type 2 diabetes self-management
5502898|NCT01283997|Solodyn|solodyn
5502998|NCT01283451|near-infrared spectroscopy|near-infrared spectroscopy
5502999|NCT01283425|MiniMed Paradigm insulin pump|minimed paradigm insulin pump
5503000|NCT01283425|insulin Lispro|insulin lispro
5503001|NCT01283425|Insulin Aspart|insulin aspart
5503002|NCT01283425|Quick-set infusion set|quick-set infusion set
5503004|NCT01283412|Dexmedetomidine|dexmedetomidine
5503005|NCT01283412|Adult Patients|adult patients
5503006|NCT01283412|Elective Major Surgery|elective major surgery
5503007|NCT01283412|General Anesthesia|general anesthesia
5503085|NCT01282983|fiber|fiber
5503086|NCT01282983|orange juice|orange juice
5503087|NCT01282983|digestive symptom|digestive symptom
5503088|NCT01282944|physical activity in adults 65 or older|physical activity in adults 65 or older
5503273|NCT01282008|Message Testing|message testing
5503491|NCT01280994|MRI|mri
5503576|NCT01280578|Migraine|migraine
5503577|NCT01280565|Melanoma|melanoma
5503584|NCT01280487|ZSTK474|zstk474
5503852|NCT01279291|Primary peritoneal cancer|primary peritoneal cancer
5503863|NCT01279265|Colic|colic
5503959|NCT01278849|safety,|safety,
5504075|NCT01278342|active acromegaly|active acromegaly
5504171|NCT01278043|Antiplatelet|antiplatelet
5504268|NCT01277640|HIV-1|hiv-1
5504269|NCT01277640|microbicide|microbicide
5504270|NCT01277640|dapivirine|dapivirine
5504271|NCT01277627|HCV|hcv
5504272|NCT01277627|HIV|hiv
5504273|NCT01277627|Nevirapine|nevirapine
5504274|NCT01277627|HCV viral load|hcv viral load
5504275|NCT01277627|Efavirenz|efavirenz
5504276|NCT01277627|Protease inhibitors|protease inhibitors
5504277|NCT01277614|lifestyle|lifestyle
5504278|NCT01277614|diet|diet
5504279|NCT01277614|exercise|exercise
5504280|NCT01277601|Chronic Hepatitis B|chronic hepatitis b
5504281|NCT01277601|Hep B|hep b
5504282|NCT01277601|Non cirrhotic|non cirrhotic
5504287|NCT01277575|stroke|stroke
5504361|NCT01277250|Transition coach|transition coach
5504362|NCT01277237|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
5504655|NCT01276002|disrupted duct|disrupted duct
5504742|NCT01275625|maraviroc|maraviroc
5505048|NCT01274507|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5505460|NCT01273090|childhood nodular lymphocyte predominant Hodgkin lymphoma|childhood nodular lymphocyte predominant hodgkin lymphoma
5505546|NCT01272648|Physiotherapy|physiotherapy
5505762|NCT01271881|Fistula|fistula
5505962|NCT01270971|crumbling nail|crumbling nail
5505963|NCT01270971|discolored nail|discolored nail
5505964|NCT01270971|weak nail|weak nail
5505965|NCT01270958|AVY-REG00108VN|avy-reg00108vn
5506161|NCT01270126|vision recovery|vision recovery
5506375|NCT01269203|NF-kB|nf-kb
5506472|NCT01268800|Induction|induction
5506871|NCT01266954|PD|pd
5507007|NCT01266343|anterior chamber paracentesis|anterior chamber paracentesis
5507008|NCT01266343|conventional Mannitol infusion|conventional mannitol infusion
5507153|NCT01265888|PAH|pah
5507322|NCT01265030|Desmoid Tumor|desmoid tumor
5507438|NCT01264549|PCT|pct
5507532|NCT01263977|goal directed volume therapy|goal directed volume therapy
5507635|NCT01263600|Pediatric|pediatric
5507728|NCT01263249|Continuous Infusion|continuous infusion
5507729|NCT01263249|Perineural Catheter|perineural catheter
5507730|NCT01263249|Volunteer|volunteer
5507732|NCT01263236|Depression|depression
5507825|NCT01262794|Healthy volunteers|healthy volunteers
5507826|NCT01262794|Japanese|japanese
5507827|NCT01262781|neonatal adiposity|neonatal adiposity
5507828|NCT01262781|metabolic syndrome|metabolic syndrome
5507916|NCT01262417|resorbable barrier membrane|resorbable barrier membrane
5508027|NCT01262040|10-180|10-180
5508028|NCT01262027|Metastatic inflammatory breast cancer|metastatic inflammatory breast cancer
5508029|NCT01262027|Stage IV disease|stage iv disease
5508030|NCT01262027|HER2-negative|her2-negative
5508031|NCT01262027|Dovitinib|dovitinib
5508032|NCT01262027|TKI258|tki258
5508033|NCT01262014|platinum|platinum
5508034|NCT01262014|resistant|resistant
5508035|NCT01262014|advanced|advanced
5508036|NCT01262014|ovarian|ovarian
5508037|NCT01262014|cancer|cancer
5508119|NCT01261572|Degarelix|degarelix
5508120|NCT01261572|ASP3550|asp3550
5508121|NCT01261572|Prostate cancer|prostate cancer
5508122|NCT01261559|Computed tomography|computed tomography
5508123|NCT01261559|Radiation dose|radiation dose
5508124|NCT01261559|Dose reduction|dose reduction
5508125|NCT01261559|Breast displacement|breast displacement
5508126|NCT01261559|Chrysalis device|chrysalis device
5508127|NCT01261559|Image quality|image quality
5508128|NCT01261546|pleural effusion, empyema, corticoids, dexamethasone|pleural effusion, empyema, corticoids, dexamethasone
5508129|NCT01261533|vitreous body substitute|vitreous body substitute
5508130|NCT01261533|foldable capsular vitreous body|foldable capsular vitreous body
5508131|NCT01261507|lung neoplasm nodule image processing computer-assisted|lung neoplasm nodule image processing computer-assisted
5510936|NCT01248754|Neurosurgery|neurosurgery
5508200|NCT01261182|Malnutrition|malnutrition
5508498|NCT01259908|aorto-iliac occlusive disease|aorto-iliac occlusive disease
5508499|NCT01259882|Pharmacokinetics Safety Tolerability Pharmacodynamics|pharmacokinetics safety tolerability pharmacodynamics
5508500|NCT01259856|Polycythemia vera|polycythemia vera
5508501|NCT01259856|Essential thrombocythemia|essential thrombocythemia
5508581|NCT01259531|BPH|bph
5508591|NCT01259479|Solid Tumor|solid tumor
5508687|NCT01259115|Transdermal|transdermal
5508785|NCT01258595|Trivalent Inactivated Influenza Vaccine|trivalent inactivated influenza vaccine
5509409|NCT01255709|shortness of breath|shortness of breath
5509700|NCT01254591|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5509701|NCT01254591|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5509702|NCT01254591|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5509703|NCT01254591|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5509704|NCT01254591|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5509705|NCT01254591|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5509706|NCT01254591|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5509707|NCT01254591|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5509708|NCT01254591|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5509709|NCT01254591|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5509710|NCT01254591|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5509711|NCT01254591|stage I salivary gland cancer|stage i salivary gland cancer
5509712|NCT01254591|stage II salivary gland cancer|stage ii salivary gland cancer
5509713|NCT01254591|stage III salivary gland cancer|stage iii salivary gland cancer
5509714|NCT01254591|tongue cancer|tongue cancer
5509715|NCT01254565|Clinical Trial, Phase 2|clinical trial, phase 2
5509967|NCT01253096|IL2|il2
5509968|NCT01253096|monoclonal|monoclonal
5509969|NCT01253096|antibody|antibody
5509970|NCT01253096|cytokine|cytokine
5509971|NCT01253096|metastatic|metastatic
5510025|NCT01252940|HIV|hiv
5510281|NCT01251809|Asparaginase|asparaginase
5510282|NCT01251809|ALL|all
5510283|NCT01251783|term babies|term babies
5510284|NCT01251770|Hyponatremia|hyponatremia
5510285|NCT01251770|Water-Electrolyte Imbalance|water-electrolyte imbalance
5510286|NCT01251757|diabetes|diabetes
5649148|NCT00706160|fMRI|fmri
5510710|NCT01249833|Mood|mood
5510795|NCT01249365|cervical neoplasia|cervical neoplasia
5510796|NCT01249365|serious adverse events (SAEs)|serious adverse events (saes)
5510797|NCT01249365|HPV vaccine|hpv vaccine
5511220|NCT01247493|fludarabine|fludarabine
5511407|NCT01246583|Multi Site|multi site
5681136|NCT00574574|CVD|cvd
5511497|NCT01246128|Schizophrenia Smokers|schizophrenia smokers
5511594|NCT01245764|genital warts|genital warts
5511614|NCT01245647|HIV|hiv
5511896|NCT01244308|Phrenic nerve stimulation|phrenic nerve stimulation
5511897|NCT01244308|LV pacing configuration|lv pacing configuration
5511898|NCT01244308|CRT|crt
5511999|NCT01243749|Real-world|real-world
5512090|NCT01243372|stage IIIC colon cancer|stage iiic colon cancer
5512091|NCT01243372|stage IVA colon cancer|stage iva colon cancer
5512100|NCT01243281|HBeAg|hbeag
5512479|NCT01241643|interleukin-7|interleukin-7
5512582|NCT01241318|maternal health|maternal health
5512805|NCT01240486|HIV|hiv
5512877|NCT01240096|Functional dyspepsia|functional dyspepsia
5512878|NCT01240096|Weight loss|weight loss
5512879|NCT01240096|Mirtazapine|mirtazapine
5513063|NCT01239199|environment|environment
5513064|NCT01239186|methylation|methylation
5513065|NCT01239186|micro array|micro array
5513066|NCT01239186|locus H19|locus h19
5513067|NCT01239186|male infertility|male infertility
5513161|NCT01238718|lidocaine|lidocaine
5513265|NCT01238380|genetic testing|genetic testing
5513602|NCT01237249|Velcade|velcade
5513786|NCT01236456|autoimmune|autoimmune
5513787|NCT01236391|Pharmacyclics|pharmacyclics
5513789|NCT01236391|Mantle Cell|mantle cell
5513790|NCT01236391|Lymphoma|lymphoma
5513791|NCT01236391|Non-Hodgkins|non-hodgkins
5513792|NCT01236391|Bortezomib|bortezomib
5513793|NCT01236391|Velcade|velcade
5513794|NCT01236391|Naive|naive
5513795|NCT01236391|PCYC|pcyc
5513884|NCT01236508|Carotid Artery Plaque Inflammation|carotid artery plaque inflammation
5513885|NCT01236508|FDG PET|fdg pet
5513886|NCT01236508|MRI|mri
5513887|NCT01236508|TIA|tia
5513888|NCT01236469|Aortic Valve|aortic valve
5513899|NCT01236313|TEE|tee
5513980|NCT01235910|Hypertension|hypertension
5514082|NCT01235364|labour|labour
5514083|NCT01235364|skin conductance|skin conductance
5514084|NCT01235364|visual analogue scale|visual analogue scale
5514085|NCT01235364|mechanical method|mechanical method
5514086|NCT01235351|Myocardial infarction|myocardial infarction
5514094|NCT01235325|adult|adult
5514346|NCT01234155|GIP|gip
5514463|NCT01233544|Liver metastases|liver metastases
5654071|NCT00685997|CT|ct
5514659|NCT01232647|vitamin K|vitamin k
5514754|NCT01232231|outpatient|outpatient
5514861|NCT01231685|Liver fibrosis|liver fibrosis
5514863|NCT01231685|Hepatitis C Virus|hepatitis c virus
5514864|NCT01231685|Coinfection|coinfection
5514932|NCT01231503|EPI|epi
5514962|NCT01231321|Adalimumab added to inadequate standard anti-rheumatic therapy in patients with active Rheumatoid Arthritis|adalimumab added to inadequate standard anti-rheumatic therapy in patients with active rheumatoid arthritis
5515048|NCT01230918|Sudden Death|sudden death
5515243|NCT01229956|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5515438|NCT01229072|Safety|safety
5515440|NCT01229059|FFA|ffa
5515533|NCT01228552|Migraine|migraine
5674664|NCT00602550|HIV|hiv
5515897|NCT01226693|pharmacokinetic|pharmacokinetic
5515906|NCT01226680|OCI|oci
5516075|NCT01225952|phacoemulsification|phacoemulsification
5516076|NCT01225952|intraocular lens|intraocular lens
5516077|NCT01225939|Type 2 diabetes mellitus|type 2 diabetes mellitus
5516078|NCT01225939|Healthy|healthy
5516080|NCT01225926|Toric|toric
5516165|NCT01225380|Hepatitis C|hepatitis c
5516167|NCT01225380|Rapid Virologic Response|rapid virologic response
5516168|NCT01225380|Sustained Virologic Response|sustained virologic response
5516169|NCT01225380|Direct Acting Antiviral|direct acting antiviral
5516170|NCT01225380|Combination Therapy|combination therapy
5516171|NCT01225380|HCV RNA|hcv rna
5516172|NCT01225380|Polymerase inhibitor|polymerase inhibitor
5516173|NCT01225380|Protease inhibitor|protease inhibitor
5516174|NCT01225380|Treatment naïve|treatment naïve
5516175|NCT01225380|GS-9190|gs-9190
5516176|NCT01225380|GS-9256|gs-9256
5516177|NCT01225354|Cheek|cheek
5516178|NCT01225354|Cheek flattening|cheek flattening
5516179|NCT01225354|Malar deficiency|malar deficiency
5516180|NCT01225354|Filler|filler
5516181|NCT01225341|HSV-1|hsv-1
5516182|NCT01225341|Herpes labialis|herpes labialis
5516183|NCT01225341|Cold sores|cold sores
5516184|NCT01225341|Fever blisters|fever blisters
5516185|NCT01225289|Multiple Sclerosis|multiple sclerosis
5516186|NCT01225289|Vitamin A|vitamin a
5516187|NCT01225289|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5516188|NCT01225289|Th1 Cells|th1 cells
5516189|NCT01225289|Th2 Cells|th2 cells
5516190|NCT01225276|CIDP|cidp
5516191|NCT01225276|IVIG|ivig
5516192|NCT01225263|Migraine disorders|migraine disorders
5516193|NCT01225263|Headache|headache
5516194|NCT01225263|Simvastatin|simvastatin
5516195|NCT01225263|Vitamin D|vitamin d
5516196|NCT01225250|Caudal septal extension graft|caudal septal extension graft
5516197|NCT01225250|Primary rhinoplasty|primary rhinoplasty
5516198|NCT01225250|Secondary rhinoplasty|secondary rhinoplasty
5516199|NCT01225237|diarrhea|diarrhea
5516200|NCT01225237|IBS|ibs
5516201|NCT01225237|Colonic disease|colonic disease
5516202|NCT01225237|YM060|ym060
5516203|NCT01225224|ASP015K|asp015k
5516204|NCT01225224|Ethnic difference|ethnic difference
5516445|NCT01224028|Prograf|prograf
5516620|NCT01223248|RT|rt
5516639|NCT01223209|Curative surgery|curative surgery
5516944|NCT01221883|Prevention|prevention
5517129|NCT01221181|Eculizumab|eculizumab
5517428|NCT01219920|Metastatic colorectal cancer|metastatic colorectal cancer
5517625|NCT01219244|cognition|cognition
5517626|NCT01219244|prevention|prevention
5517627|NCT01219244|lifestyle|lifestyle
5517628|NCT01219231|Exercise|exercise
5517629|NCT01219231|elderly|elderly
5518513|NCT01215448|Fatigue|fatigue
5518608|NCT01214889|Poliomyelitis|poliomyelitis
5518713|NCT01214395|haemodialysis|haemodialysis
5518913|NCT01213407|Somatic cell therapy|somatic cell therapy
5519153|NCT01212588|BPD|bpd
5519550|NCT01210937|Stroke|stroke
5519629|NCT01210703|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5519727|NCT01210261|OSA|osa
5519931|NCT01209273|Quality of Life|quality of life
5520040|NCT01208779|Compliance|compliance
5520129|NCT01208415|branch|branch
5520218|NCT01207947|Vardenafil|vardenafil
5520416|NCT01207089|Safety|safety
5520515|NCT01206569|glomerulonephritis|glomerulonephritis
5520608|NCT01206166|Intensive care unit|intensive care unit
5520609|NCT01206166|BMI < 25 or ≥ 35|bmi < 25 or ≥ 35
5520610|NCT01206114|2009 H1N1 influenza|2009 h1n1 influenza
5520611|NCT01206114|vaccination|vaccination
5520612|NCT01206114|pandemic|pandemic
5520907|NCT01204840|IVF|ivf
5521713|NCT01201954|pain|pain
5521941|NCT01200966|ET|et
5522021|NCT01200615|nocebo side-effects SSRI informed consent|nocebo side-effects ssri informed consent
5522022|NCT01200589|Randomized trial|randomized trial
5522023|NCT01200589|Ofatumumab|ofatumumab
5522024|NCT01200589|Rituximab|rituximab
5522025|NCT01200589|Indolent B-Cell Non Hodgkin Lymphoma|indolent b-cell non hodgkin lymphoma
5522026|NCT01200576|CRF: Case Report Form|crf: case report form
5522027|NCT01200576|DM: Data Management|dm: data management
5522028|NCT01200576|FHI: FHI (formerly known as Family Health International)|fhi: fhi (formerly known as family health international)
5671478|NCT00615888|complications|complications
5522199|NCT01200017|Precursor Cell Lymphoblastic Leukemia-Lymphoma|precursor cell lymphoblastic leukemia-lymphoma
5522200|NCT01200017|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5522201|NCT01200017|Leukemia, Myeloid|leukemia, myeloid
5522202|NCT01200017|Leukemia, Myelogenous, Chronic, BCR-ABL Positive|leukemia, myelogenous, chronic, bcr-abl positive
5522203|NCT01200017|Lymphoma|lymphoma
5522205|NCT01200017|Preleukemia|preleukemia
5522597|NCT01198418|HIV|hiv
5522617|NCT01198327|RVO|rvo
5522797|NCT01197365|Beta-palmitate|beta-palmitate
5522898|NCT01197053|Food Challenge|food challenge
5522988|NCT01196598|pelvic organ prolapse|pelvic organ prolapse
5522992|NCT01196585|CT|ct
5523382|NCT01194934|SDF-1|sdf-1
5523580|NCT01194024|Inhalation Injury, Acute|inhalation injury, acute
5523788|NCT01193101|hypertension|hypertension
5904038|NCT00007813|childhood germ cell tumor|childhood germ cell tumor
5523979|NCT01192438|prostate|prostate
5524133|NCT01191996|MS|ms
5524189|NCT01191775|Oligonucleotide|oligonucleotide
5524290|NCT01191372|pharmacodynamics|pharmacodynamics
5524484|NCT01190540|mid level health professionals.|mid level health professionals.
5524485|NCT01190540|cost effectiveness.|cost effectiveness.
5524486|NCT01190540|infectious disease.|infectious disease.
5524487|NCT01190540|capacity building.|capacity building.
5524488|NCT01190514|DVS SR|dvs sr
5524489|NCT01190514|healthy|healthy
5524490|NCT01190514|Bioequivalence study|bioequivalence study
5524491|NCT01190501|blood pressure|blood pressure
5524498|NCT01190488|Decision Aid|decision aid
5524567|NCT01190189|Cervical neoplasia|cervical neoplasia
5524569|NCT01190176|HPV vaccine|hpv vaccine
5524769|NCT01189305|Female Patients|female patients
5524858|NCT01188811|Magnetic resonance imaging|magnetic resonance imaging
5525055|NCT01187979|Cash incentive|cash incentive
5525153|NCT01187498|Clinical trial|clinical trial
5526048|NCT01183962|CVD|cvd
5526160|NCT01183663|Renal cell carcinoma|renal cell carcinoma
5526257|NCT01183247|MMF,|mmf,
5526576|NCT01181843|respiratory depression|respiratory depression
5526777|NCT01181115|Gadolinium|gadolinium
5526778|NCT01181115|Interferon Beta 1a|interferon beta 1a
5526779|NCT01181102|anticoagulant|anticoagulant
5526780|NCT01181102|venus thromboembolism|venus thromboembolism
5526878|NCT01180725|To investigate and compare the taste of dried plums and psyllium|to investigate and compare the taste of dried plums and psyllium
5527074|NCT01179919|Pharmacokinetics in Obesity|pharmacokinetics in obesity
5527075|NCT01179906|CKD|ckd
5527076|NCT01179893|Myasthenia Gravis|myasthenia gravis
5527077|NCT01179893|IVIG|ivig
5527078|NCT01179893|PLEX|plex
5527079|NCT01179880|Dermatitis|dermatitis
5527312|NCT01178684|HIV|hiv
5527379|NCT01178424|Relapse|relapse
5527573|NCT01177618|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5527574|NCT01177618|COPD|copd
5527581|NCT01177566|Elidel|elidel
5527669|NCT01177137|tinnitus retraining therapy|tinnitus retraining therapy
5527670|NCT01177137|standard of care|standard of care
5527692|NCT01177059|OZ1|oz1
5528175|NCT01175304|sleep|sleep
5528367|NCT01174576|inflammation|inflammation
5528687|NCT01173237|neonate|neonate
5528972|NCT01172028|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5529243|NCT01171261|Video Games|video games
5529346|NCT01170689|Schizophrenia|schizophrenia
5529347|NCT01170689|inpatient|inpatient
5529348|NCT01170689|obesity|obesity
5529349|NCT01170689|prevalence|prevalence
5529350|NCT01170676|asthma|asthma
5529351|NCT01170676|smoking|smoking
5529441|NCT01170312|Randomized|randomized
5529442|NCT01170312|Pilot|pilot
5529443|NCT01170299|radiation toxicity|radiation toxicity
5529444|NCT01170299|gastrointestinal complications|gastrointestinal complications
5529445|NCT01170299|cervical cancer|cervical cancer
5529446|NCT01170299|fallopian tube cancer|fallopian tube cancer
5529449|NCT01170299|ovarian sarcoma|ovarian sarcoma
5529551|NCT01169753|CML|cml
5529717|NCT01169194|Ulcerative Colitis|ulcerative colitis
5532354|NCT01157767|10-062|10-062
5529718|NCT01169194|Indeterminate Colitis|indeterminate colitis
5530007|NCT01168128|Critically ill|critically ill
5530100|NCT01167699|patient preference|patient preference
5530384|NCT01166542|carcinoma|carcinoma
5530882|NCT01164215|stage III rectal cancer|stage iii rectal cancer
5530959|NCT01164059|aripiprazole|aripiprazole
5530960|NCT01164059|haloperidol|haloperidol
5530961|NCT01164059|flupentixol|flupentixol
5531250|NCT01162668|obesity|obesity
5531346|NCT01162291|primary distribution of intramuscular NaCl representative for primary distribution of intramuscular botulinum toxin|primary distribution of intramuscular nacl representative for primary distribution of intramuscular botulinum toxin
5531347|NCT01162291|shift from extracellular to intracellular viewed by DTI technology|shift from extracellular to intracellular viewed by dti technology
5531348|NCT01162291|effect of volume|effect of volume
5531471|NCT01161693|CSE|cse
5531551|NCT01161316|cetuximab|cetuximab
5531573|NCT01161251|ABI|abi
5531767|NCT01160523|Ethiopa|ethiopa
5531920|NCT01159899|PRP|prp
5531978|NCT01159613|SVR|svr
5532173|NCT01158651|NF1|nf1
5532726|NCT01156155|osteoarthritis|osteoarthritis
5532777|NCT01156142|salivary gland cancer|salivary gland cancer
5532867|NCT01155700|allergic asthma|allergic asthma
5532868|NCT01155700|pediatric patients|pediatric patients
5532869|NCT01155687|afghanistan|afghanistan
5532870|NCT01155687|depression|depression
5532871|NCT01155687|anxiety|anxiety
5532872|NCT01155687|social stress|social stress
5532873|NCT01155687|counseling|counseling
5533450|NCT01153269|Human Immunodeficiency Virus|human immunodeficiency virus
5533451|NCT01153269|Co-infection with Hepatitis B or Hepatitis C|co-infection with hepatitis b or hepatitis c
5533452|NCT01153269|Tolerability|tolerability
5533453|NCT01153269|Effectiveness|effectiveness
5533454|NCT01153243|inflammatory markers|inflammatory markers
5533533|NCT01152918|HIV Prevention|hiv prevention
5533923|NCT01151267|Recovery from anesthesia|recovery from anesthesia
5533939|NCT01151215|Cancer|cancer
5534130|NCT01150396|outcome|outcome
5534513|NCT01148862|Type 1|type 1
5534520|NCT01148823|breast|breast
5534621|NCT01148368|fimasartan|fimasartan
5534622|NCT01148368|renal impairment|renal impairment
5534623|NCT01148368|hypertension|hypertension
5534624|NCT01148355|Craving|craving
5534627|NCT01148355|Nicotine|nicotine
5534628|NCT01148355|Reinforcement|reinforcement
5535033|NCT01147003|brain diseases|brain diseases
5535122|NCT01146574|ESRD|esrd
5535212|NCT01146132|Nutrition|nutrition
5535310|NCT01145677|Alcohol dependence|alcohol dependence
5535600|NCT01144416|Fertilization In Vitro|fertilization in vitro
5535695|NCT01143922|GI tract malignancies|gi tract malignancies
5536696|NCT01139814|atrial flutter|atrial flutter
5536716|NCT01139736|IBS|ibs
5536798|NCT01139450|Atopic Dermatitis|atopic dermatitis
5536995|NCT01138605|Darunavir|darunavir
5536996|NCT01138605|PREZISTA|prezista
5537081|NCT01138241|Serum Cystatin C[40]|serum cystatin c[40]
5537082|NCT01138241|Modification of Diet in Renal Disease (MDRD)|modification of diet in renal disease (mdrd)
5537083|NCT01138241|Cockcroft Gault Equation|cockcroft gault equation
5537084|NCT01138241|Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)|chronic kidney disease epidemiology collaboration (ckd-epi)
5537085|NCT01138241|99mTc-diethylenetriaminepentaacetic acid (Tc-99m DTPA) scan|99mtc-diethylenetriaminepentaacetic acid (tc-99m dtpa) scan
5537087|NCT01138228|intravenous cannulation|intravenous cannulation
5537099|NCT01138202|safety|safety
5537165|NCT01138020|TBI|tbi
5531653|NCT01160926|MEK inhibitor|mek inhibitor
5537371|NCT01137825|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5537372|NCT01137825|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5537389|NCT01137812|Metformin|metformin
5537455|NCT01137643|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5537456|NCT01137643|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5522323|NCT01199653|bone plates|bone plates
5537592|NCT01137630|scalp|scalp
5537862|NCT01136330|Prognosis|prognosis
5538159|NCT01134900|Medication Errors|medication errors
5538160|NCT01134900|Adverse Drug Events|adverse drug events
5538560|NCT01132885|Children|children
5538562|NCT01132885|HV|hv
5538563|NCT01132872|Serotonin 1A Receptor|serotonin 1a receptor
5538564|NCT01132872|Positron Emission Tomograhy (PET)|positron emission tomograhy (pet)
5538565|NCT01132872|Dosimetry|dosimetry
5538566|NCT01132872|Healthy Volunteer|healthy volunteer
5538567|NCT01132872|HV|hv
5538575|NCT01132833|thromboembolism|thromboembolism
5538576|NCT01132833|stage I multiple myeloma|stage i multiple myeloma
5538656|NCT01132547|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5538726|NCT01132547|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5538796|NCT01132534|OGD|ogd
5539265|NCT01130402|lymphadenopathy|lymphadenopathy
5539267|NCT01130402|sonography|sonography
5539368|NCT01129830|anti-mullerian hormone|anti-mullerian hormone
5539475|NCT01129284|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5539871|NCT01127724|Vitamin B12|vitamin b12
5539968|NCT01127282|improvement of symptom|improvement of symptom
5540172|NCT01126268|Eczema|eczema
5540760|NCT01123902|Hand-held fan|hand-held fan
5540961|NCT01123161|Brain Infarction|brain infarction
5541169|NCT01122160|gastric pH|gastric ph
5541468|NCT01120691|NVA237|nva237
5541469|NCT01120691|COPD|copd
5541470|NCT01120691|exacerbation|exacerbation
5541471|NCT01120691|combination bronchodilator|combination bronchodilator
5541472|NCT01120678|cytokines|cytokines
5541496|NCT01120561|EAP|eap
5541565|NCT01120262|recurrent prostate cancer|recurrent prostate cancer
5541566|NCT01120262|stage IV prostate cancer|stage iv prostate cancer
5541572|NCT01120210|Heart Failure|heart failure
5541671|NCT01119716|AF|af
5542068|NCT01118312|Asthma|asthma
5536603|NCT01140256|SGA|sga
5542333|NCT01117545|depression,|depression,
5542334|NCT01117545|anxiety|anxiety
5542335|NCT01117532|students,|students,
5542336|NCT01117532|depression,|depression,
5542337|NCT01117532|group therapy,|group therapy,
5846761|NCT00043498|Pollutants|pollutants
5542349|NCT01117506|ASGES|asges
5542427|NCT01117220|pediatric|pediatric
5542524|NCT01116869|Medical examinations detect no breast benign and malignant tumors|medical examinations detect no breast benign and malignant tumors
5542525|NCT01116869|Benign Breast Disease|benign breast disease
5542527|NCT01116856|Exercise|exercise
5542616|NCT01116531|Interaction|interaction
5542861|NCT01116128|dasatinib|dasatinib
5542919|NCT01115803|Non-Small Cell Lung Cancer|non-small cell lung cancer
5543020|NCT01115283|vision therapy|vision therapy
5543309|NCT01114217|IDA|ida
5543533|NCT01113346|rotavirus|rotavirus
5543834|NCT01112046|Early colorectal neoplasms|early colorectal neoplasms
5543835|NCT01112033|biliverdin reductase|biliverdin reductase
5543836|NCT01112033|BLVRA|blvra
5543837|NCT01112033|hepatitis C|hepatitis c
5543838|NCT01112033|HCV|hcv
5543929|NCT01111682|traumatic brain injury|traumatic brain injury
5544125|NCT01110824|lymphoma|lymphoma
5544213|NCT01110369|protein drink|protein drink
5544214|NCT01110369|resistance exercise|resistance exercise
5544215|NCT01110369|Skeletal muscle mass|skeletal muscle mass
5544216|NCT01110369|muscle mass in elderly|muscle mass in elderly
5544217|NCT01110343|parent stress|parent stress
5544218|NCT01110343|parent coping|parent coping
5544219|NCT01110343|parent anxiety|parent anxiety
5544220|NCT01110343|parent health|parent health
5544305|NCT01110083|advanced solid tumors|advanced solid tumors
5544403|NCT01109602|Stroke|stroke
5544498|NCT01109329|Vaccine|vaccine
5544593|NCT01108887|RebiSmart|rebismart
5544669|NCT01108614|HIV|hiv
5544889|NCT01107600|Bone Regeneration|bone regeneration
5544988|NCT01107080|invasive carcinoma|invasive carcinoma
5545086|NCT01106690|Sitagliptin (Januvia)|sitagliptin (januvia)
5545087|NCT01106690|Metformin|metformin
5545088|NCT01106690|Pioglitazone (Actos)|pioglitazone (actos)
5545089|NCT01106690|Hemoglobin A1c|hemoglobin a1c
5545090|NCT01106690|Type 2 diabetes mellitus|type 2 diabetes mellitus
5545091|NCT01106677|Type 2 diabetes mellitus|type 2 diabetes mellitus
5545092|NCT01106677|Canagliflozin|canagliflozin
5545093|NCT01106677|Placebo|placebo
5545094|NCT01106677|Sitagliptin|sitagliptin
5545095|NCT01106677|Januvia|januvia
5545096|NCT01106677|Metformin Immediate Release (IR)|metformin immediate release (ir)
5545097|NCT01106677|Hemoglobin A1c|hemoglobin a1c
5545268|NCT01105897|surgery|surgery
5545550|NCT01104779|Mental Disorders|mental disorders
5545649|NCT01104246|Testosterone|testosterone
5545742|NCT01103817|Vitamin D|vitamin d
5546132|NCT01102088|5-Fluorouracil|5-fluorouracil
5546134|NCT01102088|Adrucil|adrucil
5546135|NCT01102088|Efudex|efudex
5546136|NCT01102088|Docetaxel|docetaxel
5546137|NCT01102088|Taxotere|taxotere
5546138|NCT01102088|Radiation|radiation
5546139|NCT01102088|chemoradiation|chemoradiation
5546140|NCT01102075|Obesity|obesity
5546141|NCT01102075|Electroacupuncture|electroacupuncture
5713513|NCT00452374|CLL|cll
5546530|NCT01100996|endotoxemia|endotoxemia
5546718|NCT01100190|Facelift|facelift
5546719|NCT01100190|Rhytidectomy|rhytidectomy
5546723|NCT01100164|INSOMNIA|insomnia
5547234|NCT01098136|Chiropractic|chiropractic
5547354|NCT01097538|fatigue|fatigue
5547545|NCT01096719|Hunger|hunger
5680652|NCT00577161|pixantrone|pixantrone
5547796|NCT01095926|Ewing|ewing
5547820|NCT01095848|vaccine|vaccine
5547997|NCT01095328|Q fever|q fever
5548583|NCT01093001|Lead position|lead position
5548867|NCT01091766|heart rate|heart rate
5548872|NCT01091766|prevention|prevention
5692161|NCT00529126|pain|pain
5548970|NCT01091311|Meibomian Gland Dysfunction|meibomian gland dysfunction
5549176|NCT01090336|ACS|acs
5549244|NCT01090050|naproxen|naproxen
5549448|NCT01089257|Cardiovascular risks|cardiovascular risks
5549554|NCT01088789|GM-CSF|gm-csf
5549826|NCT01087723|EUROMAX|euromax
5550017|NCT01087203|tanezumab|tanezumab
5550156|NCT01086657|HV|hv
5550257|NCT01086124|Heart failure|heart failure
5550258|NCT01086124|Coronary artery disease|coronary artery disease
5550352|NCT01085799|Hookworm|hookworm
5550445|NCT01085435|ICD|icd
5550446|NCT01085435|defibrillator|defibrillator
5550447|NCT01085422|Prostate Cancer|prostate cancer
5550482|NCT01085279|melasma|melasma
5550533|NCT01085019|Endothelial function|endothelial function
5550727|NCT01084200|Sevoflurane|sevoflurane
5550929|NCT01083355|Variable ventilation|variable ventilation
5551040|NCT01082939|Cytoxan|cytoxan
5551225|NCT01082237|SSRI|ssri
5551238|NCT01082185|abdominal|abdominal
5551434|NCT01081574|Allergy|allergy
5551624|NCT01080833|ERCP|ercp
5551726|NCT01080274|ergometry|ergometry
5551816|NCT01079923|healthy subjects|healthy subjects
5552109|NCT01078610|Humira|humira
5552205|NCT01078272|Coronary Stenting|coronary stenting
5552444|NCT01077440|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5552532|NCT01077245|Anti-Infective Agents|anti-infective agents
5552633|NCT01076790|Heart|heart
5552742|NCT01076179|Non nucleoside reverse transcriptase inhibitors (NNRTIs)|non nucleoside reverse transcriptase inhibitors (nnrtis)
5552743|NCT01076179|Integrase inhibitors|integrase inhibitors
5552744|NCT01076179|Raltegravir|raltegravir
5552745|NCT01076179|Kaletra|kaletra
5552746|NCT01076166|Post-marketing observational study|post-marketing observational study
5552747|NCT01076166|Lower respiratory tract infections|lower respiratory tract infections
5553013|NCT01075165|scar assessment|scar assessment
5553014|NCT01075165|abnormal scarring|abnormal scarring
5553015|NCT01075165|Burn patients|burn patients
5553016|NCT01075152|cryptococcal meningitis|cryptococcal meningitis
5553017|NCT01075152|cryptococcus|cryptococcus
5553018|NCT01075152|cryptococcosis|cryptococcosis
5553019|NCT01075152|HIV|hiv
5553020|NCT01075152|AIDS|aids
5553021|NCT01075152|strategy|strategy
5553022|NCT01075139|Motivational interviewing|motivational interviewing
5553023|NCT01075139|Physical activity|physical activity
5553024|NCT01075139|Diet|diet
5553025|NCT01075126|bipolar affective disorder|bipolar affective disorder
5553026|NCT01075126|African American|african american
5553027|NCT01075126|antimanic|antimanic
5553028|NCT01075126|lithium|lithium
5553029|NCT01075126|depakote|depakote
5553030|NCT01075113|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5553298|NCT01074021|Nasopharyngeal cancer|nasopharyngeal cancer
5553299|NCT01074021|chemoradiation|chemoradiation
5553300|NCT01073995|Radiculopathy|radiculopathy
5553301|NCT01073995|Sciatica|sciatica
5553302|NCT01073995|Lumbar Disc Herniation|lumbar disc herniation
5553399|NCT01073592|HMP|hmp
5553479|NCT01073397|Yoga|yoga
5554072|NCT01070680|Chronic Alcoholic pancreatitis|chronic alcoholic pancreatitis
5554074|NCT01070667|AF|af
5554075|NCT01070667|Dronedarone|dronedarone
5554076|NCT01070667|AF Burden|af burden
5554077|NCT01070667|AFB|afb
5554078|NCT01070667|PPM|ppm
5554079|NCT01070667|Permanent Pacemaker|permanent pacemaker
5554081|NCT01070654|ARDS|ards
5554370|NCT01069367|Vaccine|vaccine
5554558|NCT01068470|Interleukin-2|interleukin-2
5554675|NCT01068015|MSM|msm
5554750|NCT01067729|Pain perception|pain perception
5554751|NCT01067729|Non adherence|non adherence
5554752|NCT01067729|Scarring|scarring
5554846|NCT01067300|young|young
5554935|NCT01067014|Lumbar spinal decompression|lumbar spinal decompression
5555621|NCT01064206|cannabis|cannabis
5555647|NCT01064089|MTD|mtd
5555727|NCT01063725|menopause|menopause
5555830|NCT01063244|pregnancy|pregnancy
5555831|NCT01063244|induction of Labor|induction of labor
5555832|NCT01063244|Cervical ripening|cervical ripening
5555833|NCT01063244|Foley balloon|foley balloon
5555922|NCT01062776|dehydration|dehydration
5555923|NCT01062776|fluid therapy|fluid therapy
5555924|NCT01062776|pharmacokinetics|pharmacokinetics
5555925|NCT01062776|hemoglobin|hemoglobin
5555926|NCT01062763|hypertension|hypertension
5555927|NCT01062763|spironolactone|spironolactone
5556336|NCT01061112|Healthy Volunteers|healthy volunteers
5556547|NCT01060202|QoL|qol
5556637|NCT01059760|Fasting|fasting
5556726|NCT01059461|Cerebrolysin|cerebrolysin
5556823|NCT01059162|Non Penetrating glaucoma surgery|non penetrating glaucoma surgery
5557020|NCT01058343|SLE|sle
5557489|NCT01056224|short acting opioid|short acting opioid
5557590|NCT01055821|Hepatitis C|hepatitis c
5557689|NCT01055483|AML|aml
5557834|NCT01054729|HCV|hcv
5558080|NCT01053819|melanoma|melanoma
5558373|NCT01052714|Weight Gain|weight gain
5558472|NCT01052311|Endothelial function|endothelial function
5558473|NCT01052311|Platelet function|platelet function
5558870|NCT01050725|proteome|proteome
5559067|NCT01049932|HIV Seronegativity|hiv seronegativity
5559264|NCT01049243|Topical|topical
5559370|NCT01048970|Inflammatory response|inflammatory response
5559371|NCT01048957|Nicotine|nicotine
5559372|NCT01048957|Craving|craving
5559495|NCT01048476|AMD|amd
5559566|NCT01048177|vulvodynia|vulvodynia
5559967|NCT01047683|pravastatin|pravastatin
5560077|NCT01047436|quinine|quinine
5560368|NCT01046409|Bifurcation|bifurcation
5560369|NCT01046409|Myocardial infarction|myocardial infarction
5560387|NCT01046305|CML|cml
5560661|NCT01045044|Breast cancer|breast cancer
5560947|NCT01043939|cardiovascular disease|cardiovascular disease
5561047|NCT01043588|Men health|men health
5561155|NCT01043081|Chlamydia|chlamydia
5561252|NCT01042717|multiple myeloma|multiple myeloma
5561459|NCT01041898|insulin|insulin
5561544|NCT01041547|Flow-mediated dilation|flow-mediated dilation
5561640|NCT01041235|Lung|lung
5561641|NCT01041235|NSCLC|nsclc
5561642|NCT01041235|Non Small Cell Lung|non small cell lung
5561643|NCT01041235|Prostate|prostate
5561644|NCT01041235|Gastric|gastric
5561645|NCT01041235|Head and Neck|head and neck
5561646|NCT01041222|Familial ALS|familial als
5561647|NCT01041222|ALS|als
5561648|NCT01041222|SOD1 Protein|sod1 protein
5561649|NCT01041222|ISIS 333611|isis 333611
5561650|NCT01041222|SOD1Rx|sod1rx
5561651|NCT01041209|Pneumonia|pneumonia
5562003|NCT01039831|white matter|white matter
5562004|NCT01039818|Graves Disease|graves disease
5562005|NCT01039818|Hyperthyroidism|hyperthyroidism
5562006|NCT01039818|Radioiodine|radioiodine
5562007|NCT01039818|Clinical trial|clinical trial
5562222|NCT01038934|DNA|dna
5562305|NCT01038583|Healthy|healthy
5562307|NCT01038583|ASPREE|aspree
5562511|NCT01037907|BGC20-0134|bgc20-0134
5562512|NCT01037907|RRMS|rrms
5562513|NCT01037894|Acupuncture,Intracerebral hemorrhage, Stroke|acupuncture,intracerebral hemorrhage, stroke
5562514|NCT01037868|depression|depression
5562515|NCT01037868|alcohol dependency syndrome|alcohol dependency syndrome
5562599|NCT01037556|Refractory ALL|refractory all
5562694|NCT01037049|Rectal Cancer|rectal cancer
5562792|NCT01036308|short-chain fatty acids|short-chain fatty acids
5563872|NCT01031719|Virus Diseases|virus diseases
5564416|NCT01029730|Treanda|treanda
5564589|NCT01029015|OAB|oab
5565155|NCT01026480|HNPCC|hnpcc
5565348|NCT01025596|hepatitis C|hepatitis c
5565349|NCT01025596|chronic hepatitis|chronic hepatitis
5565350|NCT01025596|resistance to Peg-interferon and ribavirin bi-therapy|resistance to peg-interferon and ribavirin bi-therapy
5565352|NCT01025596|phase 1|phase 1
5565442|NCT01025206|Multiple Myeloma|multiple myeloma
5565549|NCT01024829|HX4|hx4
5565644|NCT01024361|Nasal CPAP|nasal cpap
5565832|NCT01023542|Bottom-Up|bottom-up
5566042|NCT01022866|older adults|older adults
5566044|NCT01022827|massage|massage
5566611|NCT01020539|JMML|jmml
5566614|NCT01020474|pregabalin|pregabalin
5567014|NCT01020292|Adult subjects with a diagnosis of Grade IV Glioma|adult subjects with a diagnosis of grade iv glioma
5567015|NCT01020097|Stage 1 squamous cell carcinoma of the larynx|stage 1 squamous cell carcinoma of the larynx
5567018|NCT01019122|DEXA scan|dexa scan
5567019|NCT01019122|bone density|bone density
5567109|NCT01018134|Psoriasis|psoriasis
5567195|NCT01017744|Intrinsic positive end expiratory pressure|intrinsic positive end expiratory pressure
5567196|NCT01017744|Ventilatory dead space|ventilatory dead space
5567197|NCT01017744|Intensive care|intensive care
5798728|NCT00111254|photoaging|photoaging
5567206|NCT01017731|QTc|qtc
5567289|NCT01017237|Dexmedetomidine sedation|dexmedetomidine sedation
5567290|NCT01017237|Oral surgery sedation|oral surgery sedation
5567292|NCT01017211|Pain|pain
5567375|NCT01016860|OSI-906, irinotecan, colorectal cancer|osi-906, irinotecan, colorectal cancer
5567504|NCT01016340|MCS|mcs
5567724|NCT01015742|AML|aml
5568033|NCT01014611|Muscle biopsy|muscle biopsy
5568132|NCT01014208|Grupo Espanol de Linfomas|grupo espanol de linfomas
5568227|NCT01013792|DFU|dfu
5568324|NCT01013363|anesthesia|anesthesia
5568422|NCT01012947|MMSE|mmse
5568510|NCT01012544|clopidogrel|clopidogrel
5568770|NCT01011270|RDM|rdm
5569224|NCT01009398|Regional anesthesia|regional anesthesia
5569328|NCT01009125|motivation|motivation
5569552|NCT01008410|UC|uc
5569629|NCT01008124|BPPV|bppv
5569630|NCT01008124|PC|pc
5569631|NCT01008124|BPPN|bppn
5569832|NCT01007240|obturators|obturators
5569936|NCT01006811|West syndrome|west syndrome
5570026|NCT01006447|exercise|exercise
5570088|NCT01006304|Men|men
5570125|NCT01006005|Treatment experienced|treatment experienced
5570335|NCT01005212|EVAR|evar
5570504|NCT01004432|arthritis|arthritis
5570599|NCT01004094|goal setting|goal setting
5570698|NCT01003613|Tranilast|tranilast
5570823|NCT01003171|PK|pk
5570999|NCT01002482|Glucose Control|glucose control
5571108|NCT01002066|RDT|rdt
5571247|NCT01001507|HIV|hiv
5571298|NCT01001247|TMC278-C154|tmc278-c154
5571299|NCT01001247|TMC278|tmc278
5571300|NCT01001247|Healthy volunteers|healthy volunteers
5571301|NCT01001247|omeprazole|omeprazole
5571303|NCT01001247|HIV|hiv
5571391|NCT01000857|repeat dose|repeat dose
5571491|NCT01000428|NSCLC|nsclc
5571492|NCT01000428|Tarceva|tarceva
5571593|NCT00999999|Craniotomy outcome|craniotomy outcome
5571876|NCT00999011|cytokines|cytokines
5571877|NCT00999011|mechanical ventilation|mechanical ventilation
5571878|NCT00999011|activity|activity
5571879|NCT00999011|mobility therapy|mobility therapy
5571880|NCT00999011|More than 48 hours of mechanical ventilation|more than 48 hours of mechanical ventilation
5571881|NCT00998998|iron deficiency anemia|iron deficiency anemia
5571882|NCT00998998|infant behavior|infant behavior
5571883|NCT00998998|infant development|infant development
5571884|NCT00998972|kidney graft,|kidney graft,
5571885|NCT00998972|delayed graft function|delayed graft function
5571987|NCT00998465|Obesity|obesity
5572265|NCT00997477|aerolizer|aerolizer
5572266|NCT00997477|formoterol|formoterol
5572647|NCT00996138|Influenza A|influenza a
5572648|NCT00996138|H1N1 subtype|h1n1 subtype
5572650|NCT00996138|Vaccine|vaccine
5572651|NCT00996138|Adjuvant|adjuvant
5572652|NCT00996138|Swine-Origin Influenza A H1N1 Virus|swine-origin influenza a h1n1 virus
5572653|NCT00996125|Immunogenicity|immunogenicity
5572654|NCT00996125|Safety|safety
5572655|NCT00996125|Human papillomavirus|human papillomavirus
5572656|NCT00996125|China|china
5572724|NCT00996021|GSK1349572|gsk1349572
5572810|NCT00995696|Antidepressant|antidepressant
5572914|NCT00995280|needle|needle
5573018|NCT00994955|laser|laser
5573107|NCT00994487|Preload|preload
5573204|NCT00994123|ErbB3 antagonist|erbb3 antagonist
5573303|NCT00993733|acute renal failure|acute renal failure
5573304|NCT00993733|intensive care unit|intensive care unit
5573305|NCT00993720|patients with type 1 diabetes mellitus|patients with type 1 diabetes mellitus
5573308|NCT00993694|aplastic anemia|aplastic anemia
5573597|NCT00993005|Asian Pennywort|asian pennywort
5573449|NCT00993668|influenza|influenza
5573961|NCT00991588|PCL|pcl
5574106|NCT00991081|motivational interviewing|motivational interviewing
5574203|NCT00990600|immunologic efficacy|immunologic efficacy
5574401|NCT00989872|Safety|safety
5574490|NCT00989508|Troponin|troponin
5574599|NCT00989092|anemia of cancer|anemia of cancer
5574692|NCT00988650|Coronary heart disease|coronary heart disease
5574706|NCT00988559|HPV|hpv
5574792|NCT00988182|Hydrolysate whey protein|hydrolysate whey protein
5575001|NCT00987480|Anemia|anemia
5575094|NCT00987168|Hypoglycemia,|hypoglycemia,
5575584|NCT00985218|infertility|infertility
5575791|NCT00984386|Scar|scar
5575585|NCT00985218|embryo development|embryo development
5575586|NCT00985205|Randomized Clinical Trial|randomized clinical trial
5575587|NCT00985205|Glutamine|glutamine
5575588|NCT00985205|Themal Burn Injuries|themal burn injuries
5575590|NCT00985205|Outcome Assessment|outcome assessment
5575591|NCT00985205|Critical Care|critical care
5575592|NCT00985205|Total Body Surface Area|total body surface area
5575593|NCT00985192|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5575594|NCT00985192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5575777|NCT00984464|carboplatin|carboplatin
5576113|NCT00983593|Mind Body Bridging|mind body bridging
5576089|NCT00983697|tongue cancer|tongue cancer
5576283|NCT00982865|Cancer|cancer
5576580|NCT00981578|lung cancer|lung cancer
5576674|NCT00981253|Stress|stress
5576973|NCT00980083|GLP-1|glp-1
5577378|NCT00978484|PTSD|ptsd
5577491|NCT00978211|radiopeptide|radiopeptide
5577797|NCT00976859|CSA|csa
5578481|NCT00974376|Cannabis Use|cannabis use
5578652|NCT00973921|Stent|stent
5578693|NCT00973752|ALL|all
5578790|NCT00973388|ECG|ecg
5579174|NCT00971750|obesity|obesity
5579285|NCT00971204|PAF|paf
5579679|NCT00969436|Measles|measles
5579680|NCT00969436|Humans|humans
5579787|NCT00969046|DLT|dlt
5580104|NCT00968058|Leak Pressure|leak pressure
5580112|NCT00968032|PFO|pfo
5580203|NCT00967616|combination|combination
5580204|NCT00967616|chemotherapy|chemotherapy
5580205|NCT00967603|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5580302|NCT00967252|inflammation|inflammation
5580389|NCT00966888|stage II breast cancer|stage ii breast cancer
5580587|NCT00965965|health behavior|health behavior
5580588|NCT00965965|randomized controlled trials|randomized controlled trials
5580589|NCT00965965|self-efficacy|self-efficacy
5580590|NCT00965965|patient education|patient education
5580675|NCT00965562|PMS|pms
5580679|NCT00965536|Manic Disorder|manic disorder
5580680|NCT00965536|Register study|register study
5580681|NCT00965536|Quetiapine|quetiapine
5580682|NCT00965536|Quetiapine Prolong|quetiapine prolong
5580768|NCT00965276|Paclitaxel|paclitaxel
5580920|NCT00964821|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5581197|NCT00963859|RA-PLND|ra-plnd
5581541|NCT00962715|TIV|tiv
5581828|NCT00961571|capecitabine|capecitabine
5582130|NCT00960310|Treatment|treatment
5582230|NCT00959868|Radical cystectomy|radical cystectomy
5582332|NCT00959452|Hypochondria|hypochondria
5582519|NCT00958542|cerebral palsy|cerebral palsy
5672108|NCT00612989|Glioblastoma|glioblastoma
5582774|NCT00957736|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5582875|NCT00957463|endothelial function|endothelial function
5672110|NCT00612989|GBM|gbm
5582943|NCT00957242|IPF|ipf
5583030|NCT00956735|Cardiovascular disease risk factors in adults with Type II diabetes|cardiovascular disease risk factors in adults with type ii diabetes
5904058|NCT00007813|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5583032|NCT00956696|mental retardation|mental retardation
5583033|NCT00956683|infraclavicular nerve block ultrasound dual endpoint stimulation|infraclavicular nerve block ultrasound dual endpoint stimulation
5583034|NCT00956657|Randomised Controlled Trial|randomised controlled trial
5583035|NCT00956657|Adherence|adherence
5583440|NCT00955669|mononuclear cells|mononuclear cells
5583634|NCT00954941|AML|aml
5583826|NCT00953810|education|education
5584427|NCT00951730|Adult|adult
5584572|NCT00951522|CF|cf
5584774|NCT00950820|Cancer|cancer
5584963|NCT00950105|Anti TNF alpha|anti tnf alpha
5584964|NCT00950105|Crohn's Disease|crohn's disease
5585072|NCT00949624|PDGFr Inhibition;|pdgfr inhibition;
5585161|NCT00949234|HIV seronegativity|hiv seronegativity
5585386|NCT00948961|myeloma|myeloma
5585459|NCT00948740|vitamin D|vitamin d
5585460|NCT00948701|Breast cancer|breast cancer
5585467|NCT00948688|Zolinza|zolinza
5585547|NCT00948285|magnetic resonance imaging|magnetic resonance imaging
5585548|NCT00948272|Rabies|rabies
5585789|NCT00947427|T1D|t1d
5585983|NCT00946569|Chronic asthma|chronic asthma
5586126|NCT00946283|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5586614|NCT00944372|Tumor|tumor
5586916|NCT00943085|High Risk Youth|high risk youth
5587016|NCT00942786|emergency non-cardiac surgery|emergency non-cardiac surgery
5587099|NCT00942435|VTE|vte
5587112|NCT00942383|metastatic cancer|metastatic cancer
5587317|NCT00941876|ULN|uln
5587410|NCT00941538|nasopharyngeal cancer|nasopharyngeal cancer
5587615|NCT00940524|DACTINOMYCIN|dactinomycin
5587616|NCT00940524|DASATINIB|dasatinib
5587711|NCT00940160|Asthma|asthma
5587824|NCT00939601|Adherence|adherence
5587915|NCT00939120|dutasteride|dutasteride
5588213|NCT00937742|Lycopene|lycopene
5588372|NCT00937235|Anxiety|anxiety
5588484|NCT00936793|HIV|hiv
5588767|NCT00935675|Patients with head and neck squamous cell carcinomas|patients with head and neck squamous cell carcinomas
5588768|NCT00935675|head and neck squamous cell carcinomas|head and neck squamous cell carcinomas
5588769|NCT00935662|First time in man|first time in man
5588770|NCT00935662|Safety study|safety study
5588771|NCT00935662|AZD8329|azd8329
5588772|NCT00935649|Toenail Fungus|toenail fungus
5588773|NCT00935649|PinPointe|pinpointe
5588774|NCT00935649|FootLaser|footlaser
5588775|NCT00935649|Onychomycosis|onychomycosis
5588776|NCT00935649|Fungal nails|fungal nails
5588777|NCT00935636|Intubation|intubation
5588778|NCT00935623|Malaria, Plasmodium vivax|malaria, plasmodium vivax
5588779|NCT00935610|Elderly persons|elderly persons
5588780|NCT00935610|Muscle function and strength|muscle function and strength
5588853|NCT00935350|viscous|viscous
5748556|NCT00325273|Asthma|asthma
5589051|NCT00935090|primary myelofibrosis|primary myelofibrosis
5589052|NCT00935090|essential thrombocythemia|essential thrombocythemia
5589448|NCT00933283|Steady-state|steady-state
5589541|NCT00932724|Metastatic|metastatic
5589741|NCT00931866|topical|topical
5589835|NCT00931450|HER2-negative breast cancer|her2-negative breast cancer
5589836|NCT00931450|stage IA breast cancer|stage ia breast cancer
5589837|NCT00931450|stage IB breast cancer|stage ib breast cancer
5589838|NCT00931450|stage II breast cancer|stage ii breast cancer
5589839|NCT00931450|stage IIIA breast cancer|stage iiia breast cancer
5589840|NCT00931450|stage IIIB breast cancer|stage iiib breast cancer
5589841|NCT00931437|vitamin K|vitamin k
5589923|NCT00930982|Airway infection|airway infection
5590116|NCT00930215|homo-EM|homo-em
5590424|NCT00929019|chromosome 3|chromosome 3
5590514|NCT00928720|pain|pain
5590607|NCT00928304|Amyloid beta-protein|amyloid beta-protein
5590709|NCT00927940|RESTENOTIC LESION|restenotic lesion
5590710|NCT00927940|PERCUTANEOUS CORONARY INTERVENTION (PCI)|percutaneous coronary intervention (pci)
5590711|NCT00927901|QAB149|qab149
5590802|NCT00927576|cognitive training|cognitive training
5590803|NCT00927576|neuroplasticity|neuroplasticity
5590804|NCT00927576|cognitive impairment|cognitive impairment
5590805|NCT00927576|recovery of function|recovery of function
5590807|NCT00927576|attention|attention
5590994|NCT00926692|CD5+|cd5+
5591283|NCT00925457|Serious ventricular arrhythmia|serious ventricular arrhythmia
5591597|NCT00924352|Metastatic Breast Cancer|metastatic breast cancer
5591718|NCT00923936|VEGF|vegf
5591719|NCT00923936|Bevacizumab|bevacizumab
5591720|NCT00923923|stress reactivity|stress reactivity
5591922|NCT00923338|vesico-vaginal fistula|vesico-vaginal fistula
5592048|NCT00922896|Gemcitabine|gemcitabine
5592144|NCT00922441|Essential Hypertension|essential hypertension
5592363|NCT00921583|survival rate|survival rate
5592459|NCT00921219|Healthy volunteers|healthy volunteers
5592560|NCT00920868|Colorectal|colorectal
5592561|NCT00920868|Dasatinib|dasatinib
5592657|NCT00920621|Vitamin D|vitamin d
5592839|NCT00919919|progesterone|progesterone
5592941|NCT00919503|Diamond Blackfan Anemia|diamond blackfan anemia
5593241|NCT00918411|IBS|ibs
5593306|NCT00918073|HIV|hiv
5593487|NCT00917254|Thrombosis|thrombosis
5593488|NCT00917254|VTE|vte
5593489|NCT00917254|Knee Replacement|knee replacement
5593535|NCT00917098|CBT|cbt
5593587|NCT00916903|FENIB|fenib
5593683|NCT00916552|cognitive function|cognitive function
5593878|NCT00915707|obesity|obesity
5594186|NCT00914511|Semen|semen
5594486|NCT00913081|Skin|skin
5594786|NCT00911794|Pulmonary Rehabilitation|pulmonary rehabilitation
5594883|NCT00911391|Colectomy|colectomy
5594884|NCT00911391|ERAS|eras
5594885|NCT00911391|Fluid|fluid
5594982|NCT00911053|sleep|sleep
5595098|NCT00910598|clinically isolated syndrome|clinically isolated syndrome
5595099|NCT00910598|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5595100|NCT00910598|glatiramer acetate|glatiramer acetate
5595102|NCT00910585|childhood|childhood
5595191|NCT00910286|patient-ventilator interaction|patient-ventilator interaction
5595192|NCT00910286|patient comfort|patient comfort
5595193|NCT00910273|IMT evaluation in AS patients treated with etanercept|imt evaluation in as patients treated with etanercept
5595194|NCT00910260|vitamin D level under phototherapy|vitamin d level under phototherapy
5595195|NCT00910247|Seizures|seizures
5595196|NCT00910247|Epilepsy|epilepsy
5595197|NCT00910247|Anticonvulsant|anticonvulsant
5595282|NCT00909961|Biomarkers|biomarkers
5595489|NCT00909116|ODS|ods
5595768|NCT00907907|Subjects|subjects
5595961|NCT00907075|foods|foods
5596157|NCT00906178|HIV prevention|hiv prevention
5596284|NCT00905671|LCP|lcp
5596361|NCT00905333|candesartan|candesartan
5596552|NCT00904722|Rituxan|rituxan
5596803|NCT00903760|Myelodysplastic Syndrome|myelodysplastic syndrome
5597011|NCT00903084|Tenofovir|tenofovir
5597014|NCT00903084|Hair|hair
5597209|NCT00902226|SAD|sad
5597249|NCT00902031|Docusate|docusate
5597412|NCT00901550|MTX|mtx
5597454|NCT00901407|augmentation|augmentation
5597456|NCT00901407|resistance|resistance
5597457|NCT00901394|Nitrous oxide|nitrous oxide
5597458|NCT00901394|cobalamin|cobalamin
5597459|NCT00901394|homocysteine|homocysteine
5597639|NCT00900783|herpes zoster|herpes zoster
5597640|NCT00900783|shingles|shingles
5597641|NCT00900783|Phase II|phase ii
5597642|NCT00900783|FV-100|fv-100
5597643|NCT00900783|Inhibitex|inhibitex
5597644|NCT00900770|dementia|dementia
5597645|NCT00900770|mild cognitive impairment|mild cognitive impairment
5597646|NCT00900770|beta amyloid|beta amyloid
5597647|NCT00900757|Primary Glioma|primary glioma
5597648|NCT00900757|Palonosetron|palonosetron
5597649|NCT00900757|Standard Radiotherapy|standard radiotherapy
5597650|NCT00900757|Temozolomide|temozolomide
5597651|NCT00900744|Tamoxifen|tamoxifen
5597652|NCT00900744|Breast Cancer|breast cancer
5597653|NCT00900731|COPD|copd
5597654|NCT00900731|indacaterol|indacaterol
5597999|NCT00900159|eszopiclone|eszopiclone
5597915|NCT00900302|recurrent melanoma|recurrent melanoma
5598062|NCT00900120|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5598063|NCT00900120|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5598067|NCT00900120|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5598121|NCT00900120|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5598122|NCT00900120|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5598123|NCT00900120|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5598124|NCT00900120|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5598307|NCT00900068|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5598308|NCT00900068|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5598365|NCT00900055|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5598850|NCT00899301|stage IB breast cancer|stage ib breast cancer
5598492|NCT00899951|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5593001|NCT00919399|breast cancer|breast cancer
5598665|NCT00899717|Orofacial pain|orofacial pain
5598672|NCT00899717|Selective grinding|selective grinding
5598756|NCT00899496|stage IV breast cancer|stage iv breast cancer
5598901|NCT00899158|cachexia|cachexia
5599014|NCT00898859|ADAM|adam
5599038|NCT00898781|stage IV colon cancer|stage iv colon cancer
5599100|NCT00898664|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5599101|NCT00898664|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5600519|NCT00895765|Kidney|kidney
5600922|NCT00894270|Injection|injection
5599400|NCT00898378|stage II rectal cancer|stage ii rectal cancer
5599585|NCT00897923|intraocular lymphoma|intraocular lymphoma
5599949|NCT00897611|adult glioblastoma|adult glioblastoma
5600030|NCT00897273|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5600031|NCT00897273|infection|infection
5600032|NCT00897273|precancerous condition|precancerous condition
5600209|NCT00896896|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5600210|NCT00896896|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5600241|NCT00896883|implant|implant
5600266|NCT00896727|stage IA breast cancer|stage ia breast cancer
5600855|NCT00894504|Gemzar|gemzar
5600956|NCT00894075|genetic metabolic disorder|genetic metabolic disorder
5600957|NCT00894075|alkaline phosphatase|alkaline phosphatase
5600959|NCT00894075|rickets|rickets
5601053|NCT00893646|metabolic syndrome|metabolic syndrome
5601148|NCT00893230|chemokines|chemokines
5601149|NCT00893230|probiotics|probiotics
5601242|NCT00892775|Working seed virus|working seed virus
5601451|NCT00892047|Elderly|elderly
5601658|NCT00891306|AAV|aav
5601714|NCT00891137|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5601776|NCT00891137|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5601777|NCT00891137|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5601778|NCT00891137|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5601779|NCT00891137|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5601780|NCT00891137|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5601781|NCT00891137|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5601790|NCT00891124|Type II DM|type ii dm
5601950|NCT00890435|adult brain stem glioma|adult brain stem glioma
5601951|NCT00890435|adult choroid plexus tumor|adult choroid plexus tumor
5601952|NCT00890435|adult craniopharyngioma|adult craniopharyngioma
5601953|NCT00890435|adult ependymoblastoma|adult ependymoblastoma
5601954|NCT00890435|adult medulloblastoma|adult medulloblastoma
5601955|NCT00890435|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5601956|NCT00890435|adult ependymal tumors|adult ependymal tumors
5601957|NCT00890435|adult meningeal tumor|adult meningeal tumor
5601958|NCT00890435|adult mixed glioma|adult mixed glioma
5601959|NCT00890435|adult oligodendroglial tumors|adult oligodendroglial tumors
5601960|NCT00890435|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5601961|NCT00890435|recurrent adult brain tumor|recurrent adult brain tumor
5601962|NCT00890435|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5601963|NCT00890435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5601964|NCT00890435|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5601965|NCT00890435|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5601966|NCT00890435|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5587770|NCT00939900|bisphosphonate|bisphosphonate
5601967|NCT00890435|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5601968|NCT00890435|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5601969|NCT00890435|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5601970|NCT00890435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5601971|NCT00890435|acute undifferentiated leukemia|acute undifferentiated leukemia
5601972|NCT00890435|mast cell leukemia|mast cell leukemia
5601973|NCT00890435|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5601974|NCT00890435|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5601975|NCT00890435|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5601976|NCT00890435|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5601977|NCT00890435|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5601994|NCT00890370|Cystic fibrosis|cystic fibrosis
5602190|NCT00889668|Glucose monitoring|glucose monitoring
5604850|NCT00878839|AcrySof|acrysof
5602355|NCT00889161|curcumin|curcumin
5602356|NCT00889161|pediatric|pediatric
5602465|NCT00888589|Breast|breast
5602660|NCT00887744|Percutaneous|percutaneous
5602756|NCT00887328|ischemic penumbra|ischemic penumbra
5602848|NCT00886990|second line regimen|second line regimen
5847315|NCT00040196|Normal Control|normal control
5603309|NCT00885287|uncomplicated malaria|uncomplicated malaria
5603413|NCT00884910|voice prosthesis|voice prosthesis
5603516|NCT00884520|exploratory|exploratory
5603615|NCT00884065|Manual therapy|manual therapy
5603616|NCT00884065|Painful Shoulder|painful shoulder
5603617|NCT00884065|Diacutaneous Fibrolysis|diacutaneous fibrolysis
5603618|NCT00884052|Neonatal seizures|neonatal seizures
5603620|NCT00884039|transplant|transplant
5603622|NCT00884039|steroid response|steroid response
5603771|NCT00883402|CEA|cea
5603809|NCT00883259|PCOS|pcos
5603911|NCT00882895|Transplantation, Autologous|transplantation, autologous
5603912|NCT00882895|Transplantation, Homologous|transplantation, homologous
5603913|NCT00882895|Total Lymphoid Irradiation|total lymphoid irradiation
5603914|NCT00882895|Anti-thymocyte globulin|anti-thymocyte globulin
5603915|NCT00882869|Advanced Hepatocellular carcinoma|advanced hepatocellular carcinoma
5603916|NCT00882869|liver|liver
5603917|NCT00882869|cancer|cancer
5603918|NCT00882869|antisense|antisense
5604005|NCT00882414|thrombocyte|thrombocyte
5604018|NCT00882336|Obesity|obesity
5604103|NCT00881985|obstructive sleep apnea|obstructive sleep apnea
5604192|NCT00881647|Insomnia Disorder|insomnia disorder
5604288|NCT00881075|Magnetic resonance imaging|magnetic resonance imaging
5604379|NCT00880672|vascular endothelial growth factor|vascular endothelial growth factor
5604384|NCT00880633|EUS|eus
5604476|NCT00880269|refractory secondary AML|refractory secondary aml
5604677|NCT00879541|Hemophilia A|hemophilia a
5604922|NCT00878579|DDD|ddd
5604977|NCT00878332|Partially edentulous patients|partially edentulous patients
5605304|NCT00877084|COPD|copd
5605401|NCT00876798|Serum Sodium|serum sodium
5605496|NCT00876473|CPAP|cpap
5605593|NCT00876057|Sexual well-being|sexual well-being
5605678|NCT00875732|Bradycardia|bradycardia
5605679|NCT00875732|atrioventricular block|atrioventricular block
5605983|NCT00874302|Uterine fibroids|uterine fibroids
5606076|NCT00874016|Airtraq|airtraq
5606285|NCT00873197|Transdermal|transdermal
5606388|NCT00872794|Metal on Metal|metal on metal
5606404|NCT00872703|CMV|cmv
5606584|NCT00872066|Hip|hip
5606683|NCT00871689|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5606770|NCT00871442|pain|pain
5606983|NCT00870597|vitrectomy|vitrectomy
5607082|NCT00870285|UVB-311nm narrowband|uvb-311nm narrowband
5607092|NCT00870246|COPD|copd
5607184|NCT00869830|Biofeedback|biofeedback
5607276|NCT00869492|Acne|acne
5607475|NCT00868673|Low fructose diet study|low fructose diet study
5607518|NCT00868439|HF|hf
5607785|NCT00867308|IPSS Int-2|ipss int-2
5607877|NCT00866905|Cyclophosphamide|cyclophosphamide
5607878|NCT00866905|Cytoxan|cytoxan
5608183|NCT00866034|IVF|ivf
5608288|NCT00865592|dutogliptin|dutogliptin
5608281|NCT00865631|Healthy subjects|healthy subjects
5608894|NCT00862953|high protein diet|high protein diet
5609014|NCT00862498|Narrative Exposure|narrative exposure
5609223|NCT00861523|nausea|nausea
5609224|NCT00861523|vomiting|vomiting
5609225|NCT00861523|pregnancy|pregnancy
5609226|NCT00861523|thiamine|thiamine
5609227|NCT00861523|promethazine|promethazine
5609228|NCT00861523|nausea and vomiting in pregnancy|nausea and vomiting in pregnancy
5609229|NCT00861510|Small Lymphocytic Lymphoma (SLL)|small lymphocytic lymphoma (sll)
5609317|NCT00861185|inflammation|inflammation
5609319|NCT00861172|Multiple sclerosis|multiple sclerosis
5609320|NCT00861172|Active plaque|active plaque
5609321|NCT00861172|Multimodal analysis|multimodal analysis
5609323|NCT00861172|Weekly follow-up|weekly follow-up
5609510|NCT00860418|ED visits|ed visits
5798764|NCT00111163|safety|safety
5609708|NCT00859417|prosthetic trans-obturator way kit|prosthetic trans-obturator way kit
5609709|NCT00859417|randomized study|randomized study
5609712|NCT00859378|Hip|hip
5609805|NCT00858845|Leg Weakness|leg weakness
5610016|NCT00858000|markers|markers
5610215|NCT00857220|Children|children
5610314|NCT00856830|Chemonaive|chemonaive
5610414|NCT00856401|PTH|pth
5610502|NCT00856115|stage IV rectal cancer|stage iv rectal cancer
5610798|NCT00854802|Hepatitis C|hepatitis c
5610799|NCT00854789|Breast cancer|breast cancer
5610821|NCT00854672|QOL|qol
5610890|NCT00854373|Pregnancy|pregnancy
5610891|NCT00854373|in vitro fertilization|in vitro fertilization
5610990|NCT00853944|type 1 diabetes|type 1 diabetes
5610991|NCT00853944|incretin|incretin
5610992|NCT00853931|KRAS wild type|kras wild type
5610995|NCT00853918|Physician survey|physician survey
5611083|NCT00853658|Cardiovascular death|cardiovascular death
5611175|NCT00853268|Healthy Subjects|healthy subjects
5611176|NCT00853268|Bioequivalence|bioequivalence
5611177|NCT00853255|Bird Flu|bird flu
5611178|NCT00853242|Chronic Kidney Disease|chronic kidney disease
5611179|NCT00853242|Phosphate Binder|phosphate binder
5611290|NCT00852813|gastrointestinal effects|gastrointestinal effects
5611291|NCT00852800|spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5611293|NCT00852800|renal impairment|renal impairment
5611294|NCT00852800|mortality|mortality
5611295|NCT00852787|Digoxin like substances|digoxin like substances
5611368|NCT00852501|RTPCR|rtpcr
5611677|NCT00851305|endoscopy|endoscopy
5611680|NCT00851292|biopsy|biopsy
5611740|NCT00851227|Protein Binding|protein binding
5612151|NCT00849628|Nursing homes|nursing homes
5612316|NCT00848887|Flu|flu
5612354|NCT00848770|Systolic Pressure of Blood|systolic pressure of blood
5612355|NCT00848757|Diabetes|diabetes
5612455|NCT00848263|Radius|radius
5612456|NCT00848263|Surgery|surgery
5612457|NCT00848263|Osteosynthesis|osteosynthesis
5612458|NCT00848250|Cardiopulmonary Bypass|cardiopulmonary bypass
5612459|NCT00848250|ACE inhibitor|ace inhibitor
5612460|NCT00848250|Pediatrics|pediatrics
5612461|NCT00848237|Barrett's Esophagus|barrett's esophagus
5612462|NCT00848237|Dysplasia|dysplasia
5612463|NCT00848237|Intestinal Metaplasia|intestinal metaplasia
5612464|NCT00848224|coronary heart disease|coronary heart disease
5612465|NCT00848224|lipid lowering medication|lipid lowering medication
5612466|NCT00848224|NCEP guidelines|ncep guidelines
5612467|NCT00848211|HIV|hiv
5612468|NCT00848211|vaccine|vaccine
5612469|NCT00848211|lipopeptide|lipopeptide
5612470|NCT00848211|Tat|tat
5612471|NCT00848211|TUTI-16|tuti-16
5612543|NCT00847873|intimate partner violence|intimate partner violence
5612560|NCT00847808|GERD|gerd
5612846|NCT00846690|topical anesthetics|topical anesthetics
5612847|NCT00846690|topical anesthesia|topical anesthesia
5612848|NCT00846690|20% benzocaine|20% benzocaine
5612849|NCT00846690|TAC alternate gel|tac alternate gel
5612850|NCT00846690|combination topical anesthetics|combination topical anesthetics
5612943|NCT00846352|Bone Marrow Transplantation|bone marrow transplantation
5612965|NCT00846287|Helium|helium
5613420|NCT00844402|Statins|statins
5613520|NCT00843778|Certolizumab Pegol|certolizumab pegol
5613616|NCT00843440|Bevacuzimab|bevacuzimab
5613802|NCT00842686|bevacizumab|bevacizumab
5613898|NCT00842387|reflux, heartburn|reflux, heartburn
5614202|NCT00841139|idiopathic dilated cardiomyopathy|idiopathic dilated cardiomyopathy
5614289|NCT00840814|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5614567|NCT00839436|Interleukin-7|interleukin-7
5614674|NCT00839085|Grape seed extract|grape seed extract
5614675|NCT00839085|Vit C|vit c
5614676|NCT00839085|Oxidative stress|oxidative stress
5614677|NCT00839072|bioavailability|bioavailability
5614678|NCT00839072|pharmacokinetics|pharmacokinetics
5614679|NCT00839072|healthy|healthy
5614680|NCT00839072|crossover|crossover
5614681|NCT00839072|trazodone|trazodone
5614682|NCT00839059|AML|aml
5614683|NCT00839059|lenalidomide|lenalidomide
5614684|NCT00839046|Pediatric Asthma|pediatric asthma
5614685|NCT00839046|Air Filters|air filters
5614761|NCT00838799|pain|pain
5614762|NCT00838799|chronic|chronic
5614852|NCT00838526|Gastroesophageal|gastroesophageal
5614853|NCT00838526|Reflux|reflux
5614854|NCT00838526|Disease|disease
5614855|NCT00838526|GERD|gerd
5614856|NCT00838513|aHUS|ahus
5614857|NCT00838500|Venous insufficiency|venous insufficiency
5614943|NCT00838240|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5614944|NCT00838240|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5615039|NCT00837733|Endometrial biopsy|endometrial biopsy
5615465|NCT00836108|Dyspnea|dyspnea
5615746|NCT00834795|Healthy Subjects|healthy subjects
5615747|NCT00834782|PK|pk
5615748|NCT00834782|IOP|iop
5615749|NCT00834756|Bioequivalence|bioequivalence
5615755|NCT00834704|PEGPH20|pegph20
5615846|NCT00834145|Edema|edema
5615937|NCT00833703|thrombosis|thrombosis
5615938|NCT00833703|clopidogrel|clopidogrel
5616037|NCT00833404|Nicotine Replacement Therapy|nicotine replacement therapy
5616038|NCT00833404|Sexual Functioning|sexual functioning
5616039|NCT00833404|Erectile Functioning|erectile functioning
5616040|NCT00833404|Sexual Health|sexual health
5616041|NCT00833391|healthy volunteer|healthy volunteer
5616042|NCT00833391|formulations|formulations
5616043|NCT00833391|bioavailability|bioavailability
5616047|NCT00833365|PDA|pda
5616119|NCT00832949|Early inflammatory arthritis|early inflammatory arthritis
5616215|NCT00832637|Eloxatin|eloxatin
5616838|NCT00830063|pain|pain
5616936|NCT00829673|Healthy Subjects|healthy subjects
5616937|NCT00829660|Acarbose|acarbose
5616938|NCT00829647|CLL|cll
5616941|NCT00829647|sprycel|sprycel
5617036|NCT00829283|Comparator|comparator
5617056|NCT00829114|AE|ae
5618065|NCT00825487|metastatic|metastatic
5617286|NCT00828451|necrotizing enterocolitis|necrotizing enterocolitis
5617287|NCT00828451|genetics|genetics
5617378|NCT00827996|Apocrine glands|apocrine glands
5617476|NCT00827658|local anesthesia|local anesthesia
5617514|NCT00827476|human|human
5617736|NCT00826657|methylmalonic acid|methylmalonic acid
5617949|NCT00825890|glaucoma suspect|glaucoma suspect
5618240|NCT00824824|Retinal Vascular Autoregulation|retinal vascular autoregulation
5618241|NCT00824811|Epiphora|epiphora
5618242|NCT00824811|Breast Cancer|breast cancer
5618243|NCT00824811|Lung Cancer|lung cancer
5618249|NCT00824811|HNC|hnc
5618435|NCT00824135|Hematological Malignancies|hematological malignancies
5618450|NCT00824057|Phase I|phase i
5618536|NCT00823719|Oncology|oncology
5618605|NCT00823524|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5618672|NCT00823511|Cervix|cervix
5618673|NCT00823498|Cancer Prevention|cancer prevention
5618674|NCT00823498|African American|african american
5618675|NCT00823498|African American Parents|african american parents
5618866|NCT00822770|Advanced Myeloid Leukemia|advanced myeloid leukemia
5619275|NCT00821093|dyspnea|dyspnea
5619473|NCT00820313|Coronary Heart Disease|coronary heart disease
5619664|NCT00819611|Working memory training|working memory training
5619666|NCT00819611|Behavioral symptoms|behavioral symptoms
5619667|NCT00819611|Neuropsychology|neuropsychology
5619668|NCT00819611|Electropsychophysiology|electropsychophysiology
5619687|NCT00819546|MDS|mds
5619767|NCT00819208|fatigue|fatigue
5619768|NCT00819208|sleep disorders|sleep disorders
5619769|NCT00819208|depression|depression
5619909|NCT00818948|Nephritis|nephritis
5619913|NCT00818896|thyroid deficiency|thyroid deficiency
5619914|NCT00818896|pregnancy|pregnancy
5619917|NCT00818883|Essential Hypertension|essential hypertension
5620300|NCT00817583|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5620398|NCT00817206|tacrolimus|tacrolimus
5623090|NCT00807430|EMG|emg
5620656|NCT00816413|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5620730|NCT00816231|Alcohol|alcohol
5620832|NCT00815867|graft function|graft function
5621128|NCT00814697|Treatment|treatment
5684494|NCT00560248|ACS|acs
5621228|NCT00814346|Memory complaint patients cognitively normal (CNE)|memory complaint patients cognitively normal (cne)
5621229|NCT00814333|epistaxis|epistaxis
5621230|NCT00814307|Antirheumatic Agents Clinical Trial|antirheumatic agents clinical trial
5621314|NCT00813969|Mesenchymal Stem Cell|mesenchymal stem cell
5621416|NCT00813514|complement H gene polymorphism|complement h gene polymorphism
5621663|NCT00813007|Cervix|cervix
5621754|NCT00812695|Arterial stiffness|arterial stiffness
5621847|NCT00812201|pacing|pacing
5622049|NCT00811343|QFTB-G|qftb-g
5622234|NCT00810680|valproate|valproate
5622326|NCT00810368|Migraine headaches|migraine headaches
5622331|NCT00810355|work|work
5622722|NCT00808925|heat|heat
5622788|NCT00808665|General Anesthesia|general anesthesia
5622844|NCT00808457|CT|ct
5622891|NCT00808262|crohn's disease|crohn's disease
5622893|NCT00808249|GAD|gad
5623077|NCT00807482|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5623298|NCT00806715|hemochromatosis|hemochromatosis
5623324|NCT00806637|uvulopalatoplasty|uvulopalatoplasty
5623416|NCT00806234|Reducing Weight Gain|reducing weight gain
5623619|NCT00805285|Inflammatory Bowel Disease|inflammatory bowel disease
5623621|NCT00805285|Budesonide|budesonide
5623732|NCT00804778|CAD|cad
5623814|NCT00804466|Screening|screening
5623915|NCT00804102|Retinal Vein Occlusion,|retinal vein occlusion,
5624010|NCT00803647|FOLFOX7|folfox7
5624292|NCT00802464|Shingles|shingles
5624375|NCT00802048|Intralesional anesthetic infusion|intralesional anesthetic infusion
5624376|NCT00802048|Ropivacaïne|ropivacaïne
5624377|NCT00802048|Chronic|chronic
5624378|NCT00802048|Postoperative pain|postoperative pain
5624380|NCT00802048|Sternum|sternum
5624562|NCT00801333|ALS|als
5624847|NCT00800150|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5625258|NCT00798746|HRQL|hrql
5624920|NCT00800046|MR|mr
5625020|NCT00799721|VLBW|vlbw
5625021|NCT00799721|Epo|epo
5625022|NCT00799721|IUGR|iugr
5625023|NCT00799721|VEGF|vegf
5625113|NCT00799357|ultrasound|ultrasound
5625211|NCT00798850|Vascular claudication|vascular claudication
5625309|NCT00798577|Bacterial Conjunctivitis|bacterial conjunctivitis
5625430|NCT00798044|substance use disorders|substance use disorders
5625431|NCT00798031|dental implant|dental implant
5625432|NCT00798031|upper jaw|upper jaw
5625630|NCT00797264|PCA|pca
5625721|NCT00796796|temsirolimus|temsirolimus
5625827|NCT00796458|recurrent prostate cancer|recurrent prostate cancer
5625923|NCT00795990|Efficacy of early vs late use of ibuprofen for PDA closure|efficacy of early vs late use of ibuprofen for pda closure
5626014|NCT00795639|Sitaxsentan|sitaxsentan
5626112|NCT00795132|cancer|cancer
5626214|NCT00794638|Follicular Lymphoma|follicular lymphoma
5626331|NCT00794183|CRT|crt
5626417|NCT00793767|human muscle tissue|human muscle tissue
5626514|NCT00793234|VTE|vte
5626719|NCT00792376|stiffness|stiffness
5626806|NCT00791869|smoking|smoking
5627005|NCT00791167|Mood Disorders, Antipsychotic drugs|mood disorders, antipsychotic drugs
5627297|NCT00790153|Type 2 diabetes, hormonal response|type 2 diabetes, hormonal response
5627299|NCT00790140|esophagectomy|esophagectomy
5627300|NCT00790140|enteral feeding|enteral feeding
5627683|NCT00788632|BMD|bmd
5628015|NCT00787761|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5628202|NCT00787280|obese|obese
5628419|NCT00786396|HIV|hiv
5628611|NCT00785616|HIV|hiv
5628711|NCT00785213|cytochrome p450|cytochrome p450
5628809|NCT00784927|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5628888|NCT00784667|Metastasis|metastasis
5628982|NCT00784277|Pain medication|pain medication
5628984|NCT00784277|Joint pain|joint pain
5628985|NCT00784277|Analgesia|analgesia
5628986|NCT00784277|Analgesics|analgesics
5628987|NCT00784277|tapentadol|tapentadol
5628988|NCT00784277|CG5503|cg5503
5628990|NCT00784264|Asymptomatic atherosclerosis|asymptomatic atherosclerosis
5628991|NCT00784264|Intima media thickness (IMT)|intima media thickness (imt)
5628994|NCT00784251|Pain|pain
5629183|NCT00783302|CAD|cad
5629363|NCT00782548|fed|fed
5629510|NCT00782067|mast cell leukemia|mast cell leukemia
5629608|NCT00781677|Major Depressive Disorder|major depressive disorder
5629712|NCT00781183|COPD|copd
5629802|NCT00780741|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5629804|NCT00780715|Diabetes therapies|diabetes therapies
5629805|NCT00780715|Pharmacogenetics|pharmacogenetics
5629806|NCT00780702|Cocaine|cocaine
5629807|NCT00780702|Treatment|treatment
5629808|NCT00780702|Airpiprazole|airpiprazole
5629809|NCT00780702|Methadone|methadone
5629811|NCT00780702|HIV|hiv
5629993|NCT00779857|atrial fibrillation|atrial fibrillation
5630189|NCT00778986|self care|self care
5630274|NCT00778388|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5630357|NCT00778011|nausea and vomiting in the emergency department|nausea and vomiting in the emergency department
5630358|NCT00777998|Multiple Myeloma|multiple myeloma
5630862|NCT00775684|Beta-cell Secretory Capacity|beta-cell secretory capacity
5631146|NCT00774683|Raltegravir|raltegravir
5631147|NCT00774683|Cervicovaginal|cervicovaginal
5631149|NCT00774683|Women|women
5631150|NCT00774657|Aortic Stenosis|aortic stenosis
5631151|NCT00774657|Valvular heart disease|valvular heart disease
5631152|NCT00774657|Heart disease|heart disease
5631153|NCT00774657|Cardiovascular disease|cardiovascular disease
5631161|NCT00774618|Flail Chest|flail chest
5631328|NCT00773916|Attention Deficit Disorder|attention deficit disorder
5631502|NCT00773175|pediatric|pediatric
5631596|NCT00772772|levels of endotoxin|levels of endotoxin
5631693|NCT00772408|pulmonary tuberculosis|pulmonary tuberculosis
5631694|NCT00772408|Toll-like receptor 2 gene polymorphisms|toll-like receptor 2 gene polymorphisms
5631695|NCT00772408|blood lymphocyte subsets|blood lymphocyte subsets
5631696|NCT00772408|systemic symptoms|systemic symptoms
5631697|NCT00772408|pleural effusion|pleural effusion
5631785|NCT00772109|Fluzone®|fluzone®
5632230|NCT00770419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5632310|NCT00770003|patients|patients
5632527|NCT00769613|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5632528|NCT00769613|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5632529|NCT00769613|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5632530|NCT00769613|stage IIIA breast cancer|stage iiia breast cancer
5632890|NCT00767858|Genetic|genetic
5632891|NCT00767858|Genetic Literacy|genetic literacy
5633456|NCT00765440|tongue cancer|tongue cancer
5633536|NCT00764881|Oral contraceptive|oral contraceptive
5633725|NCT00763984|Kegel Exercises: How to Strengthen Pelvic Floor Muscles|kegel exercises: how to strengthen pelvic floor muscles
5633726|NCT00763984|Kegel Exercises for Your Pelvic Muscles|kegel exercises for your pelvic muscles
5633728|NCT00763984|Pelvic Support Problems|pelvic support problems
5633729|NCT00763984|Pregnancy|pregnancy
5633730|NCT00763984|Pregnancy Childbirth and Bladder Control|pregnancy childbirth and bladder control
5633731|NCT00763984|Urinary Incontinence|urinary incontinence
5633732|NCT00763984|Urinary Incontinence: Embarrassing but Treatable|urinary incontinence: embarrassing but treatable
5633733|NCT00763958|opiates|opiates
5633734|NCT00763958|HIV|hiv
5633735|NCT00763945|Acute coronary Syndrome|acute coronary syndrome
5633736|NCT00763945|STEMI|stemi
5633737|NCT00763945|NSTEMI|nstemi
5633738|NCT00763945|Registry|registry
5633739|NCT00763919|Patient Non-Adherence|patient non-adherence
5633740|NCT00763919|Patient Non-Compliance|patient non-compliance
5633741|NCT00763919|Patient Nonadherence|patient nonadherence
5633742|NCT00763919|Patient Noncompliance|patient noncompliance
5633743|NCT00763919|Patient Refusal of Treatment|patient refusal of treatment
5633744|NCT00763919|Refusal of Treatment|refusal of treatment
5633745|NCT00763919|Treatment Refusal|treatment refusal
5633746|NCT00763906|septic shock|septic shock
5633747|NCT00763906|fuzzy logic|fuzzy logic
5633748|NCT00763906|norepinephrine weaning|norepinephrine weaning
5633749|NCT00763893|Marfan syndrome|marfan syndrome
5633750|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5633751|NCT00763893|Aortic Aneurysm, Thoracic|aortic aneurysm, thoracic
5633752|NCT00763880|Hematoma block|hematoma block
5633753|NCT00763880|Lidocaine|lidocaine
5633754|NCT00763880|Forearm fracture|forearm fracture
5633755|NCT00763880|Radius fracture|radius fracture
5633756|NCT00763880|Ulna fracture|ulna fracture
5633757|NCT00763880|Ketamine|ketamine
5633758|NCT00763880|Midazolam|midazolam
5633759|NCT00763880|Procedural sedation|procedural sedation
5633760|NCT00763867|Heart Failure, Diastolic|heart failure, diastolic
5633761|NCT00763867|Decompensated Heart Failure|decompensated heart failure
5633780|NCT00763763|Combination therapy|combination therapy
5633781|NCT00763763|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5633782|NCT00763763|Philadelphia Chromosome|philadelphia chromosome
5633783|NCT00763763|Blast Crisis|blast crisis
5633784|NCT00763763|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5633968|NCT00762931|bronchoconstriction|bronchoconstriction
5634066|NCT00762684|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5634067|NCT00762684|Dyslipidemia|dyslipidemia
5634068|NCT00762658|Plaque Type Psoriasis|plaque type psoriasis
5634069|NCT00762658|Topical|topical
5634070|NCT00762645|IOP lowering efficacy|iop lowering efficacy
5634071|NCT00762645|CACG|cacg
5634072|NCT00762632|patients with c-kit+ AML|patients with c-kit+ aml
5634073|NCT00762606|Cataract|cataract
5634157|NCT00762138|wounds|wounds
5634158|NCT00762138|leg ulcers|leg ulcers
5634159|NCT00762138|pressure ulcers|pressure ulcers
5634160|NCT00762138|diabetic ulcers|diabetic ulcers
5634161|NCT00762138|management of mechanically or surgically-debrided wounds|management of mechanically or surgically-debrided wounds
5634162|NCT00762125|Fibromyalgia Syndrome|fibromyalgia syndrome
5634544|NCT00760474|Fibromyalgia; fMRI; pain; pregabalin; Lyrica; imaging|fibromyalgia; fmri; pain; pregabalin; lyrica; imaging
5634545|NCT00760435|Kawasaki disease|kawasaki disease
5635051|NCT00758082|HbA1c|hba1c
5635138|NCT00757614|bladder cancer|bladder cancer
5635227|NCT00757276|Diabetes insipidus|diabetes insipidus
5635326|NCT00756847|NSCLC|nsclc
5635529|NCT00756015|ultrasound|ultrasound
5638075|NCT00746980|areata|areata
5636325|NCT00752999|SLE|sle
5636491|NCT00752362|Agents|agents
5636571|NCT00752089|enamel fluoride uptake|enamel fluoride uptake
5636572|NCT00752089|erosion|erosion
5825136|NCT00067743|Pain|pain
5636665|NCT00751816|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5630613|NCT00776958|Cancer|cancer
5825368|NCT00067054|HV|hv
5636784|NCT00751491|Stable angina|stable angina
5636785|NCT00751491|Percutaneous Coronary Intervention|percutaneous coronary intervention
5636882|NCT00751088|single-incision|single-incision
5637086|NCT00750152|tinea cruris|tinea cruris
5639806|NCT00740558|HRV|hrv
5637278|NCT00750009|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5637348|NCT00749853|genotyping|genotyping
5826308|NCT00065455|ERG|erg
5637554|NCT00749086|Non-traumatic vertebral fracture|non-traumatic vertebral fracture
5638045|NCT00747188|lecture|lecture
5638152|NCT00746720|pain|pain
5638253|NCT00746330|Persistent asthma|persistent asthma
5638254|NCT00746304|botulinum|botulinum
5638450|NCT00745485|Osteoporosis|osteoporosis
5638555|NCT00745017|recurrent depression|recurrent depression
5638658|NCT00744627|Drug Therapy|drug therapy
5638784|NCT00744198|Mesh|mesh
5638947|NCT00743613|Ankle-Brachial Index|ankle-brachial index
5639052|NCT00743171|outcomes|outcomes
5639350|NCT00742144|Follicular lymphoma|follicular lymphoma
5639365|NCT00742079|CBT|cbt
5639565|NCT00741494|hyaluronan|hyaluronan
5639669|NCT00741130|Cirrus OCT|cirrus oct
5639670|NCT00741117|Pulse Oximetry|pulse oximetry
5639769|NCT00740701|fMRI|fmri
5639772|NCT00740701|eyeblink|eyeblink
5640339|NCT00738777|endocrine treatment|endocrine treatment
5640340|NCT00738777|drug resistance|drug resistance
5640253|NCT00739063|EGFR|egfr
5640436|NCT00738413|deferasirox|deferasirox
5640530|NCT00738049|endothelin receptor blockade|endothelin receptor blockade
5640745|NCT00737334|cerebral ischemia|cerebral ischemia
5640842|NCT00737009|adherence|adherence
5641141|NCT00735878|Advanced Lung Cancer|advanced lung cancer
5641142|NCT00735878|NSCLC|nsclc
5641143|NCT00735865|Dry Eye Syndrome|dry eye syndrome
5641175|NCT00735722|CAD|cad
5641341|NCT00735176|Spinal Fusion|spinal fusion
5641507|NCT00734851|PSA|psa
5641703|NCT00734084|Arthroplasty|arthroplasty
5641910|NCT00733317|Children|children
5642012|NCT00732953|paclitaxel eluting balloon|paclitaxel eluting balloon
5642015|NCT00732940|SLE|sle
5642195|NCT00732290|pharmacodynamic|pharmacodynamic
5642196|NCT00732290|Polymorphism, Genetic|polymorphism, genetic
5642198|NCT00732277|septicaemia|septicaemia
5642199|NCT00732277|septicemia|septicemia
5642200|NCT00732277|paediatric|paediatric
5642201|NCT00732277|pediatric|pediatric
5642300|NCT00731822|GW685698/GW642444|gw685698/gw642444
5642599|NCT00730470|HER3|her3
5642687|NCT00730210|Hypoparathyroidism|hypoparathyroidism
5643091|NCT00728650|primary liver cancer|primary liver cancer
5643187|NCT00728195|JNJ-37822681|jnj-37822681
5643292|NCT00727844|XDR-TB|xdr-tb
5643399|NCT00727454|MRI|mri
5643512|NCT00726999|Narcotic Use|narcotic use
5643514|NCT00726973|Macular edema|macular edema
5671719|NCT00614653|Avastin™|avastin™
5643652|NCT00726791|chronic pain|chronic pain
5643722|NCT00726596|stage IV prostate cancer|stage iv prostate cancer
5643723|NCT00726596|Prostate-Specific Antigen|prostate-specific antigen
5643724|NCT00726583|Cancer|cancer
5643725|NCT00726583|Solid Tumors|solid tumors
5643726|NCT00726583|Carcinoma|carcinoma
5643727|NCT00726583|PI-3K|pi-3k
5643935|NCT00725647|preterm infant|preterm infant
5644173|NCT00724867|SLE|sle
5644199|NCT00724659|Arthrogram|arthrogram
5644900|NCT00721591|Habitual abortion|habitual abortion
5644901|NCT00721591|Fetal demise|fetal demise
5644902|NCT00721591|Antiphospholipid antibodies|antiphospholipid antibodies
5645111|NCT00720850|AML|aml
5645180|NCT00720707|root coverage|root coverage
5645270|NCT00720304|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5645283|NCT00720291|Metronidazole|metronidazole
5645336|NCT00720057|Dental Pain|dental pain
5645444|NCT00719849|polycythemia vera|polycythemia vera
5847445|NCT00039715|Stress|stress
5645629|NCT00719563|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5645630|NCT00719563|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5645631|NCT00719563|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5645632|NCT00719563|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5645650|NCT00719563|intraocular lymphoma|intraocular lymphoma
5645807|NCT00718978|burns|burns
5646230|NCT00717210|PCV|pcv
5646690|NCT00715676|Vitamin D|vitamin d
5646790|NCT00715247|Myeloproliferative Disorders|myeloproliferative disorders
5646791|NCT00715247|Hematological Malignancies|hematological malignancies
5646792|NCT00715247|Polycythemia Vera|polycythemia vera
5646799|NCT00715234|Tdap|tdap
5646888|NCT00714987|PEEP with high level|peep with high level
5646889|NCT00714987|EVLW|evlw
5646890|NCT00714987|Picco® system|picco® system
5646891|NCT00714987|PaO2/FiO2 ratio|pao2/fio2 ratio
5646892|NCT00714974|Neuromuscular blocking agents|neuromuscular blocking agents
5646893|NCT00714974|Bispectral analysis|bispectral analysis
5646894|NCT00714948|Bladder|bladder
5646895|NCT00714948|Urinary|urinary
5646896|NCT00714948|SORAFENIB|sorafenib
5646897|NCT00714948|CISPLATIN|cisplatin
5646898|NCT00714948|GEMCITABINE|gemcitabine
5646899|NCT00714935|Risk Factors|risk factors
5819647|NCT00078364|MRI|mri
5684762|NCT00559078|CAH|cah
5647179|NCT00713804|Bipolar Disorder|bipolar disorder
5647183|NCT00713804|Stigma|stigma
5647283|NCT00713466|Experience|experience
5647284|NCT00713453|Pompe disease|pompe disease
5647285|NCT00713453|muscle|muscle
5647564|NCT00712426|UHDRS|uhdrs
5647761|NCT00711750|creation|creation
5648172|NCT00710255|Hyperpnea induced bronchospasm|hyperpnea induced bronchospasm
5648589|NCT00708630|patient satisfaction|patient satisfaction
5648590|NCT00708617|Liver fibrosis|liver fibrosis
5648591|NCT00708617|Alcoholic liver disease|alcoholic liver disease
5648592|NCT00708617|Non invasive diagnostic methods|non invasive diagnostic methods
5648593|NCT00708617|Transient elastography|transient elastography
5648594|NCT00708617|Fibrotest|fibrotest
5648787|NCT00707850|Thalassemia|thalassemia
5648903|NCT00707330|8-oxodG|8-oxodg
5649180|NCT00706030|HKI-272|hki-272
5649330|NCT00705302|Outpatient|outpatient
5649543|NCT00703898|HIV|hiv
5649635|NCT00703508|PCOS|pcos
5649712|NCT00703144|Pharmacokinetics|pharmacokinetics
5649822|NCT00702793|champix|champix
5650214|NCT00701220|Cardiomyopathy|cardiomyopathy
5650424|NCT00700232|cholestasis|cholestasis
5650519|NCT00699894|PONV|ponv
5650617|NCT00699439|Medical Informatics|medical informatics
5650838|NCT00698438|Open-angle glaucoma|open-angle glaucoma
5650843|NCT00698412|Pain|pain
5651247|NCT00696800|Randomized|randomized
5651578|NCT00695396|MDS|mds
5651748|NCT00694694|Africa|africa
5651945|NCT00693836|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5651946|NCT00693836|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5651947|NCT00693836|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5651948|NCT00693836|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5651954|NCT00693823|atherosclerosis|atherosclerosis
5652112|NCT00693173|genital|genital
5652611|NCT00691236|bisphosphonates|bisphosphonates
5652721|NCT00691015|stage I multiple myeloma|stage i multiple myeloma
5653174|NCT00689351|against|against
5653175|NCT00689351|pneumococcal|pneumococcal
5653176|NCT00689351|disease|disease
5653177|NCT00689351|Vaccine|vaccine
5653178|NCT00689338|Candida|candida
5653179|NCT00689338|Candidemia|candidemia
5653180|NCT00689338|Systemic Candidiasis|systemic candidiasis
5653182|NCT00689338|Intensive Care Unit|intensive care unit
5653200|NCT00689299|Cat|cat
5653583|NCT00688012|Safety in healthy volunteers|safety in healthy volunteers
5653788|NCT00687128|Metabolic syndrome|metabolic syndrome
5653789|NCT00687128|Aerobic exercise|aerobic exercise
5653790|NCT00687128|Exercise behavior|exercise behavior
5653796|NCT00687102|breast cancer|breast cancer
5653797|NCT00687102|Tamoxifen|tamoxifen
5653798|NCT00687102|Raloxifene|raloxifene
5653799|NCT00687102|hormone therapy|hormone therapy
5653800|NCT00687089|Opiates|opiates
5653885|NCT00686647|Coronary Artery Bifurcation Lesions|coronary artery bifurcation lesions
5653887|NCT00686634|type 2 diabetes|type 2 diabetes
5653888|NCT00686634|combination therapy|combination therapy
5653889|NCT00686608|Obesity|obesity
5653899|NCT00686556|ALL|all
5654119|NCT00685815|RLS|rls
5654171|NCT00685555|Overweight|overweight
5654172|NCT00685542|diacerein|diacerein
5654173|NCT00685542|osteoarthritis|osteoarthritis
5654174|NCT00685542|hand|hand
5654175|NCT00685529|COPD|copd
5654176|NCT00685529|Arformoterol|arformoterol
5657000|NCT00674583|Safety|safety
5654456|NCT00684346|pediatric|pediatric
5654562|NCT00683891|clozapine|clozapine
5654563|NCT00683891|Hypersalivation|hypersalivation
5654564|NCT00683865|Antibiotic treatment|antibiotic treatment
5654565|NCT00683865|Pelvic infection|pelvic infection
5654566|NCT00683865|Interventional study|interventional study
5654567|NCT00683865|Female|female
5654568|NCT00683852|Depression|depression
5654569|NCT00683839|Tobacco|tobacco
5654570|NCT00683839|Smoking|smoking
5654571|NCT00683839|Smokeless|smokeless
5654572|NCT00683839|Cessation|cessation
5654573|NCT00683839|Public health clinic|public health clinic
5654574|NCT00683839|Dental patients|dental patients
5654575|NCT00683839|5 As|5 as
5654576|NCT00683839|NRT|nrt
5654577|NCT00683839|Tobacco Quit Line|tobacco quit line
5654648|NCT00683618|CHD|chd
5654743|NCT00683176|OCT|oct
5654855|NCT00682825|BIS|bis
5654932|NCT00682474|School health|school health
5654933|NCT00682474|Randomized controlled trial|randomized controlled trial
5654934|NCT00682461|Nicotine Tolerability NRT|nicotine tolerability nrt
5654935|NCT00682448|Olanzapine|olanzapine
5655029|NCT00682110|End-stage liver disease|end-stage liver disease
5655223|NCT00681408|Exercise conditioning|exercise conditioning
5655224|NCT00681382|Asthma|asthma
5655225|NCT00681382|use of asthma medication|use of asthma medication
5655226|NCT00681382|asthma control|asthma control
5655227|NCT00681382|telephone survey|telephone survey
5655228|NCT00681382|patient's perception|patient's perception
5655229|NCT00681369|breast cancer|breast cancer
5655318|NCT00681018|infants|infants
5655420|NCT00680628|Thrombosis|thrombosis
5655521|NCT00680121|Benfotiamine|benfotiamine
5655522|NCT00680121|Thiamine|thiamine
5655525|NCT00680082|statins|statins
5655729|NCT00679380|Ulcerative colitis|ulcerative colitis
5655837|NCT00678873|Surgery|surgery
5655935|NCT00678535|Progression-free survival|progression-free survival
5655936|NCT00678522|Atorvastatin|atorvastatin
5655938|NCT00678522|Hemodynamics|hemodynamics
5655939|NCT00678522|Diabetes type II|diabetes type ii
5655940|NCT00678522|sodium excretion|sodium excretion
5655941|NCT00678509|HLA-A*2402|hla-a*2402
5655942|NCT00678509|Peptide Vaccine|peptide vaccine
5655943|NCT00678509|TTK|ttk
5655944|NCT00678496|CBT-software|cbt-software
5655945|NCT00678496|Computerised Cognitive Behavioural Therapy|computerised cognitive behavioural therapy
5655946|NCT00678496|CCBT|ccbt
5655947|NCT00678496|Cognitive Therapy|cognitive therapy
5655948|NCT00678496|Therapy, Computer-Assisted|therapy, computer-assisted
5655949|NCT00678496|Depression|depression
5655950|NCT00678496|Multiple Sclerosis|multiple sclerosis
5655951|NCT00678483|Cholesterol|cholesterol
5655952|NCT00678483|HDL|hdl
5655953|NCT00678483|triglycerides|triglycerides
5655954|NCT00678483|insulin|insulin
5655955|NCT00678483|blood glucose|blood glucose
5655956|NCT00678457|alcohol dependence|alcohol dependence
5655957|NCT00678457|alcohol abuse|alcohol abuse
5655958|NCT00678457|drinking|drinking
5655959|NCT00678457|alcohol|alcohol
5655960|NCT00678444|Anxiety|anxiety
5655961|NCT00678444|Satisfaction|satisfaction
5655962|NCT00678444|Incomplete bladder emptying|incomplete bladder emptying
5655963|NCT00678444|Clean Intermittent Self-catheterization|clean intermittent self-catheterization
5655964|NCT00678444|Prolapse/incontinence surgery|prolapse/incontinence surgery
5655965|NCT00678431|Alzheimer's Disease|alzheimer's disease
5655966|NCT00678431|Dementia|dementia
5655967|NCT00678431|Nutritional Supplement|nutritional supplement
5655968|NCT00678431|Resveratrol|resveratrol
5655969|NCT00678418|Addiction|addiction
5655970|NCT00678418|Opiate dependence|opiate dependence
5655971|NCT00678418|Inpatient detoxification|inpatient detoxification
5655972|NCT00678418|opioid dependence|opioid dependence
5655973|NCT00678418|heroin dependence|heroin dependence
5655974|NCT00678405|Breathlessness|breathlessness
5655975|NCT00678405|Dyspnoea|dyspnoea
5655976|NCT00678405|Dyspnea|dyspnea
5655977|NCT00678405|Palliative care|palliative care
5655978|NCT00678405|RCT|rct
5655979|NCT00678405|Randomised controlled trial|randomised controlled trial
5655992|NCT00678366|pain|pain
5656325|NCT00677118|Adjuvant chemotherapy|adjuvant chemotherapy
5656327|NCT00677105|Lymphoma|lymphoma
5656328|NCT00677105|Neoplasms|neoplasms
5656329|NCT00677105|Solid Tumors|solid tumors
5656352|NCT00677014|CRT|crt
5656528|NCT00676260|Dysmetabolic Syndrome|dysmetabolic syndrome
5656529|NCT00676260|Type II Diabetes|type ii diabetes
5656530|NCT00676260|Diabetes Mellitus|diabetes mellitus
5656531|NCT00676260|Lipoatrophic|lipoatrophic
5656630|NCT00675870|Cancer|cancer
5656725|NCT00675454|COPD|copd
5656902|NCT00674908|Tetanus|tetanus
5657017|NCT00674544|obesity|obesity
5657136|NCT00674102|Non-small cell lung cancer|non-small cell lung cancer
5657372|NCT00673179|Gemzar|gemzar
5657476|NCT00672802|COPD|copd
5657560|NCT00672451|albuminuria|albuminuria
5657561|NCT00672412|Treatment Experienced|treatment experienced
5657562|NCT00672399|Amylin|amylin
5657563|NCT00672399|Eli Lilly|eli lilly
5657564|NCT00672399|exenatide|exenatide
5657565|NCT00672399|moxifloxacin|moxifloxacin
5657624|NCT00672191|HIV|hiv
5657673|NCT00671970|GBM|gbm
5657755|NCT00671697|hypomethylating agent|hypomethylating agent
5657756|NCT00671697|oxidative stress|oxidative stress
5657757|NCT00671684|Hirschsprung's disease|hirschsprung's disease
5657758|NCT00671684|Constipation|constipation
5657949|NCT00671112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5657954|NCT00671112|hairy cell leukemia|hairy cell leukemia
5658132|NCT00670384|SLIT|slit
5658135|NCT00670384|SAR|sar
5658218|NCT00669916|Plaque psoriasis|plaque psoriasis
5658219|NCT00669890|AML|aml
5658313|NCT00669513|inflammation|inflammation
5658605|NCT00668135|Erectile Dysfunction|erectile dysfunction
5658606|NCT00668135|Vardenafil|vardenafil
5658707|NCT00667745|Lithium|lithium
5658926|NCT00667030|Aging|aging
5659017|NCT00666640|Computed tomography|computed tomography
5659313|NCT00665964|gonarthrrsis|gonarthrrsis
5659410|NCT00665535|Pressure ulcers|pressure ulcers
5659605|NCT00664768|DBPCFC|dbpcfc
5659703|NCT00664339|Heart failure,|heart failure,
5659704|NCT00664339|infection,|infection,
5659705|NCT00664339|immune system,|immune system,
5659706|NCT00664339|atherosclerosis|atherosclerosis
5659707|NCT00664326|Renal Cell Carcinoma|renal cell carcinoma
5659895|NCT00663442|ADHD|adhd
5660099|NCT00662597|NSCLC|nsclc
5660220|NCT00662129|male breast cancer|male breast cancer
5660100|NCT00662584|repetitive magnetic transcranial stimulation (rTMS)|repetitive magnetic transcranial stimulation (rtms)
5660101|NCT00662584|functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5660188|NCT00662220|genotype one|genotype one
5660276|NCT00661999|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5660277|NCT00661999|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5660285|NCT00661999|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5660402|NCT00661921|AMG 108|amg 108
5660513|NCT00661362|HbA1c|hba1c
5660708|NCT00660465|Healthy subjects|healthy subjects
5660801|NCT00660114|Cough variant asthma|cough variant asthma
5660802|NCT00660114|Pulmicort® Respules®|pulmicort® respules®
5660803|NCT00660114|Chinese patient Eligibility|chinese patient eligibility
5660805|NCT00660101|vaccine|vaccine
5660806|NCT00660101|immunotherapy|immunotherapy
5660807|NCT00660101|autologous|autologous
5660808|NCT00660075|Diabetes mellitus|diabetes mellitus
5660809|NCT00660075|Postprandial|postprandial
5660810|NCT00660075|Hyperlipidemia|hyperlipidemia
5660811|NCT00660075|Atherosclerosis|atherosclerosis
5660812|NCT00660062|Major depression|major depression
5660813|NCT00660062|relapse prevention|relapse prevention
5660814|NCT00660062|ECT|ect
5660815|NCT00660062|escitalopram|escitalopram
5660887|NCT00659698|infection|infection
5660888|NCT00659685|Bioequivalence|bioequivalence
5660959|NCT00659568|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5660960|NCT00659568|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5660961|NCT00659568|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5660962|NCT00659568|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5660963|NCT00659568|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5660969|NCT00659568|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5661758|NCT00656175|fat|fat
5661830|NCT00655876|stage IV esophageal cancer|stage iv esophageal cancer
5662138|NCT00654615|intramedullary distal radius fixation system|intramedullary distal radius fixation system
5662139|NCT00654602|cholesterol|cholesterol
5662140|NCT00654602|low density lipoproteins|low density lipoproteins
5662141|NCT00654602|dyslipidaemia|dyslipidaemia
5662430|NCT00653744|Crestor|crestor
5662523|NCT00653419|bioequivalence|bioequivalence
5662524|NCT00653419|buspirone HCl|buspirone hcl
5662526|NCT00653406|Schizophrenia|schizophrenia
5662527|NCT00653406|Risperidone|risperidone
5662528|NCT00653406|Intramuscular injection|intramuscular injection
5662611|NCT00653016|transdermal contraceptive patch|transdermal contraceptive patch
5662612|NCT00653016|EVRA|evra
5662613|NCT00653016|ORTHO EVRA|ortho evra
5662615|NCT00652977|sphincter tears|sphincter tears
5662706|NCT00652587|hepatectomy|hepatectomy
5663138|NCT00651066|Vietnam|vietnam
5663233|NCT00650468|Renal Transplantation|renal transplantation
5663331|NCT00649298|Clinical Trial|clinical trial
5663332|NCT00649298|Controlled Clinical Trial|controlled clinical trial
5663333|NCT00649298|Clinical Trial, Phase IV|clinical trial, phase iv
5663334|NCT00649298|Multicenter Study|multicenter study
5663335|NCT00649298|End Stage Kidney Disease|end stage kidney disease
5663336|NCT00649298|Hemodialysis|hemodialysis
5663426|NCT00648284|rosiglitazone|rosiglitazone
5663433|NCT00648232|HIV|hiv
5663613|NCT00647140|Calcitonin|calcitonin
5680418|NCT00577824|Amylin|amylin
5663796|NCT00646334|Incisional Hernia|incisional hernia
5663862|NCT00646139|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5663949|NCT00645879|hypotonia|hypotonia
5664054|NCT00645385|Glioblastoma|glioblastoma
5664171|NCT00644644|NTX|ntx
5664256|NCT00644163|African American|african american
5664257|NCT00644163|HIV Seronegativity|hiv seronegativity
5664258|NCT00644150|Risk Reduction Counseling|risk reduction counseling
5664259|NCT00644150|Anhui, China|anhui, china
5664260|NCT00644150|HIV|hiv
5664261|NCT00644150|STI|sti
5664262|NCT00644137|smoking sensations|smoking sensations
5664350|NCT00643812|Unintentional injury|unintentional injury
5664533|NCT00642785|HSV|hsv
5664550|NCT00642707|HIV|hiv
5664651|NCT00642226|Triamcinolone|triamcinolone
5664761|NCT00641875|cardiovascular|cardiovascular
5664868|NCT00641459|MMSE|mmse
5665238|NCT00640016|CAT-354|cat-354
5665319|NCT00639743|Pulmonary embolism|pulmonary embolism
5665320|NCT00639743|Heparin|heparin
5665321|NCT00639743|Thrombolytic therapy|thrombolytic therapy
5665322|NCT00639743|Bleeding|bleeding
5665325|NCT00639704|MRI|mri
5665624|NCT00638313|GLP-1|glp-1
5665799|NCT00637637|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5858436|NCT00013702|HIV|hiv
5665859|NCT00637637|stage IVB vulvar cancer|stage ivb vulvar cancer
5665875|NCT00637624|Acetylcysteine|acetylcysteine
5666060|NCT00636909|AML|aml
5666154|NCT00636441|Genomic Expression Profiles|genomic expression profiles
5666454|NCT00635193|Volociximab|volociximab
5666455|NCT00635193|Ovarian cancer|ovarian cancer
5666544|NCT00634725|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5666847|NCT00633568|Docetaxel|docetaxel
5666851|NCT00633542|thalidomide|thalidomide
5667090|NCT00632515|CRC|crc
5667136|NCT00632359|Revlimid|revlimid
5667224|NCT00631865|melanocytes|melanocytes
5667425|NCT00631163|MDS,|mds,
5667524|NCT00630747|hunters disease|hunters disease
5667621|NCT00630539|Urogenital atrophy|urogenital atrophy
5667813|NCT00629798|08-008|08-008
5667814|NCT00629785|asthma|asthma
5667907|NCT00629330|prostate cancer|prostate cancer
5668197|NCT00628368|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5668332|NCT00627796|GH|gh
5668456|NCT00627315|Gastric Bypass|gastric bypass
5668458|NCT00627289|Chronic pain|chronic pain
5668459|NCT00627289|groin hernia|groin hernia
5668652|NCT00626561|Bevacizumab|bevacizumab
5668756|NCT00626106|locally advanced|locally advanced
5668844|NCT00625820|Kidney Disease|kidney disease
5668932|NCT00625534|Hernia|hernia
5669513|NCT00623142|Preconditioning|preconditioning
5669782|NCT00622258|mTOR inhibitor|mtor inhibitor
5669783|NCT00622258|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5669785|NCT00622245|Bipolar disorder|bipolar disorder
5669786|NCT00622245|Placebo-controlled|placebo-controlled
5669787|NCT00622245|Double-blind|double-blind
5670254|NCT00620334|ASTHMA|asthma
5670351|NCT00619944|Antimalarials|antimalarials
5670352|NCT00619944|treatment naïve|treatment naïve
5670353|NCT00619931|Healthy adult volunteers|healthy adult volunteers
5670354|NCT00619918|bronchiolitis|bronchiolitis
5670439|NCT00619645|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5670608|NCT00619255|Adolescents|adolescents
5671052|NCT00617461|Neuropathic pain|neuropathic pain
5671161|NCT00616954|Bone marrow transplantation|bone marrow transplantation
5671162|NCT00616954|T cell depletion|t cell depletion
5671163|NCT00616954|engraftment|engraftment
5671164|NCT00616954|Patients undergoing allogeneic haplo-SCT|patients undergoing allogeneic haplo-sct
5671165|NCT00616941|NY-ESO-1 OLP4|ny-eso-1 olp4
5671166|NCT00616941|Ovarian Cancer|ovarian cancer
5671167|NCT00616941|Cancer Vaccine|cancer vaccine
5671168|NCT00616928|vaccines|vaccines
5671169|NCT00616928|immunogenicity|immunogenicity
5671171|NCT00616928|safety|safety
5671172|NCT00616928|influenza|influenza
5671173|NCT00616915|Wellbutrin SR|wellbutrin sr
5671174|NCT00616902|Zemplar, paricalcitol, PRIMO II|zemplar, paricalcitol, primo ii
5671175|NCT00616876|lactulose|lactulose
5671176|NCT00616876|prebiotic|prebiotic
5671177|NCT00616876|premature infant|premature infant
5671178|NCT00616876|enteral feeding|enteral feeding
5671179|NCT00616876|stools|stools
5671180|NCT00616876|lactobacillus|lactobacillus
5671181|NCT00616876|nutrition|nutrition
5671182|NCT00616876|growth|growth
5671183|NCT00616850|Total Knee Arthroplasty|total knee arthroplasty
5671184|NCT00616850|Intravenous Lidocaine Infusion|intravenous lidocaine infusion
5671185|NCT00616850|Femoral Block Catheter|femoral block catheter
5671186|NCT00616837|Remote consultation/*methods|remote consultation/*methods
5671187|NCT00616837|Orthopaedics methods|orthopaedics methods
5671188|NCT00616837|Telemedicine|telemedicine
5671189|NCT00616837|Follow-up study|follow-up study
5671190|NCT00616837|Ambulatory care|ambulatory care
5671191|NCT00616824|Acellular dermal matrix|acellular dermal matrix
5671192|NCT00616824|breast reconstruction|breast reconstruction
5844993|NCT00001519|VO2|vo2
5904373|NCT00023023|Hepatitis|hepatitis
5904374|NCT00023023|Blood Bank|blood bank
5904375|NCT00023023|Viruses|viruses
5904376|NCT00023023|Blood Donors|blood donors
5904377|NCT00023023|Blood Recipients|blood recipients
5904438|NCT00006150|DOCK8 Deficiency|dock8 deficiency
5904439|NCT00006150|PGM3 Deficiency|pgm3 deficiency
5904440|NCT00006150|STAT3 Mutation|stat3 mutation
5904441|NCT00006150|Job's Syndrome|job's syndrome
5904442|NCT00006150|Hyperimmunologobulin E Syndrome|hyperimmunologobulin e syndrome
5904443|NCT00006150|HIE Syndrome|hie syndrome
5904535|NCT00001756|Leukapheresis|leukapheresis
5904536|NCT00001756|Mastocytosis|mastocytosis
5904537|NCT00001756|Mast Cells|mast cells
5904538|NCT00001756|Normal Volunteer|normal volunteer
5904539|NCT00001756|Systemic Mastocytosis|systemic mastocytosis
5904628|NCT00001456|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5904629|NCT00001456|Metabolic Disease|metabolic disease
5904630|NCT00001456|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5685582|NCT00555516|Breast Cancer、 Chemotherapy、 Neutropenia、WBC|breast cancer、 chemotherapy、 neutropenia、wbc
5685583|NCT00555503|prospective study|prospective study
5685584|NCT00555503|registry|registry
5685585|NCT00555503|quality of life|quality of life
5685586|NCT00555503|mastectomy|mastectomy
5685587|NCT00555503|reconstructive surgical procedures|reconstructive surgical procedures
5685588|NCT00555503|BrCa1|brca1
5685589|NCT00555503|BrCa2|brca2
5685590|NCT00555503|breast cancer prevention|breast cancer prevention
5685591|NCT00555490|Soy|soy
5685592|NCT00555490|Diabetes|diabetes
5685593|NCT00555490|Nephropathy|nephropathy
5685594|NCT00555477|premenopausal breast cancer with chemotherapy-induced ovarian failure|premenopausal breast cancer with chemotherapy-induced ovarian failure
5685595|NCT00555464|hemangioma, steroid, prednisolone, vincristine|hemangioma, steroid, prednisolone, vincristine
5685596|NCT00555451|phase I|phase i
5685597|NCT00555451|safety|safety
5685598|NCT00555451|tolerance|tolerance
5685599|NCT00555451|insulin resistance|insulin resistance
5685600|NCT00555451|obese|obese
5685601|NCT00555451|pharmacokinetics|pharmacokinetics
5685602|NCT00555438|major orthopaedic surgery|major orthopaedic surgery
5685603|NCT00555438|venous thromboembolic events prevention|venous thromboembolic events prevention
5685604|NCT00555438|renal impairment|renal impairment
5685605|NCT00555438|Arixtra|arixtra
5685606|NCT00555438|anti-Xa activity|anti-xa activity
5685607|NCT00555425|Buprenorphine|buprenorphine
5685608|NCT00555425|Buprenorphine/naloxone|buprenorphine/naloxone
5685609|NCT00555425|Counseling|counseling
5685610|NCT00555425|Primary care|primary care
5685611|NCT00555412|pharmacokinetic|pharmacokinetic
5685612|NCT00555412|multidose|multidose
5685613|NCT00555412|Staccato Loxapine|staccato loxapine
5685614|NCT00555399|Glioblastoma Multiforme|glioblastoma multiforme
5685615|NCT00555399|Anaplastic Glioma|anaplastic glioma
5685616|NCT00555399|Vorinostat|vorinostat
5685617|NCT00555399|Suberoylanilide Hydroxamic Acid|suberoylanilide hydroxamic acid
5685618|NCT00555399|SAHA|saha
5685619|NCT00555399|MSK-390|msk-390
5685620|NCT00555399|Zolinza|zolinza
5685621|NCT00555399|Isotretinoin|isotretinoin
5685622|NCT00555399|Accutane|accutane
5685623|NCT00555399|13-cis-Retinoic Acid|13-cis-retinoic acid
5685624|NCT00555399|Carboplatin|carboplatin
5685625|NCT00555399|Paraplatin|paraplatin
5685626|NCT00555399|CBT|cbt
5685627|NCT00555399|Temozolomide|temozolomide
5685628|NCT00555399|Temodar|temodar
5685629|NCT00555386|Selenium|selenium
5685630|NCT00555386|Soy|soy
5685631|NCT00555386|Breast Cancer Risk|breast cancer risk
5685632|NCT00555373|Pediatric|pediatric
5685633|NCT00555373|Renal|renal
5685634|NCT00555373|Transplant|transplant
5685635|NCT00555360|Health Information Technology|health information technology
5685636|NCT00555360|Patient Care Management|patient care management
5685637|NCT00555360|Self Care|self care
5685638|NCT00555360|Quality of Life|quality of life
5685639|NCT00555360|Family or non-Family Informal Caregivers|family or non-family informal caregivers
5685640|NCT00555347|Sarcoidosis|sarcoidosis
5685641|NCT00555347|Fatigue|fatigue
5685642|NCT00555334|hepatocellular carcinoma|hepatocellular carcinoma
5685643|NCT00555334|liver cancer|liver cancer
5685644|NCT00555334|radiofrequency ablation|radiofrequency ablation
5685645|NCT00555334|lamivudine|lamivudine
5685646|NCT00555308|urolithiasis|urolithiasis
5685647|NCT00555308|ultrasound|ultrasound
5685648|NCT00555308|hydronephrosis|hydronephrosis
5685649|NCT00555282|central venous catheter|central venous catheter
5685650|NCT00555282|cvc|cvc
5685651|NCT00555282|coated catheter|coated catheter
5685652|NCT00555282|bacteriaemia|bacteriaemia
5685653|NCT00555282|bloodstream infection|bloodstream infection
5685654|NCT00555269|Macular pucker|macular pucker
5685655|NCT00555269|Macular hole|macular hole
5685656|NCT00555269|Membrane Blue|membrane blue
5685657|NCT00555269|Infracyanine Green|infracyanine green
5685658|NCT00555269|Peripheral Visual Field|peripheral visual field
5685659|NCT00555256|NSCLC|nsclc
5685660|NCT00555243|Laparoscopic Surgical Simulation|laparoscopic surgical simulation
5685661|NCT00555230|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5685662|NCT00555230|Crestor|crestor
5685663|NCT00555230|Rosuvastatin|rosuvastatin
5685664|NCT00555217|kidney disease|kidney disease
5685665|NCT00555217|nephropathy|nephropathy
5685666|NCT00555217|type 2 diabetes|type 2 diabetes
5685667|NCT00555217|hyperkalemia|hyperkalemia
5685668|NCT00555217|acute kidney injury|acute kidney injury
5685669|NCT00555204|mild to moderate Alzheimer's disease, memory, cognition, dementia|mild to moderate alzheimer's disease, memory, cognition, dementia
5685670|NCT00555191|fructose|fructose
5685671|NCT00555191|Irritable bowel syndrome|irritable bowel syndrome
5685672|NCT00555191|malabsorption|malabsorption
5685673|NCT00555191|Glut5 transporter gene|glut5 transporter gene
5685674|NCT00555178|Polymorphic light eruption|polymorphic light eruption
5685675|NCT00555178|Regulatory T cells (Tregs)|regulatory t cells (tregs)
5685676|NCT00555178|Seasonal fluctuation|seasonal fluctuation
4955135|NCT04269408|NicaPlant|nicaplant
4955136|NCT04269408|Nicardipine|nicardipine
4955137|NCT04269382|Blood Pressure Determination|blood pressure determination
4955141|NCT04269291|electrical impedance|electrical impedance
4955142|NCT04269291|skeletal muscle|skeletal muscle
4955143|NCT04269252|Anxiety|anxiety
4955144|NCT04269252|Test Anxiety|test anxiety
4955146|NCT04269239|Knee Arthroplasty|knee arthroplasty
4955147|NCT04269239|Hip Arthroplasty|hip arthroplasty
4955199|NCT04268914|augmented reality|augmented reality
4955200|NCT04268914|IV stick|iv stick
4955201|NCT04268914|mask induction|mask induction
4955202|NCT04268914|tonsillectomy|tonsillectomy
4955203|NCT04268914|adenoidectomy|adenoidectomy
4955204|NCT04268914|arthroscopy|arthroscopy
4955205|NCT04268914|hernia|hernia
4955206|NCT04268914|circumcision|circumcision
4955207|NCT04268914|orchiopexy|orchiopexy
4955208|NCT04268914|hymenectomy|hymenectomy
4955209|NCT04268914|esophagogastroduodenoscopy|esophagogastroduodenoscopy
4955210|NCT04268914|colonoscopy|colonoscopy
4955211|NCT04268914|tymanoplasty|tymanoplasty
4955214|NCT04268914|pain|pain
4955301|NCT04268407|transoral surgery|transoral surgery
4955302|NCT04268394|Healthy Volunteer|healthy volunteer
4955303|NCT04268394|Pharmacokinetics|pharmacokinetics
4955304|NCT04268394|Safety Tolerability|safety tolerability
4955305|NCT04268394|CC-99677|cc-99677
4955306|NCT04268381|periodontitis|periodontitis
4955307|NCT04268381|gingivitis|gingivitis
4955308|NCT04268381|matrix metalloproteinases|matrix metalloproteinases
4955320|NCT04268290|Colorectal Cancer|colorectal cancer
4955321|NCT04268290|ERAS|eras
4955322|NCT04268290|Single Incision plus one|single incision plus one
4955323|NCT04268290|Laparoscopic surgery|laparoscopic surgery
4955330|NCT04268186|cognitive functioning|cognitive functioning
4955331|NCT04268186|elderly|elderly
4955332|NCT04268186|healthy|healthy
4955333|NCT04268186|tDCS|tdcs
4955334|NCT04268186|motivation|motivation
4955335|NCT04268186|memory|memory
4955336|NCT04268186|structural MRI|structural mri
4955337|NCT04268186|resting-state fMRI|resting-state fmri
4955338|NCT04268160|glutathione peroxidase, GPx, aortic stenosis, transcatheter aortic valve replacement, TAVR|glutathione peroxidase, gpx, aortic stenosis, transcatheter aortic valve replacement, tavr
4955509|NCT04267003|EEG|eeg
4957191|NCT04256460|community|community
4958578|NCT04247490|incidence|incidence
4960068|NCT04238494|imaging|imaging
4966206|NCT04200859|chest tube removal|chest tube removal
5657129|NCT00674128|ICD|icd
4969465|NCT04180358|Trial|trial
4974964|NCT04148859|TTTS|ttts
4979521|NCT04120311|Branch Retinal Vein Occlusion|branch retinal vein occlusion
4979522|NCT04120311|Epiretinal Membrane|epiretinal membrane
4979525|NCT04120311|Vitritis|vitritis
4981329|NCT04109313|Chronic spontaneous urticaria|chronic spontaneous urticaria
4983315|NCT04096300|Idiopathic Granulomatous Mastitis|idiopathic granulomatous mastitis
4983318|NCT04096274|LOCI|loci
4995221|NCT04023682|Hand hygiene|hand hygiene
4996905|NCT04013360|Positive End Expiratory Pressure|positive end expiratory pressure
4997108|NCT04012190|Sepsis|sepsis
4998605|NCT04003285|Pain|pain
5002594|NCT03979560|Hospital discharge|hospital discharge
5006480|NCT03956004|shared decision making|shared decision making
5006481|NCT03956004|osteoarthritis|osteoarthritis
5006664|NCT03954847|Treatment response|treatment response
5006665|NCT03954847|Prognosis|prognosis
5006666|NCT03954847|Radiomic|radiomic
5006667|NCT03954847|Deep learning|deep learning
5006672|NCT03954821|Foot posture index, foot pronation ,foot orthoses|foot posture index, foot pronation ,foot orthoses
5006673|NCT03954808|Unilateral Cerebral Palsy, Motor imagery,|unilateral cerebral palsy, motor imagery,
5009438|NCT03937492|GMI|gmi
5011626|NCT03923686|Acute pancreatitis|acute pancreatitis
5011631|NCT03923660|COPD|copd
5015309|NCT03900858|preventive|preventive
5025210|NCT03840824|premenopausal|premenopausal
5026816|NCT03831256|Randomized controlled trial|randomized controlled trial
5028206|NCT03822871|prostate specific membrane antigen|prostate specific membrane antigen
5029493|NCT03814889|arm|arm
5034045|NCT03786302|Biodentine|biodentine
5034046|NCT03786302|Regenerative materials|regenerative materials
5034047|NCT03786302|pulp therapy|pulp therapy
5034348|NCT03784638|trismus|trismus
5035738|NCT03775551|counter reference|counter reference
5037624|NCT03763539|Pause|pause
5049718|NCT03687528|emergencies|emergencies
5051914|NCT03673722|Dementia|dementia
5058435|NCT03633695|Cataract|cataract
5060833|NCT03618810|PEG-rhG-CSF|peg-rhg-csf
5063042|NCT03605095|spreading vasodilation|spreading vasodilation
5068449|NCT03571347|distress|distress
5071249|NCT03553784|Therapy|therapy
5071250|NCT03553771|aneurysm|aneurysm
5071251|NCT03553771|endovascular|endovascular
5071336|NCT03553290|lower-level laser therapy|lower-level laser therapy
5071337|NCT03553277|Dengue|dengue
5071338|NCT03553277|Zika|zika
5071339|NCT03553277|Chikungunya|chikungunya
5071340|NCT03553277|Spatial repellent|spatial repellent
5071432|NCT03552692|single agent|single agent
5073124|NCT03541876|treatment|treatment
5077418|NCT03515525|Closed-suction drains|closed-suction drains
5077419|NCT03515512|Acute Myeloid Leukemia|acute myeloid leukemia
5077420|NCT03515512|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5077423|NCT03515486|Stroke|stroke
5077424|NCT03515486|Cerebellum|cerebellum
5077519|NCT03515096|Thrombopoietin|thrombopoietin
5077610|NCT03514316|orthodontic treatment|orthodontic treatment
5077611|NCT03514303|Skin test, Microarray test|skin test, microarray test
5077612|NCT03514290|Laser|laser
5077613|NCT03514290|Color|color
5077614|NCT03514264|Endodontics|endodontics
5083208|NCT03478410|Epicardial fat|epicardial fat
5083209|NCT03478397|cervical cancer prevention|cervical cancer prevention
5083210|NCT03478397|self-collection HPV test|self-collection hpv test
5083211|NCT03478397|mHealth|mhealth
5083212|NCT03478397|Argentina|argentina
5083213|NCT03478384|self-efficacy expectation|self-efficacy expectation
5083214|NCT03478371|tampon|tampon
5083215|NCT03478319|ACE-2494|ace-2494
5083216|NCT03478241|Endodontic retreatment|endodontic retreatment
5083217|NCT03478241|postoperative pain|postoperative pain
5083218|NCT03478241|OneShape|oneshape
5083219|NCT03478241|Revo-S|revo-s
5083220|NCT03478241|WaveOne|waveone
5083221|NCT03478228|fracture|fracture
5083222|NCT03478228|rehabilitation|rehabilitation
5083223|NCT03478228|wrist|wrist
5083224|NCT03478228|sensation|sensation
5083225|NCT03478228|exercise|exercise
5083226|NCT03478215|kidney transplantation|kidney transplantation
5083227|NCT03478215|graft rejection|graft rejection
5084283|NCT03472053|metastasis|metastasis
5084284|NCT03472040|BCX7353|bcx7353
5084285|NCT03472040|Hereditary Angioedema|hereditary angioedema
5084286|NCT03472040|HAE|hae
5685382|NCT00556348|bevacizumab|bevacizumab
5092962|NCT03417622|locally advanced breast cancer|locally advanced breast cancer
5095512|NCT03401320|pharmacokinetics|pharmacokinetics
5097074|NCT03391895|6-Minute Walk test|6-minute walk test
5099718|NCT03374917|carbidopa|carbidopa
5099719|NCT03374917|levodopa|levodopa
5099720|NCT03374904|Parenting|parenting
5099721|NCT03374904|Parental Mentalization|parental mentalization
5102176|NCT03359473|GSK2881078|gsk2881078
5110796|NCT03305185|AIS|ais
5111798|NCT03298802|readmission|readmission
5114387|NCT03281733|hospitalized patients|hospitalized patients
5114388|NCT03281733|dietitian|dietitian
5117871|NCT03258840|EPA|epa
5120317|NCT03243058|Diabetes, Autoimmune|diabetes, autoimmune
5120318|NCT03243058|Interleukin-2|interleukin-2
5120319|NCT03243058|Interleukin|interleukin
5120321|NCT03243045|Arterial hypertension|arterial hypertension
5120416|NCT03242395|Systemic inflammation|systemic inflammation
5125428|NCT03210753|Bortezomib|bortezomib
5127709|NCT03195959|Chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension
5128113|NCT03193658|opioid consumption|opioid consumption
5131199|NCT03174002|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5131200|NCT03174002|Mechanical ventilation|mechanical ventilation
5131201|NCT03174002|Critical illness|critical illness
5131489|NCT03172039|antimicrobial stewardship|antimicrobial stewardship
5131589|NCT03171220|PD-1 Inhibitor|pd-1 inhibitor
5131592|NCT03171220|PD-1 antibody|pd-1 antibody
5139636|NCT03118024|fluid restriction|fluid restriction
5139835|NCT03116776|walnut shell glasses moxibustion|walnut shell glasses moxibustion
5142153|NCT03102398|Sexual Dysfunction|sexual dysfunction
5142155|NCT03102385|motivation|motivation
5142348|NCT03101176|CEUS|ceus
5142650|NCT03099343|sodium|sodium
5143044|NCT03097172|Fractional Flow Reserve (FFR)|fractional flow reserve (ffr)
5143045|NCT03097172|Doppler Flow Velocity|doppler flow velocity
5143046|NCT03097172|Cardiovascular Disease|cardiovascular disease
5157375|NCT03008174|speech|speech
5162948|NCT02974192|Soluble CD40 Ligand|soluble cd40 ligand
5162949|NCT02974192|Neopetrin|neopetrin
5162950|NCT02974192|stroke risk factors|stroke risk factors
5162951|NCT02974192|functional outcome|functional outcome
5162952|NCT02974166|Temporomandibular Disorder|temporomandibular disorder
5163056|NCT02973581|paracetamol|paracetamol
5247983|NCT02457741|PEEP|peep
5253942|NCT02423161|vitreoretinal surgery|vitreoretinal surgery
5295243|NCT02200263|ocular albinism (OA)|ocular albinism (oa)
5302878|NCT02162550|Carotid Plaque|carotid plaque
5334937|NCT02017444|Obesity|obesity
5345821|NCT01968239|BRVO|brvo
5351935|NCT01940094|WG|wg
5363594|NCT01885949|Metastatic|metastatic
5363610|NCT01885871|Sun|sun
5363688|NCT01885481|dexamethasone|dexamethasone
5387429|NCT01778881|Bruxism|bruxism
5394929|NCT01744405|nifurtimox|nifurtimox
5416059|NCT01649921|Sepsis|sepsis
5431869|NCT01579760|anti-VEGF|anti-vegf
5431870|NCT01579760|VEGF-Trap|vegf-trap
5459285|NCT01464398|health education|health education
5459286|NCT01464398|women|women
5459287|NCT01464398|overweight|overweight
5459288|NCT01464398|obesity|obesity
5459289|NCT01464372|Urinary Incontinence, Urge|urinary incontinence, urge
5686650|NCT00551226|TB|tb
5459290|NCT01464372|Peripheral Nerve Stimulation|peripheral nerve stimulation
5459291|NCT01464359|umbilical cord blood transplant|umbilical cord blood transplant
5459292|NCT01464346|diabetes|diabetes
5459293|NCT01464346|glucose sensor|glucose sensor
5459295|NCT01464333|Crohn's Disease|crohn's disease
5459296|NCT01464320|Safety|safety
5459480|NCT01463514|cerebral tissue oxygenation,|cerebral tissue oxygenation,
5459482|NCT01463501|Esophageal cancer|esophageal cancer
5459483|NCT01463501|Resectable|resectable
5459484|NCT01463501|Neoadjuvant chemoradiotherapy|neoadjuvant chemoradiotherapy
5459485|NCT01463501|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5466979|NCT01432990|gait|gait
5466981|NCT01432990|robotic|robotic
5487116|NCT01349088|breast cancer|breast cancer
5500407|NCT01294332|TBI|tbi
5507975|NCT01262183|oesophagus cancer|oesophagus cancer
5507976|NCT01262183|chemoradiotherapy|chemoradiotherapy
5520245|NCT01207791|SBIRT|sbirt
5538156|NCT01134913|ACS|acs
5539240|NCT01130545|HV|hv
5555298|NCT01065558|Safety|safety
5555300|NCT01065545|leukemia|leukemia
5556183|NCT01061788|Duke|duke
5556184|NCT01061788|Subjects with refractory advanced solid tumors|subjects with refractory advanced solid tumors
5557166|NCT01057615|Asthma|asthma
5557168|NCT01057615|Inflammation|inflammation
5557255|NCT01057264|HAI|hai
5557456|NCT01056393|HIV|hiv
5557744|NCT01055249|UVB|uvb
5558238|NCT01053130|obesity|obesity
5558814|NCT01050985|advanced cancer|advanced cancer
5558815|NCT01050985|temsirolimus|temsirolimus
5558816|NCT01050985|capecitabine|capecitabine
5558817|NCT01050972|Headache|headache
5559120|NCT01049724|PRK|prk
5576984|NCT00980031|left atrial volumes|left atrial volumes
5576985|NCT00980031|diastolic function|diastolic function
5576987|NCT00980018|Leukemia|leukemia
5577385|NCT00978484|Military Medicine|military medicine
5577387|NCT00978484|Iraq|iraq
5577388|NCT00978484|Afghanistan|afghanistan
5577389|NCT00978484|Air Force Personnel|air force personnel
5577397|NCT00978484|Marines|marines
5577486|NCT00978224|hemodialysis|hemodialysis
5577487|NCT00978224|Chronic Inflammatory Syndrome|chronic inflammatory syndrome
5577488|NCT00978224|Viusid|viusid
5594350|NCT00913770|opioid dependence|opioid dependence
5643313|NCT00727792|MRI|mri
5652071|NCT00693329|Kidney|kidney
5660459|NCT00661609|Anti-mitotic|anti-mitotic
5671311|NCT00616590|stage I salivary gland cancer|stage i salivary gland cancer
5671317|NCT00616564|Interleukin|interleukin
5671400|NCT00616148|Seizures|seizures
5671401|NCT00616135|Breast|breast
5671402|NCT00616135|Stem Cell|stem cell
5671641|NCT00615043|TURBT|turbt
5671782|NCT00614367|chromosomal abnormalities in single cells|chromosomal abnormalities in single cells
5671783|NCT00614354|99mTc-glucarate imaging to detect acute coronary syndrome|99mtc-glucarate imaging to detect acute coronary syndrome
5671784|NCT00614341|diabetes mellitus|diabetes mellitus
5671785|NCT00614341|neuropathy|neuropathy
5671786|NCT00614341|distal symmetric polyneuropathy|distal symmetric polyneuropathy
5671787|NCT00614341|pulsed electric fild|pulsed electric fild
5671789|NCT00614328|Alcohol Abuse|alcohol abuse
5671872|NCT00613925|pain management|pain management
5671877|NCT00613899|ALS|als
5672035|NCT00613145|Capecitabine|capecitabine
5672036|NCT00613132|Glioblastoma|glioblastoma
5672037|NCT00613132|Gliosarcoma|gliosarcoma
5672152|NCT00612820|Vienna Challenge Chamber|vienna challenge chamber
5672222|NCT00612716|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5672223|NCT00612716|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5672316|NCT00612391|humerus fracture|humerus fracture
5672326|NCT00612339|GBM|gbm
5672527|NCT00611533|Menopause|menopause
5672597|NCT00611351|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5672598|NCT00611351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5672806|NCT00610571|GBM|gbm
5672678|NCT00611195|Children|children
5672791|NCT00610597|liver|liver
5672876|NCT00610246|Thorax|thorax
5672983|NCT00609934|sorafenib|sorafenib
5673081|NCT00609505|breast cancer|breast cancer
5673082|NCT00609505|ovarian cancer|ovarian cancer
5673275|NCT00608582|Treat Naming|treat naming
5673436|NCT00608192|HIV|hiv
5673521|NCT00607945|weight loss|weight loss
5673624|NCT00607490|Sexual dysfunction|sexual dysfunction
5887071|NCT04270123|EORTC|eortc
5674007|NCT00605566|Neuroendocrine|neuroendocrine
5674091|NCT00605098|Pregnancy|pregnancy
5674342|NCT00603915|gemcitabine|gemcitabine
5674343|NCT00603915|carboplatin|carboplatin
5674344|NCT00603915|cisplatin|cisplatin
5674345|NCT00603915|erlotinib|erlotinib
5674346|NCT00603915|tarceva|tarceva
5674347|NCT00603915|nasopharyngeal|nasopharyngeal
5674348|NCT00603902|Obesity|obesity
5674349|NCT00603902|Weight loss|weight loss
5674350|NCT00603902|lorcaserin|lorcaserin
5674440|NCT00603590|safety|safety
5888884|NCT04145011|Osteoarthritis|osteoarthritis
5888885|NCT04145011|Radiofrequency Ablation|radiofrequency ablation
5888887|NCT04145011|Genicular|genicular
5888888|NCT04145011|Coolief|coolief
5888929|NCT04141995|Resectable|resectable
5888943|NCT04140929|nursing homes|nursing homes
5674578|NCT00603018|PET|pet
5674608|NCT00602836|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5674614|NCT00602758|AIDS|aids
5674673|NCT00602537|Prevention of Depression Relapse|prevention of depression relapse
5674674|NCT00602511|Melfalan refractory multiple myeloma|melfalan refractory multiple myeloma
5674675|NCT00602511|Multiple myeloma|multiple myeloma
5674676|NCT00602511|Relapsing|relapsing
5674677|NCT00602511|Refractory|refractory
5674678|NCT00602511|Thalidomide|thalidomide
5674684|NCT00602420|pain|pain
5674737|NCT00602147|mucositis|mucositis
5889347|NCT04098198|Biomarker|biomarker
5889530|NCT04083924|Flipped classroom|flipped classroom
5889544|NCT04082455|carbon ion radiotherapy|carbon ion radiotherapy
5889552|NCT04079790|Gepotidacin|gepotidacin
5889553|NCT04079790|Pharmacokinetics|pharmacokinetics
5889554|NCT04079790|Healthy Adult|healthy adult
5674964|NCT00601406|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5674965|NCT00601406|stage IVA endometrial carcinoma|stage iva endometrial carcinoma
5674966|NCT00601406|stage IVB endometrial carcinoma|stage ivb endometrial carcinoma
5674967|NCT00601406|stage IA uterine sarcoma|stage ia uterine sarcoma
5674978|NCT00601354|Orlistat|orlistat
5890184|NCT04017312|Airway Clearance therapy|airway clearance therapy
5890186|NCT04017312|The Vest®|the vest®
5675272|NCT00600015|Non-Small Cell Lung Cancer|non-small cell lung cancer
5675413|NCT00599443|Safety|safety
5675493|NCT00598897|MAC|mac
5675494|NCT00598884|Clinical Protocols|clinical protocols
5675495|NCT00598884|Behavioral Research|behavioral research
5675496|NCT00598884|Prevention|prevention
5675499|NCT00598871|Vitrectomy|vitrectomy
5675565|NCT00598507|ZK219477|zk219477
5675675|NCT00598169|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5675676|NCT00598169|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5675677|NCT00598169|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5685579|NCT00555529|induced sputum|induced sputum
5675678|NCT00598169|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5675679|NCT00598169|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5675754|NCT00597831|depression|depression
5675757|NCT00597831|intracranial pressure|intracranial pressure
5675870|NCT00597415|Knee pain|knee pain
5892498|NCT03688009|mixed methods design|mixed methods design
5676256|NCT00595751|ADHD, Attention Deficit Hyperactivity Disorder|adhd, attention deficit hyperactivity disorder
5676257|NCT00595738|Congestive heart failure|congestive heart failure
5676418|NCT00595023|Sentinel lymph node|sentinel lymph node
5676461|NCT00594854|Arthrotec|arthrotec
5676543|NCT00594464|Rotigotine|rotigotine
5894156|NCT03474965|SEG101|seg101
5894225|NCT03470922|Advanced Cancer|advanced cancer
5894310|NCT03454451|RCC|rcc
5894311|NCT03454451|TNBC|tnbc
5676961|NCT00592358|children|children
5677177|NCT00591565|Acamprosate|acamprosate
5677322|NCT00590980|Blood Flow|blood flow
5677417|NCT00590499|craniotomy|craniotomy
5677418|NCT00590499|incidence|incidence
5677419|NCT00590499|risk factor|risk factor
5677421|NCT00590473|Interstitial Cystitis|interstitial cystitis
5677422|NCT00590473|IC|ic
5896232|NCT03160898|ALS|als
5677595|NCT00589810|genetic|genetic
5677769|NCT00589563|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5677770|NCT00589563|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5677869|NCT00589368|rehabilitation|rehabilitation
5677771|NCT00589563|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5898748|NCT02547766|Recovery of Function|recovery of function
5677844|NCT00589381|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5899135|NCT02426892|BMS-936558|bms-936558
5678033|NCT00588562|PHII|phii
5678105|NCT00588341|TMZ|tmz
5900176|NCT02083744|Spanish|spanish
5900348|NCT02039388|BRCA1 gene|brca1 gene
5678348|NCT00587145|Combination chemotherapy|combination chemotherapy
5678350|NCT00587145|Docetaxel|docetaxel
5678432|NCT00586846|Methotrexate|methotrexate
4971154|NCT04171115|botulism|botulism
5678670|NCT00585793|HIV/AIDS|hiv/aids
5678746|NCT00585208|insomnia|insomnia
5678801|NCT00584922|Esophageal injury|esophageal injury
5679075|NCT00583648|urinalysis|urinalysis
5679181|NCT00583167|brain|brain
5679343|NCT00582439|Orthopaedic Trauma Non-unions|orthopaedic trauma non-unions
5679344|NCT00582439|Reamer-Irrigator-Aspirator (RIA)|reamer-irrigator-aspirator (ria)
5679412|NCT00582179|Negative Pressure Wound Therapy (NPWT)|negative pressure wound therapy (npwt)
5798798|NCT00110981|skin|skin
5679504|NCT00581789|phase 1|phase 1
5679505|NCT00581776|Untreated Mantle Cell Lymphoma|untreated mantle cell lymphoma
5679506|NCT00581750|Biopsy|biopsy
5679507|NCT00581750|Breast|breast
5679594|NCT00581334|Post hysterectomy prolapse|post hysterectomy prolapse
5679595|NCT00581334|Symptomatic post hysterectomy prolapse of stage II or greater|symptomatic post hysterectomy prolapse of stage ii or greater
5679596|NCT00581321|water|water
5679597|NCT00581321|blood pressure|blood pressure
5679598|NCT00581321|vascular resistance|vascular resistance
5679599|NCT00581321|cardiac transplantation|cardiac transplantation
5679600|NCT00581308|atrial septal defect, septal occluder, HELEX|atrial septal defect, septal occluder, helex
5902838|NCT00831766|AML|aml
5902946|NCT00720941|SUTENT|sutent
5679850|NCT00580255|CHF|chf
5680086|NCT00579215|Advance Lung Cancer|advance lung cancer
5680087|NCT00579215|Questionaires|questionaires
5680088|NCT00579215|Stage III Lung Cancer|stage iii lung cancer
5680089|NCT00579215|Stage IV Lung Cancer|stage iv lung cancer
5680090|NCT00579202|Dialyzer|dialyzer
5680091|NCT00579189|ear tubes|ear tubes
4958072|NCT04250831|mood|mood
4961905|NCT04227834|Soil-transmitted helminth|soil-transmitted helminth
5680230|NCT00578591|AHT|aht
4965769|NCT04203368|SVT|svt
4966345|NCT04200001|women|women
4969424|NCT04180579|hair loss|hair loss
4971288|NCT04170231|19-407|19-407
4972632|NCT04162951|Breast surgery|breast surgery
4972633|NCT04162951|Postoperative pain|postoperative pain
4979368|NCT04121351|Exercises|exercises
4979369|NCT04121338|celiac ganglion block|celiac ganglion block
4979370|NCT04121338|resection|resection
4979453|NCT04120740|Validility|validility
4979455|NCT04120727|Osteoarthritis|osteoarthritis
4982477|NCT04101994|transcranial electric stimulation|transcranial electric stimulation
4982479|NCT04101929|metastatic pancreatic cancer|metastatic pancreatic cancer
4984289|NCT04090268|lymphoma|lymphoma
4988184|NCT04065269|Carcinosarcoma|carcinosarcoma
4989985|NCT04054076|orthotics|orthotics
4997322|NCT04011098|Labour Pain|labour pain
4997516|NCT04009681|IL2|il2
5007838|NCT03947294|VO2|vo2
5009592|NCT03936634|Beta cell|beta cell
5013708|NCT03911336|Osteogenesis|osteogenesis
5013808|NCT03910634|Esophageal Cancer|esophageal cancer
5013809|NCT03910634|radiotherapy|radiotherapy
5013810|NCT03910634|chemotherapy|chemotherapy
5015372|NCT03900468|Epilepsy|epilepsy
5023131|NCT03852953|Womens' perspectives|womens' perspectives
5025352|NCT03839901|wrist|wrist
5026828|NCT03831204|AHF|ahf
5026929|NCT03830502|Risk-reducing|risk-reducing
5026931|NCT03830489|Colonoscopy|colonoscopy
5027077|NCT03829410|Leucovorin|leucovorin
5027078|NCT03829410|Avastin|avastin
5031511|NCT03802136|oxidative stress|oxidative stress
5037460|NCT03764956|LGIT|lgit
5047505|NCT03702465|App|app
5063446|NCT03602742|Long term ECG monitor|long term ecg monitor
5066996|NCT03580135|propolis|propolis
5066997|NCT03580109|Lymphoedema|lymphoedema
5066998|NCT03580109|Post breast cancer|post breast cancer
5066999|NCT03580109|Spa therapy|spa therapy
5067000|NCT03580109|Education therapeutic|education therapeutic
5067093|NCT03579537|Excercise|excercise
5067196|NCT03578757|spa|spa
5067293|NCT03578315|Nevus Zygomaticus|nevus zygomaticus
5067294|NCT03578315|Harmonic Generation Microscopy|harmonic generation microscopy
5067295|NCT03578315|In Vivo|in vivo
5067298|NCT03578276|cataract surgery|cataract surgery
5067390|NCT03577730|Cognitive Impairment|cognitive impairment
5077058|NCT03517540|NASH|nash
5078694|NCT03507530|fear of falling|fear of falling
5081929|NCT03486678|BTC|btc
5084329|NCT03471806|Bulimia Nervosa|bulimia nervosa
5084330|NCT03471806|Eating disorder|eating disorder
5084331|NCT03471806|Dopamine|dopamine
5084332|NCT03471806|Food|food
5084333|NCT03471806|Reward|reward
5084334|NCT03471806|Positron Emission Tomography|positron emission tomography
5084539|NCT03470389|Noninvasive|noninvasive
5085503|NCT03464305|Intestinal Neoplasms|intestinal neoplasms
5085504|NCT03464305|Gastrointestinal Neoplasms|gastrointestinal neoplasms
5085505|NCT03464305|Digestive System Neoplasms|digestive system neoplasms
5085506|NCT03464305|Neoplasms by Site|neoplasms by site
5085584|NCT03463785|upper airway|upper airway
5085682|NCT03462979|Gluten-free diet|gluten-free diet
5086016|NCT03460626|stress|stress
5087821|NCT03448978|CART|cart
5093410|NCT03414840|statins|statins
5097829|NCT03386929|Gene expression|gene expression
5097837|NCT03386812|sarcopenia|sarcopenia
5105944|NCT03335202|diversity|diversity
5112988|NCT03290599|Hip Surgery|hip surgery
5116907|NCT03264976|miRNA|mirna
5116999|NCT03264365|Follow-up programme|follow-up programme
5117000|NCT03264365|Aftercare|aftercare
5117001|NCT03264365|Randomized controlled Trial|randomized controlled trial
5117002|NCT03264365|Multicentre|multicentre
5117003|NCT03264339|Infant|infant
5117004|NCT03264339|Hand/Growth & Development|hand/growth & development
5117005|NCT03264339|Motor activity|motor activity
5117112|NCT03263702|Persistent Atrial Fibrillation|persistent atrial fibrillation
5117113|NCT03263702|mapping|mapping
5117114|NCT03263663|colorectal cancer|colorectal cancer
5122250|NCT03231072|EIT|eit
5123038|NCT03226236|Carcinoma, Renal Cell|carcinoma, renal cell
5126262|NCT03205215|Concussion|concussion
5131186|NCT03174080|Positron-Emission|positron-emission
5135580|NCT03145909|Chromophobe renal cell carcinoma|chromophobe renal cell carcinoma
5135581|NCT03145909|Hepatocellular carcinoma|hepatocellular carcinoma
5135582|NCT03145896|vitamin D|vitamin d
5135583|NCT03145896|Anemia|anemia
5135588|NCT03145844|DAA|daa
5141863|NCT03104478|DLBCL|dlbcl
5149196|NCT03060200|CBT|cbt
5151941|NCT03042611|Tumor|tumor
5184550|NCT02836275|Early Diagnosis|early diagnosis
5185248|NCT02831959|TTF|ttf
5227501|NCT02578329|Mediterranean diet|mediterranean diet
5241324|NCT02495909|morbidity|morbidity
5241626|NCT02494258|hematological disorders|hematological disorders
5337086|NCT02008045|MRI|mri
5241934|NCT02492555|At-home monitoring|at-home monitoring
5242125|NCT02491242|HIV|hiv
5242427|NCT02488915|Brain Infarction|brain infarction
5242515|NCT02488564|pCR|pcr
5246596|NCT02465840|functional MRI|functional mri
5250277|NCT02443168|Pharmacokinetic|pharmacokinetic
5254805|NCT02418871|cataract|cataract
5260142|NCT02387658|endovascular|endovascular
5260143|NCT02387645|Endometrium|endometrium
5260144|NCT02387645|Endometrial Neoplasms|endometrial neoplasms
5260145|NCT02387645|Early detection|early detection
5260146|NCT02387645|Carcinoma of Endometrium|carcinoma of endometrium
5260147|NCT02387645|Gynaecological Cancer|gynaecological cancer
5260336|NCT02386514|gonorrhea|gonorrhea
5260337|NCT02386514|chlamydia|chlamydia
5260338|NCT02386514|presumptive therapy|presumptive therapy
5263586|NCT02368132|Caregivers|caregivers
5282940|NCT02257710|Ischemia|ischemia
5282941|NCT02257710|Angina|angina
5283820|NCT02252666|MS|ms
5289129|NCT02228057|pain|pain
5289130|NCT02228057|cold intolerance|cold intolerance
5289134|NCT02228044|HIV|hiv
5289322|NCT02227082|olaparib|olaparib
5289323|NCT02227082|breast cancer|breast cancer
5289632|NCT02225574|CML|cml
5294015|NCT02205593|psoriasis|psoriasis
5294111|NCT02205268|Neurofeedback Training|neurofeedback training
5294231|NCT02204891|Flatulence|flatulence
5294324|NCT02204423|Upper extremity dysfunction|upper extremity dysfunction
5294325|NCT02204423|Trans-Radial Percutaneous Coronary Interventions|trans-radial percutaneous coronary interventions
5312122|NCT02119988|TIPS|tips
5323701|NCT02067923|T1D|t1d
5342774|NCT01982045|RCT|rct
5347952|NCT01959087|Single port surgery|single port surgery
5376416|NCT01828905|void filler|void filler
5376417|NCT01828905|quality of life|quality of life
5376418|NCT01828905|pain|pain
5376419|NCT01828905|costs of care|costs of care
5391219|NCT01762059|CGM|cgm
5395466|NCT01742156|CAD|cad
5402782|NCT01709279|ADRC|adrc
5418591|NCT01637844|HBeAg positive|hbeag positive
5430039|NCT01587313|isosorbide|isosorbide
5439356|NCT01548014|VSL #3|vsl #3
5449533|NCT01504802|leptin|leptin
5494989|NCT01316744|intraocular lymphoma|intraocular lymphoma
5533761|NCT01152021|MRI|mri
5560020|NCT01047553|COPD|copd
5574806|NCT00988156|Double-blind|double-blind
5597134|NCT00902642|musculoskeletal pain,|musculoskeletal pain,
5627756|NCT00788216|Radical hysterectomy|radical hysterectomy
5627758|NCT00788216|Brachytherapy|brachytherapy
5640611|NCT00737815|Magnesium|magnesium
5654468|NCT00684294|solid tumor|solid tumor
5669913|NCT00621673|rFVIII|rfviii
5670027|NCT00621257|IBD|ibd
5670053|NCT00621166|Safety|safety
5670429|NCT00619671|Rituxan|rituxan
5670952|NCT00617916|wound healing|wound healing
5671146|NCT00617006|Hand Hygiene|hand hygiene
4955116|NCT04269486|Safety|safety
4955117|NCT04269486|Herbal Medicine|herbal medicine
4955118|NCT04269486|Drug Induced Liver Injury|drug induced liver injury
4955119|NCT04269486|Drug-Induced Kidney Injury|drug-induced kidney injury
4955120|NCT04269486|Prospective Observation|prospective observation
4955121|NCT04269486|Multicenter Study|multicenter study
4955122|NCT04269460|ultrasound|ultrasound
4955123|NCT04269460|quadratus lumborum|quadratus lumborum
4955124|NCT04269460|subcostal TAP|subcostal tap
4955125|NCT04269460|pediatrics|pediatrics
4955126|NCT04269460|pyeloplasty|pyeloplasty
4955127|NCT04269447|Growth Prediction|growth prediction
4955128|NCT04269447|Rupture Risk Prediction|rupture risk prediction
4955129|NCT04269447|Imaging|imaging
4955130|NCT04269447|Aortic disease|aortic disease
4960160|NCT04237948|falls|falls
5682034|NCT00570804|MAPS|maps
5690512|NCT00536120|MS|ms
5690593|NCT00535873|CLL|cll
5682509|NCT00569231|Candida|candida
5708106|NCT00471731|TS|ts
5680479|NCT00577798|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5680480|NCT00577798|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5680481|NCT00577798|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5680482|NCT00577798|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5680483|NCT00577798|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5681135|NCT00574574|cardiovascular disease|cardiovascular disease
5683091|NCT00566371|insomnia|insomnia
5683186|NCT00566085|MBI|mbi
5680484|NCT00577798|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5680485|NCT00577798|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5683757|NCT00563238|Extubation|extubation
5681137|NCT00574574|skin health|skin health
5683938|NCT00562627|knee arthroplasty|knee arthroplasty
5681138|NCT00574574|postmenopausal women|postmenopausal women
5681139|NCT00574574|anthocyanin|anthocyanin
5684390|NCT00560807|WAD III|wad iii
5693124|NCT00525720|Survey|survey
5710383|NCT00463489|BMI|bmi
5685294|NCT00556699|NHL|nhl
5680486|NCT00577798|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5680487|NCT00577798|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5710922|NCT00461643|PCOS|pcos
5711127|NCT00460811|IBS|ibs
5685828|NCT00554684|ICU|icu
5687333|NCT00547898|HIV Associated Diarrhea|hiv associated diarrhea
5687334|NCT00547885|dihydrocodeine|dihydrocodeine
5687335|NCT00547885|opioids, long acting|opioids, long acting
5687336|NCT00547885|opioids, short acting|opioids, short acting
5687337|NCT00547885|Chronic pain|chronic pain
5687338|NCT00547885|non-malignant pain|non-malignant pain
5687339|NCT00547859|microcirculation|microcirculation
5687340|NCT00547859|cardiac surgery|cardiac surgery
5687341|NCT00547859|metabolism|metabolism
5687342|NCT00547859|capnometry|capnometry
5687343|NCT00547846|Cough|cough
5687344|NCT00547846|Antitussive|antitussive
5687345|NCT00547846|PDC-748|pdc-748
5687346|NCT00547846|PhytoHealth|phytohealth
5687348|NCT00547833|language learning disabilities|language learning disabilities
5687349|NCT00547833|vocabulary|vocabulary
5687351|NCT00547820|radiation dose|radiation dose
5687352|NCT00547820|VCUG|vcug
5687353|NCT00547820|pediatric patients|pediatric patients
5687354|NCT00547807|Pain, neonate, nursing care|pain, neonate, nursing care
5687355|NCT00547729|Heart Failure|heart failure
5687356|NCT00547729|Left Atrial Pressure Monitoring|left atrial pressure monitoring
5687357|NCT00547716|Hepatitis C|hepatitis c
5687358|NCT00547716|Omega 3 fatty acids|omega 3 fatty acids
5687359|NCT00547716|Omacor|omacor
5687360|NCT00547716|Interferon|interferon
5687361|NCT00547703|Nonulcer dyspepsia|nonulcer dyspepsia
5687362|NCT00547703|Functional dyspepsia|functional dyspepsia
5687363|NCT00547703|Antidepressant use in dyspepsia|antidepressant use in dyspepsia
5687364|NCT00547703|Nortriptyline|nortriptyline
5687365|NCT00547703|Tricyclic antidepressants|tricyclic antidepressants
5687366|NCT00547677|liver metastases|liver metastases
5687367|NCT00547677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5687368|NCT00547664|Hylenex, time tagged pain pain reduction, hospice population|hylenex, time tagged pain pain reduction, hospice population
5687369|NCT00547651|Small Cell Lung Cancer|small cell lung cancer
5687370|NCT00547651|Lung Cancer|lung cancer
5685677|NCT00555178|UV radiation|uv radiation
5687371|NCT00547651|Limited Disease Sensitive Small Cell Lung Cancer|limited disease sensitive small cell lung cancer
5687372|NCT00547651|Extensive Disease Sensitive Small Cell Lung Cancer|extensive disease sensitive small cell lung cancer
5687373|NCT00547651|Limited Disease Refractory Small Cell Lung Cancer|limited disease refractory small cell lung cancer
5687374|NCT00547651|Extensive Disease Refractory Small Cell Lung Cancer|extensive disease refractory small cell lung cancer
5687375|NCT00547651|Refractory Small Cell Lung Cancer|refractory small cell lung cancer
5687376|NCT00547651|Sensitive Small Cell Lung Cancer|sensitive small cell lung cancer
5687377|NCT00547638|laceration/wound closure|laceration/wound closure
5687378|NCT00547638|topical skin adhesive|topical skin adhesive
5687379|NCT00547612|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5687380|NCT00547612|stage I pancreatic cancer|stage i pancreatic cancer
5687381|NCT00547612|stage II pancreatic cancer|stage ii pancreatic cancer
5687382|NCT00547612|stage III pancreatic cancer|stage iii pancreatic cancer
5687383|NCT00547612|stage IV pancreatic cancer|stage iv pancreatic cancer
5687384|NCT00547612|recurrent pancreatic cancer|recurrent pancreatic cancer
5687385|NCT00547560|Alzheimer Disease|alzheimer disease
5687386|NCT00547547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5687387|NCT00547534|Bortezomib|bortezomib
5687388|NCT00547534|Bendamustine|bendamustine
5687389|NCT00547534|Rituximab|rituximab
5687390|NCT00547534|Relapsed|relapsed
5687391|NCT00547534|Refractory|refractory
5687394|NCT00547482|Type 2 Diabetes|type 2 diabetes
5687395|NCT00547482|Overweight|overweight
5687396|NCT00547482|Obese|obese
5687397|NCT00547469|Irritable Bowel Syndrome|irritable bowel syndrome
5687398|NCT00547469|IBS-c|ibs-c
5687399|NCT00547469|IBS constipation|ibs constipation
5687400|NCT00547469|women with IBS|women with ibs
5687401|NCT00547469|women with constipation|women with constipation
5687402|NCT00547443|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5863035|NCT00001412|Leuprolide Acetate|leuprolide acetate
5687403|NCT00547443|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5687404|NCT00547443|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5687405|NCT00547443|adenocarcinoma of the lung|adenocarcinoma of the lung
5687406|NCT00547443|squamous cell lung cancer|squamous cell lung cancer
5687407|NCT00547443|large cell lung cancer|large cell lung cancer
5687408|NCT00547443|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5687409|NCT00547443|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5687410|NCT00547391|adults|adults
5687411|NCT00547391|children|children
5687412|NCT00547391|tonsillectomy|tonsillectomy
5687413|NCT00547378|overactive bladder, urinary incontinence, incontinence,Urgency-frequency|overactive bladder, urinary incontinence, incontinence,urgency-frequency
5687414|NCT00547365|primary systemic amyloidosis|primary systemic amyloidosis
5687415|NCT00547339|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5687416|NCT00547339|stage I prostate cancer|stage i prostate cancer
5687417|NCT00547339|stage IIB prostate cancer|stage iib prostate cancer
5687418|NCT00547339|stage IIA prostate cancer|stage iia prostate cancer
5687420|NCT00547300|Nebivolol|nebivolol
5687421|NCT00547300|Beta blocker|beta blocker
5687422|NCT00547300|Tolerability|tolerability
5687423|NCT00547261|solid tumor|solid tumor
5687424|NCT00547261|antimitotic|antimitotic
5687425|NCT00547261|tubulin binder|tubulin binder
5687426|NCT00547248|Booster vaccination.|booster vaccination.
5687427|NCT00547248|Immunogenicity|immunogenicity
5687428|NCT00547248|Pneumococcal vaccine|pneumococcal vaccine
5687429|NCT00547248|Safety|safety
5687430|NCT00547248|Pneumococcal disease|pneumococcal disease
5687431|NCT00547235|infection|infection
5687432|NCT00547235|precancerous/nonmalignant condition|precancerous/nonmalignant condition
5687433|NCT00547196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5681985|NCT00571012|glaucoma|glaucoma
5687434|NCT00547196|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5687435|NCT00547196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5687511|NCT00546975|gastrointestinal surgery|gastrointestinal surgery
5687436|NCT00547196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5687437|NCT00547196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5687438|NCT00547196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5687439|NCT00547196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5687440|NCT00547196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5687441|NCT00547196|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5687442|NCT00547196|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5687443|NCT00547196|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5687444|NCT00547196|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5687445|NCT00547196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5687446|NCT00547196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5685678|NCT00555178|Phototherapy|phototherapy
5694467|NCT00521027|Debridement|debridement
5687447|NCT00547196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5687448|NCT00547196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5687449|NCT00547196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5687450|NCT00547196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5687451|NCT00547196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5687452|NCT00547196|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5687453|NCT00547196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5687454|NCT00547196|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5687455|NCT00547196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5848033|NCT00036582|Bipolar Disorder|bipolar disorder
5687456|NCT00547196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5687457|NCT00547196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5687458|NCT00547196|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5687459|NCT00547196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5687460|NCT00547196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5687461|NCT00547196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5687462|NCT00547196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5687463|NCT00547196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5687464|NCT00547196|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5687465|NCT00547196|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5687466|NCT00547196|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5687467|NCT00547170|pelvic infection|pelvic infection
5687468|NCT00547170|abortion|abortion
5687469|NCT00547170|doxycycline|doxycycline
5687470|NCT00547157|head and neck|head and neck
5687471|NCT00547157|squamous cell carcinoma|squamous cell carcinoma
5687472|NCT00547157|radiotherapy|radiotherapy
5687473|NCT00547157|chemoradiotherapy|chemoradiotherapy
5687474|NCT00547157|panitumumab|panitumumab
5687475|NCT00547157|locally advanced head & neck cancer|locally advanced head & neck cancer
5687476|NCT00547157|EGFr|egfr
5687477|NCT00547157|epidermal growth factor receptor|epidermal growth factor receptor
5687478|NCT00547157|SCCHN|scchn
5687479|NCT00547157|locally advanced SCCHN|locally advanced scchn
5687480|NCT00547157|HNC|hnc
5687481|NCT00547157|epidermal growth factor|epidermal growth factor
5687482|NCT00547131|tumors metastatic to brain|tumors metastatic to brain
5687483|NCT00547131|recurrent adult brain tumor|recurrent adult brain tumor
5687484|NCT00547118|Metabolic abnormalities|metabolic abnormalities
5687485|NCT00547118|Safety|safety
5687486|NCT00547118|Satiety|satiety
5687487|NCT00547105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5687488|NCT00547105|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5687489|NCT00547105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5687490|NCT00547105|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5687491|NCT00547066|ITP|itp
5687492|NCT00547066|hA20|ha20
5687493|NCT00547066|Treatment|treatment
5687494|NCT00547040|calcification|calcification
5687495|NCT00547040|bone lesions|bone lesions
5687496|NCT00547027|diabetes|diabetes
5687497|NCT00547027|physical activity|physical activity
5687498|NCT00547027|print-based intervention|print-based intervention
5687499|NCT00547027|tailored intervention|tailored intervention
5687500|NCT00547014|treatment, parallel assignment, double blind, randomized, placebo control, safety study,SLE (Systemic Lupus Erythematosus)|treatment, parallel assignment, double blind, randomized, placebo control, safety study,sle (systemic lupus erythematosus)
5687501|NCT00547001|Menopause|menopause
5687502|NCT00547001|Hot flashes|hot flashes
5687503|NCT00547001|vasomotor symptoms|vasomotor symptoms
5687504|NCT00547001|tapering regimen|tapering regimen
5687505|NCT00547001|hormonal therapy|hormonal therapy
5687506|NCT00547001|Other menopausal symptoms including mood changes|other menopausal symptoms including mood changes
5687507|NCT00546988|primary treatment|primary treatment
5687508|NCT00546988|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5687509|NCT00546988|high-dose therapy|high-dose therapy
5687510|NCT00546988|cytogenetics|cytogenetics
5687512|NCT00546975|nutritional intervention|nutritional intervention
5687513|NCT00546975|functional status|functional status
5687514|NCT00546975|quality of life|quality of life
5687515|NCT00546949|Decompression, Surgical|decompression, surgical
5687517|NCT00546949|lumbar decompression|lumbar decompression
5687518|NCT00546949|spinal stenosis|spinal stenosis
5687519|NCT00546949|radiculopathy|radiculopathy
5687520|NCT00546936|Histoplasmosis|histoplasmosis
5687521|NCT00546884|End of Life|end of life
5687522|NCT00546884|Advance Directives|advance directives
5687523|NCT00546884|Randomized controlled trial|randomized controlled trial
5687524|NCT00546884|End of life care|end of life care
5687525|NCT00546884|End of life advance care planning|end of life advance care planning
5685679|NCT00555165|Macular Degeneration|macular degeneration
5687526|NCT00546858|Pelvic pain|pelvic pain
5687527|NCT00546858|Vulvar pain|vulvar pain
5687528|NCT00546806|Rehabilitation,|rehabilitation,
5687529|NCT00546806|Treatment outcome,|treatment outcome,
5687530|NCT00546806|Whiplash injuries,|whiplash injuries,
5687531|NCT00546806|Randomized Clinical Trials|randomized clinical trials
5687532|NCT00546793|humanized anti-CD20 veltuzumab (IMMU-106) administered subcutaneously|humanized anti-cd20 veltuzumab (immu-106) administered subcutaneously
5687533|NCT00546780|Multiple Myeloma|multiple myeloma
5687534|NCT00546780|Heat Shock Protein 90|heat shock protein 90
5687535|NCT00546780|Hsp90|hsp90
5687536|NCT00546780|KOS-953|kos-953
5687537|NCT00546780|17-AAG|17-aag
5687538|NCT00546780|bortezomib|bortezomib
5687539|NCT00546780|first relapse|first relapse
5687540|NCT00546780|tanespimycin|tanespimycin
5687541|NCT00546780|TIME-1|time-1
5687542|NCT00546741|Diabetes,NOS|diabetes,nos
5687543|NCT00546689|HIV|hiv
5687544|NCT00546689|aids|aids
5704142|NCT00486967|Peak VO2, Endothelial Function, Leptin, TNF.|peak vo2, endothelial function, leptin, tnf.
5704143|NCT00486954|lapatinib|lapatinib
5704144|NCT00486954|paclitaxel|paclitaxel
5704145|NCT00486954|ErbB2|erbb2
5687545|NCT00546689|intestinal parasites|intestinal parasites
5687546|NCT00546689|eosinophils|eosinophils
5687547|NCT00546689|immunoglobulins|immunoglobulins
5687548|NCT00546689|HIV/aids|hiv/aids
5687549|NCT00546689|Treatment Experienced|treatment experienced
5687550|NCT00546663|Cystic Fibrosis, hypertonic saline|cystic fibrosis, hypertonic saline
5687551|NCT00546650|Focus of study is to compare pharmacokinetics|focus of study is to compare pharmacokinetics
5687552|NCT00546611|PEP005|pep005
5687553|NCT00546611|Common Wart(s)|common wart(s)
5687554|NCT00546611|Common warts (verruca[e] vulgaris)|common warts (verruca[e] vulgaris)
5687555|NCT00546598|Total hip replacement, Total hip arthroplasty|total hip replacement, total hip arthroplasty
5687556|NCT00546585|influenza, inactivated influenza A/H7N7 vaccine, parent protocol|influenza, inactivated influenza a/h7n7 vaccine, parent protocol
5687557|NCT00546559|Lipophilic statins|lipophilic statins
5687558|NCT00546559|Insulin resistance|insulin resistance
5687656|NCT00546065|Barrett's esophagus|barrett's esophagus
5687559|NCT00546559|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.|simvastatin and pravastatin may have differential metabolic effects in hypercholesterolemic patients.
5687560|NCT00546546|Crohn|crohn
5687561|NCT00546546|immunosuppressants|immunosuppressants
5687562|NCT00546546|natural history|natural history
5687563|NCT00546546|steroids|steroids
5687564|NCT00546520|Asthma|asthma
5687565|NCT00546520|Ciclesonide|ciclesonide
5687566|NCT00546520|Airway hyperresponsiveness|airway hyperresponsiveness
5687567|NCT00546520|Sputum|sputum
5687568|NCT00546520|Nitric oxide|nitric oxide
5687569|NCT00546468|stomach cancer|stomach cancer
5687570|NCT00546468|laparoscopy|laparoscopy
5687571|NCT00546468|gastrectomy|gastrectomy
5687572|NCT00546468|QOL|qol
5687573|NCT00546468|survival|survival
5687574|NCT00546468|clinical study|clinical study
5687575|NCT00546455|Obesity|obesity
5687576|NCT00546455|insulin resistance|insulin resistance
5687577|NCT00546442|insulin resistance|insulin resistance
5687578|NCT00546442|chronic hepatitis C|chronic hepatitis c
5687579|NCT00546442|genotype 1|genotype 1
5687580|NCT00546429|Proximal femoral fracture|proximal femoral fracture
5687581|NCT00546429|Trochanteric fracture|trochanteric fracture
5687582|NCT00546429|Intramedullary nailing|intramedullary nailing
5687583|NCT00546403|Excessive Daytime Sleepiness|excessive daytime sleepiness
5687584|NCT00546377|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5687585|NCT00546377|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5687586|NCT00546377|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5687587|NCT00546377|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5687588|NCT00546377|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5687589|NCT00546377|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5687590|NCT00546377|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5687591|NCT00546377|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5682210|NCT00569946|RCC|rcc
5687592|NCT00546377|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5687594|NCT00546299|Ambulatory oxygen therapy|ambulatory oxygen therapy
5687595|NCT00546299|COPD|copd
5687596|NCT00546299|exertional hypoxemia|exertional hypoxemia
5687597|NCT00546273|LTBI (Latent tuberculosis infection)|ltbi (latent tuberculosis infection)
5687598|NCT00546273|TB(Tuberculosis)|tb(tuberculosis)
5687599|NCT00546273|Vaccine|vaccine
5687600|NCT00546260|STEMI|stemi
5687601|NCT00546260|ACS|acs
5687602|NCT00546234|asthma|asthma
5687603|NCT00546234|tiotropium|tiotropium
5687604|NCT00546234|smoking|smoking
5687605|NCT00546234|eNO|eno
5687606|NCT00546234|metabolites|metabolites
5687607|NCT00546234|Virtual Asthma Clinic|virtual asthma clinic
5687608|NCT00546221|Depression|depression
5687609|NCT00546221|Mental health|mental health
5687610|NCT00546221|Exercise|exercise
5687611|NCT00546221|Prescribed exercise|prescribed exercise
5687612|NCT00546221|Physical health|physical health
5687613|NCT00546221|Social wellbeing|social wellbeing
5687614|NCT00546208|bladder function|bladder function
5687615|NCT00546208|cutaneous ureterostomy|cutaneous ureterostomy
5687616|NCT00546208|hydronephrosis|hydronephrosis
5687617|NCT00546195|Cord Blood|cord blood
5687618|NCT00546195|Neutrophils|neutrophils
5687619|NCT00546195|Polysaccharide|polysaccharide
5687620|NCT00546195|Gene Expression|gene expression
5687621|NCT00546182|Lipophilic statins|lipophilic statins
5687622|NCT00546182|Insulin resistance|insulin resistance
5687623|NCT00546182|hypercholesterolemic patients|hypercholesterolemic patients
5687624|NCT00546169|Patients undergoing elective or acute cholecystectomy|patients undergoing elective or acute cholecystectomy
5687625|NCT00546156|ER positive|er positive
5687626|NCT00546156|PR positive|pr positive
5687627|NCT00546143|Asthma, anti-immunoglobulin E, omalizumab|asthma, anti-immunoglobulin e, omalizumab
5687628|NCT00546130|ED-SCLC|ed-sclc
5687629|NCT00546130|small cell lung cancer|small cell lung cancer
5687630|NCT00546130|CPT-11|cpt-11
5687631|NCT00546130|irinotecan hydrochloride|irinotecan hydrochloride
5687632|NCT00546130|CDDP|cddp
5687633|NCT00546130|cisplatin|cisplatin
5687635|NCT00546130|Krestin|krestin
5687636|NCT00546117|otitis media with effusion|otitis media with effusion
5687637|NCT00546117|gastroesophageal reflux|gastroesophageal reflux
5687638|NCT00546117|ear infection|ear infection
5687639|NCT00546117|proton pump inhibitor|proton pump inhibitor
5687640|NCT00546104|Advanced Breast Cancer|advanced breast cancer
5687641|NCT00546104|Breast cancer|breast cancer
5687642|NCT00546104|Dasatinib|dasatinib
5687643|NCT00546104|Inoperable Stage III Breast Cancer|inoperable stage iii breast cancer
5687644|NCT00546104|Metastatic Breast Cancer|metastatic breast cancer
5687645|NCT00546104|Stage IV Breast Cancer|stage iv breast cancer
5687646|NCT00546091|Imaging|imaging
5687647|NCT00546091|Multi-Spectral Imaging|multi-spectral imaging
5687648|NCT00546091|Thermography|thermography
5687649|NCT00546091|Laser Doppler Imaging|laser doppler imaging
5687650|NCT00546091|Vasculature|vasculature
5687651|NCT00546091|Healthy Volunteer|healthy volunteer
5687652|NCT00546091|HV|hv
5687653|NCT00546078|HPV vaccine|hpv vaccine
5687654|NCT00546078|Cervical cancer|cervical cancer
5687655|NCT00546078|Human papillomavirus infection|human papillomavirus infection
5687658|NCT00546065|esomeprazole|esomeprazole
5687659|NCT00546065|Barrett's cancer|barrett's cancer
5687660|NCT00546065|Ablation of Barrett's esophagus|ablation of barrett's esophagus
5863036|NCT00001412|Mood|mood
5687661|NCT00546065|Surveillance of Barrett's esophagus after endoscopic resection of Barrett's cancer|surveillance of barrett's esophagus after endoscopic resection of barrett's cancer
5687662|NCT00546065|Recurrence of Barrett's cancer|recurrence of barrett's cancer
5687663|NCT00546039|Prostate cancer|prostate cancer
5687664|NCT00546039|Localized prostatectomy|localized prostatectomy
5687665|NCT00546039|Laparoscopic prostatectomy|laparoscopic prostatectomy
5687666|NCT00546039|Chemoprevention|chemoprevention
5687667|NCT00546039|Genistein|genistein
5687668|NCT00546039|BONISTEIN™|bonistein™
5687669|NCT00546026|placental function|placental function
5687670|NCT00546026|high-risk pregnancies|high-risk pregnancies
5687671|NCT00546026|psychological distress|psychological distress
5687672|NCT00546013|abdominal aortic aneurysms|abdominal aortic aneurysms
5687673|NCT00546013|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5687675|NCT00545987|HIV vaccine|hiv vaccine
5687677|NCT00545987|AIDS|aids
5687678|NCT00545987|prevention|prevention
5687679|NCT00545987|HIV/AIDS|hiv/aids
5687680|NCT00545987|HIV Preventative Vaccine|hiv preventative vaccine
5687681|NCT00545987|HIV Seronegativity|hiv seronegativity
5687682|NCT00545974|Randomized|randomized
5687683|NCT00545974|Double-Blind|double-blind
5687684|NCT00545974|Placebo-Controlled|placebo-controlled
5687685|NCT00545974|memantine|memantine
5687686|NCT00545974|Namenda|namenda
5687687|NCT00545974|Frontotemporal Dementia|frontotemporal dementia
5687688|NCT00545974|Semantic Dementia|semantic dementia
5687689|NCT00545974|FTD|ftd
5687690|NCT00545974|SD|sd
5687691|NCT00545974|dementia|dementia
5687692|NCT00545974|behavioral decline|behavioral decline
5687693|NCT00545974|cognitive decline|cognitive decline
5682276|NCT00569582|ACTH|acth
5687694|NCT00545961|respiratory infection|respiratory infection
5687696|NCT00545961|rhinosinusitis|rhinosinusitis
5687697|NCT00545961|children|children
5687698|NCT00545961|middle meatal specimens|middle meatal specimens
5687699|NCT00545961|respiratory track bacteria|respiratory track bacteria
5687700|NCT00545961|amoxicillin-clavulanate|amoxicillin-clavulanate
5687701|NCT00545961|pneumococci|pneumococci
5687702|NCT00545961|haemophilus|haemophilus
5687703|NCT00545961|moraxella|moraxella
5687704|NCT00545948|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5687705|NCT00545948|NSCLC|nsclc
5687706|NCT00545948|Non-Squamous|non-squamous
5687707|NCT00545948|Genomics|genomics
5687708|NCT00545948|Guided Therapy|guided therapy
5687709|NCT00545948|Directed Therapy|directed therapy
5687710|NCT00545948|Genomic Expression Profiles|genomic expression profiles
5687711|NCT00545948|Chemotherapy Sensitivity|chemotherapy sensitivity
5687712|NCT00545922|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5687713|NCT00545922|anxiety|anxiety
5687714|NCT00545922|depression|depression
5694770|NCT00519545|one|one
5687715|NCT00545922|cognitive behavioral therapy|cognitive behavioral therapy
5687716|NCT00545883|GERD|gerd
5687717|NCT00545883|esophagitis|esophagitis
5687718|NCT00545883|PPI|ppi
5687719|NCT00545857|Type 1 diabetes|type 1 diabetes
5687720|NCT00545857|Insulin dependent diabetes|insulin dependent diabetes
5687721|NCT00545857|Juvenile onset diabetes|juvenile onset diabetes
5687722|NCT00545857|pioglitazone|pioglitazone
5687723|NCT00545831|Home Parenteral Nutrition|home parenteral nutrition
5687724|NCT00545831|Sepsis Prevention|sepsis prevention
5687725|NCT00545831|Central Venous Catheters|central venous catheters
5687726|NCT00545831|Taurolidine|taurolidine
5687727|NCT00545805|Insulin resistance|insulin resistance
5687728|NCT00545805|Metabolic syndrome X|metabolic syndrome x
5687729|NCT00545805|Obesity|obesity
5687730|NCT00545805|Intra-Abdominal Fat|intra-abdominal fat
5687731|NCT00545805|Omentum|omentum
5687732|NCT00545805|Bariatric surgery|bariatric surgery
5687733|NCT00545805|Glucose Clamp Technique|glucose clamp technique
5687734|NCT00545805|Intravenous Glucose Tolerance Test|intravenous glucose tolerance test
5687735|NCT00545805|Adiponectin|adiponectin
5687736|NCT00545805|Cytokines|cytokines
5687737|NCT00545792|Recurrent Endometrial cancer|recurrent endometrial cancer
5687738|NCT00545792|Recurrent Cervical cancer|recurrent cervical cancer
5687739|NCT00545792|Recurrent Ovarian cancer|recurrent ovarian cancer
5687740|NCT00545792|Recurrent Vaginal cancer|recurrent vaginal cancer
5687741|NCT00545792|Recurrent Vulvar cancer|recurrent vulvar cancer
5687742|NCT00545792|Vaginal recurrence|vaginal recurrence
5687743|NCT00545792|Brachytherapy|brachytherapy
5687744|NCT00545792|Radiation Treatment|radiation treatment
5687745|NCT00545792|External Beam Radiation|external beam radiation
5687746|NCT00545792|Avastin|avastin
5687747|NCT00545792|Bevacizumab|bevacizumab
5687748|NCT00545766|Prostate Cancer|prostate cancer
5687749|NCT00545766|Hormone Refractory|hormone refractory
5687750|NCT00545766|Vinflunine|vinflunine
5687751|NCT00545766|Salvage Chemotherapy|salvage chemotherapy
5687752|NCT00545753|Human Head lice|human head lice
5687753|NCT00545727|Diabetes|diabetes
5687754|NCT00545727|Children|children
5687755|NCT00545727|Adolescents|adolescents
5687756|NCT00545727|Diet|diet
5687757|NCT00545727|Glycemic index|glycemic index
5687758|NCT00545701|Influenza|influenza
5687759|NCT00545701|A/H5N1 strain|a/h5n1 strain
5687760|NCT00545701|Orthomyxoviridae Infections|orthomyxoviridae infections
5687761|NCT00545701|Influenza Pandemics|influenza pandemics
5687762|NCT00545662|traumatic brain injury|traumatic brain injury
5687763|NCT00545662|cognition|cognition
5687764|NCT00545662|behavioral outcome|behavioral outcome
5687765|NCT00545662|functional outcome|functional outcome
5687766|NCT00545662|treatment|treatment
5687767|NCT00545662|early intervention|early intervention
5687768|NCT00545662|citicoline|citicoline
5687769|NCT00545649|Fibromyalgia|fibromyalgia
5687770|NCT00545649|chronic pain|chronic pain
5687771|NCT00545649|physical|physical
5687772|NCT00545649|exercise|exercise
5687773|NCT00545649|activity|activity
5687774|NCT00545649|education|education
5687775|NCT00545623|HIV/AIDS|hiv/aids
5687776|NCT00545623|Alternative Medicine|alternative medicine
5687777|NCT00545623|Complementary Medicine|complementary medicine
5687778|NCT00545597|adrenoleukodystrophy|adrenoleukodystrophy
5687779|NCT00545597|adrenomyeloneuropathy|adrenomyeloneuropathy
5687780|NCT00545558|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5687781|NCT00545558|Coinfection|coinfection
5687782|NCT00545558|Treatment Naive|treatment naive
5687783|NCT00545545|Colorectal|colorectal
5687784|NCT00545545|Carcinoma|carcinoma
5687785|NCT00545545|Recurrent|recurrent
5687786|NCT00545545|Progressive|progressive
5687787|NCT00545545|Cetuximab|cetuximab
5687788|NCT00545545|Irinotecan|irinotecan
5687789|NCT00545545|5-Fluorouracil|5-fluorouracil
5687790|NCT00545519|Multiple Myeloma|multiple myeloma
5687791|NCT00545519|Thymoglobulin|thymoglobulin
5687792|NCT00545506|wound infection|wound infection
5687793|NCT00545506|tissue oxygen tension|tissue oxygen tension
5687794|NCT00545506|local warming|local warming
5687795|NCT00545493|Rasmussen encephalitis|rasmussen encephalitis
5687796|NCT00545493|Chronic encephalitis|chronic encephalitis
5687797|NCT00545493|Cerebral hemiatrophy|cerebral hemiatrophy
5687799|NCT00545493|Epilepsy|epilepsy
5687800|NCT00545467|Aripiprazole|aripiprazole
5687801|NCT00545467|schizophrenia|schizophrenia
5687802|NCT00545467|antipsychotics|antipsychotics
5687803|NCT00545467|pharmacogenomics|pharmacogenomics
5687804|NCT00545467|cytochrome P450 enzyme|cytochrome p450 enzyme
5687805|NCT00545454|Inflammation|inflammation
5687806|NCT00545454|anti-cytokine|anti-cytokine
5687807|NCT00545454|anti-chemokine|anti-chemokine
5687808|NCT00545441|Anal fistula|anal fistula
5687809|NCT00545441|fistula in ano|fistula in ano
5687810|NCT00545441|anorectal fistula|anorectal fistula
5687811|NCT00545428|Nasal acquired diseases|nasal acquired diseases
5687812|NCT00545428|Nasal congenital diseases|nasal congenital diseases
5687813|NCT00545428|Rhinoplasty|rhinoplasty
5687814|NCT00545428|Grafts|grafts
5687815|NCT00545415|fruit|fruit
5687816|NCT00545415|antioxidant|antioxidant
5685680|NCT00555165|Visual Impairment|visual impairment
5687817|NCT00545415|Healthy subjects|healthy subjects
5687818|NCT00545350|Prevention|prevention
5687819|NCT00545350|Falls, accidental falls|falls, accidental falls
5687820|NCT00545350|Fractures|fractures
5687821|NCT00545350|Physical injuries|physical injuries
5687822|NCT00545350|Women|women
5687823|NCT00545350|Elderly|elderly
5687824|NCT00545350|Physical exercise|physical exercise
5687825|NCT00545350|Balance exercise|balance exercise
5687826|NCT00545311|multiple inhaled, NVA237, COPD|multiple inhaled, nva237, copd
5687827|NCT00545298|Nitric Oxide|nitric oxide
5687828|NCT00545298|Venous Leg Ulcers|venous leg ulcers
5687829|NCT00545285|clinical outcomes|clinical outcomes
5687830|NCT00545285|radiographic outcomes|radiographic outcomes
5687831|NCT00545285|total hip arthroplasty|total hip arthroplasty
5687832|NCT00545285|survivorship|survivorship
5687833|NCT00545272|QMF|qmf
5687834|NCT00545272|indacaterol|indacaterol
5687835|NCT00545272|Twisthaler®|twisthaler®
5687836|NCT00545259|Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression|organ transplant, liver, pharmacokinetics, aeb071, immunosuppression
5687837|NCT00545246|VEGF Trap|vegf trap
5687838|NCT00545194|Prostaglandin E2|prostaglandin e2
5687839|NCT00545194|Intravaginal gel|intravaginal gel
5687840|NCT00545194|Bishop score|bishop score
5687841|NCT00545194|Induction of labor|induction of labor
5687842|NCT00545194|randomized trial|randomized trial
5687843|NCT00545194|Vaginal insert|vaginal insert
5687844|NCT00545181|bacterial vaginosis|bacterial vaginosis
5687845|NCT00545181|vaginal acidifying gel|vaginal acidifying gel
5687846|NCT00545181|recurrence|recurrence
5687847|NCT00545168|head lice|head lice
5687848|NCT00545077|endocrine therapy|endocrine therapy
5687849|NCT00545077|bevacizumab|bevacizumab
5687850|NCT00545077|breast cancer|breast cancer
5687851|NCT00545077|first-line therapy|first-line therapy
5687852|NCT00545025|Influenza|influenza
5687853|NCT00545025|Influenza vaccine|influenza vaccine
5687854|NCT00545012|Levetiracetam|levetiracetam
5687855|NCT00545012|Keppra|keppra
5687856|NCT00544999|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5687857|NCT00544999|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5688358|NCT00543829|tamoxifen|tamoxifen
5687858|NCT00544999|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5863037|NCT00001412|Behavior|behavior
5687859|NCT00544999|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5687860|NCT00544999|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5687861|NCT00544999|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5687862|NCT00544999|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5687863|NCT00544999|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5687864|NCT00544999|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5687865|NCT00544999|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5687866|NCT00544999|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5687867|NCT00544999|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5687868|NCT00544986|breast cancer|breast cancer
5687869|NCT00544986|post menopausal women|post menopausal women
5687870|NCT00544986|Post menopausal women with hormone sensitive advanced breast cancer|post menopausal women with hormone sensitive advanced breast cancer
5687872|NCT00544960|AT-101|at-101
5687873|NCT00544960|cancer|cancer
5687874|NCT00544960|lung|lung
5687875|NCT00544960|non-small cell|non-small cell
5687876|NCT00544960|docetaxel|docetaxel
5687877|NCT00544960|bcl|bcl
5687878|NCT00544947|Respiratory Depression|respiratory depression
5687879|NCT00544947|Caesarean Section|caesarean section
5687880|NCT00544947|Diamorphine|diamorphine
5687881|NCT00544947|Fentanyl|fentanyl
5687882|NCT00544908|stage IV pancreatic cancer|stage iv pancreatic cancer
5687883|NCT00544869|Vasopressin antagonist , Cardiac Edema ,Diuretics|vasopressin antagonist , cardiac edema ,diuretics
5698797|NCT00505128|ERCP|ercp
5687884|NCT00544856|mild Alzheimer's disease|mild alzheimer's disease
5687885|NCT00544856|mild cognitive impairment|mild cognitive impairment
5687886|NCT00544817|Concurrent Radiation Therapy|concurrent radiation therapy
5687887|NCT00544817|Temozolomide|temozolomide
5687888|NCT00544817|Sorafenib|sorafenib
5687889|NCT00544817|First-line|first-line
5687890|NCT00544817|Glioblastoma Multiforme|glioblastoma multiforme
5687891|NCT00544817|Phase II|phase ii
5687892|NCT00544804|recurrent breast cancer|recurrent breast cancer
5687893|NCT00544804|stage IIIA breast cancer|stage iiia breast cancer
5687894|NCT00544804|stage IIIB breast cancer|stage iiib breast cancer
5687895|NCT00544804|stage IIIC breast cancer|stage iiic breast cancer
5687896|NCT00544804|stage IV breast cancer|stage iv breast cancer
5687899|NCT00544791|Melatonin|melatonin
5687900|NCT00544791|Antioxidant|antioxidant
5687901|NCT00544791|Memory|memory
5687902|NCT00544791|Alzheimer|alzheimer
5687903|NCT00544778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5685681|NCT00555165|Quality of Life|quality of life
5687904|NCT00544778|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5687905|NCT00544778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5687906|NCT00544778|metastatic osteosarcoma|metastatic osteosarcoma
5687907|NCT00544778|recurrent osteosarcoma|recurrent osteosarcoma
5687908|NCT00544778|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5687909|NCT00544778|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5687910|NCT00544778|Ewing sarcoma of bone|ewing sarcoma of bone
5687911|NCT00544765|Breast cancer|breast cancer
5687912|NCT00544765|neoadjuvant therapy|neoadjuvant therapy
5687913|NCT00544765|pCR rates|pcr rates
5687914|NCT00544752|sleep apnea syndromes, ambient indoor temperature|sleep apnea syndromes, ambient indoor temperature
5687915|NCT00544739|Coronary Artery Disease|coronary artery disease
5687916|NCT00544739|Premature|premature
5687917|NCT00544739|Female|female
5687921|NCT00544687|Skin|skin
5687922|NCT00544687|Atrophy|atrophy
5687923|NCT00544687|CRX-191|crx-191
5687924|NCT00544687|mometasone furoate|mometasone furoate
5687925|NCT00544687|nortriptyline hydrochloride|nortriptyline hydrochloride
5687926|NCT00544687|Skin Thickness in Normal Healthy Volunteers|skin thickness in normal healthy volunteers
5687927|NCT00544674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5687928|NCT00544674|limited stage small cell lung cancer|limited stage small cell lung cancer
5687929|NCT00544674|recurrent small cell lung cancer|recurrent small cell lung cancer
5687930|NCT00544648|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5687931|NCT00544648|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5687932|NCT00544622|Stroke treatment|stroke treatment
5687933|NCT00544622|Rehabilitation|rehabilitation
5687934|NCT00544622|Stroke chain|stroke chain
5687935|NCT00544622|Stroke unit|stroke unit
5687936|NCT00544609|Bladder|bladder
5687937|NCT00544609|Sorafenib|sorafenib
5687938|NCT00544609|Radiotherapy|radiotherapy
5687939|NCT00544583|Abdominal wall|abdominal wall
5687940|NCT00544570|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5687941|NCT00544570|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5687942|NCT00544544|Bipolar|bipolar
5687943|NCT00544544|depression|depression
5687944|NCT00544531|MI oocytes, FISH,chromosomal aberrations|mi oocytes, fish,chromosomal aberrations
5688569|NCT00542750|Adolescent|adolescent
5687945|NCT00544518|type 2 diabetes|type 2 diabetes
5687946|NCT00544518|Benfluorex|benfluorex
5687947|NCT00544518|Metformin|metformin
5687948|NCT00544518|insulin secretion|insulin secretion
5687949|NCT00544518|glucose control|glucose control
5687950|NCT00544492|arteriovenous fistula|arteriovenous fistula
5687951|NCT00544492|dialysis access|dialysis access
5687952|NCT00544492|pain|pain
5687953|NCT00544492|anxiety|anxiety
5687954|NCT00544492|fistula related complications|fistula related complications
5687955|NCT00544492|aneurysm|aneurysm
5687956|NCT00544466|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome|acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
5687957|NCT00544466|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5687958|NCT00544466|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5687959|NCT00544466|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5687960|NCT00544466|adult acute myeloid leukemia with del(5q)|adult acute myeloid leukemia with del(5q)
5687961|NCT00544466|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5687962|NCT00544466|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5687963|NCT00544466|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5687964|NCT00544466|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5687965|NCT00544466|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5687966|NCT00544466|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5687967|NCT00544466|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5687968|NCT00544466|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5687969|NCT00544466|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5687970|NCT00544466|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5687971|NCT00544466|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5687972|NCT00544466|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5687973|NCT00544466|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5687974|NCT00544466|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5687975|NCT00544466|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5687976|NCT00544466|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5687977|NCT00544466|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5687978|NCT00544466|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5686591|NCT00551395|glaucoma|glaucoma
5687979|NCT00544466|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5687981|NCT00544453|Alzheimer disease|alzheimer disease
5687982|NCT00544440|Prostate neoplasms|prostate neoplasms
5687983|NCT00544440|Prostate cancer|prostate cancer
5687984|NCT00544440|Castration-resistant prostate cancer|castration-resistant prostate cancer
5687985|NCT00544440|Abiraterone acetate|abiraterone acetate
5687986|NCT00544440|CB7630|cb7630
5687987|NCT00544440|Prednisone|prednisone
5687988|NCT00544440|Testosterone|testosterone
5687989|NCT00544440|Bone marrow|bone marrow
5687990|NCT00544427|Upper Areo-Digestive tract|upper areo-digestive tract
5687991|NCT00544414|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5687992|NCT00544414|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5687993|NCT00544414|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5687994|NCT00544414|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5687995|NCT00544414|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5687996|NCT00544414|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5687997|NCT00544414|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5687998|NCT00544414|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5687999|NCT00544414|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5688000|NCT00544414|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5688001|NCT00544414|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5688002|NCT00544401|infertility|infertility
5688003|NCT00544401|in vitro fertilization|in vitro fertilization
5688004|NCT00544401|intracytoplasmic sperm implantation|intracytoplasmic sperm implantation
5688005|NCT00544401|acupuncture|acupuncture
5688006|NCT00544401|hypnosis|hypnosis
5688007|NCT00544401|hypnopuncture|hypnopuncture
5688008|NCT00544388|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5688009|NCT00544388|Xyzal tablet|xyzal tablet
5688010|NCT00544362|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5688011|NCT00544362|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5688012|NCT00544362|stage IIIA esophageal cancer|stage iiia esophageal cancer
5688013|NCT00544362|stage IIIB esophageal cancer|stage iiib esophageal cancer
5688014|NCT00544362|stage IIIC esophageal cancer|stage iiic esophageal cancer
5688777|NCT00541866|Voreloxin|voreloxin
5688015|NCT00544362|stage IV esophageal cancer|stage iv esophageal cancer
5688016|NCT00544349|stage IV colon cancer|stage iv colon cancer
5688017|NCT00544349|recurrent colon cancer|recurrent colon cancer
5688018|NCT00544349|stage IV rectal cancer|stage iv rectal cancer
5688019|NCT00544349|recurrent rectal cancer|recurrent rectal cancer
5688020|NCT00544349|liver metastases|liver metastases
5688021|NCT00544336|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5688022|NCT00544336|recurrent breast cancer|recurrent breast cancer
5688023|NCT00544336|stage I breast cancer|stage i breast cancer
5688024|NCT00544336|stage II breast cancer|stage ii breast cancer
5688025|NCT00544336|stage IIIA breast cancer|stage iiia breast cancer
5688026|NCT00544336|stage IIIB breast cancer|stage iiib breast cancer
5688027|NCT00544336|stage IIIC breast cancer|stage iiic breast cancer
5688028|NCT00544336|stage IV breast cancer|stage iv breast cancer
5688029|NCT00544336|recurrent prostate cancer|recurrent prostate cancer
5688030|NCT00544336|stage I prostate cancer|stage i prostate cancer
5688031|NCT00544336|stage II prostate cancer|stage ii prostate cancer
5688032|NCT00544336|stage III prostate cancer|stage iii prostate cancer
5688033|NCT00544336|stage IV prostate cancer|stage iv prostate cancer
5688034|NCT00544336|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5688035|NCT00544336|limited stage small cell lung cancer|limited stage small cell lung cancer
5688036|NCT00544336|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5688037|NCT00544336|recurrent small cell lung cancer|recurrent small cell lung cancer
5688038|NCT00544336|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5682569|NCT00568841|erlotinib|erlotinib
5688039|NCT00544336|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5688040|NCT00544336|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5688041|NCT00544336|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5688042|NCT00544336|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5688043|NCT00544336|recurrent colon cancer|recurrent colon cancer
5688044|NCT00544336|stage I colon cancer|stage i colon cancer
5688045|NCT00544336|stage II colon cancer|stage ii colon cancer
5688046|NCT00544336|stage III colon cancer|stage iii colon cancer
5688047|NCT00544336|stage IV colon cancer|stage iv colon cancer
5688048|NCT00544336|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5688408|NCT00543504|Tarceva|tarceva
5688049|NCT00544336|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5688050|NCT00544336|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5688051|NCT00544336|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5688052|NCT00544336|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5688053|NCT00544336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5688054|NCT00544336|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5688055|NCT00544336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5688056|NCT00544336|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5688057|NCT00544336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5688058|NCT00544336|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5688059|NCT00544336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5688060|NCT00544336|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5688061|NCT00544336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5688062|NCT00544336|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5688063|NCT00544336|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5688064|NCT00544336|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5688065|NCT00544336|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5688066|NCT00544336|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5688067|NCT00544336|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5688068|NCT00544336|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5688069|NCT00544336|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5688070|NCT00544336|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5688071|NCT00544336|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5688072|NCT00544336|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5688073|NCT00544336|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5688074|NCT00544336|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5688075|NCT00544336|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5688076|NCT00544336|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5688077|NCT00544336|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5863038|NCT00001412|Cognitive Function|cognitive function
5713633|NCT00451919|MRI|mri
5688078|NCT00544336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5688359|NCT00543777|Liver Cancer|liver cancer
5688079|NCT00544336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5688080|NCT00544336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5688081|NCT00544336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5688082|NCT00544336|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5688083|NCT00544336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5688084|NCT00544336|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5688085|NCT00544336|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5677821|NCT00589524|CT|ct
5688086|NCT00544336|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5688087|NCT00544336|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5688088|NCT00544336|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5688089|NCT00544336|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5688090|NCT00544336|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5688091|NCT00544336|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5688092|NCT00544336|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5688093|NCT00544336|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5688094|NCT00544336|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5688095|NCT00544336|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5688096|NCT00544336|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5688097|NCT00544336|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5688098|NCT00544336|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5688099|NCT00544336|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5688100|NCT00544336|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5688101|NCT00544336|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5688102|NCT00544336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5685682|NCT00555165|Implantable Telescope|implantable telescope
5685683|NCT00555139|anxiety,|anxiety,
5688103|NCT00544336|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5688104|NCT00544336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5688105|NCT00544336|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5688106|NCT00544336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5688107|NCT00544336|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5688108|NCT00544336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5688109|NCT00544336|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5688110|NCT00544336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5688111|NCT00544336|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5688112|NCT00544336|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5688113|NCT00544336|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5688114|NCT00544336|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5688115|NCT00544336|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5688116|NCT00544336|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5688117|NCT00544336|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5688118|NCT00544336|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5688119|NCT00544336|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5688120|NCT00544336|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5688121|NCT00544336|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5688122|NCT00544336|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5688123|NCT00544336|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5688124|NCT00544336|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5863039|NCT00001410|Recombinant Production|recombinant production
5688125|NCT00544336|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5688126|NCT00544336|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5688127|NCT00544336|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5688128|NCT00544336|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5688129|NCT00544336|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5688130|NCT00544336|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5688131|NCT00544336|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5688132|NCT00544336|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5688133|NCT00544336|recurrent salivary gland cancer|recurrent salivary gland cancer
5688134|NCT00544336|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5688135|NCT00544336|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5688136|NCT00544336|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5688137|NCT00544336|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5688138|NCT00544336|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5688139|NCT00544336|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5688140|NCT00544336|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5688141|NCT00544336|stage I salivary gland cancer|stage i salivary gland cancer
5688143|NCT00544336|stage III salivary gland cancer|stage iii salivary gland cancer
5688144|NCT00544336|stage IV salivary gland cancer|stage iv salivary gland cancer
5688145|NCT00544323|alveolar bone|alveolar bone
5688146|NCT00544323|radiographic alveolar bone changes around oral implants of various designs 12 m post loading|radiographic alveolar bone changes around oral implants of various designs 12 m post loading
5688147|NCT00544297|Actinic Keratosis|actinic keratosis
5688148|NCT00544297|Topical|topical
5688149|NCT00544297|Dermatology|dermatology
5688150|NCT00544297|Hand|hand
5688151|NCT00544284|adult glioblastoma|adult glioblastoma
5688152|NCT00544284|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5688153|NCT00544284|adult giant cell glioblastoma|adult giant cell glioblastoma
5688154|NCT00544284|recurrent adult brain tumor|recurrent adult brain tumor
5686839|NCT00550342|FSGS|fsgs
5688155|NCT00544284|adult gliosarcoma|adult gliosarcoma
5688156|NCT00544284|adult mixed glioma|adult mixed glioma
5688157|NCT00544284|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5688158|NCT00544284|primary central nervous system lymphoma|primary central nervous system lymphoma
5688159|NCT00544284|adult diffuse astrocytoma|adult diffuse astrocytoma
5688160|NCT00544284|adult brain stem glioma|adult brain stem glioma
5688161|NCT00544284|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5688162|NCT00544284|adult choroid plexus tumor|adult choroid plexus tumor
5688163|NCT00544284|adult craniopharyngioma|adult craniopharyngioma
5688164|NCT00544284|adult ependymoblastoma|adult ependymoblastoma
5688165|NCT00544284|adult medulloblastoma|adult medulloblastoma
5688166|NCT00544284|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5688167|NCT00544284|adult anaplastic ependymoma|adult anaplastic ependymoma
5688168|NCT00544284|adult ependymoma|adult ependymoma
5688169|NCT00544284|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5688170|NCT00544284|adult subependymoma|adult subependymoma
5688171|NCT00544284|adult anaplastic meningioma|adult anaplastic meningioma
5688172|NCT00544284|adult melanocytic lesion|adult melanocytic lesion
5688173|NCT00544284|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5688174|NCT00544284|adult grade I meningioma|adult grade i meningioma
5688175|NCT00544284|adult grade II meningioma|adult grade ii meningioma
5688176|NCT00544284|adult grade III meningioma|adult grade iii meningioma
5688177|NCT00544284|adult papillary meningioma|adult papillary meningioma
5688178|NCT00544284|adult oligodendroglioma|adult oligodendroglioma
5688179|NCT00544284|adult pineoblastoma|adult pineoblastoma
5688180|NCT00544284|adult pineocytoma|adult pineocytoma
5688181|NCT00544284|tumors metastatic to brain|tumors metastatic to brain
5688182|NCT00544284|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5688183|NCT00544284|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5688184|NCT00544284|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5688185|NCT00544271|BOOSTRIX|boostrix
5688186|NCT00544271|INFANRIX|infanrix
5688187|NCT00544258|Pharmacokinetic study|pharmacokinetic study
5688188|NCT00544258|Actinic Keratosis|actinic keratosis
5688189|NCT00544258|Topical|topical
5688190|NCT00544258|Dermatology|dermatology
5688191|NCT00544245|overweight|overweight
5688192|NCT00544245|obesity|obesity
5688193|NCT00544245|accelerometer|accelerometer
5688194|NCT00544245|pedometer|pedometer
5688195|NCT00544245|energy balance|energy balance
5688196|NCT00544245|weight loss|weight loss
5688197|NCT00544245|weight maintenance|weight maintenance
5688198|NCT00544232|Breast Cancer|breast cancer
5688199|NCT00544232|neoadjuvant therapy|neoadjuvant therapy
5688201|NCT00544219|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5688202|NCT00544219|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5688203|NCT00544219|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5688204|NCT00544219|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5688205|NCT00544219|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5688206|NCT00544193|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5688207|NCT00544193|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5688208|NCT00544193|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5688209|NCT00544193|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5688210|NCT00544193|stage I pancreatic cancer|stage i pancreatic cancer
5688211|NCT00544193|stage II pancreatic cancer|stage ii pancreatic cancer
5688212|NCT00544193|stage III pancreatic cancer|stage iii pancreatic cancer
5677940|NCT00589082|AML|aml
5688213|NCT00544193|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5688214|NCT00544193|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5688215|NCT00544193|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5688216|NCT00544193|localized gallbladder cancer|localized gallbladder cancer
5688217|NCT00544193|recurrent gallbladder cancer|recurrent gallbladder cancer
5688218|NCT00544193|unresectable gallbladder cancer|unresectable gallbladder cancer
5688219|NCT00544193|recurrent gastric cancer|recurrent gastric cancer
5688220|NCT00544193|stage II gastric cancer|stage ii gastric cancer
5688222|NCT00544193|stage IV gastric cancer|stage iv gastric cancer
5688223|NCT00544193|stage I gastric cancer|stage i gastric cancer
5688224|NCT00544193|recurrent pancreatic cancer|recurrent pancreatic cancer
5688225|NCT00544193|small intestine adenocarcinoma|small intestine adenocarcinoma
5688226|NCT00544193|stage IV pancreatic cancer|stage iv pancreatic cancer
5688227|NCT00544167|Breast Cancer|breast cancer
5688228|NCT00544167|Early Stage|early stage
5688229|NCT00544167|High Risk|high risk
5688230|NCT00544167|Node Positive|node positive
5688231|NCT00544167|Doxorubicin|doxorubicin
5688232|NCT00544167|Cyclophosphamide|cyclophosphamide
5688233|NCT00544167|Paclitaxel|paclitaxel
5688234|NCT00544167|Sorafenib|sorafenib
5688236|NCT00544154|Certolizumab pegol|certolizumab pegol
5688237|NCT00544141|Temperature measurement|temperature measurement
5685684|NCT00555139|depression,|depression,
5685685|NCT00555139|fMRI|fmri
5685686|NCT00555139|CRF-1 antagonists,|crf-1 antagonists,
5685687|NCT00555126|Polytrauma|polytrauma
5688239|NCT00544128|initial therapy|initial therapy
5688240|NCT00544128|once daily|once daily
5688241|NCT00544128|randomized trial|randomized trial
5688242|NCT00544128|non inferiority|non inferiority
5688243|NCT00544128|Treatment Naive|treatment naive
5688244|NCT00544115|graft versus host disease|graft versus host disease
5688245|NCT00544115|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5688246|NCT00544115|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5688247|NCT00544115|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5688248|NCT00544115|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5688350|NCT00543855|donepezil hydrochloride|donepezil hydrochloride
5688249|NCT00544115|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5688250|NCT00544115|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5688251|NCT00544115|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5688252|NCT00544115|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5688253|NCT00544115|refractory anemia with excess blasts|refractory anemia with excess blasts
5688254|NCT00544115|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5688255|NCT00544115|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5688256|NCT00544115|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5688257|NCT00544115|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5688258|NCT00544115|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5688259|NCT00544115|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5688260|NCT00544115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5688261|NCT00544115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5688262|NCT00544115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5688263|NCT00544115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5688264|NCT00544115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5688265|NCT00544115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5688266|NCT00544115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5688267|NCT00544115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5688268|NCT00544115|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5688269|NCT00544115|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5688270|NCT00544115|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5688271|NCT00544115|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5688272|NCT00544115|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5688273|NCT00544115|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5688274|NCT00544115|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5688275|NCT00544115|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5688276|NCT00544115|essential thrombocythemia|essential thrombocythemia
5688277|NCT00544115|polycythemia vera|polycythemia vera
5688278|NCT00544115|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5688279|NCT00544115|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5688280|NCT00544115|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5688281|NCT00544115|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5688282|NCT00544115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5688283|NCT00544115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5688284|NCT00544115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5688285|NCT00544115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5688286|NCT00544115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5688287|NCT00544115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5688288|NCT00544115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5688289|NCT00544115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5688290|NCT00544115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5688291|NCT00544115|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5688292|NCT00544115|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5688293|NCT00544115|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5688294|NCT00544115|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5688295|NCT00544115|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5688296|NCT00544115|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5685688|NCT00555126|Hypothermia|hypothermia
5688297|NCT00544115|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5688298|NCT00544115|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5688299|NCT00544115|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5688301|NCT00544115|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5688302|NCT00544115|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5688303|NCT00544115|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5688304|NCT00544115|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5688305|NCT00544115|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5688306|NCT00544115|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5688307|NCT00544115|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5688308|NCT00544115|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5688309|NCT00544115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5688310|NCT00544115|refractory multiple myeloma|refractory multiple myeloma
5688311|NCT00544115|stage III multiple myeloma|stage iii multiple myeloma
5688313|NCT00544115|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5688314|NCT00544115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5688315|NCT00544115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5688316|NCT00544115|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5688317|NCT00544115|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5688318|NCT00544115|stage II multiple myeloma|stage ii multiple myeloma
5688319|NCT00544102|Insulin Resistance|insulin resistance
5688320|NCT00544102|Systemic Lupus Erythematosus|systemic lupus erythematosus
5688321|NCT00544102|Atherosclerosis|atherosclerosis
5688323|NCT00544102|SLE|sle
5688324|NCT00544089|azoospermia FISH IL-18 TESTICULAR BIOPSY|azoospermia fish il-18 testicular biopsy
5688325|NCT00544063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5688326|NCT00544050|Levetiracetam|levetiracetam
5688327|NCT00544050|Keppra|keppra
5688328|NCT00544024|Mefloquine|mefloquine
5688329|NCT00544011|stage IV colon cancer|stage iv colon cancer
5688330|NCT00544011|stage IV rectal cancer|stage iv rectal cancer
5688331|NCT00544011|adenocarcinoma of the colon|adenocarcinoma of the colon
5688332|NCT00544011|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5688333|NCT00543998|Sinusitis|sinusitis
5688334|NCT00543985|metabolic syndrome|metabolic syndrome
5688335|NCT00543985|obesity|obesity
5688336|NCT00543985|exercise|exercise
5688337|NCT00543907|breast reconstruction|breast reconstruction
5688338|NCT00543907|DIEP flap|diep flap
5688339|NCT00543894|Antibiotic, ICU, hospital acquired infection.|antibiotic, icu, hospital acquired infection.
5688340|NCT00543881|telemedicine|telemedicine
5688341|NCT00543881|remote patient monitoring|remote patient monitoring
5688342|NCT00543881|chronic heart failure|chronic heart failure
5688343|NCT00543881|mortality|mortality
5688344|NCT00543881|health economics|health economics
5688345|NCT00543855|Lewy Body Disease|lewy body disease
5688346|NCT00543855|Dementia|dementia
5688347|NCT00543855|Clinical Trial|clinical trial
5688348|NCT00543855|Phase II|phase ii
5688351|NCT00543842|Rectal Cancer|rectal cancer
5688352|NCT00543842|Bevacizumab|bevacizumab
5688353|NCT00543842|Erlotinib|erlotinib
5688354|NCT00543842|Capecitabine|capecitabine
5688355|NCT00543829|breast cancer|breast cancer
5688356|NCT00543829|doxorubicin|doxorubicin
5688357|NCT00543829|docetaxel|docetaxel
5688360|NCT00543777|Magnetic Resonance Elastography|magnetic resonance elastography
5688361|NCT00543777|2-Point Dixon Magnetic Resonance Imaging|2-point dixon magnetic resonance imaging
5688362|NCT00543777|Liver Disease|liver disease
5688363|NCT00543777|Fatty Liver|fatty liver
5688364|NCT00543777|Liver Fibrosis|liver fibrosis
5688365|NCT00543777|Liver Cirrhosis|liver cirrhosis
5688366|NCT00543777|MRE|mre
5688367|NCT00543777|2PD MRI|2pd mri
5688368|NCT00543777|phase correction algorithm|phase correction algorithm
5688369|NCT00543764|Intraoperative Pathway|intraoperative pathway
5688370|NCT00543764|Breast Reconstruction|breast reconstruction
5688371|NCT00543764|DIEP flap|diep flap
5688372|NCT00543725|Antiretroviral|antiretroviral
5688373|NCT00543725|HIV-1|hiv-1
5688374|NCT00543725|AIDS|aids
5688375|NCT00543725|TMC278-C215|tmc278-c215
5688376|NCT00543725|TMC278-TiDP6-C215|tmc278-tidp6-c215
5688377|NCT00543725|Treatment Naive|treatment naive
5688378|NCT00543712|Sarcoma|sarcoma
5688379|NCT00543712|synovial sarcoma|synovial sarcoma
5688380|NCT00543712|APM4171g|apm4171g
5688381|NCT00543686|Pre-School Asthma|pre-school asthma
5688382|NCT00543686|Responder Profiles|responder profiles
5688383|NCT00543686|Fluticasone|fluticasone
5688384|NCT00543686|Montelukast|montelukast
5688385|NCT00543686|Leukotriene|leukotriene
5688386|NCT00543686|Children with Pre-School Asthma|children with pre-school asthma
5688387|NCT00543673|Healthy term infants|healthy term infants
5688388|NCT00543660|Corneal transplantation, Descemet membrane, endothelium|corneal transplantation, descemet membrane, endothelium
5688389|NCT00543647|Fenofibrate|fenofibrate
5685689|NCT00555126|Wound Infection|wound infection
5685690|NCT00555126|Blood Loss|blood loss
5688390|NCT00543647|Glomerular filtration rate|glomerular filtration rate
5688391|NCT00543647|inulin clearance|inulin clearance
5688392|NCT00543647|creatinine|creatinine
5688393|NCT00543647|healthy volunteers|healthy volunteers
5688394|NCT00543647|cross-over|cross-over
5688395|NCT00543608|pneumonia|pneumonia
5688396|NCT00543608|nosocomial pneumonia|nosocomial pneumonia
5688397|NCT00543569|kidney transplant|kidney transplant
5688398|NCT00543569|alefacept|alefacept
5688399|NCT00543530|HIV|hiv
5688400|NCT00543530|Treatment Experienced|treatment experienced
5688401|NCT00543504|Advanced Cancer|advanced cancer
5688402|NCT00543504|Bevacizumab|bevacizumab
5688403|NCT00543504|Avastin|avastin
5688404|NCT00543504|Sorafenib|sorafenib
5688405|NCT00543504|BAY 43-9006|bay 43-9006
5688409|NCT00543504|Trastuzumab|trastuzumab
5688410|NCT00543504|Herceptin|herceptin
5688411|NCT00543504|Sunitinib|sunitinib
5688412|NCT00543504|SU011248|su011248
5688413|NCT00543504|Sutent|sutent
5688414|NCT00543504|Cetuximab|cetuximab
5688415|NCT00543504|Lapatinib|lapatinib
5688416|NCT00543504|Tykerb|tykerb
5688417|NCT00543504|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5688418|NCT00543504|rhuMAb-VEGF|rhumab-vegf
5688419|NCT00543504|Erlotinib hydrochloride|erlotinib hydrochloride
5688420|NCT00543504|GW572016|gw572016
5688421|NCT00543504|Sunitinib Malate|sunitinib malate
5688422|NCT00543478|Irritable bowel syndrome|irritable bowel syndrome
5688423|NCT00543478|Diarrhea|diarrhea
5688424|NCT00543478|Probiotics|probiotics
5688425|NCT00543426|Fuzheng Huayu Tablets|fuzheng huayu tablets
5688426|NCT00543426|Multicenter clinical study|multicenter clinical study
5688427|NCT00543400|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5688428|NCT00543348|BALLOON ANGIOPLASTY|balloon angioplasty
5688429|NCT00543348|AUTOGENOUS FISTULA|autogenous fistula
5688430|NCT00543335|Non-Small Cell Lung Cancer|non-small cell lung cancer
5688431|NCT00543335|Lung Cancer|lung cancer
5688432|NCT00543335|NSCLC|nsclc
5688433|NCT00543335|Radiation Therapy|radiation therapy
5688434|NCT00543335|Sorafenib|sorafenib
5688435|NCT00543335|BAY 43-9006|bay 43-9006
5688436|NCT00543335|Thoracic Radiation|thoracic radiation
5688437|NCT00543309|Fontan Operation|fontan operation
5688438|NCT00543309|Cardiopulmonary Bypass|cardiopulmonary bypass
5688439|NCT00543309|Heart Defects, Congenital|heart defects, congenital
5688440|NCT00543309|Milrinone|milrinone
5688441|NCT00543309|Natriuretic peptide, brain|natriuretic peptide, brain
5688442|NCT00543296|uveitis|uveitis
5688443|NCT00543296|Cystoid Macular Edema (CME)|cystoid macular edema (cme)
5688444|NCT00543296|fluocinolone acetonide|fluocinolone acetonide
5688445|NCT00543296|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment
5688446|NCT00543270|EVAR|evar
5688447|NCT00543270|AAA|aaa
5688448|NCT00543270|Aneurysm|aneurysm
5688449|NCT00543270|Powerlink|powerlink
5688450|NCT00543244|Chronic hepatitis C|chronic hepatitis c
5688451|NCT00543244|Pegylated interferon|pegylated interferon
5688452|NCT00543244|Ribavirin|ribavirin
5688453|NCT00543244|Virokinetics|virokinetics
5688454|NCT00543231|ECOG|ecog
5688455|NCT00543231|MRT|mrt
5688456|NCT00543231|NCI CTC|nci ctc
5688457|NCT00543231|SAE|sae
5688458|NCT00543231|Short Intravenous Infusion to Patients with Solid Tumors|short intravenous infusion to patients with solid tumors
5688459|NCT00543192|Endometrial Cancer|endometrial cancer
5688460|NCT00543192|Sexual Function|sexual function
5688461|NCT00543166|Sjögren's syndrome|sjögren's syndrome
5688462|NCT00543166|fatigue|fatigue
5688463|NCT00543166|salivary gland|salivary gland
5688464|NCT00543166|dehydroepiandrosterone|dehydroepiandrosterone
5688465|NCT00543153|Advanced Cancer|advanced cancer
5688466|NCT00543153|Exceptional Patient|exceptional patient
5688467|NCT00543153|Cancer Care|cancer care
5688468|NCT00543153|Interview|interview
5688469|NCT00543140|Obesity|obesity
5688470|NCT00543140|Morbid Obesity|morbid obesity
5688471|NCT00543114|CLL|cll
5688472|NCT00543114|SLL|sll
5688474|NCT00543114|lenalidomide|lenalidomide
5688475|NCT00543101|HIV/AIDS|hiv/aids
5688476|NCT00543101|darunavir|darunavir
5688477|NCT00543101|Protease inhibitors|protease inhibitors
5688478|NCT00543101|Dual boosted|dual boosted
5688479|NCT00543101|Treatment experienced|treatment experienced
5688480|NCT00543088|Schizophrenia|schizophrenia
5688481|NCT00543088|Bipolar Disorder|bipolar disorder
5688482|NCT00543088|manic episode|manic episode
5688483|NCT00543088|atypical antipsychotic|atypical antipsychotic
5688484|NCT00543088|Schizophrenia or Bipolar Disorder (currently in a manic episode)|schizophrenia or bipolar disorder (currently in a manic episode)
5688485|NCT00543075|Renal Function|renal function
5688486|NCT00543075|Adult|adult
5688488|NCT00543075|oblimersen|oblimersen
5688489|NCT00543075|G3139|g3139
5688490|NCT00543075|Genta|genta
5688491|NCT00543075|Pharmacokinetics|pharmacokinetics
5688492|NCT00543062|Inhaled prochlorperazine, Thorough Qt/QTc,|inhaled prochlorperazine, thorough qt/qtc,
5688493|NCT00543049|platinum refractory|platinum refractory
5685691|NCT00555126|Combined perioperative morbidity|combined perioperative morbidity
5688494|NCT00543049|epithelial ovarian cancer|epithelial ovarian cancer
5688495|NCT00543049|primary cancer of the peritoneum|primary cancer of the peritoneum
5688496|NCT00543049|cancer of the fallopian tube|cancer of the fallopian tube
5688497|NCT00543036|Cannabis|cannabis
5688498|NCT00543036|Addiction|addiction
5688499|NCT00543036|Craving|craving
5688500|NCT00543036|TMS|tms
5688501|NCT00542997|Subcutaneous immune globulin|subcutaneous immune globulin
5688502|NCT00542997|SCIG|scig
5688503|NCT00542971|Leukemia|leukemia
5688504|NCT00542971|AML|aml
5688505|NCT00542971|High-Risk MDS|high-risk mds
5688506|NCT00542971|Acute Myeloid Leukemia|acute myeloid leukemia
5688507|NCT00542971|High-Risk Myelodysplastic Disorder|high-risk myelodysplastic disorder
5688508|NCT00542971|Idarubicin|idarubicin
5688509|NCT00542971|Ara-C|ara-c
5688510|NCT00542971|Cytarabine|cytarabine
5688511|NCT00542971|Sorafenib|sorafenib
5688512|NCT00542971|BAY43-9006|bay43-9006
5688513|NCT00542958|Cancer|cancer
5688514|NCT00542958|Refractory solid tumor|refractory solid tumor
5688515|NCT00542945|Heart Failure|heart failure
5688516|NCT00542945|ICD|icd
5688517|NCT00542945|Dilated cardiomyopathy|dilated cardiomyopathy
5688518|NCT00542932|COPD|copd
5688519|NCT00542932|Exercise|exercise
5688520|NCT00542932|Home|home
5688521|NCT00542906|healthy volunteers|healthy volunteers
5688522|NCT00542906|Somatosensory stimuli|somatosensory stimuli
5688523|NCT00542906|fMRI|fmri
5688524|NCT00542906|second somatosensory area|second somatosensory area
5688525|NCT00542906|insular cortex|insular cortex
5688526|NCT00542906|functional anatomy|functional anatomy
5688527|NCT00542893|bcl-2|bcl-2
5688528|NCT00542893|CFR|cfr
5688529|NCT00542893|DTIC|dtic
5688530|NCT00542893|ECOG|ecog
5688531|NCT00542893|EMEA|emea
5688532|NCT00542893|MedDRA|meddra
5688533|NCT00542893|NCI CTC|nci ctc
5688535|NCT00542880|COPD|copd
5688536|NCT00542880|Symbicort|symbicort
5688537|NCT00542880|Seretide|seretide
5688538|NCT00542867|Hypercholesterolemia|hypercholesterolemia
5688539|NCT00542867|Third Joint European Task Force guidelines|third joint european task force guidelines
5688540|NCT00542867|Survey|survey
5688541|NCT00542854|arrhythmia|arrhythmia
5688542|NCT00542854|pacemaker|pacemaker
5688543|NCT00542854|defibrillator|defibrillator
5688544|NCT00542854|electromagnetic interference|electromagnetic interference
5688545|NCT00542841|Adrenal Hyperplasia, Congenital|adrenal hyperplasia, congenital
5688546|NCT00542841|Steroid Biosynthesis Disorders|steroid biosynthesis disorders
5688547|NCT00542815|Chronic Kidney Disease|chronic kidney disease
5688548|NCT00542815|Dialysis|dialysis
5688549|NCT00542815|Hyperphosphatemia|hyperphosphatemia
5688550|NCT00542802|post stroke epileptic late onset seizures|post stroke epileptic late onset seizures
5688551|NCT00542789|gastrointestinal|gastrointestinal
5688552|NCT00542789|GI|gi
5688553|NCT00542789|NSAID|nsaid
5688554|NCT00542789|Japan|japan
5688555|NCT00542789|Japanese|japanese
5688556|NCT00542789|Gastric ulcer|gastric ulcer
5688557|NCT00542789|duodenal ulcer|duodenal ulcer
5688558|NCT00542776|inflammatory bowel disease (IBD)|inflammatory bowel disease (ibd)
5863040|NCT00001410|Inherited Disease|inherited disease
5688559|NCT00542776|immunosuppressed or non-immunosuppressed|immunosuppressed or non-immunosuppressed
5688560|NCT00542776|influenza vaccine|influenza vaccine
5688561|NCT00542776|antibody titers|antibody titers
5688562|NCT00542776|seroprotective titers|seroprotective titers
5688563|NCT00542776|vaccine-associated adverse events|vaccine-associated adverse events
5688564|NCT00542763|Sjogren's syndrome|sjogren's syndrome
5688565|NCT00542763|Mycophenolate sodium|mycophenolate sodium
5688566|NCT00542750|Cannabis|cannabis
5688567|NCT00542750|Marijuana|marijuana
5688568|NCT00542750|Pharmacotherapy|pharmacotherapy
5688570|NCT00542737|Acute Lung Injury|acute lung injury
5688571|NCT00542737|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5688572|NCT00542737|Acute Respiratory Failure|acute respiratory failure
5688573|NCT00542737|Web-Based Intervention|web-based intervention
5688574|NCT00542737|Lung Preventive Ventilation|lung preventive ventilation
5688575|NCT00542724|Insulin|insulin
5688576|NCT00542724|Diabetes Mellitus type I|diabetes mellitus type i
5688578|NCT00542711|Curcumin|curcumin
5688579|NCT00542711|Bioavilability|bioavilability
5688580|NCT00542711|Healthy subjects|healthy subjects
5688581|NCT00542698|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5688582|NCT00542698|Glucose Monitor graphs|glucose monitor graphs
5688583|NCT00542698|Physical Activity|physical activity
5688584|NCT00542672|Mexican American|mexican american
5688585|NCT00542672|Dietary Intake|dietary intake
5688586|NCT00542672|Child-Feeding Practices|child-feeding practices
5688587|NCT00542672|Weight|weight
5688588|NCT00542672|Cultural Values|cultural values
5688589|NCT00542659|Atrial fibrillation|atrial fibrillation
5688591|NCT00542633|Diabetes mellitus type 2|diabetes mellitus type 2
5688592|NCT00542633|Diabetes|diabetes
5688593|NCT00542633|Insulin|insulin
5688594|NCT00542633|NIDDM|niddm
5688595|NCT00542633|Rapid acting|rapid acting
5695825|NCT00515138|RICE|rice
5688596|NCT00542607|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5688597|NCT00542607|Xyzal tablets|xyzal tablets
5688598|NCT00542594|breast cancer|breast cancer
5688599|NCT00542594|anastrozole|anastrozole
5688600|NCT00542581|Visual Outcomes|visual outcomes
5688601|NCT00542581|Patient Satisfaction|patient satisfaction
5688602|NCT00542581|Ophthalmology|ophthalmology
5688603|NCT00542581|Cataractous Lens|cataractous lens
5688604|NCT00542542|Breast Cancer|breast cancer
5688605|NCT00542542|Reconstructive Surgery|reconstructive surgery
5688606|NCT00542542|Paravertebral Block|paravertebral block
5688607|NCT00542542|Anesthesia|anesthesia
5688608|NCT00542542|Propofol|propofol
5688609|NCT00542542|Fentanyl|fentanyl
5688610|NCT00542542|Ropivacaine|ropivacaine
5688611|NCT00542542|Midazolam|midazolam
5688612|NCT00542529|Healthy Subjects|healthy subjects
5688613|NCT00542516|Hip Replacement Arthroplasty|hip replacement arthroplasty
5688619|NCT00542503|MRI|mri
5688620|NCT00542503|Cardiac Stress Testing|cardiac stress testing
5688621|NCT00542490|Endometrial cancer|endometrial cancer
5688622|NCT00542490|Gynecologic Cancer|gynecologic cancer
5688623|NCT00542490|Vaginal Cuff Brachytherapy|vaginal cuff brachytherapy
5688624|NCT00542490|Vaginal radiation|vaginal radiation
5688625|NCT00542464|Safety in Healthy Adult Subjects|safety in healthy adult subjects
5688626|NCT00542451|node-negative breast cancer|node-negative breast cancer
5688627|NCT00542451|HER-2 positive|her-2 positive
5688628|NCT00542438|Cardiovascular Disease|cardiovascular disease
5688629|NCT00542438|Cancer Prevention|cancer prevention
5688630|NCT00542438|Physical Activity|physical activity
5688631|NCT00542438|Body Composition|body composition
5688632|NCT00542438|Environment|environment
5688633|NCT00542438|Exercise|exercise
5688634|NCT00542425|osteoporosis|osteoporosis
5688635|NCT00542425|postmenopausal|postmenopausal
5688636|NCT00542425|bone loss|bone loss
5688637|NCT00542399|levemir|levemir
5688638|NCT00542399|type 1 diabetes|type 1 diabetes
5688639|NCT00542386|Chronic Kidney Disease|chronic kidney disease
5688640|NCT00542386|Dialysis|dialysis
5688641|NCT00542386|Hyperphosphatemia|hyperphosphatemia
5688642|NCT00542386|Dyslipidemia|dyslipidemia
5688643|NCT00542386|Phosphate binder|phosphate binder
5688644|NCT00542360|Accidental Falls|accidental falls
5688645|NCT00542360|Aged|aged
5688646|NCT00542360|Social Marketing|social marketing
5688647|NCT00542360|Exercise|exercise
5688648|NCT00542360|Accident Prevention|accident prevention
5688649|NCT00542360|Religion|religion
5688650|NCT00542360|Randomized Controlled Trial|randomized controlled trial
5688651|NCT00542347|gastric acid|gastric acid
5688652|NCT00542347|proton pump inhibitors|proton pump inhibitors
5688653|NCT00542347|omeprazole|omeprazole
5688654|NCT00542347|esomeprazole|esomeprazole
5688655|NCT00542334|Nocturnal Hypoglycemia|nocturnal hypoglycemia
5688656|NCT00542334|Type 1 diabetes|type 1 diabetes
5688657|NCT00542334|Children|children
5688658|NCT00542334|Adolescents|adolescents
5688659|NCT00542334|CGMS|cgms
5688660|NCT00542321|lateral rotation|lateral rotation
5688661|NCT00542321|kinetic therapy|kinetic therapy
5688662|NCT00542321|mechanical ventilation|mechanical ventilation
5688663|NCT00542321|pulmonary complications|pulmonary complications
5688664|NCT00542282|lung sounds,|lung sounds,
5688665|NCT00542282|airway obstruction,|airway obstruction,
5688666|NCT00542282|asthma,|asthma,
5688667|NCT00542282|auscultation|auscultation
5688668|NCT00542269|Hypertension|hypertension
5688669|NCT00542269|Metabolic Syndrome|metabolic syndrome
5688670|NCT00542269|Dual combination therapy|dual combination therapy
5688671|NCT00542269|Triple combination therapy|triple combination therapy
5688672|NCT00542269|Aliskiren|aliskiren
5688673|NCT00542269|Direct Renin inhibitor|direct renin inhibitor
5688674|NCT00542256|Apoplexy|apoplexy
5688675|NCT00542256|Cerebral Stroke|cerebral stroke
5688676|NCT00542256|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5688677|NCT00542256|Cerebrovascular Apoplexy|cerebrovascular apoplexy
5688678|NCT00542256|Cerebrovascular Stroke|cerebrovascular stroke
5688679|NCT00542256|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5688680|NCT00542256|Stroke|stroke
5688681|NCT00542256|Stroke, Acute|stroke, acute
5688682|NCT00542256|Vascular Accident, Brain|vascular accident, brain
5688683|NCT00542243|enlarged prostate|enlarged prostate
5688684|NCT00542243|finasteride|finasteride
5688690|NCT00542217|Healthy Volunteers|healthy volunteers
5688691|NCT00542204|Diabetes|diabetes
5688692|NCT00542204|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5688693|NCT00542204|Home Blood Glucose Monitoring|home blood glucose monitoring
5688694|NCT00542204|Internet|internet
5688695|NCT00542204|Personal Health Record (PHR)|personal health record (phr)
5688696|NCT00542204|Health Information Technology (HIT)|health information technology (hit)
5688697|NCT00542204|Care management|care management
5688698|NCT00542204|Disease Management|disease management
5688699|NCT00542204|Diabetes self-management|diabetes self-management
5688700|NCT00542204|Consumer Health Information|consumer health information
5688701|NCT00542204|Medical Records Systems, Computerized|medical records systems, computerized
5688702|NCT00542204|Computerized Medical Records System|computerized medical records system
5688703|NCT00542204|Automated Medical Records System|automated medical records system
5688704|NCT00542204|Electronic Health Record (EHR)|electronic health record (ehr)
5688705|NCT00542204|Remote patient monitoring|remote patient monitoring
5688706|NCT00542191|Triple negative (ER/PR negative; HER2 negative)|triple negative (er/pr negative; her2 negative)
5688707|NCT00542178|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5688708|NCT00542178|Cardiovascular Diseases|cardiovascular diseases
5688710|NCT00542152|Ulcerative colitis|ulcerative colitis
5688711|NCT00542152|refractory to steroids|refractory to steroids
5688712|NCT00542139|Osteoarthritis|osteoarthritis
5688713|NCT00542139|Knee arthroplasty|knee arthroplasty
5688714|NCT00542139|Steroid injection|steroid injection
5688715|NCT00542139|Rehabilitation|rehabilitation
5688716|NCT00542126|GnRH analog, IVF, infertility, frozen-thawed embryos|gnrh analog, ivf, infertility, frozen-thawed embryos
5688717|NCT00542113|Parental|parental
5688718|NCT00542113|Parents|parents
5688719|NCT00542113|Prevention|prevention
5688720|NCT00542113|Energy balance|energy balance
5688721|NCT00542113|Glucose regulation|glucose regulation
5688722|NCT00542113|Healthy lifestyles|healthy lifestyles
5688723|NCT00542113|Healthy families|healthy families
5688724|NCT00542113|Active living|active living
5688725|NCT00542074|Bacterial vaginosis|bacterial vaginosis
5688726|NCT00542074|recurrence|recurrence
5688727|NCT00542074|male factor|male factor
5688728|NCT00542061|COPD|copd
5688729|NCT00542061|Asthma|asthma
5688730|NCT00542061|Lung function|lung function
5688731|NCT00542061|Monitoring|monitoring
5688732|NCT00542061|Primary Care|primary care
5688733|NCT00542048|Hepatic metastases|hepatic metastases
5688734|NCT00542048|Angiogenesis|angiogenesis
5688735|NCT00542048|EndoTAG-1|endotag-1
5688736|NCT00542048|Pharmacokinetics|pharmacokinetics
5688737|NCT00542048|Pharmacodynamics|pharmacodynamics
5688738|NCT00542048|Metastases of the liver|metastases of the liver
5688739|NCT00542035|Analgesia|analgesia
5688740|NCT00542009|Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.|phase 2a, safety and efficacy trial with ce-326,597 in patients with t2dm.
5688741|NCT00541983|Diabetes|diabetes
5688742|NCT00541983|Type 2|type 2
5688743|NCT00541983|Mellitus|mellitus
5688744|NCT00541970|viral infections|viral infections
5688745|NCT00541970|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5688746|NCT00541970|safety|safety
5688747|NCT00541970|vaccine|vaccine
5688748|NCT00541970|immunogenicity|immunogenicity
5688749|NCT00541970|cervical cancer|cervical cancer
5688750|NCT00541957|Major depression|major depression
5688751|NCT00541957|Primary care|primary care
5688752|NCT00541944|hyponatremia|hyponatremia
5688753|NCT00541944|diagnosis and treatment of hyponatremia|diagnosis and treatment of hyponatremia
5688754|NCT00541944|classification of hyponatremia|classification of hyponatremia
5688755|NCT00541918|sevoflurane,|sevoflurane,
5688756|NCT00541918|propofol,|propofol,
5688757|NCT00541918|heart surgery,|heart surgery,
5688758|NCT00541918|cardiopulmonary bypass,|cardiopulmonary bypass,
5688759|NCT00541918|memory disorders,|memory disorders,
5688760|NCT00541892|Cell Culture Techniques|cell culture techniques
5688761|NCT00541879|Childhood|childhood
5688762|NCT00541879|Prevention|prevention
5688763|NCT00541879|Energy balance|energy balance
5688764|NCT00541879|Glucose regulation|glucose regulation
5688765|NCT00541879|Healthy lifestyle|healthy lifestyle
5714413|NCT00448695|MRI|mri
5688766|NCT00541879|Healthy eating|healthy eating
5688767|NCT00541879|Active living|active living
5688768|NCT00541866|Leukemia|leukemia
5688769|NCT00541866|Acute Myeloid|acute myeloid
5688770|NCT00541866|Relapsed|relapsed
5688771|NCT00541866|Refractory|refractory
5688772|NCT00541866|Cancer|cancer
5688773|NCT00541866|AML|aml
5688774|NCT00541866|Cytarabine|cytarabine
5688775|NCT00541866|SNS-595|sns-595
5688776|NCT00541866|Phase 1|phase 1
5688778|NCT00541853|Autosomal Dominant Polycystic Kidney Disease|autosomal dominant polycystic kidney disease
5688779|NCT00541853|Hypertension|hypertension
5688780|NCT00541853|Angiotensin-2 Receptor Blocker|angiotensin-2 receptor blocker
5688781|NCT00541853|Calcium Channel Blocker|calcium channel blocker
5688782|NCT00541853|Kidney Volume|kidney volume
5688783|NCT00541840|Sarcoma|sarcoma
5688785|NCT00541840|GEIS|geis
5688786|NCT00541827|Sepsis. Shock, septic. Mitochondria.|sepsis. shock, septic. mitochondria.
5688787|NCT00541814|Renal Transplantation|renal transplantation
5688788|NCT00541814|Calcineurin Inhibitor|calcineurin inhibitor
5688789|NCT00541814|Cyclosporine|cyclosporine
5688790|NCT00541814|Withdrawal|withdrawal
5688791|NCT00541814|Minimisation|minimisation
5688792|NCT00541762|Neurotensin|neurotensin
5688793|NCT00541762|Human|human
5688794|NCT00541762|Physiology of neurotensin|physiology of neurotensin
5688795|NCT00541762|fat perfusion|fat perfusion
5688796|NCT00541762|healthy subjects|healthy subjects
5688797|NCT00541749|SLE|sle
5688798|NCT00541736|Familial Hemiplegic Migraine|familial hemiplegic migraine
5688800|NCT00541710|genistein|genistein
5688801|NCT00541710|pre-diabetes|pre-diabetes
5688802|NCT00541671|Narcotics|narcotics
5688803|NCT00541671|Nausea|nausea
5688804|NCT00541619|hypertension|hypertension
5688805|NCT00541619|sympathetic activity|sympathetic activity
5688806|NCT00541619|early renal damage|early renal damage
5688807|NCT00541606|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5688808|NCT00541606|Pharmaceutical Care|pharmaceutical care
5688809|NCT00541606|Collaborative Practice|collaborative practice
5688810|NCT00541593|Pancreatic pseudocyst|pancreatic pseudocyst
5688811|NCT00541593|NOTES|notes
5688812|NCT00541567|Wheight management in T2D|wheight management in t2d
5688813|NCT00541515|Type 1 diabetes|type 1 diabetes
5688814|NCT00541515|Artificial pancreas|artificial pancreas
5688815|NCT00541515|Insulin Pump|insulin pump
5688816|NCT00541502|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in Taiwan|evaluate the effectiveness of improving cognitive function of aripiprazole in treating adolescents and young adults with psychotic disorder in taiwan
5688817|NCT00541489|Osteoarthritis|osteoarthritis
5688818|NCT00541489|Osteoarthritis, Hip|osteoarthritis, hip
5688819|NCT00541463|HIV|hiv
5688820|NCT00541463|Treatment Experienced|treatment experienced
5688821|NCT00541437|Change from baseline of HbA1c after 16 weeks of treatment|change from baseline of hba1c after 16 weeks of treatment
5688822|NCT00541437|Change from baseline of FPG after 16 weeks of treatment|change from baseline of fpg after 16 weeks of treatment
5688823|NCT00541437|Change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment|change from baseline of diabetes self-care scale by patient on drug administration after 16 weeks of treatment
5688824|NCT00541424|Mantle Cell Lymphoma|mantle cell lymphoma
5688825|NCT00541424|Lymphoma|lymphoma
5688826|NCT00541424|CT Colonography|ct colonography
5688827|NCT00541424|PET Scan|pet scan
5688828|NCT00541424|PET/CT Scan|pet/ct scan
5688829|NCT00541424|Gas Insufflation|gas insufflation
5688830|NCT00541398|Antipsychotic polypharmacy|antipsychotic polypharmacy
5688831|NCT00541398|Schizophrenia|schizophrenia
5688832|NCT00541398|Implementation of clinical guidelines|implementation of clinical guidelines
5688833|NCT00541385|malaria|malaria
5688834|NCT00541385|pediatric|pediatric
5688835|NCT00541385|Africa|africa
5688836|NCT00541385|Phillipines|phillipines
5688837|NCT00541385|Coartem|coartem
5688838|NCT00541385|Artesunate|artesunate
5688839|NCT00541385|lumefantrine|lumefantrine
5688840|NCT00541385|Arthemeter|arthemeter
5688841|NCT00541385|pyronaridine|pyronaridine
5688842|NCT00541385|Pyramax|pyramax
5688843|NCT00541346|Autism|autism
5688844|NCT00541346|Autism Spectrum Disorders|autism spectrum disorders
5688845|NCT00541346|ADHD|adhd
5688846|NCT00541333|Dry Age Related Macular Degeneration|dry age related macular degeneration
5688847|NCT00541333|Dry AMD|dry amd
5688848|NCT00541320|Anti-thrombolytic direct Factor Xa inhibitor|anti-thrombolytic direct factor xa inhibitor
5688849|NCT00541307|Peripheral Arterial Disease|peripheral arterial disease
5688850|NCT00541307|Peripheral Vascular Disease|peripheral vascular disease
5688851|NCT00541294|Tuberculosis|tuberculosis
5688852|NCT00541294|HIV|hiv
5688853|NCT00541294|Diagnostics|diagnostics
5688854|NCT00541294|Pediatrics|pediatrics
5688855|NCT00541281|prostate cancer|prostate cancer
5688856|NCT00541281|hormone resistant|hormone resistant
5688857|NCT00541281|metastatic|metastatic
5688858|NCT00541281|estramustine combine to docetaxel|estramustine combine to docetaxel
5688859|NCT00541281|randomized study|randomized study
5688860|NCT00541268|Heart Failure|heart failure
5688861|NCT00541268|ICD|icd
5688862|NCT00541268|Dilated cardiomyopathy|dilated cardiomyopathy
5688863|NCT00541255|Bronchial Asthma|bronchial asthma
5688864|NCT00541255|Food Allergy|food allergy
5688865|NCT00541255|Bronchial Hyperresponsiveness|bronchial hyperresponsiveness
5688866|NCT00541216|congenital myasthenia|congenital myasthenia
5688867|NCT00541216|ephedrine|ephedrine
5688868|NCT00541203|tomography|tomography
5688869|NCT00541203|coronary artery disease|coronary artery disease
5688870|NCT00541203|Stress Test|stress test
5690761|NCT00535080|carcinomas|carcinomas
5688871|NCT00541203|Coronary Angiography|coronary angiography
5688872|NCT00541190|cystic fibrosis|cystic fibrosis
5688873|NCT00541190|mucociliary clearance|mucociliary clearance
5688874|NCT00541190|outcome measures|outcome measures
5688875|NCT00541177|prevention myopia|prevention myopia
5688876|NCT00541164|CMT|cmt
5688877|NCT00541164|Charcot-Marie Tooth|charcot-marie tooth
5688878|NCT00541164|CoQ10|coq10
5688879|NCT00541164|Coenzyme Q10|coenzyme q10
5688880|NCT00541151|Stress urinary incontinence in Women|stress urinary incontinence in women
5688881|NCT00541138|tumors metastatic to brain|tumors metastatic to brain
5688882|NCT00541138|recurrent adult brain tumor|recurrent adult brain tumor
5688883|NCT00541138|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5688884|NCT00541138|adult diffuse astrocytoma|adult diffuse astrocytoma
5688885|NCT00541138|adult giant cell glioblastoma|adult giant cell glioblastoma
5688886|NCT00541138|adult gliosarcoma|adult gliosarcoma
5683563|NCT00564122|Artificial-Intelligence|artificial-intelligence
5688888|NCT00541138|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5688889|NCT00541138|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5688890|NCT00541138|adult brain stem glioma|adult brain stem glioma
5688891|NCT00541138|adult anaplastic ependymoma|adult anaplastic ependymoma
5688892|NCT00541138|adult ependymoma|adult ependymoma
5688893|NCT00541138|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5688894|NCT00541138|adult subependymoma|adult subependymoma
5688895|NCT00541138|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5688896|NCT00541138|adult oligodendroglioma|adult oligodendroglioma
5688897|NCT00541138|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5688898|NCT00541138|adult mixed glioma|adult mixed glioma
5688899|NCT00541125|recurrent colon cancer|recurrent colon cancer
5690679|NCT00535431|IL-4|il-4
5688900|NCT00541125|stage IV colon cancer|stage iv colon cancer
5688901|NCT00541125|recurrent rectal cancer|recurrent rectal cancer
5688902|NCT00541125|stage IV rectal cancer|stage iv rectal cancer
5688903|NCT00541125|adenocarcinoma of the colon|adenocarcinoma of the colon
5688904|NCT00541125|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5688905|NCT00541112|stage III rectal cancer|stage iii rectal cancer
5688906|NCT00541112|stage IV rectal cancer|stage iv rectal cancer
5688907|NCT00541112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5688908|NCT00541099|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5688909|NCT00541099|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5688910|NCT00541099|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5688911|NCT00541086|stage IA breast cancer|stage ia breast cancer
5688912|NCT00541086|stage IB breast cancer|stage ib breast cancer
5688913|NCT00541086|stage II breast cancer|stage ii breast cancer
5688914|NCT00541086|stage IIIA breast cancer|stage iiia breast cancer
5688915|NCT00541086|stage IIIB breast cancer|stage iiib breast cancer
5688916|NCT00541086|stage IIIC breast cancer|stage iiic breast cancer
5688917|NCT00541086|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5848034|NCT00036582|Children and Adolescents|children and adolescents
5688918|NCT00541086|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5688919|NCT00541073|advanced malignant mesothelioma|advanced malignant mesothelioma
5688920|NCT00541073|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5688921|NCT00541060|caries susceptibility,enamel matrix,candidate genes,mutation|caries susceptibility,enamel matrix,candidate genes,mutation
5688922|NCT00541047|sexual dysfunction|sexual dysfunction
5688923|NCT00541047|urinary complications|urinary complications
5688924|NCT00541047|gastrointestinal complications|gastrointestinal complications
5688925|NCT00541047|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5688926|NCT00541047|stage I prostate cancer|stage i prostate cancer
5688927|NCT00541047|stage IIB prostate cancer|stage iib prostate cancer
5688928|NCT00541047|stage IIA prostate cancer|stage iia prostate cancer
5688929|NCT00541047|stage III prostate cancer|stage iii prostate cancer
5688930|NCT00541034|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5688931|NCT00541034|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5688932|NCT00541034|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5688933|NCT00541034|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5688934|NCT00541034|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5688935|NCT00541034|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5688936|NCT00541034|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5688937|NCT00541034|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5688938|NCT00541034|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5688939|NCT00541021|stage III pancreatic cancer|stage iii pancreatic cancer
5697583|NCT00509171|lavage|lavage
5697584|NCT00509171|TEE|tee
5697585|NCT00509171|reamer|reamer
5697586|NCT00509171|IM nail|im nail
5697587|NCT00509158|safety|safety
5697588|NCT00509158|immunogenicity|immunogenicity
5688940|NCT00541021|stage IV pancreatic cancer|stage iv pancreatic cancer
5688941|NCT00541021|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5688942|NCT00541021|recurrent pancreatic cancer|recurrent pancreatic cancer
5688943|NCT00541008|type 1 papillary renal cell carcinoma|type 1 papillary renal cell carcinoma
5688944|NCT00541008|type 2 papillary renal cell carcinoma|type 2 papillary renal cell carcinoma
5688945|NCT00541008|stage IV renal cell cancer|stage iv renal cell cancer
5688946|NCT00541008|stage III renal cell cancer|stage iii renal cell cancer
5688947|NCT00540982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5690762|NCT00535080|Bowen's|bowen's
5688948|NCT00540982|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5688949|NCT00540982|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5688950|NCT00540982|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5688951|NCT00540982|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5688952|NCT00540969|bone metastases|bone metastases
5688953|NCT00540969|pain|pain
5688954|NCT00540969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5688956|NCT00540969|stage IV renal cell cancer|stage iv renal cell cancer
5688957|NCT00540956|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5688958|NCT00540956|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5688959|NCT00540956|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5688960|NCT00540956|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5688961|NCT00540956|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5689083|NCT00540267|Bone Density|bone density
5688962|NCT00540956|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5688963|NCT00540956|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5688964|NCT00540956|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5688965|NCT00540956|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5688966|NCT00540956|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5688967|NCT00540956|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5688968|NCT00540956|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5688969|NCT00540956|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5690680|NCT00535431|IL-13|il-13
5688970|NCT00540956|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5688971|NCT00540943|cetuximab|cetuximab
5688972|NCT00540943|irinotecan,|irinotecan,
5688973|NCT00540943|pazopanib,|pazopanib,
5688974|NCT00540943|Colorectal cancer,|colorectal cancer,
5688975|NCT00540904|contrast|contrast
5688976|NCT00540904|nephropathy|nephropathy
5688977|NCT00540904|bicarbonate|bicarbonate
5688978|NCT00540904|prevention|prevention
5688979|NCT00540878|Formulation Drug Study|formulation drug study
5688980|NCT00540865|Homebound Persons|homebound persons
5688981|NCT00540865|Case Management|case management
5688982|NCT00540865|Problem Solving Therapy|problem solving therapy
5688983|NCT00540852|Breast cancer receiving chemotherapy|breast cancer receiving chemotherapy
5688984|NCT00540813|bifurcation stenosis|bifurcation stenosis
5688985|NCT00540813|Patients with documented ischemia due to a de-novo bifurcation stenosis|patients with documented ischemia due to a de-novo bifurcation stenosis
5688986|NCT00540800|anthracycline pre-treated|anthracycline pre-treated
5688987|NCT00540800|chemotherapy|chemotherapy
5688988|NCT00540800|first-line|first-line
5688989|NCT00540800|metastatic breast cancer|metastatic breast cancer
5688990|NCT00540800|locally advanced breast cancer|locally advanced breast cancer
5688991|NCT00540774|oral cancer|oral cancer
5688992|NCT00540774|oral mucositis|oral mucositis
5688993|NCT00540774|oral stomatitis|oral stomatitis
5688994|NCT00540774|Dry mouth|dry mouth
5688995|NCT00540774|Gingivitis|gingivitis
5688996|NCT00540761|Coronary Artery Disease|coronary artery disease
5688997|NCT00540761|Atherosclerosis|atherosclerosis
5688998|NCT00540748|first trimester abortion|first trimester abortion
5688999|NCT00540748|oxytocin|oxytocin
5689000|NCT00540696|Anemia|anemia
5689001|NCT00540696|Non-Myeloid Malignancies|non-myeloid malignancies
5689002|NCT00540696|darbepoetin alfa|darbepoetin alfa
5689003|NCT00540696|chemotherapy|chemotherapy
5689004|NCT00540670|Coronary artery disease|coronary artery disease
5689005|NCT00540644|Multiple Myeloma|multiple myeloma
5689006|NCT00540644|Revlimid|revlimid
5689007|NCT00540631|House Dust Mite Allergen|house dust mite allergen
5689008|NCT00540631|Aluminium hydroxide-adsorbed|aluminium hydroxide-adsorbed
5689009|NCT00540605|Microbicide|microbicide
5689010|NCT00540605|Pregnancy|pregnancy
5689011|NCT00540605|HIV Seronegativity|hiv seronegativity
5689012|NCT00540592|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
5689013|NCT00540592|Influenza infection|influenza infection
5689014|NCT00540592|Fluarix|fluarix
5689015|NCT00540579|Pancreas|pancreas
5689016|NCT00540579|Untreated|untreated
5689017|NCT00540579|Advanced|advanced
5689018|NCT00540579|Gemcitabine|gemcitabine
5689019|NCT00540579|CC-4047|cc-4047
5689020|NCT00540553|SARM,|sarm,
5689021|NCT00540553|FTIH,|ftih,
5689022|NCT00540553|pharmacokinetics|pharmacokinetics
5689023|NCT00540527|acute ischemic stroke;thrombolysis;intraarterial thrombolysis|acute ischemic stroke;thrombolysis;intraarterial thrombolysis
5689024|NCT00540514|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5689025|NCT00540501|zanamivir,|zanamivir,
5689026|NCT00540501|influenza virus,|influenza virus,
5689027|NCT00540501|healthy volunteer,|healthy volunteer,
5689028|NCT00540501|PK, drug interaction,|pk, drug interaction,
5689029|NCT00540501|IV, and oseltamivir.|iv, and oseltamivir.
5689030|NCT00540475|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5690862|NCT00534599|anxiety|anxiety
5689031|NCT00540475|Interstitial Lung Disease|interstitial lung disease
5689032|NCT00540462|Type II Diabetes Mellitus|type ii diabetes mellitus
5689033|NCT00540462|Gastric bypass|gastric bypass
5689034|NCT00540462|Obese-related diabetes mellitus|obese-related diabetes mellitus
5689035|NCT00540462|Sugar control|sugar control
5689036|NCT00540462|treatment of obesity related diabetes mellitus|treatment of obesity related diabetes mellitus
5689037|NCT00540449|TMC278-C209|tmc278-c209
5689038|NCT00540449|Antiretroviral|antiretroviral
5689039|NCT00540449|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5689042|NCT00540449|TMC278-TiDP6-C209|tmc278-tidp6-c209
5689043|NCT00540449|Treatment Naive|treatment naive
5689044|NCT00540436|Ambrisentan|ambrisentan
5689045|NCT00540436|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5689046|NCT00540436|6MWD|6mwd
5689047|NCT00540423|thrombopoietin,|thrombopoietin,
5689048|NCT00540423|immunosuppressive therapy,|immunosuppressive therapy,
5689049|NCT00540423|eltrombopag,|eltrombopag,
5689050|NCT00540423|idiopathic thrombocytopenic purpura,|idiopathic thrombocytopenic purpura,
5696329|NCT00513448|Physical Activity|physical activity
5689051|NCT00540423|blood platelet,|blood platelet,
5689052|NCT00540423|splenectomy|splenectomy
5689053|NCT00540384|Anemia|anemia
5689054|NCT00540384|Solid tumors|solid tumors
5689055|NCT00540384|Multicycle chemotherapy|multicycle chemotherapy
5689056|NCT00540384|NESP|nesp
5689057|NCT00540371|Port Wine Stain|port wine stain
5689058|NCT00540358|Triple negative breast cancer|triple negative breast cancer
5689059|NCT00540345|chronic hepatitis C|chronic hepatitis c
5689060|NCT00540345|genotype 2|genotype 2
5689061|NCT00540345|rapid virological response|rapid virological response
5689062|NCT00540345|sustained virological response|sustained virological response
5689063|NCT00540345|peginterferon|peginterferon
5689064|NCT00540345|ribavirin|ribavirin
5690778|NCT00535028|IL-13|il-13
5689065|NCT00540345|treatment duration|treatment duration
5689066|NCT00540332|Oncology|oncology
5689067|NCT00540332|KGF|kgf
5689068|NCT00540332|HNC|hnc
5689069|NCT00540332|head and neck|head and neck
5689070|NCT00540332|oral mucositis|oral mucositis
5689071|NCT00540332|OM|om
5689072|NCT00540332|proteinurea|proteinurea
5689073|NCT00540332|palifermin|palifermin
5689074|NCT00540332|clinical trial|clinical trial
5689075|NCT00540319|Risky behaviors|risky behaviors
5689076|NCT00540319|Prenatal care|prenatal care
5689077|NCT00540319|Substance use|substance use
5689078|NCT00540319|Domestic violence|domestic violence
5689079|NCT00540306|breast tissue|breast tissue
5689080|NCT00540280|NSCLC|nsclc
5689081|NCT00540267|Schizophrenia|schizophrenia
5689082|NCT00540267|Alcohol Abuse|alcohol abuse
5689084|NCT00540254|Chronic Fatigue|chronic fatigue
5689085|NCT00540254|Insomnia|insomnia
5689086|NCT00540254|Cognitive Behavioral Therapy|cognitive behavioral therapy
5689087|NCT00540228|Influenza|influenza
5689088|NCT00540228|Influenza Vaccine|influenza vaccine
5689089|NCT00540202|Effectiveness|effectiveness
5689090|NCT00540202|Oral quinine|oral quinine
5689092|NCT00540202|Uncomplicated malaria|uncomplicated malaria
5689093|NCT00540202|Children|children
5689094|NCT00540189|appendicitis, perforated, children|appendicitis, perforated, children
5689095|NCT00540176|Dichloroacetate|dichloroacetate
5689096|NCT00540176|Glioblastoma Multiforme|glioblastoma multiforme
5689097|NCT00540176|Glioma|glioma
5689098|NCT00540150|Immunotherapy|immunotherapy
5689099|NCT00540150|Mite|mite
5689100|NCT00540150|Asthma|asthma
5689101|NCT00540150|bronchial provocation|bronchial provocation
5689102|NCT00540150|SIT|sit
5689103|NCT00540150|specific immunotherapy|specific immunotherapy
5689104|NCT00540137|Antiretroviral therapy|antiretroviral therapy
5689105|NCT00540137|Neurocognitive function|neurocognitive function
5689106|NCT00540137|Magnetic resonance spectroscopy|magnetic resonance spectroscopy
5689107|NCT00540137|HIV disease|hiv disease
5689108|NCT00540137|Treatment Naive|treatment naive
5689109|NCT00540111|Soluble fiber|soluble fiber
5689110|NCT00540111|HIV/aids|hiv/aids
5689111|NCT00540111|Hypertriglyceridemia|hypertriglyceridemia
5689112|NCT00540111|Cytokines|cytokines
5689113|NCT00540111|Alternative Medicine|alternative medicine
5689114|NCT00540111|Complementary Medicine|complementary medicine
5689115|NCT00540098|panic disorder|panic disorder
5689116|NCT00540098|pharmacotherapy|pharmacotherapy
5689117|NCT00540098|non-pharmacological treatment|non-pharmacological treatment
5689118|NCT00540098|SSRI|ssri
5689119|NCT00540098|paroxetine|paroxetine
5689120|NCT00540098|exercise|exercise
5689121|NCT00540072|Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
5689122|NCT00540059|Prostate carcinoma|prostate carcinoma
5689123|NCT00540059|LHRH|lhrh
5689124|NCT00540059|Zoladex|zoladex
5689125|NCT00540046|IUD|iud
5689126|NCT00540046|Second trimester termination|second trimester termination
5689127|NCT00540046|Contraception|contraception
5689128|NCT00540033|probiotics|probiotics
5689129|NCT00540033|necrotizing enterocolitis|necrotizing enterocolitis
5689130|NCT00540033|preterm very low birth weight infants (VLBW)|preterm very low birth weight infants (vlbw)
5689131|NCT00540020|Brain Injuries|brain injuries
5689132|NCT00540020|Cognition|cognition
5689133|NCT00540020|Randomized Trials|randomized trials
5689134|NCT00540020|Rehabilitation|rehabilitation
5689135|NCT00540020|Treatment Outcome|treatment outcome
5689136|NCT00540007|Hodgkin Lymphoma|hodgkin lymphoma
5689137|NCT00540007|Lenalidomide|lenalidomide
5689138|NCT00540007|Anti-neoplastic agents|anti-neoplastic agents
5689139|NCT00540007|Thalidomide|thalidomide
5689140|NCT00539994|Altabax|altabax
5689142|NCT00539994|retapamulin|retapamulin
5689143|NCT00539994|nasal colonization|nasal colonization
5689144|NCT00539994|PK|pk
5689145|NCT00539994|tolerability|tolerability
5689146|NCT00539994|safety|safety
5689147|NCT00539994|efficacy|efficacy
5689148|NCT00539981|Influenza|influenza
5689149|NCT00539955|intimate partner violence|intimate partner violence
5689150|NCT00539955|alcohol use|alcohol use
5689151|NCT00539955|substance use|substance use
5689152|NCT00539942|Randomized Clinical Trials|randomized clinical trials
5689153|NCT00539942|Randomized Controlled Trial|randomized controlled trial
5689154|NCT00539942|Venous thrombosis|venous thrombosis
5689155|NCT00539942|Anticoagulant Drugs|anticoagulant drugs
5689156|NCT00539942|Doppler Ultrasound|doppler ultrasound
5689157|NCT00539942|Postoperative complications|postoperative complications
5689158|NCT00539903|Activity Level|activity level
5689159|NCT00539877|Gstric cancer|gstric cancer
5689160|NCT00539877|Pritoneal seeding|pritoneal seeding
5689161|NCT00539877|Intraperitoneal chemotherapy|intraperitoneal chemotherapy
5689162|NCT00539877|Irinotecan|irinotecan
5689163|NCT00539864|Influenza|influenza
5689164|NCT00539851|Allogenic Stem Cell Transplantation|allogenic stem cell transplantation
5689165|NCT00539851|Diabetes Mellitus|diabetes mellitus
5689166|NCT00539838|SLE|sle
5689167|NCT00539825|Anticholinergic,|anticholinergic,
5690779|NCT00535028|atopic|atopic
5689174|NCT00539812|substance use|substance use
5689175|NCT00539799|systemic lupus erythematosus|systemic lupus erythematosus
5689176|NCT00539799|lupus nephritis|lupus nephritis
5689177|NCT00539786|Patients with extraesophageal manifestation of gastroesophageal reflux disease|patients with extraesophageal manifestation of gastroesophageal reflux disease
5689178|NCT00539760|domain antibody|domain antibody
5689179|NCT00539760|Rheumatoid Arthritis,|rheumatoid arthritis,
5689180|NCT00539747|Presymptomatic|presymptomatic
5689181|NCT00539747|Huntington Disease|huntington disease
5689182|NCT00539747|Meaning Making|meaning making
5689183|NCT00539747|Genetic Testing|genetic testing
5689184|NCT00539747|HD|hd
5689185|NCT00539734|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5689186|NCT00539734|choroidal neovascularization membrane(CNVM)|choroidal neovascularization membrane(cnvm)
5689187|NCT00539734|ranibizumab|ranibizumab
5689188|NCT00539734|anti-vascular endothelial growth factor|anti-vascular endothelial growth factor
5689189|NCT00539734|electrophysiology|electrophysiology
5689190|NCT00539734|electroretinography|electroretinography
5689191|NCT00539721|Nausea|nausea
5689192|NCT00539721|Vomiting|vomiting
5689193|NCT00539708|Non-invasive ventilation|non-invasive ventilation
5689194|NCT00539708|Hypercapnic respiratory failure|hypercapnic respiratory failure
5689195|NCT00539708|Mechanical ventilation|mechanical ventilation
5689196|NCT00539708|Respiratory failure after extubation|respiratory failure after extubation
5689197|NCT00539695|Stem Cell transplant|stem cell transplant
5689198|NCT00539695|Graft verus host disease|graft verus host disease
5689199|NCT00539695|IL-2|il-2
5689200|NCT00539695|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5689201|NCT00539695|ALL|all
5689202|NCT00539695|acute myelogenous leukemia|acute myelogenous leukemia
5689203|NCT00539695|AML|aml
5689204|NCT00539695|chronic myelogenous leukemia|chronic myelogenous leukemia
5689205|NCT00539695|myelodysplastic syndrome|myelodysplastic syndrome
5689206|NCT00539695|myeloproliferative disorder|myeloproliferative disorder
5689207|NCT00539695|Hodgkin lymphoma|hodgkin lymphoma
5689208|NCT00539695|non-Hodgkin lymphoma|non-hodgkin lymphoma
5689209|NCT00539695|non-malignant diseases requiring allogeneic HSCT|non-malignant diseases requiring allogeneic hsct
5689216|NCT00539617|metastatic esophageal cancer|metastatic esophageal cancer
5689217|NCT00539617|erlotinib|erlotinib
5689218|NCT00539617|folfox|folfox
5689219|NCT00539617|advanced esophageal cancer|advanced esophageal cancer
5689220|NCT00539617|unresectable esophageal cancer|unresectable esophageal cancer
5689221|NCT00539604|Comparison study between MDCT and coronary angiography|comparison study between mdct and coronary angiography
5689222|NCT00539591|Cutaneous Melanoma|cutaneous melanoma
5689223|NCT00539565|biliary atresia|biliary atresia
5689224|NCT00539565|Kasai portoenterostomy|kasai portoenterostomy
5689225|NCT00539565|corticosteroids|corticosteroids
5689226|NCT00539513|obsessive-compulsive disorder|obsessive-compulsive disorder
5689227|NCT00539513|OCD|ocd
5689228|NCT00539513|glutamate|glutamate
5689229|NCT00539513|N-Acetylcysteine|n-acetylcysteine
5689230|NCT00539513|augmentation|augmentation
5689231|NCT00539500|Neuroblastoma|neuroblastoma
5689232|NCT00539500|ClinicMACS|clinicmacs
5689233|NCT00539500|CliniMACS|clinimacs
5689234|NCT00539500|Stem Cell Transplantation|stem cell transplantation
5689235|NCT00539500|Blood And Marrow Transplantation|blood and marrow transplantation
5689236|NCT00539500|Pediatric|pediatric
5689237|NCT00539500|Solid Tumors|solid tumors
5689238|NCT00539500|Carboplatin|carboplatin
5689239|NCT00539500|Paraplatin|paraplatin
5689240|NCT00539500|Etoposide|etoposide
5689241|NCT00539500|VePesid|vepesid
5689242|NCT00539500|Melphalan|melphalan
5689243|NCT00539500|Alkeran|alkeran
5689244|NCT00539500|CD133+ Cells|cd133+ cells
5689245|NCT00539474|ROLL trial|roll trial
5683937|NCT00562627|osteoarthritis|osteoarthritis
5689246|NCT00539474|Minimally invasive surgery|minimally invasive surgery
5689247|NCT00539474|Non palpable breast cancer|non palpable breast cancer
5689248|NCT00539435|Diabetes Mellitus|diabetes mellitus
5689249|NCT00539435|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
5689250|NCT00539435|Diabetic Cardiac Quality of Life|diabetic cardiac quality of life
5689251|NCT00539435|Cardiac Disease|cardiac disease
5689252|NCT00539422|breast cancer|breast cancer
5689253|NCT00539422|cytochrome 450|cytochrome 450
5689254|NCT00539422|CYP2D6*4|cyp2d6*4
5689255|NCT00539422|Ferritin|ferritin
5689256|NCT00539422|oxidative stress|oxidative stress
5689258|NCT00539422|cancer breast|cancer breast
5689259|NCT00539409|Diabetes Mellitus|diabetes mellitus
5689260|NCT00539409|Pulsatile Intravenous Insulin Therapy|pulsatile intravenous insulin therapy
5689261|NCT00539409|Diabetic Quality of Life|diabetic quality of life
5689262|NCT00539409|Orthostatic Hypotension|orthostatic hypotension
5689263|NCT00539409|Brittle or Labile diabetes|brittle or labile diabetes
5689264|NCT00539383|Lung cancer|lung cancer
5689265|NCT00539383|Breast cancer|breast cancer
5689266|NCT00539383|Melanoma|melanoma
5689267|NCT00539383|Hepatocellular carcinoma|hepatocellular carcinoma
5689268|NCT00539383|Brain metastases|brain metastases
5689269|NCT00539370|Scleritis|scleritis
5689270|NCT00539370|Intermediate Uveitis|intermediate uveitis
5689271|NCT00539370|Posterior Uveitis|posterior uveitis
5689272|NCT00539370|Intraocular Inflammatory Disease|intraocular inflammatory disease
5689273|NCT00539370|Data Analysis|data analysis
5689274|NCT00539370|Data Collection|data collection
5689275|NCT00539370|Sample Analysis|sample analysis
5689276|NCT00539357|Cranial Electrostimulation Therapy|cranial electrostimulation therapy
5689277|NCT00539344|Glioblastoma multiforme|glioblastoma multiforme
5689278|NCT00539344|Anaplastic astrocytoma|anaplastic astrocytoma
5689279|NCT00539344|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5689280|NCT00539331|Non-small Cell Lung Cancer|non-small cell lung cancer
5689281|NCT00539331|NSCLC|nsclc
5689282|NCT00539331|AZD2171|azd2171
5689283|NCT00539331|Paclitaxel/Carboplatin|paclitaxel/carboplatin
5689284|NCT00539331|Non-small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5689285|NCT00539305|selective androgen receptor modulators (SARMs)|selective androgen receptor modulators (sarms)
5689286|NCT00539305|hormone replacement therapy|hormone replacement therapy
5689287|NCT00539305|age-associated cognitive decline|age-associated cognitive decline
5848035|NCT00036582|Clozapine|clozapine
5689288|NCT00539305|testosterone supplementation|testosterone supplementation
5689289|NCT00539292|pediatrics|pediatrics
5689290|NCT00539292|gastroschisis|gastroschisis
5689291|NCT00539292|silastic spring-loaded silo|silastic spring-loaded silo
5689292|NCT00539279|Cognitive- Behavior Therapy|cognitive- behavior therapy
5689293|NCT00539279|Combat Disorders|combat disorders
5689295|NCT00539279|Geriatrics|geriatrics
5689296|NCT00539279|Implosive therapy|implosive therapy
5689297|NCT00539279|Neuropsychological Test|neuropsychological test
5689298|NCT00539279|Post-traumatic Stress Disorder|post-traumatic stress disorder
5689299|NCT00539279|Psychotherapy|psychotherapy
5689300|NCT00539279|Randomized Controlled Trial|randomized controlled trial
5689301|NCT00539279|Relaxation techniques|relaxation techniques
5689302|NCT00539266|Claudication|claudication
5689303|NCT00539266|Critical limb ischemia|critical limb ischemia
5689304|NCT00539266|Cell therapy|cell therapy
5689305|NCT00539266|Bone marrow|bone marrow
5689306|NCT00539253|liver cancer|liver cancer
5689307|NCT00539253|transarterial chemoembolization|transarterial chemoembolization
5689308|NCT00539240|acid reflux|acid reflux
5689309|NCT00539240|acid regurgitation|acid regurgitation
5689310|NCT00539240|esophagitis|esophagitis
5689311|NCT00539240|GERD|gerd
5689312|NCT00539240|heartburn|heartburn
5689313|NCT00539240|pain|pain
5689314|NCT00539240|peptic|peptic
5689315|NCT00539227|Breast Cancer|breast cancer
5689316|NCT00539227|Nipple-Areolar Complex|nipple-areolar complex
5689317|NCT00539227|Mastectomy|mastectomy
5689318|NCT00539227|Prophylactic mastectomy|prophylactic mastectomy
5689319|NCT00539227|Immediate reconstruction|immediate reconstruction
5689320|NCT00539227|Reconstructive surgery|reconstructive surgery
5689321|NCT00539227|Questionnaire|questionnaire
5689322|NCT00539227|Survey|survey
5689324|NCT00539201|GSK706769,|gsk706769,
5689325|NCT00539201|CCR5 inhibitor,|ccr5 inhibitor,
5689326|NCT00539201|HIV|hiv
5689327|NCT00539188|Borderline Personality Disorder(BPD)|borderline personality disorder(bpd)
5689328|NCT00539188|Dialectical Behavioral Therapy (DBT)|dialectical behavioral therapy (dbt)
5689329|NCT00539188|glutamate|glutamate
5689330|NCT00539188|N-Acetylcysteine|n-acetylcysteine
5689331|NCT00539188|Borderline Personality Disorder with Self-Injurious Behavior|borderline personality disorder with self-injurious behavior
5689332|NCT00539175|diabetes mellitus|diabetes mellitus
5689333|NCT00539175|neuropathy|neuropathy
5689334|NCT00539175|diabetic neuropathy|diabetic neuropathy
5689335|NCT00539162|Ovarian Cancer|ovarian cancer
5689336|NCT00539162|CA 125 Algorithm|ca 125 algorithm
5689337|NCT00539162|Cancer Detection|cancer detection
5689338|NCT00539162|Questionnaire|questionnaire
5689340|NCT00539149|Acute otitis media|acute otitis media
5684010|NCT00562341|psa|psa
5689341|NCT00539149|Otitis media with effusion|otitis media with effusion
5689342|NCT00539149|Tympanic membrane perforation|tympanic membrane perforation
5689344|NCT00539136|Pharmacokinetic,|pharmacokinetic,
5689345|NCT00539136|healthy volunteers,|healthy volunteers,
5689346|NCT00539136|Gamma Scintigraphy,|gamma scintigraphy,
5689347|NCT00539136|PillCam™,|pillcam™,
5689348|NCT00539136|acoustic vest|acoustic vest
5689349|NCT00539123|buprenorphine|buprenorphine
5689350|NCT00539123|drug counseling|drug counseling
5689351|NCT00539123|HIV risk reduction counseling|hiv risk reduction counseling
5689352|NCT00539097|pediatrics|pediatrics
5689353|NCT00539084|microneedles|microneedles
5689354|NCT00539084|microneedle|microneedle
5689355|NCT00539084|intradermal|intradermal
5696582|NCT00512616|Depression|depression
5689356|NCT00539071|schizophrenia|schizophrenia
5689357|NCT00539071|schizoaffective disorder|schizoaffective disorder
5689358|NCT00539071|long acting injectable|long acting injectable
5689359|NCT00539071|treatment resistant|treatment resistant
5689360|NCT00539045|myocardial infarction, thrombus|myocardial infarction, thrombus
5689361|NCT00539032|N. meningitidis|n. meningitidis
5689362|NCT00539032|Meningitis|meningitis
5689363|NCT00539032|Meningococcemia|meningococcemia
5689364|NCT00539019|nutrition assessment|nutrition assessment
5689365|NCT00539019|pediatric|pediatric
5689366|NCT00539006|fluticasone propionate|fluticasone propionate
5689367|NCT00539006|seasonal allergic rhinitis|seasonal allergic rhinitis
5689368|NCT00539006|fluticasone furoate|fluticasone furoate
5689369|NCT00539006|experience|experience
5689370|NCT00539006|GW685698X|gw685698x
5689371|NCT00539006|preference|preference
5689372|NCT00538980|Polycythemia Vera|polycythemia vera
5689374|NCT00538980|P Vera|p vera
5689375|NCT00538967|Collagenases|collagenases
5689376|NCT00538967|MMP|mmp
5689377|NCT00538967|Cathepsins|cathepsins
5689378|NCT00538967|Doxycycline|doxycycline
5689379|NCT00538967|Aneurysm|aneurysm
5689380|NCT00538954|Perioperative|perioperative
5689381|NCT00538954|recovery|recovery
5689382|NCT00538954|nutrition|nutrition
5689383|NCT00538954|enhanced|enhanced
5689384|NCT00538954|laxative|laxative
5689385|NCT00538941|chocolate,|chocolate,
5689386|NCT00538941|heart failure,|heart failure,
5689387|NCT00538941|endothelial function,|endothelial function,
5689388|NCT00538941|platelet adhesion,|platelet adhesion,
5689389|NCT00538941|oxidative stress,|oxidative stress,
5689390|NCT00538941|baroreceptor function,|baroreceptor function,
5689391|NCT00538928|acute respiratory distress syndrome|acute respiratory distress syndrome
5689392|NCT00538928|extracorporeal lung support|extracorporeal lung support
5689393|NCT00538928|hypoxia|hypoxia
5689394|NCT00538928|hypercapnia|hypercapnia
5689395|NCT00538928|acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5689396|NCT00538915|immunodeficiency|immunodeficiency
5689397|NCT00538915|humoral immunity|humoral immunity
5689398|NCT00538915|antibody deficiency|antibody deficiency
5689399|NCT00538915|PID|pid
5689400|NCT00538915|PIDD|pidd
5689401|NCT00538902|Humira, methotrexate|humira, methotrexate
5689402|NCT00538889|Adult|adult
5689403|NCT00538850|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5689404|NCT00538850|pain|pain
5689405|NCT00538850|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5689406|NCT00538850|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5689407|NCT00538850|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5689408|NCT00538850|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5689409|NCT00538850|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5689410|NCT00538850|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5689411|NCT00538850|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5689412|NCT00538850|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5689413|NCT00538850|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5689414|NCT00538850|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5689415|NCT00538850|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5689416|NCT00538850|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5689417|NCT00538850|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5689418|NCT00538850|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5689419|NCT00538850|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5689420|NCT00538850|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5689421|NCT00538850|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5689422|NCT00538850|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5689423|NCT00538850|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5689424|NCT00538850|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5684120|NCT00561808|IVM|ivm
5689425|NCT00538850|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5689426|NCT00538850|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5689428|NCT00538850|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5689429|NCT00538850|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5689430|NCT00538850|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5689431|NCT00538850|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5689432|NCT00538850|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5689433|NCT00538850|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5685692|NCT00555113|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5689434|NCT00538850|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5689435|NCT00538850|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5689436|NCT00538850|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5689437|NCT00538850|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5689438|NCT00538850|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5689439|NCT00538850|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5689440|NCT00538850|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5689441|NCT00538850|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5689442|NCT00538850|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5689443|NCT00538850|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5689444|NCT00538850|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5689445|NCT00538850|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5689446|NCT00538850|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5689447|NCT00538850|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5689448|NCT00538850|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5689449|NCT00538850|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5689450|NCT00538850|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5689451|NCT00538850|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5689452|NCT00538850|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5689453|NCT00538850|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5689454|NCT00538850|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5689455|NCT00538850|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5689456|NCT00538850|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5689457|NCT00538850|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5689458|NCT00538850|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5689459|NCT00538850|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5689460|NCT00538850|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5689461|NCT00538850|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5689462|NCT00538850|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5689463|NCT00538850|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5689464|NCT00538850|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5689465|NCT00538850|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5689466|NCT00538850|stage I multiple myeloma|stage i multiple myeloma
5689467|NCT00538850|stage II multiple myeloma|stage ii multiple myeloma
5689468|NCT00538850|stage III multiple myeloma|stage iii multiple myeloma
5689469|NCT00538850|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5689470|NCT00538850|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5689471|NCT00538850|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5689472|NCT00538850|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5689473|NCT00538850|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5689474|NCT00538850|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5689475|NCT00538850|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5689476|NCT00538850|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5689477|NCT00538850|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5689478|NCT00538850|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5689479|NCT00538850|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5689480|NCT00538850|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5689481|NCT00538850|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5689482|NCT00538850|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5689483|NCT00538850|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5689484|NCT00538850|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5689485|NCT00538850|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5689486|NCT00538850|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5684183|NCT00561613|SILCS|silcs
5689488|NCT00538850|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5689489|NCT00538850|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5689490|NCT00538850|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5689491|NCT00538850|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5689492|NCT00538850|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5689493|NCT00538850|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5689494|NCT00538850|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5689495|NCT00538850|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5689496|NCT00538850|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5689497|NCT00538850|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5689498|NCT00538850|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5689499|NCT00538850|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5689500|NCT00538850|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5689501|NCT00538850|refractory multiple myeloma|refractory multiple myeloma
5689502|NCT00538850|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5689503|NCT00538850|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5689504|NCT00538850|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5689505|NCT00538850|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5689506|NCT00538850|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5689507|NCT00538850|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5689508|NCT00538850|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5689509|NCT00538850|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5689510|NCT00538850|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5689511|NCT00538850|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5689512|NCT00538850|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5689513|NCT00538850|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5689514|NCT00538850|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5689515|NCT00538850|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5689516|NCT00538850|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5689517|NCT00538850|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5689518|NCT00538850|primary myelofibrosis|primary myelofibrosis
5689519|NCT00538850|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5689520|NCT00538850|essential thrombocythemia|essential thrombocythemia
5689521|NCT00538850|polycythemia vera|polycythemia vera
5689522|NCT00538850|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5689523|NCT00538850|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5689524|NCT00538850|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5689525|NCT00538850|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5689526|NCT00538850|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5689527|NCT00538850|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5689528|NCT00538850|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5689529|NCT00538850|acute undifferentiated leukemia|acute undifferentiated leukemia
5689530|NCT00538850|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5689531|NCT00538850|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5689532|NCT00538850|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5689929|NCT00538655|modafinil|modafinil
5689533|NCT00538850|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5689534|NCT00538850|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5689535|NCT00538850|refractory hairy cell leukemia|refractory hairy cell leukemia
5689536|NCT00538850|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5689537|NCT00538850|prolymphocytic leukemia|prolymphocytic leukemia
5689538|NCT00538850|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5689539|NCT00538850|Waldenström macroglobulinemia|waldenström macroglobulinemia
5689540|NCT00538850|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5689541|NCT00538850|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5689542|NCT00538850|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5689543|NCT00538850|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5689544|NCT00538850|extramedullary plasmacytoma|extramedullary plasmacytoma
5689545|NCT00538850|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5689546|NCT00538850|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5689547|NCT00538850|primary systemic amyloidosis|primary systemic amyloidosis
5689548|NCT00538850|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5685154|NCT00557440|Indacaterol|indacaterol
5689549|NCT00538850|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5689550|NCT00538850|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5689551|NCT00538850|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5689552|NCT00538850|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5689553|NCT00538850|intraocular lymphoma|intraocular lymphoma
5689554|NCT00538850|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5689555|NCT00538850|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5689556|NCT00538850|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5689557|NCT00538850|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5688200|NCT00544232|pCR rates|pcr rates
5689558|NCT00538850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5689559|NCT00538850|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5689560|NCT00538850|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5689561|NCT00538850|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5689674|NCT00538850|adult anaplastic ependymoma|adult anaplastic ependymoma
5689562|NCT00538850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5689563|NCT00538850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5689564|NCT00538850|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5689565|NCT00538850|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5689566|NCT00538850|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5689567|NCT00538850|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5689568|NCT00538850|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5689569|NCT00538850|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5689570|NCT00538850|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5689571|NCT00538850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5689572|NCT00538850|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5689573|NCT00538850|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5689574|NCT00538850|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5689575|NCT00538850|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5798864|NCT00110786|Environmental Exposure Chamber|environmental exposure chamber
5689576|NCT00538850|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5689577|NCT00538850|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5689578|NCT00538850|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5689579|NCT00538850|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5689580|NCT00538850|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5689581|NCT00538850|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5689582|NCT00538850|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5689583|NCT00538850|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5689584|NCT00538850|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5689585|NCT00538850|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5689586|NCT00538850|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5689587|NCT00538850|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5689588|NCT00538850|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5863041|NCT00001410|Lysosomal Disorder|lysosomal disorder
5680489|NCT00577798|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5680490|NCT00577798|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5680491|NCT00577798|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5680492|NCT00577798|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5689589|NCT00538850|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5689590|NCT00538850|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5689591|NCT00538850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5689592|NCT00538850|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5689593|NCT00538850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5689594|NCT00538850|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5689595|NCT00538850|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5689596|NCT00538850|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5689597|NCT00538850|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5689598|NCT00538850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5689599|NCT00538850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5689600|NCT00538850|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5689601|NCT00538850|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5689602|NCT00538850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5689603|NCT00538850|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5689604|NCT00538850|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5688322|NCT00544102|Lupus|lupus
5689605|NCT00538850|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5689606|NCT00538850|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5689607|NCT00538850|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5689608|NCT00538850|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5689609|NCT00538850|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5689610|NCT00538850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5689611|NCT00538850|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5689612|NCT00538850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5689613|NCT00538850|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5689614|NCT00538850|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5689615|NCT00538850|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5689616|NCT00538850|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5689617|NCT00538850|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5689618|NCT00538850|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5689619|NCT00538850|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5689620|NCT00538850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5689621|NCT00538850|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5689622|NCT00538850|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5689623|NCT00538850|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5689624|NCT00538850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5689625|NCT00538850|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5689626|NCT00538850|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5689627|NCT00538850|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5689628|NCT00538850|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5689629|NCT00538850|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5689630|NCT00538850|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5863042|NCT00001410|Inborn Error of Metabolism|inborn error of metabolism
5689631|NCT00538850|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5689632|NCT00538850|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5689633|NCT00538850|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5689634|NCT00538850|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5689635|NCT00538850|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5689636|NCT00538850|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5689637|NCT00538850|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5689638|NCT00538850|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5689639|NCT00538850|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5689640|NCT00538850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5689641|NCT00538850|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5689642|NCT00538850|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5689643|NCT00538850|recurrent salivary gland cancer|recurrent salivary gland cancer
5689644|NCT00538850|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5689645|NCT00538850|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5689646|NCT00538850|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5689647|NCT00538850|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5689648|NCT00538850|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5689649|NCT00538850|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5689650|NCT00538850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5689651|NCT00538850|stage I salivary gland cancer|stage i salivary gland cancer
5689652|NCT00538850|stage II salivary gland cancer|stage ii salivary gland cancer
5689653|NCT00538850|stage III salivary gland cancer|stage iii salivary gland cancer
5689654|NCT00538850|stage IV salivary gland cancer|stage iv salivary gland cancer
5689655|NCT00538850|adult grade I meningioma|adult grade i meningioma
5689656|NCT00538850|adult choroid plexus tumor|adult choroid plexus tumor
5689658|NCT00538850|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5689659|NCT00538850|adult diffuse astrocytoma|adult diffuse astrocytoma
5689660|NCT00538850|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5689661|NCT00538850|adult pineocytoma|adult pineocytoma
5689662|NCT00538850|adult ependymoma|adult ependymoma
5689663|NCT00538850|adult subependymoma|adult subependymoma
5689664|NCT00538850|adult oligodendroglioma|adult oligodendroglioma
5689665|NCT00538850|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5689666|NCT00538850|meningeal melanocytoma|meningeal melanocytoma
5689667|NCT00538850|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5689668|NCT00538850|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5689669|NCT00538850|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5689670|NCT00538850|adult medulloblastoma|adult medulloblastoma
5689671|NCT00538850|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5689672|NCT00538850|adult ependymoblastoma|adult ependymoblastoma
5689673|NCT00538850|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5689675|NCT00538850|adult glioblastoma|adult glioblastoma
5689676|NCT00538850|adult gliosarcoma|adult gliosarcoma
5689677|NCT00538850|adult giant cell glioblastoma|adult giant cell glioblastoma
5689678|NCT00538850|adult grade III meningioma|adult grade iii meningioma
5689679|NCT00538850|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5689680|NCT00538850|adult pineoblastoma|adult pineoblastoma
5689681|NCT00538850|adult mixed glioma|adult mixed glioma
5689682|NCT00538850|recurrent adult brain tumor|recurrent adult brain tumor
5689683|NCT00538850|adult anaplastic meningioma|adult anaplastic meningioma
5689684|NCT00538850|adult papillary meningioma|adult papillary meningioma
5689685|NCT00538850|adult brain stem glioma|adult brain stem glioma
5689686|NCT00538850|stage IA cervical cancer|stage ia cervical cancer
5689687|NCT00538850|stage IB cervical cancer|stage ib cervical cancer
5689688|NCT00538850|stage IIA cervical cancer|stage iia cervical cancer
5689689|NCT00538850|stage IIB cervical cancer|stage iib cervical cancer
5689690|NCT00538850|stage III cervical cancer|stage iii cervical cancer
5689691|NCT00538850|stage IVA cervical cancer|stage iva cervical cancer
5689692|NCT00538850|stage IVB cervical cancer|stage ivb cervical cancer
5689693|NCT00538850|recurrent cervical cancer|recurrent cervical cancer
5689694|NCT00538850|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5689695|NCT00538850|stage I endometrial carcinoma|stage i endometrial carcinoma
5689696|NCT00538850|stage II endometrial carcinoma|stage ii endometrial carcinoma
5689697|NCT00538850|stage III endometrial carcinoma|stage iii endometrial carcinoma
5689698|NCT00538850|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5689699|NCT00538850|fallopian tube cancer|fallopian tube cancer
5689700|NCT00538850|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5689701|NCT00538850|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5689702|NCT00538850|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5689703|NCT00538850|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5689704|NCT00538850|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5689705|NCT00538850|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5689706|NCT00538850|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5689707|NCT00538850|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5689708|NCT00538850|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5689709|NCT00538850|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5689711|NCT00538850|ovarian stromal cancer|ovarian stromal cancer
5689712|NCT00538850|recurrent uterine sarcoma|recurrent uterine sarcoma
5689713|NCT00538850|stage I uterine sarcoma|stage i uterine sarcoma
5689714|NCT00538850|stage II uterine sarcoma|stage ii uterine sarcoma
5689715|NCT00538850|stage III uterine sarcoma|stage iii uterine sarcoma
5689716|NCT00538850|stage IV uterine sarcoma|stage iv uterine sarcoma
5689717|NCT00538850|recurrent colon cancer|recurrent colon cancer
5689718|NCT00538850|stage I colon cancer|stage i colon cancer
5689719|NCT00538850|stage II colon cancer|stage ii colon cancer
5689720|NCT00538850|stage III colon cancer|stage iii colon cancer
5689721|NCT00538850|stage IV colon cancer|stage iv colon cancer
5689722|NCT00538850|recurrent bladder cancer|recurrent bladder cancer
5689723|NCT00538850|recurrent gallbladder cancer|recurrent gallbladder cancer
5689724|NCT00538850|stage I bladder cancer|stage i bladder cancer
5689725|NCT00538850|stage II bladder cancer|stage ii bladder cancer
5689726|NCT00538850|stage III bladder cancer|stage iii bladder cancer
5689727|NCT00538850|stage IV bladder cancer|stage iv bladder cancer
5689728|NCT00538850|recurrent gastric cancer|recurrent gastric cancer
5689729|NCT00538850|stage I gastric cancer|stage i gastric cancer
5689730|NCT00538850|stage II gastric cancer|stage ii gastric cancer
5689731|NCT00538850|stage III gastric cancer|stage iii gastric cancer
5689732|NCT00538850|stage IV gastric cancer|stage iv gastric cancer
5689733|NCT00538850|advanced adult primary liver cancer|advanced adult primary liver cancer
5689734|NCT00538850|recurrent small intestine cancer|recurrent small intestine cancer
5689735|NCT00538850|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5689808|NCT00538850|breast cancer in situ|breast cancer in situ
5689736|NCT00538850|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5689737|NCT00538850|recurrent renal cell cancer|recurrent renal cell cancer
5689738|NCT00538850|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5689739|NCT00538850|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5689740|NCT00538850|stage I renal cell cancer|stage i renal cell cancer
5689741|NCT00538850|stage II renal cell cancer|stage ii renal cell cancer
5689742|NCT00538850|stage III renal cell cancer|stage iii renal cell cancer
5689743|NCT00538850|stage IV renal cell cancer|stage iv renal cell cancer
5689744|NCT00538850|distal urethral cancer|distal urethral cancer
5689745|NCT00538850|proximal urethral cancer|proximal urethral cancer
5689746|NCT00538850|recurrent urethral cancer|recurrent urethral cancer
5689747|NCT00538850|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5689748|NCT00538850|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
5689749|NCT00538850|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
5689750|NCT00538850|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5690099|NCT00537771|hormone receptor|hormone receptor
5689751|NCT00538850|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5689752|NCT00538850|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5689753|NCT00538850|extragonadal germ cell tumor|extragonadal germ cell tumor
5689754|NCT00538850|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5689755|NCT00538850|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5689756|NCT00538850|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5689757|NCT00538850|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5689758|NCT00538850|gastrinoma|gastrinoma
5689759|NCT00538850|insulinoma|insulinoma
5689760|NCT00538850|WDHA syndrome|wdha syndrome
5689761|NCT00538850|glucagonoma|glucagonoma
5689762|NCT00538850|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5689763|NCT00538850|somatostatinoma|somatostatinoma
5689764|NCT00538850|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5689765|NCT00538850|carcinoma of the appendix|carcinoma of the appendix
5689766|NCT00538850|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5689767|NCT00538850|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5689768|NCT00538850|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5689769|NCT00538850|localized gallbladder cancer|localized gallbladder cancer
5689770|NCT00538850|unresectable gallbladder cancer|unresectable gallbladder cancer
5689771|NCT00538850|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5689772|NCT00538850|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5689773|NCT00538850|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5689774|NCT00538850|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5689775|NCT00538850|stage I pancreatic cancer|stage i pancreatic cancer
5689776|NCT00538850|stage II pancreatic cancer|stage ii pancreatic cancer
5689777|NCT00538850|stage III pancreatic cancer|stage iii pancreatic cancer
5689778|NCT00538850|stage IV pancreatic cancer|stage iv pancreatic cancer
5689779|NCT00538850|recurrent pancreatic cancer|recurrent pancreatic cancer
5689780|NCT00538850|small intestine adenocarcinoma|small intestine adenocarcinoma
5689781|NCT00538850|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5689782|NCT00538850|small intestine lymphoma|small intestine lymphoma
5689783|NCT00538850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5689784|NCT00538850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5689785|NCT00538850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5689786|NCT00538850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5689787|NCT00538850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5689788|NCT00538850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5689789|NCT00538850|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5689790|NCT00538850|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5689791|NCT00538850|limited stage small cell lung cancer|limited stage small cell lung cancer
5689792|NCT00538850|recurrent small cell lung cancer|recurrent small cell lung cancer
5689793|NCT00538850|liver metastases|liver metastases
5689794|NCT00538850|lung metastases|lung metastases
5689795|NCT00538850|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5689797|NCT00538850|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5689798|NCT00538850|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5689799|NCT00538850|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5689800|NCT00538850|congenital mesoblastic nephroma|congenital mesoblastic nephroma
5689801|NCT00538850|stage II breast cancer|stage ii breast cancer
5689802|NCT00538850|stage IIIA breast cancer|stage iiia breast cancer
5689803|NCT00538850|stage IIIB breast cancer|stage iiib breast cancer
5689804|NCT00538850|stage IIIC breast cancer|stage iiic breast cancer
5689805|NCT00538850|stage IV breast cancer|stage iv breast cancer
5689806|NCT00538850|recurrent breast cancer|recurrent breast cancer
5689807|NCT00538850|male breast cancer|male breast cancer
5690180|NCT00537407|Hepatitis C|hepatitis c
5689809|NCT00538850|localized osteosarcoma|localized osteosarcoma
5689810|NCT00538850|metastatic osteosarcoma|metastatic osteosarcoma
5689811|NCT00538850|recurrent osteosarcoma|recurrent osteosarcoma
5689812|NCT00538850|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5689813|NCT00538850|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5689814|NCT00538850|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5689816|NCT00538850|malignant giant cell tumor of bone|malignant giant cell tumor of bone
5689817|NCT00538850|desmoid tumor|desmoid tumor
5689818|NCT00538850|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5689819|NCT00538850|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5689820|NCT00538850|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5689821|NCT00538850|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5689822|NCT00538850|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5689823|NCT00538850|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5689824|NCT00538850|advanced malignant mesothelioma|advanced malignant mesothelioma
5690202|NCT00537342|Polymerized|polymerized
5689825|NCT00538850|localized malignant mesothelioma|localized malignant mesothelioma
5689826|NCT00538850|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5689827|NCT00538850|phosphaturic mesenchymal tumor|phosphaturic mesenchymal tumor
5689828|NCT00538850|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5689829|NCT00538850|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5689830|NCT00538850|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5689831|NCT00538850|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5689832|NCT00538850|stage 0 penile cancer|stage 0 penile cancer
5689833|NCT00538850|stage I penile cancer|stage i penile cancer
5689834|NCT00538850|stage II penile cancer|stage ii penile cancer
5689835|NCT00538850|stage III penile cancer|stage iii penile cancer
5689836|NCT00538850|stage IV penile cancer|stage iv penile cancer
5689837|NCT00538850|recurrent penile cancer|recurrent penile cancer
5689838|NCT00538850|stage I prostate cancer|stage i prostate cancer
5689839|NCT00538850|stage IIB prostate cancer|stage iib prostate cancer
5689840|NCT00538850|stage IIA prostate cancer|stage iia prostate cancer
5689841|NCT00538850|stage III prostate cancer|stage iii prostate cancer
5689842|NCT00538850|stage IV prostate cancer|stage iv prostate cancer
5689843|NCT00538850|recurrent prostate cancer|recurrent prostate cancer
5689844|NCT00538850|stage 0 vaginal cancer|stage 0 vaginal cancer
5689845|NCT00538850|stage I vaginal cancer|stage i vaginal cancer
5689846|NCT00538850|stage II vaginal cancer|stage ii vaginal cancer
5689847|NCT00538850|stage III vaginal cancer|stage iii vaginal cancer
5689848|NCT00538850|stage IVA vaginal cancer|stage iva vaginal cancer
5689849|NCT00538850|stage IVB vaginal cancer|stage ivb vaginal cancer
5689850|NCT00538850|recurrent vaginal cancer|recurrent vaginal cancer
5689851|NCT00538850|stage 0 vulvar cancer|stage 0 vulvar cancer
5689852|NCT00538850|stage I vulvar cancer|stage i vulvar cancer
5689853|NCT00538850|stage II vulvar cancer|stage ii vulvar cancer
5689854|NCT00538850|stage III vulvar cancer|stage iii vulvar cancer
5689855|NCT00538850|stage IVB vulvar cancer|stage ivb vulvar cancer
5689856|NCT00538850|recurrent vulvar cancer|recurrent vulvar cancer
5689857|NCT00538850|stage 0 anal cancer|stage 0 anal cancer
5689858|NCT00538850|stage I anal cancer|stage i anal cancer
5689859|NCT00538850|stage II anal cancer|stage ii anal cancer
5689860|NCT00538850|stage IIIA anal cancer|stage iiia anal cancer
5689861|NCT00538850|stage IIIB anal cancer|stage iiib anal cancer
5689862|NCT00538850|stage IV anal cancer|stage iv anal cancer
5689863|NCT00538850|recurrent anal cancer|recurrent anal cancer
5689864|NCT00538850|stage 0 rectal cancer|stage 0 rectal cancer
5689865|NCT00538850|stage I rectal cancer|stage i rectal cancer
5689866|NCT00538850|stage II rectal cancer|stage ii rectal cancer
5689867|NCT00538850|stage III rectal cancer|stage iii rectal cancer
5689868|NCT00538850|stage IV rectal cancer|stage iv rectal cancer
5689869|NCT00538850|recurrent rectal cancer|recurrent rectal cancer
5689870|NCT00538850|stage 0 esophageal cancer|stage 0 esophageal cancer
5689871|NCT00538850|stage I esophageal cancer|stage i esophageal cancer
5689872|NCT00538850|stage II esophageal cancer|stage ii esophageal cancer
5689873|NCT00538850|stage III esophageal cancer|stage iii esophageal cancer
5689874|NCT00538850|stage IV esophageal cancer|stage iv esophageal cancer
5689875|NCT00538850|recurrent esophageal cancer|recurrent esophageal cancer
5689877|NCT00538850|stage II thymoma|stage ii thymoma
5689878|NCT00538850|stage III thymoma|stage iii thymoma
5689879|NCT00538850|stage IVA thymoma|stage iva thymoma
5689880|NCT00538850|stage IVB thymoma|stage ivb thymoma
5689881|NCT00538850|recurrent melanoma|recurrent melanoma
5689882|NCT00538850|stage 0 melanoma|stage 0 melanoma
5689883|NCT00538850|stage IA melanoma|stage ia melanoma
5689884|NCT00538850|stage IB melanoma|stage ib melanoma
5689885|NCT00538850|stage IIA melanoma|stage iia melanoma
5689886|NCT00538850|stage IIB melanoma|stage iib melanoma
5689887|NCT00538850|stage IIC melanoma|stage iic melanoma
5689888|NCT00538850|stage IIIA melanoma|stage iiia melanoma
5689889|NCT00538850|stage IIIB melanoma|stage iiib melanoma
5689890|NCT00538850|stage IIIC melanoma|stage iiic melanoma
5689891|NCT00538850|stage IV melanoma|stage iv melanoma
5689892|NCT00538824|myeloma|myeloma
5689893|NCT00538824|relapsed or refractory multiple myeloma|relapsed or refractory multiple myeloma
5689894|NCT00538798|Pharmacokinetics|pharmacokinetics
5689895|NCT00538798|Binding Potential|binding potential
5689896|NCT00538798|Glutamate|glutamate
5689897|NCT00538798|Positron Emission Tomography|positron emission tomography
5689898|NCT00538798|Metabolic Glutamate Receptors|metabolic glutamate receptors
5689899|NCT00538798|Healthy Volunteer|healthy volunteer
5689900|NCT00538798|HV|hv
5689901|NCT00538785|Synagis, motavizumab, palivizumab, children, MEDI-524, RSV, congenital hear disease|synagis, motavizumab, palivizumab, children, medi-524, rsv, congenital hear disease
5689902|NCT00538772|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5689903|NCT00538772|Biomarkers|biomarkers
5689904|NCT00538772|Biomarkers in patients with Metastatic Renal Cell Carcinoma Who Have Progressed After Sunitinib Therapy|biomarkers in patients with metastatic renal cell carcinoma who have progressed after sunitinib therapy
5689905|NCT00538759|Aortic valve stenosis|aortic valve stenosis
5689906|NCT00538759|Balloon aortic valvuloplasty|balloon aortic valvuloplasty
5689907|NCT00538759|Aortic valve restenosis|aortic valve restenosis
5689908|NCT00538733|myeloma|myeloma
5689911|NCT00538720|PHPT|phpt
5689912|NCT00538720|Parathyroid glands|parathyroid glands
5689913|NCT00538720|Vitamin D deficiency|vitamin d deficiency
5689914|NCT00538720|Vitamin D|vitamin d
5689915|NCT00538720|Ergocalciferol|ergocalciferol
5689916|NCT00538707|mental stress|mental stress
5689917|NCT00538707|platelet adhesion|platelet adhesion
5689918|NCT00538707|platelet function|platelet function
5689919|NCT00538707|catecholamines|catecholamines
5689920|NCT00538694|Moderate to severe community-acquired acute bacterial pneumonia due to S. Pneumoniae|moderate to severe community-acquired acute bacterial pneumonia due to s. pneumoniae
5689924|NCT00538655|amphetamine|amphetamine
5689925|NCT00538655|methamphetamine|methamphetamine
5689926|NCT00538655|addition|addition
5689928|NCT00538655|drug use|drug use
5689930|NCT00538642|schizophrenia|schizophrenia
5689931|NCT00538642|antipsychotics|antipsychotics
5689932|NCT00538642|diabetes|diabetes
5689933|NCT00538642|bipolar disorder|bipolar disorder
5689934|NCT00538616|Brain Injury|brain injury
5689936|NCT00538590|collagen matrix|collagen matrix
5689937|NCT00538590|glaucoma|glaucoma
5689938|NCT00538590|trabeculectomy|trabeculectomy
5689939|NCT00538590|Mitomycin-C|mitomycin-c
5689940|NCT00538577|Necrotizing fasciitis|necrotizing fasciitis
5698963|NCT00504504|BLM|blm
5689941|NCT00538564|prolonged, painful erection|prolonged, painful erection
5689942|NCT00538564|priapism|priapism
5689943|NCT00538564|sickle cell anemia|sickle cell anemia
5689944|NCT00538551|HD|hd
5689945|NCT00538551|NHL|nhl
5689946|NCT00538538|Macular Degeneration|macular degeneration
5689947|NCT00538538|AMD|amd
5689948|NCT00538538|Hemorrhage|hemorrhage
5689949|NCT00538538|Wet AMD|wet amd
5689950|NCT00538512|Influenza|influenza
5689951|NCT00538512|Live attenuated influenza vaccine|live attenuated influenza vaccine
5689952|NCT00538512|Inactivated influenza vaccine|inactivated influenza vaccine
5689953|NCT00538512|Vaccine Efficacy|vaccine efficacy
5689954|NCT00538499|pain|pain
5689955|NCT00538499|perioperative/postoperative complications|perioperative/postoperative complications
5689956|NCT00538486|Hypertension|hypertension
5689957|NCT00538486|Abdominal obesity|abdominal obesity
5689958|NCT00538486|Treatment|treatment
5689959|NCT00538473|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
5689960|NCT00538473|Influenza Infection|influenza infection
5689961|NCT00538473|Fluarix|fluarix
5689962|NCT00538460|tomography|tomography
5689963|NCT00538460|coronary artery disease|coronary artery disease
5689964|NCT00538460|magnetic resonance imaging|magnetic resonance imaging
5689965|NCT00538447|CML|cml
5689966|NCT00538434|Eosinophilic Esophagitis|eosinophilic esophagitis
5689967|NCT00538434|GERD|gerd
5689968|NCT00538434|EE|ee
5689969|NCT00538434|Reslizumab|reslizumab
5689970|NCT00538434|IL-5|il-5
5689971|NCT00538434|Interleukin-5|interleukin-5
5689972|NCT00538434|Cinquil|cinquil
5689973|NCT00538421|propofol|propofol
5689974|NCT00538421|Anaesthesia|anaesthesia
5689975|NCT00538421|Sevoflurane|sevoflurane
5689976|NCT00538421|Abdominal|abdominal
5689977|NCT00538421|Aortic|aortic
5689978|NCT00538421|Aneurysm|aneurysm
5689979|NCT00538408|Magnetic resonance|magnetic resonance
5689980|NCT00538408|whole body|whole body
5689981|NCT00538408|angiography|angiography
5689982|NCT00538408|vasovist|vasovist
5689983|NCT00538408|gadofosveset|gadofosveset
5689985|NCT00538408|blood pool agent|blood pool agent
5689986|NCT00538382|Malaria|malaria
5689987|NCT00538382|Pregnancy|pregnancy
5689988|NCT00538382|Artesunate|artesunate
5689989|NCT00538382|Pharmacokinetics|pharmacokinetics
5689990|NCT00538382|Pharmacodynamics|pharmacodynamics
5689991|NCT00538382|Democratic Republic of Congo|democratic republic of congo
5689992|NCT00538369|Nursing|nursing
5685693|NCT00555113|Visual acuity|visual acuity
5689993|NCT00538369|critical care|critical care
5689994|NCT00538369|sedation assessment|sedation assessment
5689995|NCT00538369|Bispectral index|bispectral index
5689996|NCT00538356|Heart failure|heart failure
5689997|NCT00538356|Rehospitalization:|rehospitalization:
5689998|NCT00538356|Packer composite score|packer composite score
5689999|NCT00538356|Home Monitoring|home monitoring
5690000|NCT00538356|Cardiac resynchronization therapy|cardiac resynchronization therapy
5690001|NCT00538356|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5690002|NCT00538343|brain metastases|brain metastases
5690003|NCT00538343|breast cancer|breast cancer
5690004|NCT00538317|Acute myocardial infarction,|acute myocardial infarction,
5690005|NCT00538317|GPIIbIIIa inhibitors,|gpiibiiia inhibitors,
5690006|NCT00538317|primary angioplasty,|primary angioplasty,
5690007|NCT00538317|tirofiban|tirofiban
5690008|NCT00538291|recurrent colon cancer|recurrent colon cancer
5690009|NCT00538291|stage IV colon cancer|stage iv colon cancer
5690010|NCT00538291|recurrent rectal cancer|recurrent rectal cancer
5690011|NCT00538291|stage IV rectal cancer|stage iv rectal cancer
5690013|NCT00538265|liver transplantation, hepatitis C virus, immunoprophylaxis|liver transplantation, hepatitis c virus, immunoprophylaxis
5690014|NCT00538252|drug use, antisocial behavior, early intervention, prevention|drug use, antisocial behavior, early intervention, prevention
5690015|NCT00538213|Influenza vaccine GSK576389A|influenza vaccine gsk576389a
5690016|NCT00538213|Fluarix|fluarix
5690017|NCT00538213|Influenza infection|influenza infection
5690018|NCT00538200|Nutrition|nutrition
5690019|NCT00538200|COPD|copd
5690020|NCT00538161|Acute lung injury|acute lung injury
5690021|NCT00538161|cardiac surgery|cardiac surgery
5690022|NCT00538161|The incidence of ARDS after elective cardiac surgery is 1-3%|the incidence of ards after elective cardiac surgery is 1-3%
5690023|NCT00538161|The impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.|the impairment of lung function and oxygenation may occur in 20-80% of patients undergoing surgery.
5690024|NCT00538161|The purpose of this study is to assess the efficacy of low tidal volume ventilation.|the purpose of this study is to assess the efficacy of low tidal volume ventilation.
5707013|NCT00475956|Liver Cancer|liver cancer
5707014|NCT00475956|Myeloma|myeloma
5707015|NCT00475956|Ovarian Cancer|ovarian cancer
5707016|NCT00475956|Pancreatic Cancer|pancreatic cancer
5690025|NCT00538161|Reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.|reducing interleukin and cytokine production may prevent or reduce the incidence of acute lung injury.
5690026|NCT00538135|randomised controlled trial|randomised controlled trial
5690027|NCT00538135|borderline personality disorder|borderline personality disorder
5690028|NCT00538135|cognitive behavioural therapy|cognitive behavioural therapy
5690029|NCT00538135|treatment as usual|treatment as usual
5690030|NCT00538122|schizophrenia|schizophrenia
5690031|NCT00538122|schizoaffective disorder|schizoaffective disorder
5690032|NCT00538122|bipolar disorder|bipolar disorder
5690033|NCT00538122|antipsychotic drug treatment|antipsychotic drug treatment
5690034|NCT00538122|safety|safety
5690035|NCT00538122|arrythmias|arrythmias
5690036|NCT00538109|CML in Blast Crisis|cml in blast crisis
5690037|NCT00538109|Accelerated Phase oe Chronic Phase|accelerated phase oe chronic phase
5690038|NCT00538096|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5690039|NCT00538083|Cocoa|cocoa
5690040|NCT00538083|Overweight adults|overweight adults
5690041|NCT00538083|Endothelial function|endothelial function
5690042|NCT00538083|Blood pressure|blood pressure
5690043|NCT00538083|Cardiovascular disease risk|cardiovascular disease risk
5690044|NCT00538083|Dark chocolate|dark chocolate
5690045|NCT00538083|Sugar|sugar
5690046|NCT00538070|Sarcosine|sarcosine
5690047|NCT00538070|Glycine|glycine
5690048|NCT00538070|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5690049|NCT00538070|Schizophrenia|schizophrenia
5690050|NCT00538057|Healthy volunteers|healthy volunteers
5690051|NCT00538044|pulmonary hypertension|pulmonary hypertension
5690052|NCT00538044|simvastatin|simvastatin
5690053|NCT00538044|advanced pulmonary hypertension secondary to congenital heart disease|advanced pulmonary hypertension secondary to congenital heart disease
5690054|NCT00538044|advanced pulmonary hypertension secondary to chronic pulmonary embolism|advanced pulmonary hypertension secondary to chronic pulmonary embolism
5690055|NCT00538005|recurrent melanoma|recurrent melanoma
5690056|NCT00538005|stage IV melanoma|stage iv melanoma
5690057|NCT00537992|combined surgery,|combined surgery,
5690058|NCT00537992|cataract surgery,|cataract surgery,
5690060|NCT00537992|blue light-filter iols|blue light-filter iols
5690061|NCT00537979|Dialysis|dialysis
5690062|NCT00537979|Hyperparathyroidism|hyperparathyroidism
5690063|NCT00537979|Zemplar|zemplar
5690064|NCT00537966|Primary HIV Infection|primary hiv infection
5690065|NCT00537953|Leishmaniasis|leishmaniasis
5690066|NCT00537953|Cutaneous leishmaniasis|cutaneous leishmaniasis
5690067|NCT00537953|Miltefosine|miltefosine
5690068|NCT00537953|Glucantime|glucantime
5690069|NCT00537953|Antimony|antimony
5690070|NCT00537953|Pentavalent antimonials|pentavalent antimonials
5690071|NCT00537953|Combination therapy|combination therapy
5690072|NCT00537927|laparoscopic correction|laparoscopic correction
5690073|NCT00537927|ventral and incisional hernia|ventral and incisional hernia
5690074|NCT00537927|mesh fixation|mesh fixation
5690075|NCT00537927|postoperative pain|postoperative pain
5690076|NCT00537914|Small for Gestational Age, Omnitrope®/Somatropin, rhGH,SGA|small for gestational age, omnitrope®/somatropin, rhgh,sga
5690077|NCT00537901|Colon and Rectum Cancer|colon and rectum cancer
5690078|NCT00537862|Kidney Transplant Patients|kidney transplant patients
5690079|NCT00537862|Immunosuppresion|immunosuppresion
5690080|NCT00537862|Enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5690081|NCT00537836|Hot flushes|hot flushes
5690082|NCT00537836|Therapy of hot flushes|therapy of hot flushes
5690083|NCT00537836|17ß-estradiol (E2)|17ß-estradiol (e2)
5690084|NCT00537836|Hormone replacement therapy|hormone replacement therapy
5690085|NCT00537823|Colorectal Cancer|colorectal cancer
5690086|NCT00537823|Metastasis|metastasis
5690087|NCT00537823|Neoadjuvant Therapy|neoadjuvant therapy
5690088|NCT00537810|Obesity|obesity
5690089|NCT00537810|Binge eating|binge eating
5690090|NCT00537810|Sibutramine|sibutramine
5690091|NCT00537810|Self-help|self-help
5690092|NCT00537810|Primary care|primary care
5690093|NCT00537797|Thyroid Neoplasms|thyroid neoplasms
5690094|NCT00537797|Positron Emission Tomography|positron emission tomography
5690095|NCT00537797|18FDG|18fdg
5690096|NCT00537784|platelets tendon ligament|platelets tendon ligament
5690097|NCT00537771|Early Breast cancer|early breast cancer
5690098|NCT00537771|adjuvant therapy|adjuvant therapy
5690100|NCT00537771|hormonal therapy|hormonal therapy
5690101|NCT00537771|anastrozole|anastrozole
5690102|NCT00537771|tamoxifen|tamoxifen
5690103|NCT00537758|binge eating disorder|binge eating disorder
5690104|NCT00537758|cognitive behavior therapy|cognitive behavior therapy
5690105|NCT00537758|combination therapy|combination therapy
5690106|NCT00537758|obesity|obesity
5690107|NCT00537758|weight loss|weight loss
5690108|NCT00537758|body weight|body weight
5690109|NCT00537758|clinical trial|clinical trial
5690110|NCT00537758|dietary restriction|dietary restriction
5690111|NCT00537758|overeating|overeating
5690112|NCT00537758|weight control|weight control
5690113|NCT00537732|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5690114|NCT00537719|healthy|healthy
5690115|NCT00537719|pharmacodynamics|pharmacodynamics
5690116|NCT00537719|glucagon-like peptide 1|glucagon-like peptide 1
5690117|NCT00537719|pharmacokinetics|pharmacokinetics
5690118|NCT00537719|scintigraphy|scintigraphy
5690119|NCT00537719|radiation|radiation
5690120|NCT00537719|albiglutide|albiglutide
5690121|NCT00537706|Socioeconomic Determinants|socioeconomic determinants
5690122|NCT00537706|Health Status|health status
5690123|NCT00537706|Low-income|low-income
5690124|NCT00537706|Priority-setting|priority-setting
5690125|NCT00537706|Group Discussion|group discussion
5690126|NCT00537693|Continuous Renal Replacement Therapy (CRRT)|continuous renal replacement therapy (crrt)
5690127|NCT00537693|Sepsis|sepsis
5690128|NCT00537693|Convection|convection
5690129|NCT00537693|Diffusion|diffusion
5690130|NCT00537680|Friedreich's Ataxia|friedreich's ataxia
5690131|NCT00537680|Idebenone|idebenone
5690132|NCT00537680|ICARS|icars
5690133|NCT00537667|IL-1ra|il-1ra
5690134|NCT00537667|PEG sTNF-RI|peg stnf-ri
5690135|NCT00537667|Synovial biopsy|synovial biopsy
5690136|NCT00537667|Inflammation|inflammation
5690137|NCT00537667|Bone and Cartilage Destruction|bone and cartilage destruction
5690138|NCT00537667|Rheumatoid Arthritis|rheumatoid arthritis
5690139|NCT00537654|benign prostatic hyperplasia,|benign prostatic hyperplasia,
5690140|NCT00537654|AVODART,|avodart,
5690141|NCT00537654|FLOMAX|flomax
5690142|NCT00537641|noninvasive ventilation|noninvasive ventilation
5690143|NCT00537602|cystic fibrosis|cystic fibrosis
5690144|NCT00537602|miglustat|miglustat
5690145|NCT00537602|Zavesca|zavesca
5690146|NCT00537602|Actelion|actelion
5690147|NCT00537602|nasal potential difference|nasal potential difference
5690148|NCT00537602|transmembrane conductance regulator (CFTR)|transmembrane conductance regulator (cftr)
5690149|NCT00537589|arthrocentesis|arthrocentesis
5690150|NCT00537589|ultrasound|ultrasound
5690151|NCT00537589|emergency|emergency
5690152|NCT00537550|ALL|all
5690153|NCT00537550|Adult|adult
5690154|NCT00537537|Hepatitis B, Chronic, Hepatitis B e Antigen positive, Adults, Telbivudine, Adefovir|hepatitis b, chronic, hepatitis b e antigen positive, adults, telbivudine, adefovir
5690155|NCT00537524|Bird flu|bird flu
5690156|NCT00537524|seasonal influenza vaccine|seasonal influenza vaccine
5690157|NCT00537524|influenza vaccine|influenza vaccine
5690158|NCT00537524|prepandemic vaccine|prepandemic vaccine
5690159|NCT00537524|virus strain with the potential to cause pandemic|virus strain with the potential to cause pandemic
5690161|NCT00537524|children|children
5690162|NCT00537524|adolescents|adolescents
5690163|NCT00537498|urokinase, diabetes, wound healing, major amputation|urokinase, diabetes, wound healing, major amputation
5690164|NCT00537485|SPM 962|spm 962
5690165|NCT00537485|rotigotine|rotigotine
5690166|NCT00537485|Parkinson's disease|parkinson's disease
5690167|NCT00537485|monotherapy|monotherapy
5690168|NCT00537472|Bupivacaine|bupivacaine
5690169|NCT00537472|spinal anesthesia|spinal anesthesia
5690170|NCT00537472|total knee arthroplasty|total knee arthroplasty
5690171|NCT00537459|Premature ejaculation (PE) ejaculatory latency time (ELT)|premature ejaculation (pe) ejaculatory latency time (elt)
5690172|NCT00537446|noninvasive ventilation|noninvasive ventilation
5685694|NCT00555113|Choroidal neovascularization|choroidal neovascularization
5685695|NCT00555113|angioid streaks|angioid streaks
5685696|NCT00555087|Erectile dysfunction|erectile dysfunction
5685697|NCT00555087|Hypogonadotrophic males|hypogonadotrophic males
5690173|NCT00537433|Medication errors|medication errors
5690174|NCT00537433|Patient nonadherence|patient nonadherence
5690175|NCT00537433|Literacy|literacy
5690176|NCT00537433|Communication|communication
5690177|NCT00537420|weight loss|weight loss
5690178|NCT00537420|dieting|dieting
5690179|NCT00537407|Hepatitis|hepatitis
5690181|NCT00537394|Treatment Experienced|treatment experienced
5690182|NCT00537381|Prostatic neoplasms|prostatic neoplasms
5690183|NCT00537381|CNTO 95|cnto 95
5690184|NCT00537381|Intetumumab|intetumumab
5690185|NCT00537381|Docetaxel|docetaxel
5690186|NCT00537381|Prednisone|prednisone
5690187|NCT00537368|infusion|infusion
5690188|NCT00537368|CNTO 888|cnto 888
5690189|NCT00537368|Phase 1|phase 1
5690190|NCT00537368|solid tumor|solid tumor
5690191|NCT00537368|cancer|cancer
5690192|NCT00537355|ragweed|ragweed
5690193|NCT00537355|ragweed allergy|ragweed allergy
5690194|NCT00537355|allergy|allergy
5690195|NCT00537355|allergies|allergies
5690196|NCT00537355|allergic|allergic
5690197|NCT00537355|seasonal allergic rhinitis|seasonal allergic rhinitis
5690198|NCT00537355|allergic rhinitis|allergic rhinitis
5690199|NCT00537342|Immunotherapy|immunotherapy
5690200|NCT00537342|Allergoid|allergoid
5690201|NCT00537342|Depigmented|depigmented
5690203|NCT00537342|Allergen-extract|allergen-extract
5690204|NCT00537342|Rhinoconjunctivitis|rhinoconjunctivitis
5690205|NCT00537290|antiphospholipid syndrome|antiphospholipid syndrome
5690206|NCT00537264|health-related quality of life|health-related quality of life
5690207|NCT00537264|primary care|primary care
5690208|NCT00537264|computer-assisted instruction|computer-assisted instruction
5690209|NCT00537238|Epilepsies partial|epilepsies partial
5690210|NCT00537238|Partial Seizure Disorder|partial seizure disorder
5690211|NCT00537238|Complex Partial Seizure Disorder|complex partial seizure disorder
5690212|NCT00537238|Epilepsy|epilepsy
5690213|NCT00537225|peripheral arterial disease|peripheral arterial disease
5690214|NCT00537225|walking time|walking time
5690215|NCT00537225|lifestyle modification|lifestyle modification
5690216|NCT00537225|cardiovascular risk reduction|cardiovascular risk reduction
5690217|NCT00537225|exercise|exercise
5690218|NCT00537225|diet|diet
5690219|NCT00537225|claudication|claudication
5690220|NCT00537212|Psoriasis|psoriasis
5690221|NCT00537212|Weight loss|weight loss
5690222|NCT00537212|diet|diet
5690223|NCT00537199|Head And Neck|head and neck
5690224|NCT00537199|Oropharynx|oropharynx
5690225|NCT00537199|Oral Cancer|oral cancer
5690226|NCT00537199|OraTest|oratest
5690227|NCT00537199|OraTest Dye|oratest dye
5690228|NCT00537199|Rinse Staining Procedure|rinse staining procedure
5699225|NCT00503919|MDC|mdc
5690229|NCT00537199|Visual Examination|visual examination
5690230|NCT00537186|Congestive heart failure|congestive heart failure
5690231|NCT00537186|Anaemia|anaemia
5690232|NCT00537186|Iron oligosaccharide|iron oligosaccharide
5690233|NCT00537160|Pediatrics|pediatrics
5690234|NCT00537147|Chimeric West Nile Virus|chimeric west nile virus
5690235|NCT00537147|West Nile Virus|west nile virus
5690236|NCT00537147|Dengue Virus|dengue virus
5690237|NCT00537134|Aneurysm|aneurysm
5690238|NCT00537134|Brain|brain
5690239|NCT00537134|Unruptured|unruptured
5690240|NCT00537134|observation|observation
5690241|NCT00537134|treatment|treatment
5690242|NCT00537134|Endovascular|endovascular
5690243|NCT00537121|recurrent gastric cancer|recurrent gastric cancer
5690244|NCT00537121|stage IV gastric cancer|stage iv gastric cancer
5690245|NCT00537121|recurrent esophageal cancer|recurrent esophageal cancer
5690246|NCT00537121|stage IV esophageal cancer|stage iv esophageal cancer
5690247|NCT00537121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5690248|NCT00537121|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5690249|NCT00537121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5690250|NCT00537121|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5690251|NCT00537121|stage III gastric cancer|stage iii gastric cancer
5690252|NCT00537121|stage III esophageal cancer|stage iii esophageal cancer
5690253|NCT00537121|advanced adult primary liver cancer|advanced adult primary liver cancer
5690254|NCT00537121|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5690255|NCT00537121|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5690257|NCT00537095|follicular|follicular
5690258|NCT00537095|papillary|papillary
5690259|NCT00537082|FTY720,|fty720,
5690260|NCT00537082|MS|ms
5690261|NCT00537043|hypertension,|hypertension,
5690262|NCT00537043|carvedilol,|carvedilol,
5690263|NCT00537043|repeat-dosing|repeat-dosing
5690264|NCT00537004|primary progressive aphasia|primary progressive aphasia
5690265|NCT00537004|frontotemporal dementia|frontotemporal dementia
5690266|NCT00537004|semantic dementia|semantic dementia
5690267|NCT00537004|progressive nonfluent aphasia|progressive nonfluent aphasia
5690268|NCT00537004|progressive aphasia|progressive aphasia
5690269|NCT00537004|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5690270|NCT00536978|Lymphoma|lymphoma
5690271|NCT00536978|Leukemia|leukemia
5690272|NCT00536978|B-Cell Lymphoid Malignancies|b-cell lymphoid malignancies
5690273|NCT00536978|CLL|cll
5690274|NCT00536978|Cll/Small Lymphocytic Lymphoma|cll/small lymphocytic lymphoma
5690275|NCT00536978|Follicular Lymphoma|follicular lymphoma
5690276|NCT00536978|Mantle Cell Lymphoma|mantle cell lymphoma
5690277|NCT00536978|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5690278|NCT00536978|Splenic Lymphoma|splenic lymphoma
5690279|NCT00536978|MALT|malt
5690280|NCT00536978|Lymphoplasmacytic Lymphoma|lymphoplasmacytic lymphoma
5690281|NCT00536978|Burkitt's Lymphoma|burkitt's lymphoma
5690282|NCT00536978|ARA-C|ara-c
5690283|NCT00536978|BCNU|bcnu
5690284|NCT00536978|Campath-1H|campath-1h
5690285|NCT00536978|Cytoxan|cytoxan
5690286|NCT00536978|Etoposide|etoposide
5690287|NCT00536978|Fludarabine|fludarabine
5690288|NCT00536978|Melphalan|melphalan
5690289|NCT00536978|Rituximab|rituximab
5690290|NCT00536978|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5690291|NCT00536978|T-Cell Cell Adback|t-cell cell adback
5690292|NCT00536978|Natural Killer (NK) Cell Adback|natural killer (nk) cell adback
5690293|NCT00536965|Hyperlipidemia|hyperlipidemia
5690294|NCT00536965|Need-to-treat|need-to-treat
5690295|NCT00536965|NIS|nis
5690409|NCT00536562|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
5690376|NCT00536705|child|child
5690377|NCT00536705|transforming growth factor beta(TGF-β)|transforming growth factor beta(tgf-β)
5690296|NCT00536965|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
5690297|NCT00536952|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5690298|NCT00536952|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5798865|NCT00110721|colorectal cancer|colorectal cancer
5690299|NCT00536952|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5690300|NCT00536952|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5690301|NCT00536952|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5690302|NCT00536952|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5690303|NCT00536952|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5690304|NCT00536952|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5690305|NCT00536952|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5690306|NCT00536952|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5690307|NCT00536952|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5690308|NCT00536952|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5690309|NCT00536952|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5690310|NCT00536952|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5690311|NCT00536952|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5690312|NCT00536926|telemedicine|telemedicine
5690313|NCT00536926|lung transplantation|lung transplantation
5690314|NCT00536926|home spirometry|home spirometry
5690315|NCT00536913|Symbicort pMDI|symbicort pmdi
5690316|NCT00536913|spacer|spacer
5690317|NCT00536913|children|children
5690318|NCT00536900|Substance abuse|substance abuse
5690319|NCT00536900|Behavior therapy|behavior therapy
5690320|NCT00536900|representative payee|representative payee
5690321|NCT00536900|cocaine abuse|cocaine abuse
5690322|NCT00536900|alcohol abuse|alcohol abuse
5690323|NCT00536900|case management|case management
5690324|NCT00536900|dual diagnosis|dual diagnosis
5690325|NCT00536874|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5690326|NCT00536874|stage IA pancreatic cancer|stage ia pancreatic cancer
5690327|NCT00536874|stage IB pancreatic cancer|stage ib pancreatic cancer
5690328|NCT00536874|stage IIA pancreatic cancer|stage iia pancreatic cancer
5690329|NCT00536874|stage IIB pancreatic cancer|stage iib pancreatic cancer
5690330|NCT00536874|stage III pancreatic cancer|stage iii pancreatic cancer
5690331|NCT00536861|erlotinib|erlotinib
5690332|NCT00536861|cranial radiotherapy|cranial radiotherapy
5690333|NCT00536848|Probiotics|probiotics
5690335|NCT00536848|AIDS|aids
5690336|NCT00536848|Diarrhea|diarrhea
5690337|NCT00536848|Lactobacillus rhamnosus GR-1|lactobacillus rhamnosus gr-1
5690338|NCT00536848|Lactobacillus reuteri RC-14|lactobacillus reuteri rc-14
5690339|NCT00536848|Immune system|immune system
5690340|NCT00536848|Infectious Diseases|infectious diseases
5690341|NCT00536848|Complementary Therapies|complementary therapies
5690342|NCT00536848|Treatment Naive|treatment naive
5690343|NCT00536835|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5690344|NCT00536835|Cancer|cancer
5690345|NCT00536835|First time in human|first time in human
5690346|NCT00536835|PLK1 inhibitor|plk1 inhibitor
5690347|NCT00536835|Advanced Solid Tumor|advanced solid tumor
5690348|NCT00536835|GSK461364|gsk461364
5690349|NCT00536822|rehabilitation|rehabilitation
5690350|NCT00536822|pediatrics|pediatrics
5690351|NCT00536809|Metastatic Colorectal Cancer|metastatic colorectal cancer
5690352|NCT00536809|oxaliplatin|oxaliplatin
5690353|NCT00536809|fluoropyrimidines cancers|fluoropyrimidines cancers
5690354|NCT00536809|Advanced Colorectal Cancer|advanced colorectal cancer
5690355|NCT00536809|capecitabine|capecitabine
5690356|NCT00536809|lapatinib|lapatinib
5690357|NCT00536796|Hyperlipidemia|hyperlipidemia
5690358|NCT00536796|Need-to-treat|need-to-treat
5690359|NCT00536796|NIS|nis
5690458|NCT00536302|Knee arthritis|knee arthritis
5690459|NCT00536302|Osteoarthritis|osteoarthritis
5690360|NCT00536796|Secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PVD, etc.) and/or diabetes|secondary prevention patients with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pvd, etc.) and/or diabetes
5690361|NCT00536783|Psychiatry|psychiatry
5690362|NCT00536783|Antipsychotic|antipsychotic
5690363|NCT00536783|Psychopharmacology|psychopharmacology
5690364|NCT00536783|Clinical Trial|clinical trial
5690365|NCT00536783|Open Label|open label
5690366|NCT00536783|Schizophrenia|schizophrenia
5690367|NCT00536783|Sensory Gating|sensory gating
5690368|NCT00536783|Attention|attention
5690369|NCT00536783|Memory|memory
5690370|NCT00536731|Asthma|asthma
5690371|NCT00536731|Symbicort|symbicort
5690372|NCT00536718|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5690373|NCT00536718|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5690374|NCT00536718|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5690375|NCT00536705|asthma|asthma
5690378|NCT00536705|Leukotriene Antagonists(Montelukast)|leukotriene antagonists(montelukast)
5690379|NCT00536692|macular edema|macular edema
5690380|NCT00536692|DME|dme
5690381|NCT00536692|diabetic|diabetic
5690382|NCT00536692|mecamylamine|mecamylamine
5690383|NCT00536692|Comentis|comentis
5690384|NCT00536679|Relative Bioavailability|relative bioavailability
5690385|NCT00536679|Randomised|randomised
5690386|NCT00536679|GSK163090|gsk163090
5690387|NCT00536679|Food Effect|food effect
5690388|NCT00536666|Chronic kidney disease|chronic kidney disease
5690389|NCT00536666|Aneamia|aneamia
5690390|NCT00536666|Iron oligosaccharide|iron oligosaccharide
5690391|NCT00536666|Chronic kidney disease patients|chronic kidney disease patients
5690392|NCT00536653|prostate cancer|prostate cancer
5690393|NCT00536653|bone density|bone density
5690394|NCT00536653|osteoporosis|osteoporosis
5690395|NCT00536653|androgen antagonists|androgen antagonists
5690396|NCT00536640|Non Small Cell Lung Carcinoma (NSCLC Stage III an IV)|non small cell lung carcinoma (nsclc stage iii an iv)
5690397|NCT00536627|DNA vaccine|dna vaccine
5690398|NCT00536614|pancreatic cancer|pancreatic cancer
5690399|NCT00536614|metastatic|metastatic
5690401|NCT00536614|locally advanced pancreatic cancer|locally advanced pancreatic cancer
5690402|NCT00536575|Multiple Myeloma|multiple myeloma
5690403|NCT00536575|Relapsed|relapsed
5690404|NCT00536575|Refractory|refractory
5690405|NCT00536575|Sorafenib|sorafenib
5690406|NCT00536575|Bortezomib|bortezomib
5690407|NCT00536562|Comprehensive Cardiac Rehabilitation|comprehensive cardiac rehabilitation
5690408|NCT00536562|Randomized Controlled Trial|randomized controlled trial
5690410|NCT00536562|Mild Non-Disabling Stroke|mild non-disabling stroke
5690411|NCT00536562|Vascular Protection|vascular protection
5690412|NCT00536549|Glucose monitoring system|glucose monitoring system
5690413|NCT00536549|life style intervention|life style intervention
5690414|NCT00536536|Childhood|childhood
5690415|NCT00536536|Obesity|obesity
5690416|NCT00536536|Primary Care|primary care
5690417|NCT00536523|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5690418|NCT00536523|ovarian epithelial cancer|ovarian epithelial cancer
5690419|NCT00536523|peritoneal cavity cancer|peritoneal cavity cancer
5690420|NCT00536523|fallopian tube cancer|fallopian tube cancer
5690421|NCT00536510|High Cholesterol|high cholesterol
5690422|NCT00536510|Excess lipids|excess lipids
5690423|NCT00536497|GW842166,|gw842166,
5690424|NCT00536497|Healthy volunteers,|healthy volunteers,
5690425|NCT00536497|Inflammatory Pain.|inflammatory pain.
5690426|NCT00536484|Overactive Bladder|overactive bladder
5690427|NCT00536458|localized low grade lymphoma|localized low grade lymphoma
5690428|NCT00536458|Chemotherapy|chemotherapy
5690429|NCT00536458|Radiotherapy|radiotherapy
5690430|NCT00536458|Molecular analyses|molecular analyses
5690431|NCT00536458|primary|primary
5690432|NCT00536445|NAVA|nava
5690433|NCT00536445|Preterm|preterm
5690434|NCT00536445|Case study|case study
5690435|NCT00536406|Geriatric|geriatric
5690436|NCT00536406|Nursing Homes|nursing homes
5690437|NCT00536393|diffuse larg cells lymphoma|diffuse larg cells lymphoma
5690438|NCT00536393|chemotherapy|chemotherapy
5690440|NCT00536393|diffuse high grade lymphoma|diffuse high grade lymphoma
5690441|NCT00536367|Heart Failure, Congestive|heart failure, congestive
5690442|NCT00536367|Mortality Prediction Model|mortality prediction model
5690443|NCT00536341|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5690444|NCT00536341|untreated|untreated
5690445|NCT00536341|minimally treated|minimally treated
5690446|NCT00536341|fludarabine|fludarabine
5690447|NCT00536341|rituximab|rituximab
5690448|NCT00536341|lenalidomide|lenalidomide
5690449|NCT00536328|Reflux Impact Scale (RIS)|reflux impact scale (ris)
5690450|NCT00536328|predictive value|predictive value
5690451|NCT00536328|treatment success|treatment success
5690452|NCT00536328|patient satisfaction|patient satisfaction
5690453|NCT00536328|proton pump inhibitor|proton pump inhibitor
5690454|NCT00536328|gastro-esophageal reflux disease|gastro-esophageal reflux disease
5690456|NCT00536315|COPD|copd
5690457|NCT00536302|OA|oa
5690460|NCT00536302|Nutritional supplement|nutritional supplement
5690462|NCT00536302|MRI|mri
5690463|NCT00536289|Blunt needles|blunt needles
5690464|NCT00536289|obstetric lacerations|obstetric lacerations
5690465|NCT00536289|Needlestick injuries|needlestick injuries
5690466|NCT00536289|Needlestick injuries to physicians|needlestick injuries to physicians
5690467|NCT00536276|vitamin D|vitamin d
5690468|NCT00536250|Pre-Diabetes|pre-diabetes
5690469|NCT00536250|Childhood Obesity|childhood obesity
5690470|NCT00536250|Metabolic Syndrome|metabolic syndrome
5690471|NCT00536250|insulin resistance|insulin resistance
5690472|NCT00536250|Impaired Glucose Tolerance|impaired glucose tolerance
5690473|NCT00536250|Non Alcoholic Fatty Liver Disease|non alcoholic fatty liver disease
5690474|NCT00536250|High Molecular Weight Adiponectin|high molecular weight adiponectin
5690475|NCT00536250|Hypoadiponectinemia|hypoadiponectinemia
5690476|NCT00536224|Health promotion|health promotion
5690477|NCT00536224|Emergency Medical Services|emergency medical services
5690478|NCT00536224|Randomized controlled trial|randomized controlled trial
5690479|NCT00536224|Chest pain observation unit|chest pain observation unit
5690480|NCT00536224|Cardiovascular risk factors|cardiovascular risk factors
5690481|NCT00536211|Exercise|exercise
5690482|NCT00536211|Physical Activity|physical activity
5690483|NCT00536211|Metformin|metformin
5690484|NCT00536211|Hyperinsulinemic-Euglycemic Clamp|hyperinsulinemic-euglycemic clamp
5690485|NCT00536211|Muscle Biopsy|muscle biopsy
5690486|NCT00536211|Fatty Acid Oxidation|fatty acid oxidation
5690487|NCT00536211|Peroxisome proliferator-activated receptor gamma|peroxisome proliferator-activated receptor gamma
5690488|NCT00536211|Detraining|detraining
5690489|NCT00536211|Inactivity|inactivity
5690490|NCT00536211|Skeletal muscle|skeletal muscle
5690491|NCT00536198|Premenstrual Syndrome|premenstrual syndrome
5690492|NCT00536185|ALOX5|alox5
5690493|NCT00536185|5-lipoxygenase|5-lipoxygenase
5690494|NCT00536185|Heart Disease|heart disease
5690495|NCT00536185|Blacks|blacks
5690496|NCT00536172|Antidepressant|antidepressant
5690497|NCT00536172|Major depression|major depression
5690498|NCT00536172|Prevention|prevention
5690499|NCT00536172|Head and neck cancer|head and neck cancer
5690500|NCT00536159|nurse-community health worker team|nurse-community health worker team
5690501|NCT00536159|perinatal depression|perinatal depression
5690502|NCT00536159|stress|stress
5690503|NCT00536159|Medicaid enhanced prenatal programs|medicaid enhanced prenatal programs
5690504|NCT00536146|Glucocorticoid|glucocorticoid
5690505|NCT00536146|Steroids|steroids
5690506|NCT00536146|Dose-Responsive Curve|dose-responsive curve
5690507|NCT00536146|EC50|ec50
5690508|NCT00536146|Stress Response|stress response
5690509|NCT00536146|Alcoholism|alcoholism
5690510|NCT00536133|zinc|zinc
5690511|NCT00536133|aute lower respiratory infections|aute lower respiratory infections
5690513|NCT00536120|Multiple sclerosis|multiple sclerosis
5690514|NCT00536120|Relapsing forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5690515|NCT00536107|Non-Small Cell Lung Cancer|non-small cell lung cancer
5690516|NCT00536107|Locally Advanced or Metastatic NSCL Cancer|locally advanced or metastatic nscl cancer
5690517|NCT00536094|Cognitive behavioral therapy|cognitive behavioral therapy
5690518|NCT00536094|Youth|youth
5690519|NCT00536094|School|school
5690520|NCT00536094|African American|african american
5690521|NCT00536081|Breast cancer|breast cancer
5690522|NCT00536081|Adjuvant|adjuvant
5690523|NCT00536081|Advanced|advanced
5690524|NCT00536081|Chemotherapy|chemotherapy
5690525|NCT00536081|G-CSF|g-csf
5690526|NCT00536081|Pegfilgrastim|pegfilgrastim
5690527|NCT00536081|Prevention|prevention
5690528|NCT00536081|Febrile neutropenia|febrile neutropenia
5690529|NCT00536068|platelet|platelet
5690530|NCT00536068|aggregation|aggregation
5690531|NCT00536068|aspirin|aspirin
5685483|NCT00555919|mBC|mbc
5690532|NCT00536055|breast cancer|breast cancer
5690533|NCT00536055|prostate cancer|prostate cancer
5690534|NCT00536055|dyadic coping|dyadic coping
5690535|NCT00536042|minocycline|minocycline
5690536|NCT00536042|asthma|asthma
5690537|NCT00536042|oral steroids|oral steroids
5690539|NCT00536029|Melanoma|melanoma
5690540|NCT00536029|SIAscope|siascope
5690541|NCT00536029|pigmented skin lesions|pigmented skin lesions
5690543|NCT00536016|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5690544|NCT00536003|preterm delivery|preterm delivery
5690545|NCT00536003|preterm labor|preterm labor
5690546|NCT00536003|perinatal morbidity|perinatal morbidity
5690547|NCT00536003|perinatal mortality|perinatal mortality
5690548|NCT00535990|Cholecystectomy|cholecystectomy
5690549|NCT00535990|Appendectomy|appendectomy
5690550|NCT00535990|Esophageal|esophageal
5690551|NCT00535990|Surgical|surgical
5690552|NCT00535990|Procedures|procedures
5690553|NCT00535990|Surgery|surgery
5690554|NCT00535990|Gastric|gastric
5690555|NCT00535990|bypass|bypass
5690556|NCT00535977|Gene expression|gene expression
5690557|NCT00535977|Prostate|prostate
5690558|NCT00535977|Broccoli|broccoli
5690559|NCT00535977|Cancer|cancer
5690660|NCT00535522|pharmacodynamics|pharmacodynamics
5690560|NCT00535977|Men diagnosed with high-grade Prostatic Intraepithelia Neoplasia|men diagnosed with high-grade prostatic intraepithelia neoplasia
5690561|NCT00535964|Cigarette Smoking|cigarette smoking
5690562|NCT00535964|Tobacco Use|tobacco use
5690563|NCT00535964|Adolescents|adolescents
5690564|NCT00535964|Anxiety Sensitivity (AS)|anxiety sensitivity (as)
5690565|NCT00535951|Non-small cell lung cancer|non-small cell lung cancer
5690566|NCT00535951|NSCLC|nsclc
5690567|NCT00535951|lung cancer|lung cancer
5690568|NCT00535951|pleural mesothelioma|pleural mesothelioma
5690569|NCT00535951|malignant|malignant
5690570|NCT00535951|advanced stage|advanced stage
5690571|NCT00535951|mesothelioma|mesothelioma
5690572|NCT00535951|phase I|phase i
5690573|NCT00535951|LBH589|lbh589
5690574|NCT00535951|dextromethorphan|dextromethorphan
5690575|NCT00535951|CYP2D6|cyp2d6
5690576|NCT00535951|oral|oral
5690577|NCT00535925|type 2 diabetes|type 2 diabetes
5690578|NCT00535925|nephropathy|nephropathy
5690579|NCT00535925|CV events|cv events
5690581|NCT00535899|Aortic stenosis|aortic stenosis
5690582|NCT00535899|Speckle tracking imaging|speckle tracking imaging
5690583|NCT00535899|Low ejection fraction|low ejection fraction
5690584|NCT00535899|Aortic valve replacement|aortic valve replacement
5690585|NCT00535899|Strain|strain
5690586|NCT00535886|Trans Fatty Acids|trans fatty acids
5690587|NCT00535886|conjugated linoleic acid|conjugated linoleic acid
5690588|NCT00535886|vaccenic acid|vaccenic acid
5690589|NCT00535886|High Density Lipoprotein Cholesterol|high density lipoprotein cholesterol
5690590|NCT00535886|Low Density Lipoprotein Cholesterol|low density lipoprotein cholesterol
5690591|NCT00535886|Beef|beef
5690592|NCT00535873|Leukemia|leukemia
5690594|NCT00535873|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5690595|NCT00535873|SLL|sll
5690596|NCT00535873|small lymphocytic lymphoma|small lymphocytic lymphoma
5690597|NCT00535873|Untreated CLL|untreated cll
5690598|NCT00535873|Lenalidomide|lenalidomide
5690599|NCT00535873|CC-5013|cc-5013
5690600|NCT00535873|Revlimid|revlimid
5690601|NCT00535873|Oral|oral
5690602|NCT00535860|Osteoporosis|osteoporosis
5690604|NCT00535860|hPTH(1-34)|hpth(1-34)
5690605|NCT00535847|Genotype 1|genotype 1
5690606|NCT00535834|stage I prostate cancer|stage i prostate cancer
5690607|NCT00535834|stage II prostate cancer|stage ii prostate cancer
5690608|NCT00535834|stage III prostate cancer|stage iii prostate cancer
5690609|NCT00535834|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5690610|NCT00535821|Emergency Department|emergency department
5690611|NCT00535821|Hemodynamic Optimization|hemodynamic optimization
5690612|NCT00535821|Esophageal Doppler monitoring|esophageal doppler monitoring
5690613|NCT00535821|Early Goal-Directed Therapy|early goal-directed therapy
5690614|NCT00535769|topical|topical
5690615|NCT00535769|medication adherence|medication adherence
5690616|NCT00535769|adherence|adherence
5690617|NCT00535769|compliance|compliance
5690618|NCT00535769|medication compliance|medication compliance
5690619|NCT00535769|sunscreen|sunscreen
5690620|NCT00535769|reminder|reminder
5690621|NCT00535756|Pancreatic Exocrine Insufficiency After Pancreatic Surgery|pancreatic exocrine insufficiency after pancreatic surgery
5690622|NCT00535717|Urethral stricture|urethral stricture
5690623|NCT00535717|Ayurvedic treatment|ayurvedic treatment
5690624|NCT00535717|mutra marg sankoch|mutra marg sankoch
5690625|NCT00535717|uttarbasti|uttarbasti
5690626|NCT00535717|Sesame oil|sesame oil
5690627|NCT00535717|Honey|honey
5690628|NCT00535717|Rock salt|rock salt
5690629|NCT00535678|Mammography|mammography
5690630|NCT00535678|mammogram|mammogram
5690631|NCT00535678|breast|breast
5690632|NCT00535678|Abnormal and normal breast tissue|abnormal and normal breast tissue
5690633|NCT00535639|Tolerability of ALK Tree Tablet in patients with birch pollen induced allergy|tolerability of alk tree tablet in patients with birch pollen induced allergy
5690634|NCT00535600|Bariatric Surgery|bariatric surgery
5690636|NCT00535600|Insulin Secretion|insulin secretion
5690637|NCT00535600|Insulin Resistance|insulin resistance
5690638|NCT00535600|Gut Hormones|gut hormones
5690639|NCT00535600|Obesity|obesity
5690640|NCT00535587|Fibromyalgia|fibromyalgia
5690641|NCT00535587|Exercise|exercise
5690642|NCT00535587|Mestinon|mestinon
5690643|NCT00535574|retinoids|retinoids
5690644|NCT00535574|bexarotene|bexarotene
5690645|NCT00535574|schizophrenia|schizophrenia
5690646|NCT00535574|PANSS|panss
5690647|NCT00535574|Positive and negative symptoms of schizophrenia|positive and negative symptoms of schizophrenia
5690648|NCT00535561|iron deficiency anemia|iron deficiency anemia
5685699|NCT00555061|impetigo|impetigo
5698106|NCT00507676|Asthma|asthma
5690649|NCT00535561|anemia|anemia
5690650|NCT00535561|hypothyroidism|hypothyroidism
5690651|NCT00535561|subclinical hypothyroidism|subclinical hypothyroidism
5690652|NCT00535548|Chronic wounds|chronic wounds
5690653|NCT00535548|Pressure sores|pressure sores
5690654|NCT00535548|Hematopoietic stem cells|hematopoietic stem cells
5690655|NCT00535548|Wound healing|wound healing
5690656|NCT00535535|Elevated triglycerides|elevated triglycerides
5690657|NCT00535535|Diabetes|diabetes
5690658|NCT00535535|Cardiovascular disease|cardiovascular disease
5690659|NCT00535522|Pharmacokinetics|pharmacokinetics
5690661|NCT00535522|maximal tolerated dose|maximal tolerated dose
5690662|NCT00535483|blood microdialysis|blood microdialysis
5690663|NCT00535483|glucose monitoring|glucose monitoring
5690664|NCT00535483|glucose control|glucose control
5690665|NCT00535483|automated blood sampling|automated blood sampling
5690666|NCT00535483|online-sensor|online-sensor
5690667|NCT00535483|algorithm|algorithm
5690668|NCT00535483|type 1 diabetes|type 1 diabetes
5690670|NCT00535457|maladaptive behavior|maladaptive behavior
5690671|NCT00535457|anesthesia|anesthesia
5690672|NCT00535457|Anxiety before anesthesia and maladaptive behavior after anesthesia.|anxiety before anesthesia and maladaptive behavior after anesthesia.
5690673|NCT00535444|Hypertension|hypertension
5690674|NCT00535444|parish nurse|parish nurse
5690675|NCT00535431|Asthma|asthma
5690676|NCT00535431|allergy|allergy
5690677|NCT00535431|interleukin-4|interleukin-4
5690678|NCT00535431|interleukin-13|interleukin-13
5690681|NCT00535418|Breast cancer|breast cancer
5690682|NCT00535418|neoadjuvant treatment|neoadjuvant treatment
5690683|NCT00535418|treatment duration|treatment duration
5690684|NCT00535418|Primary hormone receptor positive|primary hormone receptor positive
5690685|NCT00535418|breast cancer in postmenopausal women|breast cancer in postmenopausal women
5690686|NCT00535405|High Cholesterol|high cholesterol
5690687|NCT00535392|Epilepsy|epilepsy
5690688|NCT00535392|Child|child
5690689|NCT00535392|Levetiracetam|levetiracetam
5690690|NCT00535392|Keppra®|keppra®
5690691|NCT00535392|Infusion|infusion
5690692|NCT00535392|Intravenous|intravenous
5690693|NCT00535379|glioblastoma multiforme|glioblastoma multiforme
5690694|NCT00535379|sunitinib|sunitinib
5690695|NCT00535379|recurrent|recurrent
5690696|NCT00535379|progressive|progressive
5690697|NCT00535353|recurrent colon cancer|recurrent colon cancer
5690698|NCT00535353|stage IV colon cancer|stage iv colon cancer
5690699|NCT00535353|recurrent rectal cancer|recurrent rectal cancer
5690700|NCT00535353|stage IV rectal cancer|stage iv rectal cancer
5690701|NCT00535353|stage III rectal cancer|stage iii rectal cancer
5690702|NCT00535353|stage III colon cancer|stage iii colon cancer
5690703|NCT00535340|Anxiety|anxiety
5690704|NCT00535340|Anti-Anxiety Agents|anti-anxiety agents
5690705|NCT00535327|Mammography|mammography
5690706|NCT00535327|mammogram|mammogram
5690707|NCT00535327|breast|breast
5690708|NCT00535327|Abnormal and normal breast tissue|abnormal and normal breast tissue
5690709|NCT00535314|Melanoma|melanoma
5690710|NCT00535301|cystocele|cystocele
5690711|NCT00535301|uterine prolapse|uterine prolapse
5690712|NCT00535301|urinary incontinence|urinary incontinence
5690713|NCT00535275|NSCLC relapse after adjuvant chemotherapy|nsclc relapse after adjuvant chemotherapy
5690714|NCT00535262|Bipolar|bipolar
5690715|NCT00535262|depression|depression
5690716|NCT00535236|Prevention of herpes zoster and HZ-related complications|prevention of herpes zoster and hz-related complications
5690717|NCT00535223|Cognitive Behavior Therapy|cognitive behavior therapy
5690718|NCT00535223|Group therapy|group therapy
5690719|NCT00535223|Posttraumatic Stress Disorder|posttraumatic stress disorder
5690720|NCT00535223|Randomized Controlled Trial|randomized controlled trial
5690721|NCT00535223|Treatment outcome|treatment outcome
5690722|NCT00535223|Veterans|veterans
5690724|NCT00535210|spinal cord injury|spinal cord injury
5690725|NCT00535210|exercise rehabilitation|exercise rehabilitation
5690726|NCT00535210|inpatient|inpatient
5690727|NCT00535210|RCT|rct
5690728|NCT00535210|physical function|physical function
5690729|NCT00535197|Stroke|stroke
5690730|NCT00535197|Middle Cerebral Artery|middle cerebral artery
5690731|NCT00535184|Mammography|mammography
5690732|NCT00535184|mammogram|mammogram
5690733|NCT00535184|breast|breast
5690734|NCT00535184|Abnormal and normal breast tissue|abnormal and normal breast tissue
5690735|NCT00535158|Chronic Kidney disease|chronic kidney disease
5690736|NCT00535158|Dialysis|dialysis
5690737|NCT00535158|Vitamin D|vitamin d
5690738|NCT00535158|Chronic kidney disease is associated with impaired muscle strength, pain and fractures.|chronic kidney disease is associated with impaired muscle strength, pain and fractures.
5690739|NCT00535145|antipsychotic|antipsychotic
5690740|NCT00535145|paliperidone ER|paliperidone er
5690741|NCT00535145|liver disease|liver disease
5690742|NCT00535145|Schizophrenia|schizophrenia
5690743|NCT00535145|Schizoaffective Disorder|schizoaffective disorder
5690745|NCT00535132|schizophrenia|schizophrenia
5690746|NCT00535132|medication satisfaction, Invega|medication satisfaction, invega
5690747|NCT00535106|Ventricular fibrillation|ventricular fibrillation
5690748|NCT00535106|Cardiac arrest|cardiac arrest
5690749|NCT00535106|Automated external defibrillator|automated external defibrillator
5690751|NCT00535106|Waveform based algorithms|waveform based algorithms
5690752|NCT00535106|VF waveform analysis|vf waveform analysis
5690753|NCT00535093|Pharyngitis|pharyngitis
5690754|NCT00535093|Community infections|community infections
5690755|NCT00535093|Rapid Testing|rapid testing
5690756|NCT00535093|Group A Streptococcus|group a streptococcus
5690757|NCT00535080|actinic|actinic
5690758|NCT00535080|keratoses|keratoses
5690759|NCT00535080|superficial|superficial
5690760|NCT00535080|basal|basal
5690763|NCT00535080|large or multiple superficial Basal Carcinomas|large or multiple superficial basal carcinomas
5690764|NCT00535067|Breast Cancer|breast cancer
5690765|NCT00535067|Questionnaire|questionnaire
5690766|NCT00535067|Survey|survey
5690767|NCT00535067|Neuropathic Pain|neuropathic pain
5690768|NCT00535067|Cancer Survivors|cancer survivors
5690769|NCT00535067|Quality of Life|quality of life
5690770|NCT00535067|QOL|qol
5690771|NCT00535054|Dry Eye Syndrome|dry eye syndrome
5690772|NCT00535041|Pilot trial of pre-operative chemo/RT using Xeloda and external beam RT followed by definite surgery in patients with localized rectal CA|pilot trial of pre-operative chemo/rt using xeloda and external beam rt followed by definite surgery in patients with localized rectal ca
5690773|NCT00535028|asthma|asthma
5690774|NCT00535028|allergy|allergy
5690775|NCT00535028|interleukin-4|interleukin-4
5690776|NCT00535028|interleukin-13|interleukin-13
5690777|NCT00535028|IL-4|il-4
5690781|NCT00535028|inflammation|inflammation
5690782|NCT00535002|Cocaine Addiction|cocaine addiction
5690783|NCT00535002|Cocaine Dependence|cocaine dependence
5690784|NCT00534989|NHL and HD|nhl and hd
5690785|NCT00534963|sonohysterography, catheter placement|sonohysterography, catheter placement
5690786|NCT00534950|Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck|randomized multicenter study of 5 vs 6 weekly fraction of rt in the treatment of scc of the head and neck
5690787|NCT00534937|Venous stasis ulcer|venous stasis ulcer
5690788|NCT00534937|Compression pump|compression pump
5690789|NCT00534937|Randomized trial|randomized trial
5690790|NCT00534937|Flexitouch compression|flexitouch compression
5690791|NCT00534924|IR injury|ir injury
5690792|NCT00534924|MRI|mri
5690793|NCT00534924|Vitamin C|vitamin c
5690794|NCT00534924|Postconditioning|postconditioning
5690795|NCT00534911|Depression|depression
5690796|NCT00534911|Physical Illness|physical illness
5690797|NCT00534911|Inflammatory Bowel Disease|inflammatory bowel disease
5690798|NCT00534911|Cognitive Behavioral Therapy|cognitive behavioral therapy
5690799|NCT00534885|inactivated hepatitis A vaccine|inactivated hepatitis a vaccine
5690800|NCT00534885|Healive|healive
5690801|NCT00534885|safety|safety
5848027|NCT00036595|Desynchronization|desynchronization
5680493|NCT00577798|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5680494|NCT00577798|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5716324|NCT00443820|Nail fungus|nail fungus
5690802|NCT00534885|immunogenicity|immunogenicity
5690803|NCT00534885|immune persistence|immune persistence
5690804|NCT00534872|4 Parallel cohorts|4 parallel cohorts
5690805|NCT00534872|Healthy Female|healthy female
5690806|NCT00534872|Healthy Elderly|healthy elderly
5690807|NCT00534872|Pharmacokinetic|pharmacokinetic
5690808|NCT00534872|Safety and Tolerability|safety and tolerability
5690809|NCT00534846|premenstrual syndrome|premenstrual syndrome
5690810|NCT00534846|mastalgia|mastalgia
5690811|NCT00534846|toremifene|toremifene
5690812|NCT00534846|selective estrogen receptor modulators|selective estrogen receptor modulators
5690813|NCT00534833|Diphtheria|diphtheria
5690814|NCT00534833|Tetanus|tetanus
5690815|NCT00534833|Pertussis|pertussis
5690816|NCT00534833|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5690817|NCT00534833|Haemophilus influenzae type b|haemophilus influenzae type b
5690818|NCT00534820|Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease|cytogenetic analysis of bone marrow specimen in non-hodgkin's lymphoma or hodgkin's disease
5690819|NCT00534781|Achilles|achilles
5690820|NCT00534781|Tendinosis|tendinosis
5690821|NCT00534781|Tendinitis|tendinitis
5690822|NCT00534781|Achilles Tendinosis|achilles tendinosis
5690823|NCT00534781|Achilles Tendinitis|achilles tendinitis
5690824|NCT00534781|Coblation|coblation
5690825|NCT00534781|Bipolar Radiofrequency|bipolar radiofrequency
5690826|NCT00534781|Surgical Debridement|surgical debridement
5690827|NCT00534781|Debridement|debridement
5690828|NCT00534781|Heel Pain|heel pain
5690829|NCT00534781|Achilles Pain|achilles pain
5690830|NCT00534742|Siblings|siblings
5690831|NCT00534729|Organ Preservation|organ preservation
5690832|NCT00534729|Carboplatin|carboplatin
5690834|NCT00534729|RT|rt
5690835|NCT00534729|laryngeal & Hypopharyngeal CA|laryngeal & hypopharyngeal ca
5690836|NCT00534729|Locally advanced laryngeal & Hypopharyngeal CA|locally advanced laryngeal & hypopharyngeal ca
5690837|NCT00534716|Cannabis|cannabis
5690838|NCT00534716|doping|doping
5690839|NCT00534716|THC|thc
5690840|NCT00534716|GC/MS|gc/ms
5690841|NCT00534716|Pharmacokinetics|pharmacokinetics
5690842|NCT00534716|Volunteers|volunteers
5690844|NCT00534690|Pulmonary disease|pulmonary disease
5690845|NCT00534690|Intubation, Intratracheal|intubation, intratracheal
5690846|NCT00534690|Positive-pressure ventilation|positive-pressure ventilation
5690848|NCT00534677|Cirrhosis|cirrhosis
5690849|NCT00534677|Vasoactive agents|vasoactive agents
5690850|NCT00534677|Terlipressin|terlipressin
5690851|NCT00534677|Octreotide|octreotide
5690852|NCT00534677|Safety & Efficacy|safety & efficacy
5690853|NCT00534638|HPV vaccine|hpv vaccine
5690854|NCT00534638|Healthy adolescents|healthy adolescents
5690855|NCT00534638|Cervical cancer|cervical cancer
5690856|NCT00534638|Safety|safety
5690857|NCT00534638|Immunogenicity|immunogenicity
5690858|NCT00534638|Cervarix|cervarix
5690859|NCT00534625|Asthma, exacerbation, pulmonary function|asthma, exacerbation, pulmonary function
5690860|NCT00534612|Parotid gland neoplasms|parotid gland neoplasms
5690861|NCT00534599|Generalized anxiety disorders|generalized anxiety disorders
5690863|NCT00534599|adjunct treatment in anxiety|adjunct treatment in anxiety
5690864|NCT00534599|anxiety disorder|anxiety disorder
5690865|NCT00534599|partial or non-responder in anxiety|partial or non-responder in anxiety
5690866|NCT00534586|Pain|pain
5690867|NCT00534586|SSEP|ssep
5690868|NCT00534586|CHEPS|cheps
5690869|NCT00534586|Propofol|propofol
5690870|NCT00534586|Sevoflurane|sevoflurane
5690871|NCT00534586|S-Ketamine|s-ketamine
5690872|NCT00534586|Remifentanil|remifentanil
5690873|NCT00534586|Healthy volunteers|healthy volunteers
5690874|NCT00534534|Pancreatitis|pancreatitis
5690875|NCT00534534|acute|acute
5690876|NCT00534534|alcoholic|alcoholic
5690877|NCT00534534|recurrence|recurrence
5690879|NCT00534534|treatment|treatment
5690880|NCT00534534|Acute alcoholic pancreatitis|acute alcoholic pancreatitis
5690881|NCT00534521|overactive bladder|overactive bladder
5690882|NCT00534521|posterior tibial nerve stimulation|posterior tibial nerve stimulation
5690883|NCT00534508|Skin|skin
5690884|NCT00534508|Pharmacokinetics|pharmacokinetics
5690885|NCT00534508|Tacrolimus|tacrolimus
5690886|NCT00534508|dermatitis, atopic|dermatitis, atopic
5690887|NCT00534495|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5690888|NCT00534495|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5690889|NCT00534495|Systemic Juvenile Rheumatoid Arthritis|systemic juvenile rheumatoid arthritis
5690890|NCT00534482|fitness|fitness
5690891|NCT00534469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5690892|NCT00534469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5680495|NCT00577798|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5690893|NCT00534469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5690894|NCT00534469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5690895|NCT00534469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5690896|NCT00534469|adult acute basophilic leukemia|adult acute basophilic leukemia
5690897|NCT00534469|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5690898|NCT00534469|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5690899|NCT00534469|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5690900|NCT00534469|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5690901|NCT00534469|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5690902|NCT00534469|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5690903|NCT00534469|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5690904|NCT00534469|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5690905|NCT00534469|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5690906|NCT00534469|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5690907|NCT00534456|exploratory study|exploratory study
5690908|NCT00534456|anemia|anemia
5690909|NCT00534456|pharmacogenetics testing|pharmacogenetics testing
5690910|NCT00534456|biomarkers|biomarkers
5690911|NCT00534456|echocardiography|echocardiography
5690912|NCT00534443|peptic ulcer|peptic ulcer
5690913|NCT00534443|gastritis|gastritis
5690914|NCT00534443|sTREM-1|strem-1
5690915|NCT00534443|cytokines|cytokines
5690916|NCT00534443|Changes of inflammatory status in gastric mucosa|changes of inflammatory status in gastric mucosa
5690917|NCT00534443|sTREM-1 as a disease marker|strem-1 as a disease marker
5690918|NCT00534430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5690919|NCT00534430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5690920|NCT00534430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5690921|NCT00534430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5690922|NCT00534430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5690923|NCT00534430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5690924|NCT00534430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5690925|NCT00534430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5690926|NCT00534430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5685700|NCT00555061|pharmacokinetics|pharmacokinetics
5685701|NCT00555061|Retapamulin ointment, 1%|retapamulin ointment, 1%
5685702|NCT00555061|Skin abnormalities|skin abnormalities
5685703|NCT00555061|Dermatoses|dermatoses
5685704|NCT00555061|pediatric|pediatric
5685705|NCT00555061|infection|infection
5685706|NCT00555061|SITL|sitl
5715213|NCT00446212|desflurane|desflurane
5690927|NCT00534430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5690928|NCT00534430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5690929|NCT00534430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5690930|NCT00534430|refractory anemia with excess blasts|refractory anemia with excess blasts
5690931|NCT00534430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5690932|NCT00534430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5690934|NCT00534417|Receptor|receptor
5690935|NCT00534417|Positive|positive
5690936|NCT00534417|Metastatic|metastatic
5690937|NCT00534417|Breast|breast
5690938|NCT00534417|Cancer|cancer
5690939|NCT00534404|Internet-Assisted Tobacco Treatments|internet-assisted tobacco treatments
5690940|NCT00534404|Online Smoking Cessation Programs|online smoking cessation programs
5690941|NCT00534404|Nicotine Patches|nicotine patches
5690942|NCT00534404|Telephone Counseling|telephone counseling
5690943|NCT00534404|Smoking Abstinence|smoking abstinence
5690944|NCT00534391|Antibiotics|antibiotics
5690945|NCT00534391|hordeolum|hordeolum
5690946|NCT00534378|Nerve agent|nerve agent
5690947|NCT00534378|Midazolam|midazolam
5690948|NCT00534378|Seizures|seizures
5690949|NCT00534378|Severe recurrent convulsive seizures induced by nerve agent exposure|severe recurrent convulsive seizures induced by nerve agent exposure
5690950|NCT00534365|stress urinary incontinence|stress urinary incontinence
5690951|NCT00534365|sling procedures|sling procedures
5690952|NCT00534365|tension-free vaginal tape|tension-free vaginal tape
5690954|NCT00534352|AIDS|aids
5691112|NCT00533923|CAMPATH-1H|campath-1h
5690955|NCT00534352|Immunodeficiency Virus, Human|immunodeficiency virus, human
5690956|NCT00534352|PREZISTA|prezista
5690957|NCT00534352|darunavir|darunavir
5690958|NCT00534352|TMC114|tmc114
5690959|NCT00534352|TMC125|tmc125
5690960|NCT00534352|Protease Inhibitor|protease inhibitor
5690961|NCT00534352|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5690962|NCT00534352|Truvada|truvada
5690963|NCT00534352|Treatment Naive|treatment naive
5690964|NCT00534300|ICD-pacemaker|icd-pacemaker
5690965|NCT00534287|sepsis|sepsis
5690966|NCT00534287|antibiotics|antibiotics
5690967|NCT00534287|carbapenems|carbapenems
5690968|NCT00534287|fluoroquinolones|fluoroquinolones
5699967|NCT00501306|Condyloma Accuminata|condyloma accuminata
5699968|NCT00501306|Low Grade Squamous Intraepithelial Lesion|low grade squamous intraepithelial lesion
5699969|NCT00501306|High Grade Squamous Intraepithelial Lesion|high grade squamous intraepithelial lesion
5699970|NCT00501306|Anal Cancer Screening|anal cancer screening
5699971|NCT00501280|Epidemiology|epidemiology
5699975|NCT00501280|Interview|interview
5690969|NCT00534287|Severe sepsis and septic shock|severe sepsis and septic shock
5690970|NCT00534274|stage II breast cancer|stage ii breast cancer
5690971|NCT00534274|stage IIIA breast cancer|stage iiia breast cancer
5690972|NCT00534261|Multiple Sclerosis|multiple sclerosis
5690973|NCT00534261|Avonex|avonex
5690974|NCT00534261|Interferon beta-1a|interferon beta-1a
5690975|NCT00534222|Patients with a manic episode|patients with a manic episode
5690976|NCT00534222|Patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the CGI at baseline|patients diagnosed w/schizophrenia, who start a treatment with an atypical antipsychotic & who are at least scored as moderately ill on the cgi at baseline
5690977|NCT00534209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5690978|NCT00534209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5690979|NCT00534196|recurrent prostate cancer|recurrent prostate cancer
5690980|NCT00534196|stage I prostate cancer|stage i prostate cancer
5690981|NCT00534196|stage IIB prostate cancer|stage iib prostate cancer
5690982|NCT00534196|stage IIA prostate cancer|stage iia prostate cancer
5690983|NCT00534196|stage III prostate cancer|stage iii prostate cancer
5690984|NCT00534183|Metabolic syndrome|metabolic syndrome
5690985|NCT00534183|Obesity|obesity
5690986|NCT00534183|Diabetes|diabetes
5690987|NCT00534170|Probiotic|probiotic
5690988|NCT00534170|Prevention of diarrhoea|prevention of diarrhoea
5690989|NCT00534170|Nutritional status|nutritional status
5690990|NCT00534157|intracranial pressure|intracranial pressure
5690991|NCT00534157|intraocular pressure|intraocular pressure
5690992|NCT00534157|tonometry|tonometry
5690993|NCT00534118|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5690994|NCT00534118|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5690995|NCT00534118|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5690996|NCT00534118|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5690997|NCT00534118|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5690998|NCT00534118|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5690999|NCT00534118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5691000|NCT00534118|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5691001|NCT00534118|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5691002|NCT00534118|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5691003|NCT00534118|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5691004|NCT00534118|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5691005|NCT00534118|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5691006|NCT00534118|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5691007|NCT00534118|stage I multiple myeloma|stage i multiple myeloma
5691008|NCT00534118|stage II multiple myeloma|stage ii multiple myeloma
5691009|NCT00534118|stage III multiple myeloma|stage iii multiple myeloma
5691010|NCT00534118|refractory multiple myeloma|refractory multiple myeloma
5691011|NCT00534118|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5691012|NCT00534118|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5691013|NCT00534118|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5691014|NCT00534118|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5691015|NCT00534118|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5691016|NCT00534118|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5691017|NCT00534118|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5691018|NCT00534118|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5691019|NCT00534118|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5691020|NCT00534118|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5691021|NCT00534118|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5691022|NCT00534118|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5691023|NCT00534118|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5691024|NCT00534118|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5691025|NCT00534118|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5691026|NCT00534118|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5691027|NCT00534118|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5691028|NCT00534118|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5691029|NCT00534118|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5691030|NCT00534118|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5691031|NCT00534118|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5691032|NCT00534118|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5798866|NCT00110721|DAVANAT|davanat
5691033|NCT00534118|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5691034|NCT00534118|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5691035|NCT00534118|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5691036|NCT00534118|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5691037|NCT00534118|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5691038|NCT00534118|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5691039|NCT00534118|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5691040|NCT00534118|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5691041|NCT00534118|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5691042|NCT00534105|Pregnancy|pregnancy
5691043|NCT00534105|Gestational diabetes|gestational diabetes
5691044|NCT00534105|Hyperlipidemia|hyperlipidemia
5691045|NCT00534092|Lumbar Spinal Stenosis|lumbar spinal stenosis
5691046|NCT00534092|X STOP|x stop
5691047|NCT00534079|Cystic Fibrosis and chronic rhinosinusitis|cystic fibrosis and chronic rhinosinusitis
5691048|NCT00534066|Natriuretic Peptide, Brain|natriuretic peptide, brain
5691049|NCT00534053|colon cancer screening|colon cancer screening
5691050|NCT00534053|mail reminders|mail reminders
5691051|NCT00534053|fecal occult blood test|fecal occult blood test
5691052|NCT00534053|compliance|compliance
5691053|NCT00534027|NSCLC|nsclc
5691054|NCT00534027|Non-Small Cell Lung Cancer|non-small cell lung cancer
5691055|NCT00534027|Paclitaxel|paclitaxel
5691056|NCT00534027|Carboplatin|carboplatin
5691057|NCT00534027|AMG 655|amg 655
5691058|NCT00534001|bladder cancer|bladder cancer
5691059|NCT00534001|cervical cancer|cervical cancer
5691060|NCT00534001|esophageal cancer|esophageal cancer
5691061|NCT00534001|gastric cancer|gastric cancer
5691062|NCT00534001|renal cell carcinoma|renal cell carcinoma
5689710|NCT00538850|ovarian sarcoma|ovarian sarcoma
5691063|NCT00534001|adult primary liver cancer|adult primary liver cancer
5686032|NCT00553293|Benefits|benefits
5691065|NCT00534001|small cell lung cancer|small cell lung cancer
5691066|NCT00534001|pancreatic cancer|pancreatic cancer
5691067|NCT00534001|hypopharyngeal cancer|hypopharyngeal cancer
5691068|NCT00534001|laryngeal cancer|laryngeal cancer
5691069|NCT00534001|lip and oral cavity cancer|lip and oral cavity cancer
5691070|NCT00534001|nasopharyngeal cancer|nasopharyngeal cancer
5691071|NCT00534001|oropharyngeal cancer|oropharyngeal cancer
5691072|NCT00534001|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5691073|NCT00534001|adult acute myeloid leukemia|adult acute myeloid leukemia
5691074|NCT00534001|tobacco use disorder|tobacco use disorder
5691075|NCT00533988|Central venous catheters|central venous catheters
5691076|NCT00533988|Antimicrobial impregnated catheters|antimicrobial impregnated catheters
5691077|NCT00533988|Duration of catheter use|duration of catheter use
5691078|NCT00533988|Catheter-related infection|catheter-related infection
5691079|NCT00533988|Insertion site|insertion site
5691080|NCT00533988|Parenteral nutrition|parenteral nutrition
5691081|NCT00533988|Critically ill patients (multidisciplinary)|critically ill patients (multidisciplinary)
5691082|NCT00533975|Colon Cancer screening|colon cancer screening
5691083|NCT00533975|immunofecal occult blood test|immunofecal occult blood test
5691085|NCT00533975|diagnostic validity|diagnostic validity
5691086|NCT00533962|Glaucoma|glaucoma
5691087|NCT00533962|Anecortave Acetate|anecortave acetate
5691088|NCT00533962|Intraocular pressure|intraocular pressure
5691089|NCT00533962|Advanced glaucoma cases with uncontrolled IOP|advanced glaucoma cases with uncontrolled iop
5691090|NCT00533949|radiation toxicity|radiation toxicity
5691091|NCT00533949|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5691092|NCT00533949|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5691093|NCT00533936|stage II breast cancer|stage ii breast cancer
5691094|NCT00533936|stage IIIA breast cancer|stage iiia breast cancer
5691095|NCT00533936|stage IIIB breast cancer|stage iiib breast cancer
5691096|NCT00533936|stage IIIC breast cancer|stage iiic breast cancer
5691413|NCT00532389|Myeloma|myeloma
5691097|NCT00533923|Nonmyeloablative Allogeneic Stem Cell Transplantation|nonmyeloablative allogeneic stem cell transplantation
5691098|NCT00533923|mini-transplant|mini-transplant
5691099|NCT00533923|AML|aml
5691100|NCT00533923|ALL|all
5691101|NCT00533923|CML|cml
5691102|NCT00533923|CLL|cll
5691103|NCT00533923|Myelodysplastic syndrome|myelodysplastic syndrome
5691104|NCT00533923|Relapsed non-Hodgkin's or Hodgkin's lymphoma|relapsed non-hodgkin's or hodgkin's lymphoma
5691105|NCT00533923|Relapsed multiple myeloma|relapsed multiple myeloma
5691106|NCT00533923|Aplastic anemia|aplastic anemia
5691107|NCT00533923|Myeloproliferative disorder|myeloproliferative disorder
5691108|NCT00533923|GM-CSF|gm-csf
5691109|NCT00533923|Cyclosporin|cyclosporin
5691110|NCT00533923|Fludarabine (FLUDARA)|fludarabine (fludara)
5691111|NCT00533923|Cyclophosphamide|cyclophosphamide
5691115|NCT00533923|AML in first remission, first relapse or subsequent remission|aml in first remission, first relapse or subsequent remission
5691116|NCT00533923|ALL in first relapse, second or subsequent remission|all in first relapse, second or subsequent remission
5798867|NCT00110721|5-fluorouracil|5-fluorouracil
5708187|NCT00471497|complete blood count|complete blood count
5708188|NCT00471497|lymphocyte|lymphocyte
5691117|NCT00533923|ALL in first remission, in a high-risk category|all in first remission, in a high-risk category
5691118|NCT00533923|Aplastic anemia characterized by ANC< 1000 and/or platelets < 30 without transfusional support|aplastic anemia characterized by anc< 1000 and/or platelets < 30 without transfusional support
5691119|NCT00533923|Myeloproliferative disorder (P Vera, CMML, ET)|myeloproliferative disorder (p vera, cmml, et)
5691120|NCT00533910|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5691121|NCT00533897|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5691122|NCT00533884|delirium|delirium
5691123|NCT00533884|cognitive/functional effects|cognitive/functional effects
5691124|NCT00533884|hypopharyngeal cancer|hypopharyngeal cancer
5691125|NCT00533884|laryngeal cancer|laryngeal cancer
5691126|NCT00533884|lip and oral cavity cancer|lip and oral cavity cancer
5691127|NCT00533884|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5691128|NCT00533884|nasopharyngeal cancer|nasopharyngeal cancer
5691129|NCT00533884|oropharyngeal cancer|oropharyngeal cancer
5691130|NCT00533884|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5691131|NCT00533884|salivary gland cancer|salivary gland cancer
5691132|NCT00533884|esophageal cancer|esophageal cancer
5691133|NCT00533884|non-small cell lung cancer|non-small cell lung cancer
5691134|NCT00533884|small cell lung cancer|small cell lung cancer
5691135|NCT00533871|Natriuretic Peptide Brain|natriuretic peptide brain
5691136|NCT00533858|Systolic hypertension|systolic hypertension
5691137|NCT00533832|depression|depression
5691138|NCT00533832|vagus nerve stimulation|vagus nerve stimulation
5691139|NCT00533819|Exercise intervention|exercise intervention
5691140|NCT00533819|Maths Scores|maths scores
5691141|NCT00533819|Blood pressure|blood pressure
5691142|NCT00533819|Female school children|female school children
5691143|NCT00533819|Body mass index|body mass index
5691144|NCT00533806|Cognitive Behavior Therapy|cognitive behavior therapy
5691145|NCT00533806|Active Control|active control
5691148|NCT00533793|bone, tibial shaft fracture|bone, tibial shaft fracture
5691149|NCT00533767|Hantavirus cardiopulmonary syndrome, Andes virus, Chile|hantavirus cardiopulmonary syndrome, andes virus, chile
5691150|NCT00533754|age-related macular degeneration, genetics|age-related macular degeneration, genetics
5691151|NCT00533741|Severe Acute Respiratory Syndrome, Coronavirus, vaccine|severe acute respiratory syndrome, coronavirus, vaccine
5691152|NCT00533715|Inspiratory Spirometry; Preschool Children; Computer games|inspiratory spirometry; preschool children; computer games
5691153|NCT00533715|Health|health
5691154|NCT00533702|Phase II|phase ii
5691155|NCT00533702|Melanoma|melanoma
5691156|NCT00533702|IMC-1121B|imc-1121b
5691157|NCT00533702|ImClone|imclone
5691158|NCT00533637|Allergic rhinitis|allergic rhinitis
5691159|NCT00533637|Nasal spray|nasal spray
5691160|NCT00533637|Anti-histamine|anti-histamine
5691161|NCT00533637|Tolerability|tolerability
5691162|NCT00533624|Gastrointestinal toxicity|gastrointestinal toxicity
5691163|NCT00533585|Non-Small Cell Lung Cancer|non-small cell lung cancer
5691164|NCT00533585|Lung Cancer|lung cancer
5691165|NCT00533585|NSCLC|nsclc
5691166|NCT00533585|malignant pleural effusions|malignant pleural effusions
5691167|NCT00533585|Sorafenib|sorafenib
5691168|NCT00533585|Paclitaxel|paclitaxel
5691169|NCT00533585|Taxol|taxol
5691170|NCT00533585|Carboplatin|carboplatin
5691171|NCT00533585|Paraplatin|paraplatin
5691172|NCT00533585|Bevacizumab|bevacizumab
5691173|NCT00533585|Avastin|avastin
5691174|NCT00533585|BAY 43-9006|bay 43-9006
5691175|NCT00533585|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5691176|NCT00533585|rhuMAb-VEGF|rhumab-vegf
5691177|NCT00533559|type 2 diabetes|type 2 diabetes
5691178|NCT00533559|free fatty acids|free fatty acids
5691179|NCT00533559|insulin resistance|insulin resistance
5691180|NCT00533559|beta cell lipotoxic effect|beta cell lipotoxic effect
5691181|NCT00533546|Acute Ischemic Stroke|acute ischemic stroke
5691182|NCT00533533|Docetaxel,Oxaliplatin|docetaxel,oxaliplatin
5691183|NCT00533533|Phase I/II study|phase i/ii study
5691184|NCT00533533|Advanced gastric cancer|advanced gastric cancer
5691185|NCT00533533|First line treatment|first line treatment
5691186|NCT00533533|Advanced gastric cancer with measurable disease|advanced gastric cancer with measurable disease
5691187|NCT00533507|Pneumococcal vaccine.|pneumococcal vaccine.
5691188|NCT00533507|Pneumococcal disease|pneumococcal disease
5691189|NCT00533507|Safety|safety
5691190|NCT00533507|Immunogenicity|immunogenicity
5691191|NCT00533507|Primary vaccination|primary vaccination
5691192|NCT00533468|pain|pain
5691193|NCT00533468|lumbar puncture|lumbar puncture
5691194|NCT00533468|neonates|neonates
5691195|NCT00533468|infants|infants
5691196|NCT00533468|emergency department|emergency department
5691197|NCT00533468|topical anesthesia|topical anesthesia
5691198|NCT00533468|LMX4|lmx4
5691199|NCT00533455|Antipsychotics, tremor|antipsychotics, tremor
5691200|NCT00533442|Rapamycin|rapamycin
5691201|NCT00533442|Mycophenolate Mofetil (MMF)|mycophenolate mofetil (mmf)
5691202|NCT00533442|Kidney-Pancreas Transplant|kidney-pancreas transplant
5798868|NCT00110708|autism|autism
5708276|NCT00471289|Peripheral arterial disease|peripheral arterial disease
5708277|NCT00471289|PAD|pad
5708278|NCT00471289|Paclitaxel|paclitaxel
5708279|NCT00471289|TAXUS|taxus
5708280|NCT00471289|Infrapopliteal|infrapopliteal
5708281|NCT00471289|Infragenicular|infragenicular
5708282|NCT00471289|Interventional Radiology|interventional radiology
5708283|NCT00471289|CLI|cli
5691206|NCT00533416|Myelodysplastic Syndrome|myelodysplastic syndrome
5691209|NCT00533390|tuberculosis|tuberculosis
5691210|NCT00533390|AIDS|aids
5691211|NCT00533390|rifampicin|rifampicin
5691212|NCT00533390|efficacy|efficacy
5691213|NCT00533390|safety|safety
5691214|NCT00533390|Treatment Naive|treatment naive
5691215|NCT00533338|Breast Cancer|breast cancer
5691216|NCT00533338|Cancer Survivors|cancer survivors
5691217|NCT00533338|Weight Gain Prevention|weight gain prevention
5691218|NCT00533338|Diet|diet
5691219|NCT00533338|Exercise|exercise
5691220|NCT00533338|Questionnaire|questionnaire
5691221|NCT00533338|Survey|survey
5691222|NCT00533299|Epigenetics, hydralazine, valproate, ovarian cancer|epigenetics, hydralazine, valproate, ovarian cancer
5691223|NCT00533286|physiotherapy|physiotherapy
5691224|NCT00533286|Tuebingen concept|tuebingen concept
5691225|NCT00533286|benzodiazepines|benzodiazepines
5691226|NCT00533286|muscle relaxants|muscle relaxants
5691227|NCT00533286|disc herniation|disc herniation
5691228|NCT00533260|Patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime|patients with a manic episode or patients diagnosed with schizophrenia , patients who are being treated with quetiapine and are on a stable dosing regime
5691229|NCT00533247|Cox-2 Inhibitor|cox-2 inhibitor
5691230|NCT00533247|Pre-emptive Pain|pre-emptive pain
5691231|NCT00533247|Preoperative Pain|preoperative pain
5691232|NCT00533247|Pain Prophylaxis|pain prophylaxis
5691233|NCT00533247|Celebrex|celebrex
5691234|NCT00533247|Celecoxib|celecoxib
5691235|NCT00533234|Elbow fracture|elbow fracture
5691237|NCT00533234|Radial head fracture|radial head fracture
5691238|NCT00533234|Radial neck fracture|radial neck fracture
5691239|NCT00533221|growth hormone|growth hormone
5691240|NCT00533221|strength|strength
5691241|NCT00533221|Spinal muscular atrophy type II and III|spinal muscular atrophy type ii and iii
5691242|NCT00533195|UVA1|uva1
5691243|NCT00533195|PUVA|puva
5691244|NCT00533195|atopic dermatitis|atopic dermatitis
5691251|NCT00533169|Neuroblastoma|neuroblastoma
5691252|NCT00533169|ZD6474|zd6474
5691253|NCT00533169|Zactima|zactima
5691254|NCT00533169|Isotretinoin|isotretinoin
5691255|NCT00533169|13-Cis Retinoic Acid|13-cis retinoic acid
5691256|NCT00533169|Accutane|accutane
5691257|NCT00533169|Pediatric Neuroblastoma|pediatric neuroblastoma
5691258|NCT00533156|Closure Device|closure device
5691259|NCT00533156|Angiography|angiography
5691260|NCT00533156|Angioplasty|angioplasty
5691261|NCT00533156|Hemostasis|hemostasis
5691262|NCT00533156|Heart Catheterization|heart catheterization
5691263|NCT00533156|Vascular Closure|vascular closure
5691264|NCT00533156|Peripheral Closure|peripheral closure
5691265|NCT00533156|Coronary Angiography|coronary angiography
5691266|NCT00533143|Solid cancer patient|solid cancer patient
5691267|NCT00533143|Non-invasive ventilation|non-invasive ventilation
5691268|NCT00533143|Acute Respiratory Failure|acute respiratory failure
5691270|NCT00533130|Pediatric|pediatric
5691271|NCT00533130|Classification|classification
5691272|NCT00533130|Long Bones|long bones
5691273|NCT00533130|fractures|fractures
5691274|NCT00533130|bones|bones
5691275|NCT00533117|suicide|suicide
5691276|NCT00533117|self-mutilation|self-mutilation
5691277|NCT00533117|fluoxetine|fluoxetine
5691278|NCT00533117|placebo|placebo
5691279|NCT00533117|dialectical behavior therapy|dialectical behavior therapy
5691280|NCT00533117|supportive therapy|supportive therapy
5691281|NCT00533104|Limb ischemia|limb ischemia
5691282|NCT00533104|Cell Therapy|cell therapy
5691283|NCT00533078|omega3 fatty acid|omega3 fatty acid
5691284|NCT00533078|parenteral nutrition|parenteral nutrition
5691285|NCT00533078|chemotherapy|chemotherapy
5691286|NCT00533078|infection|infection
5691287|NCT00533078|neutropenia|neutropenia
5691288|NCT00533065|Aging|aging
5691289|NCT00533052|Behavioral weight loss|behavioral weight loss
5691290|NCT00532974|HIV|hiv
5691291|NCT00532974|Human Immunodeficiency Virus|human immunodeficiency virus
5691292|NCT00532974|Vaccines|vaccines
5691293|NCT00532974|HIV Vaccines|hiv vaccines
5691294|NCT00532974|Peptide|peptide
5691295|NCT00532974|Peptide Vaccines|peptide vaccines
5691296|NCT00532974|HIV 1|hiv 1
5691297|NCT00532883|Sickle Cell Disease|sickle cell disease
5691298|NCT00532883|Vaso-occlusive Event|vaso-occlusive event
5691299|NCT00532883|Painful Crises|painful crises
5708385|NCT00470769|GFR|gfr
5691300|NCT00532883|Acute Chest Syndrome|acute chest syndrome
5691301|NCT00532870|laparoscopy|laparoscopy
5691302|NCT00532870|ventral hernia|ventral hernia
5691303|NCT00532870|mesh|mesh
5691400|NCT00532493|PTSD|ptsd
5691401|NCT00532493|Sleep Disturbance|sleep disturbance
5691306|NCT00532870|Surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.|surgeons have struggled to reduce the morbidity from incarceration (6% to 15% of cases) and strangulation (2%) of these hernias.
5691307|NCT00532857|Patients with HER2 + stage II/III breast cancer|patients with her2 + stage ii/iii breast cancer
5691318|NCT00532818|Hydralazine|hydralazine
5691319|NCT00532818|Valproate|valproate
5691320|NCT00532818|Cervical cancer|cervical cancer
5691321|NCT00532818|Randomized|randomized
5691322|NCT00532818|Phase III|phase iii
5691323|NCT00532805|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5691324|NCT00532792|Avian|avian
5691325|NCT00532792|Pandemic|pandemic
5691326|NCT00532792|Influenza|influenza
5691327|NCT00532792|A/H5N1|a/h5n1
5691328|NCT00532779|Obesity|obesity
5691329|NCT00532779|Antiobesity agents|antiobesity agents
5691330|NCT00532779|Antiobesity drugs|antiobesity drugs
5691331|NCT00532779|Overweight drug therapy|overweight drug therapy
5691332|NCT00532779|Obese drug therapy|obese drug therapy
5691333|NCT00532779|Weight loss drug effects|weight loss drug effects
5691334|NCT00532779|Bupropion administration and dosage|bupropion administration and dosage
5691335|NCT00532779|Naltrexone administration and dosage|naltrexone administration and dosage
5691336|NCT00532779|Double blind method|double blind method
5691337|NCT00532779|Combination drug therapy|combination drug therapy
5691338|NCT00532779|Delayed action preparations|delayed action preparations
5691339|NCT00532766|Healthy subjects|healthy subjects
5691340|NCT00532753|empowerment|empowerment
5691341|NCT00532753|health|health
5691342|NCT00532753|education|education
5691343|NCT00532740|liver metastases|liver metastases
5691344|NCT00532740|advanced adult primary liver cancer|advanced adult primary liver cancer
5691345|NCT00532727|Breast Cancer|breast cancer
5691346|NCT00532727|Triple Negative|triple negative
5691347|NCT00532701|Chronic hepatitis C|chronic hepatitis c
5691348|NCT00532701|Genotype|genotype
5691349|NCT00532701|Interferon|interferon
5691350|NCT00532701|Ribavirin|ribavirin
5691352|NCT00532701|Peginterferon|peginterferon
5691353|NCT00532688|acetylcysteine|acetylcysteine
5691354|NCT00532688|N-acetylcysteine|n-acetylcysteine
5691355|NCT00532688|heart failure|heart failure
5691356|NCT00532688|renal failure|renal failure
5685707|NCT00555048|graft versus host disease|graft versus host disease
5691357|NCT00532675|Myeloma|myeloma
5691358|NCT00532675|Multiple Myeloma|multiple myeloma
5691359|NCT00532675|Lenalidomide|lenalidomide
5691360|NCT00532675|Revlimid|revlimid
5691361|NCT00532675|Dexamethasone|dexamethasone
5691362|NCT00532675|LBH589|lbh589
5691363|NCT00532675|Combination|combination
5691364|NCT00532662|Epidural|epidural
5691365|NCT00532662|Intravenous|intravenous
5691366|NCT00532662|Ketamine|ketamine
5691367|NCT00532662|Analgesia|analgesia
5691368|NCT00532662|Caudal|caudal
5691369|NCT00532662|Pediatric|pediatric
5691370|NCT00532662|Regional|regional
5691371|NCT00532662|Local Anesthetics|local anesthetics
5691372|NCT00532636|Airway|airway
5691373|NCT00532636|Airway obstruction|airway obstruction
5691374|NCT00532636|Mouth-to-mask resuscitation|mouth-to-mask resuscitation
5691375|NCT00532636|Respiration artificial|respiration artificial
5691376|NCT00532636|Ventilation|ventilation
5691377|NCT00532636|Ventilation of an unprotected airway|ventilation of an unprotected airway
5691378|NCT00532636|Safety and efficiency of mask ventilation|safety and efficiency of mask ventilation
5691379|NCT00532636|Avoidance of stomach inflation|avoidance of stomach inflation
5691380|NCT00532610|Diabetes,|diabetes,
5691381|NCT00532610|ECG,|ecg,
5691382|NCT00532610|Healthy Volunteers|healthy volunteers
5691383|NCT00532610|GSK189075,|gsk189075,
5691384|NCT00532597|Vascular Endothelium-Dependent Relaxation|vascular endothelium-dependent relaxation
5691385|NCT00532597|Hemodialysis|hemodialysis
5691386|NCT00532597|Hemodiafiltration|hemodiafiltration
5691387|NCT00532584|COPD|copd
5691388|NCT00532584|inhaled steroids|inhaled steroids
5691389|NCT00532584|bronchodilator|bronchodilator
5691390|NCT00532584|gene expression|gene expression
5691391|NCT00532584|smoker's lungs|smoker's lungs
5691392|NCT00532571|CoQ10|coq10
5691393|NCT00532571|PSP|psp
5691394|NCT00532571|CBD|cbd
5691395|NCT00532558|Hyperlipidemia|hyperlipidemia
5691396|NCT00532558|Drug Therapy|drug therapy
5691397|NCT00532532|Multiple sclerosis|multiple sclerosis
5691398|NCT00532493|Combat Trauma|combat trauma
5691399|NCT00532493|Post traumatic stress disorder|post traumatic stress disorder
5691402|NCT00532493|Trauma-Related Nightmares|trauma-related nightmares
5691403|NCT00532480|Depression|depression
5691404|NCT00532480|Duloxetine|duloxetine
5691405|NCT00532480|fMRI|fmri
5691406|NCT00532480|pictures|pictures
5691407|NCT00532467|healthy volunteers|healthy volunteers
5691408|NCT00532415|Vitrectomy|vitrectomy
5691409|NCT00532415|Visualization|visualization
5691410|NCT00532402|Monitoring|monitoring
5691411|NCT00532402|Breathing Gas|breathing gas
5691414|NCT00532389|Multiple Myeloma|multiple myeloma
5691415|NCT00532389|Bortezomib|bortezomib
5691417|NCT00532389|Combination|combination
5691418|NCT00532376|epilepsy|epilepsy
5691419|NCT00532376|depression|depression
5691420|NCT00532376|fMRI|fmri
5691421|NCT00532376|emotion|emotion
5691422|NCT00532350|COPD|copd
5691423|NCT00532350|pharmacokinetics|pharmacokinetics
5691424|NCT00532350|plethysmography|plethysmography
5691425|NCT00532350|cycle ergometry|cycle ergometry
5691426|NCT00532350|exercise testing|exercise testing
5691427|NCT00532350|spirometry|spirometry
5691428|NCT00532337|ONO-5334|ono-5334
5691429|NCT00532337|osteoporosis|osteoporosis
5691430|NCT00532337|osteopenia|osteopenia
5691431|NCT00532324|Methicillin resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5691432|NCT00532324|Staphylococcus aureus|staphylococcus aureus
5691433|NCT00532324|Healthy term and near term neonates|healthy term and near term neonates
5691434|NCT00532324|Prevention|prevention
5691435|NCT00532324|Nasal and Vaginal Colonization rates|nasal and vaginal colonization rates
5691436|NCT00532324|Pregnant women|pregnant women
5691437|NCT00532311|Hyperlipidemia|hyperlipidemia
5691438|NCT00532311|Drug Therapy|drug therapy
5691439|NCT00532298|Fluarix|fluarix
5691440|NCT00532298|Influenza Infection|influenza infection
5691441|NCT00532298|GSK Biologicals' influenza vaccine GSK576389A|gsk biologicals' influenza vaccine gsk576389a
5691442|NCT00532259|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5691443|NCT00532259|Transformed Follicular Lymphoma|transformed follicular lymphoma
5691444|NCT00532259|Stem cell transplantation|stem cell transplantation
5691445|NCT00532259|Relapsed|relapsed
5691446|NCT00532259|Refractory|refractory
5691447|NCT00532233|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5691448|NCT00532220|osteonecrosis|osteonecrosis
5691449|NCT00532220|bone marrow edema|bone marrow edema
5691450|NCT00532220|ibandronate|ibandronate
5691451|NCT00532220|bisphosphonate|bisphosphonate
5691452|NCT00532220|knee|knee
5691453|NCT00532194|ovarian cancer|ovarian cancer
5691454|NCT00532194|fallopian tube cancer|fallopian tube cancer
5691455|NCT00532194|primary serous peritoneal cancer|primary serous peritoneal cancer
5691456|NCT00532194|gynaecological carcinoma|gynaecological carcinoma
5686397|NCT00552344|CIMZIA|cimzia
5691457|NCT00532194|randomised controlled trial|randomised controlled trial
5691458|NCT00532194|Cediranib|cediranib
5691459|NCT00532194|AZD2171|azd2171
5691460|NCT00532194|efficacy|efficacy
5691461|NCT00532181|Health insurance|health insurance
5691462|NCT00532181|Health utilization rates|health utilization rates
5691463|NCT00532181|Saving Behavior|saving behavior
5691464|NCT00532181|Risk aversion|risk aversion
5691465|NCT00532168|advanced HIV-infected patients|advanced hiv-infected patients
5691466|NCT00532168|late presenters|late presenters
5691467|NCT00532168|antiretroviral therapy|antiretroviral therapy
5691468|NCT00532168|immune reconstitution|immune reconstitution
5691469|NCT00532168|Treatment Naive|treatment naive
5691470|NCT00532155|lung cancer|lung cancer
5691471|NCT00532155|angiogenesis inhibitor|angiogenesis inhibitor
5691472|NCT00532155|chemotherapy|chemotherapy
5691473|NCT00532116|Healthy|healthy
5691474|NCT00532116|Elderly|elderly
5691475|NCT00532116|Non Elderly|non elderly
5691476|NCT00532116|Healthy Volunteers|healthy volunteers
5691477|NCT00532103|Suicidal Ideation|suicidal ideation
5691478|NCT00532103|Major Depressive Disorder|major depressive disorder
5691479|NCT00532103|Suicide Risk|suicide risk
5691480|NCT00532103|Antidepressant Medication|antidepressant medication
5691481|NCT00532077|renal,|renal,
5691482|NCT00532077|pharmacology,|pharmacology,
5691483|NCT00532077|Osteoporosis|osteoporosis
5691484|NCT00532051|cataract, lasik, laser refractive surgery|cataract, lasik, laser refractive surgery
5691485|NCT00532038|Osteoarthritis|osteoarthritis
5691486|NCT00532038|Pain|pain
5691487|NCT00532025|Sorafenib|sorafenib
5691488|NCT00532025|NSCLC|nsclc
5691489|NCT00532025|Adjuvant Treatment|adjuvant treatment
5691490|NCT00532025|resected Non-Small Cell Lung Carcinoma|resected non-small cell lung carcinoma
5691491|NCT00532012|Rheumatoid Arthritis|rheumatoid arthritis
5691492|NCT00532012|RhuDex®|rhudex®
5691493|NCT00532012|Meglumine|meglumine
5691494|NCT00532012|Oral Bioavailability|oral bioavailability
5691495|NCT00531999|Raltegravir|raltegravir
5691496|NCT00531999|Euglycaemic clamp|euglycaemic clamp
5691497|NCT00531999|healthy volunteer|healthy volunteer
5691498|NCT00531986|Monotherapy|monotherapy
5691499|NCT00531986|Neuropsychological tests|neuropsychological tests
5691500|NCT00531986|HIV viral load in ZNS|hiv viral load in zns
5691501|NCT00531986|HIV viral load in genital|hiv viral load in genital
5692252|NCT00528762|Puberty|puberty
5691502|NCT00531986|Lumbar puncture and HIV viral load in ZNS|lumbar puncture and hiv viral load in zns
5691503|NCT00531986|Monotherapy and compartment failure (ZNS and genital)|monotherapy and compartment failure (zns and genital)
5691504|NCT00531986|ZNS viral load under monotherapy|zns viral load under monotherapy
5691505|NCT00531986|Genital viral load under monotherapy|genital viral load under monotherapy
5691506|NCT00531986|Neuropsychological tests (HIV Dementia)|neuropsychological tests (hiv dementia)
5691507|NCT00531986|Treatment Experienced|treatment experienced
5691509|NCT00531973|echocardiography|echocardiography
5691510|NCT00531973|neoplasia|neoplasia
5691511|NCT00531947|Mental Health|mental health
5691512|NCT00531947|Adolescents|adolescents
5691513|NCT00531947|Major Depressive Disorder|major depressive disorder
5691514|NCT00531947|Depression|depression
5691515|NCT00531947|Adolescent Depression|adolescent depression
5691516|NCT00531947|Pediatric Depression|pediatric depression
5691517|NCT00531921|Heart Diseases|heart diseases
5691518|NCT00531921|Kidney Diseases|kidney diseases
5691519|NCT00531921|Liver Diseases|liver diseases
5691520|NCT00531921|Liver Failure|liver failure
5691521|NCT00531921|Lung Diseases|lung diseases
5691522|NCT00531921|Transplant|transplant
5691523|NCT00531921|Transplantation, Homologous|transplantation, homologous
5691524|NCT00531921|Rejection|rejection
5691525|NCT00531921|Kidney Failure|kidney failure
5691526|NCT00531908|Growth Hormone|growth hormone
5691527|NCT00531908|Epithelial sodium channel|epithelial sodium channel
5691528|NCT00531908|Hypertension|hypertension
5691529|NCT00531908|A Furosemide|a furosemide
5691530|NCT00531908|Nasal Mucosa|nasal mucosa
5691531|NCT00531895|major depression|major depression
5691532|NCT00531895|chronic headache|chronic headache
5691533|NCT00531895|antidepressant|antidepressant
5691534|NCT00531895|duloxetine|duloxetine
5691535|NCT00531882|healthy volunteers|healthy volunteers
5691536|NCT00531882|neutrophil migration|neutrophil migration
5691537|NCT00531882|anti inflammatory non-steroidal agent|anti inflammatory non-steroidal agent
5691538|NCT00531882|simvastatin|simvastatin
5691539|NCT00531882|pioglitazone|pioglitazone
5691540|NCT00531869|safewater|safewater
5691541|NCT00531869|randomized|randomized
5691542|NCT00531856|Kidney Transplant, Carbon Monoxide|kidney transplant, carbon monoxide
5691543|NCT00531843|deep vein thrombosis|deep vein thrombosis
5691544|NCT00531843|venous thromboembolism|venous thromboembolism
5691545|NCT00531843|pulmonary embolism|pulmonary embolism
5691546|NCT00531830|children with PDD|children with pdd
5691547|NCT00531791|COPD|copd
5691548|NCT00531791|exacerbation|exacerbation
5691549|NCT00531791|fluticasone|fluticasone
5691550|NCT00531791|salmeterol|salmeterol
5691551|NCT00531791|steroid|steroid
5691552|NCT00531778|Women with increased risk for developing ovarian cancer|women with increased risk for developing ovarian cancer
5691553|NCT00531778|early detection|early detection
5691554|NCT00531778|biomarker for ovarian cancer|biomarker for ovarian cancer
5691555|NCT00531765|contrast-induced-nephropathy,|contrast-induced-nephropathy,
5691556|NCT00531765|cardiac cath|cardiac cath
5691557|NCT00531765|creatinine|creatinine
5691558|NCT00531765|contrast|contrast
5691559|NCT00531765|nephropathy|nephropathy
5691560|NCT00531739|Surgery|surgery
5691561|NCT00531739|Colectomy|colectomy
5691562|NCT00531739|Proctocolectomy|proctocolectomy
5691563|NCT00531739|Adhesions|adhesions
5691564|NCT00531713|hypothyroidism, quality og life, depression|hypothyroidism, quality og life, depression
5691565|NCT00531700|influenza|influenza
5691566|NCT00531700|risk behaviors|risk behaviors
5691567|NCT00531700|immunization|immunization
5691568|NCT00531700|knowledge attitudes behaviors|knowledge attitudes behaviors
5691569|NCT00531700|personally controlled health record|personally controlled health record
5691570|NCT00531700|Indivo|indivo
5691571|NCT00531687|relapse|relapse
5691572|NCT00531674|Efficacy of public health intervention (nutrition)|efficacy of public health intervention (nutrition)
5691573|NCT00531648|Toddlers that having feeding disorders and SPD|toddlers that having feeding disorders and spd
5691574|NCT00531635|Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil|mixed hemopoietic chimerism, fludarabine, tbi, pbsc, immunosuppression, mycophenolate mofetil
5691576|NCT00531622|Major Depressive Episode|major depressive episode
5691577|NCT00531622|Antidepressant|antidepressant
5691578|NCT00531596|Elderly|elderly
5691579|NCT00531596|Non Elderly|non elderly
5691580|NCT00531596|Healthy Volunteers|healthy volunteers
5691581|NCT00531583|AML in 1st & 2nd complete remission w/no HLA matched related donor|aml in 1st & 2nd complete remission w/no hla matched related donor
5691582|NCT00531570|Women with ultrasound defined complex pelvic masses|women with ultrasound defined complex pelvic masses
5691583|NCT00531557|Darunavir|darunavir
5691584|NCT00531557|Euglycaemic clamp|euglycaemic clamp
5691585|NCT00531557|HIV|hiv
5691586|NCT00531557|Treatment Experienced|treatment experienced
5691587|NCT00531531|pulmonary infection|pulmonary infection
5691588|NCT00531531|transmission|transmission
5691589|NCT00531531|P.Aeruginosa|p.aeruginosa
5691590|NCT00531531|surfaces|surfaces
5691591|NCT00531518|Schizophrenia|schizophrenia
5691592|NCT00531518|Bipolar disorder|bipolar disorder
5691593|NCT00531518|Psychosis|psychosis
5692253|NCT00528762|Body Weight|body weight
5691594|NCT00531518|Prodromal psychosis|prodromal psychosis
5691595|NCT00531518|Family psychoeducation|family psychoeducation
5691596|NCT00531518|Supported education|supported education
5691597|NCT00531518|Supported employment|supported employment
5691598|NCT00531518|Ulra-high-risk for psychosis|ulra-high-risk for psychosis
5691599|NCT00531518|Major depression|major depression
5691600|NCT00531518|Bipolar disorder, with psychotic features|bipolar disorder, with psychotic features
5691601|NCT00531518|Major depression, with psychotic features|major depression, with psychotic features
5691602|NCT00531518|Attenuated, prodromal psychotic symptoms|attenuated, prodromal psychotic symptoms
5691603|NCT00531505|Obesity|obesity
5691604|NCT00531492|Maternal and child health|maternal and child health
5691605|NCT00531492|Developing country|developing country
5691606|NCT00531492|Skin to skin care|skin to skin care
5691607|NCT00531492|Newly born low birth weight infants and their mothers|newly born low birth weight infants and their mothers
5691608|NCT00531492|(Delivery at University Hospital Center, Mahajanga, Madagascar)|(delivery at university hospital center, mahajanga, madagascar)
5691609|NCT00531466|Spinal cord injury|spinal cord injury
5691610|NCT00531440|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
5691611|NCT00531427|Chronic pain,|chronic pain,
5691612|NCT00531427|OA of the knee,|oa of the knee,
5691613|NCT00531427|opioid,|opioid,
5691614|NCT00531427|transdermal|transdermal
5691615|NCT00531414|Asthmatic|asthmatic
5691616|NCT00531414|healthy|healthy
5691617|NCT00531401|Non-Small-Cell Lung|non-small-cell lung
5691618|NCT00531362|Atherosclerosis|atherosclerosis
5691619|NCT00531362|Aspirin|aspirin
5691620|NCT00531362|Resistance,|resistance,
5691621|NCT00531362|Acute coronary syndromes|acute coronary syndromes
5691622|NCT00531349|Endometrial Cancer|endometrial cancer
5691623|NCT00531349|Anesthesia; regional|anesthesia; regional
5691624|NCT00531349|cancer recurrence|cancer recurrence
5691625|NCT00531349|Analgesia; opioid|analgesia; opioid
5691626|NCT00531336|age-related Macular degeneration|age-related macular degeneration
5691627|NCT00531336|Macugen|macugen
5691628|NCT00531336|Avastin|avastin
5691629|NCT00531323|Pharmacokinetic|pharmacokinetic
5691630|NCT00531323|TMC125|tmc125
5691631|NCT00531323|Healthy volunteers|healthy volunteers
5691632|NCT00531323|Efavarinz|efavarinz
5691633|NCT00531310|CML|cml
5691634|NCT00531310|allogeneic SCT|allogeneic sct
5691635|NCT00531310|matched family donor|matched family donor
5691636|NCT00531310|unrelated donor|unrelated donor
5691637|NCT00531310|cord blood donor|cord blood donor
5691638|NCT00531310|persistent disease|persistent disease
5691639|NCT00531284|Non-small cell lung carcinoma|non-small cell lung carcinoma
5691640|NCT00531284|Small-cell lung carcinoma|small-cell lung carcinoma
5691641|NCT00531284|Ovarian Cancer|ovarian cancer
5691642|NCT00531284|Renal Cancer|renal cancer
5691643|NCT00531284|Other solid tumors|other solid tumors
5691644|NCT00531284|multiple myeloma|multiple myeloma
5691646|NCT00531258|Depression|depression
5691647|NCT00531258|TBI|tbi
5691648|NCT00531258|TMS|tms
5685708|NCT00555048|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5691649|NCT00531258|Major Depression resulting from a mild to moderate closed head injury|major depression resulting from a mild to moderate closed head injury
5691650|NCT00531245|TS-1 and oxaliplatin|ts-1 and oxaliplatin
5691651|NCT00531245|Phase I/II study|phase i/ii study
5691652|NCT00531245|Colorectal cancer|colorectal cancer
5691653|NCT00531245|First line treatment|first line treatment
5691654|NCT00531232|Previously treated Myelodysplastic Syndromes (MDS)|previously treated myelodysplastic syndromes (mds)
5691655|NCT00531232|oral clofarabine|oral clofarabine
5691656|NCT00531232|Intermediate-1, Intermediate-2 and High Risk Myelodysplastic Syndromes (MDS)|intermediate-1, intermediate-2 and high risk myelodysplastic syndromes (mds)
5691657|NCT00531232|secondary AML (with history of MDS)|secondary aml (with history of mds)
5691658|NCT00531219|appendicitis|appendicitis
5691659|NCT00531219|cholelithiasis|cholelithiasis
5691660|NCT00531219|gallstones|gallstones
5691661|NCT00531193|Healthy male volunteers|healthy male volunteers
5691662|NCT00531180|Esophageal Cancer|esophageal cancer
5691663|NCT00531180|Lung Cancer|lung cancer
5691664|NCT00531180|Thoracic Malignancies|thoracic malignancies
5691665|NCT00531180|4D CT scans|4d ct scans
5691666|NCT00531180|Lung Function|lung function
5691667|NCT00531167|lamivudine resistant mutations|lamivudine resistant mutations
5691668|NCT00531167|rescue therapy|rescue therapy
5691669|NCT00531141|age-related macular degeneration|age-related macular degeneration
5691670|NCT00531141|optical coherence tomography|optical coherence tomography
5691671|NCT00531141|retinal thickness|retinal thickness
5691672|NCT00531141|exudative age-related macular degeneration|exudative age-related macular degeneration
5691673|NCT00531128|Sitosterol|sitosterol
5691674|NCT00531128|Nutrigenomics|nutrigenomics
5691675|NCT00531128|Gene Expression|gene expression
5691676|NCT00531128|Insulin Resistance|insulin resistance
5691677|NCT00531128|Sitosterolemia|sitosterolemia
5691678|NCT00531115|metastatic colorectal cancer|metastatic colorectal cancer
5691679|NCT00531115|elderly patients|elderly patients
5691680|NCT00531115|cetuximab, oxaliplatin, capecitabine|cetuximab, oxaliplatin, capecitabine
5691681|NCT00531102|oxygen|oxygen
5691682|NCT00531102|continuous positive airway pressure|continuous positive airway pressure
5691683|NCT00531102|infant, newborn|infant, newborn
5692254|NCT00528762|Body Image|body image
5691684|NCT00531102|resuscitation|resuscitation
5691685|NCT00531089|TTP|ttp
5691686|NCT00531089|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5691687|NCT00531089|HUS|hus
5691688|NCT00531089|hemolytic uremic syndrome|hemolytic uremic syndrome
5691690|NCT00531076|bevacizumab|bevacizumab
5691691|NCT00531076|thoracic radiotherapy|thoracic radiotherapy
5691692|NCT00531076|locally-advanced non-small cell lung cancer|locally-advanced non-small cell lung cancer
5691693|NCT00531063|Renal transplantation, everolimus, Immunosuppressants|renal transplantation, everolimus, immunosuppressants
5691695|NCT00531050|cycle ergometry|cycle ergometry
5691696|NCT00531050|exercise testing|exercise testing
5691697|NCT00531050|spirometry|spirometry
5691698|NCT00531050|cardiovascular|cardiovascular
5691699|NCT00531050|salbutamol|salbutamol
5691700|NCT00531050|indacaterol|indacaterol
5691701|NCT00531050|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5691702|NCT00531037|AV block, SND, BTS, AAIsafeR, SafeR, PM implanted|av block, snd, bts, aaisafer, safer, pm implanted
5691703|NCT00531024|Exudative Neovascular|exudative neovascular
5691704|NCT00531024|AMD|amd
5691705|NCT00531024|Avastin|avastin
5691706|NCT00531024|Systemic|systemic
5691707|NCT00531024|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
5691708|NCT00531011|Stents|stents
5691709|NCT00531011|Drug-eluting Stent|drug-eluting stent
5691710|NCT00531011|Angioplasty|angioplasty
5691711|NCT00531011|Coronary Artery stenosis|coronary artery stenosis
5691712|NCT00531011|Coronary Artery Stent Restenosis|coronary artery stent restenosis
5691713|NCT00531011|Stent Thrombosis|stent thrombosis
5691714|NCT00530998|appendicitis|appendicitis
5691715|NCT00530998|cholelithiasis|cholelithiasis
5691716|NCT00530998|Gallstones|gallstones
5691717|NCT00530985|disability|disability
5691718|NCT00530985|substance abuse|substance abuse
5691719|NCT00530985|vocational rehabilitation|vocational rehabilitation
5691720|NCT00530985|case management|case management
5691721|NCT00530972|co-infected HCV/HIV|co-infected hcv/hiv
5691722|NCT00530972|relapsers|relapsers
5691723|NCT00530907|Advanced Cancer|advanced cancer
5691724|NCT00530907|Valproic Acid|valproic acid
5691725|NCT00530907|Depakene|depakene
5691726|NCT00530907|Bevacizumab|bevacizumab
5691727|NCT00530907|Avastin|avastin
5691728|NCT00530907|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5691729|NCT00530907|rhuMAb-VEGF|rhumab-vegf
5691730|NCT00530894|Valvular Heart Disease|valvular heart disease
5691731|NCT00530894|Critical/Severe Aortic Stenosis|critical/severe aortic stenosis
5691732|NCT00530894|High risk symptomatic patients|high risk symptomatic patients
5691733|NCT00530868|Hormonal and antibody therapy for breast cancer|hormonal and antibody therapy for breast cancer
5691734|NCT00530868|Hormonal therapy for breast cancer|hormonal therapy for breast cancer
5686684|NCT00551096|Advanced Solid Tumors|advanced solid tumors
5691735|NCT00530868|Antibody therapy for breast cancer|antibody therapy for breast cancer
5691737|NCT00530855|Partial-onset Seizures|partial-onset seizures
5691738|NCT00530855|Lacosamide|lacosamide
5691739|NCT00530855|Monotherapy|monotherapy
5691740|NCT00530855|Vimpat|vimpat
5691741|NCT00530829|diarrhea|diarrhea
5691742|NCT00530829|zinc|zinc
5691743|NCT00530829|oral rehydration therapy|oral rehydration therapy
5691744|NCT00530803|EMLA|emla
5691745|NCT00530803|venipuncture|venipuncture
5691746|NCT00530803|children|children
5691747|NCT00530803|Synera patch|synera patch
5691748|NCT00530803|pediatric|pediatric
5691749|NCT00530803|Lidocaine/prilocaine|lidocaine/prilocaine
5691750|NCT00530790|Restless Legs Syndrome|restless legs syndrome
5691751|NCT00530777|Disease Transmission, Vertical|disease transmission, vertical
5691752|NCT00530777|valacyclovir|valacyclovir
5691753|NCT00530777|Randomized Controlled Trials|randomized controlled trials
5691754|NCT00530777|HIV|hiv
5691755|NCT00530777|herpes|herpes
5691756|NCT00530777|Herpesvirus 2, Human|herpesvirus 2, human
5691757|NCT00530777|HIV Seronegativity|hiv seronegativity
5691758|NCT00530764|Pain|pain
5691759|NCT00530764|Cancer|cancer
5691760|NCT00530764|Palliative|palliative
5691761|NCT00530751|breast cancer|breast cancer
5691762|NCT00530738|HPN|hpn
5691763|NCT00530738|lipid emulsion|lipid emulsion
5691764|NCT00530738|long term|long term
5691765|NCT00530738|insufficient enteral resorption capacity|insufficient enteral resorption capacity
5691766|NCT00530725|occult pneumothorax|occult pneumothorax
5691767|NCT00530725|mechanical ventilation|mechanical ventilation
5691768|NCT00530725|critical care|critical care
5691769|NCT00530725|pneumothorax|pneumothorax
5691770|NCT00530725|thoracostomy|thoracostomy
5691771|NCT00530712|SFA|sfa
5691772|NCT00530712|Popliteal|popliteal
5691773|NCT00530712|Stent|stent
5691774|NCT00530712|EverFlex|everflex
5691775|NCT00530699|Acute Myeloid Leukaemia|acute myeloid leukaemia
5691776|NCT00530699|Phase 1|phase 1
5691777|NCT00530699|AZD1152|azd1152
5691778|NCT00530686|Diabetes Mellitus|diabetes mellitus
5691779|NCT00530686|Hypoglycemia|hypoglycemia
5691780|NCT00530686|Hyperglycemia|hyperglycemia
5691781|NCT00530686|Type 1 Diabetes|type 1 diabetes
5691782|NCT00530686|Islet cell transplantation|islet cell transplantation
5691783|NCT00530660|Pandemic influenza|pandemic influenza
5691784|NCT00530647|Brain motor network, Plasticity, functional MRI, Stroke|brain motor network, plasticity, functional mri, stroke
5680496|NCT00577798|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5680497|NCT00577798|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5680498|NCT00577798|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5680499|NCT00577798|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5680500|NCT00577798|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5680501|NCT00577798|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5691785|NCT00530634|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5691786|NCT00530634|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5691787|NCT00530634|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5691789|NCT00530582|progesterone, postmenopause, sleep-EEG|progesterone, postmenopause, sleep-eeg
5708799|NCT00469638|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5708800|NCT00469612|Myopia|myopia
5708801|NCT00469612|NeuroVision|neurovision
5708802|NCT00469612|Visual acuity|visual acuity
5691790|NCT00530569|Breast Cancer|breast cancer
5691791|NCT00530569|Herceptin Therapy|herceptin therapy
5691792|NCT00530543|Robot|robot
5691793|NCT00530543|Gait|gait
5691794|NCT00530543|Stroke|stroke
5691795|NCT00530530|ASP8825|asp8825
5691796|NCT00530530|Restless legs Syndrome|restless legs syndrome
5691797|NCT00530530|XP13512|xp13512
5691798|NCT00530517|migraine|migraine
5691799|NCT00530517|sumatripatan|sumatripatan
5691800|NCT00530504|Carotid Artery Disease|carotid artery disease
5691801|NCT00530504|Embolic Protection|embolic protection
5691802|NCT00530491|lung resection|lung resection
5691803|NCT00530491|reduced pulmonary function|reduced pulmonary function
5691804|NCT00530478|Donepezil|donepezil
5691805|NCT00530478|Stroke|stroke
5691806|NCT00530478|Cognitive function|cognitive function
5691807|NCT00530478|Cognitive neural network|cognitive neural network
5691808|NCT00530452|COX-2|cox-2
5691809|NCT00530452|carbonic anhydrase|carbonic anhydrase
5691810|NCT00530452|osteoarthritis|osteoarthritis
5691811|NCT00530452|anti-inflammatory|anti-inflammatory
5691812|NCT00530452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors
5691813|NCT00530426|Heart Failure, Congestive|heart failure, congestive
5691814|NCT00530426|Registry|registry
5691815|NCT00530426|Acute Decompensated Heart Failure|acute decompensated heart failure
5691816|NCT00530426|Dyspnea|dyspnea
5691817|NCT00530400|Antibiotic prophylaxis|antibiotic prophylaxis
5691818|NCT00530400|Bacterial Infections / prevention & control|bacterial infections / prevention & control
5691819|NCT00530400|Surgical wound infection / prevention & control|surgical wound infection / prevention & control
5686769|NCT00550615|Dasatinib|dasatinib
5691821|NCT00530400|Postoperative Complications / prevention & control|postoperative complications / prevention & control
5691822|NCT00530400|Clinical trial [publication type]|clinical trial [publication type]
5690400|NCT00536614|EGFR|egfr
5691823|NCT00530387|Photocontact|photocontact
5691824|NCT00530387|Dermatitis|dermatitis
5691825|NCT00530387|NSAID|nsaid
5691826|NCT00530387|Sunscreen|sunscreen
5691827|NCT00530387|Photopatch|photopatch
5691828|NCT00530374|Pediatrics|pediatrics
5691829|NCT00530374|Malnutrition|malnutrition
5691830|NCT00530374|Iron Deficiency|iron deficiency
5691831|NCT00530374|Sprinkles|sprinkles
5691832|NCT00530374|Oral Iron Supplementation|oral iron supplementation
5691833|NCT00530361|Myocardial Ischemia|myocardial ischemia
5691834|NCT00530361|Kidney failure|kidney failure
5691835|NCT00530361|CABG|cabg
5691836|NCT00530361|Cardiopulmonary bypass (CPB) pump|cardiopulmonary bypass (cpb) pump
5691837|NCT00530361|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5691838|NCT00530361|Heart surgery|heart surgery
5691839|NCT00530361|Nesiritide|nesiritide
5691840|NCT00530361|Coronary Heart Disease|coronary heart disease
5691841|NCT00530348|Multiple Sclerosis|multiple sclerosis
5691842|NCT00530322|Adhesions|adhesions
5691843|NCT00530322|Laparoscopy|laparoscopy
5691844|NCT00530322|Colorectal surgery|colorectal surgery
5691845|NCT00530322|Colorectal disease|colorectal disease
5691846|NCT00530309|GLP-1|glp-1
5691847|NCT00530309|type 2 diabeted mellitus|type 2 diabeted mellitus
5691848|NCT00530309|safety|safety
5691849|NCT00530309|GSK716155|gsk716155
5691850|NCT00530309|GLP-1 receptor agonist|glp-1 receptor agonist
5691851|NCT00530309|tolerability|tolerability
5691852|NCT00530309|pharmacokinetics|pharmacokinetics
5691853|NCT00530309|pharmacodynamics|pharmacodynamics
5691854|NCT00530296|Depression|depression
5691855|NCT00530296|End stage renal disease|end stage renal disease
5691856|NCT00530296|Quality of Life|quality of life
5691857|NCT00530296|Cognitive Behavioral Therapy|cognitive behavioral therapy
5680502|NCT00577798|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5680503|NCT00577798|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5680504|NCT00577798|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5717471|NCT00440713|Depression|depression
5691858|NCT00530283|Squamous|squamous
5691859|NCT00530283|Unknown Primary|unknown primary
5691860|NCT00530283|Patients with Squamous cell cancer neck nodes|patients with squamous cell cancer neck nodes
5691861|NCT00530270|Sickle Cell Disease|sickle cell disease
5691863|NCT00530270|Acute Chest Syndrome|acute chest syndrome
5691864|NCT00530270|Hgb SS|hgb ss
5691865|NCT00530270|Hgb Sβ0|hgb sβ0
5691866|NCT00530270|Dexamethasone|dexamethasone
5691867|NCT00530257|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5691868|NCT00530257|Methylphenidate|methylphenidate
5691869|NCT00530257|Attention|attention
5691870|NCT00530257|Working Memory|working memory
5691871|NCT00530244|cystic fibrosis|cystic fibrosis
5691872|NCT00530244|fatty acids|fatty acids
5691873|NCT00530244|docosahexaenoic acid|docosahexaenoic acid
5691874|NCT00530244|infant formula|infant formula
5691875|NCT00530244|growth|growth
5691876|NCT00530244|pancreatic function|pancreatic function
5691877|NCT00530231|Capsule endoscopy|capsule endoscopy
5691878|NCT00530231|Missing rate|missing rate
5691879|NCT00530205|weight changes|weight changes
5691880|NCT00530205|malnutrition|malnutrition
5848037|NCT00036582|Treatment-Refractory|treatment-refractory
5691881|NCT00530205|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5691882|NCT00530192|Refractory Cancer|refractory cancer
5691883|NCT00530192|Molecular Profile|molecular profile
5691884|NCT00530179|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5691885|NCT00530179|Positron Emission Tomography|positron emission tomography
5691886|NCT00530179|CHOP Chemotherapy protocol|chop chemotherapy protocol
5691887|NCT00530179|Stem Cell Transplantation|stem cell transplantation
5691888|NCT00530179|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5691889|NCT00530166|Asthma|asthma
5691890|NCT00530166|persistant asthma|persistant asthma
5691891|NCT00530166|controller medications|controller medications
5691892|NCT00530166|FEV1|fev1
5691893|NCT00530153|Eating|eating
5691894|NCT00530153|Food Habits|food habits
5691895|NCT00530153|Adolescent|adolescent
5691896|NCT00530153|Dental Research|dental research
5691897|NCT00530140|Follicular Lymphoma|follicular lymphoma
5691898|NCT00530140|Idiotype vaccine|idiotype vaccine
5691899|NCT00530127|Friedreich's ataxia|friedreich's ataxia
5691900|NCT00530088|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5691901|NCT00530088|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5691902|NCT00530088|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5691903|NCT00530088|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5691904|NCT00530088|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5691905|NCT00530088|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5691906|NCT00530075|Wegener Granulomatosis|wegener granulomatosis
5691907|NCT00530075|Vasculitis|vasculitis
5691908|NCT00530075|Gusperimus|gusperimus
5691909|NCT00530075|Immunosuppression|immunosuppression
5691910|NCT00530062|Asthma and Poor Coordinators of Asthma Inhalers|asthma and poor coordinators of asthma inhalers
5699458|NCT00503035|Celebrex|celebrex
5690538|NCT00536042|IgE|ige
5691911|NCT00530049|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5691912|NCT00530049|hypopharyngeal cancer|hypopharyngeal cancer
5691913|NCT00530049|laryngeal cancer|laryngeal cancer
5691914|NCT00530049|lip and oral cavity cancer|lip and oral cavity cancer
5691915|NCT00530049|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5691916|NCT00530049|nasopharyngeal cancer|nasopharyngeal cancer
5691917|NCT00530049|oropharyngeal cancer|oropharyngeal cancer
5691918|NCT00530049|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5691919|NCT00530049|salivary gland cancer|salivary gland cancer
5691920|NCT00530049|tongue cancer|tongue cancer
5691922|NCT00530036|Mortality|mortality
5691923|NCT00530036|Patient readmission|patient readmission
5691924|NCT00530036|Institutionalization|institutionalization
5691925|NCT00530010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5691926|NCT00530010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5691927|NCT00530010|advanced adult primary liver cancer|advanced adult primary liver cancer
5691928|NCT00529997|Lumbar Spine|lumbar spine
5691929|NCT00529997|Lumbar Spinal Stenosis|lumbar spinal stenosis
5691930|NCT00529997|Spondylolisthesis|spondylolisthesis
5691931|NCT00529997|Dynamic Stabilization|dynamic stabilization
5691932|NCT00529997|Motion Preserving|motion preserving
5691933|NCT00529997|Arthroplasty|arthroplasty
5691934|NCT00529997|Randomized|randomized
5691935|NCT00529997|Investigational|investigational
5691936|NCT00529997|Back Pain|back pain
5691938|NCT00529984|CEA|cea
5691939|NCT00529984|CEA-expressing malignancies|cea-expressing malignancies
5691940|NCT00529984|Metastatic malignancies|metastatic malignancies
5691941|NCT00529984|VRP Vaccine|vrp vaccine
5691942|NCT00529984|Alphavirus replicons|alphavirus replicons
5691943|NCT00529984|Molecular therapeutics|molecular therapeutics
5691944|NCT00529984|Stage III colon cancer|stage iii colon cancer
5691945|NCT00529971|Mindfulness|mindfulness
5691946|NCT00529971|HIV|hiv
5691947|NCT00529971|Male|male
5691948|NCT00529971|Living with HIV|living with hiv
5691949|NCT00529971|18-70 years of age|18-70 years of age
5691950|NCT00529971|live within one hour of hospital|live within one hour of hospital
5691951|NCT00529971|fluent in English|fluent in english
5691952|NCT00529971|Complementary Therapies|complementary therapies
5691953|NCT00529971|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5691954|NCT00529958|Anterior Cruciate Ligament (ACL) Reconstruction|anterior cruciate ligament (acl) reconstruction
5691955|NCT00529958|Patellar Tendon|patellar tendon
5691956|NCT00529958|Hamstring Tendon|hamstring tendon
5691957|NCT00529958|Double-Bundle|double-bundle
5691958|NCT00529958|Autograft|autograft
5691959|NCT00529945|PFO|pfo
5691960|NCT00529945|Stroke|stroke
5691961|NCT00529945|Transient Ischemic Attack|transient ischemic attack
5691962|NCT00529945|Migraine|migraine
5691963|NCT00529945|Decompression Illness|decompression illness
5691964|NCT00529932|Acute Myocardial Infarction|acute myocardial infarction
5691965|NCT00529932|Celltherapy|celltherapy
5691966|NCT00529932|Bone Marrow|bone marrow
5691967|NCT00529919|Overweight|overweight
5691968|NCT00529919|Obesity|obesity
5691969|NCT00529919|Weight loss|weight loss
5691970|NCT00529919|Medium chain triglycerides|medium chain triglycerides
5692255|NCT00528762|Focus Group|focus group
5691971|NCT00529919|Cardiovascular disease risk|cardiovascular disease risk
5692215|NCT00528918|hyperglycemia|hyperglycemia
5691972|NCT00529906|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5691973|NCT00529906|neuropsychological deficits|neuropsychological deficits
5691974|NCT00529906|endophenotype|endophenotype
5691975|NCT00529906|molecular genetics|molecular genetics
5691976|NCT00529906|candidate gene|candidate gene
5692263|NCT00528723|as needed|as needed
5691977|NCT00529906|family-based association study|family-based association study
5691978|NCT00529893|Attention-deficit/Hyperactivity Disorder|attention-deficit/hyperactivity disorder
5691979|NCT00529893|neuropsychological functioning|neuropsychological functioning
5691980|NCT00529893|Atomoxetine|atomoxetine
5691982|NCT00529867|Artemether/Lumefantrine suspension|artemether/lumefantrine suspension
5691983|NCT00529867|P. falciparum malaria|p. falciparum malaria
5691984|NCT00529867|children|children
5691985|NCT00529867|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
5691986|NCT00529854|Intensive care unit|intensive care unit
5691987|NCT00529854|medical documentation|medical documentation
5691988|NCT00529854|medical billing|medical billing
5691989|NCT00529841|Salt Wasting Congenital Adrenal Hyperplasia|salt wasting congenital adrenal hyperplasia
5691990|NCT00529841|Subcutaneous Hydrocortisone|subcutaneous hydrocortisone
5691992|NCT00529828|Industrial trans fatty acids|industrial trans fatty acids
5691993|NCT00529828|Oleic acid|oleic acid
5691994|NCT00529828|Controlled dietary trial|controlled dietary trial
5691995|NCT00529815|Continuous|continuous
5691996|NCT00529815|blood|blood
5691997|NCT00529815|glucose|glucose
5691998|NCT00529815|monitoring|monitoring
5691999|NCT00529815|diabetes|diabetes
5692000|NCT00529815|type2|type2
5692002|NCT00529802|renal|renal
5716152|NCT00444288|POS|pos
5690603|NCT00535860|Transdermal|transdermal
5692003|NCT00529802|cell|cell
5692004|NCT00529802|carcinoma|carcinoma
5692005|NCT00529802|cancer|cancer
5692006|NCT00529776|Prevention of ventilator associated pneumonia|prevention of ventilator associated pneumonia
5692007|NCT00529763|Chronic Phase, Advanced Phase chronic myeloid leukemia|chronic phase, advanced phase chronic myeloid leukemia
5692008|NCT00529763|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5692009|NCT00529737|Breast Cancer|breast cancer
5692010|NCT00529737|Marker Clip Migration|marker clip migration
5692011|NCT00529737|Vacuum-Assisted Biopsy|vacuum-assisted biopsy
5692012|NCT00529737|Postprocedure Mammogram|postprocedure mammogram
5692013|NCT00529737|Breast Biopsy|breast biopsy
5692014|NCT00529724|Energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, Parkinson's disease|energy metabolism, metabolic syndrome, by chronic bilateral subthalamic stimulation, parkinson's disease
5692015|NCT00529724|Patients with Parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.|patients with parkinson's disease and will be treated by chronic bilateral subthalamic stimulation.
5692016|NCT00529711|coronary|coronary
5692017|NCT00529711|artery|artery
5692018|NCT00529711|bypass|bypass
5692019|NCT00529711|grafting|grafting
5692020|NCT00529711|IV|iv
5692021|NCT00529711|cardiac output|cardiac output
5692022|NCT00529698|HIV|hiv
5692023|NCT00529698|Tat protein|tat protein
5692024|NCT00529698|Preventative vaccine|preventative vaccine
5692025|NCT00529698|Healthy volunteers|healthy volunteers
5692026|NCT00529698|HIV-1/2 uninfected|hiv-1/2 uninfected
5692027|NCT00529698|HIV Preventive Vaccine|hiv preventive vaccine
5680505|NCT00577798|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5680506|NCT00577798|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5680507|NCT00577798|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5680508|NCT00577798|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5680509|NCT00577798|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5680511|NCT00577772|SmartPill Capsule|smartpill capsule
5680512|NCT00577772|Digestive System Diseases|digestive system diseases
5680513|NCT00577772|Small Bowel Bacterial Overgrowth|small bowel bacterial overgrowth
5717685|NCT00439894|Enbrel|enbrel
5692028|NCT00529672|endovenous laser therapy|endovenous laser therapy
5692029|NCT00529672|sclerotherapy|sclerotherapy
5692030|NCT00529672|crossectomy and stripping|crossectomy and stripping
5692031|NCT00529672|surgery|surgery
5692032|NCT00529672|treatment|treatment
5692033|NCT00529672|varicose veins|varicose veins
5692034|NCT00529659|Sarcopenia (loss of muscle mass)|sarcopenia (loss of muscle mass)
5692035|NCT00529646|Healthy adult volunteers|healthy adult volunteers
5692036|NCT00529633|Inflammation|inflammation
5692037|NCT00529633|albumin|albumin
5692038|NCT00529620|Malaria|malaria
5692039|NCT00529620|IPT|ipt
5692040|NCT00529620|preventive treatment|preventive treatment
5692041|NCT00529607|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide|myocardial infarction, reperfusion injury, echocardiography, magnetic resonance imaging, inflammation, nitric oxide
5692042|NCT00529594|Laser Photocoagulation|laser photocoagulation
5692043|NCT00529594|Pain relief|pain relief
5692044|NCT00529581|multiple sclerosis|multiple sclerosis
5692045|NCT00529581|cognitive impairment|cognitive impairment
5692046|NCT00529581|cognitive dysfunction|cognitive dysfunction
5692047|NCT00529581|Cognitive Dysfunction associated with Multiple Sclerosis|cognitive dysfunction associated with multiple sclerosis
5692048|NCT00529568|hepatitis C|hepatitis c
5692049|NCT00529568|ribavirin|ribavirin
5692050|NCT00529568|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5692051|NCT00529568|thrombopoietin|thrombopoietin
5692052|NCT00529568|peginterferon alfa-2b|peginterferon alfa-2b
5692053|NCT00529568|platelets|platelets
5692054|NCT00529542|Polycystic Ovary Syndrome|polycystic ovary syndrome
5692055|NCT00529529|asthma|asthma
5692056|NCT00529529|QAB149|qab149
5692057|NCT00529529|indacaterol|indacaterol
5692058|NCT00529516|Fluarix|fluarix
5848038|NCT00036582|Bipolar|bipolar
5692059|NCT00529516|GSK Bio's influenza vaccine GSK576389A|gsk bio's influenza vaccine gsk576389a
5692060|NCT00529516|Influenza infection|influenza infection
5692061|NCT00529503|Lymphoproliferative Disorders|lymphoproliferative disorders
5692062|NCT00529503|Lymphoma|lymphoma
5692063|NCT00529503|Antigens, CD40|antigens, cd40
5692064|NCT00529503|Antibody, Monoclonal|antibody, monoclonal
5692065|NCT00529503|Combined Modality Therapy|combined modality therapy
5692066|NCT00529503|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5692067|NCT00529503|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5692068|NCT00529503|Hematologic Diseases|hematologic diseases
5692069|NCT00529503|Immunoproliferative Disorders|immunoproliferative disorders
5692070|NCT00529503|Lymphatic Diseases|lymphatic diseases
5692071|NCT00529490|coronary|coronary
5692072|NCT00529490|artery|artery
5692073|NCT00529490|bypass|bypass
5692074|NCT00529490|grafting|grafting
5692075|NCT00529490|I.V.|i.v.
5692076|NCT00529490|cardiac output|cardiac output
5687035|NCT00549367|Nutrition counselling|nutrition counselling
5692077|NCT00529464|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5692078|NCT00529464|Cervical Dysplasia|cervical dysplasia
5692079|NCT00529464|Cervical Cancer|cervical cancer
5692080|NCT00529464|Fluorescence Spectroscopy|fluorescence spectroscopy
5692081|NCT00529464|Colposcopy|colposcopy
5692082|NCT00529464|Loop Electrical Excision Procedure|loop electrical excision procedure
5692083|NCT00529464|LEEP|leep
5692084|NCT00529451|Hypertension, Aliskiren, Ramipril|hypertension, aliskiren, ramipril
5692085|NCT00529425|Femoral neck fracture|femoral neck fracture
5692086|NCT00529425|Hip fracture|hip fracture
5692087|NCT00529399|immune tolerance|immune tolerance
5692088|NCT00529399|immunotherapy|immunotherapy
5692089|NCT00529399|antigen-specific tolerance|antigen-specific tolerance
5692090|NCT00529399|vaccine induced tolerance|vaccine induced tolerance
5692091|NCT00529399|Beta-cell function|beta-cell function
5692092|NCT00529399|T-cells|t-cells
5692093|NCT00529399|DPT-1|dpt-1
5692094|NCT00529399|treatment of type 1 diabetes|treatment of type 1 diabetes
5692095|NCT00529399|new onset type 1 diabetes|new onset type 1 diabetes
5692096|NCT00529399|juvenile diabetes|juvenile diabetes
5692097|NCT00529399|T1D|t1d
5692098|NCT00529399|diabetes mellitus|diabetes mellitus
5692099|NCT00529399|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5692100|NCT00529399|TrialNet|trialnet
5692101|NCT00529386|prostatitis|prostatitis
5692102|NCT00529386|Botox|botox
5692103|NCT00529360|Acute Leukemia|acute leukemia
5692104|NCT00529360|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5692105|NCT00529360|Clofarabine|clofarabine
5692106|NCT00529360|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5692107|NCT00529360|Acute Myelogenous Leukemia|acute myelogenous leukemia
5692108|NCT00529334|Breast Cancer|breast cancer
5692109|NCT00529334|Partial breast irradiation|partial breast irradiation
5692110|NCT00529334|Radiosurgery|radiosurgery
5692111|NCT00529334|CyberKnife|cyberknife
5692112|NCT00529334|Radiotherapy|radiotherapy
5692113|NCT00529334|PBI|pbi
5692114|NCT00529308|Tourette|tourette
5692115|NCT00529308|Tourette's|tourette's
5692116|NCT00529295|misoprostol|misoprostol
5692117|NCT00529295|labor induction|labor induction
5692118|NCT00529282|Low numbers of neutrophils in the blood|low numbers of neutrophils in the blood
5692119|NCT00529282|increased body temperature|increased body temperature
5692120|NCT00529282|cancer chemotherapy|cancer chemotherapy
5692121|NCT00529282|ceftobiprole|ceftobiprole
5692122|NCT00529282|pseudomonas infections|pseudomonas infections
5692123|NCT00529269|Renal Transplant Patients, GI symptom, Enteric-coated mycophenolate sodium|renal transplant patients, gi symptom, enteric-coated mycophenolate sodium
5692124|NCT00529256|Adult smokers|adult smokers
5692125|NCT00529243|Treatment Experience|treatment experience
5692126|NCT00529243|On enfuvirtide|on enfuvirtide
5692127|NCT00529230|Advanced Cancer|advanced cancer
5692128|NCT00529230|Chronic Opioid Therapy|chronic opioid therapy
5692129|NCT00529230|Secondary Hypogonadism|secondary hypogonadism
5692130|NCT00529230|Cancer-Related Pain Syndromes|cancer-related pain syndromes
5692131|NCT00529230|Questionnaire|questionnaire
5692132|NCT00529217|Dissociative|dissociative
5692133|NCT00529217|Dissociation|dissociation
5692134|NCT00529217|Depersonalization|depersonalization
5692135|NCT00529217|Depersonalization Disorder|depersonalization disorder
5692136|NCT00529217|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5692137|NCT00529217|TMS|tms
5692138|NCT00529217|Depersonalization Disorder (DPD)|depersonalization disorder (dpd)
5692139|NCT00529217|rTMS|rtms
5692140|NCT00529204|Fatty Liver|fatty liver
5692141|NCT00529204|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5692142|NCT00529204|NAFDL|nafdl
5692143|NCT00529204|Diabetes|diabetes
5692144|NCT00529204|ALT|alt
5692145|NCT00529204|exenatide|exenatide
5692146|NCT00529191|Type I Diabetes (T1DM)|type i diabetes (t1dm)
5692147|NCT00529191|Atorvastatin (Lipitor)|atorvastatin (lipitor)
5692148|NCT00529191|Insulin|insulin
5692149|NCT00529191|Pancreas|pancreas
5692150|NCT00529191|Beta Cells|beta cells
5692151|NCT00529165|injection to meal time|injection to meal time
5692152|NCT00529165|human insulin|human insulin
5692153|NCT00529152|Iron Overload|iron overload
5692154|NCT00529139|Extended dialysis|extended dialysis
5692155|NCT00529139|Acute kidney injury|acute kidney injury
5692156|NCT00529139|Intensive care unit|intensive care unit
5692157|NCT00529139|Renal replacement therapy|renal replacement therapy
5692158|NCT00529139|Survival|survival
5692159|NCT00529139|Dialysis|dialysis
5692160|NCT00529126|hemorrhoidectomy|hemorrhoidectomy
5692162|NCT00529126|Postoperative|postoperative
5692163|NCT00529126|analgesia|analgesia
5692164|NCT00529113|pancreatic cancer|pancreatic cancer
5692165|NCT00529113|gemcitabine|gemcitabine
5692264|NCT00528723|salbutamol|salbutamol
5692166|NCT00529087|Opioid-Induced Constipation|opioid-induced constipation
5692167|NCT00529074|Epidural Analgesia|epidural analgesia
5692168|NCT00529061|Sickle Cell Disease|sickle cell disease
5692169|NCT00529061|Sickle Cell Anemia|sickle cell anemia
5692170|NCT00529048|Type 2 diabetes mellitus|type 2 diabetes mellitus
5692171|NCT00529048|Incretin effect|incretin effect
5692172|NCT00529048|Glucagon-Like Peptide 1|glucagon-like peptide 1
5685709|NCT00555048|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5685710|NCT00555048|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5685711|NCT00555048|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5692173|NCT00529048|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide
5692174|NCT00529035|Chronic GVHD|chronic gvhd
5692175|NCT00529035|Steroid refractory GVHD|steroid refractory gvhd
5692176|NCT00529035|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5692177|NCT00529022|Advanced Cancer|advanced cancer
5692178|NCT00529022|Solid Tumors|solid tumors
5692179|NCT00529022|Ovarian Cancer|ovarian cancer
5692180|NCT00529022|Fallopian Tube Cancer|fallopian tube cancer
5692181|NCT00529022|Peritoneal Cancer|peritoneal cancer
5692183|NCT00529022|5-Azacitidine|5-azacitidine
5692184|NCT00529022|5-Aza|5-aza
5692185|NCT00529022|Vidaza™|vidaza™
5692186|NCT00529022|5-AZC|5-azc
5692187|NCT00529022|AZA-CR|aza-cr
5692188|NCT00529022|Ladakamycin|ladakamycin
5692189|NCT00529022|NSC-102816|nsc-102816
5692190|NCT00529022|Vidaza|vidaza
5692191|NCT00529022|Valproic Acid|valproic acid
5692192|NCT00529022|Depakene|depakene
5692193|NCT00529022|Carboplatin|carboplatin
5692194|NCT00529022|Paraplatin|paraplatin
5692195|NCT00529009|PK analysis|pk analysis
5692196|NCT00528983|Myelodysplastic Syndromes MDS|myelodysplastic syndromes mds
5692197|NCT00528983|Acute Myelogenous Leukemia AML|acute myelogenous leukemia aml
5692198|NCT00528983|Chronic Myelomonocytic Leukemia CMML|chronic myelomonocytic leukemia cmml
5692199|NCT00528970|POI|poi
5692200|NCT00528970|Hernia|hernia
5692201|NCT00528970|Ventral Wall Hernia Repair|ventral wall hernia repair
5692202|NCT00528970|Post Operative Ileus|post operative ileus
5692203|NCT00528957|Phase 3|phase 3
5692204|NCT00528957|Randomized, Open-Label|randomized, open-label
5692205|NCT00528957|Treatment-Experienced|treatment-experienced
5692206|NCT00528957|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5692207|NCT00528957|HIV|hiv
5692208|NCT00528957|Tenofovir DF|tenofovir df
5692209|NCT00528957|Pediatrics|pediatrics
5692210|NCT00528944|alveolar volume|alveolar volume
5692211|NCT00528944|pulmonary function testing|pulmonary function testing
5692212|NCT00528944|emphysema|emphysema
5692213|NCT00528931|Assessment of AUX I and/or AUX II in human plasma|assessment of aux i and/or aux ii in human plasma
5692214|NCT00528918|diabetes|diabetes
5692216|NCT00528918|insulin|insulin
5692217|NCT00528918|Apidra|apidra
5692218|NCT00528918|Glargine|glargine
5692219|NCT00528905|Schizophrenia|schizophrenia
5692220|NCT00528905|Cognitive Deficits|cognitive deficits
5692221|NCT00528892|Treatment Experienced|treatment experienced
5692222|NCT00528879|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5692223|NCT00528879|Diabetes Mellitus|diabetes mellitus
5692224|NCT00528879|Endocrine System Diseases|endocrine system diseases
5692225|NCT00528879|Glucose Metabolism Disorders|glucose metabolism disorders
5692226|NCT00528879|Metabolic Diseases|metabolic diseases
5692227|NCT00528879|Metformin|metformin
5692228|NCT00528879|Hypoglycemic Agents|hypoglycemic agents
5692229|NCT00528879|Pharmacologic Actions|pharmacologic actions
5692230|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs
5692231|NCT00528866|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5692232|NCT00528866|stage IIB prostate cancer|stage iib prostate cancer
5692233|NCT00528866|stage IIA prostate cancer|stage iia prostate cancer
5692234|NCT00528866|stage III prostate cancer|stage iii prostate cancer
5692235|NCT00528866|stage IV prostate cancer|stage iv prostate cancer
5692236|NCT00528853|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5692237|NCT00528827|Hypertension, High Blood Pressure, Pediatric Hypertension, High blood pressure in children|hypertension, high blood pressure, pediatric hypertension, high blood pressure in children
5692238|NCT00528814|Hand Sanitizer|hand sanitizer
5692239|NCT00528814|Respiratory Infection|respiratory infection
5692240|NCT00528801|Sickle Cell Disease|sickle cell disease
5692241|NCT00528801|Sickle Cell Anemia|sickle cell anemia
5692242|NCT00528801|Hemoglobin SS|hemoglobin ss
5692243|NCT00528801|Hemoglobin SB0|hemoglobin sb0
5692244|NCT00528775|adenocarcinoma of the lung|adenocarcinoma of the lung
5692245|NCT00528775|large cell lung cancer|large cell lung cancer
5692246|NCT00528775|squamous cell lung cancer|squamous cell lung cancer
5692247|NCT00528775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5692248|NCT00528775|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5692249|NCT00528775|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5692250|NCT00528775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5692251|NCT00528762|Epidemiology|epidemiology
5692256|NCT00528749|Respiratory effort|respiratory effort
5692257|NCT00528749|Upper Airway Resistance Syndrome|upper airway resistance syndrome
5692258|NCT00528736|preterm infants < 28 weeks|preterm infants < 28 weeks
5692259|NCT00528736|B-type natriuretic peptide|b-type natriuretic peptide
5692260|NCT00528736|prediction|prediction
5685712|NCT00555048|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5692261|NCT00528736|ductus intervention|ductus intervention
5692262|NCT00528723|beclomethasone|beclomethasone
5692266|NCT00528710|S-Adenosylmethionine|s-adenosylmethionine
5692267|NCT00528684|Oncolytics Biotech|oncolytics biotech
5692268|NCT00528684|cancer alternative therapies|cancer alternative therapies
5692269|NCT00528684|malignant glioma|malignant glioma
5692270|NCT00528684|glioblastoma multiforme|glioblastoma multiforme
5692271|NCT00528684|oncolytic virus|oncolytic virus
5692272|NCT00528684|reovirus|reovirus
5692273|NCT00528684|REOLYSIN|reolysin
5692275|NCT00528671|INR self-management|inr self-management
5692276|NCT00528671|mechanical heart valve replacement|mechanical heart valve replacement
5692277|NCT00528671|bleeding|bleeding
5692278|NCT00528671|thromboembolism|thromboembolism
5692279|NCT00528658|Soft Tissue Injuries|soft tissue injuries
5692280|NCT00528632|Gallstones|gallstones
5692281|NCT00528632|Gallbladder|gallbladder
5692282|NCT00528632|Cholesterolosis|cholesterolosis
5692283|NCT00528632|Serum cholesterol|serum cholesterol
5692284|NCT00528632|triglycerides|triglycerides
5692285|NCT00528632|Body Mass Index|body mass index
5692286|NCT00528619|Solid tumor malignancy|solid tumor malignancy
5692287|NCT00528619|non-small cell lung cancer|non-small cell lung cancer
5692288|NCT00528619|sunitinib|sunitinib
5692289|NCT00528619|pemetrexed|pemetrexed
5692291|NCT00528619|Mesothelioma|mesothelioma
5692293|NCT00528593|AIDS|aids
5692294|NCT00528593|neuropathy|neuropathy
5692295|NCT00528593|Procrit|procrit
5692296|NCT00528593|epoetin alfa|epoetin alfa
5692297|NCT00528593|erythropoetin|erythropoetin
5692298|NCT00528593|Treatment Experienced|treatment experienced
5692299|NCT00528580|Sepsis|sepsis
5692300|NCT00528580|Statin|statin
5692301|NCT00528580|Infection|infection
5692302|NCT00528580|Immunomodulatory|immunomodulatory
5692303|NCT00528554|CINV|cinv
5692304|NCT00528554|chemotherapy induced nausea and vomiting (CINV)|chemotherapy induced nausea and vomiting (cinv)
5692305|NCT00528528|Chronic Hepatitis C|chronic hepatitis c
5692306|NCT00528528|Genotype 1|genotype 1
5692307|NCT00528528|Telaprevir|telaprevir
5692308|NCT00528528|Treatment-naïve|treatment-naïve
5692309|NCT00528528|VX-950-C208|vx-950-c208
5692310|NCT00528528|VX-950-TiDP24-C208|vx-950-tidp24-c208
5692311|NCT00528515|anesthesia intravenous|anesthesia intravenous
5692312|NCT00528515|propofol|propofol
5692313|NCT00528515|anesthesia inhalation|anesthesia inhalation
5692314|NCT00528515|desflurane|desflurane
5692315|NCT00528515|heart surgery|heart surgery
5692316|NCT00528515|coronary artery by-pass off-pump|coronary artery by-pass off-pump
5692317|NCT00528515|hemodynamic processes|hemodynamic processes
5692318|NCT00528515|anesthesia|anesthesia
5692319|NCT00528502|Parathyroid Disease|parathyroid disease
5692320|NCT00528502|Minimal Invasive Parathyroid Surgery|minimal invasive parathyroid surgery
5692321|NCT00528502|MIPS|mips
5692322|NCT00528502|Laryngeal Reflexes|laryngeal reflexes
5692323|NCT00528502|Lidocaine|lidocaine
5692324|NCT00528502|Saline|saline
5692325|NCT00528489|HIV Seronegativity|hiv seronegativity
5692326|NCT00528489|DNA Plasmid Vaccine|dna plasmid vaccine
5692327|NCT00528489|HIV Preventive Vaccine|hiv preventive vaccine
5692328|NCT00528476|pyelonephritis|pyelonephritis
5692329|NCT00528476|cystitis|cystitis
5692330|NCT00528476|risk factor|risk factor
5692331|NCT00528476|children|children
5692332|NCT00528476|urodynamics|urodynamics
5692333|NCT00528463|Pre-emptive analgesia|pre-emptive analgesia
5692334|NCT00528463|Peripheral nerve block (sciatic)|peripheral nerve block (sciatic)
5692335|NCT00528463|phantom lomb pain|phantom lomb pain
5692336|NCT00528450|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5692337|NCT00528450|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5692338|NCT00528450|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5692339|NCT00528437|Recurrent or refractory medulloblastoma/PNET|recurrent or refractory medulloblastoma/pnet
5692340|NCT00528437|CNS germ cell tumors|cns germ cell tumors
5692341|NCT00528437|Ependymomas|ependymomas
5692342|NCT00528437|AT/RT|at/rt
5692343|NCT00528437|High grade glioma|high grade glioma
5692344|NCT00528437|Other malignant brain tumors|other malignant brain tumors
5692345|NCT00528411|Coronary artery disease|coronary artery disease
5692347|NCT00528411|heart attack|heart attack
5692348|NCT00528411|stable angina|stable angina
5692349|NCT00528411|Stable coronary artery disease|stable coronary artery disease
5692350|NCT00528398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5692351|NCT00528398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5692352|NCT00528398|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5692353|NCT00528398|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5692354|NCT00528398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5692355|NCT00528398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5685713|NCT00555048|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5685714|NCT00555048|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5685715|NCT00555048|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5685716|NCT00555048|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5685717|NCT00555048|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5692356|NCT00528398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5692357|NCT00528398|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5692358|NCT00528398|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5692455|NCT00528034|Lymphoscintigraphy|lymphoscintigraphy
5692359|NCT00528398|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5692360|NCT00528398|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5692361|NCT00528398|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5692362|NCT00528398|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5687325|NCT00547911|Entacapone|entacapone
5692363|NCT00528398|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5692364|NCT00528398|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5692366|NCT00528385|Renin-Angiotensin-Aldosterone System|renin-angiotensin-aldosterone system
5692367|NCT00528385|Aldosterone Antagonists|aldosterone antagonists
5692368|NCT00528359|antipsychotic drugs|antipsychotic drugs
5692369|NCT00528359|schizophrenia|schizophrenia
5692370|NCT00528359|β-cell function|β-cell function
5692371|NCT00528359|insulin resistance|insulin resistance
5692372|NCT00528346|chronic pain|chronic pain
5692373|NCT00528346|functional magnetic resonance imaging|functional magnetic resonance imaging
5692374|NCT00528346|fMRI|fmri
5692375|NCT00528346|cognitive training|cognitive training
5692376|NCT00528333|Lintuzumab|lintuzumab
5692377|NCT00528333|Antigens, CD33|antigens, cd33
5692378|NCT00528333|Antibodies, Monoclonal|antibodies, monoclonal
5692379|NCT00528333|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5692380|NCT00528333|Hematologic Diseases|hematologic diseases
5692381|NCT00528333|Leukemia|leukemia
5692382|NCT00528320|Congestive Heart Failure|congestive heart failure
5692383|NCT00528320|Heart Failure|heart failure
5692384|NCT00528320|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5692385|NCT00528320|ICD|icd
5692386|NCT00528320|Implantable Cardioverter-Defibrillator|implantable cardioverter-defibrillator
5692387|NCT00528320|Defibrillator|defibrillator
5692388|NCT00528307|myocardial perfusion|myocardial perfusion
5692389|NCT00528307|His ablation|his ablation
5692390|NCT00528307|biventricular pacing|biventricular pacing
5692391|NCT00528307|His bundle ablation for atrial fibrillation|his bundle ablation for atrial fibrillation
5692392|NCT00528294|Recurrent head and neck tumors|recurrent head and neck tumors
5692393|NCT00528281|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5692394|NCT00528281|Pemetrexed,|pemetrexed,
5692395|NCT00528281|Lapatinib (GW572016),|lapatinib (gw572016),
5692396|NCT00528268|Spinal Muscular Atrophy|spinal muscular atrophy
5692397|NCT00528268|SMA|sma
5692398|NCT00528268|Sodium Phenylbutyrate|sodium phenylbutyrate
5692399|NCT00528255|cervical ripening|cervical ripening
5692400|NCT00528255|induction of labor|induction of labor
5692401|NCT00528216|Analgesics|analgesics
5692402|NCT00528216|Capsaicin|capsaicin
5692403|NCT00528203|Sickle Cell Disease|sickle cell disease
5692404|NCT00528203|Sickle Cell Anemia|sickle cell anemia
5692405|NCT00528203|DNA|dna
5692406|NCT00528190|Cystic Fibrosis|cystic fibrosis
5692407|NCT00528190|Aspergillus Fumigatus|aspergillus fumigatus
5692408|NCT00528190|randomized controlled clinical trials|randomized controlled clinical trials
5692409|NCT00528177|kappa-opioid receptor|kappa-opioid receptor
5692410|NCT00528177|my-opioid receptor|my-opioid receptor
5692411|NCT00528177|oxycodone|oxycodone
5692412|NCT00528177|morphine|morphine
5692413|NCT00528177|postoperative pain|postoperative pain
5692415|NCT00528164|overweight|overweight
5692416|NCT00528164|obesity|obesity
5692417|NCT00528164|family|family
5692418|NCT00528164|intervention|intervention
5692419|NCT00528164|control|control
5692420|NCT00528164|randomized|randomized
5692421|NCT00528164|physical activity|physical activity
5692422|NCT00528164|diet|diet
5692423|NCT00528164|nutrition|nutrition
5692424|NCT00528164|behavior|behavior
5692425|NCT00528164|body mass index|body mass index
5692426|NCT00528151|Curcumin, LHON, antioxidant, visual outcome|curcumin, lhon, antioxidant, visual outcome
5692427|NCT00528138|Appendicitis|appendicitis
5692428|NCT00528138|Hyperbilirubinemia|hyperbilirubinemia
5692429|NCT00528138|CRP|crp
5692430|NCT00528138|Values of bilirubin|values of bilirubin
5692431|NCT00528138|Values of liver function test|values of liver function test
5700104|NCT00500812|rho|rho
5692432|NCT00528138|Values of white blood cells|values of white blood cells
5692433|NCT00528138|Values of CRP|values of crp
5692434|NCT00528125|pain prevention|pain prevention
5692435|NCT00528125|neonatal pain|neonatal pain
5692436|NCT00528125|laser acupuncture|laser acupuncture
5692437|NCT00528125|complementary and alternative medicine|complementary and alternative medicine
5692438|NCT00528112|Contraception|contraception
5692439|NCT00528112|Intrauterine|intrauterine
5692440|NCT00528112|IUD|iud
5692441|NCT00528112|IUS|ius
5692442|NCT00528086|Group visits|group visits
5692443|NCT00528073|Rifaximin-EIR|rifaximin-eir
5692444|NCT00528073|Crohn's disease|crohn's disease
5692445|NCT00528073|remission|remission
5692446|NCT00528060|HIV infections|hiv infections
5692447|NCT00528060|atazanavir|atazanavir
5692448|NCT00528060|Pharmacokinetics|pharmacokinetics
5692449|NCT00528060|Treatment Naive|treatment naive
5692450|NCT00528047|Cancer|cancer
5692451|NCT00528047|Solid Tumor|solid tumor
5692452|NCT00528047|Metastatic|metastatic
5692453|NCT00528047|Neoplasm, Malignant|neoplasm, malignant
5692454|NCT00528034|Vaginal Cancer|vaginal cancer
5692456|NCT00528034|Lymphatic Mapping|lymphatic mapping
5692457|NCT00528034|Sentinel Lymph Node|sentinel lymph node
5692458|NCT00528034|Isosulfan Blue|isosulfan blue
5692460|NCT00528021|Head Lice|head lice
5692461|NCT00528021|Lice Infestation|lice infestation
5692462|NCT00528021|Pediculosis|pediculosis
5692463|NCT00528021|Pediculosis Capitis|pediculosis capitis
5692464|NCT00528008|infection|infection
5692465|NCT00528008|sepsis|sepsis
5692466|NCT00528008|povidone-iodine|povidone-iodine
5692467|NCT00528008|chlorhexidine gluconate|chlorhexidine gluconate
5692468|NCT00528008|fever|fever
5692469|NCT00528008|erythema|erythema
5692470|NCT00528008|leukocytosis|leukocytosis
5692471|NCT00528008|drainage|drainage
5692472|NCT00528008|vaginal discharge|vaginal discharge
5692473|NCT00528008|elective cesarean section|elective cesarean section
5692474|NCT00527982|Head and Neck Cancer|head and neck cancer
5692475|NCT00527982|Lung Cancer|lung cancer
5692476|NCT00527982|Non-Small Cell Lung Cancer|non-small cell lung cancer
5692477|NCT00527982|Celecoxib|celecoxib
5692478|NCT00527982|Celebrex|celebrex
5692479|NCT00527969|American ginseng extract|american ginseng extract
5692480|NCT00527969|Panax quinquefolius|panax quinquefolius
5692481|NCT00527969|Memory enhancement|memory enhancement
5692482|NCT00527969|Cognitive function|cognitive function
5692483|NCT00527969|Working memory|working memory
5692484|NCT00527969|Declarative memory|declarative memory
5692485|NCT00527969|Psychomotor speed|psychomotor speed
5692486|NCT00527969|Executive skills|executive skills
5692487|NCT00527969|Psychosocial adaptation|psychosocial adaptation
5692488|NCT00527956|Breastfeeding premature infants|breastfeeding premature infants
5692489|NCT00527930|Breast Neoplasms|breast neoplasms
5692490|NCT00527930|Oxaliplatin|oxaliplatin
5692492|NCT00527917|IC/PBS|ic/pbs
5692493|NCT00527917|Interstitial Cystitis/Painful Bladder Syndrome|interstitial cystitis/painful bladder syndrome
5692494|NCT00527904|osteoarthritis|osteoarthritis
5692495|NCT00527904|rheumatoid arthritis|rheumatoid arthritis
5692496|NCT00527904|ankylosing spondylisit|ankylosing spondylisit
5692497|NCT00527904|NSAIDS|nsaids
5692498|NCT00527891|Liver Cancer|liver cancer
5692499|NCT00527891|Magnetic Resonance Imaging|magnetic resonance imaging
5692500|NCT00527891|Signa Excite 3.0T MRI Scan|signa excite 3.0t mri scan
5692501|NCT00527878|Hyper-IgE Recurrent Infection Syndrome|hyper-ige recurrent infection syndrome
5692502|NCT00527878|Ranitidine Therapy|ranitidine therapy
5692503|NCT00527878|Job's Syndrome|job's syndrome
5692504|NCT00527878|Cross-Over Study|cross-over study
5692505|NCT00527878|Double-Blind Placebo Controlled|double-blind placebo controlled
5692506|NCT00527878|Hyper-IgE Syndrome|hyper-ige syndrome
5692507|NCT00527878|Job Syndrome|job syndrome
5692508|NCT00527878|Immune Deficiency|immune deficiency
5692509|NCT00527865|Influenza, Flu, DAS181, Fludase|influenza, flu, das181, fludase
5692510|NCT00527852|Flocked swab|flocked swab
5692511|NCT00527852|Group A streptococcus pharyngitis|group a streptococcus pharyngitis
5692512|NCT00527826|Severe and very severe COPD (GOLD stage III / IV) exacerbations|severe and very severe copd (gold stage iii / iv) exacerbations
5692513|NCT00527826|health care utilisation|health care utilisation
5692514|NCT00527826|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5692515|NCT00527826|quality of life|quality of life
5692516|NCT00527826|compliance|compliance
5692517|NCT00527826|salmeterol/fluticasone combination|salmeterol/fluticasone combination
5692518|NCT00527813|acute respiratory distress syndrome|acute respiratory distress syndrome
5692519|NCT00527813|prone position|prone position
5692520|NCT00527813|Acute respiratory distress syndrome (ARDS)|acute respiratory distress syndrome (ards)
5692521|NCT00527800|Malaria|malaria
5692522|NCT00527800|HIV|hiv
5692523|NCT00527800|Trimethoprim-sulfamethoxazole|trimethoprim-sulfamethoxazole
5692524|NCT00527800|Artemether-lumefantrine|artemether-lumefantrine
5692525|NCT00527800|Dihydroartemisinin-piperaquine|dihydroartemisinin-piperaquine
5692526|NCT00527800|Acute Infection|acute infection
5692527|NCT00527787|NSAID|nsaid
5692528|NCT00527787|gastric ulcers|gastric ulcers
5692529|NCT00527787|Vimovo|vimovo
5692530|NCT00527787|Naproxen|naproxen
5691114|NCT00533923|CMV|cmv
5692531|NCT00527787|Esomeprazole|esomeprazole
5692532|NCT00527774|Hepatitis C|hepatitis c
5692533|NCT00527774|malnutrition-inflammation complex syndrome (MICS)|malnutrition-inflammation complex syndrome (mics)
5692534|NCT00527774|dialysis|dialysis
5692535|NCT00527774|mortality|mortality
5692536|NCT00527774|hospitalization|hospitalization
5692537|NCT00527774|health-related quality of life (HRQOL)|health-related quality of life (hrqol)
5692538|NCT00527774|peripheral arterial occlusive disease (PAOD)|peripheral arterial occlusive disease (paod)
5692539|NCT00527761|Metastatic Melanoma|metastatic melanoma
5709590|NCT00466466|SCLC|sclc
5692540|NCT00527761|Temozolomide|temozolomide
5692541|NCT00527761|Temodar|temodar
5692542|NCT00527761|Taxotere|taxotere
5692543|NCT00527761|Cisplatin|cisplatin
5692544|NCT00527761|TTC|ttc
5692545|NCT00527748|Range of Motion|range of motion
5692546|NCT00527748|Ankle Fractures|ankle fractures
5692547|NCT00527748|Elderly patients|elderly patients
5692548|NCT00527735|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5692549|NCT00527735|Small Cell Lung Cancer (SCLC)|small cell lung cancer (sclc)
5692550|NCT00527722|Lung Cancer|lung cancer
5692551|NCT00527722|Bio-Seal Track Plug|bio-seal track plug
5692552|NCT00527722|Lung Biopsy|lung biopsy
5692553|NCT00527722|Lung Plug|lung plug
5692554|NCT00527722|Air Leaks|air leaks
5692555|NCT00527683|vigabatrin|vigabatrin
5692556|NCT00527683|GVG|gvg
5692557|NCT00527683|addiction|addiction
5692558|NCT00527683|treatment|treatment
5692559|NCT00527683|cocaine dependence|cocaine dependence
5692560|NCT00527670|Genomics|genomics
5692561|NCT00527657|Brain Neoplasms|brain neoplasms
5692562|NCT00527657|Melanoma|melanoma
5692563|NCT00527657|Metastatic Melanoma|metastatic melanoma
5692564|NCT00527657|Brain Metastasis|brain metastasis
5692565|NCT00527657|Temozolomide|temozolomide
5692566|NCT00527657|Temodar|temodar
5692567|NCT00527657|Thalidomide|thalidomide
5692568|NCT00527657|Thalomid|thalomid
5692569|NCT00527657|Lomustine|lomustine
5692570|NCT00527657|CCNU|ccnu
5692571|NCT00527657|CeeNU|ceenu
5692572|NCT00527644|biliary leaks after laparoscopic cholecystectomy|biliary leaks after laparoscopic cholecystectomy
5692573|NCT00527631|advanced ovarian cancer|advanced ovarian cancer
5692574|NCT00527631|whole abdominal irradiation|whole abdominal irradiation
5692575|NCT00527631|intensity modulated radiotherapy|intensity modulated radiotherapy
5692576|NCT00527631|ovarian cancer stage FIGO III|ovarian cancer stage figo iii
5692577|NCT00527618|Herpes Simplex Virus Type 2|herpes simplex virus type 2
5692578|NCT00527618|Human Immunodeficiency Virus|human immunodeficiency virus
5692579|NCT00527618|Treatment Naive|treatment naive
5692580|NCT00527605|placebo control|placebo control
5692581|NCT00527605|Chinese|chinese
5692582|NCT00527605|Dutasteride|dutasteride
5692583|NCT00527605|Randomized|randomized
5692584|NCT00527605|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5692585|NCT00527605|Double blind|double blind
5692586|NCT00527592|Comfort|comfort
5692587|NCT00527579|Epilepsy|epilepsy
5692588|NCT00527579|Taenia Solium|taenia solium
5692589|NCT00527579|Microglia|microglia
5692590|NCT00527579|Neuroinflammation|neuroinflammation
5692591|NCT00527579|Compartment Model|compartment model
5692592|NCT00527579|Neurocysticercosis|neurocysticercosis
5692593|NCT00527579|Healthy Volunteer|healthy volunteer
5692594|NCT00527579|HV|hv
5692595|NCT00527566|Churg Strauss Syndrome|churg strauss syndrome
5692596|NCT00527553|Macular pigment|macular pigment
5692597|NCT00527553|AMD|amd
5692598|NCT00527553|ARM|arm
5692599|NCT00527514|Hypertension|hypertension
5692600|NCT00527514|Angiotensin Receptor Blocker|angiotensin receptor blocker
5692601|NCT00527514|Calcium Channel Blocker|calcium channel blocker
5692602|NCT00527514|Stage I and II Hypertension|stage i and ii hypertension
5692603|NCT00527501|Open-angle glaucoma|open-angle glaucoma
5692604|NCT00527501|ocular hypertension|ocular hypertension
5692605|NCT00527488|Benign Prostate Hyperplasia|benign prostate hyperplasia
5692606|NCT00527488|BPH|bph
5692607|NCT00527488|PK/PD|pk/pd
5692608|NCT00527488|GnRH antagonist|gnrh antagonist
5692609|NCT00527475|Anti-VEGF therapy|anti-vegf therapy
5692610|NCT00527475|photodynamic therapy|photodynamic therapy
5692611|NCT00527475|neovascularization|neovascularization
5692612|NCT00527462|Asthma GINA 1|asthma gina 1
5692613|NCT00527423|VEGF Trap-Eye|vegf trap-eye
5692614|NCT00527423|Macular Degeneration|macular degeneration
5692615|NCT00527423|AMD|amd
5692616|NCT00527423|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5692617|NCT00527397|Diabetes Mellitus|diabetes mellitus
5692618|NCT00527384|Stress|stress
5692619|NCT00527371|Benign hyperplasia of the prostate|benign hyperplasia of the prostate
5692620|NCT00527358|violence|violence
5692621|NCT00527345|Asthma|asthma
5692622|NCT00527345|Diesel exhaust|diesel exhaust
5692623|NCT00527332|Hospitalization|hospitalization
5692624|NCT00527332|Postoperative care|postoperative care
5692625|NCT00527332|Quality of Life|quality of life
5692626|NCT00527332|Health economy|health economy
5692627|NCT00527332|Anesthesia. Spinal|anesthesia. spinal
5692628|NCT00527332|Anesthesia, General|anesthesia, general
5692629|NCT00527319|NSCLC|nsclc
5700296|NCT00500214|mesh repair|mesh repair
5692630|NCT00527319|anorexia|anorexia
5692631|NCT00527319|cachexia|cachexia
5692632|NCT00527319|grip strength|grip strength
5692633|NCT00527319|lean body mass|lean body mass
5692634|NCT00527306|aphthous stomatitis|aphthous stomatitis
5692635|NCT00527306|canker sores|canker sores
5692636|NCT00527306|multivitamins|multivitamins
5692637|NCT00527306|vitamin deficiency|vitamin deficiency
5692638|NCT00527293|stage I breast cancer|stage i breast cancer
5692639|NCT00527293|stage II breast cancer|stage ii breast cancer
5692640|NCT00527293|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5692641|NCT00527293|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5692642|NCT00527293|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5692643|NCT00527293|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5692644|NCT00527293|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5692645|NCT00527280|Allotransplantation:composite tissue|allotransplantation:composite tissue
5692646|NCT00527280|Face transplantation|face transplantation
5692647|NCT00527241|partner violence, spouse abuse|partner violence, spouse abuse
5692648|NCT00527228|Muscular dystrophy|muscular dystrophy
5692649|NCT00527228|therapy|therapy
5692652|NCT00527228|dysferlinopathy|dysferlinopathy
5692653|NCT00527228|LGMD|lgmd
5692655|NCT00527189|Arthritis|arthritis
5692656|NCT00527189|Exercise|exercise
5692657|NCT00527189|Balance - Postural Control|balance - postural control
5692658|NCT00527176|Systemic Lupus Erythematosus|systemic lupus erythematosus
5692659|NCT00527176|Corticosteroid|corticosteroid
5692660|NCT00527176|Pulse therapy|pulse therapy
5692661|NCT00527176|Diffusion weighted imaging|diffusion weighted imaging
5692663|NCT00527163|Echocardiogram|echocardiogram
5692664|NCT00527163|Endothelial Dysfunction|endothelial dysfunction
5692665|NCT00527163|Malaria|malaria
5692666|NCT00527163|Mali|mali
5692667|NCT00527163|Screening|screening
5692668|NCT00527098|Trauma Resuscitation|trauma resuscitation
5692669|NCT00527072|plaque psoriasis|plaque psoriasis
5692670|NCT00527072|psoriasis|psoriasis
5692671|NCT00527072|infliximab|infliximab
5692672|NCT00527072|remicade|remicade
5692673|NCT00527072|etanercept|etanercept
5692674|NCT00527072|enbrel|enbrel
5692675|NCT00527072|psunrise|psunrise
5692676|NCT00527072|C0168Z04|c0168z04
5692677|NCT00527059|Cardiorenal syndrome|cardiorenal syndrome
5692678|NCT00527033|YM178|ym178
5692679|NCT00527033|Urinary Bladder, Overactive|urinary bladder, overactive
5692680|NCT00527020|qEEG,|qeeg,
5692681|NCT00527020|GlyT-1 inhibitor,|glyt-1 inhibitor,
5692682|NCT00527020|ERP|erp
5692683|NCT00527020|GSK1018921,|gsk1018921,
5692684|NCT00527020|FTIH,|ftih,
5692685|NCT00527020|schizophrenia,|schizophrenia,
5692686|NCT00527020|single-dose,|single-dose,
5692687|NCT00527020|healthy volunteers,|healthy volunteers,
5692688|NCT00527020|MMN,|mmn,
5692689|NCT00527007|Vasopressor|vasopressor
5692690|NCT00527007|Epinephrine|epinephrine
5692691|NCT00527007|Norepinephrine|norepinephrine
5692692|NCT00527007|Cooling|cooling
5692693|NCT00527007|Fever|fever
5692694|NCT00527007|ICU|icu
5692695|NCT00526994|intimate partner violence|intimate partner violence
5692696|NCT00526994|domestic violence|domestic violence
5692697|NCT00526994|spouse abuse|spouse abuse
5692698|NCT00526994|screening|screening
5692699|NCT00526955|Manual muscle testing|manual muscle testing
5692700|NCT00526942|ACRD|acrd
5692701|NCT00526942|Visual Memory|visual memory
5692702|NCT00526942|Visual Perception|visual perception
5692703|NCT00526942|Speed|speed
5692704|NCT00526942|Computerized|computerized
5692705|NCT00526942|SAAGE|saage
5692706|NCT00526942|Cognitive Decline|cognitive decline
5692707|NCT00526916|Epilepsy|epilepsy
5692708|NCT00526916|Taenia Solium|taenia solium
5692709|NCT00526916|Microglia|microglia
5692710|NCT00526916|Neuroinflammation|neuroinflammation
5692711|NCT00526916|Compartment Model|compartment model
5692712|NCT00526916|Neurocysticercosis|neurocysticercosis
5692713|NCT00526916|Healthy Volunteer|healthy volunteer
5692714|NCT00526916|HV|hv
5692715|NCT00526903|IBS|ibs
5692716|NCT00526903|abdominal pain|abdominal pain
5692717|NCT00526903|recurrent abdominal pain|recurrent abdominal pain
5692718|NCT00526903|irritable bowel syndrome|irritable bowel syndrome
5692719|NCT00526903|diarrhea|diarrhea
5692720|NCT00526903|constipation|constipation
5692721|NCT00526903|bloating|bloating
5692722|NCT00526890|squamous cell lung cancer|squamous cell lung cancer
5692723|NCT00526890|adenocarcinoma of the lung|adenocarcinoma of the lung
5692724|NCT00526890|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5692725|NCT00526890|large cell lung cancer|large cell lung cancer
5692726|NCT00526890|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5692727|NCT00526890|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5692728|NCT00526890|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5692729|NCT00526877|Schizophrenia|schizophrenia
5692730|NCT00526877|Schizoaffective disorders|schizoaffective disorders
5692731|NCT00526877|Risperidone|risperidone
5700407|NCT00500266|vaccine|vaccine
5692732|NCT00526877|Risperdal Consta|risperdal consta
5692733|NCT00526864|Burden of Illness for Herpes zoster in Thailand.|burden of illness for herpes zoster in thailand.
5692734|NCT00526851|lip and oral cavity cancer|lip and oral cavity cancer
5692735|NCT00526851|oropharyngeal cancer|oropharyngeal cancer
5692736|NCT00526838|Solid Tumor|solid tumor
5692737|NCT00526838|Multiple Myeloma|multiple myeloma
5692738|NCT00526786|Low Grade Dysplasia|low grade dysplasia
5692739|NCT00526786|High Grade Dysplasia|high grade dysplasia
5692740|NCT00526786|Barrett's Esophagus|barrett's esophagus
5692741|NCT00526786|Cryospray ablation|cryospray ablation
5692743|NCT00526786|Cryotherapy|cryotherapy
5692744|NCT00526786|Cryo|cryo
5692745|NCT00526786|CryoSpray|cryospray
5692746|NCT00526773|motivational therapy|motivational therapy
5692747|NCT00526760|Dexmedetomidine, Sedation, Long-term, Phase 3|dexmedetomidine, sedation, long-term, phase 3
5692748|NCT00526734|stage I multiple myeloma|stage i multiple myeloma
5692749|NCT00526734|stage II multiple myeloma|stage ii multiple myeloma
5692750|NCT00526734|stage III multiple myeloma|stage iii multiple myeloma
5692751|NCT00526721|Hypercholesterolemia|hypercholesterolemia
5692752|NCT00526721|Crestor|crestor
5692753|NCT00526721|LDL target goal|ldl target goal
5692754|NCT00526721|high risk patients|high risk patients
5692755|NCT00526721|Naturalistic|naturalistic
5692756|NCT00526721|Observational|observational
5692757|NCT00526708|dyslipidemia|dyslipidemia
5692758|NCT00526708|hypertension|hypertension
5692759|NCT00526708|rosuvastatin|rosuvastatin
5692760|NCT00526708|efficacy|efficacy
5692761|NCT00526708|Naturalistic|naturalistic
5692762|NCT00526708|Observational|observational
5692763|NCT00526695|Ischemia/Reperfusion|ischemia/reperfusion
5692764|NCT00526695|Organ Protection|organ protection
5692765|NCT00526695|Anesthetics|anesthetics
5692766|NCT00526682|Antiobesity|antiobesity
5692767|NCT00526682|Weight loss|weight loss
5692768|NCT00526669|tumor biopsy|tumor biopsy
5692769|NCT00526669|capecitabine|capecitabine
5692770|NCT00526669|first line|first line
5692771|NCT00526669|Gastro Esophageal (GE) Junction Cancer|gastro esophageal (ge) junction cancer
5692772|NCT00526669|Gastric cancer|gastric cancer
5692773|NCT00526669|newly diagnosed|newly diagnosed
5692774|NCT00526669|GE junction|ge junction
5692775|NCT00526669|lapatinib|lapatinib
5692776|NCT00526669|metastatic or unresectable|metastatic or unresectable
5692777|NCT00526656|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5692779|NCT00526656|stage III bladder cancer|stage iii bladder cancer
5692780|NCT00526656|stage IV bladder cancer|stage iv bladder cancer
5692781|NCT00526643|stage IIIB|stage iiib
5692782|NCT00526643|Stage IV|stage iv
5692783|NCT00526643|chemotherapy|chemotherapy
5692784|NCT00526643|monotherapy|monotherapy
5692785|NCT00526643|combination chemotherapy|combination chemotherapy
5692786|NCT00526643|poor performance status|poor performance status
5692787|NCT00526630|freezing|freezing
5692789|NCT00526630|festination|festination
5692790|NCT00526630|shuffling|shuffling
5692791|NCT00526630|balance|balance
5692792|NCT00526617|Solid Tumor|solid tumor
5692793|NCT00526617|Melanoma|melanoma
5692794|NCT00526617|Breast cancer|breast cancer
5692795|NCT00526617|Ovarian cancer|ovarian cancer
5692796|NCT00526617|Primary peritoneal cancer|primary peritoneal cancer
5692797|NCT00526617|Fallopian tube cancer|fallopian tube cancer
5692798|NCT00526617|Hepatocellular carcinoma|hepatocellular carcinoma
5692799|NCT00526617|HCC|hcc
5692800|NCT00526617|BRCA deficient|brca deficient
5692801|NCT00526617|BRCA mutation|brca mutation
5692802|NCT00526617|Temozolomide|temozolomide
5692803|NCT00526617|Temodar|temodar
5692804|NCT00526617|TMZ|tmz
5692805|NCT00526617|ABT-888|abt-888
5692806|NCT00526617|PARP inhibitor|parp inhibitor
5692807|NCT00526604|return to work|return to work
5692808|NCT00526604|low back pain|low back pain
5692809|NCT00526604|work related rehabilitation|work related rehabilitation
5692810|NCT00526591|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5692811|NCT00526591|stage I prostate cancer|stage i prostate cancer
5692812|NCT00526591|stage II prostate cancer|stage ii prostate cancer
5692813|NCT00526591|stage III prostate cancer|stage iii prostate cancer
5692814|NCT00526578|Pancreatic Cancer|pancreatic cancer
5692815|NCT00526578|Pancreatic Cancer Genetic Epidemiology|pancreatic cancer genetic epidemiology
5692816|NCT00526578|PACGENE|pacgene
5682901|NCT00567099|Memory|memory
5692817|NCT00526578|Healthy Control|healthy control
5692818|NCT00526578|Familial Pancreatic Cancer|familial pancreatic cancer
5692819|NCT00526578|FPC|fpc
5692820|NCT00526578|Questionnaire|questionnaire
5692821|NCT00526552|dyslipidemia|dyslipidemia
5692822|NCT00526552|rosuvastatin|rosuvastatin
5692823|NCT00526552|diabetes|diabetes
5692824|NCT00526552|cholesterol|cholesterol
5692825|NCT00526552|Naturalistic|naturalistic
5692826|NCT00526552|Observational|observational
5692827|NCT00526539|THR|thr
5692828|NCT00526539|reversed hybrid|reversed hybrid
5692829|NCT00526539|wear|wear
5692830|NCT00526500|Severe Traumatic Brain Injury|severe traumatic brain injury
5692831|NCT00526500|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5692832|NCT00526500|Anoxic Brain Injury|anoxic brain injury
5692833|NCT00526500|Passive Gait Training|passive gait training
5692834|NCT00526500|Tilt Table With Integrated Stepping System|tilt table with integrated stepping system
5692835|NCT00526500|Electroencephalogram|electroencephalogram
5692836|NCT00526500|Event Related Potentials|event related potentials
5692837|NCT00526487|Thoracic Dissection|thoracic dissection
5692838|NCT00526487|Dissection|dissection
5692839|NCT00526487|Endovascular|endovascular
5692840|NCT00526461|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5692841|NCT00526461|adenocarcinoma of the lung|adenocarcinoma of the lung
5692842|NCT00526461|squamous cell lung cancer|squamous cell lung cancer
5693019|NCT00525967|Cancer Pain|cancer pain
5709883|NCT00465270|PFO|pfo
5692843|NCT00526461|large cell lung cancer|large cell lung cancer
5692844|NCT00526448|high dose of ribavirin|high dose of ribavirin
5692845|NCT00526448|extend treatment duration|extend treatment duration
5692846|NCT00526448|tailoring treatment|tailoring treatment
5692847|NCT00526435|Arthritis|arthritis
5692848|NCT00526435|osteoarthritis|osteoarthritis
5692849|NCT00526435|rheumatoid arthritis|rheumatoid arthritis
5692850|NCT00526435|fibromyalgia|fibromyalgia
5692851|NCT00526435|lupus|lupus
5692852|NCT00526422|Questionnaire, dental caries, diagnosis,treatment|questionnaire, dental caries, diagnosis,treatment
5692853|NCT00526409|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5692854|NCT00526396|chemotherapy|chemotherapy
5692855|NCT00526396|toxicity adjusted dose|toxicity adjusted dose
5692856|NCT00526383|Major depressive disorder|major depressive disorder
5692857|NCT00526383|Antidepressants|antidepressants
5692858|NCT00526383|Weight gain|weight gain
5692859|NCT00526383|Metabolic syndromes|metabolic syndromes
5692861|NCT00526370|PAP smear|pap smear
5692862|NCT00526370|tampon test|tampon test
5692863|NCT00526370|E6/E7|e6/e7
5692864|NCT00526370|mRNA|mrna
5692865|NCT00526370|HPV|hpv
5692866|NCT00526357|omega-3 fatty acids|omega-3 fatty acids
5692867|NCT00526357|asthma|asthma
5692868|NCT00526357|airway hyperresponsiveness|airway hyperresponsiveness
5692869|NCT00526357|inflammation|inflammation
5692870|NCT00526344|remission of asthma|remission of asthma
5692871|NCT00526331|Perioperative Therapy|perioperative therapy
5692872|NCT00526331|Perioperative Hydration|perioperative hydration
5692873|NCT00526331|Arterial Pressure Based Cardiac Output|arterial pressure based cardiac output
5692874|NCT00526331|Vigileo Monitor|vigileo monitor
5692875|NCT00526331|FloTrac Sensor|flotrac sensor
5692876|NCT00526331|Fluid Volume|fluid volume
5692877|NCT00526331|APCO|apco
5692878|NCT00526318|localized resectable neuroblastoma|localized resectable neuroblastoma
5692879|NCT00526318|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5692880|NCT00526318|regional neuroblastoma|regional neuroblastoma
5692881|NCT00526318|stage 4S neuroblastoma|stage 4s neuroblastoma
5692882|NCT00526318|disseminated neuroblastoma|disseminated neuroblastoma
5692883|NCT00526305|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5692884|NCT00526305|Chromosome Philadelphia positive|chromosome philadelphia positive
5692885|NCT00526292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5692886|NCT00526292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5692887|NCT00526292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5692888|NCT00526292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5692889|NCT00526292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5692890|NCT00526292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5692891|NCT00526292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5692892|NCT00526292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5692893|NCT00526292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5692894|NCT00526292|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5692895|NCT00526292|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5692896|NCT00526292|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5692897|NCT00526292|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5692898|NCT00526292|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5692899|NCT00526279|Hypertension|hypertension
5692900|NCT00526279|Atacand/Atacand plus|atacand/atacand plus
5692901|NCT00526279|COMBAT|combat
5692902|NCT00526279|Compliance|compliance
5692903|NCT00526279|Naturalistic|naturalistic
5692904|NCT00526279|Observational|observational
5692905|NCT00526253|Congestive Heart Failure|congestive heart failure
5692906|NCT00526253|CHF|chf
5692907|NCT00526253|Heart Disease|heart disease
5692908|NCT00526253|Heart Attack|heart attack
5692909|NCT00526253|Stem Cell|stem cell
5692910|NCT00526253|Myoblast|myoblast
5692911|NCT00526253|Bioheart|bioheart
5692912|NCT00526214|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5692913|NCT00526214|Acute Spontaneous, Supratentorial intracerebral hemorrhage|acute spontaneous, supratentorial intracerebral hemorrhage
5692914|NCT00526201|Arthritis|arthritis
5692915|NCT00526201|Osteoarthritis|osteoarthritis
5692916|NCT00526201|Rheumatoid Arthritis|rheumatoid arthritis
5691508|NCT00531973|breast cancer|breast cancer
5692917|NCT00526201|Fibromyalgia|fibromyalgia
5692918|NCT00526201|Lupus|lupus
5692919|NCT00526188|Primovist|primovist
5692920|NCT00526188|Chinese patients|chinese patients
5692921|NCT00526188|Liver MRI|liver mri
5692922|NCT00526175|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5692923|NCT00526175|Minimal Residual Disease|minimal residual disease
5692924|NCT00526149|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5692925|NCT00526149|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5848039|NCT00036582|Healthy Volunteer|healthy volunteer
5692926|NCT00526149|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5693018|NCT00525980|Cancer Genetics|cancer genetics
5692927|NCT00526149|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5692928|NCT00526149|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5692929|NCT00526149|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5692930|NCT00526149|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5692931|NCT00526149|recurrent breast cancer|recurrent breast cancer
5692932|NCT00526149|stage IV breast cancer|stage iv breast cancer
5692933|NCT00526149|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5692934|NCT00526149|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5692935|NCT00526149|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5687871|NCT00544960|AT101|at101
5692936|NCT00526149|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5692937|NCT00526149|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5692938|NCT00526149|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5692939|NCT00526149|adult leiomyosarcoma|adult leiomyosarcoma
5692940|NCT00526149|uterine leiomyosarcoma|uterine leiomyosarcoma
5692941|NCT00526149|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5692942|NCT00526149|adult angiosarcoma|adult angiosarcoma
5692943|NCT00526149|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5692944|NCT00526149|adult epithelioid sarcoma|adult epithelioid sarcoma
5692945|NCT00526149|adult fibrosarcoma|adult fibrosarcoma
5692946|NCT00526149|adult liposarcoma|adult liposarcoma
5692947|NCT00526149|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5692948|NCT00526149|adult malignant mesenchymoma|adult malignant mesenchymoma
5692949|NCT00526149|adult neurofibrosarcoma|adult neurofibrosarcoma
5692950|NCT00526149|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5692951|NCT00526149|adult synovial sarcoma|adult synovial sarcoma
5692952|NCT00526149|endometrial stromal sarcoma|endometrial stromal sarcoma
5692953|NCT00526149|ovarian carcinosarcoma|ovarian carcinosarcoma
5692955|NCT00526149|recurrent uterine sarcoma|recurrent uterine sarcoma
5692956|NCT00526149|stage IV uterine sarcoma|stage iv uterine sarcoma
5692957|NCT00526149|recurrent melanoma|recurrent melanoma
5692958|NCT00526149|stage IV melanoma|stage iv melanoma
5692959|NCT00526136|Atrial Fibrillation|atrial fibrillation
5692960|NCT00526123|Dialysis|dialysis
5692961|NCT00526123|Dialysis Catheter|dialysis catheter
5692962|NCT00526123|Kidney Disease|kidney disease
5692963|NCT00526123|Dialysis Clinic|dialysis clinic
5692964|NCT00526123|Chronic Catheter|chronic catheter
5692965|NCT00526123|Catheter|catheter
5692966|NCT00526123|Kidney|kidney
5692967|NCT00526110|Gastrointestinal Diseases|gastrointestinal diseases
5692968|NCT00526110|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
5692969|NCT00526110|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5692970|NCT00526110|Cancer of the Stomach|cancer of the stomach
5692971|NCT00526110|5-Fluorouracil|5-fluorouracil
5692972|NCT00526110|5-FU|5-fu
5692973|NCT00526110|Adrucil|adrucil
5692974|NCT00526110|Efudex|efudex
5692975|NCT00526110|Docetaxel|docetaxel
5692976|NCT00526110|Oxaliplatin|oxaliplatin
5692977|NCT00526110|Eloxatin|eloxatin
5692978|NCT00526110|Taxotere|taxotere
5692979|NCT00526110|Esophagus|esophagus
5692980|NCT00526084|ALL|all
5692981|NCT00526084|Healthy subjects|healthy subjects
5692982|NCT00526071|Amicus Therapeutics|amicus therapeutics
5692983|NCT00526071|AT1001|at1001
5692984|NCT00526071|Galafold|galafold
5692985|NCT00526071|Migalastat|migalastat
5692986|NCT00526071|Substrate|substrate
5692987|NCT00526058|Heparin|heparin
5692988|NCT00526058|Extracorporeal|extracorporeal
5692989|NCT00526058|Low Density Lipo-Protein (LDL) Cholesterol|low density lipo-protein (ldl) cholesterol
5692990|NCT00526058|Apheresis|apheresis
5692991|NCT00526058|Device|device
5692992|NCT00526045|AUY922|auy922
5692993|NCT00526045|Solid tumors|solid tumors
5692994|NCT00526045|Breast Cancer|breast cancer
5692995|NCT00526045|Phase I/II|phase i/ii
5692996|NCT00526045|Advanced Solid malignancies (Phase I)|advanced solid malignancies (phase i)
5692997|NCT00526045|Breast Cancer ( Phase II )|breast cancer ( phase ii )
5692998|NCT00526045|HER2+|her2+
5693000|NCT00526045|HSP90|hsp90
5693001|NCT00526032|Skin Cancer|skin cancer
5693002|NCT00526032|Cancerous skin lesions|cancerous skin lesions
5693003|NCT00526032|Melanoma Detection|melanoma detection
5693004|NCT00526032|Spectroscopic Oblique-Incidence Reflectometry|spectroscopic oblique-incidence reflectometry
5693005|NCT00526032|OIR Imaging Probe|oir imaging probe
5693006|NCT00526019|remission of asthma|remission of asthma
5693007|NCT00526006|Clinical significance of the acid rebound phenomenon after withdrawal of treatment with a PPI|clinical significance of the acid rebound phenomenon after withdrawal of treatment with a ppi
5693008|NCT00525993|sports|sports
5693009|NCT00525993|ankle|ankle
5693010|NCT00525993|sprain|sprain
5693011|NCT00525993|etoricoxib|etoricoxib
5693012|NCT00525993|antiinflammatory|antiinflammatory
5693013|NCT00525993|treatment outcome|treatment outcome
5693014|NCT00525980|Breast Cancer|breast cancer
5693015|NCT00525980|Cancer Risk|cancer risk
5693016|NCT00525980|CD-ROM|cd-rom
5693017|NCT00525980|Focus Group|focus group
5693020|NCT00525967|Methadone|methadone
5693021|NCT00525967|Morphine|morphine
5693022|NCT00525967|Acetaminophen|acetaminophen
5693023|NCT00525967|Palliative Care|palliative care
5693024|NCT00525954|Coronary|coronary
5693025|NCT00525954|Artery|artery
5693026|NCT00525954|Artheroschlerosis|artheroschlerosis
5693027|NCT00525954|Phospholipase|phospholipase
5693028|NCT00525954|CAD|cad
5693029|NCT00525954|Coronary Artery Disease (CAD)|coronary artery disease (cad)
5693030|NCT00525928|craving|craving
5693031|NCT00525928|smoking|smoking
5693033|NCT00525915|Esophageal Cancer|esophageal cancer
5693034|NCT00525915|Gastroesophageal Cancer|gastroesophageal cancer
5693035|NCT00525915|Gastroesophageal Junction|gastroesophageal junction
5693036|NCT00525915|Radiation Therapy|radiation therapy
5693037|NCT00525915|5-Fluorouracil|5-fluorouracil
5693039|NCT00525915|Adrucil|adrucil
5693040|NCT00525915|Efudex|efudex
5693041|NCT00525915|Oxaliplatin|oxaliplatin
5693042|NCT00525889|diabetes|diabetes
5693043|NCT00525889|juvenile diabetes|juvenile diabetes
5693044|NCT00525889|type 1 diabetes|type 1 diabetes
5693045|NCT00525889|diabetes mellitus|diabetes mellitus
5693046|NCT00525889|recent onset|recent onset
5693047|NCT00525889|new onset|new onset
5693048|NCT00525876|Mantle Cell Lymphoma|mantle cell lymphoma
5693049|NCT00525876|Lymphoma|lymphoma
5693050|NCT00525876|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5693051|NCT00525876|Rituximab|rituximab
5693052|NCT00525876|Cyclophosphamide|cyclophosphamide
5693053|NCT00525876|Neosar|neosar
5693054|NCT00525876|Cytoxan|cytoxan
5693055|NCT00525876|Fludarabine|fludarabine
5693056|NCT00525876|Fludara|fludara
5693057|NCT00525876|Fludarabine phosphate|fludarabine phosphate
5693058|NCT00525876|Rituxan|rituxan
5693059|NCT00525876|Alemtuzumab|alemtuzumab
5693060|NCT00525876|CAMPATH-1H|campath-1h
5693061|NCT00525876|Campath|campath
5693062|NCT00525876|Total Body Irradiation|total body irradiation
5693063|NCT00525876|TBI|tbi
5693064|NCT00525863|schizophrenia|schizophrenia
5693065|NCT00525863|oxygen therapy|oxygen therapy
5693066|NCT00525850|cardiovascular disease|cardiovascular disease
5693067|NCT00525850|weight loss|weight loss
5693068|NCT00525837|varenicline|varenicline
5693069|NCT00525837|depression|depression
5693070|NCT00525837|anhedonia|anhedonia
5693071|NCT00525837|smoking|smoking
5693072|NCT00525824|Hypercholesterolaemia|hypercholesterolaemia
5693073|NCT00525824|Coronary Heart Disease (CHD)|coronary heart disease (chd)
5693074|NCT00525824|Atherosclerosis|atherosclerosis
5693075|NCT00525798|Osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoporosis, oral salmon calcitonin, treatment, efficacy, tolerability
5693076|NCT00525785|Stomach Cancer|stomach cancer
5693077|NCT00525785|Gastric Cancer|gastric cancer
5693078|NCT00525785|Adenocarcinoma of the Stomach|adenocarcinoma of the stomach
5693079|NCT00525785|Gastroesophageal Junction|gastroesophageal junction
5693080|NCT00525785|Esophageal|esophageal
5693081|NCT00525785|Gastric|gastric
5693082|NCT00525785|5-Fluorouracil|5-fluorouracil
5693083|NCT00525785|5-FU|5-fu
5693084|NCT00525785|Adrucil|adrucil
5693085|NCT00525785|Efudex|efudex
5693086|NCT00525785|Folinic Acid|folinic acid
5693087|NCT00525785|Oxaliplatin|oxaliplatin
5693088|NCT00525785|Eloxatin|eloxatin
5693089|NCT00525785|Chemoradiotherapy|chemoradiotherapy
5693090|NCT00525785|Radiation|radiation
5693091|NCT00525785|Radiotherapy|radiotherapy
5693092|NCT00525785|XRT|xrt
5693093|NCT00525772|asthma|asthma
5693094|NCT00525772|exercise induced bronchoconstriction|exercise induced bronchoconstriction
5693095|NCT00525772|sputum eosinophils|sputum eosinophils
5693096|NCT00525759|Breast cancer|breast cancer
5693097|NCT00525759|Zoledronic acid|zoledronic acid
5693098|NCT00525759|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5693100|NCT00525759|Apoptosis|apoptosis
5693101|NCT00525746|Acute Myeloid Leukemia|acute myeloid leukemia
5693102|NCT00525746|Myelodysplastic Syndrome|myelodysplastic syndrome
5693103|NCT00525746|Leukemia|leukemia
5693104|NCT00525746|MDS|mds
5693105|NCT00525746|AML|aml
5693106|NCT00525746|Malignancy|malignancy
5693107|NCT00525746|Molecular Epidemiology|molecular epidemiology
5693108|NCT00525746|Epidemiologic markers|epidemiologic markers
5693109|NCT00525746|Clinical markers|clinical markers
5700702|NCT00499512|Survey|survey
5691689|NCT00531089|plasma exchange|plasma exchange
5693110|NCT00525746|Constitutional genetic markers|constitutional genetic markers
5693111|NCT00525746|Case-comparison study|case-comparison study
5693112|NCT00525733|HIV-1|hiv-1
5693113|NCT00525733|Acute Infection|acute infection
5693114|NCT00525733|Treatment Naive|treatment naive
5693115|NCT00525720|Prostate Cancer|prostate cancer
5693116|NCT00525720|Prostatic Carcinoma|prostatic carcinoma
5693117|NCT00525720|Intermediate prostate cancer|intermediate prostate cancer
5693118|NCT00525720|Transperineal Interstitial Permanent Brachytherapy|transperineal interstitial permanent brachytherapy
5693119|NCT00525720|Brachytherapy|brachytherapy
5693120|NCT00525720|Prostate brachytherapy|prostate brachytherapy
5693121|NCT00525720|Prostate implant|prostate implant
5693122|NCT00525720|Prostate|prostate
5693123|NCT00525720|Questionnaire|questionnaire
5693125|NCT00525707|acute heart failure|acute heart failure
5693126|NCT00525707|Actelion|actelion
5693127|NCT00525707|tezosentan|tezosentan
5693128|NCT00525707|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
5693129|NCT00525707|New onset of heart failure|new onset of heart failure
5693130|NCT00525681|Obese|obese
5693131|NCT00525681|Calcineurine inhibitor|calcineurine inhibitor
5693132|NCT00525681|Pharmacokinetics|pharmacokinetics
5693133|NCT00525681|Interaction|interaction
5693134|NCT00525668|multiple sclerosis|multiple sclerosis
5693135|NCT00525668|inflammation|inflammation
5693136|NCT00525668|neurodegeneration|neurodegeneration
5693137|NCT00525668|neuroprotection|neuroprotection
5693138|NCT00525655|Familial Adenomatous Polyposis|familial adenomatous polyposis
5693139|NCT00525655|Colorectal Cancer|colorectal cancer
5693140|NCT00525655|Multimedia Intervention|multimedia intervention
5693141|NCT00525655|Questionnaire|questionnaire
5693142|NCT00525655|Survey|survey
5693143|NCT00525655|FAP|fap
5693144|NCT00525642|Breast-adjuvant|breast-adjuvant
5693145|NCT00525642|Breast-chemotherapy|breast-chemotherapy
5693146|NCT00525642|Combination chemotherapy regimens|combination chemotherapy regimens
5693147|NCT00525616|bullous pemphigoid|bullous pemphigoid
5693148|NCT00525616|mabthera|mabthera
5693149|NCT00525603|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5693150|NCT00525603|CML|cml
5693151|NCT00525603|Leukemia|leukemia
5693152|NCT00525603|Cyclophosphamide|cyclophosphamide
5693153|NCT00525603|Fludarabine|fludarabine
5693154|NCT00525603|Alemtuzumab|alemtuzumab
5693155|NCT00525603|Rituximab|rituximab
5693156|NCT00525603|CFAR|cfar
5693157|NCT00525590|Gliadel|gliadel
5693158|NCT00525577|Type 2 diabetes, glycemic control|type 2 diabetes, glycemic control
5693159|NCT00525564|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5693160|NCT00525564|Exercise|exercise
5693161|NCT00525564|Endurance shuttle walking test|endurance shuttle walking test
5693162|NCT00525564|Bronchodilation|bronchodilation
5693163|NCT00525564|Salmeterol|salmeterol
5693164|NCT00525525|Glioblastoma|glioblastoma
5693165|NCT00525525|Gliosarcoma|gliosarcoma
5693166|NCT00525525|Bevacizumab|bevacizumab
5693167|NCT00525525|Avastin|avastin
5693168|NCT00525525|Erlotinib|erlotinib
5693169|NCT00525525|Tarceva|tarceva
5693170|NCT00525525|Temozolomide|temozolomide
5693171|NCT00525525|Temodar|temodar
5693172|NCT00525499|acne|acne
5693173|NCT00525486|Nifedipine|nifedipine
5693174|NCT00525486|Tocolysis|tocolysis
5693175|NCT00525486|Maintenance|maintenance
5693176|NCT00525486|Preterm delivery|preterm delivery
5693177|NCT00525486|extended release nifedipine|extended release nifedipine
5693178|NCT00525486|PTL|ptl
5693179|NCT00525460|fertility|fertility
5693180|NCT00525460|stage I ovarian cancer|stage i ovarian cancer
5693181|NCT00525460|stage II ovarian cancer|stage ii ovarian cancer
5693182|NCT00525460|fertility sparing|fertility sparing
5693183|NCT00525447|Antigens, CD40|antigens, cd40
5693184|NCT00525447|Antibodies, Monoclonal|antibodies, monoclonal
5693185|NCT00525447|Combined Modality Therapy|combined modality therapy
5693186|NCT00525447|Multiple Myeloma|multiple myeloma
5693187|NCT00525447|Blood Coagulation Disorders|blood coagulation disorders
5693188|NCT00525447|Hematologic Diseases|hematologic diseases
5693189|NCT00525447|Hemorrhagic Disorders|hemorrhagic disorders
5693190|NCT00525447|Hemostatic Disorders|hemostatic disorders
5693191|NCT00525447|Immunoproliferative Disorders|immunoproliferative disorders
5693192|NCT00525447|Lymphoproliferative Disorders|lymphoproliferative disorders
5693193|NCT00525447|Paraproteinemias|paraproteinemias
5693194|NCT00525447|Vascular Diseases|vascular diseases
5693195|NCT00525447|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
5693196|NCT00525434|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
5693197|NCT00525421|curcuminoids|curcuminoids
5693198|NCT00525421|oral lichen planus|oral lichen planus
5693199|NCT00525421|c reactive protein|c reactive protein
5693200|NCT00525421|interleukin 6|interleukin 6
5693201|NCT00525408|HRPC|hrpc
5693202|NCT00525408|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5693203|NCT00525408|Docetaxel|docetaxel
5693204|NCT00525408|Mycobacterium w|mycobacterium w
5685718|NCT00555048|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5685719|NCT00555048|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5685720|NCT00555048|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5685721|NCT00555048|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5685722|NCT00555048|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5691788|NCT00530595|hemodialysis|hemodialysis
5693205|NCT00525395|Phototherapy|phototherapy
5693206|NCT00525395|Vitiligo scoring system|vitiligo scoring system
5693207|NCT00525382|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5693208|NCT00525382|Xyzal tablets|xyzal tablets
5693209|NCT00525356|Aorta|aorta
5693210|NCT00525356|Dissection|dissection
5693211|NCT00525356|Thoracic|thoracic
5693212|NCT00525343|Avonex pivotal trial|avonex pivotal trial
5693213|NCT00525343|Avonex|avonex
5693214|NCT00525343|Avonex long term follow-up|avonex long term follow-up
5693215|NCT00525343|Avonex outcomes|avonex outcomes
5693216|NCT00525317|Pregnancy|pregnancy
5693217|NCT00525317|Magnesium|magnesium
5693218|NCT00525317|Leg Pain|leg pain
5693219|NCT00525304|medical co-morbidity|medical co-morbidity
5693220|NCT00525304|diabetes|diabetes
5693221|NCT00525304|heart disease|heart disease
5693222|NCT00525304|respiratory illness|respiratory illness
5693223|NCT00525291|Exercise Therapy|exercise therapy
5693224|NCT00525291|Biofeedback (Psychology)|biofeedback (psychology)
5693225|NCT00525291|Adult|adult
5693226|NCT00525291|Fecal Incontinence/*therapy|fecal incontinence/*therapy
5693227|NCT00525291|EMG - Biofeedback|emg - biofeedback
5693228|NCT00525291|EMG - Triggered Stimulation|emg - triggered stimulation
5693229|NCT00525291|Augmented biofeedback|augmented biofeedback
5693230|NCT00525278|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5693231|NCT00525278|Xyzal tablets|xyzal tablets
5693232|NCT00525265|Vasopressin antagonist|vasopressin antagonist
5693233|NCT00525265|Cardiac Edema|cardiac edema
5693234|NCT00525265|Diuretics|diuretics
5693846|NCT00523055|Ultrasound|ultrasound
5693235|NCT00525252|Liver cirrhosis|liver cirrhosis
5693236|NCT00525252|Alcoholism|alcoholism
5693237|NCT00525252|Craving|craving
5693238|NCT00525239|Lipids|lipids
5693239|NCT00525239|lipoproteins|lipoproteins
5693240|NCT00525239|VLDL|vldl
5693242|NCT00525239|apo B100|apo b100
5693244|NCT00525239|apo A1|apo a1
5693245|NCT00525239|endothelial dysfunction|endothelial dysfunction
5693246|NCT00525239|insulin secretion|insulin secretion
5693247|NCT00525239|hyperglycemic clamp|hyperglycemic clamp
5693248|NCT00525239|HIV-seronegative Volunteers|hiv-seronegative volunteers
5693249|NCT00525239|HIV-infected subjects starting an efavirenz-based regimen|hiv-infected subjects starting an efavirenz-based regimen
5702379|NCT00493571|Leukemia|leukemia
5702508|NCT00493103|thyroglobulin gene|thyroglobulin gene
5702380|NCT00493558|Roentgen Stereophotogrammetric Analysis|roentgen stereophotogrammetric analysis
5702384|NCT00493545|Multicenter|multicenter
5693250|NCT00525239|Treatment Experienced|treatment experienced
5693251|NCT00525226|Psychiatry|psychiatry
5693252|NCT00525226|Psychology|psychology
5693253|NCT00525226|Pregnancy|pregnancy
5693254|NCT00525226|Stress|stress
5693255|NCT00525226|Anxiety|anxiety
5693256|NCT00525213|Rheumatoid Arthritis|rheumatoid arthritis
5693257|NCT00525200|predictive marker|predictive marker
5693258|NCT00525200|personalized therapy|personalized therapy
5693259|NCT00525200|response assessment|response assessment
5693260|NCT00525200|p53 genotype|p53 genotype
5693261|NCT00525187|onychomycosis|onychomycosis
5693262|NCT00525187|diabetic neuropathic patients|diabetic neuropathic patients
5693263|NCT00525187|reliability of the diagnostic of onychomycosis|reliability of the diagnostic of onychomycosis
5693264|NCT00525174|Amblyopia|amblyopia
5693265|NCT00525174|Patching|patching
5693266|NCT00525174|Bangerter filters|bangerter filters
5693267|NCT00525161|breast cancer|breast cancer
5693268|NCT00525161|Sorafenib|sorafenib
5693269|NCT00525161|Nexavar|nexavar
5693270|NCT00525161|Endocrine Therapy|endocrine therapy
5693271|NCT00525122|hyperthyroidism|hyperthyroidism
5693272|NCT00525122|radioactive iodine|radioactive iodine
5693273|NCT00525122|antithyroid drugs|antithyroid drugs
5693274|NCT00525122|Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs|hyperthyroidism, treatment with radioactive iodine without antithyroid drugs
5693275|NCT00525109|Cholesterol|cholesterol
5693276|NCT00525109|Hyperlipidemia|hyperlipidemia
5693277|NCT00525109|Gene array|gene array
5693278|NCT00525083|hyperlipidemia|hyperlipidemia
5693279|NCT00525083|HDL-C|hdl-c
5685723|NCT00555048|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5685724|NCT00555048|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5685725|NCT00555048|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5693280|NCT00525083|low density lipoprotein|low density lipoprotein
5693281|NCT00525031|Melanoma|melanoma
5693282|NCT00525031|Temozolomide|temozolomide
5693283|NCT00525031|Temodar|temodar
5693284|NCT00525031|Pegylated Interferon Alpha-2b|pegylated interferon alpha-2b
5693285|NCT00525031|PEG-Intron|peg-intron
5693286|NCT00525031|PGI|pgi
5693287|NCT00525031|Resectable metastatic melanoma|resectable metastatic melanoma
5693288|NCT00525031|Surgery|surgery
5693289|NCT00525018|Pain|pain
5693290|NCT00525018|Functional neuroimaging|functional neuroimaging
5693291|NCT00525018|Neuropathy|neuropathy
5693292|NCT00525018|Thermal sensation|thermal sensation
5693293|NCT00525005|Stomach Neoplasm|stomach neoplasm
5693294|NCT00525005|Docetaxel|docetaxel
5693295|NCT00525005|Oxaliplatin|oxaliplatin
5693296|NCT00525005|S-1|s-1
5693297|NCT00524992|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5693298|NCT00524992|Collapsing Glomerulopathy|collapsing glomerulopathy
5693299|NCT00524992|Anti-Retroviral Toxicity|anti-retroviral toxicity
5693301|NCT00524992|Metabolic Syndrome|metabolic syndrome
5693302|NCT00524992|Tubular Injury|tubular injury
5693303|NCT00524992|Renal Biopsy|renal biopsy
5693304|NCT00524992|Proteinuria|proteinuria
5693305|NCT00524992|Tenofovir Toxicity|tenofovir toxicity
5693306|NCT00524992|HAART Toxicity|haart toxicity
5693307|NCT00524992|HIV Positive|hiv positive
5693308|NCT00524992|HIV-Associated Focal Segmental Glomerulosclerosis|hiv-associated focal segmental glomerulosclerosis
5693309|NCT00524953|allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5693310|NCT00524953|non-T-cell depleted|non-t-cell depleted
5693311|NCT00524953|UV-c|uv-c
5693312|NCT00524953|GVHD|gvhd
5693313|NCT00524940|Influenza|influenza
5693314|NCT00524940|Orthomyxoviruses|orthomyxoviruses
5693315|NCT00524940|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5693316|NCT00524927|Incident Pain|incident pain
5693317|NCT00524927|Bone Marrow Biopsy|bone marrow biopsy
5693318|NCT00524914|Parkinson's disease|parkinson's disease
5693319|NCT00524914|Pain|pain
5693320|NCT00524914|Nociceptive threshold|nociceptive threshold
5693321|NCT00524914|Functional imaging|functional imaging
5693322|NCT00524914|Cerebral activity|cerebral activity
5693323|NCT00524914|Dopamine agonist.|dopamine agonist.
5693324|NCT00524901|Apoptosis|apoptosis
5693325|NCT00524901|CABG|cabg
5693326|NCT00524901|Coronary Artery Disease|coronary artery disease
5693327|NCT00524901|Three Vessel Disease|three vessel disease
5693328|NCT00524901|Erythropoietin|erythropoietin
5693329|NCT00524901|EPO-receptor signaling|epo-receptor signaling
5693330|NCT00524888|Hand|hand
5693331|NCT00524888|Laceration|laceration
5693332|NCT00524888|bioadhesive|bioadhesive
5693333|NCT00524888|ER|er
5693334|NCT00524888|Hand laceration distal to the volar wrist crease|hand laceration distal to the volar wrist crease
5693954|NCT00522652|cancer|cancer
5688349|NCT00543855|E2020|e2020
5693335|NCT00524875|Proliferative diabetic retinopathy|proliferative diabetic retinopathy
5702492|NCT00493181|CML|cml
5693337|NCT00524875|Early post-vitrectomy vitreous hemorrhage|early post-vitrectomy vitreous hemorrhage
5693338|NCT00524862|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5693339|NCT00524862|Ejection Fraction|ejection fraction
5693340|NCT00524862|QRS duration|qrs duration
5693341|NCT00524849|Breast cancer|breast cancer
5693342|NCT00524849|Bone metastasis|bone metastasis
5693343|NCT00524849|Circulating VEGF|circulating vegf
5693344|NCT00524849|Zoledronic acid|zoledronic acid
5693345|NCT00524849|Angiogenesis|angiogenesis
5693346|NCT00524836|levocetirizine dihydrochloride|levocetirizine dihydrochloride
5693347|NCT00524836|Xyzal tablets|xyzal tablets
5693348|NCT00524823|Prostate Cancer|prostate cancer
5693349|NCT00524823|Hyperplasia - BPH|hyperplasia - bph
5693350|NCT00524823|FACS|facs
5693351|NCT00524823|Prostate Cancer, Hyperplasia - BPH, Malignancy|prostate cancer, hyperplasia - bph, malignancy
5693352|NCT00524797|Myelosuppression,|myelosuppression,
5693353|NCT00524797|chemotherapeutic agents,|chemotherapeutic agents,
5693354|NCT00524797|leucopenia,|leucopenia,
5693355|NCT00524797|thrombocytopenia,|thrombocytopenia,
5693356|NCT00524797|Profonycia|profonycia
5693357|NCT00524784|GVHD|gvhd
5693358|NCT00524784|HSCT|hsct
5693359|NCT00524784|BMT|bmt
5693360|NCT00524784|APOPTOTIC CELLS|apoptotic cells
5693361|NCT00524771|Contraception|contraception
5693362|NCT00524771|Contraceptive Vaginal Ring|contraceptive vaginal ring
5693363|NCT00524758|ologen|ologen
5693364|NCT00524758|oculusgen|oculusgen
5693365|NCT00524758|collagen matrix|collagen matrix
5693366|NCT00524758|trabeculectomy|trabeculectomy
5693367|NCT00524758|filtering surgery|filtering surgery
5691937|NCT00529997|Leg Pain|leg pain
5693368|NCT00524758|mitomycin-C|mitomycin-c
5693369|NCT00524758|MMC|mmc
5693370|NCT00524758|Aeon Astron|aeon astron
5693371|NCT00524745|Gardasil|gardasil
5693372|NCT00524745|Human Papillomavirus|human papillomavirus
5693373|NCT00524745|HPV vaccine|hpv vaccine
5693374|NCT00524745|Cervical cancer|cervical cancer
5693375|NCT00524732|Pertussis|pertussis
5693376|NCT00524732|Tetanus|tetanus
5693377|NCT00524732|Diphtheria|diphtheria
5693378|NCT00524706|S-1|s-1
5693379|NCT00524706|oral fluoropyrimidine|oral fluoropyrimidine
5693380|NCT00524706|tegafur|tegafur
5693381|NCT00524706|Gimeracil|gimeracil
5693382|NCT00524706|Oteracil Potassium|oteracil potassium
5693383|NCT00524706|Leucovorin|leucovorin
5693384|NCT00524706|Calcium Folinate|calcium folinate
5693385|NCT00524706|Oxaliplatin|oxaliplatin
5693386|NCT00524706|L-OHP|l-ohp
5693387|NCT00524706|colorectal cancer|colorectal cancer
5693388|NCT00524693|Bronchiolitis|bronchiolitis
5693389|NCT00524693|controlled clinical trial|controlled clinical trial
5693390|NCT00524693|pediatrics|pediatrics
5693391|NCT00524693|Infants|infants
5693392|NCT00524693|montelukast|montelukast
5693393|NCT00524693|Respiratory syncytial virus|respiratory syncytial virus
5693394|NCT00524680|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5693395|NCT00524680|recurrent prostate cancer|recurrent prostate cancer
5693396|NCT00524680|stage I prostate cancer|stage i prostate cancer
5693397|NCT00524680|stage II prostate cancer|stage ii prostate cancer
5693398|NCT00524680|stage III prostate cancer|stage iii prostate cancer
5693399|NCT00524680|stage IV prostate cancer|stage iv prostate cancer
5693400|NCT00524667|Active CLL|active cll
5693401|NCT00524654|To determine the effects of cervical spine manipulation on postural control.|to determine the effects of cervical spine manipulation on postural control.
5693402|NCT00524641|Asthma|asthma
5693403|NCT00524641|Symbicort|symbicort
5693404|NCT00524641|NIS|nis
5693405|NCT00524615|resistant hypertension treatment|resistant hypertension treatment
5693406|NCT00524615|spironolactone|spironolactone
5693407|NCT00524615|aldosterone antagonists|aldosterone antagonists
5693408|NCT00524615|resistant arterial hypertension|resistant arterial hypertension
5693409|NCT00524615|refractory arterial hypertension|refractory arterial hypertension
5693410|NCT00524602|Stereotaxis|stereotaxis
5693411|NCT00524602|Arrythmia|arrythmia
5693412|NCT00524602|Catheter ablation|catheter ablation
5693413|NCT00524602|Heart|heart
5693414|NCT00524589|recurrent prostate cancer|recurrent prostate cancer
5693415|NCT00524576|Hepatitis B|hepatitis b
5693416|NCT00524576|Persistence|persistence
5693417|NCT00524576|Challenge dose|challenge dose
5693418|NCT00524563|Acinetobacter|acinetobacter
5693419|NCT00524563|bloodstream infection|bloodstream infection
5693420|NCT00524563|Isolate|isolate
5693421|NCT00524550|Moderate alcohol consumption|moderate alcohol consumption
5693422|NCT00524550|insulin secretion|insulin secretion
5693423|NCT00524550|insulin sensitivity|insulin sensitivity
5693424|NCT00524550|Beta-cell function|beta-cell function
5693425|NCT00524550|Adiponectin|adiponectin
5693426|NCT00524550|Appetite|appetite
5693427|NCT00524550|Satiety|satiety
5693428|NCT00524550|Alcohol-induced gene expression|alcohol-induced gene expression
5693429|NCT00524550|Endocannabinoids|endocannabinoids
5693430|NCT00524550|Glucose metabolism|glucose metabolism
5693431|NCT00524550|Lipid metabolism|lipid metabolism
5693432|NCT00524550|Ratio HMW/total adiponectin|ratio hmw/total adiponectin
5694155|NCT00521976|Chest pain|chest pain
5693434|NCT00524550|Alcohol-induced adiponectin increase|alcohol-induced adiponectin increase
5693435|NCT00524537|Crohn's Disease|crohn's disease
5693436|NCT00524524|solid tumors|solid tumors
5693437|NCT00524524|biopsy|biopsy
5693438|NCT00524511|cesarean|cesarean
5693439|NCT00524511|wound|wound
5693440|NCT00524511|Dermabond|dermabond
5693441|NCT00524511|superglue|superglue
5693442|NCT00524511|staples|staples
5693443|NCT00524511|wound complications|wound complications
5693444|NCT00524498|OPC-18|opc-18
5693445|NCT00524498|Interferon-alpha|interferon-alpha
5693446|NCT00524498|Fluorouracil|fluorouracil
5693447|NCT00524485|actinic keratosis|actinic keratosis
5693448|NCT00524472|Hyperinsulinemic glucose control|hyperinsulinemic glucose control
5693449|NCT00524472|cardiac surgery|cardiac surgery
5693451|NCT00524459|stage IIIA breast cancer|stage iiia breast cancer
5693452|NCT00524459|stage IIIB breast cancer|stage iiib breast cancer
5693453|NCT00524446|Infant|infant
5693454|NCT00524446|Sub-Saharan Africa|sub-saharan africa
5693455|NCT00524446|Complementary feeding|complementary feeding
5693456|NCT00524446|Fortified spread|fortified spread
5693457|NCT00524446|Lipid-based nutrient supplement|lipid-based nutrient supplement
5693458|NCT00524446|Malnutrition|malnutrition
5693459|NCT00524446|Stunting|stunting
5693460|NCT00524446|Growth|growth
5693461|NCT00524446|Morbidity|morbidity
5693462|NCT00524446|Development|development
5693463|NCT00524446|Haemoglobin|haemoglobin
5693464|NCT00524433|acute heart failure|acute heart failure
5693465|NCT00524433|acute decompensation of chronic heart failure|acute decompensation of chronic heart failure
5693466|NCT00524433|new onset of heart failure|new onset of heart failure
5693467|NCT00524433|tezosentan|tezosentan
5685726|NCT00555048|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5685727|NCT00555048|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5685728|NCT00555048|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5685729|NCT00555048|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5685730|NCT00555048|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5685731|NCT00555048|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5685732|NCT00555048|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5680510|NCT00577785|cystectomy|cystectomy
5693468|NCT00524433|Actelion|actelion
5693469|NCT00524420|Pain|pain
5693470|NCT00524420|Fatigue|fatigue
5693471|NCT00524420|Chronic Fatigue Syndrome|chronic fatigue syndrome
5693472|NCT00524420|Chronic Fatigue-Fibromyalgia Syndrome|chronic fatigue-fibromyalgia syndrome
5693473|NCT00524420|Depression|depression
5693474|NCT00524420|Major Depressive Disorder|major depressive disorder
5693475|NCT00524407|Anemia|anemia
5693476|NCT00524407|hemoglobin|hemoglobin
5693477|NCT00524407|chemotherapy|chemotherapy
5693478|NCT00524407|hematologic response|hematologic response
5693479|NCT00524407|subcutaneous injection|subcutaneous injection
5693480|NCT00524407|Epoetin alfa|epoetin alfa
5693481|NCT00524407|FACT-An|fact-an
5693482|NCT00524407|LASA|lasa
5693483|NCT00524407|PROCRIT|procrit
5693484|NCT00524394|VLBW|vlbw
5693485|NCT00524394|sepsis|sepsis
5693486|NCT00524394|diagnosis|diagnosis
5693487|NCT00524394|suspected sepsis|suspected sepsis
5693488|NCT00524368|Human immunodeficiency virus - type 1|human immunodeficiency virus - type 1
5693489|NCT00524368|HIV-1 Infection|hiv-1 infection
5693490|NCT00524368|TMC-114|tmc-114
5693491|NCT00524368|Darunavir|darunavir
5693492|NCT00524368|Ritonavir|ritonavir
5693493|NCT00524355|GERD|gerd
5693494|NCT00524355|GIS|gis
5693495|NCT00524355|heartburn|heartburn
5693496|NCT00524355|NIS|nis
5693498|NCT00524342|IL-11|il-11
5693499|NCT00524342|von Willebrand disease|von willebrand disease
5693500|NCT00524342|von Willebrand factor|von willebrand factor
5693501|NCT00524342|VWFmRNA|vwfmrna
5693502|NCT00524342|menorrhagia|menorrhagia
5693503|NCT00524329|upper GI-symptoms|upper gi-symptoms
5693504|NCT00524329|heartburn|heartburn
5693505|NCT00524329|NSAID|nsaid
5693506|NCT00524329|risk|risk
5693507|NCT00524329|PPI|ppi
5693508|NCT00524329|Bloating|bloating
5693509|NCT00524329|Regurgitation|regurgitation
5693510|NCT00524316|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5693511|NCT00524316|advanced adult primary liver cancer|advanced adult primary liver cancer
5693512|NCT00524316|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5693513|NCT00524316|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5693514|NCT00524303|ErbB2 Overexpressing|erbb2 overexpressing
5693515|NCT00524303|ErbB2 Positive|erbb2 positive
5693516|NCT00524303|Lapatinib|lapatinib
5693517|NCT00524303|Invasive Breast Cancer|invasive breast cancer
5693518|NCT00524290|Acinetobacter|acinetobacter
5693519|NCT00524290|infection|infection
5693520|NCT00524290|isolate|isolate
5693521|NCT00524277|stage I breast cancer|stage i breast cancer
5693522|NCT00524277|stage II breast cancer|stage ii breast cancer
5693523|NCT00524277|stage IIIA breast cancer|stage iiia breast cancer
5693524|NCT00524277|stage IIIB breast cancer|stage iiib breast cancer
5693525|NCT00524277|stage IIIC breast cancer|stage iiic breast cancer
5693526|NCT00524277|male breast cancer|male breast cancer
5693527|NCT00524251|Patients with reflux complaints|patients with reflux complaints
5693528|NCT00524251|GERD|gerd
5693529|NCT00524251|quality of life|quality of life
5693530|NCT00524251|lifestyle adjustments|lifestyle adjustments
5693531|NCT00524238|hypothyroidism|hypothyroidism
5693532|NCT00524238|glucose turnover|glucose turnover
5693533|NCT00524238|clamp|clamp
5693534|NCT00524238|insulin resistance|insulin resistance
5693535|NCT00524238|lipid turnover|lipid turnover
5693536|NCT00524238|amino acid turnover|amino acid turnover
5693537|NCT00524225|IL-11|il-11
5693538|NCT00524225|von Willebrand disease|von willebrand disease
5693539|NCT00524225|von Willebrand factor|von willebrand factor
5693540|NCT00524225|VWFmRNA|vwfmrna
5693541|NCT00524225|surgery|surgery
5693542|NCT00524199|homocysteine|homocysteine
5693543|NCT00524199|hemodialysis|hemodialysis
5693544|NCT00524199|mesna|mesna
5693545|NCT00524186|stage III gastric cancer|stage iii gastric cancer
5693546|NCT00524186|stage IV gastric cancer|stage iv gastric cancer
5693547|NCT00524186|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5693548|NCT00524186|stage IV esophageal cancer|stage iv esophageal cancer
5693549|NCT00524186|recurrent gastric cancer|recurrent gastric cancer
5693550|NCT00524186|recurrent esophageal cancer|recurrent esophageal cancer
5693551|NCT00524186|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5693552|NCT00524173|Emtricitabine|emtricitabine
5693553|NCT00524173|Tenofovir|tenofovir
5693554|NCT00524173|Antiviral Therapy|antiviral therapy
5693555|NCT00524173|Hepatitis B|hepatitis b
5693556|NCT00524173|HBV|hbv
5693557|NCT00524160|Fentanyl|fentanyl
5693558|NCT00524160|opioid analgesics|opioid analgesics
5693559|NCT00524160|arthritis|arthritis
5693560|NCT00524160|osteoarthritis|osteoarthritis
5693561|NCT00524160|rheumatoid arthritis|rheumatoid arthritis
5693562|NCT00524160|transdermal administration|transdermal administration
5693563|NCT00524147|loculated pleural effusion|loculated pleural effusion
5693564|NCT00524147|pigtail drainage|pigtail drainage
5693565|NCT00524147|pleural effusion|pleural effusion
5693566|NCT00524147|pleural thickening|pleural thickening
5693567|NCT00524147|tuberculosis|tuberculosis
5693568|NCT00524134|Epilepsy|epilepsy
5693569|NCT00524134|Seizure|seizure
5693570|NCT00524134|p-glycoprotein|p-glycoprotein
5693571|NCT00524121|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5693572|NCT00524121|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5693573|NCT00524121|stage I esophageal cancer|stage i esophageal cancer
5693574|NCT00524121|stage II esophageal cancer|stage ii esophageal cancer
5693575|NCT00524121|stage III esophageal cancer|stage iii esophageal cancer
5693576|NCT00524121|stage IV esophageal cancer|stage iv esophageal cancer
5693577|NCT00524108|shunt|shunt
5693578|NCT00524108|internal ventriculoperitoneal|internal ventriculoperitoneal
5693579|NCT00524095|prophylaxis|prophylaxis
5693580|NCT00524095|Antibiotic|antibiotic
5693581|NCT00524095|inhaled steroids|inhaled steroids
5693582|NCT00524095|bronchiectasis|bronchiectasis
5693583|NCT00524095|prevalence|prevalence
5693584|NCT00524095|chronic bronchitis|chronic bronchitis
5693585|NCT00524069|stage I pancreatic cancer|stage i pancreatic cancer
5693586|NCT00524069|stage II pancreatic cancer|stage ii pancreatic cancer
5693587|NCT00524069|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5693588|NCT00524056|Essential Tremor|essential tremor
5693589|NCT00524056|Tremor|tremor
5693590|NCT00524056|Anti-epileptic drug (AED)|anti-epileptic drug (aed)
5693591|NCT00524043|Schizophrenia|schizophrenia
5693592|NCT00524030|Epilepsy|epilepsy
5693593|NCT00524030|partial seizures|partial seizures
5693594|NCT00524030|pregabalin monotherapy|pregabalin monotherapy
5693595|NCT00524030|double-blind and randomized trial|double-blind and randomized trial
5693596|NCT00524017|hypopharyngeal cancer|hypopharyngeal cancer
5693597|NCT00524017|laryngeal cancer|laryngeal cancer
5693598|NCT00524017|lip and oral cavity cancer|lip and oral cavity cancer
5693599|NCT00524017|nasopharyngeal cancer|nasopharyngeal cancer
5693600|NCT00524017|oropharyngeal cancer|oropharyngeal cancer
5693601|NCT00524017|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5693602|NCT00524017|salivary gland cancer|salivary gland cancer
5693603|NCT00524017|precancerous condition|precancerous condition
5693604|NCT00524004|Passive immunization, Bovine Milk Immunoglobulin|passive immunization, bovine milk immunoglobulin
5693605|NCT00523978|Atrial Fibrillation|atrial fibrillation
5693606|NCT00523965|Kala-azar|kala-azar
5693607|NCT00523965|miltefosine|miltefosine
5693608|NCT00523965|liposomal amphotericin B|liposomal amphotericin b
5693609|NCT00523952|dermatitis, atopic|dermatitis, atopic
5693610|NCT00523952|tacrolimus|tacrolimus
5693611|NCT00523952|adult|adult
5693612|NCT00523939|Lymphoma|lymphoma
5693613|NCT00523939|Leukemia|leukemia
5693614|NCT00523939|Leukemic Meningitis|leukemic meningitis
5693615|NCT00523939|Lymphomatous Meningitis|lymphomatous meningitis
5693616|NCT00523926|Tuberculosis|tuberculosis
5693617|NCT00523913|type 2 diabetes mellitus;|type 2 diabetes mellitus;
5693618|NCT00523913|diabetes;|diabetes;
5693619|NCT00523913|rosiglitazone|rosiglitazone
5693620|NCT00523913|Avandia;|avandia;
5693621|NCT00523900|malnutrition|malnutrition
5693622|NCT00523900|underweight|underweight
5693623|NCT00523900|low body weight|low body weight
5693629|NCT00523887|Fentanyl|fentanyl
5693630|NCT00523887|Pain|pain
5693631|NCT00523861|Glucose|glucose
5693632|NCT00523861|Insulin sensitivity|insulin sensitivity
5693633|NCT00523861|Glucose metabolism|glucose metabolism
5693634|NCT00523861|Appetite|appetite
5693635|NCT00523861|Satiety|satiety
5693636|NCT00523848|stage I multiple myeloma|stage i multiple myeloma
5693638|NCT00523848|stage III multiple myeloma|stage iii multiple myeloma
5694694|NCT00519935|adolescents|adolescents
5693639|NCT00523822|This study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.|this study seeks to determine if the correction of a sacroiliac lesion can produce a functional change in cervical spine.
5693640|NCT00523809|Breast Cancer|breast cancer
5693641|NCT00523809|Ovarian Cancer|ovarian cancer
5680514|NCT00577772|Gastrointestinal Device|gastrointestinal device
5693642|NCT00523809|Stem Cell Transplantation|stem cell transplantation
5693643|NCT00523809|Bevacizumab|bevacizumab
5693644|NCT00523809|Fludarabine|fludarabine
5693645|NCT00523809|Melphalan|melphalan
5693646|NCT00523809|Avastin|avastin
5693647|NCT00523809|Thymoglobulin|thymoglobulin
5693649|NCT00523809|Antithymocyte Globulin|antithymocyte globulin
5693650|NCT00523809|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5693651|NCT00523809|AHSCT|ahsct
5693652|NCT00523796|dyslipidemia|dyslipidemia
5693653|NCT00523796|in practice survey|in practice survey
5693654|NCT00523796|Vietnam|vietnam
5693655|NCT00523783|Schizophrenia|schizophrenia
5693656|NCT00523783|Schizoaffective|schizoaffective
5693657|NCT00523783|quetiapine|quetiapine
5693658|NCT00523783|long-term efficacy|long-term efficacy
5693659|NCT00523783|Naturalistic|naturalistic
5693660|NCT00523783|Observational|observational
5693661|NCT00523770|Invasive Pneumococcal Diseases|invasive pneumococcal diseases
5693662|NCT00523770|Pneumonia|pneumonia
5693663|NCT00523757|heart failure|heart failure
5693664|NCT00523757|collagen|collagen
5693665|NCT00523757|diastolic function|diastolic function
5693666|NCT00523744|hypertension, valsartan, amlodipine|hypertension, valsartan, amlodipine
5693667|NCT00523731|Stem cells|stem cells
5693668|NCT00523731|Rest pain|rest pain
5693669|NCT00523731|claudication|claudication
5693670|NCT00523731|chronic ischemic or non-healing ulcers|chronic ischemic or non-healing ulcers
5693671|NCT00523731|Angiogenesis|angiogenesis
5693672|NCT00523731|no-option cases|no-option cases
5693673|NCT00523718|obsessive-compulsive disorder|obsessive-compulsive disorder
5693674|NCT00523718|OCD|ocd
5693675|NCT00523718|glutamate|glutamate
5693676|NCT00523718|riluzole|riluzole
5693677|NCT00523718|augmentation|augmentation
5693678|NCT00523718|treatment|treatment
5693679|NCT00523705|premenstrual syndrome|premenstrual syndrome
5693680|NCT00523705|PMS|pms
5693681|NCT00523705|PMDD|pmdd
5693682|NCT00523705|treatment|treatment
5693683|NCT00523705|SSRI|ssri
5693684|NCT00523692|Early arthritis|early arthritis
5693685|NCT00523692|Rheumatoid arthritis|rheumatoid arthritis
5693686|NCT00523692|Rheumatoid factor|rheumatoid factor
5693687|NCT00523692|Anti CCP antibody|anti ccp antibody
5693688|NCT00523692|Remission|remission
5693689|NCT00523692|Anti-TNF therapy|anti-tnf therapy
5693690|NCT00523692|methotrexate|methotrexate
5693691|NCT00523679|Asthma|asthma
5693692|NCT00523679|Symbicort|symbicort
5693693|NCT00523679|SMART|smart
5693694|NCT00523679|inhaler|inhaler
5693695|NCT00523679|compliance|compliance
5693696|NCT00523679|Naturalistic|naturalistic
5693697|NCT00523679|Observational|observational
5693698|NCT00523666|Alzheimer's disease|alzheimer's disease
5693699|NCT00523666|diffusion tensor imaging|diffusion tensor imaging
5693700|NCT00523640|metastatic|metastatic
5693701|NCT00523640|renal cell|renal cell
5693703|NCT00523640|neoplasm|neoplasm
5693709|NCT00523614|venous thromboembolism|venous thromboembolism
5693710|NCT00523601|Bipolar depression|bipolar depression
5693711|NCT00523601|quetiapine|quetiapine
5693712|NCT00523601|observational|observational
5693713|NCT00523601|Naturalistic|naturalistic
5693714|NCT00523588|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
5693715|NCT00523588|Pulsed dye laser|pulsed dye laser
5693716|NCT00523575|Elderly|elderly
5693717|NCT00523575|Osteoporosis|osteoporosis
5693718|NCT00523575|hip fracture|hip fracture
5693719|NCT00523575|malnutrition|malnutrition
5693720|NCT00523575|nutritional support|nutritional support
5693721|NCT00523562|fructose|fructose
5693722|NCT00523562|dietary lipids|dietary lipids
5693723|NCT00523562|dietary proteins|dietary proteins
5693724|NCT00523562|hepatic steatosis|hepatic steatosis
5693725|NCT00523562|insulin resistance|insulin resistance
5693726|NCT00523562|Healthy humans|healthy humans
5694031|NCT00522353|weight loss|weight loss
5693727|NCT00523562|overweight humans|overweight humans
5693728|NCT00523562|obese humans|obese humans
5693729|NCT00523549|Hypertension|hypertension
5693730|NCT00523549|systolic blood pressure|systolic blood pressure
5693731|NCT00523549|diastolic dysfunction|diastolic dysfunction
5693732|NCT00523549|valsartan|valsartan
5693733|NCT00523549|amlodipine|amlodipine
5693734|NCT00523536|High Blood Pressure|high blood pressure
5693735|NCT00523536|Cardiovascular|cardiovascular
5693736|NCT00523523|Rehabilitation|rehabilitation
5693737|NCT00523523|hemiplegia|hemiplegia
5693739|NCT00523523|upper extremity|upper extremity
5693740|NCT00523523|motor skills|motor skills
5693741|NCT00523523|therapy|therapy
5693742|NCT00523510|breastmilk|breastmilk
5693743|NCT00523510|perinatal HIV|perinatal hiv
5693745|NCT00523510|flash heat|flash heat
5693746|NCT00523510|pasteurization|pasteurization
5693749|NCT00523510|HIV Seronegativity|hiv seronegativity
5693750|NCT00523510|Treatment Naive|treatment naive
5693751|NCT00523497|Severe community-acquired pneumonia|severe community-acquired pneumonia
5693752|NCT00523497|Noninvasive mechanical ventilation|noninvasive mechanical ventilation
5693753|NCT00523497|Acute hypoxemic respiratory failure.|acute hypoxemic respiratory failure.
5693754|NCT00523484|Beck Anxiety Inventory|beck anxiety inventory
5693755|NCT00523484|Prostate Cancer|prostate cancer
5693756|NCT00523484|Prostate Specific Antigen|prostate specific antigen
5693757|NCT00523484|Naturalistic|naturalistic
5693758|NCT00523484|Observational|observational
5693759|NCT00523471|prostate cancer|prostate cancer
5693760|NCT00523471|gamma H2AX|gamma h2ax
5693761|NCT00523471|radiosensitivity|radiosensitivity
5693762|NCT00523458|Co-infection|co-infection
5693763|NCT00523458|Tuberculosis|tuberculosis
5693764|NCT00523458|HIV|hiv
5693765|NCT00523458|Drug interactions|drug interactions
5693766|NCT00523458|Non nucleoside reverse transcriptase inhibitors|non nucleoside reverse transcriptase inhibitors
5693767|NCT00523458|Therapy|therapy
5693768|NCT00523458|Treatment Naive|treatment naive
5693769|NCT00523445|Schizophrenia|schizophrenia
5693770|NCT00523445|Cognition|cognition
5693771|NCT00523445|Varenicline|varenicline
5693772|NCT00523432|ovarian cancer|ovarian cancer
5693773|NCT00523432|cervical cancer|cervical cancer
5693774|NCT00523432|uterine cancer|uterine cancer
5693775|NCT00523432|fallopian tube cancer|fallopian tube cancer
5693776|NCT00523432|endometrial cancer|endometrial cancer
5693777|NCT00523432|vaginal cancer|vaginal cancer
5693778|NCT00523432|peritoneal cancer|peritoneal cancer
5693779|NCT00523432|reproductive cancer|reproductive cancer
5693780|NCT00523406|choroidal neovascularisation,|choroidal neovascularisation,
5693781|NCT00523406|vision,|vision,
5693782|NCT00523406|macula,|macula,
5693783|NCT00523406|macular degeneration|macular degeneration
5693784|NCT00523406|optical coherence tomography|optical coherence tomography
5693785|NCT00523406|neovascular age related macular degeneration|neovascular age related macular degeneration
5693786|NCT00523367|Gastro Esophageal Reflux Disease (GERD)|gastro esophageal reflux disease (gerd)
5693787|NCT00523367|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5693788|NCT00523354|Eosinophilic Esophagitis|eosinophilic esophagitis
5693789|NCT00523354|TNF-alpha|tnf-alpha
5693790|NCT00523354|TNF-alpha Blockade|tnf-alpha blockade
5693791|NCT00523354|Infliximab|infliximab
5693792|NCT00523341|postmenopausal osteoporosis|postmenopausal osteoporosis
5693793|NCT00523341|low bone density|low bone density
5693794|NCT00523341|fractures|fractures
5693795|NCT00523341|low bone mass|low bone mass
5693796|NCT00523328|Rheumatoid Arthritis|rheumatoid arthritis
5693797|NCT00523328|Arthritis|arthritis
5693798|NCT00523328|BG9924|bg9924
5693799|NCT00523328|methotrexate|methotrexate
5693800|NCT00523315|Aromatase Inhibitor|aromatase inhibitor
5693801|NCT00523315|Breast Cancer|breast cancer
5693802|NCT00523315|compliance|compliance
5693803|NCT00523315|Naturalistic|naturalistic
5693804|NCT00523315|Observational|observational
5693805|NCT00523302|Major Depression|major depression
5693806|NCT00523302|Fibromyalgia|fibromyalgia
5693808|NCT00523289|Ropivacaine|ropivacaine
5693809|NCT00523289|Bupivacaine|bupivacaine
5693810|NCT00523289|Upper Extremity|upper extremity
5693811|NCT00523289|Local anesthetic|local anesthetic
5693812|NCT00523276|Severe acute respiratory syndrome, SARS, China|severe acute respiratory syndrome, sars, china
5693813|NCT00523250|Glaucoma|glaucoma
5693814|NCT00523224|Stem cells|stem cells
5693815|NCT00523224|Coronary Artery Bypass grafting|coronary artery bypass grafting
5693816|NCT00523224|Congestive Heart Failure|congestive heart failure
5693817|NCT00523224|Coronary Artery Disease|coronary artery disease
5693818|NCT00523224|Angiogenesis|angiogenesis
5693819|NCT00523211|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5693820|NCT00523211|Treatment Experienced|treatment experienced
5693821|NCT00523198|Cortisol|cortisol
5693822|NCT00523185|alcohol withdrawal|alcohol withdrawal
5693823|NCT00523185|lorazepam|lorazepam
5693824|NCT00523185|diazepam|diazepam
5693825|NCT00523172|Chiropractic Manipulation|chiropractic manipulation
5693827|NCT00523146|primary dysmenorrhea|primary dysmenorrhea
5693828|NCT00523146|Herbal remedy|herbal remedy
5693829|NCT00523133|alcoholism|alcoholism
5710821|NCT00462111|obstacle avoidance|obstacle avoidance
5710822|NCT00462111|accidental falls|accidental falls
5710824|NCT00462098|hyperbaric oxygen|hyperbaric oxygen
5693830|NCT00523133|naltrexone|naltrexone
5693831|NCT00523133|motivational enhancement therapy|motivational enhancement therapy
5693832|NCT00523107|Fatigue|fatigue
5693833|NCT00523107|Standard Palliative Care|standard palliative care
5693834|NCT00523107|PG2|pg2
5693835|NCT00523107|QLQ-C30|qlq-c30
5693836|NCT00523107|Compassionate|compassionate
5693837|NCT00523081|adolescent depression treatment, cognitive behavioral therapy,|adolescent depression treatment, cognitive behavioral therapy,
5693838|NCT00523081|collaborative care|collaborative care
5693839|NCT00523068|overactive bladder|overactive bladder
5693840|NCT00523068|stress urinary incontinence|stress urinary incontinence
5693841|NCT00523068|detrusor overactivity|detrusor overactivity
5693842|NCT00523068|urodynamics|urodynamics
5693843|NCT00523055|Pain|pain
5693844|NCT00523055|Brachial Plexus Anesthesia|brachial plexus anesthesia
5693845|NCT00523055|Plasma Lidocaine Levels|plasma lidocaine levels
5693847|NCT00523029|Self-management programs|self-management programs
5693848|NCT00523029|Chronic medical illness|chronic medical illness
5701427|NCT00497055|HIV|hiv
5693849|NCT00523016|acupuncture|acupuncture
5693850|NCT00523016|electroacupuncture|electroacupuncture
5693851|NCT00523016|sham acupuncture|sham acupuncture
5693852|NCT00523016|spinal cord injury|spinal cord injury
5693853|NCT00523016|neuropathic pain|neuropathic pain
5693854|NCT00523016|burning pain|burning pain
5693855|NCT00523003|weight loss|weight loss
5693856|NCT00523003|obesity|obesity
5693857|NCT00523003|high protein|high protein
5693858|NCT00523003|meal replacement|meal replacement
5693859|NCT00522977|Myocardial strain|myocardial strain
5693860|NCT00522977|Myocardial function|myocardial function
5693861|NCT00522977|Pregnancy|pregnancy
5693862|NCT00522977|Postpartum|postpartum
5693863|NCT00522977|Echocardiography|echocardiography
5693864|NCT00522977|Myocardial adaptation to pregnancy|myocardial adaptation to pregnancy
5693865|NCT00522977|Systolic function|systolic function
5693866|NCT00522977|Diastolic function|diastolic function
5693867|NCT00522964|Chinese-American|chinese-american
5693868|NCT00522964|Children|children
5693869|NCT00522964|Obesity|obesity
5693870|NCT00522964|health behaviors|health behaviors
5693871|NCT00522964|Behavioral intervention|behavioral intervention
5693872|NCT00522964|normal|normal
5693874|NCT00522951|Brain Metastasis|brain metastasis
5693875|NCT00522951|Gadolinium|gadolinium
5693876|NCT00522951|Imaging|imaging
5693877|NCT00522951|Diagnostic Agent|diagnostic agent
5693878|NCT00522938|Lung|lung
5693879|NCT00522938|Cancer|cancer
5693880|NCT00522938|Non-small|non-small
5693881|NCT00522938|Lung Cancer|lung cancer
5693882|NCT00522938|NSCLC|nsclc
5693883|NCT00522938|erlotinib|erlotinib
5693884|NCT00522938|oral|oral
5693885|NCT00522938|Locally Advanced Non-small Cell Lung Cancer|locally advanced non-small cell lung cancer
5693886|NCT00522938|Metastatic Non-small Cell Lung Cancer|metastatic non-small cell lung cancer
5693887|NCT00522925|hypertension|hypertension
5693888|NCT00522925|high blood pressure|high blood pressure
5693889|NCT00522912|Trachoma|trachoma
5693890|NCT00522912|Trichiasis|trichiasis
5693891|NCT00522912|Surgery|surgery
5693892|NCT00522912|Epilation|epilation
5693893|NCT00522912|Ethiopia|ethiopia
5693894|NCT00522899|aged|aged
5693895|NCT00522899|exercise|exercise
5693896|NCT00522899|cognitive therapy|cognitive therapy
5693897|NCT00522899|dementia|dementia
5693898|NCT00522899|prevention|prevention
5693899|NCT00522886|cetuximab|cetuximab
5693900|NCT00522886|concurrent|concurrent
5693901|NCT00522886|iso-toxic|iso-toxic
5693902|NCT00522886|NSCLC|nsclc
5693903|NCT00522873|Postmenopausal Symptoms e.g.|postmenopausal symptoms e.g.
5693904|NCT00522873|Hot flushes|hot flushes
5693905|NCT00522873|Sweating episodes|sweating episodes
5693907|NCT00522860|Trichiasis|trichiasis
5693908|NCT00522860|Trachoma|trachoma
5693909|NCT00522860|Surgery|surgery
5693910|NCT00522860|Suture|suture
5693911|NCT00522860|Ethiopia|ethiopia
5693912|NCT00522847|Postmenopausal|postmenopausal
5693913|NCT00522847|non dry eye|non dry eye
5693914|NCT00522834|melanoma|melanoma
5693915|NCT00522834|oncology|oncology
5693916|NCT00522834|Stage IV Metastatic Melanoma|stage iv metastatic melanoma
5693917|NCT00522821|IgG subclass deficiency|igg subclass deficiency
5693918|NCT00522821|Anti-polysaccharide deficiency|anti-polysaccharide deficiency
5693919|NCT00522821|therapy|therapy
5693920|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5693921|NCT00522821|co-trimoxazole|co-trimoxazole
5693922|NCT00522808|HCV|hcv
5693923|NCT00522808|antiviral|antiviral
5693924|NCT00522808|PK|pk
5693925|NCT00522808|Safety|safety
5693927|NCT00522769|binge eating|binge eating
5693928|NCT00522769|adolescent girls|adolescent girls
5693929|NCT00522769|cognitive behavioral therapy|cognitive behavioral therapy
5693930|NCT00522756|Kidney Failure, Acute|kidney failure, acute
5693931|NCT00522756|Cardiac Surgical Procedures|cardiac surgical procedures
5693932|NCT00522756|Sodium Bicarbonate|sodium bicarbonate
5693933|NCT00522756|Sodium Chloride|sodium chloride
5693934|NCT00522756|Prevention and control|prevention and control
5693935|NCT00522743|SGA|sga
5693936|NCT00522743|GH|gh
5693937|NCT00522743|GnRHa|gnrha
5693938|NCT00522743|IGF-1|igf-1
5693939|NCT00522730|Liver failure|liver failure
5693940|NCT00522730|Liver cirrhosis|liver cirrhosis
5693941|NCT00522730|Parenteral nutrition|parenteral nutrition
5693942|NCT00522730|Enteral nutrition|enteral nutrition
5693943|NCT00522730|Lipids|lipids
5693944|NCT00522730|Safety|safety
5693945|NCT00522730|Drug tolerance|drug tolerance
5693946|NCT00522704|Arteriovenous fistula|arteriovenous fistula
5693947|NCT00522704|Access blood flow|access blood flow
5693948|NCT00522704|Extracorporeal blood flow|extracorporeal blood flow
5693949|NCT00522704|Dynamic arterial line pressure|dynamic arterial line pressure
5693950|NCT00522704|Hemodialysis treatment|hemodialysis treatment
5693951|NCT00522691|Fecal incontinence|fecal incontinence
5693952|NCT00522691|sacral nerve stimulation|sacral nerve stimulation
5693953|NCT00522678|Healthy Volunteers|healthy volunteers
5693955|NCT00522652|advanced cancer|advanced cancer
5693957|NCT00522639|lung cancer|lung cancer
5693958|NCT00522639|FDG-PET-CT|fdg-pet-ct
5701575|NCT00496587|RCC|rcc
5692491|NCT00527930|S1|s1
5693959|NCT00522639|blood proteins|blood proteins
5693960|NCT00522639|prognose|prognose
5693961|NCT00522626|Fetus|fetus
5693962|NCT00522626|Drug abuse|drug abuse
5693963|NCT00522626|Fetal development|fetal development
5693964|NCT00522626|Substance abuse|substance abuse
5693965|NCT00522626|Opioids|opioids
5693966|NCT00522626|Methadone|methadone
5693967|NCT00522613|recovery|recovery
5693968|NCT00522613|serious mental illness|serious mental illness
5693969|NCT00522613|bipolar disorder|bipolar disorder
5693970|NCT00522613|schizophrenia|schizophrenia
5693971|NCT00522613|schizoaffective disorder|schizoaffective disorder
5693972|NCT00522600|eyedrops|eyedrops
5693973|NCT00522600|compliance|compliance
5693974|NCT00522600|glaucoma medications|glaucoma medications
5693975|NCT00522600|adherence|adherence
5693976|NCT00522574|Myeloproliferative Disorders|myeloproliferative disorders
5693977|NCT00522561|Healthy volunteers|healthy volunteers
5693978|NCT00522561|running|running
5693979|NCT00522561|energetic cost|energetic cost
5693980|NCT00522561|limb mechanical characteristics|limb mechanical characteristics
5693981|NCT00522561|contractile components|contractile components
5693982|NCT00522561|elastic components|elastic components
5693983|NCT00522561|healthy men doing regularly physical activities|healthy men doing regularly physical activities
5693984|NCT00522548|African American|african american
5693985|NCT00522548|Kidney Transplant|kidney transplant
5693987|NCT00522535|Abdominal Aortic Aneurysms|abdominal aortic aneurysms
5693988|NCT00522535|Endovascular|endovascular
5693989|NCT00522535|EVAR|evar
5693990|NCT00522535|Aorta|aorta
5693991|NCT00522535|Stent Graft|stent graft
5693992|NCT00522535|Stent|stent
5693993|NCT00522535|Tortuous|tortuous
5693994|NCT00522535|High Angle|high angle
5693995|NCT00522535|Angled Necks|angled necks
5693996|NCT00522522|Naturalistic, retrospective, utilization of care services, diagnosis, epilepsy|naturalistic, retrospective, utilization of care services, diagnosis, epilepsy
5693997|NCT00522496|Craniocerebral trauma|craniocerebral trauma
5693998|NCT00522496|matrix metalloproteinase|matrix metalloproteinase
5693999|NCT00522496|microdialysis|microdialysis
5694000|NCT00522457|Breast Cancer|breast cancer
5694001|NCT00522457|investigational drug|investigational drug
5694002|NCT00522457|drug therapy|drug therapy
5694003|NCT00522457|Antineoplastic Protocols|antineoplastic protocols
5694004|NCT00522457|Immunotherapy|immunotherapy
5694005|NCT00522457|Metastatic breast cancer|metastatic breast cancer
5694006|NCT00522457|Advanced breast cancer|advanced breast cancer
5694007|NCT00522457|Stage IV breast cancer|stage iv breast cancer
5694009|NCT00522457|Her-2/neu|her-2/neu
5694010|NCT00522457|Trastuzumab refractory|trastuzumab refractory
5694011|NCT00522431|Hypogonadism|hypogonadism
5694012|NCT00522418|Epilepsy|epilepsy
5694013|NCT00522418|VNS Therapy|vns therapy
5694014|NCT00522405|Transarterial chemoembolisation|transarterial chemoembolisation
5694015|NCT00522405|Thalidomide|thalidomide
5694016|NCT00522405|Capecitabine|capecitabine
5694017|NCT00522405|Treatment|treatment
5694018|NCT00522392|Consolidation therapy|consolidation therapy
5694019|NCT00522392|First-line therapy|first-line therapy
5694020|NCT00522392|Proteasome inhibitor|proteasome inhibitor
5694021|NCT00522392|Thalidomide analogue|thalidomide analogue
5694022|NCT00522392|Quality of life|quality of life
5694023|NCT00522379|Parkinson's disease|parkinson's disease
5694024|NCT00522379|rotigotine|rotigotine
5694025|NCT00522379|patch|patch
5694026|NCT00522379|transdermal|transdermal
5694027|NCT00522379|dopamine agonist|dopamine agonist
5694028|NCT00522379|off time|off time
5694029|NCT00522379|Neupro|neupro
5694030|NCT00522353|obesity|obesity
5694032|NCT00522353|satiety hormones|satiety hormones
5694033|NCT00522353|body composition|body composition
5694034|NCT00522353|appetite ratings|appetite ratings
5694035|NCT00522340|Implantable Cardioverter Defibrillators|implantable cardioverter defibrillators
5694036|NCT00522340|ICD|icd
5694037|NCT00522340|Exercise|exercise
5694038|NCT00522340|Cardiac|cardiac
5694039|NCT00522340|Inflammation|inflammation
5694040|NCT00522327|Immigrant|immigrant
5694041|NCT00522327|Interpreting|interpreting
5694042|NCT00522314|Non-invasive ventilation|non-invasive ventilation
5694043|NCT00522314|Airway clearance|airway clearance
5694044|NCT00522314|Bronchiectasis|bronchiectasis
5694045|NCT00522301|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5694046|NCT00522301|fallopian tube cancer|fallopian tube cancer
5694047|NCT00522301|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5694048|NCT00522301|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5688784|NCT00541840|Sorafenib|sorafenib
5694049|NCT00522301|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5694050|NCT00522301|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5680516|NCT00577759|Quality assurance, health care|quality assurance, health care
5680517|NCT00577759|primary health care|primary health care
5680518|NCT00577759|community health services|community health services
5680519|NCT00577759|referral and consultation|referral and consultation
5680520|NCT00577759|exercise|exercise
5680515|NCT00577772|Oro-cecal|oro-cecal
5680523|NCT00577746|Non Small Cell Lung|non small cell lung
5719688|NCT00432861|steatorrhea|steatorrhea
5694051|NCT00522301|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5694052|NCT00522288|Myopia|myopia
5694053|NCT00522288|Self-Perception|self-perception
5694794|NCT00519454|T cells|t cells
5694054|NCT00522288|Contact Lenses|contact lenses
5694055|NCT00522288|Glasses|glasses
5694056|NCT00522288|Randomized|randomized
5694057|NCT00522288|Children|children
5694058|NCT00522288|Self-esteem|self-esteem
5694059|NCT00522275|Adjunctive treatment in epilepsy|adjunctive treatment in epilepsy
5694060|NCT00522275|add-on treatment for epilepsy|add-on treatment for epilepsy
5694061|NCT00522275|partial seizures|partial seizures
5694062|NCT00522275|AEDs|aeds
5694063|NCT00522275|antiepileptic drugs|antiepileptic drugs
5694064|NCT00522275|seizures|seizures
5694065|NCT00522262|Breast Neoplasms|breast neoplasms
5694066|NCT00522262|Exercise|exercise
5694067|NCT00522262|Physical activity|physical activity
5694068|NCT00522262|Estrone|estrone
5694069|NCT00522262|Estradiol|estradiol
5694070|NCT00522262|Adiposity|adiposity
5694071|NCT00522262|Breast density|breast density
5694072|NCT00522262|Mammographic density|mammographic density
5694073|NCT00522262|Insulin-Like Growth Factor I|insulin-like growth factor i
5694074|NCT00522262|Insulin Resistance|insulin resistance
5694075|NCT00522262|Women|women
5694076|NCT00522262|Postmenopause|postmenopause
5694077|NCT00522249|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5694078|NCT00522249|RCC|rcc
5694079|NCT00522249|M3thodist|m3thodist
5694080|NCT00522249|Pegylated Alfa Interferon|pegylated alfa interferon
5694081|NCT00522249|Sunitinib|sunitinib
5694082|NCT00522249|Tarceva|tarceva
5694083|NCT00522249|Peg IFN|peg ifn
5694084|NCT00522236|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5694085|NCT00522223|Cervical Cancer|cervical cancer
5694086|NCT00522223|Cancer Survivors|cancer survivors
5694087|NCT00522223|Cervix Cancer|cervix cancer
5694088|NCT00522223|Sexual Functioning|sexual functioning
5694089|NCT00522223|Quality Of Life|quality of life
5694090|NCT00522223|Questionnaire|questionnaire
5694091|NCT00522223|Radiation Therapy|radiation therapy
5694092|NCT00522223|Radical Hysterectomy|radical hysterectomy
5694093|NCT00522210|type 1 diabetes|type 1 diabetes
5694094|NCT00522210|children|children
5694095|NCT00522210|long acting insulin analogue|long acting insulin analogue
5694096|NCT00522210|hemoglobin A1c|hemoglobin a1c
5694097|NCT00522197|non-small cell lung cancer|non-small cell lung cancer
5694098|NCT00522197|small cell lung cancer|small cell lung cancer
5694099|NCT00522197|squamous lung dysplasia|squamous lung dysplasia
5694100|NCT00522184|intra-articular injection|intra-articular injection
5694101|NCT00522184|acute synovitis|acute synovitis
5694102|NCT00522184|etanercept|etanercept
5694103|NCT00522171|Harmonic|harmonic
5694104|NCT00522171|Massive Weight Loss|massive weight loss
5694105|NCT00522171|Electro Surgery|electro surgery
5684115|NCT00561834|naion|naion
5694106|NCT00522171|Skin and Fat Redundancy after massive weight loss|skin and fat redundancy after massive weight loss
5694108|NCT00522145|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5694109|NCT00522132|intravenous artesunate|intravenous artesunate
5694110|NCT00522132|severe malaria|severe malaria
5694111|NCT00522132|Plasmodium falciparum|plasmodium falciparum
5694112|NCT00522132|Africa|africa
5694113|NCT00522132|Severe Plasmodium falciparum Malaria|severe plasmodium falciparum malaria
5694114|NCT00522119|Essential Hypertension|essential hypertension
5694115|NCT00522119|High Blood Pressure|high blood pressure
5694116|NCT00522106|Behavioral graded activity|behavioral graded activity
5694117|NCT00522106|Hip|hip
5694118|NCT00522106|Knee|knee
5694119|NCT00522106|Physical therapy|physical therapy
5694120|NCT00522106|Exercise therapy|exercise therapy
5694121|NCT00522093|constipation|constipation
5694122|NCT00522067|influenza|influenza
5694123|NCT00522067|influenza vaccine|influenza vaccine
5694124|NCT00522067|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5694125|NCT00522067|subunit influenza vaccine|subunit influenza vaccine
5694126|NCT00522067|surface antigen|surface antigen
5694127|NCT00522054|Exercise|exercise
5694128|NCT00522054|Physical function|physical function
5694129|NCT00522054|Rheumatoid arthritis|rheumatoid arthritis
5694130|NCT00522054|Tai Chi|tai chi
5694131|NCT00522041|Pain associated with chronic anal fissure|pain associated with chronic anal fissure
5694132|NCT00522028|QoL|qol
5694133|NCT00522028|Osteodensitometry|osteodensitometry
5694134|NCT00522028|Arterial pressure|arterial pressure
5694136|NCT00522015|PSP|psp
5694137|NCT00522015|dementia|dementia
5694138|NCT00522015|neuropsychology|neuropsychology
5694139|NCT00522015|treatment|treatment
5694140|NCT00522002|Connective tissue diseases|connective tissue diseases
5694141|NCT00522002|Blood coagulation disorders|blood coagulation disorders
5694142|NCT00522002|Leg ulcers|leg ulcers
5694143|NCT00522002|Rheumatoid Arthritis|rheumatoid arthritis
5694144|NCT00522002|Systemic Lupus Erythematosus|systemic lupus erythematosus
5694145|NCT00522002|Systemic Scleroderma|systemic scleroderma
5694146|NCT00522002|Mixed Connective Tissue Disease|mixed connective tissue disease
5701731|NCT00495976|common cold|common cold
5694147|NCT00521989|Osteoarthritis|osteoarthritis
5694148|NCT00521989|Knee|knee
5694149|NCT00521989|CRx-102|crx-102
5694150|NCT00521989|prednisolone|prednisolone
5694151|NCT00521989|dipyridamole|dipyridamole
5694152|NCT00521989|CombinatoRx|combinatorx
5694153|NCT00521989|WOMAC|womac
5694154|NCT00521976|Risk assessment|risk assessment
5694156|NCT00521976|Coronary Artery Disease|coronary artery disease
5694157|NCT00521976|Acute coronary syndromes|acute coronary syndromes
5694158|NCT00521976|Factor XIIa|factor xiia
5694159|NCT00521976|B-type natriuretic peptide (BNP)|b-type natriuretic peptide (bnp)
5694160|NCT00521976|high-sensitive C-reactive protein (hsCRP)|high-sensitive c-reactive protein (hscrp)
5694161|NCT00521976|Omega-3|omega-3
5694162|NCT00521963|Intraarticular injection|intraarticular injection
5694163|NCT00521963|Infliximab|infliximab
5694164|NCT00521950|Pharmacogenetics|pharmacogenetics
5694165|NCT00521950|Cost Effectiveness|cost effectiveness
5694166|NCT00521950|Inflammatory Bowel Diseases|inflammatory bowel diseases
5694167|NCT00521950|Crohn Disease|crohn disease
5694168|NCT00521950|Ulcerative Colitis|ulcerative colitis
5694169|NCT00521950|Randomized Controlled Trials|randomized controlled trials
5694170|NCT00521911|Intervention Studies|intervention studies
5694171|NCT00521911|Randomized Controlled Trials|randomized controlled trials
5694172|NCT00521911|Cognitive Therapy|cognitive therapy
5694173|NCT00521911|Hospitals, General|hospitals, general
5694174|NCT00521911|Prevalence|prevalence
5694175|NCT00521898|Corneal transplantation, Descemet membrane|corneal transplantation, descemet membrane
5694176|NCT00521885|Bleeding rates|bleeding rates
5694177|NCT00521885|Prophylaxis for deep vein thrombosis|prophylaxis for deep vein thrombosis
5694178|NCT00521872|surgery (STARR operation)|surgery (starr operation)
5694179|NCT00521859|Hematologic Malignancies|hematologic malignancies
5694180|NCT00521859|Leukemia|leukemia
5694181|NCT00521859|Lymphoma|lymphoma
5694182|NCT00521859|Myeloma|myeloma
5694183|NCT00521859|Hodgkin's Disease|hodgkin's disease
5694184|NCT00521859|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5694185|NCT00521859|Cloretazine|cloretazine
5694186|NCT00521859|VNP40101M|vnp40101m
5694187|NCT00521859|Fludarabine|fludarabine
5694188|NCT00521859|Fludarabine Phosphate|fludarabine phosphate
5694189|NCT00521859|Fludara|fludara
5694190|NCT00521859|ATG|atg
5694191|NCT00521859|Antithymocyte|antithymocyte
5694192|NCT00521859|Thymoglobulin|thymoglobulin
5694193|NCT00521833|Kataract|kataract
5694194|NCT00521833|Astigmatism|astigmatism
5694195|NCT00521833|phacoemulsification|phacoemulsification
5694196|NCT00521820|Glucose Metabolism Disorder|glucose metabolism disorder
5694197|NCT00521820|Dysmetabolic Syndrome|dysmetabolic syndrome
5694198|NCT00521820|Type II Diabetes|type ii diabetes
5694199|NCT00521820|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5694200|NCT00521820|Dyslipidemia|dyslipidemia
5694201|NCT00521820|Drug Therapy|drug therapy
5694202|NCT00521807|Hypnosis,|hypnosis,
5684237|NCT00561444|QOL|qol
5694204|NCT00521807|CWP,|cwp,
5694205|NCT00521807|General Practice|general practice
5694206|NCT00521794|Arrhythmia|arrhythmia
5694207|NCT00521794|Muscle Weakness|muscle weakness
5694208|NCT00521794|Periodic Paralysis|periodic paralysis
5694209|NCT00521794|Channelopathy|channelopathy
5694210|NCT00521781|Unresectable or Metastatic Adenocarcinoma Prostate Cancer|unresectable or metastatic adenocarcinoma prostate cancer
5694211|NCT00521781|Hormonal Therapy|hormonal therapy
5694212|NCT00521781|Abraxane|abraxane
5694213|NCT00521781|M3thodist|m3thodist
5694214|NCT00521768|Post traumatic stress disorder|post traumatic stress disorder
5694215|NCT00521768|Anxiety disorder|anxiety disorder
5694216|NCT00521768|Comunity base intervention|comunity base intervention
5694217|NCT00521768|Education|education
5694218|NCT00521768|Behavioural treatment|behavioural treatment
5694219|NCT00521755|Laser bonding soft tissue albumin|laser bonding soft tissue albumin
5694220|NCT00521742|Glucose Metabolism Disorder|glucose metabolism disorder
5694221|NCT00521742|Dysmetabolic Syndrome|dysmetabolic syndrome
5694222|NCT00521742|Type II Diabetes|type ii diabetes
5694223|NCT00521742|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5694224|NCT00521742|Dyslipidemia|dyslipidemia
5694225|NCT00521742|Drug Therapy|drug therapy
5694226|NCT00521729|Thyroid|thyroid
5694227|NCT00521729|Thermoregulation|thermoregulation
5694228|NCT00521729|Catecholamines|catecholamines
5694229|NCT00521729|Energy Expenditure|energy expenditure
5694230|NCT00521729|Obesity|obesity
5694231|NCT00521729|Healthy Volunteer|healthy volunteer
5694232|NCT00521729|HV|hv
5694233|NCT00521716|Hip Prosthesis Implantation|hip prosthesis implantation
5694234|NCT00521703|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5694235|NCT00521703|lidocaine|lidocaine
5694236|NCT00521703|propofol|propofol
5694237|NCT00521703|child|child
5694238|NCT00521703|adolescent|adolescent
5694239|NCT00521677|VAP|vap
5694241|NCT00521677|Acquired pneumonia|acquired pneumonia
5694242|NCT00521677|Mortality|mortality
5694243|NCT00521677|LOS in ICU|los in icu
5694244|NCT00521677|LOS in hospital|los in hospital
5694245|NCT00521677|All patients on ventilator in the ICU|all patients on ventilator in the icu
5692778|NCT00526656|stage II bladder cancer|stage ii bladder cancer
5694246|NCT00521664|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy|proof of safety and cost effectiveness of the new therapeutic platelet transfusion strategy
5694247|NCT00521651|Physical Activity|physical activity
5694248|NCT00521651|Cancer Risk|cancer risk
5694249|NCT00521612|sevoflurane|sevoflurane
5694250|NCT00521612|isoflurane|isoflurane
5694251|NCT00521612|anaesthesia|anaesthesia
5694252|NCT00521586|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5694253|NCT00521560|High-Dose Radio-Immuno- and Chemotherapy|high-dose radio-immuno- and chemotherapy
5694254|NCT00521560|stem cell transplantation|stem cell transplantation
5694255|NCT00521560|90Y-Ibritumomab-Tiuxetan|90y-ibritumomab-tiuxetan
5694256|NCT00521547|Acupuncture|acupuncture
5694257|NCT00521547|Analgesia|analgesia
5694258|NCT00521547|Functional magnetic resonance imaging (fMRI)|functional magnetic resonance imaging (fmri)
5694259|NCT00521547|Neuronal Mechanisms|neuronal mechanisms
5694260|NCT00521547|Quantitative Peripheral Sensory Testings|quantitative peripheral sensory testings
5694261|NCT00521547|Normal Volunteers|normal volunteers
5694262|NCT00521534|Sleep related Breathing Disorder|sleep related breathing disorder
5694263|NCT00521534|Congestive Heart Failure|congestive heart failure
5694264|NCT00521534|Atrial Overdrive Pacing|atrial overdrive pacing
5694265|NCT00521534|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5694266|NCT00521508|IgA|iga
5694267|NCT00521508|kidney|kidney
5694268|NCT00521508|Berger'disease|berger'disease
5694269|NCT00521508|regulatory T cells|regulatory t cells
5694270|NCT00521508|pathogenesis of Berger's disease|pathogenesis of berger's disease
5694271|NCT00521495|static magnetic field|static magnetic field
5694272|NCT00521495|permanent magnet|permanent magnet
5694273|NCT00521495|carpal tunnel syndrome|carpal tunnel syndrome
5694274|NCT00521495|median nerve|median nerve
5694275|NCT00521482|recurrent|recurrent
5694276|NCT00521482|after standard therapy|after standard therapy
5694277|NCT00521469|Disequilibrium|disequilibrium
5694278|NCT00521469|Spinal Manipulation|spinal manipulation
5694279|NCT00521469|Postural control|postural control
5694280|NCT00521430|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5694281|NCT00521430|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5694282|NCT00521430|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5694283|NCT00521430|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5694284|NCT00521430|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5694285|NCT00521430|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5694286|NCT00521430|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5694287|NCT00521430|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5694288|NCT00521430|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5694289|NCT00521430|aplastic anemia|aplastic anemia
5694290|NCT00521430|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5694291|NCT00521430|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5694292|NCT00521430|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5694293|NCT00521430|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5694294|NCT00521430|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5694295|NCT00521430|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5694296|NCT00521430|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5694297|NCT00521430|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5694298|NCT00521430|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5694299|NCT00521430|refractory anemia with excess blasts|refractory anemia with excess blasts
5694300|NCT00521430|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5694301|NCT00521430|refractory anemia|refractory anemia
5694302|NCT00521430|refractory multiple myeloma|refractory multiple myeloma
5694303|NCT00521430|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5694304|NCT00521430|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5694305|NCT00521430|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5694573|NCT00520546|Choline|choline
5863043|NCT00001410|Enzyme Replacement Therapy|enzyme replacement therapy
5694306|NCT00521430|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5694307|NCT00521430|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5694308|NCT00521430|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5694309|NCT00521430|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5694310|NCT00521430|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5689040|NCT00540449|HIV-1|hiv-1
5694311|NCT00521430|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5694312|NCT00521430|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5701942|NCT00495222|stoma|stoma
5694313|NCT00521430|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5694314|NCT00521430|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5694315|NCT00521430|Waldenström macroglobulinemia|waldenström macroglobulinemia
5694316|NCT00521430|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5694317|NCT00521430|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5694318|NCT00521430|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5694319|NCT00521430|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5694320|NCT00521430|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5694496|NCT00520897|chronic HIV infection|chronic hiv infection
5694321|NCT00521430|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5694322|NCT00521430|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5694323|NCT00521430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5694324|NCT00521430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5694325|NCT00521430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5694326|NCT00521430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5694327|NCT00521430|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5694328|NCT00521430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5694329|NCT00521430|stage I multiple myeloma|stage i multiple myeloma
5694330|NCT00521430|stage II multiple myeloma|stage ii multiple myeloma
5694331|NCT00521430|stage III multiple myeloma|stage iii multiple myeloma
5694332|NCT00521430|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5694333|NCT00521430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5694334|NCT00521430|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5694335|NCT00521430|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5694336|NCT00521430|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5694337|NCT00521430|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5694338|NCT00521430|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5694339|NCT00521430|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5694340|NCT00521430|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5694341|NCT00521430|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5694342|NCT00521430|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5694343|NCT00521430|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5694344|NCT00521430|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5694345|NCT00521417|RCT|rct
5694346|NCT00521404|Pancreatic cancer|pancreatic cancer
5694347|NCT00521404|chemotherapy naive|chemotherapy naive
5694348|NCT00521404|unresectable or metastatic pancreatic cancer|unresectable or metastatic pancreatic cancer
5694349|NCT00521404|CS1008|cs1008
5694350|NCT00521404|Gemcitabine|gemcitabine
5694351|NCT00521404|Gemzar|gemzar
5694352|NCT00521391|smoking cessation|smoking cessation
5694353|NCT00521391|nicotine|nicotine
5694354|NCT00521391|physical activity|physical activity
5694355|NCT00521378|Diabetes|diabetes
5694356|NCT00521378|Type 1 and Type 2 Diabetes|type 1 and type 2 diabetes
5694357|NCT00521365|Bipolar Disorder|bipolar disorder
5694358|NCT00521365|Bipolar Affective Psychosis|bipolar affective psychosis
5694359|NCT00521365|Mania|mania
5694360|NCT00521365|Manic Disorder|manic disorder
5694361|NCT00521365|Manic State|manic state
5694362|NCT00521352|TMS|tms
5694363|NCT00521352|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5694364|NCT00521339|Apremilast,|apremilast,
5694365|NCT00521339|Psoriasis,|psoriasis,
5694366|NCT00521339|PASI-75,|pasi-75,
5694367|NCT00521339|sPGA|spga
5694368|NCT00521326|doppler|doppler
5694369|NCT00521326|coronary stenosis|coronary stenosis
5694370|NCT00521326|non-invasive testing|non-invasive testing
5694371|NCT00521326|A prospective study of a new diagnostic method.|a prospective study of a new diagnostic method.
5694372|NCT00521326|Study consists of a transthoracic doppler of LAD.|study consists of a transthoracic doppler of lad.
5694373|NCT00521326|Doppler to be performed prior to coronary angiography.|doppler to be performed prior to coronary angiography.
5694374|NCT00521326|F/U doppler examination for those who undergo PCI.|f/u doppler examination for those who undergo pci.
5848041|NCT00036582|BPD|bpd
5694375|NCT00521326|Doppler results will be compared with coronary angiography.|doppler results will be compared with coronary angiography.
5694376|NCT00521300|Acromegaly|acromegaly
5694377|NCT00521287|Immunologic Surveillance|immunologic surveillance
5694378|NCT00521287|Vaccination|vaccination
5694379|NCT00521287|Immunotherapy|immunotherapy
5694380|NCT00521287|Dendritic Cells|dendritic cells
5694574|NCT00520546|FEC|fec
5694381|NCT00521274|Progressive Hormone Refractory Prostate Cancer|progressive hormone refractory prostate cancer
5694382|NCT00521274|HRPC|hrpc
5694383|NCT00521274|MVA 5T4|mva 5t4
5694384|NCT00521274|Trovax®|trovax®
5694386|NCT00521274|M3thodist|m3thodist
5702064|NCT00494793|Mesh|mesh
5694387|NCT00521261|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5694388|NCT00521261|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5694389|NCT00521261|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5694390|NCT00521261|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5694391|NCT00521261|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5694392|NCT00521261|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5694393|NCT00521261|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5694394|NCT00521261|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5694395|NCT00521261|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5694396|NCT00521261|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5694397|NCT00521261|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5694398|NCT00521261|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5694399|NCT00521261|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5694400|NCT00521261|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5694401|NCT00521261|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5694402|NCT00521261|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5694403|NCT00521261|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5694404|NCT00521261|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5694405|NCT00521248|Neonatal Abstinence Syndrome|neonatal abstinence syndrome
5694406|NCT00521248|buprenorphine|buprenorphine
5694407|NCT00521248|neonatal|neonatal
5694408|NCT00521248|opioid withdrawal|opioid withdrawal
5694409|NCT00521235|risk factors|risk factors
5694410|NCT00521235|metabolic syndrome|metabolic syndrome
5694411|NCT00521235|dentists|dentists
5694412|NCT00521235|trainers|trainers
5694413|NCT00521235|Healthy subjects|healthy subjects
5694414|NCT00521235|students|students
5694415|NCT00521235|seniors|seniors
5694416|NCT00521222|asthma|asthma
5694417|NCT00521222|beta agonist|beta agonist
5694418|NCT00521222|bronchodilator|bronchodilator
5694419|NCT00521222|pulmonary|pulmonary
5694420|NCT00521222|genotype|genotype
5694421|NCT00521222|pharmacogenomics|pharmacogenomics
5694422|NCT00521222|corticosteroid|corticosteroid
5694423|NCT00521222|allergy|allergy
5694424|NCT00521222|immunology|immunology
5694425|NCT00521209|Impoverished Population|impoverished population
5694426|NCT00521196|migraine|migraine
5694427|NCT00521196|headache|headache
5694428|NCT00521196|chronic|chronic
5694429|NCT00521196|pain|pain
5694430|NCT00521196|brain|brain
5694431|NCT00521196|neurology|neurology
5694432|NCT00521196|stimulation|stimulation
5694433|NCT00521196|noninvasive|noninvasive
5694434|NCT00521196|transcranial|transcranial
5694435|NCT00521196|direct|direct
5694436|NCT00521196|current|current
5694437|NCT00521196|tDCS|tdcs
5694439|NCT00521196|rTMS|rtms
5694440|NCT00521196|BIDMC|bidmc
5694441|NCT00521183|adult tumors metastatic to brain|adult tumors metastatic to brain
5694442|NCT00521170|Levocetirizine|levocetirizine
5694443|NCT00521170|Wheal and flare|wheal and flare
5694444|NCT00521170|Allergic|allergic
5694445|NCT00521157|Substance abuse|substance abuse
5694446|NCT00521157|Opiate dependency|opiate dependency
5694447|NCT00521157|Treatment|treatment
5694448|NCT00521157|Relapse prevention|relapse prevention
5694449|NCT00521131|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5694450|NCT00521131|Xyzal tablets|xyzal tablets
5694451|NCT00521105|Type 1 Diabetes|type 1 diabetes
5694452|NCT00521105|Telemedicine|telemedicine
5694453|NCT00521105|Children|children
5694454|NCT00521092|Treatment Experienced|treatment experienced
5694456|NCT00521079|Bariatric surgery|bariatric surgery
5694457|NCT00521079|Excess weight loss|excess weight loss
5694458|NCT00521079|Vagus nerve|vagus nerve
5694459|NCT00521079|Vagal blocking|vagal blocking
5694460|NCT00521079|vBloc(TM) therapy|vbloc(tm) therapy
5694461|NCT00521053|immune|immune
5694462|NCT00521053|vaccine|vaccine
5694463|NCT00521053|systemic|systemic
5694464|NCT00521053|Metastatic Melanoma (AJCC Stage III or IV)|metastatic melanoma (ajcc stage iii or iv)
5694465|NCT00521040|Levocetirizine dihydrochloride|levocetirizine dihydrochloride
5694466|NCT00521040|Xyzal tablets|xyzal tablets
5694468|NCT00521027|hydrosurgery|hydrosurgery
5694469|NCT00521027|Versajet|versajet
5694470|NCT00521027|leg ulcer|leg ulcer
5694471|NCT00521014|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5694472|NCT00521014|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5694473|NCT00521014|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5694474|NCT00521001|stage IV melanoma|stage iv melanoma
5694475|NCT00520988|hypertension|hypertension
5694476|NCT00520988|intervention|intervention
5694477|NCT00520988|disease management|disease management
5694478|NCT00520988|telephone-based|telephone-based
5694479|NCT00520988|Hypertension: diagnosed but uncontrolled|hypertension: diagnosed but uncontrolled
5702333|NCT00493818|AKT|akt
5694480|NCT00520975|Trastuzumab|trastuzumab
5694481|NCT00520975|Bevacizumab|bevacizumab
5694482|NCT00520975|Metastatic Breast Cancer|metastatic breast cancer
5694483|NCT00520975|HER2/NEU|her2/neu
5694484|NCT00520962|cardiovascular disease|cardiovascular disease
5694485|NCT00520962|glucose intolerance|glucose intolerance
5694486|NCT00520962|type 2 diabetes|type 2 diabetes
5694487|NCT00520962|endothelial dysfunction|endothelial dysfunction
5694488|NCT00520962|inflammation|inflammation
5694489|NCT00520962|Age> 30 years, male and female|age> 30 years, male and female
5694490|NCT00520962|Fasting glucose below 126 mg/dl|fasting glucose below 126 mg/dl
5694491|NCT00520949|H.pylori|h.pylori
5694492|NCT00520949|Triple therapy failure|triple therapy failure
5694493|NCT00520949|Quadruple therapy|quadruple therapy
5694494|NCT00520910|Polypodium leucotomos, Ultraviolet Rays, Heliocare, calaguala, anapsos|polypodium leucotomos, ultraviolet rays, heliocare, calaguala, anapsos
5694495|NCT00520910|Skin Aging and Damage|skin aging and damage
5694497|NCT00520897|Human Immunodeficiency Virus|human immunodeficiency virus
5694498|NCT00520897|Treatment Experienced|treatment experienced
5694500|NCT00520884|ghrelin|ghrelin
5694501|NCT00520884|appetite|appetite
5694502|NCT00520884|weight loss|weight loss
5694503|NCT00520871|Cardiovascular disease|cardiovascular disease
5694504|NCT00520871|Blueberruy|blueberruy
5694505|NCT00520871|Antioxidants|antioxidants
5694506|NCT00520871|Oxidative stress|oxidative stress
5694507|NCT00520871|Inflammation|inflammation
5694508|NCT00520845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5694509|NCT00520845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5694510|NCT00520845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5694511|NCT00520845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5694512|NCT00520832|Primary Insomnia|primary insomnia
5694513|NCT00520832|Microcurrent Therapy|microcurrent therapy
5694514|NCT00520832|Sleep Surveys|sleep surveys
5694515|NCT00520819|Antioxidants|antioxidants
5694516|NCT00520819|Phytochemicals|phytochemicals
5694517|NCT00520819|Oxidative stress|oxidative stress
5694518|NCT00520819|Inflammation|inflammation
5694519|NCT00520819|Endothelial function|endothelial function
5694520|NCT00520806|Heart failure|heart failure
5694521|NCT00520806|Renal dysfunction|renal dysfunction
5694522|NCT00520806|Relaxin|relaxin
5694523|NCT00520806|Vasodilator|vasodilator
5694524|NCT00520780|Chronic Heart Failure|chronic heart failure
5694525|NCT00520780|Iron deficiency|iron deficiency
5694526|NCT00520780|Iron deficiency anaemia|iron deficiency anaemia
5694527|NCT00520780|Anaemia|anaemia
5694528|NCT00520780|Heart disease|heart disease
5694529|NCT00520767|primary systemic amyloidosis|primary systemic amyloidosis
5694530|NCT00520767|light chain deposition disease|light chain deposition disease
5694531|NCT00520754|levocetirizine dihydrochloride Xyzal tablets|levocetirizine dihydrochloride xyzal tablets
5694532|NCT00520741|Epilepsy|epilepsy
5694533|NCT00520741|Partial Onset Seizures|partial onset seizures
5694534|NCT00520741|Lacosamide|lacosamide
5694535|NCT00520741|Monotherapy|monotherapy
5694536|NCT00520741|Vimpat|vimpat
5694537|NCT00520728|Schizophrenia|schizophrenia
5694538|NCT00520728|Psychosis|psychosis
5694539|NCT00520728|Occupational Disengagement|occupational disengagement
5694540|NCT00520728|Occupational Imbalance|occupational imbalance
5684608|NCT00559663|LDL|ldl
5694541|NCT00520715|fluoroquinolone resistance|fluoroquinolone resistance
5694543|NCT00520715|carriage|carriage
5694544|NCT00520702|Non-Small Cell Lung Cancer|non-small cell lung cancer
5694545|NCT00520702|Lung Cancer|lung cancer
5694546|NCT00520702|3-Dimensional Conformal Radiation Therapy|3-dimensional conformal radiation therapy
5694547|NCT00520702|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5694548|NCT00520702|3D CRT|3d crt
5694549|NCT00520702|IMRT|imrt
5694550|NCT00520702|NSCLC|nsclc
5694551|NCT00520702|TRP|trp
5694552|NCT00520702|Treatment related pneumonitis|treatment related pneumonitis
5694553|NCT00520663|Distribution,|distribution,
5694554|NCT00520663|SB-649868,|sb-649868,
5694555|NCT00520663|Healthy,|healthy,
5694556|NCT00520663|Excretion,|excretion,
5694557|NCT00520663|Sleep disturbances|sleep disturbances
5694558|NCT00520663|Volunteer,|volunteer,
5694559|NCT00520663|Metabolism,|metabolism,
5694560|NCT00520663|Absorption,|absorption,
5694561|NCT00520624|EIL|eil
5694562|NCT00520611|Obesity|obesity
5694563|NCT00520611|Weight Loss|weight loss
5694565|NCT00520611|Lottery|lottery
5694566|NCT00520611|Deposit|deposit
5694567|NCT00520585|atorvastatin|atorvastatin
5694568|NCT00520585|repolarisation|repolarisation
5694569|NCT00520585|cardiomyocytes|cardiomyocytes
5694570|NCT00520572|Rheumatoid Arthritis|rheumatoid arthritis
5694571|NCT00520546|PET|pet
5694572|NCT00520546|MRI|mri
5694575|NCT00520546|prostate cancer|prostate cancer
5694576|NCT00520533|Clinical trials|clinical trials
5694577|NCT00520533|cG250 mAb|cg250 mab
5694578|NCT00520533|monoclonal antibody G250|monoclonal antibody g250
5694579|NCT00520533|sunitinib|sunitinib
5694580|NCT00520533|angiogenesis inhibitors|angiogenesis inhibitors
5694581|NCT00520533|Positron-Emission Tomography|positron-emission tomography
5694583|NCT00520533|Pharmacodynamics|pharmacodynamics
5694584|NCT00520520|post resuscitation|post resuscitation
5694585|NCT00520520|post ventricular fibrillation|post ventricular fibrillation
5694586|NCT00520520|patients receiving mild therapeutic hypothermia|patients receiving mild therapeutic hypothermia
5694587|NCT00520507|Depression|depression
5694588|NCT00520507|Bipolar Disorder|bipolar disorder
5694589|NCT00520507|Major|major
5694590|NCT00520494|Previously Untreated Patient (PUP)|previously untreated patient (pup)
5694591|NCT00520494|Primary Immunodeficiency (PID)|primary immunodeficiency (pid)
5694592|NCT00520494|CVID|cvid
5694594|NCT00520494|Subcutaneous immunoglobulin (SCIG)|subcutaneous immunoglobulin (scig)
5694595|NCT00520494|IgG trough level|igg trough level
5694596|NCT00520494|Quality of life|quality of life
5694597|NCT00520494|Common variable immunodeficiency (CVID)|common variable immunodeficiency (cvid)
5694598|NCT00520494|X-linked agammaglobulinemia (XLA)|x-linked agammaglobulinemia (xla)
5694599|NCT00520481|prostate cancer|prostate cancer
5694600|NCT00520468|Myelodysplastic Syndrome|myelodysplastic syndrome
5694602|NCT00520468|Erythropoietin|erythropoietin
5694603|NCT00520468|Darbepoetin alfa|darbepoetin alfa
5694604|NCT00520468|Aranesp|aranesp
5694605|NCT00520468|Erythropoiesis stimulating protein|erythropoiesis stimulating protein
5694606|NCT00520468|G-CSF|g-csf
5694607|NCT00520468|Filgrastim|filgrastim
5694608|NCT00520468|Neupogen|neupogen
5694609|NCT00520468|Prednisone|prednisone
5694610|NCT00520468|Cyclosporin A|cyclosporin a
5694611|NCT00520468|Sandimmune|sandimmune
5694612|NCT00520468|CYA|cya
5694613|NCT00520468|Cyclosporine|cyclosporine
5694614|NCT00520442|fracture|fracture
5694615|NCT00520429|Depression|depression
5694616|NCT00520429|Anxiety|anxiety
5694617|NCT00520429|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5694618|NCT00520429|Heart Failure, Congestive|heart failure, congestive
5694619|NCT00520377|Sinus Lift Surgery|sinus lift surgery
5694620|NCT00520377|Sinus Floor Augmentation|sinus floor augmentation
5694621|NCT00520377|Insufficient Bone Height|insufficient bone height
5694622|NCT00520338|celecoxib|celecoxib
5694623|NCT00520338|postoperative pain|postoperative pain
5694624|NCT00520338|thyroidectomy|thyroidectomy
5694625|NCT00520325|MBL deficient oncologic hematologic pediatric fever neutropenia|mbl deficient oncologic hematologic pediatric fever neutropenia
5694626|NCT00520312|Peripheral Arterial Disease|peripheral arterial disease
5694627|NCT00520312|PAD|pad
5694628|NCT00520312|Functional Impairment|functional impairment
5694629|NCT00520312|Magnetic Resonance Imaging|magnetic resonance imaging
5694630|NCT00520299|metastatic melanoma|metastatic melanoma
5694631|NCT00520299|ADI|adi
5694632|NCT00520299|ADI-PEG 20|adi-peg 20
5694633|NCT00520299|ADI SS PEG 20,000mw|adi ss peg 20,000mw
5694634|NCT00520299|arginine|arginine
5694635|NCT00520299|enzyme therapy|enzyme therapy
5694636|NCT00520286|Methamphetamine Dependence|methamphetamine dependence
5694637|NCT00520247|enalapril|enalapril
5694638|NCT00520247|folic acid|folic acid
5694639|NCT00520247|hyperglycemia|hyperglycemia
5694640|NCT00520247|hypertension|hypertension
5694641|NCT00520247|fasting plasma glucose|fasting plasma glucose
5694642|NCT00520234|Candida|candida
5694643|NCT00520234|Prophylaxis|prophylaxis
5694644|NCT00520234|High risk adults|high risk adults
5694646|NCT00520221|minocycline|minocycline
5694647|NCT00520221|pleurodesis|pleurodesis
5694648|NCT00520221|aspiration|aspiration
5694649|NCT00520221|pneumothorax|pneumothorax
5694650|NCT00520221|Primary spontaneous pneumothorax|primary spontaneous pneumothorax
5694651|NCT00520221|First attack|first attack
5694652|NCT00520221|Successful aspiration|successful aspiration
5694653|NCT00520208|ATRA|atra
5694654|NCT00520208|Trisenox|trisenox
5694655|NCT00520208|Arsenic|arsenic
5694656|NCT00520208|Arsenic Trioxide|arsenic trioxide
5694657|NCT00520208|APL|apl
5694658|NCT00520169|bioavailability|bioavailability
5694659|NCT00520143|GSD-II, Pompe Disease, Glycogen Storage Disease II|gsd-ii, pompe disease, glycogen storage disease ii
5694660|NCT00520130|Unrelated Donors|unrelated donors
5694661|NCT00520130|Reduced Intensity Stem Cell Transplant|reduced intensity stem cell transplant
5694662|NCT00520130|Leukemia|leukemia
5694663|NCT00520130|Lymphoma|lymphoma
5694664|NCT00520130|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5694665|NCT00520130|Myelodysplastic Syndrome|myelodysplastic syndrome
5694666|NCT00520130|Multiple Myeloma|multiple myeloma
5694667|NCT00520091|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5694668|NCT00520091|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5694669|NCT00520091|stage II esophageal cancer|stage ii esophageal cancer
5694670|NCT00520091|stage III esophageal cancer|stage iii esophageal cancer
5694671|NCT00520091|stage IV esophageal cancer|stage iv esophageal cancer
5694672|NCT00520052|bisphosphonates, prostate cancer, bone density, osteoporosis|bisphosphonates, prostate cancer, bone density, osteoporosis
5694673|NCT00520039|Otitis Media|otitis media
5694674|NCT00520039|Effusion|effusion
5694675|NCT00520039|OMM|omm
5694676|NCT00520039|OMT|omt
5694677|NCT00520039|Resolution|resolution
5694678|NCT00520026|suicide|suicide
5694679|NCT00520026|prevention|prevention
5694681|NCT00520026|suicidality|suicidality
5685733|NCT00555048|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5685734|NCT00555048|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5685735|NCT00555048|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5702377|NCT00493571|MDS|mds
5702378|NCT00493571|Gimatecan|gimatecan
5694682|NCT00520000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5694683|NCT00519987|pharmacokinetics|pharmacokinetics
5694684|NCT00519974|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5694685|NCT00519974|stage I breast cancer|stage i breast cancer
5694686|NCT00519974|stage II breast cancer|stage ii breast cancer
5694687|NCT00519974|stage IIIA breast cancer|stage iiia breast cancer
5694688|NCT00519974|stage IIIB breast cancer|stage iiib breast cancer
5694689|NCT00519974|stage IIIC breast cancer|stage iiic breast cancer
5694690|NCT00519974|stage IV breast cancer|stage iv breast cancer
5694691|NCT00519974|recurrent breast cancer|recurrent breast cancer
5694692|NCT00519935|Insulin Dependent Diabetes Mellitus|insulin dependent diabetes mellitus
5694693|NCT00519935|family therapy|family therapy
5694695|NCT00519909|dairy products, calcium, fat excretion, energy excretion|dairy products, calcium, fat excretion, energy excretion
5694696|NCT00519883|Anastrozole|anastrozole
5694697|NCT00519883|Exercise|exercise
5694698|NCT00519870|Pulmonary hypertension|pulmonary hypertension
5694699|NCT00519870|Angiotensin receptor blocker|angiotensin receptor blocker
5694700|NCT00519870|Calcium channel blocker|calcium channel blocker
5694701|NCT00519831|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5694702|NCT00519831|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5694703|NCT00519831|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5694704|NCT00519818|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5694705|NCT00519818|Hydrocortisone|hydrocortisone
5694706|NCT00519818|Pharmacokinetic|pharmacokinetic
5694707|NCT00519818|Pharmacodynamic|pharmacodynamic
5694708|NCT00519805|thromboembolism|thromboembolism
5694709|NCT00519805|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5694710|NCT00519805|limited stage small cell lung cancer|limited stage small cell lung cancer
5694711|NCT00519805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5694712|NCT00519805|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5694713|NCT00519805|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5694714|NCT00519805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5694715|NCT00519805|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5694716|NCT00519792|Relapse|relapse
5694717|NCT00519792|HCV|hcv
5694718|NCT00519792|Hepatitis C|hepatitis c
5694719|NCT00519792|Interferon|interferon
5694720|NCT00519792|Ribavirin|ribavirin
5694721|NCT00519779|affect|affect
5694722|NCT00519779|inflammation|inflammation
5694723|NCT00519766|Ratio of 3-Hydroxycotinine to Cotinine|ratio of 3-hydroxycotinine to cotinine
5694724|NCT00519766|Nicotine Metabolism|nicotine metabolism
5694725|NCT00519766|Pregnancy|pregnancy
5694726|NCT00519753|Glaucoma|glaucoma
5694727|NCT00519740|grass-pollen|grass-pollen
5694728|NCT00519740|allergy|allergy
5694729|NCT00519740|bronchial hyperreactivity|bronchial hyperreactivity
5694730|NCT00519740|asthma|asthma
5694731|NCT00519727|diabetes|diabetes
5694732|NCT00519701|sickle cell anemia|sickle cell anemia
5694733|NCT00519701|hydroxyurea|hydroxyurea
5694734|NCT00519688|tegafur|tegafur
5694735|NCT00519688|thalidomide|thalidomide
5694736|NCT00519688|advanced hepatocellular carcinoma|advanced hepatocellular carcinoma
5694737|NCT00519675|Chronic hand eczema|chronic hand eczema
5694738|NCT00519675|Chronic hand dermatitis|chronic hand dermatitis
5694739|NCT00519675|Patients with chronic hand eczema, who are refractory to topical corticosteroids|patients with chronic hand eczema, who are refractory to topical corticosteroids
5694741|NCT00519662|Tumors|tumors
5694742|NCT00519662|Advanced|advanced
5694743|NCT00519649|Hepatitis B vaccine|hepatitis b vaccine
5694744|NCT00519649|Challenge dose|challenge dose
5694745|NCT00519636|experience|experience
5694746|NCT00519636|GW685698X|gw685698x
5694747|NCT00519636|fluticasone furoate|fluticasone furoate
5694748|NCT00519636|preference|preference
5694749|NCT00519636|seasonal allergic rhinitis|seasonal allergic rhinitis
5694750|NCT00519636|fluticasone propionate|fluticasone propionate
5694751|NCT00519623|diabetes|diabetes
5694752|NCT00519623|insulin|insulin
5694753|NCT00519623|blood sugar|blood sugar
5694754|NCT00519623|type 1 diabetes|type 1 diabetes
5694755|NCT00519623|insulin dependent diabetes|insulin dependent diabetes
5694756|NCT00519623|transdermal|transdermal
5694757|NCT00519610|portal hypertension, H-graft shunt|portal hypertension, h-graft shunt
5694758|NCT00519597|Coronary Artery Disease|coronary artery disease
5694759|NCT00519597|Sleep Apnea|sleep apnea
5694760|NCT00519597|CPAP|cpap
5685736|NCT00555048|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5694761|NCT00519597|Revascularization|revascularization
5694762|NCT00519597|Mortality|mortality
5694763|NCT00519584|Interscalene nerve block|interscalene nerve block
5694764|NCT00519584|Dexamethasone|dexamethasone
5694765|NCT00519584|Ropivacaine|ropivacaine
5694766|NCT00519571|Dental Implantation, Endosseous|dental implantation, endosseous
5694767|NCT00519545|breast|breast
5694768|NCT00519545|cancer|cancer
5694769|NCT00519545|stage|stage
5694771|NCT00519545|four|four
5694772|NCT00519532|Neupro®|neupro®
5694773|NCT00519532|Rotigotine|rotigotine
5694774|NCT00519532|Parkinson's Disease|parkinson's disease
5694775|NCT00519519|Rebleeding after endoscopic therapy|rebleeding after endoscopic therapy
5694776|NCT00519506|Pulmonary Embolism|pulmonary embolism
5694777|NCT00519506|PE|pe
5694778|NCT00519493|Clozex|clozex
5694779|NCT00519493|Sutures|sutures
5694780|NCT00519480|Tolerability|tolerability
5694781|NCT00519480|GSK189075,|gsk189075,
5694782|NCT00519480|Metformin,|metformin,
5694783|NCT00519480|Safety,|safety,
5694784|NCT00519480|Diabetes,|diabetes,
5694785|NCT00519467|dose-ranging study|dose-ranging study
5694786|NCT00519467|SB-714703|sb-714703
5694787|NCT00519467|artesunate,|artesunate,
5694788|NCT00519467|malaria|malaria
5694789|NCT00519467|CDA,|cda,
5694790|NCT00519467|chlorproguanil,|chlorproguanil,
5694791|NCT00519467|dapsone,|dapsone,
5694792|NCT00519454|Systemic Lupus Erythematosus|systemic lupus erythematosus
5694793|NCT00519454|Estrogen receptors|estrogen receptors
5694796|NCT00519454|Female adult SLE|female adult sle
5694797|NCT00519441|laparoscopic Heller myotomy, achalasia, reflux|laparoscopic heller myotomy, achalasia, reflux
5694798|NCT00519428|depression|depression
5694799|NCT00519428|Major Depressive Disorder|major depressive disorder
5694800|NCT00519415|Tongue plate|tongue plate
5694801|NCT00519415|Facemask|facemask
5694802|NCT00519415|class III maxillary deficiency|class iii maxillary deficiency
5694803|NCT00519415|orthodontic angle class three|orthodontic angle class three
5694804|NCT00519402|partial tonsillectomy|partial tonsillectomy
5694805|NCT00519402|complete tonsillectomy|complete tonsillectomy
5694806|NCT00519402|tonsillectomy|tonsillectomy
5694807|NCT00519402|obstruction sleep disordered breathing OSDB|obstruction sleep disordered breathing osdb
5694809|NCT00519376|pharmacodynamics,|pharmacodynamics,
5694810|NCT00519376|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5694811|NCT00519376|safety,|safety,
5694812|NCT00519376|COPD patients|copd patients
5694813|NCT00519376|pharmacokinetics,|pharmacokinetics,
5694814|NCT00519376|tolerability,|tolerability,
5694815|NCT00519376|GW642444,|gw642444,
5694816|NCT00519363|Lupus|lupus
5694817|NCT00519363|TLR's|tlr's
5694818|NCT00519363|Hyperlipidemia|hyperlipidemia
5694819|NCT00519363|age eighteen to sixty|age eighteen to sixty
5694820|NCT00519363|female with SLE|female with sle
5694821|NCT00519363|SLEDAI, greater than four|sledai, greater than four
5694822|NCT00519363|LDL cholesterol elevated|ldl cholesterol elevated
5694823|NCT00519350|SIRS, sepsis and related syndromes|sirs, sepsis and related syndromes
5694824|NCT00519337|Atrial Fibrillation|atrial fibrillation
5694825|NCT00519337|cardiac surgery|cardiac surgery
5694826|NCT00519337|ascorbic acid|ascorbic acid
5694827|NCT00519337|vitamin-c|vitamin-c
5694828|NCT00519337|inflammation|inflammation
5694829|NCT00519324|Gastric Cancer|gastric cancer
5694830|NCT00519324|RAD001|rad001
5694831|NCT00519324|mTOR|mtor
5694832|NCT00519311|Intellectual disability|intellectual disability
5694833|NCT00519311|Health promotion|health promotion
5694834|NCT00519311|RCT|rct
5694835|NCT00519298|Alzheimer Disease|alzheimer disease
5694836|NCT00519285|metastatic|metastatic
5694837|NCT00519285|prostate|prostate
5694838|NCT00519285|cancer|cancer
5694839|NCT00519272|Cervical Cancer|cervical cancer
5694840|NCT00519272|Cervix|cervix
5694841|NCT00519272|Precancerous Lesions|precancerous lesions
5694842|NCT00519272|Cervical carcinoma in situ|cervical carcinoma in situ
5694843|NCT00519272|CIS|cis
5694844|NCT00519272|Early cervical cancer detection and treatment|early cervical cancer detection and treatment
5694845|NCT00519272|Barriers to Care|barriers to care
5694846|NCT00519272|Harris County|harris county
5694847|NCT00519272|Questionnaire|questionnaire
5694848|NCT00519246|Breast Neoplasms|breast neoplasms
5694849|NCT00519246|Non-Steroidal Anti-Inflammatory Agents|non-steroidal anti-inflammatory agents
5694850|NCT00519246|Analgesia|analgesia
5694851|NCT00519233|HRPC|hrpc
5694852|NCT00519233|Advanced hormone refractory prostate cancer|advanced hormone refractory prostate cancer
5694853|NCT00519220|achalasia, Heller myotomy|achalasia, heller myotomy
5694854|NCT00519207|pediatrics|pediatrics
5694855|NCT00519207|pain|pain
5694856|NCT00519207|infants|infants
5694857|NCT00519207|newborn screening|newborn screening
5694858|NCT00519207|venipuncture|venipuncture
5694859|NCT00519207|lidocaine|lidocaine
5694860|NCT00519207|sucrose|sucrose
5694861|NCT00519194|Arrhythmia|arrhythmia
5694862|NCT00519194|Atrial Fibrillation|atrial fibrillation
5694864|NCT00519181|HAM/TSP|ham/tsp
5694865|NCT00519181|VALPROIC ACID|valproic acid
5694866|NCT00519181|PROVIRAL LOAD|proviral load
5694867|NCT00519129|Pain|pain
5694868|NCT00519129|Patient satisfaction|patient satisfaction
5694869|NCT00519103|microarray|microarray
5694870|NCT00519103|Inflammtion|inflammtion
5694871|NCT00519103|fibrosis|fibrosis
5694872|NCT00519090|leukemia|leukemia
5694874|NCT00519090|leukemia symptoms|leukemia symptoms
5694875|NCT00519090|cml|cml
5694876|NCT00519090|complete blood count|complete blood count
5694877|NCT00519090|lymphocyte|lymphocyte
5694878|NCT00519090|blood cancer|blood cancer
5694879|NCT00519090|leukocytes|leukocytes
5694880|NCT00519090|chronic leukemia|chronic leukemia
5694881|NCT00519090|bone marrow biopsy|bone marrow biopsy
5694882|NCT00519090|leukemia research|leukemia research
5694885|NCT00519090|chronic myeloid leukemia|chronic myeloid leukemia
5694886|NCT00519090|blood cancer symptoms|blood cancer symptoms
5694887|NCT00519090|white blood cell diseases|white blood cell diseases
5694888|NCT00519090|chronic myelogenous leukemia|chronic myelogenous leukemia
5694889|NCT00519090|leukemia treatment|leukemia treatment
5694890|NCT00519090|leukemia facts|leukemia facts
5694891|NCT00519090|leucemia|leucemia
5694892|NCT00519090|facts about leukemia|facts about leukemia
5694893|NCT00519090|myelogenous leukemia|myelogenous leukemia
5694894|NCT00519090|newly diagnosed CML|newly diagnosed cml
5694895|NCT00519090|suboptimal response|suboptimal response
5694896|NCT00519090|Philadelphia chromosome positive (Ph+)|philadelphia chromosome positive (ph+)
5694897|NCT00519090|chronic myelogenous leukemia in chronic phase (CML-CP)|chronic myelogenous leukemia in chronic phase (cml-cp)
5694898|NCT00519077|cancer|cancer
5694899|NCT00519077|squamous cell|squamous cell
5694900|NCT00519077|carcinoma|carcinoma
5694901|NCT00519077|head|head
5694902|NCT00519077|neck|neck
5694903|NCT00519064|influenza|influenza
5694904|NCT00519064|influenza vaccine|influenza vaccine
5694905|NCT00519064|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5694906|NCT00519064|H5N1 influenza antigen|h5n1 influenza antigen
5694907|NCT00519051|depression|depression
5694908|NCT00519051|primary care|primary care
5694909|NCT00519051|pharmacotherapy|pharmacotherapy
5694910|NCT00519038|Critical Pathways|critical pathways
5694911|NCT00519038|Congestive Heart Failure|congestive heart failure
5694912|NCT00519038|Randomized Controlled Trial|randomized controlled trial
5694913|NCT00519038|Effectiveness|effectiveness
5694914|NCT00519025|Linezolid|linezolid
5694915|NCT00519025|Staphylococcus Aureus|staphylococcus aureus
5694916|NCT00519025|Infections|infections
5694917|NCT00519012|early nonresponse|early nonresponse
5694918|NCT00518999|cognition, attention, memory, executive functions, illness-awareness, insight.|cognition, attention, memory, executive functions, illness-awareness, insight.
5694919|NCT00518986|Obstructive Sleep Apnea/Hypopnea Syndrome|obstructive sleep apnea/hypopnea syndrome
5694920|NCT00518986|Excessive Sleepiness|excessive sleepiness
5694921|NCT00518960|ProAlgaZyme|proalgazyme
5694922|NCT00518960|Algae|algae
5694923|NCT00518960|High density lipoprotein; HDL|high density lipoprotein; hdl
5694924|NCT00518960|C-Reactive Protein; CRP|c-reactive protein; crp
5694925|NCT00518960|Hyperlipidemia|hyperlipidemia
5694926|NCT00518960|Metabolic Syndrome|metabolic syndrome
5694927|NCT00518947|Bipolar Disorder|bipolar disorder
5694928|NCT00518947|Mania|mania
5694929|NCT00518947|Antimanic|antimanic
5694930|NCT00518947|Verapamil|verapamil
5694931|NCT00518947|Lithium|lithium
5694932|NCT00518934|Safety and efficiency of angiogenesis for patients with limb|safety and efficiency of angiogenesis for patients with limb
5694933|NCT00518934|ischemia by transplantation of human cord blood mononuclear|ischemia by transplantation of human cord blood mononuclear
5694934|NCT00518934|cells|cells
5694935|NCT00518921|adenosin agonist|adenosin agonist
5694936|NCT00518921|chronic stable angina|chronic stable angina
5694937|NCT00518908|Ischemia reperfusion injury|ischemia reperfusion injury
5694939|NCT00518895|Melanoma|melanoma
5694940|NCT00518895|Advanced Melanoma|advanced melanoma
5694941|NCT00518895|Malignant Melanoma|malignant melanoma
5694942|NCT00518895|Metastatic Melanoma|metastatic melanoma
5694943|NCT00518895|Skin Cancer|skin cancer
5694944|NCT00518895|Genasense|genasense
5694945|NCT00518895|oblimersen|oblimersen
5694946|NCT00518895|antisense|antisense
5694947|NCT00518895|Bcl-2 antisense|bcl-2 antisense
5694948|NCT00518895|G3139|g3139
5694949|NCT00518895|dacarbazine|dacarbazine
5694950|NCT00518869|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5694951|NCT00518869|Complementary and Alternative Medicine (CAM)|complementary and alternative medicine (cam)
5694952|NCT00518869|Chemotherapy|chemotherapy
5694953|NCT00518869|Myelosuppression|myelosuppression
5694954|NCT00518869|Quality of Life|quality of life
5694955|NCT00518869|Fatigue|fatigue
5694956|NCT00518869|EORTC QLQ-C30 and LC13|eortc qlq-c30 and lc13
5694957|NCT00518856|birth asphyxia|birth asphyxia
5712009|NCT00457678|AMD|amd
5694958|NCT00518856|neonatal sepsis|neonatal sepsis
5694959|NCT00518856|maternal to child transmission of HIV|maternal to child transmission of hiv
5694960|NCT00518843|binge eating|binge eating
5694961|NCT00518843|purging|purging
5694962|NCT00518830|postnatal depression|postnatal depression
5694963|NCT00518830|primary care|primary care
5694964|NCT00518830|depressed women|depressed women
5694965|NCT00518817|Dystrophy|dystrophy
5694966|NCT00518817|Cardiomyopathy|cardiomyopathy
5694967|NCT00518791|Integrated health care system|integrated health care system
5694968|NCT00518791|Treatment effectiveness|treatment effectiveness
5694969|NCT00518791|Cost effectiveness|cost effectiveness
5694970|NCT00518791|Program evaluation|program evaluation
5694971|NCT00518778|fusariosis|fusariosis
5694972|NCT00518778|solid organ transplants|solid organ transplants
5694973|NCT00518765|aliskiren, renal hemodynamics, hormonal response, renin pathway, RAAS biomarkers|aliskiren, renal hemodynamics, hormonal response, renin pathway, raas biomarkers
5694975|NCT00518752|Oral Hygiene|oral hygiene
5694976|NCT00518752|Oral Care|oral care
5694977|NCT00518752|Xerostomia|xerostomia
5694978|NCT00518726|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5694979|NCT00518713|Epilepsy|epilepsy
5694980|NCT00518713|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5694981|NCT00518713|Drop seizures|drop seizures
5694982|NCT00518713|Clobazam|clobazam
5694983|NCT00518674|pain|pain
5694984|NCT00518674|local infiltration analgesia|local infiltration analgesia
5694985|NCT00518661|quinolone resistance|quinolone resistance
5694986|NCT00518661|ESBL|esbl
5694987|NCT00518661|Klebsiella species|klebsiella species
5694988|NCT00518661|Infection|infection
5694989|NCT00518648|Accidental falls|accidental falls
5694991|NCT00518648|Treatment effectiveness|treatment effectiveness
5694992|NCT00518635|Growth hormone|growth hormone
5694993|NCT00518635|Insulin sensitivity|insulin sensitivity
5694994|NCT00518635|Polycystic ovary|polycystic ovary
5694995|NCT00518609|Neonatal|neonatal
5694996|NCT00518609|Sepsis|sepsis
5694997|NCT00518609|Global Network|global network
5694998|NCT00518609|Antibiotics|antibiotics
5694999|NCT00518609|India|india
5695000|NCT00518609|International|international
5695001|NCT00518609|Maternal and child health|maternal and child health
5695002|NCT00518596|Neonatal|neonatal
5695003|NCT00518596|Sepsis|sepsis
5695004|NCT00518596|Global Network|global network
5695005|NCT00518596|Probiotics|probiotics
5695006|NCT00518596|India|india
5695007|NCT00518596|International|international
5695008|NCT00518596|Maternal and child health|maternal and child health
5695009|NCT00518583|Breast cancer|breast cancer
5695010|NCT00518583|Over-expressing Her2-neu|over-expressing her2-neu
5695011|NCT00518570|PMDD|pmdd
5695013|NCT00518570|Levetiracetam|levetiracetam
5695014|NCT00518557|liver cancer|liver cancer
5695015|NCT00518557|interventional radiology|interventional radiology
5695016|NCT00518557|Chemoembolization|chemoembolization
5695017|NCT00518557|Safety|safety
5695018|NCT00518557|Effectiveness|effectiveness
5695019|NCT00518544|hydroxyethyl starch, blood type, coagulation|hydroxyethyl starch, blood type, coagulation
5695020|NCT00518531|osteoporosis|osteoporosis
5695021|NCT00518531|low bone mineral density|low bone mineral density
5695022|NCT00518531|alendronate|alendronate
5695023|NCT00518531|denosumab|denosumab
5695024|NCT00518531|adherence|adherence
5695025|NCT00518531|preference|preference
5695026|NCT00518531|satisfaction|satisfaction
5695027|NCT00518531|postmenopausal|postmenopausal
5695028|NCT00518531|women|women
5695029|NCT00518518|Asthma|asthma
5695030|NCT00518518|Sublingual immunotherapy|sublingual immunotherapy
5695031|NCT00518518|Children|children
5695032|NCT00518505|GERD, laparoscopic surgery|gerd, laparoscopic surgery
5695033|NCT00518479|Hypertension|hypertension
5695034|NCT00518479|Left Ventricular Hypertrophy|left ventricular hypertrophy
5695035|NCT00518466|Obesity|obesity
5695036|NCT00518453|Influenza vaccine|influenza vaccine
5695037|NCT00518440|Liver disease|liver disease
5695038|NCT00518440|Liver injury|liver injury
5695039|NCT00518414|infant, formula, LC PUFA|infant, formula, lc pufa
5695040|NCT00518401|A hypoperfusion of the blood through a leg|a hypoperfusion of the blood through a leg
5695041|NCT00518401|Stem cells|stem cells
5695042|NCT00518401|Stem cell transplantation|stem cell transplantation
5695169|NCT00517868|bladder|bladder
5695043|NCT00518401|Stem cell autologous transplantation|stem cell autologous transplantation
5695044|NCT00518388|Epidemiology|epidemiology
5695045|NCT00518388|Cervical Cancer|cervical cancer
5695046|NCT00518388|Human Papillomavirus|human papillomavirus
5695047|NCT00518388|Focus Group|focus group
5695048|NCT00518388|Questionnaire|questionnaire
5695049|NCT00518388|Survey|survey
5695051|NCT00518362|TW|tw
5695052|NCT00518362|Valsartan|valsartan
5695053|NCT00518362|treatment|treatment
5695054|NCT00518362|diabetic nephropathy|diabetic nephropathy
5695055|NCT00518362|Proteinuria|proteinuria
5695056|NCT00518323|Schizophrenia|schizophrenia
5695057|NCT00518323|Antipsychotic|antipsychotic
5695058|NCT00518310|Interstitial lung disease|interstitial lung disease
5695059|NCT00518310|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5695060|NCT00518310|Usual interstitial pneumonia|usual interstitial pneumonia
5695061|NCT00518310|Cryptogenic fibrosing alveolitis|cryptogenic fibrosing alveolitis
5695062|NCT00518310|Therapy|therapy
5695063|NCT00518310|Azathioprine|azathioprine
5695064|NCT00518310|Steroids|steroids
5695065|NCT00518310|Glucocorticoids|glucocorticoids
5695066|NCT00518310|Corticosteroids|corticosteroids
5693648|NCT00523809|ATG|atg
5680525|NCT00577733|Methacholine challenge|methacholine challenge
5680526|NCT00577733|Breathing variability|breathing variability
5680527|NCT00577733|Polygraphy|polygraphy
5680528|NCT00577707|Lung Cancer|lung cancer
5680529|NCT00577707|Erlotinib|erlotinib
5680530|NCT00577707|clinical stage IB-IIIA|clinical stage ib-iiia
5680531|NCT00577694|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5695067|NCT00518310|Prednisone|prednisone
5695068|NCT00518297|Antivirals / HIV|antivirals / hiv
5695069|NCT00518284|Restenosis|restenosis
5695070|NCT00518284|Superficial Femoral Artery|superficial femoral artery
5695071|NCT00518284|Prevention of restenosis|prevention of restenosis
5695072|NCT00518284|Revascularization of the superficial Femoral Artery|revascularization of the superficial femoral artery
5695073|NCT00518258|Parkinson's Disease|parkinson's disease
5695074|NCT00518258|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5695075|NCT00518258|neuropsychological assessment|neuropsychological assessment
5695076|NCT00518245|unstable angina|unstable angina
5695077|NCT00518245|drug therapy|drug therapy
5695078|NCT00518245|myocardial ischemia|myocardial ischemia
5695079|NCT00518245|myocardial infarction|myocardial infarction
5695080|NCT00518245|hemorrhage|hemorrhage
5695081|NCT00518232|Methylphenidate|methylphenidate
5695082|NCT00518232|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5695083|NCT00518219|TW|tw
5695084|NCT00518219|Valsartan|valsartan
5695085|NCT00518219|treatment|treatment
5695086|NCT00518219|membranous nephropathy|membranous nephropathy
5695087|NCT00518219|proteinuria|proteinuria
5695088|NCT00518206|Clinical Trial|clinical trial
5695089|NCT00518206|Phase 2|phase 2
5695090|NCT00518206|Cancer Vaccine|cancer vaccine
5695666|NCT00515632|Weight gain|weight gain
5695091|NCT00518206|NY-ESO-1 protein, human|ny-eso-1 protein, human
5695092|NCT00518206|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
5695093|NCT00518206|Cyclophosphamide|cyclophosphamide
5695094|NCT00518206|T-Cells, Regulatory|t-cells, regulatory
5695095|NCT00518180|Meningococcal|meningococcal
5695096|NCT00518180|meningitis|meningitis
5695097|NCT00518180|vaccine|vaccine
5695098|NCT00518180|adolescents|adolescents
5695099|NCT00518167|Type 2 diabetes|type 2 diabetes
5695100|NCT00518167|primary prevention|primary prevention
5695101|NCT00518167|diet|diet
5695102|NCT00518167|physical activity|physical activity
5695103|NCT00518167|intervention|intervention
5695104|NCT00518167|impaired glucose tolerance|impaired glucose tolerance
5695105|NCT00518167|lifestyle|lifestyle
5695106|NCT00518167|randomized controlled study|randomized controlled study
5695107|NCT00518154|AIDS|aids
5695108|NCT00518154|Immunological non-responders|immunological non-responders
5695109|NCT00518154|Neuroimmune modulation|neuroimmune modulation
5695110|NCT00518154|Pyridostigmine|pyridostigmine
5695111|NCT00518154|Treatment Experienced|treatment experienced
5695112|NCT00518128|Obstructive Sleep Apnea|obstructive sleep apnea
5695113|NCT00518128|Leptin|leptin
5695114|NCT00518128|Homocysteine|homocysteine
5695115|NCT00518128|C-reactive protein|c-reactive protein
5695116|NCT00518115|GLP-1,|glp-1,
5695117|NCT00518115|Type 2 Diabetes,|type 2 diabetes,
5695118|NCT00518115|pharmacokinetics,|pharmacokinetics,
5695119|NCT00518115|pharmacodynamics,|pharmacodynamics,
5695120|NCT00518115|GSK716155,|gsk716155,
5695121|NCT00518115|metformin,|metformin,
5695122|NCT00518115|exenatide|exenatide
5695123|NCT00518115|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5695124|NCT00518102|REGRANEX (becaplermin)|regranex (becaplermin)
5695125|NCT00518102|Platelet-derived growth factor BB|platelet-derived growth factor bb
5695126|NCT00518102|Cancer|cancer
5695127|NCT00518102|Cancer incidence|cancer incidence
5695128|NCT00518102|Cancer mortality|cancer mortality
5695129|NCT00518076|Staphylococcus aureus carriers students nursing|staphylococcus aureus carriers students nursing
5695130|NCT00518050|Health Behaviors|health behaviors
5695131|NCT00518050|Surveillance|surveillance
5695132|NCT00518050|06-128|06-128
5695133|NCT00518024|tinnitus|tinnitus
5695134|NCT00518024|transcranial magnetic stimulation|transcranial magnetic stimulation
5695135|NCT00518024|treatment|treatment
5695136|NCT00518024|cortex|cortex
5695137|NCT00517998|Lung volume reduction|lung volume reduction
5695138|NCT00517998|Bronchoscopy|bronchoscopy
5695139|NCT00517998|Emphysema|emphysema
5695140|NCT00517998|COPD|copd
5695141|NCT00517998|NETT|nett
5695142|NCT00517998|Lung disease|lung disease
5695143|NCT00517998|COLD|cold
5695144|NCT00517998|BLVR|blvr
5695145|NCT00517985|perimenopausal depression|perimenopausal depression
5695146|NCT00517985|duloxetine|duloxetine
5695147|NCT00517985|cymbalta|cymbalta
5695148|NCT00517985|major depressive disorder|major depressive disorder
5695149|NCT00517985|women|women
5695150|NCT00517972|perimenopausal depression|perimenopausal depression
5695151|NCT00517972|omacor|omacor
5695152|NCT00517972|major depressive disorder|major depressive disorder
5695153|NCT00517972|women|women
5695154|NCT00517959|Stereotactic radiotherapy|stereotactic radiotherapy
5695155|NCT00517959|conformal radiotherapy|conformal radiotherapy
5695156|NCT00517959|late sequelae|late sequelae
5702909|NCT00491595|Genotoxicity|genotoxicity
5695157|NCT00517959|cognition|cognition
5695158|NCT00517959|endocrine dysfunction|endocrine dysfunction
5695159|NCT00517946|anti-allergy.|anti-allergy.
5695160|NCT00517946|seasonal allergic rhinitis (SAR),|seasonal allergic rhinitis (sar),
5695161|NCT00517946|intranasal allergen challenge,|intranasal allergen challenge,
5695162|NCT00517946|MRI,|mri,
5695163|NCT00517933|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5695164|NCT00517933|Pulmonary Hypertension|pulmonary hypertension
5695165|NCT00517894|lymphoma|lymphoma
5695166|NCT00517894|aggressive|aggressive
5695167|NCT00517894|chemotherapy|chemotherapy
5695168|NCT00517894|dose-dense|dose-dense
5695170|NCT00517868|pain|pain
5695171|NCT00517868|urgency|urgency
5695172|NCT00517868|frequency|frequency
5695173|NCT00517842|Parkinson's disease|parkinson's disease
5695174|NCT00517829|metastatic gastric or adenocarcinoma of the GE junction|metastatic gastric or adenocarcinoma of the ge junction
5695175|NCT00517803|micronutrients|micronutrients
5695176|NCT00517803|immunodeficiency|immunodeficiency
5695177|NCT00517803|probiotics|probiotics
5695178|NCT00517803|yogurt|yogurt
5695179|NCT00517803|Healthy|healthy
5695180|NCT00517803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5695181|NCT00517803|Complementary Therapies|complementary therapies
5695182|NCT00517790|Refractory|refractory
5695183|NCT00517790|Metastatic|metastatic
5695184|NCT00517777|sleep apnea syndrome|sleep apnea syndrome
5695185|NCT00517777|metabolic syndrome|metabolic syndrome
5695186|NCT00517777|cardiac remodelling|cardiac remodelling
5695187|NCT00517777|continuous positive airway pressure ventilation|continuous positive airway pressure ventilation
5695188|NCT00517764|major depressive disorder|major depressive disorder
5695190|NCT00517764|escitalopram|escitalopram
5695191|NCT00517764|open-label|open-label
5695192|NCT00517764|major depression|major depression
5695193|NCT00517764|serotonin transporter|serotonin transporter
5695194|NCT00517764|brain-derived neurotrophic factor|brain-derived neurotrophic factor
5695195|NCT00517751|Lumbar Spinal Stenosis|lumbar spinal stenosis
5695196|NCT00517751|X-STOP Spacer|x-stop spacer
5695197|NCT00517751|Interspinous process decompression|interspinous process decompression
5695198|NCT00517751|Neurogenic Intermittent Claudication|neurogenic intermittent claudication
5695199|NCT00517725|exercise|exercise
5695200|NCT00517725|lung diffusion|lung diffusion
5695201|NCT00517725|hypoxia|hypoxia
5695202|NCT00517725|chemoreceptor|chemoreceptor
5695203|NCT00517725|beta-blockers|beta-blockers
5695204|NCT00517725|heart failure|heart failure
5695205|NCT00517712|Acute promyelocytic leukemia|acute promyelocytic leukemia
5695206|NCT00517712|Arsenic trioxide|arsenic trioxide
5695207|NCT00517712|Molecular remission|molecular remission
5695208|NCT00517712|Toxicity profile|toxicity profile
5695209|NCT00517712|Maintenance therapy|maintenance therapy
5695210|NCT00517686|Poor risk factor control|poor risk factor control
5695211|NCT00517686|Treatment intensification|treatment intensification
5695212|NCT00517686|Medication adherence|medication adherence
5695213|NCT00517686|Cardiovascular disease (CVD)|cardiovascular disease (cvd)
5695214|NCT00517673|Healthy Volunteer|healthy volunteer
5695215|NCT00517660|Healthy subjects|healthy subjects
5695216|NCT00517660|Lower Respiratory Tract Infections|lower respiratory tract infections
5695217|NCT00517660|Upper Respiratory Tract Infections|upper respiratory tract infections
5695218|NCT00517647|ADHD|adhd
5695219|NCT00517647|atomoxetine|atomoxetine
5695220|NCT00517647|preschool children|preschool children
5695221|NCT00517647|efficacy|efficacy
5695222|NCT00517647|safety|safety
5695223|NCT00517634|asthma|asthma
5695224|NCT00517634|allergen challenge|allergen challenge
5695225|NCT00517634|IL-5|il-5
5695226|NCT00517634|eosinophils|eosinophils
5695227|NCT00517621|Peritoneal cancer|peritoneal cancer
5695228|NCT00517621|Relapse or progression|relapse or progression
5695229|NCT00517595|Non-Small Cell Lung Cancer|non-small cell lung cancer
5695230|NCT00517582|ACE Inhibitor|ace inhibitor
5695231|NCT00517582|Angioedema|angioedema
5695232|NCT00517582|Bradykinin|bradykinin
5695233|NCT00517582|Swelling|swelling
5695234|NCT00517569|Gene Therapy|gene therapy
5695235|NCT00517569|GX-12|gx-12
5695237|NCT00517569|Interleukin|interleukin
5695238|NCT00517569|AIDS|aids
5695239|NCT00517569|HIV-1 type B infection|hiv-1 type b infection
5695240|NCT00517569|Treatment Naive|treatment naive
5695241|NCT00517556|Dysmenorrhea|dysmenorrhea
5695242|NCT00517556|continuous OCP|continuous ocp
5695243|NCT00517543|inflammation|inflammation
5695244|NCT00517517|Pandemic influenza|pandemic influenza
5695245|NCT00517504|methylphenidate|methylphenidate
5695246|NCT00517504|ritalin|ritalin
5695247|NCT00517504|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5695248|NCT00517504|developmental disorder|developmental disorder
5695249|NCT00517504|preschool children|preschool children
5695250|NCT00517426|heart failure,|heart failure,
5695251|NCT00517426|exercise|exercise
5695252|NCT00517426|periodic breathing,|periodic breathing,
5695253|NCT00517426|acetazolamide|acetazolamide
5695254|NCT00517400|PTSD|ptsd
5695255|NCT00517387|Depression|depression
5695256|NCT00517387|SSRI|ssri
5712294|NCT00456313|asthma|asthma
5695257|NCT00517387|Atypical Antipsychotic|atypical antipsychotic
5695258|NCT00517387|Cognition|cognition
5695259|NCT00517387|Mood|mood
5695260|NCT00517387|Quality of Life|quality of life
5695261|NCT00517348|Adult|adult
5695262|NCT00517335|anorexia nervosa|anorexia nervosa
5695263|NCT00517335|bulimia nervosa|bulimia nervosa
5695358|NCT00516919|Obesity|obesity
5695264|NCT00517322|left atrial volume|left atrial volume
5695265|NCT00517322|hypertension|hypertension
5695266|NCT00517322|ramipril|ramipril
5695267|NCT00517322|irbesartan|irbesartan
5695268|NCT00517322|diastolic function|diastolic function
5695269|NCT00517283|diabetes|diabetes
5695270|NCT00517283|gastric emptying|gastric emptying
5695271|NCT00517283|exenatide|exenatide
5695272|NCT00517283|Byetta|byetta
5695273|NCT00517283|Amylin|amylin
5695274|NCT00517283|Lilly|lilly
5695275|NCT00517270|Non-cardiac chest pain|non-cardiac chest pain
5695276|NCT00517257|Retinal vein occlusion|retinal vein occlusion
5695277|NCT00517257|Retinal vein thrombosis|retinal vein thrombosis
5695278|NCT00517257|Central retinal vein occlusion|central retinal vein occlusion
5695279|NCT00517257|Branch retinal vein occlusion|branch retinal vein occlusion
5695280|NCT00517257|Visual loss|visual loss
5695281|NCT00517257|Atorvastatin|atorvastatin
5695282|NCT00517257|Statin|statin
5695283|NCT00517257|Neovascularization|neovascularization
5695284|NCT00517257|Thrombosis|thrombosis
5695285|NCT00517244|Children|children
5695286|NCT00517244|Healthy Controls|healthy controls
5695287|NCT00517244|Assessment|assessment
5695288|NCT00517231|Pulmonary tuberculosis|pulmonary tuberculosis
5695289|NCT00517231|Mycobacterium tuberculosis|mycobacterium tuberculosis
5695290|NCT00517231|Cytokines|cytokines
5695291|NCT00517231|Acute Phase Response|acute phase response
5695292|NCT00517231|Treatment|treatment
5695293|NCT00517218|Evaluate the Effect of Genasense on the Efficacy/Safety of Rituximab/Fludarabine Treatment in Untreated Subjects With Chronic Lymphocyctic Leukemia|evaluate the effect of genasense on the efficacy/safety of rituximab/fludarabine treatment in untreated subjects with chronic lymphocyctic leukemia
5695294|NCT00517205|upper ureteric stone|upper ureteric stone
5695295|NCT00517179|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5695296|NCT00517179|Erectile Dysfunction (ED)|erectile dysfunction (ed)
5695297|NCT00517166|tourniquet|tourniquet
5695298|NCT00517166|extremity injury|extremity injury
5695299|NCT00517166|hemostatic device|hemostatic device
5695301|NCT00517153|miglustat|miglustat
5695302|NCT00517153|Niemann-Pick Type C|niemann-pick type c
5695303|NCT00517153|Actelion|actelion
5695304|NCT00517140|Pregnancy women with a scarred uterus due to previous caesarean section|pregnancy women with a scarred uterus due to previous caesarean section
5695305|NCT00517127|Intraoperative care|intraoperative care
5695306|NCT00517127|Ringer's lactate|ringer's lactate
5695307|NCT00517127|Voluven|voluven
5695308|NCT00517127|Cardiovascular diagnostic technique|cardiovascular diagnostic technique
5695309|NCT00517127|Doppler effect|doppler effect
5695310|NCT00517114|Reflux laryngitis|reflux laryngitis
5695311|NCT00517101|spondyloarthropathy|spondyloarthropathy
5695312|NCT00517101|inflammatory bowel disease|inflammatory bowel disease
5695313|NCT00517101|antibodies|antibodies
5695314|NCT00517088|Physical Activity|physical activity
5695315|NCT00517088|Breast Cancer|breast cancer
5695316|NCT00517075|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5695317|NCT00517075|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5695318|NCT00517075|Schizophrenia|schizophrenia
5695319|NCT00517075|Schizoaffective Disorder|schizoaffective disorder
5695320|NCT00517075|Treatment|treatment
5695321|NCT00517075|Negative Symptoms|negative symptoms
5695322|NCT00517075|Social Dysfunction|social dysfunction
5695323|NCT00517075|TMS|tms
5695324|NCT00517075|rTMS|rtms
5695325|NCT00517062|Growth hormone|growth hormone
5695326|NCT00517062|insulin sensitivity|insulin sensitivity
5695327|NCT00517062|cortisol|cortisol
5695328|NCT00517049|NHL|nhl
5695329|NCT00517049|Rituxan|rituxan
5695330|NCT00517049|Lymphoma|lymphoma
5695331|NCT00517049|CD20-positive|cd20-positive
5695332|NCT00517049|B-Cell|b-cell
5695333|NCT00517049|APM4083g|apm4083g
5695334|NCT00517036|Major Depression|major depression
5695335|NCT00517036|Omega-3|omega-3
5695336|NCT00517036|Major Depressive Disorder|major depressive disorder
5695337|NCT00517023|Implantable Loop Recorder|implantable loop recorder
5695338|NCT00517023|Home monitoring|home monitoring
5695339|NCT00517023|Syncope/ Falls Clinic|syncope/ falls clinic
5695340|NCT00517010|Age-related macular degeneration|age-related macular degeneration
5695341|NCT00517010|Exudative age-related macular degeneration|exudative age-related macular degeneration
5695342|NCT00517010|Wet macular degeneration|wet macular degeneration
5695343|NCT00517010|Intravitreal injection|intravitreal injection
5695344|NCT00517010|Proton beam irradiation|proton beam irradiation
5695346|NCT00517010|Ranibizumab|ranibizumab
5695347|NCT00516984|Relationship between Osteopathic Manipulative Therapy (OMT) and the autonomic nervous system|relationship between osteopathic manipulative therapy (omt) and the autonomic nervous system
5695348|NCT00516984|LF/HF ratio|lf/hf ratio
5695349|NCT00516971|Non-erosive reflux disease|non-erosive reflux disease
5695350|NCT00516958|diabetic|diabetic
5693986|NCT00522535|AAA|aaa
5695351|NCT00516958|ulcer|ulcer
5695352|NCT00516958|infection|infection
5695353|NCT00516958|topical|topical
5695354|NCT00516958|wound|wound
5695355|NCT00516945|hepatitis B during cancer chemotherapy|hepatitis b during cancer chemotherapy
5695356|NCT00516932|Suicidal Event|suicidal event
5695357|NCT00516932|Behavioral Activation|behavioral activation
5695359|NCT00516919|Binge Eating|binge eating
5695360|NCT00516919|Monolingual Hispanic Persons|monolingual hispanic persons
5695361|NCT00516919|Orlistat|orlistat
5695362|NCT00516919|Behavioral Weight Loss Treatment|behavioral weight loss treatment
5695363|NCT00516893|natalizumab|natalizumab
5695364|NCT00516893|Tysabri|tysabri
5695365|NCT00516893|Multiple Sclerosis|multiple sclerosis
5695366|NCT00516893|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5695367|NCT00516880|chronic kidney disease|chronic kidney disease
5695368|NCT00516880|cardiovascular disease|cardiovascular disease
5695369|NCT00516854|Non-cardiac chest pain|non-cardiac chest pain
5695370|NCT00516841|epithelial ovarian cancer|epithelial ovarian cancer
5695371|NCT00516841|peritoneal cancer|peritoneal cancer
5695372|NCT00516841|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
5695373|NCT00516841|Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer|platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer
5695374|NCT00516828|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5695375|NCT00516828|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5695376|NCT00516828|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5695377|NCT00516828|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5695378|NCT00516828|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5695379|NCT00516828|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5695380|NCT00516828|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5695381|NCT00516828|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5695382|NCT00516828|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5695383|NCT00516802|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5695385|NCT00516750|recurrent bladder cancer|recurrent bladder cancer
5695386|NCT00516750|stage II bladder cancer|stage ii bladder cancer
5695387|NCT00516750|stage III bladder cancer|stage iii bladder cancer
5695388|NCT00516750|stage IV bladder cancer|stage iv bladder cancer
5695389|NCT00516724|malignant solid tumours|malignant solid tumours
5695390|NCT00516724|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5695391|NCT00516711|Surgery with Pringle maneuver needed for liver resection|surgery with pringle maneuver needed for liver resection
5695392|NCT00516698|stage I breast cancer|stage i breast cancer
5695393|NCT00516698|stage II breast cancer|stage ii breast cancer
5695394|NCT00516698|stage IIIA breast cancer|stage iiia breast cancer
5695395|NCT00516698|stage IIIC breast cancer|stage iiic breast cancer
5695396|NCT00516685|LUNG CANCER|lung cancer
5695397|NCT00516685|NSCLC|nsclc
5695399|NCT00516685|CANCER VACCINE|cancer vaccine
5695400|NCT00516685|IMMUNOTHERAPY|immunotherapy
5695401|NCT00516672|lapatinib,|lapatinib,
5695402|NCT00516672|cancer|cancer
5695403|NCT00516672|pharmacokinetics,|pharmacokinetics,
5695404|NCT00516672|safety,|safety,
5695405|NCT00516672|pazopanib,|pazopanib,
5695406|NCT00516672|Japanese patients,|japanese patients,
5695407|NCT00516659|ETEC|etec
5695408|NCT00516659|Traveler's diarrhea|traveler's diarrhea
5695409|NCT00516659|TCI|tci
5695410|NCT00516659|patch vaccine|patch vaccine
5695411|NCT00516659|diarrhea prevention|diarrhea prevention
5695412|NCT00516659|epidemiology ETEC|epidemiology etec
5695413|NCT00516659|Escherichia coli|escherichia coli
5695414|NCT00516646|Advanced Glycation End-products (AGEs)|advanced glycation end-products (ages)
5695415|NCT00516646|Alegebrium|alegebrium
5695416|NCT00516633|Asthma|asthma
5695417|NCT00516633|Adherence|adherence
5695418|NCT00516633|Burden of asthma|burden of asthma
5695419|NCT00516633|Quality of life|quality of life
5695420|NCT00516633|Questionnaires|questionnaires
5695421|NCT00516620|Body Weight|body weight
5695422|NCT00516607|recurrent adult brain tumor|recurrent adult brain tumor
5695423|NCT00516607|adult mixed glioma|adult mixed glioma
5695424|NCT00516607|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5695425|NCT00516607|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5695426|NCT00516607|adult glioblastoma|adult glioblastoma
5695427|NCT00516607|adult anaplastic ependymoma|adult anaplastic ependymoma
5695428|NCT00516607|adult giant cell glioblastoma|adult giant cell glioblastoma
5695429|NCT00516607|adult gliosarcoma|adult gliosarcoma
5695430|NCT00516607|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5695431|NCT00516581|Pneumocystis Pneumonia|pneumocystis pneumonia
5695432|NCT00516581|Acquired Immune Deficiency Syndrome|acquired immune deficiency syndrome
5695433|NCT00516581|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5695434|NCT00516581|Treatment Experienced|treatment experienced
5695435|NCT00516581|Treatment Naive|treatment naive
5695436|NCT00516555|Breech Presentation|breech presentation
5712500|NCT00455650|mecamylamine|mecamylamine
5712501|NCT00455650|varenicline|varenicline
5685737|NCT00555048|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5685738|NCT00555048|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5685739|NCT00555048|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5685740|NCT00555048|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5685741|NCT00555048|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5712502|NCT00455624|androgen deprivation therapy|androgen deprivation therapy
5695437|NCT00516555|External Cephalic version|external cephalic version
5695438|NCT00516555|Thyroid Function Tests|thyroid function tests
5695439|NCT00516542|stage IV breast cancer|stage iv breast cancer
5695440|NCT00516542|recurrent breast cancer|recurrent breast cancer
5695441|NCT00516542|male breast cancer|male breast cancer
5695442|NCT00516516|muscle cramp|muscle cramp
5695443|NCT00516516|pregnancy|pregnancy
5695444|NCT00516516|carnitine|carnitine
5695937|NCT00514618|Diabetes|diabetes
5695445|NCT00516516|randomized controlled clinical trials|randomized controlled clinical trials
5689984|NCT00538408|dotarem|dotarem
5695448|NCT00516490|luteal phase|luteal phase
5695449|NCT00516477|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5695450|NCT00516477|Leber Congenital Amaurosis|leber congenital amaurosis
5695451|NCT00516477|Gene transfer|gene transfer
5695452|NCT00516464|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5695453|NCT00516464|Vitrectomy|vitrectomy
5695454|NCT00516464|Ranibizumab|ranibizumab
5695455|NCT00516438|malignant solid tumours|malignant solid tumours
5695456|NCT00516438|Poly(ADP ribose)|poly(adp ribose)
5695457|NCT00516438|polymerases|polymerases
5695458|NCT00516425|stage IA breast cancer|stage ia breast cancer
5695459|NCT00516425|stage IB breast cancer|stage ib breast cancer
5695460|NCT00516425|stage II breast cancer|stage ii breast cancer
5695461|NCT00516425|stage IIIA breast cancer|stage iiia breast cancer
5695462|NCT00516412|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5695463|NCT00516412|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5695464|NCT00516412|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5695465|NCT00516412|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5695466|NCT00516412|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5695467|NCT00516412|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5695468|NCT00516399|Fungal keratitis|fungal keratitis
5695469|NCT00516399|povidone iodine|povidone iodine
5695470|NCT00516399|childhood blindness|childhood blindness
5695471|NCT00516399|povidone-iodine|povidone-iodine
5695472|NCT00516386|Adolescents|adolescents
5695473|NCT00516386|Anorexia nervosa (AN)|anorexia nervosa (an)
5695474|NCT00516386|Bone formation markers|bone formation markers
5695475|NCT00516386|Insulin like growth factor-1 (IGF-I)|insulin like growth factor-1 (igf-i)
5695476|NCT00516373|advanced ovarian cancer|advanced ovarian cancer
5695477|NCT00516373|BRCA 1 protein|brca 1 protein
5695478|NCT00516373|BRCA 2 protein|brca 2 protein
5695479|NCT00516373|Poly(ADP ribose)polymerases|poly(adp ribose)polymerases
5695480|NCT00516360|Catheter related bloodstream infections|catheter related bloodstream infections
5695481|NCT00516360|Infant, Newborn|infant, newborn
5695482|NCT00516360|Intensive Care Units, Neonatal|intensive care units, neonatal
5695483|NCT00516360|Neonatal Central Line Infections|neonatal central line infections
5695484|NCT00516347|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5695485|NCT00516347|esophageal cancer|esophageal cancer
5695486|NCT00516347|Barrett esophagus|barrett esophagus
5695487|NCT00516334|brain|brain
5695488|NCT00516334|electroencephalography|electroencephalography
5695489|NCT00516334|premature infant|premature infant
5695490|NCT00516334|neurodevelopment|neurodevelopment
5695491|NCT00516321|thrombopoietin|thrombopoietin
5695492|NCT00516321|hepatitis C|hepatitis c
5695493|NCT00516321|ribavirin|ribavirin
5695494|NCT00516321|platelets|platelets
5695495|NCT00516321|Hepatitis C-related thrombocytopenia|hepatitis c-related thrombocytopenia
5695496|NCT00516321|peginterferon alfa-2a|peginterferon alfa-2a
5695498|NCT00516308|Critical Limb Ischemia|critical limb ischemia
5695499|NCT00516308|PAD|pad
5695500|NCT00516308|Paripheral Arterial Disease|paripheral arterial disease
5695501|NCT00516308|Artherosclerosis|artherosclerosis
5695502|NCT00516308|Leg pain|leg pain
5695503|NCT00516308|Cardiovascular|cardiovascular
5695504|NCT00516308|Atherectomy|atherectomy
5695505|NCT00516308|NightHawk|nighthawk
5695506|NCT00516282|adult glioblastoma|adult glioblastoma
5695507|NCT00516282|adult giant cell glioblastoma|adult giant cell glioblastoma
5695508|NCT00516282|adult gliosarcoma|adult gliosarcoma
5695509|NCT00516282|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5695510|NCT00516282|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5695511|NCT00516282|adult mixed glioma|adult mixed glioma
5703294|NCT00489892|TBI|tbi
5694135|NCT00522028|PTH|pth
5695512|NCT00516269|Breast Cancer|breast cancer
5695513|NCT00516269|Gastrointestinal Cancer|gastrointestinal cancer
5695514|NCT00516269|GI Cancer|gi cancer
5695515|NCT00516269|Fatigue|fatigue
5695516|NCT00516269|OROS Methylphenidate HCl|oros methylphenidate hcl
5695517|NCT00516269|Methylphenidate|methylphenidate
5695518|NCT00516269|Methylphenidate Hydrochloride|methylphenidate hydrochloride
5695519|NCT00516269|Concerta|concerta
5695520|NCT00516269|Ritalin|ritalin
5695521|NCT00516269|Placebo|placebo
5695522|NCT00516256|Prostate Cancer|prostate cancer
5695523|NCT00516256|Quality of Life|quality of life
5695524|NCT00516256|Cancer Information Mentor|cancer information mentor
5695525|NCT00516256|CHESS|chess
5695526|NCT00516256|the Comprehensive Health Enhancement Support System|the comprehensive health enhancement support system
5695527|NCT00516256|Social support|social support
5695528|NCT00516256|Skill-building tools|skill-building tools
5695529|NCT00516230|Colonic Neoplasms|colonic neoplasms
5695530|NCT00516230|Lynch syndrome|lynch syndrome
5695658|NCT00515645|Immersion|immersion
5695531|NCT00516217|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5695532|NCT00516217|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5695533|NCT00516204|Hyperlipidemia|hyperlipidemia
5695534|NCT00516204|Diabetics|diabetics
5695535|NCT00516204|NIS|nis
5696586|NCT00512590|imagery|imagery
5695536|NCT00516204|Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.)|diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, pavk, etc.)
5695537|NCT00516191|Multiple Myeloma|multiple myeloma
5695539|NCT00516191|Doxil|doxil
5695540|NCT00516191|Melphalan|melphalan
5695541|NCT00516178|Fish oil supplement|fish oil supplement
5695542|NCT00516178|n-3 PUFA|n-3 pufa
5695543|NCT00516178|Cardiac function|cardiac function
5695544|NCT00516178|Membrane incorporation|membrane incorporation
5695545|NCT00516178|Inflammation|inflammation
5695546|NCT00516178|Clinical outcome|clinical outcome
5695547|NCT00516165|liver cancer|liver cancer
5695548|NCT00516165|RAD001|rad001
5695549|NCT00516152|Matched Unrelated Donor|matched unrelated donor
5695550|NCT00516152|Stem Cell Transplantation|stem cell transplantation
5695551|NCT00516152|Busulfan|busulfan
5695552|NCT00516152|fludarabine|fludarabine
5695553|NCT00516152|Hematopoietic Disorder|hematopoietic disorder
5695554|NCT00516139|Epilepsy elderly seizure|epilepsy elderly seizure
5695555|NCT00516126|hemostasis monitoring|hemostasis monitoring
5695556|NCT00516126|perioperative blood loss|perioperative blood loss
5695557|NCT00516113|paroxetine|paroxetine
5695558|NCT00516113|onset of action|onset of action
5695559|NCT00516113|serotonin reuptake inhibitors|serotonin reuptake inhibitors
5695560|NCT00516100|NSCLC|nsclc
5695561|NCT00516087|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5695562|NCT00516074|exenatide|exenatide
5695563|NCT00516074|Byetta|byetta
5695564|NCT00516074|type 2 diabetes|type 2 diabetes
5695565|NCT00516074|heart rate|heart rate
5695566|NCT00516074|Amylin|amylin
5695567|NCT00516074|Lilly|lilly
5695568|NCT00516048|exenatide|exenatide
5695569|NCT00516048|Byetta|byetta
5695570|NCT00516048|antibodies|antibodies
5695571|NCT00516048|Amylin|amylin
5695572|NCT00516048|Lilly|lilly
5695573|NCT00516035|Bird Flu|bird flu
5695574|NCT00516009|RADICULAR PAIN|radicular pain
5695575|NCT00516009|DISC HERNIATION|disc herniation
5695576|NCT00516009|DEXAMETHASONE|dexamethasone
5695577|NCT00516009|VAS|vas
5695578|NCT00515996|panic disorder|panic disorder
5695579|NCT00515996|paroxetine|paroxetine
5695580|NCT00515996|genetic polymorphism|genetic polymorphism
5695581|NCT00515996|serotonin|serotonin
5695582|NCT00515983|melanoma|melanoma
5695583|NCT00515983|dendritic cells|dendritic cells
5695584|NCT00515983|apoptotic/necrotic cells|apoptotic/necrotic cells
5695585|NCT00515983|therapeutic vaccine|therapeutic vaccine
5695586|NCT00515970|Carcinoma, Basal Cell|carcinoma, basal cell
5695587|NCT00515970|Curettage|curettage
5695588|NCT00515970|Excision|excision
5695589|NCT00515970|Recurrence|recurrence
5695590|NCT00515970|Complication|complication
5695591|NCT00515970|Esthetic outcome|esthetic outcome
5695592|NCT00515944|No condition|no condition
5695593|NCT00515944|healthy volunteers|healthy volunteers
5695594|NCT00515931|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5695595|NCT00515931|GIST|gist
5695596|NCT00515931|Sarcoma|sarcoma
5695597|NCT00515931|Radiation therapy|radiation therapy
5695598|NCT00515931|Radiotherapy|radiotherapy
5695599|NCT00515918|Iron deficiency|iron deficiency
5695600|NCT00515918|brain|brain
5695601|NCT00515918|cognition|cognition
5695602|NCT00515918|behavior|behavior
5695603|NCT00515879|Generalized subtype|generalized subtype
5695604|NCT00515866|Advanced pancreatic cancer|advanced pancreatic cancer
5695605|NCT00515866|Poly (ADP ribose) polymerases|poly (adp ribose) polymerases
5695606|NCT00515866|Advanced Solid Tumours|advanced solid tumours
5695607|NCT00515853|Rectal neoplasms|rectal neoplasms
5695608|NCT00515853|Biofeedback (Psychology)|biofeedback (psychology)
5703394|NCT00489593|Zyprexa|zyprexa
5695609|NCT00515853|Fecal Incontinence|fecal incontinence
5695610|NCT00515853|Aged|aged
5695611|NCT00515853|Anterior resection|anterior resection
5695612|NCT00515827|Treatment Experienced|treatment experienced
5695613|NCT00515814|Legal blindness|legal blindness
5695614|NCT00515814|Retinopathy pigmentosa|retinopathy pigmentosa
5695615|NCT00515814|Hereditary condition|hereditary condition
5695616|NCT00515814|Photo-receptor degeneration|photo-receptor degeneration
5680534|NCT00577681|Inflammatory Markers|inflammatory markers
5721367|NCT00426829|RT|rt
5695617|NCT00515814|Retina implant|retina implant
5695618|NCT00515814|Subretinal implant|subretinal implant
5695619|NCT00515801|diabetes mellitus type 1|diabetes mellitus type 1
5695620|NCT00515801|hypoglycemia|hypoglycemia
5712697|NCT00454740|Urgency|urgency
5695621|NCT00515801|sulfonylurea|sulfonylurea
5695622|NCT00515801|glucagon|glucagon
5695623|NCT00515788|Neoplastic Meningitis|neoplastic meningitis
5695624|NCT00515788|Leptomeningeal Disease|leptomeningeal disease
5695625|NCT00515788|Temozolomide|temozolomide
5695626|NCT00515788|Temodar|temodar
5695627|NCT00515788|DepoCyt|depocyt
5695628|NCT00515788|Liposomal Cytarabine|liposomal cytarabine
5695629|NCT00515788|Liposomal ara-C|liposomal ara-c
5695630|NCT00515762|persistent alopecia|persistent alopecia
5695631|NCT00515762|docetaxel|docetaxel
5695632|NCT00515762|breast cancer|breast cancer
5695633|NCT00515736|selenium|selenium
5695634|NCT00515736|oxidative stress|oxidative stress
5695635|NCT00515736|glutathione peroxidase|glutathione peroxidase
5695636|NCT00515736|critically ill|critically ill
5695638|NCT00515736|supplementation|supplementation
5695640|NCT00515723|risperidone|risperidone
5695641|NCT00515723|olanzapine|olanzapine
5695642|NCT00515723|quetiapine|quetiapine
5695643|NCT00515723|ziprasidone|ziprasidone
5695644|NCT00515710|Hemophilia B|hemophilia b
5695645|NCT00515710|Gene Transfer|gene transfer
5695646|NCT00515710|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5695647|NCT00515710|Coagulation Factor IX|coagulation factor ix
5695648|NCT00515710|Long-term Follow-up|long-term follow-up
5695649|NCT00515710|Delayed Adverse Events|delayed adverse events
5695650|NCT00515671|self-management|self-management
5695651|NCT00515671|recovery|recovery
5695652|NCT00515671|severe mental illness|severe mental illness
5695653|NCT00515658|Major depression|major depression
5695654|NCT00515658|Theta-burst rTMS|theta-burst rtms
5695655|NCT00515658|Cortical excitability|cortical excitability
5695656|NCT00515658|Hamilton depression rating scale|hamilton depression rating scale
5695657|NCT00515645|Autonomic nervous system|autonomic nervous system
5695659|NCT00515645|Heart rate variability|heart rate variability
5695660|NCT00515645|Head-down tilt|head-down tilt
5695661|NCT00515645|Healthy volunteers|healthy volunteers
5695662|NCT00515632|Type 2 diabetes mellitus on Stable insulin therapy|type 2 diabetes mellitus on stable insulin therapy
5695663|NCT00515632|Balaglitazone|balaglitazone
5695664|NCT00515632|Pioglitazone (Actos®)|pioglitazone (actos®)
5695665|NCT00515632|HbA1c|hba1c
5695668|NCT00515632|Fasting blood glucose|fasting blood glucose
5695669|NCT00515593|osteoporosis|osteoporosis
5695670|NCT00515593|postmenopausal women|postmenopausal women
5695671|NCT00515593|Severe postmenopausal osteoporosis|severe postmenopausal osteoporosis
5695672|NCT00515580|obstructive sleep apnea|obstructive sleep apnea
5695673|NCT00515580|upper airway resistance syndrome|upper airway resistance syndrome
5695674|NCT00515580|tongue suture|tongue suture
5695675|NCT00515580|retrolingual tongue collapse|retrolingual tongue collapse
5695676|NCT00515580|minimally invasive|minimally invasive
5695677|NCT00515567|explanted lungs|explanted lungs
5695678|NCT00515567|pulmonary fibrosis|pulmonary fibrosis
5695679|NCT00515554|Hodgkin lymphoma|hodgkin lymphoma
5695681|NCT00515554|advances stages|advances stages
5695682|NCT00515554|Rituximab|rituximab
5695683|NCT00515541|Platelet|platelet
5695684|NCT00515541|Cardiovascular|cardiovascular
5695685|NCT00515541|Lipid|lipid
5695686|NCT00515541|Fish Oil|fish oil
5695687|NCT00515541|Omega 3|omega 3
5695689|NCT00515541|EPA|epa
5695690|NCT00515541|Bleeding|bleeding
5695691|NCT00515541|Clotting|clotting
5695692|NCT00515541|platelet function|platelet function
5695693|NCT00515541|Lipid profile|lipid profile
5695694|NCT00515541|Weight and Bleeding risk|weight and bleeding risk
5695695|NCT00515528|metastatic melanoma|metastatic melanoma
5695696|NCT00515502|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5695697|NCT00515502|GSK573719,|gsk573719,
5695698|NCT00515502|muscarinic receptor antagonist|muscarinic receptor antagonist
5695699|NCT00515489|Schizophrenia|schizophrenia
5695700|NCT00515489|Schizoaffective Disorder|schizoaffective disorder
5695701|NCT00515489|Schizophreniform Disorders|schizophreniform disorders
5695702|NCT00515476|metabolic syndrome|metabolic syndrome
5695703|NCT00515476|HDL-Cholesterol|hdl-cholesterol
5695704|NCT00515476|EPC|epc
5695705|NCT00515476|endothelial function|endothelial function
5695706|NCT00515476|reduced blood HDL-Cholesterol level|reduced blood hdl-cholesterol level
5695707|NCT00515463|Osteopenia|osteopenia
5695708|NCT00515463|Osteoporosis|osteoporosis
5695709|NCT00515463|AMG 162|amg 162
5703514|NCT00489151|HBV|hbv
5695710|NCT00515463|Postmenopausal|postmenopausal
5695711|NCT00515463|Pre-filled syringe|pre-filled syringe
5695712|NCT00515450|Myasthenia Gravis|myasthenia gravis
5695713|NCT00515437|Sialorrhea|sialorrhea
5695714|NCT00515424|Glaucoma|glaucoma
5695715|NCT00515424|Ocular Hypertension|ocular hypertension
5695716|NCT00515424|RKI983|rki983
5863044|NCT00001410|Glucocerebrosidase|glucocerebrosidase
5695717|NCT00515424|Primary Open Angle Glaucoma and Ocular Hypertension|primary open angle glaucoma and ocular hypertension
5695718|NCT00515411|gastroesophageal junction|gastroesophageal junction
5695719|NCT00515411|gastric cancer|gastric cancer
5695720|NCT00515411|adenocarcinoma|adenocarcinoma
5695721|NCT00515411|unresectable gastric cancer|unresectable gastric cancer
5695722|NCT00515411|metastatic gastric|metastatic gastric
5695723|NCT00515385|Randomized|randomized
5695725|NCT00515385|Dose-Escalation|dose-escalation
5695726|NCT00515385|Cohort Study|cohort study
5695727|NCT00515372|Ovarian Cancer|ovarian cancer
5695728|NCT00515372|Peritoneal Cancer|peritoneal cancer
5695729|NCT00515372|Fallopian Tube Cancer|fallopian tube cancer
5695730|NCT00515372|Depression|depression
5695731|NCT00515372|Telephone Counseling|telephone counseling
5695732|NCT00515372|Quality of Life|quality of life
5695733|NCT00515359|Sedation|sedation
5695734|NCT00515359|MRI|mri
5695735|NCT00515359|pediatric|pediatric
5695736|NCT00515359|propofol|propofol
5695737|NCT00515359|brain|brain
5695738|NCT00515359|spine|spine
5695739|NCT00515359|quality of MRI|quality of mri
5695740|NCT00515359|Continuous propofol dosing|continuous propofol dosing
5695741|NCT00515359|continuous propofol administration|continuous propofol administration
5695742|NCT00515359|Intermittent propofol dosing|intermittent propofol dosing
5695743|NCT00515359|intermittent propofol administration|intermittent propofol administration
5695745|NCT00515359|propofol continuous infusions|propofol continuous infusions
5695746|NCT00515359|Recovery time|recovery time
5695747|NCT00515359|Complications of sedation|complications of sedation
5695748|NCT00515359|bolus dosing|bolus dosing
5695749|NCT00515346|CLI|cli
5695750|NCT00515346|Critical Limb Ischemia|critical limb ischemia
5695751|NCT00515333|Alzheimer|alzheimer
5695752|NCT00515333|Dementia|dementia
5695753|NCT00515320|Autism|autism
5695754|NCT00515320|children|children
5695755|NCT00515320|adolescent|adolescent
5695756|NCT00515320|Fluoxetine|fluoxetine
5695757|NCT00515320|Autistic Disorder|autistic disorder
5695758|NCT00515320|Repetitive behavior|repetitive behavior
5695759|NCT00515320|SSRI|ssri
5695760|NCT00515320|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5695761|NCT00515307|Hypercholesterolemia, Familial|hypercholesterolemia, familial
5695762|NCT00515307|Bone marrow|bone marrow
5695763|NCT00515307|Mesenchymal stem cell|mesenchymal stem cell
5695764|NCT00515307|Hepatocyte|hepatocyte
5695765|NCT00515294|Caffeine|caffeine
5695766|NCT00515294|Alcohol|alcohol
5695767|NCT00515294|Alcohol Consumption|alcohol consumption
5695768|NCT00515294|Residual Effects|residual effects
5695769|NCT00515294|Family History|family history
5695770|NCT00515294|Psychomotor Vigilance Test|psychomotor vigilance test
5695771|NCT00515294|Driving Simulation|driving simulation
5695772|NCT00515294|Reaction Time|reaction time
5695773|NCT00515281|prematurity|prematurity
5695774|NCT00515281|nitric oxide|nitric oxide
5695775|NCT00515281|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5695776|NCT00515281|intraventricular hemorrhage|intraventricular hemorrhage
5695777|NCT00515281|periventricular leukomalacia|periventricular leukomalacia
5695778|NCT00515281|neurodevelopment|neurodevelopment
5695779|NCT00515268|LPS challenge,|lps challenge,
5695780|NCT00515268|Healthy volunteers|healthy volunteers
5695781|NCT00515255|Obsessive Compulsive Disorder|obsessive compulsive disorder
5695782|NCT00515255|Neuropharm|neuropharm
5695783|NCT00515255|NPL-2003|npl-2003
5695784|NCT00515242|massage therapy|massage therapy
5695785|NCT00515242|relaxation treatments|relaxation treatments
5695786|NCT00515229|cystic fibrosis|cystic fibrosis
5695787|NCT00515229|ceramide|ceramide
5695788|NCT00515229|amitriptyline|amitriptyline
5695789|NCT00515229|Pseudomonas aeruginosa|pseudomonas aeruginosa
5695790|NCT00515229|lung function|lung function
5695791|NCT00515216|Phase II|phase ii
5695792|NCT00515216|Gastric cancer|gastric cancer
5695793|NCT00515216|Gastroesophageal cancer|gastroesophageal cancer
5695794|NCT00515216|Metastatic|metastatic
5695795|NCT00515216|FOLFOX|folfox
5695796|NCT00515216|Thymidylate synthase|thymidylate synthase
5695797|NCT00515216|Pharmacogenomic|pharmacogenomic
5695798|NCT00515203|Immune (Idiopathic) Thrombocytopenic Purpura|immune (idiopathic) thrombocytopenic purpura
5695799|NCT00515203|Pediatric Idiopathic Thrombocytopenic Purpura|pediatric idiopathic thrombocytopenic purpura
5695800|NCT00515190|Stomach Neoplasms|stomach neoplasms
5695801|NCT00515190|Secondary|secondary
5695802|NCT00515190|Combination chemotherapy|combination chemotherapy
5695803|NCT00515190|S-1|s-1
5695804|NCT00515190|oxaliplatin|oxaliplatin
5695805|NCT00515177|mindfulness|mindfulness
5695806|NCT00515177|meditation|meditation
5695807|NCT00515177|MBSR|mbsr
5695808|NCT00515177|mindfulness meditation|mindfulness meditation
5695809|NCT00515177|sleep|sleep
5680524|NCT00577733|Pulmonary function test|pulmonary function test
5695810|NCT00515177|insomnia|insomnia
5695811|NCT00515177|chronic insomnia|chronic insomnia
5695812|NCT00515177|primary insomnia|primary insomnia
5695813|NCT00515177|Minnesota|minnesota
5695814|NCT00515164|lung volume reduction|lung volume reduction
5695815|NCT00515164|emphysema|emphysema
5695816|NCT00515164|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5695817|NCT00515151|Bloodstream Infection|bloodstream infection
5695818|NCT00515151|Bacteremia|bacteremia
5695819|NCT00515151|Central Venous Catheter|central venous catheter
5695820|NCT00515151|Alcohol|alcohol
5695821|NCT00515151|Disinfection|disinfection
5695822|NCT00515151|Octenidine Dihydrochloride|octenidine dihydrochloride
5695823|NCT00515138|B-Cell NHL|b-cell nhl
5695824|NCT00515138|Autologous Stem Cell Transplant|autologous stem cell transplant
5695826|NCT00515125|Quality of life|quality of life
5695827|NCT00515125|Supplement|supplement
5695828|NCT00515125|Care home|care home
5695829|NCT00515125|Elderly|elderly
5695830|NCT00515125|Malnutrition|malnutrition
5695831|NCT00515112|prostate|prostate
5695832|NCT00515112|cancer|cancer
5695833|NCT00515112|testosterone replacement|testosterone replacement
5695834|NCT00515112|AndroGel|androgel
5695835|NCT00515112|prostatic cancer|prostatic cancer
5695836|NCT00515112|prostatic neoplasms|prostatic neoplasms
5695837|NCT00515099|New-onset Type 1 Diabetes Mellitus|new-onset type 1 diabetes mellitus
5695838|NCT00515099|New-onset T1DM|new-onset t1dm
5696587|NCT00512590|pain|pain
5695840|NCT00515099|New-onset T1D|new-onset t1d
5695841|NCT00515099|Newly Diagnosed Type 1 Diabetes Mellitus|newly diagnosed type 1 diabetes mellitus
5695842|NCT00515099|Autoimmune diabetes|autoimmune diabetes
5695843|NCT00515099|Thymoglobulin|thymoglobulin
5695844|NCT00515099|ATG|atg
5695845|NCT00515099|Rabbit antithymocyte globulin|rabbit antithymocyte globulin
5695846|NCT00515086|Glioblastoma Multiforme, GBM, RAD001, RAD|glioblastoma multiforme, gbm, rad001, rad
5695847|NCT00515073|Endometrial Cancer|endometrial cancer
5695848|NCT00515073|Papillary Serous Carcinoma|papillary serous carcinoma
5695849|NCT00515073|Pelvic Radiation Therapy|pelvic radiation therapy
5695850|NCT00515073|Paclitaxel|paclitaxel
5695851|NCT00515073|Taxol|taxol
5695852|NCT00515060|Advanced Cancer|advanced cancer
5695853|NCT00515060|Therapy-Induced Pain|therapy-induced pain
5695854|NCT00515060|Pain Threshold|pain threshold
5695855|NCT00515060|Sensory Tests|sensory tests
5695856|NCT00515060|Stimuli|stimuli
5695857|NCT00515060|Pain|pain
5695858|NCT00515047|Atopic Dermatitis|atopic dermatitis
5695859|NCT00515047|Eczema|eczema
5695860|NCT00515047|Eczema Herpeticum|eczema herpeticum
5695861|NCT00515047|Molluscum Contagiousum|molluscum contagiousum
5695862|NCT00515047|Herpes Simplex|herpes simplex
5695863|NCT00515047|Vaccinia|vaccinia
5695864|NCT00515034|Doripenem|doripenem
5695865|NCT00515034|Imipenem|imipenem
5695866|NCT00515034|Cilastatin|cilastatin
5695867|NCT00515034|Vancomycin|vancomycin
5695968|NCT00514540|Carboplatin|carboplatin
5695868|NCT00515034|DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents|doribax, doriprex, finibax, durapta, primaxin, anti bacterial agents
5695869|NCT00515034|Ileus|ileus
5695870|NCT00515034|Hospitalized|hospitalized
5695871|NCT00515034|Fever|fever
5695872|NCT00515021|Metabolic syndrome|metabolic syndrome
5695873|NCT00515021|Aldosterone inhibitor|aldosterone inhibitor
5695874|NCT00515021|Diurnal drug regimen|diurnal drug regimen
5695875|NCT00515021|PAI-1 levels|pai-1 levels
5695876|NCT00514982|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5695877|NCT00514982|Colitis|colitis
5695878|NCT00514982|Medical Therapy|medical therapy
5695879|NCT00514982|Immunopathogenesis|immunopathogenesis
5695880|NCT00514982|Cytokine|cytokine
5695881|NCT00514982|Hermansky-Pudlak Syndrome Associated Colitis|hermansky-pudlak syndrome associated colitis
5695882|NCT00514982|HPS|hps
5695883|NCT00514969|accelerated and blastic phase|accelerated and blastic phase
5695884|NCT00514969|STI571|sti571
5695885|NCT00514956|Post-Traumatic Stress Syndrome (PTSD)|post-traumatic stress syndrome (ptsd)
5695886|NCT00514930|radiofrequency ablation|radiofrequency ablation
5695887|NCT00514930|liver cancer|liver cancer
5695888|NCT00514930|complications|complications
5695889|NCT00514930|liver tumors|liver tumors
5695890|NCT00514904|safety|safety
5695891|NCT00514904|meningococcal vaccine|meningococcal vaccine
5695892|NCT00514904|immunogenicity|immunogenicity
5695893|NCT00514878|nausea|nausea
5695894|NCT00514878|postoperative nausea and vomiting|postoperative nausea and vomiting
5695895|NCT00514878|postoperative pain|postoperative pain
5695896|NCT00514865|ONO-2333Ms|ono-2333ms
5695897|NCT00514865|Major Depressive Disorder|major depressive disorder
5695898|NCT00514839|Prescription drug use disorder|prescription drug use disorder
5695899|NCT00514839|Brief intervention|brief intervention
5695900|NCT00514839|General hospital|general hospital
5695901|NCT00514839|Motivational Interviewing|motivational interviewing
5695902|NCT00514800|Home monitoring|home monitoring
5695903|NCT00514800|Primary care|primary care
5695904|NCT00514800|Hypertension|hypertension
5695905|NCT00514800|TIA|tia
5695906|NCT00514787|Asthma|asthma
5695907|NCT00514787|NIS|nis
5695908|NCT00514774|Huntington chorea|huntington chorea
5695909|NCT00514774|chorea|chorea
5695910|NCT00514774|hereditary|hereditary
5695912|NCT00514774|ursodeoxycholic acid|ursodeoxycholic acid
5695913|NCT00514774|TUDCA|tudca
5695914|NCT00514774|UDCA|udca
5695915|NCT00514761|colorectal cancer|colorectal cancer
5695916|NCT00514761|AZD6244|azd6244
5695917|NCT00514748|breast reconstruction|breast reconstruction
5695918|NCT00514748|DIEP|diep
5695919|NCT00514748|vessel pedicle|vessel pedicle
5695920|NCT00514735|atrial fibrillation|atrial fibrillation
5695921|NCT00514722|Hematopoietic malignancies|hematopoietic malignancies
5695922|NCT00514722|Umbilical cord blood transplantation|umbilical cord blood transplantation
5695923|NCT00514722|Lymphoma: diffuse large cell, mantle cell, peripheral T-cell, T-NK cell, or Hodgkin's|lymphoma: diffuse large cell, mantle cell, peripheral t-cell, t-nk cell, or hodgkin's
5695924|NCT00514709|Diphtheria|diphtheria
5695925|NCT00514709|Tetanus|tetanus
5695926|NCT00514709|Pertussis|pertussis
5695927|NCT00514709|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5695928|NCT00514709|Haemophilus influenzae type b|haemophilus influenzae type b
5695929|NCT00514696|Cancer|cancer
5695930|NCT00514696|Leukemia|leukemia
5695931|NCT00514696|GCS-100|gcs-100
5695932|NCT00514696|CLL|cll
5695933|NCT00514670|Prevention of gastrointestinal and respiratory illness|prevention of gastrointestinal and respiratory illness
5695934|NCT00514644|Panorama|panorama
5695935|NCT00514644|Carotid stenoses|carotid stenoses
5695936|NCT00514618|Term Pregnancy|term pregnancy
5695938|NCT00514618|Cervical Ripening|cervical ripening
5695939|NCT00514618|Induction|induction
5695940|NCT00514618|misoprostol|misoprostol
5695941|NCT00514618|Term Gestational Diabetics|term gestational diabetics
5695943|NCT00514605|AIDS|aids
5695944|NCT00514605|Assay|assay
5695945|NCT00514605|Rapid Test|rapid test
5695946|NCT00514605|HIV-1|hiv-1
5695947|NCT00514605|HIV Seronegativity|hiv seronegativity
5695948|NCT00514592|Carotid stenosis|carotid stenosis
5695949|NCT00514592|Carotid endarterectomy|carotid endarterectomy
5695950|NCT00514579|Cord Blood Stem Cell Transplantation|cord blood stem cell transplantation
5695951|NCT00514579|Hematologic Malignancies|hematologic malignancies
5695952|NCT00514579|Leukemia|leukemia
5695953|NCT00514579|Myelodysplastic Syndrome|myelodysplastic syndrome
5695954|NCT00514566|Polyamide|polyamide
5695955|NCT00514566|Polydioxanone|polydioxanone
5695956|NCT00514566|Midline|midline
5695957|NCT00514566|Abdominal|abdominal
5695958|NCT00514566|Closure|closure
5695959|NCT00514553|Prenatal Testing|prenatal testing
5695960|NCT00514553|Test Decision-Making|test decision-making
5695961|NCT00514553|Decision-Making Intervention|decision-making intervention
5695962|NCT00514553|Theory of Unconscious Thought|theory of unconscious thought
5695963|NCT00514553|Informed Choice|informed choice
5695964|NCT00514553|Decision Making|decision making
5695965|NCT00514553|Counseling|counseling
5695966|NCT00514540|Prostate Cancer|prostate cancer
5695967|NCT00514540|Anaplastic Prostate Cancer|anaplastic prostate cancer
5695973|NCT00514514|mycophenolate|mycophenolate
5695974|NCT00514514|CNI-free|cni-free
5695975|NCT00514514|kidney transplantation|kidney transplantation
5695976|NCT00514488|chronic myeloid leukemia|chronic myeloid leukemia
5695977|NCT00514488|STI 571|sti 571
5695978|NCT00514488|CML022|cml022
5695979|NCT00514475|Mantle cell lymphoma|mantle cell lymphoma
5695980|NCT00514475|Zevalin|zevalin
5695981|NCT00514475|90Y-ibritumomab tiuxetan|90y-ibritumomab tiuxetan
5695982|NCT00514475|Radioimmunotherapy|radioimmunotherapy
5695983|NCT00514475|High-dose therapy|high-dose therapy
5695984|NCT00514475|First line|first line
5695985|NCT00514436|Asthma|asthma
5695986|NCT00514436|children|children
5695987|NCT00514436|low-income, underserved|low-income, underserved
5695988|NCT00514436|Reduction in hospitalization|reduction in hospitalization
5695989|NCT00514410|Depression|depression
5695990|NCT00514410|Folate|folate
5695991|NCT00514410|Folic acid|folic acid
5695992|NCT00514410|Antidepressants|antidepressants
5695993|NCT00514397|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5695994|NCT00514371|Multiple Myeloma|multiple myeloma
5695995|NCT00514371|Heat Shock Protein 90|heat shock protein 90
5695996|NCT00514371|Hsp90|hsp90
5695997|NCT00514371|KOS-953|kos-953
5695998|NCT00514371|17-AAG|17-aag
5695999|NCT00514371|bortezomib|bortezomib
5696000|NCT00514371|relapsed-refractory|relapsed-refractory
5696001|NCT00514371|tanespimycin|tanespimycin
5696002|NCT00514358|Fungal|fungal
5696003|NCT00514358|Infection|infection
5696004|NCT00514358|sepsis|sepsis
5696005|NCT00514358|pharmacokinetics|pharmacokinetics
5696006|NCT00514345|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5696007|NCT00514345|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5696008|NCT00514345|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5696009|NCT00514345|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5696010|NCT00514345|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5696011|NCT00514345|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5696012|NCT00514345|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5696013|NCT00514345|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5696014|NCT00514345|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5696015|NCT00514345|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5705240|NCT00482716|anemia|anemia
5696016|NCT00514332|colorectal stents|colorectal stents
5696017|NCT00514332|colonic obstruction|colonic obstruction
5696018|NCT00514332|colonic adenocarcinoma|colonic adenocarcinoma
5696019|NCT00514332|colorectal surgery|colorectal surgery
5696020|NCT00514306|Ovarian Cancer|ovarian cancer
5696021|NCT00514306|Advanced Cancer|advanced cancer
5696022|NCT00514306|Colorectal cancer|colorectal cancer
5696023|NCT00514306|Non-small cell lung cancer|non-small cell lung cancer
5696024|NCT00514306|Metastatic Cancer|metastatic cancer
5696025|NCT00514306|Renal cancer|renal cancer
5696026|NCT00514306|Breast cancer|breast cancer
5696027|NCT00514293|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5696028|NCT00514293|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5696029|NCT00514293|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5696030|NCT00514280|Lead and Smoke Study in D.C.|lead and smoke study in d.c.
5696035|NCT00514267|Prostate Cancer|prostate cancer
5696037|NCT00514267|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5696038|NCT00514267|YM155|ym155
5696039|NCT00514267|Treatment Outcome|treatment outcome
5696040|NCT00514267|Solid Tumors|solid tumors
5696041|NCT00514254|endometrial cancer|endometrial cancer
5696042|NCT00514254|risk factors|risk factors
5696043|NCT00514254|questionnaire|questionnaire
5696044|NCT00514254|07-093|07-093
5696045|NCT00514228|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5696046|NCT00514228|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5696047|NCT00514228|advanced adult primary liver cancer|advanced adult primary liver cancer
5696048|NCT00514228|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5696049|NCT00514215|lung metastases|lung metastases
5696050|NCT00514215|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5696051|NCT00514215|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5696052|NCT00514215|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5696053|NCT00514215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5696054|NCT00514215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5696055|NCT00514215|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5696056|NCT00514215|recurrent renal cell cancer|recurrent renal cell cancer
5696057|NCT00514215|stage IV renal cell cancer|stage iv renal cell cancer
5696058|NCT00514215|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5696059|NCT00514202|cocaine|cocaine
5696060|NCT00514202|ADHD|adhd
5696061|NCT00514202|attention|attention
5696062|NCT00514202|hyperactivity|hyperactivity
5696063|NCT00514202|drug|drug
5696064|NCT00514202|dependence|dependence
5696065|NCT00514189|Acute Myelogenous Leukemia|acute myelogenous leukemia
5696066|NCT00514189|Leukemia|leukemia
5696067|NCT00514189|Autologous Dendritic Cells|autologous dendritic cells
5696068|NCT00514189|Vaccine|vaccine
5696069|NCT00514189|AML|aml
5696070|NCT00514189|mRNA|mrna
5696071|NCT00514163|pancreatic carcinoma|pancreatic carcinoma
5696072|NCT00514163|gemcitabine|gemcitabine
5696073|NCT00514163|S-1|s-1
5696074|NCT00514163|phaseⅡstudy|phaseⅱstudy
5696075|NCT00514150|angiography|angiography
5696076|NCT00514150|complications|complications
5696077|NCT00514150|contrast media|contrast media
5696078|NCT00514150|kidney|kidney
5696079|NCT00514150|prevention|prevention
5696084|NCT00514085|recurrent melanoma|recurrent melanoma
5696085|NCT00514085|stage IV melanoma|stage iv melanoma
5696086|NCT00514072|stage IV prostate cancer|stage iv prostate cancer
5696087|NCT00514072|recurrent prostate cancer|recurrent prostate cancer
5696088|NCT00514059|Diphteria-tetanus-pertussis-polio vaccine|diphteria-tetanus-pertussis-polio vaccine
5696089|NCT00514059|Booster immunization|booster immunization
5696090|NCT00514059|Vaccine effect (Diphtheria-tetanus-acellular pertussis-polio)|vaccine effect (diphtheria-tetanus-acellular pertussis-polio)
5696091|NCT00514059|Immunity|immunity
5696092|NCT00514059|Safety|safety
5696093|NCT00514046|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
5696094|NCT00514046|Medullary Thyroid Carcinoma|medullary thyroid carcinoma
5696095|NCT00514046|Molecularly-Targeted Therapy|molecularly-targeted therapy
5696096|NCT00514046|Pediatric|pediatric
5696097|NCT00514046|Pharmacokinetics|pharmacokinetics
5696098|NCT00514046|MTC|mtc
5696099|NCT00514046|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5696100|NCT00514046|MEN|men
5696101|NCT00514020|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5696102|NCT00514020|stage IV gastric cancer|stage iv gastric cancer
5696103|NCT00514020|recurrent gastric cancer|recurrent gastric cancer
5696104|NCT00514007|Advanced Cancer|advanced cancer
5696105|NCT00514007|Colorectal cancer|colorectal cancer
5696106|NCT00514007|Ovarian cancer|ovarian cancer
5696107|NCT00514007|Renal cancer|renal cancer
5696108|NCT00514007|Metastatic cancer|metastatic cancer
5696109|NCT00514007|Breast cancer|breast cancer
5696110|NCT00514007|Non-small cell lung cancer|non-small cell lung cancer
5696112|NCT00513994|Nitroglycerin|nitroglycerin
5696113|NCT00513994|pharmacokinetics study of nitroglycerin containing treatments|pharmacokinetics study of nitroglycerin containing treatments
5863045|NCT00001410|Polyethylene Glycol|polyethylene glycol
5696114|NCT00513981|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5696115|NCT00513981|recurrent osteosarcoma|recurrent osteosarcoma
5696116|NCT00513981|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5696117|NCT00513981|recurrent childhood ependymoma|recurrent childhood ependymoma
5848042|NCT00036582|Normal Control|normal control
5696118|NCT00513981|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5696119|NCT00513981|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5696120|NCT00513955|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5696121|NCT00513942|Fetal Movement|fetal movement
5696122|NCT00513942|Maternal-Fetal-Attachment|maternal-fetal-attachment
5696123|NCT00513942|Fetus|fetus
5696124|NCT00513929|Severe Pneumonia|severe pneumonia
5696125|NCT00513929|Zinc|zinc
5696126|NCT00513929|Associated pathogens|associated pathogens
5696127|NCT00513929|Severe Pneumonia by type of associated pathogens|severe pneumonia by type of associated pathogens
5696128|NCT00513929|Severe Pneumonia by basal plasma zinc status|severe pneumonia by basal plasma zinc status
5696129|NCT00513916|breast cancer|breast cancer
5696130|NCT00513916|healthy, no evidence of disease|healthy, no evidence of disease
5696131|NCT00513903|Pulmonary Diseases|pulmonary diseases
5696132|NCT00513903|Continuity of Pharmacy Care|continuity of pharmacy care
5696133|NCT00513890|Bronchiolitis|bronchiolitis
5696134|NCT00513890|Esophageal pressure mesurement|esophageal pressure mesurement
5696135|NCT00513890|Clinical score|clinical score
5696136|NCT00513890|Citical care|citical care
5696138|NCT00513877|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5696139|NCT00513877|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5696140|NCT00513877|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5696141|NCT00513877|stage II malignant mesothelioma|stage ii malignant mesothelioma
5696142|NCT00513877|stage III malignant mesothelioma|stage iii malignant mesothelioma
5696143|NCT00513877|stage IV malignant mesothelioma|stage iv malignant mesothelioma
5696144|NCT00513864|Opioid Analgesics|opioid analgesics
5696145|NCT00513864|Morphine|morphine
5696146|NCT00513864|Codeine|codeine
5696147|NCT00513864|Sickle Cell Disease|sickle cell disease
5696148|NCT00513851|Advanced Cancer|advanced cancer
5696149|NCT00513851|Non-small cell lung cancer|non-small cell lung cancer
5696150|NCT00513851|Small cell lung cancer|small cell lung cancer
5696151|NCT00513851|Uterine cancer|uterine cancer
5696152|NCT00513851|Ovarian cancer|ovarian cancer
5696153|NCT00513851|Renal cancer|renal cancer
5696154|NCT00513851|Head and neck cancer|head and neck cancer
5696155|NCT00513851|Cervical cancer|cervical cancer
5696156|NCT00513851|Metastatic cancer|metastatic cancer
5696157|NCT00513851|Colorectal cancer|colorectal cancer
5696158|NCT00513851|Gastrointestinal stromal tumors|gastrointestinal stromal tumors
5696159|NCT00513825|Contrast Nephropathy|contrast nephropathy
5696160|NCT00513825|Sodium Bicarbonate|sodium bicarbonate
5696161|NCT00513825|Prevention|prevention
5696162|NCT00513786|Endometrial Cancer|endometrial cancer
5696163|NCT00513786|Advanced Stage Endometrial Cancer|advanced stage endometrial cancer
5696164|NCT00513786|Stage 3 or 4 endometrial cancer|stage 3 or 4 endometrial cancer
5696165|NCT00513786|Cancer treatment|cancer treatment
5696166|NCT00513786|gyn cancer|gyn cancer
5696167|NCT00513773|Abdominal Aortic Aneurysm,|abdominal aortic aneurysm,
5696168|NCT00513773|Inflammation and Risk Prediction|inflammation and risk prediction
5696169|NCT00513773|Diagnostic Tool Efficacy|diagnostic tool efficacy
5696170|NCT00513760|Pharmacogenetics|pharmacogenetics
5696171|NCT00513760|Singulair|singulair
5696172|NCT00513760|montelukast|montelukast
5696173|NCT00513760|Leukotriene Antagonists|leukotriene antagonists
5696174|NCT00513760|Anti-Asthmatic Agents|anti-asthmatic agents
5696175|NCT00513760|Intestinal Absorption|intestinal absorption
5696176|NCT00513760|pharmacokinetics|pharmacokinetics
5696177|NCT00513760|absorption|absorption
5696178|NCT00513760|biochemical transport|biochemical transport
5696179|NCT00513760|Membrane Transport Proteins|membrane transport proteins
5696180|NCT00513760|Drug Interactions|drug interactions
5696181|NCT00513747|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5696182|NCT00513747|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5696183|NCT00513747|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5696184|NCT00513734|keratopathy|keratopathy
5696185|NCT00513734|exposure|exposure
5696186|NCT00513734|intensive care|intensive care
5696188|NCT00513734|ulcer|ulcer
5696189|NCT00513734|Corneal|corneal
5696190|NCT00513721|prostate|prostate
5696191|NCT00513721|prostate cancer|prostate cancer
5696192|NCT00513721|surgical margins|surgical margins
5696193|NCT00513721|gleason score|gleason score
5696194|NCT00513721|positive lateral biopsies|positive lateral biopsies
5696195|NCT00513708|Detoxification|detoxification
5696196|NCT00513708|Treatment|treatment
5696197|NCT00513682|Cystic Fibrosis|cystic fibrosis
5696199|NCT00513682|Steatorrhea|steatorrhea
5696200|NCT00513682|Children 7 to 11 years|children 7 to 11 years
5696201|NCT00513682|Pancreatic enzyme|pancreatic enzyme
5696202|NCT00513669|Malaria|malaria
5696203|NCT00513669|Vaccine|vaccine
5721906|NCT00424684|TB|tb
5696204|NCT00513669|Falciparum|falciparum
5696205|NCT00513669|Trial|trial
5696206|NCT00513669|Phase I|phase i
5696207|NCT00513669|Safety|safety
5696208|NCT00513669|Immunogenicity|immunogenicity
5696209|NCT00513656|Efficacy|efficacy
5696210|NCT00513656|chronic|chronic
5696211|NCT00513656|cancer|cancer
5696212|NCT00513656|pain|pain
5696213|NCT00513656|constipation|constipation
5696214|NCT00513656|oxycodone|oxycodone
5696215|NCT00513656|naloxone|naloxone
5696216|NCT00513656|Moderate to severe chronic cancer pain|moderate to severe chronic cancer pain
5696217|NCT00513643|euglycaemic glucose clamp|euglycaemic glucose clamp
5696218|NCT00513643|duration of action|duration of action
5696219|NCT00513643|late metabolic activity|late metabolic activity
5696220|NCT00513643|hypoglycaemia|hypoglycaemia
5696221|NCT00513617|Sickle Cell Disease|sickle cell disease
5696223|NCT00513617|Nitric Oxide|nitric oxide
5696224|NCT00513617|Vaso Occlusive Events|vaso occlusive events
5696225|NCT00513617|Arginine Supplementation|arginine supplementation
5696226|NCT00513604|Clinical Response|clinical response
5696227|NCT00513604|Immunotherapy|immunotherapy
5696228|NCT00513604|Cancer|cancer
5696230|NCT00513604|Adoptive Cell Therapy|adoptive cell therapy
5696231|NCT00513604|Melanoma|melanoma
5696232|NCT00513604|Skin Cancer|skin cancer
5696233|NCT00513604|Malignant Melanoma|malignant melanoma
5696234|NCT00513591|Pregnancy|pregnancy
5696235|NCT00513591|Lupus (systemic lupus erythematosus or cutaneous lupus)|lupus (systemic lupus erythematosus or cutaneous lupus)
5696236|NCT00513591|Rheumatoid Arthritis|rheumatoid arthritis
5696237|NCT00513591|Sjogren's Syndrome|sjogren's syndrome
5696238|NCT00513591|Scleroderma|scleroderma
5696239|NCT00513578|refractory anemia with excess blasts|refractory anemia with excess blasts
5696240|NCT00513578|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5696241|NCT00513578|refractory anemia|refractory anemia
5696242|NCT00513578|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5696243|NCT00513578|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5696244|NCT00513578|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5696245|NCT00513565|GSK561679,|gsk561679,
5696246|NCT00513565|single,|single,
5696247|NCT00513565|dose,|dose,
5696248|NCT00513565|lorazepam,|lorazepam,
5696249|NCT00513565|fMRI,|fmri,
5696250|NCT00513565|BOLD,|bold,
5696251|NCT00513565|healthy volunteers|healthy volunteers
5696252|NCT00513539|unresectable gallbladder cancer|unresectable gallbladder cancer
5696253|NCT00513539|recurrent gallbladder cancer|recurrent gallbladder cancer
5696254|NCT00513539|metastatic gallbladder cancer|metastatic gallbladder cancer
5696255|NCT00513539|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5696256|NCT00513539|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5696257|NCT00513539|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5696258|NCT00513539|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5696259|NCT00513539|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5696260|NCT00513526|infection|infection
5696261|NCT00513526|low-grade squamous intraepithelial lesion|low-grade squamous intraepithelial lesion
5696262|NCT00513526|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5696263|NCT00513513|HIV|hiv
5696264|NCT00513513|AIDS|aids
5696265|NCT00513513|TMC114|tmc114
5696266|NCT00513513|Protease inhibitor|protease inhibitor
5696267|NCT00513513|Darunavir|darunavir
5696268|NCT00513513|Antiretroviral agents|antiretroviral agents
5696269|NCT00513513|Treatment Naive|treatment naive
5696270|NCT00513500|community health care|community health care
5696271|NCT00513500|community health worker|community health worker
5696272|NCT00513500|malaria|malaria
5696273|NCT00513500|pneumonia|pneumonia
5696274|NCT00513500|rapid diagnostic test|rapid diagnostic test
5696275|NCT00513487|Allergic Rhinitis|allergic rhinitis
5696276|NCT00513487|dust mites|dust mites
5696277|NCT00513487|IgE|ige
5696278|NCT00513487|IL-13|il-13
5696279|NCT00513487|nasal|nasal
5696280|NCT00513487|inflammation|inflammation
5696281|NCT00513474|graft versus host disease|graft versus host disease
5696282|NCT00513474|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5696283|NCT00513474|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5696284|NCT00513474|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5696285|NCT00513474|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5696286|NCT00513474|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5696287|NCT00513474|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5696288|NCT00513474|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5704135|NCT00486993|Diet|diet
5694873|NCT00519090|bone marrow|bone marrow
5696289|NCT00513474|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5696290|NCT00513474|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5696291|NCT00513474|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5696292|NCT00513474|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5696293|NCT00513474|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5696294|NCT00513474|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5696295|NCT00513474|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5696296|NCT00513474|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5696297|NCT00513474|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5696298|NCT00513474|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5696299|NCT00513474|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5696300|NCT00513474|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5696301|NCT00513474|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5696302|NCT00513474|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5696303|NCT00513474|Waldenström macroglobulinemia|waldenström macroglobulinemia
5696304|NCT00513474|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5696305|NCT00513474|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5696306|NCT00513474|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5690847|NCT00534677|Variceal bleed|variceal bleed
5696307|NCT00513474|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5696308|NCT00513474|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5696309|NCT00513474|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5696310|NCT00513474|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5696311|NCT00513474|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5696312|NCT00513474|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5696313|NCT00513474|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5696314|NCT00513474|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5696315|NCT00513474|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5696316|NCT00513474|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5696317|NCT00513474|primary myelofibrosis|primary myelofibrosis
5696318|NCT00513474|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5696319|NCT00513474|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5696320|NCT00513474|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5696321|NCT00513474|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5696322|NCT00513474|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5696323|NCT00513474|refractory hairy cell leukemia|refractory hairy cell leukemia
5696324|NCT00513474|refractory multiple myeloma|refractory multiple myeloma
5696325|NCT00513474|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5696326|NCT00513474|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5696327|NCT00513448|Chronic Disabling Condition|chronic disabling condition
5696328|NCT00513448|Comparative Evaluation|comparative evaluation
5696330|NCT00513448|Physical Therapy|physical therapy
5696331|NCT00513448|Rehabilitation|rehabilitation
5696332|NCT00513422|Osteoarthritis, knee|osteoarthritis, knee
5696335|NCT00513422|Disease progression|disease progression
5696336|NCT00513422|NSAIDs|nsaids
5696337|NCT00513409|Immunogenicity|immunogenicity
5696338|NCT00513409|Pneumococcal disease|pneumococcal disease
5696339|NCT00513409|Safety|safety
5696340|NCT00513409|Booster vaccination|booster vaccination
5696341|NCT00513409|Pneumococcal vaccine|pneumococcal vaccine
5696342|NCT00513396|Randomized control trial|randomized control trial
5696343|NCT00513396|multidrug resistant tuberculosis|multidrug resistant tuberculosis
5696344|NCT00513396|isoniazid|isoniazid
5696345|NCT00513396|standardized regimen|standardized regimen
5696346|NCT00513396|adjuvant therapy|adjuvant therapy
5696347|NCT00513383|basaloid squamous cell carcinoma|basaloid squamous cell carcinoma
5696348|NCT00513383|undifferentiated carcinoma|undifferentiated carcinoma
5696349|NCT00513383|adenosquamous cell carcinoma|adenosquamous cell carcinoma
5696350|NCT00513370|Psoriasis|psoriasis
5696351|NCT00513370|adalimumab|adalimumab
5696352|NCT00513357|Gastrointestinal Cancer|gastrointestinal cancer
5696353|NCT00513357|Lung Cancer|lung cancer
5696354|NCT00513357|Cachexia|cachexia
5696355|NCT00513357|Melatonin|melatonin
5696356|NCT00513357|Placebo|placebo
5696357|NCT00513357|Anorexia|anorexia
5696358|NCT00513357|Weight Loss|weight loss
5696359|NCT00513344|Endothelial function|endothelial function
5696360|NCT00513344|Arterial stiffness|arterial stiffness
5696361|NCT00513344|Dark chocolate|dark chocolate
5696362|NCT00513344|Milk chocolate|milk chocolate
5696363|NCT00513344|Polyphenols|polyphenols
5704209|NCT00486668|trastuzumab|trastuzumab
5696364|NCT00513331|Barrett's Esophagus|barrett's esophagus
5696365|NCT00513331|GERD|gerd
5696366|NCT00513331|Carcinoma|carcinoma
5696367|NCT00513318|Umbilical cord blood transplantation|umbilical cord blood transplantation
5696368|NCT00513318|hematopoietic malignancies|hematopoietic malignancies
5696369|NCT00513305|acute myeloid leukemia, cytarabine, arsenic trioxide.|acute myeloid leukemia, cytarabine, arsenic trioxide.
5696371|NCT00513279|GSK618334|gsk618334
5696372|NCT00513279|pharmacokinetics,|pharmacokinetics,
5696373|NCT00513279|repeat dose,|repeat dose,
5696374|NCT00513279|tolerability,|tolerability,
5696375|NCT00513279|pharmacodynamics,|pharmacodynamics,
5696376|NCT00513279|placebo,|placebo,
5696377|NCT00513266|recurrent rectal cancer|recurrent rectal cancer
5696378|NCT00513266|stage IV rectal cancer|stage iv rectal cancer
5696379|NCT00513266|recurrent colon cancer|recurrent colon cancer
5696380|NCT00513266|stage IV colon cancer|stage iv colon cancer
5696381|NCT00513266|adenocarcinoma of the colon|adenocarcinoma of the colon
5696382|NCT00513266|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5696383|NCT00513266|liver metastases|liver metastases
5696384|NCT00513266|lung metastases|lung metastases
5696385|NCT00513253|lapatinib|lapatinib
5696386|NCT00513253|Healthy Adult Volunteer|healthy adult volunteer
5696387|NCT00513240|erythropoetin|erythropoetin
5696388|NCT00513240|neuroprotection|neuroprotection
5696389|NCT00513240|neonate|neonate
5696390|NCT00513240|cardiac|cardiac
5696391|NCT00513240|magnetic resonance imaging|magnetic resonance imaging
5696392|NCT00513240|brain magnetic resonance imaging|brain magnetic resonance imaging
5696393|NCT00513240|electroencephalogram|electroencephalogram
5696394|NCT00513214|Diabetes|diabetes
5696397|NCT00513201|lyspro|lyspro
5696398|NCT00513201|regular insulin|regular insulin
5696399|NCT00513201|cirrhotic patients|cirrhotic patients
5696400|NCT00513188|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5696401|NCT00513188|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5696402|NCT00513188|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5696403|NCT00513188|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5696404|NCT00513188|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5696405|NCT00513175|Allogeneic SCT|allogeneic sct
5696406|NCT00513175|Matched unrelated donors|matched unrelated donors
5696407|NCT00513175|hematologic malignancies|hematologic malignancies
5696408|NCT00513175|renal cell carcinoma|renal cell carcinoma
5696409|NCT00513175|aplastic anemia|aplastic anemia
5696410|NCT00513162|Advanced Cancers|advanced cancers
5696411|NCT00513162|Brain|brain
5696412|NCT00513162|CNS|cns
5696413|NCT00513162|Neural|neural
5696414|NCT00513162|Pediatrics|pediatrics
5696415|NCT00513162|Spinal|spinal
5696416|NCT00513162|Neuroectodermal Tumor|neuroectodermal tumor
5696417|NCT00513162|Brain Metastases|brain metastases
5696418|NCT00513162|Valproate|valproate
5696419|NCT00513162|Valproic Acid|valproic acid
5696420|NCT00513162|Depakene|depakene
5696421|NCT00513162|Etoposide|etoposide
5696422|NCT00513162|VePesid|vepesid
5696423|NCT00513149|angioplasty|angioplasty
5696424|NCT00513149|clopidogrel|clopidogrel
5696425|NCT00513149|coronary artery disease|coronary artery disease
5696426|NCT00513149|PFA|pfa
5696427|NCT00513136|Fatigue|fatigue
5696428|NCT00513136|Breast Cancer|breast cancer
5696429|NCT00513136|Behavioral Research|behavioral research
5696430|NCT00513136|Quality of Life|quality of life
5696431|NCT00513123|Digital Colposcopy for Fluorescence|digital colposcopy for fluorescence
5696432|NCT00513123|DCF|dcf
5696433|NCT00513123|Fluorescence Spectroscopy|fluorescence spectroscopy
5696434|NCT00513123|Digital Colposcopy|digital colposcopy
5696435|NCT00513123|DC|dc
5696436|NCT00513123|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5696437|NCT00513123|Cervical Cancer|cervical cancer
5696438|NCT00513123|Cervix|cervix
5696439|NCT00513123|Vagina|vagina
5696440|NCT00513123|Lesions of the cervix|lesions of the cervix
5696441|NCT00513123|Precancerous lesions|precancerous lesions
5696442|NCT00513110|Endotoxin|endotoxin
5696443|NCT00513110|Adenosine|adenosine
5696444|NCT00513110|Caffeine|caffeine
5696445|NCT00513110|AMPD1 polymorphism|ampd1 polymorphism
5696446|NCT00513097|Epidemiology|epidemiology
5696447|NCT00513097|Cancer Prevention|cancer prevention
5696448|NCT00513097|Smoking Cessation|smoking cessation
5696449|NCT00513097|Smoking Prevention|smoking prevention
5696450|NCT00513097|Focus Groups|focus groups
5696451|NCT00513084|Behavioral,|behavioral,
5696452|NCT00513084|Self-Determination Theory,|self-determination theory,
5696453|NCT00513084|Motivational Interviewing,|motivational interviewing,
5696454|NCT00513084|Exercise, Physical Activity,|exercise, physical activity,
5696455|NCT00513084|Motivation,|motivation,
5696456|NCT00513084|Moderators,|moderators,
5696457|NCT00513084|Mediators,|mediators,
5696458|NCT00513084|Predictors,|predictors,
5696459|NCT00513084|Weight|weight
5696460|NCT00513058|metastatic breast cancer|metastatic breast cancer
5696461|NCT00513058|advanced breast cancer|advanced breast cancer
5696462|NCT00513045|Nightmares|nightmares
5696463|NCT00513045|treatment|treatment
5685742|NCT00555048|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5685743|NCT00555048|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5685744|NCT00555048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5685745|NCT00555048|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5685746|NCT00555048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5685747|NCT00555035|GSK1349572,|gsk1349572,
5696464|NCT00513045|self-help|self-help
5696465|NCT00513032|propofol|propofol
5696466|NCT00513032|anaesthesia induction|anaesthesia induction
5696467|NCT00513032|parathyroidectomy|parathyroidectomy
5696468|NCT00513032|methylene blue|methylene blue
5696469|NCT00513032|General anesthesia|general anesthesia
5696470|NCT00513019|Neurotic Excoriation|neurotic excoriation
5696471|NCT00513019|Pathologic Skin Picking|pathologic skin picking
5696472|NCT00513019|Psychogenic Excoriation|psychogenic excoriation
5705718|NCT00480714|TB|tb
5696473|NCT00512993|Postoperative treatment with zoledronic acid|postoperative treatment with zoledronic acid
5696474|NCT00512993|Preoperative anthracycline/taxane containing chemotherapy|preoperative anthracycline/taxane containing chemotherapy
5696475|NCT00512980|intermediate stages|intermediate stages
5696476|NCT00512967|oxidative stress|oxidative stress
5696477|NCT00512967|antioxidants|antioxidants
5696478|NCT00512967|inflammation|inflammation
5696479|NCT00512967|quercetin|quercetin
5696480|NCT00512954|airway inflammation|airway inflammation
5696481|NCT00512954|susceptibility to infections|susceptibility to infections
5696584|NCT00512590|fibromyalgia|fibromyalgia
5696482|NCT00512954|inflammatory response in blood and urine|inflammatory response in blood and urine
5696483|NCT00512954|infective exacerbations|infective exacerbations
5696484|NCT00512954|asthma|asthma
5696485|NCT00512954|COPD|copd
5696486|NCT00512928|vitamin K2|vitamin k2
5696487|NCT00512928|oral anticoagulation|oral anticoagulation
5696488|NCT00512928|interference|interference
5696489|NCT00512928|level of anticoagulation|level of anticoagulation
5691113|NCT00533923|GVHD|gvhd
5696490|NCT00512928|carboxylation level of osteocalcin and matrix-gla protein|carboxylation level of osteocalcin and matrix-gla protein
5696491|NCT00512915|Farfield Sensing|farfield sensing
5696492|NCT00512915|Pacing lead|pacing lead
5696493|NCT00512915|Postventricular atrial blanking|postventricular atrial blanking
5696494|NCT00512915|Bradycardia|bradycardia
5696495|NCT00512902|active alveolitis in systemic sclerosis|active alveolitis in systemic sclerosis
5696497|NCT00512889|MART-1|mart-1
5696498|NCT00512889|Melan-A|melan-a
5696499|NCT00512889|artificial APC|artificial apc
5696500|NCT00512889|melanoma|melanoma
5696501|NCT00512889|metastatic melanoma|metastatic melanoma
5696502|NCT00512889|adoptive immunotherapy|adoptive immunotherapy
5696503|NCT00512889|adoptive cell transfer|adoptive cell transfer
5696504|NCT00512889|immunotherapy|immunotherapy
5696505|NCT00512850|Folic acid|folic acid
5696506|NCT00512850|Adenoma of Large Intestine|adenoma of large intestine
5696507|NCT00512837|Telemedicine|telemedicine
5696508|NCT00512837|clinical management|clinical management
5696509|NCT00512837|empowerment|empowerment
5696510|NCT00512837|engagement|engagement
5696511|NCT00512837|education|education
5696512|NCT00512824|calcium|calcium
5696513|NCT00512824|probiotics|probiotics
5696514|NCT00512824|diarrhea|diarrhea
5696515|NCT00512824|children|children
5696516|NCT00512824|Indonesia|indonesia
5696517|NCT00512824|Healthy children|healthy children
5696518|NCT00512824|acute diarrhea|acute diarrhea
5696519|NCT00512811|furosemide|furosemide
5696520|NCT00512811|inhalation|inhalation
5696521|NCT00512811|dyspnea|dyspnea
5696522|NCT00512811|spirometry|spirometry
5696523|NCT00512811|mustard gas|mustard gas
5696524|NCT00512811|bronchiolitis|bronchiolitis
5696525|NCT00512811|sulfur mustard|sulfur mustard
5696526|NCT00512798|stage III melanoma|stage iii melanoma
5696527|NCT00512798|stage IV melanoma|stage iv melanoma
5696528|NCT00512798|recurrent melanoma|recurrent melanoma
5696529|NCT00512798|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5696530|NCT00512798|recurrent adult brain tumor|recurrent adult brain tumor
5696531|NCT00512798|melanoma (skin)|melanoma (skin)
5696532|NCT00512785|Imidafenacin|imidafenacin
5696533|NCT00512785|KRP-197/ONO-8025|krp-197/ono-8025
5696534|NCT00512785|overactive bladder|overactive bladder
5696535|NCT00512785|antimuscarinic|antimuscarinic
5696536|NCT00512772|Time series|time series
5696537|NCT00512772|Implementation|implementation
5696538|NCT00512746|small cell lung cancer|small cell lung cancer
5696539|NCT00512746|non-small cell lung cancer|non-small cell lung cancer
5696540|NCT00512746|precancerous condition|precancerous condition
5696541|NCT00512733|Healthy volunteers|healthy volunteers
5696542|NCT00512720|PAD|pad
5685748|NCT00555035|healthy volunteers|healthy volunteers
5680533|NCT00577681|Lipoproteins|lipoproteins
5696543|NCT00512720|Peripheral Artery Disease|peripheral artery disease
5696544|NCT00512720|PVD|pvd
5696545|NCT00512720|Peripheral Vascular Disease|peripheral vascular disease
5696546|NCT00512720|Leg Blockage|leg blockage
5696547|NCT00512720|Angioplasty|angioplasty
5696548|NCT00512720|Stent|stent
5696549|NCT00512720|Claudication|claudication
5696550|NCT00512707|testosterone|testosterone
5696551|NCT00512707|erectile dysfunction|erectile dysfunction
5696552|NCT00512707|sildenafil|sildenafil
5696553|NCT00512694|Lupus|lupus
5696554|NCT00512694|Systemic Lupus Erythematosus|systemic lupus erythematosus
5696555|NCT00512694|Cutaneous Lupus|cutaneous lupus
5696556|NCT00512681|Stomach Neoplasms|stomach neoplasms
5696557|NCT00512681|Secondary|secondary
5696558|NCT00512681|Combination chemotherapy|combination chemotherapy
5696559|NCT00512681|S-1|s-1
5696560|NCT00512681|irinotecan|irinotecan
5696561|NCT00512681|oxaliplatin|oxaliplatin
5696562|NCT00512655|Fear of falling|fear of falling
5696563|NCT00512655|Intraindividual variability|intraindividual variability
5696564|NCT00512655|Cognition|cognition
5696565|NCT00512655|Fall prevention|fall prevention
5696566|NCT00512655|Fear|fear
5696567|NCT00512655|Frail elderly|frail elderly
5696568|NCT00512655|Intervention|intervention
5696569|NCT00512642|Cancer|cancer
5696570|NCT00512642|Lymphocytes|lymphocytes
5696571|NCT00512642|Genetics|genetics
5696572|NCT00512629|PN|pn
5696573|NCT00512629|cholestasis|cholestasis
5696574|NCT00512629|gastrointestinal disease in infants|gastrointestinal disease in infants
5696575|NCT00512629|short bowel syndrome|short bowel syndrome
5696576|NCT00512616|Ceftriaxone|ceftriaxone
5696577|NCT00512616|Acute Antidepressant Effects|acute antidepressant effects
5696578|NCT00512616|Glutamatergic System|glutamatergic system
5696579|NCT00512616|Double-Blind|double-blind
5696580|NCT00512616|Mood Disorders|mood disorders
5696581|NCT00512616|Bipolar Disorder|bipolar disorder
5696583|NCT00512603|cerebro vascular event|cerebro vascular event
5696585|NCT00512590|relaxation|relaxation
5696588|NCT00512590|functional status|functional status
5696589|NCT00512590|self efficacy|self efficacy
5696590|NCT00512590|minority health|minority health
5696591|NCT00512577|sickle cell disease|sickle cell disease
5696592|NCT00512577|pre-operative transfusion|pre-operative transfusion
5696593|NCT00512577|blood transfusion|blood transfusion
5696594|NCT00512564|Sickle Cell Anemia|sickle cell anemia
5696595|NCT00512564|Sickle Cell Thalassemia|sickle cell thalassemia
5696597|NCT00512564|Non transferrin binding iron|non transferrin binding iron
5696598|NCT00512564|Hepcidin|hepcidin
5696599|NCT00512551|Cervical Cancer|cervical cancer
5696600|NCT00512551|DNA Array Analysis|dna array analysis
5696601|NCT00512551|Gene Expression|gene expression
5696603|NCT00512538|Diabetic foot|diabetic foot
5696604|NCT00512512|transoral|transoral
5696605|NCT00512512|transluminal|transluminal
5696606|NCT00512512|endoscopic|endoscopic
5696607|NCT00512512|laparoscopic|laparoscopic
5696609|NCT00512512|biopsy|biopsy
5696610|NCT00512499|Osteoporosis|osteoporosis
5696611|NCT00512499|Fragility fractures|fragility fractures
5696612|NCT00512499|Fracture clinics|fracture clinics
5696613|NCT00512499|Orthopedic surgeons|orthopedic surgeons
5696614|NCT00512473|GH, GH receptor blockade, GH signaling, insulin resistance|gh, gh receptor blockade, gh signaling, insulin resistance
5696615|NCT00512460|Neoplastic Meningitis|neoplastic meningitis
5696616|NCT00512460|Leptomeningeal Disease|leptomeningeal disease
5696617|NCT00512460|Solid Tumor|solid tumor
5696618|NCT00512460|Lymphoma|lymphoma
5696619|NCT00512460|Leukemia|leukemia
5696620|NCT00512460|Brain Tumor|brain tumor
5696621|NCT00512460|RTA 744|rta 744
5696622|NCT00512447|Aging|aging
5696623|NCT00512434|tibial|tibial
5696624|NCT00512434|shaft|shaft
5696625|NCT00512434|fracture|fracture
5696626|NCT00512434|open|open
5696627|NCT00512434|bone-marrow|bone-marrow
5696628|NCT00512434|graft|graft
5696629|NCT00512434|injection|injection
5696630|NCT00512434|mesenchymal stem cell|mesenchymal stem cell
5696753|NCT00511992|Avastin|avastin
5696754|NCT00511992|Bevacizumab|bevacizumab
5696728|NCT00512057|cardiac syndrome X|cardiac syndrome x
5697130|NCT00510523|MS|ms
5696631|NCT00512408|To assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly CHF patients|to assess the effect of a 12 week testosterone administration on maximal exercise capacity, muscle strength and insulin resistance in elderly chf patients
5696632|NCT00512395|laparoscopic colorectal surgery|laparoscopic colorectal surgery
5696633|NCT00512395|epidural analgesia|epidural analgesia
5696634|NCT00512395|pain score|pain score
5696635|NCT00512395|postoperative ileus|postoperative ileus
5696636|NCT00512382|GER Gastrointestinal reflux|ger gastrointestinal reflux
5696637|NCT00512382|Aspiration|aspiration
5696638|NCT00512382|ASHTMA|ashtma
5696639|NCT00512382|COUGH|cough
5696640|NCT00512382|WHEEZE|wheeze
5696641|NCT00512382|PH-IMPEDANCE|ph-impedance
5696642|NCT00512382|WEEM Wheezy Monitor|weem wheezy monitor
5696643|NCT00512369|Metabolic pathways|metabolic pathways
5696644|NCT00512369|Atherosclerosis|atherosclerosis
5696645|NCT00512369|Monocyte Function|monocyte function
5696646|NCT00512343|Synovial Fluid|synovial fluid
5696647|NCT00512343|Arthritis|arthritis
5696648|NCT00512343|Paired serum/synovial fluid samples|paired serum/synovial fluid samples
5696649|NCT00512330|childhood|childhood
5696650|NCT00512330|tuberculosis|tuberculosis
5696651|NCT00512330|diagnostic|diagnostic
5696652|NCT00512330|lipoarabinomannan|lipoarabinomannan
5696653|NCT00512330|ELISA|elisa
5696654|NCT00512330|Tuberculosis in Childhood|tuberculosis in childhood
5696655|NCT00512317|partial onset epilepsy|partial onset epilepsy
5696656|NCT00512317|adult epilepsy|adult epilepsy
5696657|NCT00512317|partial seizures|partial seizures
5696658|NCT00512317|anticonvulsant|anticonvulsant
5696659|NCT00512317|catamenial epilepsy|catamenial epilepsy
5696660|NCT00512317|adult partial onset epilepsy|adult partial onset epilepsy
5696661|NCT00512291|Advanced Cancer|advanced cancer
5696662|NCT00512291|Hyperactive Delirium|hyperactive delirium
5696663|NCT00512291|Mixed Delirium|mixed delirium
5696664|NCT00512291|Olanzapine|olanzapine
5696665|NCT00512278|Hepatitis|hepatitis
5696666|NCT00512278|HCV|hcv
5696667|NCT00512278|Hepatitis C|hepatitis c
5696668|NCT00512265|n-acetylcysteine|n-acetylcysteine
5696669|NCT00512265|esophagectomy|esophagectomy
5696670|NCT00512265|inflammatory reaction|inflammatory reaction
5696671|NCT00512265|pulmonary morbidity|pulmonary morbidity
5696672|NCT00512252|Plerixafor|plerixafor
5696674|NCT00512252|Chemosensitization|chemosensitization
5696675|NCT00512239|Early Rheumatoid Arthritis|early rheumatoid arthritis
5696676|NCT00512239|Early inflammatory arthritis|early inflammatory arthritis
5696677|NCT00512239|Biomarkers|biomarkers
5696678|NCT00512239|Autoantibodies|autoantibodies
5696679|NCT00512239|Anti-Sa antibodies|anti-sa antibodies
5696680|NCT00512239|Anti-CCP antibodies|anti-ccp antibodies
5696681|NCT00512226|Sickle Cell Anemia|sickle cell anemia
5696682|NCT00512226|Sickle Cell Thalassemia|sickle cell thalassemia
5696683|NCT00512226|Iron Overload|iron overload
5696684|NCT00512226|MRI|mri
5696685|NCT00512213|preoperative Immunonutrition|preoperative immunonutrition
5696686|NCT00512213|major abdominal surgery|major abdominal surgery
5696687|NCT00512213|complication|complication
5696688|NCT00512174|Portable Ultrasound Scanner|portable ultrasound scanner
5696689|NCT00512174|Non Invasive Bladder Volume Measurement|non invasive bladder volume measurement
5696690|NCT00512174|Radical Cystectomy|radical cystectomy
5696691|NCT00512174|Bladder Reconstruction|bladder reconstruction
5696692|NCT00512161|Any patient undergoing elective cardiac surgery|any patient undergoing elective cardiac surgery
5696693|NCT00512122|early parenteral nutrition|early parenteral nutrition
5696694|NCT00512122|critical illness|critical illness
5696695|NCT00512122|respiratory failure|respiratory failure
5696696|NCT00512122|kidney failure|kidney failure
5696697|NCT00512122|hepatic failure|hepatic failure
5696698|NCT00512122|muscle strength|muscle strength
5696699|NCT00512122|rehabilitation|rehabilitation
5696700|NCT00512122|overfeeding|overfeeding
5696701|NCT00512122|Reduced Oral Intake|reduced oral intake
5696702|NCT00512109|vascular risk|vascular risk
5696703|NCT00512109|perioperative|perioperative
5696704|NCT00512109|vascular events|vascular events
5696705|NCT00512109|cohort study|cohort study
5696706|NCT00512109|surgery|surgery
5696707|NCT00512096|Genitourinary|genitourinary
5696708|NCT00512096|Penile Cancer|penile cancer
5696709|NCT00512096|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5696710|NCT00512096|Extirpative Surgery|extirpative surgery
5696711|NCT00512096|TanyN2-3M0 Squamous Cell Carcinoma of the Penis|tanyn2-3m0 squamous cell carcinoma of the penis
5696712|NCT00512096|Cisplatin|cisplatin
5696713|NCT00512096|Platinol-AQ|platinol-aq
5696714|NCT00512096|Platinol|platinol
5696715|NCT00512096|CDDP|cddp
5696716|NCT00512096|Ifosfamide|ifosfamide
5696717|NCT00512096|Ifex|ifex
5696718|NCT00512096|Paclitaxel|paclitaxel
5696719|NCT00512096|Taxol|taxol
5696720|NCT00512083|Leukemia, Myeloid + Acute Disease|leukemia, myeloid + acute disease
5696721|NCT00512070|schizophrenia|schizophrenia
5696722|NCT00512070|schizoaffective disorder|schizoaffective disorder
5696723|NCT00512070|bipolar disorder|bipolar disorder
5696724|NCT00512070|olanzapine|olanzapine
5696725|NCT00512070|melatonin|melatonin
5696726|NCT00512070|obesity|obesity
5696727|NCT00512070|metabolic syndrome|metabolic syndrome
5696729|NCT00512057|endothelial function|endothelial function
5696730|NCT00512044|anesthesia, Longo, mucosectomy, hemorrhoids|anesthesia, longo, mucosectomy, hemorrhoids
5696731|NCT00512031|atherosclerosis|atherosclerosis
5696732|NCT00512031|metabolic pathways|metabolic pathways
5696733|NCT00512031|monocyte adhesion,|monocyte adhesion,
5696734|NCT00512018|Electric Stimulation|electric stimulation
5696735|NCT00512018|Quadriceps Muscle|quadriceps muscle
5696736|NCT00512018|Muscle Strength|muscle strength
5696737|NCT00512018|Neuromuscular Properties|neuromuscular properties
5696738|NCT00512018|Tension-Length Relationship|tension-length relationship
5696739|NCT00512018|Healthy young adults|healthy young adults
5696740|NCT00512005|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
5696741|NCT00512005|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5695345|NCT00517010|Lucentis|lucentis
5696742|NCT00512005|Less invasive repair|less invasive repair
5696743|NCT00512005|Percutaneous MV repair|percutaneous mv repair
5696744|NCT00512005|Mitral Valve Repair|mitral valve repair
5696745|NCT00512005|Heart Failure|heart failure
5696746|NCT00512005|Left Ventricular Dysfunction|left ventricular dysfunction
5696747|NCT00511992|Ovarian Cancer|ovarian cancer
5696748|NCT00511992|Gynecologic Cancer|gynecologic cancer
5696749|NCT00511992|Ovarian Carcinoma|ovarian carcinoma
5696750|NCT00511992|Peritoneal Carcinoma|peritoneal carcinoma
5696751|NCT00511992|IP chemotherapy|ip chemotherapy
5696752|NCT00511992|Intraperitoneal|intraperitoneal
5696755|NCT00511979|Healthy Patients|healthy patients
5696756|NCT00511966|Gastroesophageal Reflux|gastroesophageal reflux
5696757|NCT00511966|Rabeprazole|rabeprazole
5696758|NCT00511953|Hot flashes|hot flashes
5696759|NCT00511953|Hot flushes|hot flushes
5696760|NCT00511953|Postmenopausal symptoms|postmenopausal symptoms
5696761|NCT00511927|heart|heart
5696762|NCT00511927|failure|failure
5696763|NCT00511927|growth|growth
5696764|NCT00511927|hormone|hormone
5696766|NCT00511927|dilative|dilative
5696767|NCT00511927|cardiomyopathy|cardiomyopathy
5696768|NCT00511914|Influenza vaccine|influenza vaccine
5696770|NCT00511901|function|function
5696771|NCT00511901|rehabilitation|rehabilitation
5696772|NCT00511888|chronic heart failure|chronic heart failure
5696773|NCT00511888|hypertension|hypertension
5696774|NCT00511888|beta blockers|beta blockers
5696775|NCT00511875|diabetic retinopathy|diabetic retinopathy
5696776|NCT00511875|diabetes|diabetes
5696777|NCT00511875|diabetic eye studies|diabetic eye studies
5696778|NCT00511875|neovascularization|neovascularization
5696779|NCT00511862|TheraSphere|therasphere
5696780|NCT00511862|radioactive microspheres|radioactive microspheres
5696781|NCT00511862|Yttrium-90|yttrium-90
5696782|NCT00511862|Yttrium glass microspheres|yttrium glass microspheres
5696783|NCT00511836|alcoholism|alcoholism
5696784|NCT00511836|addiction|addiction
5696785|NCT00511836|alcohol detoxification|alcohol detoxification
5696786|NCT00511823|drug-drug interaction,|drug-drug interaction,
5696787|NCT00511823|rosiglitazone,|rosiglitazone,
5696788|NCT00511823|safety|safety
5696789|NCT00511823|CYP2C8,|cyp2c8,
5696790|NCT00511823|pharmacokinetics,|pharmacokinetics,
5696791|NCT00511823|CYP3A4,|cyp3a4,
5696792|NCT00511823|granisetron,|granisetron,
5696793|NCT00511823|dolasetron,|dolasetron,
5696794|NCT00511823|CYP2D6,|cyp2d6,
5696795|NCT00511823|casopitant,|casopitant,
5696796|NCT00511810|Sadness|sadness
5696797|NCT00511810|Insomnia|insomnia
5696798|NCT00511810|Loss of appetite|loss of appetite
5696799|NCT00511810|Fatigue|fatigue
5696800|NCT00511810|Trouble thinking|trouble thinking
5696801|NCT00511797|Dysmenorrhea|dysmenorrhea
5696802|NCT00511797|Dysmenorrheal score|dysmenorrheal score
5696803|NCT00511797|Drospirenone|drospirenone
5696804|NCT00511797|DRSP|drsp
5696805|NCT00511797|Ethinylestradiol|ethinylestradiol
5696806|NCT00511784|Contraception|contraception
5696807|NCT00511784|Hormonal contraception|hormonal contraception
5696808|NCT00511784|Oral contraception|oral contraception
5696809|NCT00511784|Ethinyl estradiol, Levonorgestrel, Contraception|ethinyl estradiol, levonorgestrel, contraception
5696810|NCT00511784|Transdermal|transdermal
5696811|NCT00511784|Venous thromboembolism|venous thromboembolism
5696812|NCT00511784|Norelgestromin|norelgestromin
5696813|NCT00511771|Tegaserod, treatment IND, irritable bowel syndrome with constipation, IBS-C, chronic idiopathic constipation, CIC, chronic constipation, CC|tegaserod, treatment ind, irritable bowel syndrome with constipation, ibs-c, chronic idiopathic constipation, cic, chronic constipation, cc
5696814|NCT00511758|Cervical Dysplasia|cervical dysplasia
5696815|NCT00511758|Digital Imaging|digital imaging
5696816|NCT00511758|Colposcopy|colposcopy
5696817|NCT00511758|Cervix|cervix
5696818|NCT00511745|Interactions|interactions
5696819|NCT00511745|Adjusted doses|adjusted doses
5696820|NCT00511745|Duodenal Ulcer|duodenal ulcer
5696821|NCT00511745|Gastric Ulcer|gastric ulcer
5696822|NCT00511745|Erosive or ulcerate Gastroesophageal Reflux|erosive or ulcerate gastroesophageal reflux
5696823|NCT00511745|Rabeprazole|rabeprazole
5696824|NCT00511745|Gastroesophageal reflux|gastroesophageal reflux
5696825|NCT00511693|fragility fracture|fragility fracture
5696826|NCT00511693|management of osteoporosis|management of osteoporosis
5696827|NCT00511693|osteoporosis coordinator|osteoporosis coordinator
5697031|NCT00510874|Influenza|influenza
5696828|NCT00511693|small volume hospitals|small volume hospitals
5696829|NCT00511654|depression|depression
5696830|NCT00511654|NK1 receptor antagonists,|nk1 receptor antagonists,
5696831|NCT00511641|Ovarian Cancer|ovarian cancer
5696832|NCT00511641|Cancer Screening|cancer screening
5696833|NCT00511641|Quality of Life|quality of life
5696834|NCT00511641|Questionnaire|questionnaire
5696835|NCT00511641|Screening|screening
5696837|NCT00511628|Schizophrenia|schizophrenia
5696838|NCT00511628|Risperidone|risperidone
5696839|NCT00511628|Schizoaffective disorder|schizoaffective disorder
5696840|NCT00511628|Schizophreniform disorder|schizophreniform disorder
5696841|NCT00511628|Weight gain|weight gain
5696842|NCT00511615|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5704686|NCT00484627|HIV|hiv
5696843|NCT00511615|Loop Electrosurgical Excision Procedure|loop electrosurgical excision procedure
5696844|NCT00511615|Cervical Cancer|cervical cancer
5696845|NCT00511615|Colposcopy|colposcopy
5696846|NCT00511615|Molecular Imaging|molecular imaging
5696847|NCT00511615|LEEP|leep
5696848|NCT00511576|Advanced or Metastatic Breast Cancer|advanced or metastatic breast cancer
5696849|NCT00511576|Breast Cancer|breast cancer
5696850|NCT00511576|Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)|advanced or metastatic non-small-cell lung cancer (nsclc)
5696851|NCT00511576|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5696852|NCT00511576|Prostate Cancer|prostate cancer
5696853|NCT00511576|Gastric Cancer|gastric cancer
5696854|NCT00511576|Advanced Gastric Adenocarcinoma|advanced gastric adenocarcinoma
5696855|NCT00511576|HDAC Inhibitor|hdac inhibitor
5696856|NCT00511576|Taxotere|taxotere
5696857|NCT00511576|Docetaxel|docetaxel
5696858|NCT00511563|Cortisol,|cortisol,
5696859|NCT00511563|stress,|stress,
5696860|NCT00511563|response,|response,
5696861|NCT00511563|Irritable Bowel Syndrome,|irritable bowel syndrome,
5696862|NCT00511563|cytokine.|cytokine.
5696863|NCT00511550|peripheral blood stem cells|peripheral blood stem cells
5696865|NCT00511550|allogeneic transplantation|allogeneic transplantation
5696866|NCT00511550|Unrelated Donors for allogeneic transplantation|unrelated donors for allogeneic transplantation
5680536|NCT00577681|Treatment Experienced|treatment experienced
5696867|NCT00511537|AML|aml
5696868|NCT00511537|ALL|all
5696869|NCT00511537|CML|cml
5696870|NCT00511537|Lymphoma|lymphoma
5696871|NCT00511537|Myelodysplasia|myelodysplasia
5696872|NCT00511537|Unrelated stem cell transplantation|unrelated stem cell transplantation
5696873|NCT00511537|Hematopoietic disorders|hematopoietic disorders
5696874|NCT00511524|brain,|brain,
5696875|NCT00511524|inflammation,|inflammation,
5696876|NCT00511524|CB2,|cb2,
5696877|NCT00511524|PET|pet
5696878|NCT00511524|analgesia,|analgesia,
5696879|NCT00511511|hypertension|hypertension
5696880|NCT00511511|angiogenesis inhibitors|angiogenesis inhibitors
5696881|NCT00511511|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5696882|NCT00511511|Sunitinib|sunitinib
5696883|NCT00511498|Laparoscopic Radical Prostatectomy|laparoscopic radical prostatectomy
5696884|NCT00511498|Nightly sildenafil|nightly sildenafil
5696885|NCT00511485|Cancer|cancer
5696886|NCT00511485|Adenocarcinoma|adenocarcinoma
5696887|NCT00511485|Phase II|phase ii
5696888|NCT00511485|Lung|lung
5696889|NCT00511485|Non-small cell lung cancer|non-small cell lung cancer
5696890|NCT00511485|NSCLC|nsclc
5696891|NCT00511485|EC145|ec145
5696892|NCT00511485|EC20|ec20
5696894|NCT00511459|4-Arm|4-arm
5696895|NCT00511459|Placebo controlled|placebo controlled
5696896|NCT00511459|Phase 2 Trial|phase 2 trial
5696897|NCT00511459|AMG 386|amg 386
5696898|NCT00511459|Paclitaxel|paclitaxel
5696899|NCT00511459|Bevacizumab|bevacizumab
5696900|NCT00511459|First-line Therapy|first-line therapy
5696901|NCT00511459|Her-2 Negative|her-2 negative
5696902|NCT00511459|Metastatic or Locally Recurrent Breast Cancer|metastatic or locally recurrent breast cancer
5696903|NCT00511446|Stomach neoplasms|stomach neoplasms
5696904|NCT00511446|docetaxel|docetaxel
5696905|NCT00511446|oxaliplatin|oxaliplatin
5696906|NCT00511446|capecitabine|capecitabine
5696907|NCT00511420|cocoa|cocoa
5696908|NCT00511420|cardiovascular disease|cardiovascular disease
5696909|NCT00511420|blood pressure|blood pressure
5696910|NCT00511407|Acute renal failure|acute renal failure
5696911|NCT00511407|Bioartificial kidney|bioartificial kidney
5696912|NCT00511407|Cell therapy|cell therapy
5696913|NCT00511407|Hemofiltration|hemofiltration
5696914|NCT00511407|Septic shock|septic shock
5696915|NCT00511394|Decompensated Cirrhosis with Ascites|decompensated cirrhosis with ascites
5696916|NCT00511381|Hearing Loss|hearing loss
5696917|NCT00511381|Late-Onset Hearing Loss|late-onset hearing loss
5696918|NCT00511381|Deafness|deafness
5696920|NCT00511368|treatment experienced|treatment experienced
5696921|NCT00511368|AIDS|aids
5696922|NCT00511329|growth hormone|growth hormone
5696923|NCT00511329|short stature|short stature
5696924|NCT00511329|growth failure|growth failure
5696925|NCT00511329|chronic illness|chronic illness
5696926|NCT00511303|Philadelphia chromosome|philadelphia chromosome
5696927|NCT00511303|protein-tyrosine kinases|protein-tyrosine kinases
5697032|NCT00510874|GSK 1557484A vaccine|gsk 1557484a vaccine
5696928|NCT00511290|Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases|primary disease or condition being studied: asthma -copd-interstitial lung diseases-occupational lung diseases
5696929|NCT00511277|quetiapine|quetiapine
5696930|NCT00511277|schizophrenia|schizophrenia
5696931|NCT00511277|first-episode psychosis|first-episode psychosis
5696932|NCT00511277|depression|depression
5696933|NCT00511277|psychopathology|psychopathology
5696934|NCT00511264|Laparoscopy|laparoscopy
5696935|NCT00511264|Ultrasound|ultrasound
5696936|NCT00511264|Cancer|cancer
5696937|NCT00511264|Biopsy|biopsy
5696938|NCT00511251|IS-SEM|is-sem
5696939|NCT00511238|Onyx|onyx
5696940|NCT00511238|PR171|pr171
5696941|NCT00511238|carfilzomib|carfilzomib
5696942|NCT00511238|multiple myeloma|multiple myeloma
5696943|NCT00511238|relapsed|relapsed
5696944|NCT00511238|refractory|refractory
5696945|NCT00511225|dialysis|dialysis
5696946|NCT00511225|Vitamin D|vitamin d
5696947|NCT00511212|severe peritonitis|severe peritonitis
5696948|NCT00511212|SSI|ssi
5696949|NCT00511212|lower digestive tract surgery|lower digestive tract surgery
5696950|NCT00511212|Severe peritonitis after lower digestive tract surgery|severe peritonitis after lower digestive tract surgery
5696951|NCT00511186|Sepsis|sepsis
5696952|NCT00511186|Alkaline Phosphatase|alkaline phosphatase
5696953|NCT00511186|inflammation|inflammation
5696954|NCT00511186|infection|infection
5696955|NCT00511186|renal failure|renal failure
5696956|NCT00511173|mechanical valve|mechanical valve
5696957|NCT00511160|myocarditis|myocarditis
5696958|NCT00511160|parvovirus B19 (PVB19)|parvovirus b19 (pvb19)
5696959|NCT00511160|human herpes virus 6 (HHV6)|human herpes virus 6 (hhv6)
5696960|NCT00511160|cardiac magnetic resonance tomography (CMR)|cardiac magnetic resonance tomography (cmr)
5696961|NCT00511147|IVIG|ivig
5696962|NCT00511147|ITP|itp
5696963|NCT00511134|insomnia|insomnia
5696964|NCT00511134|nicotine dependence|nicotine dependence
5696966|NCT00511134|smoking cessation|smoking cessation
5696967|NCT00511134|zyban|zyban
5696968|NCT00511121|chronic myeloid leukemia|chronic myeloid leukemia
5696969|NCT00511121|tyrosine kinase|tyrosine kinase
5696970|NCT00511108|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5696971|NCT00511095|Hepatitis B vaccine|hepatitis b vaccine
5696972|NCT00511095|HBV vaccine|hbv vaccine
5696973|NCT00511095|Hepatitis B|hepatitis b
5696974|NCT00511095|Hepatitis|hepatitis
5696975|NCT00511095|HBV|hbv
5696976|NCT00511095|Vaccine|vaccine
5696977|NCT00511095|1018|1018
5696978|NCT00511095|HBsAg|hbsag
5696979|NCT00511069|Bortezomib|bortezomib
5696980|NCT00511069|CML033|cml033
5696981|NCT00511056|HIV|hiv
5696982|NCT00511056|Adherence|adherence
5696983|NCT00511056|Compliance|compliance
5696984|NCT00511056|Highly Active Antiretroviral Therapy (HAART)|highly active antiretroviral therapy (haart)
5696985|NCT00511056|ARV|arv
5696986|NCT00511056|ART|art
5696987|NCT00511056|Sexual Risk Behavior|sexual risk behavior
5696988|NCT00511056|Unsafe|unsafe
5696989|NCT00511056|Transmission|transmission
5696990|NCT00511043|PTK787|ptk787
5696991|NCT00511043|DLCL|dlcl
5696992|NCT00511043|Diffuse large cell lymphoma|diffuse large cell lymphoma
5696993|NCT00511030|Diabetes|diabetes
5696994|NCT00511017|Solid Tumors|solid tumors
5696995|NCT00511017|Doxercalciferol|doxercalciferol
5696996|NCT00511017|Pediatric Cancer|pediatric cancer
5696997|NCT00511017|Recurrent Pediatric Solid Tumors|recurrent pediatric solid tumors
5696999|NCT00511017|Vitamin D|vitamin d
5697000|NCT00511004|Brugia Malayi|brugia malayi
5697001|NCT00511004|Lymphatic Filariasis|lymphatic filariasis
5697002|NCT00511004|Albendazole|albendazole
5697003|NCT00511004|Diethylcarbamazine|diethylcarbamazine
5697004|NCT00510991|ASTHMA|asthma
5697005|NCT00510978|Inflammatory Bowel Disease IBD|inflammatory bowel disease ibd
5697006|NCT00510978|Ulcerative Colitis|ulcerative colitis
5697007|NCT00510978|Crohn's disease|crohn's disease
5697008|NCT00510978|Probiotics|probiotics
5697009|NCT00510978|Gastrointestinal|gastrointestinal
5697010|NCT00510965|choroidal neovascularization|choroidal neovascularization
5697011|NCT00510965|angioid streaks|angioid streaks
5697012|NCT00510965|pseudoxanthoma elasticum|pseudoxanthoma elasticum
5697013|NCT00510965|Groenblad-Strandberg-Syndrome|groenblad-strandberg-syndrome
5697014|NCT00510965|therapy|therapy
5697015|NCT00510965|ranibizumab|ranibizumab
5697016|NCT00510965|lucentis|lucentis
5697017|NCT00510965|Choroidal neovascularization in patients with PXE|choroidal neovascularization in patients with pxe
5697018|NCT00510952|diabetes|diabetes
5697019|NCT00510952|type 2|type 2
5697020|NCT00510939|Acute myeloid leukemia|acute myeloid leukemia
5697021|NCT00510939|NFkB activity and leukemia|nfkb activity and leukemia
5697022|NCT00510939|expression of NFkB|expression of nfkb
5697023|NCT00510913|Treatment efficacy|treatment efficacy
5697024|NCT00510913|Transplantation rejection|transplantation rejection
5697025|NCT00510913|Kidney transplantation|kidney transplantation
5697026|NCT00510913|Cyclosporine|cyclosporine
5697027|NCT00510913|tacrolimus|tacrolimus
5697028|NCT00510887|follicular lymphoma|follicular lymphoma
5697029|NCT00510887|Velcade|velcade
5697030|NCT00510887|VR-FND|vr-fnd
5697033|NCT00510861|male age, assisted reproduction, sperm, pregnancy outcome|male age, assisted reproduction, sperm, pregnancy outcome
5697034|NCT00510835|septic shock|septic shock
5697035|NCT00510835|resuscitation|resuscitation
5697036|NCT00510835|sepsis|sepsis
5697037|NCT00510835|cost-effectiveness|cost-effectiveness
5697038|NCT00510835|sepsis-induced organ dysfunction|sepsis-induced organ dysfunction
5697039|NCT00510835|early goal directed therapy|early goal directed therapy
5697040|NCT00510835|emergency medicine|emergency medicine
5697041|NCT00510835|critical care medicine|critical care medicine
5697042|NCT00510822|Cimicoxib|cimicoxib
5697043|NCT00510822|Cox-2 inhibitor|cox-2 inhibitor
5697044|NCT00510822|Sertraline|sertraline
5697045|NCT00510796|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
5697046|NCT00510796|Colon Cancer|colon cancer
5697047|NCT00510796|Endometrial Cancer|endometrial cancer
5685749|NCT00555022|Anticholinergic,|anticholinergic,
5685751|NCT00555022|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5697048|NCT00510796|Cancer Screening|cancer screening
5697049|NCT00510796|Interview|interview
5697050|NCT00510796|HNPCC|hnpcc
5697051|NCT00510783|tonic-clonic seizure|tonic-clonic seizure
5697052|NCT00510783|emergency department|emergency department
5697053|NCT00510783|IV levetiracetam|iv levetiracetam
5697054|NCT00510783|Keppra|keppra
5697055|NCT00510783|seizures|seizures
5697056|NCT00510783|phenytoin|phenytoin
5697057|NCT00510783|Dilantin|dilantin
5697058|NCT00510783|Grand Mal seizure|grand mal seizure
5697059|NCT00510770|CPAP|cpap
5697060|NCT00510770|Post-opreative|post-opreative
5697061|NCT00510770|ARF|arf
5697062|NCT00510770|liver transplant|liver transplant
5697063|NCT00510770|Post-operative hypoxemia in liver transplant|post-operative hypoxemia in liver transplant
5697064|NCT00510744|obesity, bariatric surgery, pancreatic secretion|obesity, bariatric surgery, pancreatic secretion
5697065|NCT00510731|Ventricular Tachycardia|ventricular tachycardia
5697066|NCT00510731|Cardiac Sudden Death|cardiac sudden death
5697067|NCT00510731|Ventricular Fibrillation|ventricular fibrillation
5697068|NCT00510731|Heart Rate Variability|heart rate variability
5697069|NCT00510718|Prostate|prostate
5697070|NCT00510718|Cancer|cancer
5697071|NCT00510718|Hormone|hormone
5697072|NCT00510718|Refractory|refractory
5697073|NCT00510718|Castration|castration
5697074|NCT00510705|adiposity|adiposity
5697075|NCT00510692|Eicosapentaenoic Acid|eicosapentaenoic acid
5697076|NCT00510692|EPA|epa
5697077|NCT00510692|EPA 99%|epa 99%
5697078|NCT00510692|Fatty acid|fatty acid
5697079|NCT00510692|omega-3|omega-3
5697080|NCT00510692|apoptosis|apoptosis
5697081|NCT00510692|cell proliferation|cell proliferation
5697082|NCT00510692|colonic mucosa|colonic mucosa
5697083|NCT00510692|polyp|polyp
5697084|NCT00510692|Familial Adenomatous Polyposis Coli|familial adenomatous polyposis coli
5697085|NCT00510692|FAP|fap
5697086|NCT00510692|resolvin|resolvin
5697087|NCT00510692|Ileo-rectal anastomosis|ileo-rectal anastomosis
5697088|NCT00510692|IRA|ira
5697089|NCT00510692|PUFA|pufa
5697090|NCT00510692|Endoscopy|endoscopy
5697091|NCT00510679|Benin|benin
5697092|NCT00510679|child health|child health
5697093|NCT00510679|developing country|developing country
5697094|NCT00510679|health services research|health services research
5697095|NCT00510679|health worker performance|health worker performance
5697096|NCT00510679|Integrated Management of Childhood Illness|integrated management of childhood illness
5697097|NCT00510666|Pain, Postoperative|pain, postoperative
5697098|NCT00510666|Analgesics, Opioid|analgesics, opioid
5697099|NCT00510666|Analgesia, Patient-Controlled|analgesia, patient-controlled
5697100|NCT00510666|Pain Measurement|pain measurement
5697102|NCT00510653|Primary Peritoneal Cancer|primary peritoneal cancer
5697103|NCT00510653|Fallopian Tube Cancer|fallopian tube cancer
5697104|NCT00510653|Recurrent Platinum-Resistant|recurrent platinum-resistant
5697105|NCT00510653|Taxane-Resistant|taxane-resistant
5697106|NCT00510653|Epithelial Ovarian Cancer|epithelial ovarian cancer
5697107|NCT00510653|Imatinib Mesylate|imatinib mesylate
5697108|NCT00510653|Gleevec|gleevec
5697109|NCT00510653|STI571|sti571
5697110|NCT00510653|Protein tyrosine kinase inhibitor|protein tyrosine kinase inhibitor
5697111|NCT00510640|thyroid carcinoma|thyroid carcinoma
5697112|NCT00510640|Sunitinib|sunitinib
5697113|NCT00510640|RECIST guidelines|recist guidelines
5697114|NCT00510627|Metastatic Liver Cancer|metastatic liver cancer
5697115|NCT00510627|Colorectal Cancer|colorectal cancer
5697116|NCT00510627|Radiofrequency Ablation|radiofrequency ablation
5697117|NCT00510627|Chemotherapy|chemotherapy
5697118|NCT00510614|Bacterial Vaginosis|bacterial vaginosis
5697119|NCT00510614|Recurrent Bacterial Vaginosis|recurrent bacterial vaginosis
5697120|NCT00510588|adiposity|adiposity
5697121|NCT00510575|Juvenile Scoliosis|juvenile scoliosis
5697122|NCT00510575|Adolescent Scoliosis|adolescent scoliosis
5697123|NCT00510575|Scoliosis Management|scoliosis management
5697124|NCT00510575|Spinal Fusion|spinal fusion
5697125|NCT00510575|Scoliosis instrumentation|scoliosis instrumentation
5697126|NCT00510575|Juvenile or Adolescent Idiopathic Scoliosis|juvenile or adolescent idiopathic scoliosis
5697127|NCT00510562|Cranial manipulation|cranial manipulation
5697128|NCT00510562|Visual function|visual function
5697129|NCT00510536|Psoriasis, arthritis, arthralgia|psoriasis, arthritis, arthralgia
5697132|NCT00510523|Multiple Sclerosis|multiple sclerosis
5697133|NCT00510510|COPD|copd
5697134|NCT00510510|glycopyrronium bromide|glycopyrronium bromide
5697135|NCT00510510|antimuscarinic|antimuscarinic
5697136|NCT00510497|dendritic cell|dendritic cell
5697137|NCT00510497|therapeutic vaccine|therapeutic vaccine
5697138|NCT00510497|HIV-1|hiv-1
5697139|NCT00510497|apoptotic cells|apoptotic cells
5697140|NCT00510497|Phase I/II|phase i/ii
5697141|NCT00510484|Pancreatic exocrine insufficiency|pancreatic exocrine insufficiency
5697142|NCT00510484|Cystic Fibrosis|cystic fibrosis
5697143|NCT00510445|Non Small Cell Lung Cancer|non small cell lung cancer
5685752|NCT00555022|Plethysmography|plethysmography
5705000|NCT00483483|HIV|hiv
5697144|NCT00510445|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
5697145|NCT00510445|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
5697146|NCT00510432|heparin|heparin
5697147|NCT00510432|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5697148|NCT00510432|HIT|hit
5697149|NCT00510432|allergy|allergy
5697150|NCT00510432|skin|skin
5697151|NCT00510432|dermatology|dermatology
5697152|NCT00510432|DTH|dth
5697153|NCT00510432|delayed-type hypersensitivity|delayed-type hypersensitivity
5697154|NCT00510432|histology|histology
5697155|NCT00510432|Patients receiving sc heparin therapy|patients receiving sc heparin therapy
5697156|NCT00510432|Age over 18 years|age over 18 years
5697157|NCT00510432|Recruitment will stop when 20 patients with skin lesions are included|recruitment will stop when 20 patients with skin lesions are included
5697158|NCT00510419|Migraine|migraine
5697159|NCT00510406|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5697160|NCT00510406|Treatment|treatment
5697161|NCT00510406|Solifenacin succinate|solifenacin succinate
5697162|NCT00510406|Tamsulosin hydrochloride|tamsulosin hydrochloride
5697163|NCT00510406|Prostatic Hyperplasia|prostatic hyperplasia
5697164|NCT00510393|Critical Limb Ischemia|critical limb ischemia
5697165|NCT00510393|CLI|cli
5697167|NCT00510393|DES|des
5697168|NCT00510393|Bare Metal Stent|bare metal stent
5697169|NCT00510393|BMS|bms
5697170|NCT00510367|Breast Cancer|breast cancer
5697171|NCT00510367|FAC|fac
5697172|NCT00510367|Doxorubicin|doxorubicin
5697173|NCT00510367|Adriamycin|adriamycin
5697174|NCT00510367|Rubex|rubex
5697175|NCT00510367|5-Fluorouracil|5-fluorouracil
5697176|NCT00510367|5-FU|5-fu
5697177|NCT00510367|Adrucil|adrucil
5697178|NCT00510367|Efudex|efudex
5697179|NCT00510367|Cyclophosphamide|cyclophosphamide
5697180|NCT00510367|Cytoxan|cytoxan
5697181|NCT00510367|Neosar|neosar
5697182|NCT00510367|Pregnancy|pregnancy
5697183|NCT00510354|Progressive GIST|progressive gist
5697184|NCT00510354|Resistance to Imatinib mesylate|resistance to imatinib mesylate
5697185|NCT00510341|Behavior Change Counseling|behavior change counseling
5697186|NCT00510341|Motivational Interviewing|motivational interviewing
5697187|NCT00510341|Chronic Care Model|chronic care model
5697188|NCT00510341|Communication|communication
5697189|NCT00510341|Residency Training|residency training
5697190|NCT00510341|Skill Assessment|skill assessment
5697191|NCT00510328|whole body vibration|whole body vibration
5697192|NCT00510328|muscle physiology|muscle physiology
5697193|NCT00510315|leukemia|leukemia
5697194|NCT00510315|survivors|survivors
5697195|NCT00510315|women|women
5697196|NCT00510315|leukemia survivors|leukemia survivors
5697197|NCT00510315|cancer or a related illness|cancer or a related illness
5697198|NCT00510315|Hodgkin's Lymphoma|hodgkin's lymphoma
5697199|NCT00510315|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5697200|NCT00510315|myelodysplastic syndrome|myelodysplastic syndrome
5697201|NCT00510315|aplastic anemia|aplastic anemia
5697202|NCT00510315|treated with total body irradiation|treated with total body irradiation
5697203|NCT00510315|followed by an allogeneic or autologous stem cell transplant|followed by an allogeneic or autologous stem cell transplant
5697204|NCT00510302|Ultraviolet Radiation|ultraviolet radiation
5697205|NCT00510302|Melanoma|melanoma
5697206|NCT00510302|Questionnaire|questionnaire
5697207|NCT00510302|Survey|survey
5697208|NCT00510302|First Degree Relative|first degree relative
5697209|NCT00510302|Interview|interview
5697210|NCT00510289|Sorafenib|sorafenib
5697211|NCT00510289|Myelodysplastic Syndromes|myelodysplastic syndromes
5697212|NCT00510289|MDS|mds
5697213|NCT00510263|Prednisolone|prednisolone
5697214|NCT00510263|Valacyclovir|valacyclovir
5697215|NCT00510250|Cervix Cancer|cervix cancer
5697216|NCT00510250|Cervical Cancer|cervical cancer
5697217|NCT00510250|Sorafenib|sorafenib
5697218|NCT00510250|Cisplatin|cisplatin
5697219|NCT00510250|Radiation|radiation
5697220|NCT00510250|Radiotherapy|radiotherapy
5697221|NCT00510250|Phase I|phase i
5697222|NCT00510250|Phase II|phase ii
5697223|NCT00510250|Carcinoma|carcinoma
5697224|NCT00510250|Cancer|cancer
5697225|NCT00510250|Cervix|cervix
5697226|NCT00510237|HIV|hiv
5697227|NCT00510237|Adolescents newly diagnosed with HIV|adolescents newly diagnosed with hiv
5697228|NCT00510198|Heart Disease|heart disease
5697229|NCT00510198|Congestive Heart Failure|congestive heart failure
5697230|NCT00510198|Thoracic Fluid Monitoring|thoracic fluid monitoring
5697231|NCT00510185|coronary artery disease|coronary artery disease
5697536|NCT00509405|sarcopenia|sarcopenia
5697232|NCT00510185|coronary angioplasty|coronary angioplasty
5697233|NCT00510185|coronary artery bypass surgery|coronary artery bypass surgery
5697234|NCT00510185|elderly|elderly
5697235|NCT00510172|Headache|headache
5697236|NCT00510172|Migraine|migraine
5697237|NCT00510172|Vasodilatation|vasodilatation
5697238|NCT00510159|Schistosoma haematobium|schistosoma haematobium
5697239|NCT00510159|Praziquantel|praziquantel
5697240|NCT00510159|Artesunate + Sulfamethoxypyrazine/pyrimethamine|artesunate + sulfamethoxypyrazine/pyrimethamine
5697241|NCT00510159|Randomized double blind placebo controlled clinical trial|randomized double blind placebo controlled clinical trial
5697242|NCT00510120|Attention Deficit and Disruptive Behavior Disorders|attention deficit and disruptive behavior disorders
5697243|NCT00510120|Conduct Disorder|conduct disorder
5697244|NCT00510120|Behavior Problems in Youth|behavior problems in youth
5697245|NCT00510120|Argumentativeness|argumentativeness
5697246|NCT00510120|Children|children
5697247|NCT00510120|Therapy|therapy
5697248|NCT00510120|Attention Deficit Disorder|attention deficit disorder
5697249|NCT00510094|Social Skills|social skills
5697250|NCT00510094|Anger Management|anger management
5697251|NCT00510094|Relational Aggression|relational aggression
5697252|NCT00510068|Phase III|phase iii
5697253|NCT00510068|Advanced Neuroendocrine Tumor in adults|advanced neuroendocrine tumor in adults
5697254|NCT00510068|RAD001|rad001
5697256|NCT00510068|everolimus|everolimus
5697257|NCT00510068|mTOr|mtor
5697258|NCT00510068|islet cell|islet cell
5697259|NCT00510068|neuroendocrine|neuroendocrine
5697260|NCT00510042|von Willebrand disease|von willebrand disease
5697261|NCT00510042|von Willebrand factor|von willebrand factor
5697262|NCT00510042|national study|national study
5697263|NCT00510042|bleeding disorder|bleeding disorder
5697264|NCT00510042|quality of life|quality of life
5697265|NCT00510016|infants|infants
5697267|NCT00510016|abstinence syndrome|abstinence syndrome
5697268|NCT00510016|methadone|methadone
5697269|NCT00510016|heroin|heroin
5697270|NCT00510003|Atopic dermatitis, children, pimecrolimus, eczema|atopic dermatitis, children, pimecrolimus, eczema
5697271|NCT00509990|Atopic dermatitis, pimecrolimus, children|atopic dermatitis, pimecrolimus, children
5697272|NCT00509951|Neuroses|neuroses
5697273|NCT00509951|Evidence-Based Treatment|evidence-based treatment
5697274|NCT00509951|Clinical Investigation|clinical investigation
5697275|NCT00509951|Young Patients|young patients
5697276|NCT00509951|Phobic Disorders|phobic disorders
5697277|NCT00509951|Fear|fear
5697278|NCT00509951|Phobias|phobias
5697279|NCT00509938|immunocompromized|immunocompromized
5697280|NCT00509938|hLF1-11|hlf1-11
5697281|NCT00509938|antimicrobial|antimicrobial
5697282|NCT00509938|peptide|peptide
5697283|NCT00509938|lactoferrin|lactoferrin
5697284|NCT00509860|Advanced Sarcomas|advanced sarcomas
5697285|NCT00509860|Irinotecan|irinotecan
5697286|NCT00509860|Camptosar|camptosar
5697287|NCT00509860|CPT-11|cpt-11
5697288|NCT00509847|S. epidermidis|s. epidermidis
5697289|NCT00509847|Staphylococcus|staphylococcus
5697290|NCT00509847|Lactoferrin|lactoferrin
5697291|NCT00509847|hLF1-11|hlf1-11
5697292|NCT00509847|Bacteraemia|bacteraemia
5697293|NCT00509834|hLF1-11|hlf1-11
5697294|NCT00509834|Candida|candida
5697295|NCT00509834|candidaemia|candidaemia
5697296|NCT00509834|lactoferrin|lactoferrin
5697297|NCT00509782|Solid Tumors|solid tumors
5697298|NCT00509782|Anti-Tumor Effects|anti-tumor effects
5697299|NCT00509782|ZIO-101|zio-101
5697301|NCT00509769|MBC|mbc
5697302|NCT00509769|Breast cancer|breast cancer
5697303|NCT00509769|HER2-positive breast cancer|her2-positive breast cancer
5697304|NCT00509769|HER2|her2
5697305|NCT00509756|healthy subjects|healthy subjects
5697306|NCT00509743|Adult volunteers|adult volunteers
5697307|NCT00509730|stress urinary incontinence|stress urinary incontinence
5697308|NCT00509730|urodynamics|urodynamics
5697309|NCT00509730|randomized clinical trial|randomized clinical trial
5697310|NCT00509730|surgery|surgery
5697311|NCT00509717|quality of health care|quality of health care
5697312|NCT00509717|prescriptions, drug|prescriptions, drug
5697313|NCT00509717|anticholesteremic agents|anticholesteremic agents
5697314|NCT00509717|community pharmacy services|community pharmacy services
5697315|NCT00509704|Sutent|sutent
5697316|NCT00509704|tumor necrosis|tumor necrosis
5697317|NCT00509704|DCE-MRI (Dynamic enhanced magnetic resonance imaging)|dce-mri (dynamic enhanced magnetic resonance imaging)
5697318|NCT00509691|infection|infection
5697319|NCT00509691|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5697320|NCT00509691|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5697321|NCT00509691|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5697322|NCT00509691|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5697323|NCT00509691|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5697324|NCT00509691|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5697325|NCT00509691|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5697326|NCT00509691|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5697327|NCT00509691|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5697328|NCT00509691|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5697329|NCT00509691|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5697330|NCT00509691|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5697331|NCT00509691|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5697332|NCT00509691|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5697333|NCT00509691|primary myelofibrosis|primary myelofibrosis
5697334|NCT00509691|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5697335|NCT00509691|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5697336|NCT00509691|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5697337|NCT00509691|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5697338|NCT00509691|disseminated neuroblastoma|disseminated neuroblastoma
5697339|NCT00509691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5697340|NCT00509691|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5697341|NCT00509691|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5697342|NCT00509691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5697343|NCT00509691|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5697344|NCT00509691|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5697345|NCT00509691|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5697346|NCT00509691|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5697347|NCT00509691|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5697348|NCT00509691|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5697349|NCT00509691|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5697350|NCT00509691|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5697351|NCT00509691|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5697352|NCT00509691|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5697353|NCT00509691|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5697354|NCT00509691|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5697355|NCT00509691|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5697356|NCT00509691|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5697357|NCT00509691|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5697358|NCT00509691|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5697359|NCT00509691|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5697360|NCT00509691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5697361|NCT00509691|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5697362|NCT00509691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5697363|NCT00509691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5691862|NCT00530270|ACS|acs
5697364|NCT00509691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5697365|NCT00509691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5697366|NCT00509691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5697367|NCT00509691|recurrent breast cancer|recurrent breast cancer
5697368|NCT00509691|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5697369|NCT00509691|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5697370|NCT00509691|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5697371|NCT00509691|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5697372|NCT00509691|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5697373|NCT00509691|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5697374|NCT00509691|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5697375|NCT00509691|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5697376|NCT00509691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5697377|NCT00509691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5697378|NCT00509691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5697379|NCT00509691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5697380|NCT00509691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5697381|NCT00509691|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5697382|NCT00509691|recurrent neuroblastoma|recurrent neuroblastoma
5697383|NCT00509691|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5697384|NCT00509691|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5697385|NCT00509691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5697386|NCT00509691|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5697387|NCT00509691|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5697388|NCT00509691|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5697389|NCT00509691|refractory hairy cell leukemia|refractory hairy cell leukemia
5697390|NCT00509691|refractory multiple myeloma|refractory multiple myeloma
5697391|NCT00509691|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5697392|NCT00509691|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5685753|NCT00555022|COPD,|copd,
5697393|NCT00509691|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5697394|NCT00509691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5697395|NCT00509691|stage I multiple myeloma|stage i multiple myeloma
5697396|NCT00509691|stage II multiple myeloma|stage ii multiple myeloma
5697397|NCT00509691|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5697398|NCT00509691|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5697399|NCT00509691|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5697400|NCT00509691|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5697401|NCT00509691|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5697402|NCT00509691|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5697403|NCT00509691|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5697404|NCT00509691|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5697405|NCT00509691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5697406|NCT00509691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5697407|NCT00509691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5697408|NCT00509691|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5697409|NCT00509691|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5697410|NCT00509691|stage III multiple myeloma|stage iii multiple myeloma
5697411|NCT00509691|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5697412|NCT00509691|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5697413|NCT00509691|stage IIIA breast cancer|stage iiia breast cancer
5697414|NCT00509691|stage IIIB breast cancer|stage iiib breast cancer
5697415|NCT00509691|stage IIIC breast cancer|stage iiic breast cancer
5697416|NCT00509691|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5697417|NCT00509691|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5697418|NCT00509691|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5697419|NCT00509691|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5697420|NCT00509691|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5697421|NCT00509691|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5697422|NCT00509691|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5697423|NCT00509691|stage IV breast cancer|stage iv breast cancer
5697424|NCT00509691|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5697425|NCT00509691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5697426|NCT00509691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5697427|NCT00509691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5697428|NCT00509691|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5697429|NCT00509691|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5697430|NCT00509691|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5697431|NCT00509691|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5697432|NCT00509691|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5697433|NCT00509691|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5697434|NCT00509691|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5697435|NCT00509691|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5697436|NCT00509691|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5697437|NCT00509691|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5697438|NCT00509691|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5697439|NCT00509691|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5697440|NCT00509691|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5697441|NCT00509691|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5697442|NCT00509691|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5697443|NCT00509691|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5697444|NCT00509691|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5697445|NCT00509678|Rituximab|rituximab
5697447|NCT00509678|Psoriatic Arthritis|psoriatic arthritis
5697448|NCT00509678|Arthritis|arthritis
5697449|NCT00509665|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5697450|NCT00509665|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5697451|NCT00509665|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5697452|NCT00509665|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5697453|NCT00509665|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5697454|NCT00509665|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5697728|NCT00508820|AMG 531|amg 531
5697455|NCT00509665|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5697456|NCT00509665|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5697457|NCT00509665|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5680535|NCT00577681|Coagulation Markers|coagulation markers
5697458|NCT00509665|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5697459|NCT00509665|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5697575|NCT00509210|Liver Disease|liver disease
5697460|NCT00509665|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5697461|NCT00509665|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5697462|NCT00509665|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5697463|NCT00509665|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5697464|NCT00509665|recurrent salivary gland cancer|recurrent salivary gland cancer
5697465|NCT00509665|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5697466|NCT00509665|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5697467|NCT00509652|Hemochromatosis|hemochromatosis
5697468|NCT00509652|Primary hemochromatosis|primary hemochromatosis
5697469|NCT00509652|Hereditary hemochromatosis|hereditary hemochromatosis
5697470|NCT00509652|Therapy|therapy
5697471|NCT00509652|Erythrocyte apheresis|erythrocyte apheresis
5697473|NCT00509652|Apheresis|apheresis
5697474|NCT00509652|Efficacy|efficacy
5697475|NCT00509626|fatigue|fatigue
5697476|NCT00509626|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5697477|NCT00509626|weight changes|weight changes
5697478|NCT00509626|depression|depression
5697479|NCT00509626|stage I breast cancer|stage i breast cancer
5697480|NCT00509626|stage II breast cancer|stage ii breast cancer
5697481|NCT00509600|Juvenile Myelomonocytic Leukemia|juvenile myelomonocytic leukemia
5697482|NCT00509600|JMML|jmml
5697483|NCT00509600|Leukemia|leukemia
5697484|NCT00509600|Etanercept|etanercept
5697485|NCT00509600|Enbrel|enbrel
5697486|NCT00509574|Single Nucleotide Polymorphism|single nucleotide polymorphism
5697487|NCT00509574|statins|statins
5697488|NCT00509574|hyperlipidemia|hyperlipidemia
5697489|NCT00509561|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5697490|NCT00509561|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5697491|NCT00509561|stage IA esophageal cancer|stage ia esophageal cancer
5697492|NCT00509561|stage IB esophageal cancer|stage ib esophageal cancer
5697493|NCT00509561|stage IIA esophageal cancer|stage iia esophageal cancer
5697494|NCT00509561|stage IIB esophageal cancer|stage iib esophageal cancer
5697495|NCT00509561|stage IIIA esophageal cancer|stage iiia esophageal cancer
5697496|NCT00509561|stage IIIB esophageal cancer|stage iiib esophageal cancer
5697497|NCT00509561|stage IIIC esophageal cancer|stage iiic esophageal cancer
5697498|NCT00509535|Vitreoscilla filiformis extract|vitreoscilla filiformis extract
5697499|NCT00509535|SCORAD|scorad
5697500|NCT00509535|pruritus|pruritus
5697501|NCT00509535|microflora|microflora
5697502|NCT00509535|TEWL|tewl
5697503|NCT00509509|Hereditary Breast Cancer (BRCA1, BRCA2)|hereditary breast cancer (brca1, brca2)
5697504|NCT00509496|Refractory|refractory
5697505|NCT00509496|Gene Therapy|gene therapy
5697506|NCT00509496|HLA-A2 Positive|hla-a2 positive
5697507|NCT00509496|Stage IV Melanoma|stage iv melanoma
5697508|NCT00509496|Melanoma|melanoma
5697509|NCT00509496|Skin Cancer|skin cancer
5697510|NCT00509496|Malignant Melanoma|malignant melanoma
5697511|NCT00509483|multinodular|multinodular
5697512|NCT00509483|goitre|goitre
5697513|NCT00509483|recombinant human TSH|recombinant human tsh
5697514|NCT00509457|NSCLC, vaccination|nsclc, vaccination
5697515|NCT00509457|Inoperable NSCLC stage IIIA/B in good performance status|inoperable nsclc stage iiia/b in good performance status
5697516|NCT00509431|adult giant cell glioblastoma|adult giant cell glioblastoma
5697517|NCT00509431|adult gliosarcoma|adult gliosarcoma
5697518|NCT00509431|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5697519|NCT00509431|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5697520|NCT00509431|adult mixed glioma|adult mixed glioma
5697521|NCT00509431|recurrent adult brain tumor|recurrent adult brain tumor
5697522|NCT00509431|adult glioblastoma|adult glioblastoma
5697523|NCT00509431|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5697524|NCT00509431|adult diffuse astrocytoma|adult diffuse astrocytoma
5697525|NCT00509431|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5697526|NCT00509431|adult oligodendroglioma|adult oligodendroglioma
5697527|NCT00509418|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5697528|NCT00509418|Nonalcoholic Fatty Liver|nonalcoholic fatty liver
5697529|NCT00509418|Nutritional supplement|nutritional supplement
5697530|NCT00509418|Diet|diet
5697531|NCT00509418|Exercise|exercise
5697532|NCT00509405|Endogenous acid production|endogenous acid production
5697533|NCT00509405|metabolic acidosis|metabolic acidosis
5697534|NCT00509405|potassium citrate|potassium citrate
5697535|NCT00509405|osteoporosis|osteoporosis
5697537|NCT00509405|hypertension|hypertension
5697538|NCT00509405|Effect of potassium citrate on bone mineral density and bone mass|effect of potassium citrate on bone mineral density and bone mass
5685754|NCT00555009|traumatic brain Injury, cognitive function|traumatic brain injury, cognitive function
5697539|NCT00509392|Varicose veins, venous reflux, GSV disease|varicose veins, venous reflux, gsv disease
5697540|NCT00509379|Relapsed/refractory indolent lymphoma|relapsed/refractory indolent lymphoma
5697541|NCT00509379|Non-follicular Lymphoma|non-follicular lymphoma
5697542|NCT00509379|Mantle cell non-Hodgkin Lymphoma|mantle cell non-hodgkin lymphoma
5697543|NCT00509379|Patients naïve or sensitive to rituximab|patients naïve or sensitive to rituximab
5697544|NCT00509379|Patients not eligible for high dose chemotherapy with ASCT|patients not eligible for high dose chemotherapy with asct
5697545|NCT00509366|genomics|genomics
5697546|NCT00509366|genomics predictor|genomics predictor
5697547|NCT00509366|genomics analysis|genomics analysis
5697548|NCT00509366|squamous|squamous
5697549|NCT00509366|non-squamous|non-squamous
5697550|NCT00509353|recurrent neuroblastoma|recurrent neuroblastoma
5697551|NCT00509340|antiretroviral|antiretroviral
5697552|NCT00509340|adherence|adherence
5697553|NCT00509340|poor antiretroviral adherence|poor antiretroviral adherence
5697554|NCT00509327|postoperative ileus|postoperative ileus
5697555|NCT00509327|colorectal surgery|colorectal surgery
5697556|NCT00509327|bisacodyl|bisacodyl
5697557|NCT00509327|laxatives|laxatives
5697558|NCT00509301|brain cancer|brain cancer
5697559|NCT00509301|Cotara|cotara
5697560|NCT00509301|radioactive isotope|radioactive isotope
5697561|NCT00509301|monoclonal antibody|monoclonal antibody
5697562|NCT00509301|radiation distribution|radiation distribution
5697563|NCT00509288|Refractory|refractory
5697564|NCT00509288|Gene Therapy|gene therapy
5697565|NCT00509288|HLA-A2 Positive|hla-a2 positive
5697566|NCT00509288|Stage IV Melanoma|stage iv melanoma
5697567|NCT00509288|Melanoma|melanoma
5697568|NCT00509288|Skin Cancer|skin cancer
5697569|NCT00509288|Malignant Melanoma|malignant melanoma
5697570|NCT00509223|Type 2 diabetes|type 2 diabetes
5697571|NCT00509223|Obstructive sleep apnea|obstructive sleep apnea
5697572|NCT00509223|Glycemic control|glycemic control
5697573|NCT00509223|Insulin resistance|insulin resistance
5697574|NCT00509223|Sleep disordered breathing|sleep disordered breathing
5697576|NCT00509197|Asthma|asthma
5697577|NCT00509197|Non-eosinophilic Asthma|non-eosinophilic asthma
5697578|NCT00509197|sputum eosinophils|sputum eosinophils
5697579|NCT00509197|Inhaled Corticosteroids|inhaled corticosteroids
5697580|NCT00509184|untreated|untreated
5697581|NCT00509171|embolism|embolism
5697582|NCT00509171|femur fracture|femur fracture
5697589|NCT00509158|efficacy|efficacy
5697590|NCT00509145|Relapsing|relapsing
5697591|NCT00509145|Remitting|remitting
5697592|NCT00509119|apoplexia|apoplexia
5697593|NCT00509119|Intracranial and intraarterial pressure curves in acute apoplectic patients|intracranial and intraarterial pressure curves in acute apoplectic patients
5697594|NCT00509106|ceftaroline|ceftaroline
5697595|NCT00509106|Community-acquired pneumonia|community-acquired pneumonia
5697597|NCT00509106|Streptococcus pneumoniae|streptococcus pneumoniae
5697598|NCT00509106|Haemophilus influenzae|haemophilus influenzae
5697599|NCT00509106|Mycoplasma pneumoniae|mycoplasma pneumoniae
5697600|NCT00509106|Chlamydophila spp|chlamydophila spp
5697601|NCT00509106|Legionella ssp|legionella ssp
5697602|NCT00509106|multi-drug resistant Streptococcus pneumoniae (MDRSP)|multi-drug resistant streptococcus pneumoniae (mdrsp)
5697603|NCT00509106|antimicrobial resistance|antimicrobial resistance
5697604|NCT00509106|pneumococci|pneumococci
5697605|NCT00509106|beta-lactam|beta-lactam
5697606|NCT00509106|ceftaroline fosamil|ceftaroline fosamil
5697607|NCT00509106|ceftriaxone|ceftriaxone
5697608|NCT00509106|antibiotic|antibiotic
5697609|NCT00509093|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5697610|NCT00509093|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5697611|NCT00509093|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5697612|NCT00509093|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5697613|NCT00509093|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5697614|NCT00509093|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5697615|NCT00509093|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5697616|NCT00509093|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5697617|NCT00509093|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5697618|NCT00509093|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5697619|NCT00509093|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5697620|NCT00509093|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5697621|NCT00509093|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5697622|NCT00509093|adult acute basophilic leukemia|adult acute basophilic leukemia
5697623|NCT00509093|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5697729|NCT00508820|Thrombopoietin|thrombopoietin
5697624|NCT00509093|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5697630|NCT00509067|Schizoaffective Disorder|schizoaffective disorder
5697631|NCT00509067|Acetylcholine|acetylcholine
5697632|NCT00509067|Nicotinic Receptors|nicotinic receptors
5697633|NCT00509067|Nicotine|nicotine
5697634|NCT00509067|Galantamine|galantamine
5697635|NCT00509067|negative symptoms|negative symptoms
5697636|NCT00509054|Parastomal hernia, wound infection, stoma care.|parastomal hernia, wound infection, stoma care.
5697637|NCT00509041|advanced malignant mesothelioma|advanced malignant mesothelioma
5697638|NCT00509041|epithelial mesothelioma|epithelial mesothelioma
5697639|NCT00509041|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5697640|NCT00509041|sarcomatous mesothelioma|sarcomatous mesothelioma
5697641|NCT00509028|Asthma|asthma
5697642|NCT00509028|Bronchial|bronchial
5697643|NCT00509015|antimalarials|antimalarials
5697644|NCT00509015|malaria transmission|malaria transmission
5697645|NCT00509015|mass drug administration|mass drug administration
5697646|NCT00509015|artemisinin-based combination therapy|artemisinin-based combination therapy
5697647|NCT00509015|primaquine|primaquine
5697648|NCT00509015|gametocytes|gametocytes
5697649|NCT00509015|QT-NASBA|qt-nasba
5697650|NCT00509002|Salivary Gland Cancer|salivary gland cancer
5697651|NCT00509002|Iressa|iressa
5697652|NCT00509002|ZD1839|zd1839
5697653|NCT00508989|Acetylcholine|acetylcholine
5697654|NCT00508989|Forearm Blood Flow|forearm blood flow
5697656|NCT00508989|L-NMMA|l-nmma
5697657|NCT00508989|Sickle Cell Anemia|sickle cell anemia
5697658|NCT00508989|Sickle Cell Disease|sickle cell disease
5697659|NCT00508976|bupivacaine|bupivacaine
5697660|NCT00508976|marcaine|marcaine
5697661|NCT00508976|lidocaine|lidocaine
5697662|NCT00508976|normal saline|normal saline
5697663|NCT00508976|narcotics|narcotics
5697664|NCT00508976|analog pain scale|analog pain scale
5697665|NCT00508976|postoperative pain|postoperative pain
5680537|NCT00577655|Pediatric, asthma, albuterol-HFA and Placebo|pediatric, asthma, albuterol-hfa and placebo
5680538|NCT00577642|aminobisphosphonates|aminobisphosphonates
5680539|NCT00577629|high risk non-hodgkins lymphoma|high risk non-hodgkins lymphoma
5680540|NCT00577629|NHL|nhl
5680541|NCT00577629|Bexxar|bexxar
5680542|NCT00577629|high dose chemotherapy|high dose chemotherapy
5680543|NCT00577616|Endovascular repair|endovascular repair
5680544|NCT00577616|Ruptured aorta-iliac aneurysms|ruptured aorta-iliac aneurysms
5680545|NCT00577616|Mortality at 30 days|mortality at 30 days
5680546|NCT00577603|stoma, hernia, mesh|stoma, hernia, mesh
5723299|NCT00419575|immunosuppression|immunosuppression
5697666|NCT00508976|preemptive|preemptive
5697667|NCT00508976|aerosolization|aerosolization
5697668|NCT00508976|streamed|streamed
5697669|NCT00508963|New World Cutaneous or Mucocutaneous Leishmaniasis|new world cutaneous or mucocutaneous leishmaniasis
5697670|NCT00508950|Vaccines|vaccines
5848044|NCT00036569|Pediatric|pediatric
5697671|NCT00508950|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5697672|NCT00508950|Adult|adult
5697673|NCT00508937|Diet|diet
5697674|NCT00508937|Protein|protein
5697675|NCT00508937|Glucose|glucose
5697676|NCT00508937|Insulin|insulin
5697677|NCT00508937|Cholesterol|cholesterol
5697678|NCT00508937|Triglycerides|triglycerides
5697679|NCT00508937|LDL subclasses|ldl subclasses
5697680|NCT00508924|Argatroban|argatroban
5697681|NCT00508924|Direct thrombin inhibitor|direct thrombin inhibitor
5697682|NCT00508924|Percutaneous coronary intervention|percutaneous coronary intervention
5697683|NCT00508924|Activated clotting time|activated clotting time
5697684|NCT00508924|PCI|pci
5697685|NCT00508924|ACT|act
5697686|NCT00508911|open-label,|open-label,
5697687|NCT00508911|oral contraceptive,|oral contraceptive,
5697688|NCT00508911|Combine Oral Contraceptives,|combine oral contraceptives,
5697689|NCT00508911|single-sequence,|single-sequence,
5697690|NCT00508911|volunteers|volunteers
5697691|NCT00508911|GW876008,|gw876008,
5697692|NCT00508911|repeat-dose,|repeat-dose,
5697693|NCT00508911|female,|female,
5697694|NCT00508911|pharmacokinetics,|pharmacokinetics,
5697695|NCT00508898|lupus nephritis|lupus nephritis
5697696|NCT00508898|proteinuria|proteinuria
5697697|NCT00508898|chronic kidney diseases|chronic kidney diseases
5697698|NCT00508898|SLE|sle
5697699|NCT00508885|hyperphosphatemia|hyperphosphatemia
5697700|NCT00508885|niacinamide|niacinamide
5697701|NCT00508885|ESRD|esrd
5697702|NCT00508885|peritoneal dialysis|peritoneal dialysis
5697703|NCT00508885|renal osteodystrophy|renal osteodystrophy
5697704|NCT00508872|Colorectal Liver Metastases|colorectal liver metastases
5697705|NCT00508872|Oxaliplatin|oxaliplatin
5697706|NCT00508872|Eloxatin|eloxatin
5697707|NCT00508872|Fluorouracil|fluorouracil
5697708|NCT00508872|Leucovorin|leucovorin
5697709|NCT00508872|Bevacizumab|bevacizumab
5697710|NCT00508872|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5697711|NCT00508872|rhuMAb-VEGF|rhumab-vegf
5697712|NCT00508872|Folfox-B|folfox-b
5697713|NCT00508872|5-FU|5-fu
5697714|NCT00508872|Avastin|avastin
5697715|NCT00508859|depression|depression
5697716|NCT00508859|adolescents|adolescents
5697717|NCT00508859|maintenance treatment|maintenance treatment
5697718|NCT00508859|antidepressant|antidepressant
5697719|NCT00508846|Hereditary Non-Polyposis Colon Cancer|hereditary non-polyposis colon cancer
5697720|NCT00508846|Gynecologic Cancers|gynecologic cancers
5697721|NCT00508846|Genetic Counseling|genetic counseling
5697722|NCT00508846|Questionnaire|questionnaire
5697723|NCT00508846|Survey|survey
5697724|NCT00508846|HNPCC|hnpcc
5697725|NCT00508833|Adjuvants|adjuvants
5697726|NCT00508833|HBsAg|hbsag
5697727|NCT00508820|Platelet|platelet
5697730|NCT00508820|blood disorder|blood disorder
5697731|NCT00508820|bleeding disorder|bleeding disorder
5697732|NCT00508820|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5697733|NCT00508820|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5697734|NCT00508820|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5697735|NCT00508820|TPO|tpo
5697736|NCT00508820|thrombopoietic protein|thrombopoietic protein
5697737|NCT00508807|Lymphoid Malignancies|lymphoid malignancies
5697738|NCT00508807|Solid Tumors|solid tumors
5697739|NCT00508807|RTA 402|rta 402
5697740|NCT00508794|Breast Cancer|breast cancer
5697741|NCT00508794|Tibetan Yoga|tibetan yoga
5697742|NCT00508794|Stretching Program|stretching program
5697743|NCT00508794|Yoga|yoga
5697744|NCT00508794|Quality of Life|quality of life
5707079|NCT00475748|trauma|trauma
5697745|NCT00508794|Questionnaire|questionnaire
5697746|NCT00508794|Survey|survey
5697747|NCT00508768|Rheumatoid Arthritis|rheumatoid arthritis
5697748|NCT00508768|Methotrexate|methotrexate
5697749|NCT00508755|cerebrovascular accident|cerebrovascular accident
5697750|NCT00508755|electrical stimulation|electrical stimulation
5697751|NCT00508755|gait training|gait training
5697752|NCT00508755|motor learning|motor learning
5697753|NCT00508742|Nasopharyngeal Colonization|nasopharyngeal colonization
5697754|NCT00508742|Streptococcus pneumoniae|streptococcus pneumoniae
5697755|NCT00508742|Healthy Infants|healthy infants
5697756|NCT00508742|Vaccines|vaccines
5697757|NCT00508742|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5697758|NCT00508716|Congestive Heart Failure|congestive heart failure
5697759|NCT00508716|Health Literacy|health literacy
5697760|NCT00508716|Health Education|health education
5697761|NCT00508716|Congestive Heart Failure (inpatients)|congestive heart failure (inpatients)
5697762|NCT00508703|Uterine Cancer|uterine cancer
5697763|NCT00508703|Cervical Cancer|cervical cancer
5697764|NCT00508703|Endometrial Cancer|endometrial cancer
5697765|NCT00508703|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5697766|NCT00508703|IMRT|imrt
5697767|NCT00508703|Computed Tomography|computed tomography
5697768|NCT00508703|CT|ct
5697769|NCT00508703|CT Scan|ct scan
5697770|NCT00508690|Antibiotic Prophylaxis|antibiotic prophylaxis
5697771|NCT00508690|Colorectal Surgery|colorectal surgery
5697772|NCT00508690|Laparoscopy|laparoscopy
5697773|NCT00508677|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5697774|NCT00508677|Mazindol|mazindol
5848045|NCT00036569|Interferon|interferon
5697775|NCT00508664|by laryngectomy operable carcinoma of the larynx and the hypopharynx|by laryngectomy operable carcinoma of the larynx and the hypopharynx
5697776|NCT00508651|parainfluenza virus, children, vaccine|parainfluenza virus, children, vaccine
5697777|NCT00508638|Heart Failure|heart failure
5697778|NCT00508612|Blood Pressure|blood pressure
5697779|NCT00508612|Systolic Blood Pressure|systolic blood pressure
5697883|NCT00508352|IMRT|imrt
5697791|NCT00508599|orthostatic response|orthostatic response
5697792|NCT00508586|Breast cancer|breast cancer
5697795|NCT00508586|Angiogenesis|angiogenesis
5697796|NCT00508586|Post-transcriptional control|post-transcriptional control
5697797|NCT00508586|Aromatase inhibitors|aromatase inhibitors
5697798|NCT00508573|Hereditary Nonpolyposis Colorectal Cancer|hereditary nonpolyposis colorectal cancer
5697799|NCT00508573|Lynch Syndrome|lynch syndrome
5697800|NCT00508573|HNPCC|hnpcc
5697801|NCT00508573|Syndrome Registry|syndrome registry
5697802|NCT00508573|Questionnaire|questionnaire
5697803|NCT00508573|Endometrial cancer|endometrial cancer
5697804|NCT00508573|Ovarian cancer|ovarian cancer
5697805|NCT00508560|Contingency management|contingency management
5697806|NCT00508560|Smoking cessation|smoking cessation
5697807|NCT00508560|Psychotic disorders|psychotic disorders
5697808|NCT00508560|Veterans|veterans
5697822|NCT00508534|pharmacokinetic study,|pharmacokinetic study,
5697823|NCT00508534|gastric pH|gastric ph
5697824|NCT00508521|cerebrovascular accident|cerebrovascular accident
5697825|NCT00508521|electrical stimulation|electrical stimulation
5697826|NCT00508521|motor learning|motor learning
5697827|NCT00508521|upper extremity rehabilitation|upper extremity rehabilitation
5697828|NCT00508508|Heart Failure|heart failure
5697829|NCT00508508|Peer Support|peer support
5697830|NCT00508508|Self Management|self management
5697831|NCT00508495|pain, postoperative|pain, postoperative
5697832|NCT00508495|replacement, total hip|replacement, total hip
5697833|NCT00508495|total hip replacement|total hip replacement
5697834|NCT00508495|arthroplasty, replacement, hip|arthroplasty, replacement, hip
5697835|NCT00508482|Acupuncture|acupuncture
5697836|NCT00508482|Functional constipation|functional constipation
5697837|NCT00508469|Intraocular pressure|intraocular pressure
5697838|NCT00508469|Open-angle glaucoma|open-angle glaucoma
5697839|NCT00508469|Ocular hypertension|ocular hypertension
5697840|NCT00508469|Adherence|adherence
5697841|NCT00508469|Compliance|compliance
5697842|NCT00508456|Glioblastoma Multiforme|glioblastoma multiforme
5697843|NCT00508456|Methionine Restriction|methionine restriction
5685755|NCT00554996|urinary tract infection|urinary tract infection
5697844|NCT00508456|Hominex-2|hominex-2
5697845|NCT00508456|Methionine Restriction Diet|methionine restriction diet
5697846|NCT00508456|Hominex-2 Amino Acid-Modified Medical Food|hominex-2 amino acid-modified medical food
5697847|NCT00508456|Temozolomide|temozolomide
5697848|NCT00508456|Temodar|temodar
5697849|NCT00508443|Stereotactic Spine Radiotherapy System|stereotactic spine radiotherapy system
5697850|NCT00508443|SSRS|ssrs
5697851|NCT00508443|CT-on-Rails|ct-on-rails
5697852|NCT00508443|Metastatic Spine Disease|metastatic spine disease
5697853|NCT00508443|Spinal Neoplasms|spinal neoplasms
5697854|NCT00508443|Radiation Therapy|radiation therapy
5697855|NCT00508443|Trilogy|trilogy
5697856|NCT00508443|Cancer|cancer
5697857|NCT00508443|Breast Cancer|breast cancer
5697858|NCT00508443|Gastrointestinal Cancer|gastrointestinal cancer
5697859|NCT00508443|Genitourinary Disease|genitourinary disease
5697860|NCT00508443|Lung Cancer|lung cancer
5697861|NCT00508443|Lymphoma|lymphoma
5697862|NCT00508443|Melanoma|melanoma
5697863|NCT00508443|Sarcoma|sarcoma
5697864|NCT00508443|Spinal Cancer|spinal cancer
5697865|NCT00508430|ASP8825|asp8825
5697866|NCT00508430|Diabetic Neuropathies|diabetic neuropathies
5697867|NCT00508430|Pain|pain
5697868|NCT00508417|Malaria Incidence|malaria incidence
5697869|NCT00508417|Anemia|anemia
5697870|NCT00508417|Clinical Malaria|clinical malaria
5697871|NCT00508378|Ovarian Cancer|ovarian cancer
5697872|NCT00508378|Quality of Life|quality of life
5697873|NCT00508378|Chemotherapy Side-Effects|chemotherapy side-effects
5697874|NCT00508378|Interview|interview
5697875|NCT00508378|Questionnaire|questionnaire
5697876|NCT00508378|Caregivers|caregivers
5697877|NCT00508365|lisinopril|lisinopril
5697878|NCT00508365|carvedilol|carvedilol
5697879|NCT00508365|hypertension|hypertension
5697880|NCT00508352|breast|breast
5697881|NCT00508352|cancer|cancer
5697882|NCT00508352|locoregional|locoregional
5697884|NCT00508352|tomotherapy|tomotherapy
5697885|NCT00508339|Soft Tissue Sarcoma|soft tissue sarcoma
5697886|NCT00508339|Limb Sparing Surgery|limb sparing surgery
5697887|NCT00508339|Toronto Extremity Salvage Score|toronto extremity salvage score
5697888|NCT00508339|Radiotherapy|radiotherapy
5697889|NCT00508339|Quality of Life|quality of life
5697890|NCT00508339|Questionnaire|questionnaire
5697891|NCT00508339|Survey|survey
5697892|NCT00508339|TESS|tess
5697893|NCT00508326|Advanced Cancer|advanced cancer
5697894|NCT00508326|Solid Tumor|solid tumor
5697895|NCT00508326|Liver Metastasis|liver metastasis
5697896|NCT00508326|Hepatic Artery Infusion|hepatic artery infusion
5697897|NCT00508326|Liver|liver
5697898|NCT00508326|Paclitaxel|paclitaxel
5697899|NCT00508326|Taxol|taxol
5697900|NCT00508313|Lung Cancer|lung cancer
5697901|NCT00508313|Healthy Control|healthy control
5697902|NCT00508313|Thermal Imaging|thermal imaging
5697903|NCT00508313|Thermal Signatures|thermal signatures
5697904|NCT00508313|Radiation Therapy|radiation therapy
5697905|NCT00508313|Chemoradiation Therapy|chemoradiation therapy
5697906|NCT00508300|laparoscopic|laparoscopic
5697907|NCT00508300|colectomy|colectomy
5697908|NCT00508300|Fast Track|fast track
5697909|NCT00508300|epidural|epidural
5697910|NCT00508274|Advanced Metastatic Breast Cancer|advanced metastatic breast cancer
5697911|NCT00508274|breast cancer|breast cancer
5697912|NCT00508274|lapatinib|lapatinib
5697913|NCT00508274|HER2+ positive|her2+ positive
5697914|NCT00508274|TYVERB|tyverb
5697915|NCT00508274|TYKERB|tykerb
5697916|NCT00508261|Meningococcal vaccine|meningococcal vaccine
5697917|NCT00508261|Immunogenicity|immunogenicity
5697918|NCT00508261|Routine infancy vaccination|routine infancy vaccination
5697919|NCT00508261|Safety|safety
5697920|NCT00508248|omega 3fatty acids|omega 3fatty acids
5697921|NCT00508235|Neurofibromatosis|neurofibromatosis
5697922|NCT00508235|Quality of Friendships|quality of friendships
5697923|NCT00508235|Disease Severity|disease severity
5697924|NCT00508235|Questionnaire|questionnaire
5697925|NCT00508235|NF-1|nf-1
5697926|NCT00508222|HIV|hiv
5697927|NCT00508222|HCV|hcv
5697928|NCT00508222|HIV/HCV Co-infection|hiv/hcv co-infection
5697929|NCT00508222|Kaletra Monotherapy|kaletra monotherapy
5697930|NCT00508222|Treatment Experienced|treatment experienced
5697931|NCT00508209|high-dose melphalan|high-dose melphalan
5697932|NCT00508209|bortezomib|bortezomib
5697933|NCT00508209|response|response
5697934|NCT00508209|toxicity|toxicity
5697935|NCT00508209|relapse|relapse
5697936|NCT00508196|right ventricular pacing|right ventricular pacing
5697937|NCT00508196|endothelial function|endothelial function
5697938|NCT00508196|cardiac output|cardiac output
5697939|NCT00508183|full thickness rotator cuff tear|full thickness rotator cuff tear
5697940|NCT00508170|Head and Neck Cancer|head and neck cancer
5697941|NCT00508170|Human Papillomavirus Infection|human papillomavirus infection
5697942|NCT00508170|Oropharyngeal Patients|oropharyngeal patients
5697943|NCT00508170|Sexual Behavior|sexual behavior
5697944|NCT00508170|Questionnaire|questionnaire
5697945|NCT00508144|Non-Small Cell Lung Cancer|non-small cell lung cancer
5697946|NCT00508144|Lung Cancer|lung cancer
5685756|NCT00554996|urinary catheter|urinary catheter
5705768|NCT00480519|meatotomy|meatotomy
5697947|NCT00508144|NSCLC|nsclc
5697948|NCT00508144|Malignant pleural effusion|malignant pleural effusion
5697949|NCT00508144|Pericardial effusion|pericardial effusion
5697950|NCT00508144|Pemetrexed|pemetrexed
5697951|NCT00508144|Alimta|alimta
5697952|NCT00508144|LY231514|ly231514
5697953|NCT00508144|Poor Performance Status|poor performance status
5697954|NCT00508144|Asymptomatic Brain Metastases|asymptomatic brain metastases
5697955|NCT00508131|Milk fortification|milk fortification
5697956|NCT00508131|Effectivness evaluation|effectivness evaluation
5697957|NCT00508131|Iron deficiency anemia|iron deficiency anemia
5697958|NCT00508131|Stunting|stunting
5697959|NCT00508131|Zinc deficiency|zinc deficiency
5697960|NCT00508118|Aortic Arch Reconstruction Surgery|aortic arch reconstruction surgery
5697961|NCT00508105|Osteoarthritis|osteoarthritis
5697962|NCT00508105|Shoulder|shoulder
5697963|NCT00508105|tenotomy|tenotomy
5697964|NCT00508105|ostotomy|ostotomy
5697965|NCT00508092|appendicectomy|appendicectomy
5697966|NCT00508092|pain|pain
5697967|NCT00508092|local anaesthetic|local anaesthetic
5697968|NCT00508092|nerve block|nerve block
5697969|NCT00508092|Post operative pain following appendicectomy|post operative pain following appendicectomy
5697970|NCT00508079|Venous Disease|venous disease
5697971|NCT00508079|Varicose Veins|varicose veins
5697972|NCT00508079|Chronic Venous Insufficiency|chronic venous insufficiency
5697973|NCT00508079|PAD|pad
5697974|NCT00508066|Congenital Scoliosis|congenital scoliosis
5697975|NCT00508066|Idiopathic Scoliosis|idiopathic scoliosis
5697976|NCT00508066|Spinal Fusion|spinal fusion
5697977|NCT00508066|Post-Operative Pain Management|post-operative pain management
5697978|NCT00508066|Infusion Catheter|infusion catheter
5697979|NCT00508053|wound infection|wound infection
5697980|NCT00508053|incisional hernia|incisional hernia
5697981|NCT00508053|wound dehiscence|wound dehiscence
5697982|NCT00508053|wound healing|wound healing
5697983|NCT00508053|postoperative complications|postoperative complications
5697984|NCT00508053|surgical techniques|surgical techniques
5700145|NCT00500708|DISCERN|discern
5697985|NCT00508040|Birdshot Retine choroidopathy|birdshot retine choroidopathy
5697986|NCT00508040|Macular edema|macular edema
5697987|NCT00508040|Prednisone|prednisone
5697988|NCT00508040|Interferon alpha 2a|interferon alpha 2a
5697989|NCT00508040|Associated with Cystoid macular edema|associated with cystoid macular edema
5697990|NCT00508040|With Visual acuity loss|with visual acuity loss
5697991|NCT00508027|sickle cell disease|sickle cell disease
5697992|NCT00508027|simvastatin|simvastatin
5697993|NCT00508027|statin drugs|statin drugs
5697994|NCT00508027|nitric oxide donors|nitric oxide donors
5697995|NCT00508027|vascular injury|vascular injury
5697996|NCT00508014|Cardiovascular disease|cardiovascular disease
5697997|NCT00508014|Diabetes|diabetes
5697998|NCT00508014|Quality improvement|quality improvement
5697999|NCT00508014|Peer review|peer review
5698000|NCT00508001|Hepatocellular carcinoma|hepatocellular carcinoma
5698001|NCT00508001|Advanced solid, malignant tumour|advanced solid, malignant tumour
5698002|NCT00507988|Cognitive Training|cognitive training
5698003|NCT00507988|Complex Problem Solving|complex problem solving
5698004|NCT00507988|Goal Management|goal management
5698005|NCT00507988|Planning|planning
5698006|NCT00507975|Smoking|smoking
5698008|NCT00507975|newborn|newborn
5698009|NCT00507975|birth weight|birth weight
5698010|NCT00507975|nicotine patch|nicotine patch
5698011|NCT00507975|birth|birth
5698012|NCT00507962|Advanced Cancer|advanced cancer
5698013|NCT00507962|Dominant Liver Involvement|dominant liver involvement
5698014|NCT00507962|Hepatic Intraarterial Cisplatin|hepatic intraarterial cisplatin
5698015|NCT00507962|Cisplatin|cisplatin
5698016|NCT00507962|Liposomal Doxorubicin|liposomal doxorubicin
5698017|NCT00507962|Platinol-AQ|platinol-aq
5698018|NCT00507962|Platinol|platinol
5698019|NCT00507962|CDDP|cddp
5698020|NCT00507962|Doxil|doxil
5698021|NCT00507962|Liposomal|liposomal
5698022|NCT00507962|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5698023|NCT00507949|COPD|copd
5698024|NCT00507949|body weight|body weight
5698025|NCT00507949|megestrol acetate|megestrol acetate
5698026|NCT00507949|cytokines|cytokines
5698027|NCT00507936|Diabetic Neuropathy|diabetic neuropathy
5698028|NCT00507936|Painful|painful
5698029|NCT00507936|Diabetic Polyneuropathy|diabetic polyneuropathy
5698030|NCT00507936|Neuralgia|neuralgia
5698031|NCT00507936|Diabetic|diabetic
5698032|NCT00507936|Diabetic Neuropathies|diabetic neuropathies
5698033|NCT00507936|Diabetic Neuralgia|diabetic neuralgia
5698034|NCT00507923|Breast Cancer|breast cancer
5698035|NCT00507923|Tibetan Yoga|tibetan yoga
5698036|NCT00507923|Stretching|stretching
5698037|NCT00507923|Yoga|yoga
5698038|NCT00507923|Fatigue|fatigue
5698039|NCT00507923|Sleep|sleep
5698040|NCT00507923|Questionnaire|questionnaire
5698041|NCT00507923|Survey|survey
5698042|NCT00507910|ankle fracture|ankle fracture
5698043|NCT00507910|pes planus|pes planus
5698044|NCT00507897|thyroid nodules, blood pressure, thyroid hormones|thyroid nodules, blood pressure, thyroid hormones
5696673|NCT00512252|CXCR4|cxcr4
5698045|NCT00507884|Kidney Neoplasms|kidney neoplasms
5698046|NCT00507884|Renal Tumors|renal tumors
5698047|NCT00507884|Magnetic Resonance Imaging|magnetic resonance imaging
5698048|NCT00507884|3 Tesla MRI|3 tesla mri
5698049|NCT00507884|MRI|mri
5698050|NCT00507871|cryptosporidiosis, Cryptosporidium, Uganda, diarrhea|cryptosporidiosis, cryptosporidium, uganda, diarrhea
5698051|NCT00507858|Head and Neck Cancer|head and neck cancer
5698052|NCT00507858|Squamous Cell Cancer|squamous cell cancer
5698053|NCT00507858|Alimta|alimta
5698054|NCT00507858|Pemetrexed|pemetrexed
5698055|NCT00507858|Dexamethasone|dexamethasone
5698056|NCT00507858|HNSCC|hnscc
5698057|NCT00507858|Decadron|decadron
5698058|NCT00507832|Prurigo nodularis|prurigo nodularis
5698059|NCT00507819|Other Single Ventricle Anatomy|other single ventricle anatomy
5698060|NCT00507819|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5698061|NCT00507819|Tricuspid Atresia|tricuspid atresia
5698062|NCT00507806|Acute Ischemic Stroke|acute ischemic stroke
5698063|NCT00507806|Microbubbles|microbubbles
5698064|NCT00507806|Transcranial Doppler ultrasound|transcranial doppler ultrasound
5698065|NCT00507806|TIBI|tibi
5698066|NCT00507806|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
5698067|NCT00507806|modified Rankin Scale|modified rankin scale
5698068|NCT00507806|Recanalization|recanalization
5698069|NCT00507806|Perflutren|perflutren
5698070|NCT00507780|GnRH Antagonist|gnrh antagonist
5698071|NCT00507780|Premature Ovarian Failure|premature ovarian failure
5698072|NCT00507780|Fertility|fertility
5698073|NCT00507780|Chemotherapy|chemotherapy
5698075|NCT00507754|Advanced Cancer|advanced cancer
5698076|NCT00507754|Solid Tumors|solid tumors
5698077|NCT00507754|Latent Mycobacterium Tuberculosis|latent mycobacterium tuberculosis
5698078|NCT00507754|Tuberculin Skin Test|tuberculin skin test
5698079|NCT00507754|Tuberculosis|tuberculosis
5698080|NCT00507754|T-SPOT TB test|t-spot tb test
5698081|NCT00507754|TB|tb
5698082|NCT00507741|Cancer|cancer
5698083|NCT00507741|Ovarian|ovarian
5698084|NCT00507741|Endometrial|endometrial
5698085|NCT00507741|Phase II|phase ii
5698086|NCT00507741|EC145|ec145
5698087|NCT00507741|EC20|ec20
5698088|NCT00507728|Pharmacogenetics|pharmacogenetics
5698089|NCT00507728|Emotional Reactivity|emotional reactivity
5698090|NCT00507728|Smoking Cessation Counseling|smoking cessation counseling
5698091|NCT00507728|Smoking|smoking
5698092|NCT00507728|Bupropion|bupropion
5698093|NCT00507728|Wellbutrin|wellbutrin
5698094|NCT00507728|Wellbutrin SR|wellbutrin sr
5698095|NCT00507728|Zyban|zyban
5698096|NCT00507728|Varenicline|varenicline
5698097|NCT00507728|Chantix|chantix
5698098|NCT00507728|Placebo|placebo
5698099|NCT00507715|Parkinson's Disease, Idiopathic|parkinson's disease, idiopathic
5698100|NCT00507715|l-dopa levels|l-dopa levels
5698101|NCT00507715|plantago ovata husk|plantago ovata husk
5698102|NCT00507689|Truvada|truvada
5698103|NCT00507689|HBIg|hbig
5698104|NCT00507689|Chronic Hepatitis B Recurrence|chronic hepatitis b recurrence
5698105|NCT00507689|Post Orthotopic Liver Transplant|post orthotopic liver transplant
5698107|NCT00507676|Wheezing|wheezing
5698108|NCT00507676|Infant|infant
5698109|NCT00507663|beta blocker|beta blocker
5698110|NCT00507663|functional recovery|functional recovery
5698111|NCT00507650|Pressure ulcers|pressure ulcers
5698112|NCT00507650|Geriatrics|geriatrics
5698114|NCT00507650|Fluid balance|fluid balance
5698115|NCT00507650|Collagen deposition|collagen deposition
5698116|NCT00507611|breast|breast
5698117|NCT00507611|sentinel lymph node|sentinel lymph node
5698118|NCT00507611|node mapping|node mapping
5698119|NCT00507598|colorectal cancer|colorectal cancer
5698120|NCT00507598|metabolomics|metabolomics
5698121|NCT00507585|Liver Cancer|liver cancer
5698122|NCT00507585|Liver metastases|liver metastases
5698123|NCT00507585|Metastatic advanced solid tumors|metastatic advanced solid tumors
5698124|NCT00507585|Advanced solid tumors metastatic to the liver|advanced solid tumors metastatic to the liver
5698125|NCT00507585|Hepatic Arterial Infusion|hepatic arterial infusion
5698126|NCT00507585|Intra-arterial hepatic oxaliplatin|intra-arterial hepatic oxaliplatin
5698127|NCT00507585|Fluorouracil|fluorouracil
5698128|NCT00507585|5-FU|5-fu
5698129|NCT00507585|Adrucil|adrucil
5698130|NCT00507585|Efudex|efudex
5698131|NCT00507585|5-fluorouracil|5-fluorouracil
5698132|NCT00507585|Avastin|avastin
5698133|NCT00507585|Leucovorin|leucovorin
5698134|NCT00507585|Oxaliplatin|oxaliplatin
5698135|NCT00507585|Bevacizumab|bevacizumab
5698136|NCT00507572|Solid Tumors|solid tumors
5698137|NCT00507572|Pregnancy|pregnancy
5698138|NCT00507572|Data Collection|data collection
5698139|NCT00507546|sleep|sleep
5698140|NCT00507546|melatonin|melatonin
5698141|NCT00507546|spinal cord injury|spinal cord injury
5698142|NCT00507546|insomnia|insomnia
5698143|NCT00507546|tetraplegia|tetraplegia
5698144|NCT00507533|CPAP|cpap
5698145|NCT00507533|Hematologic|hematologic
5698146|NCT00507533|Neutropenic|neutropenic
5698147|NCT00507533|ARF|arf
5698148|NCT00507520|RCT|rct
5698149|NCT00507520|Almonds|almonds
5698150|NCT00507520|Hyperlipidemia|hyperlipidemia
5706005|NCT00479687|HA|ha
5698151|NCT00507520|Blood Lipids|blood lipids
5698152|NCT00507507|tenofovir|tenofovir
5698153|NCT00507507|monotherapy|monotherapy
5698154|NCT00507507|emtricitabine|emtricitabine
5698155|NCT00507507|combination|combination
5698156|NCT00507507|hepatitis B|hepatitis b
5698157|NCT00507494|posttransplant diabetes mellitus|posttransplant diabetes mellitus
5698158|NCT00507494|kidney transplantation|kidney transplantation
5698159|NCT00507494|filtration fraction|filtration fraction
5698160|NCT00507494|proteinuria|proteinuria
5698164|NCT00507481|Post surgical ventilated patients|post surgical ventilated patients
5698165|NCT00507481|ICU patients|icu patients
5698166|NCT00507468|bone marrow|bone marrow
5698167|NCT00507468|autologous|autologous
5698168|NCT00507468|ejection fraction|ejection fraction
5698169|NCT00507468|left ventricle|left ventricle
5698170|NCT00507468|heart attack|heart attack
5698171|NCT00507468|myocardial infarction|myocardial infarction
5698172|NCT00507468|left ventricular dysfunction post myocardial infarction|left ventricular dysfunction post myocardial infarction
5698173|NCT00507455|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5698174|NCT00507455|Bladder Outlet Obstruction|bladder outlet obstruction
5698175|NCT00507455|Treatment|treatment
5698176|NCT00507455|Solifenacin Succinate|solifenacin succinate
5698177|NCT00507455|Tamsulosin hydrochloride|tamsulosin hydrochloride
5698178|NCT00507442|Treatment for patients with multiple myeloma|treatment for patients with multiple myeloma
5698179|NCT00507442|who have received no prior treatment|who have received no prior treatment
5698180|NCT00507429|thyroid neoplasms|thyroid neoplasms
5698181|NCT00507429|thyroid cancer|thyroid cancer
5698182|NCT00507429|thyroid carcinoma|thyroid carcinoma
5698183|NCT00507390|fish oils|fish oils
5698184|NCT00507377|Esophageal Benign Disease|esophageal benign disease
5698185|NCT00507377|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5698186|NCT00507377|Hiatal Hernia|hiatal hernia
5698187|NCT00507377|Antireflux Surgery|antireflux surgery
5698188|NCT00507377|Short Esophagus|short esophagus
5698189|NCT00507351|Breast Cancer|breast cancer
5702437|NCT00493376|comet assay|comet assay
5698190|NCT00507351|Colorectal Cancer|colorectal cancer
5698191|NCT00507351|Lung Cancer|lung cancer
5698192|NCT00507351|Prostate Cancer|prostate cancer
5698193|NCT00507351|Pain Management|pain management
5698194|NCT00507351|Questionnaire|questionnaire
5698195|NCT00507351|Survey|survey
5698196|NCT00507338|percutaneous coronary intervention|percutaneous coronary intervention
5698197|NCT00507325|Malignant Melanoma|malignant melanoma
5698198|NCT00507325|Blood Sample|blood sample
5698199|NCT00507325|Tumor Sample|tumor sample
5698200|NCT00507325|Long-term storage|long-term storage
5698201|NCT00507325|Sample Collection|sample collection
5698202|NCT00507312|To assess two new diagnostic devices for detecting early Heart Failure.|to assess two new diagnostic devices for detecting early heart failure.
5698203|NCT00507299|Child maltreatment|child maltreatment
5698204|NCT00507299|Physician education|physician education
5698205|NCT00507299|Prevention|prevention
5698206|NCT00507273|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5698207|NCT00507273|Gastrointestinal Cancer|gastrointestinal cancer
5698208|NCT00507273|GISTs|gists
5698209|NCT00507273|GIST Registry|gist registry
5698210|NCT00507273|Registry|registry
5698211|NCT00507260|Leukemia|leukemia
5698212|NCT00507260|Lymphoma|lymphoma
5692742|NCT00526786|ICE|ice
5698213|NCT00507260|Post-Allogeneic Blood and Marrow Transplantation|post-allogeneic blood and marrow transplantation
5698214|NCT00507260|Blood and Marrow Transplantation|blood and marrow transplantation
5698216|NCT00507260|Cancer-Related Fatigue|cancer-related fatigue
5698217|NCT00507260|Fatigue|fatigue
5698218|NCT00507260|Nutritional Assessment|nutritional assessment
5698219|NCT00507260|Nutritional Intervention|nutritional intervention
5698220|NCT00507260|Malnutrition|malnutrition
5698221|NCT00507247|Catheter-Related Infection|catheter-related infection
5698222|NCT00507247|Bloodstream Infections|bloodstream infections
5698223|NCT00507247|Staphylococcus Aureus|staphylococcus aureus
5698224|NCT00507247|Daptomycin|daptomycin
5698225|NCT00507234|COPD|copd
5698226|NCT00507221|HIV|hiv
5698227|NCT00507221|Helminthiasis|helminthiasis
5698228|NCT00507221|Co-infection|co-infection
5698229|NCT00507221|Treatment Naive|treatment naive
5698230|NCT00507208|trismus|trismus
5698231|NCT00507208|head and neck cancer|head and neck cancer
5698232|NCT00507195|Postanethesia cognitive recovery|postanethesia cognitive recovery
5698233|NCT00507195|Postoperative delirium|postoperative delirium
5698234|NCT00507195|hypnotics|hypnotics
5698235|NCT00507195|propofol|propofol
5698236|NCT00507195|sevoflurane|sevoflurane
5698237|NCT00507195|desflurane|desflurane
5698238|NCT00507195|postoperative cognitive recovery|postoperative cognitive recovery
5698239|NCT00507182|Oral Mucosa Lesions|oral mucosa lesions
5698240|NCT00507182|Oral Cancer|oral cancer
5698241|NCT00507182|Neoplasia and Dysplasia in oral cavity mucosa|neoplasia and dysplasia in oral cavity mucosa
5698242|NCT00507182|Fluorescence Spectroscopy|fluorescence spectroscopy
5698243|NCT00507182|Reflectance Spectroscopy|reflectance spectroscopy
5698244|NCT00507182|Pre-cancerous lesions|pre-cancerous lesions
5698245|NCT00507182|Cancerous lesions|cancerous lesions
5685757|NCT00554996|Escherichia coli|escherichia coli
5685758|NCT00554996|biofilm|biofilm
5698246|NCT00507182|Mouth|mouth
5698247|NCT00507143|Colorectal neoplasms|colorectal neoplasms
5698248|NCT00507143|Secondary|secondary
5698249|NCT00507143|irinotecan|irinotecan
5698250|NCT00507143|Pharmacokinetics|pharmacokinetics
5698251|NCT00507143|Pharmacodynamics|pharmacodynamics
5698252|NCT00507143|SLCO1B1|slco1b1
5698253|NCT00507143|PXR|pxr
5698254|NCT00507117|Obstructive Sleep Apnea|obstructive sleep apnea
5698255|NCT00507117|Polysomnography|polysomnography
5698256|NCT00507117|Non-benzodiazepine hypnotics|non-benzodiazepine hypnotics
5698257|NCT00507104|traumatic brain injury|traumatic brain injury
5698258|NCT00507104|Subarachnoid Hemorrhage|subarachnoid hemorrhage
5698259|NCT00507104|Hypopituitarism|hypopituitarism
5698260|NCT00507091|ZD6474|zd6474
5698261|NCT00507091|Irinotecan|irinotecan
5698262|NCT00507091|5-Fluorouracil|5-fluorouracil
5698263|NCT00507091|Leucovorin|leucovorin
5698264|NCT00507091|colorectal|colorectal
5698265|NCT00507078|Obstructive Sleep Apnea|obstructive sleep apnea
5698266|NCT00507078|Leptin|leptin
5698267|NCT00507078|Homocysteine|homocysteine
5698268|NCT00507078|C-reactive Protein|c-reactive protein
5698269|NCT00507052|Hemodialysis|hemodialysis
5698270|NCT00507052|Residual Renal Function|residual renal function
5698271|NCT00507039|PD20 FEV1|pd20 fev1
5698272|NCT00507039|grass pollen|grass pollen
5698273|NCT00507039|one-step|one-step
5698274|NCT00507013|vascular closure device|vascular closure device
5698275|NCT00506974|sleep|sleep
5698276|NCT00506974|normal sleepers|normal sleepers
5698277|NCT00506948|Hematological Malignancies|hematological malignancies
5698278|NCT00506948|Myelodysplastic Syndrome|myelodysplastic syndrome
5698279|NCT00506948|Graft Versus Host Disease|graft versus host disease
5698280|NCT00506948|GVHD|gvhd
5698281|NCT00506948|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5698282|NCT00506948|AHSCT|ahsct
5698283|NCT00506948|Leukemia|leukemia
5698284|NCT00506948|Lymphoma|lymphoma
5698285|NCT00506948|T-Cells|t-cells
5698286|NCT00506948|Thymoglobulin|thymoglobulin
5698287|NCT00506948|ATG|atg
5698288|NCT00506948|rATG|ratg
5702940|NCT00491400|obesity|obesity
5698289|NCT00506948|Rabbit Antithymocyte Globulin|rabbit antithymocyte globulin
5698290|NCT00506948|Rapamune|rapamune
5698291|NCT00506948|Sirolimus|sirolimus
5698292|NCT00506948|Mycophenolate Mofetil|mycophenolate mofetil
5698293|NCT00506948|Cellcept|cellcept
5698294|NCT00506948|MMF|mmf
5688235|NCT00544154|CDP870|cdp870
5698295|NCT00506935|methamphetamine|methamphetamine
5698296|NCT00506935|GVG|gvg
5698297|NCT00506935|vigabatrin|vigabatrin
5698298|NCT00506935|stimulant|stimulant
5698299|NCT00506922|Graft-Versus-Host Disease|graft-versus-host disease
5698300|NCT00506922|GVHD Prevention|gvhd prevention
5698301|NCT00506922|Hodgkin's Disease|hodgkin's disease
5698302|NCT00506922|Leukemia|leukemia
5698303|NCT00506922|Lymphoma|lymphoma
5698304|NCT00506922|Methotrexate|methotrexate
5698305|NCT00506922|Tacrolimus|tacrolimus
5698306|NCT00506922|Pentostatin|pentostatin
5698307|NCT00506909|oxytocin|oxytocin
5698308|NCT00506896|Rheumatoid Arthritis|rheumatoid arthritis
5698309|NCT00506896|glucocorticoid|glucocorticoid
5698310|NCT00506896|intraarticular injection|intraarticular injection
5698311|NCT00506896|arthritis|arthritis
5698312|NCT00506870|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5698313|NCT00506870|INR self monitoring|inr self monitoring
5698314|NCT00506870|cost benefit evaluation|cost benefit evaluation
5698315|NCT00506857|Hematologic Malignancies|hematologic malignancies
5698316|NCT00506857|Blood And Marrow Transplantation|blood and marrow transplantation
5698317|NCT00506857|Leukemia|leukemia
5698318|NCT00506857|MDS|mds
5698319|NCT00506857|Lymphoma|lymphoma
5698320|NCT00506857|Myeloma|myeloma
5698321|NCT00506857|Fludarabine|fludarabine
5698322|NCT00506857|Fludara|fludara
5698323|NCT00506857|Fludarabine Phosphate|fludarabine phosphate
5698324|NCT00506857|Busulfan|busulfan
5698325|NCT00506857|Busulfex|busulfex
5698326|NCT00506857|Myleran|myleran
5698327|NCT00506857|Progenitor Cell Transplantation|progenitor cell transplantation
5698328|NCT00506857|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
5698329|NCT00506857|G-CSF|g-csf
5698330|NCT00506857|Apheresis|apheresis
5698331|NCT00506857|Blood cell infusion|blood cell infusion
5698332|NCT00506844|Rectal neoplasms|rectal neoplasms
5698333|NCT00506844|Neoadjuvant treatment|neoadjuvant treatment
5698334|NCT00506844|Cetuximab|cetuximab
5698335|NCT00506844|Irinotecan|irinotecan
5698336|NCT00506844|Capecitabine|capecitabine
5698337|NCT00506844|Radiotherapy|radiotherapy
5698338|NCT00506844|Combination chemotherapy|combination chemotherapy
5698339|NCT00506818|emotional symptoms|emotional symptoms
5698340|NCT00506818|vascular risk-factors|vascular risk-factors
5698341|NCT00506805|solid tumor malignancy; Hsp90|solid tumor malignancy; hsp90
5698342|NCT00506792|Cystic fibrosis, QAU145, nasal potential difference|cystic fibrosis, qau145, nasal potential difference
5706266|NCT00478621|HPV|hpv
5698343|NCT00506779|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5698344|NCT00506779|Uterine Cancer|uterine cancer
5698345|NCT00506779|UPSC|upsc
5698346|NCT00506779|Taxol|taxol
5698347|NCT00506779|Paclitaxel|paclitaxel
5698348|NCT00506779|Gleevec|gleevec
5698349|NCT00506779|Imatinib Mesylate|imatinib mesylate
5698350|NCT00506779|STI571|sti571
5698351|NCT00506766|Urinary Incontinence|urinary incontinence
5698352|NCT00506766|Self efficacy|self efficacy
5698353|NCT00506766|Pelvic floor muscle training|pelvic floor muscle training
5698354|NCT00506766|Bladder training|bladder training
5698355|NCT00506753|substance abuse|substance abuse
5698356|NCT00506714|Osteoarthritis|osteoarthritis
5698357|NCT00506714|Walking Sticks|walking sticks
5698358|NCT00506714|Canes|canes
5698359|NCT00506675|Amblyopia|amblyopia
5698360|NCT00506675|Atropine|atropine
5698367|NCT00506623|Rectal neoplasm|rectal neoplasm
5698368|NCT00506623|Neoadjuvant therapy|neoadjuvant therapy
5698369|NCT00506623|Radiotherapy|radiotherapy
5698370|NCT00506623|Combination chemotherapy|combination chemotherapy
5698371|NCT00506623|Irinotecan|irinotecan
5698372|NCT00506623|Capecitabine|capecitabine
5698373|NCT00506610|Pain|pain
5698374|NCT00506610|Postherpetic Neuralgia|postherpetic neuralgia
5698375|NCT00506610|Neuralgia, Postherpetic|neuralgia, postherpetic
5698376|NCT00506610|Shingles|shingles
5698377|NCT00506610|Herpes Zoster|herpes zoster
5698378|NCT00506610|Neuropathic Pain|neuropathic pain
5698379|NCT00506597|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5698380|NCT00506597|Leukemia|leukemia
5698381|NCT00506597|Erwinia L-Asparaginase|erwinia l-asparaginase
5698382|NCT00506597|Erwinase|erwinase
5698383|NCT00506584|Human milk nutritional intervention|human milk nutritional intervention
5698384|NCT00506584|Pre-term, very low birth weight|pre-term, very low birth weight
5698385|NCT00506584|Fortification of human breast milk|fortification of human breast milk
5698386|NCT00506571|colorectal neoplasms|colorectal neoplasms
5698387|NCT00506571|secondary|secondary
5698388|NCT00506571|Combination chemotherapy|combination chemotherapy
5698390|NCT00506571|irinotecan|irinotecan
5698391|NCT00506571|oxaliplatin|oxaliplatin
5698392|NCT00506558|cervical spondylotic myelopathy|cervical spondylotic myelopathy
5698393|NCT00506558|degenerative cervical spondylosis|degenerative cervical spondylosis
5698394|NCT00506558|spinal fusion|spinal fusion
5698395|NCT00506532|Pulmonary Surfactants|pulmonary surfactants
5698396|NCT00506532|Lung transplantation|lung transplantation
5698397|NCT00506532|Primary Graft Dysfunction|primary graft dysfunction
5698398|NCT00506519|DIC associated with severe sepsis|dic associated with severe sepsis
5698399|NCT00506506|N-acetylcysteine|n-acetylcysteine
5698400|NCT00506506|Chronic kidney disease|chronic kidney disease
5698402|NCT00506506|Cystatin C|cystatin c
5698403|NCT00506506|proteinuria|proteinuria
5698404|NCT00506506|Stage 3 chronic kidney disease|stage 3 chronic kidney disease
5698405|NCT00506493|Persistent Atrial Fibrillation Surgical RF Ablation|persistent atrial fibrillation surgical rf ablation
5698406|NCT00506493|Perisistent Atrial Fibrillation|perisistent atrial fibrillation
5698407|NCT00506493|Surgical Ablation|surgical ablation
5698408|NCT00506480|Embryo Implantation|embryo implantation
5698409|NCT00506480|Endometrium|endometrium
5848046|NCT00036569|MR Imaging|mr imaging
5715214|NCT00446212|dreaming|dreaming
5715215|NCT00446212|electroencephalography|electroencephalography
5715216|NCT00446199|Vasomotor symptom relief|vasomotor symptom relief
5715217|NCT00446199|Postmenopausal women|postmenopausal women
5715219|NCT00446173|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5698410|NCT00506480|endometrial implantation|endometrial implantation
5698411|NCT00506480|Oocyte Donation|oocyte donation
5698412|NCT00506480|in vitro fertilization|in vitro fertilization
5698413|NCT00506480|endometrial sampling|endometrial sampling
5698414|NCT00506467|Intrathoracic Malignancy|intrathoracic malignancy
5698416|NCT00506467|Vibration Response Imaging|vibration response imaging
5698417|NCT00506467|VRI|vri
5698418|NCT00506454|Fatigue|fatigue
5698419|NCT00506454|Hemodialysis|hemodialysis
5698420|NCT00506454|Endotoxemia|endotoxemia
5698421|NCT00506454|Phospholipid|phospholipid
5698422|NCT00506454|Emulsion|emulsion
5698423|NCT00506441|Chronic Kidney Disease|chronic kidney disease
5698424|NCT00506441|Dialysis|dialysis
5698425|NCT00506441|Hyperphosphatemia|hyperphosphatemia
5698426|NCT00506441|Phosphate binder|phosphate binder
5698427|NCT00506428|aging|aging
5698428|NCT00506428|sleep|sleep
5698429|NCT00506428|sleep deprivation|sleep deprivation
5698430|NCT00506428|performance|performance
5698431|NCT00506428|memory|memory
5698432|NCT00506428|metabolism|metabolism
5698433|NCT00506415|Alzheimer's|alzheimer's
5698434|NCT00506415|Patch|patch
5698435|NCT00506415|Cognitive|cognitive
5698436|NCT00506415|Decline|decline
5698437|NCT00506402|Adult patients with refractory leukemias, MDS or AMM|adult patients with refractory leukemias, mds or amm
5698438|NCT00506389|Sleep Initiation and Maintenance Disorders, Sleep Disorders, Intrinsic Dyssomnias, Sleep Disorders, Nervous System Diseases, Mental Disorders|sleep initiation and maintenance disorders, sleep disorders, intrinsic dyssomnias, sleep disorders, nervous system diseases, mental disorders
5698439|NCT00506376|Cervical Cancer|cervical cancer
5698440|NCT00506376|Hysterectomy|hysterectomy
5698441|NCT00506376|Interview|interview
5698442|NCT00506363|scar|scar
5698443|NCT00506363|surgery|surgery
5698444|NCT00506363|lasers|lasers
5698445|NCT00506324|Intensity Modulated Radiotherapy|intensity modulated radiotherapy
5698446|NCT00506324|Chemotherapy|chemotherapy
5698447|NCT00506324|Head and Neck Neoplasms|head and neck neoplasms
5698448|NCT00506324|Dysphagia|dysphagia
5698449|NCT00506311|Superficial Groin Dissection|superficial groin dissection
5698450|NCT00506311|Melanoma|melanoma
5698451|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive
5698452|NCT00506311|Fibrin Sealant|fibrin sealant
5698453|NCT00506311|Tisseel|tisseel
5698454|NCT00506311|Seroma|seroma
5698455|NCT00506298|Diabetes|diabetes
5698456|NCT00506298|CRx-401|crx-401
5698457|NCT00506298|Bezafibrate|bezafibrate
5698458|NCT00506298|Diflunisal|diflunisal
5698459|NCT00506298|Metformin|metformin
5698460|NCT00506298|plasma glucose|plasma glucose
5698461|NCT00506285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5698462|NCT00506285|ADHD|adhd
5698463|NCT00506285|Adult|adult
5698569|NCT00505934|Infusion|infusion
5698464|NCT00506285|Methylphenidate Transdermal System|methylphenidate transdermal system
5698465|NCT00506285|Daytrana|daytrana
5707738|NCT00473343|Histologically confirmed complete response|histologically confirmed complete response
5707739|NCT00473330|Lucentis|lucentis
5707740|NCT00473330|DME|dme
5698466|NCT00506272|diabetes mellitus|diabetes mellitus
5698467|NCT00506272|hyperglycemia|hyperglycemia
5698468|NCT00506272|hypoglycemia|hypoglycemia
5698469|NCT00506272|self care|self care
5698470|NCT00506259|Deletion 17p11.2|deletion 17p11.2
5698471|NCT00506259|Melatonin|melatonin
5698472|NCT00506259|Phototherapy|phototherapy
5698473|NCT00506259|Behavioral Phenotype|behavioral phenotype
5698474|NCT00506259|Developmental Delay/MR|developmental delay/mr
5698475|NCT00506259|Smith-Magenis Syndrome|smith-magenis syndrome
5698476|NCT00506259|Sleep Disturbance|sleep disturbance
5698478|NCT00506259|Sleep Disorder|sleep disorder
5698479|NCT00506246|anaesthesia|anaesthesia
5698480|NCT00506233|Graft-Versus-Host Disease|graft-versus-host disease
5698481|NCT00506233|GVHD|gvhd
5698482|NCT00506233|Questionnaire|questionnaire
5698483|NCT00506207|Gastrointestinal neoplasms|gastrointestinal neoplasms
5698484|NCT00506207|Combination chemotherapy|combination chemotherapy
5698485|NCT00506207|S-1|s-1
5698486|NCT00506207|Irinotecan|irinotecan
5698487|NCT00506207|Oxaliplatin|oxaliplatin
5698488|NCT00506194|type 2 diabetes|type 2 diabetes
5698489|NCT00506194|oral glucose tolerance test|oral glucose tolerance test
5698490|NCT00506194|insulin|insulin
5698491|NCT00506194|oral anti-diabetic drug|oral anti-diabetic drug
5698492|NCT00506194|ß-cell function|ß-cell function
5698493|NCT00506168|Colorectal neoplasms|colorectal neoplasms
5698495|NCT00506168|Drug therapy, combination|drug therapy, combination
5698496|NCT00506168|Irinotecan|irinotecan
5698497|NCT00506168|Capecitabine|capecitabine
5698498|NCT00506155|Bladder Cancer|bladder cancer
5698499|NCT00506155|Urothelial Cancer|urothelial cancer
5698500|NCT00506155|Avastin|avastin
5698501|NCT00506155|Bevacizumab|bevacizumab
5698502|NCT00506155|Cisplatin|cisplatin
5698503|NCT00506155|Doxorubicin|doxorubicin
5698504|NCT00506155|Methotrexate|methotrexate
5698505|NCT00506155|Vinblastine|vinblastine
5698506|NCT00506155|M-VAC|m-vac
5698507|NCT00506129|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5698508|NCT00506129|CTCL|ctcl
5698509|NCT00506129|Allogeneic Transplantation|allogeneic transplantation
5698510|NCT00506129|Lymphoma|lymphoma
5698511|NCT00506129|Allogeneic peripheral blood progenitor cell|allogeneic peripheral blood progenitor cell
5698513|NCT00506129|Bone Marrow transplantation|bone marrow transplantation
5698514|NCT00506129|Stem Cell Transplant|stem cell transplant
5698515|NCT00506129|SCT|sct
5698516|NCT00506129|Fludarabine|fludarabine
5698517|NCT00506129|Fludarabine Phosphate|fludarabine phosphate
5698518|NCT00506129|Fludara|fludara
5698519|NCT00506129|Melphalan|melphalan
5698520|NCT00506116|Pelvic floor muscle training|pelvic floor muscle training
5698521|NCT00506116|Self-directed pushing|self-directed pushing
5698522|NCT00506116|Antenatal perineal massage|antenatal perineal massage
5698523|NCT00506103|Thyroidectomy|thyroidectomy
5698524|NCT00506103|Central neck dissection|central neck dissection
5698525|NCT00506103|Harmonic scalpel|harmonic scalpel
5698526|NCT00506103|Perioperative complications|perioperative complications
5698527|NCT00506090|scar|scar
5698528|NCT00506090|surgery|surgery
5698529|NCT00506090|lasers|lasers
5698530|NCT00506077|Undifferentiated schizophrenia|undifferentiated schizophrenia
5698531|NCT00506077|residual schizophrenia|residual schizophrenia
5698532|NCT00506064|Breast Cancer|breast cancer
5698533|NCT00506064|Sleep|sleep
5698534|NCT00506064|Melatonin|melatonin
5698535|NCT00506064|Placebo|placebo
5698536|NCT00506064|Survey|survey
5698537|NCT00506064|Postoperative Srejic Sleep SAT Survey|postoperative srejic sleep sat survey
5698538|NCT00506051|Non-small cell lung cancer|non-small cell lung cancer
5698539|NCT00506051|lung cancer|lung cancer
5698540|NCT00506051|alimta|alimta
5722703|NCT00422305|asthma|asthma
5698541|NCT00506051|vandetanib|vandetanib
5698542|NCT00506051|phase 1|phase 1
5698543|NCT00506038|Calcific Tendinitis|calcific tendinitis
5698544|NCT00506025|Pregnancy|pregnancy
5698545|NCT00506025|Cranberry|cranberry
5698546|NCT00506025|Asymptomatic Bacteruria|asymptomatic bacteruria
5698547|NCT00506012|Myoclonus Dystonia|myoclonus dystonia
5698548|NCT00506012|Essential Myoclonus|essential myoclonus
5698549|NCT00506012|Inherited Myoclonus|inherited myoclonus
5698550|NCT00506012|Dyskinesia|dyskinesia
5698551|NCT00506012|Movement Disorder|movement disorder
5698552|NCT00505999|Multiple Myeloma|multiple myeloma
5698553|NCT00505999|Etiology|etiology
5698554|NCT00505999|Risk Factors|risk factors
5698555|NCT00505999|Healthy Controls|healthy controls
5698556|NCT00505999|Questionnaire|questionnaire
5698557|NCT00505999|Survey|survey
5698558|NCT00505947|macular edema|macular edema
5698559|NCT00505947|diabetes mellitus|diabetes mellitus
5698560|NCT00505947|visual loss|visual loss
5698561|NCT00505947|diabetic retinopathy|diabetic retinopathy
5698562|NCT00505947|macula|macula
5698563|NCT00505947|maculopathy|maculopathy
5698564|NCT00505947|infliximab|infliximab
5698565|NCT00505934|Epilepsy|epilepsy
5698566|NCT00505934|Child|child
5698567|NCT00505934|Levetiracetam|levetiracetam
5698568|NCT00505934|Keppra®|keppra®
5698571|NCT00505921|T-Cell Lymphoma|t-cell lymphoma
5698572|NCT00505921|Lymphoma|lymphoma
5698573|NCT00505921|Campath-1H|campath-1h
5698574|NCT00505921|Allogenic Transplantation|allogenic transplantation
5698575|NCT00505921|Stem Cell Transplant|stem cell transplant
5698576|NCT00505921|Alemtuzumab|alemtuzumab
5698577|NCT00505895|Multiple Myeloma|multiple myeloma
5698578|NCT00505895|Fludarabine|fludarabine
5698579|NCT00505895|Fludara|fludara
5698580|NCT00505895|Fludarabine Phosphate|fludarabine phosphate
5698581|NCT00505895|Melphalan|melphalan
5698582|NCT00505895|Alkeran|alkeran
5698583|NCT00505895|Stem Cell Infusion|stem cell infusion
5698584|NCT00505895|Stem Cell Transfusion|stem cell transfusion
5698585|NCT00505895|SCT|sct
5698586|NCT00505895|Allogeneic Peripheral Blood Stem Cell Transfusion|allogeneic peripheral blood stem cell transfusion
5698587|NCT00505895|APBSCT|apbsct
5698588|NCT00505895|Bone Marrow Transplantation|bone marrow transplantation
5698589|NCT00505895|BMT|bmt
5698590|NCT00505895|Rituxan|rituxan
5698591|NCT00505895|Rituximab|rituximab
5698592|NCT00505895|FM140|fm140
5698593|NCT00505895|FM100|fm100
5698594|NCT00505882|Type 1 diabetes|type 1 diabetes
5698595|NCT00505882|Pramlintide|pramlintide
5698596|NCT00505882|Weight gain|weight gain
5698597|NCT00505882|Intensive insulin therapy|intensive insulin therapy
5698598|NCT00505882|Beta cell|beta cell
5698599|NCT00505869|Pregnant Smokers|pregnant smokers
5698600|NCT00505869|Mood Management Intervention|mood management intervention
5698601|NCT00505869|Health & Wellness Intervention|health & wellness intervention
5698602|NCT00505869|Smoking Cessation|smoking cessation
5698603|NCT00505869|Questionnaire|questionnaire
5698604|NCT00505869|Survey|survey
5698605|NCT00505830|Asperger Syndrom|asperger syndrom
5698606|NCT00505830|Autism Quotient|autism quotient
5698607|NCT00505830|French version|french version
5698608|NCT00505830|screening|screening
5698609|NCT00505830|diagnostic test|diagnostic test
5698610|NCT00505830|accuracy|accuracy
5698611|NCT00505804|dexmedetomidine|dexmedetomidine
5698612|NCT00505804|haloperidol|haloperidol
5698613|NCT00505791|Acute decompensated heart failure|acute decompensated heart failure
5698614|NCT00505791|Normal left ventricular ejection fraction|normal left ventricular ejection fraction
5698615|NCT00505791|Vasodilator therapy|vasodilator therapy
5698616|NCT00505765|Cognition|cognition
5698617|NCT00505765|Schizophrenia|schizophrenia
5698618|NCT00505752|Assisted reproductive technology, follicle stimulating hormone|assisted reproductive technology, follicle stimulating hormone
5698619|NCT00505739|Endometrial Cancer|endometrial cancer
5698620|NCT00505739|Low Grade Endometrial Stromal Sarcoma|low grade endometrial stromal sarcoma
5698621|NCT00505739|RU-486|ru-486
5698622|NCT00505739|Mifepristone|mifepristone
5698623|NCT00505739|LGESS|lgess
5698624|NCT00505726|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5698625|NCT00505726|Cervical Cancer|cervical cancer
5698626|NCT00505726|Reflectance Confocal Imaging|reflectance confocal imaging
5698627|NCT00505726|Colposcopy|colposcopy
5698628|NCT00505713|Sarcoma|sarcoma
5698629|NCT00505713|Rexin-G|rexin-g
5698630|NCT00505713|Gene Therapy|gene therapy
5698631|NCT00505700|acute myeloid leukemia|acute myeloid leukemia
5698632|NCT00505687|Rotigotine|rotigotine
5698633|NCT00505687|Neupro®|neupro®
5698634|NCT00505661|Ovarian Cancer|ovarian cancer
5698635|NCT00505661|Fallopian Tube Cancer|fallopian tube cancer
5698636|NCT00505661|Peritoneal Cancer|peritoneal cancer
5698637|NCT00505661|Letrozole|letrozole
5698638|NCT00505661|Femara|femara
5698639|NCT00505648|Hypersensitivity|hypersensitivity
5698640|NCT00505648|Syndrome|syndrome
5698641|NCT00505648|Tegeline|tegeline
5698642|NCT00505635|advanced stage IV melanoma|advanced stage iv melanoma
5698643|NCT00505635|unresectable stage III melanoma|unresectable stage iii melanoma
5698644|NCT00505635|Melanoma|melanoma
5698645|NCT00505635|Temozolomide|temozolomide
5698646|NCT00505635|Velban|velban
5698647|NCT00505635|Vinblastine|vinblastine
5698648|NCT00505635|Cisplatin|cisplatin
5698649|NCT00505635|Interleukin-2|interleukin-2
5698650|NCT00505635|Intron-A|intron-a
5698651|NCT00505635|Interferon Alpha-2b|interferon alpha-2b
5698652|NCT00505635|Thalidomide|thalidomide
5698653|NCT00505635|Thalomid|thalomid
5698654|NCT00505635|Temodar|temodar
5698655|NCT00505635|Proleukin|proleukin
5698656|NCT00505609|fertility awareness-based method|fertility awareness-based method
5698657|NCT00505609|family planning|family planning
5698658|NCT00505609|Standard Days Method|standard days method
5698659|NCT00505609|Institute for Reproductive Health|institute for reproductive health
5698660|NCT00505609|Efficacy|efficacy
5698661|NCT00505609|CycleBeads|cyclebeads
5698662|NCT00505596|Prenatal testing|prenatal testing
5698663|NCT00505596|Decisionmaking|decisionmaking
5698664|NCT00505596|Decision aid|decision aid
5698665|NCT00505596|Informed choice|informed choice
5698666|NCT00505570|Migraine|migraine
5698667|NCT00505570|Migraine with aura|migraine with aura
5698668|NCT00505570|Patent foramen ovale|patent foramen ovale
5698670|NCT00505557|augmentation mammoplasty|augmentation mammoplasty
5698671|NCT00505557|Dual plane|dual plane
5698672|NCT00505557|Endoscope|endoscope
5698782|NCT00505180|Mortality|mortality
5698673|NCT00505557|Transaxillary incision|transaxillary incision
5698674|NCT00505544|Advanced Cancer|advanced cancer
5698675|NCT00505544|Questionnaire|questionnaire
5698677|NCT00505544|Sleep Disturbance|sleep disturbance
5698678|NCT00505544|Sleep Quality|sleep quality
5698679|NCT00505531|Pain|pain
5698680|NCT00505518|Major Depressive Disorder|major depressive disorder
5698681|NCT00505518|Telepsychiatry|telepsychiatry
5698682|NCT00505518|Chinese American|chinese american
5698683|NCT00505518|Nursing Home|nursing home
5698684|NCT00505505|Neurointensive care|neurointensive care
5698685|NCT00505505|Intensive insulin infusion|intensive insulin infusion
5698686|NCT00505505|Hypoglycemia|hypoglycemia
5698687|NCT00505505|Postoperative Mortality|postoperative mortality
5698688|NCT00505505|Postoperative Morbidity|postoperative morbidity
5698689|NCT00505505|Neurologic outcome|neurologic outcome
5698690|NCT00505492|Malignant Mixed Mesodermal Tumor|malignant mixed mesodermal tumor
5698691|NCT00505492|MMMT|mmmt
5698692|NCT00505492|Uterine Neoplasms|uterine neoplasms
5698693|NCT00505492|Radiation Therapy|radiation therapy
5698694|NCT00505492|Paclitaxel|paclitaxel
5698695|NCT00505492|Carboplatin|carboplatin
5698696|NCT00505492|Cisplatin|cisplatin
5698697|NCT00505492|Taxol|taxol
5698704|NCT00505466|Genetic Testing|genetic testing
5698705|NCT00505466|p53 Mutation|p53 mutation
5698706|NCT00505466|Genetics|genetics
5698707|NCT00505453|Influenza|influenza
5698708|NCT00505427|PCOS|pcos
5698709|NCT00505427|polycystic ovary syndrome|polycystic ovary syndrome
5698710|NCT00505427|polycystic ovarian syndrome|polycystic ovarian syndrome
5698712|NCT00505427|insulin resistance|insulin resistance
5698713|NCT00505427|oxidative stress|oxidative stress
5698714|NCT00505414|Chronic Tumor Related Pain|chronic tumor related pain
5698715|NCT00505414|Analgesic|analgesic
5698716|NCT00505414|Tapentadol Extended Release|tapentadol extended release
5698717|NCT00505414|Morphine Sulfate Controlled Release|morphine sulfate controlled release
5698718|NCT00505414|Pain assessment|pain assessment
5698719|NCT00505414|Placebo|placebo
5698720|NCT00505401|HIV|hiv
5698721|NCT00505401|Tat protein|tat protein
5698722|NCT00505401|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5698723|NCT00505388|asthma|asthma
5698724|NCT00505388|bronchial|bronchial
5698726|NCT00505375|CTLA4-Ig|ctla4-ig
5698727|NCT00505375|Abatacept|abatacept
5698728|NCT00505375|Beta-cell function|beta-cell function
5698729|NCT00505375|T-cells|t-cells
5698730|NCT00505375|DPT-1|dpt-1
5698731|NCT00505375|treatment|treatment
5698732|NCT00505375|treatment of type 1 diabetes|treatment of type 1 diabetes
5698733|NCT00505375|new onset type 1 diabetes|new onset type 1 diabetes
5698734|NCT00505375|juvenile diabetes|juvenile diabetes
5698735|NCT00505375|T1D|t1d
5698736|NCT00505375|diabetes mellitus|diabetes mellitus
5698737|NCT00505375|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5698738|NCT00505375|TrialNet|trialnet
5698739|NCT00505349|neurotrophic factors|neurotrophic factors
5698740|NCT00505349|cognitive status|cognitive status
5698741|NCT00505349|young adults|young adults
5698742|NCT00505349|mature adults|mature adults
5698743|NCT00505349|cognitive training|cognitive training
5698744|NCT00505336|Diastolic heart failure|diastolic heart failure
5698745|NCT00505336|Markers of collagen turnover|markers of collagen turnover
5698746|NCT00505336|Statins|statins
5698747|NCT00505336|Aldosterone receptor blockers|aldosterone receptor blockers
5698748|NCT00505323|Cortex stimulation|cortex stimulation
5698749|NCT00505323|Focal secondary Dystonia|focal secondary dystonia
5698750|NCT00505323|Effectiveness|effectiveness
5698751|NCT00505323|Quality of life improvement|quality of life improvement
5698752|NCT00505323|Focal dystonias secondary to central grey nuclei lesions|focal dystonias secondary to central grey nuclei lesions
5698759|NCT00505297|Osteoarthritis (OA)|osteoarthritis (oa)
5698760|NCT00505297|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5698761|NCT00505297|delayed Gadolinium Enhanced MRI of cartilage (dGEMRIC)|delayed gadolinium enhanced mri of cartilage (dgemric)
5698762|NCT00505297|disease modifying osteoarthritis drug (DMOAD)|disease modifying osteoarthritis drug (dmoad)
5698763|NCT00505297|Potentially rapidly progressing osteoarthritis|potentially rapidly progressing osteoarthritis
5698764|NCT00505297|MRI measurement of cartilage|mri measurement of cartilage
5698765|NCT00505284|Diabetic neuropathy|diabetic neuropathy
5698766|NCT00505271|Breast Cancer|breast cancer
5698767|NCT00505271|Rexin-G|rexin-g
5698768|NCT00505271|Gene Therapy|gene therapy
5698769|NCT00505258|Bacteremia|bacteremia
5698770|NCT00505258|Bloodstream infection|bloodstream infection
5698771|NCT00505258|Staphylococcus aureus|staphylococcus aureus
5698772|NCT00505258|Staphylococcal Infections|staphylococcal infections
5698773|NCT00505258|MRSA|mrsa
5698774|NCT00505258|MSSA|mssa
5698775|NCT00505232|Y-90 Ibritumomab tiuxetan|y-90 ibritumomab tiuxetan
5698776|NCT00505232|Rituximab|rituximab
5698777|NCT00505232|Hyper-CVAD|hyper-cvad
5698778|NCT00505232|Mantle Cell Lymphoma Patients|mantle cell lymphoma patients
5698779|NCT00505232|Zevalin(R)|zevalin(r)
5698780|NCT00505219|Osteonecrosis|osteonecrosis
5698781|NCT00505180|Hemodialysis|hemodialysis
5698783|NCT00505167|Alzheimer's disease|alzheimer's disease
5698784|NCT00505167|Memantine|memantine
5698785|NCT00505167|Donepezil|donepezil
5698786|NCT00505167|Magnetic resonance Spectroscopy|magnetic resonance spectroscopy
5698787|NCT00505167|randomized trial|randomized trial
5698788|NCT00505154|Heart failure|heart failure
5698789|NCT00505154|inflammation|inflammation
5698790|NCT00505154|cytokines|cytokines
5698791|NCT00505141|Childhood Brain Cancer|childhood brain cancer
5698792|NCT00505141|Childhood Acute Lymphoblastic Leukemia|childhood acute lymphoblastic leukemia
5698793|NCT00505128|Biliary pancreatitis|biliary pancreatitis
5698794|NCT00505128|Bile duct stones|bile duct stones
5698801|NCT00505102|Cyclosporine Toxicity|cyclosporine toxicity
5698802|NCT00505089|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, ACZ885, patients, rheumatoid, arthritis.|pharmacokinetic, pharmacodynamic, subcutaneous, intravenous, acz885, patients, rheumatoid, arthritis.
5698803|NCT00505076|Cognition|cognition
5698804|NCT00505076|Schizophrenia|schizophrenia
5698805|NCT00505063|vaccine|vaccine
5698806|NCT00505063|childhood|childhood
5698807|NCT00505063|cancer|cancer
5698808|NCT00505050|heart failure, disease program management, treatment, education|heart failure, disease program management, treatment, education
5698809|NCT00505037|ASP1585|asp1585
5698810|NCT00505037|Renal Dialysis|renal dialysis
5698811|NCT00505037|Chronic Kidney Disease|chronic kidney disease
5698812|NCT00505037|Hyperphosphatemia|hyperphosphatemia
5698813|NCT00505024|Non-Small Cell Lung Cancer|non-small cell lung cancer
5698814|NCT00505024|Esophageal Cancer|esophageal cancer
5698815|NCT00505024|Lung Cancer|lung cancer
5698816|NCT00505024|Interactive Voice Response System|interactive voice response system
5698817|NCT00505024|IVRS|ivrs
5698818|NCT00505011|susceptibility|susceptibility
5698819|NCT00505011|genes|genes
5698820|NCT00505011|environment|environment
5698821|NCT00505011|ophthalmopathy|ophthalmopathy
5698822|NCT00505011|outcome|outcome
5698823|NCT00504998|Pancreatic cancer|pancreatic cancer
5698824|NCT00504998|Rexin-G|rexin-g
5698825|NCT00504998|Treatment|treatment
5698826|NCT00504985|Advanced Cancer|advanced cancer
5698827|NCT00504985|Hematologic Malignancy|hematologic malignancy
5698828|NCT00504985|Fatigue|fatigue
5698829|NCT00504985|Emergency Center|emergency center
5698830|NCT00504985|Survey|survey
5693300|NCT00524992|Lipodystrophy|lipodystrophy
5698831|NCT00504959|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5698832|NCT00504959|choroidal neovascularization (CNV),|choroidal neovascularization (cnv),
5698833|NCT00504959|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5698834|NCT00504946|allergen immunotherapy premedication|allergen immunotherapy premedication
5698835|NCT00504933|Rhinitis|rhinitis
5698836|NCT00504933|Allergic|allergic
5698837|NCT00504933|Seasonal|seasonal
5698838|NCT00504933|Hay Fever|hay fever
5698839|NCT00504933|Pollen Allergy|pollen allergy
5698840|NCT00504933|Pollinosis|pollinosis
5698841|NCT00504933|Rhinoconjunctivitis|rhinoconjunctivitis
5698842|NCT00504920|Leukemia|leukemia
5698843|NCT00504920|Myelodysplastic Syndrome|myelodysplastic syndrome
5698844|NCT00504920|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5698845|NCT00504920|Symptom-Related Cytokines|symptom-related cytokines
5698846|NCT00504920|Blood or Marrow Transplantation|blood or marrow transplantation
5698847|NCT00504920|Questionnaire|questionnaire
5698849|NCT00504894|N/A healthy volunteers|n/a healthy volunteers
5698850|NCT00504881|Epilepsy|epilepsy
5698851|NCT00504881|Brivaracetam|brivaracetam
5698852|NCT00504881|Partial Onset Seizures|partial onset seizures
5698853|NCT00504855|Pressure ulcer|pressure ulcer
5698854|NCT00504855|Waterproof|waterproof
5698855|NCT00504855|Gortex|gortex
5698856|NCT00504855|Cast padding|cast padding
5698857|NCT00504855|Pediatric|pediatric
5698858|NCT00504855|Heel|heel
5698859|NCT00504842|Acute Ischemic Stroke|acute ischemic stroke
5698860|NCT00504842|Microbubbles|microbubbles
5698861|NCT00504842|Transcranial Doppler ultrasound|transcranial doppler ultrasound
5698862|NCT00504842|TIBI|tibi
5698863|NCT00504842|Symptomatic Intracranial Hemorrhage|symptomatic intracranial hemorrhage
5698864|NCT00504842|modified Rankin Scale|modified rankin scale
5698865|NCT00504842|Recanalization|recanalization
5698866|NCT00504842|Perflutren|perflutren
5698874|NCT00504816|healthy female,|healthy female,
5698875|NCT00504816|pharmacokinetics,|pharmacokinetics,
5698876|NCT00504816|pharmacodynamics|pharmacodynamics
5698877|NCT00504816|drug interaction,|drug interaction,
5698878|NCT00504803|HCT, nonmyeloablative, mesenchymal stem cells, GVHD|hct, nonmyeloablative, mesenchymal stem cells, gvhd
5698879|NCT00504790|GSK923295,|gsk923295,
5698880|NCT00504790|First Time in Human,|first time in human,
5698881|NCT00504790|pharmacodynamics|pharmacodynamics
5698882|NCT00504790|cancer,|cancer,
5698883|NCT00504790|maximally tolerated dose, pharmacokinetics,|maximally tolerated dose, pharmacokinetics,
5698884|NCT00504790|Refractory Cancer|refractory cancer
5698885|NCT00504790|CENPE,|cenpe,
5698886|NCT00504790|Phase I,|phase i,
5698887|NCT00504764|Relapsed Acute Promyelocytic Leukemia|relapsed acute promyelocytic leukemia
5698888|NCT00504764|Arsenic Trioxide|arsenic trioxide
5698889|NCT00504751|diffuse large b cell|diffuse large b cell
5698890|NCT00504738|lung disease|lung disease
5708156|NCT00471588|OCD|ocd
5699164|NCT00504075|Bleeding disorders|bleeding disorders
5698891|NCT00504738|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5698892|NCT00504738|asthma|asthma
5698893|NCT00504738|smokers|smokers
5698894|NCT00504738|non-smokers|non-smokers
5698895|NCT00504725|Lobectomy|lobectomy
5698896|NCT00504725|VATS|vats
5698897|NCT00504712|Testosterone|testosterone
5698898|NCT00504712|Hypogonadism|hypogonadism
5698899|NCT00504712|Diabetes|diabetes
5698900|NCT00504712|PVD|pvd
5698901|NCT00504712|RCT|rct
5698902|NCT00504699|breast cancer|breast cancer
5698903|NCT00504699|ovarian stimulation|ovarian stimulation
5698904|NCT00504699|aromatase inhibitors|aromatase inhibitors
5698905|NCT00504699|letrozole|letrozole
5698906|NCT00504699|fertility preservation|fertility preservation
5698907|NCT00504699|recurrence|recurrence
5698908|NCT00504660|Anaplastic Glioma|anaplastic glioma
5698909|NCT00504660|Glioblastoma Multiforme|glioblastoma multiforme
5698910|NCT00504660|Brain Cancer|brain cancer
5698911|NCT00504660|6-Thioguanine|6-thioguanine
5698912|NCT00504660|Capecitabine|capecitabine
5698913|NCT00504660|Celecoxib|celecoxib
5698914|NCT00504660|Temozolomide|temozolomide
5698915|NCT00504660|Xeloda|xeloda
5698916|NCT00504660|Temodar|temodar
5698917|NCT00504660|TMZ|tmz
5698918|NCT00504660|CCNU|ccnu
5698919|NCT00504660|6-TG|6-tg
5698920|NCT00504647|Hypertrophic|hypertrophic
5698921|NCT00504647|Cardiomyopathy|cardiomyopathy
5698922|NCT00504647|Diastolic|diastolic
5698923|NCT00504647|Ventricular|ventricular
5698924|NCT00504647|Interaction|interaction
5698925|NCT00504647|Biventricular|biventricular
5698926|NCT00504647|Pacemaker|pacemaker
5698927|NCT00504634|Multiple Myeloma|multiple myeloma
5698928|NCT00504634|Post Allogeneic Transplantation|post allogeneic transplantation
5698929|NCT00504634|Bortezomib|bortezomib
5698930|NCT00504634|Velcade|velcade
5698931|NCT00504634|PS-341|ps-341
5698932|NCT00504621|personality|personality
5698933|NCT00504621|fatigue|fatigue
5698934|NCT00504621|quality of life|quality of life
5698935|NCT00504621|health care consumption|health care consumption
5698936|NCT00504595|Rheumatoid Arthritis|rheumatoid arthritis
5698937|NCT00504582|Axillary Node Dissection|axillary node dissection
5698938|NCT00504582|Fibrin Sealant|fibrin sealant
5698940|NCT00504582|Melanoma|melanoma
5698941|NCT00504582|Seroma|seroma
5698942|NCT00504556|Anti-coagulant|anti-coagulant
5698943|NCT00504556|Non-valvular|non-valvular
5698944|NCT00504556|Venous Thromboembolism|venous thromboembolism
5698945|NCT00504556|Prevention of Blood Clots|prevention of blood clots
5698946|NCT00504556|Atrial Fibrillation|atrial fibrillation
5698947|NCT00504556|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5698948|NCT00504543|Kidney transplant, AEB071|kidney transplant, aeb071
5698949|NCT00504517|Outpatient continuity training|outpatient continuity training
5698950|NCT00504517|Relevant, Patient-centered curriculum|relevant, patient-centered curriculum
5698951|NCT00504517|Evaluation|evaluation
5698952|NCT00504517|New graduation requirements|new graduation requirements
5698953|NCT00504504|Hodgkin's Disease|hodgkin's disease
5698954|NCT00504504|Lymphoma|lymphoma
5698955|NCT00504504|Rituximab|rituximab
5698956|NCT00504504|Rituxan|rituxan
5698957|NCT00504504|Adriamycin|adriamycin
5698958|NCT00504504|Doxorubicin|doxorubicin
5698959|NCT00504504|Rubex|rubex
5698960|NCT00504504|Bleomycin|bleomycin
5698961|NCT00504504|Bleomycin sulfate|bleomycin sulfate
5698962|NCT00504504|Blenoxane|blenoxane
5698964|NCT00504504|Dacarbazine|dacarbazine
5698965|NCT00504504|DTIC|dtic
5698966|NCT00504504|DTIC-Dome|dtic-dome
5698967|NCT00504504|Vincristine|vincristine
5698968|NCT00504504|Vinblastine|vinblastine
5698969|NCT00504504|Vinblastine Sulfate|vinblastine sulfate
5698970|NCT00504504|ABVD|abvd
5698971|NCT00504504|ABVD Chemotherapy Treatment|abvd chemotherapy treatment
5698972|NCT00504491|Rituximab-CHOP|rituximab-chop
5698973|NCT00504491|Alemtuzumab|alemtuzumab
5698974|NCT00504491|Chronic lymphocytic leukaemia|chronic lymphocytic leukaemia
5698975|NCT00504478|Inflammation|inflammation
5698976|NCT00504478|carbohydrates|carbohydrates
5698977|NCT00504478|omega-3|omega-3
5698978|NCT00504478|overweight|overweight
5698979|NCT00504478|diet|diet
5698980|NCT00504465|Labor|labor
5698981|NCT00504465|Labor induction|labor induction
5698982|NCT00504465|Cervical ripening|cervical ripening
5698983|NCT00504465|Dinoprostone|dinoprostone
5698984|NCT00504465|Fetal safety|fetal safety
5698985|NCT00504465|Oxytocin|oxytocin
5698986|NCT00504465|Cesarean delivery|cesarean delivery
5698988|NCT00504452|viral|viral
5698989|NCT00504452|Viral decay acceleration|viral decay acceleration
5698990|NCT00504452|ART|art
5698991|NCT00504452|HAART|haart
5698992|NCT00504452|Treatment Experienced|treatment experienced
5698993|NCT00504439|COPD,|copd,
5698994|NCT00504439|CD11b,|cd11b,
5698995|NCT00504439|CXCR2,|cxcr2,
5698996|NCT00504439|safety,|safety,
5698997|NCT00504439|repeat dose,|repeat dose,
5698998|NCT00504439|tolerability.|tolerability.
5698999|NCT00504439|SB-656933,|sb-656933,
5699000|NCT00504413|Metabolic Networks and Pathways|metabolic networks and pathways
5699001|NCT00504413|Methadone|methadone
5699002|NCT00504413|Polymorphism, genetic|polymorphism, genetic
5699003|NCT00504413|Cytochrome P-450 Enzyme System|cytochrome p-450 enzyme system
5699004|NCT00504400|macular telangiectasia|macular telangiectasia
5699005|NCT00504400|parafoveal telangiectasis|parafoveal telangiectasis
5699006|NCT00504400|nonproliferative|nonproliferative
5699007|NCT00504400|therapy|therapy
5699008|NCT00504400|intravitreal injection|intravitreal injection
5699009|NCT00504400|ranibizumab|ranibizumab
5699010|NCT00504400|lucentis|lucentis
5699011|NCT00504387|Burning mouth disorder|burning mouth disorder
5699012|NCT00504387|Taste disorder|taste disorder
5699013|NCT00504387|Quantitative sensory testing|quantitative sensory testing
5699014|NCT00504387|Gustatory testing|gustatory testing
5699015|NCT00504387|Neuropathic orofacial pain|neuropathic orofacial pain
5699016|NCT00504387|Oral burning|oral burning
5699017|NCT00504374|Lung Cancer|lung cancer
5699018|NCT00504374|Epidemiology|epidemiology
5699019|NCT00504374|Symptoms|symptoms
5699020|NCT00504374|Gene Polymorphisms|gene polymorphisms
5699021|NCT00504374|Questionnaire|questionnaire
5699022|NCT00504374|Survey|survey
5699023|NCT00504361|Asthma|asthma
5699024|NCT00504361|COPD|copd
5699025|NCT00504361|Interstitial Lung Disease|interstitial lung disease
5699026|NCT00504361|Cystic Fibrosis|cystic fibrosis
5699027|NCT00504361|Lung Cancer|lung cancer
5699029|NCT00504361|non-smokers|non-smokers
5699030|NCT00504348|Interstitial pneumonitis|interstitial pneumonitis
5699031|NCT00504348|Polymyositis|polymyositis
5699032|NCT00504348|Dermatomyositis|dermatomyositis
5699033|NCT00504348|Tacrolimus|tacrolimus
5699034|NCT00504348|Corticosteroids|corticosteroids
5699035|NCT00504335|Acute Radiation Syndrome|acute radiation syndrome
5699036|NCT00504335|Hematopoietic Syndrome|hematopoietic syndrome
5699037|NCT00504335|Radiation Injury|radiation injury
5699039|NCT00504322|Esophageal Neoplasms|esophageal neoplasms
5699040|NCT00504309|triglycerides|triglycerides
5699041|NCT00504309|hypertriglyceridemia|hypertriglyceridemia
5699042|NCT00504309|omega-3|omega-3
5699043|NCT00504309|n-3|n-3
5699044|NCT00504309|eicosapentaenoic acid|eicosapentaenoic acid
5699045|NCT00504309|EPA|epa
5699046|NCT00504309|docosahexaenoic acid|docosahexaenoic acid
5699048|NCT00504309|flow mediated dilation|flow mediated dilation
5699050|NCT00504309|Moderate hypertriglyceridemia|moderate hypertriglyceridemia
5699051|NCT00504296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5699052|NCT00504283|Renal colic, pain, protocol, emergency department|renal colic, pain, protocol, emergency department
5699053|NCT00504257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5699054|NCT00504257|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5699055|NCT00504257|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5699056|NCT00504244|SLE|sle
5699057|NCT00504244|SLEDAI|sledai
5699058|NCT00504244|Azathioprine|azathioprine
5699059|NCT00504244|Myfortic|myfortic
5699060|NCT00504231|influenza|influenza
5699061|NCT00504231|prevention|prevention
5699062|NCT00504231|intradermal|intradermal
5699063|NCT00504231|vaccine|vaccine
5699064|NCT00504231|delivery|delivery
5699065|NCT00504231|elderly|elderly
5699066|NCT00504218|Growth Factor|growth factor
5699067|NCT00504218|Hypothalamic-Pituitary Dysfunction|hypothalamic-pituitary dysfunction
5699068|NCT00504218|Primary Disorders of the Thyroid|primary disorders of the thyroid
5699069|NCT00504218|Decreased Bone Mineral Density|decreased bone mineral density
5699070|NCT00504218|Endocrine Side Effects Related to Cancer Therapy|endocrine side effects related to cancer therapy
5699071|NCT00504218|Primary Gonadal Dysfunction|primary gonadal dysfunction
5699072|NCT00504218|Obesity|obesity
5699073|NCT00504218|Impaired Glucose Tolerance|impaired glucose tolerance
5699074|NCT00504218|Thyroid Disorder|thyroid disorder
5699075|NCT00504218|Cancer Therapy Endocrine Side Effects|cancer therapy endocrine side effects
5723204|NCT00420043|CML|cml
5697655|NCT00508989|HDL|hdl
5699076|NCT00504218|Pituitary Dysfunction|pituitary dysfunction
5699077|NCT00504218|Childhood Cancer Survivors|childhood cancer survivors
5699078|NCT00504205|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5699079|NCT00504205|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5699080|NCT00504205|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5699081|NCT00504205|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5699082|NCT00504205|intraocular lymphoma|intraocular lymphoma
5699083|NCT00504205|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5699084|NCT00504205|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5699085|NCT00504205|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5699086|NCT00504205|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5699301|NCT00503763|Simvastatin|simvastatin
5699087|NCT00504205|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5699088|NCT00504205|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5699422|NCT00503230|Latino|latino
5699089|NCT00504205|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5699090|NCT00504205|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5699091|NCT00504205|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5699092|NCT00504205|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5699093|NCT00504205|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5699094|NCT00504205|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5699095|NCT00504205|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5699096|NCT00504205|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5699097|NCT00504205|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5699098|NCT00504205|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5699099|NCT00504205|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5699100|NCT00504205|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5699101|NCT00504205|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5699102|NCT00504205|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5699103|NCT00504205|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5699104|NCT00504205|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5699105|NCT00504205|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5699106|NCT00504205|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5699107|NCT00504205|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5699108|NCT00504205|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5699109|NCT00504205|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5699110|NCT00504205|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5699111|NCT00504205|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5699113|NCT00504205|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5699114|NCT00504205|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5699115|NCT00504205|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5699116|NCT00504205|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5699117|NCT00504205|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5699118|NCT00504205|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5699119|NCT00504205|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5699120|NCT00504205|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5699121|NCT00504205|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5699122|NCT00504205|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5699123|NCT00504205|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5699124|NCT00504205|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5699125|NCT00504205|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5699126|NCT00504205|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5699127|NCT00504205|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5699128|NCT00504205|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5699129|NCT00504205|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5699130|NCT00504205|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5699131|NCT00504205|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5699132|NCT00504205|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5699133|NCT00504205|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5699134|NCT00504179|coronary artery bypass graft|coronary artery bypass graft
5699135|NCT00504179|osteopathic manipulative treatment|osteopathic manipulative treatment
5699137|NCT00504140|Osteosarcoma|osteosarcoma
5699138|NCT00504140|Interferon Alpha|interferon alpha
5699140|NCT00504140|Roferon|roferon
5685759|NCT00554983|Recombinant birch pollen allergy|recombinant birch pollen allergy
5685760|NCT00554983|IgE-mediated allergic disease attributed to birch pollen|ige-mediated allergic disease attributed to birch pollen
5685761|NCT00554970|Adult Asthmatics|adult asthmatics
5685762|NCT00554944|Fluid Management|fluid management
5685763|NCT00554944|surgery|surgery
5685764|NCT00554944|Obesity|obesity
5685765|NCT00554918|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5685766|NCT00554918|recurrent prostate cancer|recurrent prostate cancer
5685767|NCT00554918|stage IV prostate cancer|stage iv prostate cancer
5685768|NCT00554918|bone metastases|bone metastases
5685769|NCT00554905|ablation|ablation
5699141|NCT00504140|Recombinant Interferon Alpha|recombinant interferon alpha
5699142|NCT00504140|Etoposide|etoposide
5699143|NCT00504140|VP-16|vp-16
5699144|NCT00504127|Arthritis|arthritis
5699145|NCT00504127|Degenerative|degenerative
5699146|NCT00504114|Osteoarthritis, knee|osteoarthritis, knee
5699147|NCT00504114|anterior cruciate ligament|anterior cruciate ligament
5699148|NCT00504114|Magnetic Resonance Imaging|magnetic resonance imaging
5699149|NCT00504101|stage I multiple myeloma|stage i multiple myeloma
5699150|NCT00504101|stage II multiple myeloma|stage ii multiple myeloma
5699151|NCT00504101|stage III multiple myeloma|stage iii multiple myeloma
5699152|NCT00504088|CLI|cli
5699153|NCT00504088|Critical Limb Ischemia|critical limb ischemia
5699154|NCT00504088|PAD|pad
5699155|NCT00504088|Peripheral Arterial Disease|peripheral arterial disease
5699156|NCT00504088|Artherosclerosis|artherosclerosis
5699157|NCT00504088|Leg Pain|leg pain
5699158|NCT00504088|Cardiovascular|cardiovascular
5699159|NCT00504088|Artherectomy|artherectomy
5699160|NCT00504088|Bypass|bypass
5699161|NCT00504088|Peripheral Bypass|peripheral bypass
5699162|NCT00504088|PROOF|proof
5699163|NCT00504075|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5699638|NCT00502385|AZD2171|azd2171
5699165|NCT00504075|Immune System and Disorders|immune system and disorders
5699166|NCT00504062|asthma|asthma
5699167|NCT00504062|bronchial|bronchial
5699168|NCT00504049|Cerebral Palsy|cerebral palsy
5699169|NCT00504049|Electromyography|electromyography
5699170|NCT00504049|Wavelet Analysis|wavelet analysis
5699171|NCT00504036|Obesity|obesity
5699172|NCT00504036|Morbid obesity|morbid obesity
5699173|NCT00504036|Gastric balloon|gastric balloon
5699174|NCT00504036|Gastric by-pass|gastric by-pass
5699175|NCT00504036|Morbid obesity with BMI > 45 kg/m²|morbid obesity with bmi > 45 kg/m²
5699176|NCT00504023|Paget disease of the vulva|paget disease of the vulva
5699177|NCT00504023|recurrent vulvar cancer|recurrent vulvar cancer
5699178|NCT00504023|stage 0 vulvar cancer|stage 0 vulvar cancer
5699179|NCT00504023|stage I vulvar cancer|stage i vulvar cancer
5699180|NCT00504023|stage II vulvar cancer|stage ii vulvar cancer
5699181|NCT00504023|stage III vulvar cancer|stage iii vulvar cancer
5699182|NCT00504023|imiquimod|imiquimod
5699183|NCT00504023|07-029|07-029
5699184|NCT00504010|arnica|arnica
5699185|NCT00504010|muscle soreness|muscle soreness
5699186|NCT00504010|exercise|exercise
5699187|NCT00504010|eccentric|eccentric
5699188|NCT00503997|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5699190|NCT00503997|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5699191|NCT00503997|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5699192|NCT00503997|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5699193|NCT00503997|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5699194|NCT00503997|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5699195|NCT00503997|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5699196|NCT00503997|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5699197|NCT00503997|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5699198|NCT00503997|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5699200|NCT00503984|Recurrent prostate cancer|recurrent prostate cancer
5699201|NCT00503984|Stage IV prostate cancer|stage iv prostate cancer
5699202|NCT00503984|Pain|pain
5699203|NCT00503971|Vorinostat|vorinostat
5699204|NCT00503971|NSCLC|nsclc
5699205|NCT00503971|EGFR|egfr
5699206|NCT00503971|Erlotinib|erlotinib
5685770|NCT00554905|catheter|catheter
5699207|NCT00503958|non-small cell lung cancer|non-small cell lung cancer
5699208|NCT00503958|small cell lung cancer|small cell lung cancer
5699209|NCT00503958|health status unknown|health status unknown
5699210|NCT00503945|sleep apnea|sleep apnea
5699211|NCT00503945|continuous positive airway pressure|continuous positive airway pressure
5699212|NCT00503945|echocardiography|echocardiography
5699213|NCT00503945|Natriuretic peptide|natriuretic peptide
5699214|NCT00503932|Rectal Cancer|rectal cancer
5699215|NCT00503932|Capecitabine|capecitabine
5699216|NCT00503932|Proton Therapy|proton therapy
5699217|NCT00503932|Adenocarcinoma of the rectum|adenocarcinoma of the rectum
5699218|NCT00503932|Gastrointestinal|gastrointestinal
5699219|NCT00503932|Proton Radiotherapy|proton radiotherapy
5699220|NCT00503919|Cervix|cervix
5699221|NCT00503919|Cervical dysplasia|cervical dysplasia
5699222|NCT00503919|Cervical neoplasia|cervical neoplasia
5699223|NCT00503919|Cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5699224|NCT00503919|Multi-spectral Digital Colposcopy|multi-spectral digital colposcopy
5699226|NCT00503919|Acetic acid|acetic acid
5699227|NCT00503919|Colposcopy|colposcopy
5699228|NCT00503919|Spectroscopy|spectroscopy
5699229|NCT00503919|Fluorescence Spectroscopy|fluorescence spectroscopy
5699230|NCT00503919|Abnormal Pap Smear|abnormal pap smear
5699231|NCT00503906|stage IV breast cancer|stage iv breast cancer
5699232|NCT00503906|recurrent breast cancer|recurrent breast cancer
5699233|NCT00503893|Wilms' Tumor|wilms' tumor
5699234|NCT00503893|Genitourinary Anomalies|genitourinary anomalies
5699235|NCT00503893|Beckwith-Wiedemann Hemihypertrophy|beckwith-wiedemann hemihypertrophy
5699236|NCT00503893|Aniridia|aniridia
5699237|NCT00503893|Questionnaire|questionnaire
5699238|NCT00503880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5699239|NCT00503880|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5699240|NCT00503880|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5699241|NCT00503867|unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5699243|NCT00503867|SIR-Spheres|sir-spheres
5699244|NCT00503867|Y-90 Microspheres|y-90 microspheres
5699245|NCT00503867|brachytherapy|brachytherapy
5699246|NCT00503867|SIRT|sirt
5699247|NCT00503867|liver cancer|liver cancer
5699248|NCT00503841|stage I breast cancer|stage i breast cancer
5699249|NCT00503841|recurrent breast cancer|recurrent breast cancer
5699250|NCT00503841|stage II breast cancer|stage ii breast cancer
5700143|NCT00500708|CAD|cad
5699251|NCT00503841|stage IIIA breast cancer|stage iiia breast cancer
5699252|NCT00503841|stage IIIB breast cancer|stage iiib breast cancer
5699253|NCT00503841|stage IIIC breast cancer|stage iiic breast cancer
5699254|NCT00503828|Derris Scandens Benth extract|derris scandens benth extract
5699255|NCT00503828|Osteoarthritis|osteoarthritis
5699257|NCT00503828|6-minute walk|6-minute walk
5699258|NCT00503815|colonoscopy|colonoscopy
5699259|NCT00503815|bowel preparation|bowel preparation
5699260|NCT00503815|prep|prep
5699261|NCT00503802|Sleep Apnea|sleep apnea
5699262|NCT00503802|Sleep disordered breathing|sleep disordered breathing
5699263|NCT00503802|Nasal Obstruction|nasal obstruction
5699264|NCT00503802|Turbinate|turbinate
5699265|NCT00503802|Radiofrequency|radiofrequency
5699266|NCT00503802|Continuous positive airway pressure|continuous positive airway pressure
5699267|NCT00503802|CPAP|cpap
5699268|NCT00503802|Sleep surgery|sleep surgery
5699269|NCT00503789|Healthy infants|healthy infants
5699270|NCT00503776|xerostomia|xerostomia
5699271|NCT00503776|mucositis|mucositis
5699272|NCT00503776|dysphagia|dysphagia
5699273|NCT00503776|radiation toxicity|radiation toxicity
5699274|NCT00503776|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5699275|NCT00503776|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5699276|NCT00503776|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5699277|NCT00503776|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5699278|NCT00503776|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5699279|NCT00503776|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5699280|NCT00503776|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5699281|NCT00503776|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5699282|NCT00503776|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5699283|NCT00503776|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5699284|NCT00503776|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5699285|NCT00503776|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5693807|NCT00523302|TMS|tms
5699286|NCT00503776|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5699287|NCT00503776|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5699288|NCT00503776|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5699289|NCT00503776|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5699290|NCT00503776|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5699291|NCT00503776|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5699292|NCT00503776|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5699293|NCT00503776|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5699294|NCT00503776|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5699295|NCT00503776|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5699296|NCT00503776|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5699297|NCT00503776|stage III salivary gland cancer|stage iii salivary gland cancer
5699298|NCT00503776|stage IV salivary gland cancer|stage iv salivary gland cancer
5699299|NCT00503776|recurrent salivary gland cancer|recurrent salivary gland cancer
5699303|NCT00503750|Breast Cancer|breast cancer
5699304|NCT00503737|colorectal cancer screening|colorectal cancer screening
5699305|NCT00503737|National Colorectal Cancer Roundtable Toolbox|national colorectal cancer roundtable toolbox
5699306|NCT00503724|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5699307|NCT00503724|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5699308|NCT00503724|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5699309|NCT00503724|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5699310|NCT00503724|childhood choroid plexus tumor|childhood choroid plexus tumor
5699311|NCT00503724|childhood craniopharyngioma|childhood craniopharyngioma
5699312|NCT00503724|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5699313|NCT00503724|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5699314|NCT00503724|recurrent childhood ependymoma|recurrent childhood ependymoma
5699315|NCT00503724|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5699316|NCT00503724|childhood oligodendroglioma|childhood oligodendroglioma
5699317|NCT00503724|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5699318|NCT00503724|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5699319|NCT00503724|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5699320|NCT00503724|childhood grade I meningioma|childhood grade i meningioma
5699321|NCT00503724|childhood grade II meningioma|childhood grade ii meningioma
5699322|NCT00503724|childhood grade III meningioma|childhood grade iii meningioma
5699423|NCT00503217|intrauterine insemination|intrauterine insemination
5699323|NCT00503724|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5699324|NCT00503724|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5699325|NCT00503724|recurrent childhood brain tumor|recurrent childhood brain tumor
5699326|NCT00503724|disseminated neuroblastoma|disseminated neuroblastoma
5699327|NCT00503724|recurrent neuroblastoma|recurrent neuroblastoma
5699328|NCT00503711|ZD6474 PK|zd6474 pk
5699329|NCT00503685|Metastatic Colorectal Cancer with Disease Progression|metastatic colorectal cancer with disease progression
5699330|NCT00503685|Failed prior to Anti-EGFr Therapy|failed prior to anti-egfr therapy
5699331|NCT00503672|Motor Activity|motor activity
5699332|NCT00503672|Pregnancy|pregnancy
5699333|NCT00503672|Accelerometer|accelerometer
5699334|NCT00503659|PC20 FEV1|pc20 fev1
5699335|NCT00503659|PD20FEV1|pd20fev1
5699336|NCT00503659|bronchial hyperreactivity|bronchial hyperreactivity
5699337|NCT00503659|bronchial asthma|bronchial asthma
5699338|NCT00503646|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5699339|NCT00503646|sexual dysfunction and infertility|sexual dysfunction and infertility
5699340|NCT00503646|sexuality and reproductive issues|sexuality and reproductive issues
5699341|NCT00503646|stage IIB prostate cancer|stage iib prostate cancer
5699342|NCT00503646|stage IIA prostate cancer|stage iia prostate cancer
5699343|NCT00503646|stage I prostate cancer|stage i prostate cancer
5699344|NCT00503633|sleep disorders|sleep disorders
5699345|NCT00503633|genetics|genetics
5699346|NCT00503620|Cerebral Palsy|cerebral palsy
5699347|NCT00503620|Botulinum Toxin|botulinum toxin
5699348|NCT00503620|Neuromuscular Function|neuromuscular function
5699349|NCT00503607|colonoscopy|colonoscopy
5699350|NCT00503607|bowel preparation|bowel preparation
5699351|NCT00503607|prep|prep
5699352|NCT00503594|Primary central nervous system lymphoma|primary central nervous system lymphoma
5699353|NCT00503594|Brain lymphoma|brain lymphoma
5699354|NCT00503594|Elderly|elderly
5699355|NCT00503594|Chemotherapy|chemotherapy
5699356|NCT00503594|Methotrexate|methotrexate
5699357|NCT00503594|Temozolomide|temozolomide
5699358|NCT00503594|Procarbazine|procarbazine
5699359|NCT00503594|Vincristine|vincristine
5699361|NCT00503568|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5699362|NCT00503568|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5699363|NCT00503568|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5699365|NCT00503555|Hispanic Americans|hispanic americans
5699366|NCT00503542|Vaginitis|vaginitis
5699367|NCT00503542|Bacterial Vaginosis|bacterial vaginosis
5699368|NCT00503542|Vaginal trichomoniasis|vaginal trichomoniasis
5699369|NCT00503542|Vulvovaginal candidiasis|vulvovaginal candidiasis
5699370|NCT00503516|weight loss, appetite, dementia, megestrol acetate|weight loss, appetite, dementia, megestrol acetate
5699371|NCT00503477|Japan|japan
5699372|NCT00503477|Phase I|phase i
5699373|NCT00503477|solid tumor|solid tumor
5699374|NCT00503477|AZD2171|azd2171
5699375|NCT00503464|guideline|guideline
5699376|NCT00503464|adherence|adherence
5699377|NCT00503451|Advanced cancer|advanced cancer
5699378|NCT00503451|solid tumors|solid tumors
5699379|NCT00503451|lymphoma|lymphoma
5699380|NCT00503451|HDAC|hdac
5699381|NCT00503451|LBH589|lbh589
5699382|NCT00503451|adults|adults
5699383|NCT00503451|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5699384|NCT00503438|Arthritis|arthritis
5699385|NCT00503438|Osteoarthritis|osteoarthritis
5699386|NCT00503438|Arthroplasty|arthroplasty
5699387|NCT00503412|phase I|phase i
5699388|NCT00503412|AZD2171|azd2171
5699389|NCT00503412|solid tumor|solid tumor
5699390|NCT00503412|metastatic tumor|metastatic tumor
5699391|NCT00503399|Glucocorticoid Induced|glucocorticoid induced
5699392|NCT00503386|chemotherapy-induced nausea and vomiting|chemotherapy-induced nausea and vomiting
5699393|NCT00503386|acute|acute
5699394|NCT00503386|delayed|delayed
5699395|NCT00503386|emesis|emesis
5699396|NCT00503386|antiemetics|antiemetics
5699397|NCT00503386|5-HT3 receptor antagonist|5-ht3 receptor antagonist
5699398|NCT00503386|granisetron|granisetron
5699399|NCT00503386|palonosetron|palonosetron
5699400|NCT00503360|Ocular Hypertension|ocular hypertension
5699401|NCT00503360|SAD448|sad448
5699402|NCT00503347|coinfection with chronic hepatitis C virus and HIV|coinfection with chronic hepatitis c virus and hiv
5699403|NCT00503347|Treatment Naive|treatment naive
5699404|NCT00503321|gastric cancer, TS-1, PSK|gastric cancer, ts-1, psk
5699405|NCT00503308|HIV Seronegativity|hiv seronegativity
5699406|NCT00503295|reovirus|reovirus
5699407|NCT00503295|oncolytic virus|oncolytic virus
5699408|NCT00503295|sarcoma|sarcoma
5699409|NCT00503295|REOLYSIN|reolysin
5699410|NCT00503295|Oncolytics Biotech|oncolytics biotech
5699411|NCT00503269|Haemorrhoidectomy|haemorrhoidectomy
5699412|NCT00503269|Local anaesthesia|local anaesthesia
5699413|NCT00503256|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5699414|NCT00503256|Leukemia|leukemia
5699415|NCT00503256|Lymphoma|lymphoma
5699416|NCT00503256|Questionnaire|questionnaire
5699417|NCT00503256|Survey|survey
5699419|NCT00503230|tobacco|tobacco
5699420|NCT00503230|smoking|smoking
5699424|NCT00503217|GnRH agonist|gnrh agonist
5699425|NCT00503217|implantation|implantation
5699426|NCT00503204|cancer|cancer
5699427|NCT00503204|tumor|tumor
5699428|NCT00503204|advance solid tumour|advance solid tumour
5699429|NCT00503204|glioblastoma|glioblastoma
5699430|NCT00503204|malignant brain tumour|malignant brain tumour
5699431|NCT00503191|Autism|autism
5699432|NCT00503191|Neurodevelopmental disorder|neurodevelopmental disorder
5699433|NCT00503165|Menitorix|menitorix
5699434|NCT00503165|vaccine|vaccine
5699435|NCT00503126|pediatrics|pediatrics
5699436|NCT00503126|bivalirudin|bivalirudin
5699437|NCT00503100|Pain|pain
5699438|NCT00503100|Preterm-Born Adolescents|preterm-born adolescents
5699439|NCT00503087|Injections|injections
5699440|NCT00503087|Vacuum|vacuum
5699441|NCT00503087|Pain|pain
5699442|NCT00503087|Pneumatic Skin Flattening|pneumatic skin flattening
5699443|NCT00503087|PSF|psf
5699444|NCT00503074|Diet, reducing|diet, reducing
5699445|NCT00503074|Television|television
5689339|NCT00539162|Survey|survey
5699446|NCT00503074|Child Behavior|child behavior
5699447|NCT00503061|pharmaceopidemiological|pharmaceopidemiological
5699448|NCT00503061|Symbicort SMART|symbicort smart
5699450|NCT00503048|atopy|atopy
5699451|NCT00503048|atopic diseases|atopic diseases
5699452|NCT00503048|children|children
5699453|NCT00503048|orphanages|orphanages
5699454|NCT00503035|Familial Adenomatous Polyposis|familial adenomatous polyposis
5699455|NCT00503035|Colorectal Tumors|colorectal tumors
5699456|NCT00503035|Molecular Targeting|molecular targeting
5699457|NCT00503035|Celecoxib|celecoxib
5699459|NCT00503035|SC-58635|sc-58635
5699460|NCT00503035|Apoptosis Induction|apoptosis induction
5699461|NCT00503035|Colon|colon
5699462|NCT00503035|Rectum|rectum
5699463|NCT00503035|colonoscopy|colonoscopy
5699464|NCT00503035|Biopsy|biopsy
5699465|NCT00503022|Wet age-related macular degeneration|wet age-related macular degeneration
5699466|NCT00503022|ACZ885|acz885
5699467|NCT00503009|Rhinovirus|rhinovirus
5699468|NCT00503009|Asthma|asthma
5699470|NCT00502983|Epidemiology|epidemiology
5699471|NCT00502983|Leukemia|leukemia
5699472|NCT00502983|Healthy Control|healthy control
5699473|NCT00502983|Lifestyle Factors|lifestyle factors
5699474|NCT00502983|Genetic Susceptibility|genetic susceptibility
5699475|NCT00502983|Interview|interview
5699476|NCT00502983|AML|aml
5699477|NCT00502970|Chronic HCV|chronic hcv
5699478|NCT00502970|Treatment|treatment
5699479|NCT00502957|biofeedback|biofeedback
5699480|NCT00502957|constipation|constipation
5699481|NCT00502944|HIV|hiv
5699482|NCT00502944|Testing|testing
5698074|NCT00507780|POF|pof
5699483|NCT00502944|HIV Seronegativity|hiv seronegativity
5699484|NCT00502905|Acute Myeloid Leukemia|acute myeloid leukemia
5699485|NCT00502905|Myelodysplastic Syndromes|myelodysplastic syndromes
5699486|NCT00502905|Busulfan|busulfan
5699487|NCT00502905|Busulfex|busulfex
5699488|NCT00502905|Myleran|myleran
5699489|NCT00502905|Fludarabine|fludarabine
5699490|NCT00502905|Fludarabine Phosphate|fludarabine phosphate
5699491|NCT00502905|Fludara|fludara
5699492|NCT00502892|Solid Tumors|solid tumors
5699493|NCT00502892|Topotecan|topotecan
5699494|NCT00502892|Hycamtin|hycamtin
5699495|NCT00502892|Ifosfamide|ifosfamide
5699496|NCT00502892|Ifex|ifex
5699497|NCT00502892|Carboplatin|carboplatin
5699498|NCT00502892|Paraplatin|paraplatin
5699499|NCT00502892|Pediatric|pediatric
5699500|NCT00502892|Children|children
5699501|NCT00502892|Young Adults|young adults
5699502|NCT00502866|breastfeeding|breastfeeding
5699503|NCT00502866|vitamin D supplementation|vitamin d supplementation
5699504|NCT00502866|rickets|rickets
5699505|NCT00502827|Human Immunodeficiency Virus|human immunodeficiency virus
5699506|NCT00502827|HIV positive|hiv positive
5699507|NCT00502827|HIV Positive Smokers|hiv positive smokers
5699508|NCT00502827|AIDS|aids
5699509|NCT00502827|Cell Phone Intervention|cell phone intervention
5699510|NCT00502827|CPI|cpi
5699511|NCT00502827|Smoking Cessation|smoking cessation
5699512|NCT00502827|Interview|interview
5699513|NCT00502814|Breast Cancer|breast cancer
5699514|NCT00502814|3-D Optical Surface Scan|3-d optical surface scan
5699515|NCT00502814|Soft Tissue Biomechanics|soft tissue biomechanics
5699516|NCT00502814|Mechanical Testing|mechanical testing
5699517|NCT00502814|Skin Ultrasound|skin ultrasound
5699518|NCT00502814|Magnetic Resonance Imaging|magnetic resonance imaging
5699519|NCT00502814|CT Scan|ct scan
5699520|NCT00502801|Pneumonia|pneumonia
5699521|NCT00502801|Lung Infection|lung infection
5699522|NCT00502801|Bacterial Infection|bacterial infection
5699523|NCT00502801|Hospital-Acquired Infection|hospital-acquired infection
5699524|NCT00502801|Ventilator Infection|ventilator infection
5699525|NCT00502801|Antibiotic Therapy|antibiotic therapy
5699526|NCT00502775|ragweed|ragweed
5699527|NCT00502775|once daily|once daily
5699528|NCT00502775|fexofenadine|fexofenadine
5699529|NCT00502775|fluticasone furoate|fluticasone furoate
5699530|NCT00502775|allergic rhinitis|allergic rhinitis
5699531|NCT00502762|small-cell lung cancer|small-cell lung cancer
5699537|NCT00502749|Quality of Life|quality of life
5699538|NCT00502749|Questionnaire|questionnaire
5699539|NCT00502749|Survey|survey
5699540|NCT00502723|Retropubic Prostatectomy|retropubic prostatectomy
5699541|NCT00502723|Surgical Procedures|surgical procedures
5699542|NCT00502723|Laparoscopic|laparoscopic
5699544|NCT00502697|prematurity|prematurity
5699545|NCT00502697|home visitation|home visitation
5699546|NCT00502697|system of care|system of care
5699547|NCT00502684|breast cancer|breast cancer
5699548|NCT00502684|surgery|surgery
5699549|NCT00502684|immune suppression|immune suppression
5699550|NCT00502684|beta blockers|beta blockers
5699551|NCT00502684|COX2 inhibitors|cox2 inhibitors
5699552|NCT00502658|Overweight|overweight
5699553|NCT00502658|Obese|obese
5699554|NCT00502658|Dietary Supplements|dietary supplements
5699555|NCT00502658|Shakes|shakes
5699556|NCT00502658|Nutrition|nutrition
5699557|NCT00502658|Overweight and Obese Adults (BMI 25-35)|overweight and obese adults (bmi 25-35)
5699558|NCT00502645|algorithm|algorithm
5699559|NCT00502645|cs-1 decision support system|cs-1 decision support system
5699560|NCT00502645|insulin|insulin
5699561|NCT00502645|hyperglycemia|hyperglycemia
5699562|NCT00502645|tight glycemic control|tight glycemic control
5699563|NCT00502645|intensive care|intensive care
5699564|NCT00502645|adults|adults
5699565|NCT00502632|Pleural empyema|pleural empyema
5699566|NCT00502632|Pleural effusion|pleural effusion
5699567|NCT00502632|Dornase alfa|dornase alfa
5699568|NCT00502632|Urokinase|urokinase
5699569|NCT00502632|Children|children
5699570|NCT00502619|Low back pain|low back pain
5699571|NCT00502619|acupuncture|acupuncture
5699572|NCT00502619|treadmill exercise|treadmill exercise
5699573|NCT00502606|provisional restoration|provisional restoration
5699574|NCT00502606|antibacterial nanoparticles|antibacterial nanoparticles
5699575|NCT00502606|cement|cement
5699576|NCT00502606|biofilm|biofilm
5699577|NCT00502606|bacteria|bacteria
5699578|NCT00502606|flora|flora
5699579|NCT00502606|plaque|plaque
5699580|NCT00502606|dental|dental
5699582|NCT00502593|Influenza|influenza
5699583|NCT00502593|Pandemic Influenza Vaccine (GSK1562902A)|pandemic influenza vaccine (gsk1562902a)
5699584|NCT00502580|Oral Cancer|oral cancer
5699585|NCT00502580|Multispectral Digital Microscope|multispectral digital microscope
5699586|NCT00502580|Multispectral Digital Imaging|multispectral digital imaging
5699587|NCT00502580|Interview|interview
5699589|NCT00502567|advanced solid tumors|advanced solid tumors
5699590|NCT00502567|AZD2171|azd2171
5699591|NCT00502567|Phase I|phase i
5699592|NCT00502554|lung function|lung function
5699593|NCT00502554|FEV1|fev1
5699594|NCT00502528|Infarction|infarction
5707444|NCT00474435|HIV|hiv
5699595|NCT00502528|Endothelin|endothelin
5699596|NCT00502528|Perfusion|perfusion
5699597|NCT00502515|Diabetes|diabetes
5699598|NCT00502515|Neuropathy|neuropathy
5699599|NCT00502502|Anal Cancer|anal cancer
5699600|NCT00502502|Colorectal Cancer|colorectal cancer
5699601|NCT00502502|Esophageal Cancer|esophageal cancer
5699602|NCT00502502|Gastric Cancer|gastric cancer
5699603|NCT00502502|Lung Cancer|lung cancer
5699604|NCT00502502|Questionnaire|questionnaire
5699605|NCT00502502|Survey|survey
5699606|NCT00502502|Chemoradiation Therapy|chemoradiation therapy
5699607|NCT00502502|Symptoms|symptoms
5699608|NCT00502502|Cytokines|cytokines
5699609|NCT00502489|prolonged mechanical ventilation; weaning;rehabilitation|prolonged mechanical ventilation; weaning;rehabilitation
5699610|NCT00502476|MRSA|mrsa
5699611|NCT00502476|VRE|vre
5699612|NCT00502476|BSI|bsi
5699613|NCT00502463|head and neck cancer, stage III/IV|head and neck cancer, stage iii/iv
5699614|NCT00502463|no prior radiotherapy of head and neck region|no prior radiotherapy of head and neck region
5699615|NCT00502450|Acute mastoiditis|acute mastoiditis
5699616|NCT00502450|Hearing loss|hearing loss
5699617|NCT00502450|Mastoidectomy|mastoidectomy
5699618|NCT00502450|Audiogram|audiogram
5699619|NCT00502424|Rheumatoid Arthritis|rheumatoid arthritis
5699620|NCT00502424|Hand|hand
5699621|NCT00502424|Splint|splint
5699622|NCT00502424|Occupational Therapy|occupational therapy
5699623|NCT00502411|Soft Tissue Sarcoma|soft tissue sarcoma
5699624|NCT00502411|External Beam Radiotherapy|external beam radiotherapy
5699625|NCT00502411|Radiation Therapy|radiation therapy
5699626|NCT00502411|Extremity and Trunk|extremity and trunk
5699627|NCT00502411|EBRT|ebrt
5699628|NCT00502411|Sarcoma|sarcoma
5699629|NCT00502411|Doxorubicin|doxorubicin
5699630|NCT00502411|AD|ad
5699631|NCT00502411|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5699632|NCT00502411|XRT|xrt
5699633|NCT00502411|RT|rt
5699634|NCT00502411|Radiotherapy|radiotherapy
5699635|NCT00502385|Phase I|phase i
5699636|NCT00502385|AML|aml
5699637|NCT00502385|de novo or secondary AML|de novo or secondary aml
5699639|NCT00502359|Gestational diabetes, screening, glucose monitoring|gestational diabetes, screening, glucose monitoring
5699640|NCT00502346|Pharmacodynamics|pharmacodynamics
5699641|NCT00502333|back pain|back pain
5699642|NCT00502333|neck pain|neck pain
5699643|NCT00502333|prognosis|prognosis
5699644|NCT00502333|catastrophizing|catastrophizing
5699645|NCT00502333|coping strategies|coping strategies
5699646|NCT00502333|disability|disability
5699647|NCT00502333|Prognosis for back and neck pain|prognosis for back and neck pain
5699648|NCT00502320|Seasonal Affective Disorder|seasonal affective disorder
5699649|NCT00502320|Ramelteon|ramelteon
5699650|NCT00502320|Psychiatry|psychiatry
5699651|NCT00502320|Randomized Controlled Trial|randomized controlled trial
5699652|NCT00502320|Hamilton Depression Rating Scale- SAD Version|hamilton depression rating scale- sad version
5699653|NCT00502320|Circadian Rhythm|circadian rhythm
5699654|NCT00502307|Renal Cell Carcinoma|renal cell carcinoma
5699655|NCT00502307|AV-951|av-951
5699656|NCT00502307|tivozanib|tivozanib
5699657|NCT00502294|Ulcerative Colitis, UC, Intravenous Steroid-Refractory Ulcerative Colitis, IVSR-UC|ulcerative colitis, uc, intravenous steroid-refractory ulcerative colitis, ivsr-uc
5699658|NCT00502281|Gonadotropins|gonadotropins
5699659|NCT00502281|Infertility|infertility
5699660|NCT00502281|Intrauterine insemination|intrauterine insemination
5699661|NCT00502281|PCOS|pcos
5699662|NCT00502281|Timed intercourse|timed intercourse
5699664|NCT00502268|Coronary Calcification|coronary calcification
5699665|NCT00502268|Endstage Renal Disease|endstage renal disease
5699666|NCT00502268|Parathyroid hormone|parathyroid hormone
5699667|NCT00502255|Telemonitoring|telemonitoring
5699668|NCT00502255|Cost-effectiveness|cost-effectiveness
5699669|NCT00502255|Heart failure|heart failure
5699670|NCT00502255|Case management|case management
5699671|NCT00502229|Clomiphene citrate|clomiphene citrate
5699672|NCT00502229|Controlled overian stimulation|controlled overian stimulation
5699673|NCT00502229|Infertility|infertility
5699674|NCT00502229|Metformin|metformin
5699675|NCT00502229|Polycystic ovary syndrome|polycystic ovary syndrome
5699676|NCT00502229|Treatment|treatment
5699677|NCT00502216|Tobacco|tobacco
5699678|NCT00502216|Smoking|smoking
5699679|NCT00502216|Weight|weight
5699680|NCT00502216|Naltrexone|naltrexone
5699681|NCT00502216|Varenicline|varenicline
5699682|NCT00502203|Uterine Neoplasms|uterine neoplasms
5699683|NCT00502203|Endometrial Cancer|endometrial cancer
5699684|NCT00502203|Paclitaxel|paclitaxel
5699685|NCT00502203|Taxol|taxol
5699686|NCT00502203|Carboplatin|carboplatin
5699687|NCT00502203|Paraplatin|paraplatin
5699688|NCT00502203|Malignant Mixed Mullerian Tumors|malignant mixed mullerian tumors
5699689|NCT00502203|MMMT|mmmt
5699690|NCT00502203|Immunohistochemical markers|immunohistochemical markers
5699691|NCT00502190|pessary|pessary
5699692|NCT00502190|extending pregnancy|extending pregnancy
5699693|NCT00502177|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
5699694|NCT00502177|Peritoneal Neoplasms|peritoneal neoplasms
5699695|NCT00502177|Quality of Life|quality of life
5707546|NCT00474084|Stent|stent
5699696|NCT00502177|Questionnaire|questionnaire
5699697|NCT00502177|Survey|survey
5699698|NCT00502177|CHPP|chpp
5699699|NCT00502164|Advanced Prostate Cancer|advanced prostate cancer
5699700|NCT00502138|diabetes|diabetes
5699701|NCT00502138|insulin|insulin
5699702|NCT00502138|pramlintide|pramlintide
5699703|NCT00502138|IDDM|iddm
5699704|NCT00502125|Reflectance Confocal Imaging|reflectance confocal imaging
5699705|NCT00502125|Oral Mucosal Lesions|oral mucosal lesions
5699706|NCT00502125|Oral Mucosa Disease|oral mucosa disease
5699707|NCT00502125|Neoplasia Detection|neoplasia detection
5699708|NCT00502112|Lintuzumab|lintuzumab
5699709|NCT00502112|Antigens, CD33|antigens, cd33
5699710|NCT00502112|Antibodies, Monoclonal|antibodies, monoclonal
5699711|NCT00502112|Combined Modality Therapy|combined modality therapy
5699712|NCT00502112|Myelodysplastic Syndromes|myelodysplastic syndromes
5699713|NCT00502112|Hematologic Diseases|hematologic diseases
5699714|NCT00502112|Preleukemia|preleukemia
5699715|NCT00502099|Chronic hepatitis C|chronic hepatitis c
5699716|NCT00502099|pegylated interferon alfa-2a|pegylated interferon alfa-2a
5699717|NCT00502099|ribavirin, rapid virologic response|ribavirin, rapid virologic response
5699718|NCT00502099|early virologic response|early virologic response
5699719|NCT00502099|sustained virologic response|sustained virologic response
5699720|NCT00502086|Chronic hepatitis C|chronic hepatitis c
5699721|NCT00502086|Cirrhosis of the liver|cirrhosis of the liver
5699722|NCT00502086|Mortality|mortality
5699723|NCT00502086|Complications|complications
5699724|NCT00502086|Health-related quality of live|health-related quality of live
5699725|NCT00502086|Hepatocellular carcinoma|hepatocellular carcinoma
5699726|NCT00502086|Nutritional supplement|nutritional supplement
5699727|NCT00502060|Phase I|phase i
5699728|NCT00502060|AZD2171|azd2171
5699729|NCT00502060|ZD1839|zd1839
5699730|NCT00502060|solid tumor|solid tumor
5699731|NCT00502047|plantago ovata husk|plantago ovata husk
5699732|NCT00502047|soluble fibre|soluble fibre
5699733|NCT00502047|hypercholesterolemia|hypercholesterolemia
5699734|NCT00502047|cardiovascular risk factor|cardiovascular risk factor
5699735|NCT00502034|Carcinoma, Renal Cell|carcinoma, renal cell
5699736|NCT00502034|Low-dose Interleukin|low-dose interleukin
5699737|NCT00502034|Adjuvant Immunotherapy|adjuvant immunotherapy
5699738|NCT00502021|obesity|obesity
5699739|NCT00502021|alpha linolenic acid|alpha linolenic acid
5699740|NCT00502021|flaxseed|flaxseed
5699741|NCT00502021|C-reactive protein|c-reactive protein
5700174|NCT00500591|Obesity|obesity
5699742|NCT00502021|inflammation|inflammation
5699743|NCT00502008|Diabetes|diabetes
5699744|NCT00502008|India|india
5699745|NCT00502008|Coccinia Cordifolia|coccinia cordifolia
5699746|NCT00502008|Coccinia indica|coccinia indica
5699747|NCT00502008|Blood glucose levels|blood glucose levels
5699748|NCT00501995|High Dose Cyclophosphamide|high dose cyclophosphamide
5699749|NCT00501995|Systemic Sclerosis|systemic sclerosis
5699750|NCT00501995|Scleroderma|scleroderma
5699751|NCT00501995|immunoablation|immunoablation
5699752|NCT00501982|surfactant|surfactant
5699754|NCT00501982|nCPAP|ncpap
5699755|NCT00501982|Mechanical Ventilation|mechanical ventilation
5699756|NCT00501982|Premature Infants|premature infants
5699757|NCT00501982|Neonatal Respiratory Distress Syndrome (nRDS)|neonatal respiratory distress syndrome (nrds)
5699758|NCT00501969|Rotigotine|rotigotine
5699759|NCT00501969|Neupro®|neupro®
5699760|NCT00501956|chronic renal replacement therapy|chronic renal replacement therapy
5699761|NCT00501956|malnutrition anorexia|malnutrition anorexia
5699762|NCT00501956|parenteral nutrition|parenteral nutrition
5699763|NCT00501930|Dose Escalation;|dose escalation;
5699764|NCT00501930|Supratherapeutic;|supratherapeutic;
5699765|NCT00501930|GSK189075;|gsk189075;
5699766|NCT00501930|Diabetes|diabetes
5699767|NCT00501917|acute myocardial infarction|acute myocardial infarction
5699768|NCT00501904|Anovulation|anovulation
5699769|NCT00501904|Infertility|infertility
5699770|NCT00501904|Metformin|metformin
5699771|NCT00501904|PCOS|pcos
5716319|NCT00443833|genetic association study|genetic association study
5716320|NCT00443833|periodic paralysis|periodic paralysis
5716321|NCT00443833|whole genome scan|whole genome scan
5699772|NCT00501904|Treatment|treatment
5699773|NCT00501891|Glioblastoma Multiforme|glioblastoma multiforme
5699774|NCT00501891|Brain and Central Nervous System Tumors|brain and central nervous system tumors
5699775|NCT00501891|Recurrent Malignant Glioma|recurrent malignant glioma
5699776|NCT00501891|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5699777|NCT00501891|Avastin|avastin
5699778|NCT00501891|Bevacizumab|bevacizumab
5699779|NCT00501891|Temodar|temodar
5699780|NCT00501891|Temozolomide|temozolomide
5699781|NCT00501878|phenylephrine|phenylephrine
5699782|NCT00501878|mydriasis|mydriasis
5699783|NCT00501878|diabetes mellitus|diabetes mellitus
5699784|NCT00501865|healthy volunteers|healthy volunteers
5699785|NCT00501865|food effect,|food effect,
5699786|NCT00501865|quantitative pharmacokinetic analysis,|quantitative pharmacokinetic analysis,
5699787|NCT00501865|GW273225,|gw273225,
5699788|NCT00501852|COPD, Age≥40 yrs, Glycopyrronium Bromide|copd, age≥40 yrs, glycopyrronium bromide
5698401|NCT00506506|eGFR|egfr
5699789|NCT00501839|Anovulation|anovulation
5699790|NCT00501839|Clomiphene citrate|clomiphene citrate
5699791|NCT00501839|Infertility|infertility
5699792|NCT00501839|PCOS|pcos
5699793|NCT00501839|Treatment|treatment
5699794|NCT00501813|Hepatocellular carcinoma|hepatocellular carcinoma
5699795|NCT00501813|Intrahepatic vessels invasion|intrahepatic vessels invasion
5699796|NCT00501813|Hepatectomy|hepatectomy
5699797|NCT00501813|Transcatheter arterial chemoembolization|transcatheter arterial chemoembolization
5699798|NCT00501813|Local regional treatment|local regional treatment
5699799|NCT00501800|Reproductive Health|reproductive health
5699800|NCT00501800|Fertility|fertility
5699801|NCT00501800|Infertility|infertility
5699802|NCT00501800|Genetics|genetics
5699803|NCT00501800|Continental Population Groups|continental population groups
5699804|NCT00501800|Epidemiology|epidemiology
5699805|NCT00501800|Aging|aging
5699806|NCT00501800|Health|health
5699807|NCT00501787|Anovulation|anovulation
5699808|NCT00501787|metformin|metformin
5699809|NCT00501787|PCOS|pcos
5699810|NCT00501787|treatment|treatment
5699811|NCT00501774|Localized vulvodynia|localized vulvodynia
5699812|NCT00501774|Helicobacter pylori|helicobacter pylori
5699813|NCT00501774|peptic disease|peptic disease
5699814|NCT00501774|omeprazole|omeprazole
5699815|NCT00501761|Endometrial Cancer|endometrial cancer
5699816|NCT00501761|Healthy Controls|healthy controls
5699817|NCT00501761|Social Cognitive Theory|social cognitive theory
5699818|NCT00501761|Behavioral Intervention|behavioral intervention
5699819|NCT00501761|Physical Activity|physical activity
5699820|NCT00501761|Exercise Program|exercise program
5699821|NCT00501761|Questionnaire|questionnaire
5699822|NCT00501748|Neuromyelitis Optica|neuromyelitis optica
5699823|NCT00501748|acute transverse myelitis|acute transverse myelitis
5699824|NCT00501735|T-Cell|t-cell
5699825|NCT00501735|Lymphoma|lymphoma
5699826|NCT00501735|Forodesine|forodesine
5699827|NCT00501735|Mycosis Fungoides|mycosis fungoides
5699828|NCT00501722|cirrhotic ascites|cirrhotic ascites
5699829|NCT00501722|hyponatraemia|hyponatraemia
5699830|NCT00501683|metabolite profiling|metabolite profiling
5699831|NCT00501683|excretion,|excretion,
5699832|NCT00501683|radioactivity,|radioactivity,
5699833|NCT00501683|pharmacokinetic,|pharmacokinetic,
5699834|NCT00501683|mass balance,|mass balance,
5699835|NCT00501670|Herpes zoster|herpes zoster
5699836|NCT00501670|PCR|pcr
5699837|NCT00501670|Varicella zoster Virus (VZV)|varicella zoster virus (vzv)
5699838|NCT00501670|Shingles|shingles
5699839|NCT00501670|GSK Biologicals|gsk biologicals
5699840|NCT00501657|gastric emptying|gastric emptying
5699841|NCT00501657|glycemia|glycemia
5699842|NCT00501657|appetite|appetite
5699843|NCT00501657|incretin hormones|incretin hormones
5699844|NCT00501644|Müllerian Carcinomas|müllerian carcinomas
5699845|NCT00501644|Ovarian Cancer|ovarian cancer
5699846|NCT00501644|Fallopian Tube Cancer|fallopian tube cancer
5699847|NCT00501644|Peritoneal Cancer|peritoneal cancer
5699848|NCT00501644|Epithelial Ovarian|epithelial ovarian
5699849|NCT00501644|Peritoneal|peritoneal
5699850|NCT00501644|Fallopian Tube|fallopian tube
5699851|NCT00501644|Chemoimmunotherapy|chemoimmunotherapy
5699852|NCT00501644|Platinum Sensitive Müllerian|platinum sensitive müllerian
5699853|NCT00501644|Carboplatin|carboplatin
5699854|NCT00501644|Paraplatin|paraplatin
5699856|NCT00501644|Sargramostim|sargramostim
5699857|NCT00501644|Interferon Gamma|interferon gamma
5699858|NCT00501644|Quality of Life|quality of life
5699860|NCT00501631|Addiction|addiction
5699861|NCT00501631|Alcoholism|alcoholism
5699862|NCT00501631|Inpatient detoxification|inpatient detoxification
5699863|NCT00501618|Schizophrenia|schizophrenia
5699864|NCT00501618|Schizoaffective Disorder|schizoaffective disorder
5716434|NCT00443378|HIV|hiv
5699865|NCT00501618|Orally dissolving clozapine|orally dissolving clozapine
5699866|NCT00501618|orally disintegrating clozapine|orally disintegrating clozapine
5699867|NCT00501618|bio-equivalence|bio-equivalence
5699868|NCT00501618|desmethylclozapine|desmethylclozapine
5699869|NCT00501618|clozapine plasma level|clozapine plasma level
5699870|NCT00501618|equivalence|equivalence
5699871|NCT00501618|fazaclo|fazaclo
5699872|NCT00501618|generic clozapine|generic clozapine
5699873|NCT00501605|Phase I|phase i
5699874|NCT00501605|AZD2171|azd2171
5699875|NCT00501605|advanced solid tumors|advanced solid tumors
5699876|NCT00501592|Farnesoid X receptor agonist|farnesoid x receptor agonist
5699877|NCT00501592|Metabolic Disorder|metabolic disorder
5699878|NCT00501592|Diabetes|diabetes
5699879|NCT00501592|NAFLD|nafld
5699880|NCT00501566|cirrhotic ascites|cirrhotic ascites
5699881|NCT00501553|Heart Failure,|heart failure,
5699883|NCT00501553|NT-proBNP|nt-probnp
5699884|NCT00501540|low-grade neuroendocrine tumors|low-grade neuroendocrine tumors
5699885|NCT00501540|lithium|lithium
5699886|NCT00501527|Allergoid|allergoid
5699887|NCT00501527|Depigmented|depigmented
5699888|NCT00501527|Polymerized|polymerized
5699889|NCT00501527|Allergen-extract|allergen-extract
5699890|NCT00501527|Rhinoconjunctivitis|rhinoconjunctivitis
5699891|NCT00501527|Asthma|asthma
5685771|NCT00554905|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5685772|NCT00554905|therapy|therapy
5685773|NCT00554905|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5699892|NCT00501514|chronic heart failure|chronic heart failure
5699893|NCT00501514|cardiopulmonary exercise|cardiopulmonary exercise
5699894|NCT00501514|oxygen consumption|oxygen consumption
5699895|NCT00501514|growth hormone|growth hormone
5699896|NCT00501501|Rehospitalization|rehospitalization
5699897|NCT00501501|Cesarean|cesarean
5699898|NCT00501501|Vaginal delivery|vaginal delivery
5699899|NCT00501488|pharmacodynamics|pharmacodynamics
5699900|NCT00501488|insulin resistance|insulin resistance
5699901|NCT00501488|therapy|therapy
5699902|NCT00501488|volunteer|volunteer
5699903|NCT00501475|N-acetylcysteine|n-acetylcysteine
5699904|NCT00501475|nephropathy|nephropathy
5699905|NCT00501475|bicarbonate|bicarbonate
5699906|NCT00501462|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5699907|NCT00501462|renal insufficiency|renal insufficiency
5699908|NCT00501449|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5699909|NCT00501449|Questionnaire|questionnaire
5699910|NCT00501449|Psychosocial|psychosocial
5699911|NCT00501449|Surveillance Behaviors|surveillance behaviors
5699912|NCT00501449|MEN Syndromes|men syndromes
5699913|NCT00501423|antiplatelet drug|antiplatelet drug
5699914|NCT00501423|resistance|resistance
5699915|NCT00501423|atherothrombosis|atherothrombosis
5699916|NCT00501410|Colorectal Cancer|colorectal cancer
5699917|NCT00501410|Dual Inhibition of EGFR|dual inhibition of egfr
5699918|NCT00501410|FOLFOX Chemotherapy|folfox chemotherapy
5699919|NCT00501410|5-FU|5-fu
5699920|NCT00501410|Cetuximab|cetuximab
5699921|NCT00501410|Dasatinib|dasatinib
5699922|NCT00501410|Leucovorin|leucovorin
5699923|NCT00501410|Oxaliplatin|oxaliplatin
5699924|NCT00501410|5-Fluorouracil|5-fluorouracil
5699925|NCT00501410|BMS-354825|bms-354825
5699926|NCT00501410|Eloxatin|eloxatin
5699927|NCT00501410|Sprycel|sprycel
5699928|NCT00501410|C225|c225
5699929|NCT00501410|Erbitux|erbitux
5699930|NCT00501410|IMC-C225|imc-c225
5699931|NCT00501410|Adrucil|adrucil
5699932|NCT00501410|Efudex|efudex
5699933|NCT00501410|Folinic Acid|folinic acid
5699934|NCT00501397|ketoconazole,|ketoconazole,
5699935|NCT00501397|drug interaction,|drug interaction,
5699936|NCT00501397|pharmacokinetics|pharmacokinetics
5699937|NCT00501397|T2DM,|t2dm,
5699938|NCT00501384|cirrhotic ascites|cirrhotic ascites
5699939|NCT00501371|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5699940|NCT00501371|MCS|mcs
5700144|NCT00500708|GWAS|gwas
5699941|NCT00501371|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5699942|NCT00501371|International prostate symptom score|international prostate symptom score
5699943|NCT00501371|Voiding|voiding
5699944|NCT00501371|Alpha-blockers|alpha-blockers
5699945|NCT00501358|SLEEP APNEA|sleep apnea
5709183|NCT00468065|IV|iv
5699946|NCT00501358|venous thromboembolism|venous thromboembolism
5699947|NCT00501358|COAGULABILITY|coagulability
5699948|NCT00501358|COAGULATION FACTORS|coagulation factors
5699949|NCT00501358|HYPOXIA|hypoxia
5699950|NCT00501345|Thrombocytopenia|thrombocytopenia
5699951|NCT00501345|Platelet Function|platelet function
5699952|NCT00501345|Acute Coronary Syndrome|acute coronary syndrome
5699953|NCT00501345|Myocardial Infarction|myocardial infarction
5699954|NCT00501345|Heart Attack|heart attack
5699955|NCT00501345|Aspirin|aspirin
5699956|NCT00501332|neutropenia|neutropenia
5699957|NCT00501332|breast|breast
5699958|NCT00501332|cancer|cancer
5699959|NCT00501332|chemotherapy|chemotherapy
5699960|NCT00501319|Interactive Voice Response Telephone System|interactive voice response telephone system
5699961|NCT00501319|Non-Small Cell Lung Cancer|non-small cell lung cancer
5699962|NCT00501319|Lung Cancer|lung cancer
5699963|NCT00501319|Questionnaire|questionnaire
5699964|NCT00501319|Survey|survey
5699965|NCT00501319|NSCLC|nsclc
5699966|NCT00501319|IVR|ivr
5699972|NCT00501280|Genetic Susceptibility|genetic susceptibility
5699973|NCT00501280|Migrant Farmworker Children|migrant farmworker children
5699974|NCT00501280|Migrant Education Program|migrant education program
5699976|NCT00501280|Questionnaire|questionnaire
5699977|NCT00501267|solabegron,|solabegron,
5699978|NCT00501267|oxybutynin,|oxybutynin,
5699979|NCT00501267|healthy adults,|healthy adults,
5699980|NCT00501267|drug interaction|drug interaction
5699981|NCT00501254|Slow release ASA|slow release asa
5699982|NCT00501254|Platelet functionalism|platelet functionalism
5699983|NCT00501254|Secondary cardiovascular prevention|secondary cardiovascular prevention
5699984|NCT00501228|Graft-Versus-Host Disease|graft-versus-host disease
5699985|NCT00501228|Stem Cell Transplantation|stem cell transplantation
5699986|NCT00501228|Tissue Repair|tissue repair
5699987|NCT00501228|Organ-Specific Tissue Damage|organ-specific tissue damage
5699988|NCT00501228|Filgrastim|filgrastim
5699990|NCT00501215|Primary Hyperparathyroidism|primary hyperparathyroidism
5699992|NCT00501215|Parathyroidectomy|parathyroidectomy
5699993|NCT00501215|Polysomnogram|polysomnogram
5699994|NCT00501215|PSG|psg
5699995|NCT00501215|Sleep Quality|sleep quality
5699996|NCT00501215|Interview|interview
5699997|NCT00501202|diabetes mellitus|diabetes mellitus
5699998|NCT00501202|diabetic microvascular injury|diabetic microvascular injury
5699999|NCT00501202|painful polyneuropathy.|painful polyneuropathy.
5700000|NCT00501189|Gardasil|gardasil
5700001|NCT00501189|Human Papilloma Virus|human papilloma virus
5700002|NCT00501189|Papanicolaou Smear|papanicolaou smear
5700003|NCT00501189|ASCUS|ascus
5700004|NCT00501189|LGSIL|lgsil
5700005|NCT00501189|Human Papilloma Virus Vaccine|human papilloma virus vaccine
5700006|NCT00501189|Human Papillomavirus Infection|human papillomavirus infection
5700007|NCT00501176|Pancreas|pancreas
5700008|NCT00501176|cancer|cancer
5700009|NCT00501176|SEMS|sems
5700010|NCT00501176|Plastic|plastic
5700011|NCT00501176|stent|stent
5700012|NCT00501176|Whipple|whipple
5700013|NCT00501176|Jaundicie|jaundicie
5700014|NCT00501163|Schizophrenia|schizophrenia
5700015|NCT00501163|Cardiovascular|cardiovascular
5700016|NCT00501163|Risk|risk
5700017|NCT00501150|linezolid|linezolid
5700018|NCT00501150|vancomycin|vancomycin
5700019|NCT00501150|glycopeptides|glycopeptides
5700020|NCT00501150|methicillin resistant staphylococcus aureus|methicillin resistant staphylococcus aureus
5700021|NCT00501150|resistant gram positive infections|resistant gram positive infections
5700022|NCT00501137|HPV|hpv
5700023|NCT00501137|HPV vaccine|hpv vaccine
5700024|NCT00501137|Gardasil|gardasil
5700025|NCT00501137|Human Papillomavirus|human papillomavirus
5700026|NCT00501137|vaccine|vaccine
5700027|NCT00501137|2 dose versus 3|2 dose versus 3
5700028|NCT00501111|Dementia|dementia
5700029|NCT00501111|Alzheimer Type|alzheimer type
5700030|NCT00501111|Alzheimer Disease|alzheimer disease
5700031|NCT00501098|Leukemia|leukemia
5700032|NCT00501098|Prophylaxis|prophylaxis
5700033|NCT00501098|Fungal Infections|fungal infections
5700034|NCT00501098|Caspofungin|caspofungin
5700035|NCT00501072|hyperglycemia|hyperglycemia
5700036|NCT00501072|hypoglycemia|hypoglycemia
5700037|NCT00501072|glucose variability|glucose variability
5700038|NCT00501072|insulin infusion system; implantable insulin pump|insulin infusion system; implantable insulin pump
5700039|NCT00501072|continuous glucose monitoring|continuous glucose monitoring
5700040|NCT00501059|Primary prevention of coronary heart disease|primary prevention of coronary heart disease
5700062|NCT00500981|Fluid responsiveness|fluid responsiveness
5700063|NCT00500968|Pancreas|pancreas
5700064|NCT00500968|Leakage|leakage
5700065|NCT00500968|Fistula|fistula
5700066|NCT00500968|tail|tail
5700067|NCT00500955|microalbuminuria,|microalbuminuria,
5700068|NCT00500955|Type 2 Diabetes|type 2 diabetes
5700069|NCT00500955|rosiglitazone,|rosiglitazone,
5700070|NCT00500942|Interventional Radiology|interventional radiology
5700071|NCT00500942|Pain Quantification|pain quantification
5700072|NCT00500942|Pain Management|pain management
5700073|NCT00500942|Patient Satisfaction|patient satisfaction
5700074|NCT00500942|Questionnaire|questionnaire
5700075|NCT00500942|Survey|survey
5700076|NCT00500929|OHSP|ohsp
5700077|NCT00500929|High risk|high risk
5700078|NCT00500929|Geriatrics|geriatrics
5700079|NCT00500903|Drug therapy|drug therapy
5700088|NCT00500877|Smoking cessation|smoking cessation
5700089|NCT00500877|Phone Counseling|phone counseling
5700090|NCT00500864|COPD|copd
5700091|NCT00500864|Magnesium|magnesium
5700092|NCT00500864|Pulmonary function|pulmonary function
5700093|NCT00500864|Exercise Physiology|exercise physiology
5700094|NCT00500851|critical illness|critical illness
5700095|NCT00500851|enteral nutrition|enteral nutrition
5700096|NCT00500851|gastrointestinal intubation|gastrointestinal intubation
5700097|NCT00500838|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5700098|NCT00500838|Transthoracic Impedance|transthoracic impedance
5700099|NCT00500825|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5700100|NCT00500825|Therapeutic hypothermia|therapeutic hypothermia
5700101|NCT00500825|resting energy expenditure|resting energy expenditure
5700102|NCT00500812|biologic drug|biologic drug
5700103|NCT00500812|transport sequence|transport sequence
5700105|NCT00500812|spinal cord injury|spinal cord injury
5700107|NCT00500812|paraplegia|paraplegia
5700108|NCT00500812|tetraplegia|tetraplegia
5700109|NCT00500812|quadraplegia|quadraplegia
5700110|NCT00500812|trauma|trauma
5700111|NCT00500812|nervous system|nervous system
5700112|NCT00500812|fibrin sealant|fibrin sealant
5700113|NCT00500812|neurosurgery|neurosurgery
5700114|NCT00500799|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5700115|NCT00500799|Blink Reflex|blink reflex
5700116|NCT00500799|Blepharospasm|blepharospasm
5700117|NCT00500799|Healthy Volunteer|healthy volunteer
5700118|NCT00500799|HV|hv
5700119|NCT00500773|cardiovascular risc factors|cardiovascular risc factors
5700120|NCT00500773|inflammation|inflammation
5700122|NCT00500760|Head and Neck Cancer|head and neck cancer
5700124|NCT00500747|hepatitis C, HCV, vaccine, recombinant vaccine, adjuvant|hepatitis c, hcv, vaccine, recombinant vaccine, adjuvant
5700125|NCT00500734|Cardiomyopathy|cardiomyopathy
5700126|NCT00500734|Tissue Bank|tissue bank
5700127|NCT00500734|Heart Disease|heart disease
5700128|NCT00500734|Heart Failure|heart failure
5700129|NCT00500734|Congestive Heart Failure|congestive heart failure
5700130|NCT00500721|healthy subjects|healthy subjects
5700131|NCT00500708|Heart failure|heart failure
5700132|NCT00500708|Implanted Cardioverter Defibrillator|implanted cardioverter defibrillator
5700133|NCT00500708|Biological Markers|biological markers
5700134|NCT00500708|Molecular Genetics|molecular genetics
5700135|NCT00500708|Coronary Heart Disease|coronary heart disease
5700136|NCT00500708|Gene Expression|gene expression
5700137|NCT00500708|GES|ges
5700138|NCT00500708|CVD|cvd
5700139|NCT00500708|CHD|chd
5700140|NCT00500708|Precision Medicine|precision medicine
5700141|NCT00500708|Genome-wide association study|genome-wide association study
5700142|NCT00500708|Cardiovascular Disease|cardiovascular disease
5700146|NCT00500682|Kidney Diseases|kidney diseases
5700147|NCT00500669|Varicose veins|varicose veins
5700148|NCT00500669|wound infection|wound infection
5700149|NCT00500669|recurrence|recurrence
5700150|NCT00500617|Atherosclerosis|atherosclerosis
5700151|NCT00500617|Biological Markers|biological markers
5700152|NCT00500617|Molecular Genetics|molecular genetics
5700153|NCT00500617|Gene Expression|gene expression
5700154|NCT00500617|GES|ges
5700155|NCT00500617|CAD|cad
5700156|NCT00500617|CVD|cvd
5700157|NCT00500617|CHD|chd
5700158|NCT00500617|Clinical Validity|clinical validity
5700159|NCT00500617|Precision Medicine|precision medicine
5700160|NCT00500617|ASGES|asges
5700161|NCT00500617|CT Angiography|ct angiography
5700162|NCT00500617|Corus CAD|corus cad
5700163|NCT00500617|Coronary angiorgram|coronary angiorgram
5700164|NCT00500617|Age/Sex/Gene expression Score|age/sex/gene expression score
5700165|NCT00500617|Coronary Artery Disease|coronary artery disease
5700166|NCT00500617|Angina Pectoris|angina pectoris
5700167|NCT00500617|Chest Pain|chest pain
5700168|NCT00500617|Cardiovascular Disease|cardiovascular disease
5700169|NCT00500617|Coronary Heart Disease|coronary heart disease
5700170|NCT00500617|CTA|cta
5700171|NCT00500617|PREDICT|predict
5700172|NCT00500591|Endometrial Abnormalities|endometrial abnormalities
5700173|NCT00500591|Endometrial Cancer|endometrial cancer
5700176|NCT00500591|Questionnaire|questionnaire
5700177|NCT00500578|Hematological Malignancies|hematological malignancies
5700178|NCT00500578|Respiratory Infection|respiratory infection
5700179|NCT00500578|Respiratory Syncytial Virus|respiratory syncytial virus
5700180|NCT00500578|RSV|rsv
5700181|NCT00500578|Ribavirin|ribavirin
5700182|NCT00500578|Virazole|virazole
5700183|NCT00500565|Breast Cancer|breast cancer
5700184|NCT00500565|On-Q Pain Relief System|on-q pain relief system
5700185|NCT00500565|Transverse Rectus Abdominous Myocutaneous|transverse rectus abdominous myocutaneous
5700186|NCT00500565|Breast Reconstruction|breast reconstruction
5700187|NCT00500565|TRAM flap|tram flap
5700188|NCT00500565|Bupivicaine|bupivicaine
5700189|NCT00500565|Pain Management|pain management
5700190|NCT00500552|Perhexiline|perhexiline
5700191|NCT00500552|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5700192|NCT00500539|Asthma|asthma
5700193|NCT00500539|omalizumab|omalizumab
5700194|NCT00500539|safety|safety
5700195|NCT00500539|allergic asthma|allergic asthma
5700196|NCT00500539|adolescents|adolescents
5700197|NCT00500526|COPD|copd
5700198|NCT00500526|Pulmonary function|pulmonary function
5700199|NCT00500526|Respiratory muscle|respiratory muscle
5700200|NCT00500526|Dyspnea|dyspnea
5700201|NCT00500526|Quality of life|quality of life
5700202|NCT00500513|Lung Cancer|lung cancer
5700203|NCT00500513|Respiratory-Induced Tumor Motion|respiratory-induced tumor motion
5700204|NCT00500513|Tumor Motion|tumor motion
5700205|NCT00500513|Pulmonary Function|pulmonary function
5700206|NCT00500513|Fiducial Marker|fiducial marker
5700207|NCT00500487|HIV prevention|hiv prevention
5700208|NCT00500487|HIV seronegativity|hiv seronegativity
5700209|NCT00500474|Meniere's disease|meniere's disease
5700210|NCT00500474|inner ear|inner ear
5700211|NCT00500474|endolymphatic sac drainage|endolymphatic sac drainage
5700212|NCT00500474|steroids|steroids
5700213|NCT00500474|declined surgery|declined surgery
5700214|NCT00500474|natural course|natural course
5700215|NCT00500474|Efficacy of steroids via endolymphatic sac|efficacy of steroids via endolymphatic sac
5700216|NCT00500474|for intractable Meniere's disease|for intractable meniere's disease
5700217|NCT00500461|Muscarinic Receptor Antagonist,|muscarinic receptor antagonist,
5700218|NCT00500461|intravenous infusion,|intravenous infusion,
5700219|NCT00500461|pharmacokinetics|pharmacokinetics
5700220|NCT00500461|healthy subjects,|healthy subjects,
5700221|NCT00500461|safety,|safety,
5700222|NCT00500461|tolerability,|tolerability,
5700223|NCT00500461|Anticholinergic,|anticholinergic,
5700224|NCT00500461|oral dosing,|oral dosing,
5700225|NCT00500448|Arthritis, Knee, Quadriceps, Electrical Stimulation, Women|arthritis, knee, quadriceps, electrical stimulation, women
5700227|NCT00500435|Laparoscopy|laparoscopy
5700228|NCT00500435|Lymph Node Dissection|lymph node dissection
5700229|NCT00500435|Extraperitoneal Laparoscopic Lymphadenectomy|extraperitoneal laparoscopic lymphadenectomy
5700230|NCT00500422|Solid Tumors|solid tumors
5700231|NCT00500422|Doxil|doxil
5700232|NCT00500422|Adriamycin|adriamycin
5700233|NCT00500422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5700234|NCT00500422|Liposomal Doxorubicin|liposomal doxorubicin
5700235|NCT00500422|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5700236|NCT00500422|Gemcitabine|gemcitabine
5700237|NCT00500422|Gemzar|gemzar
5700238|NCT00500422|Bortezomib|bortezomib
5700239|NCT00500422|Velcade|velcade
5700240|NCT00500422|PS341|ps341
5700241|NCT00500422|PS-341|ps-341
5700242|NCT00500422|LDP-341|ldp-341
5700243|NCT00500422|MLN341|mln341
5700244|NCT00500409|rhPTH(1-34)|rhpth(1-34)
5700245|NCT00500409|Osteoporosis|osteoporosis
5700246|NCT00500396|Retinopathy of Prematurity.|retinopathy of prematurity.
5700247|NCT00500396|ROP.|rop.
5700352|NCT00499954|glucose sensor|glucose sensor
5700248|NCT00500396|Vascular Endothelial Growth Factor.|vascular endothelial growth factor.
5700249|NCT00500396|VEGF.|vegf.
5700250|NCT00500396|Vitreous.|vitreous.
5700251|NCT00500396|Subretinal Fluid.|subretinal fluid.
5700252|NCT00500396|ELISA.|elisa.
5700253|NCT00500383|Breast Cancer Risk|breast cancer risk
5700254|NCT00500383|BRCA1|brca1
5700255|NCT00500383|BRCA2|brca2
5700256|NCT00500383|Breast Cancer Susceptibility gene|breast cancer susceptibility gene
5700257|NCT00500383|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5700258|NCT00500383|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5700259|NCT00500370|exenatide|exenatide
5700260|NCT00500370|obesity|obesity
5700261|NCT00500370|diabetes|diabetes
5700262|NCT00500370|Amylin|amylin
5700263|NCT00500370|Lilly|lilly
5700264|NCT00500344|Age-related Macular Degeneration|age-related macular degeneration
5700265|NCT00500344|Choroidal Neovascularization|choroidal neovascularization
5700266|NCT00500344|Electroretinography|electroretinography
5700267|NCT00500344|Retinal Function|retinal function
5700268|NCT00500331|Pioglitazone|pioglitazone
5700269|NCT00500331|HbA1c|hba1c
5700270|NCT00500331|Diabetes mellitus|diabetes mellitus
5700271|NCT00500318|Bronchitis, Chronic; Emphysema|bronchitis, chronic; emphysema
5700272|NCT00500305|indomethacin therapy|indomethacin therapy
5700273|NCT00500305|patent ductus arteriosus|patent ductus arteriosus
5700274|NCT00500292|colorectal|colorectal
5700277|NCT00500279|Drug-eluting stent|drug-eluting stent
5700278|NCT00500279|Restenosis|restenosis
5700279|NCT00500279|Celecoxib|celecoxib
5700280|NCT00500253|exhaled nitric oxide|exhaled nitric oxide
5700281|NCT00500253|asthma|asthma
5700282|NCT00500253|children|children
5700283|NCT00500253|inhaled glucocorticosteroids|inhaled glucocorticosteroids
5700284|NCT00500240|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5700285|NCT00500240|Leukemia|leukemia
5700286|NCT00500240|Lymphoma|lymphoma
5700287|NCT00500240|Burkitts Lymphoma|burkitts lymphoma
5700288|NCT00500240|Lymphoblastic Leukemia|lymphoblastic leukemia
5700289|NCT00500240|Blood Sugar|blood sugar
5700290|NCT00500240|Hyperglycemia|hyperglycemia
5700291|NCT00500240|Insulin Aspart|insulin aspart
5700292|NCT00500240|Insulin Glargine|insulin glargine
5700293|NCT00500240|Hyper-CVAD|hyper-cvad
5700294|NCT00500214|inguinal hernia|inguinal hernia
5700295|NCT00500214|herniorrhaphy|herniorrhaphy
5700297|NCT00500214|ilioinguinal neurectomy|ilioinguinal neurectomy
5700298|NCT00500214|postoperative pain in cases and controls during one year.|postoperative pain in cases and controls during one year.
5700299|NCT00500214|postoperative hyposthesia in cases and controls during one year.|postoperative hyposthesia in cases and controls during one year.
5700300|NCT00500201|Healthy Volunteer|healthy volunteer
5700301|NCT00500188|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5700302|NCT00500188|GIST|gist
5700303|NCT00500188|Kit expression|kit expression
5700304|NCT00500188|Resectable|resectable
5700305|NCT00500188|Imatinib Mesylate|imatinib mesylate
5700306|NCT00500188|Gleevec|gleevec
5700307|NCT00500188|STI-571|sti-571
5700308|NCT00500188|Imatinib|imatinib
5700310|NCT00500175|diabetes|diabetes
5700311|NCT00500175|ulceration|ulceration
5700312|NCT00500175|amputation|amputation
5700313|NCT00500175|pressure sores|pressure sores
5700314|NCT00500175|shear friction|shear friction
5700315|NCT00500136|bias|bias
5700316|NCT00500123|alpha-1|alpha-1
5700317|NCT00500123|antitrypsin|antitrypsin
5700319|NCT00500123|genetic testing|genetic testing
5700320|NCT00500123|alpha-1 antitrypsin deficiency|alpha-1 antitrypsin deficiency
5700321|NCT00500123|AATD|aatd
5700322|NCT00500110|Prostate Cancer|prostate cancer
5700323|NCT00500110|Hormonal Ablation|hormonal ablation
5700324|NCT00500110|Docetaxel|docetaxel
5700325|NCT00500110|Imatinib Mesylate|imatinib mesylate
5700326|NCT00500110|STI571|sti571
5700327|NCT00500110|Gleevec|gleevec
5700328|NCT00500110|Taxotere|taxotere
5700329|NCT00500110|Goserelin Acetate|goserelin acetate
5700331|NCT00500110|Leuprolide|leuprolide
5700332|NCT00500110|Lupron|lupron
5700333|NCT00500084|Chronic Pancreatitis|chronic pancreatitis
5700334|NCT00500084|Pancreatectomy|pancreatectomy
5700335|NCT00500058|Rituximab,|rituximab,
5700336|NCT00500058|oncology|oncology
5700337|NCT00500058|IL-18,|il-18,
5700338|NCT00500058|combination study,|combination study,
5700339|NCT00500058|cytokine,|cytokine,
5700340|NCT00500045|CRVO|crvo
5700341|NCT00500045|HRVO|hrvo
5700342|NCT00500045|BRVO|brvo
5700343|NCT00500032|Adult|adult
5685774|NCT00554905|Humans|humans
5700344|NCT00499980|Breast cancer|breast cancer
5700345|NCT00499980|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5700346|NCT00499980|Oximetry|oximetry
5700347|NCT00499967|genital warts|genital warts
5700348|NCT00499967|venereal warts|venereal warts
5700349|NCT00499967|human papilloma virus|human papilloma virus
5700350|NCT00499954|microdialysis|microdialysis
5700351|NCT00499954|subcutaneous adipose tissue|subcutaneous adipose tissue
5700353|NCT00499954|glucose monitoring|glucose monitoring
5700354|NCT00499954|type 1 diabetes|type 1 diabetes
5700355|NCT00499954|Guardian RT|guardian rt
5700356|NCT00499954|Glucoday S|glucoday s
5700357|NCT00499941|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5700358|NCT00499928|SB-751689|sb-751689
5700359|NCT00499928|osteoporosis|osteoporosis
5700360|NCT00499928|metabolism|metabolism
5700361|NCT00499928|excretion|excretion
5700362|NCT00499902|AIS|ais
5700363|NCT00499902|acute ischemic stroke|acute ischemic stroke
5700364|NCT00499902|stroke|stroke
5700365|NCT00499902|alfimeprase|alfimeprase
5700366|NCT00499902|blood clot|blood clot
5700367|NCT00499902|brain|brain
5700368|NCT00499902|thrombus|thrombus
5700369|NCT00499902|thrombolytic|thrombolytic
5700370|NCT00499902|thrombosis|thrombosis
5700371|NCT00499902|plasminogen activator|plasminogen activator
5700372|NCT00499902|arterial flow|arterial flow
5700373|NCT00499902|neurology|neurology
5700374|NCT00499902|intra-arterial|intra-arterial
5700375|NCT00499902|intra-thrombus|intra-thrombus
5700376|NCT00499902|catheter-directed|catheter-directed
5700377|NCT00499902|symptomatic ICH|symptomatic ich
5700378|NCT00499902|ICH|ich
5700379|NCT00499902|AOL|aol
5700380|NCT00499902|arterial occlusive lesion|arterial occlusive lesion
5700381|NCT00499902|recanalization|recanalization
5700382|NCT00499889|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5700383|NCT00499889|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5700385|NCT00499889|Imatinib Mesylate|imatinib mesylate
5700386|NCT00499889|Gleevec|gleevec
5700387|NCT00499889|Busulfan|busulfan
5700388|NCT00499889|Busulfex|busulfex
5700389|NCT00499889|Myleran|myleran
5700390|NCT00499889|Fludarabine|fludarabine
5700391|NCT00499889|ATG|atg
5700392|NCT00499889|STI571|sti571
5700393|NCT00499889|Antithymocyte Globulin|antithymocyte globulin
5700394|NCT00499889|Thymoglobulin|thymoglobulin
5700395|NCT00499876|Human immune deficiency virus|human immune deficiency virus
5700396|NCT00499876|Acquired immune deficiency syndrome|acquired immune deficiency syndrome
5700397|NCT00499876|malaria|malaria
5700398|NCT00499876|mefloquine|mefloquine
5700399|NCT00499876|prophylaxis|prophylaxis
5700400|NCT00499876|HIV/AIDS|hiv/aids
5700401|NCT00499876|Treatment Naive|treatment naive
5700402|NCT00499850|ZD6474|zd6474
5700403|NCT00499850|FOLFOX|folfox
5700404|NCT00499850|colorectal|colorectal
5700405|NCT00499850|adenocarcinoma|adenocarcinoma
5700406|NCT00500266|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5700408|NCT00499824|Diabetes|diabetes
5700409|NCT00499824|Management guidelines|management guidelines
5700410|NCT00499824|Efficacy|efficacy
5700411|NCT00499798|infertility|infertility
5700412|NCT00499798|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5700413|NCT00499798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5700414|NCT00499798|adult diffuse astrocytoma|adult diffuse astrocytoma
5700415|NCT00499798|adult giant cell glioblastoma|adult giant cell glioblastoma
5700416|NCT00499798|adult gliosarcoma|adult gliosarcoma
5700417|NCT00499798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5700418|NCT00499798|adult brain stem glioma|adult brain stem glioma
5690012|NCT00538278|AML|aml
5700419|NCT00499798|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5700420|NCT00499798|adult choroid plexus tumor|adult choroid plexus tumor
5700421|NCT00499798|adult craniopharyngioma|adult craniopharyngioma
5700422|NCT00499798|adult ependymoblastoma|adult ependymoblastoma
5700423|NCT00499798|adult medulloblastoma|adult medulloblastoma
5700424|NCT00499798|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5700425|NCT00499798|adult anaplastic ependymoma|adult anaplastic ependymoma
5700426|NCT00499798|adult ependymoma|adult ependymoma
5700427|NCT00499798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5700428|NCT00499798|adult subependymoma|adult subependymoma
5700429|NCT00499798|adult anaplastic meningioma|adult anaplastic meningioma
5700430|NCT00499798|meningeal melanocytoma|meningeal melanocytoma
5700431|NCT00499798|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5700433|NCT00499798|adult grade I meningioma|adult grade i meningioma
5700434|NCT00499798|adult grade II meningioma|adult grade ii meningioma
5700435|NCT00499798|adult grade III meningioma|adult grade iii meningioma
5700436|NCT00499798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5700437|NCT00499798|adult oligodendroglioma|adult oligodendroglioma
5700438|NCT00499798|adult pineoblastoma|adult pineoblastoma
5700439|NCT00499798|adult pineocytoma|adult pineocytoma
5700440|NCT00499798|adult mixed glioma|adult mixed glioma
5700441|NCT00499798|recurrent adult brain tumor|recurrent adult brain tumor
5699421|NCT00503230|HIV|hiv
5700442|NCT00499798|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5700444|NCT00499785|cognitive/functional effects|cognitive/functional effects
5700445|NCT00499785|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5700446|NCT00499785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5700518|NCT00499733|malignant giant cell tumor of bone|malignant giant cell tumor of bone
5700447|NCT00499785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5700448|NCT00499785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5700449|NCT00499785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5700450|NCT00499785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5700451|NCT00499759|fatigue|fatigue
5700452|NCT00499759|depression|depression
5700453|NCT00499759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5700454|NCT00499759|musculoskeletal complications|musculoskeletal complications
5700455|NCT00499759|acute undifferentiated leukemia|acute undifferentiated leukemia
5700456|NCT00499759|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5700457|NCT00499759|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5700458|NCT00499759|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5700459|NCT00499759|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5700460|NCT00499759|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5700461|NCT00499759|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5700462|NCT00499759|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5700463|NCT00499759|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5700464|NCT00499759|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5700680|NCT00499577|stage III multiple myeloma|stage iii multiple myeloma
5700465|NCT00499759|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5700466|NCT00499746|drug discrimination|drug discrimination
5700467|NCT00499746|opioid pharmacology|opioid pharmacology
5700468|NCT00499746|behavioral pharmacology|behavioral pharmacology
5700469|NCT00499746|human research|human research
5700470|NCT00499733|carcinoma of unknown primary|carcinoma of unknown primary
5700471|NCT00499733|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5700472|NCT00499733|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5700473|NCT00499733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5700474|NCT00499733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5863046|NCT00001410|Gaucher Disease|gaucher disease
5700475|NCT00499733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5700476|NCT00499733|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5700477|NCT00499733|recurrent small cell lung cancer|recurrent small cell lung cancer
5700478|NCT00499733|stage III renal cell cancer|stage iii renal cell cancer
5700479|NCT00499733|stage IV renal cell cancer|stage iv renal cell cancer
5700480|NCT00499733|recurrent renal cell cancer|recurrent renal cell cancer
5700481|NCT00499733|stage III prostate cancer|stage iii prostate cancer
5700482|NCT00499733|stage IV prostate cancer|stage iv prostate cancer
5700483|NCT00499733|recurrent prostate cancer|recurrent prostate cancer
5700484|NCT00499733|male breast cancer|male breast cancer
5700485|NCT00499733|recurrent breast cancer|recurrent breast cancer
5700486|NCT00499733|stage IIIA breast cancer|stage iiia breast cancer
5700487|NCT00499733|stage IIIB breast cancer|stage iiib breast cancer
5700488|NCT00499733|stage IIIC breast cancer|stage iiic breast cancer
5700490|NCT00499733|chondrosarcoma|chondrosarcoma
5700491|NCT00499733|metastatic osteosarcoma|metastatic osteosarcoma
5700492|NCT00499733|recurrent osteosarcoma|recurrent osteosarcoma
5700493|NCT00499733|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5700494|NCT00499733|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5700495|NCT00499733|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5700496|NCT00499733|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5700497|NCT00499733|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5700498|NCT00499733|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5700499|NCT00499733|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5700500|NCT00499733|ovarian sarcoma|ovarian sarcoma
5700501|NCT00499733|stage IIIB uterine sarcoma|stage iiib uterine sarcoma
5700502|NCT00499733|stage IIIC uterine sarcoma|stage iiic uterine sarcoma
5700503|NCT00499733|stage IIIA uterine sarcoma|stage iiia uterine sarcoma
5700504|NCT00499733|stage IVA uterine sarcoma|stage iva uterine sarcoma
5700505|NCT00499733|stage IVB uterine sarcoma|stage ivb uterine sarcoma
5700506|NCT00499733|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5700507|NCT00499733|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5700508|NCT00499733|stage III colon cancer|stage iii colon cancer
5700509|NCT00499733|stage IV colon cancer|stage iv colon cancer
5700510|NCT00499733|recurrent colon cancer|recurrent colon cancer
5700511|NCT00499733|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5700512|NCT00499733|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5700513|NCT00499733|recurrent childhood liver cancer|recurrent childhood liver cancer
5700514|NCT00499733|stage III childhood liver cancer|stage iii childhood liver cancer
5700515|NCT00499733|stage IV childhood liver cancer|stage iv childhood liver cancer
5700516|NCT00499733|stage III pancreatic cancer|stage iii pancreatic cancer
5700517|NCT00499733|localized osteosarcoma|localized osteosarcoma
5700519|NCT00499733|stage IV melanoma|stage iv melanoma
5700520|NCT00499733|recurrent melanoma|recurrent melanoma
5700521|NCT00499733|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5700522|NCT00499733|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5700523|NCT00499733|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5700524|NCT00499733|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5700525|NCT00499733|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5700526|NCT00499733|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5700527|NCT00499733|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5700528|NCT00499733|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5700529|NCT00499733|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5700530|NCT00499733|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5700531|NCT00499733|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5700532|NCT00499733|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5700533|NCT00499733|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5700534|NCT00499733|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5700599|NCT00499668|chronic myelogenous leukemia|chronic myelogenous leukemia
5700535|NCT00499733|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5700536|NCT00499733|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5700537|NCT00499733|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5700757|NCT00499343|Stem Cell Collection|stem cell collection
5700538|NCT00499733|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5700539|NCT00499733|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5700540|NCT00499733|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5798802|NCT00110981|combination therapy, 50 mg prefilled syringes|combination therapy, 50 mg prefilled syringes
5700541|NCT00499733|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5700542|NCT00499733|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5700543|NCT00499733|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5700544|NCT00499733|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5700545|NCT00499733|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5700546|NCT00499733|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5700547|NCT00499733|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5700548|NCT00499733|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5700549|NCT00499733|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5700550|NCT00499733|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5700551|NCT00499733|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5700552|NCT00499733|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5700553|NCT00499733|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5700554|NCT00499733|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5700555|NCT00499733|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5700556|NCT00499733|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5700557|NCT00499733|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5700558|NCT00499733|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5700559|NCT00499733|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5700560|NCT00499733|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5700561|NCT00499733|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5700562|NCT00499733|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5700563|NCT00499733|stage III salivary gland cancer|stage iii salivary gland cancer
5699242|NCT00503867|HCC|hcc
5700564|NCT00499733|stage IV salivary gland cancer|stage iv salivary gland cancer
5700565|NCT00499733|recurrent salivary gland cancer|recurrent salivary gland cancer
5700566|NCT00499733|intraocular lymphoma|intraocular lymphoma
5700567|NCT00499733|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5700568|NCT00499733|recurrent pancreatic cancer|recurrent pancreatic cancer
5700569|NCT00499733|recurrent uterine sarcoma|recurrent uterine sarcoma
5700570|NCT00499733|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5700571|NCT00499733|advanced adult primary liver cancer|advanced adult primary liver cancer
5700572|NCT00499733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5700573|NCT00499733|conjunctival melanoma|conjunctival melanoma
5700574|NCT00499733|stage IV pancreatic cancer|stage iv pancreatic cancer
5700575|NCT00499733|stage IIIA melanoma|stage iiia melanoma
5700576|NCT00499733|stage IIIB melanoma|stage iiib melanoma
5700577|NCT00499733|stage IIIC melanoma|stage iiic melanoma
5700579|NCT00499733|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
5700580|NCT00499733|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
5700581|NCT00499733|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
5700582|NCT00499733|stage IV intraocular melanoma|stage iv intraocular melanoma
5700583|NCT00499720|Cystic Fibrosis|cystic fibrosis
5700584|NCT00499720|Pseudomonas aeruginosa|pseudomonas aeruginosa
5700585|NCT00499720|airway infection|airway infection
5700586|NCT00499720|Aztreonam Lysine for Inhalation|aztreonam lysine for inhalation
5700588|NCT00499707|Drug-naive|drug-naive
5700589|NCT00499707|type 2 diabetes|type 2 diabetes
5700590|NCT00499694|stage IV prostate cancer|stage iv prostate cancer
5700591|NCT00499694|recurrent prostate cancer|recurrent prostate cancer
5700592|NCT00499694|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5700593|NCT00499681|stage I breast cancer|stage i breast cancer
5700594|NCT00499681|stage II breast cancer|stage ii breast cancer
5700595|NCT00499681|stage IIIA breast cancer|stage iiia breast cancer
5700596|NCT00499681|stage IIIB breast cancer|stage iiib breast cancer
5700597|NCT00499668|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5700598|NCT00499668|nausea and vomiting|nausea and vomiting
5701047|NCT00498537|albuminuria|albuminuria
5700600|NCT00499668|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5700601|NCT00499668|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5700602|NCT00499668|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5700603|NCT00499668|essential thrombocythemia|essential thrombocythemia
5700604|NCT00499668|polycythemia vera|polycythemia vera
5700605|NCT00499668|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5700606|NCT00499668|adult acute myeloid leukemia|adult acute myeloid leukemia
5700607|NCT00499668|acute undifferentiated leukemia|acute undifferentiated leukemia
5700608|NCT00499668|mast cell leukemia|mast cell leukemia
5700609|NCT00499668|adult T-cell leukemia/lymphoma|adult t-cell leukemia/lymphoma
5700610|NCT00499668|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5700611|NCT00499668|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5700612|NCT00499668|hairy cell leukemia|hairy cell leukemia
5700613|NCT00499668|prolymphocytic leukemia|prolymphocytic leukemia
5700614|NCT00499668|AIDS-related lymphoma|aids-related lymphoma
5700615|NCT00499668|adult Hodgkin lymphoma|adult hodgkin lymphoma
5700616|NCT00499668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5700617|NCT00499668|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5700618|NCT00499668|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5700619|NCT00499668|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
5700620|NCT00499668|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5700621|NCT00499668|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5700622|NCT00499668|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5700623|NCT00499668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5700624|NCT00499668|adult Burkitt lymphoma|adult burkitt lymphoma
5700625|NCT00499668|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5700626|NCT00499668|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5700627|NCT00499668|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5700628|NCT00499668|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5700629|NCT00499668|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5700630|NCT00499668|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5700631|NCT00499668|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5700633|NCT00499668|mantle cell lymphoma|mantle cell lymphoma
5700634|NCT00499668|marginal zone lymphoma|marginal zone lymphoma
5700635|NCT00499668|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5700636|NCT00499668|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5700637|NCT00499668|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5700638|NCT00499668|small lymphocytic lymphoma|small lymphocytic lymphoma
5700639|NCT00499668|intraocular lymphoma|intraocular lymphoma
5700640|NCT00499668|primary central nervous system lymphoma|primary central nervous system lymphoma
5700641|NCT00499668|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5700642|NCT00499668|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5700643|NCT00499668|myelodysplastic syndromes|myelodysplastic syndromes
5700644|NCT00499668|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5700645|NCT00499668|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5700646|NCT00499668|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5700647|NCT00499668|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5700648|NCT00499668|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5700650|NCT00499629|healthy subjects|healthy subjects
5700651|NCT00499616|regional neuroblastoma|regional neuroblastoma
5701816|NCT00495651|HIV|hiv
5700652|NCT00499616|disseminated neuroblastoma|disseminated neuroblastoma
5700653|NCT00499616|stage 4S neuroblastoma|stage 4s neuroblastoma
5700654|NCT00499616|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5700655|NCT00499616|localized resectable neuroblastoma|localized resectable neuroblastoma
5700656|NCT00499603|Breast Cancer|breast cancer
5700657|NCT00499603|ER negative|er negative
5700658|NCT00499603|PR negative|pr negative
5700659|NCT00499603|HER2neu negative|her2neu negative
5700660|NCT00499603|Tumor Triple Negative Receptors|tumor triple negative receptors
5700661|NCT00499603|Paclitaxel|paclitaxel
5700662|NCT00499603|Taxol|taxol
5700663|NCT00499603|RAD001|rad001
5700664|NCT00499603|FEC|fec
5700665|NCT00499603|5-Fluorouracil|5-fluorouracil
5700666|NCT00499603|5-FU|5-fu
5700667|NCT00499603|Adrucil|adrucil
5700668|NCT00499603|Efudex|efudex
5700669|NCT00499603|Epirubicin|epirubicin
5700670|NCT00499603|Cyclophosphamide|cyclophosphamide
5700671|NCT00499590|AMD|amd
5700672|NCT00499590|Macular Degeneration|macular degeneration
5700673|NCT00499590|bevasiranib|bevasiranib
5700674|NCT00499590|COBALT study|cobalt study
5700675|NCT00499590|age related macular degeneration|age related macular degeneration
5700676|NCT00499590|wet AMD|wet amd
5700677|NCT00499590|wet age related macular degeneration|wet age related macular degeneration
5700678|NCT00499577|stage I multiple myeloma|stage i multiple myeloma
5700679|NCT00499577|stage II multiple myeloma|stage ii multiple myeloma
5700681|NCT00499577|refractory multiple myeloma|refractory multiple myeloma
5700682|NCT00499551|Anterior Uveitis|anterior uveitis
5700683|NCT00499551|Posterior Uveitis|posterior uveitis
5700684|NCT00499551|Intermediate Uveitis|intermediate uveitis
5700685|NCT00499551|Panuveitis|panuveitis
5700686|NCT00499551|Iontophoresis|iontophoresis
5700687|NCT00499551|Dexamethasone|dexamethasone
5700688|NCT00499538|healthy subjects|healthy subjects
5700689|NCT00499525|male breast cancer|male breast cancer
5700690|NCT00499525|recurrent breast cancer|recurrent breast cancer
5700691|NCT00499525|stage IIIB breast cancer|stage iiib breast cancer
5700692|NCT00499525|stage IIIC breast cancer|stage iiic breast cancer
5700693|NCT00499525|stage IV breast cancer|stage iv breast cancer
5700694|NCT00499525|stage IIIA breast cancer|stage iiia breast cancer
5700695|NCT00499512|Ovarian Cancer|ovarian cancer
5700696|NCT00499512|Peritoneal Cancer|peritoneal cancer
5700697|NCT00499512|Fallopian Tube Cancer|fallopian tube cancer
5700698|NCT00499512|Spirituality|spirituality
5700699|NCT00499512|Religion|religion
5700700|NCT00499512|Quality of Life|quality of life
5700701|NCT00499512|Questionnaire|questionnaire
5700703|NCT00499499|Cancer|cancer
5700704|NCT00499499|solid tumors|solid tumors
5700705|NCT00499486|recurrent pancreatic cancer|recurrent pancreatic cancer
5700706|NCT00499486|stage III pancreatic cancer|stage iii pancreatic cancer
5700707|NCT00499486|stage IV pancreatic cancer|stage iv pancreatic cancer
5700708|NCT00499486|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5700709|NCT00499460|Healthy, No Evidence of Disease|healthy, no evidence of disease
5700710|NCT00499447|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5700711|NCT00499447|adenocarcinoma of the lung|adenocarcinoma of the lung
5700712|NCT00499447|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5700713|NCT00499447|large cell lung cancer|large cell lung cancer
5700714|NCT00499447|squamous cell lung cancer|squamous cell lung cancer
5700715|NCT00499434|aids|aids
5700716|NCT00499421|Prostate Cancer|prostate cancer
5700717|NCT00499421|External Beam Radiation Therapy|external beam radiation therapy
5700718|NCT00499421|Fiducial Markers|fiducial markers
5700719|NCT00499421|Acculoc System|acculoc system
5700720|NCT00499421|Center Of Mass|center of mass
5700722|NCT00499408|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5700723|NCT00499408|stage I prostate cancer|stage i prostate cancer
5700724|NCT00499408|stage II prostate cancer|stage ii prostate cancer
5700725|NCT00499408|stage III prostate cancer|stage iii prostate cancer
5700726|NCT00499395|stage IV colon cancer|stage iv colon cancer
5700727|NCT00499395|stage IV rectal cancer|stage iv rectal cancer
5700728|NCT00499395|recurrent colon cancer|recurrent colon cancer
5700729|NCT00499395|recurrent rectal cancer|recurrent rectal cancer
5700730|NCT00499395|liver metastases|liver metastases
5700731|NCT00499382|Advanced Cancers|advanced cancers
5700732|NCT00499382|Cardiac Function|cardiac function
5700733|NCT00499382|Nuclear Medicine Cardiac Scan|nuclear medicine cardiac scan
5700734|NCT00499382|Positron Emission Tomography|positron emission tomography
5700735|NCT00499382|Radionuclide Ventriculography|radionuclide ventriculography
5700736|NCT00499382|Ventricular Ejection Fraction|ventricular ejection fraction
5700737|NCT00499382|PET/CT|pet/ct
5700739|NCT00499356|friction|friction
5700740|NCT00499356|pressure|pressure
5700741|NCT00499356|insole|insole
5700742|NCT00499356|ulcer|ulcer
5700743|NCT00499356|prevention|prevention
5700744|NCT00499343|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5700745|NCT00499343|Lymphoma|lymphoma
5700746|NCT00499343|Etoposide|etoposide
5700747|NCT00499343|G-CSF|g-csf
5700748|NCT00499343|GM-CSF|gm-csf
5700755|NCT00499343|Neupogen|neupogen
5700756|NCT00499343|Apheresis|apheresis
5700758|NCT00499330|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5700759|NCT00499330|adenocarcinoma of the lung|adenocarcinoma of the lung
5700760|NCT00499330|squamous cell lung cancer|squamous cell lung cancer
5700761|NCT00499330|large cell lung cancer|large cell lung cancer
5700762|NCT00499330|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5700763|NCT00499330|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5700770|NCT00499304|Forced oscillation Technique (FOT)|forced oscillation technique (fot)
5700771|NCT00499304|Expiratory flow limitation (EFL)|expiratory flow limitation (efl)
5700772|NCT00499304|Breathing artifacts|breathing artifacts
5700773|NCT00499304|COPD|copd
5700774|NCT00499291|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5700775|NCT00499291|recurrent breast cancer|recurrent breast cancer
5700776|NCT00499291|stage IIIA breast cancer|stage iiia breast cancer
5700777|NCT00499291|stage IIIB breast cancer|stage iiib breast cancer
5700778|NCT00499291|stage IIIC breast cancer|stage iiic breast cancer
5700779|NCT00499291|recurrent prostate cancer|recurrent prostate cancer
5700780|NCT00499291|stage III prostate cancer|stage iii prostate cancer
5700781|NCT00499291|stage IV prostate cancer|stage iv prostate cancer
5700782|NCT00499291|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5700783|NCT00499291|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5700784|NCT00499291|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5700785|NCT00499291|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5700786|NCT00499291|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5700787|NCT00499291|recurrent small cell lung cancer|recurrent small cell lung cancer
5700788|NCT00499291|recurrent bladder cancer|recurrent bladder cancer
5700789|NCT00499291|stage III bladder cancer|stage iii bladder cancer
5700790|NCT00499291|stage IV bladder cancer|stage iv bladder cancer
5700791|NCT00499291|recurrent renal cell cancer|recurrent renal cell cancer
5717364|NCT00441077|Diabetes|diabetes
5717365|NCT00441077|Information|information
5717366|NCT00441064|High blood pressure, hypertension, aliskiren, low sodium diet|high blood pressure, hypertension, aliskiren, low sodium diet
5717367|NCT00441051|Sunburn, diclofenac, topical NSAID|sunburn, diclofenac, topical nsaid
5717368|NCT00441038|Low back pain|low back pain
5717369|NCT00441038|disability|disability
5717370|NCT00441038|health education|health education
5717371|NCT00441025|MabCampath + CHOP in PTCL|mabcampath + chop in ptcl
5717373|NCT00440999|P vivax|p vivax
5700792|NCT00499291|stage III renal cell cancer|stage iii renal cell cancer
5700793|NCT00499291|stage IV renal cell cancer|stage iv renal cell cancer
5700794|NCT00499291|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5700795|NCT00499291|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5700796|NCT00499291|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5700797|NCT00499291|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5700798|NCT00499291|recurrent cervical cancer|recurrent cervical cancer
5700799|NCT00499291|stage III cervical cancer|stage iii cervical cancer
5700800|NCT00499291|stage IVA cervical cancer|stage iva cervical cancer
5700801|NCT00499291|stage IVB cervical cancer|stage ivb cervical cancer
5700802|NCT00499291|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5700803|NCT00499291|stage III endometrial carcinoma|stage iii endometrial carcinoma
5700804|NCT00499291|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5700805|NCT00499291|fallopian tube cancer|fallopian tube cancer
5700806|NCT00499291|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5700807|NCT00499291|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5700808|NCT00499291|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5700809|NCT00499291|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5700810|NCT00499291|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5700811|NCT00499291|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5700812|NCT00499291|ovarian sarcoma|ovarian sarcoma
5700813|NCT00499291|ovarian stromal cancer|ovarian stromal cancer
5700814|NCT00499291|recurrent uterine sarcoma|recurrent uterine sarcoma
5700815|NCT00499291|stage III uterine sarcoma|stage iii uterine sarcoma
5700816|NCT00499291|stage IV uterine sarcoma|stage iv uterine sarcoma
5700817|NCT00499291|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5700818|NCT00499291|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5700819|NCT00499291|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5700820|NCT00499291|recurrent laryngeal cancer|recurrent laryngeal cancer
5700821|NCT00499291|stage III laryngeal cancer|stage iii laryngeal cancer
5700822|NCT00499291|stage IV laryngeal cancer|stage iv laryngeal cancer
5700823|NCT00499291|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5700824|NCT00499291|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5700825|NCT00499291|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5700826|NCT00499291|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5700827|NCT00499291|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5700828|NCT00499291|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5701817|NCT00495651|HAART|haart
5700829|NCT00499291|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5700830|NCT00499291|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5700831|NCT00499291|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5700832|NCT00499291|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5700833|NCT00499291|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5700834|NCT00499291|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5700835|NCT00499291|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5700836|NCT00499291|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5700837|NCT00499291|recurrent salivary gland cancer|recurrent salivary gland cancer
5700838|NCT00499291|stage III salivary gland cancer|stage iii salivary gland cancer
5700839|NCT00499291|stage IV salivary gland cancer|stage iv salivary gland cancer
5700840|NCT00499291|recurrent esophageal cancer|recurrent esophageal cancer
5700841|NCT00499291|stage III esophageal cancer|stage iii esophageal cancer
5700842|NCT00499291|stage IV esophageal cancer|stage iv esophageal cancer
5700843|NCT00499291|recurrent gastric cancer|recurrent gastric cancer
5700844|NCT00499291|stage III gastric cancer|stage iii gastric cancer
5700845|NCT00499291|stage IV gastric cancer|stage iv gastric cancer
5700846|NCT00499291|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5700847|NCT00499291|adult teratoma|adult teratoma
5700848|NCT00499291|ovarian teratoma|ovarian teratoma
5717470|NCT00440713|Posttraumatic Stress Disorder|posttraumatic stress disorder
5717472|NCT00440713|Anxiety|anxiety
5717473|NCT00440713|Efficacy|efficacy
5717474|NCT00440700|Ventilator|ventilator
5700849|NCT00499291|testicular teratoma|testicular teratoma
5700850|NCT00499291|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5700851|NCT00499291|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5700852|NCT00499291|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5700853|NCT00499291|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5710129|NCT00464347|TAC-PF|tac-pf
5700854|NCT00499278|Osteoarthritis|osteoarthritis
5700855|NCT00499278|joint|joint
5700856|NCT00499278|knee|knee
5700858|NCT00499278|surgery|surgery
5700859|NCT00499265|recurrent pancreatic cancer|recurrent pancreatic cancer
5701152|NCT00498199|nystagmus|nystagmus
5700860|NCT00499265|stage III pancreatic cancer|stage iii pancreatic cancer
5700861|NCT00499265|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5700862|NCT00499239|Hematologic Malignancies|hematologic malignancies
5700863|NCT00499239|CLL|cll
5700864|NCT00499239|NHL|nhl
5700865|NCT00499239|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5700866|NCT00499239|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5700867|NCT00499239|CLL and NHL|cll and nhl
5700868|NCT00499239|Multiple Myeloma|multiple myeloma
5700871|NCT00499187|Kidney|kidney
5700872|NCT00499187|Renal|renal
5700873|NCT00499187|HIV|hiv
5700874|NCT00499187|HIV-1|hiv-1
5700875|NCT00499187|Treatment Experienced|treatment experienced
5700876|NCT00499174|stage II prostate cancer|stage ii prostate cancer
5700877|NCT00499174|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5700878|NCT00499161|Individualized care|individualized care
5700879|NCT00499161|Relationship based care|relationship based care
5700880|NCT00499161|Negotiated care|negotiated care
5700881|NCT00499161|Patient focused care|patient focused care
5700882|NCT00499122|stage II breast cancer|stage ii breast cancer
5700883|NCT00499122|stage IIIC breast cancer|stage iiic breast cancer
5700884|NCT00499122|inflammatory breast cancer|inflammatory breast cancer
5700885|NCT00499109|RRM1|rrm1
5700886|NCT00499109|ERCC1|ercc1
5700887|NCT00499109|Customized Chemotherapy|customized chemotherapy
5700888|NCT00499096|Chronic Illness|chronic illness
5700889|NCT00499096|Disease management|disease management
5700890|NCT00499096|Health Behaviors|health behaviors
5700891|NCT00499096|Mood Disorders-Bipolar|mood disorders-bipolar
5700892|NCT00499083|stage II breast cancer|stage ii breast cancer
5700893|NCT00499083|stage IIIA breast cancer|stage iiia breast cancer
5700894|NCT00499083|stage IIIB breast cancer|stage iiib breast cancer
5700895|NCT00499083|stage IIIC breast cancer|stage iiic breast cancer
5700896|NCT00499070|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5700897|NCT00499070|aplastic anemia|aplastic anemia
5700898|NCT00499070|Fanconi anemia|fanconi anemia
5700899|NCT00499070|dyskeratosis congenita|dyskeratosis congenita
5700900|NCT00499070|Shwachman-Diamond syndrome|shwachman-diamond syndrome
5700901|NCT00499070|Pearson marrow-pancreas syndrome|pearson marrow-pancreas syndrome
5700902|NCT00499057|early stage breast cancer|early stage breast cancer
5700903|NCT00499044|cognition|cognition
5699543|NCT00502697|preterm|preterm
5700904|NCT00499044|attention|attention
5700905|NCT00499044|memory|memory
5700906|NCT00499044|concentration|concentration
5700907|NCT00499044|schizophrenia|schizophrenia
5700908|NCT00499018|Large B-Cell Lymphoma|large b-cell lymphoma
5700909|NCT00499018|Rituximab|rituximab
5700910|NCT00499018|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5700911|NCT00498992|dermatologic complications|dermatologic complications
5700912|NCT00498992|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5700913|NCT00498979|stage IV melanoma|stage iv melanoma
5700914|NCT00498979|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5700915|NCT00498979|adult diffuse astrocytoma|adult diffuse astrocytoma
5700916|NCT00498979|adult glioblastoma|adult glioblastoma
5700917|NCT00498979|adult giant cell glioblastoma|adult giant cell glioblastoma
5700918|NCT00498979|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5700919|NCT00498979|adult brain stem glioma|adult brain stem glioma
5700920|NCT00498979|adult anaplastic ependymoma|adult anaplastic ependymoma
5700921|NCT00498979|adult ependymoma|adult ependymoma
5700922|NCT00498979|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5700923|NCT00498979|adult subependymoma|adult subependymoma
5700924|NCT00498979|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5700925|NCT00498979|adult oligodendroglioma|adult oligodendroglioma
5700926|NCT00498979|mixed gliomas|mixed gliomas
5700927|NCT00498979|recurrent adult brain tumor|recurrent adult brain tumor
5700928|NCT00498979|recurrent melanoma|recurrent melanoma
5700929|NCT00498979|adult gliosarcoma|adult gliosarcoma
5700930|NCT00498979|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5700931|NCT00498979|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5700932|NCT00498966|Kidney|kidney
5700933|NCT00498966|perifosine|perifosine
5700934|NCT00498966|Progression on treatment with sunitinib or sorafenib|progression on treatment with sunitinib or sorafenib
5700935|NCT00498953|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5700936|NCT00498953|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5700937|NCT00498953|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5700938|NCT00498953|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5700939|NCT00498953|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5700940|NCT00498940|LV function, Compliance, wall motion, echocardiography|lv function, compliance, wall motion, echocardiography
5700941|NCT00498927|recurrent adult brain tumor|recurrent adult brain tumor
5700942|NCT00498927|adult giant cell glioblastoma|adult giant cell glioblastoma
5700943|NCT00498927|adult glioblastoma|adult glioblastoma
5700944|NCT00498927|adult gliosarcoma|adult gliosarcoma
5700945|NCT00498927|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5700946|NCT00498927|adult diffuse astrocytoma|adult diffuse astrocytoma
5700947|NCT00498927|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5700948|NCT00498927|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5700949|NCT00498927|adult anaplastic ependymoma|adult anaplastic ependymoma
5700950|NCT00498927|adult ependymoma|adult ependymoma
5700951|NCT00498927|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5700952|NCT00498927|adult subependymoma|adult subependymoma
5690669|NCT00535457|anxiety|anxiety
5700953|NCT00498927|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5700954|NCT00498927|adult oligodendroglioma|adult oligodendroglioma
5700955|NCT00498927|adult brain stem glioma|adult brain stem glioma
5700956|NCT00498927|adult mixed glioma|adult mixed glioma
5700957|NCT00498927|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5700958|NCT00498914|Lymphoma, Large-Cell, Diffuse|lymphoma, large-cell, diffuse
5700959|NCT00498914|Lymphoma, B-Cell|lymphoma, b-cell
5700960|NCT00498914|YM155|ym155
5700961|NCT00498914|Treatment outcomes|treatment outcomes
5700962|NCT00498914|Refractory|refractory
5700963|NCT00498901|stage IV breast cancer|stage iv breast cancer
5700964|NCT00498901|recurrent breast cancer|recurrent breast cancer
5700965|NCT00498888|urge urinary incontinence|urge urinary incontinence
5700966|NCT00498888|rehabilitation|rehabilitation
5700967|NCT00498888|anticholinergic|anticholinergic
5700968|NCT00498875|Oropharyngeal Cancer|oropharyngeal cancer
5700969|NCT00498875|Head and Neck Cancer|head and neck cancer
5700970|NCT00498875|Depression|depression
5700971|NCT00498875|Questionnaire|questionnaire
5700972|NCT00498875|Survey|survey
5700973|NCT00498875|Interview|interview
5700974|NCT00498849|Sleep apnea|sleep apnea
5700975|NCT00498849|Continuous positive airway pressure|continuous positive airway pressure
5700976|NCT00498849|Microarray|microarray
5700977|NCT00498849|Polysomnography|polysomnography
5700978|NCT00498836|CP-4055|cp-4055
5700979|NCT00498836|Elacyt|elacyt
5700980|NCT00498836|Cancer|cancer
5700981|NCT00498836|Metastatic|metastatic
5700982|NCT00498836|Malignant melanoma|malignant melanoma
5700983|NCT00498836|Combination treatment|combination treatment
5700984|NCT00498836|Sorafenib|sorafenib
5700985|NCT00498836|Nexavar|nexavar
5700986|NCT00498797|prostate cancer|prostate cancer
5700987|NCT00498797|zactima|zactima
5700988|NCT00498797|vandetanib|vandetanib
5725040|NCT00413621|MRI|mri
5700989|NCT00498797|metastatic|metastatic
5700990|NCT00498784|Intra-uterine contraception|intra-uterine contraception
5700991|NCT00498784|Intrauterine Devices|intrauterine devices
5700992|NCT00498771|Lymphedema|lymphedema
5700993|NCT00498771|Aquatic Exercise|aquatic exercise
5700994|NCT00498771|Breast Cancer|breast cancer
5700995|NCT00498758|Parkinson's disease|parkinson's disease
5700996|NCT00498758|Gait Disturbances|gait disturbances
5700997|NCT00498758|Mobility|mobility
5700998|NCT00498758|Quality of life|quality of life
5700999|NCT00498732|Obstructive sleep apnea syndrome; CPAP, microarray|obstructive sleep apnea syndrome; cpap, microarray
5701000|NCT00498719|Leukemia|leukemia
5701001|NCT00498719|Lymphoma|lymphoma
5701002|NCT00498719|Brain Tumor|brain tumor
5701003|NCT00498719|Attention Deficit|attention deficit
5701004|NCT00498719|Cognitive Training Program|cognitive training program
5701005|NCT00498719|Central Nervous System|central nervous system
5701006|NCT00498719|CNS|cns
5701007|NCT00498719|CTP|ctp
5701008|NCT00498706|Depressive Disorder, Major|depressive disorder, major
5701009|NCT00498706|Cognitive Behavioral Therapy|cognitive behavioral therapy
5701010|NCT00498706|Psychotherapy|psychotherapy
5701011|NCT00498706|Telemedicine|telemedicine
5701012|NCT00498706|Primary Care|primary care
5701013|NCT00498680|Erectile Dysfunction|erectile dysfunction
5701014|NCT00498680|Treatment|treatment
5701015|NCT00498680|PDE5i|pde5i
5701016|NCT00498667|PET/CT|pet/ct
5701017|NCT00498667|Aggressive non-Hodgkin Lymphoma|aggressive non-hodgkin lymphoma
5701018|NCT00498654|Prevention of Typhoid Fever in Adult Travelers|prevention of typhoid fever in adult travelers
5701019|NCT00498641|perceptual learning|perceptual learning
5701020|NCT00498641|occlusion therapy|occlusion therapy
5701021|NCT00498628|Alcoholism|alcoholism
5717675|NCT00439907|End-to-end repair|end-to-end repair
5717676|NCT00439907|Over-lap repair|over-lap repair
5717677|NCT00439907|Anal manometry|anal manometry
5701022|NCT00498628|Alcohol dependence|alcohol dependence
5701023|NCT00498628|Quetiapine|quetiapine
5701024|NCT00498615|scleroderma|scleroderma
5701025|NCT00498615|Raynaud's phenomenon|raynaud's phenomenon
5701026|NCT00498615|Rho-kinase inhibitor|rho-kinase inhibitor
5701027|NCT00498576|hypertension|hypertension
5701028|NCT00498576|kidney transplant|kidney transplant
5701029|NCT00498576|melatonin|melatonin
5701030|NCT00498576|adiponectin|adiponectin
5701031|NCT00498563|high altitude|high altitude
5701032|NCT00498563|sleep|sleep
5701033|NCT00498563|altitude illness|altitude illness
5701034|NCT00498563|neurobehavioral manifestations|neurobehavioral manifestations
5701035|NCT00498563|psychomotor performance|psychomotor performance
5701036|NCT00498563|mood states|mood states
5701037|NCT00498550|Clozapine|clozapine
5701038|NCT00498550|Schizophrenia|schizophrenia
5701039|NCT00498550|Dual Diagnosis|dual diagnosis
5701040|NCT00498550|Substance Abuse|substance abuse
5701041|NCT00498550|Cannabis Abuse|cannabis abuse
5701042|NCT00498537|spironolactone|spironolactone
5701043|NCT00498537|aldosterone|aldosterone
5701044|NCT00498537|diabetic nephropathy|diabetic nephropathy
5701045|NCT00498537|proteinuria|proteinuria
5701046|NCT00498537|hyperkalemia|hyperkalemia
5701048|NCT00498537|renal failure|renal failure
5701049|NCT00498524|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5701050|NCT00498524|ischemic cardiomyopathy|ischemic cardiomyopathy
5701051|NCT00498524|ventricular arrhythmias|ventricular arrhythmias
5701052|NCT00498524|sibling concordance|sibling concordance
5701053|NCT00498511|Anemia, Iron-Deficiency|anemia, iron-deficiency
5701054|NCT00498511|Endoscopy, Gastrointestinal|endoscopy, gastrointestinal
5701055|NCT00498511|Male, aged 18 to 40|male, aged 18 to 40
5701056|NCT00498498|severe head injury|severe head injury
5701057|NCT00498498|Endothelin|endothelin
5701058|NCT00498498|CSF|csf
5701059|NCT00498498|Plasma|plasma
5701060|NCT00498498|Cellular Apoptosis|cellular apoptosis
5701061|NCT00498485|chronic|chronic
5701062|NCT00498485|fatigue|fatigue
5701063|NCT00498485|pain|pain
5701064|NCT00498485|sleep|sleep
5701065|NCT00498485|xyrem|xyrem
5701066|NCT00498485|must have chronic fatigue syndrome|must have chronic fatigue syndrome
5701067|NCT00498485|no hypertension|no hypertension
5701068|NCT00498485|no sleep apnea|no sleep apnea
5701069|NCT00498472|BNP|bnp
5701070|NCT00498472|heart failure|heart failure
5701071|NCT00498459|Physical activity|physical activity
5701072|NCT00498459|Randomised trial|randomised trial
5701073|NCT00498459|Prevention|prevention
5701074|NCT00498459|Adolescents|adolescents
5701075|NCT00498459|Obesity|obesity
5701076|NCT00498459|Cardiovascular risk factors|cardiovascular risk factors
5701077|NCT00498433|Aliskiren|aliskiren
5701078|NCT00498433|Renin-Angiotensin System (RAS)|renin-angiotensin system (ras)
5701079|NCT00498433|Hypertension|hypertension
5701080|NCT00498433|Abdominal obesity|abdominal obesity
5701081|NCT00498420|HUE-MAN|hue-man
5701082|NCT00498420|Rare disorder|rare disorder
5701083|NCT00498420|Hepatosplenomegaly|hepatosplenomegaly
5701084|NCT00498420|Dysostosis|dysostosis
5701085|NCT00498407|CP-4055|cp-4055
5701086|NCT00498407|ELACYT(TM)|elacyt(tm)
5701087|NCT00498407|Cancer|cancer
5701088|NCT00498407|Colorectal cancer|colorectal cancer
5701089|NCT00498407|CRC|crc
5701090|NCT00498407|Second line therapy|second line therapy
5701091|NCT00498394|Obesity|obesity
5701092|NCT00498394|Weight loss|weight loss
5701093|NCT00498394|Diet fads|diet fads
5701094|NCT00498368|Estimated glomerular filtration rate (GFR)|estimated glomerular filtration rate (gfr)
5701095|NCT00498368|Proteinuria|proteinuria
5701096|NCT00498368|Renal Fibrosis|renal fibrosis
5701097|NCT00498355|uveitis|uveitis
5701098|NCT00498355|cytoid macular edema|cytoid macular edema
5701099|NCT00498355|steroid|steroid
5701100|NCT00498355|Lucentis|lucentis
5701101|NCT00498329|fMRI|fmri
5701102|NCT00498329|Electroencephalogram (EEG)|electroencephalogram (eeg)
5701103|NCT00498329|Attention|attention
5701104|NCT00498329|Sensorimotor Integration|sensorimotor integration
5701105|NCT00498329|Human Brain|human brain
5701106|NCT00498329|Healthy Volunteer|healthy volunteer
5701107|NCT00498329|HV|hv
5701118|NCT00498303|influenza vaccine|influenza vaccine
5701119|NCT00498290|Enhanced Recovery After Surgery Protocol(ERAS)|enhanced recovery after surgery protocol(eras)
5701120|NCT00498290|Colorectal Surgery|colorectal surgery
5701121|NCT00498277|Osteoporosis|osteoporosis
5701122|NCT00498277|Magnetic Resonance Imaging|magnetic resonance imaging
5701123|NCT00498277|Vertebral Fractures|vertebral fractures
5701124|NCT00498277|Quantitative Diffusion|quantitative diffusion
5701125|NCT00498277|Fat Imaging|fat imaging
5701126|NCT00498277|Spine|spine
5701127|NCT00498264|Exercise|exercise
5701128|NCT00498264|Rehabilitation|rehabilitation
5701129|NCT00498264|Strength exercise|strength exercise
5701130|NCT00498264|Aerobic exercise|aerobic exercise
5701131|NCT00498264|Pain|pain
5701132|NCT00498251|lung injury, acute|lung injury, acute
5701133|NCT00498251|thoracic surgical procedures|thoracic surgical procedures
5701134|NCT00498251|lung cancer|lung cancer
5701135|NCT00498251|salbutamol|salbutamol
5701136|NCT00498238|Arterial stiffness, Augmentation index, Subclinical Hypothyroidism|arterial stiffness, augmentation index, subclinical hypothyroidism
5701137|NCT00498225|Pancreatic Cancer|pancreatic cancer
5701138|NCT00498212|Heplisav|heplisav
5701139|NCT00498212|Hepatitis B|hepatitis b
5701140|NCT00498212|Hepatitis|hepatitis
5701141|NCT00498212|HBV|hbv
5701142|NCT00498212|Hepatitis B vaccine|hepatitis b vaccine
5701143|NCT00498212|kidney disease|kidney disease
5701144|NCT00498212|renal disease|renal disease
5701145|NCT00498212|kidney failure|kidney failure
5701146|NCT00498212|renal failure|renal failure
5701147|NCT00498199|Multiples sclerosis|multiples sclerosis
5701148|NCT00498199|oscillopsia|oscillopsia
5701149|NCT00498199|eye movements|eye movements
5701150|NCT00498199|motion detection|motion detection
5701151|NCT00498199|retinal slip|retinal slip
5701155|NCT00498173|Autistic Disorder|autistic disorder
5701156|NCT00498173|Autism Spectrum Disorder|autism spectrum disorder
5701157|NCT00498160|Kidney transplant|kidney transplant
5701158|NCT00498160|Tolerance|tolerance
5701159|NCT00498160|Marrow/stem cell transplant|marrow/stem cell transplant
5701160|NCT00498147|amputation|amputation
5701161|NCT00498147|angina|angina
5701162|NCT00498147|angiography|angiography
5701163|NCT00498147|angioplasty|angioplasty
5701164|NCT00498147|arterial disease|arterial disease
5701165|NCT00498147|artery disease|artery disease
5701166|NCT00498147|bypass|bypass
5701167|NCT00498147|CABG|cabg
5701168|NCT00498147|cad|cad
5701169|NCT00498147|carotid|carotid
5701170|NCT00498147|cerebral accident|cerebral accident
5701172|NCT00498147|CRF|crf
5701173|NCT00498147|CVA|cva
5701174|NCT00498147|endarterectomy|endarterectomy
5701175|NCT00498147|heart attack|heart attack
5701176|NCT00498147|heart failure|heart failure
5701177|NCT00498147|infarct|infarct
5701178|NCT00498147|kidney disease|kidney disease
5701179|NCT00498147|kidney failure|kidney failure
5701180|NCT00498147|laser|laser
5701181|NCT00498147|nephropathy|nephropathy
5701182|NCT00498147|neuropathy|neuropathy
5701183|NCT00498147|pad|pad
5701184|NCT00498147|PCI|pci
5701185|NCT00498147|percutaneous coronary|percutaneous coronary
5701186|NCT00498147|percutaneous transluminal|percutaneous transluminal
5701187|NCT00498147|pvd|pvd
5701188|NCT00498147|renal failure|renal failure
5701189|NCT00498147|retinopathy|retinopathy
5701190|NCT00498147|revascularization|revascularization
5701191|NCT00498147|schemia|schemia
5701192|NCT00498147|stenosis|stenosis
5701193|NCT00498147|stent|stent
5701194|NCT00498147|stroke|stroke
5701195|NCT00498147|transient|transient
5701196|NCT00498147|ulcer|ulcer
5701197|NCT00498147|vascular disease|vascular disease
5701198|NCT00498134|Gastric cancer|gastric cancer
5701199|NCT00498121|Ventilator associated pneumonia.|ventilator associated pneumonia.
5701200|NCT00498121|Procalcitonin.|procalcitonin.
5701201|NCT00498108|Rotigotine|rotigotine
5701202|NCT00498108|Restless Legs Syndrome|restless legs syndrome
5701203|NCT00498095|Delayed renal graft function|delayed renal graft function
5701204|NCT00498095|Acute renal allograft dysfunction|acute renal allograft dysfunction
5701205|NCT00498069|Critical limb ischemia due to peripheral arterial occlusive disease|critical limb ischemia due to peripheral arterial occlusive disease
5701206|NCT00498069|Autologous bone marrow concentrate|autologous bone marrow concentrate
5699859|NCT00501644|QOL|qol
5701207|NCT00498056|HIV Seronegativity|hiv seronegativity
5701208|NCT00498056|HIV Preventive Vaccine|hiv preventive vaccine
5701209|NCT00498043|Lymphoma|lymphoma
5701210|NCT00498043|PET|pet
5701211|NCT00498043|Chemotherapy|chemotherapy
5701212|NCT00498043|Rituximab|rituximab
5701213|NCT00498030|Insulin Resistance|insulin resistance
5701214|NCT00498030|Stress, Psychological|stress, psychological
5701215|NCT00498017|Infections|infections
5701216|NCT00498004|Quality of Life|quality of life
5701217|NCT00498004|Schizophrenia|schizophrenia
5701218|NCT00498004|Quetiapine|quetiapine
5701219|NCT00498004|Risperidone|risperidone
5701221|NCT00497991|phase I/II|phase i/ii
5701222|NCT00497991|AZD1152|azd1152
5701223|NCT00497991|Acute Myeloid Leukaemia|acute myeloid leukaemia
5701224|NCT00497965|Balance|balance
5701225|NCT00497965|Chiropractic|chiropractic
5701226|NCT00497965|Older Adults|older adults
5701227|NCT00497952|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5701228|NCT00497952|Marrow/Stem cell transplant|marrow/stem cell transplant
5717877|NCT00439192|Overactive Bladder (OAB)|overactive bladder (oab)
5701229|NCT00497939|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5701230|NCT00497939|Currently on alpha blocker|currently on alpha blocker
5701231|NCT00497926|Kidney transplant|kidney transplant
5701232|NCT00497926|Tolerance|tolerance
5701233|NCT00497926|Marrow/Enriched Hematopoetic Stem Cell Transplant|marrow/enriched hematopoetic stem cell transplant
5701234|NCT00497913|Tennis Elbow|tennis elbow
5701235|NCT00497913|Botulinum Toxin|botulinum toxin
5701236|NCT00497874|depression|depression
5701237|NCT00497874|stage of change|stage of change
5701238|NCT00497874|intervention|intervention
5701239|NCT00497874|randomized clinical trial|randomized clinical trial
5701240|NCT00497874|population-based|population-based
5701241|NCT00497874|expert system|expert system
5701242|NCT00497861|Low back pain|low back pain
5701243|NCT00497861|Chiropractic|chiropractic
5701244|NCT00497861|Spinal manipulation|spinal manipulation
5701245|NCT00497861|Activator Methods Chiropractic Technique|activator methods chiropractic technique
5701246|NCT00497835|motor seizures|motor seizures
5701247|NCT00497835|accelerometer|accelerometer
5701248|NCT00497835|algorithm|algorithm
5701249|NCT00497835|detection|detection
5701250|NCT00497835|alert|alert
5701251|NCT00497822|Dementia|dementia
5701252|NCT00497809|Breast Cancer|breast cancer
5701253|NCT00497809|Neutropenia|neutropenia
5701254|NCT00497809|Chemotherapy|chemotherapy
5701255|NCT00497809|High risk|high risk
5701256|NCT00497796|cytomegalovirus|cytomegalovirus
5701257|NCT00497796|CMV|cmv
5701258|NCT00497796|prophylaxis|prophylaxis
5701259|NCT00497796|liver|liver
5701260|NCT00497796|liver transplant|liver transplant
5701261|NCT00497757|Marrow/hematopoietic stem cell transplant|marrow/hematopoietic stem cell transplant
5701262|NCT00497744|CAPD peritonitis|capd peritonitis
5701263|NCT00497744|Peritoneal Dialysis, Continuous Ambulatory|peritoneal dialysis, continuous ambulatory
5701264|NCT00497731|Advanced solid tumors|advanced solid tumors
5701265|NCT00497705|Ebsteins Anomaly|ebsteins anomaly
5701266|NCT00497705|Heart Septal Defects, Ventricle|heart septal defects, ventricle
5701267|NCT00497705|Heart Defects, Congenital|heart defects, congenital
5701268|NCT00497705|Double Outlet Right Ventricle|double outlet right ventricle
5701269|NCT00497705|Truncus Arteriosus Persistant|truncus arteriosus persistant
5701270|NCT00497705|Ebstein's Anomaly|ebstein's anomaly
5701271|NCT00497705|Congenital Heart Disease|congenital heart disease
5701272|NCT00497705|Heart Defects|heart defects
5701273|NCT00497679|advanced solid tumours|advanced solid tumours
5701274|NCT00497666|Diabetes|diabetes
5701275|NCT00497666|Diabetic nephropathy|diabetic nephropathy
5701276|NCT00497666|renal protection|renal protection
5701277|NCT00497640|sleep apnea, titration, CPAP, neural network|sleep apnea, titration, cpap, neural network
5701278|NCT00497614|Rheumatoid arthritis|rheumatoid arthritis
5701279|NCT00497614|Positron emission tomodensitometry|positron emission tomodensitometry
5701280|NCT00497614|Tumor necrosis factor alpha inhibitor|tumor necrosis factor alpha inhibitor
5701281|NCT00497601|Visceral Leishmaniasis|visceral leishmaniasis
5701282|NCT00497601|Amphotericin B|amphotericin b
5701283|NCT00497601|Fat emulsion|fat emulsion
5701284|NCT00497588|laryngeal cancer|laryngeal cancer
5701285|NCT00497588|RADIOTHERAPY|radiotherapy
5701286|NCT00497588|Voice Quality|voice quality
5701287|NCT00497575|Congenital Hypothyroidism|congenital hypothyroidism
5701288|NCT00497575|diagnosis|diagnosis
5701290|NCT00497575|newborn screening|newborn screening
5701292|NCT00497562|growth hormone|growth hormone
5701293|NCT00497562|IGF-1|igf-1
5701295|NCT00497549|Esophagectomy|esophagectomy
5701296|NCT00497549|hand sewn anastomosis|hand sewn anastomosis
5701297|NCT00497549|side-to-side stapled|side-to-side stapled
5701298|NCT00497536|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5701299|NCT00497536|Continuous Subcutaneous Insulin Infusion (CSII)|continuous subcutaneous insulin infusion (csii)
5701300|NCT00497523|Asthma|asthma
5701301|NCT00497523|Young Children|young children
5701302|NCT00497523|Corticosteroids|corticosteroids
5701303|NCT00497523|Beclomethasone|beclomethasone
5701304|NCT00497523|Salbutamol|salbutamol
5701305|NCT00497523|Beclomethasone/Salbutamol fixed combination|beclomethasone/salbutamol fixed combination
5701306|NCT00497523|Suspension for nebulisation|suspension for nebulisation
5701307|NCT00497510|Balance|balance
5701308|NCT00497510|Chiropractic|chiropractic
5701309|NCT00497510|Older Adults|older adults
5701310|NCT00497497|CRC|crc
5701311|NCT00497497|Colon cancer|colon cancer
5701312|NCT00497497|Avastin|avastin
5701313|NCT00497497|APM4187g|apm4187g
5701314|NCT00497471|Plasmodium Falciparum|plasmodium falciparum
5701315|NCT00497471|Antimlarial chemoprophylaxis|antimlarial chemoprophylaxis
5701316|NCT00497471|Iron supplementation|iron supplementation
5701317|NCT00497471|Tanzania|tanzania
5701318|NCT00497458|breast|breast
5701319|NCT00497458|neoplasms|neoplasms
5701320|NCT00497458|anastrazole|anastrazole
5701321|NCT00497458|testosterone|testosterone
5701322|NCT00497445|Peripheral arterial disease|peripheral arterial disease
5701323|NCT00497445|Exercise therapy|exercise therapy
5701324|NCT00497445|Angioplasty|angioplasty
5701325|NCT00497445|Bypass surgery|bypass surgery
5701326|NCT00497432|Hyperbaric Oxygen|hyperbaric oxygen
5701327|NCT00497419|STEMI|stemi
5701328|NCT00497419|ST elevation myocardial infarction|st elevation myocardial infarction
5701329|NCT00497406|submandibular salivary gland transfer|submandibular salivary gland transfer
5701330|NCT00497406|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5701331|NCT00497406|helical tomotherapy|helical tomotherapy
5701332|NCT00497406|reduction of xerostomia|reduction of xerostomia
5701333|NCT00497393|Emergency department, administration, overcrowding|emergency department, administration, overcrowding
5701334|NCT00497367|safety|safety
5701335|NCT00497367|feasibility|feasibility
5701336|NCT00497367|bifurcation|bifurcation
5701337|NCT00497367|lesion|lesion
5701338|NCT00497367|de novo|de novo
5701339|NCT00497367|intervention|intervention
5701340|NCT00497354|Ultrasound, Complications, Regional Anesthesia|ultrasound, complications, regional anesthesia
5701341|NCT00497341|infection after total knee arthroplasty|infection after total knee arthroplasty
5701342|NCT00497328|contrast induced nephropathy|contrast induced nephropathy
5701343|NCT00497315|Non-Small Cell Lung Cancer|non-small cell lung cancer
5701344|NCT00497315|NSCLC|nsclc
5701345|NCT00497315|Chemoradiation|chemoradiation
5701346|NCT00497315|locally advanced NSCLC|locally advanced nsclc
5701347|NCT00497315|pemetrexed|pemetrexed
5701348|NCT00497315|lung cancer|lung cancer
5701349|NCT00497302|cocaine|cocaine
5701350|NCT00497302|opiate|opiate
5701351|NCT00497302|pregnancy|pregnancy
5701352|NCT00497302|post-partum|post-partum
5701353|NCT00497302|neonatal abstinence syndrome|neonatal abstinence syndrome
5701354|NCT00497302|contingency management|contingency management
5701355|NCT00497302|Reinforcement Based Treatment|reinforcement based treatment
5701356|NCT00497302|women|women
5701357|NCT00497289|n-3 PUFA|n-3 pufa
5701358|NCT00497289|parenteral nutrition|parenteral nutrition
5701359|NCT00497289|preterm infant|preterm infant
5701360|NCT00497276|Adults|adults
5701361|NCT00497276|Anesthesia recovery period|anesthesia recovery period
5701362|NCT00497276|Comparative study|comparative study
5701363|NCT00497276|Electric stimulation|electric stimulation
5701364|NCT00497276|Humans|humans
5701365|NCT00497276|Nerve blocks/methods/indications|nerve blocks/methods/indications
5701366|NCT00497276|Patient satisfaction|patient satisfaction
5701367|NCT00497276|Peripheral nerves|peripheral nerves
5701368|NCT00497276|Sciatic nerve/ultrasonography|sciatic nerve/ultrasonography
5701369|NCT00497276|Ultrasonography|ultrasonography
5701370|NCT00497276|Treatment outcome|treatment outcome
5701371|NCT00497276|Nerve blocks/economics|nerve blocks/economics
5701372|NCT00497250|Phase 1 Clinical Trials|phase 1 clinical trials
5701373|NCT00497250|Iressa|iressa
5701374|NCT00497250|radiation therapy|radiation therapy
5701375|NCT00497250|Chinese|chinese
5701376|NCT00497250|NSCLC|nsclc
5701377|NCT00497250|chemotherapy|chemotherapy
5701378|NCT00497237|Asthma|asthma
5701379|NCT00497237|Stepdown|stepdown
5701380|NCT00497237|Beclomethasone|beclomethasone
5701381|NCT00497237|Formoterol|formoterol
5701382|NCT00497237|Corticosteroids|corticosteroids
5701383|NCT00497224|Pancreatic Cancer|pancreatic cancer
5701384|NCT00497224|Pancreatic Carcinoma|pancreatic carcinoma
5701385|NCT00497224|Pancreas|pancreas
5701386|NCT00497224|Adenocarcinoma|adenocarcinoma
5701387|NCT00497224|Erlotinib|erlotinib
5701388|NCT00497224|Tarceva|tarceva
5701389|NCT00497224|OSI-774|osi-774
5701390|NCT00497224|Phase II|phase ii
5701391|NCT00497211|First large acute myocardial infarction|first large acute myocardial infarction
5701392|NCT00497198|Type 2 Diabetes|type 2 diabetes
5701393|NCT00497198|anion-exchange resin|anion-exchange resin
5701394|NCT00497185|Mindfulness-Based Cognitive Therapy|mindfulness-based cognitive therapy
5701395|NCT00497185|Somatization Disorder|somatization disorder
5701396|NCT00497185|Medically Unexplained Symptoms|medically unexplained symptoms
5701397|NCT00497185|Functional Somatic Symptoms|functional somatic symptoms
5701398|NCT00497185|SF-36|sf-36
5701399|NCT00497159|Trial of Dimebon to treat patients with mild-to-moderate Huntington's disease.|trial of dimebon to treat patients with mild-to-moderate huntington's disease.
5701400|NCT00497146|paricalcitol|paricalcitol
5725416|NCT00412659|surgery|surgery
5701401|NCT00497146|Zemplar|zemplar
5701402|NCT00497146|PRIMO|primo
5701403|NCT00497146|Chronic Kidney Disease Stage 3B/4|chronic kidney disease stage 3b/4
5701404|NCT00497133|glucoseintolerance|glucoseintolerance
5701405|NCT00497120|sleep apnea|sleep apnea
5701406|NCT00497120|snoring|snoring
5701407|NCT00497120|acetazolamide|acetazolamide
5701408|NCT00497120|uvulopalatopharyngoplasty|uvulopalatopharyngoplasty
5701409|NCT00497120|daytime sleepiness|daytime sleepiness
5701410|NCT00497120|upper airway|upper airway
5701413|NCT00497107|Colorectal cancer|colorectal cancer
5701414|NCT00497107|Adjuvant therapy|adjuvant therapy
5701415|NCT00497094|carotid artery stenting|carotid artery stenting
5701416|NCT00497094|atherosclerosis|atherosclerosis
5701417|NCT00497094|cerebrovascular|cerebrovascular
5701418|NCT00497094|stroke|stroke
5701419|NCT00497081|Methamphetamine|methamphetamine
5701420|NCT00497081|HIV|hiv
5701421|NCT00497081|MSM|msm
5701422|NCT00497081|HIV Seronegativity|hiv seronegativity
5701423|NCT00497068|smoking|smoking
5701424|NCT00497068|pregnancy|pregnancy
5701425|NCT00497068|neonatal abstinence syndrome|neonatal abstinence syndrome
5701426|NCT00497055|Methamphetamine|methamphetamine
5701428|NCT00497055|MSM|msm
5701429|NCT00497055|HIV Seronegativity|hiv seronegativity
5701430|NCT00497029|dental caries|dental caries
5701431|NCT00497029|early childhood caries|early childhood caries
5701432|NCT00497029|caries prevention|caries prevention
5701433|NCT00497029|infants|infants
5701434|NCT00497016|hypertension|hypertension
5701435|NCT00497016|statin|statin
5701436|NCT00497016|sympathetic|sympathetic
5701437|NCT00497003|Endothelial function|endothelial function
5701438|NCT00497003|Beta blocker|beta blocker
5701439|NCT00497003|Type 2 diabetes|type 2 diabetes
5701440|NCT00497003|Chronic heart failure|chronic heart failure
5701441|NCT00496990|male|male
5701442|NCT00496990|female|female
5701443|NCT00496990|couple|couple
5701444|NCT00496990|cocaine|cocaine
5701445|NCT00496990|opiate|opiate
5701446|NCT00496990|methadone|methadone
5701447|NCT00496990|detoxification|detoxification
5701448|NCT00496990|pregnancy|pregnancy
5701449|NCT00496977|lung cancer|lung cancer
5701450|NCT00496977|CT scan|ct scan
5701451|NCT00496977|screening|screening
5701452|NCT00496964|Botulinum toxin type A|botulinum toxin type a
5701453|NCT00496964|Patellofemoral pain syndrome|patellofemoral pain syndrome
5701454|NCT00496964|Knee Injuries|knee injuries
5701455|NCT00496964|Exercise Therapy|exercise therapy
5701456|NCT00496951|Neonatal abstinence syndrome|neonatal abstinence syndrome
5701457|NCT00496951|Methadone|methadone
5701459|NCT00496938|Stents|stents
5701460|NCT00496938|Angioplasty|angioplasty
5701461|NCT00496938|Total coronary occlusions|total coronary occlusions
5701462|NCT00496938|Coronary restenosis|coronary restenosis
5701463|NCT00496938|Stent thrombosis|stent thrombosis
5701464|NCT00496938|Everolimus|everolimus
5701465|NCT00496899|Labor|labor
5701466|NCT00496899|Obstetric|obstetric
5701467|NCT00496899|cervical dilatation|cervical dilatation
5701468|NCT00496886|Pain|pain
5701469|NCT00496886|Nociception|nociception
5701470|NCT00496873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5701472|NCT00496873|Lymphoma|lymphoma
5701473|NCT00496873|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5701474|NCT00496873|SLL|sll
5701475|NCT00496873|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5701476|NCT00496873|Lymphoplasmacytic lymphoma/immunocytoma|lymphoplasmacytic lymphoma/immunocytoma
5701478|NCT00496873|Extranodal marginal zone B-cell lymphoma of MALT type|extranodal marginal zone b-cell lymphoma of malt type
5701479|NCT00496873|Nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5701480|NCT00496873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5701481|NCT00496873|CLL|cll
5701482|NCT00496873|Bulky Lymphoma|bulky lymphoma
5701483|NCT00496873|Nipent|nipent
5701484|NCT00496873|Cytoxan|cytoxan
5701485|NCT00496873|Rituxan|rituxan
5701486|NCT00496873|Cyclophosphamide|cyclophosphamide
5701487|NCT00496873|Rituximab|rituximab
5701488|NCT00496873|Pentostatin|pentostatin
5701489|NCT00496860|cancer|cancer
5701490|NCT00496860|p53|p53
5701491|NCT00496860|immunotherapy|immunotherapy
5701492|NCT00496860|targeted|targeted
5701493|NCT00496860|metastatic|metastatic
5701494|NCT00496860|malignancy|malignancy
5701495|NCT00496860|malignancies|malignancies
5701496|NCT00496860|interleukin-2|interleukin-2
5701497|NCT00496860|IL-2|il-2
5701500|NCT00496860|melanoma|melanoma
5701501|NCT00496860|renal cancer|renal cancer
5701502|NCT00496860|lung cancer|lung cancer
5701503|NCT00496860|kidney cancer|kidney cancer
5701504|NCT00496860|breast cancer|breast cancer
5701505|NCT00496860|colorectal cancer|colorectal cancer
5701506|NCT00496860|colon cancer|colon cancer
5701507|NCT00496860|renal cell carcinoma|renal cell carcinoma
5701508|NCT00496860|advanced cancer|advanced cancer
5701509|NCT00496860|head and neck cancer|head and neck cancer
5701510|NCT00496860|breast tumors|breast tumors
5701511|NCT00496860|cancer of head and neck|cancer of head and neck
5701512|NCT00496860|esophagus cancer|esophagus cancer
5701513|NCT00496860|lymphoma|lymphoma
5701514|NCT00496860|ovarian cancer|ovarian cancer
5701515|NCT00496860|ovary cancer|ovary cancer
5701516|NCT00496860|bladder cancer|bladder cancer
5701517|NCT00496860|stomach cancer|stomach cancer
5701518|NCT00496860|TCR|tcr
5701519|NCT00496860|T-cell receptor|t-cell receptor
5701520|NCT00496860|P53 gene|p53 gene
5701521|NCT00496860|p53 tumor suppressor protein|p53 tumor suppressor protein
5701522|NCT00496847|rhPDGF,|rhpdgf,
5701523|NCT00496847|periodontal disease|periodontal disease
5701524|NCT00496821|Respiratory Syncytial Virus|respiratory syncytial virus
5701525|NCT00496808|Ductal Carcinoma In Situ|ductal carcinoma in situ
5701526|NCT00496808|Breast Cancer|breast cancer
5701527|NCT00496808|Herceptin|herceptin
5701528|NCT00496808|Trastuzumab|trastuzumab
5701529|NCT00496808|DCIS|dcis
5701530|NCT00496795|Breast cancer, chemoresistance, predictive markers.|breast cancer, chemoresistance, predictive markers.
5701531|NCT00496782|Treatment Experienced|treatment experienced
5701532|NCT00496756|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5701533|NCT00496756|stage III renal cell cancer|stage iii renal cell cancer
5701534|NCT00496756|stage IV renal cell cancer|stage iv renal cell cancer
5701535|NCT00496756|recurrent renal cell cancer|recurrent renal cell cancer
5701536|NCT00496730|Metabolic Disorder|metabolic disorder
5701537|NCT00496717|Calcium scoring/aorta/ cardiovascular risk factor/scann|calcium scoring/aorta/ cardiovascular risk factor/scann
5701538|NCT00496717|Patients with at least one cardiovascular risk factor|patients with at least one cardiovascular risk factor
5701539|NCT00496704|adenocarcinoma of the colon|adenocarcinoma of the colon
5701540|NCT00496704|recurrent colon cancer|recurrent colon cancer
5701541|NCT00496704|stage III colon cancer|stage iii colon cancer
5701542|NCT00496704|stage IV colon cancer|stage iv colon cancer
5701543|NCT00496704|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5701544|NCT00496704|recurrent rectal cancer|recurrent rectal cancer
5701545|NCT00496704|stage III rectal cancer|stage iii rectal cancer
5701546|NCT00496704|stage IV rectal cancer|stage iv rectal cancer
5701547|NCT00496691|HIV prevention|hiv prevention
5701548|NCT00496691|HIV Seronegativity|hiv seronegativity
5701549|NCT00496678|PNRP|pnrp
5701550|NCT00496678|navigation|navigation
5701551|NCT00496678|navigator|navigator
5701552|NCT00496678|activation|activation
5701553|NCT00496678|disparities|disparities
5701554|NCT00496678|randomized control trial|randomized control trial
5701555|NCT00496678|primary care|primary care
5701556|NCT00496678|racial and ethnic minorities|racial and ethnic minorities
5701557|NCT00496665|Stage IV breast cancer|stage iv breast cancer
5680547|NCT00577590|Type II Diabetes Mellitus|type ii diabetes mellitus
5680548|NCT00577590|Diabetes|diabetes
5680549|NCT00577590|PET|pet
5680550|NCT00577590|Heart Metabolism|heart metabolism
5726925|NCT00406640|MDD|mdd
5701558|NCT00496665|metronomic chemotherapy|metronomic chemotherapy
5701559|NCT00496652|Squamous Cell Carcinomas of the Head and Neck|squamous cell carcinomas of the head and neck
5701560|NCT00496652|Epidermal Growth Factor receptor|epidermal growth factor receptor
5701561|NCT00496652|Antibody|antibody
5701562|NCT00496652|Radiotherapy|radiotherapy
5701563|NCT00496639|hemodialysis|hemodialysis
5701564|NCT00496639|arterio-venous grafts|arterio-venous grafts
5701565|NCT00496639|angioplasty|angioplasty
5701567|NCT00496639|mechanical thrombectomy|mechanical thrombectomy
5701568|NCT00496626|HPV infections|hpv infections
5701569|NCT00496613|Breast cancer|breast cancer
5701570|NCT00496613|survivor|survivor
5701571|NCT00496587|Genitourinary|genitourinary
5701572|NCT00496587|Kidney Cancer|kidney cancer
5701573|NCT00496587|Sarcomatoid Renal Cell Carcinoma|sarcomatoid renal cell carcinoma
5701574|NCT00496587|Renal Cell Carcinoma|renal cell carcinoma
5701576|NCT00496587|Sarcomatoid Carcinoma of the Kidney|sarcomatoid carcinoma of the kidney
5701577|NCT00496587|Unresectable renal cell carcinoma|unresectable renal cell carcinoma
5701578|NCT00496587|Capecitabine|capecitabine
5701579|NCT00496587|Xeloda|xeloda
5701580|NCT00496587|Gemcitabine|gemcitabine
5701581|NCT00496587|Gemzar|gemzar
5701582|NCT00496587|Bevacizumab|bevacizumab
5701583|NCT00496587|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5701584|NCT00496587|rhuMAb-VEGF|rhumab-vegf
5701585|NCT00496587|Avastin|avastin
5701586|NCT00496587|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5701587|NCT00496587|VEGF|vegf
5701588|NCT00496574|asthma|asthma
5701589|NCT00496574|immunotherapy|immunotherapy
5701591|NCT00496574|children|children
5701592|NCT00496574|symptoms score|symptoms score
5701593|NCT00496574|quality of life|quality of life
5701594|NCT00496574|spirometry|spirometry
5701596|NCT00496561|asthma|asthma
5701597|NCT00496561|immunotherapy|immunotherapy
5701598|NCT00496561|children|children
5701599|NCT00496561|regulatory T cells|regulatory t cells
5701600|NCT00496561|ECP|ecp
5701601|NCT00496561|PC20M|pc20m
5701602|NCT00496561|Quality of Life|quality of life
5701603|NCT00496561|Symptoms score|symptoms score
5701604|NCT00496561|Spirometry|spirometry
5701605|NCT00496548|Crohn's Disease|crohn's disease
5701606|NCT00496535|head|head
5701607|NCT00496535|neck|neck
5701608|NCT00496535|cancer|cancer
5701609|NCT00496535|neoplasm|neoplasm
5701610|NCT00496522|Skull Base Chondrosarcoma|skull base chondrosarcoma
5701611|NCT00496522|Proton Beam Therapy|proton beam therapy
5701612|NCT00496522|Chondrosarcoma|chondrosarcoma
5701613|NCT00496522|CNS|cns
5701614|NCT00496509|ZD6474|zd6474
5701615|NCT00496509|Colorectal Cancer|colorectal cancer
5701616|NCT00496509|Liver Metastases|liver metastases
5701617|NCT00496509|Biomarkers|biomarkers
5701618|NCT00496483|Tacrolimus|tacrolimus
5701619|NCT00496483|Pharmacokinetics|pharmacokinetics
5701620|NCT00496483|Kidney Transplantation|kidney transplantation
5701621|NCT00496470|Chronic Obstructive Pulmonary Disease, COPD|chronic obstructive pulmonary disease, copd
5701622|NCT00496457|Diabetic Neuropathy|diabetic neuropathy
5701623|NCT00496457|Painful Peripheral Diabetic Neuropathy|painful peripheral diabetic neuropathy
5701624|NCT00496457|TRO19622|tro19622
5701625|NCT00496457|Trophos|trophos
5701626|NCT00496444|Advanced Cancers|advanced cancers
5701627|NCT00496444|Azacytidine|azacytidine
5701628|NCT00496444|5-Azacitidine|5-azacitidine
5701629|NCT00496444|5-aza|5-aza
5701630|NCT00496444|Vidaza|vidaza
5701631|NCT00496444|5-AZC|5-azc
5701632|NCT00496444|AZA-CR|aza-cr
5701633|NCT00496444|Ladakamycin|ladakamycin
5701634|NCT00496444|NSC-102816|nsc-102816
5701635|NCT00496444|Valproic Acid|valproic acid
5701636|NCT00496444|Depakene|depakene
5701637|NCT00496418|colostomy|colostomy
5701638|NCT00496418|parastomal|parastomal
5701639|NCT00496418|peristomal|peristomal
5701640|NCT00496418|hernia|hernia
5701641|NCT00496418|mesh|mesh
5701642|NCT00496418|surgery|surgery
5701643|NCT00496418|Indication for permanent end colostomy|indication for permanent end colostomy
5701644|NCT00496405|Vascular endothelial growth factor.|vascular endothelial growth factor.
5701645|NCT00496405|Retinal Thickness|retinal thickness
5701646|NCT00496405|Diabetic Macular Edema|diabetic macular edema
5701647|NCT00496405|Optical Coherent Tomography|optical coherent tomography
5701648|NCT00496392|breakthrough pain in patients with cancer|breakthrough pain in patients with cancer
5701649|NCT00496379|metastatic breast cancer|metastatic breast cancer
5701650|NCT00496379|invasive breast cancer|invasive breast cancer
5701651|NCT00496379|brain metastases|brain metastases
5701652|NCT00496379|ZK-EPO|zk-epo
5701653|NCT00496353|Neoplasm Malignant|neoplasm malignant
5701654|NCT00496340|Pentostatin|pentostatin
5701655|NCT00496340|Busulfan|busulfan
5701656|NCT00496340|Rituxan|rituxan
5701657|NCT00496340|Allogeneic Hematopoietic Stem Cell Transplantation|allogeneic hematopoietic stem cell transplantation
5701658|NCT00496301|renal|renal
5701659|NCT00496301|sorafenib|sorafenib
5701660|NCT00496301|Unresectable and/or metastatic renal cell cancer|unresectable and/or metastatic renal cell cancer
5701661|NCT00496288|BRCA mutation|brca mutation
5701662|NCT00496288|Breast cancer|breast cancer
5701663|NCT00496288|Prophylactic breast irradiation|prophylactic breast irradiation
5701664|NCT00496288|Prevention of contralateral breast cancer|prevention of contralateral breast cancer
5701665|NCT00496275|NSCLC|nsclc
5701666|NCT00496275|ZACTIMA|zactima
5701667|NCT00496262|Congenital fibrinogen deficiency|congenital fibrinogen deficiency
5701668|NCT00496262|Fibrinogen concentrate|fibrinogen concentrate
5701669|NCT00496262|Pharmacokinetics|pharmacokinetics
5701670|NCT00496262|Thrombelastography|thrombelastography
5701671|NCT00496249|Prostate|prostate
5701672|NCT00496249|cancer|cancer
5701673|NCT00496249|brachytherapy|brachytherapy
5701674|NCT00496249|radiation|radiation
5701675|NCT00496249|semen|semen
5701676|NCT00496249|fertility|fertility
5701677|NCT00496236|head|head
5701679|NCT00496236|cancer|cancer
5701680|NCT00496236|neoplasm|neoplasm
5701681|NCT00496223|Sunitinib|sunitinib
5701682|NCT00496223|Dacarbazine|dacarbazine
5701683|NCT00496223|Melanoma|melanoma
5701684|NCT00496210|Adaptation|adaptation
5701685|NCT00496210|Pervasive Developmental Disorder|pervasive developmental disorder
5701686|NCT00496210|Autism Spectrum Disorders|autism spectrum disorders
5701687|NCT00496210|Pervasive Developmental Disorders|pervasive developmental disorders
5701688|NCT00496210|Caregiver Adaptation|caregiver adaptation
5701689|NCT00496197|candidemia|candidemia
5701690|NCT00496197|invasive candidiasis|invasive candidiasis
5701691|NCT00496197|fungal bloodstream infection|fungal bloodstream infection
5701692|NCT00496184|Nifedipine treatment|nifedipine treatment
5701694|NCT00496184|Placebo|placebo
5701695|NCT00496158|Nucleoside Treatment-Naïve Patients with HBeAg Negative Chronic Hepatitis due to Hepatitis B Virus|nucleoside treatment-naïve patients with hbeag negative chronic hepatitis due to hepatitis b virus
5701696|NCT00496158|hepatitis b virus|hepatitis b virus
5701697|NCT00496145|diabetes|diabetes
5701698|NCT00496145|self management|self management
5701699|NCT00496145|patient education|patient education
5701700|NCT00496145|telephone reinforcement|telephone reinforcement
5701701|NCT00496145|Spanish Diabetes|spanish diabetes
5701702|NCT00496145|Tomando Control de su Diabetes|tomando control de su diabetes
5701704|NCT00496132|Leukemia|leukemia
5701705|NCT00496132|Lymph|lymph
5701706|NCT00496119|Proton Beam Therapy|proton beam therapy
5701707|NCT00496119|Skull Base Chordoma|skull base chordoma
5701708|NCT00496119|Chordoma of the Skull Base|chordoma of the skull base
5701709|NCT00496119|Chordoma|chordoma
5701710|NCT00496080|Menorrhagia associated with Uterine Fibroids|menorrhagia associated with uterine fibroids
5701711|NCT00496067|Fibroids|fibroids
5701712|NCT00496067|Menorrhagia|menorrhagia
5701713|NCT00496067|Menorrhagia associated with uterine fibroids|menorrhagia associated with uterine fibroids
5701714|NCT00496041|Stenosis (> 75%) or occlusion of the superficial femoral artery|stenosis (> 75%) or occlusion of the superficial femoral artery
5701715|NCT00496028|Solid tumors|solid tumors
5702332|NCT00493818|Lymphoma,|lymphoma,
5701716|NCT00496028|locally advanced or Metastatic Cancer suitable for treatment with carboplatin and/or paclitaxel|locally advanced or metastatic cancer suitable for treatment with carboplatin and/or paclitaxel
5701717|NCT00496015|Streptococcus Pneumoniae Vaccines|streptococcus pneumoniae vaccines
5701718|NCT00496015|Meningococcal disease|meningococcal disease
5701719|NCT00496015|Carriage|carriage
5701720|NCT00496015|Prophylactic antipyretic|prophylactic antipyretic
5701721|NCT00496015|Safety|safety
5701722|NCT00496015|Pneumococcal vaccine|pneumococcal vaccine
5701723|NCT00496015|Fever|fever
5701724|NCT00496015|Pneumococcal disease|pneumococcal disease
5701725|NCT00496015|Immunogenicity|immunogenicity
5701726|NCT00496015|Meningococcal vaccine|meningococcal vaccine
5701727|NCT00496015|Booster vaccination|booster vaccination
5701728|NCT00496002|Hepatitis B virus|hepatitis b virus
5701729|NCT00496002|Nucleoside Treatment-Naïve Patients with HBeAg Positive|nucleoside treatment-naïve patients with hbeag positive
5701730|NCT00495989|Handicapped individuals|handicapped individuals
5701732|NCT00495976|flu|flu
5701733|NCT00495976|influenza|influenza
5701734|NCT00495963|Mechanical ventilation, Ventilator- associated pneumonia, Bronchoalveolar lavage, Pediatric intensive care unit, Flexible bronchoscopy, Critical care|mechanical ventilation, ventilator- associated pneumonia, bronchoalveolar lavage, pediatric intensive care unit, flexible bronchoscopy, critical care
5701735|NCT00495950|Melanoma|melanoma
5701736|NCT00495950|Lymphedema|lymphedema
5701737|NCT00495950|Limb Swelling|limb swelling
5701738|NCT00495950|Questionnaire|questionnaire
5701739|NCT00495950|Quality of Life|quality of life
5701740|NCT00495950|Physical Function|physical function
5701741|NCT00495950|Survey|survey
5701742|NCT00495885|Sleep problems|sleep problems
5701743|NCT00495885|insomnia|insomnia
5701744|NCT00495885|sleeplessness|sleeplessness
5701745|NCT00495885|primary insomnia|primary insomnia
5701746|NCT00495885|insomnia disorder|insomnia disorder
5701747|NCT00495872|Solid Tumors|solid tumors
5701748|NCT00495872|Advanced Cancer|advanced cancer
5701749|NCT00495872|Dasatinib|dasatinib
5701750|NCT00495872|Erlotinib|erlotinib
5701751|NCT00495872|Lapatinib|lapatinib
5701752|NCT00495872|Lenalidomide|lenalidomide
5701753|NCT00495872|Sorafenib|sorafenib
5701754|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride
5701755|NCT00495872|Sunitinib Malate|sunitinib malate
5701756|NCT00495872|Sunitinib|sunitinib
5701757|NCT00495872|Valproic Acid|valproic acid
5701758|NCT00495872|SU011248|su011248
5701759|NCT00495859|Immunonutrition|immunonutrition
5701760|NCT00495859|immune enhancing diets|immune enhancing diets
5701761|NCT00495859|arginine|arginine
5701762|NCT00495859|ω-3 fatty acids|ω-3 fatty acids
5701763|NCT00495859|nucleotides|nucleotides
5701764|NCT00495859|liver transplantation|liver transplantation
5701765|NCT00495859|clinical trial|clinical trial
5701766|NCT00495846|Hepatocellular carcinoma|hepatocellular carcinoma
5701767|NCT00495846|Somatostatin analogues|somatostatin analogues
5701768|NCT00495846|Somatostatin receptors|somatostatin receptors
5691416|NCT00532389|LBH589|lbh589
5701769|NCT00495846|Octreotide|octreotide
5701770|NCT00495846|Lanreotide|lanreotide
5701771|NCT00495846|IGF-I|igf-i
5701772|NCT00495846|IGF-II|igf-ii
5701773|NCT00495833|Hypertension|hypertension
5701774|NCT00495820|Alzheimer's Disease|alzheimer's disease
5701775|NCT00495820|Apathy|apathy
5701776|NCT00495820|Dementia|dementia
5701777|NCT00495820|Methylphenidate|methylphenidate
5701778|NCT00495807|Psychological Tests|psychological tests
5701779|NCT00495807|Pain, Postoperative|pain, postoperative
5701780|NCT00495807|Nurses|nurses
5701781|NCT00495794|diabetes|diabetes
5701782|NCT00495794|hypertension|hypertension
5701783|NCT00495794|adherence|adherence
5701784|NCT00495794|implementation|implementation
5701785|NCT00495794|medications|medications
5701787|NCT00495781|functional iron deficiency|functional iron deficiency
5701788|NCT00495781|renal anemia|renal anemia
5701789|NCT00495781|dialysis|dialysis
5701790|NCT00495781|erythropoietin|erythropoietin
5701791|NCT00495781|darbepoetin|darbepoetin
5701792|NCT00495768|Hepatitis C|hepatitis c
5701793|NCT00495768|HCV|hcv
5701794|NCT00495768|Depression|depression
5701795|NCT00495768|Interferons|interferons
5701796|NCT00495768|Ribavirin|ribavirin
5701797|NCT00495755|Chronic Graft-vs-Host Disease|chronic graft-vs-host disease
5701798|NCT00495729|SB-649868,|sb-649868,
5701799|NCT00495729|Simvastatin|simvastatin
5701800|NCT00495729|Repeated dose,|repeated dose,
5701801|NCT00495703|Cancer survivors|cancer survivors
5701802|NCT00495703|Chemotherapy|chemotherapy
5701803|NCT00495703|Cognitive function|cognitive function
5701804|NCT00495703|Exercise|exercise
5701805|NCT00495703|Physical Activity|physical activity
5701806|NCT00495690|Zinc recipients|zinc recipients
5701807|NCT00495690|Placebo recipients|placebo recipients
5701808|NCT00495677|Treatment Experienced|treatment experienced
5701809|NCT00495677|Treatment Naive|treatment naive
5701810|NCT00495664|titanium|titanium
5701811|NCT00495664|paclitaxel|paclitaxel
5701812|NCT00495664|stent|stent
5701813|NCT00495664|myocardial infarction|myocardial infarction
5701814|NCT00495664|angioplasty|angioplasty
5701815|NCT00495664|PCI|pci
5701824|NCT00495638|Pulmonary Function Tests|pulmonary function tests
5701825|NCT00495638|Sickle Cell Disease|sickle cell disease
5701826|NCT00495638|SCD|scd
5701827|NCT00495638|Pulmonary Hypertension|pulmonary hypertension
5701828|NCT00495625|Hepatocellular cancer (HCC)|hepatocellular cancer (hcc)
5701829|NCT00495625|Sunitinib malate|sunitinib malate
5701830|NCT00495625|Vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5701831|NCT00495625|Platelet-derived growth factor (PDGF)|platelet-derived growth factor (pdgf)
5701832|NCT00495625|Tyrosine kinases|tyrosine kinases
5701833|NCT00495625|Liver|liver
5701834|NCT00495612|Xolair|xolair
5701835|NCT00495612|Allergic asthma|allergic asthma
5701836|NCT00495612|Cat allergy|cat allergy
5701837|NCT00495599|Obese|obese
5701838|NCT00495599|Adipose Tissue|adipose tissue
5701839|NCT00495599|Visfatin|visfatin
5701840|NCT00495599|Gastric Bypass Surgery|gastric bypass surgery
5701841|NCT00495586|COPD|copd
5701842|NCT00495586|Antibiotics|antibiotics
5701843|NCT00495560|induction|induction
5701844|NCT00495560|abortion|abortion
5701845|NCT00495560|injection, intra-amniotic|injection, intra-amniotic
5701846|NCT00495560|misoprostol|misoprostol
5701847|NCT00495547|Myelodysplastic Syndrome|myelodysplastic syndrome
5701848|NCT00495547|Red Cell transfusion dependent|red cell transfusion dependent
5701849|NCT00495521|Crohn's|crohn's
5701850|NCT00495521|Crohn's Disease|crohn's disease
5701851|NCT00495521|Acute Flare|acute flare
5701852|NCT00495521|Mild to Moderate Crohn's Disease|mild to moderate crohn's disease
5701853|NCT00495521|Children|children
5701854|NCT00495521|Pediatrics|pediatrics
5701855|NCT00495521|Ileo-cecal|ileo-cecal
5701856|NCT00495521|Pediatric Crohn's Disease|pediatric crohn's disease
5701857|NCT00495521|New Onset Crohn's Disease|new onset crohn's disease
5701858|NCT00495521|Recently diagnosed Crohn's Disease|recently diagnosed crohn's disease
5701859|NCT00495508|Quinine|quinine
5701860|NCT00495508|Artemether|artemether
5701861|NCT00495508|Lumefantrine|lumefantrine
5701862|NCT00495508|malaria|malaria
5701863|NCT00495508|Uganda|uganda
5701864|NCT00495508|Artemisinin- based combination therapy|artemisinin- based combination therapy
5701865|NCT00495508|pregnancy|pregnancy
5702305|NCT00493922|Africa|africa
5701866|NCT00495508|Malaria In Pregnancy|malaria in pregnancy
5701867|NCT00495482|Euthanasia|euthanasia
5701868|NCT00495482|Assisted Suicide|assisted suicide
5701869|NCT00495482|Assisted Dying|assisted dying
5701870|NCT00495482|Palliative Care Medicine|palliative care medicine
5701871|NCT00495469|Diabetes mellitus HbA1c|diabetes mellitus hba1c
5701872|NCT00495456|cardiovascular|cardiovascular
5701873|NCT00495456|risk|risk
5701874|NCT00495456|longitudinal|longitudinal
5701875|NCT00495456|prospective|prospective
5701876|NCT00495430|Healthy|healthy
5701877|NCT00495430|Lung sounds|lung sounds
5701878|NCT00495430|Breath sounds|breath sounds
5701879|NCT00495417|Alzheimer|alzheimer
5701880|NCT00495417|Morbus Alzheimer|morbus alzheimer
5701881|NCT00495417|Alzheimer Vaccine|alzheimer vaccine
5701882|NCT00495417|Vaccine|vaccine
5701884|NCT00495417|Aβ immunotherapy|aβ immunotherapy
5701885|NCT00495404|chronic non-malignant pain|chronic non-malignant pain
5701886|NCT00495404|opiates|opiates
5701887|NCT00495404|prescriptions|prescriptions
5701888|NCT00495404|addiction|addiction
5701889|NCT00495391|Hepatitis C, Chronic|hepatitis c, chronic
5701890|NCT00495378|PROCRIT|procrit
5701891|NCT00495378|Epoetin alfa|epoetin alfa
5701892|NCT00495378|chemotherapy related anemia|chemotherapy related anemia
5701893|NCT00495365|Anemia|anemia
5701894|NCT00495365|low blood count|low blood count
5701895|NCT00495365|chronic kidney disease|chronic kidney disease
5701896|NCT00495365|chronic kidney failure|chronic kidney failure
5701897|NCT00495365|darbepoetin alfa|darbepoetin alfa
5701898|NCT00495365|epoetin alfa|epoetin alfa
5701899|NCT00495365|recombinant human erythropoietin|recombinant human erythropoietin
5701900|NCT00495352|Schizophrenia|schizophrenia
5701902|NCT00495352|Bupropion|bupropion
5701903|NCT00495352|Stages of change|stages of change
5701904|NCT00495326|drug interactions|drug interactions
5701905|NCT00495326|Treatment Naive|treatment naive
5701906|NCT00495313|Rosacea|rosacea
5701913|NCT00495287|Acute myelogenous leukemia|acute myelogenous leukemia
5701914|NCT00495287|Adult patients|adult patients
5701915|NCT00495287|Cytogenetic risk class|cytogenetic risk class
5701916|NCT00495287|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
5701917|NCT00495287|Risk-oriented therapy|risk-oriented therapy
5701918|NCT00495274|Bioequivalent|bioequivalent
5701919|NCT00495274|pharmacodynamic|pharmacodynamic
5701920|NCT00495274|Reference formulation|reference formulation
5701921|NCT00495274|5 new formulation|5 new formulation
5701922|NCT00495274|Food effect|food effect
5701923|NCT00495274|Pharmacokinetics|pharmacokinetics
5701924|NCT00495261|Gambling|gambling
5701925|NCT00495261|Mindfulness|mindfulness
5700578|NCT00499733|tongue cancer|tongue cancer
5701926|NCT00495261|Cognitive Behavioural Therapy|cognitive behavioural therapy
5701927|NCT00495248|group intervention|group intervention
5701928|NCT00495248|stroke|stroke
5701929|NCT00495248|senior centres|senior centres
5701930|NCT00495248|health promotion|health promotion
5701931|NCT00495235|Endometrial Cancer|endometrial cancer
5701932|NCT00495235|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5701933|NCT00495235|Insulin Resistance|insulin resistance
5701934|NCT00495235|Pre-diabetes|pre-diabetes
5701935|NCT00495235|Harris County|harris county
5701936|NCT00495235|PCOS|pcos
5701937|NCT00495235|Uterus|uterus
5701938|NCT00495235|Questionnaire|questionnaire
5701939|NCT00495235|Body mass index|body mass index
5701940|NCT00495235|BMI|bmi
5701941|NCT00495222|gastrojejunostomy|gastrojejunostomy
5701943|NCT00495209|Complementary and Alternative Medicine|complementary and alternative medicine
5701944|NCT00495209|Breast Cancer|breast cancer
5701945|NCT00495209|Qigong|qigong
5701946|NCT00495209|Medical Qigong|medical qigong
5701947|NCT00495209|External Qi Therapy|external qi therapy
5701948|NCT00495209|EQT|eqt
5701949|NCT00495183|cocaine dependence|cocaine dependence
5701950|NCT00495183|cocaine use|cocaine use
5701951|NCT00495183|CNS stimulants|cns stimulants
5701952|NCT00495183|caffeine|caffeine
5701953|NCT00495183|biperiden|biperiden
5701954|NCT00495183|placebo|placebo
5701955|NCT00495170|Non-Small Cell Lung Cancer|non-small cell lung cancer
5701956|NCT00495170|Lung Cancer|lung cancer
5701957|NCT00495170|Proton Radiotherapy|proton radiotherapy
5701958|NCT00495170|Proton Beam|proton beam
5701959|NCT00495170|Paclitaxel|paclitaxel
5701960|NCT00495170|Taxol|taxol
5701961|NCT00495170|Carboplatin|carboplatin
5701962|NCT00495170|Paraplatin|paraplatin
5701963|NCT00495170|NSCLC|nsclc
5701964|NCT00495144|Phase I|phase i
5701965|NCT00495144|Advanced Solid Tumors|advanced solid tumors
5701966|NCT00495144|Hypoxia|hypoxia
5701967|NCT00495144|Prodrug|prodrug
5701968|NCT00495144|Multi-Center|multi-center
5701969|NCT00495144|Open-Label|open-label
5701970|NCT00495144|Dose-Escalation|dose-escalation
5701971|NCT00495131|Chronic hepatitis C|chronic hepatitis c
5701972|NCT00495131|Genotype 1|genotype 1
5701973|NCT00495131|Interferon|interferon
5701974|NCT00495131|Ribavirin|ribavirin
5701975|NCT00495118|schizophrenia|schizophrenia
5701976|NCT00495118|schizoaffective disorder|schizoaffective disorder
5701977|NCT00495118|risperidone|risperidone
5701978|NCT00495118|intramuscular injection|intramuscular injection
5701979|NCT00495118|long-acting injectable|long-acting injectable
5701980|NCT00495092|cocaine dependence|cocaine dependence
5701981|NCT00495092|cocaine use|cocaine use
5701982|NCT00495092|cocaine craving|cocaine craving
5701984|NCT00495079|lymphoblastic|lymphoblastic
5701985|NCT00495079|lymphocytic|lymphocytic
5701986|NCT00495079|leukemia|leukemia
5701987|NCT00495079|leukaemia|leukaemia
5701988|NCT00495079|lukemia|lukemia
5701989|NCT00495079|leukimia|leukimia
5701991|NCT00495079|Marqibo|marqibo
5701992|NCT00495079|Hana Biosciences|hana biosciences
5701993|NCT00495079|vincristine|vincristine
5701994|NCT00495079|liposomal|liposomal
5701995|NCT00495079|liposome|liposome
5701996|NCT00495079|optisome|optisome
5701997|NCT00495079|hematology|hematology
5701999|NCT00495079|hematological|hematological
5702000|NCT00495079|relapsed|relapsed
5702001|NCT00495079|anti-leukemia|anti-leukemia
5702002|NCT00495079|adult|adult
5702003|NCT00495079|chemotherapy|chemotherapy
5702004|NCT00495053|overactive bladder, urinary urgency|overactive bladder, urinary urgency
5702005|NCT00495040|Non-Small Cell Lung Cancer|non-small cell lung cancer
5702006|NCT00495040|Lung Cancer|lung cancer
5702007|NCT00495040|Proton Radiotherapy|proton radiotherapy
5702008|NCT00495040|Proton Beam|proton beam
5702009|NCT00495040|NSCLC|nsclc
5702010|NCT00495027|PTSD|ptsd
5702011|NCT00495027|prevention|prevention
5702012|NCT00495027|World Wide Web|world wide web
5702013|NCT00495027|Behavior Therapy|behavior therapy
5702014|NCT00495014|GSK376501,|gsk376501,
5702016|NCT00495014|Dose Escalation,|dose escalation,
5702017|NCT00495014|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
5702018|NCT00494949|Anesthesia, spinal|anesthesia, spinal
5702019|NCT00494949|Blood substitutes|blood substitutes
5702020|NCT00494949|Oxygen therapeutics|oxygen therapeutics
5702021|NCT00494949|Orthopedic surgery|orthopedic surgery
5702022|NCT00494949|Plasma expanders|plasma expanders
5702023|NCT00494949|Vasoconstriction|vasoconstriction
5702025|NCT00494936|HIV|hiv
5702026|NCT00494936|HCV|hcv
5702027|NCT00494936|Treatment Naive|treatment naive
5702028|NCT00494936|Treatment Experienced|treatment experienced
5702029|NCT00494936|HIV and HCV Coinfection|hiv and hcv coinfection
5702030|NCT00494910|Palliative Care|palliative care
5702031|NCT00494910|Terminally Ill|terminally ill
5702032|NCT00494910|Group Therapy|group therapy
5702033|NCT00494910|07-094|07-094
5702034|NCT00494884|Type 2 diabetes|type 2 diabetes
5702035|NCT00494884|vildagliptin|vildagliptin
5702036|NCT00494884|metformin combination|metformin combination
5702037|NCT00494871|BAY59-7939|bay59-7939
5702038|NCT00494871|Rivaroxaban|rivaroxaban
5702039|NCT00494871|Non-Valvular Atrial Fibrillation|non-valvular atrial fibrillation
5702040|NCT00494871|Japanese Patients|japanese patients
5702041|NCT00494871|Phase III|phase iii
5702042|NCT00494871|12620|12620
5702043|NCT00494858|Bulimia nervosa|bulimia nervosa
5702044|NCT00494858|Cognitive Behavioral Therapy|cognitive behavioral therapy
5702045|NCT00494858|Personality Disorders|personality disorders
5702046|NCT00494845|Mindfulness|mindfulness
5702047|NCT00494845|Elderly|elderly
5702048|NCT00494845|Chronic Illness|chronic illness
5702049|NCT00494845|Back Pain|back pain
5702050|NCT00494845|Chronic Low Back Pain|chronic low back pain
5702051|NCT00494845|Older adults over the age of sixty-five|older adults over the age of sixty-five
5702052|NCT00494845|MMSE score of over 23|mmse score of over 23
5702053|NCT00494845|Speaks English|speaks english
5702054|NCT00494832|Dexmedetomidine|dexmedetomidine
5702055|NCT00494832|Evoked potentials|evoked potentials
5702056|NCT00494832|Spine surgery|spine surgery
5702057|NCT00494819|ADHD, subtype, methylphenidate, neuropsychological measures|adhd, subtype, methylphenidate, neuropsychological measures
5702058|NCT00494806|Postoperative Ileus (POI)|postoperative ileus (poi)
5702059|NCT00494806|Rocking Chair|rocking chair
5702060|NCT00494806|Abdominal Cancer|abdominal cancer
5702061|NCT00494793|Open abdomen|open abdomen
5702062|NCT00494793|Fascial closure|fascial closure
5702063|NCT00494793|Vacuum assisted wound closure|vacuum assisted wound closure
5702065|NCT00494793|Abdominal compartment syndrome|abdominal compartment syndrome
5702066|NCT00494793|Intraabdominal pressure|intraabdominal pressure
5702067|NCT00494793|Incisional hernia|incisional hernia
5702068|NCT00494780|CHOP (cyclophosphamide,doxorubicin,vincristine,prednisolone)|chop (cyclophosphamide,doxorubicin,vincristine,prednisolone)
5702069|NCT00494780|ofatumumab|ofatumumab
5702070|NCT00494767|body composition|body composition
5702071|NCT00494767|obesity|obesity
5702072|NCT00494767|4C model|4c model
5702073|NCT00494767|hunger|hunger
5702074|NCT00494767|weight loss|weight loss
5702075|NCT00494754|autism spectrum disorder|autism spectrum disorder
5702076|NCT00494754|family genetic study|family genetic study
5702077|NCT00494754|gene|gene
5702078|NCT00494754|phenotype|phenotype
5702079|NCT00494754|endophenotype|endophenotype
5702080|NCT00494728|Smoking|smoking
5702081|NCT00494728|Depression|depression
5702082|NCT00494728|Major Depressive Disorder|major depressive disorder
5702083|NCT00494728|Cognitive Behavioral Analysis System of Psychotherapy|cognitive behavioral analysis system of psychotherapy
5702084|NCT00494728|Smoking Cessation Treatment|smoking cessation treatment
5702085|NCT00494728|Nicotine Replacement Therapy|nicotine replacement therapy
5702086|NCT00494728|Nicotine Patch|nicotine patch
5702087|NCT00494728|CBASP|cbasp
5702088|NCT00494728|MDD|mdd
5702089|NCT00494702|Asphyxia|asphyxia
5702090|NCT00494702|Resuscitation|resuscitation
5702091|NCT00494702|Oxidative stress|oxidative stress
5702092|NCT00494702|Prematurity|prematurity
5702093|NCT00494702|Follow up|follow up
5702094|NCT00494689|transcranial sonolysis or monitoring|transcranial sonolysis or monitoring
5702095|NCT00494689|rapid magnetic stimulation|rapid magnetic stimulation
5702096|NCT00494689|cerebral ischemia|cerebral ischemia
5702097|NCT00494689|hydrocephalus|hydrocephalus
5702098|NCT00494689|Barthel's index|barthel's index
5702099|NCT00494676|Hemianopia|hemianopia
5702100|NCT00494676|Mobility|mobility
5702101|NCT00494676|Rehabilitation|rehabilitation
5702102|NCT00494676|Low vision|low vision
5702103|NCT00494663|diabetes|diabetes
5702104|NCT00494663|type 2 diabetes|type 2 diabetes
5702105|NCT00494663|cholesterol|cholesterol
5702106|NCT00494650|PTSD|ptsd
5702107|NCT00494650|Schizophrenia|schizophrenia
5702108|NCT00494650|Schizoaffective Disorder|schizoaffective disorder
5702109|NCT00494650|Bipolar Disorder|bipolar disorder
5702110|NCT00494650|Major Depression|major depression
5702111|NCT00494624|Wheezing|wheezing
5702112|NCT00494624|virus|virus
5702113|NCT00494624|child|child
5702114|NCT00494598|opioids, cerebral perfusion, arterial pharmacokinetics|opioids, cerebral perfusion, arterial pharmacokinetics
5702115|NCT00494585|CEP-701|cep-701
5702116|NCT00494585|Leukemia|leukemia
5702117|NCT00494585|Myelofibrosis|myelofibrosis
5702118|NCT00494585|MF|mf
5702119|NCT00494585|JAK2|jak2
5702120|NCT00494585|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5702121|NCT00494585|Lestaurtinib|lestaurtinib
5702122|NCT00494585|Chronic Idiopathic Myelofibrosis|chronic idiopathic myelofibrosis
5702123|NCT00494585|CIMF|cimf
5702124|NCT00494572|Montelukast|montelukast
5702125|NCT00494572|Albuterol|albuterol
5702126|NCT00494572|Status Asthmaticus|status asthmaticus
5702127|NCT00494572|Asthma|asthma
5702128|NCT00494559|Type 2 Diabetes|type 2 diabetes
5702129|NCT00494559|Pioglitazone|pioglitazone
5702130|NCT00494559|restenosis|restenosis
5702131|NCT00494546|prostate|prostate
5702132|NCT00494546|brachytherapy|brachytherapy
5702133|NCT00494533|pulmonary arterial hypertension|pulmonary arterial hypertension
5702134|NCT00494533|prostacyclin analogue|prostacyclin analogue
5702135|NCT00494533|intravenous|intravenous
5702136|NCT00494520|Anomia|anomia
5702137|NCT00494520|Aphasia|aphasia
5702138|NCT00494520|Traumatic Brain Injury|traumatic brain injury
5710021|NCT00464724|PFC|pfc
5702139|NCT00494520|Cerebrovascular Accident|cerebrovascular accident
5702140|NCT00494507|periodic paralysis|periodic paralysis
5702141|NCT00494507|dichlorphenamide|dichlorphenamide
5702142|NCT00494494|cystoid macular edema|cystoid macular edema
5702143|NCT00494494|cataract|cataract
5702144|NCT00494494|nonsteroidal antiinflammatory drugs|nonsteroidal antiinflammatory drugs
5702145|NCT00494494|optical coherence tomography|optical coherence tomography
5702146|NCT00494481|Zactima|zactima
5702147|NCT00494468|Insomnia|insomnia
5702148|NCT00494468|Sleep Disorder|sleep disorder
5702149|NCT00494468|Sleep Deprivation|sleep deprivation
5702150|NCT00494455|critical illness|critical illness
5702151|NCT00494455|hyperglycemia|hyperglycemia
5702152|NCT00494455|intensive insulin therapy|intensive insulin therapy
5702153|NCT00494455|glucose monitoring|glucose monitoring
5702154|NCT00494455|shock|shock
5702155|NCT00494442|Advanced ovarian cancer|advanced ovarian cancer
5702156|NCT00494442|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5702157|NCT00494442|KU-0059436|ku-0059436
5702158|NCT00494442|AZD2281|azd2281
5702159|NCT00494442|BRCA1 protein|brca1 protein
5702160|NCT00494442|BRCA2 protein|brca2 protein
5702161|NCT00494429|Preterm Neonates|preterm neonates
5702162|NCT00494429|Morphine|morphine
5702163|NCT00494429|Critically ill|critically ill
5702164|NCT00494403|sprain proprioception|sprain proprioception
5702165|NCT00494390|Biometry|biometry
5702166|NCT00494390|corneal opacity|corneal opacity
5702167|NCT00494390|astigmatism|astigmatism
5702168|NCT00494390|refraction|refraction
5702169|NCT00494364|ear disease|ear disease
5702170|NCT00494364|otitis|otitis
5702171|NCT00494364|Eustachian tube|eustachian tube
5702172|NCT00494364|mastoid air cells|mastoid air cells
5702173|NCT00494364|Normal healthy volunteers|normal healthy volunteers
5702174|NCT00494351|Hidradenitis Suppurativa|hidradenitis suppurativa
5702175|NCT00494351|Nd:YAG laser|nd:yag laser
5863047|NCT00001410|Recombinant Enzyme|recombinant enzyme
5863048|NCT00001409|AIDS|aids
5702176|NCT00494338|Metastatic Androgen Independent Prostate Cancer (MAIPC)|metastatic androgen independent prostate cancer (maipc)
5702177|NCT00494325|age related maculopathy, macular pigment|age related maculopathy, macular pigment
5702178|NCT00494312|Glucose Metabolism Disorder|glucose metabolism disorder
5702179|NCT00494312|Dysmetabolic Syndrome|dysmetabolic syndrome
5702180|NCT00494312|Type II Diabetes|type ii diabetes
5702181|NCT00494312|Diabetes Mellitus|diabetes mellitus
5702182|NCT00494312|Lipoatrophic|lipoatrophic
5702183|NCT00494312|Dyslipidemia|dyslipidemia
5702184|NCT00494312|Liver|liver
5702185|NCT00494312|Drug Therapy|drug therapy
5702187|NCT00494299|Cancer|cancer
5702188|NCT00494299|Liver Cancer|liver cancer
5702189|NCT00494299|TACE|tace
5702190|NCT00494286|Abuse Focused Cognitive Behavioral Therapy|abuse focused cognitive behavioral therapy
5702191|NCT00494286|Treatment Effectiveness Research|treatment effectiveness research
5702192|NCT00494286|Treatment Dissemination|treatment dissemination
5702193|NCT00494273|Haitian American Adolescents|haitian american adolescents
5702194|NCT00494273|HIV Prevention|hiv prevention
5702195|NCT00494273|Cognitive Behavioral Intervention|cognitive behavioral intervention
5702196|NCT00494260|recurrent abdominal pain|recurrent abdominal pain
5702197|NCT00494260|illness behavior|illness behavior
5702198|NCT00494260|social learning|social learning
5702199|NCT00494260|cognitive behavioral therapy|cognitive behavioral therapy
5702200|NCT00494247|acute coronary syndromes|acute coronary syndromes
5702201|NCT00494247|endothelial progenitor cells|endothelial progenitor cells
5702202|NCT00494247|coronary stent|coronary stent
5702203|NCT00494234|Advanced breast cancer|advanced breast cancer
5702204|NCT00494234|Poly(ADP ribose) polymerases|poly(adp ribose) polymerases
5702205|NCT00494234|AZD2281,KU-0059436 (olaparib)|azd2281,ku-0059436 (olaparib)
5702206|NCT00494234|BRCA1 protein|brca1 protein
5702207|NCT00494234|BRCA2 protein|brca2 protein
5702208|NCT00494221|Colorectal cancer|colorectal cancer
5702209|NCT00494221|Recentin|recentin
5702211|NCT00494221|FOLFOX|folfox
5702212|NCT00494208|androgens|androgens
5702213|NCT00494208|testosterone|testosterone
5702214|NCT00494208|testosterone deficiency|testosterone deficiency
5702215|NCT00494208|women|women
5702216|NCT00494208|menopause|menopause
5702217|NCT00494208|surgical Menopause|surgical menopause
5702218|NCT00494208|hysterectomy|hysterectomy
5702219|NCT00494208|oophorectomy|oophorectomy
5702220|NCT00494208|ovariectomy|ovariectomy
5702221|NCT00494208|sexual dysfunction|sexual dysfunction
5702222|NCT00494208|sexual function|sexual function
5702223|NCT00494208|muscle function|muscle function
5702224|NCT00494208|insulin sensitivity|insulin sensitivity
5702225|NCT00494208|body composition|body composition
5702236|NCT00494195|adeno-associated virus|adeno-associated virus
5702238|NCT00494195|AAV1|aav1
5702245|NCT00494143|Amputee|amputee
5702246|NCT00494143|Economy|economy
5702247|NCT00494143|Efficiency|efficiency
5702248|NCT00494143|Foot|foot
5702249|NCT00494143|Gait|gait
5702250|NCT00494143|Kinematics|kinematics
5702251|NCT00494143|Kinetics|kinetics
5702252|NCT00494143|Prosthesis|prosthesis
5702253|NCT00494104|vitamin D deficiency|vitamin d deficiency
5702254|NCT00494104|breastfed infant|breastfed infant
5702255|NCT00494104|northern latitude|northern latitude
5702256|NCT00494104|infant|infant
5702257|NCT00494104|breastfed|breastfed
5702258|NCT00494104|winter|winter
5702259|NCT00494104|vitamin D status|vitamin d status
5702260|NCT00494078|critical illness|critical illness
5702261|NCT00494078|hyperglycemia|hyperglycemia
5702262|NCT00494078|intensive insulin therapy|intensive insulin therapy
5702263|NCT00494078|glucose monitoring|glucose monitoring
5702264|NCT00494052|Coronary Heart Disease|coronary heart disease
5702265|NCT00494052|Choice Behavior|choice behavior
5702266|NCT00494052|Risk Factors|risk factors
5702267|NCT00494052|Risk Assessment|risk assessment
5702268|NCT00494052|Primary Prevention|primary prevention
5702269|NCT00494052|Decision Making|decision making
5702270|NCT00494052|Decision Aids|decision aids
5702271|NCT00494052|Patient Compliance|patient compliance
5702272|NCT00494039|prostate|prostate
5702273|NCT00494039|cancer|cancer
5702274|NCT00494039|radiation|radiation
5702275|NCT00494039|brachytherapy|brachytherapy
5702276|NCT00494013|diabetes|diabetes
5702277|NCT00494013|type 2|type 2
5702278|NCT00493987|Testosterone|testosterone
5702279|NCT00493987|Androgens|androgens
5702280|NCT00493987|Dihydrotestosterone|dihydrotestosterone
5702281|NCT00493987|5-alpha reductase|5-alpha reductase
5702282|NCT00493987|Body Composition|body composition
5702283|NCT00493987|Muscle|muscle
5702284|NCT00493987|Sexual function|sexual function
5702286|NCT00493987|Healthy Men|healthy men
5702287|NCT00493974|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5702288|NCT00493974|COPD|copd
5702289|NCT00493974|Exacerbation|exacerbation
5702290|NCT00493974|Anti-leukotriene|anti-leukotriene
5702291|NCT00493974|Length of Stay|length of stay
5702292|NCT00493974|LOS|los
5702296|NCT00493935|bedtime snack|bedtime snack
5702297|NCT00493935|hypoglycemia|hypoglycemia
5702298|NCT00493935|Diabetes Mellitus, Type I|diabetes mellitus, type i
5702299|NCT00493935|glucose monitoring|glucose monitoring
5702300|NCT00493922|Malaria|malaria
5702301|NCT00493922|Diagnosis|diagnosis
5702302|NCT00493922|Rapid diagnostic tests|rapid diagnostic tests
5702303|NCT00493922|Microscopy|microscopy
5702304|NCT00493922|Clinical diagnosis|clinical diagnosis
5702307|NCT00493909|pain therapy|pain therapy
5702308|NCT00493909|thoracic paravertebral blockade|thoracic paravertebral blockade
5702309|NCT00493909|intrathecal opioids|intrathecal opioids
5702310|NCT00493909|thoracic epidural analgesia|thoracic epidural analgesia
5702311|NCT00493909|Analgesia after thoracotomy|analgesia after thoracotomy
5702312|NCT00493896|Venous Thromboembolism Prophylaxis|venous thromboembolism prophylaxis
5702313|NCT00493896|VTE prophylaxis|vte prophylaxis
5702314|NCT00493883|Therasphere|therasphere
5702315|NCT00493883|Yttrium|yttrium
5702316|NCT00493883|liver|liver
5702317|NCT00493883|cancer|cancer
5702318|NCT00493883|radiation|radiation
5702319|NCT00493857|Colorectal cancer|colorectal cancer
5702320|NCT00493857|Monoclonal antibody|monoclonal antibody
5702321|NCT00493857|Anti-EGFR|anti-egfr
5702322|NCT00493844|Chest pain|chest pain
5702323|NCT00493844|Unstable angina|unstable angina
5702324|NCT00493844|NT-proBNP|nt-probnp
5702325|NCT00493844|Exercise test.|exercise test.
5702326|NCT00493831|smoking reduction|smoking reduction
5702327|NCT00493831|inflammation|inflammation
5702328|NCT00493831|harm reduction|harm reduction
5702329|NCT00493831|lipid biomarkers|lipid biomarkers
5702330|NCT00493818|GSK690693,|gsk690693,
5702331|NCT00493818|Solid Tumors,|solid tumors,
5702334|NCT00493805|homeostasis model assessment of insulin resistance|homeostasis model assessment of insulin resistance
5702336|NCT00493766|Prostate Cancer|prostate cancer
5702337|NCT00493766|HRPC|hrpc
5702338|NCT00493766|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5702339|NCT00493740|Cephalic phase, oncology patients|cephalic phase, oncology patients
5702341|NCT00493727|N-acetylcysteine|n-acetylcysteine
5702342|NCT00493727|NAC|nac
5702343|NCT00493727|Isoprostane|isoprostane
5702344|NCT00493727|Proteinuria|proteinuria
5702345|NCT00493727|Diabetes|diabetes
5702346|NCT00493727|Mucomyst|mucomyst
5702347|NCT00493727|albuminuria|albuminuria
5702348|NCT00493714|Advanced Cancer|advanced cancer
5702349|NCT00493714|Delirium|delirium
5702350|NCT00493714|Restlessness|restlessness
5702351|NCT00493714|Confusion|confusion
5702352|NCT00493714|Caregivers|caregivers
5702353|NCT00493714|Questionnaire|questionnaire
5702354|NCT00493688|Abdominal Cancer|abdominal cancer
5702355|NCT00493688|Pelvic Cancer|pelvic cancer
5702356|NCT00493688|Perioperative Energy Dynamics|perioperative energy dynamics
5702357|NCT00493688|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5702358|NCT00493688|CPET|cpet
5702359|NCT00493675|Cystic duct leakage|cystic duct leakage
5702360|NCT00493636|Breast Cancer|breast cancer
5702361|NCT00493610|Oxidant stress|oxidant stress
5702362|NCT00493610|N-acetylcysteine|n-acetylcysteine
5702363|NCT00493610|Hepatitis C|hepatitis c
5702364|NCT00493610|Liver disease|liver disease
5702365|NCT00493610|Mucomyst|mucomyst
5702366|NCT00493610|Isoprostane|isoprostane
5702367|NCT00493597|Atherosclerosis|atherosclerosis
5685775|NCT00554905|Liver Neoplasms|liver neoplasms
5700857|NCT00499278|hip|hip
5702368|NCT00493597|Restenosis|restenosis
5702369|NCT00493597|EPC|epc
5702370|NCT00493597|DC|dc
5702371|NCT00493584|Myocardial Infarction|myocardial infarction
5702372|NCT00493584|Myocardial Ischemia|myocardial ischemia
5702373|NCT00493584|Myocardial Revascularization|myocardial revascularization
5702374|NCT00493584|Telemedicine|telemedicine
5702375|NCT00493584|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5702376|NCT00493571|Myelodysplastic Syndromes|myelodysplastic syndromes
5702381|NCT00493558|Trabecular Metal Posterior Lumbar Interbody Cage|trabecular metal posterior lumbar interbody cage
5702382|NCT00493558|Posterior Lumbar Interbody Fusion Cage|posterior lumbar interbody fusion cage
5702383|NCT00493558|Posterior Lumbar spine fusion surgery|posterior lumbar spine fusion surgery
5702385|NCT00493545|Open-Label|open-label
5702386|NCT00493545|Nonrandomized|nonrandomized
5702388|NCT00493519|Cephalic phase|cephalic phase
5702389|NCT00493519|Anorexia nervosa|anorexia nervosa
5702390|NCT00493519|Bulimia nervosa|bulimia nervosa
5702391|NCT00493519|obese binge eaters|obese binge eaters
5702392|NCT00493519|VAS|vas
5702393|NCT00493519|EDI|edi
5702394|NCT00493519|shame-feed procedure|shame-feed procedure
5702395|NCT00493506|ProAlgaZyme|proalgazyme
5702396|NCT00493506|HIV|hiv
5702397|NCT00493506|HAART|haart
5702398|NCT00493506|hsCRP|hscrp
5702399|NCT00493506|Oxidative stress|oxidative stress
5702400|NCT00493506|CD4+ lymphocytes|cd4+ lymphocytes
5702401|NCT00493506|Algae|algae
5702402|NCT00493506|HAART adverse effects|haart adverse effects
5702403|NCT00493506|HBV|hbv
5702404|NCT00493493|Cymetra|cymetra
5702405|NCT00493467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5702406|NCT00493467|Lymphoma|lymphoma
5702407|NCT00493467|Indolent Lymphomas|indolent lymphomas
5702408|NCT00493467|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5702409|NCT00493467|Zevalin|zevalin
5702410|NCT00493454|Indolent Lymphoma|indolent lymphoma
5702716|NCT00492323|shingles.|shingles.
5702411|NCT00493454|Extranodal Marginal|extranodal marginal
5702412|NCT00493454|Nodal Marginal Zone|nodal marginal zone
5702413|NCT00493454|Splenic Marginal|splenic marginal
5702414|NCT00493454|MALT Type|malt type
5702415|NCT00493454|Zevalin|zevalin
5702416|NCT00493454|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5702417|NCT00493454|Rituximab|rituximab
5702418|NCT00493428|Hepatocellular Carcinoma|hepatocellular carcinoma
5702419|NCT00493428|GABAergic Activity|gabaergic activity
5702420|NCT00493428|Baclofen|baclofen
5702421|NCT00493415|microcirculation|microcirculation
5702422|NCT00493415|sepsis|sepsis
5702423|NCT00493415|nitroglycerine|nitroglycerine
5702424|NCT00493415|SDF imaging|sdf imaging
5702425|NCT00493402|Antineoplastic Agents|antineoplastic agents
5702426|NCT00493402|administration & dosage|administration & dosage
5702427|NCT00493402|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5702428|NCT00493402|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5702429|NCT00493402|Humans|humans
5702430|NCT00493402|Liver Neoplasms|liver neoplasms
5702431|NCT00493402|therapy|therapy
5702432|NCT00493389|ACTH stimulation test|acth stimulation test
5702433|NCT00493389|cortisol|cortisol
5702434|NCT00493389|stress|stress
5702435|NCT00493376|tirapazamine|tirapazamine
5702436|NCT00493376|DNA damage|dna damage
5702438|NCT00493363|falciparum malaria|falciparum malaria
5702439|NCT00493363|artemisinins|artemisinins
5702440|NCT00493363|artesunate|artesunate
5702441|NCT00493363|resistance|resistance
5702442|NCT00493350|Breast Cancer|breast cancer
5702443|NCT00493350|Circulating Tumor Cells|circulating tumor cells
5702444|NCT00493350|Gene Profiling|gene profiling
5702445|NCT00493350|International Stage Stratification Study|international stage stratification study
5702446|NCT00493350|Blood Sample|blood sample
5702447|NCT00493350|ISSS|isss
5702448|NCT00493337|Adherence|adherence
5702450|NCT00493337|Statins|statins
5702451|NCT00493337|Intervention|intervention
5702452|NCT00493337|Hypercholesterolemia|hypercholesterolemia
5702453|NCT00493324|psoriasis|psoriasis
5702454|NCT00493324|alefacept|alefacept
5702455|NCT00493324|polyvalent pneumococcal vaccine|polyvalent pneumococcal vaccine
5702456|NCT00493324|Immunization|immunization
5702463|NCT00493285|Lower Respiratory Tract Illness|lower respiratory tract illness
5702464|NCT00493285|RSV and PIV3 infection|rsv and piv3 infection
5702465|NCT00493272|Blood coagulation disorder, acquired|blood coagulation disorder, acquired
5702466|NCT00493272|Hemodilution|hemodilution
5702467|NCT00493272|Fibrinogen|fibrinogen
5702468|NCT00493272|Hemostasis|hemostasis
5702470|NCT00493259|Health-Related Quality of Life|health-related quality of life
5702471|NCT00493233|schizophrenia|schizophrenia
5702472|NCT00493233|antipsychotics|antipsychotics
5702473|NCT00493233|polypharmacy|polypharmacy
5702474|NCT00493233|double-blind|double-blind
5702475|NCT00493233|randomized|randomized
5702476|NCT00493220|ceftriaxone|ceftriaxone
5702477|NCT00493220|cephalosporins|cephalosporins
5702478|NCT00493220|pharmacokinetics|pharmacokinetics
5702479|NCT00493220|subcutaneous|subcutaneous
5710262|NCT00463996|MRI|mri
5702480|NCT00493220|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5702481|NCT00493220|hyaluronidase|hyaluronidase
5702482|NCT00493220|hyaluronan|hyaluronan
5702483|NCT00493220|rHuPH20|rhuph20
5702484|NCT00493194|Cyclosporine toxicity|cyclosporine toxicity
5702485|NCT00493194|Interstitial Fibrosis|interstitial fibrosis
5702486|NCT00493194|Chronic allograft nephropathy|chronic allograft nephropathy
5702487|NCT00493194|Sirolimus|sirolimus
5702488|NCT00493181|oprelvekin|oprelvekin
5702489|NCT00493181|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5702490|NCT00493181|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5702491|NCT00493181|Leukemia|leukemia
5702493|NCT00493181|Thrombocytopenia|thrombocytopenia
5702494|NCT00493181|Imatinib|imatinib
5702495|NCT00493181|IL-11|il-11
5702496|NCT00493181|Interleukin 11|interleukin 11
5702497|NCT00493181|Neumega|neumega
5702498|NCT00493129|Systemic Mastocytosis|systemic mastocytosis
5702499|NCT00493129|SM|sm
5702500|NCT00493129|Mast Cell Leukemia|mast cell leukemia
5702501|NCT00493129|Leukemia|leukemia
5702502|NCT00493129|Denileukin Diftitox|denileukin diftitox
5702503|NCT00493129|Ontak|ontak
5702504|NCT00493116|recovery of efficacy|recovery of efficacy
5702505|NCT00493116|MxA protein|mxa protein
5702506|NCT00493116|neutralizing antibodies|neutralizing antibodies
5702507|NCT00493116|Multiple sclerosis|multiple sclerosis
5702509|NCT00493103|congenital hypothyroidism|congenital hypothyroidism
5702510|NCT00493103|gene mutations|gene mutations
5702511|NCT00493103|fetal goiter|fetal goiter
5702512|NCT00493103|iodine nutrition|iodine nutrition
5702513|NCT00493090|Professional|professional
5702514|NCT00493090|patient partnership|patient partnership
5702515|NCT00493090|patient satisfaction|patient satisfaction
5702516|NCT00493090|professional training|professional training
5702517|NCT00493077|Multiple Sclerosis|multiple sclerosis
5702518|NCT00493077|Neutralizing antibodies|neutralizing antibodies
5702520|NCT00493077|Low immunogenicity|low immunogenicity
5702521|NCT00493077|interferon|interferon
5702522|NCT00493077|interferon-beta-1a|interferon-beta-1a
5702524|NCT00493051|nonhealing|nonhealing
5702525|NCT00493051|ulcers|ulcers
5702526|NCT00493051|neuropathic|neuropathic
5702527|NCT00493038|Treatment of acute bacterial rhinosinusitis|treatment of acute bacterial rhinosinusitis
5702528|NCT00493025|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5702529|NCT00493025|stage II esophageal cancer|stage ii esophageal cancer
5702530|NCT00493025|stage III esophageal cancer|stage iii esophageal cancer
5702531|NCT00493025|stage IV esophageal cancer|stage iv esophageal cancer
5702532|NCT00493012|body weight|body weight
5702533|NCT00493012|body compostion|body compostion
5702534|NCT00493012|vitamin D|vitamin d
5702535|NCT00493012|blood pressure|blood pressure
5702536|NCT00492999|recurrent colon cancer|recurrent colon cancer
5702537|NCT00492999|stage IV colon cancer|stage iv colon cancer
5702538|NCT00492999|recurrent rectal cancer|recurrent rectal cancer
5702539|NCT00492999|stage IV rectal cancer|stage iv rectal cancer
5702540|NCT00492999|adenocarcinoma of the colon|adenocarcinoma of the colon
5702541|NCT00492999|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5702542|NCT00492999|liver metastases|liver metastases
5702543|NCT00492986|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
5702544|NCT00492986|Cancer|cancer
5702545|NCT00492973|arthroplasty|arthroplasty
5702546|NCT00492973|replacement|replacement
5702547|NCT00492973|knee|knee
5702548|NCT00492960|larazotide acetate|larazotide acetate
5702549|NCT00492947|Phase I|phase i
5702550|NCT00492947|dendritic cell|dendritic cell
5702551|NCT00492947|vaccine|vaccine
5702552|NCT00492947|intra tumoral|intra tumoral
5702553|NCT00492947|squamous cell carcinoma|squamous cell carcinoma
5702554|NCT00492934|subfertility|subfertility
5702555|NCT00492934|endometrium thickness|endometrium thickness
5702556|NCT00492934|implantation rate|implantation rate
5702557|NCT00492934|embryo cryopreservation|embryo cryopreservation
5702558|NCT00492934|embryo transfer|embryo transfer
5702559|NCT00492921|graft versus host disease|graft versus host disease
5702560|NCT00492908|Coronary Revascularization|coronary revascularization
5702561|NCT00492908|Titanium-Nitride-Oxide Coated Stent|titanium-nitride-oxide coated stent
5702562|NCT00492908|Zotarolimus-Eluting Stent|zotarolimus-eluting stent
5702563|NCT00492882|Polycystic Ovary Syndrome|polycystic ovary syndrome
5702564|NCT00492882|Follicular Arrest|follicular arrest
5702565|NCT00492882|Anti-Mullerian Hormone|anti-mullerian hormone
5702567|NCT00492869|kidney transplantation|kidney transplantation
5702569|NCT00492869|AEB071|aeb071
5702570|NCT00492869|tacrolimus|tacrolimus
5702571|NCT00492869|mycophenolic|mycophenolic
5702572|NCT00492869|basiliximab|basiliximab
5702573|NCT00492869|immunosuppression|immunosuppression
5702574|NCT00492856|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5702575|NCT00492856|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5702576|NCT00492856|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5702577|NCT00492843|Ibandronate, Lung cancer, bone metastasis|ibandronate, lung cancer, bone metastasis
5702578|NCT00492830|Phase 1|phase 1
5702579|NCT00492830|TRC093|trc093
5702580|NCT00492830|denatured collagen|denatured collagen
5702581|NCT00492830|solid tumor|solid tumor
5702582|NCT00492830|antibody|antibody
5702583|NCT00492830|TRACON|tracon
5702584|NCT00492830|Locally advanced solid tumors|locally advanced solid tumors
5702585|NCT00492830|Metastatic solid tumors|metastatic solid tumors
5702586|NCT00492817|Spinal Neoplasms|spinal neoplasms
5702587|NCT00492817|Paraspinal Metastases|paraspinal metastases
5702588|NCT00492817|Stereotactic Body Radiotherapy|stereotactic body radiotherapy
5702589|NCT00492817|CT-on-Rails|ct-on-rails
5702590|NCT00492817|Spinal Cord|spinal cord
5702591|NCT00492817|SBRT|sbrt
5702592|NCT00492804|inguinal hernia|inguinal hernia
5702593|NCT00492804|chronic pain|chronic pain
5702594|NCT00492804|neurectomy|neurectomy
5702595|NCT00492804|hypesthesia|hypesthesia
5702596|NCT00492791|crohn's disease|crohn's disease
5702597|NCT00492791|capsule endoscopes|capsule endoscopes
5702598|NCT00492765|Combination therapy|combination therapy
5702599|NCT00492765|Simvastatin|simvastatin
5702600|NCT00492765|Multiple Sclerosis|multiple sclerosis
5702601|NCT00492765|Interferon-beta-1a|interferon-beta-1a
5702602|NCT00492739|Orthotopic liver transplantation|orthotopic liver transplantation
5702603|NCT00492739|Pediatric|pediatric
5702604|NCT00492739|Immunosuppression|immunosuppression
5702605|NCT00492739|Varicella vaccine|varicella vaccine
5702606|NCT00492739|B cell response|b cell response
5702607|NCT00492739|T cell response|t cell response
5702608|NCT00492739|Antibodies|antibodies
5702609|NCT00492739|Varicella|varicella
5702610|NCT00492739|Chickenpox|chickenpox
5702611|NCT00492739|transplantation|transplantation
5702612|NCT00492726|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5702613|NCT00492713|Bioavailability|bioavailability
5702717|NCT00492310|Smoking|smoking
5702614|NCT00492713|Dark Chocolate|dark chocolate
5702615|NCT00492713|Milk Chocolate|milk chocolate
5702616|NCT00492713|Polyphenols|polyphenols
5702617|NCT00492700|steatosis,|steatosis,
5702618|NCT00492700|fibrosis,|fibrosis,
5702619|NCT00492700|diabetes,|diabetes,
5702620|NCT00492700|obesity|obesity
5680552|NCT00577525|LATENT VIRAL INFECTION|latent viral infection
5702621|NCT00492687|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5702622|NCT00492687|adult giant cell glioblastoma|adult giant cell glioblastoma
5702623|NCT00492687|adult gliosarcoma|adult gliosarcoma
5702624|NCT00492687|adult glioblastoma|adult glioblastoma
5702626|NCT00492674|Arthroplasty|arthroplasty
5702627|NCT00492674|Knee|knee
5702628|NCT00492674|Osteoarthritis|osteoarthritis
5702629|NCT00492674|Rehabilitation|rehabilitation
5702630|NCT00492661|Tacrolimus|tacrolimus
5702631|NCT00492661|Prograf|prograf
5702632|NCT00492661|PRIDE|pride
5702633|NCT00492648|GSK Biologicals|gsk biologicals
5702634|NCT00492648|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5702635|NCT00492648|Intracellular cytokine staining (ICS)|intracellular cytokine staining (ics)
5702636|NCT00492648|Vaccine|vaccine
5702637|NCT00492648|Cell mediated immunity (CMI)|cell mediated immunity (cmi)
5702638|NCT00492648|Herpes Zoster (HZ)|herpes zoster (hz)
5702639|NCT00492648|Shingles|shingles
5702640|NCT00492622|Gastroparesis|gastroparesis
5702641|NCT00492622|Gastroesophageal reflux disease|gastroesophageal reflux disease
5702644|NCT00492609|Navigation|navigation
5702646|NCT00492609|IKDC|ikdc
5702647|NCT00492609|comparative study|comparative study
5702648|NCT00492583|probiotic|probiotic
5702649|NCT00492583|health|health
5702650|NCT00492583|bifidobacterium lactis|bifidobacterium lactis
5702651|NCT00492583|BB-12|bb-12
5702652|NCT00492570|Multiple Sclerosis|multiple sclerosis
5702653|NCT00492570|Cognitive Dysfunction in Multiple sclerosis|cognitive dysfunction in multiple sclerosis
5702654|NCT00492570|early treatment|early treatment
5702655|NCT00492570|Avonex|avonex
5702656|NCT00492570|interferon beta 1a|interferon beta 1a
5702657|NCT00492570|Cognitive Dysfunction|cognitive dysfunction
5702658|NCT00492557|Pneumococcal Disease|pneumococcal disease
5702659|NCT00492557|Pneumococcal Conjugate Vaccine|pneumococcal conjugate vaccine
5702661|NCT00492544|safety|safety
5702662|NCT00492544|cervical cancer|cervical cancer
5702663|NCT00492544|immunogenicity|immunogenicity
5702664|NCT00492544|vaccine|vaccine
5702665|NCT00492544|viral infections|viral infections
5702666|NCT00492544|pre-adolescent and adolescent females|pre-adolescent and adolescent females
5702667|NCT00492531|Interventional Study|interventional study
5702668|NCT00492531|6-Minute Walk|6-minute walk
5702669|NCT00492531|Sickle Cell Anemia|sickle cell anemia
5702670|NCT00492531|Sildenafil/Viagra|sildenafil/viagra
5702671|NCT00492531|Tricuspid Regurgitant Velocity|tricuspid regurgitant velocity
5702672|NCT00492531|Sickle Cell Disease|sickle cell disease
5702673|NCT00492531|Pulmonary Hypertension|pulmonary hypertension
5702674|NCT00492518|Contrast Induced Nephropathy|contrast induced nephropathy
5702675|NCT00492518|Prophylaxis|prophylaxis
5702676|NCT00492518|Theophylline|theophylline
5702677|NCT00492518|Acetylcysteine|acetylcysteine
5702678|NCT00492518|Coronary angiography|coronary angiography
5702679|NCT00492505|stage IIIA melanoma|stage iiia melanoma
5702680|NCT00492505|stage IIIB melanoma|stage iiib melanoma
5702681|NCT00492505|stage IIIC melanoma|stage iiic melanoma
5702682|NCT00492492|radius,|radius,
5702683|NCT00492492|pinning,|pinning,
5702684|NCT00492492|fixed-angle plate,|fixed-angle plate,
5702685|NCT00492492|quick-DASH,|quick-dash,
5702686|NCT00492492|HERZBERG-score.|herzberg-score.
5702687|NCT00492466|Multiple Sclerosis|multiple sclerosis
5702688|NCT00492466|antibody|antibody
5702689|NCT00492466|Neutralizing antibody|neutralizing antibody
5702690|NCT00492466|Binding antibody|binding antibody
5702691|NCT00492466|MxA protein|mxa protein
5702692|NCT00492440|recurrent renal cell cancer|recurrent renal cell cancer
5702693|NCT00492440|stage IV renal cell cancer|stage iv renal cell cancer
5702694|NCT00492440|stage III renal cell cancer|stage iii renal cell cancer
5702695|NCT00492440|recurrent melanoma|recurrent melanoma
5702696|NCT00492440|stage IV melanoma|stage iv melanoma
5702697|NCT00492414|Panic disorder (PD)|panic disorder (pd)
5702698|NCT00492388|breakthrough|breakthrough
5702699|NCT00492388|pain|pain
5702700|NCT00492388|cancer|cancer
5702701|NCT00492362|hemodialysis|hemodialysis
5702702|NCT00492362|exercise|exercise
5702703|NCT00492362|physical fitness|physical fitness
5702704|NCT00492362|dialysis adequacy|dialysis adequacy
5702705|NCT00492349|Varenicline|varenicline
5702706|NCT00492349|Neurobiology|neurobiology
5702707|NCT00492349|clinical trial|clinical trial
5702708|NCT00492349|cognitive deficits|cognitive deficits
5702709|NCT00492349|Schizophreniform Disorder|schizophreniform disorder
5702710|NCT00492336|Cognitive impairments|cognitive impairments
5702711|NCT00492336|Negative symptoms|negative symptoms
5702712|NCT00492323|pain following the healing of rashes and blisters|pain following the healing of rashes and blisters
5702713|NCT00492323|herpes virus|herpes virus
5702714|NCT00492323|rash|rash
5702715|NCT00492323|varicella-zoster virus|varicella-zoster virus
5702721|NCT00492284|Macular Degeneration|macular degeneration
5702722|NCT00492284|AMD|amd
5702723|NCT00492284|CNV|cnv
5702724|NCT00492284|Choroidal neovascularization|choroidal neovascularization
5702725|NCT00492284|Photodynamic therapy|photodynamic therapy
5702726|NCT00492284|CNV Secondary to Age Related Macular Degeneration|cnv secondary to age related macular degeneration
5702727|NCT00492271|Friulimicin B|friulimicin b
5702728|NCT00492271|Lipopeptide Antibiotic|lipopeptide antibiotic
5702729|NCT00492271|First in Man|first in man
5702730|NCT00492258|stage II renal cell cancer|stage ii renal cell cancer
5702731|NCT00492258|stage III renal cell cancer|stage iii renal cell cancer
5702732|NCT00492258|stage IV renal cell cancer|stage iv renal cell cancer
5702733|NCT00492258|stage I renal cell cancer|stage i renal cell cancer
5702734|NCT00492258|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5702735|NCT00492258|papillary renal cell carcinoma|papillary renal cell carcinoma
5702736|NCT00492245|PTK|ptk
5702737|NCT00492245|corneal opacity|corneal opacity
5702738|NCT00492245|mitomycin|mitomycin
5702739|NCT00492232|Chronic Insomnia|chronic insomnia
5702745|NCT00492219|prosthesis|prosthesis
5702746|NCT00492206|Non Small Cell Lung Cancer|non small cell lung cancer
5702747|NCT00492206|NSCLC|nsclc
5702748|NCT00492206|EGFR Inhibitor|egfr inhibitor
5702749|NCT00492206|Radiation Therapy|radiation therapy
5692290|NCT00528619|Phase 1|phase 1
5702750|NCT00492193|Hand assist laparoscopic partial large bowel resection|hand assist laparoscopic partial large bowel resection
5702751|NCT00492193|Laparoscopic partial large bowel resection|laparoscopic partial large bowel resection
5702756|NCT00492154|FRACTURE OF DISTAL RADIUS|fracture of distal radius
5702757|NCT00492141|Ewing's Sarcoma|ewing's sarcoma
5702758|NCT00492141|Lung Involvement|lung involvement
5702759|NCT00492141|Temozolomide|temozolomide
5702760|NCT00492141|Temodar|temodar
5702761|NCT00492141|Aerosol Liposomal 9-Nitro-20(S)-Camptothecin|aerosol liposomal 9-nitro-20(s)-camptothecin
5702762|NCT00492141|Aerosol L9-NC|aerosol l9-nc
5702763|NCT00492141|L9-NC|l9-nc
5702764|NCT00492128|hypertension|hypertension
5702765|NCT00492128|angiotensin receptor blocker|angiotensin receptor blocker
5702766|NCT00492128|diuretic|diuretic
5702768|NCT00492115|sleep|sleep
5702769|NCT00492115|dementia|dementia
5702770|NCT00492115|apnea|apnea
5702771|NCT00492115|memory|memory
5702772|NCT00492115|Parkinson's disease|parkinson's disease
5702773|NCT00492102|pharmacokinetics|pharmacokinetics
5702774|NCT00492102|Montelukast|montelukast
5702775|NCT00492102|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5702776|NCT00492102|Pharmacokinetics of Montelukast|pharmacokinetics of montelukast
5702777|NCT00492076|Specific immunotherapy|specific immunotherapy
5702778|NCT00492076|Mite|mite
5702779|NCT00492076|Asthma|asthma
5702780|NCT00492063|safety|safety
5702781|NCT00492063|immunogenicity|immunogenicity
5702782|NCT00492063|non-inferiority|non-inferiority
5702783|NCT00492063|MDCK|mdck
5702784|NCT00492063|cell culture-derived|cell culture-derived
5702785|NCT00492063|subunit influenza vaccine|subunit influenza vaccine
5702786|NCT00492063|influenza prevention|influenza prevention
5702787|NCT00492050|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5702788|NCT00492050|Macroglobulinemic Lymphoma|macroglobulinemic lymphoma
5702789|NCT00492050|Stem Cell Collection|stem cell collection
5702790|NCT00492050|Bortezomib|bortezomib
5702791|NCT00492050|LDP-341|ldp-341
5702792|NCT00492050|MLN341|mln341
5702793|NCT00492050|PS-341|ps-341
5702794|NCT00492050|Velcade|velcade
5702795|NCT00492050|Rituximab|rituximab
5702796|NCT00492050|Rituxan|rituxan
5702797|NCT00492037|hyponatremia|hyponatremia
5702798|NCT00492037|hypervolemic|hypervolemic
5702799|NCT00492037|euvolemic|euvolemic
5702800|NCT00492037|conivaptan|conivaptan
5702801|NCT00492024|Respiratory Tract Infection|respiratory tract infection
5702802|NCT00492024|Bacterial Sinusitis|bacterial sinusitis
5702803|NCT00492011|Circadian Rhythm Disorders|circadian rhythm disorders
5702804|NCT00492011|Biological Clock Disturbances|biological clock disturbances
5702805|NCT00492011|Jet Lag Syndrome|jet lag syndrome
5702806|NCT00492011|Time Zone Change Syndrome|time zone change syndrome
5702807|NCT00492011|Drug Therapy|drug therapy
5702808|NCT00491985|Influenza A/H5N1 Virus|influenza a/h5n1 virus
5702809|NCT00491985|Influenza Pandemic|influenza pandemic
5702810|NCT00491985|Orthomyxoviridae Infections|orthomyxoviridae infections
5702811|NCT00491959|oral mucosa|oral mucosa
5702812|NCT00491959|limbal insufficiency|limbal insufficiency
5702813|NCT00491959|transplantation|transplantation
5702814|NCT00491959|cornea|cornea
5702815|NCT00491959|ocular surface|ocular surface
5702816|NCT00491946|Cancer|cancer
5702817|NCT00491946|Actinomycin|actinomycin
5702818|NCT00491946|Vincristine|vincristine
5702819|NCT00491920|osteoporosis|osteoporosis
5702820|NCT00491920|bone mineral density|bone mineral density
5702821|NCT00491920|vitamin D|vitamin d
5702822|NCT00491907|folic acid|folic acid
5702823|NCT00491907|endothelial function|endothelial function
5702824|NCT00491907|baroreceptor function|baroreceptor function
5702825|NCT00491907|heart failure|heart failure
5702826|NCT00491894|Mental Retardation|mental retardation
5702827|NCT00491894|Neurological Impairment|neurological impairment
5702828|NCT00491894|Cerebral Palsy|cerebral palsy
5702830|NCT00491894|Neurological Conditions|neurological conditions
5702831|NCT00491881|blood pressure|blood pressure
5702833|NCT00491881|urinary sodium|urinary sodium
5702834|NCT00491855|Advanced Peritoneal Carcinomatosis|advanced peritoneal carcinomatosis
5702835|NCT00491855|Peritoneal Cancer|peritoneal cancer
5702836|NCT00491855|Bevacizumab|bevacizumab
5702837|NCT00491855|Avastin|avastin
5702838|NCT00491855|vascular endothelial growth factor|vascular endothelial growth factor
5702853|NCT00491816|cancer|cancer
5702854|NCT00491816|breast cancer|breast cancer
5702855|NCT00491803|COPD|copd
5702856|NCT00491790|montelukast|montelukast
5702857|NCT00491790|Albuterol|albuterol
5702858|NCT00491790|Status Asthmaticus|status asthmaticus
5702859|NCT00491790|Asthma|asthma
5702860|NCT00491777|Noninvasive|noninvasive
5702861|NCT00491777|Hemodynamic|hemodynamic
5702862|NCT00491777|Monitoring|monitoring
5702863|NCT00491777|Critical Care|critical care
5702864|NCT00491777|Swan-Ganz|swan-ganz
5702865|NCT00491751|endothelium|endothelium
5702866|NCT00491751|nitric oxide|nitric oxide
5702867|NCT00491751|statins|statins
5702868|NCT00491751|ascorbic acid|ascorbic acid
5702869|NCT00491738|RCC|rcc
5702870|NCT00491738|Renal cell cancer|renal cell cancer
5702871|NCT00491738|Avastin|avastin
5702873|NCT00491712|Glaucoma|glaucoma
5702874|NCT00491712|Neovascular Glaucoma|neovascular glaucoma
5702875|NCT00491712|Drainage implant devices|drainage implant devices
5702876|NCT00491712|Silicone Ahmed Tube|silicone ahmed tube
5702877|NCT00491712|Triamcinolone|triamcinolone
5702878|NCT00491699|NSCLC|nsclc
5702879|NCT00491686|Long-term depression|long-term depression
5702880|NCT00491673|Fracture|fracture
5702881|NCT00491673|Femoral neck|femoral neck
5702882|NCT00491673|Arthroplasty|arthroplasty
5702883|NCT00491660|Gravity|gravity
5702884|NCT00491660|Mechanical ventilation|mechanical ventilation
5702885|NCT00491660|Infants|infants
5702886|NCT00491660|Ventilator-associated pneumonia|ventilator-associated pneumonia
5703011|NCT00491075|Pemetrexed|pemetrexed
5702887|NCT00491660|Types of bacterial colonies in subjects at 2-5 days of mechanical ventilation|types of bacterial colonies in subjects at 2-5 days of mechanical ventilation
5702888|NCT00491660|Colony count of an organism was cultured|colony count of an organism was cultured
5702889|NCT00491647|ADHD, time perception, treatments|adhd, time perception, treatments
5702890|NCT00491634|acute myeloid leukemia|acute myeloid leukemia
5702891|NCT00491634|myelodysplastic syndrome|myelodysplastic syndrome
5702892|NCT00491634|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5702893|NCT00491634|reduced-intensity conditioning|reduced-intensity conditioning
5702895|NCT00491621|kidney|kidney
5702896|NCT00491621|tumor|tumor
5702897|NCT00491621|Molecular Markers|molecular markers
5702898|NCT00491621|Cytology|cytology
5702899|NCT00491621|Histology|histology
5702900|NCT00491621|Cystic kidney tumor|cystic kidney tumor
5702901|NCT00491608|Phase 3b|phase 3b
5702902|NCT00491608|rThrombin|rthrombin
5702903|NCT00491608|spine surgery|spine surgery
5702904|NCT00491608|vascular surgery|vascular surgery
5702905|NCT00491608|hemostasis|hemostasis
5702906|NCT00491608|immunogenicity|immunogenicity
5702907|NCT00491608|safety|safety
5702908|NCT00491595|Soy isoflavones|soy isoflavones
5702910|NCT00491595|Apoptosis|apoptosis
5702911|NCT00491595|Estrogenic effects|estrogenic effects
5702912|NCT00491569|Schizophrenia|schizophrenia
5702913|NCT00491569|sarcosine|sarcosine
5702914|NCT00491569|D-serine|d-serine
5702915|NCT00491569|NMDA|nmda
5702916|NCT00491556|Atazanavir/Ritonavir (ATV/r)|atazanavir/ritonavir (atv/r)
5702917|NCT00491556|highly-active antiretroviral therapy (HAART)|highly-active antiretroviral therapy (haart)
5702918|NCT00491556|Treatment Naive|treatment naive
5702919|NCT00491491|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5702920|NCT00491491|autologous stem cell transplantation|autologous stem cell transplantation
5702921|NCT00491491|radioimmunotherapy|radioimmunotherapy
5702922|NCT00491491|zevalin|zevalin
5702923|NCT00491478|Repetitive behavior disorder|repetitive behavior disorder
5702924|NCT00491478|Stereotypy|stereotypy
5702925|NCT00491478|Sertraline|sertraline
5702926|NCT00491465|Type 1 Diabetes, physical activity, pediatric, metabolic control|type 1 diabetes, physical activity, pediatric, metabolic control
5702927|NCT00491452|Ischemic MR|ischemic mr
5702928|NCT00491452|Annuloplasty|annuloplasty
5702929|NCT00491439|in vivo confocal microscopy|in vivo confocal microscopy
5702930|NCT00491439|vitrectomy|vitrectomy
5702931|NCT00491439|corneal transplantation|corneal transplantation
5702932|NCT00491439|Epi-LASIK|epi-lasik
5702933|NCT00491439|wound healing|wound healing
5702934|NCT00491426|Infection|infection
5702935|NCT00491426|Anti-Infective Agents|anti-infective agents
5702936|NCT00491426|Antifungal Agents|antifungal agents
5702937|NCT00491426|Proteomics|proteomics
5702938|NCT00491413|neurodevelopmental outcomes|neurodevelopmental outcomes
5702939|NCT00491400|endothelium|endothelium
5702941|NCT00491400|diabetes mellitus|diabetes mellitus
5702942|NCT00491400|dyslipidemia|dyslipidemia
5702943|NCT00491387|hypertension|hypertension
5702944|NCT00491387|sympathetic nervous system|sympathetic nervous system
5702945|NCT00491361|ADHD, SNAP-IV, SDQ, ASRS, reliability, validity|adhd, snap-iv, sdq, asrs, reliability, validity
5702946|NCT00491348|Generalized anxiety disorder|generalized anxiety disorder
5702947|NCT00491348|fMRI|fmri
5702948|NCT00491348|Worry|worry
5702949|NCT00491335|AIDS|aids
5702950|NCT00491335|Lung Cancer|lung cancer
5702951|NCT00491335|Emphysema|emphysema
5702952|NCT00491335|Nicotine|nicotine
5702953|NCT00491335|HIV Infection|hiv infection
5702954|NCT00491335|Smoking|smoking
5702955|NCT00491322|Vitamin D|vitamin d
5702956|NCT00491322|Vitamin D deficiency|vitamin d deficiency
5702957|NCT00491322|Insulin resistance|insulin resistance
5702958|NCT00491322|Diabetes|diabetes
5702959|NCT00491322|Diabetes mellitus|diabetes mellitus
5702960|NCT00491322|FGF-23|fgf-23
5702961|NCT00491322|FGF23|fgf23
5702962|NCT00491322|Phosphate|phosphate
5702963|NCT00491296|S/P Transuretral resection of bladder tumor|s/p transuretral resection of bladder tumor
5702964|NCT00491296|Recurrent tumor after BCG Treatment|recurrent tumor after bcg treatment
5702965|NCT00491270|Vaginosis, Bacterial|vaginosis, bacterial
5702966|NCT00491270|Abortion, Spontaneous|abortion, spontaneous
5702967|NCT00491270|Premature Birth|premature birth
5702968|NCT00491257|Influenza|influenza
5692459|NCT00528034|Lymph|lymph
5702969|NCT00491257|Orthomyxoviridae Infections|orthomyxoviridae infections
5702970|NCT00491257|Orthomyxoviruses|orthomyxoviruses
5702971|NCT00491257|Split-virion influenza vaccine|split-virion influenza vaccine
5702972|NCT00491244|Chronic hepatitis C|chronic hepatitis c
5702973|NCT00491244|Hemodialysis|hemodialysis
5702974|NCT00491244|Interferon|interferon
5702975|NCT00491244|Ribavirin|ribavirin
5702976|NCT00491231|orthostatic hypotension|orthostatic hypotension
5702977|NCT00491231|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5702978|NCT00491218|impact of cardiac computed tomography on outpatient angina evaluation|impact of cardiac computed tomography on outpatient angina evaluation
5702979|NCT00491218|downstream resource utilization|downstream resource utilization
5702980|NCT00491192|Fever|fever
5702981|NCT00491192|Acute cerebral damage|acute cerebral damage
5702982|NCT00491192|Normothermia|normothermia
5702983|NCT00491192|Diclofenac|diclofenac
5702985|NCT00491192|Outcome|outcome
5702986|NCT00491192|Intracranial pressure|intracranial pressure
5702987|NCT00491192|Cerebral perfusion pressure|cerebral perfusion pressure
5702988|NCT00491192|Traumatic brain injury|traumatic brain injury
5702989|NCT00491192|Subarachnoid hemorrhage|subarachnoid hemorrhage
5702990|NCT00491179|Chronic hepatitis C|chronic hepatitis c
5702991|NCT00491179|hemodialysis|hemodialysis
5702992|NCT00491179|interferon|interferon
5702993|NCT00491179|ribavirin|ribavirin
5702994|NCT00491166|diabetic macular edema|diabetic macular edema
5702995|NCT00491166|bromfenac ophthalmic solution|bromfenac ophthalmic solution
5702996|NCT00491153|asthma|asthma
5702997|NCT00491153|airway hyperresponsiveness|airway hyperresponsiveness
5702998|NCT00491153|dry powder mannitol inhalation|dry powder mannitol inhalation
5702999|NCT00491153|methacholine|methacholine
5703000|NCT00491140|EGFR|egfr
5703001|NCT00491140|KRAS|kras
5703002|NCT00491140|BRAF|braf
5703003|NCT00491140|MET|met
5703004|NCT00491140|IGFR1|igfr1
5703005|NCT00491101|Asthma Control|asthma control
5703006|NCT00491101|Quality of Life|quality of life
5703007|NCT00491101|Children|children
5703008|NCT00491101|Polish Version of PAQLQ(S) by Juniper|polish version of paqlq(s) by juniper
5703009|NCT00491075|Renal Cell Carcinoma|renal cell carcinoma
5703010|NCT00491075|Non-Clear Cell|non-clear cell
5703012|NCT00491075|Gemcitabine|gemcitabine
5703013|NCT00491075|LY231514|ly231514
5703014|NCT00491075|Alimta|alimta
5701458|NCT00496951|Vagal tone|vagal tone
5703015|NCT00491075|MTA|mta
5703016|NCT00491075|Multitargeted Antifolate|multitargeted antifolate
5703017|NCT00491075|NSC-698037|nsc-698037
5703018|NCT00491075|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5703019|NCT00491075|Gemzar|gemzar
5703020|NCT00491075|RCC|rcc
5703021|NCT00491062|Parkinson's disease|parkinson's disease
5703022|NCT00491062|enteric nervous system|enteric nervous system
5703023|NCT00491049|prophylaxis|prophylaxis
5703024|NCT00491049|intraocular surgery|intraocular surgery
5703025|NCT00491049|endophthalmitis|endophthalmitis
5703026|NCT00491049|antibiotic|antibiotic
5703027|NCT00491036|Acute myocardial infarction|acute myocardial infarction
5703028|NCT00491036|cardiogenic shock|cardiogenic shock
5703029|NCT00491036|percutaneous coronary intervention|percutaneous coronary intervention
5703030|NCT00491036|intraaortic balloon counterpulsation|intraaortic balloon counterpulsation
5703031|NCT00491036|Acute myocardial infarction - cardiogenic shock|acute myocardial infarction - cardiogenic shock
5703032|NCT00491010|atrial flutter|atrial flutter
5703033|NCT00491010|ablation|ablation
5703034|NCT00491010|voltage targeted|voltage targeted
5703035|NCT00490997|ketamine|ketamine
5703036|NCT00490997|propofol|propofol
5703037|NCT00490997|sedation|sedation
5703038|NCT00490997|pediatric|pediatric
5703039|NCT00490997|emergency department|emergency department
5703040|NCT00490997|fracture|fracture
5703041|NCT00490984|obstructive sleep apena|obstructive sleep apena
5703042|NCT00490984|tongue|tongue
5703043|NCT00490984|surgery|surgery
5703044|NCT00490971|Bipolar Disorder|bipolar disorder
5703047|NCT00490971|Manic-Depressive Disorder|manic-depressive disorder
5703048|NCT00490958|heart Failure|heart failure
5703050|NCT00490958|telmisartan|telmisartan
5703051|NCT00490958|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5703052|NCT00490932|Watery diarrhea|watery diarrhea
5703053|NCT00490932|Bloody diarrhea|bloody diarrhea
5703054|NCT00490919|Chronic pain|chronic pain
5703055|NCT00490919|opioid|opioid
5703056|NCT00490919|transdermal|transdermal
5703057|NCT00490919|Moderate to severe chronic low back pain|moderate to severe chronic low back pain
5703058|NCT00490906|MS (Multiple Sclerosis)|ms (multiple sclerosis)
5703059|NCT00490893|counterregulation|counterregulation
5703060|NCT00490893|hypoglycemia unawareness|hypoglycemia unawareness
5703061|NCT00490893|insulin therapy|insulin therapy
5703062|NCT00490828|Cardiac surgery|cardiac surgery
5703063|NCT00490828|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5703064|NCT00490828|health-related quality of life|health-related quality of life
5703065|NCT00490802|Autism|autism
5703066|NCT00490802|Treatment|treatment
5703067|NCT00490802|Oxytocin|oxytocin
5703068|NCT00490802|Adults|adults
5703069|NCT00490802|Autism Spectrum Disorder|autism spectrum disorder
5703070|NCT00490789|tuberous sclerosis|tuberous sclerosis
5703071|NCT00490789|lymphangioleiomyomatosis|lymphangioleiomyomatosis
5703073|NCT00490789|angiomyolioma|angiomyolioma
5703074|NCT00490789|rapamycin|rapamycin
5703075|NCT00490789|mTOR|mtor
5703076|NCT00490776|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5703077|NCT00490776|adults|adults
5703078|NCT00490776|Mycosis Fungoides|mycosis fungoides
5703079|NCT00490776|Sézary Syndrome|sézary syndrome
5703080|NCT00490776|CTCL|ctcl
5703081|NCT00490763|Prostate Cancer|prostate cancer
5703082|NCT00490763|Active Surveillance|active surveillance
5703083|NCT00490763|Prostate Specific Antigen|prostate specific antigen
5703084|NCT00490763|Questionnaire|questionnaire
5703085|NCT00490763|Survey|survey
5703086|NCT00490750|Heller Dor|heller dor
5703087|NCT00490750|Heller Toupet|heller toupet
5703088|NCT00490750|Myotomy|myotomy
5703089|NCT00490737|ESRD|esrd
5703091|NCT00490737|hemodialysis|hemodialysis
5703092|NCT00490737|continuous ambulatory peritoneal dialysis|continuous ambulatory peritoneal dialysis
5703093|NCT00490724|Heart failure, congestive|heart failure, congestive
5703094|NCT00490724|Nesiritide and|nesiritide and
5703095|NCT00490724|JNS004|jns004
5703096|NCT00490698|Kidney Cancer|kidney cancer
5703097|NCT00490698|Renal Cell Carcinoma|renal cell carcinoma
5703098|NCT00490698|Bone-Targeted Therapy|bone-targeted therapy
5703099|NCT00490698|Zoledronate|zoledronate
5703100|NCT00490698|Zometa|zometa
5703101|NCT00490698|Atorvastatin|atorvastatin
5703102|NCT00490698|Lipitor|lipitor
5703103|NCT00490698|RCC|rcc
5703104|NCT00490672|Hypertension|hypertension
5703105|NCT00490672|Diabetes Mellitus|diabetes mellitus
5703106|NCT00490672|Hyperlipidaemia|hyperlipidaemia
5703107|NCT00490672|Primary Care|primary care
5703108|NCT00490672|Community Care|community care
5703109|NCT00490672|Multiple Risk Factors Interventional Strategies|multiple risk factors interventional strategies
5703110|NCT00490646|Locally advanced and/or metastatic breast cancer|locally advanced and/or metastatic breast cancer
5703111|NCT00490633|Influenza|influenza
5703112|NCT00490633|Non Pharmaceutical Intervention|non pharmaceutical intervention
5703113|NCT00490633|Face Mask|face mask
5703114|NCT00490633|Hand Hygiene|hand hygiene
5703115|NCT00490620|primary biliary cirrhosis C06.552.630.400|primary biliary cirrhosis c06.552.630.400
5703116|NCT00490620|retroviral infection C02.782.815|retroviral infection c02.782.815
5685776|NCT00554892|Rectal cancer|rectal cancer
5685777|NCT00554892|Sphincter preservation|sphincter preservation
5685778|NCT00554892|Mechanical bowel preparation|mechanical bowel preparation
5685779|NCT00554892|Post operative morbidity|post operative morbidity
5703117|NCT00490607|Hemagiomas of infancy|hemagiomas of infancy
5703118|NCT00490594|ACL|acl
5703119|NCT00490594|ligament|ligament
5703120|NCT00490594|ACL injury|acl injury
5703121|NCT00490581|Early housing after hospitalization|early housing after hospitalization
5703122|NCT00490568|cognition|cognition
5703123|NCT00490568|Alzheimer's disease|alzheimer's disease
5703124|NCT00490568|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
5703125|NCT00490568|safety|safety
5703126|NCT00490568|adjunctive therapy|adjunctive therapy
5703127|NCT00490568|BRL-049653|brl-049653
5703128|NCT00490568|tolerability|tolerability
5703129|NCT00490568|open-label extension|open-label extension
5703130|NCT00490555|Male Contraception|male contraception
5703131|NCT00490555|Testosterone|testosterone
5703132|NCT00490555|Testis|testis
5703133|NCT00490555|Contraception|contraception
5703134|NCT00490555|Prostate|prostate
5703135|NCT00490542|Bipolar Disorder|bipolar disorder
5703136|NCT00490542|Major Depression|major depression
5703137|NCT00490542|Clinical pharmacology|clinical pharmacology
5703138|NCT00490542|Clinical Trial|clinical trial
5703139|NCT00490516|Schizophrenia, psychotic disorders|schizophrenia, psychotic disorders
5703140|NCT00490503|Breast Cancer|breast cancer
5703141|NCT00490503|Magnetic Resonance Imaging|magnetic resonance imaging
5703142|NCT00490503|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5703143|NCT00490503|DCE-MRI|dce-mri
5703144|NCT00490503|DW-MRI|dw-mri
5703145|NCT00490503|MRS|mrs
5703146|NCT00490503|MRI|mri
5703147|NCT00490477|acute renal failure|acute renal failure
5703148|NCT00490477|lipopolysaccharide|lipopolysaccharide
5703149|NCT00490477|tubular apoptosis|tubular apoptosis
5703150|NCT00490477|Polymyxin-B fiber|polymyxin-b fiber
5703151|NCT00490477|Severe sepsis from gram negative infection|severe sepsis from gram negative infection
5703152|NCT00490464|Patients with SAH or ICH|patients with sah or ich
5703153|NCT00490438|perineometry|perineometry
5703154|NCT00490438|Modified Oxford Score|modified oxford score
5703155|NCT00490438|pelvic muscles evaluation|pelvic muscles evaluation
5703156|NCT00490438|urinary incontinence|urinary incontinence
5703157|NCT00490438|vaginal palpation|vaginal palpation
5703158|NCT00490425|probiotics|probiotics
5703159|NCT00490425|LGG|lgg
5703160|NCT00490425|praevention|praevention
5703161|NCT00490425|allergic asthma|allergic asthma
5703162|NCT00490425|children|children
5703163|NCT00490412|Vitamin D|vitamin d
5703164|NCT00490412|Treatment Experienced|treatment experienced
5703165|NCT00490386|Retrospective|retrospective
5703166|NCT00490386|Length of Stay|length of stay
5703167|NCT00490386|Helicobacter pylori|helicobacter pylori
5703168|NCT00490347|VentrAssistTM|ventrassisttm
5703169|NCT00490347|LVAD|lvad
5703170|NCT00490347|End-stage heart failure|end-stage heart failure
5703173|NCT00490334|Squamous Cel|squamous cel
5703174|NCT00490334|Adenocarcinoma|adenocarcinoma
5703175|NCT00490334|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5703176|NCT00490321|VentrAssistTM|ventrassisttm
5703177|NCT00490321|LVAD|lvad
5703178|NCT00490321|End-stage heart failure|end-stage heart failure
5703179|NCT00490321|Cardiomyopathy|cardiomyopathy
5703180|NCT00490308|luteal|luteal
5703181|NCT00490308|phase|phase
5703182|NCT00490308|estradiol|estradiol
5703183|NCT00490308|pregnancy|pregnancy
5703184|NCT00490308|rate|rate
5703185|NCT00490295|biomarkers|biomarkers
5703186|NCT00490295|brain ischemia|brain ischemia
5703187|NCT00490295|neonates|neonates
5703188|NCT00490295|cardiac surgery|cardiac surgery
5703189|NCT00490295|congenital heart disease|congenital heart disease
5703190|NCT00490282|Head and Neck Cancer|head and neck cancer
5697472|NCT00509652|Phlebotomy|phlebotomy
5703191|NCT00490282|Oropharyngeal Cancer|oropharyngeal cancer
5703192|NCT00490282|Adaptive Radiotherapy|adaptive radiotherapy
5703193|NCT00490282|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5703194|NCT00490282|IMRT|imrt
5703196|NCT00490269|Marijuana dependence|marijuana dependence
5703197|NCT00490256|Selective Cerebral Perfusion|selective cerebral perfusion
5703198|NCT00490256|Renal Complications|renal complications
5703199|NCT00490256|Gastrointestinal Complications|gastrointestinal complications
5703200|NCT00490256|Aortic Arch Reconstruction|aortic arch reconstruction
5703201|NCT00490256|Modified Perfusion|modified perfusion
5703202|NCT00490256|Cardiopulmonary Bypass|cardiopulmonary bypass
5703203|NCT00490256|Pediatrics|pediatrics
5703204|NCT00490256|Cardiac Defects|cardiac defects
5703205|NCT00490256|intestinal ischemia|intestinal ischemia
5703206|NCT00490256|necrotizing entercolitis|necrotizing entercolitis
5703207|NCT00490256|Near Infra-red spectroscopy|near infra-red spectroscopy
5703208|NCT00490256|Creatinine|creatinine
5680551|NCT00577590|Lovaza|lovaza
5703209|NCT00490256|C-reactive protein levels|c-reactive protein levels
5703210|NCT00490243|Asthma|asthma
5719686|NCT00432861|pancreatic insufficiency|pancreatic insufficiency
5719687|NCT00432861|PANCRECARB® MS-16 (pancrelipase)|pancrecarb® ms-16 (pancrelipase)
5719689|NCT00432835|Nausea|nausea
5719690|NCT00432835|Vomiting|vomiting
5719691|NCT00432835|Delayed gastric emptying|delayed gastric emptying
5719692|NCT00432835|Diabetes Mellitus|diabetes mellitus
5703211|NCT00490243|Children|children
5703212|NCT00490243|Exercise|exercise
5703213|NCT00490243|Pulmonary Function|pulmonary function
5703214|NCT00490243|Budesonide|budesonide
5703215|NCT00490243|Montelukast|montelukast
5703216|NCT00490243|Formoterol|formoterol
5703217|NCT00490230|Paromomycin|paromomycin
5703218|NCT00490230|Gentamicin|gentamicin
5703219|NCT00490217|Spontaneous bacterial peritonitis|spontaneous bacterial peritonitis
5703220|NCT00490217|incidence|incidence
5703221|NCT00490217|Finland|finland
5703222|NCT00490217|etiology|etiology
5703223|NCT00490217|liver cirrhosis|liver cirrhosis
5703224|NCT00490204|Perennial Allergic Rhinitis|perennial allergic rhinitis
5703225|NCT00490204|Placebo control|placebo control
5703226|NCT00490204|anti-histamine|anti-histamine
5703227|NCT00490204|Cetirizine|cetirizine
5703228|NCT00490178|Type II diabetes|type ii diabetes
5703229|NCT00490178|dyslipidemia|dyslipidemia
5703230|NCT00490178|metformin|metformin
5703231|NCT00490178|fenofibrate|fenofibrate
5703232|NCT00490178|synordia|synordia
5703233|NCT00490152|HIV|hiv
5703234|NCT00490152|Microbicide Gel|microbicide gel
5703235|NCT00490152|HIV Seronegativity|hiv seronegativity
5703236|NCT00490139|Adjuvant|adjuvant
5703237|NCT00490139|ErbB2-overexpressing|erbb2-overexpressing
5703238|NCT00490139|Early stage breast cancer|early stage breast cancer
5703239|NCT00490139|HER2/neu gene amplified|her2/neu gene amplified
5703240|NCT00490126|Laparoscopic Surgery|laparoscopic surgery
5703241|NCT00490126|Laparoscopy|laparoscopy
5703242|NCT00490126|Gynecology|gynecology
5703243|NCT00490126|Demographics|demographics
5703244|NCT00490126|Perioperative Care|perioperative care
5703245|NCT00490100|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5703246|NCT00490100|Growth Hormone|growth hormone
5703247|NCT00490100|Insulin-Like Growth Factor 1 (IGF)-1|insulin-like growth factor 1 (igf)-1
5703249|NCT00490100|Growth Failure|growth failure
5703250|NCT00490100|XSCID|xscid
5703251|NCT00490100|X-Linked Severe Combined Immunodeficiency|x-linked severe combined immunodeficiency
5703252|NCT00490087|Atypical endometrial polyps|atypical endometrial polyps
5703253|NCT00490087|Atypical Endometrial Hyperplasia|atypical endometrial hyperplasia
5703254|NCT00490087|Hysteroscopic resection|hysteroscopic resection
5703255|NCT00490087|Conservative treatment|conservative treatment
5703256|NCT00490087|Fertile women|fertile women
5703257|NCT00490074|AIDS Vaccines|aids vaccines
5703258|NCT00490074|Vaccines, DNA|vaccines, dna
5703259|NCT00490074|HIV Preventive Vaccine|hiv preventive vaccine
5703260|NCT00490074|HIV Seronegativity|hiv seronegativity
5703261|NCT00490048|Ulcerative colits|ulcerative colits
5703262|NCT00490048|lung|lung
5703263|NCT00490048|Induced sputum|induced sputum
5703264|NCT00490048|Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum|our aim to evaluate lung involvement in ulcerative colitis patients by induced sputum
5703265|NCT00490035|Epilepsy|epilepsy
5703266|NCT00490035|Brivaracetam|brivaracetam
5703267|NCT00490035|Partial Onset Seizures|partial onset seizures
5703268|NCT00490022|Dihydrotestosterone|dihydrotestosterone
5703269|NCT00490022|Androgen|androgen
5703270|NCT00490022|Prostate|prostate
5703271|NCT00489970|Persistence|persistence
5703272|NCT00489970|immunogenicity|immunogenicity
5703273|NCT00489957|congenital cardiac disorders|congenital cardiac disorders
5703274|NCT00489957|echocardiography|echocardiography
5703275|NCT00489944|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5703276|NCT00489944|extraocular extension melanoma|extraocular extension melanoma
5703277|NCT00489944|iris melanoma|iris melanoma
5703278|NCT00489944|epithelioid cell intraocular melanoma|epithelioid cell intraocular melanoma
5703279|NCT00489944|stage IIB intraocular melanoma|stage iib intraocular melanoma
5703280|NCT00489944|stage IIIA intraocular melanoma|stage iiia intraocular melanoma
5703281|NCT00489944|stage IIIB intraocular melanoma|stage iiib intraocular melanoma
5703282|NCT00489944|stage IIIC intraocular melanoma|stage iiic intraocular melanoma
5703283|NCT00489944|stage IV intraocular melanoma|stage iv intraocular melanoma
5703286|NCT00489931|Immunity|immunity
5703287|NCT00489931|Preventive|preventive
5703288|NCT00489931|Bird Flu|bird flu
5703289|NCT00489931|Healthy Volunteer|healthy volunteer
5703291|NCT00489905|prostate cancer|prostate cancer
5703292|NCT00489905|bone mineral density|bone mineral density
5703293|NCT00489892|traumatic brain injury|traumatic brain injury
5703295|NCT00489892|working memory|working memory
5703296|NCT00489892|modafinil|modafinil
5703297|NCT00489892|fMRI|fmri
5703298|NCT00489892|MRI|mri
5703299|NCT00489879|Mobile Health Units|mobile health units
5703300|NCT00489879|Chronic Disease|chronic disease
5703301|NCT00489866|PTSD|ptsd
5703302|NCT00489866|Antidepressant|antidepressant
5703303|NCT00489866|Aripiprazole|aripiprazole
5703304|NCT00489866|OEF|oef
5703305|NCT00489866|OIF|oif
5703306|NCT00489853|COPD|copd
5703307|NCT00489840|Chronic Central Serous Chorioretinopathy|chronic central serous chorioretinopathy
5703308|NCT00489827|Coronary Artery Bypass|coronary artery bypass
5703309|NCT00489827|Myocardial Protection|myocardial protection
5703310|NCT00489827|Angina, Unstable|angina, unstable
5703311|NCT00489827|Myocardial Ischemia|myocardial ischemia
5703312|NCT00489827|Myocardial Infarction|myocardial infarction
5703313|NCT00489827|Unstable Coronary Artery Disease|unstable coronary artery disease
5703314|NCT00489827|Glutamate|glutamate
5703315|NCT00489814|Prostate Cancer|prostate cancer
5703316|NCT00489814|Prostate Proton Therapy|prostate proton therapy
5703317|NCT00489814|Proton Radiation Therapy|proton radiation therapy
5703318|NCT00489814|Proton Radiotherapy|proton radiotherapy
5703319|NCT00489814|Quality of Life|quality of life
5703320|NCT00489814|QOL|qol
5703321|NCT00489814|Questionnaire|questionnaire
5703322|NCT00489801|Cardiac Rehabilitation|cardiac rehabilitation
5703323|NCT00489801|Exercise|exercise
5703324|NCT00489801|Heart failure|heart failure
5703325|NCT00489801|Coronary heart disease|coronary heart disease
5703326|NCT00489788|MRI|mri
5703327|NCT00489788|Ventricular Strain|ventricular strain
5703328|NCT00489788|Pulmonary Valve Replacement|pulmonary valve replacement
5703329|NCT00489788|Post Tetralogy of Fallot|post tetralogy of fallot
5703330|NCT00489762|Childhood|childhood
5703331|NCT00489762|Asthma|asthma
5703332|NCT00489762|Heating|heating
5703333|NCT00489762|Insulation|insulation
5703334|NCT00489762|Respiratory symptoms|respiratory symptoms
5703335|NCT00489749|Achilles tendon rupture|achilles tendon rupture
5703336|NCT00489749|Open surgical repair|open surgical repair
5703337|NCT00489749|Early functional mobilization|early functional mobilization
5703338|NCT00489749|Weightbearing|weightbearing
5703339|NCT00489749|Rehabilitation|rehabilitation
5703340|NCT00489736|Atrial Fibrillation|atrial fibrillation
5703341|NCT00489736|sinus rhythm|sinus rhythm
5703342|NCT00489736|amiodarone|amiodarone
5703343|NCT00489723|size of stone 1-2 cm|size of stone 1-2 cm
5863049|NCT00001409|Gene Therapy|gene therapy
5703344|NCT00489723|Pt. with no use of alfa bloker prior ESWL|pt. with no use of alfa bloker prior eswl
5703345|NCT00489723|Pt. without internal stent|pt. without internal stent
5703346|NCT00489710|stage IV renal cell cancer|stage iv renal cell cancer
5703347|NCT00489710|recurrent renal cell cancer|recurrent renal cell cancer
5703348|NCT00489697|colorectal cancer|colorectal cancer
5703349|NCT00489697|hepatic metastases|hepatic metastases
5703350|NCT00489697|bevacizumab|bevacizumab
5703351|NCT00489697|anti-angiogenic agent|anti-angiogenic agent
5703352|NCT00489697|chemotherapy regimens|chemotherapy regimens
5703353|NCT00489697|tumor vascularity|tumor vascularity
5703354|NCT00489697|Contrast-enhanced ultrasound|contrast-enhanced ultrasound
5703355|NCT00489671|pancreatic cancer|pancreatic cancer
5703356|NCT00489671|precancerous condition|precancerous condition
5703357|NCT00489658|Human African trypanosomiasis|human african trypanosomiasis
5703358|NCT00489658|sleeping sickness|sleeping sickness
5703359|NCT00489658|Trypanosoma brucei gambiense|trypanosoma brucei gambiense
5703360|NCT00489658|combination|combination
5703361|NCT00489658|eflornithine|eflornithine
5703362|NCT00489658|nifurtimox|nifurtimox
5703363|NCT00489658|Human African trypanosomiasis (sleeping sickness) due to Trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)|human african trypanosomiasis (sleeping sickness) due to trypanosoma brucei gambiense in the late stage (stage 2 or meningo-encephalitic)
5703364|NCT00489645|pramlintide|pramlintide
5703365|NCT00489645|gastric emptying|gastric emptying
5703366|NCT00489645|T1DM|t1dm
5703367|NCT00489645|postprandial|postprandial
5703368|NCT00489632|Leukemia|leukemia
5703369|NCT00489632|Pediatrics|pediatrics
5703370|NCT00489632|Cancer|cancer
5703371|NCT00489632|Coping|coping
5703372|NCT00489632|Caregiver|caregiver
5703373|NCT00489632|Questionnaire|questionnaire
5703374|NCT00489632|Children|children
5703375|NCT00489632|Resiliency|resiliency
5703376|NCT00489632|Adjustment|adjustment
5703377|NCT00489632|Illness-related factors|illness-related factors
5703378|NCT00489619|Infectious diseases|infectious diseases
5703379|NCT00489619|Democratic Republic of Congo|democratic republic of congo
5703380|NCT00489619|Malaria|malaria
5703381|NCT00489619|International|international
5703382|NCT00489619|Maternal and child health|maternal and child health
5703383|NCT00489619|Women's Health|women's health
5703384|NCT00489619|Global Network|global network
5703385|NCT00489619|Sexually transmitted infections (STIs)|sexually transmitted infections (stis)
5703386|NCT00489606|SK3530|sk3530
5703387|NCT00489606|tamsulosin|tamsulosin
5703388|NCT00489606|hemodynamic interaction|hemodynamic interaction
5703389|NCT00489606|safety|safety
5703390|NCT00489593|Advanced Cancer|advanced cancer
5703391|NCT00489593|Weight Loss|weight loss
5703392|NCT00489593|Cachexia|cachexia
5703393|NCT00489593|Olanzapine|olanzapine
5703395|NCT00489593|Fluoxetine|fluoxetine
5703396|NCT00489593|Symbyax|symbyax
5703397|NCT00489580|stroke|stroke
5703398|NCT00489580|weakness|weakness
5703399|NCT00489580|motor recovery|motor recovery
5703400|NCT00489567|Rotavirus gastroenteritis|rotavirus gastroenteritis
5703401|NCT00489554|Primary vaccination|primary vaccination
5703402|NCT00489554|Safety|safety
5703403|NCT00489554|Pneumococcal vaccine.|pneumococcal vaccine.
5703404|NCT00489554|Pneumococcal disease|pneumococcal disease
5703405|NCT00489554|Immunogenicity|immunogenicity
5703406|NCT00489541|paclitaxel-eluting stent|paclitaxel-eluting stent
5703407|NCT00489541|PES|pes
5703408|NCT00489528|serostim|serostim
5703409|NCT00489528|Dose-Response Relationship, Drug|dose-response relationship, drug
5703410|NCT00489528|Body Composition|body composition
5703411|NCT00489515|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5703412|NCT00489515|stage I pancreatic cancer|stage i pancreatic cancer
5703413|NCT00489515|stage II pancreatic cancer|stage ii pancreatic cancer
5703414|NCT00489515|stage III pancreatic cancer|stage iii pancreatic cancer
5703415|NCT00489515|stage IV pancreatic cancer|stage iv pancreatic cancer
5703416|NCT00489515|stage I colon cancer|stage i colon cancer
5703417|NCT00489515|stage II colon cancer|stage ii colon cancer
5703418|NCT00489515|stage III colon cancer|stage iii colon cancer
5703419|NCT00489515|stage IV colon cancer|stage iv colon cancer
5703420|NCT00489515|stage I gastric cancer|stage i gastric cancer
5703421|NCT00489515|stage II gastric cancer|stage ii gastric cancer
5703422|NCT00489515|stage III gastric cancer|stage iii gastric cancer
5703423|NCT00489515|stage IV gastric cancer|stage iv gastric cancer
5703424|NCT00489515|localized gallbladder cancer|localized gallbladder cancer
5703425|NCT00489515|small intestine adenocarcinoma|small intestine adenocarcinoma
5703426|NCT00489515|adenocarcinoma of the colon|adenocarcinoma of the colon
5703427|NCT00489515|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5703428|NCT00489515|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5703429|NCT00489489|MS|ms
5703430|NCT00489489|interferon-beta|interferon-beta
5703431|NCT00489489|adjunctive therapy|adjunctive therapy
5703432|NCT00489489|relapses|relapses
5703433|NCT00489476|Staccato® Loxapine, Migraine|staccato® loxapine, migraine
5703434|NCT00489463|LNG-IUS|lng-ius
5703435|NCT00489463|TCu 380A|tcu 380a
5703436|NCT00489463|Ultrasonography|ultrasonography
5703437|NCT00489463|Doppler color|doppler color
5703438|NCT00489463|power Doppler|power doppler
5703439|NCT00489463|female|female
5703440|NCT00489463|Volunteers|volunteers
5703443|NCT00489450|pharmacokinetics|pharmacokinetics
5703444|NCT00489450|safety|safety
5703445|NCT00489437|diagnosis|diagnosis
5703446|NCT00489424|zoledronic acid|zoledronic acid
5703447|NCT00489424|post dose symptoms|post dose symptoms
5703448|NCT00489424|transient|transient
5703449|NCT00489424|acetaminophen|acetaminophen
5703450|NCT00489424|fluvastatin|fluvastatin
5703451|NCT00489411|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5703452|NCT00489411|neurotoxicity|neurotoxicity
5703453|NCT00489411|pain|pain
5703454|NCT00489411|peripheral neuropathy|peripheral neuropathy
5703455|NCT00489385|Fibrosis|fibrosis
5703456|NCT00489385|Viral Kinetics|viral kinetics
5703457|NCT00489385|Hepatotoxicity|hepatotoxicity
5703458|NCT00489385|Immunity|immunity
5703459|NCT00489385|HIV Infection|hiv infection
5703460|NCT00489385|Hepatitis C|hepatitis c
5703462|NCT00489385|Treatment Experienced|treatment experienced
5703463|NCT00489385|Treatment Naive|treatment naive
5703464|NCT00489333|ProAlgaZyme|proalgazyme
5703465|NCT00489333|Metabolic syndrome|metabolic syndrome
5703466|NCT00489333|Inflammation|inflammation
5703467|NCT00489333|Cardiovascular|cardiovascular
5703468|NCT00489333|hsCRP|hscrp
5703469|NCT00489333|Lipids|lipids
5703470|NCT00489333|Algae|algae
5703471|NCT00489320|Coronary disease|coronary disease
5703472|NCT00489320|Arteries|arteries
5703473|NCT00489320|Atherosclerosis|atherosclerosis
5703474|NCT00489320|Arteriosclerosis|arteriosclerosis
5703475|NCT00489307|Advanced Cancer|advanced cancer
5703476|NCT00489307|Solid Tumors|solid tumors
5703477|NCT00489307|Fatigue|fatigue
5703478|NCT00489307|Pain|pain
5703479|NCT00489307|Nausea|nausea
5703480|NCT00489307|Anorexia|anorexia
5703481|NCT00489307|Dexamethasone|dexamethasone
5703482|NCT00489307|Decadron|decadron
5703483|NCT00489307|Placebo|placebo
5703484|NCT00489294|Human growth hormone|human growth hormone
5703485|NCT00489294|idiopathic short stature|idiopathic short stature
5703486|NCT00489294|short stature|short stature
5703487|NCT00489281|sickle cell disease|sickle cell disease
5703488|NCT00489268|Barrett's Esophagus|barrett's esophagus
5703489|NCT00489268|Intestinal Metaplasia|intestinal metaplasia
5703490|NCT00489268|Radiofrequency Ablation|radiofrequency ablation
5703491|NCT00489255|Parkinson's disease|parkinson's disease
5703492|NCT00489255|Anti-emetic|anti-emetic
5703493|NCT00489255|Nausea|nausea
5703494|NCT00489255|Vomiting|vomiting
5703495|NCT00489229|Rosiglitazone|rosiglitazone
5703496|NCT00489229|Ramipril|ramipril
5703497|NCT00489229|Impaired glucose tolerance|impaired glucose tolerance
5703498|NCT00489229|Arterial stiffness|arterial stiffness
5703499|NCT00489229|Diabetic vasculopathy|diabetic vasculopathy
5703500|NCT00489216|Graft Versus Host Disease|graft versus host disease
5703501|NCT00489216|GVHD|gvhd
5703502|NCT00489216|Efalizumab|efalizumab
5701990|NCT00495079|ALL|all
5703503|NCT00489216|Raptiva|raptiva
5703504|NCT00489216|Steroid|steroid
5703505|NCT00489216|Refractory|refractory
5703506|NCT00489216|Skin|skin
5703507|NCT00489216|Liver|liver
5703508|NCT00489216|Lineberger|lineberger
5703509|NCT00489216|University of North Carolina|university of north carolina
5703510|NCT00489177|cardiac resynchronization therapy|cardiac resynchronization therapy
5703511|NCT00489177|response|response
5703512|NCT00489177|Defibrillators|defibrillators
5703513|NCT00489164|DIABETIC PATIENTS WITH NATIVE CORONARY ARTERY LESIONS|diabetic patients with native coronary artery lesions
5703515|NCT00489125|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5703516|NCT00489125|recurrent breast cancer|recurrent breast cancer
5703517|NCT00489125|stage I breast cancer|stage i breast cancer
5703518|NCT00489125|stage II breast cancer|stage ii breast cancer
5703519|NCT00489125|stage IIIA breast cancer|stage iiia breast cancer
5703520|NCT00489125|stage IIIB breast cancer|stage iiib breast cancer
5703521|NCT00489125|stage IIIC breast cancer|stage iiic breast cancer
5703522|NCT00489125|stage IV breast cancer|stage iv breast cancer
5703523|NCT00489086|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5703524|NCT00489086|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5703525|NCT00489060|Cryoablation|cryoablation
5703526|NCT00489060|Radiation|radiation
5703527|NCT00489060|Prostate Cancer|prostate cancer
5703529|NCT00489034|adolescent females|adolescent females
5703530|NCT00489034|adherence|adherence
5703531|NCT00489034|clinical care|clinical care
5703532|NCT00489034|risk behaviors|risk behaviors
5703533|NCT00489021|Subacute care|subacute care
5703534|NCT00489021|Activities of Daily Living|activities of daily living
5703535|NCT00489021|Cognition assessment|cognition assessment
5703536|NCT00489021|Mood assessment|mood assessment
5703836|NCT00487903|Perfusion|perfusion
5703537|NCT00489021|Incontinence control|incontinence control
5703538|NCT00489008|Lung Cancer|lung cancer
5703539|NCT00489008|Non-Small Cell|non-small cell
5703540|NCT00489008|Stereotactic Body Radiation Therapy|stereotactic body radiation therapy
5703541|NCT00489008|SBRT|sbrt
5703542|NCT00489008|NSCLC|nsclc
5703543|NCT00488995|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5703544|NCT00488982|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5703545|NCT00488969|Morphine|morphine
5703546|NCT00488969|Chronic Pain|chronic pain
5703547|NCT00488969|Spinal Cord Injury|spinal cord injury
5703548|NCT00488969|Neuropathic Pain|neuropathic pain
5703549|NCT00488956|foot|foot
5703550|NCT00488956|ankle|ankle
5703551|NCT00488956|edema|edema
5703552|NCT00488943|Stent-Graft|stent-graft
5703554|NCT00488943|Abdominal Aortic Anuerysm|abdominal aortic anuerysm
5703555|NCT00488943|Zenith|zenith
5703556|NCT00488943|Endovascular|endovascular
5703557|NCT00488943|Treatment with Zenith Aortic Stent-Graft for repair Abdominal Aortic Aneurysm|treatment with zenith aortic stent-graft for repair abdominal aortic aneurysm
5703558|NCT00488930|Obesity|obesity
5703559|NCT00488930|Hyperglycemia|hyperglycemia
5703560|NCT00488930|Diabetes Mellitus Type I|diabetes mellitus type i
5703561|NCT00488930|Diabetes Mellitus Type II|diabetes mellitus type ii
5703562|NCT00488917|Liver cirrhosis|liver cirrhosis
5703563|NCT00488917|acute liver failure|acute liver failure
5703564|NCT00488917|liver transplantation|liver transplantation
5703565|NCT00488917|sepsis, infection|sepsis, infection
5703566|NCT00488917|endothelium|endothelium
5703567|NCT00488917|lipids|lipids
5703568|NCT00488917|diagnosis|diagnosis
5703569|NCT00488917|prognosis|prognosis
5703570|NCT00488904|infection|infection
5703571|NCT00488904|colorectalcancer|colorectalcancer
5703572|NCT00488904|omega-3 fedtsyre|omega-3 fedtsyre
5703573|NCT00488904|complications|complications
5703574|NCT00488891|Schizophrenia|schizophrenia
5703575|NCT00488891|Paliperdone ER|paliperdone er
5703576|NCT00488891|Invega|invega
5703577|NCT00488891|Observational|observational
5703578|NCT00488891|Antipsychotic agents|antipsychotic agents
5703579|NCT00488878|Ovarian Cancer|ovarian cancer
5703580|NCT00488878|Ovarian Carcinoma|ovarian carcinoma
5703581|NCT00488878|Low-Grade Serous Carcinoma|low-grade serous carcinoma
5703582|NCT00488878|Low Malignant Potential|low malignant potential
5703583|NCT00488878|Peritoneum Tumors|peritoneum tumors
5703584|NCT00488878|Psammocarcinoma|psammocarcinoma
5703585|NCT00488878|Data Collection|data collection
5703586|NCT00488878|Research Database|research database
5703587|NCT00488865|increased risk for PE require caval interruption|increased risk for pe require caval interruption
5703588|NCT00488839|Spasticity|spasticity
5703589|NCT00488839|Multiple Sclerosis|multiple sclerosis
5703590|NCT00488826|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5703591|NCT00488813|Tzh-Chi ESBL study|tzh-chi esbl study
5720073|NCT00431366|Fatigue|fatigue
5703592|NCT00488800|Pneumococcal Infections/PC (Prevention & Control)|pneumococcal infections/pc (prevention & control)
5703593|NCT00488787|dental|dental
5703594|NCT00488787|surgery|surgery
5703595|NCT00488787|analgesia|analgesia
5703596|NCT00488787|2-4 impacted third molars|2-4 impacted third molars
5703597|NCT00488774|Colitis, ulcerative|colitis, ulcerative
5703598|NCT00488774|Golimumab|golimumab
5703599|NCT00488774|CNTO 148|cnto 148
5703600|NCT00488761|Tigecycline|tigecycline
5703601|NCT00488761|cSSSI|csssi
5703602|NCT00488761|complicated skin and skin structure infections|complicated skin and skin structure infections
5703604|NCT00488748|Magnetic Seizure Therapy|magnetic seizure therapy
5703605|NCT00488748|ECT|ect
5703606|NCT00488748|Electroconvulsive Therapy|electroconvulsive therapy
5703607|NCT00488748|Depression|depression
5703608|NCT00488748|Magnetic|magnetic
5703609|NCT00488735|Randomized controlled trial|randomized controlled trial
5703610|NCT00488735|Back pain|back pain
5703611|NCT00488735|Neck pain|neck pain
5703612|NCT00488735|Rehabilitation|rehabilitation
5703613|NCT00488735|Cognitive-behavioral|cognitive-behavioral
5703614|NCT00488735|Primary care|primary care
5703615|NCT00488735|Sick-listing|sick-listing
5703616|NCT00488735|Health-care utilization.|health-care utilization.
5703617|NCT00488722|To observe the biological changes under concurrent Zoladex and CEF as neoadjuvant regimen with respect to the ER,PR,cerbB-2 status before and after therapy|to observe the biological changes under concurrent zoladex and cef as neoadjuvant regimen with respect to the er,pr,cerbb-2 status before and after therapy
5703618|NCT00488709|Acute Myeloid Leukemia|acute myeloid leukemia
5703619|NCT00488709|Multi Drug Resistance|multi drug resistance
5703620|NCT00488696|Aneurysm|aneurysm
5703621|NCT00488696|Aortic Arch|aortic arch
5703622|NCT00488696|Endovascular|endovascular
5703623|NCT00488696|Stent-Graft|stent-graft
5703624|NCT00488683|Meningococcal disease|meningococcal disease
5703625|NCT00488683|Prevention|prevention
5703626|NCT00488683|Vaccination|vaccination
5703627|NCT00488670|Alzheimer's disease|alzheimer's disease
5703628|NCT00488670|elderly|elderly
5703629|NCT00488670|open-label|open-label
5703630|NCT00488670|escitalopram|escitalopram
5703631|NCT00488657|speech|speech
5703632|NCT00488657|Parkinson's disease|parkinson's disease
5703633|NCT00488657|treatment|treatment
5703634|NCT00488657|speech intelligibility|speech intelligibility
5703635|NCT00488657|speaking rate|speaking rate
5703636|NCT00488644|Hypothyroidism|hypothyroidism
5703637|NCT00488644|Brain Tumor|brain tumor
5703638|NCT00488644|Levothyroxine|levothyroxine
5703639|NCT00488644|Liothyronine|liothyronine
5703640|NCT00488644|Synthroid|synthroid
5703642|NCT00488631|Colitis, Ulcerative|colitis, ulcerative
5703643|NCT00488631|Golimumab|golimumab
5703644|NCT00488631|CNTO 148|cnto 148
5703645|NCT00488618|Mania|mania
5703646|NCT00488618|Bipolar I Disorder|bipolar i disorder
5703647|NCT00488618|Acute Mania Associated with Bipolar I Disorder|acute mania associated with bipolar i disorder
5703648|NCT00488592|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5703649|NCT00488592|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5703650|NCT00488592|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
5703651|NCT00488592|Wilm's Tumor-1|wilm's tumor-1
5703652|NCT00488592|Proteinase-3|proteinase-3
5703653|NCT00488592|Myelodysplastic Syndrome|myelodysplastic syndrome
5703655|NCT00488592|Acute Myeloid Leukemia|acute myeloid leukemia
5703656|NCT00488592|AML|aml
5703657|NCT00488592|Chronic Myeloid Leukemia|chronic myeloid leukemia
5703658|NCT00488592|CML|cml
5703659|NCT00488579|iron prophylaxis|iron prophylaxis
5703660|NCT00488579|pregnancy|pregnancy
5703661|NCT00488579|birth weight|birth weight
5703662|NCT00488579|prematurity|prematurity
5703663|NCT00488579|perinatal mortality|perinatal mortality
5703664|NCT00488566|bipolar disorder,|bipolar disorder,
5703665|NCT00488566|single doses,|single doses,
5703666|NCT00488566|resting motor threshold|resting motor threshold
5703667|NCT00488566|TMS,|tms,
5703668|NCT00488553|Lymphoma|lymphoma
5703669|NCT00488553|Epidemiology|epidemiology
5703670|NCT00488553|Lifestyle Factors|lifestyle factors
5703671|NCT00488553|Questionnaire|questionnaire
5703672|NCT00488553|Survey|survey
5703673|NCT00488540|newborn|newborn
5703674|NCT00488540|infant|infant
5703675|NCT00488540|pain|pain
5703676|NCT00488540|acetaminophen|acetaminophen
5703677|NCT00488540|paracetamol|paracetamol
5703678|NCT00488540|mode of delivery|mode of delivery
5703679|NCT00488540|vacuum extraction|vacuum extraction
5703680|NCT00488540|forceps extraction|forceps extraction
5703681|NCT00488540|cesarean section|cesarean section
5703682|NCT00488540|EDIN scale|edin scale
5703683|NCT00488540|Bernese Pain Scale for Neonates|bernese pain scale for neonates
5703684|NCT00488540|pain after different modes of delivery in newborn infants|pain after different modes of delivery in newborn infants
5703685|NCT00488540|efficacy of acetaminophen as analgesia for newborn infants|efficacy of acetaminophen as analgesia for newborn infants
5703686|NCT00488514|Long-term Safety|long-term safety
5703687|NCT00488514|Migraine|migraine
5703688|NCT00488514|Adolescent Migraine Headache|adolescent migraine headache
5703689|NCT00488514|sumatriptan succinate|sumatriptan succinate
5703690|NCT00488514|naproxen sodium|naproxen sodium
5703691|NCT00488501|intrathoracic impedance|intrathoracic impedance
5703692|NCT00488501|cardiac resynchronization therapy|cardiac resynchronization therapy
5703693|NCT00488501|heart failure|heart failure
5703694|NCT00488462|obstetric hemorrhage|obstetric hemorrhage
5703695|NCT00488462|hypovolemic shock|hypovolemic shock
5703696|NCT00488462|non-pneumatic anti-shock garment|non-pneumatic anti-shock garment
5702285|NCT00493987|Men|men
5703697|NCT00488462|safe motherhood|safe motherhood
5703698|NCT00488462|maternal mortality|maternal mortality
5703699|NCT00488462|maternal morbidity|maternal morbidity
5703700|NCT00488449|Dose Escalation|dose escalation
5703701|NCT00488449|GSK256073A,|gsk256073a,
5703702|NCT00488436|Myelodysplastic Syndrome|myelodysplastic syndrome
5703703|NCT00488436|Antithymocyte Globulin|antithymocyte globulin
5703704|NCT00488436|Cyclosporine|cyclosporine
5703705|NCT00488423|diabetes|diabetes
5703706|NCT00488423|MIDAS|midas
5703707|NCT00488423|gut hormones|gut hormones
5703708|NCT00488423|gastric bypass|gastric bypass
5703709|NCT00488423|lap band|lap band
5703710|NCT00488410|Chronic heart failure|chronic heart failure
5703711|NCT00488410|real time three-dimensional echocardiography|real time three-dimensional echocardiography
5703712|NCT00488410|cardiac resynchronization therapy|cardiac resynchronization therapy
5703713|NCT00488410|ventricular asynchrony|ventricular asynchrony
5703714|NCT00488410|systolic dysynchrony index|systolic dysynchrony index
5703715|NCT00488397|Tygacil|tygacil
5703716|NCT00488397|microdilution method|microdilution method
5703717|NCT00488397|Tigecycline|tigecycline
5703718|NCT00488397|In-Vitro|in-vitro
5703719|NCT00488384|Squamous cell carcinoma of the skin under hemodialysis|squamous cell carcinoma of the skin under hemodialysis
5703720|NCT00488371|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
5703721|NCT00488358|abdominal|abdominal
5703722|NCT00488358|aortic|aortic
5703723|NCT00488358|aneurysm|aneurysm
5703724|NCT00488358|Zenith|zenith
5703725|NCT00488358|blood pressure|blood pressure
5703726|NCT00488345|cIAI|ciai
5703727|NCT00488345|cSSSI|csssi
5703728|NCT00488345|CAP|cap
5703729|NCT00488345|Child|child
5703730|NCT00488332|Head and Neck Cancer|head and neck cancer
5703731|NCT00488332|Oral Mucositis|oral mucositis
5703732|NCT00488332|Optical Coherence Tomography|optical coherence tomography
5703733|NCT00488332|Fluorescence Spectroscopy|fluorescence spectroscopy
5703734|NCT00488332|Optical Assessment|optical assessment
5703735|NCT00488319|Schizophrenia|schizophrenia
5703736|NCT00488319|Adolescent|adolescent
5703737|NCT00488319|Paliperidone|paliperidone
5703738|NCT00488319|Antipsychotic agents|antipsychotic agents
5703739|NCT00488319|Antipsychotic drugs|antipsychotic drugs
5703742|NCT00488306|Complicated intra-abdominal infections|complicated intra-abdominal infections
5703744|NCT00488293|Telemedicine|telemedicine
5703745|NCT00488293|Skin diseases|skin diseases
5703746|NCT00488293|Dermatology|dermatology
5703747|NCT00488293|Quality of life|quality of life
5703748|NCT00488293|Economics|economics
5703749|NCT00488280|walking|walking
5703750|NCT00488280|walking recovery|walking recovery
5703751|NCT00488280|physical therapy|physical therapy
5703752|NCT00488280|locomotor training|locomotor training
5703753|NCT00488280|body weight support|body weight support
5703754|NCT00488280|neuroplasticity|neuroplasticity
5703755|NCT00488280|step|step
5703756|NCT00488280|treadmill|treadmill
5703757|NCT00488280|treadmill training|treadmill training
5703758|NCT00488280|locomotion|locomotion
5703759|NCT00488267|Osteoarthritis|osteoarthritis
5703760|NCT00488267|Pain|pain
5703761|NCT00488254|Long QT Syndrome|long qt syndrome
5703763|NCT00488254|Jervell-Lange Nielson Syndrome|jervell-lange nielson syndrome
5703764|NCT00488241|Eczema|eczema
5703765|NCT00488241|Medical device|medical device
5703766|NCT00488215|constipation|constipation
5703767|NCT00488215|prucalopride|prucalopride
5703769|NCT00488215|cardiovascular safety|cardiovascular safety
5703770|NCT00488202|Advanced Ovarian Cancer|advanced ovarian cancer
5703771|NCT00488202|Sexual Function|sexual function
5703772|NCT00488176|seasonal allergic rhinitis|seasonal allergic rhinitis
5703773|NCT00488176|children|children
5703774|NCT00488176|montelukast|montelukast
5703775|NCT00488176|cetirizine|cetirizine
5703776|NCT00488163|schizophrenia|schizophrenia
5703777|NCT00488163|cognition|cognition
5703778|NCT00488163|atomoxetine|atomoxetine
5703779|NCT00488163|norepinephrine|norepinephrine
5703780|NCT00488163|dopamine|dopamine
5703781|NCT00488137|constipation|constipation
5703782|NCT00488137|prucalopride|prucalopride
5703783|NCT00488137|QOL|qol
5703784|NCT00488137|SCBM|scbm
5703786|NCT00488124|short stature|short stature
5703787|NCT00488111|Regional anesthesia|regional anesthesia
5703788|NCT00488111|Fluid Therapy|fluid therapy
5703789|NCT00488111|Hemostasis, Surgical|hemostasis, surgical
5703790|NCT00488098|Healthy Bioequivalence|healthy bioequivalence
5703791|NCT00488085|Crohn’s disease, obesity, REE, body composition, fat absorption|crohn’s disease, obesity, ree, body composition, fat absorption
5703792|NCT00488072|Advanced Cancer|advanced cancer
5703793|NCT00488072|Anorexia|anorexia
5703794|NCT00488072|Weight Loss|weight loss
5703795|NCT00488072|Insomnia|insomnia
5703796|NCT00488072|Appetite|appetite
5703797|NCT00488072|Mirtazapine|mirtazapine
5703798|NCT00488072|Placebo|placebo
5703799|NCT00488059|Treatment Experienced|treatment experienced
5703800|NCT00488046|Bird Flu|bird flu
5703801|NCT00488033|Coronary Artery Disease|coronary artery disease
5703802|NCT00488033|Diabetes|diabetes
5703803|NCT00488033|CT Angiography|ct angiography
5703804|NCT00488020|rest pain|rest pain
5703805|NCT00488020|ischemic ulcers|ischemic ulcers
5703806|NCT00488007|Alzheimer disease|alzheimer disease
5703807|NCT00488007|Cognitive impairment|cognitive impairment
5703808|NCT00488007|Sensorineural hearing loss|sensorineural hearing loss
5703809|NCT00488007|Hearing aids|hearing aids
5703810|NCT00487994|Hypercholesterolemia|hypercholesterolemia
5703811|NCT00487994|Hyperlipidemia|hyperlipidemia
5703812|NCT00487994|Drug Therapy|drug therapy
5703813|NCT00487981|Pain|pain
5703814|NCT00487981|Implantable stimulation device|implantable stimulation device
5703815|NCT00487981|Neuropathy|neuropathy
5703816|NCT00487968|healthy adult volunteers|healthy adult volunteers
5703817|NCT00487968|eltrombopag|eltrombopag
5703818|NCT00487955|gastritis|gastritis
5703819|NCT00487955|helicobacter pylori|helicobacter pylori
5703820|NCT00487955|REE|ree
5703821|NCT00487955|patients with gastritis that refers to helicobacter pylori treatment|patients with gastritis that refers to helicobacter pylori treatment
5703822|NCT00487929|sleep apnea|sleep apnea
5703823|NCT00487929|morbidity|morbidity
5703824|NCT00487929|cardiovascular|cardiovascular
5703825|NCT00487929|cpap|cpap
5703826|NCT00487929|oxidative stress|oxidative stress
5703827|NCT00487916|Blood Stage|blood stage
5703828|NCT00487916|Investigational|investigational
5703829|NCT00487916|Vaccine|vaccine
5703830|NCT00487916|Malaria|malaria
5703831|NCT00487916|Healthy Volunteer|healthy volunteer
5703832|NCT00487916|HV|hv
5703833|NCT00487903|Coronary Artery Disease|coronary artery disease
5703834|NCT00487903|Echocardiogram|echocardiogram
5703835|NCT00487903|Contrast|contrast
5703837|NCT00487903|Ultrasound|ultrasound
5703838|NCT00487903|Normal volunteers|normal volunteers
5703839|NCT00487890|Geriatric|geriatric
5703840|NCT00487890|Abdominal|abdominal
5703841|NCT00487890|Surgery|surgery
5703842|NCT00487890|gastrointestinal surgery|gastrointestinal surgery
5703843|NCT00487890|intrabdominal surgery|intrabdominal surgery
5703844|NCT00487877|metabolism, temperature changing, skin, heart rate|metabolism, temperature changing, skin, heart rate
5703845|NCT00487851|Pancreatic|pancreatic
5703846|NCT00487851|cancer|cancer
5703847|NCT00487851|Periampullay|periampullay
5703853|NCT00487851|pancreas cancer|pancreas cancer
5703854|NCT00487851|Pancreatic cancer|pancreatic cancer
5703855|NCT00487838|Autofluorescence Imaging|autofluorescence imaging
5703856|NCT00487838|Early Age-Related Maculopathy|early age-related maculopathy
5703857|NCT00487838|Photochemical Changes|photochemical changes
5703858|NCT00487838|Colored Sunglasses|colored sunglasses
5703859|NCT00487838|Pseudophakes|pseudophakes
5703860|NCT00487838|Fundus Camera|fundus camera
5703861|NCT00487838|Confocal Scanning Laser Ophthalmoscope|confocal scanning laser ophthalmoscope
5703862|NCT00487838|Molecular Imaging within Retina|molecular imaging within retina
5703863|NCT00487838|Spectral Balance among Photochemical Processes|spectral balance among photochemical processes
5703864|NCT00487838|Noninvasive Autofluorescence Imaging|noninvasive autofluorescence imaging
5703865|NCT00487838|Age-Related Maculopathy (AMD)|age-related maculopathy (amd)
5703866|NCT00487838|Age-Related Macular Degeneration|age-related macular degeneration
5703867|NCT00487838|AMD|amd
5703868|NCT00487838|Age-Related Macular Changes|age-related macular changes
5703869|NCT00487838|Early Age-Related Macular Changes|early age-related macular changes
5703870|NCT00487825|ACR20, ACR50, ACZ885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate|acr20, acr50, acz885 (anti-interleukin-1beta monoclonal antibody), rheumatoid arthritis, methotrexate
5703871|NCT00487812|Acute myocardial infarction|acute myocardial infarction
5703872|NCT00487812|left ventricular remodelling|left ventricular remodelling
5703873|NCT00487812|SPECT imaging|spect imaging
5703874|NCT00487799|Acute Decompensated Heart Failure|acute decompensated heart failure
5703875|NCT00487799|ADHF|adhf
5703876|NCT00487799|Heart Failure|heart failure
5703877|NCT00487786|Antisense|antisense
5703878|NCT00487786|Heat Shock Protein|heat shock protein
5703879|NCT00487773|asthma|asthma
5703880|NCT00487773|children|children
5703881|NCT00487773|inhaled glucocorticosteroids|inhaled glucocorticosteroids
5703882|NCT00487773|bone metabolism|bone metabolism
5703883|NCT00487760|Lung Cancer|lung cancer
5703884|NCT00487760|African-American Families|african-american families
5703885|NCT00487760|Genetic Risk Communication|genetic risk communication
5703886|NCT00487760|Interest in Genetic Testing and Genetics Research|interest in genetic testing and genetics research
5703887|NCT00487760|Health Disparities|health disparities
5703888|NCT00487760|Smoking Cessation|smoking cessation
5703889|NCT00487734|Metabolic Syndrome|metabolic syndrome
5703890|NCT00487734|Hypogonadism|hypogonadism
5703891|NCT00487734|Insulin Resistance|insulin resistance
5703892|NCT00487721|Prostate cancer|prostate cancer
5703893|NCT00487708|ACZ885|acz885
5703894|NCT00487708|NALP3 mutations|nalp3 mutations
5703895|NCT00487708|Interleukin-1beta|interleukin-1beta
5703896|NCT00487708|Muckle-Wells Syndrome|muckle-wells syndrome
5703897|NCT00487695|Barrett's esophagus|barrett's esophagus
5703898|NCT00487695|Esophageal adenocarcinoma|esophageal adenocarcinoma
5703899|NCT00487695|Endoscopy|endoscopy
5703900|NCT00487695|Confocal laser endomicroscopy|confocal laser endomicroscopy
5703901|NCT00487682|Valacyclovir hydrochloride|valacyclovir hydrochloride
5703902|NCT00487682|herpes zoster|herpes zoster
5703903|NCT00487682|ASP2151|asp2151
5703904|NCT00487669|paclitaxel poliglumex|paclitaxel poliglumex
5703905|NCT00487669|xyotax|xyotax
5703906|NCT00487669|alimta|alimta
5703907|NCT00487669|advanced non-small cell lung cancer|advanced non-small cell lung cancer
5703908|NCT00487643|Lacritin|lacritin
5703909|NCT00487630|Heterozygous females|heterozygous females
5703910|NCT00487630|Cardiomyopathy|cardiomyopathy
5703911|NCT00487617|Arteriopathy|arteriopathy
5703912|NCT00487617|endothelial function|endothelial function
5703913|NCT00487617|fruit juice|fruit juice
5703914|NCT00487604|Coronary Artery Disease|coronary artery disease
5703915|NCT00487604|Drug Eluting Stent|drug eluting stent
5703916|NCT00487604|Bare Metal Stent|bare metal stent
5703917|NCT00487604|Subacute thrombosis|subacute thrombosis
5703918|NCT00487604|Bleeding|bleeding
5703919|NCT00487604|Economic|economic
5703920|NCT00487591|cholesterol|cholesterol
5703921|NCT00487591|dyslipidemia|dyslipidemia
5703922|NCT00487591|omega 3|omega 3
5703923|NCT00487578|Post traumatic headache|post traumatic headache
5703924|NCT00487578|Head trauma|head trauma
5703925|NCT00487578|Head injury|head injury
5703926|NCT00487578|Headache|headache
5703927|NCT00487578|Naratriptan|naratriptan
5703928|NCT00487565|Total knee replacement|total knee replacement
5703929|NCT00487565|Total knee arthroplasty|total knee arthroplasty
5703930|NCT00487565|Osteoarthritis|osteoarthritis
5703931|NCT00487565|Rheumatoid or other inflammatory arthritis|rheumatoid or other inflammatory arthritis
5703932|NCT00487565|Post-traumatic or juvenile arthritis|post-traumatic or juvenile arthritis
5703933|NCT00487552|endoscopy|endoscopy
5703934|NCT00487552|esophagogastroduodenoscopy|esophagogastroduodenoscopy
5703935|NCT00487552|gastric outlet obstruction|gastric outlet obstruction
5703936|NCT00487552|gastro-jejunostomy|gastro-jejunostomy
5703937|NCT00487552|gastric malignancy|gastric malignancy
5703938|NCT00487552|duodenal stent|duodenal stent
5703939|NCT00487552|Malignant Gastric Outlet Obstruction|malignant gastric outlet obstruction
5703940|NCT00487539|Colitis, Ulcerative|colitis, ulcerative
5703941|NCT00487539|Golimumab|golimumab
5703942|NCT00487539|CNTO 148|cnto 148
5703943|NCT00487526|Bypass|bypass
5703944|NCT00487526|Duodenal jejunal|duodenal jejunal
5703945|NCT00487526|type 2 diabetes|type 2 diabetes
5703946|NCT00487526|non-obese adults|non-obese adults
5703947|NCT00487513|Follicular B Cell lymphoma|follicular b cell lymphoma
5703948|NCT00487513|vaccination|vaccination
5703949|NCT00487500|Major Depressive Disorder|major depressive disorder
5703950|NCT00487500|Electroconvulsive Therapy|electroconvulsive therapy
5703951|NCT00487487|Candidates for this study are survivors of paralytic poliomyelitis|candidates for this study are survivors of paralytic poliomyelitis
5703952|NCT00487461|SAH|sah
5703953|NCT00487461|Vasospasm|vasospasm
5703954|NCT00487448|Myelodysplastic Syndrome|myelodysplastic syndrome
5703955|NCT00487448|Chemotherapy|chemotherapy
5703956|NCT00487448|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
5703957|NCT00487448|Bone marrow transplantation|bone marrow transplantation
5703958|NCT00487448|Secondary Acute Myeloblastic Leukemia|secondary acute myeloblastic leukemia
5703959|NCT00487435|CG5503|cg5503
5703960|NCT00487435|Tapentadol|tapentadol
5703961|NCT00487435|chronic non-malignant pain|chronic non-malignant pain
5703962|NCT00487435|osteoarthritis|osteoarthritis
5703963|NCT00487435|lower back pain|lower back pain
5703964|NCT00487435|analgesic|analgesic
5703965|NCT00487435|opioid|opioid
5703966|NCT00487422|constipation|constipation
5703967|NCT00487422|prucalopride|prucalopride
5703969|NCT00487422|SCBM|scbm
5703970|NCT00487422|PAC-SYM|pac-sym
5703971|NCT00487409|Ulcerative colitis|ulcerative colitis
5703972|NCT00487409|Crohn's disease|crohn's disease
5703973|NCT00487409|Colorectal polyps|colorectal polyps
5703974|NCT00487409|Colorectal malignancy|colorectal malignancy
5703975|NCT00487409|Endometriosis|endometriosis
5703976|NCT00487409|Diverticulitis|diverticulitis
5703977|NCT00487409|Colonic inertia|colonic inertia
5703978|NCT00487396|capsule endoscopy|capsule endoscopy
5703979|NCT00487396|Crohn's disease|crohn's disease
5703980|NCT00487396|small bowel disease|small bowel disease
5703981|NCT00487396|inflammatory bowel disease|inflammatory bowel disease
5703982|NCT00487396|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
5703984|NCT00487383|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5703985|NCT00487383|Blepharospasm|blepharospasm
5703986|NCT00487383|DYT-1 Generalized Dystonia|dyt-1 generalized dystonia
5703987|NCT00487383|Focal Dystonia|focal dystonia
5703988|NCT00487383|Dystonia|dystonia
5703989|NCT00487383|Healthy Volunteer|healthy volunteer
5703990|NCT00487383|HV|hv
5703991|NCT00487370|Acupuncture|acupuncture
5703992|NCT00487370|Gold implantation|gold implantation
5703993|NCT00487370|Osteoarthritis|osteoarthritis
5703994|NCT00487370|Knee osteoarthritis|knee osteoarthritis
5703995|NCT00487370|Double-blind, randomized controlled trial|double-blind, randomized controlled trial
5703996|NCT00487370|Intervention|intervention
5703997|NCT00487370|Family practice|family practice
5703998|NCT00487357|Epidemiology|epidemiology
5703999|NCT00487357|Cancer Prevention|cancer prevention
5704000|NCT00487357|Questionnaire|questionnaire
5702523|NCT00493051|diabetes|diabetes
5704001|NCT00487357|MATCh|match
5704002|NCT00487357|Survey|survey
5704003|NCT00487344|medicaid|medicaid
5704004|NCT00487344|insurance|insurance
5704005|NCT00487344|education|education
5704006|NCT00487344|clinical|clinical
5704007|NCT00487344|trial|trial
5704008|NCT00487344|healthcare|healthcare
5704009|NCT00487344|reimburse|reimburse
5704010|NCT00487344|pay|pay
5704011|NCT00487344|free|free
5704012|NCT00487344|assist|assist
5704013|NCT00487344|study|study
5704014|NCT00487344|oklahoma|oklahoma
5704015|NCT00487344|edmond|edmond
5704016|NCT00487344|Oklahoma City|oklahoma city
5704017|NCT00487344|diet|diet
5704018|NCT00487344|nutrition|nutrition
5704019|NCT00487344|weight loss|weight loss
5704020|NCT00487344|body|body
5704021|NCT00487344|fat|fat
5704022|NCT00487344|obese|obese
5704023|NCT00487344|overweight|overweight
5704024|NCT00487344|health|health
5704025|NCT00487344|medical|medical
5704026|NCT00487344|therapy|therapy
5704027|NCT00487344|meal plan|meal plan
5704028|NCT00487344|jenny craig|jenny craig
5704029|NCT00487344|weight watcher|weight watcher
5704030|NCT00487344|LA Weightloss|la weightloss
5704031|NCT00487344|Bryan Attebery|bryan attebery
5704032|NCT00487344|Results|results
5704033|NCT00487344|YMCA|ymca
5704034|NCT00487344|UCO|uco
5704036|NCT00487344|OU|ou
5704037|NCT00487344|clinics|clinics
5704038|NCT00487344|physicians|physicians
5704039|NCT00487344|surgery|surgery
5704040|NCT00487344|pills|pills
5704041|NCT00487344|financial|financial
5704042|NCT00487344|money|money
5704043|NCT00487331|Solid Tumors|solid tumors
5704044|NCT00487331|Acupuncture|acupuncture
5704045|NCT00487331|Uncontrolled Pain|uncontrolled pain
5704046|NCT00487331|Pain|pain
5704047|NCT00487318|fluvastatin|fluvastatin
5704048|NCT00487318|hepatitis C|hepatitis c
5704049|NCT00487318|chronic hepatitis C|chronic hepatitis c
5704050|NCT00487318|not previously treated with pegylated interferon and ribavirin|not previously treated with pegylated interferon and ribavirin
5704051|NCT00487305|GM-CSF|gm-csf
5680553|NCT00577525|GENOME HYBRIDIZATION|genome hybridization
5680554|NCT00577525|HERPES VIRUS|herpes virus
5680556|NCT00577499|cystic fibrosis|cystic fibrosis
5680557|NCT00577499|constipation|constipation
5680558|NCT00577499|lubiprostone|lubiprostone
5680559|NCT00577499|nutrition|nutrition
5680560|NCT00577499|pulmonary function|pulmonary function
5704052|NCT00487305|vaccine|vaccine
5704058|NCT00487292|bright light pulses|bright light pulses
5704059|NCT00487292|sleep|sleep
5704060|NCT00487279|Coronary|coronary
5704061|NCT00487279|Artery|artery
5704062|NCT00487279|Disease|disease
5704063|NCT00487279|Sudden|sudden
5704064|NCT00487279|Cardiac|cardiac
5704065|NCT00487279|Death|death
5704066|NCT00487279|ICD|icd
5704067|NCT00487266|Acupuncture|acupuncture
5704068|NCT00487266|Torque|torque
5704069|NCT00487266|Force Decay|force decay
5704070|NCT00487253|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5704071|NCT00487253|Leishmania Viannia|leishmania viannia
5704072|NCT00487253|Pediatric|pediatric
5704073|NCT00487253|Miltefosine|miltefosine
5704074|NCT00487253|Randomized|randomized
5704075|NCT00487253|Colombia|colombia
5704076|NCT00487240|diabetes|diabetes
5704077|NCT00487240|type 1|type 1
5704078|NCT00487227|caffeine|caffeine
5704079|NCT00487227|coffee|coffee
5704080|NCT00487227|decaffeinated|decaffeinated
5704081|NCT00487227|cognition|cognition
5704082|NCT00487227|mood|mood
5704083|NCT00487227|autonomic|autonomic
5704084|NCT00487201|liver transplantation|liver transplantation
5704085|NCT00487201|biliary strictures|biliary strictures
5704086|NCT00487201|ERCP|ercp
5704087|NCT00487175|Pain|pain
5704088|NCT00487175|sensitization|sensitization
5704089|NCT00487175|analgesia|analgesia
5704090|NCT00487175|Healthy volunteers and pain|healthy volunteers and pain
5704091|NCT00487162|glycemic control, diabetes, obesity, comorbidities|glycemic control, diabetes, obesity, comorbidities
5704092|NCT00487149|Repeatability|repeatability
5704094|NCT00487136|Drug Interaction|drug interaction
5704095|NCT00487136|Pharmacokinetics|pharmacokinetics
5704096|NCT00487136|Pharmacodynamics|pharmacodynamics
5704097|NCT00487123|Hypertension, compliance, Valsartan, hydrochlorothiazide (HCTZ)|hypertension, compliance, valsartan, hydrochlorothiazide (hctz)
5704098|NCT00487110|Pain|pain
5704099|NCT00487110|serotonin|serotonin
5704100|NCT00487110|interaction|interaction
5704101|NCT00487110|Patients with postsurgical pain, after ear surgery|patients with postsurgical pain, after ear surgery
5704102|NCT00487097|intensive care|intensive care
5704103|NCT00487097|critically ill|critically ill
5704104|NCT00487097|fish oil|fish oil
5704105|NCT00487097|pressure sores|pressure sores
5704106|NCT00487084|analgesia|analgesia
5704107|NCT00487084|tubal ligation|tubal ligation
5704108|NCT00487084|chloroprocaine|chloroprocaine
5704109|NCT00487071|Anal fistula|anal fistula
5704110|NCT00487071|High-type|high-type
5704111|NCT00487071|Anal fistula plug|anal fistula plug
5685780|NCT00554892|Anastomotic leakage|anastomotic leakage
5702625|NCT00492674|TKA|tka
5704112|NCT00487071|Efficacy|efficacy
5704113|NCT00487071|Recurrence|recurrence
5704114|NCT00487058|Gimatecan|gimatecan
5704115|NCT00487058|topoisomerase I inhibitor|topoisomerase i inhibitor
5704116|NCT00487058|advanced solid tumors|advanced solid tumors
5704117|NCT00487045|Hemorrhoids|hemorrhoids
5704118|NCT00487045|Thrombosed External Hemorrhoids (TEH)|thrombosed external hemorrhoids (teh)
5704119|NCT00487045|Reduction|reduction
5704120|NCT00487045|Prevention|prevention
5704121|NCT00487045|Stabilizer Device|stabilizer device
5704122|NCT00487045|Pregnant|pregnant
5704123|NCT00487045|Vaginal Birth|vaginal birth
5704124|NCT00487045|Single Birth|single birth
5704125|NCT00487045|Asymptomatic Hemorrhoids|asymptomatic hemorrhoids
5704126|NCT00487032|allergic rhinitis|allergic rhinitis
5704127|NCT00487032|rhinitis medicamentosa|rhinitis medicamentosa
5704128|NCT00487032|imidazolines|imidazolines
5704129|NCT00487032|corticosteroid|corticosteroid
5704130|NCT00487019|ampicillin|ampicillin
5704131|NCT00487019|penicillin G|penicillin g
5704132|NCT00487019|gentamicin|gentamicin
5704133|NCT00487019|neonatal sepsis|neonatal sepsis
5704134|NCT00487019|empiric therapy|empiric therapy
5704136|NCT00486993|Exercise|exercise
5704137|NCT00486993|Smoking|smoking
5704138|NCT00486993|Stress|stress
5704139|NCT00486993|Polyphenols|polyphenols
5704140|NCT00486980|influenza|influenza
5704141|NCT00486967|Insulin resistance, heart failure, congestive heart failure,|insulin resistance, heart failure, congestive heart failure,
5704233|NCT00486551|Randomized trial|randomized trial
5704146|NCT00486954|Gastric cancer|gastric cancer
5704147|NCT00486954|Advanced gastric cancer|advanced gastric cancer
5704148|NCT00486941|Primary Prevention|primary prevention
5704149|NCT00486941|Health Promotion|health promotion
5704150|NCT00486941|Diet|diet
5704151|NCT00486941|Exercise|exercise
5704152|NCT00486941|Risk Factors|risk factors
5704153|NCT00486941|Randomized Controlled Trial|randomized controlled trial
5704154|NCT00486928|Valves, heart disease, prosthesis.|valves, heart disease, prosthesis.
5704155|NCT00486915|Atrial Fibrillation|atrial fibrillation
5704156|NCT00486915|Left Atrial Appendage|left atrial appendage
5704157|NCT00486915|Surgical Ligation|surgical ligation
5704158|NCT00486915|Thromboembolism|thromboembolism
5704159|NCT00486915|Cerebrovascular Accident|cerebrovascular accident
5704160|NCT00486902|Ketamine|ketamine
5704161|NCT00486902|Spinal Anesthesia|spinal anesthesia
5704162|NCT00486902|C-section|c-section
5704164|NCT00486876|Irritable bowel syndrome|irritable bowel syndrome
5704354|NCT00486057|Rejection|rejection
5704165|NCT00486876|Diarrhea predominant Irritable Bowel Syndrome|diarrhea predominant irritable bowel syndrome
5704166|NCT00486876|Alternating Irritable Bowel Syndrome|alternating irritable bowel syndrome
5704167|NCT00486863|Philippines, Schistosoma japonicum, Schistosomiasis, pregnant women, fetuses, 08-0049|philippines, schistosoma japonicum, schistosomiasis, pregnant women, fetuses, 08-0049
5704168|NCT00486850|RDS|rds
5704169|NCT00486850|Preterm|preterm
5704170|NCT00486850|SIMV|simv
5704171|NCT00486850|NIPPV|nippv
5704172|NCT00486811|Osteoarthritis|osteoarthritis
5704173|NCT00486811|Knee|knee
5704174|NCT00486811|Pain Assessment|pain assessment
5704175|NCT00486811|CG5503 PR|cg5503 pr
5704176|NCT00486811|Centrally acting analgesic|centrally acting analgesic
5704177|NCT00486811|Placebo|placebo
5704178|NCT00486811|Oxycodone|oxycodone
5704179|NCT00486811|Chronic Pain due to knee Osteoarthritis|chronic pain due to knee osteoarthritis
5704180|NCT00486811|Tapentadol|tapentadol
5704181|NCT00486798|acute schizophrenia|acute schizophrenia
5704182|NCT00486798|schizoaffective disorder|schizoaffective disorder
5704183|NCT00486798|psychosis Not Otherwise Specified (NOS)|psychosis not otherwise specified (nos)
5704184|NCT00486798|bipolar mania with psychotic symptoms|bipolar mania with psychotic symptoms
5704185|NCT00486772|This study was designed to investigate whether the suggested beneficial effects of sevelamer on VC were related to fetuin-A levels in patients with CKD.|this study was designed to investigate whether the suggested beneficial effects of sevelamer on vc were related to fetuin-a levels in patients with ckd.
5704189|NCT00486733|extracorporeal shock wave therapy|extracorporeal shock wave therapy
5704190|NCT00486733|soft tissue wounds|soft tissue wounds
5704191|NCT00486707|Ovarian Cancer|ovarian cancer
5704192|NCT00486707|Questionnaire|questionnaire
5704193|NCT00486707|Genetic Testing|genetic testing
5704194|NCT00486707|Survey|survey
5704195|NCT00486694|Malaria, vivax|malaria, vivax
5704196|NCT00486694|Afghanistan|afghanistan
5704197|NCT00486694|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5704198|NCT00486694|drug resistance|drug resistance
5704199|NCT00486681|Glucose monitoring|glucose monitoring
5704200|NCT00486681|Diabetes management|diabetes management
5704201|NCT00486681|Information system|information system
5704202|NCT00486681|In-patient glycemic control|in-patient glycemic control
5704203|NCT00486668|HER2 positive breast cancer|her2 positive breast cancer
5704204|NCT00486668|invasive breast cancer|invasive breast cancer
5704205|NCT00486668|lapatinib|lapatinib
5704206|NCT00486668|neoadjuvant|neoadjuvant
5704207|NCT00486668|NSABP|nsabp
5704208|NCT00486668|paclitaxel|paclitaxel
5704210|NCT00486668|doxorubicin|doxorubicin
5704211|NCT00486668|cyclophosphamide|cyclophosphamide
5704212|NCT00486655|Cholecystectomy|cholecystectomy
5704213|NCT00486655|NOTES|notes
5704214|NCT00486655|Transgastric|transgastric
5704215|NCT00486629|Exercise|exercise
5704216|NCT00486629|Diet|diet
5704217|NCT00486629|Pregnancy|pregnancy
5704218|NCT00486629|Obesity|obesity
5704219|NCT00486629|Macrosomia|macrosomia
5704220|NCT00486603|adult glioblastoma|adult glioblastoma
5704221|NCT00486603|adult gliosarcoma|adult gliosarcoma
5704222|NCT00486603|adult giant cell glioblastoma|adult giant cell glioblastoma
5704223|NCT00486590|Human milk fortification|human milk fortification
5704224|NCT00486590|Premature neonate|premature neonate
5704225|NCT00486590|Very low birth weight|very low birth weight
5704226|NCT00486577|Hearing Disorders, Hearing Loss, Hyperacusis, Tinnitus, chronic cortical stimulation, functional magnetic resonance imaging|hearing disorders, hearing loss, hyperacusis, tinnitus, chronic cortical stimulation, functional magnetic resonance imaging
5704227|NCT00486564|Treatment|treatment
5704228|NCT00486564|Refractory or Relapsed|refractory or relapsed
5704229|NCT00486551|Anger control training|anger control training
5704230|NCT00486551|Cognitive behavioral therapy|cognitive behavioral therapy
5704231|NCT00486551|Behavior therapy|behavior therapy
5704232|NCT00486551|Tourette Syndrome|tourette syndrome
5704234|NCT00486551|Anger|anger
5704235|NCT00486551|Aggression|aggression
5704236|NCT00486525|fatigue|fatigue
5704237|NCT00486525|depression|depression
5704238|NCT00486525|pain|pain
5704239|NCT00486525|cancer survivor|cancer survivor
5704240|NCT00486525|stage IA breast cancer|stage ia breast cancer
5704241|NCT00486525|stage IB breast cancer|stage ib breast cancer
5704242|NCT00486525|stage II breast cancer|stage ii breast cancer
5704243|NCT00486525|stage IIIA breast cancer|stage iiia breast cancer
5704244|NCT00486525|breast cancer in situ|breast cancer in situ
5704245|NCT00486512|colorectal, adenomas, prevention|colorectal, adenomas, prevention
5704246|NCT00486499|radiation|radiation
5704247|NCT00486499|brachytherapy|brachytherapy
5704248|NCT00486499|prostate|prostate
5704249|NCT00486499|cancer|cancer
5704250|NCT00486486|24-hour IOP control|24-hour iop control
5704251|NCT00486460|Locally advanced or metastatic adenocarcinoma of the|locally advanced or metastatic adenocarcinoma of the
5704252|NCT00486460|pancreas|pancreas
5704253|NCT00486460|confirmed by histology or cytology|confirmed by histology or cytology
5704254|NCT00486460|Inoperatable|inoperatable
5704255|NCT00486434|Osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability|osteoarthritis, oral salmon calcitonin, treatment, efficacy, tolerability
5704256|NCT00486421|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5704257|NCT00486408|HIV Seronegativity|hiv seronegativity
5704258|NCT00486408|HIV Preventive Vaccine|hiv preventive vaccine
5704259|NCT00486408|Adenovirus|adenovirus
5704260|NCT00486395|prematurity|prematurity
5704261|NCT00486395|randomized trial|randomized trial
5704263|NCT00486395|surfactant|surfactant
5704264|NCT00486395|CPAP|cpap
5704265|NCT00486395|ventilation|ventilation
5704266|NCT00486382|visceral leishmaniasis|visceral leishmaniasis
5704267|NCT00486382|vaccine|vaccine
5704268|NCT00486369|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
5704269|NCT00486356|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5704270|NCT00486356|recurrent gastric cancer|recurrent gastric cancer
5704271|NCT00486356|stage IV gastric cancer|stage iv gastric cancer
5704272|NCT00486356|advanced adult primary liver cancer|advanced adult primary liver cancer
5704273|NCT00486356|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5704274|NCT00486356|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5704275|NCT00486356|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5704276|NCT00486356|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5704277|NCT00486356|recurrent gallbladder cancer|recurrent gallbladder cancer
5704278|NCT00486356|unresectable gallbladder cancer|unresectable gallbladder cancer
5704279|NCT00486343|Asthma|asthma
5704280|NCT00486343|ICS|ics
5704281|NCT00486343|5-LO Inhibition|5-lo inhibition
5704282|NCT00486343|Leukotrienes|leukotrienes
5704283|NCT00486343|Asthma control|asthma control
5704284|NCT00486343|Asthma exacerbations|asthma exacerbations
5704287|NCT00486330|Buprenorphine|buprenorphine
5704288|NCT00486330|Tipranavir|tipranavir
5704289|NCT00486330|HIV Seronegativity|hiv seronegativity
5704290|NCT00486317|Osteoarthritis, oral salmon calcitonin, tolerability, biomarkers|osteoarthritis, oral salmon calcitonin, tolerability, biomarkers
5704291|NCT00486304|cachexia|cachexia
5704292|NCT00486304|weight changes|weight changes
5704293|NCT00486304|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5704294|NCT00486304|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5704295|NCT00486304|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5704296|NCT00486304|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5704297|NCT00486304|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5720736|NCT00429013|Pressure Ulcer/Prevention & control|pressure ulcer/prevention & control
5720737|NCT00429000|Hypothermia|hypothermia
5720738|NCT00429000|Infant mortality|infant mortality
5702832|NCT00491881|No added salt diet|no added salt diet
5720739|NCT00429000|Infant morbidity|infant morbidity
5720740|NCT00429000|Intervention|intervention
5720741|NCT00429000|Randomisation|randomisation
5720742|NCT00429000|Longitudinal research.|longitudinal research.
5704298|NCT00486291|Diabetes, Obese diabetics|diabetes, obese diabetics
5704299|NCT00486265|Phase I|phase i
5704300|NCT00486265|Phase II|phase ii
5704301|NCT00486265|acute myelogenous leukemia|acute myelogenous leukemia
5704302|NCT00486265|AML|aml
5704303|NCT00486265|cancer|cancer
5704304|NCT00486239|Epilepsy|epilepsy
5704305|NCT00486239|memory|memory
5704306|NCT00486239|emotion|emotion
5704307|NCT00486213|dermatologic complications|dermatologic complications
5704308|NCT00486213|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5704309|NCT00486213|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5704310|NCT00486213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5704311|NCT00486200|ASP2151|asp2151
5704312|NCT00486200|Herpes Genitalis|herpes genitalis
5704313|NCT00486200|Sexually Transmitted Disease|sexually transmitted disease
5704314|NCT00486200|Herpes Simplex Virus Genital Infection|herpes simplex virus genital infection
5704315|NCT00486200|Treatment Outcome|treatment outcome
5704316|NCT00486200|Genital Herpes|genital herpes
5704317|NCT00486187|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5704318|NCT00486187|Thiazolidinediones|thiazolidinediones
5704319|NCT00486187|Rosiglitazone|rosiglitazone
5704320|NCT00486187|Adipokine|adipokine
5704321|NCT00486187|Inflammation|inflammation
5704322|NCT00486187|Cardiometabolic risk|cardiometabolic risk
5704323|NCT00486187|Angiotensin receptor blocker|angiotensin receptor blocker
5704324|NCT00486174|Sepsis|sepsis
5704325|NCT00486174|Methylene Blue|methylene blue
5704326|NCT00486174|Norepinephrine|norepinephrine
5704327|NCT00486161|Obesity|obesity
5704328|NCT00486161|Ghrelin|ghrelin
5704329|NCT00486161|Non-esterified fatty acids|non-esterified fatty acids
5704331|NCT00486161|Insulin|insulin
5704332|NCT00486161|Cycloergometer exercise|cycloergometer exercise
5704333|NCT00486148|Formula|formula
5704334|NCT00486148|Feeding|feeding
5704335|NCT00486148|Healthy|healthy
5704336|NCT00486148|Full|full
5704337|NCT00486148|Term|term
5704338|NCT00486148|Infants|infants
5704339|NCT00486135|Cancer|cancer
5704340|NCT00486135|Solid tumors|solid tumors
5704341|NCT00486135|Lymphoma|lymphoma
5704342|NCT00486109|Diabetes|diabetes
5704343|NCT00486096|cannulation|cannulation
5704344|NCT00486096|infant|infant
5704345|NCT00486096|femoral arterial|femoral arterial
5704346|NCT00486070|cardiac anomaly|cardiac anomaly
5704347|NCT00486070|pulmonary veins|pulmonary veins
5704348|NCT00486070|cyanosis|cyanosis
5704349|NCT00486070|flow reversal|flow reversal
5704350|NCT00486070|TAPAVC|tapavc
5704351|NCT00486057|Daclizumab|daclizumab
5704352|NCT00486057|Immuno-suppression protocol|immuno-suppression protocol
5704353|NCT00486057|Heart Transplant|heart transplant
5704355|NCT00486044|amyloid protein|amyloid protein
5704356|NCT00486044|apolipoprotein|apolipoprotein
5704357|NCT00486044|cerebrospinal fluid|cerebrospinal fluid
5704358|NCT00486044|cerebrovascular circulation|cerebrovascular circulation
5704359|NCT00486044|inflammation|inflammation
5704360|NCT00486044|magnetic resonance imaging|magnetic resonance imaging
5704361|NCT00486044|prevention & control|prevention & control
5704363|NCT00486031|UC|uc
5704364|NCT00486031|Ulcerative Colitis|ulcerative colitis
5704365|NCT00486031|Inflammatory Bowel Disease|inflammatory bowel disease
5704366|NCT00486018|Lucentis|lucentis
5704367|NCT00486018|RVO|rvo
5704368|NCT00486018|BRVO|brvo
5704369|NCT00486018|Edema|edema
5704370|NCT00485992|blood stream infection|blood stream infection
5704371|NCT00485992|CICU|cicu
5704372|NCT00485992|pediatric|pediatric
5704373|NCT00485992|chlorhexidine swabs|chlorhexidine swabs
5704374|NCT00485979|Breast Cancer|breast cancer
5704375|NCT00485979|Neoadjuvant therapy|neoadjuvant therapy
5704376|NCT00485966|Adult Leukemia|adult leukemia
5704377|NCT00485966|CLL|cll
5704378|NCT00485966|B-CLL|b-cll
5704379|NCT00485966|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5704380|NCT00485966|B-cell CLL|b-cell cll
5704382|NCT00485953|breast cancer|breast cancer
5704383|NCT00485953|aromatase inhibitors|aromatase inhibitors
5704384|NCT00485953|bone loss|bone loss
5704385|NCT00485953|bone mineral density|bone mineral density
5704386|NCT00485940|constipation|constipation
5704387|NCT00485940|prucalopride|prucalopride
5704388|NCT00485940|QOL|qol
5704389|NCT00485940|SCBM|scbm
5720844|NCT00428571|Obesity|obesity
5704390|NCT00485940|PAC-SYM|pac-sym
5704391|NCT00485927|Trauma|trauma
5704392|NCT00485927|Stress|stress
5704393|NCT00485927|Simulation|simulation
5704394|NCT00485914|employment|employment
5704395|NCT00485914|work|work
5704396|NCT00485836|CRVO|crvo
5704397|NCT00485836|RVO|rvo
5704398|NCT00485836|Lucentis|lucentis
5704399|NCT00485836|Edema|edema
5704400|NCT00485797|attention deficit hyperactivity disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5704401|NCT00485797|Dual tasking|dual tasking
5704402|NCT00485797|Postural Control|postural control
5704403|NCT00485797|Methylphenidate (Ritalin)|methylphenidate (ritalin)
5704404|NCT00485797|The focus of the study is To explore the effects of Ritalin on postural control in ADHD Children, during single and dual task conditions.|the focus of the study is to explore the effects of ritalin on postural control in adhd children, during single and dual task conditions.
5704405|NCT00485784|Identify in a population of patients with a PE, an IUGR and a FD a modification of circulating endothelial biomarkers compared with normal pregnancy.|identify in a population of patients with a pe, an iugr and a fd a modification of circulating endothelial biomarkers compared with normal pregnancy.
5704406|NCT00485745|surgery|surgery
5704407|NCT00485745|repeat sternotomy|repeat sternotomy
5704408|NCT00485745|pediatrics|pediatrics
5704409|NCT00485732|Cervical neoplasia|cervical neoplasia
5704410|NCT00485732|AS04|as04
5704411|NCT00485732|Randomized|randomized
5704412|NCT00485732|Cervical cancer|cervical cancer
5704413|NCT00485732|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5704414|NCT00485732|Phase IIIb|phase iiib
5704415|NCT00485732|Korea|korea
5704416|NCT00485732|HPV|hpv
5704417|NCT00485732|Double-blind|double-blind
5704418|NCT00485732|Controlled|controlled
5704419|NCT00485719|Cancer|cancer
5704420|NCT00485719|Solid Tumors|solid tumors
5704421|NCT00485706|dialysis|dialysis
5704422|NCT00485706|vascular calcification|vascular calcification
5704423|NCT00485706|bone mineralism|bone mineralism
5704424|NCT00485706|arterial stiffness|arterial stiffness
5704425|NCT00485706|bone metabolism|bone metabolism
5704426|NCT00485706|chronic kidney disease|chronic kidney disease
5704427|NCT00485693|pain|pain
5704428|NCT00485693|postoperative|postoperative
5704429|NCT00485693|total knee arthroplasty|total knee arthroplasty
5704430|NCT00485693|analgesia|analgesia
5704431|NCT00485667|pain|pain
5704432|NCT00485667|postoperative|postoperative
5704433|NCT00485654|Heterotaxy Syndrome|heterotaxy syndrome
5704434|NCT00485654|Intestinal Malrotation|intestinal malrotation
5704435|NCT00485654|Functional Asplenia|functional asplenia
5704436|NCT00485654|Complex Cyanotic heart disease|complex cyanotic heart disease
5704437|NCT00485641|Stroke|stroke
5704438|NCT00485641|SaeboFlex|saeboflex
5704439|NCT00485641|Hand function|hand function
5704440|NCT00485615|eicosapentaenoic acid|eicosapentaenoic acid
5704441|NCT00485615|fish oil|fish oil
5704442|NCT00485615|Omega 3|omega 3
5704443|NCT00485615|Social Anxiety Disorder|social anxiety disorder
5704444|NCT00485602|malocclusion|malocclusion
5704445|NCT00485602|aligner|aligner
5704446|NCT00485602|crowding|crowding
5704447|NCT00485602|expansion|expansion
5704448|NCT00485602|orthodontic treatment|orthodontic treatment
5704449|NCT00485589|FILM|film
5704451|NCT00485589|anti-CD20|anti-cd20
5704452|NCT00485589|CD20|cd20
5704453|NCT00485563|Cancer|cancer
5704454|NCT00485563|Vaccine|vaccine
5704455|NCT00485563|Phase 2|phase 2
5704456|NCT00485563|folate-hapten conjugate|folate-hapten conjugate
5704457|NCT00485563|Progressive|progressive
5704458|NCT00485563|Metastatic|metastatic
5704459|NCT00485563|Experimental|experimental
5704460|NCT00485537|GnRH antagonist|gnrh antagonist
5704461|NCT00485537|GnRH agonist|gnrh agonist
5704463|NCT00485537|miscarriage rate|miscarriage rate
5704464|NCT00485537|pregnancy outcome|pregnancy outcome
5704465|NCT00485524|Near Infrared Spectroscopy|near infrared spectroscopy
5704466|NCT00485524|Serum Lactate Levels|serum lactate levels
5704467|NCT00485524|post operative outcomes|post operative outcomes
5704468|NCT00485485|Head and Neck Cancer|head and neck cancer
5704469|NCT00485485|Squamous Cell Cancer|squamous cell cancer
5704470|NCT00485485|Imatinib Mesylate|imatinib mesylate
5704472|NCT00485485|Imatinib|imatinib
5704473|NCT00485485|STI571|sti571
5704474|NCT00485485|Docetaxel|docetaxel
5704475|NCT00485485|Taxotere|taxotere
5704476|NCT00485472|Osteoarthritis|osteoarthritis
5704477|NCT00485472|lacosamide|lacosamide
5704478|NCT00485472|VIMPAT|vimpat
5704479|NCT00485433|hernia|hernia
5704480|NCT00485433|unilateral|unilateral
5704481|NCT00485433|postoperative|postoperative
5704482|NCT00485433|analgesia|analgesia
5704483|NCT00485420|Internet based disease management program|internet based disease management program
5704485|NCT00485394|age-related macular degeneration|age-related macular degeneration
5704486|NCT00485394|geographic atrophy|geographic atrophy
5704487|NCT00485394|GA|ga
5704488|NCT00485368|marfan syndrome|marfan syndrome
5704489|NCT00485368|aortic root diameter|aortic root diameter
5704490|NCT00485355|hysterectomy|hysterectomy
5704491|NCT00485355|Laparoscopy|laparoscopy
5704492|NCT00485355|robotics|robotics
5704493|NCT00485342|Chronic hepatitis C,Genotype1,Naïf,bitherapy,Ribavirin adaptation,ribavirin AUC|chronic hepatitis c,genotype1,naïf,bitherapy,ribavirin adaptation,ribavirin auc
5704494|NCT00485329|Chronic Wounds, Venous Ulcers, Papain, Debridement, Continuous streaming|chronic wounds, venous ulcers, papain, debridement, continuous streaming
5704495|NCT00485329|DermaStream-EnzyStream|dermastream-enzystream
5704496|NCT00485316|Colorectal carcinoma|colorectal carcinoma
5704497|NCT00485316|Rectal carcinoma|rectal carcinoma
5704498|NCT00485316|Laparoscopy|laparoscopy
5704499|NCT00485316|Laparoscopic surgery|laparoscopic surgery
5704500|NCT00485316|Open surgery|open surgery
5703049|NCT00490958|haemodialysis|haemodialysis
5704501|NCT00485316|Randomized trial|randomized trial
5704502|NCT00485303|Prostatic Neoplasms|prostatic neoplasms
5704503|NCT00485303|Prostate cancer|prostate cancer
5704504|NCT00485303|Abiraterone acetate|abiraterone acetate
5704505|NCT00485303|CB7630|cb7630
5704506|NCT00485303|Prednisone|prednisone
5704507|NCT00485290|cirrhosis, Portal Hypertension, Esophageal Varices, Meal|cirrhosis, portal hypertension, esophageal varices, meal
5704508|NCT00485277|Breast cancer|breast cancer
5704509|NCT00485277|Vaccine|vaccine
5704510|NCT00485277|Metastatic|metastatic
5704511|NCT00485277|HER-2-positive|her-2-positive
5704512|NCT00485277|Phase I|phase i
5704513|NCT00485277|HER-2 Positive Metastatic Breast Cancer|her-2 positive metastatic breast cancer
5704514|NCT00485251|operation time in minutes|operation time in minutes
5704515|NCT00485251|pain score from 1-10|pain score from 1-10
5704516|NCT00485251|recurrence|recurrence
5704517|NCT00485251|survival|survival
5704518|NCT00485238|glaucoma|glaucoma
5704519|NCT00485212|postoperative pain|postoperative pain
5704520|NCT00485199|Pneumatic Retinopexy|pneumatic retinopexy
5704521|NCT00485199|vitrectomy|vitrectomy
5704522|NCT00485199|retinal detachment|retinal detachment
5704523|NCT00485199|macular hole|macular hole
5704524|NCT00485199|treatment|treatment
5704525|NCT00485199|multi-center|multi-center
5704526|NCT00485199|Retinal Detachment due to Myopic Macular hole|retinal detachment due to myopic macular hole
5704527|NCT00485160|Patent Ductus Arteriosus|patent ductus arteriosus
5704528|NCT00485160|Indomethacin|indomethacin
5704529|NCT00485160|Ibuprofen|ibuprofen
5704530|NCT00485160|Renal effects|renal effects
5704531|NCT00485147|Claudication|claudication
5704532|NCT00485147|peripheral arterial disease|peripheral arterial disease
5704533|NCT00485147|Diagnosis|diagnosis
5704534|NCT00485147|Exercise|exercise
5680561|NCT00577447|autism|autism
5680562|NCT00577447|omega-3 fatty acids|omega-3 fatty acids
5680563|NCT00577447|docosahexaenoic acid|docosahexaenoic acid
5680564|NCT00577434|Procedural sedation|procedural sedation
5704535|NCT00485147|Walking impairment|walking impairment
5704536|NCT00485147|Disability|disability
5704537|NCT00485121|Ezetimibe|ezetimibe
5704538|NCT00485121|Statin|statin
5704539|NCT00485121|Low- density lipoprotein cholesterol|low- density lipoprotein cholesterol
5704540|NCT00485121|Adipokine|adipokine
5704541|NCT00485121|Adiponectin|adiponectin
5704542|NCT00485121|C-reactive protein|c-reactive protein
5704543|NCT00485121|Coronary artery disease|coronary artery disease
5704544|NCT00485121|Metabolic Syndrome|metabolic syndrome
5704545|NCT00485121|Obesity|obesity
5704546|NCT00485108|primary open angle glaucoma|primary open angle glaucoma
5704547|NCT00485108|pseudoexfoliation glaucoma|pseudoexfoliation glaucoma
5704548|NCT00485108|selective laser trabeculoplasty|selective laser trabeculoplasty
5704549|NCT00485108|intra ocular pressure|intra ocular pressure
5704550|NCT00485108|anti-inflammatory therapy|anti-inflammatory therapy
5704551|NCT00485108|prednisolone acetate 1%|prednisolone acetate 1%
5704552|NCT00485108|ketorolac tromethamine 0.5%|ketorolac tromethamine 0.5%
5704553|NCT00485082|Cystic Fibrosis|cystic fibrosis
5704554|NCT00485082|Disclosure|disclosure
5704555|NCT00485082|Dating Partner|dating partner
5704556|NCT00485082|Phone Interview|phone interview
5704557|NCT00485069|Ropinirole hydrochloride|ropinirole hydrochloride
5704559|NCT00485069|Parkinson's Disease|parkinson's disease
5704560|NCT00485069|Dopamine agonist|dopamine agonist
5704561|NCT00485056|Diabetes|diabetes
5704562|NCT00485056|Tissue doppler imaging|tissue doppler imaging
5704563|NCT00485056|Wave intensity analysis.|wave intensity analysis.
5704564|NCT00485043|T'ai Chi|t'ai chi
5704565|NCT00485043|Osteoarthritis|osteoarthritis
5704566|NCT00485043|Exercise|exercise
5704567|NCT00485043|Older adults|older adults
5704568|NCT00485030|coronary artery disease|coronary artery disease
5704570|NCT00485030|angioplasty|angioplasty
5704571|NCT00485017|Obesity|obesity
5704572|NCT00485017|Weight Loss|weight loss
5704573|NCT00485004|Coronary artery disease|coronary artery disease
5704574|NCT00485004|Stent|stent
5704575|NCT00485004|Angioplasty|angioplasty
5704576|NCT00484991|Phenylketonuria|phenylketonuria
5704577|NCT00484991|PKU|pku
5698987|NCT00504452|HIV|hiv
5704579|NCT00484991|Hyperphenylalaninaemia|hyperphenylalaninaemia
5704580|NCT00484991|Hydroxylase Deficiency|hydroxylase deficiency
5704581|NCT00484978|Stereotactic Radiosurgery|stereotactic radiosurgery
5704582|NCT00484978|Surgery|surgery
5704583|NCT00484978|Metastatic tumor to brain|metastatic tumor to brain
5704584|NCT00484978|radiation|radiation
5704585|NCT00484978|Brain Metastases of all pathologies|brain metastases of all pathologies
5704586|NCT00484965|Coronary stent|coronary stent
5704587|NCT00484965|Inflammation|inflammation
5704588|NCT00484965|Atherosclerosis|atherosclerosis
5704589|NCT00484965|Immunosuppressive|immunosuppressive
5704590|NCT00484952|rotavirus|rotavirus
5704591|NCT00484952|diarrheal diseases|diarrheal diseases
5704592|NCT00484952|hospitalizations|hospitalizations
5704593|NCT00484952|multicenter|multicenter
5704594|NCT00484952|children|children
5704595|NCT00484952|under five year old|under five year old
5704596|NCT00484952|Hospitalization due to diarhheal diseases|hospitalization due to diarhheal diseases
5704597|NCT00484952|Hospitalization due to rotavirus gastroenteritis|hospitalization due to rotavirus gastroenteritis
5704598|NCT00484952|Nosocomial rotavirus infections|nosocomial rotavirus infections
5704599|NCT00484926|coronary disease|coronary disease
5704600|NCT00484926|stents|stents
5704601|NCT00484926|antiplatelet drugs|antiplatelet drugs
5704602|NCT00484926|drug-eluting stents|drug-eluting stents
5704603|NCT00484913|healthy subjects|healthy subjects
5704604|NCT00484900|Open randomized multi-centre clinical trial in Africa|open randomized multi-centre clinical trial in africa
5704605|NCT00484900|Uncomplicated P. falciparum malaria|uncomplicated p. falciparum malaria
5704606|NCT00484900|Artemisinin-based Combination Therapy|artemisinin-based combination therapy
5704607|NCT00484900|Artesunate + sulfalene + pyrimethamine|artesunate + sulfalene + pyrimethamine
5704608|NCT00484900|24 hour treatment|24 hour treatment
5704609|NCT00484900|Artemether + lumefantrine|artemether + lumefantrine
5704610|NCT00484887|Hernia mesh|hernia mesh
5704611|NCT00484887|Implanted mesh material|implanted mesh material
5704612|NCT00484887|Explanted mesh material|explanted mesh material
5704613|NCT00484874|Hodgkin's lymphoma|hodgkin's lymphoma
5704614|NCT00484874|Radioimmunotherapy|radioimmunotherapy
5704615|NCT00484874|Bexxar|bexxar
5704616|NCT00484874|I-131 Tositumomab|i-131 tositumomab
5704617|NCT00484874|Safety|safety
5704618|NCT00484874|Efficacy|efficacy
5704619|NCT00484874|Nuclear Medicine|nuclear medicine
5704620|NCT00484874|Monoclonal antibody|monoclonal antibody
5704621|NCT00484874|Radiolabeled|radiolabeled
5704622|NCT00484861|Women|women
5704623|NCT00484861|Healthy Volunteers|healthy volunteers
5704624|NCT00484861|Triglyceride|triglyceride
5704625|NCT00484861|Healthy Volunteer|healthy volunteer
5704627|NCT00484848|oncology, medical|oncology, medical
5704628|NCT00484848|implantable catheter|implantable catheter
5704629|NCT00484848|vascular access ports|vascular access ports
5704630|NCT00484848|persistent withdrawal occlusion|persistent withdrawal occlusion
5704631|NCT00484848|Vortex®|vortex®
5704632|NCT00484848|Celsite®|celsite®
5704633|NCT00484848|Vacutainer®|vacutainer®
5704634|NCT00484848|venous cut-down|venous cut-down
5704635|NCT00484835|Abdominal|abdominal
5704636|NCT00484835|Hysterectomy|hysterectomy
5704637|NCT00484835|Electrocoagulation forceps|electrocoagulation forceps
5704638|NCT00484835|Electrosurgery|electrosurgery
5704639|NCT00484835|Gyrus plasma open seal forceps|gyrus plasma open seal forceps
5704640|NCT00484835|Patients undergoing abdominal hysterectomy for various reasons|patients undergoing abdominal hysterectomy for various reasons
5704641|NCT00484809|rheumatoid arthritis|rheumatoid arthritis
5704642|NCT00484809|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5704643|NCT00484796|Carotid Surgery|carotid surgery
5704644|NCT00484796|Cerebral Ischemia|cerebral ischemia
5704645|NCT00484796|Cognitive Deficits|cognitive deficits
5704646|NCT00484796|Somatosensory-evoked Potentials|somatosensory-evoked potentials
5704647|NCT00484796|Neuromonitoring|neuromonitoring
5704648|NCT00484783|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
5704649|NCT00484783|Endoscopic Surgical Procedures|endoscopic surgical procedures
5704749|NCT00484354|Acute Renal Failure|acute renal failure
5704650|NCT00484783|Laparoscopic & endoscopic procedures with a gastrotomy|laparoscopic & endoscopic procedures with a gastrotomy
5704651|NCT00484783|or opening in bladder or urethra|or opening in bladder or urethra
5704652|NCT00484770|heart failure, brain natriuretic peptide|heart failure, brain natriuretic peptide
5704653|NCT00484757|Narcolepsy|narcolepsy
5704654|NCT00484757|Orexines|orexines
5704655|NCT00484757|sleep|sleep
5704656|NCT00484757|cognition|cognition
5704657|NCT00484757|cytokines|cytokines
5704658|NCT00484744|pain|pain
5704659|NCT00484744|orthodontic|orthodontic
5704660|NCT00484744|acetaminophen|acetaminophen
5704661|NCT00484744|ibuprofen|ibuprofen
5704662|NCT00484744|separator|separator
5704663|NCT00484705|Androgens|androgens
5704664|NCT00484705|Menstrual pattern|menstrual pattern
5704665|NCT00484705|Insulin resistance|insulin resistance
5704666|NCT00484705|Adipocytes|adipocytes
5704667|NCT00484705|Obesity|obesity
5704668|NCT00484705|Stress|stress
5699028|NCT00504361|smokers|smokers
5704670|NCT00484705|Psychological distress and quality of life|psychological distress and quality of life
5704671|NCT00484692|randomized controlled trial|randomized controlled trial
5704673|NCT00484692|nicotine dependence|nicotine dependence
5704674|NCT00484692|sustained-release bupropion|sustained-release bupropion
5704675|NCT00484692|psychotherapy|psychotherapy
5704676|NCT00484692|psychodynamic model training|psychodynamic model training
5704677|NCT00484666|recurrent|recurrent
5704678|NCT00484666|platinum|platinum
5704679|NCT00484666|resistant|resistant
5704680|NCT00484666|ovarian|ovarian
5704681|NCT00484666|primary|primary
5704682|NCT00484666|peritoneal|peritoneal
5704683|NCT00484666|cancer|cancer
5704684|NCT00484653|To achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities|to achieve a quality and quantitative molecular biology assay for vaginal flora abnormalities
5704685|NCT00484627|Exercise|exercise
5704687|NCT00484627|Creatine|creatine
5704688|NCT00484627|Muscle|muscle
5704689|NCT00484614|Breast Cancer, breast conserving surgery|breast cancer, breast conserving surgery
5704690|NCT00484588|VAP|vap
5704691|NCT00484575|Sevoflurane|sevoflurane
5704692|NCT00484575|CABG|cabg
5704693|NCT00484575|cardioprotection|cardioprotection
5704694|NCT00484575|AnaConDa|anaconda
5704695|NCT00484562|oxygen|oxygen
5704696|NCT00484562|COPD|copd
5704697|NCT00484562|exercise|exercise
5704698|NCT00484549|Fabry disease, Screening, Ischemic stroke|fabry disease, screening, ischemic stroke
5704699|NCT00484536|CDP323|cdp323
5704700|NCT00484536|Relapsing Multiple Sclerosis|relapsing multiple sclerosis
5704701|NCT00484536|Magnetic Resonance Imaging|magnetic resonance imaging
5704702|NCT00484536|Oral Compound|oral compound
5704703|NCT00484536|MS|ms
5704704|NCT00484523|To constitute a standardized database of multimode neural imaging.|to constitute a standardized database of multimode neural imaging.
5704705|NCT00484510|Ascorbic Acid|ascorbic acid
5704706|NCT00484510|Vitamin C|vitamin c
5704707|NCT00484510|Charcot Marie Tooth|charcot marie tooth
5704708|NCT00484510|CMT|cmt
5704709|NCT00484510|CMT1a|cmt1a
5704710|NCT00484497|Sleep quality|sleep quality
5704711|NCT00484497|food supplement|food supplement
5704712|NCT00484497|randomized controlled trial|randomized controlled trial
5704713|NCT00484497|actigraphy|actigraphy
5704714|NCT00484497|Leeds|leeds
5704715|NCT00484497|Volunteers presenting moderate primary insomnia|volunteers presenting moderate primary insomnia
5704716|NCT00484484|Cancer|cancer
5704717|NCT00484484|Refractory pain|refractory pain
5704718|NCT00484484|Uncontrolled pain|uncontrolled pain
5704719|NCT00484484|Ketamine|ketamine
5704720|NCT00484484|Uncontrolled cancer pain|uncontrolled cancer pain
5704721|NCT00484458|Degenerative Disc Disease|degenerative disc disease
5704722|NCT00484458|Total Disc Replacement|total disc replacement
5704723|NCT00484445|Chronic critical illness|chronic critical illness
5704724|NCT00484445|Functional status|functional status
5704725|NCT00484445|Outcomes|outcomes
5704726|NCT00484445|Post-ICU|post-icu
5704727|NCT00484432|NGR-hTNF|ngr-htnf
5704728|NCT00484432|Ovarian cancer|ovarian cancer
5704729|NCT00484432|Doxorubicin|doxorubicin
5704730|NCT00484419|Colesevelam HCl,|colesevelam hcl,
5704731|NCT00484419|rosiglitazone|rosiglitazone
5704732|NCT00484419|sitagliptin|sitagliptin
5704733|NCT00484419|Type 2 diabetes|type 2 diabetes
5704734|NCT00484419|metformin|metformin
5704735|NCT00484406|Matrix Metalloproteinases|matrix metalloproteinases
5704736|NCT00484406|Atherosclerosis|atherosclerosis
5704737|NCT00484406|Genetic polymorphism|genetic polymorphism
5704738|NCT00484406|Acute coronary syndromes|acute coronary syndromes
5704739|NCT00484380|Valvular surgery|valvular surgery
5704740|NCT00484380|Diagnostic accuracy of coronary angiography|diagnostic accuracy of coronary angiography
5704741|NCT00484380|Coronary stenosis|coronary stenosis
5704742|NCT00484380|Coronary revascularisation|coronary revascularisation
5704743|NCT00484367|Alcohol abuse|alcohol abuse
5704744|NCT00484367|Substance abuse|substance abuse
5704745|NCT00484367|Cannabis abuse|cannabis abuse
5704746|NCT00484367|Adolescents|adolescents
5704747|NCT00484367|Group therapy|group therapy
5704748|NCT00484367|Family therapy|family therapy
5704750|NCT00484354|Cardiac Surgery|cardiac surgery
5704751|NCT00484354|Sodium Bicarbonate|sodium bicarbonate
5704752|NCT00484354|Length of Stay|length of stay
5704753|NCT00484354|Mortality|mortality
5704754|NCT00484341|NGR-hTNF|ngr-htnf
5704755|NCT00484341|Doxorubicin|doxorubicin
5704756|NCT00484341|Soft Tissue Sarcoma|soft tissue sarcoma
5704757|NCT00484328|hepatitis C|hepatitis c
5704758|NCT00484328|Ribavirin|ribavirin
5704759|NCT00484328|Dosage|dosage
5704760|NCT00484328|Pharmacokinetics|pharmacokinetics
5704761|NCT00484315|drug-eluting stent|drug-eluting stent
5704762|NCT00484315|paclitaxel-eluting stent|paclitaxel-eluting stent
5704763|NCT00484315|DES|des
5704764|NCT00484302|Marijuana Abuse|marijuana abuse
5704765|NCT00484302|Psychotic Disorders|psychotic disorders
5704766|NCT00484302|Schizophrenia|schizophrenia
5704767|NCT00484276|NGR-hTNF|ngr-htnf
5704769|NCT00484250|Oral Lichen Planus|oral lichen planus
5704770|NCT00484250|Metronidazole|metronidazole
5704771|NCT00484250|Doxycycline|doxycycline
5704772|NCT00484237|Rheumatoid Arthritis|rheumatoid arthritis
5704773|NCT00484211|NGR-hTNF, Hepatocellular Carcinoma (HCC)|ngr-htnf, hepatocellular carcinoma (hcc)
5704774|NCT00484185|Hemophilia B|hemophilia b
5704775|NCT00484185|BeneFIX|benefix
5704776|NCT00484185|Safety|safety
5704777|NCT00484185|Efficacy|efficacy
5704778|NCT00484172|Obesity|obesity
5704779|NCT00484159|Low back pain of suspected lumbar zygapophysial etiology|low back pain of suspected lumbar zygapophysial etiology
5704780|NCT00484146|Sepsis|sepsis
5704781|NCT00484146|Early Stage|early stage
5704782|NCT00484146|Immune System|immune system
5704783|NCT00484146|Receptors|receptors
5704784|NCT00484146|Cytokines|cytokines
5704785|NCT00484133|sepsis|sepsis
5704786|NCT00484133|severe sepsis|severe sepsis
5704787|NCT00484133|microcirculation|microcirculation
5704788|NCT00484133|Orthogonal polarisation spectral|orthogonal polarisation spectral
5704789|NCT00484120|Osteoarthritis|osteoarthritis
5704790|NCT00484120|Diclofenac|diclofenac
5704791|NCT00484120|Nano-emulsion|nano-emulsion
5704792|NCT00484094|Rapamune|rapamune
5704793|NCT00484094|Safety|safety
5704794|NCT00484094|Efficacy|efficacy
5704795|NCT00484094|Kidney Transplantation|kidney transplantation
5704796|NCT00484081|TESE|tese
5704797|NCT00484081|NON-OBSTRUCTIVE|non-obstructive
5704798|NCT00484081|MICRODISSECTION|microdissection
5704799|NCT00484081|AZOOSPERMIA|azoospermia
5704800|NCT00484081|ICSI|icsi
5704801|NCT00484068|type 2 diabetes|type 2 diabetes
5704802|NCT00484068|microalbuminuria|microalbuminuria
5704803|NCT00484068|chicken-based diet|chicken-based diet
5704804|NCT00484068|ACE inhibitor|ace inhibitor
5704805|NCT00484055|Antibiotic Prophylaxis|antibiotic prophylaxis
5704806|NCT00484042|pancreatitis|pancreatitis
5704807|NCT00484042|polyamine|polyamine
5704808|NCT00484042|cytokine|cytokine
5704809|NCT00484029|Temporomandibular Disorders|temporomandibular disorders
5704810|NCT00484029|TMD|tmd
5704811|NCT00484029|TMJ/TMD|tmj/tmd
5704812|NCT00484029|Pain Management|pain management
5704813|NCT00484029|Pain|pain
5704814|NCT00484029|Headaches|headaches
5704815|NCT00484016|adjuvant|adjuvant
5704816|NCT00484016|chemotherapy|chemotherapy
5704817|NCT00484016|observation|observation
5704818|NCT00484016|resected|resected
5704819|NCT00484016|cancers|cancers
5704820|NCT00484003|Atopic eczema|atopic eczema
5704821|NCT00484003|Pimecrolimus|pimecrolimus
5704822|NCT00484003|Children|children
5704823|NCT00484003|Quality of life|quality of life
5704824|NCT00484003|Safety|safety
5704825|NCT00484003|Atopic dermatitis|atopic dermatitis
5704826|NCT00483990|Phase I Study in healthy subjects|phase i study in healthy subjects
5713785|NCT00451269|pLDH|pldh
5713786|NCT00451269|HRP2|hrp2
5713787|NCT00451269|Patients with fever and history of travel in a malaria|patients with fever and history of travel in a malaria
5704827|NCT00483964|Schizophrenia|schizophrenia
5704828|NCT00483964|Herbal extracts|herbal extracts
5704829|NCT00483964|Randomized|randomized
5704830|NCT00483964|Controlled|controlled
5704831|NCT00483964|Clinical Trial|clinical trial
5704832|NCT00483951|Transthoracic echocardiography|transthoracic echocardiography
5704833|NCT00483951|Ischemia|ischemia
5704834|NCT00483951|Cardiovascular Disease|cardiovascular disease
5704835|NCT00483951|Heart Disease|heart disease
5704836|NCT00483951|Congenital Heart Disease|congenital heart disease
5704837|NCT00483951|Heart Valve Disease|heart valve disease
5704838|NCT00483951|Atherosclerosis|atherosclerosis
5704839|NCT00483925|Langerhans cell histiocytosis|langerhans cell histiocytosis
5704840|NCT00483925|flow mediated dilatation|flow mediated dilatation
5704841|NCT00483925|intima media thickness|intima media thickness
5704842|NCT00483925|insulin resistance|insulin resistance
5704843|NCT00483925|hypopituitarism|hypopituitarism
5704844|NCT00483925|glucose and lipid metabolism,|glucose and lipid metabolism,
5704845|NCT00483925|structural arterial and functional endothelial properties in patients with multisystem LCH|structural arterial and functional endothelial properties in patients with multisystem lch
5704846|NCT00483912|pancreatitis, MARS|pancreatitis, mars
5704847|NCT00483912|severe acute pancreatitis with early multiple organ failure|severe acute pancreatitis with early multiple organ failure
5704848|NCT00483899|GW870086X Asthma Crossover repeat dose inhaled|gw870086x asthma crossover repeat dose inhaled
5704849|NCT00483886|constipation|constipation
5704850|NCT00483886|prucalopride|prucalopride
5704854|NCT00483873|Cardiac Arrest, Neurological Recovery, EEG, Quantitative EEG|cardiac arrest, neurological recovery, eeg, quantitative eeg
5704855|NCT00483860|Cancer|cancer
5704856|NCT00483860|Solid tumor,|solid tumor,
5704857|NCT00483860|normal renal function|normal renal function
5704858|NCT00483860|renal impairment,|renal impairment,
5704859|NCT00483860|prior platinum-based chemotherapy,|prior platinum-based chemotherapy,
5704860|NCT00483847|TYGRIS - Rest of World (ROW)|tygris - rest of world (row)
5704861|NCT00483847|TYSABRI|tysabri
5704862|NCT00483847|natalizumab|natalizumab
5704863|NCT00483847|Multiple Sclerosis|multiple sclerosis
5704866|NCT00483834|CPT-11|cpt-11
5704867|NCT00483834|Irinotecan|irinotecan
5704868|NCT00483834|Camptothecin-11|camptothecin-11
5704869|NCT00483834|Capecitabine|capecitabine
5704870|NCT00483834|Xeloda|xeloda
5704871|NCT00483834|Metastatic|metastatic
5704872|NCT00483834|Colorectal|colorectal
5704873|NCT00483834|Colon|colon
5704874|NCT00483834|Rectal|rectal
5704875|NCT00483821|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5704876|NCT00483821|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5704877|NCT00483821|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5704878|NCT00483821|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5704879|NCT00483821|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5704880|NCT00483821|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5704881|NCT00483821|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5704882|NCT00483821|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5704883|NCT00483821|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5704884|NCT00483821|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5704885|NCT00483821|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5703461|NCT00489385|HCV|hcv
5704886|NCT00483821|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5704887|NCT00483821|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5704888|NCT00483821|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5704889|NCT00483821|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5704890|NCT00483821|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5704891|NCT00483821|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5704892|NCT00483821|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5704893|NCT00483821|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5704894|NCT00483821|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5704895|NCT00483821|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5704896|NCT00483821|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5704897|NCT00483821|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5704898|NCT00483821|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5704899|NCT00483782|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5730114|NCT00393965|Brain|brain
5713866|NCT00450931|health status unknown|health status unknown
5713867|NCT00450918|Kartagener Syndrome|kartagener syndrome
5713869|NCT00450892|inflammatory breast cancer|inflammatory breast cancer
5704900|NCT00483782|Brenner tumor|brenner tumor
5704901|NCT00483782|ovarian carcinosarcoma|ovarian carcinosarcoma
5704902|NCT00483782|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5704903|NCT00483782|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5705089|NCT00483054|nevirapine|nevirapine
5704904|NCT00483782|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5704905|NCT00483782|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5704906|NCT00483782|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5704907|NCT00483782|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5704908|NCT00483782|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5704909|NCT00483782|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5704910|NCT00483782|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5704911|NCT00483782|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5704912|NCT00483782|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5704913|NCT00483782|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5704914|NCT00483782|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5704915|NCT00483782|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5704916|NCT00483782|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5704917|NCT00483782|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5704918|NCT00483782|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5704919|NCT00483782|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5704920|NCT00483782|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5704921|NCT00483782|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5704922|NCT00483782|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5704923|NCT00483782|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5704924|NCT00483782|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5704925|NCT00483782|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5704926|NCT00483782|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5704927|NCT00483782|stage IA primary peritoneal cavity cancer|stage ia primary peritoneal cavity cancer
5699302|NCT00503763|Paraprotein|paraprotein
5704928|NCT00483782|stage IB primary peritoneal cavity cancer|stage ib primary peritoneal cavity cancer
5704929|NCT00483782|stage IC primary peritoneal cavity cancer|stage ic primary peritoneal cavity cancer
5704930|NCT00483782|stage IIA primary peritoneal cavity cancer|stage iia primary peritoneal cavity cancer
5704931|NCT00483782|stage IIB primary peritoneal cavity cancer|stage iib primary peritoneal cavity cancer
5704932|NCT00483782|stage IIC primary peritoneal cavity cancer|stage iic primary peritoneal cavity cancer
5704933|NCT00483782|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5704934|NCT00483782|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5704935|NCT00483782|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5704936|NCT00483782|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5704939|NCT00483769|Glargine|glargine
5704940|NCT00483769|FEV1%|fev1%
5704941|NCT00483756|Immunosuppression|immunosuppression
5704942|NCT00483756|JAK3 inhibitor|jak3 inhibitor
5704943|NCT00483756|kidney transplantation.|kidney transplantation.
5704944|NCT00483717|Migraine|migraine
5704945|NCT00483717|Ketorolac|ketorolac
5704946|NCT00483704|multiple attacks of moderate to severe migraine headaches|multiple attacks of moderate to severe migraine headaches
5704947|NCT00483691|Intervention|intervention
5704948|NCT00483691|Home Visit|home visit
5704949|NCT00483691|Growth|growth
5704950|NCT00483691|Child Development|child development
5704951|NCT00483678|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5703603|NCT00488748|MST|mst
5704952|NCT00483678|sexual dysfunction|sexual dysfunction
5704953|NCT00483678|sexuality and reproductive issues|sexuality and reproductive issues
5704954|NCT00483678|recurrent prostate cancer|recurrent prostate cancer
5704955|NCT00483678|stage III prostate cancer|stage iii prostate cancer
5704956|NCT00483678|stage IV prostate cancer|stage iv prostate cancer
5704957|NCT00483665|endoleak|endoleak
5704958|NCT00483652|multiple sclerosis|multiple sclerosis
5704960|NCT00483652|walking|walking
5704961|NCT00483652|leg strength|leg strength
5704962|NCT00483652|demyelination|demyelination
5704963|NCT00483639|anxiety disorder|anxiety disorder
5704964|NCT00483639|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5704965|NCT00483639|head and neck cancer|head and neck cancer
5704966|NCT00483639|non-small cell lung cancer|non-small cell lung cancer
5704967|NCT00483639|small cell lung cancer|small cell lung cancer
5704968|NCT00483626|hemodynamic|hemodynamic
5704969|NCT00483626|pulmonary hypertension|pulmonary hypertension
5704970|NCT00483626|sildenafil|sildenafil
5704971|NCT00483613|Daily stress|daily stress
5680565|NCT00577434|Sedation for diagnostic imaging|sedation for diagnostic imaging
5680566|NCT00577408|Opiate Dependence|opiate dependence
5680567|NCT00577408|Heroin Dependence|heroin dependence
5680568|NCT00577408|Naltrexone|naltrexone
5704972|NCT00483613|Cognitive-behavioral therapy|cognitive-behavioral therapy
5704973|NCT00483613|Quality of life|quality of life
5704974|NCT00483613|SLEDAI|sledai
5704975|NCT00483600|Fondaparinux|fondaparinux
5704976|NCT00483600|Pharmacokinetic|pharmacokinetic
5704977|NCT00483587|NSTEMI|nstemi
5704978|NCT00483587|Acute coronary syndrome|acute coronary syndrome
5704979|NCT00483587|Heme arginate|heme arginate
5704980|NCT00483587|HO-1|ho-1
5704981|NCT00483587|Heme oxygenase-1|heme oxygenase-1
5704982|NCT00483574|Menactra® vaccine|menactra® vaccine
5704983|NCT00483574|Meningococcal meningitis|meningococcal meningitis
5704984|NCT00483574|Measles|measles
5704985|NCT00483574|Mumps|mumps
5704986|NCT00483574|Rubella|rubella
5704987|NCT00483574|Varicella virus|varicella virus
5704988|NCT00483574|Haemophilus influenzae type b|haemophilus influenzae type b
5704989|NCT00483574|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5704990|NCT00483561|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5705117|NCT00482911|conjunctival melanoma|conjunctival melanoma
5704991|NCT00483561|recurrent prostate cancer|recurrent prostate cancer
5704992|NCT00483561|stage III prostate cancer|stage iii prostate cancer
5704993|NCT00483561|stage IV prostate cancer|stage iv prostate cancer
5704994|NCT00483535|Gw273225, Oral Contraceptive Interaction|gw273225, oral contraceptive interaction
5704995|NCT00483522|Rehabilitation|rehabilitation
5704996|NCT00483522|Directive counseling|directive counseling
5704997|NCT00483522|Brain injuries|brain injuries
5704998|NCT00483509|NGR-hTNF|ngr-htnf
5704999|NCT00483509|SCLC|sclc
5705001|NCT00483483|Unsafe sex|unsafe sex
5705002|NCT00483483|High-risk sex|high-risk sex
5705003|NCT00483483|Needle sharing|needle sharing
5705004|NCT00483483|STDs|stds
5705005|NCT00483470|Hepatitis A|hepatitis a
5705006|NCT00483457|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5705007|NCT00483444|Rehabilitation|rehabilitation
5705008|NCT00483444|Brain injuries|brain injuries
5705009|NCT00483444|Directive counseling|directive counseling
5705010|NCT00483431|vitamin K2|vitamin k2
5705011|NCT00483431|dosis-response|dosis-response
5705012|NCT00483431|osteocalcin|osteocalcin
5705013|NCT00483431|matrix-gla protein|matrix-gla protein
5705014|NCT00483418|male|male
5705015|NCT00483418|cancer|cancer
5705016|NCT00483405|advanced adult primary liver cancer|advanced adult primary liver cancer
5705017|NCT00483405|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5705018|NCT00483405|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5705019|NCT00483405|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5705021|NCT00483392|rosiglitazone|rosiglitazone
5705022|NCT00483392|metformin|metformin
5705024|NCT00483392|protease inhibitors|protease inhibitors
5705025|NCT00483366|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5705026|NCT00483327|Well|well
5705027|NCT00483327|Moderately|moderately
5705028|NCT00483327|Differentiated|differentiated
5705029|NCT00483301|Melanoma|melanoma
5705030|NCT00483301|Abraxane|abraxane
5705031|NCT00483301|Sorafenib|sorafenib
5705032|NCT00483301|BAY 43-9006|bay 43-9006
5705033|NCT00483301|Abraxis|abraxis
5705034|NCT00483288|cervical cancer|cervical cancer
5705035|NCT00483275|Accidental Falls|accidental falls
5705036|NCT00483275|Accident Prevention|accident prevention
5705037|NCT00483275|Patient Education|patient education
5705038|NCT00483275|Exercise Training|exercise training
5705039|NCT00483275|Alfacalcidol|alfacalcidol
5705040|NCT00483262|Temsirolimus|temsirolimus
5705041|NCT00483262|Bortezomib|bortezomib
5705042|NCT00483249|Thoracoabdominal|thoracoabdominal
5705043|NCT00483249|Paravisceral|paravisceral
5705044|NCT00483249|Aneurysm|aneurysm
5705045|NCT00483249|Endovascular|endovascular
5712790|NCT00454415|BMI|bmi
5705046|NCT00483249|Stent-Graft|stent-graft
5705047|NCT00483249|Aorta|aorta
5705048|NCT00483236|Non-Ischaemic Cardiomyopathy|non-ischaemic cardiomyopathy
5705049|NCT00483223|ER negative|er negative
5705050|NCT00483223|PgR negative|pgr negative
5705051|NCT00483223|HER2 negative|her2 negative
5705052|NCT00483223|cisplatin|cisplatin
5705053|NCT00483223|carboplatinum|carboplatinum
5705054|NCT00483223|platinum|platinum
5705056|NCT00483223|p73|p73
5705057|NCT00483197|VentrAssistTM|ventrassisttm
5705058|NCT00483197|LVAD|lvad
5705059|NCT00483197|End-stage heart failure|end-stage heart failure
5705060|NCT00483197|Cardiomyopathy|cardiomyopathy
5705061|NCT00483158|Helicobacter pylori|helicobacter pylori
5705062|NCT00483158|Fluoroquinolones|fluoroquinolones
5705063|NCT00483158|First in Man|first in man
5705064|NCT00483119|pemphigus vulgaris|pemphigus vulgaris
5705065|NCT00483119|IVIg|ivig
5705066|NCT00483119|cyclophosphamide|cyclophosphamide
5705067|NCT00483119|treatment|treatment
5705068|NCT00483119|pemphigus antibodies|pemphigus antibodies
5705069|NCT00483106|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5705070|NCT00483106|Genetics|genetics
5705071|NCT00483106|Pharmacogenetics|pharmacogenetics
5705072|NCT00483093|NGR-hTNF|ngr-htnf
5705073|NCT00483093|cisplatin|cisplatin
5705074|NCT00483093|solid tumors|solid tumors
5705075|NCT00483080|NGR-hTNF|ngr-htnf
5705076|NCT00483080|CRC|crc
5705077|NCT00483067|Idiopathic Hypereosinophilic Syndrome|idiopathic hypereosinophilic syndrome
5705078|NCT00483067|Leukemia|leukemia
5705079|NCT00483067|2-Chlorodeoxyadenosine|2-chlorodeoxyadenosine
5705080|NCT00483067|Cladribine|cladribine
5705081|NCT00483067|Cytarabine|cytarabine
5705082|NCT00483067|Ara-C|ara-c
5705083|NCT00483067|2-CdA|2-cda
5705084|NCT00483067|G-CSF|g-csf
5705085|NCT00483067|HES|hes
5705086|NCT00483054|HIV|hiv
5705087|NCT00483054|tuberculosis|tuberculosis
5705088|NCT00483054|efavirenz|efavirenz
5705090|NCT00483054|rifampicin|rifampicin
5705091|NCT00483054|co-infected HIV and tuberculosis patients|co-infected hiv and tuberculosis patients
5705092|NCT00483015|presentation|presentation
5705093|NCT00483015|outcome|outcome
5705094|NCT00483015|response|response
5705095|NCT00483015|never- smokers|never- smokers
5705096|NCT00483002|A prospective and observational program to monitor use in real practice including efficacy of Varenicline in Korea.|a prospective and observational program to monitor use in real practice including efficacy of varenicline in korea.
5705097|NCT00482963|HIV|hiv
5705098|NCT00482963|Contraception|contraception
5705099|NCT00482963|Antiretroviral agents|antiretroviral agents
5705100|NCT00482963|Pharmacokinetics|pharmacokinetics
5705101|NCT00482937|Safety|safety
5705102|NCT00482937|Heart Failure|heart failure
5705103|NCT00482924|obesity|obesity
5705104|NCT00482924|cardiovascular risk profiles|cardiovascular risk profiles
5705105|NCT00482924|adipokines|adipokines
5705106|NCT00482924|preatherosclerosis|preatherosclerosis
5705107|NCT00482924|low grade inflammation|low grade inflammation
5705108|NCT00482924|dyslipidemia|dyslipidemia
5705109|NCT00482924|insulin resistance|insulin resistance
5705110|NCT00482924|brown adipose tissue|brown adipose tissue
5705111|NCT00482924|white adipose tissue|white adipose tissue
5705112|NCT00482911|recurrent intraocular melanoma|recurrent intraocular melanoma
5705113|NCT00482911|metastatic intraocular melanoma|metastatic intraocular melanoma
5705114|NCT00482911|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5705115|NCT00482911|extraocular extension melanoma|extraocular extension melanoma
5705116|NCT00482911|iris melanoma|iris melanoma
5705120|NCT00482885|Contractile Pressure|contractile pressure
5705121|NCT00482885|Coordination of contraction|coordination of contraction
5705122|NCT00482885|Bolus transport|bolus transport
5705123|NCT00482885|Esophageal function|esophageal function
5705124|NCT00482872|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5705125|NCT00482872|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5705126|NCT00482872|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5705127|NCT00482872|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5705128|NCT00482872|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5705129|NCT00482872|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5705130|NCT00482872|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5705131|NCT00482872|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5705132|NCT00482872|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5705133|NCT00482872|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5705134|NCT00482872|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5705135|NCT00482872|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5705136|NCT00482872|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5705137|NCT00482872|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5705138|NCT00482872|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5705139|NCT00482872|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5705140|NCT00482872|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5705141|NCT00482872|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5705142|NCT00482872|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5705143|NCT00482872|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5705144|NCT00482872|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5705145|NCT00482872|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5680569|NCT00577382|Sutent|sutent
5680570|NCT00577382|malignant melanoma|malignant melanoma
5680571|NCT00577369|arterial line|arterial line
5680572|NCT00577369|end-expiratory desflurane|end-expiratory desflurane
5705146|NCT00482872|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5705147|NCT00482872|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5705148|NCT00482872|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5705149|NCT00482872|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5705150|NCT00482872|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5705151|NCT00482872|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5705152|NCT00482872|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5705153|NCT00482872|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5705154|NCT00482872|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5705155|NCT00482872|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5705156|NCT00482872|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5705157|NCT00482872|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5705158|NCT00482872|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5705159|NCT00482872|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5705160|NCT00482872|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5705161|NCT00482872|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5705162|NCT00482872|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5705163|NCT00482872|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5705164|NCT00482872|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5705165|NCT00482872|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5705166|NCT00482872|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5705167|NCT00482872|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5705168|NCT00482859|Fibromyalgia Syndrome|fibromyalgia syndrome
5705170|NCT00482846|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5705171|NCT00482846|stage II multiple myeloma|stage ii multiple myeloma
5705172|NCT00482846|stage III multiple myeloma|stage iii multiple myeloma
5705173|NCT00482846|refractory multiple myeloma|refractory multiple myeloma
5705175|NCT00482833|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5705176|NCT00482833|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5705178|NCT00482820|attention-biases|attention-biases
5705179|NCT00482820|children|children
5705180|NCT00482807|stage I prostate cancer|stage i prostate cancer
5705181|NCT00482807|stage II prostate cancer|stage ii prostate cancer
5705182|NCT00482807|stage III prostate cancer|stage iii prostate cancer
5705183|NCT00482807|stage IV prostate cancer|stage iv prostate cancer
5705184|NCT00482807|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5705185|NCT00482807|recurrent prostate cancer|recurrent prostate cancer
5705186|NCT00482794|Antiphospholipid Antibody Syndrome|antiphospholipid antibody syndrome
5705188|NCT00482781|Bradycardia|bradycardia
5705189|NCT00482781|Preterm Infant|preterm infant
5705190|NCT00482781|Immunization|immunization
5705191|NCT00482781|DTaP|dtap
5705192|NCT00482768|Diabetes, type II; Primary Health Care; Outpatient Care|diabetes, type ii; primary health care; outpatient care
5705193|NCT00482755|male breast cancer|male breast cancer
5705194|NCT00482755|stage II breast cancer|stage ii breast cancer
5705195|NCT00482755|stage IIIA breast cancer|stage iiia breast cancer
5705196|NCT00482742|Chronic Total Occlusion|chronic total occlusion
5705197|NCT00482716|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5705198|NCT00482716|refractory multiple myeloma|refractory multiple myeloma
5705199|NCT00482716|stage I multiple myeloma|stage i multiple myeloma
5705200|NCT00482716|stage II multiple myeloma|stage ii multiple myeloma
5705201|NCT00482716|stage III multiple myeloma|stage iii multiple myeloma
5705202|NCT00482716|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5705203|NCT00482716|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5705204|NCT00482716|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5705205|NCT00482716|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5705206|NCT00482716|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5863050|NCT00001409|T Cell Universal Receptor|t cell universal receptor
5705207|NCT00482716|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5705208|NCT00482716|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5705209|NCT00482716|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5705210|NCT00482716|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5705211|NCT00482716|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5705212|NCT00482716|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5705213|NCT00482716|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5705214|NCT00482716|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5705215|NCT00482716|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5705216|NCT00482716|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5705217|NCT00482716|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5705218|NCT00482716|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5705219|NCT00482716|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5705220|NCT00482716|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5705221|NCT00482716|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5705222|NCT00482716|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5705223|NCT00482716|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5705224|NCT00482716|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5705404|NCT00481923|hypocaloric diet|hypocaloric diet
5705225|NCT00482716|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5705226|NCT00482716|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5705227|NCT00482716|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5705228|NCT00482716|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5705229|NCT00482716|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5705230|NCT00482716|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5705231|NCT00482716|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5705232|NCT00482716|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5705233|NCT00482716|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5705234|NCT00482716|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5705235|NCT00482716|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5705236|NCT00482716|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5705237|NCT00482716|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5705238|NCT00482716|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5705239|NCT00482716|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5699663|NCT00502281|Treatment|treatment
5705241|NCT00482703|Imatinib resistant or intolerant chronic phase CML|imatinib resistant or intolerant chronic phase cml
5705242|NCT00482690|Smoking cessation|smoking cessation
5705243|NCT00482690|Biomarkers|biomarkers
5705244|NCT00482690|Aldehydes|aldehydes
5705245|NCT00482690|Exhaled breath|exhaled breath
5705246|NCT00482690|Harm Reduction|harm reduction
5705247|NCT00482690|Cigarette smoking|cigarette smoking
5705248|NCT00482690|cessation|cessation
5705250|NCT00482677|adult glioblastoma|adult glioblastoma
5705251|NCT00482677|adult giant cell glioblastoma|adult giant cell glioblastoma
5705252|NCT00482677|adult gliosarcoma|adult gliosarcoma
5694808|NCT00519402|apnea|apnea
5705253|NCT00482586|adult primary liver cancer|adult primary liver cancer
5705254|NCT00482586|liver metastases|liver metastases
5705255|NCT00482573|Electrocardiography, ambulatory/methods|electrocardiography, ambulatory/methods
5705256|NCT00482573|Blood Pressure monitoring, ambulatory/methods|blood pressure monitoring, ambulatory/methods
5705257|NCT00482573|Cardiotocography/methods|cardiotocography/methods
5705258|NCT00482573|Dental restoration, permanent|dental restoration, permanent
5705259|NCT00482573|Anesthesia, local /methods|anesthesia, local /methods
5705260|NCT00482573|Lidocaine|lidocaine
5705261|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents
5705262|NCT00482573|Epinephrine|epinephrine
5705263|NCT00482573|Pregnancy|pregnancy
5705264|NCT00482573|Rheumatic Heart Disease|rheumatic heart disease
5705265|NCT00482560|Sucrose|sucrose
5705266|NCT00482560|Breastfeeding|breastfeeding
5705267|NCT00482560|Heel lance|heel lance
5705268|NCT00482547|urinary tract infection|urinary tract infection
5705269|NCT00482547|urinary catheter|urinary catheter
5705270|NCT00482521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5705271|NCT00482508|Asthma|asthma
5721838|NCT00425113|TB|tb
5705272|NCT00482508|anti immunoglobulin E|anti immunoglobulin e
5705273|NCT00482508|omalizumab|omalizumab
5705274|NCT00482495|refractory multiple myeloma|refractory multiple myeloma
5705275|NCT00482495|stage I multiple myeloma|stage i multiple myeloma
5705276|NCT00482495|stage II multiple myeloma|stage ii multiple myeloma
5705277|NCT00482495|stage III multiple myeloma|stage iii multiple myeloma
5705278|NCT00482482|Yoga|yoga
5705279|NCT00482482|Bipolar disorder|bipolar disorder
5705280|NCT00482482|Major depression|major depression
5705281|NCT00482482|Dysthymia|dysthymia
5705282|NCT00482482|Randomized|randomized
5705284|NCT00482469|ischemia|ischemia
5705285|NCT00482469|reperfusion|reperfusion
5705286|NCT00482469|DIEP-flap|diep-flap
5705287|NCT00482469|flap|flap
5705288|NCT00482456|Nitrous oxide|nitrous oxide
5705289|NCT00482456|Homocysteine|homocysteine
5705290|NCT00482456|folate|folate
5705291|NCT00482456|vitamin B12|vitamin b12
5705292|NCT00482430|Undifferentiated schizophrenia|undifferentiated schizophrenia
5705293|NCT00482430|Residual schizophrenia|residual schizophrenia
5705294|NCT00482391|recurrent breast cancer|recurrent breast cancer
5705295|NCT00482391|stage I breast cancer|stage i breast cancer
5705296|NCT00482391|stage II breast cancer|stage ii breast cancer
5705297|NCT00482391|stage IIIA breast cancer|stage iiia breast cancer
5705298|NCT00482391|stage IIIB breast cancer|stage iiib breast cancer
5705299|NCT00482391|stage IIIC breast cancer|stage iiic breast cancer
5705300|NCT00482391|male breast cancer|male breast cancer
5705301|NCT00482378|stage I multiple myeloma|stage i multiple myeloma
5705302|NCT00482378|stage II multiple myeloma|stage ii multiple myeloma
5705303|NCT00482378|stage III multiple myeloma|stage iii multiple myeloma
5705304|NCT00482378|refractory multiple myeloma|refractory multiple myeloma
5705305|NCT00482378|pain|pain
5705306|NCT00482365|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5705307|NCT00482365|advanced adult primary liver cancer|advanced adult primary liver cancer
5705308|NCT00482365|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5705309|NCT00482365|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5705310|NCT00482365|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5705311|NCT00482339|bacterial contamination|bacterial contamination
5705312|NCT00482339|platelet concentrates|platelet concentrates
5705313|NCT00482339|blood donation|blood donation
5705314|NCT00482339|looxster|looxster
5705315|NCT00482339|pureprove|pureprove
5705316|NCT00482339|bacterial genomic DNA|bacterial genomic dna
5705317|NCT00482339|bacterial contamination of platelet concentrates|bacterial contamination of platelet concentrates
5705318|NCT00482339|"Preparation of bacterial DNA in blood"|"preparation of bacterial dna in blood"
5705319|NCT00482339|comparison of blood culture versus NAT|comparison of blood culture versus nat
5705320|NCT00482313|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5705323|NCT00482313|Treatment|treatment
5705324|NCT00482313|Randomized|randomized
5705325|NCT00482313|Double-Blind|double-blind
5705326|NCT00482313|Placebo Control|placebo control
5705327|NCT00482313|Parallel Assignment|parallel assignment
5705328|NCT00482313|Efficacy Study|efficacy study
5705329|NCT00482300|Histologically proved endometrial carcinoma preoperatively supposed stage I-II|histologically proved endometrial carcinoma preoperatively supposed stage i-ii
5705330|NCT00482274|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5705331|NCT00482274|recurrent prostate cancer|recurrent prostate cancer
5705333|NCT00482274|stage II prostate cancer|stage ii prostate cancer
5705334|NCT00482274|stage III prostate cancer|stage iii prostate cancer
5705335|NCT00482274|stage IV prostate cancer|stage iv prostate cancer
5705336|NCT00482261|myeloma|myeloma
5705337|NCT00482261|relapse|relapse
5705338|NCT00482261|refractory|refractory
5705339|NCT00482261|elderly|elderly
5705340|NCT00482261|lenalidomide|lenalidomide
5705342|NCT00482248|anti-immunoglobulin E|anti-immunoglobulin e
5705343|NCT00482248|omalizumab|omalizumab
5705344|NCT00482248|allergic asthma|allergic asthma
5705345|NCT00482222|adenocarcinoma of the colon|adenocarcinoma of the colon
5705346|NCT00482222|stage IV colon cancer|stage iv colon cancer
5705347|NCT00482222|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5705348|NCT00482222|stage IV rectal cancer|stage iv rectal cancer
5705349|NCT00482222|liver metastases|liver metastases
5705350|NCT00482222|recurrent colon cancer|recurrent colon cancer
5705351|NCT00482222|recurrent rectal cancer|recurrent rectal cancer
5705352|NCT00482209|mifepristone, misoprostol, medical abortion|mifepristone, misoprostol, medical abortion
5705353|NCT00482183|Bare metal stent|bare metal stent
5705354|NCT00482183|Major adverse cardiac events|major adverse cardiac events
5705355|NCT00482183|Pioglitazone|pioglitazone
5705356|NCT00482183|Restenosis|restenosis
5705357|NCT00482183|Sirolimus eluting stent|sirolimus eluting stent
5705358|NCT00482144|Pulsed-Dye Laser|pulsed-dye laser
5705359|NCT00482118|Air Pollution|air pollution
5705360|NCT00482118|Tumor Markers|tumor markers
5705361|NCT00482118|Genetic Polymorphisms|genetic polymorphisms
5705362|NCT00482118|Molecular Epidemiology|molecular epidemiology
5685781|NCT00554827|Relapsed or Refractory Cutaneous T-cell Lymphoma|relapsed or refractory cutaneous t-cell lymphoma
5685782|NCT00554827|Lymphoma|lymphoma
5686807|NCT00550511|ultrasound|ultrasound
5685783|NCT00554827|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5685784|NCT00554827|T-cell Lymphoma|t-cell lymphoma
5685785|NCT00554827|Mycosis fungoides|mycosis fungoides
5680555|NCT00577525|ADENOVIRUS|adenovirus
5705363|NCT00482118|Environmental Epidemiology|environmental epidemiology
5705364|NCT00482105|melanoma|melanoma
5705365|NCT00482092|Crohn's disease|crohn's disease
5705366|NCT00482092|adult stem cell therapy|adult stem cell therapy
5705367|NCT00482066|Wegener's granulomatosis|wegener's granulomatosis
5705368|NCT00482066|Microscopic polyangiitis|microscopic polyangiitis
5705369|NCT00482066|Churg Strauss Syndrome|churg strauss syndrome
5705371|NCT00482040|CPAP|cpap
5705372|NCT00482040|Preterm|preterm
5705373|NCT00482040|Prematurity|prematurity
5705374|NCT00482040|Apnea of prematurity|apnea of prematurity
5705375|NCT00482027|HIV vaccine|hiv vaccine
5705376|NCT00482027|Adeno-associated virus vactored vaccine|adeno-associated virus vactored vaccine
5705377|NCT00482027|HIV-1 subtype C|hiv-1 subtype c
5705378|NCT00482027|Safety|safety
5705379|NCT00482027|Immunogenicity|immunogenicity
5705380|NCT00482027|Biodistribution|biodistribution
5705381|NCT00482027|HIV prevention|hiv prevention
5705382|NCT00482001|Donepezil|donepezil
5705383|NCT00482001|Driving|driving
5705384|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors
5705385|NCT00482001|Geriatric Psychiatry|geriatric psychiatry
5705386|NCT00482001|Psychopharmacology|psychopharmacology
5705387|NCT00482001|Aricept|aricept
5705388|NCT00481988|depression|depression
5705389|NCT00481988|transcranial direct current stimulation|transcranial direct current stimulation
5705390|NCT00481988|direct current stimulation|direct current stimulation
5705391|NCT00481988|tdcs|tdcs
5705392|NCT00481975|binge eating|binge eating
5705393|NCT00481975|eating disorders|eating disorders
5705394|NCT00481975|obesity|obesity
5705395|NCT00481949|Gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5705396|NCT00481949|pH measurement|ph measurement
5705397|NCT00481949|symptom association|symptom association
5705398|NCT00481949|wireless pH monitoring system|wireless ph monitoring system
5705399|NCT00481949|Functional Heartburn|functional heartburn
5705400|NCT00481949|Gastro-esophageal reflux disease|gastro-esophageal reflux disease
5705401|NCT00481936|Neoplasms|neoplasms
5705402|NCT00481936|Neoplasm, Epithelial|neoplasm, epithelial
5705403|NCT00481936|Neoplasm, Glandular|neoplasm, glandular
5705405|NCT00481923|energy intake|energy intake
5705406|NCT00481897|overweight|overweight
5705407|NCT00481897|obesity|obesity
5705408|NCT00481897|type 2 diabetes|type 2 diabetes
5705409|NCT00481897|diabetes|diabetes
5705410|NCT00481897|worksite cost|worksite cost
5705411|NCT00481897|nutrition|nutrition
5705412|NCT00481884|Breast Cancer|breast cancer
5705413|NCT00481884|Radiation Dermatitis|radiation dermatitis
5705414|NCT00481884|RadiaPlexRx Gel|radiaplexrx gel
5705415|NCT00481884|Aquaphor|aquaphor
5705416|NCT00481871|Lymphoproliferative malignancies|lymphoproliferative malignancies
5705417|NCT00481871|Lymphoma|lymphoma
5705418|NCT00481871|Hodgkin's lymphoma (HL)|hodgkin's lymphoma (hl)
5705419|NCT00481871|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5705420|NCT00481871|PTCL|ptcl
5705421|NCT00481871|T/NK-cell leukemia/lymphoma|t/nk-cell leukemia/lymphoma
5705422|NCT00481871|T-cell lymphoma/leukemia (HTLV 1+)|t-cell lymphoma/leukemia (htlv 1+)
5705423|NCT00481871|Angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5705424|NCT00481871|Blastic NK lymphoma|blastic nk lymphoma
5705425|NCT00481871|Anaplastic large cell lymphoma|anaplastic large cell lymphoma
5705426|NCT00481871|T/NK-cell lymphoma|t/nk-cell lymphoma
5705427|NCT00481871|Enteropathy-type intestinal lymphoma|enteropathy-type intestinal lymphoma
5705428|NCT00481871|Hepatosplenic T-cell lymphoma|hepatosplenic t-cell lymphoma
5705429|NCT00481871|Extranodal peripheral T/NK-cell lymphoma|extranodal peripheral t/nk-cell lymphoma
5705430|NCT00481871|Subcutaneous panniculitis T-cell lymphoma|subcutaneous panniculitis t-cell lymphoma
5705431|NCT00481871|Transformed mycosis fungoides|transformed mycosis fungoides
5705433|NCT00481871|Pralatrexate|pralatrexate
5705434|NCT00481871|Gemcitabine|gemcitabine
5705435|NCT00481871|Gemzar|gemzar
5705436|NCT00481871|Vitamin B12|vitamin b12
5705437|NCT00481871|Folic acid|folic acid
5705742|NCT00480597|gemcitabine|gemcitabine
5705438|NCT00481858|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5705439|NCT00481858|biomarker|biomarker
5705440|NCT00481858|prognosis|prognosis
5705441|NCT00481858|apoptosis|apoptosis
5705442|NCT00481858|neoplasm/cancer diagnosis|neoplasm/cancer diagnosis
5705443|NCT00481858|stable isotope|stable isotope
5705444|NCT00481858|diagnosis evaluation|diagnosis evaluation
5705445|NCT00481858|outcomes|outcomes
5705447|NCT00481858|CD5|cd5
5705448|NCT00481819|Kidney Transplantation|kidney transplantation
5705449|NCT00481819|Tacrolimus|tacrolimus
5705450|NCT00481819|Methylprednisolone|methylprednisolone
5705451|NCT00481819|Prednisolone|prednisolone
5705452|NCT00481819|Mycophenolate Mofetil|mycophenolate mofetil
5705453|NCT00481806|Virchow's Triad|virchow's triad
5705454|NCT00481806|Thrombin|thrombin
5705455|NCT00481806|Graft Failure|graft failure
5705456|NCT00481793|Plutonium|plutonium
5705457|NCT00481793|Ionizing Radiation|ionizing radiation
5705458|NCT00481793|Polymorphism|polymorphism
5705459|NCT00481793|Biological Marker|biological marker
5705460|NCT00481793|Russia|russia
5705461|NCT00481767|Safety|safety
5705462|NCT00481767|Immunogenicity|immunogenicity
5705463|NCT00481767|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5705464|NCT00481754|Endometrium|endometrium
5705465|NCT00481754|PTEN|pten
5705466|NCT00481754|Hormones|hormones
5705467|NCT00481754|Carcinogenesis|carcinogenesis
5705468|NCT00481754|Etiology|etiology
5705469|NCT00481754|Tissue Evaluation|tissue evaluation
5705470|NCT00481754|Questionnaire|questionnaire
5705471|NCT00481741|Angioplasty, Percutaneous TransluminalCoronary|angioplasty, percutaneous transluminalcoronary
5705472|NCT00481715|Web-Based Weight Loss Program|web-based weight loss program
5705473|NCT00481715|Cash Incentive Weight Loss Program|cash incentive weight loss program
5705474|NCT00481715|North Carolina|north carolina
5705475|NCT00481689|Cipro|cipro
5705476|NCT00481689|Complicated UTI|complicated uti
5705477|NCT00481689|Pseudomonas aeruginosa|pseudomonas aeruginosa
5705478|NCT00481676|Chronic urticaria, omalizumab, thyroperoxidase, IgE|chronic urticaria, omalizumab, thyroperoxidase, ige
5705479|NCT00481637|paraneoplastic; autoimmunity;|paraneoplastic; autoimmunity;
5705480|NCT00481624|advanced lung cancer|advanced lung cancer
5705481|NCT00481624|Procrit|procrit
5705482|NCT00481624|Epoetin Alfa|epoetin alfa
5705483|NCT00481624|Ferric Gluconate|ferric gluconate
5705484|NCT00481624|iron supplementation|iron supplementation
5705485|NCT00481611|Industry Hygiene|industry hygiene
5705486|NCT00481611|Molecular Epidemiology|molecular epidemiology
5705487|NCT00481611|Cancer Susceptibility|cancer susceptibility
5705488|NCT00481611|Genotoxicity|genotoxicity
5705489|NCT00481611|Immune Function|immune function
5705490|NCT00481611|Cancer Susceptability|cancer susceptability
5705491|NCT00481585|claudin|claudin
5705492|NCT00481585|electrophysiology|electrophysiology
5705493|NCT00481585|breast|breast
5705494|NCT00481585|screening|screening
5705495|NCT00481572|Sepsis|sepsis
5705496|NCT00481572|Septic Shock|septic shock
5705497|NCT00481572|vasopressin|vasopressin
5705498|NCT00481572|terlipressin|terlipressin
5705499|NCT00481559|Voraxaze|voraxaze
5705500|NCT00481559|glucarpidase|glucarpidase
5705501|NCT00481559|carboxypeptidase|carboxypeptidase
5705502|NCT00481559|cancer|cancer
5705503|NCT00481559|lymphoma|lymphoma
5705504|NCT00481559|leukemia|leukemia
5705505|NCT00481559|osteosarcoma|osteosarcoma
5705506|NCT00481559|methotrexate|methotrexate
5705507|NCT00481559|delayed elimination|delayed elimination
5705508|NCT00481559|renal insufficiency|renal insufficiency
5705509|NCT00481559|toxicity|toxicity
5705510|NCT00481546|Leber congenital amaurosis|leber congenital amaurosis
5705511|NCT00481546|LCA|lca
5705512|NCT00481546|RPE65|rpe65
5705513|NCT00481546|Retinal disease due to RPE65 mutations|retinal disease due to rpe65 mutations
5705514|NCT00481546|RPE65-associated Leber congenital amaurosis|rpe65-associated leber congenital amaurosis
5705515|NCT00481533|Cesarean Delivery|cesarean delivery
5705516|NCT00481533|Uterine Contractility|uterine contractility
5705517|NCT00481507|Probiotic|probiotic
5705518|NCT00481507|Cultured dairy drink|cultured dairy drink
5705519|NCT00481507|Health|health
5705520|NCT00481507|10 day antibiotic|10 day antibiotic
5705521|NCT00481507|Otherwise healthy|otherwise healthy
5705522|NCT00481494|Glaucoma|glaucoma
5705523|NCT00481494|Drug compliance|drug compliance
5705524|NCT00481494|Personality|personality
5705525|NCT00481481|Tacrolimus, Kidney Transplantation|tacrolimus, kidney transplantation
5705526|NCT00481468|Coronary artery disease|coronary artery disease
5705527|NCT00481468|chest pain|chest pain
5705528|NCT00481455|Glioblastoma Multiforme|glioblastoma multiforme
5705529|NCT00481455|temozolomide|temozolomide
5705530|NCT00481442|Septic shock|septic shock
5705532|NCT00481442|Norepinephrine|norepinephrine
5705533|NCT00481442|Phenylephrine|phenylephrine
5705534|NCT00481429|Biomarker|biomarker
5705535|NCT00481429|Glitazone|glitazone
5705536|NCT00481429|Diabetes|diabetes
5705537|NCT00481416|Esophageal Varices|esophageal varices
5705538|NCT00481416|PillCam Eso|pillcam eso
5705539|NCT00481416|Capsule Endoscopy|capsule endoscopy
5705540|NCT00481416|Given Imaging|given imaging
5705541|NCT00481416|Inscope|inscope
5705543|NCT00481390|HIV|hiv
5705544|NCT00481390|HLA-B*5701|hla-b*5701
5705545|NCT00481390|prevalence|prevalence
5705546|NCT00481390|Treatment Experienced|treatment experienced
5705547|NCT00481390|Treatment Naive|treatment naive
5705548|NCT00481377|Ablation|ablation
5705549|NCT00481377|Ventricular tachycardia|ventricular tachycardia
5705550|NCT00481377|coronary artery disease|coronary artery disease
5704851|NCT00483886|QOL|qol
5705551|NCT00481377|Implantable cardioverter defibrillator interventions|implantable cardioverter defibrillator interventions
5705552|NCT00481364|hemodialysis|hemodialysis
5705553|NCT00481364|endothelial function|endothelial function
5705554|NCT00481364|coronary artery calcification|coronary artery calcification
5705555|NCT00481364|atherosclerosis|atherosclerosis
5705556|NCT00481364|statin|statin
5705557|NCT00481351|artificial chilomicrons kinetics|artificial chilomicrons kinetics
5705558|NCT00481351|ezetimibe plus statin|ezetimibe plus statin
5705559|NCT00481351|lipid lowering therapy|lipid lowering therapy
5705560|NCT00481338|Cohort|cohort
5705561|NCT00481338|Quality of life|quality of life
5705562|NCT00481338|Health resource use|health resource use
5705563|NCT00481338|Disability|disability
5705564|NCT00481338|Prognosis|prognosis
5705565|NCT00481312|Initial Sedation|initial sedation
5705566|NCT00481312|Mechanical ventilation|mechanical ventilation
5705567|NCT00481299|Insulin|insulin
5705568|NCT00481299|glucose|glucose
5705569|NCT00481299|lipids|lipids
5705570|NCT00481299|prolactinoma|prolactinoma
5705571|NCT00481299|hyperprolactinemia|hyperprolactinemia
5705572|NCT00481286|Group clinics|group clinics
5705573|NCT00481286|Goal setting|goal setting
5705574|NCT00481286|Diabetes|diabetes
5705575|NCT00481286|Hypertension|hypertension
5705576|NCT00481286|Age 50+|age 50+
5705577|NCT00481273|MDS|mds
5705578|NCT00481260|Hgb C|hgb c
5705579|NCT00481260|Screening|screening
5705580|NCT00481247|Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia|chronic phase philadelphia chromosome positive chronic myeloid leukemia
5705581|NCT00481234|Anesthesia, General|anesthesia, general
5705582|NCT00481234|Abnormalities, Cardiovascular|abnormalities, cardiovascular
5705583|NCT00481234|Heart Rate|heart rate
5705584|NCT00481234|Forecasting|forecasting
5705585|NCT00481221|Thalassemia|thalassemia
5705586|NCT00481221|Iron Deficiency|iron deficiency
5705587|NCT00481221|Carrier screening|carrier screening
5705588|NCT00481208|open-angle glaucoma|open-angle glaucoma
5705589|NCT00481208|diurnal fluctuation|diurnal fluctuation
5705590|NCT00481208|intraocular pressure|intraocular pressure
5705591|NCT00481208|peripapillary retinal blood flow|peripapillary retinal blood flow
5705592|NCT00481208|latent asymmetric intraocular pressure|latent asymmetric intraocular pressure
5705593|NCT00481182|PK|pk
5705594|NCT00481182|PD|pd
5705595|NCT00481182|FPV|fpv
5705596|NCT00481182|RTV|rtv
5705597|NCT00481182|APV|apv
5705598|NCT00481182|ritonavir|ritonavir
5705599|NCT00481182|fosamprenavir|fosamprenavir
5705600|NCT00481182|amprenavir|amprenavir
5705601|NCT00481182|methadone|methadone
5705602|NCT00481182|pharmacokinetics|pharmacokinetics
5705603|NCT00481182|pharmacodynamics|pharmacodynamics
5705604|NCT00481169|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5705605|NCT00481143|Myelodysplastic Syndrome|myelodysplastic syndrome
5705606|NCT00481143|MDS|mds
5705607|NCT00481143|iron overload|iron overload
5705608|NCT00481143|chelation|chelation
5705609|NCT00481143|chelators|chelators
5705610|NCT00481143|ICL670|icl670
5705611|NCT00481143|Deferasirox|deferasirox
5705612|NCT00481143|serum ferritin|serum ferritin
5705613|NCT00481143|LIC|lic
5705614|NCT00481143|transfusional hemosiderosis|transfusional hemosiderosis
5705615|NCT00481143|Refractory Anemia|refractory anemia
5705616|NCT00481143|RA|ra
5705617|NCT00481143|Refractory Anemia with Ringed Sideroblasts|refractory anemia with ringed sideroblasts
5705618|NCT00481143|RARS|rars
5705619|NCT00481143|blood transfusions|blood transfusions
5705620|NCT00481143|Mydelodysplastic Syndrome(s)|mydelodysplastic syndrome(s)
5705621|NCT00481130|Alport Syndrome|alport syndrome
5705622|NCT00481130|x linked|x linked
5705623|NCT00481130|autosomal dominant Alport syndrome|autosomal dominant alport syndrome
5705624|NCT00481130|glomerular basement membrane|glomerular basement membrane
5705625|NCT00481130|hereditary nephritis|hereditary nephritis
5705626|NCT00481130|familial benign haematuria|familial benign haematuria
5705627|NCT00481130|type IV collagen|type iv collagen
5705628|NCT00481130|hereditary nephritis with neurosensory deafness|hereditary nephritis with neurosensory deafness
5705629|NCT00481130|vison loss|vison loss
5705630|NCT00481104|Obesity|obesity
5705631|NCT00481065|Bird flu|bird flu
5700106|NCT00500812|paralysis|paralysis
5705632|NCT00481065|influenza vaccine|influenza vaccine
5705633|NCT00481065|Seasonal influenza vaccine|seasonal influenza vaccine
5705634|NCT00481065|Prepandemic vaccine|prepandemic vaccine
5705635|NCT00481052|Adult|adult
5705636|NCT00481052|CML|cml
5705637|NCT00481052|Philadelphia positive|philadelphia positive
5705638|NCT00481052|Nilotinib|nilotinib
5705639|NCT00481052|early chronic phase|early chronic phase
5705743|NCT00480597|vinorelbine|vinorelbine
5705744|NCT00480597|cisplatin|cisplatin
5705640|NCT00481052|untreated or treated only with Hydroxyurea or Anagrelide|untreated or treated only with hydroxyurea or anagrelide
5705641|NCT00481052|Chronic Myeloid Leukemia|chronic myeloid leukemia
5705643|NCT00481039|Sickle cell thalassemia|sickle cell thalassemia
5705644|NCT00481039|Population screening|population screening
5705645|NCT00481013|Spinal Muscular Atrophy|spinal muscular atrophy
5705647|NCT00481000|Dialectical Cognitive Therapy|dialectical cognitive therapy
5704330|NCT00486161|Growth hormone|growth hormone
5705648|NCT00481000|Clinical Psychology|clinical psychology
5705649|NCT00480987|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
5705650|NCT00480987|Acute Myeloid Leukemia|acute myeloid leukemia
5705651|NCT00480987|Leukemia|leukemia
5705652|NCT00480987|Oxaliplatin|oxaliplatin
5705653|NCT00480987|Fludarabine|fludarabine
5705654|NCT00480987|Cytarabine|cytarabine
5705655|NCT00480987|AML|aml
5705656|NCT00480987|MDS|mds
5705657|NCT00480974|Sickle cell anemia|sickle cell anemia
5705658|NCT00480974|Sickle cell thalassemia|sickle cell thalassemia
5705659|NCT00480974|Hydroxyurea|hydroxyurea
5705660|NCT00480948|infant|infant
5705661|NCT00480948|infant formula|infant formula
5705662|NCT00480948|fatty acids|fatty acids
5705663|NCT00480948|palmitic acid|palmitic acid
5705664|NCT00480948|stool|stool
5705665|NCT00480948|calcium|calcium
5705666|NCT00480935|Localized|localized
5705667|NCT00480935|Renal Cell Carcinoma|renal cell carcinoma
5705668|NCT00480935|Neoadjuvant|neoadjuvant
5705669|NCT00480935|Sunitinib Malate (Sutent)|sunitinib malate (sutent)
5705670|NCT00480922|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5705671|NCT00480922|steatohepatitis|steatohepatitis
5705672|NCT00480922|overweight|overweight
5705673|NCT00480922|insulin resistance|insulin resistance
5705674|NCT00480896|Dermatitis, atopic|dermatitis, atopic
5705675|NCT00480896|Tacrolimus|tacrolimus
5705676|NCT00480896|Child|child
5705677|NCT00480896|treatment outcomes|treatment outcomes
5705678|NCT00480883|cutaneous leishmaniasis of the old world|cutaneous leishmaniasis of the old world
5705679|NCT00480870|Alzheimer|alzheimer
5705680|NCT00480870|polysomnography|polysomnography
5705681|NCT00480870|REM sleep|rem sleep
5705682|NCT00480870|donepezil|donepezil
5705683|NCT00480870|sleep apnea|sleep apnea
5705684|NCT00480870|oxygen saturation|oxygen saturation
5705685|NCT00480857|Prostate|prostate
5705686|NCT00480857|Radiation|radiation
5705687|NCT00480844|schizophrenia|schizophrenia
5705688|NCT00480844|Sertindole|sertindole
5705689|NCT00480844|Risperidone|risperidone
5705690|NCT00480844|cognitive impairment|cognitive impairment
5705691|NCT00480831|NSCLC|nsclc
5705692|NCT00480831|Cancer|cancer
5705693|NCT00480831|Avastin|avastin
5705694|NCT00480831|APM4074g|apm4074g
5705695|NCT00480792|Hepatitis B vaccination|hepatitis b vaccination
5705696|NCT00480792|GenHevac-B Pasteur|genhevac-b pasteur
5705697|NCT00480792|HIV Infections|hiv infections
5705698|NCT00480779|Prediabetes|prediabetes
5705699|NCT00480779|Metabolic syndrome|metabolic syndrome
5705700|NCT00480779|Prevention|prevention
5705701|NCT00480779|Lifestyle intervention|lifestyle intervention
5705702|NCT00480766|Glucocorticoid|glucocorticoid
5705703|NCT00480753|Raynaud's phenomenon|raynaud's phenomenon
5705704|NCT00480753|Raynaud's Disease|raynaud's disease
5705705|NCT00480753|Raynaud's disease secondary to scleroderma|raynaud's disease secondary to scleroderma
5705810|NCT00480402|Preterm birth in twin gestations|preterm birth in twin gestations
5705706|NCT00480753|Raynaud's phenomenon secondary to autoimmune disease|raynaud's phenomenon secondary to autoimmune disease
5705707|NCT00480740|Dexmedetomidine|dexmedetomidine
5705708|NCT00480740|Congenital heart disease|congenital heart disease
5705709|NCT00480740|pharmacokinetics|pharmacokinetics
5705710|NCT00480740|pharmacodynamics|pharmacodynamics
5705711|NCT00480740|pediatric|pediatric
5705712|NCT00480740|Bidirectional cavopulmonary anastomosis|bidirectional cavopulmonary anastomosis
5705713|NCT00480740|Fontan physiology|fontan physiology
5705714|NCT00480740|Cardiac transplant|cardiac transplant
5705715|NCT00480727|Halo Thoracic Orthosis|halo thoracic orthosis
5705716|NCT00480727|Re-tension|re-tension
5705717|NCT00480727|Pin loosening|pin loosening
5705719|NCT00480714|Vaccine|vaccine
5705720|NCT00480714|BCG|bcg
5705721|NCT00480701|Alzheimer|alzheimer
5705722|NCT00480701|Parkinson|parkinson
5705723|NCT00480701|dementia|dementia
5705724|NCT00480701|neurologic|neurologic
5705725|NCT00480688|TB|tb
5705726|NCT00480688|BCG|bcg
5705727|NCT00480675|bursitis|bursitis
5705728|NCT00480675|injection|injection
5705729|NCT00480675|fluoroscopy|fluoroscopy
5705730|NCT00480662|Paget's bone disease|paget's bone disease
5705731|NCT00480649|SERETIDE|seretide
5705732|NCT00480649|asthma|asthma
5705733|NCT00480649|Korean|korean
5705734|NCT00480649|ACT|act
5705736|NCT00480623|Biochemical Failure|biochemical failure
5705737|NCT00480623|Radical Prostatectomy|radical prostatectomy
5705738|NCT00480610|Dermatitis, atopic|dermatitis, atopic
5705739|NCT00480610|Tacrolimus|tacrolimus
5705740|NCT00480610|Adult|adult
5705741|NCT00480610|treatment outcomes|treatment outcomes
5705745|NCT00480597|capecitabine|capecitabine
5705746|NCT00480597|pretreated metastatic breast cancer|pretreated metastatic breast cancer
5705748|NCT00480584|gemcitabine|gemcitabine
5705749|NCT00480584|erlotinib (HER1/epidermal growth factor receptor [EGFR] tyrosine kinase inhibitor)|erlotinib (her1/epidermal growth factor receptor [egfr] tyrosine kinase inhibitor)
5705750|NCT00480584|capecitabine|capecitabine
5705751|NCT00480571|chronic schizophrenia or schizo-affective disorder|chronic schizophrenia or schizo-affective disorder
5705753|NCT00480558|MVA85A|mva85a
5705754|NCT00480558|TB|tb
5704450|NCT00485589|RA|ra
5705755|NCT00480558|Tuberculosis|tuberculosis
5705756|NCT00480558|Human Immunodeficiency Virus|human immunodeficiency virus
5705757|NCT00480558|Safety|safety
5705758|NCT00480558|Immunogenicity|immunogenicity
5705759|NCT00480558|Efficacy|efficacy
5705760|NCT00480558|Treatment Naive|treatment naive
5705761|NCT00480545|Women with bleeding disorders|women with bleeding disorders
5705762|NCT00480545|Menstrual cycle|menstrual cycle
5705763|NCT00480545|Women|women
5705764|NCT00480545|Healthy volunteers|healthy volunteers
5705765|NCT00480532|birth control|birth control
5705766|NCT00480532|continuous contraception|continuous contraception
5705767|NCT00480532|break-through bleeding|break-through bleeding
5705769|NCT00480519|meatal stenosis|meatal stenosis
5705770|NCT00480519|local anaesthesia|local anaesthesia
5705771|NCT00480519|feasibility|feasibility
5705772|NCT00480519|pain control|pain control
5705773|NCT00480506|chimerism|chimerism
5705774|NCT00480506|allogenic hematopoietic transplantation|allogenic hematopoietic transplantation
5705775|NCT00480506|assay|assay
5705776|NCT00480480|Trauma|trauma
5705777|NCT00480480|Grief|grief
5705778|NCT00480480|Depression|depression
5705779|NCT00480480|Adolescent|adolescent
5705780|NCT00480480|War|war
5705781|NCT00480480|Group|group
5705782|NCT00480480|Therapy|therapy
5705783|NCT00480480|Treatment|treatment
5705784|NCT00480480|Intervention|intervention
5705785|NCT00480480|School|school
5705786|NCT00480480|Development|development
5705787|NCT00480454|TB|tb
5705788|NCT00480454|Tuberculosis|tuberculosis
5705789|NCT00480454|Infants|infants
5680573|NCT00577304|Raynaud's|raynaud's
5680574|NCT00577304|Nitroglycerin|nitroglycerin
5680575|NCT00577304|Scleroderma|scleroderma
5680576|NCT00577278|graft versus host disease|graft versus host disease
5705790|NCT00480454|EPI|epi
5705791|NCT00480441|Marijuana|marijuana
5705792|NCT00480441|Addiction|addiction
5705793|NCT00480441|Substance Withdrawal Syndrome|substance withdrawal syndrome
5705794|NCT00480441|Clinical Trial|clinical trial
5705795|NCT00480441|Dronabinol|dronabinol
5705796|NCT00480441|Behavioral Therapy|behavioral therapy
5705797|NCT00480441|Adults|adults
5705798|NCT00480441|Neuroimaging|neuroimaging
5705799|NCT00480441|Neuropsychological Testing|neuropsychological testing
5705800|NCT00480441|Neurocognitive Testing|neurocognitive testing
5705801|NCT00480441|Behavioral Probes|behavioral probes
5705802|NCT00480428|Radioactive Fallout|radioactive fallout
5705803|NCT00480428|Childhood Exposures|childhood exposures
5705804|NCT00480428|External Radiation Dose|external radiation dose
5705805|NCT00480428|Internal Radiation Dose to Thyroid Gland|internal radiation dose to thyroid gland
5705806|NCT00480428|Pasture-Dairy Animal- Milk- Thyroid Pathway|pasture-dairy animal- milk- thyroid pathway
5705807|NCT00480402|preterm birth|preterm birth
5705808|NCT00480402|progesterone|progesterone
5705809|NCT00480402|twins|twins
5706016|NCT00479635|Taxane|taxane
5705811|NCT00480389|Clear cell Renal cell carcinoma|clear cell renal cell carcinoma
5705812|NCT00480389|Metastatic|metastatic
5705813|NCT00480389|Sorafenib tosylate|sorafenib tosylate
5705814|NCT00480389|Preoperative treatment|preoperative treatment
5705815|NCT00480376|transrectal biopsy|transrectal biopsy
5705816|NCT00480376|prostate|prostate
5705817|NCT00480376|prophylaxis antibiotic|prophylaxis antibiotic
5705818|NCT00480363|Smoldering Multiple Myeloma|smoldering multiple myeloma
5705819|NCT00480363|PETHEMA|pethema
5705820|NCT00480363|Smoldering|smoldering
5705821|NCT00480350|HIV|hiv
5705822|NCT00480350|virological response|virological response
5705823|NCT00480350|CD4|cd4
5705824|NCT00480350|food supplement|food supplement
5705825|NCT00480350|Human Immunodeficiency Virus|human immunodeficiency virus
5705826|NCT00480350|Complementary Therapies|complementary therapies
5705827|NCT00480337|PCOS|pcos
5705828|NCT00480337|Fertility Preservation|fertility preservation
5705829|NCT00480337|Repeated IVF Failure|repeated ivf failure
5705830|NCT00480337|S/P Hyperstimulation|s/p hyperstimulation
5705831|NCT00480311|symptomatic|symptomatic
5705832|NCT00480311|lumbar spinal stenosis|lumbar spinal stenosis
5705833|NCT00480311|disability|disability
5705834|NCT00480311|fear avoidance beliefs|fear avoidance beliefs
5705835|NCT00480311|quality of life|quality of life
5705836|NCT00480285|Gastroesophageal reflux disease|gastroesophageal reflux disease
5705837|NCT00480285|Laparoscopic Nissen Fundoplication|laparoscopic nissen fundoplication
5705838|NCT00480285|Laparoscopic anterior partial fundoplication|laparoscopic anterior partial fundoplication
5705839|NCT00480272|rheumatoid arthritis|rheumatoid arthritis
5705840|NCT00480272|clinical remission|clinical remission
5705841|NCT00480259|blood urea nitrogen|blood urea nitrogen
5705842|NCT00480259|nitrogen balance|nitrogen balance
5705844|NCT00480259|intensive care|intensive care
5705845|NCT00480246|receptor oocupancy|receptor oocupancy
5705846|NCT00480233|depression|depression
5705847|NCT00480233|screening|screening
5705848|NCT00480233|primary care|primary care
5705849|NCT00480233|validity|validity
5705851|NCT00480233|Primary care and general medical patients|primary care and general medical patients
5705852|NCT00480220|specific care|specific care
5705853|NCT00480220|assistance plan|assistance plan
5685786|NCT00554827|Sézary syndrome|sézary syndrome
5685787|NCT00554827|Primary cutaneous anaplastic large cell|primary cutaneous anaplastic large cell
5685788|NCT00554814|Iron deficiency|iron deficiency
5685789|NCT00554814|Ferritin|ferritin
5705854|NCT00480220|Alzheimer's disease|alzheimer's disease
5705855|NCT00480181|Neuropathic pain|neuropathic pain
5705856|NCT00480181|Multiple Sclerosis|multiple sclerosis
5705857|NCT00480181|Nabilone|nabilone
5705858|NCT00480181|Gabapentin|gabapentin
5705859|NCT00480168|child|child
5705860|NCT00480168|adolescent|adolescent
5705861|NCT00480168|weight gain|weight gain
5705862|NCT00480168|endocrine disruptors|endocrine disruptors
5705863|NCT00480129|grass allergies,|grass allergies,
5705864|NCT00480129|ragweed allergies,|ragweed allergies,
5705865|NCT00480129|probiotics, lactobacillus,|probiotics, lactobacillus,
5705866|NCT00480129|bifidobacterium,|bifidobacterium,
5705867|NCT00480129|functional foods,|functional foods,
5705868|NCT00480129|yogurt,|yogurt,
5705869|NCT00480129|inflammatory cytokines|inflammatory cytokines
5705870|NCT00480116|Consistency|consistency
5705871|NCT00480116|Immunogenicity|immunogenicity
5705872|NCT00480103|Embryo morphological and chromosomal features|embryo morphological and chromosomal features
5705873|NCT00480103|Implantation and pregnancy rate|implantation and pregnancy rate
5705874|NCT00480090|Prostate|prostate
5705875|NCT00480090|Androgen independent|androgen independent
5705876|NCT00480090|Phase II|phase ii
5705877|NCT00480090|Second line|second line
5705878|NCT00480090|Androgen-independent prostate cancer|androgen-independent prostate cancer
5705879|NCT00480077|Heart Failure, randomized, OptiVol® Fluid status monitoring|heart failure, randomized, optivol® fluid status monitoring
5705880|NCT00480064|AML|aml
5705881|NCT00480064|older patients|older patients
5705882|NCT00480064|lomustine|lomustine
5705883|NCT00480051|Cardiac Failure|cardiac failure
5705884|NCT00480051|Pacemaker|pacemaker
5705885|NCT00480051|Dyssynchrony|dyssynchrony
5705886|NCT00480051|Cardiac Magnetic Resonance|cardiac magnetic resonance
5705887|NCT00480051|Narrow QRS|narrow qrs
5705888|NCT00480038|symptomatic|symptomatic
5705889|NCT00480038|lumbar disc herniation|lumbar disc herniation
5705890|NCT00480038|disability|disability
5705891|NCT00480038|fear avoidance beliefs|fear avoidance beliefs
5705892|NCT00480038|quality of life|quality of life
5705893|NCT00480025|ASCI|asci
5705894|NCT00480025|Immunotherapeutic|immunotherapeutic
5705895|NCT00480025|MAGRIT|magrit
5705896|NCT00480025|Tumor antigen|tumor antigen
5705897|NCT00480025|Non-small-cell lung cancer|non-small-cell lung cancer
5705898|NCT00480025|Adjuvant cancer therapy|adjuvant cancer therapy
5705899|NCT00480012|healthy subjects|healthy subjects
5705900|NCT00479999|HIV-Negative|hiv-negative
5705901|NCT00479999|Healthy|healthy
5705902|NCT00479999|Immunity|immunity
5705903|NCT00479999|Preventive|preventive
5705904|NCT00479999|Virus|virus
5705905|NCT00479999|Healthy Volunteer|healthy volunteer
5705906|NCT00479999|HV|hv
5705907|NCT00479999|HIV Preventive Vaccine|hiv preventive vaccine
5705908|NCT00479986|diabetes mellitus|diabetes mellitus
5705909|NCT00479986|monocyte activation|monocyte activation
5706017|NCT00479635|MDR|mdr
5705910|NCT00479986|cardiovascular risk|cardiovascular risk
5705911|NCT00479973|diabetes|diabetes
5705912|NCT00479973|non-insulin dependant diabetes|non-insulin dependant diabetes
5705913|NCT00479973|type 2 diabetes|type 2 diabetes
5705914|NCT00479973|cinnamon|cinnamon
5705915|NCT00479973|natural health product|natural health product
5705916|NCT00479973|hypercholesterolemia|hypercholesterolemia
5705917|NCT00479973|dyslipidemia|dyslipidemia
5705918|NCT00479973|elevated cholesterol|elevated cholesterol
5705919|NCT00479960|Asthenozoospermia|asthenozoospermia
5705920|NCT00479960|Azoospermia|azoospermia
5705921|NCT00479960|Oligospermia|oligospermia
5705922|NCT00479960|Omega-3|omega-3
5705923|NCT00479960|Fatty Acids|fatty acids
5705924|NCT00479947|Yeast vaginitis|yeast vaginitis
5705925|NCT00479947|Probiotics|probiotics
5705926|NCT00479947|Lactobacilli|lactobacilli
5705927|NCT00479947|Fluconazole|fluconazole
5705928|NCT00479934|scleroderma|scleroderma
5705929|NCT00479934|imatinib|imatinib
5705930|NCT00479934|PDGFR|pdgfr
5705931|NCT00479934|Rodnan|rodnan
5705932|NCT00479921|Influenza|influenza
5705933|NCT00479921|Vaccine|vaccine
5705934|NCT00479921|CHMP criteria|chmp criteria
5705935|NCT00479908|Blood pressure|blood pressure
5705936|NCT00479908|Angina|angina
5705937|NCT00479908|Sildenafil|sildenafil
5700443|NCT00499785|depression|depression
5705938|NCT00479908|Phosphodiesterase type 5|phosphodiesterase type 5
5705940|NCT00479908|Glyceryl trinitrate|glyceryl trinitrate
5705941|NCT00479908|Drug interaction|drug interaction
5705942|NCT00479895|Percutaneous Coronary Intervention|percutaneous coronary intervention
5705943|NCT00479895|Myocardial Ischemia|myocardial ischemia
5705944|NCT00479895|Balloon Occlusion|balloon occlusion
5705945|NCT00479895|Catheter Lab|catheter lab
5705946|NCT00479856|ErbB1|erbb1
5705947|NCT00479856|ErbB2|erbb2
5705950|NCT00479856|Relapsed breast cancer|relapsed breast cancer
5705951|NCT00479856|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
5705953|NCT00479856|EGFR|egfr
5705954|NCT00479856|Her-2/neu|her-2/neu
5705955|NCT00479856|FISH amplification|fish amplification
5705956|NCT00479843|Alzheimer Disease|alzheimer disease
5705957|NCT00479843|Dementia|dementia
5705958|NCT00479843|Elderly|elderly
5705959|NCT00479843|Nutrition|nutrition
5705960|NCT00479843|Malnutrition|malnutrition
5705961|NCT00479843|Weight Loss|weight loss
5705962|NCT00479830|Epidemiology|epidemiology
5705963|NCT00479830|Health Risks|health risks
5705964|NCT00479830|Questionnaire|questionnaire
5705965|NCT00479830|Interview|interview
5705966|NCT00479830|South Asian|south asian
5705967|NCT00479830|Asian Indian|asian indian
5705968|NCT00479830|Bangladeshi|bangladeshi
5705969|NCT00479830|Pakistani|pakistani
5705970|NCT00479830|Sri Lankan|sri lankan
5705971|NCT00479817|Advanced Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer|advanced recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
5705972|NCT00479804|indication for CMR|indication for cmr
5705973|NCT00479791|Type 2 diabetes mellitus|type 2 diabetes mellitus
5722327|NCT00423657|TAK-599|tak-599
5705974|NCT00479791|Fatty acids|fatty acids
5705975|NCT00479791|Postprandial response|postprandial response
5705976|NCT00479791|Insulin|insulin
5705977|NCT00479791|Glucose|glucose
5705978|NCT00479791|Triglycerides|triglycerides
5705979|NCT00479778|Postmenopause|postmenopause
5705980|NCT00479765|glioblastoma multiforme|glioblastoma multiforme
5705981|NCT00479765|recurrent|recurrent
5705982|NCT00479765|Phase 1|phase 1
5705983|NCT00479765|Phase 2|phase 2
5705984|NCT00479765|Phase I|phase i
5705985|NCT00479765|Phase II|phase ii
5705986|NCT00479765|brain|brain
5714864|NCT00447642|cornea|cornea
5705987|NCT00479765|cancer|cancer
5705988|NCT00479765|paclitaxel|paclitaxel
5705989|NCT00479765|intracranial|intracranial
5705990|NCT00479765|tumor|tumor
5705991|NCT00479765|local|local
5705992|NCT00479765|chemotherapy|chemotherapy
5705993|NCT00479765|brain tumor|brain tumor
5705994|NCT00479765|brain cancer|brain cancer
5705995|NCT00479765|glioma|glioma
5705996|NCT00479765|OncoGel|oncogel
5705997|NCT00479739|formoterol/budesonide|formoterol/budesonide
5705998|NCT00479739|exacerbations|exacerbations
5705999|NCT00479739|Salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5706000|NCT00479739|adjustable maintenance dosing|adjustable maintenance dosing
5706001|NCT00479739|asthma control|asthma control
5706002|NCT00479713|High Cholesterol|high cholesterol
5706003|NCT00479687|Osteoarthritis|osteoarthritis
5706004|NCT00479687|Shoulder|shoulder
5706006|NCT00479674|Metastatic Breast Cancer|metastatic breast cancer
5706007|NCT00479674|Advanced Breast Cancer|advanced breast cancer
5706008|NCT00479674|Hormone Receptor AND Her2/neu Negative|hormone receptor and her2/neu negative
5706009|NCT00479674|Triple Negative|triple negative
5706010|NCT00479674|Triple Negative Breast Cancer|triple negative breast cancer
5706011|NCT00479674|Stage IV or Inoperable Stage III Breast Cancer|stage iv or inoperable stage iii breast cancer
5706012|NCT00479661|initial sedation|initial sedation
5706013|NCT00479661|mechanical ventilation|mechanical ventilation
5706014|NCT00479635|HRPC|hrpc
5706015|NCT00479635|TPI 287|tpi 287
5706018|NCT00479635|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5706019|NCT00479622|Membranous Nephropathy|membranous nephropathy
5706020|NCT00479622|Systemic Lupus Erythematosus|systemic lupus erythematosus
5706021|NCT00479609|Insulin resistance|insulin resistance
5706022|NCT00479609|Glucose tolerance|glucose tolerance
5706023|NCT00479609|Type 2 diabetes|type 2 diabetes
5706024|NCT00479609|Androgen sensitivity|androgen sensitivity
5706025|NCT00479596|Overactive Bladder|overactive bladder
5706027|NCT00479596|Refractory OAB|refractory oab
5706028|NCT00479596|Botox|botox
5706029|NCT00479596|Bladder|bladder
5706030|NCT00479583|Cancer (solid tumors)|cancer (solid tumors)
5706031|NCT00479557|Alzheimer's Disease|alzheimer's disease
5706032|NCT00479557|active immunization|active immunization
5706033|NCT00479531|Restless Legs Syndrome|restless legs syndrome
5706034|NCT00479531|Sequential Compression Device|sequential compression device
5706035|NCT00479531|Sleep Quality|sleep quality
5706036|NCT00479531|Quality of Life|quality of life
5706037|NCT00479518|stroke|stroke
5706038|NCT00479518|transient ischemic attack|transient ischemic attack
5706039|NCT00479518|albuminuria|albuminuria
5706040|NCT00479518|BNP|bnp
5706041|NCT00479518|Cystatin C|cystatin c
5706042|NCT00479492|Obesity, weight loss|obesity, weight loss
5706043|NCT00479479|cobalamin|cobalamin
5706045|NCT00479479|homocysteine|homocysteine
5706046|NCT00479479|folate|folate
5706047|NCT00479479|newborns|newborns
5706048|NCT00479479|infants|infants
5706049|NCT00479479|Deficiency Disease|deficiency disease
5706050|NCT00479479|Breastfeeding|breastfeeding
5706051|NCT00479479|Infant|infant
5706052|NCT00479427|osteoarthritis pain assessments|osteoarthritis pain assessments
5706053|NCT00479375|screening|screening
5706054|NCT00479375|human papillomavirus|human papillomavirus
5706055|NCT00479362|Pacemaker|pacemaker
5706056|NCT00479362|Cardioverter-defibrillator|cardioverter-defibrillator
5706057|NCT00479362|Hemorrhage|hemorrhage
5706058|NCT00479362|Hematoma|hematoma
5706059|NCT00479362|Thrombosis|thrombosis
5706060|NCT00479362|Embolism|embolism
5706061|NCT00479336|OPC-41061|opc-41061
5706062|NCT00479336|Tolvaptan|tolvaptan
5706063|NCT00479336|ascites|ascites
5706064|NCT00479336|Cirrhosis|cirrhosis
5706065|NCT00479323|pneumococcal vaccine, Pneumovax, reference sera, serum 89SF|pneumococcal vaccine, pneumovax, reference sera, serum 89sf
5706066|NCT00479284|Non-invasive ventilation|non-invasive ventilation
5706067|NCT00479284|Polysomnography|polysomnography
5706068|NCT00479284|Average volume assured pressure support|average volume assured pressure support
5706070|NCT00479271|Dementia|dementia
5706071|NCT00479271|community trial|community trial
5706072|NCT00479271|Homebased care|homebased care
5706073|NCT00479271|caregiver burden|caregiver burden
5706074|NCT00479271|Behavioural problems|behavioural problems
5706075|NCT00479271|Dementia in subjects|dementia in subjects
5706076|NCT00479271|behavioral problems in subjects|behavioral problems in subjects
5706077|NCT00479271|Mental health of carers|mental health of carers
5722428|NCT00423436|Survey|survey
5706078|NCT00479245|nonspecific low back pain|nonspecific low back pain
5706079|NCT00479245|disability|disability
5706080|NCT00479245|fear avoidance beliefs|fear avoidance beliefs
5706081|NCT00479245|quality of life|quality of life
5706082|NCT00479232|Leukemia|leukemia
5706083|NCT00479232|Myelocytic|myelocytic
5706084|NCT00479232|Acute Myelodysplastic Syndromes|acute myelodysplastic syndromes
5706085|NCT00479206|artesuante|artesuante
5706086|NCT00479206|falciparum malaria|falciparum malaria
5706087|NCT00479206|Cambodia|cambodia
5706088|NCT00479206|Artemisinin resistance|artemisinin resistance
5680577|NCT00577278|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5680578|NCT00577278|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5706089|NCT00479193|Burns|burns
5706090|NCT00479193|Dressing change|dressing change
5706091|NCT00479180|Hemodialysis access|hemodialysis access
5706092|NCT00479180|Arteriovenous graft|arteriovenous graft
5706093|NCT00479180|Arteriovenous fistula|arteriovenous fistula
5706094|NCT00479180|End stage renal disease|end stage renal disease
5706095|NCT00479167|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5706096|NCT00479167|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5706097|NCT00479167|Lymphoma|lymphoma
5706098|NCT00479154|Restless Leg Syndrome|restless leg syndrome
5706099|NCT00479154|Botulinum Toxin|botulinum toxin
5706101|NCT00479141|Treatment Naive|treatment naive
5706102|NCT00479141|Treatment Experienced|treatment experienced
5706103|NCT00479141|Complementary Therapies|complementary therapies
5706104|NCT00479128|Solid Tumor|solid tumor
5706105|NCT00479128|Bladder Cancer|bladder cancer
5706106|NCT00479128|Ureteral Cancer|ureteral cancer
5706107|NCT00479128|Urothelial Cancer|urothelial cancer
5706108|NCT00479128|Urethral Cancer|urethral cancer
5706109|NCT00479128|Renal Pelvis Tumor|renal pelvis tumor
5706110|NCT00479128|Bortezomib|bortezomib
5706111|NCT00479128|Gemcitabine|gemcitabine
5706112|NCT00479128|Doxorubicin|doxorubicin
5706113|NCT00479128|Gemzar|gemzar
5706114|NCT00479128|Adriamycin|adriamycin
5706115|NCT00479128|Velcade|velcade
5706116|NCT00479128|LDP-341|ldp-341
5706117|NCT00479128|MLN341|mln341
5706118|NCT00479128|PS-341|ps-341
5706119|NCT00479128|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5706121|NCT00479128|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5706122|NCT00479102|Iron supplementation|iron supplementation
5706123|NCT00479102|Babies|babies
5706124|NCT00479102|Prevention|prevention
5706125|NCT00479089|Transitional Cell Carcinoma|transitional cell carcinoma
5706126|NCT00479089|Urothelium|urothelium
5706127|NCT00479089|Urothelial Cancer|urothelial cancer
5706128|NCT00479089|Bladder Cancer|bladder cancer
5706129|NCT00479089|Docetaxel|docetaxel
5706130|NCT00479089|Taxotere|taxotere
5706131|NCT00479089|ZD1839|zd1839
5706132|NCT00479089|Gefitinib|gefitinib
5706133|NCT00479089|Iressa|iressa
5706134|NCT00479089|Consolidation Therapy|consolidation therapy
5706135|NCT00479076|antineoplastic agents|antineoplastic agents
5706136|NCT00479076|VEGF Trap|vegf trap
5706137|NCT00479063|MODIC changes|modic changes
5706138|NCT00479063|chronic low back pain|chronic low back pain
5706139|NCT00479063|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5706140|NCT00479063|vertebrae|vertebrae
5706141|NCT00479063|intervertebral disc|intervertebral disc
5706142|NCT00479050|Hepatocellular carcinoma,treatment|hepatocellular carcinoma,treatment
5706143|NCT00479037|postmenopausal women with primary osteoporosis|postmenopausal women with primary osteoporosis
5706145|NCT00479011|arterial pulse pressure variation|arterial pulse pressure variation
5706146|NCT00479011|high-risk surgery|high-risk surgery
5706147|NCT00478998|expulsion therapy|expulsion therapy
5706148|NCT00478998|tamsulosin|tamsulosin
5706149|NCT00478998|ureterolithiasis|ureterolithiasis
5706150|NCT00478998|stents|stents
5706151|NCT00478985|Leukemia|leukemia
5706152|NCT00478985|Adult Chronic|adult chronic
5706153|NCT00478985|Myeloid|myeloid
5706154|NCT00478972|obese|obese
5706155|NCT00478972|diabetes|diabetes
5706156|NCT00478972|cannabinoid-1 receptor|cannabinoid-1 receptor
5685790|NCT00554814|Encapsulated iron|encapsulated iron
5685791|NCT00554814|Infant formula|infant formula
5685792|NCT00554801|Central Auditory Processing|central auditory processing
5706157|NCT00478959|Lenalidomide|lenalidomide
5706161|NCT00478959|Hodgkin's Lymphoma|hodgkin's lymphoma
5706162|NCT00478959|Hodgkin's Disease|hodgkin's disease
5706163|NCT00478959|Lymphoma|lymphoma
5706164|NCT00478946|colorectal cancer|colorectal cancer
5706165|NCT00478946|picoplatin|picoplatin
5706166|NCT00478946|FOLFOX|folfox
5706167|NCT00478946|FOLPI|folpi
5706168|NCT00478946|chemotherapy|chemotherapy
5706169|NCT00478933|Arrhythmia|arrhythmia
5706170|NCT00478933|Ventricular|ventricular
5706171|NCT00478933|Atrial|atrial
5706172|NCT00478933|Tachycardia|tachycardia
5706173|NCT00478933|Fibrillation|fibrillation
5706174|NCT00478933|Flutter|flutter
5706175|NCT00478933|GNB3|gnb3
5706176|NCT00478933|GNAS|gnas
5706177|NCT00478933|GNAQ|gnaq
5706178|NCT00478907|oculocardiac reflex; strabismus surgery;|oculocardiac reflex; strabismus surgery;
5706179|NCT00478894|Anterior cruciate ligament / injuries|anterior cruciate ligament / injuries
5706180|NCT00478894|Anterior cruciate ligament / surgery|anterior cruciate ligament / surgery
5706181|NCT00478894|knee injuries / surgery|knee injuries / surgery
5706182|NCT00478894|outcomes research|outcomes research
5706183|NCT00478894|prospective studies|prospective studies
5706184|NCT00478894|osteoarthritis|osteoarthritis
5706185|NCT00478868|MODIC changes|modic changes
5706186|NCT00478868|chronic low back pain|chronic low back pain
5706187|NCT00478868|magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5706188|NCT00478868|vertebrae|vertebrae
5706189|NCT00478868|intervertebral disc|intervertebral disc
5706190|NCT00478842|Gilles de la Tourette syndrome|gilles de la tourette syndrome
5706191|NCT00478842|Deep brain stimulation|deep brain stimulation
5706192|NCT00478842|Globus PALLIDUS|globus pallidus
5706193|NCT00478816|Bird flu|bird flu
5706194|NCT00478816|influenza vaccine|influenza vaccine
5706195|NCT00478816|prepandemic vaccine|prepandemic vaccine
5706196|NCT00478803|Standardized surgical procedure|standardized surgical procedure
5706197|NCT00478803|Aortic root aneurysm|aortic root aneurysm
5706198|NCT00478803|Dystrophic aortic insufficiency|dystrophic aortic insufficiency
5706199|NCT00478803|Conservative aortic valve surgery|conservative aortic valve surgery
5706200|NCT00478803|Aortic annuloplasty|aortic annuloplasty
5706201|NCT00478803|Mechanical aortic valve replacement|mechanical aortic valve replacement
5706202|NCT00478803|Sinus of Valsalva|sinus of valsalva
5706203|NCT00478803|Cardiac Surgical Procedures|cardiac surgical procedures
5706204|NCT00478790|Glaucoma|glaucoma
5706205|NCT00478790|Pterygium|pterygium
5706206|NCT00478790|collagen matrix|collagen matrix
5706207|NCT00478790|OculusGen|oculusgen
5706208|NCT00478790|trabeculectomy|trabeculectomy
5706209|NCT00478790|Anti scarring|anti scarring
5706210|NCT00478790|pterygium recurrence|pterygium recurrence
5706211|NCT00478790|tissue engineering|tissue engineering
5706212|NCT00478790|ologen|ologen
5706213|NCT00478790|Aeon Astron|aeon astron
5706214|NCT00478777|CC-5013|cc-5013
5706215|NCT00478777|Revlimid|revlimid
5706216|NCT00478777|Lenalidomide|lenalidomide
5706217|NCT00478777|Celgene|celgene
5706218|NCT00478777|Multiple Myeloma|multiple myeloma
5706219|NCT00478764|intraocular|intraocular
5706220|NCT00478764|triamcinolone|triamcinolone
5706221|NCT00478764|gatifloxicin|gatifloxicin
5706222|NCT00478764|inflammation|inflammation
5706223|NCT00478764|visual acuity|visual acuity
5706224|NCT00478751|Visible light, Long UVA,Pigmentation|visible light, long uva,pigmentation
5706225|NCT00478751|Normal healthy volunteers with dark skin type.|normal healthy volunteers with dark skin type.
5706226|NCT00478738|b-agonist,|b-agonist,
5706227|NCT00478738|COPD.|copd.
5706228|NCT00478738|pharmacodynamic,|pharmacodynamic,
5706229|NCT00478738|pharmacokinetic,|pharmacokinetic,
5706230|NCT00478738|anti muscarinic,|anti muscarinic,
5706231|NCT00478725|Metastatic Cancer|metastatic cancer
5706232|NCT00478725|Advanced Cancer|advanced cancer
5706233|NCT00478712|Hirschsprung|hirschsprung
5706234|NCT00478699|SCAT|scat
5706235|NCT00478699|BRCA1|brca1
5706236|NCT00478699|BRCA1 mRNA Levels|brca1 mrna levels
5706237|NCT00478699|ADJUVANT|adjuvant
5706238|NCT00478699|LUNG|lung
5706239|NCT00478699|GECP-SCAT|gecp-scat
5706240|NCT00478686|Breast Cancer|breast cancer
5706241|NCT00478686|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5706242|NCT00478686|DPYD|dpyd
5706243|NCT00478686|DPYD Variants|dpyd variants
5706244|NCT00478686|Toxicity|toxicity
5706245|NCT00478686|Capecitabine|capecitabine
5706247|NCT00478673|NexStent|nexstent
5706248|NCT00478673|FilterWire EZ|filterwire ez
5706249|NCT00478673|Boston Scientific|boston scientific
5706250|NCT00478673|Carotid Artery|carotid artery
5706251|NCT00478673|Carotid Endarterectomy|carotid endarterectomy
5706252|NCT00478673|Carotid Revascularization|carotid revascularization
5706253|NCT00478647|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5706254|NCT00478647|human|human
5685793|NCT00554801|Traumatic Brain Injury|traumatic brain injury
5685794|NCT00554801|Hearing Loss|hearing loss
5685795|NCT00554775|tumors metastatic to brain|tumors metastatic to brain
5685796|NCT00554775|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5706255|NCT00478647|glucocerebrosidase|glucocerebrosidase
5706256|NCT00478647|Gaucher disease|gaucher disease
5706257|NCT00478647|Enzyme Replacement Therapy|enzyme replacement therapy
5706258|NCT00478647|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5706259|NCT00478647|glucosylceramidase|glucosylceramidase
5706260|NCT00478647|gene activation|gene activation
5706261|NCT00478647|beta-glucocerebrosidase|beta-glucocerebrosidase
5706262|NCT00478634|Colorectal Cancer|colorectal cancer
5706263|NCT00478634|Colorectal Carcinoma|colorectal carcinoma
5706264|NCT00478634|Colorectal Tumors|colorectal tumors
5706265|NCT00478634|Neoplasms, Colorectal|neoplasms, colorectal
5706267|NCT00478595|obese|obese
5706268|NCT00478595|diabetes|diabetes
5706269|NCT00478595|cannabinoid-1 receptor|cannabinoid-1 receptor
5706270|NCT00478582|Anemia|anemia
5706271|NCT00478582|Visual scale|visual scale
5706272|NCT00478582|nephrological patients|nephrological patients
5706273|NCT00478582|Anemia in nephrological patients|anemia in nephrological patients
5706274|NCT00478556|CT scan|ct scan
5706275|NCT00478556|oral contrast|oral contrast
5706276|NCT00478543|Loop diuretics|loop diuretics
5706277|NCT00478543|Chronic Kidney Disease|chronic kidney disease
5706278|NCT00478543|Hypertension|hypertension
5706279|NCT00478543|Blood pressure control|blood pressure control
5706280|NCT00478543|Left ventricular mass|left ventricular mass
5706281|NCT00478517|Spinal trauma|spinal trauma
5706282|NCT00478517|erythropoietin|erythropoietin
5706283|NCT00478517|dose escalation study|dose escalation study
5706284|NCT00478504|anovulation|anovulation
5706285|NCT00478504|ovulation induction,|ovulation induction,
5706286|NCT00478504|polycystic ovarian syndrome|polycystic ovarian syndrome
5706287|NCT00478504|clomifene citrate|clomifene citrate
5706288|NCT00478504|letrozole|letrozole
5706289|NCT00478478|Stroke|stroke
5706290|NCT00478478|Ischemic|ischemic
5706291|NCT00478478|Thrombus|thrombus
5706292|NCT00478478|Embolectomy|embolectomy
5706293|NCT00478478|Thrombectomy|thrombectomy
5706294|NCT00478478|Merci|merci
5706295|NCT00478478|Concentric|concentric
5706296|NCT00478478|Embolus|embolus
5706297|NCT00478478|Embolism|embolism
5706298|NCT00478478|Mechanical|mechanical
5706299|NCT00478465|chronic fatigue syndrome|chronic fatigue syndrome
5706300|NCT00478465|fatigue|fatigue
5706301|NCT00478465|valganciclovir|valganciclovir
5706302|NCT00478465|valcyte|valcyte
5706303|NCT00478465|Epstein-Barr virus|epstein-barr virus
5706304|NCT00478465|EBV|ebv
5706305|NCT00478465|Human herpes virus 6|human herpes virus 6
5706306|NCT00478465|HHV 6|hhv 6
5706307|NCT00478465|herpes viruses|herpes viruses
5706308|NCT00478465|herpes|herpes
5706309|NCT00478439|aging|aging
5706310|NCT00478439|age-related macular degeneration|age-related macular degeneration
5706311|NCT00478439|macular pigment|macular pigment
5706312|NCT00478439|dark adaptation|dark adaptation
5706313|NCT00478400|Recovery|recovery
5706314|NCT00478400|Magnetic resonance imaging|magnetic resonance imaging
5706315|NCT00478400|Awareness|awareness
5706316|NCT00478400|Neurologic deficits|neurologic deficits
5706317|NCT00478387|Advanced Ovarian and Primary Peritoneal Cancer in Remission|advanced ovarian and primary peritoneal cancer in remission
5706318|NCT00478348|Postoperative Complications|postoperative complications
5706319|NCT00478348|Drainage|drainage
5706320|NCT00478348|Infection|infection
5706321|NCT00478348|Seroma|seroma
5706322|NCT00478348|Hematoma|hematoma
5706323|NCT00478348|Recurrence|recurrence
5706324|NCT00478348|Abdominal Wall|abdominal wall
5706325|NCT00478348|Hernia|hernia
5706326|NCT00478348|Surgical Mesh|surgical mesh
5706327|NCT00478335|congenital nephrogenic diabetes insipidus|congenital nephrogenic diabetes insipidus
5706328|NCT00478335|polyuria|polyuria
5706329|NCT00478335|urine osmolality|urine osmolality
5706330|NCT00478335|aquaporin-2|aquaporin-2
5706331|NCT00478335|vasopressin V2 receptor|vasopressin v2 receptor
5706332|NCT00478322|Diabetes;|diabetes;
5706333|NCT00478322|Type II diabetes;|type ii diabetes;
5706334|NCT00478322|Non-insulin dependent diabetes;|non-insulin dependent diabetes;
5706335|NCT00478322|Obesity|obesity
5706336|NCT00478309|colon cancer|colon cancer
5706337|NCT00478309|rectal cancer|rectal cancer
5706338|NCT00478309|healthy, no evidence of disease|healthy, no evidence of disease
5706339|NCT00478296|Pulmonary hypertension|pulmonary hypertension
5706340|NCT00478296|Sildenafil|sildenafil
5706341|NCT00478296|Bosentan|bosentan
5706342|NCT00478296|Trisomy 21|trisomy 21
5706343|NCT00478296|Atrial septal defect|atrial septal defect
5706344|NCT00478283|breast cancer|breast cancer
5706345|NCT00478257|fatigue|fatigue
5706346|NCT00478257|sleep|sleep
5706347|NCT00478257|quality of life|quality of life
5706348|NCT00478257|light|light
5685797|NCT00554775|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5685798|NCT00554762|mechanical pain,|mechanical pain,
5685799|NCT00554762|heat pain,|heat pain,
5685800|NCT00554762|dose,|dose,
5705055|NCT00483223|p63|p63
5706349|NCT00478257|cancer|cancer
5706350|NCT00478244|epidermolysis bullosa|epidermolysis bullosa
5706351|NCT00478244|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa
5706352|NCT00478231|Multicenter|multicenter
5706353|NCT00478231|Open Label|open label
5706354|NCT00478231|Non-Comparative Safety Study Of Maraviroc|non-comparative safety study of maraviroc
5706355|NCT00478231|Treatment Experienced|treatment experienced
5706356|NCT00478218|stage I multiple myeloma|stage i multiple myeloma
5706357|NCT00478218|stage II multiple myeloma|stage ii multiple myeloma
5706358|NCT00478218|stage III multiple myeloma|stage iii multiple myeloma
5706359|NCT00478205|Moderate to Severe Alzheimer's Disease|moderate to severe alzheimer's disease
5706360|NCT00478192|hyponatremia|hyponatremia
5706361|NCT00478192|hypervolemic|hypervolemic
5706362|NCT00478192|euvolemic|euvolemic
5706365|NCT00478179|herpes zoster|herpes zoster
5706366|NCT00478179|shingles|shingles
5706368|NCT00478179|post herpetic neuralgia|post herpetic neuralgia
5706369|NCT00478179|neuropathic pain|neuropathic pain
5706370|NCT00478114|Renal Cell Carcinoma|renal cell carcinoma
5706371|NCT00478114|Sorafenib|sorafenib
5706372|NCT00478101|Pain|pain
5706373|NCT00478088|Single Level|single level
5706374|NCT00478088|Cervical Disc Disease|cervical disc disease
5706375|NCT00478075|stage I multiple myeloma|stage i multiple myeloma
5706376|NCT00478075|stage II multiple myeloma|stage ii multiple myeloma
5706377|NCT00478075|stage III multiple myeloma|stage iii multiple myeloma
5706378|NCT00478075|refractory multiple myeloma|refractory multiple myeloma
5706379|NCT00478062|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5706380|NCT00478062|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5706381|NCT00478062|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5706382|NCT00478062|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5706383|NCT00478049|Non-Small Cell Lung Cancer|non-small cell lung cancer
5706384|NCT00478036|glaucoma|glaucoma
5706385|NCT00478036|selective laser trabeculoplasty|selective laser trabeculoplasty
5706386|NCT00478036|anterior chamber flare|anterior chamber flare
5706387|NCT00478023|Opioid|opioid
5706388|NCT00478023|Central acting analgesic|central acting analgesic
5706389|NCT00478023|Pain postoperative|pain postoperative
5706390|NCT00478023|Abdomen acute|abdomen acute
5706391|NCT00478023|CG5503 IR|cg5503 ir
5731652|NCT00388154|Gemzar|gemzar
5706392|NCT00478023|Morphine|morphine
5706393|NCT00478023|Placebo|placebo
5706394|NCT00478010|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5706395|NCT00478010|stage III colon cancer|stage iii colon cancer
5706396|NCT00478010|stage IV colon cancer|stage iv colon cancer
5706397|NCT00478010|stage III rectal cancer|stage iii rectal cancer
5706398|NCT00478010|stage IV rectal cancer|stage iv rectal cancer
5706399|NCT00478010|stage II pancreatic cancer|stage ii pancreatic cancer
5706400|NCT00478010|stage III pancreatic cancer|stage iii pancreatic cancer
5706401|NCT00478010|stage IV pancreatic cancer|stage iv pancreatic cancer
5706402|NCT00477997|Growth Hormone|growth hormone
5706403|NCT00477997|Insulin Signaling|insulin signaling
5706404|NCT00477997|GH signaling|gh signaling
5706405|NCT00477984|Alcohol|alcohol
5706406|NCT00477984|Driving|driving
5706407|NCT00477984|Multitasking|multitasking
5706409|NCT00477984|social drinkers|social drinkers
5706410|NCT00477971|primary systemic amyloidosis|primary systemic amyloidosis
5706411|NCT00477958|cognitive/functional effects|cognitive/functional effects
5706412|NCT00477958|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5706413|NCT00477958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5706414|NCT00477945|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5706415|NCT00477945|High Risk or Refractory Non Hodgkin's Lymphoma|high risk or refractory non hodgkin's lymphoma
5706416|NCT00477945|APBSCT|apbsct
5706417|NCT00477945|clofarabine|clofarabine
5706901|NCT00476359|Saquinavir|saquinavir
5706418|NCT00477932|Pentalogy of Cantrell|pentalogy of cantrell
5706419|NCT00477932|mutations|mutations
5706420|NCT00477932|DNA|dna
5706421|NCT00477932|RNA|rna
5706422|NCT00477919|stage IV melanoma|stage iv melanoma
5706423|NCT00477919|stage IV renal cell cancer|stage iv renal cell cancer
5706424|NCT00477919|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5706425|NCT00477919|advanced malignant mesothelioma|advanced malignant mesothelioma
5706426|NCT00477919|stage IV prostate cancer|stage iv prostate cancer
5706427|NCT00477919|adult giant cell glioblastoma|adult giant cell glioblastoma
5706428|NCT00477919|adult gliosarcoma|adult gliosarcoma
5706429|NCT00477919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5706430|NCT00477919|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5706431|NCT00477919|stage IV colon cancer|stage iv colon cancer
5706432|NCT00477919|stage IV gastric cancer|stage iv gastric cancer
5706433|NCT00477919|stage IV esophageal cancer|stage iv esophageal cancer
5706434|NCT00477919|stage IV bladder cancer|stage iv bladder cancer
5706435|NCT00477919|male breast cancer|male breast cancer
5706436|NCT00477919|stage IV breast cancer|stage iv breast cancer
5706437|NCT00477919|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5706438|NCT00477919|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5706439|NCT00477919|ovarian sarcoma|ovarian sarcoma
5706441|NCT00477919|fatigue|fatigue
5706442|NCT00477919|anorexia|anorexia
5706443|NCT00477919|cachexia|cachexia
5706444|NCT00477919|pain|pain
5706445|NCT00477919|weight changes|weight changes
5706446|NCT00477919|depression|depression
5706447|NCT00477919|poor performance status|poor performance status
5706448|NCT00477919|recurrent adult brain tumor|recurrent adult brain tumor
5706449|NCT00477919|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5706450|NCT00477919|advanced adult primary liver cancer|advanced adult primary liver cancer
5706451|NCT00477919|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5706452|NCT00477919|recurrent small cell lung cancer|recurrent small cell lung cancer
5706453|NCT00477919|recurrent bladder cancer|recurrent bladder cancer
5706454|NCT00477919|recurrent breast cancer|recurrent breast cancer
5706455|NCT00477919|recurrent colon cancer|recurrent colon cancer
5706456|NCT00477919|recurrent esophageal cancer|recurrent esophageal cancer
5706457|NCT00477919|recurrent gastric cancer|recurrent gastric cancer
5706458|NCT00477919|recurrent melanoma|recurrent melanoma
5706459|NCT00477919|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5706460|NCT00477919|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5706461|NCT00477919|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5706462|NCT00477919|stage IV pancreatic cancer|stage iv pancreatic cancer
5706463|NCT00477919|recurrent prostate cancer|recurrent prostate cancer
5706464|NCT00477919|recurrent renal cell cancer|recurrent renal cell cancer
5706465|NCT00477919|recurrent pancreatic cancer|recurrent pancreatic cancer
5706466|NCT00477919|stage IV rectal cancer|stage iv rectal cancer
5706467|NCT00477919|recurrent rectal cancer|recurrent rectal cancer
5706468|NCT00477919|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5706469|NCT00477919|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5706470|NCT00477919|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5706471|NCT00477919|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5706472|NCT00477919|stage IV uterine sarcoma|stage iv uterine sarcoma
5706473|NCT00477919|recurrent uterine sarcoma|recurrent uterine sarcoma
5706474|NCT00477919|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5706475|NCT00477919|unresectable gallbladder cancer|unresectable gallbladder cancer
5706476|NCT00477919|recurrent gallbladder cancer|recurrent gallbladder cancer
5706477|NCT00477919|adult glioblastoma|adult glioblastoma
5706478|NCT00477906|melanoma|melanoma
5706480|NCT00477906|metastatic|metastatic
5706481|NCT00477906|autologous|autologous
5706482|NCT00477880|gastric cancer|gastric cancer
5706483|NCT00477880|giant hypertrophic gastritis|giant hypertrophic gastritis
5706484|NCT00477867|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5706485|NCT00477841|esophageal Cancer|esophageal cancer
5706486|NCT00477841|Dysphagia|dysphagia
5706487|NCT00477841|Stent|stent
5706488|NCT00477841|interstitial brachytherapy|interstitial brachytherapy
5706489|NCT00477828|sleep apnea|sleep apnea
5706490|NCT00477828|dementia|dementia
5706491|NCT00477828|excessive sleepiness|excessive sleepiness
5706492|NCT00477828|cognition|cognition
5706493|NCT00477815|stage I multiple myeloma|stage i multiple myeloma
5706494|NCT00477815|refractory multiple myeloma|refractory multiple myeloma
5706495|NCT00477815|stage II multiple myeloma|stage ii multiple myeloma
5706496|NCT00477815|stage III multiple myeloma|stage iii multiple myeloma
5706497|NCT00477802|Parkinson's disease|parkinson's disease
5706498|NCT00477802|levodopa-induced cervical dyskinesias|levodopa-induced cervical dyskinesias
5706499|NCT00477789|chronic heart failure|chronic heart failure
5706500|NCT00477789|diastolic dysfunction|diastolic dysfunction
5706501|NCT00477789|uric acid|uric acid
5706502|NCT00477776|Beginning of breastfeeding|beginning of breastfeeding
5706503|NCT00477750|stage I multiple myeloma|stage i multiple myeloma
5707789|NCT00473148|Diuretics|diuretics
5706504|NCT00477750|stage II multiple myeloma|stage ii multiple myeloma
5706505|NCT00477750|stage III multiple myeloma|stage iii multiple myeloma
5706506|NCT00477737|cardioprotection|cardioprotection
5706507|NCT00477737|sevoflurane|sevoflurane
5706508|NCT00477737|esophageal Doppler|esophageal doppler
5706509|NCT00477737|thermodilution|thermodilution
5706510|NCT00477737|coronary artery bypass|coronary artery bypass
5706511|NCT00477724|latent|latent
5706512|NCT00477711|Cetuximab|cetuximab
5706513|NCT00477711|cisplatin|cisplatin
5706514|NCT00477711|capecitabine|capecitabine
5706515|NCT00477711|first line treatment|first line treatment
5706516|NCT00477685|Glaucoma|glaucoma
5706517|NCT00477685|Collagen matrix|collagen matrix
5706518|NCT00477685|OculusGen|oculusgen
5706519|NCT00477685|Phacotrabeculectomy|phacotrabeculectomy
5706520|NCT00477685|anti scarring|anti scarring
5685801|NCT00554762|efficacy|efficacy
5685802|NCT00554762|dose response,|dose response,
5685803|NCT00554762|GW842166,|gw842166,
5685804|NCT00554762|Single,|single,
5685805|NCT00554762|pharmacodynamics,|pharmacodynamics,
5706521|NCT00477685|tissue engineering|tissue engineering
5706522|NCT00477685|ologen|ologen
5706523|NCT00477685|Aeon Astron|aeon astron
5706524|NCT00477672|Parkinson's disease, psychotic disorders|parkinson's disease, psychotic disorders
5706525|NCT00477659|fMRI study; open-label donepezil|fmri study; open-label donepezil
5706526|NCT00477646|colon cancer|colon cancer
5706527|NCT00477646|rectal cancer|rectal cancer
5706528|NCT00477646|breast cancer|breast cancer
5706529|NCT00477646|cervical cancer|cervical cancer
5706530|NCT00477633|Contraception|contraception
5706531|NCT00477620|Myopia|myopia
5706532|NCT00477620|Prevention|prevention
5706533|NCT00477594|Familial Hypercholesterolemia|familial hypercholesterolemia
5706534|NCT00477594|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5706535|NCT00477594|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5706536|NCT00477594|ISIS 301012|isis 301012
5706537|NCT00477594|mipomersen|mipomersen
5706538|NCT00477594|Open Label Extension|open label extension
5706539|NCT00477581|diabetes|diabetes
5706540|NCT00477581|exenatide|exenatide
5706541|NCT00477581|sitagliptin|sitagliptin
5706542|NCT00477581|Amylin|amylin
5706543|NCT00477581|Lilly|lilly
5706544|NCT00477568|Wheelchair users|wheelchair users
5706547|NCT00477568|Risk factors|risk factors
5706548|NCT00477555|aortic valve|aortic valve
5706549|NCT00477555|concomitant procedures|concomitant procedures
5706550|NCT00477555|porcine bioprosthesis|porcine bioprosthesis
5706551|NCT00477555|stented valve|stented valve
5706552|NCT00477542|Clofarabine|clofarabine
5706553|NCT00477542|allogeneic HSCT|allogeneic hsct
5706554|NCT00477542|refractory malignancies|refractory malignancies
5706555|NCT00477503|Central Nervous System Tumors|central nervous system tumors
5706556|NCT00477503|Brain Tumors|brain tumors
5706557|NCT00477503|Leptomeningeal Metastasis|leptomeningeal metastasis
5706558|NCT00477503|Cerebral Spinal Fluid|cerebral spinal fluid
5706559|NCT00477503|Human CSF Flow|human csf flow
5706560|NCT00477503|Nuclear Imaging|nuclear imaging
5706561|NCT00477503|Gallium-67 Citrate|gallium-67 citrate
5706562|NCT00477503|In-111 DTPA|in-111 dtpa
5706563|NCT00477477|overweight|overweight
5706564|NCT00477477|metabolic syndrome|metabolic syndrome
5706565|NCT00477477|adolescent|adolescent
5706566|NCT00477477|cardiovascular|cardiovascular
5706567|NCT00477477|risk factors|risk factors
5706568|NCT00477477|hypertension|hypertension
5706569|NCT00477477|dyslipidemia|dyslipidemia
5706570|NCT00477477|inflammation|inflammation
5706571|NCT00477477|coagulopathy|coagulopathy
5706572|NCT00477464|dual kinase inhibitor,|dual kinase inhibitor,
5706573|NCT00477464|EGFR/ErbB1,|egfr/erbb1,
5706574|NCT00477464|ErbB2-overexpressing,|erbb2-overexpressing,
5706575|NCT00477464|GW572016,|gw572016,
5706576|NCT00477464|advanced/metastatic breast cancer, Lapatinib,|advanced/metastatic breast cancer, lapatinib,
5706577|NCT00477464|HER-2/new,|her-2/new,
5706578|NCT00477464|pharmacokinetics|pharmacokinetics
5706579|NCT00477451|Staccato™ Alprazolam, Panic Attack, Inhaled alprazolam|staccato™ alprazolam, panic attack, inhaled alprazolam
5706580|NCT00477425|Avastin|avastin
5706581|NCT00477399|Obesity|obesity
5706582|NCT00477399|Weight loss maintenance|weight loss maintenance
5706584|NCT00477399|Life Style|life style
5706585|NCT00477399|Follow Up|follow up
5706586|NCT00477386|recurrent ovarian cancer|recurrent ovarian cancer
5706587|NCT00477386|platinum resistant|platinum resistant
5706588|NCT00477386|decitabine|decitabine
5706589|NCT00477347|Liver Transplantation|liver transplantation
5706590|NCT00477347|Anesthesia, general|anesthesia, general
5706591|NCT00477347|Closed-loop|closed-loop
5706592|NCT00477334|Recurrent genital herpes|recurrent genital herpes
5706593|NCT00477334|Black population|black population
5706594|NCT00477321|Interleukin 7|interleukin 7
5706595|NCT00477321|Immune Reconstitution|immune reconstitution
5706596|NCT00477321|T Cell Turnover|t cell turnover
5706597|NCT00477321|CD4 Lymphenia|cd4 lymphenia
5706598|NCT00477321|Immune-Based Therapies|immune-based therapies
5706599|NCT00477321|HIV Infection|hiv infection
5706600|NCT00477308|HIV children|hiv children
5706601|NCT00477308|genotypic resistance|genotypic resistance
5706602|NCT00477308|dual NRTIs|dual nrtis
5706603|NCT00477308|Salvage therapy|salvage therapy
5706604|NCT00477308|treatment outcome|treatment outcome
5706605|NCT00477308|Salvage therapy based on genotyping results|salvage therapy based on genotyping results
5706606|NCT00477308|Treatment Failure|treatment failure
5706607|NCT00477295|Epilepsy|epilepsy
5706608|NCT00477282|Ovarian|ovarian
5706609|NCT00477282|Cancer|cancer
5706610|NCT00477282|Advanced Ovarian Cancer|advanced ovarian cancer
5706611|NCT00477269|Pulmonary Arterial Hypertension, tyrosine kinase inhibitor, STI571|pulmonary arterial hypertension, tyrosine kinase inhibitor, sti571
5706612|NCT00477256|Pediatric Cancer|pediatric cancer
5706613|NCT00477256|Child Adjustment|child adjustment
5706614|NCT00477256|School Reintegration|school reintegration
5706615|NCT00477256|Caregiver|caregiver
5706616|NCT00477256|Questionnaire|questionnaire
5706617|NCT00477256|Quality of Life|quality of life
5706618|NCT00477256|Survey|survey
5706619|NCT00477243|Advanced Cancer|advanced cancer
5706620|NCT00477243|Palliative Care Patients|palliative care patients
5706621|NCT00477243|Spirituality|spirituality
5706622|NCT00477243|Locus of Control|locus of control
5706623|NCT00477243|Questionnaire|questionnaire
5706624|NCT00477230|AF|af
5706625|NCT00477230|PAF|paf
5706626|NCT00477230|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5706627|NCT00477230|ablation|ablation
5706628|NCT00477230|failed drugs|failed drugs
5706629|NCT00477217|Osteonecrosis|osteonecrosis
5706630|NCT00477217|zoledronic acid|zoledronic acid
5706632|NCT00477204|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5706633|NCT00477204|dyslipidemia|dyslipidemia
5706634|NCT00477204|adolescents|adolescents
5706635|NCT00477191|psoriasis|psoriasis
5706636|NCT00477191|metabolic syndrome|metabolic syndrome
5706637|NCT00477191|Syndrome X|syndrome x
5706638|NCT00477191|diabetes|diabetes
5706639|NCT00477191|insulin resistance|insulin resistance
5706640|NCT00477191|obesity|obesity
5706641|NCT00477191|hypertension|hypertension
5706642|NCT00477191|hyperlipidemia|hyperlipidemia
5706643|NCT00477191|hypercholesterolemia|hypercholesterolemia
5706644|NCT00477178|possible problems using codeine when driving|possible problems using codeine when driving
5706645|NCT00477165|Irritable bowel syndrome|irritable bowel syndrome
5706646|NCT00477165|Antidepressant|antidepressant
5706648|NCT00477165|Serotonin-reuptake inhibitor|serotonin-reuptake inhibitor
5706649|NCT00477165|SSRI|ssri
5706650|NCT00477165|Visceral sensitivity|visceral sensitivity
5706651|NCT00477165|Barostat|barostat
5706652|NCT00477165|Quality of life|quality of life
5706653|NCT00477165|Depression|depression
5706654|NCT00477152|dehydration|dehydration
5706655|NCT00477152|fluid therapy|fluid therapy
5706656|NCT00477152|pediatrics|pediatrics
5706657|NCT00477152|emergency medicine|emergency medicine
5706658|NCT00477152|hyaluronoglucosaminidase|hyaluronoglucosaminidase
5706659|NCT00477152|hyaluronidase|hyaluronidase
5706660|NCT00477152|hypodermoclysis|hypodermoclysis
5706661|NCT00477152|clysis|clysis
5706662|NCT00477152|subcutaneous hydration|subcutaneous hydration
5706663|NCT00477152|subcutaneous rehydration|subcutaneous rehydration
5706664|NCT00477152|hyaluronan|hyaluronan
5706665|NCT00477152|rHuPH20|rhuph20
5706666|NCT00477126|ritonavir generic capsule|ritonavir generic capsule
5706667|NCT00477126|Norvir®|norvir®
5706668|NCT00477126|Thailand|thailand
5706669|NCT00477126|Determine bioequivalence between Norvir and GPO ritonavir|determine bioequivalence between norvir and gpo ritonavir
5706670|NCT00477113|natalizumab|natalizumab
5706672|NCT00477113|Tysabri|tysabri
5706673|NCT00477113|Multiple Sclerosis|multiple sclerosis
5706674|NCT00477113|TYGRIS|tygris
5863051|NCT00001409|Ex Vivo Activation|ex vivo activation
5706675|NCT00477074|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5706676|NCT00477074|emphysema|emphysema
5706677|NCT00477074|inflammation|inflammation
5706678|NCT00477074|repair|repair
5706679|NCT00477061|MORPHINE|morphine
5706680|NCT00477061|ANALGESIA|analgesia
5706681|NCT00477061|ACUTE APPENDICITS|acute appendicits
5706682|NCT00477048|IDV nephrotoxicity|idv nephrotoxicity
5706683|NCT00477022|Diabetic Foot Ulcer|diabetic foot ulcer
5706684|NCT00477022|Vacuum compression therapy|vacuum compression therapy
5706685|NCT00477022|Stereology|stereology
5706686|NCT00477022|Ulcer Area|ulcer area
5706687|NCT00477022|Vasotrain|vasotrain
5706688|NCT00477022|Random Controlled Trial.|random controlled trial.
5706689|NCT00477009|Sleep apnea syndromes|sleep apnea syndromes
5706690|NCT00477009|Snoring|snoring
5706691|NCT00477009|Mandibular advancement|mandibular advancement
5706692|NCT00477009|Activator appliances|activator appliances
5706693|NCT00477009|Disorders of excessive somnolence|disorders of excessive somnolence
5706694|NCT00477009|Blood pressure|blood pressure
5706695|NCT00477009|Inflammation|inflammation
5706696|NCT00477009|Oxidative stress|oxidative stress
5706697|NCT00477009|Hormones|hormones
5706698|NCT00477009|Markers of Metabolic Syndrome X|markers of metabolic syndrome x
5706699|NCT00476996|RA|ra
5706700|NCT00476996|SCRIPT|script
5706701|NCT00476996|anti-CD20|anti-cd20
5706702|NCT00476996|CD20|cd20
5706703|NCT00476983|saquinavir/ritonavir 1500/100 mg once daily|saquinavir/ritonavir 1500/100 mg once daily
5706704|NCT00476970|Colorectal Cancer|colorectal cancer
5706705|NCT00476970|Cancer Screening|cancer screening
5706706|NCT00476970|Patient Navigation|patient navigation
5706707|NCT00476970|Low English Proficiency|low english proficiency
5706708|NCT00476957|Drug Eluting Stents|drug eluting stents
5706709|NCT00476957|Interventional Cardiology|interventional cardiology
5706710|NCT00476944|CAD|cad
5706711|NCT00476944|Coronary Artery Disease|coronary artery disease
5706712|NCT00476944|Angiomax|angiomax
5706713|NCT00476944|Bivalirudin|bivalirudin
5706714|NCT00476944|PCI|pci
5706715|NCT00476944|MAVE|mave
5706716|NCT00476944|Heparin|heparin
5705283|NCT00482469|ischemia-reperfusion|ischemia-reperfusion
5706717|NCT00476931|Diabetic neuropathy|diabetic neuropathy
5706718|NCT00476931|Diabetes Type 1 or 2|diabetes type 1 or 2
5706719|NCT00476931|Moderate to severe sensorimotor diabetic polyneuropathy|moderate to severe sensorimotor diabetic polyneuropathy
5706720|NCT00476931|Unmeasurable nerve conduction velocity|unmeasurable nerve conduction velocity
5706721|NCT00476918|diabetic macular edema|diabetic macular edema
5706722|NCT00476918|triamcinolone acetonide|triamcinolone acetonide
5706723|NCT00476918|intravitreal|intravitreal
5706724|NCT00476918|steroid|steroid
5706725|NCT00476905|Basal Cell Carcinoma|basal cell carcinoma
5706726|NCT00476905|Squamous Cell Carcinoma|squamous cell carcinoma
5706727|NCT00476905|Pre-Cancer Lesions|pre-cancer lesions
5706728|NCT00476905|Pigmented Lesions|pigmented lesions
5706729|NCT00476905|Benign Lesions|benign lesions
5706730|NCT00476905|Skin Cancer|skin cancer
5706732|NCT00476905|Optical Spectroscopy|optical spectroscopy
5706733|NCT00476892|Pelvic organ prolapse|pelvic organ prolapse
5706734|NCT00476892|Pelvic floor muscle training|pelvic floor muscle training
5706735|NCT00476892|Prolapse symptoms|prolapse symptoms
5706736|NCT00476892|Urinary symptoms|urinary symptoms
5706737|NCT00476892|Sexual function|sexual function
5706738|NCT00476892|randomised controlled trial|randomised controlled trial
5706739|NCT00476879|Growth hormone|growth hormone
5706740|NCT00476879|Fasting|fasting
5706741|NCT00476879|Signaltransduction|signaltransduction
5706742|NCT00476879|fatty liver|fatty liver
5706743|NCT00476879|insulin sensitivity|insulin sensitivity
5706744|NCT00476879|forearm model|forearm model
5706745|NCT00476879|protein metabolism|protein metabolism
5706746|NCT00476879|respiratory quotient|respiratory quotient
5706747|NCT00476866|Paraplegia|paraplegia
5706749|NCT00476866|lung compliance|lung compliance
5706750|NCT00476866|work of breathing|work of breathing
5706751|NCT00476866|hyperinflation|hyperinflation
5706752|NCT00476866|rehabilitation|rehabilitation
5706753|NCT00476853|HIV-TB|hiv-tb
5706754|NCT00476853|nevirapine based HAART with rifampin treated TB|nevirapine based haart with rifampin treated tb
5706755|NCT00476853|Compare PK profile, efficacy, safety and tolerability of HAART containing nevirapine 400mg/day versus 600 mg/day in HIV/TB co-infected patients|compare pk profile, efficacy, safety and tolerability of haart containing nevirapine 400mg/day versus 600 mg/day in hiv/tb co-infected patients
5706756|NCT00476853|Treatment Naive|treatment naive
5706757|NCT00476827|Breast Cancer|breast cancer
5706758|NCT00476827|Metastatic|metastatic
5706759|NCT00476827|Brain|brain
5706760|NCT00476827|Anti-angiogenesis|anti-angiogenesis
5706761|NCT00476814|cystic fibrosis,|cystic fibrosis,
5706762|NCT00476814|nasal potential difference,|nasal potential difference,
5706763|NCT00476814|primary sclerosing cholangitis|primary sclerosing cholangitis
5706764|NCT00476801|UVA1|uva1
5706765|NCT00476801|scleroderma|scleroderma
5706766|NCT00476801|keloids|keloids
5706767|NCT00476801|light therapy|light therapy
5706768|NCT00476801|morphea|morphea
5706769|NCT00476788|pediatrics|pediatrics
5706770|NCT00476788|CSII|csii
5706771|NCT00476788|diabetes|diabetes
5715575|NCT00445822|CML|cml
5706772|NCT00476788|C-peptide|c-peptide
5706773|NCT00476788|adverse events|adverse events
5706774|NCT00476775|obesity|obesity
5706775|NCT00476775|prevention|prevention
5706776|NCT00476775|girls|girls
5706777|NCT00476775|Latina/Hispanic|latina/hispanic
5706778|NCT00476775|Dance|dance
5706779|NCT00476775|television|television
5706780|NCT00476775|screen time|screen time
5706781|NCT00476736|COPD|copd
5706782|NCT00476736|Pulmonary function|pulmonary function
5706783|NCT00476736|Air trapping|air trapping
5706784|NCT00476736|Acetyl cystein|acetyl cystein
5706785|NCT00476723|HIV infection|hiv infection
5706786|NCT00476723|Hepatitis coinfection|hepatitis coinfection
5706787|NCT00476710|Type 2 diabetes mellitus|type 2 diabetes mellitus
5706788|NCT00476710|Bile acid|bile acid
5706789|NCT00476710|Stable isotope|stable isotope
5706790|NCT00476710|Colesevelam HCl|colesevelam hcl
5706791|NCT00476710|Impaired Glucose Tolerance|impaired glucose tolerance
5706792|NCT00476697|UVA1|uva1
5706793|NCT00476697|scleroderma|scleroderma
5706794|NCT00476697|keloids|keloids
5706795|NCT00476697|morphea|morphea
5706796|NCT00476697|light therapy|light therapy
5706797|NCT00476684|radiofrequency|radiofrequency
5706798|NCT00476671|neuropsychiatric|neuropsychiatric
5706799|NCT00476671|neurocognitive|neurocognitive
5706800|NCT00476671|psychiatric|psychiatric
5706801|NCT00476671|HIV related dementia|hiv related dementia
5706802|NCT00476671|MCMD|mcmd
5706803|NCT00476671|HIV-1|hiv-1
5706902|NCT00476359|Dual boosted PIs|dual boosted pis
5708712|NCT00469911|Transplant|transplant
5706804|NCT00476671|Prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in HIV-1 infected patients with undetectable viral load in the HAART era.|prevalence, risk factors of neurocognitive impairment and psychiatric comorbidities in hiv-1 infected patients with undetectable viral load in the haart era.
5706805|NCT00476671|Treatment Experienced|treatment experienced
5706806|NCT00476658|Obesity|obesity
5706807|NCT00476658|macrophage infiltration|macrophage infiltration
5706808|NCT00476658|insulinoresistance|insulinoresistance
5706809|NCT00476658|inflammation|inflammation
5706810|NCT00476632|Epidemiology|epidemiology
5706811|NCT00476632|Questionnaire|questionnaire
5706812|NCT00476632|Controls|controls
5706813|NCT00476619|Contrast|contrast
5706814|NCT00476619|Nephropathy|nephropathy
5706815|NCT00476619|acute renal failure|acute renal failure
5706816|NCT00476619|Erythropoietin|erythropoietin
5706817|NCT00476619|CT scan|ct scan
5706818|NCT00476606|HIV children|hiv children
5706819|NCT00476606|HAART|haart
5706821|NCT00476606|Second line HAART|second line haart
5706822|NCT00476606|Viral Load|viral load
5706823|NCT00476606|Combination drug|combination drug
5706824|NCT00476606|Treatment Experienced|treatment experienced
5706825|NCT00476606|Treatment Naive|treatment naive
5706826|NCT00476593|Uveitis|uveitis
5706827|NCT00476593|Iritis|iritis
5706828|NCT00476593|Macular Thickness|macular thickness
5706829|NCT00476593|HLA-B27 related|hla-b27 related
5706830|NCT00476593|Macular edema|macular edema
5706831|NCT00476593|Macular thickening|macular thickening
5706832|NCT00476593|OCT|oct
5706833|NCT00476593|mfERG|mferg
5706834|NCT00476593|Eye drops|eye drops
5706835|NCT00476593|Dexamethosone|dexamethosone
5706836|NCT00476593|Diclofenac|diclofenac
5706837|NCT00476593|Retinal aging|retinal aging
5706838|NCT00476580|Sri Lankan Sinhalese|sri lankan sinhalese
5706839|NCT00476580|Epidemiology|epidemiology
5706840|NCT00476580|Cancer Risk|cancer risk
5706841|NCT00476580|US Migrant|us migrant
5706842|NCT00476580|Questionnaire|questionnaire
5706843|NCT00476580|Survey|survey
5706844|NCT00476580|Acculturation|acculturation
5706845|NCT00476580|Health and Cancer Risks|health and cancer risks
5706846|NCT00476580|Health Habits|health habits
5706847|NCT00476567|exercise|exercise
5706848|NCT00476567|pregnancy|pregnancy
5706850|NCT00476567|pregnancy-related diseases|pregnancy-related diseases
5706851|NCT00476567|labor|labor
5706853|NCT00476567|physiotherapy|physiotherapy
5706854|NCT00476554|CTCL|ctcl
5706855|NCT00476541|AML|aml
5706856|NCT00476541|Children|children
5706857|NCT00476541|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5706858|NCT00476541|Stem cell transplantation|stem cell transplantation
5706859|NCT00476528|Posttraumatic amnesia|posttraumatic amnesia
5706860|NCT00476528|Early intervention|early intervention
5706861|NCT00476528|A systematic nursing programme in the ICU|a systematic nursing programme in the icu
5706862|NCT00476528|Early identification of patients with posttraumatic amnesia|early identification of patients with posttraumatic amnesia
5706863|NCT00476515|Kidney transplantation|kidney transplantation
5706864|NCT00476515|Donor specific antibodies|donor specific antibodies
5706865|NCT00476515|Positive cross match|positive cross match
5706866|NCT00476502|genetic polymorphism|genetic polymorphism
5706867|NCT00476502|CYP 3A|cyp 3a
5706868|NCT00476502|MDR-1|mdr-1
5706869|NCT00476502|Thai|thai
5706870|NCT00476502|HIV|hiv
5706871|NCT00476502|Treatment Experienced|treatment experienced
5706872|NCT00476489|secondary adrenal insuffiency|secondary adrenal insuffiency
5706873|NCT00476489|hypothalamus-pituitary-adrenal axis impairement|hypothalamus-pituitary-adrenal axis impairement
5706874|NCT00476489|topical steroids|topical steroids
5706875|NCT00476476|Tarceva|tarceva
5706876|NCT00476476|erlotinib|erlotinib
5706877|NCT00476476|squamous cell carcinoma of the vulvar|squamous cell carcinoma of the vulvar
5706878|NCT00476463|TDF+FTC|tdf+ftc
5706879|NCT00476463|FTC|ftc
5706880|NCT00476463|HIV/HBV|hiv/hbv
5706881|NCT00476463|TDF compared to TDF+FTC in HIV/HBV|tdf compared to tdf+ftc in hiv/hbv
5706882|NCT00476463|Treatment Naive|treatment naive
5706883|NCT00476450|Oral Microbial Flora|oral microbial flora
5706884|NCT00476450|Hematopoietic Stem Cell Transplant|hematopoietic stem cell transplant
5706885|NCT00476450|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5706886|NCT00476424|once daily Efavirenz 400 mg|once daily efavirenz 400 mg
5706887|NCT00476424|PK once daily Efavirenz 400 mg versus 600 mg|pk once daily efavirenz 400 mg versus 600 mg
5706888|NCT00476424|Treatment Experienced|treatment experienced
5706889|NCT00476411|isolated HBc|isolated hbc
5706890|NCT00476411|HBV vaccine response|hbv vaccine response
5706891|NCT00476411|occult HBV in isolated antiHBC compared HIV to non HIV|occult hbv in isolated antihbc compared hiv to non hiv
5706892|NCT00476398|Capsule endoscopy|capsule endoscopy
5706893|NCT00476398|Wireless imaging|wireless imaging
5706894|NCT00476398|esophagus|esophagus
5706895|NCT00476398|stomach|stomach
5706896|NCT00476372|neuropsychology|neuropsychology
5706897|NCT00476372|cognitive impairment|cognitive impairment
5706898|NCT00476372|motor disorder|motor disorder
5706899|NCT00476372|parkinson's disease|parkinson's disease
5706900|NCT00476359|Lopinavir/r|lopinavir/r
5706903|NCT00476359|Pharmacokinetics|pharmacokinetics
5706904|NCT00476359|HIV children|hiv children
5706905|NCT00476359|C min|c min
5706906|NCT00476359|Second line HAART|second line haart
5706907|NCT00476359|ARV|arv
5706908|NCT00476359|VL failure|vl failure
5706909|NCT00476359|Dosage|dosage
5706910|NCT00476359|To evaluate treatment response|to evaluate treatment response
5706911|NCT00476359|Treatment Experienced|treatment experienced
5706912|NCT00476346|physical training|physical training
5706913|NCT00476346|military training|military training
5706914|NCT00476346|bone|bone
5706915|NCT00476346|fracture prevention|fracture prevention
5706916|NCT00476346|young adult|young adult
5706917|NCT00476333|EMG|emg
5706918|NCT00476333|Kinetics|kinetics
5706919|NCT00476333|Kinematics|kinematics
5706920|NCT00476333|Perturbation|perturbation
5706921|NCT00476333|Footwear|footwear
5706922|NCT00476320|echocardiography|echocardiography
5706923|NCT00476320|myocardial infarction|myocardial infarction
5706924|NCT00476320|magnetic resonance imaging|magnetic resonance imaging
5706925|NCT00476320|revascularization|revascularization
5706926|NCT00476320|viability|viability
5706927|NCT00476307|Flu vaccine|flu vaccine
5706928|NCT00476294|Multiple Myeloma|multiple myeloma
5706929|NCT00476294|Disease-Free Survival|disease-free survival
5706930|NCT00476294|AMD3100|amd3100
5706931|NCT00476294|G-CSF|g-csf
5706932|NCT00476294|Autologous Transplantation|autologous transplantation
5706933|NCT00476255|child safety restraint|child safety restraint
5706934|NCT00476255|injury prevention|injury prevention
5706935|NCT00476255|automotive|automotive
5706936|NCT00476242|heroin abuse|heroin abuse
5706937|NCT00476242|opiate abuse|opiate abuse
5706938|NCT00476242|opioid dependence|opioid dependence
5706939|NCT00476242|naltrexone|naltrexone
5706940|NCT00476242|memantine|memantine
5706941|NCT00476229|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5706942|NCT00476229|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5706943|NCT00476229|Hodgkin's Lymphoma|hodgkin's lymphoma
5706944|NCT00476229|Lymphoma|lymphoma
5706945|NCT00476229|Leukemia|leukemia
5706946|NCT00476229|Mycophenolate Mofetil|mycophenolate mofetil
5706947|NCT00476229|Tacrolimus|tacrolimus
5706948|NCT00476229|Thymoglobulin|thymoglobulin
5706949|NCT00476229|Total Lymphoid Irradiation|total lymphoid irradiation
5706950|NCT00476216|Non-Small Cell Lung Cancer|non-small cell lung cancer
5706951|NCT00476216|Venous Thromboembolism|venous thromboembolism
5706952|NCT00476216|VTE|vte
5706953|NCT00476216|Arixtra|arixtra
5706954|NCT00476203|Breast Cancer|breast cancer
5706955|NCT00476203|Yoga|yoga
5706956|NCT00476203|Quality of Life|quality of life
5706957|NCT00476203|Obesity|obesity
5706958|NCT00476203|Fatigue|fatigue
5706959|NCT00476203|Weight|weight
5706960|NCT00476190|ALL|all
5706961|NCT00476177|DC|dc
5706962|NCT00476177|DLI|dli
5706963|NCT00476177|graft vs. host disease|graft vs. host disease
5706964|NCT00476177|GVHD|gvhd
5706965|NCT00476164|chronic allograft nephropathy|chronic allograft nephropathy
5706966|NCT00476164|C4d|c4d
5706967|NCT00476164|Anti-CD20|anti-cd20
5706968|NCT00476164|B cells|b cells
5706969|NCT00476164|Antibody|antibody
5706970|NCT00476151|DPN|dpn
5706971|NCT00476151|Diabetic|diabetic
5706972|NCT00476151|Nerve Pain|nerve pain
5723300|NCT00419575|monitoring|monitoring
5723313|NCT00419549|ERCP|ercp
5723314|NCT00419549|Pancreatitis|pancreatitis
5723315|NCT00419549|Nitroglycerine|nitroglycerine
5723316|NCT00419549|Valdecoxib|valdecoxib
5723317|NCT00419536|LBH|lbh
5723318|NCT00419536|LBH589|lbh589
5723319|NCT00419536|Prostate Cancer|prostate cancer
5723320|NCT00419536|HRPC|hrpc
5723321|NCT00419510|Genetic counseling|genetic counseling
5723322|NCT00419510|BRCA1 and BRCA2|brca1 and brca2
5723323|NCT00419510|African American|african american
5723324|NCT00419497|Paleolithic diet|paleolithic diet
5706973|NCT00476138|Epigallocatechin-Gallate|epigallocatechin-gallate
5706974|NCT00476138|Glaucoma|glaucoma
5706975|NCT00476138|Optic Nerve|optic nerve
5706976|NCT00476138|Pattern Electroretinogram|pattern electroretinogram
5706977|NCT00476138|Retinal Ganglion Cells|retinal ganglion cells
5706978|NCT00476112|Atrial flutter|atrial flutter
5706979|NCT00476112|RSD1235|rsd1235
5706980|NCT00476086|oxaliplatin|oxaliplatin
5706981|NCT00476086|gemcitabine|gemcitabine
5706982|NCT00476086|MMMT|mmmt
5706983|NCT00476060|Cirrhosis|cirrhosis
5706984|NCT00476060|Bone marrow|bone marrow
5706985|NCT00476060|Mesenchymal stem cell|mesenchymal stem cell
5706986|NCT00476060|MELD score|meld score
5706987|NCT00476060|Quality of life|quality of life
5706988|NCT00476034|Osteoarthritis|osteoarthritis
5706989|NCT00476034|lumiracoxib|lumiracoxib
5706990|NCT00476034|celecoxib|celecoxib
5706991|NCT00476034|Cox-2|cox-2
5706992|NCT00476034|knee|knee
5706993|NCT00476021|postpartum|postpartum
5706994|NCT00476021|contraception|contraception
5706995|NCT00476021|postplacental IUD|postplacental iud
5706996|NCT00476021|intrauterine devices|intrauterine devices
5706997|NCT00476008|Alzheimer's Disease|alzheimer's disease
5706998|NCT00476008|Mild Alzheimer's Disease|mild alzheimer's disease
5706999|NCT00476008|Driving|driving
5707000|NCT00476008|Driving Impairment|driving impairment
5707001|NCT00475982|Diet|diet
5707002|NCT00475982|Insulin-like Growth Factor|insulin-like growth factor
5707003|NCT00475982|Weight Loss|weight loss
5707004|NCT00475956|Cancer|cancer
5707005|NCT00475956|Tumour|tumour
5707006|NCT00475956|Advanced Solid Tumour|advanced solid tumour
5707007|NCT00475956|Lung Cancer|lung cancer
5707008|NCT00475956|Breast Cancer|breast cancer
5707009|NCT00475956|Cholangiocarcinoma|cholangiocarcinoma
5707010|NCT00475956|Colon Cancer|colon cancer
5707011|NCT00475956|Gastric Cancer|gastric cancer
5707017|NCT00475956|Peritoneal Cancer|peritoneal cancer
5707018|NCT00475943|Swallowing Disorders|swallowing disorders
5707019|NCT00475943|Swallowing|swallowing
5707020|NCT00475943|Videofluoroscopy|videofluoroscopy
5707021|NCT00475943|Dysphagia|dysphagia
5707022|NCT00475943|Epiglottis|epiglottis
5707023|NCT00475943|Healthy Volunteer|healthy volunteer
5707024|NCT00475943|HV|hv
5707025|NCT00475930|MRSA|mrsa
5707026|NCT00475930|Staphylococcus aureus|staphylococcus aureus
5707027|NCT00475917|Advanced malignancies|advanced malignancies
5707028|NCT00475917|Solid tumor|solid tumor
5707029|NCT00475904|Post Herpetic Neuralgia|post herpetic neuralgia
5707030|NCT00475904|PHN|phn
5707031|NCT00475904|Neuropathy|neuropathy
5707032|NCT00475904|Nerve Pain|nerve pain
5707033|NCT00475904|Topical|topical
5707034|NCT00475891|isolate|isolate
5707035|NCT00475891|infection|infection
5707037|NCT00475878|opiate use|opiate use
5707038|NCT00475878|depression|depression
5707039|NCT00475878|buprenorphine|buprenorphine
5707040|NCT00475878|escitalopram|escitalopram
5707041|NCT00475865|MS|ms
5707042|NCT00475865|glatiramer acetate|glatiramer acetate
5707043|NCT00475865|adjunctive therapy|adjunctive therapy
5707044|NCT00475865|relapses|relapses
5707045|NCT00475852|Heart Decompensation|heart decompensation
5707046|NCT00475852|Dyspnea|dyspnea
5707047|NCT00475852|Heart failure|heart failure
5707048|NCT00475852|Nesiritide|nesiritide
5707049|NCT00475852|Decompensated|decompensated
5707050|NCT00475852|ADHF|adhf
5707051|NCT00475839|stress urinary incontinence|stress urinary incontinence
5707052|NCT00475839|sling procedures|sling procedures
5707053|NCT00475839|tension-free vaginal tape|tension-free vaginal tape
5707054|NCT00475839|transobturator|transobturator
5707055|NCT00475826|Heterozigous Familial Hypercholesterolemia|heterozigous familial hypercholesterolemia
5707056|NCT00475826|Sub-clinical atherosclerosis|sub-clinical atherosclerosis
5707057|NCT00475826|Chylomicrons metabolism|chylomicrons metabolism
5707058|NCT00475826|Statin plus ezetimibe|statin plus ezetimibe
5707059|NCT00475826|Coronary artery calcification|coronary artery calcification
5707060|NCT00475813|Paediatric subjects with asthma|paediatric subjects with asthma
5707062|NCT00475800|lumiracoxib|lumiracoxib
5707063|NCT00475800|celecoxib|celecoxib
5707066|NCT00475787|Older Adults|older adults
5707067|NCT00475787|Patient Education|patient education
5707068|NCT00475787|Randomized Controlled Trial|randomized controlled trial
5707069|NCT00475787|Sham procedure|sham procedure
5707070|NCT00475787|Spinal Manipulation|spinal manipulation
5707071|NCT00475787|Veterans|veterans
5707077|NCT00475748|cervical spine|cervical spine
5707078|NCT00475748|spinal cord|spinal cord
5707080|NCT00475748|spinal cord injury|spinal cord injury
5707081|NCT00475748|central cord syndrome|central cord syndrome
5707082|NCT00475722|cancer|cancer
5707083|NCT00475722|colon|colon
5707084|NCT00475722|prevention|prevention
5707085|NCT00475722|healthy eating|healthy eating
5707086|NCT00475722|Mediterranean diet|mediterranean diet
5707087|NCT00475722|PGE2|pge2
5707088|NCT00475722|cyclooxygenase|cyclooxygenase
5707089|NCT00475722|lipoxygenase|lipoxygenase
5707090|NCT00475722|Healthy People 2010 diet|healthy people 2010 diet
5707091|NCT00475722|dietary prevention of colon cancer|dietary prevention of colon cancer
5707092|NCT00475709|aortic valve|aortic valve
5707093|NCT00475709|heart valve|heart valve
5707094|NCT00475709|tissue valve|tissue valve
5707095|NCT00475709|bioprosthesis|bioprosthesis
5707096|NCT00475709|valve disorder|valve disorder
5707097|NCT00475709|valve disease|valve disease
5707098|NCT00475709|cardiac surgery|cardiac surgery
5707099|NCT00475709|aortic valve stenosis|aortic valve stenosis
5707100|NCT00475709|aortic valve regurgitation|aortic valve regurgitation
5707101|NCT00475683|Doxorubicin|doxorubicin
5707102|NCT00475683|Mucositis|mucositis
5707103|NCT00475683|Prevention|prevention
5707104|NCT00475683|Curcumin|curcumin
5707105|NCT00475631|Clubfoot|clubfoot
5707106|NCT00475631|Chart review|chart review
5707107|NCT00475618|Early chilhood caries|early chilhood caries
5707108|NCT00475618|Prevention|prevention
5707109|NCT00475618|Fluoride varnish|fluoride varnish
5707110|NCT00475618|fluoride toothpaste|fluoride toothpaste
5707111|NCT00475618|non fluoride tooth paste|non fluoride tooth paste
5707112|NCT00475618|Professional cleaning|professional cleaning
5707113|NCT00475605|atopic dermatitis|atopic dermatitis
5707114|NCT00475605|child|child
5707115|NCT00475605|tacrolimus ointment|tacrolimus ointment
5707116|NCT00475605|Protopic Ointment|protopic ointment
5707117|NCT00475592|Esophageal Varices|esophageal varices
5707118|NCT00475592|Gastric Varices|gastric varices
5707119|NCT00475592|Capsule Endoscopy|capsule endoscopy
5707120|NCT00475592|Portal Hypertension|portal hypertension
5707121|NCT00475592|Cirrhosis|cirrhosis
5707122|NCT00475592|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5707123|NCT00475579|ventilator-associated pneumonia|ventilator-associated pneumonia
5707124|NCT00475579|endotracheal tube|endotracheal tube
5707125|NCT00475579|polyurethane cuff|polyurethane cuff
5707126|NCT00475579|polyvinyl cuff|polyvinyl cuff
5707127|NCT00475579|subglottic secretion drainage|subglottic secretion drainage
5707128|NCT00475553|spotting|spotting
5707129|NCT00475553|PMS|pms
5707130|NCT00475553|nuvaring|nuvaring
5707131|NCT00475553|birth control|birth control
5707132|NCT00475553|pelvic pain|pelvic pain
5707133|NCT00475553|headache|headache
5707134|NCT00475553|mood swings|mood swings
5707135|NCT00475553|continuous use|continuous use
5707136|NCT00475540|prolapse|prolapse
5707137|NCT00475540|uterus|uterus
5707138|NCT00475540|pelvic organ|pelvic organ
5707139|NCT00475540|vaginal prolpase|vaginal prolpase
5707140|NCT00475514|Menstrually-related Migraine Headache|menstrually-related migraine headache
5707141|NCT00475514|'Difficult to Treat' as specified in protocol|'difficult to treat' as specified in protocol
5707142|NCT00475501|anabolic effects|anabolic effects
5707143|NCT00475501|finasteride|finasteride
5707144|NCT00475501|male hypogonadism|male hypogonadism
5707145|NCT00475501|sarcopenia|sarcopenia
5707146|NCT00475501|testosterone|testosterone
5707147|NCT00475488|radial artery|radial artery
5707148|NCT00475488|right internal thoracic artery|right internal thoracic artery
5707149|NCT00475488|saphenous vein|saphenous vein
5707150|NCT00475488|grafts|grafts
5707151|NCT00475488|coronary bypass surgery|coronary bypass surgery
5707152|NCT00475475|Overweight|overweight
5707153|NCT00475475|Obesity|obesity
5707154|NCT00475475|Appetite|appetite
5707155|NCT00475475|Dietary sugars|dietary sugars
5707156|NCT00475475|Fructose|fructose
5707157|NCT00475475|Glucose|glucose
5707158|NCT00475475|Leptin|leptin
5707159|NCT00475475|Insulin|insulin
5707160|NCT00475475|Ghrelin|ghrelin
5707161|NCT00475462|Metoprolol and Syncope|metoprolol and syncope
5707162|NCT00475449|percutaneous coronary intervention|percutaneous coronary intervention
5707163|NCT00475449|Stent|stent
5707164|NCT00475449|coronary artery bypass grafting|coronary artery bypass grafting
5707165|NCT00475436|muscarinic receptor antagonist|muscarinic receptor antagonist
5707166|NCT00475436|GSK573719,|gsk573719,
5707167|NCT00475436|chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5707168|NCT00475410|Autologous adipose-derived stem cells|autologous adipose-derived stem cells
5707169|NCT00475410|Complex perianal fistula|complex perianal fistula
5707170|NCT00475410|Inflammatory Bowel Disease|inflammatory bowel disease
5707171|NCT00475410|Advanced cell therapy|advanced cell therapy
5707174|NCT00475371|Diabetes Mellitus: Type II|diabetes mellitus: type ii
5707175|NCT00475345|Nocturnal hypoglycemia|nocturnal hypoglycemia
5707176|NCT00475345|Bedtime snacks|bedtime snacks
5707177|NCT00475345|Continuous glucose monitoring|continuous glucose monitoring
5707178|NCT00475345|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5707179|NCT00475345|CSII|csii
5707180|NCT00475345|Intensive therapy|intensive therapy
5707181|NCT00475319|Dry Eye Syndromes|dry eye syndromes
5707182|NCT00475319|OPC-12759|opc-12759
5707183|NCT00475306|Metoclopramide|metoclopramide
5707184|NCT00475306|Nausea|nausea
5707185|NCT00475306|Akathisia|akathisia
5707186|NCT00475306|Emergency department|emergency department
5707187|NCT00475293|metastatic colorectal cancer|metastatic colorectal cancer
5715813|NCT00445497|neutropenia|neutropenia
5707188|NCT00475293|2nd-line Therapy|2nd-line therapy
5707189|NCT00475293|panitumumab|panitumumab
5707190|NCT00475293|irinotecan|irinotecan
5707191|NCT00475280|geriatric assessment adapted therapy|geriatric assessment adapted therapy
5707192|NCT00475280|Leukemia, Lymphoblastic, Acute|leukemia, lymphoblastic, acute
5707193|NCT00475280|Older patients|older patients
5707194|NCT00475280|> 60 years old|> 60 years old
5707195|NCT00475280|Ph negative|ph negative
5707196|NCT00475267|aortic valve|aortic valve
5707197|NCT00475267|heart valve|heart valve
5707198|NCT00475267|tissue valve|tissue valve
5707199|NCT00475267|bioprosthesis|bioprosthesis
5707200|NCT00475267|valve disorder|valve disorder
5707201|NCT00475267|valve disease|valve disease
5707202|NCT00475267|cardiac surgery|cardiac surgery
5707203|NCT00475267|aortic valve stenosis|aortic valve stenosis
5707204|NCT00475267|aortic valve regurgitation|aortic valve regurgitation
5707205|NCT00475254|Retinitis Pigmentosa|retinitis pigmentosa
5707206|NCT00475254|stress|stress
5707207|NCT00475254|sleepiness|sleepiness
5707208|NCT00475254|low vision|low vision
5707209|NCT00475254|mind-body|mind-body
5707210|NCT00475241|Combat Disorders|combat disorders
5707211|NCT00475241|Cortisol|cortisol
5707212|NCT00475241|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5707213|NCT00475241|Psychophysiology|psychophysiology
5707214|NCT00475241|Therapy|therapy
5707215|NCT00475241|Treatment|treatment
5707216|NCT00475241|Veterans|veterans
5707217|NCT00475228|levonorgestrel IUD|levonorgestrel iud
5707219|NCT00475228|dilation and evacuation|dilation and evacuation
5707220|NCT00475228|contraception|contraception
5707221|NCT00475189|birth control|birth control
5707223|NCT00475189|headaches|headaches
5707224|NCT00475189|mood swings|mood swings
5707225|NCT00475189|pelvic pain|pelvic pain
5707226|NCT00475176|Hepatitis C Virus Genotype 1|hepatitis c virus genotype 1
5707227|NCT00475176|Non-Responders|non-responders
5707228|NCT00475176|SAMe|same
5707229|NCT00475176|Natural Killer Cells|natural killer cells
5707230|NCT00475176|Interferon Signaling|interferon signaling
5707231|NCT00475176|Ribavirin|ribavirin
5707232|NCT00475176|Peginterferon|peginterferon
5707233|NCT00475176|Hemolysis|hemolysis
5685806|NCT00554762|repeat dose,|repeat dose,
5685807|NCT00554749|Selective mutism|selective mutism
5685808|NCT00554749|Children|children
5685809|NCT00554749|Treatment|treatment
5707234|NCT00475176|STAT|stat
5707235|NCT00475176|Hepatitis C|hepatitis c
5707236|NCT00475163|Obesity|obesity
5707237|NCT00475163|Mentoring|mentoring
5707238|NCT00475163|Fitness|fitness
5707239|NCT00475163|Self-esteem|self-esteem
5707240|NCT00475137|Bipolar II Disorder|bipolar ii disorder
5707241|NCT00475137|depression|depression
5707242|NCT00475137|Lamotrigine|lamotrigine
5707243|NCT00475137|Add On antidepressant|add on antidepressant
5707244|NCT00475137|randomized|randomized
5707245|NCT00475137|single blind|single blind
5707246|NCT00475137|parallel group|parallel group
5707247|NCT00475124|Pacemaker follow-up|pacemaker follow-up
5707248|NCT00475124|Telecardiology|telecardiology
5707249|NCT00475124|Home Monitoring|home monitoring
5707250|NCT00475111|Cognitive Behavioral Intervention|cognitive behavioral intervention
5707252|NCT00475111|Pain Management|pain management
5707253|NCT00475111|Psychological Adaptation|psychological adaptation
5707254|NCT00475111|Coping Efficacy|coping efficacy
5707255|NCT00475111|Markers of Disease Activity|markers of disease activity
5707256|NCT00475098|Low molecular weight heparin|low molecular weight heparin
5707257|NCT00475098|Lung cancer|lung cancer
5707258|NCT00475098|Non small cell lung cancer|non small cell lung cancer
5707259|NCT00475098|Adjuvant therapy|adjuvant therapy
5707260|NCT00475098|Anticoagulants|anticoagulants
5707261|NCT00475098|Heparin|heparin
5707262|NCT00475085|nausea and vomiting|nausea and vomiting
5707263|NCT00475085|recurrent breast cancer|recurrent breast cancer
5707264|NCT00475085|stage I breast cancer|stage i breast cancer
5707265|NCT00475085|stage II breast cancer|stage ii breast cancer
5707266|NCT00475085|stage IIIA breast cancer|stage iiia breast cancer
5707267|NCT00475085|stage IIIB breast cancer|stage iiib breast cancer
5707268|NCT00475085|stage IIIC breast cancer|stage iiic breast cancer
5707269|NCT00475085|stage IV breast cancer|stage iv breast cancer
5707270|NCT00475085|inflammatory breast cancer|inflammatory breast cancer
5707271|NCT00475085|male breast cancer|male breast cancer
5707272|NCT00475059|kidney transplantation|kidney transplantation
5707273|NCT00475059|Glomerular filtration rate|glomerular filtration rate
5707274|NCT00475059|inulin clearance|inulin clearance
5707275|NCT00475059|MDRD equation|mdrd equation
5707276|NCT00475059|cystatin C|cystatin c
5707277|NCT00475059|cimetidine|cimetidine
5707279|NCT00475046|post partum|post partum
5707280|NCT00475046|relapse prevention|relapse prevention
5707281|NCT00475046|motivational interviewing|motivational interviewing
5707282|NCT00475046|TTM|ttm
5707283|NCT00475046|implement motivational enhancement interventions in pediatric practices|implement motivational enhancement interventions in pediatric practices
5707284|NCT00475046|examine the effectiveness of the intervention|examine the effectiveness of the intervention
5707285|NCT00475046|develop measurements appropriate to tailor interventions|develop measurements appropriate to tailor interventions
5863052|NCT00001408|Lymphocytes|lymphocytes
5732513|NCT00385112|Surgery|surgery
5707286|NCT00475046|analyze further unfavorable and favorable factors outlined by previous research|analyze further unfavorable and favorable factors outlined by previous research
5707287|NCT00475020|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5707288|NCT00475020|Myelofibrosis|myelofibrosis
5707289|NCT00475020|Essential Thrombocythemia|essential thrombocythemia
5707290|NCT00475020|Polycythemia Vera|polycythemia vera
5707291|NCT00475020|Busulfan|busulfan
5707292|NCT00475020|Antithymocyte Globulin|antithymocyte globulin
5707293|NCT00475020|ATG|atg
5707294|NCT00475020|Fludarabine|fludarabine
5707295|NCT00475020|Thymoglobulin|thymoglobulin
5707296|NCT00475007|Emphysema|emphysema
5707297|NCT00475007|IBV® Valve|ibv® valve
5707298|NCT00475007|COPD|copd
5707299|NCT00475007|Shortness of Breath|shortness of breath
5707300|NCT00475007|Spiration|spiration
5707301|NCT00474994|chondrosarcoma|chondrosarcoma
5707302|NCT00474994|recurrent osteosarcoma|recurrent osteosarcoma
5707303|NCT00474994|localized adult malignant fibrous histiocytoma of bone|localized adult malignant fibrous histiocytoma of bone
5707304|NCT00474994|metastatic adult malignant fibrous histiocytoma of bone|metastatic adult malignant fibrous histiocytoma of bone
5707305|NCT00474994|recurrent adult malignant fibrous histiocytoma of bone|recurrent adult malignant fibrous histiocytoma of bone
5707306|NCT00474994|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5707307|NCT00474994|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5707308|NCT00474994|recurrent uterine sarcoma|recurrent uterine sarcoma
5707309|NCT00474994|adult leiomyosarcoma|adult leiomyosarcoma
5707310|NCT00474994|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5707311|NCT00474994|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5707312|NCT00474994|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5707313|NCT00474994|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5707314|NCT00474994|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5707315|NCT00474994|ovarian sarcoma|ovarian sarcoma
5714737|NCT00448123|Flomax|flomax
5707316|NCT00474994|uterine leiomyosarcoma|uterine leiomyosarcoma
5707317|NCT00474994|stage III uterine sarcoma|stage iii uterine sarcoma
5707318|NCT00474994|stage IV uterine sarcoma|stage iv uterine sarcoma
5707319|NCT00474994|desmoid tumor|desmoid tumor
5707320|NCT00474994|adult angiosarcoma|adult angiosarcoma
5707321|NCT00474994|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5707322|NCT00474994|uterine carcinosarcoma|uterine carcinosarcoma
5707323|NCT00474994|endometrial stromal sarcoma|endometrial stromal sarcoma
5707324|NCT00474994|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5707325|NCT00474994|chondrosarcomatous osteosarcoma|chondrosarcomatous osteosarcoma
5707326|NCT00474994|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5707327|NCT00474994|adult epithelioid sarcoma|adult epithelioid sarcoma
5707328|NCT00474994|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5707329|NCT00474994|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5707330|NCT00474994|adult fibrosarcoma|adult fibrosarcoma
5707331|NCT00474994|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5707333|NCT00474994|adult neurofibrosarcoma|adult neurofibrosarcoma
5707334|NCT00474994|adult synovial sarcoma|adult synovial sarcoma
5707335|NCT00474994|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5707336|NCT00474994|adult liposarcoma|adult liposarcoma
5707337|NCT00474994|anaplastic osteosarcoma|anaplastic osteosarcoma
5707338|NCT00474994|mixed osteosarcoma|mixed osteosarcoma
5707339|NCT00474994|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5707340|NCT00474994|osteoblastic osteosarcoma|osteoblastic osteosarcoma
5707341|NCT00474994|telangiectatic osteosarcoma|telangiectatic osteosarcoma
5707342|NCT00474994|classic Kaposi sarcoma|classic kaposi sarcoma
5707343|NCT00474994|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5707344|NCT00474994|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5707345|NCT00474981|neonatal mortality|neonatal mortality
5696836|NCT00511641|Survey|survey
5707346|NCT00474981|infant mortality|infant mortality
5707347|NCT00474981|newborn caring practices|newborn caring practices
5707348|NCT00474942|Hypertension|hypertension
5707349|NCT00474942|Metabolic Alkalosis|metabolic alkalosis
5707351|NCT00474929|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5707352|NCT00474929|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5707353|NCT00474929|stage III multiple myeloma|stage iii multiple myeloma
5707354|NCT00474929|refractory multiple myeloma|refractory multiple myeloma
5707438|NCT00474448|Survey|survey
5707355|NCT00474929|Waldenström macroglobulinemia|waldenström macroglobulinemia
5707356|NCT00474929|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5707357|NCT00474929|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5707358|NCT00474929|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5707359|NCT00474929|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5707360|NCT00474929|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5707361|NCT00474929|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5863053|NCT00001408|Asthma|asthma
5707362|NCT00474929|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5707363|NCT00474929|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5707364|NCT00474929|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5707365|NCT00474929|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5707366|NCT00474929|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5707367|NCT00474929|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5707368|NCT00474929|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5707369|NCT00474929|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5707370|NCT00474929|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5707371|NCT00474929|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5707372|NCT00474929|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5707373|NCT00474929|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5707374|NCT00474916|Neuropathic pain|neuropathic pain
5707375|NCT00474916|Cancer|cancer
5707376|NCT00474890|Seasonal allergic rhinitis|seasonal allergic rhinitis
5707377|NCT00474877|Clinical|clinical
5707378|NCT00474877|Splints|splints
5707379|NCT00474877|Rheumatoid|rheumatoid
5707380|NCT00474864|Endothelial Function,|endothelial function,
5707381|NCT00474864|vascular compliance,|vascular compliance,
5707382|NCT00474864|atherosclerosis|atherosclerosis
5707383|NCT00474851|Endometriosis|endometriosis
5707384|NCT00474851|Adolescents|adolescents
5707385|NCT00474851|Bone density|bone density
5707386|NCT00474851|GnRH Agonist|gnrh agonist
5707387|NCT00474851|Add-back therapy|add-back therapy
5707482|NCT00474318|Bariatrics|bariatrics
5707388|NCT00474838|type 2 diabetes mellitus|type 2 diabetes mellitus
5707389|NCT00474838|intensive insulin therapy|intensive insulin therapy
5707390|NCT00474786|Metastatic or Advanced Renal Cell Carcinoma|metastatic or advanced renal cell carcinoma
5706026|NCT00479596|OAB|oab
5707391|NCT00474734|hepatocellular carcinoma|hepatocellular carcinoma
5707392|NCT00474734|liver transplantation|liver transplantation
5707393|NCT00474734|staging|staging
5707394|NCT00474734|intravascular ultrasound|intravascular ultrasound
5707395|NCT00474721|child|child
5707396|NCT00474721|pain|pain
5707397|NCT00474721|analgesics|analgesics
5707398|NCT00474695|Exudative age-related macular degeneration|exudative age-related macular degeneration
5707399|NCT00474682|ferric pyrophosphate, iron bioavailability, fortification,|ferric pyrophosphate, iron bioavailability, fortification,
5707400|NCT00474669|Ovarian Carcinoma|ovarian carcinoma
5707401|NCT00474656|high frequency oscillation|high frequency oscillation
5707402|NCT00474656|lung-protective ventilation|lung-protective ventilation
5707403|NCT00474656|ARDS|ards
5707404|NCT00474656|ventilator-induced lung injury|ventilator-induced lung injury
5707405|NCT00474630|Obesity|obesity
5707406|NCT00474630|Overweight|overweight
5707407|NCT00474630|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5707408|NCT00474604|breast cancer|breast cancer
5707409|NCT00474591|Coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation|coronary artery bypass surgery, fondaparinux, graft patency, graft occlusion, graft failure, anticoagulation
5707410|NCT00474565|Catheter,|catheter,
5707411|NCT00474565|Aortic root injection,|aortic root injection,
5707412|NCT00474565|low dose contrast injection,|low dose contrast injection,
5707413|NCT00474565|coronary artery angiogarm and|coronary artery angiogarm and
5707414|NCT00474565|coronary artery bypass graft imaging.|coronary artery bypass graft imaging.
5707416|NCT00474526|Meningococcal|meningococcal
5707417|NCT00474526|meningitis|meningitis
5707418|NCT00474526|vaccine|vaccine
5707419|NCT00474526|infants|infants
5707420|NCT00474526|Meningococcal meningitis|meningococcal meningitis
5707421|NCT00474526|Meningococcal disease|meningococcal disease
5707422|NCT00474513|AD, H3, Brain, Cognitive Impairment|ad, h3, brain, cognitive impairment
5707423|NCT00474500|Iron absorption|iron absorption
5707424|NCT00474500|Coca-Cola|coca-cola
5707425|NCT00474487|Meningococcal|meningococcal
5707426|NCT00474487|meningitis|meningitis
5707427|NCT00474487|vaccine|vaccine
5707428|NCT00474487|adolescents|adolescents
5707429|NCT00474487|adults|adults
5707430|NCT00474474|virtual patient|virtual patient
5707431|NCT00474474|therapeutic decision making|therapeutic decision making
5707432|NCT00474461|coronary artery disease|coronary artery disease
5707433|NCT00474461|Heart Attack|heart attack
5707434|NCT00474461|Heart failure|heart failure
5707435|NCT00474461|Cardiac Stem Cells|cardiac stem cells
5707436|NCT00474461|Coronary Artery Bypass|coronary artery bypass
5707437|NCT00474448|Hereditary Multiple Exostoses|hereditary multiple exostoses
5707439|NCT00474448|Quality of Life|quality of life
5707440|NCT00474448|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5707441|NCT00474448|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5707442|NCT00474448|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5707443|NCT00474435|Tuberculosis|tuberculosis
5707445|NCT00474435|Coinfection|coinfection
5707446|NCT00474435|Pharmacokinetics|pharmacokinetics
5863054|NCT00001408|Cytokines|cytokines
5716056|NCT00444691|sensitivity to change|sensitivity to change
5716057|NCT00444691|clinical examination|clinical examination
5716058|NCT00444691|ultra-sonography|ultra-sonography
5716060|NCT00444678|Metastatic Colorectal Cancer|metastatic colorectal cancer
5707447|NCT00474435|Emtricitabine|emtricitabine
5707448|NCT00474435|Tenofovir|tenofovir
5707449|NCT00474435|Rifampin|rifampin
5707450|NCT00474435|Efavirenz|efavirenz
5707451|NCT00474435|Treatment Naive|treatment naive
5707452|NCT00474422|breastfeeding|breastfeeding
5707453|NCT00474422|support|support
5707454|NCT00474409|Vertigo|vertigo
5707455|NCT00474409|Posterior circulation infarction|posterior circulation infarction
5707456|NCT00474396|Uric acid|uric acid
5707457|NCT00474396|Dairy|dairy
5707458|NCT00474396|Diet|diet
5707459|NCT00474383|Prostate neoplasms|prostate neoplasms
5707460|NCT00474383|CB7630|cb7630
5707461|NCT00474383|Abiraterone acetate|abiraterone acetate
5707462|NCT00474383|Glucocorticoid|glucocorticoid
5707463|NCT00474383|Prednisone|prednisone
5707464|NCT00474383|Prednisolone|prednisolone
5707465|NCT00474370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5707466|NCT00474357|Bipolar affective disorder|bipolar affective disorder
5707467|NCT00474357|myths|myths
5707468|NCT00474357|preconceived notions|preconceived notions
5707469|NCT00474357|stigma|stigma
5707470|NCT00474357|hope|hope
5707471|NCT00474344|Genetics|genetics
5707472|NCT00474344|Clubfoot|clubfoot
5707473|NCT00474344|DNA|dna
5707474|NCT00474344|Idiopathic Talipes Equinovarus also known as Clubfoot|idiopathic talipes equinovarus also known as clubfoot
5707475|NCT00474331|DNA sequencing|dna sequencing
5707476|NCT00474331|EXT genes|ext genes
5707477|NCT00474331|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5707478|NCT00474331|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5707479|NCT00474331|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5707480|NCT00474318|Adolescents|adolescents
5685810|NCT00554736|Pollen Allergy|pollen allergy
5685811|NCT00554736|Allergy|allergy
5685812|NCT00554723|Stroke|stroke
5685813|NCT00554723|Cerebral infarct|cerebral infarct
5707481|NCT00474318|Obesity|obesity
5707483|NCT00474318|Surgery for Weight Loss|surgery for weight loss
5707484|NCT00474318|Teen-LABS|teen-labs
5707485|NCT00474305|PTSD|ptsd
5707486|NCT00474305|Prolonged Exposure|prolonged exposure
5707487|NCT00474305|Virtual Reality|virtual reality
5707488|NCT00474292|Stroke|stroke
5707489|NCT00474292|Rehabilitation|rehabilitation
5707490|NCT00474292|Plasticity|plasticity
5707491|NCT00474292|fMRI|fmri
5707492|NCT00474292|Reorganization|reorganization
5707493|NCT00474279|Growth hormone secretagogue|growth hormone secretagogue
5707494|NCT00474279|Body composition|body composition
5707495|NCT00474279|Functional ability|functional ability
5707496|NCT00474279|Aging|aging
5707497|NCT00474279|Sarcopenia|sarcopenia
5707498|NCT00474266|MMRV vaccine|mmrv vaccine
5707499|NCT00474266|co-administration|co-administration
5707500|NCT00474266|immunogenicity|immunogenicity
5707501|NCT00474266|meningococcal vaccine|meningococcal vaccine
5707502|NCT00474266|conjugate vaccine|conjugate vaccine
5707505|NCT00474227|weight gain|weight gain
5707506|NCT00474227|schizophrenia|schizophrenia
5707507|NCT00474227|schizoaffective disorder|schizoaffective disorder
5707508|NCT00474227|antipsychotic induced weight gain|antipsychotic induced weight gain
5707509|NCT00474214|STEMI|stemi
5707510|NCT00474214|Primary PCI|primary pci
5707511|NCT00474214|Length of Stay|length of stay
5707512|NCT00474214|Early Discharge|early discharge
5707513|NCT00474201|Pharmacokinetic|pharmacokinetic
5707514|NCT00474201|HIV|hiv
5707515|NCT00474201|Drug-Drug Interaction|drug-drug interaction
5707516|NCT00474201|Lopinavir/Ritonavir|lopinavir/ritonavir
5707517|NCT00474201|Gemfibrozil|gemfibrozil
5707518|NCT00474201|Healthy Volunteer|healthy volunteer
5707519|NCT00474201|HV|hv
5707520|NCT00474188|Celgene|celgene
5707521|NCT00474188|Revlimid|revlimid
5707522|NCT00474188|Lenalidomide|lenalidomide
5707523|NCT00474188|Diffuse Large B-cell lymphoma|diffuse large b-cell lymphoma
5707524|NCT00474188|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5707525|NCT00474188|CC-5013|cc-5013
5707526|NCT00474188|Response Rate|response rate
5707527|NCT00474188|Tumor Control Rate|tumor control rate
5707528|NCT00474188|Duration of Response|duration of response
5707529|NCT00474188|Time to Progression|time to progression
5707530|NCT00474188|Progression-free survival and safety|progression-free survival and safety
5707532|NCT00474162|coagulation changes|coagulation changes
5707533|NCT00474123|angina|angina
5707534|NCT00474123|atherosclerosis|atherosclerosis
5707535|NCT00474123|simvastatin|simvastatin
5707536|NCT00474123|ezetimibe|ezetimibe
5707537|NCT00474123|inflammation|inflammation
5707538|NCT00474110|Ketamine|ketamine
5707539|NCT00474110|hydromorphone|hydromorphone
5707540|NCT00474110|pediatric mucositis|pediatric mucositis
5707541|NCT00474097|Colorectal Neoplasms|colorectal neoplasms
5707542|NCT00474097|Colitis, Ulcerative|colitis, ulcerative
5707543|NCT00474097|Diverticulitis|diverticulitis
5707544|NCT00474097|Colonic Polyps|colonic polyps
5707545|NCT00474097|Crohn Disease|crohn disease
5707547|NCT00474084|Hydroxyapatite|hydroxyapatite
5707548|NCT00474084|Coronary Artery Stenosis|coronary artery stenosis
5707549|NCT00474084|Angioplasty|angioplasty
5707550|NCT00474071|Remifentanil|remifentanil
5707551|NCT00474071|endotracheal intubation|endotracheal intubation
5707552|NCT00474071|pediatrics|pediatrics
5707553|NCT00474058|rotigotine|rotigotine
5707554|NCT00474058|Neupro®|neupro®
5707555|NCT00474058|Parkinson's Disease|parkinson's disease
5707556|NCT00474032|Idiopathic clubfoot|idiopathic clubfoot
5707557|NCT00474032|Botox injection|botox injection
5707558|NCT00474032|Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot|idiopathic talipes equinovarus, also known as idiopathic clubfoot
5707559|NCT00474019|pediatrics|pediatrics
5707560|NCT00474019|neonates|neonates
5707561|NCT00473993|Hepatitis C|hepatitis c
5707562|NCT00473993|Opioid Maintenance Treatment|opioid maintenance treatment
5707563|NCT00473993|Methadone|methadone
5707564|NCT00473993|Buprenorphine|buprenorphine
5707565|NCT00473993|Heroin|heroin
5707566|NCT00473993|Interferon, pegylated|interferon, pegylated
5707567|NCT00473980|MHC|mhc
5707568|NCT00473980|CTLs|ctls
5707569|NCT00473980|Colon carcinoma|colon carcinoma
5707570|NCT00473980|NSAID|nsaid
5707571|NCT00473980|Survival|survival
5707572|NCT00473967|Vaccine|vaccine
5707573|NCT00473967|Hookworm|hookworm
5707574|NCT00473967|Phase 1|phase 1
5707575|NCT00473967|Na-ASP-2|na-asp-2
5707576|NCT00473941|colorectal cancer|colorectal cancer
5707577|NCT00473941|colon cancer|colon cancer
5707578|NCT00473941|rectal cancer|rectal cancer
5707579|NCT00473928|Macular|macular
5707580|NCT00473928|degeration|degeration
5707581|NCT00473928|Complement|complement
5707582|NCT00473876|Chronic Heart Failure|chronic heart failure
5707583|NCT00473876|Insulin Resistance|insulin resistance
5707584|NCT00473876|Metformin|metformin
5707585|NCT00473876|Peak VO2|peak vo2
5707586|NCT00473863|Acute coronary syndrome|acute coronary syndrome
5707587|NCT00473863|Acute myocardial infarction|acute myocardial infarction
5707588|NCT00473863|Unstable angina|unstable angina
5707589|NCT00473863|Coronary computed tomographic angiography|coronary computed tomographic angiography
5707590|NCT00473863|Coronary Angiography|coronary angiography
5707591|NCT00473863|Tomography, X-Ray Computed|tomography, x-ray computed
5707592|NCT00473863|Tomography, Spiral Computed|tomography, spiral computed
5707593|NCT00473850|DNA sequencing|dna sequencing
5707594|NCT00473850|EXT genes|ext genes
5707595|NCT00473850|Hereditary Multiple Exostoses,|hereditary multiple exostoses,
5707596|NCT00473850|also known as Multiple Hereditary Exostoses,|also known as multiple hereditary exostoses,
5707597|NCT00473850|also known as Hereditary Multiple Osteochondromas|also known as hereditary multiple osteochondromas
5707598|NCT00473837|malaria|malaria
5707599|NCT00473837|anaemia|anaemia
5707600|NCT00473837|chloroquine|chloroquine
5707601|NCT00473837|iron delocalisation|iron delocalisation
5707602|NCT00473837|macrophages|macrophages
5707603|NCT00473824|hepatitis C|hepatitis c
5707604|NCT00473824|liver transplantation|liver transplantation
5707605|NCT00473824|immune globulin|immune globulin
5707606|NCT00473811|Glycemic index|glycemic index
5707607|NCT00473811|carbohydrates|carbohydrates
5707608|NCT00473811|diabetes mellitus, type 2|diabetes mellitus, type 2
5707609|NCT00473811|randomized clinical trial|randomized clinical trial
5707610|NCT00473798|Patient Satisfaction|patient satisfaction
5707611|NCT00473798|Quality of Life|quality of life
5707612|NCT00473798|Psychological Distress|psychological distress
5707613|NCT00473798|Cervical Cancer|cervical cancer
5707614|NCT00473798|Cervical Cancer Screening|cervical cancer screening
5707615|NCT00473798|Questionnaire|questionnaire
5707616|NCT00473785|Cardiovascular disease|cardiovascular disease
5707617|NCT00473785|Prevention|prevention
5707618|NCT00473785|Lifestyle|lifestyle
5707619|NCT00473772|cobalt chromium stent|cobalt chromium stent
5707620|NCT00473772|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5707621|NCT00473772|DEBlue|deblue
5707622|NCT00473772|drug eluting balloon|drug eluting balloon
5707623|NCT00473746|Prostate neoplasms|prostate neoplasms
5707624|NCT00473746|Hormone refractory prostate cancer|hormone refractory prostate cancer
5707625|NCT00473746|Abiraterone acetate|abiraterone acetate
5707626|NCT00473746|CB7630|cb7630
5707627|NCT00473733|PATIENTS WITH DIABETES MELLITUS TYPE 2|patients with diabetes mellitus type 2
5707628|NCT00473733|UNDERGO UPPER ENDOSCOPY|undergo upper endoscopy
5707629|NCT00473733|BIOPSIES FOR GLP RECEPTORS EXPRESSION|biopsies for glp receptors expression
5707630|NCT00473733|PCR ANALYSIS|pcr analysis
5707631|NCT00473707|Third stage of labor|third stage of labor
5707632|NCT00473668|Hepatitis B|hepatitis b
5707633|NCT00473668|Tetanus|tetanus
5707634|NCT00473668|Diphtheria|diphtheria
5707635|NCT00473668|Pertussis|pertussis
5707636|NCT00473668|Haemophilus influenzae type b Vaccines|haemophilus influenzae type b vaccines
5707637|NCT00473655|Triglycerides|triglycerides
5707638|NCT00473655|hypertriglyceridemia|hypertriglyceridemia
5707639|NCT00473655|statins|statins
5707640|NCT00473655|rosuvastatin|rosuvastatin
5707641|NCT00473655|hyperlipoproteinemia|hyperlipoproteinemia
5707642|NCT00473655|Fredrickson Type IIb or IV|fredrickson type iib or iv
5707643|NCT00473642|Ranibizumab|ranibizumab
5707644|NCT00473642|Lucentis|lucentis
5707645|NCT00473642|Verteporfin|verteporfin
5707646|NCT00473642|Visudyne|visudyne
5707647|NCT00473642|Photodynamic therapy|photodynamic therapy
5707649|NCT00473616|solid tumors|solid tumors
5707650|NCT00473616|solid malignancies|solid malignancies
5707651|NCT00473616|cancer Eligibility|cancer eligibility
5707652|NCT00473603|androgens|androgens
5707653|NCT00473603|fatty acids|fatty acids
5707654|NCT00473590|Avastin|avastin
5707655|NCT00473590|AMBER|amber
5707656|NCT00473590|Myeloma|myeloma
5707657|NCT00473590|Velcade|velcade
5707658|NCT00473564|Lesions|lesions
5707659|NCT00473564|Biopsy|biopsy
5707660|NCT00473564|Surgery|surgery
5707661|NCT00473551|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5707662|NCT00473551|Lymphoma|lymphoma
5707663|NCT00473551|Myeloma|myeloma
5707664|NCT00473551|Leukemia|leukemia
5707665|NCT00473551|Anti-Third Party Cytolytic Lymphocytes|anti-third party cytolytic lymphocytes
5707666|NCT00473551|Indolent Lymphoid Malignancies|indolent lymphoid malignancies
5707667|NCT00473551|Fludarabine|fludarabine
5707668|NCT00473551|Fludara|fludara
5707669|NCT00473551|Rituximab|rituximab
5707670|NCT00473551|Rituxan|rituxan
5707671|NCT00473551|Cyclophosphamide|cyclophosphamide
5707672|NCT00473551|Cytoxan®|cytoxan®
5707673|NCT00473551|Neosar®|neosar®
5707674|NCT00473551|Stem Cell Transplantation|stem cell transplantation
5707675|NCT00473551|T-lymphocytes|t-lymphocytes
5707676|NCT00473551|Miltenyi CliniMACS System|miltenyi clinimacs system
5707677|NCT00473551|Graft vs. Host Disease|graft vs. host disease
5707678|NCT00473551|GVHD|gvhd
5707679|NCT00473551|Allogenic Transplant|allogenic transplant
5707680|NCT00473551|Sirolimus|sirolimus
5707681|NCT00473551|Rapamycin|rapamycin
5707682|NCT00473538|Structured exercise training program|structured exercise training program
5707683|NCT00473538|Infertility|infertility
5707684|NCT00473538|Menstrual cycle|menstrual cycle
5707685|NCT00473538|PCOS|pcos
5707686|NCT00473538|Treatment|treatment
5707687|NCT00473512|Abiraterone acetate|abiraterone acetate
5707688|NCT00473512|CB7630|cb7630
5707689|NCT00473512|Prostatic neoplasms|prostatic neoplasms
5707690|NCT00473512|Hormone refractory prostate cancer|hormone refractory prostate cancer
5707691|NCT00473512|Castration resistant prostate cancer|castration resistant prostate cancer
5707692|NCT00473512|Castration refractory prostate cancer|castration refractory prostate cancer
5707693|NCT00473499|drug eluting balloon|drug eluting balloon
5707694|NCT00473499|drug eluting stent|drug eluting stent
5707695|NCT00473499|stem cells|stem cells
5707696|NCT00473473|homeopathy|homeopathy
5707697|NCT00473473|Traumeel|traumeel
5707698|NCT00473473|mechanical ventilation|mechanical ventilation
5707699|NCT00473473|secretions|secretions
5707700|NCT00473460|Chronic bronchitis|chronic bronchitis
5707701|NCT00473460|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5707702|NCT00473460|Acute exacerbation of chronic bronchitis|acute exacerbation of chronic bronchitis
5707703|NCT00473460|Prevention therapy|prevention therapy
5707704|NCT00473460|Antibiotics|antibiotics
5707705|NCT00473460|Fluoroquinolone|fluoroquinolone
5707706|NCT00473460|Moxifloxacin|moxifloxacin
5707708|NCT00473447|Rehabilitation|rehabilitation
5707709|NCT00473447|Children|children
5707710|NCT00473447|Cerebral Palsy|cerebral palsy
5707712|NCT00473447|Paresis|paresis
5707713|NCT00473434|Schizophrenia|schizophrenia
5707714|NCT00473434|Drug Therapy|drug therapy
5707715|NCT00473434|Treatment Outcome|treatment outcome
5707716|NCT00473408|Glioma|glioma
5707717|NCT00473408|DCE-MRI|dce-mri
5707718|NCT00473408|Angiogenesis|angiogenesis
5707719|NCT00473408|Cancer stem cells|cancer stem cells
5707720|NCT00473408|Tumor vasculature|tumor vasculature
5707721|NCT00473382|Lucentis|lucentis
5707722|NCT00473382|DME|dme
5707723|NCT00473382|Diabetes|diabetes
5707724|NCT00473382|Vision loss|vision loss
5707725|NCT00473369|atypical adenoma|atypical adenoma
5707726|NCT00473369|Ki-67|ki-67
5707727|NCT00473369|p53|p53
5707728|NCT00473369|pituitary|pituitary
5707729|NCT00473369|prognosis|prognosis
5707730|NCT00473356|Morbid obesity|morbid obesity
5707731|NCT00473356|Lean body mass|lean body mass
5707732|NCT00473356|amino acid supplement|amino acid supplement
5707733|NCT00473356|laparoscopic gastric bypass|laparoscopic gastric bypass
5707734|NCT00473343|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
5707735|NCT00473343|PDT with Metvix cream|pdt with metvix cream
5707736|NCT00473343|"High risk BCC"|"high risk bcc"
5707737|NCT00473343|Basal Cell carcinoma|basal cell carcinoma
5798803|NCT00110968|Abdominal Symptom relief|abdominal symptom relief
5707741|NCT00473330|Diabetes|diabetes
5707742|NCT00473330|Vision loss|vision loss
5707743|NCT00473317|sunlight|sunlight
5707744|NCT00473317|UVB|uvb
5707745|NCT00473317|Vitamin D|vitamin d
5707749|NCT00473304|myopia and contact lens wear in children|myopia and contact lens wear in children
5707750|NCT00473291|pleural effusion|pleural effusion
5707751|NCT00473291|lung sounds|lung sounds
5716408|NCT00443443|RA|ra
5707752|NCT00473291|acoustic monitoring|acoustic monitoring
5707753|NCT00473278|tear protein|tear protein
5707754|NCT00473252|aspergillus infections|aspergillus infections
5707755|NCT00473252|immunosuppression|immunosuppression
5707756|NCT00473252|kidney transplantation|kidney transplantation
5707757|NCT00473252|hemodialysis|hemodialysis
5707758|NCT00473252|galactomannan test|galactomannan test
5707759|NCT00473252|fine dust|fine dust
5707760|NCT00473252|construction activity|construction activity
5707761|NCT00473252|airborne aspergillus spores|airborne aspergillus spores
5707762|NCT00473239|vitamin D|vitamin d
5707763|NCT00473239|cholecalciferol|cholecalciferol
5707764|NCT00473239|25-hydroxyvitamin D|25-hydroxyvitamin d
5707765|NCT00473213|Multiple Sclerosis|multiple sclerosis
5707766|NCT00473213|Interferon|interferon
5707767|NCT00473213|Magnetic Resonance|magnetic resonance
5707768|NCT00473200|hyperhomocysteinemia|hyperhomocysteinemia
5707769|NCT00473200|homocysteine|homocysteine
5707770|NCT00473200|S-adenosylmethionine|s-adenosylmethionine
5707771|NCT00473200|SAMe|same
5707772|NCT00473200|Asymmetric dimethylagrinine (ADMA)|asymmetric dimethylagrinine (adma)
5707773|NCT00473187|X-linked dominant hypophosphatemic rickets|x-linked dominant hypophosphatemic rickets
5707774|NCT00473187|growth disorders|growth disorders
5707775|NCT00473187|anthropometry|anthropometry
5707776|NCT00473187|human growth hormone|human growth hormone
5707777|NCT00473174|Ramipril|ramipril
5707778|NCT00473174|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5707779|NCT00473174|Chronotherapy|chronotherapy
5707780|NCT00473174|Circadian|circadian
5707781|NCT00473174|Non-dipper|non-dipper
5707782|NCT00473161|movement disorders|movement disorders
5707783|NCT00473161|childhood|childhood
5707784|NCT00473148|Duration of weaning from invasive ventilation|duration of weaning from invasive ventilation
5707785|NCT00473148|Mechanical ventilation|mechanical ventilation
5707786|NCT00473148|Weaning|weaning
5707787|NCT00473148|B-type natriuretic peptide|b-type natriuretic peptide
5707788|NCT00473148|Fluid balance|fluid balance
5685814|NCT00554723|Recovery|recovery
5706408|NCT00477984|ERP|erp
5707790|NCT00473148|Intubated patient receiving mechanical ventilation|intubated patient receiving mechanical ventilation
5707791|NCT00473148|for at least 24 hours|for at least 24 hours
5707792|NCT00473148|Respiratory insufficiency|respiratory insufficiency
5707793|NCT00473135|Dengue Fever|dengue fever
5707794|NCT00473135|Dengue Vaccine|dengue vaccine
5707795|NCT00473135|Dengue Virus|dengue virus
5707796|NCT00473135|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5707797|NCT00473135|Dengue Shock Syndrome|dengue shock syndrome
5707798|NCT00473122|Breast Cancer|breast cancer
5707799|NCT00473122|Breast Reconstruction|breast reconstruction
5707800|NCT00473122|Delayed-Immediate Reconstruction|delayed-immediate reconstruction
5707801|NCT00473122|Postmastectomy Radiation Therapy|postmastectomy radiation therapy
5707802|NCT00473122|Mastectomy|mastectomy
5707804|NCT00473109|Hemodialysis|hemodialysis
5707805|NCT00473109|Heparin|heparin
5707806|NCT00473109|Clotting|clotting
5707811|NCT00473083|Rash|rash
5707812|NCT00473083|Erlotinib|erlotinib
5707813|NCT00473083|Lung Cancer|lung cancer
5707814|NCT00473057|acute stroke|acute stroke
5707815|NCT00473057|middle cerebral artery|middle cerebral artery
5702237|NCT00494195|AAV|aav
5707816|NCT00473057|autologous transplantation|autologous transplantation
5707817|NCT00473057|bone marrow cells|bone marrow cells
5707819|NCT00473057|cell therapy|cell therapy
5707820|NCT00473031|bone mass|bone mass
5707821|NCT00473031|calcium absorption|calcium absorption
5707822|NCT00473031|bone quality|bone quality
5707823|NCT00473031|fracture risk|fracture risk
5707824|NCT00473018|postexposure prophylaxis|postexposure prophylaxis
5707825|NCT00473018|HIV Seronegativity|hiv seronegativity
5707826|NCT00472992|Pregnancy|pregnancy
5707827|NCT00472992|TYSABRI|tysabri
5707828|NCT00472940|Cancer|cancer
5707829|NCT00472940|Hypogonadism|hypogonadism
5707830|NCT00472940|testosterone|testosterone
5707831|NCT00472940|cachexia|cachexia
5707832|NCT00472914|Hypertonia|hypertonia
5707833|NCT00472914|Childhood|childhood
5707834|NCT00472901|Polymorphic Light Eruption (PLE)|polymorphic light eruption (ple)
5707835|NCT00472901|Afamelanotide|afamelanotide
5707836|NCT00472901|CUV1647|cuv1647
5707837|NCT00472901|photoprotection|photoprotection
5707838|NCT00472901|sun poisoning|sun poisoning
5707839|NCT00472888|Alpha-adrenergic blockers|alpha-adrenergic blockers
5707840|NCT00472888|cataract surgery|cataract surgery
5707841|NCT00472888|pseudoexfoliation syndrome|pseudoexfoliation syndrome
5707842|NCT00472888|diabetes mellitus|diabetes mellitus
5707844|NCT00472888|pupil|pupil
5707845|NCT00472875|hypoglycaemia|hypoglycaemia
5707846|NCT00472875|type 1 diabetes mellitus|type 1 diabetes mellitus
5707847|NCT00472849|OFAR 2|ofar 2
5707848|NCT00472849|Oxaliplatin|oxaliplatin
5707853|NCT00472849|Richter's Transformation|richter's transformation
5707854|NCT00472849|Prolymphocytic Leukemia|prolymphocytic leukemia
5707855|NCT00472849|B-Cell Chronic Lymphocytic Leukemia|b-cell chronic lymphocytic leukemia
5707856|NCT00472849|Leukemia|leukemia
5707858|NCT00472823|cholecalciferol|cholecalciferol
5707859|NCT00472823|vitamin D deficiency|vitamin d deficiency
5707860|NCT00472823|bone density|bone density
5707861|NCT00472823|dietary calcium|dietary calcium
5707862|NCT00472823|hypercalcemia|hypercalcemia
5707863|NCT00472823|hypercalciuria|hypercalciuria
5707864|NCT00472810|Glaucoma|glaucoma
5707865|NCT00472810|Collagen matrix|collagen matrix
5707866|NCT00472810|ologen|ologen
5707867|NCT00472810|OculusGen|oculusgen
5707868|NCT00472810|Antifibrotic|antifibrotic
5707869|NCT00472810|Trabeculectomy|trabeculectomy
5707870|NCT00472810|anti scarring|anti scarring
5707871|NCT00472810|tissue engineering|tissue engineering
5707872|NCT00472810|high risk patient for trabeculectomy|high risk patient for trabeculectomy
5707873|NCT00472810|Aeon Astron|aeon astron
5707874|NCT00472771|Recurrent extensive small cell lung cancer|recurrent extensive small cell lung cancer
5707875|NCT00472745|bone mass|bone mass
5707876|NCT00472745|calcium absorption|calcium absorption
5707877|NCT00472745|bone quality|bone quality
5707878|NCT00472745|fracture risk|fracture risk
5707879|NCT00472745|arthritis|arthritis
5707880|NCT00472745|osteoporosis|osteoporosis
5707881|NCT00472732|UCD|ucd
5707882|NCT00472732|OTCD|otcd
5707883|NCT00472732|Ammonia|ammonia
5707884|NCT00472732|Urea Metabolism|urea metabolism
5707885|NCT00472732|Inborn Errors|inborn errors
5707886|NCT00472719|HIV Seronegativity|hiv seronegativity
5707887|NCT00472719|HIV Preventive Vaccine|hiv preventive vaccine
5707888|NCT00472719|Adenovirus|adenovirus
5707889|NCT00472706|Treatment|treatment
5707890|NCT00472706|Excision|excision
5707891|NCT00472706|Photodynamic therapy|photodynamic therapy
5707892|NCT00472706|Recurrence rate|recurrence rate
5707893|NCT00472706|Cosmetic outcome|cosmetic outcome
5707894|NCT00472693|Breast cancer|breast cancer
5707895|NCT00472693|Metastatic breast cancer|metastatic breast cancer
5707896|NCT00472693|Second-Line Therapy|second-line therapy
5707897|NCT00472693|Triple Negative|triple negative
5707898|NCT00472693|Her-2 negative|her-2 negative
5707899|NCT00472693|Hormone receptor negative|hormone receptor negative
5707900|NCT00472693|Abraxane|abraxane
5707901|NCT00472693|Bevacizumab|bevacizumab
5707902|NCT00472680|bone mass|bone mass
5707903|NCT00472680|calcium absorption|calcium absorption
5707904|NCT00472680|bone quality|bone quality
5707905|NCT00472680|fracture risk|fracture risk
5707906|NCT00472667|Bacterial infections|bacterial infections
5707907|NCT00472667|Procalcitonin|procalcitonin
5707908|NCT00472667|Intensive care unit|intensive care unit
5707909|NCT00472667|Antibiotic therapy|antibiotic therapy
5707910|NCT00472667|Suspicion of bacterial infection or proven|suspicion of bacterial infection or proven
5707911|NCT00472654|bone mass|bone mass
5707912|NCT00472654|calcium absorption|calcium absorption
5707913|NCT00472654|bone quality|bone quality
5707914|NCT00472654|fracture risk|fracture risk
5707915|NCT00472615|Bipolar Disorder|bipolar disorder
5707916|NCT00472615|Menstrual Cycle|menstrual cycle
5707917|NCT00472615|Depression|depression
5707918|NCT00472615|Mania or Hypomania|mania or hypomania
5707919|NCT00472615|Predictor|predictor
5707920|NCT00472602|Opisthorchis viverrini, liver fluke, Thailand, cancer|opisthorchis viverrini, liver fluke, thailand, cancer
5707921|NCT00472576|NMDA Receptor|nmda receptor
5707922|NCT00472576|Depression Treatment|depression treatment
5707923|NCT00472576|Unipolar Depression|unipolar depression
5707924|NCT00472576|Treatment Resistant|treatment resistant
5707925|NCT00472576|Glutamatergic|glutamatergic
5707926|NCT00472576|Depression|depression
5707927|NCT00472576|Major Depression|major depression
5707928|NCT00472563|bicarbonate|bicarbonate
5707929|NCT00472563|nephropathy|nephropathy
5707930|NCT00472563|contrast|contrast
5707931|NCT00472550|esomeprazole, gastric emptying, reflux|esomeprazole, gastric emptying, reflux
5707932|NCT00472537|Ventral hernia|ventral hernia
5707933|NCT00472537|Incisional hernia|incisional hernia
5707934|NCT00472498|Cardiac Arrest|cardiac arrest
5707935|NCT00472498|Biphasic Defibrillator|biphasic defibrillator
5707936|NCT00472472|restenosis|restenosis
5707937|NCT00472472|peripheral arterial disease|peripheral arterial disease
5707938|NCT00472472|paccocath|paccocath
5707939|NCT00472472|drug-coated balloon|drug-coated balloon
5707940|NCT00472459|Non-melanoma skin cancer|non-melanoma skin cancer
5707941|NCT00472459|Organ transplant recipients|organ transplant recipients
5707942|NCT00472459|Photodynamic therapy|photodynamic therapy
5707943|NCT00472459|Actinic keratosis|actinic keratosis
5707945|NCT00472446|Thyroid gland|thyroid gland
5707946|NCT00472446|cervical block|cervical block
5707947|NCT00472446|Pain, Postoperative|pain, postoperative
5707948|NCT00472433|Alemtuzumab in autoimmune cytopenias|alemtuzumab in autoimmune cytopenias
5707949|NCT00472407|Normal|normal
5707950|NCT00472394|Medical abortion|medical abortion
5707951|NCT00472394|Preferences|preferences
5707952|NCT00472394|Willingness to Pay|willingness to pay
5707953|NCT00472381|Acute Ischemic Stroke|acute ischemic stroke
5707954|NCT00472381|Post-Stroke Hyperglycaemia|post-stroke hyperglycaemia
5707955|NCT00472381|Insulin treatment|insulin treatment
5707956|NCT00472381|Insulin|insulin
5707958|NCT00472381|MRI|mri
5707959|NCT00472368|Advanced cancer|advanced cancer
5707960|NCT00472368|lymphoma|lymphoma
5707961|NCT00472368|chronic hematological malignancies|chronic hematological malignancies
5707962|NCT00472368|adult|adult
5707963|NCT00472355|Parkinson's disease|parkinson's disease
5707964|NCT00472355|PD|pd
5707965|NCT00472355|apomorphine|apomorphine
5707966|NCT00472342|impaired glucose tolerance|impaired glucose tolerance
5707967|NCT00472342|impaired fasting glucose|impaired fasting glucose
5707968|NCT00472342|diabetes|diabetes
5707969|NCT00472342|adipokine|adipokine
5707970|NCT00472342|adiponectin|adiponectin
5707971|NCT00472342|RBP-4|rbp-4
5707972|NCT00472342|adrenomedullin|adrenomedullin
5707973|NCT00472303|Opioid|opioid
5707974|NCT00472303|Central acting analgesic|central acting analgesic
5707975|NCT00472303|CG5503 PR|cg5503 pr
5707976|NCT00472303|Tumor related pain|tumor related pain
5707977|NCT00472303|Cancer related pain|cancer related pain
5707978|NCT00472303|Morphine|morphine
5707979|NCT00472303|Pain assessment|pain assessment
5707980|NCT00472303|Placebo|placebo
5707981|NCT00472290|Hematology|hematology
5707982|NCT00472290|MDS|mds
5707983|NCT00472290|Myelodysplastic Syndromes|myelodysplastic syndromes
5707984|NCT00472290|Thrombocytopenia|thrombocytopenia
5707985|NCT00472264|methodology study, PET Imaging, COPD patients|methodology study, pet imaging, copd patients
5707986|NCT00472251|dutasteride|dutasteride
5707987|NCT00472251|body mass index|body mass index
5707988|NCT00472251|testosterone|testosterone
5707989|NCT00472225|Chronic graft-versus-host disease|chronic graft-versus-host disease
5707990|NCT00472225|rituximab|rituximab
5707991|NCT00472186|Tonsillectomy|tonsillectomy
5707992|NCT00472186|Pain|pain
5707993|NCT00472173|Apexification|apexification
5707994|NCT00472173|Pulp necrosis|pulp necrosis
5707995|NCT00472173|Calcium hydroxide|calcium hydroxide
5707996|NCT00472173|MTA|mta
5707997|NCT00472173|pulp necrosis of an anterior immature tooth|pulp necrosis of an anterior immature tooth
5707998|NCT00472160|Preoxygenation|preoxygenation
5707999|NCT00472160|Non Invasive Ventilation|non invasive ventilation
5731819|NCT00387673|hand|hand
5708000|NCT00472160|Continuous Positive Airway Pressure,|continuous positive airway pressure,
5708001|NCT00472160|Intubation,|intubation,
5708002|NCT00472160|Organ failure|organ failure
5708003|NCT00472134|Hernia|hernia
5708004|NCT00472134|Ventral|ventral
5708005|NCT00472134|Laparoscopic Hernia Repair|laparoscopic hernia repair
5708006|NCT00472108|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
5708007|NCT00472108|Basal Cell Carcinoma|basal cell carcinoma
5708008|NCT00472108|PDT with Metvix 160 mg/g cream|pdt with metvix 160 mg/g cream
5708009|NCT00472108|PDT with placebo cream|pdt with placebo cream
5708010|NCT00472108|Histological verification|histological verification
5708011|NCT00472095|diabetes|diabetes
5708012|NCT00472095|fotonovela|fotonovela
5708013|NCT00472095|Latino|latino
5708014|NCT00472082|Immunosuppression|immunosuppression
5708015|NCT00472082|Renal Transplantation|renal transplantation
5708016|NCT00472069|Stress Urinary Incontinence|stress urinary incontinence
5708017|NCT00472069|striated urethral sphincter insufficiency|striated urethral sphincter insufficiency
5708018|NCT00472069|myofibers|myofibers
5708019|NCT00472069|satellite cells|satellite cells
5708020|NCT00472069|myotubes|myotubes
5708021|NCT00472069|urethral|urethral
5708022|NCT00472069|Muscle fibres|muscle fibres
5702469|NCT00493272|HES|hes
5708024|NCT00472056|Lymphoid Malignancies|lymphoid malignancies
5708025|NCT00472056|Lymphoma|lymphoma
5708026|NCT00472056|BEAM Chemotherapy|beam chemotherapy
5708027|NCT00472056|Carmustine|carmustine
5708028|NCT00472056|BCNU|bcnu
5708029|NCT00472056|BiCNU|bicnu
5708030|NCT00472056|Etoposide|etoposide
5708031|NCT00472056|VePesid|vepesid
5708032|NCT00472056|Cytarabine|cytarabine
5708033|NCT00472056|Cytosar|cytosar
5708034|NCT00472056|DepoCyt|depocyt
5708035|NCT00472056|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5708036|NCT00472056|Ara-C|ara-c
5708037|NCT00472056|Melphalan|melphalan
5708038|NCT00472056|Rituximab|rituximab
5708039|NCT00472056|Rituxan|rituxan
5708040|NCT00472043|Nodular Basal Cell Carcinoma|nodular basal cell carcinoma
5708041|NCT00472043|Basal Cell Carcinoma|basal cell carcinoma
5708042|NCT00472043|Photodynamic therapy (PDT)|photodynamic therapy (pdt)
5708043|NCT00472043|Metvix|metvix
5708044|NCT00472043|Histological verification|histological verification
5708045|NCT00472043|PDT with Metvix cream|pdt with metvix cream
5708046|NCT00472043|PDT with Placebo cream|pdt with placebo cream
5708047|NCT00472030|bullous pemphigoid|bullous pemphigoid
5708048|NCT00472030|omalizumab|omalizumab
5708049|NCT00472030|xolair|xolair
5708050|NCT00472030|IgE|ige
5708051|NCT00472030|autoimmunity|autoimmunity
5708052|NCT00472030|skin disease|skin disease
5708053|NCT00472017|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5708054|NCT00471991|Oral contraceptive|oral contraceptive
5708055|NCT00471991|ovulation inhibitory effect|ovulation inhibitory effect
5708056|NCT00471978|non-small cell lung cancer|non-small cell lung cancer
5708057|NCT00471978|small cell lung cancer|small cell lung cancer
5708058|NCT00471978|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5708059|NCT00471952|Migraine|migraine
5708060|NCT00471939|Burn, Meshed skin graft, PDGF|burn, meshed skin graft, pdgf
5708061|NCT00471939|deep partial thickness or full thickness burns|deep partial thickness or full thickness burns
5708062|NCT00471926|Diabetes Care|diabetes care
5708064|NCT00471913|Fracture|fracture
5708065|NCT00471913|Antegrade|antegrade
5708066|NCT00471913|Nailing|nailing
5708067|NCT00471913|Shaft|shaft
5708068|NCT00471913|Abductor|abductor
5708069|NCT00471887|stage III melanoma|stage iii melanoma
5708070|NCT00471887|stage IV melanoma|stage iv melanoma
5708071|NCT00471887|recurrent melanoma|recurrent melanoma
5708072|NCT00471861|Inflammatory Markers|inflammatory markers
5708073|NCT00471861|Migraine|migraine
5708074|NCT00471848|Thymoglobuline|thymoglobuline
5708075|NCT00471848|Rabbit ATG|rabbit atg
5708076|NCT00471848|Ciclosporin|ciclosporin
5708077|NCT00471848|Aplastic Anemia|aplastic anemia
5708078|NCT00471835|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5708079|NCT00471835|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5708080|NCT00471835|adenocarcinoma of the lung|adenocarcinoma of the lung
5708081|NCT00471835|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5708082|NCT00471835|large cell lung cancer|large cell lung cancer
5708083|NCT00471835|squamous cell lung cancer|squamous cell lung cancer
5708084|NCT00471822|Streptococcus pneumoniae nasopharyngeal carriage|streptococcus pneumoniae nasopharyngeal carriage
5708085|NCT00471796|Patients with functional chest pain and functional heartburns|patients with functional chest pain and functional heartburns
5708086|NCT00471783|gingivitis|gingivitis
5708087|NCT00471783|chlorhexidine|chlorhexidine
5708088|NCT00471783|dental floss|dental floss
5708089|NCT00471783|RCT|rct
5708090|NCT00471783|bleeding on probing|bleeding on probing
5708091|NCT00471783|gingival and plaque indices|gingival and plaque indices
5708092|NCT00471757|pnuemonia|pnuemonia
5708093|NCT00471757|influenca|influenca
5708094|NCT00471744|benign epilepsy|benign epilepsy
5708095|NCT00471744|pediatrics|pediatrics
5708096|NCT00471744|children|children
5708097|NCT00471744|rolandic epilepsy|rolandic epilepsy
5731947|NCT00387283|WNV|wnv
5708098|NCT00471744|levetiracetam|levetiracetam
5708099|NCT00471744|sulthiame|sulthiame
5708100|NCT00471731|Ocular Surface Disease|ocular surface disease
5708101|NCT00471731|Imprinting|imprinting
5708102|NCT00471731|Eye Abnormalities|eye abnormalities
5708103|NCT00471731|Ovarian Insufficiency|ovarian insufficiency
5708104|NCT00471731|Women's Eye Health and Disease|women's eye health and disease
5708105|NCT00471731|Turner Syndrome|turner syndrome
5708107|NCT00471731|Premature Ovarian Failure|premature ovarian failure
5708108|NCT00471731|POF|pof
5708109|NCT00471731|Healthy Volunteer|healthy volunteer
5708110|NCT00471731|HV|hv
5708111|NCT00471718|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5708112|NCT00471718|stage IV prostate cancer|stage iv prostate cancer
5708113|NCT00471718|recurrent prostate cancer|recurrent prostate cancer
5708114|NCT00471705|Miltefosine|miltefosine
5708115|NCT00471705|Leishmaniasis|leishmaniasis
5708116|NCT00471705|Glucantime|glucantime
5708117|NCT00471705|Thermotherapy|thermotherapy
5708118|NCT00471705|Colombia|colombia
5708119|NCT00471679|disseminated neuroblastoma|disseminated neuroblastoma
5708120|NCT00471679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5708121|NCT00471679|recurrent neuroblastoma|recurrent neuroblastoma
5708123|NCT00471679|stage 4S neuroblastoma|stage 4s neuroblastoma
5708124|NCT00471666|Malaria|malaria
5708125|NCT00471666|Filariasis|filariasis
5708126|NCT00471666|Coinfection|coinfection
5708127|NCT00471666|Co-Infection|co-infection
5708128|NCT00471653|thrombocytopenia|thrombocytopenia
5708129|NCT00471653|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5708130|NCT00471653|adult brain stem glioma|adult brain stem glioma
5708131|NCT00471653|adult mixed glioma|adult mixed glioma
5708132|NCT00471653|adult giant cell glioblastoma|adult giant cell glioblastoma
5708133|NCT00471653|adult gliosarcoma|adult gliosarcoma
5708134|NCT00471653|adult glioblastoma|adult glioblastoma
5708135|NCT00471653|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5708136|NCT00471653|adult anaplastic ependymoma|adult anaplastic ependymoma
5708137|NCT00471653|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5708138|NCT00471640|pneumonia|pneumonia
5708139|NCT00471640|dexamethasone|dexamethasone
5708140|NCT00471640|community-acquired pneumonia|community-acquired pneumonia
5708141|NCT00471614|HIV|hiv
5708142|NCT00471614|AIDS|aids
5708143|NCT00471614|uridine|uridine
5708144|NCT00471614|mitochondria|mitochondria
5708145|NCT00471614|insulin resistance|insulin resistance
5708146|NCT00471614|Treatment Experienced|treatment experienced
5708147|NCT00471601|recurrent breast cancer|recurrent breast cancer
5708148|NCT00471601|stage IA breast cancer|stage ia breast cancer
5708149|NCT00471601|stage IB breast cancer|stage ib breast cancer
5708150|NCT00471601|stage II breast cancer|stage ii breast cancer
5708151|NCT00471601|stage IIIA breast cancer|stage iiia breast cancer
5708152|NCT00471601|stage IIIB breast cancer|stage iiib breast cancer
5708153|NCT00471601|stage IIIC breast cancer|stage iiic breast cancer
5708154|NCT00471601|stage IV breast cancer|stage iv breast cancer
5708155|NCT00471588|Dopamine|dopamine
5708157|NCT00471588|MRI|mri
5708158|NCT00471588|stimulant users|stimulant users
5708159|NCT00471575|fatty liver|fatty liver
5708160|NCT00471575|pregnancy|pregnancy
5708161|NCT00471575|ultra sound|ultra sound
5708162|NCT00471575|Pregnant women at the end of pregnancy or immediately after birth.|pregnant women at the end of pregnancy or immediately after birth.
5708163|NCT00471575|controls-women with normal liver|controls-women with normal liver
5708164|NCT00471575|correlation between ultrasonography and nutritional, obsthetric and laboratory data.|correlation between ultrasonography and nutritional, obsthetric and laboratory data.
5708165|NCT00471562|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708166|NCT00471549|Diabetes|diabetes
5708167|NCT00471549|Dyslipidaemia|dyslipidaemia
5708168|NCT00471549|Atherosclerosis|atherosclerosis
5708169|NCT00471549|Osteoprotegerin|osteoprotegerin
5708170|NCT00471549|Adhesion molecules|adhesion molecules
5708171|NCT00471549|Simvastatin|simvastatin
5708172|NCT00471523|Anovulation|anovulation
5708173|NCT00471523|Clomiphene citrate|clomiphene citrate
5708174|NCT00471523|Infertility|infertility
5708175|NCT00471523|Metformin|metformin
5708177|NCT00471523|Treatment|treatment
5708178|NCT00471510|androgenetic alopecia|androgenetic alopecia
5708179|NCT00471510|male pattern hair loss|male pattern hair loss
5708180|NCT00471510|male pattern baldness|male pattern baldness
5708181|NCT00471510|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
5708182|NCT00471497|leukemia|leukemia
5708183|NCT00471497|bone marrow|bone marrow
5708184|NCT00471497|leukemia symptoms|leukemia symptoms
5708185|NCT00471497|lukemia|lukemia
5708186|NCT00471497|cml|cml
5708189|NCT00471497|blood cancer|blood cancer
5708190|NCT00471497|leukocytes|leukocytes
5708191|NCT00471497|chronic leukemia|chronic leukemia
5708192|NCT00471497|bone marrow biopsy|bone marrow biopsy
5708193|NCT00471497|leukemia research|leukemia research
5708194|NCT00471497|leukemia cells|leukemia cells
5708195|NCT00471497|bone marrow disease|bone marrow disease
5708196|NCT00471497|chronic myeloid leukemia|chronic myeloid leukemia
5708197|NCT00471497|blood cancer symptoms|blood cancer symptoms
5708198|NCT00471497|white blood cell diseases|white blood cell diseases
5708199|NCT00471497|chronic myelogenous leukemia|chronic myelogenous leukemia
5708200|NCT00471497|leukemia treatment|leukemia treatment
5708201|NCT00471497|leukemia facts|leukemia facts
5708202|NCT00471497|leucemia|leucemia
5708203|NCT00471497|facts about leukemia|facts about leukemia
5708204|NCT00471497|myelogenous leukemia|myelogenous leukemia
5708205|NCT00471497|newly diagnosed CML|newly diagnosed cml
5708206|NCT00471497|newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)|newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukemia in chronic phase (cml-cp)
5708207|NCT00471484|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5708208|NCT00471484|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5708209|NCT00471484|advanced adult primary liver cancer|advanced adult primary liver cancer
5708210|NCT00471484|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5708211|NCT00471484|stage III childhood liver cancer|stage iii childhood liver cancer
5708212|NCT00471484|stage IV childhood liver cancer|stage iv childhood liver cancer
5708213|NCT00471471|recurrent melanoma|recurrent melanoma
5708214|NCT00471471|stage IV melanoma|stage iv melanoma
5708215|NCT00471471|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5708216|NCT00471471|extraocular extension melanoma|extraocular extension melanoma
5708217|NCT00471471|iris melanoma|iris melanoma
5708218|NCT00471471|recurrent intraocular melanoma|recurrent intraocular melanoma
5708219|NCT00471471|metastatic intraocular melanoma|metastatic intraocular melanoma
5708220|NCT00471471|conjunctival melanoma|conjunctival melanoma
5708221|NCT00471471|stage IIIA melanoma|stage iiia melanoma
5708222|NCT00471471|stage IIIB melanoma|stage iiib melanoma
5708223|NCT00471471|stage IIIC melanoma|stage iiic melanoma
5708224|NCT00471458|Radioiodine|radioiodine
5708225|NCT00471458|Hyperthyroidism|hyperthyroidism
5708226|NCT00471458|Morbidity|morbidity
5708227|NCT00471458|Cardiovascular diseases|cardiovascular diseases
5708228|NCT00471445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708229|NCT00471445|pain|pain
5708230|NCT00471445|neurotoxicity|neurotoxicity
5708231|NCT00471445|peripheral neuropathy|peripheral neuropathy
5708232|NCT00471432|recurrent prostate cancer|recurrent prostate cancer
5708233|NCT00471432|stage IV prostate cancer|stage iv prostate cancer
5708234|NCT00471432|recurrent renal cell cancer|recurrent renal cell cancer
5708235|NCT00471432|stage IV renal cell cancer|stage iv renal cell cancer
5708236|NCT00471432|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5708237|NCT00471432|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5708238|NCT00471432|recurrent bladder cancer|recurrent bladder cancer
5708239|NCT00471432|stage IV bladder cancer|stage iv bladder cancer
5708240|NCT00471432|recurrent breast cancer|recurrent breast cancer
5708241|NCT00471432|stage IV breast cancer|stage iv breast cancer
5708242|NCT00471432|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5708243|NCT00471432|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5863055|NCT00001408|Interleukin-5|interleukin-5
5708244|NCT00471432|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708245|NCT00471432|male breast cancer|male breast cancer
5708246|NCT00471393|TMJ|tmj
5708247|NCT00471393|Osteoarthritis|osteoarthritis
5708248|NCT00471393|Degenerative Joint disease|degenerative joint disease
5708249|NCT00471367|Phase I|phase i
5708250|NCT00471367|AZD4877|azd4877
5708251|NCT00471367|Lymphoma|lymphoma
5708252|NCT00471367|B-cell non-Hodgkin lymphoma|b-cell non-hodgkin lymphoma
5708253|NCT00471341|arteriosclerosis|arteriosclerosis
5708254|NCT00471341|coronary disease|coronary disease
5708255|NCT00471341|inflammation|inflammation
5708256|NCT00471341|COX-2 inhibition|cox-2 inhibition
5708257|NCT00471341|hypertension|hypertension
5708258|NCT00471328|GIST|gist
5708259|NCT00471328|adults|adults
5708260|NCT00471328|imatinib resistant|imatinib resistant
5708261|NCT00471328|sunitinib resistant|sunitinib resistant
5708262|NCT00471328|AMN107|amn107
5708263|NCT00471328|nilotinib|nilotinib
5708264|NCT00471328|treatment|treatment
5708265|NCT00471328|Gastrointestinal stromal tumor (GIST)|gastrointestinal stromal tumor (gist)
5708266|NCT00471315|SOD|sod
5708267|NCT00471315|Common Bile Duct Diseases|common bile duct diseases
5708268|NCT00471315|Sphincterotomy|sphincterotomy
5708269|NCT00471315|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5708273|NCT00471289|Critical Limb Ischemia|critical limb ischemia
5708274|NCT00471289|Stents|stents
5708275|NCT00471289|Drug Eluting Stents|drug eluting stents
5708284|NCT00471289|DES|des
5708285|NCT00471276|Metastatic Breast Cancer|metastatic breast cancer
5708293|NCT00471237|bone mineral density,|bone mineral density,
5708294|NCT00471237|Ronacaleret|ronacaleret
5708295|NCT00471237|teriparatide|teriparatide
5708296|NCT00471237|alendronate,|alendronate,
5708297|NCT00471237|Post-menopausal women,|post-menopausal women,
5708298|NCT00471237|osteoporosis,|osteoporosis,
5708299|NCT00471237|SB-751689|sb-751689
5708300|NCT00471185|Male Contraception|male contraception
5708301|NCT00471185|Acyline|acyline
5732101|NCT00386763|Malaria|malaria
5708302|NCT00471146|Randomized Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For Advanced Pancreatic Cancer.|randomized study of gemcitabine plus ag-013736 versus gemcitabine plus placebo for advanced pancreatic cancer.
5708303|NCT00471133|melanoma|melanoma
5708304|NCT00471133|DNA vaccine|dna vaccine
5708305|NCT00471133|tyrosinase|tyrosinase
5708306|NCT00471133|electroporation|electroporation
5708307|NCT00471107|Frontal Lobe|frontal lobe
5708308|NCT00471107|Language|language
5708309|NCT00471107|Dementia|dementia
5708310|NCT00471107|Healthy Volunteer|healthy volunteer
5708311|NCT00471107|HV|hv
5708312|NCT00471094|heartburn|heartburn
5708313|NCT00471094|erosive esophagitis|erosive esophagitis
5708314|NCT00471094|healing|healing
5708315|NCT00471094|population pharmacokinetics|population pharmacokinetics
5708316|NCT00471094|Quality of Life (QoL)|quality of life (qol)
5708317|NCT00471081|Neisseria meningitidis;|neisseria meningitidis;
5708318|NCT00471081|Humans;|humans;
5708319|NCT00471081|Meningococcal vaccines;|meningococcal vaccines;
5708320|NCT00471081|Safety|safety
5708321|NCT00471081|Vaccines, conjugate;|vaccines, conjugate;
5708322|NCT00471081|Toddlers;|toddlers;
5708323|NCT00471081|Immunogenicity;|immunogenicity;
5708324|NCT00471055|osteoarthritis|osteoarthritis
5708326|NCT00471055|capsaicin gel|capsaicin gel
5708327|NCT00471055|capsicum|capsicum
5708328|NCT00471042|Heroin Dependence|heroin dependence
5708329|NCT00471042|Opioid Dependence|opioid dependence
5708330|NCT00471042|Primary Care|primary care
5708331|NCT00471042|Buprenorphine|buprenorphine
5708332|NCT00471029|pH study, peptic ulcer, proton pump inhibitor|ph study, peptic ulcer, proton pump inhibitor
5708333|NCT00471003|Hypertension|hypertension
5708334|NCT00470990|IHH|ihh
5708335|NCT00470990|Kallmann syndrome|kallmann syndrome
5708336|NCT00470990|hypogonadism|hypogonadism
5708337|NCT00470964|laser trabeculoplasty, glaucoma, argon, titanium-sapphire|laser trabeculoplasty, glaucoma, argon, titanium-sapphire
5708338|NCT00470964|IOP lowering effect|iop lowering effect
5708339|NCT00470964|Adverse effects|adverse effects
5708340|NCT00470964|IOP spikes|iop spikes
5708341|NCT00470951|rectal cancer|rectal cancer
5708342|NCT00470951|laparoscopic assisted resection|laparoscopic assisted resection
5708343|NCT00470951|open resection|open resection
5708344|NCT00470951|preoperative chemoradiation|preoperative chemoradiation
5708345|NCT00470951|randomized trial|randomized trial
5708346|NCT00470925|Neurological|neurological
5708347|NCT00470925|Dopamine|dopamine
5708348|NCT00470912|cutaneous lupus erythemaosus|cutaneous lupus erythemaosus
5708349|NCT00470912|photoprotection|photoprotection
5708350|NCT00470912|photoprovocation|photoprovocation
5708351|NCT00470912|Sunscreen RV 2547C|sunscreen rv 2547c
5708352|NCT00470899|Feto-maternal transfusion|feto-maternal transfusion
5708353|NCT00470899|Kleihauer-Betke|kleihauer-betke
5708354|NCT00470847|Herceptin|herceptin
5708355|NCT00470847|breast cancer|breast cancer
5708356|NCT00470847|radiation therapy|radiation therapy
5708357|NCT00470847|stereotactic radiosurgery|stereotactic radiosurgery
5708358|NCT00470847|SRS|srs
5708359|NCT00470847|whole brain radiation|whole brain radiation
5708360|NCT00470847|WBRT|wbrt
5708361|NCT00470834|prostate cancer|prostate cancer
5708362|NCT00470834|androgen deprivation therapy|androgen deprivation therapy
5708363|NCT00470821|melatonin|melatonin
5708364|NCT00470821|actigraphy|actigraphy
5708365|NCT00470821|sedation|sedation
5708366|NCT00470821|critical patients|critical patients
5708367|NCT00470821|ICU|icu
5708368|NCT00470808|Minors|minors
5708369|NCT00470808|Enrollment in another study|enrollment in another study
5708370|NCT00470808|Males|males
5708371|NCT00470808|HBA1C greater than 7|hba1c greater than 7
5708372|NCT00470808|Drug therapy for DM|drug therapy for dm
5708373|NCT00470795|diabetes|diabetes
5708374|NCT00470795|gastroparesis|gastroparesis
5708375|NCT00470795|acupuncture|acupuncture
5708376|NCT00470795|symptoms|symptoms
5708377|NCT00470795|gastric emptying|gastric emptying
5708378|NCT00470782|colonic neoplasms|colonic neoplasms
5708379|NCT00470782|exercise|exercise
5708380|NCT00470782|body composition|body composition
5708381|NCT00470782|anthropometry|anthropometry
5708382|NCT00470769|Color-Doppler Ultrasonography|color-doppler ultrasonography
5708383|NCT00470769|Renal scintigraphy|renal scintigraphy
5708384|NCT00470769|Kidney failure|kidney failure
5708386|NCT00470743|Ibuprofen|ibuprofen
5708387|NCT00470743|Indomethacin|indomethacin
5708388|NCT00470743|Infant, very low birth weight|infant, very low birth weight
5708389|NCT00470743|Prematurity|prematurity
5708390|NCT00470743|Ductus Arteriosus, patent|ductus arteriosus, patent
5708391|NCT00470717|late preterm infant|late preterm infant
5708392|NCT00470717|breastfeeding|breastfeeding
5708393|NCT00470717|formula feeding|formula feeding
5708394|NCT00470717|rehospitalization|rehospitalization
5708395|NCT00470717|telephone|telephone
5708396|NCT00470704|HER2-positive breast cancer|her2-positive breast cancer
5708397|NCT00470704|Herceptin|herceptin
5708398|NCT00470704|trastuzumab|trastuzumab
5708399|NCT00470678|Age-related|age-related
5708400|NCT00470678|macular|macular
5708401|NCT00470678|degeneration|degeneration
5708402|NCT00470678|AMD|amd
5708403|NCT00470678|Ranibizumab|ranibizumab
5708404|NCT00470678|Anti-VEGF|anti-vegf
5708405|NCT00470678|choroidal|choroidal
5708406|NCT00470678|neovascularization|neovascularization
5708407|NCT00470678|CNV|cnv
5708408|NCT00470678|Asian patients|asian patients
5708409|NCT00470678|Korea|korea
5708410|NCT00470678|Taiwan|taiwan
5708411|NCT00470678|associated|associated
5708412|NCT00470652|pain|pain
5708413|NCT00470652|Pain Measurement|pain measurement
5708414|NCT00470652|Decision Making, Computer-Assisted|decision making, computer-assisted
5708415|NCT00470652|Informatics|informatics
5708416|NCT00470639|TMS|tms
5708417|NCT00470639|Treatment|treatment
5708418|NCT00470639|Bipolar|bipolar
5708419|NCT00470639|Efficacy|efficacy
5708420|NCT00470626|Pulmonary Embolism|pulmonary embolism
5708421|NCT00470626|Venous Thromboembolism|venous thromboembolism
5708422|NCT00470626|Inferior Vena Cava Filter|inferior vena cava filter
5708423|NCT00470626|IVC|ivc
5708424|NCT00470626|PE|pe
5708425|NCT00470613|Neoplasm|neoplasm
5708426|NCT00470587|chest pain|chest pain
5708427|NCT00470587|myocardial infarction|myocardial infarction
5708428|NCT00470587|unstable angina|unstable angina
5702872|NCT00491738|Sutent|sutent
5708430|NCT00470574|stage IV breast cancer|stage iv breast cancer
5708431|NCT00470574|male breast cancer|male breast cancer
5708432|NCT00470561|mammographic breast density aspirin|mammographic breast density aspirin
5708433|NCT00470548|male breast cancer|male breast cancer
5708434|NCT00470548|recurrent breast cancer|recurrent breast cancer
5708435|NCT00470548|stage IIIA breast cancer|stage iiia breast cancer
5708436|NCT00470548|stage IIIB breast cancer|stage iiib breast cancer
5708437|NCT00470548|stage IIIC breast cancer|stage iiic breast cancer
5708438|NCT00470548|stage IV breast cancer|stage iv breast cancer
5708439|NCT00470548|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5708440|NCT00470548|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5708441|NCT00470548|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5708442|NCT00470548|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5708443|NCT00470548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708546|NCT00470366|ovarian mature teratoma|ovarian mature teratoma
5708444|NCT00470535|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5708445|NCT00470535|recurrent pancreatic cancer|recurrent pancreatic cancer
5708446|NCT00470535|stage III pancreatic cancer|stage iii pancreatic cancer
5708447|NCT00470535|stage IV pancreatic cancer|stage iv pancreatic cancer
5708448|NCT00470522|methotrexate|methotrexate
5708449|NCT00470522|folic acid|folic acid
5708450|NCT00470522|systemic lupus erythematosus|systemic lupus erythematosus
5708451|NCT00470522|steroid|steroid
5708453|NCT00470483|Social Anxiety Disorder|social anxiety disorder
5708454|NCT00470483|fRMI|frmi
5708455|NCT00470444|Cardiac Surgery|cardiac surgery
5708456|NCT00470444|Transfusion Medicine|transfusion medicine
5708457|NCT00470444|Cardiac Anesthesia Risk Evaluation (CARE) Score of 3 or 4|cardiac anesthesia risk evaluation (care) score of 3 or 4
5863056|NCT00001408|Late Phase Response|late phase response
5708458|NCT00470444|(Dupuis J-Y et al, Anesthesiology 2001;94: 194-204)|(dupuis j-y et al, anesthesiology 2001;94: 194-204)
5708459|NCT00470418|Alzheimer Disease|alzheimer disease
5708460|NCT00470418|Alzheimer Type Senile Dementia|alzheimer type senile dementia
5708461|NCT00470418|Alzheimer's Disease|alzheimer's disease
5708462|NCT00470418|clinical trial|clinical trial
5708463|NCT00470418|dementia|dementia
5708464|NCT00470418|diabetes|diabetes
5708465|NCT00470418|dietary supplements|dietary supplements
5708466|NCT00470418|Senile Dementia, Alzheimer Type|senile dementia, alzheimer type
5708467|NCT00470418|Therapeutics|therapeutics
5708468|NCT00470405|adult solid tumor|adult solid tumor
5708469|NCT00470405|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708470|NCT00470405|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5708471|NCT00470405|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5708472|NCT00470405|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5708473|NCT00470405|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5708474|NCT00470405|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5708475|NCT00470405|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5708476|NCT00470405|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5708477|NCT00470405|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5708478|NCT00470405|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5708479|NCT00470405|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5708480|NCT00470405|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5708481|NCT00470405|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5708482|NCT00470405|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5708483|NCT00470405|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5708484|NCT00470405|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5708485|NCT00470405|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5708486|NCT00470405|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5708487|NCT00470405|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5708488|NCT00470405|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5708489|NCT00470405|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5708490|NCT00470405|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5708491|NCT00470405|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5708492|NCT00470405|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5708493|NCT00470405|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5708494|NCT00470405|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5708495|NCT00470405|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5708496|NCT00470405|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5708497|NCT00470405|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5708498|NCT00470405|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5708499|NCT00470405|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5708500|NCT00470405|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5708501|NCT00470405|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5708502|NCT00470405|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5708503|NCT00470405|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5708504|NCT00470405|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5708505|NCT00470405|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5708506|NCT00470405|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5708507|NCT00470405|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5708508|NCT00470405|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5708509|NCT00470405|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5708511|NCT00470392|optimization|optimization
5708512|NCT00470392|Papule|papule
5708513|NCT00470392|Plaque|plaque
5708514|NCT00470392|pretreatment|pretreatment
5708515|NCT00470392|T cells|t cells
5708516|NCT00470392|UVB laser light|uvb laser light
5708517|NCT00470392|psoriasis|psoriasis
5708518|NCT00470392|topical administration|topical administration
5708519|NCT00470379|stage II melanoma|stage ii melanoma
5708520|NCT00470379|stage III melanoma|stage iii melanoma
5708521|NCT00470379|stage IV melanoma|stage iv melanoma
5708522|NCT00470366|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5708523|NCT00470366|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5708524|NCT00470366|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5708525|NCT00470366|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5708526|NCT00470366|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5863057|NCT00001407|Cytokines|cytokines
5717057|NCT00442286|Blood Pressure|blood pressure
5717058|NCT00442286|Cardiovascular Disease|cardiovascular disease
5717059|NCT00442286|Resistant Hypertension|resistant hypertension
5717060|NCT00442286|Stage 2 Hypertension|stage 2 hypertension
5717061|NCT00442286|Hypertension that is resistant to treatment|hypertension that is resistant to treatment
5708527|NCT00470366|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5708528|NCT00470366|testicular choriocarcinoma|testicular choriocarcinoma
5708529|NCT00470366|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5708530|NCT00470366|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5708531|NCT00470366|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5708532|NCT00470366|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5708533|NCT00470366|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5708534|NCT00470366|testicular embryonal carcinoma|testicular embryonal carcinoma
5708535|NCT00470366|testicular seminoma|testicular seminoma
5708536|NCT00470366|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5708537|NCT00470366|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5708538|NCT00470366|testicular yolk sac tumor|testicular yolk sac tumor
5708539|NCT00470366|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5708540|NCT00470366|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5708541|NCT00470366|ovarian choriocarcinoma|ovarian choriocarcinoma
5708542|NCT00470366|ovarian dysgerminoma|ovarian dysgerminoma
5708543|NCT00470366|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5708544|NCT00470366|ovarian yolk sac tumor|ovarian yolk sac tumor
5708545|NCT00470366|ovarian immature teratoma|ovarian immature teratoma
5708547|NCT00470366|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5708548|NCT00470366|ovarian polyembryoma|ovarian polyembryoma
5708549|NCT00470366|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5708550|NCT00470366|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5708551|NCT00470366|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5685815|NCT00554723|Double blind|double blind
5708552|NCT00470366|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5708553|NCT00470366|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5708554|NCT00470366|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5708555|NCT00470366|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5708556|NCT00470366|adult teratoma|adult teratoma
5708557|NCT00470366|testicular immature teratoma|testicular immature teratoma
5708558|NCT00470366|testicular mature teratoma|testicular mature teratoma
5708559|NCT00470366|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5708560|NCT00470366|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5708561|NCT00470366|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5708562|NCT00470366|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5708563|NCT00470366|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5708564|NCT00470366|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5708565|NCT00470366|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5708567|NCT00470366|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5708568|NCT00470353|recurrent colon cancer|recurrent colon cancer
5708569|NCT00470353|stage I colon cancer|stage i colon cancer
5708570|NCT00470353|stage II colon cancer|stage ii colon cancer
5708571|NCT00470353|stage III colon cancer|stage iii colon cancer
5708572|NCT00470340|Recurrence|recurrence
5708573|NCT00470340|Neoplasm Recurrence, Local|neoplasm recurrence, local
5708574|NCT00470340|Liver|liver
5708575|NCT00470340|Liver Neoplasms|liver neoplasms
5708576|NCT00470340|Liver Cirrhosis|liver cirrhosis
5708577|NCT00470340|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5708578|NCT00470340|Iodized Oil|iodized oil
5708579|NCT00470340|gemcitabine [Substance Name]|gemcitabine [substance name]
5708580|NCT00470340|oxaliplatin [Substance Name]|oxaliplatin [substance name]
5708581|NCT00470340|gemcitabine-oxaliplatin regimen [Substance Name]|gemcitabine-oxaliplatin regimen [substance name]
5708582|NCT00470340|Randomized Controlled Trials|randomized controlled trials
5708583|NCT00470340|Multicenter Studies|multicenter studies
5708584|NCT00470340|Cisplatin|cisplatin
5708585|NCT00470340|Injections, Intra-Arterial|injections, intra-arterial
5708586|NCT00470340|Injections, Intravenous|injections, intravenous
5708587|NCT00470340|Chemotherapy, Adjuvant|chemotherapy, adjuvant
5708588|NCT00470327|Interstitial lung diseases|interstitial lung diseases
5708589|NCT00470327|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5708590|NCT00470327|Sarcoidosis|sarcoidosis
5708591|NCT00470327|mRNA and cytokine expression|mrna and cytokine expression
5708592|NCT00470314|Acute liver failure|acute liver failure
5708593|NCT00470314|Ornithine Aspartate|ornithine aspartate
5708594|NCT00470314|Ammonia|ammonia
5708595|NCT00470314|Encephalopathy|encephalopathy
5708596|NCT00470288|cesarean delivery|cesarean delivery
5708597|NCT00470288|bladder flaps|bladder flaps
5708598|NCT00470275|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5708599|NCT00470262|fatty acid oxidation complex|fatty acid oxidation complex
5708600|NCT00470262|fenofibrate|fenofibrate
5708601|NCT00470262|Inflammation|inflammation
5708602|NCT00470262|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5708603|NCT00470262|pioglitazone|pioglitazone
5708604|NCT00470262|Prediabetic State|prediabetic state
5708605|NCT00470262|insulin resistance|insulin resistance
5708606|NCT00470249|stage IIIB breast cancer|stage iiib breast cancer
5708607|NCT00470249|stage IIIC breast cancer|stage iiic breast cancer
5708608|NCT00470249|stage IV breast cancer|stage iv breast cancer
5708609|NCT00470249|recurrent breast cancer|recurrent breast cancer
5708610|NCT00470249|male breast cancer|male breast cancer
5708611|NCT00470249|stage IIIA breast cancer|stage iiia breast cancer
5708612|NCT00470236|Ductal carcinoma in-situ|ductal carcinoma in-situ
5708613|NCT00470236|Breast conserving therapy|breast conserving therapy
5708614|NCT00470236|Whole breast radiation therapy|whole breast radiation therapy
5708615|NCT00470236|Tumour bed boost|tumour bed boost
5708616|NCT00470236|Fractionation schedules|fractionation schedules
5708617|NCT00470236|Completely excised non-low risk DCIS|completely excised non-low risk dcis
5708618|NCT00470223|localized osteosarcoma|localized osteosarcoma
5708619|NCT00470223|metastatic osteosarcoma|metastatic osteosarcoma
5708620|NCT00470210|Ribavirin|ribavirin
5708621|NCT00470210|non-responders|non-responders
5708622|NCT00470210|HCV co-infected patients|hcv co-infected patients
5708623|NCT00470210|sustained virological response|sustained virological response
5708624|NCT00470210|Treatment Experienced|treatment experienced
5708625|NCT00470184|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5708626|NCT00470184|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5708627|NCT00470184|stage II esophageal cancer|stage ii esophageal cancer
5708628|NCT00470184|stage III esophageal cancer|stage iii esophageal cancer
5708629|NCT00470184|stage IV esophageal cancer|stage iv esophageal cancer
5708630|NCT00470158|zinc|zinc
5708631|NCT00470158|iron|iron
5708632|NCT00470158|interaction|interaction
5708633|NCT00470158|diarrhea|diarrhea
5685816|NCT00554723|Randomized|randomized
5708634|NCT00470158|delivery|delivery
5708635|NCT00470145|unmilled formulation,|unmilled formulation,
5708636|NCT00470145|micronised formulation|micronised formulation
5708637|NCT00470145|relative bioavailability,|relative bioavailability,
5708638|NCT00470132|ventricular shunt|ventricular shunt
5708639|NCT00470119|breast cancer|breast cancer
5708640|NCT00470119|obesity|obesity
5708641|NCT00470119|weight changes|weight changes
5708642|NCT00470106|Cognition|cognition
5708643|NCT00470106|Remediation|remediation
5708644|NCT00470106|Schizophrenia|schizophrenia
5708645|NCT00470106|Social Cognition|social cognition
5708646|NCT00470093|refractory multiple myeloma|refractory multiple myeloma
5708647|NCT00470093|stage I multiple myeloma|stage i multiple myeloma
5708648|NCT00470093|stage II multiple myeloma|stage ii multiple myeloma
5708649|NCT00470093|stage III multiple myeloma|stage iii multiple myeloma
5708650|NCT00470080|Venepuncture|venepuncture
5708651|NCT00470080|Pain|pain
5708652|NCT00470080|Emla cream|emla cream
5708653|NCT00470080|Oral sucrose solution|oral sucrose solution
5708655|NCT00470080|Premature infant admitted to the care baby unit were|premature infant admitted to the care baby unit were
5708656|NCT00470080|included in the study.|included in the study.
5708657|NCT00470080|Programed venepuncture is performed with analgesia.|programed venepuncture is performed with analgesia.
5708658|NCT00470067|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5708659|NCT00470067|stage III endometrial carcinoma|stage iii endometrial carcinoma
5708660|NCT00470067|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5708661|NCT00470041|Healthy volunteers|healthy volunteers
5708662|NCT00470028|TMS|tms
5708663|NCT00470028|Treatment|treatment
5708664|NCT00470028|Adolescents|adolescents
5708665|NCT00470028|Safety|safety
5708666|NCT00470028|Efficacy|efficacy
5708667|NCT00470015|stage II melanoma|stage ii melanoma
5708668|NCT00470015|stage III melanoma|stage iii melanoma
5708669|NCT00470015|stage IV melanoma|stage iv melanoma
5708670|NCT00470015|recurrent melanoma|recurrent melanoma
5708671|NCT00470002|growth hormone|growth hormone
5708672|NCT00470002|nitric oxide|nitric oxide
5708673|NCT00470002|nitrate|nitrate
5708674|NCT00470002|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5708675|NCT00470002|insulin-like growth factor-1|insulin-like growth factor-1
5708676|NCT00470002|asymmetric dimethylarginine|asymmetric dimethylarginine
5708677|NCT00470002|blood pressure|blood pressure
5708678|NCT00470002|endothelial progenitor cells|endothelial progenitor cells
5708679|NCT00469989|immune system|immune system
5708680|NCT00469989|allergy|allergy
5708681|NCT00469989|hookworm infection|hookworm infection
5717287|NCT00441298|safety|safety
5708682|NCT00469989|parasite infection|parasite infection
5708683|NCT00469989|asthma|asthma
5708684|NCT00469976|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5708685|NCT00469976|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5708686|NCT00469976|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5708687|NCT00469963|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5708688|NCT00469963|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5798805|NCT00110968|Bloating|bloating
5708689|NCT00469963|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5708690|NCT00469963|advanced adult primary liver cancer|advanced adult primary liver cancer
5708691|NCT00469950|PCI|pci
5708692|NCT00469950|stent|stent
5708693|NCT00469950|training|training
5708694|NCT00469950|endothelial function|endothelial function
5708695|NCT00469950|restenosis|restenosis
5708696|NCT00469950|late luminal loss|late luminal loss
5708697|NCT00469950|heart rate variability|heart rate variability
5708698|NCT00469950|oxygen uptake capacity|oxygen uptake capacity
5708699|NCT00469950|inflammatory markers|inflammatory markers
5708700|NCT00469937|radiation toxicity|radiation toxicity
5708701|NCT00469937|neurotoxicity|neurotoxicity
5708702|NCT00469937|cognitive/functional effects|cognitive/functional effects
5708703|NCT00469937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5708704|NCT00469937|adult tumors metastatic to brain|adult tumors metastatic to brain
5708705|NCT00469924|Informatics|informatics
5708706|NCT00469924|Clinical Laboratory Information Systems|clinical laboratory information systems
5708707|NCT00469924|Hospital Communication Systems|hospital communication systems
5708708|NCT00469924|Laboratory Techniques and Procedures|laboratory techniques and procedures
5708709|NCT00469924|Point-of-Care Systems|point-of-care systems
5708710|NCT00469924|Therapy, Computer-Assisted|therapy, computer-assisted
5708711|NCT00469911|Heart|heart
5708714|NCT00469911|MRI|mri
5708715|NCT00469911|Spectroscopy|spectroscopy
5708716|NCT00469898|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5708717|NCT00469885|Smoking cessation|smoking cessation
5708718|NCT00469885|cardiovascular disease|cardiovascular disease
5708719|NCT00469885|smoking reduction|smoking reduction
5708720|NCT00469885|nicotine replacement|nicotine replacement
5708721|NCT00469859|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5708722|NCT00469859|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5732609|NCT00384644|sepsis|sepsis
5708723|NCT00469859|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5708724|NCT00469859|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5708725|NCT00469859|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5708726|NCT00469859|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5708727|NCT00469859|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5708728|NCT00469859|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5708729|NCT00469846|Pre-Eclampsia|pre-eclampsia
5708730|NCT00469846|Hypertension,pregnancy-induced|hypertension,pregnancy-induced
5708731|NCT00469846|Preterm labor|preterm labor
5708732|NCT00469833|Diabetes|diabetes
5708733|NCT00469833|Glucose Tolerance|glucose tolerance
5708734|NCT00469833|Incretin|incretin
5708735|NCT00469833|Insulin|insulin
5708736|NCT00469820|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5703285|NCT00489931|Healthy|healthy
5708737|NCT00469820|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5708738|NCT00469820|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5708739|NCT00469820|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5708740|NCT00469820|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5708741|NCT00469820|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5708742|NCT00469820|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5708743|NCT00469820|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5708744|NCT00469820|stage III multiple myeloma|stage iii multiple myeloma
5708745|NCT00469820|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5708746|NCT00469820|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5708747|NCT00469820|stage I multiple myeloma|stage i multiple myeloma
5708748|NCT00469820|stage II multiple myeloma|stage ii multiple myeloma
5708749|NCT00469820|refractory multiple myeloma|refractory multiple myeloma
5708750|NCT00469807|Ghrelin|ghrelin
5708751|NCT00469807|Pregnancy outcome|pregnancy outcome
5708752|NCT00469794|arrhythmias|arrhythmias
5708753|NCT00469794|Athletes|athletes
5708754|NCT00469794|exercise|exercise
5708755|NCT00469768|HIV-1 infection|hiv-1 infection
5708756|NCT00469768|HIV Seronegativity|hiv seronegativity
5708757|NCT00469742|Cardiology|cardiology
5708758|NCT00469742|Pediatrics|pediatrics
5708759|NCT00469742|Cardiac Defects|cardiac defects
5708760|NCT00469742|Cardiopulmonary Bypass Surgery|cardiopulmonary bypass surgery
5708761|NCT00469742|Aprotinin|aprotinin
5708762|NCT00469742|thrombosis|thrombosis
5708763|NCT00469742|renal dysfunction|renal dysfunction
5708764|NCT00469729|Tetraethylenepentamine|tetraethylenepentamine
5708765|NCT00469729|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5708766|NCT00469729|Hematological Malignancies|hematological malignancies
5708767|NCT00469729|Acute Lymphoid Leukemia|acute lymphoid leukemia
5708768|NCT00469729|Subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation|subjects with high-risk hematologic malignancies who are candidates for allogeneic stem cell transplantation
5708769|NCT00469716|Fluid balance|fluid balance
5708770|NCT00469716|respiratory function|respiratory function
5708771|NCT00469716|cardiac function|cardiac function
5708772|NCT00469716|inflammation|inflammation
5708773|NCT00469716|Cardiopulmonary bypass|cardiopulmonary bypass
5708774|NCT00469703|Pancreatitis|pancreatitis
5708775|NCT00469664|Schizophrenia|schizophrenia
5708776|NCT00469664|Schizoaffective|schizoaffective
5708777|NCT00469664|Cognitive Impairment|cognitive impairment
5708781|NCT00469664|Concentration|concentration
5708782|NCT00469651|Malaria|malaria
5708783|NCT00469651|vaccine|vaccine
5708784|NCT00469651|MSP3LSP|msp3lsp
5708785|NCT00469651|Safety|safety
5708786|NCT00469651|children|children
5708787|NCT00469651|Tanzania|tanzania
5708788|NCT00469638|atrial fibrillation|atrial fibrillation
5708789|NCT00469638|paroxysmal|paroxysmal
5708790|NCT00469638|persistent|persistent
5708791|NCT00469638|symptomatic|symptomatic
5708792|NCT00469638|ablation|ablation
5708793|NCT00469638|catheter|catheter
5708794|NCT00469638|introducer|introducer
5708795|NCT00469638|Agilis NxT|agilis nxt
5708796|NCT00469638|sinus rhythm|sinus rhythm
5708797|NCT00469638|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5708798|NCT00469638|persistent atrial fibrillation|persistent atrial fibrillation
5708803|NCT00469612|Contrast sensitivity|contrast sensitivity
5708804|NCT00469599|Hyperparathyroidism, Secondary|hyperparathyroidism, secondary
5708805|NCT00469599|Kidney Failure, Chronic|kidney failure, chronic
5708806|NCT00469599|Renal Insufficiency, Chronic|renal insufficiency, chronic
5708807|NCT00469599|Vitamin D Deficiency|vitamin d deficiency
5708808|NCT00469599|Renal Osteodystrophy|renal osteodystrophy
5708809|NCT00469599|Hemodialysis|hemodialysis
5708811|NCT00469560|Chronic transfusional hemosiderosis|chronic transfusional hemosiderosis
5708812|NCT00469560|Deferasirox|deferasirox
5685817|NCT00554723|Placebo|placebo
5685818|NCT00554723|Traditional Chinese Medicine|traditional chinese medicine
5685819|NCT00554723|Neuroaid|neuroaid
5685820|NCT00554710|Crohn's disease|crohn's disease
5685821|NCT00554710|immunomodulators|immunomodulators
5708813|NCT00469547|ethanol, microbicide, sexually transmitted, Kenya, males|ethanol, microbicide, sexually transmitted, kenya, males
5708814|NCT00469547|HIV Seronegativity|hiv seronegativity
5708815|NCT00469534|minimized time to beam|minimized time to beam
5708816|NCT00469534|hypofractionated 3D CRT plus IMRT|hypofractionated 3d crt plus imrt
5708817|NCT00469534|PET-scan|pet-scan
5708818|NCT00469508|Methamphetamine|methamphetamine
5708819|NCT00469508|Modafinil|modafinil
5708820|NCT00469508|Medication|medication
5708821|NCT00469508|Contingency Management|contingency management
5708822|NCT00469508|Crystal meth|crystal meth
5708823|NCT00469508|Los Angeles|los angeles
5708824|NCT00469508|Addiction|addiction
5708825|NCT00469508|Meth|meth
5708826|NCT00469482|Delirium|delirium
5708827|NCT00469482|Cognitive Impairment|cognitive impairment
5708828|NCT00469482|Sleep|sleep
5708829|NCT00469482|Polysomnography|polysomnography
5708830|NCT00469482|Sedation|sedation
5708831|NCT00469482|Mechanical Ventilation|mechanical ventilation
5708832|NCT00469482|Critical Illness|critical illness
5708833|NCT00469469|Adrenal Cortex|adrenal cortex
5708834|NCT00469469|ACC|acc
5708835|NCT00469456|memantine|memantine
5708836|NCT00469456|Alzheimer's Disease|alzheimer's disease
5708837|NCT00469456|communication|communication
5708838|NCT00469443|Metastatic colorectal cancer|metastatic colorectal cancer
5708839|NCT00469443|Irinotecan|irinotecan
5708840|NCT00469443|Capecitabine|capecitabine
5708841|NCT00469443|Bevacizumab|bevacizumab
5708842|NCT00469430|appendicitis|appendicitis
5708843|NCT00469430|treatment|treatment
5708844|NCT00469430|antibiotics|antibiotics
5708845|NCT00469417|Methyl aminolevulinate|methyl aminolevulinate
5708846|NCT00469417|Photodynamic therapy|photodynamic therapy
5708847|NCT00469417|Primary Superficial Basal Cell Carcinoma|primary superficial basal cell carcinoma
5708848|NCT00469404|Transdermal patch|transdermal patch
5708849|NCT00469404|Centrally acting analgesic|centrally acting analgesic
5708850|NCT00469404|Plasma level|plasma level
5708851|NCT00469404|Healthy volunteers|healthy volunteers
5708852|NCT00469391|Weight Reduction|weight reduction
5708853|NCT00469378|firategrast|firategrast
5708854|NCT00469378|lymphocytes|lymphocytes
5708855|NCT00469378|leukocytes|leukocytes
5708856|NCT00469378|SB-683699|sb-683699
5708857|NCT00469378|cerebrospinal fluid|cerebrospinal fluid
5708858|NCT00469378|relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5708859|NCT00469365|clinical trial, medication adherence, pharmacy intervention|clinical trial, medication adherence, pharmacy intervention
5708860|NCT00469365|Patients with specific chronic diseases|patients with specific chronic diseases
5708861|NCT00469352|Pharmacogenetics|pharmacogenetics
5708862|NCT00469352|Genetics|genetics
5708863|NCT00469352|Treatment response|treatment response
5708865|NCT00469352|Wet AMD|wet amd
5708866|NCT00469352|Age-related macular degeneration|age-related macular degeneration
5708871|NCT00469326|coronary artery disease|coronary artery disease
5708872|NCT00469326|percutaneous coronary intervention|percutaneous coronary intervention
5708873|NCT00469326|atorvastatin|atorvastatin
5708874|NCT00469313|copd|copd
5708875|NCT00469313|inspiratory muscle training|inspiratory muscle training
5708876|NCT00469313|IF|if
5708877|NCT00469300|herpes labialis|herpes labialis
5708878|NCT00469300|cold sore|cold sore
5708879|NCT00469300|acyclovir|acyclovir
5708880|NCT00469300|iontophoresis|iontophoresis
5708881|NCT00469300|topical|topical
5708882|NCT00469287|diabetes mellitus|diabetes mellitus
5708883|NCT00469287|blood sugar|blood sugar
5708884|NCT00469287|overweight|overweight
5708885|NCT00469287|obesity|obesity
5708886|NCT00469287|Traditional Chinese medicine|traditional chinese medicine
5708887|NCT00469274|Pertussis|pertussis
5708888|NCT00469274|Healthcare worker|healthcare worker
5709755|NCT00465790|Huntington|huntington
5708889|NCT00469274|Post-exposure prophylaxis|post-exposure prophylaxis
5708890|NCT00469274|Vaccination|vaccination
5708891|NCT00469274|Pertussis in healthcare workers following occupational|pertussis in healthcare workers following occupational
5708892|NCT00469274|exposure to pertussis|exposure to pertussis
5708893|NCT00469261|Myocardial infarction|myocardial infarction
5708894|NCT00469261|Ventricular remodeling|ventricular remodeling
5708895|NCT00469261|Matrix metalloproteinases|matrix metalloproteinases
5708896|NCT00469261|Doxycycline|doxycycline
5708897|NCT00469248|Myocardial infarction|myocardial infarction
5708898|NCT00469248|Cardiogenic shock|cardiogenic shock
5708899|NCT00469248|Systemic inflammatory response syndrome|systemic inflammatory response syndrome
5708900|NCT00469248|Percutaneous coronary intervention|percutaneous coronary intervention
5708901|NCT00469248|aortic balloon counterpulsation|aortic balloon counterpulsation
5708902|NCT00469222|small cell lung cancer|small cell lung cancer
5685822|NCT00554710|biologicals|biologicals
5708903|NCT00469222|radiotherapy dose escalation|radiotherapy dose escalation
5708904|NCT00469209|Multiple Myeloma|multiple myeloma
5708905|NCT00469209|Melphalan|melphalan
5708906|NCT00469209|Trisenox|trisenox
5708907|NCT00469209|Arsenic Trioxide|arsenic trioxide
5708908|NCT00469209|Ascorbic Acid|ascorbic acid
5708909|NCT00469209|Vitamin C|vitamin c
5708910|NCT00469209|Velcade|velcade
5708911|NCT00469209|Bortezomib|bortezomib
5708912|NCT00469196|mesothelioma|mesothelioma
5708913|NCT00469196|tomotherapy|tomotherapy
5708914|NCT00469170|HIV-1|hiv-1
5708915|NCT00469170|HIV seronegativity|hiv seronegativity
5708916|NCT00469157|compatibility of Optive after PRK or LASIK|compatibility of optive after prk or lasik
5708917|NCT00469144|Stem Cell Transplantation|stem cell transplantation
5708918|NCT00469144|Leukemia|leukemia
5708919|NCT00469144|Busulfan|busulfan
5708920|NCT00469144|Fludarabine|fludarabine
5708922|NCT00469144|AML|aml
5708923|NCT00469131|liver transplantation,|liver transplantation,
5708924|NCT00469131|HCV recurrence,|hcv recurrence,
5708925|NCT00469131|immunosuppression|immunosuppression
5708926|NCT00469105|Type 2 Diabetes|type 2 diabetes
5708927|NCT00469105|Diabetes Education|diabetes education
5708928|NCT00469105|Health Literacy|health literacy
5708929|NCT00469079|Biomarkers|biomarkers
5708930|NCT00469079|Smoking|smoking
5708931|NCT00469079|Tobacco|tobacco
5708932|NCT00469079|Cessation|cessation
5708933|NCT00469066|small cell lung cancer|small cell lung cancer
5708934|NCT00469066|bladder cancer|bladder cancer
5708935|NCT00469066|conformal radiotherapy|conformal radiotherapy
5708936|NCT00469053|Transdermal patch|transdermal patch
5708937|NCT00469053|multidose|multidose
5708938|NCT00469053|Centrally acting analgesic|centrally acting analgesic
5708939|NCT00469053|Plasma level|plasma level
5708940|NCT00469053|Healthy volunteers|healthy volunteers
5708941|NCT00469040|GW642444,|gw642444,
5708942|NCT00469040|healthy subjects|healthy subjects
5708943|NCT00469040|magnesium stearate,|magnesium stearate,
5708944|NCT00469027|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5708945|NCT00469014|Acute Myeloid Leukemia|acute myeloid leukemia
5708947|NCT00469014|Myelodysplastic Syndrome|myelodysplastic syndrome
5708948|NCT00469014|MDS|mds
5708949|NCT00469014|Chronic Myeloid Leukemia|chronic myeloid leukemia
5708950|NCT00469014|CML|cml
5708951|NCT00469014|Busulfan|busulfan
5708952|NCT00469014|Busulfex|busulfex
5708953|NCT00469014|Myleran|myleran
5708954|NCT00469014|Fludarabine|fludarabine
5708955|NCT00469014|Fludara|fludara
5708956|NCT00469014|Fludarabine Phosphate|fludarabine phosphate
5708957|NCT00469014|Clofarabine|clofarabine
5708958|NCT00469014|Clofarex|clofarex
5708959|NCT00469014|Clolar|clolar
5708960|NCT00469014|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5708961|NCT00469014|ASCT|asct
5708962|NCT00469014|Stem Cell|stem cell
5708963|NCT00469014|Gleevec|gleevec
5708964|NCT00469014|Imatinib Mesylate|imatinib mesylate
5708965|NCT00469001|Hospitalization and death from exacerbation CHF.|hospitalization and death from exacerbation chf.
5708966|NCT00468949|Health-Related Quality of Life|health-related quality of life
5708967|NCT00468949|Dupuytren's Disease|dupuytren's disease
5680579|NCT00577278|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5680580|NCT00577278|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5680581|NCT00577278|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5680582|NCT00577278|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5734202|NCT00378781|stage II melanoma|stage ii melanoma
5708968|NCT00468949|Health Utilities Index|health utilities index
5708969|NCT00468949|Short Form-36;|short form-36;
5708970|NCT00468949|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
5708971|NCT00468936|anti-rejection|anti-rejection
5708972|NCT00468936|GI side effects|gi side effects
5708973|NCT00468936|heart transplant patients|heart transplant patients
5708974|NCT00468923|Primary prevention|primary prevention
5708975|NCT00468923|Cholesterol lowering|cholesterol lowering
5708976|NCT00468923|Blood pressure lowering|blood pressure lowering
5708977|NCT00468923|Cardiovascular disease prevention|cardiovascular disease prevention
5708978|NCT00468897|Alzheimers Disease|alzheimers disease
5708979|NCT00468897|healthy volunteers|healthy volunteers
5708980|NCT00468897|bioequivalence|bioequivalence
5708981|NCT00468884|Kinetics of GLP-1 and PYY3-36; increasing oral doses|kinetics of glp-1 and pyy3-36; increasing oral doses
5708982|NCT00468858|Dengue|dengue
5708983|NCT00468858|Virus|virus
5708984|NCT00468858|Live-attenuated|live-attenuated
5708985|NCT00468858|Vaccine|vaccine
5708986|NCT00468858|Dengue viral infection|dengue viral infection
5708987|NCT00468858|Dengue Vaccine|dengue vaccine
5708988|NCT00468845|pain after hysterectomy|pain after hysterectomy
5708989|NCT00468845|amount of opioids used|amount of opioids used
5708990|NCT00468819|Contrast-enhanced MRI|contrast-enhanced mri
5708991|NCT00468819|MR angiography (MRA) Children 2-17 years|mr angiography (mra) children 2-17 years
5708992|NCT00468806|PET scan|pet scan
5708993|NCT00468806|Health Males|health males
5707648|NCT00473616|Phase I|phase i
5708994|NCT00468793|central venous saturation|central venous saturation
5708995|NCT00468793|bowel surgery|bowel surgery
5708996|NCT00468793|morbidity|morbidity
5708997|NCT00468793|intravenous infusions|intravenous infusions
5708998|NCT00468780|Canadian Triage Acuity Scale|canadian triage acuity scale
5708999|NCT00468780|paramedics|paramedics
5709000|NCT00468780|triage nurse|triage nurse
5709001|NCT00468780|triage levels|triage levels
5709002|NCT00468780|inter-rater reliability|inter-rater reliability
5709003|NCT00468780|health services outcomes|health services outcomes
5709004|NCT00468767|Atrial fibrillation|atrial fibrillation
5709005|NCT00468767|RSD1235|rsd1235
5709006|NCT00468767|Atrial fibrillation of 3 hours to 7 days duration.|atrial fibrillation of 3 hours to 7 days duration.
5709007|NCT00468767|Atrial fibrillation of 3 hours to 45 days duration.|atrial fibrillation of 3 hours to 45 days duration.
5709008|NCT00468741|Breast Cancer|breast cancer
5709009|NCT00468741|Internet|internet
5709010|NCT00468741|Computer|computer
5709011|NCT00468741|Support|support
5709012|NCT00468741|Information|information
5709013|NCT00468741|Education|education
5709014|NCT00468741|Control Group: Usual care and Internet access|control group: usual care and internet access
5709015|NCT00468741|CHESS Information Services only|chess information services only
5709016|NCT00468741|CHESS Social Support & Information Services|chess social support & information services
5709017|NCT00468741|CHESS Information, Social Support & Skills Services|chess information, social support & skills services
5709018|NCT00468728|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
5709019|NCT00468728|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5709020|NCT00468715|stage IV breast cancer|stage iv breast cancer
5709021|NCT00468715|recurrent breast cancer|recurrent breast cancer
5709022|NCT00468715|male breast cancer|male breast cancer
5709023|NCT00468689|SB-751689,|sb-751689,
5709024|NCT00468689|Calcium-sensing receptor antagonist (CaR),|calcium-sensing receptor antagonist (car),
5709025|NCT00468689|Osteoporosis,|osteoporosis,
5709026|NCT00468689|Parathyroid hormone (PTH),|parathyroid hormone (pth),
5709027|NCT00468689|Oral dose|oral dose
5709028|NCT00468676|major Depressive Disorder|major depressive disorder
5709029|NCT00468676|Diabetes|diabetes
5709030|NCT00468676|Heart Disease|heart disease
5709031|NCT00468663|preeclampsia|preeclampsia
5709032|NCT00468663|preterm delivery|preterm delivery
5709033|NCT00468663|lipid peroxidation|lipid peroxidation
5709034|NCT00468663|inflammation|inflammation
5709035|NCT00468637|heart failure|heart failure
5709036|NCT00468637|cardiovascular high risk|cardiovascular high risk
5709037|NCT00468637|erectile dysfunction|erectile dysfunction
5709038|NCT00468637|cardiovascular disease|cardiovascular disease
5709039|NCT00468624|Growth hormone|growth hormone
5709040|NCT00468624|insulin-like growth factor 1|insulin-like growth factor 1
5709041|NCT00468624|pegvisomant|pegvisomant
5709042|NCT00468611|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5709043|NCT00468611|Multiple Sclerosis|multiple sclerosis
5709044|NCT00468598|troponin|troponin
5709045|NCT00468598|long-term outcome|long-term outcome
5709046|NCT00468598|on-pump cardiac surgery|on-pump cardiac surgery
5709047|NCT00468585|Breast cancer|breast cancer
5709048|NCT00468585|Metastatic breast cancer|metastatic breast cancer
5709049|NCT00468585|Breast|breast
5709050|NCT00468585|Metastatic|metastatic
5709051|NCT00468572|Emotion|emotion
5709052|NCT00468572|Oxytocin|oxytocin
5709053|NCT00468572|Cortisol|cortisol
5709054|NCT00468559|pediatrics|pediatrics
5709055|NCT00468559|neonates|neonates
5709056|NCT00468533|Arupiprazole, prolacin, PANSS, CGI, AIMS|arupiprazole, prolacin, panss, cgi, aims
5709057|NCT00468520|induction of labor|induction of labor
5709058|NCT00468520|cervical ripening|cervical ripening
5709059|NCT00468520|Foley catheter|foley catheter
5709060|NCT00468520|oxytocin|oxytocin
5709061|NCT00468507|CCK release|cck release
5709062|NCT00468494|non diabetic|non diabetic
5709063|NCT00468494|catabolic energy state|catabolic energy state
5709064|NCT00468481|Healthy women requesting contraception|healthy women requesting contraception
5709065|NCT00468481|Folic Acid|folic acid
5709066|NCT00468468|breast cancer|breast cancer
5709067|NCT00468468|Internet|internet
5709069|NCT00468468|support|support
5709070|NCT00468468|information|information
5709071|NCT00468468|education|education
5709072|NCT00468455|Colorectal Surgery|colorectal surgery
5709073|NCT00468455|Abdominal Surgery|abdominal surgery
5709074|NCT00468455|Diverticulitis|diverticulitis
5709075|NCT00468455|Colon Cancer|colon cancer
5709076|NCT00468455|Rectal Cancer|rectal cancer
5709077|NCT00468455|Colon Polyp|colon polyp
5709078|NCT00468455|Rectal Polyp|rectal polyp
5709079|NCT00468455|Crohn's Disease|crohn's disease
5709080|NCT00468442|Insulin dependence|insulin dependence
5709081|NCT00468442|Hypoglycemia|hypoglycemia
5710436|NCT00463359|treatment|treatment
5709082|NCT00468442|Hypoglycemia unawareness|hypoglycemia unawareness
5709083|NCT00468429|Glaucoma|glaucoma
5709084|NCT00468429|Bevacizumab|bevacizumab
5709085|NCT00468429|Glaucoma Filtration Surgery|glaucoma filtration surgery
5709086|NCT00468429|Mitomycin C|mitomycin c
5685823|NCT00554697|tissue oxygenation|tissue oxygenation
5709087|NCT00468429|Intraocular Pressure|intraocular pressure
5709088|NCT00468403|Insulin dependence|insulin dependence
5709089|NCT00468403|Hypoglycemia|hypoglycemia
5709297|NCT00467675|NonDiabetes|nondiabetes
5709090|NCT00468403|Hypoglycemia unawareness|hypoglycemia unawareness
5709091|NCT00468364|Hypoglycemia, bedtime insulin, long-acting insulin|hypoglycemia, bedtime insulin, long-acting insulin
5709092|NCT00468351|bevacizumab|bevacizumab
5709093|NCT00468351|diabetes|diabetes
5709094|NCT00468351|intravitreal|intravitreal
5709095|NCT00468351|macular edema|macular edema
5709096|NCT00468351|triamcinolone|triamcinolone
5709097|NCT00468351|VEGF|vegf
5709098|NCT00468338|general anesthesia|general anesthesia
5709099|NCT00468338|dental rehabilitation|dental rehabilitation
5709100|NCT00468338|mental retardation|mental retardation
5709101|NCT00468325|coronary artery disease|coronary artery disease
5709102|NCT00468325|chest pain|chest pain
5709103|NCT00468325|emergency room|emergency room
5709104|NCT00468299|early|early
5709105|NCT00468299|pregnancy|pregnancy
5709106|NCT00468299|failure|failure
5709107|NCT00468299|mifepristone|mifepristone
5709108|NCT00468299|misoprostol|misoprostol
5709109|NCT00468299|buccal|buccal
5709110|NCT00468299|miscarriage|miscarriage
5709111|NCT00468299|fetal|fetal
5709112|NCT00468299|demise|demise
5709113|NCT00468299|anembryonic|anembryonic
5709114|NCT00468299|progesterone|progesterone
5709115|NCT00468286|Prostate Cancer|prostate cancer
5709116|NCT00468273|Deficiency Syndromes, Antibody|deficiency syndromes, antibody
5709117|NCT00468273|Antibody Deficiency Syndrome|antibody deficiency syndrome
5709118|NCT00468273|Bruton's agammaglobulinemia|bruton's agammaglobulinemia
5709119|NCT00468273|Common Variable Immune Deficiency|common variable immune deficiency
5709120|NCT00468273|Hyper IgM syndromes|hyper igm syndromes
5709121|NCT00468260|Cancer|cancer
5709123|NCT00468260|Patupilone|patupilone
5709124|NCT00468247|mean systemic pressure|mean systemic pressure
5709125|NCT00468247|fluid therapy|fluid therapy
5709126|NCT00468247|closed loop control|closed loop control
5709127|NCT00468247|circulation modelling|circulation modelling
5709128|NCT00468234|smoking cessation|smoking cessation
5709129|NCT00468234|harm reduction|harm reduction
5709130|NCT00468234|biomarker|biomarker
5709131|NCT00468234|exhaled breath condensate|exhaled breath condensate
5709132|NCT00468221|Ozone|ozone
5709133|NCT00468221|Healthy Adults|healthy adults
5709134|NCT00468208|Vasculitis|vasculitis
5709135|NCT00468208|Relapse|relapse
5709136|NCT00468208|Wegener's|wegener's
5709137|NCT00468208|Treatment|treatment
5709138|NCT00468195|tomography|tomography
5709139|NCT00468195|coronary artery disease|coronary artery disease
5709140|NCT00468195|obesity|obesity
5709141|NCT00468182|Multiple sclerosis|multiple sclerosis
5709142|NCT00468182|Interferon beta|interferon beta
5863058|NCT00001407|Mycobacteria|mycobacteria
5709143|NCT00468182|plasmacytoid dendritic cells|plasmacytoid dendritic cells
5709144|NCT00468169|Cetuximab|cetuximab
5709145|NCT00468169|Erbitux|erbitux
5709146|NCT00468169|locally|locally
5709147|NCT00468169|advanced|advanced
5709148|NCT00468169|head|head
5709149|NCT00468169|neck|neck
5709150|NCT00468169|cancer|cancer
5709151|NCT00468169|neoplasms|neoplasms
5709152|NCT00468169|squamous|squamous
5709153|NCT00468169|carcinoma|carcinoma
5709154|NCT00468169|lymphoepithelioma|lymphoepithelioma
5709155|NCT00468156|fruit|fruit
5709156|NCT00468156|vegetables|vegetables
5709157|NCT00468156|prevention|prevention
5709158|NCT00468156|cancer|cancer
5709159|NCT00468156|counseling|counseling
5709160|NCT00468156|cancer risk|cancer risk
5709161|NCT00468130|Aggression|aggression
5709162|NCT00468130|Irritability|irritability
5709163|NCT00468130|Global autism severity|global autism severity
5709164|NCT00468117|Hypoglycemia|hypoglycemia
5709165|NCT00468117|Kidney Transplant|kidney transplant
5709166|NCT00468117|Insulin independence|insulin independence
5709167|NCT00468117|Islet Transplantation|islet transplantation
5709168|NCT00468117|Intensive Insulin Therapy|intensive insulin therapy
5709169|NCT00468104|parapneumonic pleural effusion|parapneumonic pleural effusion
5709170|NCT00468104|empyema|empyema
5698676|NCT00505544|Survey|survey
5709171|NCT00468104|TPA (Activase, Alteplase)|tpa (activase, alteplase)
5709173|NCT00468091|exendin(9-39)|exendin(9-39)
5709174|NCT00468091|atropine|atropine
5709175|NCT00468091|human|human
5709176|NCT00468091|motility|motility
5709177|NCT00468078|Parkinson's disease|parkinson's disease
5709178|NCT00468078|Essential tremor|essential tremor
5709179|NCT00468078|F-18 FPCIT|f-18 fpcit
5709181|NCT00468065|intravenous|intravenous
5709182|NCT00468065|catheter|catheter
5709184|NCT00468052|obstructive sleep apnea|obstructive sleep apnea
5709185|NCT00468052|tonsillectomy|tonsillectomy
5709186|NCT00468052|adenoidectomy|adenoidectomy
5709187|NCT00468039|metformin|metformin
5709188|NCT00468039|vildagliptin|vildagliptin
5709189|NCT00468039|initial combination|initial combination
5709190|NCT00468026|BPH|bph
5709191|NCT00468026|Prostate|prostate
5709192|NCT00468026|Stent|stent
5709193|NCT00468026|Benign prostatic hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5709194|NCT00468013|Fibromyalgia|fibromyalgia
5709195|NCT00468013|Irritable Bowel|irritable bowel
5709196|NCT00468013|Chronic Fatigue|chronic fatigue
5709197|NCT00468013|Medically Unexplained Symptoms|medically unexplained symptoms
5709198|NCT00468013|Resilience Building Exercises|resilience building exercises
5709199|NCT00468013|Depression|depression
5709200|NCT00468013|Well-Being|well-being
5709201|NCT00468000|Peripheral Arterial Disease|peripheral arterial disease
5709202|NCT00468000|Critical Limb Ischemia|critical limb ischemia
5709203|NCT00468000|Ischemia|ischemia
5709204|NCT00468000|Peripheral Vascular Disease|peripheral vascular disease
5709205|NCT00468000|ixmyelocel-T|ixmyelocel-t
5709206|NCT00467961|CML (Chronic Myelogenous Leukemia)|cml (chronic myelogenous leukemia)
5709207|NCT00467961|CLL (Chronic Lymphocytic Leukemia)|cll (chronic lymphocytic leukemia)
5709208|NCT00467961|AML (Acute Myelogenous Leukemia)|aml (acute myelogenous leukemia)
5709209|NCT00467961|Leukemia|leukemia
5709210|NCT00467961|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5709211|NCT00467961|CLL|cll
5709212|NCT00467961|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5709213|NCT00467961|CML|cml
5709214|NCT00467961|Acute Myelogenous Leukemia|acute myelogenous leukemia
5709215|NCT00467961|AML|aml
5709216|NCT00467961|Acute B-Lymphoblastic Leukemia|acute b-lymphoblastic leukemia
5709217|NCT00467961|ALL|all
5709218|NCT00467961|Myelodysplastic Syndrome|myelodysplastic syndrome
5709219|NCT00467961|MDS|mds
5709220|NCT00467948|clean contaminated, laryngectomy, wound infection|clean contaminated, laryngectomy, wound infection
5709221|NCT00467935|amd|amd
5709222|NCT00467935|disciform|disciform
5709223|NCT00467935|fibrosis|fibrosis
5709224|NCT00467935|Lucentis|lucentis
5709225|NCT00467935|scotoma|scotoma
5709226|NCT00467922|Hand-assisted colorectal surgery|hand-assisted colorectal surgery
5709227|NCT00467922|colorectal disease|colorectal disease
5709228|NCT00467922|Crohn's|crohn's
5709229|NCT00467922|diverticulitis|diverticulitis
5709230|NCT00467922|Colorectal resections|colorectal resections
5709231|NCT00467909|micronutrients|micronutrients
5709232|NCT00467909|cognition|cognition
5709233|NCT00467909|DHA|dha
5709234|NCT00467909|healthy children|healthy children
5709235|NCT00467896|PAH|pah
5709236|NCT00467896|iloprost|iloprost
5709237|NCT00467896|Ventavis|ventavis
5709238|NCT00467896|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5709239|NCT00467896|Actelion Pharmaceuticals|actelion pharmaceuticals
5709240|NCT00467896|Cotherix|cotherix
5709241|NCT00467883|Zygomycosis|zygomycosis
5709242|NCT00467883|High dose liposomal amphotericin B|high dose liposomal amphotericin b
5709243|NCT00467870|investigational|investigational
5709244|NCT00467870|testosterone|testosterone
5709245|NCT00467870|testosterone undecanoate|testosterone undecanoate
5709246|NCT00467870|TU|tu
5709247|NCT00467870|Hypogonadism|hypogonadism
5709248|NCT00467870|primary hypogonadism|primary hypogonadism
5709249|NCT00467870|secondary hypogonadism|secondary hypogonadism
5709250|NCT00467857|cyanoacrylates|cyanoacrylates
5709251|NCT00467857|microbial sealants|microbial sealants
5709252|NCT00467857|skin flora contamination|skin flora contamination
5709253|NCT00467857|surgery|surgery
5709254|NCT00467844|Cachexia|cachexia
5709255|NCT00467844|Muscle Wasting|muscle wasting
5709256|NCT00467844|Non-Small Cell Lung Cancer|non-small cell lung cancer
5709257|NCT00467844|Colorectal Cancer|colorectal cancer
5709258|NCT00467844|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5709259|NCT00467844|Stage 3 or 4 Breast Cancer|stage 3 or 4 breast cancer
5709260|NCT00467844|Chronis Lymphocytic Leukemia|chronis lymphocytic leukemia
5709261|NCT00467831|Restrictive Lung Disease|restrictive lung disease
5709262|NCT00467831|Pulmonary Fibrosis|pulmonary fibrosis
5709263|NCT00467831|Albinism|albinism
5709264|NCT00467831|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5709265|NCT00467831|Metabolic Disease|metabolic disease
5709266|NCT00467831|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5709267|NCT00467831|HPS|hps
5709268|NCT00467831|Lung Disease|lung disease
5709269|NCT00467818|Aggression|aggression
5709270|NCT00467818|Irritability|irritability
5709271|NCT00467818|Global severity|global severity
5709272|NCT00467805|Light exposure|light exposure
5709273|NCT00467805|light spectrum|light spectrum
5709274|NCT00467805|reproductive hormones|reproductive hormones
5709276|NCT00467792|urticaria pigmentosa|urticaria pigmentosa
5709277|NCT00467792|mastocytosis|mastocytosis
5709278|NCT00467792|mastocytomas|mastocytomas
5709279|NCT00467766|dementia|dementia
5709280|NCT00467766|Counseling|counseling
5709281|NCT00467753|Irritability|irritability
5709282|NCT00467753|Functional Ability|functional ability
5709283|NCT00467753|Aggression|aggression
5709284|NCT00467753|Mood Instability|mood instability
5709285|NCT00467727|Diagnostic Mammography|diagnostic mammography
5709286|NCT00467727|Breast Imaging|breast imaging
5709287|NCT00467727|Phase Contrast Mammography|phase contrast mammography
5710437|NCT00463346|Treatment|treatment
5709288|NCT00467727|X-Ray Mammography|x-ray mammography
5709289|NCT00467714|RHINOPLASTY ,ESTHETIC SURGERY|rhinoplasty ,esthetic surgery
5709290|NCT00467701|pneumonia|pneumonia
5716524|NCT00020267|stage, colon cancer|stage, colon cancer
5709291|NCT00467701|Legionnaires disease|legionnaires disease
5709292|NCT00467701|risk factors|risk factors
5709293|NCT00467688|type 1 diabetes|type 1 diabetes
5709294|NCT00467688|glucose excursion|glucose excursion
5709295|NCT00467688|hypoglycemia awareness|hypoglycemia awareness
5709296|NCT00467688|continuous glucose monitoring|continuous glucose monitoring
5709298|NCT00467675|CGM|cgm
5709299|NCT00467649|Symlin|symlin
5709300|NCT00467649|Amylin|amylin
5709301|NCT00467649|insulin|insulin
5709302|NCT00467649|Humalog|humalog
5709303|NCT00467649|Novolog|novolog
5709304|NCT00467649|Apidra|apidra
5709305|NCT00467636|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5709306|NCT00467636|Corticosteroid induced hyperglycaemia|corticosteroid induced hyperglycaemia
5709307|NCT00467636|Insulin|insulin
5709308|NCT00467623|Pregnancy|pregnancy
5709309|NCT00467623|holotranscobalamin|holotranscobalamin
5709310|NCT00467623|cobalamin|cobalamin
5709311|NCT00467623|vitamin B12 analogues|vitamin b12 analogues
5709312|NCT00467623|reference interval|reference interval
5709313|NCT00467610|myelodysplastic|myelodysplastic
5709314|NCT00467610|MDS|mds
5709315|NCT00467610|Panhematin|panhematin
5709316|NCT00467610|Hemin|hemin
5709317|NCT00467597|Dyskinesia|dyskinesia
5709318|NCT00467597|Levodopa|levodopa
5709319|NCT00467597|Movement Disorders|movement disorders
5709320|NCT00467597|Parkinson Disease|parkinson disease
5709321|NCT00467571|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
5709322|NCT00467571|Helicobacter pylori infection|helicobacter pylori infection
5709323|NCT00467571|platelet|platelet
5709324|NCT00467558|Impulse Control Disorder|impulse control disorder
5709325|NCT00467558|Compulsive Sexual Behavior|compulsive sexual behavior
5709326|NCT00467545|HBeAg-positive|hbeag-positive
5709327|NCT00467545|chronic hepatitis B|chronic hepatitis b
5709328|NCT00467545|telbivudine|telbivudine
5709329|NCT00467519|Tetanus; Diphtheria; Pertussis; ADACEL; DAPTACEL|tetanus; diphtheria; pertussis; adacel; daptacel
5709330|NCT00467506|Recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery|recurrence of medullary thyroid carcinoma: abnormal calcitonin level and biomarkers doubling time lower than 5 years after initial surgery
5709331|NCT00467454|Pyromania|pyromania
5709332|NCT00467454|Fire Setting|fire setting
5709333|NCT00467454|Compulsive Fire Setting|compulsive fire setting
5709335|NCT00467415|Walking|walking
5709336|NCT00467415|Treadmill|treadmill
5709337|NCT00467415|Partial Weightbearing|partial weightbearing
5709338|NCT00467402|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5709339|NCT00467389|Acetylcholine|acetylcholine
5709340|NCT00467389|Acetylcholinesterase|acetylcholinesterase
5709341|NCT00467389|Butyrylcholinesterase|butyrylcholinesterase
5709342|NCT00467389|Cholinesterase Inhibitor|cholinesterase inhibitor
5709343|NCT00467350|constipation|constipation
5709344|NCT00467350|treatment|treatment
5709345|NCT00467350|fecal impaction|fecal impaction
5709346|NCT00467350|pediatric|pediatric
5709347|NCT00467337|insole|insole
5709348|NCT00467337|osteoarthritis|osteoarthritis
5709349|NCT00467337|pain|pain
5709350|NCT00467337|valgus knee|valgus knee
5709351|NCT00467324|obstructive sleep apnea|obstructive sleep apnea
5709352|NCT00467324|surgery|surgery
5709353|NCT00467324|tongue|tongue
5709354|NCT00467311|Contrast-induced nephropathy|contrast-induced nephropathy
5709355|NCT00467311|Cystatin C|cystatin c
5709356|NCT00467311|Contrast media|contrast media
5709357|NCT00467311|Creatinine|creatinine
5709358|NCT00467311|Cardiac Catheterization|cardiac catheterization
5709359|NCT00467298|Exercise|exercise
5709360|NCT00467298|heart failure|heart failure
5709361|NCT00467298|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5709362|NCT00467298|patient education|patient education
5709363|NCT00467298|costs|costs
5709364|NCT00467298|quality of life|quality of life
5709365|NCT00467285|Bone Density|bone density
5709366|NCT00467285|C-telopeptide|c-telopeptide
5709367|NCT00467285|Dual-Energy X-Ray Absorptiometry|dual-energy x-ray absorptiometry
5709368|NCT00467285|N-telopeptide|n-telopeptide
5709369|NCT00467285|Osteocalcin|osteocalcin
5709370|NCT00467285|Osteoporosis|osteoporosis
5709371|NCT00467285|Thiazolidinediones|thiazolidinediones
5709372|NCT00467285|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5709373|NCT00467272|Catheter-Related Bloodstream Infections|catheter-related bloodstream infections
5709374|NCT00467272|Bloodstream Infection|bloodstream infection
5709375|NCT00467272|Daptomycin|daptomycin
5709376|NCT00467272|Cubicin|cubicin
5709377|NCT00467272|CRBSI|crbsi
5709378|NCT00467259|Natural Menopause|natural menopause
5709379|NCT00467246|Diabetes emergencies|diabetes emergencies
5709380|NCT00467220|Calorie restriction|calorie restriction
5709381|NCT00467220|alternate day fasting|alternate day fasting
5709382|NCT00467220|calorie intake|calorie intake
5709383|NCT00467194|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5709384|NCT00467194|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5709385|NCT00467194|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5709386|NCT00467194|advanced adult primary liver cancer|advanced adult primary liver cancer
5709387|NCT00467181|cardiac surgery|cardiac surgery
5709388|NCT00467181|renal dysfunction|renal dysfunction
5709389|NCT00467168|dietary fatty acid composition|dietary fatty acid composition
5709390|NCT00467168|postprandial|postprandial
5709391|NCT00467168|triglyceride-rich lipoprotein|triglyceride-rich lipoprotein
5709392|NCT00467168|type 2 diabetes|type 2 diabetes
5709393|NCT00467155|Helicobacter pylori, children, infants, Gambia|helicobacter pylori, children, infants, gambia
5709394|NCT00467142|stage IV colon cancer|stage iv colon cancer
5709395|NCT00467142|stage IV rectal cancer|stage iv rectal cancer
5709396|NCT00467142|adenocarcinoma of the colon|adenocarcinoma of the colon
5709397|NCT00467142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5709398|NCT00467142|recurrent colon cancer|recurrent colon cancer
5709399|NCT00467142|recurrent rectal cancer|recurrent rectal cancer
5709400|NCT00467129|stage IV colon cancer|stage iv colon cancer
5709401|NCT00467129|stage IV rectal cancer|stage iv rectal cancer
5709402|NCT00467116|stage III pancreatic cancer|stage iii pancreatic cancer
5709403|NCT00467116|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5709404|NCT00467116|stage II pancreatic cancer|stage ii pancreatic cancer
5709405|NCT00467116|recurrent pancreatic cancer|recurrent pancreatic cancer
5709406|NCT00467103|Adult Aphasia|adult aphasia
5709407|NCT00467103|Diffusion Tensor Imaging|diffusion tensor imaging
5709408|NCT00467103|functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5709409|NCT00467103|Language Recovery|language recovery
5709410|NCT00467103|Left Middle Cerebral Artery Stroke|left middle cerebral artery stroke
5709411|NCT00467103|Nonfluent Aphasia|nonfluent aphasia
5709412|NCT00467090|Parkinson's Disease|parkinson's disease
5709413|NCT00467090|Gene|gene
5709414|NCT00467090|Genetic|genetic
5709415|NCT00467090|Family Studies|family studies
5709416|NCT00467090|LRRK-2|lrrk-2
5703968|NCT00487422|QOL|qol
5709417|NCT00467090|Parkinson Disease|parkinson disease
5709419|NCT00467077|recurrent renal cell cancer|recurrent renal cell cancer
5709420|NCT00467077|stage IV renal cell cancer|stage iv renal cell cancer
5709421|NCT00467077|stage III renal cell cancer|stage iii renal cell cancer
5709422|NCT00467064|Disease self-management|disease self-management
5709423|NCT00467064|Community programs|community programs
5709424|NCT00467038|affect|affect
5709425|NCT00467038|aggression|aggression
5709426|NCT00467038|anger|anger
5709427|NCT00467038|behavior therapy|behavior therapy
5709428|NCT00467038|borderline personality disorder|borderline personality disorder
5709429|NCT00467038|MRI, functional|mri, functional
5709430|NCT00467025|Metastatic clear cell carcinoma of the kidney|metastatic clear cell carcinoma of the kidney
5709431|NCT00467025|RCC|rcc
5709432|NCT00467012|Inoperable metastatic breast cancer|inoperable metastatic breast cancer
5709433|NCT00466999|misoprostol|misoprostol
5709434|NCT00466999|incomplete abortion|incomplete abortion
5709435|NCT00466999|PAC|pac
5709436|NCT00466986|recurrent|recurrent
5709437|NCT00466986|ovarian|ovarian
5709438|NCT00466986|cancer|cancer
5709439|NCT00466986|platinum sensitive|platinum sensitive
5709440|NCT00466973|Atrial fibrillation|atrial fibrillation
5709441|NCT00466973|ablation device comparison|ablation device comparison
5709442|NCT00466973|ablation in right atria|ablation in right atria
5709443|NCT00466947|Otitis media|otitis media
5709444|NCT00466947|Pneumonia|pneumonia
5709445|NCT00466947|Community acquired pneumonia (CAP)|community acquired pneumonia (cap)
5709446|NCT00466947|Pneumococcal disease|pneumococcal disease
5709447|NCT00466947|Booster vaccination|booster vaccination
5709448|NCT00466947|Immunogenicity|immunogenicity
5709449|NCT00466947|Pneumococcal vaccine|pneumococcal vaccine
5709451|NCT00466947|Efficacy|efficacy
5709452|NCT00466947|Carriage|carriage
5709453|NCT00466934|Cerebral Blood Flow|cerebral blood flow
5709454|NCT00466934|Cerebral Cortex|cerebral cortex
5709455|NCT00466934|Cognition|cognition
5709456|NCT00466934|Optical Imaging|optical imaging
5709457|NCT00466934|Healthy Volunteer|healthy volunteer
5709458|NCT00466934|HV|hv
5709459|NCT00466921|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5709460|NCT00466921|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5709461|NCT00466921|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5709462|NCT00466921|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5709463|NCT00466921|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5709464|NCT00466895|Leukemia|leukemia
5709465|NCT00466895|Lenalidomide|lenalidomide
5709467|NCT00466882|renal failure|renal failure
5709468|NCT00466882|renal transplant candidate|renal transplant candidate
5709469|NCT00466882|Hemodialysis BMI between 36 and 42|hemodialysis bmi between 36 and 42
5709470|NCT00466856|neoplastic syndrome|neoplastic syndrome
5709471|NCT00466856|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5709472|NCT00466856|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5709473|NCT00466856|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5709474|NCT00466856|metastatic pheochromocytoma|metastatic pheochromocytoma
5710630|NCT00462761|11q23|11q23
5709475|NCT00466856|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5709476|NCT00466856|liver metastases|liver metastases
5733454|NCT00381303|HIV|hiv
5708176|NCT00471523|PCOS|pcos
5709477|NCT00466856|recurrent pheochromocytoma|recurrent pheochromocytoma
5709478|NCT00466856|gastrinoma|gastrinoma
5709479|NCT00466856|insulinoma|insulinoma
5709480|NCT00466856|WDHA syndrome|wdha syndrome
5709481|NCT00466856|glucagonoma|glucagonoma
5709482|NCT00466856|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5709483|NCT00466856|somatostatinoma|somatostatinoma
5709484|NCT00466843|Abnormal hematopoiesis|abnormal hematopoiesis
5709485|NCT00466843|Leukemia|leukemia
5709486|NCT00466843|Autoimmune Disease|autoimmune disease
5709487|NCT00466830|pain|pain
5709488|NCT00466830|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5709489|NCT00466830|stage IIIA breast cancer|stage iiia breast cancer
5709490|NCT00466830|stage IIIB breast cancer|stage iiib breast cancer
5709491|NCT00466830|stage I breast cancer|stage i breast cancer
5709492|NCT00466830|stage II breast cancer|stage ii breast cancer
5709493|NCT00466830|stage IIIC breast cancer|stage iiic breast cancer
5709494|NCT00466817|Cytomegalovirus, congenital, infants|cytomegalovirus, congenital, infants
5709495|NCT00466804|heart transplant recipients|heart transplant recipients
5709496|NCT00466804|organ transplantation|organ transplantation
5709497|NCT00466804|immune biomarkers|immune biomarkers
5709498|NCT00466804|transplant rejection|transplant rejection
5709499|NCT00466765|Fat Grafting|fat grafting
5709500|NCT00466765|Breast Augmentation|breast augmentation
5709501|NCT00466765|Liposuctioned Fat Transfer|liposuctioned fat transfer
5709502|NCT00466765|Lumpectomy|lumpectomy
5709503|NCT00466765|Mastectomy|mastectomy
5709504|NCT00466765|Micromastia|micromastia
5709505|NCT00466765|Asymmetry|asymmetry
5709506|NCT00466765|Post Lumpectomy Filling Defects|post lumpectomy filling defects
5709507|NCT00466765|Post implant removal filling defect|post implant removal filling defect
5709508|NCT00466765|Post Mastectomy|post mastectomy
5709509|NCT00466765|Autologous Fat Transfer|autologous fat transfer
5709510|NCT00466765|Tubular breasts|tubular breasts
5709511|NCT00466765|Tuberous breasts|tuberous breasts
5709512|NCT00466765|Constricted breasts|constricted breasts
5709513|NCT00466726|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5709514|NCT00466726|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5709515|NCT00466726|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5709516|NCT00466726|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5709517|NCT00466726|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5709518|NCT00466713|Nonischemic dilated cardiomyopathy|nonischemic dilated cardiomyopathy
5709519|NCT00466700|Helicobacter pylori, Gambia, endoscopy, Africa|helicobacter pylori, gambia, endoscopy, africa
5709520|NCT00466687|stage IV melanoma|stage iv melanoma
5709521|NCT00466687|recurrent melanoma|recurrent melanoma
5709522|NCT00466674|Myeloma|myeloma
5709523|NCT00466674|RICT|rict
5709524|NCT00466674|conditioning|conditioning
5709525|NCT00466674|allograft|allograft
5709526|NCT00466661|Acamprosate|acamprosate
5709527|NCT00466661|Alcoholism|alcoholism
5709528|NCT00466661|Bipolar disorder|bipolar disorder
5709529|NCT00466661|Comorbidity|comorbidity
5709530|NCT00466661|Craving|craving
5709531|NCT00466661|Depression|depression
5709532|NCT00466661|GABA|gaba
5709533|NCT00466661|Glutamate|glutamate
5709534|NCT00466661|Mania|mania
5709535|NCT00466661|Pharmacotherapy|pharmacotherapy
5709536|NCT00466661|Withdrawal|withdrawal
5709537|NCT00466648|laparoscopy, port site, closure, Dermabond|laparoscopy, port site, closure, dermabond
5709538|NCT00466635|Clostridium difficile Disease|clostridium difficile disease
5709539|NCT00466635|Infectious diarrhea|infectious diarrhea
5709540|NCT00466635|C. difficile|c. difficile
5709541|NCT00466635|CDAD|cdad
5709542|NCT00466635|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5709543|NCT00466635|Clostridium difficile diarrhea|clostridium difficile diarrhea
5709544|NCT00466635|Antibiotic-Associated Colitis|antibiotic-associated colitis
5709545|NCT00466635|Clostridium Enterocolitis|clostridium enterocolitis
5709546|NCT00466635|Antibiotic-Associated Diarrhea|antibiotic-associated diarrhea
5709547|NCT00466635|Pseudomembranous Colitis|pseudomembranous colitis
5709548|NCT00466635|Clostridium difficile|clostridium difficile
5709549|NCT00466622|PCOS|pcos
5709551|NCT00466622|metformin|metformin
5709552|NCT00466622|blood flow|blood flow
5709553|NCT00466622|Pulsatility index|pulsatility index
5709554|NCT00466609|clomipramine|clomipramine
5709555|NCT00466609|quetiapine|quetiapine
5709556|NCT00466609|fluoxetine|fluoxetine
5709558|NCT00466609|augmentation|augmentation
5709559|NCT00466609|obsessive compulsive disorder|obsessive compulsive disorder
5709560|NCT00466596|allergic rhinitis|allergic rhinitis
5709561|NCT00466596|mild asthma|mild asthma
5709562|NCT00466596|dust mite allergy|dust mite allergy
5709563|NCT00466596|gamma tocopherol|gamma tocopherol
5709564|NCT00466583|Carcinoma, Lymphoma|carcinoma, lymphoma
5709565|NCT00466557|Malaria, Plasmodium falciparum, mosquito, Africa, Anopheles|malaria, plasmodium falciparum, mosquito, africa, anopheles
5709566|NCT00466544|Chronic tonsillitis|chronic tonsillitis
5709567|NCT00466544|Recurrent tonsillitis|recurrent tonsillitis
5709568|NCT00466531|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5709569|NCT00466531|06-138|06-138
5709570|NCT00466518|Kidney transplant|kidney transplant
5709571|NCT00466518|type 2 diabetes|type 2 diabetes
5709572|NCT00466518|sitagliptin|sitagliptin
5709573|NCT00466505|recurrent colon cancer|recurrent colon cancer
5709574|NCT00466505|stage IV colon cancer|stage iv colon cancer
5709575|NCT00466505|recurrent rectal cancer|recurrent rectal cancer
5709576|NCT00466505|stage IV rectal cancer|stage iv rectal cancer
5709577|NCT00466492|Drug Administration Schedule|drug administration schedule
5709578|NCT00466492|Intensive Care Units|intensive care units
5709579|NCT00466492|Length of Stay|length of stay
5709580|NCT00466492|Respiration, Artificial|respiration, artificial
5709581|NCT00466492|Stress Disorders, Post-Traumatic/etiology/*psychology|stress disorders, post-traumatic/etiology/*psychology
5709582|NCT00466492|Critical Illness/*psychology|critical illness/*psychology
5709583|NCT00466492|Pneumonia/prevention & control|pneumonia/prevention & control
5709584|NCT00466492|Hypnotics and Sedatives/*administration & dosage|hypnotics and sedatives/*administration & dosage
5709585|NCT00466479|neuroprotection|neuroprotection
5709586|NCT00466479|alpha one agonists|alpha one agonists
5709587|NCT00466479|glaucoma|glaucoma
5709588|NCT00466479|visual field|visual field
5709589|NCT00466466|Small-Cell Lung Cancer|small-cell lung cancer
5709591|NCT00466466|Advanced Lung Cancer|advanced lung cancer
5709592|NCT00466466|RAD|rad
5709593|NCT00466466|RAD001|rad001
5709594|NCT00466466|Chemotherapy|chemotherapy
5709595|NCT00466466|Cisplatin|cisplatin
5709596|NCT00466466|Etoposide|etoposide
5709597|NCT00466375|hemangioma|hemangioma
5709598|NCT00466375|vascular anomaly|vascular anomaly
5709599|NCT00466375|infantile hemangioma|infantile hemangioma
5709600|NCT00466362|Obesity|obesity
5709601|NCT00466362|Diabetes|diabetes
5709602|NCT00466362|Weight|weight
5709603|NCT00466362|Lifestyle|lifestyle
5709604|NCT00466362|Follow up|follow up
5709605|NCT00466349|SMA Type I|sma type i
5709606|NCT00466349|SMA Type II|sma type ii
5709607|NCT00466349|SMA Type III|sma type iii
5709608|NCT00466349|SMN|smn
5709609|NCT00466349|Werdnig-Hoffman Disease|werdnig-hoffman disease
5709610|NCT00466349|Spinal Muscular Atrophy|spinal muscular atrophy
5709611|NCT00466349|Registry|registry
5709612|NCT00466349|SMA Type IV|sma type iv
5709613|NCT00466336|Chronic hepatitis C|chronic hepatitis c
5709614|NCT00466336|Non-invasive diagnosis|non-invasive diagnosis
5709615|NCT00466336|Duplex Doppler ultrasonography|duplex doppler ultrasonography
5709616|NCT00466336|Biochemical indices|biochemical indices
5709617|NCT00466336|Hepatic fibrosis|hepatic fibrosis
5709618|NCT00466336|Cirrhosis|cirrhosis
5709619|NCT00466323|Mental Illness|mental illness
5709620|NCT00466323|Schizophrenia|schizophrenia
5709621|NCT00466323|Education|education
5709622|NCT00466323|Family member treatment|family member treatment
5709623|NCT00466323|Active psychoses|active psychoses
5709624|NCT00466310|Schizophrenia|schizophrenia
5709625|NCT00466310|Metabolomics|metabolomics
5709626|NCT00466297|Interprofessional|interprofessional
5709627|NCT00466297|Collaboration|collaboration
5709628|NCT00466297|Teamwork|teamwork
5709629|NCT00466297|General internal medicine|general internal medicine
5709630|NCT00466297|Cluster randomized|cluster randomized
5709631|NCT00466271|Chronic hepatitis C|chronic hepatitis c
5709632|NCT00466271|Persistently normal alanine aminotransferase levels|persistently normal alanine aminotransferase levels
5709633|NCT00466271|Hepatic fibrosis|hepatic fibrosis
5709634|NCT00466271|Non-invasive diagnosis|non-invasive diagnosis
5709635|NCT00466271|Splenic arterial pulsatility index|splenic arterial pulsatility index
5709636|NCT00466258|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5709637|NCT00466258|HIV|hiv
5709638|NCT00466258|R-CHOP|r-chop
5709639|NCT00466258|Highly active antiretroviral therapy|highly active antiretroviral therapy
5709640|NCT00466258|Treatment Experienced|treatment experienced
5709641|NCT00466245|MVA Vaccine|mva vaccine
5709642|NCT00466232|Small Cell|small cell
5709643|NCT00466232|Lung Cancer|lung cancer
5709644|NCT00466232|Treatment|treatment
5709645|NCT00466219|Presence of HCV RNA in serum|presence of hcv rna in serum
5709646|NCT00466219|Absence of graft rejection|absence of graft rejection
5709647|NCT00466219|Recurrent hepatitis C after liver transplantation|recurrent hepatitis c after liver transplantation
5709648|NCT00466206|pectus excavatum|pectus excavatum
5709649|NCT00466206|magnetic alteration|magnetic alteration
5709650|NCT00466206|chest wall deformity|chest wall deformity
5709651|NCT00466193|Insomnia|insomnia
5709652|NCT00466180|Once-a-day|once-a-day
5709653|NCT00466180|Adherence|adherence
5709654|NCT00466180|Nevirapine|nevirapine
5709655|NCT00466180|Patient noncompliance|patient noncompliance
5709656|NCT00466180|Administration and dosage|administration and dosage
5709657|NCT00466180|Treatment Experienced|treatment experienced
5709658|NCT00466154|Aspirin resistance|aspirin resistance
5709659|NCT00466154|Platelet activation|platelet activation
5709660|NCT00466154|Hypercholesterolemia|hypercholesterolemia
5709661|NCT00466128|fetal membranes, preterm rupture|fetal membranes, preterm rupture
5709662|NCT00466128|preterm rupture|preterm rupture
5709664|NCT00466102|Breast Cancer|breast cancer
5733612|NCT00380575|YM087|ym087
5709665|NCT00466102|Bone metastases as only metastatic site|bone metastases as only metastatic site
5709666|NCT00466102|Breast cancer, HER2 negative|breast cancer, her2 negative
5709667|NCT00466102|Bone metastasis as only metastatic site|bone metastasis as only metastatic site
5709668|NCT00466102|Pretreated with endocrine therapy|pretreated with endocrine therapy
5709669|NCT00466102|Up to one previous chemotherapy|up to one previous chemotherapy
5709670|NCT00466102|Previous treatment with bisphosphonates allowed|previous treatment with bisphosphonates allowed
5709671|NCT00466089|NSCLC, lung cancer|nsclc, lung cancer
5709672|NCT00466089|Patients with localized-unresectable (IA-IIIB) non-small cell lung cancer non susceptible for chemotherapy treatment.|patients with localized-unresectable (ia-iiib) non-small cell lung cancer non susceptible for chemotherapy treatment.
5709673|NCT00466076|Drusen|drusen
5709674|NCT00466076|AMD|amd
5709675|NCT00466076|Dry form of Age related Macular Degeneration|dry form of age related macular degeneration
5709676|NCT00466063|Iron overload|iron overload
5709677|NCT00466063|children|children
5709678|NCT00466063|deferasirox|deferasirox
5709679|NCT00466063|Transfusion-dependent anemia|transfusion-dependent anemia
5709680|NCT00466050|plaque rupture,|plaque rupture,
5709681|NCT00466050|acute coronary thrombose,|acute coronary thrombose,
5709682|NCT00466050|coronary angiography,|coronary angiography,
5709683|NCT00466050|IVUS|ivus
5709684|NCT00466037|Rheumatoid|rheumatoid
5709685|NCT00466037|rituximab|rituximab
5709686|NCT00466037|influenza|influenza
5709687|NCT00466024|Asthma|asthma
5709688|NCT00466024|persistent|persistent
5709689|NCT00466024|children|children
5709690|NCT00466024|particulates|particulates
5709691|NCT00466024|ETS|ets
5709692|NCT00465998|Ultrasound|ultrasound
5709693|NCT00465998|Induced labor|induced labor
5709694|NCT00465998|Cervical length|cervical length
5709695|NCT00465998|Engagement of fetal head|engagement of fetal head
5709696|NCT00465998|Occiput posterior|occiput posterior
5709697|NCT00465998|Outcome of labor|outcome of labor
5709698|NCT00465985|Muckle-Wells Syndrome|muckle-wells syndrome
5709700|NCT00465985|systemic autoinflammatory disease|systemic autoinflammatory disease
5709701|NCT00465985|CIAS-1 gene|cias-1 gene
5709702|NCT00465985|NALP-3|nalp-3
5709703|NCT00465985|ACZ885|acz885
5709704|NCT00465985|human monoclonal anti-human interleukin-1beta (IL-1beta)|human monoclonal anti-human interleukin-1beta (il-1beta)
5709705|NCT00465985|antibody|antibody
5709706|NCT00465985|autosomal dominant|autosomal dominant
5709707|NCT00465985|familial autoinflammatory syndrome|familial autoinflammatory syndrome
5709708|NCT00465972|HIV|hiv
5709709|NCT00465972|Insomnia|insomnia
5709710|NCT00465972|Cytokines|cytokines
5709711|NCT00465972|Adherence|adherence
5709712|NCT00465959|COPD|copd
5709713|NCT00465946|Salt supplementation|salt supplementation
5709714|NCT00465946|Vasovagal syncope|vasovagal syncope
5709715|NCT00465946|Orthostatic tolerance|orthostatic tolerance
5709716|NCT00465946|Healthy volunteers|healthy volunteers
5709717|NCT00465933|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5709718|NCT00465933|AIDA|aida
5709719|NCT00465920|schizophrenia|schizophrenia
5709720|NCT00465920|cognitive behavioural therapy|cognitive behavioural therapy
5680583|NCT00577278|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5709721|NCT00465920|early onset psychosis|early onset psychosis
5709722|NCT00465920|Psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to DSM IV) in adolescents|psychotic disorders (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder according to dsm iv) in adolescents
5709723|NCT00465907|lung cancer with malignant pleural effusion|lung cancer with malignant pleural effusion
5709724|NCT00465894|overactive bladder|overactive bladder
5709725|NCT00465894|urge leakage|urge leakage
5709726|NCT00465894|nightime urination|nightime urination
5709727|NCT00465894|incontinence|incontinence
5709728|NCT00465894|urinary frequency|urinary frequency
5709729|NCT00465881|Diabetes|diabetes
5709730|NCT00465881|CGM|cgm
5709731|NCT00465868|Acute Myocardial Infarction|acute myocardial infarction
5709732|NCT00465868|Coronary Revascularization|coronary revascularization
5709733|NCT00465868|Microvascular Obstruction|microvascular obstruction
5709734|NCT00465868|Cardiac MR|cardiac mr
5709735|NCT00465868|Collagen Turnover|collagen turnover
5709736|NCT00465868|Heart failure, post-mi|heart failure, post-mi
5709737|NCT00465855|Carbon monoxide poisoning|carbon monoxide poisoning
5709738|NCT00465855|Hyperbaric oxygen therapy|hyperbaric oxygen therapy
5709739|NCT00465855|Randomized controlled trial|randomized controlled trial
5709740|NCT00465855|Clinical investigation|clinical investigation
5709741|NCT00465842|Hepatitis|hepatitis
5709742|NCT00465842|Liver Cirrhosis|liver cirrhosis
5709744|NCT00465829|Obesity|obesity
5709745|NCT00465816|non-inferiority|non-inferiority
5709746|NCT00465816|adolescents|adolescents
5709747|NCT00465816|meningococcal vaccine|meningococcal vaccine
5709748|NCT00465803|Open-angle glaucoma or ocular hypertension|open-angle glaucoma or ocular hypertension
5709749|NCT00465790|biomarkers|biomarkers
5709750|NCT00465790|neuroimaging|neuroimaging
5709751|NCT00465790|genetics|genetics
5709752|NCT00465790|PET|pet
5709753|NCT00465790|Genetic and Idiopathic Parkinson|genetic and idiopathic parkinson
5716970|NCT00442442|Malaria|malaria
5709754|NCT00465790|Multiple Systemic Atrophy|multiple systemic atrophy
5709756|NCT00465790|Dopa Responsive Dystonia|dopa responsive dystonia
5709757|NCT00465777|malaria|malaria
5709758|NCT00465777|mortality|mortality
5709759|NCT00465777|hospital|hospital
5709760|NCT00465777|incentive|incentive
5709761|NCT00465777|personnel|personnel
5709762|NCT00465777|paediatric|paediatric
5709763|NCT00465764|healthy infants|healthy infants
5709764|NCT00465725|Picoplatin|picoplatin
5709765|NCT00465725|tumor|tumor
5709766|NCT00465725|cancer|cancer
5709767|NCT00465725|sarcoma|sarcoma
5709768|NCT00465725|neoplasm|neoplasm
5709769|NCT00465725|advanced|advanced
5709770|NCT00465725|platinum|platinum
5709771|NCT00465725|chemotherapy|chemotherapy
5709772|NCT00465725|Solid Tumor|solid tumor
5709773|NCT00465712|transabdominal amnioinfusion|transabdominal amnioinfusion
5709774|NCT00465712|external cephalic version|external cephalic version
5709775|NCT00465712|breech presentation|breech presentation
5709776|NCT00465699|Eczema|eczema
5709777|NCT00465699|Pediatric|pediatric
5709778|NCT00465699|Vitamin B12|vitamin b12
5709779|NCT00465686|handwriting|handwriting
5709780|NCT00465686|child|child
5709781|NCT00465686|primary school|primary school
5709782|NCT00465686|posture|posture
5709783|NCT00465686|assistive device|assistive device
5709784|NCT00465673|breast cancer|breast cancer
5709785|NCT00465673|brain metastatsis|brain metastatsis
5709786|NCT00465673|Lipo-Dox|lipo-dox
5709787|NCT00465660|Osteoarthritis|osteoarthritis
5709788|NCT00465660|Cartilage|cartilage
5709789|NCT00465660|Exercise|exercise
5709790|NCT00465660|Progressive Resistance Training|progressive resistance training
5709791|NCT00465647|Postoperative pain|postoperative pain
5709792|NCT00465647|Hydromorphone oral solution|hydromorphone oral solution
5709793|NCT00465647|opioid|opioid
5709794|NCT00465647|pharmacokinetics|pharmacokinetics
5709795|NCT00465647|pharmacodynamics|pharmacodynamics
5709796|NCT00465634|Screening|screening
5709797|NCT00465634|uterine artery Doppler|uterine artery doppler
5709798|NCT00465634|HELLP syndrome|hellp syndrome
5709800|NCT00465621|Open-angle glaucoma|open-angle glaucoma
5709801|NCT00465621|ocular hypertension|ocular hypertension
5709802|NCT00465608|adults|adults
5709803|NCT00465608|PTSD|ptsd
5709804|NCT00465608|trauma|trauma
5709805|NCT00465608|AZF|azf
5709806|NCT00465608|propranolol|propranolol
5709807|NCT00465608|reconsolidation|reconsolidation
5709808|NCT00465608|Post traumatic stress disorder|post traumatic stress disorder
5709809|NCT00465608|chronic form|chronic form
5709810|NCT00465608|PTSD (Post-Traumatic Stress Disorder)|ptsd (post-traumatic stress disorder)
5709811|NCT00465582|carriage|carriage
5709812|NCT00465582|Neisseria meningitidis|neisseria meningitidis
5709813|NCT00465582|risk factors|risk factors
5709814|NCT00465569|Food Allergy|food allergy
5709815|NCT00465569|Oral Immunotherapy|oral immunotherapy
5709816|NCT00465569|Immunoglobulin E|immunoglobulin e
5709817|NCT00465543|Nasal polyposis|nasal polyposis
5709818|NCT00465543|Mint tea|mint tea
5863059|NCT00001407|Pneumonia|pneumonia
5718468|NCT00436917|osteoporosis|osteoporosis
5709819|NCT00465543|Double-blind|double-blind
5709820|NCT00465543|Placebo-controlled|placebo-controlled
5709821|NCT00465543|Crossover|crossover
5709822|NCT00465517|Partial onset seizures|partial onset seizures
5709823|NCT00465517|Complex-partial seizures|complex-partial seizures
5709824|NCT00465517|Anticonvulsant|anticonvulsant
5709825|NCT00465517|Partial seizures|partial seizures
5709826|NCT00465517|Catamenial epilepsy|catamenial epilepsy
5709827|NCT00465504|local analgesia|local analgesia
5709828|NCT00465504|intra-articular corticosteroid injection|intra-articular corticosteroid injection
5709829|NCT00465504|iontophoresis|iontophoresis
5709830|NCT00465504|Local analgesia for intra-articular corticosteroid injection|local analgesia for intra-articular corticosteroid injection
5709831|NCT00465491|refractory|refractory
5709832|NCT00465491|chemotherapy|chemotherapy
5709833|NCT00465491|progressed|progressed
5709834|NCT00465491|second-line treatment|second-line treatment
5709835|NCT00465491|small cell lung cancer|small cell lung cancer
5709836|NCT00465491|best supportive care|best supportive care
5709837|NCT00465491|picoplatin|picoplatin
5709838|NCT00465478|Diabetes Mellitus|diabetes mellitus
5709839|NCT00465478|Bone Marros Mononuclear Cells|bone marros mononuclear cells
5709840|NCT00465478|Transplantation|transplantation
5709841|NCT00465465|Tuberculosis|tuberculosis
5709842|NCT00465465|TB|tb
5709843|NCT00465465|MVA 85A|mva 85a
5709844|NCT00465465|BCG|bcg
5709845|NCT00465439|femoral artery sheath|femoral artery sheath
5709846|NCT00465439|vasovagal reaction|vasovagal reaction
5709847|NCT00465439|pain|pain
5709848|NCT00465439|perception|perception
5709849|NCT00465426|HIV Infection|hiv infection
5709850|NCT00465426|Cardiovascular Disease|cardiovascular disease
5709851|NCT00465426|Antiretroviral Therapy|antiretroviral therapy
5709852|NCT00465426|Inflammatory Markers|inflammatory markers
5709853|NCT00465426|Treatment Experienced|treatment experienced
5709854|NCT00465413|metered-dose inhalers (MDI)|metered-dose inhalers (mdi)
5702226|NCT00494195|limb girdle muscular dystrophy type 2D|limb girdle muscular dystrophy type 2d
5702227|NCT00494195|alpha-sarcoglycanopathy|alpha-sarcoglycanopathy
5702228|NCT00494195|LGMD|lgmd
5702229|NCT00494195|LGMD2D|lgmd2d
5702230|NCT00494195|gene therapy|gene therapy
5702231|NCT00494195|gene transfer|gene transfer
5709855|NCT00465413|forced expiratory volume in 1 second (FEV1)|forced expiratory volume in 1 second (fev1)
5709856|NCT00465413|forced expiratory flow rate (FEF25-75%)|forced expiratory flow rate (fef25-75%)
5709958|NCT00464958|Sublingual Tizanidine|sublingual tizanidine
5709857|NCT00465400|exudative age-related macular degeneration (AMD)|exudative age-related macular degeneration (amd)
5709858|NCT00465400|non-exudative age-related macular degeneration (AMD)|non-exudative age-related macular degeneration (amd)
5709859|NCT00465400|oxidative stress|oxidative stress
5709860|NCT00465400|photodynamic therapy|photodynamic therapy
5709861|NCT00465374|ARDS|ards
5709862|NCT00465374|Pressure/time curve|pressure/time curve
5709863|NCT00465374|Stress Index|stress index
5709864|NCT00465361|Growth and Development|growth and development
5709865|NCT00465361|Child Development|child development
5709866|NCT00465361|Developmental Surveillance|developmental surveillance
5709867|NCT00465361|Medical Education|medical education
5709868|NCT00465361|Internship and Residency|internship and residency
5709869|NCT00465348|normal tension glaucoma|normal tension glaucoma
5709870|NCT00465348|vascular dysregulation|vascular dysregulation
5709871|NCT00465335|computed tomography|computed tomography
5709872|NCT00465335|stress test|stress test
5709873|NCT00465335|equivocal|equivocal
5709874|NCT00465335|catheterization|catheterization
5709875|NCT00465309|Respiratory Insufficiency|respiratory insufficiency
5709876|NCT00465309|CO2 removal|co2 removal
5709877|NCT00465309|protective ventilation|protective ventilation
5709878|NCT00465309|ARDS|ards
5709879|NCT00466388|dry mouth|dry mouth
5709880|NCT00465283|Donepezil, ECT, Memory Disfunction|donepezil, ect, memory disfunction
5709881|NCT00465270|Cryptogenic|cryptogenic
5709882|NCT00465270|Stroke|stroke
5709884|NCT00465270|Patent foramen ovale|patent foramen ovale
5709885|NCT00465270|AMPLATZER|amplatzer
5709886|NCT00465270|Occluder|occluder
5709887|NCT00465244|Prehospital and ED seizures|prehospital and ed seizures
5709888|NCT00465231|Induction of labour|induction of labour
5709889|NCT00465231|Bupivacaine consumption|bupivacaine consumption
5709890|NCT00465231|Prevention|prevention
5709891|NCT00465218|Bioprosthesis|bioprosthesis
5709892|NCT00465218|Thrombosis|thrombosis
5709893|NCT00465218|Cerebral emboli|cerebral emboli
5709894|NCT00465218|Transcranial Doppler|transcranial doppler
5709895|NCT00465218|Platelet function tests|platelet function tests
5709896|NCT00465205|HIV infection|hiv infection
5709897|NCT00465205|HIV Shedding|hiv shedding
5709898|NCT00465205|HSV suppression|hsv suppression
5709899|NCT00465205|Co-infected|co-infected
5709901|NCT00465205|Reactivation|reactivation
5709902|NCT00465205|Valacyclovir|valacyclovir
5709903|NCT00465205|Treatment Naive|treatment naive
5709904|NCT00465179|Non-Clear Cell Renal Carcinoma|non-clear cell renal carcinoma
5709905|NCT00465179|Non-clear cell renal cell cancer|non-clear cell renal cell cancer
5709906|NCT00465179|Renal Cell Cancer|renal cell cancer
5709907|NCT00465179|Kidney Cancer|kidney cancer
5709908|NCT00465179|Papillary|papillary
5709909|NCT00465179|Chromophobe|chromophobe
5709910|NCT00465179|Collecting duct carcinoma|collecting duct carcinoma
5709911|NCT00465179|CDC|cdc
5709912|NCT00465179|Renal medullary carcinoma|renal medullary carcinoma
5709913|NCT00465179|RMC|rmc
5709914|NCT00465179|Sunitinib Malate|sunitinib malate
5709915|NCT00465179|Sutent|sutent
5709916|NCT00465179|SU011248|su011248
5709917|NCT00465166|Accidental dural puncture|accidental dural puncture
5709918|NCT00465166|Labour epidural|labour epidural
5709919|NCT00465166|Ultrasound|ultrasound
5709920|NCT00465166|Ligamentum flavum|ligamentum flavum
5709921|NCT00465153|Inflammation|inflammation
5709922|NCT00465153|cytokines|cytokines
5709923|NCT00465153|sarcopenia|sarcopenia
5709924|NCT00465153|strength|strength
5709925|NCT00465153|muscle|muscle
5709926|NCT00465153|aging|aging
5709927|NCT00465153|exercise|exercise
5709928|NCT00465114|Preeclampsia|preeclampsia
5709929|NCT00465114|Hemodynamic monitoring|hemodynamic monitoring
5709930|NCT00465101|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5709931|NCT00465101|Transurethral resection of the prostate|transurethral resection of the prostate
5709932|NCT00465101|Lower urinary tract symptoms|lower urinary tract symptoms
5709933|NCT00465101|GreenLight|greenlight
5709934|NCT00465101|Laserscope|laserscope
5709935|NCT00465101|Photoselective vaporization of the prostate|photoselective vaporization of the prostate
5709936|NCT00465101|enlarged prostate|enlarged prostate
5709937|NCT00465062|Lysosomal Disease|lysosomal disease
5709939|NCT00465062|B Lymphocytes|b lymphocytes
5709940|NCT00465062|Brain Damage|brain damage
5709941|NCT00465062|Gaucher Disease|gaucher disease
5717167|NCT00441805|Acne|acne
5709942|NCT00465062|GD|gd
5709943|NCT00465049|abscess, primary closure, secondary closure|abscess, primary closure, secondary closure
5798806|NCT00110968|Indigestion|indigestion
5709944|NCT00465036|fat absorption|fat absorption
5709945|NCT00465036|fibres|fibres
5709946|NCT00465023|proton beam irradiation|proton beam irradiation
5709947|NCT00465023|liver cancer|liver cancer
5709948|NCT00465010|Adolescence|adolescence
5709949|NCT00465010|Sexual health|sexual health
5709950|NCT00465010|Communication|communication
5709951|NCT00465010|Parenting|parenting
5709952|NCT00464997|methotrexate aspirin pharmacokinetics|methotrexate aspirin pharmacokinetics
5709953|NCT00464984|Weight loss|weight loss
5709954|NCT00464984|Physical fitness|physical fitness
5709955|NCT00464984|Quality of life|quality of life
5709956|NCT00464958|Fatigue|fatigue
5709957|NCT00464958|Spasticity|spasticity
5709959|NCT00464958|Epworth Sleepiness Scale|epworth sleepiness scale
5709960|NCT00464958|Fatigue Severity Scale|fatigue severity scale
5709961|NCT00464932|COPD|copd
5709962|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide
5709963|NCT00464932|Lung Function|lung function
5709964|NCT00464919|Advance, hepatocellular carcinoma|advance, hepatocellular carcinoma
5709965|NCT00464893|gastric cancer|gastric cancer
5709966|NCT00464893|catumaxomab|catumaxomab
5709967|NCT00464893|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5709968|NCT00464893|phase II|phase ii
5709969|NCT00464893|interoperative|interoperative
5709970|NCT00464893|trifunctional antibody|trifunctional antibody
5709971|NCT00464880|Placebo-controlled study|placebo-controlled study
5709972|NCT00464880|assess the renoprotective effect of renin inhibition|assess the renoprotective effect of renin inhibition
5709973|NCT00464880|Aliskiren as an alternative to irbesartan|aliskiren as an alternative to irbesartan
5709974|NCT00464880|Type 2 diabetes patients|type 2 diabetes patients
5709975|NCT00464880|incipient/overt diabetic nephropathy|incipient/overt diabetic nephropathy
5709976|NCT00464867|Bifidobacterium breve|bifidobacterium breve
5709977|NCT00464867|oral whole cell cholera vaccine|oral whole cell cholera vaccine
5709978|NCT00464867|immunogenicity|immunogenicity
5709979|NCT00464867|Supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine|supplementation with probiotic improves vibriocidal antibody response in 2-5 year old childern given the killed oral cholera vaccine
5709980|NCT00464867|Supplementation with probiotics results in improving the ASC responses to CT and LPS of V. cholerae O1|supplementation with probiotics results in improving the asc responses to ct and lps of v. cholerae o1
5709981|NCT00464854|Glucose control|glucose control
5709982|NCT00464854|Subcutaneous insulin treatment|subcutaneous insulin treatment
5709983|NCT00464854|Multiple daily injections|multiple daily injections
5709984|NCT00464841|Tsui Test|tsui test
5709985|NCT00464841|Combined Spinal Epidural|combined spinal epidural
5709986|NCT00464841|Labour|labour
5709987|NCT00464828|Central venous cannulation|central venous cannulation
5709988|NCT00464828|Internal jugular vein|internal jugular vein
5709989|NCT00464828|Ultrasound|ultrasound
5709990|NCT00464828|Obstetrics|obstetrics
5709991|NCT00464815|immunogenicity|immunogenicity
5709992|NCT00464815|safety|safety
5709993|NCT00464815|meningococcal vaccine|meningococcal vaccine
5709994|NCT00464802|healthy|healthy
5709995|NCT00464802|safety|safety
5709996|NCT00464789|Postmenopausal|postmenopausal
5709997|NCT00464776|Randomized|randomized
5709998|NCT00464776|double-blind|double-blind
5709999|NCT00464776|cross-over|cross-over
5710000|NCT00464776|4-period|4-period
5710001|NCT00464776|4 treatment|4 treatment
5710002|NCT00464776|within-subject placebo-controlled study|within-subject placebo-controlled study
5710245|NCT00464061|Sleep problems|sleep problems
5710003|NCT00464776|assess optimal renoprotective dose of Aliskiren|assess optimal renoprotective dose of aliskiren
5710004|NCT00464776|hypertensive type 2 diabetes patients|hypertensive type 2 diabetes patients
5710005|NCT00464776|incipient or overt nephropathy|incipient or overt nephropathy
5710006|NCT00464763|Mental Health|mental health
5710007|NCT00464763|Neurological Disease|neurological disease
5710008|NCT00464763|Heart Valve Repair Surgery|heart valve repair surgery
5710009|NCT00464750|Cardiac output|cardiac output
5710010|NCT00464750|Thermodilution|thermodilution
5710011|NCT00464737|Fibromyalgia Syndrome|fibromyalgia syndrome
5710012|NCT00464737|Rotigotine|rotigotine
5710013|NCT00464737|Neupro|neupro
5710014|NCT00464724|Prostate Cancer|prostate cancer
5710015|NCT00464724|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
5710016|NCT00464724|Perfluorocarbon Compound|perfluorocarbon compound
5710017|NCT00464724|AIR-MRSI|air-mrsi
5710018|NCT00464724|PFC-MRSI|pfc-mrsi
5710019|NCT00464724|3 Tesla|3 tesla
5710020|NCT00464724|MRSI|mrsi
5710022|NCT00464711|depression|depression
5710023|NCT00464711|biology|biology
5710024|NCT00464698|OCD|ocd
5710025|NCT00464698|Obsessive Compulsive Disorder|obsessive compulsive disorder
5710026|NCT00464698|Obsessions|obsessions
5710027|NCT00464698|Compulsions|compulsions
5710028|NCT00464698|Duloxetine|duloxetine
5710029|NCT00464698|Cymbalta|cymbalta
5702232|NCT00494195|muscular dystrophy|muscular dystrophy
5710030|NCT00464672|Influenza, Egg-Derived, Healthy Children, Healthy Adolescents, Healthy Adults, Safety, Immunogenicity, Trivalent, Inactivated, Vaccination|influenza, egg-derived, healthy children, healthy adolescents, healthy adults, safety, immunogenicity, trivalent, inactivated, vaccination
5710031|NCT00464659|Sleep apnea obstructive syndrome (SAOS)|sleep apnea obstructive syndrome (saos)
5710032|NCT00464659|memory deficit|memory deficit
5710033|NCT00464659|Continuous Positive Airway Pression (CPAP)|continuous positive airway pression (cpap)
5710034|NCT00464659|Sham CPAP|sham cpap
5710035|NCT00464646|NSABP|nsabp
5710036|NCT00464646|Epirubicin|epirubicin
5710037|NCT00464646|Cyclophosphamide|cyclophosphamide
5710038|NCT00464646|Docetaxel|docetaxel
5710039|NCT00464646|Trastuzumab|trastuzumab
5710040|NCT00464646|Bevacizumab|bevacizumab
5710041|NCT00464646|Neoadjuvant Therapy|neoadjuvant therapy
5710042|NCT00464646|HER2|her2
5710043|NCT00464646|Locally Advanced Breast Cancer|locally advanced breast cancer
5710044|NCT00464646|Adjuvant Therapy|adjuvant therapy
5710045|NCT00464646|Pathologic Stage III Breast Cancer|pathologic stage iii breast cancer
5710336|NCT00463697|GW642444,|gw642444,
5710046|NCT00464646|Inflammatory Breast Cancer|inflammatory breast cancer
5710047|NCT00464633|CLL|cll
5710048|NCT00464633|PLL|pll
5710049|NCT00464633|flavopiridol|flavopiridol
5710050|NCT00464620|Dasatinib|dasatinib
5710051|NCT00464620|Rhabdomyosarcoma|rhabdomyosarcoma
5710052|NCT00464620|Malignant peripheral nerve sheath tumor|malignant peripheral nerve sheath tumor
5710053|NCT00464620|Chondrosarcoma|chondrosarcoma
5710054|NCT00464620|Ewing's|ewing's
5710150|NCT00464243|Insomnia|insomnia
5710055|NCT00464620|Alveolar soft part sarcoma (ASPS)|alveolar soft part sarcoma (asps)
5710056|NCT00464620|Chordoma|chordoma
5710057|NCT00464620|Epithelioid sarcoma|epithelioid sarcoma
5710058|NCT00464620|Giant cell tumor of bone|giant cell tumor of bone
5710059|NCT00464620|Hemangiopericytoma/solitary fibrous tumor|hemangiopericytoma/solitary fibrous tumor
5710060|NCT00464620|Gastrointestinal Stromal Tumor (GIST)|gastrointestinal stromal tumor (gist)
5710061|NCT00464594|Japan Early Diabetes Intervention Study|japan early diabetes intervention study
5710062|NCT00464581|non-ischemic retinopathy|non-ischemic retinopathy
5710063|NCT00464568|Seasonal allergic rhinitis,|seasonal allergic rhinitis,
5710064|NCT00464568|hayfever|hayfever
5710065|NCT00464555|Allogeneic Islets|allogeneic islets
5710066|NCT00464555|Allogeneic Islet Transplantation|allogeneic islet transplantation
5710067|NCT00464555|Type 1 diabetes mellitus|type 1 diabetes mellitus
5710068|NCT00464555|Type 1 diabetes|type 1 diabetes
5710069|NCT00464555|T1D|t1d
5710070|NCT00464555|T1DM|t1dm
5710071|NCT00464555|Insulin dependence|insulin dependence
5710072|NCT00464555|Hypoglycemia unawareness in T1D|hypoglycemia unawareness in t1d
5710073|NCT00464555|Islet transplant|islet transplant
5710074|NCT00464555|Islet transplantation|islet transplantation
5710075|NCT00464555|Islet graft|islet graft
5710076|NCT00464542|herpes simplex virus|herpes simplex virus
5710077|NCT00464529|blood glucose|blood glucose
5710078|NCT00464529|hyperglycemia|hyperglycemia
5710079|NCT00464529|hypoglycemia|hypoglycemia
5710080|NCT00464529|Perioperative care|perioperative care
5710081|NCT00464529|inpatient|inpatient
5710082|NCT00464516|Breast cancer (Estrogen Receptor positive)|breast cancer (estrogen receptor positive)
5710083|NCT00464503|statins|statins
5710084|NCT00464503|proteinuria|proteinuria
5710085|NCT00464503|proteomic analysis|proteomic analysis
5710086|NCT00464503|healthy volunteers|healthy volunteers
5710087|NCT00464490|Weaning|weaning
5710088|NCT00464490|Extuvation|extuvation
5710089|NCT00464490|Dexmedetomidine|dexmedetomidine
5710090|NCT00464477|Autism|autism
5710091|NCT00464477|Autistic disorder|autistic disorder
5710092|NCT00464477|Pervasive developmental disorder|pervasive developmental disorder
5710093|NCT00464477|Asperger syndrome|asperger syndrome
5710094|NCT00464477|Childhood disintegrative disorder|childhood disintegrative disorder
5710095|NCT00464477|Rett syndrome|rett syndrome
5710096|NCT00464464|Parkinson's disease|parkinson's disease
5710097|NCT00464464|PD|pd
5710098|NCT00464464|depression|depression
5710099|NCT00464464|cognitive-behavioral therapy|cognitive-behavioral therapy
5710100|NCT00464464|social support|social support
5710101|NCT00464425|Electroacupuncture|electroacupuncture
5710102|NCT00464425|Postoperative ileus|postoperative ileus
5710103|NCT00464425|Colorectal surgery|colorectal surgery
5710104|NCT00464425|Laparoscopic surgery|laparoscopic surgery
5710105|NCT00464425|Randomised trial|randomised trial
5710106|NCT00464412|Osteoporosis|osteoporosis
5710107|NCT00464412|Knowledge|knowledge
5710108|NCT00464412|Beliefs|beliefs
5710109|NCT00464412|Education|education
5710110|NCT00464412|Women|women
5710111|NCT00464399|De novo renal transplantation|de novo renal transplantation
5710112|NCT00464399|CNI-free protocol|cni-free protocol
5710113|NCT00464399|adults|adults
5710114|NCT00464399|everolimus|everolimus
5710115|NCT00464399|rejections|rejections
5710116|NCT00464386|Severe burns|severe burns
5710117|NCT00464386|Severe Trauma|severe trauma
5710118|NCT00464386|Closed loop insulin|closed loop insulin
5710119|NCT00464386|continuous glucose monitoring|continuous glucose monitoring
5710120|NCT00464373|Prostatitis|prostatitis
5710121|NCT00464373|Chronic Prostatitis with Chronic Pelvic Pain Syndrome|chronic prostatitis with chronic pelvic pain syndrome
5710122|NCT00464373|Botulinum Toxin Type A|botulinum toxin type a
5710246|NCT00464061|Insomnia|insomnia
5710124|NCT00464373|Injections, intramuscular|injections, intramuscular
5710126|NCT00464347|wet AMD|wet amd
5710127|NCT00464347|verteporfin PDT|verteporfin pdt
5710128|NCT00464347|Avastin|avastin
5710130|NCT00464308|Gastroesophageal Reflux|gastroesophageal reflux
5710131|NCT00464308|Heartburn|heartburn
5710132|NCT00464308|Proton pump inhibitor|proton pump inhibitor
5710133|NCT00464308|GORD|gord
5710134|NCT00464295|Hepatocellular Carcinoma|hepatocellular carcinoma
5710135|NCT00464295|Phase 2 Trial|phase 2 trial
5710136|NCT00464295|Capecitabine|capecitabine
5710137|NCT00464295|Treatment Efficacy|treatment efficacy
5710138|NCT00464282|Fluorine–18-α–methyltyrosine,|fluorine–18-α–methyltyrosine,
5710139|NCT00464282|Positron emission tomography,|positron emission tomography,
5710140|NCT00464282|Fluorodeoxyglucose|fluorodeoxyglucose
5710141|NCT00464282|Lung cancer,|lung cancer,
5710142|NCT00464282|Amino acid transportor 1,|amino acid transportor 1,
5710143|NCT00464282|Ki-67|ki-67
5710144|NCT00464282|Proven or suspected non-small cell lung cancer were enrolled in the study|proven or suspected non-small cell lung cancer were enrolled in the study
5710145|NCT00464269|Epilepsy|epilepsy
5710146|NCT00464269|Brivaracetam|brivaracetam
5710147|NCT00464269|Partial Onset Seizures, Adolescents & Adults|partial onset seizures, adolescents & adults
5710148|NCT00464256|abstinence|abstinence
5710149|NCT00464243|Sleep problems|sleep problems
5710151|NCT00464243|Sleeplessness|sleeplessness
5710152|NCT00464243|Polysomnographic|polysomnographic
5710153|NCT00464230|Displaced Femoral Neck Fractures|displaced femoral neck fractures
5710154|NCT00464230|Treatment|treatment
5710155|NCT00464230|Function|function
5710156|NCT00464230|Pain|pain
5710157|NCT00464230|Quality of life|quality of life
5710158|NCT00464230|Complications|complications
5710159|NCT00464230|Reoperations|reoperations
5710160|NCT00464230|Internal Fixation|internal fixation
5710161|NCT00464230|Hemiarthroplasty|hemiarthroplasty
5710162|NCT00464230|Activities of Daily Living|activities of daily living
5710163|NCT00464217|Acute Myeloblastic Leukaemia|acute myeloblastic leukaemia
5710164|NCT00464191|bipolar depression|bipolar depression
5710165|NCT00464191|SSRI|ssri
5710166|NCT00464191|escitalopram|escitalopram
5710167|NCT00464191|bipolar disorder|bipolar disorder
5710168|NCT00464191|antidepressant|antidepressant
5710169|NCT00464191|treatment trial|treatment trial
5710170|NCT00464191|RCT|rct
5710171|NCT00464178|multiple myeloma|multiple myeloma
5710172|NCT00464178|myeloma|myeloma
5710173|NCT00464178|relapsed myeloma|relapsed myeloma
5710174|NCT00464178|refractory myeloma|refractory myeloma
5710175|NCT00464178|relapsed, refractory myeloma|relapsed, refractory myeloma
5710176|NCT00464178|relapsed, refractory multiple myeloma|relapsed, refractory multiple myeloma
5710177|NCT00464178|refractory multiple myeloma|refractory multiple myeloma
5710178|NCT00464178|relapsed multiple myeloma|relapsed multiple myeloma
5710179|NCT00464178|B lymphoid malignancies|b lymphoid malignancies
5710180|NCT00464178|Myeloma, Plasma-Cell|myeloma, plasma-cell
5710181|NCT00464178|Myeloma Proteins|myeloma proteins
5710182|NCT00464178|hnRNP A1|hnrnp a1
5710183|NCT00464178|myeloma helix-destabilizing protein, mouse|myeloma helix-destabilizing protein, mouse
5710184|NCT00464178|IgC3kappa Jir protein, human|igc3kappa jir protein, human
5710185|NCT00464178|gamma 3 myeloma protein Jir, human|gamma 3 myeloma protein jir, human
5710186|NCT00464178|M-proteins (Myeloma)|m-proteins (myeloma)
5710187|NCT00464178|M315 myeloma protein, mouse|m315 myeloma protein, mouse
5710188|NCT00464178|myeloma protein M 315, mouse|myeloma protein m 315, mouse
5710189|NCT00464178|McPC603 antibody|mcpc603 antibody
5710190|NCT00464178|myeloma protein McPC603 antibody|myeloma protein mcpc603 antibody
5710191|NCT00464178|multiple myeloma M-proteins|multiple myeloma m-proteins
5710192|NCT00464178|M protein, multiple myeloma|m protein, multiple myeloma
5710193|NCT00464178|myeloma cell activator|myeloma cell activator
5710194|NCT00464178|myeloma immunoglobulins|myeloma immunoglobulins
5710195|NCT00464178|myeloma immunoglobulin M603|myeloma immunoglobulin m603
5710196|NCT00464178|myeloma immunoglobulin S15|myeloma immunoglobulin s15
5710197|NCT00464178|myeloma protein A48, mouse|myeloma protein a48, mouse
5710198|NCT00464178|A48 myeloma protein, mouse|a48 myeloma protein, mouse
5710199|NCT00464178|ABPC48 myeloma protein, mouse|abpc48 myeloma protein, mouse
5710200|NCT00464178|myeloma protein A 48, mouse|myeloma protein a 48, mouse
5710201|NCT00464178|myeloma protein Dob|myeloma protein dob
5710202|NCT00464178|myeloma protein M 467|myeloma protein m 467
5710203|NCT00464178|myeloma protein M467|myeloma protein m467
5710204|NCT00464178|myeloma protein MOPC 141, mouse|myeloma protein mopc 141, mouse
5710205|NCT00464178|MOPC141 myeloma protein, mouse|mopc141 myeloma protein, mouse
5710206|NCT00464178|myeloma protein MOPC 173|myeloma protein mopc 173
5710207|NCT00464178|myeloma protein Rou|myeloma protein rou
5710208|NCT00464178|IgA2 myeloma protein Rou|iga2 myeloma protein rou
5710209|NCT00464178|myeloma protein TEPC15|myeloma protein tepc15
5710210|NCT00464178|myeloma protein T15|myeloma protein t15
5710211|NCT00464178|myeloma protein TEPC 15|myeloma protein tepc 15
5710212|NCT00464178|myeloma protein W3129|myeloma protein w3129
5708864|NCT00469352|AMD|amd
5710215|NCT00464178|myeloma antigen KMA|myeloma antigen kma
5710216|NCT00464178|MYEOV protein, human|myeov protein, human
5710217|NCT00464178|protein 460|protein 460
5710218|NCT00464178|myeloma protein MOPC 460|myeloma protein mopc 460
5710219|NCT00464178|TRAPPC1 protein, human|trappc1 protein, human
5710220|NCT00464178|multiple myeloma protein 2, human|multiple myeloma protein 2, human
5710221|NCT00464178|Wis heavy-chain disease protein, human|wis heavy-chain disease protein, human
5710222|NCT00464178|myeloma protein Wis, human|myeloma protein wis, human
5710223|NCT00464165|abstinence|abstinence
5710224|NCT00464139|endometriosis|endometriosis
5710225|NCT00464139|prevalence|prevalence
5710226|NCT00464139|fertility|fertility
5710228|NCT00464139|ultrasound|ultrasound
5710229|NCT00464126|crystalloid|crystalloid
5710230|NCT00464126|colloid|colloid
5710231|NCT00464126|pediatric|pediatric
5710232|NCT00464126|cardiac|cardiac
5710233|NCT00464126|resuscitation|resuscitation
5710234|NCT00464126|Postoperative|postoperative
5710235|NCT00464113|Myeloid Leukemia|myeloid leukemia
5710236|NCT00464113|Lymphocytic Leukemia|lymphocytic leukemia
5710237|NCT00464113|Ph+ ALL|ph+ all
5710238|NCT00464100|Neurodevelopmental outcomes|neurodevelopmental outcomes
5710239|NCT00464100|congenital heart disease|congenital heart disease
5710240|NCT00464100|NIRS monitoring|nirs monitoring
5710241|NCT00464100|hypoxia|hypoxia
5710242|NCT00464074|fatigue|fatigue
5710243|NCT00464074|Tysabri|tysabri
5710244|NCT00464074|cognition|cognition
5710247|NCT00464061|Sleeplessness|sleeplessness
5710248|NCT00464061|Primary insomnia|primary insomnia
5710249|NCT00464061|Insomnia disorder|insomnia disorder
5710250|NCT00464035|Obesity|obesity
5710251|NCT00464035|Calcium|calcium
5710252|NCT00464035|Fat absorption|fat absorption
5710253|NCT00464035|Postprandial lipid profile|postprandial lipid profile
5710254|NCT00464035|appetite|appetite
5710255|NCT00464022|pain, endoscopy|pain, endoscopy
5710256|NCT00464022|Pain, endoscopy, randomised trial|pain, endoscopy, randomised trial
5710257|NCT00464009|Early childhood caries - ECC|early childhood caries - ecc
5710258|NCT00464009|Prevention|prevention
5710259|NCT00464009|Continuing medical education|continuing medical education
5710260|NCT00464009|Randomized controlled trial|randomized controlled trial
5710261|NCT00463996|Ovarian cancer|ovarian cancer
5710263|NCT00463996|Contrast agent|contrast agent
5710264|NCT00463970|Chronic low back pain|chronic low back pain
5710265|NCT00463970|Brief cognitive intervention|brief cognitive intervention
5710266|NCT00463970|Cognitive behavior therapy|cognitive behavior therapy
5710267|NCT00463970|Seal oil|seal oil
5710268|NCT00463957|sildenafil|sildenafil
5710269|NCT00463957|tadalafil|tadalafil
5710270|NCT00463957|phosphodiesterase|phosphodiesterase
5710271|NCT00463957|visual persistence|visual persistence
5710272|NCT00463957|reaction time|reaction time
5710273|NCT00463944|Electronic voting system|electronic voting system
5710274|NCT00463931|Schistosomiasis|schistosomiasis
5704865|NCT00483834|Avastin|avastin
5710276|NCT00463931|Community-based volunteer|community-based volunteer
5710277|NCT00463931|School based treatment approach|school based treatment approach
5710278|NCT00463905|osteoporosis|osteoporosis
5710279|NCT00463905|vertebral fractures|vertebral fractures
5710280|NCT00463905|randomised controlled trial|randomised controlled trial
5710281|NCT00463905|screening|screening
5710282|NCT00463892|melanoma|melanoma
5710283|NCT00463892|lymph nodes|lymph nodes
5710284|NCT00463892|magnetic resonance imaging|magnetic resonance imaging
5710285|NCT00463892|screening|screening
5710286|NCT00463892|detection|detection
5710287|NCT00463879|Schizophrenia|schizophrenia
5710288|NCT00463879|Cognition|cognition
5710289|NCT00463879|Smoking|smoking
5710290|NCT00463879|Galantamine|galantamine
5710291|NCT00463879|Nicotine|nicotine
5710292|NCT00463879|Cognitive Deficits|cognitive deficits
5710293|NCT00463866|Asthma|asthma
5710294|NCT00463853|Bone Marrow Cells|bone marrow cells
5710295|NCT00463853|Cardiovascular Surgery|cardiovascular surgery
5735460|NCT00374920|bipolar|bipolar
5718951|NCT00435175|UCP2|ucp2
5710296|NCT00463853|Coronary Artery Bypass Graft|coronary artery bypass graft
5710297|NCT00463853|Phase I Study|phase i study
5710298|NCT00463853|Stem Cells|stem cells
5710299|NCT00463840|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5710300|NCT00463840|oxaliplatin|oxaliplatin
5710301|NCT00463840|chemoradiation|chemoradiation
5710302|NCT00463840|5FU|5fu
5710303|NCT00463827|asthma|asthma
5710304|NCT00463827|smokers|smokers
5710305|NCT00463827|statin|statin
5710306|NCT00463827|atorvastatin|atorvastatin
5710307|NCT00463827|randomised|randomised
5710308|NCT00463827|placebo|placebo
5710309|NCT00463827|cigarette|cigarette
5710310|NCT00463827|blind|blind
5710311|NCT00463827|COPD|copd
5710312|NCT00463814|Advanced Malignancy|advanced malignancy
5710313|NCT00463814|Cancer Eligibility|cancer eligibility
5710314|NCT00463814|Malignancy|malignancy
5699855|NCT00501644|GM-CSF|gm-csf
5710315|NCT00463801|Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis|complicated skin and skin-structure infections, daptomycin, mrsa, diabetic foot, abscess, cellulitis
5702233|NCT00494195|SGCA|sgca
5702234|NCT00494195|sarcoglycan|sarcoglycan
5702235|NCT00494195|limb girdle|limb girdle
5685824|NCT00554697|perioperative|perioperative
5685825|NCT00554697|outcome|outcome
5685826|NCT00554684|Outcome|outcome
5685827|NCT00554684|Elderly|elderly
5685829|NCT00554684|Quality of Life|quality of life
5685830|NCT00554671|Diabetes Mellitus|diabetes mellitus
5685831|NCT00554671|Clinical pharmacists|clinical pharmacists
5680653|NCT00577161|NHL|nhl
5710316|NCT00463801|Complicated skin and skin-structure infections|complicated skin and skin-structure infections
5710318|NCT00463788|breast|breast
5710319|NCT00463788|metastatic|metastatic
5710320|NCT00463788|triple negative|triple negative
5710321|NCT00463775|Treatment|treatment
5710322|NCT00463775|Topiramate|topiramate
5710323|NCT00463775|Alcohol Dependence|alcohol dependence
5710324|NCT00463775|Borderline Personality Disorder|borderline personality disorder
5710325|NCT00463749|primary PCI|primary pci
5710326|NCT00463749|nephropathy|nephropathy
5710327|NCT00463749|infarct size|infarct size
5710328|NCT00463749|infarction|infarction
5710329|NCT00463749|ST-elevation myocardial infarction|st-elevation myocardial infarction
5710330|NCT00463736|short term tocolysis|short term tocolysis
5710331|NCT00463736|preterm premature rupture of membranes|preterm premature rupture of membranes
5710332|NCT00463723|penetrating keratoplasty|penetrating keratoplasty
5710333|NCT00463723|graft rejection|graft rejection
5710334|NCT00463723|immunosuppression|immunosuppression
5710335|NCT00463710|MTI, DWI, Avonex, MRI|mti, dwi, avonex, mri
5710337|NCT00463697|magnesium stearate,|magnesium stearate,
5710338|NCT00463697|asthmatic patients|asthmatic patients
5710339|NCT00463658|Falls|falls
5710340|NCT00463658|Home Care|home care
5710341|NCT00463658|Aging Population|aging population
5710342|NCT00463658|Clinical Effectiveness|clinical effectiveness
5710343|NCT00463658|Health Economics|health economics
5710344|NCT00463632|schistosomiasis|schistosomiasis
5710345|NCT00463632|anaemia|anaemia
5710346|NCT00463632|pregnancy|pregnancy
5710347|NCT00463593|schistosomiasis|schistosomiasis
5710348|NCT00463593|helminthes|helminthes
5710349|NCT00463593|anaemia|anaemia
5710350|NCT00463580|depression|depression
5710351|NCT00463580|TNF-alpha antagonist|tnf-alpha antagonist
5710352|NCT00463580|infliximab|infliximab
5710353|NCT00463580|treatment resistant depression|treatment resistant depression
5710354|NCT00463580|major depressive disorder (MDD)|major depressive disorder (mdd)
5710355|NCT00463580|bipolar I disorder|bipolar i disorder
5710356|NCT00463580|bipolar II disorder|bipolar ii disorder
5710357|NCT00463567|indacaterol|indacaterol
5710358|NCT00463567|long acting beta-2 agonist|long acting beta-2 agonist
5710359|NCT00463554|Incontinence|incontinence
5710360|NCT00463554|Stress Urinary|stress urinary
5710361|NCT00463541|Urinary Bladder, Overactive|urinary bladder, overactive
5710362|NCT00463541|Urgency|urgency
5710363|NCT00463541|VESIcare®|vesicare®
5710364|NCT00463541|Solifenacin succinate|solifenacin succinate
5710365|NCT00463528|schistosomiasis|schistosomiasis
5710366|NCT00463528|gender perspectives|gender perspectives
5710367|NCT00463515|Non-Small Cell Lung Cancer|non-small cell lung cancer
5710368|NCT00463515|NSCLC|nsclc
5710369|NCT00463515|Chemoradiation|chemoradiation
5710370|NCT00463515|lung cancer|lung cancer
5710371|NCT00463515|induction chemotherapy|induction chemotherapy
5710372|NCT00463515|chemo-radiotherapy|chemo-radiotherapy
5704937|NCT00483769|Cystis Fibrosis|cystis fibrosis
5710373|NCT00463502|The purpose of study was investigated the effect of|the purpose of study was investigated the effect of
5710374|NCT00463502|metformin on thyroid hormone metabolism in euthyroid patients|metformin on thyroid hormone metabolism in euthyroid patients
5710375|NCT00463502|with type 2 DM. The results revealed significant decreases|with type 2 dm. the results revealed significant decreases
5710376|NCT00463502|in TSH and fT4|in tsh and ft4
5710377|NCT00463489|lifestyle intervention|lifestyle intervention
5710378|NCT00463489|breast|breast
5710379|NCT00463489|cancer|cancer
5710380|NCT00463489|adjuvant|adjuvant
5710381|NCT00463489|letrozole|letrozole
5710382|NCT00463489|weight loss|weight loss
5710384|NCT00463489|post-menopausal|post-menopausal
5710385|NCT00463489|estrogen receptor positive|estrogen receptor positive
5710386|NCT00463489|progesterone receptor positive|progesterone receptor positive
5710387|NCT00463450|Hormone Replacement Therapy|hormone replacement therapy
5710388|NCT00463450|Impaired well-being, mood and sexuality|impaired well-being, mood and sexuality
5710389|NCT00463437|Fever.|fever.
5710390|NCT00463437|Meningococcal disease.|meningococcal disease.
5710391|NCT00463437|Pneumococcal disease.|pneumococcal disease.
5710392|NCT00463437|Meningococcal vaccine.|meningococcal vaccine.
5710393|NCT00463437|Pneumococcal vaccine.|pneumococcal vaccine.
5710394|NCT00463437|Immunogenicity.|immunogenicity.
5710395|NCT00463437|Booster vaccination.|booster vaccination.
5710396|NCT00463437|Safety.|safety.
5710397|NCT00463424|Metacarpophalangeal Joint|metacarpophalangeal joint
5710398|NCT00463424|Arthroplasty, Replacement|arthroplasty, replacement
5710399|NCT00463424|Range of Motion, Articular|range of motion, articular
5710400|NCT00463424|Randomized Controlled Trials|randomized controlled trials
5710401|NCT00463424|Swanson|swanson
5710402|NCT00463424|NeuFlex|neuflex
5710403|NCT00463411|osteoporosis|osteoporosis
5710404|NCT00463411|male|male
5710405|NCT00463411|fracture risk|fracture risk
5710406|NCT00463411|genetical epidemiology|genetical epidemiology
5710407|NCT00463398|Endometriosis|endometriosis
5710408|NCT00463398|Fertility Surgery|fertility surgery
5710409|NCT00463398|Quality of Life|quality of life
5710410|NCT00463398|Pain|pain
5710411|NCT00463398|Sexual Function|sexual function
5710412|NCT00463398|Health economics|health economics
5710413|NCT00463398|Recurrence|recurrence
5710414|NCT00463398|Pregnancy|pregnancy
5710415|NCT00463385|Celgene|celgene
5710416|NCT00463385|CC-4047|cc-4047
5710417|NCT00463385|Myelofibrosis|myelofibrosis
5710418|NCT00463385|myelofibrosis with myeloid metaplasia|myelofibrosis with myeloid metaplasia
5710419|NCT00463385|myeloid metaplasia|myeloid metaplasia
5710420|NCT00463385|JAK2|jak2
5710421|NCT00463385|CC-4047-MMM-001|cc-4047-mmm-001
5710422|NCT00463385|Prednisone|prednisone
5710423|NCT00463385|Phase II|phase ii
5710424|NCT00463385|pomalidomide|pomalidomide
5710425|NCT00463385|bone marrow histology|bone marrow histology
5710426|NCT00463385|imids|imids
5710428|NCT00463385|Ashkenazi Jewish Population|ashkenazi jewish population
5710429|NCT00463385|exposure to Thorotrast|exposure to thorotrast
5710430|NCT00463385|exposure to solvents (benzene and toluene)|exposure to solvents (benzene and toluene)
5710431|NCT00463385|acute megakaryocytic leukemia|acute megakaryocytic leukemia
5710432|NCT00463385|history of polycythemia vera|history of polycythemia vera
5710433|NCT00463359|basal cell carcinoma|basal cell carcinoma
5710434|NCT00463359|curettage|curettage
5710435|NCT00463359|Imiquimod|imiquimod
5710438|NCT00463346|Alcohol Dependence|alcohol dependence
5710439|NCT00463346|Schizophrenia|schizophrenia
5710440|NCT00463333|postoperative delirium|postoperative delirium
5710441|NCT00463333|psychometric testing|psychometric testing
5710443|NCT00463333|serum markers|serum markers
5710444|NCT00463320|Age-related macular degeneration (AMD),|age-related macular degeneration (amd),
5710445|NCT00463320|vascular endothelial growth factor (VEGF)receptor (VEGFR)|vascular endothelial growth factor (vegf)receptor (vegfr)
5710446|NCT00463320|choroidal neovascularization,|choroidal neovascularization,
5710447|NCT00463307|schistosomiasis|schistosomiasis
5710448|NCT00463307|Schistosoma mansoni|schistosoma mansoni
5710449|NCT00463307|Circulating cathodic antigen urine dipstick|circulating cathodic antigen urine dipstick
5710450|NCT00463294|CABG|cabg
5710451|NCT00463294|On-pump|on-pump
5710452|NCT00463294|Off-pump|off-pump
5710453|NCT00463281|stroke, ischemic|stroke, ischemic
5710454|NCT00463281|computed tomography|computed tomography
5710455|NCT00463281|thrombolysis|thrombolysis
5710456|NCT00463268|osteopenia|osteopenia
5710457|NCT00463268|osteoporosis prevention|osteoporosis prevention
5710458|NCT00463268|alendronate|alendronate
5710459|NCT00463255|Diet|diet
5710460|NCT00463255|elderly|elderly
5710461|NCT00463255|age-related diseases|age-related diseases
5710462|NCT00463255|prevention|prevention
5710463|NCT00463255|cognitive decline|cognitive decline
5710464|NCT00463255|Clinical study|clinical study
5710465|NCT00463242|agomelatine, Major Depressive Disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5710466|NCT00463229|stroke|stroke
5710467|NCT00463229|rehabilitation|rehabilitation
5710468|NCT00463229|home care services|home care services
5710469|NCT00463229|effectiveness|effectiveness
5710470|NCT00463229|quantitative research|quantitative research
5705023|NCT00483392|hiv|hiv
5710472|NCT00463229|cost|cost
5710473|NCT00463229|health services research, integrated|health services research, integrated
5710474|NCT00463216|back, neck, pain, sick leave|back, neck, pain, sick leave
5710475|NCT00463203|primary malignant brain tumor|primary malignant brain tumor
5710476|NCT00463203|grade II glioma|grade ii glioma
5710477|NCT00463203|meningeoma|meningeoma
5710478|NCT00463203|ependymoma|ependymoma
5710479|NCT00463203|Recurrence or progression after standard treatment|recurrence or progression after standard treatment
5710480|NCT00463190|Probiotics|probiotics
5710481|NCT00463190|Diarrhea|diarrhea
5710482|NCT00463190|Enterocolitis|enterocolitis
5710483|NCT00463177|Pain|pain
5710484|NCT00463177|Chronic pain|chronic pain
5710485|NCT00463177|Pain disorder|pain disorder
5710486|NCT00463177|Functional MRI|functional mri
5710487|NCT00463177|Sensitization|sensitization
5710488|NCT00463164|functional MRI|functional mri
5710489|NCT00463151|Rebamipide|rebamipide
5710490|NCT00463151|Enema|enema
5710491|NCT00463151|Ulcerative Colitis|ulcerative colitis
5710492|NCT00463138|perceived increase or decrease in symptoms post treatment|perceived increase or decrease in symptoms post treatment
5710493|NCT00463138|Satisfaction with the treatment|satisfaction with the treatment
5710494|NCT00463125|Scleroderma, systemic|scleroderma, systemic
5710495|NCT00463125|therapeutic|therapeutic
5710496|NCT00463125|platelet gel|platelet gel
5710497|NCT00463112|Obesity|obesity
5710498|NCT00463112|Polycystic Ovary Syndrome|polycystic ovary syndrome
5710499|NCT00463112|weight loss|weight loss
5710500|NCT00463112|Hyperadrogonemia|hyperadrogonemia
5710501|NCT00463112|Sibutramine|sibutramine
5710502|NCT00463099|Anterior Cruciate Ligament/injuries|anterior cruciate ligament/injuries
5710503|NCT00463099|Anterior Cruciate Ligament/surgery|anterior cruciate ligament/surgery
5710504|NCT00463099|Knee injuries/surgery|knee injuries/surgery
5710505|NCT00463099|Outcomes research|outcomes research
5710506|NCT00463099|Prospective Studies|prospective studies
5710507|NCT00463086|Tuberculosis|tuberculosis
5710508|NCT00463086|TB|tb
5710509|NCT00463086|Mycobacteria|mycobacteria
5710510|NCT00463086|HIV|hiv
5710511|NCT00463086|Human immunodeficiency virus|human immunodeficiency virus
5710512|NCT00463086|Latent tuberculosis infection|latent tuberculosis infection
5710513|NCT00463086|HAART|haart
5710514|NCT00463086|Highly active anti-retroviral therapy|highly active anti-retroviral therapy
5710515|NCT00463086|Isoniazid preventive therapy|isoniazid preventive therapy
5710516|NCT00463086|INH|inh
5710517|NCT00463086|Opportunistic infections|opportunistic infections
5710518|NCT00463086|HIV-1|hiv-1
5710519|NCT00463086|Treatment Experienced|treatment experienced
5710520|NCT00463086|AIDS|aids
5710521|NCT00463086|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5710522|NCT00463073|Progressive primary Glioblastoma multiforme|progressive primary glioblastoma multiforme
5710523|NCT00463060|erlotinib|erlotinib
5710524|NCT00463060|celecoxib|celecoxib
5710525|NCT00463060|radiation|radiation
5710526|NCT00463060|progression-free survival|progression-free survival
5710527|NCT00463047|Breakthrough pain|breakthrough pain
5710528|NCT00463047|Opioid-tolerant|opioid-tolerant
5710529|NCT00463047|Chronic pain|chronic pain
5710530|NCT00463034|stage IV breast cancer|stage iv breast cancer
5710531|NCT00463034|stage I breast cancer|stage i breast cancer
5710532|NCT00463034|stage II breast cancer|stage ii breast cancer
5710533|NCT00463034|stage IIIA breast cancer|stage iiia breast cancer
5710534|NCT00463034|stage IIIB breast cancer|stage iiib breast cancer
5710535|NCT00463034|stage IIIC breast cancer|stage iiic breast cancer
5710536|NCT00463021|Hectorol (doxercalciferol capsules)|hectorol (doxercalciferol capsules)
5710537|NCT00463021|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
5710538|NCT00463008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5710539|NCT00463008|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5710540|NCT00463008|adult glioblastoma|adult glioblastoma
5710541|NCT00463008|recurrent adult brain tumor|recurrent adult brain tumor
5710542|NCT00463008|adult gliosarcoma|adult gliosarcoma
5710543|NCT00463008|adult giant cell glioblastoma|adult giant cell glioblastoma
5710544|NCT00462995|Non Small Cell Lung Cancer|non small cell lung cancer
5710545|NCT00462995|Lung Cancer|lung cancer
5710546|NCT00462995|Erlotinib|erlotinib
5710547|NCT00462995|Neoadjuvant Treatment|neoadjuvant treatment
5710548|NCT00462982|stage IV melanoma|stage iv melanoma
5710549|NCT00462982|tumors metastatic to brain|tumors metastatic to brain
5710550|NCT00462982|stage IV renal cell cancer|stage iv renal cell cancer
5710551|NCT00462982|recurrent melanoma|recurrent melanoma
5710552|NCT00462982|recurrent renal cell cancer|recurrent renal cell cancer
5710553|NCT00462969|Endometrial cancer|endometrial cancer
5710554|NCT00462969|Sonohysterography|sonohysterography
5710555|NCT00462956|lapatinib|lapatinib
5710556|NCT00462956|metastatic breast cancer|metastatic breast cancer
5710557|NCT00462956|trastuzumab (Herceptin)|trastuzumab (herceptin)
5710558|NCT00462956|Stage IV breast cancer|stage iv breast cancer
5710559|NCT00462956|ErbB2|erbb2
5710560|NCT00462956|ErbB1|erbb1
5710561|NCT00462943|CML|cml
5710562|NCT00462943|HHT|hht
5710563|NCT00462943|Homoharringtonine|homoharringtonine
5710565|NCT00462917|disease /disorder proneness /risk|disease /disorder proneness /risk
5710567|NCT00462917|genetic counseling|genetic counseling
5710568|NCT00462917|genetic marker|genetic marker
5710569|NCT00462917|genetic polymorphism|genetic polymorphism
5710570|NCT00462917|genetic screening|genetic screening
5710571|NCT00462917|genetic susceptibility|genetic susceptibility
5710572|NCT00462891|breast cancer|breast cancer
5710573|NCT00462878|Febrile neutropenia|febrile neutropenia
5710574|NCT00462865|breast cancer|breast cancer
5710575|NCT00462865|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5710576|NCT00462865|adjuvant treatment|adjuvant treatment
5710577|NCT00462865|consolidation therapy|consolidation therapy
5710578|NCT00462865|anti-angiogenesis therapy|anti-angiogenesis therapy
5710579|NCT00462852|thromboembolism|thromboembolism
5710580|NCT00462852|stage III pancreatic cancer|stage iii pancreatic cancer
5710581|NCT00462852|stage IV pancreatic cancer|stage iv pancreatic cancer
5710582|NCT00462852|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5710583|NCT00462852|recurrent pancreatic cancer|recurrent pancreatic cancer
5710584|NCT00462852|stage II pancreatic cancer|stage ii pancreatic cancer
5710585|NCT00462839|Estimated Blood Loss|estimated blood loss
5710586|NCT00462839|Obstetrics|obstetrics
5710587|NCT00462839|postpartum hemorrhage|postpartum hemorrhage
5710588|NCT00462813|cervical cancer|cervical cancer
5710589|NCT00462813|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5710590|NCT00462813|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5710591|NCT00462813|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5710592|NCT00462787|acute undifferentiated leukemia|acute undifferentiated leukemia
5710593|NCT00462787|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5710594|NCT00462787|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5710595|NCT00462787|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5710596|NCT00462787|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5710597|NCT00462774|Myocardial infarction|myocardial infarction
5710599|NCT00462774|Cell therapy|cell therapy
5710600|NCT00462774|Bone marrow|bone marrow
5710601|NCT00462774|CD133|cd133
5710602|NCT00462774|Bypass surgery|bypass surgery
5710603|NCT00462774|Stem cells|stem cells
5710604|NCT00462761|RTK|rtk
5710605|NCT00462761|kinase|kinase
5710606|NCT00462761|inhibitor|inhibitor
5710607|NCT00462761|tyrosine|tyrosine
5710608|NCT00462761|acute|acute
5710609|NCT00462761|FLT3|flt3
5710610|NCT00462761|AC220|ac220
5710611|NCT00462761|pharmacokinetic|pharmacokinetic
5710612|NCT00462761|pharmacokinetics|pharmacokinetics
5710613|NCT00462761|PK|pk
5710614|NCT00462761|pharmacodynamic|pharmacodynamic
5710615|NCT00462761|pharmacodynamics|pharmacodynamics
5710616|NCT00462761|mutations|mutations
5710617|NCT00462761|PD|pd
5710618|NCT00462761|receptor|receptor
5710619|NCT00462761|class III|class iii
5710620|NCT00462761|relapsed|relapsed
5710621|NCT00462761|refractory|refractory
5710622|NCT00462761|t(8;21)|t(8;21)
5710623|NCT00462761|q22;q22|q22;q22
5710624|NCT00462761|AML1/ETO|aml1/eto
5710625|NCT00462761|t(16;16|t(16;16
5710626|NCT00462761|p13;q22|p13;q22
5710627|NCT00462761|CBFbeta/MYH11|cbfbeta/myh11
5710628|NCT00462761|inv(16)|inv(16)
5710629|NCT00462761|p13q22|p13q22
5710633|NCT00462761|myelomonocytic|myelomonocytic
5710634|NCT00462761|monoblastic|monoblastic
5710635|NCT00462761|monocytic|monocytic
5710636|NCT00462761|erythroid|erythroid
5710637|NCT00462761|erythroleukemia|erythroleukemia
5710638|NCT00462761|megakaryoblastic|megakaryoblastic
5710639|NCT00462761|basophilic|basophilic
5710640|NCT00462761|panmyelosis|panmyelosis
5710641|NCT00462761|myelofibrosis|myelofibrosis
5710642|NCT00462735|Cancer of the Nasal Cavity|cancer of the nasal cavity
5710643|NCT00462722|body composition|body composition
5710644|NCT00462722|bone density|bone density
5710645|NCT00462722|cyclooxygenase inhibitor|cyclooxygenase inhibitor
5710646|NCT00462722|bone metabolism|bone metabolism
5710647|NCT00462722|muscle function|muscle function
5710648|NCT00462722|muscle strength|muscle strength
5710649|NCT00462709|Hereditary angioedema|hereditary angioedema
5710650|NCT00462709|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5710651|NCT00462696|stage II breast cancer|stage ii breast cancer
5710652|NCT00462696|stage IIIA breast cancer|stage iiia breast cancer
5710653|NCT00462696|stage IIIB breast cancer|stage iiib breast cancer
5710654|NCT00462696|stage IIIC breast cancer|stage iiic breast cancer
5710655|NCT00462683|Stroke|stroke
5710656|NCT00462683|Anoxia|anoxia
5710657|NCT00462683|Brain Injury|brain injury
5710658|NCT00462683|Rehabilitation|rehabilitation
5710659|NCT00462683|Osteoporosis|osteoporosis
5710660|NCT00462683|Osteopenia|osteopenia
5710661|NCT00462670|Cardiac edema|cardiac edema
5710662|NCT00462670|OPC-41061|opc-41061
5710663|NCT00462670|Vasopressin antagonist|vasopressin antagonist
5710664|NCT00462657|infection|infection
5705187|NCT00482781|Apnea|apnea
5710665|NCT00462657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5710666|NCT00462657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5710667|NCT00462657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5710668|NCT00462657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5710669|NCT00462657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5710670|NCT00462657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5710671|NCT00462657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5710672|NCT00462657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5710673|NCT00462657|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5710674|NCT00462657|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5710675|NCT00462657|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5710676|NCT00462657|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5710677|NCT00462657|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5710678|NCT00462657|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5710679|NCT00462657|graft versus host disease|graft versus host disease
5710680|NCT00462644|adrenal insufficiency|adrenal insufficiency
5710682|NCT00462644|rapid sequence induction|rapid sequence induction
5710683|NCT00462631|coronary artery|coronary artery
5710684|NCT00462631|Diabetes|diabetes
5710685|NCT00462618|Insomnia|insomnia
5710686|NCT00462618|Elderly|elderly
5710687|NCT00462618|Affective disorders|affective disorders
5710688|NCT00462592|exercise-induced bronchoconstriction (EIB)|exercise-induced bronchoconstriction (eib)
5710689|NCT00462592|airway inflammation|airway inflammation
5710690|NCT00462579|carbapenem-resistant acinetobacter baumannii|carbapenem-resistant acinetobacter baumannii
5710691|NCT00462579|positive culture|positive culture
5710692|NCT00462579|positive culture for carbapenem-resistant acinetobacter|positive culture for carbapenem-resistant acinetobacter
5710693|NCT00462566|Motor cortex stimulation|motor cortex stimulation
5710694|NCT00462566|neuropathic|neuropathic
5710695|NCT00462566|pain|pain
5710696|NCT00462566|complex regional pain syndrome|complex regional pain syndrome
5710697|NCT00462566|deafferentation facial pain|deafferentation facial pain
5710698|NCT00462540|COPD|copd
5710699|NCT00462540|Formoterol|formoterol
5710700|NCT00462540|Ipratropium|ipratropium
5710701|NCT00462540|Crossover|crossover
5710702|NCT00462527|Cystatin C|cystatin c
5710703|NCT00462527|Acute renal failure|acute renal failure
5710704|NCT00462527|Gastroenteritis|gastroenteritis
5710705|NCT00462527|Dehydration|dehydration
5710706|NCT00462501|stage II rectal cancer|stage ii rectal cancer
5710707|NCT00462501|stage III rectal cancer|stage iii rectal cancer
5710708|NCT00462501|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5710709|NCT00462475|GH|gh
5710710|NCT00462475|IGF-I|igf-i
5710711|NCT00462475|GH deficiency|gh deficiency
5710712|NCT00462475|Atherosclerosis|atherosclerosis
5710713|NCT00462475|Insulin resistance syndrome|insulin resistance syndrome
5710714|NCT00462449|Botulinum Toxin|botulinum toxin
5710715|NCT00462449|Ness H200|ness h200
5710716|NCT00462449|Functional Electrical Stimulation|functional electrical stimulation
5710717|NCT00462449|Repetitive Task Practice|repetitive task practice
5710718|NCT00462436|functional foods|functional foods
5710719|NCT00462436|soy|soy
5710720|NCT00462436|nuts|nuts
5710721|NCT00462436|LDL cholesterol|ldl cholesterol
5710722|NCT00462436|fibre|fibre
5710723|NCT00462436|secondary prevention|secondary prevention
5710724|NCT00462436|risk reduction|risk reduction
5710725|NCT00462436|endothelial function|endothelial function
5710726|NCT00462436|endothelial progenitor cells|endothelial progenitor cells
5710727|NCT00462436|inflammation|inflammation
5710728|NCT00462436|glycemic control|glycemic control
5710729|NCT00462436|HOMA|homa
5710730|NCT00462423|Metastatic malignant melanoma|metastatic malignant melanoma
5710731|NCT00462423|First-line therapy|first-line therapy
5710732|NCT00462410|recurrent breast cancer|recurrent breast cancer
5710733|NCT00462410|stage I breast cancer|stage i breast cancer
5710734|NCT00462410|stage II breast cancer|stage ii breast cancer
5710735|NCT00462410|stage IIIA breast cancer|stage iiia breast cancer
5710736|NCT00462410|stage IIIB breast cancer|stage iiib breast cancer
5710987|NCT00461487|Sexual Behavior|sexual behavior
5710737|NCT00462410|stage IIIC breast cancer|stage iiic breast cancer
5710738|NCT00462410|stage IV breast cancer|stage iv breast cancer
5710739|NCT00462397|cervical adenocarcinoma|cervical adenocarcinoma
5710740|NCT00462397|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5710741|NCT00462397|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5710742|NCT00462397|stage IB cervical cancer|stage ib cervical cancer
5710743|NCT00462397|stage IIA cervical cancer|stage iia cervical cancer
5710744|NCT00462397|stage IIB cervical cancer|stage iib cervical cancer
5710745|NCT00462397|stage III cervical cancer|stage iii cervical cancer
5710746|NCT00462397|stage IVA cervical cancer|stage iva cervical cancer
5710747|NCT00462397|recurrent cervical cancer|recurrent cervical cancer
5710749|NCT00462371|child diabetes mellitus type 1|child diabetes mellitus type 1
5710750|NCT00462371|Continuous subcutaneous insulin infusion(CSII)|continuous subcutaneous insulin infusion(csii)
5710751|NCT00462371|metabolic control|metabolic control
5710752|NCT00462332|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5710753|NCT00462332|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5710754|NCT00462306|Obstructive Sleep Apnea|obstructive sleep apnea
5710755|NCT00462306|Pregnancy|pregnancy
5710756|NCT00462306|Berlin Questionnaire|berlin questionnaire
5710757|NCT00462267|Nutrition|nutrition
5710758|NCT00462267|Exercise|exercise
5710759|NCT00462267|Body mass index|body mass index
5710760|NCT00462267|Lifestyle change|lifestyle change
5710761|NCT00462267|Obesity|obesity
5710762|NCT00462267|Overweight|overweight
5710763|NCT00462267|Adolescents|adolescents
5710764|NCT00462267|Teens|teens
5710765|NCT00462254|Ramelteon|ramelteon
5710766|NCT00462254|Parkinson's disease|parkinson's disease
5710767|NCT00462254|Sleep disturbances|sleep disturbances
5710768|NCT00462241|Chest pain|chest pain
5710769|NCT00462241|Chest wall|chest wall
5710770|NCT00462241|Atypical chest pain|atypical chest pain
5710771|NCT00462241|Non-cardiac chest pain|non-cardiac chest pain
5710772|NCT00462241|Undiagnosed chest pain|undiagnosed chest pain
5710773|NCT00462241|Physical examination|physical examination
5710774|NCT00462241|Randomized controlled trial|randomized controlled trial
5710775|NCT00462241|Treatment study|treatment study
5710776|NCT00462241|Chiropractor|chiropractor
5710777|NCT00462228|traumatic brain injury|traumatic brain injury
5710778|NCT00462228|memory|memory
5710779|NCT00462228|attention|attention
5709450|NCT00466947|Safety|safety
5710780|NCT00462202|Diabetes|diabetes
5710781|NCT00462202|Microalbuminuria|microalbuminuria
5710782|NCT00462202|Proteinuria|proteinuria
5710783|NCT00462202|Albuminuria|albuminuria
5710784|NCT00462202|KRX-101|krx-101
5710785|NCT00462202|Sulodexide|sulodexide
5710786|NCT00462202|Nephropathy|nephropathy
5710787|NCT00462202|Keryx|keryx
5710788|NCT00462202|Collaborative Study Group|collaborative study group
5710789|NCT00462202|Diabetic nephropathy with persistent microalbuminuria|diabetic nephropathy with persistent microalbuminuria
5710790|NCT00462189|CAT-8015|cat-8015
5710793|NCT00462189|Relapse|relapse
5710794|NCT00462189|Refractory|refractory
5710795|NCT00462189|immunotherapy|immunotherapy
5710796|NCT00462189|immunotoxin|immunotoxin
5710797|NCT00462176|colorectal endometriosis|colorectal endometriosis
5710798|NCT00462176|deep infiltrating endometriosis|deep infiltrating endometriosis
5710799|NCT00462176|dysmenorroe|dysmenorroe
5710800|NCT00462176|dyspareunia|dyspareunia
5710801|NCT00462176|quality of life|quality of life
5726921|NCT00406692|Alcohol|alcohol
5726922|NCT00406679|pain, postoperative|pain, postoperative
5726923|NCT00406679|surgery, oral|surgery, oral
5726924|NCT00406679|surgery, dental|surgery, dental
5710802|NCT00462150|arthritis, rheumatoid|arthritis, rheumatoid
5710803|NCT00462150|expressed emotion|expressed emotion
5710804|NCT00462150|randomized controlled trial|randomized controlled trial
5710805|NCT00462150|affect|affect
5710806|NCT00462150|blood sedimentation|blood sedimentation
5710807|NCT00462150|psychophysiology|psychophysiology
5710808|NCT00462150|feasibility studies|feasibility studies
5710809|NCT00462150|intervention studies|intervention studies
5710810|NCT00462150|time management|time management
5710811|NCT00462137|GERD|gerd
5710812|NCT00462137|Gastroesphageal Reflux Disease (GERD)|gastroesphageal reflux disease (gerd)
5710813|NCT00462124|Prostate|prostate
5710814|NCT00462124|cancer|cancer
5710815|NCT00462124|radiation|radiation
5710816|NCT00462124|biodegradable implantable balloon|biodegradable implantable balloon
5710817|NCT00462124|intrarectal balloon|intrarectal balloon
5710819|NCT00462111|reaction time|reaction time
5710820|NCT00462111|postural balance|postural balance
5711224|NCT00460434|Prolapse|prolapse
5710823|NCT00462098|Osteonecrosis of the jaw|osteonecrosis of the jaw
5710825|NCT00462098|bisphosphonates|bisphosphonates
5710826|NCT00462085|cerebral palsy|cerebral palsy
5710827|NCT00462085|ankle foot orthosis|ankle foot orthosis
5710828|NCT00462085|emg|emg
5710829|NCT00462085|surface electromyography|surface electromyography
5710830|NCT00462085|gait analysis|gait analysis
5710831|NCT00462059|Transition of care|transition of care
5710832|NCT00462059|Continuity of care|continuity of care
5710833|NCT00462046|Berberine|berberine
5710834|NCT00462046|Type 2 diabetes|type 2 diabetes
5710835|NCT00462046|Dyslipidemia|dyslipidemia
5710836|NCT00462020|appendicitis, perforation, abscess, treatment|appendicitis, perforation, abscess, treatment
5710837|NCT00461994|OBESITY|obesity
5710838|NCT00461994|CHILDREN|children
5710839|NCT00461994|METABOLIC PARAMETERS|metabolic parameters
5710840|NCT00461994|DIET|diet
5710841|NCT00461994|EXERCISE|exercise
5710842|NCT00461981|Live, attenuated influenza virus vaccine (LAIV)|live, attenuated influenza virus vaccine (laiv)
5710843|NCT00461981|Trivalent inactivated influenza virus vaccine (TIV)|trivalent inactivated influenza virus vaccine (tiv)
5710844|NCT00461981|FluMist|flumist
5710845|NCT00461968|Cholesterol|cholesterol
5710846|NCT00461968|LDL|ldl
5710847|NCT00461968|Ezetimibe|ezetimibe
5710849|NCT00461968|Zetia|zetia
5710850|NCT00461968|Zocor|zocor
5710851|NCT00461968|Simvastin|simvastin
5710852|NCT00461955|Symptomatic Multiple Myeloma|symptomatic multiple myeloma
5710853|NCT00461955|first line treatment|first line treatment
5710854|NCT00461955|first autologous Stem Cell Transplantation|first autologous stem cell transplantation
5710855|NCT00461955|ex vivo amplified autologous peripheral blood stem cells|ex vivo amplified autologous peripheral blood stem cells
5710856|NCT00461942|Health Food;|health food;
5710857|NCT00461942|Green Tea;|green tea;
5710858|NCT00461942|Neuroprotection|neuroprotection
5710859|NCT00461929|chronic myeloid leukemia|chronic myeloid leukemia
5710860|NCT00461929|gastrointestinal stromal cell tumors|gastrointestinal stromal cell tumors
5710861|NCT00461929|chromosome abnormality|chromosome abnormality
5710862|NCT00461929|imatinib|imatinib
5710863|NCT00461929|bone marrow aspiration|bone marrow aspiration
5710864|NCT00461916|half-dose depot triptorelin|half-dose depot triptorelin
5710865|NCT00461916|reduced-dose daily buserelin|reduced-dose daily buserelin
5710866|NCT00461916|controlled ovarian stimulation|controlled ovarian stimulation
5710867|NCT00461916|long protocol|long protocol
5710868|NCT00461916|ICSI|icsi
5710871|NCT00461890|Alcohol|alcohol
5710872|NCT00461890|Veterans|veterans
5710873|NCT00461890|Primary Care|primary care
5710874|NCT00461890|Naltrexone|naltrexone
5710875|NCT00461864|fracture|fracture
5710876|NCT00461864|occult|occult
5710878|NCT00461851|Advanced/Metastatic Bladder Carcinoma|advanced/metastatic bladder carcinoma
5710879|NCT00461838|colorectal endometriosis|colorectal endometriosis
5710880|NCT00461838|deep infiltrating endometriosis|deep infiltrating endometriosis
5710881|NCT00461838|dysmenorroe|dysmenorroe
5718165|NCT00438334|Benefit|benefit
5710882|NCT00461838|dyspareunia|dyspareunia
5710883|NCT00461838|quality of life|quality of life
5710884|NCT00461825|Immunosuppression|immunosuppression
5710885|NCT00461825|Kidney transplantation|kidney transplantation
5710886|NCT00461825|multicenter study|multicenter study
5710887|NCT00461799|Crigler-Najjar disease.|crigler-najjar disease.
5710888|NCT00461799|Bilirubin.|bilirubin.
5710889|NCT00461799|Phototherapy.|phototherapy.
5710890|NCT00461799|Orlistat.|orlistat.
5710891|NCT00461799|Unconjugated hyperbilirubinemia.|unconjugated hyperbilirubinemia.
5710892|NCT00461773|Neoadjuvant treatment|neoadjuvant treatment
5710893|NCT00461760|HPV Screening/Testing for cervical cancer screening|hpv screening/testing for cervical cancer screening
5710894|NCT00461747|Untreated|untreated
5710895|NCT00461747|Transplant|transplant
5710896|NCT00461747|Younger|younger
5710897|NCT00461734|Right Ventricular High Septal Pacing|right ventricular high septal pacing
5710898|NCT00461734|Right Ventricular Apical Pacing|right ventricular apical pacing
5710899|NCT00461734|Left Ventricular Dysfunction|left ventricular dysfunction
5710900|NCT00461734|Heart Block|heart block
5710901|NCT00461734|Pacemaker|pacemaker
5710902|NCT00461734|Atrial Fibrillation|atrial fibrillation
5710903|NCT00461734|Ejection Fraction|ejection fraction
5710904|NCT00461695|Cytomegalovirus (CMV)|cytomegalovirus (cmv)
5710905|NCT00461695|Tick-borne encephalitis virus (TBEV)|tick-borne encephalitis virus (tbev)
5710906|NCT00461695|Ageing|ageing
5710907|NCT00461695|Vaccine|vaccine
5710908|NCT00461695|Immunity|immunity
5710909|NCT00461682|TRPV1 antagonist|trpv1 antagonist
5710910|NCT00461682|Fecal Urgency|fecal urgency
5710911|NCT00461682|rectal pain|rectal pain
5710912|NCT00461682|IBS|ibs
5710913|NCT00461669|hip|hip
5710914|NCT00461669|fracture|fracture
5710915|NCT00461669|ultrasound|ultrasound
5710916|NCT00461656|Antiseptic|antiseptic
5710917|NCT00461656|Povidone-Iodine|povidone-iodine
5710918|NCT00461643|Anovulation|anovulation
5710919|NCT00461643|Clomiphene citrate|clomiphene citrate
5710920|NCT00461643|Infertility|infertility
5710921|NCT00461643|Metformin|metformin
5710923|NCT00461643|RCT|rct
5710925|NCT00461630|coronary heart disease|coronary heart disease
5710926|NCT00461630|cardiovascular disease|cardiovascular disease
5710928|NCT00461630|peripheral arterial disease|peripheral arterial disease
5710929|NCT00461630|diabetes mellitus|diabetes mellitus
5710930|NCT00461630|cholesterol|cholesterol
5710931|NCT00461630|HDL cholesterol|hdl cholesterol
5710932|NCT00461630|simvastatin|simvastatin
5710933|NCT00461630|ezetimibe|ezetimibe
5710934|NCT00461630|ER niacin|er niacin
5710935|NCT00461630|laropiprant|laropiprant
5710936|NCT00461617|diabetes|diabetes
5710937|NCT00461617|rapid and short acting insulin secretagogue|rapid and short acting insulin secretagogue
5710938|NCT00461617|α-glucosidase inhibitor|α-glucosidase inhibitor
5710939|NCT00461617|HbA1C|hba1c
5710940|NCT00461617|insulin|insulin
5710941|NCT00461604|gastroesophageal reflux disease|gastroesophageal reflux disease
5710942|NCT00461604|baclofen|baclofen
5710943|NCT00461604|impedance|impedance
5710944|NCT00461591|Noninvasive Bladder Cancer|noninvasive bladder cancer
5710945|NCT00461578|P.falciparum|p.falciparum
5710946|NCT00461578|malaria|malaria
5710947|NCT00461578|lapdap+artesunate|lapdap+artesunate
5710948|NCT00461578|safety|safety
5710949|NCT00461578|efficay|efficay
5710950|NCT00461565|Retina|retina
5710951|NCT00461565|PDE-5|pde-5
5710952|NCT00461565|Levitra|levitra
5710953|NCT00461565|Viagra|viagra
5710954|NCT00461565|Normal healthy volunteers for evaluation of retinal function|normal healthy volunteers for evaluation of retinal function
5710957|NCT00461552|HAART|haart
5710958|NCT00461552|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5710959|NCT00461552|Lipodystrophy syndrome|lipodystrophy syndrome
5710960|NCT00461552|HIV-Associated Lipodystrophy|hiv-associated lipodystrophy
5710961|NCT00461552|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5710962|NCT00461552|Treatment Experienced|treatment experienced
5710963|NCT00461539|Tobacco Use|tobacco use
5710964|NCT00461539|Alcohol and Drug Use|alcohol and drug use
5710965|NCT00461539|Obesity|obesity
5710966|NCT00461539|Risky Sexual Behavior|risky sexual behavior
5710967|NCT00461526|IBS|ibs
5710968|NCT00461526|d-IBS|d-ibs
5710969|NCT00461526|Irritable Bowel Syndrome|irritable bowel syndrome
5710970|NCT00461513|Heart Failure, Congestive|heart failure, congestive
5710971|NCT00461513|Disease Management|disease management
5710972|NCT00461513|Health Status|health status
5710973|NCT00461513|Quality of Life|quality of life
5710974|NCT00461513|Telemedicine|telemedicine
5710975|NCT00461513|Depression|depression
5710976|NCT00461500|persistent|persistent
5710977|NCT00461500|moderate|moderate
5710978|NCT00461500|asthma|asthma
5710979|NCT00461500|adults|adults
5710980|NCT00461500|Initial|initial
5710981|NCT00461500|Maintenance|maintenance
5710982|NCT00461500|Therapy|therapy
5710983|NCT00461487|Adolescent Behavior|adolescent behavior
5710984|NCT00461487|Communication|communication
5710985|NCT00461487|Health Behavior|health behavior
5710986|NCT00461487|Risk-Taking|risk-taking
5710988|NCT00461474|Shoulder pain|shoulder pain
5710989|NCT00461474|Chronic Spinal Cord Injury|chronic spinal cord injury
5710990|NCT00461474|Exercise|exercise
5710991|NCT00461474|Physical therapy techniques|physical therapy techniques
5710992|NCT00461474|Motor performance|motor performance
5710993|NCT00461448|Potassium supplement|potassium supplement
5710994|NCT00461448|Rheumatoid Arthritis|rheumatoid arthritis
5710995|NCT00461448|Pain|pain
5710996|NCT00461448|Disease Activity|disease activity
5710998|NCT00461422|GnRH antagonist|gnrh antagonist
5710999|NCT00461396|Relapsing-Remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5711000|NCT00461396|First demyelinating event|first demyelinating event
5711001|NCT00461396|MRI features consistent with MS|mri features consistent with ms
5711002|NCT00461370|safety|safety
5711003|NCT00461370|Phase 1|phase 1
5711004|NCT00461370|pharmacokinetics|pharmacokinetics
5711005|NCT00461370|SRX251|srx251
5711006|NCT00461370|Azevan|azevan
5711007|NCT00461370|safety in healthy volunteers|safety in healthy volunteers
5711008|NCT00461357|Old for Old|old for old
5711009|NCT00461357|Eurotransplant Senior Program|eurotransplant senior program
5711010|NCT00461357|Glomerular Filtration Rate|glomerular filtration rate
5711011|NCT00461344|Breast|breast
5711012|NCT00461331|Type 1 diabetes mellitus|type 1 diabetes mellitus
5711013|NCT00461331|Glycemic control|glycemic control
5711014|NCT00461331|Continuous subcutaneous insulin infusion|continuous subcutaneous insulin infusion
5711015|NCT00461331|Continuous glucose monitoring system|continuous glucose monitoring system
5711016|NCT00461318|vocational rehabilitation|vocational rehabilitation
5711017|NCT00461318|psychosis|psychosis
5711018|NCT00461318|cross country comparison|cross country comparison
5711019|NCT00461305|Dysmenorrhea|dysmenorrhea
5711020|NCT00461305|Intracyclic bleeding|intracyclic bleeding
5711021|NCT00461305|Drospirenone (DRSP)|drospirenone (drsp)
5711022|NCT00461305|Ethinylestradiol|ethinylestradiol
5711023|NCT00461279|attachment|attachment
5711024|NCT00461279|depression|depression
5711026|NCT00461279|CBT|cbt
5711027|NCT00461279|pharmacotherapy|pharmacotherapy
5711028|NCT00461266|Treatment Experienced|treatment experienced
5711029|NCT00461253|breast cancer|breast cancer
5711030|NCT00461240|heart|heart
5711031|NCT00461240|MRS|mrs
5711032|NCT00461240|acromegaly|acromegaly
5711033|NCT00461240|growth hormone|growth hormone
5711034|NCT00461227|Puerto Rican|puerto rican
5711035|NCT00461227|Allergies|allergies
5711036|NCT00461214|laparoscopy|laparoscopy
5711037|NCT00461214|surgery|surgery
5711038|NCT00461214|technical skills|technical skills
5711039|NCT00461214|outcomes|outcomes
5711040|NCT00461214|resident training|resident training
5711041|NCT00461201|Health Services Research|health services research
5711042|NCT00461201|Nurse Practitioners|nurse practitioners
5711043|NCT00461201|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5711044|NCT00461201|Patient Acceptance of Health Care|patient acceptance of health care
5711045|NCT00461201|Patient Satisfaction|patient satisfaction
5711046|NCT00461201|Primary Health Care|primary health care
5711047|NCT00461201|Professional Autonomy|professional autonomy
5711048|NCT00461188|acromegaly|acromegaly
5711049|NCT00461188|gigantism|gigantism
5711050|NCT00461188|familial pituitary adenoma|familial pituitary adenoma
5711051|NCT00461188|Familial acromegaly|familial acromegaly
5711052|NCT00461188|Familial Isolated Pituitary Adenoma|familial isolated pituitary adenoma
5711053|NCT00461188|FIPA|fipa
5711054|NCT00461188|Pituitary adenoma predisposition|pituitary adenoma predisposition
5711056|NCT00461175|Uterine Perforation|uterine perforation
5711057|NCT00461149|Acromegaly|acromegaly
5711058|NCT00461149|GH|gh
5711059|NCT00461149|IGF-I|igf-i
5711060|NCT00461149|Pituitary tumors|pituitary tumors
5711061|NCT00461149|Octreotide|octreotide
5711062|NCT00461136|Time course|time course
5711063|NCT00461136|antiproteinuric|antiproteinuric
5711064|NCT00461136|blood pressure|blood pressure
5711065|NCT00461136|lowering effect|lowering effect
5711066|NCT00461136|initiation of renin inhibition|initiation of renin inhibition
5711067|NCT00461136|Aliskiren in Type 2 diabetes|aliskiren in type 2 diabetes
5711068|NCT00461136|incipient and/or established nephropathy|incipient and/or established nephropathy
5711069|NCT00461097|Egg Allergy|egg allergy
5711070|NCT00461097|Egg Oral Immunotherapy (OIT)|egg oral immunotherapy (oit)
5711071|NCT00461097|Food Allergy|food allergy
5711072|NCT00461084|Lymphoma|lymphoma
5711073|NCT00461084|Advanced Stage|advanced stage
5711074|NCT00461084|Untreated|untreated
5711075|NCT00461084|Advanced Stage Lymphoma|advanced stage lymphoma
5711076|NCT00461084|Untreated Lymphoma|untreated lymphoma
5711077|NCT00461084|07-038|07-038
5736246|NCT00372177|RA|ra
5711078|NCT00461071|Bulimia nervosa|bulimia nervosa
5711079|NCT00461071|Guided Self-help|guided self-help
5711080|NCT00461071|Psycho-education|psycho-education
5711081|NCT00461045|multiple myeloma|multiple myeloma
5711082|NCT00461045|proteasome inhibitor|proteasome inhibitor
5711083|NCT00461045|relapsed|relapsed
5711084|NCT00461045|refractory|refractory
5711085|NCT00460993|Aging|aging
5711086|NCT00460993|Sleep|sleep
5711087|NCT00460993|Nursing Home|nursing home
5711088|NCT00460993|Sleep in nursing homes|sleep in nursing homes
5685832|NCT00554671|guideline adherence|guideline adherence
5711089|NCT00460980|resident training|resident training
5711090|NCT00460980|laparoscopic skills|laparoscopic skills
5711091|NCT00460980|surgical skills assessment|surgical skills assessment
5711092|NCT00460967|non-Exudative (Dry) Age-Related Macular Degeneration|non-exudative (dry) age-related macular degeneration
5711093|NCT00460928|congenital heart block|congenital heart block
5711094|NCT00460928|neonatal lupus|neonatal lupus
5711095|NCT00460928|systemic lupus erythematosus|systemic lupus erythematosus
5711096|NCT00460928|Sjogren syndrome|sjogren syndrome
5711097|NCT00460928|autoantibodies|autoantibodies
5711098|NCT00460928|SSA/Ro|ssa/ro
5711099|NCT00460928|SSB/La|ssb/la
5711100|NCT00460928|autoimmunity|autoimmunity
5711101|NCT00460928|pregnancy|pregnancy
5711102|NCT00460928|intravenous immune globulin|intravenous immune globulin
5711103|NCT00460928|IVIG|ivig
5711104|NCT00460928|immunoglobulin|immunoglobulin
5711105|NCT00460915|Lacidipine|lacidipine
5711106|NCT00460915|Amlodipine|amlodipine
5711107|NCT00460902|TMS|tms
5711108|NCT00460902|drug resistant depression|drug resistant depression
5711109|NCT00460889|hand assist|hand assist
5711110|NCT00460889|laparoscopy|laparoscopy
5711111|NCT00460889|renal donor|renal donor
5711112|NCT00460889|outcomes|outcomes
5711113|NCT00460876|topotecan|topotecan
5711114|NCT00460876|periocular|periocular
5711115|NCT00460876|chemotherapy|chemotherapy
5711116|NCT00460863|sleep|sleep
5711117|NCT00460863|hemodialysis|hemodialysis
5711118|NCT00460863|daytime sleepiness|daytime sleepiness
5711119|NCT00460863|temperature|temperature
5711120|NCT00460837|colorectal cancer|colorectal cancer
5711121|NCT00460837|bowel preparation regimen|bowel preparation regimen
5711122|NCT00460837|patients with symptoms attributable to colorectal cancer|patients with symptoms attributable to colorectal cancer
5711123|NCT00460824|transplant|transplant
5711124|NCT00460824|HLA antibodies matching|hla antibodies matching
5711125|NCT00460824|immunologic mismatching|immunologic mismatching
5711126|NCT00460811|Irritable Bowel Syndrome with Constipation|irritable bowel syndrome with constipation
5711128|NCT00460811|Irritable Bowel Syndrome|irritable bowel syndrome
5711129|NCT00460811|linaclotide acetate|linaclotide acetate
5711130|NCT00460811|linaclotide|linaclotide
5711131|NCT00460811|MD-1100|md-1100
5711132|NCT00460798|Sunitinib|sunitinib
5711133|NCT00460798|kidney diseases|kidney diseases
5711134|NCT00460798|urogenital neoplasms|urogenital neoplasms
5711135|NCT00460798|kidney cancer|kidney cancer
5711136|NCT00460759|Mycobacterium tuberculosis, rifapentine, moxifloxacin|mycobacterium tuberculosis, rifapentine, moxifloxacin
5711137|NCT00460746|HIV|hiv
5711138|NCT00460746|AIDS|aids
5711139|NCT00460746|Immunodeficiency Virus, Human|immunodeficiency virus, human
5711140|NCT00460746|PREZISTA|prezista
5711141|NCT00460746|darunavir|darunavir
5711142|NCT00460746|TMC114|tmc114
5711143|NCT00460746|TMC125|tmc125
5711144|NCT00460746|Protease Inhibitor|protease inhibitor
5711145|NCT00460746|Non-Nucleoside Reverse Transcriptase Inhibitor|non-nucleoside reverse transcriptase inhibitor
5711146|NCT00460746|enfuvirtide|enfuvirtide
5711147|NCT00460746|Treatment Experienced|treatment experienced
5711148|NCT00460720|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5711149|NCT00460720|ADHD|adhd
5711150|NCT00460720|Methylphenidate|methylphenidate
5711151|NCT00460720|MPH|mph
5711152|NCT00460720|Extended-Release Methylphenidate|extended-release methylphenidate
5711154|NCT00460707|healthy adult subjects|healthy adult subjects
5711155|NCT00460707|casopitant|casopitant
5711156|NCT00460707|ketoconazole|ketoconazole
5711157|NCT00460694|allogeneic transplant|allogeneic transplant
5711158|NCT00460694|haematological malignancies|haematological malignancies
5711159|NCT00460694|allogeneic CIK cells|allogeneic cik cells
5711160|NCT00460681|Hepatocellular Carcinoma|hepatocellular carcinoma
5711161|NCT00460681|Thymopentin|thymopentin
5711162|NCT00460681|Recurrence|recurrence
5711163|NCT00460681|Resection|resection
5711164|NCT00460668|elective thoracotomy|elective thoracotomy
5711165|NCT00460668|pulmonary rehabilitation|pulmonary rehabilitation
5711166|NCT00460668|quality of life|quality of life
5711167|NCT00460655|Post-Stroke|post-stroke
5711168|NCT00460655|Lower Limb|lower limb
5711169|NCT00460655|botulinum toxin type A|botulinum toxin type a
5711170|NCT00460655|Spasticity|spasticity
5711171|NCT00460642|Frozen embryo transfers (FET).|frozen embryo transfers (fet).
5711172|NCT00460642|Egg donation (ED).|egg donation (ed).
5711173|NCT00460642|IVF.|ivf.
5711174|NCT00460642|ART.|art.
5711175|NCT00460642|Implantation.|implantation.
5711176|NCT00460642|GnRH antagonist.|gnrh antagonist.
5711177|NCT00460642|Cetrotide.|cetrotide.
5711178|NCT00460642|Endometrial response.|endometrial response.
5711179|NCT00460642|Infertility treatments:|infertility treatments:
5711180|NCT00460642|Transfer of embryos from egg donation (ED) to recipients.|transfer of embryos from egg donation (ed) to recipients.
5711181|NCT00460629|Adoptive immunotherapy|adoptive immunotherapy
5711182|NCT00460629|BCR-ABL reactive T cells|bcr-abl reactive t cells
5711183|NCT00460629|Allogeneic Transplantation|allogeneic transplantation
5711184|NCT00460616|Prolactin|prolactin
5711185|NCT00460616|Prolactinomas|prolactinomas
5685833|NCT00554671|group medical visits|group medical visits
5711186|NCT00460616|Dopamine-Agonists|dopamine-agonists
5711187|NCT00460616|Cabergoline|cabergoline
5711188|NCT00460616|Cardiac valve disease|cardiac valve disease
5711189|NCT00460603|GI neoplasms (phase 1)|gi neoplasms (phase 1)
5711190|NCT00460590|Tuberculosis|tuberculosis
5711191|NCT00460590|TB|tb
5711192|NCT00460590|MVA 85A|mva 85a
5711193|NCT00460577|Asthma, Formoterol, Bronchial Obstruction, Children|asthma, formoterol, bronchial obstruction, children
5711194|NCT00460564|Spasticity|spasticity
5711195|NCT00460564|Post-Stroke|post-stroke
5711196|NCT00460564|botulinum toxin type A|botulinum toxin type a
5711197|NCT00460564|Upper Limb|upper limb
5711198|NCT00460538|Seasonal allergic rhinitis|seasonal allergic rhinitis
5711199|NCT00460538|lectranal|lectranal
5711200|NCT00460538|allergy|allergy
5711201|NCT00460525|malaria, Mali, children, Plasmodium falciparum, vaccine|malaria, mali, children, plasmodium falciparum, vaccine
5711202|NCT00460512|Schizophrenia|schizophrenia
5711203|NCT00460512|Flexible dosing|flexible dosing
5711204|NCT00460512|Non-acute patients|non-acute patients
5711205|NCT00460512|Antipsychotic|antipsychotic
5711206|NCT00460512|Atypical|atypical
5711207|NCT00460512|INVEGA|invega
5711208|NCT00460499|Diabetes|diabetes
5711209|NCT00460473|Mental Health|mental health
5711210|NCT00460473|Neurological Disease|neurological disease
5711211|NCT00460473|Hip Injuries and Disorders|hip injuries and disorders
5711212|NCT00460460|Phase I|phase i
5711213|NCT00460460|cancer|cancer
5711214|NCT00460460|lymphoma|lymphoma
5711215|NCT00460460|leukemia|leukemia
5711216|NCT00460460|myeloma|myeloma
5711217|NCT00460460|AML|aml
5711218|NCT00460460|ALL|all
5711219|NCT00460460|NHL|nhl
5711220|NCT00460460|MM|mm
5711221|NCT00460447|anti-CD33|anti-cd33
5711222|NCT00460447|Immunotoxin|immunotoxin
5711223|NCT00460447|Acute myeloid leukemia|acute myeloid leukemia
5711225|NCT00460434|Urinary incontinence|urinary incontinence
5711226|NCT00460434|TVT|tvt
5711227|NCT00460421|Oral Mucositis|oral mucositis
5711228|NCT00460421|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5711229|NCT00460421|Acute Myeloid Leukemia|acute myeloid leukemia
5711230|NCT00460421|Palifermin|palifermin
5711232|NCT00460408|Macular degeneration|macular degeneration
5711233|NCT00460408|Safety|safety
5711234|NCT00460408|Non-interventional|non-interventional
5711235|NCT00460408|Non-randomized|non-randomized
5711236|NCT00460395|Brain Metastasis|brain metastasis
5711237|NCT00460395|Cerebral Metastases|cerebral metastases
5711238|NCT00460395|Brain Cancer|brain cancer
5711239|NCT00460395|Stereotactic Radiosurgery|stereotactic radiosurgery
5711240|NCT00460395|Craniotomy|craniotomy
5711241|NCT00460382|HIV infections|hiv infections
5711242|NCT00460382|HIV integrase inhibitor|hiv integrase inhibitor
5711243|NCT00460382|etravirine|etravirine
5711244|NCT00460382|darunavir|darunavir
5711245|NCT00460382|MK 0518|mk 0518
5711246|NCT00460382|raltegravir|raltegravir
5711247|NCT00460382|Treatment Experienced|treatment experienced
5711248|NCT00460382|Antiviral drug resistance|antiviral drug resistance
5711249|NCT00460369|uncomplicated malaria|uncomplicated malaria
5711250|NCT00460369|children|children
5711251|NCT00460369|treatment|treatment
5711252|NCT00460369|effectiveness|effectiveness
5711253|NCT00460343|patient non-adherence|patient non-adherence
5711254|NCT00460343|antihypertensive agents|antihypertensive agents
5711255|NCT00460343|community pharmacy services|community pharmacy services
5711257|NCT00460330|diagnosis|diagnosis
5711258|NCT00460330|galactomannan|galactomannan
5711259|NCT00460330|glucan|glucan
5711260|NCT00460330|real-time PCR|real-time pcr
5711261|NCT00460330|invasive fungal infection|invasive fungal infection
5711262|NCT00460330|aspergillosis|aspergillosis
5711263|NCT00460330|Chinese patients|chinese patients
5711264|NCT00460317|lung|lung
5711265|NCT00460317|cancer|cancer
5711266|NCT00460317|chemotherapy|chemotherapy
5711267|NCT00460317|paclitaxel|paclitaxel
5711268|NCT00460317|carboplatin|carboplatin
5711269|NCT00460317|placebo|placebo
5711270|NCT00460317|angiogenesis|angiogenesis
5711271|NCT00460317|VEGF|vegf
5711272|NCT00460317|multi kinase inhibitor|multi kinase inhibitor
5711273|NCT00460304|Type I diabetes|type i diabetes
5711274|NCT00460304|Insulin pump|insulin pump
5711275|NCT00460304|Continuous glucose monitoring|continuous glucose monitoring
5711276|NCT00460304|Insulin to carbohydrate ratio|insulin to carbohydrate ratio
5711277|NCT00460304|Correction factor|correction factor
5711278|NCT00460304|Pramlintide|pramlintide
5711279|NCT00460291|PAD|pad
5711280|NCT00460291|vein bypass|vein bypass
5711281|NCT00460291|supported varicose veins|supported varicose veins
5711282|NCT00460278|Cancer|cancer
5711283|NCT00460278|Solid Tumors|solid tumors
5711284|NCT00460265|Squamous Cell Carcinoma|squamous cell carcinoma
5711285|NCT00460265|Epidermal Growth Factor|epidermal growth factor
5711286|NCT00460265|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5711287|NCT00460265|SCCHN|scchn
5711288|NCT00460265|Metastatic Head and Neck Cancer|metastatic head and neck cancer
5711289|NCT00460265|EGFr|egfr
5711290|NCT00460265|Head and Neck Cancer|head and neck cancer
5718582|NCT00436592|acute|acute
5711291|NCT00460265|Recurrent Head and Neck Cancer|recurrent head and neck cancer
5711292|NCT00460252|algorithm|algorithm
5711293|NCT00460252|insulin|insulin
5711294|NCT00460252|hyperglycemia|hyperglycemia
5711295|NCT00460252|tight glycemic control|tight glycemic control
5711296|NCT00460252|intensive care|intensive care
5711297|NCT00460252|adults|adults
5711298|NCT00460239|Opioid addiction|opioid addiction
5711299|NCT00460239|Opioid dependence|opioid dependence
5711300|NCT00460239|Buprenorphine|buprenorphine
5711301|NCT00460226|Korean|korean
5711302|NCT00460226|Bipolar I disorder|bipolar i disorder
5711303|NCT00460226|Non-serious rash|non-serious rash
5711304|NCT00460226|Lamotrigine|lamotrigine
5711305|NCT00460213|home blood pressure|home blood pressure
5711306|NCT00460200|depression|depression
5711307|NCT00460200|fatigue|fatigue
5711308|NCT00460200|sleep disorders|sleep disorders
5798807|NCT00110968|Functional dyspepsia|functional dyspepsia
5711309|NCT00460200|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5711310|NCT00460200|ovarian epithelial cancer|ovarian epithelial cancer
5711311|NCT00460187|carotid artery, distal protection device, carotid stenting|carotid artery, distal protection device, carotid stenting
5711312|NCT00460174|stage I pancreatic cancer|stage i pancreatic cancer
5711313|NCT00460174|stage II pancreatic cancer|stage ii pancreatic cancer
5711314|NCT00460174|stage III pancreatic cancer|stage iii pancreatic cancer
5711315|NCT00460161|acupuncture|acupuncture
5711316|NCT00460161|amputation|amputation
5711317|NCT00460161|phantom limb pain|phantom limb pain
5711318|NCT00460148|ropinirole PR/CR,|ropinirole pr/cr,
5711319|NCT00460148|pharmacokinetic,|pharmacokinetic,
5711320|NCT00460148|formulation,|formulation,
5711321|NCT00460148|food effect,|food effect,
5711322|NCT00460148|SK&F101468,|sk&f101468,
5711324|NCT00460135|Resistance|resistance
5711325|NCT00460135|Training|training
5711326|NCT00460135|Obesity|obesity
5711327|NCT00460135|Children|children
5711328|NCT00460122|Human Leukocyte Antigens (HLA)|human leukocyte antigens (hla)
5711329|NCT00460122|Transfusion Reactions|transfusion reactions
5711330|NCT00460122|Platelet Donors|platelet donors
5711331|NCT00460109|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5711999|NCT00457704|MRSA|mrsa
5711332|NCT00460109|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5711333|NCT00460109|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5711334|NCT00460109|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5711335|NCT00460096|Pulmonary Emphysema|pulmonary emphysema
5711336|NCT00460083|Atopic Dermatitis|atopic dermatitis
5711337|NCT00460083|eczema|eczema
5711338|NCT00460083|dermatitis|dermatitis
5711339|NCT00460083|skin barrier|skin barrier
5711340|NCT00460083|barrier repair|barrier repair
5711341|NCT00460083|ceramide|ceramide
5711342|NCT00460083|physiologic lipid|physiologic lipid
5711343|NCT00460083|pruritus|pruritus
5711344|NCT00460083|Elidel|elidel
5711345|NCT00460083|Epiceram|epiceram
5711346|NCT00460083|topical steroid|topical steroid
5711347|NCT00460057|osteoporosis|osteoporosis
5711348|NCT00460057|alendronate|alendronate
5711349|NCT00460057|bone marker|bone marker
5711350|NCT00460044|ADMA|adma
5711351|NCT00460044|Preterms|preterms
5711352|NCT00460044|infants|infants
5711353|NCT00460044|mechanical ventilation|mechanical ventilation
5711354|NCT00460044|Preterm infants|preterm infants
5711355|NCT00460031|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5711356|NCT00460031|stage III prostate cancer|stage iii prostate cancer
5711357|NCT00460031|stage IV prostate cancer|stage iv prostate cancer
5711358|NCT00460031|recurrent prostate cancer|recurrent prostate cancer
5711359|NCT00460018|Gestational Diabetes Mellitus|gestational diabetes mellitus
5711360|NCT00460018|Weight Loss|weight loss
5711361|NCT00460018|Physical Activity|physical activity
5711362|NCT00460018|Breastfeeding|breastfeeding
5711363|NCT00460018|Pregnancy|pregnancy
5711364|NCT00460018|Postpartum|postpartum
5711365|NCT00460018|Intervention|intervention
5711366|NCT00460018|Prevention|prevention
5711367|NCT00460005|Migraine|migraine
5711368|NCT00460005|headache|headache
5711369|NCT00460005|observational|observational
5711370|NCT00459992|Obesity|obesity
5711371|NCT00459992|Weight Gain|weight gain
5711372|NCT00459992|Adult|adult
5711373|NCT00459992|Histamine|histamine
5711374|NCT00459992|Metabolism|metabolism
5711375|NCT00459992|Overweight|overweight
5711376|NCT00459979|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5711377|NCT00459979|stage III renal cell cancer|stage iii renal cell cancer
5711378|NCT00459979|stage IV renal cell cancer|stage iv renal cell cancer
5711379|NCT00459979|papillary renal cell carcinoma|papillary renal cell carcinoma
5711380|NCT00459940|Growth hormone|growth hormone
5711381|NCT00459940|Lipolysis|lipolysis
5711382|NCT00459940|Insulin resistance|insulin resistance
5711383|NCT00459940|Pioglitazone|pioglitazone
5711384|NCT00459940|Growth hormone replaced growth hormone deficient adults|growth hormone replaced growth hormone deficient adults
5711385|NCT00459927|Adenotonsillectomy|adenotonsillectomy
5711386|NCT00459927|Coblation tonsillectomy|coblation tonsillectomy
5711388|NCT00459914|sleep apnea|sleep apnea
5711389|NCT00459914|refractory hypertension|refractory hypertension
5711390|NCT00459914|continuous positive airway pressure|continuous positive airway pressure
5711391|NCT00459901|Metastatic Colorectal Cancer|metastatic colorectal cancer
5711392|NCT00459888|CLI|cli
5711393|NCT00459888|Critical Limb Ischemia|critical limb ischemia
5711394|NCT00459888|Infrapopliteal|infrapopliteal
5711395|NCT00459888|Cryoplasty|cryoplasty
5711396|NCT00459875|recurrent renal cell cancer|recurrent renal cell cancer
5711397|NCT00459875|stage IV renal cell cancer|stage iv renal cell cancer
5711398|NCT00459849|Melanoma|melanoma
5711399|NCT00459849|Brachytherapy|brachytherapy
5711400|NCT00459849|Ultrasonography|ultrasonography
5711401|NCT00459836|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5711402|NCT00459823|Cancer|cancer
5711403|NCT00459823|solid tumors|solid tumors
5711404|NCT00459810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5711405|NCT00459810|recurrent prostate cancer|recurrent prostate cancer
5711406|NCT00459810|stage IV prostate cancer|stage iv prostate cancer
5711407|NCT00459797|GlideScope|glidescope
5711408|NCT00459797|cobalt|cobalt
5711409|NCT00459797|single-use|single-use
5711410|NCT00459797|intubation|intubation
5711411|NCT00459797|airway|airway
5711412|NCT00459797|Elective surgical patients requiring orotracheal intubation|elective surgical patients requiring orotracheal intubation
5711413|NCT00459784|Improvement|improvement
5711414|NCT00459784|Dementia early diagnosis|dementia early diagnosis
5711415|NCT00459784|Dementia management|dementia management
5711416|NCT00459784|Primary care|primary care
5711417|NCT00459771|angiotensin II-receptor (AT1) blocker|angiotensin ii-receptor (at1) blocker
5711418|NCT00459771|prevention|prevention
5711419|NCT00459771|trastuzumab|trastuzumab
5711420|NCT00459771|cardiotoxicity|cardiotoxicity
5711421|NCT00459758|hypertension|hypertension
5711422|NCT00459758|Hans|hans
5711423|NCT00459758|Electrical stimulation|electrical stimulation
5711626|NCT00458952|Ultratrace|ultratrace
5711424|NCT00459745|Cardiovascular Disease|cardiovascular disease
5711425|NCT00459745|Fenofibrate|fenofibrate
5711426|NCT00459745|LDL cholesterol|ldl cholesterol
5711427|NCT00459745|HDL cholesterol|hdl cholesterol
5711428|NCT00459745|Hyperlipidemia|hyperlipidemia
5711429|NCT00459745|Pravastatin|pravastatin
5711430|NCT00459745|Triglycerides|triglycerides
5711431|NCT00459732|zinc, thalassemia, bone mineral density|zinc, thalassemia, bone mineral density
5711432|NCT00459719|Liver Transplantation|liver transplantation
5711433|NCT00459719|Tacrolimus|tacrolimus
5711434|NCT00459719|Methylprednisolone|methylprednisolone
5711435|NCT00459719|Prednisolone|prednisolone
5711436|NCT00459706|Rheumatoid Arthritis|rheumatoid arthritis
5711437|NCT00459693|HIV-Dementia|hiv-dementia
5711439|NCT00459693|PET|pet
5711440|NCT00459693|PBR28|pbr28
5711441|NCT00459693|MCMD|mcmd
5711442|NCT00459693|HIV Positive|hiv positive
5711443|NCT00459693|HIV Dementia|hiv dementia
5711444|NCT00459693|AIDS Related Dementia|aids related dementia
5711445|NCT00459693|Minor Cognitive Motor Disorder|minor cognitive motor disorder
5711446|NCT00459693|Healthy Volunteer|healthy volunteer
5711447|NCT00459693|HV|hv
5711448|NCT00459680|hypertension|hypertension
5711449|NCT00459680|acupuncture|acupuncture
5711450|NCT00459680|laser|laser
5711451|NCT00459667|Relapsing multiple sclerosis|relapsing multiple sclerosis
5711452|NCT00459667|interferon beta 1b|interferon beta 1b
5711453|NCT00459667|Betaferon|betaferon
5711454|NCT00459667|Betaseron|betaseron
5711456|NCT00459654|Recurrent Prostate Cancer|recurrent prostate cancer
5711457|NCT00459654|Metastatic Cancer|metastatic cancer
5711458|NCT00459641|Osteogenic Gel|osteogenic gel
5711459|NCT00459641|Solitary Bone Cysts|solitary bone cysts
5711460|NCT00459628|early breast cancer|early breast cancer
5711461|NCT00459628|post-operative radiation treatment|post-operative radiation treatment
5711462|NCT00459602|laparoscopic surgery|laparoscopic surgery
5711463|NCT00459589|Cancer|cancer
5711464|NCT00459589|elderly|elderly
5711465|NCT00459589|malnutrition|malnutrition
5711466|NCT00459589|chemotherapy|chemotherapy
5711467|NCT00459589|survival|survival
5711468|NCT00459589|comprehensive geriatric assessment|comprehensive geriatric assessment
5711469|NCT00459589|morbidity|morbidity
5711470|NCT00459576|Asthma|asthma
5711471|NCT00459576|Eczema|eczema
5711472|NCT00459576|Dermatitis, Atopic|dermatitis, atopic
5711473|NCT00459576|Infant|infant
5711474|NCT00459563|vitamin D|vitamin d
5711475|NCT00459563|blood pressure|blood pressure
5711476|NCT00459563|hypertension|hypertension
5711477|NCT00459563|Vitamin D insufficient|vitamin d insufficient
5711478|NCT00459563|Systolic blood pressure between 130 and 150 mmHg|systolic blood pressure between 130 and 150 mmhg
5711479|NCT00459550|Alzheimer's Disease|alzheimer's disease
5711480|NCT00459550|First Time in Human (FTIH) Study|first time in human (ftih) study
5711481|NCT00459537|Toenail fungus|toenail fungus
5711482|NCT00459537|Onychomycosis|onychomycosis
5711483|NCT00459537|Nail fungus|nail fungus
5711484|NCT00459537|Toenail fungal infection|toenail fungal infection
5711485|NCT00459537|Tinea unguium|tinea unguium
5711486|NCT00459537|Dermatophytes|dermatophytes
5711487|NCT00459537|Foot dermatoses|foot dermatoses
5710125|NCT00464347|AMD|amd
5711488|NCT00459524|Acute Myelogenous Leukemia|acute myelogenous leukemia
5711489|NCT00459524|Myelodysplastic Syndrome|myelodysplastic syndrome
5711490|NCT00459524|Leukemia|leukemia
5711491|NCT00459524|Quality of Life|quality of life
5711492|NCT00459524|Questionnaire|questionnaire
5711494|NCT00459524|Neurocognitive Function|neurocognitive function
5711495|NCT00459524|AML|aml
5711496|NCT00459524|MDS|mds
5711497|NCT00459524|QOL|qol
5711498|NCT00459511|Adrenomedullin|adrenomedullin
5711499|NCT00459511|Glucose|glucose
5711500|NCT00459511|Insulin|insulin
5711501|NCT00459511|Systemic Inflammatory response Syndrome|systemic inflammatory response syndrome
5711502|NCT00459511|Pediatric|pediatric
5711503|NCT00459511|Cortisol|cortisol
5711504|NCT00459511|ACTH|acth
5711506|NCT00459498|thyroid adenoma|thyroid adenoma
5711507|NCT00459498|thyroid cancer|thyroid cancer
5711508|NCT00459498|Iodine uptake|iodine uptake
5711509|NCT00459498|expression|expression
5711510|NCT00459485|Plasm zinc concentration|plasm zinc concentration
5711511|NCT00459485|Zinc supplementation|zinc supplementation
5711512|NCT00459485|Assessment of zinc status|assessment of zinc status
5711513|NCT00459485|Plasma zinc concentration|plasma zinc concentration
5711514|NCT00459472|resident training|resident training
5711515|NCT00459472|laparoscopy|laparoscopy
5711516|NCT00459472|virtual reality|virtual reality
5711517|NCT00459472|surgical education|surgical education
5711518|NCT00459446|Magnetic Resonance Imaging|magnetic resonance imaging
5711519|NCT00459446|Gadolinium Contrast|gadolinium contrast
5711520|NCT00459446|Gadofosveset|gadofosveset
5711521|NCT00459446|Atherosclerosis|atherosclerosis
5711522|NCT00459446|Chronic Total Arterial Occlusions|chronic total arterial occlusions
5711523|NCT00459446|Cardiovascular Disease|cardiovascular disease
5711524|NCT00459446|Blocked Arteries|blocked arteries
5711525|NCT00459446|Peripheral Artery Disease|peripheral artery disease
5711526|NCT00459446|PAD|pad
5711527|NCT00459446|Intermittent Claudication|intermittent claudication
5711528|NCT00459446|Chronic Total Arterial Occlusion|chronic total arterial occlusion
5711529|NCT00459433|Low back pain|low back pain
5711530|NCT00459433|Return to work|return to work
5711531|NCT00459433|Biopsychosocial|biopsychosocial
5711532|NCT00459433|Screening|screening
5711533|NCT00459433|SMS|sms
5711534|NCT00459433|Non specific low back pain|non specific low back pain
5711535|NCT00459420|Parkinson's disease|parkinson's disease
5711536|NCT00459420|Excessive Daytime Somnolence|excessive daytime somnolence
5711537|NCT00459420|Caffeine|caffeine
5711538|NCT00459420|Disease-Modifying|disease-modifying
5711539|NCT00459368|asthma|asthma
5711540|NCT00459368|patient compliance|patient compliance
5711541|NCT00459368|metered dose inhalers|metered dose inhalers
5711542|NCT00459368|corticosteroids|corticosteroids
5711543|NCT00459368|health behaviour|health behaviour
5711544|NCT00459368|prevention & control|prevention & control
5711545|NCT00459355|Alzheimer's disease|alzheimer's disease
5711546|NCT00459355|Dementia|dementia
5711547|NCT00459355|Safety|safety
5711548|NCT00459355|Home Care Services|home care services
5711549|NCT00459329|Depression|depression
5711550|NCT00459329|Epilepsy|epilepsy
5711551|NCT00459329|Problem-Solving Therapy|problem-solving therapy
5711552|NCT00459329|Mental Health|mental health
5711553|NCT00459329|Neurology|neurology
5711554|NCT00459329|Home-based health care|home-based health care
5711555|NCT00459329|Community-based program|community-based program
5711556|NCT00459329|Collaborative care|collaborative care
5711558|NCT00459303|aspherical intraocular lenses|aspherical intraocular lenses
5711559|NCT00459303|functional vision|functional vision
5711560|NCT00459290|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5711561|NCT00459290|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5711562|NCT00459290|fallopian tube cancer|fallopian tube cancer
5711564|NCT00459277|Cancer|cancer
5711565|NCT00459264|Folic Acid|folic acid
5711566|NCT00459264|Prevention|prevention
5711567|NCT00459264|Depression|depression
5711568|NCT00459264|Bipolar Disorder|bipolar disorder
5711569|NCT00459264|Teenagers|teenagers
5711570|NCT00459251|N-acetyltransferase|n-acetyltransferase
5711571|NCT00459251|Pharmacogenetics|pharmacogenetics
5711572|NCT00459238|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5711573|NCT00459225|Pediatrics|pediatrics
5711574|NCT00459225|Cardiac Defect|cardiac defect
5711575|NCT00459225|Cardiac Surgery|cardiac surgery
5711576|NCT00459225|Single Ventricle|single ventricle
5711577|NCT00459225|Anemia|anemia
5711578|NCT00459225|blood transfusions|blood transfusions
5711579|NCT00459225|red cell volume|red cell volume
5711580|NCT00459225|red cell distribution|red cell distribution
5720215|NCT00430872|Survey|survey
5711581|NCT00459225|oral iron|oral iron
5711582|NCT00459225|ferrous sulfate|ferrous sulfate
5711583|NCT00459225|Congenital Cardiac Defects|congenital cardiac defects
5711584|NCT00459225|Hemoglobin|hemoglobin
5711585|NCT00459225|Iron Deficiency|iron deficiency
5711586|NCT00459186|prostate cancer|prostate cancer
5711587|NCT00459186|RAD001|rad001
5711588|NCT00459186|mTOR inhibition|mtor inhibition
5711589|NCT00459186|docetaxel|docetaxel
5711590|NCT00459173|abstinence|abstinence
5711591|NCT00459173|maintenance|maintenance
5711592|NCT00459160|Hypotensive Resuscitation|hypotensive resuscitation
5711593|NCT00459160|Hypotensive Anesthesia|hypotensive anesthesia
5711594|NCT00459160|Hemorrhagic Shock|hemorrhagic shock
5711595|NCT00459160|Penetrating Trauma|penetrating trauma
5711596|NCT00459134|sexual dysfunction|sexual dysfunction
5711597|NCT00459134|sexuality and reproductive issues|sexuality and reproductive issues
5711598|NCT00459134|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5711599|NCT00459121|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5711600|NCT00459121|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5711601|NCT00459121|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5711602|NCT00459082|Dexmedetomine|dexmedetomine
5711603|NCT00459082|Post-operative cardiac surgery|post-operative cardiac surgery
5711604|NCT00459069|tumor vaccine|tumor vaccine
5711605|NCT00459069|GM-CSF|gm-csf
5711606|NCT00459043|SCCHN|scchn
5711607|NCT00459030|colon cancer|colon cancer
5711608|NCT00459030|rectal cancer|rectal cancer
5711609|NCT00459017|24 hour ambulatory blood pressure measurement|24 hour ambulatory blood pressure measurement
5711610|NCT00459017|Mean blood pressure|mean blood pressure
5711611|NCT00459017|Wrist manometer|wrist manometer
5711612|NCT00459017|Frequent measurement|frequent measurement
5711613|NCT00459004|weight loss|weight loss
5711614|NCT00458991|Recombinant Human Growth Hormone|recombinant human growth hormone
5711615|NCT00458991|growth hormone deficiency|growth hormone deficiency
5711616|NCT00458991|short stature|short stature
5711617|NCT00458991|phenotyping|phenotyping
5711619|NCT00458952|iobenguane|iobenguane
5711620|NCT00458952|iodine|iodine
5711621|NCT00458952|I 131|i 131
5711622|NCT00458952|radiotherapy|radiotherapy
5711623|NCT00458952|radiopharmaceutical|radiopharmaceutical
5711624|NCT00458952|dosimetry|dosimetry
5711625|NCT00458952|neuroendocrine tumor|neuroendocrine tumor
5711627|NCT00458952|no carrier added|no carrier added
5711628|NCT00458952|metaiodobenzyl-guanidine|metaiodobenzyl-guanidine
5711629|NCT00458926|ventilation, mechanical|ventilation, mechanical
5711630|NCT00458926|intubation, endotracheal|intubation, endotracheal
5711631|NCT00458926|respiratory insufficiency|respiratory insufficiency
5712000|NCT00457704|Home Care|home care
5711632|NCT00458913|localized malignant mesothelioma|localized malignant mesothelioma
5711633|NCT00458913|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5711634|NCT00458913|advanced malignant mesothelioma|advanced malignant mesothelioma
5711635|NCT00458887|ototoxicity|ototoxicity
5711636|NCT00458887|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5711637|NCT00458874|CV risk factors|cv risk factors
5711638|NCT00458874|subclinical atherosclerosis|subclinical atherosclerosis
5711639|NCT00458874|lifestyle intervention|lifestyle intervention
5711640|NCT00458874|motivation|motivation
5711641|NCT00458861|Active Rheumatoid Arthritis (RA)|active rheumatoid arthritis (ra)
5711642|NCT00458848|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5711643|NCT00458848|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5711644|NCT00458848|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5711645|NCT00458848|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5711646|NCT00458848|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5711647|NCT00458848|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5711648|NCT00458835|Allergic rhinitis|allergic rhinitis
5711649|NCT00458822|primary systemic amyloidosis|primary systemic amyloidosis
5711650|NCT00458809|recurrent colon cancer|recurrent colon cancer
5711651|NCT00458809|stage IV colon cancer|stage iv colon cancer
5711652|NCT00458809|carcinoma of the appendix|carcinoma of the appendix
5711653|NCT00458809|recurrent rectal cancer|recurrent rectal cancer
5711654|NCT00458809|stage IV rectal cancer|stage iv rectal cancer
5711655|NCT00458809|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5711656|NCT00458796|hypercalcemia of malignancy|hypercalcemia of malignancy
5711657|NCT00458796|musculoskeletal complications|musculoskeletal complications
5711659|NCT00458796|stage IV breast cancer|stage iv breast cancer
5711660|NCT00458796|male breast cancer|male breast cancer
5711661|NCT00458796|recurrent breast cancer|recurrent breast cancer
5711662|NCT00458796|bone metastases|bone metastases
5711663|NCT00458783|Transfusion|transfusion
5711664|NCT00458783|Cardiac|cardiac
5711665|NCT00458783|Blood storage duration|blood storage duration
5789081|NCT00150007|Kidney, maintenance transplant, GI complaints, patient reported outcome|kidney, maintenance transplant, gi complaints, patient reported outcome
5863605|NCT00001241|Gastric Acid Secretion|gastric acid secretion
5711666|NCT00458770|Comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with IHS criteria|comparison of a spontaneous acute cluster headache attack and rest (no pain) in ten patients with cluster headache defined with ihs criteria
5711667|NCT00458757|Amputees|amputees
5711668|NCT00458757|Affordance|affordance
5711669|NCT00458757|Peripersonal space|peripersonal space
5711670|NCT00458757|Pseudo neglect|pseudo neglect
5711671|NCT00458757|Reaching|reaching
5711672|NCT00458757|Spatial|spatial
5711673|NCT00458757|visual|visual
5685834|NCT00554671|behavioral modification|behavioral modification
5685835|NCT00554671|pharmacotherapy|pharmacotherapy
5711674|NCT00458744|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5711675|NCT00458744|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5711676|NCT00458744|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5711677|NCT00458744|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5711678|NCT00458744|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5711679|NCT00458744|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5711680|NCT00458744|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5711681|NCT00458744|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5711682|NCT00458744|childhood choroid plexus tumor|childhood choroid plexus tumor
5711683|NCT00458744|childhood craniopharyngioma|childhood craniopharyngioma
5711684|NCT00458744|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5711685|NCT00458744|childhood grade I meningioma|childhood grade i meningioma
5711686|NCT00458744|childhood grade II meningioma|childhood grade ii meningioma
5711687|NCT00458744|childhood grade III meningioma|childhood grade iii meningioma
5711688|NCT00458744|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5711689|NCT00458744|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5711690|NCT00458744|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5711691|NCT00458744|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5711692|NCT00458744|recurrent childhood ependymoma|recurrent childhood ependymoma
5711693|NCT00458744|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5711694|NCT00458744|recurrent childhood supratentorial primitive neuroectodermal tumors|recurrent childhood supratentorial primitive neuroectodermal tumors
5711695|NCT00458744|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5711696|NCT00458744|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5711697|NCT00458744|high-grade childhood cerebral astrocytoma|high-grade childhood cerebral astrocytoma
5711698|NCT00458744|low-grade childhood cerebral astrocytoma|low-grade childhood cerebral astrocytoma
5711699|NCT00458744|recurrent childhood brain tumor|recurrent childhood brain tumor
5711700|NCT00458744|childhood spinal cord tumor|childhood spinal cord tumor
5711701|NCT00458744|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5711702|NCT00458744|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5711703|NCT00458744|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5711704|NCT00458744|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5711705|NCT00458744|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5711706|NCT00458744|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5711707|NCT00458744|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5711708|NCT00458744|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5711709|NCT00458744|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5711710|NCT00458744|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5711711|NCT00458744|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5711712|NCT00458744|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5711714|NCT00458718|nicotine patch|nicotine patch
5711715|NCT00458705|stage I multiple myeloma|stage i multiple myeloma
5711716|NCT00458705|stage II multiple myeloma|stage ii multiple myeloma
5711717|NCT00458705|stage III multiple myeloma|stage iii multiple myeloma
5711718|NCT00458705|refractory multiple myeloma|refractory multiple myeloma
5711719|NCT00458679|CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)|chronic lymphocytic leukemia (b-cll)
5711720|NCT00458679|CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS|cd40 ligand and il-2-expressing tumor cells
5711721|NCT00458666|Amniotic fluid|amniotic fluid
5711723|NCT00458666|coagulation|coagulation
5711724|NCT00458666|factor X activation|factor x activation
5711725|NCT00458653|DC/tumor cell fusions|dc/tumor cell fusions
5711726|NCT00458653|GM-CSF|gm-csf
5711727|NCT00458653|high dose chemotherapy|high dose chemotherapy
5711728|NCT00458627|Plethysmograpy|plethysmograpy
5711729|NCT00458627|preschool|preschool
5711730|NCT00458627|methacholine challenge|methacholine challenge
5711731|NCT00458627|spirometry|spirometry
5711732|NCT00458627|asthma|asthma
5711733|NCT00458614|Cystic Fibrosis|cystic fibrosis
5711734|NCT00458601|EGFRvIII vaccinetemozolomidecancer vaccineimmunotherapy|egfrviii vaccinetemozolomidecancer vaccineimmunotherapy
5711735|NCT00458588|breast cancer|breast cancer
5711736|NCT00458575|Retinitis Pigmentosa|retinitis pigmentosa
5736946|NCT00369486|DME|dme
5711737|NCT00458575|Advanced retinitis pigmentosa (RP)|advanced retinitis pigmentosa (rp)
5711738|NCT00458575|CNTO 2476|cnto 2476
5711739|NCT00458575|Subretinal|subretinal
5711740|NCT00458575|Human umbilical tissue-derived cells (hUTC)|human umbilical tissue-derived cells (hutc)
5711741|NCT00458575|Light perception (LP)|light perception (lp)
5711742|NCT00458575|Hand motion (HM)|hand motion (hm)
5711743|NCT00458562|cervical cancer|cervical cancer
5710427|NCT00463385|MMM|mmm
5711744|NCT00458562|atypical squamous cells of undetermined significance|atypical squamous cells of undetermined significance
5711745|NCT00458562|stage 0 cervical cancer|stage 0 cervical cancer
5711746|NCT00458562|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5711747|NCT00458562|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5711748|NCT00458562|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5711749|NCT00458549|stage I prostate cancer|stage i prostate cancer
5711750|NCT00458549|stage II prostate cancer|stage ii prostate cancer
5711751|NCT00458549|stage III prostate cancer|stage iii prostate cancer
5711752|NCT00458549|stage IV prostate cancer|stage iv prostate cancer
5711753|NCT00458536|GM-CSF|gm-csf
5711754|NCT00458536|vaccine|vaccine
5711755|NCT00458536|debulking nephrectomy|debulking nephrectomy
5711756|NCT00458536|dendritic cells|dendritic cells
5711757|NCT00458523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5711758|NCT00458523|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5711759|NCT00458523|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5711760|NCT00458523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5711761|NCT00458523|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5711762|NCT00458523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5727931|NCT00402610|HIV|hiv
5711763|NCT00458510|Pain|pain
5711764|NCT00458510|Cancer|cancer
5711765|NCT00458510|Breakthrough|breakthrough
5711766|NCT00458497|Holofiber|holofiber
5711767|NCT00458497|chronic foot pain|chronic foot pain
5711768|NCT00458497|sleep quality|sleep quality
5711769|NCT00458484|stage I renal cell cancer|stage i renal cell cancer
5711770|NCT00458484|stage II renal cell cancer|stage ii renal cell cancer
5711771|NCT00458484|stage III renal cell cancer|stage iii renal cell cancer
5711772|NCT00458484|stage IV renal cell cancer|stage iv renal cell cancer
5711773|NCT00458471|Urinary Catheter|urinary catheter
5711774|NCT00458471|Spinal Cord Injury|spinal cord injury
5711775|NCT00458471|Escherichia Coli|escherichia coli
5711776|NCT00458471|Urinary Tract Infection|urinary tract infection
5711777|NCT00458458|Endometriosis|endometriosis
5711778|NCT00458458|Dysmenorrhea|dysmenorrhea
5711779|NCT00458458|Pelvic Pain|pelvic pain
5711780|NCT00458458|Period Pain|period pain
5711781|NCT00458458|Menstrual Cramps|menstrual cramps
5711782|NCT00458458|Dyspareunia|dyspareunia
5711783|NCT00458458|Norethindrone Acetate|norethindrone acetate
5711784|NCT00458458|Lupron Depot|lupron depot
5711785|NCT00458458|Bone Density|bone density
5711786|NCT00458458|Lipid Profile|lipid profile
5711787|NCT00458445|Attention-Deficit Hyperactivity Disorder (ADHD)|attention-deficit hyperactivity disorder (adhd)
5711788|NCT00458432|fMRI|fmri
5711789|NCT00458432|Pavlovian Conditioning|pavlovian conditioning
5711790|NCT00458432|Functional Activity|functional activity
5711791|NCT00458432|Brain|brain
5711792|NCT00458432|Fear|fear
5711793|NCT00458432|Healthy Volunteer|healthy volunteer
5711794|NCT00458432|HV|hv
5711795|NCT00458419|dyspnea; leg discomfort; exercise duration|dyspnea; leg discomfort; exercise duration
5711796|NCT00458406|obstructive sleep apnea|obstructive sleep apnea
5711797|NCT00458406|child|child
5711798|NCT00458406|CPAP|cpap
5711799|NCT00458393|HIV|hiv
5711800|NCT00458393|Chemoprophylaxis|chemoprophylaxis
5711801|NCT00458393|Hepatitis|hepatitis
5711802|NCT00458393|Viral human hepatitis|viral human hepatitis
5711803|NCT00458393|HIV Seronegativity|hiv seronegativity
5706367|NCT00478179|PHN|phn
5711804|NCT00458380|Doppler ultrasonography|doppler ultrasonography
5711806|NCT00458380|Infertility|infertility
5711807|NCT00458380|IVF|ivf
5711808|NCT00458380|Oocytes|oocytes
5711809|NCT00458380|Tubal factor|tubal factor
5711810|NCT00458380|unexplained infertility|unexplained infertility
5711811|NCT00458367|PASS|pass
5711812|NCT00458367|Safety Assessment|safety assessment
5711813|NCT00458367|Efficacy Assessment|efficacy assessment
5711814|NCT00458367|long-acting injectable risperidone|long-acting injectable risperidone
5711815|NCT00458354|Spinal Sealant|spinal sealant
5711816|NCT00458354|Spinal Sealant System|spinal sealant system
5711817|NCT00458354|Dural Repair|dural repair
5711818|NCT00458354|Spinal Surgery|spinal surgery
5711819|NCT00458341|Cystic fibrosis|cystic fibrosis
5711820|NCT00458341|Nonsense mutation|nonsense mutation
5711821|NCT00458341|Premature stop codon|premature stop codon
5711822|NCT00458302|HIV|hiv
5711823|NCT00458302|Monotherapy|monotherapy
5711824|NCT00458302|Darunavir|darunavir
5711825|NCT00458302|Protease inhibitor|protease inhibitor
5711826|NCT00458302|Early pre-treated|early pre-treated
5711827|NCT00458302|Undetectable|undetectable
5711828|NCT00458302|Treatment Experienced|treatment experienced
5711829|NCT00458276|Left sided heart disease|left sided heart disease
5711830|NCT00458276|Elevated pulmonary arterial pressure|elevated pulmonary arterial pressure
5711831|NCT00458276|Right ventricular failure|right ventricular failure
5711832|NCT00458276|Cardiac surgery|cardiac surgery
5711833|NCT00458276|heart-lung machine|heart-lung machine
5711834|NCT00458276|cardiopulmonary bypass|cardiopulmonary bypass
5711835|NCT00458276|tezosentan|tezosentan
5711836|NCT00458276|Actelion|actelion
5711837|NCT00458263|Growth Hormone treatment|growth hormone treatment
5711838|NCT00458263|ISS|iss
5711839|NCT00458263|Biochemical markers|biochemical markers
5711840|NCT00458263|Growth response|growth response
5711841|NCT00458250|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5711842|NCT00458250|Haploidentical|haploidentical
5711843|NCT00458250|Hematologic Neoplasms|hematologic neoplasms
5711844|NCT00458250|human, Bone Marrow|human, bone marrow
5711845|NCT00458250|Granulocyte Colony-stimulating Factor|granulocyte colony-stimulating factor
5711846|NCT00458250|CAMPATH|campath
5711847|NCT00458250|Alemtuzumab|alemtuzumab
5711848|NCT00458250|AML|aml
5711849|NCT00458250|ALL|all
5711850|NCT00458250|10. Eligibility|10. eligibility
5711851|NCT00458237|HER2 positive|her2 positive
5711852|NCT00458237|metastatic breast cancer|metastatic breast cancer
5711853|NCT00458237|RAD001|rad001
5711854|NCT00458237|Herceptin|herceptin
5711855|NCT00458224|overweight|overweight
5711857|NCT00458224|child|child
5711858|NCT00458211|Schizophrenia|schizophrenia
5711859|NCT00458211|Ziprasidone|ziprasidone
5711860|NCT00458198|Selective Mutism|selective mutism
5711861|NCT00458172|lay theories|lay theories
5711862|NCT00458172|health concepts|health concepts
5711863|NCT00458172|survey|survey
5711864|NCT00458172|internet research|internet research
5711865|NCT00458172|Ideas about health|ideas about health
5711866|NCT00458159|CC-11006|cc-11006
5711867|NCT00458159|RA|ra
5711868|NCT00458159|MDS|mds
5711869|NCT00458159|Celgene|celgene
5711870|NCT00458159|RCMD-RS|rcmd-rs
5711871|NCT00458159|RARS|rars
5711872|NCT00458159|RAEB-1|raeb-1
5711873|NCT00458159|Low-or Intermediate-1-Risk Myelodysplastic Syndrome (MDS)|low-or intermediate-1-risk myelodysplastic syndrome (mds)
5711874|NCT00458133|aerobic exercise|aerobic exercise
5711875|NCT00458133|resistance exercise|resistance exercise
5711876|NCT00458133|type 2 diabetes|type 2 diabetes
5711877|NCT00458133|hemoglobin A1C|hemoglobin a1c
5711878|NCT00458133|exercise|exercise
5711879|NCT00458120|Dengue Fever|dengue fever
5711880|NCT00458120|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5711881|NCT00458120|Dengue Vaccination|dengue vaccination
5711882|NCT00458107|Pharmacokinetics|pharmacokinetics
5711883|NCT00458107|Pharmacodynamics|pharmacodynamics
5711884|NCT00458094|Exercise|exercise
5711885|NCT00458094|Mental Illness|mental illness
5711886|NCT00458094|Community Psychiatry|community psychiatry
5711887|NCT00458094|Peer Support|peer support
5711888|NCT00458094|Mental Disorders|mental disorders
5711889|NCT00458068|preterm infant|preterm infant
5711890|NCT00458068|iron supplementation|iron supplementation
5711891|NCT00458068|iron deficiency|iron deficiency
5711892|NCT00458068|blood transfusion|blood transfusion
5711893|NCT00458055|Lipid lowering agents|lipid lowering agents
5711894|NCT00458055|Drug treatment|drug treatment
5711895|NCT00458055|Statin|statin
5711896|NCT00458055|Fibrate|fibrate
5711897|NCT00458055|Niacin|niacin
5711898|NCT00458055|Cellular cholesterol efflux|cellular cholesterol efflux
5711899|NCT00458042|Ventavis|ventavis
5711900|NCT00458042|iloporst|iloporst
5711901|NCT00458042|Remodulin|remodulin
5711902|NCT00458042|treprostinil|treprostinil
5711904|NCT00458042|prostacyclin|prostacyclin
5711905|NCT00458029|type 2 diabetes risk factors|type 2 diabetes risk factors
5711906|NCT00458029|obesity|obesity
5711907|NCT00458029|prevention|prevention
5711908|NCT00458029|adolescence|adolescence
5706479|NCT00477906|vaccine|vaccine
5711909|NCT00458029|school based|school based
5711910|NCT00458003|Preeclampsia|preeclampsia
5711911|NCT00458003|Spinal Anesthesia|spinal anesthesia
5711912|NCT00458003|Hypotension|hypotension
5711913|NCT00458003|Cesarean Delivery|cesarean delivery
5711914|NCT00458003|Phenylephrine|phenylephrine
5711915|NCT00458003|Ephedrine|ephedrine
5711916|NCT00457990|Neurocognitive outcome|neurocognitive outcome
5711917|NCT00457990|preterm infant|preterm infant
5711918|NCT00457990|very low birth weight|very low birth weight
5711919|NCT00457990|iron deficiency|iron deficiency
5711920|NCT00457990|iron supplementation|iron supplementation
5711921|NCT00457977|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5711922|NCT00457977|COPD|copd
5711923|NCT00457977|Pneumococcal|pneumococcal
5711924|NCT00457977|Vaccine|vaccine
5711925|NCT00457977|Opsonization|opsonization
5711926|NCT00457977|Antibodies|antibodies
5711927|NCT00457964|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5711928|NCT00457964|Lymyphangioleiomyomatosis|lymyphangioleiomyomatosis
5711929|NCT00457964|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5711930|NCT00457964|RAD001|rad001
5711931|NCT00457964|Angiomyolipmas|angiomyolipmas
5711932|NCT00457951|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5680584|NCT00577278|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5680585|NCT00577278|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5711933|NCT00457951|COPD|copd
5711934|NCT00457951|Heparin|heparin
5711935|NCT00457951|ODSH|odsh
5711936|NCT00457951|Exacerbations of COPD|exacerbations of copd
5711937|NCT00457938|lipodystrophy|lipodystrophy
5711938|NCT00457925|absorption,|absorption,
5711939|NCT00457925|metabolism,|metabolism,
5711940|NCT00457925|excretion|excretion
5711941|NCT00457925|distribution,|distribution,
5711942|NCT00457899|schizophrenia|schizophrenia
5711943|NCT00457899|schizoaffective disorder|schizoaffective disorder
5711944|NCT00457899|quetiapine|quetiapine
5711945|NCT00457899|seroquel|seroquel
5711946|NCT00457899|titration|titration
5711947|NCT00457873|surgery|surgery
5711948|NCT00457860|CLL|cll
5711949|NCT00457860|PLL|pll
5711950|NCT00457860|SLL|sll
5711951|NCT00457860|Relapse|relapse
5711952|NCT00457860|Refractory|refractory
5711953|NCT00457860|immunotoxin|immunotoxin
5711954|NCT00457860|HA22|ha22
5711955|NCT00457860|CAT-8015|cat-8015
5711956|NCT00457860|immunotherapy|immunotherapy
5711957|NCT00457847|PGD|pgd
5711958|NCT00457834|Heart failure|heart failure
5711959|NCT00457834|Dyssynchrony|dyssynchrony
5711960|NCT00457834|Cardiac resynchronization therapy|cardiac resynchronization therapy
5711961|NCT00457834|Atrial fibrillation|atrial fibrillation
5711962|NCT00457834|RVOT|rvot
5711964|NCT00457821|G551D mutation|g551d mutation
5711965|NCT00457821|Fibrosis|fibrosis
5711966|NCT00457821|Pancreatic Diseases|pancreatic diseases
5711967|NCT00457821|Digestive System Diseases|digestive system diseases
5711968|NCT00457821|Lung Diseases|lung diseases
5711969|NCT00457821|Respiratory Tract Diseases|respiratory tract diseases
5711970|NCT00457821|Genetic Diseases, Inborn|genetic diseases, inborn
5711971|NCT00457821|Infant, Newborn, Diseases|infant, newborn, diseases
5711972|NCT00457821|Pathologic Processes|pathologic processes
5711973|NCT00457808|TSC and LAM|tsc and lam
5711974|NCT00457808|Tuberous Sclerosis Complex and sporadic LAM|tuberous sclerosis complex and sporadic lam
5711975|NCT00457782|Cancer|cancer
5711976|NCT00457782|Blood disorders|blood disorders
5711977|NCT00457782|Leukaemia, Adult Chronic|leukaemia, adult chronic
5711978|NCT00457782|Lymphoma|lymphoma
5711979|NCT00457782|Multiple Myeloma|multiple myeloma
5711980|NCT00457769|Aricept|aricept
5711981|NCT00457769|Donepezil|donepezil
5711982|NCT00457769|Memory|memory
5711983|NCT00457769|vascular dementia|vascular dementia
5711984|NCT00457769|stroke|stroke
5711985|NCT00457769|functional tasks|functional tasks
5711986|NCT00457769|self-generation|self-generation
5711987|NCT00457756|LDL cholesterol|ldl cholesterol
5711988|NCT00457756|HDL cholesterol|hdl cholesterol
5711989|NCT00457756|natural supplement|natural supplement
5711990|NCT00457756|guar gum|guar gum
5711991|NCT00457756|phytosterols|phytosterols
5711992|NCT00457756|policosanol|policosanol
5711993|NCT00457756|chrysanthemum|chrysanthemum
5711994|NCT00457743|Evaluate of RTD for Japanese GIST patients|evaluate of rtd for japanese gist patients
5711995|NCT00457730|Multiple Sclerosis|multiple sclerosis
5711996|NCT00457730|Duloxetine|duloxetine
5711997|NCT00457730|Pain|pain
5711998|NCT00457717|myopia, auricular acupoint, atropine, RCT|myopia, auricular acupoint, atropine, rct
5712001|NCT00457704|Risk factors|risk factors
5712002|NCT00457704|transmissions|transmissions
5712003|NCT00457704|observational study|observational study
5712004|NCT00457691|colorectal neoplasms|colorectal neoplasms
5712005|NCT00457678|Vision loss|vision loss
5712006|NCT00457678|Retina|retina
5712007|NCT00457678|VEG-F|veg-f
5712008|NCT00457678|Fovea|fovea
5712011|NCT00457665|Lipodystrophy|lipodystrophy
5712012|NCT00457665|Treatment Experienced|treatment experienced
5712013|NCT00457652|Rosuvastatin|rosuvastatin
5712014|NCT00457652|Caffeine|caffeine
5712016|NCT00457652|Reperfusion|reperfusion
5712017|NCT00457639|lipodystrophy|lipodystrophy
5712018|NCT00457626|Children|children
5712019|NCT00457626|pediatrics|pediatrics
5712020|NCT00457626|High Blood Pressure|high blood pressure
5712021|NCT00457626|Hypertension|hypertension
5712022|NCT00457626|Valsartan|valsartan
5712023|NCT00457613|alkaline phosphatase|alkaline phosphatase
5712024|NCT00457613|sepsis|sepsis
5712025|NCT00457613|kidney function|kidney function
5712026|NCT00457600|information technology|information technology
5712027|NCT00457600|emergency department|emergency department
5712028|NCT00457600|medication error|medication error
5712029|NCT00457600|quality of care|quality of care
5712030|NCT00457600|patient-centered care|patient-centered care
5712031|NCT00457561|The relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level|the relationship between all-cause mortality in patients introduced hemodialysis and recombinant human erythropoietin dose and serum adiponectin level
5680586|NCT00577278|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5680587|NCT00577278|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5680588|NCT00577278|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5737179|NCT00368433|Sensory Processing|sensory processing
5712032|NCT00457548|Alcohol use|alcohol use
5712033|NCT00457548|Brief Interventions|brief interventions
5712034|NCT00457548|Injuries|injuries
5712035|NCT00457548|Emergency Department Patients|emergency department patients
5712036|NCT00457548|Harmful and hazardous alcohol use among ED injured patients|harmful and hazardous alcohol use among ed injured patients
5712037|NCT00457535|recombinant human erythropoietin|recombinant human erythropoietin
5712038|NCT00457535|adiponectin|adiponectin
5685836|NCT00554645|obesity|obesity
5712039|NCT00457535|mortality|mortality
5712040|NCT00457522|intimate partner violence|intimate partner violence
5712041|NCT00457522|depression|depression
5712043|NCT00457522|fatigue|fatigue
5712044|NCT00457509|Pandemic influenza|pandemic influenza
5712045|NCT00457509|Avian influenza|avian influenza
5712046|NCT00457509|Orthomyxoviridae Infections|orthomyxoviridae infections
5712047|NCT00457509|A/H5N1|a/h5n1
5712048|NCT00457496|Behavior Therapy|behavior therapy
5712049|NCT00457496|Relaxation Techniques|relaxation techniques
5712050|NCT00457496|Cognitive Therapy|cognitive therapy
5712051|NCT00457496|Exercise Movement Techniques|exercise movement techniques
5712052|NCT00457483|hypertension|hypertension
5712053|NCT00457483|diuretic|diuretic
5712054|NCT00457483|angiotensin receptor blockers|angiotensin receptor blockers
5712055|NCT00457483|prediction|prediction
5712056|NCT00457457|With or without erectile dysfunction|with or without erectile dysfunction
5712057|NCT00457431|in-hospital cardiac arrest|in-hospital cardiac arrest
5712058|NCT00457431|resuscitation|resuscitation
5712059|NCT00457431|mild therapeutic hypothermia|mild therapeutic hypothermia
5712060|NCT00457405|ischemia-reperfusion injury|ischemia-reperfusion injury
5712061|NCT00457405|atherosclerosis|atherosclerosis
5712062|NCT00457405|dipyridamole|dipyridamole
5712063|NCT00457405|annexin A5 targeting|annexin a5 targeting
5712064|NCT00457392|Non-small cell lung cancer|non-small cell lung cancer
5712065|NCT00457392|sunitinib|sunitinib
5712066|NCT00457392|erlotinib|erlotinib
5712067|NCT00457392|Phase 3|phase 3
5712068|NCT00457379|Coronary artery disease|coronary artery disease
5712069|NCT00457379|HDL-Cholesterol|hdl-cholesterol
5712070|NCT00457379|Endothelial Function|endothelial function
5712071|NCT00457379|Endothelial Progenitor Cells|endothelial progenitor cells
5712072|NCT00457379|normal blood HDL-Cholesterol level|normal blood hdl-cholesterol level
5712073|NCT00457340|Tachycardia, Ventricular|tachycardia, ventricular
5712074|NCT00457340|Ventricular Fibrillation|ventricular fibrillation
5712075|NCT00457327|protective ileostomy|protective ileostomy
5712076|NCT00457327|rectal cancer|rectal cancer
5712077|NCT00457327|low anterior resection|low anterior resection
5712078|NCT00457314|single-large scale deletions|single-large scale deletions
5712079|NCT00457314|point mutations in mtDNA|point mutations in mtdna
5712080|NCT00457301|Lung transplantation, health-related quality of life.|lung transplantation, health-related quality of life.
5712081|NCT00457288|Cutaneous Mastocytosis|cutaneous mastocytosis
5712082|NCT00457288|Topical treatment|topical treatment
5712083|NCT00457262|paraoxonase1 activity|paraoxonase1 activity
5712084|NCT00457262|LDL|ldl
5712085|NCT00457262|HDL|hdl
5712086|NCT00457262|postmenopausal women|postmenopausal women
5712187|NCT00456911|dietary|dietary
5712087|NCT00457262|postmenopausal women and hyperlipidemia|postmenopausal women and hyperlipidemia
5712088|NCT00457249|Pertussis|pertussis
5712089|NCT00457249|Tetanus|tetanus
5712090|NCT00457249|Diphtheria|diphtheria
5712091|NCT00457249|Tdap|tdap
5712092|NCT00457236|Clopidogrel|clopidogrel
5712093|NCT00457236|Coronary Artery Disease|coronary artery disease
5712094|NCT00457236|Dose-Response Relationship, Drug|dose-response relationship, drug
5712095|NCT00457236|Drug Resistance|drug resistance
5712096|NCT00457236|PCI|pci
5712097|NCT00457223|pterygium|pterygium
5712098|NCT00457223|pterygia|pterygia
5712099|NCT00457223|excision|excision
5712100|NCT00457223|amniotic membrane transplantation|amniotic membrane transplantation
5712101|NCT00457223|fibrin glue|fibrin glue
5712102|NCT00457223|suture|suture
5712103|NCT00457210|Psychology|psychology
5712104|NCT00457197|bipolar disorder|bipolar disorder
5712105|NCT00457197|alcohol dependence|alcohol dependence
5712106|NCT00457197|mania|mania
5712107|NCT00457197|manic disorder|manic disorder
5712108|NCT00457197|depression|depression
5712109|NCT00457184|Migraine|migraine
5712110|NCT00457184|Thrombosis|thrombosis
5712111|NCT00457184|Thrombophilia|thrombophilia
5712112|NCT00457171|GI-270384 colitis patients ECAM oral|gi-270384 colitis patients ecam oral
5712113|NCT00457158|pulmonary embolism|pulmonary embolism
5712114|NCT00457158|inferior vena cava filters|inferior vena cava filters
5712115|NCT00457158|venous thrombosis|venous thrombosis
5680589|NCT00577278|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5680590|NCT00577278|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5680591|NCT00577278|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5680592|NCT00577278|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5680593|NCT00577278|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5680594|NCT00577278|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5680595|NCT00577278|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5680596|NCT00577278|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5680597|NCT00577278|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5712116|NCT00457158|randomized controlled trial|randomized controlled trial
5712117|NCT00457145|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
5712118|NCT00457145|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
5710792|NCT00462189|HCL|hcl
5712119|NCT00457145|Retinal Edema/Thinning|retinal edema/thinning
5712120|NCT00457145|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5712121|NCT00457145|Macular Telangiectasia|macular telangiectasia
5712122|NCT00457132|Knee|knee
5712123|NCT00457132|Osteoarthritis|osteoarthritis
5712124|NCT00457132|WOMAC|womac
5712125|NCT00457132|ALF|alf
5712126|NCT00457132|Wedging|wedging
5712127|NCT00457119|Non Small Cell Lung Cancer|non small cell lung cancer
5712128|NCT00457119|NSCLC|nsclc
5712129|NCT00457119|Advanced Lung Cancer|advanced lung cancer
5712130|NCT00457119|RAD|rad
5712131|NCT00457119|RAD001|rad001
5712132|NCT00457119|chemotherapy|chemotherapy
5712133|NCT00457119|carboplatin|carboplatin
5712134|NCT00457119|paclitaxel|paclitaxel
5712135|NCT00457119|bevacizumab|bevacizumab
5712136|NCT00457106|panic|panic
5712137|NCT00457093|Type 2 Diabetes|type 2 diabetes
5712138|NCT00457093|continuous glucose monitoring|continuous glucose monitoring
5712139|NCT00457093|basal insulin|basal insulin
5712140|NCT00457080|capnography|capnography
5712141|NCT00457080|safety|safety
5712142|NCT00457080|opioids|opioids
5712143|NCT00457080|respiratory depression|respiratory depression
5712144|NCT00457080|postoperative|postoperative
5712145|NCT00457080|orthopedic|orthopedic
5712146|NCT00457080|OSA|osa
5712147|NCT00457080|apnea|apnea
5712148|NCT00457067|Hyperfluorescence on Fluorescein|hyperfluorescence on fluorescein
5712149|NCT00457067|Idiopathic Juxtafoveal Telangiectasia|idiopathic juxtafoveal telangiectasia
5712150|NCT00457067|Retinal Edema/Thinning|retinal edema/thinning
5712151|NCT00457067|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5712152|NCT00457067|Macular Telangiectasia|macular telangiectasia
5712153|NCT00457054|Mood Regulating Circuit|mood regulating circuit
5712154|NCT00457054|Lithium|lithium
5712155|NCT00457054|fMRI|fmri
5712156|NCT00457041|Trust|trust
5712157|NCT00457041|Decision Making|decision making
5712158|NCT00457041|Vulnerability|vulnerability
5712159|NCT00457041|Survey|survey
5712160|NCT00457028|Obsessive Compulsive Disorder|obsessive compulsive disorder
5712161|NCT00457028|Anxiety|anxiety
5712162|NCT00457028|Treatment efficacy|treatment efficacy
5712163|NCT00457002|Prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients|prevention of deep vein thrombosis and pulmonary embolism with acutely ill hospitalized patients
5712164|NCT00456989|Androgen Independent|androgen independent
5712165|NCT00456989|Prostate Cancer|prostate cancer
5712166|NCT00456989|Taxotere|taxotere
5712167|NCT00456989|Doxil|doxil
5712168|NCT00456989|AIPC|aipc
5712169|NCT00456989|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
5712170|NCT00456976|Seligiline|seligiline
5712171|NCT00456976|Negative symptoms|negative symptoms
5712172|NCT00456976|Schizopherenia|schizopherenia
5712173|NCT00456963|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5712174|NCT00456963|angiotensin receptor blockers|angiotensin receptor blockers
5712175|NCT00456963|diabetes|diabetes
5712176|NCT00456963|hypertension|hypertension
5712177|NCT00456963|therapeutic strategies|therapeutic strategies
5712178|NCT00456950|coronary atherosclerosis|coronary atherosclerosis
5712179|NCT00456950|magnetic resonance imaging|magnetic resonance imaging
5712180|NCT00456950|vulnerable plaque|vulnerable plaque
5680598|NCT00577278|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5680599|NCT00577278|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5680600|NCT00577278|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5680601|NCT00577278|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5712181|NCT00456924|progesterone receptor modulator|progesterone receptor modulator
5712184|NCT00456911|children|children
5712185|NCT00456911|adults|adults
5712186|NCT00456911|family|family
5712188|NCT00456911|coaching|coaching
5712189|NCT00456911|body mass index|body mass index
5712190|NCT00456911|fat mass|fat mass
5712191|NCT00456885|obesity|obesity
5712192|NCT00456885|double blind|double blind
5712193|NCT00456885|placebo controlled|placebo controlled
5712194|NCT00456885|weight loss|weight loss
5712195|NCT00456885|appetite|appetite
5712196|NCT00456885|energy expenditure|energy expenditure
5712197|NCT00456872|Pain during injection of the pre-procedure anesthetic|pain during injection of the pre-procedure anesthetic
5712198|NCT00456859|chronic kidney disease|chronic kidney disease
5712199|NCT00456859|oral carbonaceous adsorbent|oral carbonaceous adsorbent
5712200|NCT00456859|randomized clinical trial|randomized clinical trial
5712201|NCT00456859|composite endpoint|composite endpoint
5712202|NCT00456846|Metastatic Breast Cancer, ABI-007, Abraxane|metastatic breast cancer, abi-007, abraxane
5712203|NCT00456833|Non Small Cell Lung Cancer|non small cell lung cancer
5712204|NCT00456833|NSCLC|nsclc
5712205|NCT00456833|Advanced lung cancer|advanced lung cancer
5712207|NCT00456833|RAD001|rad001
5712208|NCT00456833|erlotinib|erlotinib
5712209|NCT00456820|Mood Regulating Circuit|mood regulating circuit
5712210|NCT00456820|SSRI|ssri
5712211|NCT00456820|fMRI|fmri
5712212|NCT00456807|Human Papillomavirus|human papillomavirus
5712213|NCT00456794|Parkinson's disease|parkinson's disease
5712214|NCT00456794|Levodopa|levodopa
5712215|NCT00456794|End of dose wearing off|end of dose wearing off
5712216|NCT00456794|OFF time|off time
5712217|NCT00456781|rotator cuff|rotator cuff
5712218|NCT00456781|randomized clinical trial|randomized clinical trial
5712219|NCT00456768|Panic Disorder|panic disorder
5712220|NCT00456768|Anxiety|anxiety
5712221|NCT00456768|Treatment efficacy|treatment efficacy
5712222|NCT00456755|Perennial Allergic rhinitis|perennial allergic rhinitis
5712223|NCT00456755|Traditional Chinese Medicine|traditional chinese medicine
5712224|NCT00456742|Generalized Anxiety Disorder|generalized anxiety disorder
5712225|NCT00456742|Anxiety|anxiety
5712226|NCT00456742|Treatment efficacy|treatment efficacy
5712227|NCT00456729|Iron deficiency|iron deficiency
5712228|NCT00456729|Malabsorption|malabsorption
5712229|NCT00456729|Giardiasis|giardiasis
5712230|NCT00456716|BAC lung cancer|bac lung cancer
5712231|NCT00456716|adenocarcinoma of the lung|adenocarcinoma of the lung
5712232|NCT00456703|fluids,|fluids,
5712233|NCT00456703|restriction,|restriction,
5712234|NCT00456703|infection,|infection,
5712235|NCT00456703|bowel surgery,|bowel surgery,
5712236|NCT00456703|open abdominal|open abdominal
5712237|NCT00456690|Thalassemia|thalassemia
5712238|NCT00456690|Nutrition|nutrition
5712239|NCT00456690|Endocrine|endocrine
5712240|NCT00456690|BMI|bmi
5712241|NCT00456677|minocycline|minocycline
5712242|NCT00456677|asthma|asthma
5712243|NCT00456677|oral corticosteroids|oral corticosteroids
5712244|NCT00456664|CMV|cmv
5712245|NCT00456664|IRIS|iris
5712246|NCT00456651|Sleep Apnea|sleep apnea
5712247|NCT00456651|Obesity|obesity
5712248|NCT00456651|Neuropeptides|neuropeptides
5712249|NCT00456651|Hormones|hormones
5712250|NCT00456638|OP-CABG|op-cabg
5712251|NCT00456638|Depodur traditional drug|depodur traditional drug
5712252|NCT00456625|Hepatitis B vaccine|hepatitis b vaccine
5712253|NCT00456625|Challenge dose|challenge dose
5712254|NCT00456586|Parkinson's disease|parkinson's disease
5712255|NCT00456586|Levodopa therapy|levodopa therapy
5712256|NCT00456586|End of dose wearing off|end of dose wearing off
5712257|NCT00456586|Off time|off time
5712258|NCT00456573|Pediatric Obstructive sleep apnea syndrome|pediatric obstructive sleep apnea syndrome
5712259|NCT00456547|Cesarean hysterectomy|cesarean hysterectomy
5712260|NCT00456547|Postpartum hemorrhage|postpartum hemorrhage
5712262|NCT00456534|Smoking|smoking
5712263|NCT00456521|Obesity|obesity
5712264|NCT00456521|Behavior Modification|behavior modification
5712265|NCT00456469|TB|tb
5712266|NCT00456469|latent|latent
5712267|NCT00456469|infection|infection
5712268|NCT00456469|Ethiopia|ethiopia
5712269|NCT00456443|Thalassemia|thalassemia
5712270|NCT00456443|Sickle cell anemia|sickle cell anemia
5712271|NCT00456443|Splenectomy|splenectomy
5712272|NCT00456443|Infections|infections
5712273|NCT00456443|Streptococcal Pneumonia|streptococcal pneumonia
5712274|NCT00456417|Neurological|neurological
5712275|NCT00456417|Alzheimers|alzheimers
5712276|NCT00456404|peppermint water|peppermint water
5712277|NCT00456404|nipple crack|nipple crack
5712278|NCT00456404|lactating women|lactating women
5712279|NCT00456391|Brain CT scan|brain ct scan
5712280|NCT00456391|Pediatric emergency room|pediatric emergency room
5712281|NCT00456365|Autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5712282|NCT00456365|Cystic kidney disease|cystic kidney disease
5712283|NCT00456365|High blood pressure|high blood pressure
5712284|NCT00456365|Statin|statin
5712285|NCT00456339|Obstructive sleep apnea syndrome (OSAS) in children|obstructive sleep apnea syndrome (osas) in children
5712286|NCT00456326|Heparin|heparin
5712287|NCT00456326|Unfractionated Heparin|unfractionated heparin
5712288|NCT00456326|Low Molecular Weight Heparin|low molecular weight heparin
5712289|NCT00456326|Anticoagulation|anticoagulation
5712290|NCT00456326|Thrombocytopenia|thrombocytopenia
5712291|NCT00456326|Thrombosis|thrombosis
5712292|NCT00456326|Venous Thrombosis|venous thrombosis
5712293|NCT00456326|Pulmonary Embolism|pulmonary embolism
5712295|NCT00456313|fluticasone propionate|fluticasone propionate
5712296|NCT00456313|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5712297|NCT00456313|combination product|combination product
5712403|NCT00456001|medication|medication
5712298|NCT00456313|innate immune response|innate immune response
5712299|NCT00456313|neutrophil priming|neutrophil priming
5712300|NCT00456300|Hypoglycemia|hypoglycemia
5712301|NCT00456300|Hyperglycemia|hyperglycemia
5712302|NCT00456287|Sleep Apnea|sleep apnea
5712303|NCT00456287|Clotting- fibrinolysis patterns|clotting- fibrinolysis patterns
5712304|NCT00456287|Platelet function markers|platelet function markers
5712305|NCT00456287|Endothelial dysfunction|endothelial dysfunction
5712306|NCT00456274|Hypothalamic Amenorrhea|hypothalamic amenorrhea
5712307|NCT00456274|Idiopathic hypogonadotropic hypogonadism|idiopathic hypogonadotropic hypogonadism
5712308|NCT00456274|Acquired hypogonadotropic hypogonadism|acquired hypogonadotropic hypogonadism
5712309|NCT00456274|Kallmann's Syndrome|kallmann's syndrome
5712310|NCT00456274|Amenorrhea|amenorrhea
5712311|NCT00456274|Gonadotropin Releasing Hormone|gonadotropin releasing hormone
5712312|NCT00456261|Non Small Cell Lung Cancer|non small cell lung cancer
5712313|NCT00456248|Chronic Hepatitis C|chronic hepatitis c
5712314|NCT00456248|Liver|liver
5711025|NCT00461279|IPT|ipt
5712315|NCT00456248|Pegylated|pegylated
5712316|NCT00456248|Interferon|interferon
5712317|NCT00456248|Ribavirin|ribavirin
5712318|NCT00456248|Combination|combination
5712319|NCT00456248|Nonresponder|nonresponder
5712320|NCT00456248|Relapser|relapser
5712322|NCT00456248|Infergen|infergen
5712323|NCT00456248|SVR|svr
5712324|NCT00456222|Sleep|sleep
5712325|NCT00456222|Circadian rhythms|circadian rhythms
5712326|NCT00456222|Menstrual cycle|menstrual cycle
5712327|NCT00456209|Lived Experiences|lived experiences
5712328|NCT00456209|Adolescents|adolescents
5712329|NCT00456209|Cancer Treatment|cancer treatment
5712330|NCT00456209|Occupations|occupations
5712331|NCT00456196|COPD|copd
5712332|NCT00456196|Thrombosis|thrombosis
5712333|NCT00456196|Cancer|cancer
5712334|NCT00456196|Renal|renal
5712335|NCT00456196|Elderly|elderly
5712336|NCT00456196|Surgery|surgery
5712337|NCT00456196|Orthopedic Surgery|orthopedic surgery
5712338|NCT00456196|Medically Ill|medically ill
5712339|NCT00456196|Deep Vein Thrombosis|deep vein thrombosis
5712340|NCT00456196|Pulmonary Embolism|pulmonary embolism
5712341|NCT00456196|Anticoagulation|anticoagulation
5712342|NCT00456183|Tuberculosis|tuberculosis
5712343|NCT00456183|Latent|latent
5712344|NCT00456183|TB|tb
5712345|NCT00456183|Vaccine|vaccine
5712346|NCT00456183|MVA 85A|mva 85a
5712347|NCT00456170|Vaginal|vaginal
5712348|NCT00456170|Hysterectomy|hysterectomy
5712349|NCT00456170|Harmonic|harmonic
5712350|NCT00456170|Ligasure|ligasure
5712351|NCT00456170|Sutures|sutures
5712352|NCT00456170|Modern|modern
5712353|NCT00456170|Patients undergoing vaginal hysterectomy for various reasons|patients undergoing vaginal hysterectomy for various reasons
5712354|NCT00456157|Osteoarthritis|osteoarthritis
5712355|NCT00456157|Osteophytes|osteophytes
5712356|NCT00456157|Knee|knee
5712357|NCT00456157|Intra-articular|intra-articular
5712358|NCT00456157|OP-1|op-1
5712359|NCT00456144|GnRH|gnrh
5712360|NCT00456144|Insulin sensitivity|insulin sensitivity
5712361|NCT00456118|recurrent pregnancy losses|recurrent pregnancy losses
5712362|NCT00456118|preeclampsia|preeclampsia
5712363|NCT00456118|intervillositis|intervillositis
5712364|NCT00456118|maternofetal alloimmunization|maternofetal alloimmunization
5712366|NCT00456105|Post-op dysglycemia|post-op dysglycemia
5712367|NCT00456105|Peripheral vascular disease|peripheral vascular disease
5712368|NCT00456105|Infrainguinal bypass surgery|infrainguinal bypass surgery
5712369|NCT00456092|psoriatic arthritis|psoriatic arthritis
5712370|NCT00456092|ACR|acr
5712371|NCT00456092|PASI|pasi
5712372|NCT00456092|DAS|das
5712373|NCT00456092|pharmacokinetic|pharmacokinetic
5712374|NCT00456092|biopsy|biopsy
5712375|NCT00456066|Acute myocardial infarction|acute myocardial infarction
5712376|NCT00456066|Thromboaspiration|thromboaspiration
5712377|NCT00456066|Infarct size|infarct size
5712378|NCT00456066|Left ventricular remodelling|left ventricular remodelling
5712379|NCT00456053|Renal Anemia|renal anemia
5712380|NCT00456053|Renal Failure|renal failure
5712381|NCT00456053|Kidney Disease|kidney disease
5712382|NCT00456053|Human EPO|human epo
5712383|NCT00456040|amyloidosis|amyloidosis
5712384|NCT00456040|heart failure|heart failure
5712385|NCT00456040|heart transplant|heart transplant
5712386|NCT00456040|stem cell transplant|stem cell transplant
5712387|NCT00456027|Type 2 Diabetes|type 2 diabetes
5712388|NCT00456027|LADA|lada
5712389|NCT00456027|Latent Autoimmune Diabetes in Adult|latent autoimmune diabetes in adult
5712391|NCT00456027|HbA1c|hba1c
5712392|NCT00456027|C-peptide|c-peptide
5712393|NCT00456014|Major Depression|major depression
5712394|NCT00456014|Antidepressants|antidepressants
5712395|NCT00456001|heparin|heparin
5712396|NCT00456001|low molecular weight heparin|low molecular weight heparin
5712397|NCT00456001|enoxaparin|enoxaparin
5712398|NCT00456001|anticoagulation|anticoagulation
5712399|NCT00456001|thrombosis|thrombosis
5712400|NCT00456001|venous thrombosis|venous thrombosis
5712401|NCT00456001|thromboembolism|thromboembolism
5712402|NCT00456001|pulmonary embolism|pulmonary embolism
5712404|NCT00455988|questionnaire developement|questionnaire developement
5712405|NCT00455988|regularity|regularity
5712406|NCT00455988|lifestyle|lifestyle
5712407|NCT00455988|type 2 diabetes|type 2 diabetes
5712408|NCT00455975|Kidney Cancer|kidney cancer
5712409|NCT00455975|Renal Cancer|renal cancer
5712410|NCT00455975|Clear Cell Carcinoma|clear cell carcinoma
5712411|NCT00455962|estrogen|estrogen
5712412|NCT00455962|progesterone|progesterone
5712413|NCT00455962|African-American|african-american
5712414|NCT00455962|Caucasian|caucasian
5712415|NCT00455962|infusion|infusion
5712416|NCT00455962|gonadotropins|gonadotropins
5712417|NCT00455962|healthy|healthy
5712418|NCT00455936|Adenocarcinoma|adenocarcinoma
5712419|NCT00455936|NSCLC|nsclc
5712420|NCT00455936|gemcitabine|gemcitabine
5712421|NCT00455936|Cisplatin|cisplatin
5712422|NCT00455936|Gefitinib|gefitinib
5712423|NCT00455936|Never smoker|never smoker
5712424|NCT00455923|asthma|asthma
5712425|NCT00455923|exacerbation|exacerbation
5712426|NCT00455923|persistent|persistent
5685837|NCT00554645|children|children
5712427|NCT00455923|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5712428|NCT00455923|mild|mild
5712429|NCT00455923|GINAII|ginaii
5712430|NCT00455910|Low risk myelodysplastic syndromes|low risk myelodysplastic syndromes
5712431|NCT00455910|MDS|mds
5712432|NCT00455910|Bone marrow diseases|bone marrow diseases
5712433|NCT00455910|Thalidomide|thalidomide
5712434|NCT00455910|Cytopenias|cytopenias
5712435|NCT00455910|Anemia|anemia
5712436|NCT00455897|granulocyte monocyte colony stimulating factor|granulocyte monocyte colony stimulating factor
5712437|NCT00455897|Leukine|leukine
5712438|NCT00455897|Sargramostim|sargramostim
5712439|NCT00455897|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5712440|NCT00455897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5712441|NCT00455871|macular degeneration|macular degeneration
5712442|NCT00455845|Endometriosis|endometriosis
5712443|NCT00455845|Lng IUD|lng iud
5712444|NCT00455832|sperm chromatin structure integrity|sperm chromatin structure integrity
5712445|NCT00455832|sperm concentration|sperm concentration
5712446|NCT00455832|sperm motility|sperm motility
5712447|NCT00455832|sperm morphology|sperm morphology
5712448|NCT00455832|peginterferon|peginterferon
5712449|NCT00455832|ribavirin|ribavirin
5712450|NCT00455832|hepatitis C|hepatitis c
5712451|NCT00455819|pulmonary embolism|pulmonary embolism
5712452|NCT00455819|pro-BNP|pro-bnp
5712453|NCT00455819|home treatment|home treatment
5712454|NCT00455806|Helicobacter pylori|helicobacter pylori
5712455|NCT00455806|rescue therapy|rescue therapy
5712456|NCT00455806|eradication therapy|eradication therapy
5712457|NCT00455806|esomeprazole|esomeprazole
5712458|NCT00455806|moxifloxacin|moxifloxacin
5712459|NCT00455806|resistance|resistance
5712460|NCT00455793|HIV|hiv
5712461|NCT00455793|atherosclerosis|atherosclerosis
5712462|NCT00455780|Eating|eating
5712463|NCT00455780|Dieting|dieting
5712464|NCT00455780|Meal replacements|meal replacements
5712465|NCT00455780|Energy Density|energy density
5712466|NCT00455780|Weight Loss Maintenance|weight loss maintenance
5712467|NCT00455767|persistent ARDS|persistent ards
5712468|NCT00455767|alveolar inflammation|alveolar inflammation
5712469|NCT00455767|early pulmonary fibrosis|early pulmonary fibrosis
5712470|NCT00455767|mechanichal ventilation|mechanichal ventilation
5712471|NCT00455767|P/V curve|p/v curve
5712472|NCT00455767|Static compliance|static compliance
5712473|NCT00455767|elastase activity|elastase activity
5712474|NCT00455767|inhibitor of Human Neutrophil Elastase|inhibitor of human neutrophil elastase
5712475|NCT00455741|menopause|menopause
5712476|NCT00455741|estrogen|estrogen
5712477|NCT00455741|progesterone|progesterone
5712478|NCT00455741|hormone replacement|hormone replacement
5712479|NCT00455741|aging|aging
5712480|NCT00455741|PET|pet
5712481|NCT00455715|Schizophrenia|schizophrenia
5712482|NCT00455715|Cognition|cognition
5712483|NCT00455715|Sildenafil|sildenafil
5712484|NCT00455715|PDE5 Inhibitor|pde5 inhibitor
5712485|NCT00455702|schizophrenia|schizophrenia
5712486|NCT00455702|cognition|cognition
5712487|NCT00455702|d-cycloserine|d-cycloserine
5712488|NCT00455702|memory|memory
5712489|NCT00455689|Lupron|lupron
5712490|NCT00455689|Premenopausal|premenopausal
5712491|NCT00455689|Hot flashes|hot flashes
5712492|NCT00455676|Scarf Osteotomy|scarf osteotomy
5712493|NCT00455676|Chevron Osteotomy|chevron osteotomy
5712494|NCT00455676|Comparison|comparison
5712495|NCT00455663|Schizoaffective Disorder|schizoaffective disorder
5712496|NCT00455663|Medication Adherence|medication adherence
5712497|NCT00455650|schizophrenia|schizophrenia
5712499|NCT00455650|nicotinic receptors|nicotinic receptors
5712503|NCT00455624|insulin resistance|insulin resistance
5712504|NCT00455611|Heart Failure, Congestive|heart failure, congestive
5712505|NCT00455611|Continuous Positive Airway Pressure|continuous positive airway pressure
5712506|NCT00455611|Baroreflex|baroreflex
5712507|NCT00455611|Echocardiography|echocardiography
5712508|NCT00455598|Diabetes|diabetes
5712509|NCT00455585|Pharmacokinetics|pharmacokinetics
5712510|NCT00455585|Antiretrovirals|antiretrovirals
5712511|NCT00455585|Uganda|uganda
5712512|NCT00455585|HIV|hiv
5712513|NCT00455585|Treatment Experienced|treatment experienced
5712514|NCT00455572|Immunotherapeutic|immunotherapeutic
5712515|NCT00455572|Adjuvant cancer therapy|adjuvant cancer therapy
5712516|NCT00455572|Non-small-cell lung cancer|non-small-cell lung cancer
5712518|NCT00455559|Resistant Gastrointestinal Stromal Tumor|resistant gastrointestinal stromal tumor
5712519|NCT00455559|GIST|gist
5712520|NCT00455559|Perifosine|perifosine
5712521|NCT00455559|Gleevec|gleevec
5712522|NCT00455546|Coronary|coronary
5712523|NCT00455546|Artery|artery
5712524|NCT00455546|Atherosclerosis|atherosclerosis
5712525|NCT00455546|Phospholipase|phospholipase
5712526|NCT00455546|CAD|cad
5712527|NCT00455533|Early Breast Cancer|early breast cancer
5712528|NCT00455520|Diabetic neuropathy|diabetic neuropathy
5712529|NCT00455520|Painful Diabetic Polyneuropathy|painful diabetic polyneuropathy
5712530|NCT00455520|Polyneuropathy|polyneuropathy
5712531|NCT00455520|Peripheral neuropathy|peripheral neuropathy
5712532|NCT00455507|Parkinson's disease|parkinson's disease
5712533|NCT00455507|levodopa|levodopa
5712534|NCT00455507|end of dose wearing off|end of dose wearing off
5712535|NCT00455507|OFF time|off time
5712536|NCT00455494|Drug-resistant malaria|drug-resistant malaria
5712537|NCT00455494|Bioavailability|bioavailability
5712538|NCT00455494|Food-effect study|food-effect study
5712539|NCT00455468|Severe pneumonia|severe pneumonia
5712540|NCT00455468|children|children
5712541|NCT00455468|day care management|day care management
5712542|NCT00455468|hospitalized management|hospitalized management
5712543|NCT00455468|Randomized controlled trial|randomized controlled trial
5712544|NCT00455468|Under five children|under five children
5712545|NCT00455429|Atopic Dermatitis|atopic dermatitis
5712546|NCT00455429|JNJ-26113100|jnj-26113100
5712547|NCT00455416|Low grade lymphoma|low grade lymphoma
5712548|NCT00455416|Diet|diet
5712549|NCT00455416|Antioxidants|antioxidants
5712550|NCT00455416|Non Hodgkin Lymphoma - Follicular Lymphoma grade 1&2 stage III/IV|non hodgkin lymphoma - follicular lymphoma grade 1&2 stage iii/iv
5712551|NCT00455403|Metabolic Syndrome|metabolic syndrome
5712552|NCT00455403|Atherosclerosis|atherosclerosis
5712553|NCT00455390|Post immediate Psychotherapeutic Intervention|post immediate psychotherapeutic intervention
5712554|NCT00455390|Psychotraumatic disorders|psychotraumatic disorders
5712555|NCT00455390|PTSD post traumatic syndrome disorder|ptsd post traumatic syndrome disorder
5712556|NCT00455390|CUMP Cellules d’Urgence Médico Psychologique|cump cellules d’urgence médico psychologique
5712557|NCT00455377|Cement dust exposure|cement dust exposure
5712558|NCT00455377|Induced sputum|induced sputum
5712559|NCT00455377|Airway inflammation|airway inflammation
5712560|NCT00455377|Peripheral blood inflammation markers|peripheral blood inflammation markers
5712561|NCT00455364|Fungal infection prophylaxis|fungal infection prophylaxis
5712562|NCT00455364|Lung transplant|lung transplant
5712563|NCT00455364|Fungal infection post lung transplant|fungal infection post lung transplant
5712564|NCT00455351|Palliative treatment|palliative treatment
5712565|NCT00455351|Max. tolerable dose|max. tolerable dose
5712566|NCT00455338|meal|meal
5712567|NCT00455338|composition|composition
5712568|NCT00455338|postprandial|postprandial
5712569|NCT00455338|PCOS|pcos
5712570|NCT00455338|androgen|androgen
5712574|NCT00455312|Dyskeratosis Congenita|dyskeratosis congenita
5712575|NCT00455312|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5712576|NCT00455312|Severe Aplastic Anemia|severe aplastic anemia
5712577|NCT00455299|Laparoscopy, ventral, hernia, repair, surgery|laparoscopy, ventral, hernia, repair, surgery
5712578|NCT00455286|CNS Lymphoma|cns lymphoma
5712579|NCT00455273|Breast Cancer|breast cancer
5712580|NCT00455273|DCE MRI|dce mri
5712581|NCT00455234|Aggression|aggression
5712582|NCT00455234|Violent behaviour in people with psychotic illness|violent behaviour in people with psychotic illness
5712584|NCT00455221|Imatinib|imatinib
5712585|NCT00455221|vaccine|vaccine
5712586|NCT00455221|peptide|peptide
5712587|NCT00455221|gene|gene
5712588|NCT00455221|MRD|mrd
5712589|NCT00455221|DNA|dna
5712590|NCT00455182|Acupuncture|acupuncture
5712591|NCT00455182|Hip Arthroplasty|hip arthroplasty
5712592|NCT00455182|Knee Arthroplasty|knee arthroplasty
5712593|NCT00455182|Pain Management|pain management
5712594|NCT00455169|Influenza|influenza
5712595|NCT00455169|Infant, Premature|infant, premature
5712596|NCT00455169|Immunization|immunization
5712597|NCT00455169|Vaccination|vaccination
5712598|NCT00455156|Contraception|contraception
5712600|NCT00455143|Postoperative delirium|postoperative delirium
5712602|NCT00455143|Postoperative cognitive dysfunction|postoperative cognitive dysfunction
5712603|NCT00455143|POCD|pocd
5712604|NCT00455130|mannitol|mannitol
5712605|NCT00455130|cystic fibrosis|cystic fibrosis
5712606|NCT00455130|mucolytic|mucolytic
5712607|NCT00455130|mucoactive|mucoactive
5712608|NCT00455117|analgesia|analgesia
5712609|NCT00455117|pain|pain
5712610|NCT00455117|neurosurgery|neurosurgery
5712611|NCT00455117|NSAIDS|nsaids
5712612|NCT00455117|parecoxib|parecoxib
5712613|NCT00455117|morphine consumption|morphine consumption
5712614|NCT00455104|Fabry Disease|fabry disease
5712615|NCT00455104|National Registry|national registry
5712616|NCT00455091|Post-operative Hepatocellular Carcinoma.|post-operative hepatocellular carcinoma.
5712617|NCT00455078|Gastric reflux|gastric reflux
5712618|NCT00455078|Lung transplant|lung transplant
5712619|NCT00455078|chronic rejection|chronic rejection
5712620|NCT00455078|Gastric reflux in lung transplant as it relates to chronic rejection|gastric reflux in lung transplant as it relates to chronic rejection
5712621|NCT00455065|whole grain|whole grain
5712622|NCT00455065|metabolic syndrome|metabolic syndrome
5712623|NCT00455065|weight loss|weight loss
5712624|NCT00455052|XMT-1001|xmt-1001
5712625|NCT00455052|cancer|cancer
5712626|NCT00455052|tumor|tumor
5712627|NCT00455052|camptothecin|camptothecin
5712628|NCT00455052|Fleximer|fleximer
5712629|NCT00455052|polymer|polymer
5712630|NCT00455052|Phase 1|phase 1
5712631|NCT00455052|safety|safety
5712632|NCT00455052|pharmacokinetics|pharmacokinetics
5712633|NCT00455052|maximum tolerated dose|maximum tolerated dose
5712634|NCT00455052|NSCLC|nsclc
5712635|NCT00455052|non-small cell lung cancer|non-small cell lung cancer
5712636|NCT00455052|SCLC|sclc
5712637|NCT00455052|small cell lung cancer|small cell lung cancer
5712638|NCT00455039|neoadjuvant, HER2, Breast,GSK,lapatinib|neoadjuvant, her2, breast,gsk,lapatinib
5712639|NCT00455013|Kidney transplant|kidney transplant
5712640|NCT00454987|antibody persistence|antibody persistence
5712641|NCT00454987|Meningococcal serogroup C vaccine|meningococcal serogroup c vaccine
5712642|NCT00454987|conjugate vaccine|conjugate vaccine
5712643|NCT00454987|Haemophilus influenzae type b vaccine|haemophilus influenzae type b vaccine
5712644|NCT00454974|end stage renal failure|end stage renal failure
5712645|NCT00454974|dialysis|dialysis
5712646|NCT00454974|wearable artificial kidney|wearable artificial kidney
5712647|NCT00454961|Malaria|malaria
5712648|NCT00454961|Plasmodium falciparum|plasmodium falciparum
5712649|NCT00454961|artemether-lumefantrine|artemether-lumefantrine
5712650|NCT00454961|effectiveness|effectiveness
5712651|NCT00454948|Obesity prevention|obesity prevention
5712652|NCT00454948|Dietary intake|dietary intake
5712653|NCT00454948|Physical activity|physical activity
5712654|NCT00454948|Mexican American|mexican american
5712655|NCT00454948|Family Characteristics|family characteristics
5712656|NCT00454935|epilepsy|epilepsy
5712657|NCT00454935|glioma|glioma
5712658|NCT00454922|glaucoma|glaucoma
5712659|NCT00454922|patient educator|patient educator
5712660|NCT00454909|Meningococcal Serogroups A, C, W-135 and/or Y Disease|meningococcal serogroups a, c, w-135 and/or y disease
5712661|NCT00454896|Urinary Bladder, Overactive|urinary bladder, overactive
5712662|NCT00454896|Urgency|urgency
5712663|NCT00454896|VESIcare®|vesicare®
5712664|NCT00454896|Solifenacin succinate|solifenacin succinate
5712665|NCT00454883|Safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.|safety of ziprasidone, efficacy of ziprasidone, manic episodes in bipolar disorder, mixed episodes in bipolar disorder, schizoaffective disorder.
5712666|NCT00454870|Alzheimer's Disease|alzheimer's disease
5712667|NCT00454870|Cognition|cognition
5712668|NCT00454870|Cognitive impairment|cognitive impairment
5712669|NCT00454857|Thrombocytopenia|thrombocytopenia
5712670|NCT00454857|Chart Review|chart review
5712671|NCT00454857|Platelet|platelet
5712672|NCT00454857|Retrospective|retrospective
5712673|NCT00454857|Prospective|prospective
5712674|NCT00454857|Non-interventional|non-interventional
5712675|NCT00454857|Health Resource Utilization (HRU)|health resource utilization (hru)
5712676|NCT00454857|Quality of Life (QOL)|quality of life (qol)
5712677|NCT00454857|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
5712678|NCT00454857|Idiopathic Thrombocytopenic Purpura (ITP)|idiopathic thrombocytopenic purpura (itp)
5712679|NCT00454857|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5712680|NCT00454857|Observational|observational
5712681|NCT00454831|Hypercholesterolemia|hypercholesterolemia
5680602|NCT00577278|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5681144|NCT00574548|Vaccines, Pneumococcal Conjugate Vaccine|vaccines, pneumococcal conjugate vaccine
5712682|NCT00454831|LDL-cholesterol|ldl-cholesterol
5712683|NCT00454831|chitosan|chitosan
5712684|NCT00454831|HEP-40|hep-40
5712685|NCT00454805|Advanced Breast Cancer|advanced breast cancer
5712686|NCT00454792|Low back pain|low back pain
5712687|NCT00454792|Modic changes|modic changes
5712688|NCT00454779|SCCHNC|scchnc
5712689|NCT00454779|Metastatic|metastatic
5712691|NCT00454766|Patient Education|patient education
5712692|NCT00454766|Cervical Dysplasia|cervical dysplasia
5712693|NCT00454766|Questionnaire|questionnaire
5712694|NCT00454753|Myeloid, Chronic|myeloid, chronic
5712695|NCT00454753|Lymphocytic, Acute|lymphocytic, acute
5712696|NCT00454740|Urinary Bladder, Overactive|urinary bladder, overactive
5712698|NCT00454740|VESIcare®|vesicare®
5712699|NCT00454740|Solifenacin succinate|solifenacin succinate
5712700|NCT00454701|Psoriasis|psoriasis
5712701|NCT00454701|Alefacept|alefacept
5712702|NCT00454701|Amevive®|amevive®
5712703|NCT00454701|Drug exposure|drug exposure
5712704|NCT00454688|Irritable Bowel Syndrome|irritable bowel syndrome
5712705|NCT00454688|Asimadoline|asimadoline
5712706|NCT00454675|Smokers|smokers
5712707|NCT00454675|Chronic Bronchitis|chronic bronchitis
5712708|NCT00454675|Pulmonary Function Test Abnormalities|pulmonary function test abnormalities
5712709|NCT00454675|COPD|copd
5712711|NCT00454662|Hypertension|hypertension
5712712|NCT00454662|Cardiovascular Diseases|cardiovascular diseases
5712713|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5712714|NCT00454662|Calcium Channel Blockers|calcium channel blockers
5712715|NCT00454662|Diuretics|diuretics
5712716|NCT00454662|Combination Drug Therapy|combination drug therapy
5712717|NCT00454662|Diabetes|diabetes
5712718|NCT00454649|axitinib|axitinib
5712719|NCT00454649|chemotherapy|chemotherapy
5712720|NCT00454649|anti-angiogenesis|anti-angiogenesis
5712721|NCT00454649|VEGF inhibition|vegf inhibition
5712722|NCT00454623|Adiponectin|adiponectin
5712723|NCT00454623|diabetes|diabetes
5712724|NCT00454623|metabolism|metabolism
5712725|NCT00454623|Adiponectin levels|adiponectin levels
5712726|NCT00454610|Pediatric|pediatric
5712727|NCT00454610|Overweight|overweight
5712728|NCT00454610|Obesity|obesity
5712729|NCT00454610|Intervention|intervention
5711387|NCT00459927|Floseal|floseal
5712730|NCT00454610|Prevention|prevention
5712731|NCT00454610|Mexican American|mexican american
5712732|NCT00454584|Psoriasis|psoriasis
5712733|NCT00454584|CNTO 1275|cnto 1275
5712734|NCT00454584|Etanercept|etanercept
5712735|NCT00454584|Immune diorder|immune diorder
5712736|NCT00454584|Skin disorder|skin disorder
5712737|NCT00454558|Pulmonary Arterial Hypertension (PAH)|pulmonary arterial hypertension (pah)
5712738|NCT00454558|Chronic Thromboembolic Pulmonary Hypertension (CTEPH)|chronic thromboembolic pulmonary hypertension (cteph)
5712739|NCT00454532|Breast Cancer|breast cancer
5712740|NCT00454532|Bionovo|bionovo
5712741|NCT00454532|BZL101|bzl101
5712742|NCT00454532|Chinese Herbs|chinese herbs
5712743|NCT00454519|peritoneal carcinomatosis|peritoneal carcinomatosis
5712744|NCT00454519|cisplatin|cisplatin
5712745|NCT00454519|mitomycin|mitomycin
5712746|NCT00454519|gastric cancer|gastric cancer
5712747|NCT00454519|colorectal cancer|colorectal cancer
5712748|NCT00454493|omacor|omacor
5712749|NCT00454493|fish oil|fish oil
5712750|NCT00454493|omega 3|omega 3
5712751|NCT00454493|fatty acids|fatty acids
5712752|NCT00454493|coronary artery disease|coronary artery disease
5712753|NCT00454493|endothelial function|endothelial function
5712754|NCT00454493|heart rate variability|heart rate variability
5712755|NCT00454493|carotid intimal media thickness|carotid intimal media thickness
5712756|NCT00454493|QT dispersion|qt dispersion
5712757|NCT00454480|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5712758|NCT00454480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5712759|NCT00454480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5712760|NCT00454480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5712761|NCT00454480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5712762|NCT00454480|refractory anemia with excess blasts|refractory anemia with excess blasts
5712763|NCT00454480|adult acute basophilic leukemia|adult acute basophilic leukemia
5712764|NCT00454480|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5712765|NCT00454480|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5712766|NCT00454480|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5712768|NCT00454480|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5712769|NCT00454480|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5712770|NCT00454480|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5712771|NCT00454480|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5712772|NCT00454480|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5712773|NCT00454480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5712774|NCT00454480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5712775|NCT00454480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5712776|NCT00454480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5712777|NCT00454480|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5712778|NCT00454480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5712779|NCT00454454|memory|memory
5712780|NCT00454454|display enhanced testing|display enhanced testing
5712782|NCT00454441|Menopausal Symptoms|menopausal symptoms
5712783|NCT00454441|Actigraph|actigraph
5712784|NCT00454441|Bionovo|bionovo
5712785|NCT00454441|MF101|mf101
5712786|NCT00454428|Bypass Surgery|bypass surgery
5712787|NCT00454428|Coronary Artery|coronary artery
5712788|NCT00454415|Diet|diet
5712789|NCT00454415|Body Mass Index|body mass index
5712791|NCT00454389|Macular|macular
5712792|NCT00454389|Degeneration|degeneration
5712793|NCT00454389|AMD|amd
5712794|NCT00454389|Wet Age-Related macular degeneration|wet age-related macular degeneration
5712795|NCT00454376|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5712796|NCT00454376|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5712797|NCT00454376|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5712798|NCT00454376|gastrinoma|gastrinoma
5712800|NCT00454376|WDHA syndrome|wdha syndrome
5712801|NCT00454376|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5712802|NCT00454376|somatostatinoma|somatostatinoma
5712803|NCT00454376|glucagonoma|glucagonoma
5712804|NCT00454376|liver metastases|liver metastases
5712805|NCT00454350|Hectorol (doxercalciferol injection)|hectorol (doxercalciferol injection)
5712806|NCT00454350|Zemplar (paricalcitol injection)|zemplar (paricalcitol injection)
5712807|NCT00454337|HIV-1 infection|hiv-1 infection
5712808|NCT00454337|enfuvirtide|enfuvirtide
5712809|NCT00454337|raltegravir|raltegravir
5712810|NCT00454337|treatment experienced|treatment experienced
5712811|NCT00454324|Lung cancer|lung cancer
5712812|NCT00454324|Small cell lung cancer|small cell lung cancer
5712813|NCT00454324|Abraxane|abraxane
5712814|NCT00454324|Paclitaxel|paclitaxel
5712815|NCT00454324|Carboplatin|carboplatin
5712816|NCT00454324|Phase II|phase ii
5712817|NCT00454324|Randomized|randomized
5712818|NCT00454324|Lineberger|lineberger
5712819|NCT00454324|LCCC|lccc
5712820|NCT00454311|Pregnancy and implantation rates|pregnancy and implantation rates
5712821|NCT00454311|Efficiency and accuracy of the genetic testing|efficiency and accuracy of the genetic testing
5712822|NCT00454298|Severe Osteoarthritis|severe osteoarthritis
5712823|NCT00454298|Arthritis|arthritis
5712824|NCT00454285|bacteremia,cultures, infective endocarditis, prophylaxis|bacteremia,cultures, infective endocarditis, prophylaxis
5712825|NCT00454272|febrile|febrile
5712826|NCT00454272|neutropenia|neutropenia
5712827|NCT00454272|cancer|cancer
5712828|NCT00454272|Gram positive infection|gram positive infection
5712829|NCT00454259|Postoperative Hyperalgesia|postoperative hyperalgesia
5712830|NCT00454259|Human volunteer|human volunteer
5712831|NCT00454259|Fentanyl|fentanyl
5712832|NCT00454259|Randomized Controlled Trial|randomized controlled trial
5712833|NCT00454259|Pain chronicisation|pain chronicisation
5712834|NCT00454259|Predictive test|predictive test
5712835|NCT00454233|Diabetes Mellitus Type 2|diabetes mellitus type 2
5712836|NCT00454233|YM543|ym543
5712837|NCT00454233|Treatment|treatment
5712838|NCT00454233|Safety|safety
5712839|NCT00454233|efficacy|efficacy
5712840|NCT00454207|Pulmonary Arterial Hypertension, PAH|pulmonary arterial hypertension, pah
5712841|NCT00454194|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5712842|NCT00454194|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5712843|NCT00454194|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5712844|NCT00454194|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5712845|NCT00454194|adenocarcinoma of the lung|adenocarcinoma of the lung
5712846|NCT00454181|human immunodeficiency virus|human immunodeficiency virus
5712847|NCT00454181|human papilloma virus|human papilloma virus
5712848|NCT00454181|warts, oral|warts, oral
5712849|NCT00454181|papillomatosis|papillomatosis
5712850|NCT00454181|treatment experienced|treatment experienced
5712851|NCT00454168|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5712852|NCT00454168|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5712853|NCT00454168|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5712854|NCT00454168|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5712855|NCT00454168|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5712856|NCT00454168|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5863796|NCT00001183|Fiberoptic Bronchoscopy|fiberoptic bronchoscopy
5712857|NCT00454168|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5712858|NCT00454168|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5712859|NCT00454168|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5712860|NCT00454168|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5712861|NCT00454168|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5712862|NCT00454168|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5712863|NCT00454168|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5712864|NCT00454168|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5712866|NCT00454168|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5712867|NCT00454168|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5712868|NCT00454155|HSCT|hsct
5712869|NCT00454155|AGVHD|agvhd
5712870|NCT00454155|Myeloablative|myeloablative
5712871|NCT00454155|Allogeneic|allogeneic
5712872|NCT00454155|Hematopoietic|hematopoietic
5712873|NCT00454155|Stem|stem
5712874|NCT00454155|Cell|cell
5712875|NCT00454155|Transplantation|transplantation
5712876|NCT00454129|Feasibilty of cholangiography via double-balloon enteroscopy|feasibilty of cholangiography via double-balloon enteroscopy
5712877|NCT00454116|Colon Cancer|colon cancer
5712878|NCT00454116|Rectal Cancer|rectal cancer
5712879|NCT00454103|adrenocortical carcinoma (ACC)|adrenocortical carcinoma (acc)
5712880|NCT00454103|adrenal tumor|adrenal tumor
5712881|NCT00454103|metastastic adrenocortical carcinoma|metastastic adrenocortical carcinoma
5712882|NCT00454090|Advanced Malignancies|advanced malignancies
5712883|NCT00454077|thyroid cancer; rhTSH; thyroid ablation|thyroid cancer; rhtsh; thyroid ablation
5712884|NCT00454064|cognitive-behavioral therapy|cognitive-behavioral therapy
5712885|NCT00454064|back pain|back pain
5712886|NCT00454064|low back pain|low back pain
5712887|NCT00454064|biofeedback|biofeedback
5712888|NCT00454064|randomized controlled study|randomized controlled study
5712889|NCT00454064|EMG biofeedback|emg biofeedback
5712890|NCT00454051|Asthma, anti-immunoglobulin E, omalizumab, IgE receptors|asthma, anti-immunoglobulin e, omalizumab, ige receptors
5712891|NCT00454038|cystectomy|cystectomy
5712892|NCT00454038|augmentation|augmentation
5712893|NCT00454038|sinus|sinus
5712894|NCT00454038|amputation|amputation
5712895|NCT00454038|implant|implant
5712896|NCT00454025|glaucoma|glaucoma
5712897|NCT00454025|intraocular pressure|intraocular pressure
5712898|NCT00454025|postural changes|postural changes
5712899|NCT00454012|non reassuring fetal heart rate tracing|non reassuring fetal heart rate tracing
5712900|NCT00454012|biophysical profile|biophysical profile
5685935|NCT00554242|flavonoids|flavonoids
5712901|NCT00454012|assessing fetal wellbeing|assessing fetal wellbeing
5712902|NCT00453999|influenza|influenza
5712903|NCT00453999|flu|flu
5712904|NCT00453986|immunogenicity|immunogenicity
5712905|NCT00453986|Meningococcal serogroups A, C, W-135 and/or Y disease|meningococcal serogroups a, c, w-135 and/or y disease
5712906|NCT00453986|co-administration|co-administration
5712907|NCT00453986|meningococcal vaccine|meningococcal vaccine
5712908|NCT00453986|lot-to-lot consistency|lot-to-lot consistency
5712909|NCT00453986|conjugate vaccine|conjugate vaccine
5712910|NCT00453973|anemia|anemia
5712911|NCT00453973|chronic kidney disease|chronic kidney disease
5712912|NCT00453973|CKD|ckd
5712913|NCT00453973|chronic renal failure|chronic renal failure
5712914|NCT00453973|CRF|crf
5712915|NCT00453973|dialysis|dialysis
5712916|NCT00453973|erythropoietin|erythropoietin
5712917|NCT00453973|EPO|epo
5712918|NCT00453973|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5712919|NCT00453973|ESA|esa
5712920|NCT00453973|Hematide™|hematide™
5712921|NCT00453973|hemodialysis|hemodialysis
5712922|NCT00453973|hemoglobin|hemoglobin
5712923|NCT00453973|Hb|hb
5712924|NCT00453973|Hgb|hgb
5712925|NCT00453973|Omontys|omontys
5712926|NCT00453973|peginesatide|peginesatide
5712927|NCT00453973|red blood cell|red blood cell
5712928|NCT00453973|red blood cell production|red blood cell production
5712929|NCT00453960|Endometrial hyperplasia|endometrial hyperplasia
5712930|NCT00453960|Genistein|genistein
5712931|NCT00453960|Isoflavones|isoflavones
5712932|NCT00453960|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5712933|NCT00453934|Diabetes|diabetes
5712934|NCT00453934|Type 1 Diabetes|type 1 diabetes
5712935|NCT00453934|Type 2 Diabetes|type 2 diabetes
5712936|NCT00453934|Physiologic Insulin|physiologic insulin
5712937|NCT00453934|Basal Insulin|basal insulin
5712938|NCT00453934|Bolus Insulin|bolus insulin
5712939|NCT00453934|Mealtime insulin|mealtime insulin
5712940|NCT00453934|Insulin patch|insulin patch
5712941|NCT00453934|Multiple daily injections|multiple daily injections
5712942|NCT00453921|TBI|tbi
5712943|NCT00453921|Memory|memory
5712944|NCT00453921|Methylphenidate|methylphenidate
5712945|NCT00453921|Ritalin|ritalin
5712946|NCT00453921|Memory and Attention Training|memory and attention training
5712947|NCT00453895|Adrenal cancer refractory to cytotoxic therapy|adrenal cancer refractory to cytotoxic therapy
5712948|NCT00453895|Sunitinib|sunitinib
5712949|NCT00453895|Multitargeted tyrosine-kinase inhibitor|multitargeted tyrosine-kinase inhibitor
5712950|NCT00453869|Liver fibrosis|liver fibrosis
5712951|NCT00453869|Hepatitis B virus and C virus|hepatitis b virus and c virus
5712952|NCT00453869|FibroMeter|fibrometer
5712953|NCT00453869|FibroScan®|fibroscan®
5712954|NCT00453856|Malaria|malaria
5712955|NCT00453856|Sulfadoxine|sulfadoxine
5712956|NCT00453856|Pyrimethamine|pyrimethamine
5712957|NCT00453856|Resistance|resistance
5712958|NCT00453856|Gabon|gabon
5712959|NCT00453843|Stroke|stroke
5712960|NCT00453843|movement therapy|movement therapy
5712961|NCT00453843|robotics|robotics
5712962|NCT00453843|rehabilitation robotics|rehabilitation robotics
5712963|NCT00453843|shoulder, elbow, wrist|shoulder, elbow, wrist
5712964|NCT00453830|Diverticulitis; laparoscopy; short term outcome|diverticulitis; laparoscopy; short term outcome
5712965|NCT00453817|islet transplantation|islet transplantation
5712966|NCT00453817|imaging|imaging
5712967|NCT00453817|graft monitoring|graft monitoring
5712968|NCT00453817|magnetic resonance imaging|magnetic resonance imaging
5712969|NCT00453804|Alcohol dependence|alcohol dependence
5712970|NCT00453804|Major Mental Illness|major mental illness
5712971|NCT00453804|Injectable naltrexone|injectable naltrexone
5712972|NCT00453791|GW805858|gw805858
5712974|NCT00453791|asthma|asthma
5712975|NCT00453791|surfactant|surfactant
5712976|NCT00453778|mild asthma|mild asthma
5712977|NCT00453778|FLIXOTIDE|flixotide
5712978|NCT00453778|methacholine|methacholine
5712979|NCT00453778|bronchial challenge|bronchial challenge
5712980|NCT00453778|leukotriene D4|leukotriene d4
5712981|NCT00453765|cough|cough
5712982|NCT00453765|hyperreactivity|hyperreactivity
5712983|NCT00453765|montelukast|montelukast
5712984|NCT00453752|systemic sclerosis|systemic sclerosis
5712985|NCT00453752|pulmonary hypertension|pulmonary hypertension
5712986|NCT00453752|echocardiography|echocardiography
5712987|NCT00453752|N-Terminal proBNP|n-terminal probnp
5712988|NCT00453726|Natriuretic peptide brain|natriuretic peptide brain
5712989|NCT00453726|Continuous positive airway pressure|continuous positive airway pressure
5712990|NCT00453726|Intermittent positive pressure breathing|intermittent positive pressure breathing
5712991|NCT00453726|Respiratory insufficiency|respiratory insufficiency
5712992|NCT00453713|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5712993|NCT00453713|Interstitial lung disease|interstitial lung disease
5712994|NCT00453713|Diffuse parenchymal lung disease|diffuse parenchymal lung disease
5712995|NCT00453713|Health disparities|health disparities
5712996|NCT00453700|chagas|chagas
5712997|NCT00453700|trypanosoma cruzi|trypanosoma cruzi
5712998|NCT00453687|COPD|copd
5712999|NCT00453687|GSK233705,|gsk233705,
5713000|NCT00453687|Magnesium Stearate,|magnesium stearate,
5720303|NCT00430560|treatment outcome|treatment outcome
5713001|NCT00453674|Adrenal cancer|adrenal cancer
5713002|NCT00453674|Treatment|treatment
5713003|NCT00453674|Surgery|surgery
5713004|NCT00453674|Mitotane|mitotane
5713005|NCT00453661|Breast Cancer|breast cancer
5713006|NCT00453661|Cervical Cancer|cervical cancer
5713007|NCT00453661|Prostate Cancer|prostate cancer
5713008|NCT00453661|Colorectal Cancer|colorectal cancer
5713009|NCT00453661|Lung Cancer|lung cancer
5713010|NCT00453661|Cancer Prevention|cancer prevention
5713011|NCT00453661|Treatment Demonstration for Ethnic and Racial Minorities|treatment demonstration for ethnic and racial minorities
5713012|NCT00453661|Centers for Medicare and Medicaid Services|centers for medicare and medicaid services
5713013|NCT00453661|CMS|cms
5713014|NCT00453661|Hispanic American|hispanic american
5713015|NCT00453661|Cancer Screening Assessment|cancer screening assessment
5713016|NCT00453661|Annual Questionnaire|annual questionnaire
5713017|NCT00453661|Patient Navigator|patient navigator
5713018|NCT00453661|Educational Materials|educational materials
5713019|NCT00453648|stable isotopes|stable isotopes
5713020|NCT00453648|vitamin A|vitamin a
5713021|NCT00453648|beta-carotene|beta-carotene
5713022|NCT00453648|orange-fleshed sweet potatoes|orange-fleshed sweet potatoes
5713023|NCT00453648|iron|iron
5713024|NCT00453648|zinc|zinc
5713025|NCT00453648|absorption|absorption
5713026|NCT00453648|bioavailability|bioavailability
5713027|NCT00453648|vitamin A equivalency|vitamin a equivalency
5713028|NCT00453648|Bangladesh|bangladesh
5713029|NCT00453648|women|women
5713030|NCT00453635|Cancer|cancer
5713031|NCT00453635|Breast cancer|breast cancer
5713032|NCT00453635|First line treatment|first line treatment
5713033|NCT00453635|Docetaxel|docetaxel
5713034|NCT00453635|Carboplatin|carboplatin
5713035|NCT00453635|Herceptin|herceptin
5713036|NCT00453635|Vinorelbine|vinorelbine
5713037|NCT00453622|Heart Failure|heart failure
5713038|NCT00453622|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5713039|NCT00453622|Risk stratification|risk stratification
5713040|NCT00453622|Prediction|prediction
5713041|NCT00453622|Proteomics|proteomics
5713042|NCT00453622|Chemokine|chemokine
5713044|NCT00453622|Brain Natriuretic Peptide|brain natriuretic peptide
5713045|NCT00453609|Bipolar Disorders|bipolar disorders
5713046|NCT00453609|Schizophrenia|schizophrenia
5713047|NCT00453609|Schizoaffective Disorders|schizoaffective disorders
5713048|NCT00453609|Alcohol Dependence|alcohol dependence
5863797|NCT00001183|Pulmonary Function Testing|pulmonary function testing
5713049|NCT00453609|Long-lasting injectable naltrexone|long-lasting injectable naltrexone
5713050|NCT00453596|infertile women|infertile women
5713051|NCT00453596|thin endometrial thickness|thin endometrial thickness
5713052|NCT00453596|implantation failure|implantation failure
5713053|NCT00453583|Pediatric|pediatric
5713054|NCT00453583|Allergies|allergies
5713055|NCT00453583|Antihistamines|antihistamines
5713056|NCT00453583|Non-interventional|non-interventional
5713057|NCT00453570|Diphteria|diphteria
5713058|NCT00453570|Tetanus|tetanus
5713059|NCT00453570|Haemophilus influenzae type b|haemophilus influenzae type b
5713060|NCT00453570|Poliomyelitis|poliomyelitis
5713061|NCT00453570|Pertussis|pertussis
5713062|NCT00453557|growth hormone, obesity, visceral adiposity|growth hormone, obesity, visceral adiposity
5713063|NCT00453544|computer assisted instruction|computer assisted instruction
5713064|NCT00453544|decision making|decision making
5713065|NCT00453544|educational resource design /development|educational resource design /development
5713066|NCT00453544|executive function|executive function
5713067|NCT00453531|Forearm Ischemia|forearm ischemia
5713068|NCT00453531|Endothelial Function|endothelial function
5713069|NCT00453531|Acetyicholine Vasodilation|acetyicholine vasodilation
5713070|NCT00453531|Venous Plethysmography|venous plethysmography
5713071|NCT00453531|Healthy Volunteer|healthy volunteer
5713072|NCT00453531|HV|hv
5713073|NCT00453518|SVG|svg
5713074|NCT00453518|Saphenous Vein Graft|saphenous vein graft
5713075|NCT00453518|Embolic Protection|embolic protection
5713076|NCT00453518|Distal Protection|distal protection
5713077|NCT00453518|EPD|epd
5713078|NCT00453518|FiberNet|fibernet
5713079|NCT00453518|Saphenous Vein Graft intervention|saphenous vein graft intervention
5713080|NCT00453505|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5713081|NCT00453505|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5713082|NCT00453505|Peripheral Nerve Stimulation|peripheral nerve stimulation
5713083|NCT00453505|Primary Motor Cortex|primary motor cortex
5713084|NCT00453505|Corticomotor Excitability|corticomotor excitability
5713085|NCT00453505|Healthy Volunteer|healthy volunteer
5713086|NCT00453505|HV|hv
5713087|NCT00453479|muscarinic receptor,|muscarinic receptor,
5713088|NCT00453479|bronchodilators|bronchodilators
5713089|NCT00453479|Chronic obstructive pulmonary disease,|chronic obstructive pulmonary disease,
5713090|NCT00453466|women experiencing domestic violence|women experiencing domestic violence
5713091|NCT00453453|Congestive heart failure|congestive heart failure
5713092|NCT00453453|observation unit|observation unit
5713093|NCT00453453|nesiritide|nesiritide
5713094|NCT00453440|HIV|hiv
5685838|NCT00554645|psychological intervention|psychological intervention
5713095|NCT00453440|HLA-B*5701|hla-b*5701
5713096|NCT00453440|Abacavir hypersensitivity reaction|abacavir hypersensitivity reaction
5713097|NCT00453440|HIV Infection|hiv infection
5713098|NCT00453427|PTL NOS|ptl nos
5713099|NCT00453427|AILD|aild
5713100|NCT00453427|NHL|nhl
5713101|NCT00453427|CHOP|chop
5713102|NCT00453414|PAH|pah
5713103|NCT00453414|Pediatric|pediatric
5713104|NCT00453414|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5713105|NCT00453401|cold sore|cold sore
5713106|NCT00453375|Diabetic|diabetic
5713107|NCT00453375|Diabetes|diabetes
5713108|NCT00453375|Type 1 Diabetes|type 1 diabetes
5713109|NCT00453375|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5713110|NCT00453375|autoimmune disease|autoimmune disease
5713111|NCT00453362|NSCLC|nsclc
5713112|NCT00453362|Tarceva|tarceva
5713113|NCT00453362|Positron emission technology|positron emission technology
5713114|NCT00453362|PET|pet
5713115|NCT00453362|Computerized tomography|computerized tomography
5713116|NCT00453362|CT|ct
5713117|NCT00453349|Uncomplicated pelvic inflammatory disease|uncomplicated pelvic inflammatory disease
5713118|NCT00453336|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5713119|NCT00453336|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5713120|NCT00453336|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5713121|NCT00453336|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5713122|NCT00453336|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5713123|NCT00453336|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5713124|NCT00453336|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5713125|NCT00453336|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5713126|NCT00453336|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5713127|NCT00453336|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5713128|NCT00453336|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5713129|NCT00453336|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5713130|NCT00453336|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5789082|NCT00149994|Liver transplant, adults, C2 monitoring|liver transplant, adults, c2 monitoring
5713131|NCT00453336|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5713132|NCT00453336|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5713134|NCT00453323|Esophageal Cancer|esophageal cancer
5713135|NCT00453323|Phase II|phase ii
5713136|NCT00453323|Metastatic esophageal cancer|metastatic esophageal cancer
5713137|NCT00453323|Recurrent esophageal cancer|recurrent esophageal cancer
5713138|NCT00453310|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5798808|NCT00110955|Non-myeloid malignancy|non-myeloid malignancy
5729216|NCT00397488|recurrent urethral cancer|recurrent urethral cancer
5729217|NCT00397488|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5729218|NCT00397488|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5729221|NCT00397462|Sarcopenia|sarcopenia
5713139|NCT00453310|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5713140|NCT00453310|ovarian choriocarcinoma|ovarian choriocarcinoma
5713141|NCT00453310|ovarian immature teratoma|ovarian immature teratoma
5713142|NCT00453310|ovarian mature teratoma|ovarian mature teratoma
5713143|NCT00453310|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5713144|NCT00453310|testicular choriocarcinoma|testicular choriocarcinoma
5713145|NCT00453310|testicular seminoma|testicular seminoma
5713146|NCT00453310|testicular yolk sac tumor|testicular yolk sac tumor
5713147|NCT00453310|ovarian dysgerminoma|ovarian dysgerminoma
5713148|NCT00453310|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5713149|NCT00453310|ovarian yolk sac tumor|ovarian yolk sac tumor
5713150|NCT00453310|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5713151|NCT00453310|ovarian polyembryoma|ovarian polyembryoma
5713152|NCT00453310|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5713153|NCT00453310|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5713154|NCT00453310|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5713155|NCT00453310|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5713156|NCT00453310|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5713157|NCT00453310|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5713158|NCT00453310|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5713159|NCT00453310|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5713160|NCT00453310|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5713161|NCT00453310|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5713162|NCT00453310|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5713163|NCT00453310|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5713164|NCT00453310|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5713165|NCT00453310|testicular embryonal carcinoma|testicular embryonal carcinoma
5713166|NCT00453310|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5713167|NCT00453310|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5713168|NCT00453310|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5713169|NCT00453310|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5713170|NCT00453310|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5713171|NCT00453310|testicular immature teratoma|testicular immature teratoma
5713172|NCT00453310|testicular mature teratoma|testicular mature teratoma
5713173|NCT00453310|adult teratoma|adult teratoma
5713174|NCT00453297|Bionovo|bionovo
5713175|NCT00453297|MF101|mf101
5713176|NCT00453297|Herbs|herbs
5713177|NCT00453297|The primary goal of this study is to identify the highest safe oral dose of MF101 that is well tolerated in humans.|the primary goal of this study is to identify the highest safe oral dose of mf101 that is well tolerated in humans.
5713178|NCT00453271|chronic persistent infection of the nail bed or plate|chronic persistent infection of the nail bed or plate
5713179|NCT00453258|ocular proteomics|ocular proteomics
5713180|NCT00453258|eye disease|eye disease
5713181|NCT00453258|proteomics|proteomics
5713182|NCT00453232|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5713183|NCT00453232|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5713184|NCT00453232|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5713185|NCT00453232|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5713186|NCT00453232|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5713187|NCT00453232|testicular choriocarcinoma|testicular choriocarcinoma
5713188|NCT00453232|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5713280|NCT00453206|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5713189|NCT00453232|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5713190|NCT00453232|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5713191|NCT00453232|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5713192|NCT00453232|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5713194|NCT00453232|testicular seminoma|testicular seminoma
5713195|NCT00453232|testicular yolk sac tumor|testicular yolk sac tumor
5713196|NCT00453232|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5713197|NCT00453232|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5713198|NCT00453232|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5713199|NCT00453232|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5713200|NCT00453232|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5707843|NCT00472888|hypertension|hypertension
5713201|NCT00453232|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5713202|NCT00453232|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5713203|NCT00453232|adult teratoma|adult teratoma
5713204|NCT00453232|testicular immature teratoma|testicular immature teratoma
5713205|NCT00453232|testicular mature teratoma|testicular mature teratoma
5713206|NCT00453232|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5713207|NCT00453206|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5713208|NCT00453206|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5713209|NCT00453206|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5713210|NCT00453206|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5713211|NCT00453206|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5713212|NCT00453206|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5713213|NCT00453206|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5713214|NCT00453206|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5713215|NCT00453206|primary myelofibrosis|primary myelofibrosis
5713216|NCT00453206|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5713217|NCT00453206|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5713218|NCT00453206|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5713219|NCT00453206|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5713220|NCT00453206|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5713221|NCT00453206|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5713287|NCT00453206|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5685839|NCT00554632|Contraceptive|contraceptive
5685840|NCT00554632|Venous thrombosis|venous thrombosis
5685841|NCT00554632|Coagulation parameter|coagulation parameter
5737071|NCT00368940|Problem Solving Therapy|problem solving therapy
5713222|NCT00453206|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5713223|NCT00453206|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5713224|NCT00453206|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5713225|NCT00453206|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5713226|NCT00453206|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5713227|NCT00453206|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5713228|NCT00453206|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5713229|NCT00453206|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5713230|NCT00453206|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5713231|NCT00453206|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5713232|NCT00453206|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5713233|NCT00453206|prolymphocytic leukemia|prolymphocytic leukemia
5713234|NCT00453206|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5713235|NCT00453206|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5713236|NCT00453206|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5713237|NCT00453206|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5713238|NCT00453206|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5713239|NCT00453206|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5713240|NCT00453206|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5713241|NCT00453206|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5713242|NCT00453206|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5713243|NCT00453206|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5713244|NCT00453206|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5713245|NCT00453206|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5713246|NCT00453206|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5713247|NCT00453206|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5713248|NCT00453206|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5713250|NCT00453206|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5713251|NCT00453206|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5863953|NCT00001155|Wegener's Granulomatosis|wegener's granulomatosis
5713252|NCT00453206|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5713253|NCT00453206|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5713254|NCT00453206|stage I multiple myeloma|stage i multiple myeloma
5713255|NCT00453206|stage II multiple myeloma|stage ii multiple myeloma
5713256|NCT00453206|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5713257|NCT00453206|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5713258|NCT00453206|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5713259|NCT00453206|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5713260|NCT00453206|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5713261|NCT00453206|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5713262|NCT00453206|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5713263|NCT00453206|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5713264|NCT00453206|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5713265|NCT00453206|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5713266|NCT00453206|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5713267|NCT00453206|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5713268|NCT00453206|stage III multiple myeloma|stage iii multiple myeloma
5713269|NCT00453206|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5713270|NCT00453206|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5713271|NCT00453206|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5713272|NCT00453206|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5713273|NCT00453206|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5713274|NCT00453206|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5713275|NCT00453206|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5713276|NCT00453206|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5713277|NCT00453206|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5713278|NCT00453206|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5685842|NCT00554619|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5685843|NCT00554619|Ambrisentan|ambrisentan
5685844|NCT00554606|Rheumatoid Arthritis|rheumatoid arthritis
5685845|NCT00554606|Anit-interleukin-1 beta|anit-interleukin-1 beta
5685846|NCT00554606|ACZ885|acz885
5712042|NCT00457522|PTSD|ptsd
5713279|NCT00453206|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5713503|NCT00452439|Bone Loss|bone loss
5713281|NCT00453206|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5713282|NCT00453206|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5713283|NCT00453206|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5713284|NCT00453206|polycythemia vera|polycythemia vera
5713285|NCT00453206|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5713286|NCT00453206|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5713288|NCT00453206|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5713289|NCT00453206|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5713290|NCT00453206|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5713291|NCT00453206|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5713292|NCT00453206|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5713293|NCT00453206|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5713294|NCT00453206|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5713295|NCT00453206|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5713296|NCT00453206|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5713297|NCT00453206|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5713298|NCT00453206|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5713299|NCT00453206|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5713300|NCT00453206|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5713301|NCT00453206|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5713302|NCT00453206|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5713303|NCT00453206|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5713304|NCT00453206|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5713305|NCT00453206|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5713306|NCT00453206|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5713307|NCT00453206|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5713308|NCT00453206|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5713309|NCT00453206|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5713310|NCT00453206|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5713311|NCT00453206|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5713312|NCT00453206|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5713313|NCT00453193|T-Cell Neoplasms|t-cell neoplasms
5713314|NCT00453193|Alemtuzumab|alemtuzumab
5713315|NCT00453193|Pentostatin|pentostatin
5713316|NCT00453193|Campath-1H|campath-1h
5713317|NCT00453193|Deoxycoformycin|deoxycoformycin
5713318|NCT00453193|Lymphoma|lymphoma
5680603|NCT00577278|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5681208|NCT00574314|Registry|registry
5680604|NCT00577278|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5680605|NCT00577278|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5738601|NCT00363051|Pancreatic|pancreatic
5713319|NCT00453193|Leukemia|leukemia
5713320|NCT00453180|Autistic Disorder|autistic disorder
5713321|NCT00453180|Asperger's|asperger's
5713323|NCT00453180|Pervasive Developmental Disorder|pervasive developmental disorder
5713324|NCT00453180|Autism|autism
5713325|NCT00453180|N-acetylcysteine|n-acetylcysteine
5713327|NCT00453180|NAC|nac
5713328|NCT00453180|antioxidant|antioxidant
5713329|NCT00453180|treatment|treatment
5713330|NCT00453180|core symptoms|core symptoms
5713331|NCT00453180|Autism Spectrum Disorders|autism spectrum disorders
5713332|NCT00453180|Asperger's Disorder|asperger's disorder
5713333|NCT00453180|Pervasive Developmental Disorder Not Otherwise Specified|pervasive developmental disorder not otherwise specified
5713334|NCT00453180|Pervasive Developmental Disorders|pervasive developmental disorders
5713335|NCT00453167|Small cell lung cancer|small cell lung cancer
5713336|NCT00453167|second-line therapy|second-line therapy
5713337|NCT00453141|Betamethasone for preterm labor|betamethasone for preterm labor
5713338|NCT00453141|Preterm delivery|preterm delivery
5713339|NCT00453141|Infant Respiratory Distress Syndrome|infant respiratory distress syndrome
5685847|NCT00554580|continuous positive airway pressure|continuous positive airway pressure
5685848|NCT00554580|outcome measure|outcome measure
5685849|NCT00554580|clinical trial|clinical trial
5685850|NCT00554567|HIV/AIDS|hiv/aids
5685851|NCT00554567|Voluntary Counseling and Testing|voluntary counseling and testing
5685852|NCT00554567|Rural India|rural india
5685853|NCT00554567|HIV Care|hiv care
5685854|NCT00554567|Health Services Research|health services research
5685855|NCT00554528|Cervical|cervical
5685856|NCT00554528|disc|disc
5685857|NCT00554528|prosthesis|prosthesis
5685858|NCT00554528|adjacent|adjacent
5685859|NCT00554528|disease|disease
5685860|NCT00554528|randomized|randomized
5685861|NCT00554528|prospective|prospective
5685862|NCT00554528|study|study
5685863|NCT00554515|Kidney|kidney
5685864|NCT00554515|Renal Cell|renal cell
5713340|NCT00453128|Calcium Pyrophosphate|calcium pyrophosphate
5713341|NCT00453128|associated conditions|associated conditions
5713342|NCT00453115|Non small cell lung cancer|non small cell lung cancer
5713343|NCT00453115|advanced stage IIIB|advanced stage iiib
5713344|NCT00453115|Stage IV|stage iv
5713345|NCT00453102|Marginal Zone Lymphoma|marginal zone lymphoma
5713346|NCT00453102|Non-gastric extranodal Marginal Zone Lymphoma|non-gastric extranodal marginal zone lymphoma
5713347|NCT00453102|Splenic Marginal Zone Lymphoma|splenic marginal zone lymphoma
5713348|NCT00453102|Nodal Marginal Zone Lymphoma|nodal marginal zone lymphoma
5713349|NCT00453102|Gastric Marginal Zone Lymphoma|gastric marginal zone lymphoma
5713350|NCT00453102|MZL|mzl
5713351|NCT00453102|Non-gastric extranodal MZL|non-gastric extranodal mzl
5713352|NCT00453102|Splenic MZL|splenic mzl
5713353|NCT00453102|Nodal MZL|nodal mzl
5713354|NCT00453102|Gastric MZL|gastric mzl
5713355|NCT00453089|Chinese Herbs|chinese herbs
5713356|NCT00453089|Postmenopausal|postmenopausal
5713357|NCT00453089|Vaginal Atrophy|vaginal atrophy
5713358|NCT00453089|Vulvar Atrophy|vulvar atrophy
5713359|NCT00453089|Symptoms|symptoms
5713360|NCT00453089|Bionovo|bionovo
5713361|NCT00453089|VG101|vg101
5713362|NCT00453076|Biliary Obstruction|biliary obstruction
5713363|NCT00453050|stage III melanoma|stage iii melanoma
5713364|NCT00453050|stage IV melanoma|stage iv melanoma
5713365|NCT00453050|skin metastases|skin metastases
5713366|NCT00453037|hypertension|hypertension
5713367|NCT00453037|self measurement of blood pressure|self measurement of blood pressure
5713368|NCT00453037|education program|education program
5713370|NCT00453024|Advanced glaucoma|advanced glaucoma
5713371|NCT00453024|Ahmed glaucoma implant|ahmed glaucoma implant
5713372|NCT00453024|Anterior segment optical coherence tomography|anterior segment optical coherence tomography
5713373|NCT00453024|Pericardial patch graft|pericardial patch graft
5713374|NCT00453024|Tissue glue|tissue glue
5713375|NCT00453024|Scleral flap|scleral flap
5713376|NCT00453024|Sutures|sutures
5713377|NCT00453011|vitreous loss|vitreous loss
5713378|NCT00453011|intraocular lenses|intraocular lenses
5713379|NCT00453011|Patients undergoing extracapsular cataract surgery|patients undergoing extracapsular cataract surgery
5713380|NCT00453011|Vitreous loss with sufficient capsular support for an unsutured posterior chamber lens|vitreous loss with sufficient capsular support for an unsutured posterior chamber lens
5713381|NCT00453011|5% random sample of patients with no vitreous loss|5% random sample of patients with no vitreous loss
5713382|NCT00452998|Sequential Laser Iridotomy|sequential laser iridotomy
5713383|NCT00452998|Q-Switched 532 nm Laser|q-switched 532 nm laser
5713384|NCT00452998|Frequency Doubled Neodymium Yag Laser|frequency doubled neodymium yag laser
5713385|NCT00452972|Cesarean delivery|cesarean delivery
5713386|NCT00452972|Spinal anesthesia|spinal anesthesia
5713387|NCT00452972|Nausea|nausea
5713388|NCT00452972|Vomiting|vomiting
5713389|NCT00452972|Pain|pain
5713390|NCT00452920|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5713391|NCT00452920|stage IIB cervical cancer|stage iib cervical cancer
5713392|NCT00452920|stage III cervical cancer|stage iii cervical cancer
5713393|NCT00452920|stage IVA cervical cancer|stage iva cervical cancer
5713394|NCT00452881|Non-small cell lung cancer|non-small cell lung cancer
5713395|NCT00452881|adjuvant chemotherapy|adjuvant chemotherapy
5713396|NCT00452868|cognitive/functional effects|cognitive/functional effects
5713397|NCT00452868|neurotoxicity|neurotoxicity
5713398|NCT00452868|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5685865|NCT00554515|Metastatic|metastatic
5685866|NCT00554515|interleukin-2|interleukin-2
5685867|NCT00554515|select|select
5685868|NCT00554489|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5685869|NCT00554489|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5712182|NCT00456911|obesity|obesity
5713399|NCT00452868|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5713400|NCT00452868|radiation toxicity|radiation toxicity
5713401|NCT00452868|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5713402|NCT00452868|childhood choroid plexus tumor|childhood choroid plexus tumor
5713403|NCT00452868|childhood craniopharyngioma|childhood craniopharyngioma
5713404|NCT00452868|childhood grade I meningioma|childhood grade i meningioma
5713405|NCT00452868|childhood grade II meningioma|childhood grade ii meningioma
5713406|NCT00452868|childhood grade III meningioma|childhood grade iii meningioma
5713407|NCT00452868|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5713408|NCT00452868|childhood brain stem glioma|childhood brain stem glioma
5713409|NCT00452868|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5713410|NCT00452868|childhood medulloblastoma|childhood medulloblastoma
5713411|NCT00452868|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5713412|NCT00452868|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5713413|NCT00452868|childhood subependymal giant cell astrocytoma|childhood subependymal giant cell astrocytoma
5713414|NCT00452868|childhood ependymoma|childhood ependymoma
5713415|NCT00452868|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5713416|NCT00452855|Nausea|nausea
5713417|NCT00452855|Vomiting|vomiting
5713418|NCT00452855|Post operative|post operative
5713419|NCT00452855|Propofol remifentanil anaesthesia|propofol remifentanil anaesthesia
5713420|NCT00452855|Sevoflurane remifentanil anaesthesia|sevoflurane remifentanil anaesthesia
5713421|NCT00452816|Chronic Disease|chronic disease
5713422|NCT00452816|Employer Health Costs|employer health costs
5713423|NCT00452816|Health Promotion|health promotion
5713424|NCT00452816|Insurance Benefits|insurance benefits
5713425|NCT00452816|Marketing of Health Services|marketing of health services
5713426|NCT00452816|Mass Screening|mass screening
5713427|NCT00452816|Prevention & Control|prevention & control
5713428|NCT00452816|Tobacco Use Cessation|tobacco use cessation
5713429|NCT00452816|Workplace|workplace
5713430|NCT00452803|Non small cell lung cancer|non small cell lung cancer
5713431|NCT00452790|Vaccines, Pneumococcal|vaccines, pneumococcal
5713527|NCT00452374|DepoCyt|depocyt
5713432|NCT00452777|Diabetic neuropathy, painful|diabetic neuropathy, painful
5713433|NCT00452777|Adenosine A2A receptor|adenosine a2a receptor
5713434|NCT00452764|COPD|copd
5713435|NCT00452764|Healthy|healthy
5713436|NCT00452764|Regulatory T cell|regulatory t cell
5713437|NCT00452764|Heme oxygenase-1|heme oxygenase-1
5713438|NCT00452764|peripheral blood|peripheral blood
5713439|NCT00452751|gastric cancer|gastric cancer
5713440|NCT00452751|laparoscopic surgery|laparoscopic surgery
5713441|NCT00452751|survival|survival
5713442|NCT00452751|preoperative staging|preoperative staging
5713443|NCT00452751|morbidity|morbidity
5713444|NCT00452751|quality of life|quality of life
5713445|NCT00452751|acute inflammatory reaction|acute inflammatory reaction
5713446|NCT00452751|cost|cost
5713447|NCT00452738|animal-assisted intervention|animal-assisted intervention
5713448|NCT00452738|pre surgery anxiety|pre surgery anxiety
5713449|NCT00452738|post surgery pain medication consumption|post surgery pain medication consumption
5713450|NCT00452712|orthostatism|orthostatism
5713451|NCT00452712|fever|fever
5713452|NCT00452699|fluticasone propionate|fluticasone propionate
5713453|NCT00452699|long-term study|long-term study
5713454|NCT00452699|Salmeterol|salmeterol
5713455|NCT00452699|FLOVENT 250|flovent 250
5713456|NCT00452699|Asthma|asthma
5713457|NCT00452699|ADVAIR 250|advair 250
5713458|NCT00452686|Chinese DT vaccin|chinese dt vaccin
5713459|NCT00452660|IRON|iron
5713460|NCT00452660|oxidative stress|oxidative stress
5713462|NCT00452647|Condition: No specific disease is being studied, few procedures are excluded.|condition: no specific disease is being studied, few procedures are excluded.
5713463|NCT00452647|Focus: To obtain blood pressure data and detect any trends to a statistically significant degree.|focus: to obtain blood pressure data and detect any trends to a statistically significant degree.
5713464|NCT00452634|Irinotecan|irinotecan
5713465|NCT00452634|cisplatin|cisplatin
5713466|NCT00452634|Simvastatin|simvastatin
5713467|NCT00452634|Extensive disease|extensive disease
5713468|NCT00452634|SCLC|sclc
5713469|NCT00452621|blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children|blood draw five years after booster-immunization with tbe vaccine to investigate immunogenicity in children
5713471|NCT00452582|ischemic stroke|ischemic stroke
5712321|NCT00456248|HCV|hcv
5713472|NCT00452582|recovery|recovery
5713473|NCT00452582|sildenafil|sildenafil
5713474|NCT00452569|Relapsed Refractory Multiple Myeloma|relapsed refractory multiple myeloma
5713475|NCT00452556|Prostatic Neoplasms|prostatic neoplasms
5713476|NCT00452556|Radiotherapy|radiotherapy
5713477|NCT00452556|Docetaxel|docetaxel
5713478|NCT00452556|Leuprolide Acetate|leuprolide acetate
5713479|NCT00452543|Major depressive disorder|major depressive disorder
5713480|NCT00452543|Alcoholism|alcoholism
5713481|NCT00452543|Alcohol abuse|alcohol abuse
5713482|NCT00452543|Alcohol dependence|alcohol dependence
5680606|NCT00577278|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5681145|NCT00574535|Reproductive Hormones|reproductive hormones
5713483|NCT00452530|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
5713484|NCT00452517|bare metal stents|bare metal stents
5713485|NCT00452517|sirolimus-eluting stents|sirolimus-eluting stents
5713486|NCT00452517|coronary polytetrafluoroethylene stent graft|coronary polytetrafluoroethylene stent graft
5713487|NCT00452517|acute coronary syndrome|acute coronary syndrome
5713488|NCT00452517|quantitative coronary angiography analysis|quantitative coronary angiography analysis
5713489|NCT00452517|major adverse cardiac events|major adverse cardiac events
5713490|NCT00452517|in-stent restenosis|in-stent restenosis
5713491|NCT00452517|target lesion revascularisation|target lesion revascularisation
5713492|NCT00452478|Hyperphosphataemia|hyperphosphataemia
5713493|NCT00452465|Elderly|elderly
5713494|NCT00452465|Nursing care plan|nursing care plan
5729712|NCT00395512|Type II Diabetes|type ii diabetes
5729713|NCT00395512|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5729716|NCT00395499|Risperidone|risperidone
5713495|NCT00452465|Quality of Life|quality of life
5713496|NCT00452452|Pneumococcal Vaccines|pneumococcal vaccines
5713497|NCT00452439|Leukemia|leukemia
5713498|NCT00452439|Lymphoma|lymphoma
5713499|NCT00452439|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5713500|NCT00452439|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5713501|NCT00452439|Actonel|actonel
5713502|NCT00452439|Risedronate|risedronate
5713504|NCT00452439|Osteoporosis|osteoporosis
5713505|NCT00452426|Propofol|propofol
5713506|NCT00452426|Diprivan|diprivan
5713507|NCT00452426|Colonoscopy|colonoscopy
5713508|NCT00452426|Endoscopy, Digestive System|endoscopy, digestive system
5713509|NCT00452426|Conscious Sedation|conscious sedation
5713510|NCT00452387|Prostate Cancer|prostate cancer
5713511|NCT00452374|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5713512|NCT00452374|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5713514|NCT00452374|Prolymphocytic Leukemia|prolymphocytic leukemia
5713515|NCT00452374|PLL|pll
5713516|NCT00452374|Richter's Transformation|richter's transformation
5713517|NCT00452374|High-grade non-Hodgkin's lymphoma|high-grade non-hodgkin's lymphoma
5713518|NCT00452374|Hodgkin's disease|hodgkin's disease
5713519|NCT00452374|Acute leukemia|acute leukemia
5713520|NCT00452374|Small lymphocytic lymphoma|small lymphocytic lymphoma
5713521|NCT00452374|Oxaliplatin|oxaliplatin
5713522|NCT00452374|Eloxatin|eloxatin
5713523|NCT00452374|Fludarabine|fludarabine
5713524|NCT00452374|Cytarabine|cytarabine
5713525|NCT00452374|Ara-C|ara-c
5713526|NCT00452374|Cytosar|cytosar
5713528|NCT00452374|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5713529|NCT00452374|Rituximab|rituximab
5713530|NCT00452374|Rituxan|rituxan
5713531|NCT00452348|FLOVENT|flovent
5713532|NCT00452348|fluticasone|fluticasone
5713533|NCT00452348|12 month|12 month
5713534|NCT00452348|salmeterol|salmeterol
5713535|NCT00452348|asthma|asthma
5713536|NCT00452348|ADVAIR|advair
5713537|NCT00452322|Testosterone|testosterone
5713538|NCT00452322|Hypogonadism|hypogonadism
5713539|NCT00452322|Safety|safety
5713540|NCT00452309|peripheral arterial disease|peripheral arterial disease
5713541|NCT00452309|pad|pad
5713542|NCT00452309|ankle brachial index|ankle brachial index
5713543|NCT00452309|abi|abi
5713544|NCT00452296|inpatients with COPD|inpatients with copd
5713545|NCT00452296|glucose control|glucose control
5713546|NCT00452270|Common cold, xylometazoline|common cold, xylometazoline
5713547|NCT00452244|Gefitinib|gefitinib
5713548|NCT00452244|Simvastatin|simvastatin
5713549|NCT00452244|NSCLC|nsclc
5713550|NCT00452244|Advanced NSCLC|advanced nsclc
5713551|NCT00452231|Post-traumatic Stress Disorder|post-traumatic stress disorder
5713552|NCT00452231|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5713553|NCT00452218|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5713554|NCT00452218|PAH|pah
5713555|NCT00452205|bone marrow-derived stem cell|bone marrow-derived stem cell
5713556|NCT00452205|bone marrow transplantation|bone marrow transplantation
5713557|NCT00452205|graft versus host disease|graft versus host disease
5713558|NCT00452205|gastrointestinal cancer|gastrointestinal cancer
5713559|NCT00452205|after receiving bone marrow transplantation|after receiving bone marrow transplantation
5713560|NCT00452192|Metabolic syndrome|metabolic syndrome
5713561|NCT00452179|Sleep maintenance|sleep maintenance
5713562|NCT00452179|Insomnia|insomnia
5713563|NCT00452179|Sleep Consolidation|sleep consolidation
5721028|NCT00427908|Persistence|persistence
5713564|NCT00452179|Sleep|sleep
5713565|NCT00452179|Insomnia, primarily sleep maintenance|insomnia, primarily sleep maintenance
5713566|NCT00452153|legionellosis|legionellosis
5713567|NCT00452153|diagnosis of legionellosis|diagnosis of legionellosis
5713568|NCT00452153|PCR|pcr
5713569|NCT00452140|Breast Cancer|breast cancer
5713570|NCT00452140|investigational drug|investigational drug
5713571|NCT00452140|drug therapy|drug therapy
5713572|NCT00452140|Antineoplastic Protocols|antineoplastic protocols
5713573|NCT00452140|Immunotherapy|immunotherapy
5713574|NCT00452140|Metastatic breast cancer|metastatic breast cancer
5713575|NCT00452140|Advanced breast cancer|advanced breast cancer
5713576|NCT00452140|Stage III to IV breast cancer|stage iii to iv breast cancer
5713577|NCT00452140|Hormonal therapy refractory|hormonal therapy refractory
5713578|NCT00452140|Failure of hormonal therapy|failure of hormonal therapy
5713579|NCT00452140|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5713580|NCT00452140|Her-2/neu|her-2/neu
5713582|NCT00452127|Indolent|indolent
5713583|NCT00452127|Follicular|follicular
5713584|NCT00452114|Bronchiectasis|bronchiectasis
5713585|NCT00452101|Osteoarthritis|osteoarthritis
5713586|NCT00452101|Clinical trial|clinical trial
5713587|NCT00452101|Aquamin F|aquamin f
5713588|NCT00452101|Glucosamine|glucosamine
5713589|NCT00452088|Malaria vaccine|malaria vaccine
5713590|NCT00452088|Safety of MSP 3 LSP|safety of msp 3 lsp
5713591|NCT00452088|Immunogenicity of MSP 3 LSP|immunogenicity of msp 3 lsp
5713592|NCT00452088|Burkina Faso children|burkina faso children
5713593|NCT00452075|EGFR expression|egfr expression
5713594|NCT00452075|erlotinib|erlotinib
5713595|NCT00452062|cuff-leak test|cuff-leak test
5713596|NCT00452062|intubation|intubation
5713597|NCT00452062|corticosteroids|corticosteroids
5713598|NCT00452062|dexamethasone to reduce the occurrence of post-extubation airway obstruction|dexamethasone to reduce the occurrence of post-extubation airway obstruction
5713599|NCT00452049|parathyroidectomy|parathyroidectomy
5713600|NCT00452049|arterial stiffness|arterial stiffness
5713601|NCT00452049|renal function|renal function
5713602|NCT00452036|risk factors|risk factors
5713603|NCT00452036|plain x ray|plain x ray
5713604|NCT00452036|cranial computed tomography|cranial computed tomography
5713605|NCT00452036|minor head injury|minor head injury
5713606|NCT00452023|Myeloproliferative Disorders|myeloproliferative disorders
5713607|NCT00452023|Essential Thrombocythemia|essential thrombocythemia
5713608|NCT00452023|Polycythemia Vera|polycythemia vera
5713609|NCT00452023|Pegasys|pegasys
5713610|NCT00452023|IFN-alpha2a|ifn-alpha2a
5713611|NCT00452023|Pegylated-Interferon Alpha-2A|pegylated-interferon alpha-2a
5713612|NCT00452023|PEG-IFNa-2a|peg-ifna-2a
5713613|NCT00452010|TENS|tens
5713614|NCT00452010|chronic low back pain|chronic low back pain
5713615|NCT00452010|chronic lumbo-radiculalgia|chronic lumbo-radiculalgia
5713616|NCT00452010|placebo|placebo
5713617|NCT00452010|Roland scale|roland scale
5713618|NCT00451997|AML|aml
5713619|NCT00451997|MDS|mds
5713620|NCT00451997|Gleevec|gleevec
5713621|NCT00451997|Ara-C|ara-c
5713622|NCT00451997|C-Kit Positive Acute Myeloid Leukemia|c-kit positive acute myeloid leukemia
5713623|NCT00451997|High-Risk Myelodysplastic Syndromes|high-risk myelodysplastic syndromes
5713624|NCT00451984|interleukin-2|interleukin-2
5713625|NCT00451984|vaccination|vaccination
5713626|NCT00451984|treatment experienced|treatment experienced
5713627|NCT00451958|Degarelix|degarelix
5713628|NCT00451958|prostate cancer|prostate cancer
5713629|NCT00451932|Malononitrilamide|malononitrilamide
5713630|NCT00451932|Immunosuppression|immunosuppression
5713631|NCT00451932|treatment efficacy|treatment efficacy
5713632|NCT00451932|treatment effectiveness|treatment effectiveness
5713634|NCT00451919|Neuropsychology|neuropsychology
5713635|NCT00451893|Inguinal hernia|inguinal hernia
5713636|NCT00451893|polypropylene mesh|polypropylene mesh
5713637|NCT00451893|heavy-weight mesh|heavy-weight mesh
5713638|NCT00451893|light-weight mesh|light-weight mesh
5713639|NCT00451880|Cancer|cancer
5713640|NCT00451880|Solid Tumors|solid tumors
5713641|NCT00451880|NSCLC|nsclc
5713642|NCT00451867|interstitial cystitis research|interstitial cystitis research
5713643|NCT00451867|painful bladder syndrome research|painful bladder syndrome research
5713644|NCT00451867|pelvic pain research|pelvic pain research
5713645|NCT00451867|interstitial cystitis and autoimmune|interstitial cystitis and autoimmune
5713646|NCT00451867|interstitial cystitis and cellcept|interstitial cystitis and cellcept
5713647|NCT00451867|interstitial cystitis and mycophenolate mofetil|interstitial cystitis and mycophenolate mofetil
5713648|NCT00451867|interstitial cystitis and MMF|interstitial cystitis and mmf
5713649|NCT00451867|interstitial cystitis and inflammation|interstitial cystitis and inflammation
5713650|NCT00451867|inflammatory diseases and immunosupression|inflammatory diseases and immunosupression
5713651|NCT00451854|Drug testing|drug testing
5713652|NCT00451854|Adolescence|adolescence
5713653|NCT00451854|Student athlete|student athlete
5713654|NCT00451854|Substance abuse|substance abuse
5713655|NCT00451854|Alcohol use|alcohol use
5713656|NCT00451854|Drug use|drug use
5713657|NCT00451841|Cough|cough
5713658|NCT00451841|Gastroesophageal reflux|gastroesophageal reflux
5737682|NCT00366223|candida|candida
5713659|NCT00451841|Exhaled breath condensate|exhaled breath condensate
5713660|NCT00451828|Statins|statins
5713661|NCT00451828|Cholesterol|cholesterol
5713662|NCT00451828|Pharmacogenetics|pharmacogenetics
5713663|NCT00451802|Biotechnology|biotechnology
5713664|NCT00451802|Specimen|specimen
5713665|NCT00451802|Health Management Center|health management center
5713666|NCT00451789|Minor head injury|minor head injury
5713667|NCT00451789|iintracranial bleeding|iintracranial bleeding
5713668|NCT00451789|traumatic brain injury|traumatic brain injury
5713669|NCT00451789|Cranial computed tomography|cranial computed tomography
5713670|NCT00451789|anticoagulatory drugs|anticoagulatory drugs
5713671|NCT00451776|cardiac surgery|cardiac surgery
5713672|NCT00451776|adrenal insufficiency|adrenal insufficiency
5713673|NCT00451776|etomidate|etomidate
5713674|NCT00451776|propofol|propofol
5713675|NCT00451763|Fovea centralis/pathology|fovea centralis/pathology
5713676|NCT00451763|Fundus oculi|fundus oculi
5713677|NCT00451763|Retinal neovascularization|retinal neovascularization
5713678|NCT00451763|Telangiectasis/diagnosis|telangiectasis/diagnosis
5713679|NCT00451763|Tomography, optical coherence|tomography, optical coherence
5713680|NCT00451763|Vitreous Body/drug effects|vitreous body/drug effects
5713682|NCT00451750|cortisol|cortisol
5713683|NCT00451750|memory|memory
5713684|NCT00451750|treatment|treatment
5713685|NCT00451737|Six-minute walk test|six-minute walk test
5713686|NCT00451737|Neuromuscular system|neuromuscular system
5713687|NCT00451737|Influence factors|influence factors
5713688|NCT00451724|Prospective|prospective
5713689|NCT00451724|Randomized|randomized
5713690|NCT00451724|Double blinded|double blinded
5713691|NCT00451724|Sedation|sedation
5713692|NCT00451724|Ketamine|ketamine
5713693|NCT00451724|Intranasal|intranasal
5713694|NCT00451711|Prophylaxis|prophylaxis
5713696|NCT00451711|Acute myeloid leukaemia|acute myeloid leukaemia
5713697|NCT00451711|Invasive Fungal Infections|invasive fungal infections
5713698|NCT00451698|Erythropoietin|erythropoietin
5713699|NCT00451698|Congenital heart surgery|congenital heart surgery
5713700|NCT00451672|aldosteronism, bromocriptin, hypertension|aldosteronism, bromocriptin, hypertension
5713701|NCT00451659|PTSD|ptsd
5713702|NCT00451659|Veterans|veterans
5713703|NCT00451659|Deployed|deployed
5713704|NCT00451620|Type 2 diabetes|type 2 diabetes
5713705|NCT00451620|Hypoglycemia|hypoglycemia
5713706|NCT00451620|Oral hypoglycemic agents|oral hypoglycemic agents
5713707|NCT00451620|Insulin levels|insulin levels
5713708|NCT00451607|premature|premature
5713709|NCT00451607|newborn|newborn
5713710|NCT00451607|heart rate variability|heart rate variability
5713711|NCT00451607|individualized sensorimotor care|individualized sensorimotor care
5713712|NCT00451607|noise|noise
5713714|NCT00451581|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
5713715|NCT00451581|Endoscopic sphincterotomy|endoscopic sphincterotomy
5713716|NCT00451581|Choledocholithiasis|choledocholithiasis
5713717|NCT00451581|Efficacy|efficacy
5713718|NCT00451581|Complication|complication
5713719|NCT00451568|Polycystic ovary syndrome|polycystic ovary syndrome
5713720|NCT00451542|Bipolar Disorder|bipolar disorder
5713721|NCT00451542|Relapse|relapse
5713722|NCT00451542|Retrospective|retrospective
5713723|NCT00451516|Plant, medicine|plant, medicine
5713724|NCT00451516|Psychiatry|psychiatry
5713725|NCT00451516|Major depressive disorder|major depressive disorder
5713726|NCT00451516|Anxiety|anxiety
5713727|NCT00451516|Major Depressive Disorder with comorbid anxiety|major depressive disorder with comorbid anxiety
5713728|NCT00451503|Hearing|hearing
5713729|NCT00451503|Auditory rehabilitation|auditory rehabilitation
5713730|NCT00451503|Middle ear implant|middle ear implant
5713731|NCT00451503|Surgery|surgery
5713732|NCT00451490|agomelatin|agomelatin
5713733|NCT00451490|prozac|prozac
5713734|NCT00451490|heart rate variability|heart rate variability
5713735|NCT00451490|major depression|major depression
5713736|NCT00451490|sleep|sleep
5713737|NCT00451490|depressive symptoms|depressive symptoms
5713738|NCT00451464|Apolipoprotein, Gene polymorphism, Hyperlipidemia|apolipoprotein, gene polymorphism, hyperlipidemia
5713739|NCT00451451|relapsing|relapsing
5713740|NCT00451451|multiple sclerosis|multiple sclerosis
5713741|NCT00451451|oral|oral
5713742|NCT00451451|remitting|remitting
5713743|NCT00451438|patellofemoral pain syndrome|patellofemoral pain syndrome
5713744|NCT00451438|electromyography|electromyography
5713745|NCT00451438|gluteus medius|gluteus medius
5714015|NCT00450437|adults|adults
5713746|NCT00451438|tensor fascia lata|tensor fascia lata
5713747|NCT00451425|pregnancy|pregnancy
5713748|NCT00451425|weight gain|weight gain
5713749|NCT00451425|obesity|obesity
5713750|NCT00451425|macrosomia|macrosomia
5713751|NCT00451412|Venous thromboembolism|venous thromboembolism
5713752|NCT00451412|Medical patients|medical patients
5713753|NCT00451412|Heparin|heparin
5713754|NCT00451412|Low molecular weight heparin|low molecular weight heparin
5713755|NCT00451412|Deep vein thrombosis|deep vein thrombosis
5713756|NCT00451412|Certoparin|certoparin
5713757|NCT00451412|Embolism and Thrombosis|embolism and thrombosis
5713758|NCT00451399|Weight gain|weight gain
5713759|NCT00451399|antipsychotic|antipsychotic
5713760|NCT00451399|lifestyle interventions|lifestyle interventions
5713761|NCT00451399|metformin|metformin
5713762|NCT00451399|antipsychotic-induced weight gain.|antipsychotic-induced weight gain.
5713763|NCT00451373|ARF, dialysis, cytokine, free radical, major operations|arf, dialysis, cytokine, free radical, major operations
5713764|NCT00451360|Diacerein|diacerein
5713765|NCT00451360|Hip osteoarthritis|hip osteoarthritis
5713766|NCT00451360|Structure-modifying effect / Chondromodulating effect|structure-modifying effect / chondromodulating effect
5713767|NCT00451360|Double blind study|double blind study
5713768|NCT00451321|type 1 diabetes mellitus|type 1 diabetes mellitus
5713769|NCT00451321|diabetes mellitus type 1|diabetes mellitus type 1
5713770|NCT00451321|type 1 diabetes|type 1 diabetes
5713771|NCT00451321|diabetes mellitus|diabetes mellitus
5713772|NCT00451321|diabetes|diabetes
5713773|NCT00451308|Induction of labor|induction of labor
5713774|NCT00451308|vaginal delivery|vaginal delivery
5713775|NCT00451308|cesarean section|cesarean section
5713776|NCT00451308|foley balloon cathether|foley balloon cathether
5713777|NCT00451308|method of labor induction|method of labor induction
5713778|NCT00451308|perinatal outcomes|perinatal outcomes
5713779|NCT00451295|Chronic Kidney Disease|chronic kidney disease
5713780|NCT00451295|Dialysis|dialysis
5713781|NCT00451295|Hyperphosphatemia|hyperphosphatemia
5713782|NCT00451269|Malaria|malaria
5713783|NCT00451269|Diagnosis|diagnosis
5713784|NCT00451269|RDT|rdt
5713788|NCT00451269|country|country
5713789|NCT00451256|coronary artery bypass|coronary artery bypass
5713790|NCT00451256|cardiovascular disease|cardiovascular disease
5713791|NCT00451243|psoriatic arthritis|psoriatic arthritis
5798804|NCT00110968|Fullness|fullness
5713792|NCT00451230|craving, insulin, leptin|craving, insulin, leptin
5713793|NCT00451204|Multiple sclerosis|multiple sclerosis
5713794|NCT00451204|estrogen|estrogen
5713796|NCT00451204|progesterone|progesterone
5713797|NCT00451191|benign prostatic hyperplasia|benign prostatic hyperplasia
5713798|NCT00451191|BPH|bph
5713799|NCT00451191|botulinum toxin|botulinum toxin
5713800|NCT00451191|BoNT/A|bont/a
5713801|NCT00451165|Laparoscopic|laparoscopic
5713802|NCT00451165|Colon|colon
5713803|NCT00451165|Rectal|rectal
5713804|NCT00451165|Surgery|surgery
5713805|NCT00451165|Urinary function|urinary function
5713806|NCT00451165|Sexual function|sexual function
5713807|NCT00451165|Bowel function|bowel function
5713808|NCT00451165|Male|male
5713809|NCT00451152|glaucoma|glaucoma
5713810|NCT00451126|emotion|emotion
5713811|NCT00451126|personality|personality
5713812|NCT00451126|social stress|social stress
5713813|NCT00451126|appraisal|appraisal
5713814|NCT00451113|Type 2 diabetes|type 2 diabetes
5713815|NCT00451113|Older adults|older adults
5713816|NCT00451113|Incretins|incretins
5713817|NCT00451113|Hyperglycemia|hyperglycemia
5713818|NCT00451113|Insulin resistance|insulin resistance
5713819|NCT00451087|mechanical properties|mechanical properties
5713820|NCT00451087|electromechanical delay|electromechanical delay
5713821|NCT00451087|viscoelasticity|viscoelasticity
5713822|NCT00451087|VMO|vmo
5713823|NCT00451087|patellofemoral pain syndrome|patellofemoral pain syndrome
5713993|NCT00450502|Toxicity|toxicity
5713824|NCT00451074|Stop codon mutations|stop codon mutations
5713825|NCT00451061|distal ureterolithiasis|distal ureterolithiasis
5713826|NCT00451061|α adrenoreceptors antagonist|α adrenoreceptors antagonist
5713827|NCT00451035|Refractory Chronic Myeloid Leukemia in Chronic Phase|refractory chronic myeloid leukemia in chronic phase
5713828|NCT00451035|adults|adults
5713829|NCT00451035|oral LBH589|oral lbh589
5713833|NCT00451009|IVF|ivf
5713834|NCT00451009|Male factor infertility|male factor infertility
5713835|NCT00451009|Cryopreservation|cryopreservation
5713836|NCT00451009|Cryoprotective agents|cryoprotective agents
5713837|NCT00451009|Egg Freezing|egg freezing
5713838|NCT00450983|graft versus host disease|graft versus host disease
5713839|NCT00450983|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5713840|NCT00450983|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5713841|NCT00450983|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5714199|NCT00449735|ecoli|ecoli
5713842|NCT00450983|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5713843|NCT00450983|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5713844|NCT00450983|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5713845|NCT00450983|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5713846|NCT00450983|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5713847|NCT00450983|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5713848|NCT00450983|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5713849|NCT00450983|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5713850|NCT00450983|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5713851|NCT00450983|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5713852|NCT00450983|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5685870|NCT00554489|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5685871|NCT00554489|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5713853|NCT00450983|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5713854|NCT00450983|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5713855|NCT00450983|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5713856|NCT00450983|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5713857|NCT00450983|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5713858|NCT00450983|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5713859|NCT00450983|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5713860|NCT00450983|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5713861|NCT00450970|Hormone Refractory Prostate Cancer (HRPC)|hormone refractory prostate cancer (hrpc)
5713862|NCT00450970|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5713863|NCT00450970|Unlimited Prior Cytotoxic Chemotherapy Regimens|unlimited prior cytotoxic chemotherapy regimens
5713864|NCT00450944|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5713865|NCT00450944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5713868|NCT00450905|Chronic musculoskeletal pain secondary to Fibromyalgia|chronic musculoskeletal pain secondary to fibromyalgia
5713870|NCT00450892|stage II breast cancer|stage ii breast cancer
5713871|NCT00450892|stage IIIA breast cancer|stage iiia breast cancer
5713872|NCT00450892|stage IIIB breast cancer|stage iiib breast cancer
5713873|NCT00450892|stage IIIC breast cancer|stage iiic breast cancer
5713874|NCT00450866|recurrent breast cancer|recurrent breast cancer
5713875|NCT00450866|stage IV breast cancer|stage iv breast cancer
5713876|NCT00450866|tumors metastatic to brain|tumors metastatic to brain
5713877|NCT00450866|leptomeningeal metastases|leptomeningeal metastases
5713879|NCT00450853|emesis|emesis
5713880|NCT00450853|granisetron|granisetron
5713881|NCT00450853|pharmacokinetics|pharmacokinetics
5713882|NCT00450853|subcutaneous.|subcutaneous.
5713883|NCT00450840|septic shock|septic shock
5713884|NCT00450840|simvastatin|simvastatin
5713885|NCT00450827|recurrent neuroblastoma|recurrent neuroblastoma
5713886|NCT00450801|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5713887|NCT00450801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5713888|NCT00450801|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5713889|NCT00450801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5713890|NCT00450801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5713894|NCT00450762|pretreated|pretreated
5713895|NCT00450762|metastatic|metastatic
5713896|NCT00450736|chondrosarcoma|chondrosarcoma
5713897|NCT00450736|adult angiosarcoma|adult angiosarcoma
5713898|NCT00450736|adult fibrosarcoma|adult fibrosarcoma
5713899|NCT00450736|adult leiomyosarcoma|adult leiomyosarcoma
5713900|NCT00450736|adult liposarcoma|adult liposarcoma
5713901|NCT00450736|adult neurofibrosarcoma|adult neurofibrosarcoma
5713902|NCT00450736|adult synovial sarcoma|adult synovial sarcoma
5713903|NCT00450736|childhood angiosarcoma|childhood angiosarcoma
5713904|NCT00450736|childhood fibrosarcoma|childhood fibrosarcoma
5713905|NCT00450736|childhood leiomyosarcoma|childhood leiomyosarcoma
5713906|NCT00450736|childhood liposarcoma|childhood liposarcoma
5713907|NCT00450736|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5713908|NCT00450736|childhood synovial sarcoma|childhood synovial sarcoma
5713909|NCT00450736|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5713910|NCT00450736|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5713911|NCT00450736|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5713912|NCT00450736|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5713913|NCT00450736|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5713914|NCT00450736|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5713915|NCT00450736|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5713916|NCT00450723|stage I breast cancer|stage i breast cancer
5713917|NCT00450723|stage II breast cancer|stage ii breast cancer
5713918|NCT00450723|male breast cancer|male breast cancer
5713919|NCT00450697|Feeding intolerance in premature infants|feeding intolerance in premature infants
5713920|NCT00450697|Bolus feeding every 4 hours versus every 3 hours|bolus feeding every 4 hours versus every 3 hours
5713921|NCT00450697|Feeding method in premature infants|feeding method in premature infants
5713922|NCT00450671|Fistula-in-ano|fistula-in-ano
5713923|NCT00450671|Anal fistula|anal fistula
5713924|NCT00450671|Perirectal fistula|perirectal fistula
5713925|NCT00450671|Collagen plug|collagen plug
5713926|NCT00450671|Surgisis|surgisis
5713927|NCT00450671|Seton|seton
5713928|NCT00450658|ibuprofen|ibuprofen
5713929|NCT00450658|famotidine|famotidine
5713930|NCT00450658|ulcers|ulcers
5713931|NCT00450658|NSAIDS|nsaids
5713932|NCT00450658|pain|pain
5713933|NCT00450658|arthritis|arthritis
5721403|NCT00426699|sepsis|sepsis
5713934|NCT00450658|chronic regional pain syndrome|chronic regional pain syndrome
5713935|NCT00450658|chronic soft tissue pain|chronic soft tissue pain
5713936|NCT00450658|osteoarthritis|osteoarthritis
5713937|NCT00450658|rheumatoid arthritis|rheumatoid arthritis
5713938|NCT00450658|chronic low back pain|chronic low back pain
5713939|NCT00450645|Cancer|cancer
5713940|NCT00450645|Residual vein thrombosis|residual vein thrombosis
5713941|NCT00450645|Low Molecular Weight Heparin|low molecular weight heparin
5713942|NCT00450645|Optimal duration|optimal duration
5713943|NCT00450632|meningococcal infections|meningococcal infections
5713944|NCT00450632|biotheque|biotheque
5713945|NCT00450632|genetic markers|genetic markers
5713946|NCT00450619|Radionuclide|radionuclide
5713947|NCT00450619|Immunotherapy|immunotherapy
5713948|NCT00450619|Radiation|radiation
5713949|NCT00450619|PSA|psa
5713950|NCT00450619|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5713951|NCT00450619|Prostate Cancer|prostate cancer
5713952|NCT00450593|melanoma|melanoma
5730212|NCT00393562|hypersomnolence|hypersomnolence
5730213|NCT00393562|Parkinson's disease|parkinson's disease
5730214|NCT00393549|Median Neuropathy at the wrist (MNW)|median neuropathy at the wrist (mnw)
5730225|NCT00393471|Safety|safety
5713953|NCT00450593|hereditary multiple melanoma|hereditary multiple melanoma
5713955|NCT00450593|stage 0 melanoma|stage 0 melanoma
5713956|NCT00450593|stage IV melanoma|stage iv melanoma
5713957|NCT00450593|stage IA melanoma|stage ia melanoma
5713958|NCT00450593|stage IB melanoma|stage ib melanoma
5713959|NCT00450593|stage IIA melanoma|stage iia melanoma
5713960|NCT00450593|stage IIB melanoma|stage iib melanoma
5713961|NCT00450593|stage IIC melanoma|stage iic melanoma
5713962|NCT00450593|stage IIIA melanoma|stage iiia melanoma
5713963|NCT00450593|stage IIIB melanoma|stage iiib melanoma
5713964|NCT00450593|stage IIIC melanoma|stage iiic melanoma
5713965|NCT00450580|protease inhibitor,|protease inhibitor,
5713966|NCT00450580|HIV-1,|hiv-1,
5713967|NCT00450580|Fosamprenavir,|fosamprenavir,
5713968|NCT00450580|non-HDL cholesterol|non-hdl cholesterol
5713969|NCT00450580|ritonavir,|ritonavir,
5713971|NCT00450567|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5713972|NCT00450567|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5713973|NCT00450567|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5713974|NCT00450567|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5713975|NCT00450567|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5713976|NCT00450567|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5713977|NCT00450554|Neisseria meningitidis B:14, P1-7, 16|neisseria meningitidis b:14, p1-7, 16
5713978|NCT00450554|Serum bactericidal activity|serum bactericidal activity
5713979|NCT00450554|Menbvac|menbvac
5713980|NCT00450541|Advanced Cancer|advanced cancer
5713981|NCT00450541|Fatigue|fatigue
5713982|NCT00450541|Interview|interview
5713983|NCT00450541|Questionnaire|questionnaire
5713984|NCT00450541|Survey|survey
5713985|NCT00450528|D-dimers|d-dimers
5713986|NCT00450528|surgery|surgery
5713987|NCT00450528|kinetics|kinetics
5713988|NCT00450515|recurrent breast cancer|recurrent breast cancer
5713989|NCT00450515|stage IV breast cancer|stage iv breast cancer
5713990|NCT00450515|male breast cancer|male breast cancer
5713991|NCT00450502|Cytotoxic|cytotoxic
5713992|NCT00450502|Pharmacokinetics|pharmacokinetics
5713994|NCT00450502|Neoplasms|neoplasms
5713995|NCT00450502|Pharmacogenomics|pharmacogenomics
5713996|NCT00450502|Solid Tumor|solid tumor
5713997|NCT00450502|Lymphoma|lymphoma
5713998|NCT00450489|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5713999|NCT00450489|Quality of Life|quality of life
5714000|NCT00450489|Satisfaction of medical care delivery|satisfaction of medical care delivery
5714001|NCT00450476|ventilator associated pneumonia|ventilator associated pneumonia
5714002|NCT00450476|prevention|prevention
5714003|NCT00450476|endotracheal intubation|endotracheal intubation
5714004|NCT00450476|mechanical ventilation|mechanical ventilation
5714005|NCT00450463|Immunotherapy|immunotherapy
5714006|NCT00450463|Hormonal Therapy|hormonal therapy
5714007|NCT00450463|Combination Therapy|combination therapy
5714008|NCT00450463|Prostate Specific Antigen|prostate specific antigen
5714009|NCT00450463|Immunoassay|immunoassay
5714010|NCT00450463|Prostate Cancer|prostate cancer
5714011|NCT00450437|Meningococcal|meningococcal
5714012|NCT00450437|meningitis|meningitis
5714013|NCT00450437|vaccine|vaccine
5714014|NCT00450437|adolescents|adolescents
5714016|NCT00450424|colon cancer|colon cancer
5714017|NCT00450424|rectal cancer|rectal cancer
5714018|NCT00450424|hereditary non-polyposis colon cancer|hereditary non-polyposis colon cancer
5714019|NCT00450424|recurrent colon cancer|recurrent colon cancer
5714020|NCT00450424|stage I colon cancer|stage i colon cancer
5714021|NCT00450424|stage IIA colon cancer|stage iia colon cancer
5714022|NCT00450424|stage IIB colon cancer|stage iib colon cancer
5714023|NCT00450424|stage IIIA colon cancer|stage iiia colon cancer
5714024|NCT00450424|stage IIIB colon cancer|stage iiib colon cancer
5714025|NCT00450424|stage IIIC colon cancer|stage iiic colon cancer
5714026|NCT00450424|stage IVA colon cancer|stage iva colon cancer
5721509|NCT00426335|breast|breast
5714027|NCT00450424|stage IVB colon cancer|stage ivb colon cancer
5714028|NCT00450424|recurrent rectal cancer|recurrent rectal cancer
5714029|NCT00450424|stage I rectal cancer|stage i rectal cancer
5714030|NCT00450424|stage IIA rectal cancer|stage iia rectal cancer
5714031|NCT00450424|stage IIB rectal cancer|stage iib rectal cancer
5714032|NCT00450424|stage IIC rectal cancer|stage iic rectal cancer
5714033|NCT00450424|stage IIIA rectal cancer|stage iiia rectal cancer
5714034|NCT00450424|stage IIIB rectal cancer|stage iiib rectal cancer
5714035|NCT00450424|stage IIIC rectal cancer|stage iiic rectal cancer
5714036|NCT00450424|stage IVA rectal cancer|stage iva rectal cancer
5714037|NCT00450424|stage IVB rectal cancer|stage ivb rectal cancer
5714038|NCT00450411|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5714039|NCT00450411|recurrent prostate cancer|recurrent prostate cancer
5714040|NCT00450411|stage I prostate cancer|stage i prostate cancer
5714041|NCT00450411|stage IIB prostate cancer|stage iib prostate cancer
5714042|NCT00450411|stage IIA prostate cancer|stage iia prostate cancer
5714043|NCT00450398|Delayed graft function|delayed graft function
5714044|NCT00450385|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5714045|NCT00450385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5714046|NCT00450385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5714047|NCT00450385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5714048|NCT00450385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5714049|NCT00450385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5714050|NCT00450372|recurrent melanoma|recurrent melanoma
5714051|NCT00450372|stage IV melanoma|stage iv melanoma
5714052|NCT00450359|breast cancer|breast cancer
5714053|NCT00450333|Chronic|chronic
5714054|NCT00450320|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5714055|NCT00450320|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5714056|NCT00450307|recurrent neuroblastoma|recurrent neuroblastoma
5714057|NCT00450307|stage 4S neuroblastoma|stage 4s neuroblastoma
5714058|NCT00450307|disseminated neuroblastoma|disseminated neuroblastoma
5714059|NCT00450307|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5714060|NCT00450307|regional neuroblastoma|regional neuroblastoma
5714061|NCT00450281|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5714062|NCT00450281|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5714063|NCT00450281|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5714064|NCT00450281|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5714065|NCT00450281|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5714066|NCT00450281|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5714067|NCT00450268|Graft versus host disease|graft versus host disease
5714068|NCT00450268|Allogeneic hematpoietic stem cell transplantation|allogeneic hematpoietic stem cell transplantation
5714069|NCT00450242|vulvar vestibulitis|vulvar vestibulitis
5714070|NCT00450242|vestibulitis|vestibulitis
5714071|NCT00450216|ibuprofen|ibuprofen
5714072|NCT00450216|famotidine|famotidine
5714073|NCT00450216|ulcers|ulcers
5714074|NCT00450216|NSAIDS|nsaids
5714075|NCT00450216|pain|pain
5714076|NCT00450216|arthritis|arthritis
5714077|NCT00450216|chronic regional pain syndrome|chronic regional pain syndrome
5714078|NCT00450216|chronic soft tissue pain|chronic soft tissue pain
5714079|NCT00450216|osteoarthritis|osteoarthritis
5714080|NCT00450216|rheumatoid arthritis|rheumatoid arthritis
5714081|NCT00450216|chronic low back pain|chronic low back pain
5714082|NCT00450203|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5714083|NCT00450203|adenocarcinoma of the gastro oesophageal junction|adenocarcinoma of the gastro oesophageal junction
5714084|NCT00450203|adenocarcinoma of the lower oesophagus|adenocarcinoma of the lower oesophagus
5714085|NCT00450190|Growth disorders|growth disorders
5714086|NCT00450177|iron|iron
5714087|NCT00450177|critical illness|critical illness
5714088|NCT00450177|anemia|anemia
5714089|NCT00450177|infection|infection
5714090|NCT00450164|Variceal bleeding|variceal bleeding
5714091|NCT00450164|Secondary profilaxis|secondary profilaxis
5714092|NCT00450164|Hemodynamic|hemodynamic
5714093|NCT00450164|Portal hypertension|portal hypertension
5714094|NCT00450151|Pediatric|pediatric
5714095|NCT00450151|Cardiopulmonary bypass Surgery|cardiopulmonary bypass surgery
5714096|NCT00450151|Cardiac Surgery|cardiac surgery
5714097|NCT00450151|Platelet|platelet
5714098|NCT00450151|Platelet Activation Markers|platelet activation markers
5714099|NCT00450151|Platelet Factor4|platelet factor4
5714100|NCT00450151|Transforming Growth Factor Beta|transforming growth factor beta
5714101|NCT00450138|Squamous Cell Carcinoma|squamous cell carcinoma
5714102|NCT00450125|Lung Cancer|lung cancer
5714103|NCT00450125|Lung Resection|lung resection
5714104|NCT00450125|Exercise Stress Test|exercise stress test
5714105|NCT00450125|Six-Minute Walk Test|six-minute walk test
5714106|NCT00450099|Epidural|epidural
5714107|NCT00450099|Labor Analgesia|labor analgesia
5714108|NCT00450099|Bupivacaine|bupivacaine
5714109|NCT00450099|Dose-response|dose-response
5714110|NCT00450099|Minimum effective volume|minimum effective volume
5714111|NCT00450060|postlumbar puncture headache|postlumbar puncture headache
5714112|NCT00450060|atraumatic needle|atraumatic needle
5714113|NCT00450060|Sprotte|sprotte
5714114|NCT00450060|Quincke|quincke
5714115|NCT00450060|lumbar puncture|lumbar puncture
5714116|NCT00450060|headache|headache
5714117|NCT00450060|backache|backache
5714118|NCT00450047|cognitive impairment, ergometer, speed-feedback therapy|cognitive impairment, ergometer, speed-feedback therapy
5714119|NCT00450034|Frail Elderly|frail elderly
5714120|NCT00450034|Patient Education|patient education
5714121|NCT00450034|Drug optimization|drug optimization
5714122|NCT00450034|Underuse|underuse
5714123|NCT00450034|Vulnerable|vulnerable
5714124|NCT00450034|Drug related hospitalization|drug related hospitalization
5714125|NCT00450034|Medical intervention|medical intervention
5714126|NCT00450021|PET|pet
5714127|NCT00450021|CB1 Receptor|cb1 receptor
5730413|NCT00392886|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5730414|NCT00392886|childhood oligodendroglioma|childhood oligodendroglioma
5730416|NCT00392886|childhood choroid plexus tumor|childhood choroid plexus tumor
5680607|NCT00577278|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5680608|NCT00577278|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5680609|NCT00577278|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5681147|NCT00574522|AIDS|aids
5714128|NCT00450021|Cannabinoid|cannabinoid
5714129|NCT00450021|[11C] MePPEP|[11c] meppep
5714130|NCT00450021|Brain Imaging|brain imaging
5714131|NCT00450021|Healthy Volunteer|healthy volunteer
5714132|NCT00450021|HV|hv
5714133|NCT00450008|Prostate Cancer|prostate cancer
5714134|NCT00450008|Hormone-Naïve Prostate Cancer|hormone-naïve prostate cancer
5714135|NCT00450008|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5714137|NCT00449982|Condylomata acuminata|condylomata acuminata
5714138|NCT00449982|Human Papillomavirus|human papillomavirus
5714139|NCT00449982|Polyphenon E|polyphenon e
5714140|NCT00449982|Green tea extract|green tea extract
5714141|NCT00449982|Vulva|vulva
5714142|NCT00449982|Penis|penis
5714143|NCT00449982|Anus|anus
5714144|NCT00449969|AED (automated external defibrillation)|aed (automated external defibrillation)
5714145|NCT00449969|feedback|feedback
5714146|NCT00449969|out of hospital resuscitation|out of hospital resuscitation
5714147|NCT00449943|Cardiac Invasive Catheterization Angiography|cardiac invasive catheterization angiography
5714148|NCT00449943|Single Photon Emission Computed Tomography|single photon emission computed tomography
5714149|NCT00449943|Computed Tomography Angiography|computed tomography angiography
5714150|NCT00449917|visual caracteristics|visual caracteristics
5714151|NCT00449917|macular pigment optical density|macular pigment optical density
5714152|NCT00449917|visual acuity|visual acuity
5714153|NCT00449917|contrast sensibility|contrast sensibility
5714155|NCT00449917|docosahexaenoic acid (DHA)|docosahexaenoic acid (dha)
5714156|NCT00449904|Cystic fibrosis-related exocrine pancreatic insufficiency|cystic fibrosis-related exocrine pancreatic insufficiency
5714157|NCT00449891|Type 1 diabetes mellitus|type 1 diabetes mellitus
5714158|NCT00449878|cystic fibrosis-related pancreatic insufficiency|cystic fibrosis-related pancreatic insufficiency
5714159|NCT00449865|Parkinson's disease|parkinson's disease
5714160|NCT00449865|creatine|creatine
5714161|NCT00449865|NET-PD|net-pd
5714162|NCT00449865|neuroprotection|neuroprotection
5714163|NCT00449865|PD|pd
5714164|NCT00449852|Randomized Control Trial|randomized control trial
5714165|NCT00449852|Smoking Cessation|smoking cessation
5714166|NCT00449852|Secondary Prevention|secondary prevention
5714167|NCT00449852|Rehabilitation|rehabilitation
5714168|NCT00449852|Counseling|counseling
5714169|NCT00449839|Insulin pump treatment CSII|insulin pump treatment csii
5714170|NCT00449839|Absorption|absorption
5714171|NCT00449839|Insulin Aspart|insulin aspart
5714172|NCT00449826|ACS|acs
5714173|NCT00449826|Unstable Angina|unstable angina
5714174|NCT00449826|NSTEMI|nstemi
5714175|NCT00449813|Gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5714176|NCT00449813|Non erosive reflux disease (NERD)|non erosive reflux disease (nerd)
5714177|NCT00449800|Sepsis|sepsis
5714178|NCT00449800|Ceftriaxone|ceftriaxone
5714179|NCT00449800|Pharmacokinetic|pharmacokinetic
5714180|NCT00449800|Intensive care unit|intensive care unit
5714181|NCT00449787|Emergency department|emergency department
5714182|NCT00449787|headache|headache
5714183|NCT00449787|migraine|migraine
5714184|NCT00449774|Food effect|food effect
5714185|NCT00449774|Safety|safety
5714186|NCT00449774|Tolerability|tolerability
5714187|NCT00449774|Water effect|water effect
5714188|NCT00449774|Bioequivalence|bioequivalence
5714189|NCT00449761|Refractory|refractory
5714190|NCT00449761|Chronic Myeloid|chronic myeloid
5714191|NCT00449761|Leukemia|leukemia
5714192|NCT00449761|accelerated phase|accelerated phase
5714193|NCT00449761|blast phase (blast crisis)|blast phase (blast crisis)
5714194|NCT00449761|adults|adults
5714195|NCT00449761|oral LBH589|oral lbh589
5714196|NCT00449748|Systemic Mastocytosis|systemic mastocytosis
5714197|NCT00449748|RAD001|rad001
5714198|NCT00449735|positive isolates|positive isolates
5714200|NCT00449735|blood cultures|blood cultures
5714201|NCT00449735|positive cultures for ecoli|positive cultures for ecoli
5721671|NCT00425789|Hyperbaric Therapy|hyperbaric therapy
5714202|NCT00449735|blood stream infections|blood stream infections
5714203|NCT00449709|Pre-term labor,|pre-term labor,
5714204|NCT00449709|modified release formulation|modified release formulation
5714205|NCT00449709|pharmacokinetics,|pharmacokinetics,
5714206|NCT00449683|Depressive Disorders|depressive disorders
5714207|NCT00449683|Excessive Sweating|excessive sweating
5714208|NCT00449683|Sweating caused by antidepressants for those a depressive disorder|sweating caused by antidepressants for those a depressive disorder
5714209|NCT00449670|Influenza|influenza
5714210|NCT00449670|Influenza Vaccine|influenza vaccine
5714211|NCT00449644|Tuberculosis|tuberculosis
5714213|NCT00449631|Glaucoma|glaucoma
5714214|NCT00449631|Drug Resistance, Multiple|drug resistance, multiple
5714215|NCT00449631|Trabeculectomy|trabeculectomy
5798809|NCT00110955|Chemotherapy-induced anemia|chemotherapy-induced anemia
5714217|NCT00449618|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5714218|NCT00449618|Chronotherapy|chronotherapy
5714219|NCT00449618|Circadian|circadian
5714220|NCT00449605|Diabetes|diabetes
5714221|NCT00449605|Metformin|metformin
5714222|NCT00449592|Stem cell transplantation|stem cell transplantation
5714223|NCT00449592|Mucositis|mucositis
5714224|NCT00449592|Zinc|zinc
5714225|NCT00449579|Ischemia|ischemia
5714226|NCT00449579|Myocardial|myocardial
5714227|NCT00449579|HF-ECG|hf-ecg
5714228|NCT00449566|Magnetic Resonance Imaging|magnetic resonance imaging
5714229|NCT00449566|Diffusion Tensor Imaging|diffusion tensor imaging
5714230|NCT00449553|Glucose Metabolism Disorder|glucose metabolism disorder
5714231|NCT00449553|Dysmetabolic Syndrome|dysmetabolic syndrome
5714232|NCT00449553|Type II Diabetes|type ii diabetes
5714233|NCT00449553|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5714235|NCT00449553|Drug Therapy|drug therapy
5714236|NCT00449540|Migraine with aura|migraine with aura
5714237|NCT00449540|aura|aura
5714238|NCT00449540|TMS|tms
5714239|NCT00449527|Mild asthma|mild asthma
5714240|NCT00449527|Moderate asthma|moderate asthma
5714241|NCT00449514|infertility|infertility
5714242|NCT00449514|ovulation dysfunction|ovulation dysfunction
5714243|NCT00449514|endometrium|endometrium
5714245|NCT00449514|clomiphene citrate|clomiphene citrate
5714246|NCT00449501|Mild Asthma|mild asthma
5714247|NCT00449501|Moderate Asthma|moderate asthma
5714248|NCT00449488|erythropoietin|erythropoietin
5714249|NCT00449488|myocardial infarction|myocardial infarction
5714250|NCT00449488|PCI|pci
5714251|NCT00449488|left ventricular function|left ventricular function
5714252|NCT00449462|CLA|cla
5714253|NCT00449462|liver|liver
5714254|NCT00449462|kidney|kidney
5714255|NCT00449449|Pertubation, tubal flushing, intrauterine insemination.|pertubation, tubal flushing, intrauterine insemination.
5714256|NCT00449436|treatment experienced|treatment experienced
5714257|NCT00449436|HIV|hiv
5714258|NCT00449423|Acute heart failure|acute heart failure
5714259|NCT00449423|Metabolic modulation|metabolic modulation
5714260|NCT00449410|Atrial Fibrillation|atrial fibrillation
5714261|NCT00449410|elderly|elderly
5714262|NCT00449410|cholesterol lowering|cholesterol lowering
5714263|NCT00449410|neurocognitive function|neurocognitive function
5714264|NCT00449410|cerebrovascular lesion|cerebrovascular lesion
5714265|NCT00449397|First Episode Psychosis|first episode psychosis
5714266|NCT00449384|Severe Impairment Battery|severe impairment battery
5714267|NCT00449384|Clinical Dementia Rating|clinical dementia rating
5714268|NCT00449358|bcc|bcc
5714269|NCT00449345|Latent tuberculosis infection|latent tuberculosis infection
5714270|NCT00449345|Health care workers|health care workers
5714271|NCT00449345|Tuberculin skin test|tuberculin skin test
5714272|NCT00449345|Mantoux skin test|mantoux skin test
5714273|NCT00449345|Interferon gamma|interferon gamma
5714274|NCT00449345|Quantiferon|quantiferon
5714275|NCT00449345|Cost effectiveness|cost effectiveness
5714362|NCT00448942|Bacteremia [C01.252.100]|bacteremia [c01.252.100]
5714276|NCT00449332|Chronic rejection, lung transplant, cytokines, bos|chronic rejection, lung transplant, cytokines, bos
5714277|NCT00449319|AML|aml
5714278|NCT00449319|adult|adult
5714279|NCT00449319|Hydroxyurea|hydroxyurea
5714280|NCT00449319|Transplant|transplant
5714281|NCT00449319|Toevaluate biological characteristics at diagnosis.|toevaluate biological characteristics at diagnosis.
5714282|NCT00449319|To identify genetic alterations with prognostic relevance.|to identify genetic alterations with prognostic relevance.
5714283|NCT00449319|To follow up cases monitoring minimal disease during remission.|to follow up cases monitoring minimal disease during remission.
5714284|NCT00449319|To evaluate pretreatment therapy in terms of response rate and toxicity.|to evaluate pretreatment therapy in terms of response rate and toxicity.
5714285|NCT00449319|Disease free survival.|disease free survival.
5714286|NCT00449319|Overal survival.|overal survival.
5714287|NCT00449306|Atherosclerosis|atherosclerosis
5714288|NCT00449306|Carotid plaque|carotid plaque
5714289|NCT00449306|Abdominal aortic aneurysm|abdominal aortic aneurysm
5714290|NCT00449306|Vulnerable plaque|vulnerable plaque
5714291|NCT00449306|Angiogenesis|angiogenesis
5714292|NCT00449306|Intraplaque hemorrhage|intraplaque hemorrhage
5714293|NCT00449306|Carotid artery atherosclerosis|carotid artery atherosclerosis
5714294|NCT00449293|Smoking cessation|smoking cessation
5714295|NCT00449293|Tobacco dependence|tobacco dependence
5714296|NCT00449293|Mindfulness|mindfulness
5714297|NCT00449293|fMRI|fmri
5714298|NCT00449293|Craving|craving
5714299|NCT00449280|metastatic|metastatic
5714300|NCT00449280|advanced disease|advanced disease
5714301|NCT00449280|phase I|phase i
5714302|NCT00449267|Lenses, Intraocular|lenses, intraocular
5714303|NCT00449267|Prospective Studies|prospective studies
5714304|NCT00449267|Visual acuity|visual acuity
5714305|NCT00449267|Clinical Trial|clinical trial
5714306|NCT00449241|Acupuncture, Endoscopy|acupuncture, endoscopy
5714307|NCT00449228|Osteoarthritis,|osteoarthritis,
5714308|NCT00449228|hip replacement,|hip replacement,
5714309|NCT00449228|education,|education,
5680610|NCT00577278|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5680611|NCT00577278|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5680612|NCT00577278|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5714310|NCT00449228|randomized controlled trial,|randomized controlled trial,
5714311|NCT00449228|mini-invasive surgery|mini-invasive surgery
5714312|NCT00449215|Peak Bone Mass; Male; Genetic Polymorphisms|peak bone mass; male; genetic polymorphisms
5714313|NCT00449176|Low Back Pain|low back pain
5714314|NCT00449176|Chronic Pain|chronic pain
5714315|NCT00449176|Pain Assessment|pain assessment
5714316|NCT00449176|Tapentadol|tapentadol
5714317|NCT00449163|stage IV colon cancer|stage iv colon cancer
5714318|NCT00449163|stage IV rectal cancer|stage iv rectal cancer
5714319|NCT00449163|adenocarcinoma of the colon|adenocarcinoma of the colon
5714320|NCT00449163|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5714321|NCT00449150|Cetrorelix|cetrorelix
5714322|NCT00449137|recurrent colon cancer|recurrent colon cancer
5714323|NCT00449137|stage IV colon cancer|stage iv colon cancer
5714324|NCT00449137|recurrent rectal cancer|recurrent rectal cancer
5714325|NCT00449137|stage IV rectal cancer|stage iv rectal cancer
5714326|NCT00449124|hepatitis C, vaccine, TG4040|hepatitis c, vaccine, tg4040
5714327|NCT00449098|Glaucoma|glaucoma
5714328|NCT00449098|Collagen matrix|collagen matrix
5714330|NCT00449098|OculusGen|oculusgen
5714331|NCT00449098|Trabeculectomy|trabeculectomy
5714333|NCT00449098|tissue engineering|tissue engineering
5714334|NCT00449098|high risk patient for trabeculectomy|high risk patient for trabeculectomy
5714335|NCT00449098|Aeon Astron|aeon astron
5714336|NCT00449059|heart transplantation|heart transplantation
5714337|NCT00449059|cyclosporine|cyclosporine
5714338|NCT00449059|hypertension|hypertension
5714339|NCT00449059|nitroglycerin|nitroglycerin
5714340|NCT00449046|salmeterol/fluticasone propionate combination|salmeterol/fluticasone propionate combination
5714341|NCT00449046|pediatric bronchial asthma|pediatric bronchial asthma
5714342|NCT00449033|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5714343|NCT00449033|Cancer|cancer
5714344|NCT00449020|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5714345|NCT00449020|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5714346|NCT00449007|Major depressive disorder|major depressive disorder
5714347|NCT00449007|Alcohol abuse|alcohol abuse
5714348|NCT00449007|Alcohol dependence|alcohol dependence
5714349|NCT00449007|Suicide|suicide
5714350|NCT00448994|adenovirus, fungal, diagnostics, children|adenovirus, fungal, diagnostics, children
5714351|NCT00448981|Preventing upper respiratory tract infections|preventing upper respiratory tract infections
5714352|NCT00448981|Preventing influenza|preventing influenza
5714353|NCT00448981|Preventing the common cold|preventing the common cold
5714354|NCT00448981|Hand hygiene and upper respiratory infections|hand hygiene and upper respiratory infections
5714355|NCT00448981|Mask use in preventing upper respiratory infections|mask use in preventing upper respiratory infections
5714356|NCT00448968|Sepsis|sepsis
5714357|NCT00448968|Ischemia Modified Albumin|ischemia modified albumin
5714358|NCT00448968|Systemic Inflammatory Response Syndrome|systemic inflammatory response syndrome
5714359|NCT00448942|Staphylococcus aureus [B03.510.400.790.750.100]|staphylococcus aureus [b03.510.400.790.750.100]
5714360|NCT00448942|Enterococcus faecalis [B03.510.400.800.280.280]|enterococcus faecalis [b03.510.400.800.280.280]
5714361|NCT00448942|Enterococcus faecium [B03.510.400.800.280.300]|enterococcus faecium [b03.510.400.800.280.300]
5714514|NCT00448396|Cancer|cancer
5714363|NCT00448942|Fungemia [C01.703.360]|fungemia [c01.703.360]
5714364|NCT00448942|Infection Control [G03.850.780.200.450]|infection control [g03.850.780.200.450]
5714365|NCT00448942|Antisepsis [G03.850.780.200.450.150]|antisepsis [g03.850.780.200.450.150]
5714366|NCT00448929|Glaucoma|glaucoma
5714367|NCT00448929|Collagen matrix|collagen matrix
5714368|NCT00448929|ologen|ologen
5714369|NCT00448929|OculusGen|oculusgen
5714370|NCT00448929|Trabeculectomy|trabeculectomy
5714371|NCT00448916|Partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability|partial-onset seizures; epilepsy; pediatric; pregabalin; 1 year extension study; safety; tolerability
5714372|NCT00448903|diabetic|diabetic
5714373|NCT00448903|foot|foot
5714374|NCT00448903|ulcer|ulcer
5714375|NCT00448903|bemiparin|bemiparin
5714376|NCT00448903|neuropathy|neuropathy
5714377|NCT00448903|neuroishemic|neuroishemic
5714378|NCT00448903|diabetes|diabetes
5714379|NCT00448890|AMPA positive modulator, healthy volunteers|ampa positive modulator, healthy volunteers
5738406|NCT00363857|RLS|rls
5714380|NCT00448877|No specific disease is being studied, few procedures are excluded.|no specific disease is being studied, few procedures are excluded.
5714381|NCT00448877|The focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.|the focus of the study is to rule out the efficacy of the device, so the aim is to include as wide a variety of procedures as possible.
5714382|NCT00448851|asthma|asthma
5714383|NCT00448851|allergy|allergy
5714384|NCT00448838|recurrent pancreatic cancer|recurrent pancreatic cancer
5714385|NCT00448838|stage III pancreatic cancer|stage iii pancreatic cancer
5714386|NCT00448838|stage IV pancreatic cancer|stage iv pancreatic cancer
5714387|NCT00448838|stage II pancreatic cancer|stage ii pancreatic cancer
5714388|NCT00448825|alcohol dependence|alcohol dependence
5714389|NCT00448825|alcoholism|alcoholism
5714390|NCT00448825|cocaine addiction|cocaine addiction
5714391|NCT00448825|cocaine dependence|cocaine dependence
5714392|NCT00448799|neurological|neurological
5714393|NCT00448799|alzheimers|alzheimers
5714394|NCT00448786|gallbladder|gallbladder
5714395|NCT00448786|AMG 706|amg 706
5714396|NCT00448786|solid tumors|solid tumors
5714397|NCT00448786|Phase 1b|phase 1b
5714398|NCT00448786|Amgen|amgen
5714399|NCT00448760|stage II esophageal cancer|stage ii esophageal cancer
5714400|NCT00448760|stage III esophageal cancer|stage iii esophageal cancer
5714401|NCT00448760|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5714402|NCT00448747|Ghrelin mimetic, growth hormone secretagogue|ghrelin mimetic, growth hormone secretagogue
5714403|NCT00448734|metastatic|metastatic
5714404|NCT00448734|hormone-refractory|hormone-refractory
5714405|NCT00448734|prostate cancer|prostate cancer
5714406|NCT00448734|picoplatin|picoplatin
5714408|NCT00448734|chemotherapy|chemotherapy
5714409|NCT00448734|docetaxel|docetaxel
5714410|NCT00448721|renal cell carcinoma|renal cell carcinoma
5714411|NCT00448721|tyrosine kinase inhibitor failure|tyrosine kinase inhibitor failure
5714412|NCT00448708|Hemodialysis Access|hemodialysis access
5714414|NCT00448695|Laser Thermal Therapy|laser thermal therapy
5714415|NCT00448695|Focal Ablation|focal ablation
5714416|NCT00448695|Prostate Cancer|prostate cancer
5709172|NCT00468091|GLP-1|glp-1
5714417|NCT00448682|recurrent gastric cancer|recurrent gastric cancer
5714418|NCT00448682|stage IV gastric cancer|stage iv gastric cancer
5714419|NCT00448682|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5714420|NCT00448669|HIV incidence|hiv incidence
5714421|NCT00448669|HIV prevention|hiv prevention
5714422|NCT00448669|Tenofovir|tenofovir
5714423|NCT00448669|Emtricitabine|emtricitabine
5714424|NCT00448669|Botswana|botswana
5714425|NCT00448669|HIV seronegativity|hiv seronegativity
5714426|NCT00448656|atrial fibrillation|atrial fibrillation
5714427|NCT00448656|epicardial ablation pulmonary veins|epicardial ablation pulmonary veins
5714428|NCT00448656|video assisted thoracic surgery|video assisted thoracic surgery
5714429|NCT00448643|endometrial adenocarcinoma|endometrial adenocarcinoma
5714430|NCT00448643|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5714431|NCT00448643|endometrial papillary carcinoma|endometrial papillary carcinoma
5714432|NCT00448643|stage III endometrial carcinoma|stage iii endometrial carcinoma
5714433|NCT00448643|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5714434|NCT00448630|Atypical antipsychotics, Metabolic syndrome, Safety|atypical antipsychotics, metabolic syndrome, safety
5714435|NCT00448617|live attenuated influenza virus|live attenuated influenza virus
5714436|NCT00448617|inflammation|inflammation
5714437|NCT00448617|flu vaccine|flu vaccine
5714439|NCT00448617|smokers|smokers
5714440|NCT00448604|procalcitonin|procalcitonin
5714441|NCT00448604|acute exacerbation|acute exacerbation
5714442|NCT00448604|RT-PCR|rt-pcr
5714443|NCT00448604|Biological Markers|biological markers
5714444|NCT00448578|Acute Mania|acute mania
5714445|NCT00448565|extubation|extubation
5714446|NCT00448565|prediction|prediction
5714447|NCT00448552|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5714448|NCT00448552|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5714449|NCT00448552|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5714450|NCT00448552|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5714451|NCT00448552|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5714452|NCT00448552|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5714453|NCT00448552|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5714454|NCT00448552|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5714455|NCT00448552|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5714456|NCT00448552|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5714457|NCT00448552|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5714458|NCT00448552|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5714459|NCT00448552|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5714460|NCT00448552|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5714461|NCT00448552|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5714462|NCT00448552|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5714463|NCT00448552|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5714464|NCT00448552|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5714465|NCT00448552|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5714466|NCT00448552|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5714467|NCT00448552|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5714468|NCT00448552|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5714469|NCT00448552|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5714470|NCT00448552|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5714471|NCT00448552|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5798810|NCT00110942|Intra-articular|intra-articular
5714472|NCT00448552|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5714473|NCT00448552|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5714474|NCT00448552|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5714475|NCT00448552|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5714476|NCT00448552|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5714477|NCT00448552|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5714478|NCT00448552|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5714479|NCT00448552|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5714480|NCT00448552|recurrent salivary gland cancer|recurrent salivary gland cancer
5714481|NCT00448552|stage IV salivary gland cancer|stage iv salivary gland cancer
5714482|NCT00448552|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5714483|NCT00448552|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5714484|NCT00448539|Refractory Partial Onset Seizures, epilepsy|refractory partial onset seizures, epilepsy
5714485|NCT00448526|Low protein diet, type 2 Diabetic nephropathy|low protein diet, type 2 diabetic nephropathy
5714486|NCT00448526|Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet|comparing the effect of low protein diet on diabetic nephropathy to that of normal protein diet
5714488|NCT00448513|oxidative stress|oxidative stress
5714489|NCT00448513|chromosome damage|chromosome damage
5714490|NCT00448513|aged|aged
5714491|NCT00448500|COPD|copd
5714492|NCT00448500|exhaled breath condenate|exhaled breath condenate
5714493|NCT00448500|Exhaled breath condenate, acute exacerbation of COPD|exhaled breath condenate, acute exacerbation of copd
5714494|NCT00448487|Diabetes|diabetes
5714495|NCT00448487|Cardiovascular Disease|cardiovascular disease
5714496|NCT00448487|Haptoglobin|haptoglobin
5714497|NCT00448474|Disease self-management|disease self-management
5714498|NCT00448474|Community program|community program
5714499|NCT00448461|coronary artery disease|coronary artery disease
5714500|NCT00448461|percutaneous coronary interventions|percutaneous coronary interventions
5714501|NCT00448448|adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5714502|NCT00448448|orthotics|orthotics
5714503|NCT00448448|bracing|bracing
5714504|NCT00448448|partially randomized preference design|partially randomized preference design
5714505|NCT00448435|Salmeterol|salmeterol
5714506|NCT00448435|Fluticasone propionate|fluticasone propionate
5714507|NCT00448435|Salmeterol/Fluticasone propionate combination|salmeterol/fluticasone propionate combination
5714508|NCT00448435|Pediatric bronchial asthma|pediatric bronchial asthma
5714509|NCT00448422|Traveler's|traveler's
5714510|NCT00448422|Diarrhea|diarrhea
5714511|NCT00448409|Prostate cancer|prostate cancer
5714512|NCT00448409|hormone refractory prostate cancer|hormone refractory prostate cancer
5714513|NCT00448409|androgen resistant prostate cancer|androgen resistant prostate cancer
5714516|NCT00448396|Patupilone|patupilone
5714517|NCT00448396|Solid tumors|solid tumors
5714518|NCT00448396|Advanced malignancies|advanced malignancies
5714519|NCT00448370|Anemia, sickle cell|anemia, sickle cell
5714520|NCT00448357|refractory multiple myeloma|refractory multiple myeloma
5714521|NCT00448357|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5714522|NCT00448357|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5714523|NCT00448357|stage II multiple myeloma|stage ii multiple myeloma
5714524|NCT00448357|stage III multiple myeloma|stage iii multiple myeloma
5714525|NCT00448357|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5714526|NCT00448357|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5714527|NCT00448357|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5685872|NCT00554489|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5685873|NCT00554489|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5685874|NCT00554476|Lateral Epicondylitis|lateral epicondylitis
5685875|NCT00554476|Treatment|treatment
5685876|NCT00554476|Corticosteroid|corticosteroid
5713322|NCT00453180|PDD NOS|pdd nos
5714528|NCT00448357|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5714529|NCT00448357|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5714530|NCT00448357|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5714531|NCT00448357|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5714532|NCT00448357|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5714533|NCT00448357|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5681148|NCT00574522|Radiation|radiation
5723286|NCT00419666|PK|pk
5714534|NCT00448357|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5714535|NCT00448357|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5714536|NCT00448357|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5714537|NCT00448357|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5714538|NCT00448357|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5714539|NCT00448357|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5714540|NCT00448357|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5714541|NCT00448357|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5714542|NCT00448357|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5714543|NCT00448357|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5714544|NCT00448357|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5714545|NCT00448357|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5714546|NCT00448357|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5704462|NCT00485537|ICSI|icsi
5714547|NCT00448357|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5714548|NCT00448357|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5714549|NCT00448357|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5714550|NCT00448357|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5714551|NCT00448357|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5714552|NCT00448357|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5714553|NCT00448357|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5714554|NCT00448357|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5714555|NCT00448357|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5714556|NCT00448357|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5714557|NCT00448357|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5714558|NCT00448357|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5714559|NCT00448357|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5714560|NCT00448357|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5714561|NCT00448357|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5714562|NCT00448357|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5714563|NCT00448357|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5714564|NCT00448357|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5714565|NCT00448357|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5714566|NCT00448357|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5714567|NCT00448357|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5714568|NCT00448357|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5714569|NCT00448357|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5714570|NCT00448357|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5714571|NCT00448357|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5714572|NCT00448357|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5714573|NCT00448357|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5714574|NCT00448357|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5714575|NCT00448357|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5714576|NCT00448357|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5714577|NCT00448357|primary myelofibrosis|primary myelofibrosis
5714578|NCT00448357|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5714579|NCT00448357|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5714580|NCT00448357|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5714581|NCT00448357|prolymphocytic leukemia|prolymphocytic leukemia
5714582|NCT00448357|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5714583|NCT00448357|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5714584|NCT00448357|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5714585|NCT00448357|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5714586|NCT00448357|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5714587|NCT00448357|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5714588|NCT00448357|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5714589|NCT00448357|polycythemia vera|polycythemia vera
5714590|NCT00448357|essential thrombocythemia|essential thrombocythemia
5714591|NCT00448357|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5714592|NCT00448357|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5714593|NCT00448357|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5714594|NCT00448357|stage I multiple myeloma|stage i multiple myeloma
5714595|NCT00448357|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5714835|NCT00447759|Professor Tom MacDonald|professor tom macdonald
5714596|NCT00448357|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
5714598|NCT00448344|smoking cessation|smoking cessation
5714599|NCT00448331|Mental Disorders|mental disorders
5714600|NCT00448331|Mentally Ill Persons|mentally ill persons
5714601|NCT00448331|Emergency Medicine|emergency medicine
5714602|NCT00448331|Emergency Department|emergency department
5714603|NCT00448331|Screening|screening
5714604|NCT00448318|Controlled clinical trial|controlled clinical trial
5714605|NCT00448305|breast cancer|breast cancer
5714606|NCT00448305|metastatic|metastatic
5714607|NCT00448305|relapsed|relapsed
5714608|NCT00448305|triple-receptor negative|triple-receptor negative
5714609|NCT00448305|EndoTAG-1|endotag-1
5714610|NCT00448305|metastatic or relapsed breast neoplasm|metastatic or relapsed breast neoplasm
5714611|NCT00448292|Depression|depression
5714612|NCT00448292|Major Depressive Disorder|major depressive disorder
5714613|NCT00448292|Major Depression|major depression
5704558|NCT00485069|L-dopa|l-dopa
5714616|NCT00448266|high-dose chemotherapy|high-dose chemotherapy
5714617|NCT00448266|Homologous Recombination Deficiency|homologous recombination deficiency
5714618|NCT00448266|Alkylator therapy|alkylator therapy
5714619|NCT00448266|Peripheral Blood Progenitor Cell Support|peripheral blood progenitor cell support
5714620|NCT00448253|Inhalational Anthrax|inhalational anthrax
5714621|NCT00448253|Human Immune globulin|human immune globulin
5714622|NCT00448227|Infants, Herpes simplex infection|infants, herpes simplex infection
5714623|NCT00448214|Factor Xa inhibitor|factor xa inhibitor
5709466|NCT00466882|obese|obese
5714625|NCT00448214|Stroke|stroke
5714626|NCT00448214|Ischemic attack|ischemic attack
5714627|NCT00448214|thromboembolism|thromboembolism
5714628|NCT00448214|Prevention and control|prevention and control
5714629|NCT00448201|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5714630|NCT00448201|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5714631|NCT00448201|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5714632|NCT00448201|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5714633|NCT00448201|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5714634|NCT00448201|prolymphocytic leukemia|prolymphocytic leukemia
5714635|NCT00448201|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5714636|NCT00448201|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5714637|NCT00448201|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5714638|NCT00448201|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5714639|NCT00448201|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5714640|NCT00448201|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5714641|NCT00448201|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5714642|NCT00448201|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5714643|NCT00448201|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5714644|NCT00448201|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5714645|NCT00448201|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5714646|NCT00448201|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5714647|NCT00448201|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5714648|NCT00448201|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5714649|NCT00448201|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5714650|NCT00448201|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5685877|NCT00554476|Elbow Cast|elbow cast
5685878|NCT00554476|Icing|icing
5685879|NCT00554476|NSAIDs|nsaids
5714651|NCT00448201|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5714652|NCT00448201|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5714653|NCT00448201|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5714654|NCT00448201|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5714655|NCT00448201|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5714656|NCT00448201|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5714657|NCT00448201|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5714658|NCT00448201|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5714659|NCT00448201|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5714660|NCT00448201|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5714661|NCT00448201|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5714662|NCT00448201|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5680614|NCT00577278|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5680615|NCT00577278|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5680616|NCT00577278|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5740106|NCT00357513|Stroke|stroke
5714663|NCT00448201|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5714664|NCT00448201|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5714935|NCT00447304|cholecystectomy|cholecystectomy
5714665|NCT00448201|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5714666|NCT00448201|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5714667|NCT00448201|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5714668|NCT00448201|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5714669|NCT00448201|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5714670|NCT00448201|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5714671|NCT00448201|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5731075|NCT00390338|recurrent melanoma|recurrent melanoma
5731076|NCT00390338|stage IV melanoma|stage iv melanoma
5731077|NCT00390338|stage IIIA melanoma|stage iiia melanoma
5714672|NCT00448201|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5714673|NCT00448201|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5714674|NCT00448201|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5714675|NCT00448201|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5714676|NCT00448201|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5714677|NCT00448201|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5714678|NCT00448201|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5714679|NCT00448201|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5714680|NCT00448201|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5714681|NCT00448201|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5714682|NCT00448201|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5714683|NCT00448201|refractory multiple myeloma|refractory multiple myeloma
5714684|NCT00448201|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5714685|NCT00448201|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5714686|NCT00448201|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5714687|NCT00448201|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5714688|NCT00448201|stage I multiple myeloma|stage i multiple myeloma
5714689|NCT00448201|stage II multiple myeloma|stage ii multiple myeloma
5714690|NCT00448201|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5714691|NCT00448201|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5714692|NCT00448201|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5714693|NCT00448201|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5714694|NCT00448201|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5714695|NCT00448201|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5714696|NCT00448201|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5714697|NCT00448201|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5714698|NCT00448201|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5714699|NCT00448201|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5714700|NCT00448201|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5714701|NCT00448201|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5714702|NCT00448201|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5714703|NCT00448201|stage III multiple myeloma|stage iii multiple myeloma
5713581|NCT00452127|NHL|nhl
5714704|NCT00448201|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5714705|NCT00448201|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5714706|NCT00448201|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5714707|NCT00448201|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5714708|NCT00448201|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5714709|NCT00448201|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5714710|NCT00448201|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5714711|NCT00448201|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5714712|NCT00448201|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5714713|NCT00448201|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5714714|NCT00448201|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5714715|NCT00448201|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5714716|NCT00448201|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5714717|NCT00448201|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5714718|NCT00448201|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5714719|NCT00448201|primary myelofibrosis|primary myelofibrosis
5714720|NCT00448201|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5714721|NCT00448201|adult nasal type extranodal natural killer (NK)/T-cell lymphoma|adult nasal type extranodal natural killer (nk)/t-cell lymphoma
5714722|NCT00448201|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5714723|NCT00448201|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5714724|NCT00448188|central venous catheter|central venous catheter
5714725|NCT00448188|international normalized ratio|international normalized ratio
5714727|NCT00448188|bleeding risk|bleeding risk
5714728|NCT00448188|all patients in need of central venous line|all patients in need of central venous line
5714729|NCT00448188|comparison of patients with normal hemostasis to such with disorders in hemostasis|comparison of patients with normal hemostasis to such with disorders in hemostasis
5714936|NCT00447304|antibiotic treatment|antibiotic treatment
5714730|NCT00448175|OAB symptoms of urgency, frequency, and urge incontinence|oab symptoms of urgency, frequency, and urge incontinence
5714731|NCT00448162|hypertension, ENaC, Liddle's syndrome, variation|hypertension, enac, liddle's syndrome, variation
5714732|NCT00448149|Kidney cancer|kidney cancer
5714733|NCT00448149|Renal cell carcinoma|renal cell carcinoma
5714734|NCT00448149|Metastatic RCC|metastatic rcc
5714735|NCT00448123|Kidney Stones|kidney stones
5714736|NCT00448123|Ureteral Stones|ureteral stones
5714738|NCT00448123|Emergency Medicine|emergency medicine
5714739|NCT00448123|Urology|urology
5714740|NCT00448097|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5714741|NCT00448097|Prostate cancer|prostate cancer
5714742|NCT00448097|Pre-Prostatectomy|pre-prostatectomy
5714743|NCT00448097|Neoadjuvant|neoadjuvant
5714744|NCT00448084|Psychogenic Movement Disorders|psychogenic movement disorders
5714745|NCT00448084|Volition|volition
5714746|NCT00448084|fMRI|fmri
5714747|NCT00448084|Functional MRI|functional mri
5714748|NCT00448084|Functional Movement Disorder|functional movement disorder
5714750|NCT00448084|HV|hv
5714751|NCT00448071|Hypotension|hypotension
5714752|NCT00448071|End Stage Renal Disease|end stage renal disease
5714753|NCT00448071|Intra Dialytic Hypotension|intra dialytic hypotension
5714754|NCT00448071|ESRD|esrd
5714755|NCT00448071|Blood Pressure|blood pressure
5714756|NCT00448071|Dialysis|dialysis
5714757|NCT00448058|Flexible-dose|flexible-dose
5714758|NCT00448058|GSK372475|gsk372475
5714759|NCT00448058|MDD|mdd
5714760|NCT00448058|Venlafaxine XR|venlafaxine xr
5714761|NCT00448058|Major Depressive Disorder|major depressive disorder
5714762|NCT00448045|Spinal cord injuries|spinal cord injuries
5714763|NCT00448045|Cough|cough
5714764|NCT00448045|Peak cough flow|peak cough flow
5714765|NCT00448045|Respiratory therapy|respiratory therapy
5714766|NCT00448045|Rehabilitation|rehabilitation
5714767|NCT00448019|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5714768|NCT00448019|Fludarabine|fludarabine
5714769|NCT00448019|Cyclophosphamide|cyclophosphamide
5714770|NCT00448019|Rituximab|rituximab
5714771|NCT00448019|Bevacizumab|bevacizumab
5714772|NCT00448019|CLL|cll
5714773|NCT00448006|common|common
5714774|NCT00448006|bile|bile
5714775|NCT00448006|duct|duct
5714776|NCT00448006|biliary|biliary
5714777|NCT00448006|malignant|malignant
5714778|NCT00448006|obstruction|obstruction
5714779|NCT00448006|stent|stent
5714780|NCT00447993|Retinitis Pigmentosa|retinitis pigmentosa
5714781|NCT00447993|eye disease|eye disease
5714782|NCT00447993|retinal disorder|retinal disorder
5714783|NCT00447993|CNTF|cntf
5714784|NCT00447980|Retinitis Pigmentosa|retinitis pigmentosa
5714785|NCT00447980|eye disease|eye disease
5714786|NCT00447980|retinal disorder|retinal disorder
5714787|NCT00447980|CNTF|cntf
5714788|NCT00447967|Metastatic Gastric Cancer|metastatic gastric cancer
5714789|NCT00447967|Oxaliplatin|oxaliplatin
5714790|NCT00447967|Irinotecan|irinotecan
5714791|NCT00447954|eye disease|eye disease
5714792|NCT00447954|retinal disorder|retinal disorder
5714793|NCT00447954|CNTF|cntf
5714794|NCT00447928|tendonitis|tendonitis
5714795|NCT00447928|nitroglycerin|nitroglycerin
5714796|NCT00447928|nitric oxide|nitric oxide
5714797|NCT00447928|lateral epicondylitis|lateral epicondylitis
5714798|NCT00447902|treatment experienced|treatment experienced
5714799|NCT00447837|Chronic Sinusitis|chronic sinusitis
5714800|NCT00447824|Pain|pain
5714801|NCT00447824|Neonates|neonates
5714802|NCT00447824|NIDCAP|nidcap
5714803|NCT00447824|Venous|venous
5714804|NCT00447824|Capillary|capillary
5714805|NCT00447811|Methadone|methadone
5714806|NCT00447798|HIV positive|hiv positive
5714807|NCT00447798|crack cocaine user|crack cocaine user
5714808|NCT00447798|inpatient hospital setting|inpatient hospital setting
5714809|NCT00447798|HIV knowledge|hiv knowledge
5714810|NCT00447798|motivation|motivation
5714811|NCT00447798|perceived self-efficacy|perceived self-efficacy
5714812|NCT00447798|risky sexual behavior|risky sexual behavior
5714813|NCT00447798|HIV seronegativity|hiv seronegativity
5714814|NCT00447785|alcoholism|alcoholism
5714815|NCT00447785|nutrition|nutrition
5714816|NCT00447785|craving|craving
5714817|NCT00447785|energy supplies|energy supplies
5714818|NCT00447785|water supplies|water supplies
5714819|NCT00447772|Dysport, Cervical Dystonia|dysport, cervical dystonia
5714820|NCT00447759|Celecoxib|celecoxib
5714821|NCT00447759|Celebrex|celebrex
5714822|NCT00447759|Ibuprofen|ibuprofen
5714823|NCT00447759|Diclofenac|diclofenac
5714824|NCT00447759|NSAID|nsaid
5714825|NCT00447759|Osteoarthritis|osteoarthritis
5714826|NCT00447759|Rheumatoid Arthritis|rheumatoid arthritis
5714827|NCT00447759|Arthritis|arthritis
5714828|NCT00447759|Safety study|safety study
5714829|NCT00447759|Cardiovascular safety|cardiovascular safety
5714830|NCT00447759|Clinical trial|clinical trial
5714831|NCT00447759|PROBE design|probe design
5714832|NCT00447759|University of Dundee|university of dundee
5714833|NCT00447759|Medicines Monitoring Unit|medicines monitoring unit
5714834|NCT00447759|MEMO|memo
5715240|NCT00446147|prevention|prevention
5714836|NCT00447746|Comparison between D1 and D2 lymphadenectomy for gastric cancer|comparison between d1 and d2 lymphadenectomy for gastric cancer
5714837|NCT00447733|mental health|mental health
5714838|NCT00447733|substance use|substance use
5714839|NCT00447733|treatment|treatment
5714840|NCT00447720|HIV prevention skills|hiv prevention skills
5714841|NCT00447720|Seriously Mentally Ill (SMI)|seriously mentally ill (smi)
5714842|NCT00447720|Substance abuse|substance abuse
5714843|NCT00447720|Philadelphia|philadelphia
5714844|NCT00447720|HIV seronegativity|hiv seronegativity
5714845|NCT00447707|Substance use|substance use
5714846|NCT00447707|Unprotected sex|unprotected sex
5714847|NCT00447707|Behavioral intervention|behavioral intervention
5714848|NCT00447707|HIV care|hiv care
5714849|NCT00447707|Prevention with Positives|prevention with positives
5714850|NCT00447707|HIV seronegativity|hiv seronegativity
5714851|NCT00447694|Iron Chelation|iron chelation
5714852|NCT00447694|Deferasirox|deferasirox
5714854|NCT00447694|Desferal|desferal
5714855|NCT00447694|beta-thalassemia|beta-thalassemia
5714856|NCT00447694|Iron overload|iron overload
5714857|NCT00447668|Chronic Low Back Pain|chronic low back pain
5714859|NCT00447655|Amputation|amputation
5714860|NCT00447655|Self-management|self-management
5714861|NCT00447655|Rehabilitation|rehabilitation
5714862|NCT00447655|Peer support|peer support
5714863|NCT00447642|immunology|immunology
5714865|NCT00447642|allograft|allograft
5714866|NCT00447642|corneal allograft rejection|corneal allograft rejection
5714867|NCT00447642|graft failure|graft failure
5714868|NCT00447616|Prostate Cancer|prostate cancer
5714869|NCT00447616|Prostatectomy|prostatectomy
5714870|NCT00447564|opioid dependence|opioid dependence
5714871|NCT00447564|opioid addiction|opioid addiction
5714872|NCT00447564|buprenorphine|buprenorphine
5714873|NCT00447564|methadone|methadone
5714874|NCT00447564|heroin|heroin
5714875|NCT00447564|implant|implant
5714876|NCT00447564|opioid withdrawal|opioid withdrawal
5714877|NCT00447564|opioid pain medication|opioid pain medication
5714878|NCT00447564|suboxone|suboxone
5714879|NCT00447551|Aesthetic facial volume enhancement|aesthetic facial volume enhancement
5714880|NCT00447525|Prevention of : Diphtheria, Tetanus and Poliomyelitis|prevention of : diphtheria, tetanus and poliomyelitis
5714881|NCT00447499|Acromegaly|acromegaly
5714882|NCT00447499|Somatostatin Analogs|somatostatin analogs
5714883|NCT00447499|Somatuline® Autogel®|somatuline® autogel®
5714884|NCT00447499|lanreotide|lanreotide
5714885|NCT00447499|growth hormone|growth hormone
5714886|NCT00447499|IGF-1|igf-1
5714887|NCT00447499|Inappropriate Growth Hormone Secretion Syndrome|inappropriate growth hormone secretion syndrome
5714888|NCT00447499|Somatotropin Hypersecretion Syndrome|somatotropin hypersecretion syndrome
5714889|NCT00447499|Inappropriate GH Secretion Syndrome|inappropriate gh secretion syndrome
5714890|NCT00447486|Osteoarthritis,|osteoarthritis,
5714891|NCT00447486|knee,|knee,
5714892|NCT00447486|GW842166,|gw842166,
5714893|NCT00447486|pain,|pain,
5714894|NCT00447486|efficacy,|efficacy,
5714895|NCT00447486|safety|safety
5714896|NCT00447473|Prostate Cancer|prostate cancer
5714897|NCT00447473|progressive hormone refractory prostate cancer|progressive hormone refractory prostate cancer
5714898|NCT00447460|Graft-vs-host disease (GVHD)|graft-vs-host disease (gvhd)
5714899|NCT00447460|Mesenchymal stem cell (MSC)|mesenchymal stem cell (msc)
5714900|NCT00447460|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5714901|NCT00447460|Allotransplant|allotransplant
5714902|NCT00447460|Allogenic|allogenic
5714903|NCT00447460|Refractory|refractory
5714904|NCT00447460|CSM/EICH2005|csm/eich2005
5714905|NCT00447434|Nattokinase|nattokinase
5714906|NCT00447434|fibrinolytic factors|fibrinolytic factors
5714907|NCT00447434|blood lipids|blood lipids
5714908|NCT00447434|nutrimental supplement|nutrimental supplement
5714909|NCT00447408|hemodialysis|hemodialysis
5714910|NCT00447408|dietary adherence|dietary adherence
5714911|NCT00447408|sodium|sodium
5714912|NCT00447369|pregabalin|pregabalin
5714913|NCT00447369|Valproic acid|valproic acid
5714914|NCT00447369|migraine|migraine
5714915|NCT00447369|prophylaxis|prophylaxis
5714916|NCT00447369|prevention|prevention
5714917|NCT00447369|treatment|treatment
5714918|NCT00447343|Functional MRI|functional mri
5714919|NCT00447343|Cervical myelopathy|cervical myelopathy
5714920|NCT00447343|Cervical radiculopathy|cervical radiculopathy
5714921|NCT00447343|Brain plasticity and regeneration|brain plasticity and regeneration
5714922|NCT00447330|metastatic esophagogastric adenocarcinomas|metastatic esophagogastric adenocarcinomas
5714923|NCT00447330|ESOPHAGEAL CANCER|esophageal cancer
5714924|NCT00447330|GASTRIC CANCER|gastric cancer
5714925|NCT00447330|ADENOCARCINOMA|adenocarcinoma
5714926|NCT00447330|TARGTED THERAPY|targted therapy
5714927|NCT00447330|BEVACIZUMAB|bevacizumab
5714928|NCT00447330|CAPECITBAINE|capecitbaine
5714929|NCT00447330|OXALIPLATIN|oxaliplatin
5714930|NCT00447330|METASTATIC|metastatic
5714931|NCT00447317|peritoneal dialysis|peritoneal dialysis
5714932|NCT00447317|diet|diet
5714933|NCT00447317|sodium|sodium
5714934|NCT00447304|acute cholecystitis|acute cholecystitis
5714937|NCT00447304|moxifloxacin|moxifloxacin
5714938|NCT00447304|intraabdominal infection|intraabdominal infection
5798811|NCT00110942|Osteoarthritis|osteoarthritis
5731345|NCT00389311|HIV prevention|hiv prevention
5731346|NCT00389311|HIV Seronegativity|hiv seronegativity
5731347|NCT00389298|Chronic hepatitis C|chronic hepatitis c
5731361|NCT00389246|obesity|obesity
5714939|NCT00447304|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy|morbidity and mortality of patients with acute cholecystitis, early surgery versus conservative therapy
5714940|NCT00447291|Overweight|overweight
5714941|NCT00447291|Obesity|obesity
5714942|NCT00447291|Fish Oil|fish oil
5714943|NCT00447252|bereavement|bereavement
5714944|NCT00447252|grief|grief
5714945|NCT00447239|mechanical ventilated|mechanical ventilated
5714946|NCT00447239|surgical patients|surgical patients
5714947|NCT00447239|pneumonia|pneumonia
5714948|NCT00447239|blood glucose|blood glucose
5714949|NCT00447239|insulin infusion|insulin infusion
5714951|NCT00447226|Ovarian Cancer|ovarian cancer
5714952|NCT00447226|Bladder Cancer|bladder cancer
5714953|NCT00447226|ErbB2 positive|erbb2 positive
5714954|NCT00447226|Lapatinib|lapatinib
5714955|NCT00447226|Gastric/Esophageal Cancer|gastric/esophageal cancer
5714956|NCT00447226|Uterine Serous Papillary Cancer|uterine serous papillary cancer
5714957|NCT00447200|Stroke volume|stroke volume
5714958|NCT00447200|SV variation|sv variation
5714959|NCT00447200|Esophagus Doppler|esophagus doppler
5714960|NCT00447200|Goal Directed Therapy|goal directed therapy
5714961|NCT00447187|corneal graft failure|corneal graft failure
5714962|NCT00447187|corneal graft rejection|corneal graft rejection
5714963|NCT00447187|corneal transplant rejection|corneal transplant rejection
5714964|NCT00447174|Grief|grief
5714965|NCT00447174|parental bereavement|parental bereavement
5714966|NCT00447135|Elderly|elderly
5714967|NCT00447135|Trauma|trauma
5714968|NCT00447135|Polymorphonuclear Leukocyte|polymorphonuclear leukocyte
5714969|NCT00447135|Immunity|immunity
5714970|NCT00447122|Pancreatic Cancer|pancreatic cancer
5714971|NCT00447096|Bipolar Type II|bipolar type ii
5714972|NCT00447096|Depression|depression
5714973|NCT00447096|rTMS|rtms
5714974|NCT00447083|Tanning|tanning
5714975|NCT00447083|Musculoskeletal|musculoskeletal
5714976|NCT00447083|Fibromyalgia Syndrome|fibromyalgia syndrome
5714977|NCT00447070|HIV-infection|hiv-infection
5714978|NCT00447070|Dyslipidemia|dyslipidemia
5714979|NCT00447070|Endothelial Dysfunction|endothelial dysfunction
5714980|NCT00447070|Atherosclerosis|atherosclerosis
5714981|NCT00447070|Protease inhibitor|protease inhibitor
5714982|NCT00447070|treatment experienced|treatment experienced
5714983|NCT00447057|nonsquamous|nonsquamous
5714984|NCT00447044|Muscle loss and Maintenance of Muscle function|muscle loss and maintenance of muscle function
5714985|NCT00447031|age related macular degeneration|age related macular degeneration
5714986|NCT00447031|intravitreal bevacizumab|intravitreal bevacizumab
5714987|NCT00447031|intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5714988|NCT00447031|neovascular age related macular degeneration|neovascular age related macular degeneration
5714989|NCT00447018|intracranial pressure|intracranial pressure
5714990|NCT00447018|mannitol|mannitol
5714991|NCT00447018|hypertonic saline solution|hypertonic saline solution
5714992|NCT00447018|brain injury|brain injury
5714993|NCT00447018|traumatic brain injury|traumatic brain injury
5714994|NCT00447018|Adult patients|adult patients
5714995|NCT00447018|With elevation of intracranial pressure (ICP > 20 mmHg)|with elevation of intracranial pressure (icp > 20 mmhg)
5714996|NCT00447005|Safety|safety
5714997|NCT00447005|PK|pk
5714998|NCT00447005|Biomarker|biomarker
5714999|NCT00446992|Schizophrenia|schizophrenia
5715000|NCT00446992|Schizoaffective|schizoaffective
5715001|NCT00446992|psychosis|psychosis
5715002|NCT00446992|olanzapine|olanzapine
5715003|NCT00446979|Microbicides|microbicides
5715004|NCT00446979|HIV seronegativity|hiv seronegativity
5715005|NCT00446966|atrial fibrillation|atrial fibrillation
5715006|NCT00446966|coronary artery disease bypass graft surgery|coronary artery disease bypass graft surgery
5715007|NCT00446953|Caesarean section|caesarean section
5715008|NCT00446953|Corticosteroids|corticosteroids
5715009|NCT00446953|Betamethasone|betamethasone
5715010|NCT00446953|Neonatal distress|neonatal distress
5715011|NCT00446927|Pediatrics|pediatrics
5715012|NCT00446927|Cardiology|cardiology
5715013|NCT00446927|Cardiopulmonary Bypass|cardiopulmonary bypass
5715014|NCT00446927|Heart Surgery|heart surgery
5715015|NCT00446927|Cardiac Catheterization|cardiac catheterization
5715016|NCT00446927|Echocardiography|echocardiography
5715017|NCT00446927|Imaging|imaging
5715018|NCT00446927|ICG green dye|icg green dye
5715019|NCT00446914|Hypertension|hypertension
5715020|NCT00446914|Blood Pressure|blood pressure
5715021|NCT00446901|Prostate Cancer|prostate cancer
5715022|NCT00446901|Selenium|selenium
5715023|NCT00446901|Chemoprevention|chemoprevention
5715024|NCT00446901|Gene expression|gene expression
5715025|NCT00446888|cancer|cancer
5715026|NCT00446888|metastasis|metastasis
5715027|NCT00446875|Pain|pain
5715028|NCT00446875|Procedural pain|procedural pain
5715029|NCT00446875|Sucrose|sucrose
5715030|NCT00446875|Infant|infant
5715031|NCT00446862|Definition: Fabry disease|definition: fabry disease
5715032|NCT00446862|Definition: Progression|definition: progression
5715033|NCT00446862|Definition: MDRD GFR|definition: mdrd gfr
5715241|NCT00446134|Phase 2b Dose-Ranging Study|phase 2b dose-ranging study
5715034|NCT00446862|Definition: Chronic Kidney Disease|definition: chronic kidney disease
5715035|NCT00446862|Definition: Proteinuria|definition: proteinuria
5715036|NCT00446862|Definition: Enzyme Replacement Therapy|definition: enzyme replacement therapy
5715037|NCT00446862|Definition: Anti-proteinuric therapy|definition: anti-proteinuric therapy
5715038|NCT00446849|ulcerative colitis|ulcerative colitis
5715039|NCT00446849|compliance|compliance
5715040|NCT00446849|mesalamine|mesalamine
5715041|NCT00446849|clinical study|clinical study
5715042|NCT00446849|clinical trial|clinical trial
5715043|NCT00446849|clinical research|clinical research
5715044|NCT00446849|maintenance|maintenance
5715045|NCT00446849|long term|long term
5715046|NCT00446849|uc study|uc study
5715047|NCT00446849|uc trial|uc trial
5715048|NCT00446849|uc research|uc research
5715049|NCT00446849|open label|open label
5715050|NCT00446849|once a day|once a day
5715051|NCT00446849|once|once
5715052|NCT00446849|daily|daily
5715053|NCT00446849|daily dosing|daily dosing
5715054|NCT00446849|simple|simple
5715055|NCT00446849|oral|oral
5715056|NCT00446836|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5715057|NCT00446836|Recurrent prostate cancer|recurrent prostate cancer
5715058|NCT00446836|Hormone refractory prostate cancer|hormone refractory prostate cancer
5715059|NCT00446823|Wound healing|wound healing
5715060|NCT00446823|Venous stasis ulcer|venous stasis ulcer
5715061|NCT00446823|Cellulose dressing|cellulose dressing
5715062|NCT00446823|Gauze dressing|gauze dressing
5715063|NCT00446823|Chronic wound|chronic wound
5715064|NCT00446810|diabetes|diabetes
5715065|NCT00446810|endothelial dysfunction|endothelial dysfunction
5715066|NCT00446810|benfotiamine|benfotiamine
5715067|NCT00446810|postprandial|postprandial
5715068|NCT00446810|autonomic neuropathy|autonomic neuropathy
5715069|NCT00446810|advanced glycation end products|advanced glycation end products
5715070|NCT00446797|Ankle sprain, acute pain, NSAID, celecoxib,|ankle sprain, acute pain, nsaid, celecoxib,
5715071|NCT00446758|Zinc|zinc
5715073|NCT00446758|Infants|infants
5715074|NCT00446758|Children|children
5715075|NCT00446758|Morbidity|morbidity
5715076|NCT00446758|Child health outcomes|child health outcomes
5715077|NCT00446758|treatment naive|treatment naive
5715078|NCT00446758|treatment experienced|treatment experienced
5715079|NCT00446745|Nutritional and Metabolic Diseases|nutritional and metabolic diseases
5715080|NCT00446745|Insulin resistance|insulin resistance
5715081|NCT00446745|Energy Metabolisms|energy metabolisms
5715082|NCT00446745|Skeletal muscle|skeletal muscle
5715083|NCT00446745|Visceral Adipose Tissue|visceral adipose tissue
5715084|NCT00446719|major depression|major depression
5715085|NCT00446719|antidepressant|antidepressant
5715086|NCT00446719|quality of life|quality of life
5715087|NCT00446719|anxiety|anxiety
5715088|NCT00446706|Intrinsic PEEP|intrinsic peep
5715089|NCT00446680|Mannitol|mannitol
5715090|NCT00446680|Cystic Fibrosis|cystic fibrosis
5715091|NCT00446680|Mucolytic|mucolytic
5715092|NCT00446680|Exacerbation|exacerbation
5715093|NCT00446680|FEV1|fev1
5715094|NCT00446680|Quality of Life|quality of life
5715095|NCT00446641|Infarction, Cerebral|infarction, cerebral
5715096|NCT00446641|Cilostazol|cilostazol
5715097|NCT00446641|Aspirin Resistance|aspirin resistance
5715098|NCT00446628|Non-pharmaceutical|non-pharmaceutical
5715099|NCT00446628|influenza|influenza
5715100|NCT00446628|pandemic|pandemic
5715101|NCT00446615|computer decision support|computer decision support
5715102|NCT00446615|primary care|primary care
5715103|NCT00446615|kidney disease, chronic|kidney disease, chronic
5715104|NCT00446615|prescribing|prescribing
5715105|NCT00446602|PROCRIT|procrit
5715106|NCT00446602|Epoetin alfa|epoetin alfa
5715107|NCT00446602|Myelodysplastic Syndromes|myelodysplastic syndromes
5715109|NCT00446576|Anemia|anemia
5715110|NCT00446576|early renal insufficiency|early renal insufficiency
5715111|NCT00446563|Left ventricular hypertrophy, hypertension, valsartan, amlodipine|left ventricular hypertrophy, hypertension, valsartan, amlodipine
5715112|NCT00446550|Amicus Therapeutics|amicus therapeutics
5715113|NCT00446550|afegostat tartrate|afegostat tartrate
5715114|NCT00446550|isofagomine tartrate|isofagomine tartrate
5715115|NCT00446550|AT2101|at2101
5715116|NCT00446537|Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate|skill acquisition and the evolution of long term procedural memory in participants with adhd: the effect of methylphenidate
5715117|NCT00446524|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5715118|NCT00446511|children|children
5715119|NCT00446511|pediatrics|pediatrics
5715120|NCT00446511|high blood pressure|high blood pressure
5715121|NCT00446511|hypertension|hypertension
5715122|NCT00446511|valsartan|valsartan
5715123|NCT00446511|enalapril|enalapril
5715124|NCT00446485|ginkgo biloba|ginkgo biloba
5715125|NCT00446485|cerebrovascular insufficiency|cerebrovascular insufficiency
5715126|NCT00446485|mild cognitive impairment|mild cognitive impairment
5715127|NCT00446485|concentration impairment|concentration impairment
5715128|NCT00446472|diabetes mellitus|diabetes mellitus
5715129|NCT00446472|diabetic neuropathies|diabetic neuropathies
5715242|NCT00446121|COPD|copd
5715130|NCT00446472|peripheral vascular diseases|peripheral vascular diseases
5715131|NCT00446459|CellCept|cellcept
5715132|NCT00446459|Dialysis|dialysis
5715133|NCT00446459|Kidney|kidney
5715134|NCT00446459|Renal|renal
5715135|NCT00446459|Nephropathy|nephropathy
5715136|NCT00446459|Glomerulonephropathy|glomerulonephropathy
5715137|NCT00446459|Immunosuppression|immunosuppression
5715138|NCT00446459|Allograft|allograft
5715139|NCT00446459|Compatibility|compatibility
5715140|NCT00446459|HLA|hla
5715141|NCT00446459|PRA|pra
5715142|NCT00446459|Transplant|transplant
5715143|NCT00446459|Sensitization|sensitization
5715144|NCT00446459|Antibodies|antibodies
5715145|NCT00446459|Diabetes|diabetes
5715147|NCT00446459|Transplantation, Kidney|transplantation, kidney
5715148|NCT00446407|Depression|depression
5715149|NCT00446407|Primary Care|primary care
5715150|NCT00446407|Developing Countries|developing countries
5715151|NCT00446407|Common mental disorders (depressive and anxiety disorders)|common mental disorders (depressive and anxiety disorders)
5715152|NCT00446394|cognition disorder|cognition disorder
5715153|NCT00446394|functional ability|functional ability
5715154|NCT00446394|psychomotor function|psychomotor function
5715155|NCT00446394|psychopathology|psychopathology
5715156|NCT00446394|quality of life|quality of life
5715157|NCT00446381|Proliferative Diabetic Retinopathy|proliferative diabetic retinopathy
5715158|NCT00446381|Clinically Significant Diabetic Macular Edema|clinically significant diabetic macular edema
5715160|NCT00446381|Macugen (pegaptanib)|macugen (pegaptanib)
5715161|NCT00446368|metastatic kidney cancer|metastatic kidney cancer
5715162|NCT00446368|metastatic renal cell cancer|metastatic renal cell cancer
5715163|NCT00446355|C diff|c diff
5715164|NCT00446355|antibiotics|antibiotics
5715165|NCT00446342|leukemia|leukemia
5715166|NCT00446342|lymphoma|lymphoma
5715167|NCT00446342|myeloma|myeloma
5715168|NCT00446342|non-Hodgkin's|non-hodgkin's
5715169|NCT00446342|CLL|cll
5715170|NCT00446342|MCL|mcl
5715171|NCT00446342|MM|mm
5715172|NCT00446342|Phase 1|phase 1
5715173|NCT00446342|hematological malignancy|hematological malignancy
5715174|NCT00446316|Pharmacokinetics|pharmacokinetics
5715175|NCT00446316|Healthy volunteers|healthy volunteers
5715176|NCT00446316|No condition|no condition
5715177|NCT00446316|Pharmacokinetics study|pharmacokinetics study
5715178|NCT00446303|MDS|mds
5715179|NCT00446303|Myelodysplastic Syndromes|myelodysplastic syndromes
5715180|NCT00446303|AML|aml
5715181|NCT00446303|Intensive chemotherapy|intensive chemotherapy
5715182|NCT00446303|azacitidine|azacitidine
5715183|NCT00446290|To determine maximal tolerated dose of DXO regimen|to determine maximal tolerated dose of dxo regimen
5715184|NCT00446277|cataract surgery, endothelial cell, cell loss, diabetes|cataract surgery, endothelial cell, cell loss, diabetes
5715185|NCT00446277|mellitus type II|mellitus type ii
5715186|NCT00446264|diabetes|diabetes
5715187|NCT00446264|hypoglycemia|hypoglycemia
5715188|NCT00446251|Dialysis|dialysis
5715189|NCT00446251|Kidney|kidney
5715190|NCT00446251|Renal|renal
5715191|NCT00446251|Nephropathy|nephropathy
5715192|NCT00446251|Glomerulonephropathy|glomerulonephropathy
5715193|NCT00446251|Immunosuppression|immunosuppression
5715194|NCT00446251|Graft|graft
5715195|NCT00446251|Compatibility|compatibility
5715196|NCT00446251|Transplant|transplant
5715197|NCT00446251|Diabetes|diabetes
5715198|NCT00446251|Hypertension|hypertension
5715199|NCT00446251|Transplantation, Kidney|transplantation, kidney
5715200|NCT00446238|Depression|depression
5715201|NCT00446238|Physical Illness|physical illness
5715202|NCT00446238|Inflammatory Bowel Disease|inflammatory bowel disease
5715203|NCT00446238|Cognitive Behavioral Therapy|cognitive behavioral therapy
5715204|NCT00446225|Lung|lung
5715205|NCT00446225|cancer|cancer
5715206|NCT00446225|EGFR|egfr
5715207|NCT00446225|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5715208|NCT00446225|tyrosine kinase|tyrosine kinase
5715209|NCT00446225|Tarceva®|tarceva®
5715210|NCT00446225|Erlotinib|erlotinib
5715211|NCT00446212|anaesthesia|anaesthesia
5715212|NCT00446212|propofol|propofol
5715218|NCT00446199|Severe to Moderate Vasomotor symptoms|severe to moderate vasomotor symptoms
5715220|NCT00446173|Leukemia|leukemia
5715221|NCT00446173|Philadelphia (Ph) chromosome positive CML|philadelphia (ph) chromosome positive cml
5715222|NCT00446173|Busulfan|busulfan
5715223|NCT00446173|Busulfex|busulfex
5715224|NCT00446173|Myleran|myleran
5715225|NCT00446173|Cyclophosphamide|cyclophosphamide
5715226|NCT00446173|Cytoxan|cytoxan
5715227|NCT00446173|Neosar|neosar
5715228|NCT00446173|G-CSF|g-csf
5715229|NCT00446173|Filgrastim|filgrastim
5715230|NCT00446173|Neupogen|neupogen
5715231|NCT00446173|GM-CSF|gm-csf
5715232|NCT00446173|Sargramostim|sargramostim
5715233|NCT00446173|Leukine|leukine
5715234|NCT00446160|Congenital Heart Disease|congenital heart disease
5715235|NCT00446160|Surgery|surgery
5715236|NCT00446160|Adult|adult
5715237|NCT00446147|hand-foot syndrome|hand-foot syndrome
5715238|NCT00446147|capecitabine|capecitabine
5715239|NCT00446147|pyridoxine|pyridoxine
5715243|NCT00446108|Pulmonary Stenosis|pulmonary stenosis
5715244|NCT00446108|Right Ventricular Dilation|right ventricular dilation
5715245|NCT00446108|Right Heart Failure|right heart failure
5715246|NCT00446108|Imaging|imaging
5715247|NCT00446108|Tetralogy of Fallot|tetralogy of fallot
5715248|NCT00446095|DLCL|dlcl
5715249|NCT00446095|Nodular lymphoma|nodular lymphoma
5715250|NCT00446095|Mantle cell lymphoma|mantle cell lymphoma
5715251|NCT00446095|Syk kinase|syk kinase
5715252|NCT00446082|Refractory/ resistant carcinoid disease|refractory/ resistant carcinoid disease
5715254|NCT00446082|adults|adults
5715255|NCT00446082|pasireotide LAR|pasireotide lar
5715256|NCT00446082|somatostatin analogue|somatostatin analogue
5715258|NCT00446082|pharmacokinetics|pharmacokinetics
5715261|NCT00446043|Adapalene|adapalene
5715262|NCT00446043|Benzoyl Peroxide|benzoyl peroxide
5715263|NCT00446017|coronary artery bypass grafting|coronary artery bypass grafting
5715264|NCT00446017|inotropes|inotropes
5715265|NCT00446017|metabolism|metabolism
5715266|NCT00446017|renal failure|renal failure
5715267|NCT00446004|Pharmacokinetics|pharmacokinetics
5715268|NCT00446004|Healthy volunteers|healthy volunteers
5715269|NCT00446004|No condition|no condition
5715270|NCT00446004|Pharmacokinetics study|pharmacokinetics study
5715279|NCT00445965|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5715280|NCT00445965|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5715281|NCT00445965|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5715282|NCT00445965|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5715283|NCT00445965|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5715284|NCT00445965|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5715285|NCT00445965|adult diffuse astrocytoma|adult diffuse astrocytoma
5715286|NCT00445965|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5715287|NCT00445965|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5715288|NCT00445965|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5715289|NCT00445965|untreated childhood subependymal giant cell astrocytoma|untreated childhood subependymal giant cell astrocytoma
5715290|NCT00445965|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5715291|NCT00445965|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5715292|NCT00445965|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5715293|NCT00445965|adult brain stem glioma|adult brain stem glioma
5715294|NCT00445965|adult mixed glioma|adult mixed glioma
5715295|NCT00445965|childhood mixed glioma|childhood mixed glioma
5715296|NCT00445965|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5715297|NCT00445965|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5715298|NCT00445965|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5715299|NCT00445965|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5685880|NCT00554463|limited stage small cell lung cancer|limited stage small cell lung cancer
5685881|NCT00554437|Accidental Falls|accidental falls
5685882|NCT00554437|RCT|rct
5685883|NCT00554437|Age 65 and older|age 65 and older
5685884|NCT00554437|noninstitualized populations|noninstitualized populations
5681146|NCT00574522|HIV|hiv
5715300|NCT00445965|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5715301|NCT00445965|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5715302|NCT00445965|regional neuroblastoma|regional neuroblastoma
5715303|NCT00445965|disseminated neuroblastoma|disseminated neuroblastoma
5715304|NCT00445965|recurrent neuroblastoma|recurrent neuroblastoma
5715305|NCT00445965|extraocular retinoblastoma|extraocular retinoblastoma
5715306|NCT00445965|recurrent retinoblastoma|recurrent retinoblastoma
5715307|NCT00445965|adult anaplastic ependymoma|adult anaplastic ependymoma
5715308|NCT00445965|adult ependymoblastoma|adult ependymoblastoma
5715309|NCT00445965|adult ependymoma|adult ependymoma
5715310|NCT00445965|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5715311|NCT00445965|adult subependymoma|adult subependymoma
5715312|NCT00445965|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5715313|NCT00445965|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5715314|NCT00445965|recurrent childhood ependymoma|recurrent childhood ependymoma
5715315|NCT00445965|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5715316|NCT00445965|recurrent melanoma|recurrent melanoma
5715317|NCT00445965|stage IV melanoma|stage iv melanoma
5715318|NCT00445965|adult medulloblastoma|adult medulloblastoma
5715319|NCT00445965|chondrosarcoma|chondrosarcoma
5715320|NCT00445965|metastatic osteosarcoma|metastatic osteosarcoma
5715321|NCT00445965|recurrent osteosarcoma|recurrent osteosarcoma
5715322|NCT00445965|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5715323|NCT00445965|ovarian sarcoma|ovarian sarcoma
5715324|NCT00445965|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5715325|NCT00445965|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5715326|NCT00445965|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5715327|NCT00445965|stage III uterine sarcoma|stage iii uterine sarcoma
5715328|NCT00445965|stage IV uterine sarcoma|stage iv uterine sarcoma
5715329|NCT00445965|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5715330|NCT00445965|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5715331|NCT00445965|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5715332|NCT00445965|adult desmoplastic small round cell tumor|adult desmoplastic small round cell tumor
5715333|NCT00445965|adult oligodendroglioma|adult oligodendroglioma
5715334|NCT00445965|adult giant cell glioblastoma|adult giant cell glioblastoma
5715335|NCT00445965|adult gliosarcoma|adult gliosarcoma
5715336|NCT00445965|tumors metastatic to brain|tumors metastatic to brain
5715338|NCT00445965|childhood oligodendroglioma|childhood oligodendroglioma
5715339|NCT00445965|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5715340|NCT00445965|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5715341|NCT00445965|intraocular retinoblastoma|intraocular retinoblastoma
5715342|NCT00445965|recurrent adult brain tumor|recurrent adult brain tumor
5715343|NCT00445965|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5715344|NCT00445965|recurrent uterine sarcoma|recurrent uterine sarcoma
5715345|NCT00445965|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5715346|NCT00445965|recurrent small intestine cancer|recurrent small intestine cancer
5715347|NCT00445965|recurrent small cell lung cancer|recurrent small cell lung cancer
5715348|NCT00445965|extraocular extension melanoma|extraocular extension melanoma
5715349|NCT00445965|recurrent intraocular melanoma|recurrent intraocular melanoma
5715350|NCT00445965|metastatic intraocular melanoma|metastatic intraocular melanoma
5715351|NCT00445965|iris melanoma|iris melanoma
5715352|NCT00445965|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5715353|NCT00445965|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5715354|NCT00445965|adult glioblastoma|adult glioblastoma
5715355|NCT00445965|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5715356|NCT00445965|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5715357|NCT00445965|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5715358|NCT00445965|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5715359|NCT00445965|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5715360|NCT00445965|stage IIIA melanoma|stage iiia melanoma
5715361|NCT00445965|stage IIIB melanoma|stage iiib melanoma
5715362|NCT00445965|stage IIIC melanoma|stage iiic melanoma
5715363|NCT00445965|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5715364|NCT00445965|untreated childhood anaplastic astrocytoma|untreated childhood anaplastic astrocytoma
5714216|NCT00449618|Aspirin|aspirin
5715365|NCT00445965|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5715366|NCT00445965|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5715367|NCT00445965|untreated childhood anaplastic oligoastrocytoma|untreated childhood anaplastic oligoastrocytoma
5715368|NCT00445965|untreated childhood anaplastic oligodendroglioma|untreated childhood anaplastic oligodendroglioma
5715369|NCT00445965|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5715370|NCT00445965|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5715371|NCT00445965|untreated childhood giant cell glioblastoma|untreated childhood giant cell glioblastoma
5715372|NCT00445965|untreated childhood glioblastoma|untreated childhood glioblastoma
5715373|NCT00445965|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5715374|NCT00445965|untreated childhood gliosarcoma|untreated childhood gliosarcoma
5715711|NCT00445627|Overweight|overweight
5715375|NCT00445965|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5715376|NCT00445965|untreated childhood gliomatosis cerebri|untreated childhood gliomatosis cerebri
5715377|NCT00445965|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5715378|NCT00445965|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5715379|NCT00445952|breast cancer in situ|breast cancer in situ
5715380|NCT00445952|stage I breast cancer|stage i breast cancer
5715381|NCT00445952|stage II breast cancer|stage ii breast cancer
5715382|NCT00445952|stage IIIA breast cancer|stage iiia breast cancer
5715383|NCT00445952|stage IIIB breast cancer|stage iiib breast cancer
5715384|NCT00445952|stage IIIC breast cancer|stage iiic breast cancer
5715385|NCT00445952|stage IV breast cancer|stage iv breast cancer
5715386|NCT00445952|recurrent breast cancer|recurrent breast cancer
5715387|NCT00445952|male breast cancer|male breast cancer
5715388|NCT00445952|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5715389|NCT00445952|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5715390|NCT00445952|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5715391|NCT00445952|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5715392|NCT00445952|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5715393|NCT00445952|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5715394|NCT00445952|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5715395|NCT00445952|recurrent colon cancer|recurrent colon cancer
5715396|NCT00445952|stage I colon cancer|stage i colon cancer
5715397|NCT00445952|stage II colon cancer|stage ii colon cancer
5715398|NCT00445952|stage III colon cancer|stage iii colon cancer
5715399|NCT00445952|stage IV colon cancer|stage iv colon cancer
5715400|NCT00445952|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5715401|NCT00445952|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5715402|NCT00445952|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5715403|NCT00445952|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5715404|NCT00445952|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5715405|NCT00445952|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5715406|NCT00445952|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5715407|NCT00445952|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5715408|NCT00445952|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5715409|NCT00445952|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5715410|NCT00445952|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5715411|NCT00445952|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5715412|NCT00445952|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5715413|NCT00445952|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5715414|NCT00445952|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5715415|NCT00445952|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5715416|NCT00445952|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5715417|NCT00445952|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5715418|NCT00445952|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5715419|NCT00445952|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5715420|NCT00445952|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5715421|NCT00445952|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5715422|NCT00445952|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5715423|NCT00445952|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5715424|NCT00445952|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5715425|NCT00445952|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5685885|NCT00554424|oocyte retrieval|oocyte retrieval
5685886|NCT00554424|pain relief|pain relief
5685887|NCT00554424|Local anaesthetic|local anaesthetic
5685888|NCT00554411|Travatan Z|travatan z
5685889|NCT00554411|glaucoma|glaucoma
5715426|NCT00445952|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5715427|NCT00445952|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5715428|NCT00445952|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5715429|NCT00445952|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5715430|NCT00445952|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5715431|NCT00445952|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5715432|NCT00445952|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5715433|NCT00445952|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5715434|NCT00445952|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5715435|NCT00445952|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5715436|NCT00445952|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5715437|NCT00445952|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5715438|NCT00445952|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5715712|NCT00445614|nutrition|nutrition
5715439|NCT00445952|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5715440|NCT00445952|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5715441|NCT00445952|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5715442|NCT00445952|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5715443|NCT00445952|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5715444|NCT00445952|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5715445|NCT00445952|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5715446|NCT00445952|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5715447|NCT00445952|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5715448|NCT00445952|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5715449|NCT00445952|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5715450|NCT00445952|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5715451|NCT00445952|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5715452|NCT00445952|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5715453|NCT00445952|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5715964|NCT00445081|ciclosporine|ciclosporine
5715454|NCT00445952|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5715455|NCT00445952|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5715456|NCT00445952|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5715457|NCT00445952|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5715458|NCT00445952|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5715459|NCT00445952|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5715460|NCT00445952|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5715461|NCT00445952|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5715462|NCT00445952|stage I multiple myeloma|stage i multiple myeloma
5715463|NCT00445952|stage II multiple myeloma|stage ii multiple myeloma
5715464|NCT00445952|stage III multiple myeloma|stage iii multiple myeloma
5715465|NCT00445952|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5715466|NCT00445952|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5715467|NCT00445952|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5715468|NCT00445952|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5715469|NCT00445952|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5715470|NCT00445952|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5715471|NCT00445952|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5715472|NCT00445952|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5715473|NCT00445952|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5715474|NCT00445952|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5715475|NCT00445952|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5715476|NCT00445952|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5715477|NCT00445952|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5715478|NCT00445952|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5715479|NCT00445952|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5715480|NCT00445952|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5704262|NCT00486395|RDS|rds
5715481|NCT00445952|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5715482|NCT00445952|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5715483|NCT00445952|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5715484|NCT00445952|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5715485|NCT00445952|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5715486|NCT00445952|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5715487|NCT00445952|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5715488|NCT00445952|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5715489|NCT00445952|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5715490|NCT00445952|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5715491|NCT00445952|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5715492|NCT00445952|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5715493|NCT00445952|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5715494|NCT00445952|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5715495|NCT00445952|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5715496|NCT00445952|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5715497|NCT00445952|refractory multiple myeloma|refractory multiple myeloma
5715498|NCT00445952|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5715499|NCT00445952|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5715500|NCT00445952|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5715501|NCT00445952|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5715946|NCT00445146|Phase 2|phase 2
5715502|NCT00445952|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5715503|NCT00445952|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5715504|NCT00445952|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5715505|NCT00445952|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5715506|NCT00445952|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5715507|NCT00445952|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5715508|NCT00445952|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5715509|NCT00445952|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5715510|NCT00445952|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5715511|NCT00445952|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5715512|NCT00445952|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5715513|NCT00445952|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5715514|NCT00445952|primary myelofibrosis|primary myelofibrosis
5715515|NCT00445952|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5715516|NCT00445952|essential thrombocythemia|essential thrombocythemia
5715518|NCT00445952|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5715519|NCT00445952|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5715520|NCT00445952|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5715521|NCT00445952|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5715522|NCT00445952|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5715523|NCT00445952|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5715524|NCT00445952|acute undifferentiated leukemia|acute undifferentiated leukemia
5715525|NCT00445952|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5715526|NCT00445952|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5715527|NCT00445952|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5715528|NCT00445952|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5715529|NCT00445952|refractory hairy cell leukemia|refractory hairy cell leukemia
5715530|NCT00445952|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5715531|NCT00445952|prolymphocytic leukemia|prolymphocytic leukemia
5715532|NCT00445952|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5715533|NCT00445952|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5715534|NCT00445952|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5715535|NCT00445952|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5715536|NCT00445952|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5715537|NCT00445952|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5715538|NCT00445952|extramedullary plasmacytoma|extramedullary plasmacytoma
5715539|NCT00445952|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5715540|NCT00445952|primary systemic amyloidosis|primary systemic amyloidosis
5715541|NCT00445952|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5715542|NCT00445952|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5723209|NCT00420030|PCI|pci
5715543|NCT00445952|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5715544|NCT00445952|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5715545|NCT00445952|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5715546|NCT00445952|intraocular lymphoma|intraocular lymphoma
5715547|NCT00445952|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5715548|NCT00445952|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5715549|NCT00445952|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5715550|NCT00445952|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5715552|NCT00445952|limited stage small cell lung cancer|limited stage small cell lung cancer
5715553|NCT00445952|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5715555|NCT00445913|dendritic cells|dendritic cells
5715556|NCT00445913|cell vaccine|cell vaccine
5715558|NCT00445913|reversal|reversal
5715559|NCT00445900|primary myelofibrosis|primary myelofibrosis
5715560|NCT00445900|essential thrombocythemia|essential thrombocythemia
5715561|NCT00445900|polycythemia vera|polycythemia vera
5715562|NCT00445900|secondary myelofibrosis|secondary myelofibrosis
5715563|NCT00445874|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5715564|NCT00445861|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5715565|NCT00445861|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5715566|NCT00445861|stage II esophageal cancer|stage ii esophageal cancer
5715567|NCT00445861|stage III esophageal cancer|stage iii esophageal cancer
5715568|NCT00445848|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5715569|NCT00445848|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5680617|NCT00577278|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5680618|NCT00577278|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5680619|NCT00577278|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5680620|NCT00577278|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5715570|NCT00445848|adenocarcinoma of the lung|adenocarcinoma of the lung
5715571|NCT00445835|coronary artery disease|coronary artery disease
5715572|NCT00445835|myocardial infarction|myocardial infarction
5715573|NCT00445835|atherothrombosis|atherothrombosis
5715574|NCT00445835|atherosclerosis|atherosclerosis
5715576|NCT00445822|Children|children
5715577|NCT00445822|Imatinib|imatinib
5715578|NCT00445822|bcr-abl|bcr-abl
5715579|NCT00445822|Response|response
5715580|NCT00445822|Imatinib mesylate|imatinib mesylate
5715581|NCT00445809|Kidney|kidney
5715582|NCT00445809|Renal|renal
5715583|NCT00445809|Cardiac Surgery with bypass|cardiac surgery with bypass
5715584|NCT00445809|Cardiovascular surgery with cardiopulmonary bypass|cardiovascular surgery with cardiopulmonary bypass
5715585|NCT00445783|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
5715586|NCT00445783|stage IV melanoma|stage iv melanoma
5715587|NCT00445783|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
5715588|NCT00445783|nodular malignant melanoma|nodular malignant melanoma
5715589|NCT00445783|stage IA melanoma|stage ia melanoma
5715590|NCT00445783|stage IB melanoma|stage ib melanoma
5715591|NCT00445783|stage IIA melanoma|stage iia melanoma
5715592|NCT00445783|stage IIB melanoma|stage iib melanoma
5715593|NCT00445783|stage IIC melanoma|stage iic melanoma
5715594|NCT00445783|stage IIIA melanoma|stage iiia melanoma
5715595|NCT00445783|stage IIIB melanoma|stage iiib melanoma
5715596|NCT00445783|stage IIIC melanoma|stage iiic melanoma
5715597|NCT00445770|Rheumatoid Arthritis|rheumatoid arthritis
5715598|NCT00445770|Arthritis|arthritis
5715599|NCT00445757|stage I renal cell cancer|stage i renal cell cancer
5715600|NCT00445757|stage II renal cell cancer|stage ii renal cell cancer
5715601|NCT00445731|poor performance status|poor performance status
5715602|NCT00445731|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5710598|NCT00462774|Heart failure|heart failure
5715603|NCT00445731|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5715604|NCT00445731|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5715605|NCT00445731|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5715606|NCT00445731|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5715607|NCT00445731|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5715608|NCT00445731|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5715609|NCT00445731|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5715610|NCT00445731|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5715611|NCT00445731|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5715612|NCT00445731|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5715614|NCT00445731|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5715615|NCT00445731|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5715616|NCT00445731|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5715617|NCT00445731|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5685890|NCT00554411|tear film break up time|tear film break up time
5685891|NCT00554398|Raltegravir|raltegravir
5715618|NCT00445731|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5715619|NCT00445731|disseminated neuroblastoma|disseminated neuroblastoma
5715620|NCT00445731|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5715621|NCT00445731|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5715622|NCT00445731|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5715623|NCT00445731|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5715624|NCT00445731|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5715625|NCT00445731|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5715626|NCT00445731|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5715627|NCT00445731|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5715628|NCT00445731|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5715629|NCT00445731|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5715630|NCT00445731|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5715631|NCT00445731|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5715632|NCT00445731|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5680621|NCT00577278|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5680622|NCT00577278|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5680623|NCT00577278|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5715633|NCT00445731|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5715634|NCT00445731|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5715635|NCT00445731|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5715636|NCT00445731|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5715637|NCT00445731|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5715638|NCT00445731|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5715639|NCT00445731|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5715640|NCT00445731|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5715641|NCT00445731|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5715642|NCT00445731|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5715643|NCT00445731|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5715644|NCT00445731|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5715645|NCT00445731|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5715646|NCT00445731|recurrent breast cancer|recurrent breast cancer
5715965|NCT00445081|SCORAD|scorad
5715647|NCT00445731|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5715648|NCT00445731|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5715649|NCT00445731|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5715650|NCT00445731|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5798813|NCT00110942|anakinra|anakinra
5715651|NCT00445731|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5715652|NCT00445731|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5715653|NCT00445731|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5715654|NCT00445731|recurrent neuroblastoma|recurrent neuroblastoma
5715655|NCT00445731|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5715656|NCT00445731|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5715657|NCT00445731|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5715658|NCT00445731|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5715659|NCT00445731|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5715661|NCT00445731|refractory multiple myeloma|refractory multiple myeloma
5705752|NCT00480558|HIV|hiv
5715662|NCT00445731|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5715744|NCT00445523|metastatic renal cancer|metastatic renal cancer
5715663|NCT00445731|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5715664|NCT00445731|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5715665|NCT00445731|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5715666|NCT00445731|stage I multiple myeloma|stage i multiple myeloma
5715667|NCT00445731|stage II multiple myeloma|stage ii multiple myeloma
5715668|NCT00445731|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5715669|NCT00445731|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5715670|NCT00445731|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5715671|NCT00445731|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5685892|NCT00554398|MK-0518|mk-0518
5715672|NCT00445731|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5715673|NCT00445731|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5715674|NCT00445731|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5715675|NCT00445731|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5715676|NCT00445731|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5715677|NCT00445731|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5715678|NCT00445731|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5715679|NCT00445731|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5715680|NCT00445731|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5715681|NCT00445731|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5715682|NCT00445731|stage III multiple myeloma|stage iii multiple myeloma
5715683|NCT00445731|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5715684|NCT00445731|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5715685|NCT00445731|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5715686|NCT00445731|stage IIIA breast cancer|stage iiia breast cancer
5715687|NCT00445731|stage IIIB breast cancer|stage iiib breast cancer
5715688|NCT00445731|stage IIIC breast cancer|stage iiic breast cancer
5715689|NCT00445731|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5715690|NCT00445731|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5715691|NCT00445731|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5715692|NCT00445731|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5715693|NCT00445731|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5715694|NCT00445731|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5715695|NCT00445731|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5715696|NCT00445731|stage IV breast cancer|stage iv breast cancer
5715697|NCT00445731|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5715698|NCT00445731|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5715699|NCT00445731|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5715700|NCT00445731|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5715701|NCT00445731|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5715702|NCT00445731|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5715703|NCT00445731|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5715704|NCT00445731|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5715705|NCT00445679|major depressive disorder|major depressive disorder
5715707|NCT00445679|depression|depression
5715708|NCT00445653|Barrett esophagus|barrett esophagus
5715709|NCT00445627|Type 2 Diabetes|type 2 diabetes
5715710|NCT00445627|Obesity|obesity
5715713|NCT00445614|cardiovascular risk|cardiovascular risk
5715714|NCT00445614|inflammation|inflammation
5715715|NCT00445614|vascular function|vascular function
5715716|NCT00445601|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5715717|NCT00445601|stage 0 bladder cancer|stage 0 bladder cancer
5715718|NCT00445601|stage I bladder cancer|stage i bladder cancer
5715719|NCT00445601|recurrent bladder cancer|recurrent bladder cancer
5715720|NCT00445575|fibrous dysplasia of bone|fibrous dysplasia of bone
5715721|NCT00445575|Mac Cune Albright syndrome|mac cune albright syndrome
5715722|NCT00445575|bisphosphonates|bisphosphonates
5715723|NCT00445575|risedronate|risedronate
5715724|NCT00445562|male breast cancer|male breast cancer
5798814|NCT00110942|Amgen|amgen
5715725|NCT00445562|recurrent breast cancer|recurrent breast cancer
5715726|NCT00445562|stage IA breast cancer|stage ia breast cancer
5715727|NCT00445562|stage IB breast cancer|stage ib breast cancer
5715728|NCT00445562|stage II breast cancer|stage ii breast cancer
5715729|NCT00445562|stage IIIA breast cancer|stage iiia breast cancer
5715730|NCT00445562|stage IIIB breast cancer|stage iiib breast cancer
5715731|NCT00445562|stage IIIC breast cancer|stage iiic breast cancer
5715732|NCT00445562|stage IV breast cancer|stage iv breast cancer
5715733|NCT00445549|Ovarian|ovarian
5715734|NCT00445549|VEGFR2|vegfr2
5715735|NCT00445549|EGFR|egfr
5715736|NCT00445549|Angiogenesis|angiogenesis
5715737|NCT00445549|Tyrosine Kinase|tyrosine kinase
5715738|NCT00445549|Protein Phosphorylation|protein phosphorylation
5715739|NCT00445549|Vandetanib|vandetanib
5715740|NCT00445549|Ovarian Cancer|ovarian cancer
5715741|NCT00445549|Fallopian Tube Cancer|fallopian tube cancer
5715742|NCT00445549|Peritoneal Cancer|peritoneal cancer
5715743|NCT00445523|Advanced renal cancer|advanced renal cancer
5715746|NCT00445523|kidney cancer|kidney cancer
5715747|NCT00445523|M3thodist|m3thodist
5715748|NCT00445510|GSK256066,|gsk256066,
5715749|NCT00445510|allergen,|allergen,
5715750|NCT00445510|challenge,|challenge,
5715751|NCT00445510|repeat dose,|repeat dose,
5715752|NCT00445510|AMP,|amp,
5715753|NCT00445510|mild asthmatics|mild asthmatics
5715754|NCT00445497|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5715755|NCT00445497|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5685893|NCT00554398|Treatment intensification|treatment intensification
5685894|NCT00554398|HIV-1 latency|hiv-1 latency
5685895|NCT00554398|HIV eradication|hiv eradication
5685896|NCT00554398|treatment experienced|treatment experienced
5685897|NCT00554372|Jennerex|jennerex
5685898|NCT00554372|HCC|hcc
5680613|NCT00577278|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5715756|NCT00445497|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5715757|NCT00445497|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5715758|NCT00445497|intraocular lymphoma|intraocular lymphoma
5715759|NCT00445497|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5715760|NCT00445497|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5715761|NCT00445497|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5715762|NCT00445497|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5715763|NCT00445497|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5715764|NCT00445497|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5715765|NCT00445497|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5715766|NCT00445497|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5715767|NCT00445497|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5715768|NCT00445497|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5715769|NCT00445497|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5680624|NCT00577278|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5680625|NCT00577278|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5680626|NCT00577278|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5680627|NCT00577278|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5680628|NCT00577278|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5681151|NCT00574522|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5715770|NCT00445497|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5715771|NCT00445497|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5715772|NCT00445497|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5715773|NCT00445497|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5715774|NCT00445497|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5715775|NCT00445497|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5715776|NCT00445497|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5715777|NCT00445497|small intestine lymphoma|small intestine lymphoma
5715778|NCT00445497|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5715779|NCT00445497|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5715780|NCT00445497|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5715781|NCT00445497|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5715782|NCT00445497|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5715783|NCT00445497|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5715784|NCT00445497|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5715785|NCT00445497|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5715786|NCT00445497|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5715787|NCT00445497|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5715788|NCT00445497|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5715789|NCT00445497|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5715790|NCT00445497|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5715791|NCT00445497|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5715792|NCT00445497|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5715793|NCT00445497|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5715794|NCT00445497|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5715795|NCT00445497|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5715796|NCT00445497|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5715797|NCT00445497|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5715798|NCT00445497|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5715799|NCT00445497|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5715800|NCT00445497|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5715801|NCT00445497|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5715802|NCT00445497|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5715803|NCT00445497|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5715804|NCT00445497|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5715805|NCT00445497|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5715806|NCT00445497|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5715807|NCT00445497|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5715808|NCT00445497|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5715809|NCT00445497|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5715810|NCT00445497|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5715811|NCT00445497|Waldenström macroglobulinemia|waldenström macroglobulinemia
5715812|NCT00445497|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5715814|NCT00445497|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5715815|NCT00445497|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5715816|NCT00445497|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5715817|NCT00445497|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5715818|NCT00445497|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5715819|NCT00445497|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5715820|NCT00445497|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5680629|NCT00577278|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5680630|NCT00577278|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5680631|NCT00577278|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5715821|NCT00445497|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5715822|NCT00445497|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5715823|NCT00445497|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5715824|NCT00445497|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5715825|NCT00445497|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5715826|NCT00445497|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5715827|NCT00445497|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5715828|NCT00445497|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5715829|NCT00445497|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5715830|NCT00445497|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5715831|NCT00445497|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5715832|NCT00445497|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5715833|NCT00445497|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5715834|NCT00445497|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5715835|NCT00445497|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5715836|NCT00445497|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5715837|NCT00445497|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5715838|NCT00445497|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5715839|NCT00445497|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5715840|NCT00445497|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5715841|NCT00445497|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5715842|NCT00445497|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5715843|NCT00445497|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5715844|NCT00445497|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5715845|NCT00445497|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5715846|NCT00445497|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5715847|NCT00445497|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5715848|NCT00445497|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5715849|NCT00445497|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5715850|NCT00445497|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5715851|NCT00445497|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5715852|NCT00445497|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5715853|NCT00445497|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5715854|NCT00445497|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5715855|NCT00445497|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5715856|NCT00445484|stage II multiple myeloma|stage ii multiple myeloma
5715857|NCT00445484|stage III multiple myeloma|stage iii multiple myeloma
5715858|NCT00445484|refractory multiple myeloma|refractory multiple myeloma
5715859|NCT00445471|Autism Spectrum Disorder|autism spectrum disorder
5740309|NCT00357071|Uveitis|uveitis
5715860|NCT00445471|Autistic Disorder|autistic disorder
5715861|NCT00445471|Pervasive Developmental Disorder|pervasive developmental disorder
5715862|NCT00445458|cancer|cancer
5715863|NCT00445458|HKI-272|hki-272
5715864|NCT00445458|neratinib|neratinib
5715865|NCT00445458|paclitaxel|paclitaxel
5715866|NCT00445458|Taxol|taxol
5715867|NCT00445458|breast cancer|breast cancer
5715868|NCT00445458|Nerlynx|nerlynx
5715869|NCT00445445|stage I breast cancer|stage i breast cancer
5715870|NCT00445445|stage II breast cancer|stage ii breast cancer
5715871|NCT00445445|stage IIIA breast cancer|stage iiia breast cancer
5715872|NCT00445445|stage IIIB breast cancer|stage iiib breast cancer
5715873|NCT00445445|stage IIIC breast cancer|stage iiic breast cancer
5715874|NCT00445445|stage IV breast cancer|stage iv breast cancer
5715875|NCT00445445|recurrent breast cancer|recurrent breast cancer
5715876|NCT00445445|breast cancer in situ|breast cancer in situ
5715877|NCT00445419|Hepatitis C|hepatitis c
5715878|NCT00445419|Liver disease|liver disease
5715879|NCT00445419|Viral infection|viral infection
5715880|NCT00445419|Virosome|virosome
5715881|NCT00445419|Vaccine|vaccine
5715882|NCT00445419|therapeutic vaccine|therapeutic vaccine
5715883|NCT00445419|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
5715884|NCT00445406|recurrent breast cancer|recurrent breast cancer
5715885|NCT00445406|stage IV breast cancer|stage iv breast cancer
5715886|NCT00445393|Observation|observation
5715887|NCT00445393|Mental health|mental health
5715888|NCT00445393|Scoliosis|scoliosis
5715889|NCT00445393|Screening|screening
5715890|NCT00445393|Adolescent idiopathic scoliosis|adolescent idiopathic scoliosis
5715891|NCT00445367|Multiple Sclerosis|multiple sclerosis
5715892|NCT00445367|Clinically Isolated Syndrome|clinically isolated syndrome
5715893|NCT00445367|Transverse Myelitis|transverse myelitis
5715894|NCT00445367|Neuromyelitis Optica|neuromyelitis optica
5715895|NCT00445367|Acute Disseminated Encephalomyelitis|acute disseminated encephalomyelitis
5715896|NCT00445367|Optic Neuritis|optic neuritis
5715897|NCT00445367|Repository|repository
5715898|NCT00445367|Biobank|biobank
5715899|NCT00445354|cinnamon|cinnamon
5715900|NCT00445354|diabetes|diabetes
5715901|NCT00445354|hemoglobin a1c|hemoglobin a1c
5715902|NCT00445341|Microarray|microarray
5715903|NCT00445341|Proteomics|proteomics
5715904|NCT00445341|Hybrid Schedule|hybrid schedule
5715905|NCT00445341|Tumor Lysis Syndrome|tumor lysis syndrome
5715906|NCT00445341|Cyclin D1|cyclin d1
5715907|NCT00445341|Lymphoma|lymphoma
5715908|NCT00445341|Mantle Cell Lymphoma|mantle cell lymphoma
5715910|NCT00445341|Diffuse Large B-Cell Lymphoma|diffuse large b-cell lymphoma
5715911|NCT00445341|DLBCL|dlbcl
5715912|NCT00445328|hospitalised acutely medically ill patients; Venous Thromboembolism, Infection, Inflammatory Bowel Diseases, Heart Failure, Congestive, Sciatica|hospitalised acutely medically ill patients; venous thromboembolism, infection, inflammatory bowel diseases, heart failure, congestive, sciatica
5715913|NCT00445302|AMD3100|amd3100
5715914|NCT00445289|mechanical ventilation|mechanical ventilation
5715915|NCT00445289|ventilator weaning|ventilator weaning
5715916|NCT00445289|closed-loop|closed-loop
5715917|NCT00445289|ventilation time|ventilation time
5715918|NCT00445276|Osteoarthritis|osteoarthritis
5715919|NCT00445276|Knee|knee
5715920|NCT00445276|Diacerein|diacerein
5715921|NCT00445276|Painful osteoarthritis|painful osteoarthritis
5715922|NCT00445276|Clinical trial|clinical trial
5715923|NCT00445263|CORONARY DISEASE|coronary disease
5715924|NCT00445250|Calcipotriol|calcipotriol
5715925|NCT00445250|Breast|breast
5715926|NCT00445250|Cancer|cancer
5715927|NCT00445250|Radiotherapy|radiotherapy
5715928|NCT00445250|Radiodermatitis in Breast Cancer|radiodermatitis in breast cancer
5715929|NCT00445237|major depression|major depression
5715931|NCT00445224|Knee pain|knee pain
5715932|NCT00445224|Rehabilitation|rehabilitation
5715933|NCT00445211|Intraaortic balloon pumping|intraaortic balloon pumping
5715934|NCT00445211|Heparin|heparin
5715935|NCT00445211|Limb ischemia|limb ischemia
5715936|NCT00445211|Bleeding|bleeding
5715937|NCT00445198|SCLC|sclc
5715938|NCT00445185|Dialysis|dialysis
5715939|NCT00445185|Pre-dialysis|pre-dialysis
5715940|NCT00445185|Hepatitis B vaccine|hepatitis b vaccine
5715941|NCT00445185|vaccine|vaccine
5715942|NCT00445172|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5715943|NCT00445172|Motor Neurons|motor neurons
5715944|NCT00445172|Muscular Atrophy|muscular atrophy
5715945|NCT00445159|UT-15C SR, Peripheral Vascular Disease, treprostinil|ut-15c sr, peripheral vascular disease, treprostinil
5715948|NCT00445146|Rollover|rollover
5715949|NCT00445146|Integrase Inhibitor|integrase inhibitor
5715950|NCT00445146|Antiretroviral Agents|antiretroviral agents
5715951|NCT00445146|Highly Active Antiretroviral Activity|highly active antiretroviral activity
5715952|NCT00445146|HAART|haart
5715953|NCT00445146|HIV, HIV-1, AIDS virus, Human Immunodeficiency Virus|hiv, hiv-1, aids virus, human immunodeficiency virus
5798816|NCT00110929|Secondary HPT|secondary hpt
5715954|NCT00445146|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5715955|NCT00445146|treatment experienced|treatment experienced
5798812|NCT00110942|OA|oa
5715956|NCT00445133|Neck Pain/Lumbar pain/Magnets/sleep deficiency/ insomnia/|neck pain/lumbar pain/magnets/sleep deficiency/ insomnia/
5715957|NCT00445120|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5715958|NCT00445120|probiotic|probiotic
5715959|NCT00445120|Lactobacillus Rhamnosus GG|lactobacillus rhamnosus gg
5715960|NCT00445120|Children|children
5715961|NCT00445120|Clinical trial|clinical trial
5715962|NCT00445081|atopic dermatitis|atopic dermatitis
5715963|NCT00445081|prednisolone|prednisolone
5715966|NCT00445081|DLQI|dlqi
5715967|NCT00445081|QALY|qaly
5715969|NCT00445068|Multiple myeloma|multiple myeloma
5715970|NCT00445068|adults|adults
5715971|NCT00445068|LBH589|lbh589
5715972|NCT00445068|refractory|refractory
5715973|NCT00445055|Thyroidectomy|thyroidectomy
5715974|NCT00445055|Nausea|nausea
5715975|NCT00445055|Vomiting|vomiting
5715976|NCT00445055|Droperidol|droperidol
5715977|NCT00445042|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5715978|NCT00445042|Metastatic RCC|metastatic rcc
5715979|NCT00445042|Kidney Cancer|kidney cancer
5715980|NCT00445042|M3thodist|m3thodist
5715981|NCT00445029|Allergic contact dermatitis|allergic contact dermatitis
5715982|NCT00445029|para-phenylenediamine|para-phenylenediamine
5715983|NCT00445029|effector cells|effector cells
5724854|NCT00414518|ART|art
5715984|NCT00445029|regulatory cells|regulatory cells
5715985|NCT00445029|pathophysiology|pathophysiology
5715986|NCT00445016|peripheral regional anesthesia|peripheral regional anesthesia
5715987|NCT00445016|nerve damage|nerve damage
5715988|NCT00445016|adverse effects|adverse effects
5715989|NCT00445016|neurologic complication|neurologic complication
5715990|NCT00445016|neuropathy|neuropathy
5715991|NCT00445003|Diabetic Retinopathy|diabetic retinopathy
5715992|NCT00445003|Diabetic Macular Edema|diabetic macular edema
5715993|NCT00445003|Lucentis|lucentis
5715994|NCT00445003|Ranibizumab|ranibizumab
5715995|NCT00445003|Triamcinolone|triamcinolone
5715996|NCT00445003|Panretinal Photocoagulation|panretinal photocoagulation
5715997|NCT00445003|Combination Therapy|combination therapy
5715998|NCT00445003|pdr|pdr
5715999|NCT00444990|Lumbar pain|lumbar pain
5716000|NCT00444990|magnets|magnets
5716001|NCT00444990|Reduce low back pain|reduce low back pain
5716002|NCT00444977|HIV positive persons|hiv positive persons
5716003|NCT00444977|Not received oral health care in the preceding 12 months.|not received oral health care in the preceding 12 months.
5716004|NCT00444977|treatment naive|treatment naive
5716005|NCT00444977|treatment experienced|treatment experienced
5716006|NCT00444951|N meningitidis|n meningitidis
5716007|NCT00444912|AMD3100|amd3100
5716008|NCT00444912|stem cell mobilization|stem cell mobilization
5716009|NCT00444912|autologous transplant|autologous transplant
5716010|NCT00444912|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5716011|NCT00444912|Hodgkin Disease|hodgkin disease
5716012|NCT00444899|Intensive treatment|intensive treatment
5716013|NCT00444899|dietician|dietician
5716014|NCT00444886|Thoracic Outlet Syndrome (TOS)|thoracic outlet syndrome (tos)
5716015|NCT00444886|Botulinum Toxin|botulinum toxin
5716016|NCT00444886|Botox|botox
5716017|NCT00444886|Pain|pain
5716018|NCT00444873|Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)|inappropriate growth hormone secretion syndrome (acromegaly)
5716019|NCT00444847|AIDS|aids
5716020|NCT00444847|HIV|hiv
5716021|NCT00444847|Hyperbaric Chamber|hyperbaric chamber
5716022|NCT00444847|treatment experienced|treatment experienced
5716023|NCT00444821|AAA|aaa
5716024|NCT00444821|Aneurysm|aneurysm
5716025|NCT00444821|AneuRx|aneurx
5716026|NCT00444821|Talent|talent
5716027|NCT00444808|Rib fracture|rib fracture
5716028|NCT00444808|Pain|pain
5716029|NCT00444808|intranasal calcitonin|intranasal calcitonin
5716030|NCT00444795|SUTENE|sutene
5716031|NCT00444795|post-marketing surveillance|post-marketing surveillance
5716032|NCT00444795|GIST|gist
5716033|NCT00444795|RCC|rcc
5716034|NCT00444795|Korea|korea
5716035|NCT00444782|Advanced Carcinoma, Hepatocellular|advanced carcinoma, hepatocellular
5716036|NCT00444769|analgesia|analgesia
5716037|NCT00444769|post-operative pain|post-operative pain
5716038|NCT00444769|GW842166|gw842166
5716039|NCT00444769|non-cannabinoid agonist|non-cannabinoid agonist
5716040|NCT00444769|third molar tooth extraction|third molar tooth extraction
5716041|NCT00444756|local anesthesia|local anesthesia
5716042|NCT00444756|analgesia|analgesia
5716043|NCT00444756|peripheral IV|peripheral iv
5716044|NCT00444756|Local anesthesia prior to peripheral IV insertion|local anesthesia prior to peripheral iv insertion
5716045|NCT00444730|Prostate Cancer|prostate cancer
5716046|NCT00444730|Prostatectomy|prostatectomy
5716047|NCT00444730|Pelvic pain|pelvic pain
5716048|NCT00444730|urgency|urgency
5716049|NCT00444730|incontinence|incontinence
5716050|NCT00444730|frequency|frequency
5716051|NCT00444717|statin|statin
5716052|NCT00444717|metabolic syndrome|metabolic syndrome
5716053|NCT00444717|oxidative stress|oxidative stress
5716055|NCT00444691|synovitis score|synovitis score
5716059|NCT00444678|Previously untreated metastatic colorectal cancer|previously untreated metastatic colorectal cancer
5716061|NCT00444678|combined therapy|combined therapy
5715072|NCT00446758|HIV|hiv
5716062|NCT00444678|biologics therapy|biologics therapy
5716063|NCT00444678|antibody|antibody
5716064|NCT00444678|chemotherapy|chemotherapy
5716065|NCT00444678|EGFR|egfr
5716066|NCT00444665|Glaucoma|glaucoma
5716067|NCT00444652|Thromboprophylaxis|thromboprophylaxis
5716068|NCT00444652|Bariatric surgery|bariatric surgery
5716069|NCT00444652|prevention of venous thromboembolism in bariatric surgery|prevention of venous thromboembolism in bariatric surgery
5716070|NCT00444626|nasolabial folds|nasolabial folds
5716071|NCT00444626|facial wrinkles|facial wrinkles
5716072|NCT00444613|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5716073|NCT00444613|motor neurons|motor neurons
5716074|NCT00444613|muscular atrophy|muscular atrophy
5716075|NCT00444613|Lou Gehrig's Disease|lou gehrig's disease
5716076|NCT00444600|Diabetic Retinopathy|diabetic retinopathy
5716077|NCT00444600|Diabetic Macular Edema|diabetic macular edema
5716078|NCT00444600|Lucentis|lucentis
5716079|NCT00444600|Ranibizumab|ranibizumab
5716080|NCT00444600|Triamcinolone|triamcinolone
5716081|NCT00444600|Laser photocoagulation|laser photocoagulation
5716460|NCT00020345|cancer|cancer
5716082|NCT00444600|Combination Therapy|combination therapy
5716083|NCT00444574|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5716084|NCT00444561|pramlintide|pramlintide
5716085|NCT00444561|Symlin|symlin
5716086|NCT00444561|Amylin|amylin
5716087|NCT00444548|Equipment|equipment
5716088|NCT00444548|Supplies|supplies
5716089|NCT00444535|VEGF|vegf
5716090|NCT00444535|Tyrosine kinase|tyrosine kinase
5716091|NCT00444535|ErbB2|erbb2
5716092|NCT00444535|Her2-neu|her2-neu
5716093|NCT00444535|metastatic breast cancer|metastatic breast cancer
5716094|NCT00444535|EGFR|egfr
5716095|NCT00444535|ErbB1|erbb1
5716096|NCT00444535|bevacizumab|bevacizumab
5716097|NCT00444535|lapatinib|lapatinib
5716098|NCT00444522|Panic attacks, Staccato® Alprazolam|panic attacks, staccato® alprazolam
5716099|NCT00444509|Asthmatic Patients|asthmatic patients
5716100|NCT00444470|tranexamic acid|tranexamic acid
5716101|NCT00444470|safety|safety
5716102|NCT00444470|efficacy|efficacy
5716103|NCT00444470|spine surgery|spine surgery
5716104|NCT00444470|spinal fusion and decompression|spinal fusion and decompression
5716105|NCT00444470|adult|adult
5716106|NCT00444470|perioperative|perioperative
5716107|NCT00444470|blood loss|blood loss
5716108|NCT00444470|bleeding|bleeding
5716109|NCT00444470|blood transfusion|blood transfusion
5716110|NCT00444457|Vaccine|vaccine
5716111|NCT00444457|Infants|infants
5716112|NCT00444457|Pneumococcal Conjugate Vaccines|pneumococcal conjugate vaccines
5716113|NCT00444457|Vaccines, Pneumococcal|vaccines, pneumococcal
5716114|NCT00444444|Autoimmune pancreatitis, HLA, relapse, Sequence-based typing|autoimmune pancreatitis, hla, relapse, sequence-based typing
5716115|NCT00444418|Drinking|drinking
5716116|NCT00444418|Alcohol problems|alcohol problems
5716117|NCT00444418|Alcoholism|alcoholism
5716118|NCT00444418|Gay men|gay men
5716119|NCT00444418|Bisexual men|bisexual men
5716120|NCT00444418|Moderation-oriented treatment|moderation-oriented treatment
5716121|NCT00444418|Controlled drinking|controlled drinking
5716122|NCT00444418|Non-abstinence based treatment|non-abstinence based treatment
5716129|NCT00444392|Obese|obese
5716130|NCT00444392|type 2 Diabetes Mellitus|type 2 diabetes mellitus
5716131|NCT00444392|Gastric Bypass Surgery|gastric bypass surgery
5716132|NCT00444392|Risk of CVD|risk of cvd
5716133|NCT00444379|Kaposi's sarcoma|kaposi's sarcoma
5716134|NCT00444379|KSHV|kshv
5716135|NCT00444379|AIDS|aids
5716136|NCT00444379|HHV-8|hhv-8
5716137|NCT00444379|treatment naive|treatment naive
5716138|NCT00444327|single nucleotide polymorphism|single nucleotide polymorphism
5716139|NCT00444301|Heart failure|heart failure
5716140|NCT00444301|Pain|pain
5716141|NCT00444301|Symptoms|symptoms
5716142|NCT00444301|Advanced heart failure|advanced heart failure
5716143|NCT00444301|Pain frequency, severity, location, treatments|pain frequency, severity, location, treatments
5716144|NCT00444301|Shortness of breath, anxiety, depression, cognitive function|shortness of breath, anxiety, depression, cognitive function
5716145|NCT00444301|Social support, other conditions and illnesses|social support, other conditions and illnesses
5716146|NCT00444288|Cystic Ovaries|cystic ovaries
5716147|NCT00444288|Hyperandrogenism|hyperandrogenism
5716148|NCT00444288|Anovulation|anovulation
5716149|NCT00444288|Concordance Rates|concordance rates
5716150|NCT00444288|Baseline Heritability|baseline heritability
5716151|NCT00444288|Polycystic Ovary Syndrome|polycystic ovary syndrome
5716153|NCT00444275|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5716154|NCT00444275|Acid Reflux|acid reflux
5716155|NCT00444262|Hemodynamic optimisation|hemodynamic optimisation
5716156|NCT00444262|Esophageal Doppler|esophageal doppler
5716157|NCT00444262|Hydroxy ethyl starch|hydroxy ethyl starch
5716158|NCT00444262|Hip fracture|hip fracture
5716159|NCT00444262|Outcome|outcome
5711323|NCT00460148|PD|pd
5716160|NCT00444262|Elderly subjects (≥ 70 year old)|elderly subjects (≥ 70 year old)
5716161|NCT00444262|General anesthesia|general anesthesia
5716162|NCT00444249|age-related macular degeneration|age-related macular degeneration
5715108|NCT00446602|MDS|mds
5716163|NCT00444249|melatonin|melatonin
5716164|NCT00444249|blue-light filter|blue-light filter
5716165|NCT00444236|asthma|asthma
5716166|NCT00444236|GERD|gerd
5716167|NCT00444236|reflux|reflux
5716168|NCT00444236|exercise|exercise
5716169|NCT00444223|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5716170|NCT00444223|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5716171|NCT00444223|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5716172|NCT00444184|travoprost/timolol fixed combination|travoprost/timolol fixed combination
5716173|NCT00444171|critically ill|critically ill
5716174|NCT00444171|insulin resistance|insulin resistance
5716175|NCT00444171|intensive insulin therapy|intensive insulin therapy
5716176|NCT00444171|computer algorithm|computer algorithm
5716177|NCT00444158|opioids|opioids
5716178|NCT00444158|chronic pain|chronic pain
5716179|NCT00444132|clopidogrel|clopidogrel
5716180|NCT00444132|platelets|platelets
5716181|NCT00444132|acute coronary syndrome|acute coronary syndrome
5716182|NCT00444132|percutaneous coronary intervention|percutaneous coronary intervention
5716183|NCT00444119|adrenal insufficiency|adrenal insufficiency
5716184|NCT00444119|subjective health status|subjective health status
5716185|NCT00444119|quality of life|quality of life
5716186|NCT00444119|adrenal crisis|adrenal crisis
5716187|NCT00444119|hormone replacement|hormone replacement
5716189|NCT00444106|Malaria|malaria
5716190|NCT00444106|hearing|hearing
5716191|NCT00444106|co-artemether|co-artemether
5716192|NCT00444106|auditory|auditory
5716193|NCT00444106|Plasmodium falciparum|plasmodium falciparum
5716194|NCT00444106|marsh fever|marsh fever
5716195|NCT00444106|Plasmodium infections|plasmodium infections
5716196|NCT00444106|remittent fever|remittent fever
5716197|NCT00444106|paludism|paludism
5716198|NCT00444106|artemether|artemether
5716199|NCT00444106|artemisinins|artemisinins
5716200|NCT00444106|benflumetol|benflumetol
5716201|NCT00444106|lumefantrine|lumefantrine
5716202|NCT00444093|radiation therapy|radiation therapy
5716203|NCT00444093|diarrhea|diarrhea
5716204|NCT00444093|enteritis|enteritis
5716205|NCT00444093|supportive therapy|supportive therapy
5716206|NCT00444093|therapy associated diarrhea|therapy associated diarrhea
5716207|NCT00444093|therapy associated enteritis|therapy associated enteritis
5716208|NCT00444093|radiation therapy of the small pelvis|radiation therapy of the small pelvis
5716209|NCT00444080|Ex-PRESS|ex-press
5716210|NCT00444080|TRABECULECTOMY|trabeculectomy
5716211|NCT00444067|Prevention of CSF leak|prevention of csf leak
5716212|NCT00444054|Diet|diet
5716213|NCT00444054|Cancer|cancer
5716214|NCT00444054|Alternative|alternative
5716215|NCT00444054|Breast|breast
5716216|NCT00444054|Colon|colon
5716217|NCT00444054|Cervix|cervix
5716218|NCT00444054|Uterus|uterus
5716219|NCT00444054|Ovary|ovary
5716220|NCT00444054|Metastatic|metastatic
5716221|NCT00444054|Nutrition|nutrition
5716222|NCT00444054|Carbohydrate|carbohydrate
5716223|NCT00444041|metastatic colorectal cancer|metastatic colorectal cancer
5716224|NCT00444041|surgery|surgery
5716225|NCT00444041|chemotherapy|chemotherapy
5716226|NCT00444028|Schizophrenia, Staccato Loxapine|schizophrenia, staccato loxapine
5716227|NCT00444015|Erlotinib|erlotinib
5716228|NCT00444015|Dasatinib|dasatinib
5716229|NCT00444015|Epidermal growth factor receptor (EGFR)|epidermal growth factor receptor (egfr)
5716230|NCT00444015|Tyrosine kinase|tyrosine kinase
5716231|NCT00444015|NSCLC|nsclc
5716232|NCT00444015|Pharmacokinetics (PK)|pharmacokinetics (pk)
5716233|NCT00444015|Lung|lung
5716234|NCT00444002|Hepatitis C|hepatitis c
5716235|NCT00444002|Steatosis|steatosis
5716236|NCT00444002|Oxidative Stress|oxidative stress
5716237|NCT00444002|Antioxidants|antioxidants
5716238|NCT00444002|Inflammation|inflammation
5716239|NCT00444002|Fatty acids|fatty acids
5716240|NCT00443989|Perioperative Myocardial Infarction|perioperative myocardial infarction
5716241|NCT00443989|Stroke|stroke
5716242|NCT00443989|Cardiac Death|cardiac death
5716243|NCT00443989|Cardiac Arrest|cardiac arrest
5716244|NCT00443989|Troponin-T|troponin-t
5716245|NCT00443989|Non-Cardiac surgery|non-cardiac surgery
5716246|NCT00443989|Death|death
5716247|NCT00443976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5716248|NCT00443976|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5716249|NCT00443976|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5716250|NCT00443976|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5716251|NCT00443976|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5716252|NCT00443976|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5716253|NCT00443976|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5716254|NCT00443976|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5716255|NCT00443976|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5716256|NCT00443976|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5716257|NCT00443976|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5716258|NCT00443976|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5716259|NCT00443976|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5716260|NCT00443976|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5716261|NCT00443976|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5716262|NCT00443976|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5716263|NCT00443976|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5716264|NCT00443976|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5716265|NCT00443976|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5716266|NCT00443976|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5716267|NCT00443976|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5716268|NCT00443976|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5716269|NCT00443976|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5716270|NCT00443976|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5717204|NCT00441636|depression|depression
5716271|NCT00443976|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5716272|NCT00443976|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5716273|NCT00443976|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5680632|NCT00577278|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5680633|NCT00577278|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5680634|NCT00577265|Asthma Control|asthma control
5680635|NCT00577252|Cystic fibrosis|cystic fibrosis
5716274|NCT00443976|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5716275|NCT00443976|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5716276|NCT00443976|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5716277|NCT00443976|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5716278|NCT00443976|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5716279|NCT00443976|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5716280|NCT00443976|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5716281|NCT00443976|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5716282|NCT00443976|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5716283|NCT00443976|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5716284|NCT00443976|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5716285|NCT00443976|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5716286|NCT00443976|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5716287|NCT00443976|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5716288|NCT00443976|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5716289|NCT00443976|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5716290|NCT00443963|Dyspepsia in patients taking NSAIDs|dyspepsia in patients taking nsaids
5716291|NCT00443950|Arthritis|arthritis
5716292|NCT00443950|Chinese|chinese
5716293|NCT00443937|Kidney Transplantation|kidney transplantation
5716294|NCT00443937|Renal Transplantation|renal transplantation
5716295|NCT00443937|Mycophenolate|mycophenolate
5716296|NCT00443937|Cyclosporine|cyclosporine
5716297|NCT00443937|Everolimus|everolimus
5716298|NCT00443924|Bilateral ocular hypertension or early primary open angle glaucoma|bilateral ocular hypertension or early primary open angle glaucoma
5716299|NCT00443911|age-related macular degeneration, rheopheresis, lutein|age-related macular degeneration, rheopheresis, lutein
5716300|NCT00443898|Toenail fungus|toenail fungus
5716301|NCT00443898|Onychomycosis|onychomycosis
5716302|NCT00443898|Nail fungus|nail fungus
5716303|NCT00443898|Toenail fungal infection|toenail fungal infection
5716304|NCT00443898|Tinea unguium|tinea unguium
5716305|NCT00443898|Dermatophytes|dermatophytes
5716306|NCT00443898|Foot dermatoses|foot dermatoses
5716307|NCT00443885|meropenem|meropenem
5716308|NCT00443885|imipenem|imipenem
5716309|NCT00443885|gram negative organism|gram negative organism
5716310|NCT00443872|Parkinson's disease|parkinson's disease
5716311|NCT00443872|Dopamine agonist adverse effects|dopamine agonist adverse effects
5716312|NCT00443872|MAO-B inhibitor|mao-b inhibitor
5716313|NCT00443872|orally disintegrating selegiline|orally disintegrating selegiline
5716314|NCT00443872|Zelapar|zelapar
5716315|NCT00443859|Persistent Pulmonary Hypertension|persistent pulmonary hypertension
5716316|NCT00443859|N-terminal pro brain natriuretic peptide|n-terminal pro brain natriuretic peptide
5716317|NCT00443846|Prevention of Gastroenteritis due to rotavirus infection. And prevention of Invasive disease caused by Neisseria meningitidis serogroup C.|prevention of gastroenteritis due to rotavirus infection. and prevention of invasive disease caused by neisseria meningitidis serogroup c.
5716318|NCT00443833|Thyrotoxicosis|thyrotoxicosis
5716322|NCT00443820|Toenail fungus|toenail fungus
5716323|NCT00443820|Onychomycosis|onychomycosis
5716325|NCT00443820|Toenail fungal infection|toenail fungal infection
5716326|NCT00443820|Tinea unguium|tinea unguium
5716328|NCT00443820|Foot dermatoses|foot dermatoses
5716329|NCT00443794|POLYCAP, Primary Prevention,CVD|polycap, primary prevention,cvd
5716330|NCT00443781|low back pain, degenerative disc disease|low back pain, degenerative disc disease
5716331|NCT00443768|Medication|medication
5716332|NCT00443768|Diagnosis|diagnosis
5716333|NCT00443768|Community|community
5716334|NCT00443755|Inflammatory cytokine|inflammatory cytokine
5716335|NCT00443755|Cardiovascular Disease|cardiovascular disease
5716336|NCT00443755|Thrombotic factors|thrombotic factors
5716337|NCT00443755|Dyslipidemia|dyslipidemia
5716338|NCT00443742|Depression|depression
5716339|NCT00443742|Validation|validation
5716340|NCT00443742|Adolescent|adolescent
5716341|NCT00443742|Validation of three key questions and questionnaire|validation of three key questions and questionnaire
5716342|NCT00443729|treatment experienced|treatment experienced
5716343|NCT00443703|treatment experienced|treatment experienced
5716344|NCT00443690|heart failure|heart failure
5716345|NCT00443690|diuretic|diuretic
5716346|NCT00443690|renal impairment|renal impairment
5716347|NCT00443690|renal function|renal function
5716348|NCT00443664|Primary Open Angle Glaucoma|primary open angle glaucoma
5716351|NCT00443651|DMARD|dmard
5716352|NCT00443651|Active Rheumatoid Arthritis|active rheumatoid arthritis
5716353|NCT00443625|SK3530|sk3530
5716354|NCT00443625|Food effect|food effect
5716355|NCT00443625|Pharmacokinetics|pharmacokinetics
5716360|NCT00443586|Nurse|nurse
5716361|NCT00443586|Home Visitation|home visitation
5716362|NCT00443586|Welfare|welfare
5716363|NCT00443586|Social Behavior|social behavior
5716364|NCT00443573|metastatic colorectal carcinoma (mCRC)|metastatic colorectal carcinoma (mcrc)
5716365|NCT00443573|colorectal carcinoma (CRC)|colorectal carcinoma (crc)
5716366|NCT00443573|tissue factor|tissue factor
5716367|NCT00443573|factor VIIa|factor viia
5716368|NCT00443573|rNAPc2|rnapc2
5716369|NCT00443573|adenocarcinoma|adenocarcinoma
5716370|NCT00443573|targeted therapy|targeted therapy
5716371|NCT00443573|coagulation-dependent|coagulation-dependent
5716372|NCT00443573|RECIST|recist
5716373|NCT00443573|5-FU-based chemotherapy|5-fu-based chemotherapy
5716374|NCT00443573|FOLFOX|folfox
5716375|NCT00443573|FOLFIRI|folfiri
5716376|NCT00443573|leucovorin|leucovorin
5716377|NCT00443573|XELOX|xelox
5716378|NCT00443560|Labor|labor
5716379|NCT00443560|Epidural Analgesia|epidural analgesia
5716380|NCT00443560|delivery|delivery
5716381|NCT00443560|vacuum extraction|vacuum extraction
5716382|NCT00443560|obstetrical Forceps|obstetrical forceps
5716383|NCT00443547|Prospective|prospective
5716384|NCT00443547|Degenerative Disc Disease|degenerative disc disease
5716385|NCT00443547|Cervical|cervical
5716386|NCT00443547|Translational Plate|translational plate
5716387|NCT00443521|Diabetes Mellitus/ complications|diabetes mellitus/ complications
5716388|NCT00443521|Diabetic Retinopathy|diabetic retinopathy
5716389|NCT00443521|Triamcinolone|triamcinolone
5716390|NCT00443521|Laser coagulation|laser coagulation
5716391|NCT00443521|Tomography, optical coherence|tomography, optical coherence
5716392|NCT00443508|everolimus|everolimus
5716393|NCT00443508|renal transplant|renal transplant
5716394|NCT00443508|tacrolimus|tacrolimus
5716395|NCT00443508|Certican|certican
5716396|NCT00443508|CHRONIC ALLOGRAFT NEPHROPATHY|chronic allograft nephropathy
5716397|NCT00443508|Renal transplant patients|renal transplant patients
5716398|NCT00443482|Asthma|asthma
5716399|NCT00443482|adults|adults
5716400|NCT00443482|B2 agonist|b2 agonist
5716401|NCT00443482|formoterol|formoterol
5716402|NCT00443469|magnetic stimulation|magnetic stimulation
5716403|NCT00443469|neuropathic pain|neuropathic pain
5716404|NCT00443469|spinal|spinal
5716405|NCT00443469|lower limb|lower limb
5716406|NCT00443469|clinical trial|clinical trial
5716407|NCT00443443|Rituximab|rituximab
5716409|NCT00443443|Sunstone|sunstone
5716410|NCT00443443|anti-TNF|anti-tnf
5716411|NCT00443443|Rituxan|rituxan
5716412|NCT00443430|Childhood Arthritis|childhood arthritis
5716413|NCT00443430|Juvenile Arthritis|juvenile arthritis
5716414|NCT00443430|Juvenile Arthritis Treatment|juvenile arthritis treatment
5716415|NCT00443430|Childhood Arthritis Drug Treatment|childhood arthritis drug treatment
5716416|NCT00443430|Juvenile Arthritis Remission|juvenile arthritis remission
5716417|NCT00443430|Inactive Disease in Juvenile Arthritis|inactive disease in juvenile arthritis
5716418|NCT00443430|Childhood Polyarthritis|childhood polyarthritis
5716419|NCT00443430|Extended Oligoarthritis|extended oligoarthritis
5716420|NCT00443404|phantom|phantom
5716421|NCT00443404|amputation|amputation
5716422|NCT00443404|analgesia|analgesia
5716423|NCT00443404|pain|pain
5716424|NCT00443404|preemptive|preemptive
5716425|NCT00443404|perioperative|perioperative
5716426|NCT00443404|lower limb amputation|lower limb amputation
5716427|NCT00443404|intensity of phantom limb pain|intensity of phantom limb pain
5716428|NCT00443404|preemptive analgesia reduces phantom pain|preemptive analgesia reduces phantom pain
5716429|NCT00443404|perioperative analgesia reduces phantom pain|perioperative analgesia reduces phantom pain
5716430|NCT00443404|Severe Phantom Limb Pain (VAS>70 mm)|severe phantom limb pain (vas>70 mm)
5798817|NCT00110929|Mimpara®|mimpara®
5716431|NCT00443404|resistant to medical treatment one week before amputation|resistant to medical treatment one week before amputation
5716433|NCT00443378|computer counseling|computer counseling
5716435|NCT00443378|antiretroviral adherence|antiretroviral adherence
5716436|NCT00443378|sexual behavior|sexual behavior
5724182|NCT00416624|anemia|anemia
5716437|NCT00443378|prevention with positives|prevention with positives
5716438|NCT00443378|HIV seronegativity|hiv seronegativity
5716439|NCT00443339|Myelodysplastic syndromes with IPSS Low or Int-1|myelodysplastic syndromes with ipss low or int-1
5716440|NCT00443339|Anemia|anemia
5716441|NCT00020475|adult solid tumor|adult solid tumor
5716442|NCT00020475|body system/site cancer|body system/site cancer
5716443|NCT00020475|cancer|cancer
5716444|NCT00020475|extraocular extension melanoma|extraocular extension melanoma
5716445|NCT00020475|eye cancer|eye cancer
5716446|NCT00020475|intraocular melanoma|intraocular melanoma
5716447|NCT00020475|recurrent intraocular melanoma|recurrent intraocular melanoma
5716448|NCT00020475|solid tumor|solid tumor
5716449|NCT00020475|stage, intraocular melanoma|stage, intraocular melanoma
5716450|NCT00020371|adult solid tumor|adult solid tumor
5716451|NCT00020371|bone marrow suppression|bone marrow suppression
5716452|NCT00020371|cancer|cancer
5716453|NCT00020371|cancer-related problem/condition|cancer-related problem/condition
5716454|NCT00020371|neutropenia|neutropenia
5716455|NCT00020371|solid tumor|solid tumor
5716456|NCT00020371|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5716457|NCT00020345|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5716458|NCT00020345|adult solid tumor|adult solid tumor
5716459|NCT00020345|body system/site cancer|body system/site cancer
5716461|NCT00020345|cellular diagnosis, pancreatic cancer|cellular diagnosis, pancreatic cancer
5716462|NCT00020345|gastrointestinal cancer|gastrointestinal cancer
5716463|NCT00020345|pancreatic cancer|pancreatic cancer
5716465|NCT00020345|stage III pancreatic cancer|stage iii pancreatic cancer
5716466|NCT00020345|stage IV pancreatic cancer|stage iv pancreatic cancer
5716467|NCT00020345|stage IVA pancreatic cancer|stage iva pancreatic cancer
5716468|NCT00020345|stage, pancreatic cancer|stage, pancreatic cancer
5716469|NCT00020267|Ewing's family of tumors|ewing's family of tumors
5716470|NCT00020267|adult soft tissue sarcoma|adult soft tissue sarcoma
5716471|NCT00020267|adult solid tumor|adult solid tumor
5716472|NCT00020267|body system/site cancer|body system/site cancer
5716473|NCT00020267|bone cancer|bone cancer
5716474|NCT00020267|breast cancer|breast cancer
5716475|NCT00020267|cancer|cancer
5716476|NCT00020267|childhood cancer|childhood cancer
5716477|NCT00020267|childhood solid tumor|childhood solid tumor
5716478|NCT00020267|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5716479|NCT00020267|colon cancer|colon cancer
5716480|NCT00020267|colorectal cancer|colorectal cancer
5716481|NCT00020267|extraocular extension melanoma|extraocular extension melanoma
5716482|NCT00020267|eye cancer|eye cancer
5716483|NCT00020267|female reproductive cancer|female reproductive cancer
5716484|NCT00020267|gastrointestinal cancer|gastrointestinal cancer
5716485|NCT00020267|genetic condition|genetic condition
5716486|NCT00020267|intraocular melanoma|intraocular melanoma
5716487|NCT00020267|lung cancer|lung cancer
5716488|NCT00020267|male breast cancer|male breast cancer
5716489|NCT00020267|melanoma|melanoma
5716490|NCT00020267|metastatic osteosarcoma|metastatic osteosarcoma
5716491|NCT00020267|metastatic tumors of the Ewing's family|metastatic tumors of the ewing's family
5716492|NCT00020267|muscle cancer|muscle cancer
5716493|NCT00020267|musculoskeletal cancer|musculoskeletal cancer
5716494|NCT00020267|non-small cell lung cancer|non-small cell lung cancer
5716495|NCT00020267|osteosarcoma|osteosarcoma
5716496|NCT00020267|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
5716497|NCT00020267|ovarian sarcoma|ovarian sarcoma
5716498|NCT00020267|rectal cancer|rectal cancer
5716499|NCT00020267|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5716500|NCT00020267|recurrent breast cancer|recurrent breast cancer
5716501|NCT00020267|recurrent colon cancer|recurrent colon cancer
5716502|NCT00020267|recurrent intraocular melanoma|recurrent intraocular melanoma
5716503|NCT00020267|recurrent melanoma|recurrent melanoma
5716504|NCT00020267|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5716505|NCT00020267|recurrent osteosarcoma|recurrent osteosarcoma
5716506|NCT00020267|recurrent rectal cancer|recurrent rectal cancer
5716507|NCT00020267|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
5716508|NCT00020267|recurrent uterine sarcoma|recurrent uterine sarcoma
5716509|NCT00020267|skin tumor|skin tumor
5716510|NCT00020267|solid tumor|solid tumor
5716511|NCT00020267|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
5716512|NCT00020267|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5716513|NCT00020267|stage IV breast cancer|stage iv breast cancer
5716514|NCT00020267|stage IV colon cancer|stage iv colon cancer
5716515|NCT00020267|stage IV melanoma|stage iv melanoma
5716516|NCT00020267|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5716517|NCT00020267|stage IV rectal cancer|stage iv rectal cancer
5716518|NCT00020267|stage IV uterine sarcoma|stage iv uterine sarcoma
5798818|NCT00110929|Cinacalcet|cinacalcet
5716519|NCT00020267|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
5716520|NCT00020267|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
5716521|NCT00020267|stage, Ewing's family of tumors|stage, ewing's family of tumors
5681149|NCT00574522|Far infrared|far infrared
5716522|NCT00020267|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
5716523|NCT00020267|stage, breast cancer|stage, breast cancer
5716525|NCT00020267|stage, intraocular melanoma|stage, intraocular melanoma
5716526|NCT00020267|stage, melanoma|stage, melanoma
5716527|NCT00020267|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5716528|NCT00020267|stage, osteosarcoma|stage, osteosarcoma
5716529|NCT00020267|stage, rectal cancer|stage, rectal cancer
5716530|NCT00020267|stage, uterine sarcoma|stage, uterine sarcoma
5716531|NCT00020267|thorax/respiratory cancer|thorax/respiratory cancer
5716532|NCT00020267|uterine sarcoma|uterine sarcoma
5716533|NCT00019643|adult solid tumor|adult solid tumor
5716534|NCT00019643|body system/site cancer|body system/site cancer
5716535|NCT00019643|breast cancer|breast cancer
5716537|NCT00019643|cancer-related problem/condition|cancer-related problem/condition
5716538|NCT00019643|depression|depression
5716539|NCT00019643|depression and suicide|depression and suicide
5716540|NCT00019643|nutrition|nutrition
5716541|NCT00019643|psychosocial effects/treatment|psychosocial effects/treatment
5716542|NCT00019643|quality of life|quality of life
5716543|NCT00019643|solid tumor|solid tumor
5716544|NCT00019643|stage I breast cancer|stage i breast cancer
5716545|NCT00019643|stage I, II, and IIIA breast cancer|stage i, ii, and iiia breast cancer
5716546|NCT00019643|stage II breast cancer|stage ii breast cancer
5716547|NCT00019643|stage III breast cancer|stage iii breast cancer
5716548|NCT00019643|stage IIIA breast cancer|stage iiia breast cancer
5716549|NCT00019643|stage IIIB, IV, recurrent, and metastatic breast cancer|stage iiib, iv, recurrent, and metastatic breast cancer
5716550|NCT00019643|stage, breast cancer|stage, breast cancer
5716552|NCT00443326|PASI|pasi
5716553|NCT00443326|Skin Biopsy|skin biopsy
5716554|NCT00443326|Human Monoclonal Antibody|human monoclonal antibody
5716555|NCT00443313|Cervical neoplasia|cervical neoplasia
5716556|NCT00443313|Screening|screening
5716557|NCT00443313|HPV|hpv
5716558|NCT00443313|Cervical Cancer Screening|cervical cancer screening
5716559|NCT00443300|AML|aml
5716560|NCT00443300|MDS|mds
5716561|NCT00443300|Protected Environment|protected environment
5716562|NCT00443287|Peripheral|peripheral
5716563|NCT00443287|Artery|artery
5716564|NCT00443287|Disease|disease
5716565|NCT00443261|Head and Neck Cancer|head and neck cancer
5716566|NCT00443235|Older patients|older patients
5716567|NCT00443235|untreated patients|untreated patients
5716568|NCT00443222|infliximab|infliximab
5716569|NCT00443222|polymyositis|polymyositis
5716570|NCT00443222|dermatomyositis|dermatomyositis
5716571|NCT00443222|inclusion body myositis|inclusion body myositis
5716572|NCT00443196|Chemosensitivity|chemosensitivity
5716573|NCT00443196|Ovarian Cancer|ovarian cancer
5716574|NCT00443196|Chemotherapy|chemotherapy
5716575|NCT00443196|Fallopian Adenocarcinoma|fallopian adenocarcinoma
5716576|NCT00443196|Peritoneal Adenocarcinoma|peritoneal adenocarcinoma
5716577|NCT00443196|Patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.|patients with pathological diagnoses of ovarian, fallopian and primary peritoneal adenocarcinomas.
5716578|NCT00443196|Patients with de novo malignancies and no previous chemotherapy|patients with de novo malignancies and no previous chemotherapy
5716579|NCT00443196|Patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.|patients with advanced refractory malignancies who received no more than 2 standard chemotherapy treatment protocols.
5716580|NCT00443170|repeat dose,|repeat dose,
5716581|NCT00443170|GSK626616AC,|gsk626616ac,
5716582|NCT00443170|pharmacokinetic,|pharmacokinetic,
5716583|NCT00443170|single dose,|single dose,
5716584|NCT00443170|cytochrome P450,|cytochrome p450,
5716585|NCT00443170|First time in human,|first time in human,
5716586|NCT00443170|healthy volunteers|healthy volunteers
5716587|NCT00443157|meningococcal B vaccine|meningococcal b vaccine
5716588|NCT00443144|growth hormone receptor polymorphism|growth hormone receptor polymorphism
5716589|NCT00443144|pharmacogenomics|pharmacogenomics
5716590|NCT00443144|growth promoting therapy|growth promoting therapy
5716591|NCT00443131|Adjuvant|adjuvant
5716593|NCT00443131|Safety|safety
5716594|NCT00443131|Immunogenicity|immunogenicity
5716595|NCT00443118|Bag and mask|bag and mask
5716596|NCT00443118|Neopuff|neopuff
5716597|NCT00443118|Resuscitation|resuscitation
5716598|NCT00443118|Newborn|newborn
5716599|NCT00443118|Intubation|intubation
5716600|NCT00443118|devices|devices
5716601|NCT00443118|PEEP|peep
5716602|NCT00443092|osteoarthritis|osteoarthritis
5716603|NCT00443092|gout|gout
5716604|NCT00443092|pain|pain
5716605|NCT00443092|uric acid|uric acid
5716606|NCT00443092|tart cherry|tart cherry
5716607|NCT00443092|alternative medicine|alternative medicine
5716608|NCT00443092|knees|knees
5716609|NCT00443079|Clinical Trials|clinical trials
5716610|NCT00443079|Pilot Projects|pilot projects
5716611|NCT00443079|Milk Thistle|milk thistle
5716612|NCT00443079|Liver Function Tests|liver function tests
5716613|NCT00443066|pediatric|pediatric
5716615|NCT00443053|superficial vein thrombosis|superficial vein thrombosis
5716616|NCT00443053|superficial thrombophlebitis|superficial thrombophlebitis
5716617|NCT00443053|fondaparinux|fondaparinux
5681150|NCT00574522|Treatment|treatment
5715517|NCT00445952|polycythemia vera|polycythemia vera
5716618|NCT00443053|deep vein thrombosis|deep vein thrombosis
5716619|NCT00443053|venous thromboembolism treatment|venous thromboembolism treatment
5716620|NCT00443053|thrombosis|thrombosis
5716621|NCT00443014|Stimulation therapy|stimulation therapy
5716622|NCT00443014|Acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
5716623|NCT00443014|Synergetic|synergetic
5716624|NCT00443001|Non-Invasive Blood Pressure|non-invasive blood pressure
5716625|NCT00443001|Sinus Rhythm|sinus rhythm
5716626|NCT00443001|Oscillometric|oscillometric
5716627|NCT00443001|Invasive Blood Pressure|invasive blood pressure
5716628|NCT00443001|AAMI/ANSI SP10 Standard|aami/ansi sp10 standard
5716629|NCT00443001|Compliance with ANSI/AAMI SP10 2002 standard|compliance with ansi/aami sp10 2002 standard
5716630|NCT00442988|NODAT|nodat
5716631|NCT00442988|OGTT|ogtt
5716632|NCT00442988|FPG|fpg
5716633|NCT00442988|Renal Transplanation|renal transplanation
5716634|NCT00442988|Risk Factors|risk factors
5716635|NCT00442988|Predictive value|predictive value
5716636|NCT00442975|Influenza Vaccine|influenza vaccine
5716637|NCT00442975|CMV|cmv
5716638|NCT00442949|Acute coronary syndrome|acute coronary syndrome
5716639|NCT00442949|Angioplasty|angioplasty
5716640|NCT00442949|Abciximab|abciximab
5716641|NCT00442949|Troponin release|troponin release
5716642|NCT00442923|Methamphetamine|methamphetamine
5716643|NCT00442923|Coreg|coreg
5716644|NCT00442923|Withdrawal|withdrawal
5716645|NCT00442923|anxiety|anxiety
5716646|NCT00442923|Substance Addiction|substance addiction
5716647|NCT00442910|Safety and Acceptability|safety and acceptability
5716648|NCT00442897|Hypercholesterolaemia|hypercholesterolaemia
5716649|NCT00442884|glucose control in acute stress|glucose control in acute stress
5716650|NCT00442871|Renal Impairment,|renal impairment,
5716651|NCT00442871|chronic immune thrombocytopenia purpura,|chronic immune thrombocytopenia purpura,
5716652|NCT00442871|thrombocytopenia,|thrombocytopenia,
5716653|NCT00442871|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5716654|NCT00442858|cardiac disease|cardiac disease
5716655|NCT00442858|cerebrovascular disease|cerebrovascular disease
5716656|NCT00442858|GH deficiency|gh deficiency
5716657|NCT00442858|diabetes mellitus|diabetes mellitus
5716658|NCT00442858|hypertension|hypertension
5716659|NCT00442858|GH therapy|gh therapy
5716660|NCT00442858|GH deficiency and hypopituitarims|gh deficiency and hypopituitarims
5716661|NCT00020202|adult solid tumor|adult solid tumor
5716662|NCT00020202|body system/site cancer|body system/site cancer
5716664|NCT00020202|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5716665|NCT00020202|genetic condition|genetic condition
5716666|NCT00020202|lung cancer|lung cancer
5716667|NCT00020202|non-small cell lung cancer|non-small cell lung cancer
5716668|NCT00020202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5716669|NCT00020202|recurrent small cell lung cancer|recurrent small cell lung cancer
5716670|NCT00020202|small cell lung cancer|small cell lung cancer
5716671|NCT00020202|solid tumor|solid tumor
5716672|NCT00020202|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5716673|NCT00020202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5716674|NCT00020202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5716675|NCT00020202|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5716676|NCT00020202|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5716677|NCT00020202|stage, small cell lung cancer|stage, small cell lung cancer
5716678|NCT00020202|thorax/respiratory cancer|thorax/respiratory cancer
5716679|NCT00020046|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5716680|NCT00020046|adult solid tumor|adult solid tumor
5716681|NCT00020046|body system/site cancer|body system/site cancer
5716682|NCT00020046|cancer|cancer
5716683|NCT00020046|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
5716684|NCT00020046|genetic condition|genetic condition
5716685|NCT00020046|male reproductive cancer|male reproductive cancer
5716686|NCT00020046|prostate cancer|prostate cancer
5716687|NCT00020046|recurrent prostate cancer|recurrent prostate cancer
5716688|NCT00020046|solid tumor|solid tumor
5716689|NCT00020046|stage IV prostate cancer|stage iv prostate cancer
5716690|NCT00020046|stage, prostate cancer|stage, prostate cancer
5716691|NCT00019968|adult soft tissue sarcoma|adult soft tissue sarcoma
5716692|NCT00019968|adult solid tumor|adult solid tumor
5716693|NCT00019968|body system/site cancer|body system/site cancer
5716694|NCT00019968|cancer|cancer
5716695|NCT00019968|muscle cancer|muscle cancer
5716696|NCT00019968|musculoskeletal cancer|musculoskeletal cancer
5716697|NCT00019968|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5716698|NCT00019968|solid tumor|solid tumor
5716699|NCT00019968|stage IA, IB, and IIA adult soft tissue sarcoma|stage ia, ib, and iia adult soft tissue sarcoma
5716700|NCT00019968|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5716701|NCT00019968|stage IIB adult soft tissue sarcoma|stage iib adult soft tissue sarcoma
5711856|NCT00458224|obesity|obesity
5716702|NCT00019968|stage IIB, IIC, and III adult soft tissue sarcoma|stage iib, iic, and iii adult soft tissue sarcoma
5685899|NCT00554372|unresectable primary hepatocellular carcinoma|unresectable primary hepatocellular carcinoma
5685900|NCT00554372|hepatocellular carcinoma|hepatocellular carcinoma
5685901|NCT00554372|liver cancer|liver cancer
5685902|NCT00554372|Phase 2|phase 2
5685903|NCT00554372|oncolytic virus|oncolytic virus
5685904|NCT00554372|Pexa-Vec|pexa-vec
5716703|NCT00019968|stage IIC adult soft tissue sarcoma|stage iic adult soft tissue sarcoma
5716704|NCT00019968|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5716705|NCT00019968|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5716706|NCT00019968|stage IVA adult soft tissue sarcoma|stage iva adult soft tissue sarcoma
5716707|NCT00019968|stage IVB adult soft tissue sarcoma|stage ivb adult soft tissue sarcoma
5716708|NCT00019968|stage, adult soft tissue sarcoma|stage, adult soft tissue sarcoma
5716709|NCT00019890|adult solid tumor|adult solid tumor
5716710|NCT00019890|body system/site cancer|body system/site cancer
5716712|NCT00019890|melanoma|melanoma
5716713|NCT00019890|recurrent melanoma|recurrent melanoma
5716714|NCT00019890|skin tumor|skin tumor
5716715|NCT00019890|solid tumor|solid tumor
5716716|NCT00019890|stage III melanoma|stage iii melanoma
5716717|NCT00019890|stage IV melanoma|stage iv melanoma
5716718|NCT00019890|stage, melanoma|stage, melanoma
5716719|NCT00019760|adult solid tumor|adult solid tumor
5716720|NCT00019760|body system/site cancer|body system/site cancer
5716721|NCT00019760|cancer|cancer
5716722|NCT00019760|colon cancer|colon cancer
5716723|NCT00019760|colorectal cancer|colorectal cancer
5716724|NCT00019760|gastrointestinal cancer|gastrointestinal cancer
5716725|NCT00019760|genetic condition|genetic condition
5716726|NCT00019760|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5680636|NCT00577252|Adolescents|adolescents
5716727|NCT00019760|liver metastases|liver metastases
5716728|NCT00019760|metastatic cancer|metastatic cancer
5716729|NCT00019760|rectal cancer|rectal cancer
5716730|NCT00019760|recurrent colon cancer|recurrent colon cancer
5716731|NCT00019760|recurrent rectal cancer|recurrent rectal cancer
5716732|NCT00019760|site, metastatic cancer|site, metastatic cancer
5716733|NCT00019760|solid tumor|solid tumor
5716734|NCT00019760|stage IV colon cancer|stage iv colon cancer
5716735|NCT00019760|stage IV rectal cancer|stage iv rectal cancer
5716736|NCT00019760|stage, colon cancer|stage, colon cancer
5716737|NCT00019760|stage, rectal cancer|stage, rectal cancer
5716738|NCT00019760|unclassified/other cancer|unclassified/other cancer
5716739|NCT00019695|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5716740|NCT00019695|adult solid tumor|adult solid tumor
5716741|NCT00019695|body system/site cancer|body system/site cancer
5716742|NCT00019695|bone metastases|bone metastases
5716743|NCT00019695|cancer|cancer
5716744|NCT00019695|cellular diagnosis, prostate cancer|cellular diagnosis, prostate cancer
5716745|NCT00019695|genetic condition|genetic condition
5716746|NCT00019695|male reproductive cancer|male reproductive cancer
5716747|NCT00019695|metastatic cancer|metastatic cancer
5716748|NCT00019695|prostate cancer|prostate cancer
5716749|NCT00019695|recurrent prostate cancer|recurrent prostate cancer
5716750|NCT00019695|site, metastatic cancer|site, metastatic cancer
5716751|NCT00019695|solid tumor|solid tumor
5716752|NCT00019695|stage IV prostate cancer|stage iv prostate cancer
5716753|NCT00019695|stage, prostate cancer|stage, prostate cancer
5716754|NCT00019695|unclassified/other cancer|unclassified/other cancer
5716755|NCT00019630|Ewing's family of tumors|ewing's family of tumors
5716756|NCT00019630|Wilms' tumor|wilms' tumor
5716757|NCT00019630|adult solid tumor|adult solid tumor
5716758|NCT00019630|body system/site cancer|body system/site cancer
5716759|NCT00019630|bone cancer|bone cancer
5716760|NCT00019630|brain tumor|brain tumor
5716761|NCT00019630|cancer|cancer
5716762|NCT00019630|central nervous system cancer|central nervous system cancer
5716763|NCT00019630|childhood brain stem glioma|childhood brain stem glioma
5716764|NCT00019630|childhood brain tumor|childhood brain tumor
5716765|NCT00019630|childhood cancer|childhood cancer
5716766|NCT00019630|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5716767|NCT00019630|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5716768|NCT00019630|childhood cerebral astrocytoma|childhood cerebral astrocytoma
5716769|NCT00019630|childhood choroid plexus tumor|childhood choroid plexus tumor
5716770|NCT00019630|childhood craniopharyngioma|childhood craniopharyngioma
5716771|NCT00019630|childhood ependymoma|childhood ependymoma
5716772|NCT00019630|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5716773|NCT00019630|childhood extragonadal malignant germ cell tumor|childhood extragonadal malignant germ cell tumor
5716774|NCT00019630|childhood liver cancer|childhood liver cancer
5716775|NCT00019630|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5716776|NCT00019630|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5716777|NCT00019630|childhood mature and immature teratomas|childhood mature and immature teratomas
5685905|NCT00554359|Acute Kidney Injury|acute kidney injury
5685906|NCT00554359|Acute Renal Failure|acute renal failure
5685907|NCT00554346|COX-2; post-operative ; sports injury; surgical pain|cox-2; post-operative ; sports injury; surgical pain
5685908|NCT00554320|vulvodynia|vulvodynia
5685909|NCT00554320|painful bladder syndrome|painful bladder syndrome
5741216|NCT00353743|metronidazole|metronidazole
5716778|NCT00019630|childhood medulloblastoma|childhood medulloblastoma
5716779|NCT00019630|childhood meningioma|childhood meningioma
5716780|NCT00019630|childhood oligodendroglioma|childhood oligodendroglioma
5716781|NCT00019630|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5716782|NCT00019630|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5716783|NCT00019630|childhood solid tumor|childhood solid tumor
5716784|NCT00019630|childhood supratentorial primitive neuroectodermal and pineal tumors|childhood supratentorial primitive neuroectodermal and pineal tumors
5716785|NCT00019630|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5716786|NCT00019630|endocrine cancer|endocrine cancer
5716787|NCT00019630|gastrointestinal cancer|gastrointestinal cancer
5716788|NCT00019630|genetic condition|genetic condition
5716789|NCT00019630|kidney tumor|kidney tumor
5716790|NCT00019630|kidney/urinary cancer|kidney/urinary cancer
5716791|NCT00019630|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5716792|NCT00019630|muscle cancer|muscle cancer
5716793|NCT00019630|musculoskeletal cancer|musculoskeletal cancer
5716794|NCT00019630|neuroblastoma|neuroblastoma
5716795|NCT00019630|osteosarcoma|osteosarcoma
5716796|NCT00019630|osteosarcoma/malignant fibrous histiocytoma of bone|osteosarcoma/malignant fibrous histiocytoma of bone
5716797|NCT00019630|pediatric germ cell tumor|pediatric germ cell tumor
5716798|NCT00019630|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5716799|NCT00019630|recurrent Wilms' tumor|recurrent wilms' tumor
5716800|NCT00019630|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5716801|NCT00019630|recurrent childhood brain tumor|recurrent childhood brain tumor
5716802|NCT00019630|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5716803|NCT00019630|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5716804|NCT00019630|recurrent childhood ependymoma|recurrent childhood ependymoma
5716805|NCT00019630|recurrent childhood liver cancer|recurrent childhood liver cancer
5863954|NCT00001155|Cyclophosphamide|cyclophosphamide
5716806|NCT00019630|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5716807|NCT00019630|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5716808|NCT00019630|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5716809|NCT00019630|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5716810|NCT00019630|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors|recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
5716811|NCT00019630|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5716812|NCT00019630|recurrent neuroblastoma|recurrent neuroblastoma
5716813|NCT00019630|recurrent osteosarcoma|recurrent osteosarcoma
5716814|NCT00019630|recurrent tumors of the Ewing's family|recurrent tumors of the ewing's family
5716816|NCT00019630|stage, Ewing's family of tumors|stage, ewing's family of tumors
5716817|NCT00019630|stage, Wilms' tumor|stage, wilms' tumor
5716818|NCT00019630|stage, childhood extracranial germ cell tumor|stage, childhood extracranial germ cell tumor
5716819|NCT00019630|stage, childhood liver cancer|stage, childhood liver cancer
5716820|NCT00019630|stage, childhood medulloblastoma|stage, childhood medulloblastoma
5716821|NCT00019630|stage, childhood rhabdomyosarcoma|stage, childhood rhabdomyosarcoma
5716822|NCT00019630|stage, childhood soft tissue sarcoma|stage, childhood soft tissue sarcoma
5716823|NCT00019630|stage, neuroblastoma|stage, neuroblastoma
5716824|NCT00019630|stage, osteosarcoma|stage, osteosarcoma
5716825|NCT00019630|stage/type, childhood brain tumor|stage/type, childhood brain tumor
5716826|NCT00019630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5716827|NCT00019448|adult solid tumor|adult solid tumor
5716828|NCT00019448|body system/site cancer|body system/site cancer
5716829|NCT00019448|cancer|cancer
5716830|NCT00019448|melanoma|melanoma
5716831|NCT00019448|recurrent melanoma|recurrent melanoma
5716832|NCT00019448|skin tumor|skin tumor
5716833|NCT00019448|solid tumor|solid tumor
5716834|NCT00019448|stage IV melanoma|stage iv melanoma
5716835|NCT00019448|stage, melanoma|stage, melanoma
5716836|NCT00019396|adult solid tumor|adult solid tumor
5716837|NCT00019396|body system/site cancer|body system/site cancer
5716838|NCT00019396|cancer|cancer
5716839|NCT00019396|kidney tumor|kidney tumor
5716840|NCT00019396|kidney/urinary cancer|kidney/urinary cancer
5716841|NCT00019396|melanoma|melanoma
5716842|NCT00019396|recurrent melanoma|recurrent melanoma
5716843|NCT00019396|recurrent renal cell cancer|recurrent renal cell cancer
5715745|NCT00445523|RCC|rcc
5716844|NCT00019396|renal cell cancer|renal cell cancer
5716845|NCT00019396|skin tumor|skin tumor
5716846|NCT00019396|solid tumor|solid tumor
5716847|NCT00019396|stage IV melanoma|stage iv melanoma
5716848|NCT00019396|stage IV renal cell cancer|stage iv renal cell cancer
5716849|NCT00019396|stage, melanoma|stage, melanoma
5716850|NCT00019396|stage, renal cell cancer|stage, renal cell cancer
5716851|NCT00019188|AIDS-related malignancies|aids-related malignancies
5716852|NCT00019188|Kaposi's sarcoma|kaposi's sarcoma
5716853|NCT00019188|adult solid tumor|adult solid tumor
5716854|NCT00019188|body system/site cancer|body system/site cancer
5716855|NCT00019188|cancer|cancer
5716856|NCT00019188|epidemic Kaposi's sarcoma|epidemic kaposi's sarcoma
5716857|NCT00019188|recurrent Kaposi's sarcoma|recurrent kaposi's sarcoma
5716858|NCT00019188|skin tumor|skin tumor
5716859|NCT00019188|solid tumor|solid tumor
5716860|NCT00019188|stage, Kaposi's sarcoma|stage, kaposi's sarcoma
5716861|NCT00019097|body system/site cancer|body system/site cancer
5716862|NCT00019097|cancer|cancer
5716863|NCT00019097|genetic condition|genetic condition
5716864|NCT00019097|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5716865|NCT00019097|multiple myeloma|multiple myeloma
5716866|NCT00019097|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5716867|NCT00019097|plasma cell neoplasm|plasma cell neoplasm
5716868|NCT00019097|refractory plasma cell neoplasm|refractory plasma cell neoplasm
5716869|NCT00019097|stage II multiple myeloma|stage ii multiple myeloma
5716870|NCT00019097|stage III multiple myeloma|stage iii multiple myeloma
5716871|NCT00019097|stage, plasma cell neoplasm|stage, plasma cell neoplasm
5716872|NCT00003552|adult solid tumor|adult solid tumor
5716873|NCT00003552|body system/site cancer|body system/site cancer
5716875|NCT00003552|melanoma|melanoma
5716876|NCT00003552|recurrent melanoma|recurrent melanoma
5716877|NCT00003552|skin tumor|skin tumor
5716878|NCT00003552|solid tumor|solid tumor
5716879|NCT00003552|stage IV melanoma|stage iv melanoma
5716880|NCT00003552|stage, melanoma|stage, melanoma
5716881|NCT00442832|cSSSI|csssi
5716882|NCT00442832|Staph|staph
5716883|NCT00442832|MRSA|mrsa
5716884|NCT00442819|Uremic Pruritus|uremic pruritus
5716885|NCT00442819|Cytokines|cytokines
5716886|NCT00442819|Polymethylmethacrylate Artificial Kidney|polymethylmethacrylate artificial kidney
5716887|NCT00442819|Hemodialysis|hemodialysis
5716888|NCT00442806|ADRC|adrc
5716889|NCT00442806|Stem Cells|stem cells
5716890|NCT00442806|Myocardial Infarction|myocardial infarction
5716891|NCT00442806|STEMI|stemi
5716892|NCT00442806|Heart Disease|heart disease
5716893|NCT00442806|Coronary Artery Disease|coronary artery disease
5716894|NCT00442806|Coronary Disease|coronary disease
5716895|NCT00442806|ST-Elevation|st-elevation
5716896|NCT00442806|AMI|ami
5716897|NCT00442806|Interventional Cardiology|interventional cardiology
5716898|NCT00442806|Heart Attack|heart attack
5707218|NCT00475228|IUD|iud
5716900|NCT00442780|MOBILE|mobile
5716901|NCT00442780|BIIB014|biib014
5716902|NCT00442767|pediatric|pediatric
5716903|NCT00442767|juvenile|juvenile
5716904|NCT00442767|diabetes mellitus|diabetes mellitus
5716905|NCT00442767|Pediatric type 1 diabetes mellitus|pediatric type 1 diabetes mellitus
5716906|NCT00442754|dendritic cell|dendritic cell
5716907|NCT00442754|tumor vaccine|tumor vaccine
5716908|NCT00442754|NSCLC|nsclc
5716909|NCT00442741|Cancer|cancer
5716910|NCT00442741|EPO906|epo906
5716911|NCT00442741|Patupilone|patupilone
5716912|NCT00442728|Functional electrical stimulation|functional electrical stimulation
5716913|NCT00442728|muscular atrophy|muscular atrophy
5716914|NCT00442728|intensive care|intensive care
5716915|NCT00442715|Exercise-induced asthma,|exercise-induced asthma,
5716916|NCT00442715|early childhood;|early childhood;
5716917|NCT00442715|spirometry,|spirometry,
5716918|NCT00442715|exercise challenge|exercise challenge
5716919|NCT00442715|Data from preschool children who were referred to the Pediatric|data from preschool children who were referred to the pediatric
5716920|NCT00442715|Pulmonary Clinic over a 1-year period were recruited|pulmonary clinic over a 1-year period were recruited
5716921|NCT00442689|Polycystic Ovary Syndrome|polycystic ovary syndrome
5716922|NCT00442689|Metabolic Syndrome|metabolic syndrome
5716923|NCT00442689|PCOS|pcos
5716924|NCT00442689|overweight|overweight
5716925|NCT00442689|infertility|infertility
5716926|NCT00442689|Insulin Resistance|insulin resistance
5716927|NCT00442689|menstrual cycle|menstrual cycle
5716928|NCT00442663|Labor Induction|labor induction
5716929|NCT00442663|Cervical Ripening|cervical ripening
5716930|NCT00442663|Foley Catheter|foley catheter
5716931|NCT00442637|CAIRO3|cairo3
5716932|NCT00442637|DCCG|dccg
5716933|NCT00442637|colorectal cancer|colorectal cancer
5716934|NCT00442637|induction|induction
5716935|NCT00442637|metronomic chemotherapy|metronomic chemotherapy
5716936|NCT00442637|observation|observation
5716937|NCT00442637|capecitabine|capecitabine
5716938|NCT00442637|bevacizumab|bevacizumab
5716939|NCT00442637|oxaliplatin|oxaliplatin
5716940|NCT00442624|insomnia|insomnia
5716941|NCT00442624|glucose metabolism|glucose metabolism
5716942|NCT00442624|insulin resistance|insulin resistance
5685910|NCT00554320|myofascial pain syndrome|myofascial pain syndrome
5685911|NCT00554320|pelvic floor tension myalgia|pelvic floor tension myalgia
5685912|NCT00554307|patent ductus arteriosus|patent ductus arteriosus
5685913|NCT00554307|indomethacin|indomethacin
5685914|NCT00554307|neoprofen|neoprofen
5685915|NCT00554307|blood flow|blood flow
5685916|NCT00554294|children|children
5685917|NCT00554294|primary prevention|primary prevention
5685918|NCT00554294|environmental change|environmental change
5685919|NCT00554294|behavioural change|behavioural change
5716943|NCT00442598|Ovarian|ovarian
5716944|NCT00442598|Cancer|cancer
5716945|NCT00442598|CA-125|ca-125
5716946|NCT00442598|Third-line|third-line
5716947|NCT00442598|Glufosfamide|glufosfamide
5716948|NCT00442546|opioid|opioid
5716949|NCT00442533|Carcinoid|carcinoid
5716950|NCT00442533|Islet Cell Cancer|islet cell cancer
5716951|NCT00442533|Paraganglioma|paraganglioma
5716952|NCT00442533|Pheochromocytoma|pheochromocytoma
5716953|NCT00442507|Esophagus|esophagus
5716954|NCT00442507|Esophagogastric Junction|esophagogastric junction
5716955|NCT00442507|Avastin|avastin
5716956|NCT00442507|Bevacizumab|bevacizumab
5716957|NCT00442507|Erlotinib|erlotinib
5716958|NCT00442494|Atrial fibrillation after cardiac surgery|atrial fibrillation after cardiac surgery
5716959|NCT00442481|MDD|mdd
5716960|NCT00442481|Escitalopram|escitalopram
5716961|NCT00442481|Cipralex|cipralex
5716962|NCT00442481|Sleep|sleep
5716963|NCT00442481|REM|rem
5716964|NCT00442481|SWS|sws
5716965|NCT00442481|Polysomnography|polysomnography
5716966|NCT00442468|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5716967|NCT00442468|Chronic Bronchitis|chronic bronchitis
5716968|NCT00442468|Spirometry|spirometry
5716969|NCT00442455|Head Neck Carcinoma Erlotinib|head neck carcinoma erlotinib
5716972|NCT00442442|mosquito coils|mosquito coils
5716973|NCT00442442|LLIN|llin
5716974|NCT00442429|depression; dialysis; kidney failure, chronic|depression; dialysis; kidney failure, chronic
5716975|NCT00019578|adult brain stem glioma|adult brain stem glioma
5716976|NCT00019578|adult brain tumor|adult brain tumor
5716977|NCT00019578|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5716978|NCT00019578|adult craniopharyngioma|adult craniopharyngioma
5716979|NCT00019578|adult ependymoma|adult ependymoma
5716980|NCT00019578|adult infiltrating astrocytoma|adult infiltrating astrocytoma
5716981|NCT00019578|adult malignant meningioma|adult malignant meningioma
5716982|NCT00019578|adult medulloblastoma|adult medulloblastoma
5716983|NCT00019578|adult meningioma|adult meningioma
5716984|NCT00019578|adult noninfiltrating astrocytoma|adult noninfiltrating astrocytoma
5716985|NCT00019578|adult oligodendroglioma|adult oligodendroglioma
5716986|NCT00019578|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5716987|NCT00019578|adult solid tumor|adult solid tumor
5716988|NCT00019578|body system/site cancer|body system/site cancer
5716989|NCT00019578|brain metastases|brain metastases
5716990|NCT00019578|brain tumor|brain tumor
5716991|NCT00019578|cancer|cancer
5716992|NCT00019578|central nervous system cancer|central nervous system cancer
5716993|NCT00019578|genetic condition|genetic condition
5716994|NCT00019578|metastatic cancer|metastatic cancer
5716995|NCT00019578|mixed gliomas|mixed gliomas
5716996|NCT00019578|site, metastatic cancer|site, metastatic cancer
5716997|NCT00019578|solid tumor|solid tumor
5716998|NCT00019578|stage IV peripheral primitive neuroectodermal tumor|stage iv peripheral primitive neuroectodermal tumor
5716999|NCT00019578|stage/type, adult brain tumor|stage/type, adult brain tumor
5717000|NCT00019578|unclassified/other cancer|unclassified/other cancer
5717001|NCT00019006|adult solid tumor|adult solid tumor
5717002|NCT00019006|body system/site cancer|body system/site cancer
5717003|NCT00019006|cancer|cancer
5717004|NCT00019006|colon cancer|colon cancer
5717005|NCT00019006|colorectal cancer|colorectal cancer
5717006|NCT00019006|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5717007|NCT00019006|gastrointestinal cancer|gastrointestinal cancer
5717008|NCT00019006|genetic condition|genetic condition
5717009|NCT00019006|limited stage small cell lung cancer|limited stage small cell lung cancer
5717010|NCT00019006|lung cancer|lung cancer
5717011|NCT00019006|non-small cell lung cancer|non-small cell lung cancer
5717012|NCT00019006|pancreatic cancer|pancreatic cancer
5717013|NCT00019006|rectal cancer|rectal cancer
5717014|NCT00019006|recurrent colon cancer|recurrent colon cancer
5717015|NCT00019006|recurrent pancreatic cancer|recurrent pancreatic cancer
5717016|NCT00019006|recurrent rectal cancer|recurrent rectal cancer
5717017|NCT00019006|small cell lung cancer|small cell lung cancer
5717018|NCT00019006|solid tumor|solid tumor
5685920|NCT00554294|school setting|school setting
5685921|NCT00554294|changing of drinking habits|changing of drinking habits
5685922|NCT00554294|promotion of drinking tap water|promotion of drinking tap water
5685923|NCT00554281|Type 1 diabetes|type 1 diabetes
5685924|NCT00554281|Hypoglycemia|hypoglycemia
5717019|NCT00019006|stage I pancreatic cancer|stage i pancreatic cancer
5717020|NCT00019006|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5717021|NCT00019006|stage II pancreatic cancer|stage ii pancreatic cancer
5717022|NCT00019006|stage III colon cancer|stage iii colon cancer
5717023|NCT00019006|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5717024|NCT00019006|stage III pancreatic cancer|stage iii pancreatic cancer
5717025|NCT00019006|stage III rectal cancer|stage iii rectal cancer
5717026|NCT00019006|stage IV pancreatic cancer|stage iv pancreatic cancer
5717027|NCT00019006|stage IVA pancreatic cancer|stage iva pancreatic cancer
5717028|NCT00019006|stage IVB pancreatic cancer|stage ivb pancreatic cancer
5717029|NCT00019006|stage, colon cancer|stage, colon cancer
5717030|NCT00019006|stage, non-small cell lung cancer|stage, non-small cell lung cancer
5717031|NCT00019006|stage, pancreatic cancer|stage, pancreatic cancer
5717032|NCT00019006|stage, rectal cancer|stage, rectal cancer
5717033|NCT00019006|stage, small cell lung cancer|stage, small cell lung cancer
5717034|NCT00019006|thorax/respiratory cancer|thorax/respiratory cancer
5717035|NCT00442403|Malaria|malaria
5717036|NCT00442403|Plasmodium falciparum|plasmodium falciparum
5717037|NCT00442403|Chemotherapy|chemotherapy
5717038|NCT00442403|Chloroquine|chloroquine
5717039|NCT00442403|Dehydroepiandrosterone sulphate|dehydroepiandrosterone sulphate
5717040|NCT00442390|Cortisol|cortisol
5717041|NCT00442390|adrenal insufficiency|adrenal insufficiency
5717042|NCT00442390|glucose metabolism|glucose metabolism
5717043|NCT00442390|protein metabolism|protein metabolism
5717044|NCT00442390|lipid metabolism|lipid metabolism
5717045|NCT00442390|insulin sensitivity.|insulin sensitivity.
5717046|NCT00442377|Falciparum|falciparum
5717047|NCT00442377|Plasmodium|plasmodium
5717048|NCT00442377|Malaria|malaria
5717049|NCT00442364|PFO|pfo
5717050|NCT00442364|Patent Foramen Ovale|patent foramen ovale
5717051|NCT00442364|Right-to-Left Shunt|right-to-left shunt
5717052|NCT00442364|Sclerotherapy|sclerotherapy
5717053|NCT00442312|Combigan|combigan
5717054|NCT00442299|hemodialysis, urmeic retention solute, biocompatibility|hemodialysis, urmeic retention solute, biocompatibility
5717055|NCT00442286|Hypertension|hypertension
5717056|NCT00442286|High Blood Pressure|high blood pressure
5717062|NCT00442260|breast cancer|breast cancer
5717063|NCT00442260|advanced breast cancer|advanced breast cancer
5717064|NCT00442247|anterior vaginal wall prolapse, Pelvicol, biomesh|anterior vaginal wall prolapse, pelvicol, biomesh
5717066|NCT00442234|Acute|acute
5717067|NCT00442234|pulmonary|pulmonary
5717068|NCT00442234|embolism|embolism
5717069|NCT00442234|accompanying|accompanying
5717070|NCT00442234|hemodynamic|hemodynamic
5717071|NCT00442234|instability|instability
5717072|NCT00442221|Migrane headaches|migrane headaches
5717073|NCT00442208|Healthy adults|healthy adults
5717074|NCT00442208|Phase I|phase i
5717081|NCT00442182|autoinflammatory syndromes|autoinflammatory syndromes
5717082|NCT00442169|West Nile Disease|west nile disease
5717083|NCT00442169|Antibody response|antibody response
5717084|NCT00442169|Viremia|viremia
5717085|NCT00442169|Safety|safety
5717086|NCT00442169|Tolerability|tolerability
5717087|NCT00442169|Prevention|prevention
5717088|NCT00442156|Laser photocoagulation|laser photocoagulation
5717089|NCT00442143|CLI|cli
5717090|NCT00442143|PAOD|paod
5717091|NCT00442143|Severe lower limb ischemia|severe lower limb ischemia
5717092|NCT00442130|GM-CSF|gm-csf
5717093|NCT00442130|GM-K562|gm-k562
5717094|NCT00442130|vaccine|vaccine
5717095|NCT00442104|infantile spasms|infantile spasms
5717096|NCT00442104|anticonvulsant|anticonvulsant
5717097|NCT00442104|pediatric epilepsy|pediatric epilepsy
5717098|NCT00442104|West Syndrome|west syndrome
5717099|NCT00442104|epileptic spasms|epileptic spasms
5717100|NCT00442091|Dandelion|dandelion
5717101|NCT00442091|herbal remedy|herbal remedy
5717102|NCT00442091|hand eczema|hand eczema
5717104|NCT00442078|Incontinence|incontinence
5717105|NCT00442078|Urinary|urinary
5717106|NCT00442078|Male|male
5717107|NCT00442078|Tape|tape
5717108|NCT00442078|Transobturator|transobturator
5717109|NCT00442065|Abdominal aortic aneurysm study|abdominal aortic aneurysm study
5717110|NCT00442052|Gastroprotective effects|gastroprotective effects
5717111|NCT00442052|Aspirin|aspirin
5717112|NCT00442039|Mania, Lithium, Bipolar, BPCA, pediatrics|mania, lithium, bipolar, bpca, pediatrics
5717113|NCT00442026|Cancer|cancer
5717114|NCT00442026|NSCLC|nsclc
5717115|NCT00442026|Elderly|elderly
5717116|NCT00442026|Chemotherapy|chemotherapy
5717117|NCT00442026|Docetaxel|docetaxel
5717118|NCT00442026|Gemcitabine|gemcitabine
5717119|NCT00442000|Prostate Cancer|prostate cancer
5717120|NCT00442000|Prostatectomy|prostatectomy
5717121|NCT00441987|Japanese|japanese
5717122|NCT00441987|Healthy|healthy
5717123|NCT00441987|Alzheimers Disease|alzheimers disease
5717124|NCT00441974|adefovir dipivoxil|adefovir dipivoxil
5717125|NCT00441974|compensated|compensated
5717126|NCT00441974|chronic hepatitis B|chronic hepatitis b
5717127|NCT00441974|Chinese|chinese
5717128|NCT00441961|Eosinophilic fasciitis, Shulman's syndrome, methotrexate|eosinophilic fasciitis, shulman's syndrome, methotrexate
5717129|NCT00441948|Hirsutism|hirsutism
5717130|NCT00441948|Hypertrichosis|hypertrichosis
5717131|NCT00441935|Urinary Retention|urinary retention
5717132|NCT00441935|Urinary Incontinence|urinary incontinence
5717133|NCT00441935|Pelvic Pain|pelvic pain
5717134|NCT00441922|Cancer|cancer
5717135|NCT00441922|Elderly|elderly
5717136|NCT00441922|Chemotherapy|chemotherapy
5717137|NCT00441922|Docetaxel|docetaxel
5717138|NCT00441922|Vinorelbine|vinorelbine
5717139|NCT00441909|Anti-Infective Agents, Local|anti-infective agents, local
5717140|NCT00441909|Healthy Women|healthy women
5717141|NCT00441909|Microbicides|microbicides
5717142|NCT00441909|UC-781|uc-781
5717143|NCT00441909|Vaginal Gel|vaginal gel
5717144|NCT00441909|HIV Seronegativity|hiv seronegativity
5717145|NCT00441896|infantile spasms|infantile spasms
5717146|NCT00441896|anticonvulsant|anticonvulsant
5717147|NCT00441896|pediatric epilepsy|pediatric epilepsy
5717148|NCT00441896|West Syndrome|west syndrome
5717149|NCT00441896|epileptic spasms|epileptic spasms
5717150|NCT00441870|Cancer|cancer
5717151|NCT00441870|Phase 1|phase 1
5717152|NCT00441870|EC0225|ec0225
5717153|NCT00441870|EC20|ec20
5717154|NCT00441870|Refractory|refractory
5717155|NCT00441870|Metastatic|metastatic
5717156|NCT00441870|Experimental|experimental
5717157|NCT00441857|plant sterols|plant sterols
5717158|NCT00441857|plant stanols|plant stanols
5717159|NCT00441857|cholesterol absorption|cholesterol absorption
5717160|NCT00441844|diabetes, statin, monocyte, crp, inflammation|diabetes, statin, monocyte, crp, inflammation
5717161|NCT00441831|Helicobacter pylori infection|helicobacter pylori infection
5717162|NCT00441831|peptic ulcer disease|peptic ulcer disease
5717163|NCT00441831|distal partial gastrectomy|distal partial gastrectomy
5717164|NCT00441831|bile reflux|bile reflux
5717165|NCT00441831|gastritis|gastritis
5717166|NCT00441831|gastrectomy|gastrectomy
5717168|NCT00441805|RadioFrequency|radiofrequency
5717169|NCT00441792|Sepsis|sepsis
5717170|NCT00441792|Etomidate|etomidate
5717171|NCT00441792|midazolam|midazolam
5717172|NCT00441792|ketamine|ketamine
5717173|NCT00441779|Microchimerism|microchimerism
5717174|NCT00441779|Injuries|injuries
5717175|NCT00441779|Burns|burns
5717176|NCT00441779|Orthopedic Surgery|orthopedic surgery
5717177|NCT00441779|Leukocytes|leukocytes
5717178|NCT00441740|NSCLC|nsclc
5717179|NCT00441740|1st line treatment|1st line treatment
5717180|NCT00441740|Gemcitabine|gemcitabine
5717181|NCT00441740|Vinorelbine|vinorelbine
5717182|NCT00441740|Docetaxel|docetaxel
5717183|NCT00441727|Peptic ulcer|peptic ulcer
5717184|NCT00441727|low-dose ASA|low-dose asa
5717185|NCT00441714|cardiovascular disease|cardiovascular disease
5717186|NCT00441714|ischemia-reperfusion injury|ischemia-reperfusion injury
5717187|NCT00441714|postconditioning|postconditioning
5717188|NCT00441714|annexin targeting|annexin targeting
5717189|NCT00441688|Human Immunodeficiency virus|human immunodeficiency virus
5717190|NCT00441688|HLAgenetics polymorphism|hlagenetics polymorphism
5717191|NCT00441675|Adolescents|adolescents
5717192|NCT00441675|Asthma|asthma
5717193|NCT00441675|long-term follow-up|long-term follow-up
5717194|NCT00441675|symptoms|symptoms
5717195|NCT00441675|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5717196|NCT00441662|Melanoma|melanoma
5717197|NCT00441662|Uvea|uvea
5717198|NCT00441662|Macula|macula
5717199|NCT00441662|Edema|edema
5717200|NCT00441662|Plaque radiotherapy|plaque radiotherapy
5717201|NCT00441662|Brachytherapy|brachytherapy
5717202|NCT00441662|Triamcinolone|triamcinolone
5717203|NCT00441649|ADHD|adhd
5717206|NCT00441636|obstructive sleep apnea|obstructive sleep apnea
5717207|NCT00441623|chronic kidney disease|chronic kidney disease
5717208|NCT00441623|cardiovascular disease|cardiovascular disease
5680639|NCT00577226|scoliosis, immature spine|scoliosis, immature spine
5717209|NCT00441623|risk stratification|risk stratification
5717210|NCT00441610|Gimatecan|gimatecan
5717211|NCT00441610|topoisomerase I inhibitor|topoisomerase i inhibitor
5717212|NCT00441610|advanced solid tumors|advanced solid tumors
5717213|NCT00441597|ischemia reperfusion injury|ischemia reperfusion injury
5717214|NCT00441597|atorvastatine|atorvastatine
5717215|NCT00441597|preconditioning|preconditioning
5717216|NCT00441597|cardiovascular disease|cardiovascular disease
5717217|NCT00441571|prostate cancer|prostate cancer
5717218|NCT00441571|radiolabeled antibody|radiolabeled antibody
5717219|NCT00441532|prostate|prostate
5717220|NCT00441519|Gastroprotective effects|gastroprotective effects
5717222|NCT00441506|interruption|interruption
5717223|NCT00441506|critically ill|critically ill
5717224|NCT00441506|sedation|sedation
5717225|NCT00441506|pediatrics|pediatrics
5717226|NCT00441506|critically ill, ventilated children|critically ill, ventilated children
5685925|NCT00554281|Glucose sensor|glucose sensor
5717227|NCT00441493|Hepatitis C|hepatitis c
5717228|NCT00441493|fluvastatin|fluvastatin
5717229|NCT00441480|Hypercholesterolemia|hypercholesterolemia
5717230|NCT00441480|Hypertriglyceridemia|hypertriglyceridemia
5717231|NCT00441480|Plant sterol|plant sterol
5717232|NCT00441480|Cholesterol|cholesterol
5717233|NCT00441480|Fish oil|fish oil
5717234|NCT00441454|stress urinary incontinence|stress urinary incontinence
5717235|NCT00441454|surgery|surgery
5717236|NCT00441454|tension-free vaginal tape|tension-free vaginal tape
5717237|NCT00441454|retropubic|retropubic
5717238|NCT00441454|transobturator|transobturator
5717239|NCT00441454|quality-of-life|quality-of-life
5717240|NCT00441441|asthma|asthma
5717241|NCT00441441|fluticasone propionate|fluticasone propionate
5717242|NCT00441441|children|children
5717243|NCT00441441|fluticasone propionate/salmeterol|fluticasone propionate/salmeterol
5717244|NCT00441389|Bacteria|bacteria
5717245|NCT00441389|Viruses|viruses
5717246|NCT00441389|COPD|copd
5717247|NCT00441389|infectious etiology for acute exacerbation of COPD|infectious etiology for acute exacerbation of copd
5717248|NCT00441376|Radiofrequency ablation|radiofrequency ablation
5717249|NCT00441376|RFA|rfa
5717250|NCT00441376|Doxorubicin|doxorubicin
5717251|NCT00441376|Liposome|liposome
5717252|NCT00441376|HCC|hcc
5717253|NCT00441376|MLC|mlc
5717254|NCT00441376|hepatocellular carcinoma|hepatocellular carcinoma
5717255|NCT00441376|liver tumor|liver tumor
5717256|NCT00441376|tumor|tumor
5717257|NCT00441376|ablation|ablation
5717258|NCT00441376|heat therapy|heat therapy
5717259|NCT00441376|anti-tumor|anti-tumor
5717260|NCT00441376|liver cancer|liver cancer
5717261|NCT00441376|metastatic liver cancer (MLC)|metastatic liver cancer (mlc)
5717262|NCT00441363|diabetes|diabetes
5717263|NCT00441363|diabetes mellitus|diabetes mellitus
5717264|NCT00441337|malignancies|malignancies
5717265|NCT00441337|cancer|cancer
5717266|NCT00441337|non small cell lung cancer|non small cell lung cancer
5717267|NCT00441337|lung cancer|lung cancer
5717268|NCT00441337|colorectal cancer|colorectal cancer
5717269|NCT00441337|adenocarcinoma|adenocarcinoma
5717270|NCT00441337|melanoma|melanoma
5717271|NCT00441337|malignant melanoma|malignant melanoma
5717272|NCT00441337|renal cancer|renal cancer
5717273|NCT00441337|renal carcinoma|renal carcinoma
5717274|NCT00441337|carcinoma|carcinoma
5717275|NCT00441337|prostate cancer|prostate cancer
5717276|NCT00441337|prostate adenocarcinoma|prostate adenocarcinoma
5717277|NCT00441337|Recurrent or treatment refractory malignancies|recurrent or treatment refractory malignancies
5717278|NCT00441324|Ovarian follicle|ovarian follicle
5717279|NCT00441324|Thecal cells|thecal cells
5717280|NCT00441324|Androgens|androgens
5717281|NCT00441324|FSH sensitivity|fsh sensitivity
5717282|NCT00441311|colorectal cancer screening|colorectal cancer screening
5717284|NCT00441311|health disparities|health disparities
5717285|NCT00441311|stratified randomized clinical trial|stratified randomized clinical trial
5717286|NCT00441298|microbicides|microbicides
5717288|NCT00441298|effectiveness|effectiveness
5717289|NCT00441298|Tenofovir gel|tenofovir gel
5717290|NCT00441298|HIV|hiv
5717291|NCT00441298|young women|young women
5717292|NCT00441298|HIV Seronegativity|hiv seronegativity
5717293|NCT00441285|neurocysticercosis|neurocysticercosis
5717294|NCT00441285|NCC|ncc
5717295|NCT00441285|praziquantel|praziquantel
5717296|NCT00441285|PZQ|pzq
5717297|NCT00441285|albendazole|albendazole
5717298|NCT00441285|ABZ|abz
5717299|NCT00441285|parasite|parasite
5717300|NCT00441285|pig tapeworm|pig tapeworm
5717301|NCT00441285|Taenia solium|taenia solium
5717302|NCT00441285|epilepsy|epilepsy
5717303|NCT00441285|late-onset epilepsy|late-onset epilepsy
5717304|NCT00441285|acquired epilepsy|acquired epilepsy
5717305|NCT00441272|Pioglitazone|pioglitazone
5717306|NCT00441272|Hepatic Steatosis|hepatic steatosis
5717307|NCT00441272|Liver Toxicity|liver toxicity
5717308|NCT00441272|Liver Biopsy|liver biopsy
5717309|NCT00441272|HIV|hiv
5717310|NCT00441272|Treatment Experienced|treatment experienced
5680640|NCT00577213|Diagnosis|diagnosis
5680641|NCT00577213|Hemangiomas|hemangiomas
5680642|NCT00577213|Vascular Malformations|vascular malformations
5680643|NCT00577213|Venular Malformations|venular malformations
5726096|NCT00410397|Low back pain|low back pain
5717311|NCT00441272|Treatment Naive|treatment naive
5717312|NCT00441259|Japanese Encephalitis|japanese encephalitis
5717313|NCT00441246|Acute Respiratory Infection|acute respiratory infection
5717314|NCT00441246|Bronchitis|bronchitis
5717315|NCT00441246|Rhinosinusitis|rhinosinusitis
5717316|NCT00441220|Genetic polymorphisms|genetic polymorphisms
5717317|NCT00441220|Cyclophosphamide|cyclophosphamide
5717318|NCT00441220|Cytochrome p450 CYP2C19 (Human)|cytochrome p450 cyp2c19 (human)
5717319|NCT00441220|Systemic Lupus Erythematosus|systemic lupus erythematosus
5717320|NCT00441207|IV Ascorbic Acid|iv ascorbic acid
5717321|NCT00441207|IV Vitamin C|iv vitamin c
5717323|NCT00441207|Advanced Solid Tumors|advanced solid tumors
5717324|NCT00441194|Perimetry|perimetry
5717325|NCT00441194|Visual Field|visual field
5717326|NCT00441194|Octopus|octopus
5717327|NCT00441181|Neovascular glaucoma|neovascular glaucoma
5717328|NCT00441181|Travoprost|travoprost
5717329|NCT00441168|Multiple Myeloma|multiple myeloma
5717330|NCT00441168|bortezomib|bortezomib
5717331|NCT00441168|Cancer|cancer
5717332|NCT00441168|Hematology|hematology
5717333|NCT00441168|bone marrow|bone marrow
5717334|NCT00441168|immunoglobulin|immunoglobulin
5717335|NCT00441168|relapse|relapse
5717336|NCT00441168|refractory|refractory
5717337|NCT00441168|plasma cell|plasma cell
5717338|NCT00441168|Velcade|velcade
5717339|NCT00441168|adriamycin|adriamycin
5717340|NCT00441168|dexamethasone|dexamethasone
5717341|NCT00441168|vincristine|vincristine
5717342|NCT00441155|Oncology|oncology
5717343|NCT00441155|Cancer|cancer
5717344|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors|imatinib-resistant gastrointestinal stromal tumors
5717345|NCT00441155|GIST|gist
5717346|NCT00441155|Nilotinib|nilotinib
5717347|NCT00441155|Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST)|imatinib-resistant gastrointestinal stromal tumors (gist)
5717348|NCT00441142|Newly diagnosed malignant brain tumors.|newly diagnosed malignant brain tumors.
5717349|NCT00441129|Improvement of the blood glucose control|improvement of the blood glucose control
5717350|NCT00441116|dutasteride|dutasteride
5717351|NCT00441116|Androgenic alopecia|androgenic alopecia
5717352|NCT00441116|phase 3|phase 3
5717353|NCT00441103|Subjects with relapsing remitting multiple sclerosis|subjects with relapsing remitting multiple sclerosis
5717354|NCT00441090|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5717355|NCT00441090|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5717356|NCT00441090|ITP|itp
5717357|NCT00441077|Genetics|genetics
5717358|NCT00441077|Family History|family history
5717359|NCT00441077|Latino|latino
5717360|NCT00441077|Information Seeking|information seeking
5717361|NCT00441077|Lay Health Advisors|lay health advisors
5717362|NCT00441077|Cancer|cancer
5717363|NCT00441077|Heart Disease|heart disease
5717372|NCT00441012|Haemophilus Influenza, type b and Hepatitis B|haemophilus influenza, type b and hepatitis b
5717374|NCT00440999|malaria|malaria
5717375|NCT00440999|ACT|act
5717376|NCT00440986|Clinical Management|clinical management
5717377|NCT00440986|Phlebotomy|phlebotomy
5717378|NCT00440986|Eritrocytoapheresis|eritrocytoapheresis
5717379|NCT00440973|kidney cancer|kidney cancer
5717380|NCT00440973|M3thodist|m3thodist
5717381|NCT00440960|alfentanil|alfentanil
5717382|NCT00440960|anesthesia|anesthesia
5717383|NCT00440960|bronchoscopy|bronchoscopy
5717384|NCT00440960|lidocaine|lidocaine
5717385|NCT00440960|midazolam|midazolam
5717386|NCT00440960|propofol.|propofol.
5717387|NCT00440947|NORVIR|norvir
5717388|NCT00440947|ARIES|aries
5717389|NCT00440947|EPZICOM|epzicom
5717391|NCT00440947|HIV|hiv
5717392|NCT00440947|simplification|simplification
5717393|NCT00440947|Antiretroviral-naive|antiretroviral-naive
5717394|NCT00440934|carcinoma, hepatocellular|carcinoma, hepatocellular
5717395|NCT00440934|electromagnetic fields|electromagnetic fields
5717396|NCT00440921|fibrin sealnat|fibrin sealnat
5717397|NCT00440921|knee replacement|knee replacement
5717398|NCT00440921|hip replacement|hip replacement
5717399|NCT00440921|woud healing|woud healing
5717400|NCT00440921|blood loss|blood loss
5717401|NCT00440921|clinical trial|clinical trial
5717402|NCT00440921|randomized|randomized
5717403|NCT00440908|Dialyzer reuse|dialyzer reuse
5717404|NCT00440908|Inflammatory markers|inflammatory markers
5717405|NCT00440908|Nutritional status|nutritional status
5717406|NCT00440895|Coronary artery stenting|coronary artery stenting
5717407|NCT00440895|Trans-radial|trans-radial
5717408|NCT00440895|Intracoronary|intracoronary
5717409|NCT00440895|Rescue-PCI|rescue-pci
5717410|NCT00440869|N-acetylcysteine|n-acetylcysteine
5717411|NCT00440869|oxidative stress|oxidative stress
5717412|NCT00440869|muscle fatigue|muscle fatigue
5717413|NCT00440869|end-stage renal disease|end-stage renal disease
5717414|NCT00440869|hemodialysis|hemodialysis
5717415|NCT00440856|Intervertebral disc|intervertebral disc
5717416|NCT00440856|Lumbar discectomy|lumbar discectomy
5717417|NCT00440856|Outcome|outcome
5717418|NCT00440856|Radiculopathy due to prolapsed intervertebral disc.|radiculopathy due to prolapsed intervertebral disc.
5717419|NCT00440843|schizophrenia|schizophrenia
5717421|NCT00440843|task engagement|task engagement
5717422|NCT00440843|antipsychotics|antipsychotics
5717423|NCT00440843|cognition|cognition
5717424|NCT00440843|cognitive rehabilitation|cognitive rehabilitation
5717425|NCT00440830|acute pain|acute pain
5717426|NCT00440830|nicotine|nicotine
5717428|NCT00440830|sedation|sedation
5717429|NCT00440817|Lymphoma|lymphoma
5717430|NCT00440817|Rheumatoid arthritis|rheumatoid arthritis
5717431|NCT00440817|Crohn's disease|crohn's disease
5717432|NCT00440817|Remicade|remicade
5717433|NCT00440817|Infliximab|infliximab
5717434|NCT00440804|patent ductus arterious|patent ductus arterious
5717435|NCT00440791|Colon|colon
5717436|NCT00440791|colonic disease|colonic disease
5717437|NCT00440791|capsule endoscopy|capsule endoscopy
5717438|NCT00440791|Suspected or known colonic disease|suspected or known colonic disease
5717439|NCT00440778|Coronary artery stenting|coronary artery stenting
5717440|NCT00440778|Trans-radial|trans-radial
5716188|NCT00444119|DHEA|dhea
5717441|NCT00440778|Intracoronary|intracoronary
5717442|NCT00440765|Multiple Myeloma|multiple myeloma
5717443|NCT00440765|hematological Neoplasms|hematological neoplasms
5717444|NCT00440765|chemotherapy|chemotherapy
5717445|NCT00440765|efficacy|efficacy
5717446|NCT00440765|safety|safety
5717447|NCT00440765|bortezomib|bortezomib
5717448|NCT00440765|proteasome inhibitor|proteasome inhibitor
5717449|NCT00440752|Artemether-lumefantrine|artemether-lumefantrine
5717450|NCT00440752|Plasmodium falciparum|plasmodium falciparum
5717451|NCT00440752|drug resistance genes|drug resistance genes
5717452|NCT00440739|postoperative pain, etoticoxib, etoricoxib|postoperative pain, etoticoxib, etoricoxib
5717453|NCT00440739|Pain relief after transurethral resection of prostate.|pain relief after transurethral resection of prostate.
5717475|NCT00440700|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5717476|NCT00440700|Anxiety|anxiety
5717477|NCT00440687|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5717478|NCT00440687|primary care|primary care
5717479|NCT00440687|randomised trials|randomised trials
5717480|NCT00440687|therapeutic interventions|therapeutic interventions
5717481|NCT00440674|Direct Stenting|direct stenting
5717482|NCT00440674|Angioplasty|angioplasty
5717483|NCT00440674|Pre-dilatation|pre-dilatation
5717484|NCT00440674|Drug-eluting stent|drug-eluting stent
5717485|NCT00440661|Osteoarthritis, IL-1|osteoarthritis, il-1
5717486|NCT00440635|Multiple myeloma|multiple myeloma
5717487|NCT00440635|bortezomib, Hematology|bortezomib, hematology
5717488|NCT00440622|Cancer|cancer
5717489|NCT00440622|Metastatic Breast cancer|metastatic breast cancer
5717490|NCT00440622|Her-2 expression|her-2 expression
5717491|NCT00440622|Gemcitabine|gemcitabine
5717492|NCT00440622|Capecitabine|capecitabine
5717493|NCT00440622|Herceptin|herceptin
5717494|NCT00440583|CHOP-Z|chop-z
5717495|NCT00440570|cancer|cancer
5717496|NCT00440570|electromagnetic fields|electromagnetic fields
5717497|NCT00440570|treatment|treatment
5717498|NCT00440557|Anemia|anemia
5717499|NCT00440557|Chronic Kidney disease|chronic kidney disease
5717500|NCT00440557|Kidney disease|kidney disease
5717501|NCT00440557|Epoetin alfa|epoetin alfa
5717502|NCT00440557|Procrit|procrit
5717503|NCT00440544|Tuberculosis|tuberculosis
5717504|NCT00440544|vaccine|vaccine
5717505|NCT00440544|nasal immunization|nasal immunization
5717506|NCT00440518|Lacosamide|lacosamide
5717507|NCT00440518|migraine prophylaxis|migraine prophylaxis
5717508|NCT00440518|Vimpat|vimpat
5717509|NCT00440505|chronic pain|chronic pain
5717510|NCT00440505|pelvic pain|pelvic pain
5717511|NCT00440505|nicotine patch|nicotine patch
5717512|NCT00440479|Multiple Myeloma|multiple myeloma
5717514|NCT00440479|chemotherapy|chemotherapy
5717516|NCT00440479|safety|safety
5717517|NCT00440479|bortezomib|bortezomib
5717518|NCT00440479|proteasome inhibitor|proteasome inhibitor
5717519|NCT00440466|Anemia|anemia
5717520|NCT00440466|Reduction in the number of erythrocytes|reduction in the number of erythrocytes
5717521|NCT00440466|Hemoglobin low level|hemoglobin low level
5717522|NCT00440466|Red blood cell deficiency|red blood cell deficiency
5717523|NCT00440466|Procrit|procrit
5717524|NCT00440466|Epoetin alfa|epoetin alfa
5717525|NCT00440466|Chronic kidney disease|chronic kidney disease
5717526|NCT00440453|Internal medicine patients|internal medicine patients
5717527|NCT00440440|hypogonadism|hypogonadism
5717528|NCT00440440|diabetes|diabetes
5717529|NCT00440440|visceral fat|visceral fat
5717530|NCT00440440|hepatic fat|hepatic fat
5717531|NCT00440440|lean mass|lean mass
5717532|NCT00440427|Major Depressive Disorder|major depressive disorder
5717533|NCT00440427|MDD|mdd
5717535|NCT00440414|Non-small-cell lung cancer|non-small-cell lung cancer
5717536|NCT00440414|Chemotherapy|chemotherapy
5717537|NCT00440414|Pemetrexed|pemetrexed
5717538|NCT00440414|Erlotinib|erlotinib
5717539|NCT00440401|Surgical treatment of haemorrhage|surgical treatment of haemorrhage
5717540|NCT00440388|cancer|cancer
5717541|NCT00440388|lymphoma|lymphoma
5717542|NCT00440388|Non-Hodgkin's|non-hodgkin's
5717543|NCT00440388|Non-Hodgkins|non-hodgkins
5717550|NCT00440362|A/Wyoming/03/2003|a/wyoming/03/2003
5717551|NCT00440362|Alphavirus|alphavirus
5717681|NCT00439907|Anal sphincter|anal sphincter
5717552|NCT00440349|Retroperitoneal fibrosis|retroperitoneal fibrosis
5717553|NCT00440349|Tamoxifen|tamoxifen
5717555|NCT00440349|Obstructive uropathy|obstructive uropathy
5717556|NCT00440349|Periaortic fibrosis|periaortic fibrosis
5717557|NCT00440349|Chronic periaortitis|chronic periaortitis
5717558|NCT00440336|IOP|iop
5717559|NCT00440336|SLT|slt
5717560|NCT00440336|Laser|laser
5717561|NCT00440336|Cosopt|cosopt
5717562|NCT00440323|Noise induced Situational insomnia,|noise induced situational insomnia,
5717563|NCT00440323|healthy volunteers|healthy volunteers
5717564|NCT00440323|SB-649868,|sb-649868,
5717565|NCT00440323|Zolpidem,|zolpidem,
5717566|NCT00440310|Liver neoplasms|liver neoplasms
5717567|NCT00440310|Liver metastases|liver metastases
5717568|NCT00440310|MCRC|mcrc
5717569|NCT00440310|Litx™|litx™
5717570|NCT00440310|LS11|ls11
5685926|NCT00554268|Advanced Cancers|advanced cancers
5685927|NCT00554268|Solid Tumors|solid tumors
5685928|NCT00554268|PBI-05204|pbi-05204
5685929|NCT00554255|Pharmacodynamics|pharmacodynamics
5685930|NCT00554255|Japanese|japanese
5717571|NCT00440310|Colorectal cancer with recurrent liver metastases|colorectal cancer with recurrent liver metastases
5717572|NCT00440297|hepatitis B virus|hepatitis b virus
5717573|NCT00440284|conventional insulin therapy|conventional insulin therapy
5717574|NCT00440284|intensive insulin therapy|intensive insulin therapy
5717575|NCT00440284|self-management|self-management
5717576|NCT00440284|patient education|patient education
5717577|NCT00440284|RCT|rct
5717578|NCT00440284|glycosylated hemoglobin|glycosylated hemoglobin
5717579|NCT00440284|hypoglycemia|hypoglycemia
5717580|NCT00440284|patient preference|patient preference
5717581|NCT00440258|Ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2|ovarian hyperstimulation syndrome, dopamine agonists, cabergoline, hemoconcentration, ascites, ovarian perfusion, dopamine receptor 2
5717582|NCT00440219|Nasal polyps|nasal polyps
5717583|NCT00440219|Steroids|steroids
5717584|NCT00440219|Prednisone|prednisone
5717585|NCT00440219|Nasal polypectomy|nasal polypectomy
5717586|NCT00440219|Blood loss, surgical|blood loss, surgical
5717587|NCT00440206|HIV|hiv
5717588|NCT00440206|Immune Markers|immune markers
5717589|NCT00440180|Obesity|obesity
5717590|NCT00440180|Low sperm count|low sperm count
5717591|NCT00440180|Male infertility|male infertility
5717592|NCT00440167|capecitabine|capecitabine
5717593|NCT00440167|gemcitabine|gemcitabine
5717594|NCT00440167|Erlotinib|erlotinib
5717595|NCT00440167|pancreatic cancer|pancreatic cancer
5717596|NCT00440167|advanced|advanced
5717597|NCT00440128|Casopitant,|casopitant,
5717598|NCT00440128|Neurokinin-1 Receptor Antagonist,|neurokinin-1 receptor antagonist,
5717599|NCT00440128|Drug-Interaction,|drug-interaction,
5717600|NCT00440128|CYP3A|cyp3a
5717601|NCT00440128|NK-1 Receptor Antagonist,|nk-1 receptor antagonist,
5717602|NCT00440128|GW679769,|gw679769,
5717603|NCT00440128|Docetaxel,|docetaxel,
5717604|NCT00440102|ETOMIDATE|etomidate
5717605|NCT00440102|KETAMINE|ketamine
5717606|NCT00440102|RAPID SEQUENCE INTUBATION|rapid sequence intubation
5717607|NCT00440102|PREHOSPITAL|prehospital
5734203|NCT00378781|stage III melanoma|stage iii melanoma
5734204|NCT00378781|stage IV melanoma|stage iv melanoma
5734205|NCT00378781|recurrent melanoma|recurrent melanoma
5734206|NCT00378781|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5734207|NCT00378781|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5734208|NCT00378781|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5717608|NCT00440102|During rapid sequence intubation|during rapid sequence intubation
5717609|NCT00440089|Cancer|cancer
5717610|NCT00440089|Fatigue|fatigue
5717611|NCT00440089|Breast Cancer|breast cancer
5717612|NCT00440089|Healing|healing
5717613|NCT00440089|Energy Healing|energy healing
5717614|NCT00440089|Complementary|complementary
5717615|NCT00440089|Alternative|alternative
5717616|NCT00440089|Immune|immune
5717617|NCT00440089|Cytokine|cytokine
5717618|NCT00440089|Hormone|hormone
5717619|NCT00440089|Cortisol|cortisol
5717620|NCT00440089|Placebo|placebo
5717621|NCT00440089|Mock Healing|mock healing
5717622|NCT00440076|MDS|mds
5717623|NCT00440076|Velcade|velcade
5717624|NCT00440050|fish oil|fish oil
5717625|NCT00440050|omega-3 fatty acids|omega-3 fatty acids
5717626|NCT00440050|EPA|epa
5717627|NCT00440037|AMG 531|amg 531
5717628|NCT00440037|ITP|itp
5717629|NCT00440037|Long term treatment|long term treatment
5717630|NCT00440037|Japanese|japanese
5717631|NCT00440037|Romiplostim|romiplostim
5717632|NCT00440024|Sun-Damaged Skin|sun-damaged skin
5717633|NCT00440024|Retinoid Intolerance|retinoid intolerance
5717634|NCT00440024|Tazarotene Cream|tazarotene cream
5717635|NCT00440024|Dove facial cleanser|dove facial cleanser
5717636|NCT00440024|Dove moisturizer|dove moisturizer
5717637|NCT00439998|Ultrasound|ultrasound
5717638|NCT00439998|Obesity|obesity
5717639|NCT00439998|Needle Depth|needle depth
5717640|NCT00439985|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5717641|NCT00439985|Metabolic Control|metabolic control
5717642|NCT00439985|Adherence|adherence
5717643|NCT00439985|Optimism|optimism
5717644|NCT00439985|Parent-Child Collaboration|parent-child collaboration
5717645|NCT00439985|Prevention|prevention
5717646|NCT00439972|Lipoproteins|lipoproteins
5717647|NCT00439972|Apolipoproteins|apolipoproteins
5707857|NCT00472849|CLL|cll
5717648|NCT00439972|Insulin sensitivity|insulin sensitivity
5717649|NCT00439972|Inflammation|inflammation
5717650|NCT00439972|Clotting|clotting
5717651|NCT00439972|Antioxidant status|antioxidant status
5717652|NCT00439972|Vascular reactivity|vascular reactivity
5717655|NCT00439959|Hepatitis C,|hepatitis c,
5717656|NCT00439959|metabolic probe,|metabolic probe,
5717657|NCT00439959|food-effect,|food-effect,
5717658|NCT00439959|HCV,|hcv,
5717659|NCT00439959|FTIH|ftih
5717660|NCT00439959|polymerase,|polymerase,
5717661|NCT00439946|pulmonary hypertension|pulmonary hypertension
5717663|NCT00439946|Remodulin|remodulin
5717664|NCT00439946|treprostinil|treprostinil
5717665|NCT00439946|Quality of Life|quality of life
5717666|NCT00439946|rapid switch|rapid switch
5717667|NCT00439933|Obesity|obesity
5717668|NCT00439933|Children|children
5717669|NCT00439933|Weight loss|weight loss
5717670|NCT00439933|Endothelial dysfunction|endothelial dysfunction
5717671|NCT00439933|Intervention|intervention
5717672|NCT00439920|ALL|all
5717673|NCT00439907|Anal sphincter Delivery|anal sphincter delivery
5717674|NCT00439907|Primary repair|primary repair
5717678|NCT00439907|Anal sonography|anal sonography
5717679|NCT00439907|Weksner Score|weksner score
5717680|NCT00439907|Rupture of the external anal sphincter during delivery|rupture of the external anal sphincter during delivery
5717682|NCT00439907|Anal sphincter rupture|anal sphincter rupture
5717683|NCT00439894|Rheumatoid Arthritis|rheumatoid arthritis
5717684|NCT00439894|etanercept|etanercept
5717686|NCT00439894|Amgen|amgen
5717687|NCT00439881|inflammation,|inflammation,
5717688|NCT00439881|intravenous,|intravenous,
5717689|NCT00439881|Chronic Obstructive Pulmonary Disease,|chronic obstructive pulmonary disease,
5717690|NCT00439881|P38 inhibitor|p38 inhibitor
5717691|NCT00439881|SB-681323,|sb-681323,
5717692|NCT00439881|rheumatoid arthritis,|rheumatoid arthritis,
5717693|NCT00439868|WELLBUTRIN XL, intraocular pressure, healthy volunteers|wellbutrin xl, intraocular pressure, healthy volunteers
5717694|NCT00439855|Enoxaparin, heparin, hemorrhages|enoxaparin, heparin, hemorrhages
5717695|NCT00439829|follicle|follicle
5717696|NCT00439829|ovary|ovary
5717697|NCT00439829|poor responder|poor responder
5717698|NCT00439829|stimulation|stimulation
5717699|NCT00439829|follicle wave emergence|follicle wave emergence
5717700|NCT00439816|Hypertension Outcomes|hypertension outcomes
5717701|NCT00439816|Health Outcomes|health outcomes
5717702|NCT00439816|Outpatient|outpatient
5717703|NCT00439816|Racial Preference|racial preference
5717704|NCT00439816|Blood Pressure Control|blood pressure control
5717705|NCT00439816|Clinical Trial|clinical trial
5717706|NCT00439816|Intervention|intervention
5717707|NCT00439816|Lifestyle modifications|lifestyle modifications
5717708|NCT00439816|Ethnic Differences|ethnic differences
5717709|NCT00439816|Randomized|randomized
5717710|NCT00439803|CMV|cmv
5717711|NCT00439803|cytomegalovirus|cytomegalovirus
5717712|NCT00439803|Alphavirus|alphavirus
5717713|NCT00439790|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5717714|NCT00439790|Heart failure|heart failure
5717715|NCT00439790|Sudden Cardiac Arrest|sudden cardiac arrest
5717716|NCT00439790|appropriate shock|appropriate shock
5717717|NCT00439790|Defibrillators, Implantable|defibrillators, implantable
5717718|NCT00439764|Low back pain, health education, physical therapy|low back pain, health education, physical therapy
5717719|NCT00439751|Prostate Cancer|prostate cancer
5717720|NCT00439751|Androgen Deprivation Therapy|androgen deprivation therapy
5717721|NCT00439751|Recurrence|recurrence
5717722|NCT00439751|Biochemical Failure|biochemical failure
5717723|NCT00439751|Goserelin|goserelin
5717724|NCT00439738|Obesity, hypertension, valsartan/hydrochlorothiazide|obesity, hypertension, valsartan/hydrochlorothiazide
5717725|NCT00439699|Essential Tremor|essential tremor
5717726|NCT00439699|Memantine|memantine
5717727|NCT00439699|Clinical Trial|clinical trial
5717728|NCT00439673|MDS|mds
5717729|NCT00439673|5-Azacytidine|5-azacytidine
5717730|NCT00439673|valproic acid|valproic acid
5717731|NCT00439673|atra|atra
5717732|NCT00439673|intermediate or high risk|intermediate or high risk
5717733|NCT00439673|Age ≥18 yearsAge|age ≥18 yearsage
5717734|NCT00439660|Rotavirus, diarrhea, vaccine|rotavirus, diarrhea, vaccine
5717735|NCT00439647|Osteoporosis|osteoporosis
5717736|NCT00439647|males|males
5717737|NCT00439647|vertebral fractures|vertebral fractures
5717738|NCT00439647|clinical fractures|clinical fractures
5717739|NCT00439647|bone mineral density|bone mineral density
5717740|NCT00439647|bone biomarkers|bone biomarkers
5717741|NCT00439647|zoledronic acid|zoledronic acid
5717742|NCT00439634|psychometrics|psychometrics
5717743|NCT00439634|schizophrenia|schizophrenia
5717744|NCT00439621|immunotherapy|immunotherapy
5717749|NCT00439595|Anaemia|anaemia
5717750|NCT00439595|Diagnosis|diagnosis
5717751|NCT00439595|Primary|primary
5717752|NCT00439595|Care|care
5717753|NCT00439595|Treatment|treatment
5717754|NCT00439582|Lipoproteins|lipoproteins
5717755|NCT00439582|Milk fat|milk fat
5717756|NCT00439582|Public health nutrition|public health nutrition
5717757|NCT00439582|trans fatty acid|trans fatty acid
5707957|NCT00472381|DWI|dwi
5717758|NCT00439569|spinal muscular atrophy type II/III|spinal muscular atrophy type ii/iii
5717759|NCT00439569|SMA type II/III|sma type ii/iii
5717760|NCT00439569|spinal muscular atrophy|spinal muscular atrophy
5717762|NCT00439569|sodium phenylbutyrate|sodium phenylbutyrate
5718221|NCT00438152|Lopinavir|lopinavir
5717763|NCT00439569|motor neuron disease|motor neuron disease
5717764|NCT00439569|neuromuscular|neuromuscular
5717765|NCT00439569|survival motor neuron|survival motor neuron
5717767|NCT00439569|dose escalation|dose escalation
5717768|NCT00439543|Pulmonary fibrosis|pulmonary fibrosis
5717769|NCT00439543|pulmonary hypertension|pulmonary hypertension
5717770|NCT00439543|Iloprost|iloprost
5717771|NCT00439543|Efficacy|efficacy
5717772|NCT00439530|oseltamivir|oseltamivir
5717773|NCT00439530|pharmacokinetics|pharmacokinetics
5717774|NCT00439530|probenecid|probenecid
5717775|NCT00439530|avian influenza|avian influenza
5717776|NCT00439517|Cancer|cancer
5717777|NCT00439517|Colorectal|colorectal
5717778|NCT00439517|Metastatic|metastatic
5717779|NCT00439517|Untreated|untreated
5717780|NCT00439491|Obesity|obesity
5717781|NCT00439491|Insulin resistance|insulin resistance
5717782|NCT00439491|Hypocaloric diet|hypocaloric diet
5717783|NCT00439491|Adipose tissue|adipose tissue
5717784|NCT00439491|adipocytokine|adipocytokine
5717785|NCT00439478|Radioiodine, Thyroid Cancer, Sialadenitis, Xerostomia|radioiodine, thyroid cancer, sialadenitis, xerostomia
5717786|NCT00439387|Serotonin|serotonin
5717787|NCT00439387|Epilepsy|epilepsy
5717788|NCT00439387|Healthy Volunteer|healthy volunteer
5717789|NCT00439387|HV|hv
5717790|NCT00439374|nulliparous|nulliparous
5717791|NCT00439374|pregnancy|pregnancy
5717792|NCT00439374|short cervix|short cervix
5717793|NCT00439374|progesterone|progesterone
5717794|NCT00439361|Hodgkin Lymphoma|hodgkin lymphoma
5717795|NCT00439361|HL|hl
5717796|NCT00439361|Relapsed Classical Hodgkin Lymphoma|relapsed classical hodgkin lymphoma
5717797|NCT00439361|Refractory|refractory
5717798|NCT00439361|Lymphoma|lymphoma
5717799|NCT00439361|Nodular sclerosis|nodular sclerosis
5717800|NCT00439361|Mixed cellularity|mixed cellularity
5717801|NCT00439361|Lymphocyte-rich classical HL|lymphocyte-rich classical hl
5717802|NCT00439361|Bortezomib|bortezomib
5717803|NCT00439361|Velcade|velcade
5717804|NCT00439361|LDP-341|ldp-341
5717805|NCT00439361|MLN341|mln341
5717806|NCT00439361|PS-341|ps-341
5717807|NCT00439361|Carboplatin|carboplatin
5717808|NCT00439361|Paraplatin|paraplatin
5717809|NCT00439361|Etoposide|etoposide
5717810|NCT00439361|VePesid®|vepesid®
5717811|NCT00439361|Ifosfamide|ifosfamide
5717813|NCT00439361|Mesnex|mesnex
5717814|NCT00439361|ICE|ice
5717815|NCT00439348|Calcium|calcium
5717816|NCT00439348|Compliance|compliance
5717817|NCT00439348|Medication compliance|medication compliance
5717818|NCT00439348|electronic prescription|electronic prescription
5717819|NCT00439348|over-the-counter medications|over-the-counter medications
5717820|NCT00439348|OTC medications|otc medications
5717821|NCT00439335|Influenza, vaccine, A/H5N1|influenza, vaccine, a/h5n1
5717822|NCT00439322|PTSD|ptsd
5717823|NCT00439296|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5717824|NCT00439296|Pediatrics|pediatrics
5717825|NCT00439296|Relapsed|relapsed
5717826|NCT00439296|Recurrence|recurrence
5717827|NCT00439296|ABT-751|abt-751
5717828|NCT00439296|Therapeutic Advances in Childhood Leukemia|therapeutic advances in childhood leukemia
5717829|NCT00439296|Investigational|investigational
5717830|NCT00439296|Childhood|childhood
5717831|NCT00439296|ALL|all
5717833|NCT00439296|Refractory ALL|refractory all
5717834|NCT00439296|Relapsed pediatric ALL|relapsed pediatric all
5717835|NCT00439296|Refractory pediatric ALL|refractory pediatric all
5717836|NCT00439296|TACL|tacl
5717837|NCT00439283|Ankylosing spondylitis|ankylosing spondylitis
5717838|NCT00439283|infliximab|infliximab
5717839|NCT00439283|Systematic regimen|systematic regimen
5717840|NCT00439283|On-demand regimen|on-demand regimen
5717841|NCT00439270|Metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
5717842|NCT00439244|Bone Mineral Density (BMD)|bone mineral density (bmd)
5717843|NCT00439244|C-Telopeptides (CTx)|c-telopeptides (ctx)
5717844|NCT00439244|dual x-ray absorptiometry (DXA)|dual x-ray absorptiometry (dxa)
5717845|NCT00439244|pro-collagen type 1 N-propeptide (P1NP)|pro-collagen type 1 n-propeptide (p1np)
5717846|NCT00439244|teriparatide|teriparatide
5717847|NCT00439244|zoledronic acid|zoledronic acid
5717849|NCT00439244|postmenopausal women|postmenopausal women
5717850|NCT00439231|Monoclonal Antibody Therapy|monoclonal antibody therapy
5717851|NCT00439231|Biologic Response Modifier Therapy|biologic response modifier therapy
5717852|NCT00439231|CLL|cll
5717853|NCT00439231|SLL|sll
5717854|NCT00439231|chemo-care (CC) 5013- Revlimid|chemo-care (cc) 5013- revlimid
5717855|NCT00439231|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5717856|NCT00439231|Small Lymphocytic Leukemia|small lymphocytic leukemia
5717857|NCT00439218|spinal muscular atrophy type I|spinal muscular atrophy type i
5717858|NCT00439218|SMA type I|sma type i
5717859|NCT00439218|spinal muscular atrophy|spinal muscular atrophy
5717861|NCT00439218|sodium phenylbutyrate|sodium phenylbutyrate
5717862|NCT00439218|motor neuron disease|motor neuron disease
5717863|NCT00439218|neuromuscular|neuromuscular
5717864|NCT00439218|survival motor neuron|survival motor neuron
5717865|NCT00439218|SMN|smn
5717866|NCT00439218|dose escalation|dose escalation
5717867|NCT00439205|Oral Tumors|oral tumors
5717868|NCT00439205|Oral Margin Spectroscopy|oral margin spectroscopy
5717869|NCT00439205|Oral Spectroscopy|oral spectroscopy
5717870|NCT00439205|Optical Spectroscopy|optical spectroscopy
5717871|NCT00439205|Oral neoplastic lesions|oral neoplastic lesions
5725418|NCT00412646|HIV|hiv
5717872|NCT00439205|FastEEM4 System|fasteem4 system
5717873|NCT00439205|Multispectral Digital Microscope|multispectral digital microscope
5717875|NCT00439205|Nonstandard imaging technology|nonstandard imaging technology
5717876|NCT00439192|OAB, proof of concept|oab, proof of concept
5717878|NCT00439192|with incontinence|with incontinence
5717880|NCT00439166|doxycycline|doxycycline
5717881|NCT00439166|rifampicin|rifampicin
5717882|NCT00439166|cerebrospinal fluid|cerebrospinal fluid
5717883|NCT00439166|biomarkers|biomarkers
5717884|NCT00439166|beta amyloid|beta amyloid
5717885|NCT00439166|tau|tau
5717886|NCT00439127|thyroglobulin|thyroglobulin
5717887|NCT00439127|thyroid carcinoma|thyroid carcinoma
5717888|NCT00439127|tumour marker|tumour marker
5717889|NCT00439127|radioiodine|radioiodine
5717890|NCT00439127|recombinant human TSH|recombinant human tsh
5717891|NCT00439114|Corneal topography, corneal opacity, keratitis, trachoma|corneal topography, corneal opacity, keratitis, trachoma
5717892|NCT00439101|weight loss|weight loss
5717893|NCT00439101|malignancy|malignancy
5717894|NCT00439101|corticosteroids|corticosteroids
5717895|NCT00439101|supplemental feeding|supplemental feeding
5717896|NCT00439101|adrenal insufficiency|adrenal insufficiency
5717897|NCT00439101|diabetes|diabetes
5717898|NCT00439088|Ambulation|ambulation
5717899|NCT00439088|Ambulatory Monitoring|ambulatory monitoring
5717900|NCT00439088|Activities of Daily Living|activities of daily living
5717901|NCT00439088|Pedometer|pedometer
5717902|NCT00439088|Validation Studies [PT]|validation studies [pt]
5717903|NCT00439075|pulmonary disease|pulmonary disease
5717904|NCT00439075|CPO|cpo
5717905|NCT00439075|CPAP|cpap
5717906|NCT00439075|oxygenation|oxygenation
5717907|NCT00439075|out-of-hospital intervention|out-of-hospital intervention
5717908|NCT00439062|Roxithromycin,Rheumatoid arthritis,Macrolides|roxithromycin,rheumatoid arthritis,macrolides
5717909|NCT00439049|Substance Abuse|substance abuse
5717910|NCT00439049|Treatment|treatment
5717911|NCT00439049|Eligibility|eligibility
5717912|NCT00439036|Opiate|opiate
5717913|NCT00439036|Behavior Therapy|behavior therapy
5717914|NCT00439036|Methadone|methadone
5717915|NCT00439036|Acceptance and Commitment Therapy (ACT)|acceptance and commitment therapy (act)
5717916|NCT00439023|Chronic renal failure, dialysis, hemodialysis,|chronic renal failure, dialysis, hemodialysis,
5717917|NCT00439010|neurological|neurological
5717918|NCT00439010|alzheimer|alzheimer
5717919|NCT00438971|Panic Disorder|panic disorder
5717920|NCT00438971|Anxiety Disorder|anxiety disorder
5717921|NCT00438971|Duloxetine|duloxetine
5717922|NCT00438958|graft versus host disease|graft versus host disease
5717923|NCT00438958|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5717924|NCT00438958|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5717925|NCT00438958|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5717926|NCT00438958|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5713043|NCT00453622|cardiac enzymes|cardiac enzymes
5717927|NCT00438958|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5717928|NCT00438958|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5717929|NCT00438958|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5717930|NCT00438958|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5717931|NCT00438958|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5717932|NCT00438958|refractory anemia with excess blasts|refractory anemia with excess blasts
5717933|NCT00438958|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5717935|NCT00438958|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5717936|NCT00438958|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5717937|NCT00438958|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5680644|NCT00577213|Venous Malformations|venous malformations
5680645|NCT00577213|Lymphatic Malformations|lymphatic malformations
5680646|NCT00577213|Arteriovenous Malformations|arteriovenous malformations
5680647|NCT00577174|Children|children
5717938|NCT00438958|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5717939|NCT00438958|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5717940|NCT00438958|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5717941|NCT00438958|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5717942|NCT00438958|primary myelofibrosis|primary myelofibrosis
5717943|NCT00438958|secondary myelofibrosis|secondary myelofibrosis
5717944|NCT00438958|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5717945|NCT00438958|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5717946|NCT00438958|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5717947|NCT00438958|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5717948|NCT00438958|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5717949|NCT00438958|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5717950|NCT00438958|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5717951|NCT00438958|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5717952|NCT00438958|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5717953|NCT00438958|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5717954|NCT00438958|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5717955|NCT00438958|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5717956|NCT00438958|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5717957|NCT00438958|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5717958|NCT00438958|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5717959|NCT00438958|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5717960|NCT00438958|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5717961|NCT00438958|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5717962|NCT00438958|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5717963|NCT00438958|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5717964|NCT00438958|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5717965|NCT00438958|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5717966|NCT00438958|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5717967|NCT00438958|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5717968|NCT00438958|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5717969|NCT00438958|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5717970|NCT00438958|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5717971|NCT00438958|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5717972|NCT00438958|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5717973|NCT00438958|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5717974|NCT00438958|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5717975|NCT00438958|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5717976|NCT00438958|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5717977|NCT00438958|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5717978|NCT00438958|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5717979|NCT00438958|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5717980|NCT00438958|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5717981|NCT00438958|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5717982|NCT00438958|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5717983|NCT00438958|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5717984|NCT00438958|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5717985|NCT00438958|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5717986|NCT00438958|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5717987|NCT00438958|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5717989|NCT00438958|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5717990|NCT00438958|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5717991|NCT00438932|phosphate, phosphorus, FGF-23, PTH, 1,25D|phosphate, phosphorus, fgf-23, pth, 1,25d
5717992|NCT00438906|pancreatic lesions|pancreatic lesions
5717993|NCT00438906|pancreatic cancer|pancreatic cancer
5717994|NCT00438906|peutz-jeghers syndrome|peutz-jeghers syndrome
5717995|NCT00438906|BRCA 2 gene mutation|brca 2 gene mutation
5717996|NCT00438906|FAMMM/p16|fammm/p16
5717997|NCT00438906|Genes, BRCA2|genes, brca2
5717998|NCT00438893|Viscous dietary fiber|viscous dietary fiber
5717999|NCT00438893|Soy protein|soy protein
5718000|NCT00438893|Nuts|nuts
5718001|NCT00438893|Plant sterols|plant sterols
5718002|NCT00438893|Dietary Portfolio|dietary portfolio
5718003|NCT00438893|Compliance|compliance
5718004|NCT00438893|Blood lipids|blood lipids
5718005|NCT00438893|Blood pressure|blood pressure
5718006|NCT00438867|angina|angina
5718007|NCT00438867|FGF-4|fgf-4
5718008|NCT00438867|angiogenesis|angiogenesis
5718009|NCT00438867|growth factor|growth factor
5718010|NCT00438867|myocardia ischemia|myocardia ischemia
5718011|NCT00438867|revascularization|revascularization
5718012|NCT00438854|dasatinib|dasatinib
5718013|NCT00438854|BMS-354825|bms-354825
5718016|NCT00438854|LYN kinase|lyn kinase
5718017|NCT00438841|stage I multiple myeloma|stage i multiple myeloma
5718018|NCT00438841|stage II multiple myeloma|stage ii multiple myeloma
5718019|NCT00438841|stage III multiple myeloma|stage iii multiple myeloma
5718020|NCT00438828|radiation therapy|radiation therapy
5718021|NCT00438828|palliative|palliative
5718022|NCT00438828|pain|pain
5718023|NCT00438815|Hereditary angioedema|hereditary angioedema
5718024|NCT00438815|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5718025|NCT00438802|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5718026|NCT00438802|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5718027|NCT00438802|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5718123|NCT00438451|focal epilepsy|focal epilepsy
5685931|NCT00554255|safety|safety
5718028|NCT00438802|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5718029|NCT00438802|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5718030|NCT00438763|CMC arthritis|cmc arthritis
5718031|NCT00438763|splint treatment|splint treatment
5718032|NCT00438763|patient satisfaction|patient satisfaction
5718033|NCT00438763|DASH questionnaire|dash questionnaire
5718034|NCT00438750|distal radius fracture|distal radius fracture
5718035|NCT00438750|rehabilitation|rehabilitation
5718036|NCT00438750|volar plate fixation|volar plate fixation
5718037|NCT00438750|DASH questionnaire|dash questionnaire
5718038|NCT00438737|liver metastases|liver metastases
5718039|NCT00438737|stage IV colon cancer|stage iv colon cancer
5718040|NCT00438737|stage IV rectal cancer|stage iv rectal cancer
5718041|NCT00438737|recurrent colon cancer|recurrent colon cancer
5718042|NCT00438737|recurrent rectal cancer|recurrent rectal cancer
5718043|NCT00438724|Caregivers|caregivers
5718044|NCT00438724|Caregiving|caregiving
5718045|NCT00438724|Spousal relationships|spousal relationships
5718046|NCT00438724|cognition disorders|cognition disorders
5718048|NCT00438724|mental health|mental health
5718049|NCT00438724|psychosocial|psychosocial
5718050|NCT00438698|Nutrition|nutrition
5718051|NCT00438698|Type 2 Diabetes|type 2 diabetes
5718052|NCT00438685|Substance-Related Disorders|substance-related disorders
5718053|NCT00438685|Depressive Disorder|depressive disorder
5718054|NCT00438685|Anxiety Disorder|anxiety disorder
5718055|NCT00438685|Adolescent|adolescent
5718056|NCT00438685|Behavior Therapy|behavior therapy
5718057|NCT00438685|Cognitive Therapy|cognitive therapy
5718058|NCT00438685|Outpatients|outpatients
5718059|NCT00438685|Family Relations|family relations
5718060|NCT00438685|Systems Theory|systems theory
5718061|NCT00438672|lateral elbow pain|lateral elbow pain
5718062|NCT00438672|tennis elbow|tennis elbow
5718063|NCT00438672|pain|pain
5718064|NCT00438672|psychology|psychology
5718065|NCT00438659|dermatologic complications|dermatologic complications
5718066|NCT00438659|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5718067|NCT00438659|radiation toxicity|radiation toxicity
5718068|NCT00438659|breast cancer in situ|breast cancer in situ
5718069|NCT00438659|recurrent breast cancer|recurrent breast cancer
5718070|NCT00438659|stage I breast cancer|stage i breast cancer
5718071|NCT00438659|stage II breast cancer|stage ii breast cancer
5718072|NCT00438659|stage IIIA breast cancer|stage iiia breast cancer
5718073|NCT00438659|stage IIIB breast cancer|stage iiib breast cancer
5718074|NCT00438659|stage IIIC breast cancer|stage iiic breast cancer
5718075|NCT00438659|male breast cancer|male breast cancer
5718076|NCT00438659|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5718077|NCT00438659|stage IV breast cancer|stage iv breast cancer
5718078|NCT00438646|Allergy|allergy
5718079|NCT00438646|Asthma|asthma
5718080|NCT00438646|Eczema|eczema
5718081|NCT00438646|Hay Fever|hay fever
5718084|NCT00438633|rehabilitation|rehabilitation
5718085|NCT00438633|non-operative treatment|non-operative treatment
5718086|NCT00438633|DASH and Constant instruments|dash and constant instruments
5718087|NCT00438607|Moderate to late stage Parkinson's Disease|moderate to late stage parkinson's disease
5718088|NCT00438594|nurse|nurse
5718089|NCT00438594|paraprofessional|paraprofessional
5718090|NCT00438594|home visits|home visits
5718091|NCT00438594|pregnancy|pregnancy
5718092|NCT00438594|welfare|welfare
5718093|NCT00438594|child development|child development
5718094|NCT00438581|Zevalin|zevalin
5718095|NCT00438581|Autologous one Marrow Transplant|autologous one marrow transplant
5718096|NCT00438581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5718097|NCT00438568|amyloid protein|amyloid protein
5718098|NCT00438568|brain metabolism|brain metabolism
5718099|NCT00438568|glucose metabolism|glucose metabolism
5718100|NCT00438568|insulin sensitivity /resistance|insulin sensitivity /resistance
5718101|NCT00438568|cognition disorders|cognition disorders
5718102|NCT00438555|obesity,prevention,pediatric|obesity,prevention,pediatric
5718103|NCT00438542|Adiponectin, cord blood, pre-eclampsia|adiponectin, cord blood, pre-eclampsia
5718104|NCT00438516|home visits|home visits
5718105|NCT00438516|pregnancy|pregnancy
5718106|NCT00438516|welfare|welfare
5718107|NCT00438516|child development|child development
5718108|NCT00438516|mortality|mortality
5718109|NCT00438503|Hemodialysis, diabetes mellitus,|hemodialysis, diabetes mellitus,
5718110|NCT00438503|Chronic renal failure, dialysis ,|chronic renal failure, dialysis ,
5718111|NCT00438490|galactorrhea|galactorrhea
5718112|NCT00438490|prolactin|prolactin
5718113|NCT00438490|bone turnover|bone turnover
5718114|NCT00438490|menstrual cycle|menstrual cycle
5718115|NCT00438490|Control Groups|control groups
5718116|NCT00438490|Women|women
5718117|NCT00438477|recurrent breast cancer|recurrent breast cancer
5718118|NCT00438477|stage IIIA breast cancer|stage iiia breast cancer
5718119|NCT00438477|stage IIIB breast cancer|stage iiib breast cancer
5718120|NCT00438477|stage IIIC breast cancer|stage iiic breast cancer
5718121|NCT00438477|stage II breast cancer|stage ii breast cancer
5718122|NCT00438451|elderly|elderly
5718124|NCT00438451|anticonvulsive|anticonvulsive
5718125|NCT00438451|treatment|treatment
5718126|NCT00438451|levetiracetam|levetiracetam
5718127|NCT00438451|lamotrigine|lamotrigine
5718128|NCT00438451|carbamazepine|carbamazepine
5718129|NCT00438438|forced desynchrony|forced desynchrony
5718130|NCT00438438|circadian rhythms|circadian rhythms
5718131|NCT00438438|sleep restriction|sleep restriction
5718132|NCT00438438|sleep homeostasis|sleep homeostasis
5718133|NCT00438438|neurobehavioral performance|neurobehavioral performance
5718134|NCT00438425|Hyperlipidemia|hyperlipidemia
5718135|NCT00438425|Hypercholesterolemia|hypercholesterolemia
5718136|NCT00438425|Dietary modification|dietary modification
5718137|NCT00438425|Portfolio|portfolio
5718138|NCT00438412|Noradrenalin|noradrenalin
5718139|NCT00438412|Endothelin-1|endothelin-1
5718140|NCT00438412|Angiotensin II|angiotensin ii
5718141|NCT00438412|Arginine vasopressin|arginine vasopressin
5718142|NCT00438412|Aldosterone|aldosterone
5718143|NCT00438412|Renin|renin
5718144|NCT00438412|Atrial natriuretic peptide|atrial natriuretic peptide
5718145|NCT00438412|Brain natriuretic peptide|brain natriuretic peptide
5718146|NCT00438412|Blood pressure|blood pressure
5718147|NCT00438412|Apnea|apnea
5718148|NCT00438399|1 Galderma,|1 galderma,
5718149|NCT00438399|2 Scalp Psoriasis|2 scalp psoriasis
5718150|NCT00438399|3 Subject preference|3 subject preference
5718151|NCT00438399|4 Clobetasol propionate|4 clobetasol propionate
5718152|NCT00438399|5 Shampoo|5 shampoo
5718153|NCT00438386|Generalized Anxiety Disorder|generalized anxiety disorder
5718154|NCT00438386|Panic Disorder|panic disorder
5718155|NCT00438386|Anxiety Disorder|anxiety disorder
5718156|NCT00438386|Aripiprazole|aripiprazole
5718157|NCT00438373|Subfertility, Luteinizing hormone, receptor|subfertility, luteinizing hormone, receptor
5718158|NCT00438360|Cyclosporine, chronic plaque psoriasis, intermittent therapy|cyclosporine, chronic plaque psoriasis, intermittent therapy
5718159|NCT00438347|Mild Cognitive Impairment|mild cognitive impairment
5718160|NCT00438347|cognition disorders|cognition disorders
5718161|NCT00438347|brain health|brain health
5718162|NCT00438347|psychological aspect of aging|psychological aspect of aging
5718163|NCT00438347|exercise|exercise
5718164|NCT00438347|physical fitness|physical fitness
5718166|NCT00438334|Directional microphones|directional microphones
5718167|NCT00438334|Hearing|hearing
5718168|NCT00438334|Hearing aids|hearing aids
5718169|NCT00438334|Hearing loss|hearing loss
5718170|NCT00438334|Noise|noise
5718171|NCT00438334|Objective benefit|objective benefit
5718172|NCT00438334|Signal-to-noise ratio|signal-to-noise ratio
5718173|NCT00438334|Speech understanding|speech understanding
5718174|NCT00438334|Subjective benefit|subjective benefit
5718175|NCT00438321|Overweight|overweight
5718176|NCT00438321|obesity|obesity
5718177|NCT00438321|testosterone|testosterone
5718178|NCT00438321|diabetes|diabetes
5718179|NCT00438321|metabolic syndrome|metabolic syndrome
5718180|NCT00438321|aging|aging
5718181|NCT00438308|distal radius fracture|distal radius fracture
5718182|NCT00438308|rehabilitation|rehabilitation
5718183|NCT00438308|volar plate fixation|volar plate fixation
5718184|NCT00438308|DASH questionnaire|dash questionnaire
5718185|NCT00438295|glucose in dialysis water, dialysis treatment, temperature|glucose in dialysis water, dialysis treatment, temperature
5718186|NCT00438282|nurse|nurse
5718187|NCT00438282|home visits|home visits
5718188|NCT00438282|pregnancy|pregnancy
5718189|NCT00438282|welfare|welfare
5718190|NCT00438282|child development|child development
5718191|NCT00438269|Infection|infection
5718192|NCT00438269|Empiric|empiric
5718193|NCT00438269|Antibiotics|antibiotics
5718194|NCT00438269|Nosocomial|nosocomial
5718195|NCT00438269|Pyrexia|pyrexia
5680649|NCT00577174|Insulin resistance|insulin resistance
5680650|NCT00577174|Diabetes|diabetes
5680651|NCT00577174|Mitochondrial Function|mitochondrial function
5680667|NCT00577096|exercise|exercise
5680668|NCT00577083|miss rates|miss rates
5680669|NCT00577057|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5680670|NCT00577057|Stage III - IVB|stage iii - ivb
5680671|NCT00577044|NAFLD|nafld
5680672|NCT00577005|GABAergic|gabaergic
5680673|NCT00577005|levetiracetam|levetiracetam
5680674|NCT00576992|Barrett's Esophagus|barrett's esophagus
5680675|NCT00576992|Demographics|demographics
5680676|NCT00576992|Questionnaire|questionnaire
5680677|NCT00576992|Heartburn|heartburn
5680678|NCT00576979|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5680679|NCT00576979|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5680680|NCT00576940|enteral nutrition, immunomodulating nutrition|enteral nutrition, immunomodulating nutrition
5680681|NCT00576927|Sleep hygiene|sleep hygiene
5680682|NCT00576927|Sleep latency|sleep latency
5718196|NCT00438269|Leukocytosis|leukocytosis
5718197|NCT00438269|Resistance|resistance
5718198|NCT00438256|accelerated short course|accelerated short course
5718199|NCT00438256|proton beam radiation|proton beam radiation
5718200|NCT00438243|Pseudophakic macular edema|pseudophakic macular edema
5718201|NCT00438230|Residual vein thrombosis|residual vein thrombosis
5718202|NCT00438230|Optimal duration|optimal duration
5718203|NCT00438230|Oral anticoagulants|oral anticoagulants
5718204|NCT00438217|precocious puberty, genetics, environmental factors|precocious puberty, genetics, environmental factors
5680637|NCT00577252|Coping Compliance|coping compliance
5718205|NCT00438204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5718206|NCT00438204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5718207|NCT00438204|adenocarcinoma of the lung|adenocarcinoma of the lung
5718208|NCT00438204|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5718209|NCT00438204|large cell lung cancer|large cell lung cancer
5718210|NCT00438204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5718211|NCT00438191|DeQuervain's tenosynovitis|dequervain's tenosynovitis
5718212|NCT00438191|splinting|splinting
5718213|NCT00438191|grip strength|grip strength
5718214|NCT00438191|satisfaction|satisfaction
5718215|NCT00438191|DASH questionnaire|dash questionnaire
5718216|NCT00438165|nurse|nurse
5718217|NCT00438165|home visits|home visits
5718218|NCT00438165|pregnancy|pregnancy
5718219|NCT00438165|welfare|welfare
5718220|NCT00438165|child development|child development
5718225|NCT00438152|Treatment Experienced|treatment experienced
5718226|NCT00438139|marijuana dependence|marijuana dependence
5718227|NCT00438126|diabetes|diabetes
5718228|NCT00438126|Prevention|prevention
5718229|NCT00438126|American Indian|american indian
5718230|NCT00438113|blood pressure|blood pressure
5718231|NCT00438113|atrial fibrillation|atrial fibrillation
5718232|NCT00438113|catheter ablation|catheter ablation
5718233|NCT00438100|Breast Neoplasms|breast neoplasms
5718234|NCT00438100|Drug Therapy|drug therapy
5718235|NCT00438087|Facial palsy|facial palsy
5718236|NCT00438087|Vestibular schwannoma|vestibular schwannoma
5718237|NCT00438087|Anti-inflammatory drugs|anti-inflammatory drugs
5718238|NCT00438087|Post surgery of vestibular schwannoma|post surgery of vestibular schwannoma
5718239|NCT00438087|or of cranial base tumors|or of cranial base tumors
5718240|NCT00438074|Breast Cancer|breast cancer
5718241|NCT00438074|Diffuse Optical Spectroscopy|diffuse optical spectroscopy
5718242|NCT00438061|Lipoprotein metabolism|lipoprotein metabolism
5718243|NCT00438061|Cardiovascular disease|cardiovascular disease
5718244|NCT00438061|Obesity|obesity
5718245|NCT00438048|Pilocarpine|pilocarpine
5718246|NCT00438048|Artificial saliva|artificial saliva
5718247|NCT00438048|Xerostomia|xerostomia
5718248|NCT00438048|Xerostomy|xerostomy
5718249|NCT00438048|Primary Sjogren|primary sjogren
5718250|NCT00438048|Secondary Sjogren|secondary sjogren
5718251|NCT00438035|Postoperative pain|postoperative pain
5718252|NCT00438035|Heart rate variability, sympathetic, parasympathetic|heart rate variability, sympathetic, parasympathetic
5680683|NCT00576927|Elderly sleep|elderly sleep
5680684|NCT00576927|Nursing Home sleep|nursing home sleep
5680685|NCT00576914|adjuvant therapy|adjuvant therapy
5680686|NCT00576914|non-small cell lung cancer|non-small cell lung cancer
5680687|NCT00576914|vinorelbine|vinorelbine
5680688|NCT00576914|cisplatin|cisplatin
5680689|NCT00576914|recombinant human endostatin(endostar)|recombinant human endostatin(endostar)
5680690|NCT00576888|Multifocal lymphangioendoltheliomatosis with thrombocytopenia|multifocal lymphangioendoltheliomatosis with thrombocytopenia
5680691|NCT00576888|Cutaneovisceral angiomatosis with thrombocytopenia|cutaneovisceral angiomatosis with thrombocytopenia
5680693|NCT00576888|Hemangiomas|hemangiomas
5680694|NCT00576888|Hemangiomatosis|hemangiomatosis
5680695|NCT00576888|Lymphatic malformation|lymphatic malformation
5680696|NCT00576888|Kasabach-Merritt|kasabach-merritt
5680697|NCT00576888|Blue-rubber bleb nevus|blue-rubber bleb nevus
5718253|NCT00438035|Visual analog pain scale|visual analog pain scale
5718254|NCT00438035|Spectral analysis of ECG|spectral analysis of ecg
5718255|NCT00438022|Atopic Dermatitis|atopic dermatitis
5718256|NCT00438022|Eczema Herpeticum|eczema herpeticum
5718257|NCT00438009|coxsackievirus type a21|coxsackievirus type a21
5718258|NCT00438009|oncolytic virus|oncolytic virus
5718259|NCT00438009|melanoma|melanoma
5718260|NCT00437996|Labor analgesia - clonidine - epidural|labor analgesia - clonidine - epidural
5718261|NCT00437957|histone deacetylase|histone deacetylase
5718262|NCT00437957|unresectable brain metastases|unresectable brain metastases
5718263|NCT00437931|hypothyroidism|hypothyroidism
5718264|NCT00437931|hyperthyroidism|hyperthyroidism
5718265|NCT00437931|thyroid dysfunction|thyroid dysfunction
5718266|NCT00437931|ultrasound|ultrasound
5718268|NCT00437905|peripheral vascular disease|peripheral vascular disease
5718269|NCT00437905|percutaneous transluminal angioplasty|percutaneous transluminal angioplasty
5718270|NCT00437905|cutting balloon|cutting balloon
5718271|NCT00437905|balloon angioplasty|balloon angioplasty
5718272|NCT00437905|randomized controlled trial|randomized controlled trial
5718273|NCT00437905|restenosis|restenosis
5718274|NCT00437905|inflammation|inflammation
5718275|NCT00437892|Statins|statins
5718276|NCT00437892|secondary prevention|secondary prevention
5718277|NCT00437892|venous thromboembolism|venous thromboembolism
5718278|NCT00437892|d-dimer|d-dimer
5718279|NCT00437879|Breast Cancer|breast cancer
5718280|NCT00437879|Ultrasound|ultrasound
5718281|NCT00437840|healthy volunteers,|healthy volunteers,
5718282|NCT00437840|tolerability,|tolerability,
5718283|NCT00437840|pharmacokinetics,|pharmacokinetics,
5718284|NCT00437840|pharmacodynamics|pharmacodynamics
5718285|NCT00437840|safety,|safety,
5718286|NCT00437840|smoking,|smoking,
5718287|NCT00437827|Depression|depression
5718288|NCT00437814|Ketamine|ketamine
5718289|NCT00437814|Traumatic Brain Injury|traumatic brain injury
5718290|NCT00437814|Intracranial Hypertension|intracranial hypertension
5718291|NCT00437788|imaging|imaging
5718292|NCT00437775|Diabetes Mellitus type 2|diabetes mellitus type 2
5718293|NCT00437775|ACE Inhibitors|ace inhibitors
5718294|NCT00437775|ARBs|arbs
5718295|NCT00437775|Adverse drug effect|adverse drug effect
5718296|NCT00437762|Lateral epicondylitis, tennis elbow, treatment|lateral epicondylitis, tennis elbow, treatment
5718297|NCT00437749|Non small cell lung cancer|non small cell lung cancer
5718298|NCT00437749|Advanced|advanced
5718299|NCT00437749|Inoperable|inoperable
5718300|NCT00437749|taxanes|taxanes
5718301|NCT00437749|carboplatin|carboplatin
5718302|NCT00437749|multi-drug resistance|multi-drug resistance
5718303|NCT00437736|solid tumor|solid tumor
5718304|NCT00437736|phase I study|phase i study
5718305|NCT00437736|dose-escalation|dose-escalation
5718306|NCT00437710|bone marrow, cell transplantation, stem cells, PTCA|bone marrow, cell transplantation, stem cells, ptca
5718307|NCT00437697|dalteparin, critically ill, thromboprophylaxis|dalteparin, critically ill, thromboprophylaxis
5718308|NCT00437684|HIV/HCV|hiv/hcv
5718309|NCT00437684|HIV and HCV coinfected patients|hiv and hcv coinfected patients
5718310|NCT00437684|Treatment Experienced|treatment experienced
5718311|NCT00437671|trismus|trismus
5718312|NCT00437671|lockjaw|lockjaw
5718313|NCT00437645|Essential hypertension|essential hypertension
5718314|NCT00437645|blood pressure|blood pressure
5680698|NCT00576888|Angiomatosis|angiomatosis
5680699|NCT00576875|Depression|depression
5680700|NCT00576875|Elderly|elderly
5680701|NCT00576875|Neuroimaging|neuroimaging
5680702|NCT00576875|Postmortem|postmortem
5680703|NCT00576875|Knockout mouse|knockout mouse
5680718|NCT00576823|child|child
5680719|NCT00576823|bladder|bladder
5680720|NCT00576823|neuropathic|neuropathic
5680721|NCT00576823|alpha blockers|alpha blockers
5680722|NCT00576797|vaginal|vaginal
5680723|NCT00576797|bacteria|bacteria
5680724|NCT00576797|microflora|microflora
5680725|NCT00576797|bacterial DNA|bacterial dna
5681152|NCT00574522|Complimentary therapies|complimentary therapies
5718315|NCT00437645|edema|edema
5718316|NCT00437645|valsartan|valsartan
5718317|NCT00437645|amlodipine|amlodipine
5718318|NCT00437645|combination treatment|combination treatment
5718319|NCT00437632|repeat dose,|repeat dose,
5718320|NCT00437632|placebo,|placebo,
5718321|NCT00437632|Safety,|safety,
5718322|NCT00437632|pharmacodynamics,|pharmacodynamics,
5718323|NCT00437632|tolerability,|tolerability,
5718324|NCT00437632|GSK598809|gsk598809
5718325|NCT00437632|pharmacokinetics,|pharmacokinetics,
5718326|NCT00437593|preretinal membrane|preretinal membrane
5718327|NCT00437593|vitrectomy|vitrectomy
5718328|NCT00437593|uhr-oct|uhr-oct
5718329|NCT00437593|hd-oct|hd-oct
5718434|NCT00437073|lapatinib|lapatinib
5718330|NCT00437580|Vancomycin Resistant Enterococcus, probiotic|vancomycin resistant enterococcus, probiotic
5718331|NCT00437567|galacto-oligosaccharides|galacto-oligosaccharides
5718332|NCT00437567|prebiotics|prebiotics
5718333|NCT00437567|NEC|nec
5718334|NCT00437541|Insulation|insulation
5718335|NCT00437541|Warmth|warmth
5718336|NCT00437541|Humidity|humidity
5718337|NCT00437541|Damp|damp
5718338|NCT00437541|Cold|cold
5718339|NCT00437541|Respiratory|respiratory
5718340|NCT00437541|Mould|mould
5718341|NCT00437528|Heat flow|heat flow
5718342|NCT00437528|Sensor|sensor
5718343|NCT00437528|Overactive bladder|overactive bladder
5718344|NCT00437528|Urinary incontinence|urinary incontinence
5718345|NCT00437502|Immunotherapeutic vaccine|immunotherapeutic vaccine
5718346|NCT00437502|Ovarian cancer|ovarian cancer
5718347|NCT00437502|epithelial ovarian cancer|epithelial ovarian cancer
5718348|NCT00437502|tubal cancer|tubal cancer
5718349|NCT00437502|peritoneal cancer|peritoneal cancer
5718350|NCT00437502|immunotherapy|immunotherapy
5718351|NCT00437476|HIV/HCV|hiv/hcv
5718352|NCT00437476|HIV and HCV coinfected patients|hiv and hcv coinfected patients
5718353|NCT00437476|Treatment Naive|treatment naive
5718354|NCT00437450|Anemia|anemia
5718355|NCT00437450|myelodysplastic syndromes|myelodysplastic syndromes
5718356|NCT00437450|Low risk|low risk
5718357|NCT00437450|Bone Marrow diseases|bone marrow diseases
5718358|NCT00437437|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5718359|NCT00437424|Hepatocellular cancer|hepatocellular cancer
5718360|NCT00437424|Other advanced solid malignancies|other advanced solid malignancies
5718361|NCT00437411|Fibromyalgia|fibromyalgia
5718362|NCT00437411|Affect|affect
5734903|NCT00376779|Finland|finland
5718363|NCT00437411|Pain|pain
5718364|NCT00437411|Fatigue|fatigue
5718365|NCT00437411|Sleep|sleep
5718366|NCT00437411|Stress|stress
5718367|NCT00437411|Quality of Life|quality of life
5718368|NCT00437411|Stress, Psychological|stress, psychological
5718369|NCT00437411|Psychophysiology|psychophysiology
5718370|NCT00437411|Randomized Controlled Trials|randomized controlled trials
5718371|NCT00437398|hypoglycemic unawareness|hypoglycemic unawareness
5718372|NCT00437385|therapy resistant depression, severe depression|therapy resistant depression, severe depression
5718373|NCT00437372|solid tumor|solid tumor
5680638|NCT00577252|Adjustment|adjustment
5718374|NCT00437372|central nervous system|central nervous system
5718375|NCT00437372|head and neck|head and neck
5718376|NCT00437372|thorax|thorax
5718377|NCT00437372|pelvic area|pelvic area
5718378|NCT00437359|Breast Neoplasms|breast neoplasms
5718379|NCT00437359|Drug Therapy|drug therapy
5718380|NCT00437346|dyspepsia|dyspepsia
5718381|NCT00437346|functional dyspepsia|functional dyspepsia
5718382|NCT00437346|treatment|treatment
5718383|NCT00437346|drug therapy|drug therapy
5718384|NCT00437346|information|information
5718385|NCT00437333|Insulin sensitivity|insulin sensitivity
5718386|NCT00437333|Insulin-sensitizing drug|insulin-sensitizing drug
5718387|NCT00437333|Metformin|metformin
5718388|NCT00437333|PCOS|pcos
5718389|NCT00437333|Treatment|treatment
5718390|NCT00437320|PDT|pdt
5680726|NCT00576797|To determine the normal bacteria in the vagina|to determine the normal bacteria in the vagina
5680727|NCT00576784|type 2 diabetes|type 2 diabetes
5680728|NCT00576784|insulin treatment|insulin treatment
5680729|NCT00576784|ß-cell function|ß-cell function
5680730|NCT00576745|Sutures|sutures
5680731|NCT00576732|Irritability|irritability
5680732|NCT00576732|Risperidone|risperidone
5680733|NCT00576732|Antipsychotic agent|antipsychotic agent
5680734|NCT00576732|Autism|autism
5680735|NCT00576732|Adolescents|adolescents
5680736|NCT00576732|Children|children
5680737|NCT00576706|Patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous NSAIDs therapy|patients with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis or any other arthritis-like disease requiring continuous nsaids therapy
5744240|NCT00342056|Cancer|cancer
5718391|NCT00437320|Photoaging|photoaging
5718392|NCT00437320|Galderma|galderma
5718393|NCT00437281|Partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics|partial-onset seizures; epilepsy; pediatric; pregabalin; safety; tolerability; pharmacokinetics
5718394|NCT00437242|interval,|interval,
5718395|NCT00437242|atrial fibrillation|atrial fibrillation
5718396|NCT00437242|QT,|qt,
5718397|NCT00437242|odiparcil,|odiparcil,
5718398|NCT00437229|GW679769,|gw679769,
5718399|NCT00437229|Casopitant,|casopitant,
5718400|NCT00437229|Dexamethasone,|dexamethasone,
5718401|NCT00437229|Healthy Human Volunteer|healthy human volunteer
5718402|NCT00437229|Ondansetron,|ondansetron,
5718403|NCT00437203|Advanced cancer|advanced cancer
5718404|NCT00437190|Cervical Disc Replacement|cervical disc replacement
5718405|NCT00437190|Spondylotic radiculopathy|spondylotic radiculopathy
5718406|NCT00437190|Spondylotic myelopathy|spondylotic myelopathy
5718407|NCT00437190|Myelopathy|myelopathy
5718408|NCT00437190|Radiculopathy|radiculopathy
5718409|NCT00437177|alcoholism|alcoholism
5718410|NCT00437177|apomorphine|apomorphine
5718411|NCT00437177|iodobenzamide|iodobenzamide
5718412|NCT00437177|imaging|imaging
5718414|NCT00437177|relapse|relapse
5718415|NCT00437164|NaBr|nabr
5718416|NCT00437164|Sodium Bromide|sodium bromide
5718417|NCT00437164|DEXA Deuterium|dexa deuterium
5718418|NCT00437164|Total Body Water|total body water
5718419|NCT00437164|Insulin|insulin
5718421|NCT00437164|GW677954|gw677954
5718422|NCT00437164|Randomized Withdrawal|randomized withdrawal
5718423|NCT00437164|T2DM|t2dm
5718424|NCT00437138|Air pollution|air pollution
5718425|NCT00437138|Myocardial ischemia|myocardial ischemia
5718426|NCT00437138|Endothelium|endothelium
5718427|NCT00437138|Fibrinolysis|fibrinolysis
5718428|NCT00437138|Pathophysiology|pathophysiology
5718429|NCT00437138|Diesel exhaust|diesel exhaust
5718430|NCT00437086|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5718431|NCT00437086|primary myelofibrosis|primary myelofibrosis
5718432|NCT00437073|brain metastases|brain metastases
5718433|NCT00437073|ErbB2|erbb2
5718435|NCT00437073|Breast Cancer|breast cancer
5718436|NCT00437073|HYCAMTIN|hycamtin
5718437|NCT00437073|topotecan|topotecan
5718438|NCT00437073|capecitabine|capecitabine
5718439|NCT00437073|metastatic breast cancer|metastatic breast cancer
5718440|NCT00437073|TYKERB|tykerb
5718441|NCT00437073|XELODA|xeloda
5718442|NCT00437021|smallpox, vaccine, IMVAMUNE®|smallpox, vaccine, imvamune®
5718443|NCT00437008|endothelial dysfunction|endothelial dysfunction
5718444|NCT00437008|flow-mediated dilatation|flow-mediated dilatation
5718445|NCT00437008|advanced glycation end products|advanced glycation end products
5718446|NCT00437008|postprandial|postprandial
5718447|NCT00436995|Dialysis|dialysis
5718448|NCT00436995|Anaemia|anaemia
5718449|NCT00436969|Orthovisc|orthovisc
5718450|NCT00436969|Osteoarthritis|osteoarthritis
5718451|NCT00436969|Shoulder|shoulder
5718452|NCT00436969|Randomized|randomized
5718453|NCT00436956|VEGF|vegf
5718454|NCT00436956|Angiogenesis|angiogenesis
5718455|NCT00436956|Hormone-Refractory|hormone-refractory
5718456|NCT00436956|Bone Metastases|bone metastases
5718457|NCT00436956|Docetaxel-Resistant|docetaxel-resistant
5718458|NCT00436956|Prostate Cancer|prostate cancer
5718459|NCT00436943|smoking cessation|smoking cessation
5718460|NCT00436943|nicotine replacement therapy|nicotine replacement therapy
5718461|NCT00436943|bupropion|bupropion
5718462|NCT00436943|smoking|smoking
5685932|NCT00554255|Pharmacokinetics|pharmacokinetics
5717221|NCT00441519|Aspirin|aspirin
5680738|NCT00576693|ischemic stroke|ischemic stroke
5680739|NCT00576693|intracranial stenting|intracranial stenting
5680740|NCT00576693|vascular risk factor management|vascular risk factor management
5680741|NCT00576680|RAD001|rad001
5680742|NCT00576680|temozolomide|temozolomide
5680743|NCT00576667|NASH|nash
5680744|NCT00576667|chronic liver disease|chronic liver disease
5680745|NCT00576615|healthy volunteers|healthy volunteers
5680746|NCT00576615|amnesic effects|amnesic effects
5680747|NCT00576589|Safety in patients with Asymptomatic cholelithiasis/gallstones.|safety in patients with asymptomatic cholelithiasis/gallstones.
5680758|NCT00576524|Decrease complications during dialysis|decrease complications during dialysis
5680759|NCT00576524|Low Blood Pressure|low blood pressure
5680760|NCT00576511|Constipation|constipation
5680761|NCT00576511|Prucalopride|prucalopride
5680762|NCT00576511|Colonic Transit Time|colonic transit time
5680763|NCT00576498|GERD|gerd
5680764|NCT00576498|NBI|nbi
5680765|NCT00576498|AFI|afi
5718463|NCT00436930|recurrent melanoma|recurrent melanoma
5718464|NCT00436930|stage IV melanoma|stage iv melanoma
5718465|NCT00436917|stage I breast cancer|stage i breast cancer
5718466|NCT00436917|stage II breast cancer|stage ii breast cancer
5718467|NCT00436917|stage IIIA breast cancer|stage iiia breast cancer
5718469|NCT00436904|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5718470|NCT00436904|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5718471|NCT00436904|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5718472|NCT00436904|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5718473|NCT00436891|Group A Streptococcus, scabies, pyoderma, Fiji|group a streptococcus, scabies, pyoderma, fiji
5718474|NCT00436878|Eating Behavior|eating behavior
5718475|NCT00436878|Children|children
5718476|NCT00436878|Portion size|portion size
5718477|NCT00436878|Experimental|experimental
5718478|NCT00436826|Multiple Sclerosis|multiple sclerosis
5718479|NCT00436826|Relapsing forms|relapsing forms
5718480|NCT00436826|Interferon-beta therapy|interferon-beta therapy
5718481|NCT00436787|Anticoagulation Prophylaxis|anticoagulation prophylaxis
5718482|NCT00436787|Venous Thrombosis|venous thrombosis
5718483|NCT00436787|Deep Vein Thrombosis|deep vein thrombosis
5718484|NCT00436787|Pulmonary Embolism|pulmonary embolism
5718485|NCT00436787|Fondaparinux Sodium|fondaparinux sodium
5718486|NCT00436787|Arixtra|arixtra
5718487|NCT00436787|Pharmakinetics|pharmakinetics
5718488|NCT00436774|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5718489|NCT00436774|neurotoxicity|neurotoxicity
5718490|NCT00436774|gastrointestinal complications|gastrointestinal complications
5718491|NCT00436774|pulmonary complications|pulmonary complications
5718492|NCT00436774|sexual dysfunction|sexual dysfunction
5718493|NCT00436774|infertility|infertility
5718494|NCT00436774|urinary complications|urinary complications
5718495|NCT00436774|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5718496|NCT00436774|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5718497|NCT00436774|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5718499|NCT00436761|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5718500|NCT00436748|Chronic Kidney Disease|chronic kidney disease
5718501|NCT00436748|Dialysis|dialysis
5718502|NCT00436748|Anemia|anemia
5718503|NCT00436748|Nephrology|nephrology
5718504|NCT00436748|Pediatric|pediatric
5718505|NCT00436748|Hemodialysis|hemodialysis
5718506|NCT00436748|Peritoneal Dialysis|peritoneal dialysis
5718507|NCT00436748|Chronic Renal Insufficiency|chronic renal insufficiency
5718508|NCT00436722|Liver|liver
5718509|NCT00436722|Transplantation|transplantation
5718510|NCT00436722|Tolerance|tolerance
5718511|NCT00436722|Induction|induction
5718512|NCT00436722|Tacrolimus|tacrolimus
5718513|NCT00436722|Liver transplantation|liver transplantation
5718514|NCT00436722|Adult|adult
5718515|NCT00436709|male breast cancer|male breast cancer
5718516|NCT00436709|stage I breast cancer|stage i breast cancer
5718517|NCT00436709|stage II breast cancer|stage ii breast cancer
5680766|NCT00576498|IM|im
5680767|NCT00576498|SSBE|ssbe
5680768|NCT00576498|LSBE|lsbe
5680769|NCT00576498|LGD|lgd
5680770|NCT00576498|HGD|hgd
5680771|NCT00576485|Cataract|cataract
5680772|NCT00576485|Intraocular lens|intraocular lens
5680773|NCT00576485|Spherical aberration|spherical aberration
5680774|NCT00576485|Contrast sensitivity|contrast sensitivity
5680775|NCT00576472|Brain Tumor, Acute Lymphoblastic Leukemia, Methylphenidate, Cognitive Late Effects|brain tumor, acute lymphoblastic leukemia, methylphenidate, cognitive late effects
5680786|NCT00576394|Glucose, Insulin|glucose, insulin
5680787|NCT00576381|Precedex|precedex
5680788|NCT00576381|Open Heart Surgery|open heart surgery
5680789|NCT00576381|Dexmedetomidine|dexmedetomidine
5680790|NCT00576381|Sedation|sedation
5680791|NCT00576355|Adolescent|adolescent
5680792|NCT00576355|Psychopathology|psychopathology
5680793|NCT00576355|Interpersonal Therapy|interpersonal therapy
5685933|NCT00554242|endothelium|endothelium
5711438|NCT00459693|Brain|brain
5685934|NCT00554242|antioxidants|antioxidants
5685936|NCT00554229|Hormone Resistant Prostate Cancer|hormone resistant prostate cancer
5685937|NCT00554229|Endothelin A Receptor Antagonist|endothelin a receptor antagonist
5680794|NCT00576355|Interpersonal and Social Rhythm Therapy|interpersonal and social rhythm therapy
5680795|NCT00576329|vitreoretinal surgery, ketorolac, Acular, mydriasis|vitreoretinal surgery, ketorolac, acular, mydriasis
5718518|NCT00436709|stage IIIA breast cancer|stage iiia breast cancer
5718519|NCT00436683|Hyperphosphataemia|hyperphosphataemia
5718520|NCT00436683|Phosphate binder|phosphate binder
5718522|NCT00436670|Allergy|allergy
5718528|NCT00436657|Peritoneal Tumor|peritoneal tumor
5718529|NCT00436657|Retroperitoneal Tumor|retroperitoneal tumor
5718530|NCT00436657|Gastrointestinal Adenocarcinoma|gastrointestinal adenocarcinoma
5718531|NCT00436657|Desmoplastic Round Cell Tumor|desmoplastic round cell tumor
5718532|NCT00436657|Neuroblastoma|neuroblastoma
5718533|NCT00436657|Ovarian Germ Cell|ovarian germ cell
5718534|NCT00436657|Sarcoma|sarcoma
5718535|NCT00436657|Adrenocorticocarcinoma|adrenocorticocarcinoma
5718536|NCT00436657|Wilms' Tumor|wilms' tumor
5718537|NCT00436657|Rhabdomyosarcoma|rhabdomyosarcoma
5718538|NCT00436657|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5718539|NCT00436657|Recurrent Tumors|recurrent tumors
5718540|NCT00436657|Cisplatin|cisplatin
5718541|NCT00436657|Platinol®-AQ|platinol®-aq
5718542|NCT00436657|Platinol®|platinol®
5718543|NCT00436657|CDDP|cddp
5718544|NCT00436657|Abdominal Wash|abdominal wash
5718545|NCT00436657|Hyperthermic Perfusion|hyperthermic perfusion
5718546|NCT00436657|Continuous Hyperthermic Peritoneal Perfusion|continuous hyperthermic peritoneal perfusion
5718547|NCT00436657|CHPP|chpp
5718548|NCT00436644|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5718549|NCT00436644|peritoneal cavity cancer|peritoneal cavity cancer
5718550|NCT00436631|epilepsy|epilepsy
5718551|NCT00436631|seizures|seizures
5718552|NCT00436631|intractable|intractable
5718553|NCT00436631|ketosis|ketosis
5718554|NCT00436631|ketogenic|ketogenic
5718555|NCT00436631|diet|diet
5718556|NCT00436618|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5718557|NCT00436618|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5718558|NCT00436618|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5718559|NCT00436618|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5718560|NCT00436618|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5718561|NCT00436618|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5718562|NCT00436618|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5718563|NCT00436618|small intestine lymphoma|small intestine lymphoma
5718564|NCT00436618|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5718565|NCT00436618|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5718566|NCT00436618|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5718567|NCT00436618|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5718568|NCT00436618|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5713681|NCT00451750|phobia|phobia
5718570|NCT00436618|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5680796|NCT00576316|Asthma|asthma
5680797|NCT00576264|open abdominal surgery|open abdominal surgery
5680798|NCT00576264|abdominal laparoscopic surgery|abdominal laparoscopic surgery
5718571|NCT00436618|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5718572|NCT00436618|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5718573|NCT00436618|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5718574|NCT00436618|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5718575|NCT00436618|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5718576|NCT00436618|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5718577|NCT00436618|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5718578|NCT00436618|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5718579|NCT00436618|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5718580|NCT00436618|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5718581|NCT00436618|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5718583|NCT00436592|ischemic|ischemic
5718584|NCT00436592|stroke|stroke
5718585|NCT00436592|device|device
5718586|NCT00436592|treatment|treatment
5718587|NCT00436566|cardiac toxicity|cardiac toxicity
5718588|NCT00436566|male breast cancer|male breast cancer
5718589|NCT00436566|stage I breast cancer|stage i breast cancer
5718590|NCT00436566|stage II breast cancer|stage ii breast cancer
5718591|NCT00436566|stage IIIA breast cancer|stage iiia breast cancer
5726212|NCT00409916|TEB|teb
5718592|NCT00436553|Age-related macular degeneration; AMD|age-related macular degeneration; amd
5718593|NCT00436553|choroidal neovascularization|choroidal neovascularization
5718594|NCT00436553|verteporfin|verteporfin
5718595|NCT00436553|ranibizumab|ranibizumab
5718596|NCT00436514|patients|patients
5718597|NCT00436514|medium risk|medium risk
5718598|NCT00436514|asymptomatic|asymptomatic
5718599|NCT00436514|between 50 and 74 years old|between 50 and 74 years old
5718600|NCT00436514|high risk|high risk
5718601|NCT00436514|case|case
5718602|NCT00436514|history of neoplastic colic|history of neoplastic colic
5718603|NCT00436514|cancers|cancers
5718604|NCT00436514|polyps|polyps
5718605|NCT00436501|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5718606|NCT00436501|Ovarian Epithelial Cancer|ovarian epithelial cancer
5718607|NCT00436501|Peritoneal Cancer|peritoneal cancer
5718608|NCT00436501|Fallopian Tube Cancer|fallopian tube cancer
5718609|NCT00436501|VEGF Trap|vegf trap
5718610|NCT00436501|aflibercept|aflibercept
5718611|NCT00436501|vascular endothelial growth factor trap|vascular endothelial growth factor trap
5718612|NCT00436501|Zaltrap|zaltrap
5718619|NCT00436488|Gene variants|gene variants
5718620|NCT00436475|Glucose intolerance|glucose intolerance
5718621|NCT00436475|Type 2 diabetes mellitus|type 2 diabetes mellitus
5718622|NCT00436475|Metabolic syndrome|metabolic syndrome
5718623|NCT00436462|Steroid receptors|steroid receptors
5718624|NCT00436462|Endometrium|endometrium
5718625|NCT00436462|IVF|ivf
5718626|NCT00436462|Follicular phase|follicular phase
5718627|NCT00436436|adult giant cell glioblastoma|adult giant cell glioblastoma
5718628|NCT00436436|adult gliosarcoma|adult gliosarcoma
5718629|NCT00436436|recurrent adult brain tumor|recurrent adult brain tumor
5718630|NCT00436436|adult glioblastoma|adult glioblastoma
5718631|NCT00436423|pancreatic neoplasm|pancreatic neoplasm
5718632|NCT00436423|drug therapy|drug therapy
5718633|NCT00436423|gemcitabine|gemcitabine
5718634|NCT00436423|TS-1|ts-1
5718635|NCT00436410|stage IV colon cancer|stage iv colon cancer
5718636|NCT00436410|stage IV rectal cancer|stage iv rectal cancer
5718637|NCT00436410|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5718638|NCT00436410|stage IV pancreatic cancer|stage iv pancreatic cancer
5718639|NCT00436410|male breast cancer|male breast cancer
5718640|NCT00436410|stage IV breast cancer|stage iv breast cancer
5718641|NCT00436410|stage IV melanoma|stage iv melanoma
5718642|NCT00436410|stage I breast cancer|stage i breast cancer
5718643|NCT00436410|stage II breast cancer|stage ii breast cancer
5718644|NCT00436410|stage IIIA breast cancer|stage iiia breast cancer
5718645|NCT00436410|stage IIIB breast cancer|stage iiib breast cancer
5718646|NCT00436410|stage IIIC breast cancer|stage iiic breast cancer
5718647|NCT00436410|recurrent breast cancer|recurrent breast cancer
5718648|NCT00436410|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5718649|NCT00436410|stage I adrenocortical carcinoma|stage i adrenocortical carcinoma
5718650|NCT00436410|stage II adrenocortical carcinoma|stage ii adrenocortical carcinoma
5718651|NCT00436410|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5718652|NCT00436410|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5718653|NCT00436410|recurrent colon cancer|recurrent colon cancer
5718654|NCT00436410|stage I colon cancer|stage i colon cancer
5718655|NCT00436410|stage II colon cancer|stage ii colon cancer
5718656|NCT00436410|stage III colon cancer|stage iii colon cancer
5680799|NCT00576264|peritoneal stem cells|peritoneal stem cells
5680800|NCT00576264|patients scheduled for any type of elective intra-abdominal surgery at Cedars-Sinai Medical Center with designated surgeons|patients scheduled for any type of elective intra-abdominal surgery at cedars-sinai medical center with designated surgeons
5680802|NCT00576251|blepharaconjunctivitis|blepharaconjunctivitis
5680803|NCT00576238|Atopic eczema|atopic eczema
5680804|NCT00576238|Topical corticosteroid|topical corticosteroid
5680805|NCT00576225|NSCLC|nsclc
5680806|NCT00576225|women|women
5680807|NCT00576225|CT-2103|ct-2103
5718657|NCT00436410|recurrent rectal cancer|recurrent rectal cancer
5718658|NCT00436410|stage I rectal cancer|stage i rectal cancer
5718659|NCT00436410|stage II rectal cancer|stage ii rectal cancer
5718660|NCT00436410|stage III rectal cancer|stage iii rectal cancer
5718661|NCT00436410|advanced adult primary liver cancer|advanced adult primary liver cancer
5718662|NCT00436410|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5718663|NCT00436410|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5718664|NCT00436410|recurrent pancreatic cancer|recurrent pancreatic cancer
5718665|NCT00436410|stage I pancreatic cancer|stage i pancreatic cancer
5718666|NCT00436410|stage II pancreatic cancer|stage ii pancreatic cancer
5718667|NCT00436410|stage III pancreatic cancer|stage iii pancreatic cancer
5718668|NCT00436410|recurrent melanoma|recurrent melanoma
5718669|NCT00436410|stage I melanoma|stage i melanoma
5718670|NCT00436410|stage II melanoma|stage ii melanoma
5718671|NCT00436410|stage III melanoma|stage iii melanoma
5718672|NCT00436410|stage I renal cell cancer|stage i renal cell cancer
5718673|NCT00436410|stage II renal cell cancer|stage ii renal cell cancer
5718674|NCT00436410|stage III renal cell cancer|stage iii renal cell cancer
5718675|NCT00436410|stage IV renal cell cancer|stage iv renal cell cancer
5717534|NCT00440414|Cancer|cancer
5718676|NCT00436410|recurrent renal cell cancer|recurrent renal cell cancer
5718677|NCT00436410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5718678|NCT00436410|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5718679|NCT00436410|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5718680|NCT00436410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5718681|NCT00436410|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5718682|NCT00436410|gastrointestinal cancer|gastrointestinal cancer
5718683|NCT00436410|adult fibrosarcoma|adult fibrosarcoma
5718684|NCT00436410|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5718685|NCT00436410|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5718686|NCT00436410|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5718687|NCT00436410|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5718688|NCT00436410|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5718689|NCT00436397|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5718690|NCT00436384|liver transplant|liver transplant
5718691|NCT00436384|lung transplant|lung transplant
5718692|NCT00436384|kidney transplant|kidney transplant
5718693|NCT00436384|heart transplant|heart transplant
5718694|NCT00436384|CMV CMI|cmv cmi
5718695|NCT00436358|Mexico|mexico
5718696|NCT00436358|Intussusception|intussusception
5718698|NCT00436345|analgesia|analgesia
5718699|NCT00436345|Mechanical ventilation|mechanical ventilation
5718700|NCT00436345|pharmaco-economic|pharmaco-economic
5718702|NCT00436332|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5718703|NCT00436332|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5718901|NCT00435357|knee|knee
5718704|NCT00436332|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5718705|NCT00436332|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5718706|NCT00436332|adenocarcinoma of the lung|adenocarcinoma of the lung
5718707|NCT00436319|Infertility, downregulation, stimulation, agonists, long|infertility, downregulation, stimulation, agonists, long
5718708|NCT00436306|prevention|prevention
5718709|NCT00436306|behavior|behavior
5718710|NCT00436306|risk reduction behavior|risk reduction behavior
5718711|NCT00436267|recurrent pancreatic cancer|recurrent pancreatic cancer
5718712|NCT00436267|stage IV pancreatic cancer|stage iv pancreatic cancer
5718713|NCT00436267|liver metastases|liver metastases
5718714|NCT00436228|healthy volunteer,|healthy volunteer,
5718715|NCT00436228|Bioavailability,|bioavailability,
5718716|NCT00436228|safety|safety
5718717|NCT00436228|Phase I,|phase i,
5718718|NCT00436215|Sorafenib|sorafenib
5718719|NCT00436215|Ovarian Cancer|ovarian cancer
5718720|NCT00436215|Fallopian Cancer|fallopian cancer
5718721|NCT00436215|Bevacizumab|bevacizumab
5680809|NCT00576225|carboplatin|carboplatin
5680810|NCT00576212|termination fetal anomaly|termination fetal anomaly
5680811|NCT00576212|psychological sequelae pregnancy termination for anomalies|psychological sequelae pregnancy termination for anomalies
5680812|NCT00576212|supportive follow-up pregnancy termination anomalies|supportive follow-up pregnancy termination anomalies
5680813|NCT00576173|Cancer pain|cancer pain
5718722|NCT00436215|Peritoneal Cancer|peritoneal cancer
5718723|NCT00436215|Fallopian Tube Cancer|fallopian tube cancer
5718724|NCT00436202|Anemia|anemia
5718725|NCT00436202|Iron|iron
5718726|NCT00436202|Supplement|supplement
5718727|NCT00436189|Ovarian|ovarian
5718728|NCT00436189|Cancer|cancer
5718731|NCT00436189|Tumor|tumor
5718732|NCT00436189|Adnexal|adnexal
5718733|NCT00436189|Proteomics|proteomics
5718734|NCT00436176|Diabetes mellitus|diabetes mellitus
5718735|NCT00436176|Quality of Health Care|quality of health care
5718736|NCT00436176|Cultural Competency|cultural competency
5718737|NCT00436176|Performance Feedback|performance feedback
5718738|NCT00436176|Health navigator|health navigator
5718739|NCT00436176|Health disparities|health disparities
5718740|NCT00436176|Racial disparities|racial disparities
5718741|NCT00436150|Adolescents|adolescents
5718742|NCT00436150|Depression, postpartum|depression, postpartum
5718743|NCT00436137|Colorectal cancer|colorectal cancer
5718744|NCT00436137|Fecal occult blood test|fecal occult blood test
5718745|NCT00436137|Abnormal test result|abnormal test result
5718746|NCT00436137|Missed diagnosis|missed diagnosis
5718747|NCT00436137|Delayed diagnosis|delayed diagnosis
5718748|NCT00436111|hyperprolactinemia|hyperprolactinemia
5718749|NCT00436111|autoantibody|autoantibody
5718750|NCT00436098|congenital heart disease|congenital heart disease
5718751|NCT00436098|exercise training|exercise training
5718752|NCT00436098|motorpedagogical exercise|motorpedagogical exercise
5718753|NCT00436098|children|children
5718754|NCT00436098|CHD: hemodynamically not significant defects|chd: hemodynamically not significant defects
5718755|NCT00436098|CHD: acyanotic defects after repair|chd: acyanotic defects after repair
5718756|NCT00436098|CHD: cyanotic defects after repair|chd: cyanotic defects after repair
5718757|NCT00436072|ZD6474|zd6474
5718758|NCT00436072|cetuximab|cetuximab
5718759|NCT00436072|irinotecan|irinotecan
5718760|NCT00436046|interferon, vaccine, influenza|interferon, vaccine, influenza
5718761|NCT00436020|clinical trial|clinical trial
5726404|NCT00409123|LDF|ldf
5718762|NCT00436020|TMS|tms
5718763|NCT00436020|depression|depression
5718764|NCT00436020|bipolar disorder|bipolar disorder
5718765|NCT00436007|Africa|africa
5718766|NCT00436007|Plasmodium falciparum|plasmodium falciparum
5718767|NCT00436007|Malaria|malaria
5718768|NCT00435994|Infant|infant
5718769|NCT00435994|Respiratory Syncytial Virus|respiratory syncytial virus
5718770|NCT00435994|Bronchiolitis|bronchiolitis
5718771|NCT00435981|Type 1 diabetes|type 1 diabetes
5718772|NCT00435981|GAD65|gad65
5718773|NCT00435981|Autoimmunity|autoimmunity
5718774|NCT00435981|C-peptide|c-peptide
5718775|NCT00435981|Children|children
5718776|NCT00435968|NK Cells|nk cells
5718777|NCT00435968|Cytokines|cytokines
5718778|NCT00435968|Lymphocytes|lymphocytes
5718779|NCT00435968|Immunoglobulins|immunoglobulins
5718780|NCT00435968|Th1 response|th1 response
5718781|NCT00435955|Follicular lymphoma|follicular lymphoma
5718782|NCT00435955|age adjusted IPI >1|age adjusted ipi >1
5718783|NCT00435955|IIL score > 2|iil score > 2
5718784|NCT00435955|Molecular remission|molecular remission
5718785|NCT00435955|High dose chemotherapy and autologous transplantation|high dose chemotherapy and autologous transplantation
5718786|NCT00435955|Rituximab|rituximab
5718787|NCT00435929|Treatment Naive|treatment naive
5718788|NCT00435916|Antigens, CD40|antigens, cd40
5718789|NCT00435916|Antibody, Monoclonal|antibody, monoclonal
5718790|NCT00435916|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5718791|NCT00435916|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5718792|NCT00435916|Hematologic Diseases|hematologic diseases
5718793|NCT00435916|Immunoproliferative Disorders|immunoproliferative disorders
5718794|NCT00435916|Lymphatic Diseases|lymphatic diseases
5718795|NCT00435916|Lymphoproliferative Disorders|lymphoproliferative disorders
5718796|NCT00435916|Lymphoma|lymphoma
5718798|NCT00435903|self-monitoring|self-monitoring
5718799|NCT00435903|major mental illness|major mental illness
5718800|NCT00435903|palm pilots|palm pilots
5718801|NCT00435903|subjects with DSM-IV Axis I diagnosis|subjects with dsm-iv axis i diagnosis
5718802|NCT00435890|ED Overcrowding|ed overcrowding
5718803|NCT00435890|Length of stay|length of stay
5718804|NCT00435890|Emergency triage|emergency triage
5718805|NCT00435890|triage|triage
5718806|NCT00435877|Connective Tissue|connective tissue
5680814|NCT00576173|Breakthrough pain|breakthrough pain
5680815|NCT00576173|acetaminophen|acetaminophen
5680816|NCT00576173|tramadol hydrochloride|tramadol hydrochloride
5680817|NCT00576173|Ultracet|ultracet
5680818|NCT00576160|medication adherence|medication adherence
5680819|NCT00576147|TBI|tbi
5680820|NCT00576147|NIRS|nirs
5680821|NCT00576147|Hematoma|hematoma
5680822|NCT00576134|Larynx, tracheotomy, titanium beads|larynx, tracheotomy, titanium beads
5680823|NCT00576082|Lyme borreliosis|lyme borreliosis
5680824|NCT00576082|Erythema migrans|erythema migrans
5680825|NCT00576082|Borrelial lymphocytoma|borrelial lymphocytoma
5680826|NCT00576082|Acrodermatitis chronica atrophicans|acrodermatitis chronica atrophicans
5681301|NCT00573911|GERD|gerd
5680827|NCT00576082|Borrelia burgdorferi|borrelia burgdorferi
5680828|NCT00576082|Borrelia afzelii|borrelia afzelii
5680829|NCT00576082|Borrelia garinii|borrelia garinii
5680830|NCT00576069|asthma|asthma
5680831|NCT00576069|lung function|lung function
5680832|NCT00576069|inflammation|inflammation
5680833|NCT00576056|Hepatocellular|hepatocellular
5680834|NCT00576056|Carcinoma|carcinoma
5744880|NCT00340301|ALS|als
5718807|NCT00435877|Stromal Cells|stromal cells
5718808|NCT00435877|Surgical Waste|surgical waste
5718809|NCT00435877|In Vivo Studies|in vivo studies
5718810|NCT00435877|Tissue Analysis|tissue analysis
5718811|NCT00435864|recipient of a HSC graft in Acute Myeloblastic Leukemia therapy|recipient of a hsc graft in acute myeloblastic leukemia therapy
5718812|NCT00435864|recipient of a HSC graft in others pathologies treated in hematology of Nantes university hospital or Angers university hospital|recipient of a hsc graft in others pathologies treated in hematology of nantes university hospital or angers university hospital
5718813|NCT00435864|donors are healthy subjects|donors are healthy subjects
5718814|NCT00435838|HLa-B*5701 Abacavir|hla-b*5701 abacavir
5718815|NCT00435812|HBV vaccine|hbv vaccine
5718816|NCT00435812|Hepatitis B vaccine|hepatitis b vaccine
5718817|NCT00435812|Hepatitis B|hepatitis b
5718818|NCT00435812|Hepatitis|hepatitis
5718819|NCT00435812|HBV|hbv
5718820|NCT00435812|Immunostimulatory sequence (ISS)|immunostimulatory sequence (iss)
5718821|NCT00435799|keratoconus|keratoconus
5718822|NCT00435799|corneal cross-linking|corneal cross-linking
5718823|NCT00435799|riboflavine|riboflavine
5718824|NCT00435799|ultraviolet type A rays (UVA)|ultraviolet type a rays (uva)
5718825|NCT00435773|Osteoarthritis|osteoarthritis
5718826|NCT00435773|Leeching|leeching
5718827|NCT00435773|Randomized Controlled Trial|randomized controlled trial
5718828|NCT00435773|Arthralgia|arthralgia
5718829|NCT00435760|COPD|copd
5718830|NCT00435721|schizophrenia|schizophrenia
5718831|NCT00435721|family psychoeducation|family psychoeducation
5718832|NCT00435708|COPD|copd
5718833|NCT00435708|Fruit|fruit
5718834|NCT00435708|Vegetables|vegetables
5718835|NCT00435708|Oxidative stress|oxidative stress
5718836|NCT00435708|Inflammation|inflammation
5717745|NCT00439621|allergy|allergy
5718837|NCT00435695|PET scan|pet scan
5718838|NCT00435695|healthy males|healthy males
5718839|NCT00435682|The trial is performed on healthy normal males.|the trial is performed on healthy normal males.
5718840|NCT00435669|Advanced or metastatic solid tumors|advanced or metastatic solid tumors
5718841|NCT00435656|Human immunodeficiency virus|human immunodeficiency virus
5718842|NCT00435643|Sleep apnea,|sleep apnea,
5718843|NCT00435643|adiponectin ,|adiponectin ,
5718844|NCT00435643|HPA axis|hpa axis
5718845|NCT00435630|Education|education
5718846|NCT00435630|Virtual Reality|virtual reality
5718847|NCT00435630|Laparoscopic Surgery|laparoscopic surgery
5718848|NCT00435630|Learning Curve|learning curve
5718849|NCT00435617|stroke rehabilitation|stroke rehabilitation
5718850|NCT00435617|stroke therapy|stroke therapy
5718851|NCT00435617|hand therapy|hand therapy
5718852|NCT00435617|stroke|stroke
5718853|NCT00435617|cerebrovascular stroke|cerebrovascular stroke
5718854|NCT00435617|cerebral stroke|cerebral stroke
5718855|NCT00435604|hyaluronidase|hyaluronidase
5718856|NCT00435604|subcutaneous drug delivery|subcutaneous drug delivery
5718857|NCT00435604|Volunteer Subjects|volunteer subjects
5680837|NCT00576056|Transcatheter Arterial Chemoembolization|transcatheter arterial chemoembolization
5680838|NCT00576056|Nexavar|nexavar
5680839|NCT00576056|Unresectable|unresectable
5680840|NCT00576043|training|training
5680841|NCT00576043|Patient satisfaction|patient satisfaction
5680842|NCT00576043|endoscopy|endoscopy
5680843|NCT00576043|simulator|simulator
5680845|NCT00576017|Cancer pain treatment|cancer pain treatment
5680846|NCT00576017|Fentanyl TTS|fentanyl tts
5680847|NCT00576017|Dihydrocodeine|dihydrocodeine
5680848|NCT00576017|Tramadol|tramadol
5680849|NCT00576017|Cancer pain|cancer pain
5680850|NCT00576017|Durogesic|durogesic
5680851|NCT00576017|Ultram|ultram
5680852|NCT00576004|Pelvic organ prolapse, Urinary incontinence, Burch colposuspension, surgery|pelvic organ prolapse, urinary incontinence, burch colposuspension, surgery
5680853|NCT00575991|conjugated linoleic acid, body fat, children, overweight|conjugated linoleic acid, body fat, children, overweight
5680854|NCT00575978|breast cancer|breast cancer
5680855|NCT00575965|simvastatin|simvastatin
5680856|NCT00575939|HIV|hiv
5680857|NCT00575939|IMT|imt
5680858|NCT00575939|coronary|coronary
5718858|NCT00435591|Hyponatremia|hyponatremia
5718859|NCT00435591|Euvolemia|euvolemia
5718860|NCT00435591|Hypervolemia|hypervolemia
5718861|NCT00435591|Conivaptan|conivaptan
5718862|NCT00435591|Vaprisol®|vaprisol®
5718863|NCT00435591|YM087|ym087
5718864|NCT00435578|Recurrent Sensitive Small-Cell Lung Cancer|recurrent sensitive small-cell lung cancer
5718865|NCT00435539|Vitreomacular Traction|vitreomacular traction
5718866|NCT00435539|Maculopathy|maculopathy
5718867|NCT00435539|VMT|vmt
5718868|NCT00435539|PVD|pvd
5718869|NCT00435526|traveler's diarrhea|traveler's diarrhea
5718870|NCT00435526|ETEC diarrhea|etec diarrhea
5718871|NCT00435526|passive immunization|passive immunization
5718872|NCT00435526|bovine milk prophylaxis|bovine milk prophylaxis
5718873|NCT00435500|Dental caries, topical fluorides|dental caries, topical fluorides
5718874|NCT00435487|Non-ST Elevation Acute Coronary Syndromes coronary interventions|non-st elevation acute coronary syndromes coronary interventions
5718875|NCT00435474|Cancer|cancer
5718876|NCT00435474|Malignant wounds|malignant wounds
5718877|NCT00435474|Quality of life|quality of life
5718878|NCT00435474|Body-Image|body-image
5718879|NCT00435474|Cancer patients|cancer patients
5718881|NCT00435461|mountain cedar|mountain cedar
5718882|NCT00435461|fexofenadine|fexofenadine
5718883|NCT00435461|allergic rhinitis|allergic rhinitis
5718884|NCT00435461|fluticasone furoate|fluticasone furoate
5718885|NCT00435448|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5718886|NCT00435448|BPH|bph
5718887|NCT00435448|Enlarged Prostate|enlarged prostate
5718888|NCT00435435|Alcoholism|alcoholism
5718889|NCT00435435|Dependence|dependence
5718890|NCT00435435|Randomization|randomization
5718891|NCT00435435|Effect|effect
5718892|NCT00435435|Disulfiram|disulfiram
5718893|NCT00435435|Naltrexone|naltrexone
5718894|NCT00435435|Acamprosate|acamprosate
5718895|NCT00435383|Caudal Block|caudal block
5718896|NCT00435383|Oxygen Saturation|oxygen saturation
5718897|NCT00435383|Uni or Bilateral Orchidopexy|uni or bilateral orchidopexy
5718898|NCT00435357|Mobile-bearing|mobile-bearing
5718899|NCT00435357|arthroplasty|arthroplasty
5718900|NCT00435357|fixed-bearing|fixed-bearing
5718903|NCT00435357|posterior stabilized TKA|posterior stabilized tka
5718904|NCT00435344|Pediatric practice|pediatric practice
5718905|NCT00435344|Smoking cessation|smoking cessation
5718906|NCT00435344|Smoking prevention|smoking prevention
5718907|NCT00435344|Adolescents|adolescents
5718908|NCT00435331|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5718909|NCT00435331|PPH|pph
5718910|NCT00435305|continuous infusion|continuous infusion
5718911|NCT00435305|epithelial lining fluid|epithelial lining fluid
5718912|NCT00435305|antibiotics|antibiotics
5718913|NCT00435305|pneumonia|pneumonia
5718914|NCT00435305|critical illness|critical illness
5680859|NCT00575939|Treatment Naive|treatment naive
5680860|NCT00575926|Randomized controlled trial|randomized controlled trial
5717848|NCT00439244|Osteoporosis|osteoporosis
5680862|NCT00575926|Immune functions|immune functions
5680863|NCT00575926|Quality of life|quality of life
5680864|NCT00575926|Survival|survival
5680865|NCT00575900|Adolescent obesity,|adolescent obesity,
5680866|NCT00575900|low carbohydrate diets|low carbohydrate diets
5680867|NCT00575900|metabolic risk factors|metabolic risk factors
5680868|NCT00575900|BMI|bmi
5680869|NCT00575887|Temozolomide|temozolomide
5680870|NCT00575887|Brain Tumor, Recurrent|brain tumor, recurrent
5680871|NCT00575887|Chemotherapy|chemotherapy
5680872|NCT00575874|rivoglitazone HCl|rivoglitazone hcl
5718915|NCT00435279|Insomnia|insomnia
5718916|NCT00435279|Depression|depression
5718917|NCT00435279|Major Depressive Disorder|major depressive disorder
5718918|NCT00435266|myocardial infarction|myocardial infarction
5718919|NCT00435266|remote|remote
5718920|NCT00435266|preconditioning|preconditioning
5718921|NCT00435266|perconditioning|perconditioning
5718922|NCT00435266|cardioprotection|cardioprotection
5718923|NCT00435253|emphysema|emphysema
5718924|NCT00435253|COPD|copd
5718925|NCT00435253|lung volume reduction|lung volume reduction
5718926|NCT00435253|NETT|nett
5718927|NCT00435253|BLVR|blvr
5718928|NCT00435253|biologic lung volume reduction|biologic lung volume reduction
5718929|NCT00435253|bronchoscopic lung volume reduction|bronchoscopic lung volume reduction
5718930|NCT00435227|Respiratory Syncytial Viruses|respiratory syncytial viruses
5718931|NCT00435214|Cytology|cytology
5718932|NCT00435214|papilloma virus|papilloma virus
5718933|NCT00435214|CIN|cin
5718934|NCT00435214|Screening|screening
5718935|NCT00435214|Cervix|cervix
5718936|NCT00435214|Cervical Cancer|cervical cancer
5718937|NCT00435188|Aging|aging
5718938|NCT00435188|Cost analysis|cost analysis
5718939|NCT00435188|Counseling|counseling
5718940|NCT00435188|Disabled Persons|disabled persons
5718941|NCT00435188|Health Promotion|health promotion
5718942|NCT00435188|Mobility Limitation|mobility limitation
5718943|NCT00435188|Physical Activity|physical activity
5718944|NCT00435188|Primary Care|primary care
5718945|NCT00435188|Randomized Clinical Trial|randomized clinical trial
5718946|NCT00435188|Veterans|veterans
5718947|NCT00435175|Estradiol|estradiol
5718948|NCT00435175|Lipolysis|lipolysis
5718949|NCT00435175|Estrogen receptor|estrogen receptor
5718950|NCT00435175|Adrenergic receptors|adrenergic receptors
5718952|NCT00435175|Postmenopausal women|postmenopausal women
5718953|NCT00435162|Children|children
5718954|NCT00435162|pediatrics|pediatrics
5718955|NCT00435162|High Blood Pressure|high blood pressure
5718956|NCT00435162|Hypertension|hypertension
5718957|NCT00435162|Valsartan|valsartan
5718958|NCT00435123|Malnutrition|malnutrition
5718959|NCT00435123|ESRD|esrd
5718960|NCT00435123|Hemodialysis|hemodialysis
5718961|NCT00435110|ARDS|ards
5718962|NCT00435110|ALI|ali
5718963|NCT00435110|Mechanical Ventilation|mechanical ventilation
5718964|NCT00435110|Outcome|outcome
5718965|NCT00435097|colon cancer|colon cancer
5718966|NCT00435097|metastatic colorectal cancer|metastatic colorectal cancer
5718967|NCT00435097|MRI|mri
5718968|NCT00435097|Magnetic resonance imaging|magnetic resonance imaging
5718969|NCT00435097|Early cancer detection|early cancer detection
5718970|NCT00435097|medical image processing|medical image processing
5718971|NCT00435097|machine learning|machine learning
5718972|NCT00435097|disease modeling|disease modeling
5718974|NCT00435084|Refractory B-CLL|refractory b-cll
5718975|NCT00435084|phase I/II|phase i/ii
5718976|NCT00435084|CD38|cd38
5718977|NCT00435058|intraocular pressure|intraocular pressure
5718978|NCT00435058|contrast sensitivity|contrast sensitivity
5718979|NCT00435058|visual function|visual function
5718980|NCT00435045|Lovaza|lovaza
5718981|NCT00435045|Hyperlipidemias|hyperlipidemias
5718982|NCT00435045|Triglycerides|triglycerides
5718983|NCT00435045|Lipids|lipids
5718984|NCT00435045|omega-3 fatty acids|omega-3 fatty acids
5718985|NCT00435045|Hypercholesterolemia|hypercholesterolemia
5718986|NCT00435045|Hypertriglyceridemia|hypertriglyceridemia
5718987|NCT00435045|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5718988|NCT00435045|Omacor|omacor
5718989|NCT00435045|Dyslipidemias|dyslipidemias
5680873|NCT00575874|pioglitazone HCl|pioglitazone hcl
5680874|NCT00575874|thiazolidinedione|thiazolidinedione
5680875|NCT00575874|peroxisome proliferator-activated receptor gamma (PPAR gamma)|peroxisome proliferator-activated receptor gamma (ppar gamma)
5680876|NCT00575874|type 2 diabetes mellitus|type 2 diabetes mellitus
5680877|NCT00575861|asthma|asthma
5680878|NCT00575861|nitric oxide gas exchange|nitric oxide gas exchange
5680879|NCT00575861|lung function|lung function
5680880|NCT00575848|Schizophrenia|schizophrenia
5680881|NCT00575848|Glycine|glycine
5680882|NCT00575848|Magnetic Resonance Spectroscopy (MRS)|magnetic resonance spectroscopy (mrs)
5718990|NCT00435032|ruptured appendicitis|ruptured appendicitis
5718991|NCT00435032|children|children
5718992|NCT00435032|surgery|surgery
5718993|NCT00435032|randomized trial|randomized trial
5718994|NCT00434993|Acute Lung Injury|acute lung injury
5718995|NCT00434993|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5685938|NCT00554229|Endothelin A|endothelin a
5685939|NCT00554229|Endothelin A antagonist|endothelin a antagonist
5685940|NCT00554216|Obesity, morbid obesity|obesity, morbid obesity
5685941|NCT00554190|rhinosinusitis, ethmoid|rhinosinusitis, ethmoid
5718996|NCT00434993|Albuterol|albuterol
5718997|NCT00434993|Aerosolized|aerosolized
5718998|NCT00434993|Critical Care|critical care
5718999|NCT00434993|Ventilator|ventilator
5719000|NCT00434980|Cognitive adaption|cognitive adaption
5719001|NCT00434980|Schizophrenia|schizophrenia
5719002|NCT00434980|Cognitive rehabilitation|cognitive rehabilitation
5719003|NCT00434980|Family treatment|family treatment
5719004|NCT00434980|Cognitive deficits|cognitive deficits
5719005|NCT00434980|Serious mental illness|serious mental illness
5719106|NCT00434577|Vaccine|vaccine
5719006|NCT00434967|Blood pressure reduction|blood pressure reduction
5719007|NCT00434967|combination therapy|combination therapy
5719008|NCT00434967|candesartan cilexetil|candesartan cilexetil
5719009|NCT00434967|hydrochlorothiazide|hydrochlorothiazide
5719010|NCT00434954|diabetes|diabetes
5719011|NCT00434954|exenatide|exenatide
5719012|NCT00434954|Byetta|byetta
5719013|NCT00434954|Amylin|amylin
5719014|NCT00434954|Lilly|lilly
5719015|NCT00434941|Administration of capecitabine concomitant to radiotherapy|administration of capecitabine concomitant to radiotherapy
5719016|NCT00434941|Her2: negative|her2: negative
5719017|NCT00434928|observational|observational
5719018|NCT00434928|dietary intake|dietary intake
5719019|NCT00434928|nutrient status|nutrient status
5719020|NCT00434928|serum assessors|serum assessors
5719021|NCT00434928|Attention-Deficit/Hyperactivity Disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
5719022|NCT00434902|Doppler Echocardiography|doppler echocardiography
5719023|NCT00434902|Pulmonary hypertension|pulmonary hypertension
5719024|NCT00434902|Sickle cell disease|sickle cell disease
5719025|NCT00434889|dementia|dementia
5719026|NCT00434889|falls|falls
5719027|NCT00434889|risk factors|risk factors
5719028|NCT00434876|Alcoholism|alcoholism
5719029|NCT00434876|Insomnia|insomnia
5719030|NCT00434876|Quetiapine|quetiapine
5719031|NCT00434876|Seroquel|seroquel
5719032|NCT00434863|botulinum toxin type A|botulinum toxin type a
5719033|NCT00434863|Dysport®|dysport®
5719034|NCT00434863|Botox®|botox®
5719035|NCT00434863|hyperfunctional forehead lines|hyperfunctional forehead lines
5719036|NCT00434863|randomized controlled trial|randomized controlled trial
5719037|NCT00434863|double-blinded trial|double-blinded trial
5719038|NCT00434863|electromyogram (EMG)|electromyogram (emg)
5719039|NCT00434850|Insulin dependence|insulin dependence
5719040|NCT00434850|Hypoglycemia|hypoglycemia
5719041|NCT00434850|Hyperglycemia unawareness|hyperglycemia unawareness
5719042|NCT00434837|Knee|knee
5719043|NCT00434837|Ligament|ligament
5719045|NCT00434837|Reconstruction|reconstruction
5719046|NCT00434837|Cartilage|cartilage
5719047|NCT00434837|Osteoarthritis|osteoarthritis
5719048|NCT00434811|Insulin dependence|insulin dependence
5719049|NCT00434811|Hypoglycemia|hypoglycemia
5719050|NCT00434811|Hypoglycemia unawareness|hypoglycemia unawareness
5719051|NCT00434798|Campylobacter infections|campylobacter infections
5719052|NCT00434772|hypoglycemia|hypoglycemia
5719053|NCT00434772|glucagon|glucagon
5719054|NCT00434772|neonatal|neonatal
5719055|NCT00434772|gestational diabetes|gestational diabetes
5719056|NCT00434772|insulin|insulin
5719057|NCT00434772|glyburide|glyburide
5719058|NCT00434759|randomized controlled trial|randomized controlled trial
5719059|NCT00434759|stepped-care program|stepped-care program
5714234|NCT00449553|Dyslipidemia|dyslipidemia
5719060|NCT00434759|cognitive therapy of social phobia according to D.M. Clark|cognitive therapy of social phobia according to d.m. clark
5719062|NCT00434720|GlideScope|glidescope
5719063|NCT00434720|Stylet|stylet
5719064|NCT00434707|glaucoma|glaucoma
5719065|NCT00434707|catarat|catarat
5719066|NCT00434707|small pupils|small pupils
5719067|NCT00434694|Atrial Fibrillation|atrial fibrillation
5719068|NCT00434694|Catheter ablation|catheter ablation
5719069|NCT00434694|Pulmonary Vein|pulmonary vein
5719070|NCT00434668|Non-Small Cell Lung Cancer|non-small cell lung cancer
5719071|NCT00434668|NSCLC|nsclc
5719072|NCT00434668|Adjuvant chemotherapy for completely resected NSCLC|adjuvant chemotherapy for completely resected nsclc
5719073|NCT00434655|Morbid obesity|morbid obesity
5719074|NCT00434655|Bariatric surgery|bariatric surgery
5719075|NCT00434655|Obesity surgery|obesity surgery
5719076|NCT00434655|Gastric banding|gastric banding
5719077|NCT00434655|Sleeve gastrectomy|sleeve gastrectomy
5719078|NCT00434642|Avastin|avastin
5719079|NCT00434642|Ovarian carcinoma|ovarian carcinoma
5719080|NCT00434642|Peritoneal carcinoma|peritoneal carcinoma
5719081|NCT00434642|Peritoneal cancer|peritoneal cancer
5719082|NCT00434642|Fallopian tube cancer|fallopian tube cancer
5719083|NCT00434642|Fallopian tube carcinoma|fallopian tube carcinoma
5719084|NCT00434642|OCEANS|oceans
5719085|NCT00434629|lymphoma|lymphoma
5719086|NCT00434629|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5718015|NCT00438854|SLL|sll
5719087|NCT00434629|B-cell lymphoma|b-cell lymphoma
5719088|NCT00434629|Radioimmunotherapy|radioimmunotherapy
5719089|NCT00434629|Bexxar|bexxar
5719090|NCT00434629|tositumomab|tositumomab
5719091|NCT00434629|autologous hematopoietic stem cell transplantation|autologous hematopoietic stem cell transplantation
5719092|NCT00434616|angiogenesis|angiogenesis
5719093|NCT00434616|Arterial Occlusive Diseases|arterial occlusive diseases
5719094|NCT00434616|Leg Ulcer|leg ulcer
5719096|NCT00434616|Ischemia|ischemia
5719097|NCT00434616|PAOD|paod
5719098|NCT00434616|Amputation|amputation
5719099|NCT00434616|bone marrow|bone marrow
5719100|NCT00434590|Kidney Transplantation|kidney transplantation
5719101|NCT00434590|Mycophenolic Acid|mycophenolic acid
5719102|NCT00434590|Immunosuppression|immunosuppression
5719103|NCT00434590|Cyclosporine|cyclosporine
5719104|NCT00434577|GSK Biologicals|gsk biologicals
5719105|NCT00434577|Herpes Zoster (HZ)|herpes zoster (hz)
5719107|NCT00434577|Varicella Zoster Virus (VZV)|varicella zoster virus (vzv)
5719108|NCT00434577|Shingles|shingles
5719109|NCT00434564|Stress nuclear scan|stress nuclear scan
5719110|NCT00434564|Acute chest pain|acute chest pain
5719111|NCT00434551|small bowel Crohn's disease|small bowel crohn's disease
5719112|NCT00434551|capsule endoscopy|capsule endoscopy
5719113|NCT00434551|PillCam SB|pillcam sb
5719114|NCT00434551|Patients with suspected small bowel Crohn's disease|patients with suspected small bowel crohn's disease
5719115|NCT00434538|Diabetic|diabetic
5719116|NCT00434538|Foot|foot
5719117|NCT00434538|Ulcer|ulcer
5719118|NCT00434538|Neuropathic|neuropathic
5719119|NCT00434538|Chitosan|chitosan
5719120|NCT00434525|Morbid obesity|morbid obesity
5719121|NCT00434525|Bariatric Surgery|bariatric surgery
5719122|NCT00434525|Obesity Surgery|obesity surgery
5719123|NCT00434525|Omentectomy|omentectomy
5719124|NCT00434525|Sleeve gastrectomy|sleeve gastrectomy
5719125|NCT00434512|Gag|gag
5719126|NCT00434512|vaccine|vaccine
5719127|NCT00434512|adjuvant|adjuvant
5719128|NCT00434512|HIV|hiv
5719129|NCT00434512|Pol|pol
5719130|NCT00434512|Nef|nef
5719131|NCT00434499|Green Tea|green tea
5719132|NCT00434499|Insulin Resistance|insulin resistance
5719133|NCT00434499|Endothelial Dysfunction|endothelial dysfunction
5719134|NCT00434499|Nitric Oxide|nitric oxide
5719135|NCT00434499|Inflammation|inflammation
5719136|NCT00434499|Obesity|obesity
5719137|NCT00434499|Overweight|overweight
5719138|NCT00434499|Diabetes Type 2|diabetes type 2
5719139|NCT00434499|High Blood Pressure|high blood pressure
5719140|NCT00434499|Healthy Volunteer|healthy volunteer
5719141|NCT00434499|HV|hv
5719142|NCT00434460|Ventilator Associated Pneumonia|ventilator associated pneumonia
5719143|NCT00434460|Knowledge Translation|knowledge translation
5719144|NCT00434460|Clinical Practice Guidelines|clinical practice guidelines
5719145|NCT00434460|Education|education
5719146|NCT00434460|Behaviour Change|behaviour change
5719147|NCT00434447|Prostate Cancer|prostate cancer
5719148|NCT00434447|Breast Cancer|breast cancer
5719149|NCT00434447|Multiple Myeloma|multiple myeloma
5719150|NCT00434447|Zoledronic acid|zoledronic acid
5719151|NCT00434447|Bone metastases|bone metastases
5719152|NCT00434447|Skeletal Related Events (SREs)|skeletal related events (sres)
5719153|NCT00434447|Renal Impairment|renal impairment
5719154|NCT00434447|Osteonecrosis of the Jaw (ONJ)|osteonecrosis of the jaw (onj)
5719155|NCT00434447|Bone involvement|bone involvement
5719156|NCT00434447|Multiple Myeloma (MM)|multiple myeloma (mm)
5719157|NCT00434434|AQUA|aqua
5719158|NCT00434434|anti-CD11|anti-cd11
5719159|NCT00434434|CD11a|cd11a
5719160|NCT00434434|Asthma|asthma
5719161|NCT00434434|Allergy|allergy
5719162|NCT00434421|Perennial Allergic Rhinitis|perennial allergic rhinitis
5719164|NCT00434421|Sublingual Immunotherapy (SLIT)|sublingual immunotherapy (slit)
5719165|NCT00434408|omphalitis|omphalitis
5719166|NCT00434408|neonates|neonates
5719167|NCT00434408|umbilical cord|umbilical cord
5719168|NCT00434408|infection|infection
5719169|NCT00434408|infant mortality|infant mortality
5719170|NCT00434408|neonate morbidity|neonate morbidity
5719171|NCT00434408|chlorhexidine|chlorhexidine
5719172|NCT00434382|auditory evoked potentials|auditory evoked potentials
5719173|NCT00434382|sensory processing|sensory processing
5719174|NCT00434382|monitoring|monitoring
5719175|NCT00434382|general anesthesia|general anesthesia
5719176|NCT00434356|Avastin|avastin
5719177|NCT00434356|MBC|mbc
5719178|NCT00434356|Breast Cancer|breast cancer
5719179|NCT00434356|Sutent|sutent
5719180|NCT00434343|Interstitial Cystitis|interstitial cystitis
5719181|NCT00434343|Painful Bladder Syndrome|painful bladder syndrome
5719182|NCT00434343|Chronic Prostatitis|chronic prostatitis
5719183|NCT00434343|Chronic Pelvic Pain Syndrome|chronic pelvic pain syndrome
5719184|NCT00434330|anemia|anemia
5719185|NCT00434330|chronic kidney disease|chronic kidney disease
5719186|NCT00434330|CKD|ckd
5719187|NCT00434330|chronic renal failure|chronic renal failure
5719188|NCT00434330|CRF|crf
5719189|NCT00434330|dialysis|dialysis
5719190|NCT00434330|erythropoietin|erythropoietin
5719191|NCT00434330|EPO|epo
5719192|NCT00434330|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5719193|NCT00434330|ESA|esa
5719194|NCT00434330|Hematide™|hematide™
5719195|NCT00434330|hemodialysis|hemodialysis
5719196|NCT00434330|hemoglobin|hemoglobin
5719197|NCT00434330|Hb|hb
5719198|NCT00434330|Hgb|hgb
5719199|NCT00434330|Omontys|omontys
5719200|NCT00434330|peginesatide|peginesatide
5719201|NCT00434330|red blood cell|red blood cell
5719202|NCT00434330|red blood cell production|red blood cell production
5719204|NCT00434317|Neoplasm|neoplasm
5719205|NCT00434317|pain|pain
5719206|NCT00434317|breast cancer|breast cancer
5719207|NCT00434317|prostate cancer|prostate cancer
5719208|NCT00434317|bone metastasis|bone metastasis
5719209|NCT00434304|Parkinson's Disease|parkinson's disease
5719210|NCT00434304|PD|pd
5719211|NCT00434291|Community-acquired Pneumonia|community-acquired pneumonia
5719212|NCT00434291|fluoroquinolone|fluoroquinolone
5719213|NCT00434291|TG-873870|tg-873870
5719215|NCT00434278|Lung disease|lung disease
5719217|NCT00434278|Pulmozyme|pulmozyme
5719218|NCT00434265|Obesity|obesity
5719219|NCT00434265|Exercise|exercise
5719220|NCT00434265|Fat oxidation|fat oxidation
5719221|NCT00434265|Overweigh (IMC>25 and IMC<30)|overweigh (imc>25 and imc<30)
5719222|NCT00434252|Avastin|avastin
5719223|NCT00434252|BEAM|beam
5719224|NCT00434252|Metastatic melanoma|metastatic melanoma
5719225|NCT00434239|Myelodysplasia|myelodysplasia
5719226|NCT00434239|Lenalidomide|lenalidomide
5719227|NCT00434239|Ancestim|ancestim
5719228|NCT00434239|Pilot trial|pilot trial
5719229|NCT00434239|Biomarkers|biomarkers
5719230|NCT00434226|SABER-L|saber-l
5719231|NCT00434226|NSCLC|nsclc
5719232|NCT00434226|Avastin|avastin
5719233|NCT00434226|Sutent|sutent
5719234|NCT00434200|rheumatoid arthritis|rheumatoid arthritis
5719235|NCT00434200|exercise|exercise
5719236|NCT00434200|damage|damage
5719237|NCT00434187|healthy|healthy
5719238|NCT00434174|Lung cancer|lung cancer
5719239|NCT00434174|Non small cell lung cancer|non small cell lung cancer
5719240|NCT00434174|NSCLC|nsclc
5719241|NCT00434174|RAD001|rad001
5719242|NCT00434174|Everolimus|everolimus
5719243|NCT00434174|Afinitor|afinitor
5719244|NCT00434174|Pemetrexed|pemetrexed
5719245|NCT00434161|Palifermin|palifermin
5719246|NCT00434161|KGF|kgf
5719247|NCT00434161|Clinical Trial|clinical trial
5719248|NCT00434161|Oncology|oncology
5719249|NCT00434161|Oral Mucositis|oral mucositis
5719250|NCT00434161|Multiple Myeloma|multiple myeloma
5719251|NCT00434161|Cataract|cataract
5719252|NCT00434148|Cushing's Disease|cushing's disease
5719253|NCT00434148|pasireotide|pasireotide
5719254|NCT00434148|SOM230|som230
5719255|NCT00434135|gemcitabine|gemcitabine
5719256|NCT00434135|pemetrexed|pemetrexed
5719257|NCT00434135|non-small cell lung cancer|non-small cell lung cancer
5719258|NCT00434122|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
5719259|NCT00434122|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies|oocyte donors undergoing controlled ovarian hyperstimulation for assisted reproductive technologies
5719260|NCT00434109|Carcinoid|carcinoid
5719261|NCT00434109|Pancreatic|pancreatic
5719262|NCT00434109|Metastatic|metastatic
5719263|NCT00434109|Neuroendocrine|neuroendocrine
5719264|NCT00434109|Tumors|tumors
5719265|NCT00434109|Hepatic|hepatic
5719266|NCT00434109|Artery|artery
5719267|NCT00434109|Embolization|embolization
5719268|NCT00434109|Angiogenesis|angiogenesis
5719269|NCT00434109|Sunitinib|sunitinib
5719270|NCT00434109|Malate|malate
5719271|NCT00434109|Sutent|sutent
5719272|NCT00434109|Tyrosine|tyrosine
5719273|NCT00434109|Kinase|kinase
5719274|NCT00434109|Inhibitor|inhibitor
5719276|NCT00434096|cannabinoid-1 receptor|cannabinoid-1 receptor
5719277|NCT00434083|TREXIMA|trexima
5719278|NCT00434083|MIGRAINE HEADACHES|migraine headaches
5719404|NCT00433719|Tuberculous meningitis|tuberculous meningitis
5719279|NCT00434083|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
5680883|NCT00575835|vitamin D|vitamin d
5719280|NCT00434070|HIV|hiv
5719281|NCT00434070|Antiretrovial Therapy|antiretrovial therapy
5719282|NCT00434070|Resistance|resistance
5719283|NCT00434070|Monitoring|monitoring
5719284|NCT00434070|TAMS|tams
5719285|NCT00434070|Treatment Experienced|treatment experienced
5719286|NCT00434057|Pigmented Skin Lesions|pigmented skin lesions
5719287|NCT00434057|Dermatology|dermatology
5719288|NCT00434057|Skin Cancer|skin cancer
5719289|NCT00434057|Melanoma|melanoma
5719290|NCT00434057|MelaFind|melafind
5719291|NCT00434031|locally advanced|locally advanced
5719292|NCT00434031|stage II|stage ii
5719293|NCT00434031|stage IIIa|stage iiia
5719294|NCT00434031|stage IIIb|stage iiib
5719295|NCT00434031|HER-2 positive|her-2 positive
5719296|NCT00434031|primary|primary
5719297|NCT00434018|Wheelchairs|wheelchairs
5719298|NCT00434018|Safety|safety
5719299|NCT00434005|Air pollution|air pollution
5719300|NCT00434005|diesel|diesel
5719301|NCT00434005|antioxidant|antioxidant
5719302|NCT00434005|oxidative stress|oxidative stress
5719303|NCT00434005|endothelial|endothelial
5719304|NCT00434005|HRV|hrv
5685942|NCT00554177|sexual|sexual
5685943|NCT00554177|combat|combat
5685944|NCT00554177|PTSD|ptsd
5685945|NCT00554177|Clinical trial|clinical trial
5685946|NCT00554177|Trauma|trauma
5685947|NCT00554177|PTSD treatment|ptsd treatment
5685948|NCT00554177|PTSD medication|ptsd medication
5685949|NCT00554177|Post traumatic stress disorder|post traumatic stress disorder
5685950|NCT00554164|Aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
5685951|NCT00554164|Positron emission tomography|positron emission tomography
5685952|NCT00554164|Chemotherapy|chemotherapy
5685953|NCT00554138|rosuvastatin|rosuvastatin
5685954|NCT00554138|dipyridamole|dipyridamole
5685955|NCT00554138|caffeine|caffeine
5685956|NCT00554125|Sirolimus; Orthotopic liver transplantation; HCC|sirolimus; orthotopic liver transplantation; hcc
5685957|NCT00554112|Exercise Training|exercise training
5685958|NCT00554112|Glucose Intolerance|glucose intolerance
5685959|NCT00554112|Human Aging|human aging
5685960|NCT00554112|Insulin Secretion|insulin secretion
5685961|NCT00554073|Magnetic resonance|magnetic resonance
5719305|NCT00434005|BAR|bar
5719306|NCT00433992|Mitochondria|mitochondria
5719307|NCT00433992|Fat apoptosis|fat apoptosis
5719308|NCT00433992|Lipoatrophy|lipoatrophy
5719309|NCT00433992|Lipodystrophy|lipodystrophy
5719310|NCT00433992|Thymidine|thymidine
5719311|NCT00433992|Treatment experienced|treatment experienced
5719312|NCT00433979|Anti-HIV agents|anti-hiv agents
5719313|NCT00433979|Physiological Effects of Drugs|physiological effects of drugs
5719314|NCT00433979|ARV-associated Adverse Events|arv-associated adverse events
5719315|NCT00433979|HAART|haart
5719316|NCT00433979|Pharmacokinetics|pharmacokinetics
5719317|NCT00433979|Protease Inhibitors|protease inhibitors
5719418|NCT00433641|pharmacogenetics|pharmacogenetics
5719318|NCT00433979|Non-nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
5719319|NCT00433979|Women|women
5719320|NCT00433966|Myocardial Infarction|myocardial infarction
5719321|NCT00433966|Angioplasty|angioplasty
5719322|NCT00433966|Myocardial Ischemia|myocardial ischemia
5719323|NCT00433966|Myocardial Reperfusion|myocardial reperfusion
5719324|NCT00433966|Stents|stents
5719325|NCT00433966|Heart Disease|heart disease
5719326|NCT00433953|Pediatric Kidney Transplant|pediatric kidney transplant
5719327|NCT00433953|Kidney Transplant|kidney transplant
5719328|NCT00433953|CellCept|cellcept
5719329|NCT00433953|Mycophenolate Mofetil|mycophenolate mofetil
5719330|NCT00433953|Mycophenolic Acid|mycophenolic acid
5719331|NCT00433940|Hemangioma|hemangioma
5719332|NCT00433940|Corticosteroid|corticosteroid
5719333|NCT00433940|Prednisone|prednisone
5719334|NCT00433927|metastatic|metastatic
5719335|NCT00433914|Meningococcal disease, prevention, vaccination|meningococcal disease, prevention, vaccination
5719336|NCT00433901|obesity in children|obesity in children
5719337|NCT00433901|childhood disorders|childhood disorders
5719338|NCT00433901|overweight children|overweight children
5719339|NCT00433901|physical activity|physical activity
5719340|NCT00433901|home environment|home environment
5719341|NCT00433862|Polycythemia Vera|polycythemia vera
5719342|NCT00433862|Essential Thrombocytosis|essential thrombocytosis
5719343|NCT00433862|Idiopathic Myelofibrosis|idiopathic myelofibrosis
5719344|NCT00433862|Janus Kinase 2|janus kinase 2
5719345|NCT00433862|CD177|cd177
5719346|NCT00433862|Chronic Myeloproliferative Disorders|chronic myeloproliferative disorders
5719347|NCT00433862|PV|pv
5719348|NCT00433862|Essential Thrombocythemia|essential thrombocythemia
5719349|NCT00433862|ET|et
5719350|NCT00433862|IM|im
5719351|NCT00433836|Children|children
5719352|NCT00433836|pediatrics|pediatrics
5719353|NCT00433836|High Blood Pressure|high blood pressure
5719354|NCT00433836|Hypertension|hypertension
5719355|NCT00433836|Valsartan|valsartan
5719356|NCT00433836|enalapril|enalapril
5719357|NCT00433823|Very low level of LDL|very low level of ldl
5719358|NCT00433823|Steroid hormones|steroid hormones
5719359|NCT00433823|Atorvastatin|atorvastatin
5719360|NCT00433823|Ezetimibe|ezetimibe
5719361|NCT00433823|Lipoprotein-a|lipoprotein-a
5685962|NCT00554073|whole body|whole body
5685963|NCT00554073|angiography|angiography
5685964|NCT00554073|vasovist|vasovist
5685965|NCT00554073|gadofosveset|gadofosveset
5685966|NCT00554073|blood pool agent|blood pool agent
5685967|NCT00554073|3T|3t
5685968|NCT00554073|1.5T|1.5t
5685969|NCT00554073|Field strength|field strength
5685970|NCT00554047|Dementia|dementia
5685971|NCT00554047|Caregivers|caregivers
5685972|NCT00554047|Costs and cost analysis|costs and cost analysis
5685973|NCT00554047|Multicenter study|multicenter study
5685974|NCT00554047|Randomized controlled trial|randomized controlled trial
5685975|NCT00554047|Quality Adjusted Life Years|quality adjusted life years
5685976|NCT00554047|Quality of life|quality of life
5685977|NCT00554047|Technology assessment, biomedical; Methods|technology assessment, biomedical; methods
5685978|NCT00554034|gingivitis, localized treatment|gingivitis, localized treatment
5718267|NCT00437931|doppler|doppler
5719362|NCT00433810|obesity|obesity
5719363|NCT00433810|bariatric surgery|bariatric surgery
5719364|NCT00433810|30-day mortality|30-day mortality
5719365|NCT00433797|Prostate cancer|prostate cancer
5719366|NCT00433797|PSA|psa
5719367|NCT00433797|antioxidant|antioxidant
5719368|NCT00433797|phytochemical|phytochemical
5719369|NCT00433797|tomatoes|tomatoes
5719370|NCT00433797|PUFA|pufa
5719371|NCT00433797|selenium|selenium
5719372|NCT00433797|soy|soy
5719373|NCT00433797|pomegranate|pomegranate
5719374|NCT00433797|grapes|grapes
5719375|NCT00433784|clopidogrel|clopidogrel
5719376|NCT00433784|platelet aggregation|platelet aggregation
5719378|NCT00433784|H2 haplotype|h2 haplotype
5719379|NCT00433784|polymorphisms|polymorphisms
5719380|NCT00433771|Malignant|malignant
5719381|NCT00433771|Cholestasis, Extrahepatic|cholestasis, extrahepatic
5719382|NCT00433771|Biliary obstruction|biliary obstruction
5719383|NCT00433758|Diabetes|diabetes
5681153|NCT00574509|NHL|nhl
5719384|NCT00433758|Blood glucose monitoring|blood glucose monitoring
5719385|NCT00433758|Non invasive Blood glucose monitoring|non invasive blood glucose monitoring
5719386|NCT00433745|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5719387|NCT00433745|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5719388|NCT00433745|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5719389|NCT00433745|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5719390|NCT00433745|Wilm's Tumor-1 Peptide|wilm's tumor-1 peptide
5719391|NCT00433745|Leukemia|leukemia
5719392|NCT00433745|Myelodysplastic Syndrome|myelodysplastic syndrome
5719393|NCT00433745|MDS|mds
5719394|NCT00433745|Acute Myelogenous Leukemia|acute myelogenous leukemia
5719395|NCT00433745|AML|aml
5719396|NCT00433745|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5719397|NCT00433745|CML|cml
5719398|NCT00433745|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5719399|NCT00433745|ALL|all
5719400|NCT00433732|TREXIMA|trexima
5719401|NCT00433732|MIGRAINE HEADACHES|migraine headaches
5719402|NCT00433732|Subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches|subjects may be enrolled if they are 18-65 years of age, have a demonstrated history of migraine headaches
5719403|NCT00433719|Human immunodeficiency virus|human immunodeficiency virus
5719405|NCT00433719|Treatment Naive|treatment naive
5719406|NCT00433706|Prostate adenocarcinoma treated by radiotherapy|prostate adenocarcinoma treated by radiotherapy
5719407|NCT00433680|adolescent|adolescent
5719408|NCT00433680|female|female
5719409|NCT00433680|obesity|obesity
5719410|NCT00433680|body dissatisfaction|body dissatisfaction
5719411|NCT00433667|RWJ-333369|rwj-333369
5719412|NCT00433667|anticonvulsants|anticonvulsants
5719413|NCT00433667|antiepileptic drugs|antiepileptic drugs
5719414|NCT00433654|Bradycardia|bradycardia
5719415|NCT00433654|Slow heart beat|slow heart beat
5719416|NCT00433654|Magnetic resonance imaging (MRI)|magnetic resonance imaging (mri)
5719417|NCT00433641|obesity|obesity
5719419|NCT00433641|sibutramine|sibutramine
5719420|NCT00433641|adrenergic|adrenergic
5719421|NCT00433641|serotonergic|serotonergic
5719422|NCT00433641|body composition|body composition
5719423|NCT00433641|gastric emptying|gastric emptying
5719424|NCT00433628|Hemoglobin A1C|hemoglobin a1c
5719425|NCT00433628|HIV|hiv
5719426|NCT00433628|Diabetes|diabetes
5685979|NCT00554021|Central venous catheter|central venous catheter
5685980|NCT00554021|nosocomial infection|nosocomial infection
5685981|NCT00554008|Appendicitis|appendicitis
5685982|NCT00554008|laparoscopy|laparoscopy
5685983|NCT00554008|randomized trial|randomized trial
5685984|NCT00554008|children|children
5685985|NCT00554008|pediatric|pediatric
5685986|NCT00553982|Replacement|replacement
5685987|NCT00553982|Knee|knee
5685988|NCT00553982|Patella|patella
5685989|NCT00553982|Arthroplasty|arthroplasty
5685990|NCT00553969|cardiovascular disease prevention|cardiovascular disease prevention
5685991|NCT00553943|lymphoma|lymphoma
5719427|NCT00433628|Diabetes Type 2|diabetes type 2
5719428|NCT00433628|Hyperglycemia|hyperglycemia
5719429|NCT00433602|thromboembolism|thromboembolism
5719430|NCT00433602|recurrent breast cancer|recurrent breast cancer
5719431|NCT00433602|stage IV breast cancer|stage iv breast cancer
5719432|NCT00433602|recurrent colon cancer|recurrent colon cancer
5719433|NCT00433602|stage I colon cancer|stage i colon cancer
5719434|NCT00433602|stage II colon cancer|stage ii colon cancer
5719435|NCT00433602|stage III colon cancer|stage iii colon cancer
5719436|NCT00433602|stage IV colon cancer|stage iv colon cancer
5719437|NCT00433602|recurrent rectal cancer|recurrent rectal cancer
5719438|NCT00433602|stage I rectal cancer|stage i rectal cancer
5719439|NCT00433602|stage II rectal cancer|stage ii rectal cancer
5719440|NCT00433602|stage III rectal cancer|stage iii rectal cancer
5719441|NCT00433602|stage IV rectal cancer|stage iv rectal cancer
5719442|NCT00433602|recurrent gastric cancer|recurrent gastric cancer
5719443|NCT00433602|stage I gastric cancer|stage i gastric cancer
5719444|NCT00433602|stage II gastric cancer|stage ii gastric cancer
5719445|NCT00433602|stage III gastric cancer|stage iii gastric cancer
5719446|NCT00433602|stage IV gastric cancer|stage iv gastric cancer
5719447|NCT00433602|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5719448|NCT00433602|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5719449|NCT00433602|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5719450|NCT00433602|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5719451|NCT00433602|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5719452|NCT00433602|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5719453|NCT00433602|recurrent small cell lung cancer|recurrent small cell lung cancer
5719454|NCT00433602|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5719455|NCT00433602|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5719456|NCT00433602|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5719457|NCT00433602|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5719458|NCT00433602|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5719459|NCT00433602|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5719460|NCT00433602|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5719461|NCT00433602|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5719462|NCT00433602|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5714614|NCT00448292|MDD|mdd
5719463|NCT00433602|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5719465|NCT00433602|ovarian stromal cancer|ovarian stromal cancer
5719466|NCT00433602|recurrent pancreatic cancer|recurrent pancreatic cancer
5719467|NCT00433602|stage I pancreatic cancer|stage i pancreatic cancer
5719468|NCT00433602|stage II pancreatic cancer|stage ii pancreatic cancer
5719469|NCT00433602|stage III pancreatic cancer|stage iii pancreatic cancer
5719470|NCT00433602|stage IV pancreatic cancer|stage iv pancreatic cancer
5719471|NCT00433602|recurrent prostate cancer|recurrent prostate cancer
5719472|NCT00433602|stage III prostate cancer|stage iii prostate cancer
5719473|NCT00433602|stage IV prostate cancer|stage iv prostate cancer
5719474|NCT00433602|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5719475|NCT00433602|limited stage small cell lung cancer|limited stage small cell lung cancer
5719476|NCT00433602|stage IIB prostate cancer|stage iib prostate cancer
5719477|NCT00433602|stage IIA prostate cancer|stage iia prostate cancer
5719478|NCT00433602|male breast cancer|male breast cancer
5719479|NCT00433589|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5719480|NCT00433589|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5719481|NCT00433589|stage IA breast cancer|stage ia breast cancer
5719482|NCT00433589|stage IB breast cancer|stage ib breast cancer
5719483|NCT00433589|stage II breast cancer|stage ii breast cancer
5719484|NCT00433589|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5685992|NCT00553943|cerebral lymphoma|cerebral lymphoma
5685993|NCT00553943|central nervous system|central nervous system
5685994|NCT00553943|cytarabine|cytarabine
5685995|NCT00553943|rituximab|rituximab
5685996|NCT00553943|Diffuse large B-cell lymphomas, with cerebral or neuromeningeal involvement|diffuse large b-cell lymphomas, with cerebral or neuromeningeal involvement
5685997|NCT00553930|HCV/HIV-coinfected patients|hcv/hiv-coinfected patients
5685998|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a
5685999|NCT00553917|Pregnancy|pregnancy
5686000|NCT00553917|Depression|depression
5686001|NCT00553917|Antidepressants|antidepressants
5686002|NCT00553852|Very Severe Obesity|very severe obesity
5686003|NCT00553852|Body Composition|body composition
5686004|NCT00553852|GH deficiency|gh deficiency
5686005|NCT00553852|IGF-I|igf-i
5686006|NCT00553852|LASGB|lasgb
5719485|NCT00433589|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5719486|NCT00433563|limited stage small cell lung cancer|limited stage small cell lung cancer
5719487|NCT00433524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5719488|NCT00433498|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5719489|NCT00433498|limited stage small cell lung cancer|limited stage small cell lung cancer
5719490|NCT00433485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5719491|NCT00433485|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5719492|NCT00433472|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5719493|NCT00433472|adult giant cell glioblastoma|adult giant cell glioblastoma
5719494|NCT00433472|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5719495|NCT00433472|recurrent adult brain tumor|recurrent adult brain tumor
5719496|NCT00433472|adult glioblastoma|adult glioblastoma
5719497|NCT00433472|adult gliosarcoma|adult gliosarcoma
5719498|NCT00433459|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5719499|NCT00433459|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5719694|NCT00432835|Idiopathic|idiopathic
5719500|NCT00433459|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5719501|NCT00433459|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5719502|NCT00433459|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5719503|NCT00433459|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5719504|NCT00433459|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5719505|NCT00433446|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5719506|NCT00433446|stage IV prostate cancer|stage iv prostate cancer
5719507|NCT00433446|recurrent prostate cancer|recurrent prostate cancer
5719508|NCT00433433|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5719509|NCT00433433|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5719510|NCT00433433|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5719511|NCT00433433|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5719512|NCT00433433|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5719513|NCT00433420|stage II breast cancer|stage ii breast cancer
5719514|NCT00433420|stage IIIA breast cancer|stage iiia breast cancer
5719515|NCT00433420|stage IIIB breast cancer|stage iiib breast cancer
5719516|NCT00433420|stage IIIC breast cancer|stage iiic breast cancer
5719517|NCT00433407|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5719518|NCT00433407|stage I breast cancer|stage i breast cancer
5719519|NCT00433407|stage II breast cancer|stage ii breast cancer
5719520|NCT00433407|stage IIIA breast cancer|stage iiia breast cancer
5719521|NCT00433407|stage IIIB breast cancer|stage iiib breast cancer
5719522|NCT00433407|stage IIIC breast cancer|stage iiic breast cancer
5719523|NCT00433407|stage IV breast cancer|stage iv breast cancer
5719524|NCT00433407|male breast cancer|male breast cancer
5719525|NCT00433407|recurrent breast cancer|recurrent breast cancer
5719526|NCT00433407|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5719527|NCT00433407|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5719528|NCT00433407|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5719529|NCT00433407|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5719530|NCT00433407|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5719531|NCT00433407|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5686007|NCT00553852|GH therapy|gh therapy
5686008|NCT00553839|anesthesia|anesthesia
5686009|NCT00553839|children|children
5686010|NCT00553839|ketamine|ketamine
5686011|NCT00553839|pharmacokinetics|pharmacokinetics
5686012|NCT00553813|Unresectable|unresectable
5686013|NCT00553813|Gemcitabine|gemcitabine
5686014|NCT00553813|Taxane|taxane
5686015|NCT00553813|TPI 287|tpi 287
5686016|NCT00553787|Obesity, Type 2 diabetes|obesity, type 2 diabetes
5686017|NCT00553774|CAD Patients on Optimal Treatment|cad patients on optimal treatment
5686018|NCT00553761|Band atrophy|band atrophy
5686019|NCT00553761|Pattern electroretinogram|pattern electroretinogram
5686020|NCT00553761|Chiasmal compression|chiasmal compression
5686021|NCT00553761|Neural loss|neural loss
5686022|NCT00553761|Electrophysiological tests|electrophysiological tests
5686023|NCT00553735|Dry Eye|dry eye
5686024|NCT00553735|Graft versus Host Disease|graft versus host disease
5686025|NCT00553735|GVHD|gvhd
5686026|NCT00553722|hypertension|hypertension
5719532|NCT00433407|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5719533|NCT00433407|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5719534|NCT00433407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5719535|NCT00433407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5719536|NCT00433407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5719537|NCT00433407|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5719538|NCT00433407|limited stage small cell lung cancer|limited stage small cell lung cancer
5719539|NCT00433407|recurrent small cell lung cancer|recurrent small cell lung cancer
5719540|NCT00433407|stage I prostate cancer|stage i prostate cancer
5719541|NCT00433407|stage IIB prostate cancer|stage iib prostate cancer
5719542|NCT00433407|stage IIA prostate cancer|stage iia prostate cancer
5719543|NCT00433407|stage III prostate cancer|stage iii prostate cancer
5719544|NCT00433407|stage IV prostate cancer|stage iv prostate cancer
5719545|NCT00433407|recurrent prostate cancer|recurrent prostate cancer
5719546|NCT00433407|stage I uterine sarcoma|stage i uterine sarcoma
5719547|NCT00433407|stage II uterine sarcoma|stage ii uterine sarcoma
5719548|NCT00433407|stage III uterine sarcoma|stage iii uterine sarcoma
5719549|NCT00433407|stage IV uterine sarcoma|stage iv uterine sarcoma
5719550|NCT00433407|recurrent uterine sarcoma|recurrent uterine sarcoma
5719551|NCT00433394|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5719552|NCT00433368|L-ornithine-L-aspartate,|l-ornithine-l-aspartate,
5719553|NCT00433368|porto-systemic encephalopathy,|porto-systemic encephalopathy,
5719554|NCT00433368|hepatic encephalopathy,|hepatic encephalopathy,
5719555|NCT00433368|liver cirrhosis,|liver cirrhosis,
5719556|NCT00433368|mental state|mental state
5719557|NCT00433355|Chronic Fatigue Syndrome|chronic fatigue syndrome
5719558|NCT00433355|Epstein-Barr Virus|epstein-barr virus
5719559|NCT00433342|Antibiotic|antibiotic
5719560|NCT00433342|p-cresol|p-cresol
5719561|NCT00433342|peritoneal dialysis|peritoneal dialysis
5719562|NCT00433329|pulmonary arterial hypertension|pulmonary arterial hypertension
5719563|NCT00433329|bosentan|bosentan
5719564|NCT00433329|sildenafil|sildenafil
5719565|NCT00433329|combination therapy|combination therapy
5719566|NCT00433329|Compass 3|compass 3
5719567|NCT00433316|ropivacaine|ropivacaine
5719568|NCT00433316|laparoscopy|laparoscopy
5719569|NCT00433316|intraperitoneal|intraperitoneal
5719570|NCT00433316|nebulization|nebulization
5719572|NCT00433316|local analgesic|local analgesic
5719573|NCT00433316|gynecology|gynecology
5719574|NCT00433264|peritoneal dialysis|peritoneal dialysis
5719575|NCT00433264|endothelium|endothelium
5719576|NCT00433264|endothelial dysfunction|endothelial dysfunction
5719578|NCT00433238|Chinese|chinese
5719579|NCT00433238|community living|community living
5719580|NCT00433238|measurement|measurement
5719581|NCT00433238|depression|depression
5719582|NCT00433238|dementia|dementia
5719978|NCT00431769|Bortezomib|bortezomib
5719583|NCT00433238|Geriatric Depression Scale|geriatric depression scale
5719584|NCT00433238|MiniCog|minicog
5719585|NCT00433212|prematurity|prematurity
5686027|NCT00553722|dialysis|dialysis
5686028|NCT00553722|hyperaldosteronism|hyperaldosteronism
5686029|NCT00553293|infertility|infertility
5686030|NCT00553293|in vitro fertilization|in vitro fertilization
5686031|NCT00553293|LH supplementation|lh supplementation
5686033|NCT00553111|syphilis|syphilis
5686034|NCT00553111|video education|video education
5686035|NCT00553111|knowledge|knowledge
5686036|NCT00553111|black|black
5686037|NCT00553111|hispanic|hispanic
5686038|NCT00553709|nausea|nausea
5686039|NCT00553709|vomiting|vomiting
5686040|NCT00553709|retching|retching
5686041|NCT00553709|emesis|emesis
5686042|NCT00553709|surgery|surgery
5686043|NCT00553709|anesthesia|anesthesia
5686044|NCT00553696|chemotherapy|chemotherapy
5686045|NCT00553696|combination|combination
5686046|NCT00553683|stage IV pancreatic cancer|stage iv pancreatic cancer
5686047|NCT00553683|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5686048|NCT00553683|advanced adult primary liver cancer|advanced adult primary liver cancer
5686049|NCT00553683|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5719586|NCT00433212|respiratory insufficiency|respiratory insufficiency
5719587|NCT00433212|non-invasive ventilation|non-invasive ventilation
5719588|NCT00433212|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5719589|NCT00433212|hyaline membrane disease|hyaline membrane disease
5719590|NCT00433199|Hypogonadism|hypogonadism
5719591|NCT00433199|Testosterone Deficiency|testosterone deficiency
5719592|NCT00433186|Scleroderma|scleroderma
5719593|NCT00433173|testosterone|testosterone
5719594|NCT00433173|insulin sensitivity|insulin sensitivity
5719595|NCT00433173|insulin resistance|insulin resistance
5719596|NCT00433173|metabolic disorders|metabolic disorders
5719597|NCT00433147|afegostat tartrate|afegostat tartrate
5719598|NCT00433147|isofagomine tartrate|isofagomine tartrate
5719599|NCT00433147|AT2101|at2101
5719600|NCT00433147|Amicus Therapeutics|amicus therapeutics
5719601|NCT00433134|renal transplant recipient|renal transplant recipient
5719602|NCT00433134|adherence|adherence
5719603|NCT00433134|compliance|compliance
5719604|NCT00433134|immunosuppression|immunosuppression
5719605|NCT00433121|Antidepressive Agents|antidepressive agents
5719606|NCT00433121|Neuroleptica|neuroleptica
5719607|NCT00433121|Dementia|dementia
5719608|NCT00433121|Discontinuation study|discontinuation study
5719609|NCT00433121|Behavioural- and Psychological Symptoms in Dementia|behavioural- and psychological symptoms in dementia
5719610|NCT00433108|Hepatitis C|hepatitis c
5719611|NCT00433108|antioxidant|antioxidant
5719612|NCT00433108|liver enzymes|liver enzymes
5719614|NCT00433095|Navelbine|navelbine
5719615|NCT00433095|Herceptin|herceptin
5719616|NCT00433095|oral|oral
5719617|NCT00433095|breast cancer|breast cancer
5719618|NCT00433082|Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,|metabolic syndrome,ramadan,fasting,inflammatory markers,
5719619|NCT00433082|Iran|iran
5719620|NCT00433069|Chronic hepatitis C|chronic hepatitis c
5719621|NCT00433069|Insulin resistance|insulin resistance
5719622|NCT00433069|Pioglitazone|pioglitazone
5719623|NCT00433069|Non-responders|non-responders
5719624|NCT00433056|STI|sti
5719625|NCT00433056|HIV|hiv
5719626|NCT00433056|CD4|cd4
5719627|NCT00433056|HIV-RNA|hiv-rna
5719628|NCT00433056|HAART|haart
5719629|NCT00433043|Heart Failure|heart failure
5719630|NCT00433043|Beta blockers|beta blockers
5719631|NCT00433043|Resynchronization|resynchronization
5719632|NCT00433043|Congestive Heart Failure, NYHA III-IV|congestive heart failure, nyha iii-iv
5719633|NCT00433043|Candidate for BIVPM|candidate for bivpm
5719634|NCT00433043|Not on Target Dose (Coreg 25 Bid or Toprol XL 200 qd)|not on target dose (coreg 25 bid or toprol xl 200 qd)
5719635|NCT00433030|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5719636|NCT00433030|HIV Viral load|hiv viral load
5719637|NCT00433030|HIV drug Resistance|hiv drug resistance
5719638|NCT00433030|Thailand|thailand
5719639|NCT00433017|Age-related macular degeneration|age-related macular degeneration
5719640|NCT00433017|AMD|amd
5686050|NCT00553683|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5686051|NCT00553683|recurrent pancreatic cancer|recurrent pancreatic cancer
5686052|NCT00553683|recurrent colon cancer|recurrent colon cancer
5727421|NCT00404482|jia|jia
5719641|NCT00433017|Choroidal neovascularization|choroidal neovascularization
5719642|NCT00433017|Verteporfin|verteporfin
5719643|NCT00433017|Ranibizumab|ranibizumab
5719644|NCT00433004|Teen|teen
5719645|NCT00433004|Plan B|plan b
5719646|NCT00433004|Post Partum|post partum
5719647|NCT00433004|Emergency Contraception|emergency contraception
5719648|NCT00432991|Nausea|nausea
5719649|NCT00432991|Vomiting|vomiting
5719650|NCT00432991|Cesarean Section|cesarean section
5719651|NCT00432978|hypoxia|hypoxia
5719652|NCT00432978|endothelin|endothelin
5719653|NCT00432978|exercise|exercise
5719654|NCT00432965|Wound closure|wound closure
5719655|NCT00432965|Accelerated healing|accelerated healing
5719656|NCT00432952|Cardiovascular Heart Disease|cardiovascular heart disease
5719657|NCT00432939|Primary Hyperparathyroidism|primary hyperparathyroidism
5719658|NCT00432926|HIV|hiv
5719659|NCT00432926|STDs|stds
5719660|NCT00432926|Methamphetamine abuse|methamphetamine abuse
5719661|NCT00432926|MSM|msm
5719662|NCT00432926|HIV Seronegativity|hiv seronegativity
5719663|NCT00432913|Eicosapentaenoic acid|eicosapentaenoic acid
5719664|NCT00432913|EPA|epa
5719665|NCT00432913|EPA 99%|epa 99%
5719666|NCT00432913|Fatty acid|fatty acid
5719667|NCT00432913|omega-3|omega-3
5719668|NCT00432913|apoptosis|apoptosis
5719669|NCT00432913|cell proliferation|cell proliferation
5719670|NCT00432913|colonic mucosa|colonic mucosa
5719671|NCT00432913|polyps|polyps
5719672|NCT00432913|adenomatous polyps|adenomatous polyps
5719673|NCT00432913|endoscopy|endoscopy
5719674|NCT00432913|PUFA|pufa
5719675|NCT00432900|Inflammation|inflammation
5719676|NCT00432900|Neuroimmunology|neuroimmunology
5719677|NCT00432900|Multiple Sclerosis|multiple sclerosis
5719679|NCT00432900|Healthy Volunteer|healthy volunteer
5719680|NCT00432900|HV|hv
5719681|NCT00432887|caffeine|caffeine
5719682|NCT00432887|coffee|coffee
5719683|NCT00432887|glucose|glucose
5719684|NCT00432887|insulin|insulin
5719685|NCT00432861|cystic fibrosis|cystic fibrosis
5720255|NCT00430768|AAV|aav
5719693|NCT00432835|Post-Surgical|post-surgical
5719695|NCT00432822|phenylketonuria|phenylketonuria
5719696|NCT00432822|phenylalanine hydroxylase deficiency|phenylalanine hydroxylase deficiency
5719697|NCT00432822|BH4|bh4
5719698|NCT00432822|responsive|responsive
5719699|NCT00432822|tetrahydrobiopterin|tetrahydrobiopterin
5719700|NCT00432822|newborns|newborns
5719701|NCT00432822|infants|infants
5719702|NCT00432822|children|children
5719703|NCT00432822|adolescents|adolescents
5719704|NCT00432809|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5719705|NCT00432809|Obesity|obesity
5719713|NCT00432783|HIV, antiretroviral therapy, adherence, ritonavir|hiv, antiretroviral therapy, adherence, ritonavir
5719714|NCT00432757|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5719715|NCT00432744|mitochondrial diseases|mitochondrial diseases
5719716|NCT00432744|respiratory chain complex I deficiencies|respiratory chain complex i deficiencies
5719717|NCT00432744|respiratory chain complex II deficiencies|respiratory chain complex ii deficiencies
5719718|NCT00432744|respiratory chain complex III deficiencies|respiratory chain complex iii deficiencies
5719719|NCT00432744|respiratory chain complex IV deficiencies|respiratory chain complex iv deficiencies
5719720|NCT00432744|mutations of a gene coding for a respiratory chain component|mutations of a gene coding for a respiratory chain component
5719721|NCT00432731|Prevention of : Varicella|prevention of : varicella
5719722|NCT00432731|Measles|measles
5719723|NCT00432731|Mumps|mumps
5719724|NCT00432731|Rubella|rubella
5719725|NCT00432718|Pneumonia|pneumonia
5719726|NCT00432718|Ventilator Associated Pneumonia|ventilator associated pneumonia
5719727|NCT00432718|Prevention|prevention
5719728|NCT00432705|ankle|ankle
5719729|NCT00432705|sensorimotor|sensorimotor
5719730|NCT00432705|reflex|reflex
5719731|NCT00432705|training|training
5719732|NCT00432692|osteoporosis|osteoporosis
5719733|NCT00432692|falls|falls
5719734|NCT00432692|prevention|prevention
5719735|NCT00432692|elderly|elderly
5719736|NCT00432692|exercise|exercise
5719737|NCT00432692|incidence|incidence
5719738|NCT00432692|obstacle avoidance|obstacle avoidance
5719739|NCT00432679|rosiglitazone|rosiglitazone
5719740|NCT00432679|Avandia|avandia
5719741|NCT00432679|type 2 diabetes mellitus|type 2 diabetes mellitus
5719742|NCT00432679|diabetes|diabetes
5719743|NCT00432653|ankylosing spondylitis|ankylosing spondylitis
5719744|NCT00432653|rituximab|rituximab
5719745|NCT00432653|therapy|therapy
5719746|NCT00432653|magnetic resonance imaging|magnetic resonance imaging
5719747|NCT00432640|(suspected) Non Small Cell Lung Cancer|(suspected) non small cell lung cancer
5719748|NCT00432627|Hepatic impairment|hepatic impairment
5686053|NCT00553683|recurrent breast cancer|recurrent breast cancer
5686054|NCT00553683|recurrent gastric cancer|recurrent gastric cancer
5686055|NCT00553683|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5686056|NCT00553683|recurrent melanoma|recurrent melanoma
5686057|NCT00553683|stage IV breast cancer|stage iv breast cancer
5686058|NCT00553683|stage IV gastric cancer|stage iv gastric cancer
5686059|NCT00553683|stage IV colon cancer|stage iv colon cancer
5686060|NCT00553683|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5686061|NCT00553683|stage IV melanoma|stage iv melanoma
5718701|NCT00436345|ICU|icu
5719749|NCT00432627|adults|adults
5719750|NCT00432627|deferasirox|deferasirox
5719751|NCT00432614|Mental Disorder|mental disorder
5719752|NCT00432614|Mood Disorder|mood disorder
5719753|NCT00432614|Depressive Disorder|depressive disorder
5719754|NCT00432601|decision aid|decision aid
5719755|NCT00432601|prostate cancer|prostate cancer
5719756|NCT00432601|patient-physician communication|patient-physician communication
5719757|NCT00432601|decision making|decision making
5719758|NCT00432601|literacy|literacy
5719759|NCT00432588|IUFD|iufd
5719760|NCT00432588|POSTTERM|postterm
5719761|NCT00432588|ROM|rom
5719762|NCT00432575|tobacco use cessation|tobacco use cessation
5719763|NCT00432575|cigarette smokers|cigarette smokers
5719764|NCT00432549|Medication overuse|medication overuse
5719765|NCT00432536|Neuro-monitoring|neuro-monitoring
5719766|NCT00432536|Quality Improvement|quality improvement
5719767|NCT00432536|Cerebral emboli|cerebral emboli
5719768|NCT00432536|Cerebral desaturation|cerebral desaturation
5719769|NCT00432536|Hypotension|hypotension
5719770|NCT00432523|Prevention of : Measles, Mumps, Rubella and Varicella diseases|prevention of : measles, mumps, rubella and varicella diseases
5719771|NCT00432510|Hereditary angioedema|hereditary angioedema
5719772|NCT00432510|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5719773|NCT00432484|Lingzhi|lingzhi
5719774|NCT00432484|Sen Miao San|sen miao san
5719775|NCT00432484|Rheumatoid Arthritis|rheumatoid arthritis
5719776|NCT00432471|Skin Cancer|skin cancer
5719777|NCT00432471|Non-Melanoma Skin Cancer|non-melanoma skin cancer
5719778|NCT00432471|Optical Imaging|optical imaging
5719779|NCT00432471|Multispectral Digital Microscope System|multispectral digital microscope system
5719780|NCT00432471|MDM|mdm
5719781|NCT00432458|stage I multiple myeloma|stage i multiple myeloma
5719782|NCT00432445|Children with retinoblastoma|children with retinoblastoma
5719783|NCT00432445|Retinoblastoma|retinoblastoma
5719784|NCT00432445|Pediatrics|pediatrics
5719785|NCT00432445|Proton Beam Radiation Therapy|proton beam radiation therapy
5719786|NCT00432445|Radiation Therapy|radiation therapy
5719787|NCT00432445|Tumor of the Eye|tumor of the eye
5719788|NCT00432445|Ophthalmic EUA|ophthalmic eua
5719789|NCT00432445|Examination under anesthesia|examination under anesthesia
5719790|NCT00432445|Bilateral retinoblastoma|bilateral retinoblastoma
5719791|NCT00432445|Unilateral retinoblastoma|unilateral retinoblastoma
5719792|NCT00432445|Extraocular disease|extraocular disease
5719793|NCT00432445|Intraocular procedure|intraocular procedure
5719794|NCT00432432|Ankylosing Spondylitis|ankylosing spondylitis
5719795|NCT00432432|MTX|mtx
5719796|NCT00432432|Infliximab|infliximab
5719797|NCT00432419|HIV|hiv
5719798|NCT00432419|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5719799|NCT00432419|Peripheral blood stem cells transplantation|peripheral blood stem cells transplantation
5719800|NCT00432406|Psoriatic Arthritis|psoriatic arthritis
5719801|NCT00432406|TNF-α|tnf-α
5719802|NCT00432406|Cardiovascular risk|cardiovascular risk
5719803|NCT00432406|Immunomodulatory activities|immunomodulatory activities
5719804|NCT00432380|Placebo|placebo
5719805|NCT00432380|Double blind|double blind
5719806|NCT00432380|Gastroenteritis|gastroenteritis
5719807|NCT00432380|Randomized|randomized
5719808|NCT00432380|Oral live attenuated human rotavirus liquid vaccine|oral live attenuated human rotavirus liquid vaccine
5719809|NCT00432367|Malaria in pregnancy|malaria in pregnancy
5719810|NCT00432367|Case management|case management
5719811|NCT00432367|Screening|screening
5719812|NCT00432367|RDT|rdt
5719813|NCT00432367|IPTp|iptp
5719814|NCT00432367|Amodiaquine|amodiaquine
5719815|NCT00432367|Artesunate|artesunate
5719816|NCT00432354|statin|statin
5719817|NCT00432354|systemic lupus erythematosus|systemic lupus erythematosus
5719818|NCT00432354|microcirculation|microcirculation
5719819|NCT00432302|Cancer|cancer
5719820|NCT00432302|Tumor|tumor
5719821|NCT00432302|Malignancy|malignancy
5719822|NCT00432302|Mass Balance|mass balance
5719823|NCT00432302|Chemotherapy|chemotherapy
5719824|NCT00432302|Drug|drug
5686062|NCT00553683|liver metastases|liver metastases
5686063|NCT00553670|coronary artery|coronary artery
5686064|NCT00553670|bifurcation|bifurcation
5686065|NCT00553670|stent|stent
5686066|NCT00553670|intravascular ultrasound|intravascular ultrasound
5686067|NCT00553670|fractional flow reserve|fractional flow reserve
5686068|NCT00553657|Experimental Medicine|experimental medicine
5680808|NCT00576225|paclitaxel|paclitaxel
5719825|NCT00432302|Cancer Treatment|cancer treatment
5719826|NCT00432302|Intravenous Infusion|intravenous infusion
5719827|NCT00432302|Epothilone|epothilone
5719828|NCT00432302|Solid Tumor|solid tumor
5719829|NCT00432289|neurological function|neurological function
5719830|NCT00432276|Glucose Metabolism Disorder|glucose metabolism disorder
5719831|NCT00432276|Dysmetabolic Syndrome|dysmetabolic syndrome
5719832|NCT00432276|Type II Diabetes|type ii diabetes
5719833|NCT00432276|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5719834|NCT00432276|Dyslipidemia|dyslipidemia
5719835|NCT00432276|Hyperglycemia|hyperglycemia
5719836|NCT00432276|Drug Therapy|drug therapy
5719837|NCT00432250|Preterm labor|preterm labor
5719838|NCT00432250|Cervical ultrasonography|cervical ultrasonography
5719839|NCT00432250|Hospital stay|hospital stay
5719840|NCT00432198|Insomnia|insomnia
5719841|NCT00432198|Zolpidem|zolpidem
5719842|NCT00432198|Adolescent|adolescent
5719843|NCT00432185|sBCC|sbcc
5719844|NCT00432185|Topical|topical
5719845|NCT00432185|Dermatology|dermatology
5719846|NCT00432172|Her2neu negative breast cancer.|her2neu negative breast cancer.
5719847|NCT00432172|Neoadjuvant treatment.|neoadjuvant treatment.
5719848|NCT00432159|cervical|cervical
5719849|NCT00432159|spinal|spinal
5719850|NCT00432159|arthroplasty|arthroplasty
5719851|NCT00432159|disc|disc
5719852|NCT00432159|surgical|surgical
5719853|NCT00432159|ACDF|acdf
5719854|NCT00432159|DDD|ddd
5719855|NCT00432146|Graves' disease, Lugol's solution|graves' disease, lugol's solution
5719856|NCT00432133|Physical Activity|physical activity
5719857|NCT00432133|Behavior Change|behavior change
5719858|NCT00432133|Mechanism|mechanism
5719859|NCT00432133|Environmental|environmental
5719860|NCT00432133|Ecological Model of Physical Activity|ecological model of physical activity
5719861|NCT00432107|Advanced cutaneous melanoma|advanced cutaneous melanoma
5719862|NCT00432107|Phase II study|phase ii study
5719863|NCT00432094|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5719864|NCT00432094|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5719865|NCT00432094|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5719866|NCT00432094|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5719867|NCT00432094|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5719868|NCT00432094|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5719869|NCT00432094|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5719870|NCT00432094|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5719871|NCT00432094|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5719872|NCT00432094|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5719873|NCT00432094|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5719960|NCT00431847|Afghan War, 2001-|afghan war, 2001-
5719874|NCT00432094|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5719875|NCT00432094|testicular choriocarcinoma|testicular choriocarcinoma
5719876|NCT00432094|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5719877|NCT00432094|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5719878|NCT00432094|testicular embryonal carcinoma|testicular embryonal carcinoma
5719879|NCT00432094|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5719880|NCT00432094|testicular yolk sac tumor|testicular yolk sac tumor
5719881|NCT00432094|testicular seminoma|testicular seminoma
5719882|NCT00432094|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5719883|NCT00432094|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5719884|NCT00432094|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5719885|NCT00432094|stage I extragonadal seminoma|stage i extragonadal seminoma
5719886|NCT00432094|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5719887|NCT00432094|stage II extragonadal seminoma|stage ii extragonadal seminoma
5719888|NCT00432094|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5719889|NCT00432094|stage III extragonadal seminoma|stage iii extragonadal seminoma
5686069|NCT00553631|Enzyme Replacement Therapy|enzyme replacement therapy
5686070|NCT00553631|Gaucher disease|gaucher disease
5686071|NCT00553631|glucocerebrosidase|glucocerebrosidase
5686072|NCT00553631|beta-glucocerebrosidase|beta-glucocerebrosidase
5686073|NCT00553631|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5686074|NCT00553631|glucosylceramidase|glucosylceramidase
5686075|NCT00553631|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5686076|NCT00553631|gene activation|gene activation
5686077|NCT00553631|human|human
5686078|NCT00553618|Interleukin 2|interleukin 2
5686079|NCT00553618|Proleukin|proleukin
5686080|NCT00553618|DTIC|dtic
5686081|NCT00553618|Dacarbazine|dacarbazine
5686082|NCT00553618|metastatic melanoma|metastatic melanoma
5686083|NCT00553618|adjuvant|adjuvant
5686084|NCT00553605|Renal Colic Pain Urinary Tract Colic|renal colic pain urinary tract colic
5686085|NCT00553579|contrast sensitivity, retention time|contrast sensitivity, retention time
5686086|NCT00553566|stage 0 bladder cancer|stage 0 bladder cancer
5686087|NCT00553566|stage I bladder cancer|stage i bladder cancer
5686088|NCT00553566|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5719890|NCT00432094|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5719891|NCT00432094|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5719892|NCT00432094|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5719893|NCT00432094|adult teratoma|adult teratoma
5719894|NCT00432094|childhood teratoma|childhood teratoma
5719895|NCT00432094|testicular immature teratoma|testicular immature teratoma
5719896|NCT00432094|testicular mature teratoma|testicular mature teratoma
5719897|NCT00432094|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5719898|NCT00432094|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5719899|NCT00432081|Dementia|dementia
5719900|NCT00432081|Inflammation|inflammation
5719901|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents
5719902|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5719903|NCT00432081|Drug Therapy|drug therapy
5719904|NCT00432068|Healthy volunteers|healthy volunteers
5719905|NCT00432068|octreotide pamoate|octreotide pamoate
5719906|NCT00432068|pharmacokinetics|pharmacokinetics
5719908|NCT00432055|Cerebral Palsy|cerebral palsy
5719909|NCT00432055|Spastic contractures|spastic contractures
5719910|NCT00432055|Botulinum toxin type A|botulinum toxin type a
5719911|NCT00432042|Mumps and Rubella|mumps and rubella
5719912|NCT00432042|Haemophilus influenzae type b (Infanrix® hexa)|haemophilus influenzae type b (infanrix® hexa)
5719913|NCT00432029|Flicker induced vasodilatation|flicker induced vasodilatation
5719914|NCT00432029|Flow mediated vasodilatation|flow mediated vasodilatation
5719915|NCT00432029|Forearm blood flow|forearm blood flow
5719916|NCT00432029|Retinal vessel diameter|retinal vessel diameter
5719917|NCT00432029|Endothelial dysfunction|endothelial dysfunction
5719918|NCT00432016|HIV|hiv
5719919|NCT00432016|pharmacokinetics|pharmacokinetics
5719920|NCT00432016|zidovudine|zidovudine
5719921|NCT00432016|amdoxovir|amdoxovir
5719922|NCT00432016|DAPD|dapd
5719923|NCT00432016|AMDX|amdx
5719924|NCT00432016|Treatment Naive|treatment naive
5719925|NCT00432003|Treatment Experienced|treatment experienced
5719927|NCT00432003|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5719928|NCT00431977|Coronary Atherosclerosis|coronary atherosclerosis
5719929|NCT00431977|Diabetes Mellitus|diabetes mellitus
5719930|NCT00431964|azithromycin, Zithromax|azithromycin, zithromax
5719931|NCT00431951|Healthy Volunteers|healthy volunteers
5719932|NCT00431925|head and neck cancer|head and neck cancer
5719933|NCT00431925|radiation therapy|radiation therapy
5719934|NCT00431925|chemotherapy|chemotherapy
5719935|NCT00431925|mucositis|mucositis
5719936|NCT00431925|cytokines|cytokines
5719937|NCT00431925|gastrostomy|gastrostomy
5719938|NCT00431925|radiotherapy|radiotherapy
5719939|NCT00431912|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5686089|NCT00553553|Intrathecal morphine ITM intravenous morphine remifentanil hepatic resection|intrathecal morphine itm intravenous morphine remifentanil hepatic resection
5686090|NCT00553553|Adult|adult
5686091|NCT00553553|ASA I-III (stable)|asa i-iii (stable)
5686092|NCT00553553|Liver dysfunction requiring primary parenchymal resection|liver dysfunction requiring primary parenchymal resection
5686093|NCT00553540|backache|backache
5686094|NCT00553540|low backpain|low backpain
5686095|NCT00553540|sciatica|sciatica
5686096|NCT00553514|Infertility|infertility
5686097|NCT00553514|Oligo-anovulation|oligo-anovulation
5686098|NCT00553514|GONAL-f®|gonal-f®
5686099|NCT00553514|AS900672-Enriched|as900672-enriched
5686100|NCT00553514|hyperglycosylated recombinant human follicle stimulating hormone (r-hFSH)|hyperglycosylated recombinant human follicle stimulating hormone (r-hfsh)
5686101|NCT00553501|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5686102|NCT00553501|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5686103|NCT00553501|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5686104|NCT00553501|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5680836|NCT00576056|Sorafenib|sorafenib
5719940|NCT00431912|mycosis fungoides|mycosis fungoides
5719941|NCT00431912|Sézary syndrome|sézary syndrome
5719942|NCT00431912|APO866|apo866
5719943|NCT00431912|phase II study|phase ii study
5719944|NCT00431899|nutrition|nutrition
5719945|NCT00431899|omega 3 fatty acids|omega 3 fatty acids
5719946|NCT00431899|insulin resistance|insulin resistance
5719947|NCT00431886|Chest pains|chest pains
5719948|NCT00431886|Computed tomography|computed tomography
5719949|NCT00431886|Emergency|emergency
5719950|NCT00431873|Lymphocytic Leukemia, Chronic (Refractory)|lymphocytic leukemia, chronic (refractory)
5719951|NCT00431873|Phase II|phase ii
5719952|NCT00431860|Coronary atherosclerosis, Spiral Computed Tomography|coronary atherosclerosis, spiral computed tomography
5719953|NCT00431847|Anesthesia, Regional|anesthesia, regional
5719954|NCT00431847|Causalgia|causalgia
5719955|NCT00431847|Trauma|trauma
5719956|NCT00431847|Complex Regional Pain Syndrome Type II|complex regional pain syndrome type ii
5719957|NCT00431847|Neuropathic Pain|neuropathic pain
5719958|NCT00431847|PTSD|ptsd
5719959|NCT00431847|Combat Stress Disorders|combat stress disorders
5719961|NCT00431847|Iraq War, 2003-|iraq war, 2003-
5719962|NCT00431834|Permanent Atrial Fibrillation Surgical RF Ablation|permanent atrial fibrillation surgical rf ablation
5719963|NCT00431834|Permanent Atrial Fibrillation|permanent atrial fibrillation
5719965|NCT00431821|Rehabilitation|rehabilitation
5719966|NCT00431821|Stroke|stroke
5719967|NCT00431808|Malaria|malaria
5719968|NCT00431808|vaccine|vaccine
5719969|NCT00431808|Apical Membrane Antigene|apical membrane antigene
5719970|NCT00431808|Mali|mali
5719971|NCT00431808|Adults|adults
5719972|NCT00431795|Advanced breast cancer|advanced breast cancer
5719973|NCT00431795|Pegylated liposomal doxorubicin|pegylated liposomal doxorubicin
5719974|NCT00431795|Epirubicin|epirubicin
5719975|NCT00431782|Atrial fibrillation|atrial fibrillation
5719976|NCT00431782|Anticoagulation|anticoagulation
5719977|NCT00431769|Multiple myeloma|multiple myeloma
5719979|NCT00431769|Dexamethasone|dexamethasone
5719980|NCT00431769|VELCADE|velcade
5719981|NCT00431756|Barrett's esophagus|barrett's esophagus
5719982|NCT00431756|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5719983|NCT00431756|esophageal cancer|esophageal cancer
5719984|NCT00431756|DNA methylation|dna methylation
5719985|NCT00431743|Fluid Therapy|fluid therapy
5719986|NCT00431743|Crystalloid|crystalloid
5719987|NCT00431743|Colloid|colloid
5719988|NCT00431743|Perioperative|perioperative
5719989|NCT00431743|Optimization|optimization
5719990|NCT00431743|Goal-directed Therapy|goal-directed therapy
5719991|NCT00431717|Coronary Atherosclerosis|coronary atherosclerosis
5719992|NCT00431717|Diabetes Mellitus|diabetes mellitus
5719993|NCT00431704|advanced|advanced
5719994|NCT00431704|her-2 positive|her-2 positive
5719995|NCT00431678|Community-acquired Pneumonia|community-acquired pneumonia
5686105|NCT00553501|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5686106|NCT00553501|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5686107|NCT00553501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5686108|NCT00553501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5686109|NCT00553501|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5686110|NCT00553488|diabetes|diabetes
5686111|NCT00553488|insulin|insulin
5686112|NCT00553488|subcutaneous|subcutaneous
5686113|NCT00553488|intra-dermal|intra-dermal
5686114|NCT00553488|blood glucose|blood glucose
5686115|NCT00553462|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5680861|NCT00575926|Lingzhi|lingzhi
5719996|NCT00431665|Renal Plasma Flow|renal plasma flow
5719997|NCT00431665|Glomerular Filtration Rate|glomerular filtration rate
5719998|NCT00431665|Free fatty acids|free fatty acids
5719999|NCT00431639|Animal-Assisted Therapy|animal-assisted therapy
5720000|NCT00431639|Pain|pain
5720001|NCT00431639|Oncology|oncology
5720002|NCT00431639|Cancer Pain|cancer pain
5720003|NCT00431626|Benign|benign
5720004|NCT00431626|Prostatic|prostatic
5720005|NCT00431626|Hyperplasia|hyperplasia
5720006|NCT00431626|Lower|lower
5720007|NCT00431626|Urinary|urinary
5720008|NCT00431626|Track|track
5720009|NCT00431626|Symptoms|symptoms
5720010|NCT00431626|Laser|laser
5720011|NCT00431626|Transurethral|transurethral
5720012|NCT00431626|Prostate|prostate
5720013|NCT00431613|NSCLC|nsclc
5720014|NCT00431613|Induction chemotherapy|induction chemotherapy
5720015|NCT00431613|Concurrent chemoradiotherapy|concurrent chemoradiotherapy
5720016|NCT00431613|Consolidation therapy|consolidation therapy
5720017|NCT00431613|Docetaxel|docetaxel
5720018|NCT00431613|Gemcitabine|gemcitabine
5720019|NCT00431613|Carboplatin|carboplatin
5720020|NCT00431600|Regional Blood Flow|regional blood flow
5720021|NCT00431600|Color Doppler Optical Coherence Tomography|color doppler optical coherence tomography
5720022|NCT00431600|CDOCT|cdoct
5720023|NCT00431600|Retinal Blood Flow|retinal blood flow
5720024|NCT00431600|Hyperoxia|hyperoxia
5720025|NCT00431600|Vasoconstriction|vasoconstriction
5720026|NCT00431600|Laser Doppler Velocimetry|laser doppler velocimetry
5720027|NCT00431600|Retinal Vessel Analyzer|retinal vessel analyzer
5720028|NCT00431587|morbid obesity|morbid obesity
5720029|NCT00431587|metabolic syndrome|metabolic syndrome
5720030|NCT00431587|visceral fat|visceral fat
5720031|NCT00431587|peripheral fat|peripheral fat
5720032|NCT00431574|schizophrenia|schizophrenia
5720033|NCT00431574|schizoaffective|schizoaffective
5720034|NCT00431574|antipsychotic|antipsychotic
5720035|NCT00431574|randomized control trial|randomized control trial
5720036|NCT00431561|Glioblastoma|glioblastoma
5720037|NCT00431561|Anaplastic astrocytoma|anaplastic astrocytoma
5720039|NCT00431561|Cancer|cancer
5720040|NCT00431561|Transforming growth factor beta2 (TGF-beta2)|transforming growth factor beta2 (tgf-beta2)
5720041|NCT00431561|Targeted therapy|targeted therapy
5720042|NCT00431561|Immunotherapy|immunotherapy
5720043|NCT00431561|Brain tumor|brain tumor
5720044|NCT00431561|Central nervous system (CNS)|central nervous system (cns)
5720045|NCT00431561|Convection-enhanced delivery (CED) / microperfusion|convection-enhanced delivery (ced) / microperfusion
5720046|NCT00431561|Locoregional application|locoregional application
5720047|NCT00431535|Fluid|fluid
5720048|NCT00431535|SvO2|svo2
5720049|NCT00431535|Mobilisation|mobilisation
5720050|NCT00431535|Orthostatic function|orthostatic function
5720051|NCT00431509|Osteoarthritis|osteoarthritis
5720052|NCT00431509|Arthroplasty|arthroplasty
5720053|NCT00431509|Replacement|replacement
5720054|NCT00431509|Knee|knee
5720055|NCT00431509|Instrumentation|instrumentation
5720056|NCT00431496|Anemia|anemia
5720057|NCT00431496|Intact Parathyroid Hormone (iPTH)|intact parathyroid hormone (ipth)
5720058|NCT00431496|Secondary Hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5720059|NCT00431483|antibacterial agents|antibacterial agents
5720060|NCT00431483|surgery|surgery
5720061|NCT00431483|pharmacist|pharmacist
5720062|NCT00431483|economics, pharmaceutical|economics, pharmaceutical
5720063|NCT00431470|Classroom violence, character, bullying, self esteem|classroom violence, character, bullying, self esteem
5720064|NCT00431444|Osteoporosis|osteoporosis
5720065|NCT00431444|Post-menopausal|post-menopausal
5686116|NCT00553462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5686117|NCT00553462|adenocarcinoma of the lung|adenocarcinoma of the lung
5694564|NCT00520611|Financial Incentives|financial incentives
5686118|NCT00553462|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5686119|NCT00553462|large cell lung cancer|large cell lung cancer
5686120|NCT00553462|squamous cell lung cancer|squamous cell lung cancer
5686121|NCT00553449|nocturnal heartburn|nocturnal heartburn
5686122|NCT00553449|day-time heartburn|day-time heartburn
5686124|NCT00553449|GERD|gerd
5686125|NCT00553436|colon|colon
5720066|NCT00431444|Bone mineral density|bone mineral density
5720067|NCT00431405|rheumatoid arthritis|rheumatoid arthritis
5720068|NCT00431405|cardiovascular disease|cardiovascular disease
5720069|NCT00431405|coronary disease|coronary disease
5720070|NCT00431392|Choroidal blood flow|choroidal blood flow
5720071|NCT00431392|NO-synthase|no-synthase
5720072|NCT00431392|light/dark transition|light/dark transition
5720074|NCT00431366|Repetitive TMS (rTMS)|repetitive tms (rtms)
5720075|NCT00431366|Parkinson's Disease|parkinson's disease
5720076|NCT00431366|Peg Board Test|peg board test
5720077|NCT00431366|Levodopa|levodopa
5720078|NCT00431366|Parkinson Disease|parkinson disease
5720079|NCT00431366|PD|pd
5720080|NCT00431340|Multiple myeloma|multiple myeloma
5720081|NCT00431340|myeloma|myeloma
5720082|NCT00431340|plasma cell myeloma|plasma cell myeloma
5720083|NCT00431340|bone marrow cancer|bone marrow cancer
5720084|NCT00431340|myelomatosis|myelomatosis
5720085|NCT00431340|Kahler's disease|kahler's disease
5720086|NCT00431340|PXD101|pxd101
5720087|NCT00431340|belinostat|belinostat
5720088|NCT00431340|bortezomib|bortezomib
5720089|NCT00431327|patient navigator|patient navigator
5720090|NCT00431327|peer support|peer support
5720091|NCT00431327|colonoscopy|colonoscopy
5720092|NCT00431327|adherence|adherence
5720093|NCT00431327|None: have to be scheduled for screening or diagnostic colonoscopy|none: have to be scheduled for screening or diagnostic colonoscopy
5720094|NCT00431314|End Stage Renal Disease|end stage renal disease
5720095|NCT00431314|Hemodialysis|hemodialysis
5720096|NCT00431314|Critical Limb Ischemia|critical limb ischemia
5720097|NCT00431314|Autofluorescence|autofluorescence
5720098|NCT00431301|Progressive Supranuclear Palsy|progressive supranuclear palsy
5720099|NCT00431301|Epidemiology|epidemiology
5720100|NCT00431301|Case-Control|case-control
5720101|NCT00431301|Genetic|genetic
5720102|NCT00431301|Environmental|environmental
5720103|NCT00431301|Neurodegenerative Disease|neurodegenerative disease
5720104|NCT00431301|Movement Disorders|movement disorders
5720105|NCT00431301|Atypical Parkinsonism|atypical parkinsonism
5720106|NCT00431301|Parkinson Plus|parkinson plus
5720107|NCT00431301|Steele-Richardson-Olszewski|steele-richardson-olszewski
5720108|NCT00431301|PSP|psp
5720109|NCT00431288|nutrition|nutrition
5720110|NCT00431288|adolescent nutrition|adolescent nutrition
5720111|NCT00431288|blood pressure|blood pressure
5720112|NCT00431288|hypertension|hypertension
5720113|NCT00431288|diet therapy|diet therapy
5720114|NCT00431288|patient education|patient education
5720115|NCT00431262|alcoholism|alcoholism
5720116|NCT00431262|antabuse|antabuse
5720117|NCT00431262|disulfiram|disulfiram
5720118|NCT00431262|abstinence|abstinence
5720119|NCT00431262|cognitive behavioural therapy|cognitive behavioural therapy
5720120|NCT00431236|cisplatin|cisplatin
5720121|NCT00431236|CINV|cinv
5720122|NCT00431236|highly emetogenic|highly emetogenic
5720123|NCT00431223|fMRI|fmri
5720124|NCT00431223|working memory|working memory
5720125|NCT00431223|schizophrenia|schizophrenia
5720126|NCT00431223|treatment refractory|treatment refractory
5720127|NCT00431223|cognitive skills training|cognitive skills training
5720128|NCT00431223|dorsolateral prefrontal cortex|dorsolateral prefrontal cortex
5720129|NCT00431223|cognitive remediation|cognitive remediation
5720130|NCT00431223|treatment refractory schizophrenia of > 5 years duration|treatment refractory schizophrenia of > 5 years duration
5720132|NCT00431210|EPV|epv
5720133|NCT00431184|bipolar disorder|bipolar disorder
5720134|NCT00431184|bipolar mania|bipolar mania
5720135|NCT00431184|schizoaffective disorder|schizoaffective disorder
5720136|NCT00431184|schizoaffective mania|schizoaffective mania
5720137|NCT00431184|mania|mania
5720138|NCT00431184|kappa opiates|kappa opiates
5720139|NCT00431184|opiates|opiates
5720140|NCT00431171|spinal cord injuries|spinal cord injuries
5720141|NCT00431171|lithium|lithium
5720142|NCT00431158|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5720143|NCT00431158|ARDS|ards
5720144|NCT00431158|Respiratory failure|respiratory failure
5720145|NCT00431158|Mechanical Ventilation|mechanical ventilation
5720146|NCT00431158|Positive end expiratory pressure|positive end expiratory pressure
5720147|NCT00431158|Lung recruitment maneuver|lung recruitment maneuver
5720148|NCT00431119|bullous autoimmune disease|bullous autoimmune disease
5720149|NCT00431119|bullous pemphigoid|bullous pemphigoid
5720150|NCT00431119|immunosuppressants|immunosuppressants
5720151|NCT00431119|corticosteroids|corticosteroids
5720152|NCT00431119|mycophenolate mofetil|mycophenolate mofetil
5720153|NCT00431106|Breast cancer|breast cancer
5720154|NCT00431106|Chemotherapy|chemotherapy
5720155|NCT00431106|Vinorelbine|vinorelbine
5720156|NCT00431106|Gemcitabine|gemcitabine
5720157|NCT00431106|Capecitabine|capecitabine
5720158|NCT00431080|Early breast cancer|early breast cancer
5720159|NCT00431080|Axillary node positive|axillary node positive
5720160|NCT00431080|Adjuvant chemotherapy|adjuvant chemotherapy
5720161|NCT00431080|Dose dense|dose dense
5720162|NCT00431080|Docetaxel|docetaxel
5720163|NCT00431080|Paclitaxel|paclitaxel
5720164|NCT00431080|FEC|fec
5720166|NCT00431054|Fallopian Tube Cancer|fallopian tube cancer
5720167|NCT00431054|Peritoneal Cancer|peritoneal cancer
5720168|NCT00431054|Perifosine|perifosine
5720169|NCT00431054|Docetaxel|docetaxel
5720170|NCT00431054|Taxotere|taxotere
5720171|NCT00431041|Solifenacin succinate|solifenacin succinate
5720172|NCT00431041|Oxybutynin immediate release|oxybutynin immediate release
5720173|NCT00431041|Xerostomia|xerostomia
5720174|NCT00431041|Overactive bladder|overactive bladder
5720175|NCT00431028|Cataract|cataract
5720176|NCT00431028|Endophthalmitis|endophthalmitis
5720177|NCT00431028|Antibiotics|antibiotics
5720178|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents
5720179|NCT00431028|Drug Delivery Systems|drug delivery systems
5720181|NCT00431015|Cancer of the lung|cancer of the lung
5720182|NCT00431015|Non-small cell lung cancer|non-small cell lung cancer
5720183|NCT00431002|Exercise|exercise
5720184|NCT00431002|Resistance training|resistance training
5720185|NCT00430989|Anaesthesia|anaesthesia
5720186|NCT00430989|Major Surgery|major surgery
5720187|NCT00430989|Coronary artery disease|coronary artery disease
5720188|NCT00430989|Nitrous oxide|nitrous oxide
5720189|NCT00430989|Effects of Nitrous Oxide following Anaesthesia|effects of nitrous oxide following anaesthesia
5720190|NCT00430989|Anaesthesia and coronary artery disease|anaesthesia and coronary artery disease
5720191|NCT00430976|psychomotor function|psychomotor function
5720192|NCT00430976|neuromuscular system|neuromuscular system
5720193|NCT00430976|memory|memory
5720194|NCT00430976|brain electrical activity|brain electrical activity
5720195|NCT00430976|Mental Processes|mental processes
5720196|NCT00430950|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
5720197|NCT00430950|Essential Hypertension|essential hypertension
5720198|NCT00430950|Combination Therapy|combination therapy
5720199|NCT00430950|Fixed-Combination Dose|fixed-combination dose
5720200|NCT00430937|Complicated Skin and Soft Tissue Infections. Daptomycin, Vancomycin, Teicoplanin|complicated skin and soft tissue infections. daptomycin, vancomycin, teicoplanin
5720201|NCT00430937|Complicated skin and soft tissue infections|complicated skin and soft tissue infections
5720202|NCT00430924|Kidney Failure, Chronic|kidney failure, chronic
5720203|NCT00430924|Proteinuria|proteinuria
5720204|NCT00430924|Aldosterone|aldosterone
5720205|NCT00430924|Renin-Angiotensin System|renin-angiotensin system
5720206|NCT00430911|malignant gliomas|malignant gliomas
5720207|NCT00430898|ulcerative colitis basiliximab|ulcerative colitis basiliximab
5720208|NCT00430885|Heart failure|heart failure
5720209|NCT00430885|Myocardial infarction|myocardial infarction
5720210|NCT00430885|Patients with acute myocardial infarction|patients with acute myocardial infarction
5720211|NCT00430872|Spinal Cord Tumor|spinal cord tumor
5720212|NCT00430872|Intramedullary Spinal Cord Tumor|intramedullary spinal cord tumor
5720213|NCT00430872|Extramedullary Spinal Cord Tumor|extramedullary spinal cord tumor
5720214|NCT00430872|Symptoms|symptoms
5720216|NCT00430859|Sepsis|sepsis
5720217|NCT00430859|Alkaline|alkaline
5720218|NCT00430859|Phosphatase|phosphatase
5720219|NCT00430859|Lipopolysaccharide|lipopolysaccharide
5720220|NCT00430846|Antigens,CD30|antigens,cd30
5720221|NCT00430846|Antibody-Drug Conjugate|antibody-drug conjugate
5720222|NCT00430846|Antibodies, Monoclonal|antibodies, monoclonal
5720223|NCT00430846|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5720225|NCT00430846|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5720226|NCT00430846|Hematologic Diseases|hematologic diseases
5720227|NCT00430846|Lymphoma|lymphoma
5720228|NCT00430820|Biomarkers|biomarkers
5720229|NCT00430820|Proteomics|proteomics
5720230|NCT00430820|Mass spectrometry|mass spectrometry
5720231|NCT00430820|Atherosclerosis|atherosclerosis
5720232|NCT00430820|Acute coronary syndromes|acute coronary syndromes
5720233|NCT00430820|Myocardial infarction|myocardial infarction
5720234|NCT00430820|Coronary artery disease|coronary artery disease
5720235|NCT00430807|giant cell arteritis,|giant cell arteritis,
5720236|NCT00430807|hydroxychloroquine,|hydroxychloroquine,
5720237|NCT00430807|corticosteroid sparing,|corticosteroid sparing,
5720238|NCT00430807|corticodependence|corticodependence
5720239|NCT00430794|resistant hypertension|resistant hypertension
5720240|NCT00430794|Spironolactone|spironolactone
5720241|NCT00430794|double-blind|double-blind
5720242|NCT00430794|randomised controlled trial|randomised controlled trial
5720243|NCT00430794|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5720244|NCT00430781|pazopanib|pazopanib
5720245|NCT00430781|ErB1/ErB2|erb1/erb2
5720246|NCT00430781|lapatinib|lapatinib
5720247|NCT00430781|persistent|persistent
5720248|NCT00430781|VEGF|vegf
5720249|NCT00430781|recurrent|recurrent
5720250|NCT00430781|metastatic cervical cancer|metastatic cervical cancer
5720251|NCT00430781|advanced|advanced
5720252|NCT00430781|FIGO Stage IVB|figo stage ivb
5720253|NCT00430768|Gene Transfer Techniques|gene transfer techniques
5720254|NCT00430768|Gene Therapy|gene therapy
5720257|NCT00430768|Phase I|phase i
5720258|NCT00430768|Intramuscular transfer|intramuscular transfer
5720259|NCT00430729|Roflumilast|roflumilast
5720260|NCT00430703|severe traumatic brain injury|severe traumatic brain injury
5720261|NCT00430703|body weight support treadmill training|body weight support treadmill training
5720262|NCT00430703|Electroencephalogram|electroencephalogram
5720263|NCT00430703|Event Related Potentials|event related potentials
5720264|NCT00430664|pleurodesis|pleurodesis
5720265|NCT00430664|talc|talc
5720266|NCT00430664|iodopovidone|iodopovidone
5720267|NCT00430651|Non Small Cell Lung Cancer|non small cell lung cancer
5720268|NCT00430651|2nd line chemotherapy|2nd line chemotherapy
5720269|NCT00430651|Docetaxel|docetaxel
5720270|NCT00430638|Hypertension|hypertension
5720271|NCT00430638|Angiotensin Receptor Blocker|angiotensin receptor blocker
5720272|NCT00430638|Calcium Channel Blocker|calcium channel blocker
5720273|NCT00430638|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5722352|NCT00423605|Fibro|fibro
5720274|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide
5720275|NCT00430638|Stage I and II Hypertension|stage i and ii hypertension
5720276|NCT00430625|VPRIV®|vpriv®
5720277|NCT00430625|Enzyme Replacement Therapy|enzyme replacement therapy
5720278|NCT00430625|Gaucher disease|gaucher disease
5720279|NCT00430625|glucocerebrosidase|glucocerebrosidase
5720280|NCT00430625|beta-glucocerebrosidase|beta-glucocerebrosidase
5720281|NCT00430625|Acid beta-glucocerebrosidase|acid beta-glucocerebrosidase
5720282|NCT00430625|glucosylceramidase|glucosylceramidase
5720283|NCT00430625|D-glucosyl-N-acylsphingosine glucohydrolase|d-glucosyl-n-acylsphingosine glucohydrolase
5720284|NCT00430625|gene activation|gene activation
5720285|NCT00430625|human|human
5720286|NCT00430612|Myocardial Infarction|myocardial infarction
5720287|NCT00430612|Heart Attack|heart attack
5720288|NCT00430612|Beta Blockers|beta blockers
5720289|NCT00430612|Survival|survival
5720290|NCT00430573|cognitive-behavior therapy|cognitive-behavior therapy
5720291|NCT00430573|d-cycloserine|d-cycloserine
5720292|NCT00430573|cognitive enhancer|cognitive enhancer
5720293|NCT00430573|drug dependence|drug dependence
5720294|NCT00430573|opiate dependence|opiate dependence
5720295|NCT00430573|exposure|exposure
5720296|NCT00430573|isolated doses of d-cycloserine|isolated doses of d-cycloserine
5720297|NCT00430573|isolated doses of matching pill placebo|isolated doses of matching pill placebo
5720298|NCT00430573|DCS|dcs
5720299|NCT00430560|work therapy|work therapy
5720300|NCT00430560|cognitive rehabilitation|cognitive rehabilitation
5720301|NCT00430560|schizophrenia|schizophrenia
5720302|NCT00430560|schizoaffective disorder|schizoaffective disorder
5720304|NCT00430534|Epstein Barr Virus|epstein barr virus
5720305|NCT00430534|Belgium|belgium
5720306|NCT00430534|Infectious mononucleosis|infectious mononucleosis
5720307|NCT00430521|Pandemic Flu|pandemic flu
5720308|NCT00430521|Pandemic influenza vaccine (GSK1119711A)|pandemic influenza vaccine (gsk1119711a)
5720309|NCT00430508|Moderate-to-Severe Hypertension|moderate-to-severe hypertension
5720310|NCT00430508|Essential Hypertension|essential hypertension
5720311|NCT00430508|Combination Therapy|combination therapy
5720312|NCT00430508|Fixed-Combination Dose|fixed-combination dose
5720313|NCT00430495|atacicept|atacicept
5720314|NCT00430495|arthritis|arthritis
5720315|NCT00430482|Substance Dependence|substance dependence
5720316|NCT00430482|Cognitive-Behavior Therapy|cognitive-behavior therapy
5720317|NCT00430482|Opiate Dependence|opiate dependence
5720318|NCT00430482|Treatment Moderators|treatment moderators
5720319|NCT00430469|Lactoferrin|lactoferrin
5720320|NCT00430469|hLF|hlf
5720321|NCT00430469|Neutropenia|neutropenia
5720322|NCT00430469|Myeloablative|myeloablative
5720323|NCT00430469|Treatment|treatment
5720324|NCT00430469|Fungal|fungal
5720325|NCT00430469|Bacterial|bacterial
5720326|NCT00430469|Infections|infections
5720327|NCT00430469|Bone marrow transplant|bone marrow transplant
5720328|NCT00430456|Aerobic exercise|aerobic exercise
5720329|NCT00430456|Balance, postural|balance, postural
5720330|NCT00430456|Cardiovascular deconditioning|cardiovascular deconditioning
5720331|NCT00430456|Gait|gait
5720332|NCT00430456|MRI, functional|mri, functional
5720333|NCT00430456|Physical therapy techniques|physical therapy techniques
5720334|NCT00430456|Self Efficacy|self efficacy
5720335|NCT00430456|Treadmill test|treadmill test
5720336|NCT00430443|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5720337|NCT00430443|Acute Myelogenous Leukemia|acute myelogenous leukemia
5686126|NCT00553436|rectum|rectum
5720338|NCT00430443|Annamycin|annamycin
5720339|NCT00430443|Liposomal Annamycin|liposomal annamycin
5720340|NCT00430417|Pregnancy|pregnancy
5720341|NCT00430417|Lactation|lactation
5720342|NCT00430417|Endocrine System Diseases|endocrine system diseases
5720343|NCT00430417|MusculoSkeletal System Disease|musculoskeletal system disease
5720344|NCT00430417|Hormone|hormone
5720345|NCT00430417|Physiologic Properties|physiologic properties
5720346|NCT00430391|DVD|dvd
5720347|NCT00430391|Multi-media|multi-media
5720348|NCT00430391|Schizophrenia|schizophrenia
5720349|NCT00430391|Normal Comparison|normal comparison
5720350|NCT00430391|Consent procedures|consent procedures
5720351|NCT00430378|Xerostomia|xerostomia
5720352|NCT00430378|Dry Mouth|dry mouth
5723003|NCT00420992|Embeda|embeda
5720353|NCT00430378|Mouth Dryness|mouth dryness
5720354|NCT00430378|Nasopharyngeal Cancer|nasopharyngeal cancer
5720355|NCT00430378|Acupuncture|acupuncture
5720356|NCT00430365|Myeloma|myeloma
5720357|NCT00430365|Revlimid|revlimid
5720359|NCT00430365|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5720360|NCT00430313|Nausea|nausea
5720361|NCT00430313|Vomiting|vomiting
5720362|NCT00430313|Electro-Stimulation|electro-stimulation
5720364|NCT00430313|K1 Acupuncture Point|k1 acupuncture point
5720365|NCT00430313|Yongquan Acupuncture Point|yongquan acupuncture point
5720366|NCT00430313|TAI|tai
5720367|NCT00430313|transarterial infusion|transarterial infusion
5720368|NCT00430313|liver metastasis|liver metastasis
5720369|NCT00430313|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5720371|NCT00430313|Cisplatin|cisplatin
5720372|NCT00430313|Oxaliplatin|oxaliplatin
5720373|NCT00430300|Dry Powder for Inhalation|dry powder for inhalation
5720374|NCT00430300|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5720375|NCT00430300|Lung Function testing|lung function testing
5720376|NCT00430287|primary open angle glaucoma|primary open angle glaucoma
5720377|NCT00430287|low tension glaucoma|low tension glaucoma
5720378|NCT00430287|pigmentary glaucoma|pigmentary glaucoma
5720379|NCT00430287|exfoliative glaucoma|exfoliative glaucoma
5720380|NCT00430274|glaucoma|glaucoma
5720381|NCT00430274|retinal gliosis-like alterations|retinal gliosis-like alterations
5720382|NCT00430274|optical coherence tomography|optical coherence tomography
5720383|NCT00430274|automated microperimetry|automated microperimetry
5720384|NCT00430261|bronchoalveolar carcinoma|bronchoalveolar carcinoma
5720385|NCT00430261|BAC|bac
5720386|NCT00430261|adenocarcinoma|adenocarcinoma
5720387|NCT00430261|lung cancer|lung cancer
5720388|NCT00430261|oral|oral
5720389|NCT00430261|Stage IIIB and IV lung cancer|stage iiib and iv lung cancer
5720390|NCT00430261|Any bronchoalveolar carcinoma (BAC)|any bronchoalveolar carcinoma (bac)
5720391|NCT00430261|Any adenocarcinoma in a never-smoker|any adenocarcinoma in a never-smoker
5720392|NCT00430248|tophi|tophi
5720393|NCT00430248|hyperuricemia|hyperuricemia
5720394|NCT00430248|uric acid|uric acid
5720395|NCT00430248|Drug Therapy|drug therapy
5720396|NCT00430235|prostate|prostate
5720397|NCT00430235|cancer|cancer
5720398|NCT00430235|BAY 43-9006|bay 43-9006
5720399|NCT00430183|stage I prostate cancer|stage i prostate cancer
5720400|NCT00430183|stage IIB prostate cancer|stage iib prostate cancer
5720401|NCT00430183|stage IIA prostate cancer|stage iia prostate cancer
5720402|NCT00430183|stage III prostate cancer|stage iii prostate cancer
5720403|NCT00430183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5720404|NCT00430170|ischemia-reperfusion injury|ischemia-reperfusion injury
5720405|NCT00430170|adenosine|adenosine
5720406|NCT00430170|dipyridamole|dipyridamole
5720407|NCT00430170|caffeine|caffeine
5720408|NCT00430157|Vienna Challenge Chamber|vienna challenge chamber
5720409|NCT00430157|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5720410|NCT00430157|Inflammation|inflammation
5720411|NCT00430118|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5720412|NCT00430118|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5720413|NCT00430118|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5720414|NCT00430118|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5720415|NCT00430105|Vasculitis|vasculitis
5720416|NCT00430105|ANCA|anca
5720417|NCT00430105|Wegener's granulomatosis|wegener's granulomatosis
5720419|NCT00430105|Cyclophosphamide|cyclophosphamide
5720420|NCT00430053|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5720421|NCT00430053|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5863955|NCT00001155|Renal Biopsy|renal biopsy
5720422|NCT00430053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5720423|NCT00430053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5720424|NCT00430053|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5720425|NCT00430053|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5720426|NCT00430053|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5686127|NCT00553436|polyp|polyp
5720427|NCT00430053|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5720428|NCT00430040|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5720429|NCT00430040|Hypertension|hypertension
5720430|NCT00430040|Carvedilol CR|carvedilol cr
5720431|NCT00430040|Beta-blocker|beta-blocker
5720432|NCT00430040|Oxidative stress|oxidative stress
5720433|NCT00430040|Inflammation|inflammation
5720434|NCT00430040|Vascular benefits|vascular benefits
5720435|NCT00430027|Esophageal|esophageal
5720436|NCT00430027|Esophagus|esophagus
5720437|NCT00430014|Advanced Cancer|advanced cancer
5720438|NCT00430014|Relapsed|relapsed
5720439|NCT00430014|Atiprimod|atiprimod
5720440|NCT00430014|Guanylyl cyclase receptor antagonist|guanylyl cyclase receptor antagonist
5720441|NCT00430001|Metastatic breast neoplasm|metastatic breast neoplasm
5720442|NCT00429988|breast cancer|breast cancer
5720443|NCT00429975|fluorquinolones,|fluorquinolones,
5720444|NCT00429975|b-lactams,|b-lactams,
5720445|NCT00429975|immunomodulation.|immunomodulation.
5720446|NCT00429962|subfoveal choroidal neovascularization (CNV)|subfoveal choroidal neovascularization (cnv)
5720447|NCT00429962|age-related macular degeneration|age-related macular degeneration
5720448|NCT00429962|ranibizumab monotherapy|ranibizumab monotherapy
5720449|NCT00429962|combined verteporfin-therapy|combined verteporfin-therapy
5720450|NCT00429962|Lucentis® (ranibizumab)|lucentis® (ranibizumab)
5720452|NCT00429962|photodynamic therapy|photodynamic therapy
5720453|NCT00429949|Dasatinib|dasatinib
5720454|NCT00429949|Plateau phase|plateau phase
5720455|NCT00429936|Dry Age Related Macular Degeneration|dry age related macular degeneration
5720456|NCT00429936|Geographic Atrophy|geographic atrophy
5720457|NCT00429910|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5720554|NCT00429507|Breast Cancer|breast cancer
5720458|NCT00429910|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5720459|NCT00429910|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5720460|NCT00429910|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5720461|NCT00429897|Hypertension|hypertension
5720462|NCT00429897|Low Renin|low renin
5720463|NCT00429884|Atrial fibrillation|atrial fibrillation
5720464|NCT00429871|Metastatic breast cancer;|metastatic breast cancer;
5720465|NCT00429871|First line chemotherapy;|first line chemotherapy;
5720466|NCT00429871|Docetaxel;|docetaxel;
5720467|NCT00429871|Epirubicin;|epirubicin;
5720468|NCT00429871|Capecitabine|capecitabine
5720469|NCT00429858|recurrent pancreatic cancer|recurrent pancreatic cancer
5720470|NCT00429858|stage III pancreatic cancer|stage iii pancreatic cancer
5720471|NCT00429858|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5720472|NCT00429858|stage IV pancreatic cancer|stage iv pancreatic cancer
5720473|NCT00429845|HIV|hiv
5720474|NCT00429845|HAART|haart
5720475|NCT00429845|Nutrition|nutrition
5720476|NCT00429845|Dyslipidemia|dyslipidemia
5720477|NCT00429832|Nausea, vomiting, antiemetic|nausea, vomiting, antiemetic
5720478|NCT00429806|Vaginal atrophy|vaginal atrophy
5720479|NCT00429806|DHEA|dhea
5720480|NCT00429806|Prasterone|prasterone
5720481|NCT00429806|Menopause|menopause
5720482|NCT00429780|Leishmaniasis vaccine|leishmaniasis vaccine
5720483|NCT00429780|Alum-ALM|alum-alm
5720484|NCT00429780|First generation vaccine|first generation vaccine
5720485|NCT00429780|Leishmanin positive|leishmanin positive
5720486|NCT00429780|Healthy Volunteers|healthy volunteers
5720487|NCT00429780|Response to Leishmanin (Leishmanin Skin Test>0)|response to leishmanin (leishmanin skin test>0)
5720488|NCT00429780|No History of Cutaneous Leishmaniasis|no history of cutaneous leishmaniasis
5720489|NCT00429767|Opioid|opioid
5720490|NCT00429767|Cocaine|cocaine
5720491|NCT00429767|Drug Self Administration|drug self administration
5720492|NCT00429754|Nausea and vomiting after using cytostatic drugs|nausea and vomiting after using cytostatic drugs
5720493|NCT00429728|Pharmacokinetics,|pharmacokinetics,
5720494|NCT00429728|tolerability,|tolerability,
5720495|NCT00429728|healthy,|healthy,
5720496|NCT00429728|subjects,|subjects,
5720497|NCT00429728|smokers,|smokers,
5720498|NCT00429728|non-smokers|non-smokers
5720499|NCT00429715|Leishmaniasis vaccine|leishmaniasis vaccine
5720500|NCT00429715|Alum-ALM|alum-alm
5720501|NCT00429715|First generation vaccine|first generation vaccine
5720502|NCT00429715|Healthy volunteers|healthy volunteers
5720504|NCT00429715|No history of cutaneous leishmaniasis|no history of cutaneous leishmaniasis
5720505|NCT00429702|nausea|nausea
5720506|NCT00429702|vomiting|vomiting
5720507|NCT00429702|emetic chemotherapy|emetic chemotherapy
5720508|NCT00429702|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5720509|NCT00429689|Male, MDD, Testosterone, DHEA-S,Cortisol|male, mdd, testosterone, dhea-s,cortisol
5720510|NCT00429689|Male|male
5720511|NCT00429689|18-65|18-65
5720512|NCT00429689|Major Depression|major depression
5720513|NCT00429676|Randomized|randomized
5720514|NCT00429676|Controlled|controlled
5720515|NCT00429676|Trial|trial
5720516|NCT00429676|Delirium|delirium
5720517|NCT00429676|Haloperidol|haloperidol
5720518|NCT00429663|distal femur|distal femur
5720519|NCT00429663|femur fracture|femur fracture
5720520|NCT00429650|Weight maintenance|weight maintenance
5720521|NCT00429650|Weight loss|weight loss
5720522|NCT00429637|EBC pH|ebc ph
5720523|NCT00429637|Airway acidification|airway acidification
5720524|NCT00429637|Condensimetry|condensimetry
5720525|NCT00429637|ARDS|ards
5720526|NCT00429637|RSV|rsv
5720527|NCT00429637|ALI|ali
5720528|NCT00429637|Airway reconstruction|airway reconstruction
5720529|NCT00429624|Neck Pain|neck pain
5720530|NCT00429624|Chiropractic manipulation|chiropractic manipulation
5720531|NCT00429624|Randomized controlled trial|randomized controlled trial
5720532|NCT00429611|biphasic defibrillation|biphasic defibrillation
5720533|NCT00429611|inhospital|inhospital
5720534|NCT00429611|post-resuscitation myocardial function|post-resuscitation myocardial function
5720535|NCT00429611|defibrillation efficacy|defibrillation efficacy
5720536|NCT00429611|high energy versus low energy|high energy versus low energy
5720537|NCT00429611|cardiac arrest patients|cardiac arrest patients
5720538|NCT00429585|tibia fracture|tibia fracture
5720539|NCT00429585|proximal tibia|proximal tibia
5720540|NCT00429585|interlocking intramedullary nail|interlocking intramedullary nail
5720541|NCT00429585|locking periarticular plate|locking periarticular plate
5720542|NCT00429585|open reduction|open reduction
5720543|NCT00429585|internal fixation|internal fixation
5720544|NCT00429572|Breast Cancer|breast cancer
5720545|NCT00429572|PBPC Transplantation|pbpc transplantation
5720546|NCT00429572|Stem Cell Infusion|stem cell infusion
5720548|NCT00429572|Melphalan|melphalan
5720549|NCT00429559|Cancer;|cancer;
5720550|NCT00429559|Ovarian cancer;|ovarian cancer;
5720551|NCT00429559|Recurrent ovarian cancer platinum-resistant|recurrent ovarian cancer platinum-resistant
5720552|NCT00429546|Disclosure|disclosure
5720553|NCT00429546|Serostatus|serostatus
5720555|NCT00429507|Blood Stem Cell|blood stem cell
5720556|NCT00429507|Bone Metastases|bone metastases
5720557|NCT00429507|Radiation Therapy|radiation therapy
5720558|NCT00429507|Gamma Camera|gamma camera
5720559|NCT00429507|Sm-EDTMP|sm-edtmp
5720560|NCT00429507|Samarium 153-EDTMP|samarium 153-edtmp
5720561|NCT00429507|Stem Cell Transplant|stem cell transplant
5720562|NCT00429507|Autologous Peripheral Blood Stem Cell Transplantation|autologous peripheral blood stem cell transplantation
5720563|NCT00429507|PBSCT|pbsct
5720564|NCT00429507|Questionnaire|questionnaire
5720565|NCT00429494|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5720566|NCT00429494|GnRH Analogue|gnrh analogue
5720567|NCT00429494|Gonadotropin-releasing hormone analogue|gonadotropin-releasing hormone analogue
5720568|NCT00429494|GnRH-a|gnrh-a
5720569|NCT00429494|Ovarian Function|ovarian function
5720570|NCT00429494|Fertility|fertility
5720571|NCT00429494|Leuprolide Acetate|leuprolide acetate
5720572|NCT00429494|Lupron Depot|lupron depot
5720573|NCT00429494|premature ovarian failure|premature ovarian failure
5720574|NCT00429494|POF|pof
5720575|NCT00429494|Abnormal suppression of menstruation|abnormal suppression of menstruation
5720576|NCT00429494|absence of menstruation|absence of menstruation
5720577|NCT00429481|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
5720578|NCT00429481|Gastroenteritis|gastroenteritis
5720579|NCT00429481|Vomiting|vomiting
5720580|NCT00429455|Fertility|fertility
5737072|NCT00368914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5737073|NCT00368901|Aranesp|aranesp
5737074|NCT00368901|Anemia|anemia
5720581|NCT00429455|Menopause|menopause
5720582|NCT00429455|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5720583|NCT00429455|Questionnaire|questionnaire
5720584|NCT00429455|Survey|survey
5720585|NCT00429442|Simvastatin|simvastatin
5720586|NCT00429442|CNS Inflammation|cns inflammation
5720587|NCT00429442|Copaxone|copaxone
5720588|NCT00429429|Peanut allergy|peanut allergy
5720589|NCT00429416|Hematologic Malignancies|hematologic malignancies
5720590|NCT00429416|GVHD|gvhd
5720591|NCT00429416|Graft-Versus-Host-Disease|graft-versus-host-disease
5720592|NCT00429416|LLME|llme
5720593|NCT00429416|CD34+ stem cell infusions|cd34+ stem cell infusions
5720594|NCT00429416|CD34- fraction|cd34- fraction
5720595|NCT00429416|Cyclosporine|cyclosporine
5720596|NCT00429416|Mycophenolate Mofetil|mycophenolate mofetil
5720597|NCT00429416|HSCT|hsct
5720599|NCT00429403|Breast Cancer|breast cancer
5720600|NCT00429403|Chemotherapy|chemotherapy
5720601|NCT00429403|Ovarian Function|ovarian function
5720602|NCT00429403|Goserelin|goserelin
5720603|NCT00429403|Zoladex|zoladex
5720604|NCT00429403|Ovary function|ovary function
5720605|NCT00429403|Fertility|fertility
5720606|NCT00429403|Early Menopause|early menopause
5720607|NCT00429390|Metabolic syndrome|metabolic syndrome
5720608|NCT00429390|Ramadan Fasting|ramadan fasting
5720609|NCT00429390|Insulin sensitivity|insulin sensitivity
5720610|NCT00429390|Iran|iran
5720611|NCT00429377|tacrolimus|tacrolimus
5720612|NCT00429377|FK506|fk506
5720613|NCT00429377|lupus nephritis|lupus nephritis
5720614|NCT00429364|Aortic Root Dissection|aortic root dissection
5720615|NCT00429364|Aortic Root Dilation|aortic root dilation
5720616|NCT00429364|Pediatric Heart Network|pediatric heart network
5720617|NCT00429338|Genitourinary|genitourinary
5719577|NCT00433238|elderly|elderly
5720618|NCT00429338|Prostate Cancer|prostate cancer
5720619|NCT00429338|Magnetic Resonance Imaging|magnetic resonance imaging
5720620|NCT00429338|MRI|mri
5720621|NCT00429338|Magnetic Resonance Spectroscopic Imaging|magnetic resonance spectroscopic imaging
5720622|NCT00429338|MRSI|mrsi
5720623|NCT00429338|Endorectal MRSI|endorectal mrsi
5720624|NCT00429338|Endorectal magnetic resonance spectroscopy imaging|endorectal magnetic resonance spectroscopy imaging
5720625|NCT00429338|3 Tesla|3 tesla
5720626|NCT00429338|3T Scan|3t scan
5720627|NCT00429338|Endorectal coil|endorectal coil
5720628|NCT00429338|Perfluorocarbon compound|perfluorocarbon compound
5720629|NCT00429338|PFC|pfc
5720630|NCT00429338|PFC-filled endorectal coil|pfc-filled endorectal coil
5720631|NCT00429338|PFC-MRSI|pfc-mrsi
5720632|NCT00429338|AIR-MRSI|air-mrsi
5720633|NCT00429325|acute infectious diarrhea,|acute infectious diarrhea,
5720634|NCT00429325|fecal calprotectin,|fecal calprotectin,
5720635|NCT00429325|stool culture,|stool culture,
5720636|NCT00429325|hemoccult test,|hemoccult test,
5720637|NCT00429325|Guaiac fecal occult blood test (FOBT)|guaiac fecal occult blood test (fobt)
5720638|NCT00429325|fecal lactoferrin|fecal lactoferrin
5720640|NCT00429312|Oncolytic virus|oncolytic virus
5720641|NCT00429312|Pexa-Vec|pexa-vec
5720642|NCT00429299|neo-adjuvant trastuzumab early breast cancer lapatinib|neo-adjuvant trastuzumab early breast cancer lapatinib
5720643|NCT00429286|Health Services Research|health services research
5720644|NCT00429273|ADHD|adhd
5720645|NCT00429273|Guanfacine|guanfacine
5720646|NCT00429273|Methylphenidate|methylphenidate
5720647|NCT00429273|Focalin XR|focalin xr
5720648|NCT00429273|Pediatric|pediatric
5720649|NCT00429273|Cognitive function|cognitive function
5720650|NCT00429273|Combination therapy|combination therapy
5720651|NCT00429260|depression|depression
5720652|NCT00429260|antidepressive agents|antidepressive agents
5721342|NCT00426894|children|children
5720653|NCT00429247|Occult tumor cells|occult tumor cells
5720654|NCT00429247|Micrometastatic cells|micrometastatic cells
5720655|NCT00429247|Cytokeratin-19|cytokeratin-19
5720656|NCT00429247|Trastuzumab|trastuzumab
5720657|NCT00429247|Completion of Adjuvant Treatment|completion of adjuvant treatment
5720658|NCT00429234|Advanced Cancer|advanced cancer
5720659|NCT00429234|Solid Tumors|solid tumors
5720660|NCT00429234|Dasatinib|dasatinib
5720661|NCT00429234|BMS-354825|bms-354825
5720662|NCT00429234|Sprycel|sprycel
5720663|NCT00429234|Gemcitabine|gemcitabine
5720664|NCT00429234|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5720665|NCT00429234|Gemzar|gemzar
5720666|NCT00429221|ADHD|adhd
5720667|NCT00429208|Nicotine Dependence|nicotine dependence
5720668|NCT00429208|Smoking|smoking
5720669|NCT00429208|Tobacco Use Disorder|tobacco use disorder
5720670|NCT00429208|Nicotine Use Disorder|nicotine use disorder
5720671|NCT00429195|LIPGENE|lipgene
5720672|NCT00429195|Fatty acid|fatty acid
5737180|NCT00368433|Electromyogram|electromyogram
5737181|NCT00368433|Tic Disorder|tic disorder
5737182|NCT00368433|Tourette Syndrome|tourette syndrome
5737183|NCT00368433|Tourette's Syndrome|tourette's syndrome
5737185|NCT00368433|HV|hv
5720673|NCT00429195|Dietary intervention|dietary intervention
5720674|NCT00429195|Metabolic syndrome|metabolic syndrome
5720675|NCT00429195|Insulin resistance|insulin resistance
5720676|NCT00429182|Breast Cancer|breast cancer
5720677|NCT00429182|breast carcinoma|breast carcinoma
5720678|NCT00429182|Carboplatin|carboplatin
5720679|NCT00429182|Paraplatin|paraplatin
5720680|NCT00429182|Cyclophosphamide|cyclophosphamide
5720681|NCT00429182|Neosar|neosar
5720682|NCT00429182|Cytoxan|cytoxan
5720683|NCT00429182|Thiotepa|thiotepa
5720684|NCT00429182|Purged Autologous Stem Cells|purged autologous stem cells
5720685|NCT00429182|Circulating Tumor Cells|circulating tumor cells
5720686|NCT00429182|CTCs|ctcs
5720687|NCT00429169|Major Depressive Disorder|major depressive disorder
5720688|NCT00429169|MDD|mdd
5720689|NCT00429156|Non-invasive ventilation|non-invasive ventilation
5720690|NCT00429156|Non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5720691|NCT00429156|Home ventilation|home ventilation
5720692|NCT00429156|Domiciliary ventilation|domiciliary ventilation
5720693|NCT00429156|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5720695|NCT00429156|Respiratory failure|respiratory failure
5720696|NCT00429156|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
5720697|NCT00429156|NIV|niv
5720698|NCT00429156|NIPPV|nippv
5863961|NCT00001151|Calciferol|calciferol
5720699|NCT00429156|Type II respiratory failure|type ii respiratory failure
5720700|NCT00429143|Hematologic Malignancies|hematologic malignancies
5720701|NCT00429143|Two Step Approach|two step approach
5720702|NCT00429143|Haploidentical Transplant|haploidentical transplant
5720703|NCT00429117|Spirituality|spirituality
5720704|NCT00429117|Work Related Stress|work related stress
5720705|NCT00429117|Religious Beliefs|religious beliefs
5720706|NCT00429117|Survey|survey
5720707|NCT00429104|Breast Cancer|breast cancer
5720708|NCT00429104|Carcinoma of the Breast|carcinoma of the breast
5720709|NCT00429104|HER-2/neu Overexpression|her-2/neu overexpression
5720710|NCT00429104|Herceptin|herceptin
5728407|NCT00400881|weaning|weaning
5720711|NCT00429104|Trastuzumab|trastuzumab
5720712|NCT00429104|GM-CSF|gm-csf
5720713|NCT00429104|Sargramostim|sargramostim
5720714|NCT00429104|Leukine|leukine
5720715|NCT00429078|Gastric Cancer|gastric cancer
5720716|NCT00429078|T Cells|t cells
5720717|NCT00429078|Gene Transfer|gene transfer
5720718|NCT00429065|Non-Hodgkin lymphoma|non-hodgkin lymphoma
5720719|NCT00429065|rituximab|rituximab
5720720|NCT00429065|immunotherapy|immunotherapy
5720721|NCT00429052|Coronary Disease|coronary disease
5720722|NCT00429052|Coronary Stenosis|coronary stenosis
5720723|NCT00429052|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5720724|NCT00429052|Stents|stents
5720725|NCT00429052|Sirolimus|sirolimus
5720726|NCT00429026|Kidney Cancer|kidney cancer
5720727|NCT00429026|Renal Cell Cancer|renal cell cancer
5710927|NCT00461630|stroke|stroke
5720728|NCT00429026|Stem Cell Transplant|stem cell transplant
5720729|NCT00429026|Cyclophosphamide|cyclophosphamide
5720730|NCT00429026|Fludarabine|fludarabine
5720731|NCT00429026|Melphalan|melphalan
5720732|NCT00429026|NST|nst
5720733|NCT00429013|Pressure ulcer|pressure ulcer
5720860|NCT00428545|Bortezomib|bortezomib
5720734|NCT00429013|Lingual electric stimulation|lingual electric stimulation
5720735|NCT00429013|Paraplegic patient|paraplegic patient
5720743|NCT00429000|Low-income country|low-income country
5720752|NCT00428974|Psoriasis|psoriasis
5720753|NCT00428961|diabetes mellitus|diabetes mellitus
5720754|NCT00428961|insulin resistance|insulin resistance
5720755|NCT00428961|atherosclerosis|atherosclerosis
5720756|NCT00428948|ADPKD|adpkd
5720757|NCT00428948|Polycystic|polycystic
5720758|NCT00428948|kidney|kidney
5720759|NCT00428948|ADPKD (Autosomal Dominant Polycystic Kidney Disease)|adpkd (autosomal dominant polycystic kidney disease)
5720760|NCT00428935|Duchenne|duchenne
5720761|NCT00428935|Muscle|muscle
5720762|NCT00428935|Muscular Dystrophy|muscular dystrophy
5720763|NCT00428935|Gene Therapy|gene therapy
5720764|NCT00428935|Dystrophin|dystrophin
5720765|NCT00428935|Adeno-Associated Virus|adeno-associated virus
5720766|NCT00428935|AAV|aav
5720767|NCT00428922|Metastatic|metastatic
5720768|NCT00428922|Breast Cancer|breast cancer
5720769|NCT00428922|MBC|mbc
5720770|NCT00428909|Pharmacokinetic|pharmacokinetic
5720771|NCT00428909|STI571|sti571
5720772|NCT00428909|imatinib|imatinib
5720773|NCT00428909|CML|cml
5720774|NCT00428909|Chronic Myeloid Leukemia|chronic myeloid leukemia
5720775|NCT00428909|Philadelphia Chromosome|philadelphia chromosome
5720776|NCT00428909|acetaminophen|acetaminophen
5720777|NCT00428896|Breast cancer|breast cancer
5737273|NCT00368095|Dyslipidemia|dyslipidemia
5737274|NCT00368095|Obesity|obesity
5737275|NCT00368095|Cardiovascular disease|cardiovascular disease
5737276|NCT00368095|Cerebrovascular disease|cerebrovascular disease
5737277|NCT00368095|Myocardial infarction|myocardial infarction
5737278|NCT00368095|stroke|stroke
5737279|NCT00368095|Metabolic syndrome|metabolic syndrome
5737280|NCT00368095|CVD-CAD|cvd-cad
5737289|NCT00368069|Epilepsy|epilepsy
5737290|NCT00368069|Keppra® XR|keppra® xr
5737291|NCT00368069|Levetiracetam XR|levetiracetam xr
5737292|NCT00368069|Extended release|extended release
5737293|NCT00368043|Pituitary|pituitary
5737294|NCT00368043|Adrenal|adrenal
5737295|NCT00368043|Growth|growth
5737296|NCT00368043|Cortisol|cortisol
5720778|NCT00428896|iressa circulating tumor cells|iressa circulating tumor cells
5720779|NCT00428883|Scleroderma, Systemic|scleroderma, systemic
5720780|NCT00428883|Scleroderma, Diffuse|scleroderma, diffuse
5720781|NCT00428870|Shoulder|shoulder
5720782|NCT00428870|impingement|impingement
5720783|NCT00428870|conservative|conservative
5720784|NCT00428870|acromioplasty|acromioplasty
5720785|NCT00428870|arthroscopy|arthroscopy
5720786|NCT00428844|Osteomyelitis|osteomyelitis
5720787|NCT00428844|Prosthetic Hip|prosthetic hip
5720788|NCT00428844|Prosthetic Knee|prosthetic knee
5720789|NCT00428844|MRSA|mrsa
5720790|NCT00428844|Osteomyelitis Associated with an Infected Prosthetic Hip or Knee Joint|osteomyelitis associated with an infected prosthetic hip or knee joint
5720791|NCT00428844|Staphylococci|staphylococci
5720792|NCT00428831|influenza, genomic data, nasopharyngeal aspirate|influenza, genomic data, nasopharyngeal aspirate
5720793|NCT00428818|MRSA|mrsa
5720794|NCT00428805|body composition|body composition
5720795|NCT00428805|physical activity|physical activity
5720796|NCT00428805|dietary intake|dietary intake
5720797|NCT00428805|children|children
5720798|NCT00428792|ADHD|adhd
5720799|NCT00428792|methylphenidate|methylphenidate
5680884|NCT00575835|seasonal variation|seasonal variation
5680886|NCT00575835|bone markers|bone markers
5680887|NCT00575822|GERD|gerd
5680888|NCT00575822|Sham|sham
5720800|NCT00428792|children|children
5720801|NCT00428792|food effect|food effect
5720802|NCT00428792|Attention-Deficit Hyperactivity Disorder (ADHD) in children|attention-deficit hyperactivity disorder (adhd) in children
5720803|NCT00428779|Running during 24 hours|running during 24 hours
5720804|NCT00428779|Voluntary evoked force on the muscles|voluntary evoked force on the muscles
5728507|NCT00400543|CPAP|cpap
5720805|NCT00428779|Electrically evoked force on the muscles|electrically evoked force on the muscles
5720806|NCT00428779|EMG activity|emg activity
5720807|NCT00428779|Muscle biopsy|muscle biopsy
5720808|NCT00428779|subjects will be recruited among experienced ultra-runners|subjects will be recruited among experienced ultra-runners
5720809|NCT00428753|avian influenza, China, H5N1|avian influenza, china, h5n1
5720810|NCT00428727|Diabetic foot|diabetic foot
5720811|NCT00428727|Ulcer|ulcer
5720812|NCT00428727|nitric oxide|nitric oxide
5720813|NCT00428727|treatment|treatment
5720814|NCT00428727|donor|donor
5720815|NCT00428727|controlled trial|controlled trial
5720816|NCT00428701|stress ulcer|stress ulcer
5720817|NCT00428701|critically ill|critically ill
5720818|NCT00428701|gastric acid|gastric acid
5720819|NCT00428701|gastric aspirates|gastric aspirates
5720820|NCT00428701|esomeprazole|esomeprazole
5720821|NCT00428688|Hodgkin's lymphoma|hodgkin's lymphoma
5720822|NCT00428688|cardiovascular disease|cardiovascular disease
5720823|NCT00428688|radiation therapy|radiation therapy
5720824|NCT00428688|Brachial artery flow-mediated dilation (FMD)|brachial artery flow-mediated dilation (fmd)
5720825|NCT00428675|screening|screening
5720827|NCT00428662|coronary stenting|coronary stenting
5720828|NCT00428662|drug eluting stents|drug eluting stents
5720829|NCT00428662|paclitaxel|paclitaxel
5720830|NCT00428662|nanoporous|nanoporous
5720831|NCT00428649|Selenium supplements|selenium supplements
5720832|NCT00428649|Selenoprotein P|selenoprotein p
5720833|NCT00428649|Optimization|optimization
5720834|NCT00428636|ileostomy|ileostomy
5720835|NCT00428636|rectal resection|rectal resection
5720836|NCT00428636|proctectomy|proctectomy
5720837|NCT00428636|stoma closure|stoma closure
5720838|NCT00428623|Patient comfort|patient comfort
5720839|NCT00428623|Wound dressings|wound dressings
5720840|NCT00428623|infection|infection
5720841|NCT00428623|vascular surgery|vascular surgery
5720842|NCT00428571|Type 2 Diabetes|type 2 diabetes
5720843|NCT00428571|Bariatric surgery|bariatric surgery
5737369|NCT00367757|Pulmonary vein isolation|pulmonary vein isolation
5737370|NCT00367757|AF trigger|af trigger
5737371|NCT00367757|complex fractionated electrograms|complex fractionated electrograms
5737372|NCT00367757|CFE|cfe
5737373|NCT00367757|CFAE|cfae
5737376|NCT00367757|PVAI|pvai
5720845|NCT00428571|Laparoscopic gastric bypass|laparoscopic gastric bypass
5720846|NCT00428571|Laparoscopic adjustable gastric banding|laparoscopic adjustable gastric banding
5720847|NCT00428558|acute myeloid leukemia|acute myeloid leukemia
5720848|NCT00428558|Core Binding Factor|core binding factor
5720849|NCT00428558|t(8;21)|t(8;21)
5720850|NCT00428558|inv(16)|inv(16)
5720851|NCT00428558|timed-sequential induction|timed-sequential induction
5720852|NCT00428545|Advanced Malignancy|advanced malignancy
5720853|NCT00428545|Lymphoma|lymphoma
5720854|NCT00428545|Myeloma|myeloma
5720855|NCT00428545|Solid Tumors|solid tumors
5720856|NCT00428545|Bevacizumab|bevacizumab
5720857|NCT00428545|Avastin|avastin
5720858|NCT00428545|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5720859|NCT00428545|rhuMAb-VEGF|rhumab-vegf
5720861|NCT00428545|Velcade|velcade
5720862|NCT00428545|PS-341|ps-341
5720863|NCT00428545|LDP-341|ldp-341
5720864|NCT00428545|MLN341|mln341
5720865|NCT00428519|HIV infection|hiv infection
5720866|NCT00428519|Neurokinin-1 receptor antagonist|neurokinin-1 receptor antagonist
5720867|NCT00428519|CCR5 expression|ccr5 expression
5720868|NCT00428519|Treatment Naive|treatment naive
5720869|NCT00428506|ascites|ascites
5720870|NCT00428506|cirrhosis|cirrhosis
5722123|NCT00424099|Placebo|placebo
5720871|NCT00428506|post-paracentesis circulatory dysfunction|post-paracentesis circulatory dysfunction
5720872|NCT00428506|albumin|albumin
5720873|NCT00428506|portal-hypertension|portal-hypertension
5720874|NCT00428493|human influenza A, H5N1, bird flu, avian influenza, China|human influenza a, h5n1, bird flu, avian influenza, china
5720875|NCT00428467|Heart Failure|heart failure
5720876|NCT00428467|LV Geometry|lv geometry
5720877|NCT00428467|Heart MRT|heart mrt
5720878|NCT00428454|drug-eluting stent|drug-eluting stent
5720879|NCT00428454|chronic total occlusion|chronic total occlusion
5720880|NCT00428454|sirolimus-eluting stent|sirolimus-eluting stent
5720881|NCT00428454|zotarolimus-eluting stent|zotarolimus-eluting stent
5720882|NCT00428454|QCA|qca
5720884|NCT00428441|Recurrence|recurrence
5720885|NCT00428441|Venous thromboembolism|venous thromboembolism
5680889|NCT00575822|Randomized Controlled Study|randomized controlled study
5720886|NCT00428428|kidney stone|kidney stone
5720887|NCT00428428|ureteroscopy|ureteroscopy
5720888|NCT00428402|Education|education
5720889|NCT00428402|4th-8th Grade Student|4th-8th grade student
5720890|NCT00428402|MIDAS Project|midas project
5720891|NCT00428402|Focus Group Discussion|focus group discussion
5720892|NCT00428402|Bastrop|bastrop
5720893|NCT00428389|Dementia, Alzheimer's, Rivastigmine, donepezil|dementia, alzheimer's, rivastigmine, donepezil
5720894|NCT00428363|posterior capsule opacification|posterior capsule opacification
5720895|NCT00428363|PCO|pco
5720896|NCT00428363|after cataract|after cataract
5720897|NCT00428363|intraocular lens|intraocular lens
5720898|NCT00428363|optic edge design|optic edge design
5720899|NCT00428363|sharp optic edge|sharp optic edge
5720900|NCT00428337|HIV Seronegativity|hiv seronegativity
5720901|NCT00428337|EP1233|ep1233
5720902|NCT00428337|MVA-mBN32|mva-mbn32
5720903|NCT00428337|HIV Preventive Vaccine|hiv preventive vaccine
5720904|NCT00428311|Polycystic ovary syndrome|polycystic ovary syndrome
5720905|NCT00428311|Hyperandrogenism|hyperandrogenism
5720906|NCT00428311|Hirsutism|hirsutism
5720907|NCT00428311|Cardiovascular risk|cardiovascular risk
5720908|NCT00428311|Chronic inflammation|chronic inflammation
5720909|NCT00428311|Metformin|metformin
5720910|NCT00428311|Cyproterone acetate|cyproterone acetate
5720911|NCT00428311|Oral contraceptives|oral contraceptives
5720912|NCT00428298|Bipolar|bipolar
5720913|NCT00428298|Cognitive|cognitive
5720914|NCT00428298|Attention|attention
5720915|NCT00428298|Memory|memory
5720916|NCT00428298|Manic Depression|manic depression
5720917|NCT00428298|Bi-polar|bi-polar
5720918|NCT00428285|Human Papilloma Virus|human papilloma virus
5720919|NCT00428285|HIV infected MSM|hiv infected msm
5720920|NCT00428285|Treatment Experienced|treatment experienced
5720921|NCT00428285|Treatment Naive|treatment naive
5720922|NCT00428285|Anal Intraepithelial Neoplasia|anal intraepithelial neoplasia
5720923|NCT00428272|Monoclonal Antibody Lexatumumab|monoclonal antibody lexatumumab
5720924|NCT00428272|Interferon Gamma|interferon gamma
5720925|NCT00428272|Solid Tumor|solid tumor
5720926|NCT00428272|Phase I|phase i
5720927|NCT00428272|Malignant Tumor|malignant tumor
5720928|NCT00428272|Metastatic Tumor|metastatic tumor
5720929|NCT00428272|Pediatric Solid Tumor|pediatric solid tumor
5720930|NCT00428272|Ewing Sarcoma|ewing sarcoma
5720931|NCT00428272|Osteosarcoma|osteosarcoma
5720932|NCT00428272|Neuroblastoma|neuroblastoma
5720933|NCT00428272|Rhabdomyosarcoma|rhabdomyosarcoma
5720934|NCT00428246|Chronic Kidney Disease|chronic kidney disease
5720935|NCT00428246|Endothelial dysfunction|endothelial dysfunction
5720936|NCT00428246|Inflammation|inflammation
5720937|NCT00428246|Hypertension|hypertension
5720938|NCT00428246|paricalcitol|paricalcitol
5720939|NCT00428246|Blood pressure|blood pressure
5720940|NCT00428246|Vitamin D|vitamin d
5720941|NCT00428246|Glomerular filtration rate|glomerular filtration rate
5720942|NCT00428233|CLL|cll
5720943|NCT00428233|vaccine|vaccine
5720944|NCT00428220|Potentially other tumor types in the future|potentially other tumor types in the future
5720945|NCT00428207|type 1 diabetes, insulin pump therapy, glycemic stability|type 1 diabetes, insulin pump therapy, glycemic stability
5720946|NCT00428194|stage IIA cervical cancer|stage iia cervical cancer
5720947|NCT00428194|stage IB cervical cancer|stage ib cervical cancer
5720948|NCT00428194|stage IIB cervical cancer|stage iib cervical cancer
5720949|NCT00428194|stage III cervical cancer|stage iii cervical cancer
5720950|NCT00428194|stage IVA cervical cancer|stage iva cervical cancer
5720951|NCT00428194|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5720952|NCT00428181|Brief alcohol intervention|brief alcohol intervention
5720953|NCT00428181|Booster session|booster session
5720954|NCT00428181|Personalized feedback|personalized feedback
5720955|NCT00428181|Motivational interview|motivational interview
5720956|NCT00428181|Injury recidivism|injury recidivism
5720957|NCT00428181|Psychological Interview|psychological interview
5720958|NCT00428181|Risk Reduction Behaviors|risk reduction behaviors
5720959|NCT00428168|Betahistine|betahistine
5720960|NCT00428168|Weight Gain Control|weight gain control
5720961|NCT00428168|Weight Gain due to Olanzapine Treatment|weight gain due to olanzapine treatment
5720962|NCT00428168|Obesity|obesity
5720963|NCT00428168|Schizophrenic disorder|schizophrenic disorder
5720964|NCT00428155|hemostasis|hemostasis
5720965|NCT00428155|angioplasty|angioplasty
5720966|NCT00428155|stenting|stenting
5720967|NCT00428155|closure device|closure device
5720968|NCT00428155|angioseal|angioseal
5720969|NCT00428155|starclose|starclose
5720970|NCT00428142|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5720971|NCT00428142|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5720972|NCT00428142|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5720973|NCT00428142|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5720974|NCT00428142|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5715947|NCT00445146|Open-label|open-label
5720975|NCT00428142|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5720976|NCT00428129|Acute Iliofemoral Deep Vein Thrombosis|acute iliofemoral deep vein thrombosis
5720977|NCT00428116|HIV-1|hiv-1
5720978|NCT00428116|Pediatric|pediatric
5720979|NCT00428116|HAART|haart
5720980|NCT00428116|Treatment Naive|treatment naive
5720981|NCT00428103|Mitral valve regurgitation|mitral valve regurgitation
5720982|NCT00428090|apolipoprotein E|apolipoprotein e
5720983|NCT00428090|monotherapy|monotherapy
5720984|NCT00428090|cognition|cognition
5720985|NCT00428090|mild|mild
5720986|NCT00428090|rosiglitazone|rosiglitazone
5720987|NCT00428090|Alzheimer's disease|alzheimer's disease
5720988|NCT00428090|moderate|moderate
5720989|NCT00428077|Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia|philadelphia chromosome positive (ph+) chronic myelogenous leukemia
5720990|NCT00428077|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5720991|NCT00428064|Renal allograft|renal allograft
5720992|NCT00428064|Renal|renal
5720993|NCT00428064|Kidney|kidney
5720994|NCT00428064|Transplant|transplant
5720995|NCT00428051|Epidemiology|epidemiology
5720996|NCT00428051|Surveillance|surveillance
5720997|NCT00428051|Streptococcal Pneumonia|streptococcal pneumonia
5720998|NCT00428038|Infant, Premature|infant, premature
5720999|NCT00428038|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5721000|NCT00428038|Asthma|asthma
5721001|NCT00428025|pancreatitis|pancreatitis
5721002|NCT00428012|quality of life, kidney transplantation|quality of life, kidney transplantation
5721003|NCT00427999|Hormone-refractory|hormone-refractory
5721004|NCT00427999|prostate cancer|prostate cancer
5721005|NCT00427999|multitargeted|multitargeted
5721006|NCT00427999|tyrosinkinase|tyrosinkinase
5721007|NCT00427986|Diabetes|diabetes
5721008|NCT00427986|Macular oedema|macular oedema
5721009|NCT00427986|Osmosis|osmosis
5721010|NCT00427986|Galactose|galactose
5721011|NCT00427986|Intravenous|intravenous
5721012|NCT00427986|Retinal thickness|retinal thickness
5721013|NCT00427986|Starling|starling
5721014|NCT00427960|cholesterol|cholesterol
5721015|NCT00427960|statin|statin
5721016|NCT00427960|Asian|asian
5721017|NCT00427960|LDL-cholesterol|ldl-cholesterol
5721018|NCT00427947|phantom limb pain|phantom limb pain
5721020|NCT00427947|anesthetics, local|anesthetics, local
5721021|NCT00427947|postoperative analgesia|postoperative analgesia
5721022|NCT00427947|ropivacaine|ropivacaine
5721023|NCT00427947|analgesia|analgesia
5721024|NCT00427908|Meningococcal serogroups A, C, W-135 and/or Y diseases|meningococcal serogroups a, c, w-135 and/or y diseases
5721025|NCT00427908|Conjugate vaccine|conjugate vaccine
5721026|NCT00427908|Immunogenicity|immunogenicity
5721027|NCT00427908|Meningococcal vaccine|meningococcal vaccine
5721029|NCT00427908|Non-inferiority|non-inferiority
5721030|NCT00427895|Vaccine|vaccine
5721229|NCT00427258|healthy subjects|healthy subjects
5721031|NCT00427895|Pneumococcal Infections Prevention and Control|pneumococcal infections prevention and control
5721032|NCT00427843|osteoarthritis|osteoarthritis
5721033|NCT00427843|knee|knee
5721034|NCT00427843|gait|gait
5721035|NCT00427843|muscle strength|muscle strength
5721037|NCT00427843|exercise|exercise
5721038|NCT00427830|Mycobacterium tuberculosis|mycobacterium tuberculosis
5721039|NCT00427830|85A antigen|85a antigen
5721040|NCT00427830|Recombinant Modified Vaccinia Ankara|recombinant modified vaccinia ankara
5721041|NCT00427830|Phase I study|phase i study
5721042|NCT00427830|Immunogenicity|immunogenicity
5721043|NCT00427830|BCG|bcg
5721044|NCT00427817|Adenoma, Prostatic|adenoma, prostatic
5721045|NCT00427817|Prostate|prostate
5721046|NCT00427817|Proteomics|proteomics
5721047|NCT00427817|Urology|urology
5721048|NCT00427804|Calcium absorption|calcium absorption
5721049|NCT00427804|Vitamin D|vitamin d
5721050|NCT00427791|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5721051|NCT00427791|Leukemia|leukemia
5721052|NCT00427791|Total Body Irradiation|total body irradiation
5721053|NCT00427791|Etoposide|etoposide
5721054|NCT00427791|Rituximab|rituximab
5721055|NCT00427791|Rituxan|rituxan
5721056|NCT00427791|TBI|tbi
5721057|NCT00427791|ALL|all
5721058|NCT00427778|incontinence ring|incontinence ring
5721059|NCT00427778|pessary|pessary
5721060|NCT00427778|urinary incontinence|urinary incontinence
5721061|NCT00427778|urodynamic study|urodynamic study
5721062|NCT00427778|quality of life|quality of life
5721063|NCT00427778|crossover trial|crossover trial
5721064|NCT00427778|randomised trial|randomised trial
5721065|NCT00427765|Multiple Myeloma|multiple myeloma
5721066|NCT00427765|Hodgkin's Disease|hodgkin's disease
5721067|NCT00427765|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5721068|NCT00427765|Leukemia|leukemia
5721069|NCT00427765|Lymphoma|lymphoma
5721070|NCT00427765|Busulfan|busulfan
5721071|NCT00427765|Melphalan|melphalan
5721072|NCT00427765|Autologous bone marrow|autologous bone marrow
5721073|NCT00427765|BMT|bmt
5721074|NCT00427765|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
5721075|NCT00427765|PBSCT|pbsct
5721076|NCT00427752|Transgastric|transgastric
5721077|NCT00427752|Endoluminal|endoluminal
5721078|NCT00427752|Peritoneoscopy|peritoneoscopy
5721079|NCT00427752|Diagnostic|diagnostic
5721080|NCT00427752|Feasibility|feasibility
5721081|NCT00427739|Axial Flow Ventricular Assist Device|axial flow ventricular assist device
5721082|NCT00427739|Cardiac CT|cardiac ct
5721083|NCT00427739|Stage IV heart failure|stage iv heart failure
5721084|NCT00427726|Gene Transfer|gene transfer
5721085|NCT00427726|Hematopoietic Stem Cells|hematopoietic stem cells
5721086|NCT00427726|Follow-Up|follow-up
5721087|NCT00427713|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5721088|NCT00427713|stage III rectal cancer|stage iii rectal cancer
5721089|NCT00427713|stage II rectal cancer|stage ii rectal cancer
5721090|NCT00427700|Polycystic Ovary Syndrome|polycystic ovary syndrome
5721091|NCT00427700|clomiphene citrate|clomiphene citrate
5721092|NCT00427700|Raloxifene|raloxifene
5721093|NCT00427674|Parkinson|parkinson
5721094|NCT00427674|Imaging|imaging
5721095|NCT00427661|Sickle Cell Disease|sickle cell disease
5721096|NCT00427661|Thalassemia|thalassemia
5721097|NCT00427661|Hemoglobinopathies|hemoglobinopathies
5721098|NCT00427648|Administration, Intravesical|administration, intravesical
5721099|NCT00427648|Anesthetics, Local|anesthetics, local
5721100|NCT00427635|neonates|neonates
5721101|NCT00427635|infants|infants
5721102|NCT00427635|GERD|gerd
5721103|NCT00427635|reflux|reflux
5721104|NCT00427622|hot flashes|hot flashes
5721105|NCT00427609|Treatment|treatment
5721106|NCT00427609|Psoriasis|psoriasis
5721107|NCT00427609|efficacy|efficacy
5721108|NCT00427609|Bicillin|bicillin
5721109|NCT00427596|GW427353 oral tablets,|gw427353 oral tablets,
5721110|NCT00427596|healthy adult subjects,|healthy adult subjects,
5721111|NCT00427596|food effect|food effect
5721112|NCT00427583|Malignant,|malignant,
5721113|NCT00427583|peripheral,|peripheral,
5721114|NCT00427583|nerve sheath tumors,|nerve sheath tumors,
5721115|NCT00427583|MPNST,|mpnst,
5721116|NCT00427583|neurofibromatosis,|neurofibromatosis,
5721117|NCT00427583|NF1,|nf1,
5721118|NCT00427583|Imatinib mesylate|imatinib mesylate
5721119|NCT00427570|stage II colon cancer|stage ii colon cancer
5721120|NCT00427570|stage III colon cancer|stage iii colon cancer
5721121|NCT00427557|Multiple Myeloma|multiple myeloma
5721122|NCT00427557|Acute Myeloid Leukemia|acute myeloid leukemia
5721123|NCT00427557|Myelodysplastic Syndrome|myelodysplastic syndrome
5721124|NCT00427557|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5721125|NCT00427557|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5721126|NCT00427557|Hodgkin's Lymphoma|hodgkin's lymphoma
5721127|NCT00427557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5721128|NCT00427557|Cellular Therapy|cellular therapy
5721129|NCT00427557|Umbilical Cord Blood Cells|umbilical cord blood cells
5721130|NCT00427557|Cord Blood Transplantation|cord blood transplantation
5721131|NCT00427557|Stem Cells|stem cells
5721132|NCT00427557|Stem Cell Transplantation|stem cell transplantation
5721133|NCT00427557|Allogeneic|allogeneic
5721134|NCT00427557|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5721135|NCT00427557|Graft vs. Host Disease|graft vs. host disease
5721136|NCT00427557|GVD|gvd
5721137|NCT00427557|Fludarabine|fludarabine
5721138|NCT00427557|Fludarabine Phosphate|fludarabine phosphate
5721139|NCT00427557|Fludara|fludara
5721140|NCT00427557|Melphalan|melphalan
5721141|NCT00427557|Rituximab|rituximab
5721142|NCT00427557|Rituxan|rituxan
5721143|NCT00427557|Leukemia|leukemia
5721144|NCT00427557|Lymphoma|lymphoma
5721145|NCT00427544|Uterine leiomyomata (Fibroids)|uterine leiomyomata (fibroids)
5721146|NCT00427531|hot flashes|hot flashes
5721147|NCT00427505|Interaction|interaction
5721148|NCT00427505|healthy volunteers|healthy volunteers
5721149|NCT00427505|deferasirox|deferasirox
5721150|NCT00427505|midazolam|midazolam
5721151|NCT00427479|Allergy|allergy
5721152|NCT00427479|Food|food
5721153|NCT00427479|Hay fever|hay fever
5721154|NCT00427479|Screening|screening
5721155|NCT00427453|Mycobacterium tuberculosis|mycobacterium tuberculosis
5721156|NCT00427453|85A antigen|85a antigen
5721157|NCT00427453|Recombinant Modified Vaccinia Virus Ankara|recombinant modified vaccinia virus ankara
5721158|NCT00427453|Phase I study|phase i study
5721159|NCT00427453|Immunogenicity|immunogenicity
5721160|NCT00427453|BCG|bcg
5721161|NCT00427440|Glioma|glioma
5721162|NCT00427440|Brain Tumor|brain tumor
5721163|NCT00427427|non-metastatic breast cancer|non-metastatic breast cancer
5721164|NCT00427427|HER-2 positive breast cancer|her-2 positive breast cancer
5721165|NCT00427427|Herceptin (trastuzumab)|herceptin (trastuzumab)
5721166|NCT00427427|delayed adjuvant therapy|delayed adjuvant therapy
5721167|NCT00427427|acceptability rate|acceptability rate
5721168|NCT00427427|non-metastatic, HER-2 positive breast cancer|non-metastatic, her-2 positive breast cancer
5721169|NCT00427414|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5721170|NCT00427414|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5721171|NCT00427388|Cardiac Surgical Procedures|cardiac surgical procedures
5721172|NCT00427388|Cardiopulmonary Bypass|cardiopulmonary bypass
5721173|NCT00427388|Systemic inflammatory Response Syndrome|systemic inflammatory response syndrome
5721174|NCT00427388|Steroid|steroid
5721175|NCT00427388|Myocardial Infarction|myocardial infarction
5721176|NCT00427388|Randomized Clinical Trial|randomized clinical trial
5721177|NCT00427375|Rectal cancer surgery|rectal cancer surgery
5747444|NCT00329706|FDG|fdg
5721178|NCT00427375|Neoadjuvant radiochemotherapy|neoadjuvant radiochemotherapy
5721179|NCT00427375|Randomized clinical trial|randomized clinical trial
5721180|NCT00427375|Multicenter study|multicenter study
5721181|NCT00427349|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5721182|NCT00427349|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5721183|NCT00427349|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5721184|NCT00427349|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5721185|NCT00427349|gastrinoma|gastrinoma
5721186|NCT00427349|insulinoma|insulinoma
5721187|NCT00427349|WDHA syndrome|wdha syndrome
5721188|NCT00427349|glucagonoma|glucagonoma
5721189|NCT00427349|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5721190|NCT00427349|somatostatinoma|somatostatinoma
5721191|NCT00427349|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5721192|NCT00427349|neuroendocrine tumor|neuroendocrine tumor
5721193|NCT00427336|Severe Aplastic Anemia|severe aplastic anemia
5721194|NCT00427336|Bone Marrow Failure|bone marrow failure
5721195|NCT00427336|Stem Cell Transplantation|stem cell transplantation
5721196|NCT00427336|Fludarabine|fludarabine
5721197|NCT00427336|Cyclophosphamide|cyclophosphamide
5721198|NCT00427336|Antithymocyte Globulin|antithymocyte globulin
5721201|NCT00427336|Cytoxan|cytoxan
5721202|NCT00427336|Neosar|neosar
5721203|NCT00427336|Fludarabine Phosphate|fludarabine phosphate
5721204|NCT00427336|Thymoglobulin|thymoglobulin
5721205|NCT00427323|sleep|sleep
5721206|NCT00427323|aging|aging
5721207|NCT00427323|biological rhythm|biological rhythm
5721208|NCT00427323|melatonin|melatonin
5721209|NCT00427323|alertness|alertness
5721210|NCT00427323|early morning awakening|early morning awakening
5721211|NCT00427323|daytime sleepiness|daytime sleepiness
5721212|NCT00427323|difficulty maintaining sleep|difficulty maintaining sleep
5721213|NCT00427323|sleep maintenance insomnia|sleep maintenance insomnia
5721214|NCT00427310|stage I colon cancer|stage i colon cancer
5721215|NCT00427310|stage II colon cancer|stage ii colon cancer
5721216|NCT00427310|stage III colon cancer|stage iii colon cancer
5721217|NCT00427310|adenocarcinoma of the colon|adenocarcinoma of the colon
5721218|NCT00427297|HIV-1|hiv-1
5721219|NCT00427297|Pediatric|pediatric
5721220|NCT00427297|nevirapine|nevirapine
5721221|NCT00427297|HAART|haart
5721222|NCT00427297|Resistance|resistance
5721223|NCT00427297|Treatment Naive|treatment naive
5798820|NCT00110929|End-Stage Renal Disease (ESRD)|end-stage renal disease (esrd)
5798821|NCT00110916|Intra-articular|intra-articular
5721224|NCT00427284|Eplerenone auf die Endothelfunktion bei Patienten mit stabiler koronarer Herzkrankheit|eplerenone auf die endothelfunktion bei patienten mit stabiler koronarer herzkrankheit
5721225|NCT00427271|aspirin|aspirin
5721226|NCT00427271|enalapril|enalapril
5721227|NCT00427271|microalbuminuria|microalbuminuria
5721228|NCT00427271|glomerular filtration rate|glomerular filtration rate
5721944|NCT00424385|prostate|prostate
5721230|NCT00427245|menopausal symptoms|menopausal symptoms
5721231|NCT00427245|infertility|infertility
5721232|NCT00427245|stage IA breast cancer|stage ia breast cancer
5721233|NCT00427245|stage IB breast cancer|stage ib breast cancer
5721234|NCT00427245|stage II breast cancer|stage ii breast cancer
5721235|NCT00427245|stage IIIA breast cancer|stage iiia breast cancer
5721236|NCT00427245|stage IIIB breast cancer|stage iiib breast cancer
5721237|NCT00427245|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5721238|NCT00427245|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5721239|NCT00427245|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5721240|NCT00427232|coronary heart disease|coronary heart disease
5721241|NCT00427232|endothelins|endothelins
5721242|NCT00427232|coronary angiography|coronary angiography
5721243|NCT00427232|blood flow velocity|blood flow velocity
5721244|NCT00427232|fractional flow reserve, myocardial|fractional flow reserve, myocardial
5721245|NCT00427219|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5721246|NCT00427219|Prostatic Adenoma, Benign|prostatic adenoma, benign
5721247|NCT00427219|Prostatic Hypertrophy, Benign|prostatic hypertrophy, benign
5721248|NCT00427219|Enlarged Prostate|enlarged prostate
5721249|NCT00427219|Prostatism|prostatism
5721250|NCT00427219|Adenoma, Prostatic|adenoma, prostatic
5721251|NCT00427206|acetaminophen|acetaminophen
5721252|NCT00427206|alcohol|alcohol
5721253|NCT00427206|liver injury|liver injury
5721254|NCT00427193|dietary restriction|dietary restriction
5721255|NCT00427193|disease /disorder prevention /control|disease /disorder prevention /control
5721256|NCT00427193|nutrition of aging|nutrition of aging
5721257|NCT00427193|bioenergetics|bioenergetics
5721258|NCT00427193|cardiovascular function|cardiovascular function
5721259|NCT00427193|disease /disorder proneness /risk|disease /disorder proneness /risk
5721260|NCT00427193|insulin sensitivity / resistance|insulin sensitivity / resistance
5721261|NCT00427180|Visual Perception|visual perception
5721262|NCT00427180|Retina|retina
5721263|NCT00427180|Light|light
5721264|NCT00427180|Retinitis Pigmentosa|retinitis pigmentosa
5721265|NCT00427180|Visual acuity|visual acuity
5730076|NCT00394056|placebo|placebo
5721266|NCT00427180|Retinal Implant|retinal implant
5721267|NCT00427180|Electrical stimulation|electrical stimulation
5721268|NCT00427167|Blood Stage|blood stage
5721269|NCT00427167|Investigational|investigational
5721270|NCT00427167|Vaccine|vaccine
5721271|NCT00427167|Malaria|malaria
5721272|NCT00427167|Healthy Volunteer|healthy volunteer
5721273|NCT00427167|HV|hv
5721274|NCT00427141|tolerability,|tolerability,
5721275|NCT00427141|pharmacokinetics,|pharmacokinetics,
5721276|NCT00427141|first time in human,|first time in human,
5721277|NCT00427141|food effect|food effect
5721278|NCT00427141|safety,|safety,
5721279|NCT00427128|Major Depression|major depression
5721280|NCT00427128|"true drug response"|"true drug response"
5721281|NCT00427128|"placebo response pattern"|"placebo response pattern"
5721282|NCT00427128|continuation treatment outcomes|continuation treatment outcomes
5721283|NCT00427115|Patients undergoing allogeneic stem cell transplantations|patients undergoing allogeneic stem cell transplantations
5721284|NCT00427102|Oral MRX-1024|oral mrx-1024
5721285|NCT00427102|High-Dose Cisplatin Chemotherapy|high-dose cisplatin chemotherapy
5721286|NCT00427102|Standard Radiation Therapy|standard radiation therapy
5721287|NCT00427089|Colon cleansing|colon cleansing
5721288|NCT00427089|Polyethylene Glycol|polyethylene glycol
5721289|NCT00427089|Sodium Phosphate|sodium phosphate
5721290|NCT00427076|vancomycin|vancomycin
5721291|NCT00427076|cotrimoxazole|cotrimoxazole
5721292|NCT00427076|trimethoprim/ sulfamethoxazole|trimethoprim/ sulfamethoxazole
5721293|NCT00427076|methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5721294|NCT00427076|Health care association infections|health care association infections
5721295|NCT00427076|MRSA bacteremia or other microbiologically documented MRSA infections (defined clinically by CDC criteria)|mrsa bacteremia or other microbiologically documented mrsa infections (defined clinically by cdc criteria)
5721296|NCT00427076|Suspected neurosurgical meningitis|suspected neurosurgical meningitis
5721297|NCT00427076|Sepsis during hemodialysis, catheter-associated and catheter-related infections|sepsis during hemodialysis, catheter-associated and catheter-related infections
5721298|NCT00427076|Ventilator-associated pneumonia|ventilator-associated pneumonia
5721299|NCT00427076|Surgical site infection in the presence of a foreign body|surgical site infection in the presence of a foreign body
5721300|NCT00427063|retinal vessels|retinal vessels
5721301|NCT00427063|tortuosity|tortuosity
5721302|NCT00427050|Actinic Keratoses (AK)|actinic keratoses (ak)
5721303|NCT00427050|PEP005|pep005
5721304|NCT00427050|Topical|topical
5721305|NCT00427050|Dermatology|dermatology
5721306|NCT00427037|Vitamin D deficiency|vitamin d deficiency
5721307|NCT00427037|Chronic Kidney Disease|chronic kidney disease
5721308|NCT00427024|renal transplantation|renal transplantation
5721309|NCT00427024|acute rejection|acute rejection
5721310|NCT00427024|transport|transport
5737859|NCT00365599|Aromatase inhibitors (Ais)|aromatase inhibitors (ais)
5737860|NCT00365599|Histone deacetylase (HDAC) inhibitors|histone deacetylase (hdac) inhibitors
5721311|NCT00427024|transporter|transporter
5721312|NCT00427024|acute rejection after renal transplantation|acute rejection after renal transplantation
5721313|NCT00426998|Choroidal neovascularization due to age-related macular degeneration|choroidal neovascularization due to age-related macular degeneration
5721314|NCT00426985|Tendonitis|tendonitis
5721315|NCT00426985|Bursitis|bursitis
5721316|NCT00426985|Pain|pain
5721317|NCT00426985|Shoulder Pain|shoulder pain
5721318|NCT00426985|Elbow Pain|elbow pain
5721319|NCT00426985|Knee Pain|knee pain
5721320|NCT00426985|Tendon Injury|tendon injury
5721321|NCT00426985|Muscle, Bone and Cartilage Disorders|muscle, bone and cartilage disorders
5721322|NCT00426959|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5721323|NCT00426959|PSA of less than 10 ng/mL|psa of less than 10 ng/ml
5721324|NCT00426959|Combined Gleason score 6 or less|combined gleason score 6 or less
5721325|NCT00426959|International Prostate Symptom Score (IPSS) must <or= to 18|international prostate symptom score (ipss) must <or= to 18
5721326|NCT00426946|Depression Children Reboxetine|depression children reboxetine
5721327|NCT00426946|A diagnosis of major depressive disorder or a dysthimic disorder according to DSM-IV-TR.|a diagnosis of major depressive disorder or a dysthimic disorder according to dsm-iv-tr.
5721328|NCT00426946|Drug naïve or without chronic medication for at least one month.|drug naïve or without chronic medication for at least one month.
5721329|NCT00426946|Only children who agree to participate and whose parents will sign and informed consent form will be included.|only children who agree to participate and whose parents will sign and informed consent form will be included.
5721330|NCT00426933|cSSSI|csssi
5721331|NCT00426933|MRSA|mrsa
5721332|NCT00426920|pharmacokinetics|pharmacokinetics
5721333|NCT00426920|pharmacodynamics|pharmacodynamics
5721334|NCT00426920|inhaled|inhaled
5721335|NCT00426920|recombinant human insulin|recombinant human insulin
5721336|NCT00426907|Osteoarthritis, Knee|osteoarthritis, knee
5721337|NCT00426907|Osteotomy|osteotomy
5721338|NCT00426907|Healing|healing
5721339|NCT00426907|Rehabilitation|rehabilitation
5721340|NCT00426907|Roentgen Stereometric Analysis|roentgen stereometric analysis
5721341|NCT00426894|surveillance cultures|surveillance cultures
5721343|NCT00426894|cardiac surgery|cardiac surgery
5721344|NCT00426894|perioperative prophylaxis|perioperative prophylaxis
5721345|NCT00426881|Exercise|exercise
5721347|NCT00426868|ADRC|adrc
5721348|NCT00426868|Stem Cells|stem cells
5721349|NCT00426868|chronic ischemia|chronic ischemia
5721350|NCT00426868|heart disease|heart disease
5721351|NCT00426868|coronary artery disease|coronary artery disease
5721352|NCT00426868|inducible reversible ischemia|inducible reversible ischemia
5721353|NCT00426855|Lymphoma, Non-Hodgkin, Low-Grade|lymphoma, non-hodgkin, low-grade
5721354|NCT00426842|Blood pressure|blood pressure
5721355|NCT00426842|Orthostatic hypotension|orthostatic hypotension
5721356|NCT00426842|Spinal Cord Injury|spinal cord injury
5721357|NCT00426842|Sympathetic vascular control|sympathetic vascular control
5721359|NCT00426829|Liver Cancer|liver cancer
5721360|NCT00426829|Biliary Tract|biliary tract
5721361|NCT00426829|Hepatocellular Carcinoma|hepatocellular carcinoma
5721362|NCT00426829|Cholangiocarcinoma|cholangiocarcinoma
5721363|NCT00426829|Bevacizumab|bevacizumab
5721364|NCT00426829|Proton Therapy|proton therapy
5721365|NCT00426829|Radiation Therapy|radiation therapy
5721368|NCT00426829|Proton RT|proton rt
5721369|NCT00426829|Avastin|avastin
5721370|NCT00426829|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5721371|NCT00426829|rhuMAb-VEGF|rhumab-vegf
5721372|NCT00426816|primary insomnia|primary insomnia
5721373|NCT00426816|PSG sleep recordings|psg sleep recordings
5721374|NCT00426816|daytime cognitive function|daytime cognitive function
5721375|NCT00426816|Insomnia|insomnia
5721376|NCT00426816|SB-649868|sb-649868
5721377|NCT00426777|prostate cancer|prostate cancer
5721378|NCT00426777|prostatic adenoma|prostatic adenoma
5721379|NCT00426777|prostatic neoplasm|prostatic neoplasm
5721380|NCT00426764|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5721381|NCT00426764|T-cell lymphoma|t-cell lymphoma
5721382|NCT00426764|romidepsin|romidepsin
5721383|NCT00426751|Eptifibatide|eptifibatide
5721384|NCT00426751|ST-elevation Myocardial Infarction|st-elevation myocardial infarction
5721385|NCT00426751|STEMI|stemi
5721386|NCT00426751|Abciximab|abciximab
5721387|NCT00426725|labor|labor
5721388|NCT00426725|pain|pain
5721389|NCT00426725|relief|relief
5721390|NCT00426725|labour|labour
5721391|NCT00426725|device|device
5721392|NCT00426712|Chronic kidney failure|chronic kidney failure
5721393|NCT00426712|Chronic kidney disease|chronic kidney disease
5721394|NCT00426712|Hemodialysis|hemodialysis
5721395|NCT00426712|HBV vaccine|hbv vaccine
5721396|NCT00426712|Hepatitis B vaccine|hepatitis b vaccine
5721397|NCT00426712|Hepatitis B|hepatitis b
5721398|NCT00426712|Hepatitis|hepatitis
5721399|NCT00426712|HBV|hbv
5721400|NCT00426712|Prevention & Control|prevention & control
5721401|NCT00426699|enterovirus|enterovirus
5721402|NCT00426699|meningitis|meningitis
5721404|NCT00426699|myocarditis|myocarditis
5721405|NCT00426699|kidney|kidney
5721406|NCT00426699|urine|urine
5721407|NCT00426699|glomerulonephritis|glomerulonephritis
5721408|NCT00426686|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura
5721409|NCT00426686|prognostic factors|prognostic factors
5721410|NCT00426686|ADAMTS13|adamts13
5721411|NCT00426673|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction|partial onset seizures, phenytoin, dilatin, brivaracetam, interaction
5721412|NCT00426660|HIV Infections|hiv infections
5721413|NCT00426647|Osteoarthritis|osteoarthritis
5721414|NCT00426647|Pain|pain
5721415|NCT00426647|Norspan|norspan
5721416|NCT00426647|Buprenorphine|buprenorphine
5721417|NCT00426647|Tramadol|tramadol
5721418|NCT00426634|Asthma|asthma
5721419|NCT00426634|Allergens|allergens
5721420|NCT00426634|Mold|mold
5721421|NCT00426634|Asthma Counselor|asthma counselor
5721422|NCT00426634|Environmental Remediation|environmental remediation
5721423|NCT00426621|Knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical NSAID,|knee osteoarthritis, degenerative joint disease, knee pain, joint pain, topical nsaid,
5721424|NCT00426621|diclofenac sodium|diclofenac sodium
5721425|NCT00426608|HPA axis,|hpa axis,
5721426|NCT00426608|Healthy volunteers|healthy volunteers
5721427|NCT00426608|hormones,|hormones,
5721428|NCT00426608|GSK561679,|gsk561679,
5721429|NCT00426608|cortisol,|cortisol,
5721430|NCT00426582|Cancer|cancer
5721431|NCT00426582|maximum tolerated dose|maximum tolerated dose
5721432|NCT00426582|dose-limiting toxicity|dose-limiting toxicity
5721433|NCT00426582|patupilone|patupilone
5721434|NCT00426582|carboplatin|carboplatin
5721435|NCT00426582|pharmacokinetics|pharmacokinetics
5721436|NCT00426556|Breast cancer|breast cancer
5721437|NCT00426556|Cancer of the breast|cancer of the breast
5721438|NCT00426556|Human mammary carcinoma|human mammary carcinoma
5721439|NCT00426556|HER-2|her-2
5721440|NCT00426556|Metastatic|metastatic
5721441|NCT00426556|everolimus|everolimus
5721442|NCT00426556|trastuzumab|trastuzumab
5721443|NCT00426556|paclitaxel|paclitaxel
5721444|NCT00426543|Clinical trial|clinical trial
5721445|NCT00426543|Intervention study|intervention study
5721446|NCT00426543|Double-blind randomised controlled study|double-blind randomised controlled study
5721447|NCT00426530|HER2-overexpressing metastatic breast cancer|her2-overexpressing metastatic breast cancer
5721448|NCT00426530|Breast cancer|breast cancer
5730284|NCT00393341|Breast Cancer|breast cancer
5730285|NCT00393315|in stent restenosis|in stent restenosis
5730286|NCT00393315|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5730287|NCT00393315|pepcad|pepcad
5730318|NCT00393172|obesity|obesity
5721449|NCT00426530|Cancer of the breast|cancer of the breast
5721450|NCT00426530|Human mammary carcinoma|human mammary carcinoma
5721451|NCT00426530|HER-2|her-2
5721452|NCT00426530|metastatic|metastatic
5721453|NCT00426530|everolimus|everolimus
5721454|NCT00426530|trastuzumab|trastuzumab
5721455|NCT00426530|vinorelbine|vinorelbine
5721456|NCT00426517|MUD Transplant|mud transplant
5721457|NCT00426517|Transplant|transplant
5721458|NCT00426517|AlloPBSC|allopbsc
5721459|NCT00426517|HLA Matched Transplant|hla matched transplant
5721461|NCT00426517|Congenital Immunodeficiency|congenital immunodeficiency
5721462|NCT00426517|Bone Marrow Transplant|bone marrow transplant
5721463|NCT00426504|Head,|head,
5721464|NCT00426504|Neck,|neck,
5721465|NCT00426504|Cancer,|cancer,
5721466|NCT00426504|Tomotherapy,|tomotherapy,
5721467|NCT00426504|IMRT,|imrt,
5729194|NCT00397579|CD123+|cd123+
5721468|NCT00426478|AMPM, SBP, DBP, Valsartan plus Hydrochlorothiazide, Amlodipine, high blood pressure|ampm, sbp, dbp, valsartan plus hydrochlorothiazide, amlodipine, high blood pressure
5721469|NCT00426465|Motor Practice|motor practice
5721470|NCT00426465|Magnetic Stimulation|magnetic stimulation
5721471|NCT00426465|Stroke|stroke
5721472|NCT00426465|Spacing Effect|spacing effect
5721473|NCT00426465|Massed Practice|massed practice
5721474|NCT00426465|Healthy Volunteer|healthy volunteer
5721475|NCT00426465|HV|hv
5721476|NCT00426452|Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor|vascular endothelial growth factor receptor (vegf-r) tyrosine kinase inhibitor
5721477|NCT00426452|Vatalinib|vatalinib
5721478|NCT00426452|Proton-pump inhibitors|proton-pump inhibitors
5721479|NCT00426452|Omeprazole|omeprazole
5721480|NCT00426452|Healthy Postmenopausal Female Volunteers|healthy postmenopausal female volunteers
5721481|NCT00426439|malaria|malaria
5721482|NCT00426439|Plasmodium falciparum|plasmodium falciparum
5721483|NCT00426439|children|children
5721484|NCT00426439|Guinea-Bissau|guinea-bissau
5721485|NCT00426439|artemether|artemether
5721486|NCT00426439|lumefantrine|lumefantrine
5721487|NCT00426439|chloroquine|chloroquine
5721488|NCT00426439|Coartem|coartem
5721489|NCT00426413|ketosis-prone diabetes|ketosis-prone diabetes
5721490|NCT00426413|diabetic ketoacidosis|diabetic ketoacidosis
5721491|NCT00426413|obesity|obesity
5721492|NCT00426413|insulin dependence|insulin dependence
5721493|NCT00426413|mechanisms|mechanisms
5721495|NCT00426374|AIDS|aids
5721496|NCT00426374|Troponin|troponin
5721497|NCT00426374|natriuretic peptide|natriuretic peptide
5721499|NCT00426374|heart disease children|heart disease children
5721500|NCT00426374|HIV pediatric|hiv pediatric
5721501|NCT00426374|AIDS pediatric|aids pediatric
5721502|NCT00426361|Human Papillomavirus|human papillomavirus
5721503|NCT00426348|IgA nephropathy|iga nephropathy
5721504|NCT00426348|probucol|probucol
5721505|NCT00426348|valsartan|valsartan
5721506|NCT00426348|treatment|treatment
5721507|NCT00426348|antioxidant|antioxidant
5721508|NCT00426348|IGA nephropathy：a kind of glomerulonephritis,which IgA is the dominant immunodeposit in mesangial areas|iga nephropathy：a kind of glomerulonephritis,which iga is the dominant immunodeposit in mesangial areas
5721510|NCT00426335|cancer|cancer
5721511|NCT00426335|cognitive behaviour therapy|cognitive behaviour therapy
5722319|NCT00423657|PPI-0903|ppi-0903
5721512|NCT00426335|psychological|psychological
5721513|NCT00426322|maxillary sinus augmentation|maxillary sinus augmentation
5721514|NCT00426322|bone graft|bone graft
5721515|NCT00426322|bovine bone mineral|bovine bone mineral
5721516|NCT00426322|dental implants|dental implants
5721517|NCT00426296|HIV|hiv
5721518|NCT00426296|Reyataz|reyataz
5721519|NCT00426296|atazanavir|atazanavir
5721520|NCT00426296|Norvir|norvir
5721521|NCT00426296|ritonavir|ritonavir
5721522|NCT00426296|Boosted|boosted
5721523|NCT00426296|Lipodystrophy|lipodystrophy
5721524|NCT00426296|Treatment Experienced|treatment experienced
5721525|NCT00426283|Eosinophilic Esophagitis|eosinophilic esophagitis
5721526|NCT00426257|Ovarian Cancer|ovarian cancer
5721527|NCT00426257|stage III|stage iii
5721528|NCT00426257|hyperthermic intraperitoneal chemotherapy|hyperthermic intraperitoneal chemotherapy
5721529|NCT00426257|debulking surgery|debulking surgery
5721530|NCT00426257|HIPEC|hipec
5721531|NCT00426244|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5721532|NCT00426244|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5721533|NCT00426244|Pregnancy|pregnancy
5721534|NCT00426244|Physiologic|physiologic
5721535|NCT00426244|Gait|gait
5721536|NCT00426244|Low back pain|low back pain
5721537|NCT00426244|Heart rate variability|heart rate variability
5721538|NCT00426231|Randomized Controlled Trials|randomized controlled trials
5721539|NCT00426231|Health Education|health education
5721540|NCT00426231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5721541|NCT00426231|Patient Nonadherence|patient nonadherence
5721542|NCT00426218|Systemic Juvenile Idiopathic Arthritis|systemic juvenile idiopathic arthritis
5721543|NCT00426218|Immunogenicity|immunogenicity
5721544|NCT00426218|Pharmacokinetics|pharmacokinetics
5721545|NCT00426218|Anti-IL-1ß Monoclonal Antibody|anti-il-1ß monoclonal antibody
5721548|NCT00426218|Pediatrics|pediatrics
5721549|NCT00426205|GM-CSF|gm-csf
5721550|NCT00426205|GVAX|gvax
5721551|NCT00426205|Cancer vaccine|cancer vaccine
5721552|NCT00426205|blood stem cell transplantation|blood stem cell transplantation
5721555|NCT00426205|CML|cml
5721556|NCT00426192|Immunedefense Suppression|immunedefense suppression
5721557|NCT00426192|Cardiopulmonary Bypass|cardiopulmonary bypass
5721558|NCT00426192|Mannitol|mannitol
5721559|NCT00426192|Hemofiltration|hemofiltration
5721560|NCT00426192|Cytokines|cytokines
5721561|NCT00426192|Receptors, Surface CD14|receptors, surface cd14
5721562|NCT00426179|Imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, Timothy grass pollen, c-kit inhibition|imatinib, allergic inflammation, out of allergy season, repeated nasal allergen, seasonal allergic rhinitis, sensitive, timothy grass pollen, c-kit inhibition
5721563|NCT00426140|EPO|epo
5721564|NCT00426140|Patupilone|patupilone
5721565|NCT00426140|Solid Tumors|solid tumors
5729287|NCT00397137|stapled anopexy|stapled anopexy
5721566|NCT00426127|Pancreatic|pancreatic
5721567|NCT00426127|Docetaxel|docetaxel
5721568|NCT00426127|Doxorubicin|doxorubicin
5721569|NCT00426127|Enoxaparin|enoxaparin
5721570|NCT00426101|Hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5721571|NCT00426075|Deep vein thrombosis of the lower extremities|deep vein thrombosis of the lower extremities
5721572|NCT00426062|Squamous Cell Carcinoma of Tongue and mouth floor|squamous cell carcinoma of tongue and mouth floor
5721573|NCT00426049|Coronary artery disease|coronary artery disease
5721574|NCT00426049|Stents|stents
5721575|NCT00426049|Immunosuppressive Agents|immunosuppressive agents
5721576|NCT00426049|Coronary restenosis|coronary restenosis
5721577|NCT00426049|Safety|safety
5721578|NCT00426036|Open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.|open-label study, healthy subjects, stable impaired renal function, licarbazepine, pharmacokinetics, metabolism, safety.
5721579|NCT00426023|Vernal keratoconjunctivitis|vernal keratoconjunctivitis
5721580|NCT00426023|Cyclosporine|cyclosporine
5721581|NCT00426023|Children|children
5721582|NCT00426023|Clinical trial|clinical trial
5721583|NCT00426010|Placebo effect|placebo effect
5721584|NCT00426010|Caffeine|caffeine
5721585|NCT00426010|Systolic BP|systolic bp
5721586|NCT00426010|VAS|vas
5721587|NCT00425997|Hypertension, valsartan/HCTZ, amlodipine and HCTZ|hypertension, valsartan/hctz, amlodipine and hctz
5721588|NCT00425984|HIV|hiv
5721589|NCT00425984|Male circumcision|male circumcision
5721591|NCT00425984|Sexual risk behaviors|sexual risk behaviors
5721592|NCT00425984|Adult males|adult males
5721593|NCT00425984|Haemophilus ducreyi|haemophilus ducreyi
5721594|NCT00425984|Human papillomavirus|human papillomavirus
5721595|NCT00425984|Rakai|rakai
5721596|NCT00425984|Uganda|uganda
5721597|NCT00425984|HIV seronegativity|hiv seronegativity
5721598|NCT00425984|HPV|hpv
5721599|NCT00425984|STI|sti
5721600|NCT00425958|year and more after TBI|year and more after tbi
5721601|NCT00425958|good vision|good vision
5721602|NCT00425958|at least one functinal hand|at least one functinal hand
5721603|NCT00425958|cap[able od doing shopping during everyday life|cap[able od doing shopping during everyday life
5721604|NCT00425932|Magnetic Resonance Imaging|magnetic resonance imaging
5721605|NCT00425932|Rituximab|rituximab
5721606|NCT00425932|Low Field MRI|low field mri
5721607|NCT00425932|Biomarkers|biomarkers
5721608|NCT00425919|Type 2 Diabetes|type 2 diabetes
5721609|NCT00425919|Diabetes|diabetes
5721610|NCT00425906|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5721611|NCT00425906|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5721612|NCT00425906|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5721613|NCT00425906|anorexia|anorexia
5721614|NCT00425906|pain|pain
5721615|NCT00425893|influenza|influenza
5721616|NCT00425893|masks|masks
5721617|NCT00425893|transmission|transmission
5721618|NCT00425893|hand hygiene|hand hygiene
5721619|NCT00425893|non-pharmacologic interventions|non-pharmacologic interventions
5721620|NCT00425880|Pregnancy|pregnancy
5721621|NCT00425880|Asthma|asthma
5721622|NCT00425880|Tobacco Abuse|tobacco abuse
5721623|NCT00425880|Exhaled Nitric Oxide|exhaled nitric oxide
5721624|NCT00425867|PAR1 gene|par1 gene
5721625|NCT00425867|polymorphisms|polymorphisms
5721626|NCT00425867|abortions|abortions
5721627|NCT00425867|reccurent abortions|reccurent abortions
5721628|NCT00425867|premature delivery|premature delivery
5721629|NCT00425841|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5721630|NCT00425841|stage III pancreatic cancer|stage iii pancreatic cancer
5721631|NCT00425841|stage II pancreatic cancer|stage ii pancreatic cancer
5721632|NCT00425815|Cognition|cognition
5721633|NCT00425815|Ampakines|ampakines
5721634|NCT00425815|Schizophrenia|schizophrenia
5721635|NCT00425802|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5721636|NCT00425802|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5721637|NCT00425802|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5721638|NCT00425802|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5721639|NCT00425802|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5721640|NCT00425802|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5721641|NCT00425802|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5721642|NCT00425802|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5721643|NCT00425802|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5721645|NCT00425802|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5721646|NCT00425802|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5721647|NCT00425802|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5721648|NCT00425802|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5721649|NCT00425802|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5721650|NCT00425802|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5721651|NCT00425802|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5729387|NCT00396734|Imaging|imaging
5721652|NCT00425802|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5721653|NCT00425802|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5721654|NCT00425802|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5721655|NCT00425802|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5721656|NCT00425802|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5721657|NCT00425802|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5721658|NCT00425802|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5721659|NCT00425802|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5721660|NCT00425802|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5721661|NCT00425802|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5721662|NCT00425802|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5721663|NCT00425802|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5721664|NCT00425802|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5721665|NCT00425802|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5721666|NCT00425802|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5711903|NCT00458042|PAH|pah
5721667|NCT00425802|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5721668|NCT00425802|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5721669|NCT00425802|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5721670|NCT00425789|Deep Chemical Peeling|deep chemical peeling
5721673|NCT00425776|Breast cancer|breast cancer
5721674|NCT00425776|Acupuncture|acupuncture
5721675|NCT00425776|Post-menopausal hot flushes|post-menopausal hot flushes
5721676|NCT00425776|Se-estradiol|se-estradiol
5721677|NCT00425776|Se-endorphine|se-endorphine
5721678|NCT00425763|malaria|malaria
5721679|NCT00425763|efficacy|efficacy
5721680|NCT00425763|intermittent preventive therapy in infants|intermittent preventive therapy in infants
5721681|NCT00425763|drug resistance|drug resistance
5721682|NCT00425750|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5721683|NCT00425750|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5721684|NCT00425750|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5721685|NCT00425750|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5721686|NCT00425750|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5721687|NCT00425750|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5721688|NCT00425750|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5721689|NCT00425750|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5721690|NCT00425737|Oral live attenuated human rotavirus vaccine|oral live attenuated human rotavirus vaccine
5721691|NCT00425737|Gastroenteritis|gastroenteritis
5721692|NCT00425724|proteinuria|proteinuria
5721693|NCT00425724|nephritis|nephritis
5721694|NCT00425724|nephrotic syndrome|nephrotic syndrome
5721695|NCT00425724|glomerulonephritis|glomerulonephritis
5721696|NCT00425711|Acamprosate|acamprosate
5721697|NCT00425711|Alcohol Dependence|alcohol dependence
5721698|NCT00425711|Driving Under the Influence|driving under the influence
5721699|NCT00425711|Drug Court|drug court
5721700|NCT00425711|DUI Court|dui court
5721701|NCT00425685|cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.|cardiopulmonary resuscitation, ecmo, shock, survival, heart failure, transplantation, heart assist device.
5721702|NCT00425659|Health utility|health utility
5721703|NCT00425659|Home sleep study|home sleep study
5721704|NCT00425646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5721705|NCT00425646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5721706|NCT00425646|adenocarcinoma of the lung|adenocarcinoma of the lung
5721707|NCT00425646|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5721708|NCT00425646|large cell lung cancer|large cell lung cancer
5721709|NCT00425646|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5721710|NCT00425633|Homeopathic|homeopathic
5721712|NCT00425633|Dichromate|dichromate
5721713|NCT00425633|Kalium|kalium
5721714|NCT00425633|Bichromicum|bichromicum
5721715|NCT00425633|Mechanical|mechanical
5721716|NCT00425633|Ventilation|ventilation
5721717|NCT00425633|Secretions|secretions
5721718|NCT00425620|Chronic Sinusitis|chronic sinusitis
5721719|NCT00425620|Chronic Rhinosinusitis|chronic rhinosinusitis
5721720|NCT00425607|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5721721|NCT00425607|HGPS|hgps
5721722|NCT00425607|Progeria|progeria
5721723|NCT00425607|FTI|fti
5721724|NCT00425607|Farnesyltransferase Inhibitor|farnesyltransferase inhibitor
5721725|NCT00425607|Lonafarnib|lonafarnib
5721726|NCT00425594|colonoscopy|colonoscopy
5721727|NCT00425594|bowel preparation|bowel preparation
5721728|NCT00425594|prep|prep
5721729|NCT00425581|N-terminal pro-BNP,|n-terminal pro-bnp,
5721730|NCT00425581|Cardiac Troponin-T,|cardiac troponin-t,
5721731|NCT00425581|Very low birth weight infants|very low birth weight infants
5721732|NCT00425581|hemodynamic instability|hemodynamic instability
5721733|NCT00425581|myocardial dysfunction|myocardial dysfunction
5721734|NCT00425568|hypogonadism|hypogonadism
5721735|NCT00425568|low testosterone level|low testosterone level
5721736|NCT00425568|gonadal deficiency|gonadal deficiency
5721737|NCT00425555|Cutaneous T-Cell Lymphoma, adults|cutaneous t-cell lymphoma, adults
5721738|NCT00425555|Mycosis Fungoides|mycosis fungoides
5721739|NCT00425555|Sézary Syndrome|sézary syndrome
5721740|NCT00425555|CTCL|ctcl
5721741|NCT00425542|Pulmonary embolism|pulmonary embolism
5721742|NCT00425542|Outpatient care|outpatient care
5721743|NCT00425542|Prognosis|prognosis
5721744|NCT00425516|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5721745|NCT00425516|breast cancer|breast cancer
5721746|NCT00425516|sequential treatment|sequential treatment
5721747|NCT00425503|Prostate Cancer|prostate cancer
5721748|NCT00425503|Bortezomib|bortezomib
5721749|NCT00425503|Radical Prostatectomy|radical prostatectomy
5721750|NCT00425503|Phase 2 Clinical Trial|phase 2 clinical trial
5721751|NCT00425477|refractory anemia with excess blasts|refractory anemia with excess blasts
5712010|NCT00457665|HIV|hiv
5721752|NCT00425477|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5721753|NCT00425477|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5721754|NCT00425477|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5721755|NCT00425477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5721756|NCT00425477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5721757|NCT00425477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5721758|NCT00425477|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5721759|NCT00425477|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5721760|NCT00425477|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5721761|NCT00425477|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5721762|NCT00425477|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5721763|NCT00425477|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5722320|NCT00423657|Prodrug|prodrug
5721764|NCT00425477|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5721765|NCT00425477|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5721766|NCT00425477|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5721767|NCT00425477|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5721768|NCT00425477|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5721769|NCT00425477|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5721770|NCT00425477|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5721771|NCT00425477|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5721772|NCT00425477|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5721773|NCT00425477|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5721774|NCT00425477|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5721775|NCT00425451|Periodontitis|periodontitis
5721776|NCT00425451|Dental Care|dental care
5721777|NCT00425451|Efficacy|efficacy
5721778|NCT00425451|Safety|safety
5721779|NCT00425425|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5721780|NCT00425425|stage IIA esophageal cancer|stage iia esophageal cancer
5721781|NCT00425425|stage IIB esophageal cancer|stage iib esophageal cancer
5721782|NCT00425425|stage IIIA esophageal cancer|stage iiia esophageal cancer
5721783|NCT00425425|stage IIIB esophageal cancer|stage iiib esophageal cancer
5721784|NCT00425425|stage IIIC esophageal cancer|stage iiic esophageal cancer
5721785|NCT00425399|Schizophrenia|schizophrenia
5721786|NCT00425399|Shiatsu|shiatsu
5721787|NCT00425386|stage III renal cell cancer|stage iii renal cell cancer
5722124|NCT00424099|Ritalin|ritalin
5721788|NCT00425386|stage IV renal cell cancer|stage iv renal cell cancer
5721789|NCT00425386|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5721790|NCT00425386|recurrent renal cell cancer|recurrent renal cell cancer
5721791|NCT00425373|Hypertension, Valsartan, Amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5721792|NCT00425360|stage III pancreatic cancer|stage iii pancreatic cancer
5721793|NCT00425360|stage IV pancreatic cancer|stage iv pancreatic cancer
5721794|NCT00425360|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5721795|NCT00425360|recurrent pancreatic cancer|recurrent pancreatic cancer
5721796|NCT00425347|Multiple myeloma, MM, plasma cell myeloma, cancer|multiple myeloma, mm, plasma cell myeloma, cancer
5721798|NCT00425334|Ischemia|ischemia
5721799|NCT00425334|Hemoglobin|hemoglobin
5721800|NCT00425334|Blood Substitutes|blood substitutes
5721801|NCT00425334|Plasma Expanders|plasma expanders
5721802|NCT00425321|Arthritis|arthritis
5721803|NCT00425321|Joints|joints
5721804|NCT00425321|Auto immune|auto immune
5686129|NCT00553436|Established indication for a procedure greater than colonoscopy and colonic polypectomy|established indication for a procedure greater than colonoscopy and colonic polypectomy
5686130|NCT00553410|stage IA breast cancer|stage ia breast cancer
5680885|NCT00575835|PTH|pth
5721805|NCT00425308|Everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy|everolimus, calcineurine inhibitor, renal transplantation in maintenance, chronic allograft nephropathy
5721806|NCT00425282|RWJ-333369|rwj-333369
5721807|NCT00425282|anticonvulsants|anticonvulsants
5721808|NCT00425282|antiepileptic drugs|antiepileptic drugs
5721809|NCT00425269|lifestyle intervention|lifestyle intervention
5721810|NCT00425269|Type 2 Diabetes|type 2 diabetes
5721811|NCT00425269|Metabolic syndrome|metabolic syndrome
5721812|NCT00425269|Pakistani women|pakistani women
5721813|NCT00425269|dietary change|dietary change
5721814|NCT00425269|Physical activity|physical activity
5721815|NCT00425269|Norway|norway
5721816|NCT00425243|primary insomnia|primary insomnia
5721817|NCT00425243|chronic insomnia|chronic insomnia
5721818|NCT00425178|Chronic wounds|chronic wounds
5721819|NCT00425178|Diabetes|diabetes
5721820|NCT00425178|Ulcers|ulcers
5721821|NCT00425178|Arterial bypass|arterial bypass
5721822|NCT00425178|Angioplasty|angioplasty
5721823|NCT00425178|Diabetic ulcers|diabetic ulcers
5721824|NCT00425152|stage II colon cancer|stage ii colon cancer
5721825|NCT00425152|stage III colon cancer|stage iii colon cancer
5721826|NCT00425139|Cancer|cancer
5721827|NCT00425139|Video game|video game
5721828|NCT00425139|Adolescent|adolescent
5721829|NCT00425139|Young adult|young adult
5721832|NCT00425113|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5721833|NCT00425113|Anaerobic|anaerobic
5721834|NCT00425113|FDG-PET-HRCT|fdg-pet-hrct
5721835|NCT00425113|HRCT|hrct
5721836|NCT00425113|Lesion Matrix|lesion matrix
5721837|NCT00425113|Tuberculosis|tuberculosis
5721839|NCT00425074|slow release ASA|slow release asa
5721840|NCT00425074|platelet functionalism|platelet functionalism
5721841|NCT00425074|secondary cardiovascular prevention|secondary cardiovascular prevention
5721842|NCT00425035|Renal Cancer|renal cancer
5721843|NCT00425022|lung cancer|lung cancer
5721844|NCT00425022|video-assisted thoracic surgery|video-assisted thoracic surgery
5721845|NCT00425009|Berberine|berberine
5721846|NCT00425009|Type 2 diabetes|type 2 diabetes
5721847|NCT00425009|Treatment|treatment
5721848|NCT00424983|Multiple myeloma|multiple myeloma
5721849|NCT00424983|breast cancer|breast cancer
5721850|NCT00424983|zoledronic acid|zoledronic acid
5721851|NCT00424983|pharmacokinetics|pharmacokinetics
5721852|NCT00424970|high altitude|high altitude
5721853|NCT00424970|hypoxia|hypoxia
5721854|NCT00424970|pulmonary hypertension|pulmonary hypertension
5721855|NCT00424970|polycythemia|polycythemia
5721856|NCT00424970|hypoventilation|hypoventilation
5721857|NCT00424957|Ammonia|ammonia
5721858|NCT00424957|Astrocytes|astrocytes
5721859|NCT00424957|Citric acid cycle|citric acid cycle
5721860|NCT00424957|Alpha ketoglutarate dehydrogenase|alpha ketoglutarate dehydrogenase
5721861|NCT00424944|Malaria|malaria
5721862|NCT00424944|Vaccine|vaccine
5721863|NCT00424944|GMZ2|gmz2
5721864|NCT00424944|Safety|safety
5721865|NCT00424944|African|african
5721866|NCT00424944|immunogenicity|immunogenicity
5721867|NCT00424931|narcolepsy|narcolepsy
5721868|NCT00424931|sleepiness|sleepiness
5721869|NCT00424918|Dance|dance
5721870|NCT00424918|Peers|peers
5721871|NCT00424918|middle school-based|middle school-based
5721872|NCT00424918|feasibility|feasibility
5721873|NCT00424866|Peripheral Arterial Disease|peripheral arterial disease
5721874|NCT00424866|Ischemia|ischemia
5721875|NCT00424866|Intermittent Claudication|intermittent claudication
5721876|NCT00424840|lung cancer, Carboplatin, bortezomib, Bevacizumab|lung cancer, carboplatin, bortezomib, bevacizumab
5721877|NCT00424827|pancreatic cancer, gemcitabine, 5-FU, cetuximab, radiation|pancreatic cancer, gemcitabine, 5-fu, cetuximab, radiation
5721878|NCT00424814|HIV mother to child prevention|hiv mother to child prevention
5721879|NCT00424814|HIV Infections|hiv infections
5721880|NCT00424814|Kaletra|kaletra
5680890|NCT00575822|Endoscopic Full-thickness Plication|endoscopic full-thickness plication
5680891|NCT00575822|Plicator|plicator
5680892|NCT00575809|Mucositis, hematopoietic stem cell transplantation, chemotherapy|mucositis, hematopoietic stem cell transplantation, chemotherapy
5680893|NCT00575796|pediatrics|pediatrics
5730759|NCT00391495|ADHD|adhd
5721881|NCT00424814|Combivir|combivir
5721882|NCT00424814|HIV Seronegativity|hiv seronegativity
5721883|NCT00424788|multiple sclerosis (MS)|multiple sclerosis (ms)
5721884|NCT00424775|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5721885|NCT00424762|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5721886|NCT00424762|Congestive Heart Failure|congestive heart failure
5721887|NCT00424762|Cardiopulmonary exercise testing|cardiopulmonary exercise testing
5721888|NCT00424762|intracellular cardiomyocyte triglycerides|intracellular cardiomyocyte triglycerides
5721889|NCT00424762|thiazolidinedione|thiazolidinedione
5686131|NCT00553410|stage IB breast cancer|stage ib breast cancer
5721890|NCT00424762|rosiglitazone|rosiglitazone
5721891|NCT00424762|nuclear magnetic resonance|nuclear magnetic resonance
5721892|NCT00424749|Antineutrophil cytoplasmic antibody associated vasculitis|antineutrophil cytoplasmic antibody associated vasculitis
5721893|NCT00424749|Glomerulonephritis|glomerulonephritis
5721894|NCT00424749|Rituximab|rituximab
5721895|NCT00424736|blunt trauma, pediatric patient, imaging, computer tomography|blunt trauma, pediatric patient, imaging, computer tomography
5721896|NCT00424723|pemetrexed|pemetrexed
5721897|NCT00424723|neuroendocrine tumors|neuroendocrine tumors
5721898|NCT00424723|metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
5721899|NCT00424710|choroidal neovascularization|choroidal neovascularization
5721900|NCT00424697|Brain imaging,|brain imaging,
5721901|NCT00424697|fMRI,|fmri,
5721902|NCT00424697|stimulation,|stimulation,
5721903|NCT00424697|pharmacodynamics,|pharmacodynamics,
5721904|NCT00424697|tolerability,|tolerability,
5721905|NCT00424697|healthy subjects|healthy subjects
5721907|NCT00424684|Chronic Liver Disease|chronic liver disease
5721908|NCT00424658|breathing disorders|breathing disorders
5721909|NCT00424645|Hematologic Malignancy|hematologic malignancy
5721910|NCT00424645|Solid Tumor|solid tumor
5721911|NCT00424645|Glucarpidase|glucarpidase
5721912|NCT00424645|Voraxaze|voraxaze
5721913|NCT00424645|Delayed Methotrexate Clearance|delayed methotrexate clearance
5721914|NCT00424645|Placebo|placebo
5721915|NCT00424619|Vitamin D|vitamin d
5721916|NCT00424619|Hip fracture|hip fracture
5721917|NCT00424619|Optimal level|optimal level
5721918|NCT00424619|Deficiency|deficiency
5721919|NCT00424619|Functional muscle strength|functional muscle strength
5721920|NCT00424606|High risk node negative|high risk node negative
5721921|NCT00424567|Fracture|fracture
5721922|NCT00424567|non union fracture|non union fracture
5721923|NCT00424567|ununited fracture|ununited fracture
5721924|NCT00424567|pseudarthrosis|pseudarthrosis
5721925|NCT00424541|Pharmacokinetics, pharmacodynamics, safety, RAS profile, SPP100, aliskiren, Japanese, essential hypertension|pharmacokinetics, pharmacodynamics, safety, ras profile, spp100, aliskiren, japanese, essential hypertension
5721926|NCT00424541|Mild to moderate essential hypertension|mild to moderate essential hypertension
5721927|NCT00424528|COPD including chronic bronchitis and emphysema|copd including chronic bronchitis and emphysema
5721929|NCT00424515|Gleevec|gleevec
5721930|NCT00424489|Refractory Myasthenia Gravis|refractory myasthenia gravis
5721931|NCT00424489|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5721932|NCT00424489|Cyclophosphamide and ATG|cyclophosphamide and atg
5721933|NCT00424476|Autoimmune Diseases|autoimmune diseases
5721934|NCT00424476|Lupus|lupus
5721935|NCT00424476|SLE|sle
5721936|NCT00424476|Systemic Lupus Erythematosus|systemic lupus erythematosus
5721937|NCT00424476|Belimumab|belimumab
5721938|NCT00424476|Antibodies|antibodies
5721939|NCT00424463|Amyotrophic lateral sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5721940|NCT00424450|contrast ultrasound|contrast ultrasound
5721941|NCT00424450|muscle perfusion|muscle perfusion
5721942|NCT00424424|Postoperative Dental Pain|postoperative dental pain
5721943|NCT00424385|AIPC, Prostate cancer|aipc, prostate cancer
5721945|NCT00424359|Mulitple Sclerosis|mulitple sclerosis
5721946|NCT00424359|Ambulation|ambulation
5721947|NCT00424346|Active Rheumatoid Arthritis|active rheumatoid arthritis
5721948|NCT00424346|anti-interleukin-1beta monoclonal antibody|anti-interleukin-1beta monoclonal antibody
5721949|NCT00424346|methotrexate|methotrexate
5721950|NCT00424320|Acute kidney failure|acute kidney failure
5721951|NCT00424320|Contrast-induced nephropathy|contrast-induced nephropathy
5721952|NCT00424320|Non-ionic contrast media|non-ionic contrast media
5721953|NCT00424320|Ionic contrast media|ionic contrast media
5721954|NCT00424320|Iopamidol|iopamidol
5721955|NCT00424320|Percutaneous coronary intervention|percutaneous coronary intervention
5721956|NCT00424320|Coronariography|coronariography
5721957|NCT00424281|Arixtra, fondaparinux, vasopressor, venous thrombolism|arixtra, fondaparinux, vasopressor, venous thrombolism
5721958|NCT00424268|COPD|copd
5721959|NCT00424268|Roflumilast|roflumilast
5721960|NCT00424255|Cancer of the Head and Neck|cancer of the head and neck
5721961|NCT00424255|Neck cancer|neck cancer
5721962|NCT00424255|Adjuvant|adjuvant
5721963|NCT00424255|Head and neck cancer|head and neck cancer
5721964|NCT00424255|High-risk head and neck cancer|high-risk head and neck cancer
5721965|NCT00424255|Post-surgery|post-surgery
5721966|NCT00424255|Head cancer|head cancer
5721967|NCT00424242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5721968|NCT00424242|tumors metastatic to brain|tumors metastatic to brain
5721969|NCT00424242|leptomeningeal metastases|leptomeningeal metastases
5721970|NCT00424242|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5716815|NCT00019630|solid tumor|solid tumor
5721971|NCT00424242|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5721973|NCT00424242|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5721974|NCT00424242|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5721975|NCT00424242|primary myelofibrosis|primary myelofibrosis
5721976|NCT00424242|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5729779|NCT00395330|Distal Airways|distal airways
5721977|NCT00424242|essential thrombocythemia|essential thrombocythemia
5721978|NCT00424242|polycythemia vera|polycythemia vera
5721979|NCT00424242|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5721980|NCT00424242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5721981|NCT00424242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5721982|NCT00424242|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5721983|NCT00424242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5721984|NCT00424242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5721985|NCT00424242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5721986|NCT00424242|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5721987|NCT00424242|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5721988|NCT00424242|acute undifferentiated leukemia|acute undifferentiated leukemia
5721989|NCT00424242|mast cell leukemia|mast cell leukemia
5721990|NCT00424242|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5721991|NCT00424242|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5721992|NCT00424242|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5721993|NCT00424242|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5721994|NCT00424242|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5721995|NCT00424242|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5721996|NCT00424242|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5721997|NCT00424242|refractory hairy cell leukemia|refractory hairy cell leukemia
5721998|NCT00424242|prolymphocytic leukemia|prolymphocytic leukemia
5721999|NCT00424242|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5722000|NCT00424242|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5722001|NCT00424242|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5722002|NCT00424242|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5722003|NCT00424242|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5722004|NCT00424242|intraocular lymphoma|intraocular lymphoma
5738588|NCT00363090|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5738589|NCT00363090|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5738590|NCT00363090|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5722005|NCT00424242|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5722006|NCT00424242|refractory multiple myeloma|refractory multiple myeloma
5722007|NCT00424242|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5722008|NCT00424242|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5722009|NCT00424242|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5722010|NCT00424242|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5722011|NCT00424242|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5722012|NCT00424242|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5722013|NCT00424242|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5722014|NCT00424242|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5722015|NCT00424242|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5722016|NCT00424242|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5722017|NCT00424242|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5722018|NCT00424242|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5722019|NCT00424242|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5722020|NCT00424242|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5722021|NCT00424242|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5722022|NCT00424242|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5722023|NCT00424242|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5722024|NCT00424242|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5722025|NCT00424242|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5722026|NCT00424242|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5722027|NCT00424242|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5722028|NCT00424242|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5722029|NCT00424242|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5722030|NCT00424242|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5722031|NCT00424242|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5722032|NCT00424242|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5722033|NCT00424242|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5722034|NCT00424242|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5729898|NCT00394836|NHL|nhl
5722035|NCT00424242|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5722036|NCT00424242|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5722037|NCT00424242|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5722038|NCT00424242|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5722039|NCT00424242|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5722040|NCT00424242|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5722041|NCT00424242|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5722042|NCT00424242|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5722043|NCT00424242|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5722044|NCT00424242|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5722045|NCT00424242|secondary myelofibrosis|secondary myelofibrosis
5722046|NCT00424242|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5722047|NCT00424242|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5722048|NCT00424242|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5722049|NCT00424242|stage III multiple myeloma|stage iii multiple myeloma
5722050|NCT00424242|primary systemic amyloidosis|primary systemic amyloidosis
5722051|NCT00424242|extramedullary plasmacytoma|extramedullary plasmacytoma
5722052|NCT00424242|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5722053|NCT00424242|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5722054|NCT00424229|MDS INT-2MDS HIGH RISKDELETION 5q[31]Lenalidomide|mds int-2mds high riskdeletion 5q[31]lenalidomide
5722055|NCT00424216|Mood|mood
5722056|NCT00424216|Emotion|emotion
5722057|NCT00424216|Judgment|judgment
5722058|NCT00424216|Cortex|cortex
5722059|NCT00424216|Brain Stimulation|brain stimulation
5722060|NCT00424216|Healthy Volunteer|healthy volunteer
5722061|NCT00424216|HV|hv
5722062|NCT00424203|cognitive/functional effects|cognitive/functional effects
5722064|NCT00424203|malnutrition|malnutrition
5722065|NCT00424203|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5722066|NCT00424203|stage IA breast cancer|stage ia breast cancer
5722067|NCT00424203|stage IB breast cancer|stage ib breast cancer
5722068|NCT00424203|stage II breast cancer|stage ii breast cancer
5722069|NCT00424203|stage IIIA breast cancer|stage iiia breast cancer
5722070|NCT00424203|stage IIIB breast cancer|stage iiib breast cancer
5722071|NCT00424203|stage IIIC breast cancer|stage iiic breast cancer
5722072|NCT00424203|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5722073|NCT00424203|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5722074|NCT00424190|Abscess|abscess
5722075|NCT00424190|Antibacterial|antibacterial
5722076|NCT00424190|Antibiotic|antibiotic
5722077|NCT00424190|Antimicrobial|antimicrobial
5722078|NCT00424190|Bacterial infection, skin|bacterial infection, skin
5722079|NCT00424190|Ceftaroline|ceftaroline
5722080|NCT00424190|Ceftaroline acetate|ceftaroline acetate
5722081|NCT00424190|Cellulitis|cellulitis
5722082|NCT00424190|Cephalosporin|cephalosporin
5722083|NCT00424190|Complicated skin and skin structure infection|complicated skin and skin structure infection
5722084|NCT00424190|cSSSI|csssi
5722085|NCT00424190|Intravenous|intravenous
5722086|NCT00424190|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5722087|NCT00424190|PPI-0903|ppi-0903
5722088|NCT00424190|Prodrug|prodrug
5722089|NCT00424190|Skin disease, bacterial|skin disease, bacterial
5722090|NCT00424190|Skin infection|skin infection
5722091|NCT00424190|Staphylococcal skin infection|staphylococcal skin infection
5722092|NCT00424190|Staphylococcus aureus|staphylococcus aureus
5722999|NCT00420992|Alpharma|alpharma
5722093|NCT00424190|Streptococcal skin infection|streptococcal skin infection
5722094|NCT00424190|Surgical site infection|surgical site infection
5722095|NCT00424190|TAK-599|tak-599
5722096|NCT00424177|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5722097|NCT00424177|ITP|itp
5722098|NCT00424177|thrombocytopenia|thrombocytopenia
5722099|NCT00424177|platelets|platelets
5722100|NCT00424164|male breast cancer|male breast cancer
5722101|NCT00424164|stage IIIB breast cancer|stage iiib breast cancer
5722102|NCT00424164|stage IIIC breast cancer|stage iiic breast cancer
5722103|NCT00424164|stage IV breast cancer|stage iv breast cancer
5722104|NCT00424164|recurrent breast cancer|recurrent breast cancer
5722105|NCT00424151|Graves' Disease|graves' disease
5722106|NCT00424151|Dysthyroid Ophthalmopathy|dysthyroid ophthalmopathy
5722107|NCT00424151|Thyroid related orbitopathy|thyroid related orbitopathy
5722108|NCT00424138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5722109|NCT00424138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5717205|NCT00441636|CPAP|cpap
5722110|NCT00424138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5722111|NCT00424138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5722113|NCT00424125|Compliance|compliance
5722114|NCT00424125|Randomized clinical trial|randomized clinical trial
5722115|NCT00424112|motivation to change|motivation to change
5722116|NCT00424112|treatment motivation|treatment motivation
5686132|NCT00553410|stage II breast cancer|stage ii breast cancer
5722117|NCT00424112|alcohol use disorders|alcohol use disorders
5722118|NCT00424099|Advanced Cancer|advanced cancer
5722119|NCT00424099|Fatigue|fatigue
5722120|NCT00424099|Nursing Telephone Intervention|nursing telephone intervention
5722121|NCT00424099|NTI|nti
5722122|NCT00424099|Methylphenidate|methylphenidate
5722126|NCT00424060|recurrent adult brain tumor|recurrent adult brain tumor
5722127|NCT00424060|adult giant cell glioblastoma|adult giant cell glioblastoma
5722128|NCT00424060|adult gliosarcoma|adult gliosarcoma
5722129|NCT00424047|Multiple Myeloma|multiple myeloma
5722130|NCT00424047|Celgene|celgene
5722131|NCT00424047|Revlimid|revlimid
5722132|NCT00424047|CC-5013|cc-5013
5722133|NCT00424034|safety|safety
5722134|NCT00424034|Pharmacokinetics|pharmacokinetics
5722135|NCT00424034|effect of food on pharmacokinetics|effect of food on pharmacokinetics
5722136|NCT00424008|Glucocorticosteroids|glucocorticosteroids
5722137|NCT00424008|Dry Powder Inhaler|dry powder inhaler
5722138|NCT00424008|Bronchodilator|bronchodilator
5722139|NCT00424008|Metered-Dose Inhaler|metered-dose inhaler
5722140|NCT00423969|Depression|depression
5722141|NCT00423969|Cognitive Impairment|cognitive impairment
5722142|NCT00423956|Teeth root resorption, ultrasound, therapy|teeth root resorption, ultrasound, therapy
5722143|NCT00423943|cognition|cognition
5722144|NCT00423943|memory|memory
5722145|NCT00423930|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5722146|NCT00423930|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5722147|NCT00423930|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5722148|NCT00423930|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5722149|NCT00423930|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5722358|NCT00423605|Muscular Pain|muscular pain
5722150|NCT00423930|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5798823|NCT00110916|OA|oa
5738775|NCT00362193|Chronic disease management|chronic disease management
5738776|NCT00362193|Relapse|relapse
5722151|NCT00423930|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5722152|NCT00423930|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5722153|NCT00423930|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5722154|NCT00423930|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5722155|NCT00423930|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5722156|NCT00423930|tongue cancer|tongue cancer
5722157|NCT00423917|stage IV breast cancer|stage iv breast cancer
5722158|NCT00423917|male breast cancer|male breast cancer
5722159|NCT00423917|recurrent breast cancer|recurrent breast cancer
5722160|NCT00423904|Early intervention|early intervention
5722161|NCT00423904|Brief intervention|brief intervention
5722162|NCT00423904|alcohol|alcohol
5722163|NCT00423904|general hospital|general hospital
5722164|NCT00423865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5722165|NCT00423865|CISPLATIN|cisplatin
5722166|NCT00423865|RAD001 (EVEROLIMUS)|rad001 (everolimus)
5722167|NCT00423865|06-129|06-129
5722168|NCT00423852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5722169|NCT00423852|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5722170|NCT00423852|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5722171|NCT00423852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5722172|NCT00423852|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5722173|NCT00423852|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5723000|NCT00420992|naltrexone|naltrexone
5722174|NCT00423852|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5722175|NCT00423852|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5722176|NCT00423852|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5722177|NCT00423852|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5722178|NCT00423852|stage III extragonadal seminoma|stage iii extragonadal seminoma
5722179|NCT00423852|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5722180|NCT00423852|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5722181|NCT00423852|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5722182|NCT00423852|adult teratoma|adult teratoma
5722183|NCT00423852|testicular immature teratoma|testicular immature teratoma
5722184|NCT00423852|testicular mature teratoma|testicular mature teratoma
5722185|NCT00423839|Mycobacterium tuberculosis|mycobacterium tuberculosis
5722187|NCT00423839|Modified Vaccinia Virus Ankara (MVA).|modified vaccinia virus ankara (mva).
5722188|NCT00423826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5722189|NCT00423826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5686133|NCT00553410|stage IIIA breast cancer|stage iiia breast cancer
5722190|NCT00423826|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5722191|NCT00423826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5722192|NCT00423826|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5722193|NCT00423826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5722194|NCT00423826|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5722195|NCT00423826|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5722196|NCT00423826|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5722197|NCT00423826|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5722198|NCT00423826|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5722199|NCT00423826|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5722200|NCT00423826|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5722201|NCT00423826|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5722202|NCT00423826|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5722203|NCT00423826|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5722204|NCT00423826|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5722205|NCT00423826|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5722206|NCT00423826|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5722207|NCT00423826|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5722208|NCT00423826|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5722209|NCT00423826|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5722210|NCT00423826|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5722211|NCT00423826|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5722212|NCT00423826|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5722213|NCT00423826|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5722214|NCT00423826|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5722215|NCT00423826|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5722216|NCT00423826|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5722217|NCT00423826|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5722218|NCT00423826|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5722219|NCT00423826|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5722220|NCT00423826|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5722221|NCT00423826|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5722222|NCT00423826|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5722223|NCT00423826|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5722224|NCT00423826|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5722225|NCT00423826|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5722226|NCT00423826|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5722227|NCT00423826|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5722228|NCT00423826|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5722230|NCT00423826|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5722231|NCT00423826|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5722232|NCT00423826|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5722233|NCT00423826|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5722234|NCT00423826|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5722235|NCT00423826|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5722236|NCT00423826|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5722237|NCT00423826|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5722238|NCT00423826|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5722239|NCT00423826|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5722240|NCT00423826|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5722241|NCT00423826|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5722242|NCT00423826|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5722243|NCT00423826|stage I multiple myeloma|stage i multiple myeloma
5722244|NCT00423826|stage II multiple myeloma|stage ii multiple myeloma
5722245|NCT00423826|stage III multiple myeloma|stage iii multiple myeloma
5722246|NCT00423826|extramedullary plasmacytoma|extramedullary plasmacytoma
5722247|NCT00423826|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5722248|NCT00423826|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5721346|NCT00426881|Resistance training|resistance training
5722249|NCT00423826|primary systemic amyloidosis|primary systemic amyloidosis
5722250|NCT00423826|refractory multiple myeloma|refractory multiple myeloma
5722251|NCT00423826|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5722252|NCT00423826|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5722253|NCT00423826|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5722254|NCT00423826|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5722255|NCT00423826|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5722256|NCT00423826|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5722257|NCT00423826|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5722258|NCT00423826|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5722259|NCT00423826|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5722260|NCT00423826|Burkitt lymphoma|burkitt lymphoma
5722261|NCT00423826|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5722262|NCT00423826|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5722263|NCT00423826|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5722264|NCT00423826|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5722265|NCT00423826|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5722266|NCT00423826|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5722267|NCT00423826|secondary myelofibrosis|secondary myelofibrosis
5722270|NCT00423813|pain|pain
5722271|NCT00423813|Body pain|body pain
5722272|NCT00423813|tenderness|tenderness
5722273|NCT00423813|stiffness|stiffness
5722274|NCT00423813|muscular pain|muscular pain
5722275|NCT00423813|joint pain|joint pain
5722276|NCT00423787|Allergy|allergy
5722277|NCT00423787|Allergoid|allergoid
5722278|NCT00423787|Specific Immunotherapy|specific immunotherapy
5798824|NCT00110916|anakinra|anakinra
5722279|NCT00423774|Allogeneic Hematopoietic Stem Cell Transplant|allogeneic hematopoietic stem cell transplant
5722280|NCT00423774|Psychological Distress|psychological distress
5722281|NCT00423774|Coping|coping
5722282|NCT00423774|Cognitive Behavior Therapy|cognitive behavior therapy
5722283|NCT00423774|Bone Marrow Transplant|bone marrow transplant
5722284|NCT00423774|Coping Skills|coping skills
5722285|NCT00423761|Pharmacokinetics,|pharmacokinetics,
5722286|NCT00423761|tolerability,|tolerability,
5722287|NCT00423761|healthy,|healthy,
5722288|NCT00423761|subjects|subjects
5722289|NCT00423722|Advanced Cancer|advanced cancer
5722290|NCT00423722|Hospice Care|hospice care
5722291|NCT00423722|Caregiver|caregiver
5722292|NCT00423722|Saline|saline
5722293|NCT00423722|Hydration|hydration
5722294|NCT00423722|Dehydration|dehydration
5722295|NCT00423709|Hodgkin's Disease|hodgkin's disease
5722296|NCT00423709|Allogeneic Blood Stem Cell Transplantation|allogeneic blood stem cell transplantation
5722297|NCT00423709|Bone Marrow Transplantation|bone marrow transplantation
5722298|NCT00423709|Fludarabine|fludarabine
5722299|NCT00423709|Melphalan|melphalan
5722300|NCT00423696|stage IV colon cancer|stage iv colon cancer
5722301|NCT00423696|stage IV rectal cancer|stage iv rectal cancer
5722302|NCT00423696|recurrent colon cancer|recurrent colon cancer
5722303|NCT00423696|recurrent rectal cancer|recurrent rectal cancer
5722304|NCT00423683|Cancer|cancer
5722305|NCT00423683|thromboembolism|thromboembolism
5722306|NCT00423657|Abscess|abscess
5722307|NCT00423657|Antibacterial|antibacterial
5722308|NCT00423657|Antibiotic|antibiotic
5722309|NCT00423657|Antimicrobial|antimicrobial
5722310|NCT00423657|Bacterial infection, skin|bacterial infection, skin
5722311|NCT00423657|Ceftaroline|ceftaroline
5722312|NCT00423657|Ceftaroline acetate|ceftaroline acetate
5722313|NCT00423657|Cellulitis|cellulitis
5722314|NCT00423657|Cephalosporin|cephalosporin
5722315|NCT00423657|Complicated skin and skin structure infection (cSSSI)|complicated skin and skin structure infection (csssi)
5722316|NCT00423657|cSSSI|csssi
5722317|NCT00423657|Intravenous|intravenous
5722318|NCT00423657|Methicillin-resistant Staphylococcus Aureus (MRSA)|methicillin-resistant staphylococcus aureus (mrsa)
5722321|NCT00423657|Skin disease, bacterial|skin disease, bacterial
5722322|NCT00423657|Skin infection|skin infection
5722323|NCT00423657|Staphylococcal skin infection|staphylococcal skin infection
5722324|NCT00423657|Staphylococcus aureus|staphylococcus aureus
5722325|NCT00423657|Streptococcal skin infection|streptococcal skin infection
5722326|NCT00423657|Surgical site infection|surgical site infection
5722328|NCT00423644|Multiple Myeloma|multiple myeloma
5722330|NCT00423644|cancer study|cancer study
5722331|NCT00423644|failed treatment|failed treatment
5722332|NCT00423631|Pain|pain
5722333|NCT00423631|Fibromyalgia|fibromyalgia
5722334|NCT00423631|Internet|internet
5722335|NCT00423618|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5722336|NCT00423618|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5722337|NCT00423618|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5686134|NCT00553397|Living donor lung transplant|living donor lung transplant
5686135|NCT00553397|End stage lung disease|end stage lung disease
5686136|NCT00553384|smell|smell
5686137|NCT00553384|olfaction|olfaction
5686138|NCT00553384|androstadienone|androstadienone
5721460|NCT00426517|BMT|bmt
5722338|NCT00423618|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5722340|NCT00423618|adult angiosarcoma|adult angiosarcoma
5722341|NCT00423618|adult epithelioid sarcoma|adult epithelioid sarcoma
5722342|NCT00423618|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5722343|NCT00423618|adult leiomyosarcoma|adult leiomyosarcoma
5722344|NCT00423618|adult liposarcoma|adult liposarcoma
5722345|NCT00423618|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5722346|NCT00423618|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5722347|NCT00423618|adult malignant mesenchymoma|adult malignant mesenchymoma
5722348|NCT00423618|adult fibrosarcoma|adult fibrosarcoma
5722349|NCT00423618|adult neurofibrosarcoma|adult neurofibrosarcoma
5722350|NCT00423618|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5722351|NCT00423605|FMS|fms
5722359|NCT00423566|Mycobacterium tuberculosis|mycobacterium tuberculosis
5722360|NCT00423566|85A antigen|85a antigen
5722361|NCT00423566|Recombinant Modified Vaccinia virus Ankara|recombinant modified vaccinia virus ankara
5722362|NCT00423566|Phase I study|phase i study
5722363|NCT00423566|Immunogenicity|immunogenicity
5722364|NCT00423553|Nitrite and Cytoprotection|nitrite and cytoprotection
5722365|NCT00423553|Ischemic Preconditioning|ischemic preconditioning
5722366|NCT00423553|Atrial Trabeculae Contractile Function|atrial trabeculae contractile function
5722367|NCT00423553|Ischemia|ischemia
5722368|NCT00423540|magnesium infusion|magnesium infusion
5722369|NCT00423540|magnesium sulfate|magnesium sulfate
5722370|NCT00423540|rest cramps|rest cramps
5722371|NCT00423540|nocturnal leg cramps|nocturnal leg cramps
5722372|NCT00423540|muscle cramps|muscle cramps
5722373|NCT00423540|fractional urinary excretion|fractional urinary excretion
5722374|NCT00423540|urinary excretion|urinary excretion
5722375|NCT00423540|24 hour urine|24 hour urine
5722376|NCT00423540|serum magnesium|serum magnesium
5722377|NCT00423540|magnesium deficiency|magnesium deficiency
5722378|NCT00423540|family practice|family practice
5722379|NCT00423540|general practice|general practice
5722380|NCT00423540|richmond|richmond
5722381|NCT00423540|cramp frequency|cramp frequency
5722382|NCT00423540|magnesium status|magnesium status
5722383|NCT00423540|urinary magnesium|urinary magnesium
5722385|NCT00423540|sf 36|sf 36
5722386|NCT00423527|multiple sclerosis|multiple sclerosis
5722387|NCT00423527|central pain|central pain
5722388|NCT00423527|levetiracetam|levetiracetam
5722389|NCT00423514|graft versus host disease|graft versus host disease
5722390|NCT00423514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5722391|NCT00423514|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5722392|NCT00423514|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5722393|NCT00423514|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5722394|NCT00423514|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5722395|NCT00423514|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5722396|NCT00423514|acute undifferentiated leukemia|acute undifferentiated leukemia
5722397|NCT00423514|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5722398|NCT00423514|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5722399|NCT00423514|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5722400|NCT00423514|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5722401|NCT00423514|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5722402|NCT00423514|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5722403|NCT00423514|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5722404|NCT00423514|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5722405|NCT00423514|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5722406|NCT00423514|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5722407|NCT00423514|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5722408|NCT00423514|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5722409|NCT00423514|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5722410|NCT00423514|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5722411|NCT00423514|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5722412|NCT00423514|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5722413|NCT00423514|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5721547|NCT00426218|SJIA|sjia
5722414|NCT00423514|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5722415|NCT00423475|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5722416|NCT00423475|stage IIB prostate cancer|stage iib prostate cancer
5722417|NCT00423475|stage IIA prostate cancer|stage iia prostate cancer
5722418|NCT00423475|stage III prostate cancer|stage iii prostate cancer
5717427|NCT00440830|nausea|nausea
5722420|NCT00423475|stage IV prostate cancer|stage iv prostate cancer
5722421|NCT00423462|Psychotherapy|psychotherapy
5722422|NCT00423462|Long-term effects|long-term effects
5722423|NCT00423449|Advanced Stage IIIB/IV Non-Small Cell Lung Cancer|advanced stage iiib/iv non-small cell lung cancer
5722424|NCT00423436|Non-Small Cell Lung Cancer|non-small cell lung cancer
5722425|NCT00423436|Small Cell Lung Cancer|small cell lung cancer
5722426|NCT00423436|Voice Response System|voice response system
5722427|NCT00423436|Questionnaire|questionnaire
5722429|NCT00423436|NSCLC|nsclc
5722430|NCT00423410|Cancer|cancer
5722431|NCT00423410|Tumor|tumor
5722432|NCT00423410|Lymphoma|lymphoma
5722433|NCT00423397|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5722434|NCT00423397|recurrent skin cancer|recurrent skin cancer
5722435|NCT00423384|Ibandronate|ibandronate
5722436|NCT00423384|Placebo|placebo
5722437|NCT00423384|Doubleblind|doubleblind
5722438|NCT00423384|Bone|bone
5722439|NCT00423384|loss|loss
5722440|NCT00423384|Kidney|kidney
5722441|NCT00423384|transplant|transplant
5722442|NCT00423371|first Carpometacarpal (CMC) Joint|first carpometacarpal (cmc) joint
5722443|NCT00423358|rheumatoid arthritis|rheumatoid arthritis
5722444|NCT00423358|hypovitaminosis D|hypovitaminosis d
5722445|NCT00423358|bone turnover|bone turnover
5722446|NCT00423358|ergocalciferol|ergocalciferol
5722447|NCT00423332|cancer|cancer
5722448|NCT00423332|tumour|tumour
5722449|NCT00423332|advanced cancer|advanced cancer
5722450|NCT00423332|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5722451|NCT00423332|kidney cancer|kidney cancer
5722452|NCT00423332|RECENTIN|recentin
5722453|NCT00423319|Prevention of deep vein thrombosis and|prevention of deep vein thrombosis and
5722454|NCT00423319|pulmonary embolism after total hip replacement surgery|pulmonary embolism after total hip replacement surgery
5722455|NCT00423293|stage II anal cancer|stage ii anal cancer
5722456|NCT00423293|stage IIIA anal cancer|stage iiia anal cancer
5722457|NCT00423293|stage IIIB anal cancer|stage iiib anal cancer
5722458|NCT00423293|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5722459|NCT00423293|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5722460|NCT00423293|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5722461|NCT00423280|Endothelium|endothelium
5722462|NCT00423280|Nitric Oxide|nitric oxide
5798825|NCT00110916|Amgen|amgen
5722463|NCT00423280|Magnetic Resonance Imaging|magnetic resonance imaging
5722464|NCT00423280|Tetrahydrobiopterin|tetrahydrobiopterin
5722465|NCT00423254|Cancer Vaccine|cancer vaccine
5722466|NCT00423228|Alzheimer's disease|alzheimer's disease
5722467|NCT00423228|cognitive impairment|cognitive impairment
5722468|NCT00423228|cholinesterase inhibitors|cholinesterase inhibitors
5722469|NCT00423228|sustained-release implants|sustained-release implants
5722470|NCT00423228|long acting treatment|long acting treatment
5722472|NCT00423189|Lucentis|lucentis
5722473|NCT00423189|Visudyne|visudyne
5722475|NCT00423189|AMD|amd
5722476|NCT00423189|ARMD|armd
5722477|NCT00423189|Age|age
5722478|NCT00423189|Related|related
5722479|NCT00423189|Macular|macular
5722480|NCT00423189|Degeneration|degeneration
5722481|NCT00423163|Aspergillosis/blood|aspergillosis/blood
5722482|NCT00423163|micafungin|micafungin
5722483|NCT00423163|voriconazole|voriconazole
5722484|NCT00423163|Aspergillus|aspergillus
5722485|NCT00423124|Hematological malignancies|hematological malignancies
5722486|NCT00423124|HSV-TK|hsv-tk
5722487|NCT00423124|Haploidentical HCT|haploidentical hct
5722488|NCT00423124|GvHD|gvhd
5722489|NCT00423124|GvL|gvl
5722490|NCT00423111|Multiple sclerosis|multiple sclerosis
5722491|NCT00423111|Memory|memory
5722492|NCT00423111|Cognitive deficits|cognitive deficits
5722493|NCT00423111|MRI|mri
5722494|NCT00423111|Hippocampus|hippocampus
5722495|NCT00423111|Prefrontal cortex|prefrontal cortex
5722496|NCT00423098|Lupus Nephritis|lupus nephritis
5722497|NCT00423098|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5722498|NCT00423098|EC-MPS|ec-mps
5722499|NCT00423098|Myfortic|myfortic
5722500|NCT00423085|rivastigmine，Alzheimer's Disease, transdermal patch|rivastigmine，alzheimer's disease, transdermal patch
5722501|NCT00423072|cleft palate|cleft palate
5722502|NCT00423072|palatoplasty|palatoplasty
5722503|NCT00423072|otitis|otitis
5722504|NCT00423072|middle ear|middle ear
5722505|NCT00423072|Eustachian tube|eustachian tube
5722506|NCT00423059|intravitreal bevacizumab|intravitreal bevacizumab
5722507|NCT00423059|proliferative diabetic retinopathy|proliferative diabetic retinopathy
5722508|NCT00423059|VEGF|vegf
5722509|NCT00423059|PEDF|pedf
5722510|NCT00423046|Vaccines|vaccines
5722511|NCT00423046|Cervical cancer|cervical cancer
5722512|NCT00423046|Immunogenicity|immunogenicity
5722513|NCT00423046|Humans|humans
5722514|NCT00423046|Safety|safety
5722515|NCT00423046|Viral infections|viral infections
5722516|NCT00423046|Human papillomavirus (HPV)|human papillomavirus (hpv)
5722517|NCT00423046|Comparative study|comparative study
5722518|NCT00423046|Human papillomavirus vaccine|human papillomavirus vaccine
5722519|NCT00423046|Adults|adults
5722520|NCT00423020|Acute myocardial infarction|acute myocardial infarction
5722521|NCT00423020|Restenosis|restenosis
5722522|NCT00423020|erythropoietin|erythropoietin
5722523|NCT00423020|EPOC-AMI|epoc-ami
5722524|NCT00422994|end stage renal impairment|end stage renal impairment
5722525|NCT00422994|tolerability|tolerability
5722526|NCT00422994|ropinirole|ropinirole
5722527|NCT00422994|pharmacokinetics|pharmacokinetics
5722528|NCT00422994|hemodialysis|hemodialysis
5722529|NCT00422981|Dementia|dementia
5722531|NCT00422981|Alzheimers|alzheimers
5722532|NCT00422981|Cognition|cognition
5722533|NCT00422981|Mind|mind
5722534|NCT00422981|Aging|aging
5722535|NCT00422968|Coronary artery disease|coronary artery disease
5722536|NCT00422968|Stent|stent
5722537|NCT00422968|Bypass surgery, coronary artery|bypass surgery, coronary artery
5722538|NCT00422955|fluid retention|fluid retention
5722539|NCT00422955|Autonomic Neuropathy|autonomic neuropathy
5722540|NCT00422929|otitis media|otitis media
5722542|NCT00422929|acute otitis|acute otitis
5722543|NCT00422929|middle ear|middle ear
5722544|NCT00422929|Eustachian tube|eustachian tube
5722545|NCT00422929|recurrent acute otitis media|recurrent acute otitis media
5722546|NCT00422929|chronic otitis media with effusion|chronic otitis media with effusion
5722547|NCT00422929|no significant history of otitis media|no significant history of otitis media
5722548|NCT00422903|neo-adjuvant|neo-adjuvant
5722549|NCT00422903|letrozole|letrozole
5722550|NCT00422903|lapatinib|lapatinib
5722551|NCT00422903|primary breast cancer|primary breast cancer
5722552|NCT00422890|Acute myeloid leukaemia or Myelodysplastic syndrome|acute myeloid leukaemia or myelodysplastic syndrome
5722553|NCT00422877|Liver Cancer|liver cancer
5722554|NCT00422851|otitis|otitis
5722555|NCT00422851|gas diffusion|gas diffusion
5722556|NCT00422851|Eustachian tube|eustachian tube
5722557|NCT00422851|tympanic membrane|tympanic membrane
5722558|NCT00422838|Hepatitis C|hepatitis c
5722559|NCT00422838|Liver|liver
5722560|NCT00422838|immunology|immunology
5722561|NCT00422838|regulation|regulation
5722562|NCT00422838|Genotype 1,2,3|genotype 1,2,3
5722563|NCT00422838|Treatment|treatment
5722564|NCT00422838|Chronic|chronic
5722565|NCT00422838|Pegylated interferon|pegylated interferon
5722566|NCT00422838|Ribavirin|ribavirin
5722567|NCT00422825|Food effect|food effect
5722569|NCT00422825|pharmacokinetic|pharmacokinetic
5722570|NCT00422825|imatinib|imatinib
5722571|NCT00422825|STI571|sti571
5722572|NCT00422825|modified release formulation of STI571|modified release formulation of sti571
5722573|NCT00422825|CML|cml
5722574|NCT00422825|Chronic Myeloid Leukemia|chronic myeloid leukemia
5722575|NCT00422825|Philadelphia Chromosome|philadelphia chromosome
5722576|NCT00422812|Migraine, Staccato Prochlorperazine|migraine, staccato prochlorperazine
5722577|NCT00422812|Migraine headache with or without aura.|migraine headache with or without aura.
5722578|NCT00422799|relapsed Waldenstrom's macroglobulinemia|relapsed waldenstrom's macroglobulinemia
5722579|NCT00422799|refractory Waldenstrom's macroglobulinemia|refractory waldenstrom's macroglobulinemia
5722580|NCT00422799|Velcade|velcade
5722581|NCT00422799|WM|wm
5722582|NCT00422786|Refractory Clear Cell Renal Cell Carcinoma|refractory clear cell renal cell carcinoma
5722583|NCT00422786|Phase II|phase ii
5722584|NCT00422786|Thallion|thallion
5722585|NCT00422786|TLN-232|tln-232
5722586|NCT00422786|CAP-232|cap-232
5722587|NCT00422786|M2PK|m2pk
5722588|NCT00422773|phase I/II|phase i/ii
5722589|NCT00422773|cetuximab|cetuximab
5722590|NCT00422773|oxaliplatin|oxaliplatin
5722591|NCT00422773|irinotecan|irinotecan
5722592|NCT00422773|5-FU|5-fu
5722593|NCT00422773|chemotherapy|chemotherapy
5722594|NCT00422773|dose escalation|dose escalation
5722595|NCT00422773|safety|safety
5722596|NCT00422760|esophageal perforation|esophageal perforation
5722597|NCT00422760|COPD|copd
5722598|NCT00422747|asthma|asthma
5722599|NCT00422747|transient wheezing|transient wheezing
5722600|NCT00422747|early diagnosis|early diagnosis
5722601|NCT00422747|exhaled air|exhaled air
5722602|NCT00422747|nitrogen monoxide|nitrogen monoxide
5722603|NCT00422747|airway resistance|airway resistance
5723001|NCT00420992|Opioid|opioid
5722604|NCT00422721|early severe retinal dystrophy|early severe retinal dystrophy
5722605|NCT00422721|amaurosis of leber|amaurosis of leber
5722606|NCT00422695|HIV|hiv
5722607|NCT00422695|Quantitative Sensory Testing|quantitative sensory testing
5722608|NCT00422695|Neuropathy|neuropathy
5722609|NCT00422695|Treatment Experienced|treatment experienced
5722610|NCT00422695|Treatment Naive|treatment naive
5722611|NCT00422682|Solid tumors|solid tumors
5722612|NCT00422669|Pacemaker|pacemaker
5722613|NCT00422669|Implantable Pulse Generator (IPG)|implantable pulse generator (ipg)
5722614|NCT00422669|AV Conduction Disturbance|av conduction disturbance
5722615|NCT00422669|Select Site Pacing|select site pacing
5722616|NCT00422656|relapsed Waldenstrom's Macroglobulinemia|relapsed waldenstrom's macroglobulinemia
5730568|NCT00392509|PVD|pvd
5722617|NCT00422656|refractory Waldenstrom's Macroglobulinemia|refractory waldenstrom's macroglobulinemia
5722618|NCT00422656|WM|wm
5722619|NCT00422656|perifosine|perifosine
5722620|NCT00422643|OA,HA,Intra-articular|oa,ha,intra-articular
5717662|NCT00439946|PAH|pah
5722621|NCT00422630|Weight loss|weight loss
5722622|NCT00422630|Obesity|obesity
5722623|NCT00422630|Metabolic Syndrome|metabolic syndrome
5722624|NCT00422630|Diet|diet
5722625|NCT00422630|Hypertension|hypertension
5722626|NCT00422630|Diabetes|diabetes
5722627|NCT00422630|Cholesterol|cholesterol
5722628|NCT00422617|psoriasis|psoriasis
5722629|NCT00422617|alefacept|alefacept
5722630|NCT00422604|COPD|copd
5722631|NCT00422604|plethysmography.|plethysmography.
5722632|NCT00422604|muscarinic receptor antagonist|muscarinic receptor antagonist
5722633|NCT00422604|anticholinergic|anticholinergic
5722634|NCT00422591|Cytarabine, Idarubicin|cytarabine, idarubicin
5722635|NCT00422591|Leukemia|leukemia
5722636|NCT00422591|Acute Myeloid Leukemia|acute myeloid leukemia
5722638|NCT00422591|Cytarabine|cytarabine
5722639|NCT00422591|Idarubicin|idarubicin
5722640|NCT00422578|erectile dysfunction|erectile dysfunction
5722641|NCT00422578|tadalafil|tadalafil
5722642|NCT00422565|Coronary Artery Disease|coronary artery disease
5722643|NCT00422565|Stent|stent
5722644|NCT00422565|Myocardial Infarction|myocardial infarction
5723467|NCT00418938|bevacizumab|bevacizumab
5722645|NCT00422552|inspiratory capacity, FEV1, COPD|inspiratory capacity, fev1, copd
5722646|NCT00422539|trichloroacetic acid|trichloroacetic acid
5722647|NCT00422539|varicella scar|varicella scar
5722648|NCT00422526|Preterm delivery, short cervix, progesterone|preterm delivery, short cervix, progesterone
5722649|NCT00422500|Lung Cancer|lung cancer
5722650|NCT00422500|Advanced Lung Cancer|advanced lung cancer
5722651|NCT00422500|Chemotherapy Symptoms|chemotherapy symptoms
5722652|NCT00422500|Disease-Related Symptoms|disease-related symptoms
5722653|NCT00422500|Treatment-Related Symptoms|treatment-related symptoms
5722654|NCT00422500|Symptom Management|symptom management
5722655|NCT00422500|Questionnaire|questionnaire
5722656|NCT00422500|Telephone Interactive System|telephone interactive system
5722657|NCT00422500|IVR Telephone System|ivr telephone system
5722658|NCT00422500|DNA Repair Capacity|dna repair capacity
5722659|NCT00422500|DRC|drc
5722660|NCT00422500|Cognitive Symptoms|cognitive symptoms
5722661|NCT00422487|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5722662|NCT00422474|Ischemic stroke|ischemic stroke
5722663|NCT00422474|Baroreflex sensitivity|baroreflex sensitivity
5722664|NCT00422474|Prognosis|prognosis
5722665|NCT00422474|Cardiovascular autonomic regulation|cardiovascular autonomic regulation
5798826|NCT00110903|Rheumatoid arthritis|rheumatoid arthritis
5722666|NCT00422461|Clinical Trial, Randomized Controlled Trial, Humans, Cyclic Nucleotide Phosphodiesterases Type 5|clinical trial, randomized controlled trial, humans, cyclic nucleotide phosphodiesterases type 5
5722667|NCT00422448|Dermoscopy|dermoscopy
5722668|NCT00422448|Histopathology|histopathology
5722669|NCT00422448|Genetics|genetics
5722670|NCT00422448|Nevi|nevi
5722671|NCT00422448|Nevogenesis|nevogenesis
5722672|NCT00422435|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5722673|NCT00422435|Drug eluting stent (DES)|drug eluting stent (des)
5722674|NCT00422422|Brivaracetam|brivaracetam
5722675|NCT00422422|Epilepsy|epilepsy
5722676|NCT00422422|Child|child
5722677|NCT00422422|Pharmacokinetics|pharmacokinetics
5722678|NCT00422422|Adolescents|adolescents
5722679|NCT00422409|SEMS|sems
5722680|NCT00422396|Hypertrigliceridemia|hypertrigliceridemia
5722681|NCT00422396|Metabolic syndrome|metabolic syndrome
5722682|NCT00422396|Obesity|obesity
5722683|NCT00422396|Fenofibrate|fenofibrate
5722684|NCT00422396|Lipoproteins|lipoproteins
5722685|NCT00422396|Cytokines|cytokines
5722686|NCT00422357|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5722687|NCT00422357|Urtica Dioica (or stinging nettle)|urtica dioica (or stinging nettle)
5722688|NCT00422357|Hypoglycemic agents|hypoglycemic agents
5722689|NCT00422344|RAD001|rad001
5722690|NCT00422344|Sunitinib|sunitinib
5722691|NCT00422344|renal|renal
5722692|NCT00422344|kidney|kidney
5722693|NCT00422331|Bipolar I Disorder|bipolar i disorder
5722694|NCT00422331|Bipolar Disorder|bipolar disorder
5722695|NCT00422331|Lithium|lithium
5722696|NCT00422318|Heart Failure|heart failure
5722697|NCT00422318|Insulin|insulin
5722698|NCT00422318|Metabolism|metabolism
5722699|NCT00422318|Pharmacology|pharmacology
5722700|NCT00422318|Uric Acid|uric acid
5722701|NCT00422305|Infant, Premature|infant, premature
5723002|NCT00420992|morphine|morphine
5722702|NCT00422305|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5722704|NCT00422292|Menactra vaccine|menactra vaccine
5722705|NCT00422292|Meningococcal meningitis|meningococcal meningitis
5722706|NCT00422292|Measles|measles
5722707|NCT00422292|Mumps|mumps
5722708|NCT00422292|Rubella|rubella
5722709|NCT00422292|Varicella vaccines|varicella vaccines
5722710|NCT00422292|Haemophilus influenzae type b|haemophilus influenzae type b
5722711|NCT00422292|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5722712|NCT00422279|Bone Inductive Implant|bone inductive implant
5722713|NCT00422266|Dyslipidemia|dyslipidemia
5722714|NCT00422253|insulin resistance|insulin resistance
5722715|NCT00422253|insulin secretion|insulin secretion
5722716|NCT00422253|advanced glycation end-products|advanced glycation end-products
5722717|NCT00422240|Acne vulgaris|acne vulgaris
5722719|NCT00422240|Benzoyl Peroxide|benzoyl peroxide
5722720|NCT00422214|Bipolar Disorder|bipolar disorder
5722721|NCT00422214|Bipolar Depression,|bipolar depression,
5722722|NCT00422214|Manic Depression|manic depression
5722723|NCT00422214|Seroquel|seroquel
5722724|NCT00422214|Seroquel SR|seroquel sr
5722725|NCT00422214|quetiapine fumarate|quetiapine fumarate
5722726|NCT00422201|Cortisol|cortisol
5722727|NCT00422201|Cushing's Syndrome|cushing's syndrome
5722728|NCT00422201|Ectopic ACTH Secretion|ectopic acth secretion
5722729|NCT00422201|Cushing Syndrome|cushing syndrome
5722730|NCT00422175|Safety, tolerability, pharmacokinetics, pharmacodynamics, oral, BAF312, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, oral, baf312, healthy volunteers
5722731|NCT00422149|Sublingual immunotherapy|sublingual immunotherapy
5722732|NCT00422149|Rhinoconjunctivitis|rhinoconjunctivitis
5722733|NCT00422136|middle ear|middle ear
5722734|NCT00422136|otitis|otitis
5722735|NCT00422136|genetics|genetics
5722736|NCT00422123|Bipolar Disorder|bipolar disorder
5722737|NCT00422123|Bipolar Mania|bipolar mania
5722738|NCT00422123|Manic Depression|manic depression
5722739|NCT00422123|Seroquel|seroquel
5722740|NCT00422123|Seroquel SR|seroquel sr
5723468|NCT00418899|Brain Tumor|brain tumor
5722741|NCT00422123|quetiapine fumarate|quetiapine fumarate
5722742|NCT00422110|Seletracetam|seletracetam
5722743|NCT00422110|Epilepsies|epilepsies
5722744|NCT00422110|Partial|partial
5722745|NCT00422110|Epilepsy|epilepsy
5722746|NCT00422110|Focal|focal
5722747|NCT00422084|Malaria|malaria
5722748|NCT00422084|ACT|act
5722749|NCT00422084|P falciparum|p falciparum
5722750|NCT00422071|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5722751|NCT00422071|Dopamine|dopamine
5722752|NCT00422071|Gambling|gambling
5722753|NCT00422071|Healthy Volunteer|healthy volunteer
5722754|NCT00422071|HV|hv
5722755|NCT00422032|Myelodysplastic Syndrome|myelodysplastic syndrome
5722756|NCT00422032|Leukemia|leukemia
5722757|NCT00422032|Clofarabine|clofarabine
5722758|NCT00422032|MDS|mds
5722759|NCT00422019|Renal Cancer|renal cancer
5722760|NCT00422019|Kidney Cancer|kidney cancer
5722761|NCT00422006|bariatric surgery planned|bariatric surgery planned
5722762|NCT00421993|Acne vulgaris|acne vulgaris
5722763|NCT00421993|Adapalene|adapalene
5739424|NCT00360009|mood|mood
5739425|NCT00360009|motor symptoms|motor symptoms
5739426|NCT00360009|cognition|cognition
5739427|NCT00360009|emotion|emotion
5722766|NCT00421954|psychosis NOS|psychosis nos
5722767|NCT00421954|MDD w/ psychotic features|mdd w/ psychotic features
5722768|NCT00421954|bipolar disorder w. psychotic features|bipolar disorder w. psychotic features
5722769|NCT00421941|enteral feeding|enteral feeding
5722770|NCT00421941|critical care|critical care
5722771|NCT00421941|fish oil|fish oil
5722772|NCT00421941|surgical|surgical
5722773|NCT00421928|Chronic Pain|chronic pain
5722774|NCT00421928|Osteoarthritis, Knee|osteoarthritis, knee
5722775|NCT00421928|tapentadol|tapentadol
5722776|NCT00421928|Pain Assessment|pain assessment
5722777|NCT00421902|Hot flashes, prostate cancer, acupuncture|hot flashes, prostate cancer, acupuncture
5722778|NCT00421889|Ovarian cancer|ovarian cancer
5722779|NCT00421889|Ovarian Neoplasms|ovarian neoplasms
5722780|NCT00421889|Primary peritoneal|primary peritoneal
5722781|NCT00421889|Epithelial ovarian|epithelial ovarian
5722782|NCT00421889|Fallopian tube|fallopian tube
5722783|NCT00421889|Bladder cancer|bladder cancer
5722784|NCT00421889|belinostat|belinostat
5722785|NCT00421889|PXD101|pxd101
5722786|NCT00421889|mixed mullerian cancer of ovarian origin|mixed mullerian cancer of ovarian origin
5722787|NCT00421876|cardiac rehabilitation|cardiac rehabilitation
5722788|NCT00421876|lifestyle management|lifestyle management
5722789|NCT00421876|risk factor management|risk factor management
5722790|NCT00421876|myocardial infarction|myocardial infarction
5722791|NCT00421876|randomized trials|randomized trials
5722792|NCT00421863|hypertension|hypertension
5722793|NCT00421863|systolic blood pressure|systolic blood pressure
5722794|NCT00421837|influenza, flu, genotypic analysis, sub-study|influenza, flu, genotypic analysis, sub-study
5722795|NCT00421811|cancer|cancer
5722796|NCT00421811|tumors|tumors
5722797|NCT00421811|melanoma|melanoma
5722798|NCT00421811|anticarcinogenic agents|anticarcinogenic agents
5722799|NCT00421811|antineoplastic agents|antineoplastic agents
5722800|NCT00421811|cadherins|cadherins
5722801|NCT00421811|solid tumors|solid tumors
5722802|NCT00421798|tuberculosis, paucibacillary, mycobacteria, Mexico, Colombia|tuberculosis, paucibacillary, mycobacteria, mexico, colombia
5722803|NCT00421785|N-acetylcysteine|n-acetylcysteine
5722804|NCT00421785|Peritoneal Dialysis|peritoneal dialysis
5722806|NCT00421772|cerebral ventriculomegaly|cerebral ventriculomegaly
5722807|NCT00421772|prenatal diagnostic|prenatal diagnostic
5722808|NCT00421772|neuropsychological outcome|neuropsychological outcome
5722809|NCT00421759|Sensory loss|sensory loss
5722810|NCT00421759|psychomotor function|psychomotor function
5686139|NCT00553384|women|women
5686140|NCT00553384|pheromones|pheromones
5686141|NCT00553384|Healthy Volunteers|healthy volunteers
5686142|NCT00553384|Physiological Effects of Androstadienone Exposure|physiological effects of androstadienone exposure
5686143|NCT00553371|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5722811|NCT00421759|balance|balance
5722812|NCT00421759|gait|gait
5722813|NCT00421733|Type 2 Diabetic Nephropathy|type 2 diabetic nephropathy
5722814|NCT00421720|remifentanil|remifentanil
5722816|NCT00421720|propofol|propofol
5722817|NCT00421720|analgesia|analgesia
5722818|NCT00421720|sedation|sedation
5722819|NCT00421720|mechanically ventilated|mechanically ventilated
5722820|NCT00421720|intensive care|intensive care
5722821|NCT00421720|pharmacoeconomic|pharmacoeconomic
5722822|NCT00421720|weaning|weaning
5722823|NCT00421720|delirium|delirium
5722824|NCT00421720|randomized|randomized
5722825|NCT00421720|Germany|germany
5722826|NCT00421707|Irritable Bowel Syndrome safety|irritable bowel syndrome safety
5722827|NCT00421681|Aging|aging
5722828|NCT00421681|exercise|exercise
5722829|NCT00421681|health behavior|health behavior
5722831|NCT00421668|Tanzania|tanzania
5722832|NCT00421668|Micronutrients|micronutrients
5722833|NCT00421668|Infants/children|infants/children
5722834|NCT00421668|Infectious Disease|infectious disease
5722835|NCT00421668|Growth faltering|growth faltering
5722836|NCT00421629|health insurance|health insurance
5722837|NCT00421629|hospitalization insurance|hospitalization insurance
5722838|NCT00421629|community based health insurance|community based health insurance
5722839|NCT00421629|health care access|health care access
5722840|NCT00421629|developing countries|developing countries
5722933|NCT00421239|arterial hypertension|arterial hypertension
5722841|NCT00421629|randomized controlled trials|randomized controlled trials
5722842|NCT00421616|Calorimetry|calorimetry
5722843|NCT00421616|Overweight|overweight
5722844|NCT00421616|Weight loss|weight loss
5722845|NCT00421616|Appetite|appetite
5722846|NCT00421603|Cocaine|cocaine
5722847|NCT00421603|Adderall|adderall
5722848|NCT00421603|Topiramate|topiramate
5722849|NCT00421603|ADHD|adhd
5722971|NCT00421070|Stress|stress
5722972|NCT00421070|Psychiatric inpatient|psychiatric inpatient
5798827|NCT00110903|RA|ra
5798828|NCT00110903|etanercept|etanercept
5798829|NCT00110903|Immunex|immunex
5722850|NCT00421590|Randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, SMC021|randomized, partially blind, placebo controlled, crossover, drug interaction with concomitant antacid, pharmacokinetics, pharmacodynamics, smc021
5722851|NCT00421577|Caries Diagnosis|caries diagnosis
5722852|NCT00421577|Replica technique|replica technique
5722853|NCT00421564|Menopausal|menopausal
5722854|NCT00421564|Traditional Chinese Medicine|traditional chinese medicine
5722855|NCT00421551|HIV Infections|hiv infections
5722856|NCT00421551|darunavir|darunavir
5722857|NCT00421551|Ritonavir|ritonavir
5722858|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors
5722859|NCT00421551|treatment experienced|treatment experienced
5722860|NCT00421538|Deep vein Thrombosis|deep vein thrombosis
5722861|NCT00421538|Calf vein thrombosis|calf vein thrombosis
5722862|NCT00421538|Low-molecular weight heparin|low-molecular weight heparin
5722863|NCT00421538|Placebo|placebo
5722864|NCT00421538|Elastic contention|elastic contention
5722865|NCT00421538|Compression Ultrasonography|compression ultrasonography
5722866|NCT00421525|multiple myeloma|multiple myeloma
5722867|NCT00421525|Myeloma, Plasma-Cell|myeloma, plasma-cell
5722868|NCT00421525|PLASMACYTOMA|plasmacytoma
5722869|NCT00421512|Renal cell carcinoma|renal cell carcinoma
5722870|NCT00421512|Metastatic|metastatic
5722871|NCT00421512|Kidney Cancer|kidney cancer
5722872|NCT00421512|Bevacizumab|bevacizumab
5722873|NCT00421512|Sunitinib|sunitinib
5722874|NCT00421486|Oral human papillomavirus infection|oral human papillomavirus infection
5722875|NCT00421486|HIV-infection|hiv-infection
5722876|NCT00421486|High-risk HPV viral load|high-risk hpv viral load
5722877|NCT00421486|Oral human papillomavirus infection in HIV-positive men|oral human papillomavirus infection in hiv-positive men
5722878|NCT00421486|Treatment Experienced|treatment experienced
5722879|NCT00421486|Treatment Naive|treatment naive
5722880|NCT00421473|HIV|hiv
5722881|NCT00421473|Malaria prophylaxis|malaria prophylaxis
5722882|NCT00421473|Treatment Experienced|treatment experienced
5722883|NCT00421460|Nebido in hypogonadism with erectile dysfunction|nebido in hypogonadism with erectile dysfunction
5722884|NCT00421447|Breast Cancer|breast cancer
5722885|NCT00421447|pQCT|pqct
5722886|NCT00421447|Anastrozole|anastrozole
5722887|NCT00421447|bone geometry|bone geometry
5722888|NCT00421434|Hepatitis C|hepatitis c
5722889|NCT00421421|Acute Urinary Retention|acute urinary retention
5722890|NCT00421421|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5748331|NCT00326209|UC|uc
5722891|NCT00421421|Trial Without Catheter|trial without catheter
5722892|NCT00421408|Dietary protein|dietary protein
5722893|NCT00421408|Calcium|calcium
5722894|NCT00421408|Parathyroid hormone|parathyroid hormone
5722895|NCT00421408|Bone markers|bone markers
5722896|NCT00421408|Bone mineral density|bone mineral density
5722897|NCT00421408|IGF-1|igf-1
5722898|NCT00421408|Urine Calcium|urine calcium
5722899|NCT00421395|NHL|nhl
5722900|NCT00421395|B-cell NHL|b-cell nhl
5722901|NCT00421395|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5722902|NCT00421369|Major depressive disorder|major depressive disorder
5722903|NCT00421369|Antidepressants|antidepressants
5722904|NCT00421369|Triiodothyronine (T3)|triiodothyronine (t3)
5722905|NCT00421369|Thyroid Function|thyroid function
5722907|NCT00421369|Thyroid pathway genes|thyroid pathway genes
5722908|NCT00421356|amputation, transfemoral, lower extremity, prosthetic knee|amputation, transfemoral, lower extremity, prosthetic knee
5722909|NCT00421343|disease/disorder proneness/risk|disease/disorder proneness/risk
5722910|NCT00421343|osteoporotic fractures|osteoporotic fractures
5722911|NCT00421343|accidental falls|accidental falls
5722912|NCT00421343|aging|aging
5722913|NCT00421330|Abdominal aortic aneurysm|abdominal aortic aneurysm
5722914|NCT00421330|AAA|aaa
5722915|NCT00421330|randomised controlled trial|randomised controlled trial
5722916|NCT00421330|Endovascular repair|endovascular repair
5722917|NCT00421330|conventional open repair|conventional open repair
5722918|NCT00421317|Ocular, Metastatic melanoma|ocular, metastatic melanoma
5722919|NCT00421265|prostate cancer|prostate cancer
5722920|NCT00421265|active surveillance|active surveillance
5722921|NCT00421265|indolent features|indolent features
5722922|NCT00421252|clopidogrel|clopidogrel
5722923|NCT00421252|hemorrhagic complication|hemorrhagic complication
5722924|NCT00421252|vascular complication|vascular complication
5722925|NCT00421252|antiplatelet agent|antiplatelet agent
5722926|NCT00421252|stenting|stenting
5722927|NCT00421252|percutaneous coronary intervention|percutaneous coronary intervention
5722928|NCT00421252|risk|risk
5722929|NCT00421252|ischemia|ischemia
5722930|NCT00421252|troponin|troponin
5722931|NCT00421252|sheath size|sheath size
5722932|NCT00421239|hypertensive urgency|hypertensive urgency
5723464|NCT00418938|mCRC|mcrc
5722934|NCT00421226|Safety, tolerability, pharmacokinetics, pharmacodynamics, ACZ885, Japanese,|safety, tolerability, pharmacokinetics, pharmacodynamics, acz885, japanese,
5722935|NCT00421213|APL|apl
5722936|NCT00421213|Lymphoma|lymphoma
5722937|NCT00421213|T-cell Lymphoma|t-cell lymphoma
5722938|NCT00421213|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5722939|NCT00421200|Hip arthroplasty|hip arthroplasty
5722940|NCT00421200|Anesthesia, spinal|anesthesia, spinal
5722941|NCT00421200|Hypotension|hypotension
5739626|NCT00359294|Zalypsis|zalypsis
5739628|NCT00359294|PM00104|pm00104
5739629|NCT00359281|healthy volunteers|healthy volunteers
5739634|NCT00359255|Exercise|exercise
5722942|NCT00421200|Ischemia|ischemia
5722943|NCT00421200|Blood substitutes|blood substitutes
5722944|NCT00421200|Plasma expanders|plasma expanders
5722945|NCT00421187|Antibiotic resistant neutropenic fever|antibiotic resistant neutropenic fever
5722946|NCT00421187|ARNF|arnf
5722947|NCT00421187|Ambisome|ambisome
5722948|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b
5722949|NCT00421174|Etanercept|etanercept
5722950|NCT00421174|IPS|ips
5722951|NCT00421161|olive oil|olive oil
5722952|NCT00421161|stasis dermatitis|stasis dermatitis
5722953|NCT00421161|Patients with stasis dermatitis for at least six months.|patients with stasis dermatitis for at least six months.
5722954|NCT00421122|Chinese patients|chinese patients
5722955|NCT00421122|COPD|copd
5722956|NCT00421109|Urticaria|urticaria
5722957|NCT00421109|Hives|hives
5722958|NCT00421109|Wheals|wheals
5722959|NCT00421109|Flare|flare
5722960|NCT00421109|Chronic|chronic
5722961|NCT00421109|Idiopathic|idiopathic
5722962|NCT00421109|Erythema|erythema
5722963|NCT00421109|Skin diseases, vascular|skin diseases, vascular
5722964|NCT00421109|Hypersensitivity, Immediate|hypersensitivity, immediate
5722965|NCT00421109|Allergic|allergic
5722966|NCT00421109|Cutaneous|cutaneous
5722967|NCT00421096|uterine cervical cancer|uterine cervical cancer
5722968|NCT00421083|Erectile dysfunction as a result of traumatic spinal cord injury|erectile dysfunction as a result of traumatic spinal cord injury
5722969|NCT00421070|Aggression|aggression
5722970|NCT00421070|Massage|massage
5722973|NCT00421057|Breast Cancer|breast cancer
5722974|NCT00421057|Cancer-Related Fatigue|cancer-related fatigue
5722975|NCT00421057|Fatigue|fatigue
5722976|NCT00421057|Exercise|exercise
5722977|NCT00421057|Strength Training|strength training
5722978|NCT00421057|Endurance Exercise|endurance exercise
5722979|NCT00421057|Questionnaire|questionnaire
5722980|NCT00421057|Survey|survey
5722981|NCT00421044|EPO|epo
5722982|NCT00421044|Patupilone|patupilone
5722983|NCT00421044|Solid Tumors|solid tumors
5722984|NCT00421018|Asthma|asthma
5722985|NCT00421018|Allergy|allergy
5722986|NCT00421018|Cytokines|cytokines
5722987|NCT00421018|Glucocorticoids|glucocorticoids
5722988|NCT00421018|Inflammation|inflammation
5722989|NCT00421018|Nitric Oxide (NO)|nitric oxide (no)
5722990|NCT00421018|Quality of Life|quality of life
5680895|NCT00575796|Vinblastine|vinblastine
5680896|NCT00575783|type 1 diabetes|type 1 diabetes
5680897|NCT00575783|hypoglycemia|hypoglycemia
5680898|NCT00575783|magnetic resonance imaging|magnetic resonance imaging
5680899|NCT00575757|Steatosis|steatosis
5680900|NCT00575757|NASH|nash
5749406|NCT00322166|vitamin D|vitamin d
5722991|NCT00421018|Self-Rated Health|self-rated health
5722992|NCT00421018|Stress|stress
5722993|NCT00420992|hip|hip
5722994|NCT00420992|knee|knee
5722995|NCT00420992|pain|pain
5722996|NCT00420992|osteoarthritis|osteoarthritis
5722997|NCT00420992|OA|oa
5722998|NCT00420992|Kadian|kadian
5723004|NCT00420992|ALO-01|alo-01
5723005|NCT00420966|lower respiratory tract infection|lower respiratory tract infection
5723006|NCT00420966|respiratory syncytial virus infections|respiratory syncytial virus infections
5723007|NCT00420966|palivizumab|palivizumab
5723008|NCT00420966|outcomes|outcomes
5723009|NCT00420966|utilization|utilization
5723010|NCT00420966|compliance|compliance
5723011|NCT00420940|vibration|vibration
5723012|NCT00420940|mechanical loading|mechanical loading
5723013|NCT00420940|bone mineral density|bone mineral density
5723014|NCT00420940|women's health|women's health
5723015|NCT00420940|osteoporosis|osteoporosis
5723016|NCT00420927|Early Rheumatoid Arthritis|early rheumatoid arthritis
5723017|NCT00420927|Tumor Necrosis Factor Optimization|tumor necrosis factor optimization
5723018|NCT00420914|Thrombocytopenia|thrombocytopenia
5723019|NCT00420914|Platelets|platelets
5723020|NCT00420914|Dose|dose
5723021|NCT00420914|Bleeding|bleeding
5723022|NCT00420901|function|function
5723023|NCT00420901|inhibition|inhibition
5723024|NCT00420875|plantar fasciitis|plantar fasciitis
5723025|NCT00420875|plantar fasciosis|plantar fasciosis
5723026|NCT00420875|Achilles tendinosis|achilles tendinosis
5723027|NCT00420875|Achilles tendinitis|achilles tendinitis
5723028|NCT00420875|heel pain|heel pain
5723029|NCT00420875|fasciosis|fasciosis
5723030|NCT00420875|fasciitis|fasciitis
5723031|NCT00420875|tendinosis|tendinosis
5723032|NCT00420875|tendinitis|tendinitis
5723033|NCT00420875|conservative treatment|conservative treatment
5723034|NCT00420862|Lung neoplasms|lung neoplasms
5723035|NCT00420862|Early diagnosis|early diagnosis
5723036|NCT00420862|Screening|screening
5723037|NCT00420862|Spiral Computed Tomography|spiral computed tomography
5723038|NCT00420862|Randomized Controlled Trial|randomized controlled trial
5723039|NCT00420836|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacokinetic|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacokinetic
5723040|NCT00420823|First Episode Psychosis|first episode psychosis
5723041|NCT00420797|Faecal seepage|faecal seepage
5723042|NCT00420797|ileal pouch anal anastomosis (IPAA)|ileal pouch anal anastomosis (ipaa)
5723043|NCT00420797|quality of life|quality of life
5723044|NCT00420797|faecal incontinence|faecal incontinence
5723045|NCT00420797|ileo-anal pouch construction|ileo-anal pouch construction
5723046|NCT00420797|phenylephrine hydrochloride gel|phenylephrine hydrochloride gel
5723047|NCT00420797|IPAA-related faecal incontinence|ipaa-related faecal incontinence
5723048|NCT00420797|placebo|placebo
5723049|NCT00420784|Genotype 1|genotype 1
5723050|NCT00420771|Benzodiazepine|benzodiazepine
5723051|NCT00420771|Gabapentin|gabapentin
5723052|NCT00420771|Methadone|methadone
5723053|NCT00420758|Infant|infant
5723054|NCT00420758|Malnutrition|malnutrition
5723055|NCT00420758|Sub-Saharan Africa|sub-saharan africa
5723056|NCT00420758|Treatment|treatment
5723057|NCT00420758|Growth|growth
5723058|NCT00420758|Haemoglobin|haemoglobin
5723059|NCT00420758|Fortified spread|fortified spread
5723060|NCT00420758|Food supplement|food supplement
5723062|NCT00420719|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5723063|NCT00420719|Lou Gehrig's disease|lou gehrig's disease
5723064|NCT00420719|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
5723065|NCT00420719|Diaphragm Pacing|diaphragm pacing
5723066|NCT00420667|unfractionated heparin|unfractionated heparin
5723067|NCT00420667|enoxaparin|enoxaparin
5723068|NCT00420667|low molecular weight heparin|low molecular weight heparin
5723069|NCT00420667|bypass surgery|bypass surgery
5723070|NCT00420667|bleeding|bleeding
5723071|NCT00420654|Turner syndrome|turner syndrome
5723072|NCT00420654|growth hormone treatment|growth hormone treatment
5723073|NCT00420654|positron emission tomography|positron emission tomography
5723074|NCT00420654|heart|heart
5723075|NCT00420641|MDD|mdd
5723076|NCT00420641|flexible-dose|flexible-dose
5723077|NCT00420641|Major Depressive Disorder|major depressive disorder
5723078|NCT00420641|paroxetine|paroxetine
5723079|NCT00420641|GSK372475|gsk372475
5723080|NCT00420615|Cancer|cancer
5723081|NCT00420615|EPO906|epo906
5723082|NCT00420615|Patupilone|patupilone
5723083|NCT00420589|Weight loss|weight loss
5723084|NCT00420589|Weight regain|weight regain
5723086|NCT00420576|Post-menopausal|post-menopausal
5723087|NCT00420576|Traditional Chinese Medicine|traditional chinese medicine
5723088|NCT00420576|Randomized|randomized
5723089|NCT00420563|Cancer, palliative treatment|cancer, palliative treatment
5723090|NCT00420550|Interstitial Cystitis|interstitial cystitis
5723091|NCT00420550|Pelvic pain|pelvic pain
5723092|NCT00420550|Guided Imagery|guided imagery
5723093|NCT00420537|Kidney|kidney
5723094|NCT00420537|Heart Transplantation|heart transplantation
5723095|NCT00420537|Creatinine|creatinine
5723096|NCT00420537|Glomerular Filtration Rate|glomerular filtration rate
5723097|NCT00420524|EPO|epo
5723098|NCT00420524|Patupilone|patupilone
5723099|NCT00420524|Solid Tumors|solid tumors
5723100|NCT00420511|Type 2 diabetes|type 2 diabetes
5723101|NCT00420511|beta-cell function|beta-cell function
5723102|NCT00420511|sitagliptin|sitagliptin
5723103|NCT00420511|intensive insulin therapy|intensive insulin therapy
5723104|NCT00420498|Schizophrenia|schizophrenia
5723105|NCT00420498|Prefrontal Cortical Function|prefrontal cortical function
5723106|NCT00420498|Smoking|smoking
5723107|NCT00420498|Cognition|cognition
5723108|NCT00420498|Positive and Negative Symptoms|positive and negative symptoms
5723109|NCT00420498|Tobacco|tobacco
5723110|NCT00420498|Cigarette Smoking|cigarette smoking
5723111|NCT00420498|Dopamine|dopamine
5723112|NCT00420485|Maximum Tolerated Dose|maximum tolerated dose
5723113|NCT00420485|Solid Tumors|solid tumors
5723114|NCT00420485|Dose Limiting Toxicity|dose limiting toxicity
5723115|NCT00420485|Topoisomerase-1 Inhibitor|topoisomerase-1 inhibitor
5723116|NCT00420433|Breast Cancer|breast cancer
5723117|NCT00420433|Bone Metastases|bone metastases
5723118|NCT00420433|Radiography|radiography
5723119|NCT00420433|X-Ray|x-ray
5723120|NCT00420433|Computed Tomography|computed tomography
5723121|NCT00420433|CT Scan|ct scan
5723122|NCT00420433|Skeletal Scintigraphy|skeletal scintigraphy
5723123|NCT00420394|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5723124|NCT00420394|Adjuvant chemoradiotherapy|adjuvant chemoradiotherapy
5723125|NCT00420394|Adenocarcinoma of stomach and gastroesophageal junction|adenocarcinoma of stomach and gastroesophageal junction
5723126|NCT00420381|Recurrent Cancer|recurrent cancer
5723127|NCT00420368|Infant|infant
5723128|NCT00420368|Malnutrition|malnutrition
5723129|NCT00420368|Sub-Saharan Africa|sub-saharan africa
5723130|NCT00420368|Treatment|treatment
5723131|NCT00420368|Growth|growth
5723132|NCT00420368|Haemoglobin|haemoglobin
5723133|NCT00420368|Fortified spread|fortified spread
5723134|NCT00420368|Food supplement|food supplement
5723135|NCT00420355|antiretroviral therapy|antiretroviral therapy
5723136|NCT00420355|protease inhibitors|protease inhibitors
5723137|NCT00420355|drug interactions|drug interactions
5723138|NCT00420355|HIV infection|hiv infection
5723139|NCT00420355|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5723140|NCT00420355|Treatment Experienced|treatment experienced
5723141|NCT00420342|Pre-Hypertension in Postmenopausal Women|pre-hypertension in postmenopausal women
5723142|NCT00420316|Intussusception|intussusception
5723143|NCT00420316|Gastroenteritis|gastroenteritis
5723145|NCT00420303|Refractory Heel Enthesitis in Spondylarthropathy|refractory heel enthesitis in spondylarthropathy
5723146|NCT00420303|Spondylarthropathy|spondylarthropathy
5723147|NCT00420303|Refractory Heel Enthesitis|refractory heel enthesitis
5723148|NCT00420290|inflammation|inflammation
5723149|NCT00420290|end stage renal disease|end stage renal disease
5723150|NCT00420277|Hip arthroplasty|hip arthroplasty
5723151|NCT00420277|Anesthesia, spinal|anesthesia, spinal
5723152|NCT00420277|Hypotension|hypotension
5723153|NCT00420277|Ischemia|ischemia
5723154|NCT00420277|Blood substitutes|blood substitutes
5723155|NCT00420277|Plasma expanders|plasma expanders
5723156|NCT00420238|Axial Ankylosing Spondylitis|axial ankylosing spondylitis
5723157|NCT00420238|Adult|adult
5723158|NCT00420225|Cystocele|cystocele
5723159|NCT00420225|surgery|surgery
5723160|NCT00420225|mesh|mesh
5723161|NCT00420225|genital prolapse|genital prolapse
5723162|NCT00420212|relapsing|relapsing
5723163|NCT00420212|oral|oral
5723164|NCT00420212|remitting|remitting
5723165|NCT00420212|multiple sclerosis|multiple sclerosis
5723166|NCT00420173|cutaneous lupus erythematosus|cutaneous lupus erythematosus
5723167|NCT00420173|standardized evaluation|standardized evaluation
5723168|NCT00420173|core set questionnaire|core set questionnaire
5723169|NCT00420173|epidemiological data|epidemiological data
5723170|NCT00420173|laboratory features|laboratory features
5723171|NCT00420160|Smoking cessation|smoking cessation
5723172|NCT00420160|Exercise|exercise
5723173|NCT00420160|Nicotine Patch|nicotine patch
5723174|NCT00420160|Disease Prevention|disease prevention
5723175|NCT00420147|knee osteoarthritis|knee osteoarthritis
5723176|NCT00420147|orthosis|orthosis
5723177|NCT00420147|wedge|wedge
5723178|NCT00420147|gait|gait
5723179|NCT00420134|mesenchymal stem cell|mesenchymal stem cell
5723180|NCT00420134|end stage liver disease|end stage liver disease
5723181|NCT00420134|Cirrhosis|cirrhosis
5723182|NCT00420134|stem cell therapy|stem cell therapy
5723183|NCT00420121|standardized evaluation|standardized evaluation
5723184|NCT00420121|core set questionnaire|core set questionnaire
5723185|NCT00420121|epidemiological data|epidemiological data
5723186|NCT00420121|laboratory analysis|laboratory analysis
5723187|NCT00420108|Heart Failure, Congestive|heart failure, congestive
5723188|NCT00420108|Cardiac Pacemaker, Artificial|cardiac pacemaker, artificial
5731155|NCT00390091|Lupus|lupus
5723189|NCT00420108|Ventricular Pressure|ventricular pressure
5723190|NCT00420095|diabetes|diabetes
5723191|NCT00420095|type 1|type 1
5723192|NCT00420095|type 2|type 2
5723193|NCT00420082|Rhinitis|rhinitis
5723194|NCT00420082|Seasonal|seasonal
5723195|NCT00420082|Allergic|allergic
5723196|NCT00420082|Pollen allergy|pollen allergy
5723197|NCT00420082|Environmental Exposure Chamber|environmental exposure chamber
5723198|NCT00420082|Challenge Chamber|challenge chamber
5723199|NCT00420043|Food effect|food effect
5723200|NCT00420043|bioavailability|bioavailability
5723201|NCT00420043|pharmacokinetic|pharmacokinetic
5723202|NCT00420043|STI571|sti571
5723500|NCT00418769|tablet|tablet
5723203|NCT00420043|modified release formulation of STI571|modified release formulation of sti571
5723205|NCT00420043|Chronic Myeloid Leukemia|chronic myeloid leukemia
5723206|NCT00420043|Philadelphia Chromosome|philadelphia chromosome
5723207|NCT00420043|imatinib|imatinib
5723208|NCT00420030|upfront abciximab|upfront abciximab
5723210|NCT00420030|cardiogenic shock|cardiogenic shock
5723211|NCT00420017|Amiodarone|amiodarone
5723212|NCT00420017|Atrial fibrillation|atrial fibrillation
5723213|NCT00420017|Surgical procedures, thoracic|surgical procedures, thoracic
5723214|NCT00419991|Tigecycline|tigecycline
5723215|NCT00419991|Staphylococcal Infections|staphylococcal infections
5723216|NCT00419991|Catheter|catheter
5723217|NCT00419952|Moderate Asthma|moderate asthma
5723218|NCT00419952|Severe Asthma|severe asthma
5723219|NCT00419939|Severe traumatic brain injury|severe traumatic brain injury
5723220|NCT00419939|Intensive neurorehabilitation|intensive neurorehabilitation
5723221|NCT00419939|"Patient Participation[Professional-Patient Relations"|"patient participation[professional-patient relations"
5723222|NCT00419939|Re-learning|re-learning
5723223|NCT00419939|Daily life activities|daily life activities
5723224|NCT00419939|Rehabilitation|rehabilitation
5723225|NCT00419926|Renal, Kidney, Intensified, Enteric-coated mycophenolate sodium, Transplant|renal, kidney, intensified, enteric-coated mycophenolate sodium, transplant
5723226|NCT00419913|Ovulation Induction|ovulation induction
5723227|NCT00419913|In vitro Fertilization|in vitro fertilization
5723228|NCT00419913|Pregnancy|pregnancy
5723229|NCT00419900|breast cancer|breast cancer
5723230|NCT00419900|diagnosis|diagnosis
5723231|NCT00419900|x-ray diffraction|x-ray diffraction
5723232|NCT00419900|synchrotron|synchrotron
5723233|NCT00419900|hair|hair
5723234|NCT00419887|Safety, tolerability, pharmacokinetics, pharmacodynamics, LAF237, vildagliptin, Chinese, healthy volunteers|safety, tolerability, pharmacokinetics, pharmacodynamics, laf237, vildagliptin, chinese, healthy volunteers
5723235|NCT00419874|Blood-brain barrier|blood-brain barrier
5723236|NCT00419874|Post traumatic epilepsy|post traumatic epilepsy
5723237|NCT00419874|Seizures|seizures
5723465|NCT00418938|Irinotecan|irinotecan
5723238|NCT00419861|Influenza, surveillance, flu, parent protocol|influenza, surveillance, flu, parent protocol
5739932|NCT00358189|gait|gait
5723239|NCT00419848|Acne|acne
5723240|NCT00419848|Azithromycin|azithromycin
5723241|NCT00419848|Doxycycline|doxycycline
5723242|NCT00419835|diabetic nephropathy|diabetic nephropathy
5723243|NCT00419835|proteinuria|proteinuria
5723244|NCT00419835|CKD progression|ckd progression
5723245|NCT00419835|dialysis|dialysis
5723246|NCT00419822|Acupuncture|acupuncture
5723247|NCT00419822|Range of Motion|range of motion
5723248|NCT00419822|Quality of Life|quality of life
5723249|NCT00419809|methotrexate,|methotrexate,
5723250|NCT00419809|SB-681323,|sb-681323,
5723251|NCT00419809|p38 MAP Kinase Inhibitor,|p38 map kinase inhibitor,
5723252|NCT00419809|liver function|liver function
5723253|NCT00419809|Rheumatoid Arthritis,|rheumatoid arthritis,
5723254|NCT00419796|Osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure|osteoarthritis, controlled hypertension, lumiracoxib, ibuprofen, high blood pressure
5723255|NCT00419783|Allergic rhinitis|allergic rhinitis
5723256|NCT00419783|Urticaria|urticaria
5723257|NCT00419770|zygomycosis|zygomycosis
5723258|NCT00419770|Rhizopus|rhizopus
5723259|NCT00419770|iron|iron
5723260|NCT00419770|iron-chelation|iron-chelation
5723261|NCT00419770|adjunctive therapy|adjunctive therapy
5723262|NCT00419757|Moderate asthma|moderate asthma
5723263|NCT00419757|Severe asthma|severe asthma
5723264|NCT00419744|COPD|copd
5723265|NCT00419731|nicotine|nicotine
5723266|NCT00419731|smoking|smoking
5723267|NCT00419731|addiction|addiction
5723268|NCT00419705|acute stroke|acute stroke
5723269|NCT00419705|infrared laser therapy|infrared laser therapy
5723270|NCT00419705|clinical trial|clinical trial
5723271|NCT00419705|safety|safety
5723272|NCT00419705|effectiveness|effectiveness
5723273|NCT00419692|pharmacokinetic,|pharmacokinetic,
5723275|NCT00419692|formulation,|formulation,
5723276|NCT00419692|food effect,|food effect,
5723277|NCT00419692|controlled release for RLS,|controlled release for rls,
5723278|NCT00419692|SK&F101468,|sk&f101468,
5723279|NCT00419679|breast cancer|breast cancer
5723280|NCT00419679|hair|hair
5723281|NCT00419679|fibre|fibre
5723282|NCT00419679|synchrotron|synchrotron
5723283|NCT00419679|x-ray diffraction|x-ray diffraction
5723284|NCT00419666|Calcitriol|calcitriol
5723285|NCT00419666|Psoriasis|psoriasis
5723287|NCT00419666|Adolescents|adolescents
5723288|NCT00419653|schizophrenia fMRI drug therapy amisulpride|schizophrenia fmri drug therapy amisulpride
5723289|NCT00419640|Sinus node disease|sinus node disease
5723290|NCT00419640|AV node disease|av node disease
5723291|NCT00419627|proteomics of solid tumors|proteomics of solid tumors
5723292|NCT00419601|ventilated newborns (≥ 36 SSW)and infants (≤60 days)|ventilated newborns (≥ 36 ssw)and infants (≤60 days)
5723293|NCT00419601|of any medical condition|of any medical condition
5723294|NCT00419588|infant, premature|infant, premature
5723295|NCT00419588|Bronchopulmonary dysplasia|bronchopulmonary dysplasia
5723296|NCT00419588|asthma|asthma
5723297|NCT00419575|renal|renal
5723298|NCT00419575|transplantation|transplantation
5723325|NCT00419497|Mediterranean-style diet|mediterranean-style diet
5723326|NCT00419497|Glucose tolerance|glucose tolerance
5723327|NCT00419497|Diabetes type 2|diabetes type 2
5723328|NCT00419497|Weight loss|weight loss
5723330|NCT00419471|Depression|depression
5723331|NCT00419471|Myocardial infarction|myocardial infarction
5723332|NCT00419471|Angina, unstable|angina, unstable
5723333|NCT00419458|ventilator weaning|ventilator weaning
5723334|NCT00419458|weaning|weaning
5723335|NCT00419458|respiratory failure|respiratory failure
5723336|NCT00419458|inspiratory muscle strength training|inspiratory muscle strength training
5723337|NCT00419445|Attention Deficit Hyperactivity Disorder in adults|attention deficit hyperactivity disorder in adults
5723338|NCT00419432|Pediatrics|pediatrics
5723339|NCT00419432|Cerebral Palsy|cerebral palsy
5723340|NCT00419432|Gait Analysis|gait analysis
5723341|NCT00419432|Orthopedic Surgery|orthopedic surgery
5723342|NCT00419419|Raynaud's|raynaud's
5723343|NCT00419406|UVA1|uva1
5723344|NCT00419406|N-B UVB|n-b uvb
5723345|NCT00419406|phototherapy|phototherapy
5723346|NCT00419406|atopic dermatitis|atopic dermatitis
5723347|NCT00419406|SCORAD index|scorad index
5723348|NCT00419393|Keppra XR|keppra xr
5723349|NCT00419393|Levetiracetam XR|levetiracetam xr
5723350|NCT00419393|long term|long term
5723351|NCT00419393|partial seizures|partial seizures
5723352|NCT00419380|clogged ear tubes|clogged ear tubes
5723353|NCT00419354|Pacemaker|pacemaker
5723354|NCT00419354|Tricuspid regurgitation|tricuspid regurgitation
5723355|NCT00419341|Immune globulin subcutaneous|immune globulin subcutaneous
5723356|NCT00419341|SCIG|scig
5723357|NCT00419341|Primary immunodeficiency|primary immunodeficiency
5723358|NCT00419341|PID|pid
5723359|NCT00419328|solid tumors NGR-hTNF|solid tumors ngr-htnf
5723360|NCT00419315|alcoholism|alcoholism
5723361|NCT00419315|primary care|primary care
5723362|NCT00419315|treatment|treatment
5723363|NCT00419289|COPD, rehabilitation, quality of life|copd, rehabilitation, quality of life
5723466|NCT00418938|panitumumab|panitumumab
5798830|NCT00110903|Amgen|amgen
5723364|NCT00419276|Total knee arthroplasty, postoperative analgesia|total knee arthroplasty, postoperative analgesia
5723365|NCT00419276|Primary, unilateral, total knee arthroplasty|primary, unilateral, total knee arthroplasty
5723366|NCT00419263|influenza|influenza
5723368|NCT00419250|relapsed|relapsed
5723369|NCT00419250|refractory|refractory
5723370|NCT00419250|fludarabine|fludarabine
5723371|NCT00419250|Revlimid|revlimid
5723372|NCT00419250|lenalidomide|lenalidomide
5723373|NCT00419250|CLL|cll
5723374|NCT00419250|B-cell CLL|b-cell cll
5723375|NCT00419250|CC-5013|cc-5013
5723376|NCT00419250|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5723377|NCT00419237|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
5723378|NCT00419224|Peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5723379|NCT00419224|Non-myeloabalative|non-myeloabalative
5723380|NCT00419224|Influenza vaccination|influenza vaccination
5723381|NCT00419224|Humoral immune response|humoral immune response
5723382|NCT00419224|Immunogenicity|immunogenicity
5723383|NCT00419211|Pregnancy, Exercise, Depression|pregnancy, exercise, depression
5723384|NCT00419198|Ischemia|ischemia
5723385|NCT00419198|Reperfusion|reperfusion
5723386|NCT00419198|Myocardial infarction|myocardial infarction
5723387|NCT00419198|Postconditioning|postconditioning
5723388|NCT00419185|macular hole surgery|macular hole surgery
5723389|NCT00419185|indocyanine green|indocyanine green
5723390|NCT00419185|trypan blue|trypan blue
5723391|NCT00419185|internal limiting membrane|internal limiting membrane
5723392|NCT00419172|Pharmacokinetics|pharmacokinetics
5723393|NCT00419172|Deferasirox|deferasirox
5723394|NCT00419172|Exjade|exjade
5723395|NCT00419172|ICL670|icl670
5723396|NCT00419172|Rifampicin|rifampicin
5723397|NCT00419172|Healthy, Volunteers|healthy, volunteers
5723398|NCT00419159|Colorectal cancer|colorectal cancer
5723399|NCT00419159|metastatic colorectal adenocarcinoma|metastatic colorectal adenocarcinoma
5723400|NCT00419159|anti-EGFR antibody|anti-egfr antibody
5723401|NCT00419146|Schizophrenia|schizophrenia
5723402|NCT00419146|Schizophreniform disorders|schizophreniform disorders
5723403|NCT00419146|Schizoaffective disorder|schizoaffective disorder
5723404|NCT00419146|Psychotic disorders|psychotic disorders
5723405|NCT00419146|Randomized Controlled Trials|randomized controlled trials
5723406|NCT00419146|Longitudinal Studies|longitudinal studies
5723407|NCT00419146|Fatty Acids, Omega-3|fatty acids, omega-3
5723408|NCT00419146|Eicosapentaenoic Acid|eicosapentaenoic acid
5722329|NCT00423644|arsenic|arsenic
5723409|NCT00419146|Vitamins|vitamins
5723410|NCT00419146|Antioxidants|antioxidants
5723411|NCT00419146|Ascorbic Acid|ascorbic acid
5723412|NCT00419146|Alpha-Tocopherol|alpha-tocopherol
5723413|NCT00419146|Placebos|placebos
5723414|NCT00419146|Antipsychotic Agents|antipsychotic agents
5723415|NCT00419146|Oxidative Stress|oxidative stress
5723416|NCT00419146|Fatty Acids, Unsaturated|fatty acids, unsaturated
5723417|NCT00419146|Phospholipases|phospholipases
5723418|NCT00419146|Niacin|niacin
5723419|NCT00419146|Adverse effects|adverse effects
5723420|NCT00419146|Delusions|delusions
5723421|NCT00419146|Hallucinations|hallucinations
5723422|NCT00419146|Neuropsychological Tests|neuropsychological tests
5723423|NCT00419146|Attention|attention
5723424|NCT00419146|Memory|memory
5723425|NCT00419146|Hypertriglyceridemia|hypertriglyceridemia
5723427|NCT00419133|Cholera|cholera
5723428|NCT00419133|Vaccine|vaccine
5723429|NCT00419133|Kolkata|kolkata
5723430|NCT00419133|West Bengal|west bengal
5723431|NCT00419133|India|india
5723432|NCT00419133|Immunogenicity|immunogenicity
5723433|NCT00419133|Safety|safety
5723434|NCT00419094|Keppra XR|keppra xr
5723435|NCT00419094|conversion to monotherapy|conversion to monotherapy
5723436|NCT00419094|partial seizures|partial seizures
5723437|NCT00419081|leukemia|leukemia
5723438|NCT00419081|lymphoma|lymphoma
5723439|NCT00419055|percutaneous coronary intervention|percutaneous coronary intervention
5723440|NCT00419042|cancer|cancer
5723441|NCT00419042|Lung cancer|lung cancer
5723442|NCT00419042|None small-cell lung cancer|none small-cell lung cancer
5723443|NCT00419029|combat|combat
5723444|NCT00419029|depression|depression
5723445|NCT00419029|PTSD|ptsd
5723446|NCT00419029|substance abuse|substance abuse
5723447|NCT00418990|Multivitamin|multivitamin
5723448|NCT00418990|Academic performance|academic performance
5723449|NCT00418977|Anorexia Nervosa|anorexia nervosa
5723450|NCT00418964|Anterior cruciate ligament rupture|anterior cruciate ligament rupture
5723451|NCT00418964|Anterior cruciate ligament(A02.513.514.100)|anterior cruciate ligament(a02.513.514.100)
5723452|NCT00418951|Voriconazole|voriconazole
5723453|NCT00418951|Vfend|vfend
5723454|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b
5723455|NCT00418951|Ambisome|ambisome
5723456|NCT00418951|Acute Myelogenous Leukemia|acute myelogenous leukemia
5723457|NCT00418951|Myelodysplastic Syndrome|myelodysplastic syndrome
5723458|NCT00418951|AML|aml
5723459|NCT00418951|MDS|mds
5723460|NCT00418938|EGFR|egfr
5723461|NCT00418938|FOLFIRI|folfiri
5723462|NCT00418938|2nd Line Therapy|2nd line therapy
5723463|NCT00418938|2nd Line mCRC Therapy|2nd line mcrc therapy
5723470|NCT00418899|Linkage Study|linkage study
5740107|NCT00357513|CVA|cva
5740108|NCT00357513|Healthy Volunteer|healthy volunteer
5740109|NCT00357513|HV|hv
5740110|NCT00357513|Normal Control|normal control
5740111|NCT00357500|Metronomic|metronomic
5740112|NCT00357500|antiangiogenic|antiangiogenic
5740113|NCT00357487|Sentinel lymph node|sentinel lymph node
5723471|NCT00418899|Survey|survey
5723472|NCT00418899|Gliogene|gliogene
5723473|NCT00418899|High-risk familial brain tumor pedigrees|high-risk familial brain tumor pedigrees
5723474|NCT00418886|NSCLC|nsclc
5723475|NCT00418886|Non Small Cell Lung Cancer|non small cell lung cancer
5723476|NCT00418873|schizophrenia|schizophrenia
5723477|NCT00418873|zotepine|zotepine
5723478|NCT00418873|risperidone|risperidone
5723479|NCT00418873|second generation antipsychotic|second generation antipsychotic
5723480|NCT00418860|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5723481|NCT00418860|Stent thrombosis|stent thrombosis
5723482|NCT00418860|Zotarolimus-eluting stent|zotarolimus-eluting stent
5723483|NCT00418847|pediatrics|pediatrics
5723484|NCT00418847|lysosomal storage diseases|lysosomal storage diseases
5723485|NCT00418847|Gangliosidoses GM2|gangliosidoses gm2
5723486|NCT00418847|Tay-Sachs disease|tay-sachs disease
5723487|NCT00418847|Sandhoff disease|sandhoff disease
5723488|NCT00418847|Infantile GM2-activator deficiency|infantile gm2-activator deficiency
5723489|NCT00418847|Miglustat|miglustat
5723490|NCT00418808|motor|motor
5723491|NCT00418808|development|development
5723492|NCT00418808|multiple pregnancies|multiple pregnancies
5723493|NCT00418808|general movement|general movement
5723494|NCT00418808|video recording|video recording
5723495|NCT00418795|Acute Intermittent Porphyria|acute intermittent porphyria
5723496|NCT00418795|treatment|treatment
5723497|NCT00418795|Acute attack|acute attack
5723498|NCT00418769|nilotinib|nilotinib
5723499|NCT00418769|bioavailability|bioavailability
5723501|NCT00418769|capsule|capsule
5723502|NCT00418769|PK|pk
5723503|NCT00418769|healthy, subject(s),|healthy, subject(s),
5723504|NCT00418756|nilotinib|nilotinib
5723505|NCT00418756|Rifampin|rifampin
5723506|NCT00418756|PK|pk
5723507|NCT00418756|healthy subjects|healthy subjects
5723508|NCT00418743|cancer|cancer
5723509|NCT00418743|Lung cancer|lung cancer
5723510|NCT00418743|small-cell lung cancer|small-cell lung cancer
5723511|NCT00418730|androgenetic alopecia|androgenetic alopecia
5731429|NCT00388934|Stent|stent
5723512|NCT00418730|male pattern hair loss|male pattern hair loss
5723513|NCT00418730|male pattern baldness|male pattern baldness
5723514|NCT00418730|androgenetic alopecia or male pattern hair loss|androgenetic alopecia or male pattern hair loss
5723515|NCT00418704|cancer|cancer
5723516|NCT00418704|Lung cancer|lung cancer
5723517|NCT00418704|None small-cell lung cancer|none small-cell lung cancer
5723518|NCT00418691|Brain Tumor|brain tumor
5723519|NCT00418691|Methylphenidate|methylphenidate
5723520|NCT00418691|Ritalin|ritalin
5723521|NCT00418691|Modafinil|modafinil
5723522|NCT00418691|Provigil|provigil
5723523|NCT00418691|Fatigue|fatigue
5723524|NCT00418691|Concentration|concentration
5723525|NCT00418665|Revlimid|revlimid
5723526|NCT00418665|Lenalidomide|lenalidomide
5723527|NCT00418665|Low Platelet Count|low platelet count
5718521|NCT00436670|Asthma|asthma
5723528|NCT00418665|Low Risk Myelodysplastic Syndrome|low risk myelodysplastic syndrome
5723529|NCT00418665|Intermediate 1 Myelodysplastic Syndrome|intermediate 1 myelodysplastic syndrome
5723530|NCT00418665|MDS|mds
5723531|NCT00418665|Myelodysplastic Syndrome|myelodysplastic syndrome
5723532|NCT00418652|Normal Controls|normal controls
5723533|NCT00418639|Chronic Hepatitis C|chronic hepatitis c
5723534|NCT00418626|nilotinib|nilotinib
5723535|NCT00418626|hepatic impairment|hepatic impairment
5723536|NCT00418626|Child-Pugh scale|child-pugh scale
5723537|NCT00418626|PK|pk
5723538|NCT00418626|healthy, subject(s)|healthy, subject(s)
5723539|NCT00418626|Subjects with impaired hepatic function and healthy subjects|subjects with impaired hepatic function and healthy subjects
5723540|NCT00418600|Secondary Hyperparathyroidism|secondary hyperparathyroidism
5723541|NCT00418600|Hectorol® (doxercalciferol capsules)|hectorol® (doxercalciferol capsules)
5723542|NCT00418600|Hectorol® (doxercalciferol injection)|hectorol® (doxercalciferol injection)
5723543|NCT00418587|Vitamin D|vitamin d
5723544|NCT00418587|Lupus|lupus
5723545|NCT00418574|Ovarian cancer|ovarian cancer
5723546|NCT00418574|Abagovomab|abagovomab
5723547|NCT00418561|rhASA|rhasa
5723548|NCT00418561|MLD|mld
5723549|NCT00418561|Metazym|metazym
5723550|NCT00418535|Lymphoma, NK/T-Cell|lymphoma, nk/t-cell
5723551|NCT00418522|Insulin Glargine Diabetes HbA1c|insulin glargine diabetes hba1c
5723552|NCT00418509|Dose proportionality|dose proportionality
5723553|NCT00418509|pharmacokinetics|pharmacokinetics
5723554|NCT00418509|mometasone|mometasone
5723555|NCT00418509|formoterol|formoterol
5723556|NCT00418509|Healthy volunteers study|healthy volunteers study
5723557|NCT00418496|Unresectable|unresectable
5723558|NCT00418496|Metastatic|metastatic
5723559|NCT00418483|thrombolytic|thrombolytic
5723560|NCT00418483|thrombolysis|thrombolysis
5723561|NCT00418483|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5723562|NCT00418483|peripheral vascular disease|peripheral vascular disease
5723563|NCT00418483|thrombosis|thrombosis
5723564|NCT00418483|endovascular|endovascular
5723565|NCT00418470|Cystic fibrosis|cystic fibrosis
5723566|NCT00418470|Catheterization, peripheral|catheterization, peripheral
5723567|NCT00418470|Phlebitis|phlebitis
5723568|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents
5723569|NCT00418470|Osmolar Concentration|osmolar concentration
5723570|NCT00418457|Breast Cancer|breast cancer
5723571|NCT00418457|Anesthesia; regional|anesthesia; regional
5723572|NCT00418457|cancer recurrence|cancer recurrence
5723573|NCT00418457|Anesthesia; inhalational|anesthesia; inhalational
5723574|NCT00418457|Analgesia; opioid|analgesia; opioid
5723575|NCT00418444|Breast cancer,group psychotherapy,RCT,women's mental health|breast cancer,group psychotherapy,rct,women's mental health
5723576|NCT00418418|Cell transplantation|cell transplantation
5723577|NCT00418418|Heart failure|heart failure
5723578|NCT00418418|Clinical trials|clinical trials
5723579|NCT00418405|Arthritis, Rheumatoid|arthritis, rheumatoid
5723580|NCT00418405|Cohort Studies|cohort studies
5723581|NCT00418392|pneumothorax, aspiration, minocycline, pleurodesis|pneumothorax, aspiration, minocycline, pleurodesis
5723582|NCT00418379|Sublingual immunotherapy|sublingual immunotherapy
5723583|NCT00418379|Grass pollen tablet|grass pollen tablet
5723584|NCT00418379|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5723585|NCT00418366|Mild, moderate, severe renal insufficiency|mild, moderate, severe renal insufficiency
5723586|NCT00418366|End stage renal disease|end stage renal disease
5723587|NCT00418353|Antenatal corticosteroids|antenatal corticosteroids
5723588|NCT00418353|Betamethasone|betamethasone
5723589|NCT00418353|Dexamethasone|dexamethasone
5723590|NCT00418353|Premature|premature
5723591|NCT00418340|Irritable Bowel Syndrome,|irritable bowel syndrome,
5723592|NCT00418340|Visceral hypersensitivity,|visceral hypersensitivity,
5723593|NCT00418340|probiotic therapy,|probiotic therapy,
5723594|NCT00418340|immune response|immune response
5723595|NCT00418327|Tarceva|tarceva
5723786|NCT00417508|Body Composition|body composition
5723596|NCT00418327|refractory and relapsed malignant brain tumors|refractory and relapsed malignant brain tumors
5723597|NCT00418327|newly diagnosed brain stem glioma|newly diagnosed brain stem glioma
5723598|NCT00418301|Pain|pain
5723599|NCT00418301|Neurostimulation|neurostimulation
5723600|NCT00418288|GLP-1|glp-1
5723601|NCT00418288|glucose metabolism|glucose metabolism
5723602|NCT00418288|Type 2 diabetes|type 2 diabetes
5722541|NCT00422929|ear|ear
5723603|NCT00418288|brain|brain
5723605|NCT00418275|Cerebrovascular Stroke|cerebrovascular stroke
5723606|NCT00418262|fetal alcohol syndrome|fetal alcohol syndrome
5723607|NCT00418262|attention deficit disorder|attention deficit disorder
5723608|NCT00418262|attention deficit disorder with hyperactivity|attention deficit disorder with hyperactivity
5723609|NCT00418262|ADD|add
5723610|NCT00418262|FAS|fas
5723611|NCT00418262|FASD|fasd
5723612|NCT00418262|ADHD|adhd
5723613|NCT00418249|Androgenetic Alopecia|androgenetic alopecia
5723614|NCT00418249|Telogen effluvium|telogen effluvium
5723615|NCT00418249|Chronic telogen effluvium|chronic telogen effluvium
5723616|NCT00418249|Menopause|menopause
5723617|NCT00418249|Female Androgenetic Alopecia (FAGA)|female androgenetic alopecia (faga)
5723618|NCT00418223|Urinary retention|urinary retention
5723619|NCT00418223|Child birth|child birth
5723620|NCT00418223|Catheterization|catheterization
5723622|NCT00418210|Accelerated Partial Breast Irradiation|accelerated partial breast irradiation
5723623|NCT00418210|Conformal Radiation Therapy|conformal radiation therapy
5723624|NCT00418210|Feasibility|feasibility
5723625|NCT00418210|Early breast cancer|early breast cancer
5723626|NCT00418197|spinal stenosis|spinal stenosis
5723627|NCT00418197|low back pain|low back pain
5723628|NCT00418197|spondylolisthesis|spondylolisthesis
5723629|NCT00418197|lumbar spinal stenosis|lumbar spinal stenosis
5723630|NCT00418197|leg pain|leg pain
5723631|NCT00418197|spinal diseases|spinal diseases
5723632|NCT00418184|ADHD|adhd
5723633|NCT00418184|inattentive|inattentive
5723634|NCT00418184|impulsive|impulsive
5723635|NCT00418184|hyperactive|hyperactive
5723636|NCT00418184|poor academic performance|poor academic performance
5723637|NCT00418184|poor self-discipline|poor self-discipline
5723638|NCT00418184|low self-esteem|low self-esteem
5723639|NCT00418158|Pulmonary complications|pulmonary complications
5723640|NCT00418145|Relapsing Forms of Multiple Sclerosis|relapsing forms of multiple sclerosis
5723642|NCT00418132|Systemic Sclerosis|systemic sclerosis
5723643|NCT00418132|Progressive Systemic Sclerosis|progressive systemic sclerosis
5723644|NCT00418106|Premature birth|premature birth
5723645|NCT00418106|Pumping breast milk|pumping breast milk
5723646|NCT00418106|Kangaroo holding|kangaroo holding
5723647|NCT00418093|mullerian carcinoma|mullerian carcinoma
5723648|NCT00418067|Coronary Artery Disease|coronary artery disease
5723649|NCT00418067|Stent|stent
5723650|NCT00418028|capecitabine|capecitabine
5723651|NCT00418028|schedule|schedule
5723652|NCT00418028|breast cancer|breast cancer
5723653|NCT00418015|µ-opioid receptor|µ-opioid receptor
5723654|NCT00418015|neuraxial labor analgesia|neuraxial labor analgesia
5723655|NCT00418015|pharmacogenetics|pharmacogenetics
5723656|NCT00418002|Single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.|single-rising dose , multiple rising dose, elderly, cognitive, , pharmacokinetic, impairment.
5723657|NCT00418002|Healthy elderly male and female subjects|healthy elderly male and female subjects
5723658|NCT00417989|Glycemic control|glycemic control
5723659|NCT00417989|Sensor|sensor
5723660|NCT00417976|Advanced Pancreatic Cancer|advanced pancreatic cancer
5723661|NCT00417963|Carotid|carotid
5723667|NCT00417950|inflammation|inflammation
5723668|NCT00417950|oxidative stress|oxidative stress
5723669|NCT00417950|Mild diabetes mellitus|mild diabetes mellitus
5723670|NCT00417924|Patient education|patient education
5723671|NCT00417924|Patient satisfaction|patient satisfaction
5723672|NCT00417924|Eye health|eye health
5723673|NCT00417911|multiple myeloma|multiple myeloma
5723674|NCT00417911|autologous stem cell transplantation|autologous stem cell transplantation
5723675|NCT00417911|high-dose melphalan|high-dose melphalan
5723676|NCT00417911|bortezomib|bortezomib
5723677|NCT00417911|consolidation|consolidation
5723678|NCT00417911|event free survival|event free survival
5723679|NCT00417911|phase III|phase iii
5723681|NCT00417898|Cerebral Ischemia|cerebral ischemia
5723682|NCT00417898|Tissue Plasminogen Activator|tissue plasminogen activator
5723684|NCT00417898|Human|human
5723685|NCT00417898|Cerebral Reperfusion|cerebral reperfusion
5723686|NCT00417872|Clostridium difficile|clostridium difficile
5723687|NCT00417846|Age-Related Macular Degeneration|age-related macular degeneration
5723688|NCT00417846|Optical Coherence Tomography, OCT|optical coherence tomography, oct
5723689|NCT00417846|Preferential Hyperacuity Perimeter, PHP|preferential hyperacuity perimeter, php
5723690|NCT00417846|Amsler Grid|amsler grid
5723787|NCT00417495|adenocarcinoma, breast, multifocal lesions, surgery|adenocarcinoma, breast, multifocal lesions, surgery
5723691|NCT00417820|Safety, tolerability, pharmacodynamics, single administration, BCT194, healthy volunteers, psoriasis|safety, tolerability, pharmacodynamics, single administration, bct194, healthy volunteers, psoriasis
5723692|NCT00417807|refractory desmoplastic small round cell tumors|refractory desmoplastic small round cell tumors
5723693|NCT00417807|PDGF-R|pdgf-r
5723694|NCT00417794|attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5723695|NCT00417794|ADHD|adhd
5723696|NCT00417794|fetal alcohol syndrome|fetal alcohol syndrome
5723697|NCT00417794|FAS|fas
5723698|NCT00417794|FASD|fasd
5723699|NCT00417794|atomoxetine hcl|atomoxetine hcl
5731634|NCT00388206|Avastin|avastin
5723700|NCT00417781|ADHD, adolescence, family study, endophenotype, outcome|adhd, adolescence, family study, endophenotype, outcome
5723701|NCT00417768|tissue plasminogen activator|tissue plasminogen activator
5723702|NCT00417768|intraabdominal|intraabdominal
5723703|NCT00417768|abscess|abscess
5723704|NCT00417768|percutaneous drainage|percutaneous drainage
5723705|NCT00417755|Nutritional intake|nutritional intake
5723706|NCT00417755|Mechanical ventilation|mechanical ventilation
5723707|NCT00417755|Enteral feeding|enteral feeding
5723708|NCT00417742|headache|headache
5723709|NCT00417742|migraine headache|migraine headache
5723710|NCT00417742|tension headache|tension headache
5723711|NCT00417729|Diabetes|diabetes
5723712|NCT00417729|Acarobse|acarobse
5723713|NCT00417729|Metformin|metformin
5723714|NCT00417729|oxidative stress|oxidative stress
5723715|NCT00417729|Mean amplitude Glycemic Excursion|mean amplitude glycemic excursion
5723716|NCT00417729|Meal test|meal test
5723717|NCT00417716|Diffuse Diabetic Macular Edema|diffuse diabetic macular edema
5723718|NCT00417716|Intravitreal Bevacizumab|intravitreal bevacizumab
5723720|NCT00417703|Intraocular Pressure|intraocular pressure
5723721|NCT00417703|Intravitreous Injection|intravitreous injection
5723722|NCT00417703|Ranibizumab|ranibizumab
5723723|NCT00417690|Crohn's Disease|crohn's disease
5723724|NCT00417690|Acute Flare|acute flare
5723725|NCT00417690|Mild to moderate Crohn's Disease|mild to moderate crohn's disease
5723726|NCT00417690|Ileocecal distribution|ileocecal distribution
5723727|NCT00417677|Advanced Renal Carcinoma|advanced renal carcinoma
5723728|NCT00417664|cardiac surgery|cardiac surgery
5723729|NCT00417664|valvular surgery|valvular surgery
5723730|NCT00417664|delirium|delirium
5723731|NCT00417664|postoperative delirium|postoperative delirium
5723732|NCT00417664|cognitive dysfunction|cognitive dysfunction
5723733|NCT00417664|altered mental status|altered mental status
5723734|NCT00417651|Bacterial|bacterial
5723735|NCT00417651|contamination|contamination
5723736|NCT00417651|gastrotomy|gastrotomy
5723737|NCT00417651|Complications|complications
5723738|NCT00417638|myocardial infarction|myocardial infarction
5723739|NCT00417638|acute intervention|acute intervention
5723740|NCT00417638|percutaneous intervention|percutaneous intervention
5723741|NCT00417638|endovascular cooling|endovascular cooling
5723742|NCT00417638|endovascular rewarming|endovascular rewarming
5723743|NCT00417625|Coronary Artery Perfusion|coronary artery perfusion
5723744|NCT00417625|MRI|mri
5723745|NCT00417625|Fractional Flow Reserve|fractional flow reserve
5723746|NCT00417625|Coronary Flow Reserve|coronary flow reserve
5723747|NCT00417625|Collateral Artery Perfusion|collateral artery perfusion
5723748|NCT00417625|Cardiovascular Disease|cardiovascular disease
5723749|NCT00417625|Coronary Artery Disease|coronary artery disease
5723750|NCT00417625|CAD|cad
5723751|NCT00417612|Rickets, Hypophosphatemia|rickets, hypophosphatemia
5723752|NCT00417612|Rickets, Vitamin D-Resistant|rickets, vitamin d-resistant
5723753|NCT00417612|Rickets, X-linked hypophosphatemic|rickets, x-linked hypophosphatemic
5723754|NCT00417599|Prevention of overweight|prevention of overweight
5723755|NCT00417599|Prevention of obesity|prevention of obesity
5723756|NCT00417599|Treatment of overweight|treatment of overweight
5723757|NCT00417599|Treatment of obesity|treatment of obesity
5723758|NCT00417586|Stroke|stroke
5723759|NCT00417573|Immunodeficiency|immunodeficiency
5723760|NCT00417573|Gammaglobulin|gammaglobulin
5723761|NCT00417573|IgG subclass deficiency with recurrent infections|igg subclass deficiency with recurrent infections
5723763|NCT00417560|vaccine|vaccine
5723764|NCT00417560|avian influenza H5N1|avian influenza h5n1
5723765|NCT00417560|H5N1|h5n1
5723766|NCT00417547|Self Concept|self concept
5723767|NCT00417547|Eating Disorder|eating disorder
5723768|NCT00417547|Body Mass Index|body mass index
5723769|NCT00417547|Dressing|dressing
5723770|NCT00417547|Islamic Veil|islamic veil
5723771|NCT00417534|Coronary Disease|coronary disease
5723772|NCT00417534|Inflammation|inflammation
5723773|NCT00417534|Genetics|genetics
5723774|NCT00417534|HLA Antigens|hla antigens
5723775|NCT00417534|Aortic Valve|aortic valve
5723776|NCT00417521|Adolescents|adolescents
5723777|NCT00417521|Anorexia|anorexia
5723778|NCT00417521|Eating disorder|eating disorder
5723779|NCT00417521|Family therapy|family therapy
5723780|NCT00417508|function|function
5723781|NCT00417508|elderly|elderly
5723782|NCT00417508|ADL|adl
5723783|NCT00417508|nutritional supplementation|nutritional supplementation
5723784|NCT00417508|Quality of life|quality of life
5723785|NCT00417508|handgrip strength|handgrip strength
5723788|NCT00417482|Risperidone treatment, psychosis, agitation, aggression,|risperidone treatment, psychosis, agitation, aggression,
5723789|NCT00417482|discontinuation, placebo|discontinuation, placebo
5723790|NCT00417456|Acne|acne
5723791|NCT00417456|Telemedicine|telemedicine
5723792|NCT00417456|Dermatology|dermatology
5723793|NCT00417443|epidural|epidural
5723794|NCT00417443|clonidine|clonidine
5723795|NCT00417443|hyperalgesia|hyperalgesia
5680901|NCT00575744|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5723796|NCT00417443|laparotomy|laparotomy
5723797|NCT00417417|Endothelium|endothelium
5680894|NCT00575796|Low Grade Glioma|low grade glioma
5723798|NCT00417417|Inflammation|inflammation
5723799|NCT00417417|Nitric Oxide|nitric oxide
5723800|NCT00417417|Rilonacept|rilonacept
5723801|NCT00417417|Cytokines|cytokines
5723802|NCT00417417|Coronary Artery Disease|coronary artery disease
5723804|NCT00417417|Atherosclerosis|atherosclerosis
5723805|NCT00417404|preterm|preterm
5723806|NCT00417404|nutrition|nutrition
5723807|NCT00417404|vitamin A|vitamin a
5723808|NCT00417404|electroretinogram|electroretinogram
5723809|NCT00417404|conjunctiva|conjunctiva
5723810|NCT00417404|vitamin A status|vitamin a status
5723811|NCT00417404|conjunctival health|conjunctival health
5723812|NCT00417378|ACS|acs
5723813|NCT00417365|odor|odor
5723814|NCT00417365|douching|douching
5723815|NCT00417365|BV|bv
5723816|NCT00417365|vaginitis|vaginitis
5723817|NCT00417365|vaginal|vaginal
5723818|NCT00417365|yeast|yeast
5723819|NCT00417365|ecosystem|ecosystem
5723821|NCT00417365|Nugent|nugent
5723822|NCT00417365|Amsel|amsel
5723823|NCT00417352|no intervention|no intervention
5723824|NCT00417352|bracing restricted forearm and wrist movement|bracing restricted forearm and wrist movement
5723825|NCT00417352|bracing with added mass near elbow|bracing with added mass near elbow
5723826|NCT00417352|bracing with added mass near wrist|bracing with added mass near wrist
5723827|NCT00417339|hemodialysis|hemodialysis
5723828|NCT00417339|dialysis adequacy|dialysis adequacy
5723829|NCT00417339|uremic retention solute|uremic retention solute
5723830|NCT00417326|ONO-5046Na|ono-5046na
5723831|NCT00417326|acute respiratory failure|acute respiratory failure
5723832|NCT00417326|community-acquired pneumonia|community-acquired pneumonia
5723833|NCT00417313|knee pain|knee pain
5723834|NCT00417313|acupuncture /acupressure|acupuncture /acupressure
5723835|NCT00417313|alternative medicine|alternative medicine
5723836|NCT00417313|analgesia|analgesia
5723837|NCT00417313|arthritis therapy|arthritis therapy
5723838|NCT00417313|chronic pain|chronic pain
5723839|NCT00417313|functional ability|functional ability
5723840|NCT00417287|Pancreas|pancreas
5723841|NCT00417287|Cancer|cancer
5723842|NCT00417287|Carcinoma|carcinoma
5723843|NCT00417274|Cancer of Prostate|cancer of prostate
5723844|NCT00417274|Prostate Cancer|prostate cancer
5723845|NCT00417274|Cancer of the Prostate|cancer of the prostate
5723846|NCT00417274|Neoplasms, Prostate|neoplasms, prostate
5723847|NCT00417274|Neoplasms, Prostatic|neoplasms, prostatic
5723848|NCT00417274|Prostate Neoplasms|prostate neoplasms
5723849|NCT00417274|Prostatic Cancer|prostatic cancer
5723850|NCT00417274|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
5723851|NCT00417261|ATF936, AXT914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis|atf936, axt914, healthy subjects, pharmacokinetics, parathyroid hormone, osteoporosis
5723852|NCT00417261|Healthy male and female subjects|healthy male and female subjects
5723853|NCT00417235|catheter related infection|catheter related infection
5723854|NCT00417235|catheter dressing|catheter dressing
5723855|NCT00417235|prevention|prevention
5723856|NCT00417235|Chlorhexidine impregnated dressings|chlorhexidine impregnated dressings
5723857|NCT00417235|Infection|infection
5723858|NCT00417235|catheterization|catheterization
5724787|NCT00414830|fracture|fracture
5723859|NCT00417209|advanced pancreatic cancer|advanced pancreatic cancer
5723860|NCT00417196|pharmacodynamic effects, safety, healthy subjects,|pharmacodynamic effects, safety, healthy subjects,
5723861|NCT00417196|Healthy male and female subjects|healthy male and female subjects
5723863|NCT00417183|GnRH agonist|gnrh agonist
5723864|NCT00417183|Long protocol|long protocol
5723865|NCT00417183|Flexible|flexible
5723866|NCT00417170|High Blood pressure|high blood pressure
5723867|NCT00417170|Hypertension|hypertension
5723868|NCT00417170|metabolic syndrome|metabolic syndrome
5723869|NCT00417170|insulin resistance|insulin resistance
5723870|NCT00417170|endothelial dysfunction|endothelial dysfunction
5723871|NCT00417170|pre-diabetic|pre-diabetic
5723872|NCT00417170|amlodipine,|amlodipine,
5723873|NCT00417170|aliskiren,|aliskiren,
5723874|NCT00417170|IGT,|igt,
5723875|NCT00417170|IFG,|ifg,
5723876|NCT00417170|MBF|mbf
5723877|NCT00417157|GnRH antagonist|gnrh antagonist
5723878|NCT00417157|Poor responders|poor responders
5723879|NCT00417157|Oocyte donation|oocyte donation
5723880|NCT00417157|Modified natural cycle|modified natural cycle
5723881|NCT00417144|OHSS|ohss
5723882|NCT00417144|PCOS|pcos
5723883|NCT00417144|GnRH antagonist|gnrh antagonist
5723884|NCT00417144|GnRH agonist|gnrh agonist
5723885|NCT00417131|Islet transplantation,|islet transplantation,
5723886|NCT00417131|coagulation,|coagulation,
5723887|NCT00417131|graft destruction,|graft destruction,
5723888|NCT00417131|islet imaging|islet imaging
5723889|NCT00417118|Anxiety|anxiety
5723890|NCT00417118|clinical trials|clinical trials
5723891|NCT00417105|hemodialysis|hemodialysis
5723892|NCT00417105|dialysis adequacy|dialysis adequacy
5723893|NCT00417105|chronic kidney disease|chronic kidney disease
5723894|NCT00417092|coronary artery bypass grafting|coronary artery bypass grafting
5723895|NCT00417092|reduced left ventricular function|reduced left ventricular function
5723896|NCT00417092|postoperative pacing|postoperative pacing
5722805|NCT00421785|ADMA|adma
5723897|NCT00417092|cardiac resynchronization|cardiac resynchronization
5723898|NCT00417079|Cancer|cancer
5723899|NCT00417079|Prostate|prostate
5723900|NCT00417066|poor responders|poor responders
5723901|NCT00417066|GnRH antagonist|gnrh antagonist
5723902|NCT00417066|GnRH agonist|gnrh agonist
5723903|NCT00417066|flare up|flare up
5723904|NCT00417066|short protocol|short protocol
5723905|NCT00417053|disseminated neuroblastoma|disseminated neuroblastoma
5723906|NCT00417053|localized resectable neuroblastoma|localized resectable neuroblastoma
5723907|NCT00417053|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5723908|NCT00417053|regional neuroblastoma|regional neuroblastoma
5723909|NCT00417053|stage 4S neuroblastoma|stage 4s neuroblastoma
5723910|NCT00417040|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5723911|NCT00417040|recurrent prostate cancer|recurrent prostate cancer
5723912|NCT00417040|stage IV prostate cancer|stage iv prostate cancer
5723913|NCT00417027|Patient controlled epidural analgesia|patient controlled epidural analgesia
5723915|NCT00417027|Epidural analgesia|epidural analgesia
5723916|NCT00417014|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5723917|NCT00417014|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5723918|NCT00417014|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5723919|NCT00417014|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5723920|NCT00417014|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5723921|NCT00417001|sedation|sedation
5723922|NCT00417001|colonoscopy|colonoscopy
5723923|NCT00417001|Aroma therapy|aroma therapy
5723924|NCT00416988|melanoma|melanoma
5723925|NCT00416988|weight changes|weight changes
5723926|NCT00416975|breast cancer|breast cancer
5723927|NCT00416962|Oseltamivir, amantidine, Symmetrel, Tamiflu|oseltamivir, amantidine, symmetrel, tamiflu
5723928|NCT00416949|anaplastic thyroid cancer|anaplastic thyroid cancer
5723929|NCT00416949|insular thyroid cancer|insular thyroid cancer
5723930|NCT00416949|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5723931|NCT00416949|recurrent thyroid cancer|recurrent thyroid cancer
5723932|NCT00416949|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5723933|NCT00416949|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5723934|NCT00416949|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5723935|NCT00416949|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5723936|NCT00416949|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5848047|NCT00036569|Angiogenesis|angiogenesis
5723937|NCT00416949|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5723938|NCT00416949|stage IVA follicular thyroid cancer|stage iva follicular thyroid cancer
5723939|NCT00416949|stage IVB follicular thyroid cancer|stage ivb follicular thyroid cancer
5723940|NCT00416949|stage IVC follicular thyroid cancer|stage ivc follicular thyroid cancer
5723941|NCT00416949|stage IVA papillary thyroid cancer|stage iva papillary thyroid cancer
5723942|NCT00416949|stage IVB papillary thyroid cancer|stage ivb papillary thyroid cancer
5723943|NCT00416949|stage IVC papillary thyroid cancer|stage ivc papillary thyroid cancer
5723944|NCT00416923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5723945|NCT00416923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5723946|NCT00416923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5714212|NCT00449644|MDR TB|mdr tb
5723947|NCT00416923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5723948|NCT00416923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5723949|NCT00416923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5723950|NCT00416923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5723951|NCT00416923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5723952|NCT00416923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5723953|NCT00416923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5723954|NCT00416923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5723955|NCT00416923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5723956|NCT00416923|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5723957|NCT00416923|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5723958|NCT00416923|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5724469|NCT00415857|Leukine|leukine
5723959|NCT00416923|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5723960|NCT00416923|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5723961|NCT00416923|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5723962|NCT00416923|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5723963|NCT00416923|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5724814|NCT00414687|Inhaled|inhaled
5723964|NCT00416923|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5723965|NCT00416923|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5723966|NCT00416923|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5723967|NCT00416923|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5723968|NCT00416923|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5723969|NCT00416923|leptomeningeal metastases|leptomeningeal metastases
5723970|NCT00416923|intraocular lymphoma|intraocular lymphoma
5723971|NCT00416923|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5723972|NCT00416923|Waldenström macroglobulinemia|waldenström macroglobulinemia
5723973|NCT00416923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5723974|NCT00416923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5723975|NCT00416923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5723976|NCT00416910|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5723977|NCT00416910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5723978|NCT00416910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5719044|NCT00434837|ACL|acl
5723979|NCT00416910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5723980|NCT00416910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5723982|NCT00416897|stage II multiple myeloma|stage ii multiple myeloma
5723983|NCT00416897|stage III multiple myeloma|stage iii multiple myeloma
5723984|NCT00416897|renal failure|renal failure
5723985|NCT00416884|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5723986|NCT00416884|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5723987|NCT00416884|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5723988|NCT00416871|stage IV renal cell cancer|stage iv renal cell cancer
5723989|NCT00416871|recurrent renal cell cancer|recurrent renal cell cancer
5723990|NCT00416858|stage III esophageal cancer|stage iii esophageal cancer
5723991|NCT00416845|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (S1P) receptor modulator|pharmacodynamic effects, cardiac effects, healthy subjects, synthetic sphingosine 1 phosphate (s1p) receptor modulator
5723992|NCT00416845|Healthy male and female subjects|healthy male and female subjects
5723993|NCT00416832|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5723994|NCT00416832|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5723995|NCT00416832|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5723996|NCT00416832|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5723997|NCT00416819|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5723998|NCT00416819|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5723999|NCT00416780|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5724000|NCT00416780|recurrent breast cancer|recurrent breast cancer
5724001|NCT00416780|stage I breast cancer|stage i breast cancer
5724002|NCT00416780|stage II breast cancer|stage ii breast cancer
5724003|NCT00416780|stage IV breast cancer|stage iv breast cancer
5724004|NCT00416767|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5724005|NCT00416767|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5724006|NCT00416767|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5724007|NCT00416767|gastrinoma|gastrinoma
5724008|NCT00416767|insulinoma|insulinoma
5724009|NCT00416767|WDHA syndrome|wdha syndrome
5724010|NCT00416767|glucagonoma|glucagonoma
5724011|NCT00416767|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5724012|NCT00416767|somatostatinoma|somatostatinoma
5724013|NCT00416767|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5724014|NCT00416754|breast cancer|breast cancer
5724015|NCT00416754|stage I breast cancer|stage i breast cancer
5724016|NCT00416754|stage II breast cancer|stage ii breast cancer
5724017|NCT00416754|stage IIIA breast cancer|stage iiia breast cancer
5724018|NCT00416754|stage IIIB breast cancer|stage iiib breast cancer
5724019|NCT00416754|stage IIIC breast cancer|stage iiic breast cancer
5724020|NCT00416754|stage IV breast cancer|stage iv breast cancer
5724021|NCT00416741|Metabolic Syndrome|metabolic syndrome
5724023|NCT00416741|Hyperlipidemia|hyperlipidemia
5724024|NCT00416741|High blood pressure|high blood pressure
5724025|NCT00416741|Diabetes|diabetes
5724026|NCT00416728|Aliskiren , Valsartan , bioavailability, hypertension|aliskiren , valsartan , bioavailability, hypertension
5724027|NCT00416728|Healthy male and female subjects|healthy male and female subjects
5724028|NCT00416702|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver|safety study, pharmacokinetic effects, healthy subjects, hepatic impairment, liver
5724029|NCT00416702|Subjects with mild and moderate hepatic impairment and healthy subjects|subjects with mild and moderate hepatic impairment and healthy subjects
5724030|NCT00416689|nausea and vomiting|nausea and vomiting
5724031|NCT00416689|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5724032|NCT00416689|recurrent breast cancer|recurrent breast cancer
5724033|NCT00416689|stage I breast cancer|stage i breast cancer
5724034|NCT00416689|stage II breast cancer|stage ii breast cancer
5724035|NCT00416689|stage IIIA breast cancer|stage iiia breast cancer
5724036|NCT00416689|stage IIIB breast cancer|stage iiib breast cancer
5724037|NCT00416689|stage IIIC breast cancer|stage iiic breast cancer
5724038|NCT00416689|stage IV breast cancer|stage iv breast cancer
5724039|NCT00416689|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5724040|NCT00416689|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5686144|NCT00553371|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5686145|NCT00553358|Lapatinib|lapatinib
5686146|NCT00553358|ErbB2+|erbb2+
5686147|NCT00553358|Early Breast Cancer|early breast cancer
5686148|NCT00553358|Neoadjuvant|neoadjuvant
5686149|NCT00553345|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5724041|NCT00416689|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5724042|NCT00416689|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5724043|NCT00416689|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5724044|NCT00416689|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5724045|NCT00416689|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5724046|NCT00416689|limited stage small cell lung cancer|limited stage small cell lung cancer
5724047|NCT00416689|recurrent small cell lung cancer|recurrent small cell lung cancer
5724048|NCT00416676|localized resectable neuroblastoma|localized resectable neuroblastoma
5724049|NCT00416676|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5724050|NCT00416676|regional neuroblastoma|regional neuroblastoma
5724051|NCT00416663|Stem cells|stem cells
5724053|NCT00416663|Angina Pectoris|angina pectoris
5724054|NCT00416663|Heart Failure|heart failure
5724055|NCT00416663|Angiogenesis|angiogenesis
5724056|NCT00416650|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5724057|NCT00416650|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5724058|NCT00416650|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5724059|NCT00416650|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5724060|NCT00416637|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5724061|NCT00416624|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5724062|NCT00416624|extramedullary plasmacytoma|extramedullary plasmacytoma
5724063|NCT00416624|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5724064|NCT00416624|refractory multiple myeloma|refractory multiple myeloma
5724065|NCT00416624|stage I multiple myeloma|stage i multiple myeloma
5724066|NCT00416624|stage II multiple myeloma|stage ii multiple myeloma
5724067|NCT00416624|stage III multiple myeloma|stage iii multiple myeloma
5724068|NCT00416624|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5724069|NCT00416624|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5724070|NCT00416624|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5724071|NCT00416624|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5724072|NCT00416624|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5724073|NCT00416624|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5724074|NCT00416624|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5724075|NCT00416624|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5724076|NCT00416624|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5724077|NCT00416624|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5724078|NCT00416624|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5724079|NCT00416624|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5724080|NCT00416624|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5724081|NCT00416624|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5724082|NCT00416624|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5724083|NCT00416624|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5724084|NCT00416624|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5724085|NCT00416624|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5724086|NCT00416624|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5724087|NCT00416624|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5724088|NCT00416624|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5724089|NCT00416624|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5724090|NCT00416624|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5724091|NCT00416624|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5724092|NCT00416624|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5724093|NCT00416624|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5724094|NCT00416624|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5724095|NCT00416624|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5724096|NCT00416624|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5724097|NCT00416624|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5724098|NCT00416624|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5724099|NCT00416624|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5723085|NCT00420589|Weight maintenance|weight maintenance
5724100|NCT00416624|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5724101|NCT00416624|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5724102|NCT00416624|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5724103|NCT00416624|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5724104|NCT00416624|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5724105|NCT00416624|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5724106|NCT00416624|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5724107|NCT00416624|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5724108|NCT00416624|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5724109|NCT00416624|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5724110|NCT00416624|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5724111|NCT00416624|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5724112|NCT00416624|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5719203|NCT00434317|Metastasis|metastasis
5724113|NCT00416624|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5724114|NCT00416624|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5724115|NCT00416624|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5724116|NCT00416624|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5724117|NCT00416624|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5724118|NCT00416624|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5724120|NCT00416624|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5724121|NCT00416624|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5724122|NCT00416624|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5724123|NCT00416624|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5724124|NCT00416624|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5724125|NCT00416624|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5724126|NCT00416624|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5724127|NCT00416624|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5724128|NCT00416624|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5724129|NCT00416624|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5724130|NCT00416624|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5724131|NCT00416624|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5724132|NCT00416624|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5724133|NCT00416624|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5848048|NCT00036569|Brain Tumor|brain tumor
5724134|NCT00416624|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5724135|NCT00416624|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5724136|NCT00416624|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5724137|NCT00416624|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5724138|NCT00416624|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5724139|NCT00416624|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5724140|NCT00416624|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5724141|NCT00416624|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5724142|NCT00416624|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5724143|NCT00416624|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5724144|NCT00416624|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5724145|NCT00416624|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5724218|NCT00416520|Phosphate binder|phosphate binder
5724146|NCT00416624|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5724147|NCT00416624|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5724148|NCT00416624|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5724149|NCT00416624|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5724150|NCT00416624|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5724151|NCT00416624|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5724152|NCT00416624|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5724153|NCT00416624|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5724154|NCT00416624|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5724155|NCT00416624|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5724156|NCT00416624|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5724157|NCT00416624|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5724158|NCT00416624|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5724159|NCT00416624|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5724160|NCT00416624|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5863962|NCT00001151|Hypocalcemia|hypocalcemia
5680902|NCT00575744|Axillary Node Dissection|axillary node dissection
5724161|NCT00416624|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5724162|NCT00416624|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5724163|NCT00416624|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5724164|NCT00416624|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5724165|NCT00416624|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5724166|NCT00416624|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5724167|NCT00416624|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5724168|NCT00416624|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5724169|NCT00416624|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5724170|NCT00416624|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5724171|NCT00416624|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5724172|NCT00416624|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5724173|NCT00416624|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5724174|NCT00416624|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5724175|NCT00416624|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5724176|NCT00416624|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5724177|NCT00416624|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5724178|NCT00416624|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5724179|NCT00416624|refractory hairy cell leukemia|refractory hairy cell leukemia
5724180|NCT00416624|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5724181|NCT00416624|prolymphocytic leukemia|prolymphocytic leukemia
5724183|NCT00416624|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5724184|NCT00416624|primary systemic amyloidosis|primary systemic amyloidosis
5724185|NCT00416624|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5724186|NCT00416624|acute undifferentiated leukemia|acute undifferentiated leukemia
5724187|NCT00416624|mast cell leukemia|mast cell leukemia
5724188|NCT00416624|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5724189|NCT00416624|untreated hairy cell leukemia|untreated hairy cell leukemia
5724190|NCT00416611|High blood pressure|high blood pressure
5724193|NCT00416611|Effective Control|effective control
5724194|NCT00416611|Coronary heart disease risk reduction|coronary heart disease risk reduction
5724195|NCT00416611|Hypertension|hypertension
5724196|NCT00416585|acne|acne
5724197|NCT00416585|isotretinoin|isotretinoin
5724198|NCT00416585|calcium. vitamin D|calcium. vitamin d
5724199|NCT00416572|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5724200|NCT00416572|stage I breast cancer|stage i breast cancer
5724201|NCT00416572|stage II breast cancer|stage ii breast cancer
5740950|NCT00354627|HIV-1|hiv-1
5724202|NCT00416559|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5724203|NCT00416559|localized resectable neuroblastoma|localized resectable neuroblastoma
5724204|NCT00416559|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5724205|NCT00416559|regional neuroblastoma|regional neuroblastoma
5724206|NCT00416546|Healthy Caucasians|healthy caucasians
5724207|NCT00416546|Healthy Japanese subjects|healthy japanese subjects
5724208|NCT00416546|Immunosuppressant|immunosuppressant
5724209|NCT00416546|early T-cell activation blockers|early t-cell activation blockers
5724210|NCT00416546|inhibition of protein kinase C|inhibition of protein kinase c
5724211|NCT00416533|recurrent prostate cancer|recurrent prostate cancer
5724212|NCT00416533|stage III prostate cancer|stage iii prostate cancer
5724213|NCT00416533|stage IV prostate cancer|stage iv prostate cancer
5724214|NCT00416533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5724215|NCT00416520|Chronic Kidney Disease|chronic kidney disease
5724216|NCT00416520|Dialysis|dialysis
5724217|NCT00416520|Hyperphosphatemia|hyperphosphatemia
5726006|NCT00410644|analgesics|analgesics
5724219|NCT00416507|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5724220|NCT00416507|stage III pancreatic cancer|stage iii pancreatic cancer
5724221|NCT00416507|stage II pancreatic cancer|stage ii pancreatic cancer
5724222|NCT00416494|adenocarcinoma of the colon|adenocarcinoma of the colon
5724223|NCT00416494|recurrent colon cancer|recurrent colon cancer
5724224|NCT00416494|stage IV colon cancer|stage iv colon cancer
5724225|NCT00416494|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5724226|NCT00416494|recurrent rectal cancer|recurrent rectal cancer
5724227|NCT00416494|stage IV rectal cancer|stage iv rectal cancer
5724228|NCT00416481|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5724229|NCT00416468|Aliskiren , Valsartan, bioavailability, hypertension|aliskiren , valsartan, bioavailability, hypertension
5724230|NCT00416468|Healthy male and female subjects|healthy male and female subjects
5724231|NCT00416442|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine|healthy subjects, safety, tolerability, dose escalation, pharmacokinetics, benzodiazepine
5724232|NCT00416442|Healthy male and female subjects|healthy male and female subjects
5724233|NCT00416429|recurrent renal cell cancer|recurrent renal cell cancer
5724234|NCT00416429|stage IV renal cell cancer|stage iv renal cell cancer
5724235|NCT00416403|breast cancer in situ|breast cancer in situ
5724236|NCT00416403|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5724237|NCT00416403|stage IA breast cancer|stage ia breast cancer
5724238|NCT00416403|stage IB breast cancer|stage ib breast cancer
5724239|NCT00416390|benign prostatic hyperplasia|benign prostatic hyperplasia
5724240|NCT00416390|stage I prostate cancer|stage i prostate cancer
5724241|NCT00416390|stage IIB prostate cancer|stage iib prostate cancer
5724242|NCT00416390|stage IIA prostate cancer|stage iia prostate cancer
5724243|NCT00416390|stage III prostate cancer|stage iii prostate cancer
5724244|NCT00416390|stage IV prostate cancer|stage iv prostate cancer
5724245|NCT00416377|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5724246|NCT00416377|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5724247|NCT00416377|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5724248|NCT00416377|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5724249|NCT00416377|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5724252|NCT00416364|quality of life|quality of life
5724253|NCT00416351|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5724254|NCT00416351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5724255|NCT00416351|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5724256|NCT00416351|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5724257|NCT00416351|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5724258|NCT00416351|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5724259|NCT00416351|prolymphocytic leukemia|prolymphocytic leukemia
5724260|NCT00416351|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5724261|NCT00416351|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5724262|NCT00416351|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5724263|NCT00416351|small intestine lymphoma|small intestine lymphoma
5724264|NCT00416338|renal failure|renal failure
5724265|NCT00416338|infection|infection
5724266|NCT00416338|peritonitis|peritonitis
5724267|NCT00416325|prostate cancer|prostate cancer
5724268|NCT00416312|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5724269|NCT00416312|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5724270|NCT00416312|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5724271|NCT00416312|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5724272|NCT00416312|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5724273|NCT00416312|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5848049|NCT00036569|Glioma|glioma
5724274|NCT00416312|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5724275|NCT00416312|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5724276|NCT00416312|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5724277|NCT00416312|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5724278|NCT00416312|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5724279|NCT00416312|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5724280|NCT00416312|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5724281|NCT00416312|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5724282|NCT00416312|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5724283|NCT00416312|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5724284|NCT00416312|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5724285|NCT00416312|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5724286|NCT00416312|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5724287|NCT00416312|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5724288|NCT00416312|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5724351|NCT00416299|postoperative complications|postoperative complications
5724289|NCT00416312|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5724290|NCT00416312|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5724291|NCT00416312|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5724292|NCT00416312|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5724293|NCT00416312|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5724294|NCT00416312|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5724295|NCT00416312|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5724296|NCT00416312|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5732467|NCT00385333|AMD|amd
5724297|NCT00416312|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5724298|NCT00416312|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5863963|NCT00001151|Rickets|rickets
5724299|NCT00416312|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5724300|NCT00416312|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5724301|NCT00416312|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5724302|NCT00416312|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5724303|NCT00416312|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5724304|NCT00416312|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5724305|NCT00416312|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5724306|NCT00416312|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5724307|NCT00416312|Waldenström macroglobulinemia|waldenström macroglobulinemia
5724308|NCT00416312|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5724309|NCT00416312|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5724310|NCT00416312|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5724311|NCT00416312|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5724312|NCT00416312|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5724313|NCT00416312|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5724314|NCT00416312|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5724315|NCT00416312|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5724316|NCT00416312|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5724317|NCT00416312|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5724318|NCT00416312|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5724319|NCT00416312|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5724320|NCT00416312|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5724321|NCT00416312|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5724322|NCT00416312|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5724323|NCT00416312|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5724324|NCT00416312|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5724325|NCT00416312|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5724326|NCT00416312|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5724327|NCT00416312|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5724328|NCT00416312|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5724329|NCT00416312|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5724330|NCT00416312|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5724331|NCT00416312|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5724332|NCT00416312|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5741114|NCT00354068|adult glioblastoma|adult glioblastoma
5741116|NCT00354042|Asthma|asthma
5741117|NCT00354042|Crossover|crossover
5741118|NCT00354042|dose ascending|dose ascending
5741119|NCT00354042|repeat dose|repeat dose
5741120|NCT00354042|inhaled|inhaled
5724333|NCT00416312|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5724334|NCT00416312|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5724335|NCT00416312|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5724336|NCT00416312|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5724337|NCT00416312|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5724338|NCT00416312|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5724339|NCT00416312|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5724340|NCT00416312|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5724341|NCT00416312|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5724342|NCT00416312|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5724343|NCT00416312|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5724344|NCT00416312|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5724345|NCT00416312|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5724346|NCT00416312|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5724347|NCT00416312|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5724348|NCT00416299|Cardiac biomarker|cardiac biomarker
5724349|NCT00416299|cardiac surgery|cardiac surgery
5724350|NCT00416299|elderly|elderly
5724352|NCT00416299|Patients aged 75 years or older undergoing cardiac surgery|patients aged 75 years or older undergoing cardiac surgery
5724353|NCT00416286|Cetylpyridinium chlorid|cetylpyridinium chlorid
5724354|NCT00416286|Sustained release|sustained release
5724355|NCT00416286|orthodontic patients|orthodontic patients
5724356|NCT00416286|streptococcus mutans|streptococcus mutans
5724357|NCT00416286|Lactobacillus|lactobacillus
5724358|NCT00416286|Rate of bacterial load in saliva of orthodontic patients|rate of bacterial load in saliva of orthodontic patients
5724359|NCT00416273|Multiple Myeloma|multiple myeloma
5724360|NCT00416273|Bortezomib|bortezomib
5724361|NCT00416273|PS341|ps341
5724362|NCT00416273|Proteasome inhibitor|proteasome inhibitor
5724363|NCT00416273|Consolidation therapy|consolidation therapy
5724364|NCT00416260|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5724365|NCT00416260|High-Frequency Ventilation|high-frequency ventilation
5724366|NCT00416260|Respiration, Artificial|respiration, artificial
5724367|NCT00416247|Hypnosis|hypnosis
5724368|NCT00416247|TMS|tms
5724369|NCT00416247|Cortical excitability|cortical excitability
5724370|NCT00416221|Depression|depression
5724371|NCT00416221|Lexapro|lexapro
5724372|NCT00416208|Multiple Myeloma|multiple myeloma
5724373|NCT00416208|Clinical trial|clinical trial
5724374|NCT00416208|Bortezomib|bortezomib
5724375|NCT00416208|PS341|ps341
5724376|NCT00416208|Proteasome inhibitor|proteasome inhibitor
5724377|NCT00416208|Consolidation therapy|consolidation therapy
5724378|NCT00416182|Cystic fibrosis|cystic fibrosis
5724379|NCT00416182|chronic sinusitis|chronic sinusitis
5724380|NCT00416182|mucolytic|mucolytic
5724381|NCT00416169|Frontotemporal Dementia|frontotemporal dementia
5724382|NCT00416169|Pick Complex|pick complex
5724383|NCT00416169|galantamine hydrobromide|galantamine hydrobromide
5724384|NCT00416156|Obesity|obesity
5724385|NCT00416156|Inflammation|inflammation
5724386|NCT00416143|Bed rest for idiopathic sudden sensorineural hearing loss|bed rest for idiopathic sudden sensorineural hearing loss
5724387|NCT00416130|Phase I/II Clinical Trial|phase i/ii clinical trial
5724388|NCT00416130|Vorinostat|vorinostat
5724389|NCT00416130|SAHA|saha
5724390|NCT00416130|Recurrent Breast Cancer|recurrent breast cancer
5724391|NCT00416130|Metastatic Breast Cancer|metastatic breast cancer
5724392|NCT00416117|Neck pain|neck pain
5724393|NCT00416117|Cervical pain|cervical pain
5724394|NCT00416117|Radicular pain|radicular pain
5724395|NCT00416117|Manual therapy|manual therapy
5724396|NCT00416117|Mobilization|mobilization
5724397|NCT00416117|Manipulation|manipulation
5724398|NCT00416104|analgesia|analgesia
5724399|NCT00416091|Tourette disorder, ADHD, comorbidity, neuropsychological|tourette disorder, adhd, comorbidity, neuropsychological
5724400|NCT00416078|technology development and assessment|technology development and assessment
5724401|NCT00416078|internet|internet
5724402|NCT00416078|randomized control trial|randomized control trial
5724403|NCT00416052|calcium|calcium
5724404|NCT00416052|calciuria|calciuria
5724405|NCT00416052|PTH|pth
5724406|NCT00416052|1,25-vitamin D|1,25-vitamin d
5724407|NCT00416052|Calcitriol|calcitriol
5724408|NCT00416052|bone mineral density|bone mineral density
5741217|NCT00353743|placebo|placebo
5741218|NCT00353730|Serial Analysis of Gene Expression|serial analysis of gene expression
5741219|NCT00353730|Carotid Artery Plaque|carotid artery plaque
5741220|NCT00353730|Atherosclerosis|atherosclerosis
5741221|NCT00353717|breast|breast
5724409|NCT00416052|osteodensitometry|osteodensitometry
5724410|NCT00416039|midazolam|midazolam
5724411|NCT00416039|sublingual|sublingual
5724412|NCT00416039|oral morphine|oral morphine
5724413|NCT00416039|children|children
5724414|NCT00416039|bone fracture|bone fracture
5724415|NCT00416039|bone fracture with a deformed member|bone fracture with a deformed member
5724416|NCT00416026|Quality improvement|quality improvement
5724417|NCT00416026|Patient-centered care|patient-centered care
5724418|NCT00416026|Acute coronary syndrome|acute coronary syndrome
5724419|NCT00416026|Telephone counseling|telephone counseling
5724420|NCT00416013|Beta Natriuretic Peptide|beta natriuretic peptide
5724421|NCT00416013|Troponin|troponin
5724422|NCT00416013|Hemodialysis|hemodialysis
5724423|NCT00416000|Open/Elective EVAR patients|open/elective evar patients
5724424|NCT00415987|Multiple Myeloma|multiple myeloma
5724425|NCT00415974|Weight Loss|weight loss
5724426|NCT00415974|Obesity|obesity
5724427|NCT00415974|Overweight|overweight
5724428|NCT00415974|Physical Activity|physical activity
5724429|NCT00415974|Nutrition|nutrition
5724430|NCT00415974|Primary Care Physicians|primary care physicians
5724431|NCT00415974|Primary Care|primary care
5724432|NCT00415974|Counseling|counseling
5724434|NCT00415961|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5724435|NCT00415961|Drug-eluting stent (DES)|drug-eluting stent (des)
5724436|NCT00415948|Heart|heart
5724437|NCT00415948|Cardiac|cardiac
5724438|NCT00415948|Acute Coronary Syndrome|acute coronary syndrome
5724439|NCT00415948|Sample Procurement|sample procurement
5724440|NCT00415922|Bioequivalence|bioequivalence
5724441|NCT00415922|bioavailability|bioavailability
5724442|NCT00415922|carbidopa|carbidopa
5724443|NCT00415922|levodopa|levodopa
5724444|NCT00415922|entacapone|entacapone
5724445|NCT00415922|fasting condition|fasting condition
5724446|NCT00415922|Healthy volunteers study|healthy volunteers study
5732585|NCT00384722|Pacing|pacing
5724447|NCT00415909|Leukemia|leukemia
5726007|NCT00410644|opioid|opioid
5724448|NCT00415909|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5724449|NCT00415909|CML|cml
5724450|NCT00415909|Imatinib|imatinib
5751137|NCT00315705|ALL|all
5724451|NCT00415909|Gleevec|gleevec
5724452|NCT00415909|TALL-104|tall-104
5724453|NCT00415896|weaning|weaning
5724454|NCT00415896|work of breathing|work of breathing
5724455|NCT00415896|spontaneous breathing trial|spontaneous breathing trial
5724456|NCT00415896|rapid shallow breathing|rapid shallow breathing
5724457|NCT00415883|Relative bioavailability, formulation, Japanese, valsartan, healthy subjects|relative bioavailability, formulation, japanese, valsartan, healthy subjects
5724458|NCT00415870|Overweight|overweight
5724459|NCT00415870|Cell Phone|cell phone
5724460|NCT00415870|Technology|technology
5724461|NCT00415857|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5724462|NCT00415857|Leukemia|leukemia
5724463|NCT00415857|Peptide Vaccine|peptide vaccine
5724464|NCT00415857|PR1 Peptide|pr1 peptide
5724465|NCT00415857|Imatinib|imatinib
5724466|NCT00415857|Gleevec|gleevec
5724467|NCT00415857|GM-CSF|gm-csf
5724468|NCT00415857|Sargramostim|sargramostim
5719678|NCT00432900|MS|ms
5724470|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b
5724471|NCT00415857|Peg-Intron|peg-intron
5724472|NCT00415844|Bioequivalence|bioequivalence
5724473|NCT00415844|bioavailability|bioavailability
5724474|NCT00415844|carbidopa|carbidopa
5724475|NCT00415844|levodopa|levodopa
5724476|NCT00415844|entacapone|entacapone
5724477|NCT00415844|fasting condition|fasting condition
5724478|NCT00415844|Healthy volunteers study|healthy volunteers study
5724479|NCT00415831|Bioequivalence|bioequivalence
5724480|NCT00415831|bioavailability|bioavailability
5724481|NCT00415831|carbidopa|carbidopa
5724482|NCT00415831|levodopa|levodopa
5724483|NCT00415831|entacapone|entacapone
5724484|NCT00415831|fed condition|fed condition
5724485|NCT00415831|Healthy volunteers study|healthy volunteers study
5724486|NCT00415818|Lung Cancer|lung cancer
5724487|NCT00415818|NSCLC|nsclc
5724488|NCT00415818|Cancer Vaccine|cancer vaccine
5724489|NCT00415818|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5724490|NCT00415818|Stage IIIb Non-Small Cell Lung Cancer with effusion|stage iiib non-small cell lung cancer with effusion
5724491|NCT00415792|Ovulation induction|ovulation induction
5724492|NCT00415792|hCG|hcg
5724493|NCT00415792|GnRH agonist|gnrh agonist
5724494|NCT00415792|hyper-responders|hyper-responders
5724495|NCT00415779|hormone refractory|hormone refractory
5724496|NCT00415779|bone metastasis|bone metastasis
5724497|NCT00415779|chemotherapy|chemotherapy
5724498|NCT00415779|biphosphonates|biphosphonates
5724499|NCT00415766|recombinant hCG|recombinant hcg
5724500|NCT00415766|urinary hCG|urinary hcg
5724501|NCT00415740|Bioequivalence|bioequivalence
5724502|NCT00415740|bioavailability|bioavailability
5724503|NCT00415740|carbidopa|carbidopa
5724504|NCT00415740|levodopa|levodopa
5724505|NCT00415740|entacapone|entacapone
5724506|NCT00415740|fasting|fasting
5724507|NCT00415740|Healthy volunteers study|healthy volunteers study
5724508|NCT00415714|Primary Insomnia|primary insomnia
5724509|NCT00415714|Chronic Insomnia|chronic insomnia
5724510|NCT00415714|Biofeedback|biofeedback
5724511|NCT00415714|Sleeplessness|sleeplessness
5724512|NCT00415701|Etomidate|etomidate
5724513|NCT00415701|Propofol|propofol
5724514|NCT00415701|Adrenocortical Insufficiency|adrenocortical insufficiency
5724515|NCT00415701|Hemodynamic Process|hemodynamic process
5724516|NCT00415701|Vasoactive Agonists|vasoactive agonists
5724517|NCT00415701|Coronary Artery Bypass|coronary artery bypass
5724518|NCT00415701|Ischemic Coronary Heart Disease|ischemic coronary heart disease
5724519|NCT00415701|Mitral valve reconstruction/replacement|mitral valve reconstruction/replacement
5724520|NCT00415701|Mitral valve regurgitation|mitral valve regurgitation
5724521|NCT00415701|Heart Valve Prosthesis|heart valve prosthesis
5724522|NCT00415701|Cardiopulmonary Bypass|cardiopulmonary bypass
5724523|NCT00415688|lifestyle modification|lifestyle modification
5724524|NCT00415688|weight loss|weight loss
5724525|NCT00415688|hyperglycemia|hyperglycemia
5724526|NCT00415688|hypoglycemic agents|hypoglycemic agents
5724527|NCT00415675|Lung Cancer|lung cancer
5724528|NCT00415675|Abdominal Cancer|abdominal cancer
5724529|NCT00415675|Tissue Motion|tissue motion
5724530|NCT00415675|Breathing|breathing
5724531|NCT00415675|Motion CT Scans|motion ct scans
5724532|NCT00415649|HIV Preventive Vaccine|hiv preventive vaccine
5714858|NCT00447668|Yoga|yoga
5724534|NCT00415610|cerebral hemorrhage|cerebral hemorrhage
5724535|NCT00415610|intracerebral hemorrhage|intracerebral hemorrhage
5724536|NCT00415610|stroke|stroke
5724537|NCT00415610|hypertension|hypertension
5724538|NCT00415610|blood pressure|blood pressure
5724539|NCT00415610|nicardipine|nicardipine
5724540|NCT00415610|antihypertensive agent|antihypertensive agent
5724541|NCT00415610|hematoma expansion|hematoma expansion
5724542|NCT00415597|chronic pain|chronic pain
5724543|NCT00415597|joint pain|joint pain
5724544|NCT00415597|back pain|back pain
5724545|NCT00415597|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5724546|NCT00415597|post herpetic neuralgia|post herpetic neuralgia
5724547|NCT00415597|ALO-01|alo-01
5724548|NCT00415597|Embeda|embeda
5724549|NCT00415597|Chronic Non-Malignant Pain|chronic non-malignant pain
5724550|NCT00415584|hypercalcemia|hypercalcemia
5724551|NCT00415584|transplant|transplant
5724552|NCT00415571|Hypogonadism|hypogonadism
5724553|NCT00415571|Erectile Dysfunction|erectile dysfunction
5724554|NCT00415558|Atrial Fibrillation|atrial fibrillation
5724555|NCT00415545|Heart Failure|heart failure
5724556|NCT00415545|Patient Education|patient education
5724557|NCT00415532|splenectomy|splenectomy
5724558|NCT00415532|platelet|platelet
5724559|NCT00415532|AMG 531|amg 531
5724560|NCT00415532|thrombopoietin|thrombopoietin
5724561|NCT00415532|blood disorder|blood disorder
5724562|NCT00415532|bleeding disorder|bleeding disorder
5724563|NCT00415532|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5724564|NCT00415532|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5724565|NCT00415532|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5724567|NCT00415532|thrombopoietic protein|thrombopoietic protein
5724568|NCT00415519|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5724569|NCT00415519|free radical scavenger|free radical scavenger
5724570|NCT00415493|rhinitis|rhinitis
5724572|NCT00415493|rhinomanometry|rhinomanometry
5724573|NCT00415493|cold air|cold air
5724574|NCT00415493|triggers: cold, dry air inhalation|triggers: cold, dry air inhalation
5724575|NCT00415493|warm, most air inhalation|warm, most air inhalation
5724576|NCT00415493|Nonallergic rhinitis; normal controls|nonallergic rhinitis; normal controls
5724577|NCT00415467|Brain Tumor|brain tumor
5724578|NCT00415467|Radiation Therapy System|radiation therapy system
5724579|NCT00415467|GliaSite RTS|gliasite rts
5724580|NCT00415454|Pancreatic Cancer|pancreatic cancer
5724581|NCT00415441|physiotherapy|physiotherapy
5724582|NCT00415441|exercise|exercise
5724583|NCT00415441|manual therapy|manual therapy
5724584|NCT00415441|shoulder pain|shoulder pain
5724585|NCT00415441|rotator cuff|rotator cuff
5724586|NCT00415415|Racial Disparities|racial disparities
5724587|NCT00415415|Psychosocial Risk Factors|psychosocial risk factors
5724588|NCT00415415|Neighborhood Socioeconomic Status|neighborhood socioeconomic status
5724589|NCT00415415|CVD|cvd
5724590|NCT00415415|CHD|chd
5724591|NCT00415402|Vitamin D3|vitamin d3
5724592|NCT00415402|morbidity|morbidity
5724593|NCT00415402|mortality|mortality
5724594|NCT00415402|low birth weight|low birth weight
5724595|NCT00415402|supplementation|supplementation
5724596|NCT00415402|TH1|th1
5724597|NCT00415402|TH2|th2
5741424|NCT00352950|Panitumumab|panitumumab
5741425|NCT00352950|Sirolimus|sirolimus
5741426|NCT00352950|mTOR|mtor
5741427|NCT00352950|Monoclonal antibody|monoclonal antibody
5741428|NCT00352937|Coronary Arteriosclerosis|coronary arteriosclerosis
5741429|NCT00352937|Tomography, X-Ray Computed|tomography, x-ray computed
5741430|NCT00352937|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5741434|NCT00352911|HIV-1|hiv-1
5741435|NCT00352885|Cancer|cancer
5741450|NCT00352859|RCC|rcc
5724598|NCT00415402|CRP|crp
5724599|NCT00415402|Neopterin|neopterin
5724600|NCT00415402|immune response|immune response
5724601|NCT00415389|Stroke|stroke
5724602|NCT00415389|interactive educational program|interactive educational program
5724603|NCT00415389|acute ischemic stroke|acute ischemic stroke
5724604|NCT00415376|seizure|seizure
5724605|NCT00415376|adult tumors metastatic to brain|adult tumors metastatic to brain
5724606|NCT00415376|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5724607|NCT00415350|Bronchiectasis|bronchiectasis
5724608|NCT00415350|Macrolide|macrolide
5724609|NCT00415350|Azithromycin|azithromycin
5724610|NCT00415350|Antibiotic prophylaxis|antibiotic prophylaxis
5724611|NCT00415350|Immunomodulation|immunomodulation
5724612|NCT00415350|Inflammation|inflammation
5724613|NCT00415350|Lung function|lung function
5724614|NCT00415350|Sputum|sputum
5724615|NCT00415350|Bacterial colonization|bacterial colonization
5724616|NCT00415337|lung|lung
5724617|NCT00415337|neoplasm|neoplasm
5724618|NCT00415337|bronchoscopy|bronchoscopy
5724619|NCT00415337|ultrasonography|ultrasonography
5724620|NCT00415337|histology|histology
5724621|NCT00415311|Liver Transplantation|liver transplantation
5724622|NCT00415311|rhMBL|rhmbl
5724623|NCT00415298|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5724624|NCT00415298|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5724625|NCT00415298|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5724626|NCT00415298|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5724627|NCT00415298|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5724628|NCT00415298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5724629|NCT00415298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5724630|NCT00415298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5686150|NCT00553345|stage 0 bladder cancer|stage 0 bladder cancer
5723803|NCT00417417|CAD|cad
5724631|NCT00415298|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5724632|NCT00415298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5724633|NCT00415298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5724634|NCT00415298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5724635|NCT00415298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5724636|NCT00415298|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5724637|NCT00415298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5724638|NCT00415285|Breast|breast
5724639|NCT00415285|Cancer|cancer
5724640|NCT00415285|Early-Stage|early-stage
5724641|NCT00415285|Chemotherapy|chemotherapy
5724642|NCT00415233|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5724643|NCT00415233|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5724644|NCT00415233|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5724645|NCT00415233|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5724646|NCT00415233|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5724647|NCT00415233|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5724648|NCT00415233|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5724649|NCT00415233|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5724651|NCT00415220|Manipulation|manipulation
5724652|NCT00415220|Back surgery|back surgery
5724653|NCT00415220|Herniated lumbar disc|herniated lumbar disc
5724654|NCT00415220|Sciatica|sciatica
5724655|NCT00415220|Lumbar microdiscectomy|lumbar microdiscectomy
5724656|NCT00415220|Cost-effectiveness|cost-effectiveness
5724657|NCT00415207|CYP2C8|cyp2c8
5724658|NCT00415207|MDR1|mdr1
5724659|NCT00415207|Pharmacogenetics|pharmacogenetics
5724660|NCT00415207|Paclitaxel|paclitaxel
5741532|NCT00352586|Healthy Volunteer|healthy volunteer
5741534|NCT00352586|Normal Control|normal control
5741540|NCT00352560|Patients with Paroxysmal Atrial Fibrillation (PAF)|patients with paroxysmal atrial fibrillation (paf)
5724661|NCT00415181|CYP2C8|cyp2c8
5724662|NCT00415181|MDR1|mdr1
5724663|NCT00415181|Pharmacogenetics|pharmacogenetics
5724664|NCT00415181|Paclitaxel|paclitaxel
5724665|NCT00415142|Depression|depression
5724666|NCT00415142|Major depressive disorders|major depressive disorders
5724667|NCT00415142|Controlled clinical trial|controlled clinical trial
5724668|NCT00415129|Influenza|influenza
5724669|NCT00415129|Orthomyxoviridae Infections|orthomyxoviridae infections
5724670|NCT00415129|Influenza Pandemics|influenza pandemics
5724671|NCT00415129|A/H5N1 strain|a/h5n1 strain
5724672|NCT00415116|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5724673|NCT00415103|Emesis|emesis
5724674|NCT00415103|Nausea|nausea
5724675|NCT00415103|leukemia|leukemia
5724676|NCT00415103|lymphoma|lymphoma
5724677|NCT00415090|Nevirapine|nevirapine
5724678|NCT00415090|Antiretroviral treatment|antiretroviral treatment
5724679|NCT00415090|Triple nucleoside therapy|triple nucleoside therapy
5724680|NCT00415090|HIV|hiv
5724681|NCT00415090|Treatment Experienced|treatment experienced
5724682|NCT00415064|Multiple Myeloma|multiple myeloma
5724683|NCT00415064|Perifosine|perifosine
5724684|NCT00415064|Lenalidomide|lenalidomide
5724685|NCT00415064|Dexamethasone|dexamethasone
5724686|NCT00415051|Rift Valley Fever, vaccine|rift valley fever, vaccine
5724687|NCT00415038|hypertension|hypertension
5724688|NCT00415038|pharmacogenomic|pharmacogenomic
5724689|NCT00415038|adducin|adducin
5724690|NCT00415038|ouabain|ouabain
5724691|NCT00415038|rostafuroxin|rostafuroxin
5724692|NCT00415025|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5724693|NCT00415025|oral complications of radiation therapy|oral complications of radiation therapy
5724694|NCT00415025|radiation toxicity|radiation toxicity
5724695|NCT00415025|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5724696|NCT00415025|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5724697|NCT00415025|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5724698|NCT00415025|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5724699|NCT00415025|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5724700|NCT00415025|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5724701|NCT00415025|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5724702|NCT00415025|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5724703|NCT00415025|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5724704|NCT00415025|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5724705|NCT00415025|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5724706|NCT00415025|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5724707|NCT00415025|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5724708|NCT00415025|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5724709|NCT00415025|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5724710|NCT00415025|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5724711|NCT00415025|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5724712|NCT00415025|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5724713|NCT00415025|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5724714|NCT00415025|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5724715|NCT00415025|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5724786|NCT00414830|population based|population based
5724716|NCT00415025|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5724717|NCT00415025|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5724718|NCT00415025|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5719964|NCT00431821|Exercise|exercise
5724719|NCT00415025|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5724720|NCT00415025|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5724721|NCT00415025|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5724722|NCT00415025|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5724723|NCT00415025|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5724724|NCT00415025|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5724725|NCT00415025|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5724726|NCT00415025|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5724727|NCT00415025|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5724728|NCT00415025|stage III salivary gland cancer|stage iii salivary gland cancer
5724729|NCT00415025|stage IV salivary gland cancer|stage iv salivary gland cancer
5724730|NCT00415025|recurrent salivary gland cancer|recurrent salivary gland cancer
5724731|NCT00415025|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5724732|NCT00415025|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5724733|NCT00415025|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5724734|NCT00415025|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5724735|NCT00415025|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5724736|NCT00415025|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5724737|NCT00415025|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5724738|NCT00415025|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5724739|NCT00415025|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5724740|NCT00415025|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5724741|NCT00415025|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5724742|NCT00415025|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5724743|NCT00415025|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5724744|NCT00415025|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5724745|NCT00415025|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5724746|NCT00415025|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5724747|NCT00415025|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5724748|NCT00415025|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5724749|NCT00414999|Macular degeneration|macular degeneration
5724750|NCT00414999|Vascular diseases|vascular diseases
5724751|NCT00414999|Retinal disorders|retinal disorders
5724752|NCT00414999|Macular edema|macular edema
5724753|NCT00414960|Healthy|healthy
5724754|NCT00414960|Prevention|prevention
5724755|NCT00414947|Bioequivalence|bioequivalence
5724756|NCT00414947|safety|safety
5724757|NCT00414947|LAF237|laf237
5724758|NCT00414947|vildagliptin|vildagliptin
5724759|NCT00414947|Chinese|chinese
5724760|NCT00414947|healthy subjects|healthy subjects
5724761|NCT00414934|cancer|cancer
5732982|NCT00382954|AML|aml
5724762|NCT00414934|bone scan|bone scan
5724763|NCT00414934|NaF bone PET|naf bone pet
5724764|NCT00414921|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5724765|NCT00414921|ADHD|adhd
5724766|NCT00414921|clonidine|clonidine
5724767|NCT00414921|methylphenidate|methylphenidate
5724769|NCT00414908|Chronic Pancreatitis|chronic pancreatitis
5724770|NCT00414908|Pancreatectomy|pancreatectomy
5724771|NCT00414908|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5724772|NCT00414882|TB, tuberculosis, Mycobacterium tuberculosis, Brazil|tb, tuberculosis, mycobacterium tuberculosis, brazil
5724773|NCT00414869|Liver|liver
5724774|NCT00414869|Portal pressure|portal pressure
5724775|NCT00414869|Fibrosis|fibrosis
5724776|NCT00414869|Nitric oxide|nitric oxide
5724777|NCT00414856|GERD|gerd
5724778|NCT00414856|gastroesophageal reflux disease|gastroesophageal reflux disease
5724779|NCT00414856|meal-induced gastroesophageal reflux events|meal-induced gastroesophageal reflux events
5724780|NCT00414843|Storage|storage
5724781|NCT00414843|Bile|bile
5724782|NCT00414843|Biomarkers|biomarkers
5724783|NCT00414843|biliary malignancies|biliary malignancies
5724784|NCT00414830|prevention|prevention
5724788|NCT00414817|Inhaled Corticosteroids|inhaled corticosteroids
5724789|NCT00414817|ICS|ics
5724790|NCT00414817|Adherence|adherence
5724791|NCT00414804|Pain|pain
5724792|NCT00414804|Neurostimulation|neurostimulation
5724793|NCT00414778|Safety, pharmacokinetics, oral, single dose, multiple dose, LHT344, Chinese, healthy subjects|safety, pharmacokinetics, oral, single dose, multiple dose, lht344, chinese, healthy subjects
5724794|NCT00414765|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5724796|NCT00414765|Aldesleukin|aldesleukin
5724797|NCT00414765|IL-2|il-2
5724798|NCT00414752|Smoking, abstinence, craving, smoker, AFQ056, nicotine, placebo|smoking, abstinence, craving, smoker, afq056, nicotine, placebo
5724799|NCT00414739|growth of dendritic cells|growth of dendritic cells
5724800|NCT00414739|prevention|prevention
5724801|NCT00414726|ischemic stroke|ischemic stroke
5724802|NCT00414726|normobaric oxygen therapy|normobaric oxygen therapy
5724803|NCT00414713|Upper GI bleeding|upper gi bleeding
5724804|NCT00414713|Cirrhosis|cirrhosis
5724805|NCT00414713|Portal hypertension|portal hypertension
5724806|NCT00414713|Non-variceal bleeding|non-variceal bleeding
5724807|NCT00414713|Transfusion|transfusion
5724808|NCT00414700|Cartilage|cartilage
5724809|NCT00414700|Articular|articular
5724810|NCT00414700|Femoral|femoral
5724811|NCT00414700|Knee|knee
5724812|NCT00414687|Primary or secondary Pulmonary hypertension|primary or secondary pulmonary hypertension
5724813|NCT00414687|Iloprost|iloprost
5724815|NCT00414687|Long-term treatment|long-term treatment
5724816|NCT00414661|Observational non-interventional long-term safety|observational non-interventional long-term safety
5724817|NCT00414648|Lymphangiomyomatosis|lymphangiomyomatosis
5724818|NCT00414648|Lung Disease|lung disease
5724819|NCT00414635|HIV/AIDS|hiv/aids
5724820|NCT00414635|efavirenz|efavirenz
5724821|NCT00414635|tenofovir|tenofovir
5724822|NCT00414635|emtricitabine|emtricitabine
5724823|NCT00414635|FOTO|foto
5724824|NCT00414635|treatment interruption|treatment interruption
5724825|NCT00414635|Atripla|atripla
5724826|NCT00414635|Truvada|truvada
5724827|NCT00414635|Treatment Experienced|treatment experienced
5724828|NCT00414622|Alzheimer|alzheimer
5724829|NCT00414622|Probable Alzheimer disease|probable alzheimer disease
5724830|NCT00414609|myocardial infarction, aliskiren, heart failure|myocardial infarction, aliskiren, heart failure
5724831|NCT00414609|Post acute myocardial infarction with systolic dysfunction|post acute myocardial infarction with systolic dysfunction
5724832|NCT00414583|Cerebrovascular Accident|cerebrovascular accident
5724833|NCT00414583|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5724834|NCT00414583|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5724835|NCT00414583|Cerebral Stroke|cerebral stroke
5724836|NCT00414583|Stroke, Acute|stroke, acute
5724837|NCT00414583|Cerebrovascular Stroke|cerebrovascular stroke
5724838|NCT00414583|Fabry Disease|fabry disease
5724839|NCT00414583|Anderson-Fabry Disease|anderson-fabry disease
5724840|NCT00414583|Fabry's Disease|fabry's disease
5724841|NCT00414570|Positron Emission Tomography (PET)|positron emission tomography (pet)
5724842|NCT00414570|3'-deoxy-3'(18F)fluorothymidine ([18]F-FLT)|3'-deoxy-3'(18f)fluorothymidine ([18]f-flt)
5724843|NCT00414557|Musculoskeletal diseases|musculoskeletal diseases
5724844|NCT00414557|Joint diseases|joint diseases
5724845|NCT00414544|Nasolabial folds|nasolabial folds
5724847|NCT00414544|Injectable dermal filler|injectable dermal filler
5724848|NCT00414544|Soft tissue augmentation|soft tissue augmentation
5724849|NCT00414518|Acute Infection|acute infection
5724850|NCT00414518|Early HIV Infection|early hiv infection
5724851|NCT00414518|Short-Term Antiretroviral Therapy|short-term antiretroviral therapy
5724852|NCT00414518|Treatment Interruption|treatment interruption
5724853|NCT00414518|Antiretroviral Drug (ARV)|antiretroviral drug (arv)
5724855|NCT00414492|metastatic colorectal cancer|metastatic colorectal cancer
5724856|NCT00414492|liver metastasis|liver metastasis
5724857|NCT00414492|tumor margins|tumor margins
5724858|NCT00414492|neoadjuvant therapy|neoadjuvant therapy
5724859|NCT00414479|schistosomiasis|schistosomiasis
5724860|NCT00414479|anaemia|anaemia
5724861|NCT00414479|malaria|malaria
5724862|NCT00414479|iron deficiency|iron deficiency
5724863|NCT00414453|Neuropathic pain|neuropathic pain
5724864|NCT00414453|Chronic pain|chronic pain
5724865|NCT00414453|Multiple sclerosis|multiple sclerosis
5724866|NCT00414453|Central neuropathic pain|central neuropathic pain
5724867|NCT00414453|Peripheral neuropathic pain|peripheral neuropathic pain
5724868|NCT00414453|Opioid analgesic|opioid analgesic
5724869|NCT00414453|Lidocaine|lidocaine
5724870|NCT00414440|end-stage renal disease, ESRD, autosomal dominant polycystic kidney disease, ADPKD, everolimus|end-stage renal disease, esrd, autosomal dominant polycystic kidney disease, adpkd, everolimus
5724871|NCT00414427|Knee Osteoarthritis|knee osteoarthritis
5724872|NCT00414427|Ultrasonography|ultrasonography
5724873|NCT00414427|Corticosteroids|corticosteroids
5724875|NCT00414414|Tuberculosis|tuberculosis
5724876|NCT00414414|HIV|hiv
5724877|NCT00414414|Co-infection|co-infection
5724878|NCT00414414|Steroid|steroid
5724879|NCT00414414|Prednisone|prednisone
5724880|NCT00414414|oral corticosteroids|oral corticosteroids
5724881|NCT00414414|TB Treatment|tb treatment
5724882|NCT00414414|South Africa|south africa
5724883|NCT00414388|AIPC|aipc
5724884|NCT00414375|Perforated Appendicitis|perforated appendicitis
5724885|NCT00414375|Abscess|abscess
5724886|NCT00414375|Appendectomy|appendectomy
5724887|NCT00414362|Bacteremia|bacteremia
5724888|NCT00414362|Urinary Tract Infections|urinary tract infections
5724889|NCT00414362|Fluoroquinolone|fluoroquinolone
5724890|NCT00414349|Topical analgesic|topical analgesic
5724891|NCT00414349|Multiple dose|multiple dose
5724892|NCT00414336|Blood Stage|blood stage
5724893|NCT00414336|Investigational|investigational
5724894|NCT00414336|Endemic|endemic
5724895|NCT00414336|Malaria|malaria
5724896|NCT00414310|Decitabine|decitabine
5724897|NCT00414310|Dacogen|dacogen
5724898|NCT00414310|5-AZA|5-aza
5724899|NCT00414310|Valproic Acid|valproic acid
5724900|NCT00414310|Myelodysplastic Syndrome|myelodysplastic syndrome
5724901|NCT00414310|Acute Myelogenous Leukemia|acute myelogenous leukemia
5724902|NCT00414310|MDS|mds
5724903|NCT00414310|AML|aml
5724904|NCT00414297|CAD|cad
5724905|NCT00414297|ECP|ecp
5724906|NCT00414297|CFI|cfi
5724907|NCT00414297|CPI|cpi
5724908|NCT00414297|MPR|mpr
5724909|NCT00414284|HIV/AIDS|hiv/aids
5724910|NCT00414284|viremia|viremia
5724911|NCT00414284|Kaletra|kaletra
5724912|NCT00414284|pharmacokinetics|pharmacokinetics
5724913|NCT00414284|viral load|viral load
5724914|NCT00414284|LPV/r|lpv/r
5724915|NCT00414284|Treatment Experienced|treatment experienced
5724916|NCT00414271|gastric cancer, neo-adjuvant chemotherapy|gastric cancer, neo-adjuvant chemotherapy
5724917|NCT00414258|Pain Response|pain response
5724918|NCT00414232|Rectal Cancer|rectal cancer
5724919|NCT00414232|Chemoradiation|chemoradiation
5724920|NCT00414232|Rectal Cancer receiving chemoradiation.|rectal cancer receiving chemoradiation.
5724921|NCT00414206|AMD|amd
5724922|NCT00414206|Wet AMD|wet amd
5724923|NCT00414193|AmpC beta-lactamase|ampc beta-lactamase
5724924|NCT00414193|Bacteremia|bacteremia
5724925|NCT00414193|Piperacillin|piperacillin
5724926|NCT00414193|Tazobactam|tazobactam
5724927|NCT00414167|Binge eating|binge eating
5724928|NCT00414167|Obesity|obesity
5724929|NCT00414167|Medication|medication
5724930|NCT00414167|Craving|craving
5724931|NCT00414167|Emotional eating|emotional eating
5724932|NCT00414154|Group based patient education,|group based patient education,
5724933|NCT00414154|multidisciplinary,|multidisciplinary,
5724934|NCT00414154|physical activity,|physical activity,
5724935|NCT00414154|adherence to treatment,|adherence to treatment,
5724936|NCT00414154|quality of life|quality of life
5724937|NCT00414141|Allergy|allergy
5724938|NCT00414141|Allergoid|allergoid
5724939|NCT00414141|Specific Immunotherapy|specific immunotherapy
5724940|NCT00414128|vasculitis|vasculitis
5724941|NCT00414128|ANCA|anca
5724942|NCT00414128|mycophenolate mofetil|mycophenolate mofetil
5724943|NCT00414128|cyclophosphamide|cyclophosphamide
5724944|NCT00414128|Anti neutrophil cytoplasm antibody associated vasculitis|anti neutrophil cytoplasm antibody associated vasculitis
5724945|NCT00414115|Observational controlled study|observational controlled study
5724946|NCT00414115|Genomic biomarkers|genomic biomarkers
5724947|NCT00414115|Adverse drug reaction|adverse drug reaction
5724948|NCT00414115|In children OR adults|in children or adults
5724949|NCT00414102|Chronic Insomnia|chronic insomnia
5724950|NCT00414102|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5724951|NCT00414102|Drug Therapy|drug therapy
5724952|NCT00414076|Uterine Leiomyosarcoma|uterine leiomyosarcoma
5724953|NCT00414076|Uterine Neoplasm|uterine neoplasm
5724954|NCT00414076|Uterine Sarcomas|uterine sarcomas
5724955|NCT00414076|Uterine Cancer|uterine cancer
5724956|NCT00414076|Uterus|uterus
5724957|NCT00414076|LMS|lms
5724958|NCT00414076|ER Positivity|er positivity
5724959|NCT00414076|Femara|femara
5724960|NCT00414076|Letrozole|letrozole
5724961|NCT00414063|Fecal Energy|fecal energy
5724962|NCT00414063|Urine Energy|urine energy
5724963|NCT00414063|Bomb Calorimetry|bomb calorimetry
5724964|NCT00414063|Gut Maintenance Flora|gut maintenance flora
5724965|NCT00414063|Obesity|obesity
5750570|NCT00317772|Iressa|iressa
5724966|NCT00414063|Energy Metabolism|energy metabolism
5724967|NCT00414037|insomnia|insomnia
5724968|NCT00414037|lunesta|lunesta
5724969|NCT00414037|eszopiclone|eszopiclone
5724970|NCT00414037|pain|pain
5724971|NCT00414037|fMRI|fmri
5724972|NCT00414024|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5724973|NCT00414011|Removal of corneal epithelium followed by excimer laser treatment during prk|removal of corneal epithelium followed by excimer laser treatment during prk
5724974|NCT00413998|Functional ischaemic mitral regurgitation|functional ischaemic mitral regurgitation
5724975|NCT00413985|Low Birth Weight|low birth weight
5724976|NCT00413985|Fortified Human Milk|fortified human milk
5724977|NCT00413985|breastfeeding|breastfeeding
5724978|NCT00413985|infants|infants
5724979|NCT00413985|growth|growth
5724980|NCT00413959|NHL|nhl
5724981|NCT00413946|Premature infant|premature infant
5724982|NCT00413946|developmental outcome|developmental outcome
5724983|NCT00413933|falls|falls
5724984|NCT00413933|prevention|prevention
5724985|NCT00413933|elderly|elderly
5725077|NCT00413543|pulmonary rehabilitation|pulmonary rehabilitation
5724986|NCT00413933|multidisciplinary intervention|multidisciplinary intervention
5724987|NCT00413933|health care utilization|health care utilization
5724988|NCT00413920|Steroids avoidance,|steroids avoidance,
5724989|NCT00413920|enteric-coated mycophenolate sodium (EC-MPS),|enteric-coated mycophenolate sodium (ec-mps),
5724991|NCT00413881|Residual refractive error left over from initial LASIK correction.|residual refractive error left over from initial lasik correction.
5724992|NCT00413881|Higher Order aberrations measured using a wavefront analyzer.|higher order aberrations measured using a wavefront analyzer.
5724993|NCT00413868|Myopia with our without astigmatism|myopia with our without astigmatism
5724994|NCT00413855|Abdominal pain|abdominal pain
5724995|NCT00413855|Appendectomy|appendectomy
5724997|NCT00413855|Chronic appendicitis|chronic appendicitis
5724998|NCT00413855|Appendicopathy|appendicopathy
5724999|NCT00413842|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5725000|NCT00413842|Plasticity|plasticity
5725001|NCT00413842|Primary Motor Cortex|primary motor cortex
5725002|NCT00413842|Cerebellum|cerebellum
5725003|NCT00413842|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5725004|NCT00413842|Healthy Volunteer|healthy volunteer
5725005|NCT00413842|HV|hv
5725006|NCT00413829|age related macular degeneration|age related macular degeneration
5725007|NCT00413829|anti-VEGF therapy|anti-vegf therapy
5725008|NCT00413816|Anemia|anemia
5725009|NCT00413816|Critically ill|critically ill
5725010|NCT00413803|Hemodialysis|hemodialysis
5725011|NCT00413803|Nocturnal dialysis|nocturnal dialysis
5725012|NCT00413803|Cardiovascular disease|cardiovascular disease
5725013|NCT00413803|Quality of Life|quality of life
5725014|NCT00413803|left ventricular hypertrophy|left ventricular hypertrophy
5725015|NCT00413790|Heart rate, overactive bladder|heart rate, overactive bladder
5725016|NCT00413751|Large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia|large pupils rendering night vision difficulties such as haloes, glare, and monocular diplopia
5725017|NCT00413738|Central venous catheter|central venous catheter
5725018|NCT00413738|Catheter related bloodstream infection|catheter related bloodstream infection
5725019|NCT00413738|Heparin|heparin
5725020|NCT00413738|Chlorhexidine|chlorhexidine
5725021|NCT00413738|Sulfadiazine|sulfadiazine
5725022|NCT00413725|HIV Seronegativity|hiv seronegativity
5725023|NCT00413725|HIV Preventive Vaccine|hiv preventive vaccine
5725024|NCT00413725|Adenovirus|adenovirus
5725025|NCT00413712|Supraventricular Tachycardia|supraventricular tachycardia
5725026|NCT00413712|Calcium Channel Blockers|calcium channel blockers
5725027|NCT00413712|Verapamil|verapamil
5725028|NCT00413712|Diltiazem|diltiazem
5725029|NCT00413712|Adenosine|adenosine
5725030|NCT00413699|long-term|long-term
5725031|NCT00413699|open-label|open-label
5725032|NCT00413699|safety|safety
5725033|NCT00413686|Mixed solid tumors|mixed solid tumors
5725034|NCT00413673|Naturally occurring low to moderate myopia, with or without low levels of astigmatism in U.S. Army personnel|naturally occurring low to moderate myopia, with or without low levels of astigmatism in u.s. army personnel
5725035|NCT00413660|DMARD therapy|dmard therapy
5725036|NCT00413647|CardioPET|cardiopet
5725037|NCT00413647|Coronary Artery Disease|coronary artery disease
5725038|NCT00413647|Electrocardiogram|electrocardiogram
5725039|NCT00413647|Radiation Dosimetry|radiation dosimetry
5725041|NCT00413621|Alzheimer Disease|alzheimer disease
5725042|NCT00413621|Amyloid|amyloid
5725044|NCT00413621|Healthy Volunteer|healthy volunteer
5725045|NCT00413621|HV|hv
5725046|NCT00413608|Human|human
5725047|NCT00413608|Adults|adults
5725048|NCT00413608|Male|male
5725049|NCT00413608|Alleles|alleles
5725050|NCT00413608|Genotype|genotype
5725051|NCT00413608|Platelet Aggregation/drug effects|platelet aggregation/drug effects
5725052|NCT00413608|Platelet Aggregation Inhibitors/*pharmacology|platelet aggregation inhibitors/*pharmacology
5725053|NCT00413608|Platelet Function Tests|platelet function tests
5725054|NCT00413608|Pharmacogenetics|pharmacogenetics
5725055|NCT00413608|*Polymorphism, Genetic|*polymorphism, genetic
5725056|NCT00413608|Ticlopidine/*analogs & derivatives/pharmacology|ticlopidine/*analogs & derivatives/pharmacology
5686151|NCT00553345|stage I bladder cancer|stage i bladder cancer
5725057|NCT00413608|Healthy subjects|healthy subjects
5725058|NCT00413595|Cerebrovascular Accident|cerebrovascular accident
5725059|NCT00413595|Cerebrovascular Accident, Acute|cerebrovascular accident, acute
5725060|NCT00413595|Fabry Disease|fabry disease
5725061|NCT00413595|Fabry's Disease|fabry's disease
5725062|NCT00413595|Anderson-Fabry Disease|anderson-fabry disease
5725063|NCT00413595|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5725064|NCT00413595|Stroke, acute|stroke, acute
5725065|NCT00413595|Cerebral Stroke|cerebral stroke
5725066|NCT00413582|Pectus Excavatum|pectus excavatum
5725067|NCT00413582|Bar Repair|bar repair
5725068|NCT00413582|Pain Control|pain control
5725069|NCT00413582|Pectus Excavatum Repair|pectus excavatum repair
5725070|NCT00413556|Rhinitis|rhinitis
5725071|NCT00413556|Oral tablets|oral tablets
5725072|NCT00413556|Ig G4|ig g4
5725073|NCT00413556|grass pollen|grass pollen
5725074|NCT00413556|inmunotherapy|inmunotherapy
5725075|NCT00413543|COPD|copd
5725076|NCT00413543|exacerbation|exacerbation
5725278|NCT00413153|Lipids|lipids
5725078|NCT00413543|exercise tolerance|exercise tolerance
5725079|NCT00413543|exacerbations|exacerbations
5725080|NCT00413543|quality of life|quality of life
5725081|NCT00413543|readmissions|readmissions
5725082|NCT00413517|Naturally occurring myopia with or without astigmatism|naturally occurring myopia with or without astigmatism
5725084|NCT00413504|Monotherapy|monotherapy
5725085|NCT00413504|Deep Vein thrombosis|deep vein thrombosis
5725086|NCT00413504|Pulmonary Embolism|pulmonary embolism
5725087|NCT00413504|Anticoagulation|anticoagulation
5725088|NCT00413491|Breast Cancer|breast cancer
5725089|NCT00413491|BRCA1 gene|brca1 gene
5725090|NCT00413491|BRCA2 gene|brca2 gene
5725091|NCT00413491|Magnetic Resonance Imaging|magnetic resonance imaging
5741987|NCT00351208|Stimulation pulse-widths|stimulation pulse-widths
5741988|NCT00351208|Varying settings|varying settings
5741989|NCT00351195|Hepatocellular carcinoma|hepatocellular carcinoma
5741990|NCT00351195|Etoposide|etoposide
5725092|NCT00413491|Mammography|mammography
5725093|NCT00413491|Ultrasonography|ultrasonography
5725094|NCT00413478|5-Aza|5-aza
5725095|NCT00413478|Azacytidine|azacytidine
5725096|NCT00413478|Vidaza|vidaza
5725098|NCT00413478|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5725099|NCT00413478|Richter's transformation|richter's transformation
5725100|NCT00413478|Leukemia|leukemia
5725101|NCT00413465|Renal Plasma Flow|renal plasma flow
5725102|NCT00413465|Endotoxemia|endotoxemia
5725103|NCT00413465|Type 2 diabetes|type 2 diabetes
5725104|NCT00413452|Rheumatoid Arthritis|rheumatoid arthritis
5725105|NCT00413452|Etanercept|etanercept
5725106|NCT00413452|Enbrel|enbrel
5725108|NCT00413439|Isavuconazole|isavuconazole
5725109|NCT00413439|BAL8557|bal8557
5725110|NCT00413439|ASP9766|asp9766
5725111|NCT00413439|chemotherapy|chemotherapy
5725112|NCT00413439|prophylaxis|prophylaxis
5725113|NCT00413439|systemic fungal infection|systemic fungal infection
5725114|NCT00413426|Pharmacokinetics|pharmacokinetics
5725115|NCT00413426|oral|oral
5725116|NCT00413426|single dose|single dose
5725117|NCT00413426|table|table
5725118|NCT00413426|suspension|suspension
5725119|NCT00413426|release|release
5725120|NCT00413426|darifenacin|darifenacin
5725121|NCT00413426|healthy subjects|healthy subjects
5725122|NCT00413426|Healthy volunteers study|healthy volunteers study
5725123|NCT00413413|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5725124|NCT00413400|Inflammation|inflammation
5725125|NCT00413400|Visceral adiposity|visceral adiposity
5725127|NCT00413400|Adiponectin|adiponectin
5725128|NCT00413400|glucose tolerance|glucose tolerance
5725129|NCT00413400|endothelial function|endothelial function
5725130|NCT00413400|metabolic syndrome|metabolic syndrome
5725131|NCT00413387|Asthma|asthma
5725132|NCT00413387|Combinations|combinations
5725133|NCT00413387|Inhaled therapy|inhaled therapy
5725134|NCT00413387|Corticosteroids|corticosteroids
5725135|NCT00413387|Long acting bronchodilators|long acting bronchodilators
5725136|NCT00413387|Beclomethasone|beclomethasone
5725137|NCT00413387|Formoterol|formoterol
5725138|NCT00413387|Budesonide|budesonide
5725139|NCT00413374|Lovenox|lovenox
5725140|NCT00413374|Enoxaparin|enoxaparin
5725142|NCT00413374|Pulmonary Embolism|pulmonary embolism
5725143|NCT00413374|Acute Deep Vein Thrombosis|acute deep vein thrombosis
5725144|NCT00413374|Venous Thrombosis|venous thrombosis
5725145|NCT00413374|Thrombosis|thrombosis
5725146|NCT00413374|Anticoagulation|anticoagulation
5725147|NCT00413361|Systemic Lupus Erythematosus|systemic lupus erythematosus
5725148|NCT00413361|Hydroxychloroquine|hydroxychloroquine
5725149|NCT00413348|Type 2 diabetes|type 2 diabetes
5725150|NCT00413348|Probiotics|probiotics
5725151|NCT00413348|Insulin-resistance|insulin-resistance
5725152|NCT00413348|Inflammation|inflammation
5725153|NCT00413348|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5725154|NCT00413348|Endotoxin|endotoxin
5725155|NCT00413335|Childhood and Adolescent Obesity|childhood and adolescent obesity
5725156|NCT00413335|Metabolic phenotype|metabolic phenotype
5724250|NCT00416364|hernia|hernia
5725157|NCT00413335|Impaired Glucose Tolerance|impaired glucose tolerance
5725158|NCT00413335|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5725159|NCT00413335|Insulin Sensitivity|insulin sensitivity
5725160|NCT00413335|Insulin Resistance|insulin resistance
5725161|NCT00413335|Abdominal fat partitioning|abdominal fat partitioning
5725162|NCT00413335|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
5725163|NCT00413335|Type 2 Diabetes Mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5725164|NCT00413322|Advanced Solid tumor|advanced solid tumor
5725165|NCT00413322|Adenosarcoma|adenosarcoma
5725166|NCT00413322|Androgen-independent prostate cancer|androgen-independent prostate cancer
5725167|NCT00413322|belinostat|belinostat
5725168|NCT00413322|bladder cancer|bladder cancer
5725169|NCT00413322|bladder neoplasms|bladder neoplasms
5725170|NCT00413322|Breast cancer|breast cancer
5725171|NCT00413322|Carcinoma, Bronchogenic|carcinoma, bronchogenic
5725172|NCT00413322|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5725173|NCT00413322|Carcinoma, Small Cell|carcinoma, small cell
5725174|NCT00413322|Carcinosarcoma|carcinosarcoma
5725175|NCT00413322|Chondrosarcoma|chondrosarcoma
5725176|NCT00413322|Coin Lesion, Pulmonary|coin lesion, pulmonary
5725177|NCT00413322|colorectal cancer|colorectal cancer
5725178|NCT00413322|Esophageal Neoplasms|esophageal neoplasms
5725180|NCT00413322|Fibrosarcoma|fibrosarcoma
5725181|NCT00413322|head and neck cancer|head and neck cancer
5725182|NCT00413322|Hemangiosarcoma|hemangiosarcoma
5725183|NCT00413322|Histiocytoma, Malignant Fibrous|histiocytoma, malignant fibrous
5725184|NCT00413322|kidney cancer|kidney cancer
5725185|NCT00413322|Leiomyosarcoma|leiomyosarcoma
5725186|NCT00413322|Liposarcoma|liposarcoma
5725187|NCT00413322|lung cancer|lung cancer
5725188|NCT00413322|lung neoplasms|lung neoplasms
5725189|NCT00413322|Lymphangiosarcoma|lymphangiosarcoma
5725190|NCT00413322|mesothelioma|mesothelioma
5725191|NCT00413322|mesothelioma, cystic|mesothelioma, cystic
5725192|NCT00413322|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
5725193|NCT00413322|Mouth Neoplasms|mouth neoplasms
5725194|NCT00413322|Myosarcoma|myosarcoma
5725195|NCT00413322|Myxosarcoma|myxosarcoma
5725196|NCT00413322|Osteosarcoma|osteosarcoma
5725197|NCT00413322|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
5725198|NCT00413322|Ovarian cancer|ovarian cancer
5725199|NCT00413322|Pancoast's Syndrome|pancoast's syndrome
5725200|NCT00413322|Parathyroid Neoplasms|parathyroid neoplasms
5725201|NCT00413322|Phyllodes Tumor|phyllodes tumor
5725202|NCT00413322|Pulmonary Sclerosing Hemangioma|pulmonary sclerosing hemangioma
5725203|NCT00413322|sarcoma|sarcoma
5725204|NCT00413322|thyroid cancer|thyroid cancer
5725205|NCT00413322|Thyroid Neoplasms|thyroid neoplasms
5725206|NCT00413322|Tracheal Neoplasms|tracheal neoplasms
5725208|NCT00413309|Acute Coronary Syndrome|acute coronary syndrome
5725209|NCT00413309|Percutaneous Coronary Intervention|percutaneous coronary intervention
5725210|NCT00413309|Antiplatelet Therapy|antiplatelet therapy
5725211|NCT00413309|PillCam|pillcam
5725212|NCT00413309|Endoscopy|endoscopy
5725213|NCT00413296|PTSD|ptsd
5725214|NCT00413296|Anxiety|anxiety
5725215|NCT00413296|Pharmacotherapy|pharmacotherapy
5725216|NCT00413296|Levetiracetam|levetiracetam
5725217|NCT00413296|Relapse prevention|relapse prevention
5725218|NCT00413283|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5725219|NCT00413283|Chemotherapy Induced Thrombocytopenia|chemotherapy induced thrombocytopenia
5725220|NCT00413283|CIT|cit
5725221|NCT00413283|NSCLC|nsclc
5725222|NCT00413283|Stage IIIB NSCLC|stage iiib nsclc
5725223|NCT00413283|Stage IV NSCLC|stage iv nsclc
5725224|NCT00413283|Gemcitabine|gemcitabine
5725225|NCT00413283|Carboplatin|carboplatin
5725226|NCT00413283|Cisplatin|cisplatin
5725227|NCT00413270|Imatinib resistant,|imatinib resistant,
5725228|NCT00413270|Imatinib intolerant,|imatinib intolerant,
5725229|NCT00413270|CML- blast crisis,|cml- blast crisis,
5725230|NCT00413270|CML- Accelerated phase,|cml- accelerated phase,
5725231|NCT00413270|CML- chronic phase,|cml- chronic phase,
5725232|NCT00413270|nilotinib,|nilotinib,
5725233|NCT00413270|Chronic myelogenous leukemia,|chronic myelogenous leukemia,
5725234|NCT00413270|blast crisis,|blast crisis,
5725235|NCT00413270|accelerated phase,|accelerated phase,
5725236|NCT00413270|chronic phase|chronic phase
5725237|NCT00413257|Postoperative Hyperalgesia|postoperative hyperalgesia
5725238|NCT00413257|cardiac Surgical Procedures|cardiac surgical procedures
5725239|NCT00413257|Nefopam|nefopam
5725240|NCT00413257|Randomized Controlled Trials|randomized controlled trials
5725241|NCT00413257|Pain and chronic disease|pain and chronic disease
5725242|NCT00413244|Hypogonadal|hypogonadal
5725243|NCT00413244|coronary artery disease|coronary artery disease
5725244|NCT00413244|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5725245|NCT00413231|Thoracic Aneurysm|thoracic aneurysm
5725246|NCT00413231|Endovascular Aortic Repair (EVAR)|endovascular aortic repair (evar)
5725247|NCT00413231|Endovascular Stent Graft|endovascular stent graft
5725248|NCT00413231|Endograft|endograft
5725249|NCT00413231|Thoracic Aortic Aneurysm|thoracic aortic aneurysm
5725250|NCT00413231|Endovascular procedure|endovascular procedure
5725251|NCT00413231|Descending Thoracic Aneurysm|descending thoracic aneurysm
5686152|NCT00553319|ADHD|adhd
5725252|NCT00413231|Valiant Stent Graft System|valiant stent graft system
5725253|NCT00413218|Invasive Candida infections|invasive candida infections
5725254|NCT00413218|BAL8557|bal8557
5725255|NCT00413218|ASP9766|asp9766
5725256|NCT00413218|Isavuconazole|isavuconazole
5725257|NCT00413218|Candidemia|candidemia
5725258|NCT00413218|Candidemia and other invasive candida infections|candidemia and other invasive candida infections
5725259|NCT00413218|Phase III study|phase iii study
5725260|NCT00413179|Polycystic Ovarian Syndrome|polycystic ovarian syndrome
5725261|NCT00413179|Chronic Anovulation|chronic anovulation
5725262|NCT00413179|Chronic Oligoovulation|chronic oligoovulation
5725263|NCT00413179|Infertility|infertility
5725264|NCT00413179|Hyperandrogenism|hyperandrogenism
5725265|NCT00413179|Metformin|metformin
5725266|NCT00413179|Ovulation induction|ovulation induction
5725267|NCT00413166|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5725269|NCT00413166|ATRA|atra
5725270|NCT00413166|All-Trans Retinoic Acid|all-trans retinoic acid
5725271|NCT00413166|Arsenic Trioxide|arsenic trioxide
5725272|NCT00413166|Theophylline|theophylline
5725273|NCT00413166|Gemtuzumab|gemtuzumab
5725274|NCT00413153|HIV|hiv
5725275|NCT00413153|Kaletra|kaletra
5725276|NCT00413153|Reyataz|reyataz
5725277|NCT00413153|Insulin sensitivity|insulin sensitivity
5725280|NCT00413153|Receiving Kaletra|receiving kaletra
5725281|NCT00413153|Treatment Experienced|treatment experienced
5725282|NCT00413140|childhood disease|childhood disease
5725283|NCT00413140|cystic fibrosis|cystic fibrosis
5725284|NCT00413140|exhaled breath condensate|exhaled breath condensate
5725285|NCT00413140|exhaled nitric oxide|exhaled nitric oxide
5725286|NCT00413140|airway inflammation|airway inflammation
5725287|NCT00413140|non-invasive inflammatory markers|non-invasive inflammatory markers
5725288|NCT00413140|controls|controls
5725289|NCT00413140|children|children
5725290|NCT00413127|Systemic lidocaine|systemic lidocaine
5725291|NCT00413127|peridural lidocaine|peridural lidocaine
5725292|NCT00413127|perioperative analgesia|perioperative analgesia
5725293|NCT00413127|inflammation|inflammation
5725294|NCT00413127|Anesthesia|anesthesia
5725295|NCT00413088|renal insufficency|renal insufficency
5725296|NCT00413088|low molecular weight heparin|low molecular weight heparin
5725297|NCT00413088|pharmacokinetics|pharmacokinetics
5725298|NCT00413088|elderly|elderly
5725299|NCT00413075|Solid tumors|solid tumors
5725300|NCT00413075|Adenosarcoma|adenosarcoma
5725301|NCT00413075|B-cell lymphoma|b-cell lymphoma
5725302|NCT00413075|belinostat|belinostat
5725303|NCT00413075|bladder cancer|bladder cancer
5725304|NCT00413075|Breast cancer|breast cancer
5725305|NCT00413075|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5725306|NCT00413075|Carcinoma, Small Cell|carcinoma, small cell
5725307|NCT00413075|Chondrosarcoma|chondrosarcoma
5725308|NCT00413075|colorectal cancer|colorectal cancer
5725309|NCT00413075|Esophageal Neoplasms|esophageal neoplasms
5725310|NCT00413075|Fibrosarcoma|fibrosarcoma
5725311|NCT00413075|head and neck cancer|head and neck cancer
5725312|NCT00413075|Hemangiosarcoma|hemangiosarcoma
5725313|NCT00413075|Hodgkins Disease|hodgkins disease
5725314|NCT00413075|kidney cancer|kidney cancer
5725315|NCT00413075|Leiomyosarcoma|leiomyosarcoma
5725316|NCT00413075|Liposarcoma|liposarcoma
5725317|NCT00413075|lung cancer|lung cancer
5725318|NCT00413075|lymphoma|lymphoma
5725319|NCT00413075|mesothelioma|mesothelioma
5725320|NCT00413075|mesothelioma, cystic|mesothelioma, cystic
5725321|NCT00413075|Mixed Tumor, Mesodermal|mixed tumor, mesodermal
5725322|NCT00413075|Osteosarcoma|osteosarcoma
5725323|NCT00413075|Otorhinolaryngologic Neoplasms|otorhinolaryngologic neoplasms
5725324|NCT00413075|Ovarian cancer|ovarian cancer
5725325|NCT00413075|Parathyroid Neoplasms|parathyroid neoplasms
5725326|NCT00413075|Prostate cancer|prostate cancer
5725327|NCT00413075|sarcoma|sarcoma
5725328|NCT00413075|T-cell lymphoma|t-cell lymphoma
5725329|NCT00413075|thyroid cancer|thyroid cancer
5725330|NCT00413075|PXD101|pxd101
5725331|NCT00413049|Hypertension, valsartan, amlodipine, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5725332|NCT00413036|Celgene|celgene
5725333|NCT00413036|Revlimid|revlimid
5725334|NCT00413036|CC-5013|cc-5013
5725335|NCT00413036|Non-hodgkin's lymphoma|non-hodgkin's lymphoma
5725336|NCT00413036|Lenalidomide|lenalidomide
5725337|NCT00413036|CC5013|cc5013
5725338|NCT00413036|NHL|nhl
5725339|NCT00413023|depression|depression
5725340|NCT00413023|major depressive disorder|major depressive disorder
5725341|NCT00413023|MDD|mdd
5725342|NCT00412997|advanced solid tumor|advanced solid tumor
5725343|NCT00412997|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5725344|NCT00412997|Phase I|phase i
5725345|NCT00412997|HDAC inhibitor|hdac inhibitor
5725346|NCT00412997|Adult patients|adult patients
5725347|NCT00412971|Recurrence of bladder cancer|recurrence of bladder cancer
5725348|NCT00412971|Fluorescence cystoscopy|fluorescence cystoscopy
5725349|NCT00412932|Hypertension|hypertension
5725350|NCT00412932|Angiotensin Receptor Blocker|angiotensin receptor blocker
5725351|NCT00412932|Calcium Channel Blocker|calcium channel blocker
5725352|NCT00412932|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5725353|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide
5725354|NCT00412932|Stage I and II Hypertension|stage i and ii hypertension
5725355|NCT00412919|Myeloma|myeloma
5725356|NCT00412919|Relapsed|relapsed
5725357|NCT00412919|Refractory|refractory
5725358|NCT00412906|Low-grade inflammation|low-grade inflammation
5725359|NCT00412906|insulin resistance|insulin resistance
5725360|NCT00412906|Metabolism|metabolism
5725361|NCT00412906|Type 2 diabetes|type 2 diabetes
5725362|NCT00412906|Endotoxemia|endotoxemia
5725363|NCT00412906|Fat tissue|fat tissue
5725364|NCT00412906|Muscle tissue|muscle tissue
5725366|NCT00412893|Invasive fungal disease|invasive fungal disease
5725367|NCT00412893|BAL8557|bal8557
5725368|NCT00412893|Isavuconazole|isavuconazole
5725369|NCT00412893|ASP9766|asp9766
5725370|NCT00412893|Filamentous fungi|filamentous fungi
5725371|NCT00412893|Phase III|phase iii
5725372|NCT00412893|Aspergillus species|aspergillus species
5725373|NCT00412867|Cerebral Infarction|cerebral infarction
5725374|NCT00412867|acute ischemic stroke|acute ischemic stroke
5725375|NCT00412867|Brain ischemia|brain ischemia
5725376|NCT00412841|Avascular Necrosis|avascular necrosis
5725377|NCT00412841|Lipitor|lipitor
5725378|NCT00412841|SLE|sle
5725379|NCT00412828|Melanoma|melanoma
5725487|NCT00412386|Pediatric|pediatric
5725380|NCT00412828|CR011-vcMMAE|cr011-vcmmae
5725381|NCT00412815|insulin sensitivity|insulin sensitivity
5725382|NCT00412815|coronary artery disease|coronary artery disease
5725383|NCT00412815|exercise training|exercise training
5725384|NCT00412802|enoxaparine|enoxaparine
5725385|NCT00412802|acute coronary syndrome|acute coronary syndrome
5725386|NCT00412802|renal failure|renal failure
5725387|NCT00412802|dose adaptation|dose adaptation
5725388|NCT00412789|Advanced solid tumor|advanced solid tumor
5725389|NCT00412789|Patupilone|patupilone
5725390|NCT00412763|Acute hepatitis|acute hepatitis
5725391|NCT00412763|Acute viral hepatitis|acute viral hepatitis
5725392|NCT00412763|Acute nonviral hepatitis|acute nonviral hepatitis
5725393|NCT00412763|Silymarin|silymarin
5725394|NCT00412763|Milk Thistle|milk thistle
5725395|NCT00412750|hepatitis B|hepatitis b
5725396|NCT00412750|hepatitis B Virus (HBV)|hepatitis b virus (hbv)
5725397|NCT00412750|chronic hepatitis B|chronic hepatitis b
5725398|NCT00412750|telbivudine|telbivudine
5725399|NCT00412750|peginterferon|peginterferon
5725400|NCT00412724|diet|diet
5725401|NCT00412724|acceptability|acceptability
5725402|NCT00412724|palatability|palatability
5725403|NCT00412724|food|food
5725404|NCT00412724|questionnaire|questionnaire
5725405|NCT00412724|Food habits|food habits
5725406|NCT00412672|Myocardial infarction|myocardial infarction
5725407|NCT00412672|contrast echocardiography|contrast echocardiography
5725408|NCT00412672|collateral circulation|collateral circulation
5725409|NCT00412659|Sinus, Pilonidal|sinus, pilonidal
5725410|NCT00412659|Pilonidal sinus|pilonidal sinus
5725411|NCT00412659|Pilonidal cysts|pilonidal cysts
5725412|NCT00412659|Pilonidal disease|pilonidal disease
5725413|NCT00412659|midline excision|midline excision
5725414|NCT00412659|Karydakis operation|karydakis operation
5725415|NCT00412659|expertise based study|expertise based study
5725417|NCT00412659|therapy|therapy
5725419|NCT00412646|AIDS|aids
5725420|NCT00412646|Dose finding study|dose finding study
5725421|NCT00412646|TMC125-C203|tmc125-c203
5725422|NCT00412646|Treatment Experienced|treatment experienced
5725423|NCT00412633|Obesity|obesity
5725424|NCT00412633|Men|men
5725425|NCT00412633|Overweight|overweight
5725426|NCT00412607|Ventricular Tachycardia|ventricular tachycardia
5725427|NCT00412607|Heart Diseases|heart diseases
5725428|NCT00412607|Arrhythmia|arrhythmia
5725429|NCT00412581|Melanoma|melanoma
5725430|NCT00412581|Lenalidomide|lenalidomide
5725431|NCT00412581|Dacarbazine|dacarbazine
5725432|NCT00412581|CC-5013|cc-5013
5725433|NCT00412581|Revlimid|revlimid
5725434|NCT00412581|DTIC|dtic
5725435|NCT00412568|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
5725436|NCT00412542|Glioblastoma Multiforme|glioblastoma multiforme
5725437|NCT00412542|Glioma|glioma
5725438|NCT00412542|Thalidomide|thalidomide
5725439|NCT00412542|Thalomid|thalomid
5725440|NCT00412542|CPT-11|cpt-11
5725441|NCT00412542|Irinotecan|irinotecan
5725442|NCT00412542|malignant glioma|malignant glioma
5725443|NCT00412529|HBeAg-positive, chronic hepatitis B|hbeag-positive, chronic hepatitis b
5725444|NCT00412529|telbivudine|telbivudine
5725445|NCT00412529|entecavir|entecavir
5725446|NCT00412529|viral kinetics|viral kinetics
5725447|NCT00412516|Japanese Encephalitis|japanese encephalitis
5725448|NCT00412516|Japanese B Encephalitis|japanese b encephalitis
5725449|NCT00412516|Japanese B Viral Encephalitis|japanese b viral encephalitis
5725450|NCT00412516|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
5725451|NCT00412490|Oral Cavity Cancer|oral cavity cancer
5725452|NCT00412490|Body Image|body image
5725453|NCT00412490|Smoking|smoking
5725454|NCT00412490|Appearance|appearance
5725455|NCT00412490|Questionnaire|questionnaire
5725456|NCT00412490|Interview|interview
5725457|NCT00412477|HIV|hiv
5725458|NCT00412477|Lfn-p24|lfn-p24
5725459|NCT00412477|Anthrax|anthrax
5725460|NCT00412477|IM|im
5686153|NCT00553319|Cocaine|cocaine
5725461|NCT00412477|HIV-1|hiv-1
5725462|NCT00412477|HIV Preventive Vaccine|hiv preventive vaccine
5725463|NCT00412464|fondaparinux|fondaparinux
5725464|NCT00412464|thrombosis|thrombosis
5725465|NCT00412464|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5725466|NCT00412464|pediatrics|pediatrics
5734672|NCT00377026|weight loss|weight loss
5725467|NCT00412451|Diabetic Macular Edema|diabetic macular edema
5725468|NCT00412451|PVD|pvd
5725469|NCT00412451|DME|dme
5725470|NCT00412451|Diabetic Retinopathy|diabetic retinopathy
5725471|NCT00412438|Atrial Fibrillation|atrial fibrillation
5725472|NCT00412425|Melanoma|melanoma
5725473|NCT00412425|Nausea|nausea
5725474|NCT00412425|Vomiting|vomiting
5725475|NCT00412425|Palonosetron|palonosetron
5725476|NCT00412425|Cisplatin|cisplatin
5725477|NCT00412425|Vinblastine|vinblastine
5725478|NCT00412425|Loss of Appetite|loss of appetite
5725479|NCT00412425|Weight loss|weight loss
5725480|NCT00412412|Cancer of Breast|cancer of breast
5725481|NCT00412412|Cancer of the Breast|cancer of the breast
5725482|NCT00412399|Employment|employment
5725483|NCT00412399|Negative workplace events|negative workplace events
5725484|NCT00412399|Healthy controls|healthy controls
5725485|NCT00412399|Fatigue|fatigue
5725488|NCT00412386|Congenital Heart Disease|congenital heart disease
5725489|NCT00412386|Imaging|imaging
5725490|NCT00412373|Schizoaffective Disorder|schizoaffective disorder
5725491|NCT00412373|antipsychotic|antipsychotic
5725492|NCT00412373|paliperidone|paliperidone
5725493|NCT00412373|placebo|placebo
5725494|NCT00412360|Double cord blood|double cord blood
5725495|NCT00412347|hyperglycemia|hyperglycemia
5725496|NCT00412347|diabetes|diabetes
5725497|NCT00412347|insulin drip|insulin drip
5725498|NCT00412347|hypoglycemia|hypoglycemia
5725499|NCT00412347|general wards|general wards
5725500|NCT00412321|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5725501|NCT00412321|Multiple Myeloma|multiple myeloma
5725502|NCT00412321|Castleman's disease|castleman's disease
5725503|NCT00412321|intravenous|intravenous
5725504|NCT00412321|IL-6|il-6
5725505|NCT00412308|spinal cord injury|spinal cord injury
5725506|NCT00412308|ventilator dependency|ventilator dependency
5725507|NCT00412308|ventilator weaning|ventilator weaning
5725508|NCT00412308|tidal volume|tidal volume
5725509|NCT00412295|Naturally occuring myopia with or without astigmatism.|naturally occuring myopia with or without astigmatism.
5725510|NCT00412295|Wavefront errors|wavefront errors
5725511|NCT00412269|Insulin Sensitivity|insulin sensitivity
5725512|NCT00412269|Total abdominal fat|total abdominal fat
5725513|NCT00412269|Visceral abdominal fat|visceral abdominal fat
5725514|NCT00412269|Reproductive Hormones|reproductive hormones
5725515|NCT00412269|Menopause|menopause
5725516|NCT00412269|Diabetes|diabetes
5725517|NCT00412269|Fat Distribution|fat distribution
5725518|NCT00412269|Sex Hormones|sex hormones
5725519|NCT00412256|Treatment|treatment
5725520|NCT00412256|Disease activity|disease activity
5725521|NCT00412256|Clinical trial|clinical trial
5725522|NCT00412243|Burkitt's Lymphoma|burkitt's lymphoma
5725523|NCT00412243|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5725524|NCT00412243|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5725525|NCT00412243|Clofarabine|clofarabine
5725526|NCT00412243|Clofarex|clofarex
5725527|NCT00412243|Clolar|clolar
5725528|NCT00412243|Cyclophosphamide|cyclophosphamide
5725529|NCT00412243|Neosar|neosar
5725530|NCT00412243|Cytoxan|cytoxan
5725531|NCT00412230|Pre-eclampsia|pre-eclampsia
5725532|NCT00412230|Gestational diabetes|gestational diabetes
5725533|NCT00412230|Insulin resistance|insulin resistance
5725534|NCT00412230|hypertension in pregnancy|hypertension in pregnancy
5725535|NCT00412204|double-blind|double-blind
5725536|NCT00412204|placebo-controlled|placebo-controlled
5725537|NCT00412204|crossover|crossover
5725538|NCT00412204|effects of tiotropium bromide|effects of tiotropium bromide
5725539|NCT00412204|gas exchange|gas exchange
5725540|NCT00412204|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5725541|NCT00412204|exercise.|exercise.
5725542|NCT00412191|healthy volunteers|healthy volunteers
5725543|NCT00412191|bioequivalence|bioequivalence
5725544|NCT00412191|food effects|food effects
5725545|NCT00412178|Internet|internet
5725546|NCT00412178|mobile communication|mobile communication
5725547|NCT00412178|glucose monitoring|glucose monitoring
5725548|NCT00412165|Prevention of Type 2 Diabetes|prevention of type 2 diabetes
5725549|NCT00412165|Adolescents|adolescents
5725550|NCT00412165|Obesity|obesity
5725551|NCT00412165|Overweight|overweight
5725552|NCT00412165|Internet Technology|internet technology
5725553|NCT00412165|Cell Phone|cell phone
5725554|NCT00412152|A randomised|a randomised
5725555|NCT00412152|double blind|double blind
5725556|NCT00412152|parallel group|parallel group
5725557|NCT00412152|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain|multicentre study to demonstrate improvement in symptoms of constipation in subjects with non malignant pain
5725558|NCT00412152|Moderate to severe chronic non-malignant pain|moderate to severe chronic non-malignant pain
5724566|NCT00415532|TPO|tpo
5725559|NCT00412139|vascular calcifications|vascular calcifications
5725560|NCT00412139|uremic toxins|uremic toxins
5725561|NCT00412139|renal osteodystrophy|renal osteodystrophy
5725562|NCT00412139|Dialysis|dialysis
5725563|NCT00412126|Diabetes Mellitus|diabetes mellitus
5725564|NCT00412126|Coronary Restenosis|coronary restenosis
5735858|NCT00373412|T cell|t cell
5725565|NCT00412126|Insulin|insulin
5725566|NCT00412126|Angioplasty|angioplasty
5725567|NCT00412100|A randomised|a randomised
5725568|NCT00412100|double-blind|double-blind
5725569|NCT00412100|double-dummy|double-dummy
5725570|NCT00412100|parallel-group multicentre study to demonstrate improvement in symptoms of constipation|parallel-group multicentre study to demonstrate improvement in symptoms of constipation
5725571|NCT00412100|Moderate to severe, chronic non-malignant pain|moderate to severe, chronic non-malignant pain
5725572|NCT00412087|vitamin D|vitamin d
5725573|NCT00412087|cholecalciferol|cholecalciferol
5725574|NCT00412087|pregnant women|pregnant women
5725575|NCT00412074|Breastfeeding|breastfeeding
5725576|NCT00412074|Vitamin D|vitamin d
5725577|NCT00412074|Vitamin D deficiency|vitamin d deficiency
5725578|NCT00412061|Cancer|cancer
5725579|NCT00412061|Carcinoid|carcinoid
5725580|NCT00412061|Tumor|tumor
5725581|NCT00412061|Neuroendocrine|neuroendocrine
5725582|NCT00412061|Carcinoma|carcinoma
5725583|NCT00412061|Everolimus|everolimus
5725584|NCT00412061|Octreotide|octreotide
5725585|NCT00412022|early breast cancer|early breast cancer
5725586|NCT00412022|adjuvant therapy|adjuvant therapy
5725587|NCT00412022|premenopause|premenopause
5725588|NCT00412022|premenopausal|premenopausal
5725589|NCT00412022|menopausal status|menopausal status
5725590|NCT00412022|postmenopause|postmenopause
5725591|NCT00412022|bone mineral density|bone mineral density
5725592|NCT00412022|hormone sensitive|hormone sensitive
5725593|NCT00412022|aromatase inhibitors|aromatase inhibitors
5725594|NCT00412022|letrozole|letrozole
5725595|NCT00412022|disease-free survival|disease-free survival
5725596|NCT00412009|tuberculosis|tuberculosis
5725598|NCT00412009|treatment|treatment
5725599|NCT00412009|adherence|adherence
5725600|NCT00411996|indinavir/ritonavir|indinavir/ritonavir
5725601|NCT00411996|HIV/TB|hiv/tb
5725602|NCT00411996|rifampicin|rifampicin
5725603|NCT00411996|PK and efficacy of IDV/RTV 600/100 mg BID with rifampicin|pk and efficacy of idv/rtv 600/100 mg bid with rifampicin
5725604|NCT00411996|Treatment Naive|treatment naive
5725605|NCT00411983|chronic HIV infection|chronic hiv infection
5725606|NCT00411983|long term cohort of HIV infection|long term cohort of hiv infection
5725607|NCT00411970|23 gauge pars plana vitrectomy|23 gauge pars plana vitrectomy
5725608|NCT00411970|conjunctival erythema and injection|conjunctival erythema and injection
5725609|NCT00411970|20 gauge pars plana vitrectomy|20 gauge pars plana vitrectomy
5725610|NCT00411970|vitreous and retinal surgery|vitreous and retinal surgery
5725611|NCT00411957|atazanavir/ritonavir|atazanavir/ritonavir
5725612|NCT00411957|pharmacokinetic of ATV/r200/100 OD+2NRTIs|pharmacokinetic of atv/r200/100 od+2nrtis
5725613|NCT00411944|tacrolimus pharmacokinetics|tacrolimus pharmacokinetics
5725614|NCT00411944|CYP3A4 - CYP3A5|cyp3a4 - cyp3a5
5725615|NCT00411944|P-glycoprotein|p-glycoprotein
5725616|NCT00411944|single nucleotide polymorphisms|single nucleotide polymorphisms
5725617|NCT00411944|renal transplantation|renal transplantation
5725618|NCT00411944|calcineurin-inhibitor-associated nephrotoxicity|calcineurin-inhibitor-associated nephrotoxicity
5725619|NCT00411905|Myelodysplastic syndromes|myelodysplastic syndromes
5725620|NCT00411905|IPSS Int-2 and High risk|ipss int-2 and high risk
5725621|NCT00411905|Bortezomib|bortezomib
5725622|NCT00411905|Low dose Cytarabine|low dose cytarabine
5725623|NCT00411905|Bone Marrow diseases|bone marrow diseases
5725624|NCT00411879|Heart Arrest|heart arrest
5725625|NCT00411879|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5725626|NCT00411879|Epinephrine|epinephrine
5725627|NCT00411879|Vasopressin|vasopressin
5725628|NCT00411879|Adrenal Cortex Hormones|adrenal cortex hormones
5725629|NCT00411866|safety|safety
5725630|NCT00411866|pharmacokinetics,|pharmacokinetics,
5725631|NCT00411853|Prostate, Hormone Refractory, Cancer|prostate, hormone refractory, cancer
5725632|NCT00411840|stem cell therapy|stem cell therapy
5725633|NCT00411840|peripheral arterial disease|peripheral arterial disease
5725634|NCT00411840|limb ischemia|limb ischemia
5725635|NCT00411827|Cytology|cytology
5725636|NCT00411827|Keratomileusis, Laser In Situ|keratomileusis, laser in situ
5725637|NCT00411827|Keratectomy, Photorefractive, Excimer Laser|keratectomy, photorefractive, excimer laser
5725638|NCT00411814|melbourne,|melbourne,
5725639|NCT00411814|healthy|healthy
5725641|NCT00411814|male,|male,
5725642|NCT00411814|Safety and pharmacokinetic study,|safety and pharmacokinetic study,
5725643|NCT00411814|mild asthmatic patients,|mild asthmatic patients,
5725644|NCT00411814|australia|australia
5725645|NCT00411814|monoclonal|monoclonal
5725646|NCT00411814|female,|female,
5725647|NCT00411814|volunteers,|volunteers,
5725648|NCT00411801|bleeding disorder|bleeding disorder
5725649|NCT00411801|universal plasma|universal plasma
5725650|NCT00411801|plasma|plasma
5725651|NCT00411801|plasma exchange|plasma exchange
5725652|NCT00411788|HER-2 positive|her-2 positive
5725653|NCT00411788|breast cancer|breast cancer
5725654|NCT00411788|HER-2 positive breast cancer|her-2 positive breast cancer
5725655|NCT00411762|Pancreatic|pancreatic
5725656|NCT00411736|Cystic Fibrosis|cystic fibrosis
5725657|NCT00411736|Pseudomonas aeruginosa|pseudomonas aeruginosa
5725658|NCT00411736|Azithromycin|azithromycin
5725659|NCT00411736|Intermittent pulmonary infection|intermittent pulmonary infection
5725660|NCT00411723|multiple sclerosis, chronic-progressive, relapsing-remitting|multiple sclerosis, chronic-progressive, relapsing-remitting
5725661|NCT00411671|Lung Cancer|lung cancer
5725662|NCT00411671|Non-Small Cell Lung Cancer|non-small cell lung cancer
5725663|NCT00411671|NSCLC|nsclc
5725664|NCT00411671|Sorafenib|sorafenib
5725665|NCT00411671|BAY 43-9006|bay 43-9006
5725666|NCT00411671|Battle Program|battle program
5725667|NCT00411645|prevention|prevention
5725668|NCT00411645|prophylaxis|prophylaxis
5725669|NCT00411645|Cytomegalovirus|cytomegalovirus
5725670|NCT00411645|CMV|cmv
5725671|NCT00411645|allogeneic stem cell transplant|allogeneic stem cell transplant
5725672|NCT00411645|SCT|sct
5725673|NCT00411632|Lung Cancer|lung cancer
5725674|NCT00411632|Non-Small Cell Lung Cancer|non-small cell lung cancer
5725675|NCT00411632|NSCLC|nsclc
5725676|NCT00411632|Erlotinib|erlotinib
5725677|NCT00411632|Tarceva|tarceva
5725678|NCT00411632|Bexarotene|bexarotene
5725679|NCT00411632|Targretin|targretin
5725681|NCT00411632|Battle Program|battle program
5725682|NCT00411619|Tuberous Sclerosis Complex (TSC)|tuberous sclerosis complex (tsc)
5725683|NCT00411619|Subendymal Giant Cell Astrocytomas (SEGA'S)|subendymal giant cell astrocytomas (sega's)
5725684|NCT00411619|Mammalian Target of Rapamycin (mTOR)|mammalian target of rapamycin (mtor)
5725685|NCT00411619|Everolimus (RAD001)|everolimus (rad001)
5725686|NCT00411619|Tuberous Sclerosis with Subependymal Giant Cell Astrocytomas|tuberous sclerosis with subependymal giant cell astrocytomas
5725687|NCT00411606|Healthy|healthy
5725688|NCT00411606|Allergy|allergy
5725689|NCT00411606|Allergic Rhinoconjunctivitis|allergic rhinoconjunctivitis
5725690|NCT00411593|Non-Small Cell Lung Cancer|non-small cell lung cancer
5725691|NCT00411593|Lung Cancer|lung cancer
5725692|NCT00411593|NSCLC|nsclc
5725693|NCT00411593|Bortezomib|bortezomib
5725694|NCT00411593|Bevacizumab|bevacizumab
5725695|NCT00411580|Mild, moderate Alzheimer's Disease (AD), Aß-specific antibody, CAD106|mild, moderate alzheimer's disease (ad), aß-specific antibody, cad106
5725696|NCT00411567|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma|markers, inflammation, optimal, sub-optimal, corticosteroid, bronchial asthma
5725697|NCT00411541|acute lymphoblastic leukemia, maintenance, BFM protocol|acute lymphoblastic leukemia, maintenance, bfm protocol
5725698|NCT00411541|intermediate risk childhood acute lymphoblastic leukemia|intermediate risk childhood acute lymphoblastic leukemia
5725699|NCT00411528|Prostate Cancer|prostate cancer
5725700|NCT00411528|Hormone Refractory|hormone refractory
5725701|NCT00411528|patupilone|patupilone
5725702|NCT00411528|docetaxel|docetaxel
5725703|NCT00411463|Interpersonal Therapy|interpersonal therapy
5725704|NCT00411463|Social Rhythm Therapy|social rhythm therapy
5725705|NCT00411463|Bipolar Disorder|bipolar disorder
5725706|NCT00411463|Depression|depression
5725707|NCT00411463|Seroquel|seroquel
5725708|NCT00411450|k-ras|k-ras
5725709|NCT00411450|biomarker|biomarker
5725710|NCT00411450|colorectal|colorectal
5725711|NCT00411450|colon|colon
5725712|NCT00411450|rectal|rectal
5725713|NCT00411450|FOLFOX|folfox
5725714|NCT00411450|FOLFIRI|folfiri
5725715|NCT00411424|Rheumatoid Arthritis|rheumatoid arthritis
5725716|NCT00411424|Randomized Control Trial|randomized control trial
5725717|NCT00411424|Treatment outcomes|treatment outcomes
5725718|NCT00411424|Monoclonal antibody|monoclonal antibody
5725719|NCT00411411|GLP-1|glp-1
5725720|NCT00411411|GIP|gip
5725721|NCT00411411|Incretin hormones|incretin hormones
5725722|NCT00411411|DPP-IV inhibitor|dpp-iv inhibitor
5725723|NCT00411411|Hyperglycaemic clamp|hyperglycaemic clamp
5725724|NCT00411411|Meal test|meal test
5725725|NCT00411398|Anxiety, SNRI, SSRI,GAD,SAD|anxiety, snri, ssri,gad,sad
5725726|NCT00411385|Chronic Hepatitis C|chronic hepatitis c
5725727|NCT00411385|Hepatitis C|hepatitis c
5725728|NCT00411385|CHC|chc
5725729|NCT00411385|HepC|hepc
5725730|NCT00411385|Genotype 1|genotype 1
5725731|NCT00411385|Hepatitis|hepatitis
5725732|NCT00411385|HCV|hcv
5725733|NCT00411372|Questionnaire|questionnaire
5725734|NCT00411372|COPD|copd
5725735|NCT00411372|Shortness of Breath|shortness of breath
5725736|NCT00411359|Refractory angina|refractory angina
5725737|NCT00411359|Cardiac rehabilitation|cardiac rehabilitation
5725739|NCT00411359|Physical ability|physical ability
5725740|NCT00411359|Exercise|exercise
5725741|NCT00411359|Psychology|psychology
5725742|NCT00411359|Quality of life|quality of life
5725743|NCT00411359|Risk factors|risk factors
5725744|NCT00411346|Asthma|asthma
5725745|NCT00411346|Self-Monitoring|self-monitoring
5725746|NCT00411346|Cost-effectiveness|cost-effectiveness
5725747|NCT00411333|diabetic retinopathy|diabetic retinopathy
5725748|NCT00411333|fluorescein angiography|fluorescein angiography
5725749|NCT00411333|steroid|steroid
5725750|NCT00411333|anti-angiogenesis|anti-angiogenesis
5725751|NCT00411320|Asthma|asthma
5725752|NCT00411320|Smoking|smoking
5725753|NCT00411320|Steroid Resistance|steroid resistance
5724768|NCT00414921|MPH|mph
5725754|NCT00411320|Corticosteroid insensitivity|corticosteroid insensitivity
5725755|NCT00411307|Analgesia|analgesia
5725756|NCT00411307|Postoperative pain|postoperative pain
5725757|NCT00411294|ergocalciferol|ergocalciferol
5725758|NCT00411294|chronic kidney disease|chronic kidney disease
5725759|NCT00411294|secondary hyperparathyroidism|secondary hyperparathyroidism
5725760|NCT00411294|vitamin D deficiency|vitamin d deficiency
5725761|NCT00411281|acute myeloid leukemia/transient myeloproliferative disorder|acute myeloid leukemia/transient myeloproliferative disorder
5725762|NCT00411268|Chronic low back pain|chronic low back pain
5725763|NCT00411268|OROS hydromorphone slow release tablet|oros hydromorphone slow release tablet
5725764|NCT00411268|Quality of Life|quality of life
5725765|NCT00411255|Blink Reflex|blink reflex
5725766|NCT00411255|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5725767|NCT00411255|Dystonia|dystonia
5725768|NCT00411255|Blepharospasm|blepharospasm
5725769|NCT00411255|BSP|bsp
5725770|NCT00411255|Focal Dystonia|focal dystonia
5725771|NCT00411242|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5725772|NCT00411216|vestibular rehabilitation|vestibular rehabilitation
5725773|NCT00411216|vestibular hypofunction|vestibular hypofunction
5721019|NCT00427947|amputation|amputation
5725774|NCT00411203|Protein kinase C, tamoxifen, acute mania, clinical trial|protein kinase c, tamoxifen, acute mania, clinical trial
5725775|NCT00411190|Osteoarthritis|osteoarthritis
5725776|NCT00411190|Postmenopausal|postmenopausal
5725777|NCT00411190|Osteoporosis|osteoporosis
5725778|NCT00411177|end-stage renal disease|end-stage renal disease
5725779|NCT00411177|hemodialysis|hemodialysis
5725780|NCT00411177|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5742657|NCT00348049|PRK|prk
5725781|NCT00411177|high flux dialyser|high flux dialyser
5725782|NCT00411177|on-line hemodiafiltration|on-line hemodiafiltration
5725783|NCT00411177|arterial stiffness|arterial stiffness
5725784|NCT00411177|inflammation|inflammation
5725785|NCT00411177|life quality|life quality
5725786|NCT00411177|left ventricular hypertrophy|left ventricular hypertrophy
5725787|NCT00411164|knee pain|knee pain
5725788|NCT00411164|hip pain|hip pain
5725789|NCT00411164|opioid|opioid
5725790|NCT00411151|Adenocarcinoma of esophagogastric junction|adenocarcinoma of esophagogastric junction
5725791|NCT00411151|Adenocarcinoma of lower esophagus (Barrett carcinoma)|adenocarcinoma of lower esophagus (barrett carcinoma)
5725792|NCT00411138|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5725793|NCT00411138|stage II endometrial carcinoma|stage ii endometrial carcinoma
5725794|NCT00411138|stage IA grade 3 endometrial carcinoma|stage ia grade 3 endometrial carcinoma
5725795|NCT00411138|stage IB endometrial carcinoma|stage ib endometrial carcinoma
5725796|NCT00411138|stage IIIA endometrial carcinoma|stage iiia endometrial carcinoma
5725797|NCT00411138|stage IIIB endometrial carcinoma|stage iiib endometrial carcinoma
5725798|NCT00411138|stage IIIC endometrial carcinoma|stage iiic endometrial carcinoma
5725799|NCT00411125|Postmenopausal|postmenopausal
5725800|NCT00411125|osteoporosis|osteoporosis
5725801|NCT00411125|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
5725802|NCT00411125|Calcitonin|calcitonin
5725803|NCT00411112|Sentinel node|sentinel node
5725804|NCT00411112|Isosulphan blue|isosulphan blue
5725805|NCT00411112|Isotopic detection|isotopic detection
5725806|NCT00411112|Survival|survival
5725807|NCT00411099|agomelatine, major depressive disorder, MDD, depression|agomelatine, major depressive disorder, mdd, depression
5725808|NCT00411086|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5725809|NCT00411086|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5725810|NCT00411086|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5725811|NCT00411086|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5725812|NCT00411086|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5725813|NCT00411086|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5725814|NCT00411086|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5725815|NCT00411086|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5725816|NCT00411086|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5725817|NCT00411086|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5725818|NCT00411086|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5725819|NCT00411086|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5725820|NCT00411086|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5725821|NCT00411086|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5725822|NCT00411086|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5725823|NCT00411086|Granulocyte-Macrophage Colony Stimulating Factor|granulocyte-macrophage colony stimulating factor
5725824|NCT00411086|GM-CSF|gm-csf
5725825|NCT00411086|Rituximab|rituximab
5725826|NCT00411086|Rituxan|rituxan
5725827|NCT00411073|darapladib|darapladib
5725828|NCT00411073|moxifloxacin|moxifloxacin
5725829|NCT00411073|QT study|qt study
5725830|NCT00411060|Rotator Cuff Tear|rotator cuff tear
5686154|NCT00553319|Treatment|treatment
5725831|NCT00411047|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5725832|NCT00411047|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5725833|NCT00411047|adenocarcinoma of the lung|adenocarcinoma of the lung
5725834|NCT00411047|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5725835|NCT00411047|large cell lung cancer|large cell lung cancer
5725836|NCT00411034|Opioids|opioids
5725837|NCT00411034|Chronic Cancer Pain|chronic cancer pain
5725838|NCT00411034|analgesic|analgesic
5725839|NCT00410995|Physically fit volunteers|physically fit volunteers
5725840|NCT00410982|Lymphoid Malignancies|lymphoid malignancies
5725841|NCT00410982|Hodgkin's Disease|hodgkin's disease
5725842|NCT00410982|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5725843|NCT00410982|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5725844|NCT00410982|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5725845|NCT00410982|Hematopoietic Cell Transplantation|hematopoietic cell transplantation
5725846|NCT00410982|Myeloma|myeloma
5725847|NCT00410982|Leukemia|leukemia
5725848|NCT00410982|Lymphoma|lymphoma
5725849|NCT00410982|Busulfan|busulfan
5725850|NCT00410982|Busulfex|busulfex
5725851|NCT00410982|Myleran|myleran
5725852|NCT00410982|Gemcitabine|gemcitabine
5725853|NCT00410982|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5725854|NCT00410982|Gemzar|gemzar
5725855|NCT00410982|Melphalan|melphalan
5725857|NCT00410969|resuscitation|resuscitation
5725858|NCT00410969|hypothermia|hypothermia
5725942|NCT00410657|disseminated neuroblastoma|disseminated neuroblastoma
5725859|NCT00410956|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5725860|NCT00410956|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5725861|NCT00410956|advanced adult primary liver cancer|advanced adult primary liver cancer
5725862|NCT00410956|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5725863|NCT00410956|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5725864|NCT00410943|Cancer pain|cancer pain
5725865|NCT00410943|Oral analgesic|oral analgesic
5725866|NCT00410943|OROS hydromorphone HCI|oros hydromorphone hci
5725867|NCT00410930|Immunotherapy, major allergen, birch|immunotherapy, major allergen, birch
5725868|NCT00410878|Opioids|opioids
5725869|NCT00410878|Chronic cancer pain|chronic cancer pain
5725870|NCT00410878|Analgesic|analgesic
5725871|NCT00410865|Oral Premalignancies|oral premalignancies
5725872|NCT00410865|Mouth Cancer|mouth cancer
5725873|NCT00410865|Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity|dysplasia/carcinoma in situ (cis) of the oral cavity
5725874|NCT00410865|Dysplasia/Carcinoma in situ (CIS) of the Oral Pharynx|dysplasia/carcinoma in situ (cis) of the oral pharynx
5725875|NCT00410865|Advexin|advexin
5725876|NCT00410865|Gene Therapy|gene therapy
5725877|NCT00410865|INGN 201|ingn 201
5725878|NCT00410865|Wild Type p53 Gene Induction|wild type p53 gene induction
5725879|NCT00410852|Insulin|insulin
5725880|NCT00410852|Hyperglycemia|hyperglycemia
5725881|NCT00410852|Hypoglycemia|hypoglycemia
5725882|NCT00410852|Intensive care|intensive care
5725883|NCT00410852|Critical care|critical care
5725884|NCT00410813|stage IV breast cancer|stage iv breast cancer
5725885|NCT00410813|male breast cancer|male breast cancer
5725886|NCT00410813|recurrent breast cancer|recurrent breast cancer
5725887|NCT00410813|bone metastases|bone metastases
5725888|NCT00410800|Insulin Resistance|insulin resistance
5725889|NCT00410800|Body Composition|body composition
5725890|NCT00410800|Kinetic Modeling|kinetic modeling
5725891|NCT00410787|Chronic cancer pain|chronic cancer pain
5725892|NCT00410787|OROS hydromorphone HCI (slow release)|oros hydromorphone hci (slow release)
5725893|NCT00410787|long-term repeated dosing|long-term repeated dosing
5725894|NCT00410774|stage III pancreatic cancer|stage iii pancreatic cancer
5725895|NCT00410774|stage I pancreatic cancer|stage i pancreatic cancer
5725896|NCT00410774|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5725897|NCT00410774|stage II pancreatic cancer|stage ii pancreatic cancer
5725898|NCT00410761|ZD6474|zd6474
5725899|NCT00410761|MTC|mtc
5725900|NCT00410761|Hereditary Medullary Thyroid Cancer|hereditary medullary thyroid cancer
5725901|NCT00410761|Sporadic Medullary Thyroid Cancer|sporadic medullary thyroid cancer
5725902|NCT00410761|Medullary Thyroid Cancer|medullary thyroid cancer
5725903|NCT00410748|Chronic cancer pain|chronic cancer pain
5725904|NCT00410748|chronic pain|chronic pain
5725905|NCT00410735|ONO-1078|ono-1078
5725906|NCT00410735|chronic sinusitis|chronic sinusitis
5725907|NCT00410722|Nutrition|nutrition
5725908|NCT00410722|Type 2 Diabetes|type 2 diabetes
5725909|NCT00410709|Pediculosis Capitis|pediculosis capitis
5725910|NCT00410709|Head Lice|head lice
5725911|NCT00410709|Crawlers|crawlers
5725912|NCT00410709|Ova|ova
5725913|NCT00410709|Nits|nits
5725914|NCT00410696|High-dose chemotherapy|high-dose chemotherapy
5725915|NCT00410696|Growth factor|growth factor
5725916|NCT00410696|Pegfilgrastim|pegfilgrastim
5725917|NCT00410683|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5725918|NCT00410683|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5725919|NCT00410670|Gene|gene
5725920|NCT00410670|Genetics|genetics
5724874|NCT00414414|TB|tb
5725921|NCT00410670|Family History|family history
5725922|NCT00410670|Radiation Therapy|radiation therapy
5725923|NCT00410670|Children|children
5725924|NCT00410657|graft versus host disease|graft versus host disease
5725925|NCT00410657|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5725926|NCT00410657|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5863964|NCT00001150|Blister Formation|blister formation
5725927|NCT00410657|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5725928|NCT00410657|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5725929|NCT00410657|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5725930|NCT00410657|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5725931|NCT00410657|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5725932|NCT00410657|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5725933|NCT00410657|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5725934|NCT00410657|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5725935|NCT00410657|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5725936|NCT00410657|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5725937|NCT00410657|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5725938|NCT00410657|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5725939|NCT00410657|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5725940|NCT00410657|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5725941|NCT00410657|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5725943|NCT00410657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5725944|NCT00410657|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5725945|NCT00410657|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5725946|NCT00410657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5725947|NCT00410657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5725948|NCT00410657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5725949|NCT00410657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5725950|NCT00410657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5725951|NCT00410657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5725952|NCT00410657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5725953|NCT00410657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5725954|NCT00410657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5725955|NCT00410657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5725956|NCT00410657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5725957|NCT00410657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5726030|NCT00410579|stage II rectal cancer|stage ii rectal cancer
5725958|NCT00410657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5725959|NCT00410657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5725960|NCT00410657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5725961|NCT00410657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5725962|NCT00410657|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5725963|NCT00410657|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5725964|NCT00410657|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5725965|NCT00410657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5725966|NCT00410657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5725967|NCT00410657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5725968|NCT00410657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5725969|NCT00410657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5725970|NCT00410657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5725971|NCT00410657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5725972|NCT00410657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5725973|NCT00410657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5725974|NCT00410657|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5725975|NCT00410657|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5725976|NCT00410657|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5725977|NCT00410657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5725978|NCT00410657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5725979|NCT00410657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5686155|NCT00553241|TIA|tia
5725980|NCT00410657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5725981|NCT00410657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5725982|NCT00410657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5725983|NCT00410657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5725984|NCT00410657|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5725985|NCT00410657|stage I multiple myeloma|stage i multiple myeloma
5725986|NCT00410657|stage II multiple myeloma|stage ii multiple myeloma
5725987|NCT00410657|stage III multiple myeloma|stage iii multiple myeloma
5725988|NCT00410657|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5725989|NCT00410657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5725990|NCT00410657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5725991|NCT00410657|aggressive, noncontiguous stage II adult non-Hodgkin lymphoma|aggressive, noncontiguous stage ii adult non-hodgkin lymphoma
5725992|NCT00410657|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5725993|NCT00410657|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5725994|NCT00410657|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5725995|NCT00410657|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5725996|NCT00410657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5725997|NCT00410657|stage IIIA breast cancer|stage iiia breast cancer
5725998|NCT00410657|stage IIIB breast cancer|stage iiib breast cancer
5725999|NCT00410657|stage IIIC breast cancer|stage iiic breast cancer
5726001|NCT00410657|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5726002|NCT00410657|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5726003|NCT00410657|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5726004|NCT00410644|Non-malignant chronic pain|non-malignant chronic pain
5726008|NCT00410631|localized resectable neuroblastoma|localized resectable neuroblastoma
5726009|NCT00410631|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5726010|NCT00410631|regional neuroblastoma|regional neuroblastoma
5726011|NCT00410631|stage 4S neuroblastoma|stage 4s neuroblastoma
5726012|NCT00410631|disseminated neuroblastoma|disseminated neuroblastoma
5726013|NCT00410631|recurrent neuroblastoma|recurrent neuroblastoma
5726014|NCT00410618|cognitive/functional effects|cognitive/functional effects
5726015|NCT00410618|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5726016|NCT00410618|recurrent colon cancer|recurrent colon cancer
5726017|NCT00410618|stage I colon cancer|stage i colon cancer
5726018|NCT00410618|stage II colon cancer|stage ii colon cancer
5726019|NCT00410618|stage III colon cancer|stage iii colon cancer
5726020|NCT00410618|stage IV colon cancer|stage iv colon cancer
5726022|NCT00410592|acid reflux|acid reflux
5726023|NCT00410592|heartburn|heartburn
5726024|NCT00410592|PPI|ppi
5726025|NCT00410592|Hispanic|hispanic
5726026|NCT00410579|pain|pain
5726027|NCT00410579|fatigue|fatigue
5726028|NCT00410579|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5726029|NCT00410579|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5726031|NCT00410579|stage III rectal cancer|stage iii rectal cancer
5726032|NCT00410579|stage II colon cancer|stage ii colon cancer
5726033|NCT00410579|stage III colon cancer|stage iii colon cancer
5726034|NCT00410579|adenocarcinoma of the colon|adenocarcinoma of the colon
5726035|NCT00410566|Acid sphingomyelinase deficiency|acid sphingomyelinase deficiency
5726036|NCT00410566|Niemann-Pick disease|niemann-pick disease
5726037|NCT00410566|Lysosomal storage disorder|lysosomal storage disorder
5726038|NCT00410566|Enzyme replacement therapy|enzyme replacement therapy
5726039|NCT00410566|Treatment|treatment
5726040|NCT00410540|Cancer pain|cancer pain
5726041|NCT00410540|Oral analgesic|oral analgesic
5726042|NCT00410540|OROS hydromorphone HCL|oros hydromorphone hcl
5726043|NCT00410540|Morphine sulfate|morphine sulfate
5726044|NCT00410527|Antibacterials|antibacterials
5726045|NCT00410527|Colonization|colonization
5726046|NCT00410527|Infection|infection
5726047|NCT00410527|Pneumonia|pneumonia
5726048|NCT00410527|Resistance|resistance
5726049|NCT00410514|Beta-3 Receptor Agonist|beta-3 receptor agonist
5726050|NCT00410514|YM178|ym178
5726051|NCT00410514|Men|men
5726052|NCT00410514|Lower Urinary Tract Symptoms|lower urinary tract symptoms
5726053|NCT00410514|Bladder Outlet Obstruction|bladder outlet obstruction
5726054|NCT00410501|Pharmacokinetics, interaction, QAB149, indacaterol, ketoconazole, healthy subjects|pharmacokinetics, interaction, qab149, indacaterol, ketoconazole, healthy subjects
5726055|NCT00410488|Sarcoma|sarcoma
5726056|NCT00410488|Palonosetron|palonosetron
5726057|NCT00410488|Aloxi|aloxi
5726058|NCT00410488|Nausea|nausea
5726059|NCT00410488|Vomiting|vomiting
5726060|NCT00410475|Ionizing Radiation|ionizing radiation
5726061|NCT00410475|Cohort Study|cohort study
5726062|NCT00410475|Radiation-Induced Neoplasms|radiation-induced neoplasms
5726063|NCT00410475|Radiologic Technologists|radiologic technologists
5726064|NCT00410475|Ultraviolet Radiation|ultraviolet radiation
5726065|NCT00410462|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5726066|NCT00410462|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5726067|NCT00410462|adult liposarcoma|adult liposarcoma
5726068|NCT00410462|adult fibrosarcoma|adult fibrosarcoma
5726069|NCT00410462|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5726070|NCT00410462|adult leiomyosarcoma|adult leiomyosarcoma
5726071|NCT00410462|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5726072|NCT00410462|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5726073|NCT00410462|adult malignant mesenchymoma|adult malignant mesenchymoma
5726074|NCT00410462|adult angiosarcoma|adult angiosarcoma
5726075|NCT00410462|adult epithelioid sarcoma|adult epithelioid sarcoma
5726076|NCT00410462|adult neurofibrosarcoma|adult neurofibrosarcoma
5726077|NCT00410462|adult synovial sarcoma|adult synovial sarcoma
5726078|NCT00410462|recurrent uterine sarcoma|recurrent uterine sarcoma
5726079|NCT00410462|stage IV uterine sarcoma|stage iv uterine sarcoma
5726080|NCT00410462|ovarian sarcoma|ovarian sarcoma
5726081|NCT00410462|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5726082|NCT00410462|recurrent small intestine cancer|recurrent small intestine cancer
5726083|NCT00410449|End stage renal disease treated by hemodialysis|end stage renal disease treated by hemodialysis
5726084|NCT00410449|Hemodialysis vascular access patency|hemodialysis vascular access patency
5726085|NCT00410449|Vitamin E|vitamin e
5726086|NCT00410449|oxidative markers|oxidative markers
5726087|NCT00410449|pentosidine|pentosidine
5726088|NCT00410449|hydroxynonenal|hydroxynonenal
5726089|NCT00410449|levuglandin|levuglandin
5726091|NCT00410436|Resistance Exercise|resistance exercise
5726092|NCT00410436|Aerobic Exercise|aerobic exercise
5726093|NCT00410423|Leukemia|leukemia
5726094|NCT00410423|Acute Myeloid Leukemia|acute myeloid leukemia
5726095|NCT00410423|Acute Lymphoid / Lymphoblastic Leukemia|acute lymphoid / lymphoblastic leukemia
5726097|NCT00410397|Hip pain|hip pain
5726099|NCT00410384|Autoimmune Diseases|autoimmune diseases
5726100|NCT00410384|Systemic Lupus Erythematosus|systemic lupus erythematosus
5726102|NCT00410384|Belimumab|belimumab
5726103|NCT00410384|Lupus|lupus
5726104|NCT00410371|tolerability|tolerability
5726105|NCT00410371|safety|safety
5726106|NCT00410371|Pharmacokinetic characteristics|pharmacokinetic characteristics
5726107|NCT00410358|Gimatecan|gimatecan
5726108|NCT00410358|topoisomerase I inhibitor|topoisomerase i inhibitor
5726109|NCT00410358|advanced solid tumors|advanced solid tumors
5726110|NCT00410332|tonsillectomy|tonsillectomy
5726111|NCT00410332|pain|pain
5726112|NCT00410332|homeopathy|homeopathy
5726113|NCT00410332|Traumeel|traumeel
5726114|NCT00410306|Hypogonadism|hypogonadism
5726115|NCT00410306|Nebido|nebido
5726116|NCT00410306|Testosterone|testosterone
5726117|NCT00410306|Observational Study|observational study
5726118|NCT00410293|Heart failure|heart failure
5726119|NCT00410293|Diagnostic|diagnostic
5726120|NCT00410293|Natriuretic peptide|natriuretic peptide
5726121|NCT00410293|NT-pro B-type natriuretic peptide|nt-pro b-type natriuretic peptide
5726122|NCT00410293|Length of stay|length of stay
5726123|NCT00410293|Costs|costs
5726124|NCT00410267|glaucoma|glaucoma
5726425|NCT00409071|Nausea|nausea
5726125|NCT00410267|Post operative from selective laser trabeculoplasty|post operative from selective laser trabeculoplasty
5726131|NCT00410228|safety, tolerability, pharmacokinetics, pharmacodynamics, AHT956|safety, tolerability, pharmacokinetics, pharmacodynamics, aht956
5726132|NCT00410189|Non-Small Cell Lung Cancer|non-small cell lung cancer
5726133|NCT00410189|NSCLC|nsclc
5726134|NCT00410189|Lung Cancer|lung cancer
5726135|NCT00410189|ZD6474|zd6474
5726136|NCT00410189|Zactima|zactima
5726137|NCT00410189|Vandetanib|vandetanib
5726138|NCT00410189|BATTLE Program|battle program
5726139|NCT00410163|B-cell|b-cell
5726140|NCT00410163|cyclophosphamide|cyclophosphamide
5726141|NCT00410163|fludarabine|fludarabine
5726142|NCT00410163|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5726143|NCT00410163|Ofatumumab|ofatumumab
5726144|NCT00410150|Status asthmaticus|status asthmaticus
5726145|NCT00410150|Asthma|asthma
5726146|NCT00410150|Helium|helium
5726147|NCT00410150|Children|children
5726148|NCT00410124|advanced kidney cancer|advanced kidney cancer
5726149|NCT00410124|everolimus|everolimus
5726150|NCT00410124|kidney cancer|kidney cancer
5726151|NCT00410124|oral therapy|oral therapy
5726152|NCT00410111|sepsis|sepsis
5726153|NCT00410111|encephalopathy|encephalopathy
5726154|NCT00410111|cerebral perfusion|cerebral perfusion
5726155|NCT00410111|electroencephalogram|electroencephalogram
5726156|NCT00410098|asthma|asthma
5726157|NCT00410098|yoga|yoga
5726158|NCT00410098|heat|heat
5726159|NCT00410098|humidity|humidity
5726160|NCT00410098|bikram|bikram
5726161|NCT00410059|Non-Small Cell Lung Cancer|non-small cell lung cancer
5726162|NCT00410059|Lung Cancer|lung cancer
5726163|NCT00410059|NSCLC|nsclc
5726164|NCT00410059|Erlotinib|erlotinib
5726165|NCT00410059|Tarceva|tarceva
5726166|NCT00410059|OSI-774|osi-774
5726167|NCT00410059|Battle Program|battle program
5726168|NCT00410020|alpha linolenic acid|alpha linolenic acid
5726169|NCT00410020|atrial fibrillation|atrial fibrillation
5726170|NCT00410020|omega 3 fatty acids|omega 3 fatty acids
5726171|NCT00410020|diet|diet
5726172|NCT00410020|rapeseed oil|rapeseed oil
5726173|NCT00410020|canola oil|canola oil
5726174|NCT00410020|cardiovascular diseases|cardiovascular diseases
5726175|NCT00410007|ADPKD|adpkd
5726176|NCT00410007|Urinary Aquaporin-2|urinary aquaporin-2
5726177|NCT00410007|ENaC|enac
5726178|NCT00410007|Fractional sodium excretion|fractional sodium excretion
5726179|NCT00410007|High/low sodium diet|high/low sodium diet
5726180|NCT00409994|Colorectal cancer|colorectal cancer
5726181|NCT00409994|M-tor inhibitor|m-tor inhibitor
5726182|NCT00409994|Rapamycin|rapamycin
5726183|NCT00409981|in stent restenosis|in stent restenosis
5726184|NCT00409981|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5726185|NCT00409981|paccocath|paccocath
5726186|NCT00409981|drug eluting balloon|drug eluting balloon
5726187|NCT00409968|Lung Cancer|lung cancer
5726188|NCT00409968|Non Small Cell Lung Cancer|non small cell lung cancer
5726189|NCT00409968|BATTLE Program|battle program
5726190|NCT00409968|Umbrella Trial|umbrella trial
5726191|NCT00409968|Tumor Biopsy|tumor biopsy
5726192|NCT00409968|NSCLC|nsclc
5726193|NCT00409955|Lamellar transplant|lamellar transplant
5726194|NCT00409955|Lyophilization|lyophilization
5726195|NCT00409955|Corneas storage|corneas storage
5726196|NCT00409955|Keratoconus patients|keratoconus patients
5726197|NCT00409955|Best corrected visual acuity < 20/60|best corrected visual acuity < 20/60
5726198|NCT00409955|Signed the consent inform|signed the consent inform
5726200|NCT00409942|Torasemide prolonged release|torasemide prolonged release
5726202|NCT00409942|Loop diuretics|loop diuretics
5726203|NCT00409942|Peptide of procollagen type 1|peptide of procollagen type 1
5726204|NCT00409929|Safety, tolerability, pharmacokinetics, pharmacodynamics, AEB071, healthy subjects, transplantation|safety, tolerability, pharmacokinetics, pharmacodynamics, aeb071, healthy subjects, transplantation
5726205|NCT00409916|chronic heart failure|chronic heart failure
5726206|NCT00409916|heart failure|heart failure
5726207|NCT00409916|congestive heart failure|congestive heart failure
5726208|NCT00409916|impedance cardiography|impedance cardiography
5726210|NCT00409916|transthoracic electrical bioimpedance|transthoracic electrical bioimpedance
5726211|NCT00409916|non-invasive|non-invasive
5726213|NCT00409890|Buscopan|buscopan
5726214|NCT00409890|Hyoscine|hyoscine
5726215|NCT00409890|Shortens|shortens
5726216|NCT00409890|Labor|labor
5726217|NCT00409890|Stage|stage
5726218|NCT00409864|Gallbaldder Cancer|gallbaldder cancer
5726219|NCT00409864|Endoscopic stenting|endoscopic stenting
5726220|NCT00409864|Percutaneous biliary drainage|percutaneous biliary drainage
5726221|NCT00409851|HYPERTENSION, VALSARTAN, AMLODIPINE,SAFETY|hypertension, valsartan, amlodipine,safety
5726222|NCT00409838|Rheumatoid Arthritis, with inadequate response to methotrexate|rheumatoid arthritis, with inadequate response to methotrexate
5726223|NCT00409799|Bone graft substitute|bone graft substitute
5726224|NCT00409799|Promotion of bone healing|promotion of bone healing
5726225|NCT00409786|Obesity|obesity
5726226|NCT00409786|Diabetes|diabetes
5726227|NCT00409786|Internet|internet
5726228|NCT00409786|Obesity with high cardiovascular risk|obesity with high cardiovascular risk
5726229|NCT00409760|HYEPRTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hyeprtension, valsartan, amlodipine, high blood pressure
5726230|NCT00409747|Immunology|immunology
5726231|NCT00409747|Microglia|microglia
5726232|NCT00409747|NF-Kappa-B|nf-kappa-b
5726233|NCT00409747|Antibiotic|antibiotic
5726234|NCT00409747|Autism|autism
5726235|NCT00409747|Minocycline|minocycline
5726236|NCT00409747|Regressive Autism|regressive autism
5726237|NCT00409734|pyloric|pyloric
5726238|NCT00409734|stenosis|stenosis
5726239|NCT00409721|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5726240|NCT00409721|ALS|als
5726241|NCT00409721|Motor Neuron Disease|motor neuron disease
5726242|NCT00409721|MND|mnd
5726243|NCT00409721|Memantine|memantine
5726244|NCT00409708|Attention Deficit Hyperactivity Disorder,|attention deficit hyperactivity disorder,
5726245|NCT00409708|ADHD|adhd
5726246|NCT00409708|Cytogenetic abnormalities,|cytogenetic abnormalities,
5726247|NCT00409708|extended-release methylphenidate,|extended-release methylphenidate,
5726248|NCT00409695|Acute Graft versus Host Disease|acute graft versus host disease
5726249|NCT00409695|aGVHD|agvhd
5726250|NCT00409695|Blood And Marrow Transplantation|blood and marrow transplantation
5726251|NCT00409695|Thymoglobulin|thymoglobulin
5726252|NCT00409695|ATG|atg
5726253|NCT00409682|Crohn's Disease|crohn's disease
5726254|NCT00409669|Barraquer tonometer|barraquer tonometer
5726255|NCT00409669|Intraocular pressure|intraocular pressure
5726256|NCT00409669|Tonometry|tonometry
5726257|NCT00409643|HYPERTENSION, VALSARTAN, AMLODIPINE, high blood pressure|hypertension, valsartan, amlodipine, high blood pressure
5726258|NCT00409630|Asthma|asthma
5726259|NCT00409591|Thailand|thailand
5726260|NCT00409591|Developing Countries|developing countries
5726261|NCT00409591|Prophylaxis|prophylaxis
5726262|NCT00409591|Mother-to-child transmission|mother-to-child transmission
5726263|NCT00409591|HIV-1|hiv-1
5726264|NCT00409591|HIV-1 infection|hiv-1 infection
5726265|NCT00409591|HIV Seronegativity|hiv seronegativity
5726266|NCT00409578|Post acute coronary syndrome|post acute coronary syndrome
5726267|NCT00409578|Acute|acute
5726268|NCT00409578|coronary syndrome|coronary syndrome
5726269|NCT00409578|B-type natriuretic peptide|b-type natriuretic peptide
5725268|NCT00413166|APL|apl
5726270|NCT00409578|N-terminal|n-terminal
5726271|NCT00409578|pro-B-type natriuretic peptide|pro-b-type natriuretic peptide
5726272|NCT00409578|myocardial infarctions|myocardial infarctions
5726273|NCT00409565|head and neck cancer|head and neck cancer
5726274|NCT00409565|cetuximab|cetuximab
5726275|NCT00409565|bevacizumab|bevacizumab
5726276|NCT00409565|squamous cell carcinoma|squamous cell carcinoma
5680904|NCT00575744|Lumpectomy|lumpectomy
5680905|NCT00575744|Mastectomy|mastectomy
5680906|NCT00575718|Quitting tobacco|quitting tobacco
5726277|NCT00409565|SCCHN|scchn
5726278|NCT00409565|Squamous Cell Carcinoma of the Head and Neck|squamous cell carcinoma of the head and neck
5726279|NCT00409526|Iloprost|iloprost
5726280|NCT00409526|PPHN|pphn
5726281|NCT00409526|Newborn|newborn
5726282|NCT00409526|Pulmonary Hypertension|pulmonary hypertension
5726283|NCT00409526|Term|term
5726284|NCT00409526|Persistent Pulmonary Hypertension of the Newborn|persistent pulmonary hypertension of the newborn
5726285|NCT00409500|Safety, tolerability, pharmacokinetics, AQW051, food, Japanese, healthy male subjects|safety, tolerability, pharmacokinetics, aqw051, food, japanese, healthy male subjects
5726286|NCT00409500|Healthy volunteers study|healthy volunteers study
5726288|NCT00409487|hypertension|hypertension
5726289|NCT00409487|ambulatory bloop pressure monitoring|ambulatory bloop pressure monitoring
5726290|NCT00409448|TBI|tbi
5726291|NCT00409448|intracranial edema|intracranial edema
5726292|NCT00409448|brain edema|brain edema
5726293|NCT00409448|craniocerebral trauma|craniocerebral trauma
5726295|NCT00409448|brain hemorrhage, traumatic|brain hemorrhage, traumatic
5726296|NCT00409448|subdural hematoma|subdural hematoma
5726297|NCT00409448|brain concussion|brain concussion
5726298|NCT00409448|head injuries, closed|head injuries, closed
5726299|NCT00409448|epidural hematoma|epidural hematoma
5726300|NCT00409448|extra-axial hemorrhage|extra-axial hemorrhage
5726301|NCT00409448|cortical contusion|cortical contusion
5726302|NCT00409435|Postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
5726303|NCT00409422|pediatric obesity|pediatric obesity
5726304|NCT00409422|overweight|overweight
5726305|NCT00409422|insulin resistance|insulin resistance
5726306|NCT00409422|hyperinsulinemia|hyperinsulinemia
5726307|NCT00409422|weight management program|weight management program
5726308|NCT00409422|family-based|family-based
5726309|NCT00409409|Sublingual immunotherapy|sublingual immunotherapy
5726310|NCT00409409|Grass pollen tablet|grass pollen tablet
5726311|NCT00409409|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5726312|NCT00409396|Ulcerative|ulcerative
5726313|NCT00409396|Colitis|colitis
5726314|NCT00409396|PGE-M|pge-m
5726315|NCT00409396|fecal calprotectin|fecal calprotectin
5726316|NCT00409396|disease biomarkers|disease biomarkers
5726317|NCT00409383|Advanced Melanoma|advanced melanoma
5726318|NCT00409383|Normal baseline LDH|normal baseline ldh
5726319|NCT00409383|Chemotherapy naive|chemotherapy naive
5726320|NCT00409357|urinary tract|urinary tract
5726321|NCT00409344|Thoracoabdominal Aortic Aneurysm|thoracoabdominal aortic aneurysm
5726322|NCT00409344|Dexmedetomidine|dexmedetomidine
5726323|NCT00409344|Mechanical ventilation|mechanical ventilation
5726324|NCT00409331|Head and Neck Cancer|head and neck cancer
5726325|NCT00409331|HNSCC|hnscc
5726326|NCT00409331|Submandibular and Sublingual Salivary Sparing|submandibular and sublingual salivary sparing
5726327|NCT00409331|Amifostine|amifostine
5726328|NCT00409331|Ethyol|ethyol
5726329|NCT00409331|Radiation Therapy|radiation therapy
5726330|NCT00409318|Inflammation|inflammation
5726331|NCT00409318|Visceral adiposity|visceral adiposity
5726332|NCT00409318|TNF|tnf
5726333|NCT00409318|CRP|crp
5726334|NCT00409318|Adiponectin|adiponectin
5726335|NCT00409318|Insulin resistance|insulin resistance
5726336|NCT00409318|metabolic syndrome|metabolic syndrome
5726337|NCT00409292|RAD001|rad001
5726338|NCT00409292|metastatic pancreatic cancer|metastatic pancreatic cancer
5726339|NCT00409279|Aging|aging
5726340|NCT00409279|Parent / Adult-child interaction|parent / adult-child interaction
5726341|NCT00409279|Family caregivers|family caregivers
5726342|NCT00409279|Alzheimer's|alzheimer's
5726343|NCT00409279|Caregiving|caregiving
5726344|NCT00409253|PRE-ECLAMPSIA-URAPIDIL-NICARDIPINE|pre-eclampsia-urapidil-nicardipine
5726345|NCT00409240|Group Intervention|group intervention
5726346|NCT00409240|Pharmacotherapy|pharmacotherapy
5726347|NCT00409240|Behavioral Modification|behavioral modification
5726348|NCT00409240|Diabetes|diabetes
5726349|NCT00409227|swl|swl
5726350|NCT00409227|lithotripsy|lithotripsy
5726351|NCT00409227|stone disease|stone disease
5726352|NCT00409227|urolithiasis|urolithiasis
5726353|NCT00409227|nephrolithiasis|nephrolithiasis
5726354|NCT00409214|Glioma|glioma
5726355|NCT00409214|Litx™|litx™
5726356|NCT00409214|LS11|ls11
5726358|NCT00409214|Anaplastic Astrocytoma|anaplastic astrocytoma
5726359|NCT00409214|GBM|gbm
5726360|NCT00409214|AA|aa
5726361|NCT00409201|schizophrenia|schizophrenia
5726362|NCT00409201|reboxetine|reboxetine
5726363|NCT00409201|cognitive|cognitive
5726364|NCT00409201|behavior|behavior
5726365|NCT00409188|Non-Small Cell Lung Carcinoma;|non-small cell lung carcinoma;
5726366|NCT00409188|stage III;|stage iii;
5725365|NCT00412906|RT-PCR|rt-pcr
5726367|NCT00409188|unresectable;|unresectable;
5726368|NCT00409188|vaccine; Tecemotide; L-BLP25;|vaccine; tecemotide; l-blp25;
5726369|NCT00409188|Cyclophosphamide;|cyclophosphamide;
5726370|NCT00409188|placebo controlled;|placebo controlled;
5726371|NCT00409188|randomized;|randomized;
5726372|NCT00409188|double blind;|double blind;
5726373|NCT00409188|immunotherapy;|immunotherapy;
5726374|NCT00409175|FAP|fap
5726375|NCT00409175|Fx-1006A|fx-1006a
5726376|NCT00409175|transthyretin|transthyretin
5726377|NCT00409175|TTR|ttr
5726378|NCT00409175|amyloid|amyloid
5726379|NCT00409175|polyneuropathy|polyneuropathy
5726380|NCT00409175|V30M|v30m
5726381|NCT00409175|familial|familial
5726382|NCT00409175|hereditary|hereditary
5726383|NCT00409175|amyloidosis|amyloidosis
5726384|NCT00409175|FoldRx|foldrx
5726385|NCT00409162|Tattoo removal|tattoo removal
5726386|NCT00409149|Hypertension|hypertension
5726387|NCT00409149|Diet|diet
5726388|NCT00409149|physical exercise|physical exercise
5726389|NCT00409149|naturopathic|naturopathic
5726390|NCT00409149|group therapy|group therapy
5726391|NCT00409149|Qi Gong|qi gong
5726392|NCT00409136|Alert|alert
5726393|NCT00409136|Deep Vein Thrombosis|deep vein thrombosis
5726394|NCT00409136|Pulmonary Embolism|pulmonary embolism
5726395|NCT00409136|Venous Thromboembolism|venous thromboembolism
5726396|NCT00409136|Prophylaxis|prophylaxis
5726397|NCT00409136|Anticoagulation|anticoagulation
5726398|NCT00409123|vasospastic women|vasospastic women
5726400|NCT00409123|core cooling|core cooling
5726401|NCT00409123|core warming|core warming
5726402|NCT00409123|external cooling|external cooling
5726403|NCT00409123|external warming|external warming
5726405|NCT00409123|choroidal blood flow|choroidal blood flow
5726406|NCT00409123|temperature|temperature
5726407|NCT00409123|vasospastic subjects|vasospastic subjects
5726408|NCT00409123|normal subjects|normal subjects
5726409|NCT00409110|Ocular Pulse Amplitude|ocular pulse amplitude
5726410|NCT00409110|Dynamic Contour Tonometry|dynamic contour tonometry
5726411|NCT00409110|Pulsatility Index|pulsatility index
5726412|NCT00409110|Choroidal Laser Doppler Flowmetry|choroidal laser doppler flowmetry
5726413|NCT00409110|Finometer|finometer
5726414|NCT00409097|ADMA|adma
5726415|NCT00409097|MOF|mof
5726416|NCT00409097|Critical illness|critical illness
5726417|NCT00409084|varices|varices
5726418|NCT00409084|band ligation|band ligation
5726419|NCT00409084|portal hypertension|portal hypertension
5726420|NCT00409084|primary prophylaxis|primary prophylaxis
5726421|NCT00409084|cirrhosis|cirrhosis
5726422|NCT00409084|beta blockers|beta blockers
5726423|NCT00409071|Non metastatic breast cancer|non metastatic breast cancer
5726424|NCT00409071|Adjuvant chemotherapy|adjuvant chemotherapy
5726426|NCT00409071|Vomiting|vomiting
5726427|NCT00409071|Quality of life|quality of life
5726428|NCT00409071|Homeopathy|homeopathy
5726429|NCT00409058|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5726430|NCT00409058|Intracranial Edema|intracranial edema
5726431|NCT00409058|Brain Edema|brain edema
5726432|NCT00409058|Craniocerebral Trauma|craniocerebral trauma
5726433|NCT00409058|Head Injury|head injury
5726434|NCT00409058|Brain Hemorrhage, Traumatic|brain hemorrhage, traumatic
5726435|NCT00409058|Subdural Hematoma|subdural hematoma
5726436|NCT00409058|Brain Concussion|brain concussion
5726437|NCT00409058|Head Injuries, Closed|head injuries, closed
5726438|NCT00409045|Obstructive Sleep Apnea|obstructive sleep apnea
5726439|NCT00409045|Pulmonary Embolism|pulmonary embolism
5726440|NCT00409045|male and female patients suspected of having a pulmonary embolism.|male and female patients suspected of having a pulmonary embolism.
5726441|NCT00409032|osteoporosis|osteoporosis
5726442|NCT00409032|BMD|bmd
5726443|NCT00409032|CTX|ctx
5726444|NCT00409032|Post menopausal|post menopausal
5726445|NCT00409032|strontium|strontium
5726446|NCT00409032|bone turnover|bone turnover
5726447|NCT00409032|clinical development|clinical development
5726448|NCT00408980|diet|diet
5726449|NCT00408980|breast milk fat|breast milk fat
5726450|NCT00408967|Ovarian|ovarian
5726451|NCT00408967|Cancer|cancer
5726452|NCT00408967|Epithelial|epithelial
5726453|NCT00408967|Recurrent|recurrent
5726454|NCT00408967|Platinum|platinum
5726455|NCT00408967|Second-line therapy|second-line therapy
5726456|NCT00408967|Maintenance Therapy|maintenance therapy
5726457|NCT00408967|Biologic|biologic
5726458|NCT00408967|Targeted Therapy|targeted therapy
5726459|NCT00408967|Antibody|antibody
5726460|NCT00408941|EEG|eeg
5726461|NCT00408941|AEP|aep
5726462|NCT00408941|Artefacts|artefacts
5726463|NCT00408941|Propofol|propofol
5726464|NCT00408941|Local Anaesthesia|local anaesthesia
5726465|NCT00408928|Graft-versus-Host Disease|graft-versus-host disease
5726466|NCT00408928|bortezomib|bortezomib
5726467|NCT00408915|Lisuride|lisuride
5726468|NCT00408915|Continuous Dopaminergic Stimulation|continuous dopaminergic stimulation
5726469|NCT00408915|Motor Fluctuations|motor fluctuations
5726470|NCT00408915|Off-Times|off-times
5726471|NCT00408915|Troublesome Dyskinesia|troublesome dyskinesia
5686156|NCT00553241|prognosis|prognosis
5726472|NCT00408915|Parkinson's Disease with motor fluctuations with OFF periods and/or troublesome dyskinesias of more than four hours per day|parkinson's disease with motor fluctuations with off periods and/or troublesome dyskinesias of more than four hours per day
5726473|NCT00408889|liver transplantation|liver transplantation
5726474|NCT00408889|organ failure|organ failure
5726475|NCT00408889|outcome|outcome
5726476|NCT00408863|Breast cancer|breast cancer
5726477|NCT00408863|Tibolone|tibolone
5726478|NCT00408863|Climacteric symptoms|climacteric symptoms
5726479|NCT00408850|sympathetic nervous system, pioglitazone, metabolic syndrome|sympathetic nervous system, pioglitazone, metabolic syndrome
5726480|NCT00408824|insulin resistance|insulin resistance
5726481|NCT00408824|adipocytokine|adipocytokine
5726482|NCT00408824|Metabolic syndrome|metabolic syndrome
5726483|NCT00408824|Diabetes|diabetes
5726484|NCT00408798|Treatment of Alopecia areata with intracutaneous injections of Botulinum Toxin A|treatment of alopecia areata with intracutaneous injections of botulinum toxin a
5726485|NCT00408785|Botulinum Toxin Type A|botulinum toxin type a
5726486|NCT00408785|safety|safety
5726487|NCT00408785|efficacy|efficacy
5726488|NCT00408785|glabellar lines|glabellar lines
5726489|NCT00408772|liver metastases|liver metastases
5726490|NCT00408772|stage IV colon cancer|stage iv colon cancer
5726491|NCT00408772|stage IV rectal cancer|stage iv rectal cancer
5726494|NCT00408772|recurrent colon cancer|recurrent colon cancer
5726495|NCT00408772|recurrent rectal cancer|recurrent rectal cancer
5726496|NCT00408759|xerostomia|xerostomia
5726497|NCT00408759|hypnosis|hypnosis
5726499|NCT00408759|radiotherapy|radiotherapy
5726500|NCT00408759|head and neck cancer|head and neck cancer
5726501|NCT00408746|stomatognathic system|stomatognathic system
5726503|NCT00408746|palate|palate
5726504|NCT00408746|development|development
5726505|NCT00408720|Spectral OCT|spectral oct
5726506|NCT00408720|SLO|slo
5726507|NCT00408720|Retinal Imagining|retinal imagining
5726508|NCT00408707|local infiltration analgesia|local infiltration analgesia
5726509|NCT00408707|postoperative pain|postoperative pain
5726510|NCT00408707|ropivacaine|ropivacaine
5726511|NCT00408668|Malaria Vaccine|malaria vaccine
5726512|NCT00408642|adherence|adherence
5726513|NCT00408642|treatment|treatment
5726514|NCT00408642|antiretroviral|antiretroviral
5726515|NCT00408642|HAART|haart
5726516|NCT00408642|HIV|hiv
5726517|NCT00408642|Treatment Naive|treatment naive
5726518|NCT00408629|Ulcerative Colitis|ulcerative colitis
5726519|NCT00408629|Adalimumab|adalimumab
5726520|NCT00408629|TNF Antagonist|tnf antagonist
5726521|NCT00408629|Mayo Score|mayo score
5726522|NCT00408603|second line treatment|second line treatment
5726523|NCT00408603|platinum resistant|platinum resistant
5726524|NCT00408603|ovary|ovary
5726525|NCT00408603|ovaries|ovaries
5726526|NCT00408603|cancer|cancer
5726527|NCT00408603|epithelial|epithelial
5726528|NCT00408603|carcinomas|carcinomas
5726529|NCT00408603|tumor|tumor
5726530|NCT00408590|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5726531|NCT00408590|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5726532|NCT00408590|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5726533|NCT00408590|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5726534|NCT00408590|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5726535|NCT00408590|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5726536|NCT00408590|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5726537|NCT00408590|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5726538|NCT00408590|Brenner tumor|brenner tumor
5726539|NCT00408577|glucose intolerance|glucose intolerance
5726540|NCT00408577|cardiovascular disease|cardiovascular disease
5726541|NCT00408577|insulin resistance|insulin resistance
5726542|NCT00408577|endothelial dysfunction|endothelial dysfunction
5726543|NCT00408564|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5726544|NCT00408564|stage II pancreatic cancer|stage ii pancreatic cancer
5726545|NCT00408564|stage III pancreatic cancer|stage iii pancreatic cancer
5726546|NCT00408551|stage IV colon cancer|stage iv colon cancer
5726547|NCT00408551|stage IV rectal cancer|stage iv rectal cancer
5726548|NCT00408551|liver metastases|liver metastases
5726549|NCT00408551|recurrent colon cancer|recurrent colon cancer
5726550|NCT00408551|recurrent rectal cancer|recurrent rectal cancer
5726551|NCT00408538|Microbicide|microbicide
5726552|NCT00408538|HIV|hiv
5726553|NCT00408538|Prevention|prevention
5726554|NCT00408538|Rectal|rectal
5726555|NCT00408538|HIV Prevention|hiv prevention
5726556|NCT00408525|memory loss|memory loss
5726557|NCT00408525|memory problems|memory problems
5726558|NCT00408525|alzheimer's|alzheimer's
5726559|NCT00408525|forgetfulness|forgetfulness
5726560|NCT00408525|forgetting|forgetting
5726561|NCT00408512|treatment|treatment
5726562|NCT00408512|adverse events|adverse events
5726563|NCT00408512|adherence|adherence
5726564|NCT00408512|gene|gene
5726565|NCT00408512|polymorphism|polymorphism
5726566|NCT00408499|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5726567|NCT00408499|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5686157|NCT00553241|evaluation|evaluation
5686158|NCT00553241|management|management
5863965|NCT00001150|Inflammatory Mediator Assay|inflammatory mediator assay
5726568|NCT00408499|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5726569|NCT00408499|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5726570|NCT00408499|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5726571|NCT00408447|stem cell transplant|stem cell transplant
5726572|NCT00408447|sickle cell disease|sickle cell disease
5726573|NCT00408447|thalassemia|thalassemia
5726574|NCT00408447|moderately ablative|moderately ablative
5726575|NCT00408447|cord blood transplant|cord blood transplant
5726576|NCT00408447|matched family donor|matched family donor
5726577|NCT00408434|PPARgamma agonist|ppargamma agonist
5726578|NCT00408434|advanced or metastatic malignancies|advanced or metastatic malignancies
5726579|NCT00408434|Tumor|tumor
5726580|NCT00408434|Cancer|cancer
5726581|NCT00408408|stage I breast cancer|stage i breast cancer
5726582|NCT00408408|stage II breast cancer|stage ii breast cancer
5726583|NCT00408408|stage IIIA breast cancer|stage iiia breast cancer
5726584|NCT00408395|influenza|influenza
5726585|NCT00408395|children|children
5726586|NCT00408395|vaccine|vaccine
5726588|NCT00408382|Lipitor|lipitor
5726589|NCT00408382|atorvastatin|atorvastatin
5726590|NCT00408382|Hypercholesteremia|hypercholesteremia
5726591|NCT00408382|yellow coronary plaque|yellow coronary plaque
5726592|NCT00408369|prophylactic|prophylactic
5726593|NCT00408369|malaria|malaria
5726594|NCT00408369|challenge|challenge
5726595|NCT00408356|Zinc treatment|zinc treatment
5726596|NCT00408356|supplementation|supplementation
5726597|NCT00408356|Enterotoxigenic E. coli|enterotoxigenic e. coli
5726598|NCT00408356|diarrhoea|diarrhoea
5726599|NCT00408317|Cystic Fibrosis|cystic fibrosis
5726600|NCT00408317|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5726601|NCT00408317|Ultrase® MT20|ultrase® mt20
5726602|NCT00408304|interferon alpha|interferon alpha
5726603|NCT00408304|depression|depression
5726604|NCT00408304|omega 3|omega 3
5726605|NCT00408291|fracture|fracture
5726606|NCT00408291|shoulder|shoulder
5726607|NCT00408291|bone density|bone density
5726608|NCT00408291|healing|healing
5726609|NCT00408278|Acute Promyelocytic Leukemia|acute promyelocytic leukemia
5726610|NCT00408265|Nicotine Dependence|nicotine dependence
5726611|NCT00408265|Contingency Management|contingency management
5726612|NCT00408252|recurrent or locally advanced|recurrent or locally advanced
5726613|NCT00408252|cytokine failure|cytokine failure
5726614|NCT00408239|Factor Xa inhibitor|factor xa inhibitor
5726615|NCT00408239|Thromboembolism|thromboembolism
5726616|NCT00408239|Arthroplasty|arthroplasty
5726617|NCT00408239|Knee Replacement|knee replacement
5726618|NCT00408239|Prevention and Control|prevention and control
5726619|NCT00408200|Atrial fibrillation|atrial fibrillation
5726620|NCT00408200|Atrial arrhythmia|atrial arrhythmia
5726621|NCT00408187|Randomized Controlled Trials|randomized controlled trials
5726622|NCT00408187|Immunosuppression|immunosuppression
5726623|NCT00408187|Adult|adult
5726624|NCT00408187|Chronic Disease|chronic disease
5726625|NCT00408187|Dermatologic Agents|dermatologic agents
5726626|NCT00408187|Female|female
5726627|NCT00408187|Humans|humans
5726628|NCT00408187|Male|male
5726629|NCT00408187|Middle Aged|middle aged
5726630|NCT00408187|Severity of Illness Index|severity of illness index
5726631|NCT00408187|Treatment Outcome|treatment outcome
5726632|NCT00408187|Quality of Life|quality of life
5726633|NCT00408187|Double-Blind Method|double-blind method
5726634|NCT00408174|IBD|ibd
5726635|NCT00408174|UC|uc
5726636|NCT00408174|Ulcerative Colitis|ulcerative colitis
5726637|NCT00408174|Inflammatory Bowel Disease|inflammatory bowel disease
5726638|NCT00408161|Contingency Management|contingency management
5726639|NCT00408161|Alcohol Dependence|alcohol dependence
5726640|NCT00408135|Respiratory Tract Infections|respiratory tract infections
5726641|NCT00408135|Skin Diseases|skin diseases
5726642|NCT00408135|Sinusitis|sinusitis
5726643|NCT00408109|Avian Influenza|avian influenza
5726644|NCT00408109|Healthy|healthy
5726645|NCT00408109|Immunity|immunity
5726646|NCT00408109|Preventive|preventive
5726647|NCT00408109|Bird Flu|bird flu
5726648|NCT00408109|Healthy Volunteer|healthy volunteer
5726649|NCT00408109|HV|hv
5726650|NCT00408096|osteoarthritis|osteoarthritis
5726651|NCT00408096|shoulder|shoulder
5726652|NCT00408096|resurfacing|resurfacing
5726653|NCT00408096|prosthesis|prosthesis
5726654|NCT00408070|ovarian cancer|ovarian cancer
5726655|NCT00408070|fallopian tube cancer|fallopian tube cancer
5726656|NCT00408070|peritoneal cancer|peritoneal cancer
5726657|NCT00408057|lipid lowering|lipid lowering
5726658|NCT00408057|target achievement|target achievement
5726659|NCT00408057|Patients with established cardiovascular disease|patients with established cardiovascular disease
5726660|NCT00408031|Major depressive disorder|major depressive disorder
5726662|NCT00408031|Treatment-Resistant|treatment-resistant
5726663|NCT00408031|D-cycloserine|d-cycloserine
5726664|NCT00407992|Headache|headache
5726665|NCT00407992|Migraine|migraine
5726666|NCT00407940|Thrombosis|thrombosis
5726667|NCT00407940|Claudication|claudication
5726668|NCT00407914|wrinkles|wrinkles
5726669|NCT00407914|soft tissue filler|soft tissue filler
5726670|NCT00407914|Aquamid|aquamid
5726671|NCT00407901|Visually Challenged|visually challenged
5726672|NCT00407901|Legally Blind|legally blind
5726673|NCT00407901|Functional Assessment Questionnaire|functional assessment questionnaire
5726674|NCT00407901|Low Functioning|low functioning
5726675|NCT00407901|High Functioning|high functioning
5726676|NCT00407875|Prostate|prostate
5726677|NCT00407875|Cancer|cancer
5726678|NCT00407875|Radiation|radiation
5726679|NCT00407862|insulin resistance|insulin resistance
5726680|NCT00407862|beta cell function|beta cell function
5726681|NCT00407862|endothelial dysfunction|endothelial dysfunction
5726682|NCT00407836|HIV|hiv
5726683|NCT00407836|CD4 T cell level|cd4 t cell level
5726684|NCT00407836|CD4 autoimmunity|cd4 autoimmunity
5726685|NCT00407836|Viral load|viral load
5726686|NCT00407836|T cell vaccination|t cell vaccination
5726687|NCT00407836|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5726688|NCT00407823|Child|child
5726689|NCT00407823|Septic shock|septic shock
5726690|NCT00407823|Resuscitation|resuscitation
5726691|NCT00407823|Central venous oxygen saturation|central venous oxygen saturation
5726692|NCT00407823|Cardiac output|cardiac output
5726693|NCT00407823|Goal-directed therapy|goal-directed therapy
5726694|NCT00407797|Lyrica|lyrica
5726695|NCT00407797|Epilepsies - Partial|epilepsies - partial
5726696|NCT00407784|primary aldosteronism|primary aldosteronism
5726697|NCT00407784|hypertension|hypertension
5743626|NCT00344266|Obesity|obesity
5743627|NCT00344266|Adipose Tissue|adipose tissue
5743628|NCT00344266|Microarrays|microarrays
5743629|NCT00344266|Cytokines|cytokines
5743630|NCT00344266|Eicosanoids|eicosanoids
5726698|NCT00407784|aldosteron-renin ratio|aldosteron-renin ratio
5726699|NCT00407784|eplerenone|eplerenone
5726700|NCT00407784|aldosteron-receptor antagonist|aldosteron-receptor antagonist
5726701|NCT00407784|screening|screening
5726702|NCT00407771|platelet function assay|platelet function assay
5726703|NCT00407771|Glycoprotein inhibitors|glycoprotein inhibitors
5726704|NCT00407771|percutaneous coronary intervention|percutaneous coronary intervention
5726705|NCT00407771|Diabetes Mellitus|diabetes mellitus
5726706|NCT00407758|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5726707|NCT00407758|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5726708|NCT00407745|Pain|pain
5726709|NCT00407745|central neuropathic pain|central neuropathic pain
5726710|NCT00407732|hepatitis C|hepatitis c
5726711|NCT00407732|mental disorder|mental disorder
5726712|NCT00407732|substance use|substance use
5726713|NCT00407732|psychosocial intervention|psychosocial intervention
5726714|NCT00407719|Choroidal Neovascularization|choroidal neovascularization
5726715|NCT00407706|Breast Cancer, FACS, SCM, Malignant, Benign, Lymphocytes|breast cancer, facs, scm, malignant, benign, lymphocytes
5726716|NCT00407693|Dosimetry|dosimetry
5726717|NCT00407693|Effective Dose|effective dose
5726718|NCT00407693|Radiation-Absorbed Dose|radiation-absorbed dose
5726719|NCT00407680|Type 2 diabetes mellitus|type 2 diabetes mellitus
5726720|NCT00407680|Hypertension|hypertension
5726721|NCT00407680|Angiotensin II Receptor Blocker|angiotensin ii receptor blocker
5726722|NCT00407680|Diabetic nephropathy|diabetic nephropathy
5726723|NCT00407667|hemiparesis|hemiparesis
5726724|NCT00407667|rehabilitation|rehabilitation
5726725|NCT00407667|upper limb rehabilitation|upper limb rehabilitation
5726726|NCT00407667|arm therapy|arm therapy
5726727|NCT00407641|diabetes mellitus|diabetes mellitus
5726728|NCT00407641|chronic hemodialysis|chronic hemodialysis
5726729|NCT00407641|anticoagulation|anticoagulation
5726730|NCT00407641|outcome|outcome
5726731|NCT00407628|Stroke|stroke
5726732|NCT00407628|Diffusion spectrum tractography|diffusion spectrum tractography
5726733|NCT00407628|Functional MRI (fMRI)|functional mri (fmri)
5726734|NCT00407628|Lower extremity|lower extremity
5726735|NCT00407602|retinitis pigmentosa|retinitis pigmentosa
5726736|NCT00407602|device|device
5726737|NCT00407602|retinal implant|retinal implant
5726738|NCT00407602|retinal prosthesis|retinal prosthesis
5726740|NCT00407602|outer retinal degeneration|outer retinal degeneration
5726741|NCT00407576|Alzheimer's Disease|alzheimer's disease
5726742|NCT00407576|Positron Emission Tomography|positron emission tomography
5726743|NCT00407576|Brain|brain
5726744|NCT00407576|Neurochemistry|neurochemistry
5726745|NCT00407576|Beta-Amyloid Plaques|beta-amyloid plaques
5726746|NCT00407576|PET|pet
5726747|NCT00407576|MeS-IMPY|mes-impy
5726748|NCT00407576|Alzheimer Disease|alzheimer disease
5726749|NCT00407576|AD|ad
5726750|NCT00407576|Dementia|dementia
5726751|NCT00407576|Healthy Volunteer|healthy volunteer
5726752|NCT00407576|HV|hv
5726753|NCT00407550|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5726754|NCT00407550|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5726755|NCT00407550|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5726756|NCT00407498|P 276-00|p 276-00
5726757|NCT00407498|Advanced Refractory Neoplasm|advanced refractory neoplasm
5726758|NCT00407498|Maximum Tolerated Dose|maximum tolerated dose
5726759|NCT00407498|Dose Limiting Toxicity|dose limiting toxicity
5726760|NCT00407498|Pharmacokinetics|pharmacokinetics
5863966|NCT00001150|Ultraviolet Radiation|ultraviolet radiation
5726761|NCT00407472|Bio-equivalence study in healthy volunteers, indication|bio-equivalence study in healthy volunteers, indication
5726762|NCT00407472|of product is growth hormone deficiency|of product is growth hormone deficiency
5726763|NCT00407446|PDE5 inhibition|pde5 inhibition
5726764|NCT00407446|chronic heart failure|chronic heart failure
5726765|NCT00407446|endothelial function|endothelial function
5726766|NCT00407446|exercise ventilation|exercise ventilation
5726767|NCT00407433|Gemcitabine|gemcitabine
5726768|NCT00407433|Oxaliplatine|oxaliplatine
5726769|NCT00407433|Paediatric solid tumors|paediatric solid tumors
5726770|NCT00407433|Other CNS tumors|other cns tumors
5726771|NCT00407433|Other miscellaneous solid non-CNS tumours|other miscellaneous solid non-cns tumours
5726772|NCT00407420|Childhood|childhood
5726774|NCT00407420|Behavior modification|behavior modification
5726775|NCT00407420|Insulin resistance|insulin resistance
5726776|NCT00407407|Epithelial ovarian|epithelial ovarian
5726777|NCT00407407|Primary peritoneal or fallopian tube carcinoma|primary peritoneal or fallopian tube carcinoma
5726778|NCT00407407|Abraxane|abraxane
5726779|NCT00407407|Carboplatin|carboplatin
5726781|NCT00407394|Wheezing|wheezing
5726782|NCT00407394|Treatment|treatment
5726783|NCT00407394|Children|children
5726786|NCT00407355|vein occlusion|vein occlusion
5726787|NCT00407355|macular edema|macular edema
5726788|NCT00407342|Psoriasis|psoriasis
5726789|NCT00407342|biologics|biologics
5726790|NCT00407342|alefacept|alefacept
5726791|NCT00407342|Narrowband UVB|narrowband uvb
5726792|NCT00407342|Phototherapy|phototherapy
5726793|NCT00407342|Half-side comparison|half-side comparison
5726794|NCT00407329|BPH|bph
5726795|NCT00407316|Uveitis|uveitis
5726796|NCT00407316|Quality of life|quality of life
5726797|NCT00407316|Visual function|visual function
5726798|NCT00407290|pregnancy|pregnancy
5726799|NCT00407290|vaginal delivery|vaginal delivery
5726800|NCT00407277|nicotine dependence|nicotine dependence
5726801|NCT00407277|smoking|smoking
5726802|NCT00407277|nicotine patch|nicotine patch
5726803|NCT00407277|double-blind|double-blind
5726804|NCT00407277|randomized|randomized
5726805|NCT00407277|placebo|placebo
5726806|NCT00407277|psychosis|psychosis
5726807|NCT00407277|schizophrenia|schizophrenia
5726808|NCT00407277|schizophreniform|schizophreniform
5726809|NCT00407277|schizoaffective disorder|schizoaffective disorder
5726810|NCT00407264|bronchial squamous metaplasia|bronchial squamous metaplasia
5726811|NCT00407264|bronchial squamous dysplasia|bronchial squamous dysplasia
5726812|NCT00407251|refractory|refractory
5726813|NCT00407251|prostate|prostate
5726814|NCT00407251|hormone|hormone
5726815|NCT00407238|barrier function, multi-purpose solutions, silicone hydrogel contact lenses|barrier function, multi-purpose solutions, silicone hydrogel contact lenses
5726816|NCT00407212|early stage idiopathic Parkinson's disease|early stage idiopathic parkinson's disease
5726817|NCT00407199|social phobia, anxiety, quetiapine|social phobia, anxiety, quetiapine
5726818|NCT00407186|CRITICS|critics
5726819|NCT00407186|gastric cancer|gastric cancer
5726820|NCT00407186|surgery|surgery
5726821|NCT00407186|adjuvant|adjuvant
5726822|NCT00407186|chemotherapy|chemotherapy
5726823|NCT00407186|chemoradiotherapy|chemoradiotherapy
5726824|NCT00407186|capecitabine|capecitabine
5726825|NCT00407186|cisplatin|cisplatin
5726826|NCT00407186|epirubicin|epirubicin
5726827|NCT00407160|Kidney transplant|kidney transplant
5726828|NCT00407160|Tolerance induction|tolerance induction
5726829|NCT00407160|High Panel Reactive Antibody (PRA) kidney recipients|high panel reactive antibody (pra) kidney recipients
5726830|NCT00407147|bacterial infection|bacterial infection
5726831|NCT00407147|empiric antibiotic treatment|empiric antibiotic treatment
5726832|NCT00407147|duration antibiotic treatment|duration antibiotic treatment
5726833|NCT00407147|reduce antibiotic treatment|reduce antibiotic treatment
5726834|NCT00407147|procalcitonin|procalcitonin
5726835|NCT00407147|PCT Kryptor|pct kryptor
5726836|NCT00407147|sepsis|sepsis
5726837|NCT00407147|Intensive Care Unit|intensive care unit
5726838|NCT00407147|antibiotic treatment|antibiotic treatment
5726839|NCT00407121|Neovascular Membrane|neovascular membrane
5726840|NCT00407121|Uveitis|uveitis
5726841|NCT00407121|Bevacizumab|bevacizumab
5726842|NCT00407108|vitreoretinal surgery|vitreoretinal surgery
5726843|NCT00407095|Parkinson Disease|parkinson disease
5726844|NCT00407043|Dry Eye Disease|dry eye disease
5726845|NCT00407043|Lotemax|lotemax
5726846|NCT00407043|Restasis|restasis
5726847|NCT00407043|Loteprednol|loteprednol
5726848|NCT00407043|Cyclosporine|cyclosporine
5726849|NCT00407004|acute-on-chronic liver failure, MARS, Prometheus, bilirubin, bile acids, cytokines|acute-on-chronic liver failure, mars, prometheus, bilirubin, bile acids, cytokines
5726850|NCT00406991|retinal blood flow|retinal blood flow
5726851|NCT00406991|diabetic retinopathy|diabetic retinopathy
5726852|NCT00406991|microthrombosis|microthrombosis
5726853|NCT00406991|aspirin|aspirin
5726854|NCT00406991|clopidogrel|clopidogrel
5726855|NCT00406978|MYELOMA|myeloma
5726856|NCT00406978|THALIDOMIDE|thalidomide
5726857|NCT00406978|DEFIBRODITE|defibrodite
5726858|NCT00406939|Gene Therapy|gene therapy
5734962|NCT00376545|HV|hv
5726859|NCT00406939|Immunology|immunology
5726860|NCT00406939|Phase I Clinical Trial|phase i clinical trial
5726861|NCT00406900|uveal melanoma|uveal melanoma
5726862|NCT00406900|metastatic disease|metastatic disease
5726863|NCT00406874|infertility|infertility
5726864|NCT00406874|semen quality|semen quality
5726865|NCT00406874|sexual function|sexual function
5726866|NCT00406874|blood pressure|blood pressure
5726867|NCT00406874|omega 3 fats|omega 3 fats
5726868|NCT00406874|folic acid|folic acid
5726869|NCT00406861|reaction|reaction
5726871|NCT00406861|leprosy|leprosy
5726872|NCT00406835|Whole Brain Radiation Therapy|whole brain radiation therapy
5726873|NCT00406835|Stereotactic Radiosurgery|stereotactic radiosurgery
5726874|NCT00406835|Brain metastases|brain metastases
5726875|NCT00406822|Glaucoma|glaucoma
5726876|NCT00406822|collagen matrix|collagen matrix
5726877|NCT00406822|OculusGen|oculusgen
5726878|NCT00406822|trabeculectomy|trabeculectomy
5726879|NCT00406822|tissue engineering|tissue engineering
5726880|NCT00406809|Sezary syndrome|sezary syndrome
5726881|NCT00406809|cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5726882|NCT00406809|follicular lymphoma|follicular lymphoma
5726883|NCT00406809|marginal zone lymphoma|marginal zone lymphoma
5726884|NCT00406809|indolent T-cell lymphoma|indolent t-cell lymphoma
5726886|NCT00406809|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5726887|NCT00406809|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5726888|NCT00406809|ABT-263|abt-263
5726889|NCT00406809|lymphoid malignancies|lymphoid malignancies
5726890|NCT00406809|chronic lymphoid leukemia|chronic lymphoid leukemia
5726891|NCT00406809|mycosis fungoides|mycosis fungoides
5726892|NCT00406809|mantle cell lymphoma|mantle cell lymphoma
5726893|NCT00406783|Allergic Rhinitis|allergic rhinitis
5728246|NCT00401505|immunity|immunity
5726894|NCT00406783|Intermittent Allergic Rhinitis|intermittent allergic rhinitis
5726895|NCT00406770|Obesity|obesity
5726896|NCT00406770|Light therapy|light therapy
5726897|NCT00406770|Hypocaloric diet|hypocaloric diet
5726898|NCT00406757|T-cell|t-cell
5726899|NCT00406757|T-ALL|t-all
5726900|NCT00406757|T-LBL|t-lbl
5726901|NCT00406757|506U78|506u78
5726902|NCT00406757|ara-G|ara-g
5726903|NCT00406757|ara-GTP|ara-gtp
5726904|NCT00406757|Lymphoma|lymphoma
5726905|NCT00406757|Leukemia|leukemia
5726906|NCT00406744|neovascularization|neovascularization
5726907|NCT00406731|Endothelin-1|endothelin-1
5726908|NCT00406731|L-NG-Monomethyl Arginine|l-ng-monomethyl arginine
5726909|NCT00406731|Optic Nerve Head blood flow|optic nerve head blood flow
5726910|NCT00406718|Medication Adherence|medication adherence
5726911|NCT00406718|Psychosocial Treatment|psychosocial treatment
5726912|NCT00406718|Cognitive Adaptation Training|cognitive adaptation training
5726913|NCT00406718|Med-e Monitor|med-e monitor
5726914|NCT00406718|Adaptive Function|adaptive function
5726915|NCT00406705|Exercise Tolerance|exercise tolerance
5726916|NCT00406705|Dyspnea|dyspnea
5726917|NCT00406705|Rehabilitation|rehabilitation
5726918|NCT00406705|Helium|helium
5726919|NCT00406692|Zonisamide|zonisamide
5726920|NCT00406692|Alcoholism|alcoholism
5726926|NCT00406640|Major Depressive Disorder|major depressive disorder
5726927|NCT00406640|Depression|depression
5726928|NCT00406627|filariasis, lymphatic filariasis, Egypt|filariasis, lymphatic filariasis, egypt
5726929|NCT00406614|High Blood Pressure|high blood pressure
5726930|NCT00406588|Parkinson Disease|parkinson disease
5726931|NCT00406575|Congestive heart failure|congestive heart failure
5726932|NCT00406575|Relaxin|relaxin
5726933|NCT00406575|Hemodynamics|hemodynamics
5726934|NCT00406575|Renal function|renal function
5726935|NCT00406562|uncontrolled|uncontrolled
5726936|NCT00406549|Staphylococcus aureus|staphylococcus aureus
5726937|NCT00406549|Nasal colonization|nasal colonization
5726938|NCT00406549|pre-surgical patients|pre-surgical patients
5726939|NCT00406549|Sensitivity|sensitivity
5726940|NCT00406549|Specificity|specificity
5726941|NCT00406549|Nasal Staphylococcus aureus in pre-surgical patients|nasal staphylococcus aureus in pre-surgical patients
5726942|NCT00406536|Cystic Fibrosis|cystic fibrosis
5726943|NCT00406536|Pancreatic Insufficiency|pancreatic insufficiency
5726944|NCT00406536|LYM-X-SORB™|lym-x-sorb™
5726945|NCT00406536|LXS|lxs
5726946|NCT00406484|Methadone|methadone
5726947|NCT00406484|Counseling|counseling
5726948|NCT00406484|HIV risk reduction|hiv risk reduction
5726949|NCT00406484|HIV Seronegativity|hiv seronegativity
5726950|NCT00406471|Ischemic|ischemic
5726951|NCT00406471|Central|central
5726952|NCT00406471|Retinal|retinal
5726953|NCT00406471|Vein|vein
5726954|NCT00406471|Occlusion|occlusion
5726955|NCT00406471|Ranibizumab|ranibizumab
5726956|NCT00406471|Lucentis|lucentis
5726957|NCT00406471|CRVO|crvo
5726958|NCT00406471|ISCRVO|iscrvo
5726959|NCT00406458|Diabetic neuropathy|diabetic neuropathy
5726960|NCT00406458|Diabetes Type I or II|diabetes type i or ii
5726961|NCT00406458|Mild to moderate sensorimotor diabetic polyneuropathy|mild to moderate sensorimotor diabetic polyneuropathy
5726966|NCT00406432|BRL029060/Paroxetine CR|brl029060/paroxetine cr
5726967|NCT00406432|pharmacokinetics|pharmacokinetics
5726968|NCT00406432|repeat dose|repeat dose
5726969|NCT00406419|anti-CD20|anti-cd20
5726970|NCT00406419|stage|stage
5726971|NCT00406419|CD20|cd20
5726973|NCT00406393|Acute Myelogenous Leukemia|acute myelogenous leukemia
5726974|NCT00406393|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5726975|NCT00406393|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5726976|NCT00406380|Telangiectasias|telangiectasias
5726977|NCT00406380|Leakage|leakage
5726978|NCT00406380|Bevacizumab|bevacizumab
5726979|NCT00406380|Telangiectasias secondary to Branch Retinal Vein Occlusion (BRVO)|telangiectasias secondary to branch retinal vein occlusion (brvo)
5726980|NCT00406380|Idiopathic juxtafoveal retinal telangiectasias|idiopathic juxtafoveal retinal telangiectasias
5726981|NCT00406315|ziprasidone, quetiapine (Seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder|ziprasidone, quetiapine (seroquel) switch, open label, flexible dose, schizophrenia, schizoaffective disorder
5726982|NCT00406302|NSCLC|nsclc
5726983|NCT00406302|non-small-cell lung cancer|non-small-cell lung cancer
5726984|NCT00406276|Lung Cancer|lung cancer
5726985|NCT00406263|nuclear sclerotic cataract|nuclear sclerotic cataract
5726986|NCT00406263|cataract|cataract
5726987|NCT00406211|Rubella|rubella
5726989|NCT00406211|Measles|measles
5726990|NCT00406211|Mumps|mumps
5726991|NCT00406211|Germany|germany
5726992|NCT00406211|Austria|austria
5743906|NCT00343135|1gm|1gm
5743907|NCT00343135|Soft|soft
5743908|NCT00343135|tissue|tissue
5743909|NCT00343135|Infections|infections
5743910|NCT00343122|liver|liver
5743911|NCT00343122|cirrhosis|cirrhosis
5743912|NCT00343122|hepatopulmonary syndrome|hepatopulmonary syndrome
5743913|NCT00343096|intranasal|intranasal
5743914|NCT00343096|buccal|buccal
5743915|NCT00343096|lorazepam|lorazepam
5743916|NCT00343096|paediatric|paediatric
5743917|NCT00343096|convulsions|convulsions
5743918|NCT00343083|Head and Neck Neoplasms|head and neck neoplasms
5743919|NCT00343044|platinum resistant ovarian cancer|platinum resistant ovarian cancer
5743920|NCT00343044|recurrent ovarian cancer|recurrent ovarian cancer
5743921|NCT00343044|platinum resistant cancer|platinum resistant cancer
5743922|NCT00343031|Insecticides|insecticides
5743923|NCT00343031|Children|children
5743924|NCT00343031|Women|women
5743925|NCT00343031|Infection|infection
5743926|NCT00343031|DDT|ddt
5743927|NCT00343031|Contaminant|contaminant
5743931|NCT00343018|Memory|memory
5726993|NCT00406198|Sepsis syndrom|sepsis syndrom
5726994|NCT00406198|severe sepsis|severe sepsis
5726995|NCT00406198|septic shock|septic shock
5726996|NCT00406198|hemofiltration|hemofiltration
5726997|NCT00406198|multiple organ failure|multiple organ failure
5726998|NCT00406185|Registry|registry
5726999|NCT00406185|cardiac catheterization laboratory|cardiac catheterization laboratory
5727000|NCT00406185|coronary heart disease|coronary heart disease
5727001|NCT00406185|cardiovascular disease|cardiovascular disease
5727002|NCT00406159|Autism|autism
5727003|NCT00406159|Hyperbaric Oxygen Therapy|hyperbaric oxygen therapy
5727004|NCT00406159|Behavioral assessments|behavioral assessments
5727005|NCT00406120|eye|eye
5727006|NCT00406120|uvea|uvea
5727007|NCT00406120|iris|iris
5727008|NCT00406120|choroid|choroid
5727009|NCT00406120|ciliary body|ciliary body
5727010|NCT00406120|melanoma|melanoma
5727011|NCT00406120|iris melanoma|iris melanoma
5727012|NCT00406120|choroidal melanoma|choroidal melanoma
5727013|NCT00406120|ciliary body melanoma|ciliary body melanoma
5727014|NCT00406120|uveal melanoma|uveal melanoma
5727015|NCT00406120|posterior uveal melanoma|posterior uveal melanoma
5727016|NCT00406120|prognosis|prognosis
5727017|NCT00406120|metastasis|metastasis
5727018|NCT00406120|genetic testing|genetic testing
5727019|NCT00406120|molecular testing|molecular testing
5727328|NCT00404859|asthma|asthma
5727020|NCT00406120|gene expression profiling|gene expression profiling
5727021|NCT00406107|branch retinal vein occlusion|branch retinal vein occlusion
5727022|NCT00406107|macular edema|macular edema
5727023|NCT00406107|pegaptanib sodium|pegaptanib sodium
5727024|NCT00406107|vascular endothelial growth factor|vascular endothelial growth factor
5727025|NCT00406094|NARES|nares
5727026|NCT00406094|eosinophils|eosinophils
5727027|NCT00406094|nasal symptoms|nasal symptoms
5727028|NCT00406068|Bladder neoplasm|bladder neoplasm
5727029|NCT00406068|Intravesical drug administration|intravesical drug administration
5727030|NCT00406068|Neoplasm recurrence, local|neoplasm recurrence, local
5727031|NCT00406068|Transitional cell, carcinoma|transitional cell, carcinoma
5727032|NCT00406068|Carcinoma in situ|carcinoma in situ
5727033|NCT00406068|Mycobacterium|mycobacterium
5727034|NCT00406042|glaucoma|glaucoma
5727035|NCT00406042|trabeculoplasty|trabeculoplasty
5727036|NCT00406042|steroids|steroids
5727037|NCT00406016|Acute spinal cord injury;|acute spinal cord injury;
5727038|NCT00406003|BRL029060/Paroxetine CR|brl029060/paroxetine cr
5727039|NCT00406003|pharmacokinetics|pharmacokinetics
5727041|NCT00405990|HIV|hiv
5727042|NCT00405990|MTCT|mtct
5727043|NCT00405990|heterosexual behaviour|heterosexual behaviour
5727044|NCT00405990|sexual risk behaviour|sexual risk behaviour
5727045|NCT00405990|couple counselling|couple counselling
5727046|NCT00405990|Voluntary counselling and testing|voluntary counselling and testing
5680909|NCT00575679|Driving under the influence|driving under the influence
5680910|NCT00575679|Interview, psychological|interview, psychological
5680911|NCT00575679|Brief intervention|brief intervention
5680912|NCT00575679|Brief motivational interview|brief motivational interview
5680913|NCT00575666|cognition, psychopathology|cognition, psychopathology
5727047|NCT00405990|HIV Seronegativity|hiv seronegativity
5727048|NCT00405977|Neuromuscular block|neuromuscular block
5727049|NCT00405977|Magnesium|magnesium
5744016|NCT00342693|Cancer|cancer
5744017|NCT00342693|Nodules|nodules
5744018|NCT00342693|Nuclear|nuclear
5744019|NCT00342693|Thyroid Screening|thyroid screening
5744020|NCT00342693|Thyroid Gland|thyroid gland
5744021|NCT00342667|Pregnancy|pregnancy
5744022|NCT00342667|Preterm Birth|preterm birth
5744023|NCT00342667|Predictors of Outcome|predictors of outcome
5744024|NCT00342667|Neonatal/Infant Complications|neonatal/infant complications
5744025|NCT00342667|Neurologic Development|neurologic development
5744026|NCT00342667|(SqrRoot) mniotic Fluid|(sqrroot) mniotic fluid
5744027|NCT00342667|Cerebral Palsy|cerebral palsy
5744028|NCT00342667|Risk Factors|risk factors
5744029|NCT00342667|Pregnancy Complications|pregnancy complications
5744035|NCT00342641|Lymphoma|lymphoma
5744036|NCT00342641|Multiple Myeloma|multiple myeloma
5744037|NCT00342641|Thyroiditis|thyroiditis
5744038|NCT00342641|Cohort Study|cohort study
5727050|NCT00405977|Rocuronium|rocuronium
5727051|NCT00405977|Time course of action|time course of action
5727052|NCT00405938|Breast cancer|breast cancer
5727053|NCT00405938|Metastatic breast cancer|metastatic breast cancer
5727054|NCT00405938|Bevacizumab|bevacizumab
5727055|NCT00405938|Anastrozole|anastrozole
5727056|NCT00405938|Fulvestrant|fulvestrant
5727057|NCT00405925|AIDS|aids
5727058|NCT00405925|Treatment Naive|treatment naive
5727059|NCT00405899|Allergy|allergy
5727060|NCT00405899|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5727061|NCT00405899|Perennial Allergic Rhinitis|perennial allergic rhinitis
5727062|NCT00405873|Primary hepatocellular carcinoma|primary hepatocellular carcinoma
5727063|NCT00405873|Liver cancer|liver cancer
5727064|NCT00405873|Tumour response|tumour response
5727065|NCT00405873|Quality of life|quality of life
5727066|NCT00405847|Sleep|sleep
5727067|NCT00405847|Critical illness|critical illness
5727068|NCT00405847|Cytokine|cytokine
5727069|NCT00405834|Pressure Ulcers|pressure ulcers
5727070|NCT00405821|AIDS|aids
5727071|NCT00405821|HIV Disease Progression|hiv disease progression
5727072|NCT00405821|Quality of Life|quality of life
5727073|NCT00405821|HIV Viral Load|hiv viral load
5727074|NCT00405821|Genital Ulcers|genital ulcers
5727076|NCT00405821|Treatment Naive|treatment naive
5727077|NCT00405795|Pressure Ulcer|pressure ulcer
5727078|NCT00405782|metastatic breast cancer|metastatic breast cancer
5727079|NCT00405782|exercise intervention|exercise intervention
5727080|NCT00405769|statin intolerance|statin intolerance
5727081|NCT00405769|hyperlipidemia|hyperlipidemia
5727082|NCT00405769|lifestyle changes|lifestyle changes
5727083|NCT00405769|red yeast rice|red yeast rice
5727084|NCT00405756|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5727085|NCT00405756|Celgene|celgene
5727086|NCT00405756|CC-5013|cc-5013
5727087|NCT00405756|Revlimid|revlimid
5727088|NCT00405756|Lenalidomide|lenalidomide
5727089|NCT00405756|Melphalan|melphalan
5727090|NCT00405756|Prednisone|prednisone
5727091|NCT00405756|Elderly|elderly
5727092|NCT00405743|CP-4055|cp-4055
5727093|NCT00405743|ELACYT™|elacyt™
5727094|NCT00405743|Cancer|cancer
5727095|NCT00405743|Refractory|refractory
5727096|NCT00405743|Relapsed|relapsed
5727097|NCT00405743|Hematologic Malignancies|hematologic malignancies
5727098|NCT00405743|Leukemia|leukemia
5727099|NCT00405743|ALL|all
5727100|NCT00405743|AML|aml
5727101|NCT00405743|AMM|amm
5727102|NCT00405743|CLL|cll
5727103|NCT00405743|CML|cml
5727104|NCT00405743|CMML|cmml
5727105|NCT00405743|MDS|mds
5727106|NCT00405730|Cataracts|cataracts
5727107|NCT00405717|ischemic heart disease|ischemic heart disease
5727108|NCT00405717|acute coronary syndromes|acute coronary syndromes
5727109|NCT00405717|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5727111|NCT00405717|clopidogrel|clopidogrel
5727112|NCT00405704|Vesicoureteral Reflux|vesicoureteral reflux
5727113|NCT00405704|Urinary Tract Infections|urinary tract infections
5727114|NCT00405704|Renal Scarring|renal scarring
5727115|NCT00405704|Antibiotic Resistance|antibiotic resistance
5727116|NCT00405704|Controlled Clinical Trial|controlled clinical trial
5727117|NCT00405704|Trimethoprim-Sulfamethoxazole|trimethoprim-sulfamethoxazole
5727118|NCT00405704|Children|children
5744125|NCT00342355|Protease Inhibitors|protease inhibitors
5744126|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5744127|NCT00342355|AIDS|aids
5744128|NCT00342355|Opportunistic Infections|opportunistic infections
5744129|NCT00342355|Resource-Poor|resource-poor
5744134|NCT00342329|Case-Control|case-control
5744135|NCT00342329|Hydrocarbons|hydrocarbons
5744136|NCT00342329|Metals|metals
5744137|NCT00342329|Silica|silica
5744138|NCT00342329|Tobacco Smoke|tobacco smoke
5744139|NCT00342329|Lupus Nephritis|lupus nephritis
5744140|NCT00342329|Environmental Exposures|environmental exposures
5735245|NCT00375648|Prostate|prostate
5744145|NCT00342316|Survival|survival
5727119|NCT00405691|Medical Device|medical device
5727120|NCT00405691|Spine|spine
5727121|NCT00405691|Lumbar Spinal Stenosis|lumbar spinal stenosis
5727122|NCT00405691|Degenerative Spondylolisthesis|degenerative spondylolisthesis
5727123|NCT00405691|Facet Arthrosis|facet arthrosis
5727124|NCT00405691|Back and Leg Pain|back and leg pain
5727125|NCT00405691|Spine Research|spine research
5727126|NCT00405691|Medical Device Research|medical device research
5727127|NCT00405691|Impliant|impliant
5727128|NCT00405691|Lumbar Treatment|lumbar treatment
5727129|NCT00405691|Spinal Treatment|spinal treatment
5727130|NCT00405691|Spinal Device|spinal device
5727131|NCT00405678|Exercise Intervention|exercise intervention
5727132|NCT00405678|Breast Cancer|breast cancer
5727133|NCT00405678|Neo-Adjuvant Therapy|neo-adjuvant therapy
5727134|NCT00405678|Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy|operable breast cancer stage i-ii receiving neo-adjuvant chemotherapy
5727136|NCT00405665|L-Arginine|l-arginine
5727137|NCT00405665|Pediatrics|pediatrics
5727138|NCT00405665|pulmonary function|pulmonary function
5727139|NCT00405652|Liver transplantation, mycophenolate, GI problems, Quality of Life|liver transplantation, mycophenolate, gi problems, quality of life
5727140|NCT00405626|post partum hemmorhage,Arnica montana,Bellis Perenis|post partum hemmorhage,arnica montana,bellis perenis
5727141|NCT00405613|Aspirin|aspirin
5727142|NCT00405613|Bleeding|bleeding
5727143|NCT00405613|Clinical Trial|clinical trial
5727144|NCT00405613|Dental Extraction|dental extraction
5727145|NCT00405600|Lumbar degenerative disease|lumbar degenerative disease
5727146|NCT00405600|spinal stenosis|spinal stenosis
5727147|NCT00405600|spondylolisthesis|spondylolisthesis
5727148|NCT00405600|non instrumented surgery|non instrumented surgery
5727149|NCT00405600|instrumented surgery|instrumented surgery
5727150|NCT00405600|BMP-2|bmp-2
5727151|NCT00405574|prostate|prostate
5727153|NCT00405574|antiangiogenic|antiangiogenic
5727154|NCT00405574|copper|copper
5727155|NCT00405574|ATN-224|atn-224
5727156|NCT00405561|Advanced Colorectal Carcinoma|advanced colorectal carcinoma
5727157|NCT00405535|OCD|ocd
5727158|NCT00405535|Obsessive Compulsive Disorder|obsessive compulsive disorder
5727159|NCT00405535|Glycine|glycine
5727160|NCT00405522|Lumbar Puncture|lumbar puncture
5727161|NCT00405522|Pediatrics|pediatrics
5727162|NCT00405522|Propofol|propofol
5727163|NCT00405522|Remifentanil|remifentanil
5727164|NCT00405522|sedation|sedation
5727165|NCT00405522|Oncology|oncology
5727166|NCT00405509|Upper Respiratory Infection|upper respiratory infection
5727167|NCT00405509|Common Cold|common cold
5727168|NCT00405483|arthroplasty|arthroplasty
5727169|NCT00405483|RSA|rsa
5727170|NCT00405483|micromotion|micromotion
5727171|NCT00405483|osteoarthritis|osteoarthritis
5727172|NCT00405483|minimally invasive|minimally invasive
5727173|NCT00405483|ProfemurZ|profemurz
5727174|NCT00405470|arthroplasty|arthroplasty
5727175|NCT00405470|RSA|rsa
5727176|NCT00405470|micromotion|micromotion
5727177|NCT00405470|osteoarthritis|osteoarthritis
5727178|NCT00405444|Pediatrics|pediatrics
5727179|NCT00405444|Pain|pain
5727180|NCT00405444|Voiding Cystourethrogram|voiding cystourethrogram
5727181|NCT00405444|Catheterization|catheterization
5727182|NCT00405444|Fentanyl|fentanyl
5727183|NCT00405431|glaucoma filtering surgery|glaucoma filtering surgery
5727184|NCT00405431|restasis|restasis
5727185|NCT00405431|conjunctival inflammation|conjunctival inflammation
5727186|NCT00405405|Head and neck cancer|head and neck cancer
5727187|NCT00405405|Parotid gland cancer|parotid gland cancer
5727188|NCT00405405|thyroid gland cancer|thyroid gland cancer
5727189|NCT00405405|melanoma|melanoma
5727190|NCT00405405|Chemoradiotherapy|chemoradiotherapy
5727191|NCT00405405|bevacizumab|bevacizumab
5727192|NCT00405405|erlotinib|erlotinib
5744231|NCT00342069|Attitudes Toward Reproductive Options|attitudes toward reproductive options
5744232|NCT00342069|Beliefs About Down Syndrome Risk|beliefs about down syndrome risk
5744233|NCT00342069|Down Syndrome Risk|down syndrome risk
5744234|NCT00342069|Pregnancy|pregnancy
5744235|NCT00342056|Pharmacogenetics|pharmacogenetics
5744236|NCT00342056|Transporter Proteins|transporter proteins
5744237|NCT00342056|Drug Exposure|drug exposure
5744238|NCT00342056|Imatinib|imatinib
5744239|NCT00342056|Retrospective|retrospective
5744241|NCT00342043|Sickle Trait|sickle trait
5744242|NCT00342043|Fetal Hemoglobin|fetal hemoglobin
5744243|NCT00342043|Hemoglobin C|hemoglobin c
5744244|NCT00342043|Beta-Thalassemia|beta-thalassemia
5744245|NCT00342043|Artesunate-Amodiaquine|artesunate-amodiaquine
5727193|NCT00405392|risedronate|risedronate
5727194|NCT00405392|Ibandronate|ibandronate
5727195|NCT00405392|preference|preference
5727196|NCT00405392|Osteoporosis|osteoporosis
5727197|NCT00405379|arthroplasty|arthroplasty
5727198|NCT00405379|RSA|rsa
5727199|NCT00405379|Osteoarthritis|osteoarthritis
5727200|NCT00405379|trabecular metal mesh|trabecular metal mesh
5727201|NCT00405366|stage II renal cell cancer|stage ii renal cell cancer
5727202|NCT00405366|stage III renal cell cancer|stage iii renal cell cancer
5727203|NCT00405366|stage IV renal cell cancer|stage iv renal cell cancer
5727204|NCT00405353|multiple sclerosis|multiple sclerosis
5727205|NCT00405353|testosterone|testosterone
5727206|NCT00405327|tumor vaccine|tumor vaccine
5727207|NCT00405327|metastatic solid tumors|metastatic solid tumors
5727208|NCT00405327|recurrent tumors|recurrent tumors
5727209|NCT00405314|respiratory failure|respiratory failure
5727210|NCT00405314|non invasive ventilation|non invasive ventilation
5727211|NCT00405314|prehospital|prehospital
5727212|NCT00405314|endotracheal intubation|endotracheal intubation
5727213|NCT00405314|continuous positive airway pressure|continuous positive airway pressure
5727214|NCT00405301|Tuberculosis|tuberculosis
5727215|NCT00405301|Drug Induced Hepatotoxicity|drug induced hepatotoxicity
5727216|NCT00405301|Anti-tuberculosis drugs|anti-tuberculosis drugs
5727217|NCT00405301|India|india
5727218|NCT00405288|Hemorrhoids|hemorrhoids
5727219|NCT00405288|Pregnancy|pregnancy
5727220|NCT00405288|antihemorrhoidal|antihemorrhoidal
5727221|NCT00405288|Proctofoam|proctofoam
5727222|NCT00405288|infants|infants
5727223|NCT00405275|antineoplastic|antineoplastic
5727224|NCT00405275|antiparasitics|antiparasitics
5727225|NCT00405275|antirheumatics|antirheumatics
5727226|NCT00405275|chronic diseases|chronic diseases
5727227|NCT00405275|clinical trial|clinical trial
5727228|NCT00405275|connective tissue|connective tissue
5727229|NCT00405275|double-blind|double-blind
5727230|NCT00405275|drug treatment|drug treatment
5727231|NCT00405275|gastric medications|gastric medications
5727232|NCT00405275|joint|joint
5727233|NCT00405275|multi-site trial|multi-site trial
5727234|NCT00405275|musculoskeletal|musculoskeletal
5727235|NCT00405275|randomized|randomized
5727236|NCT00405275|rheumatoid arthritis|rheumatoid arthritis
5727237|NCT00405262|Pediatrics|pediatrics
5727238|NCT00405262|Postoperative Analgesia|postoperative analgesia
5727239|NCT00405262|orthopedic surgery|orthopedic surgery
5727240|NCT00405262|Iliac Crest Bone Graft|iliac crest bone graft
5727241|NCT00405262|Osteotomy|osteotomy
5727242|NCT00405262|cleft palate|cleft palate
5727243|NCT00405249|HIV-1|hiv-1
5727244|NCT00405249|Treatment Experienced|treatment experienced
5727245|NCT00405236|inflammation|inflammation
5727246|NCT00405236|exacerbations|exacerbations
5727247|NCT00405210|hormone-resistant|hormone-resistant
5727248|NCT00405210|metastatic prostatic cancer|metastatic prostatic cancer
5727249|NCT00405210|pharmacokinetics|pharmacokinetics
5727250|NCT00405210|naïve patient|naïve patient
5727251|NCT00405197|MUFA|mufa
5727252|NCT00405197|Mediterranean diet|mediterranean diet
5727253|NCT00405197|Insulin resistance|insulin resistance
5727254|NCT00405197|metabolic syndrome X|metabolic syndrome x
5727256|NCT00405184|IVIg|ivig
5727257|NCT00405184|IntragamP|intragamp
5727258|NCT00405171|Efavirenz|efavirenz
5727259|NCT00405171|Nevirapine|nevirapine
5727260|NCT00405171|Dyslipidemia|dyslipidemia
5727261|NCT00405171|HIV|hiv
5727262|NCT00405158|Lactation mastitis|lactation mastitis
5727263|NCT00405158|Breast inflammation|breast inflammation
5744338|NCT00341757|Questionnaire|questionnaire
5744339|NCT00341757|Validity|validity
5744340|NCT00341757|Surveillance|surveillance
5744341|NCT00341744|Vision|vision
5744342|NCT00341744|Aids|aids
5744343|NCT00341731|Cystic Ovaries|cystic ovaries
5744344|NCT00341731|Environmental Factors|environmental factors
5744345|NCT00341731|Heritability|heritability
5744346|NCT00341731|Hyperandrogenism|hyperandrogenism
5744347|NCT00341731|Twin Study|twin study
5744348|NCT00341718|Interview|interview
5744349|NCT00341718|Genetics|genetics
5744350|NCT00341705|AIDS|aids
5744351|NCT00341705|Cancer|cancer
5744352|NCT00341705|Hepatitis C Virus|hepatitis c virus
5744353|NCT00341705|HIV|hiv
5744354|NCT00341705|Natural History|natural history
5744355|NCT00341705|Hemophilia|hemophilia
5744356|NCT00341705|Hepatitis C|hepatitis c
5744357|NCT00341692|Mammary|mammary
5744358|NCT00341692|Development|development
5744359|NCT00341692|Cancer|cancer
5727264|NCT00405158|Breastfeeding|breastfeeding
5727265|NCT00405158|Care interventions|care interventions
5727266|NCT00405158|Acupuncture treatment|acupuncture treatment
5727267|NCT00405158|Antibiotic therapy|antibiotic therapy
5727268|NCT00405145|Epilepsy|epilepsy
5727269|NCT00405145|MRI|mri
5727270|NCT00405145|EEG|eeg
5727271|NCT00405145|Neuroimaging|neuroimaging
5727272|NCT00405119|tolerance|tolerance
5727273|NCT00405119|pharmacodynamics|pharmacodynamics
5727274|NCT00405119|ranitidine|ranitidine
5727275|NCT00405119|esomeprazole|esomeprazole
5727276|NCT00405119|pharmacokinetics|pharmacokinetics
5727277|NCT00405119|gastroesophageal reflux disease (GERD)|gastroesophageal reflux disease (gerd)
5727278|NCT00405119|AH23844|ah23844
5727279|NCT00405106|stress|stress
5727280|NCT00405106|anxiety|anxiety
5727281|NCT00405106|myopia progression|myopia progression
5727282|NCT00405106|accommodation|accommodation
5727283|NCT00405106|vergence|vergence
5727284|NCT00405093|cardiopulmonary bypass|cardiopulmonary bypass
5727285|NCT00405093|circulatory arrest|circulatory arrest
5727286|NCT00405093|aprotinin|aprotinin
5727287|NCT00405093|thoracic aorta surgery|thoracic aorta surgery
5727288|NCT00405080|Rifampin GW679769|rifampin gw679769
5727289|NCT00405067|Cholesterol|cholesterol
5686159|NCT00553228|maternal immunization|maternal immunization
5686160|NCT00553228|whooping cough|whooping cough
5686161|NCT00553228|pertussis|pertussis
5680903|NCT00575744|Intraoperative Injection|intraoperative injection
5727290|NCT00405015|rosiglitazone|rosiglitazone
5727291|NCT00405015|ischemia-reperfusion injury|ischemia-reperfusion injury
5727292|NCT00405015|human|human
5727293|NCT00405015|Annexin A5 scintigraphy|annexin a5 scintigraphy
5727294|NCT00405015|metabolic syndrome|metabolic syndrome
5727295|NCT00405002|Acute respiratory failure|acute respiratory failure
5727296|NCT00404989|HIV|hiv
5727297|NCT00404989|HBV|hbv
5727298|NCT00404989|Hepatitis|hepatitis
5727299|NCT00404989|Pregnancy|pregnancy
5727300|NCT00404989|Registry|registry
5727301|NCT00404976|inflammometry|inflammometry
5727302|NCT00404976|exhaled breath condensate|exhaled breath condensate
5727303|NCT00404976|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5727304|NCT00404976|asthma|asthma
5727305|NCT00404976|children|children
5727306|NCT00404963|GSK376501,|gsk376501,
5727307|NCT00404963|First Time in Human,|first time in human,
5727308|NCT00404963|Single Dose,|single dose,
5727310|NCT00404963|Healthy Overweight/Obese Volunteer|healthy overweight/obese volunteer
5727311|NCT00404950|hyperglycemia|hyperglycemia
5727312|NCT00404950|cardiopulmonary bypass|cardiopulmonary bypass
5727313|NCT00404950|renal injury|renal injury
5727314|NCT00404950|diabetes|diabetes
5727315|NCT00404924|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5727316|NCT00404924|Adenocarcinoma|adenocarcinoma
5727317|NCT00404924|Squamous Cell Carcinoma|squamous cell carcinoma
5727318|NCT00404924|Large Cell Carcinoma|large cell carcinoma
5727319|NCT00404911|Oppositional Defiant Disorder|oppositional defiant disorder
5727320|NCT00404898|World Trade Center dust|world trade center dust
5727321|NCT00404885|uveitis|uveitis
5727322|NCT00404885|calcineurin|calcineurin
5727323|NCT00404885|inflammation|inflammation
5727324|NCT00404872|Stroke|stroke
5727325|NCT00404859|inflammometry|inflammometry
5727326|NCT00404859|exhaled breath condensate|exhaled breath condensate
5744448|NCT00341432|Smoking Cessation|smoking cessation
5744449|NCT00341419|ABC Transporter|abc transporter
5744450|NCT00341419|ABCC6|abcc6
5744451|NCT00341419|Slkin Laxity|slkin laxity
5744452|NCT00341419|Genetic Association|genetic association
5744453|NCT00341419|Angiod Streaks|angiod streaks
5744454|NCT00341419|Pseudoxanthoma Elasticum|pseudoxanthoma elasticum
5744455|NCT00341419|PXE|pxe
5744461|NCT00341393|HIV Infection|hiv infection
5744462|NCT00341393|AIDS|aids
5744463|NCT00341393|Viral Load|viral load
5744464|NCT00341393|Retroviral Treatment|retroviral treatment
5744465|NCT00341393|Uganda|uganda
5744466|NCT00341380|Cancer|cancer
5744467|NCT00341380|Lung Cancer|lung cancer
5744468|NCT00341380|Surgical Resection|surgical resection
5744469|NCT00341380|Non-Small Cell Lung Cancer|non-small cell lung cancer
5744470|NCT00341380|NSCLC|nsclc
5744471|NCT00341367|Analgesic|analgesic
5744472|NCT00341367|Back Pain|back pain
5744473|NCT00341367|Lumbar Disc|lumbar disc
5744474|NCT00341367|Nerve|nerve
5744475|NCT00341367|Radiculopathy|radiculopathy
5744476|NCT00341354|Pneumonia|pneumonia
5727327|NCT00404859|fractional exhaled nitric oxide|fractional exhaled nitric oxide
5727329|NCT00404859|cystic fibrosis|cystic fibrosis
5727330|NCT00404859|monitoring|monitoring
5727331|NCT00404859|exacerbations|exacerbations
5727332|NCT00404859|paediatric|paediatric
5727333|NCT00404846|Hyperbaric oxygenation therapy|hyperbaric oxygenation therapy
5727334|NCT00404846|HBOT|hbot
5727335|NCT00404846|Autism|autism
5727336|NCT00404833|idiopathic membranous nephropathy or focal segmental glomerulosclerosis|idiopathic membranous nephropathy or focal segmental glomerulosclerosis
5727337|NCT00404820|osteoporosis|osteoporosis
5727338|NCT00404820|bisphosphonate|bisphosphonate
5727339|NCT00404820|biomarker|biomarker
5727340|NCT00404820|zoledronic acid|zoledronic acid
5727341|NCT00404820|alendronate|alendronate
5727342|NCT00404820|postmenopausal|postmenopausal
5727343|NCT00404807|Continuous positive airway pressure|continuous positive airway pressure
5727344|NCT00404807|cardiovascular diseases|cardiovascular diseases
5727345|NCT00404807|sleep apnea syndromes|sleep apnea syndromes
5727346|NCT00404807|sleep breathing disorders|sleep breathing disorders
5727347|NCT00404807|sham CPAP|sham cpap
5727348|NCT00404794|membranous lupus nephritis|membranous lupus nephritis
5727349|NCT00404781|ischemic heart disease|ischemic heart disease
5727350|NCT00404781|acute coronary syndromes|acute coronary syndromes
5727351|NCT00404781|percutaneous transluminal coronary angioplasty|percutaneous transluminal coronary angioplasty
5727352|NCT00404781|platelet function|platelet function
5727353|NCT00404781|aspirin|aspirin
5727354|NCT00404781|clopidogrel|clopidogrel
5727355|NCT00404781|cilostazol|cilostazol
5727356|NCT00404768|Premature Labor|premature labor
5727357|NCT00404768|Pre Term Labor|pre term labor
5727358|NCT00404768|intravenous|intravenous
5727359|NCT00404768|fetal fibronectin|fetal fibronectin
5727360|NCT00404755|Depression|depression
5680907|NCT00575718|tobacco use|tobacco use
5727361|NCT00404742|uveitis|uveitis
5727362|NCT00404742|calcineurin|calcineurin
5727363|NCT00404729|Glaucoma|glaucoma
5727364|NCT00404729|Optic Neuropathy, Ischemic|optic neuropathy, ischemic
5727365|NCT00404729|Visual Pathways,|visual pathways,
5727366|NCT00404729|Optic nerve|optic nerve
5727367|NCT00404729|Neural conduction|neural conduction
5727368|NCT00404690|Gastroschisis|gastroschisis
5727369|NCT00404690|Silo|silo
5727370|NCT00404690|Operative closure|operative closure
5727371|NCT00404664|influenza vaccine|influenza vaccine
5727372|NCT00404664|influenza immunization|influenza immunization
5727373|NCT00404664|reminder letters|reminder letters
5727374|NCT00404664|raffle prize|raffle prize
5727375|NCT00404651|Diphtheria|diphtheria
5727376|NCT00404651|Tetanus|tetanus
5727377|NCT00404651|Pertussis|pertussis
5727378|NCT00404651|Hepatitis B|hepatitis b
5727379|NCT00404651|Poliomyelitis|poliomyelitis
5727380|NCT00404651|Invasive Haemophilus influenzae type b.|invasive haemophilus influenzae type b.
5727381|NCT00404638|Enuresis Nocturna|enuresis nocturna
5727382|NCT00404638|Paula Method|paula method
5744560|NCT00341159|Association|association
5744561|NCT00341159|Breast Cancer|breast cancer
5744562|NCT00341159|Population-Based|population-based
5744564|NCT00341146|Cancer|cancer
5727383|NCT00404638|Circular muscle exercise|circular muscle exercise
5727384|NCT00404638|Sphincter|sphincter
5727385|NCT00404625|Bacteremia caused by ESBL-producing Enterobacteriaceae|bacteremia caused by esbl-producing enterobacteriaceae
5727386|NCT00404625|Pneumonia caused by ESBL-producing Enterobacteriaceae|pneumonia caused by esbl-producing enterobacteriaceae
5727387|NCT00404625|Abdomen infections due to ESBL-producing Enterobacteriaceae|abdomen infections due to esbl-producing enterobacteriaceae
5727388|NCT00404625|Skin infections caused by ESBL-producing Enterobacteriaceae|skin infections caused by esbl-producing enterobacteriaceae
5727389|NCT00404625|Urinary infections due to ESBL-producing Enterobacteriaceae|urinary infections due to esbl-producing enterobacteriaceae
5727390|NCT00404612|uveitis|uveitis
5727391|NCT00404612|calcineurin|calcineurin
5727392|NCT00404599|simvastatin, atorvastatin, oxidative stress|simvastatin, atorvastatin, oxidative stress
5727393|NCT00404586|Environmental Challenge Chamber|environmental challenge chamber
5727394|NCT00404586|GW784568X|gw784568x
5727395|NCT00404586|Intranasal|intranasal
5727396|NCT00404573|Schizophrenia|schizophrenia
5727397|NCT00404560|Primary Immune Deficiency|primary immune deficiency
5727398|NCT00404560|Autoimmune|autoimmune
5727399|NCT00404560|Genetic Defects|genetic defects
5727400|NCT00404560|Immune Defects|immune defects
5727401|NCT00404560|Infection Susceptibility|infection susceptibility
5727402|NCT00404560|Recurrent Infections|recurrent infections
5727403|NCT00404560|Immune Disorders|immune disorders
5727404|NCT00404560|Immune Defects of Phagocytes|immune defects of phagocytes
5728247|NCT00401492|elderly|elderly
5727405|NCT00404560|Unusual, Chronic Bacterial, Mycobacterial, and Fungal Infections|unusual, chronic bacterial, mycobacterial, and fungal infections
5727406|NCT00404547|Asthma|asthma
5727407|NCT00404547|Alvesco®|alvesco®
5727408|NCT00404547|Ciclesonide|ciclesonide
5727409|NCT00404534|functional dyspepsia|functional dyspepsia
5727410|NCT00404534|Helicobacter pylori|helicobacter pylori
5727411|NCT00404534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5727412|NCT00404534|Gastritis|gastritis
5727413|NCT00404521|Tumor|tumor
5727414|NCT00404521|PM02734|pm02734
5727415|NCT00404521|PharmaMar|pharmamar
5727416|NCT00404508|Hydralazine|hydralazine
5727417|NCT00404508|Magnesium Valproate|magnesium valproate
5727418|NCT00404508|Chemotherapy resistance|chemotherapy resistance
5727419|NCT00404508|Epigenetic therapy|epigenetic therapy
5727420|NCT00404482|uveitis|uveitis
5727422|NCT00404482|Cyclosporine A|cyclosporine a
5727424|NCT00404443|Acupuncture|acupuncture
5727425|NCT00404443|Electroacupuncture|electroacupuncture
5727426|NCT00404443|Rheumatoid arthritis|rheumatoid arthritis
5727427|NCT00404430|Endothelial function|endothelial function
5727428|NCT00404430|Peripheral Arterial Tone|peripheral arterial tone
5727429|NCT00404430|Systemic Inflammation|systemic inflammation
5727430|NCT00404430|Oxidative Stress|oxidative stress
5727431|NCT00404430|Respiratory and peripheral muscular function|respiratory and peripheral muscular function
5727432|NCT00404430|Cardiovascular risk|cardiovascular risk
5727433|NCT00404430|COPD severity|copd severity
5727434|NCT00404417|pain|pain
5727435|NCT00404417|lumbar|lumbar
5727436|NCT00404404|recurrent breast cancer|recurrent breast cancer
5727437|NCT00404404|stage IV breast cancer|stage iv breast cancer
5727438|NCT00404391|Moderate to severe pain following bunionectomy surgery|moderate to severe pain following bunionectomy surgery
5727439|NCT00404378|Healthy subjects|healthy subjects
5727440|NCT00404378|Pharmacokinetics|pharmacokinetics
5727441|NCT00404378|Drug interaction|drug interaction
5727442|NCT00404378|Ketoconazole|ketoconazole
5727443|NCT00404378|Casopitant|casopitant
5727444|NCT00404365|depression|depression
5727445|NCT00404365|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5727446|NCT00404365|limited stage small cell lung cancer|limited stage small cell lung cancer
5727447|NCT00404365|recurrent small cell lung cancer|recurrent small cell lung cancer
5680908|NCT00575679|Automobile driving|automobile driving
5727448|NCT00404365|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5727449|NCT00404365|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5727450|NCT00404365|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5727451|NCT00404365|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5727452|NCT00404365|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5727453|NCT00404365|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5727454|NCT00404352|Rebif New Formulation|rebif new formulation
5727455|NCT00404352|Clinical Isolated Syndrome|clinical isolated syndrome
5727457|NCT00404339|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5727458|NCT00404339|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5798831|NCT00110890|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5744663|NCT00340886|Genetic Susceptibility|genetic susceptibility
5744664|NCT00340886|Single Nucleotide Polymorphism|single nucleotide polymorphism
5744665|NCT00340886|Environmental Risk Factor|environmental risk factor
5744666|NCT00340886|Allelic Variants|allelic variants
5744667|NCT00340886|Ascertainment by Genotype|ascertainment by genotype
5744675|NCT00340847|Molecular Profiling|molecular profiling
5744676|NCT00340847|In Situ Hybridization|in situ hybridization
5744677|NCT00340847|SAGE|sage
5744678|NCT00340847|Tumor Markers|tumor markers
5727460|NCT00404339|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5727461|NCT00404339|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5727462|NCT00404339|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5727463|NCT00404339|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5727464|NCT00404339|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5727465|NCT00404339|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5727466|NCT00404339|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5727467|NCT00404339|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5727468|NCT00404339|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5727469|NCT00404339|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5727470|NCT00404339|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5727471|NCT00404339|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5727472|NCT00404339|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5727473|NCT00404339|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5727474|NCT00404339|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5727475|NCT00404339|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5727476|NCT00404339|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5727477|NCT00404339|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5727478|NCT00404339|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5727479|NCT00404339|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5727480|NCT00404339|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5727481|NCT00404339|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5727482|NCT00404339|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5727483|NCT00404339|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5727484|NCT00404339|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5727485|NCT00404339|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5727486|NCT00404339|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5727487|NCT00404339|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5727488|NCT00404339|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5727489|NCT00404339|tongue cancer|tongue cancer
5727490|NCT00404326|Cervical carcinoma|cervical carcinoma
5727491|NCT00404326|Epigenetic therapy|epigenetic therapy
5727492|NCT00404326|Hydralazine|hydralazine
5727493|NCT00404326|Valproate|valproate
5727494|NCT00404326|Microarray analysis|microarray analysis
5727495|NCT00404287|C reactive protein|c reactive protein
5727496|NCT00404287|Inflammation|inflammation
5727497|NCT00404287|Aortic valve stenosis|aortic valve stenosis
5727498|NCT00404287|progression|progression
5727499|NCT00404274|healthy human volunteer|healthy human volunteer
5727500|NCT00404274|GW679769|gw679769
5727501|NCT00404274|warfarin|warfarin
5727502|NCT00404274|casopitant|casopitant
5727503|NCT00404261|Fluticasone Propionate|fluticasone propionate
5727504|NCT00404261|healthcare professional satisfaction|healthcare professional satisfaction
5744770|NCT00340587|ZP1, ZP2, ZP3|zp1, zp2, zp3
5744771|NCT00340587|Fertilization|fertilization
5744773|NCT00340574|Clinical Trial|clinical trial
5744774|NCT00340574|Mosquito|mosquito
5744775|NCT00340574|Healthy Volunteer|healthy volunteer
5744777|NCT00340561|Test Track|test track
5744778|NCT00340561|Distraction|distraction
5727505|NCT00404261|patient satisfaction|patient satisfaction
5727506|NCT00404261|metered dose inhaler with counter|metered dose inhaler with counter
5727507|NCT00404261|Salmeterol|salmeterol
5727508|NCT00404261|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5727509|NCT00404248|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5727510|NCT00404248|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5727511|NCT00404248|adult giant cell glioblastoma|adult giant cell glioblastoma
5727512|NCT00404248|recurrent adult brain tumor|recurrent adult brain tumor
5727513|NCT00404248|adult glioblastoma|adult glioblastoma
5739423|NCT00360009|GPi|gpi
5727515|NCT00404235|stage IV melanoma|stage iv melanoma
5727516|NCT00404235|recurrent melanoma|recurrent melanoma
5727517|NCT00404222|Acute Pain following Bunionectomy|acute pain following bunionectomy
5727518|NCT00404183|Pain associated with osteoarthritis|pain associated with osteoarthritis
5727519|NCT00404170|imaging|imaging
5727520|NCT00404170|Parkinson|parkinson
5727521|NCT00404170|progression|progression
5727522|NCT00404157|Lupus|lupus
5727523|NCT00404157|U2970g|u2970g
5727524|NCT00404144|small vessel|small vessel
5727525|NCT00404144|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5727526|NCT00404144|pepcad|pepcad
5727527|NCT00404144|drug eluting balloon|drug eluting balloon
5727528|NCT00404118|long-term care|long-term care
5727529|NCT00404118|satisfaction|satisfaction
5727530|NCT00404118|cost|cost
5727531|NCT00404105|Excimer laser|excimer laser
5727532|NCT00404092|aspergillosis|aspergillosis
5727533|NCT00404092|caspofungin|caspofungin
5727534|NCT00404092|maximum tolerated dose|maximum tolerated dose
5727535|NCT00404079|Chronic low back pain|chronic low back pain
5727536|NCT00404014|MCI following CABG surgery|mci following cabg surgery
5727537|NCT00404001|Microbia|microbia
5727538|NCT00404001|MD-0727|md-0727
5727539|NCT00404001|Primary Hypercholesterolemia|primary hypercholesterolemia
5727540|NCT00404001|Hypercholesterolemia|hypercholesterolemia
5727541|NCT00404001|Hyperlipidemia|hyperlipidemia
5727542|NCT00404001|Dyslipidemia|dyslipidemia
5727543|NCT00404001|Cholesterol|cholesterol
5727544|NCT00404001|LDL|ldl
5727545|NCT00403962|anxiety|anxiety
5727546|NCT00403962|Social Anxiety Disorder|social anxiety disorder
5727547|NCT00403962|SAD|sad
5727548|NCT00403936|osteopathic manipulation|osteopathic manipulation
5727549|NCT00403936|autonomic nervous system|autonomic nervous system
5727550|NCT00403923|Lactose intolerance|lactose intolerance
5727551|NCT00403923|Ulcerative colitis|ulcerative colitis
5727552|NCT00403923|Lactose|lactose
5727553|NCT00403923|Threshold|threshold
5727554|NCT00403897|Constipation|constipation
5727555|NCT00403884|Drusen|drusen
5727556|NCT00403884|Geographic atrophy|geographic atrophy
5727557|NCT00403884|diabetes|diabetes
5727558|NCT00403884|macular edema|macular edema
5727559|NCT00403884|laser|laser
5727560|NCT00403884|retinal pigment epithelium|retinal pigment epithelium
5727561|NCT00403871|Anaesthesia|anaesthesia
5727562|NCT00403871|Pregnency|pregnency
5727563|NCT00403871|Heart disease|heart disease
5727564|NCT00403845|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5727565|NCT00403845|COPD|copd
5727566|NCT00403845|QAB149|qab149
5727567|NCT00403845|indacaterol|indacaterol
5727568|NCT00403845|long acting β2-agonist|long acting β2-agonist
5727569|NCT00403806|Adenotonsillectomy|adenotonsillectomy
5727570|NCT00403806|Pediatrics|pediatrics
5727571|NCT00403806|Postoperative Nausea and Vomiting|postoperative nausea and vomiting
5727572|NCT00403806|Pain|pain
5727573|NCT00403806|Oral intake|oral intake
5727574|NCT00403806|Dexamethasone|dexamethasone
5727575|NCT00403806|Dose finding|dose finding
5727576|NCT00403780|Critical limb ischemia|critical limb ischemia
5727577|NCT00403780|Pain control|pain control
5727578|NCT00403780|Rest pain in lower limb ischemia|rest pain in lower limb ischemia
5727579|NCT00403780|pregabalin|pregabalin
5727580|NCT00403780|randomized controlled study|randomized controlled study
5727581|NCT00403780|Ischemia, therapy|ischemia, therapy
5727582|NCT00403780|Lower extremity, blood supply|lower extremity, blood supply
5727583|NCT00403780|Pain, prevention & control|pain, prevention & control
5727584|NCT00403780|Pain, therapy|pain, therapy
5727683|NCT00403403|SCLC|sclc
5680914|NCT00575653|Guillain-Barre Syndrome|guillain-barre syndrome
5680915|NCT00575653|Meningococcal vaccines|meningococcal vaccines
5680916|NCT00575653|Tetravalent Meningococcal Vaccine|tetravalent meningococcal vaccine
5680917|NCT00575653|Vaccination|vaccination
5727585|NCT00403767|Atrial Fibrillation|atrial fibrillation
5727586|NCT00403767|Stroke|stroke
5744879|NCT00340301|Neurodegenerative Diseases|neurodegenerative diseases
5744881|NCT00340288|Neoplasms|neoplasms
5753439|NCT00306592|MS|ms
5744882|NCT00340288|Life Style/Endrocrinology|life style/endrocrinology
5744883|NCT00340288|Magnetic Resonance Imaging|magnetic resonance imaging
5744884|NCT00340288|Molecular Characterization|molecular characterization
5744885|NCT00340288|Leiomyoma|leiomyoma
5744886|NCT00340275|Bacterial Vaginosis|bacterial vaginosis
5744887|NCT00340275|Vaginal Infection|vaginal infection
5744888|NCT00340275|Vaginitis|vaginitis
5744889|NCT00340275|Cohort Study|cohort study
5744890|NCT00340275|Sexually Transmitted Disease|sexually transmitted disease
5744891|NCT00340262|Supplemental Hormone Use|supplemental hormone use
5744892|NCT00340262|Osteoporosis|osteoporosis
5744893|NCT00340262|Endogenous Sex Hormones|endogenous sex hormones
5744894|NCT00340249|Premature Rupture of the Membranes (PROM)|premature rupture of the membranes (prom)
5744895|NCT00340249|Preterm Delivery|preterm delivery
5744896|NCT00340249|In-Utero Fetal Demise|in-utero fetal demise
5744897|NCT00340249|Chorioamnionitis|chorioamnionitis
5744898|NCT00340249|Spontaneous Abortion|spontaneous abortion
5744903|NCT00340223|RNA|rna
5727587|NCT00403767|Embolism|embolism
5727588|NCT00403767|Non-central nervous system systemic embolism|non-central nervous system systemic embolism
5727589|NCT00403767|Non-valvular atrial fibrillation|non-valvular atrial fibrillation
5727591|NCT00403767|Rivaroxaban|rivaroxaban
5727592|NCT00403767|Warfarin|warfarin
5727593|NCT00403767|Anticoagulants|anticoagulants
5727594|NCT00403767|Arrhythmias, Cardiac|arrhythmias, cardiac
5727595|NCT00403754|asthma|asthma
5727596|NCT00403754|QAB149|qab149
5727597|NCT00403754|indacaterol|indacaterol
5727598|NCT00403754|long acting β2-agonist|long acting β2-agonist
5727599|NCT00403754|bronchodilator|bronchodilator
5727600|NCT00403741|behavior|behavior
5727601|NCT00403741|physical activity|physical activity
5727602|NCT00403741|motivation|motivation
5727603|NCT00403728|Ischemia|ischemia
5727604|NCT00403728|Reperfusion|reperfusion
5727605|NCT00403728|Myocardial infarction|myocardial infarction
5727606|NCT00403728|ciclosporin A|ciclosporin a
5727607|NCT00403728|acute myocardial infarction|acute myocardial infarction
5727608|NCT00403702|Retinal detachment|retinal detachment
5727609|NCT00403702|proliferative vitreoretinopathy|proliferative vitreoretinopathy
5727610|NCT00403702|heavier-than-water internal tamponades|heavier-than-water internal tamponades
5727611|NCT00403689|Increased non-specific inflammatory markers|increased non-specific inflammatory markers
5727612|NCT00403676|nurse practitioner|nurse practitioner
5727613|NCT00403676|rheumatology care|rheumatology care
5727614|NCT00403676|outpatient clinic|outpatient clinic
5727615|NCT00403676|patient satisfaction|patient satisfaction
5727616|NCT00403663|Body mass index|body mass index
5727617|NCT00403663|Combined Spinal-Epidural Anesthesia|combined spinal-epidural anesthesia
5727618|NCT00403663|Cesarean section|cesarean section
5727619|NCT00403663|Obesity|obesity
5727620|NCT00403650|Sarcoidosis|sarcoidosis
5727621|NCT00403650|Dyspnea|dyspnea
5727622|NCT00403650|Interstitial lung disease|interstitial lung disease
5727623|NCT00403637|Asthma, indacaterol, long acting β2-agonist|asthma, indacaterol, long acting β2-agonist
5727624|NCT00403585|Adefovir Dipivoxil(Hepsera)|adefovir dipivoxil(hepsera)
5727625|NCT00403585|Chronic Hepatitis B (CHB)|chronic hepatitis b (chb)
5727626|NCT00403572|Preeclampsia|preeclampsia
5727627|NCT00403572|Trans cranial Doppler|trans cranial doppler
5727628|NCT00403572|Cardiac output|cardiac output
5727629|NCT00403572|systemic vascular resistance|systemic vascular resistance
5727630|NCT00403572|blood pressure|blood pressure
5727631|NCT00403559|seborrheic dermatitis|seborrheic dermatitis
5727632|NCT00403546|Schizophrenia|schizophrenia
5727633|NCT00403533|Hepatitis C|hepatitis c
5727634|NCT00403533|viral load|viral load
5727635|NCT00403533|antiviral therapy|antiviral therapy
5727636|NCT00403533|cholesterol|cholesterol
5727637|NCT00403533|atorvastatin|atorvastatin
5727638|NCT00403520|Alzheimer's disease|alzheimer's disease
5744989|NCT00339911|Repository|repository
5744990|NCT00339911|Phlebotomy|phlebotomy
5744991|NCT00339911|Venipuncture|venipuncture
5744992|NCT00339911|Anemia|anemia
5744993|NCT00339911|Occupational Health Services|occupational health services
5744994|NCT00339898|Minimal Residual Disease|minimal residual disease
5744995|NCT00339898|Ewings Sarcoma|ewings sarcoma
5744996|NCT00339885|Monogenic Diabetes|monogenic diabetes
5744997|NCT00339885|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5744998|NCT00339885|QTL|qtl
5744999|NCT00339872|healthy subjects|healthy subjects
5745000|NCT00339859|Molecular Epidemiology of Lung Cancer|molecular epidemiology of lung cancer
5745001|NCT00339859|Health Disparities|health disparities
5680918|NCT00575653|Vaccines|vaccines
5745002|NCT00339846|Craniosynostosis|craniosynostosis
5745003|NCT00339846|Craniofrontonasal Syndrome|craniofrontonasal syndrome
5745004|NCT00339846|CFNS|cfns
5745005|NCT00339833|Salsalate|salsalate
5745006|NCT00339833|Insulin Resistance|insulin resistance
5745007|NCT00339833|Diabetes Mellitus|diabetes mellitus
5745008|NCT00339833|Inflammation|inflammation
5745009|NCT00339833|Diabetes|diabetes
5745010|NCT00339833|HCV|hcv
5727639|NCT00403520|Mild cognitive impairment|mild cognitive impairment
5727640|NCT00403507|Mild Dementia|mild dementia
5727641|NCT00403507|Mild Alzheimer|mild alzheimer
5735935|NCT00373139|Pregnancy,|pregnancy,
5726785|NCT00407381|DME|dme
5727642|NCT00403507|Cognitive Impairment|cognitive impairment
5727643|NCT00403507|Cholinesterase Inhibitor|cholinesterase inhibitor
5727644|NCT00403507|Exercise|exercise
5727645|NCT00403507|Physical activity|physical activity
5727646|NCT00403507|Behavior|behavior
5727647|NCT00403507|Memory loss|memory loss
5727648|NCT00403494|Intermittent Claudication|intermittent claudication
5727649|NCT00403494|IC|ic
5727650|NCT00403494|Symptomatic Peripheral Arterial Disease|symptomatic peripheral arterial disease
5727651|NCT00403494|Peripheral Arterial Disease|peripheral arterial disease
5727652|NCT00403494|PAD|pad
5727653|NCT00403494|6R-BH4|6r-bh4
5727654|NCT00403494|BH4|bh4
5727655|NCT00403494|sapropterin dihydrochloride|sapropterin dihydrochloride
5727656|NCT00403494|endothelial dysfunction|endothelial dysfunction
5727657|NCT00403494|Nitric Oxide|nitric oxide
5727658|NCT00403494|NO|no
5727659|NCT00403481|Hypertension|hypertension
5727660|NCT00403481|Angiotensin Receptor Blocker|angiotensin receptor blocker
5727661|NCT00403481|Calcium Channel Blocker|calcium channel blocker
5727662|NCT00403481|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5727664|NCT00403481|Stage I and II Hypertension|stage i and ii hypertension
5727665|NCT00403481|Type II Diabetes|type ii diabetes
5727666|NCT00403455|Clinical|clinical
5727667|NCT00403455|Genetics|genetics
5727668|NCT00403455|Monoamine transporter|monoamine transporter
5727669|NCT00403455|Pharmacogenetics|pharmacogenetics
5727670|NCT00403455|Post Traumatic Stress Disorder|post traumatic stress disorder
5727671|NCT00403442|Macular Degeneration|macular degeneration
5727672|NCT00403429|oral chemotherapy|oral chemotherapy
5727673|NCT00403429|platinum resistant|platinum resistant
5727674|NCT00403429|platinum refractory|platinum refractory
5727675|NCT00403429|second line|second line
5727676|NCT00403416|AEB071|aeb071
5727677|NCT00403416|Tacrolimus|tacrolimus
5727678|NCT00403416|Mycophenolic acid|mycophenolic acid
5727679|NCT00403416|Basiliximab|basiliximab
5727680|NCT00403416|Rejection|rejection
5727681|NCT00403416|Kidney function|kidney function
5727682|NCT00403416|Immunosuppression|immunosuppression
5727684|NCT00403403|SALUTE|salute
5727685|NCT00403403|Lung Cancer|lung cancer
5727686|NCT00403403|Avastin|avastin
5727687|NCT00403377|melanoma|melanoma
5727688|NCT00403377|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5727689|NCT00403377|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5727690|NCT00403364|Helicobacter pylori infection|helicobacter pylori infection
5727691|NCT00403364|Treatment|treatment
5727692|NCT00403364|Double blind placebo controlled trial|double blind placebo controlled trial
5727693|NCT00403351|Risk|risk
5745096|NCT00339547|Leiomyomas|leiomyomas
5745097|NCT00339547|Ultrasound|ultrasound
5745098|NCT00339547|Hysterectomy|hysterectomy
5745099|NCT00339547|Epidemiology|epidemiology
5745100|NCT00339547|Hyperinsulinemia|hyperinsulinemia
5745110|NCT00339508|Linkage Analysis|linkage analysis
5745111|NCT00339508|Cancer Genetics|cancer genetics
5745112|NCT00339508|Software|software
5745113|NCT00339508|Bug Reports|bug reports
5745114|NCT00339508|Computer Programs|computer programs
5745115|NCT00339508|Data Analysis|data analysis
5727694|NCT00403351|Coronary artery disease|coronary artery disease
5727695|NCT00403351|Heart Rate variability|heart rate variability
5727696|NCT00403351|Pulse wave analysis|pulse wave analysis
5727697|NCT00403351|BNP|bnp
5727698|NCT00403351|CRP|crp
5727699|NCT00403338|myocardial ischemia|myocardial ischemia
5727700|NCT00403338|coronary disease|coronary disease
5727701|NCT00403338|heart disease|heart disease
5727702|NCT00403338|Coronary Stenosis [MeSH heading: C14.280.647.250.285]|coronary stenosis [mesh heading: c14.280.647.250.285]
5727703|NCT00403325|Central Serous Chorioretinopathy|central serous chorioretinopathy
5727704|NCT00403312|Physical Activity|physical activity
5727705|NCT00403312|Wellness Programs|wellness programs
5727706|NCT00403312|Pharmacological Smoking Cessation|pharmacological smoking cessation
5727707|NCT00403299|Coronary artery disease|coronary artery disease
5727708|NCT00403299|Cardiac transplantation|cardiac transplantation
5727709|NCT00403299|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
5727710|NCT00403286|Chronic|chronic
5727711|NCT00403286|Obstructive|obstructive
5727712|NCT00403286|Pulmonary|pulmonary
5737035|NCT00369070|AMG 706|amg 706
5727713|NCT00403286|Disease|disease
5727714|NCT00403286|COPD|copd
5727715|NCT00403286|Safety|safety
5727716|NCT00403286|Efficacy|efficacy
5727717|NCT00403286|Pharmacokinetic|pharmacokinetic
5727718|NCT00403286|Dose-finding|dose-finding
5727719|NCT00403273|Painful Knee Arthroplasty|painful knee arthroplasty
5727720|NCT00403273|Botulinum Toxin A|botulinum toxin a
5727721|NCT00403273|Randomized Controlled Trial|randomized controlled trial
5727722|NCT00403273|Pain and Function|pain and function
5727723|NCT00403260|malaria|malaria
5727724|NCT00403260|ACT|act
5727725|NCT00403260|P falciparum|p falciparum
5727726|NCT00403260|pyronaridine|pyronaridine
5727727|NCT00403260|artesunate|artesunate
5727728|NCT00403247|Schizophrenia|schizophrenia
5727729|NCT00403247|Schizoaffective Disorder|schizoaffective disorder
5727730|NCT00403247|Homocysteine|homocysteine
5727731|NCT00403247|Vitamins|vitamins
5727732|NCT00403234|Postoperative pain|postoperative pain
5727734|NCT00403234|transdermal|transdermal
5727735|NCT00403234|TKA (total knee arthroplasty)|tka (total knee arthroplasty)
5727736|NCT00403221|Gene therapy|gene therapy
5727737|NCT00403221|Prostate cancer|prostate cancer
5727738|NCT00403221|Immunology, Angiogenesis inhibition|immunology, angiogenesis inhibition
5727739|NCT00403221|Phase I clinical trial|phase i clinical trial
5727740|NCT00403208|Ventilation, Mechanical|ventilation, mechanical
5727741|NCT00403208|Sedation|sedation
5727742|NCT00403195|Ocular Ischemic Syndrome|ocular ischemic syndrome
5727743|NCT00403182|recurrent breast cancer|recurrent breast cancer
5727744|NCT00403182|stage IIIA breast cancer|stage iiia breast cancer
5727745|NCT00403182|stage IIIB breast cancer|stage iiib breast cancer
5727746|NCT00403182|stage IIIC breast cancer|stage iiic breast cancer
5727747|NCT00403182|stage IV breast cancer|stage iv breast cancer
5727748|NCT00403169|stage III renal cell cancer|stage iii renal cell cancer
5727749|NCT00403169|stage IV renal cell cancer|stage iv renal cell cancer
5727750|NCT00403169|recurrent renal cell cancer|recurrent renal cell cancer
5727751|NCT00403156|Macular Degeneration|macular degeneration
5727752|NCT00403143|intraocular lens, colour vision, blue-light filtering|intraocular lens, colour vision, blue-light filtering
5727753|NCT00403117|Naltrexone|naltrexone
5727754|NCT00403117|Smoked Marijuana|smoked marijuana
5727755|NCT00403104|ONO-2506PO|ono-2506po
5727756|NCT00403104|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5727757|NCT00403104|ALS|als
5727758|NCT00403091|Diabetes mellitus|diabetes mellitus
5727759|NCT00403091|Internet|internet
5727760|NCT00403091|Education, Professional|education, professional
5745206|NCT00339274|Ukraine|ukraine
5745207|NCT00339261|Cardiovascular|cardiovascular
5745208|NCT00339261|Renal|renal
5745209|NCT00339261|Autoimmune Disease|autoimmune disease
5745210|NCT00339261|Genetics|genetics
5745211|NCT00339261|Mortality|mortality
5745212|NCT00339248|Hyperplasia|hyperplasia
5745213|NCT00339248|Atypia|atypia
5745214|NCT00339248|Polymorphism|polymorphism
5745215|NCT00339248|Progression|progression
5745216|NCT00339248|Epidemiology|epidemiology
5745229|NCT00339209|Genetic Polymorphisms|genetic polymorphisms
5745230|NCT00339209|Acute Rejection|acute rejection
5728533|NCT00400452|caregivers|caregivers
5727761|NCT00403091|Quality Indicators, Health Care|quality indicators, health care
5727762|NCT00403091|Quality of Health Care|quality of health care
5727763|NCT00403091|Hypertension|hypertension
5727764|NCT00403091|Hyperlipidemia|hyperlipidemia
5727765|NCT00403078|Carotid Artery Stenting (Endovascular)|carotid artery stenting (endovascular)
5727766|NCT00403065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5727767|NCT00403065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5727768|NCT00403065|tumors metastatic to brain|tumors metastatic to brain
5727769|NCT00403052|colorectal|colorectal
5727770|NCT00403052|cancer|cancer
5727771|NCT00403052|carcinoma|carcinoma
5727772|NCT00403052|metastatic|metastatic
5727773|NCT00403052|colon|colon
5727774|NCT00403052|rectal|rectal
5727775|NCT00403052|neoplasm|neoplasm
5727776|NCT00403052|cetuximab|cetuximab
5727777|NCT00403052|irinotecan|irinotecan
5727778|NCT00403052|1018 ISS|1018 iss
5727779|NCT00403052|combination therapy|combination therapy
5727780|NCT00403039|Central Retinal Vein Occlusion|central retinal vein occlusion
5727781|NCT00403026|Bevacizumab (Avastin)|bevacizumab (avastin)
5727782|NCT00403026|Intravitreal injection|intravitreal injection
5727783|NCT00403026|VEGF|vegf
5727784|NCT00403026|CRVO|crvo
5727785|NCT00403026|BRVO|brvo
5727786|NCT00403026|PDR|pdr
5727787|NCT00403026|CNVM|cnvm
5727788|NCT00403013|nerve block/*methods|nerve block/*methods
5727789|NCT00403013|Anesthetics, Local/pharmacokinetics|anesthetics, local/pharmacokinetics
5727790|NCT00403013|*Brachial Plexus|*brachial plexus
5727791|NCT00403000|recurrent prostate cancer|recurrent prostate cancer
5727792|NCT00402987|sore throat|sore throat
5727793|NCT00402987|acute pain|acute pain
5727794|NCT00402974|osteocalcin|osteocalcin
5727795|NCT00402974|vitamin K|vitamin k
5727796|NCT00402974|carboxylation|carboxylation
5727797|NCT00402974|healthy children|healthy children
5727798|NCT00402961|Acupuncture|acupuncture
5737271|NCT00368095|DM|dm
5727799|NCT00402961|Post-Colectomy Ileus|post-colectomy ileus
5727800|NCT00402961|Abdominal Surgery|abdominal surgery
5727801|NCT00402961|Colon Surgery|colon surgery
5727802|NCT00402948|High eosinophils level in sputum|high eosinophils level in sputum
5727803|NCT00402935|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5727804|NCT00402935|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5727805|NCT00402935|sexual dysfunction and infertility|sexual dysfunction and infertility
5727806|NCT00402935|sexuality and reproductive issues|sexuality and reproductive issues
5727807|NCT00402935|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5727808|NCT00402935|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5727809|NCT00402935|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5727810|NCT00402935|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5727811|NCT00402935|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5727812|NCT00402935|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5727813|NCT00402935|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5727814|NCT00402935|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5727815|NCT00402935|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5727816|NCT00402935|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5727817|NCT00402935|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5727818|NCT00402935|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5727819|NCT00402935|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5727820|NCT00402935|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5727821|NCT00402935|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5727822|NCT00402935|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5727823|NCT00402935|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5727824|NCT00402935|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5727825|NCT00402935|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5727826|NCT00402935|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5727827|NCT00402935|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5727828|NCT00402935|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5727829|NCT00402935|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5727830|NCT00402935|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5727831|NCT00402935|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5727832|NCT00402935|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5727833|NCT00402935|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5727834|NCT00402935|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5727835|NCT00402935|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5727836|NCT00402935|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5727837|NCT00402922|Coronary Heart Disease|coronary heart disease
5728638|NCT00399997|Exercise|exercise
5727838|NCT00402909|Type 2 diabetes,|type 2 diabetes,
5727839|NCT00402909|fasting glucose,|fasting glucose,
5727840|NCT00402909|postprandial glucose,|postprandial glucose,
5727841|NCT00402909|blood sugar,|blood sugar,
5727842|NCT00402909|HbA1c,|hba1c,
5727843|NCT00402909|insulin,|insulin,
5727844|NCT00402909|glargine,|glargine,
5727845|NCT00402909|metformin,|metformin,
5727846|NCT00402909|thiazolidinedione|thiazolidinedione
5727847|NCT00402896|Lung Cancer|lung cancer
5727848|NCT00402896|Non-Small Cell Lung Cancer|non-small cell lung cancer
5727849|NCT00402896|Pleural Effusion|pleural effusion
5727979|NCT00402532|Mortality|mortality
5727850|NCT00402896|Indwelling Intrapleural Denver Catheter|indwelling intrapleural denver catheter
5727851|NCT00402896|ZD6474|zd6474
5727852|NCT00402896|Vascular Endothelial Growth Factor Receptor|vascular endothelial growth factor receptor
5727853|NCT00402896|VEGFR|vegfr
5727854|NCT00402896|Epidermal Growth factor Receptor|epidermal growth factor receptor
5727855|NCT00402896|EGFR|egfr
5727960|NCT00402558|Busulfex|busulfex
5727856|NCT00402896|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5727857|NCT00402857|Parenting Education|parenting education
5727858|NCT00402857|Child, Preschool|child, preschool
5727859|NCT00402857|Preventive Intervention|preventive intervention
5727860|NCT00402857|Primary Health Care|primary health care
5727861|NCT00402857|Pediatrics|pediatrics
5727862|NCT00402857|Attention Deficit Disorders|attention deficit disorders
5727863|NCT00402857|Oppositional Defiant Disorder|oppositional defiant disorder
5727864|NCT00402857|Disruptive Behavior Disorder|disruptive behavior disorder
5727865|NCT00402844|Multicenter|multicenter
5727866|NCT00402844|Pelvic organ prolapse|pelvic organ prolapse
5727867|NCT00402844|Prospective|prospective
5727868|NCT00402844|Transvaginal mesh|transvaginal mesh
5727869|NCT00402818|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5727870|NCT00402805|Influenza vaccine|influenza vaccine
5727871|NCT00402805|Intradermal|intradermal
5727872|NCT00402805|Lung transplantation|lung transplantation
5727873|NCT00402792|Acute pain following bunionectomy surgery|acute pain following bunionectomy surgery
5727874|NCT00402779|Oral Cancer|oral cancer
5727875|NCT00402779|Oral IEN Lesion with LOH|oral ien lesion with loh
5727876|NCT00402779|Loss of Heterozygosity|loss of heterozygosity
5727877|NCT00402779|Intraepithelial Neoplasia|intraepithelial neoplasia
5727879|NCT00402779|Erlotinib|erlotinib
5727880|NCT00402779|Tarceva|tarceva
5727881|NCT00402779|OSI-774|osi-774
5727882|NCT00402766|Mesothelioma|mesothelioma
5727883|NCT00402766|Pleural Mesothelioma|pleural mesothelioma
5727884|NCT00402766|Peritoneal Mesothelioma|peritoneal mesothelioma
5727885|NCT00402766|PDGF-R|pdgf-r
5686162|NCT00553215|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5686163|NCT00553215|stage 0 bladder cancer|stage 0 bladder cancer
5686164|NCT00553215|stage I bladder cancer|stage i bladder cancer
5686165|NCT00553215|stage II bladder cancer|stage ii bladder cancer
5686166|NCT00553202|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5727886|NCT00402766|Pemetrexed|pemetrexed
5727887|NCT00402766|Alimta|alimta
5727888|NCT00402766|Cisplatin|cisplatin
5727889|NCT00402766|Imatinib Mesylate|imatinib mesylate
5727890|NCT00402766|Gleevec|gleevec
5727891|NCT00402766|Platinol|platinol
5727892|NCT00402766|Platinol-AQ|platinol-aq
5727893|NCT00402766|CDDP|cddp
5727894|NCT00402766|Ly231514|ly231514
5727895|NCT00402766|Multitargeted Antifolate|multitargeted antifolate
5727896|NCT00402766|NSC-698037|nsc-698037
5727897|NCT00402766|STI571|sti571
5727898|NCT00402766|NSSC-716051|nssc-716051
5727899|NCT00402753|Cancer, Exercise, Health Related Quality of Life, PBSCT|cancer, exercise, health related quality of life, pbsct
5727900|NCT00402740|Carotid|carotid
5727901|NCT00402740|Artery|artery
5727902|NCT00402740|Disease|disease
5727903|NCT00402740|Stent|stent
5727904|NCT00402740|PROTECT|protect
5727905|NCT00402740|XACT|xact
5727906|NCT00402740|EMBOSHIELD|emboshield
5727907|NCT00402714|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5727908|NCT00402701|walking|walking
5727909|NCT00402701|motor activity|motor activity
5727910|NCT00402701|students|students
5727911|NCT00402701|schools|schools
5727912|NCT00402701|transportation|transportation
5727913|NCT00402701|motor vehicles|motor vehicles
5727914|NCT00402688|Chronic Prostatitis|chronic prostatitis
5727915|NCT00402688|Prostatitis|prostatitis
5727916|NCT00402688|levofloxacin|levofloxacin
5727917|NCT00402688|Levaquin|levaquin
5727918|NCT00402675|NSTEMI|nstemi
5727919|NCT00402675|infarction|infarction
5727920|NCT00402675|treatment|treatment
5727921|NCT00402675|percutaneous coronary intervention|percutaneous coronary intervention
5727922|NCT00402675|non-ST-elevation myocardial infarction|non-st-elevation myocardial infarction
5727923|NCT00402662|everolimus|everolimus
5727924|NCT00402662|imatinib|imatinib
5727925|NCT00402649|influenza, A/H5N1, avian influenza, vaccine|influenza, a/h5n1, avian influenza, vaccine
5727926|NCT00402623|sarcoidosis|sarcoidosis
5727927|NCT00402623|quercetin|quercetin
5727928|NCT00402623|supplementation|supplementation
5727929|NCT00402623|oxidative stress|oxidative stress
5727930|NCT00402623|inflammation|inflammation
5727932|NCT00402610|Tuberculosis|tuberculosis
5727933|NCT00402610|Chemoprophylaxis|chemoprophylaxis
5727934|NCT00402610|Anergy|anergy
5727935|NCT00402610|AIDS|aids
5727936|NCT00402597|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5727937|NCT00402597|Myocardial Ischemia|myocardial ischemia
5727938|NCT00402597|Rivaroxaban (BAY59-7939)|rivaroxaban (bay59-7939)
5727939|NCT00402597|Anti-platelet agents|anti-platelet agents
5727941|NCT00402597|Thienopyridine|thienopyridine
5727942|NCT00402597|Clopidogrel|clopidogrel
5727943|NCT00402571|acetaminophen|acetaminophen
5727944|NCT00402571|alcohol|alcohol
5727945|NCT00402571|liver injury|liver injury
5727946|NCT00402558|Acute Myeloid Leukemia|acute myeloid leukemia
5727947|NCT00402558|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5727948|NCT00402558|Myelodysplastic Syndrome|myelodysplastic syndrome
5727949|NCT00402558|Leukemia|leukemia
5727950|NCT00402558|NK Cells|nk cells
5727951|NCT00402558|Natural Killer Cells|natural killer cells
5727952|NCT00402558|Fludarabine|fludarabine
5727953|NCT00402558|Busulfan|busulfan
5727954|NCT00402558|Thymoglobulin|thymoglobulin
5727955|NCT00402558|AML|aml
5727956|NCT00402558|CML|cml
5727957|NCT00402558|MDS|mds
5727958|NCT00402558|ATG|atg
5727959|NCT00402558|Antithymocyte globulin|antithymocyte globulin
5727961|NCT00402558|Myleran®|myleran®
5727962|NCT00402558|Fludarabine Phosphate|fludarabine phosphate
5727963|NCT00402558|G-CSF|g-csf
5727964|NCT00402558|Filgrastim|filgrastim
5727965|NCT00402558|Neupogen|neupogen
5727966|NCT00402558|Interleukin-2|interleukin-2
5727967|NCT00402558|IL-2|il-2
5727968|NCT00402558|Aldesleukin|aldesleukin
5727969|NCT00402558|Proleukin|proleukin
5727970|NCT00402558|Tacrolimus|tacrolimus
5727971|NCT00402558|Prograf|prograf
5727972|NCT00402558|Methotrexate|methotrexate
5727973|NCT00402545|SCCHN|scchn
5727974|NCT00402545|C-TPF|c-tpf
5727975|NCT00402545|5-FU|5-fu
5727976|NCT00402545|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5727977|NCT00402532|Lung Transplantation|lung transplantation
5737386|NCT00367744|HIV|hiv
5727978|NCT00402532|Immunosuppression|immunosuppression
5727980|NCT00402532|Graft rejection|graft rejection
5727981|NCT00402532|Bronchiolitis obliterans|bronchiolitis obliterans
5753823|NCT00305500|OCD|ocd
5727982|NCT00402532|Opportunistic infections|opportunistic infections
5727983|NCT00402532|Nephrotoxicity|nephrotoxicity
5727984|NCT00402519|accelerated partial breast irradiation|accelerated partial breast irradiation
5727985|NCT00402519|multicatheter brachytherapy|multicatheter brachytherapy
5727986|NCT00402519|high dose rate brachytherapy|high dose rate brachytherapy
5727987|NCT00402519|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
5727988|NCT00402506|coronary|coronary
5727989|NCT00402506|surgery|surgery
5727990|NCT00402506|ischemia|ischemia
5727991|NCT00402506|reperfusion injury|reperfusion injury
5727992|NCT00402506|cardiac|cardiac
5727993|NCT00402506|heart|heart
5727994|NCT00402506|neurological|neurological
5727995|NCT00402506|cardiopulmonary bypass|cardiopulmonary bypass
5727996|NCT00402506|cardioprotection|cardioprotection
5727997|NCT00402506|myocardium|myocardium
5727998|NCT00402506|myocardial|myocardial
5727999|NCT00402506|myocardial revascularization|myocardial revascularization
5728000|NCT00402493|Glaucoma|glaucoma
5728001|NCT00402493|Ocular Hypertension|ocular hypertension
5728002|NCT00402493|Xalatan|xalatan
5728003|NCT00402493|Alpahgan|alpahgan
5728004|NCT00402493|Ibuprofen|ibuprofen
5728005|NCT00402493|Non-Steroidal Anti-Inflammatory|non-steroidal anti-inflammatory
5728006|NCT00402493|Brimonidine|brimonidine
5728007|NCT00402493|Latanoprost|latanoprost
5728008|NCT00402493|Eye Pressure|eye pressure
5728009|NCT00402493|Intra-Ocular Pressure|intra-ocular pressure
5728010|NCT00402480|Sickle Cell Anemia with Elevated TCD flow velocity|sickle cell anemia with elevated tcd flow velocity
5728011|NCT00402467|Prevention of venous thromboembolism|prevention of venous thromboembolism
5728012|NCT00402454|HIV|hiv
5728013|NCT00402454|Tuberculosis|tuberculosis
5728014|NCT00402454|Prophylaxis|prophylaxis
5728015|NCT00402454|AIDS|aids
5728016|NCT00402428|Chronic Hepatitis C|chronic hepatitis c
5728017|NCT00402428|Hepatitis C|hepatitis c
5745603|NCT00337636|NCL|ncl
5728019|NCT00402428|HepC|hepc
5728020|NCT00402428|Genotype 1|genotype 1
5728021|NCT00402428|Hepatitis|hepatitis
5728022|NCT00402428|HCV|hcv
5728023|NCT00402415|metastatic|metastatic
5728024|NCT00402415|malignancy|malignancy
5728025|NCT00402415|advanced solid tumors|advanced solid tumors
5728026|NCT00402415|unresectable|unresectable
5728027|NCT00402415|Solid Tumors|solid tumors
5728028|NCT00402402|Tuberculin skin test|tuberculin skin test
5728029|NCT00402402|Quantiferon-TB Gold assay|quantiferon-tb gold assay
5728030|NCT00402402|Chronic liver disease|chronic liver disease
5728031|NCT00402402|Liver transplantation|liver transplantation
5728032|NCT00402402|Latent tuberculosis infection|latent tuberculosis infection
5728033|NCT00402389|Perinatal Depression|perinatal depression
5728034|NCT00402389|Postpartum Depression|postpartum depression
5728035|NCT00402389|Omega-3 Fatty Acids|omega-3 fatty acids
5728036|NCT00402389|Eicosapentaenoic Acid (EPA)|eicosapentaenoic acid (epa)
5728037|NCT00402389|Docosahexaenoic Acid (DHA)|docosahexaenoic acid (dha)
5728038|NCT00402389|Pregnancy|pregnancy
5728039|NCT00402389|Psychotherapy|psychotherapy
5728040|NCT00402376|End-stage heart failure|end-stage heart failure
5728041|NCT00402376|heart failure;|heart failure;
5728042|NCT00402376|ventricular assist device;|ventricular assist device;
5728043|NCT00402376|statin;|statin;
5728044|NCT00402376|heart transplantation;|heart transplantation;
5728045|NCT00402376|myocardial function;|myocardial function;
5728046|NCT00402376|mitochondrial respiratory function;|mitochondrial respiratory function;
5728047|NCT00402363|Lovaza|lovaza
5728048|NCT00402363|Omega-3 fatty acids|omega-3 fatty acids
5728049|NCT00402363|Omacor|omacor
5728050|NCT00402363|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5728051|NCT00402350|Staccato Fentanyl, Pharmacokinetics, Pharmacodynamics, inhaled fentanyl|staccato fentanyl, pharmacokinetics, pharmacodynamics, inhaled fentanyl
5728052|NCT00402337|Constipation|constipation
5728053|NCT00402337|Chronic Constipation|chronic constipation
5728054|NCT00402337|Microbia|microbia
5728055|NCT00402337|linaclotide|linaclotide
5728056|NCT00402337|linaclotide acetate|linaclotide acetate
5728057|NCT00402337|MD-1100|md-1100
5728058|NCT00402324|Mixed episode associated with Bipolar I|mixed episode associated with bipolar i
5728059|NCT00402311|Health Services for the Aged|health services for the aged
5728060|NCT00402311|Geriatric Psychiatry|geriatric psychiatry
5728061|NCT00402298|PTSD|ptsd
5728062|NCT00402298|MDMA|mdma
5728063|NCT00402298|psychotherapy|psychotherapy
5728064|NCT00402298|Posttraumatic stress disorder|posttraumatic stress disorder
5728065|NCT00402298|Israel|israel
5728066|NCT00402285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5728067|NCT00402285|stage I prostate cancer|stage i prostate cancer
5728068|NCT00402285|stage IIB prostate cancer|stage iib prostate cancer
5728069|NCT00402285|stage IIA prostate cancer|stage iia prostate cancer
5728070|NCT00402272|drug eluting stents|drug eluting stents
5728071|NCT00402272|stents|stents
5728072|NCT00402272|Angioplasty|angioplasty
5728073|NCT00402272|coronary artery disease|coronary artery disease
5728074|NCT00402272|total coronary occlusion|total coronary occlusion
5728075|NCT00402272|coronary artery restenosis|coronary artery restenosis
5728076|NCT00402272|stent thrombosis|stent thrombosis
5753920|NCT00305149|BEACOPP|beacopp
5728077|NCT00402272|vascular disease|vascular disease
5728078|NCT00402272|myocardial ischemia|myocardial ischemia
5728079|NCT00402272|coronary artery stenosis|coronary artery stenosis
5728080|NCT00402259|acute non-variceal upper gastrointestinal bleeding|acute non-variceal upper gastrointestinal bleeding
5728081|NCT00402246|Randomized Controlled Trials|randomized controlled trials
5728082|NCT00402246|Defibrillators|defibrillators
5728083|NCT00402246|Remote Consultation|remote consultation
5728084|NCT00402207|asthma|asthma
5728085|NCT00402207|non-invasive inflammometry|non-invasive inflammometry
5728086|NCT00402207|exhaled nitric oxide|exhaled nitric oxide
5728087|NCT00402207|exhaled breath condensate|exhaled breath condensate
5728088|NCT00402207|paediatric|paediatric
5728089|NCT00402207|extrafine HFA-beclomethasone|extrafine hfa-beclomethasone
5728090|NCT00402207|HFA-fluticasone|hfa-fluticasone
5728091|NCT00402194|Obesity|obesity
5728092|NCT00402194|Insulin resistance|insulin resistance
5728093|NCT00402194|Impaired glucose tolerance|impaired glucose tolerance
5728094|NCT00402194|pre-diabetes|pre-diabetes
5728095|NCT00402181|Myeloma|myeloma
5728096|NCT00402181|Intravenous|intravenous
5728097|NCT00402181|Monoclonal antibody|monoclonal antibody
5728098|NCT00402181|Siltuximab|siltuximab
5728099|NCT00402181|Dexamethasone|dexamethasone
5728100|NCT00402181|CNTO 328|cnto 328
5728101|NCT00402155|electroretinogram|electroretinogram
5728102|NCT00402155|visual evoked potential|visual evoked potential
5728103|NCT00402155|contrast sensitivity|contrast sensitivity
5728104|NCT00402142|HIV Infection|hiv infection
5728105|NCT00402142|Dendritic cell vaccine|dendritic cell vaccine
5728106|NCT00402142|Autologous virus|autologous virus
5728107|NCT00402142|Heat inactivated|heat inactivated
5728108|NCT00402142|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5728109|NCT00402129|Ethnic Skin|ethnic skin
5728110|NCT00402129|Laser|laser
5728111|NCT00402129|Photobiology|photobiology
5728112|NCT00402129|Quality of life|quality of life
5728113|NCT00402103|Hypertension, aliskiren, amlodipine, HCTZ, blood pressure|hypertension, aliskiren, amlodipine, hctz, blood pressure
5728114|NCT00402090|thiopurines|thiopurines
5728115|NCT00402090|thiopurine methyl transferase|thiopurine methyl transferase
5728116|NCT00402090|toxicity|toxicity
5728117|NCT00402090|pharmacogenomics|pharmacogenomics
5728118|NCT00402077|overweight|overweight
5728119|NCT00402077|obesity|obesity
5728120|NCT00402077|pramlintide|pramlintide
5728121|NCT00402077|Symlin|symlin
5728122|NCT00402077|sibutramine|sibutramine
5728123|NCT00402077|Meridia|meridia
5728124|NCT00402077|phentermine|phentermine
5728125|NCT00402077|Amylin|amylin
5728126|NCT00402064|bisphosphonates|bisphosphonates
5728127|NCT00402064|children|children
5728128|NCT00402064|dental|dental
5728129|NCT00402064|Osteomyelitis|osteomyelitis
5728130|NCT00402064|medication|medication
5728131|NCT00402025|Metastatic|metastatic
5728132|NCT00402025|Pancreas|pancreas
5728133|NCT00402025|Adenocarcinoma|adenocarcinoma
5728134|NCT00402012|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5728135|NCT00401999|PET|pet
5728136|NCT00401999|C-11 Raclopride|c-11 raclopride
5728137|NCT00401999|Dopamine|dopamine
5728138|NCT00401999|OPRM1|oprm1
5728139|NCT00401999|Alcohol|alcohol
5728140|NCT00401999|Healthy Volunteer|healthy volunteer
5728141|NCT00401999|HV|hv
5728142|NCT00401986|Refractory Asthma|refractory asthma
5728143|NCT00401986|Bronchial Thermoplasty|bronchial thermoplasty
5728144|NCT00401986|Alair System|alair system
5728145|NCT00401986|RISA (Research in Severe Asthma)|risa (research in severe asthma)
5728146|NCT00401960|Enterococcus|enterococcus
5728147|NCT00401960|Daptomycin|daptomycin
5728148|NCT00401960|Endocarditis|endocarditis
5728150|NCT00401947|Chronic|chronic
5728151|NCT00401947|Hepatitis|hepatitis
5728152|NCT00401934|cholera, Vibrio cholerae, diarrhea, Bangladesh, children|cholera, vibrio cholerae, diarrhea, bangladesh, children
5728153|NCT00401908|Acute gastrointestinal bleeding|acute gastrointestinal bleeding
5728154|NCT00401908|Acute coronary syndrome|acute coronary syndrome
5728155|NCT00401895|TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT|transjugular intrahepatic portosystemic shunt
5728156|NCT00401895|Covered stents|covered stents
5728157|NCT00401895|portal hypertension|portal hypertension
5728158|NCT00401895|hepatic encephalopathy|hepatic encephalopathy
5728159|NCT00401882|Cardiac arrest|cardiac arrest
5728160|NCT00401882|Sudden Cardiac Death|sudden cardiac death
5728161|NCT00401882|Ventricular Fibrillation|ventricular fibrillation
5728162|NCT00401882|Pulseless Ventricular Tachycardia|pulseless ventricular tachycardia
5728163|NCT00401882|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5728164|NCT00401869|vigor|vigor
5728165|NCT00401869|function|function
5728166|NCT00401869|well-being|well-being
5728167|NCT00401869|hand-strength|hand-strength
5728168|NCT00401869|surgery|surgery
5728169|NCT00401869|anemia|anemia
5728170|NCT00401869|transfusion|transfusion
5728171|NCT00401869|strength|strength
5728172|NCT00401869|quality-of-life|quality-of-life
5728173|NCT00401856|Cardiomyopathy|cardiomyopathy
5728174|NCT00401856|Fibrosis|fibrosis
5737630|NCT00366431|OIC|oic
5728175|NCT00401856|Magnetic-Resonance|magnetic-resonance
5728176|NCT00401856|Eplerenone|eplerenone
5728177|NCT00401843|multiple myeloma|multiple myeloma
5728178|NCT00401843|Monoclonal Antibody|monoclonal antibody
5728179|NCT00401843|Intravenous|intravenous
5728180|NCT00401843|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
5728181|NCT00401843|velcade|velcade
5728182|NCT00401843|bortezomib|bortezomib
5728183|NCT00401830|Fibromyalgia Syndrome|fibromyalgia syndrome
5728184|NCT00401830|Lacosamide|lacosamide
5728185|NCT00401830|Vimpat|vimpat
5728186|NCT00401830|Harkoseride|harkoseride
5728187|NCT00401804|Multiple Myeloma|multiple myeloma
5728188|NCT00401804|renal impairment|renal impairment
5728189|NCT00401804|Velcade|velcade
5728190|NCT00401778|Lung Cancer|lung cancer
5728191|NCT00401765|Prostatic neoplasm|prostatic neoplasm
5728192|NCT00401765|intravenous|intravenous
5728193|NCT00401765|docetaxel|docetaxel
5728194|NCT00401765|monoclonal antibody|monoclonal antibody
5728195|NCT00401752|NSAID-associated gastric ulcer|nsaid-associated gastric ulcer
5728196|NCT00401726|Major Depressive Disorder|major depressive disorder
5728197|NCT00401726|Depression|depression
5728198|NCT00401726|Anxiety|anxiety
5728199|NCT00401713|submacular membrane|submacular membrane
5728200|NCT00401713|transplantation of RPE|transplantation of rpe
5728201|NCT00401713|translocation of RPE and Choroid|translocation of rpe and choroid
5728203|NCT00401700|influenza vaccine|influenza vaccine
5728204|NCT00401700|pregnancy|pregnancy
5728205|NCT00401687|Reduced Heart Function|reduced heart function
5728206|NCT00401674|ovarian cancer|ovarian cancer
5728207|NCT00401674|elderly|elderly
5728208|NCT00401674|weekly chemotherapy|weekly chemotherapy
5728209|NCT00401674|first-line|first-line
5728210|NCT00401648|POC|poc
5728211|NCT00401648|photosensitive|photosensitive
5728212|NCT00401648|epileptic|epileptic
5728213|NCT00401648|brivaracetam|brivaracetam
5728214|NCT00401648|PPR|ppr
5728215|NCT00401648|AED|aed
5728216|NCT00401635|advanced|advanced
5728217|NCT00401635|recurrent|recurrent
5728218|NCT00401635|chemotherapy|chemotherapy
5728220|NCT00401609|elderly|elderly
5728221|NCT00401596|ALTO|alto
5728222|NCT00401583|GW786034 (pazopanib) cytochrome P450 interaction|gw786034 (pazopanib) cytochrome p450 interaction
5728223|NCT00401570|Antibody|antibody
5728224|NCT00401570|Pancreas|pancreas
5728225|NCT00401570|Carcinoma|carcinoma
5728226|NCT00401570|Cancer|cancer
5728227|NCT00401570|Pancreatic|pancreatic
5728228|NCT00401557|Leishmaniasis, Leishmania (Viannia), Colombia|leishmaniasis, leishmania (viannia), colombia
5728229|NCT00401544|anemia|anemia
5728230|NCT00401544|chemotherapy induced anemia|chemotherapy induced anemia
5728231|NCT00401544|darbepoetin alfa|darbepoetin alfa
5728232|NCT00401544|cancer|cancer
5728233|NCT00401531|Hepatitis B|hepatitis b
5728234|NCT00401531|Polio|polio
5728235|NCT00401531|Diphtheria|diphtheria
5728236|NCT00401531|Pertussis|pertussis
5728237|NCT00401531|H. influenzae type b|h. influenzae type b
5728238|NCT00401518|Spinal Stenosis|spinal stenosis
5728239|NCT00401518|Lumbar Spinal Stenosis|lumbar spinal stenosis
5728240|NCT00401518|Facet Arthroplasty|facet arthroplasty
5728241|NCT00401518|Posterior Fusion|posterior fusion
5728242|NCT00401518|Facet Arthritis|facet arthritis
5728243|NCT00401505|rubella|rubella
5728244|NCT00401505|rubella vaccine|rubella vaccine
5728245|NCT00401505|postpartum|postpartum
5728248|NCT00401492|chemotherapy|chemotherapy
5728249|NCT00401492|quality of life|quality of life
5728250|NCT00401492|ADL|adl
5728251|NCT00401492|toxicity|toxicity
5728252|NCT00401479|GW427353|gw427353
5728253|NCT00401479|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
5728254|NCT00401479|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5728255|NCT00401479|pharmacokinetics|pharmacokinetics
5728256|NCT00401479|tolerability|tolerability
5728257|NCT00401479|gastrointestinal transit|gastrointestinal transit
5728258|NCT00401466|prophylactic ICD therapy|prophylactic icd therapy
5728259|NCT00401466|home monitoring|home monitoring
5728260|NCT00401466|follow-up interval|follow-up interval
5728261|NCT00401466|remote follow-up|remote follow-up
5728262|NCT00401440|Medical termination of pregnancy|medical termination of pregnancy
5728263|NCT00401440|Induction of abortion|induction of abortion
5728264|NCT00401440|Misoprostol|misoprostol
5728265|NCT00401440|MTP in second trimester|mtp in second trimester
5728266|NCT00401440|400 microgram vaginal misoprostol|400 microgram vaginal misoprostol
5728267|NCT00401427|HER2 overexpression|her2 overexpression
5728268|NCT00401427|combination therapy|combination therapy
5728269|NCT00401414|Warfarin|warfarin
5728270|NCT00401414|Thrombosis|thrombosis
5728271|NCT00401414|Genetics|genetics
5728272|NCT00401414|Nomogram|nomogram
5728273|NCT00401414|Pulmonary Embolism|pulmonary embolism
5728274|NCT00401414|Deep Vein Thrombosis|deep vein thrombosis
5728275|NCT00401414|Dosing|dosing
5728276|NCT00401414|INR|inr
5728277|NCT00401414|Anticoagulation|anticoagulation
5728278|NCT00401414|Therapy|therapy
5728279|NCT00401414|Orthopedic Surgery|orthopedic surgery
5728280|NCT00401388|Chemo Insensitive Sarcomas|chemo insensitive sarcomas
5728282|NCT00401388|Alveolar soft part sarcomas|alveolar soft part sarcomas
5728283|NCT00401388|Extra skeletal myxoid chondrosarcomas|extra skeletal myxoid chondrosarcomas
5736570|NCT00370786|Bevacizumab|bevacizumab
5728284|NCT00401388|Perifosine|perifosine
5728285|NCT00401349|Leishmania|leishmania
5728286|NCT00401349|Mif Alleles|mif alleles
5728287|NCT00401349|Colombia|colombia
5728288|NCT00401349|children|children
5728289|NCT00401336|Magnetic resonance imaging|magnetic resonance imaging
5728290|NCT00401336|Hepatic iron|hepatic iron
5728291|NCT00401336|Steatosis|steatosis
5728292|NCT00401297|Leishmaniasis|leishmaniasis
5728293|NCT00401297|L. Viannia|l. viannia
5728294|NCT00401297|Leishmania|leishmania
5728295|NCT00401297|Colombia|colombia
5728296|NCT00401258|IBS|ibs
5728297|NCT00401258|irritable bowel syndrome|irritable bowel syndrome
5728298|NCT00401258|irritable bowel|irritable bowel
5728299|NCT00401206|dexmedetomidine|dexmedetomidine
5728300|NCT00401206|sedation|sedation
5728301|NCT00401206|bronchoscopy|bronchoscopy
5728302|NCT00401206|COPD|copd
5728303|NCT00401193|Menorrhagia|menorrhagia
5728304|NCT00401193|Heavy Menstrual Bleeding|heavy menstrual bleeding
5728305|NCT00401180|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5728306|NCT00401167|Alzheimer's disease|alzheimer's disease
5728307|NCT00401167|behavioral and psychological symptoms of dementia|behavioral and psychological symptoms of dementia
5728308|NCT00401167|severe Alzheimer's disease|severe alzheimer's disease
5728310|NCT00401167|agitation|agitation
5728311|NCT00401167|aggression|aggression
5728312|NCT00401154|Spastic Diplegia|spastic diplegia
5728313|NCT00401154|Cerebral Palsy|cerebral palsy
5728314|NCT00401154|Children|children
5728315|NCT00401154|Adolescents|adolescents
5728316|NCT00401154|Strengthening|strengthening
5728317|NCT00401154|Endurance|endurance
5728318|NCT00401141|Systemic lupus|systemic lupus
5728319|NCT00401141|B lymphocytes|b lymphocytes
5728320|NCT00401141|transcriptomas|transcriptomas
5728321|NCT00401128|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5728322|NCT00401128|recurrent renal cell cancer|recurrent renal cell cancer
5723683|NCT00417898|Aspirin|aspirin
5728323|NCT00401128|papillary renal cell carcinoma|papillary renal cell carcinoma
5728324|NCT00401128|stage IV renal cell cancer|stage iv renal cell cancer
5728325|NCT00401102|self-injurious behavior|self-injurious behavior
5728327|NCT00401102|adolescents|adolescents
5728328|NCT00401102|psychotherapy|psychotherapy
5728329|NCT00401089|negative symptoms schizophrenia|negative symptoms schizophrenia
5728330|NCT00401089|Atypical antipsychotics|atypical antipsychotics
5728331|NCT00401089|Neurocognition impairment|neurocognition impairment
5728332|NCT00401089|obesity risk factor|obesity risk factor
5728333|NCT00401089|Diabetes insulin resistance schizophrenia|diabetes insulin resistance schizophrenia
5728334|NCT00401076|SA-001|sa-001
5728335|NCT00401076|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5728336|NCT00401076|Chronic Pancreatitis|chronic pancreatitis
5728337|NCT00401076|Pancreatectomy|pancreatectomy
5728338|NCT00401063|Cancer|cancer
5728339|NCT00401063|Acupuncture|acupuncture
5728340|NCT00401063|Cancer Pain|cancer pain
5728341|NCT00401063|Quality of life|quality of life
5728342|NCT00401050|patellofemoral pain syndrome|patellofemoral pain syndrome
5728343|NCT00401050|chiropractic|chiropractic
5728344|NCT00401050|knee pain|knee pain
5728345|NCT00401050|chiropractic manipulation|chiropractic manipulation
5728736|NCT00399516|Pain|pain
5728346|NCT00401050|Graston Instrument Soft Tissue Mobilization(GISTM)|graston instrument soft tissue mobilization(gistm)
5728347|NCT00401024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5728348|NCT00401024|adult oligodendroglioma|adult oligodendroglioma
5728349|NCT00401024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5728350|NCT00401024|adult giant cell glioblastoma|adult giant cell glioblastoma
5728351|NCT00401024|adult gliosarcoma|adult gliosarcoma
5728352|NCT00401024|recurrent adult brain tumor|recurrent adult brain tumor
5728353|NCT00401024|adult brain stem glioma|adult brain stem glioma
5728354|NCT00401024|adult mixed glioma|adult mixed glioma
5728355|NCT00401024|adult glioblastoma|adult glioblastoma
5728356|NCT00401024|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5728357|NCT00401024|adult diffuse astrocytoma|adult diffuse astrocytoma
5728358|NCT00401024|adult anaplastic ependymoma|adult anaplastic ependymoma
5728359|NCT00401024|adult ependymoma|adult ependymoma
5728360|NCT00401024|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5728361|NCT00401024|adult subependymoma|adult subependymoma
5728362|NCT00401024|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5728363|NCT00401024|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5728364|NCT00401011|Perifosine|perifosine
5728365|NCT00401011|Bortezomib|bortezomib
5728366|NCT00401011|Dexamethasone|dexamethasone
5728367|NCT00401011|Relapsed or Refractory Multiple Myeloma|relapsed or refractory multiple myeloma
5728368|NCT00400998|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5728369|NCT00400998|Quality of Life|quality of life
5728370|NCT00400998|Efficacy|efficacy
5728371|NCT00400998|Validation|validation
5728372|NCT00400998|Fluticasone Propionate|fluticasone propionate
5728373|NCT00400985|Heart Failure, Congestive|heart failure, congestive
5728374|NCT00400985|Diagnostic|diagnostic
5728375|NCT00400985|Ambulatory Monitoring|ambulatory monitoring
5728376|NCT00400985|Intrathoracic Impedance|intrathoracic impedance
5736683|NCT00370357|SPL7013|spl7013
5728377|NCT00400972|GlideScope|glidescope
5728378|NCT00400972|videolaryngoscopy|videolaryngoscopy
5728379|NCT00400972|intubation|intubation
5728380|NCT00400972|nasal|nasal
5728381|NCT00400972|nasotracheal|nasotracheal
5728382|NCT00400972|laryngoscopy|laryngoscopy
5728383|NCT00400972|anesthesia|anesthesia
5728384|NCT00400959|cell therapy|cell therapy
5728385|NCT00400959|acute myocardial infarction|acute myocardial infarction
5728386|NCT00400946|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5728387|NCT00400946|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5728388|NCT00400946|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5728389|NCT00400946|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5728390|NCT00400946|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5728391|NCT00400933|Psycho-education|psycho-education
5728392|NCT00400933|Eating disorders|eating disorders
5728393|NCT00400933|Personality disorders|personality disorders
5728394|NCT00400933|Relatives and close friends|relatives and close friends
5728395|NCT00400933|Caregiver burden|caregiver burden
5728396|NCT00400907|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5728397|NCT00400907|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5728398|NCT00400907|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5728399|NCT00400907|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5728400|NCT00400907|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5728401|NCT00400907|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5728402|NCT00400894|prostate cancer|prostate cancer
5728403|NCT00400894|annexin A3|annexin a3
5728404|NCT00400894|early detection|early detection
5728405|NCT00400894|exprimate urine|exprimate urine
5723762|NCT00417560|Influenza A/H5N1|influenza a/h5n1
5728408|NCT00400881|respiratory failure|respiratory failure
5728409|NCT00400881|spontaneous breathing trial|spontaneous breathing trial
5728410|NCT00400868|rheumatoid arthritis, occupational therapy, joint protection|rheumatoid arthritis, occupational therapy, joint protection
5728411|NCT00400855|Asthma|asthma
5728412|NCT00400855|AMP challenge|amp challenge
5728413|NCT00400842|SA-001|sa-001
5728414|NCT00400842|Pancreatic Exocrine Insufficiency|pancreatic exocrine insufficiency
5728415|NCT00400842|Pancreatectomy|pancreatectomy
5728416|NCT00400816|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5728417|NCT00400816|adult mixed glioma|adult mixed glioma
5728418|NCT00400803|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5728419|NCT00400803|Gemcitabine|gemcitabine
5728420|NCT00400803|Carboplatin|carboplatin
5728421|NCT00400803|Bevacizumab|bevacizumab
5728422|NCT00400803|Biological therapy|biological therapy
5728423|NCT00400803|Drug therapy|drug therapy
5728424|NCT00400790|neurocognitive decline|neurocognitive decline
5728425|NCT00400790|coronary artery bypass surgery|coronary artery bypass surgery
5728426|NCT00400790|composite morbidity|composite morbidity
5728427|NCT00400790|postoperative care cost|postoperative care cost
5728428|NCT00400777|Valsartan|valsartan
5728429|NCT00400777|hydrochlorothiazide|hydrochlorothiazide
5728430|NCT00400777|amlodipine|amlodipine
5728431|NCT00400777|hypertension|hypertension
5728432|NCT00400777|high blood pressure|high blood pressure
5728433|NCT00400764|NHL|nhl
5728434|NCT00400764|Follicular NHL|follicular nhl
5728435|NCT00400764|Rituxan|rituxan
5728436|NCT00400764|Apo2L/TRAIL|apo2l/trail
5728437|NCT00400751|Health-compromised smokers, family cessation intervention|health-compromised smokers, family cessation intervention
5728438|NCT00400738|HIV-1 infection|hiv-1 infection
5728439|NCT00400738|pharmacokinetics|pharmacokinetics
5728440|NCT00400738|protease inhibitor|protease inhibitor
5728441|NCT00400738|double boosted protease inhibitors|double boosted protease inhibitors
5728442|NCT00400738|PIs|pis
5728443|NCT00400738|Treatment Naive|treatment naive
5728444|NCT00400725|maintenance|maintenance
5728445|NCT00400725|scalp psoriasis|scalp psoriasis
5728446|NCT00400725|Galderma|galderma
5728447|NCT00400712|mobility|mobility
5728448|NCT00400712|strength|strength
5728449|NCT00400712|balance|balance
5728450|NCT00400712|function|function
5728451|NCT00400712|reintegration|reintegration
5728452|NCT00400712|community|community
5728453|NCT00400699|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5728454|NCT00400699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5728455|NCT00400686|anemia|anemia
5728456|NCT00400686|stage I multiple myeloma|stage i multiple myeloma
5728457|NCT00400686|stage II multiple myeloma|stage ii multiple myeloma
5728458|NCT00400686|stage III multiple myeloma|stage iii multiple myeloma
5728459|NCT00400686|refractory multiple myeloma|refractory multiple myeloma
5728460|NCT00400673|Acute myelogenous leukemia|acute myelogenous leukemia
5728461|NCT00400673|Adult patients|adult patients
5728462|NCT00400673|Cytogenetic risk class|cytogenetic risk class
5728463|NCT00400673|Clinico-cytogenetic risk model|clinico-cytogenetic risk model
5728464|NCT00400673|Risk-oriented therapy|risk-oriented therapy
5754268|NCT00303914|pain|pain
5744772|NCT00340574|Human|human
5728465|NCT00400660|GSK615915 asthma surfactant MDI|gsk615915 asthma surfactant mdi
5728466|NCT00400647|kidney transplant|kidney transplant
5728467|NCT00400647|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5728468|NCT00400647|quality of life|quality of life
5728469|NCT00400647|gastrointestinal symptoms|gastrointestinal symptoms
5728470|NCT00400621|acetaminophen|acetaminophen
5728471|NCT00400621|alcohol|alcohol
5728472|NCT00400621|liver injury|liver injury
5728473|NCT00400608|pediatrics|pediatrics
5728474|NCT00400608|ADVAIR Inhaler|advair inhaler
5728475|NCT00400608|Asthma|asthma
5728476|NCT00400608|ADVAIR DISKUS|advair diskus
5728477|NCT00400595|peritonitis|peritonitis
5728478|NCT00400595|catheter related infection|catheter related infection
5728479|NCT00400595|exit site ointments|exit site ointments
5728480|NCT00400595|mupirocin|mupirocin
5728481|NCT00400595|Polysporin Triple|polysporin triple
5728482|NCT00400582|Heart failure|heart failure
5728483|NCT00400582|Gene polymorphism|gene polymorphism
5728484|NCT00400582|Candesartan|candesartan
5728485|NCT00400582|ACE inhibitors|ace inhibitors
5728486|NCT00400582|BNP|bnp
5728487|NCT00400582|Pharmacogenomics|pharmacogenomics
5728488|NCT00400569|Sunitinib malate|sunitinib malate
5728489|NCT00400569|SUTENT|sutent
5728490|NCT00400569|SU011248|su011248
5728491|NCT00400569|Soft tissue sarcoma|soft tissue sarcoma
5728492|NCT00400569|Gastrointestinal stromal tumors (GIST)|gastrointestinal stromal tumors (gist)
5728493|NCT00400569|MFH|mfh
5728494|NCT00400569|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5728495|NCT00400569|Imatinib mesylate|imatinib mesylate
5728496|NCT00400569|Phase II|phase ii
5728497|NCT00400556|mobilization|mobilization
5728498|NCT00400556|ATRA|atra
5728499|NCT00400556|G-CSF|g-csf
5728500|NCT00400556|filgrastim|filgrastim
5728501|NCT00400556|retinoids|retinoids
5728502|NCT00400556|stem cell mobilization|stem cell mobilization
5723862|NCT00417183|GnRH antagonist|gnrh antagonist
5728503|NCT00400556|hematopoietic stem and progenitor cells|hematopoietic stem and progenitor cells
5728504|NCT00400543|obstructive sleep apnea|obstructive sleep apnea
5728505|NCT00400543|arterial stiffness|arterial stiffness
5728508|NCT00400543|heart disease|heart disease
5728509|NCT00400517|stage III prostate cancer|stage iii prostate cancer
5728510|NCT00400517|stage II prostate cancer|stage ii prostate cancer
5728511|NCT00400517|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5728512|NCT00400517|stage I prostate cancer|stage i prostate cancer
5728513|NCT00400517|stage IV prostate cancer|stage iv prostate cancer
5728514|NCT00400504|Thrombelastograph|thrombelastograph
5728515|NCT00400504|Cancer|cancer
5728516|NCT00400504|Thromboembolism|thromboembolism
5728517|NCT00400504|Hypercoagulable|hypercoagulable
5728518|NCT00400491|diabetes|diabetes
5728519|NCT00400491|insulin|insulin
5728520|NCT00400491|glycated hemoglobin|glycated hemoglobin
5728521|NCT00400491|cholecalciferol|cholecalciferol
5728522|NCT00400491|vitamin D|vitamin d
5728523|NCT00400478|DLBCL|dlbcl
5728524|NCT00400478|NHL 13|nhl 13
5728525|NCT00400478|Rituximab|rituximab
5728526|NCT00400478|maintenance|maintenance
5728527|NCT00400465|thyroid|thyroid
5728528|NCT00400465|thyroidectomy|thyroidectomy
5728529|NCT00400465|dressing|dressing
5728530|NCT00400452|wheelchair|wheelchair
5728531|NCT00400452|skills|skills
5728532|NCT00400452|long-term-care|long-term-care
5728534|NCT00400426|Palliative radiotherapy|palliative radiotherapy
5728535|NCT00400426|Recurrent|recurrent
5728536|NCT00400426|Head and neck Neoplasm|head and neck neoplasm
5728537|NCT00400426|Quality of life|quality of life
5728538|NCT00400413|Neuropsychology|neuropsychology
5728539|NCT00400413|fMRI|fmri
5728540|NCT00400413|Reading|reading
5728541|NCT00400413|Phonology|phonology
5728542|NCT00400413|Deafness|deafness
5728543|NCT00400400|RenalTransplantation|renaltransplantation
5728544|NCT00400400|KidneyTransplantation|kidneytransplantation
5728545|NCT00400400|MPA|mpa
5728546|NCT00400400|EC-MPS|ec-mps
5728547|NCT00400387|recurrent pregnancy loss|recurrent pregnancy loss
5728548|NCT00400374|Head and Neck Cancer|head and neck cancer
5728549|NCT00400335|Testosterone|testosterone
5728550|NCT00400335|Men|men
5728551|NCT00400335|Hypogonadism|hypogonadism
5728552|NCT00400335|Dutasteride|dutasteride
5728553|NCT00400335|DHT|dht
5728554|NCT00400335|Androgen deficiency|androgen deficiency
5728555|NCT00400322|glioblastoma multiforme|glioblastoma multiforme
5728556|NCT00400322|cytomegalovirus infection|cytomegalovirus infection
5728557|NCT00400322|antiviral treatment|antiviral treatment
5728558|NCT00400322|valganciclovir|valganciclovir
5728559|NCT00400270|Asthma|asthma
5728560|NCT00400270|Randomised controlled trial|randomised controlled trial
5728561|NCT00400270|Breathing exercises|breathing exercises
5728562|NCT00400270|Relaxation exercises|relaxation exercises
5728563|NCT00400270|Primary care|primary care
5728564|NCT00400257|Heart Failure|heart failure
5728565|NCT00400257|BNP|bnp
5728566|NCT00400244|wheelchairs|wheelchairs
5728567|NCT00400244|skills|skills
5728568|NCT00400244|french|french
5686167|NCT00553202|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5686168|NCT00553189|PARP Inhibitor|parp inhibitor
5686169|NCT00553189|Advanced Cancer|advanced cancer
5686170|NCT00553189|Combination Therapy|combination therapy
5728569|NCT00400231|metabolic syndrome|metabolic syndrome
5728570|NCT00400231|Triglycerides|triglycerides
5728571|NCT00400231|Insulin Resistance|insulin resistance
5728572|NCT00400231|inflammation|inflammation
5728573|NCT00400231|Cardiovascular Disease|cardiovascular disease
5728574|NCT00400231|Elevated triglycerides|elevated triglycerides
5728575|NCT00400231|without diabetes|without diabetes
5728576|NCT00400205|Squamous Cell Carcinoma of the Oral Cavity|squamous cell carcinoma of the oral cavity
5728577|NCT00400192|Microchimerism|microchimerism
5728578|NCT00400192|Injuries|injuries
5728579|NCT00400192|Leukocytes|leukocytes
5728580|NCT00400192|Immunologic Techniques|immunologic techniques
5728581|NCT00400179|Gastric Cancer|gastric cancer
5728582|NCT00400166|Peer support|peer support
5728583|NCT00400166|Psychiatric disability|psychiatric disability
5728584|NCT00400166|Mutual support|mutual support
5728585|NCT00400166|Psychiatric Rehabilitation|psychiatric rehabilitation
5728586|NCT00400140|Myopia, defocus|myopia, defocus
5728587|NCT00400127|transfemoral amputee|transfemoral amputee
5728588|NCT00400127|silicon suspension|silicon suspension
5728589|NCT00400127|balance|balance
5728590|NCT00400127|gait|gait
5728591|NCT00400114|esophageal|esophageal
5728593|NCT00400114|cancer|cancer
5728594|NCT00400114|sutent|sutent
5728595|NCT00400114|sunitinib|sunitinib
5728596|NCT00400101|Malaria|malaria
5728597|NCT00400101|Vaccine|vaccine
5728598|NCT00400101|Plasmodium|plasmodium
5728599|NCT00400101|falciparum|falciparum
5728600|NCT00400101|Phase I|phase i
5728601|NCT00400101|Peptide|peptide
5728602|NCT00400101|Virosome|virosome
5728603|NCT00400101|safety|safety
5728604|NCT00400101|immunogenicity|immunogenicity
5728605|NCT00400088|Major Depressive Disorder|major depressive disorder
5728606|NCT00400088|Depression|depression
5728607|NCT00400088|Bipolar Disorder|bipolar disorder
5728608|NCT00400088|Manic Depressive Illness|manic depressive illness
5728609|NCT00400088|Randomized Trial|randomized trial
5728610|NCT00400088|Antidepressant Treatment|antidepressant treatment
5728611|NCT00400088|Lithium Treatment|lithium treatment
5728612|NCT00400075|Polyarteritis|polyarteritis
5728613|NCT00400075|Vasculitis|vasculitis
5728614|NCT00400075|Therapy|therapy
5728615|NCT00400075|Cyclophosphamide|cyclophosphamide
5728616|NCT00400075|Azathioprine|azathioprine
5728617|NCT00400062|Critical care|critical care
5728618|NCT00400062|delirium|delirium
5728619|NCT00400062|long-term cognitive impairment|long-term cognitive impairment
5728620|NCT00400062|mechanical ventilation|mechanical ventilation
5728621|NCT00400062|critical illness|critical illness
5728622|NCT00400062|dementia|dementia
5728623|NCT00400062|aging|aging
5728624|NCT00400062|sedatives and analgesics|sedatives and analgesics
5728625|NCT00400036|cod protein|cod protein
5728626|NCT00400036|insulin sensitivity|insulin sensitivity
5728627|NCT00400036|plasma lipids|plasma lipids
5728628|NCT00400036|glucose tolerance|glucose tolerance
5728629|NCT00400036|plasma inflammatory markers|plasma inflammatory markers
5728630|NCT00400036|skeletal muscle insulin signaling|skeletal muscle insulin signaling
5728631|NCT00400036|type 2 diabetes|type 2 diabetes
5728632|NCT00400036|humans|humans
5728633|NCT00400023|Advanced Solid Tumors|advanced solid tumors
5728634|NCT00400010|Expert system|expert system
5728635|NCT00400010|Transtheoretical Model of Behavior Change|transtheoretical model of behavior change
5728636|NCT00400010|Brief intervention|brief intervention
5728637|NCT00400010|General hospital|general hospital
5728639|NCT00399997|Exercise referral|exercise referral
5728640|NCT00399997|Lifestyle diseases|lifestyle diseases
5728641|NCT00399997|Sedentary behavior|sedentary behavior
5728642|NCT00399984|Continuing Medical Education|continuing medical education
5728643|NCT00399971|Idiopathic Aplastic Anemia|idiopathic aplastic anemia
5728644|NCT00399971|Has Failed Conventional Immunosuppressive Therapy|has failed conventional immunosuppressive therapy
5728645|NCT00399971|Not Eligible For Bone Marrow Transplantation|not eligible for bone marrow transplantation
5728646|NCT00399971|C15.378.071.085|c15.378.071.085
5728647|NCT00399945|Cystic fibrosis, tobramycin, PARI eFlow, PARI LC Plus, nebulizer, pharmacoscintigraphy|cystic fibrosis, tobramycin, pari eflow, pari lc plus, nebulizer, pharmacoscintigraphy
5728648|NCT00399932|metabolic syndrome|metabolic syndrome
5728649|NCT00399932|insulin resistance|insulin resistance
5728650|NCT00399932|NASH|nash
5728651|NCT00399932|hepatic fibrosis|hepatic fibrosis
5728652|NCT00399932|Fibroscan|fibroscan
5728653|NCT00399932|elastography by MRI|elastography by mri
5728654|NCT00399919|Perhipheral Artery Disease|perhipheral artery disease
5728655|NCT00399919|Claudication|claudication
5728656|NCT00399919|Exercise|exercise
5728657|NCT00399919|Intermittent Claudication due to Peripheral Artery Disease|intermittent claudication due to peripheral artery disease
5728658|NCT00399893|Childhood obesity|childhood obesity
5686171|NCT00553189|Early Trial|early trial
5686172|NCT00553189|DNA Damage Repair|dna damage repair
5686173|NCT00553189|Topotecan|topotecan
5686174|NCT00553189|Cancer|cancer
5686175|NCT00553189|Solid Tumor|solid tumor
5686176|NCT00553189|Lymphoma|lymphoma
5728659|NCT00399893|Prader-Willi Syndrome|prader-willi syndrome
5728660|NCT00399893|Octreotide|octreotide
5728661|NCT00399893|Ghrelin|ghrelin
5728662|NCT00399893|Weight loss|weight loss
5728663|NCT00399893|Body composition|body composition
5728664|NCT00399893|Energy expenditure|energy expenditure
5728665|NCT00399880|Clinical Trial|clinical trial
5728666|NCT00399880|Behavioral/Social|behavioral/social
5728667|NCT00399880|Cardiovascular Disease|cardiovascular disease
5728668|NCT00399880|Risk Factors/Analysis|risk factors/analysis
5728669|NCT00399867|multiple myeloma|multiple myeloma
5728670|NCT00399867|refractory|refractory
5728671|NCT00399867|cell adhesion mediated drug resistance|cell adhesion mediated drug resistance
5728672|NCT00399841|Pain|pain
5728673|NCT00399841|Chronic Pain|chronic pain
5728674|NCT00399841|Neurostimulation|neurostimulation
5728675|NCT00399815|Chronic viral hepatitis C|chronic viral hepatitis c
5728676|NCT00399815|HCV RNA|hcv rna
5728677|NCT00399815|Fibroscan|fibroscan
5728678|NCT00399815|Fibrotest|fibrotest
5728679|NCT00399815|hepatic elastography by MRI|hepatic elastography by mri
5728680|NCT00399789|Non-Small-Cell Lung|non-small-cell lung
5728681|NCT00399789|Perifosine|perifosine
5728682|NCT00399776|bone mineral|bone mineral
5728683|NCT00399776|antipsychotic therapy|antipsychotic therapy
5728684|NCT00399776|bone mineral accrual|bone mineral accrual
5728685|NCT00399776|bone mineral content|bone mineral content
5728686|NCT00399763|Adolescent|adolescent
5728687|NCT00399763|ADHD|adhd
5728688|NCT00399763|SUD|sud
5728689|NCT00399737|ACE activity|ace activity
5728690|NCT00399737|Fermented milk peptides|fermented milk peptides
5728691|NCT00399737|Healthy male volunteers|healthy male volunteers
5728692|NCT00399698|Severe conduct problems|severe conduct problems
5728693|NCT00399698|Risperidone|risperidone
5728694|NCT00399698|Risperdal|risperdal
5728696|NCT00399672|HCV|hcv
5728697|NCT00399672|injection drug users|injection drug users
5728698|NCT00399672|ribavirin|ribavirin
5728699|NCT00399672|pegylated interferon|pegylated interferon
5728700|NCT00399672|illicit drug users|illicit drug users
5728701|NCT00399659|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5728702|NCT00399633|VIP|vip
5728703|NCT00399633|PACAP|pacap
5728704|NCT00399633|CGRP|cgrp
5728705|NCT00399633|Prostanoids|prostanoids
5728706|NCT00399620|Periodontitis|periodontitis
5728707|NCT00399620|Diabetes|diabetes
5728708|NCT00399620|Gingival crevicular fluid|gingival crevicular fluid
5728709|NCT00399620|GCF|gcf
5728711|NCT00399620|Chromogranin|chromogranin
5728712|NCT00399620|Electrophorèse|electrophorèse
5728713|NCT00399620|Western Blot|western blot
5728714|NCT00399620|RT-HPLC|rt-hplc
5728715|NCT00399607|colonic neoplasms|colonic neoplasms
5728716|NCT00399607|colorectal adenoma|colorectal adenoma
5728717|NCT00399607|calcium|calcium
5728718|NCT00399607|vitamin D|vitamin d
5728719|NCT00399594|Mechanical dyssynchrony|mechanical dyssynchrony
5728720|NCT00399594|Biventricular pacing|biventricular pacing
5728721|NCT00399594|Cardiac resynchronization therapy|cardiac resynchronization therapy
5728722|NCT00399581|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5728723|NCT00399581|Acute Lung Injury|acute lung injury
5728724|NCT00399581|Mechanical Ventilation|mechanical ventilation
5728725|NCT00399581|Lung|lung
5728726|NCT00399568|Pain|pain
5728727|NCT00399568|Gynecologic|gynecologic
5728728|NCT00399568|IV Acetaminophen|iv acetaminophen
5728729|NCT00399568|Postoperative|postoperative
5728730|NCT00399568|Analgesic|analgesic
5728731|NCT00399555|Single Ventricle|single ventricle
5728732|NCT00399555|Hypoplastic Left Heart|hypoplastic left heart
5728733|NCT00399555|Developmental|developmental
5728734|NCT00399542|Irritable Bowel Syndrome With Constipation|irritable bowel syndrome with constipation
5728735|NCT00399529|Stage IV HER-2/neu overexpressing breast cancer|stage iv her-2/neu overexpressing breast cancer
5728737|NCT00399516|Neurostimulation|neurostimulation
5728738|NCT00399516|Back pain|back pain
5728739|NCT00399516|Chronic Pain|chronic pain
5728740|NCT00399503|Noninvasive assessment|noninvasive assessment
5728741|NCT00399503|Combined parameter|combined parameter
5728742|NCT00399503|Holter|holter
5728743|NCT00399490|Monoclonal antibody|monoclonal antibody
5728744|NCT00399464|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5728745|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists
5728746|NCT00399464|alfuzosin|alfuzosin
5728747|NCT00399451|Sleep Apnea,Obstructive|sleep apnea,obstructive
5728748|NCT00399451|apnea-hypopnea index (AHI)|apnea-hypopnea index (ahi)
5728749|NCT00399451|polidocanol|polidocanol
5728750|NCT00399451|sclerotherapy|sclerotherapy
5728751|NCT00399451|pharynges|pharynges
5686177|NCT00553176|Infliximab|infliximab
5728752|NCT00399438|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
5728753|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5728754|NCT00399425|Bemiparin|bemiparin
5728755|NCT00399425|Foot Ulcer, Diabetic|foot ulcer, diabetic
5728756|NCT00399425|Diabetic Angiopathies|diabetic angiopathies
5728757|NCT00399425|Primary Health Care|primary health care
5728758|NCT00399412|S-ICD|s-icd
5728759|NCT00399412|ICD|icd
5728760|NCT00399412|ECG signals|ecg signals
5728761|NCT00399412|Resting|resting
5728762|NCT00399399|Churg-Strauss|churg-strauss
5728763|NCT00399399|Vasculitis|vasculitis
5728764|NCT00399399|Therapy|therapy
5728765|NCT00399399|Cyclophosphamide|cyclophosphamide
5728766|NCT00399399|Azathioprine|azathioprine
5728767|NCT00399386|S ICD|s icd
5728768|NCT00399386|ICD|icd
5728769|NCT00399386|Ablation|ablation
5728770|NCT00399386|EP study|ep study
5728771|NCT00399386|Paediatric|paediatric
5728772|NCT00399386|ECG|ecg
5728773|NCT00399373|disease management|disease management
5728774|NCT00399373|substance abuse|substance abuse
5728775|NCT00399360|HIV|hiv
5728776|NCT00399360|Metabolic Syndrome|metabolic syndrome
5728777|NCT00399360|Lifestyle Modification|lifestyle modification
5728778|NCT00399360|Metformin|metformin
5728779|NCT00399360|Treatment Experienced|treatment experienced
5728780|NCT00399347|Diabetes Mellitus, prevalence , Ethiopians Jews, Israel|diabetes mellitus, prevalence , ethiopians jews, israel
5728781|NCT00399334|Schizophrenia|schizophrenia
5728782|NCT00399334|Schizoaffective|schizoaffective
5728783|NCT00399334|relapse|relapse
5728784|NCT00399334|risk factors|risk factors
5728785|NCT00399334|Observational study|observational study
5728786|NCT00399334|Antipsychotic medication|antipsychotic medication
5728787|NCT00399321|Post menopause women receiving adjuvant care|post menopause women receiving adjuvant care
5728788|NCT00399308|wound|wound
5728789|NCT00399308|leg|leg
5728790|NCT00399308|venous|venous
5728791|NCT00399308|chronic|chronic
5728792|NCT00399308|wound healing|wound healing
5728793|NCT00399295|Analgesia|analgesia
5728794|NCT00399282|Rheumatoid arthritis|rheumatoid arthritis
5728795|NCT00399282|Health related quality of life|health related quality of life
5728796|NCT00399282|Omega 3 fatty acids|omega 3 fatty acids
5728797|NCT00399282|Vitamin E|vitamin e
5728798|NCT00399269|Anemia|anemia
5728799|NCT00399256|contrast-induced nephropathy|contrast-induced nephropathy
5728800|NCT00399256|Acetylcysteine|acetylcysteine
5728801|NCT00399256|Zinc|zinc
5728802|NCT00399256|Cystatin C|cystatin c
5728803|NCT00399256|Creatinine|creatinine
5728804|NCT00399243|cluster headache|cluster headache
5728805|NCT00399243|sumatriptan|sumatriptan
5728806|NCT00399217|subcutaneous ICD|subcutaneous icd
5728807|NCT00399217|ICD|icd
5728808|NCT00399217|DFT|dft
5728809|NCT00399217|Pacing threshold|pacing threshold
5728810|NCT00399217|Polarity|polarity
5728811|NCT00399191|anemia|anemia
5728812|NCT00399191|iron deficiency anemia|iron deficiency anemia
5728814|NCT00399191|absorption|absorption
5728815|NCT00399191|iron absorption|iron absorption
5728816|NCT00399191|iron uptake|iron uptake
5728817|NCT00399178|Osteoarthritis|osteoarthritis
5728818|NCT00399178|Norspan versus Tramadol|norspan versus tramadol
5728819|NCT00399178|Randomised|randomised
5728820|NCT00399178|Efficacy and safety|efficacy and safety
5728821|NCT00399178|OA pain of the hip and/or knee|oa pain of the hip and/or knee
5728822|NCT00399165|Oral Contraception for Men|oral contraception for men
5728823|NCT00399165|Contraceptive agent|contraceptive agent
5728824|NCT00399152|Perifosine|perifosine
5728825|NCT00399152|Sunitinib Malate|sunitinib malate
5728826|NCT00399152|Renal cancer|renal cancer
5728827|NCT00399152|GIST|gist
5728828|NCT00399152|advanced cancers|advanced cancers
5728829|NCT00399074|Sickle Cell anemia|sickle cell anemia
5728830|NCT00399074|Malaria|malaria
5728831|NCT00399074|Presumptive treatment|presumptive treatment
5728832|NCT00399074|Sulfadoxine- pyrimethamine|sulfadoxine- pyrimethamine
5728833|NCT00399074|Children|children
5728834|NCT00399074|Uganda|uganda
5728835|NCT00399048|Pain|pain
5728836|NCT00399048|Osteoarthritis|osteoarthritis
5728837|NCT00399048|knee Osteoarthritis|knee osteoarthritis
5728838|NCT00399048|hip Osteoarthritis .|hip osteoarthritis .
5728839|NCT00399035|Colorectal Cancer|colorectal cancer
5728840|NCT00399035|Cediranib|cediranib
5728842|NCT00399009|Circular stapling devices|circular stapling devices
5728843|NCT00399009|anastomotic leak|anastomotic leak
5728844|NCT00399009|anastomotic dehiscence|anastomotic dehiscence
5728845|NCT00399009|rectal cancer|rectal cancer
5728846|NCT00398996|antiretroviral therapy|antiretroviral therapy
5728847|NCT00398996|HIV|hiv
5728848|NCT00398996|Opportunistic infections|opportunistic infections
5728849|NCT00398996|CD4|cd4
5728850|NCT00398996|Viral load|viral load
5728851|NCT00398996|TB/HIV co infection|tb/hiv co infection
5728852|NCT00398996|Treatment Naive|treatment naive
5728853|NCT00398983|Acute Myelogenous Leukemia|acute myelogenous leukemia
5728854|NCT00398983|AML|aml
5728855|NCT00398983|Remission|remission
5728856|NCT00398983|Decitabine|decitabine
5686178|NCT00553176|Immune disorder|immune disorder
5728857|NCT00398983|Maintenance Therapy|maintenance therapy
5728858|NCT00398970|Endobronchial ultrasonography|endobronchial ultrasonography
5728859|NCT00398970|Fluoroscopy|fluoroscopy
5728860|NCT00398970|Guide sheath|guide sheath
5728861|NCT00398970|Peripheral pulmonary lesion|peripheral pulmonary lesion
5728862|NCT00398970|Transbronchial biopsy|transbronchial biopsy
5728863|NCT00398957|Analgesia|analgesia
5728864|NCT00398944|Guideline based decision support system, Hypertension, Diabetes|guideline based decision support system, hypertension, diabetes
5728865|NCT00398905|Prevention of venous thromboembolism|prevention of venous thromboembolism
5728866|NCT00398892|Type 2 diabetes mellitus|type 2 diabetes mellitus
5728867|NCT00398892|Glycaemic control|glycaemic control
5728868|NCT00398892|Lipoic acid|lipoic acid
5728869|NCT00398892|Diabetic nephropathy|diabetic nephropathy
5728870|NCT00398879|Capecitabine|capecitabine
5728871|NCT00398866|Hyaluronan|hyaluronan
5728872|NCT00398866|Carpometacarpal|carpometacarpal
5680919|NCT00575653|Vaccines, Conjugate|vaccines, conjugate
5728873|NCT00398866|Outcomes|outcomes
5728874|NCT00398866|Carpometacarpal Joints|carpometacarpal joints
5728875|NCT00398853|insulin|insulin
5728876|NCT00398853|glucose|glucose
5728877|NCT00398853|chromium|chromium
5728878|NCT00398840|Cancer|cancer
5728879|NCT00398840|Solid Tumors|solid tumors
5728880|NCT00398840|advanced solid tumors|advanced solid tumors
5728881|NCT00398827|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
5728882|NCT00398827|Observer's Assessment of Alertness Scale (OAA/S)|observer's assessment of alertness scale (oaa/s)
5728883|NCT00398827|Aldrete Scoring System|aldrete scoring system
5728884|NCT00398827|Surgery or procedure using monitored care anesthesia|surgery or procedure using monitored care anesthesia
5728885|NCT00398827|Surgery or procedure at least 30 minutes in duration|surgery or procedure at least 30 minutes in duration
5728886|NCT00398814|Perifosine|perifosine
5728887|NCT00398814|Sorafenib|sorafenib
5728888|NCT00398814|Renal cancer|renal cancer
5728889|NCT00398814|Hepatocellular cancer|hepatocellular cancer
5728890|NCT00398814|other advanced solid tumors|other advanced solid tumors
5728891|NCT00398801|gastroparesis|gastroparesis
5728892|NCT00398788|Pain|pain
5728893|NCT00398775|procalcitonin guided antibiotic discontinuation|procalcitonin guided antibiotic discontinuation
5728894|NCT00398775|fever of unknown origin|fever of unknown origin
5728895|NCT00398749|Anemia|anemia
5728896|NCT00398749|Neoplasms|neoplasms
5728897|NCT00398749|Antineoplastic agents|antineoplastic agents
5728898|NCT00398749|Chemotherapy|chemotherapy
5728899|NCT00398749|Efficacy|efficacy
5728900|NCT00398749|Epoetin alfa|epoetin alfa
5728901|NCT00398736|Presence of severe sepsis and septic shock, mechanical ventilation|presence of severe sepsis and septic shock, mechanical ventilation
5728902|NCT00398723|Narrowband UBV Phototherapy|narrowband ubv phototherapy
5728903|NCT00398723|Skin biopsies|skin biopsies
5728904|NCT00398710|Waldenström's Macroglobulinemia|waldenström's macroglobulinemia
5728905|NCT00398710|Perifosine|perifosine
5728906|NCT00398697|perifosine|perifosine
5728907|NCT00398697|gemcitabine|gemcitabine
5728908|NCT00398684|Thailand|thailand
5728909|NCT00398684|Developing countries|developing countries
5728910|NCT00398684|prophylaxis|prophylaxis
5728911|NCT00398684|mother to child transmission|mother to child transmission
5728912|NCT00398684|HIV-1|hiv-1
5728913|NCT00398684|HIV-1 infection|hiv-1 infection
5728914|NCT00398684|HIV Seronegativity|hiv seronegativity
5728915|NCT00398671|primary successful cardio-pulmonary resuscitation|primary successful cardio-pulmonary resuscitation
5728916|NCT00398671|pre-hospital setting|pre-hospital setting
5728917|NCT00398658|Endophthalmitis|endophthalmitis
5728918|NCT00398658|Post-traumatic Endophthalmitis|post-traumatic endophthalmitis
5728919|NCT00398658|Bacterial Endophthalmitis|bacterial endophthalmitis
5728920|NCT00398658|Prophylaxis of Endophthalmitis|prophylaxis of endophthalmitis
5728921|NCT00398658|Intra Ocular Injection of antibiotics|intra ocular injection of antibiotics
5728922|NCT00398645|GW685698X|gw685698x
5728923|NCT00398645|Adults|adults
5728924|NCT00398645|Pharmacokinetics|pharmacokinetics
5728925|NCT00398645|Pharmacogenetics|pharmacogenetics
5728926|NCT00398645|Asthma|asthma
5728927|NCT00398645|Adolescents|adolescents
5728928|NCT00398593|Adherence with therapy|adherence with therapy
5728929|NCT00398593|Adherence enhancing intervention|adherence enhancing intervention
5728930|NCT00398593|Nonadherence|nonadherence
5728931|NCT00398593|Ulcerative colitis|ulcerative colitis
5728933|NCT00398580|Testosterone|testosterone
5728934|NCT00398580|Hypogonadism|hypogonadism
5728935|NCT00398580|Dutasteride|dutasteride
5728936|NCT00398580|Androgen deficiency|androgen deficiency
5728937|NCT00398567|HKI-272|hki-272
5728938|NCT00398567|neratinib|neratinib
5728939|NCT00398567|trastuzumab|trastuzumab
5728940|NCT00398567|breast cancer|breast cancer
5728941|NCT00398567|Nerlynx|nerlynx
5728942|NCT00398567|PB-272|pb-272
5728943|NCT00398567|HER2|her2
5728944|NCT00398554|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5728945|NCT00398554|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5728946|NCT00398554|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5727878|NCT00402779|Placebo|placebo
5728947|NCT00398554|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5728948|NCT00398554|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5728949|NCT00398554|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5728950|NCT00398554|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5728951|NCT00398528|Multiple Sclerosis|multiple sclerosis
5728952|NCT00398528|Disease Modifying Therapy|disease modifying therapy
5728953|NCT00398489|stage IIIA breast cancer|stage iiia breast cancer
5728954|NCT00398489|stage IIIB breast cancer|stage iiib breast cancer
5728955|NCT00398489|stage IIIC breast cancer|stage iiic breast cancer
5728956|NCT00398489|stage II breast cancer|stage ii breast cancer
5728957|NCT00398489|inflammatory breast cancer|inflammatory breast cancer
5728958|NCT00398476|taste|taste
5728959|NCT00398476|questionnaire|questionnaire
5728960|NCT00398476|preference|preference
5728961|NCT00398476|attributes|attributes
5728962|NCT00398476|odor|odor
5728964|NCT00398476|scent|scent
5728965|NCT00398463|tirofiban|tirofiban
5728966|NCT00398463|aspirin resistance|aspirin resistance
5728967|NCT00398463|clopidogrel resistance|clopidogrel resistance
5728968|NCT00398450|recurrent melanoma|recurrent melanoma
5728969|NCT00398450|stage IV melanoma|stage iv melanoma
5728970|NCT00398437|tumors metastatic to brain|tumors metastatic to brain
5728971|NCT00398437|stage IV breast cancer|stage iv breast cancer
5728972|NCT00398424|Impaired Hepatic Function|impaired hepatic function
5728973|NCT00398411|prophylaxis|prophylaxis
5728974|NCT00398411|bacteremia|bacteremia
5728975|NCT00398411|moxifloxacin|moxifloxacin
5728976|NCT00398411|stem cell transplantation|stem cell transplantation
5728977|NCT00398411|Hodgkin disease|hodgkin disease
5728978|NCT00398411|non-Hodgkin lymphoma|non-hodgkin lymphoma
5728979|NCT00398411|multiple myeloma|multiple myeloma
5728980|NCT00398411|solid tumor|solid tumor
5728981|NCT00398411|autologous stem cell transplantation|autologous stem cell transplantation
5728982|NCT00398398|gastric cancer|gastric cancer
5728983|NCT00398398|chemotherapy|chemotherapy
5728984|NCT00398398|cetuximab|cetuximab
5728985|NCT00398398|capecitabine|capecitabine
5728986|NCT00398398|oxaliplatin|oxaliplatin
5728987|NCT00398385|squamous cell lung cancer|squamous cell lung cancer
5728988|NCT00398385|adenocarcinoma of the lung|adenocarcinoma of the lung
5728989|NCT00398385|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5728990|NCT00398385|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5728992|NCT00398385|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5728993|NCT00398385|stage IIA non-small cell lung cancer|stage iia non-small cell lung cancer
5728994|NCT00398385|stage IIB non-small cell lung cancer|stage iib non-small cell lung cancer
5728995|NCT00398359|Obesity|obesity
5728996|NCT00398359|Overweight|overweight
5728997|NCT00398359|Children|children
5728998|NCT00398359|Behavioral|behavioral
5728999|NCT00398359|Motivational|motivational
5729000|NCT00398359|Family|family
5729001|NCT00398359|Primary care|primary care
5729002|NCT00398333|Colorectal Neoplasms|colorectal neoplasms
5729003|NCT00398333|Eicosapentaenoic Acid|eicosapentaenoic acid
5729004|NCT00398333|Quality of Life|quality of life
5729006|NCT00398307|Renal Impairment|renal impairment
5729007|NCT00398281|prostate cancer|prostate cancer
5729008|NCT00398268|Fracture|fracture
5729009|NCT00398268|Forearm|forearm
5729010|NCT00398268|Distal|distal
5729011|NCT00398268|Child|child
5729012|NCT00398268|Treatment|treatment
5729013|NCT00398255|arthritis|arthritis
5729014|NCT00398255|self management|self management
5729015|NCT00398255|patient education|patient education
5729016|NCT00398242|fracture|fracture
5729017|NCT00398242|forearm|forearm
5729018|NCT00398242|midshaft|midshaft
5729019|NCT00398242|child|child
5729020|NCT00398242|treatment|treatment
5729021|NCT00398229|In-Vitro Fertilization|in-vitro fertilization
5729022|NCT00398229|human chorionic gonadotropin|human chorionic gonadotropin
5729023|NCT00398229|frozen-thawed embryo transfer|frozen-thawed embryo transfer
5729024|NCT00398229|implantation rate|implantation rate
5729025|NCT00398216|Anti-coagulant|anti-coagulant
5729026|NCT00398216|hip replacement|hip replacement
5729027|NCT00398216|hip replacement surgery|hip replacement surgery
5729028|NCT00398216|unilateral hip replacement surgery|unilateral hip replacement surgery
5729029|NCT00398216|DeepVein Thrombosis|deepvein thrombosis
5729030|NCT00398216|Venous Thromboembolism|venous thromboembolism
5729031|NCT00398216|pulmonary embolism|pulmonary embolism
5729032|NCT00398216|Prevention of Blood Clots|prevention of blood clots
5729033|NCT00398203|NaviAid™ BGE Device|naviaid™ bge device
5729034|NCT00398203|Small Intestine|small intestine
5729035|NCT00398203|Intestinal Diseases|intestinal diseases
5729036|NCT00398190|Smoking|smoking
5729037|NCT00398190|Tobacco use disorder|tobacco use disorder
5729038|NCT00398138|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5729039|NCT00398138|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5729040|NCT00398138|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5686179|NCT00553176|Remicade|remicade
5729041|NCT00398138|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5729042|NCT00398138|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5729043|NCT00398138|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5729310|NCT00397033|placebo|placebo
5729044|NCT00398138|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5729045|NCT00398138|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5729046|NCT00398138|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5729047|NCT00398138|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5729048|NCT00398138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5729049|NCT00398138|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5729050|NCT00398138|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5729051|NCT00398138|advanced malignant mesothelioma|advanced malignant mesothelioma
5729052|NCT00398138|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5729053|NCT00398138|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5729054|NCT00398125|GSK364735|gsk364735
5729055|NCT00398125|HIV-1|hiv-1
5729056|NCT00398125|integrase inhibitor|integrase inhibitor
5729057|NCT00398086|Metastatic Pancreatic Cancer, Abraxane, Gemcitabine|metastatic pancreatic cancer, abraxane, gemcitabine
5729058|NCT00398073|stage II melanoma|stage ii melanoma
5729059|NCT00398073|stage III melanoma|stage iii melanoma
5729060|NCT00398073|stage IV melanoma|stage iv melanoma
5729061|NCT00398073|recurrent melanoma|recurrent melanoma
5729062|NCT00398073|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5729063|NCT00398073|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5729064|NCT00398073|recurrent intraocular melanoma|recurrent intraocular melanoma
5729065|NCT00398073|metastatic intraocular melanoma|metastatic intraocular melanoma
5729066|NCT00398060|life-style counseling|life-style counseling
5729067|NCT00398060|type 2 diabetes|type 2 diabetes
5729068|NCT00398060|prediabetes|prediabetes
5729069|NCT00398060|physical activity|physical activity
5729070|NCT00398060|diet|diet
5729071|NCT00398060|cognitive-behavioral|cognitive-behavioral
5729072|NCT00398047|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5729073|NCT00398047|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5729074|NCT00398047|refractory anemia with excess blasts|refractory anemia with excess blasts
5729076|NCT00398047|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5729077|NCT00398047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5729078|NCT00398047|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5729079|NCT00398047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5729080|NCT00398034|opioids|opioids
5729081|NCT00398034|pain|pain
5729082|NCT00398034|hypogonadism|hypogonadism
5729083|NCT00398034|depression|depression
5729084|NCT00398034|fatigue|fatigue
5729085|NCT00398034|cognition|cognition
5729086|NCT00398034|libido|libido
5729087|NCT00398021|constipation|constipation
5729088|NCT00398021|bowel habits|bowel habits
5729089|NCT00398008|Buprenorphine|buprenorphine
5729090|NCT00398008|Naltrexone|naltrexone
5729091|NCT00398008|HIV risk reduction behavior|hiv risk reduction behavior
5729092|NCT00398008|Counseling|counseling
5729093|NCT00398008|HIV Seronegativity|hiv seronegativity
5729094|NCT00397995|Fracture|fracture
5729095|NCT00397995|Forearm|forearm
5729096|NCT00397995|Distal|distal
5729097|NCT00397995|Child|child
5729098|NCT00397995|Treatment|treatment
5729099|NCT00397969|colon cancer|colon cancer
5729100|NCT00397969|rectal cancer|rectal cancer
5729101|NCT00397969|precancerous condition|precancerous condition
5729102|NCT00397943|Tuberculosis|tuberculosis
5729103|NCT00397930|cancer-related sleep disturbance|cancer-related sleep disturbance
5729104|NCT00397930|fatigue|fatigue
5729105|NCT00397930|sleep disorders|sleep disorders
5729106|NCT00397904|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5729107|NCT00397904|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5729108|NCT00397904|recurrent esophageal cancer|recurrent esophageal cancer
5729109|NCT00397904|recurrent gastric cancer|recurrent gastric cancer
5729110|NCT00397904|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5729111|NCT00397904|stage IV esophageal cancer|stage iv esophageal cancer
5729112|NCT00397904|stage IV gastric cancer|stage iv gastric cancer
5729113|NCT00397865|Obesity|obesity
5729114|NCT00397865|Overweight|overweight
5729115|NCT00397852|Fracture|fracture
5729116|NCT00397852|Forearm|forearm
5729120|NCT00397839|male osteoporosis|male osteoporosis
5729121|NCT00397839|osteoporosis|osteoporosis
5729122|NCT00397839|bisphonates|bisphonates
5729123|NCT00397839|bone|bone
5729124|NCT00397800|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5729125|NCT00397800|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5729126|NCT00397800|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5729127|NCT00397800|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5729128|NCT00397800|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5729129|NCT00397800|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5729130|NCT00397800|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5729311|NCT00397020|quetiapine|quetiapine
5729131|NCT00397800|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5729132|NCT00397774|Palliative care|palliative care
5729133|NCT00397774|Physical exercise|physical exercise
5729134|NCT00397774|Physical function|physical function
5729135|NCT00397761|inflammatory breast cancer|inflammatory breast cancer
5729136|NCT00397761|stage II breast cancer|stage ii breast cancer
5729137|NCT00397761|stage IIIA breast cancer|stage iiia breast cancer
5729138|NCT00397761|stage IIIB breast cancer|stage iiib breast cancer
5729139|NCT00397748|Phospholipase A2|phospholipase a2
5729140|NCT00397748|D2 Receptors|d2 receptors
5729141|NCT00397748|Apomorphine|apomorphine
5729142|NCT00397748|Trimethobenzamide|trimethobenzamide
5729143|NCT00397748|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5680921|NCT00575627|persistently normal ALT|persistently normal alt
5680922|NCT00575627|pNNALT|pnnalt
5680923|NCT00575627|Theraphy for Hepatitis C|theraphy for hepatitis c
5729144|NCT00397748|ADHD|adhd
5729145|NCT00397748|Healthy Volunteer|healthy volunteer
5729146|NCT00397748|HV|hv
5729147|NCT00397735|pregnancy|pregnancy
5729148|NCT00397735|chorioamnionitis|chorioamnionitis
5729149|NCT00397735|preterm labor|preterm labor
5729150|NCT00397735|preterm premature rupture of the membranes|preterm premature rupture of the membranes
5729151|NCT00397735|Intra-amniotic infection|intra-amniotic infection
5729152|NCT00397735|Intra-amniotic inflammation|intra-amniotic inflammation
5729153|NCT00397722|safety|safety
5729154|NCT00397722|outpatients with a diagnosis of Social Anxiety disorder (SocAD).|outpatients with a diagnosis of social anxiety disorder (socad).
5729155|NCT00397722|effectiveness|effectiveness
5729156|NCT00397709|Latent tuberculosis infection.|latent tuberculosis infection.
5729157|NCT00397709|Isoniazid.|isoniazid.
5729158|NCT00397709|Rifampin.|rifampin.
5729159|NCT00397709|Clinical trial.|clinical trial.
5729160|NCT00397709|treatment of latent tuberculosis infection|treatment of latent tuberculosis infection
5729161|NCT00397696|Parkinson|parkinson
5729162|NCT00397696|imaging|imaging
5729163|NCT00397696|nicotinic receptors|nicotinic receptors
5729164|NCT00397657|carotid intima media thickness|carotid intima media thickness
5729166|NCT00397657|niacin|niacin
5729167|NCT00397657|coronary heart disease|coronary heart disease
5729168|NCT00397657|HDL-C|hdl-c
5729169|NCT00397657|LDL-C|ldl-c
5729170|NCT00397644|pediatrician|pediatrician
5729171|NCT00397644|well-child care visit|well-child care visit
5729172|NCT00397644|low-income children|low-income children
5729173|NCT00397644|family psychosocial problem|family psychosocial problem
5729174|NCT00397605|bipolar|bipolar
5729175|NCT00397605|therapeutic potential|therapeutic potential
5729176|NCT00397605|neurocognitive performance|neurocognitive performance
5729177|NCT00397605|cannabinoids|cannabinoids
5729178|NCT00397592|Growth Hormone|growth hormone
5729179|NCT00397592|Cardiovascular System|cardiovascular system
5729180|NCT00397592|Endothelial Progenitor Cells|endothelial progenitor cells
5729181|NCT00397579|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5729182|NCT00397579|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5729183|NCT00397579|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5729184|NCT00397579|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5729185|NCT00397579|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5729186|NCT00397579|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5729187|NCT00397579|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5729188|NCT00397579|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5729189|NCT00397579|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5729190|NCT00397579|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5729191|NCT00397579|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5729192|NCT00397579|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm
5729193|NCT00397579|plasmacytoid dendritic cell leukemia|plasmacytoid dendritic cell leukemia
5729195|NCT00397566|HIV|hiv
5729196|NCT00397566|Treatment Experienced|treatment experienced
5729197|NCT00397540|HBV DNA|hbv dna
5729198|NCT00397540|HCC|hcc
5729199|NCT00397540|recurrence|recurrence
5729200|NCT00397540|PEIT|peit
5729201|NCT00397540|RFTA|rfta
5729202|NCT00397514|Biventricular pacing|biventricular pacing
5729203|NCT00397514|Congenital heart disease|congenital heart disease
5729204|NCT00397514|Tissue Doppler echocardiography|tissue doppler echocardiography
5729205|NCT00397501|cognitive/functional effects|cognitive/functional effects
5729206|NCT00397501|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5729207|NCT00397501|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5729208|NCT00397501|recurrent breast cancer|recurrent breast cancer
5729209|NCT00397501|stage IV breast cancer|stage iv breast cancer
5686180|NCT00553176|Registry|registry
5686181|NCT00553176|Crohn's Disease|crohn's disease
5729210|NCT00397501|adult tumors metastatic to brain|adult tumors metastatic to brain
5729211|NCT00397488|recurrent bladder cancer|recurrent bladder cancer
5729212|NCT00397488|stage IV bladder cancer|stage iv bladder cancer
5729213|NCT00397488|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5729214|NCT00397488|anterior urethral cancer|anterior urethral cancer
5729215|NCT00397488|posterior urethral cancer|posterior urethral cancer
5729312|NCT00397020|divalproex|divalproex
5729219|NCT00397488|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5729222|NCT00397462|Calf muscle pump|calf muscle pump
5729223|NCT00397462|Venous insufficiency|venous insufficiency
5729225|NCT00397462|Soleus muscle|soleus muscle
5863967|NCT00001149|Anticonvulsants|anticonvulsants
5729227|NCT00397449|Malaria, malaria vaccine, randomised, safety, immunogenicity|malaria, malaria vaccine, randomised, safety, immunogenicity
5729228|NCT00397423|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5729229|NCT00397423|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5729230|NCT00397423|Randomized Control Trial Study|randomized control trial study
5729231|NCT00397410|hip protectors|hip protectors
5729232|NCT00397410|uptake and adherence|uptake and adherence
5729233|NCT00397410|Nursing home residents|nursing home residents
5729234|NCT00397410|efficacy|efficacy
5729235|NCT00397410|prevention|prevention
5729236|NCT00397397|Urinary Calculi|urinary calculi
5729237|NCT00397397|Rowatinex|rowatinex
5729238|NCT00397397|Alfuzosin|alfuzosin
5729239|NCT00397397|Drug Therapy|drug therapy
5729240|NCT00397358|Peritoneal Dialysis|peritoneal dialysis
5729241|NCT00397358|Hypertriglyceridemia|hypertriglyceridemia
5729242|NCT00397358|Extraneal(7.5% icodextrin)Peritoneal Dialysis Solution|extraneal(7.5% icodextrin)peritoneal dialysis solution
5729243|NCT00397345|Renal|renal
5729244|NCT00397345|TroVax|trovax
5729245|NCT00397345|survival|survival
5729246|NCT00397345|metastatic|metastatic
5729247|NCT00397345|Kidney|kidney
5729248|NCT00397345|cancer|cancer
5729249|NCT00397345|immunotherapy|immunotherapy
5729250|NCT00397345|Locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.|locally advanced or metastatic, measurable, histologically proven clear cell renal carcinoma.
5729251|NCT00397332|GVHD|gvhd
5729252|NCT00397319|Growth Hormone|growth hormone
5729253|NCT00397319|Cardiovascular System|cardiovascular system
5729254|NCT00397293|AT101|at101
5729255|NCT00397293|AT-101|at-101
5729256|NCT00397293|cancer|cancer
5729257|NCT00397293|lung|lung
5729258|NCT00397293|small-cell|small-cell
5729259|NCT00397293|topotecan|topotecan
5729262|NCT00397267|Dyspnea|dyspnea
5729263|NCT00397267|Cough|cough
5729264|NCT00397254|Migraine|migraine
5729265|NCT00397254|rizatriptan|rizatriptan
5729266|NCT00397228|Parkinson|parkinson
5729267|NCT00397228|imaging|imaging
5729268|NCT00397228|dopamine transporter|dopamine transporter
5729269|NCT00397215|H5N1|h5n1
5729270|NCT00397215|influenza|influenza
5729271|NCT00397215|vaccine|vaccine
5729272|NCT00397202|Menstruation|menstruation
5729273|NCT00397189|Primary insomnia as defined by DSM IV criteria|primary insomnia as defined by dsm iv criteria
5729274|NCT00397163|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5729275|NCT00397163|Remote ischemic preconditioning|remote ischemic preconditioning
5729277|NCT00397150|Infant Nutrition [G06.696.259.750]|infant nutrition [g06.696.259.750]
5729278|NCT00397150|Infant Care [N02.421.088.120] +|infant care [n02.421.088.120] +
5729279|NCT00397150|Diarrhea, Infantile [C23.888.821.214.500]|diarrhea, infantile [c23.888.821.214.500]
5729280|NCT00397150|Child Health Services [N02.421.143.130] +|child health services [n02.421.143.130] +
5729281|NCT00397150|Counseling [N02.421.143.303]|counseling [n02.421.143.303]
5729282|NCT00397150|Growth [G07.574.249] +|growth [g07.574.249] +
5729283|NCT00397150|Micronutrients [D11.430]|micronutrients [d11.430]
5729284|NCT00397150|Breast Feeding [G06.696.259.750.500]|breast feeding [g06.696.259.750.500]
5729285|NCT00397137|Symptomatic haemorrhoids|symptomatic haemorrhoids
5729286|NCT00397137|haemorrhoidectomy|haemorrhoidectomy
5729295|NCT00397098|Anxiety disorders, Relapse prevention|anxiety disorders, relapse prevention
5729296|NCT00397072|Glioblastoma recurrent,temozolomide, epothilone|glioblastoma recurrent,temozolomide, epothilone
5729297|NCT00397059|Escitalopram|escitalopram
5729298|NCT00397059|Pharmacokinetics|pharmacokinetics
5729299|NCT00397059|Pharmacodynamics|pharmacodynamics
5729300|NCT00397059|CYP2C19|cyp2c19
5729301|NCT00397059|Pupillometry|pupillometry
5729302|NCT00397059|healthy volunteers|healthy volunteers
5729303|NCT00397046|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5729304|NCT00397046|HKI-272|hki-272
5729305|NCT00397046|Neratinib|neratinib
5729306|NCT00397046|Nerlynx|nerlynx
5729307|NCT00397033|Schizoaffective Disorder|schizoaffective disorder
5729308|NCT00397033|antipsychotic|antipsychotic
5729309|NCT00397033|paliperidone|paliperidone
5729313|NCT00397007|tinnitus|tinnitus
5729314|NCT00397007|biofeedback|biofeedback
5729315|NCT00397007|psychophysiological reactivity|psychophysiological reactivity
5728281|NCT00401388|Chondrosarcomas|chondrosarcomas
5729316|NCT00397007|intervention|intervention
5729317|NCT00396994|biomechanics|biomechanics
5729318|NCT00396994|osteogenesis|osteogenesis
5729319|NCT00396994|osteoporosis|osteoporosis
5729320|NCT00396994|bone regeneration|bone regeneration
5729321|NCT00396981|Intracranial saccular aneurysms|intracranial saccular aneurysms
5729322|NCT00396981|Endovascular coiling therapy|endovascular coiling therapy
5729323|NCT00396981|Retreatment|retreatment
5729324|NCT00396981|Raymond scale|raymond scale
5729325|NCT00396981|Matrix|matrix
5729326|NCT00396981|GDC|gdc
5729327|NCT00396981|Guglielmi Detachable Coil|guglielmi detachable coil
5729328|NCT00396968|AMD3100|amd3100
5729329|NCT00396968|Acute Myelogenous Leukemai|acute myelogenous leukemai
5729330|NCT00396968|Myelodysplastic Syndromes|myelodysplastic syndromes
5729331|NCT00396968|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5729332|NCT00396955|osteoarthritis|osteoarthritis
5729333|NCT00396955|arthritis|arthritis
5729334|NCT00396955|pain|pain
5729335|NCT00396942|Electroencephalogram (EEG)|electroencephalogram (eeg)
5729336|NCT00396942|Nerve Conduction Study|nerve conduction study
5729337|NCT00396942|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5729338|NCT00396942|Motor Evoked Potential|motor evoked potential
5729339|NCT00396942|Parkinson Disease|parkinson disease
5729340|NCT00396942|PD|pd
5729341|NCT00396942|Healthy Volunteer|healthy volunteer
5729342|NCT00396942|HV|hv
5729343|NCT00396929|Paclitaxel|paclitaxel
5729344|NCT00396929|Restenosis|restenosis
5729345|NCT00396929|Stent|stent
5729346|NCT00396929|Intracoronary Dosis|intracoronary dosis
5729347|NCT00396929|Paclitaxel-eluting Stent|paclitaxel-eluting stent
5729348|NCT00396916|cancer patients|cancer patients
5729349|NCT00396903|Anaesthetic techniques|anaesthetic techniques
5729350|NCT00396903|epidural catheters|epidural catheters
5729351|NCT00396903|paraesthesia|paraesthesia
5729352|NCT00396903|side effects.|side effects.
5729353|NCT00396890|Theta Burst Stimulation|theta burst stimulation
5729354|NCT00396890|Repetitive TMS (rTMS)|repetitive tms (rtms)
5729355|NCT00396890|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5729356|NCT00396890|Primary Motor Cortex|primary motor cortex
5729357|NCT00396890|Interhemispheric Disinhibition|interhemispheric disinhibition
5729358|NCT00396890|Healthy Volunteer|healthy volunteer
5729359|NCT00396890|HV|hv
5729360|NCT00396877|cyanotic congenital heart disease|cyanotic congenital heart disease
5729361|NCT00396877|shunt palliation|shunt palliation
5729362|NCT00396877|thrombosis|thrombosis
5729363|NCT00396877|clopidogrel|clopidogrel
5729364|NCT00396864|cutaneous lymphoma|cutaneous lymphoma
5729365|NCT00396864|marginal zone lymphoma|marginal zone lymphoma
5729366|NCT00396825|Care giving|care giving
5729367|NCT00396825|Alzheimer's Disease|alzheimer's disease
5729368|NCT00396825|Stress management|stress management
5729369|NCT00396812|Autoimmune disease|autoimmune disease
5729370|NCT00396812|Biologic response modifiers|biologic response modifiers
5729371|NCT00396812|Disease-modifying antirheumatic drugs (DMARDS)|disease-modifying antirheumatic drugs (dmards)
5729372|NCT00396812|Immune system|immune system
5729373|NCT00396812|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5729374|NCT00396812|Rituximab (anti-CD20 monoclonal antibodies)|rituximab (anti-cd20 monoclonal antibodies)
5729375|NCT00396786|Prevention of venous thromboembolism|prevention of venous thromboembolism
5724533|NCT00415649|HIV Seronegativity|hiv seronegativity
5729376|NCT00396773|electrocoagulation,pregnancy,brian waves|electrocoagulation,pregnancy,brian waves
5729378|NCT00396760|blood transfusion|blood transfusion
5729379|NCT00396760|antifibrinolytics|antifibrinolytics
5729380|NCT00396760|aprotinin|aprotinin
5729381|NCT00396760|tranexamic acid|tranexamic acid
5729382|NCT00396747|Early rheumatoid arthritis,|early rheumatoid arthritis,
5729383|NCT00396747|glucocorticoids,|glucocorticoids,
5729384|NCT00396747|pulse therapy,|pulse therapy,
5729385|NCT00396747|infliximab,|infliximab,
5729386|NCT00396747|TNF blockade|tnf blockade
5729388|NCT00396734|cocaine|cocaine
5729389|NCT00396734|methadone|methadone
5729390|NCT00396734|craving|craving
5729392|NCT00396734|FDG|fdg
5729393|NCT00396734|D2|d2
5729394|NCT00396734|Modafinil|modafinil
5729395|NCT00396734|Topiramate|topiramate
5729396|NCT00396721|Nephropathy, IGA|nephropathy, iga
5729397|NCT00396721|Pilot trial|pilot trial
5729398|NCT00396721|Sirolimus|sirolimus
5729399|NCT00396721|Rapamune|rapamune
5729400|NCT00396708|Robotics|robotics
5729401|NCT00396708|Rehabilitation|rehabilitation
5729402|NCT00396708|Arm|arm
5729403|NCT00396708|Stroke|stroke
5729404|NCT00396708|Weakness|weakness
5729405|NCT00396708|Outpatient|outpatient
5729406|NCT00396708|Chronic|chronic
5729407|NCT00396695|PTSD, traumatic memory|ptsd, traumatic memory
5729408|NCT00396682|HCC|hcc
5729409|NCT00396682|T cell|t cell
5729410|NCT00396669|Nicotine|nicotine
5729411|NCT00396669|Dopamine|dopamine
5729412|NCT00396669|Imaging|imaging
5729413|NCT00396669|Raclopride|raclopride
5729416|NCT00396656|hypertension|hypertension
5729417|NCT00396656|valsartan|valsartan
5729418|NCT00396656|atenolol|atenolol
5737846|NCT00365612|HIV|hiv
5729419|NCT00396656|hydrochlorothiazide|hydrochlorothiazide
5729420|NCT00396656|microcirculation|microcirculation
5729421|NCT00396656|arterial compliance|arterial compliance
5729422|NCT00396656|pulse wave analysis|pulse wave analysis
5729423|NCT00396643|Ultra-High Risk|ultra-high risk
5729424|NCT00396643|Psychosis|psychosis
5729425|NCT00396643|Schizophrenia|schizophrenia
5729426|NCT00396643|Omega-3 fatty acids|omega-3 fatty acids
5729427|NCT00396643|RCT|rct
5729428|NCT00396630|Transmission|transmission
5729429|NCT00396630|Gastroenteritis|gastroenteritis
5729430|NCT00396630|Shedding|shedding
5729431|NCT00396630|rotavirus|rotavirus
5729432|NCT00396630|HRV vaccine|hrv vaccine
5729433|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma,|laryngeal or pharyngo-laryngeal's carcinoma,
5729434|NCT00396617|voice prosthesis tracheooesophageal shunt,|voice prosthesis tracheooesophageal shunt,
5729435|NCT00396617|titanium beads,|titanium beads,
5729436|NCT00396617|cellular colonization|cellular colonization
5729437|NCT00396617|Laryngeal or pharyngo-laryngeal's carcinoma|laryngeal or pharyngo-laryngeal's carcinoma
5729438|NCT00396604|indacaterol|indacaterol
5729439|NCT00396604|long acting beta agonist|long acting beta agonist
5729440|NCT00396591|Ovarian cancer|ovarian cancer
5729441|NCT00396591|malignant ascites|malignant ascites
5729442|NCT00396591|angiogenesis|angiogenesis
5729443|NCT00396591|angiogenesis inhibition|angiogenesis inhibition
5729444|NCT00396591|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
5729445|NCT00396578|aerosolized antibiotics|aerosolized antibiotics
5729446|NCT00396578|ventilator associated pneumonia|ventilator associated pneumonia
5729447|NCT00396578|clinical pulmonary infection score|clinical pulmonary infection score
5729448|NCT00396578|bacterial resistance|bacterial resistance
5729449|NCT00396565|Schizophrenia|schizophrenia
5729450|NCT00396565|JNS007ER|jns007er
5729451|NCT00396565|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
5729452|NCT00396565|Paliperidone|paliperidone
5729453|NCT00396565|Extended Release Osmotic Controlled-Release Oral Delivery System (OROS) paliperidone|extended release osmotic controlled-release oral delivery system (oros) paliperidone
5729454|NCT00396552|refractory transcranial magnetic stimulation|refractory transcranial magnetic stimulation
5729455|NCT00396552|obsessive compulsive disorder|obsessive compulsive disorder
5729456|NCT00396552|randomized|randomized
5729457|NCT00396552|placebo-controlled|placebo-controlled
5729458|NCT00396552|double-blind|double-blind
5729459|NCT00396526|Nonsevere pneumonia|nonsevere pneumonia
5729460|NCT00396526|treatment|treatment
5729461|NCT00396526|underfives|underfives
5729462|NCT00396526|children|children
5729463|NCT00396526|Community|community
5729464|NCT00396526|India|india
5729465|NCT00396513|PCOS|pcos
5729466|NCT00396513|Statin|statin
5729467|NCT00396513|Metformin|metformin
5729468|NCT00396513|Testosterone|testosterone
5729469|NCT00396513|Menstrual cycle|menstrual cycle
5729470|NCT00396513|Lipids|lipids
5729471|NCT00396500|Deworming|deworming
5729472|NCT00396500|Malnutrition|malnutrition
5729473|NCT00396500|children|children
5729474|NCT00396500|Community|community
5729475|NCT00396500|India|india
5729476|NCT00396487|Metastatic colorectal cancer|metastatic colorectal cancer
5729477|NCT00396487|tailored treatment|tailored treatment
5729478|NCT00396487|genetic markers|genetic markers
5729479|NCT00396487|gene polymorphism|gene polymorphism
5798832|NCT00110890|Dialysis, End Stage Renal Disease (ESRD)|dialysis, end stage renal disease (esrd)
5729481|NCT00396474|Small for gestational age, Insulin Sensitivity Index, growth hormone treatment|small for gestational age, insulin sensitivity index, growth hormone treatment
5729482|NCT00396461|Critical Illness|critical illness
5729483|NCT00396461|Fat Emulsions, Intravenous|fat emulsions, intravenous
5729484|NCT00396461|Superinfection|superinfection
5729485|NCT00396461|Parenteral Nutrition|parenteral nutrition
5729486|NCT00396435|anaemia|anaemia
5729487|NCT00396435|renal transplantation|renal transplantation
5729488|NCT00396435|kidney failure|kidney failure
5729489|NCT00396422|psoriasis|psoriasis
5729490|NCT00396422|skin|skin
5729491|NCT00396422|auto immune|auto immune
5729492|NCT00396396|Creatinine clearance|creatinine clearance
5729493|NCT00396396|Acetylcysteine|acetylcysteine
5729494|NCT00396383|Multiple Myeloma|multiple myeloma
5729495|NCT00396383|Stem cell mobilization|stem cell mobilization
5729496|NCT00396383|apheresis|apheresis
5729497|NCT00396370|Bacillus Calmette-Guérin|bacillus calmette-guérin
5729498|NCT00396370|parent protocol|parent protocol
5729499|NCT00396370|tuberculosis|tuberculosis
5729500|NCT00396357|Type 2 diabetes|type 2 diabetes
5729501|NCT00396357|vildagliptin|vildagliptin
5729502|NCT00396357|hemoglobin A1c|hemoglobin a1c
5729503|NCT00396357|metformin|metformin
5729504|NCT00396344|Systemic sepsis|systemic sepsis
5729505|NCT00396331|Multiple Myeloma|multiple myeloma
5729506|NCT00396331|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5729507|NCT00396331|autologous transplantation|autologous transplantation
5729508|NCT00396331|AMD3100|amd3100
5729509|NCT00396331|stem cell mobilization|stem cell mobilization
5729510|NCT00396331|plerixafor|plerixafor
5729511|NCT00396318|TNKase|tnkase
5729514|NCT00396318|Central venous access catheter|central venous access catheter
5729515|NCT00396305|Influenza, vaccine, efficacy, elderly|influenza, vaccine, efficacy, elderly
5729517|NCT00396292|postpartum|postpartum
5729518|NCT00396292|Postpartum anemia|postpartum anemia
5729519|NCT00396279|Giant Cell Tumor of Bone|giant cell tumor of bone
5729520|NCT00396266|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5729521|NCT00396266|Multiple Myeloma|multiple myeloma
5729522|NCT00396266|stem cell mobilization|stem cell mobilization
5729523|NCT00396266|AMD3100|amd3100
5729524|NCT00396266|autologous transplantation|autologous transplantation
5729525|NCT00396253|HD|hd
5729526|NCT00396253|TNKase|tnkase
5729527|NCT00396253|Hemodialysis|hemodialysis
5729528|NCT00396253|Catheter clearance|catheter clearance
5729529|NCT00396240|rosuvastatin|rosuvastatin
5729530|NCT00396240|hypercholesterolaemia|hypercholesterolaemia
5729531|NCT00396240|cholesterol|cholesterol
5729532|NCT00396240|LDL-C|ldl-c
5729533|NCT00396240|triglyceride|triglyceride
5729534|NCT00396240|plasma lipids|plasma lipids
5729535|NCT00396240|compliance|compliance
5729536|NCT00396227|Type 2 diabetes|type 2 diabetes
5729537|NCT00396227|vildagliptin|vildagliptin
5729538|NCT00396227|hemoglobin A1c|hemoglobin a1c
5729539|NCT00396227|metformin|metformin
5729540|NCT00396214|Schizophrenia|schizophrenia
5729541|NCT00396214|weight changes|weight changes
5729542|NCT00396201|Hodgkin's Disease|hodgkin's disease
5729543|NCT00396201|Stem cell mobilization|stem cell mobilization
5729544|NCT00396201|apheresis|apheresis
5729545|NCT00396188|Keratoconus|keratoconus
5729546|NCT00396188|LASIK|lasik
5729547|NCT00396188|Orthokeratology|orthokeratology
5729548|NCT00396188|Pellucid Marginal Degeneration|pellucid marginal degeneration
5729549|NCT00396188|Refractive Surgery|refractive surgery
5729550|NCT00396188|normal cornea|normal cornea
5729551|NCT00396188|post myopic LASIK|post myopic lasik
5729552|NCT00396188|post hyperopic LASIK|post hyperopic lasik
5729553|NCT00396188|corneal pathologies (e.g. pellucid marginal degeneration)|corneal pathologies (e.g. pellucid marginal degeneration)
5729554|NCT00396149|rBet v 1|rbet v 1
5729555|NCT00396149|Birch pollen allergy|birch pollen allergy
5729556|NCT00396149|Sublingual Immunotherapy|sublingual immunotherapy
5729557|NCT00396136|Congestive Heart Failure|congestive heart failure
5729558|NCT00396136|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5729559|NCT00396136|Left Ventricular Lead|left ventricular lead
5729560|NCT00396123|Chronic Kidney Disease|chronic kidney disease
5729561|NCT00396123|Anemia|anemia
5729562|NCT00396110|cholesterol|cholesterol
5729563|NCT00396110|coronary heart disease|coronary heart disease
5729564|NCT00396110|rosuvastatin|rosuvastatin
5729565|NCT00396110|LDL-C goal|ldl-c goal
5729566|NCT00396110|hypercholesterolemia|hypercholesterolemia
5729567|NCT00396097|ISS|iss
5729568|NCT00396097|human growth hormone|human growth hormone
5729569|NCT00396084|Brazil|brazil
5729570|NCT00396084|gatifloxacin|gatifloxacin
5729571|NCT00396084|isoniazid|isoniazid
5729572|NCT00396084|levofloxacin|levofloxacin
5729573|NCT00396084|linezolid|linezolid
5729574|NCT00396084|moxifloxacin|moxifloxacin
5729575|NCT00396084|tuberculosis|tuberculosis
5729576|NCT00396071|Type 2 diabetes|type 2 diabetes
5729577|NCT00396071|vildagliptin|vildagliptin
5729578|NCT00396071|incretin effect|incretin effect
5729579|NCT00396071|metformin|metformin
5729580|NCT00396045|Multiple Myeloma, Lenalidomide, elderly patients|multiple myeloma, lenalidomide, elderly patients
5729581|NCT00396032|HD|hd
5729582|NCT00396032|Hemodialysis|hemodialysis
5747011|NCT00331448|Triglycerides|triglycerides
5747012|NCT00331448|MRI|mri
5747013|NCT00331448|DXA|dxa
5747014|NCT00331448|Carotid IMT|carotid imt
5747015|NCT00331448|LDL|ldl
5747016|NCT00331448|HDL|hdl
5729583|NCT00396032|Catheter clearance|catheter clearance
5729584|NCT00396032|TNKase|tnkase
5729585|NCT00396032|Renal Insufficiency|renal insufficiency
5729586|NCT00395993|anemia|anemia
5729587|NCT00395993|heavy uterine bleeding|heavy uterine bleeding
5729588|NCT00395993|menorrhagia|menorrhagia
5729589|NCT00395993|Anemia secondary to heavy uterine bleeding|anemia secondary to heavy uterine bleeding
5729590|NCT00395967|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5729591|NCT00395967|Multiple Myeloma|multiple myeloma
5729592|NCT00395967|stem cell mobilization|stem cell mobilization
5729593|NCT00395967|autologous transplantation|autologous transplantation
5729594|NCT00395967|AMD3100|amd3100
5729595|NCT00395954|Lactose Intolerance|lactose intolerance
5729596|NCT00395954|Lactose|lactose
5729597|NCT00395954|Threshold|threshold
5729598|NCT00395928|heart|heart
5729599|NCT00395928|echocardiography|echocardiography
5729600|NCT00395928|diastolic function|diastolic function
5729601|NCT00395928|left ventricle|left ventricle
5729602|NCT00395928|right ventricle|right ventricle
5729603|NCT00395928|cigarette smoking|cigarette smoking
5729604|NCT00395928|Smoking|smoking
5729605|NCT00395928|Heart Ventricles|heart ventricles
5729606|NCT00395928|Diastole|diastole
5729607|NCT00395928|Doppler Echocardiography|doppler echocardiography
5729608|NCT00395915|schizophrenia|schizophrenia
5729609|NCT00395915|antipsychotics|antipsychotics
5729610|NCT00395915|treatment non response|treatment non response
5729611|NCT00395915|pragmatic trial|pragmatic trial
5729612|NCT00395902|Sensipar|sensipar
5729613|NCT00395902|cinacalcet|cinacalcet
5729614|NCT00395902|Mimpara|mimpara
5729615|NCT00395889|Lung Transplantation|lung transplantation
5729616|NCT00395889|Physical Activities in Daily Life|physical activities in daily life
5729617|NCT00395889|Pulmonary Rehabilitation|pulmonary rehabilitation
5729618|NCT00395889|Functional Status|functional status
5729619|NCT00395876|TNKase|tnkase
5729620|NCT00395876|CVA|cva
5729621|NCT00395876|CVAD|cvad
5729622|NCT00395876|Central venous access catheter|central venous access catheter
5729623|NCT00395876|CVA catheter|cva catheter
5729624|NCT00395850|cocaine dependence|cocaine dependence
5729625|NCT00395850|disulfiram|disulfiram
5729626|NCT00395850|clinical trial|clinical trial
5729627|NCT00395850|methadone maintenance|methadone maintenance
5729628|NCT00395850|pharmacogenetics|pharmacogenetics
5729629|NCT00395850|dopamine beta-hydroxylase|dopamine beta-hydroxylase
5729630|NCT00395837|Aging|aging
5729631|NCT00395837|Wellness|wellness
5729632|NCT00395837|Aerobic exercise|aerobic exercise
5729633|NCT00395837|Prevention|prevention
5729634|NCT00395824|citrate|citrate
5729635|NCT00395824|anticoagulation|anticoagulation
5729636|NCT00395824|heparin-coated membrane|heparin-coated membrane
5729637|NCT00395811|Myocardial Infarction|myocardial infarction
5729638|NCT00395811|stem cell therapy|stem cell therapy
5729639|NCT00395811|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5729640|NCT00395798|cervical intervertebral disc displacement|cervical intervertebral disc displacement
5729641|NCT00395798|cervical spondylosis|cervical spondylosis
5729642|NCT00395798|radiculopathy|radiculopathy
5729643|NCT00395798|neck collar|neck collar
5729644|NCT00395798|brace|brace
5729645|NCT00395798|physiotherapy|physiotherapy
5729646|NCT00395798|treatment|treatment
5729647|NCT00395798|rehabilitation|rehabilitation
5729648|NCT00395785|Carotid stenosis|carotid stenosis
5729649|NCT00395785|Intracranial Embolism|intracranial embolism
5729650|NCT00395785|Carotid artery|carotid artery
5729651|NCT00395785|Carotid stent|carotid stent
5729652|NCT00395785|Embolic protection|embolic protection
5729653|NCT00395785|TriActiv ProGuard System|triactiv proguard system
5729654|NCT00395785|Carotid angioplasty|carotid angioplasty
5729655|NCT00395772|Treatment of venous thromboembolism|treatment of venous thromboembolism
5729656|NCT00395759|contrast sensitivity|contrast sensitivity
5729657|NCT00395733|Gadovist|gadovist
5729658|NCT00395733|Gadavist|gadavist
5729659|NCT00395733|MRI Imaging|mri imaging
5729660|NCT00395733|vascular diseases|vascular diseases
5729661|NCT00395733|Chinese|chinese
5729662|NCT00395720|TB|tb
5729663|NCT00395720|Tuberculosis|tuberculosis
5729664|NCT00395720|HIV|hiv
5729665|NCT00395720|Vaccine|vaccine
5729666|NCT00395720|MVA85A|mva85a
5729667|NCT00395720|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5729668|NCT00395707|Macular Degeneration|macular degeneration
5729669|NCT00395707|Age Related Macular Degeneration|age related macular degeneration
5729670|NCT00395707|Retinal Angiomatous Proliferations|retinal angiomatous proliferations
5729671|NCT00395694|epilepsy|epilepsy
5729672|NCT00395694|Incidence of rash|incidence of rash
5729673|NCT00395694|safety evaluation for initial dose|safety evaluation for initial dose
5729674|NCT00395694|patients with Valproic acid|patients with valproic acid
5747107|NCT00331045|Opioids|opioids
5729677|NCT00395681|Morbidly obese|morbidly obese
5729678|NCT00395681|BMI|bmi
5729679|NCT00395668|TETRA|tetra
5729680|NCT00395668|EMF|emf
5729681|NCT00395668|Human exposure study|human exposure study
5729682|NCT00395668|Symptoms|symptoms
5729683|NCT00395668|Well-being|well-being
5729684|NCT00395668|Cognitive function|cognitive function
5729685|NCT00395655|locally advanced breast cancer|locally advanced breast cancer
5729686|NCT00395655|hydralazine|hydralazine
5729687|NCT00395655|magnesium valproate|magnesium valproate
5729688|NCT00395655|epigenetic therapy|epigenetic therapy
5729689|NCT00395655|gene expression|gene expression
5729690|NCT00395642|Congestive Heart Failure|congestive heart failure
5729691|NCT00395642|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5729692|NCT00395642|Home Monitoring|home monitoring
5729693|NCT00395642|Telemonitoring|telemonitoring
5729694|NCT00395642|Remote Monitoring|remote monitoring
5729695|NCT00395629|Deferasirox|deferasirox
5729696|NCT00395629|ICL670A|icl670a
5729697|NCT00395629|Iron chelators|iron chelators
5729698|NCT00395629|Deferiprone|deferiprone
5729699|NCT00395629|Transfusional Hemochromatosis|transfusional hemochromatosis
5729700|NCT00395590|OSA inflammatory cytokines, metabolic syndrome|osa inflammatory cytokines, metabolic syndrome
5729701|NCT00395564|Urologic Surgery|urologic surgery
5729702|NCT00395551|choroidal neovascularization|choroidal neovascularization
5729703|NCT00395551|Choroidal Neovascularization Not related to Age-Related Macular Degeneration|choroidal neovascularization not related to age-related macular degeneration
5729704|NCT00395538|Parathyroid|parathyroid
5729705|NCT00395538|Bone Biopsy|bone biopsy
5729706|NCT00395538|Calcium-Sensing Receptor|calcium-sensing receptor
5729707|NCT00395538|Bone Density|bone density
5729708|NCT00395538|Bone Turnover|bone turnover
5729709|NCT00395538|Hypoparathyroidism|hypoparathyroidism
5729710|NCT00395512|Glucose Metabolism Disorder|glucose metabolism disorder
5729711|NCT00395512|Dysmetabolic Syndrome|dysmetabolic syndrome
5729714|NCT00395512|Dyslipidemia|dyslipidemia
5729715|NCT00395512|Drug Therapy|drug therapy
5729717|NCT00395499|9-Hydroxyrisperidone|9-hydroxyrisperidone
5729718|NCT00395499|Plasma|plasma
5729719|NCT00395499|Saliva|saliva
5729720|NCT00395499|children|children
5729721|NCT00395486|rosuvastatin|rosuvastatin
5729722|NCT00395486|lipoprotein|lipoprotein
5729723|NCT00395486|metabolic syndrome|metabolic syndrome
5729724|NCT00395460|Gadovist|gadovist
5729725|NCT00395460|Gadavist|gadavist
5729726|NCT00395460|Contrast agent|contrast agent
5729727|NCT00395460|Brain|brain
5729728|NCT00395460|Spine disease|spine disease
5729729|NCT00395460|Magnetic Resonance Imaging|magnetic resonance imaging
5729730|NCT00395447|Cardiac Pacemaker|cardiac pacemaker
5729731|NCT00395447|Defibrillator|defibrillator
5729732|NCT00395447|Replacement|replacement
5729734|NCT00395434|Advanced Solid Tumors|advanced solid tumors
5729735|NCT00395434|Advanced Solid Tumours|advanced solid tumours
5729736|NCT00395434|Advanced Solid Tumor|advanced solid tumor
5729737|NCT00395434|Advanced Solid Tumour|advanced solid tumour
5729738|NCT00395434|Advanced|advanced
5729739|NCT00395434|Malignant|malignant
5729740|NCT00395434|Solid|solid
5729741|NCT00395434|Tumors|tumors
5729742|NCT00395434|Tumours|tumours
5729743|NCT00395434|Tumor|tumor
5729744|NCT00395434|Tumour|tumour
5729745|NCT00395434|Cancer|cancer
5729746|NCT00395434|Malignant Solid Tumors|malignant solid tumors
5729747|NCT00395434|Malignant Solid Tumours|malignant solid tumours
5729748|NCT00395434|Malignant Solid Tumor|malignant solid tumor
5729749|NCT00395434|Malignant Solid Tumour|malignant solid tumour
5729750|NCT00395434|Metastatic Cancer|metastatic cancer
5729751|NCT00395434|Metastatic Disease|metastatic disease
5729752|NCT00395434|Advanced Cancer|advanced cancer
5729753|NCT00395434|Vascular Disrupting Agent|vascular disrupting agent
5729754|NCT00395434|Anti-angiogenesis agent|anti-angiogenesis agent
5729755|NCT00395434|Phase 1|phase 1
5729756|NCT00395421|treatment-naive|treatment-naive
5729757|NCT00395395|Postmenopausal|postmenopausal
5729758|NCT00395395|osteoporosis|osteoporosis
5729759|NCT00395395|Pharmacokinetics/dynamics|pharmacokinetics/dynamics
5729760|NCT00395395|Calcitonin|calcitonin
5729761|NCT00395382|Vascular calcification|vascular calcification
5729762|NCT00395382|Arterial stiffness|arterial stiffness
5729763|NCT00395382|Cardiovascular risk|cardiovascular risk
5729764|NCT00395382|Bone mineral metabolism|bone mineral metabolism
5729765|NCT00395382|Calcium|calcium
5729766|NCT00395369|aprotinin|aprotinin
5729767|NCT00395369|cardiac surgery|cardiac surgery
5729768|NCT00395369|neurological dysfunction|neurological dysfunction
5729769|NCT00395369|optical coherance tomography|optical coherance tomography
5729770|NCT00395356|Diet|diet
5729771|NCT00395356|Caloric restriction|caloric restriction
5729772|NCT00395356|Intermittent diet|intermittent diet
5729773|NCT00395356|Obesity|obesity
5729774|NCT00395356|Postmenopausal women|postmenopausal women
5729775|NCT00395330|Respiratory Function Tests|respiratory function tests
5729776|NCT00395330|Oscillometry|oscillometry
5729777|NCT00395330|World Trade Center Disaster|world trade center disaster
5729778|NCT00395330|Environmental Exposure|environmental exposure
5729780|NCT00395317|magnetic resonance imaging|magnetic resonance imaging
5729782|NCT00395317|SB-683699|sb-683699
5729783|NCT00395291|Chronic kidney disease|chronic kidney disease
5729784|NCT00395291|End stage renal disease|end stage renal disease
5729789|NCT00395265|Deep Vein Thrombosis|deep vein thrombosis
5729790|NCT00395265|Chronic Venous Insufficiency|chronic venous insufficiency
5729791|NCT00395265|Post Thrombotic Syndrome|post thrombotic syndrome
5729792|NCT00395265|Blood Coagulation|blood coagulation
5729793|NCT00395265|Inflammation|inflammation
5729794|NCT00395252|pancreatic cancer|pancreatic cancer
5729795|NCT00395252|adjuvant chemotherapy|adjuvant chemotherapy
5729796|NCT00395252|phase 2|phase 2
5729797|NCT00395252|R0 or R1 resected Adenocarcinoma of the Pancreas|r0 or r1 resected adenocarcinoma of the pancreas
5729798|NCT00395239|Asthma|asthma
5729799|NCT00395239|Inhaled corticosteroid|inhaled corticosteroid
5729800|NCT00395239|ICS|ics
5729801|NCT00395239|Metabolites|metabolites
5729802|NCT00395239|Induced sputum|induced sputum
5729803|NCT00395239|Virtual Asthma Clinic|virtual asthma clinic
5729804|NCT00395226|Rosacea|rosacea
5729805|NCT00395213|Anxiety|anxiety
5729806|NCT00395213|Major Depression|major depression
5729807|NCT00395213|Anorexia|anorexia
5729808|NCT00395213|Bulimia|bulimia
5729809|NCT00395213|OCD|ocd
5729810|NCT00395213|Antidepressant|antidepressant
5729811|NCT00395213|SSRI|ssri
5729812|NCT00395213|SNRI|snri
5729813|NCT00395200|Multiple Sclerosis|multiple sclerosis
5729814|NCT00395200|Safety|safety
5729815|NCT00395200|Therapeutics|therapeutics
5729816|NCT00395200|Mesenchymal Stem Cells|mesenchymal stem cells
5729817|NCT00395200|Multipotent Mesenchymal Stromal Cells|multipotent mesenchymal stromal cells
5729818|NCT00395200|Optic Neuritis|optic neuritis
5729819|NCT00395174|Influenza|influenza
5729820|NCT00395161|sepsis|sepsis
5729821|NCT00395161|prevention|prevention
5729822|NCT00395161|mineral supplementation|mineral supplementation
5738113|NCT00365105|pain|pain
5729828|NCT00395135|Hypertension|hypertension
5729829|NCT00395135|Dyslipidemia|dyslipidemia
5729830|NCT00395135|Sleep apnea|sleep apnea
5729831|NCT00395135|glucose tolerance|glucose tolerance
5729832|NCT00395135|cardiovascular disease|cardiovascular disease
5729833|NCT00395135|Arena|arena
5729834|NCT00395122|Band Atrophy|band atrophy
5729835|NCT00395122|Optical Coherence Tomography|optical coherence tomography
5729959|NCT00394550|obstructive sleep apnea|obstructive sleep apnea
5729836|NCT00395122|Scanning Laser Polarimetry|scanning laser polarimetry
5729837|NCT00395122|Chiasmal Lesions|chiasmal lesions
5729838|NCT00395109|cancer|cancer
5729839|NCT00395109|hypoxia|hypoxia
5729840|NCT00395109|PET scan|pet scan
5729841|NCT00395109|CT scan|ct scan
5729842|NCT00395096|Exhaled Nitric Oxide|exhaled nitric oxide
5729843|NCT00395096|Asthma|asthma
5729844|NCT00395096|Tobacco Smoke|tobacco smoke
5729845|NCT00395096|Allergen|allergen
5729846|NCT00395070|Melanoma|melanoma
5729847|NCT00395070|DTIC|dtic
5729848|NCT00395070|TMZ|tmz
5729849|NCT00395070|Stage 3|stage 3
5729850|NCT00395070|Stage 4|stage 4
5729851|NCT00395070|Metastatic|metastatic
5729852|NCT00395070|Metastatic Melanoma (Stage 3, Stage 4 Melanoma)|metastatic melanoma (stage 3, stage 4 melanoma)
5729853|NCT00395044|Cannabis treatment|cannabis treatment
5729854|NCT00395044|marijuana treatment|marijuana treatment
5729855|NCT00395031|schizophrenia|schizophrenia
5729856|NCT00395031|Schizoaffective Disorder|schizoaffective disorder
5729857|NCT00395031|metabolic markers|metabolic markers
5729858|NCT00395031|ziprasidone|ziprasidone
5729859|NCT00395031|diabetes|diabetes
5729860|NCT00395018|Chronic Hepatitis B Virus, Liver Transplant|chronic hepatitis b virus, liver transplant
5729861|NCT00395005|Kallikrein|kallikrein
5729862|NCT00395005|Cytokines|cytokines
5729863|NCT00395005|Proteinuria|proteinuria
5729864|NCT00395005|Renal function|renal function
5729865|NCT00395005|Chronic kidney disease|chronic kidney disease
5729866|NCT00394992|Colorectal cancer|colorectal cancer
5729867|NCT00394992|Liver metastasis|liver metastasis
5729868|NCT00394992|Radical resection|radical resection
5729869|NCT00394992|Adjuvant therapy|adjuvant therapy
5729870|NCT00394992|Bevacizumab|bevacizumab
5729871|NCT00394992|Capecitabine|capecitabine
5729872|NCT00394992|Oxaliplatin|oxaliplatin
5729873|NCT00394992|Hepatica|hepatica
5729874|NCT00394940|COPD|copd
5729875|NCT00394940|Emphysema|emphysema
5729876|NCT00394940|Chronic Bronchitis|chronic bronchitis
5729877|NCT00394940|Inflammation|inflammation
5729878|NCT00394940|CD14|cd14
5729879|NCT00394940|TLR4|tlr4
5729880|NCT00394940|Proteomics|proteomics
5729881|NCT00394927|Non-Interventional|non-interventional
5729882|NCT00394927|Surveillance|surveillance
5729883|NCT00394927|Adverse Effects|adverse effects
5729884|NCT00394927|AntiEpileptic Drug treatment|antiepileptic drug treatment
5729885|NCT00394888|Hemangioma|hemangioma
5729886|NCT00394888|PHACE|phace
5729887|NCT00394888|Lumbosacral hemangioma|lumbosacral hemangioma
5729888|NCT00394888|Occult Spinal Dysraphism|occult spinal dysraphism
5729889|NCT00394875|Randomized controlled trial|randomized controlled trial
5729890|NCT00394875|Delegation, Professional|delegation, professional
5729892|NCT00394849|Tonsillectomy|tonsillectomy
5729893|NCT00394849|Suturing of tonsillar pillars|suturing of tonsillar pillars
5729894|NCT00394849|pain|pain
5729895|NCT00394849|postoperative hemorrhage, bleeding|postoperative hemorrhage, bleeding
5729896|NCT00394836|ofatumumab|ofatumumab
5729897|NCT00394836|rituximab|rituximab
5729899|NCT00394836|CD20|cd20
5729900|NCT00394836|refractory|refractory
5729901|NCT00394823|Hypertension, valsartan, compliance|hypertension, valsartan, compliance
5729902|NCT00394784|gram negative bacteria|gram negative bacteria
5729903|NCT00394784|culture|culture
5729904|NCT00394784|infection|infection
5729905|NCT00394771|oral contraceptives|oral contraceptives
5729906|NCT00394771|breakthrough bleeding|breakthrough bleeding
5729907|NCT00394771|spotting|spotting
5729908|NCT00394758|ultrasonic surgical aspiration|ultrasonic surgical aspiration
5729909|NCT00394758|CO2 laser surgery|co2 laser surgery
5729910|NCT00394758|vulvar dysplasia|vulvar dysplasia
5729911|NCT00394758|vaginal dysplasia|vaginal dysplasia
5729912|NCT00394758|recurrence|recurrence
5729913|NCT00394745|Hypertension, Metabolic Syndrome, lipid subfractions|hypertension, metabolic syndrome, lipid subfractions
5729914|NCT00394732|chronic low back pain|chronic low back pain
5729915|NCT00394732|total disc replacement|total disc replacement
5729916|NCT00394732|multidisciplinary rehabilitation|multidisciplinary rehabilitation
5730496|NCT00392730|Manganese|manganese
5729917|NCT00394732|clinical effects|clinical effects
5729918|NCT00394732|cost effectiveness|cost effectiveness
5729919|NCT00394732|randomized controlled trial|randomized controlled trial
5729920|NCT00394732|multicenter study|multicenter study
5729921|NCT00394706|cardiac arrest|cardiac arrest
5729922|NCT00394706|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5729923|NCT00394693|Primary CBCL including (WHO/EORTC classification 2005)|primary cbcl including (who/eortc classification 2005)
5729924|NCT00394693|Primary cutaneous marginal zone B-cell lymphoma|primary cutaneous marginal zone b-cell lymphoma
5686182|NCT00553163|Hypnotherapy|hypnotherapy
5730227|NCT00393458|COPD|copd
5729925|NCT00394693|Primary cutaneous follicle center B-cell lymphoma|primary cutaneous follicle center b-cell lymphoma
5729926|NCT00394693|Primary cutaneous diffuse large B-cell other than leg type|primary cutaneous diffuse large b-cell other than leg type
5729927|NCT00394693|Histologically consistent with primary CBCL|histologically consistent with primary cbcl
5729928|NCT00394693|Relapse or active disease|relapse or active disease
5729929|NCT00394680|coronary revascularization|coronary revascularization
5729930|NCT00394680|stent inmplantation|stent inmplantation
5729931|NCT00394680|coronary bypass|coronary bypass
5729932|NCT00394628|Glioblastoma Multiforme|glioblastoma multiforme
5729933|NCT00394628|Radiotherapy|radiotherapy
5729934|NCT00394628|temozolomide|temozolomide
5729935|NCT00394628|adjuvant temozolomide|adjuvant temozolomide
5729936|NCT00394602|Gastric Cancer|gastric cancer
5729937|NCT00394602|Pancreatic Cancer|pancreatic cancer
5729938|NCT00394602|Cervical Cancer|cervical cancer
5729939|NCT00394602|Vulvar Cancer|vulvar cancer
5729940|NCT00394602|Endometrial Cancer|endometrial cancer
5729941|NCT00394602|Anal Cancer|anal cancer
5729942|NCT00394602|Quality of Life|quality of life
5729943|NCT00394602|Questionnaire|questionnaire
5729944|NCT00394602|Interview|interview
5729945|NCT00394602|Emesis|emesis
5729946|NCT00394602|Nausea|nausea
5729947|NCT00394602|Survey|survey
5729948|NCT00394576|Kidney School|kidney school
5729949|NCT00394576|Short Test of Functional Health Literacy|short test of functional health literacy
5729950|NCT00394576|Chronic Kidney Disease Knowledge Assessment Tool of Nutrition|chronic kidney disease knowledge assessment tool of nutrition
5729951|NCT00394576|Short Form 12 version 2|short form 12 version 2
5729952|NCT00394576|Three Day Dietary Diary|three day dietary diary
5729953|NCT00394576|Kidney Disease Self-Management Survey|kidney disease self-management survey
5729954|NCT00394563|osteoarthritis monoclonal antibody|osteoarthritis monoclonal antibody
5729955|NCT00394550|laryngomalacia|laryngomalacia
5729956|NCT00394550|supraglottoplasty|supraglottoplasty
5729957|NCT00394550|Tonsillectomy|tonsillectomy
5729958|NCT00394550|Adenoidectomy|adenoidectomy
5729960|NCT00394550|Laser|laser
5729961|NCT00394550|Polysomnogram|polysomnogram
5729962|NCT00394550|airway obstruction|airway obstruction
5729963|NCT00394524|ICU|icu
5729964|NCT00394524|hyperglycemia|hyperglycemia
5729965|NCT00394524|glucommander|glucommander
5729966|NCT00394498|Myocardial Infarction|myocardial infarction
5729967|NCT00394498|Stem Cells|stem cells
5729968|NCT00394485|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5729969|NCT00394485|Procaterol|procaterol
5729970|NCT00394485|Tiotropium|tiotropium
5729971|NCT00394472|Heartburn|heartburn
5729972|NCT00394472|Patient reported symptoms|patient reported symptoms
5729973|NCT00394472|Proton pump inhibitor|proton pump inhibitor
5729974|NCT00394459|Anaesthetic techniques|anaesthetic techniques
5729975|NCT00394459|epidural|epidural
5729976|NCT00394459|catheters|catheters
5729977|NCT00394459|paraesthesia|paraesthesia
5729978|NCT00394459|side effects|side effects
5729979|NCT00394459|Anesthesia, Epidural [E03.155.086.131]|anesthesia, epidural [e03.155.086.131]
5729980|NCT00394446|Solid Tumors|solid tumors
5725043|NCT00413621|AD|ad
5729982|NCT00394446|Brain|brain
5729983|NCT00394433|TPCA|tpca
5729984|NCT00394433|Taxotere|taxotere
5729985|NCT00394433|Platinum|platinum
5729986|NCT00394433|Avastin|avastin
5729987|NCT00394433|Camptosar|camptosar
5729988|NCT00394433|gastric cancer|gastric cancer
5729989|NCT00394407|inpatient|inpatient
5729990|NCT00394407|diabetes management|diabetes management
5729991|NCT00394407|insulin therapy|insulin therapy
5729992|NCT00394381|acute myeloid leukemia|acute myeloid leukemia
5729993|NCT00394381|myelodysplastic syndrome|myelodysplastic syndrome
5729994|NCT00394381|autologous CIK cells|autologous cik cells
5729995|NCT00394381|autologous peripheral blood stem cell transplant|autologous peripheral blood stem cell transplant
5729996|NCT00394368|asthma|asthma
5729997|NCT00394368|combinations|combinations
5729998|NCT00394368|inhaled therapy|inhaled therapy
5729999|NCT00394368|corticosteroids|corticosteroids
5730000|NCT00394368|long acting bronchodilators|long acting bronchodilators
5730001|NCT00394368|salmeterol|salmeterol
5730002|NCT00394368|beclomethasone|beclomethasone
5730003|NCT00394368|formoterol|formoterol
5730004|NCT00394368|fluticasone|fluticasone
5730005|NCT00394316|CD34 Stem Cells|cd34 stem cells
5730006|NCT00394316|Busulfan|busulfan
5730007|NCT00394316|Gene Therapy|gene therapy
5730008|NCT00394316|Immune Reconstitution|immune reconstitution
5730009|NCT00394316|Engraftment|engraftment
5730010|NCT00394316|Chronic Granulomatous Disease (CGD)|chronic granulomatous disease (cgd)
5730011|NCT00394316|Gp91 Phox Deficiency|gp91 phox deficiency
5730585|NCT00392418|infancy|infancy
5730012|NCT00394316|Peripheral Blood Stem Cells|peripheral blood stem cells
5730013|NCT00394316|Bone Marrow Transplantation|bone marrow transplantation
5730014|NCT00394316|Chronic Granulomatous Disease|chronic granulomatous disease
5730015|NCT00394316|CGD|cgd
5730016|NCT00394303|Open heart surgery|open heart surgery
5730017|NCT00394303|Diabetes mellitus|diabetes mellitus
5730018|NCT00394303|Hyperglycemia|hyperglycemia
5728963|NCT00398476|after taste|after taste
5730019|NCT00394303|Surgical site infection|surgical site infection
5730020|NCT00394303|Normoglycemia|normoglycemia
5730021|NCT00394290|Down Syndrome|down syndrome
5730022|NCT00394290|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5730023|NCT00394290|Continuous Positive Pressure|continuous positive pressure
5730024|NCT00394290|Hypersomnia|hypersomnia
5730025|NCT00394264|low back pain|low back pain
5730026|NCT00394264|active duty military personnel|active duty military personnel
5730027|NCT00394264|manual/manipulative therapy|manual/manipulative therapy
5730028|NCT00394264|osteopathic manipulative treatment|osteopathic manipulative treatment
5730029|NCT00394264|physical medicine|physical medicine
5730030|NCT00394251|Adjuvant therapy|adjuvant therapy
5730031|NCT00394251|Bevacizumab|bevacizumab
5730032|NCT00394251|Abraxane|abraxane
5730033|NCT00394251|Early stage breast cancer|early stage breast cancer
5730034|NCT00394225|6-Minute Walk Test|6-minute walk test
5730035|NCT00394225|COPD|copd
5730036|NCT00394225|Helium-Hyperoxia|helium-hyperoxia
5730037|NCT00394225|Exercise|exercise
5730038|NCT00394225|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5730039|NCT00394212|Weight Loss|weight loss
5730040|NCT00394212|Transoral Suturing|transoral suturing
5730041|NCT00394212|Dilated gastrojejunostomy|dilated gastrojejunostomy
5730042|NCT00394212|Inadequate weight loss following primary RYGB|inadequate weight loss following primary rygb
5730043|NCT00394199|Asthma|asthma
5730044|NCT00394199|Fluticasone Propionate|fluticasone propionate
5730045|NCT00394199|formoterol fumarate|formoterol fumarate
5730046|NCT00394199|Pressurized metered dose inhaler|pressurized metered dose inhaler
5730047|NCT00394199|Hydrofluoroalkane|hydrofluoroalkane
5730048|NCT00394199|Mild to Moderate Asthma|mild to moderate asthma
5730049|NCT00394186|GW427353|gw427353
5730050|NCT00394186|b3-Adrenergic Receptor Agonist|b3-adrenergic receptor agonist
5730051|NCT00394186|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5730052|NCT00394186|efficacy|efficacy
5730053|NCT00394186|tolerability|tolerability
5730054|NCT00394186|pharmacokinetics|pharmacokinetics
5730055|NCT00394173|IBS|ibs
5730056|NCT00394173|diarrhea|diarrhea
5730057|NCT00394173|gastrointestinal functional disorder|gastrointestinal functional disorder
5730058|NCT00394173|IBS-D|ibs-d
5730059|NCT00394147|advanced|advanced
5730060|NCT00394147|head|head
5730061|NCT00394147|neck|neck
5730062|NCT00394147|cancer|cancer
5730063|NCT00394134|Melanoma|melanoma
5730064|NCT00394134|Sun Exposure|sun exposure
5730065|NCT00394134|Sun Protection|sun protection
5730066|NCT00394134|Interview|interview
5730067|NCT00394121|Asthma|asthma
5730068|NCT00394121|Fluticasone Propionate|fluticasone propionate
5730069|NCT00394121|Formoterol Fumarate|formoterol fumarate
5730070|NCT00394121|Pressurized metered does inhaler|pressurized metered does inhaler
5730071|NCT00394121|Hydrofluoroalkane|hydrofluoroalkane
5730072|NCT00394121|Mild to moderate-severe asthma|mild to moderate-severe asthma
5730073|NCT00394095|Bipolar Disorder|bipolar disorder
5730074|NCT00394095|Weight Gain|weight gain
5730075|NCT00394082|Metastatic breast cancer, Abraxane, Bevacizumab|metastatic breast cancer, abraxane, bevacizumab
5730077|NCT00394056|balanced|balanced
5730078|NCT00394056|paroxetine|paroxetine
5730079|NCT00394056|repeated dose|repeated dose
5730080|NCT00394056|Hearing Loss|hearing loss
5730081|NCT00394056|loudness|loudness
5730082|NCT00394056|combination|combination
5730083|NCT00394056|Tinnitus|tinnitus
5730084|NCT00394056|vestipitant (GW597599)|vestipitant (gw597599)
5730085|NCT00394056|randomised|randomised
5730086|NCT00394056|annoyance|annoyance
5730087|NCT00394056|crossover|crossover
5730088|NCT00394043|Carpal Tunnel Sydrome|carpal tunnel sydrome
5730089|NCT00394043|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5730090|NCT00394043|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5730091|NCT00394043|Physical Medicine|physical medicine
5730092|NCT00394030|GSK716155 pharmacodynamics pharmacokinetics injection site|gsk716155 pharmacodynamics pharmacokinetics injection site
5730093|NCT00394017|Heading Health Plan Implementation|heading health plan implementation
5730094|NCT00394017|Computer-Assisted Instruction|computer-assisted instruction
5730095|NCT00394017|General Practice|general practice
5730096|NCT00394017|Dementia|dementia
5730097|NCT00394017|education|education
5730098|NCT00394004|Decision Making|decision making
5730099|NCT00394004|Health Disparities|health disparities
5730100|NCT00394004|Hispanic|hispanic
5730101|NCT00394004|African-American|african-american
5730102|NCT00394004|Clinical Trials|clinical trials
5730103|NCT00394004|HIV Positive|hiv positive
5730104|NCT00393991|Asthma|asthma
5730105|NCT00393991|Fluticasone Propionate|fluticasone propionate
5730106|NCT00393991|Formoterol Fumarate|formoterol fumarate
5730107|NCT00393991|Pressurized metered dose inhaler|pressurized metered dose inhaler
5730108|NCT00393991|Hydrofluoroalkane|hydrofluoroalkane
5730109|NCT00393991|Mild to Moderate Asthma|mild to moderate asthma
5730110|NCT00393978|Bipolar mania|bipolar mania
5730111|NCT00393978|Cannabis consumption|cannabis consumption
5730112|NCT00393965|Metastases|metastases
5730113|NCT00393965|Refractory|refractory
5730115|NCT00393952|Asthma|asthma
5730116|NCT00393952|Fluticasone Propionate|fluticasone propionate
5730117|NCT00393952|Formoterol Fumarate|formoterol fumarate
5730118|NCT00393952|Pressurized metered dose inhaler|pressurized metered dose inhaler
5730119|NCT00393952|Hydrofluoroalkane|hydrofluoroalkane
5730120|NCT00393952|Moderate-Severe Asthma|moderate-severe asthma
5730121|NCT00393939|advanced breast cancer|advanced breast cancer
5730122|NCT00393939|sunitinib|sunitinib
5730123|NCT00393939|docetaxel|docetaxel
5730124|NCT00393939|Phase 3|phase 3
5730125|NCT00393926|Robotics|robotics
5730126|NCT00393926|Rehabilitation|rehabilitation
5730127|NCT00393926|Upper Extremity|upper extremity
5730128|NCT00393926|CVA|cva
5730129|NCT00393913|Sleep Apnea|sleep apnea
5730130|NCT00393913|Sleep-Disordered Breathing|sleep-disordered breathing
5730131|NCT00393913|Snoring|snoring
5730132|NCT00393900|otitis media|otitis media
5730133|NCT00393900|tympanostomy tube|tympanostomy tube
5730134|NCT00393900|eustachian tube function|eustachian tube function
5730135|NCT00393900|gas exchange|gas exchange
5730136|NCT00393900|tympanostomy tubes|tympanostomy tubes
5730137|NCT00393887|Inguinal hernia|inguinal hernia
5730138|NCT00393887|polypropylene|polypropylene
5730139|NCT00393887|Biodesign IHM|biodesign ihm
5730140|NCT00393887|lichtenstein|lichtenstein
5730141|NCT00393874|Anxiety D/O|anxiety d/o
5730142|NCT00393874|Mood D/O|mood d/o
5730143|NCT00393861|Germ Cell Tumor|germ cell tumor
5730144|NCT00393861|Germ Cell Cancer|germ cell cancer
5730145|NCT00393848|Hip Replacement Arthroplasty|hip replacement arthroplasty
5730146|NCT00393848|Hip Replacement Surgery|hip replacement surgery
5730147|NCT00393848|Hip Surgery|hip surgery
5730148|NCT00393848|Hip Rehabilitation|hip rehabilitation
5730149|NCT00393848|Avascular Necrosis|avascular necrosis
5730150|NCT00393848|Knee replacement surgery|knee replacement surgery
5730151|NCT00393848|Total knee arthroplasty|total knee arthroplasty
5730152|NCT00393822|KGF|kgf
5730153|NCT00393822|Palifermin|palifermin
5730154|NCT00393822|Oral Mucositis|oral mucositis
5730155|NCT00393822|Clinical Trial|clinical trial
5730156|NCT00393822|Amgen|amgen
5730157|NCT00393822|Oncology|oncology
5730158|NCT00393822|Colon Cancer|colon cancer
5730159|NCT00393809|transitional cell carcinoma|transitional cell carcinoma
5730160|NCT00393809|H19 gene|h19 gene
5730161|NCT00393809|plasmid|plasmid
5730162|NCT00393809|diphtheria toxin|diphtheria toxin
5730163|NCT00393783|Breast Cancer|breast cancer
5730164|NCT00393783|Metastatic|metastatic
5730165|NCT00393783|HER2|her2
5730166|NCT00393783|04-101|04-101
5730167|NCT00393770|Risk of type 2 diabetes|risk of type 2 diabetes
5730168|NCT00393757|Malaria, Plasmodium falciparum, Kenya|malaria, plasmodium falciparum, kenya
5730169|NCT00393731|labor|labor
5730170|NCT00393731|induction|induction
5730171|NCT00393731|misoprostol|misoprostol
5730172|NCT00393731|oxytocin|oxytocin
5730173|NCT00393705|diabetes|diabetes
5730174|NCT00393705|type 2|type 2
5730175|NCT00393692|Age-related macular degeneration|age-related macular degeneration
5730176|NCT00393692|Geographic atrophy|geographic atrophy
5730177|NCT00393692|drusen|drusen
5730178|NCT00393679|Children 6-59 months|children 6-59 months
5730179|NCT00393679|P.falciparum|p.falciparum
5730180|NCT00393679|Haemoglobin|haemoglobin
5730181|NCT00393679|Informed consent|informed consent
5730182|NCT00393679|ACT|act
5730183|NCT00393666|Absence|absence
5730184|NCT00393666|Epilepsy|epilepsy
5730185|NCT00393666|Seizure|seizure
5730186|NCT00393666|Brain|brain
5730187|NCT00393653|osteoarthritis|osteoarthritis
5730188|NCT00393653|gastroesophageal reflux disease|gastroesophageal reflux disease
5730189|NCT00393653|practice-based research|practice-based research
5730190|NCT00393653|N-of-1 trial|n-of-1 trial
5730191|NCT00393653|prescription|prescription
5730192|NCT00393653|single-patient trial|single-patient trial
5730193|NCT00393640|Early Initiation of lactogenesis II|early initiation of lactogenesis ii
5730194|NCT00393627|Dementia|dementia
5730195|NCT00393627|Sleep disturbance|sleep disturbance
5730196|NCT00393627|Behavioral strategies|behavioral strategies
5730197|NCT00393627|Alzheimer's Disease|alzheimer's disease
5730198|NCT00393627|Adult Family Homes|adult family homes
5730199|NCT00393614|CSWS, interiktal epileptiform activity|csws, interiktal epileptiform activity
5730200|NCT00393601|Cystectomy|cystectomy
5730201|NCT00393588|Brain|brain
5730202|NCT00393588|Cognitive Deficits|cognitive deficits
5730203|NCT00393588|Cognitive Testing|cognitive testing
5730204|NCT00393588|MRI|mri
5730205|NCT00393588|Multiple Sclerosis|multiple sclerosis
5730206|NCT00393588|MS|ms
5730207|NCT00393588|Healthy Volunteer|healthy volunteer
5730208|NCT00393588|HV|hv
5730209|NCT00393575|HIV Prevention|hiv prevention
5730210|NCT00393575|HIV positive communities|hiv positive communities
5730211|NCT00393562|excessive sleepiness|excessive sleepiness
5730215|NCT00393536|Depression|depression
5730216|NCT00393536|Guidelines|guidelines
5730217|NCT00393536|Educational outreach visiting|educational outreach visiting
5730218|NCT00393536|Prescribing|prescribing
5730219|NCT00393510|Diabetic Foot Ulcer|diabetic foot ulcer
5730220|NCT00393510|Traditional Chinese Medicine|traditional chinese medicine
5730221|NCT00393497|Breast Cancer|breast cancer
5686183|NCT00553163|Prevention of relapse|prevention of relapse
5686184|NCT00553163|ulcerative colitis|ulcerative colitis
5686185|NCT00553150|adult gliosarcoma|adult gliosarcoma
5680920|NCT00575627|Hepatitis C|hepatitis c
5730222|NCT00393497|lymphedema|lymphedema
5730223|NCT00393471|Arthritis|arthritis
5730224|NCT00393471|Rheumatoid|rheumatoid
5730226|NCT00393458|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5730229|NCT00393458|long-acting β2 agonist|long-acting β2 agonist
5730230|NCT00393445|GLP-1|glp-1
5730231|NCT00393445|Exendin(9-39)|exendin(9-39)
5730232|NCT00393445|Insulin|insulin
5730233|NCT00393445|Glucagon|glucagon
5730234|NCT00393445|Human physiology|human physiology
5730235|NCT00393432|Action Observation|action observation
5730236|NCT00393432|Motor Memory|motor memory
5730237|NCT00393432|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5730238|NCT00393432|Use-Dependent Plasticity|use-dependent plasticity
5730239|NCT00393432|Healthy Volunteer|healthy volunteer
5730241|NCT00393419|hypertension|hypertension
5730242|NCT00393419|hyperlipidemia|hyperlipidemia
5730243|NCT00393419|adherence|adherence
5730244|NCT00393419|pharmacist|pharmacist
5730245|NCT00393419|elderly|elderly
5730246|NCT00393419|medication|medication
5730247|NCT00393406|Objective Risk|objective risk
5730248|NCT00393406|Gail Model|gail model
5730249|NCT00393406|Subjective Risk|subjective risk
5730250|NCT00393406|Medical Risk-Reducing Strategies|medical risk-reducing strategies
5730251|NCT00393406|Physical Activity, Diet, Alcohol Use|physical activity, diet, alcohol use
5730252|NCT00393406|Breast Cancer Risk|breast cancer risk
5730253|NCT00393393|osteoarthritis|osteoarthritis
5730254|NCT00393393|knee|knee
5730255|NCT00393393|hylan|hylan
5730256|NCT00393380|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
5730257|NCT00393380|Myelodysplasia|myelodysplasia
5730258|NCT00393380|Parathyroid Hormone|parathyroid hormone
5730259|NCT00393380|Umbilical Cord Blood Stem Cell Transplantation|umbilical cord blood stem cell transplantation
5730260|NCT00393367|Asthma|asthma
5730261|NCT00393367|Acute|acute
5730262|NCT00393367|Treatment|treatment
5730263|NCT00393367|Children|children
5730264|NCT00393367|Pediatric|pediatric
5730265|NCT00393367|Inhaled corticosteroid|inhaled corticosteroid
5730266|NCT00393367|Budesonide|budesonide
5730267|NCT00393367|Budesonide inhalation suspension|budesonide inhalation suspension
5730268|NCT00393367|Asthma score|asthma score
5730269|NCT00393367|Emergency|emergency
5730270|NCT00393367|Emergency Department|emergency department
5730271|NCT00393367|Asthma flare|asthma flare
5730272|NCT00393367|Clinical trial|clinical trial
5730273|NCT00393367|Randomized clinical trial|randomized clinical trial
5730274|NCT00393367|Randomized trial|randomized trial
5730275|NCT00393367|Pulmonary index score|pulmonary index score
5730276|NCT00393367|Hospitalization|hospitalization
5730277|NCT00393367|Moderate asthma|moderate asthma
5730278|NCT00393367|Severe asthma|severe asthma
5730279|NCT00393367|Mixing budesonide|mixing budesonide
5730280|NCT00393367|Budesonide admixture|budesonide admixture
5730281|NCT00393367|Albuterol|albuterol
5730282|NCT00393367|Continuous albuterol|continuous albuterol
5730283|NCT00393367|Ipratropium bromide|ipratropium bromide
5730288|NCT00393315|drug eluting balloon|drug eluting balloon
5730289|NCT00393302|HIV testing in pregnant women|hiv testing in pregnant women
5730290|NCT00393289|Calcium absorption|calcium absorption
5730291|NCT00393289|D-vitamin status|d-vitamin status
5730292|NCT00393289|Whole body calcium retention|whole body calcium retention
5730293|NCT00393289|Calcium intake|calcium intake
5730294|NCT00393289|PTH status|pth status
5730295|NCT00393276|Treatment Experienced|treatment experienced
5730296|NCT00393276|Treatment Naive|treatment naive
5730297|NCT00393276|Immunizations|immunizations
5730309|NCT00393198|Intrauterine System|intrauterine system
5730310|NCT00393198|Contraception|contraception
5730311|NCT00393198|Menorrhagia|menorrhagia
5730312|NCT00393185|Immunosuppression|immunosuppression
5730586|NCT00392418|pediatrics|pediatrics
5730313|NCT00393185|Primary Biliary Cirrhosis|primary biliary cirrhosis
5730314|NCT00393185|Allogeneic Hematopoietic Stem Cell|allogeneic hematopoietic stem cell
5730315|NCT00393172|exercise|exercise
5730316|NCT00393172|breast cancer|breast cancer
5730317|NCT00393172|prevention|prevention
5730319|NCT00393172|estrogen metabolism|estrogen metabolism
5730320|NCT00393172|oxidative stress|oxidative stress
5730321|NCT00393172|IGF-1|igf-1
5730322|NCT00393159|Effusion|effusion
5730323|NCT00393159|Otitis|otitis
5730324|NCT00393159|Media|media
5730325|NCT00393159|Ear|ear
5730326|NCT00393159|Popper|popper
5730327|NCT00393159|Children|children
5730328|NCT00393146|Rheumatoid arthritis|rheumatoid arthritis
5730329|NCT00393146|MRI|mri
5730330|NCT00393120|HIV-infection|hiv-infection
5730331|NCT00393120|viral load|viral load
5730332|NCT00393120|CCR5|ccr5
5730333|NCT00393120|viral tropism|viral tropism
5730334|NCT00393120|HIV-1 infection|hiv-1 infection
5730335|NCT00393120|Treatment Naive|treatment naive
5730336|NCT00393107|follicular lymphoma|follicular lymphoma
5730337|NCT00393107|non-Hodgkin lymphoma|non-hodgkin lymphoma
5730338|NCT00393107|Fludarabine|fludarabine
5730339|NCT00393107|Cyclophosphamide|cyclophosphamide
5730340|NCT00393107|Rituximab|rituximab
5730341|NCT00393107|combination|combination
5730342|NCT00393107|immuno-chemotherapy|immuno-chemotherapy
5730343|NCT00393107|relapsed|relapsed
5730344|NCT00393094|Brain Tumor|brain tumor
5730345|NCT00393094|Chemotherapy|chemotherapy
5730346|NCT00393094|Progression|progression
5730347|NCT00393094|Radiotherapy|radiotherapy
5730348|NCT00393094|Antiangiogenesis|antiangiogenesis
5730349|NCT00393094|Glioma|glioma
5730350|NCT00393042|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5730351|NCT00393042|sleep|sleep
5730352|NCT00393042|side effects|side effects
5730353|NCT00393042|stimulants|stimulants
5730354|NCT00393029|Tumor Regression|tumor regression
5730355|NCT00393029|In Vivo Cell Survival|in vivo cell survival
5730356|NCT00393029|Toxicity Profile|toxicity profile
5680925|NCT00575627|Combined therapy|combined therapy
5680926|NCT00575614|Constipation|constipation
5680927|NCT00575614|Prucalopride|prucalopride
5680928|NCT00575614|Ano-rectal physiology|ano-rectal physiology
5680929|NCT00575614|Oro-caecal transit time|oro-caecal transit time
5680931|NCT00575601|pco|pco
5680932|NCT00575601|simvastatin|simvastatin
5680933|NCT00575601|ivf|ivf
5680934|NCT00575601|embryo transfer|embryo transfer
5739674|NCT00359099|Surgery|surgery
5730357|NCT00393029|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5730358|NCT00393029|Cancer|cancer
5730359|NCT00393029|Metastatic Cancer|metastatic cancer
5730360|NCT00393003|Anesthesia|anesthesia
5730361|NCT00393003|Sedation|sedation
5730362|NCT00392990|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5730363|NCT00392990|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5730364|NCT00392990|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5730365|NCT00392990|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5730366|NCT00392990|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5730367|NCT00392990|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5730368|NCT00392977|Manganese|manganese
5730369|NCT00392977|Neonatal Intensive Care|neonatal intensive care
5730370|NCT00392977|MRI|mri
5730371|NCT00392977|Parenteral Nutrition|parenteral nutrition
5730372|NCT00392977|Prematurity|prematurity
5730373|NCT00392964|Antacids|antacids
5730374|NCT00392964|Proton pump inhibitors|proton pump inhibitors
5730375|NCT00392964|aspirin|aspirin
5730376|NCT00392964|ischemic heart disease|ischemic heart disease
5730377|NCT00392964|Dyspepsia|dyspepsia
5730378|NCT00392951|ALPS|alps
5730379|NCT00392951|Autoimmune|autoimmune
5730380|NCT00392951|Cytopenias|cytopenias
5730381|NCT00392951|Treatment|treatment
5730382|NCT00392951|Sirolimus|sirolimus
5730383|NCT00392951|Rapamycin|rapamycin
5730384|NCT00392951|Lymph Nodes|lymph nodes
5730385|NCT00392951|Spleen|spleen
5730386|NCT00392951|Hemolytic Anemia|hemolytic anemia
5730387|NCT00392951|Immune Thrombocytopenia|immune thrombocytopenia
5730388|NCT00392951|Neutropenia|neutropenia
5730389|NCT00392951|ITP|itp
5730390|NCT00392951|Lupus|lupus
5730391|NCT00392938|recurrent prostate cancer|recurrent prostate cancer
5730392|NCT00392938|stage IV prostate cancer|stage iv prostate cancer
5730393|NCT00392938|bone metastases|bone metastases
5730394|NCT00392925|overweight|overweight
5730395|NCT00392925|obesity|obesity
5730396|NCT00392925|pramlintide|pramlintide
5730397|NCT00392925|leptin|leptin
5730398|NCT00392925|Amylin|amylin
5730399|NCT00392912|testosterone|testosterone
5730400|NCT00392912|hypogonadal|hypogonadal
5730401|NCT00392912|cerebral glucose metabolism|cerebral glucose metabolism
5730402|NCT00392912|PET scan|pet scan
5730403|NCT00392912|Alzheimer's disease|alzheimer's disease
5730404|NCT00392899|stage II colon cancer|stage ii colon cancer
5730405|NCT00392899|stage II rectal cancer|stage ii rectal cancer
5730406|NCT00392899|adenocarcinoma of the colon|adenocarcinoma of the colon
5730407|NCT00392899|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5730408|NCT00392886|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5730409|NCT00392886|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5730410|NCT00392886|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5730411|NCT00392886|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5730412|NCT00392886|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5730587|NCT00392418|Sprinkles®|sprinkles®
5730415|NCT00392886|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5730417|NCT00392886|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5730418|NCT00392886|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5730419|NCT00392886|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5730420|NCT00392873|Amenorrhea|amenorrhea
5730421|NCT00392873|Energy deficiency|energy deficiency
5730422|NCT00392873|Resting energy expenditure|resting energy expenditure
5730423|NCT00392873|Bone metabolism|bone metabolism
5730424|NCT00392873|Bone mineral density|bone mineral density
5730425|NCT00392873|Exercise|exercise
5730426|NCT00392860|Wheelchair|wheelchair
5730427|NCT00392860|Handrims|handrims
5730428|NCT00392860|Rehabilitation|rehabilitation
5730429|NCT00392860|Upper extremity|upper extremity
5730430|NCT00392847|Child mental disorder|child mental disorder
5730431|NCT00392847|Home visit|home visit
5730432|NCT00392847|Postnatal depression|postnatal depression
5730433|NCT00392847|Social Support|social support
5680935|NCT00575588|DPP-4 Inhibitors|dpp-4 inhibitors
5730434|NCT00392847|Random selection|random selection
5730435|NCT00392834|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5730436|NCT00392834|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5730437|NCT00392834|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5730438|NCT00392834|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5730439|NCT00392834|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5730440|NCT00392834|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5730441|NCT00392808|Meningococcal vaccine|meningococcal vaccine
5730442|NCT00392808|Immunization, secondary|immunization, secondary
5730443|NCT00392808|vaccines conjugated|vaccines conjugated
5730444|NCT00392808|Meningococcal disease|meningococcal disease
5730445|NCT00392795|Critical Care|critical care
5730446|NCT00392795|Delirium|delirium
5730447|NCT00392795|Long-term cognitive impairment|long-term cognitive impairment
5730448|NCT00392795|mechanical ventilation|mechanical ventilation
5730449|NCT00392795|Critical illness|critical illness
5730450|NCT00392795|dementia|dementia
5730451|NCT00392795|sedatives and analgesics|sedatives and analgesics
5730452|NCT00392795|aging|aging
5730453|NCT00392782|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5730454|NCT00392782|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5730455|NCT00392782|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5730456|NCT00392782|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5730457|NCT00392782|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5730458|NCT00392782|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5730459|NCT00392782|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5730460|NCT00392782|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5730461|NCT00392782|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5730462|NCT00392782|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5730463|NCT00392782|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5730464|NCT00392782|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5730465|NCT00392782|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5730466|NCT00392782|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5730467|NCT00392782|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5730468|NCT00392782|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5730469|NCT00392782|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5730470|NCT00392769|Endometrial Cancer|endometrial cancer
5730471|NCT00392769|Progressive or Recurrent Endometrial Cancer|progressive or recurrent endometrial cancer
5730472|NCT00392769|Cetuximab|cetuximab
5730473|NCT00392769|C225|c225
5730474|NCT00392769|Erbitux™|erbitux™
5730475|NCT00392769|IMC-C225|imc-c225
5730476|NCT00392769|Epidermal growth factor receptor|epidermal growth factor receptor
5730478|NCT00392769|Endometrioid Tumor|endometrioid tumor
5730480|NCT00392769|Clear cell Tumor|clear cell tumor
5730481|NCT00392769|Mixed malignant Mullerian Tumors|mixed malignant mullerian tumors
5730486|NCT00392743|Bolus|bolus
5730487|NCT00392743|11C-Raclopride|11c-raclopride
5730488|NCT00392743|Schizophrenia|schizophrenia
5730489|NCT00392743|123I-IBZM|123i-ibzm
5730490|NCT00392743|SPECT|spect
5730491|NCT00392743|Receptor Occupancy|receptor occupancy
5730493|NCT00392743|MRI|mri
5730494|NCT00392743|Antipsychotics|antipsychotics
5730495|NCT00392743|Bolus/Infusion|bolus/infusion
5730497|NCT00392730|Neonatal Intensive Care|neonatal intensive care
5730498|NCT00392730|MRI|mri
5730499|NCT00392730|Parenteral Nutrition|parenteral nutrition
5730500|NCT00392730|Prematurity|prematurity
5730501|NCT00392717|lipoprotein metabolism|lipoprotein metabolism
5730502|NCT00392717|cardiovascular disease|cardiovascular disease
5730503|NCT00392717|obesity|obesity
5730504|NCT00392691|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5730505|NCT00392691|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5730506|NCT00392691|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5730507|NCT00392691|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5730508|NCT00392691|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5730509|NCT00392691|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5730510|NCT00392691|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5738796|NCT00362141|status|status
5729512|NCT00396318|CVA|cva
5730511|NCT00392691|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5730512|NCT00392691|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5730513|NCT00392691|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5730514|NCT00392691|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5730515|NCT00392691|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5730516|NCT00392691|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5730517|NCT00392691|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5730518|NCT00392691|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5730519|NCT00392691|Waldenström macroglobulinemia|waldenström macroglobulinemia
5730520|NCT00392678|Type 2 Diabetes|type 2 diabetes
5730521|NCT00392678|Inflammation|inflammation
5730523|NCT00392678|Metabolic Syndrome|metabolic syndrome
5730524|NCT00392665|SCCHN|scchn
5730525|NCT00392665|erlotinib|erlotinib
5730526|NCT00392665|tarceva|tarceva
5730527|NCT00392639|Heart arrest|heart arrest
5730528|NCT00392639|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5730529|NCT00392639|Humans|humans
5730530|NCT00392639|Hypothermia|hypothermia
5730531|NCT00392639|Brain diseases|brain diseases
5730532|NCT00392639|Hypoxia-ischemia|hypoxia-ischemia
5730533|NCT00392639|Cost Benefit Analysis|cost benefit analysis
5730534|NCT00392639|Prospective study|prospective study
5730535|NCT00392639|Comparative study|comparative study
5730536|NCT00392639|Treatment outcome|treatment outcome
5730537|NCT00392639|Hypothermia for|hypothermia for
5730538|NCT00392639|out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5730539|NCT00392639|from cardiac origin|from cardiac origin
5730540|NCT00392639|successfully resuscitated|successfully resuscitated
5730541|NCT00392587|Pharmacodynamics|pharmacodynamics
5730542|NCT00392587|Pharmacokinetics|pharmacokinetics
5730543|NCT00392587|Tolerability|tolerability
5730544|NCT00392587|COPD|copd
5730545|NCT00392587|Safety|safety
5730546|NCT00392574|Gastroenteritis|gastroenteritis
5730547|NCT00392548|GBM|gbm
5730548|NCT00392548|glioblastoma|glioblastoma
5730549|NCT00392548|urine|urine
5730550|NCT00392548|VEGF|vegf
5730551|NCT00392548|radiation|radiation
5730552|NCT00392548|Patients must be enrolled to an RTOG GBM study that prescribes 6000 cGy of radiation therapy.|patients must be enrolled to an rtog gbm study that prescribes 6000 cgy of radiation therapy.
5730553|NCT00392535|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5730554|NCT00392535|stage IIB prostate cancer|stage iib prostate cancer
5730555|NCT00392535|stage IIA prostate cancer|stage iia prostate cancer
5730556|NCT00392535|stage III prostate cancer|stage iii prostate cancer
5730557|NCT00392522|Anxiety|anxiety
5730558|NCT00392522|Cough|cough
5730559|NCT00392522|Number of general anaesthesias (due to procedure failure)|number of general anaesthesias (due to procedure failure)
5730560|NCT00392522|Patients satisfaction|patients satisfaction
5730561|NCT00392522|Chest physician satisfaction|chest physician satisfaction
5730562|NCT00392509|critical limb ischemia|critical limb ischemia
5730563|NCT00392509|cell therapy for angiogenesis|cell therapy for angiogenesis
5730564|NCT00392509|aldehyde dehydrogenase-bright cells|aldehyde dehydrogenase-bright cells
5730565|NCT00392509|peripheral artery disease|peripheral artery disease
5730566|NCT00392509|peripheral vascular disease|peripheral vascular disease
5730567|NCT00392509|leg pain|leg pain
5730569|NCT00392509|PAD|pad
5730570|NCT00392509|CLI|cli
5730571|NCT00392509|amputation|amputation
5730572|NCT00392509|limb salvage|limb salvage
5730573|NCT00392483|Heading Health Plan Implementation|heading health plan implementation
5725640|NCT00411814|antibody,|antibody,
5730574|NCT00392483|Computer-Assisted Instruction|computer-assisted instruction
5730577|NCT00392470|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5730578|NCT00392470|stage III rectal cancer|stage iii rectal cancer
5730579|NCT00392470|stage IV rectal cancer|stage iv rectal cancer
5730580|NCT00392457|Idiopathic Hypogonadotropic Hypogonadism|idiopathic hypogonadotropic hypogonadism
5730581|NCT00392457|Kallmann Syndrome|kallmann syndrome
5730582|NCT00392457|Agonadal|agonadal
5730583|NCT00392418|iron deficiency anemia|iron deficiency anemia
5730584|NCT00392418|hematologic disease|hematologic disease
5730588|NCT00392418|iron|iron
5730589|NCT00392418|micronutrient|micronutrient
5730590|NCT00392405|Contrast Induced Nephropathy|contrast induced nephropathy
5730591|NCT00392392|Breast Cancer|breast cancer
5730592|NCT00392379|Tobacco use disorder|tobacco use disorder
5730593|NCT00392379|Tobacco cessation|tobacco cessation
5730594|NCT00392366|MRI guided Laser Therapy|mri guided laser therapy
5730595|NCT00392366|Laser Interstitial Thermal Therapy|laser interstitial thermal therapy
5730596|NCT00392366|Magnetic Resonance Thermal Imaging|magnetic resonance thermal imaging
5730597|NCT00392366|Liver Metastasis|liver metastasis
5730598|NCT00392340|recurrent neuroblastoma|recurrent neuroblastoma
5730599|NCT00392340|disseminated neuroblastoma|disseminated neuroblastoma
5730600|NCT00392314|hodgkin lymphoma|hodgkin lymphoma
5730601|NCT00392314|PET/CT|pet/ct
5730602|NCT00392314|Therapy|therapy
5730603|NCT00392301|wound healing|wound healing
5730604|NCT00392301|skin|skin
5730605|NCT00392301|graft donor site|graft donor site
5730606|NCT00392301|donor site|donor site
5730607|NCT00392301|transepidermal water loss|transepidermal water loss
5730608|NCT00392288|Bronchial Asthma|bronchial asthma
5730609|NCT00392275|Cataract|cataract
5730610|NCT00392275|Aqueous absorption|aqueous absorption
5730611|NCT00392275|Funtioning Filtering Blebs|funtioning filtering blebs
5730612|NCT00392262|Moderate essential hypertension (WHO grade II)|moderate essential hypertension (who grade ii)
5730613|NCT00392249|Schizophrenia|schizophrenia
5730614|NCT00392249|Drug adherence|drug adherence
5730615|NCT00392236|Schizoaffective Disorder|schizoaffective disorder
5730616|NCT00392197|OPC-14597|opc-14597
5730617|NCT00392197|Schizophrenia|schizophrenia
5730618|NCT00392184|accelerated partial breast irradiation|accelerated partial breast irradiation
5730619|NCT00392184|multicatheter brachytherapy|multicatheter brachytherapy
5730620|NCT00392184|high dose rate brachytherapy|high dose rate brachytherapy
5730621|NCT00392184|pulsed dose rate brachytherapy|pulsed dose rate brachytherapy
5730622|NCT00392145|Pediatrics|pediatrics
5730623|NCT00392145|Gastroenteritis|gastroenteritis
5730624|NCT00392145|Dehydration|dehydration
5730625|NCT00392145|IV Rehydration|iv rehydration
5730626|NCT00392132|HIV|hiv
5730627|NCT00392119|MR-guided therapy|mr-guided therapy
5730628|NCT00392119|Laser interstitial thermal therapy|laser interstitial thermal therapy
5730629|NCT00392119|brain metastasis|brain metastasis
5730630|NCT00392119|Magnetic Resonance Thermal imaging (MRTI)|magnetic resonance thermal imaging (mrti)
5730631|NCT00392106|atrial fibrillation|atrial fibrillation
5730632|NCT00392106|arrhythmia|arrhythmia
5730633|NCT00392106|AF ablation|af ablation
5730634|NCT00392106|antiarrhythmic agent|antiarrhythmic agent
5730635|NCT00392106|catheter ablation|catheter ablation
5730636|NCT00392106|pulmonary veins|pulmonary veins
5730637|NCT00392093|Systemic lupus erythematosus|systemic lupus erythematosus
5730638|NCT00392093|Menopause hormonal therapy|menopause hormonal therapy
5730639|NCT00392093|Menopausal symptoms|menopausal symptoms
5730640|NCT00392093|Bone mineral density|bone mineral density
5730641|NCT00392054|Atrial Fibrillation|atrial fibrillation
5730642|NCT00392054|Paroxysmal|paroxysmal
5730643|NCT00392054|Pulmonary Vein Isolation|pulmonary vein isolation
5730644|NCT00392054|Ablation Catheter|ablation catheter
5730645|NCT00392054|Anti-arrhythmic Drug Therapy|anti-arrhythmic drug therapy
5730646|NCT00392054|First Line Therapy|first line therapy
5730647|NCT00392041|Fibromyalgia|fibromyalgia
5730648|NCT00392041|Insomnia|insomnia
5730649|NCT00392041|Sleep|sleep
5730650|NCT00392041|Eszopiclone|eszopiclone
5730651|NCT00392041|Lunesta|lunesta
5730652|NCT00392028|Ertapenem|ertapenem
5730653|NCT00392028|Bone drug level|bone drug level
5730654|NCT00392028|Blood drug level|blood drug level
5730655|NCT00392028|Tissue drug level|tissue drug level
5730656|NCT00392015|Malaria Vaccine|malaria vaccine
5730657|NCT00392015|Adenovirus|adenovirus
5730658|NCT00392015|Plasmodium falciparum|plasmodium falciparum
5730659|NCT00392002|GERD|gerd
5730660|NCT00391989|Ph+ Acute Lymphoblastic Leukaemia|ph+ acute lymphoblastic leukaemia
5730661|NCT00391989|Dasatinib|dasatinib
5730662|NCT00391989|targeted therapy|targeted therapy
5730663|NCT00391989|Patients with Ph positive and or BCR ABL positive ALL|patients with ph positive and or bcr abl positive all
5730664|NCT00391976|Cystic fibrosis|cystic fibrosis
5730665|NCT00391950|Prostate cancer|prostate cancer
5730666|NCT00391950|Cancer treatment induced bone loss (CTIBL)|cancer treatment induced bone loss (ctibl)
5730667|NCT00391950|Androgen deprivation therapy (ADT)|androgen deprivation therapy (adt)
5730668|NCT00391937|"resurfacing hip [MESH]"|"resurfacing hip [mesh]"
5730669|NCT00391937|"conventional position method"|"conventional position method"
5730670|NCT00391937|"surgery, computer-assisted [MESH]"|"surgery, computer-assisted [mesh]"
5730671|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone
5730673|NCT00391924|Quality of life|quality of life
5730674|NCT00391924|Lupus Erythematosus, Systemic|lupus erythematosus, systemic
5730675|NCT00391924|Sjogren's Syndrome|sjogren's syndrome
5730676|NCT00391924|Bone mineral density|bone mineral density
5730677|NCT00391911|Rhabdomyolysis|rhabdomyolysis
5730679|NCT00391911|N-Acetylcysteine|n-acetylcysteine
5730778|NCT00391430|PTSD|ptsd
5730779|NCT00391430|Trauma|trauma
5730780|NCT00391430|Sexual Abuse|sexual abuse
5730680|NCT00391898|Parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living|parkinson's disease, adults, levodopa/carbidopa/entacapone, wearing-off, activities of daily living
5730681|NCT00391872|ACS|acs
5730682|NCT00391872|Acute coronary syndrome|acute coronary syndrome
5730683|NCT00391872|Heart attack|heart attack
5730684|NCT00391872|Unstable angina|unstable angina
5730685|NCT00391872|Coronary artery disease|coronary artery disease
5730686|NCT00391859|Pharmacist-initiated Intervention Trial in OsteoArthritis|pharmacist-initiated intervention trial in osteoarthritis
5730687|NCT00391846|Heart Failure|heart failure
5730688|NCT00391846|Ventricular Dysfunction|ventricular dysfunction
5730689|NCT00391846|NTproBNP|ntprobnp
5730690|NCT00391833|Alzheimer's disease, Ginseng, CD34|alzheimer's disease, ginseng, cd34
5730691|NCT00391820|constipation|constipation
5730692|NCT00391820|chronic|chronic
5730693|NCT00391820|bowel function|bowel function
5730694|NCT00391807|Contraception|contraception
5739020|NCT00361244|Sutent|sutent
5730695|NCT00391794|Memory|memory
5730696|NCT00391794|Alzheimer's disease|alzheimer's disease
5730697|NCT00391794|Dementia|dementia
5730698|NCT00391794|Support Group|support group
5730699|NCT00391794|Psychosocial|psychosocial
5730700|NCT00391781|mechanical infertility|mechanical infertility
5730701|NCT00391781|hysterosalpingogram|hysterosalpingogram
5730702|NCT00391781|hysterosalpingography|hysterosalpingography
5789083|NCT00149981|Kidney, heart, lung, liver, pancreas|kidney, heart, lung, liver, pancreas
5740050|NCT00357643|calcium|calcium
5730703|NCT00391768|influenza, oseltamivir, Tamiflu®, antiviral, children, infants|influenza, oseltamivir, tamiflu®, antiviral, children, infants
5730704|NCT00391755|Migraine Headache|migraine headache
5730705|NCT00391742|Brief intervention|brief intervention
5730706|NCT00391742|Motivational Interviewing|motivational interviewing
5730707|NCT00391742|Primary care|primary care
5730708|NCT00391742|Stepped-care|stepped-care
5730709|NCT00391729|ADHD|adhd
5730710|NCT00391716|Alcohol|alcohol
5730711|NCT00391716|Alcohol treatment|alcohol treatment
5730712|NCT00391716|Alcoholism|alcoholism
5730713|NCT00391716|Alcohol Dependence|alcohol dependence
5730714|NCT00391703|Cystic fibrosis|cystic fibrosis
5730715|NCT00391703|mucoviscidosis|mucoviscidosis
5730716|NCT00391703|electrostimulation|electrostimulation
5730717|NCT00391703|retraining|retraining
5730718|NCT00391690|Serum bone marker|serum bone marker
5730719|NCT00391690|Prostate cancer|prostate cancer
5730720|NCT00391690|Bisphosphonates|bisphosphonates
5730721|NCT00391690|Early detection of metastasis|early detection of metastasis
5730722|NCT00391677|Cognitive Rehabilitation|cognitive rehabilitation
5730723|NCT00391677|Behavior Therapy|behavior therapy
5730724|NCT00391664|Endometrial cancer|endometrial cancer
5730725|NCT00391664|Ovarian Cancer|ovarian cancer
5730726|NCT00391664|Cervical Cancer|cervical cancer
5730727|NCT00391664|Genital Cancer|genital cancer
5730728|NCT00391664|Vulvar Cancer|vulvar cancer
5730729|NCT00391664|Vaginal Cancer|vaginal cancer
5730730|NCT00391664|Other Gynecological Cancers|other gynecological cancers
5730731|NCT00391651|UTI|uti
5730732|NCT00391638|HIV and Hepatitis B coinfection|hiv and hepatitis b coinfection
5730733|NCT00391638|Peg interferon|peg interferon
5730734|NCT00391638|tenofovir|tenofovir
5730735|NCT00391638|emtricitabine|emtricitabine
5730736|NCT00391638|Hepatitis B e Antigens|hepatitis b e antigens
5730737|NCT00391638|Treatment Experienced|treatment experienced
5730738|NCT00391625|Gaucher disease, Enzyme Replacement Therapy|gaucher disease, enzyme replacement therapy
5730739|NCT00391612|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5730740|NCT00391612|Emphysema|emphysema
5730741|NCT00391612|Hyperinflation|hyperinflation
5730742|NCT00391612|Minimally Invasive|minimally invasive
5730743|NCT00391599|Cesarean Section,|cesarean section,
5730744|NCT00391599|Enema|enema
5730745|NCT00391586|erlotinib|erlotinib
5730746|NCT00391586|NSCLC|nsclc
5730747|NCT00391586|chemotherapy|chemotherapy
5730748|NCT00391586|platinum|platinum
5730749|NCT00391586|lung|lung
5730750|NCT00391586|lung cancer|lung cancer
5730751|NCT00391560|refractory leukemia|refractory leukemia
5730752|NCT00391547|Gingivitis Disease|gingivitis disease
5730753|NCT00391534|Epilepsy|epilepsy
5730754|NCT00391534|oxcarbazepine|oxcarbazepine
5730755|NCT00391521|Oncology. All solid Tumour disease.|oncology. all solid tumour disease.
5730756|NCT00391508|Ostomy|ostomy
5730757|NCT00391508|Peristomal skin|peristomal skin
5730758|NCT00391508|Skin complication|skin complication
5748220|NCT00326677|Prevention of Depression|prevention of depression
5721199|NCT00427336|SAA|saa
5748221|NCT00326677|Depression in the Elderly|depression in the elderly
5748222|NCT00326677|Late Life Depression|late life depression
5748223|NCT00326677|Depression in Old Age|depression in old age
5748225|NCT00326677|Sub syndromal depression|sub syndromal depression
5730760|NCT00391495|Cytokines|cytokines
5730761|NCT00391495|CR-P|cr-p
5730762|NCT00391482|IV Drug Users|iv drug users
5730763|NCT00391482|Hepatitis C Virus|hepatitis c virus
5730764|NCT00391482|Human Immunodeficiency Virus|human immunodeficiency virus
5730765|NCT00391482|Intervention|intervention
5730766|NCT00391482|HIV Seronegativity|hiv seronegativity
5730767|NCT00391469|cardiac arrest|cardiac arrest
5730768|NCT00391469|mild hypothermia|mild hypothermia
5730769|NCT00391456|animal-assisted therapy|animal-assisted therapy
5730770|NCT00391456|dog hospital visit|dog hospital visit
5730771|NCT00391456|heart failure|heart failure
5730772|NCT00391443|BUILD 3|build 3
5730773|NCT00391443|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5730774|NCT00391443|Tracleer|tracleer
5730775|NCT00391443|Interstitial Lung Disease|interstitial lung disease
5730776|NCT00391443|bosentan|bosentan
5730777|NCT00391443|Actelion|actelion
5730781|NCT00391430|Sexual Assault|sexual assault
5730782|NCT00391417|hot flush|hot flush
5730783|NCT00391417|hot flash|hot flash
5730784|NCT00391417|estrogen|estrogen
5730785|NCT00391417|vaginal atrophy|vaginal atrophy
5730786|NCT00391404|Childhood cancer survivors|childhood cancer survivors
5730787|NCT00391404|Osteoporosis|osteoporosis
5730788|NCT00391404|Bone mineral density|bone mineral density
5729733|NCT00395447|Upgrade|upgrade
5730789|NCT00391404|Therapy|therapy
5730790|NCT00391404|Bisphosphonate|bisphosphonate
5730791|NCT00391404|Randomized controlled trial|randomized controlled trial
5730792|NCT00391391|Influenza|influenza
5730793|NCT00391391|Orthomyxoviruses|orthomyxoviruses
5730794|NCT00391391|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5730795|NCT00391391|Infants|infants
5730796|NCT00391391|children.|children.
5730797|NCT00391378|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5680936|NCT00575588|HbA1c|hba1c
5730798|NCT00391378|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5730799|NCT00391378|Stroke|stroke
5730800|NCT00391378|Cognition|cognition
5730801|NCT00391378|Heart|heart
5730802|NCT00391365|ankle osteoarthritis|ankle osteoarthritis
5730803|NCT00391365|arthritis|arthritis
5730804|NCT00391365|arthrodesis|arthrodesis
5730805|NCT00391365|arthroplasty|arthroplasty
5730806|NCT00391365|Gait|gait
5730807|NCT00391365|step count|step count
5730808|NCT00391365|walking|walking
5730809|NCT00391352|Multiple Sclerosis|multiple sclerosis
5730810|NCT00391352|Disease Modifying Therapy|disease modifying therapy
5730811|NCT00391339|Bryophyllum p.|bryophyllum p.
5730812|NCT00391339|Nifedipine|nifedipine
5730813|NCT00391339|Tocolysis|tocolysis
5730814|NCT00391326|Bivalirudin|bivalirudin
5730815|NCT00391326|Heparin|heparin
5730816|NCT00391326|Bleeding|bleeding
5730817|NCT00391326|TIMI flow|timi flow
5730818|NCT00391326|STEMI|stemi
5730819|NCT00391313|Chikungunya|chikungunya
5730820|NCT00391313|Chikungunya disease|chikungunya disease
5730821|NCT00391300|melanoma|melanoma
5730822|NCT00391300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5730823|NCT00391300|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5730824|NCT00391287|Red-Cell Aplasia due to Chronic Kidney Failure|red-cell aplasia due to chronic kidney failure
5730825|NCT00391287|Aplastic Anemia|aplastic anemia
5730826|NCT00391287|Recombinant Erythropoietin|recombinant erythropoietin
5730827|NCT00391287|Surveillance Registry|surveillance registry
5730828|NCT00391287|Registries|registries
5730829|NCT00391261|weight gain|weight gain
5730830|NCT00391261|obesity|obesity
5730831|NCT00391261|metabolism|metabolism
5730832|NCT00391248|non-small cell lung cancer|non-small cell lung cancer
5730833|NCT00391248|palliative radiation|palliative radiation
5730834|NCT00391248|tarceva|tarceva
5730835|NCT00391248|palliative thoracic radiation therapy|palliative thoracic radiation therapy
5730836|NCT00391235|bipolar disorder|bipolar disorder
5730837|NCT00391235|magnetic resonance imaging|magnetic resonance imaging
5730838|NCT00391235|white matter|white matter
5730839|NCT00391235|diffusion tensor imaging|diffusion tensor imaging
5730840|NCT00391235|children|children
5730841|NCT00391235|adolescents|adolescents
5730842|NCT00391222|Bipolar I Disorder|bipolar i disorder
5730843|NCT00391222|Intramuscular injection|intramuscular injection
5730844|NCT00391222|prevention of mood episodes|prevention of mood episodes
5730845|NCT00391222|long acting injectable|long acting injectable
5730846|NCT00391222|risperidone|risperidone
5730847|NCT00391183|Gallbladder cancer|gallbladder cancer
5730848|NCT00391183|Quality of life|quality of life
5730849|NCT00391183|Stenting|stenting
5730850|NCT00391183|Survival|survival
5730851|NCT00391183|Performance status|performance status
5730852|NCT00391170|Oral Chronic GVHD|oral chronic gvhd
5730853|NCT00391170|Topical Dexamethasone|topical dexamethasone
5730854|NCT00391170|Tissue Markers|tissue markers
5730855|NCT00391170|Salivary Proteomics|salivary proteomics
5730856|NCT00391170|Quality of Life|quality of life
5730857|NCT00391170|Oral Chronic Graft Versus Host Disease|oral chronic graft versus host disease
5730858|NCT00391170|Oral Pain|oral pain
5730860|NCT00391157|Múltiple Myeloma|múltiple myeloma
5730862|NCT00391157|Patients <65 years.|patients <65 years.
5730863|NCT00391144|Pattern Dystrophy|pattern dystrophy
5730864|NCT00391144|Choroidal Neovascularization|choroidal neovascularization
5730865|NCT00391144|Intravitreal Avastin Injection|intravitreal avastin injection
5730866|NCT00391131|PID|pid
5730867|NCT00391131|SCIG|scig
5730868|NCT00391131|Ig|ig
5730869|NCT00391131|Quality of Life|quality of life
5730870|NCT00391131|Serious Bacterial Infections|serious bacterial infections
5730871|NCT00391105|intubation|intubation
5730872|NCT00391105|Sedation|sedation
5730873|NCT00391105|Analgesia|analgesia
5730874|NCT00391105|preterm neonate|preterm neonate
5730875|NCT00391105|remifentanil|remifentanil
5730876|NCT00391105|morphine|morphine
5730877|NCT00391105|respiratory distress syndrome|respiratory distress syndrome
5730878|NCT00391079|Central Neuropathic Pain|central neuropathic pain
5730879|NCT00391066|CD23+/CD20+ B-cell CLL|cd23+/cd20+ b-cell cll
5730880|NCT00391066|CLL|cll
5730881|NCT00391053|Influenza|influenza
5730882|NCT00391053|Orthomyxoviruses|orthomyxoviruses
5730883|NCT00391053|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5730884|NCT00391053|Adults|adults
5730885|NCT00391040|diabetes mellitus, structured treatment and teaching, education,|diabetes mellitus, structured treatment and teaching, education,
5730886|NCT00391040|elderly patients, geriatrics|elderly patients, geriatrics
5739158|NCT00361023|losartan|losartan
5730887|NCT00391027|type 2 diabetes, insulin, glycemic control|type 2 diabetes, insulin, glycemic control
5730888|NCT00391014|Acute myeloid Leukemia|acute myeloid leukemia
5730889|NCT00391014|Allogeneic haematopoietic progenitor cell transplant|allogeneic haematopoietic progenitor cell transplant
5730890|NCT00391014|Acute Invasive Aspergillosis|acute invasive aspergillosis
5730891|NCT00391001|mania|mania
5730892|NCT00391001|bipolar disorder|bipolar disorder
5730893|NCT00391001|taurine|taurine
5730894|NCT00391001|adolescents|adolescents
5730895|NCT00390988|blood count|blood count
5730896|NCT00390988|capillary|capillary
5730897|NCT00390988|venous|venous
5730898|NCT00390988|Adult|adult
5730899|NCT00390988|reference values|reference values
5730900|NCT00390975|Tegaserod|tegaserod
5730901|NCT00390975|diabetes|diabetes
5730902|NCT00390975|diabetic gastroparesis|diabetic gastroparesis
5730903|NCT00390975|gastric emptying|gastric emptying
5730904|NCT00390975|gastric retention|gastric retention
5730905|NCT00390975|electrogastrography|electrogastrography
5730906|NCT00390962|copeptin|copeptin
5730907|NCT00390962|vasopressin|vasopressin
5730910|NCT00390962|diabetes insipidus|diabetes insipidus
5730911|NCT00390962|stroke|stroke
5730912|NCT00390962|risk factors|risk factors
5730913|NCT00390962|Neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.|neurological patients with ischemic and hemorrhagic stroke and patients undergoing intracranial surgery.
5730914|NCT00390949|HIV prevention|hiv prevention
5730915|NCT00390949|Zimbabwe|zimbabwe
5730916|NCT00390949|Core groups|core groups
5730917|NCT00390949|Peer education|peer education
5730918|NCT00390949|Syndromic management|syndromic management
5730919|NCT00390949|Commercial sex workers|commercial sex workers
5730920|NCT00390949|Condom distribution|condom distribution
5730921|NCT00390949|HIV Seronegativity|hiv seronegativity
5730922|NCT00390923|smoking|smoking
5730923|NCT00390923|nicotine dependence|nicotine dependence
5730924|NCT00390923|double-blind|double-blind
5730925|NCT00390923|placebo-controlled|placebo-controlled
5730926|NCT00390923|randomized|randomized
5730927|NCT00390923|full substitution therapy|full substitution therapy
5730928|NCT00390923|selegiline|selegiline
5730929|NCT00390910|Pneumococcal vaccine|pneumococcal vaccine
5730930|NCT00390910|Preterm|preterm
5730931|NCT00390910|Safety|safety
5730932|NCT00390910|Pneumococcal disease|pneumococcal disease
5730933|NCT00390910|Immunogenicity|immunogenicity
5730934|NCT00390897|chronic myeloid leukaemia|chronic myeloid leukaemia
5730935|NCT00390897|Glivec|glivec
5730936|NCT00390897|Interferon|interferon
5730937|NCT00390884|Fluzone®|fluzone®
5730938|NCT00390884|Influenza|influenza
5730939|NCT00390884|Influenza virus infection|influenza virus infection
5730940|NCT00390884|Influenza vaccine|influenza vaccine
5730941|NCT00390858|β-thalassemia major|β-thalassemia major
5730942|NCT00390858|iron overload|iron overload
5730943|NCT00390858|deferasirox|deferasirox
5730944|NCT00390858|pediatric rare anemia|pediatric rare anemia
5730945|NCT00390845|MAP kinase|map kinase
5730946|NCT00390845|SB681323|sb681323
5730947|NCT00390845|neuropathic pain|neuropathic pain
5730948|NCT00390845|patients|patients
5730950|NCT00390845|nerve trauma|nerve trauma
5730951|NCT00390832|STEMI|stemi
5730952|NCT00390819|Community acquired pneumonia|community acquired pneumonia
5730953|NCT00390806|Brain metastases from Non-Small Cell Lung Cancer|brain metastases from non-small cell lung cancer
5730954|NCT00390806|Brain metastases brain tumor lung cancer oral chemotherapy HYCAMTIN topotecan NSCLC WBRT whole brain radiation|brain metastases brain tumor lung cancer oral chemotherapy hycamtin topotecan nsclc wbrt whole brain radiation
5730955|NCT00390780|Miconazole Lauriad|miconazole lauriad
5730956|NCT00390780|Oropharyngeal candidiasis|oropharyngeal candidiasis
5730958|NCT00390780|Mycology|mycology
5730959|NCT00390780|Clinical picture of Oropharyngeal candidiasis|clinical picture of oropharyngeal candidiasis
5730960|NCT00390780|Candida culture positive|candida culture positive
5730961|NCT00390780|Treatment Experienced|treatment experienced
5730962|NCT00390767|Peripheral arterial disease|peripheral arterial disease
5730963|NCT00390767|Peripheral vascular disease|peripheral vascular disease
5730964|NCT00390767|Claudication|claudication
5730965|NCT00390767|Cell therapy|cell therapy
5730966|NCT00390767|Gene therapy|gene therapy
5730967|NCT00390767|Endothelial cells|endothelial cells
5730968|NCT00390767|Smooth muscle cells|smooth muscle cells
5730969|NCT00390767|Angiogenesis|angiogenesis
5730970|NCT00390754|pregnancy|pregnancy
5730971|NCT00390754|unintended|unintended
5730972|NCT00390754|menses|menses
5730973|NCT00390741|hip fracture|hip fracture
5730974|NCT00390741|bone mineral density|bone mineral density
5730975|NCT00390741|exercise|exercise
5730976|NCT00390715|Acute Myeloblastic Leukemia|acute myeloblastic leukemia
5730977|NCT00390702|Ventricular septal defect|ventricular septal defect
5730979|NCT00390676|cancer|cancer
5730980|NCT00390676|tumors|tumors
5730981|NCT00390676|anticarcinogenic agents|anticarcinogenic agents
5730982|NCT00390676|antineoplastic agents|antineoplastic agents
5730983|NCT00390676|cadherins|cadherins
5730984|NCT00390676|solid tumors|solid tumors
5730985|NCT00390663|Paediatric|paediatric
5739327|NCT00360438|TLS|tls
5730986|NCT00390663|Epistaxis|epistaxis
5730987|NCT00390663|Nose bleed|nose bleed
5730988|NCT00390663|Naseptin|naseptin
5730989|NCT00390650|Anxiety|anxiety
5730990|NCT00390650|clinical trials|clinical trials
5730991|NCT00390637|Diogenes|diogenes
5730992|NCT00390637|Diet Intervention|diet intervention
5730993|NCT00390637|Family|family
5730994|NCT00390637|Glycemic Index|glycemic index
5730995|NCT00390637|Protein|protein
5730996|NCT00390624|Urodilatin|urodilatin
5730997|NCT00390624|Mannitol|mannitol
5730998|NCT00390624|Acute Kidney Failure|acute kidney failure
5730999|NCT00390611|Ovarian Cancer|ovarian cancer
5731000|NCT00390598|colonoscopy|colonoscopy
5731001|NCT00390598|large bowel preparation|large bowel preparation
5731002|NCT00390598|bowel cleansing|bowel cleansing
5731003|NCT00390598|randomized controlled trial|randomized controlled trial
5731004|NCT00390585|Renal Insufficiency|renal insufficiency
5731005|NCT00390585|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5731006|NCT00390585|Contrast media|contrast media
5731007|NCT00390572|sleep|sleep
5731107|NCT00390195|Rapamycin|rapamycin
5731008|NCT00390572|consultation and referral|consultation and referral
5731009|NCT00390572|outcome assessment|outcome assessment
5731010|NCT00390572|primary care|primary care
5731011|NCT00390559|Nicotine Replacement Therapy|nicotine replacement therapy
5731012|NCT00390559|Tobacco Smoking|tobacco smoking
5731013|NCT00390559|Smoking stimuli|smoking stimuli
5731014|NCT00390559|Gender|gender
5731015|NCT00390533|Anxiety|anxiety
5731016|NCT00390533|clinical trials|clinical trials
5731017|NCT00390520|Type 2 diabetes|type 2 diabetes
5731018|NCT00390520|vildagliptin|vildagliptin
5731019|NCT00390520|glucagon|glucagon
5731020|NCT00390520|hypoglycemia|hypoglycemia
5731021|NCT00390507|Acceleromyography|acceleromyography
5731022|NCT00390507|TOF-Watch|tof-watch
5731023|NCT00390507|Posttetanic count|posttetanic count
5731024|NCT00390507|Train of four|train of four
5731025|NCT00390507|Neuromuscular blockade|neuromuscular blockade
5731026|NCT00390494|Fibroids|fibroids
5731027|NCT00390494|Leiomyoma|leiomyoma
5731028|NCT00390494|Hysterectomy|hysterectomy
5731029|NCT00390494|Myomectomy|myomectomy
5731030|NCT00390494|Uterine Fibroid Embolization|uterine fibroid embolization
5731031|NCT00390494|Questionnaire|questionnaire
5731032|NCT00390481|Carotid Occlusion|carotid occlusion
5731033|NCT00390481|Cognition|cognition
5731034|NCT00390468|Tandutinib|tandutinib
5731035|NCT00390468|MLN518|mln518
5731036|NCT00390468|CT53518|ct53518
5731037|NCT00390468|pain|pain
5731038|NCT00390468|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5731039|NCT00390468|recurrent prostate cancer|recurrent prostate cancer
5731040|NCT00390468|stage IV prostate cancer|stage iv prostate cancer
5731041|NCT00390468|bone metastases|bone metastases
5731042|NCT00390468|hormone-based castration|hormone-based castration
5731043|NCT00390442|cardiogenic pulmonary edema|cardiogenic pulmonary edema
5731044|NCT00390442|non invasive ventilation|non invasive ventilation
5731045|NCT00390442|CPAP|cpap
5731046|NCT00390429|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5731047|NCT00390429|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5731048|NCT00390429|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5731049|NCT00390429|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731050|NCT00390416|Metastatic|metastatic
5731051|NCT00390416|Gastroesophageal|gastroesophageal
5731052|NCT00390416|Docetaxel|docetaxel
5731053|NCT00390416|Cisplatin|cisplatin
5731054|NCT00390416|Fluorouracil|fluorouracil
5731055|NCT00390416|Bevacizumab|bevacizumab
5731058|NCT00390403|adult glioblastoma|adult glioblastoma
5731059|NCT00390403|adult gliosarcoma|adult gliosarcoma
5731060|NCT00390403|adult giant cell glioblastoma|adult giant cell glioblastoma
5731061|NCT00390390|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
5731062|NCT00390377|x-ray diffraction|x-ray diffraction
5731063|NCT00390377|hair|hair
5731064|NCT00390377|breast cancer|breast cancer
5731065|NCT00390377|synchrotron|synchrotron
5731066|NCT00390364|adenocarcinoma of the colon|adenocarcinoma of the colon
5731067|NCT00390364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5731068|NCT00390364|recurrent colon cancer|recurrent colon cancer
5731069|NCT00390364|stage III colon cancer|stage iii colon cancer
5731070|NCT00390364|stage IV colon cancer|stage iv colon cancer
5731071|NCT00390364|recurrent rectal cancer|recurrent rectal cancer
5731072|NCT00390364|stage III rectal cancer|stage iii rectal cancer
5731073|NCT00390364|stage IV rectal cancer|stage iv rectal cancer
5731074|NCT00390351|Optical coherence tomography|optical coherence tomography
5731078|NCT00390338|stage IIIB melanoma|stage iiib melanoma
5731079|NCT00390338|stage IIIC melanoma|stage iiic melanoma
5731080|NCT00390312|Post operative pain|post operative pain
5731081|NCT00390312|Third molar extraction|third molar extraction
5731082|NCT00390312|Dental surgery|dental surgery
5731083|NCT00390312|Morphine|morphine
5731084|NCT00390286|Telemedicine|telemedicine
5731085|NCT00390273|diabetes|diabetes
5731086|NCT00390273|metformin|metformin
5731087|NCT00390273|hyperlactatemia|hyperlactatemia
5731088|NCT00390221|MS|ms
5731089|NCT00390221|multiple sclerosis|multiple sclerosis
5731090|NCT00390208|Macular Degeneration|macular degeneration
5731091|NCT00390208|Degenerative changes in the macula lutea of the retina.|degenerative changes in the macula lutea of the retina.
5731092|NCT00390208|Maculopathy, Age-Related|maculopathy, age-related
5731093|NCT00390208|Age-Related Maculopathies|age-related maculopathies
5731094|NCT00390208|Age-Related Maculopathy|age-related maculopathy
5731095|NCT00390208|Maculopathies, Age-Related|maculopathies, age-related
5731096|NCT00390208|RETINAL DEGENERATION|retinal degeneration
5731097|NCT00390208|ARMD|armd
5731098|NCT00390208|AMD|amd
5731099|NCT00390208|Lucentis|lucentis
5731100|NCT00390208|Visudyne|visudyne
5731101|NCT00390208|Photodynamic Therapy|photodynamic therapy
5731102|NCT00390208|Verteporfin|verteporfin
5731103|NCT00390208|Ranibizumab|ranibizumab
5731104|NCT00390208|Intravitreal Dexamethasone|intravitreal dexamethasone
5731105|NCT00390195|Hepatocellular carcinoma|hepatocellular carcinoma
5731106|NCT00390195|RAD001|rad001
5731111|NCT00390195|Pharmacokinetics|pharmacokinetics
5731112|NCT00390182|GI tumors|gi tumors
5731113|NCT00390182|Locally Advanced|locally advanced
5731114|NCT00390182|Metastatic|metastatic
5731115|NCT00390182|Hepatobiliary|hepatobiliary
5731116|NCT00390182|Ovary|ovary
5731117|NCT00390169|breast neoplasms|breast neoplasms
5731118|NCT00390169|stress|stress
5731119|NCT00390169|personality|personality
5731120|NCT00390169|psychology|psychology
5731121|NCT00390156|refractory|refractory
5731122|NCT00390156|prior treatment|prior treatment
5731123|NCT00390156|solid tumors|solid tumors
5731124|NCT00390156|phase I|phase i
5731125|NCT00390156|phase 1|phase 1
5731126|NCT00390143|Immunogenicity|immunogenicity
5731127|NCT00390143|Meningococcal vaccine|meningococcal vaccine
5731128|NCT00390143|Conjugate vaccine|conjugate vaccine
5731129|NCT00390143|Persistence|persistence
5731130|NCT00390130|Vaccination|vaccination
5731131|NCT00390130|Pediatrics|pediatrics
5731132|NCT00390130|Pain|pain
5731133|NCT00390117|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731134|NCT00390117|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5731135|NCT00390117|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5731136|NCT00390117|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5731137|NCT00390117|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5731138|NCT00390117|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5731139|NCT00390117|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5731140|NCT00390117|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5731141|NCT00390117|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5731142|NCT00390117|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5731143|NCT00390117|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5731144|NCT00390117|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5798833|NCT00110890|KDOQI, Cinacalcet|kdoqi, cinacalcet
5731145|NCT00390117|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5731146|NCT00390117|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5731147|NCT00390117|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5731148|NCT00390117|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5721546|NCT00426218|ACZ885|acz885
5731149|NCT00390117|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5731151|NCT00390117|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5731157|NCT00390091|Kidney|kidney
5731158|NCT00390091|SLE|sle
5731159|NCT00390091|Systemic Lupus Erythematosus|systemic lupus erythematosus
5731160|NCT00390091|Nephritis, Lupus|nephritis, lupus
5731161|NCT00390078|Vaccine|vaccine
5731162|NCT00390078|Safety|safety
5731163|NCT00390078|T-cell epitope|t-cell epitope
5731164|NCT00390078|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5731165|NCT00390078|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5731166|NCT00390065|Follow-up|follow-up
5731167|NCT00390065|Premature infants|premature infants
5731168|NCT00390065|Nitric Oxide|nitric oxide
5731169|NCT00390065|Respiratory function testing|respiratory function testing
5731170|NCT00390065|Neurodevelopmental outcomes|neurodevelopmental outcomes
5731171|NCT00390039|Pain, postoperative|pain, postoperative
5731172|NCT00390039|Surgery, orthopedic|surgery, orthopedic
5731173|NCT00390039|Morphine|morphine
5731174|NCT00390026|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5731175|NCT00390026|Bevacizumab|bevacizumab
5731176|NCT00390026|Photodynamic therapy|photodynamic therapy
5731177|NCT00390013|Vulvar Pain|vulvar pain
5731178|NCT00389948|Heartburn, frequent heartburn, proton pump inhibitor, lansoprazole|heartburn, frequent heartburn, proton pump inhibitor, lansoprazole
5731179|NCT00389935|Gastrointestinal Bleeding|gastrointestinal bleeding
5731180|NCT00389935|Arteriovenous Malformation|arteriovenous malformation
5731181|NCT00389935|Angiodysplasia|angiodysplasia
5680924|NCT00575627|Pegylated Interferon|pegylated interferon
5731182|NCT00389935|Hereditary Hemorrhagic Telangiectasia|hereditary hemorrhagic telangiectasia
5731183|NCT00389935|Obscure Bleeding|obscure bleeding
5731184|NCT00389922|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731185|NCT00389909|Premature infants|premature infants
5731186|NCT00389909|Apnea|apnea
5731187|NCT00389909|Doxapram|doxapram
5731188|NCT00389909|pharmacokinetics|pharmacokinetics
5731189|NCT00389883|supratentorial brain tumors|supratentorial brain tumors
5731190|NCT00389883|propofol|propofol
5731191|NCT00389883|sevoflurane|sevoflurane
5731192|NCT00389883|remifentanil|remifentanil
5731193|NCT00389883|sufentanil.|sufentanil.
5731194|NCT00389870|recurrent colon cancer|recurrent colon cancer
5731195|NCT00389870|stage IV colon cancer|stage iv colon cancer
5731196|NCT00389870|recurrent rectal cancer|recurrent rectal cancer
5731197|NCT00389870|stage IV rectal cancer|stage iv rectal cancer
5731198|NCT00389870|adenocarcinoma of the colon|adenocarcinoma of the colon
5731199|NCT00389870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5731200|NCT00389857|Influenza|influenza
5731482|NCT00388804|Lupron|lupron
5731201|NCT00389857|Influenza Virus Vaccine|influenza virus vaccine
5731202|NCT00389857|Fluzone®|fluzone®
5731203|NCT00389844|hip fracture|hip fracture
5731204|NCT00389844|exercise|exercise
5731205|NCT00389844|motivation|motivation
5731206|NCT00389831|Rotigotine|rotigotine
5731207|NCT00389831|Rotigotine nasal spray|rotigotine nasal spray
5731208|NCT00389831|Efficacy, safety and tolerability|efficacy, safety and tolerability
5731209|NCT00389831|Restless Legs Syndrome|restless legs syndrome
5731210|NCT00389818|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5731211|NCT00389818|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5731212|NCT00389818|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5731213|NCT00389818|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5731214|NCT00389818|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5731215|NCT00389818|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5731216|NCT00389818|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5731217|NCT00389818|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5731218|NCT00389818|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5731219|NCT00389818|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5731220|NCT00389818|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5731221|NCT00389818|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5731222|NCT00389818|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5731223|NCT00389818|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5731224|NCT00389818|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5731225|NCT00389818|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5731226|NCT00389818|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5731227|NCT00389818|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5731228|NCT00389805|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5731229|NCT00389805|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5731230|NCT00389805|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5731231|NCT00389805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731232|NCT00389766|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5731234|NCT00389766|regional neuroblastoma|regional neuroblastoma
5731235|NCT00389766|localized resectable neuroblastoma|localized resectable neuroblastoma
5731236|NCT00389766|disseminated neuroblastoma|disseminated neuroblastoma
5731237|NCT00389753|Scars|scars
5731238|NCT00389753|Hydratation|hydratation
5731239|NCT00389753|After Treatment|after treatment
5731240|NCT00389714|pedodontics|pedodontics
5731241|NCT00389714|carious|carious
5731242|NCT00389714|dental restoration|dental restoration
5731243|NCT00389714|antibacterial|antibacterial
5731244|NCT00389714|nanoparticles|nanoparticles
5731245|NCT00389701|stage I multiple myeloma|stage i multiple myeloma
5731539|NCT00388622|Compliance|compliance
5731246|NCT00389701|stage II multiple myeloma|stage ii multiple myeloma
5731247|NCT00389701|stage III multiple myeloma|stage iii multiple myeloma
5731248|NCT00389701|refractory multiple myeloma|refractory multiple myeloma
5731249|NCT00389688|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5731250|NCT00389688|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5731251|NCT00389649|congestive heart failure|congestive heart failure
5731252|NCT00389649|pacemaker|pacemaker
5731253|NCT00389649|heart rate|heart rate
5731254|NCT00389636|Diabetes|diabetes
5731255|NCT00389636|Foot|foot
5731256|NCT00389636|Extremity|extremity
5731257|NCT00389636|Ulcer|ulcer
5731258|NCT00389636|Wound|wound
5731259|NCT00389636|Gauze|gauze
5730240|NCT00393432|HV|hv
5731260|NCT00389610|stage I pancreatic cancer|stage i pancreatic cancer
5731261|NCT00389610|stage II pancreatic cancer|stage ii pancreatic cancer
5731262|NCT00389610|stage III pancreatic cancer|stage iii pancreatic cancer
5731263|NCT00389610|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5731264|NCT00389597|degenerative disc disease|degenerative disc disease
5731265|NCT00389597|cervical arthroplasty|cervical arthroplasty
5731266|NCT00389597|Mobi C|mobi c
5731267|NCT00389597|multilevel|multilevel
5731268|NCT00389597|anterior cervical discectomy and fusion|anterior cervical discectomy and fusion
5731269|NCT00389584|cognitive/functional effects|cognitive/functional effects
5731270|NCT00389584|poor performance status|poor performance status
5731271|NCT00389584|long-term effects secondary to cancer therapy in adults|long-term effects secondary to cancer therapy in adults
5731272|NCT00389584|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5731273|NCT00389584|adult tumors metastatic to brain|adult tumors metastatic to brain
5731274|NCT00389584|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731275|NCT00389584|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5731276|NCT00389558|Skin colonization|skin colonization
5731277|NCT00389558|Antiseptic|antiseptic
5731278|NCT00389558|Epicutaneocavous catheter dressing|epicutaneocavous catheter dressing
5731279|NCT00389558|Infant|infant
5731280|NCT00389532|Influenza|influenza
5731281|NCT00389532|Influenza Vaccine|influenza vaccine
5731282|NCT00389519|Hypertension/*etiology|hypertension/*etiology
5731283|NCT00389519|Blood Pressure|blood pressure
5731284|NCT00389519|Pediatric|pediatric
5731285|NCT00389519|Adolescent|adolescent
5731286|NCT00389519|Child|child
5731287|NCT00389506|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5731288|NCT00389506|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5731289|NCT00389506|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5731290|NCT00389506|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5731292|NCT00389493|Augmentation|augmentation
5731293|NCT00389493|Antipsychotics|antipsychotics
5731294|NCT00389493|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5731295|NCT00389480|Solid Tumors|solid tumors
5731296|NCT00389480|Solid Malignancies|solid malignancies
5731297|NCT00389480|Phase I|phase i
5731298|NCT00389467|stroke|stroke
5731299|NCT00389467|ischemic stroke|ischemic stroke
5731300|NCT00389467|blood clot|blood clot
5731301|NCT00389467|Merci Retriever|merci retriever
5731302|NCT00389467|Penumbra System|penumbra system
5731303|NCT00389467|embolectomy|embolectomy
5731304|NCT00389467|magnetic resonance imaging|magnetic resonance imaging
5731306|NCT00389467|CT|ct
5731307|NCT00389467|SPOTRIAS|spotrias
5731308|NCT00389454|Acetaminophen|acetaminophen
5731309|NCT00389454|Fever|fever
5731310|NCT00389454|cerebro spinal fluid|cerebro spinal fluid
5731311|NCT00389454|Infants|infants
5731312|NCT00389441|VEGFR inhibitor|vegfr inhibitor
5731313|NCT00389441|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5731314|NCT00389441|anti-angiogenic|anti-angiogenic
5731315|NCT00389441|carcinoma|carcinoma
5731316|NCT00389441|papillary|papillary
5731317|NCT00389441|follicular|follicular
5731318|NCT00389441|medullary|medullary
5731319|NCT00389441|anaplastic|anaplastic
5731320|NCT00389428|Hematologic malignancies|hematologic malignancies
5731321|NCT00389428|Malignancies, hematologic|malignancies, hematologic
5731322|NCT00389428|Hematopoietic malignancies|hematopoietic malignancies
5731323|NCT00389415|Type 2 Diabetes|type 2 diabetes
5731324|NCT00389415|Vildagliptin|vildagliptin
5731325|NCT00389415|HbA1c|hba1c
5731326|NCT00389402|lipids|lipids
5731327|NCT00389402|lipodystrophy|lipodystrophy
5731328|NCT00389402|fat distribution|fat distribution
5731329|NCT00389402|hiv-1|hiv-1
5731330|NCT00389402|antiretroviral therapy|antiretroviral therapy
5731331|NCT00389402|Treatment Naive|treatment naive
5731332|NCT00389389|Advanced Solid Malignancies|advanced solid malignancies
5731333|NCT00389389|Advanced solid tumors|advanced solid tumors
5731334|NCT00389389|Cancer|cancer
5731335|NCT00389389|Phase I|phase i
5731336|NCT00389389|Solid tumors|solid tumors
5731337|NCT00389389|Solid malignancies|solid malignancies
5731338|NCT00389337|Sepsis|sepsis
5731339|NCT00389337|SIRS|sirs
5731340|NCT00389337|Biomarkers|biomarkers
5731341|NCT00389337|xMAP|xmap
5731342|NCT00389324|Primary immune deficiency|primary immune deficiency
5731343|NCT00389311|Microbicide|microbicide
5731344|NCT00389311|Safety|safety
5731348|NCT00389298|Viral kinetics|viral kinetics
5731349|NCT00389298|Phase II|phase ii
5731350|NCT00389298|Pharmacokinetics (PK)|pharmacokinetics (pk)
5731351|NCT00389298|Safety and tolerability|safety and tolerability
5731352|NCT00389285|Carcinoma, renal cell|carcinoma, renal cell
5731353|NCT00389285|interleukin-21|interleukin-21
5731354|NCT00389285|sorafenib|sorafenib
5731355|NCT00389285|Immunotherapy|immunotherapy
5731356|NCT00389259|Insecticides|insecticides
5731357|NCT00389259|Organophosphate|organophosphate
5731358|NCT00389259|Scopolamine|scopolamine
5731359|NCT00389259|randomized control study|randomized control study
5686186|NCT00553150|adult giant cell glioblastoma|adult giant cell glioblastoma
5686187|NCT00553150|adult glioblastoma|adult glioblastoma
5686188|NCT00553150|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5686189|NCT00553150|adult diffuse astrocytoma|adult diffuse astrocytoma
5686190|NCT00553150|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5686191|NCT00553150|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5686192|NCT00553137|oropharyngeal candidiasis|oropharyngeal candidiasis
5680930|NCT00575614|QOL|qol
5731360|NCT00389259|Organophosphate or carbamate intoxication|organophosphate or carbamate intoxication
5731362|NCT00389246|genetic consultation|genetic consultation
5731363|NCT00389246|randomized controlled trial|randomized controlled trial
5731364|NCT00389220|Coronary Disease|coronary disease
5731365|NCT00389220|Coronary Stenosis|coronary stenosis
5731366|NCT00389220|Angioplasty|angioplasty
5731367|NCT00389220|Coronary Restenosis|coronary restenosis
5731368|NCT00389220|Drug Eluting Stent|drug eluting stent
5731369|NCT00389194|HIV-1 infection|hiv-1 infection
5731370|NCT00389194|fat distribution|fat distribution
5731371|NCT00389194|lipodystrophy|lipodystrophy
5731372|NCT00389194|lipids|lipids
5731373|NCT00389194|kidney function|kidney function
5731374|NCT00389194|Treatment Experienced|treatment experienced
5731375|NCT00389181|Unruptured brain arteriovenous malformation|unruptured brain arteriovenous malformation
5731376|NCT00389181|AVM|avm
5731377|NCT00389181|BAVM|bavm
5731378|NCT00389181|Stroke|stroke
5731379|NCT00389181|Intracranial Hemorrhage|intracranial hemorrhage
5731380|NCT00389168|Hypertension|hypertension
5731381|NCT00389168|Cardiac hypertrophy|cardiac hypertrophy
5731382|NCT00389168|Angiotensin|angiotensin
5731383|NCT00389168|Human|human
5731384|NCT00389155|Advanced or metastatic transitional cell carcinoma of the urothelium|advanced or metastatic transitional cell carcinoma of the urothelium
5731389|NCT00389129|Platelets|platelets
5731390|NCT00389129|Aspirin Resistance|aspirin resistance
5731391|NCT00389129|Platelet aggregation|platelet aggregation
5731392|NCT00389090|temozolomide resistant|temozolomide resistant
5731393|NCT00389090|anaplastic glioma|anaplastic glioma
5731394|NCT00389090|anaplastic astrocytoma|anaplastic astrocytoma
5731395|NCT00389090|anaplastic oligodendroglioma|anaplastic oligodendroglioma
5731396|NCT00389090|anaplastic oligoastrocytoma|anaplastic oligoastrocytoma
5731397|NCT00389077|perifosine|perifosine
5731398|NCT00389077|solid tumors|solid tumors
5731399|NCT00389077|lymphomas|lymphomas
5731400|NCT00389077|anticancer agent|anticancer agent
5731401|NCT00389064|Generalised Anxiety Disorder|generalised anxiety disorder
5731402|NCT00389064|GAD|gad
5731403|NCT00389051|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5731404|NCT00389051|Malignant lymphoma|malignant lymphoma
5731405|NCT00389038|headache|headache
5731406|NCT00389038|coping skills training|coping skills training
5731407|NCT00389038|amitriptyline|amitriptyline
5731408|NCT00389038|attention control|attention control
5731409|NCT00389025|Subject with clinical history of seasonal allergic conjunctivitis|subject with clinical history of seasonal allergic conjunctivitis
5731410|NCT00389012|rehabilitation|rehabilitation
5731411|NCT00389012|hemiplegic gait|hemiplegic gait
5731412|NCT00389012|exercise therapy|exercise therapy
5731413|NCT00389012|physical therapy|physical therapy
5731414|NCT00388999|Multiple Myeloma|multiple myeloma
5731415|NCT00388999|Stem Cell Transplant|stem cell transplant
5731416|NCT00388999|rhMBL|rhmbl
5731417|NCT00388973|Major Depressive Disorder|major depressive disorder
5731418|NCT00388973|MDD|mdd
5731419|NCT00388960|small cell lung cancer|small cell lung cancer
5731420|NCT00388960|amrubicin|amrubicin
5731421|NCT00388947|vaginal prolapse|vaginal prolapse
5731422|NCT00388947|cystocele|cystocele
5731423|NCT00388947|rectocele|rectocele
5731424|NCT00388947|enterocele|enterocele
5731425|NCT00388947|apical prolapse|apical prolapse
5731426|NCT00388947|vaginal vault prolapse|vaginal vault prolapse
5731427|NCT00388934|Percutaneous coronary intervention|percutaneous coronary intervention
5731428|NCT00388934|Angina pectoris|angina pectoris
5731430|NCT00388921|Vitamin A|vitamin a
5731431|NCT00388921|Children|children
5731432|NCT00388921|Severe malnutrition|severe malnutrition
5731433|NCT00388921|Retinol|retinol
5731434|NCT00388921|Retinol binding protein|retinol binding protein
5731435|NCT00388921|Diarrhoea|diarrhoea
5731437|NCT00388921|Age 6-59 months|age 6-59 months
5731438|NCT00388921|Either sex|either sex
5731439|NCT00388921|Severe malnutrition as defined by the presence of any of the followings:|severe malnutrition as defined by the presence of any of the followings:
5731440|NCT00388921|Bipedal oedema|bipedal oedema
5731536|NCT00388635|Patients over 65 years old|patients over 65 years old
5731537|NCT00388622|Heart failure|heart failure
5686193|NCT00553124|stage 0 bladder cancer|stage 0 bladder cancer
5730492|NCT00392743|PET|pet
5731441|NCT00388921|Weight (measured after correction of dehydration) for height Z score <-3 of the National Center for Health Statistics (NCHS) reference|weight (measured after correction of dehydration) for height z score <-3 of the national center for health statistics (nchs) reference
5731442|NCT00388921|Written informed consent of respective parents/ guardians for participation of the children in the study.|written informed consent of respective parents/ guardians for participation of the children in the study.
5731443|NCT00388921|Children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.|children having diarrhoea (watery or invasive) or cough and cold or both for the last 48 hours.
5731444|NCT00388908|vertebral fractures|vertebral fractures
5731445|NCT00388908|osteoporosis|osteoporosis
5731446|NCT00388908|prevention|prevention
5731447|NCT00388908|case-finding|case-finding
5731448|NCT00388908|quality improvement|quality improvement
5731449|NCT00388895|Acute lymphoblastic Leukemia|acute lymphoblastic leukemia
5731450|NCT00388869|renal artery|renal artery
5731451|NCT00388869|calcium|calcium
5731452|NCT00388869|CT|ct
5731453|NCT00388869|hypertension|hypertension
5731454|NCT00388856|antioxidant supplementation|antioxidant supplementation
5731455|NCT00388856|preeclampsia|preeclampsia
5731456|NCT00388856|prevention|prevention
5731457|NCT00388843|carotid atherosclerosis|carotid atherosclerosis
5731458|NCT00388843|magnetic resonance imaging|magnetic resonance imaging
5731459|NCT00388843|atherosclerosis|atherosclerosis
5731460|NCT00388843|ultrasound|ultrasound
5731461|NCT00388843|inflammation|inflammation
5731462|NCT00388843|statins|statins
5731463|NCT00388843|vulnerable plaque|vulnerable plaque
5731464|NCT00388843|stroke|stroke
5731465|NCT00388830|Gallbladder|gallbladder
5731466|NCT00388830|Ultrasound|ultrasound
5731467|NCT00388830|Emergency Medicine|emergency medicine
5731468|NCT00388817|Hypertension|hypertension
5731469|NCT00388817|Blood pressure|blood pressure
5731470|NCT00388817|Adherence|adherence
5731471|NCT00388817|Compliance|compliance
5731472|NCT00388817|Pharmacist|pharmacist
5731473|NCT00388817|Pharmacy|pharmacy
5731474|NCT00388817|Costs|costs
5731475|NCT00388804|Prostate Cancer|prostate cancer
5731476|NCT00388804|External Beam Radiotherapy|external beam radiotherapy
5731477|NCT00388804|Radiation Therapy|radiation therapy
5731478|NCT00388804|Hormone Therapy|hormone therapy
5731479|NCT00388804|Bicalutamide|bicalutamide
5731480|NCT00388804|Casodex|casodex
5731481|NCT00388804|Leuprolide|leuprolide
5731487|NCT00388791|symptomatology|symptomatology
5731488|NCT00388791|Schein questionnaire|schein questionnaire
5731489|NCT00388791|fluoresceien staining|fluoresceien staining
5731490|NCT00388765|bronchoscopy|bronchoscopy
5731491|NCT00388765|sample bank|sample bank
5731492|NCT00388765|research study volunteer|research study volunteer
5731493|NCT00388752|Acupuncture|acupuncture
5731494|NCT00388752|Phantom limb pain|phantom limb pain
5731495|NCT00388752|Residual limb pain|residual limb pain
5731496|NCT00388752|amputation|amputation
5731497|NCT00388752|amputee|amputee
5731498|NCT00388752|traumatic|traumatic
5731499|NCT00388752|surgical|surgical
5731500|NCT00388752|Traumatic amputation upper extremity|traumatic amputation upper extremity
5731501|NCT00388752|Traumatic amputation lower extremity|traumatic amputation lower extremity
5731502|NCT00388752|Surgical amputation upper extremity|surgical amputation upper extremity
5731503|NCT00388752|Surgical amputation lower extremity|surgical amputation lower extremity
5731504|NCT00388739|Pediatric Asthma|pediatric asthma
5731505|NCT00388739|Pulmicort|pulmicort
5731506|NCT00388739|TEDAS ED|tedas ed
5731507|NCT00388739|Acute exacerbation of asthma|acute exacerbation of asthma
5731508|NCT00388739|Chronic asthma|chronic asthma
5731509|NCT00388726|Locally recurrent breast cancer|locally recurrent breast cancer
5731510|NCT00388726|metastatic breast cancer|metastatic breast cancer
5731511|NCT00388713|Radiation therapy|radiation therapy
5731512|NCT00388713|Radiation-Induced Atherosclerosis|radiation-induced atherosclerosis
5731513|NCT00388713|Carotid Artery Diseases|carotid artery diseases
5731514|NCT00388713|Breast Cancer|breast cancer
5731515|NCT00388713|Intima Media thickening Ultrasound|intima media thickening ultrasound
5731516|NCT00388700|Colorectal cancer, DAVANAT, colon cancer, 5-FU|colorectal cancer, davanat, colon cancer, 5-fu
5731517|NCT00388687|Hypoxia|hypoxia
5731518|NCT00388687|FAZA|faza
5731519|NCT00388687|PET|pet
5731520|NCT00388687|Radiochemotherapy|radiochemotherapy
5731521|NCT00388674|Chronic Hepatitis B Virus|chronic hepatitis b virus
5731522|NCT00388661|sleep problems|sleep problems
5731523|NCT00388661|quality of life|quality of life
5731524|NCT00388661|melatonin|melatonin
5731525|NCT00388661|sleep apnea|sleep apnea
5731526|NCT00388661|medication|medication
5731527|NCT00388661|preload|preload
5731528|NCT00388661|nutritional status|nutritional status
5731529|NCT00388661|ProBNP|probnp
5731530|NCT00388648|Dialysis|dialysis
5731531|NCT00388648|Vegan Diet|vegan diet
5731533|NCT00388648|Morbidity|morbidity
5731534|NCT00388648|Treatment outcome|treatment outcome
5731535|NCT00388635|Multiple Myeloma|multiple myeloma
5731538|NCT00388622|Adherence|adherence
5731540|NCT00388622|Pharmacy|pharmacy
5731541|NCT00388622|Pharmacist|pharmacist
5731542|NCT00388622|Health-related quality of life|health-related quality of life
5731543|NCT00388622|Clinical exacerbation|clinical exacerbation
5731544|NCT00388622|Costs|costs
5731545|NCT00388596|SB-751689|sb-751689
5731546|NCT00388596|osteoporosis|osteoporosis
5731547|NCT00388596|drug interaction|drug interaction
5731548|NCT00388596|ketoconazole|ketoconazole
5731549|NCT00388596|atorvastatin|atorvastatin
5731550|NCT00388596|rosuvastatin|rosuvastatin
5731551|NCT00388583|Influenza|influenza
5731552|NCT00388583|Orthomyxoviruses|orthomyxoviruses
5731553|NCT00388583|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5731554|NCT00388583|Elderly.|elderly.
5731555|NCT00388570|Asthma|asthma
5731556|NCT00388570|adult|adult
5731557|NCT00388570|paediatric|paediatric
5731558|NCT00388570|NIOX MINO®|niox mino®
5731559|NCT00388570|NIOX®|niox®
5731560|NCT00388570|nitric oxide|nitric oxide
5731561|NCT00388570|airway inflammation|airway inflammation
5731562|NCT00388570|open−label|open−label
5731563|NCT00388570|single−cohort|single−cohort
5731564|NCT00388531|Acute Lymphoblastic Leucemia|acute lymphoblastic leucemia
5731565|NCT00388531|Aggressive Non-Hodgkin-Lymphoma|aggressive non-hodgkin-lymphoma
5731566|NCT00388531|CNS relapse|cns relapse
5731567|NCT00388531|Cytarabine liposome|cytarabine liposome
5731568|NCT00388505|tobramycin|tobramycin
5731569|NCT00388492|HIV Infected|hiv infected
5731570|NCT00388466|whole body vibration|whole body vibration
5731571|NCT00388466|muscle function|muscle function
5731572|NCT00388466|cystic fibrosis|cystic fibrosis
5731573|NCT00388466|mechanography|mechanography
5731574|NCT00388466|chair-rising-test|chair-rising-test
5731575|NCT00388453|Healthy volunteers|healthy volunteers
5731576|NCT00388440|Mumps|mumps
5731577|NCT00388440|Singapore|singapore
5731578|NCT00388440|Rubella|rubella
5731579|NCT00388440|Measles|measles
5731580|NCT00388427|advanced cancer|advanced cancer
5731581|NCT00388427|solid tumor|solid tumor
5731582|NCT00388427|solid malignancies|solid malignancies
5731583|NCT00388427|phase I|phase i
5731584|NCT00388401|Postoperative Ileus|postoperative ileus
5731585|NCT00388388|Remodeling|remodeling
5731586|NCT00388388|Resistance arteries|resistance arteries
5731587|NCT00388388|angiotensin receptor blocker|angiotensin receptor blocker
5731588|NCT00388388|thiazide diuretic|thiazide diuretic
5731589|NCT00388362|GVHD|gvhd
5731590|NCT00388336|Anemia|anemia
5731591|NCT00388336|Neoplasms, Hemoglobin values|neoplasms, hemoglobin values
5731593|NCT00388336|Epoetin alfa|epoetin alfa
5731594|NCT00388323|Alcohol|alcohol
5731595|NCT00388323|Hepatitis|hepatitis
5731596|NCT00388323|Cirrhosis|cirrhosis
5731597|NCT00388323|Inflammation|inflammation
5731598|NCT00388323|Cytokines|cytokines
5731599|NCT00388323|ADIPOKINES|adipokines
5731600|NCT00388323|Adipose tissue|adipose tissue
5731601|NCT00388310|cellulitis|cellulitis
5731602|NCT00388310|furuncles|furuncles
5731603|NCT00388310|carbuncles|carbuncles
5731604|NCT00388310|abscess|abscess
5731605|NCT00388297|Subclinical Hypothyroidism|subclinical hypothyroidism
5731606|NCT00388297|Hypothyroxinemia|hypothyroxinemia
5731607|NCT00388297|Thyroid|thyroid
5731608|NCT00388297|Pregnancy|pregnancy
5731609|NCT00388297|Intellectual Development|intellectual development
5731610|NCT00388284|hemostasis|hemostasis
5731611|NCT00388284|arterial sealing|arterial sealing
5731612|NCT00388271|Alpha-blocker|alpha-blocker
5731613|NCT00388271|Alfuzosin|alfuzosin
5731614|NCT00388271|Xatral|xatral
5731615|NCT00388271|ESWL|eswl
5731616|NCT00388258|Postoperative ileus|postoperative ileus
5731617|NCT00388245|PCI|pci
5731618|NCT00388245|CABG|cabg
5731619|NCT00388245|Ejection Fraction|ejection fraction
5731620|NCT00388245|Myocardial Revascularization|myocardial revascularization
5731621|NCT00388232|COPD|copd
5731622|NCT00388232|prevalence|prevalence
5731623|NCT00388232|smoke|smoke
5731624|NCT00388232|biomass|biomass
5731625|NCT00388232|occupational|occupational
5731626|NCT00388232|Malatya|malatya
5731627|NCT00388232|Turkey|turkey
5731628|NCT00388219|Buprenorphine|buprenorphine
5731629|NCT00388219|Transdermal patch|transdermal patch
5731630|NCT00388219|Centrally acting analgesic|centrally acting analgesic
5731631|NCT00388219|Plasma level|plasma level
5731632|NCT00388219|Healthy volunteers|healthy volunteers
5731633|NCT00388206|NSCLC|nsclc
5731635|NCT00388206|anti-VEGF|anti-vegf
5731636|NCT00388206|lung cancer|lung cancer
5731637|NCT00388206|colorectal cancer|colorectal cancer
5731638|NCT00388206|ARIES|aries
5731639|NCT00388206|Colon Cancer|colon cancer
5731640|NCT00388193|ALL (L3)|all (l3)
5731641|NCT00388193|BURKITT's LYMPHOMA|burkitt's lymphoma
5731642|NCT00388193|RITUXIMAB|rituximab
5731643|NCT00388180|cholesterol|cholesterol
5731644|NCT00388180|inflammation|inflammation
5731647|NCT00388167|Invasive Aspergillosis (AI)|invasive aspergillosis (ai)
5731811|NCT00387712|exercise|exercise
5731648|NCT00388167|Invasive Candidiasis (CI)|invasive candidiasis (ci)
5731649|NCT00388167|Caspofungin acetate|caspofungin acetate
5731650|NCT00388154|Endometrial Cancer|endometrial cancer
5731651|NCT00388154|Gemcitabine|gemcitabine
5731653|NCT00388154|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5731654|NCT00388154|Cisplatin|cisplatin
5731655|NCT00388154|Platinol-AQ|platinol-aq
5731656|NCT00388154|Platinol|platinol
5731657|NCT00388154|CDDP|cddp
5731658|NCT00388141|Preterm Infant;|preterm infant;
5731659|NCT00388141|NIDCAP;|nidcap;
5731660|NCT00388141|Neonatal Care,|neonatal care,
5731661|NCT00388141|Intervention Study;|intervention study;
5731662|NCT00388141|Growth and Development;|growth and development;
5731663|NCT00388141|Maternal Self-esteem.|maternal self-esteem.
5731664|NCT00388141|Maternal Social support|maternal social support
5731665|NCT00388141|NICU|nicu
5731666|NCT00388128|Intermittent Claudication|intermittent claudication
5731667|NCT00388128|PAD|pad
5731668|NCT00388128|Caffeine|caffeine
5731669|NCT00388128|Walking capacity|walking capacity
5731670|NCT00388128|ABI|abi
5731671|NCT00388128|QoL|qol
5731672|NCT00388128|Growth factor|growth factor
5731673|NCT00388115|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5731674|NCT00388115|stage I breast cancer|stage i breast cancer
5731675|NCT00388115|stage II breast cancer|stage ii breast cancer
5731676|NCT00388115|breast cancer in situ|breast cancer in situ
5731677|NCT00388089|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731678|NCT00388089|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5731679|NCT00388089|recurrent small cell lung cancer|recurrent small cell lung cancer
5731680|NCT00388076|carboplatin|carboplatin
5731681|NCT00388076|lapatinib|lapatinib
5731682|NCT00388076|TAXOL|taxol
5731683|NCT00388076|PARAPLATIN|paraplatin
5731684|NCT00388076|paclitaxel|paclitaxel
5731685|NCT00388076|TYKERB|tykerb
5731687|NCT00388063|Neuroendocrine|neuroendocrine
5731688|NCT00388063|Carcinoma|carcinoma
5731689|NCT00388063|Atiprimod|atiprimod
5731690|NCT00388063|Carcinoid|carcinoid
5731691|NCT00388050|Decision aid, diabetes, primary care|decision aid, diabetes, primary care
5731692|NCT00388024|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5731693|NCT00388024|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5731694|NCT00388024|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5731695|NCT00388024|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5731696|NCT00388024|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5731697|NCT00388024|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5731698|NCT00388024|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5731699|NCT00388024|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5731700|NCT00388024|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5731701|NCT00388024|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5731702|NCT00388024|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5731703|NCT00388024|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5731704|NCT00388024|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5731705|NCT00388024|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5731706|NCT00388024|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5731707|NCT00388024|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5731708|NCT00388024|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5731709|NCT00388024|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5731710|NCT00388011|Post surgical pain|post surgical pain
5731711|NCT00388011|Bunionectomy|bunionectomy
5731712|NCT00388011|Hammer Toe Syndrome|hammer toe syndrome
5731713|NCT00388011|Morphine|morphine
5731714|NCT00387998|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731715|NCT00387972|Type 2 diabetes mellitus (T2DM)|type 2 diabetes mellitus (t2dm)
5731716|NCT00387972|glycosylated hemoglobin (HbA1c)|glycosylated hemoglobin (hba1c)
5731717|NCT00387972|denagliptin|denagliptin
5749121|NCT00323557|CLL|cll
5731718|NCT00387972|diabetes treatment|diabetes treatment
5731719|NCT00387972|glycemic control|glycemic control
5731720|NCT00387959|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5731721|NCT00387959|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5731722|NCT00387959|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5731723|NCT00387959|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5731724|NCT00387959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5726773|NCT00407420|Obesity|obesity
5731725|NCT00387959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5731726|NCT00387959|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5731727|NCT00387959|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5731728|NCT00387959|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5731729|NCT00387959|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5686194|NCT00553124|stage I bladder cancer|stage i bladder cancer
5731730|NCT00387959|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5731731|NCT00387959|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5731732|NCT00387959|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5731733|NCT00387959|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5731734|NCT00387959|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5731735|NCT00387959|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5731736|NCT00387959|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5731737|NCT00387959|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5731738|NCT00387959|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5731739|NCT00387959|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5731740|NCT00387959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5731741|NCT00387959|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5731742|NCT00387959|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5731743|NCT00387959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5731744|NCT00387959|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5731745|NCT00387959|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5731746|NCT00387959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5731747|NCT00387959|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5731748|NCT00387959|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5731749|NCT00387959|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5731750|NCT00387959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5731751|NCT00387959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5731752|NCT00387959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5731753|NCT00387959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5731754|NCT00387959|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5731756|NCT00387946|cessation|cessation
5731757|NCT00387946|tobacco|tobacco
5731758|NCT00387933|recurrent adult brain tumor|recurrent adult brain tumor
5731759|NCT00387933|adult glioblastoma|adult glioblastoma
5731760|NCT00387933|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5732862|NCT00383409|fatigue|fatigue
5731761|NCT00387933|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5731762|NCT00387933|adult gliosarcoma|adult gliosarcoma
5731763|NCT00387933|adult giant cell glioblastoma|adult giant cell glioblastoma
5731764|NCT00387933|adult anaplastic ependymoma|adult anaplastic ependymoma
5731765|NCT00387933|adult brain stem glioma|adult brain stem glioma
5731766|NCT00387933|adult mixed glioma|adult mixed glioma
5731767|NCT00387933|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5731768|NCT00387907|Herceptin|herceptin
5731769|NCT00387907|Taxane|taxane
5731770|NCT00387907|Breast Cancer|breast cancer
5731771|NCT00387894|adult glioblastoma|adult glioblastoma
5731772|NCT00387894|adult gliosarcoma|adult gliosarcoma
5731773|NCT00387894|recurrent adult brain tumor|recurrent adult brain tumor
5731774|NCT00387881|sumatriptan succinate,|sumatriptan succinate,
5731775|NCT00387881|naproxen sodium,|naproxen sodium,
5731776|NCT00387881|parallel group,|parallel group,
5731777|NCT00387881|double-blind,|double-blind,
5731778|NCT00387881|placebo-controlled,|placebo-controlled,
5731779|NCT00387881|Combination product,|combination product,
5731780|NCT00387881|migrainous headache|migrainous headache
5731781|NCT00387881|Probable migraine, a sub-type of Migraine|probable migraine, a sub-type of migraine
5731782|NCT00387881|probable migraine,|probable migraine,
5731783|NCT00387868|Thymoma|thymoma
5731784|NCT00387868|Thymic carcinoma|thymic carcinoma
5731785|NCT00387868|Preoperative chemotherapy and radiation|preoperative chemotherapy and radiation
5731786|NCT00387868|Response rate|response rate
5731787|NCT00387855|suicide|suicide
5731788|NCT00387855|depression|depression
5731789|NCT00387777|Buprenorphine|buprenorphine
5731790|NCT00387777|Transdermal patch|transdermal patch
5731791|NCT00387777|multidose|multidose
5731792|NCT00387777|Centrally acting analgesic|centrally acting analgesic
5731793|NCT00387777|Plasma level|plasma level
5731794|NCT00387777|Healthy volunteers|healthy volunteers
5731795|NCT00387764|renal cell carcinoma|renal cell carcinoma
5731796|NCT00387764|pazopanib|pazopanib
5731797|NCT00387764|anti-angiogenic therapy|anti-angiogenic therapy
5731798|NCT00387764|open label|open label
5731799|NCT00387738|Ragweed|ragweed
5731800|NCT00387738|Allergy|allergy
5731801|NCT00387738|Allergic|allergic
5731802|NCT00387738|Rhinitis|rhinitis
5731803|NCT00387738|Hay Fever|hay fever
5731805|NCT00387738|Treatment|treatment
5731806|NCT00387738|Immunotherapy|immunotherapy
5731807|NCT00387738|Vaccine|vaccine
5731808|NCT00387725|Adolescent|adolescent
5731809|NCT00387725|Meningococcal|meningococcal
5731810|NCT00387725|Safety|safety
5686195|NCT00553124|stage II bladder cancer|stage ii bladder cancer
5731812|NCT00387712|inflammation|inflammation
5731813|NCT00387712|motor performance|motor performance
5731814|NCT00387712|skeletal muscle|skeletal muscle
5731815|NCT00387712|chronic stroke survivors|chronic stroke survivors
5731816|NCT00387712|treadmill exercise|treadmill exercise
5731817|NCT00387699|limited stage small cell lung cancer|limited stage small cell lung cancer
5731818|NCT00387673|electrical stimulation|electrical stimulation
5731820|NCT00387673|Rehabilitation|rehabilitation
5731821|NCT00387673|spinal cord injury|spinal cord injury
5731822|NCT00387660|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5731823|NCT00387660|limited stage small cell lung cancer|limited stage small cell lung cancer
5731824|NCT00387660|recurrent small cell lung cancer|recurrent small cell lung cancer
5731825|NCT00387647|myeloid|myeloid
5731826|NCT00387647|acute|acute
5731827|NCT00387647|monocytic|monocytic
5731828|NCT00387634|tick born encephalitis, TBE, adults|tick born encephalitis, tbe, adults
5731829|NCT00387621|heart failure|heart failure
5731830|NCT00387621|diastolic dysfunction|diastolic dysfunction
5731831|NCT00387621|systolic dysfunction|systolic dysfunction
5731832|NCT00387621|preclinical|preclinical
5731833|NCT00387621|natriuretic peptide|natriuretic peptide
5731834|NCT00387621|B-type natriuretic peptide|b-type natriuretic peptide
5731835|NCT00387621|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5731836|NCT00387608|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731837|NCT00387608|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5731838|NCT00387608|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5731839|NCT00387608|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5731840|NCT00387608|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5731841|NCT00387608|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5731842|NCT00387608|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5731843|NCT00387608|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5731844|NCT00387608|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5731845|NCT00387608|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5731846|NCT00387608|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5731847|NCT00387608|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5731848|NCT00387608|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5731849|NCT00387595|Family History|family history
5731852|NCT00387595|cIMT|cimt
5731853|NCT00387595|CV Risk Factors|cv risk factors
5731854|NCT00387582|Diabetes|diabetes
5731855|NCT00387582|Macular Edema|macular edema
5731856|NCT00387582|Diabetic Retinopathy|diabetic retinopathy
5731857|NCT00387582|Lucentis|lucentis
5731858|NCT00387582|Ranibizumab|ranibizumab
5731859|NCT00387569|Toddlers|toddlers
5731860|NCT00387569|Vaccine|vaccine
5731861|NCT00387569|Safety|safety
5731862|NCT00387556|ketamine|ketamine
5731863|NCT00387556|children|children
5731864|NCT00387556|emesis|emesis
5731865|NCT00387530|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5731866|NCT00387530|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5731867|NCT00387530|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5731868|NCT00387530|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5731869|NCT00387530|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5731870|NCT00387530|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5731871|NCT00387530|recurrent gastric cancer|recurrent gastric cancer
5731872|NCT00387517|Diastolic|diastolic
5731873|NCT00387517|systolic|systolic
5731874|NCT00387517|hypertension|hypertension
5731875|NCT00387517|aliskiren|aliskiren
5731876|NCT00387517|blood pressure|blood pressure
5731877|NCT00387517|hydrochlorothiazide|hydrochlorothiazide
5731878|NCT00387517|HCTZ|hctz
5731879|NCT00387504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731880|NCT00387478|Allergy|allergy
5731881|NCT00387478|Specific Immunotherapy|specific immunotherapy
5731882|NCT00387478|Tree|tree
5731883|NCT00387478|Environmental Exposure Chamber|environmental exposure chamber
5731884|NCT00387452|Aging|aging
5731885|NCT00387452|Type 2 diabetes|type 2 diabetes
5731886|NCT00387452|exercise|exercise
5731887|NCT00387452|aerobic training|aerobic training
5731888|NCT00387452|strength training|strength training
5731889|NCT00387452|glucose metabolism arterial baroreceptors|glucose metabolism arterial baroreceptors
5731890|NCT00387452|heart rate variability|heart rate variability
5731891|NCT00387452|cerebral autoregulation|cerebral autoregulation
5731892|NCT00387452|tilt table study|tilt table study
5731893|NCT00387452|transcranial Doppler|transcranial doppler
5726972|NCT00406419|RA|ra
5731894|NCT00387452|autonomic nervous system|autonomic nervous system
5731896|NCT00387439|Gastroenterology|gastroenterology
5731897|NCT00387439|Anoperineal physiotherapy|anoperineal physiotherapy
5731898|NCT00387439|Randomized clinical trial|randomized clinical trial
5731900|NCT00387413|GSK189254|gsk189254
5731901|NCT00387413|Healthy volunteers|healthy volunteers
5731902|NCT00387413|Phase I.|phase i.
5731903|NCT00387413|Electrical hyperalgesia model|electrical hyperalgesia model
5731904|NCT00387400|adult giant cell glioblastoma|adult giant cell glioblastoma
5731905|NCT00387400|adult gliosarcoma|adult gliosarcoma
5731906|NCT00387400|recurrent adult brain tumor|recurrent adult brain tumor
5731907|NCT00387400|adult glioblastoma|adult glioblastoma
5731908|NCT00387387|pharmacokinetics|pharmacokinetics
5731909|NCT00387387|colorectal cancer|colorectal cancer
5731910|NCT00387387|pazopanib|pazopanib
5731911|NCT00387387|capecitabine|capecitabine
5731912|NCT00387387|CapeOx|capeox
5731913|NCT00387387|5-fluorouracil|5-fluorouracil
5731914|NCT00387387|oxaliplatin|oxaliplatin
5731915|NCT00387387|combination therapy|combination therapy
5731916|NCT00387387|FOLFOX 6|folfox 6
5731917|NCT00387361|Post-Operative Nausea|post-operative nausea
5731918|NCT00387361|Nausea|nausea
5731919|NCT00387361|Anesthesia|anesthesia
5731920|NCT00387361|Osteopathic Manipulative Treatment|osteopathic manipulative treatment
5731921|NCT00387361|Osteopathic Manipulative Medicine|osteopathic manipulative medicine
5731922|NCT00387361|Manipulation, Osteopathic|manipulation, osteopathic
5731923|NCT00387361|Osteopathy|osteopathy
5731924|NCT00387361|Texas College of Osteopathic Medicine|texas college of osteopathic medicine
5731925|NCT00387348|fatigue|fatigue
5731926|NCT00387348|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5731927|NCT00387348|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5731928|NCT00387348|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5731929|NCT00387348|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5731930|NCT00387348|advanced adult primary liver cancer|advanced adult primary liver cancer
5731931|NCT00387348|depression|depression
5731932|NCT00387348|stage III pancreatic cancer|stage iii pancreatic cancer
5731933|NCT00387348|stage IV pancreatic cancer|stage iv pancreatic cancer
5731934|NCT00387348|stage IV esophageal cancer|stage iv esophageal cancer
5731935|NCT00387348|stage IV gastric cancer|stage iv gastric cancer
5731936|NCT00387348|stage IVA colon cancer|stage iva colon cancer
5731937|NCT00387348|stage IVB colon cancer|stage ivb colon cancer
5731938|NCT00387348|stage IVA rectal cancer|stage iva rectal cancer
5731939|NCT00387348|stage IVB rectal cancer|stage ivb rectal cancer
5731940|NCT00387348|unresectable gallbladder cancer|unresectable gallbladder cancer
5731941|NCT00387348|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5731942|NCT00387322|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5731943|NCT00387322|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5731944|NCT00387322|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5731945|NCT00387322|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5731946|NCT00387309|Bowel|bowel
5731948|NCT00387283|West Nile virus|west nile virus
5731949|NCT00387283|WNV meningoencephalitis|wnv meningoencephalitis
5731950|NCT00387270|Huntington's disease|huntington's disease
5731951|NCT00387270|Dimebon|dimebon
5731952|NCT00387270|dose-escalation|dose-escalation
5731953|NCT00387270|Phase 1-2a|phase 1-2a
5731954|NCT00387270|randomized|randomized
5731955|NCT00387270|controlled|controlled
5731956|NCT00387270|double-blind|double-blind
5731957|NCT00387270|Unified Huntington's Disease Rating Scale|unified huntington's disease rating scale
5731958|NCT00387257|platelet aggregation|platelet aggregation
5731959|NCT00387257|SB-659032|sb-659032
5731960|NCT00387257|rilapladib|rilapladib
5731961|NCT00387244|Pain;|pain;
5731962|NCT00387244|Back Pain;|back pain;
5731963|NCT00387244|Neurostimulation|neurostimulation
5731964|NCT00387231|Myocardial Ischemia|myocardial ischemia
5731965|NCT00387231|Randomized Controlled Trials|randomized controlled trials
5731966|NCT00387231|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5731967|NCT00387231|Drug Therapy|drug therapy
5731968|NCT00387218|Exercise|exercise
5731969|NCT00387218|Physical Functional Ability|physical functional ability
5731970|NCT00387218|Spinal Range of Motion|spinal range of motion
5731971|NCT00387218|Balance|balance
5731972|NCT00387218|Economy of Movement|economy of movement
5731973|NCT00387218|Aerobic Conditioning|aerobic conditioning
5731974|NCT00387218|Quality of Life|quality of life
5749405|NCT00322166|accidental falls|accidental falls
5749407|NCT00322166|parathyroid hormone|parathyroid hormone
5749408|NCT00322166|osteoporosis|osteoporosis
5749409|NCT00322153|memantine|memantine
5749410|NCT00322153|Alzheimer's disease|alzheimer's disease
5749432|NCT00322023|NMDA|nmda
5731975|NCT00387218|Adherence|adherence
5731976|NCT00387205|chronic administration|chronic administration
5731977|NCT00387205|monotherapy and combination therapies|monotherapy and combination therapies
5731978|NCT00387205|solid|solid
5731979|NCT00387205|lapatinib (TYKERB, TYVERB)|lapatinib (tykerb, tyverb)
5731981|NCT00387205|Pazopanib|pazopanib
5731982|NCT00387205|GW786034|gw786034
5731983|NCT00387205|cancer|cancer
5731984|NCT00387205|safety|safety
5731985|NCT00387192|Von Willebrand Disease|von willebrand disease
5731986|NCT00387192|Factor VIII|factor viii
5731987|NCT00387192|Von Willebrand Factor|von willebrand factor
5731988|NCT00387192|Pharmacokinetics|pharmacokinetics
5731989|NCT00387179|Circadian Rhythm Sleep Disorders|circadian rhythm sleep disorders
5731990|NCT00387166|Type 2 Diabetes|type 2 diabetes
5731991|NCT00387166|Cardiovascular|cardiovascular
5731992|NCT00387166|Blood Pressure|blood pressure
5731993|NCT00387166|Hispanic|hispanic
5731994|NCT00387166|Women|women
5731995|NCT00387166|Social Context|social context
5731996|NCT00387166|Psychosocial|psychosocial
5731997|NCT00387153|Oncology|oncology
5731998|NCT00387153|Cancer|cancer
5731999|NCT00387153|Blood Cancers|blood cancers
5732000|NCT00387140|Dental Pain, Postoperative|dental pain, postoperative
5732001|NCT00387127|Neck Cancer|neck cancer
5732002|NCT00387127|Locally advanced head and neck cancer|locally advanced head and neck cancer
5732003|NCT00387127|locally advanced|locally advanced
5732004|NCT00387127|Head and Neck cancer|head and neck cancer
5732005|NCT00387127|lapatinib|lapatinib
5732006|NCT00387127|EGFR/ErbB2 inhibitor|egfr/erbb2 inhibitor
5732007|NCT00387127|Head Cancer|head cancer
5732008|NCT00387114|C-reactive protein|c-reactive protein
5732009|NCT00387114|nitrotyrosine|nitrotyrosine
5732010|NCT00387114|oxidative stress|oxidative stress
5732011|NCT00387114|resistin|resistin
5732012|NCT00387114|vitamin C|vitamin c
5732013|NCT00387101|Diabetic Foot Ulcer|diabetic foot ulcer
5732014|NCT00387101|Diabetes Mellitus|diabetes mellitus
5732015|NCT00387101|Debridement|debridement
5732016|NCT00387101|Dermal-LSR|dermal-lsr
5732017|NCT00387101|Standard of Care|standard of care
5732018|NCT00387075|Parkinson Disease|parkinson disease
5732019|NCT00387075|SPECT imaging|spect imaging
5732020|NCT00387062|Breast Cancer|breast cancer
5732021|NCT00387062|Cognitive Impairment|cognitive impairment
5732022|NCT00387062|Chemofog|chemofog
5732023|NCT00387062|Chemobrain|chemobrain
5732024|NCT00387062|Post-chemotherapy cognitive impairment|post-chemotherapy cognitive impairment
5732025|NCT00387049|Anxiety Sensitivity|anxiety sensitivity
5732026|NCT00387023|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5732027|NCT00387023|Orbital Lymphoma|orbital lymphoma
5732028|NCT00387023|Rituximab|rituximab
5732030|NCT00387023|Zevalin|zevalin
5732031|NCT00387023|Ibritumomab tiuxetan|ibritumomab tiuxetan
5732032|NCT00387023|IDEC-Y2B8|idec-y2b8
5732034|NCT00386984|hepatocellular carcinoma; Sandostatin-LAR; RCT|hepatocellular carcinoma; sandostatin-lar; rct
5732035|NCT00386971|L-carnitine|l-carnitine
5732036|NCT00386971|HIV|hiv
5732037|NCT00386971|TGRL metabolism|tgrl metabolism
5732038|NCT00386971|postprandial|postprandial
5732039|NCT00386971|HIV Treatment Experienced|hiv treatment experienced
5732040|NCT00386958|corneal ulcers|corneal ulcers
5732041|NCT00386958|bacterial keratitis|bacterial keratitis
5732042|NCT00386958|childhood blindness|childhood blindness
5732043|NCT00386958|povidone-iodine|povidone-iodine
5732044|NCT00386945|Tobacco|tobacco
5732045|NCT00386945|Cessation.|cessation.
5732046|NCT00386945|Chiropractic patients.|chiropractic patients.
5732047|NCT00386945|Doctors of Chiropractic.|doctors of chiropractic.
5732048|NCT00386945|Health care providers.|health care providers.
5732049|NCT00386945|Behavioral intervention.|behavioral intervention.
5732050|NCT00386945|Tobacco intervention.|tobacco intervention.
5732051|NCT00386945|Cigarettes.|cigarettes.
5732052|NCT00386945|Smokeless tobacco.|smokeless tobacco.
5732053|NCT00386945|Smoking intervention.|smoking intervention.
5732054|NCT00386906|Melanoma|melanoma
5732055|NCT00386906|Conjunctival Melanoma|conjunctival melanoma
5732056|NCT00386906|Malignant Melanoma of the Conjunctiva|malignant melanoma of the conjunctiva
5732057|NCT00386906|Malignant Melanoma of the Eyelid|malignant melanoma of the eyelid
5732058|NCT00386906|Sebaceous Cell Carcinoma|sebaceous cell carcinoma
5732059|NCT00386906|Sebaceous Cell Carcinoma of the Conjunctiva|sebaceous cell carcinoma of the conjunctiva
5732060|NCT00386906|Sebaceous Cell Carcinoma of the Eyelid|sebaceous cell carcinoma of the eyelid
5732061|NCT00386906|Sentinel Lymph Node|sentinel lymph node
5732062|NCT00386906|Lymphatic Mapping|lymphatic mapping
5732063|NCT00386906|Eyelid|eyelid
5732064|NCT00386906|Eyelid Lesion|eyelid lesion
5732065|NCT00386867|medical abortion|medical abortion
5732066|NCT00386867|mifepristone|mifepristone
5732067|NCT00386867|misoprostol|misoprostol
5732068|NCT00386867|buccal administration|buccal administration
5732069|NCT00386854|exercise|exercise
5732070|NCT00386854|lipid metabolism|lipid metabolism
5732071|NCT00386854|lipoproteins|lipoproteins
5732072|NCT00386854|insulin resistance|insulin resistance
5732073|NCT00386854|inflammation|inflammation
5732074|NCT00386841|Major depression|major depression
5732075|NCT00386841|First degree relatives|first degree relatives
5732076|NCT00386841|Escitalopram|escitalopram
5732077|NCT00386841|Cortisol|cortisol
5732078|NCT00386841|Cognition|cognition
5732079|NCT00386841|Personality|personality
5732080|NCT00386841|Endo-phenotype|endo-phenotype
5732081|NCT00386828|colorectal cancer|colorectal cancer
5732082|NCT00386828|advanced colorectal cancer|advanced colorectal cancer
5732084|NCT00386802|Antifungals|antifungals
5732085|NCT00386789|Typhoid Fever|typhoid fever
5732086|NCT00386789|Serological Survey|serological survey
5732087|NCT00386789|Follow-Up|follow-up
5732088|NCT00386789|Protection|protection
5732089|NCT00386776|computers|computers
5732090|NCT00386776|diagnosis|diagnosis
5732091|NCT00386776|medical records|medical records
5732301|NCT00386074|NaFeEDTA|nafeedta
5732092|NCT00386776|physician patient relations|physician patient relations
5732093|NCT00386776|medical history taking|medical history taking
5732094|NCT00386776|medical informatics applications|medical informatics applications
5732095|NCT00386763|Marsh fever|marsh fever
5732096|NCT00386763|Plasmodium infections|plasmodium infections
5732097|NCT00386763|Remittent fever|remittent fever
5732098|NCT00386763|Paludism|paludism
5732099|NCT00386763|Artemether|artemether
5732100|NCT00386763|Artemisinins|artemisinins
5732102|NCT00386763|Benflumetol|benflumetol
5732103|NCT00386763|Lumefantrine|lumefantrine
5732104|NCT00386750|Malaria|malaria
5732105|NCT00386750|hearing|hearing
5732106|NCT00386750|co-artemether|co-artemether
5732107|NCT00386750|auditory|auditory
5732108|NCT00386750|Plasmodium falciparum|plasmodium falciparum
5732109|NCT00386750|marsh fever|marsh fever
5732110|NCT00386750|Plasmodium infections|plasmodium infections
5732111|NCT00386750|remittent fever|remittent fever
5732112|NCT00386750|paludism|paludism
5732113|NCT00386750|artemether|artemether
5732114|NCT00386750|artemisinins|artemisinins
5732115|NCT00386750|benflumetol|benflumetol
5732116|NCT00386750|lumefantrine|lumefantrine
5732117|NCT00386737|Asthma|asthma
5732118|NCT00386737|Breath Testing|breath testing
5732119|NCT00386737|Laser Spectroscopy|laser spectroscopy
5732120|NCT00386737|eNO|eno
5732121|NCT00386737|Nitric Oxide|nitric oxide
5732122|NCT00386737|Lower Airway Inflammation|lower airway inflammation
5732123|NCT00386737|Carbon Dioxide|carbon dioxide
5732124|NCT00386737|CO2|co2
5732125|NCT00386724|Pain|pain
5732126|NCT00386724|Neurostimulation|neurostimulation
5732127|NCT00386724|Leg Pain|leg pain
5732128|NCT00386724|Back Pain|back pain
5732129|NCT00386711|suicide|suicide
5732130|NCT00386711|depressed patients|depressed patients
5732131|NCT00386711|primary care|primary care
5732132|NCT00386698|Influenza,|influenza,
5732133|NCT00386698|improved vaccine,|improved vaccine,
5732134|NCT00386698|influenza disease|influenza disease
5732135|NCT00386698|elderly|elderly
5732136|NCT00386685|Cancer|cancer
5732137|NCT00386685|Breast|breast
5732138|NCT00386685|metastatic breast cancer|metastatic breast cancer
5732139|NCT00386672|Calcium|calcium
5732140|NCT00386672|Vitamin D|vitamin d
5732141|NCT00386672|Weight Loss|weight loss
5732142|NCT00386672|Overweight|overweight
5732143|NCT00386672|Obesity|obesity
5732144|NCT00386672|Lite Orange Juice|lite orange juice
5732145|NCT00386646|Dry eye syndromes therapy|dry eye syndromes therapy
5732146|NCT00386633|Vaccine|vaccine
5732147|NCT00386633|Safety|safety
5732148|NCT00386633|T-cell epitope|t-cell epitope
5732252|NCT00386243|self-management|self-management
5732149|NCT00386633|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5732150|NCT00386633|HIV Preventive Vaccine|hiv preventive vaccine
5732151|NCT00386620|Breast Cancer|breast cancer
5732152|NCT00386620|Cancer Control|cancer control
5732153|NCT00386620|Spousal Relationships|spousal relationships
5732154|NCT00386620|Questionnaire|questionnaire
5732155|NCT00386620|Interview|interview
5732156|NCT00386620|Pain|pain
5732157|NCT00386607|Hypertension, aliskiren, valsartan, HCTZ, blood pressure|hypertension, aliskiren, valsartan, hctz, blood pressure
5732158|NCT00386594|Barrett Esophagus|barrett esophagus
5732159|NCT00386594|High grade dysplasia|high grade dysplasia
5732160|NCT00386594|Carcinoma in situ|carcinoma in situ
5732161|NCT00386594|825A|825a
5732162|NCT00386542|vaccination|vaccination
5732163|NCT00386542|influenza vaccine|influenza vaccine
5732164|NCT00386542|jet injection|jet injection
5732165|NCT00386542|intradermal injection|intradermal injection
5732166|NCT00386542|infancy|infancy
5732167|NCT00386542|children|children
5732168|NCT00386542|dose-sparing|dose-sparing
5732169|NCT00386542|cutaneous vaccination|cutaneous vaccination
5732170|NCT00386542|Dominican Republic|dominican republic
5732171|NCT00386542|pandemic preparedness|pandemic preparedness
5732172|NCT00386542|jet injector|jet injector
5732173|NCT00386542|reduced dosage|reduced dosage
5732174|NCT00386542|immunogenicity|immunogenicity
5732175|NCT00386542|reactogenicity|reactogenicity
5732176|NCT00386542|safety|safety
5732177|NCT00386542|needle-free|needle-free
5732178|NCT00386542|immune response|immune response
5732179|NCT00386542|hemagglutination inhibition|hemagglutination inhibition
5732180|NCT00386542|Infant|infant
5732181|NCT00386529|low dose aspirin|low dose aspirin
5732182|NCT00386529|Hypertension|hypertension
5732183|NCT00386529|administration time dependent effect|administration time dependent effect
5732184|NCT00386516|cholangiocarcinoma|cholangiocarcinoma
5732185|NCT00386516|bile duct|bile duct
5732186|NCT00386516|biliary|biliary
5732188|NCT00386516|extra-hepatic|extra-hepatic
5732189|NCT00386516|gall bladder|gall bladder
5732190|NCT00386516|cancer|cancer
5732191|NCT00386516|carcinoma|carcinoma
5732192|NCT00386516|metastatic|metastatic
5732193|NCT00386516|metastasis|metastasis
5732194|NCT00386516|advanced|advanced
5732195|NCT00386516|recurrent|recurrent
5732196|NCT00386490|celiac disease|celiac disease
5732197|NCT00386490|larazotide acetate|larazotide acetate
5732198|NCT00386477|Povidone iodine|povidone iodine
5732199|NCT00386477|postoperative infection|postoperative infection
5732200|NCT00386477|presurgical cleansing|presurgical cleansing
5732201|NCT00386464|bipap|bipap
5732202|NCT00386464|lou gehrigs disease|lou gehrigs disease
5732203|NCT00386464|motor neuron disease|motor neuron disease
5732204|NCT00386464|respiratory muscles|respiratory muscles
5732205|NCT00386451|Intravenous chemotherapy|intravenous chemotherapy
5732206|NCT00386412|Cytomegalovirus infection|cytomegalovirus infection
5732207|NCT00386399|Advanced Pancreatic Cancer|advanced pancreatic cancer
5732208|NCT00386399|Mutated BRCA2 Gene|mutated brca2 gene
5732209|NCT00386399|Recurrent Pancreatic Cancer|recurrent pancreatic cancer
5732210|NCT00386386|hydration|hydration
5732211|NCT00386386|prehospital|prehospital
5732212|NCT00386386|mass casualty incident|mass casualty incident
5732213|NCT00386373|Chronic Myeloid Leukemia|chronic myeloid leukemia
5732214|NCT00386373|CML|cml
5732215|NCT00386373|ALL|all
5732216|NCT00386373|AML|aml
5732217|NCT00386373|Leukemia|leukemia
5732218|NCT00386373|Imatinib Mesylate|imatinib mesylate
5732219|NCT00386373|Gleevec|gleevec
5732220|NCT00386373|Philadelphia-Positive|philadelphia-positive
5732221|NCT00386373|Bone marrow transplant|bone marrow transplant
5732222|NCT00386373|BMT|bmt
5732223|NCT00386373|Stem cell transplant|stem cell transplant
5732224|NCT00386373|SCT|sct
5732225|NCT00386347|HIV|hiv
5732226|NCT00386347|repeat dose|repeat dose
5732227|NCT00386347|pharmacokinetics|pharmacokinetics
5732228|NCT00386347|bioavailability|bioavailability
5732229|NCT00386347|single-dose|single-dose
5732230|NCT00386347|food effect|food effect
5732231|NCT00386334|insomnia|insomnia
5732233|NCT00386334|primary|primary
5732234|NCT00386321|Zevalin|zevalin
5732235|NCT00386321|Zevalin plus CHOP|zevalin plus chop
5732236|NCT00386321|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5732237|NCT00386321|First line Diffuse large B-cell lymphoma|first line diffuse large b-cell lymphoma
5732238|NCT00386308|Heavy Menstrual Bleeding|heavy menstrual bleeding
5732239|NCT00386308|Menorrhagia|menorrhagia
5732240|NCT00386282|Mifepristone|mifepristone
5732241|NCT00386282|Misoprostol|misoprostol
5732242|NCT00386282|Buccal administration|buccal administration
5732243|NCT00386269|codeine phosphate analgesia|codeine phosphate analgesia
5732244|NCT00386256|telehealth|telehealth
5732245|NCT00386256|telerehabilitation|telerehabilitation
5732246|NCT00386256|deconditioning|deconditioning
5732247|NCT00386256|exercise|exercise
5732248|NCT00386243|analgesia|analgesia
5732249|NCT00386243|analgesics|analgesics
5732250|NCT00386243|cognitive behavioral therapy|cognitive behavioral therapy
5732251|NCT00386243|Pain|pain
5732253|NCT00386243|stepped care|stepped care
5732254|NCT00386243|musculoskeletal pain|musculoskeletal pain
5732255|NCT00386230|transmission|transmission
5732256|NCT00386230|infant|infant
5732257|NCT00386230|HIV|hiv
5732258|NCT00386230|pregnancy|pregnancy
5732259|NCT00386230|HIV-1 infection|hiv-1 infection
5732260|NCT00386230|HIV Seronegativity|hiv seronegativity
5732261|NCT00386217|Cervical Cancer|cervical cancer
5732262|NCT00386217|Breast Cancer|breast cancer
5732263|NCT00386217|Hodgkin's Disease|hodgkin's disease
5732264|NCT00386217|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5732265|NCT00386217|Female Infertility|female infertility
5732266|NCT00386217|Telephone Survey|telephone survey
5732267|NCT00386204|Q-switched Ruby laser|q-switched ruby laser
5732268|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5732269|NCT00386191|Ischemic cerebrovascular disease|ischemic cerebrovascular disease
5732270|NCT00386178|vitamin E|vitamin e
5732271|NCT00386178|gamma tocopherol|gamma tocopherol
5732272|NCT00386178|moderate to severe asthma|moderate to severe asthma
5732273|NCT00386178|healthy subjects|healthy subjects
5732274|NCT00386165|larazotide acetate|larazotide acetate
5732275|NCT00386152|Anemia|anemia
5732276|NCT00386152|Cancer|cancer
5732277|NCT00386152|Chemotherapy-Induced Anemia|chemotherapy-induced anemia
5732278|NCT00386152|Epoetin alfa|epoetin alfa
5732279|NCT00386152|Darbepoetin alfa|darbepoetin alfa
5732280|NCT00386139|Diastolic|diastolic
5732281|NCT00386139|systolic|systolic
5732282|NCT00386139|hypertension|hypertension
5732283|NCT00386139|aliskiren|aliskiren
5732284|NCT00386139|blood pressure|blood pressure
5732285|NCT00386139|hydrochlorothiazide, HCTZ|hydrochlorothiazide, hctz
5732286|NCT00386126|Heart Failure|heart failure
5732287|NCT00386126|Anemia|anemia
5732288|NCT00386126|Treatment|treatment
5732289|NCT00386113|Influenza|influenza
5732290|NCT00386113|improved vaccine|improved vaccine
5732292|NCT00386100|Fasting Plasma Glucose|fasting plasma glucose
5732293|NCT00386100|Dual energy X ray absorptiometry (DXA)|dual energy x ray absorptiometry (dxa)
5732295|NCT00386100|Type 2 diabetes mellitus|type 2 diabetes mellitus
5732296|NCT00386100|Bone Mineral Density|bone mineral density
5732297|NCT00386100|Hyperglycemia|hyperglycemia
5732298|NCT00386100|HbA1c|hba1c
5732299|NCT00386087|Breast Cancer|breast cancer
5732300|NCT00386087|Cancer of the Breast|cancer of the breast
5732302|NCT00386074|electrolytic iron|electrolytic iron
5732303|NCT00386074|efficacy|efficacy
5732304|NCT00386074|whole maize flour|whole maize flour
5680937|NCT00575588|incretins|incretins
5732305|NCT00386074|phytate|phytate
5732306|NCT00386074|school-age children|school-age children
5732307|NCT00386074|controlled trial|controlled trial
5732308|NCT00386074|Africa|africa
5732309|NCT00386061|Obesity|obesity
5732310|NCT00386061|risk factors|risk factors
5732311|NCT00386048|Cognitive Behavioral Therapy|cognitive behavioral therapy
5732312|NCT00386048|Pediatric Sickle Cell Disease|pediatric sickle cell disease
5732313|NCT00386048|Pain Management|pain management
5732314|NCT00386035|Treatment Experienced|treatment experienced
5732315|NCT00386022|Gonadotropin-releasing hormone|gonadotropin-releasing hormone
5732316|NCT00386022|Estrogens|estrogens
5732317|NCT00386022|postmenopausal women|postmenopausal women
5732318|NCT00386022|Pituitary hormones|pituitary hormones
5732319|NCT00386009|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5732320|NCT00386009|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5732321|NCT00385996|Carcinoma,non-small cell lung|carcinoma,non-small cell lung
5732322|NCT00385996|preoperative|preoperative
5732323|NCT00385996|Tarceva|tarceva
5732324|NCT00385996|Response rate|response rate
5732325|NCT00385983|thyroidectomy|thyroidectomy
5732326|NCT00385983|thyroid neoplasm|thyroid neoplasm
5732327|NCT00385983|postoperative complications|postoperative complications
5732328|NCT00385983|cost effectiveness|cost effectiveness
5732329|NCT00385957|Treatment Naive|treatment naive
5732330|NCT00385931|Hypertension|hypertension
5732331|NCT00385931|high cholesterol|high cholesterol
5732332|NCT00385931|valsartan|valsartan
5732333|NCT00385931|simvastatin|simvastatin
5732334|NCT00385918|Cardiovascular Fitness|cardiovascular fitness
5732335|NCT00385918|Exercise|exercise
5732336|NCT00385918|Gait|gait
5732337|NCT00385918|Spinal Cord Injury|spinal cord injury
5732338|NCT00385918|Treadmill Training|treadmill training
5732339|NCT00385892|Healthy volonteers|healthy volonteers
5732340|NCT00385892|Abdominal binder|abdominal binder
5732341|NCT00385892|IAP|iap
5732342|NCT00385892|MAP|map
5732343|NCT00385892|APP|app
5732344|NCT00385866|Patient Navigator|patient navigator
5732345|NCT00385866|Community health|community health
5732346|NCT00385866|Communication|communication
5732347|NCT00385853|PTK|ptk
5732348|NCT00385853|temozolomide|temozolomide
5732349|NCT00385853|glioblastoma|glioblastoma
5732350|NCT00385840|Influenza vaccine|influenza vaccine
5732351|NCT00385840|Influenza|influenza
5732352|NCT00385827|Cancer|cancer
5732353|NCT00385827|Prostate|prostate
5732354|NCT00385827|IL-6|il-6
5732355|NCT00385827|Mitoxantrone|mitoxantrone
5732861|NCT00383409|cancer|cancer
5732356|NCT00385827|Metastatic prostate cancer|metastatic prostate cancer
5732357|NCT00385801|cocaine|cocaine
5732358|NCT00385801|dependence|dependence
5732359|NCT00385801|risperidal|risperidal
5732360|NCT00385801|MRI|mri
5732361|NCT00385788|Hodgkin's Disease|hodgkin's disease
5732362|NCT00385788|Stem Cell Transplantation|stem cell transplantation
5732363|NCT00385788|Antithymocyte Globulin|antithymocyte globulin
5732364|NCT00385788|Gemcitabine|gemcitabine
5732365|NCT00385788|Gemzar|gemzar
5732366|NCT00385788|Fludarabine|fludarabine
5732367|NCT00385788|Fludarabine Phosphate|fludarabine phosphate
5732368|NCT00385788|Melphalan|melphalan
5732369|NCT00385788|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5732370|NCT00385788|AST|ast
5732371|NCT00385788|SCT|sct
5732372|NCT00385788|ATG|atg
5732373|NCT00385788|Thymoglobulin|thymoglobulin
5732374|NCT00385775|Cancer|cancer
5732375|NCT00385775|solid tumours|solid tumours
5732376|NCT00385775|refractory|refractory
5732377|NCT00385775|antisense|antisense
5732378|NCT00385775|oligonucleotide|oligonucleotide
5732379|NCT00385762|Human volunteers|human volunteers
5732380|NCT00385749|Implanted cardioverter defibrillator|implanted cardioverter defibrillator
5732381|NCT00385749|congestive heart failure|congestive heart failure
5732382|NCT00385749|right ventricular lead placement|right ventricular lead placement
5732383|NCT00385749|select site pacing|select site pacing
5732384|NCT00385736|Moderate to Severe Ulcerative Colitis|moderate to severe ulcerative colitis
5732385|NCT00385736|Double-blind|double-blind
5732386|NCT00385736|Adalimumab|adalimumab
5732387|NCT00385736|Induction of Clinical Remission|induction of clinical remission
5732388|NCT00385723|affect|affect
5732389|NCT00385723|inflammation|inflammation
5732390|NCT00385710|Progressive supranuclear palsy (PSP)|progressive supranuclear palsy (psp)
5732391|NCT00385697|Randomized|randomized
5732392|NCT00385697|Double Blind|double blind
5732393|NCT00385697|Parallel Group|parallel group
5727423|NCT00404482|MTX|mtx
5732394|NCT00385697|Controlled Clinical Trial|controlled clinical trial
5732396|NCT00385684|Alzheimer Disease|alzheimer disease
5732397|NCT00385684|Analgesics|analgesics
5732398|NCT00385684|Dementia|dementia
5732399|NCT00385684|Narcotics|narcotics
5732400|NCT00385684|Opioid|opioid
5732401|NCT00385684|Pain|pain
5732402|NCT00385684|Palliative Care|palliative care
5732403|NCT00385684|Psychomotor|psychomotor
5732404|NCT00385684|Suffering, Physical|suffering, physical
5732405|NCT00385658|Dyslipidemia|dyslipidemia
5740704|NCT00355498|tau|tau
5732406|NCT00385658|metabolic syndrome|metabolic syndrome
5732407|NCT00385658|fluvastatin|fluvastatin
5732408|NCT00385658|fenofibrate|fenofibrate
5732409|NCT00385658|simvastatin|simvastatin
5732410|NCT00385658|ezetimibe|ezetimibe
5732411|NCT00385645|HIV seronegativity|hiv seronegativity
5732412|NCT00385632|Treatment Experienced|treatment experienced
5732413|NCT00385606|prolonged continuous infusion|prolonged continuous infusion
5732414|NCT00385606|Cox-2 inhibitors|cox-2 inhibitors
5732415|NCT00385567|AIDS|aids
5732416|NCT00385567|Treatment Experienced|treatment experienced
5732417|NCT00385554|Microbicide|microbicide
5732418|NCT00385554|HIV prevention|hiv prevention
5732419|NCT00385554|Botswana|botswana
5732420|NCT00385554|Preventing acquisition of HIV infection|preventing acquisition of hiv infection
5732421|NCT00385554|HIV Seronegativity|hiv seronegativity
5732422|NCT00385541|pain|pain
5732423|NCT00385541|morphine|morphine
5732424|NCT00385541|hydromorphone|hydromorphone
5732425|NCT00385541|nausea|nausea
5732426|NCT00385541|vomiting|vomiting
5732427|NCT00385541|pruritis|pruritis
5732428|NCT00385528|Case complexity|case complexity
5732429|NCT00385528|INTERMED|intermed
5732430|NCT00385528|Consultation liaison psychiatry|consultation liaison psychiatry
5732431|NCT00385528|depression|depression
5732432|NCT00385502|toenail|toenail
5732433|NCT00385502|fungus|fungus
5732434|NCT00385502|onychomycosis|onychomycosis
5732435|NCT00385502|antifungal|antifungal
5732436|NCT00385502|anti-fungal|anti-fungal
5732438|NCT00385476|Advanced Cancer|advanced cancer
5732439|NCT00385476|Medication Knowledge|medication knowledge
5732440|NCT00385476|Emergency Center|emergency center
5732441|NCT00385476|Questionnaire|questionnaire
5732442|NCT00385476|Survey|survey
5732443|NCT00385463|Asthma|asthma
5732444|NCT00385463|Rhinitis|rhinitis
5732445|NCT00385463|Allergic Asthma|allergic asthma
5732446|NCT00385437|Driving safety|driving safety
5732447|NCT00385437|maintenance of wakefulness test|maintenance of wakefulness test
5732448|NCT00385437|major depressive disorder|major depressive disorder
5732449|NCT00385437|mirtazapine|mirtazapine
5732450|NCT00385398|tumors metastatic to brain|tumors metastatic to brain
5732451|NCT00385398|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5732452|NCT00385372|low pseudoallergen diet|low pseudoallergen diet
5732453|NCT00385372|elimination diet|elimination diet
5732454|NCT00385372|provocation diet|provocation diet
5732455|NCT00385372|oral provocation|oral provocation
5732456|NCT00385372|natural food ingredients|natural food ingredients
5732457|NCT00385372|food additives|food additives
5732458|NCT00385372|flavours|flavours
5732459|NCT00385346|Expressive writing|expressive writing
5732460|NCT00385346|Male infertility|male infertility
5732461|NCT00385333|Mitochondrion|mitochondrion
5732462|NCT00385333|Retina|retina
5732463|NCT00385333|Mitochondria|mitochondria
5732464|NCT00385333|Metabolism|metabolism
5732465|NCT00385333|In Vivo Imaging|in vivo imaging
5732466|NCT00385333|Age-Related Macular Degeneration|age-related macular degeneration
5732468|NCT00385333|Diabetic Retinopathy|diabetic retinopathy
5732469|NCT00385333|DR|dr
5732470|NCT00385333|Hippel-Lindau Disease|hippel-lindau disease
5732471|NCT00385333|VHL|vhl
5732472|NCT00385307|Depression|depression
5732473|NCT00385307|Clinical Trials|clinical trials
5732474|NCT00385307|Major Depressive Disorder|major depressive disorder
5732475|NCT00385294|Genetic|genetic
5732476|NCT00385294|pain|pain
5732477|NCT00385294|obstetrical|obstetrical
5798834|NCT00110890|Clinical Trial, Amgen|clinical trial, amgen
5732478|NCT00385281|proteomic profiling, influenza, vaccine, FluMist|proteomic profiling, influenza, vaccine, flumist
5732479|NCT00385268|cocaine|cocaine
5732480|NCT00385255|Immunogenicity,|immunogenicity,
5732481|NCT00385255|Influenza|influenza
5732482|NCT00385255|Co-administration,|co-administration,
5732483|NCT00385255|Tdap,|tdap,
5732484|NCT00385242|coronary artery disease|coronary artery disease
5732485|NCT00385242|left ventricular dysfunction|left ventricular dysfunction
5732486|NCT00385242|positron emission tomography|positron emission tomography
5732487|NCT00385242|viable myocardium|viable myocardium
5732488|NCT00385242|revascularization|revascularization
5732489|NCT00385242|cost effectiveness|cost effectiveness
5732490|NCT00385229|Asphyxia neonatorum|asphyxia neonatorum
5732491|NCT00385229|Birth Injury|birth injury
5732492|NCT00385229|Meconium Aspiration Syndrome|meconium aspiration syndrome
5732493|NCT00385216|Third Molar|third molar
5732494|NCT00385216|Pain|pain
5732495|NCT00385203|cancer|cancer
5732496|NCT00385203|tumour|tumour
5732497|NCT00385203|advanced cancer|advanced cancer
5732498|NCT00385203|Metastatic Gastro-Intestinal Stromal Tumours|metastatic gastro-intestinal stromal tumours
5732499|NCT00385203|gastro-intestinal cancer|gastro-intestinal cancer
5732500|NCT00385203|RECENTIN|recentin
5732502|NCT00385164|lung neoplasms|lung neoplasms
5732503|NCT00385164|positron emissions tomography|positron emissions tomography
5732504|NCT00385164|radiotherapy planning|radiotherapy planning
5732505|NCT00385151|Post conditioning|post conditioning
5732506|NCT00385138|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5732507|NCT00385138|ACS|acs
5732508|NCT00385125|relapsed|relapsed
5732509|NCT00385125|refractory|refractory
5732510|NCT00385125|CD 20 positive|cd 20 positive
5732511|NCT00385112|Cardiology|cardiology
5732512|NCT00385112|Echocardiograms|echocardiograms
5732514|NCT00385112|Valve Disease|valve disease
5732515|NCT00385112|Heart Valve Disease|heart valve disease
5732516|NCT00385099|IBS|ibs
5732517|NCT00385099|stress|stress
5732518|NCT00385099|CRF1|crf1
5732519|NCT00385086|Sciatica|sciatica
5732520|NCT00385086|Pain|pain
5732521|NCT00385086|TNF-alpha|tnf-alpha
5732522|NCT00385086|Discectomy|discectomy
5732523|NCT00385086|Fibrosis|fibrosis
5732524|NCT00385086|Spine|spine
5732525|NCT00385047|malaria|malaria
5732526|NCT00385047|vaccine|vaccine
5732527|NCT00385047|AMA-1 (apical membrane antigen-1)|ama-1 (apical membrane antigen-1)
5732528|NCT00385047|efficacy|efficacy
5732529|NCT00385034|randomized controlled trial|randomized controlled trial
5732530|NCT00385034|RCT|rct
5732531|NCT00385034|partner violence|partner violence
5732533|NCT00385034|screening|screening
5732534|NCT00385034|family practice|family practice
5732535|NCT00385034|computer|computer
5732536|NCT00385021|Advanced|advanced
5732537|NCT00385021|metastatic|metastatic
5732538|NCT00385021|colorectal|colorectal
5732539|NCT00385021|cancer|cancer
5732540|NCT00385021|Avastin|avastin
5680938|NCT00575575|Suicidal ideation|suicidal ideation
5741918|NCT00351481|IVF|ivf
5732541|NCT00385008|Combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy|combination product, sumatriptan succinate, naproxen sodium, absorption, pharmacokinetics, disintegration, gastric transit, gastric scintigraphy
5732542|NCT00384995|Contrast Induced Nephropathy|contrast induced nephropathy
5732543|NCT00384995|Chronic Kidney Disease|chronic kidney disease
5732544|NCT00384995|Acute Renal Failure|acute renal failure
5732545|NCT00384995|End-stage Renal Disease|end-stage renal disease
5732546|NCT00384995|Cardiovascular diseases|cardiovascular diseases
5732547|NCT00384995|Coronary catheterization|coronary catheterization
5732548|NCT00384995|Percutaneous coronary intervention|percutaneous coronary intervention
5732549|NCT00384995|Intra-arterial angiography|intra-arterial angiography
5732550|NCT00384995|Bicarbonate|bicarbonate
5732551|NCT00384995|Saline|saline
5732552|NCT00384982|Bone marrow-derived stem cells|bone marrow-derived stem cells
5732553|NCT00384982|Acute myocardial infarction|acute myocardial infarction
5732554|NCT00384969|RAD001|rad001
5732555|NCT00384969|Sorafenib|sorafenib
5732556|NCT00384969|Renal Cell Carcinoma|renal cell carcinoma
5732557|NCT00384969|Metastatic|metastatic
5732558|NCT00384956|MDS either de novo or secondary, fitting any of the WHO classifications.|mds either de novo or secondary, fitting any of the who classifications.
5732559|NCT00384943|postpartum depression|postpartum depression
5732560|NCT00384943|exercise|exercise
5732561|NCT00384891|Superficial urothelial cell carcinoma of bladder|superficial urothelial cell carcinoma of bladder
5732562|NCT00384891|NMIBC|nmibc
5732563|NCT00384891|Non Muscle Invasive Bladder Cancer|non muscle invasive bladder cancer
5732564|NCT00384891|Hyperthermia|hyperthermia
5732565|NCT00384891|Bladder instillation|bladder instillation
5732566|NCT00384891|Mitomycin C|mitomycin c
5732567|NCT00384891|RITE|rite
5732568|NCT00384891|SHTC|shtc
5732569|NCT00384891|Intravesical|intravesical
5732570|NCT00384865|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5732571|NCT00384852|Fracture|fracture
5732572|NCT00384852|Humerus|humerus
5732573|NCT00384826|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
5732574|NCT00384787|HIV Seronegativity|hiv seronegativity
5732575|NCT00384787|Adenoviral Vector Vaccine|adenoviral vector vaccine
5732576|NCT00384787|DNA Plasmid Vaccine|dna plasmid vaccine
5732577|NCT00384787|HIV Preventive Vaccine|hiv preventive vaccine
5732578|NCT00384774|Migraine|migraine
5732579|NCT00384748|Cerebrovascular Accident|cerebrovascular accident
5732580|NCT00384748|Rehabilitation|rehabilitation
5732581|NCT00384748|Telemedicine|telemedicine
5732582|NCT00384735|bone tumor|bone tumor
5732583|NCT00384735|soft tissue tumor|soft tissue tumor
5732584|NCT00384722|Left ventricular lead|left ventricular lead
5732586|NCT00384722|Heart Failure|heart failure
5732587|NCT00384709|Elderly|elderly
5732588|NCT00384709|Hospitalization|hospitalization
5732589|NCT00384709|Geriatrics|geriatrics
5732590|NCT00384709|Mortality|mortality
5732591|NCT00384709|Readmission|readmission
5732592|NCT00384709|Length of Stay|length of stay
5732593|NCT00384696|Risk Perception|risk perception
5732594|NCT00384696|Smoking Cessation|smoking cessation
5732595|NCT00384696|Nicotine Replacement Therapy|nicotine replacement therapy
5732597|NCT00384696|Nicotine|nicotine
5732598|NCT00384683|Endothelial Dysfunction|endothelial dysfunction
5732599|NCT00384683|Endothelial Cells|endothelial cells
5732600|NCT00384683|Perioperative Outcome|perioperative outcome
5732601|NCT00384683|Blood Sample|blood sample
5732602|NCT00384670|dengue|dengue
5732603|NCT00384670|vaccine|vaccine
5732604|NCT00384657|chronic heart failure|chronic heart failure
5732605|NCT00384657|chronic kidney disease|chronic kidney disease
5732606|NCT00384657|anemia|anemia
5732607|NCT00384657|intravenous iron|intravenous iron
5732608|NCT00384644|heart failure|heart failure
5732610|NCT00384644|septic shock|septic shock
5732611|NCT00384644|cardiogenic shock|cardiogenic shock
5732612|NCT00384631|Neovascular|neovascular
5732613|NCT00384631|Glaucoma|glaucoma
5732614|NCT00384631|Bevacizumab|bevacizumab
5732615|NCT00384631|Avastin|avastin
5732616|NCT00384631|Intravitreal|intravitreal
5732617|NCT00384631|IOP|iop
5732618|NCT00384618|Kidney, Antioxidants, Statin, Carotid IMT|kidney, antioxidants, statin, carotid imt
5732619|NCT00384592|heartburn|heartburn
5732620|NCT00384592|reflux|reflux
5732621|NCT00384592|proton pump inhibitor|proton pump inhibitor
5732622|NCT00384592|GERD|gerd
5732623|NCT00384592|GORD|gord
5732624|NCT00384579|back|back
5732625|NCT00384579|pain|pain
5732626|NCT00384540|-Heart Transplant, Allograft Vasculopathy, Dobutamine Stress Echocardiography, Brain Natriuretic Peptide|-heart transplant, allograft vasculopathy, dobutamine stress echocardiography, brain natriuretic peptide
5732627|NCT00384540|Vasculopathy|vasculopathy
5732628|NCT00384527|Clostridium difficile|clostridium difficile
5732629|NCT00384514|Coronary Artery disease with chronic stable angina|coronary artery disease with chronic stable angina
5732630|NCT00384501|keratoconus|keratoconus
5732631|NCT00384501|Intacs|intacs
5732632|NCT00384488|Diabetes mellitus|diabetes mellitus
5732633|NCT00384488|Weight control|weight control
5732634|NCT00384488|Healthy eating|healthy eating
5732635|NCT00384488|Physical Activity|physical activity
5732636|NCT00384475|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5732637|NCT00384475|Ciclesonide|ciclesonide
5732638|NCT00384475|Hay Fever|hay fever
5732640|NCT00384462|Premature infants (32-35 weeks GA) <6 months of age at the start of the RSV season who are not receiving palivizumab and do not have CLD of prematurity|premature infants (32-35 weeks ga) <6 months of age at the start of the rsv season who are not receiving palivizumab and do not have cld of prematurity
5732641|NCT00384462|Respiratory Syncytial Viruses|respiratory syncytial viruses
5732642|NCT00384449|Eales|eales
5732643|NCT00384436|Major Depressive Disorder|major depressive disorder
5732644|NCT00384423|Alzheimer's Disease|alzheimer's disease
5732645|NCT00384423|AD|ad
5732646|NCT00384423|PRX-03140|prx-03140
5732647|NCT00384423|Dementia|dementia
5732648|NCT00384423|Epix|epix
5732649|NCT00384423|Predix|predix
5732650|NCT00384423|Cognition enhancing|cognition enhancing
5732651|NCT00384410|Pain|pain
5732652|NCT00384410|Insomnia|insomnia
5732653|NCT00384410|Nabilone|nabilone
5732654|NCT00384397|Menactra vaccine|menactra vaccine
5732655|NCT00384397|Meningococcal meningitis|meningococcal meningitis
5732656|NCT00384397|Measles|measles
5732657|NCT00384397|Mumps|mumps
5732658|NCT00384397|Rubella|rubella
5732659|NCT00384397|Varicella virus|varicella virus
5732660|NCT00384397|Haemophilus influenzae type b|haemophilus influenzae type b
5732661|NCT00384397|Pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5732662|NCT00384384|Dialysis|dialysis
5732663|NCT00384384|Serum potassium|serum potassium
5732664|NCT00384384|18b glycyrrhetinic acid|18b glycyrrhetinic acid
5732665|NCT00384384|insulin sensitivity|insulin sensitivity
5732666|NCT00384371|back|back
5732667|NCT00384371|pain|pain
5732668|NCT00384358|Fractures|fractures
5732669|NCT00384345|bright light treatment|bright light treatment
5732670|NCT00384345|exercise|exercise
5732671|NCT00384345|body fat index|body fat index
5732672|NCT00384345|mood|mood
5732673|NCT00384345|sleep|sleep
5732674|NCT00384345|fatigue|fatigue
5732675|NCT00384332|Bipolar Depression|bipolar depression
5732676|NCT00384332|Weight gain bipolar medicine|weight gain bipolar medicine
5732677|NCT00384332|side effects olanzapine|side effects olanzapine
5732678|NCT00384332|gastrointestinal hormones bipolar medicine|gastrointestinal hormones bipolar medicine
5732679|NCT00384319|resuscitation|resuscitation
5732680|NCT00384319|hypothermia|hypothermia
5732681|NCT00384306|COPD|copd
5732682|NCT00384306|prednisolone|prednisolone
5732683|NCT00384306|bone biopsy|bone biopsy
5732684|NCT00384306|tetracycline labelling|tetracycline labelling
5732685|NCT00384267|malaria, infants, preterm babies, neonates, Mali|malaria, infants, preterm babies, neonates, mali
5732686|NCT00384254|Tobacco.|tobacco.
5732687|NCT00384254|Cessation.|cessation.
5732688|NCT00384254|Dental patients.|dental patients.
5732689|NCT00384254|Dentists.|dentists.
5732690|NCT00384254|Hygienists.|hygienists.
5732691|NCT00384254|Dental assistants.|dental assistants.
5732692|NCT00384254|Health care providers.|health care providers.
5732693|NCT00384254|Behavioral intervention.|behavioral intervention.
5732694|NCT00384254|Tobacco intervention.|tobacco intervention.
5732695|NCT00384254|Cigarettes.|cigarettes.
5732696|NCT00384254|Smokeless tobacco.|smokeless tobacco.
5732697|NCT00384254|Smoking intervention.|smoking intervention.
5732698|NCT00384241|Blood Pressure, High|blood pressure, high
5732700|NCT00384241|Inflammation|inflammation
5732701|NCT00384228|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5732702|NCT00384228|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5732704|NCT00384202|Liver Transplantation|liver transplantation
5732705|NCT00384189|Asthma|asthma
5732706|NCT00384189|Ciclesonide|ciclesonide
5732707|NCT00384189|children|children
5732708|NCT00384176|Metastatic Colorectal Cancer|metastatic colorectal cancer
5732709|NCT00384176|RECENTIN|recentin
5731686|NCT00388076|Pazopanib|pazopanib
5732710|NCT00384163|cardiac|cardiac
5732711|NCT00384163|adult|adult
5732712|NCT00384163|PVR|pvr
5732713|NCT00384150|galiximab|galiximab
5732714|NCT00384150|antibody|antibody
5732715|NCT00384150|refractory|refractory
5732716|NCT00384150|follicular|follicular
5732717|NCT00384150|relapsed|relapsed
5732718|NCT00384150|NHL|nhl
5732719|NCT00384150|rituximab|rituximab
5732720|NCT00384150|retreatment|retreatment
5732721|NCT00384137|Tacrolimus|tacrolimus
5732722|NCT00384137|Kidney Transplantation|kidney transplantation
5732723|NCT00384124|Bowens disease|bowens disease
5732724|NCT00384124|Squamous cell carcinoma in situ of the skin|squamous cell carcinoma in situ of the skin
5732725|NCT00384124|imiquimod|imiquimod
5732726|NCT00384098|Psoriasis|psoriasis
5732727|NCT00384072|postmenopausal|postmenopausal
5732728|NCT00384072|women|women
5732729|NCT00384072|SERM|serm
5732730|NCT00384072|osteoporosis|osteoporosis
5732731|NCT00384033|MDD|mdd
5732732|NCT00384033|Major Depressive Disorder|major depressive disorder
5732733|NCT00384033|Depression|depression
5732734|NCT00384020|Major Depression Disorder|major depression disorder
5732735|NCT00384020|Antidepressant|antidepressant
5732736|NCT00384020|Pharmacogenomics|pharmacogenomics
5732737|NCT00384020|Cytochrome P450|cytochrome p450
5732738|NCT00384020|Serotonin Transporter|serotonin transporter
5732739|NCT00384007|back pain|back pain
5732740|NCT00384007|herniated disc|herniated disc
5732741|NCT00384007|leg pain|leg pain
5732742|NCT00384007|pinched nerves|pinched nerves
5732743|NCT00384007|sciatica|sciatica
5732744|NCT00384007|radiculopathy|radiculopathy
5732745|NCT00383994|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5732746|NCT00383994|CLL|cll
5732747|NCT00383994|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5732748|NCT00383994|B-Cell Lymphoma|b-cell lymphoma
5732749|NCT00383994|Lymphoma|lymphoma
5732750|NCT00383994|granulocyte-macrophage colony-stimulating factor|granulocyte-macrophage colony-stimulating factor
5732751|NCT00383994|Leukemia|leukemia
5732752|NCT00383994|NK Cells|nk cells
5732753|NCT00383994|Rituximab|rituximab
5732754|NCT00383994|GM-CSF|gm-csf
5732755|NCT00383994|Non-myeloablative Allogeneic Stem Cell Transplantation|non-myeloablative allogeneic stem cell transplantation
5732756|NCT00383994|Stem Cell Transplant|stem cell transplant
5732757|NCT00383981|malondialdehyde optoelectronic vitamin complex|malondialdehyde optoelectronic vitamin complex
5732758|NCT00383942|Pregnancy|pregnancy
5732759|NCT00383942|Extra amniotic saline infusion|extra amniotic saline infusion
5732760|NCT00383942|Misoprostol|misoprostol
5732761|NCT00383942|Labor induction|labor induction
5732762|NCT00383929|Blood pressure reduction|blood pressure reduction
5732763|NCT00383929|combination therapy|combination therapy
5732764|NCT00383929|candesartan cilexetil|candesartan cilexetil
5732765|NCT00383929|hydrochlorothiazide|hydrochlorothiazide
5732766|NCT00383916|healthy|healthy
5732767|NCT00383890|American Society of Anesthesiologists (ASA)|american society of anesthesiologists (asa)
5732768|NCT00383890|Mallampati Score|mallampati score
5732769|NCT00383890|Ramsay Sedation Scale (RSS)|ramsay sedation scale (rss)
5732770|NCT00383864|liver fibrosis|liver fibrosis
5732771|NCT00383864|portal pressure|portal pressure
5732772|NCT00383864|antiviral therapy|antiviral therapy
5732773|NCT00383851|ATN-224|atn-224
5732774|NCT00383851|Temozolomide|temozolomide
5732775|NCT00383851|Combination|combination
5732776|NCT00383851|Sequential|sequential
5732777|NCT00383851|Anti-angiogenic|anti-angiogenic
5750200|NCT00319085|Hip,|hip,
5732778|NCT00383851|Copper|copper
5732779|NCT00383838|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
5732780|NCT00383825|conjunctival autografts|conjunctival autografts
5732781|NCT00383825|amniotic membrane|amniotic membrane
5732782|NCT00383825|indocyanine green angiography|indocyanine green angiography
5732783|NCT00383825|pterygium surgery|pterygium surgery
5732784|NCT00383812|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5732785|NCT00383812|Intravitreal Bevacizumab|intravitreal bevacizumab
5732786|NCT00383799|Ventricular tachycardia|ventricular tachycardia
5732787|NCT00383786|PTSD|ptsd
5732788|NCT00383786|Substance P|substance p
5732789|NCT00383786|Treatment Study|treatment study
5732790|NCT00383786|Placebo|placebo
5732791|NCT00383786|Controlled|controlled
5732792|NCT00383786|Post Traumatic Stress Disorder|post traumatic stress disorder
5732793|NCT00383773|retinal vein occlusion|retinal vein occlusion
5732794|NCT00383773|rTPA|rtpa
5732795|NCT00383747|cognition|cognition
5732797|NCT00383747|schizophrenia|schizophrenia
5732798|NCT00383734|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5732799|NCT00383734|polylactic acid|polylactic acid
5732800|NCT00383734|polyacrylamide gels|polyacrylamide gels
5732801|NCT00383695|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5732802|NCT00383695|stage I rectal cancer|stage i rectal cancer
5732803|NCT00383695|stage II rectal cancer|stage ii rectal cancer
5732804|NCT00383695|stage III rectal cancer|stage iii rectal cancer
5732805|NCT00383682|postamputation pain|postamputation pain
5732806|NCT00383682|phantom pain|phantom pain
5732808|NCT00383682|neuroma pain|neuroma pain
5732809|NCT00383682|opioid|opioid
5732810|NCT00383682|mexiletine|mexiletine
5732811|NCT00383669|HIV|hiv
5732812|NCT00383669|AIDS|aids
5732813|NCT00383669|Disease Progression|disease progression
5732814|NCT00383669|Multivitamins|multivitamins
5732815|NCT00383669|Anti-Retroviral Therapy|anti-retroviral therapy
5732816|NCT00383669|HAART|haart
5732817|NCT00383669|Tanzania|tanzania
5732818|NCT00383669|Africa|africa
5732819|NCT00383656|gonadotropin releasing hormone|gonadotropin releasing hormone
5732820|NCT00383656|GnRH deficiency|gnrh deficiency
5732821|NCT00383656|hypothalamic amenorrhea|hypothalamic amenorrhea
5732822|NCT00383656|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5732823|NCT00383656|Kallman's syndrome|kallman's syndrome
5732824|NCT00383656|infertility|infertility
5732825|NCT00383630|End Stage Heart Failure|end stage heart failure
5732826|NCT00383630|LVAD|lvad
5732827|NCT00383630|Bone Marrow Transplantation|bone marrow transplantation
5732828|NCT00383630|Stem Cell Transplantation|stem cell transplantation
5732829|NCT00383617|pre-radiographic|pre-radiographic
5732830|NCT00383617|screening|screening
5732831|NCT00383617|early diagnosis|early diagnosis
5732832|NCT00383578|Type 2 diabetes|type 2 diabetes
5732833|NCT00383578|vildagliptin|vildagliptin
5732834|NCT00383578|hemoglobin A1c|hemoglobin a1c
5732836|NCT00383539|Influenza|influenza
5732837|NCT00383539|Orthomyxoviruses|orthomyxoviruses
5732838|NCT00383539|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5732839|NCT00383539|Adults|adults
5732840|NCT00383526|Influenza|influenza
5732841|NCT00383526|Orthomyxoviruses|orthomyxoviruses
5732842|NCT00383526|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5732843|NCT00383526|elderly|elderly
5732844|NCT00383513|Lupus|lupus
5732845|NCT00383513|Antibody|antibody
5732846|NCT00383513|B-Cell Immunotherapy|b-cell immunotherapy
5732847|NCT00383461|tobacco use disorder|tobacco use disorder
5732848|NCT00383448|Stem cell transplantation|stem cell transplantation
5732849|NCT00383448|Inborn errors of metabolism|inborn errors of metabolism
5732850|NCT00383448|Adrenoleukodystrophy (ALD)|adrenoleukodystrophy (ald)
5732851|NCT00383448|Metachromatic leukodystrophy (MLD)|metachromatic leukodystrophy (mld)
5732852|NCT00383448|Globoid cell leukodystrophy (GLD or Krabbe)|globoid cell leukodystrophy (gld or krabbe)
5732853|NCT00383448|Tay Sachs|tay sachs
5732854|NCT00383448|Sandhoff|sandhoff
5732855|NCT00383448|Sanfilippo syndrome|sanfilippo syndrome
5732856|NCT00383448|Mucopolysaccharidosis III (MPS-III)|mucopolysaccharidosis iii (mps-iii)
5732857|NCT00383448|GM1 gangliosidosis|gm1 gangliosidosis
5732858|NCT00383448|I-cell|i-cell
5732859|NCT00383448|mucolipidosis|mucolipidosis
5732860|NCT00383409|breast|breast
5732863|NCT00383409|multivitamins|multivitamins
5732864|NCT00383357|Performance|performance
5732865|NCT00383357|Gait stability|gait stability
5732866|NCT00383357|sedative|sedative
5732867|NCT00383357|hypnotic|hypnotic
5732868|NCT00383357|quality of life|quality of life
5732869|NCT00383357|sleep disorder|sleep disorder
5732870|NCT00383357|wakefulness|wakefulness
5732871|NCT00383357|sleeping pills|sleeping pills
5732872|NCT00383357|Cognitive function|cognitive function
5732873|NCT00383344|Crohn Disease|crohn disease
5732874|NCT00383344|Positron Emission Tomography|positron emission tomography
5732875|NCT00383344|Colonoscopy|colonoscopy
5732876|NCT00383318|Neonate|neonate
5732877|NCT00383318|Hyperbilirubinemia|hyperbilirubinemia
5732878|NCT00383318|Jaundice|jaundice
5732879|NCT00383318|G6PD Deficiency|g6pd deficiency
5732880|NCT00383318|Gilbert's Syndrome|gilbert's syndrome
5732881|NCT00383305|neonatal|neonatal
5732882|NCT00383305|hypoxic|hypoxic
5732883|NCT00383305|ischemic|ischemic
5732884|NCT00383305|encephalopathy|encephalopathy
5732885|NCT00383305|HIE|hie
5732886|NCT00383305|birth asphyxia|birth asphyxia
5732887|NCT00383305|neonatal encephalopathy|neonatal encephalopathy
5732888|NCT00383305|Asphyxia Neonatorum|asphyxia neonatorum
5732889|NCT00383305|hypothermia, therapeutic|hypothermia, therapeutic
5732890|NCT00383305|brain cooling|brain cooling
5732891|NCT00383305|selective head cooling|selective head cooling
5732892|NCT00383279|recurrent cervical cancer|recurrent cervical cancer
5732893|NCT00383279|stage 0 cervical cancer|stage 0 cervical cancer
5732894|NCT00383279|stage IA cervical cancer|stage ia cervical cancer
5732895|NCT00383279|stage IB cervical cancer|stage ib cervical cancer
5732896|NCT00383279|stage IIA cervical cancer|stage iia cervical cancer
5732897|NCT00383279|stage IIB cervical cancer|stage iib cervical cancer
5727733|NCT00403234|opioid|opioid
5732898|NCT00383279|stage III cervical cancer|stage iii cervical cancer
5732899|NCT00383279|stage IVA cervical cancer|stage iva cervical cancer
5732900|NCT00383279|stage IVB cervical cancer|stage ivb cervical cancer
5732901|NCT00383279|recurrent uterine sarcoma|recurrent uterine sarcoma
5732902|NCT00383279|stage I uterine sarcoma|stage i uterine sarcoma
5732903|NCT00383279|stage II uterine sarcoma|stage ii uterine sarcoma
5732904|NCT00383279|stage III uterine sarcoma|stage iii uterine sarcoma
5733281|NCT00381914|Vitamin D|vitamin d
5732905|NCT00383279|stage IV uterine sarcoma|stage iv uterine sarcoma
5732906|NCT00383279|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5732907|NCT00383279|ovarian sarcoma|ovarian sarcoma
5731850|NCT00387595|CAD|cad
5732908|NCT00383279|ovarian stromal cancer|ovarian stromal cancer
5732909|NCT00383279|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5732910|NCT00383279|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5732911|NCT00383279|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5732912|NCT00383279|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5732913|NCT00383279|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5732914|NCT00383279|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5732915|NCT00383279|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5732916|NCT00383279|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5732917|NCT00383279|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5732918|NCT00383279|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5732919|NCT00383214|Lupus,|lupus,
5732920|NCT00383214|antibody,|antibody,
5732921|NCT00383214|B-cell immunotherapy|b-cell immunotherapy
5732922|NCT00383201|Contact Lens Care|contact lens care
5732923|NCT00383188|Arthritis, Rheumatoid|arthritis, rheumatoid
5732924|NCT00383175|Ocular Accommodation|ocular accommodation
5732925|NCT00383175|Reading|reading
5742296|NCT00349765|saturated fat|saturated fat
5732926|NCT00383162|Combination Product|combination product
5732927|NCT00383162|naproxen sodium|naproxen sodium
5732928|NCT00383162|sumatriptan succinate|sumatriptan succinate
5732929|NCT00383162|short acting triptan|short acting triptan
5732930|NCT00383162|migraine, acute|migraine, acute
5732931|NCT00383162|Poor response|poor response
5732933|NCT00383136|Primary Angioplasty|primary angioplasty
5732934|NCT00383136|Abciximab|abciximab
5732935|NCT00383136|Tirofiban|tirofiban
5732936|NCT00383123|Fluarix|fluarix
5732937|NCT00383123|Influenza|influenza
5732938|NCT00383110|Diabetes|diabetes
5732939|NCT00383110|Health Outcomes|health outcomes
5732940|NCT00383110|Racial Preference|racial preference
5732941|NCT00383110|Clinical Trial|clinical trial
5732942|NCT00383110|Ethnic Differences|ethnic differences
5732943|NCT00383097|CTLs|ctls
5732944|NCT00383097|LMP1|lmp1
5732945|NCT00383097|LMP2|lmp2
5732946|NCT00383097|CYTOTOXIC T-LYMPHOCYTES|cytotoxic t-lymphocytes
5732947|NCT00383097|CD45|cd45
5732948|NCT00383097|ANTIBODY|antibody
5732949|NCT00383097|EBV-POSITIVE HODGKIN'S|ebv-positive hodgkin's
5732950|NCT00383097|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
5732951|NCT00383084|Pain|pain
5732952|NCT00383084|Physical Activity|physical activity
5732953|NCT00383084|Fatigue|fatigue
5732954|NCT00383084|Lifestyle Activity|lifestyle activity
5732955|NCT00383071|Apheresis|apheresis
5732956|NCT00383071|Avian Flu|avian flu
5732957|NCT00383071|Healthy Volunteers|healthy volunteers
5732958|NCT00383071|Infectious Diseases|infectious diseases
5732960|NCT00383071|Healthy Volunteer|healthy volunteer
5732962|NCT00383058|obesity|obesity
5732963|NCT00383058|green tea|green tea
5732964|NCT00383045|Buprenorphine|buprenorphine
5732965|NCT00383045|Naltrexone|naltrexone
5732966|NCT00383045|HIV risk reduction behavior|hiv risk reduction behavior
5732967|NCT00383045|Counseling|counseling
5732968|NCT00383006|Psychotherapy, Group|psychotherapy, group
5732969|NCT00383006|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5732970|NCT00383006|Ambulatory Care|ambulatory care
5732971|NCT00382993|migraine with or without aura|migraine with or without aura
5732972|NCT00382993|naproxen sodium|naproxen sodium
5732973|NCT00382993|combination product|combination product
5732974|NCT00382993|sumatriptan succinate|sumatriptan succinate
5732975|NCT00382993|poor response|poor response
5732976|NCT00382993|short acting triptan|short acting triptan
5732977|NCT00382993|migraine, acute|migraine, acute
5732978|NCT00382980|influenza, vaccine, A/H5N1, aluminum hydroxide, Vero cell|influenza, vaccine, a/h5n1, aluminum hydroxide, vero cell
5732979|NCT00382967|Parkinsonian Syndromes, Parkinsonism, DaTSCAN, SPECT, clinical management, quality of life, movement disorder|parkinsonian syndromes, parkinsonism, datscan, spect, clinical management, quality of life, movement disorder
5732980|NCT00382967|Clinically uncertain Parkinsonian Syndromes|clinically uncertain parkinsonian syndromes
5732981|NCT00382954|Acute Myelogenous Leukemia|acute myelogenous leukemia
5732983|NCT00382954|Relapse|relapse
5732984|NCT00382954|Elderly|elderly
5732985|NCT00382954|Velcade|velcade
5732986|NCT00382954|Idarubicin|idarubicin
5732987|NCT00382954|Bortezomib|bortezomib
5732988|NCT00382928|Randomized Controlled Trials|randomized controlled trials
5732989|NCT00382928|Defibrillators|defibrillators
5732991|NCT00382915|Smoking|smoking
5732992|NCT00382915|Topography|topography
5732993|NCT00382915|Nicotine|nicotine
5732994|NCT00382902|Contact Lens Care|contact lens care
5732995|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents
5732996|NCT00382889|corticosteroids|corticosteroids
5732997|NCT00382889|symptom-driven|symptom-driven
5732998|NCT00382889|beclomethasone|beclomethasone
5732999|NCT00382889|salbutamol|salbutamol
5733103|NCT00382551|Flow-mediated vasodilation|flow-mediated vasodilation
5733000|NCT00382876|apnea, hypoxia, car seat, car bed|apnea, hypoxia, car seat, car bed
5733001|NCT00382863|heart failure|heart failure
5733002|NCT00382863|cardiac support|cardiac support
5733003|NCT00382863|Paracor|paracor
5733004|NCT00382863|HeartNet|heartnet
5758409|NCT00290498|AD|ad
5732959|NCT00383071|IVIG|ivig
5733005|NCT00382863|PEERLESS-HF|peerless-hf
5733006|NCT00382850|Nissen fundoplication|nissen fundoplication
5733007|NCT00382850|gastroesophageal reflux|gastroesophageal reflux
5733008|NCT00382837|Lupus,|lupus,
5733009|NCT00382837|Antibody,|antibody,
5733010|NCT00382837|B-Cell immunotherapy|b-cell immunotherapy
5733011|NCT00382824|Progressive Supranuclear Palsy|progressive supranuclear palsy
5733012|NCT00382824|CoQ10|coq10
5733013|NCT00382824|Coenzyme Q10|coenzyme q10
5733014|NCT00382811|Recurrent Ovarian Epithelial Cancer|recurrent ovarian epithelial cancer
5733015|NCT00382811|Stage IV Ovarian Epithelial Cancer|stage iv ovarian epithelial cancer
5733016|NCT00382811|Peritoneal Cavity Cancer|peritoneal cavity cancer
5733017|NCT00382811|Stage III Ovarian Epithelial Cancer|stage iii ovarian epithelial cancer
5733018|NCT00382785|online|online
5733019|NCT00382785|support|support
5733020|NCT00382785|breast cancer|breast cancer
5733021|NCT00382772|HRV vaccine|hrv vaccine
5733022|NCT00382772|Diarrhoea|diarrhoea
5733023|NCT00382772|Rotavirus|rotavirus
5733024|NCT00382746|Congestive|congestive
5733025|NCT00382746|Heart|heart
5733026|NCT00382746|Failure|failure
5733027|NCT00382746|CHF|chf
5733028|NCT00382733|Solid Tumors|solid tumors
5733029|NCT00382707|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5733030|NCT00382707|low frequency|low frequency
5733031|NCT00382707|frontal lobe epilepsy|frontal lobe epilepsy
5733032|NCT00382707|brain excitability|brain excitability
5733033|NCT00382707|electromyography|electromyography
5733034|NCT00382694|Myeloma|myeloma
5733035|NCT00382694|Induction therapy|induction therapy
5733036|NCT00382694|High-dose melphalan|high-dose melphalan
5733037|NCT00382694|Autologous stem cell support|autologous stem cell support
5733038|NCT00382694|Fludarabine|fludarabine
5733039|NCT00382694|Cyclophosphamide|cyclophosphamide
5733040|NCT00382694|Dexamethasone|dexamethasone
5733041|NCT00382694|Safety|safety
5733042|NCT00382694|Toxicity|toxicity
5733043|NCT00382681|Contact Lens Care|contact lens care
5733044|NCT00382668|hepatically impaired|hepatically impaired
5733045|NCT00382655|Prevention|prevention
5733046|NCT00382655|Emergency Medical Services|emergency medical services
5733047|NCT00382655|Emergency Medical Technicians|emergency medical technicians
5733048|NCT00382642|alcoholism, alcohol disorder, drinking,alcohol|alcoholism, alcohol disorder, drinking,alcohol
5733049|NCT00382629|Multiple sclerosis|multiple sclerosis
5733050|NCT00382629|MS|ms
5733051|NCT00382629|Bayhill|bayhill
5733052|NCT00382629|BHT-3009|bht-3009
5733053|NCT00382629|immunotherapy|immunotherapy
5733054|NCT00382616|behavioral problems|behavioral problems
5733055|NCT00382616|learning problems|learning problems
5733056|NCT00382616|inattentive|inattentive
5733060|NCT00382616|phosphatidylserine|phosphatidylserine
5733061|NCT00382616|long-chain polyunsaturated fatty acid|long-chain polyunsaturated fatty acid
5733062|NCT00382616|eicosapentaenoic acid|eicosapentaenoic acid
5733063|NCT00382616|docosahexaenoic acid|docosahexaenoic acid
5733064|NCT00382616|omega3:omega6 ratio|omega3:omega6 ratio
5733065|NCT00382616|eicosapentaenoic acid:arachidonic acid ratio|eicosapentaenoic acid:arachidonic acid ratio
5733066|NCT00382616|Test of Variables of Attention|test of variables of attention
5733067|NCT00382616|ADHD index scores|adhd index scores
5733068|NCT00382603|Contact Lens Care|contact lens care
5733069|NCT00382590|Acute Myelogenous Leukemia|acute myelogenous leukemia
5733071|NCT00382590|Myelodysplastic Syndrome|myelodysplastic syndrome
5733072|NCT00382590|Leukemia|leukemia
5733073|NCT00382590|MDS|mds
5733074|NCT00382590|Azacytidine|azacytidine
5733075|NCT00382590|5-Azacytidine|5-azacytidine
5733076|NCT00382590|5-aza|5-aza
5733077|NCT00382590|Vidaza|vidaza
5733078|NCT00382590|5-AZC|5-azc
5733079|NCT00382590|AZA-CR|aza-cr
5733080|NCT00382590|Ladakamycin|ladakamycin
5733081|NCT00382590|Ara-C|ara-c
5733082|NCT00382590|Cytarabine|cytarabine
5733083|NCT00382590|Cytosar|cytosar
5733084|NCT00382590|DepoCyt|depocyt
5733085|NCT00382590|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5733086|NCT00382590|Valproic Acid|valproic acid
5733087|NCT00382590|VPA|vpa
5733088|NCT00382590|Depakene|depakene
5733089|NCT00382564|Imaging|imaging
5733090|NCT00382564|Arteriosclerosis|arteriosclerosis
5733091|NCT00382564|Hardening of the arteries|hardening of the arteries
5733092|NCT00382564|MRA|mra
5733093|NCT00382564|Narrowing of Vessels|narrowing of vessels
5733094|NCT00382564|Noninvasive Plaque Imaging|noninvasive plaque imaging
5733095|NCT00382564|Atherosclerotic Disease|atherosclerotic disease
5733096|NCT00382564|Plaque|plaque
5733097|NCT00382564|Arteries|arteries
5733098|NCT00382564|Diabetes|diabetes
5733099|NCT00382564|Hypertension|hypertension
5733100|NCT00382551|Alcohol|alcohol
5733101|NCT00382551|Red wine|red wine
5733102|NCT00382551|Endothelial function|endothelial function
5733104|NCT00382551|Cardiovascular disease|cardiovascular disease
5733105|NCT00382538|mifepristone|mifepristone
5733106|NCT00382538|induction|induction
5733107|NCT00382538|abortion|abortion
5733108|NCT00382538|injection, intra-amniotic|injection, intra-amniotic
5741410|NCT00353015|CDDP|cddp
5732029|NCT00387023|Rituxan|rituxan
5733109|NCT00382525|Bradyarrhythmia|bradyarrhythmia
5733110|NCT00382525|Atrial Fibrillation|atrial fibrillation
5733111|NCT00382525|Ventricular Tachycardia|ventricular tachycardia
5733112|NCT00382525|Ventricular Fibrillation|ventricular fibrillation
5733113|NCT00382525|Heart Failure|heart failure
5733114|NCT00382525|Pacemaker|pacemaker
5733115|NCT00382525|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5733116|NCT00382525|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5733117|NCT00382525|Loop recorder|loop recorder
5733118|NCT00382525|Registry|registry
5733119|NCT00382512|Moderate Plaque Psoriasis|moderate plaque psoriasis
5733120|NCT00382499|Intravenous Lidocaine|intravenous lidocaine
5733121|NCT00382499|Lidocaine Infusion|lidocaine infusion
5733122|NCT00382499|Total Abdominal Hysterectomy|total abdominal hysterectomy
5733123|NCT00382499|Analgesia|analgesia
5733124|NCT00382499|Anesthesia|anesthesia
5733125|NCT00382499|Adjunct|adjunct
5733126|NCT00382486|Intestinal transplant|intestinal transplant
5733127|NCT00382486|Bone marrow|bone marrow
5733128|NCT00382486|Irradiation of allograft|irradiation of allograft
5733129|NCT00382473|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5733130|NCT00382473|Overweight|overweight
5733131|NCT00382473|Fatty acid oxidation|fatty acid oxidation
5733132|NCT00382473|Mitochondria|mitochondria
5733133|NCT00382473|Exercise|exercise
5733134|NCT00382447|breath actuated nebulizer|breath actuated nebulizer
5733135|NCT00382447|nebulizer|nebulizer
5733136|NCT00382434|emergency pharmacist|emergency pharmacist
5733137|NCT00382434|emergency medicine|emergency medicine
5733138|NCT00382434|emergency department|emergency department
5733139|NCT00382434|medical error|medical error
5733140|NCT00382434|adverse event|adverse event
5733141|NCT00382434|pharmacist|pharmacist
5733142|NCT00382434|patient safety|patient safety
5733143|NCT00382421|Myocardial Ischemia|myocardial ischemia
5733144|NCT00382421|Randomized Controlled Trials|randomized controlled trials
5733145|NCT00382421|Drug Therapy|drug therapy
5733146|NCT00382408|Acute respiratory disease prevention|acute respiratory disease prevention
5733147|NCT00382408|Adenovirus|adenovirus
5733148|NCT00382395|Glaucoma shunt|glaucoma shunt
5733149|NCT00382395|Ocular implant|ocular implant
5733150|NCT00382395|Gold|gold
5733151|NCT00382395|trabeculectomy|trabeculectomy
5733152|NCT00382382|Autism|autism
5733153|NCT00382382|Asperger Syndrome|asperger syndrome
5733154|NCT00382382|Restricted repetitive behavior|restricted repetitive behavior
5733155|NCT00382382|Stereotyped patterns of behavior|stereotyped patterns of behavior
5733156|NCT00382382|Typically Developing children|typically developing children
5733157|NCT00382382|Human Volunteers|human volunteers
5733158|NCT00382369|familial vocal cord paralysis|familial vocal cord paralysis
5733159|NCT00382369|genetic screening|genetic screening
5733160|NCT00382356|Benign Prostatic Enlargement|benign prostatic enlargement
5733161|NCT00382356|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5733162|NCT00382356|Dutasteride|dutasteride
5733163|NCT00382356|5-alpha reductase inhibitors|5-alpha reductase inhibitors
5733164|NCT00382356|Hormonal therapy|hormonal therapy
5733165|NCT00382343|Prevention|prevention
5733166|NCT00382343|Pyelonephritis|pyelonephritis
5733167|NCT00382343|Renal scars|renal scars
5733168|NCT00382343|Vesico-ureteral reflux|vesico-ureteral reflux
5733169|NCT00382343|Dimercaptosuccinic acid renal scan (DMSA)|dimercaptosuccinic acid renal scan (dmsa)
5733170|NCT00382330|Vulva|vulva
5733171|NCT00382317|MSCT indications|msct indications
5733172|NCT00382304|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5733173|NCT00382304|C. difficile|c. difficile
5733174|NCT00382304|CDAD|cdad
5733175|NCT00382304|Clostridium difficile|clostridium difficile
5733176|NCT00382304|Clostridium difficile Disease|clostridium difficile disease
5733177|NCT00382304|Clostridium Enterocolitis|clostridium enterocolitis
5733178|NCT00382304|Antibiotic-Associated Colitis|antibiotic-associated colitis
5733179|NCT00382304|Infectious diarrhea|infectious diarrhea
5733181|NCT00382291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation
5733182|NCT00382291|Placebos|placebos
5733183|NCT00382291|Cognitive Behavior Therapy|cognitive behavior therapy
5733184|NCT00382291|Child Psychiatry|child psychiatry
5733185|NCT00382291|Activation Syndrome|activation syndrome
5733186|NCT00382291|Psychometrics|psychometrics
5733187|NCT00382278|Stem cell|stem cell
5733188|NCT00382278|Liver cirrhosis|liver cirrhosis
5733189|NCT00382278|Cellular therapy|cellular therapy
5733190|NCT00382278|Autologous|autologous
5733191|NCT00382278|Bone marrow|bone marrow
5733192|NCT00382265|urolithiasis|urolithiasis
5733193|NCT00382265|renal colic|renal colic
5733195|NCT00382265|urinary stone disease|urinary stone disease
5733196|NCT00382252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5733197|NCT00382252|lung metastases|lung metastases
5733198|NCT00382239|diabetes|diabetes
5733199|NCT00382239|exenatide|exenatide
5733200|NCT00382239|LY2148568|ly2148568
5733201|NCT00382239|Lilly|lilly
5733202|NCT00382239|Amylin|amylin
5741567|NCT00352469|GAD|gad
5733203|NCT00382239|Japan|japan
5733204|NCT00382226|Glaucoma|glaucoma
5733205|NCT00382200|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5733206|NCT00382200|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5733207|NCT00382187|influenza|influenza
5733208|NCT00382187|pandemic influenza|pandemic influenza
5733209|NCT00382187|influenza vaccine|influenza vaccine
5733210|NCT00382187|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5733211|NCT00382187|H5N1 influenza antigen|h5n1 influenza antigen
5733212|NCT00382187|MF59|mf59
5733213|NCT00382187|Pandemic influenza disease|pandemic influenza disease
5733214|NCT00382174|pressure ulcers|pressure ulcers
5733215|NCT00382174|cutaneous wound- healing|cutaneous wound- healing
5733216|NCT00382174|chronic wound-healing|chronic wound-healing
5733217|NCT00382174|Thymosin Beta 4|thymosin beta 4
5733218|NCT00382174|laminin-5|laminin-5
5733219|NCT00382161|impotence|impotence
5733220|NCT00382161|erectile dysfunction|erectile dysfunction
5733221|NCT00382161|cardiovascular risk factor|cardiovascular risk factor
5733222|NCT00382161|statin|statin
5733223|NCT00382148|TOPS|tops
5733224|NCT00382148|Peanut allergy|peanut allergy
5733225|NCT00382148|Peanut-induced allergy|peanut-induced allergy
5733226|NCT00382148|Allergy|allergy
5733227|NCT00382135|Impotence|impotence
5733228|NCT00382135|erectile dysfunction|erectile dysfunction
5733229|NCT00382135|semen|semen
5733230|NCT00382135|sperm|sperm
5733231|NCT00382135|Healthy male volunteers|healthy male volunteers
5733232|NCT00382135|men with mild erectile dysfunction|men with mild erectile dysfunction
5733233|NCT00382122|Glaucoma|glaucoma
5733234|NCT00382122|Ocular hypertension|ocular hypertension
5733235|NCT00382122|Dry eye|dry eye
5733236|NCT00382122|Ocular surface disease|ocular surface disease
5733237|NCT00382096|Type 2 diabetes|type 2 diabetes
5733238|NCT00382096|vildagliptin|vildagliptin
5733239|NCT00382096|metformin|metformin
5733240|NCT00382096|hemoglobin A1c|hemoglobin a1c
5733241|NCT00382083|Mammogram|mammogram
5733242|NCT00382083|Pain|pain
5733243|NCT00382083|Discomfort|discomfort
5733244|NCT00382083|Breast|breast
5733245|NCT00382083|Pre-medication|pre-medication
5733246|NCT00382070|stage I breast cancer|stage i breast cancer
5733247|NCT00382070|stage II breast cancer|stage ii breast cancer
5733248|NCT00382070|stage IIIA breast cancer|stage iiia breast cancer
5733249|NCT00382057|Testosterone|testosterone
5733250|NCT00382057|Insulin resistance|insulin resistance
5733251|NCT00382057|Insulin sensitivity|insulin sensitivity
5733252|NCT00382057|Metabolic disorders|metabolic disorders
5733253|NCT00382044|Kidney Failure, Chronic|kidney failure, chronic
5733254|NCT00382044|Dialysis|dialysis
5733255|NCT00382044|Anemia|anemia
5733256|NCT00382044|epoetin|epoetin
5733257|NCT00382018|recurrent breast cancer|recurrent breast cancer
5733258|NCT00382018|stage IV breast cancer|stage iv breast cancer
5733259|NCT00381992|sexual risk behavior|sexual risk behavior
5733260|NCT00381992|diabetes mellitus|diabetes mellitus
5733261|NCT00381992|hypertension|hypertension
5733262|NCT00381992|obesity|obesity
5733263|NCT00381992|human immunodeficiency virus|human immunodeficiency virus
5733264|NCT00381992|hyperlipidemia|hyperlipidemia
5733265|NCT00381992|chlamydia|chlamydia
5733266|NCT00381979|Depression|depression
5733267|NCT00381979|Anxiety|anxiety
5733268|NCT00381979|Adolescents|adolescents
5733269|NCT00381979|Treatment|treatment
5733270|NCT00381979|Supportive Expressive Therapy|supportive expressive therapy
5733271|NCT00381966|Prostate Cancer|prostate cancer
5733272|NCT00381966|Brachytherapy|brachytherapy
5733273|NCT00381927|Breast Cancer Risk|breast cancer risk
5733274|NCT00381927|Counseling|counseling
5733275|NCT00381927|Prevention|prevention
5733276|NCT00381927|Anxiety|anxiety
5733277|NCT00381927|BRCA1 mutation|brca1 mutation
5733278|NCT00381927|BRCA2 mutation|brca2 mutation
5733279|NCT00381927|Tamoxifen|tamoxifen
5733280|NCT00381914|Infants|infants
5733282|NCT00381914|Dose-response|dose-response
5733283|NCT00381901|stage II breast cancer|stage ii breast cancer
5733284|NCT00381901|stage IIIA breast cancer|stage iiia breast cancer
5733285|NCT00381901|stage IIIB breast cancer|stage iiib breast cancer
5733286|NCT00381901|stage IA breast cancer|stage ia breast cancer
5733287|NCT00381901|stage IB breast cancer|stage ib breast cancer
5733288|NCT00381901|recurrent breast cancer|recurrent breast cancer
5733289|NCT00381901|stage IIIC breast cancer|stage iiic breast cancer
5733290|NCT00381888|thromboembolism|thromboembolism
5733291|NCT00381888|cervical cancer|cervical cancer
5733292|NCT00381888|endometrial cancer|endometrial cancer
5733293|NCT00381888|ovarian epithelial cancer|ovarian epithelial cancer
5733294|NCT00381888|ovarian germ cell tumor|ovarian germ cell tumor
5733295|NCT00381888|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5733297|NCT00381888|ovarian stromal cancer|ovarian stromal cancer
5733298|NCT00381888|uterine sarcoma|uterine sarcoma
5733299|NCT00381888|vaginal cancer|vaginal cancer
5733300|NCT00381888|vulvar cancer|vulvar cancer
5733301|NCT00381888|fallopian tube cancer|fallopian tube cancer
5733302|NCT00381875|HIV infection|hiv infection
5733303|NCT00381862|nausea and vomiting|nausea and vomiting
5732232|NCT00386334|chronic|chronic
5733304|NCT00381862|recurrent colon cancer|recurrent colon cancer
5733305|NCT00381862|stage IV colon cancer|stage iv colon cancer
5733306|NCT00381862|recurrent rectal cancer|recurrent rectal cancer
5733307|NCT00381862|stage IV rectal cancer|stage iv rectal cancer
5733309|NCT00381849|Uricare|uricare
5733310|NCT00381849|Computerized tomography|computerized tomography
5733311|NCT00381849|Kidney calculi|kidney calculi
5733312|NCT00381849|Supersaturation|supersaturation
5733313|NCT00381849|Nephrolithiasis|nephrolithiasis
5733314|NCT00381849|Quantitative CT|quantitative ct
5733315|NCT00381836|Prostate Cancer|prostate cancer
5733316|NCT00381836|Anemia|anemia
5733317|NCT00381836|Blood transfusion|blood transfusion
5733318|NCT00381836|Cancer|cancer
5733319|NCT00381836|Critical illness|critical illness
5733320|NCT00381836|Drug efficacy|drug efficacy
5733321|NCT00381836|Drug safety|drug safety
5733322|NCT00381836|Drug tolerability|drug tolerability
5733323|NCT00381836|Erythropoietin|erythropoietin
5733324|NCT00381836|Fatigue|fatigue
5733325|NCT00381836|Hemoglobin|hemoglobin
5733326|NCT00381836|Human|human
5733327|NCT00381836|Male|male
5733328|NCT00381836|Multicenter study|multicenter study
5733329|NCT00381836|Quality of life|quality of life
5733330|NCT00381836|Questionnaire|questionnaire
5733331|NCT00381836|Randomized controlled trial|randomized controlled trial
5733332|NCT00381836|Recombinant erythropoietin|recombinant erythropoietin
5733333|NCT00381823|Pregnant women|pregnant women
5733334|NCT00381823|Intervention Studies|intervention studies
5733335|NCT00381823|African Americans|african americans
5733336|NCT00381823|Infant Mortality|infant mortality
5733337|NCT00381823|Environmental Tobacco Smoke Pollution|environmental tobacco smoke pollution
5733338|NCT00381823|Depression|depression
5733339|NCT00381823|Partner Abuse|partner abuse
5733340|NCT00381823|Tobacco Smoke|tobacco smoke
5733341|NCT00381810|Rituxan|rituxan
5733342|NCT00381810|SLE|sle
5733343|NCT00381810|Lupus|lupus
5733344|NCT00381784|YMSM|ymsm
5733345|NCT00381784|HIV/AIDS|hiv/aids
5733346|NCT00381784|Condom use|condom use
5733347|NCT00381784|Drug users|drug users
5733348|NCT00381784|Minority women|minority women
5733349|NCT00381771|Globus Pharyngeus|globus pharyngeus
5733350|NCT00381771|Xerostomia|xerostomia
5733351|NCT00381771|Salivary Hypofunction|salivary hypofunction
5733352|NCT00381771|Pharyngoxerosis|pharyngoxerosis
5733353|NCT00381758|ADHD|adhd
5733354|NCT00381758|Methylphenidate|methylphenidate
5733355|NCT00381758|Metadate CD|metadate cd
5733356|NCT00381758|Concerta|concerta
5733357|NCT00381758|COMACS|comacs
5733358|NCT00381758|Attention Deficit Hyperactivity Disorder (ADHD)|attention deficit hyperactivity disorder (adhd)
5733359|NCT00381732|Impotence|impotence
5733360|NCT00381732|erectile dysfunction|erectile dysfunction
5733361|NCT00381706|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5733362|NCT00381706|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5733363|NCT00381706|stage IV esophageal cancer|stage iv esophageal cancer
5733364|NCT00381706|recurrent esophageal cancer|recurrent esophageal cancer
5733365|NCT00381693|primary myelofibrosis|primary myelofibrosis
5733366|NCT00381693|polycythemia vera|polycythemia vera
5733367|NCT00381693|essential thrombocythemia|essential thrombocythemia
5733368|NCT00381693|secondary myelofibrosis|secondary myelofibrosis
5733369|NCT00381667|safety|safety
5733370|NCT00381667|GW642444M|gw642444m
5733371|NCT00381667|Single Dose|single dose
5733372|NCT00381667|pharmacodynamics|pharmacodynamics
5733373|NCT00381667|pharmacokinetics|pharmacokinetics
5733374|NCT00381667|GW642444H|gw642444h
5733375|NCT00381667|tolerability|tolerability
5733376|NCT00381654|Solid Tumors|solid tumors
5733377|NCT00381654|Tyrosine Kinases|tyrosine kinases
5733378|NCT00381628|Anatomy|anatomy
5733379|NCT00381628|cells|cells
5733380|NCT00381628|epithelial cells|epithelial cells
5733381|NCT00381628|blood cells|blood cells
5733382|NCT00381628|cystic fibrosis|cystic fibrosis
5733383|NCT00381628|equipment and supplies|equipment and supplies
5733384|NCT00381628|disposable equipment|disposable equipment
5733385|NCT00381628|reagent kits|reagent kits
5733386|NCT00381615|Meningococcal disease|meningococcal disease
5733387|NCT00381615|prevention|prevention
5733388|NCT00381615|vaccination|vaccination
5733389|NCT00381602|End stage renal disease|end stage renal disease
5733390|NCT00381602|Hemodialysis|hemodialysis
5733391|NCT00381602|Malnutrition|malnutrition
5733392|NCT00381602|End stage renal disease (ESRD)|end stage renal disease (esrd)
5723680|NCT00417898|Stroke|stroke
5733393|NCT00381589|clozapine-induced hypersalivation|clozapine-induced hypersalivation
5733394|NCT00381576|Resistance training|resistance training
5733396|NCT00381576|Training adaptations|training adaptations
5733398|NCT00381563|Bracing|bracing
5733399|NCT00381563|Patellofemoral|patellofemoral
5733400|NCT00381563|Osteoarthritis|osteoarthritis
5733401|NCT00381537|childhood epilepsy|childhood epilepsy
5733402|NCT00381537|Active childhood epilepsy|active childhood epilepsy
5733403|NCT00381524|human immunodeficiency virus|human immunodeficiency virus
5733404|NCT00381524|behavior change|behavior change
5733405|NCT00381511|pulmonary embolism,|pulmonary embolism,
5733406|NCT00381511|deferred diagnosis,|deferred diagnosis,
5733407|NCT00381511|protective anticoagulation|protective anticoagulation
5733408|NCT00381511|anticoagulants|anticoagulants
5733409|NCT00381472|Parkinson's Disease|parkinson's disease
5733410|NCT00381472|Dyskinesia|dyskinesia
5733411|NCT00381472|Adjunctive Therapy with L-dopa|adjunctive therapy with l-dopa
5733412|NCT00381446|corneal staining|corneal staining
5733413|NCT00381446|contact lens care|contact lens care
5733414|NCT00381446|multipurpose solution|multipurpose solution
5733416|NCT00381433|Hepatitis C virus|hepatitis c virus
5733417|NCT00381407|ADHD|adhd
5733418|NCT00381407|Organizational Skills|organizational skills
5733419|NCT00381407|Contingency Management|contingency management
5733420|NCT00381394|amphotericin B|amphotericin b
5733421|NCT00381394|safety|safety
5733422|NCT00381394|tolerability and pharmacokinetics of oral sitamaquine|tolerability and pharmacokinetics of oral sitamaquine
5733423|NCT00381394|Visceral leishmaniasis|visceral leishmaniasis
5733424|NCT00381381|Alzheimer's disease|alzheimer's disease
5733425|NCT00381368|breast cancer|breast cancer
5733426|NCT00381368|skeletal metastases|skeletal metastases
5733427|NCT00381368|bisphosphonate therapy|bisphosphonate therapy
5733428|NCT00381368|Breast cancer with painful skeletal metastases|breast cancer with painful skeletal metastases
5733429|NCT00381355|asthma|asthma
5742763|NCT00347542|Vitamin D|vitamin d
5733430|NCT00381355|children|children
5733431|NCT00381355|written action plan|written action plan
5733432|NCT00381355|education|education
5733433|NCT00381355|guided self-management|guided self-management
5733434|NCT00381355|efficacy|efficacy
5733435|NCT00381355|compliance|compliance
5733436|NCT00381355|b2-agonists|b2-agonists
5733437|NCT00381355|inhaled corticosteroids|inhaled corticosteroids
5733438|NCT00381355|oral steroids|oral steroids
5733439|NCT00381355|relapse|relapse
5733440|NCT00381355|randomised controlled trial|randomised controlled trial
5733441|NCT00381355|emergency department|emergency department
5733442|NCT00381342|diabetes|diabetes
5733443|NCT00381342|exenatide|exenatide
5733444|NCT00381342|Amylin|amylin
5733445|NCT00381342|Lilly|lilly
5733446|NCT00381342|monotherapy|monotherapy
5733447|NCT00381329|Motivational Interviewing|motivational interviewing
5733448|NCT00381329|Structured Brief Advice|structured brief advice
5733449|NCT00381329|Adolescent Smoking|adolescent smoking
5733450|NCT00381329|Behavioral Intervention|behavioral intervention
5733451|NCT00381329|Smoking|smoking
5733452|NCT00381329|Primary Care|primary care
5733453|NCT00381329|Tobacco|tobacco
5733455|NCT00381303|AIDS|aids
5733456|NCT00381303|Immunodeficiency Virus, Human|immunodeficiency virus, human
5733457|NCT00381303|Females|females
5733458|NCT00381303|Women|women
5733459|NCT00381303|PREZISTA|prezista
5733460|NCT00381303|darunavir|darunavir
5733461|NCT00381303|TMC114|tmc114
5733462|NCT00381303|Protease Inhibitor|protease inhibitor
5733463|NCT00381290|Arthritis|arthritis
5733464|NCT00381290|Arthritis, Degenerative|arthritis, degenerative
5733465|NCT00381290|Knee Health|knee health
5733466|NCT00381290|Obesity|obesity
5733467|NCT00381290|Overweight|overweight
5733468|NCT00381290|Osteoarthritis|osteoarthritis
5733469|NCT00381290|Weight Loss|weight loss
5733470|NCT00381290|Diet|diet
5733471|NCT00381290|Exercise|exercise
5733472|NCT00381290|Knee Pain|knee pain
5733473|NCT00381277|nephrolithiasis|nephrolithiasis
5733474|NCT00381277|citrate|citrate
5733475|NCT00381277|oxalate|oxalate
5733476|NCT00381251|vaginal atrophy|vaginal atrophy
5733477|NCT00381251|postmenopausal osteoporosis|postmenopausal osteoporosis
5733478|NCT00381251|menopause|menopause
5733479|NCT00381251|hot flashes|hot flashes
5733480|NCT00381238|Alzheimer's Disease|alzheimer's disease
5733481|NCT00381238|Rosiglitazone|rosiglitazone
5733482|NCT00381225|Radio-frequency ablation; Head and Neck neoplasia.|radio-frequency ablation; head and neck neoplasia.
5733483|NCT00381212|Immunotherapeutic injection|immunotherapeutic injection
5733484|NCT00381199|fibromyalgia|fibromyalgia
5733485|NCT00381199|cannabinoid|cannabinoid
5733486|NCT00381199|chronic pain|chronic pain
5733487|NCT00381199|sleep|sleep
5733488|NCT00381199|insomnia|insomnia
5733489|NCT00381199|diffuse widespread pain|diffuse widespread pain
5733490|NCT00381199|antidepressant|antidepressant
5733491|NCT00381186|impaired glucose tolerance|impaired glucose tolerance
5733492|NCT00381186|type 2 diabetes|type 2 diabetes
5733493|NCT00381173|MGI PHARMA|mgi pharma
5733494|NCT00381173|ZYC3-002|zyc3-002
5733495|NCT00381173|ZYC300|zyc300
5733496|NCT00381173|plasmid DNA|plasmid dna
5733497|NCT00381173|cyclophosphamide|cyclophosphamide
5733498|NCT00381173|Cytoxan|cytoxan
5733499|NCT00381173|advanced breast cancer|advanced breast cancer
5733500|NCT00381173|advanced ovarian cancer|advanced ovarian cancer
5733501|NCT00381173|hormone refractory prostate cancer|hormone refractory prostate cancer
5733502|NCT00381173|advanced colon cancer|advanced colon cancer
5733503|NCT00381173|advanced renal cancer|advanced renal cancer
5733504|NCT00381173|advanced stage malignancies|advanced stage malignancies
5733505|NCT00381173|immune therapy|immune therapy
5733506|NCT00381173|gene therapy|gene therapy
5733507|NCT00381173|biologic therapy|biologic therapy
5733508|NCT00381173|T-regulatory cells|t-regulatory cells
5732437|NCT00385502|nail|nail
5733509|NCT00381173|cancer vaccine|cancer vaccine
5733510|NCT00381173|vaccine|vaccine
5733511|NCT00381173|Advanced stage malignancies-ovary, breast, colon, prostate|advanced stage malignancies-ovary, breast, colon, prostate
5733512|NCT00381160|weight loss|weight loss
5733513|NCT00381160|obesity|obesity
5733514|NCT00381160|sugar-sweetened beverages|sugar-sweetened beverages
5733515|NCT00381160|diet|diet
5733516|NCT00381160|adolescence|adolescence
5733517|NCT00381134|double-blind|double-blind
5733518|NCT00381134|placebo-controlled|placebo-controlled
5733519|NCT00381134|nephropathy|nephropathy
5733520|NCT00381134|blood pressure|blood pressure
5733521|NCT00381134|urine albumin to creatinine ratio|urine albumin to creatinine ratio
5733522|NCT00381134|placebo|placebo
5733523|NCT00381121|Tissue Biobank|tissue biobank
5733524|NCT00381121|molecular markers|molecular markers
5733525|NCT00381121|molecular pathways|molecular pathways
5733527|NCT00381082|Pediculus|pediculus
5733528|NCT00381082|capitis|capitis
5733529|NCT00381082|lice|lice
5733530|NCT00381069|Recreation Centers|recreation centers
5733531|NCT00381069|Families|families
5733532|NCT00381069|Obesity Prevention|obesity prevention
5733533|NCT00381056|labor and delivery care|labor and delivery care
5742861|NCT00347139|Safety|safety
5733534|NCT00381056|teamwork training|teamwork training
5733535|NCT00381056|crew resource management|crew resource management
5733536|NCT00381056|cluster-randomized trial|cluster-randomized trial
5733537|NCT00381043|Alcohol Dependence|alcohol dependence
5733538|NCT00381043|Family Medicine Setting|family medicine setting
5733539|NCT00381043|University of North Carolina at Chapel Hill|university of north carolina at chapel hill
5733540|NCT00381030|beta-Adrenergic Blockers|beta-adrenergic blockers
5733541|NCT00381030|Disease Management|disease management
5733542|NCT00381004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5733543|NCT00381004|Leukemia|leukemia
5733544|NCT00381004|Cyclophosphamide|cyclophosphamide
5733545|NCT00381004|Fludarabine|fludarabine
5733546|NCT00381004|Sargramostim|sargramostim
5733547|NCT00381004|Rituximab|rituximab
5733548|NCT00381004|GM-CSF|gm-csf
5733550|NCT00380978|labor pain|labor pain
5733551|NCT00380978|cesarean section|cesarean section
5733552|NCT00380978|epidural analgesia|epidural analgesia
5733553|NCT00380978|opioid analgesics|opioid analgesics
5733554|NCT00380978|local anesthetics|local anesthetics
5733555|NCT00380978|labor induced|labor induced
5733556|NCT00380965|Chemotherapy-induced|chemotherapy-induced
5733557|NCT00380965|neuropathy|neuropathy
5733558|NCT00380965|cancer|cancer
5733559|NCT00380952|IDC|idc
5733560|NCT00380952|DCIS|dcis
5733561|NCT00380952|ILC|ilc
5733562|NCT00380926|polyunsatturated fatty acids|polyunsatturated fatty acids
5733563|NCT00380926|nutrition|nutrition
5733564|NCT00380926|low-dose allergen challenge|low-dose allergen challenge
5733565|NCT00380926|exhaled nitric oxide|exhaled nitric oxide
5733566|NCT00380887|bioavailability|bioavailability
5733567|NCT00380887|bioequivalence|bioequivalence
5733568|NCT00380887|marketed product|marketed product
5733569|NCT00380887|Premarin|premarin
5733570|NCT00380887|Medroxyprogesterone acetate|medroxyprogesterone acetate
5733571|NCT00380887|MPA|mpa
5733572|NCT00380887|Postmenopausal|postmenopausal
5733573|NCT00380887|vasomotor symptoms|vasomotor symptoms
5733574|NCT00380874|Pain|pain
5733575|NCT00380874|chemotherapy|chemotherapy
5733576|NCT00380861|Total Knee Replacement|total knee replacement
5733577|NCT00380861|Flexion|flexion
5733578|NCT00380861|Range of Motion|range of motion
5733579|NCT00380861|Activities of Daily Living|activities of daily living
5733580|NCT00380861|Implant design|implant design
5733581|NCT00380861|Subject Satisfaction|subject satisfaction
5733582|NCT00380861|Non-inflammatory arthritis|non-inflammatory arthritis
5733583|NCT00380848|sleep apnea|sleep apnea
5733584|NCT00380848|end stage renal disease|end stage renal disease
5733585|NCT00380848|hemodiafiltration|hemodiafiltration
5733586|NCT00380835|metastatic breast cancer|metastatic breast cancer
5733587|NCT00380835|amrubicin|amrubicin
5733588|NCT00380822|alpa-glucosidase inhibitor|alpa-glucosidase inhibitor
5733589|NCT00380796|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5733590|NCT00380796|COPD|copd
5733591|NCT00380770|HIV|hiv
5733592|NCT00380770|AIDS|aids
5733593|NCT00380770|Kaposi's sarcoma|kaposi's sarcoma
5733594|NCT00380770|Human herpesvirus 8|human herpesvirus 8
5733595|NCT00380757|cardiac arrest|cardiac arrest
5733596|NCT00380757|CPR|cpr
5733597|NCT00380757|resuscitation|resuscitation
5733598|NCT00380757|fatigue|fatigue
5733599|NCT00380757|quality|quality
5733600|NCT00380731|Social Anxiety Disorder|social anxiety disorder
5733601|NCT00380731|Magnetic Resonance Imaging|magnetic resonance imaging
5733602|NCT00380731|Cognitive Behavior Therapy|cognitive behavior therapy
5733603|NCT00380640|Pediatrics|pediatrics
5733604|NCT00380640|Epidermolysis Bullosa|epidermolysis bullosa
5733605|NCT00380640|Trimethoprim|trimethoprim
5733606|NCT00380640|Wound Healing|wound healing
5733607|NCT00380614|Acute Hepatitis B, Lamivudine|acute hepatitis b, lamivudine
5733608|NCT00380575|hyponatremia|hyponatremia
5733609|NCT00380575|hypervolemic|hypervolemic
5686196|NCT00553124|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5733610|NCT00380575|euvolemic|euvolemic
5733611|NCT00380575|vasopressins|vasopressins
5733613|NCT00380562|Quality of life|quality of life
5733614|NCT00380562|Cognitive Functioning|cognitive functioning
5733615|NCT00380562|Activities of Daily Living|activities of daily living
5733616|NCT00380562|Disability prevention|disability prevention
5733617|NCT00380549|osteoarthritis, hip replacement|osteoarthritis, hip replacement
5733618|NCT00380536|Peer-led Education|peer-led education
5733619|NCT00380510|Family Physicians|family physicians
5733620|NCT00380510|Adolescents|adolescents
5733621|NCT00380510|Preventive Care|preventive care
5733622|NCT00380510|Health Behavior|health behavior
5733623|NCT00380497|Pediatrics|pediatrics
5733624|NCT00380497|Colonoscopy|colonoscopy
5733625|NCT00380497|Bowel cleanout|bowel cleanout
5733626|NCT00380497|Poly-Ethylene Glycol|poly-ethylene glycol
5733627|NCT00380497|Pico-Salax|pico-salax
5733628|NCT00380471|bath PUVA|bath puva
5733629|NCT00380458|Obstructive|obstructive
5733630|NCT00380458|Sleep|sleep
5733631|NCT00380458|Apnea|apnea
5733632|NCT00380458|Pain|pain
5733633|NCT00380458|UPPP|uppp
5733634|NCT00380458|Tonsillectomy|tonsillectomy
5733635|NCT00380458|Narcotics|narcotics
5760056|NCT00283322|HIT|hit
5733636|NCT00380445|Vildagliptin, Type 2 diabetes|vildagliptin, type 2 diabetes
5733637|NCT00380419|Pregnancy|pregnancy
5733638|NCT00380419|Postpartum Depression|postpartum depression
5733639|NCT00380406|Gonadotropin releasing hormone agonist|gonadotropin releasing hormone agonist
5733640|NCT00380406|GnRH|gnrh
5733641|NCT00380406|Fertility|fertility
5733642|NCT00380406|Fertility preservation|fertility preservation
5733643|NCT00380406|Oncology|oncology
5733644|NCT00380406|Cancer|cancer
5733645|NCT00380406|Chemotherapy|chemotherapy
5733646|NCT00380393|Malaria|malaria
5733647|NCT00380393|Plasmodium|plasmodium
5733648|NCT00380393|RTS|rts
5733649|NCT00380393|S/AS01|s/as01
5733650|NCT00380393|Falciparum|falciparum
5733651|NCT00380380|Vildagliptin, type 2 diabetes, gastric emptying|vildagliptin, type 2 diabetes, gastric emptying
5733652|NCT00380354|allergen|allergen
5733653|NCT00380354|methacholine|methacholine
5733654|NCT00380354|GSK256066|gsk256066
5733655|NCT00380354|mild asthmatics|mild asthmatics
5733656|NCT00380354|repeat dose|repeat dose
5733657|NCT00380354|challenge|challenge
5733658|NCT00380354|late asthmatic response|late asthmatic response
5733659|NCT00380328|Pharmacokinetic|pharmacokinetic
5733660|NCT00380328|healthy subjects|healthy subjects
5733661|NCT00380315|Cough|cough
5733662|NCT00380315|Chronic bronchitis|chronic bronchitis
5733663|NCT00380315|PNDs|pnds
5733664|NCT00380315|Post Nasal Drip syndrome|post nasal drip syndrome
5733665|NCT00380315|GERD|gerd
5733666|NCT00380315|gastroesophageal reflux disease|gastroesophageal reflux disease
5733667|NCT00380315|bronchiectasis|bronchiectasis
5733668|NCT00380302|Alzheimer's disease|alzheimer's disease
5733669|NCT00380302|symptomatic|symptomatic
5733670|NCT00380302|cognition|cognition
5733671|NCT00380289|Essential hypertension|essential hypertension
5733672|NCT00380289|Glucose metabolism|glucose metabolism
5733673|NCT00380289|Thiazides|thiazides
5733674|NCT00380289|Beta blockers|beta blockers
5733675|NCT00380276|Alzheimer's|alzheimer's
5733676|NCT00380276|Dementia|dementia
5733677|NCT00380276|Dementia of Alzheimer Type|dementia of alzheimer type
5733678|NCT00380237|Bird Flu|bird flu
5733679|NCT00380237|Avian Flu|avian flu
5733680|NCT00380224|schizophrenia|schizophrenia
5733681|NCT00380211|Thimerosal reduced content|thimerosal reduced content
5733682|NCT00380211|Immunogenicity, safety, reactogenicity|immunogenicity, safety, reactogenicity
5733683|NCT00380211|Young and elderly adults|young and elderly adults
5733684|NCT00380211|Influenza vaccine|influenza vaccine
5733685|NCT00380185|Peripheral Arterial Disease|peripheral arterial disease
5733686|NCT00380185|Atherosclerosis|atherosclerosis
5733688|NCT00380172|Macular Degeneration|macular degeneration
5733689|NCT00380172|Retinal Degeneration|retinal degeneration
5733690|NCT00380159|Extension study to ACH443-014A|extension study to ach443-014a
5733691|NCT00380146|Malaria|malaria
5733692|NCT00380146|Intermittent presumptive treatment|intermittent presumptive treatment
5733693|NCT00380146|IPT|ipt
5733694|NCT00380146|Pharmacokinetic|pharmacokinetic
5733695|NCT00380146|Efficacy|efficacy
5733696|NCT00380146|Gametocyte|gametocyte
5733697|NCT00380146|Molecular markers|molecular markers
5733698|NCT00380133|COPD SB-681323 prednisolone biomarkers|copd sb-681323 prednisolone biomarkers
5733699|NCT00380107|Minor surgery|minor surgery
5733700|NCT00380107|Volume optimization|volume optimization
5733701|NCT00380107|Volume deficit|volume deficit
5733702|NCT00380107|Epidural anesthesia|epidural anesthesia
5733705|NCT00380094|Myeloperoxidase|myeloperoxidase
5733706|NCT00380094|nonST segment elevation myocardial infarction|nonst segment elevation myocardial infarction
5733707|NCT00380081|Insomnia|insomnia
5733708|NCT00380055|Cancer Screening|cancer screening
5733709|NCT00380055|Navigators|navigators
5733710|NCT00380055|Community Outreach|community outreach
5733711|NCT00380055|Behavioral Change|behavioral change
5732639|NCT00384475|SAR|sar
5733712|NCT00380055|Access|access
5733713|NCT00380042|Cortical Electrical Stimulation|cortical electrical stimulation
5733714|NCT00380042|Treatment Resistant Depression|treatment resistant depression
5733715|NCT00380042|Major Depressive Disorder|major depressive disorder
5733716|NCT00380029|stage II bladder cancer|stage ii bladder cancer
5733717|NCT00380029|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5733718|NCT00380016|Angioplasty|angioplasty
5733719|NCT00380016|Stent|stent
5733720|NCT00380016|Coronary Artery Disease|coronary artery disease
5733721|NCT00380016|Peripheral Artery Disease|peripheral artery disease
5733722|NCT00380016|Percutaneous Coronary Intervention|percutaneous coronary intervention
5733723|NCT00380016|CAD|cad
5733724|NCT00380016|PAD|pad
5733725|NCT00380016|Cardiovascular Disease|cardiovascular disease
5733726|NCT00379990|iNOS|inos
5733727|NCT00379990|Exhaled NO|exhaled no
5733728|NCT00379990|Rheumatoid arthritis|rheumatoid arthritis
5733729|NCT00379938|Parvovirus B-19, Parvoviridae, vaccine|parvovirus b-19, parvoviridae, vaccine
5733730|NCT00379925|Physical Activity|physical activity
5733731|NCT00379925|Exercise|exercise
5733732|NCT00379925|Dietary Habits|dietary habits
5733733|NCT00379899|calcification|calcification
5733734|NCT00379899|vascular calcification|vascular calcification
5733735|NCT00379899|coronary vascular calcification|coronary vascular calcification
5733736|NCT00379899|chronic kidney disease|chronic kidney disease
5733737|NCT00379899|end stage renal disease|end stage renal disease
5733738|NCT00379899|dialysis|dialysis
5733739|NCT00379886|ECT|ect
5733740|NCT00379886|Depression|depression
5733741|NCT00379886|Anesthiticum|anesthiticum
5733742|NCT00379886|Propofol|propofol
5733743|NCT00379886|Thiopental|thiopental
5733744|NCT00379847|hyponatremia|hyponatremia
5733745|NCT00379847|hypervolemic|hypervolemic
5733746|NCT00379847|euvolemic|euvolemic
5733747|NCT00379847|treatment outcomes|treatment outcomes
5733748|NCT00379847|YM087|ym087
5733749|NCT00379834|glaucoma|glaucoma
5733750|NCT00379834|diurnal|diurnal
5733751|NCT00379834|intraocular pressure|intraocular pressure
5733752|NCT00379821|chloroquine, malaria, Plasmodium falciparum, Malawi, children|chloroquine, malaria, plasmodium falciparum, malawi, children
5733753|NCT00379808|coronary heart disease|coronary heart disease
5733754|NCT00379808|montelukast|montelukast
5733755|NCT00379808|inflammation|inflammation
5733756|NCT00379795|CNV|cnv
5733757|NCT00379795|Lucentis|lucentis
5733758|NCT00379795|AMD|amd
5733759|NCT00379795|Age-related macular degeneration|age-related macular degeneration
5733760|NCT00379795|RVO|rvo
5733761|NCT00379769|diabetes|diabetes
5733762|NCT00379769|CV outcomes|cv outcomes
5733763|NCT00379769|rosiglitazone|rosiglitazone
5733764|NCT00379769|Type II diabetes|type ii diabetes
5733765|NCT00379769|sulfonylurea|sulfonylurea
5733766|NCT00379769|RECORD|record
5733767|NCT00379769|metformin|metformin
5733768|NCT00379756|Erectile dysfunction, impotence|erectile dysfunction, impotence
5733769|NCT00379730|CT scan|ct scan
5733770|NCT00379730|breathing tests|breathing tests
5733771|NCT00379730|lung function tests|lung function tests
5733773|NCT00379730|prednisolone|prednisolone
5733774|NCT00379730|IOS|ios
5733775|NCT00379730|COPD|copd
5733776|NCT00379730|clinical outcomes|clinical outcomes
5733777|NCT00379717|helical tomotherapy|helical tomotherapy
5733778|NCT00379717|dose escalation|dose escalation
5733779|NCT00379717|chemotherapy|chemotherapy
5733780|NCT00379704|Tissue factor|tissue factor
5733781|NCT00379704|Obesity|obesity
5733782|NCT00379704|Adipose tissue|adipose tissue
5733783|NCT00379704|Microparticles|microparticles
5733784|NCT00379691|spinal|spinal
5733785|NCT00379691|Cesarean section|cesarean section
5733786|NCT00379691|hypotension|hypotension
5733787|NCT00379691|nausea|nausea
5733788|NCT00379691|vomiting|vomiting
5733789|NCT00379691|phenylephrine|phenylephrine
5733790|NCT00379678|atopic dermatitis|atopic dermatitis
5733791|NCT00379665|Lung|lung
5733792|NCT00379665|Chemotherapy|chemotherapy
5733793|NCT00379665|Cisplatin|cisplatin
5733794|NCT00379665|Intratumoral|intratumoral
5733795|NCT00379665|Bronchoscope|bronchoscope
5733796|NCT00379665|Brachytherapy|brachytherapy
5733797|NCT00379652|Community Health Centers|community health centers
5733798|NCT00379652|Diabetes|diabetes
5733799|NCT00379652|Blood Pressure, High|blood pressure, high
5733800|NCT00379639|Pancreatic cancer|pancreatic cancer
5733801|NCT00379639|advanced solid tumors|advanced solid tumors
5733802|NCT00379626|Paraphilia|paraphilia
5733803|NCT00379626|Hormonal treatment|hormonal treatment
5733804|NCT00379626|Cognitive treatment|cognitive treatment
5733805|NCT00379600|Anti-inflammatory treatment|anti-inflammatory treatment
5733806|NCT00379600|Rheumatoid Arthritis|rheumatoid arthritis
5733808|NCT00379587|Chronic GVHD|chronic gvhd
5733809|NCT00379574|diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5733810|NCT00379574|Bortezomib|bortezomib
5733811|NCT00379574|CHOP|chop
5733812|NCT00379574|Lenograstim|lenograstim
5733813|NCT00379561|Prostate Cancer|prostate cancer
5733911|NCT00379210|fMRI|fmri
5733814|NCT00379561|Recurrent Prostate Cancer|recurrent prostate cancer
5733815|NCT00379561|Non-Metastatic prostate cancer|non-metastatic prostate cancer
5733816|NCT00379561|Recurrent Localized Prostate Cancer with Biochemical Failure|recurrent localized prostate cancer with biochemical failure
5733817|NCT00379535|pregnancy , lack of iodine|pregnancy , lack of iodine
5733818|NCT00379535|lack of iodine during pregnancy|lack of iodine during pregnancy
5733819|NCT00379522|hemorrhagic|hemorrhagic
5733820|NCT00379522|shock|shock
5733821|NCT00379522|traumatic|traumatic
5733822|NCT00379522|shock treatment|shock treatment
5733823|NCT00379522|vasopressin|vasopressin
5733824|NCT00379522|Circulatory Collapse|circulatory collapse
5733825|NCT00379522|Hypovolemic Shock|hypovolemic shock
5733826|NCT00379509|recurrent breast cancer|recurrent breast cancer
5733827|NCT00379509|stage IIIA breast cancer|stage iiia breast cancer
5733828|NCT00379509|stage IIIB breast cancer|stage iiib breast cancer
5733829|NCT00379509|stage IIIC breast cancer|stage iiic breast cancer
5733830|NCT00379509|stage IV breast cancer|stage iv breast cancer
5733831|NCT00379509|male breast cancer|male breast cancer
5733832|NCT00379496|Fibromyalgia|fibromyalgia
5733833|NCT00379496|Acupuncture|acupuncture
5733834|NCT00379496|Randomized study|randomized study
5733835|NCT00379483|Transfusional iron overload|transfusional iron overload
5733836|NCT00379483|Deferasirox|deferasirox
5733837|NCT00379470|Brain tumor|brain tumor
5680939|NCT00575575|cognitive behavior therapy|cognitive behavior therapy
5733838|NCT00379470|Treatment|treatment
5733839|NCT00379470|Minimal toxicity|minimal toxicity
5733841|NCT00379470|Glioblastoma|glioblastoma
5733842|NCT00379470|Recurrent|recurrent
5733843|NCT00379470|TTFields|ttfields
5733844|NCT00379457|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5733845|NCT00379457|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5733846|NCT00379457|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5733847|NCT00379457|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5733848|NCT00379457|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5733849|NCT00379457|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5733850|NCT00379444|tobacco, intervention, tobacco cessation, ALaska Natives,|tobacco, intervention, tobacco cessation, alaska natives,
5733851|NCT00379444|Native Americans, pregnancy, women|native americans, pregnancy, women
5733852|NCT00379405|Saquinavir/ritonavir|saquinavir/ritonavir
5733853|NCT00379405|Single therapy|single therapy
5733854|NCT00379405|Virological efficacy|virological efficacy
5733855|NCT00379405|Safety|safety
5733856|NCT00379405|HIV-1|hiv-1
5733857|NCT00379392|Stroke|stroke
5733858|NCT00379392|Mental Imagery|mental imagery
5733859|NCT00379392|Constraint Induced Therapy|constraint induced therapy
5733860|NCT00379379|electroacupuncture, plasma glucose, plasma insulin|electroacupuncture, plasma glucose, plasma insulin
5733861|NCT00379366|Randomized Controlled Trials|randomized controlled trials
5733862|NCT00379366|Renal Dialysis|renal dialysis
5733863|NCT00379366|Graft Occlusion, Vascular|graft occlusion, vascular
5733864|NCT00379366|Angioplasty|angioplasty
5733865|NCT00379366|Vascular Patency|vascular patency
5733866|NCT00379366|Radiation, Ionizing|radiation, ionizing
5733867|NCT00379353|Advanced Cancers|advanced cancers
5733874|NCT00379327|Pregnancy Outcome|pregnancy outcome
5733875|NCT00379327|Randomized Controlled Trial|randomized controlled trial
5733876|NCT00379327|Double-Blind Method|double-blind method
5733877|NCT00379314|Incontinence|incontinence
5733878|NCT00379314|Urinary|urinary
5733879|NCT00379314|Female|female
5733880|NCT00379314|Surgery|surgery
5733881|NCT00379314|Complications|complications
5733882|NCT00379301|Atrial Fibrillation|atrial fibrillation
5733883|NCT00379301|A-Fib|a-fib
5733884|NCT00379301|AF|af
5733885|NCT00379301|Persistent|persistent
5733886|NCT00379301|Permanent|permanent
5733887|NCT00379301|Pulmonary Vein Isolation|pulmonary vein isolation
5733888|NCT00379301|Ablation|ablation
5733889|NCT00379275|Sarcoidosis|sarcoidosis
5733890|NCT00379275|Uveitis|uveitis
5733891|NCT00379275|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5733892|NCT00379275|HLA-Typing|hla-typing
5733893|NCT00379275|Cytokines|cytokines
5733894|NCT00379275|Serum Markers|serum markers
5733895|NCT00379262|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5733896|NCT00379262|Chemoradiotherapy|chemoradiotherapy
5733897|NCT00379262|Accelerated Fractionation|accelerated fractionation
5733898|NCT00379249|hypercholesterolemia|hypercholesterolemia
5733899|NCT00379249|statin|statin
5733900|NCT00379249|compliance|compliance
5733901|NCT00379236|osteoarthritis|osteoarthritis
5733902|NCT00379236|knee|knee
5733903|NCT00379223|retinal vein occlusion|retinal vein occlusion
5733904|NCT00379223|vitrectomy|vitrectomy
5733905|NCT00379223|surgery|surgery
5728695|NCT00399685|HIV|hiv
5733906|NCT00379223|retinal disorders|retinal disorders
5733907|NCT00379223|vascular diseases|vascular diseases
5733908|NCT00379210|Attention|attention
5733910|NCT00379210|event-related potentials|event-related potentials
5733912|NCT00379210|functional magnetic resonance imaging|functional magnetic resonance imaging
5733913|NCT00379210|MBSR|mbsr
5733914|NCT00379210|Mindfulness Based Stress Reduction|mindfulness based stress reduction
5733915|NCT00379210|Mindfulness Meditation Training|mindfulness meditation training
5732835|NCT00383578|metformin|metformin
5733917|NCT00379197|stage IV breast cancer, estrogen receptor positive|stage iv breast cancer, estrogen receptor positive
5733918|NCT00379197|recurrent breast cancer|recurrent breast cancer
5733919|NCT00379197|hormone-refractory, metastatic breast cancer|hormone-refractory, metastatic breast cancer
5733920|NCT00379184|arthritis|arthritis
5733921|NCT00379171|Children|children
5733922|NCT00379171|Complementary feeding|complementary feeding
5733923|NCT00379171|Breast feeding|breast feeding
5733924|NCT00379171|Cow's milk|cow's milk
5733925|NCT00379171|Formula|formula
5733926|NCT00379171|Protein|protein
5733927|NCT00379171|LCPUFA|lcpufa
5733928|NCT00379171|Fish oil|fish oil
5733929|NCT00379171|Lipid profile|lipid profile
5733930|NCT00379171|Intestinal inflammation|intestinal inflammation
5733931|NCT00379171|Intestinal microbiota|intestinal microbiota
5733932|NCT00379158|multiple micronutrient supplements|multiple micronutrient supplements
5733933|NCT00379158|home-fortification|home-fortification
5733934|NCT00379158|complementary foods|complementary foods
5733935|NCT00379158|infants|infants
5733936|NCT00379158|Ghana|ghana
5733937|NCT00379145|uterine leiomyosarcoma|uterine leiomyosarcoma
5733938|NCT00379145|recurrent uterine sarcoma|recurrent uterine sarcoma
5733939|NCT00379145|stage III uterine sarcoma|stage iii uterine sarcoma
5743230|NCT00345839|Sensipar|sensipar
5743232|NCT00345839|Calcimimetic|calcimimetic
5733940|NCT00379145|stage IV uterine sarcoma|stage iv uterine sarcoma
5733941|NCT00379132|Glioma|glioma
5733942|NCT00379132|prostatic|prostatic
5733943|NCT00379132|breast|breast
5733944|NCT00379132|non-small cell lung|non-small cell lung
5733945|NCT00379132|melanoma|melanoma
5733946|NCT00379132|colorectal|colorectal
5733947|NCT00379132|pancreatic|pancreatic
5733948|NCT00379119|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5733949|NCT00379119|recurrent prostate cancer|recurrent prostate cancer
5733950|NCT00379119|stage I prostate cancer|stage i prostate cancer
5733951|NCT00379119|stage IIB prostate cancer|stage iib prostate cancer
5733952|NCT00379119|stage IIA prostate cancer|stage iia prostate cancer
5733953|NCT00379119|stage III prostate cancer|stage iii prostate cancer
5733954|NCT00379106|Supportive|supportive
5733955|NCT00379106|Mastectomy|mastectomy
5733956|NCT00379106|Quality of Life|quality of life
5733957|NCT00379106|Arm Function|arm function
5733958|NCT00379093|Alcohol|alcohol
5733959|NCT00379093|Comorbidity|comorbidity
5733960|NCT00379093|Aging|aging
5733961|NCT00379093|Brief Advice|brief advice
5733962|NCT00379093|Randomized Trial|randomized trial
5733963|NCT00379067|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5733964|NCT00379067|Nocturia|nocturia
5733965|NCT00379067|Actigraphy|actigraphy
5733966|NCT00379067|Tamsulosin|tamsulosin
5733967|NCT00379054|social support, smoking, smoking cessation, intervention,|social support, smoking, smoking cessation, intervention,
5733968|NCT00379054|telephone counseling|telephone counseling
5733969|NCT00379041|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5733970|NCT00379041|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5733971|NCT00379028|COPD|copd
5733972|NCT00379015|stage IIIB breast cancer|stage iiib breast cancer
5733973|NCT00379015|stage IIIC breast cancer|stage iiic breast cancer
5733974|NCT00379015|stage IV breast cancer|stage iv breast cancer
5734367|NCT00378300|Probiotics|probiotics
5733975|NCT00379002|Interstitial Cystitis|interstitial cystitis
5733976|NCT00379002|Sexual Dysfunction|sexual dysfunction
5733977|NCT00379002|Vulvodynia|vulvodynia
5733978|NCT00379002|Pelvic Pain|pelvic pain
5733979|NCT00379002|incontinence|incontinence
5733980|NCT00378976|HIV infection|hiv infection
5733981|NCT00378976|HIV shedding|hiv shedding
5733982|NCT00378976|HSV suppression|hsv suppression
5733983|NCT00378976|Co-infected|co-infected
5733984|NCT00378976|MSM|msm
5733985|NCT00378976|Reactivation|reactivation
5733986|NCT00378976|Valacyclovir|valacyclovir
5733987|NCT00378950|Congestive Heart Failure|congestive heart failure
5733988|NCT00378937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5733989|NCT00378937|pain|pain
5733990|NCT00378885|HIV-prevention|hiv-prevention
5733991|NCT00378885|Internet Prevention intervention|internet prevention intervention
5733992|NCT00378885|Online randomized controlled trial|online randomized controlled trial
5733993|NCT00378885|Effect evaluation|effect evaluation
5733994|NCT00378885|MSM|msm
5733995|NCT00378885|Steady relationships|steady relationships
5733996|NCT00378859|Children|children
5733997|NCT00378859|Milk|milk
5733998|NCT00378859|Meat|meat
5733999|NCT00378859|Animal Protein|animal protein
5734000|NCT00378859|Growth Factors|growth factors
5734001|NCT00378859|IGF-I|igf-i
5734002|NCT00378859|IGFBP-3|igfbp-3
5734003|NCT00378859|Insulin|insulin
5734004|NCT00378846|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5734005|NCT00378833|Primary Hypercholesterolemia or Mixed Hyperlipidemia|primary hypercholesterolemia or mixed hyperlipidemia
5734009|NCT00378820|Milk minerals|milk minerals
5734010|NCT00378820|Growth factors|growth factors
5734011|NCT00378820|IGF-I|igf-i
5734012|NCT00378820|Insulin|insulin
5734013|NCT00378781|infection|infection
5732932|NCT00383136|STEMI|stemi
5734014|NCT00378781|poor vascular access|poor vascular access
5734015|NCT00378781|thromboembolism|thromboembolism
5734016|NCT00378781|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5734017|NCT00378781|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5734018|NCT00378781|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5734019|NCT00378781|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5734020|NCT00378781|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5734021|NCT00378781|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5734022|NCT00378781|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5734023|NCT00378781|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5734024|NCT00378781|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5734025|NCT00378781|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5734026|NCT00378781|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5734027|NCT00378781|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5734028|NCT00378781|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5734029|NCT00378781|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5734031|NCT00378781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5734032|NCT00378781|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5734033|NCT00378781|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5734034|NCT00378781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5734035|NCT00378781|disseminated neuroblastoma|disseminated neuroblastoma
5734036|NCT00378781|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5734037|NCT00378781|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5734038|NCT00378781|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5734039|NCT00378781|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5734040|NCT00378781|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5734041|NCT00378781|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5734042|NCT00378781|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5734043|NCT00378781|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5734044|NCT00378781|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5734045|NCT00378781|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5734046|NCT00378781|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5734047|NCT00378781|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5734048|NCT00378781|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5734049|NCT00378781|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5734050|NCT00378781|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5734051|NCT00378781|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5734052|NCT00378781|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5734053|NCT00378781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5734054|NCT00378781|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5734055|NCT00378781|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5734056|NCT00378781|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5734057|NCT00378781|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5734058|NCT00378781|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5734059|NCT00378781|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5734060|NCT00378781|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5734061|NCT00378781|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5734062|NCT00378781|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5734063|NCT00378781|recurrent breast cancer|recurrent breast cancer
5734064|NCT00378781|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5734065|NCT00378781|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5734066|NCT00378781|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5734067|NCT00378781|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5728932|NCT00398580|DHT|dht
5734069|NCT00378781|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5734070|NCT00378781|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5734071|NCT00378781|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5734072|NCT00378781|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5734073|NCT00378781|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5734074|NCT00378781|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5734075|NCT00378781|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5734076|NCT00378781|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5734077|NCT00378781|recurrent neuroblastoma|recurrent neuroblastoma
5734078|NCT00378781|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5734079|NCT00378781|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5734080|NCT00378781|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5734081|NCT00378781|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5734082|NCT00378781|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5734083|NCT00378781|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5734084|NCT00378781|refractory hairy cell leukemia|refractory hairy cell leukemia
5734085|NCT00378781|refractory multiple myeloma|refractory multiple myeloma
5734086|NCT00378781|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5734087|NCT00378781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5734088|NCT00378781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5734089|NCT00378781|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5734090|NCT00378781|stage I multiple myeloma|stage i multiple myeloma
5734091|NCT00378781|stage II multiple myeloma|stage ii multiple myeloma
5734092|NCT00378781|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5734093|NCT00378781|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5734094|NCT00378781|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5734095|NCT00378781|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5734096|NCT00378781|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5734097|NCT00378781|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5734098|NCT00378781|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5734099|NCT00378781|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5734100|NCT00378781|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5734101|NCT00378781|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5734102|NCT00378781|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5734103|NCT00378781|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5734104|NCT00378781|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5734105|NCT00378781|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5734106|NCT00378781|stage III multiple myeloma|stage iii multiple myeloma
5734107|NCT00378781|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5734108|NCT00378781|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5734109|NCT00378781|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5734110|NCT00378781|stage IIIA breast cancer|stage iiia breast cancer
5734111|NCT00378781|stage IIIB breast cancer|stage iiib breast cancer
5734112|NCT00378781|stage IIIC breast cancer|stage iiic breast cancer
5734113|NCT00378781|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5734114|NCT00378781|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5734115|NCT00378781|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5734116|NCT00378781|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5734117|NCT00378781|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5734118|NCT00378781|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5734119|NCT00378781|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5734120|NCT00378781|stage IV breast cancer|stage iv breast cancer
5734121|NCT00378781|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5734122|NCT00378781|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5734123|NCT00378781|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5734124|NCT00378781|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5734125|NCT00378781|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5734126|NCT00378781|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5734127|NCT00378781|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5734128|NCT00378781|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5734129|NCT00378781|acute undifferentiated leukemia|acute undifferentiated leukemia
5734130|NCT00378781|mast cell leukemia|mast cell leukemia
5734131|NCT00378781|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5734132|NCT00378781|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5734133|NCT00378781|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5734134|NCT00378781|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5734135|NCT00378781|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5734136|NCT00378781|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5734137|NCT00378781|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5734138|NCT00378781|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5734139|NCT00378781|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5742500|NCT00348933|Ataxia|ataxia
5734141|NCT00378781|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5734142|NCT00378781|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5734143|NCT00378781|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5734144|NCT00378781|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5734145|NCT00378781|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5734146|NCT00378781|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5734147|NCT00378781|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5734148|NCT00378781|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5734149|NCT00378781|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5734150|NCT00378781|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5734151|NCT00378781|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5734152|NCT00378781|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5734153|NCT00378781|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5734154|NCT00378781|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5734155|NCT00378781|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5734156|NCT00378781|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5734157|NCT00378781|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5734158|NCT00378781|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5734159|NCT00378781|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5734160|NCT00378781|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5734161|NCT00378781|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5734162|NCT00378781|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5734163|NCT00378781|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5734164|NCT00378781|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5734165|NCT00378781|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5734166|NCT00378781|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5734167|NCT00378781|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5734168|NCT00378781|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5734169|NCT00378781|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5734170|NCT00378781|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5734171|NCT00378781|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5734172|NCT00378781|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5734173|NCT00378781|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5734174|NCT00378781|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5734175|NCT00378781|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5734176|NCT00378781|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5734177|NCT00378781|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5734178|NCT00378781|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5734179|NCT00378781|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5734180|NCT00378781|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5734181|NCT00378781|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5734182|NCT00378781|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5734183|NCT00378781|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5734184|NCT00378781|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5734185|NCT00378781|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5734186|NCT00378781|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5734187|NCT00378781|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5734188|NCT00378781|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5734189|NCT00378781|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5734190|NCT00378781|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5734191|NCT00378781|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5734192|NCT00378781|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5734193|NCT00378781|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5729075|NCT00398047|refractory anemia|refractory anemia
5734194|NCT00378781|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5734195|NCT00378781|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5734196|NCT00378781|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5734197|NCT00378781|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5734198|NCT00378781|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5734199|NCT00378781|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5734201|NCT00378781|stage I melanoma|stage i melanoma
5734485|NCT00377845|self test|self test
5734209|NCT00378781|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5734210|NCT00378781|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5734211|NCT00378781|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5734212|NCT00378781|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5734213|NCT00378781|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5734214|NCT00378781|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5734215|NCT00378781|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5734216|NCT00378781|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5734217|NCT00378781|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5734338|NCT00378404|Metastatic|metastatic
5734218|NCT00378781|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5734219|NCT00378781|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5734220|NCT00378781|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5734221|NCT00378781|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5734222|NCT00378781|recurrent uterine sarcoma|recurrent uterine sarcoma
5734223|NCT00378781|stage I uterine sarcoma|stage i uterine sarcoma
5734224|NCT00378781|stage II uterine sarcoma|stage ii uterine sarcoma
5734225|NCT00378781|stage III uterine sarcoma|stage iii uterine sarcoma
5734226|NCT00378781|stage IV uterine sarcoma|stage iv uterine sarcoma
5734227|NCT00378781|localized osteosarcoma|localized osteosarcoma
5734228|NCT00378781|metastatic osteosarcoma|metastatic osteosarcoma
5734229|NCT00378781|recurrent osteosarcoma|recurrent osteosarcoma
5734230|NCT00378781|chondrosarcoma|chondrosarcoma
5734231|NCT00378781|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5734232|NCT00378781|recurrent small intestine cancer|recurrent small intestine cancer
5734233|NCT00378781|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5734234|NCT00378768|stage I multiple myeloma|stage i multiple myeloma
5734235|NCT00378768|stage II multiple myeloma|stage ii multiple myeloma
5734236|NCT00378768|stage III multiple myeloma|stage iii multiple myeloma
5734237|NCT00378768|refractory multiple myeloma|refractory multiple myeloma
5734238|NCT00378755|velcade|velcade
5734239|NCT00378755|myeloma|myeloma
5734240|NCT00378755|VAD regimen|vad regimen
5734241|NCT00378755|Transplantation, Autologous|transplantation, autologous
5734251|NCT00378729|PCOS|pcos
5734252|NCT00378729|FERTILOSCOPY|fertiloscopy
5734253|NCT00378729|Ovarian hyperstimulation|ovarian hyperstimulation
5734254|NCT00378729|Multiple pregnancies|multiple pregnancies
5734255|NCT00378729|Patient with PCOS (Rotterdam criteria)|patient with pcos (rotterdam criteria)
5734256|NCT00378729|Failure of treatment with Clomiphene Citrate|failure of treatment with clomiphene citrate
5734257|NCT00378729|Age between 18 and 36 years old|age between 18 and 36 years old
5734258|NCT00378729|Spermogram must be normal|spermogram must be normal
5734259|NCT00378729|Permeability of Fallopian tubes|permeability of fallopian tubes
5734260|NCT00378716|stage II colon cancer|stage ii colon cancer
5734261|NCT00378716|stage III colon cancer|stage iii colon cancer
5734262|NCT00378716|adenocarcinoma of the colon|adenocarcinoma of the colon
5734263|NCT00378690|Prostate Cancer|prostate cancer
5734264|NCT00378690|Prostate Specific Antigen|prostate specific antigen
5734265|NCT00378677|Powder inhalation|powder inhalation
5734266|NCT00378677|Side effects|side effects
5734267|NCT00378677|Nephrotoxicity|nephrotoxicity
5734268|NCT00378677|Calcineurin inhibitor|calcineurin inhibitor
5734269|NCT00378677|Bronchiolitis obliterans syndrome|bronchiolitis obliterans syndrome
5734270|NCT00378677|Forced Expiratory Volume|forced expiratory volume
5734271|NCT00378664|urinary incontinence|urinary incontinence
5734272|NCT00378664|spinal cord injury|spinal cord injury
5734273|NCT00378664|spina bifida|spina bifida
5734274|NCT00378651|Intubation, Endotracheal|intubation, endotracheal
5734275|NCT00378651|Anesthesia, General|anesthesia, general
5734276|NCT00378638|lymph|lymph
5734277|NCT00378638|node|node
5734278|NCT00378638|positive|positive
5734279|NCT00378638|breast|breast
5734280|NCT00378638|cancer|cancer
5734281|NCT00378638|metastases|metastases
5734282|NCT00378638|angiogenesis|angiogenesis
5734283|NCT00378638|bevacizumab|bevacizumab
5734284|NCT00378638|chemotherapy|chemotherapy
5734285|NCT00378612|trials|trials
5734286|NCT00378612|stents|stents
5734287|NCT00378612|coronary occlusions|coronary occlusions
5734288|NCT00378547|Tonsillectomy|tonsillectomy
5734289|NCT00378547|pregabalin|pregabalin
5734290|NCT00378547|dexamethasone|dexamethasone
5734291|NCT00378547|multimodal postoperative analgesia|multimodal postoperative analgesia
5734292|NCT00378534|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5734293|NCT00378534|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5734294|NCT00378534|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5734295|NCT00378534|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5734296|NCT00378534|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5742692|NCT00347880|ANP|anp
5734297|NCT00378534|Leukemia|leukemia
5734298|NCT00378534|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5734300|NCT00378534|Acute Myeloid Leukemia|acute myeloid leukemia
5734302|NCT00378534|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5734303|NCT00378534|CLL|cll
5734304|NCT00378534|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5734305|NCT00378534|ALL|all
5734306|NCT00378534|Myelodysplasia Syndrome|myelodysplasia syndrome
5734307|NCT00378521|Raynaud's|raynaud's
5734308|NCT00378521|Nitroglycerin|nitroglycerin
5734309|NCT00378521|topical gel|topical gel
5734310|NCT00378521|cold hands|cold hands
5734311|NCT00378521|painful hands|painful hands
5734312|NCT00378521|scleroderma|scleroderma
5734313|NCT00378508|immune therapy|immune therapy
5734314|NCT00378508|autoimmunity|autoimmunity
5734315|NCT00378508|insulin secretion|insulin secretion
5734316|NCT00378508|diabetes mellitus|diabetes mellitus
5734317|NCT00378495|miltefosine|miltefosine
5734318|NCT00378495|kala azar|kala azar
5734319|NCT00378495|Brazil|brazil
5734320|NCT00378482|Melanoma and other tumors|melanoma and other tumors
5734321|NCT00378469|Hepcidin|hepcidin
5734322|NCT00378469|Hemojuvelin|hemojuvelin
5734323|NCT00378469|Iron|iron
5734324|NCT00378469|Healthy volunteers|healthy volunteers
5734325|NCT00378417|Otitis Media|otitis media
5734326|NCT00378417|Pneumococcal Infections|pneumococcal infections
5734327|NCT00378417|Pneumococcal Vaccines|pneumococcal vaccines
5734328|NCT00378417|Proportional Hazards Models|proportional hazards models
5734329|NCT00378417|Prospective Studies|prospective studies
5734330|NCT00378417|Streptococcus pneumoniae|streptococcus pneumoniae
5734331|NCT00378417|Vaccines, Conjugate|vaccines, conjugate
5734332|NCT00378404|NSCLC|nsclc
5734333|NCT00378404|Non-Small Cell Lung Cancer|non-small cell lung cancer
5734334|NCT00378404|Non-Small Cell|non-small cell
5734335|NCT00378404|Lung Cancer|lung cancer
5734336|NCT00378404|Docetaxel|docetaxel
5734337|NCT00378404|Radiation|radiation
5734339|NCT00378404|Recurrent|recurrent
5734340|NCT00378391|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5734341|NCT00378391|upstream abciximab|upstream abciximab
5734342|NCT00378391|guideline adherence|guideline adherence
5734343|NCT00378391|hospital networking|hospital networking
5734344|NCT00378365|Acute promyelocytic leukaemia|acute promyelocytic leukaemia
5734345|NCT00378365|ATRA|atra
5734346|NCT00378365|Idarubicin|idarubicin
5734347|NCT00378365|Arsenic trioxide|arsenic trioxide
5734348|NCT00378365|Patient with a newly acute promyelocytic leukaemia (APL)|patient with a newly acute promyelocytic leukaemia (apl)
5734349|NCT00378365|Unmapped MeSH term|unmapped mesh term
5734350|NCT00378352|Acute Myocardial Infarction|acute myocardial infarction
5734351|NCT00378352|Left Ventricular Remodeling|left ventricular remodeling
5734352|NCT00378352|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5734353|NCT00378352|Endothelial Progenitor Cells|endothelial progenitor cells
5734354|NCT00378352|Infarct Size|infarct size
5734355|NCT00378339|arthrosis|arthrosis
5734356|NCT00378339|gold|gold
5734357|NCT00378326|paraneoplastic syndrome|paraneoplastic syndrome
5734358|NCT00378313|NSABP|nsabp
5734359|NCT00378313|gemcitabine|gemcitabine
5734360|NCT00378313|epirubicin|epirubicin
5734361|NCT00378313|paclitaxel|paclitaxel
5734362|NCT00378313|Taxol|taxol
5734363|NCT00378313|breast cancer|breast cancer
5734364|NCT00378313|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5734365|NCT00378313|primary chemotherapy|primary chemotherapy
5734366|NCT00378300|Atopic Dermatitis|atopic dermatitis
5734368|NCT00378300|T Regulatory Cells|t regulatory cells
5734369|NCT00378287|Acid Reflux|acid reflux
5734370|NCT00378287|Proton Pump Inhibitor|proton pump inhibitor
5734371|NCT00378287|GERD|gerd
5734372|NCT00378274|Neuropathic pain|neuropathic pain
5734373|NCT00378274|Chronic pain|chronic pain
5734374|NCT00378274|Depression|depression
5734375|NCT00378274|Anxiety|anxiety
5734376|NCT00378261|Rheumatoid Arthritis|rheumatoid arthritis
5734377|NCT00378248|Personality disorders,|personality disorders,
5734378|NCT00378248|Day treatment,|day treatment,
5734379|NCT00378248|Group psychotherapy,|group psychotherapy,
5734380|NCT00378248|Combined psychotherapy,|combined psychotherapy,
5734381|NCT00378248|Outcome,|outcome,
5734382|NCT00378248|Attachment pattern|attachment pattern
5734383|NCT00378235|neurosurgery, craniotomy|neurosurgery, craniotomy
5734486|NCT00377845|PAP smear|pap smear
5734384|NCT00378235|convection-enhanced delivery|convection-enhanced delivery
5734385|NCT00378235|CNS interstitial infusion|cns interstitial infusion
5734386|NCT00378235|recombinant toxins|recombinant toxins
5734387|NCT00378235|malignant glioma, recurrent|malignant glioma, recurrent
5734388|NCT00378235|catheter,|catheter,
5734389|NCT00378235|intratumoral therapy|intratumoral therapy
5734390|NCT00378235|positive pressure microinfusion|positive pressure microinfusion
5734391|NCT00378222|Myeloma previously untreated|myeloma previously untreated
5734392|NCT00378222|Single autologous transplantation|single autologous transplantation
5734393|NCT00378222|Double autologous transplantation|double autologous transplantation
5734394|NCT00378222|Complete response|complete response
5734395|NCT00378209|relapsed multiple myeloma|relapsed multiple myeloma
5686197|NCT00553085|anxiety disorders|anxiety disorders
5733526|NCT00381108|BPH|bph
5734396|NCT00378209|refractory multiple myeloma|refractory multiple myeloma
5734397|NCT00378196|Idiopathic Parafoveal Telangiectasia (IPT)|idiopathic parafoveal telangiectasia (ipt)
5734398|NCT00378196|Also Known As Idiopathic Juxtafoveal Telangiectasia (IJFT)|also known as idiopathic juxtafoveal telangiectasia (ijft)
5734399|NCT00378183|weight loss|weight loss
5734400|NCT00378183|behavioral therapy|behavioral therapy
5734401|NCT00378183|risperidone|risperidone
5734402|NCT00378183|switching antipsychotics|switching antipsychotics
5734403|NCT00378183|schizoaffective disorder|schizoaffective disorder
5734404|NCT00378183|Risperdal|risperdal
5734405|NCT00378183|schizophrenia|schizophrenia
5734406|NCT00378183|olanzapine|olanzapine
5734407|NCT00378183|Zyprexa|zyprexa
5734408|NCT00378170|intubation|intubation
5734409|NCT00378170|difficulty|difficulty
5734410|NCT00378170|Macintosh|macintosh
5734411|NCT00378170|dental damage|dental damage
5734412|NCT00378170|complications|complications
5734413|NCT00378157|autism|autism
5734414|NCT00378157|joint attention|joint attention
5734415|NCT00378157|intervention|intervention
5734416|NCT00378157|joint engagement|joint engagement
5734417|NCT00378157|language|language
5734419|NCT00378118|HIV-2|hiv-2
5734420|NCT00378105|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5734421|NCT00378092|Schizophrenia|schizophrenia
5734422|NCT00378092|Risperidone|risperidone
5734423|NCT00378092|Risperdal consta|risperdal consta
5734424|NCT00378053|Radiation|radiation
5734425|NCT00378053|Exposure|exposure
5734426|NCT00378053|Hand|hand
5734427|NCT00378053|Orthopaedic|orthopaedic
5734428|NCT00378053|Surgeons|surgeons
5734429|NCT00378027|Pulmonary Embolism|pulmonary embolism
5734430|NCT00378027|PE|pe
5734431|NCT00378027|Outpatient|outpatient
5734432|NCT00378027|Anticoagulation|anticoagulation
5734433|NCT00378014|Liver transplantation, everolimus, CNI|liver transplantation, everolimus, cni
5734434|NCT00378001|Infertility, FSH, IVF, Ovarian stimulation|infertility, fsh, ivf, ovarian stimulation
5734435|NCT00377988|Contraception|contraception
5734436|NCT00377988|Hormonal contraception|hormonal contraception
5734437|NCT00377988|Oral contraception|oral contraception
5734438|NCT00377988|Ethinyl estradiol|ethinyl estradiol
5734439|NCT00377988|Progestin|progestin
5734440|NCT00377988|Transdermal|transdermal
5734441|NCT00377988|Thrombosis|thrombosis
5734442|NCT00377988|Venous thromboembolism|venous thromboembolism
5734443|NCT00377975|UCP-1|ucp-1
5734444|NCT00377975|ephedrine|ephedrine
5734445|NCT00377975|caffeine|caffeine
5734446|NCT00377975|pioglitazone|pioglitazone
5734447|NCT00377962|thoracic transplant recipients|thoracic transplant recipients
5734448|NCT00377962|everolimus|everolimus
5734449|NCT00377962|immunosuppressants|immunosuppressants
5734450|NCT00377949|Systemic Sclerosis|systemic sclerosis
5734451|NCT00377949|Scleroderma|scleroderma
5734452|NCT00377949|Pulmonary Hypertension|pulmonary hypertension
5734453|NCT00377949|PHAROS|pharos
5734454|NCT00377949|PHROS|phros
5734455|NCT00377949|Exercise Echocardiogram|exercise echocardiogram
5734456|NCT00377949|Pulmonary Functional Tests|pulmonary functional tests
5734457|NCT00377949|Six minute walk tests|six minute walk tests
5734458|NCT00377949|6 minute walk tests|6 minute walk tests
5734459|NCT00377949|Right heart catheterization|right heart catheterization
5734460|NCT00377936|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5734461|NCT00377936|Locally advanced|locally advanced
5734462|NCT00377936|Metastatic|metastatic
5734463|NCT00377923|pharmacodynamic and pharmacokinetic study|pharmacodynamic and pharmacokinetic study
5734464|NCT00377923|Progesterone|progesterone
5734465|NCT00377923|healthy volunteers|healthy volunteers
5734466|NCT00377923|Endometrial decidualisation|endometrial decidualisation
5734467|NCT00377910|Chronic Achilles tendinopathy|chronic achilles tendinopathy
5734468|NCT00377910|Polidocanol|polidocanol
5734469|NCT00377910|Ultrasound|ultrasound
5734470|NCT00377910|Efficacy|efficacy
5734471|NCT00377910|RCT|rct
5734472|NCT00377897|critical leg ischemia|critical leg ischemia
5734473|NCT00377897|PAD|pad
5734474|NCT00377897|cell therapy|cell therapy
5734475|NCT00377884|THA|tha
5734476|NCT00377871|Stentless|stentless
5734477|NCT00377871|Biological|biological
5734478|NCT00377871|aortic|aortic
5734479|NCT00377871|heart|heart
5734480|NCT00377871|valve|valve
5734481|NCT00377871|prosthesis|prosthesis
5734482|NCT00377871|artificial|artificial
5734483|NCT00377858|diabetes|diabetes
5734487|NCT00377845|tampon test|tampon test
5734488|NCT00377845|cervical dysplasia|cervical dysplasia
5734489|NCT00377832|Fetal tachycardia|fetal tachycardia
5734490|NCT00377832|Fever in labor|fever in labor
5734491|NCT00377832|Acetaminophen|acetaminophen
5734492|NCT00377832|Non reassuring fetal status|non reassuring fetal status
5734493|NCT00377819|RANKL|rankl
5734494|NCT00377819|RANK|rank
5734495|NCT00377819|denosumab|denosumab
5734496|NCT00377819|AMG 162|amg 162
5734497|NCT00377819|osteoporosis|osteoporosis
5734498|NCT00377819|bone turnover|bone turnover
5734499|NCT00377819|bone mineral density|bone mineral density
5686198|NCT00553085|children|children
5734500|NCT00377819|clinical trial|clinical trial
5734501|NCT00377819|postmenopausal osteoporosis|postmenopausal osteoporosis
5734502|NCT00377819|alendronate|alendronate
5734503|NCT00377819|total hip bone mineral density|total hip bone mineral density
5734504|NCT00377806|Superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs|superficial thrombophlebitis, diclofenac gel, non steroidal antiinflammatory drugs
5734505|NCT00377780|Breast cancer|breast cancer
5734506|NCT00377780|metastatic|metastatic
5734507|NCT00377780|cardiotoxicity|cardiotoxicity
5734508|NCT00377780|liposomal|liposomal
5734509|NCT00377780|doxorubicin|doxorubicin
5734510|NCT00377780|trastuzumab|trastuzumab
5734511|NCT00377780|docetaxel|docetaxel
5734512|NCT00377780|HER2/neu positive metastatic breast cancer|her2/neu positive metastatic breast cancer
5734513|NCT00377767|Chronic Care Model|chronic care model
5734514|NCT00377767|Obesity|obesity
5734515|NCT00377767|Overweight|overweight
5734516|NCT00377767|Children|children
5734517|NCT00377767|Body Mass Index|body mass index
5734518|NCT00377767|Primary Care|primary care
5734519|NCT00377754|dengue virus, immunity, hemorrhagic fever, Philippines|dengue virus, immunity, hemorrhagic fever, philippines
5734520|NCT00377728|Seasonal Allergic Rhinitis Inflammation Vienna CHallenge Chamber|seasonal allergic rhinitis inflammation vienna challenge chamber
5743935|NCT00343005|Malaria|malaria
5743936|NCT00343005|Vaccine|vaccine
5743942|NCT00342966|Metabolism|metabolism
5734521|NCT00377715|Dimebon, Alzheimer's Disease, Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)|dimebon, alzheimer's disease, alzheimer's disease assessment scale-cognitive subscale (adas-cog)
5734522|NCT00377702|Coronary Heart Disease|coronary heart disease
5734523|NCT00377702|Risk Factors|risk factors
5734524|NCT00377702|Heart Failure|heart failure
5734525|NCT00377689|Accidental falls|accidental falls
5734526|NCT00377689|Cerebrovascular accident|cerebrovascular accident
5734527|NCT00377689|Balance|balance
5734529|NCT00377689|Self efficacy|self efficacy
5734530|NCT00377689|Quality of Life|quality of life
5734531|NCT00377689|Gait parameters|gait parameters
5734532|NCT00377676|diabetes|diabetes
5734533|NCT00377676|diabetes mellitus|diabetes mellitus
5734534|NCT00377611|Influenza vaccine|influenza vaccine
5734535|NCT00377598|Herpes Zoster|herpes zoster
5734536|NCT00377598|Neuralgia|neuralgia
5734537|NCT00377598|Drug Therapy|drug therapy
5734538|NCT00377585|Elderly|elderly
5734539|NCT00377585|Improved vaccine|improved vaccine
5734540|NCT00377585|Influenza|influenza
5734541|NCT00377585|Influenza disease|influenza disease
5734542|NCT00377572|Immunoglobulins|immunoglobulins
5734543|NCT00377572|Immunoglobulin E|immunoglobulin e
5734544|NCT00377572|omalizumab|omalizumab
5734545|NCT00377572|anti-IgE|anti-ige
5734546|NCT00377559|Breast cancer|breast cancer
5734547|NCT00377559|metastatic|metastatic
5734548|NCT00377559|cardiotoxicity|cardiotoxicity
5734549|NCT00377559|liposomal|liposomal
5734550|NCT00377559|doxorubicin|doxorubicin
5734551|NCT00377559|docetaxel|docetaxel
5734552|NCT00377559|HER2/neu negative metastatic breast cancer|her2/neu negative metastatic breast cancer
5734553|NCT00377546|Retinal Surgery|retinal surgery
5734554|NCT00377533|wheelchairs|wheelchairs
5734555|NCT00377533|caregivers|caregivers
5734556|NCT00377533|skills|skills
5734557|NCT00377507|catechin|catechin
5734558|NCT00377507|elderly|elderly
5734559|NCT00377507|mouth washing|mouth washing
5734560|NCT00377507|disabled|disabled
5734561|NCT00377507|colonized|colonized
5734562|NCT00377494|malaria, Plasmodium falciparum, vaccine, Ghana|malaria, plasmodium falciparum, vaccine, ghana
5734563|NCT00377468|THC|thc
5734564|NCT00377468|CRPS|crps
5734565|NCT00377468|Pain|pain
5734566|NCT00377468|Complex Regional Pain Syndrome|complex regional pain syndrome
5734567|NCT00377468|Neuropathic Pain|neuropathic pain
5734568|NCT00377468|Chronic|chronic
5734569|NCT00377468|Prevention|prevention
5734571|NCT00377455|systemic sclerosis|systemic sclerosis
5734572|NCT00377455|bosentan|bosentan
5734573|NCT00377455|pulmonary hypertension|pulmonary hypertension
5734574|NCT00377455|PHAROS|pharos
5734575|NCT00377455|PHROS|phros
5734576|NCT00377455|exercise echocardiogram|exercise echocardiogram
5734577|NCT00377429|Epithelial Cancer|epithelial cancer
5734578|NCT00377429|Epithelial Carcinoma|epithelial carcinoma
5734579|NCT00377429|Epithelial Ovarian Cancer|epithelial ovarian cancer
5734580|NCT00377429|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
5734581|NCT00377429|Fallopian Tube Cancer|fallopian tube cancer
5734582|NCT00377429|Fallopian Tube Carcinoma|fallopian tube carcinoma
5734583|NCT00377429|Ovarian Cancer|ovarian cancer
5734584|NCT00377429|Ovarian Carcinoma|ovarian carcinoma
5734585|NCT00377429|Ovarian Epithelial Cancer|ovarian epithelial cancer
5734586|NCT00377429|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
5734587|NCT00377429|Peritoneal Cancer|peritoneal cancer
5734588|NCT00377429|Peritoneal Carcinoma|peritoneal carcinoma
5734589|NCT00377429|Advanced Epithelial Ovarian Cancer|advanced epithelial ovarian cancer
5734590|NCT00377416|Gene Transfer Techniques|gene transfer techniques
5734591|NCT00377416|Gene Therapy|gene therapy
5734592|NCT00377403|rhinosinusitis, sinusitis, amoxicillin|rhinosinusitis, sinusitis, amoxicillin
5734594|NCT00377390|IgE|ige
5686199|NCT00553085|neurodevelopmental disorder|neurodevelopmental disorder
5734595|NCT00377390|Omalizumab|omalizumab
5734596|NCT00377377|GH release|gh release
5734597|NCT00377377|Pharmacokinetics|pharmacokinetics
5734598|NCT00377377|Safety|safety
5734599|NCT00377364|Acetaminophen|acetaminophen
5734600|NCT00377364|corticosteroids|corticosteroids
5734601|NCT00377364|prednisone|prednisone
5734602|NCT00377351|Public Health|public health
5734603|NCT00377351|Elderly Population|elderly population
5734604|NCT00377351|Neurodegenerative Diseases|neurodegenerative diseases
5734605|NCT00377351|Exposure|exposure
5734606|NCT00377351|Lifestyle|lifestyle
5734607|NCT00377338|Bronchoscopy|bronchoscopy
5734608|NCT00377338|Diagnostic imaging|diagnostic imaging
5734609|NCT00377338|Laser scanning confocal microscopy|laser scanning confocal microscopy
5734610|NCT00377338|Pulmonary Alveoli|pulmonary alveoli
5734611|NCT00377338|Healthy volunteers|healthy volunteers
5734612|NCT00377338|Diffuse peripheral lung disease|diffuse peripheral lung disease
5734613|NCT00377338|Focal peripheral lung disease|focal peripheral lung disease
5734614|NCT00377312|Endocrine System Diseases|endocrine system diseases
5789084|NCT00149968|Renal transplantation|renal transplantation
5734615|NCT00377312|MusculoSkeletal System Disease|musculoskeletal system disease
5734616|NCT00377312|Hormone|hormone
5734617|NCT00377312|Physiologic Properties|physiologic properties
5734618|NCT00377299|Amphetamine Abuse|amphetamine abuse
5734619|NCT00377299|Amphetamine Dependence|amphetamine dependence
5734620|NCT00377299|Bipolar Disorder|bipolar disorder
5734621|NCT00377299|Major Depressive Disorder|major depressive disorder
5734622|NCT00377299|Citicoline|citicoline
5734623|NCT00377286|Osteoarthritis|osteoarthritis
5734624|NCT00377286|Knee Pain|knee pain
5734625|NCT00377286|Glucosamine|glucosamine
5734626|NCT00377286|MRI|mri
5734627|NCT00377286|CTX-II|ctx-ii
5734628|NCT00377286|Biomarkers|biomarkers
5734629|NCT00377286|Skin quality|skin quality
5734630|NCT00377260|acute otitis media, infants, children|acute otitis media, infants, children
5734631|NCT00377247|Carcinoma|carcinoma
5734632|NCT00377247|Head|head
5734633|NCT00377247|Neck|neck
5734634|NCT00377247|Oral Cavity|oral cavity
5734635|NCT00377247|Oropharynx|oropharynx
5734636|NCT00377247|Mouth|mouth
5734637|NCT00377208|Blood Pressure, High|blood pressure, high
5734638|NCT00377195|Marginal Zone Lymphoma|marginal zone lymphoma
5734639|NCT00377195|Involved field radiotherapy|involved field radiotherapy
5734640|NCT00377195|H. pylori|h. pylori
5734641|NCT00377169|Treatment Experienced|treatment experienced
5734642|NCT00377156|cognitive/functional effects|cognitive/functional effects
5734643|NCT00377156|tumors metastatic to brain|tumors metastatic to brain
5734644|NCT00377156|stage IV breast cancer|stage iv breast cancer
5734645|NCT00377156|stage IV prostate cancer|stage iv prostate cancer
5734646|NCT00377156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5734647|NCT00377156|male breast cancer|male breast cancer
5734648|NCT00377156|recurrent breast cancer|recurrent breast cancer
5734649|NCT00377156|recurrent prostate cancer|recurrent prostate cancer
5734650|NCT00377156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5734651|NCT00377143|warfarin|warfarin
5734652|NCT00377143|pharmacogenomic|pharmacogenomic
5734653|NCT00377143|CYP2C9|cyp2c9
5734654|NCT00377143|VKORC1|vkorc1
5734655|NCT00377143|polymorphism, single nucleotide|polymorphism, single nucleotide
5734656|NCT00377130|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5734657|NCT00377130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5734658|NCT00377091|pulmonary embolism|pulmonary embolism
5734659|NCT00377091|venous thromboembolism|venous thromboembolism
5734660|NCT00377091|pharmacoeconomic|pharmacoeconomic
5734661|NCT00377091|heparin|heparin
5734662|NCT00377091|unfractionated heparin|unfractionated heparin
5734663|NCT00377091|fondaparinux|fondaparinux
5734664|NCT00377091|length of stay|length of stay
5734665|NCT00377091|costs|costs
5734666|NCT00377091|bleeding|bleeding
5734668|NCT00377078|recombinant human lactoferrin|recombinant human lactoferrin
5734669|NCT00377052|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5734670|NCT00377039|ACR 1990 Fibromyalgia|acr 1990 fibromyalgia
5734671|NCT00377039|Fibromyalgia Impact Questionnaire|fibromyalgia impact questionnaire
5734673|NCT00377026|postpartum|postpartum
5734674|NCT00377026|weight retention|weight retention
5734675|NCT00376987|renal cell carcinoma|renal cell carcinoma
5734676|NCT00376987|bladder cancer|bladder cancer
5734677|NCT00376987|cervical cancer|cervical cancer
5734678|NCT00376987|esophageal cancer|esophageal cancer
5734679|NCT00376987|gastric cancer|gastric cancer
5734680|NCT00376987|adult acute myeloid leukemia|adult acute myeloid leukemia
5735658|NCT00374153|College|college
5734681|NCT00376987|pancreatic cancer|pancreatic cancer
5734682|NCT00376987|hypopharyngeal cancer|hypopharyngeal cancer
5734683|NCT00376987|lip and oral cavity cancer|lip and oral cavity cancer
5734684|NCT00376987|laryngeal cancer|laryngeal cancer
5734685|NCT00376987|nasopharyngeal cancer|nasopharyngeal cancer
5734687|NCT00376987|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5734688|NCT00376987|non-small cell lung cancer|non-small cell lung cancer
5734689|NCT00376987|small cell lung cancer|small cell lung cancer
5734690|NCT00376987|adult primary liver cancer|adult primary liver cancer
5734691|NCT00376987|tongue cancer|tongue cancer
5734692|NCT00376987|tobacco use disorder|tobacco use disorder
5734693|NCT00376974|glaucoma|glaucoma
5734694|NCT00376974|compliance|compliance
5734695|NCT00376974|intraocular pressure|intraocular pressure
5734696|NCT00376974|video|video
5734697|NCT00376961|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5734698|NCT00376961|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5734699|NCT00376961|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5734700|NCT00376961|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5734701|NCT00376948|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5734702|NCT00376948|stage III pancreatic cancer|stage iii pancreatic cancer
5734703|NCT00376948|stage IV pancreatic cancer|stage iv pancreatic cancer
5734704|NCT00376948|recurrent pancreatic cancer|recurrent pancreatic cancer
5734705|NCT00376935|Treatment Experienced|treatment experienced
5734706|NCT00376922|pain|pain
5734707|NCT00376922|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5734708|NCT00376922|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5734709|NCT00376922|acute undifferentiated leukemia|acute undifferentiated leukemia
5734710|NCT00376922|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5734711|NCT00376922|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5734712|NCT00376922|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5734713|NCT00376922|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5734714|NCT00376922|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5734715|NCT00376922|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5734716|NCT00376922|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5734717|NCT00376922|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5734718|NCT00376922|primary myelofibrosis|primary myelofibrosis
5734719|NCT00376922|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5734720|NCT00376922|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5734721|NCT00376922|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5734722|NCT00376922|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5734723|NCT00376922|essential thrombocythemia|essential thrombocythemia
5734724|NCT00376922|extramedullary plasmacytoma|extramedullary plasmacytoma
5734725|NCT00376922|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5734726|NCT00376922|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5734727|NCT00376922|polycythemia vera|polycythemia vera
5734728|NCT00376922|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5734729|NCT00376922|primary systemic amyloidosis|primary systemic amyloidosis
5734730|NCT00376922|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5734731|NCT00376922|prolymphocytic leukemia|prolymphocytic leukemia
5734732|NCT00376922|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5734733|NCT00376922|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5734734|NCT00376922|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5734735|NCT00376922|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5734736|NCT00376922|stage III multiple myeloma|stage iii multiple myeloma
5734737|NCT00376922|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5734738|NCT00376922|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5734739|NCT00376922|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5734740|NCT00376922|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5734741|NCT00376922|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5734872|NCT00376870|Coronary|coronary
5734742|NCT00376922|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5734743|NCT00376922|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5734744|NCT00376922|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5734745|NCT00376922|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5734746|NCT00376922|mast cell leukemia|mast cell leukemia
5734747|NCT00376922|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5734748|NCT00376922|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5734749|NCT00376922|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5734750|NCT00376922|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5734751|NCT00376922|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5734752|NCT00376922|refractory hairy cell leukemia|refractory hairy cell leukemia
5734753|NCT00376922|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5734754|NCT00376922|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5734755|NCT00376922|untreated hairy cell leukemia|untreated hairy cell leukemia
5686200|NCT00553085|neurodevelopmental delay|neurodevelopmental delay
5686201|NCT00553085|temperament|temperament
5734756|NCT00376922|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5734758|NCT00376922|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5734759|NCT00376922|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5734760|NCT00376922|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5734761|NCT00376922|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5734762|NCT00376922|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5734763|NCT00376922|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5734764|NCT00376922|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5734765|NCT00376922|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5734766|NCT00376922|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5734767|NCT00376922|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5734768|NCT00376922|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5734769|NCT00376922|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5789085|NCT00149968|MMF|mmf
5789086|NCT00149968|EC-MPS|ec-mps
5734770|NCT00376922|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5734771|NCT00376922|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5734772|NCT00376922|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5734773|NCT00376922|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5734774|NCT00376922|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5734775|NCT00376922|Waldenström macroglobulinemia|waldenström macroglobulinemia
5734776|NCT00376922|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5734777|NCT00376922|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5734778|NCT00376922|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5734779|NCT00376922|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5734780|NCT00376922|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5734781|NCT00376922|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5734782|NCT00376922|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5734783|NCT00376922|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5734784|NCT00376922|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5734785|NCT00376922|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5734786|NCT00376922|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5734787|NCT00376922|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5734788|NCT00376922|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5734789|NCT00376922|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5734790|NCT00376922|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5734791|NCT00376922|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5734792|NCT00376922|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5734793|NCT00376922|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5734794|NCT00376922|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5734795|NCT00376922|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5734796|NCT00376922|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5734797|NCT00376922|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5734798|NCT00376922|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5734799|NCT00376922|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5734800|NCT00376922|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5734801|NCT00376922|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5798835|NCT00111072|Mucosal Disease|mucosal disease
5734802|NCT00376922|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5734803|NCT00376922|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5734804|NCT00376922|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5734805|NCT00376922|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5734806|NCT00376922|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5734807|NCT00376922|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5734808|NCT00376922|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5734809|NCT00376922|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5734810|NCT00376922|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5734811|NCT00376922|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5686202|NCT00553072|Asphyxia|asphyxia
5686203|NCT00553072|perinatal|perinatal
5735859|NCT00373412|antibodies|antibodies
5734812|NCT00376922|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5734813|NCT00376922|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5734814|NCT00376922|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5734815|NCT00376922|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5734816|NCT00376922|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5734817|NCT00376922|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5734818|NCT00376922|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5734819|NCT00376922|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5734820|NCT00376922|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5734821|NCT00376922|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5734822|NCT00376922|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5734823|NCT00376922|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5734824|NCT00376922|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5734825|NCT00376922|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5734826|NCT00376922|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5734827|NCT00376922|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5734828|NCT00376922|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5734829|NCT00376922|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5734830|NCT00376922|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5734831|NCT00376922|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5734832|NCT00376922|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5734833|NCT00376922|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5734834|NCT00376922|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5734835|NCT00376922|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5734836|NCT00376922|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5734837|NCT00376922|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5734838|NCT00376922|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5734839|NCT00376922|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5734840|NCT00376922|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5734841|NCT00376922|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5734842|NCT00376922|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5734843|NCT00376922|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5734844|NCT00376922|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5734845|NCT00376922|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5734846|NCT00376922|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5734847|NCT00376922|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5734848|NCT00376922|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5734849|NCT00376922|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5734850|NCT00376922|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5734851|NCT00376922|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5734852|NCT00376922|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5734853|NCT00376922|refractory multiple myeloma|refractory multiple myeloma
5734854|NCT00376922|stage I multiple myeloma|stage i multiple myeloma
5734855|NCT00376922|stage II multiple myeloma|stage ii multiple myeloma
5734856|NCT00376922|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5734857|NCT00376922|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5734859|NCT00376909|cervical cancer|cervical cancer
5734860|NCT00376909|colon cancer|colon cancer
5734861|NCT00376909|rectal cancer|rectal cancer
5734862|NCT00376896|IBS fMRI|ibs fmri
5734863|NCT00376883|multiple myeloma|multiple myeloma
5734864|NCT00376883|pamidronate prophylaxis|pamidronate prophylaxis
5734865|NCT00376883|dose comparison|dose comparison
5734866|NCT00376883|quality of life|quality of life
5734867|NCT00376883|skeletal event|skeletal event
5734868|NCT00376883|response|response
5734869|NCT00376883|survival|survival
5734873|NCT00376870|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5734874|NCT00376857|Indocyanine green, toxicity, epiretinal membrane, visual field defect|indocyanine green, toxicity, epiretinal membrane, visual field defect
5734875|NCT00376844|stage I endometrial carcinoma|stage i endometrial carcinoma
5734876|NCT00376831|colonoscopy|colonoscopy
5734877|NCT00376831|conscious sedation|conscious sedation
5734878|NCT00376831|midazolam|midazolam
5734879|NCT00376831|ketamine|ketamine
5734880|NCT00376831|fentanyl|fentanyl
5734881|NCT00376818|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5734882|NCT00376818|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5734883|NCT00376818|adult anaplastic ependymoma|adult anaplastic ependymoma
5734030|NCT00378781|primary myelofibrosis|primary myelofibrosis
5734884|NCT00376818|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5736243|NCT00372190|treatment|treatment
5734885|NCT00376818|adult giant cell glioblastoma|adult giant cell glioblastoma
5734886|NCT00376818|adult gliosarcoma|adult gliosarcoma
5734887|NCT00376818|adult medulloblastoma|adult medulloblastoma
5734888|NCT00376818|adult anaplastic meningioma|adult anaplastic meningioma
5734889|NCT00376818|adult papillary meningioma|adult papillary meningioma
5734890|NCT00376818|adult mixed glioma|adult mixed glioma
5734891|NCT00376818|recurrent adult brain tumor|recurrent adult brain tumor
5734892|NCT00376818|adult glioblastoma|adult glioblastoma
5734893|NCT00376818|adult grade III meningioma|adult grade iii meningioma
5734894|NCT00376805|stage IV breast cancer|stage iv breast cancer
5734895|NCT00376805|male breast cancer|male breast cancer
5734896|NCT00376805|recurrent breast cancer|recurrent breast cancer
5734897|NCT00376792|stage IIB prostate cancer|stage iib prostate cancer
5734898|NCT00376792|stage IIA prostate cancer|stage iia prostate cancer
5734899|NCT00376792|stage III prostate cancer|stage iii prostate cancer
5734900|NCT00376792|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5735267|NCT00375544|Osteoarthritis|osteoarthritis
5734901|NCT00376779|Haemophilus influenzae type b|haemophilus influenzae type b
5734904|NCT00376779|randomized|randomized
5734905|NCT00376779|phase 2|phase 2
5734906|NCT00376779|GSK Biologicals|gsk biologicals
5734907|NCT00376779|DTPa-HBV-IPV/Hib|dtpa-hbv-ipv/hib
5734908|NCT00376766|Cluster seizure|cluster seizure
5734909|NCT00376766|seizure clustering|seizure clustering
5734910|NCT00376766|repetitive seizure|repetitive seizure
5734911|NCT00376766|Drug resistant epilepsy|drug resistant epilepsy
5734912|NCT00376766|Levetiracetam|levetiracetam
5734913|NCT00376766|keppra|keppra
5734914|NCT00376753|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5734915|NCT00376753|Writer's Cramp|writer's cramp
5734916|NCT00376753|Electromyogram|electromyogram
5734917|NCT00376753|Focal Hand Dystonia|focal hand dystonia
5734918|NCT00376753|FHD|fhd
5734919|NCT00376753|Healthy Volunteer|healthy volunteer
5734920|NCT00376753|HV|hv
5734921|NCT00376740|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density|breast cancer, postmenopausal, letrozole, zoledronic acid, adjuvant,bone mineral density
5734922|NCT00376727|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5734923|NCT00376714|plethysmography|plethysmography
5734924|NCT00376714|muscarinic receptor antagonist|muscarinic receptor antagonist
5734925|NCT00376714|COPD|copd
5734926|NCT00376714|repeat dosing|repeat dosing
5734927|NCT00376701|Choroidal Neovascularization|choroidal neovascularization
5734928|NCT00376701|Photodynamic Therapy|photodynamic therapy
5734929|NCT00376701|Age Related Macular Degeneration|age related macular degeneration
5734930|NCT00376701|Triamcinolone Acetonide|triamcinolone acetonide
5734931|NCT00376701|Avastin|avastin
5734932|NCT00376701|Visudyne|visudyne
5734933|NCT00376675|fatigue|fatigue
5734934|NCT00376675|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5734935|NCT00376662|HRT|hrt
5734936|NCT00376662|Etidronate|etidronate
5734937|NCT00376662|Fractures|fractures
5734938|NCT00376662|Osteoporosis|osteoporosis
5734939|NCT00376662|Asthma|asthma
5734940|NCT00376662|Glucocorticoids|glucocorticoids
5734941|NCT00376649|crohns|crohns
5734942|NCT00376649|quality of life|quality of life
5734943|NCT00376649|lifestyle changing|lifestyle changing
5734944|NCT00376649|remmision|remmision
5734945|NCT00376597|lymphedema|lymphedema
5734946|NCT00376597|stage IA breast cancer|stage ia breast cancer
5734947|NCT00376597|stage IB breast cancer|stage ib breast cancer
5734948|NCT00376597|stage II breast cancer|stage ii breast cancer
5734949|NCT00376597|stage IIIA breast cancer|stage iiia breast cancer
5734950|NCT00376597|stage IIIB breast cancer|stage iiib breast cancer
5734951|NCT00376597|stage IIIC breast cancer|stage iiic breast cancer
5734952|NCT00376584|Primary Hypercholesteremia|primary hypercholesteremia
5734953|NCT00376584|Mixed Hyperlipidemia|mixed hyperlipidemia
5734954|NCT00376571|PCI|pci
5734955|NCT00376571|Bifurcation lesion|bifurcation lesion
5734956|NCT00376558|cocaine dependence|cocaine dependence
5734957|NCT00376545|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5734958|NCT00376545|Visuomotor|visuomotor
5734959|NCT00376545|Occipital Cortex|occipital cortex
5734960|NCT00376545|Prefrontal Cortex|prefrontal cortex
5734961|NCT00376545|Healthy Volunteer|healthy volunteer
5734963|NCT00376532|Cardiac Ischemia|cardiac ischemia
5734964|NCT00376532|Cardiac Arrhythmia|cardiac arrhythmia
5734965|NCT00376532|Defibrillator|defibrillator
5734966|NCT00376532|Matrix Metalloproteinase|matrix metalloproteinase
5734967|NCT00376532|Genetic Polymorphism|genetic polymorphism
5734968|NCT00376519|graft versus host disease|graft versus host disease
5734969|NCT00376519|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5734970|NCT00376519|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5734971|NCT00376519|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5734972|NCT00376519|refractory anemia with excess blasts|refractory anemia with excess blasts
5734570|NCT00377455|scleroderma|scleroderma
5734973|NCT00376519|myelodysplastic syndromes|myelodysplastic syndromes
5734974|NCT00376519|chronic myelogenous leukemia|chronic myelogenous leukemia
5734975|NCT00376519|refractory anemia|refractory anemia
5734976|NCT00376519|prolymphocytic leukemia|prolymphocytic leukemia
5734977|NCT00376519|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5734978|NCT00376519|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5734979|NCT00376519|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5734980|NCT00376519|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5734981|NCT00376519|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5734983|NCT00376519|mantle cell lymphoma|mantle cell lymphoma
5734984|NCT00376519|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5734985|NCT00376519|secondary myelofibrosis|secondary myelofibrosis
5734986|NCT00376519|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5734987|NCT00376519|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5734988|NCT00376519|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5734989|NCT00376519|marginal zone lymphoma|marginal zone lymphoma
5734990|NCT00376519|diffuse large cell lymphoma|diffuse large cell lymphoma
5734991|NCT00376519|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5734992|NCT00376519|lymphoblastic lymphoma|lymphoblastic lymphoma
5734993|NCT00376519|immunoblastic large cell lymphoma|immunoblastic large cell lymphoma
5734994|NCT00376519|multiple myeloma|multiple myeloma
5734995|NCT00376506|Aspiration|aspiration
5734996|NCT00376506|Rehabilitation|rehabilitation
5734997|NCT00376506|Swallowing Disorders|swallowing disorders
5734999|NCT00376506|Parkinson's Disease|parkinson's disease
5735000|NCT00376506|Dysphagia|dysphagia
5735001|NCT00376506|Parkinson Disease|parkinson disease
5735002|NCT00376506|PD|pd
5735003|NCT00376493|Abortion|abortion
5735004|NCT00376493|Infection|infection
5735005|NCT00376493|Antibiotics|antibiotics
5735006|NCT00376493|Treatment|treatment
5735007|NCT00376493|Pregnancy complications|pregnancy complications
5735008|NCT00376480|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5735009|NCT00376480|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5735010|NCT00376480|refractory anemia with excess blasts|refractory anemia with excess blasts
5735011|NCT00376480|refractory anemia|refractory anemia
5735012|NCT00376480|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5735013|NCT00376480|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5735014|NCT00376480|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5735015|NCT00376480|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5735016|NCT00376480|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5735017|NCT00376480|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5735018|NCT00376480|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5735019|NCT00376480|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5735020|NCT00376480|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5735021|NCT00376480|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5735022|NCT00376480|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5735023|NCT00376480|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5735024|NCT00376480|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5735025|NCT00376467|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5735026|NCT00376467|Philadelphia positive|philadelphia positive
5735027|NCT00376467|Adult|adult
5735028|NCT00376467|Elderly|elderly
5735029|NCT00376467|Imatinib|imatinib
5735030|NCT00376454|neuropathic pain|neuropathic pain
5735031|NCT00376441|vaginal|vaginal
5735032|NCT00376441|incontinence|incontinence
5735033|NCT00376441|sexual function|sexual function
5735034|NCT00376428|Cystic Fibrosis Transmembrane Conductance Regulator|cystic fibrosis transmembrane conductance regulator
5735035|NCT00376428|Premature termination codon|premature termination codon
5735036|NCT00376428|Gentamicin-induced readthrough|gentamicin-induced readthrough
5735037|NCT00376415|Lessertia frutescens|lessertia frutescens
5735038|NCT00376415|Sutherlandia frutescens|sutherlandia frutescens
5735039|NCT00376415|Phase 1 clinical trial|phase 1 clinical trial
5735040|NCT00376415|Human safety study|human safety study
5735041|NCT00376402|Pandemic|pandemic
5735042|NCT00376402|Influenza|influenza
5735043|NCT00376402|Prevention|prevention
5735044|NCT00376402|Vaccine|vaccine
5735045|NCT00376402|Prevention of Pandemic Influenza|prevention of pandemic influenza
5735046|NCT00376376|levofloxacin|levofloxacin
5735047|NCT00376376|pharmacodynamic|pharmacodynamic
5735048|NCT00376376|bactericidal|bactericidal
5735049|NCT00376363|glaucoma|glaucoma
5735050|NCT00376363|Ahmed implant|ahmed implant
5735051|NCT00376363|Baerveldt implant|baerveldt implant
5735052|NCT00376350|Low Back Pain|low back pain
5735053|NCT00376350|Chronic|chronic
5735054|NCT00376350|Manipulation|manipulation
5735055|NCT00376350|Chiropractic|chiropractic
5735056|NCT00376350|Massage|massage
5735057|NCT00376337|Invasive Aspergillosis|invasive aspergillosis
5735058|NCT00376337|Salvage Therapy|salvage therapy
5735059|NCT00376337|Micafungin|micafungin
5735060|NCT00376324|pharmacokinetics|pharmacokinetics
5735061|NCT00376324|human bone|human bone
5735062|NCT00376311|Lequesne's algo-functional score|lequesne's algo-functional score
5735063|NCT00376311|Biomarkers of joint metabolism|biomarkers of joint metabolism
5735064|NCT00376298|incontinence|incontinence
5735065|NCT00376298|prostate cancer|prostate cancer
5735066|NCT00376298|interstitial cystitis|interstitial cystitis
5735067|NCT00376272|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan|atrial fibrillation,atrial remodeling,dysrhythmias,valsartan
5735068|NCT00376259|lamivudine resistance|lamivudine resistance
5735069|NCT00376259|Hepatitis B virus|hepatitis b virus
5735070|NCT00376233|Schizophrenia,|schizophrenia,
5735071|NCT00376233|Cannabinoids,|cannabinoids,
5735072|NCT00376233|Arachidonic Acid,|arachidonic acid,
5735073|NCT00376233|Niacin,|niacin,
5735074|NCT00376233|Prostaglandins|prostaglandins
5735075|NCT00376220|Bipolar|bipolar
5735076|NCT00376220|Depression|depression
5735077|NCT00376207|Cerebral infarct|cerebral infarct
5735078|NCT00376207|physical exercise|physical exercise
5735079|NCT00376207|insulin sensitivity|insulin sensitivity
5735080|NCT00376207|low grade chronic inflammation|low grade chronic inflammation
5735081|NCT00376207|intervention|intervention
5735082|NCT00376207|HOMA|homa
5735083|NCT00376207|PASE|pase
5735084|NCT00376194|Pervasive Developmental Disorder|pervasive developmental disorder
5735085|NCT00376194|Alternative Therapy|alternative therapy
5735086|NCT00376194|Autism|autism
5735087|NCT00376194|Asperger's Disorder|asperger's disorder
5735088|NCT00376194|Clinical Trial|clinical trial
5735089|NCT00376194|Autism Spectrum Disorder|autism spectrum disorder
5735090|NCT00376194|ASD|asd
5735091|NCT00376194|Asperger Disorder|asperger disorder
5735092|NCT00376181|type 2 diabetes|type 2 diabetes
5735093|NCT00376181|hypertension|hypertension
5735094|NCT00376181|blood pressure|blood pressure
5735095|NCT00376181|diastolic blood pressure|diastolic blood pressure
5735096|NCT00376155|malaria|malaria
5735097|NCT00376155|prevention|prevention
5735098|NCT00376155|intermittent|intermittent
5735099|NCT00376155|drugs|drugs
5735100|NCT00376142|Intention|intention
5735101|NCT00376142|Behaviour|behaviour
5735102|NCT00376142|Evidence-based practice|evidence-based practice
5735103|NCT00376142|Intervention|intervention
5735104|NCT00376116|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5735105|NCT00376116|Pacemaker|pacemaker
5735106|NCT00376116|Cardiac resynchronisation therapy|cardiac resynchronisation therapy
5735107|NCT00376116|Heart failure|heart failure
5735108|NCT00376116|Predictor|predictor
5735109|NCT00376116|Mortality|mortality
5735110|NCT00376116|Rehospitalization|rehospitalization
5735111|NCT00376116|Telemedicine|telemedicine
5735112|NCT00376116|Home Monitoring|home monitoring
5735113|NCT00376103|Brain Tumor|brain tumor
5735114|NCT00376103|GBM|gbm
5735115|NCT00376103|Glioblastoma Multiforme|glioblastoma multiforme
5735116|NCT00376103|Glioblastoma|glioblastoma
5735117|NCT00376103|Brachytherapy|brachytherapy
5735118|NCT00376103|Temozolomide|temozolomide
5735119|NCT00376103|Temodar|temodar
5735120|NCT00376090|MVA vector|mva vector
5735121|NCT00376090|Immunogenicity|immunogenicity
5735122|NCT00376090|HIV vaccine|hiv vaccine
5735123|NCT00376090|HIV preventative vaccine|hiv preventative vaccine
5735124|NCT00376077|Thrombocytopenia|thrombocytopenia
5735125|NCT00376077|pediatric|pediatric
5735126|NCT00376077|methylprednisolone|methylprednisolone
5735127|NCT00376077|intracranial hemorrhage|intracranial hemorrhage
5735128|NCT00376077|intravenous immune globulin|intravenous immune globulin
5735129|NCT00376064|Growth hormone (GH)|growth hormone (gh)
5735130|NCT00376064|IGF-1|igf-1
5735131|NCT00376064|Acromegaly|acromegaly
5735132|NCT00376064|Pituitary adenoma|pituitary adenoma
5735133|NCT00376064|Brain tumor|brain tumor
5735134|NCT00376064|Brain cancer|brain cancer
5735135|NCT00376064|Octreotide acetate|octreotide acetate
5735136|NCT00376051|frontotemporal lobar degeneration|frontotemporal lobar degeneration
5735137|NCT00376051|frontotemporal dementia|frontotemporal dementia
5735138|NCT00376051|serotonin|serotonin
5735139|NCT00376051|dementia|dementia
5735140|NCT00376051|behavioural disturbances|behavioural disturbances
5735141|NCT00376038|GSK189074|gsk189074
5735142|NCT00376038|T2DM|t2dm
5735143|NCT00376038|GSK189075|gsk189075
5735144|NCT00376038|Glucophage|glucophage
5735145|NCT00376038|Obesity|obesity
5735146|NCT00376038|Diabetes|diabetes
5735147|NCT00376038|Metformin|metformin
5735148|NCT00376038|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5735149|NCT00376038|Drug Interaction|drug interaction
5735150|NCT00376025|Kashin-Beck Disease|kashin-beck disease
5735151|NCT00376025|Kashin-Beck Osteoarthropathy|kashin-beck osteoarthropathy
5735152|NCT00376012|Chemotherapy for TB in HIV infection|chemotherapy for tb in hiv infection
5735153|NCT00375986|Cesarean delivery|cesarean delivery
5735154|NCT00375986|Placental removal|placental removal
5735155|NCT00375986|Blood loss|blood loss
5735156|NCT00375973|Fatigue|fatigue
5735157|NCT00375973|Fatigue syndrome, chronic|fatigue syndrome, chronic
5735158|NCT00375973|Chronic fatigue syndrome|chronic fatigue syndrome
5735159|NCT00375973|CFS|cfs
5735160|NCT00375973|Fibromyalgia|fibromyalgia
5735161|NCT00375960|Pain associated with diabetes Type I or Type II|pain associated with diabetes type i or type ii
5735162|NCT00375960|Neuropathic Pain due to diabetes|neuropathic pain due to diabetes
5735163|NCT00375960|Diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
5735164|NCT00375960|Pain|pain
5735165|NCT00375960|Diabetes with burning sensation in the arms and/or legs|diabetes with burning sensation in the arms and/or legs
5735166|NCT00375960|Diabetes with tingling sensation in the arms and/or legs|diabetes with tingling sensation in the arms and/or legs
5735167|NCT00375960|Neuropathic Pain Due to Diabetes Type I or Type II|neuropathic pain due to diabetes type i or type ii
5735168|NCT00375947|exercise|exercise
5735169|NCT00375947|hand disability|hand disability
5735170|NCT00375947|arthritis|arthritis
5735171|NCT00375947|AUSCAN|auscan
5735172|NCT00375934|Bunionectomy|bunionectomy
5735173|NCT00375934|Bunion surgery|bunion surgery
5735174|NCT00375934|Post-operative pain|post-operative pain
5735175|NCT00375921|diet|diet
5735176|NCT00375921|food|food
5680942|NCT00575536|surgery|surgery
5680943|NCT00575523|atropine|atropine
5761561|NCT00278135|DHA|dha
5735177|NCT00375921|taste|taste
5735178|NCT00375921|smell|smell
5735179|NCT00375921|head and neck|head and neck
5735180|NCT00375921|radiation|radiation
5735181|NCT00375921|chemotherapy|chemotherapy
5735182|NCT00375908|Neonatal Encephalopathy|neonatal encephalopathy
5735183|NCT00375908|Hypoxic-Ischemic Brain Injury|hypoxic-ischemic brain injury
5735184|NCT00375908|Umbilical Cord Blood|umbilical cord blood
5735185|NCT00375908|Proteomics|proteomics
5735186|NCT00375895|Cyclosporin|cyclosporin
5735187|NCT00375895|Peginterferon|peginterferon
5735188|NCT00375895|Ribavirin|ribavirin
5735189|NCT00375895|Chronic hepatitis C|chronic hepatitis c
5735190|NCT00375895|Liver transplantation|liver transplantation
5735191|NCT00375869|Neuroprotection|neuroprotection
5735192|NCT00375869|neuron specific enolase|neuron specific enolase
5735193|NCT00375869|CSF glutamate levels|csf glutamate levels
5735194|NCT00375869|Darbepoetin Alfa|darbepoetin alfa
5735195|NCT00375856|arthroplasty|arthroplasty
5735196|NCT00375856|knee|knee
5735197|NCT00375856|computer-assist|computer-assist
5735198|NCT00375856|gait|gait
5735199|NCT00375856|Total knee arthroplasty|total knee arthroplasty
5735200|NCT00375856|knee prostheses|knee prostheses
5735201|NCT00375804|Endometrial Cancer|endometrial cancer
5735202|NCT00375791|Relapsed Multiple Myeloma|relapsed multiple myeloma
5735203|NCT00375791|Refractory Multiple Myeloma|refractory multiple myeloma
5735204|NCT00375778|Parkinson's Disease|parkinson's disease
5735205|NCT00375778|Positron Emission Tomography|positron emission tomography
5735206|NCT00375778|Memantine|memantine
5735207|NCT00375778|NMDA antagonists|nmda antagonists
5735208|NCT00375778|Cerebral Blood Flow|cerebral blood flow
5735209|NCT00375778|Cerebral Metabolic Rate of Oxygen|cerebral metabolic rate of oxygen
5735210|NCT00375765|Dutasteride|dutasteride
5735211|NCT00375765|BPH|bph
5735212|NCT00375765|Prostate cancer|prostate cancer
5735213|NCT00375765|Gene expression|gene expression
5735214|NCT00375765|PSA|psa
5735215|NCT00375752|Breast cancer|breast cancer
5735216|NCT00375752|Anti tumor potential|anti tumor potential
5735217|NCT00375752|Letrozole|letrozole
5735218|NCT00375752|Zoledronic acid|zoledronic acid
5735219|NCT00375752|Neoadjuvant treatment|neoadjuvant treatment
5735220|NCT00375752|Hormone responsive breast cancer|hormone responsive breast cancer
5735221|NCT00375739|Actinic Keratosis|actinic keratosis
5735222|NCT00375739|Topical|topical
5735223|NCT00375739|Solar Keratosis|solar keratosis
5735224|NCT00375739|Sun Spots|sun spots
5735225|NCT00375739|Dermatology|dermatology
5735226|NCT00375726|Dengue Fever|dengue fever
5735227|NCT00375726|Dengue Vaccine|dengue vaccine
5735228|NCT00375726|Dengue Virus|dengue virus
5735229|NCT00375726|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5735230|NCT00375726|Dengue Shock Syndrome|dengue shock syndrome
5735231|NCT00375713|Dermatitis|dermatitis
5735232|NCT00375713|Eczema|eczema
5735233|NCT00375713|Pruritus|pruritus
5735234|NCT00375713|Xyzal|xyzal
5735235|NCT00375713|Zyrtec|zyrtec
5735236|NCT00375713|Levocetirizine|levocetirizine
5735237|NCT00375713|Cetirizine|cetirizine
5735238|NCT00375700|food|food
5735239|NCT00375700|diet|diet
5735240|NCT00375700|oral supplement|oral supplement
5735241|NCT00375700|head and neck cancer|head and neck cancer
5735242|NCT00375700|radiation|radiation
5735243|NCT00375687|Prostate cancer|prostate cancer
5735244|NCT00375661|hepatocellular carcinoma|hepatocellular carcinoma
5735246|NCT00375648|Cancer|cancer
5735643|NCT00374205|ACT|act
5735247|NCT00375648|Bone metastases|bone metastases
5735248|NCT00375648|Zoledronic acid|zoledronic acid
5735249|NCT00375648|Bone metastases-related pain|bone metastases-related pain
5735250|NCT00375648|Prostate cancer|prostate cancer
5735251|NCT00375635|mFPSA|mfpsa
5735252|NCT00375635|Uremic toxins|uremic toxins
5735253|NCT00375635|Protein bound toxins|protein bound toxins
5735254|NCT00375635|Uremia|uremia
5735255|NCT00375635|Chronic hemodialysis|chronic hemodialysis
5735256|NCT00375622|HHT|hht
5743782|NCT00343668|S-1|s-1
5735257|NCT00375622|Epistaxis|epistaxis
5735258|NCT00375622|Tamoxifen|tamoxifen
5735259|NCT00375622|Hemoglobin|hemoglobin
5735260|NCT00375609|Prevention of Venous Thromboembolism|prevention of venous thromboembolism
5735261|NCT00375583|Lymphatic Filariasis|lymphatic filariasis
5735262|NCT00375583|Diethylcarbamazine|diethylcarbamazine
5735263|NCT00375583|Microfilariae|microfilariae
5735266|NCT00375544|Laser Therapy, Low-Level|laser therapy, low-level
5735268|NCT00375544|Phototherapy|phototherapy
5735269|NCT00375544|Osteoarthritis, knee|osteoarthritis, knee
5735270|NCT00375544|Light-emitting diode|light-emitting diode
5735271|NCT00375531|Post Traumatic Stress Disorder|post traumatic stress disorder
5735272|NCT00375531|Mindfulness Meditation|mindfulness meditation
5735273|NCT00375518|Thoracic Surgery|thoracic surgery
5735274|NCT00375518|Cardiopulmonary complications|cardiopulmonary complications
5735275|NCT00375518|Atorvastatin|atorvastatin
5735276|NCT00375505|Breast Cancer|breast cancer
5735277|NCT00375505|Premenopausal|premenopausal
5735278|NCT00375505|Bone mineral density|bone mineral density
5735279|NCT00375505|Cancer therapy induced bone loss|cancer therapy induced bone loss
5735280|NCT00375505|zoledronic acid|zoledronic acid
5735282|NCT00375492|overweight|overweight
5735283|NCT00375492|obesity|obesity
5735284|NCT00375492|weight loss|weight loss
5735285|NCT00375492|exenatide|exenatide
5735286|NCT00375492|Amylin|amylin
5735287|NCT00375492|Lilly|lilly
5735288|NCT00375466|Hemorrhage|hemorrhage
5735289|NCT00375466|Transfusion|transfusion
5735290|NCT00375466|Blood components|blood components
5735291|NCT00375466|Fibrinolysis|fibrinolysis
5735292|NCT00375466|Platelet activation|platelet activation
5735293|NCT00375453|Paclitaxel|paclitaxel
5735294|NCT00375453|Advanced Solid Tumors|advanced solid tumors
5735295|NCT00375440|Tranexamic Acid|tranexamic acid
5735296|NCT00375440|Revision Total Hip Replacement|revision total hip replacement
5735297|NCT00375440|Reduction in Blood Loss|reduction in blood loss
5735298|NCT00375427|Breast cancer|breast cancer
5735299|NCT00375427|Zoledronic acid|zoledronic acid
5735300|NCT00375427|Skeletal related events (SRE)|skeletal related events (sre)
5735301|NCT00375414|Enteral tube feeding,|enteral tube feeding,
5735302|NCT00375414|endoscopic gastropexy,|endoscopic gastropexy,
5735303|NCT00375414|percutaneous endoscopic gastrostomy,|percutaneous endoscopic gastrostomy,
5735304|NCT00375414|PEG|peg
5735305|NCT00375388|Type 2 diabetes mellitus|type 2 diabetes mellitus
5735306|NCT00375388|Metformin on top of insulin therapy|metformin on top of insulin therapy
5735307|NCT00375388|Randomized placebo-controlled trial|randomized placebo-controlled trial
5735308|NCT00375388|Diabetes regulation|diabetes regulation
5735309|NCT00375388|Daily dose of insulin|daily dose of insulin
5735310|NCT00375388|Body Weight|body weight
5735311|NCT00375388|Patients with type 2 diabetes|patients with type 2 diabetes
5735312|NCT00375388|Intensive insulin therapy|intensive insulin therapy
5735313|NCT00375388|Age: 30-80 years|age: 30-80 years
5735314|NCT00375388|Body mass index|body mass index
5735315|NCT00375388|Lipids|lipids
5735316|NCT00375388|Blood Pressure|blood pressure
5735317|NCT00375388|Endothelial function|endothelial function
5735318|NCT00375388|Low grade inflammation|low grade inflammation
5735319|NCT00375388|Fibrinolysis|fibrinolysis
5735320|NCT00375388|Microvascular complications|microvascular complications
5735321|NCT00375388|Macrovascular complications|macrovascular complications
5735322|NCT00375375|Minimal hepatic encephalopathy|minimal hepatic encephalopathy
5735323|NCT00375375|Hepatic encephalopathy|hepatic encephalopathy
5735324|NCT00375375|Subclinical hepatic encephalopathy|subclinical hepatic encephalopathy
5735325|NCT00375375|Health related quality of life|health related quality of life
5735326|NCT00375362|nitroglycerin|nitroglycerin
5735327|NCT00375362|morphine|morphine
5735328|NCT00375362|patient controlled analgesia|patient controlled analgesia
5735329|NCT00375362|total knee arthroplasty|total knee arthroplasty
5735330|NCT00375349|fatty liver|fatty liver
5735331|NCT00375349|statin|statin
5735332|NCT00375349|non-alcoholic|non-alcoholic
5735333|NCT00375336|Aortic valve|aortic valve
5735334|NCT00375336|Calcification|calcification
5735335|NCT00375336|Endothelial dysfunction|endothelial dysfunction
5735336|NCT00375336|Calcium metabolism|calcium metabolism
5735337|NCT00375336|Coronary artery disease|coronary artery disease
5735338|NCT00375323|factor VIII inhibitor|factor viii inhibitor
5735339|NCT00375310|Phase I|phase i
5735340|NCT00375310|Pancreas Cancer|pancreas cancer
5735341|NCT00375310|Chemo-radiotherapy|chemo-radiotherapy
5735342|NCT00375297|antidepressants|antidepressants
5735343|NCT00375297|sexual dysfunction|sexual dysfunction
5735344|NCT00375297|women|women
5735345|NCT00375297|sildenafil|sildenafil
5735346|NCT00375297|PDE5 inhibitors|pde5 inhibitors
5735347|NCT00375297|serotonin reuptake inhibitor antidepressants|serotonin reuptake inhibitor antidepressants
5735348|NCT00375271|Monitoring, Intraoperative|monitoring, intraoperative
5735349|NCT00375271|Hemodynamic Processes|hemodynamic processes
5735350|NCT00375271|Treatment Protocols|treatment protocols
5735351|NCT00375258|Adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage|adult trauma patients with ongoing significant haemorrhage or at risk of significant haemorrhage
5735352|NCT00375245|phase I|phase i
5734418|NCT00378118|HIV-1|hiv-1
5735353|NCT00375245|metastatic|metastatic
5735354|NCT00375245|advanced cancer|advanced cancer
5735355|NCT00375245|lung cancer|lung cancer
5735356|NCT00375245|renal cancer|renal cancer
5735357|NCT00375245|kidney cancer|kidney cancer
5735358|NCT00375245|head and neck cancer|head and neck cancer
5735359|NCT00375245|bladder cancer|bladder cancer
5735361|NCT00375245|colorectal cancer|colorectal cancer
5735362|NCT00375245|esophagus|esophagus
5735363|NCT00375245|GIST|gist
5735364|NCT00375245|liver cancer|liver cancer
5735365|NCT00375245|melanoma|melanoma
5735366|NCT00375245|mesothelioma|mesothelioma
5735367|NCT00375245|lymphoma|lymphoma
5735368|NCT00375245|ovary cancer|ovary cancer
5735369|NCT00375245|ovarian cancer|ovarian cancer
5735370|NCT00375245|pancreas cancer|pancreas cancer
5735371|NCT00375245|pancreatic cancer|pancreatic cancer
5735372|NCT00375245|prostate cancer|prostate cancer
5735373|NCT00375245|stomach cancer|stomach cancer
5735374|NCT00375245|thyroid cancer|thyroid cancer
5735375|NCT00375245|Metastatic solid tumor|metastatic solid tumor
5735376|NCT00375232|Exercise-Induced Bronchospasm|exercise-induced bronchospasm
5735377|NCT00375232|Asthma|asthma
5735378|NCT00375232|Cardiopulmonary Stress Test|cardiopulmonary stress test
5735379|NCT00375232|Eucapnic Voluntary Hyperventilation|eucapnic voluntary hyperventilation
5735380|NCT00375232|Induced sputum|induced sputum
5735381|NCT00375219|Chronic Myeloid Leukemia|chronic myeloid leukemia
5735382|NCT00375219|CML|cml
5735383|NCT00375219|HHT|hht
5735384|NCT00375219|Homoharringtonine|homoharringtonine
5735385|NCT00375219|Omacetaxine|omacetaxine
5735386|NCT00375219|T315i|t315i
5735387|NCT00375219|ChemGenex|chemgenex
5735388|NCT00375219|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
5735389|NCT00375206|PowderMed, DNA vaccine, influenza|powdermed, dna vaccine, influenza
5735390|NCT00375193|small cell lung cancer|small cell lung cancer
5735391|NCT00375193|amrubicin|amrubicin
5735392|NCT00375180|food|food
5735393|NCT00375180|diet|diet
5735394|NCT00375180|mucositis|mucositis
5735395|NCT00375180|xerostomia|xerostomia
5735396|NCT00375180|dysphagia|dysphagia
5735397|NCT00375180|taste|taste
5735398|NCT00375180|smell|smell
5735399|NCT00375180|head and neck|head and neck
5735400|NCT00375180|radiation|radiation
5735401|NCT00375180|chemotherapy|chemotherapy
5735402|NCT00375167|Recovery, Hope, Empowerment, Randomized Control Trial|recovery, hope, empowerment, randomized control trial
5735403|NCT00375154|Acute respiratory failure|acute respiratory failure
5735404|NCT00375154|Prehospital care|prehospital care
5735405|NCT00375154|Noninvasive ventilation|noninvasive ventilation
5735406|NCT00375154|Emergency|emergency
5735407|NCT00375128|Malaria|malaria
5735408|NCT00375128|Vaccine|vaccine
5735409|NCT00375128|Prime-boost|prime-boost
5735410|NCT00375128|Challenge|challenge
5735411|NCT00375102|acupuncture|acupuncture
5735412|NCT00375102|relaxation response|relaxation response
5735413|NCT00375102|homeless|homeless
5735414|NCT00375102|veterans|veterans
5735415|NCT00375102|randomized trials|randomized trials
5735416|NCT00375089|Early-onset Morbid Obesity|early-onset morbid obesity
5735417|NCT00375063|left main stenosis|left main stenosis
5735418|NCT00375063|Percutaneous Coronary Intervention|percutaneous coronary intervention
5735419|NCT00375063|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5735420|NCT00375037|hand washing|hand washing
5735421|NCT00375037|cluster randomized trial|cluster randomized trial
5735422|NCT00375037|performance feedback|performance feedback
5735423|NCT00375037|healthcare workers|healthcare workers
5735424|NCT00375037|Hand hygiene|hand hygiene
5735425|NCT00375037|hand washing adherence|hand washing adherence
5735426|NCT00375024|Patient navigation|patient navigation
5735427|NCT00375024|Breast cancer|breast cancer
5735428|NCT00375024|Colon cancer|colon cancer
5735429|NCT00375024|Questionnaire|questionnaire
5735430|NCT00375011|MELD-Model of End Stage Liver Disease score|meld-model of end stage liver disease score
5735431|NCT00375011|CTP-Child-Turcotte-Pugh score|ctp-child-turcotte-pugh score
5735432|NCT00375011|MEGX-monoethylglycinexylidide-resultant of metabolism of lidocaine|megx-monoethylglycinexylidide-resultant of metabolism of lidocaine
5735433|NCT00375011|HCC-Hepatocellular carcinoma|hcc-hepatocellular carcinoma
5735434|NCT00375011|HCV-Hepatitis C virus|hcv-hepatitis c virus
5735435|NCT00375011|NASH-Non-alcoholic Steatohepatitis|nash-non-alcoholic steatohepatitis
5735436|NCT00374998|Malaria|malaria
5735437|NCT00374998|Vaccine|vaccine
5753002|NCT00308256|nurse-counselling;|nurse-counselling;
5753003|NCT00308256|adolescent|adolescent
5753004|NCT00308243|Cystic Fibrosis|cystic fibrosis
5753005|NCT00308243|Sodium Pyruvate|sodium pyruvate
5735438|NCT00374998|Prime-boost|prime-boost
5735439|NCT00374985|chemoradiation|chemoradiation
5735440|NCT00374985|docetaxel|docetaxel
5735441|NCT00374985|oxaliplatin|oxaliplatin
5735442|NCT00374985|gastric|gastric
5735443|NCT00374985|neoadjuvant|neoadjuvant
5735444|NCT00374985|radiochemotherapy|radiochemotherapy
5735445|NCT00374959|Prevention of pneumonia|prevention of pneumonia
5735446|NCT00374959|ceftriaxone|ceftriaxone
5735447|NCT00374959|continuous aspiration|continuous aspiration
5735448|NCT00374959|subglottic secretions|subglottic secretions
5686204|NCT00553072|magnesium sulphate|magnesium sulphate
5686205|NCT00553059|nausea and vomiting|nausea and vomiting
5743934|NCT00343005|Endemic|endemic
5735449|NCT00374959|Mechanical ventilation with Endotracheal intubation.|mechanical ventilation with endotracheal intubation.
5735450|NCT00374959|Absence of infection|absence of infection
5735451|NCT00374933|AML|aml
5735452|NCT00374933|ALL|all
5735453|NCT00374933|MDS|mds
5735454|NCT00374933|Allogeneic transplant|allogeneic transplant
5735456|NCT00374933|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5735457|NCT00374933|Myelodysplastic Syndrome|myelodysplastic syndrome
5735458|NCT00374933|Adoptive cell therapy|adoptive cell therapy
5735459|NCT00374933|Non-myeloablative|non-myeloablative
5735461|NCT00374920|mania|mania
5735462|NCT00374920|mixed|mixed
5735463|NCT00374894|2,3-dimercaptosuccinic acid|2,3-dimercaptosuccinic acid
5735464|NCT00374894|Blood Lead Levels|blood lead levels
5735465|NCT00374894|children|children
5735466|NCT00374894|multi-nutrients|multi-nutrients
5745524|NCT00338065|Intraocular Pressure|intraocular pressure
5735467|NCT00374842|Influenza vaccine|influenza vaccine
5735468|NCT00374842|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5735469|NCT00374829|randomised prospective trial|randomised prospective trial
5735470|NCT00374829|medication refill compliance|medication refill compliance
5735471|NCT00374829|hypertension|hypertension
5735472|NCT00374829|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5735473|NCT00374829|information technology based patient support system|information technology based patient support system
5735474|NCT00374829|process of care, quality of life, pharmacoeconomics|process of care, quality of life, pharmacoeconomics
5735475|NCT00374829|multidisciplinary patient management|multidisciplinary patient management
5735476|NCT00374803|Kidney|kidney
5735477|NCT00374803|Transplant|transplant
5735478|NCT00374803|Corticosteroid|corticosteroid
5735479|NCT00374803|Myfortic|myfortic
5735480|NCT00374790|Lead toxicity|lead toxicity
5735481|NCT00374777|Insomnia|insomnia
5735482|NCT00374777|schizophrenia|schizophrenia
5735483|NCT00374777|manic-depressive psychosis|manic-depressive psychosis
5735484|NCT00374777|zolpidem|zolpidem
5735485|NCT00374764|Autism, Applied Behavioral Analysis, Risperidone|autism, applied behavioral analysis, risperidone
5735486|NCT00374751|Samarium|samarium
5735487|NCT00374751|Kyphoplasty|kyphoplasty
5735488|NCT00374751|Pain management|pain management
5735489|NCT00374751|Bone metastases|bone metastases
5735490|NCT00374751|Histologically proven malignancy in the primary site|histologically proven malignancy in the primary site
5735491|NCT00374751|Radiographic evidence of bone metastasis|radiographic evidence of bone metastasis
5735492|NCT00374751|Significant pain equal or more than score 5|significant pain equal or more than score 5
5735493|NCT00374751|Karnofsky Performance status >40|karnofsky performance status >40
5735494|NCT00374751|The patient must sign a study specific informed consent|the patient must sign a study specific informed consent
5735495|NCT00374738|Guided Imagery for Trauma (GIFT)|guided imagery for trauma (gift)
5735496|NCT00374738|Posttraumatic Stress Disorder (PTSD)|posttraumatic stress disorder (ptsd)
5735497|NCT00374738|Military Sexual Trauma (MST)|military sexual trauma (mst)
5735498|NCT00374738|Military Sexual Trauma - related PTSD|military sexual trauma - related ptsd
5735499|NCT00374725|Ulcerative Colitis|ulcerative colitis
5735500|NCT00374725|Probiotic|probiotic
5735501|NCT00374725|Placebo controlled trial|placebo controlled trial
5735502|NCT00374725|Lactobacillus rhamnosus|lactobacillus rhamnosus
5735503|NCT00374725|Lactobacillus acidophilus|lactobacillus acidophilus
5735504|NCT00374712|Phosphate|phosphate
5735505|NCT00374712|Dialysis|dialysis
5735506|NCT00374712|Klotho|klotho
5735507|NCT00374712|Hemodialysis|hemodialysis
5735508|NCT00374699|Velcade|velcade
5735509|NCT00374699|Bortezomib|bortezomib
5735510|NCT00374699|CHOP|chop
5735511|NCT00374699|Peripheral T-cell lymphomas(PTCLs)|peripheral t-cell lymphomas(ptcls)
5735512|NCT00374699|natural killer (NK)-cell lymphomas|natural killer (nk)-cell lymphomas
5735513|NCT00374686|cytomegalovirus|cytomegalovirus
5735514|NCT00374686|kidney|kidney
5735515|NCT00374686|transplantation|transplantation
5735516|NCT00374686|valganciclovir|valganciclovir
5735517|NCT00374686|preemptive|preemptive
5735518|NCT00374673|TMS|tms
5735519|NCT00374673|chronic pain|chronic pain
5735520|NCT00374673|fibromyalgia|fibromyalgia
5735521|NCT00374673|IBS|ibs
5735522|NCT00374673|burning mouth syndrome|burning mouth syndrome
5735523|NCT00374673|predictive factors|predictive factors
5753106|NCT00307853|pain|pain
5735524|NCT00374660|Irofulven|irofulven
5735525|NCT00374660|Oxaliplatin|oxaliplatin
5735526|NCT00374647|Renal|renal
5735527|NCT00374647|Kidney|kidney
5735528|NCT00374647|Transplant|transplant
5735529|NCT00374608|pediatric|pediatric
5735530|NCT00374608|congenital complete heart block|congenital complete heart block
5735531|NCT00374608|dual chamber pacemaker|dual chamber pacemaker
5735532|NCT00374595|Kidney Transplant|kidney transplant
5735533|NCT00374595|Vascular Risk|vascular risk
5735534|NCT00374595|inflammation|inflammation
5735535|NCT00374595|Diabetes|diabetes
5744122|NCT00342368|ALI|ali
5735536|NCT00374595|Insulin resistance|insulin resistance
5735537|NCT00374595|Chronic kidney disease|chronic kidney disease
5735538|NCT00374582|Bioelectric impedance analysis|bioelectric impedance analysis
5735539|NCT00374582|BIA|bia
5735540|NCT00374582|ESLD|esld
5735541|NCT00374582|LVP|lvp
5735542|NCT00374582|Large volume paracentesis|large volume paracentesis
5735543|NCT00374582|Ascites|ascites
5735544|NCT00374582|Liver|liver
5735545|NCT00374582|Hepatic|hepatic
5730575|NCT00392483|General Practice|general practice
5735546|NCT00374569|Gymnastics, Computerized Dynamic Posturography, Balance|gymnastics, computerized dynamic posturography, balance
5735548|NCT00374556|insomnia|insomnia
5735549|NCT00374543|Bipolar Disorder|bipolar disorder
5735550|NCT00374543|Generalized Anxiety Disorder|generalized anxiety disorder
5735551|NCT00374543|Double-blind|double-blind
5735552|NCT00374543|Placebo-controlled|placebo-controlled
5735553|NCT00374543|Ziprasidone|ziprasidone
5735554|NCT00374517|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5735555|NCT00374517|Pimonidazole Hydrochloride|pimonidazole hydrochloride
5735556|NCT00374517|Recurrent Tuberculosis|recurrent tuberculosis
5745633|NCT00337506|Multiple Myeloma|multiple myeloma
5735557|NCT00374517|Hypoxyprobe|hypoxyprobe
5735558|NCT00374517|mRNA Expression|mrna expression
5735559|NCT00374517|Pulmonary Tuberculosis|pulmonary tuberculosis
5735561|NCT00374491|Bone Screw|bone screw
5735562|NCT00374491|Knee|knee
5735563|NCT00374478|Scopolamine|scopolamine
5735564|NCT00374478|Antiemetic|antiemetic
5735565|NCT00374478|Task performance and analysis|task performance and analysis
5735566|NCT00374478|Psychomotor vigilance test|psychomotor vigilance test
5735567|NCT00374465|Dilated Cardiomyopathy|dilated cardiomyopathy
5735568|NCT00374465|Heart Failure|heart failure
5735569|NCT00374452|hypertension|hypertension
5735570|NCT00374452|practice guidelines|practice guidelines
5735571|NCT00374452|quality of health care|quality of health care
5735572|NCT00374452|decision support systems|decision support systems
5735573|NCT00374452|evidence-based medicine|evidence-based medicine
5735574|NCT00374452|medical informatics|medical informatics
5735575|NCT00374439|depression|depression
5735576|NCT00374439|adolescents|adolescents
5735577|NCT00374439|prevention|prevention
5735578|NCT00374439|schools|schools
5735579|NCT00374426|depression|depression
5735580|NCT00374426|diabetes mellitus|diabetes mellitus
5735581|NCT00374426|depression recurrence|depression recurrence
5735582|NCT00374413|DDD|ddd
5735583|NCT00374413|artificial disc|artificial disc
5735584|NCT00374400|Kidney|kidney
5735585|NCT00374400|Transplant|transplant
5735586|NCT00374400|Paired donation|paired donation
5735587|NCT00374400|Living donor|living donor
5735588|NCT00374387|Healthy women|healthy women
5735589|NCT00374374|probiotic|probiotic
5735590|NCT00374361|insulin sensitivity|insulin sensitivity
5735591|NCT00374361|endothelial function|endothelial function
5735592|NCT00374361|adolescence|adolescence
5735593|NCT00374361|lipids|lipids
5735594|NCT00374361|puberty|puberty
5735595|NCT00374348|Schizophrenia with OCD|schizophrenia with ocd
5735596|NCT00374348|Schizophrenia with-comorbid symptoms of Obsessive Compulsive Disorder(OCD)|schizophrenia with-comorbid symptoms of obsessive compulsive disorder(ocd)
5735597|NCT00374335|prospective cohort study|prospective cohort study
5735598|NCT00374322|Breast Cancer|breast cancer
5735599|NCT00374322|ErbB2-overexpressing|erbb2-overexpressing
5735600|NCT00374322|early-stage breast cancer|early-stage breast cancer
5735601|NCT00374322|adjuvant|adjuvant
5735602|NCT00374309|Hemorrhagic Fever|hemorrhagic fever
5735603|NCT00374309|Healthy|healthy
5735604|NCT00374309|Immunity|immunity
5735605|NCT00374309|T -Cells|t -cells
5735606|NCT00374309|Filovirus|filovirus
5735607|NCT00374309|Healthy Volunteer|healthy volunteer
5735608|NCT00374309|HV|hv
5735609|NCT00374296|Leukemia|leukemia
5735610|NCT00374296|MDS|mds
5735611|NCT00374296|Phase II|phase ii
5735612|NCT00374296|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5735613|NCT00374296|High Risk Myelodysplastic Syndromes (MDS)|high risk myelodysplastic syndromes (mds)
5735614|NCT00374283|Monitoring|monitoring
5735615|NCT00374283|Polyomavirus|polyomavirus
5735616|NCT00374283|Kidney|kidney
5735617|NCT00374283|Pancreas|pancreas
5735618|NCT00374283|Transplant|transplant
5735619|NCT00374270|Diabetes (type I and type II)|diabetes (type i and type ii)
5735620|NCT00374257|NB-UVB|nb-uvb
5735621|NCT00374257|cGVHD|cgvhd
5735622|NCT00374244|schizophrenia|schizophrenia
5735623|NCT00374244|pimozide|pimozide
5735624|NCT00374244|clozapine|clozapine
5735625|NCT00374231|Liver|liver
5753205|NCT00307437|IL-12|il-12
5735626|NCT00374231|Transplant|transplant
5735627|NCT00374231|Corticosteroid withdrawal|corticosteroid withdrawal
5735628|NCT00374231|Tacrolimus|tacrolimus
5735629|NCT00374231|CellCept|cellcept
5735630|NCT00374231|MMF|mmf
5735631|NCT00374231|Mycophenolate mofetil|mycophenolate mofetil
5735632|NCT00374218|Carbohydrate|carbohydrate
5735633|NCT00374218|Glycemic index|glycemic index
5735634|NCT00374218|Randomized|randomized
5735635|NCT00374218|Double-blind|double-blind
5735636|NCT00374218|Glucose|glucose
5744266|NCT00341965|DDT|ddt
5735637|NCT00374218|Insulin|insulin
5735638|NCT00374218|C-reactive protein|c-reactive protein
5735639|NCT00374205|Ghana|ghana
5735640|NCT00374205|Effectiveness|effectiveness
5735641|NCT00374205|Safety|safety
5735642|NCT00374205|Drug-Resistance|drug-resistance
5735652|NCT00374192|Quality of Life|quality of life
5735653|NCT00374166|Anti-anxiety agents|anti-anxiety agents
5735654|NCT00374166|antidepressive agents|antidepressive agents
5735655|NCT00374166|controlled clinical trial|controlled clinical trial
5735656|NCT00374153|Alcohol|alcohol
5735657|NCT00374153|Drinking|drinking
5735659|NCT00374153|Motivational|motivational
5735660|NCT00374153|Feedback|feedback
5735661|NCT00374153|Assessment|assessment
5735662|NCT00374140|small cell|small cell
5735663|NCT00374140|lung|lung
5735664|NCT00374127|Marijuana|marijuana
5735665|NCT00374127|Comparison between joints and blunts|comparison between joints and blunts
5735666|NCT00374127|Pharmacokinetic effects|pharmacokinetic effects
5735667|NCT00374114|cervical|cervical
5735668|NCT00374114|dysplasia|dysplasia
5735669|NCT00374101|PPIs,|ppis,
5735670|NCT00374101|endoscopic therapy,|endoscopic therapy,
5681154|NCT00574509|Non Hodgkins Lymphoma|non hodgkins lymphoma
5735671|NCT00374101|peptic ulcers,|peptic ulcers,
5735672|NCT00374101|upper gastrointestinal bleeding,|upper gastrointestinal bleeding,
5735673|NCT00374101|non-variceal upper gastrointestinal bleeding|non-variceal upper gastrointestinal bleeding
5735674|NCT00374088|N-acetylcysteine|n-acetylcysteine
5735675|NCT00374088|Myocardial dysfunction|myocardial dysfunction
5735676|NCT00374088|Transposition of the Great Arteries|transposition of the great arteries
5735677|NCT00374075|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5735678|NCT00374075|Valproic Acid|valproic acid
5735679|NCT00374062|Mohs Surgery|mohs surgery
5735680|NCT00374049|Prostate|prostate
5735681|NCT00374049|vaccine|vaccine
5735682|NCT00374049|immunosuppression|immunosuppression
5735683|NCT00374049|dendritic cells|dendritic cells
5735684|NCT00374036|chemotherapy|chemotherapy
5735685|NCT00374036|stomach cancer metastatic|stomach cancer metastatic
5735686|NCT00374036|Capecitabine|capecitabine
5735687|NCT00374036|Irinotecan|irinotecan
5735688|NCT00374023|Zinc|zinc
5735689|NCT00374023|vitamin A|vitamin a
5735690|NCT00374023|immunity|immunity
5735691|NCT00374023|morbidity|morbidity
5735692|NCT00374023|height gain|height gain
5735693|NCT00374023|weight gain|weight gain
5735694|NCT00374023|Children aged between 1 and 3 years|children aged between 1 and 3 years
5735695|NCT00374023|Weight for age between 70% and 61% of NCHS standard|weight for age between 70% and 61% of nchs standard
5735696|NCT00374023|Acute diarrhoeal Patients|acute diarrhoeal patients
5735697|NCT00374023|No signs of vitamin A deficiency|no signs of vitamin a deficiency
5735698|NCT00374023|Who has not received measles vaccine|who has not received measles vaccine
5735699|NCT00374010|end-of-life decision making|end-of-life decision making
5735700|NCT00374010|advance care planning|advance care planning
5735701|NCT00373984|shoulder|shoulder
5735702|NCT00373984|thoracotomy|thoracotomy
5735703|NCT00373971|Activities of daily living|activities of daily living
5735704|NCT00373971|Elderly|elderly
5735705|NCT00373971|Nutrition|nutrition
5735706|NCT00373971|Postoperative|postoperative
5735707|NCT00373971|Hip fractures|hip fractures
5735708|NCT00373971|Hip replacement|hip replacement
5735709|NCT00373971|Knee replacement|knee replacement
5735710|NCT00373945|HLA-B*5701|hla-b*5701
5735711|NCT00373945|pharmacogenetic marker|pharmacogenetic marker
5735712|NCT00373945|hypersensitivity to abacavir,|hypersensitivity to abacavir,
5735713|NCT00373945|retrospective analysis|retrospective analysis
5735714|NCT00373932|Exercise|exercise
5735715|NCT00373932|Physical Activity|physical activity
5735716|NCT00373932|Adherence|adherence
5735717|NCT00373906|MALT Lymphoma, Bortezomib|malt lymphoma, bortezomib
5735718|NCT00373893|Pain|pain
5735719|NCT00373893|Hyperalgesia|hyperalgesia
5735720|NCT00373893|capsaicin|capsaicin
5735721|NCT00373880|Aripiprazole|aripiprazole
5735722|NCT00373880|Cocaine abuse|cocaine abuse
5735723|NCT00373867|Secondary prevention|secondary prevention
5735724|NCT00373867|Physical therapy|physical therapy
5735725|NCT00373867|Fear-avoidance beliefs|fear-avoidance beliefs
5735726|NCT00373867|Disability|disability
5735727|NCT00373854|Hypoglycemia|hypoglycemia
5735728|NCT00373854|Endothelial function|endothelial function
5735729|NCT00373841|Lung|lung
5735730|NCT00373841|Fibrosis|fibrosis
5735731|NCT00373841|Idiopathic|idiopathic
5735732|NCT00373841|Biomarkers|biomarkers
5735733|NCT00373841|Genomics|genomics
5735734|NCT00373841|Longitudinal|longitudinal
5735735|NCT00373828|Chest Pain|chest pain
5735736|NCT00373828|Chest Wall|chest wall
5735737|NCT00373828|Angina Pectoris|angina pectoris
5735738|NCT00373828|Atypical Chest Pain|atypical chest pain
5735739|NCT00373828|Physical Examination|physical examination
5735740|NCT00373828|Myocardial Perfusion Imaging|myocardial perfusion imaging
5735741|NCT00373828|Observational Study|observational study
5735742|NCT00373828|Non-Cardiac Chest Pain|non-cardiac chest pain
5735743|NCT00373828|Ischemic Heart Disease|ischemic heart disease
5735744|NCT00373815|acute GVHD|acute gvhd
5735745|NCT00373815|Immunosuppression|immunosuppression
5735746|NCT00373789|Botulinum Toxin A|botulinum toxin a
5735747|NCT00373789|Urinary Incontinence|urinary incontinence
5735748|NCT00373789|Detrusor Overactivity|detrusor overactivity
5735749|NCT00373776|mucosal|mucosal
5735750|NCT00373776|leishmaniasis|leishmaniasis
5735751|NCT00373776|miltefosine|miltefosine
5736306|NCT00371904|rejection|rejection
5735752|NCT00373763|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5735753|NCT00373763|tracheal occlusion|tracheal occlusion
5735754|NCT00373763|fetus|fetus
5735755|NCT00373763|fetal surgery|fetal surgery
5735756|NCT00373763|fetoscopy|fetoscopy
5735757|NCT00373750|Native American health|native american health
5735758|NCT00373750|Teen pregnancy|teen pregnancy
5735759|NCT00373750|Family strengthening|family strengthening
5735760|NCT00373750|Substance abuse prevention|substance abuse prevention
5735761|NCT00373750|Injury prevention|injury prevention
5735762|NCT00373724|sacroiliac joint|sacroiliac joint
5735763|NCT00373724|low back pain|low back pain
5735764|NCT00373724|radiofrequency|radiofrequency
5735765|NCT00373698|Stress Disorders, Posttraumatic|stress disorders, posttraumatic
5735766|NCT00373698|Delivery of Health Care, Integrated|delivery of health care, integrated
5735767|NCT00373698|Primary Health Care|primary health care
5735768|NCT00373698|Veterans|veterans
5735769|NCT00373698|Depression|depression
5735770|NCT00373685|GI events in patients with moderate GI risk treated with NSAIDS|gi events in patients with moderate gi risk treated with nsaids
5735771|NCT00373672|schizophrenia|schizophrenia
5735772|NCT00373672|cognition|cognition
5735773|NCT00373659|Neovascularization|neovascularization
5735774|NCT00373659|Age-related macular degeneration|age-related macular degeneration
5735775|NCT00373659|Ranibizumab (Lucentis)|ranibizumab (lucentis)
5735776|NCT00373659|Optical coherence tomography|optical coherence tomography
5735777|NCT00373659|Intravitreal injection|intravitreal injection
5735778|NCT00373646|MALT Lymphoma|malt lymphoma
5735779|NCT00373646|thalidomide|thalidomide
5735780|NCT00373646|disseminated MALT Lymphoma or at relapse following HP-eradication|disseminated malt lymphoma or at relapse following hp-eradication
5735781|NCT00373646|or chemotherapy or radiation|or chemotherapy or radiation
5735782|NCT00373633|THoracic Surgery|thoracic surgery
5735783|NCT00373633|thoracic epidural|thoracic epidural
5735784|NCT00373633|epidural|epidural
5735785|NCT00373633|thoracotomy|thoracotomy
5735786|NCT00373633|intercostal nerve block|intercostal nerve block
5735787|NCT00373633|intercostal|intercostal
5735788|NCT00373633|nerve block|nerve block
5735789|NCT00373620|endometrial cancer|endometrial cancer
5735790|NCT00373620|high risk|high risk
5735791|NCT00373620|weekly paclitaxel|weekly paclitaxel
5735792|NCT00373620|Cuncurrent chemoradiation|cuncurrent chemoradiation
5735793|NCT00373607|Non complicated malaria|non complicated malaria
5735794|NCT00373607|Microscopy|microscopy
5735796|NCT00373607|Children|children
5735797|NCT00373594|Cold agglutinin disease|cold agglutinin disease
5735798|NCT00373594|Hemolytic|hemolytic
5735799|NCT00373594|Anemia|anemia
5735800|NCT00373594|Lymphoproliferative disease|lymphoproliferative disease
5735801|NCT00373594|Monoclonal antibodies|monoclonal antibodies
5735802|NCT00373594|Rituximab|rituximab
5735803|NCT00373594|Fludarabine|fludarabine
5735804|NCT00373581|Vigabatrin|vigabatrin
5735805|NCT00373581|GABA levels|gaba levels
5735806|NCT00373581|Smoked cocaine|smoked cocaine
5735807|NCT00373568|mucosal|mucosal
5735808|NCT00373568|miltefosine|miltefosine
5735809|NCT00373555|Sarcoidosis|sarcoidosis
5735810|NCT00373555|mediastinal adenopathy|mediastinal adenopathy
5735811|NCT00373555|bronchoscopy|bronchoscopy
5735812|NCT00373555|Transbronchial needle aspiration|transbronchial needle aspiration
5735813|NCT00373555|endobronchial ultrasonography|endobronchial ultrasonography
5735814|NCT00373542|Restless Legs Syndrome|restless legs syndrome
5735815|NCT00373542|ropinirole|ropinirole
5735816|NCT00373542|polysomnography|polysomnography
5735818|NCT00373542|PSG|psg
5735819|NCT00373529|Acute myelogenous leukemia|acute myelogenous leukemia
5735820|NCT00373529|Acute myeloid leukemia|acute myeloid leukemia
5735821|NCT00373529|newly Diagnosed AML|newly diagnosed aml
5735822|NCT00373529|Clofarabine|clofarabine
5735823|NCT00373529|CLASSIC II|classic ii
5735824|NCT00373529|CLO243|clo243
5735825|NCT00373516|psoriasis|psoriasis
5735826|NCT00373516|topical therapy|topical therapy
5735827|NCT00373503|Lofexidine|lofexidine
5735828|NCT00373503|Oral THC|oral thc
5735829|NCT00373503|Cannabinoids|cannabinoids
5735830|NCT00373477|Depression|depression
5735831|NCT00373477|Primary Care|primary care
5735832|NCT00373477|Care Manager|care manager
5735833|NCT00373464|Postoperative pain|postoperative pain
5735834|NCT00373464|Opioid|opioid
5735835|NCT00373464|Etoricoxib|etoricoxib
5735836|NCT00373464|Ketorolac|ketorolac
5735837|NCT00373464|Laparoscopic Surgery|laparoscopic surgery
5735838|NCT00373464|Surgical Procedures, Gynecologic|surgical procedures, gynecologic
5735839|NCT00373451|NSTEMI|nstemi
5735840|NCT00373438|Congenital diaphragmatic hernia|congenital diaphragmatic hernia
5735841|NCT00373438|tracheal occlusion|tracheal occlusion
5735842|NCT00373438|fetus|fetus
5735843|NCT00373438|fetal surgery|fetal surgery
5735844|NCT00373438|fetoscopy|fetoscopy
5680940|NCT00575536|spasticity|spasticity
5734871|NCT00376870|STENT|stent
5735845|NCT00373438|ECMO|ecmo
5735846|NCT00373425|Adjuvant Non-small Cell Lung Cancer|adjuvant non-small cell lung cancer
5735847|NCT00373425|Tarceva|tarceva
5735848|NCT00373425|Early-stage Lung Cancer|early-stage lung cancer
5735849|NCT00373425|Adjuvant|adjuvant
5735850|NCT00373425|RADIANT|radiant
5735851|NCT00373425|NSCLC|nsclc
5735852|NCT00373425|EGFR-positive tumor|egfr-positive tumor
5735853|NCT00373425|Stage IB Non-small Cell Lung Cancer|stage ib non-small cell lung cancer
5735854|NCT00373425|Stage II Non-small Cell Lung Cancer|stage ii non-small cell lung cancer
5735855|NCT00373425|Stage IIIA Non-small Cell Lung Cancer|stage iiia non-small cell lung cancer
5735857|NCT00373412|vaccine|vaccine
5735860|NCT00373399|Cannabinoids|cannabinoids
5735861|NCT00373399|Risk taking|risk taking
5735862|NCT00373399|Decision making|decision making
5735864|NCT00373386|endothelial function|endothelial function
5735865|NCT00373373|Sorafenib|sorafenib
5735866|NCT00373373|Acute Myeloid Leukemia|acute myeloid leukemia
5735867|NCT00373373|Flt3|flt3
5735868|NCT00373373|AML|aml
5680944|NCT00575523|percutaneous ethanol instillation|percutaneous ethanol instillation
5680946|NCT00575523|bradycardia|bradycardia
5680947|NCT00575523|arrhythmia|arrhythmia
5680948|NCT00575510|unified theory of behavior|unified theory of behavior
5680949|NCT00575510|Pap test|pap test
5680950|NCT00575510|cervical dysplasia|cervical dysplasia
5680951|NCT00575510|women's health|women's health
5745881|NCT00336505|Pulmonary|pulmonary
5735869|NCT00373373|Kinase Inhibitor|kinase inhibitor
5735870|NCT00373360|pulmonary hypertension|pulmonary hypertension
5735871|NCT00373360|PAH|pah
5735872|NCT00373360|Remodulin|remodulin
5735873|NCT00373360|treprostinil|treprostinil
5735874|NCT00373360|Quality of Life|quality of life
5735875|NCT00373360|Rapid Switch|rapid switch
5735876|NCT00373334|gastroesophageal reflux disease|gastroesophageal reflux disease
5735877|NCT00373334|GERD|gerd
5735878|NCT00373334|heartburn|heartburn
5735879|NCT00373308|Quality of Life|quality of life
5735880|NCT00373295|Baclofen|baclofen
5735881|NCT00373295|Marijuana Dependence|marijuana dependence
5735882|NCT00373295|Marijuana Withdrawal|marijuana withdrawal
5735883|NCT00373282|PVR|pvr
5735884|NCT00373282|Retinal detachment|retinal detachment
5735885|NCT00373282|Silicone oil|silicone oil
5735886|NCT00373282|Triamcinolone|triamcinolone
5735887|NCT00373269|Acute ischemic stroke|acute ischemic stroke
5735888|NCT00373269|Stroke|stroke
5735889|NCT00373269|Hyperglycemia|hyperglycemia
5735890|NCT00373269|Procoagulation|procoagulation
5735891|NCT00373269|Diabetes|diabetes
5735892|NCT00373269|Blood coagulation|blood coagulation
5735893|NCT00373256|Breast cancer|breast cancer
5735894|NCT00373256|advanced|advanced
5735895|NCT00373256|sunitinib|sunitinib
5735896|NCT00373256|bevacizumab|bevacizumab
5735897|NCT00373256|paclitaxel|paclitaxel
5735898|NCT00373256|Phase 3|phase 3
5735899|NCT00373243|hepatic impairment pharmacokinetics|hepatic impairment pharmacokinetics
5735900|NCT00373230|weight loss|weight loss
5735901|NCT00373230|telemedicine|telemedicine
5735902|NCT00373230|african-american|african-american
5735903|NCT00373230|rural|rural
5735904|NCT00373217|fallopian tube cancer|fallopian tube cancer
5735905|NCT00373217|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5735906|NCT00373217|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5735907|NCT00373217|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5735908|NCT00373204|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5735909|NCT00373204|Non-small cell lung cancer|non-small cell lung cancer
5735910|NCT00373204|Lung cancer|lung cancer
5735911|NCT00373204|Metastatic lung cancer|metastatic lung cancer
5735912|NCT00373204|Second line treatment for advanced lung cancer|second line treatment for advanced lung cancer
5735913|NCT00373204|Cancer|cancer
5735914|NCT00373204|Advanced lung cancer|advanced lung cancer
5735915|NCT00373191|stage I breast cancer|stage i breast cancer
5735916|NCT00373191|stage II breast cancer|stage ii breast cancer
5735917|NCT00373191|stage IIIA breast cancer|stage iiia breast cancer
5735918|NCT00373191|stage IIIB breast cancer|stage iiib breast cancer
5735919|NCT00373191|stage IIIC breast cancer|stage iiic breast cancer
5735920|NCT00373191|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5735921|NCT00373178|rosiglitazone|rosiglitazone
5735922|NCT00373178|metformin|metformin
5735923|NCT00373165|Renal Transplantation|renal transplantation
5735924|NCT00373165|CMV|cmv
5735925|NCT00373165|Ganciclovir|ganciclovir
5735926|NCT00373165|Prophylaxis|prophylaxis
5735927|NCT00373165|Preemptive Therapy|preemptive therapy
5735928|NCT00373165|Graft Survival|graft survival
5735929|NCT00373165|Proteomics|proteomics
5735930|NCT00373152|stage I breast cancer|stage i breast cancer
5735931|NCT00373152|stage II breast cancer|stage ii breast cancer
5735932|NCT00373152|stage IIIA breast cancer|stage iiia breast cancer
5735933|NCT00373152|stage IIIC breast cancer|stage iiic breast cancer
5735934|NCT00373152|stage IV breast cancer|stage iv breast cancer
5735936|NCT00373139|Screening,|screening,
5735937|NCT00373139|Whole Blood|whole blood
5734902|NCT00376779|Double-blind|double-blind
5735938|NCT00373126|nicotine|nicotine
5735939|NCT00373126|schizophrenia|schizophrenia
5735940|NCT00373126|reward|reward
5735941|NCT00373126|withdrawal|withdrawal
5735942|NCT00373113|advanced breast cancer|advanced breast cancer
5735943|NCT00373113|metastatic breast cancer|metastatic breast cancer
5735944|NCT00373113|treatment resistant|treatment resistant
5735945|NCT00373113|treatment failure|treatment failure
5735946|NCT00373100|Zinc|zinc
5735947|NCT00373100|placebo|placebo
5735948|NCT00373100|severe pneumonia|severe pneumonia
5735949|NCT00373100|children|children
5735950|NCT00373087|Parkinson's disease|parkinson's disease
5735951|NCT00373087|Catechol O-methyltransferase|catechol o-methyltransferase
5735954|NCT00373074|Spinal Puncture Headache|spinal puncture headache
5735955|NCT00373048|HIV-1 malaria Clinical Trial|hiv-1 malaria clinical trial
5735956|NCT00373035|prostate cancer|prostate cancer
5735957|NCT00373022|depression|depression
5735958|NCT00373022|anxiety disorder|anxiety disorder
5735959|NCT00373022|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5735960|NCT00373022|stage II colon cancer|stage ii colon cancer
5735961|NCT00373022|stage III colon cancer|stage iii colon cancer
5735962|NCT00373022|stage II rectal cancer|stage ii rectal cancer
5735963|NCT00373022|stage III rectal cancer|stage iii rectal cancer
5735964|NCT00373009|Low back pain|low back pain
5735965|NCT00373009|Primary prevention|primary prevention
5735966|NCT00373009|Secondary prevention|secondary prevention
5735967|NCT00373009|Lumbar stabilization|lumbar stabilization
5735968|NCT00373009|Psychosocial education|psychosocial education
5735969|NCT00372983|chronic HCV|chronic hcv
5735970|NCT00372983|Failed treatment|failed treatment
5735971|NCT00372983|genotype 1|genotype 1
5735972|NCT00372983|failed treatment with pegylated interferon plus ribavirin|failed treatment with pegylated interferon plus ribavirin
5735973|NCT00372970|gastroparesis|gastroparesis
5735974|NCT00372970|vomiting|vomiting
5735976|NCT00372970|bloating|bloating
5735977|NCT00372970|dyspepsia|dyspepsia
5735978|NCT00372957|pharmacodynamics|pharmacodynamics
5735979|NCT00372957|Diabetes|diabetes
5735980|NCT00372957|pharmacokinetics|pharmacokinetics
5735981|NCT00372944|advanced pancreatic cancer|advanced pancreatic cancer
5735982|NCT00372944|metastatic pancreatic cancer|metastatic pancreatic cancer
5735983|NCT00372944|AZD6244|azd6244
5735984|NCT00372905|follicular lymphoma|follicular lymphoma
5735985|NCT00372892|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5735986|NCT00372892|Rituximab|rituximab
5735987|NCT00372892|Feasibility study|feasibility study
5735988|NCT00372879|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5735989|NCT00372879|vitamin E|vitamin e
5735990|NCT00372879|muscle cramp|muscle cramp
5735991|NCT00372840|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5735992|NCT00372840|stage I breast cancer|stage i breast cancer
5735993|NCT00372840|stage II breast cancer|stage ii breast cancer
5735994|NCT00372840|stage IIIA breast cancer|stage iiia breast cancer
5735995|NCT00372840|stage IIIA colon cancer|stage iiia colon cancer
5735996|NCT00372840|stage I prostate cancer|stage i prostate cancer
5735997|NCT00372840|stage IIB prostate cancer|stage iib prostate cancer
5735998|NCT00372840|stage IIA prostate cancer|stage iia prostate cancer
5735999|NCT00372840|stage III prostate cancer|stage iii prostate cancer
5736000|NCT00372840|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5736001|NCT00372840|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5736002|NCT00372840|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5736003|NCT00372840|limited stage small cell lung cancer|limited stage small cell lung cancer
5736004|NCT00372840|stage I rectal cancer|stage i rectal cancer
5736005|NCT00372840|stage IIA rectal cancer|stage iia rectal cancer
5736006|NCT00372840|stage IIB rectal cancer|stage iib rectal cancer
5736007|NCT00372840|stage IIC rectal cancer|stage iic rectal cancer
5736008|NCT00372840|stage IIIA rectal cancer|stage iiia rectal cancer
5736009|NCT00372840|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5736010|NCT00372840|stage I thymoma|stage i thymoma
5736011|NCT00372840|stage II thymoma|stage ii thymoma
5736012|NCT00372840|stage III thymoma|stage iii thymoma
5736013|NCT00372840|stage I colon cancer|stage i colon cancer
5736014|NCT00372840|stage IIA colon cancer|stage iia colon cancer
5736015|NCT00372840|stage IIB colon cancer|stage iib colon cancer
5736016|NCT00372840|stage IIC colon cancer|stage iic colon cancer
5736017|NCT00372840|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5736018|NCT00372840|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5736019|NCT00372840|stage II malignant mesothelioma|stage ii malignant mesothelioma
5736020|NCT00372840|stage III malignant mesothelioma|stage iii malignant mesothelioma
5736021|NCT00372814|diabetes|diabetes
5736022|NCT00372814|regimen adherence|regimen adherence
5736023|NCT00372814|metabolic control|metabolic control
5736024|NCT00372814|adolescents|adolescents
5736025|NCT00372814|family therapy|family therapy
5736026|NCT00372801|Osteoarthritis|osteoarthritis
5736027|NCT00372801|Ibuprofen|ibuprofen
5736028|NCT00372801|COX2|cox2
5736029|NCT00372801|VAS|vas
5680941|NCT00575536|rhizotomy|rhizotomy
5734998|NCT00376506|Stroke|stroke
5736030|NCT00372801|knee|knee
5736031|NCT00372801|single dose|single dose
5736032|NCT00372788|NSCLC|nsclc
5736033|NCT00372788|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5736034|NCT00372788|AZD6244|azd6244
5736035|NCT00372775|brain metastases|brain metastases
5736036|NCT00372775|Sunitinib|sunitinib
5736037|NCT00372775|Phase 2|phase 2
5736038|NCT00372762|Insulin resistance|insulin resistance
5736039|NCT00372762|heart failure|heart failure
5736040|NCT00372762|diuretic therapy|diuretic therapy
5736041|NCT00372749|Alcohol dependence|alcohol dependence
5736042|NCT00372749|Craving|craving
5736044|NCT00372749|Cue exposure|cue exposure
5736045|NCT00372736|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5736047|NCT00372723|ten|ten
5736048|NCT00372710|Breast cancer|breast cancer
5736049|NCT00372710|Palliation|palliation
5736050|NCT00372710|Bone metastasis|bone metastasis
5736051|NCT00372710|Zoledronic acid|zoledronic acid
5736052|NCT00372697|acromegaly|acromegaly
5736053|NCT00372697|octreotide acetate|octreotide acetate
5736054|NCT00372697|partial responder patients|partial responder patients
5726209|NCT00409916|ICG|icg
5736056|NCT00372684|Malaria|malaria
5736057|NCT00372684|Imported malaria|imported malaria
5736058|NCT00372684|Severe malaria|severe malaria
5736059|NCT00372684|Uncomplicated malaria|uncomplicated malaria
5736060|NCT00372684|Intensive Care Units|intensive care units
5736061|NCT00372684|Polymorphism, Genetic|polymorphism, genetic
5736062|NCT00372684|Parasitic Sensitivity Tests|parasitic sensitivity tests
5736063|NCT00372684|Inflammation Mediators|inflammation mediators
5736064|NCT00372671|Cardiac Rehabilitation|cardiac rehabilitation
5736065|NCT00372671|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
5736066|NCT00372658|hysterosalpingogram|hysterosalpingogram
5736067|NCT00372658|intracervical local anesthesia|intracervical local anesthesia
5736068|NCT00372658|pain perception|pain perception
5736069|NCT00372658|visual analogue scale|visual analogue scale
5736070|NCT00372645|Healthy|healthy
5736071|NCT00372632|Pregnancy malaria prevention|pregnancy malaria prevention
5736072|NCT00372619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5736073|NCT00372619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5736074|NCT00372619|acute undifferentiated leukemia|acute undifferentiated leukemia
5736075|NCT00372619|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5736076|NCT00372619|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5736077|NCT00372619|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5736078|NCT00372619|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5736079|NCT00372619|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5736080|NCT00372619|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5736081|NCT00372619|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5736082|NCT00372619|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5736083|NCT00372619|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5736084|NCT00372619|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5736085|NCT00372619|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5736086|NCT00372619|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5736087|NCT00372619|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5736088|NCT00372619|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5736089|NCT00372619|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5736090|NCT00372619|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5736091|NCT00372619|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5736092|NCT00372619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5736093|NCT00372619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5736094|NCT00372606|Obesity|obesity
5736095|NCT00372606|Overweight|overweight
5736096|NCT00372606|Hispanics|hispanics
5736097|NCT00372606|Online|online
5736098|NCT00372606|Weight Loss|weight loss
5736099|NCT00372593|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5736100|NCT00372593|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5736101|NCT00372593|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5736102|NCT00372593|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5736103|NCT00372593|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5736104|NCT00372593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5736105|NCT00372593|adult acute basophilic leukemia|adult acute basophilic leukemia
5736106|NCT00372593|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5736107|NCT00372593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5736108|NCT00372593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5736109|NCT00372593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5736110|NCT00372593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5736111|NCT00372593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5736112|NCT00372593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5736113|NCT00372593|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5736114|NCT00372593|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5731156|NCT00390091|Nephritis|nephritis
5736115|NCT00372593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5736116|NCT00372593|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5736117|NCT00372593|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5736118|NCT00372593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5736119|NCT00372593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5736120|NCT00372593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5736121|NCT00372593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5736122|NCT00372593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5736123|NCT00372593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5736124|NCT00372593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5736125|NCT00372593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5736126|NCT00372541|ceftriaxone|ceftriaxone
5736127|NCT00372541|chloramphenicol|chloramphenicol
5736128|NCT00372541|severe pneumonia|severe pneumonia
5736129|NCT00372541|children|children
5736130|NCT00372515|epidermal growth factor|epidermal growth factor
5736131|NCT00372515|EGFR|egfr
5736132|NCT00372515|lung cancer|lung cancer
5736133|NCT00372515|Iressa|iressa
5736134|NCT00372515|Gefitinib|gefitinib
5736135|NCT00372502|sepsis|sepsis
5736136|NCT00372502|shock|shock
5736137|NCT00372502|emergency department|emergency department
5736138|NCT00372502|resuscitation|resuscitation
5736139|NCT00372489|anemia|anemia
5736140|NCT00372489|chronic kidney disease|chronic kidney disease
5736141|NCT00372489|CKD|ckd
5736142|NCT00372489|chronic renal failure|chronic renal failure
5736143|NCT00372489|CRF|crf
5736144|NCT00372489|dialysis|dialysis
5736145|NCT00372489|erythropoietin|erythropoietin
5736146|NCT00372489|EPO|epo
5736147|NCT00372489|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5736148|NCT00372489|ESA|esa
5736149|NCT00372489|Hematide™|hematide™
5736150|NCT00372489|hemodialysis|hemodialysis
5736151|NCT00372489|hemoglobin|hemoglobin
5736152|NCT00372489|Hb|hb
5736153|NCT00372489|Hgb|hgb
5736154|NCT00372489|Omontys|omontys
5736155|NCT00372489|peginesatide|peginesatide
5736156|NCT00372489|red blood cell|red blood cell
5736157|NCT00372489|red blood cell production|red blood cell production
5736158|NCT00372476|Breast cancer|breast cancer
5736159|NCT00372476|Tyrosine inhibitor|tyrosine inhibitor
5736160|NCT00372476|Chemotherapy|chemotherapy
5736161|NCT00372476|Imatinib|imatinib
5736162|NCT00372463|diabetes|diabetes
5736163|NCT00372463|type 2 diabetes|type 2 diabetes
5736164|NCT00372463|type II diabetes|type ii diabetes
5736165|NCT00372463|diabetes mellitus|diabetes mellitus
5736166|NCT00372463|diabetes type 2|diabetes type 2
5736167|NCT00372463|diabetes type II|diabetes type ii
5736168|NCT00372463|diabetes education|diabetes education
5736169|NCT00372463|patient education|patient education
5736170|NCT00372463|workshop|workshop
5736171|NCT00372463|class|class
5736172|NCT00372463|education|education
5736173|NCT00372463|online|online
5736174|NCT00372463|on-line|on-line
5736175|NCT00372463|internet|internet
5736176|NCT00372463|web|web
5736177|NCT00372450|recurrent esophageal cancer|recurrent esophageal cancer
5736178|NCT00372450|stage III esophageal cancer|stage iii esophageal cancer
5736179|NCT00372450|stage IV esophageal cancer|stage iv esophageal cancer
5736180|NCT00372450|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5736181|NCT00372450|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5736182|NCT00372450|gastrointestinal complications|gastrointestinal complications
5736183|NCT00372437|Refractory solid tumors|refractory solid tumors
5736184|NCT00372437|Phase I/II|phase i/ii
5736185|NCT00372437|Refractory and solid tumors|refractory and solid tumors
5736186|NCT00372424|Breast cancer over-expressing HER2. First-line treatment with sunitinib/docetaxel/trastuzumab.|breast cancer over-expressing her2. first-line treatment with sunitinib/docetaxel/trastuzumab.
5736187|NCT00372411|Stroke|stroke
5736188|NCT00372411|Rehabilitation|rehabilitation
5736189|NCT00372411|Single-blind|single-blind
5736190|NCT00372411|Clinical Trial|clinical trial
5736191|NCT00372411|Randomized controlled trial|randomized controlled trial
5736192|NCT00372411|Upper extremity|upper extremity
5686206|NCT00553059|unspecified adult solid tumor|unspecified adult solid tumor
5686207|NCT00553059|Palonosetron|palonosetron
5736193|NCT00372411|Robotics|robotics
5753729|NCT00305838|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5753730|NCT00305838|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5753731|NCT00305838|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5753732|NCT00305838|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5753777|NCT00305643|pain|pain
5736194|NCT00372398|scleroderma|scleroderma
5736195|NCT00372398|sclerosis|sclerosis
5736196|NCT00372398|atherosclerosis|atherosclerosis
5736197|NCT00372372|corticosteroids, bone mineral, risedronate, bisphosphonate|corticosteroids, bone mineral, risedronate, bisphosphonate
5736198|NCT00372359|Attention Deficit Disorder|attention deficit disorder
5736199|NCT00372359|Hyperactivity|hyperactivity
5736200|NCT00372359|Methylphenidate|methylphenidate
5736201|NCT00372333|musculoskeletal pain; soft tissue inflammation; IDEA-033|musculoskeletal pain; soft tissue inflammation; idea-033
5736202|NCT00372320|Adenovirus|adenovirus
5736203|NCT00372320|Aquaporin-1|aquaporin-1
5736204|NCT00372320|Gene Transfer|gene transfer
5736205|NCT00372320|Radiation-Induced Salivary Hypofunction|radiation-induced salivary hypofunction
5736206|NCT00372320|Salivary Gland|salivary gland
5736207|NCT00372320|Xerostomia|xerostomia
5736208|NCT00372320|Salivary Dysfunction|salivary dysfunction
5736209|NCT00372320|Hyposalivation|hyposalivation
5736211|NCT00372320|head and neck cancer|head and neck cancer
5736212|NCT00372320|side effects radiation damage|side effects radiation damage
5736213|NCT00372294|Toxoplasmosis|toxoplasmosis
5736214|NCT00372294|Chorioretinitis|chorioretinitis
5736215|NCT00372294|Intravitreal Clindamycin|intravitreal clindamycin
5736216|NCT00372294|Dexamethasone in chorioretinitis|dexamethasone in chorioretinitis
5736217|NCT00372294|Toxoplasmic|toxoplasmic
5736218|NCT00372281|MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE|mri, cliavist, macrophage, infection, spine
5736219|NCT00372268|Comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.|comparison of four conditionings of the insufflated gas during laparoscopy and their consequences on the core temperature and the post-operative pain.
5736220|NCT00372268|Women with womb pathology needing laparoscopic surgery|women with womb pathology needing laparoscopic surgery
5736221|NCT00372268|No emergency|no emergency
5736222|NCT00372268|Aged over 18 years|aged over 18 years
5736223|NCT00372242|Mal-nutrition|mal-nutrition
5736224|NCT00372242|Morbidity|morbidity
5736225|NCT00372242|Nutrition Education|nutrition education
5736226|NCT00372242|Complementary Feeding|complementary feeding
5736227|NCT00372242|Weight gain|weight gain
5736228|NCT00372242|Height|height
5736229|NCT00372216|myocardial infarction|myocardial infarction
5736230|NCT00372216|Clopidogrel|clopidogrel
5736231|NCT00372216|primary PCI|primary pci
5736232|NCT00372216|TIMI-flow|timi-flow
5736233|NCT00372216|STEMI within 6 hrs.|stemi within 6 hrs.
5736234|NCT00372203|Non-small cell lung cancer|non-small cell lung cancer
5736235|NCT00372203|NSCLC|nsclc
5736236|NCT00372203|EBUS|ebus
5736237|NCT00372203|Endobronchial ultrasound|endobronchial ultrasound
5736238|NCT00372203|mediastinoscopy|mediastinoscopy
5736239|NCT00372190|Pelvic organ prolapse|pelvic organ prolapse
5736240|NCT00372190|recurrence|recurrence
5736241|NCT00372190|mesh|mesh
5736242|NCT00372190|complications|complications
5736244|NCT00372177|monoclonal antibody|monoclonal antibody
5736245|NCT00372177|diagnostics|diagnostics
5736247|NCT00372177|Immunoglobulins|immunoglobulins
5736248|NCT00372177|molecular target|molecular target
5736249|NCT00372177|Tc99m-pertechnetate|tc99m-pertechnetate
5736250|NCT00372177|Fab-fragment of Anti-human CD4|fab-fragment of anti-human cd4
5736251|NCT00372177|Radiopharmaceutical|radiopharmaceutical
5736252|NCT00372177|chronic inflammatory diseases|chronic inflammatory diseases
5736253|NCT00372177|active Rheumatoid Arthritis|active rheumatoid arthritis
5736254|NCT00372164|ASIPP|asipp
5736255|NCT00372164|Guidelines|guidelines
5736256|NCT00372151|Schizophrenia|schizophrenia
5736257|NCT00372151|Schizoaffective disorders|schizoaffective disorders
5736258|NCT00372151|Theonine|theonine
5736259|NCT00372151|Augmentation|augmentation
5736260|NCT00372138|Abdominal aortic aneurysms|abdominal aortic aneurysms
5736261|NCT00372138|Endoleaks|endoleaks
5736262|NCT00372138|Prevention|prevention
5736263|NCT00372125|Prader-Willi syndrome|prader-willi syndrome
5736264|NCT00372125|Growth hormone|growth hormone
5736265|NCT00372125|Body composition|body composition
5736266|NCT00372112|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5736267|NCT00372112|COPD|copd
5736268|NCT00372099|Postmenopausal women|postmenopausal women
5736269|NCT00372099|bone microarchitecture|bone microarchitecture
5736270|NCT00372099|peripheral quantitative micro-CT|peripheral quantitative micro-ct
5736271|NCT00372099|salmon calcitonin|salmon calcitonin
5736272|NCT00372034|contact lenses|contact lenses
5736273|NCT00372034|intolerance|intolerance
5736274|NCT00372034|punctal plugs|punctal plugs
5736275|NCT00372034|tear volume|tear volume
5735281|NCT00375492|diabetes|diabetes
5736276|NCT00372034|Intolerance to contact lens wear due to dryness symptoms|intolerance to contact lens wear due to dryness symptoms
5736277|NCT00372021|non arthritic ischemic optic neuropathy|non arthritic ischemic optic neuropathy
5736278|NCT00372021|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy
5736279|NCT00372021|Optic nerve Neurotomy|optic nerve neurotomy
5736280|NCT00371995|Visceral leishmaniasis|visceral leishmaniasis
5736281|NCT00371995|kala-azar|kala-azar
5736282|NCT00371995|miltefosine|miltefosine
5736283|NCT00371995|AmBisome|ambisome
5736284|NCT00371982|Fish oil|fish oil
5736285|NCT00371982|Type 2 diabetic women|type 2 diabetic women
5736286|NCT00371982|adiposity|adiposity
5736287|NCT00371982|adipose tissue inflammation|adipose tissue inflammation
5736288|NCT00371982|PAI-1|pai-1
5736289|NCT00371982|Insulin sensitivity|insulin sensitivity
5736290|NCT00371969|Unsafe drinking|unsafe drinking
5736291|NCT00371969|Human Immunodeficiency Virus|human immunodeficiency virus
5736292|NCT00371969|Motivational Interviewing|motivational interviewing
5736293|NCT00371956|raloxifene|raloxifene
5736294|NCT00371956|estrogen|estrogen
5736295|NCT00371956|receptor|receptor
5736296|NCT00371956|modulation|modulation
5736297|NCT00371956|osteoporosis|osteoporosis
5736298|NCT00371956|steroid|steroid
5736299|NCT00371956|Steroids|steroids
5736300|NCT00371943|variceal bleeding,band ligation, beta-blocker|variceal bleeding,band ligation, beta-blocker
5736301|NCT00371943|had history of esophageal variceal bleeding|had history of esophageal variceal bleeding
5736302|NCT00371904|Rituximab|rituximab
5736303|NCT00371904|donor|donor
5736304|NCT00371904|sensitised|sensitised
5736305|NCT00371904|antibody|antibody
5736309|NCT00371878|Bronchoalveolar lavage|bronchoalveolar lavage
5736310|NCT00371878|Lymphocyte|lymphocyte
5736311|NCT00371878|Immunoglobulin|immunoglobulin
5736313|NCT00371878|Streptococcus pneumoniae|streptococcus pneumoniae
5736314|NCT00371878|Conjugate vaccine|conjugate vaccine
5736315|NCT00371865|Behavior therapy|behavior therapy
5736316|NCT00371865|Chronic pain|chronic pain
5736317|NCT00371865|Cognitive therapy|cognitive therapy
5736318|NCT00371865|Meditation|meditation
5736319|NCT00371865|Mindfulness|mindfulness
5736320|NCT00371865|Psychotherapy|psychotherapy
5736321|NCT00371839|Hearing Loss|hearing loss
5736322|NCT00371839|Hearing Aids|hearing aids
5736323|NCT00371839|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5736324|NCT00371826|Renal transplantation|renal transplantation
5736325|NCT00371826|everolimus|everolimus
5736326|NCT00371826|Immunosuppressants|immunosuppressants
5736327|NCT00371800|Cinnamon|cinnamon
5736328|NCT00371800|Type 1 Diabetes|type 1 diabetes
5736329|NCT00371800|Adolescent|adolescent
5736330|NCT00371800|HbA1c|hba1c
5736331|NCT00371774|Psoriasis|psoriasis
5736332|NCT00371774|Plaque Psoriasis|plaque psoriasis
5736333|NCT00371774|Amevive®|amevive®
5736334|NCT00371774|alefacept|alefacept
5736335|NCT00371761|Hepatitis B virus|hepatitis b virus
5736336|NCT00371761|Pegylated interferon alfa-2b (PegIntron)|pegylated interferon alfa-2b (pegintron)
5736337|NCT00371735|Malaria CDA LAPDAP Africa|malaria cda lapdap africa
5736338|NCT00371722|Cesarean section|cesarean section
5736339|NCT00371722|Appendectomy|appendectomy
5736340|NCT00371683|Prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery|prevention of deep vein thrombosis and pulmonary embolism after total knee replacement surgery
5736341|NCT00371670|Knee, osteoarthritis, pain, disease modifying|knee, osteoarthritis, pain, disease modifying
5736342|NCT00371657|obesity|obesity
5736343|NCT00371657|small for gestation age|small for gestation age
5736344|NCT00371657|intrauterine growth restriction|intrauterine growth restriction
5736345|NCT00371644|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5736346|NCT00371644|Cognitive Processing Therapy|cognitive processing therapy
5736347|NCT00371644|Military sexual trauma|military sexual trauma
5736348|NCT00371644|Psychology, Military|psychology, military
5736349|NCT00371644|Veterans|veterans
5736350|NCT00371644|Rape|rape
5736351|NCT00371644|Veterans, psychology|veterans, psychology
5736352|NCT00371644|Healthcare utilization|healthcare utilization
5736353|NCT00371631|biofilm|biofilm
5736354|NCT00371631|clinical trial|clinical trial
5736355|NCT00371631|Escherichia coli|escherichia coli
5736356|NCT00371631|urinary catheter|urinary catheter
5736357|NCT00371618|Fluoroscopy|fluoroscopy
5736358|NCT00371618|Interventional Pain Management Procedures|interventional pain management procedures
5736359|NCT00371605|Voriconazole|voriconazole
5736360|NCT00371605|Liver Transplant|liver transplant
5736361|NCT00371605|Fungal Infection|fungal infection
5736362|NCT00371592|Treatment Naive|treatment naive
5736363|NCT00371579|rosuvastatin|rosuvastatin
5736364|NCT00371579|hepatitis C|hepatitis c
5736365|NCT00371579|geranylgeranylation|geranylgeranylation
5736366|NCT00371579|HCV-RNA load|hcv-rna load
5736367|NCT00371566|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5736368|NCT00371566|lapatinib|lapatinib
5736369|NCT00371566|ErbB1/ErbB2 inhibitor|erbb1/erbb2 inhibitor
5736370|NCT00371566|apoptosis|apoptosis
5736371|NCT00371553|relapsed or cisplatin-refractory germ cell cancer|relapsed or cisplatin-refractory germ cell cancer
5761739|NCT00277290|Cancer|cancer
5736372|NCT00371553|germ cell cancer|germ cell cancer
5736373|NCT00371553|SU011248 (Sunitinib)|su011248 (sunitinib)
5736374|NCT00371540|Africa|africa
5736375|NCT00371540|Antiretrovirals|antiretrovirals
5736376|NCT00371527|Bronchitis|bronchitis
5736377|NCT00371527|Acute bronchitis|acute bronchitis
5736378|NCT00371527|Ipratropium|ipratropium
5736379|NCT00371527|Cough|cough
5736380|NCT00371527|Metered dose inhaler|metered dose inhaler
5736381|NCT00371527|Antibiotic prescriptions|antibiotic prescriptions
5736382|NCT00371527|Sputum production|sputum production
5736383|NCT00371501|lupus|lupus
5736384|NCT00371501|atherosclerosis|atherosclerosis
5736385|NCT00371501|thrombosis|thrombosis
5736386|NCT00371501|statin|statin
5736387|NCT00371501|lipid|lipid
5736388|NCT00371488|ErbB2|erbb2
5736389|NCT00371488|Stage IV breast cancer|stage iv breast cancer
5736390|NCT00371488|ErbB1|erbb1
5736391|NCT00371488|breast cancer|breast cancer
5736392|NCT00371488|lapatinib|lapatinib
5736394|NCT00371488|trastuzumab|trastuzumab
5736395|NCT00371462|intervention study|intervention study
5736396|NCT00371462|technology|technology
5731436|NCT00388921|ALRI|alri
5736397|NCT00371462|weight loss|weight loss
5736398|NCT00371449|hearing loss|hearing loss
5736399|NCT00371449|hearing aids|hearing aids
5736400|NCT00371436|Counseling|counseling
5736401|NCT00371436|Education|education
5736402|NCT00371436|Evaluation studies|evaluation studies
5736403|NCT00371436|Quality of health care|quality of health care
5736404|NCT00371436|Rehabilitation of hearing impaired|rehabilitation of hearing impaired
5736406|NCT00371410|Vitrectomy|vitrectomy
5736407|NCT00371410|Intravitreal triamcinolone acetonide|intravitreal triamcinolone acetonide
5736408|NCT00371410|Macular focal laser photocoagulation|macular focal laser photocoagulation
5736409|NCT00371410|Best-corrected visual acuity|best-corrected visual acuity
5736410|NCT00371410|Central macular thickness|central macular thickness
5736411|NCT00371397|yoga|yoga
5736412|NCT00371397|immune function|immune function
5736413|NCT00371397|stress|stress
5736414|NCT00371397|health|health
5736415|NCT00371397|mood|mood
5736416|NCT00371397|skin barrier repair|skin barrier repair
5736417|NCT00371384|massage|massage
5736418|NCT00371384|back pain|back pain
5736419|NCT00371384|effectiveness|effectiveness
5736420|NCT00371371|clinical trial|clinical trial
5736421|NCT00371371|chronic critical limb ischemia|chronic critical limb ischemia
5736422|NCT00371371|leg pain|leg pain
5736423|NCT00371371|cell therapy|cell therapy
5736424|NCT00371371|bone marrow|bone marrow
5736425|NCT00371371|mononuclear|mononuclear
5736426|NCT00371371|progenitor cell|progenitor cell
5736427|NCT00371371|stem cell|stem cell
5736428|NCT00371371|critical limb ischemia|critical limb ischemia
5736429|NCT00371371|nonhealing leg ulcer|nonhealing leg ulcer
5736430|NCT00371345|Recurrent, locally-advanced, or metastatic breast cancer|recurrent, locally-advanced, or metastatic breast cancer
5736431|NCT00371332|chronic periodontitis, mouth|chronic periodontitis, mouth
5736432|NCT00371332|Moderate to advanced chronic periodontitis|moderate to advanced chronic periodontitis
5736433|NCT00371319|lupus|lupus
5736434|NCT00371319|nephritis|nephritis
5736435|NCT00371319|tacrolimus|tacrolimus
5736436|NCT00371319|mycophenolate mofetil|mycophenolate mofetil
5736437|NCT00371306|Diabetes|diabetes
5736438|NCT00371306|Pregnancy|pregnancy
5736439|NCT00371293|Sleep Apnea|sleep apnea
5736440|NCT00371293|C-Reactive Protein|c-reactive protein
5736441|NCT00371293|Obesity|obesity
5736442|NCT00371293|Insulin Resistance|insulin resistance
5736443|NCT00371293|Arterial stiffness|arterial stiffness
5736444|NCT00371280|hydroxyapatite|hydroxyapatite
5736445|NCT00371280|peg|peg
5736446|NCT00371280|prosthetic motility|prosthetic motility
5736447|NCT00371280|orbital implant|orbital implant
5736448|NCT00371267|cognitive behavioral therapy|cognitive behavioral therapy
5736449|NCT00371267|pain|pain
5736450|NCT00371254|Recurrent, locally-advanced, or 'triple negative' metastatic breast cancer|recurrent, locally-advanced, or 'triple negative' metastatic breast cancer
5736451|NCT00371241|ECMO|ecmo
5736452|NCT00371241|extracorporeal membrane oxygenation|extracorporeal membrane oxygenation
5736453|NCT00371241|cytokines|cytokines
5736454|NCT00371241|chemokines|chemokines
5736455|NCT00371228|cord clamping|cord clamping
5736456|NCT00371228|hematocrit|hematocrit
5736457|NCT00371228|hemoglobin|hemoglobin
5736458|NCT00371228|timing|timing
5736459|NCT00371215|hemostasis|hemostasis
5736460|NCT00371215|grafting, skin|grafting, skin
5736461|NCT00371215|hemostatics|hemostatics
5736462|NCT00371215|phase 2|phase 2
5736463|NCT00371202|keratoconus, penetrating keratoplasty,|keratoconus, penetrating keratoplasty,
5736464|NCT00371202|deep lamellar keratoplasty|deep lamellar keratoplasty
5736465|NCT00371202|big bubble technique|big bubble technique
5736466|NCT00371189|circumsporozoite, malaria, vaccine|circumsporozoite, malaria, vaccine
5736467|NCT00371176|Cognitive Behavior Therapy|cognitive behavior therapy
5736468|NCT00371176|Cognitive enhancers|cognitive enhancers
5736469|NCT00371176|Combat Disorders|combat disorders
5736470|NCT00371176|D-Cycloserine|d-cycloserine
5736471|NCT00371176|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5686208|NCT00553059|Dexamethasone|dexamethasone
5686209|NCT00553046|ethics|ethics
5736472|NCT00371163|Identification of genes by microarray analyses.|identification of genes by microarray analyses.
5736473|NCT00371137|FMS|fms
5736474|NCT00371137|Fibro|fibro
5736475|NCT00371137|pain|pain
5736476|NCT00371137|Body pain|body pain
5736477|NCT00371137|tenderness|tenderness
5736478|NCT00371137|joint pain|joint pain
5736479|NCT00371137|stiffness|stiffness
5736480|NCT00371137|muscular pain|muscular pain
5736481|NCT00371124|Myopia treatment|myopia treatment
5736482|NCT00371124|Atropine|atropine
5736483|NCT00371111|Resistant uveitic cystoid macular edema|resistant uveitic cystoid macular edema
5736484|NCT00371111|intravitreal triamcinolone|intravitreal triamcinolone
5736485|NCT00371111|intravitreal bevacizumab|intravitreal bevacizumab
5736486|NCT00371098|influenza vaccination|influenza vaccination
5736487|NCT00371098|coronary artery disease|coronary artery disease
5736488|NCT00371098|prevention|prevention
5736489|NCT00371098|acute coronary syndromes|acute coronary syndromes
5736490|NCT00371085|heart failure|heart failure
5736491|NCT00371085|quality improvement|quality improvement
5736492|NCT00371085|patient education|patient education
5736493|NCT00371085|health care economics|health care economics
5736494|NCT00371072|Aphakic Glaucoma|aphakic glaucoma
5736495|NCT00371072|trabeculectomy with mitomycin- C|trabeculectomy with mitomycin- c
5736496|NCT00371072|Ahmed glaucoma implant|ahmed glaucoma implant
5736497|NCT00371059|Agitation|agitation
5736498|NCT00371059|Dementia|dementia
5736499|NCT00371059|Alzheimer's|alzheimer's
5736500|NCT00371046|preterm labor|preterm labor
5736501|NCT00371046|transvaginal ultrasound cervical length|transvaginal ultrasound cervical length
5736502|NCT00371046|fetal fibronectin|fetal fibronectin
5736503|NCT00371046|preterm birth|preterm birth
5736504|NCT00371020|silicone oil|silicone oil
5736506|NCT00371020|retinal redetachment|retinal redetachment
5736507|NCT00371020|low molecular weight heparin|low molecular weight heparin
5736508|NCT00371020|5-FU|5-fu
5736509|NCT00370994|post-lumbar surgery syndrome|post-lumbar surgery syndrome
5736510|NCT00370994|percutaneous lumbar epidural adhesiolysis|percutaneous lumbar epidural adhesiolysis
5736511|NCT00370994|hypertonic saline neurolysis|hypertonic saline neurolysis
5736512|NCT00370981|investigational drug|investigational drug
5736513|NCT00370981|ejaculation|ejaculation
5736514|NCT00370968|Children|children
5736515|NCT00370968|India|india
5736516|NCT00370968|Hospital|hospital
5736517|NCT00370968|Zinc|zinc
5736518|NCT00370968|Malnutrition|malnutrition
5736519|NCT00370968|Treatment|treatment
5736520|NCT00370955|Phacoemulsification|phacoemulsification
5736521|NCT00370955|Corneal endothelial cell loss|corneal endothelial cell loss
5736522|NCT00370955|Hydrodynamic parameters|hydrodynamic parameters
5736523|NCT00370955|Total ultrasound energy|total ultrasound energy
5736524|NCT00370955|Total infused fluids|total infused fluids
5736525|NCT00370942|GW823093C|gw823093c
5736526|NCT00370942|diabetes|diabetes
5736527|NCT00370942|type 2 diabetes mellitus|type 2 diabetes mellitus
5736528|NCT00370942|DPP-IV inhibitor|dpp-iv inhibitor
5736529|NCT00370916|Clinical Decision Support Systems|clinical decision support systems
5736530|NCT00370916|Continuity of Patient Care|continuity of patient care
5736531|NCT00370916|Medication Errors|medication errors
5736532|NCT00370916|Drug Adverse Effects|drug adverse effects
5736533|NCT00370903|cesarean|cesarean
5736534|NCT00370903|planned|planned
5736535|NCT00370903|emergent|emergent
5736536|NCT00370903|postpartum depression|postpartum depression
5736537|NCT00370890|nasopharyngeal cancer|nasopharyngeal cancer
5736538|NCT00370890|adjuvant chemotherapy|adjuvant chemotherapy
5736539|NCT00370890|EBV DNA|ebv dna
5736540|NCT00370890|PET CT scan|pet ct scan
5736541|NCT00370877|Post-partum hemorrhage|post-partum hemorrhage
5736542|NCT00370877|Arterial embolization|arterial embolization
5736543|NCT00370877|Surgery|surgery
5736544|NCT00370877|Hysterectomy|hysterectomy
5736545|NCT00370877|Activated recombinant human factor VII|activated recombinant human factor vii
5736546|NCT00370864|Pandemic|pandemic
5736547|NCT00370864|Influenza|influenza
5736548|NCT00370864|Prevention|prevention
5736549|NCT00370864|Vaccine|vaccine
5736550|NCT00370864|Prevention of Pandemic Influenza|prevention of pandemic influenza
5736551|NCT00370851|intravitreal Avastin|intravitreal avastin
5736552|NCT00370851|BRVO|brvo
5736553|NCT00370851|Macular edema|macular edema
5736554|NCT00370838|Tics|tics
5736555|NCT00370838|Tourette syndrome|tourette syndrome
5736556|NCT00370838|levetiracetam|levetiracetam
5736557|NCT00370838|clonidine|clonidine
5736558|NCT00370825|Visceral leishmaniasis|visceral leishmaniasis
5736559|NCT00370825|miltefosine|miltefosine
5736560|NCT00370825|AmBisome|ambisome
5736561|NCT00370825|Combination|combination
5736562|NCT00370812|amniotic membrane transplantation|amniotic membrane transplantation
5736563|NCT00370812|ocular chemical burns|ocular chemical burns
5736564|NCT00370799|Caudal Epidural injections|caudal epidural injections
5736565|NCT00370799|lumbar disc herniation|lumbar disc herniation
5736566|NCT00370799|spinal stenosis|spinal stenosis
5686210|NCT00553046|COPD|copd
5736567|NCT00370799|discogenic pain|discogenic pain
5736568|NCT00370799|post-lumbar laminectomy syndrome|post-lumbar laminectomy syndrome
5736569|NCT00370786|Choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5736571|NCT00370786|Non AMD|non amd
5736572|NCT00370786|High myopia|high myopia
5736573|NCT00370786|angioid streaks|angioid streaks
5736574|NCT00370786|Ocular histoplasmosis|ocular histoplasmosis
5736575|NCT00370786|Idiopathic|idiopathic
5736576|NCT00370773|Failed Back Surgery Syndrome|failed back surgery syndrome
5736577|NCT00370773|Back Pain|back pain
5736578|NCT00370773|Chronic Pain|chronic pain
5736579|NCT00370773|Spinal Cord Stimulation|spinal cord stimulation
5736581|NCT00370760|Oral colchicine|oral colchicine
5736582|NCT00370760|Dexamethasone|dexamethasone
5736583|NCT00370760|low molecular weight heparin|low molecular weight heparin
5736584|NCT00370760|5-FU|5-fu
5736585|NCT00370734|botulinum toxin|botulinum toxin
5736586|NCT00370734|thyroid eye disease|thyroid eye disease
5736587|NCT00370734|lid retraction|lid retraction
5736588|NCT00370721|Proliferative diabetic retinopathy(PDR)|proliferative diabetic retinopathy(pdr)
5736589|NCT00370721|Pan retinal photocoagulation (PRP)|pan retinal photocoagulation (prp)
5736590|NCT00370721|Vitreous hemorrhage|vitreous hemorrhage
5736591|NCT00370721|Traction retinal detachment|traction retinal detachment
5736592|NCT00370721|Neovascularization on disc (NVD)|neovascularization on disc (nvd)
5736593|NCT00370721|Neovascularization elsewhere (NVE)|neovascularization elsewhere (nve)
5736594|NCT00370721|Fibrous proliferation on disc (FPD)|fibrous proliferation on disc (fpd)
5736595|NCT00370721|Fibrous proliferaiton elsewhere (FPE)|fibrous proliferaiton elsewhere (fpe)
5736596|NCT00370708|Cesarean|cesarean
5736598|NCT00370708|Intake|intake
5736599|NCT00370695|Chronic back pain|chronic back pain
5736600|NCT00370695|Intractable neuropathic back pain|intractable neuropathic back pain
5736601|NCT00370695|Lumbar radiculopathy|lumbar radiculopathy
5736602|NCT00370695|Spinal cord stimulation|spinal cord stimulation
5736603|NCT00370669|Bevacizumab|bevacizumab
5736605|NCT00370669|MPC|mpc
5736606|NCT00370669|Triamcinolone acetonide|triamcinolone acetonide
5736607|NCT00370656|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5736608|NCT00370643|hyperglycaemia|hyperglycaemia
5736609|NCT00370643|open heart surgery|open heart surgery
5736610|NCT00370643|intensive care unit|intensive care unit
5736611|NCT00370630|CRVO|crvo
5736612|NCT00370630|Intravitreal Avastin|intravitreal avastin
5736613|NCT00370630|Intravitreal triamcinolone|intravitreal triamcinolone
5736614|NCT00370617|chronic hepatitis C|chronic hepatitis c
5736615|NCT00370617|insulin resistance|insulin resistance
5736616|NCT00370617|therapy|therapy
5736617|NCT00370604|Parturient|parturient
5736618|NCT00370604|Obstetrics|obstetrics
5736619|NCT00370604|Pregnancy|pregnancy
5736620|NCT00370604|Labour|labour
5736621|NCT00370604|Labor|labor
5736622|NCT00370604|Headache|headache
5736623|NCT00370604|Epidural|epidural
5736624|NCT00370604|Analgesia|analgesia
5736625|NCT00370604|Anesthesia|anesthesia
5736626|NCT00370604|Anaesthesia|anaesthesia
5736627|NCT00370591|Inhaled corticosteroids|inhaled corticosteroids
5736628|NCT00370591|Asthma|asthma
5736629|NCT00370578|STEMI, THROMBUS, ASPIRATION DEVICE, NO REFLOW|stemi, thrombus, aspiration device, no reflow
5736630|NCT00370539|Photodynamic therapy,|photodynamic therapy,
5736631|NCT00370539|Bevacizumab,|bevacizumab,
5736632|NCT00370539|Triamcinolone,|triamcinolone,
5736633|NCT00370539|Age-related macular degeneration,|age-related macular degeneration,
5736634|NCT00370539|Choroidal neovascular membrane|choroidal neovascular membrane
5736635|NCT00370526|heart failure|heart failure
5736636|NCT00370526|resynchronization|resynchronization
5736637|NCT00370526|CRT|crt
5736638|NCT00370526|Bi-V pacemaker|bi-v pacemaker
5736639|NCT00370526|LV lead placement|lv lead placement
5736640|NCT00370526|hemodynamic assessment|hemodynamic assessment
5736641|NCT00370526|CRT Outcomes|crt outcomes
5736642|NCT00370513|pazopanib|pazopanib
5736643|NCT00370513|liver cancer|liver cancer
5736644|NCT00370513|hepatocellular cancer|hepatocellular cancer
5736645|NCT00370500|Schizophrenia|schizophrenia
5736646|NCT00370500|Dopamine transporter gene|dopamine transporter gene
5736647|NCT00370500|DNA methylation|dna methylation
5736648|NCT00370500|Epigenetics|epigenetics
5736649|NCT00370487|Abortion|abortion
5736650|NCT00370487|Midlevel providers|midlevel providers
5736651|NCT00370487|South Africa|south africa
5736652|NCT00370487|Viet Nam|viet nam
5736653|NCT00370474|Bi-V lead|bi-v lead
5736654|NCT00370474|Magnetic Navigation|magnetic navigation
5736655|NCT00370474|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5736656|NCT00370461|Basic Cardiac Life Support|basic cardiac life support
5736657|NCT00370461|Termination of Resuscitation|termination of resuscitation
5736658|NCT00370461|Emergency Medical Services|emergency medical services
5736659|NCT00370461|Primary Care Paramedics|primary care paramedics
5736660|NCT00370461|Out of Hospital Cardiac Arrest|out of hospital cardiac arrest
5736661|NCT00370435|rheumatoid arthritis|rheumatoid arthritis
5736662|NCT00370435|safety|safety
5736663|NCT00370435|GW274150|gw274150
5736664|NCT00370435|pharmacokinetics|pharmacokinetics
5736665|NCT00370435|tolerability|tolerability
5686211|NCT00553046|end of life|end of life
5736666|NCT00370422|Cystoid macular edema|cystoid macular edema
5736667|NCT00370422|Diabetic macular edema|diabetic macular edema
5736668|NCT00370422|Hard exudates|hard exudates
5736669|NCT00370422|Intravitreal bevacizumab|intravitreal bevacizumab
5736670|NCT00370422|Intravitreal triamcinolone|intravitreal triamcinolone
5736671|NCT00370422|Macular thickness|macular thickness
5736672|NCT00370409|Rebleeding|rebleeding
5736673|NCT00370409|Diabetic vitreous hemorrhage|diabetic vitreous hemorrhage
5736674|NCT00370409|Cryotherapy|cryotherapy
5736675|NCT00370396|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
5736676|NCT00370383|Non Small Cell Lung Cancer|non small cell lung cancer
5736677|NCT00370383|PATIENTS ≥ 70 YEARS WITH UNRESECTABLE STAGE 3 OR 4 NSCLC|patients ≥ 70 years with unresectable stage 3 or 4 nsclc
5736678|NCT00370370|Bevacizumab,|bevacizumab,
5736679|NCT00370370|Triamcinolone|triamcinolone
5736680|NCT00370370|Age-related macular degeneration|age-related macular degeneration
5736681|NCT00370370|Choroidal neovascular membrane|choroidal neovascular membrane
5736682|NCT00370357|Microbicide|microbicide
5736684|NCT00370357|VivaGel|vivagel
5736685|NCT00370344|Gallbladder diseases|gallbladder diseases
5736686|NCT00370344|gallstones|gallstones
5736687|NCT00370344|cholecystectomy|cholecystectomy
5680952|NCT00575497|Hemodialysis|hemodialysis
5680953|NCT00575497|Adequacy|adequacy
5680954|NCT00575497|Frequency|frequency
5680956|NCT00575484|Renal Insufficiency|renal insufficiency
5680957|NCT00575484|Hypertonic Saline Solution|hypertonic saline solution
5680958|NCT00575484|Diuretic Resistance|diuretic resistance
5680959|NCT00575484|Cardiorenal Syndrome|cardiorenal syndrome
5736688|NCT00370344|minilaparotomy|minilaparotomy
5736689|NCT00370344|laparoscopy|laparoscopy
5736691|NCT00370331|idiopathic|idiopathic
5736692|NCT00370331|platelets|platelets
5736693|NCT00370331|purpura|purpura
5736694|NCT00370331|thrombocytopenia|thrombocytopenia
5736695|NCT00370331|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5736696|NCT00370331|thrombocytopenic|thrombocytopenic
5736697|NCT00370318|Pneumococcal Disease|pneumococcal disease
5736698|NCT00370305|11ß-hydroxysteroid dehydrogenase|11ß-hydroxysteroid dehydrogenase
5736699|NCT00370305|rosiglitazone|rosiglitazone
5736700|NCT00370305|insulin sensitivity|insulin sensitivity
5736701|NCT00370305|Impaired glucose tolerance|impaired glucose tolerance
5736702|NCT00370279|Pseudophakic retinal detachment,|pseudophakic retinal detachment,
5736970|NCT00369395|antibody|antibody
5736703|NCT00370279|Aphakic retinal detachment,|aphakic retinal detachment,
5736704|NCT00370279|Scleral buckling,|scleral buckling,
5736705|NCT00370279|Primary vitrectomy,|primary vitrectomy,
5736706|NCT00370279|Proliferative vitreoretinopathy|proliferative vitreoretinopathy
5736707|NCT00370266|Macular edema|macular edema
5736708|NCT00370266|Branch retinal vein occlusion|branch retinal vein occlusion
5736709|NCT00370266|Intravitreal triamcinolone|intravitreal triamcinolone
5736710|NCT00370266|Macular thickness|macular thickness
5736711|NCT00370266|Retinal neovascularization|retinal neovascularization
5736712|NCT00370253|hepatorenal syndrome|hepatorenal syndrome
5736713|NCT00370253|ascites|ascites
5736714|NCT00370253|portal hypertension|portal hypertension
5736715|NCT00370253|cirrhosis|cirrhosis
5736716|NCT00370240|Female|female
5736717|NCT00370240|Anesthetics,local|anesthetics,local
5736718|NCT00370227|Streptococcus pneumonia, pneumococcal conjugate vaccine|streptococcus pneumonia, pneumococcal conjugate vaccine
5736719|NCT00370214|Pulmonary arterial hypertension|pulmonary arterial hypertension
5736720|NCT00370214|Lung diseases|lung diseases
5736721|NCT00370214|Heart diseases|heart diseases
5736722|NCT00370214|Pulmonary circulation|pulmonary circulation
5736723|NCT00370214|Vascular resistance|vascular resistance
5736724|NCT00370214|PAH|pah
5736725|NCT00370214|Hypertension|hypertension
5736726|NCT00370201|retinal detachment|retinal detachment
5736727|NCT00370201|proliferative vitreoretinopathy|proliferative vitreoretinopathy
5736728|NCT00370188|problem gambling|problem gambling
5736729|NCT00370188|topiramate|topiramate
5736730|NCT00370123|endometriosis|endometriosis
5736731|NCT00370123|apoptosis|apoptosis
5736732|NCT00370123|regulatory T cells|regulatory t cells
5736733|NCT00370097|Asthma infants FLOVENT spacer|asthma infants flovent spacer
5736734|NCT00370071|MS|ms
5736735|NCT00370058|ect|ect
5736736|NCT00370058|depression|depression
5736737|NCT00370058|homocysteine|homocysteine
5736738|NCT00370058|mthfr genotype|mthfr genotype
5736739|NCT00370032|mucosal blood flow d-IBS|mucosal blood flow d-ibs
5736740|NCT00370019|Premature Ovarian Failure|premature ovarian failure
5736741|NCT00370019|Ovulation|ovulation
5736742|NCT00370019|Fertility|fertility
5736743|NCT00370019|Estrogen Replacement|estrogen replacement
5736744|NCT00370019|Follicle Function|follicle function
5736745|NCT00370019|Premature Menopause|premature menopause
5736746|NCT00370019|POF|pof
5736747|NCT00370006|cytomegalovirus|cytomegalovirus
5736748|NCT00370006|vaccine|vaccine
5736749|NCT00370006|T cell|t cell
5736750|NCT00370006|antibodies|antibodies
5736751|NCT00369993|asthma|asthma
5736752|NCT00369993|spacer|spacer
5736753|NCT00369967|Contraception|contraception
5736754|NCT00369967|Adolescents|adolescents
5675751|NCT00597870|TAA|taa
5745796|NCT00336843|Zevalin|zevalin
5736755|NCT00369967|Contraceptive vaginal ring|contraceptive vaginal ring
5736756|NCT00369967|Quick start|quick start
5736757|NCT00369954|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5736758|NCT00369954|fallopian tube cancer|fallopian tube cancer
5736759|NCT00369954|peritoneal cavity cancer|peritoneal cavity cancer
5736760|NCT00369915|Cholinergic|cholinergic
5736761|NCT00369915|Unipolar|unipolar
5736762|NCT00369915|Bipolar|bipolar
5736763|NCT00369915|Depression|depression
5736764|NCT00369915|Muscarinic|muscarinic
5736765|NCT00369915|Scopolamine|scopolamine
5736766|NCT00369915|Major Depressive Disorder|major depressive disorder
5736767|NCT00369915|MDD|mdd
5736768|NCT00369915|Bipolar Disorder|bipolar disorder
5736769|NCT00369915|BP|bp
5736770|NCT00369902|pain|pain
5746862|NCT00332176|HCV|hcv
5736771|NCT00369902|acupuncture|acupuncture
5736772|NCT00369889|Thymoma|thymoma
5736773|NCT00369889|Thymic Cancer|thymic cancer
5736774|NCT00369876|Burns|burns
5736775|NCT00369876|Anorexia|anorexia
5736776|NCT00369876|Neuropeptide|neuropeptide
5736777|NCT00369876|Leptin|leptin
5736778|NCT00369876|Adiponectin|adiponectin
5736779|NCT00369876|Gherlin|gherlin
5736780|NCT00369863|Cystoid macular edema|cystoid macular edema
5736781|NCT00369863|Diabetic macular edema|diabetic macular edema
5736782|NCT00369863|Hard exudates|hard exudates
5736783|NCT00369863|Intravitreal triamcinolone|intravitreal triamcinolone
5736785|NCT00369850|osteoporosis|osteoporosis
5736786|NCT00369850|stage I breast cancer|stage i breast cancer
5736787|NCT00369850|stage II breast cancer|stage ii breast cancer
5736788|NCT00369850|stage IIIA breast cancer|stage iiia breast cancer
5736789|NCT00369824|HPV|hpv
5736790|NCT00369824|HPV, diptheria, pertussis, tetanus, meningitis|hpv, diptheria, pertussis, tetanus, meningitis
5736791|NCT00369811|Cholecystectomy, postoperative|cholecystectomy, postoperative
5736792|NCT00369798|Unipolar Depression|unipolar depression
5736793|NCT00369798|Phosphorylation|phosphorylation
5736794|NCT00369798|Affinity States|affinity states
5736795|NCT00369798|Compartment Analysis|compartment analysis
5736796|NCT00369798|(R)-(11)C Rolipram|(r)-(11)c rolipram
5736797|NCT00369798|Depression|depression
5736798|NCT00369798|Major Depressive Disorder|major depressive disorder
5736801|NCT00369798|HV|hv
5736802|NCT00369785|cognitive/functional effects|cognitive/functional effects
5736803|NCT00369785|fatigue|fatigue
5736971|NCT00369395|angiogenesis|angiogenesis
5736804|NCT00369785|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5736805|NCT00369785|radiation toxicity|radiation toxicity
5736806|NCT00369785|tumors metastatic to brain|tumors metastatic to brain
5736807|NCT00369785|adult brain stem glioma|adult brain stem glioma
5736808|NCT00369785|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5736809|NCT00369785|adult choroid plexus tumor|adult choroid plexus tumor
5736810|NCT00369785|adult craniopharyngioma|adult craniopharyngioma
5736811|NCT00369785|adult mixed glioma|adult mixed glioma
5736812|NCT00369785|adult anaplastic meningioma|adult anaplastic meningioma
5736813|NCT00369785|meningeal melanocytoma|meningeal melanocytoma
5736814|NCT00369785|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5736815|NCT00369785|adult grade I meningioma|adult grade i meningioma
5736816|NCT00369785|adult grade II meningioma|adult grade ii meningioma
5736817|NCT00369785|adult grade III meningioma|adult grade iii meningioma
5736818|NCT00369785|adult papillary meningioma|adult papillary meningioma
5736819|NCT00369785|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5736820|NCT00369785|adult oligodendroglioma|adult oligodendroglioma
5736821|NCT00369785|adult pineoblastoma|adult pineoblastoma
5736822|NCT00369785|adult pineocytoma|adult pineocytoma
5736823|NCT00369785|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5736824|NCT00369785|adult diffuse astrocytoma|adult diffuse astrocytoma
5736825|NCT00369785|adult glioblastoma|adult glioblastoma
5736826|NCT00369785|adult giant cell glioblastoma|adult giant cell glioblastoma
5736827|NCT00369785|adult gliosarcoma|adult gliosarcoma
5736828|NCT00369785|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5736829|NCT00369785|adult ependymoblastoma|adult ependymoblastoma
5736830|NCT00369785|adult medulloblastoma|adult medulloblastoma
5736831|NCT00369785|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5736832|NCT00369785|adult anaplastic ependymoma|adult anaplastic ependymoma
5736833|NCT00369785|adult ependymoma|adult ependymoma
5736834|NCT00369785|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5736835|NCT00369785|adult subependymoma|adult subependymoma
5736836|NCT00369772|Aranesp|aranesp
5736837|NCT00369772|Anemia|anemia
5736838|NCT00369772|Kidney Disease|kidney disease
5736839|NCT00369772|Hemoglobin|hemoglobin
5736840|NCT00369772|darbepoetin alfa|darbepoetin alfa
5736841|NCT00369772|QoL|qol
5736842|NCT00369759|Acute Lower Respiratory Infection|acute lower respiratory infection
5736843|NCT00369759|Retractions|retractions
5736844|NCT00369759|Bronchiolitis or pneumonia|bronchiolitis or pneumonia
5736845|NCT00369759|Wheezing|wheezing
5736846|NCT00369759|Rales|rales
5736847|NCT00369759|Crackles|crackles
5686213|NCT00553046|CRF home ventilated patients|crf home ventilated patients
5686214|NCT00553033|Patients must be candidable to liver resection|patients must be candidable to liver resection
5686215|NCT00553007|Periodontal disease|periodontal disease
5686216|NCT00553007|Metabolic Syndrome|metabolic syndrome
5686217|NCT00552994|Drug eluting stent|drug eluting stent
5686219|NCT00552994|Intravascular ultrasound|intravascular ultrasound
5680945|NCT00575523|hepatoma|hepatoma
5736848|NCT00369746|Depression|depression
5736849|NCT00369746|Alcohol Abuse|alcohol abuse
5736850|NCT00369746|Alcohol Dependence|alcohol dependence
5736851|NCT00369733|Aranesp|aranesp
5736852|NCT00369733|Anemia|anemia
5736853|NCT00369733|Kidney Disease|kidney disease
5736854|NCT00369733|Hemoglobin|hemoglobin
5736855|NCT00369733|darbepoetin alfa|darbepoetin alfa
5736856|NCT00369733|QoL|qol
5736857|NCT00369720|Prematurity|prematurity
5754337|NCT00303875|recurrent breast cancer|recurrent breast cancer
5754338|NCT00303875|stage I breast cancer|stage i breast cancer
5754339|NCT00303875|stage II breast cancer|stage ii breast cancer
5754340|NCT00303875|stage IIIA breast cancer|stage iiia breast cancer
5736858|NCT00369720|Resuscitation|resuscitation
5736859|NCT00369720|Room Air|room air
5736860|NCT00369707|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5736861|NCT00369694|Esophageal varices|esophageal varices
5736862|NCT00369694|Portal Hypertension|portal hypertension
5736863|NCT00369694|Melena|melena
5736864|NCT00369694|Hematemesis|hematemesis
5736865|NCT00369694|Gastrointestinal Hemorrhage|gastrointestinal hemorrhage
5736866|NCT00369694|Terlipressin|terlipressin
5736867|NCT00369694|Efficacy|efficacy
5736868|NCT00369694|Safety|safety
5736869|NCT00369681|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5736870|NCT00369681|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5736871|NCT00369681|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5736872|NCT00369681|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5736873|NCT00369681|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5736874|NCT00369681|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5736875|NCT00369668|Rehabilitation|rehabilitation
5736876|NCT00369668|Physical Therapy Techniques|physical therapy techniques
5736877|NCT00369668|Occupational Therapy|occupational therapy
5736878|NCT00369668|Upper Extremity; Motor skills|upper extremity; motor skills
5736879|NCT00369642|Cognitive-behavioral therapy|cognitive-behavioral therapy
5736880|NCT00369642|Children|children
5736881|NCT00369642|Obsessive-compulsive disorder|obsessive-compulsive disorder
5736882|NCT00369642|Intensive Cognitive-behavioral therapy|intensive cognitive-behavioral therapy
5736883|NCT00369642|Weekly Cognitive-behavioral therapy|weekly cognitive-behavioral therapy
5736884|NCT00369629|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5736885|NCT00369629|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5736886|NCT00369629|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5737067|NCT00368940|Geriatric Depression|geriatric depression
5736887|NCT00369629|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5736888|NCT00369629|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5736889|NCT00369629|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5736972|NCT00369395|volociximab|volociximab
5736890|NCT00369629|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5736891|NCT00369629|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5736892|NCT00369629|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5736893|NCT00369629|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5736894|NCT00369603|Alzheimer's Disease|alzheimer's disease
5736896|NCT00369603|Functional Neuroimaging|functional neuroimaging
5736897|NCT00369603|Allosteric Nicotinic Receptor Modulation|allosteric nicotinic receptor modulation
5736898|NCT00369603|Acetylcholinesterase Inhibition|acetylcholinesterase inhibition
5736899|NCT00369603|Head to head|head to head
5736900|NCT00369603|Dose escalation|dose escalation
5736901|NCT00369603|Biomarker|biomarker
5736902|NCT00369577|Agitation|agitation
5736903|NCT00369577|Schizophrenia|schizophrenia
5736904|NCT00369564|neurotoxicity|neurotoxicity
5736905|NCT00369564|peripheral neuropathy|peripheral neuropathy
5736906|NCT00369564|stage I Wilms tumor|stage i wilms tumor
5736907|NCT00369564|stage II Wilms tumor|stage ii wilms tumor
5736908|NCT00369564|stage III Wilms tumor|stage iii wilms tumor
5736909|NCT00369564|stage IV Wilms tumor|stage iv wilms tumor
5736910|NCT00369564|stage V Wilms tumor|stage v wilms tumor
5736911|NCT00369564|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5736912|NCT00369564|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5745969|NCT00336102|fatigue|fatigue
5735975|NCT00372970|nausea|nausea
5736913|NCT00369564|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5736914|NCT00369564|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5736915|NCT00369564|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5736916|NCT00369564|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5736917|NCT00369564|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5736918|NCT00369564|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5736919|NCT00369564|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5736920|NCT00369564|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5736921|NCT00369564|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5736922|NCT00369564|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5736923|NCT00369564|childhood Burkitt lymphoma|childhood burkitt lymphoma
5736924|NCT00369564|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5798836|NCT00111072|Topical Steroids|topical steroids
5754445|NCT00303446|SBMA|sbma
5736925|NCT00369564|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5736926|NCT00369564|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5736927|NCT00369564|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5736928|NCT00369564|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5736929|NCT00369538|Podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis|podocyte - podocyturia - microparticles - angiotensin receptor antagonist - glomerulosclerosis
5789088|NCT00149942|Enteric coated mycophenolate sodium|enteric coated mycophenolate sodium
5736930|NCT00369538|Patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension|patients presenting with stable glomerular nephropathy with proteinuria, normal or slightly altered renal function, with hypertension
5736931|NCT00369512|Phase II|phase ii
5736932|NCT00369512|Erlotinib|erlotinib
5736933|NCT00369512|Radiotherapy|radiotherapy
5736934|NCT00369512|Squamous Cell Carcinomas|squamous cell carcinomas
5736935|NCT00369512|Cutaneous|cutaneous
5736936|NCT00369512|Stage III|stage iii
5736937|NCT00369486|diabetic|diabetic
5736939|NCT00369486|edema|edema
5736940|NCT00369486|peribulbar|peribulbar
5736941|NCT00369486|triamcinolone|triamcinolone
5736942|NCT00369486|acetonide|acetonide
5736943|NCT00369486|laser|laser
5736944|NCT00369486|photocoagulation|photocoagulation
5736945|NCT00369486|intraocular|intraocular
5736947|NCT00369473|rheumatoid arthritis|rheumatoid arthritis
5736948|NCT00369460|recurrent pancreatic cancer|recurrent pancreatic cancer
5736949|NCT00369460|stage III pancreatic cancer|stage iii pancreatic cancer
5736950|NCT00369460|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5736951|NCT00369460|stage IV pancreatic cancer|stage iv pancreatic cancer
5736952|NCT00369447|Non small cell lung cancer|non small cell lung cancer
5736953|NCT00369447|NSCLC|nsclc
5736954|NCT00369447|Nimotuzumab|nimotuzumab
5736955|NCT00369447|TheraCIM|theracim
5736956|NCT00369447|h-R3|h-r3
5736957|NCT00369447|YM BioSciences|ym biosciences
5736958|NCT00369447|Radiation|radiation
5736959|NCT00369447|Non small cell lung cancer, Stage IIb, III and IV|non small cell lung cancer, stage iib, iii and iv
5736960|NCT00369421|Biochemical Diseases|biochemical diseases
5736961|NCT00369421|Rare Diseases|rare diseases
5736962|NCT00369421|Family Studies|family studies
5736963|NCT00369421|Screening|screening
5736964|NCT00369421|Next Generation Sequencing|next generation sequencing
5736965|NCT00369408|Randomized Trial|randomized trial
5736966|NCT00369408|Medication for Heavy Drinking|medication for heavy drinking
5736967|NCT00369408|Naltrexone Treatment|naltrexone treatment
5736968|NCT00369408|Daily vs. Targeted Administration|daily vs. targeted administration
5736969|NCT00369395|melanoma|melanoma
5736973|NCT00369382|Heart Transplant|heart transplant
5736974|NCT00369382|Kidney Failure|kidney failure
5736975|NCT00369343|Major Depressive Disorder|major depressive disorder
5736976|NCT00369343|vasomotor symptoms|vasomotor symptoms
5736977|NCT00369343|menopause|menopause
5736978|NCT00369343|diabetic neuropathy|diabetic neuropathy
5736979|NCT00369343|fibromyalgia|fibromyalgia
5736980|NCT00369330|atrial fibrillation|atrial fibrillation
5736981|NCT00369330|early cardioversion|early cardioversion
5736982|NCT00369330|electrical cardioversion|electrical cardioversion
5736983|NCT00369304|Health|health
5736984|NCT00369278|Renal transplantation, mycophenolate|renal transplantation, mycophenolate
5736985|NCT00369265|Gastroesophageal reflux|gastroesophageal reflux
5736986|NCT00369265|Laryngitis|laryngitis
5736987|NCT00369265|Hoarseness|hoarseness
5736988|NCT00369265|Dysphonia|dysphonia
5736989|NCT00369265|Proton pump inhibitor|proton pump inhibitor
5736990|NCT00369252|Nimotuzumab|nimotuzumab
5736991|NCT00369252|TheraCIM|theracim
5736992|NCT00369252|H-R3|h-r3
5736993|NCT00369252|Solid tumours|solid tumours
5736994|NCT00369252|EGFR|egfr
5736995|NCT00369252|Monoclonal antibody|monoclonal antibody
5736996|NCT00369239|Early psychosis|early psychosis
5736043|NCT00372749|Disulfiram|disulfiram
5736997|NCT00369239|premorbid functioning|premorbid functioning
5736998|NCT00369239|Scale for Assessment of Insight|scale for assessment of insight
5736999|NCT00369239|Risperdal Consta|risperdal consta
5737000|NCT00369239|risperidone long acting injectable|risperidone long acting injectable
5737001|NCT00369226|Velcade|velcade
5737002|NCT00369226|Bortezomib|bortezomib
5737003|NCT00369226|Allogeneic Stem Cell Transplant|allogeneic stem cell transplant
5737004|NCT00369226|GVHD|gvhd
5737005|NCT00369213|Crossover trial|crossover trial
5737006|NCT00369213|condom failure|condom failure
5737007|NCT00369213|additional spermicidal lubricant|additional spermicidal lubricant
5737008|NCT00369148|glinides|glinides
5737009|NCT00369148|premixed insulin|premixed insulin
5737010|NCT00369148|combination therapy|combination therapy
5737011|NCT00369148|glycemic control|glycemic control
5737012|NCT00369135|work|work
5737013|NCT00369135|Musculoskeletal Disorders|musculoskeletal disorders
5737014|NCT00369109|recurrent colon cancer|recurrent colon cancer
5737015|NCT00369109|stage III colon cancer|stage iii colon cancer
5737016|NCT00369109|stage IV colon cancer|stage iv colon cancer
5737017|NCT00369109|recurrent rectal cancer|recurrent rectal cancer
5737018|NCT00369109|stage III rectal cancer|stage iii rectal cancer
5737019|NCT00369109|stage IV rectal cancer|stage iv rectal cancer
5737020|NCT00369109|recurrent pancreatic cancer|recurrent pancreatic cancer
5737021|NCT00369109|stage II pancreatic cancer|stage ii pancreatic cancer
5737022|NCT00369109|stage III pancreatic cancer|stage iii pancreatic cancer
5737023|NCT00369109|stage IV pancreatic cancer|stage iv pancreatic cancer
5737024|NCT00369109|recurrent breast cancer|recurrent breast cancer
5737025|NCT00369109|stage IIIA breast cancer|stage iiia breast cancer
5737026|NCT00369109|stage IIIB breast cancer|stage iiib breast cancer
5737027|NCT00369109|stage IIIC breast cancer|stage iiic breast cancer
5737028|NCT00369109|stage IV breast cancer|stage iv breast cancer
5737029|NCT00369096|Peritoneal Dialysis|peritoneal dialysis
5737030|NCT00369096|Bemiparin|bemiparin
5737031|NCT00369096|Icodextrin|icodextrin
5737032|NCT00369096|Peritoneal Transport Disorders|peritoneal transport disorders
5737033|NCT00369083|Frail elderly|frail elderly
5737034|NCT00369083|Hospital at home|hospital at home
5737036|NCT00369070|Bevacizumab|bevacizumab
5737037|NCT00369070|Paclitaxel and Carboplatin|paclitaxel and carboplatin
5737038|NCT00369070|Randomized|randomized
5737039|NCT00369070|Non-Small Cell Lung Cancer|non-small cell lung cancer
5737040|NCT00369057|Intraocular pressure|intraocular pressure
5737041|NCT00369057|Prostatectomy|prostatectomy
5737043|NCT00369057|Glaucoma|glaucoma
5737044|NCT00369057|Carbon dioxide|carbon dioxide
5737045|NCT00369044|decompensated heart failure|decompensated heart failure
5737046|NCT00369044|prednisone|prednisone
5737047|NCT00369044|diuretics|diuretics
5737048|NCT00369044|diuresis|diuresis
5737050|NCT00369031|vaccine|vaccine
5737051|NCT00369031|nasal immunization|nasal immunization
5737052|NCT00369018|photodynamic therapy|photodynamic therapy
5737053|NCT00369018|methyl aminolevulinate|methyl aminolevulinate
5737054|NCT00369018|hexaminolevulinate|hexaminolevulinate
5737055|NCT00369018|dose-finding|dose-finding
5737056|NCT00369018|cervical dysplasia|cervical dysplasia
5737057|NCT00369005|Transfusions|transfusions
5737058|NCT00369005|Erythrocyte|erythrocyte
5737059|NCT00369005|Anemia|anemia
5737060|NCT00369005|Brain|brain
5737061|NCT00369005|Infant, Premature|infant, premature
5737062|NCT00368979|Benign Prostatic Hyperplasia BPH dutasteride|benign prostatic hyperplasia bph dutasteride
5737063|NCT00368966|Pneumococcal|pneumococcal
5737064|NCT00368966|Pediatric|pediatric
5737065|NCT00368966|Vaccine|vaccine
5737066|NCT00368940|Memory Deficits|memory deficits
5737068|NCT00368940|Cognitive Impairment|cognitive impairment
5737069|NCT00368940|Executive Dysfunction|executive dysfunction
5737070|NCT00368940|Disability|disability
5737270|NCT00368121|Cetuximab|cetuximab
5737075|NCT00368901|Kidney Disease|kidney disease
5737076|NCT00368901|Hemoglobin|hemoglobin
5737077|NCT00368901|darbepoetin alfa|darbepoetin alfa
5737078|NCT00368901|QoL|qol
5737079|NCT00368862|Alcoholism|alcoholism
5737080|NCT00368862|Depression|depression
5737081|NCT00368862|Efficacy study|efficacy study
5737082|NCT00368862|Memantine|memantine
5737083|NCT00368862|Escitalopram|escitalopram
5737084|NCT00368849|Huntington Disease|huntington disease
5737085|NCT00368849|Chorea|chorea
5737086|NCT00368849|Attention|attention
5737087|NCT00368849|ADHD|adhd
5737088|NCT00368849|ADD|add
5737089|NCT00368849|Strattera|strattera
5737090|NCT00368849|Atomoxetine|atomoxetine
5737091|NCT00368836|Capnography|capnography
5737092|NCT00368836|Thromboembolism|thromboembolism
5737093|NCT00368836|Arthroplasty|arthroplasty
5737094|NCT00368836|D-dimer|d-dimer
5737095|NCT00368823|point of care|point of care
5737096|NCT00368823|evidence based medicine|evidence based medicine
5737097|NCT00368810|Children|children
5737098|NCT00368810|Cross-Sectional|cross-sectional
5737099|NCT00368810|Glycosylphosphatidylinositol|glycosylphosphatidylinositol
5737100|NCT00368810|Cytokines|cytokines
5737101|NCT00368810|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5737102|NCT00368810|Malaria|malaria
5737103|NCT00368797|Gene Therapy|gene therapy
5737104|NCT00368797|PAOD|paod
5737105|NCT00368797|CLI|cli
5737106|NCT00368771|Irritable Bowel Syndrome|irritable bowel syndrome
5737107|NCT00368771|Abdominal Pain|abdominal pain
5737108|NCT00368771|Abdominal Discomfort|abdominal discomfort
5737109|NCT00368771|Diarrhea|diarrhea
5737110|NCT00368771|Constipation|constipation
5737111|NCT00368771|IBS|ibs
5737112|NCT00368758|Meteorism|meteorism
5737113|NCT00368758|Bloating|bloating
5737114|NCT00368758|Irritable bowel syndrome (IBS)|irritable bowel syndrome (ibs)
5737115|NCT00368758|Probiotics|probiotics
5737116|NCT00368758|Bowel gas|bowel gas
5737117|NCT00368732|Congenital Heart Defects|congenital heart defects
5737118|NCT00368706|solifenacin|solifenacin
5737119|NCT00368706|Overactive bladder|overactive bladder
5737120|NCT00368706|Urinary incontinence|urinary incontinence
5737121|NCT00368706|Treatment outcomes|treatment outcomes
5737122|NCT00368706|VESIcare|vesicare
5737123|NCT00368680|Respiratory Distress Syndrome|respiratory distress syndrome
5737124|NCT00368680|Early Bubble CPAP|early bubble cpap
5737125|NCT00368680|Mechanical Ventilation|mechanical ventilation
5737126|NCT00368680|Surfactant|surfactant
5737127|NCT00368667|Anorexia Nervosa|anorexia nervosa
5737128|NCT00368667|Body Composition|body composition
5737129|NCT00368667|Metabolic Rate|metabolic rate
5737130|NCT00368628|acute ischemic stroke|acute ischemic stroke
5737131|NCT00368628|sleep apnea|sleep apnea
5737132|NCT00368628|continuous positive airway pressure|continuous positive airway pressure
5737133|NCT00368615|melanoma|melanoma
5737134|NCT00368615|malignant melanoma|malignant melanoma
5737135|NCT00368589|atherosclerotic plaque|atherosclerotic plaque
5737136|NCT00368589|USPIO|uspio
5737137|NCT00368589|Atheroma|atheroma
5737138|NCT00368589|thrombo-embolic stroke|thrombo-embolic stroke
5737139|NCT00368589|magnetic resonance imaging|magnetic resonance imaging
5737140|NCT00368589|Ultra small Super-Paramagnetic Iron Oxide|ultra small super-paramagnetic iron oxide
5737141|NCT00368576|SB-480848|sb-480848
5737142|NCT00368576|methacholine challenge|methacholine challenge
5737143|NCT00368576|asthma|asthma
5737144|NCT00368576|inhaled steroid|inhaled steroid
5737145|NCT00368550|Alcohol Drinking|alcohol drinking
5737146|NCT00368550|Alcohol Dependence|alcohol dependence
5737147|NCT00368550|Sertraline Pharmacotherapy|sertraline pharmacotherapy
5737148|NCT00368550|Alcoholism Subtypes|alcoholism subtypes
5737149|NCT00368550|Early- versus Late-Onset Alcoholism|early- versus late-onset alcoholism
5737151|NCT00368537|antibiotics|antibiotics
5737152|NCT00368524|cocaine dependence|cocaine dependence
5737153|NCT00368524|mental disorder|mental disorder
5737154|NCT00368524|dual diagnoses|dual diagnoses
5737155|NCT00368524|homelessness|homelessness
5737156|NCT00368511|Fall Prevention|fall prevention
5737157|NCT00368511|Dynamic Posturography|dynamic posturography
5737158|NCT00368511|Nolwenn Effect|nolwenn effect
5737159|NCT00368511|Music Listening|music listening
5737160|NCT00368498|teicoplanin|teicoplanin
5737161|NCT00368485|diaphragm electrical activity|diaphragm electrical activity
5737162|NCT00368485|non invasive ventilation|non invasive ventilation
5737163|NCT00368485|patient ventilator interaction|patient ventilator interaction
5737164|NCT00368472|Refractory|refractory
5737165|NCT00368472|Partial|partial
5737166|NCT00368472|Seizures|seizures
5737167|NCT00368459|raloxifene, women|raloxifene, women
5737184|NCT00368433|Healthy Volunteer|healthy volunteer
5737186|NCT00368420|ovarian cancer|ovarian cancer
5737187|NCT00368420|recurrence|recurrence
5737188|NCT00368420|surgery|surgery
5737189|NCT00368407|308-nm excimer laser|308-nm excimer laser
5737190|NCT00368407|vitiligo|vitiligo
5737191|NCT00368394|Insulin glulisine|insulin glulisine
5737192|NCT00368394|Euglycaemic clamp|euglycaemic clamp
5737193|NCT00368394|Diabetes mellitus Type 1|diabetes mellitus type 1
5737194|NCT00368381|sepsis|sepsis
5737195|NCT00368381|septicemia|septicemia
5737196|NCT00368381|sepsis syndrome|sepsis syndrome
5737197|NCT00368381|adrenal insufficiency|adrenal insufficiency
5737198|NCT00368381|adrenal cortex hormones|adrenal cortex hormones
5737199|NCT00368381|hydrocortisone|hydrocortisone
5737200|NCT00368381|fludrocortisone|fludrocortisone
5737201|NCT00368355|haploidenticalstem cell transplant|haploidenticalstem cell transplant
5737202|NCT00368355|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5737203|NCT00368355|Non Hodgkins Lymphoma|non hodgkins lymphoma
5737204|NCT00368355|Myelodysplastic Syndrome|myelodysplastic syndrome
5737205|NCT00368355|Acute myeloid leukemia|acute myeloid leukemia
5737206|NCT00368355|Chronic myelogenous leukemia|chronic myelogenous leukemia
5737207|NCT00368355|Hemophagocytic lymphohistiocytosis (HLH)|hemophagocytic lymphohistiocytosis (hlh)
5737208|NCT00368355|Familial hemophagocytic lymphohistiocytosis (FLH)|familial hemophagocytic lymphohistiocytosis (flh)
5737209|NCT00368355|Viral-associated hemophagocytic syndrome (VAHS)|viral-associated hemophagocytic syndrome (vahs)
5737210|NCT00368355|X-linked lymphoproliferative disease (XLP)|x-linked lymphoproliferative disease (xlp)
5737211|NCT00368316|Dysentery|dysentery
5737212|NCT00368316|S. sonnei|s. sonnei
5737213|NCT00368316|Antibody Response|antibody response
5737214|NCT00368316|Protection|protection
5737215|NCT00368303|Major Depression|major depression
5737216|NCT00368303|paroxetine controlled release (CR)|paroxetine controlled release (cr)
5746236|NCT00334906|MRI|mri
5737217|NCT00368303|paroxetine immediate release (IR)|paroxetine immediate release (ir)
5737218|NCT00368290|cocaine dependence|cocaine dependence
5737219|NCT00368290|hiv prevention|hiv prevention
5737220|NCT00368277|Systolic hypertension|systolic hypertension
5737221|NCT00368277|hypertension|hypertension
5737222|NCT00368277|aliskiren|aliskiren
5737223|NCT00368277|blood pressure|blood pressure
5737224|NCT00368277|ramipril|ramipril
5737225|NCT00368277|HTN|htn
5737226|NCT00368264|lupus|lupus
5737227|NCT00368264|nephritis|nephritis
5737228|NCT00368264|membraneous|membraneous
5737229|NCT00368264|proteinuria|proteinuria
5737230|NCT00368264|TNF|tnf
5737231|NCT00368264|infliximab|infliximab
5737232|NCT00368264|azathioprine|azathioprine
5737233|NCT00368264|autoantibodies|autoantibodies
5737234|NCT00368251|Unverricht-Lundborg Disease|unverricht-lundborg disease
5737235|NCT00368251|Baltic Myoclonus|baltic myoclonus
5737236|NCT00368251|Progressive Myoclonic Epilepsies|progressive myoclonic epilepsies
5737237|NCT00368251|Myoclonus|myoclonus
5737238|NCT00368251|Brivaracetam|brivaracetam
5737239|NCT00368238|Platelet function tests|platelet function tests
5737240|NCT00368238|Erythropoietin|erythropoietin
5737241|NCT00368238|Aspirin|aspirin
5737242|NCT00368238|Clopidogrel|clopidogrel
5737243|NCT00368225|Viral Hepatitis|viral hepatitis
5737244|NCT00368225|Hepatitis C|hepatitis c
5737245|NCT00368225|HCV|hcv
5737246|NCT00368225|Liver Transplant|liver transplant
5737247|NCT00368225|Renal Transplant|renal transplant
5737248|NCT00368225|Kidney Transplant|kidney transplant
5737249|NCT00368212|Somatization|somatization
5737250|NCT00368212|Refractory Symptoms|refractory symptoms
5737251|NCT00368199|single photon emission computer tomography (SPECT)|single photon emission computer tomography (spect)
5737252|NCT00368199|transcranial sonography|transcranial sonography
5737253|NCT00368199|transcranial duplex scanning|transcranial duplex scanning
5737254|NCT00368199|parkinson's disease|parkinson's disease
5737255|NCT00368199|atypical parkinson syndromes|atypical parkinson syndromes
5737256|NCT00368199|parkinsonism|parkinsonism
5737257|NCT00368199|parkinsonian|parkinsonian
5737258|NCT00368199|diagnostic|diagnostic
5732291|NCT00386113|elderly|elderly
5737259|NCT00368199|progressive supranuclear paralysis|progressive supranuclear paralysis
5737260|NCT00368160|Next day driving|next day driving
5737261|NCT00368147|Hemodialysis|hemodialysis
5737262|NCT00368147|Arteriovenous Fistula|arteriovenous fistula
5737263|NCT00368147|Arteriovenous Graft|arteriovenous graft
5737264|NCT00368147|Left Ventricular Hypertrophy|left ventricular hypertrophy
5737265|NCT00368147|Brain Natriuretic Peptide|brain natriuretic peptide
5737266|NCT00368134|Type 2 Diabetes|type 2 diabetes
5737267|NCT00368134|Vildagliptin|vildagliptin
5737268|NCT00368134|HbA1c|hba1c
5737269|NCT00368121|Multiple Myeloma|multiple myeloma
5737297|NCT00368043|Stress Response|stress response
5737298|NCT00368043|Adoption|adoption
5737299|NCT00368043|Thyroid Hormone|thyroid hormone
5737300|NCT00368043|Psychosocial Adjustment|psychosocial adjustment
5737301|NCT00368043|Healthy Volunteer|healthy volunteer
5737302|NCT00368043|HV|hv
5737303|NCT00368030|Insomnia related to major depressive disorder.|insomnia related to major depressive disorder.
5737304|NCT00368004|Coloboma|coloboma
5737305|NCT00368004|Genetics|genetics
5737306|NCT00368004|Optic Nerve Coloboma|optic nerve coloboma
5737307|NCT00368004|Chorioretinal Coloboma|chorioretinal coloboma
5737308|NCT00368004|Iris Coloboma|iris coloboma
5737309|NCT00368004|Uveal Coloboma|uveal coloboma
5737310|NCT00367991|Platelet function tests|platelet function tests
5737311|NCT00367991|Erythropoietin|erythropoietin
5737312|NCT00367991|Myocardial infarction|myocardial infarction
5737419|NCT00367575|randomized|randomized
5737313|NCT00367978|Hypertension, diabetes, African-American, amlodipine/benazepril|hypertension, diabetes, african-american, amlodipine/benazepril
5737314|NCT00367965|Insomnia related to rheumatoid arthritis (RA)|insomnia related to rheumatoid arthritis (ra)
5737315|NCT00367952|HIV|hiv
5737316|NCT00367952|apricitabine|apricitabine
5737317|NCT00367952|drug resistance|drug resistance
5737318|NCT00367952|reverse transcriptase|reverse transcriptase
5737319|NCT00367952|lamivudine|lamivudine
5737320|NCT00367939|Hypertension|hypertension
5737321|NCT00367926|ginseng|ginseng
5737322|NCT00367926|polysaccharides|polysaccharides
5737323|NCT00367926|postprandial glycemia|postprandial glycemia
5737324|NCT00367926|area under the glucose curve|area under the glucose curve
5737325|NCT00367926|peak incremental glucose|peak incremental glucose
5737326|NCT00367913|pulmonary disease|pulmonary disease
5737327|NCT00367913|Treatment of Opportunist Mycobacteria|treatment of opportunist mycobacteria
5737328|NCT00367913|Clarithromycin|clarithromycin
5737329|NCT00367913|Ciprofloxacin|ciprofloxacin
5737330|NCT00367913|M.vaccae|m.vaccae
5737331|NCT00367913|Pulmonary diseases caused by Opportunist Mycobacteria|pulmonary diseases caused by opportunist mycobacteria
5737339|NCT00367887|Hepatitis C|hepatitis c
5737340|NCT00367874|Opiate dependence|opiate dependence
5737341|NCT00367874|Benzodiazepine dependence|benzodiazepine dependence
5737342|NCT00367874|Polydrug Abuse|polydrug abuse
5737343|NCT00367874|Detoxification|detoxification
5737344|NCT00367874|Withdrawal Treatment|withdrawal treatment
5746322|NCT00334529|HV|hv
5737345|NCT00367861|GIST|gist
5737346|NCT00367861|Glivec®|glivec®
5737347|NCT00367861|randomized|randomized
5737348|NCT00367861|phase III|phase iii
5737349|NCT00367848|suspected fractures in the ankle and wrist|suspected fractures in the ankle and wrist
5737350|NCT00367822|Restless Legs Syndrome|restless legs syndrome
5737351|NCT00367822|dopamine agonist|dopamine agonist
5737352|NCT00367822|lisuride|lisuride
5737353|NCT00367822|ropinirole|ropinirole
5737354|NCT00367809|Meditation|meditation
5737355|NCT00367809|Mindfulness|mindfulness
5737356|NCT00367809|Organ Transplant|organ transplant
5737357|NCT00367809|Transplantation|transplantation
5737358|NCT00367809|Minnesota|minnesota
5737359|NCT00367809|Immune suppressive therapy|immune suppressive therapy
5737360|NCT00367796|Craniosynostosis|craniosynostosis
5737361|NCT00367796|Philadelphia Type|philadelphia type
5737362|NCT00367770|bosentan|bosentan
5737363|NCT00367770|PAH related to Eisenmenger physiology|pah related to eisenmenger physiology
5737364|NCT00367770|Tracleer|tracleer
5737365|NCT00367757|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5737366|NCT00367757|persistent atrial fibrillation|persistent atrial fibrillation
5737367|NCT00367757|high burden of atrial fibrillation|high burden of atrial fibrillation
5737368|NCT00367757|atrial fibrillation ablation|atrial fibrillation ablation
5737374|NCT00367757|complex fractionated atrial electrograms|complex fractionated atrial electrograms
5737375|NCT00367757|refractory antiarrhythmic medication|refractory antiarrhythmic medication
5737377|NCT00367757|Ensite NavX|ensite navx
5737378|NCT00367757|NavX|navx
5737379|NCT00367757|CoolPath catheter|coolpath catheter
5737380|NCT00367757|irrigated ablation catheter|irrigated ablation catheter
5737381|NCT00367757|high burden of paroxysmal or persistent atrial fibrillation|high burden of paroxysmal or persistent atrial fibrillation
5737382|NCT00367757|candidates for AF ablation|candidates for af ablation
5737383|NCT00367757|symptomatic AF|symptomatic af
5737384|NCT00367757|AF is refractory to at least one antiarrhythmic medication|af is refractory to at least one antiarrhythmic medication
5737385|NCT00367744|mitochondria|mitochondria
5737387|NCT00367744|lipoatrophy|lipoatrophy
5737389|NCT00367731|AIDS|aids
5737390|NCT00367731|Neurological complications|neurological complications
5737391|NCT00367731|HAART|haart
5737392|NCT00367692|Scleritis|scleritis
5737393|NCT00367679|pazopanib|pazopanib
5737394|NCT00367679|I-ELCAP|i-elcap
5737395|NCT00367679|non-small cell lung cancer|non-small cell lung cancer
5737396|NCT00367679|antiangiogenesis|antiangiogenesis
5737397|NCT00367679|NSCLC|nsclc
5737398|NCT00367679|GW786034|gw786034
5737399|NCT00367640|Sublingual immunotherapy|sublingual immunotherapy
5737400|NCT00367640|Grass pollen tablet|grass pollen tablet
5737401|NCT00367640|Allergic rhinoconjunctivitis|allergic rhinoconjunctivitis
5737402|NCT00367627|Children|children
5737403|NCT00367627|Malnutrition|malnutrition
5737404|NCT00367627|Ascaris Lumbricoides|ascaris lumbricoides
5737405|NCT00367627|Trichuris trichiura Morbidity|trichuris trichiura morbidity
5737406|NCT00367627|Helminthiasis|helminthiasis
5737407|NCT00367627|Children 2-5 years|children 2-5 years
5737408|NCT00367627|Stool RME +ve for helminthiasis|stool rme +ve for helminthiasis
5737409|NCT00367614|Adolescents|adolescents
5737410|NCT00367614|GERD|gerd
5737411|NCT00367588|chemotherapy|chemotherapy
5737412|NCT00367588|diet|diet
5737413|NCT00367588|hematological malignancy|hematological malignancy
5737415|NCT00367588|protective isolation|protective isolation
5737416|NCT00367588|Patients with cytopenia due to intensive chemotherapy for hematological malignancy|patients with cytopenia due to intensive chemotherapy for hematological malignancy
5737417|NCT00367575|alcoholism|alcoholism
5737418|NCT00367575|drinking|drinking
5737420|NCT00367575|internet personalized alcohol feedback|internet personalized alcohol feedback
5737421|NCT00367562|IGA NEPHROPATHY|iga nephropathy
5737422|NCT00367562|STEROIDS|steroids
5737423|NCT00367562|ENALAPRIL|enalapril
5737424|NCT00367562|VALSARTAN|valsartan
5737425|NCT00367562|PROTEINURIA|proteinuria
5737426|NCT00367562|IMMUNOGLOBULIN A NEPHROPATHY (IGA NEPHROPATHY)|immunoglobulin a nephropathy (iga nephropathy)
5737427|NCT00367549|Labor|labor
5737428|NCT00367549|instrumental delivery|instrumental delivery
5737429|NCT00367549|nutrition|nutrition
5737430|NCT00367549|epidural anesthesia|epidural anesthesia
5737431|NCT00367549|oxytocin|oxytocin
5737432|NCT00367536|Health|health
5737433|NCT00367523|Echocardiogram|echocardiogram
5737434|NCT00367523|Nigeria|nigeria
5737435|NCT00367523|Screening|screening
5737436|NCT00367523|Sickle Cell Disease|sickle cell disease
5737437|NCT00367523|Genetics|genetics
5737438|NCT00367497|aggressive non-Hodgkin's lymphoma|aggressive non-hodgkin's lymphoma
5737439|NCT00367497|salvage chemotherapy|salvage chemotherapy
5737440|NCT00367497|rituximab|rituximab
5737441|NCT00367471|metastatic|metastatic
5737442|NCT00367471|paclitaxel|paclitaxel
5737443|NCT00367471|lapatinib|lapatinib
5737444|NCT00367471|trastuzumab|trastuzumab
5737445|NCT00367471|carboplatin|carboplatin
5737446|NCT00367471|breast cancer|breast cancer
5737454|NCT00367432|Epilepsies|epilepsies
5737455|NCT00367432|Partial|partial
5737456|NCT00367432|Keppra|keppra
5737457|NCT00367432|levetiracetam|levetiracetam
5736393|NCT00371488|Herceptin|herceptin
5737458|NCT00367393|Pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema|pimecrolimus, skin atrophy, dermoscopy, atopic dermatitis, eczema
5737459|NCT00367380|Malaria|malaria
5737460|NCT00367380|Sporozoite|sporozoite
5737461|NCT00367380|Challenge Model|challenge model
5737462|NCT00367380|Plasmodium vivax|plasmodium vivax
5737463|NCT00367380|Human Volunteers|human volunteers
5737464|NCT00367367|embryo transfer|embryo transfer
5737465|NCT00367367|hysteroscopy|hysteroscopy
5737466|NCT00367367|curettage|curettage
5737467|NCT00367367|iv-vitro fertilization|iv-vitro fertilization
5737468|NCT00367367|molecular markers|molecular markers
5737469|NCT00367367|endometrial receptivity|endometrial receptivity
5737470|NCT00367367|endometrial dating|endometrial dating
5737471|NCT00367354|Imaging Technology|imaging technology
5737472|NCT00367354|Cardiology|cardiology
5737473|NCT00367341|Depression, Treatment, Imaging|depression, treatment, imaging
5737474|NCT00367328|Hidradenitis Supperativa|hidradenitis supperativa
5798837|NCT00111072|Salivary Diagnostics|salivary diagnostics
5737475|NCT00367315|Osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors|osteoarthritis, lumiracoxib, celecoxib, cyclooxygenase-2 inhibitors
5737476|NCT00367302|addiction|addiction
5737477|NCT00367302|jail|jail
5737478|NCT00367302|opiates|opiates
5737479|NCT00367302|buprenorphine|buprenorphine
5737480|NCT00367302|clinical trial|clinical trial
5737481|NCT00367276|Females requiring contraceptives|females requiring contraceptives
5737482|NCT00367263|Asthma|asthma
5737483|NCT00367224|vitiligo|vitiligo
5737484|NCT00367224|tolerance|tolerance
5737485|NCT00367224|ultraviolet B.|ultraviolet b.
5680960|NCT00575471|rivoglitazone HCl|rivoglitazone hcl
5680961|NCT00575471|thiazolidinedione|thiazolidinedione
5680962|NCT00575471|peroxisome proliferator-activated receptor gamma (PPARgamma)|peroxisome proliferator-activated receptor gamma (ppargamma)
5737486|NCT00367211|Gastric Ulcers|gastric ulcers
5737487|NCT00367211|NSAID|nsaid
5737488|NCT00367211|Arthritis|arthritis
5737489|NCT00367185|Multiple myeloma|multiple myeloma
5737490|NCT00367185|Elderly patients|elderly patients
5737491|NCT00367185|Thalidomide|thalidomide
5737492|NCT00367185|Autologous transplantation|autologous transplantation
5737493|NCT00367172|human immunodeficiency virus|human immunodeficiency virus
5737494|NCT00367172|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5737495|NCT00367172|substance abuse|substance abuse
5737496|NCT00367172|directly administered antiretroviral therapy|directly administered antiretroviral therapy
5737497|NCT00367172|adherence, directly observed therapy|adherence, directly observed therapy
5737498|NCT00367159|Vesico-ureteral reflux, autologous adipocytes, adipocytes graft|vesico-ureteral reflux, autologous adipocytes, adipocytes graft
5737499|NCT00367146|liver transplantation|liver transplantation
5737500|NCT00367146|children|children
5737501|NCT00367146|immunosuppression|immunosuppression
5737502|NCT00367146|mycophenolatmofetil|mycophenolatmofetil
5737503|NCT00367146|calcineurin inhibitor|calcineurin inhibitor
5737504|NCT00367146|kidney disease|kidney disease
5737505|NCT00367133|diabetic|diabetic
5737506|NCT00367133|macular|macular
5737507|NCT00367133|edema|edema
5737508|NCT00367133|intravitreal|intravitreal
5737509|NCT00367133|triamcinolone|triamcinolone
5737510|NCT00367133|laser|laser
5737511|NCT00367133|photocoagulation|photocoagulation
5737513|NCT00367107|Autism spectrum disorders|autism spectrum disorders
5737514|NCT00367107|long-term outcomes|long-term outcomes
5737515|NCT00367107|caregiver burden|caregiver burden
5737516|NCT00367107|birth cohort|birth cohort
5737517|NCT00367107|nested case-control study|nested case-control study
5737518|NCT00367094|Hypertension, benazepril, hydrochlorothiazide, fixed combination|hypertension, benazepril, hydrochlorothiazide, fixed combination
5737519|NCT00367081|Toxoplasmic Encephalitis|toxoplasmic encephalitis
5737520|NCT00367081|AIDS|aids
5737521|NCT00367068|Cerebral palsy|cerebral palsy
5737522|NCT00367068|Spasticity|spasticity
5737523|NCT00367068|Child|child
5737524|NCT00367068|Baclofen|baclofen
5737525|NCT00367068|Intrathecal injection|intrathecal injection
5737526|NCT00367055|Beta cell function|beta cell function
5737527|NCT00367055|Type 2 diabetes|type 2 diabetes
5737528|NCT00367055|Combination treatment|combination treatment
5737529|NCT00367029|Physical Activity|physical activity
5737530|NCT00367003|Depression, Unipolar, Bipolar-II, DBS, Imaging|depression, unipolar, bipolar-ii, dbs, imaging
5737531|NCT00366990|Arterial Stiffening|arterial stiffening
5737532|NCT00366977|Cessation|cessation
5737533|NCT00366977|Smoking|smoking
5737534|NCT00366977|Quitline|quitline
5737535|NCT00366977|Policies|policies
5737536|NCT00366977|Counseling|counseling
5737537|NCT00366951|Cervical Ripening|cervical ripening
5737538|NCT00366951|Labor, Induced|labor, induced
5737539|NCT00366951|Balloon Dilation|balloon dilation
5737540|NCT00366951|Oxytocin|oxytocin
5737541|NCT00366938|Osteoarthritis, lumiracoxib, celecoxib, Cox-2|osteoarthritis, lumiracoxib, celecoxib, cox-2
5737542|NCT00366912|work of breathing|work of breathing
5737543|NCT00366912|pressure time product|pressure time product
5737544|NCT00366912|muscle pressures|muscle pressures
5737545|NCT00366899|Vaccine|vaccine
5737546|NCT00366899|Infants|infants
5737547|NCT00366886|cardiac|cardiac
5737548|NCT00366886|pediatric|pediatric
5737549|NCT00366886|surgery|surgery
5737550|NCT00366886|blood markers|blood markers
5737551|NCT00366873|Infant|infant
5737552|NCT00366873|Term|term
5737553|NCT00366860|soy|soy
5737554|NCT00366860|isoflavones|isoflavones
5737555|NCT00366860|bone resorption|bone resorption
5737556|NCT00366860|osteogenesis|osteogenesis
5737557|NCT00366860|diet|diet
5737558|NCT00366860|hyperlipidemia|hyperlipidemia
5737559|NCT00366847|cardiac|cardiac
5737560|NCT00366847|MRI|mri
5737561|NCT00366847|pediatrics|pediatrics
5737562|NCT00366834|Anthracycline|anthracycline
5737563|NCT00366834|Cyclophosphamide|cyclophosphamide
5737564|NCT00366834|Moderately|moderately
5737565|NCT00366834|Nausea|nausea
5737566|NCT00366834|Emetogenic|emetogenic
5737567|NCT00366834|Vomiting|vomiting
5737568|NCT00366821|cardiac|cardiac
5737569|NCT00366821|pediatric|pediatric
5737570|NCT00366821|genetic|genetic
5737571|NCT00366782|Respiratory Tract Disease|respiratory tract disease
5737572|NCT00366782|Bovine|bovine
5737573|NCT00366782|Chimeric Vaccine|chimeric vaccine
5737574|NCT00366756|Vision|vision
5737575|NCT00366756|Visual Acuity|visual acuity
5737576|NCT00366730|Amebiasis|amebiasis
5737577|NCT00366730|Entamoeba histolytica|entamoeba histolytica
5737578|NCT00366717|Cancer under chemotherapy|cancer under chemotherapy
5737579|NCT00366704|Schizophrenia|schizophrenia
5737580|NCT00366691|cataract|cataract
5737581|NCT00366678|Safety|safety
5737582|NCT00366678|Vaccine|vaccine
5737583|NCT00366652|Healthy|healthy
5737584|NCT00366639|Heart failure, congestive|heart failure, congestive
5737585|NCT00366639|Heart decompensation|heart decompensation
5737586|NCT00366626|Alcohol dependence|alcohol dependence
5737587|NCT00366626|Alcoholism|alcoholism
5737588|NCT00366626|Craving|craving
5737589|NCT00366626|Genetic|genetic
5737590|NCT00366613|Cataract|cataract
5737591|NCT00366613|Cataract Extraction|cataract extraction
5737592|NCT00366600|Breast Cancer|breast cancer
5737593|NCT00366600|Health|health
5737594|NCT00366600|Pharmacokinetics|pharmacokinetics
5737595|NCT00366600|healthy subjects|healthy subjects
5737596|NCT00366561|neonates|neonates
5737597|NCT00366561|neurological complications|neurological complications
5737598|NCT00366561|surgery|surgery
5737599|NCT00366548|Vaccine|vaccine
5737601|NCT00366535|Muscle Pain|muscle pain
5737602|NCT00366535|Fibrositis Allodynia|fibrositis allodynia
5737603|NCT00366535|Stiffness|stiffness
5737604|NCT00366535|Tender Points|tender points
5737605|NCT00366535|Fibromyalgia|fibromyalgia
5737606|NCT00366522|Safety|safety
5737607|NCT00366522|Healthy|healthy
5737608|NCT00366522|healthy subjects|healthy subjects
5737609|NCT00366509|Vac A Toxin|vac a toxin
5737610|NCT00366509|Lung|lung
5737611|NCT00366509|Bronchoscopy|bronchoscopy
5737612|NCT00366509|Endoscopy|endoscopy
5737613|NCT00366509|Cytotoxin|cytotoxin
5737614|NCT00366509|Pulmonary Disease|pulmonary disease
5737615|NCT00366509|Lung Disease|lung disease
5737616|NCT00366509|Genetic Disease|genetic disease
5737617|NCT00366509|Oropharyngeal Disease|oropharyngeal disease
5737618|NCT00366509|Pulmonary Fibrosis|pulmonary fibrosis
5737619|NCT00366509|Asthma|asthma
5737620|NCT00366483|healthy young volunteers|healthy young volunteers
5737621|NCT00366483|healthy elderly volunteers|healthy elderly volunteers
5737622|NCT00366483|Alzheimer's disease|alzheimer's disease
5737623|NCT00366483|5HT1A antagonist|5ht1a antagonist
5737624|NCT00366483|Health|health
5737625|NCT00366483|Pharmacokinetics|pharmacokinetics
5737627|NCT00366444|Bunion surgery|bunion surgery
5737628|NCT00366444|Post-operative pain|post-operative pain
5737629|NCT00366431|OIBD|oibd
5737631|NCT00366431|Opioid|opioid
5737632|NCT00366431|Constipation|constipation
5737633|NCT00366431|Laxative|laxative
5737634|NCT00366418|CLL|cll
5737635|NCT00366418|Monoclonal Antibody Therapy|monoclonal antibody therapy
5737636|NCT00366418|Anti CD20|anti cd20
5737637|NCT00366418|Biologic Response Modifier Therapy|biologic response modifier therapy
5737638|NCT00366418|Fractionated-Dose|fractionated-dose
5737639|NCT00366418|Low-Dose|low-dose
5737640|NCT00366418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5737641|NCT00366405|cataract|cataract
5737642|NCT00366392|Low Vision|low vision
5737643|NCT00366392|Optical Aids|optical aids
5737644|NCT00366353|Mechanical Ventilation|mechanical ventilation
5737645|NCT00366353|Spontaneous Breathing Trial|spontaneous breathing trial
5737646|NCT00366353|Sedation|sedation
5737647|NCT00366340|safety|safety
5737648|NCT00366340|Vaccine|vaccine
5737649|NCT00366327|Schizophrenia|schizophrenia
5737650|NCT00366314|Blood samples|blood samples
5737651|NCT00366314|Medication administration|medication administration
5737652|NCT00366314|CICU|cicu
5737653|NCT00366314|PICU|picu
5737654|NCT00366314|NICU|nicu
5737655|NCT00366301|type 2 diabetes|type 2 diabetes
5737656|NCT00366301|insulin|insulin
5737657|NCT00366301|insulin injection|insulin injection
5737658|NCT00366301|metformin|metformin
5737659|NCT00366301|C-reactive protein|c-reactive protein
5737660|NCT00366301|insulin sensitivity|insulin sensitivity
5737661|NCT00366301|glycemic control|glycemic control
5737662|NCT00366301|inflammation|inflammation
5737663|NCT00366288|Healthy|healthy
5737664|NCT00366288|Safety|safety
5737665|NCT00366275|follicular lymphoma|follicular lymphoma
5737666|NCT00366275|rituximab|rituximab
5737667|NCT00366275|immunochemotherapy|immunochemotherapy
5737668|NCT00366275|peripheral blood stem cells (PBSC) mobilization|peripheral blood stem cells (pbsc) mobilization
5737669|NCT00366275|in vivo purging|in vivo purging
5737670|NCT00366275|autotransplant|autotransplant
5737671|NCT00366275|bcl-2 rearrangement|bcl-2 rearrangement
5737672|NCT00366275|molecular response|molecular response
5737673|NCT00366262|Health|health
5737674|NCT00366249|Diabetic foot infection|diabetic foot infection
5737675|NCT00366249|Osteomyelitis|osteomyelitis
5737676|NCT00366249|Diabetes Complications|diabetes complications
5737677|NCT00366249|Foot ulcer|foot ulcer
5737678|NCT00366249|Skin infection|skin infection
5737679|NCT00366236|Amebiasis|amebiasis
5737680|NCT00366236|Entamoeba histolytica|entamoeba histolytica
5737681|NCT00366223|infection|infection
5737683|NCT00366210|stroke|stroke
5737684|NCT00366210|rehabilitation|rehabilitation
5737685|NCT00366210|physical therapy|physical therapy
5737686|NCT00366210|occupational therapy|occupational therapy
5737687|NCT00366210|arm|arm
5737688|NCT00366197|Rapid Shallow Breathing Index|rapid shallow breathing index
5737689|NCT00366197|Mechanical Ventilation|mechanical ventilation
5680963|NCT00575471|diabetes mellitus, type 2|diabetes mellitus, type 2
5680964|NCT00575432|magnetic resonance imaging|magnetic resonance imaging
5680965|NCT00575432|renal function|renal function
5680966|NCT00575432|renal transplant|renal transplant
5680967|NCT00575432|urinary calculi|urinary calculi
5763955|NCT00268203|Bexxar®|bexxar®
5737690|NCT00366184|Neuromodulation|neuromodulation
5737691|NCT00366184|Stroke|stroke
5737692|NCT00366184|Motor Cortex|motor cortex
5737693|NCT00366184|Motor Learning|motor learning
5737694|NCT00366184|L-Dopa|l-dopa
5737695|NCT00366184|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5737696|NCT00366184|Levodopa|levodopa
5737697|NCT00366184|Healthy Volunteer|healthy volunteer
5737698|NCT00366184|HV|hv
5737699|NCT00366171|Schizophrenia|schizophrenia
5737700|NCT00366158|Patients with intact AV conduction|patients with intact av conduction
5737702|NCT00366145|steroid refractory GVHD|steroid refractory gvhd
5737703|NCT00366145|severe steroid refractory acute GVHD|severe steroid refractory acute gvhd
5737704|NCT00366145|steroid refractory|steroid refractory
5737705|NCT00366145|Steroid Refractory Acute Graft Versus Host Disease|steroid refractory acute graft versus host disease
5737706|NCT00366132|Diabetic|diabetic
5737707|NCT00366132|Foot Ulcers|foot ulcers
5737709|NCT00366132|DermaGold|dermagold
5737710|NCT00366132|Shockwave|shockwave
5737711|NCT00366132|ESWT|eswt
5737712|NCT00366132|Diabetes Mellitus|diabetes mellitus
5737713|NCT00366119|hypertension|hypertension
5737714|NCT00366119|ramipril|ramipril
5737715|NCT00366119|blood pressure|blood pressure
5737716|NCT00366119|artery stiffness|artery stiffness
5737717|NCT00366119|BNP|bnp
5737718|NCT00366119|CRP|crp
5737719|NCT00366106|Relapsed Multiple Myeloma|relapsed multiple myeloma
5737720|NCT00366106|Refractory Multiple Myeloma|refractory multiple myeloma
5737721|NCT00366093|Menopause|menopause
5737722|NCT00366093|Perimenopause|perimenopause
5737723|NCT00366080|GSK189254 H3 Histamine Narcolepsy|gsk189254 h3 histamine narcolepsy
5737724|NCT00366067|Bronchial asthma|bronchial asthma
5737725|NCT00366067|Phenytoin|phenytoin
5737726|NCT00366067|Antiepileptic drugs|antiepileptic drugs
5737727|NCT00366067|Efficacy|efficacy
5737728|NCT00366028|Organization Innovation|organization innovation
5737729|NCT00366028|Diffusion of Innovation|diffusion of innovation
5737731|NCT00366028|Infection Control|infection control
5737732|NCT00366015|Coronary Artery Disease|coronary artery disease
5737733|NCT00366015|PCI|pci
5737734|NCT00366015|Drug eluting stents|drug eluting stents
5737735|NCT00366015|Coronary Hybrid Revascularization|coronary hybrid revascularization
5737736|NCT00366015|Robotic CABG|robotic cabg
5737818|NCT00365768|neurotoxicity|neurotoxicity
5737737|NCT00366002|Darifenacin,Overactive Bladder,antimuscarinic,M3 muscarinic receptor antagonist|darifenacin,overactive bladder,antimuscarinic,m3 muscarinic receptor antagonist
5737738|NCT00365989|Fibroids|fibroids
5737739|NCT00365989|leiomyoma|leiomyoma
5737740|NCT00365989|neoplasm|neoplasm
5737741|NCT00365989|benign tumors|benign tumors
5737742|NCT00365976|Insomnia|insomnia
5737743|NCT00365976|Low Back Pain|low back pain
5737744|NCT00365976|Hypnotics|hypnotics
5737745|NCT00365976|Eszopiclone|eszopiclone
5737746|NCT00365976|Pain|pain
5737747|NCT00365976|Disability|disability
5737748|NCT00365963|lung cancer, caregivers, support, resources, education|lung cancer, caregivers, support, resources, education
5737749|NCT00365950|Duration of anticoagulation|duration of anticoagulation
5737750|NCT00365950|Deep vein thrombosis and/or pulmonary embolism|deep vein thrombosis and/or pulmonary embolism
5737751|NCT00365937|immunotherapy|immunotherapy
5737752|NCT00365937|adjuvants|adjuvants
5737753|NCT00365937|IMP321|imp321
5737754|NCT00365937|Montanide ISA51 VG|montanide isa51 vg
5737755|NCT00365937|tumor-specific peptides|tumor-specific peptides
5686220|NCT00552994|Pathophysiologic (neointimal hyperplasia and peri-stent remodeling)|pathophysiologic (neointimal hyperplasia and peri-stent remodeling)
5686221|NCT00552981|common cold|common cold
5686222|NCT00552981|Finnish sauna|finnish sauna
5686224|NCT00552968|trauma|trauma
5686225|NCT00552968|pain|pain
5686226|NCT00552955|Lymphangioleiomyomatosis|lymphangioleiomyomatosis
5686227|NCT00552955|Abdominal Lymphangioleiomyomas|abdominal lymphangioleiomyomas
5736690|NCT00370331|ITP|itp
5737756|NCT00365924|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters|12 month therapy with postmenopausal women with osteoporosis to examine changes in bone quality parameters
5737757|NCT00365911|No specific condition|no specific condition
5737758|NCT00365898|Chronic non-malignant pain, opioid|chronic non-malignant pain, opioid
5737759|NCT00365885|Medical Informatics|medical informatics
5737760|NCT00365885|Decision Support Systems, Clinical|decision support systems, clinical
5737761|NCT00365885|Community Health Services|community health services
5737762|NCT00365885|Costs and Cost analysis|costs and cost analysis
5737763|NCT00365872|Sarcoma|sarcoma
5737764|NCT00365872|Intratumoral injection|intratumoral injection
5737765|NCT00365872|Dendritic cells|dendritic cells
5737766|NCT00365872|Neo-adjuvant treatment|neo-adjuvant treatment
5737767|NCT00365872|Immunotherapy|immunotherapy
5737768|NCT00365872|Pheresis|pheresis
5737769|NCT00365872|Radiation|radiation
5737770|NCT00365859|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5737771|NCT00365859|behavioral problems|behavioral problems
5737772|NCT00365846|prevent kidney rejection|prevent kidney rejection
5737773|NCT00365833|Transplantation|transplantation
5737774|NCT00365833|Cardiovascular|cardiovascular
5737776|NCT00365820|Opioid, constipation, tegaserod|opioid, constipation, tegaserod
5737777|NCT00365820|Opioid-induced constipation|opioid-induced constipation
5737778|NCT00365807|Obesity|obesity
5737779|NCT00365807|Overweight|overweight
5737780|NCT00365807|Behavioral treatment|behavioral treatment
5737781|NCT00365807|Family involvement|family involvement
5737782|NCT00365794|Aging|aging
5737783|NCT00365794|Older men|older men
5737784|NCT00365794|Abdominal obesity|abdominal obesity
5737785|NCT00365794|Central obesity|central obesity
5737786|NCT00365794|Insulin resistance|insulin resistance
5737787|NCT00365794|Low testosterone|low testosterone
5737788|NCT00365781|Injection Site Reaction|injection site reaction
5737789|NCT00365781|Subcutaneous administration|subcutaneous administration
5737790|NCT00365781|Dermatological effects|dermatological effects
5737791|NCT00365781|Antisense|antisense
5737792|NCT00365768|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5732796|NCT00383747|nicotine|nicotine
5737793|NCT00365768|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5737794|NCT00365768|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5737796|NCT00365768|stage II Wilms tumor|stage ii wilms tumor
5737797|NCT00365768|stage III Wilms tumor|stage iii wilms tumor
5737798|NCT00365768|stage IV Wilms tumor|stage iv wilms tumor
5737799|NCT00365768|stage V Wilms tumor|stage v wilms tumor
5737800|NCT00365768|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5737801|NCT00365768|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5737802|NCT00365768|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5737803|NCT00365768|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5737804|NCT00365768|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5737805|NCT00365768|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5737806|NCT00365768|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5737807|NCT00365768|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5737808|NCT00365768|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5737809|NCT00365768|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5737810|NCT00365768|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5727940|NCT00402597|Aspirin|aspirin
5737811|NCT00365768|childhood Burkitt lymphoma|childhood burkitt lymphoma
5737812|NCT00365768|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5737813|NCT00365768|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5737814|NCT00365768|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5737815|NCT00365768|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5737816|NCT00365768|localized Ewing sarcoma/PNET|localized ewing sarcoma/pnet
5737817|NCT00365768|metastatic Ewing sarcoma/PNET|metastatic ewing sarcoma/pnet
5737819|NCT00365768|peripheral neuropathy|peripheral neuropathy
5686228|NCT00552955|Chyle|chyle
5737820|NCT00365755|disseminated neuroblastoma|disseminated neuroblastoma
5737821|NCT00365742|red yeast rice|red yeast rice
5737822|NCT00365742|pharmaceutical grade fish oil|pharmaceutical grade fish oil
5737823|NCT00365742|simvastatin|simvastatin
5737824|NCT00365742|primary prevention|primary prevention
5737825|NCT00365729|genitoanal HPV infection|genitoanal hpv infection
5737826|NCT00365729|HIV infection|hiv infection
5737827|NCT00365716|HPV 6/11/16/18 infection and related genital disease|hpv 6/11/16/18 infection and related genital disease
5737828|NCT00365703|Infant, Premature|infant, premature
5737829|NCT00365703|Tube feeding|tube feeding
5737830|NCT00365690|AIDS|aids
5737831|NCT00365690|Older Adults|older adults
5737832|NCT00365690|Telephone|telephone
5737833|NCT00365690|Telemedicine|telemedicine
5737834|NCT00365651|obesity|obesity
5737835|NCT00365651|overweight|overweight
5737836|NCT00365638|PCOS|pcos
5737837|NCT00365638|statin|statin
5737838|NCT00365638|testosterone|testosterone
5737839|NCT00365638|lipids|lipids
5737840|NCT00365625|Psoriasis|psoriasis
5737841|NCT00365625|JAM3 protein, human|jam3 protein, human
5737842|NCT00365625|Cell Adhesion Molecules|cell adhesion molecules
5737843|NCT00365625|Skin|skin
5737844|NCT00365625|Inflammation|inflammation
5737845|NCT00365625|Lymphocytes|lymphocytes
5737847|NCT00365612|HIV-1|hiv-1
5737848|NCT00365612|AIDS|aids
5737849|NCT00365612|Human Immunodeficiency Virus|human immunodeficiency virus
5737850|NCT00365612|HIV-1 Infection|hiv-1 infection
5737851|NCT00365599|Breast cancer|breast cancer
5737852|NCT00365599|Suberoylanilide hydroxamic acid (SAHA)|suberoylanilide hydroxamic acid (saha)
5737853|NCT00365599|Vorinostat|vorinostat
5737854|NCT00365599|Tamoxifen|tamoxifen
5737855|NCT00365599|Anti-hormonal therapy|anti-hormonal therapy
5737856|NCT00365599|Estrogen receptor positive|estrogen receptor positive
5737857|NCT00365599|Progesterone receptor positive|progesterone receptor positive
5737858|NCT00365599|Metastatic disease|metastatic disease
5737861|NCT00365599|Selective estrogen receptor modulators(SERMS)|selective estrogen receptor modulators(serms)
5737866|NCT00365547|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5737867|NCT00365547|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5737868|NCT00365547|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5737869|NCT00365547|adenocarcinoma of the lung|adenocarcinoma of the lung
5737870|NCT00365547|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5737871|NCT00365547|large cell lung cancer|large cell lung cancer
5737872|NCT00365534|First colonoscopy examination|first colonoscopy examination
5737873|NCT00365521|Organ transplant patients receiving immunosuppressive therapy|organ transplant patients receiving immunosuppressive therapy
5737874|NCT00365508|bladder cancer|bladder cancer
5737875|NCT00365508|cervical cancer|cervical cancer
5737876|NCT00365508|esophageal cancer|esophageal cancer
5737877|NCT00365508|gastric cancer|gastric cancer
5737878|NCT00365508|renal cell carcinoma|renal cell carcinoma
5737879|NCT00365508|adult primary liver cancer|adult primary liver cancer
5737880|NCT00365508|non-small cell lung cancer|non-small cell lung cancer
5737882|NCT00365508|pancreatic cancer|pancreatic cancer
5737883|NCT00365508|hypopharyngeal cancer|hypopharyngeal cancer
5737884|NCT00365508|laryngeal cancer|laryngeal cancer
5737885|NCT00365508|lip and oral cavity cancer|lip and oral cavity cancer
5737886|NCT00365508|nasopharyngeal cancer|nasopharyngeal cancer
5737887|NCT00365508|oropharyngeal cancer|oropharyngeal cancer
5737888|NCT00365508|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5737889|NCT00365508|adult acute myeloid leukemia|adult acute myeloid leukemia
5737890|NCT00365508|tongue cancer|tongue cancer
5737891|NCT00365508|tobacco use disorder|tobacco use disorder
5737892|NCT00365495|Type 2 diabetes|type 2 diabetes
5737893|NCT00365495|physical training|physical training
5737894|NCT00365495|mitochondrial function|mitochondrial function
5737895|NCT00365482|Epilepsy|epilepsy
5737896|NCT00365482|Bipolar Disorder|bipolar disorder
5737897|NCT00365469|Probiotics|probiotics
5737898|NCT00365469|Eczema|eczema
5737899|NCT00365469|Asthma|asthma
5737900|NCT00365469|Allergic Rhinitis|allergic rhinitis
5737901|NCT00365469|Prevention|prevention
5737902|NCT00365469|Immunological responses|immunological responses
5737903|NCT00365456|Lumbar Spine Bone Mineral Density (BMD)|lumbar spine bone mineral density (bmd)
5737904|NCT00365443|anogenital warts|anogenital warts
5737905|NCT00365443|premalignancy|premalignancy
5737907|NCT00365443|Human papillomavirus|human papillomavirus
5737908|NCT00365430|Patient safety|patient safety
5737909|NCT00365430|Adverse event|adverse event
5737911|NCT00365430|Knowledge|knowledge
5737912|NCT00365430|Inpatient|inpatient
5737913|NCT00365430|Hospital|hospital
5737914|NCT00365430|Nursing home|nursing home
5737915|NCT00365430|Long term care|long term care
5737916|NCT00365430|Nurse|nurse
5737917|NCT00365417|NSABP|nsabp
5737918|NCT00365417|Doxorubicin|doxorubicin
5737919|NCT00365417|Cyclophosphamide|cyclophosphamide
5737920|NCT00365417|Bevacizumab|bevacizumab
5737921|NCT00365417|Capecitabine|capecitabine
5737922|NCT00365417|Docetaxel|docetaxel
5737923|NCT00365417|Breast cancer|breast cancer
5737924|NCT00365417|Locally advanced|locally advanced
5737925|NCT00365417|Neoadjuvant|neoadjuvant
5737926|NCT00365417|Locally advanced breast cancer|locally advanced breast cancer
5737927|NCT00365404|Behavioral change|behavioral change
5737928|NCT00365404|Weight management|weight management
5737929|NCT00365404|Physical activity|physical activity
5737930|NCT00365339|HIV|hiv
5737931|NCT00365339|Protease Inhibitor|protease inhibitor
5737932|NCT00365326|AC133|ac133
5737933|NCT00365326|coronary|coronary
5737934|NCT00365326|bone marrow|bone marrow
5737935|NCT00365326|autologous|autologous
5737936|NCT00365326|coronary artery disease|coronary artery disease
5737937|NCT00365313|celecoxib|celecoxib
5737938|NCT00365313|oesomeprazole|oesomeprazole
5737939|NCT00365313|arthritis|arthritis
5737940|NCT00365313|ulcer bleeding|ulcer bleeding
5737941|NCT00365300|GERD|gerd
5737942|NCT00365300|Infants|infants
5737943|NCT00365300|Gastroesophageal Reflux|gastroesophageal reflux
5737944|NCT00365287|stage IV breast cancer|stage iv breast cancer
5737945|NCT00365287|recurrent renal cell cancer|recurrent renal cell cancer
5737946|NCT00365287|stage III renal cell cancer|stage iii renal cell cancer
5737947|NCT00365287|stage IV renal cell cancer|stage iv renal cell cancer
5737948|NCT00365287|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5737949|NCT00365287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5737950|NCT00365287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5737951|NCT00365287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5738094|NCT00365183|Lung Cancer|lung cancer
5737952|NCT00365287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5737953|NCT00365287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5737954|NCT00365287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5737955|NCT00365287|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5737956|NCT00365287|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5737957|NCT00365287|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5737958|NCT00365287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5798838|NCT00111072|Oral Pain|oral pain
5737959|NCT00365287|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5737960|NCT00365287|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5737961|NCT00365287|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5737962|NCT00365287|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5737963|NCT00365287|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5737964|NCT00365287|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5737965|NCT00365287|stage I multiple myeloma|stage i multiple myeloma
5737966|NCT00365287|stage II multiple myeloma|stage ii multiple myeloma
5737967|NCT00365287|stage III multiple myeloma|stage iii multiple myeloma
5737969|NCT00365287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5737970|NCT00365287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5737971|NCT00365287|refractory anemia|refractory anemia
5737972|NCT00365287|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5737973|NCT00365287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5737974|NCT00365287|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5737975|NCT00365287|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5737976|NCT00365287|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5737977|NCT00365287|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5737978|NCT00365287|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5737979|NCT00365287|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5737980|NCT00365287|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5737981|NCT00365287|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5737982|NCT00365287|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5737983|NCT00365287|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5737984|NCT00365287|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5737985|NCT00365287|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5737986|NCT00365287|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5737987|NCT00365287|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5737988|NCT00365287|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5737989|NCT00365287|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5737990|NCT00365287|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5738061|NCT00365274|Immune System Diseases|immune system diseases
5737991|NCT00365287|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5737992|NCT00365287|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5737993|NCT00365287|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5737994|NCT00365287|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5737995|NCT00365287|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5737996|NCT00365287|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5737997|NCT00365287|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5737998|NCT00365287|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5737999|NCT00365287|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5738000|NCT00365287|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5738001|NCT00365287|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5738002|NCT00365287|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5738003|NCT00365287|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5738004|NCT00365287|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5738005|NCT00365287|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5738006|NCT00365287|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5738007|NCT00365287|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5738008|NCT00365287|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5738009|NCT00365287|refractory multiple myeloma|refractory multiple myeloma
5738010|NCT00365287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5738011|NCT00365287|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5738012|NCT00365287|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5738095|NCT00365183|Metastatic Lung Cancer|metastatic lung cancer
5738013|NCT00365287|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5738014|NCT00365287|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5738015|NCT00365287|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5738016|NCT00365287|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5738017|NCT00365287|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5738018|NCT00365287|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5738019|NCT00365287|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5738020|NCT00365287|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5738021|NCT00365287|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5738022|NCT00365287|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5738023|NCT00365287|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5738024|NCT00365287|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5738025|NCT00365287|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5738026|NCT00365287|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5738027|NCT00365287|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5738028|NCT00365287|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5738029|NCT00365287|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5738030|NCT00365287|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5738031|NCT00365287|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5738032|NCT00365287|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5738033|NCT00365287|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5738034|NCT00365287|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5738035|NCT00365287|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5738036|NCT00365287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5738037|NCT00365287|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5738038|NCT00365287|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5738039|NCT00365287|refractory anemia with excess blasts|refractory anemia with excess blasts
5738040|NCT00365287|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5738041|NCT00365274|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5738043|NCT00365274|murine monoclonal antibody|murine monoclonal antibody
5738045|NCT00365274|SGN-30|sgn-30
5738046|NCT00365274|CHOP|chop
5738048|NCT00365274|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5738049|NCT00365274|Vincristine|vincristine
5738050|NCT00365274|Prednisone|prednisone
5738051|NCT00365274|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5738052|NCT00365274|Lymphoma|lymphoma
5738053|NCT00365274|Lymphoma, Large B-Cell, Diffuse|lymphoma, large b-cell, diffuse
5738054|NCT00365274|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5738055|NCT00365274|Lymphoma, Large-Cell, Anaplastic|lymphoma, large-cell, anaplastic
5738056|NCT00365274|Neoplasms by Histologic Type|neoplasms by histologic type
5738057|NCT00365274|Neoplasms|neoplasms
5738058|NCT00365274|Lymphoproliferative Disorders|lymphoproliferative disorders
5738059|NCT00365274|Lymphatic Diseases|lymphatic diseases
5738060|NCT00365274|Immunoproliferative Disorders|immunoproliferative disorders
5738062|NCT00365274|Lymphoma, B-Cell|lymphoma, b-cell
5738063|NCT00365274|Lymphoma, T-Cell|lymphoma, t-cell
5737049|NCT00369031|HIV|hiv
5738064|NCT00365274|Antibodies|antibodies
5738065|NCT00365274|Antibodies, Monoclonal|antibodies, monoclonal
5738066|NCT00365274|Immunologic Factors|immunologic factors
5738067|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs
5738068|NCT00365274|Pharmacologic Actions|pharmacologic actions
5738069|NCT00365274|Immunosuppressive Agents|immunosuppressive agents
5738070|NCT00365274|Antirheumatic Agents|antirheumatic agents
5738071|NCT00365274|Therapeutic Uses|therapeutic uses
5738072|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5738073|NCT00365274|Alkylating Agents|alkylating agents
5738074|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5738075|NCT00365274|Antineoplastic Agents|antineoplastic agents
5738076|NCT00365274|Myeloablative Agonists|myeloablative agonists
5738077|NCT00365274|Antibiotics|antibiotics
5738078|NCT00365274|Antineoplastic|antineoplastic
5738079|NCT00365261|pain|pain
5738080|NCT00365261|fatigue|fatigue
5738081|NCT00365261|sleep|sleep
5738082|NCT00365261|bone marrow transplant|bone marrow transplant
5738083|NCT00365261|cancer|cancer
5738084|NCT00365248|Surgical resection of the liver with or without segmental transplantation|surgical resection of the liver with or without segmental transplantation
5738085|NCT00365222|Temozolomide|temozolomide
5738086|NCT00365222|Temodar|temodar
5738087|NCT00365222|Glioblastoma|glioblastoma
5738088|NCT00365222|Gliosarcoma|gliosarcoma
5738089|NCT00365222|Brain Tumor|brain tumor
5738090|NCT00365222|Quality of Life|quality of life
5738091|NCT00365222|Neurological|neurological
5738092|NCT00365196|Autonomic Nervous System|autonomic nervous system
5738093|NCT00365183|Non Small Cell Lung Cancer|non small cell lung cancer
5738096|NCT00365183|Inoperable Lung Cancer|inoperable lung cancer
5738097|NCT00365183|Advanced Lung Cancer|advanced lung cancer
5738098|NCT00365183|Large Cell Lung Cancer|large cell lung cancer
5738099|NCT00365183|Adenocarcinoma, lung|adenocarcinoma, lung
5738100|NCT00365183|Squamous Cell Carcinoma, lung|squamous cell carcinoma, lung
5738101|NCT00365183|Squamous Cell Lung Cancer|squamous cell lung cancer
5738102|NCT00365183|Large Cell Carcinoma, lung|large cell carcinoma, lung
5738103|NCT00365183|Cancer of the Lung|cancer of the lung
5738104|NCT00365183|Carcinoma|carcinoma
5738105|NCT00365183|Bronchogenic|bronchogenic
5738106|NCT00365144|stage IV pancreatic cancer|stage iv pancreatic cancer
5738107|NCT00365144|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5738108|NCT00365144|recurrent pancreatic cancer|recurrent pancreatic cancer
5738109|NCT00365131|Type I Gaucher disease|type i gaucher disease
5738110|NCT00365131|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5738111|NCT00365118|Port wine stains|port wine stains
5738112|NCT00365118|naevus flammeus|naevus flammeus
5738114|NCT00365105|bone metastases|bone metastases
5750707|NCT00317317|IVF|ivf
5738115|NCT00365105|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5738117|NCT00365105|stage IV breast cancer|stage iv breast cancer
5738118|NCT00365105|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5738119|NCT00365105|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5738120|NCT00365105|recurrent prostate cancer|recurrent prostate cancer
5738121|NCT00365105|stage IV prostate cancer|stage iv prostate cancer
5738122|NCT00365092|Insertion of tympanostomy tubes|insertion of tympanostomy tubes
5738123|NCT00365092|Otitis media with effusion|otitis media with effusion
5738124|NCT00365092|Child development|child development
5738125|NCT00365092|Literacy|literacy
5738126|NCT00365092|Attention|attention
5738127|NCT00365092|Middle-ear effusion|middle-ear effusion
5738128|NCT00365092|Educational status|educational status
5738129|NCT00365092|Behavior|behavior
5738130|NCT00365092|Social behavior|social behavior
5738131|NCT00365092|Achievement|achievement
5738133|NCT00365040|excimer laser|excimer laser
5738134|NCT00365027|GNRH agonist|gnrh agonist
5738135|NCT00365027|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome
5738136|NCT00365027|Embryo cryopreservation|embryo cryopreservation
5738137|NCT00365014|aplastic anemia|aplastic anemia
5738138|NCT00365014|myelodysplastic syndromes|myelodysplastic syndromes
5738139|NCT00365014|cytopenias|cytopenias
5738140|NCT00365014|acute myeloid leukemia|acute myeloid leukemia
5738141|NCT00365014|myelodysplastic/myeloproliferative diseases|myelodysplastic/myeloproliferative diseases
5738142|NCT00365014|benzene poisoning|benzene poisoning
5738143|NCT00364988|pioglitazone|pioglitazone
5738144|NCT00364988|losartan|losartan
5738145|NCT00364988|proteinuria|proteinuria
5738146|NCT00364988|end stage renal disease (ESRD)|end stage renal disease (esrd)
5738147|NCT00364975|gourmet healthy cooking|gourmet healthy cooking
5738148|NCT00364975|quality of life|quality of life
5738149|NCT00364975|adjuvant chemotherapy|adjuvant chemotherapy
5738150|NCT00364975|weight|weight
5738151|NCT00364975|breast cancer|breast cancer
5738152|NCT00364962|NPC|npc
5738153|NCT00364962|Nasopharyngectomy|nasopharyngectomy
5738154|NCT00364962|KTP laser|ktp laser
5738155|NCT00364962|recurrence|recurrence
5738156|NCT00364949|Polycystic Ovary Syndrome|polycystic ovary syndrome
5738160|NCT00364936|palliative care|palliative care
5738161|NCT00364936|hospice|hospice
5738162|NCT00364936|end-of-life|end-of-life
5686229|NCT00552955|Ascites|ascites
5763480|NCT00270088|epogen|epogen
5738163|NCT00364936|symptom control|symptom control
5738164|NCT00364936|evaluation|evaluation
5738165|NCT00364936|effectiveness|effectiveness
5738166|NCT00364923|Peripheral T-cell Lymphoma|peripheral t-cell lymphoma
5738167|NCT00364923|T-cell Lymphoma|t-cell lymphoma
5738168|NCT00364923|Lymphoma|lymphoma
5738169|NCT00364923|PDX|pdx
5738170|NCT00364923|Pralatrexate|pralatrexate
5738171|NCT00364923|Vitamin B12|vitamin b12
5738172|NCT00364923|Folic acid|folic acid
5738173|NCT00364910|Myocardial Infarction (MI)|myocardial infarction (mi)
5738174|NCT00364910|Cognitive Behavioral Therapy (CBT)|cognitive behavioral therapy (cbt)
5738175|NCT00364910|Adherence|adherence
5738176|NCT00364910|Depression|depression
5738177|NCT00364884|chronic kidney disease|chronic kidney disease
5738178|NCT00364871|Obesity|obesity
5738179|NCT00364858|Type 1 Gaucher Disease|type 1 gaucher disease
5738180|NCT00364858|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5738181|NCT00364845|Quality of Life|quality of life
5738182|NCT00364845|Chronic Kidney Disease|chronic kidney disease
5738183|NCT00364845|Anemia|anemia
5738184|NCT00364819|Primary Biliary Cirrhosis|primary biliary cirrhosis
5738185|NCT00364806|Migraine|migraine
5738186|NCT00364806|Headache|headache
5738187|NCT00364793|HIV, Pediatric|hiv, pediatric
5738188|NCT00364767|Moderate alcohol consumption|moderate alcohol consumption
5738189|NCT00364767|Fat and carbohydrate oxidative capacity|fat and carbohydrate oxidative capacity
5738190|NCT00364767|Postprandial glycemic response|postprandial glycemic response
5738191|NCT00364754|Tesmilifene|tesmilifene
5738192|NCT00364754|DPPE|dppe
5738193|NCT00364754|Breast cancer|breast cancer
5738194|NCT00364754|Cyclophosphamide|cyclophosphamide
5738195|NCT00364754|Epirubicin|epirubicin
5738196|NCT00364754|Pharmacokinetic|pharmacokinetic
5738197|NCT00364715|Nuclear localization, annexin A1, oral SCC|nuclear localization, annexin a1, oral scc
5738198|NCT00364702|Virtual Reality|virtual reality
5738199|NCT00364702|ADHD|adhd
5738200|NCT00364702|Methylphenidate|methylphenidate
5738201|NCT00364689|Encephalopathy, Hepatic|encephalopathy, hepatic
5738202|NCT00364689|Portosystemic Encephalopathy|portosystemic encephalopathy
5738203|NCT00364689|Encephalopathy, Hepatocerebral|encephalopathy, hepatocerebral
5738204|NCT00364689|Encephalopathy, Portal-Systemic|encephalopathy, portal-systemic
5738205|NCT00364689|Encephalopathy, Portosystemic|encephalopathy, portosystemic
5738206|NCT00364689|Hepatic Coma|hepatic coma
5738207|NCT00364689|Hepatic Stupor|hepatic stupor
5738208|NCT00364689|Hepatocerebral Encephalopathy|hepatocerebral encephalopathy
5738209|NCT00364689|Portal-Systemic Encephalopathy|portal-systemic encephalopathy
5738210|NCT00364676|Vinorelbine|vinorelbine
5738211|NCT00364676|solid tumors|solid tumors
5738212|NCT00364676|Hodgkins|hodgkins
5738213|NCT00364676|Non hodgkins|non hodgkins
5738214|NCT00364676|Lymphoma|lymphoma
5738215|NCT00364676|Advanced solid tumors|advanced solid tumors
5738216|NCT00364663|NSCLC|nsclc
5738217|NCT00364663|staging|staging
5738218|NCT00364663|18F-FDG PET|18f-fdg pet
5738219|NCT00364663|decision tree model|decision tree model
5738220|NCT00364663|cost-effectiveness|cost-effectiveness
5738221|NCT00364650|Renal transplantation|renal transplantation
5738222|NCT00364650|Diarrhea|diarrhea
5738223|NCT00364650|Immunosuppression|immunosuppression
5738224|NCT00364650|Probiotics|probiotics
5738225|NCT00364637|Sevoflurane|sevoflurane
5738226|NCT00364637|Anesthesia|anesthesia
5738227|NCT00364637|Troponin|troponin
5738228|NCT00364637|Myocardial Preconditioning|myocardial preconditioning
5738229|NCT00364637|Surgery, Cardiac|surgery, cardiac
5738230|NCT00364637|Stents|stents
5738231|NCT00364637|Non-cardiac Surgery|non-cardiac surgery
5738232|NCT00364637|Surgery|surgery
5738233|NCT00364624|lung cancer|lung cancer
5738234|NCT00364624|adrenal insufficiency|adrenal insufficiency
5738235|NCT00364598|Anginera|anginera
5738236|NCT00364598|LVAD|lvad
5738237|NCT00364598|Transplant|transplant
5738238|NCT00364598|Histology|histology
5738239|NCT00364598|LVAD implantation as a bridge to transplant|lvad implantation as a bridge to transplant
5738240|NCT00364572|sciatica|sciatica
5738241|NCT00364572|low back pain|low back pain
5738242|NCT00364572|epidural|epidural
5738243|NCT00364572|tumor necrosis factor|tumor necrosis factor
5738244|NCT00364559|intracerebral hemorrhage|intracerebral hemorrhage
5738246|NCT00364559|rosuvastatin|rosuvastatin
5738247|NCT00364559|stroke|stroke
5738248|NCT00364546|Osteoarthritis|osteoarthritis
5738249|NCT00364546|Pain|pain
5738250|NCT00364546|Low Back Pain|low back pain
5738251|NCT00364546|Hip Pain|hip pain
5738252|NCT00364546|Knee Pain|knee pain
5738253|NCT00364546|Backache|backache
5738254|NCT00364546|tapentadol|tapentadol
5738255|NCT00364533|Arthralgia|arthralgia
5738256|NCT00364533|Pain|pain
5738257|NCT00364533|Pain Assessment|pain assessment
5738258|NCT00364533|Hip Replacement|hip replacement
5738259|NCT00364533|Tapentadol|tapentadol
5738260|NCT00364520|Hematologic Diseases|hematologic diseases
5738261|NCT00364520|Benzene|benzene
5738262|NCT00364520|Genetic Polymorphisms|genetic polymorphisms
5763588|NCT00269828|NSCLC|nsclc
5738264|NCT00364494|Hemodilution|hemodilution
5738265|NCT00364494|Blood Transfusion|blood transfusion
5738266|NCT00364494|Cardiopulmonary Bypass|cardiopulmonary bypass
5738267|NCT00364494|Multiple Organ Failure|multiple organ failure
5738268|NCT00364494|Surgery, Cardiac|surgery, cardiac
5738269|NCT00364494|Kidney Failure|kidney failure
5738270|NCT00364494|Cardiac Surgical Procedures|cardiac surgical procedures
5738271|NCT00364481|apnea|apnea
5738272|NCT00364481|tongue|tongue
5738273|NCT00364481|exercises|exercises
5738274|NCT00364481|reflux|reflux
5738275|NCT00364481|airway|airway
5738276|NCT00364481|upper|upper
5738277|NCT00364481|fatigue|fatigue
5738278|NCT00364468|pegfilgrastim|pegfilgrastim
5738279|NCT00364468|neutropenia|neutropenia
5738280|NCT00364468|cancer patients|cancer patients
5738281|NCT00364468|lymphoma|lymphoma
5738282|NCT00364455|Hormone refractory prostate cancer|hormone refractory prostate cancer
5738283|NCT00364455|Anemia|anemia
5738284|NCT00364455|Quality-of-life|quality-of-life
5738285|NCT00364442|asthma|asthma
5738286|NCT00364429|schizophrenic patients|schizophrenic patients
5738287|NCT00364429|SPET|spet
5738288|NCT00364429|NMDA receptor|nmda receptor
5738289|NCT00364429|ligand [123]I-CNS 1261|ligand [123]i-cns 1261
5738290|NCT00364416|Heart Failure, congestive|heart failure, congestive
5738291|NCT00364416|Heart decompensation|heart decompensation
5738292|NCT00364403|Glycemic index|glycemic index
5738293|NCT00364403|Glycemic load|glycemic load
5738294|NCT00364403|Low fat|low fat
5738295|NCT00364403|Impaired glucose tolerance|impaired glucose tolerance
5738398|NCT00363896|Exacerbations|exacerbations
5738296|NCT00364403|Large for gestational age infant|large for gestational age infant
5738297|NCT00364403|Excessive body weight|excessive body weight
5738298|NCT00364390|CABG|cabg
5738299|NCT00364390|Anginera|anginera
5738301|NCT00364351|Non Small Cell Lung Cancer|non small cell lung cancer
5738302|NCT00364351|NSCLC|nsclc
5738303|NCT00364338|gourmet healthy cooking|gourmet healthy cooking
5738304|NCT00364338|quality of life|quality of life
5738305|NCT00364338|preimenopause|preimenopause
5738306|NCT00364338|weight|weight
5738307|NCT00364338|lipids|lipids
5738308|NCT00364325|Heart failure, congestive|heart failure, congestive
5738309|NCT00364325|Heart decompensation|heart decompensation
5738310|NCT00364312|behavior therapy|behavior therapy
5738311|NCT00364312|dietary control|dietary control
5738312|NCT00364312|exercise|exercise
5738313|NCT00364312|diabetes mellitus|diabetes mellitus
5738314|NCT00364312|behavior modification|behavior modification
5738315|NCT00364312|blood glucose|blood glucose
5738316|NCT00364312|clinical trial|clinical trial
5738317|NCT00364312|diabetes education|diabetes education
5738318|NCT00364312|health behavior|health behavior
5738319|NCT00364312|health care service utilization|health care service utilization
5738320|NCT00364312|obesity|obesity
5738321|NCT00364312|quality of life|quality of life
5738322|NCT00364299|Ventilator-associated pneumonia|ventilator-associated pneumonia
5738323|NCT00364299|Mechanical ventilation|mechanical ventilation
5738324|NCT00364299|Tracheal tube cuff pressure|tracheal tube cuff pressure
5738325|NCT00364286|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5738326|NCT00364286|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5738327|NCT00364286|Prolymphocytic Leukemia|prolymphocytic leukemia
5738328|NCT00364286|Leukemia|leukemia
5738329|NCT00364286|Lymphoma|lymphoma
5738330|NCT00364286|Dasatinib|dasatinib
5738331|NCT00364286|BMS-354825|bms-354825
5738332|NCT00364273|Asthma|asthma
5738333|NCT00364260|Anemia|anemia
5738334|NCT00364260|epoetin alfa|epoetin alfa
5738335|NCT00364247|Acute pain|acute pain
5738336|NCT00364247|bunionectomy|bunionectomy
5738337|NCT00364234|Renal Osteodystrophy|renal osteodystrophy
5738338|NCT00364195|Metastatic breast cancer|metastatic breast cancer
5738339|NCT00364195|Tesmilifene|tesmilifene
5738340|NCT00364195|DPPE|dppe
5738341|NCT00364182|Hemophilia B|hemophilia b
5738342|NCT00364182|BeneFIX|benefix
5738343|NCT00364169|constipation|constipation
5738344|NCT00364169|cancer|cancer
5738345|NCT00364169|surgery|surgery
5738346|NCT00364169|intervention|intervention
5738347|NCT00364169|nursing|nursing
5738348|NCT00364169|postoperative|postoperative
5738349|NCT00364143|Cancer|cancer
5738350|NCT00364143|Advanced Solid Tumor|advanced solid tumor
5738351|NCT00364143|Oncology|oncology
5738352|NCT00364117|150 discharges|150 discharges
5738353|NCT00364117|adults|adults
5738354|NCT00364117|Internal Medicine|internal medicine
5738355|NCT00364104|Iron deficiency|iron deficiency
5738356|NCT00364104|Helicobacter infection|helicobacter infection
5738357|NCT00364104|Epidemiology|epidemiology
5738358|NCT00364091|allergic conjunctivitis, ophthalmology, multicenter, controlled|allergic conjunctivitis, ophthalmology, multicenter, controlled
5738359|NCT00364078|Cross-sectional correlational study|cross-sectional correlational study
5738360|NCT00364078|Uncertainty|uncertainty
5738361|NCT00364078|Locus of Control|locus of control
5738362|NCT00364078|Quality of life|quality of life
5738363|NCT00364078|Transitoriness|transitoriness
5738364|NCT00364078|Cancer care|cancer care
5737388|NCT00367731|HIV|hiv
5738365|NCT00364052|Valganciclovir, Oral Ganciclovir, Liver transplant|valganciclovir, oral ganciclovir, liver transplant
5738368|NCT00364013|metastatic colorectal cancer|metastatic colorectal cancer
5738369|NCT00364013|EGFr|egfr
5738370|NCT00364013|Panitumumab|panitumumab
5738371|NCT00364013|Clinical Trail|clinical trail
5738372|NCT00364013|Amgen|amgen
5738373|NCT00364000|haemodialysis|haemodialysis
5738374|NCT00364000|hyperphosphatemia|hyperphosphatemia
5738375|NCT00364000|sevelamer|sevelamer
5738376|NCT00364000|calcium acetate|calcium acetate
5738377|NCT00363987|nephropathy with type 2 diabetes|nephropathy with type 2 diabetes
5738378|NCT00363974|AML|aml
5738379|NCT00363974|leukemia|leukemia
5738380|NCT00363974|relapse|relapse
5738381|NCT00363974|refractory|refractory
5738382|NCT00363974|antisense|antisense
5738383|NCT00363974|oligonucleotide|oligonucleotide
5738384|NCT00363961|End stage renal disease|end stage renal disease
5738385|NCT00363961|Maintenance dialysis|maintenance dialysis
5738386|NCT00363961|Resistance exercise|resistance exercise
5738387|NCT00363961|Muscle wasting|muscle wasting
5738388|NCT00363961|Disability|disability
5738389|NCT00363948|MK-0431|mk-0431
5738390|NCT00363948|ONO-5435|ono-5435
5738391|NCT00363948|Type 2 diabetes mellitus|type 2 diabetes mellitus
5738392|NCT00363922|Coronary Artery Bypass [E04.100.376.719.332]|coronary artery bypass [e04.100.376.719.332]
5738393|NCT00363909|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5738394|NCT00363909|hot flashes|hot flashes
5738395|NCT00363909|breast cancer|breast cancer
5738396|NCT00363896|COPD|copd
5738397|NCT00363896|Lung function|lung function
5738399|NCT00363896|Quality of Life|quality of life
5738400|NCT00363870|Influenza vaccine|influenza vaccine
5738401|NCT00363870|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5748495|NCT00325637|CHERISH|cherish
5738402|NCT00363857|fatigue|fatigue
5738403|NCT00363857|sleep|sleep
5738404|NCT00363857|sleep disorder|sleep disorder
5738405|NCT00363857|Legs|legs
5738407|NCT00363857|Restless Legs Syndrome|restless legs syndrome
5738408|NCT00363857|Ropinirole|ropinirole
5738409|NCT00363844|MK-0431|mk-0431
5738410|NCT00363844|ONO-5435|ono-5435
5738411|NCT00363844|Type 2 diabetes mellitus|type 2 diabetes mellitus
5738412|NCT00363818|Endothelial function|endothelial function
5738413|NCT00363818|Platelet function|platelet function
5738414|NCT00363818|Coronary artery disease|coronary artery disease
5738415|NCT00363818|Thrombosis|thrombosis
5738416|NCT00363818|Aggregation|aggregation
5738417|NCT00363805|lung cancer|lung cancer
5738418|NCT00363805|prevention|prevention
5738419|NCT00363805|green tea|green tea
5738420|NCT00363805|former smokers|former smokers
5738421|NCT00363792|Healthy subjects|healthy subjects
5738422|NCT00363779|Large Granular Lymphocyte (LGL)|large granular lymphocyte (lgl)
5738423|NCT00363779|LGL|lgl
5738424|NCT00363779|Leukemia|leukemia
5738425|NCT00363779|Cyclosporine|cyclosporine
5738426|NCT00363779|Microarray|microarray
5738428|NCT00363779|Cyclosporin|cyclosporin
5738429|NCT00363779|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
5738430|NCT00363779|LGL Leukemia|lgl leukemia
5738431|NCT00363753|Transient ischemic attack|transient ischemic attack
5738432|NCT00363753|Stroke|stroke
5738433|NCT00363753|Aspirin|aspirin
5738434|NCT00363753|Clopidogrel|clopidogrel
5738435|NCT00363740|GW685698X|gw685698x
5738436|NCT00363740|allergic rhinitis|allergic rhinitis
5738437|NCT00363740|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5738438|NCT00363727|dyskinesia|dyskinesia
5738439|NCT00363727|SINEMET|sinemet
5738440|NCT00363727|Parkinson's disease|parkinson's disease
5738441|NCT00363727|controlled release ropinirole|controlled release ropinirole
5738442|NCT00363701|Protonpumpinhibitors|protonpumpinhibitors
5738443|NCT00363701|withdrawal|withdrawal
5738444|NCT00363701|longterm treatment|longterm treatment
5738445|NCT00363701|dyspepsia|dyspepsia
5738446|NCT00363701|functional dyspepsia|functional dyspepsia
5738447|NCT00363701|gastrooesophageal reflux|gastrooesophageal reflux
5738448|NCT00363701|upper endoscopy|upper endoscopy
5738449|NCT00363688|Non life threatening allergic reaction|non life threatening allergic reaction
5738450|NCT00363688|oral challenge|oral challenge
5738451|NCT00363688|penicillin|penicillin
5738452|NCT00363688|skin testing|skin testing
5738453|NCT00363675|Hand Burns|hand burns
5738454|NCT00363675|Pediatrics|pediatrics
5738455|NCT00363649|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5738456|NCT00363649|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5738458|NCT00363636|NHL|nhl
5738459|NCT00363636|pharmacokinetics|pharmacokinetics
5738460|NCT00363636|antibody|antibody
5738461|NCT00363636|safety|safety
5738462|NCT00363636|galiximab|galiximab
5738463|NCT00363636|efficacy|efficacy
5738464|NCT00363636|rituximab|rituximab
5738465|NCT00363636|refractory|refractory
5738466|NCT00363610|Advanced and/or Metastatic Solid Tumors and Lymphoma|advanced and/or metastatic solid tumors and lymphoma
5738467|NCT00363597|dyspepsia|dyspepsia
5738468|NCT00363597|gastrointestinal disease|gastrointestinal disease
5686230|NCT00552955|Tuberous Sclerosis Complex|tuberous sclerosis complex
5686231|NCT00552955|LAM|lam
5686232|NCT00552942|obesity|obesity
5686233|NCT00552942|diabetes|diabetes
5686234|NCT00552942|cytokines|cytokines
5738469|NCT00363597|indigestion|indigestion
5738470|NCT00363584|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5738471|NCT00363584|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5738472|NCT00363584|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5738473|NCT00363584|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5738474|NCT00363584|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5738475|NCT00363584|anaplastic carcinoma of the gallbladder|anaplastic carcinoma of the gallbladder
5738476|NCT00363584|localized gallbladder cancer|localized gallbladder cancer
5738477|NCT00363584|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5738478|NCT00363584|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5738479|NCT00363584|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5738480|NCT00363558|skin graft|skin graft
5738481|NCT00363558|fixation|fixation
5738482|NCT00363558|cyanoacrylate glue|cyanoacrylate glue
5738483|NCT00363558|skin staples|skin staples
5738484|NCT00363545|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
5738485|NCT00363532|migraine with out aura|migraine with out aura
5738486|NCT00363519|MK-0431|mk-0431
5738487|NCT00363519|ONO-5435|ono-5435
5738488|NCT00363519|Type 2 diabetes mellitus|type 2 diabetes mellitus
5738489|NCT00363506|nutritional|nutritional
5738490|NCT00363506|C10.228.140.546.399.750|c10.228.140.546.399.750
5738491|NCT00363480|Asthma|asthma
5738492|NCT00363480|Asthma Control Test|asthma control test
5738493|NCT00363480|SERETIDE|seretide
5738494|NCT00363467|Busulfan|busulfan
5738495|NCT00363467|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5789089|NCT00149942|transplantation|transplantation
5738496|NCT00363467|Hematopoietic Stem Cell Transplantation (HSCT)|hematopoietic stem cell transplantation (hsct)
5738497|NCT00363467|Dendritic cells|dendritic cells
5738498|NCT00363467|Bone marrow transplantation|bone marrow transplantation
5738499|NCT00363467|PBSC mobilization|pbsc mobilization
5738500|NCT00363467|Autologous stem cells|autologous stem cells
5738501|NCT00363454|Phase I|phase i
5738502|NCT00363454|Pharmacokinetics|pharmacokinetics
5738503|NCT00363454|TCN-PM|tcn-pm
5755915|NCT00298077|Infection|infection
5755916|NCT00298077|transplant recipients|transplant recipients
5755917|NCT00298064|Cervical cancer|cervical cancer
5755918|NCT00298064|EGFR|egfr
5738504|NCT00363454|VD-0002|vd-0002
5738505|NCT00363454|Immunohistochemistry|immunohistochemistry
5738506|NCT00363454|Serum tumor marker|serum tumor marker
5738507|NCT00363454|Akt phosphorylation|akt phosphorylation
5738508|NCT00363454|Ex vivo testing|ex vivo testing
5738509|NCT00363454|metastatic|metastatic
5738510|NCT00363441|head and neck neoplasms|head and neck neoplasms
5738511|NCT00363441|squamous cell cancer|squamous cell cancer
5738512|NCT00363441|intensity modulated radiotherapy|intensity modulated radiotherapy
5738513|NCT00363428|pulmonary complications|pulmonary complications
5738514|NCT00363428|perioperative/postoperative complications|perioperative/postoperative complications
5738516|NCT00363428|non-small cell lung cancer|non-small cell lung cancer
5738517|NCT00363428|small cell lung cancer|small cell lung cancer
5738518|NCT00363402|Cystic Fibrosis|cystic fibrosis
5738519|NCT00363389|Hysteroscopy|hysteroscopy
5738520|NCT00363389|Misoprostol|misoprostol
5738521|NCT00363389|Uterine hemorrhage|uterine hemorrhage
5738522|NCT00363389|Uterine cervix|uterine cervix
5738523|NCT00363389|Dilatation|dilatation
5738524|NCT00363376|olanzapine|olanzapine
5738525|NCT00363376|zonisamide|zonisamide
5738526|NCT00363376|weight gain|weight gain
5738527|NCT00363376|bipolar disorder|bipolar disorder
5738528|NCT00363376|psychotic disorders|psychotic disorders
5738529|NCT00363363|Pediatrics|pediatrics
5738530|NCT00363363|Fontan Procedure|fontan procedure
5738531|NCT00363363|Physical Activity|physical activity
5738532|NCT00363363|Physical Fitness|physical fitness
5738533|NCT00363363|Congenital Heart Defects|congenital heart defects
5738534|NCT00363363|exercise rehabilitation|exercise rehabilitation
5738535|NCT00363337|Adults|adults
5738536|NCT00363337|Bipolar Depression|bipolar depression
5738537|NCT00363337|Bipolar Disorder|bipolar disorder
5738538|NCT00363337|Bipolar I|bipolar i
5738539|NCT00363337|Bipolar II|bipolar ii
5738540|NCT00363337|Depression|depression
5738541|NCT00363324|stem cell|stem cell
5738542|NCT00363324|acute myocardial infarction|acute myocardial infarction
5738543|NCT00363311|Dutasteride Prostate Cancer Expectant management REDEEM|dutasteride prostate cancer expectant management redeem
5738544|NCT00363298|D-amphetamine, dextro-amphetamine, stimulant drug|d-amphetamine, dextro-amphetamine, stimulant drug
5738545|NCT00363285|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5738546|NCT00363285|stage III prostate cancer|stage iii prostate cancer
5738547|NCT00363285|stage IV prostate cancer|stage iv prostate cancer
5738549|NCT00363246|Fall risk|fall risk
5738550|NCT00363246|Veterans|veterans
5738551|NCT00363246|WheelChairs|wheelchairs
5738552|NCT00363246|Injury|injury
5738553|NCT00363233|type 2 diabetes|type 2 diabetes
5738554|NCT00363233|lignans|lignans
5738555|NCT00363233|flaxseed|flaxseed
5738556|NCT00363233|cholesterol|cholesterol
5738557|NCT00363220|Infection|infection
5738558|NCT00363220|E coli|e coli
5738559|NCT00363220|Klebsiella|klebsiella
5738560|NCT00363220|ESBL|esbl
5738561|NCT00363207|behavior|behavior
5738562|NCT00363207|local anesthesia|local anesthesia
5738563|NCT00363207|behavior after dental local anesthesia|behavior after dental local anesthesia
5738564|NCT00363194|Pazopanib GW786034 Advanced cancer Metastatic cancer|pazopanib gw786034 advanced cancer metastatic cancer
5738565|NCT00363181|Insulin resistance|insulin resistance
5738566|NCT00363181|Metabolic problems|metabolic problems
5738567|NCT00363181|Weight gain|weight gain
5738568|NCT00363181|Mental health problems|mental health problems
5738569|NCT00363181|Mental disorders|mental disorders
5738570|NCT00363181|Antipsychotic medication|antipsychotic medication
5738571|NCT00363181|Olanzapine|olanzapine
5738572|NCT00363168|Hemorrhagic Choroidal Neovascularization|hemorrhagic choroidal neovascularization
5738573|NCT00363155|chronic|chronic
5738574|NCT00363155|hepatitis b|hepatitis b
5738575|NCT00363142|HIV-1 LEXIVA Ritonavir Once-daily|hiv-1 lexiva ritonavir once-daily
5738576|NCT00363129|neurotoxicity|neurotoxicity
5738577|NCT00363129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5738578|NCT00363116|Kidney transplant|kidney transplant
5738579|NCT00363116|Pancreas transplant|pancreas transplant
5738580|NCT00363116|Daclizumab|daclizumab
5738581|NCT00363116|Tacrolimus|tacrolimus
5738582|NCT00363116|Mycophenolate mofetil|mycophenolate mofetil
5738583|NCT00363116|Steroids|steroids
5738584|NCT00363116|Immunosuppression|immunosuppression
5738585|NCT00363116|Acute allograft rejection|acute allograft rejection
5738586|NCT00363090|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5738587|NCT00363090|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5738591|NCT00363090|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5738592|NCT00363090|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5738593|NCT00363090|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5738594|NCT00363090|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5738595|NCT00363090|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5738596|NCT00363090|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5738597|NCT00363090|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5738598|NCT00363090|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5738599|NCT00363077|Influenza vaccine|influenza vaccine
5738600|NCT00363077|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5738602|NCT00363051|Tumor|tumor
5738603|NCT00363051|Islet Cell|islet cell
5738604|NCT00363051|Carcinoma|carcinoma
5738605|NCT00363051|Neuroendocrine|neuroendocrine
5738606|NCT00363051|Endocrine|endocrine
5738607|NCT00363051|Atypical Carcinoid|atypical carcinoid
5738608|NCT00363051|RADIANT1|radiant1
5738610|NCT00363038|Bruising|bruising
5738611|NCT00363038|Topical 20% arnica|topical 20% arnica
5738612|NCT00363025|Acute myeloid leukemia|acute myeloid leukemia
5738613|NCT00363025|Older patients|older patients
5738614|NCT00363025|Patient aged 65 years or more|patient aged 65 years or more
5738615|NCT00363012|stage IIIA breast cancer|stage iiia breast cancer
5738616|NCT00363012|stage IIIB breast cancer|stage iiib breast cancer
5738617|NCT00363012|stage IIIC breast cancer|stage iiic breast cancer
5738618|NCT00363012|stage IV breast cancer|stage iv breast cancer
5738619|NCT00363012|male breast cancer|male breast cancer
5738620|NCT00362999|Allergic|allergic
5738621|NCT00362999|Rhinitis|rhinitis
5738622|NCT00362999|Pharmacogenetics|pharmacogenetics
5738623|NCT00362999|Histamine|histamine
5738624|NCT00362986|dermatologic complications|dermatologic complications
5738625|NCT00362986|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5738626|NCT00362973|male breast cancer|male breast cancer
5738627|NCT00362973|recurrent breast cancer|recurrent breast cancer
5738628|NCT00362973|stage I breast cancer|stage i breast cancer
5738629|NCT00362973|stage II breast cancer|stage ii breast cancer
5738630|NCT00362973|stage IIIA breast cancer|stage iiia breast cancer
5738631|NCT00362973|stage IIIB breast cancer|stage iiib breast cancer
5738632|NCT00362973|stage IIIC breast cancer|stage iiic breast cancer
5738633|NCT00362973|stage IV breast cancer|stage iv breast cancer
5738634|NCT00362960|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5738635|NCT00362960|Diabetic Nephropathy|diabetic nephropathy
5738636|NCT00362960|Inflammatory Markers|inflammatory markers
5738637|NCT00362960|Proteinuria|proteinuria
5738638|NCT00362960|Renal Disease|renal disease
5738639|NCT00362947|Superficial vein thrombosis|superficial vein thrombosis
5738640|NCT00362947|thrombophlebitis|thrombophlebitis
5738642|NCT00362947|parnaparin|parnaparin
5686235|NCT00552890|obesity|obesity
5686236|NCT00552890|atkins|atkins
5686237|NCT00552890|weight reduction|weight reduction
5686238|NCT00552890|kidney function|kidney function
5686239|NCT00552877|PCI|pci
5686240|NCT00552877|Drug-eluting stent|drug-eluting stent
5686241|NCT00552851|acromegaly|acromegaly
5738643|NCT00362934|Hyperlipidemia Combined|hyperlipidemia combined
5738644|NCT00362934|efficacy combination fenofibrate simvastatin versus atorvastatin|efficacy combination fenofibrate simvastatin versus atorvastatin
5738645|NCT00362921|adult glioblastoma multiforme|adult glioblastoma multiforme
5738646|NCT00362921|adult gliosarcoma|adult gliosarcoma
5738647|NCT00362921|recurrent adult brain tumor|recurrent adult brain tumor
5738649|NCT00362908|Hypertension|hypertension
5738650|NCT00362908|Insulin Resistance|insulin resistance
5738651|NCT00362869|Enteroaggregative Escherichia coli, diarrhea, challenge|enteroaggregative escherichia coli, diarrhea, challenge
5738652|NCT00362856|larazotide acetate|larazotide acetate
5738659|NCT00362817|Recurrent|recurrent
5738660|NCT00362817|Symptomatic|symptomatic
5738661|NCT00362804|tetrabenazine|tetrabenazine
5738662|NCT00362804|partial response|partial response
5738663|NCT00362804|psychosis|psychosis
5738664|NCT00362804|schizophrenia|schizophrenia
5738665|NCT00362804|schizoaffective disorder|schizoaffective disorder
5738666|NCT00362804|partial response to antipsychotics|partial response to antipsychotics
5738667|NCT00362791|voluntary counseling and testing|voluntary counseling and testing
5738668|NCT00362791|HIV/STD prevention counseling|hiv/std prevention counseling
5738669|NCT00362791|HIV/STD prevention intervention|hiv/std prevention intervention
5738670|NCT00362791|counseling efficacy|counseling efficacy
5738671|NCT00362765|Type 2 Diabetes|type 2 diabetes
5738672|NCT00362765|Dyslipidemia|dyslipidemia
5738673|NCT00362765|Hyperinsulinemic|hyperinsulinemic
5738674|NCT00362765|Clamp|clamp
5738675|NCT00362765|Metformin|metformin
5738676|NCT00362765|Fenofibrate|fenofibrate
5738677|NCT00362752|norfloxacin|norfloxacin
5738678|NCT00362752|hepatopulmonary syndrome|hepatopulmonary syndrome
5738679|NCT00362726|HIV|hiv
5738680|NCT00362687|HIV, HAART|hiv, haart
5738681|NCT00362661|PTSD|ptsd
5738682|NCT00362661|cortisol|cortisol
5738683|NCT00362661|memory|memory
5738684|NCT00362661|treatment|treatment
5738685|NCT00362622|Travalert|travalert
5738686|NCT00362622|open angle glaucoma|open angle glaucoma
5738687|NCT00362609|Safety|safety
5738688|NCT00362596|Acyclovir|acyclovir
5738689|NCT00362596|HIV|hiv
5738690|NCT00362596|HSV|hsv
5738691|NCT00362583|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
5738692|NCT00362570|Newly diagnosed|newly diagnosed
5738693|NCT00362544|antifungal prophylaxis|antifungal prophylaxis
5738694|NCT00362544|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5738695|NCT00362544|acute leukaemia|acute leukaemia
5738696|NCT00362544|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia|antifungal prophylaxis treatment of allogeneic stem-cell transplantation and acute leukaemia
5738697|NCT00362518|atherosclerosis|atherosclerosis
5738698|NCT00362518|vitamin C|vitamin c
5738699|NCT00362518|vitamin E|vitamin e
5738700|NCT00362492|TKR|tkr
5738701|NCT00362492|Ultrasonography|ultrasonography
5738702|NCT00362492|asymptomatic deep venous thrombosis|asymptomatic deep venous thrombosis
5738703|NCT00362492|extended duration prophylaxis|extended duration prophylaxis
5738704|NCT00362492|short duration prophylaxis|short duration prophylaxis
5738705|NCT00362479|pregnancy prevention|pregnancy prevention
5738706|NCT00362479|oral contraceptives|oral contraceptives
5733840|NCT00379470|GBM|gbm
5738707|NCT00362466|Leukemia (chronic myeloid leukemia - chronic phase)|leukemia (chronic myeloid leukemia - chronic phase)
5738709|NCT00362440|Leptin|leptin
5738710|NCT00362440|Fat wasting|fat wasting
5738711|NCT00362440|Pioglitazone|pioglitazone
5738712|NCT00362440|Insulin resistance|insulin resistance
5738713|NCT00362427|Hepatitis B|hepatitis b
5738714|NCT00362427|Pertussis|pertussis
5738715|NCT00362427|Diphtheria|diphtheria
5738716|NCT00362427|Tetanus|tetanus
5738717|NCT00362427|H. influenzae type b|h. influenzae type b
5738718|NCT00362427|Polio|polio
5738719|NCT00362414|Stroke|stroke
5738720|NCT00362401|Psychoacoustics|psychoacoustics
5738721|NCT00362401|Quality of Life|quality of life
5738722|NCT00362401|Heart Valve Prosthesis|heart valve prosthesis
5738723|NCT00362388|Coronary artery disease|coronary artery disease
5738724|NCT00362388|Ischemic heart disease|ischemic heart disease
5738725|NCT00362388|Angiogenesis|angiogenesis
5738726|NCT00362388|Cells|cells
5738727|NCT00362388|Cardiac surgery|cardiac surgery
5738728|NCT00362375|Adult|adult
5738729|NCT00362375|*HIV Infections/pc [Prevention & Control]|*hiv infections/pc [prevention & control]
5738730|NCT00362375|Female|female
5738731|NCT00362375|Humans|humans
5738732|NCT00362375|Risk-Taking|risk-taking
5738733|NCT00362375|Safe Sex|safe sex
5738734|NCT00362375|Sexual Behavior|sexual behavior
5737775|NCT00365833|Renal|renal
5738735|NCT00362375|HIV Testing|hiv testing
5738736|NCT00362362|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5738737|NCT00362362|Primary Lateral Sclerosis|primary lateral sclerosis
5738738|NCT00362362|Genetics|genetics
5738739|NCT00362362|Blood Sample|blood sample
5738740|NCT00362362|PLS|pls
5738741|NCT00362362|ALS|als
5738742|NCT00362349|ITP|itp
5738743|NCT00362349|IVIg|ivig
5738744|NCT00362349|Platelet count|platelet count
5738745|NCT00362349|Bleeding|bleeding
5738746|NCT00362336|Hepatitis B|hepatitis b
5738747|NCT00362336|Polio|polio
5738748|NCT00362336|Diphtheria|diphtheria
5738749|NCT00362336|Pertussis|pertussis
5738750|NCT00362336|H. influenzae type b|h. influenzae type b
5738751|NCT00362323|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5738752|NCT00362310|classical kaposi's sarcoma|classical kaposi's sarcoma
5738753|NCT00362310|treatment|treatment
5738754|NCT00362310|HIV protease inhibitor indinavir|hiv protease inhibitor indinavir
5738755|NCT00362284|Alzheimer's disease|alzheimer's disease
5738756|NCT00362284|coping|coping
5738757|NCT00362284|quality of life|quality of life
5738758|NCT00362284|caregiving|caregiving
5738759|NCT00362271|Healthy Subjects|healthy subjects
5738760|NCT00362245|Amikacin|amikacin
5738761|NCT00362245|Pharmacokinetics|pharmacokinetics
5738762|NCT00362245|Pharmacodynamics|pharmacodynamics
5738763|NCT00362245|Intra-Thecal injection|intra-thecal injection
5738764|NCT00362232|Prevention of venous thromboembolism|prevention of venous thromboembolism
5738765|NCT00362219|topical|topical
5738766|NCT00362219|morphine|morphine
5738767|NCT00362219|pain|pain
5738768|NCT00362219|skin-wound|skin-wound
5738769|NCT00362219|skin-graft|skin-graft
5738770|NCT00362219|peripheral analgesia|peripheral analgesia
5738771|NCT00362219|burn|burn
5738772|NCT00362206|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin versus pravastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin versus pravastatin
5738773|NCT00362206|Hyperlipidemia Combined|hyperlipidemia combined
5738774|NCT00362193|Diabetes|diabetes
5739311|NCT00360568|Duodopa|duodopa
5738777|NCT00362180|LDL-cholesterol|ldl-cholesterol
5738778|NCT00362180|apoB-100|apob-100
5738779|NCT00362180|apoB-48|apob-48
5738780|NCT00362180|triglyceride|triglyceride
5738781|NCT00362180|HeFH|hefh
5738782|NCT00362180|FHBL|fhbl
5738783|NCT00362167|Clinical Experience|clinical experience
5738784|NCT00362167|Educational Training|educational training
5738785|NCT00362167|Pain Syndromes|pain syndromes
5738786|NCT00362167|Analgesia|analgesia
5738787|NCT00362167|Pain Medicine|pain medicine
5738788|NCT00362167|Therapy|therapy
5738789|NCT00362167|Neuropathic|neuropathic
5738790|NCT00362167|Chronic Pain|chronic pain
5738791|NCT00362167|Acute Pain|acute pain
5738792|NCT00362167|Analgesics|analgesics
5738793|NCT00362167|Medication|medication
5738794|NCT00362167|Evaluation|evaluation
5738795|NCT00362141|levetiracetam|levetiracetam
5738797|NCT00362141|epilepticus|epilepticus
5738798|NCT00362128|Blood Pressure, High|blood pressure, high
5738799|NCT00362128|Obesity|obesity
5738800|NCT00362128|Tobacco Use Disorder|tobacco use disorder
5738801|NCT00362115|hypertension|hypertension
5738802|NCT00362115|blood pressure|blood pressure
5738803|NCT00362115|diastolic blood pressure|diastolic blood pressure
5738804|NCT00362115|drug therapy|drug therapy
5738805|NCT00362102|EGFR-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure|egfr-detectable metastatic colorectal carcinoma with documented progressive disease to irinotecan-based chemotherapy and failure
5738806|NCT00362089|n-3 fatty acids|n-3 fatty acids
5738807|NCT00362089|n-6 fatty acids|n-6 fatty acids
5738808|NCT00362089|long chain polyunsaturated fatty acids|long chain polyunsaturated fatty acids
5738811|NCT00362089|breast feeding|breast feeding
5738812|NCT00362089|breast milk|breast milk
5738813|NCT00362089|adipose tissue|adipose tissue
5738814|NCT00362089|newborn|newborn
5738815|NCT00362089|fetal development|fetal development
5738816|NCT00362076|Perception|perception
5738817|NCT00362076|Development|development
5738818|NCT00362076|Cognition|cognition
5738819|NCT00362076|Vision|vision
5738820|NCT00362076|Infants|infants
5738821|NCT00362076|Autonomic Function|autonomic function
5738822|NCT00362076|Cardiac Vagal Tone|cardiac vagal tone
5738823|NCT00362076|Categorization|categorization
5738824|NCT00362076|Habituation|habituation
5738825|NCT00362076|Motion-Carried Information|motion-carried information
5738826|NCT00362063|growth hormone|growth hormone
5738827|NCT00362050|malaria, falciparum|malaria, falciparum
5738828|NCT00362050|uncomplicated Plasmodium falciparum malaria|uncomplicated plasmodium falciparum malaria
5738829|NCT00361998|Uncomplicated Cystitis|uncomplicated cystitis
5738830|NCT00361998|Nitrofurantoin Macrocrystals|nitrofurantoin macrocrystals
5738831|NCT00361985|Gastric bypass|gastric bypass
5738832|NCT00361985|Anastomotic stricture|anastomotic stricture
5738833|NCT00361985|Morbid obesity|morbid obesity
5738834|NCT00361985|Bariatric surgery|bariatric surgery
5738835|NCT00361985|Omeprazole|omeprazole
5738836|NCT00361959|fluticasone propionate/salmeterol combination|fluticasone propionate/salmeterol combination
5686242|NCT00552851|heart failure|heart failure
5747982|NCT00327613|PEX|pex
5738837|NCT00361959|tiotropium|tiotropium
5738838|NCT00361959|SERETIDE|seretide
5738839|NCT00361959|COPD exacerbation|copd exacerbation
5738840|NCT00361946|Type 2 diabetes|type 2 diabetes
5738841|NCT00361946|Lean|lean
5738842|NCT00361946|Obese|obese
5738843|NCT00361920|steroid resistant asthma|steroid resistant asthma
5738844|NCT00361907|Pulsatile intravenous insulin|pulsatile intravenous insulin
5738845|NCT00361907|Oral carbohydrate loading|oral carbohydrate loading
5738846|NCT00361907|Respiratory Quotients|respiratory quotients
5738847|NCT00361907|Hypoglycemia|hypoglycemia
5738848|NCT00361907|Diabetic Complications|diabetic complications
5738849|NCT00361907|Circulating vascular and inflammatory markers|circulating vascular and inflammatory markers
5738850|NCT00361868|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5738852|NCT00361842|Colorectal cancer|colorectal cancer
5738853|NCT00361842|Colorectal carcinoma|colorectal carcinoma
5738854|NCT00361842|Colonic cancer|colonic cancer
5738855|NCT00361842|Rectal cancer|rectal cancer
5738858|NCT00361816|Maternal Effect Gene|maternal effect gene
5738859|NCT00361816|Embryonic Development|embryonic development
5738860|NCT00361816|Infertility|infertility
5738861|NCT00361803|chemotherapy|chemotherapy
5738866|NCT00361803|pharmacokinetics|pharmacokinetics
5738867|NCT00361790|Healthy Subjects|healthy subjects
5738868|NCT00361777|Dexamethasone|dexamethasone
5738869|NCT00361777|Cushing Syndrome|cushing syndrome
5738870|NCT00361751|Glucose metabolism|glucose metabolism
5738871|NCT00361751|Fat Metabolism|fat metabolism
5738872|NCT00361751|Insulin Resistance|insulin resistance
5738873|NCT00361751|Protein Metabolism|protein metabolism
5738874|NCT00361751|Tracer Methodology|tracer methodology
5738875|NCT00361738|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5738876|NCT00361725|severe sepsis|severe sepsis
5738877|NCT00361725|organ failure|organ failure
5738878|NCT00361725|activated protein C|activated protein c
5738879|NCT00361725|thrombomodulin|thrombomodulin
5738880|NCT00361725|EPCR|epcr
5738881|NCT00361712|Epidural|epidural
5738882|NCT00361712|analgesia|analgesia
5738883|NCT00361712|labor|labor
5738884|NCT00361712|cytokines|cytokines
5738885|NCT00361699|stroke|stroke
5738886|NCT00361699|brain ischemia|brain ischemia
5738887|NCT00361699|cerebrovascular accident|cerebrovascular accident
5738888|NCT00361699|statin|statin
5738889|NCT00361699|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5738890|NCT00361699|cholesterol|cholesterol
5680968|NCT00575432|healthy controls|healthy controls
5765165|NCT00263237|Lamina Propria|lamina propria
5738891|NCT00361699|hypercholesterolemia|hypercholesterolemia
5738892|NCT00361699|hyperlipidemia|hyperlipidemia
5738893|NCT00361699|multicenter studies|multicenter studies
5738894|NCT00361699|prospective studies|prospective studies
5738895|NCT00361699|endpoint determination|endpoint determination
5738896|NCT00361699|randomized controlled trials|randomized controlled trials
5738897|NCT00361699|recurrence|recurrence
5738898|NCT00361699|pravastatin|pravastatin
5738899|NCT00361699|c-reactive Protein|c-reactive protein
5738900|NCT00361686|tramadol|tramadol
5738901|NCT00361686|remifentanyl|remifentanyl
5738902|NCT00361686|patient controlled analgesia|patient controlled analgesia
5738903|NCT00361686|abortion|abortion
5738904|NCT00361673|Health Disparities|health disparities
5738905|NCT00361673|Built Environments|built environments
5738906|NCT00361660|Motor skills|motor skills
5738907|NCT00361660|Occupational Therapy|occupational therapy
5738908|NCT00361660|Physical Therapy Techniques|physical therapy techniques
5738909|NCT00361660|Rehabilitation|rehabilitation
5738910|NCT00361660|Upper Extremity|upper extremity
5738912|NCT00361634|Etanercept|etanercept
5738913|NCT00361634|Enbrel|enbrel
5738914|NCT00361634|DCE-MRI|dce-mri
5738915|NCT00361634|RA|ra
5738916|NCT00361621|VELCADE|velcade
5738917|NCT00361608|diabetes|diabetes
5738918|NCT00361608|hypoglycemia|hypoglycemia
5738919|NCT00361608|monitor|monitor
5738920|NCT00361608|children with Type I Diabetes|children with type i diabetes
5738921|NCT00361595|osteoporosis|osteoporosis
5738922|NCT00361595|zoledronic acid|zoledronic acid
5738923|NCT00361595|forteo|forteo
5738924|NCT00361582|Osteoarthritis|osteoarthritis
5738925|NCT00361582|tapentadol|tapentadol
5738926|NCT00361582|knee-replacement|knee-replacement
5738927|NCT00361582|hip replacement|hip replacement
5738928|NCT00361582|pain|pain
5738929|NCT00361569|vaginal atrophy|vaginal atrophy
5738930|NCT00361569|vaginal dryness|vaginal dryness
5738931|NCT00361569|vaginal itching|vaginal itching
5738932|NCT00361569|vaginal pain|vaginal pain
5738933|NCT00361556|low back pain|low back pain
5738934|NCT00361556|disability|disability
5738935|NCT00361556|health education|health education
5738936|NCT00361556|primary care|primary care
5738937|NCT00361543|Schizophrenia|schizophrenia
5738938|NCT00361543|Mental Illness|mental illness
5738939|NCT00361543|SERM|serm
5738940|NCT00361543|Raloxifene|raloxifene
5738941|NCT00361543|Cognition|cognition
5728149|NCT00401947|HCV|hcv
5738942|NCT00361530|stroke|stroke
5738943|NCT00361530|brain ischemia|brain ischemia
5738944|NCT00361530|cerebrovascular accident|cerebrovascular accident
5738945|NCT00361530|statin|statin
5738946|NCT00361530|hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5738947|NCT00361530|cholesterol|cholesterol
5738948|NCT00361530|hypercholesterolemia|hypercholesterolemia
5738949|NCT00361530|hyperlipidemia|hyperlipidemia
5738950|NCT00361530|multicenter studies|multicenter studies
5738951|NCT00361530|prospective studies|prospective studies
5738952|NCT00361530|endpoint determination|endpoint determination
5738953|NCT00361530|randomized controlled trials|randomized controlled trials
5738954|NCT00361530|recurrence|recurrence
5738955|NCT00361530|pravastatin|pravastatin
5738956|NCT00361530|plaque|plaque
5738957|NCT00361530|tunica intima|tunica intima
5738958|NCT00361530|tunica media|tunica media
5738959|NCT00361530|ultrasonography|ultrasonography
5738960|NCT00361530|carotid arteries|carotid arteries
5738961|NCT00361517|GM monitoring|gm monitoring
5738962|NCT00361517|Immunocompromised|immunocompromised
5738963|NCT00361517|hematological disorder|hematological disorder
5738964|NCT00361517|Allogenic HSCT recipients|allogenic hsct recipients
5738965|NCT00361517|Aspergillus PCR assay|aspergillus pcr assay
5738966|NCT00361504|Osteoarthritis|osteoarthritis
5738967|NCT00361504|Pain|pain
5738968|NCT00361504|Low Back Pain|low back pain
5738969|NCT00361504|Hip Pain|hip pain
5738974|NCT00361491|antidepressive disorders|antidepressive disorders
5738975|NCT00361491|controlled clinical trial|controlled clinical trial
5738976|NCT00361478|exercise|exercise
5738977|NCT00361478|postnatal depression|postnatal depression
5738978|NCT00361478|psychological health|psychological health
5738979|NCT00361478|well-being|well-being
5738980|NCT00361426|COPD|copd
5738981|NCT00361426|Respiration Rate|respiration rate
5738982|NCT00361426|Monitoring|monitoring
5738983|NCT00361413|Stem cell transplantation|stem cell transplantation
5738984|NCT00361413|GVHD|gvhd
5738985|NCT00361413|Graft Versus Host Disease|graft versus host disease
5738986|NCT00361400|pregnancy|pregnancy
5738987|NCT00361400|hormonal contraception|hormonal contraception
5738988|NCT00361387|Sarcoidosis|sarcoidosis
5738989|NCT00361387|Sarcoid|sarcoid
5738990|NCT00361374|Depression|depression
5738991|NCT00361374|Omega-3|omega-3
5738992|NCT00361374|Boston|boston
5738993|NCT00361348|Palifermin|palifermin
5680970|NCT00575419|Contrast Induced Nephropathy|contrast induced nephropathy
5680971|NCT00575393|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5738994|NCT00361348|drug interaction|drug interaction
5738995|NCT00361335|Rheumatoid arthritis|rheumatoid arthritis
5738996|NCT00361335|Golimumab|golimumab
5738997|NCT00361335|Methotrexate|methotrexate
5738998|NCT00361335|Tumor Necrosis Factor-alpha|tumor necrosis factor-alpha
5738999|NCT00361335|Immunology|immunology
5739000|NCT00361309|liver cancer|liver cancer
5739001|NCT00361309|HCC|hcc
5739002|NCT00361296|refractory anemia with excess blasts|refractory anemia with excess blasts
5739003|NCT00361296|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5739004|NCT00361296|refractory anemia|refractory anemia
5739005|NCT00361296|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5739006|NCT00361296|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5739007|NCT00361296|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5739008|NCT00361296|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5739009|NCT00361270|Biofeedback|biofeedback
5739010|NCT00361270|Hypnosis|hypnosis
5739011|NCT00361270|Low Back Pain, Recurrent|low back pain, recurrent
5739012|NCT00361270|Pain beliefs|pain beliefs
5734484|NCT00377858|type 2|type 2
5739014|NCT00361270|Pain intensity|pain intensity
5739015|NCT00361270|Pain interference|pain interference
5739016|NCT00361270|Pain quality|pain quality
5739017|NCT00361270|Self-help treatment|self-help treatment
5739018|NCT00361270|Sleep dysfunction|sleep dysfunction
5739019|NCT00361257|Treatment Experienced|treatment experienced
5739021|NCT00361231|Avastin|avastin
5739022|NCT00361231|GEMOX|gemox
5739023|NCT00361218|depression|depression
5739024|NCT00361218|biology|biology
5739025|NCT00361205|Parkinson's Disease, pharmacology, compliance, dopaminergic|parkinson's disease, pharmacology, compliance, dopaminergic
5739026|NCT00361192|temporal arteritis|temporal arteritis
5739027|NCT00361192|duplex of temporal artery|duplex of temporal artery
5739028|NCT00361192|biopsy of temporal artery|biopsy of temporal artery
5739029|NCT00361179|Observation|observation
5739030|NCT00361179|Post-treatment|post-treatment
5739031|NCT00361166|Schizophrenia|schizophrenia
5739032|NCT00361166|psychosis|psychosis
5739033|NCT00361166|delusions|delusions
5739034|NCT00361166|hallucination|hallucination
5739035|NCT00361140|Busulfan|busulfan
5739036|NCT00361140|Fludarabine|fludarabine
5739037|NCT00361140|Chimerism|chimerism
5739038|NCT00361140|Allogeneic stem cell transplantation (HCT)|allogeneic stem cell transplantation (hct)
5739039|NCT00361140|Myelodysplastic Syndromes|myelodysplastic syndromes
5686243|NCT00552851|hypertrophy|hypertrophy
5739040|NCT00361140|Leukemia Myeloproliferative disorders (MPD)|leukemia myeloproliferative disorders (mpd)
5739041|NCT00361140|Leukemia, Lymphocytic|leukemia, lymphocytic
5739042|NCT00361140|Myeloma|myeloma
5739043|NCT00361140|Lymphoma|lymphoma
5739044|NCT00361140|AUC|auc
5739045|NCT00361140|Hematologic malignancies|hematologic malignancies
5739046|NCT00361127|Heart failure|heart failure
5739047|NCT00361127|pulmonary edema|pulmonary edema
5739048|NCT00361127|ACE-inhibitors|ace-inhibitors
5739049|NCT00361127|lung diffusion|lung diffusion
5739050|NCT00361127|exercise capacity|exercise capacity
5739051|NCT00361127|Chronic heart failure|chronic heart failure
5739052|NCT00361101|HIV|hiv
5739053|NCT00361101|X4 tropic virus|x4 tropic virus
5739054|NCT00361088|Velcade (PS-341)|velcade (ps-341)
5739055|NCT00361088|Bortezomib|bortezomib
5739056|NCT00361088|Zarnestra (R115777)|zarnestra (r115777)
5739057|NCT00361088|Tipifarnib|tipifarnib
5739058|NCT00361075|Perimenopause|perimenopause
5739059|NCT00361075|Abdominal adipose tissue|abdominal adipose tissue
5739060|NCT00361075|Women's health|women's health
5739061|NCT00361075|Cholesterol|cholesterol
5739062|NCT00361075|Lipid Metabolism|lipid metabolism
5739063|NCT00361062|aggressive|aggressive
5739064|NCT00361062|SSRI's|ssri's
5739065|NCT00361062|simulation|simulation
5739066|NCT00361062|behavioral|behavioral
5739067|NCT00361062|Side Effects, Psychological|side effects, psychological
5739068|NCT00361062|adverse effects|adverse effects
5739069|NCT00361062|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5739070|NCT00361062|aggressive behavior|aggressive behavior
5739071|NCT00361062|computer simulation|computer simulation
5739072|NCT00361049|graft versus host disease|graft versus host disease
5739073|NCT00361049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5739074|NCT00361049|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5739075|NCT00361049|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5739076|NCT00361049|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5739077|NCT00361049|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5739078|NCT00361049|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5739079|NCT00361049|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5739080|NCT00361049|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5739081|NCT00361049|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5739082|NCT00361049|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5739083|NCT00361049|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5739084|NCT00361049|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5739085|NCT00361049|primary myelofibrosis|primary myelofibrosis
5739086|NCT00361049|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5739087|NCT00361049|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5739088|NCT00361049|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5739089|NCT00361049|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5739090|NCT00361049|disseminated neuroblastoma|disseminated neuroblastoma
5798839|NCT00111072|Quality of Life Indicators|quality of life indicators
5739091|NCT00361049|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5739092|NCT00361049|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5739093|NCT00361049|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5739094|NCT00361049|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5739095|NCT00361049|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5739096|NCT00361049|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5739097|NCT00361049|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5739098|NCT00361049|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5739099|NCT00361049|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5739100|NCT00361049|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5739101|NCT00361049|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5739102|NCT00361049|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5739103|NCT00361049|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5739104|NCT00361049|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5739105|NCT00361049|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5739106|NCT00361049|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5739107|NCT00361049|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5739108|NCT00361049|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5739109|NCT00361049|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5738132|NCT00365040|myopia|myopia
5739110|NCT00361049|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5739111|NCT00361049|stage I multiple myeloma|stage i multiple myeloma
5739112|NCT00361049|stage II multiple myeloma|stage ii multiple myeloma
5739113|NCT00361049|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5739114|NCT00361049|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5739115|NCT00361049|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5739116|NCT00361049|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5739117|NCT00361049|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5739118|NCT00361049|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5739119|NCT00361049|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5739120|NCT00361049|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5739121|NCT00361049|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5739122|NCT00361049|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5739123|NCT00361049|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5739124|NCT00361049|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5739125|NCT00361049|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5739126|NCT00361049|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5739127|NCT00361049|stage III multiple myeloma|stage iii multiple myeloma
5739128|NCT00361049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5739129|NCT00361049|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5739130|NCT00361049|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5739131|NCT00361049|stage IIIA breast cancer|stage iiia breast cancer
5739132|NCT00361049|stage IIIB breast cancer|stage iiib breast cancer
5739133|NCT00361049|stage IIIC breast cancer|stage iiic breast cancer
5739134|NCT00361049|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5739135|NCT00361049|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5739136|NCT00361049|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5739216|NCT00360854|childhood craniopharyngioma|childhood craniopharyngioma
5739137|NCT00361049|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5739138|NCT00361049|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5680972|NCT00575393|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5680973|NCT00575393|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5680975|NCT00575354|Isoflurane|isoflurane
5680976|NCT00575354|Breast tumor|breast tumor
5739139|NCT00361049|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5739140|NCT00361049|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5739141|NCT00361049|stage IV breast cancer|stage iv breast cancer
5739142|NCT00361049|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5739143|NCT00361049|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5739144|NCT00361049|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5739145|NCT00361049|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5739146|NCT00361049|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5739147|NCT00361049|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5739148|NCT00361049|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5739149|NCT00361049|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5739150|NCT00361036|Leiomyoma|leiomyoma
5739151|NCT00361036|Leiomyomatosis|leiomyomatosis
5739152|NCT00361036|Uterine Neoplasms|uterine neoplasms
5739153|NCT00361036|BeadBlock|beadblock
5739154|NCT00361036|Embsophere|embsophere
5739155|NCT00361036|Embolization|embolization
5739156|NCT00361036|Uterine fibroid embolization|uterine fibroid embolization
5739157|NCT00361023|Angiotensin type 1 receptor blocker (ARB)|angiotensin type 1 receptor blocker (arb)
5739159|NCT00361023|type 2 diabetes|type 2 diabetes
5739160|NCT00361023|insulin sensitivity and secretion|insulin sensitivity and secretion
5739161|NCT00361023|glucose metabolism|glucose metabolism
5739162|NCT00361010|Keppra|keppra
5739163|NCT00361010|Epilepsy|epilepsy
5739164|NCT00361010|Childhood Absence Epilepsy|childhood absence epilepsy
5739165|NCT00361010|Seizures|seizures
5739166|NCT00360997|Stroke rehabilitation|stroke rehabilitation
5739167|NCT00360997|Physical therapy|physical therapy
5739168|NCT00360984|CSII|csii
5739169|NCT00360984|insulin analog|insulin analog
5739170|NCT00360984|severe hypoglycaemia|severe hypoglycaemia
5739171|NCT00360984|altered hypoglycaemia awareness|altered hypoglycaemia awareness
5739172|NCT00360984|diabetes quality of life|diabetes quality of life
5739173|NCT00360984|CGMS|cgms
5739174|NCT00360971|mucositis|mucositis
5739175|NCT00360971|pain|pain
5739176|NCT00360971|radiation toxicity|radiation toxicity
5739177|NCT00360971|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5739178|NCT00360971|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5739179|NCT00360971|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5755674|NCT00299182|AD|ad
5739180|NCT00360971|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5739181|NCT00360971|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5739182|NCT00360971|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5739183|NCT00360971|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5739184|NCT00360971|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5739185|NCT00360958|ultrafiltration|ultrafiltration
5739186|NCT00360958|heart failure|heart failure
5739187|NCT00360958|fluid overload|fluid overload
5739188|NCT00360945|childhood oligodendroglioma|childhood oligodendroglioma
5739189|NCT00360945|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5739190|NCT00360945|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5739191|NCT00360945|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5739192|NCT00360945|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5739193|NCT00360945|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5739194|NCT00360945|recurrent childhood brain tumor|recurrent childhood brain tumor
5739196|NCT00360932|HIV/AIDs|hiv/aids
5739197|NCT00360919|casomorphin|casomorphin
5739198|NCT00360919|cheese|cheese
5739199|NCT00360919|craving|craving
5739200|NCT00360919|casein|casein
5739201|NCT00360919|milk|milk
5739202|NCT00360906|RRMS|rrms
5739203|NCT00360906|Omega-3|omega-3
5739204|NCT00360906|Treatment|treatment
5739205|NCT00360867|Extension study|extension study
5739206|NCT00360867|solid tumors|solid tumors
5739207|NCT00360854|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5739208|NCT00360854|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5739209|NCT00360854|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5739210|NCT00360854|recurrent childhood ependymoma|recurrent childhood ependymoma
5739211|NCT00360854|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5863968|NCT00001149|Intensive Monitoring|intensive monitoring
5739212|NCT00360854|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5739213|NCT00360854|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5739214|NCT00360854|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5739215|NCT00360854|childhood choroid plexus tumor|childhood choroid plexus tumor
5739217|NCT00360854|childhood grade I meningioma|childhood grade i meningioma
5739218|NCT00360854|childhood grade II meningioma|childhood grade ii meningioma
5739219|NCT00360854|childhood grade III meningioma|childhood grade iii meningioma
5739220|NCT00360854|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5739221|NCT00360854|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5739222|NCT00360854|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5739223|NCT00360854|recurrent childhood brain tumor|recurrent childhood brain tumor
5739224|NCT00360854|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5739225|NCT00360854|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5739226|NCT00360841|auricular|auricular
5739227|NCT00360841|acupuncture|acupuncture
5739228|NCT00360828|Recurrent Anaplastic Astrocytoma|recurrent anaplastic astrocytoma
5739229|NCT00360828|Mixed Malignant Glioma|mixed malignant glioma
5739230|NCT00360828|Oligodendroglioma|oligodendroglioma
5739231|NCT00360828|Irinotecan|irinotecan
5739232|NCT00360828|Brain tumor|brain tumor
5739233|NCT00360828|Nitrosoureas|nitrosoureas
5739234|NCT00360828|Brain and nervous system|brain and nervous system
5739235|NCT00360802|chronic low back pain|chronic low back pain
5739236|NCT00360802|cognitive-behavioral therapy|cognitive-behavioral therapy
5739237|NCT00360802|Mindful Based Stress Reduction|mindful based stress reduction
5739238|NCT00360802|pain clinics|pain clinics
5739240|NCT00360802|quality of life|quality of life
5739241|NCT00360802|chronic pain|chronic pain
5739242|NCT00360789|STROKE REHABILITATION|stroke rehabilitation
5739243|NCT00360789|pHYSICAL THERAPY|physical therapy
5739244|NCT00360750|intraocular retinoblastoma|intraocular retinoblastoma
5739245|NCT00360750|extraocular retinoblastoma|extraocular retinoblastoma
5739246|NCT00360737|Clinical Trials|clinical trials
5739247|NCT00360737|Investigational Drug|investigational drug
5739248|NCT00360737|Healthy Volunteers|healthy volunteers
5739249|NCT00360737|Botulinum Antitoxin|botulinum antitoxin
5739250|NCT00360737|Phoenix, Arizona|phoenix, arizona
5739251|NCT00360724|dysthymia|dysthymia
5739252|NCT00360724|dysthymic disorder|dysthymic disorder
5739253|NCT00360724|chronic depression|chronic depression
5739254|NCT00360724|chronic low-grade depression|chronic low-grade depression
5739255|NCT00360724|atypical depression|atypical depression
5739256|NCT00360724|minor depression|minor depression
5739257|NCT00360724|depression NOS|depression nos
5739258|NCT00360724|depression|depression
5739259|NCT00360724|depressive disorder|depressive disorder
5739260|NCT00360724|mood disorder|mood disorder
5739261|NCT00360724|unipolar depression|unipolar depression
5764668|NCT00265616|safety.|safety.
5739262|NCT00360724|low-grade depression|low-grade depression
5739263|NCT00360711|Moral Distress|moral distress
5739264|NCT00360711|Nondirectiveness|nondirectiveness
5739265|NCT00360711|Ethical Dilemma|ethical dilemma
5739266|NCT00360685|Tacrolimus|tacrolimus
5739267|NCT00360685|Methotrexate|methotrexate
5739268|NCT00360685|Mycophenolate mofetil|mycophenolate mofetil
5739269|NCT00360685|Mucositis|mucositis
5739270|NCT00360685|Acute graft-versus-host disease (aGVHD)|acute graft-versus-host disease (agvhd)
5739271|NCT00360685|Engraftment|engraftment
5739272|NCT00360685|hemolytic/uremic syndrome (HUS)|hemolytic/uremic syndrome (hus)
5739273|NCT00360685|Thrombotic thrombocytopenic purpura (TTP)|thrombotic thrombocytopenic purpura (ttp)
5739274|NCT00360672|Acute Myelogenous Leukemia|acute myelogenous leukemia
5739275|NCT00360672|Myelodysplastic Syndrome|myelodysplastic syndrome
5739276|NCT00360659|Obstructive sleep Apnea|obstructive sleep apnea
5739277|NCT00360659|Hypertension|hypertension
5739278|NCT00360659|Vasoactive hormones|vasoactive hormones
5739279|NCT00360646|LIVER DIS|liver dis
5739280|NCT00360646|CHEM IND|chem ind
5739281|NCT00360646|Drugs|drugs
5739282|NCT00360646|Drug induced liver injury|drug induced liver injury
5739283|NCT00360646|phenotype|phenotype
5739284|NCT00360646|cholestatic liver injury|cholestatic liver injury
5739285|NCT00360646|hepatocellular liver injury|hepatocellular liver injury
5739286|NCT00360646|mixed liver injury|mixed liver injury
5739287|NCT00360646|genotype|genotype
5739288|NCT00360633|Parkinson's Disease|parkinson's disease
5739289|NCT00360633|Impulse control disorder|impulse control disorder
5739290|NCT00360633|Dopamine agonist withdrawal syndrome|dopamine agonist withdrawal syndrome
5739291|NCT00360633|Anxiety|anxiety
5739292|NCT00360633|Depression|depression
5739293|NCT00360633|Healthcare Utilization|healthcare utilization
5739294|NCT00360633|Disability|disability
5739295|NCT00360633|Quality of life|quality of life
5739296|NCT00360633|Cognitive function|cognitive function
5739297|NCT00360633|Psychosis|psychosis
5739298|NCT00360633|Apathy|apathy
5739299|NCT00360633|Dyskinesias|dyskinesias
5739300|NCT00360633|Wearing off|wearing off
5749445|NCT00321997|AMD|amd
5739301|NCT00360594|alcoholism|alcoholism
5739302|NCT00360581|Smoking abstinence|smoking abstinence
5739303|NCT00360568|carbidopa|carbidopa
5739304|NCT00360568|severe motor fluctuations|severe motor fluctuations
5739305|NCT00360568|intestinal gel|intestinal gel
5739308|NCT00360568|levodopa carbidopa intestinal gel|levodopa carbidopa intestinal gel
5739309|NCT00360568|dyskinesia|dyskinesia
5739310|NCT00360568|Parkinson's Disease|parkinson's disease
5739312|NCT00360568|levodopa-carbidopa|levodopa-carbidopa
5739313|NCT00360568|DUOPA|duopa
5739314|NCT00360516|healthy volunteers|healthy volunteers
5739315|NCT00360503|Cystic fibrosis|cystic fibrosis
5739316|NCT00360503|Antibiotic resistance|antibiotic resistance
5739317|NCT00360503|Microbiology|microbiology
5739318|NCT00360490|Idiopathic Menorrhagia|idiopathic menorrhagia
5739319|NCT00360477|Kidney stone removal surgery|kidney stone removal surgery
5739320|NCT00360451|Prevention|prevention
5739321|NCT00360451|Child|child
5739322|NCT00360451|Adolescent|adolescent
5739323|NCT00360451|Parent|parent
5739324|NCT00360438|Leukemia|leukemia
5739325|NCT00360438|Lymphoma|lymphoma
5739326|NCT00360438|Tumor Lysis Syndrome|tumor lysis syndrome
5739328|NCT00360438|Rasburicase|rasburicase
5739329|NCT00360438|Elitek|elitek
5739330|NCT00360425|anemia|anemia
5739331|NCT00360425|intravenous iron|intravenous iron
5739332|NCT00360425|pharmacokinetics|pharmacokinetics
5739333|NCT00360425|QTc|qtc
5739334|NCT00360399|Escitalopram|escitalopram
5739335|NCT00360399|Duloxetine|duloxetine
5739336|NCT00360399|Cognitive Behavioral Therapy|cognitive behavioral therapy
5739337|NCT00360399|PET|pet
5739338|NCT00360399|fMRI|fmri
5739339|NCT00360373|bariatric|bariatric
5739340|NCT00360373|obesity|obesity
5739341|NCT00360373|insulin resistance|insulin resistance
5739342|NCT00360373|gastric bypass|gastric bypass
5739344|NCT00360360|Neoplasm, Unknown Primary|neoplasm, unknown primary
5739345|NCT00360334|diabetes|diabetes
5739346|NCT00360334|exenatide|exenatide
5739347|NCT00360334|insulin glargine|insulin glargine
5739348|NCT00360334|Lilly|lilly
5739349|NCT00360334|Amylin|amylin
5739350|NCT00360282|Migraine|migraine
5739351|NCT00360282|Triptans|triptans
5739352|NCT00360282|Motion Sickness|motion sickness
5739353|NCT00360256|Depression|depression
5739354|NCT00360256|Amplichip P450 tests|amplichip p450 tests
5739355|NCT00360256|Antidepressants|antidepressants
5739356|NCT00360230|Vaccine|vaccine
5739357|NCT00360230|Prophylaxis Plasmodium falciparum malaria|prophylaxis plasmodium falciparum malaria
5739358|NCT00360230|Plasmodium falciparum|plasmodium falciparum
5739359|NCT00360230|Malaria|malaria
5739360|NCT00360217|Omega-3|omega-3
5739361|NCT00360217|Triglyceride|triglyceride
5739362|NCT00360217|Hyperlipidemia|hyperlipidemia
5739363|NCT00360217|Coronary Artery Disease|coronary artery disease
5739364|NCT00360217|Fatty Acids|fatty acids
5739365|NCT00360217|Safety|safety
5739366|NCT00360217|Fish Oil|fish oil
5739367|NCT00360217|Docosohexanoic Acid|docosohexanoic acid
5686244|NCT00552851|cardiomegaly|cardiomegaly
5739368|NCT00360204|Infant health|infant health
5739369|NCT00360204|parenting competence|parenting competence
5739370|NCT00360204|Home nurse visit|home nurse visit
5739371|NCT00360204|maternal post-partum care|maternal post-partum care
5739372|NCT00360204|postpartum health utilization|postpartum health utilization
5739373|NCT00360204|Breastfeeding|breastfeeding
5739374|NCT00360178|hypertension|hypertension
5739375|NCT00360178|valsartan|valsartan
5739376|NCT00360178|amlodipine|amlodipine
5739377|NCT00360178|hydrochlorothiazide|hydrochlorothiazide
5739378|NCT00360152|Breast Cancer|breast cancer
5739379|NCT00360152|Axilla|axilla
5739380|NCT00360152|Ultrasound|ultrasound
5739381|NCT00360152|FNA|fna
5739382|NCT00360152|Molecular Analysis|molecular analysis
5739383|NCT00360139|Sculptra|sculptra
5739384|NCT00360139|lipoatrophy|lipoatrophy
5739385|NCT00360139|emaciation|emaciation
5739386|NCT00360139|facial|facial
5739387|NCT00360139|dermal filler|dermal filler
5739388|NCT00360139|poly-L-lactic acid|poly-l-lactic acid
5739389|NCT00360139|Dermik|dermik
5739390|NCT00360139|SpaMD|spamd
5739391|NCT00360139|Sanofi|sanofi
5739392|NCT00360139|Facial lipoatrophy|facial lipoatrophy
5739393|NCT00360139|Facial emaciation|facial emaciation
5739394|NCT00360126|Lamictal|lamictal
5739395|NCT00360126|lamotrigine|lamotrigine
5739396|NCT00360126|Open-Label Extension Study|open-label extension study
5739397|NCT00360126|Bipolar Disorder|bipolar disorder
5739398|NCT00360087|Treatment Study|treatment study
5739399|NCT00360087|Sickle Cell Anemia|sickle cell anemia
5739400|NCT00360087|6-Minute Walk|6-minute walk
5739401|NCT00360087|Right Heart Catheterization|right heart catheterization
5739402|NCT00360087|Tracleer|tracleer
5739403|NCT00360087|Sickle Cell|sickle cell
5739405|NCT00360074|secondary hypothyroidism|secondary hypothyroidism
5739406|NCT00360074|body weight adjusted thyroxin dose|body weight adjusted thyroxin dose
5739407|NCT00360074|triiodothyronine supplementation|triiodothyronine supplementation
5739408|NCT00360061|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5739409|NCT00360061|Adolescents|adolescents
5739410|NCT00360061|Cognitive Behaviour Therapy|cognitive behaviour therapy
5739411|NCT00360048|oxytocin|oxytocin
5739412|NCT00360048|tnf|tnf
5739413|NCT00360048|sepsis|sepsis
5739414|NCT00360048|lps|lps
5739415|NCT00360009|Parkinson's disease|parkinson's disease
5739416|NCT00360009|Parkinson disease|parkinson disease
5739418|NCT00360009|deep brain stimulation|deep brain stimulation
5739419|NCT00360009|DBS|dbs
5739420|NCT00360009|subthalamic nucleus|subthalamic nucleus
5739428|NCT00360009|memory|memory
5739429|NCT00360009|attention|attention
5739430|NCT00360009|tremor|tremor
5739431|NCT00360009|rigidity|rigidity
5739432|NCT00360009|bradykinesia|bradykinesia
5739433|NCT00359996|diabetes|diabetes
5739434|NCT00359996|quality improvement|quality improvement
5739435|NCT00359996|community health center|community health center
5739436|NCT00359996|health disparities|health disparities
5739437|NCT00359983|Humans|humans
5739438|NCT00359983|Meningococcal vaccines|meningococcal vaccines
5739439|NCT00359983|Immunogenicity|immunogenicity
5739440|NCT00359983|Vaccines|vaccines
5739441|NCT00359983|H. influenzae type b vaccine|h. influenzae type b vaccine
5739442|NCT00359983|Conjugate|conjugate
5739443|NCT00359983|Toddlers|toddlers
5739444|NCT00359983|Comparative study|comparative study
5739445|NCT00359983|Neisseria meningitidis|neisseria meningitidis
5739446|NCT00359970|Diarrhea|diarrhea
5739447|NCT00359970|Travel|travel
5739448|NCT00359970|Travelers' diarrhea|travelers' diarrhea
5739449|NCT00359970|Azithromycin|azithromycin
5739450|NCT00359970|Loperamide|loperamide
5739451|NCT00359970|Treatment|treatment
5739452|NCT00359970|Antibiotic|antibiotic
5739453|NCT00359957|Pediatric obesity|pediatric obesity
5739454|NCT00359957|Physical activity|physical activity
5739455|NCT00359957|Visceral fat|visceral fat
5756785|NCT00295646|12|12
5739457|NCT00359944|Alzheimer|alzheimer
5739458|NCT00359944|Dementia|dementia
5739459|NCT00359931|Neural Networks|neural networks
5739460|NCT00359931|Mathematical Modeling|mathematical modeling
5739461|NCT00359931|Auditory Processing|auditory processing
5739462|NCT00359931|Tinnitis|tinnitis
5739463|NCT00359931|Hearing Loss|hearing loss
5739464|NCT00359918|infarction|infarction
5739465|NCT00359918|facilitated PCI|facilitated pci
5739466|NCT00359918|primary PCI|primary pci
5739467|NCT00359918|infarct size|infarct size
5739468|NCT00359918|fibrinolysis|fibrinolysis
5739469|NCT00359918|ST-elevation myocardial infarction (STEMI)|st-elevation myocardial infarction (stemi)
5739470|NCT00359905|Benign prostatic hyperplasia|benign prostatic hyperplasia
5739471|NCT00359905|alpha-blockers|alpha-blockers
5739472|NCT00359879|diabetes|diabetes
5739473|NCT00359879|exenatide|exenatide
5739474|NCT00359879|Lilly|lilly
5739475|NCT00359879|Amylin|amylin
5739476|NCT00359853|Norfloxacin, primary prophylaxis, SBP|norfloxacin, primary prophylaxis, sbp
5739477|NCT00359840|darbepoetin alfa|darbepoetin alfa
5739478|NCT00359840|anemia|anemia
5739479|NCT00359840|cancer patients|cancer patients
5739480|NCT00359840|chemotherapy|chemotherapy
5764785|NCT00265122|C01275|c01275
5739481|NCT00359814|Cyclosporine|cyclosporine
5739482|NCT00359814|renal insufficiency, chronic|renal insufficiency, chronic
5739483|NCT00359814|long-term care|long-term care
5739484|NCT00359801|Large Simple Trial|large simple trial
5739485|NCT00359775|Coping|coping
5739486|NCT00359775|psychosocial|psychosocial
5739487|NCT00359775|Quality of Life|quality of life
5739488|NCT00359775|problem solving|problem solving
5739489|NCT00359762|exenatide|exenatide
5739490|NCT00359762|diabetes|diabetes
5739491|NCT00359762|Amylin|amylin
5739492|NCT00359762|Lilly|lilly
5739493|NCT00359762|glimepiride|glimepiride
5739494|NCT00359736|alveolitis, fibrosing|alveolitis, fibrosing
5739495|NCT00359736|exercise, aerobic|exercise, aerobic
5739496|NCT00359736|fibrosis, pulmonary|fibrosis, pulmonary
5739497|NCT00359736|hypertension, pulmonary|hypertension, pulmonary
5739498|NCT00359723|Parkinson's disease|parkinson's disease
5739499|NCT00359723|PD|pd
5739500|NCT00359723|methylphenidate|methylphenidate
5739501|NCT00359723|Ritalin|ritalin
5739502|NCT00359723|MPD|mpd
5739503|NCT00359710|Multiracial Populations|multiracial populations
5739504|NCT00359710|Human Genetic Variation|human genetic variation
5739505|NCT00359710|Family History|family history
5739506|NCT00359710|Admixture|admixture
5739507|NCT00359710|Physician-Patient Communication|physician-patient communication
5739508|NCT00359710|Ancestry|ancestry
5739509|NCT00359710|Self-Identified Multiracial Adults|self-identified multiracial adults
5739510|NCT00359710|Interview|interview
5739516|NCT00359658|Cyclosporine|cyclosporine
5739517|NCT00359658|Glucocorticoids|glucocorticoids
5739518|NCT00359658|renal insufficiency, chronic|renal insufficiency, chronic
5739519|NCT00359658|long-term care|long-term care
5739520|NCT00359645|Screening|screening
5739521|NCT00359645|Upper aerodigestive tract cancer|upper aerodigestive tract cancer
5739522|NCT00359645|Alcohol|alcohol
5739523|NCT00359645|Tobacco|tobacco
5739524|NCT00359645|Randomized trial|randomized trial
5739525|NCT00359632|Optic neuropathy following long-term linezolid use|optic neuropathy following long-term linezolid use
5739526|NCT00359619|HPV vaccine|hpv vaccine
5863969|NCT00001149|Epilepsy|epilepsy
5739527|NCT00359606|DNA Methylation|dna methylation
5739528|NCT00359606|Advanced Cancer|advanced cancer
5739529|NCT00359606|Methyltransferase Inhibitor|methyltransferase inhibitor
5739530|NCT00359606|Epigenetics|epigenetics
5739531|NCT00359606|Gene Re-Expression|gene re-expression
5739532|NCT00359593|Stroke|stroke
5739533|NCT00359593|Rehabilitation|rehabilitation
5739941|NCT00358163|Taxol|taxol
5739534|NCT00359593|Knowledge translation|knowledge translation
5739535|NCT00359593|Evidence based practice|evidence based practice
5739536|NCT00359593|Outcomes|outcomes
5739537|NCT00359580|Rare Diseases|rare diseases
5739538|NCT00359580|Consanguinity|consanguinity
5739539|NCT00359567|nausea and vomiting|nausea and vomiting
5739540|NCT00359554|Influenza|influenza
5739541|NCT00359541|CYP2C9|cyp2c9
5739542|NCT00359541|CYP2C19|cyp2c19
5739543|NCT00359541|Pharmacology|pharmacology
5739544|NCT00359541|Genotype|genotype
5739545|NCT00359541|Metabolism|metabolism
5739546|NCT00359515|Archived Samples|archived samples
5739547|NCT00359515|Mutation Screening|mutation screening
5739548|NCT00359515|Genotype-Phenotype Correlation|genotype-phenotype correlation
5739549|NCT00359515|Pediatric Developmental Disorder|pediatric developmental disorder
5739550|NCT00359515|Cataracts|cataracts
5739551|NCT00359515|Mutation Detection|mutation detection
5739552|NCT00359515|Lowe Syndrome|lowe syndrome
5739553|NCT00359515|Genotype|genotype
5739554|NCT00359476|Locally advanced/metastatic gastric adenocarcinoma|locally advanced/metastatic gastric adenocarcinoma
5739555|NCT00359476|adenocarcinoma-gastroesophageal junction|adenocarcinoma-gastroesophageal junction
5739556|NCT00359476|Gastric Adenocarcinoma|gastric adenocarcinoma
5739557|NCT00359463|hepatitis C-associated thrombocytopenia|hepatitis c-associated thrombocytopenia
5739558|NCT00359463|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5739559|NCT00359463|thrombocytopenia|thrombocytopenia
5739560|NCT00359463|hepatic impairment|hepatic impairment
5739561|NCT00359463|chronic immune thrombocytopenia purpura|chronic immune thrombocytopenia purpura
5739562|NCT00359450|Locally advanced or metastatic non-small cell lung cancer|locally advanced or metastatic non-small cell lung cancer
5739563|NCT00359424|acute ischemic stroke|acute ischemic stroke
5739564|NCT00359424|rt-PA|rt-pa
5739565|NCT00359424|thrombolytic|thrombolytic
5739566|NCT00359424|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5739567|NCT00359424|recanalization|recanalization
5739568|NCT00359424|blood clot|blood clot
5739569|NCT00359424|stroke|stroke
5739570|NCT00359424|clot-dissolving|clot-dissolving
5739571|NCT00359424|Activase®|activase®
5739572|NCT00359424|Actilyse®|actilyse®
5739573|NCT00359424|Concentric Merci® Retriever|concentric merci® retriever
5739574|NCT00359424|EKOS® Micro-Infusion catheter (MicroLysus)|ekos® micro-infusion catheter (microlysus)
5739575|NCT00359424|The Penumbra System™|the penumbra system™
5739576|NCT00359424|Standard microcatheter|standard microcatheter
5739577|NCT00359411|Epstein-Barr Virus|epstein-barr virus
5739578|NCT00359411|B-Cell Lymphoma|b-cell lymphoma
5739579|NCT00359411|Herpes Virus|herpes virus
5748687|NCT00324727|iris melanoma|iris melanoma
5739580|NCT00359411|Infectious Mononucleosis|infectious mononucleosis
5739581|NCT00359398|Cardiopulmonary bypass|cardiopulmonary bypass
5739582|NCT00359398|Blood component removal|blood component removal
5739583|NCT00359385|primary hyperparathyroidism|primary hyperparathyroidism
5739584|NCT00359385|hyperparathyroidism|hyperparathyroidism
5739585|NCT00359385|PHPT|phpt
5739587|NCT00359385|hypercalcemia|hypercalcemia
5739588|NCT00359385|bone density|bone density
5739589|NCT00359385|osteoporosis|osteoporosis
5739590|NCT00359385|bone turnover|bone turnover
5739592|NCT00359385|pQCT|pqct
5739593|NCT00359385|cQCT|cqct
5739594|NCT00359385|alendronate|alendronate
5739595|NCT00359385|Fosamax|fosamax
5739596|NCT00359385|parathyroid hormone|parathyroid hormone
5739597|NCT00359385|parathyroid surgery|parathyroid surgery
5739598|NCT00359385|parathyroidectomy|parathyroidectomy
5739599|NCT00359385|Silverberg|silverberg
5739600|NCT00359385|Rubin|rubin
5739601|NCT00359385|Bilezikian|bilezikian
5739602|NCT00359385|treatment|treatment
5739603|NCT00359372|Chronic Heart Failure|chronic heart failure
5739604|NCT00359372|Cardiac Resynchronization|cardiac resynchronization
5739605|NCT00359372|Magnetic Resonance Imaging|magnetic resonance imaging
5739606|NCT00359372|Biventricular Pacing|biventricular pacing
5739609|NCT00359359|Small Cell Lung Cancer|small cell lung cancer
5739610|NCT00359346|Plasmapheresis|plasmapheresis
5739611|NCT00359346|Auto-antibodies|auto-antibodies
5739612|NCT00359346|Autonomic Nervous System|autonomic nervous system
5739613|NCT00359346|Dysautonomia|dysautonomia
5739614|NCT00359346|Sympathetic Nervous System|sympathetic nervous system
5739615|NCT00359346|Autonomic Failure|autonomic failure
5739616|NCT00359320|Pancreaticoduodenectomy|pancreaticoduodenectomy
5739617|NCT00359320|Pancreaticojejunostomy|pancreaticojejunostomy
5739618|NCT00359320|Pancreatic Cancer|pancreatic cancer
5739619|NCT00359307|Genetic|genetic
5739620|NCT00359307|Longitudinal|longitudinal
5739621|NCT00359307|Prospective|prospective
5739622|NCT00359307|Epidemiology|epidemiology
5739623|NCT00359307|Heart Attack|heart attack
5739624|NCT00359294|Tumor|tumor
5739625|NCT00359294|Lymphoma|lymphoma
5863970|NCT00001148|Metastasis|metastasis
5680977|NCT00575354|Anesthesia|anesthesia
5739635|NCT00359255|rehabilitation|rehabilitation
5739636|NCT00359255|upper limb|upper limb
5739637|NCT00359255|inpatient|inpatient
5739638|NCT00359255|RCT|rct
5739639|NCT00359255|activities of daily living|activities of daily living
5739640|NCT00359242|Infant Sleep|infant sleep
5739641|NCT00359242|Infant Diet|infant diet
5739642|NCT00359242|Infant Temperament|infant temperament
5739643|NCT00359242|Rapid Infant weight gain|rapid infant weight gain
5739644|NCT00359242|Infant Development|infant development
5739645|NCT00359242|Parenting Competence|parenting competence
5739646|NCT00359242|infant weight gain|infant weight gain
5739647|NCT00359216|Hypopnea Syndrome|hypopnea syndrome
5739649|NCT00359203|implantable loop recorder|implantable loop recorder
5739650|NCT00359190|lapatinib|lapatinib
5739651|NCT00359190|breast cancer|breast cancer
5739652|NCT00359190|treatment-naive|treatment-naive
5739653|NCT00359177|emesis liver problems hepatic impairment GW679769|emesis liver problems hepatic impairment gw679769
5739655|NCT00359164|Avastin|avastin
5739656|NCT00359164|Visudyne|visudyne
5739657|NCT00359164|Medical condition being studied AMD|medical condition being studied amd
5739658|NCT00359151|Perioperative care of total arthroplasty assessing opioid consumption|perioperative care of total arthroplasty assessing opioid consumption
5739659|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists
5739660|NCT00359138|Anti-Allergic Agents|anti-allergic agents
5739661|NCT00359125|bipolar|bipolar
5739662|NCT00359125|RU-486|ru-486
5739663|NCT00359125|mifepristone|mifepristone
5739664|NCT00359125|neurocognition|neurocognition
5739665|NCT00359125|mood|mood
5739666|NCT00359125|cortisol|cortisol
5739667|NCT00359125|HPA axis|hpa axis
5739668|NCT00359112|Type 2 diabetes|type 2 diabetes
5756976|NCT00294814|Microemboli|microemboli
5756977|NCT00294814|Transcranial Doppler|transcranial doppler
5756978|NCT00294814|Cognitive Decline|cognitive decline
5756979|NCT00294814|Anastomotic Device|anastomotic device
5756980|NCT00294814|Proximal Anastomosis|proximal anastomosis
5756981|NCT00294814|Coronary Artery Bypass Graft (CABG)|coronary artery bypass graft (cabg)
5756982|NCT00294801|knee osteoarthritis|knee osteoarthritis
5756983|NCT00294788|Influenza|influenza
5756984|NCT00294788|bioadjuvant|bioadjuvant
5739671|NCT00359112|metformin|metformin
5739672|NCT00359112|sulphonylurea|sulphonylurea
5739673|NCT00359099|Hepatic Medicine|hepatic medicine
5739675|NCT00359086|Relapsed and Refractory Lymphoma|relapsed and refractory lymphoma
5739676|NCT00359086|Phase II|phase ii
5739677|NCT00359073|asthma|asthma
5739678|NCT00359073|leukotrienes|leukotrienes
5739679|NCT00359073|rhinovirus|rhinovirus
5739680|NCT00359060|Physical activity|physical activity
5739681|NCT00359060|Sex steroid hormones|sex steroid hormones
5739682|NCT00359060|Breast cancer risk|breast cancer risk
5739683|NCT00359060|Intervention study|intervention study
5739684|NCT00359060|Postmenopausal women|postmenopausal women
5748815|NCT00324428|TMS|tms
5739685|NCT00359047|Osteoporosis|osteoporosis
5739686|NCT00359047|Fragility fracture|fragility fracture
5739687|NCT00359047|Women|women
5739688|NCT00359047|Randomised control trial|randomised control trial
5739689|NCT00359047|Patient education|patient education
5739690|NCT00359047|Diagnosis|diagnosis
5739691|NCT00359047|Treatment|treatment
5739692|NCT00359034|Doppler ultrasound|doppler ultrasound
5739693|NCT00359034|pulsewave velocity|pulsewave velocity
5739694|NCT00359034|intrauterine growth restriction|intrauterine growth restriction
5739695|NCT00359034|Fetal Pulsewave Velocity|fetal pulsewave velocity
5739696|NCT00359021|HIV-1|hiv-1
5739697|NCT00359021|treatment experienced|treatment experienced
5739698|NCT00359021|virologic failure|virologic failure
5739699|NCT00359008|AMD|amd
5739700|NCT00359008|CNV|cnv
5739701|NCT00359008|PHP|php
5739702|NCT00358995|Cognitive Behavioral Therapy|cognitive behavioral therapy
5739703|NCT00358995|Primary Obsessions|primary obsessions
5739704|NCT00358995|Obsessive Compulsive Disorder|obsessive compulsive disorder
5739705|NCT00358995|Compulsive Disorder|compulsive disorder
5739706|NCT00358982|Relapsed or Refractory Hodgkin's Lymphoma|relapsed or refractory hodgkin's lymphoma
5739707|NCT00358982|Phase II|phase ii
5739708|NCT00358969|borderline personality disorder|borderline personality disorder
5739709|NCT00358969|guanfacine|guanfacine
5739710|NCT00358969|impulsivity|impulsivity
5739711|NCT00358969|aggression|aggression
5739712|NCT00358969|affective instability|affective instability
5739713|NCT00358956|medullary thyroid cancer|medullary thyroid cancer
5739714|NCT00358956|MTC|mtc
5739715|NCT00358956|hereditary medullary thyroid cancer|hereditary medullary thyroid cancer
5739716|NCT00358956|thyroid cancer|thyroid cancer
5739717|NCT00358943|Gaucher Disease|gaucher disease
5739718|NCT00358943|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5739719|NCT00358930|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5739720|NCT00358904|Hill Sachs|hill sachs
5739721|NCT00358904|Weber osteotomy|weber osteotomy
5739722|NCT00358904|shoulder dislocation|shoulder dislocation
5739723|NCT00358891|Prematurity|prematurity
5739724|NCT00358891|Chronic Lung Disease|chronic lung disease
5739725|NCT00358891|Respiratory Health|respiratory health
5739726|NCT00358891|Neurodevelopment|neurodevelopment
5739727|NCT00358891|Preschool|preschool
5739728|NCT00358891|Influencing Factors|influencing factors
5739729|NCT00358878|Ascites|ascites
5739730|NCT00358878|Liver Cirrhosis|liver cirrhosis
5739731|NCT00358865|Virtual Reality|virtual reality
5739732|NCT00358865|ABI|abi
5739733|NCT00358865|Projected system|projected system
5739734|NCT00358852|Schizophrenia|schizophrenia
5739735|NCT00358852|Mental disorder|mental disorder
5739736|NCT00358852|Schizoaffective disorder|schizoaffective disorder
5739737|NCT00358852|Schizophreniform disorder|schizophreniform disorder
5739738|NCT00358852|Epidemiological study|epidemiological study
5739739|NCT00358852|Scale validation|scale validation
5739740|NCT00358852|Relapse|relapse
5739741|NCT00358852|Short Term Hospitalization|short term hospitalization
5739742|NCT00358852|PRE-COG|pre-cog
5739743|NCT00358852|RISSCH4075|rissch4075
5739744|NCT00358839|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
5739745|NCT00358839|CGRP|cgrp
5739746|NCT00358839|middle cerebral artery|middle cerebral artery
5739747|NCT00358839|superficial temporal artery|superficial temporal artery
5739748|NCT00358839|headache|headache
5739749|NCT00358839|genotype|genotype
5739750|NCT00358839|Healthy Volunteers|healthy volunteers
5757080|NCT00294489|HCV|hcv
5739751|NCT00358813|emesis|emesis
5739752|NCT00358813|renal impairment|renal impairment
5739753|NCT00358813|GW679769|gw679769
5739754|NCT00358813|kidney problems|kidney problems
5739755|NCT00358800|OSAHS and REMStar Auto with C-Flex|osahs and remstar auto with c-flex
5739756|NCT00358787|Supracondylar fracture|supracondylar fracture
5739757|NCT00358787|humerus|humerus
5739759|NCT00358787|Baumann's angle|baumann's angle
5739760|NCT00358787|Supracondylar fracture of the humerus|supracondylar fracture of the humerus
5739761|NCT00358774|homeopathic|homeopathic
5739762|NCT00358774|common cold|common cold
5739763|NCT00358774|Research Subjects|research subjects
5739764|NCT00358761|Lone Star Tick|lone star tick
5739765|NCT00358761|Borrelia|borrelia
5739766|NCT00358761|Skin Biopsy|skin biopsy
5739767|NCT00358761|Spirochete|spirochete
5739768|NCT00358761|Erythema Migrans|erythema migrans
5739769|NCT00358761|Southern Tick-Assoicated Rash Illness|southern tick-assoicated rash illness
5739770|NCT00358761|STARI|stari
5739771|NCT00358748|Preterm|preterm
5739772|NCT00358748|hypotension|hypotension
5739773|NCT00358748|steroids|steroids
5739774|NCT00358748|hydrocortisone|hydrocortisone
5739775|NCT00358735|SAFE|safe
5739776|NCT00358735|CECT|cect
5739777|NCT00358735|SFT|sft
5739778|NCT00358735|ActiveCare|activecare
5739779|NCT00358735|ActiveCare+SFT|activecare+sft
5739780|NCT00358735|Deep Vein Thrombosis prevention|deep vein thrombosis prevention
5739781|NCT00358735|Total Hip Replacement|total hip replacement
5739782|NCT00358735|Total Hip Arthroplasty|total hip arthroplasty
5739783|NCT00358735|Low Molecular Weight Heparin|low molecular weight heparin
5765099|NCT00263523|HV|hv
5739784|NCT00358735|MCS|mcs
5739785|NCT00358709|Cognitive-behavioral therapy|cognitive-behavioral therapy
5739786|NCT00358709|symptom management|symptom management
5739787|NCT00358709|first psychotic episode|first psychotic episode
5739788|NCT00358696|tenofovir|tenofovir
5739789|NCT00358696|didanosine|didanosine
5739790|NCT00358696|hiv|hiv
5739791|NCT00358696|hepatitis c virus infection|hepatitis c virus infection
5739792|NCT00358696|treatment|treatment
5739793|NCT00358683|certolizunab pegol|certolizunab pegol
5739794|NCT00358683|long term safety follow-up|long term safety follow-up
5739795|NCT00358683|Chrohn's disease|chrohn's disease
5739796|NCT00358683|infliximab failures patients|infliximab failures patients
5739797|NCT00358683|Greek population|greek population
5739798|NCT00358644|Acute Myeloid Leukemia|acute myeloid leukemia
5739799|NCT00358644|AML|aml
5739800|NCT00358644|Decitabine|decitabine
5739801|NCT00358644|Dacogen|dacogen
5739802|NCT00358644|MGI PHARMA, INC.|mgi pharma, inc.
5739803|NCT00358631|depression|depression
5739804|NCT00358631|antidepressive agents|antidepressive agents
5739805|NCT00358631|controlled clinical trial|controlled clinical trial
5739806|NCT00358618|Randomized|randomized
5739807|NCT00358618|double-blind|double-blind
5739808|NCT00358618|3-group clinical interventional study|3-group clinical interventional study
5739809|NCT00358605|OSAHS|osahs
5739810|NCT00358605|Oral Appliance|oral appliance
5739811|NCT00358605|Hypopnoea Syndrome|hypopnoea syndrome
5739812|NCT00358592|surgical instruments|surgical instruments
5739813|NCT00358592|cesarean section|cesarean section
5739814|NCT00358592|obesity|obesity
5739815|NCT00358579|Vasopressin|vasopressin
5739816|NCT00358579|Adrenaline|adrenaline
5739817|NCT00358579|Survival|survival
5739818|NCT00358579|Return of spontaneous of circulation|return of spontaneous of circulation
5739819|NCT00358566|Advanced|advanced
5739820|NCT00358566|Unresesctable|unresesctable
5739821|NCT00358566|Adenocarcinoma|adenocarcinoma
5739822|NCT00358566|Pancreatic cancer|pancreatic cancer
5739823|NCT00358553|Human Volunteers|human volunteers
5739824|NCT00358540|sarcoma|sarcoma
5739825|NCT00358540|eltrombopag|eltrombopag
5739826|NCT00358540|thrombopoiesis|thrombopoiesis
5739827|NCT00358540|thrombocytopenia|thrombocytopenia
5739828|NCT00358514|Tibia|tibia
5739829|NCT00358514|fracture|fracture
5739830|NCT00358514|compartment syndrome|compartment syndrome
5739831|NCT00358514|fasciotomy|fasciotomy
5739832|NCT00358501|Defibrotide|defibrotide
5739833|NCT00358501|Severe veno occlusive disease|severe veno occlusive disease
5739834|NCT00358501|Multi organ failure|multi organ failure
5739835|NCT00358501|Stem cell transplant|stem cell transplant
5739836|NCT00358501|Liver|liver
5739837|NCT00358501|Regimen related toxicity|regimen related toxicity
5739838|NCT00358501|Day 100 survival|day 100 survival
5739839|NCT00358488|Safety|safety
5739840|NCT00358488|Asthmatic patients|asthmatic patients
5739841|NCT00358488|GSK159797|gsk159797
5739842|NCT00358488|Efficacy|efficacy
5740128|NCT00357435|Gene|gene
5739843|NCT00358475|perennial allergic rhinitis|perennial allergic rhinitis
5739844|NCT00358462|NGU, M genitalium, Ureaplasma, azithromycin, doxycycline|ngu, m genitalium, ureaplasma, azithromycin, doxycycline
5739845|NCT00358449|eosinophilic|eosinophilic
5739846|NCT00358449|mepolizumab|mepolizumab
5739847|NCT00358449|esophagitis|esophagitis
5739848|NCT00358436|COPD|copd
5739849|NCT00358436|Lung function|lung function
5739850|NCT00358436|Exacerbations|exacerbations
5739851|NCT00358436|Quality of Life|quality of life
5739853|NCT00358423|Pegaptanib|pegaptanib
5739854|NCT00358423|Post-Surgical Ocular Inflammation|post-surgical ocular inflammation
5739855|NCT00358410|Functional Dyspepsia|functional dyspepsia
5739856|NCT00358410|Barostat|barostat
5739857|NCT00358410|Stomach|stomach
5739858|NCT00358397|Solid Tumor|solid tumor
5739859|NCT00358397|Clostridial|clostridial
5739860|NCT00358397|Spore-forming bacteria|spore-forming bacteria
5739861|NCT00358397|hypoxia|hypoxia
5739862|NCT00358397|anaerobes|anaerobes
5739863|NCT00358397|Clostridium novyi|clostridium novyi
5739864|NCT00358397|Bacteria|bacteria
5739865|NCT00358397|Bacteriolytic|bacteriolytic
5739866|NCT00358397|Tumor lysis|tumor lysis
5739867|NCT00358397|Necrosis|necrosis
5739868|NCT00358397|Colon Cancer|colon cancer
5739869|NCT00358397|Lung Cancer|lung cancer
5739870|NCT00358397|Sarcoma|sarcoma
5739871|NCT00358397|Bladder Cancer|bladder cancer
5739872|NCT00358397|Rectal Cancer|rectal cancer
5739873|NCT00358397|Gastric Cancer|gastric cancer
5739874|NCT00358397|Pancreatic Cancer|pancreatic cancer
5739875|NCT00358397|Experimental Therapy|experimental therapy
5739876|NCT00358397|Solid Tumors|solid tumors
5739877|NCT00358384|tolerability|tolerability
5739878|NCT00358384|safety|safety
5739879|NCT00358384|angiogenesis|angiogenesis
5739880|NCT00358384|vascular endothelial growth factor|vascular endothelial growth factor
5739881|NCT00358384|pharmacodynamics|pharmacodynamics
5739882|NCT00358384|pharmacokinetics|pharmacokinetics
5739883|NCT00358384|microplaque|microplaque
5739884|NCT00358384|VEGF|vegf
5739885|NCT00358384|GW786034|gw786034
5686245|NCT00552838|Antimicrobial prescribing|antimicrobial prescribing
5686246|NCT00552838|Antimicrobial utilization|antimicrobial utilization
5680969|NCT00575432|kidney|kidney
5739886|NCT00358371|bioavailability flucloxacillin|bioavailability flucloxacillin
5739887|NCT00358358|COPD|copd
5739888|NCT00358358|Impulse Oscillometry System|impulse oscillometry system
5739889|NCT00358358|Computerized Tomography|computerized tomography
5739891|NCT00358332|malaria, vaccine, Mali, children|malaria, vaccine, mali, children
5739892|NCT00358319|Valproic Acid (VPA)|valproic acid (vpa)
5739893|NCT00358319|Karenitecin|karenitecin
5739894|NCT00358319|Malignant Melanoma|malignant melanoma
5739895|NCT00358319|Histone deacetylases (HDAC)inhibitors|histone deacetylases (hdac)inhibitors
5739896|NCT00358319|Topoisomerase I inhibitor|topoisomerase i inhibitor
5739897|NCT00358319|metastatic|metastatic
5739898|NCT00358306|Endothelium|endothelium
5739899|NCT00358306|Chronic Kidney Disease|chronic kidney disease
5739900|NCT00358306|Acute Kidney Injury|acute kidney injury
5739901|NCT00358306|Hemolytic-uremic syndrome (HUS)|hemolytic-uremic syndrome (hus)
5739902|NCT00358293|Multiple Sclerosis|multiple sclerosis
5739903|NCT00358293|Spasticity|spasticity
5739904|NCT00358293|Sublingual Tizanidine|sublingual tizanidine
5739905|NCT00358293|Ashworth Scores|ashworth scores
5739906|NCT00358293|Spasticity in Multiple Sclerosis Patients|spasticity in multiple sclerosis patients
5739907|NCT00358280|Patients ASA category I ～ II|patients asa category i ～ ii
5739908|NCT00358280|Unilateral Lower limb surgery|unilateral lower limb surgery
5739909|NCT00358280|Spinal Anesthesia|spinal anesthesia
5739910|NCT00358267|Inferior Turbinate Reduction|inferior turbinate reduction
5739911|NCT00358267|Partial Resection of Inferior Turbinates (PRIT)|partial resection of inferior turbinates (prit)
5739912|NCT00358267|Radiofrequency Ablation (RFA)|radiofrequency ablation (rfa)
5739913|NCT00358267|NOSE scale|nose scale
5739914|NCT00358267|Nasal Obstruction|nasal obstruction
5739915|NCT00358241|Nerve block, postoperative pain, analgesia|nerve block, postoperative pain, analgesia
5739916|NCT00358228|Smoking cessation|smoking cessation
5739917|NCT00358228|Abstinence|abstinence
5739918|NCT00358215|Survival study|survival study
5739919|NCT00358215|morbidity and mortality|morbidity and mortality
5739920|NCT00358215|heart failure hospitalization|heart failure hospitalization
5739921|NCT00358215|all-cause death|all-cause death
5739922|NCT00358215|patient-reported outcomes|patient-reported outcomes
5739923|NCT00358215|Kansas City Cardiomyopathy questionnaire|kansas city cardiomyopathy questionnaire
5739924|NCT00358215|anemia treatment|anemia treatment
5739925|NCT00358202|intramuscular antibiotics|intramuscular antibiotics
5739926|NCT00358202|nursing home acquired pneumonia|nursing home acquired pneumonia
5739928|NCT00358202|pharmacoeconomics|pharmacoeconomics
5739929|NCT00358202|cefepime|cefepime
5739930|NCT00358202|ceftriaxone|ceftriaxone
5739931|NCT00358189|deep brain stimulation|deep brain stimulation
5739933|NCT00358189|manual dexterity|manual dexterity
5739934|NCT00358189|parkinson's disease|parkinson's disease
5739935|NCT00358176|Treatment osteoporosis postmenopausal|treatment osteoporosis postmenopausal
5739936|NCT00358163|angiogenesis|angiogenesis
5739937|NCT00358163|taxane|taxane
5739938|NCT00358163|tyrosine kinase|tyrosine kinase
5739939|NCT00358163|pharmacokinetics|pharmacokinetics
5739940|NCT00358163|Vatalanib|vatalanib
5739942|NCT00358150|Type 1 Gaucher Disease|type 1 gaucher disease
5739943|NCT00358150|Glucocerebrosidase Deficiency Disease|glucocerebrosidase deficiency disease
5739944|NCT00358137|Blood Pressure, High|blood pressure, high
5739945|NCT00358111|high-grade disease|high-grade disease
5739946|NCT00358111|Cervical examination|cervical examination
5739947|NCT00358111|targeting biopsies|targeting biopsies
5739948|NCT00358111|dysplasia|dysplasia
5739949|NCT00358111|cancer|cancer
5739951|NCT00358098|hormone positive breast cancer|hormone positive breast cancer
5739952|NCT00358085|Endovascular|endovascular
5739953|NCT00358085|Vascular Surgical Procedures|vascular surgical procedures
5739954|NCT00358085|Aneurysm|aneurysm
5739955|NCT00358085|Expertise Based Methodology|expertise based methodology
5739956|NCT00358072|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5739957|NCT00358072|Adult patients|adult patients
5739959|NCT00358072|Risk-oriented therapy|risk-oriented therapy
5739960|NCT00358059|diabetes mellitus|diabetes mellitus
5739961|NCT00358059|adolescence|adolescence
5739962|NCT00358059|adherence|adherence
5739963|NCT00358059|glycemic control|glycemic control
5739964|NCT00358059|adaptation|adaptation
5739965|NCT00358059|communication|communication
5739966|NCT00358046|Hyperphosphatemia|hyperphosphatemia
5739967|NCT00358046|Chronic kidney disease|chronic kidney disease
5739968|NCT00358046|Dialysis|dialysis
5739969|NCT00358046|Hyperphosphatemia in CKD patients on dialysis|hyperphosphatemia in ckd patients on dialysis
5739970|NCT00358020|MYELOMA, THALIDOMIDE, BORTEZOMIB|myeloma, thalidomide, bortezomib
5739971|NCT00358007|Kilovoltage Imaging|kilovoltage imaging
5739972|NCT00358007|Cone-beam CT|cone-beam ct
5739973|NCT00358007|CBCT|cbct
5739974|NCT00358007|radiation therapy|radiation therapy
5739975|NCT00358007|head and neck neoplasms|head and neck neoplasms
5686247|NCT00552825|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5686248|NCT00552825|long-term lung function|long-term lung function
5686249|NCT00552812|Aortic Coarctation|aortic coarctation
5748970|NCT00324220|Phase I/II|phase i/ii
5739976|NCT00357994|carbidopa|carbidopa
5739977|NCT00357994|levodopa-carbidopa|levodopa-carbidopa
5739978|NCT00357994|levodopa|levodopa
5739979|NCT00357994|levodopa/carbidopa suspension|levodopa/carbidopa suspension
5739980|NCT00357994|dyskinesia|dyskinesia
5739981|NCT00357994|Duodopa|duodopa
5739982|NCT00357994|levodopa-carbidopa intestinal gel|levodopa-carbidopa intestinal gel
5739983|NCT00357994|Severe Motor Fluctuations|severe motor fluctuations
5739984|NCT00357994|DUOPA|duopa
5739985|NCT00357981|Contraceptive patch|contraceptive patch
5739986|NCT00357981|menstruation|menstruation
5739987|NCT00357981|economics|economics
5739988|NCT00357942|Morphine|morphine
5739989|NCT00357942|Mouthwash|mouthwash
5739990|NCT00357942|Mucositis|mucositis
5739991|NCT00357942|Pain|pain
5739992|NCT00357942|Cancer|cancer
5739993|NCT00357942|Child|child
5739994|NCT00357942|Adolescent|adolescent
5739995|NCT00357929|permissive hypercarbia|permissive hypercarbia
5739996|NCT00357929|weaning from mechanical ventilation|weaning from mechanical ventilation
5739997|NCT00357916|PEP005|pep005
5739998|NCT00357916|Safety|safety
5739999|NCT00357903|Rheumatoid Arthritis, Etanercept, Long-term Safety, Enbrel|rheumatoid arthritis, etanercept, long-term safety, enbrel
5740000|NCT00357890|type 1 diabetes|type 1 diabetes
5740001|NCT00357890|diabetes|diabetes
5740002|NCT00357890|new onset|new onset
5740003|NCT00357890|CSII|csii
5740004|NCT00357890|insulin glargine|insulin glargine
5740005|NCT00357890|insulin sensitivity|insulin sensitivity
5740006|NCT00357890|beta cell function|beta cell function
5740008|NCT00357851|pancreatitis, blood loss|pancreatitis, blood loss
5740009|NCT00357838|normal healthy women|normal healthy women
5740010|NCT00357812|Herpes Simplex Virus Type 1|herpes simplex virus type 1
5740011|NCT00357812|Herpes Simplex Keratitis|herpes simplex keratitis
5740012|NCT00357812|Cornea|cornea
5740013|NCT00357812|Dendretic Ulcer|dendretic ulcer
5740014|NCT00357812|In vivo Confocal Microscopy|in vivo confocal microscopy
5740015|NCT00357812|Nested Multi-plex PCR|nested multi-plex pcr
5740016|NCT00357812|Monoclonal Antibody|monoclonal antibody
5740017|NCT00357812|Glycoprotein D|glycoprotein d
5740018|NCT00357812|Glycoprotein C|glycoprotein c
5740019|NCT00357799|Venipuncture|venipuncture
5740020|NCT00357799|Randomized Controlled Trial|randomized controlled trial
5740021|NCT00357799|Intravenous Access|intravenous access
5740022|NCT00357799|Children|children
5740023|NCT00357799|Emergency Department Nursing|emergency department nursing
5766364|NCT00258193|C-IBS|c-ibs
5750056|NCT00319683|Tumors|tumors
5740024|NCT00357799|VeinViewer|veinviewer
5740025|NCT00357799|Pediatrics|pediatrics
5740026|NCT00357799|Emergency Nursing|emergency nursing
5740027|NCT00357786|Lysosomal Disease|lysosomal disease
5740028|NCT00357786|Glycolipid|glycolipid
5740029|NCT00357786|Stroke|stroke
5740030|NCT00357786|Peripheral Neuropathy|peripheral neuropathy
5740031|NCT00357786|Storage Disorder|storage disorder
5740032|NCT00357760|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5740033|NCT00357760|VEGF Trap|vegf trap
5740034|NCT00357747|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5740035|NCT00357734|lung cancer|lung cancer
5740036|NCT00357734|breast cancer|breast cancer
5740037|NCT00357695|Praxis|praxis
5740038|NCT00357695|Grasping|grasping
5740039|NCT00357695|Premotor Cortex|premotor cortex
5740040|NCT00357695|Visuo-Motor Integration|visuo-motor integration
5740041|NCT00357695|Motor Imagination|motor imagination
5740042|NCT00357682|esophageal cancer|esophageal cancer
5740043|NCT00357682|Barrett's esophagus|barrett's esophagus
5740044|NCT00357669|Unverricht-Lundborg disease|unverricht-lundborg disease
5740045|NCT00357669|Baltic myoclonus|baltic myoclonus
5740046|NCT00357669|progressive myoclonic epilepsies|progressive myoclonic epilepsies
5740047|NCT00357669|myoclonus|myoclonus
5740048|NCT00357669|brivaracetam|brivaracetam
5740049|NCT00357656|Hemophilia A (severe or moderately severe)|hemophilia a (severe or moderately severe)
5740051|NCT00357643|vitamin D|vitamin d
5740052|NCT00357643|bone loss|bone loss
5740053|NCT00357630|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5734982|NCT00376519|follicular lymphoma|follicular lymphoma
5740054|NCT00357630|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5740055|NCT00357630|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5740056|NCT00357630|pain|pain
5740057|NCT00357617|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5740058|NCT00357617|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5740059|NCT00357617|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5740060|NCT00357617|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5740061|NCT00357617|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5740062|NCT00357617|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5740063|NCT00357617|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5740064|NCT00357617|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5740065|NCT00357617|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5740066|NCT00357617|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5740067|NCT00357617|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5740068|NCT00357617|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5740069|NCT00357617|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5740070|NCT00357617|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5740071|NCT00357617|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5740072|NCT00357617|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5740073|NCT00357617|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5740074|NCT00357617|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5740075|NCT00357617|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5740076|NCT00357617|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5740077|NCT00357604|HIV|hiv
5740078|NCT00357604|Protease Inhibitor|protease inhibitor
5740079|NCT00357591|Heart Failure|heart failure
5740080|NCT00357591|Acute Decompensation|acute decompensation
5740081|NCT00357591|Chronic Heart Failure|chronic heart failure
5740082|NCT00357578|Macrophages|macrophages
5740083|NCT00357578|Biopsy|biopsy
5740084|NCT00357578|Genetic Analysis|genetic analysis
5740085|NCT00357578|Geographic Atrophy|geographic atrophy
5740086|NCT00357578|Choroidal Neovascularization|choroidal neovascularization
5740087|NCT00357578|Fibroblast|fibroblast
5740088|NCT00357578|Disciform|disciform
5740089|NCT00357578|Age-Related Macular Degeneration|age-related macular degeneration
5740090|NCT00357565|MDS|mds
5740091|NCT00357565|AML|aml
5740092|NCT00357552|Treatment Experienced|treatment experienced
5740093|NCT00357526|vaginal ring|vaginal ring
5740094|NCT00357526|Oral contraceptive pills|oral contraceptive pills
5740095|NCT00357526|Teenagers|teenagers
5740096|NCT00357526|Young women|young women
5740097|NCT00357526|Patient satisfaction|patient satisfaction
5740098|NCT00357513|Cerebrovascular Disease|cerebrovascular disease
5740099|NCT00357513|Gene Chip|gene chip
5740100|NCT00357513|Inflammation|inflammation
5740101|NCT00357513|Pathophysiology Stroke|pathophysiology stroke
5750166|NCT00319215|driving|driving
5740102|NCT00357513|Stroke Genomics|stroke genomics
5740103|NCT00357513|Stroke Subtypes|stroke subtypes
5740104|NCT00357513|Neuroimaging|neuroimaging
5740105|NCT00357513|Clinical Outcome Measures|clinical outcome measures
5740114|NCT00357487|Breast cancer|breast cancer
5740115|NCT00357487|Lymphoscintigraphy|lymphoscintigraphy
5740116|NCT00357487|Probe|probe
5740117|NCT00357487|Operative gamma camera|operative gamma camera
5740118|NCT00357487|Breast cancer and sentinel lymph node biopsy|breast cancer and sentinel lymph node biopsy
5740119|NCT00357487|Use of lymphoscintigraphy|use of lymphoscintigraphy
5740120|NCT00357487|Use of intraoperative gamma camera|use of intraoperative gamma camera
5740121|NCT00357487|Use of intraoperative probe|use of intraoperative probe
5740122|NCT00357474|HCC, TACE, PEIT|hcc, tace, peit
5740123|NCT00357461|stage IV melanoma|stage iv melanoma
5740124|NCT00357461|recurrent melanoma|recurrent melanoma
5740125|NCT00357435|Cornea|cornea
5740126|NCT00357435|Genetics|genetics
5740127|NCT00357435|Dystrophy|dystrophy
5740133|NCT00357435|Positional Cloning|positional cloning
5740135|NCT00357422|HCC, operation, percutaneous ethanol injection|hcc, operation, percutaneous ethanol injection
5740136|NCT00357409|GABA|gaba
5740137|NCT00357409|Occipital|occipital
5740138|NCT00357409|Vision|vision
5740139|NCT00357409|Plasticity|plasticity
5740140|NCT00357409|MRS|mrs
5740141|NCT00357409|Blind|blind
5740142|NCT00357396|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5740143|NCT00357396|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5740144|NCT00357357|Alzheimer's disease|alzheimer's disease
5740145|NCT00357344|Obesity|obesity
5740147|NCT00357344|Eating Behavior|eating behavior
5740148|NCT00357344|Brain MRI|brain mri
5740149|NCT00357344|Body Weight Regulation|body weight regulation
5740150|NCT00357331|postmenopausal osteopenia|postmenopausal osteopenia
5740151|NCT00357331|treatment|treatment
5740152|NCT00357331|bone loss|bone loss
5740153|NCT00357266|Uveitis|uveitis
5740154|NCT00357266|Interleukin 2|interleukin 2
5740155|NCT00357266|Interleukin 2 Receptor|interleukin 2 receptor
5740156|NCT00357266|Microarrays|microarrays
5740157|NCT00357266|Genetic Expression|genetic expression
5740158|NCT00357266|Daclizumab|daclizumab
5740159|NCT00357266|HAT|hat
5686250|NCT00552812|Heart Defects, Congenital|heart defects, congenital
5686251|NCT00552812|Stents|stents
5686252|NCT00552812|Heart Catheterization|heart catheterization
5686253|NCT00552799|cellulitis|cellulitis
5686254|NCT00552799|lymphoedema|lymphoedema
5686255|NCT00552799|penicillin|penicillin
5740160|NCT00357266|Zenapax|zenapax
5740161|NCT00357266|Proteins|proteins
5740162|NCT00357266|RNA|rna
5740163|NCT00357266|Ocular Inflammatory Disease|ocular inflammatory disease
5740164|NCT00357253|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5740165|NCT00357253|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5740166|NCT00357253|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5740167|NCT00357240|Protease inhibitor|protease inhibitor
5740168|NCT00357227|Atrial fibrillation|atrial fibrillation
5740169|NCT00357227|Stroke|stroke
5740170|NCT00357227|Vascular Dementia|vascular dementia
5740171|NCT00357227|Mild Cognitive Impairment|mild cognitive impairment
5740179|NCT00357123|abdominal sepsis|abdominal sepsis
5740180|NCT00357123|sepsis|sepsis
5740181|NCT00357123|rosuvastatin|rosuvastatin
5740182|NCT00357110|Breast neoplasms|breast neoplasms
5740183|NCT00357110|breast cancer|breast cancer
5740184|NCT00357110|early breast cancer|early breast cancer
5740185|NCT00357110|oncology|oncology
5740186|NCT00357110|cancer|cancer
5740187|NCT00357110|breast cancer micrometastasis|breast cancer micrometastasis
5740188|NCT00357110|fulvestrant|fulvestrant
5740189|NCT00357097|randomised|randomised
5740190|NCT00357097|ropinirole|ropinirole
5740191|NCT00357097|depression|depression
5740192|NCT00357097|RLS|rls
5740193|NCT00357097|placebo|placebo
5740194|NCT00357097|mood|mood
5740195|NCT00357097|double-blind|double-blind
5740196|NCT00357097|restless legs syndrome|restless legs syndrome
5740197|NCT00357097|germany|germany
5740198|NCT00357084|graft versus host disease|graft versus host disease
5740199|NCT00357084|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5740200|NCT00357084|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5740201|NCT00357084|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5740202|NCT00357084|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5740203|NCT00357084|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5740204|NCT00357084|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5740205|NCT00357084|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5740206|NCT00357084|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5740207|NCT00357084|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5740208|NCT00357084|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5740209|NCT00357084|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5740210|NCT00357084|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5863971|NCT00001148|Glioma|glioma
5740211|NCT00357084|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5740212|NCT00357084|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5740213|NCT00357084|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5740214|NCT00357084|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5740215|NCT00357084|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5740216|NCT00357084|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5740217|NCT00357084|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5740218|NCT00357084|disseminated neuroblastoma|disseminated neuroblastoma
5740219|NCT00357084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5740220|NCT00357084|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5740221|NCT00357084|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5740222|NCT00357084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5740223|NCT00357084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5740224|NCT00357084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5740225|NCT00357084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5740226|NCT00357084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5740227|NCT00357084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5740228|NCT00357084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5740229|NCT00357084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5740230|NCT00357084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5749317|NCT00322673|AML|aml
5740231|NCT00357084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5740232|NCT00357084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5740233|NCT00357084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5740234|NCT00357084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5740235|NCT00357084|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5740236|NCT00357084|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5740464|NCT00356343|Cerebral Palsy|cerebral palsy
5740237|NCT00357084|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5740238|NCT00357084|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5740239|NCT00357084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5740240|NCT00357084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5740241|NCT00357084|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5740242|NCT00357084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5740243|NCT00357084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5740244|NCT00357084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5740245|NCT00357084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5740246|NCT00357084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5740247|NCT00357084|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5740248|NCT00357084|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5740249|NCT00357084|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5740250|NCT00357084|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5740251|NCT00357084|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5740252|NCT00357084|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5740253|NCT00357084|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5740254|NCT00357084|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5740255|NCT00357084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5740256|NCT00357084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5740257|NCT00357084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5740258|NCT00357084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5740259|NCT00357084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5740260|NCT00357084|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5740261|NCT00357084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5740262|NCT00357084|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5740263|NCT00357084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5740264|NCT00357084|refractory hairy cell leukemia|refractory hairy cell leukemia
5740265|NCT00357084|refractory multiple myeloma|refractory multiple myeloma
5740266|NCT00357084|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5740267|NCT00357084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5740268|NCT00357084|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5740269|NCT00357084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5740270|NCT00357084|stage I multiple myeloma|stage i multiple myeloma
5740271|NCT00357084|stage II multiple myeloma|stage ii multiple myeloma
5740272|NCT00357084|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5740273|NCT00357084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5740274|NCT00357084|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5740275|NCT00357084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5740276|NCT00357084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5740277|NCT00357084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5740278|NCT00357084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5740279|NCT00357084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5740280|NCT00357084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5740281|NCT00357084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5740282|NCT00357084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5740283|NCT00357084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5740284|NCT00357084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5740285|NCT00357084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5740286|NCT00357084|stage III multiple myeloma|stage iii multiple myeloma
5740287|NCT00357084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5740288|NCT00357084|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5740289|NCT00357084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5740290|NCT00357084|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5735264|NCT00375583|Helminths|helminths
5740291|NCT00357084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5686256|NCT00552799|clinical trial|clinical trial
5740292|NCT00357084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5740293|NCT00357084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5740294|NCT00357084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5740295|NCT00357084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5740296|NCT00357084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5740297|NCT00357084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5740298|NCT00357084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5740299|NCT00357084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5740300|NCT00357084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5740301|NCT00357084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5740302|NCT00357084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5740303|NCT00357084|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5740304|NCT00357084|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5740305|NCT00357071|Autoimmunity|autoimmunity
5740306|NCT00357071|Cell Mediated Immunity|cell mediated immunity
5740307|NCT00357071|S Antigen|s antigen
5740308|NCT00357071|Cell Proliferation|cell proliferation
5740310|NCT00357071|Cell Proliferation Assays|cell proliferation assays
5740311|NCT00357071|Auto-Antibody|auto-antibody
5740312|NCT00357071|Auto-Antigens|auto-antigens
5740313|NCT00357058|Deafferentiation-Induced Plasticity|deafferentiation-induced plasticity
5740314|NCT00357058|fMRI|fmri
5740315|NCT00357058|Cortical Reorganization|cortical reorganization
5740316|NCT00357058|Tactile Performance|tactile performance
5740317|NCT00357058|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5740318|NCT00357058|Tactile Discrimination|tactile discrimination
5740319|NCT00357058|Plasticity|plasticity
5740320|NCT00357058|Healthy Volunteer|healthy volunteer
5740322|NCT00357058|Normal Control|normal control
5740323|NCT00357006|Schizophrenia|schizophrenia
5740324|NCT00357006|Estrogen|estrogen
5740325|NCT00357006|Psychosis|psychosis
5740326|NCT00356993|nicotine replacement therapy|nicotine replacement therapy
5740327|NCT00356993|smoking cessation|smoking cessation
5740328|NCT00356980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5740329|NCT00356967|smoking|smoking
5740330|NCT00356967|cessation|cessation
5740331|NCT00356967|tobacco|tobacco
5740332|NCT00356967|smoking cessation|smoking cessation
5740333|NCT00356967|tobacco use cessation|tobacco use cessation
5740334|NCT00356954|Kidney failure|kidney failure
5740335|NCT00356954|Contrast media|contrast media
5740336|NCT00356954|Antioxidant|antioxidant
5740337|NCT00356954|Prevention|prevention
5740338|NCT00356941|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5740339|NCT00356941|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5740340|NCT00356941|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5740341|NCT00356941|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5740342|NCT00356928|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5740343|NCT00356928|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5740344|NCT00356928|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5740345|NCT00356928|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5740346|NCT00356928|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5740347|NCT00356915|Nail fungus|nail fungus
5740348|NCT00356915|Onychomycosis|onychomycosis
5740349|NCT00356915|Itraconazole|itraconazole
5740350|NCT00356915|Toenail|toenail
5740351|NCT00356863|Intervention|intervention
5740352|NCT00356863|Awareness|awareness
5740353|NCT00356863|Cardiac Rehabilitation (CR)|cardiac rehabilitation (cr)
5740354|NCT00356863|Coronary Artery Patients|coronary artery patients
5740355|NCT00356863|Coronary Artery Bypass Grafting Surgery (CABG)|coronary artery bypass grafting surgery (cabg)
5740356|NCT00356824|Child|child
5740357|NCT00356811|Lapatinib|lapatinib
5740358|NCT00356811|Metastatic breast cancer|metastatic breast cancer
5740359|NCT00356811|Paclitaxel|paclitaxel
5740360|NCT00356811|ErbB2-amplification|erbb2-amplification
5740361|NCT00356811|GW572016|gw572016
5740362|NCT00356798|pandemic|pandemic
5740363|NCT00356798|influenza|influenza
5740364|NCT00356798|H5N1|h5n1
5740365|NCT00356798|vaccine|vaccine
5740366|NCT00356785|lifestyle|lifestyle
5740367|NCT00356785|diet|diet
5740368|NCT00356785|exercise|exercise
5740369|NCT00356785|physical activity|physical activity
5740370|NCT00356785|obesity|obesity
5740371|NCT00356759|warfarin|warfarin
5740372|NCT00356759|prothrombin time|prothrombin time
5740373|NCT00356759|monitoring|monitoring
5740374|NCT00356746|Perioperative inflammatory response|perioperative inflammatory response
5740375|NCT00356746|General anesthesia|general anesthesia
5740376|NCT00356746|Toll-Like Receptors|toll-like receptors
5740377|NCT00356733|cardiorenal syndrome|cardiorenal syndrome
5740378|NCT00356733|erythropoietin|erythropoietin
5740379|NCT00356733|Heart Failure, Congestive|heart failure, congestive
5740380|NCT00356733|Renal Insufficiency, Chronic|renal insufficiency, chronic
5740381|NCT00356707|Body Mass Index|body mass index
5740382|NCT00356681|AMG 706|amg 706
5740383|NCT00356681|Paclitaxel|paclitaxel
5740384|NCT00356681|Metastatic Breast Cancer|metastatic breast cancer
5740385|NCT00356681|Antiangiogenic|antiangiogenic
5740386|NCT00356681|Bevacizumab|bevacizumab
5740387|NCT00356668|HFNC|hfnc
5740388|NCT00356668|NCPAP|ncpap
5740389|NCT00356668|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5740390|NCT00356668|humidified high flow nasal cannula|humidified high flow nasal cannula
5740391|NCT00356668|esophageal pressure|esophageal pressure
5740392|NCT00356668|gas flow|gas flow
5740393|NCT00356655|Depressive disorder|depressive disorder
5740394|NCT00356655|Patient compliance|patient compliance
5740395|NCT00356655|Antidepressive Agents|antidepressive agents
5740396|NCT00356655|Patient education|patient education
5740397|NCT00356655|Community pharmacy services|community pharmacy services
5740398|NCT00356655|Counseling|counseling
5740399|NCT00356642|PK|pk
5740400|NCT00356642|GW842470X|gw842470x
5740401|NCT00356642|safety|safety
5740402|NCT00356642|tolerability|tolerability
5740403|NCT00356642|PD|pd
5740404|NCT00356642|Atopic Dermatitis|atopic dermatitis
5740405|NCT00356629|bronchopulmonary ignition|bronchopulmonary ignition
5740406|NCT00356629|condensate of exhaled air|condensate of exhaled air
5740407|NCT00356629|Mucoviscidosis|mucoviscidosis
5740408|NCT00356629|Asthma|asthma
5740409|NCT00356616|Antiretroviral treatment|antiretroviral treatment
5740410|NCT00356616|virological failure|virological failure
5740411|NCT00356616|HIV|hiv
5740412|NCT00356603|Migraine|migraine
5740413|NCT00356603|Sumatriptan Succinate Injection Kit|sumatriptan succinate injection kit
5740414|NCT00356603|Cluster Headache|cluster headache
5740415|NCT00356603|self-injection|self-injection
5740416|NCT00356590|Rheumatoid Arthritis|rheumatoid arthritis
5740417|NCT00356590|Etanercept|etanercept
5740418|NCT00356590|Long-term Safety|long-term safety
5740419|NCT00356590|Enbrel|enbrel
5740420|NCT00356564|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
5740421|NCT00356551|Teen pregnancy|teen pregnancy
5740422|NCT00356551|Family strengthening|family strengthening
5740423|NCT00356551|Substance abuse prevention|substance abuse prevention
5740424|NCT00356551|Depression prevention|depression prevention
5740425|NCT00356551|Parent involvement|parent involvement
5740426|NCT00356512|Phosphate|phosphate
5740427|NCT00356512|Vitamin D|vitamin d
5740428|NCT00356512|Hypoparathyroidism|hypoparathyroidism
5740429|NCT00356512|Phosphatonin|phosphatonin
5740430|NCT00356512|Clamp|clamp
5740431|NCT00356486|Chronic Hepatitis C|chronic hepatitis c
5740432|NCT00356486|Co-infection|co-infection
5740433|NCT00356486|Induction dose|induction dose
5740434|NCT00356486|HIV|hiv
5740435|NCT00356486|HIV Infections|hiv infections
5740436|NCT00356473|Rheumatoid arthritis|rheumatoid arthritis
5740437|NCT00356473|Atherosclerosis|atherosclerosis
5740438|NCT00356473|High density lipoprotein (HDL) cholesterol|high density lipoprotein (hdl) cholesterol
5740439|NCT00356473|Statins|statins
5740440|NCT00356473|HDL anti-inflammatory properties|hdl anti-inflammatory properties
5740441|NCT00356473|Atorvastatin|atorvastatin
5740442|NCT00356434|deep vein thrombosis|deep vein thrombosis
5740443|NCT00356434|thrombophilia|thrombophilia
5740444|NCT00356434|pregnancy|pregnancy
5740445|NCT00356434|thromboprophylaxis|thromboprophylaxis
5740446|NCT00356434|decreased mobility|decreased mobility
5740447|NCT00356434|hospitalization|hospitalization
5740448|NCT00356408|CDP870|cdp870
5863972|NCT00001148|Venous|venous
5740449|NCT00356408|certolizumab pegol|certolizumab pegol
5740450|NCT00356408|Crohn's Disease|crohn's disease
5740451|NCT00356395|endothelial function, insulin resistance, adipocytokines|endothelial function, insulin resistance, adipocytokines
5740452|NCT00356382|probiotic|probiotic
5740453|NCT00356382|Lactobacillus (L.) casei|lactobacillus (l.) casei
5740454|NCT00356382|cultured dairy drink|cultured dairy drink
5740455|NCT00356382|Health|health
5740456|NCT00356369|Immunogenicity|immunogenicity
5740457|NCT00356369|Healthy|healthy
5740458|NCT00356369|Persistence|persistence
5740459|NCT00356369|Meningococcal vaccine|meningococcal vaccine
5740460|NCT00356369|Non-inferiority|non-inferiority
5740461|NCT00356369|Meningococcal A C W Y Diseases|meningococcal a c w y diseases
5740462|NCT00356369|meningococcal serogroups A, C, W & Y diseases|meningococcal serogroups a, c, w & y diseases
5740463|NCT00356343|NMES|nmes
5740465|NCT00356343|Spastic Diplegia|spastic diplegia
5740466|NCT00356343|Electrical Stimulation|electrical stimulation
5740467|NCT00356343|Children|children
5740468|NCT00356330|pacemaker|pacemaker
5740469|NCT00356330|magnetic resonance imaging|magnetic resonance imaging
5740470|NCT00356330|safety|safety
5740471|NCT00356317|Culture|culture
5740475|NCT00356304|Major Depression|major depression
5740476|NCT00356304|Hispanics|hispanics
5740477|NCT00356304|Latinos|latinos
5740478|NCT00356304|Motivational Interviewing|motivational interviewing
5740479|NCT00356304|Adherence|adherence
5740481|NCT00356291|AIDS|aids
5740482|NCT00356291|Prevention|prevention
5740483|NCT00356291|Serious Mental Illness|serious mental illness
5740484|NCT00356278|D-Cycloserine|d-cycloserine
5740485|NCT00356278|Virtual Reality|virtual reality
5740486|NCT00356278|Exposure Therapy|exposure therapy
5740487|NCT00356278|Veterans|veterans
5740488|NCT00356278|Cognitive Behavior Therapy|cognitive behavior therapy
5740489|NCT00356278|Translational Research|translational research
5740490|NCT00356265|Blood Pressure Nitric Oxide|blood pressure nitric oxide
5740491|NCT00356265|L-NMMA|l-nmma
5740492|NCT00356265|Phenylephrine|phenylephrine
5740493|NCT00356265|Vasoreactivity|vasoreactivity
5740494|NCT00356265|Blood Pressure|blood pressure
5740495|NCT00356239|Defibrillators, Implantable|defibrillators, implantable
5740496|NCT00356239|Heart Failure, Congestive|heart failure, congestive
5740497|NCT00356239|Magnetic Resonance Imaging|magnetic resonance imaging
5740498|NCT00356226|norepinephrine|norepinephrine
5740499|NCT00356226|renin|renin
5740500|NCT00356226|aldosterone|aldosterone
5740501|NCT00356226|hemodynamics|hemodynamics
5740502|NCT00356226|spironolactone|spironolactone
5740503|NCT00356213|morbid obesity|morbid obesity
5740504|NCT00356213|bariatric surgery|bariatric surgery
5740505|NCT00356213|sleeve-gastrectomy|sleeve-gastrectomy
5740506|NCT00356213|Roux-Y-gastric bypass|roux-y-gastric bypass
5740507|NCT00356213|outcome|outcome
5740508|NCT00356213|weight loss|weight loss
5740509|NCT00356174|Food Allergy|food allergy
5740510|NCT00356161|colorectal neoplasms|colorectal neoplasms
5740511|NCT00356161|hepatocellular carcinoma|hepatocellular carcinoma
5740512|NCT00356161|gallbladder cancer|gallbladder cancer
5740513|NCT00356161|bile duct cancer|bile duct cancer
5740514|NCT00356161|hepatic arterial infusion|hepatic arterial infusion
5740515|NCT00356148|breast cancer|breast cancer
5740516|NCT00356148|breast surgery|breast surgery
5740517|NCT00356148|clean wound|clean wound
5740518|NCT00356148|overweight|overweight
5740519|NCT00356148|prophylaxis|prophylaxis
5740520|NCT00356148|antibiotics|antibiotics
5740521|NCT00356122|Lung|lung
5740522|NCT00356122|non-small cell|non-small cell
5740523|NCT00356122|chemotherapy|chemotherapy
5740524|NCT00356122|tumor|tumor
5740525|NCT00356122|advanced|advanced
5740526|NCT00356122|recurrent|recurrent
5740527|NCT00356122|metastatic|metastatic
5740528|NCT00356122|Non-Small Cell Lung Cancer (NSCLC)|non-small cell lung cancer (nsclc)
5740529|NCT00356070|Attention Deficit Hyperactivity Disorder, treatment,|attention deficit hyperactivity disorder, treatment,
5740530|NCT00356070|Strattera,|strattera,
5740531|NCT00356070|rehabilitation|rehabilitation
5740532|NCT00356057|atrial fibrillation|atrial fibrillation
5740533|NCT00356057|AV node ablation|av node ablation
5740534|NCT00356057|pacemaker|pacemaker
5740535|NCT00356057|congestive heart failure|congestive heart failure
5740536|NCT00356044|Transradial access|transradial access
5740537|NCT00356044|Femoral access|femoral access
5740538|NCT00356044|Femoral vs radial access|femoral vs radial access
5740539|NCT00356031|Avastin|avastin
5740540|NCT00356018|Epilepsy|epilepsy
5740541|NCT00356018|Compliance|compliance
5740542|NCT00356005|falciparum malaria|falciparum malaria
5740543|NCT00356005|therapy|therapy
5740544|NCT00356005|azithromycin|azithromycin
5740545|NCT00356005|artesunate|artesunate
5740546|NCT00356005|Coartem|coartem
5740547|NCT00356005|Bangladesh|bangladesh
5740548|NCT00355992|Myocardial Ischemia|myocardial ischemia
5740549|NCT00355992|Chest pain|chest pain
5740550|NCT00355992|Ischemia Modified Albumin|ischemia modified albumin
5740551|NCT00355992|Acute Coronary Syndrome|acute coronary syndrome
5740552|NCT00355979|Obesity, intragastric balloon, Pharmacotherapy|obesity, intragastric balloon, pharmacotherapy
5740553|NCT00355966|Premature rupture of membranes|premature rupture of membranes
5740554|NCT00355966|Induction of labour with Misoprostol|induction of labour with misoprostol
5740555|NCT00355966|Induction of labour with PGE2 gel|induction of labour with pge2 gel
5740556|NCT00355953|Post-Menopausal Women|post-menopausal women
5740557|NCT00355953|Osteoporosis|osteoporosis
5740558|NCT00355953|Phytoestrogen|phytoestrogen
5740559|NCT00355953|Genistein|genistein
5740560|NCT00355940|endovascular|endovascular
5740561|NCT00355940|aortic|aortic
5740562|NCT00355940|repair|repair
5740563|NCT00355940|navigation|navigation
5740564|NCT00355940|DynaCT|dynact
5740565|NCT00355940|position|position
5740566|NCT00355940|sensor|sensor
5740567|NCT00355927|Deep brain stimulation|deep brain stimulation
5740568|NCT00355927|Microelectrode recordings|microelectrode recordings
5740569|NCT00355927|Basal Ganglia|basal ganglia
5740570|NCT00355927|Sedation|sedation
5740571|NCT00355927|Propofol|propofol
5740572|NCT00355914|Lumbar Facet Joint Nerve Block|lumbar facet joint nerve block
5740573|NCT00355901|Ulcerative Colitis|ulcerative colitis
5740574|NCT00355901|Colitis|colitis
5740575|NCT00355901|Steroid-Refractory|steroid-refractory
5740576|NCT00355901|Visilizumab|visilizumab
5740679|NCT00355576|Creatine|creatine
5740577|NCT00355901|Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)|intravenous steroid-refractory ulcerative colitis (ivsr-uc)
5740578|NCT00355888|Cancer|cancer
5740579|NCT00355888|Advanced or Metastatic Solid Tumor|advanced or metastatic solid tumor
5740580|NCT00355875|newborn|newborn
5740581|NCT00355875|preterm|preterm
5740582|NCT00355875|resuscitation|resuscitation
5740583|NCT00355875|oxidative injury|oxidative injury
5740584|NCT00355875|protein carbonyl|protein carbonyl
5740585|NCT00355862|Sirolimus|sirolimus
5686257|NCT00552786|noise|noise
5740586|NCT00355862|mTOR|mtor
5798840|NCT00111072|Oral Lichen Planus|oral lichen planus
5740587|NCT00355862|HCC-recurrence free survival|hcc-recurrence free survival
5740588|NCT00355862|Liver transplant recipients|liver transplant recipients
5740589|NCT00355862|HCC recurrence free survival|hcc recurrence free survival
5740590|NCT00355836|Motor Imagery|motor imagery
5740591|NCT00355836|Stroke|stroke
5740592|NCT00355836|Neuro-rehabilitation|neuro-rehabilitation
5740593|NCT00355836|health psychology|health psychology
5740594|NCT00355836|neuroscience|neuroscience
5740595|NCT00355836|randomised controlled trial|randomised controlled trial
5740596|NCT00355823|electric field|electric field
5740597|NCT00355823|wound current|wound current
5740598|NCT00355823|wound healing|wound healing
5740599|NCT00355823|bioelectric field|bioelectric field
5740600|NCT00355823|chronic ulcer|chronic ulcer
5740601|NCT00355823|diabetic|diabetic
5740602|NCT00355823|Diabetes|diabetes
5740603|NCT00355823|aging|aging
5740604|NCT00355810|Probiotics|probiotics
5740605|NCT00355797|Bradycardia|bradycardia
5740606|NCT00355797|Sinus Node Dysfunction|sinus node dysfunction
5740607|NCT00355797|Chronotropic incompetence|chronotropic incompetence
5740608|NCT00355797|Pacemaker|pacemaker
5740609|NCT00355797|Rate adaptive|rate adaptive
5740610|NCT00355784|growth hormone|growth hormone
5740611|NCT00355784|overfeeding|overfeeding
5740612|NCT00355784|energy expenditure|energy expenditure
5740613|NCT00355784|protein metabolism|protein metabolism
5740614|NCT00355784|lipid metabolism|lipid metabolism
5740615|NCT00355771|allergic rhinitis|allergic rhinitis
5740616|NCT00355771|histamine antagonist|histamine antagonist
5740617|NCT00355771|sleep disorder|sleep disorder
5740618|NCT00355758|Prostate Cancer Detection by Serum Proteomic Profiling|prostate cancer detection by serum proteomic profiling
5740619|NCT00355745|Breast|breast
5740620|NCT00355745|tumor|tumor
5740621|NCT00355745|ultrasound|ultrasound
5740622|NCT00355745|biopsy|biopsy
5740623|NCT00355745|Breast mammographic or ultrasound findings|breast mammographic or ultrasound findings
5740624|NCT00355732|Respiration|respiration
5740625|NCT00355732|COPD|copd
5740626|NCT00355732|Mechanical Ventilation|mechanical ventilation
5740627|NCT00355732|Ventilator Weaning|ventilator weaning
5740628|NCT00355732|Respiratory Failure|respiratory failure
5740630|NCT00355732|Pressure Support Ventilation|pressure support ventilation
5740631|NCT00355719|Nevirapine|nevirapine
5740632|NCT00355719|Atazanavir|atazanavir
5740633|NCT00355719|Pharmacokinetics|pharmacokinetics
5740634|NCT00355719|Interactions|interactions
5740635|NCT00355706|chronic low back pain|chronic low back pain
5740636|NCT00355706|thoracic facet joint|thoracic facet joint
5740637|NCT00355706|nerve block|nerve block
5740638|NCT00355693|Anxiety|anxiety
5740639|NCT00355693|Dental|dental
5740640|NCT00355693|Oral|oral
5740641|NCT00355693|Surgery|surgery
5740642|NCT00355693|Colonoscopy|colonoscopy
5740643|NCT00355693|Propofol|propofol
5740644|NCT00355693|Sedation|sedation
5740645|NCT00355693|Effect|effect
5740647|NCT00355680|Retina|retina
5740648|NCT00355680|Retinal Diseases|retinal diseases
5740649|NCT00355680|Retinal Vessels|retinal vessels
5740650|NCT00355680|Laser Coagulation|laser coagulation
5740651|NCT00355667|diuretics|diuretics
5740652|NCT00355667|furosemide|furosemide
5740653|NCT00355667|azosemide|azosemide
5740654|NCT00355667|congestive heart failure|congestive heart failure
5740655|NCT00355654|Diphtheria|diphtheria
5740656|NCT00355654|Tetanus|tetanus
5740657|NCT00355654|Pertussis|pertussis
5740658|NCT00355654|Poliomyelitis|poliomyelitis
5740659|NCT00355654|Haemophilus influenzae type b|haemophilus influenzae type b
5740660|NCT00355654|Hepatitis B|hepatitis b
5740661|NCT00355641|Ropinirole|ropinirole
5740662|NCT00355641|Restless Legs Syndrome|restless legs syndrome
5740664|NCT00355628|Pain|pain
5740665|NCT00355628|Cancer|cancer
5740666|NCT00355628|Neoplasm|neoplasm
5740667|NCT00355628|Continual Reassessment Method|continual reassessment method
5740668|NCT00355628|Pain Associated with Cancer/Neoplasms|pain associated with cancer/neoplasms
5740669|NCT00355615|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5740670|NCT00355602|Antibiotics|antibiotics
5740671|NCT00355602|Controlled Clinical Trial|controlled clinical trial
5740672|NCT00355589|Hypertension|hypertension
5740673|NCT00355589|High Blood Pressure|high blood pressure
5740674|NCT00355589|Diuretic|diuretic
5740675|NCT00355589|Angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5740676|NCT00355589|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5740677|NCT00355576|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5740678|NCT00355576|Celecoxib|celecoxib
5740684|NCT00355576|Motor Neuron Disease|motor neuron disease
5740685|NCT00355550|Mild Cognitive Impairment|mild cognitive impairment
5740686|NCT00355550|Cognition disorders|cognition disorders
5740687|NCT00355550|nutritional supplement|nutritional supplement
5740688|NCT00355550|dietary supplement|dietary supplement
5740690|NCT00355524|Darunavir|darunavir
5740691|NCT00355524|Ritonavir|ritonavir
5740692|NCT00355524|TMC114|tmc114
5749770|NCT00320840|twins|twins
5740693|NCT00355511|heart failure, congestive|heart failure, congestive
5740695|NCT00355511|randomized controlled trial|randomized controlled trial
5740696|NCT00355511|disease management|disease management
5740697|NCT00355511|drug therapy|drug therapy
5740698|NCT00355511|diet therapy|diet therapy
5740699|NCT00355511|hospitalization|hospitalization
5740700|NCT00355511|mortality|mortality
5740701|NCT00355498|functional magnetic resonance imaging|functional magnetic resonance imaging
5740702|NCT00355498|positron emission tomography|positron emission tomography
5740703|NCT00355498|beta-amyloid|beta-amyloid
5740705|NCT00355485|Acne|acne
5740706|NCT00355485|Microdermabrasion|microdermabrasion
5740707|NCT00355472|Adult T-Cell Leukemia|adult t-cell leukemia
5740708|NCT00355472|ATL|atl
5740709|NCT00355472|Adult Peripheral T-Cell Lymphoma|adult peripheral t-cell lymphoma
5740710|NCT00355472|PTCL|ptcl
5740711|NCT00355459|Meibomian Gland Dystrophy|meibomian gland dystrophy
5740712|NCT00355446|Cataract|cataract
5740713|NCT00355446|Human Aqueous|human aqueous
5740714|NCT00355433|urinary incontinence|urinary incontinence
5740715|NCT00355433|urodynamics|urodynamics
5740716|NCT00355433|temperature|temperature
5740717|NCT00355407|Aranesp|aranesp
5740718|NCT00355407|allogeneic stem cell transplant|allogeneic stem cell transplant
5740719|NCT00355381|Information Services|information services
5740720|NCT00355381|Randomized Controlled Trials|randomized controlled trials
5740721|NCT00355381|Medical Records Systems, Computerized|medical records systems, computerized
5740722|NCT00355381|Internet|internet
5740723|NCT00355381|Librarians|librarians
5740724|NCT00355381|Breast Neoplasms|breast neoplasms
5740725|NCT00355381|Patient Satisfaction|patient satisfaction
5740726|NCT00355381|Health Personnel|health personnel
5740727|NCT00355381|Costs and Cost Analysis|costs and cost analysis
5740728|NCT00355381|Premature Birth|premature birth
5740729|NCT00355368|intubation|intubation
5740730|NCT00355368|intensive care|intensive care
5740731|NCT00355368|neuromuscular depolarizing agents|neuromuscular depolarizing agents
5740732|NCT00355368|neuromuscular nondepolarizing agents|neuromuscular nondepolarizing agents
5740733|NCT00355368|neuromuscular blocking agents|neuromuscular blocking agents
5740734|NCT00355355|Hepatocellular carcinoma|hepatocellular carcinoma
5740735|NCT00355355|HCC|hcc
5740736|NCT00355355|Liver Neoplasms|liver neoplasms
5740737|NCT00355355|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
5740738|NCT00355355|Light emitting diodes (LEDs)|light emitting diodes (leds)
5740739|NCT00355355|Light activation|light activation
5740740|NCT00355342|Osteoporosis|osteoporosis
5740741|NCT00355342|Bone Mineral Density|bone mineral density
5740742|NCT00355342|Osteopenia|osteopenia
5740743|NCT00355342|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5740744|NCT00355342|COPD|copd
5740745|NCT00355329|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
5740746|NCT00355329|Autism|autism
5740747|NCT00355329|Autistic Spectrum Disorder|autistic spectrum disorder
5740748|NCT00355329|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
5740749|NCT00355329|18F-fluorodeoxyglucose Positron Emission Tomography (PET)|18f-fluorodeoxyglucose positron emission tomography (pet)
5740750|NCT00355329|children|children
5740751|NCT00355316|Breast Cancer|breast cancer
5740752|NCT00355316|Peripheral|peripheral
5740753|NCT00355316|Blood|blood
5740754|NCT00355303|Premature rupture of membranes at term|premature rupture of membranes at term
5740755|NCT00355303|Induction of labour|induction of labour
5740756|NCT00355303|Misoprostol|misoprostol
5740757|NCT00355303|PGE2 gel|pge2 gel
5750859|NCT00316719|CHB|chb
5740758|NCT00355303|Immediate induction with PGE2 gel|immediate induction with pge2 gel
5740759|NCT00355303|Immediate induction with Misoprostol|immediate induction with misoprostol
5740760|NCT00355290|Chronic Oral Anticoagulation|chronic oral anticoagulation
5740761|NCT00355277|Tricyclic antidepressants|tricyclic antidepressants
5740762|NCT00355277|Neuropathic pain|neuropathic pain
5740763|NCT00355277|Local anaesthesia|local anaesthesia
5740764|NCT00355277|Transcutaneous|transcutaneous
5740765|NCT00355251|Atorvastatin|atorvastatin
5740766|NCT00355251|Viral replication|viral replication
5740767|NCT00355251|HIV-1|hiv-1
5740768|NCT00355251|plasma cholesterol|plasma cholesterol
5740769|NCT00355251|Cell membrane cholesterol|cell membrane cholesterol
5740770|NCT00355225|insecticide-treated bednets|insecticide-treated bednets
5740771|NCT00355225|malaria|malaria
5740772|NCT00355225|africa|africa
5740773|NCT00355225|social marketing|social marketing
5740774|NCT00355225|ante-natal care|ante-natal care
5740775|NCT00355225|ITN coverage|itn coverage
5740776|NCT00355225|ITn use|itn use
5740777|NCT00355212|percutaneous ethanol injection|percutaneous ethanol injection
5740778|NCT00355212|radiofrequency|radiofrequency
5740779|NCT00355212|liver cirrhosis|liver cirrhosis
5740780|NCT00355212|carcinoma, hepatocellular|carcinoma, hepatocellular
5740781|NCT00355199|DLBCL|dlbcl
5740782|NCT00355199|R-HDS|r-hds
5740783|NCT00355199|R-CHOP14|r-chop14
5740784|NCT00355186|acute myocardial infarction|acute myocardial infarction
5740785|NCT00355186|MRI|mri
5740786|NCT00355186|bone marrow cells|bone marrow cells
5740787|NCT00355186|stem cells|stem cells
5740788|NCT00355186|remodeling|remodeling
5740790|NCT00355160|Sinusitis|sinusitis
5740791|NCT00355160|Rhinitis|rhinitis
5740792|NCT00355160|Facial Pain|facial pain
5740793|NCT00355147|Ischemic stroke|ischemic stroke
5740794|NCT00355147|Preventive medicine|preventive medicine
5740795|NCT00355147|Transient Ischemic Attack|transient ischemic attack
5740796|NCT00355147|Neurology|neurology
5740797|NCT00355147|Risk management|risk management
5740798|NCT00355134|fingolimod|fingolimod
5740799|NCT00355134|FTY720|fty720
5740800|NCT00355134|relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5740801|NCT00355134|MS|ms
5740802|NCT00355134|RRMS|rrms
5740803|NCT00355121|Meningococcal meningitis|meningococcal meningitis
5740804|NCT00355121|Tetanus|tetanus
5740805|NCT00355121|Diphtheria|diphtheria
5740806|NCT00355121|Pertussis|pertussis
5740807|NCT00355121|Poliomyelitis|poliomyelitis
5740808|NCT00355121|Neisseria meningitidis|neisseria meningitidis
5740809|NCT00355108|Rendu Osler syndrome|rendu osler syndrome
5740810|NCT00355108|Epistaxis|epistaxis
5740811|NCT00355108|Tranexamic acid|tranexamic acid
5740812|NCT00355108|clinical trial|clinical trial
5740813|NCT00355095|multiple sclerosis|multiple sclerosis
5740814|NCT00355095|add-on Therapy|add-on therapy
5740815|NCT00355095|erythropoietin|erythropoietin
5740816|NCT00355095|methylprednisolone|methylprednisolone
5740817|NCT00355095|autoimmune optic neuritis|autoimmune optic neuritis
5740818|NCT00355082|epilepsy|epilepsy
5740819|NCT00355082|lamotrigine|lamotrigine
5740820|NCT00355082|Lamictal|lamictal
5740821|NCT00355082|monotherapy|monotherapy
5740822|NCT00355069|pediatric|pediatric
5740823|NCT00355069|asthma|asthma
5740824|NCT00355069|translational research|translational research
5740825|NCT00355069|health information technology|health information technology
5740826|NCT00355056|Migraine|migraine
5740827|NCT00355056|PFO|pfo
5740828|NCT00355056|Migraine Headache|migraine headache
5740829|NCT00355056|patent foramen ovale|patent foramen ovale
5740830|NCT00355043|Zinc treatment|zinc treatment
5740831|NCT00355043|Bronchiolitis|bronchiolitis
5740832|NCT00355043|Wheezing|wheezing
5740833|NCT00355043|Children aged 2 months to 23 months|children aged 2 months to 23 months
5740834|NCT00355043|Diagnosed case of acute bronchiolitis|diagnosed case of acute bronchiolitis
5740835|NCT00355004|colon cancer|colon cancer
5740836|NCT00355004|rectal cancer|rectal cancer
5740837|NCT00354978|Colorectal Cancer|colorectal cancer
5740838|NCT00354978|FOLFIRI|folfiri
5740839|NCT00354978|Irinotecan|irinotecan
5740840|NCT00354978|CPT-11|cpt-11
5740841|NCT00354978|Leucovorin|leucovorin
5740842|NCT00354978|LV|lv
5740843|NCT00354978|Folinic Acid|folinic acid
5740844|NCT00354978|Fluorouracil|fluorouracil
5740845|NCT00354978|5-FU|5-fu
5740846|NCT00354978|Adrucil|adrucil
5740847|NCT00354978|Efudex|efudex
5740848|NCT00354978|Bevacizumab|bevacizumab
5740849|NCT00354978|Avastin|avastin
5740850|NCT00354978|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5740851|NCT00354978|rhuMAb-VEGF|rhumab-vegf
5740853|NCT00354965|Acute Bacterial|acute bacterial
5740854|NCT00354965|Sinusitis|sinusitis
5740855|NCT00354965|Bacterial Sinusitis|bacterial sinusitis
5740856|NCT00354952|Healthy volunteers|healthy volunteers
5740857|NCT00354952|Antibiotic exposure|antibiotic exposure
5740858|NCT00354952|Resistance selection|resistance selection
5740859|NCT00354926|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5740860|NCT00354926|rituximab|rituximab
5740861|NCT00354926|humanized monoclonal antibody|humanized monoclonal antibody
5740862|NCT00354926|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5740863|NCT00354913|adult grade I meningioma|adult grade i meningioma
5740864|NCT00354913|adult grade II meningioma|adult grade ii meningioma
5740865|NCT00354913|adult grade III meningioma|adult grade iii meningioma
5740866|NCT00354913|adult papillary meningioma|adult papillary meningioma
5740867|NCT00354913|adult anaplastic meningioma|adult anaplastic meningioma
5740868|NCT00354913|recurrent adult brain tumor|recurrent adult brain tumor
5740869|NCT00354913|glioblastoma multiforme (GBM)|glioblastoma multiforme (gbm)
5740870|NCT00354913|Imatinib|imatinib
5740871|NCT00354913|Imatinib mesylate|imatinib mesylate
5740872|NCT00354913|Hydroxyurea|hydroxyurea
5740873|NCT00354913|Droxia|droxia
5740874|NCT00354913|Hydrea|hydrea
5740875|NCT00354913|Hydroxycarbamide|hydroxycarbamide
5740876|NCT00354913|Gleevec|gleevec
5740877|NCT00354913|Meningioma|meningioma
5740878|NCT00354900|breast cancer|breast cancer
5740879|NCT00354900|fibrinolysis|fibrinolysis
5740880|NCT00354900|urokinase-type plasminogen activator|urokinase-type plasminogen activator
5740881|NCT00354900|plasminogen activator inhibitor|plasminogen activator inhibitor
5740882|NCT00354900|aprotinin|aprotinin
5740883|NCT00354900|plasmin/alpha-2-antiplasmin complex|plasmin/alpha-2-antiplasmin complex
5740884|NCT00354887|Gastrointestinal Cancer|gastrointestinal cancer
5740885|NCT00354887|Small Bowel Cancer|small bowel cancer
5740886|NCT00354887|Ampulla of Vater|ampulla of vater
5740887|NCT00354887|Capecitabine|capecitabine
5740888|NCT00354887|Xeloda|xeloda
5740889|NCT00354887|Oxaliplatin|oxaliplatin
5740890|NCT00354887|Eloxatin|eloxatin
5735863|NCT00373386|growth hormone|growth hormone
5740891|NCT00354874|GW642444 asthmatic subjects safety tolerability PD and PK|gw642444 asthmatic subjects safety tolerability pd and pk
5740892|NCT00354861|Healthy volunteers|healthy volunteers
5740894|NCT00354861|Adjuvant|adjuvant
5740895|NCT00354861|Pharmacodynamics|pharmacodynamics
5740896|NCT00354822|Zevalin|zevalin
5740897|NCT00354822|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5740898|NCT00354809|cognition|cognition
5740899|NCT00354809|Primary Insomnia|primary insomnia
5740900|NCT00354809|sleep|sleep
5740901|NCT00354809|polysomnography|polysomnography
5740902|NCT00354796|bleeding|bleeding
5740903|NCT00354796|anticoagulation|anticoagulation
5740904|NCT00354796|LMWH|lmwh
5740905|NCT00354796|Enoxaparin|enoxaparin
5740906|NCT00354783|Very low birth weight premature infants|very low birth weight premature infants
5740907|NCT00354783|Kicking|kicking
5740908|NCT00354783|Stepping|stepping
5740909|NCT00354783|Walking|walking
5740910|NCT00354783|Motor development|motor development
5740911|NCT00354783|Kinematics|kinematics
5740912|NCT00354770|Trichotillomania|trichotillomania
5740913|NCT00354770|Hair-pulling|hair-pulling
5740914|NCT00354757|gastroesophageal reflux disease, proton-pump inhibitor test|gastroesophageal reflux disease, proton-pump inhibitor test
5740915|NCT00354744|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5740916|NCT00354744|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5740917|NCT00354744|adult malignant mesenchymoma|adult malignant mesenchymoma
5740918|NCT00354744|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5740919|NCT00354744|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5740920|NCT00354744|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5740921|NCT00354731|nephrotic syndrome, pentoxifylline, corticosteroid|nephrotic syndrome, pentoxifylline, corticosteroid
5740922|NCT00354705|Colon Cancer|colon cancer
5740923|NCT00354705|Adenocarcinoma of the Colon|adenocarcinoma of the colon
5740924|NCT00354705|Cancer Recurrence|cancer recurrence
5740925|NCT00354705|Survey|survey
5740926|NCT00354705|Chemotherapy|chemotherapy
5740927|NCT00354705|Surgery|surgery
5740928|NCT00354679|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5740929|NCT00354679|recurrent esophageal cancer|recurrent esophageal cancer
5740930|NCT00354679|stage III esophageal cancer|stage iii esophageal cancer
5740931|NCT00354679|stage II esophageal cancer|stage ii esophageal cancer
5740932|NCT00354666|inhaled|inhaled
5740933|NCT00354666|asthmatic subjects|asthmatic subjects
5740934|NCT00354666|GSK159797|gsk159797
5740935|NCT00354666|safety and tolerability|safety and tolerability
5740936|NCT00354666|efficacy|efficacy
5740937|NCT00354666|dry powder|dry powder
5740938|NCT00354653|HBeAg|hbeag
5740939|NCT00354653|HBV|hbv
5740940|NCT00354653|CHRONIC HEPATITIS|chronic hepatitis
5740941|NCT00354653|lamivudine|lamivudine
5740942|NCT00354640|breast cancer|breast cancer
5740943|NCT00354640|breast cancer in situ|breast cancer in situ
5740944|NCT00354640|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5740945|NCT00354640|stage I breast cancer|stage i breast cancer
5740946|NCT00354640|stage II breast cancer|stage ii breast cancer
5740947|NCT00354640|stage IIIA breast cancer|stage iiia breast cancer
5740948|NCT00354640|stage IIIB breast cancer|stage iiib breast cancer
5740949|NCT00354640|stage IIIC breast cancer|stage iiic breast cancer
5740951|NCT00354627|Early Access Program (EAP)|early access program (eap)
5740952|NCT00354627|TMC125|tmc125
5740953|NCT00354627|treatment-experienced|treatment-experienced
5740954|NCT00354627|failing multiple antiretroviral (ARV) regimens|failing multiple antiretroviral (arv) regimens
5740955|NCT00354627|limited to no treatment options|limited to no treatment options
5740956|NCT00354601|fallopian tube cancer|fallopian tube cancer
5740957|NCT00354601|peritoneal cavity cancer|peritoneal cavity cancer
5740958|NCT00354601|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5740959|NCT00354601|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5740960|NCT00354601|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5740961|NCT00354601|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5740962|NCT00354601|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5740963|NCT00354601|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5740964|NCT00354588|chronic renal failure|chronic renal failure
5740965|NCT00354588|arterial stiffness|arterial stiffness
5740966|NCT00354588|arterial wave reflections|arterial wave reflections
5740967|NCT00354575|Constipation;|constipation;
5740968|NCT00354575|Chinese herb;|chinese herb;
5740969|NCT00354575|Long-term care;|long-term care;
5740970|NCT00354575|Integrative Chinese Medicine and Western Medicine;|integrative chinese medicine and western medicine;
5740971|NCT00354562|Lung Cancer|lung cancer
5740972|NCT00354562|Non-Small Cell Lung Cancer|non-small cell lung cancer
5740973|NCT00354562|NSCLC|nsclc
5740974|NCT00354562|ABT-751|abt-751
5740977|NCT00354549|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5740978|NCT00354549|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5740979|NCT00354549|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5740980|NCT00354549|adenocarcinoma of the lung|adenocarcinoma of the lung
5740981|NCT00354549|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5740983|NCT00354536|GSK716155|gsk716155
5686258|NCT00552786|hearing loss|hearing loss
5686259|NCT00552786|temporary threshold shift|temporary threshold shift
5740984|NCT00354536|albiglutide|albiglutide
5740985|NCT00354536|pharmacodynamics|pharmacodynamics
5740986|NCT00354536|pharmacokinetics|pharmacokinetics
5740987|NCT00354523|Solid Tumor|solid tumor
5740988|NCT00354523|Thyroid Cancer|thyroid cancer
5740989|NCT00354523|Medullary Thyroid Cancer|medullary thyroid cancer
5740991|NCT00354523|Advanced Metastatic Medullary Thyroid Carcinoma|advanced metastatic medullary thyroid carcinoma
5740992|NCT00354523|Capecitabine|capecitabine
5740993|NCT00354523|Dacarbazine|dacarbazine
5740994|NCT00354523|Imatinib|imatinib
5740996|NCT00354523|Imatinib Mesylate|imatinib mesylate
5740997|NCT00354523|DTIC-Dome|dtic-dome
5740998|NCT00354523|Xeloda|xeloda
5740999|NCT00354510|atopic dermatitis|atopic dermatitis
5741000|NCT00354510|GW842470X|gw842470x
5741001|NCT00354510|PDE4 inhibitor|pde4 inhibitor
5741002|NCT00354497|prostate cancer|prostate cancer
5741003|NCT00354484|anemia|anemia
5741004|NCT00354484|postpartum|postpartum
5741005|NCT00354458|heart failure|heart failure
5741006|NCT00354458|diuretic|diuretic
5741007|NCT00354458|renal impairment|renal impairment
5741008|NCT00354458|renal function|renal function
5741009|NCT00354445|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5741010|NCT00354445|pegaptanib sodium|pegaptanib sodium
5741011|NCT00354445|subfoveal CNV|subfoveal cnv
5741012|NCT00354445|macugen|macugen
5741013|NCT00354432|recurrent prostate cancer|recurrent prostate cancer
5741014|NCT00354432|stage I prostate cancer|stage i prostate cancer
5741015|NCT00354432|stage IIB prostate cancer|stage iib prostate cancer
5741016|NCT00354432|stage IIA prostate cancer|stage iia prostate cancer
5741017|NCT00354432|stage III prostate cancer|stage iii prostate cancer
5741018|NCT00354432|stage IV prostate cancer|stage iv prostate cancer
5741019|NCT00354432|hot flashes|hot flashes
5741020|NCT00354406|Abciximab|abciximab
5741021|NCT00354406|Magnetic Resonance Imaging|magnetic resonance imaging
5741022|NCT00354406|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5741023|NCT00354393|localized malignant mesothelioma|localized malignant mesothelioma
5741024|NCT00354393|sarcomatous mesothelioma|sarcomatous mesothelioma
5741025|NCT00354393|advanced malignant mesothelioma|advanced malignant mesothelioma
5741026|NCT00354393|epithelial mesothelioma|epithelial mesothelioma
5741027|NCT00354380|Malaria|malaria
5741028|NCT00354380|Africa|africa
5741029|NCT00354380|Methalyne-blue|methalyne-blue
5741030|NCT00354380|Artesunate|artesunate
5741031|NCT00354380|Amodiaquine|amodiaquine
5741032|NCT00354367|Crohn Disease|crohn disease
5741033|NCT00354367|Certolizumab pegol|certolizumab pegol
5741034|NCT00354367|Fistula|fistula
5741035|NCT00354354|COPD|copd
5741036|NCT00354354|Combivent|combivent
5741037|NCT00354354|Exercise|exercise
5741038|NCT00354354|Bronchodilator|bronchodilator
5741039|NCT00354354|Kinetics|kinetics
5741041|NCT00354328|Echocardiography|echocardiography
5741042|NCT00354328|Diastolic Dysfunction|diastolic dysfunction
5741043|NCT00354328|Enalapril|enalapril
5741044|NCT00354315|Shared decision making|shared decision making
5741045|NCT00354315|Optimal drug prescription|optimal drug prescription
5741046|NCT00354302|osteoporosis|osteoporosis
5741047|NCT00354302|stage I breast cancer|stage i breast cancer
5741048|NCT00354302|stage II breast cancer|stage ii breast cancer
5741049|NCT00354302|stage IIIA breast cancer|stage iiia breast cancer
5741050|NCT00354276|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5767225|NCT00255346|CMML|cmml
5741051|NCT00354276|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5741052|NCT00354276|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5741053|NCT00354276|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5741054|NCT00354276|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5741055|NCT00354276|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5741056|NCT00354276|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5741057|NCT00354276|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5741058|NCT00354276|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5741059|NCT00354276|adult acute basophilic leukemia|adult acute basophilic leukemia
5741060|NCT00354276|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5741061|NCT00354276|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5741062|NCT00354276|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5741063|NCT00354276|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5741064|NCT00354263|Healthy male volunteers|healthy male volunteers
5741065|NCT00354263|IMP321|imp321
5741068|NCT00354263|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5741069|NCT00354237|diabetes mellitus|diabetes mellitus
5741070|NCT00354237|cardiac rehabilitation|cardiac rehabilitation
5741071|NCT00354237|insulin|insulin
5741072|NCT00354224|recurrent gastric cancer|recurrent gastric cancer
5686260|NCT00552773|SINUSITIS|sinusitis
5741073|NCT00354224|stage III gastric cancer|stage iii gastric cancer
5741074|NCT00354224|stage IV gastric cancer|stage iv gastric cancer
5741075|NCT00354211|Cardiac Output|cardiac output
5741076|NCT00354211|Hemodynamic Phenomena|hemodynamic phenomena
5741077|NCT00354198|rapidly progressive glomerulonephritis|rapidly progressive glomerulonephritis
5741078|NCT00354198|pentoxifylline|pentoxifylline
5741079|NCT00354172|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5741080|NCT00354172|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5741081|NCT00354172|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5741082|NCT00354172|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5741083|NCT00354172|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5741084|NCT00354172|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5741085|NCT00354172|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5741086|NCT00354172|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5741087|NCT00354172|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5741088|NCT00354172|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5741089|NCT00354172|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5741090|NCT00354172|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5741091|NCT00354172|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5741092|NCT00354172|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5741093|NCT00354172|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5741094|NCT00354159|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5741095|NCT00354159|Intracardiac pressures|intracardiac pressures
5741096|NCT00354146|Farnesyl transferase inhibitor|farnesyl transferase inhibitor
5741097|NCT00354146|relapsed or refractory acute myeloid leukemia|relapsed or refractory acute myeloid leukemia
5741098|NCT00354133|Parkinson Disease|parkinson disease
5741099|NCT00354133|Deep Brain Stimulation|deep brain stimulation
5741100|NCT00354133|PDQ-39|pdq-39
5741101|NCT00354081|Coronary Artery Disease|coronary artery disease
5741102|NCT00354081|Myocardial Infarction|myocardial infarction
5741103|NCT00354081|Cerebrovascular Stroke|cerebrovascular stroke
5741104|NCT00354081|Homocysteine|homocysteine
5741105|NCT00354081|Folic Acid|folic acid
5741106|NCT00354081|Vitamin B 12|vitamin b 12
5741107|NCT00354081|Vitamin B 6|vitamin b 6
5741108|NCT00354068|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5741109|NCT00354068|adult giant cell glioblastoma|adult giant cell glioblastoma
5741110|NCT00354068|adult gliosarcoma|adult gliosarcoma
5741111|NCT00354068|adult mixed glioma|adult mixed glioma
5741112|NCT00354068|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5741113|NCT00354068|recurrent adult brain tumor|recurrent adult brain tumor
5741121|NCT00354029|hemorrhoids|hemorrhoids
5741122|NCT00354029|hemorrhoidectomy|hemorrhoidectomy
5741123|NCT00354029|S (+) ketamine|s (+) ketamine
5741124|NCT00354029|pain|pain
5741125|NCT00354016|influenza|influenza
5741127|NCT00354003|Parkinson|parkinson
5741128|NCT00354003|Imaging|imaging
5741129|NCT00353990|insulin|insulin
5741130|NCT00353990|bioavailability|bioavailability
5741131|NCT00353990|duodenum|duodenum
5741132|NCT00353990|infusion|infusion
5741133|NCT00353990|healthy|healthy
5741134|NCT00353990|diabetes|diabetes
5741135|NCT00353990|absorption|absorption
5741136|NCT00353977|Cytomegalovirus|cytomegalovirus
5741137|NCT00353977|Vaccine|vaccine
5741138|NCT00353977|CMV|cmv
5741139|NCT00353977|Immunization|immunization
5741140|NCT00353977|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5741141|NCT00353977|Stem Cell Allotransplant|stem cell allotransplant
5741142|NCT00353951|primary care|primary care
5741143|NCT00353951|lower respiratory tract infection|lower respiratory tract infection
5741144|NCT00353951|antibiotics|antibiotics
5741145|NCT00353951|cough|cough
5741146|NCT00353938|PTSD, MDMA, psychotherapy, Switzerland|ptsd, mdma, psychotherapy, switzerland
5741147|NCT00353925|Hypertrophy|hypertrophy
5741148|NCT00353925|LVH|lvh
5741149|NCT00353925|Cardiac|cardiac
5741150|NCT00353925|Blood Pressure|blood pressure
5741151|NCT00353925|Papillary Muscle|papillary muscle
5741152|NCT00353912|Blood|blood
5741153|NCT00353912|Venous|venous
5741154|NCT00353912|Systolic|systolic
5741155|NCT00353912|Diastolic|diastolic
5741156|NCT00353912|Pulse|pulse
5741157|NCT00353912|Pressure|pressure
5741158|NCT00353899|Magnetic Resonance Imaging|magnetic resonance imaging
5741159|NCT00353899|Pediatric|pediatric
5741160|NCT00353899|Normal Volunteer|normal volunteer
5741161|NCT00353899|Electrocardiogram|electrocardiogram
5741162|NCT00353899|Cardiac|cardiac
5741163|NCT00353899|Healthy Volunteer|healthy volunteer
5741164|NCT00353899|HV|hv
5741165|NCT00353886|Retrospective|retrospective
5741167|NCT00353886|Antiepileptic Drugs|antiepileptic drugs
5741168|NCT00353886|Behavioral Development|behavioral development
5741169|NCT00353886|Intellectual Development|intellectual development
5741170|NCT00353873|FLIXOTIDE|flixotide
5741171|NCT00353873|asthmatics children 4-11 years|asthmatics children 4-11 years
5741173|NCT00353873|asthma-control|asthma-control
5741174|NCT00353860|Leukemia|leukemia
5741175|NCT00353860|Transplant - Mortality|transplant - mortality
5741176|NCT00353860|Immunosuppression|immunosuppression
5741177|NCT00353860|Radiation|radiation
5741178|NCT00353860|Cure|cure
5741179|NCT00353860|Peripheral Blood Stem Cells|peripheral blood stem cells
5741180|NCT00353860|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5741181|NCT00353860|Graft-Versus-Host Disease|graft-versus-host disease
5741182|NCT00353860|Cyclosporine|cyclosporine
5741183|NCT00353860|Fludarabine|fludarabine
5741184|NCT00353847|acupuncture, RCTs, chronic LBP|acupuncture, rcts, chronic lbp
5741185|NCT00353834|endothelial dysfunction|endothelial dysfunction
5741186|NCT00353834|subclinical inflammation|subclinical inflammation
5741187|NCT00353834|flow mediated brachial artery dilation|flow mediated brachial artery dilation
5741188|NCT00353834|pulse wave analysis|pulse wave analysis
5741189|NCT00353834|glucagon like polypeptide mimetics|glucagon like polypeptide mimetics
5741190|NCT00353834|type 2 diabetes mellitus|type 2 diabetes mellitus
5741191|NCT00353821|Tumor Necrosis Factor Alpha (TNF-Alpha)|tumor necrosis factor alpha (tnf-alpha)
5741192|NCT00353821|Interferon-Gamma (IFN-Gamma)|interferon-gamma (ifn-gamma)
5741193|NCT00353821|Interleukin-10 (IL-10)|interleukin-10 (il-10)
5741194|NCT00353821|Interleukin-6 (IL-6)|interleukin-6 (il-6)
5741195|NCT00353821|Interleukin-1 (IL-1 Ra)|interleukin-1 (il-1 ra)
5741196|NCT00353821|Interleukin-1 Receptor Antagonist (IL-1 Ra)|interleukin-1 receptor antagonist (il-1 ra)
5741197|NCT00353821|Vitamin D Receptor (VitD R)|vitamin d receptor (vitd r)
5741198|NCT00353795|MESA|mesa
5741200|NCT00353795|Cardiovascular|cardiovascular
5741201|NCT00353795|Cardiac|cardiac
5741202|NCT00353795|Coronary|coronary
5741203|NCT00353795|Atherosclerosis|atherosclerosis
5741209|NCT00353769|scalp laceration|scalp laceration
5741210|NCT00353769|tissue adhesive|tissue adhesive
5741211|NCT00353769|wound care|wound care
5741212|NCT00353769|cost effectiveness|cost effectiveness
5741213|NCT00353743|infected abortion|infected abortion
5741214|NCT00353743|treatment period|treatment period
5741215|NCT00353743|doxycycline|doxycycline
5741222|NCT00353717|basal like|basal like
5741223|NCT00353717|carcinoma|carcinoma
5741224|NCT00353717|metastatic|metastatic
5741225|NCT00353717|EGFR|egfr
5741226|NCT00353704|Intervertebral disk displacement|intervertebral disk displacement
5741227|NCT00353704|disk prolapse|disk prolapse
5741228|NCT00353704|pregabalin|pregabalin
5741229|NCT00353678|Hip replacement|hip replacement
5741230|NCT00353678|Arthroplasty|arthroplasty
5741231|NCT00353678|Prevention|prevention
5741232|NCT00353678|Thromboembolism|thromboembolism
5741233|NCT00353678|Treatment outcomes|treatment outcomes
5741234|NCT00353678|Arthroplasty, replacement, hip|arthroplasty, replacement, hip
5741235|NCT00353665|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5741236|NCT00353665|motor neuron disease|motor neuron disease
5741237|NCT00353665|memantine|memantine
5741238|NCT00353665|clinical trial|clinical trial
5741239|NCT00353652|Blood Pressure, High|blood pressure, high
5741248|NCT00353626|Amputation|amputation
5741249|NCT00353626|trans tibial|trans tibial
5741250|NCT00353626|prosthesis|prosthesis
5741251|NCT00353626|motion analysis|motion analysis
5741252|NCT00353613|Antibiotic prophylaxis|antibiotic prophylaxis
5741253|NCT00353600|Proteinuria|proteinuria
5741254|NCT00353600|Renal Failure|renal failure
5741255|NCT00353600|Angiotension Converting Enzyme Inhibitor|angiotension converting enzyme inhibitor
5741256|NCT00353600|Glomerular Filtration Rate|glomerular filtration rate
5741257|NCT00353587|insulin sensitizer|insulin sensitizer
5751325|NCT00314990|Folate|folate
5741258|NCT00353587|type 2 diabetes|type 2 diabetes
5741259|NCT00353587|diabetes|diabetes
5741260|NCT00353587|glucose control|glucose control
5741261|NCT00353574|Resistant Hypertension|resistant hypertension
5741262|NCT00353548|Bulimia Nervosa|bulimia nervosa
5741263|NCT00353548|Binge Eating Disorder|binge eating disorder
5741264|NCT00353548|Obesity|obesity
5741265|NCT00353548|Anorexia Nervosa|anorexia nervosa
5741266|NCT00353535|glomerulosclerosis, focal|glomerulosclerosis, focal
5741267|NCT00353535|pretransplant immunosuppression|pretransplant immunosuppression
5741268|NCT00353535|total lymphoid irradiation|total lymphoid irradiation
5741269|NCT00353535|renal transplant|renal transplant
5741270|NCT00353535|recurrence|recurrence
5741271|NCT00353496|Non functioning entero-pancreatic tumours|non functioning entero-pancreatic tumours
5741272|NCT00353483|Breast Cancer|breast cancer
5741273|NCT00353483|Neoadjuvant|neoadjuvant
5741275|NCT00353470|CBT|cbt
5741276|NCT00353470|PFPP|pfpp
5741277|NCT00353457|Adjuvant therapy|adjuvant therapy
5741278|NCT00353457|Rectal cancer|rectal cancer
5741279|NCT00353457|Capecitabine|capecitabine
5741280|NCT00353457|Oxaliplatin|oxaliplatin
5741281|NCT00353457|Cetuximab|cetuximab
5741282|NCT00353457|Erbitux|erbitux
5741283|NCT00353444|head injury|head injury
5741284|NCT00353444|transcranial Doppler|transcranial doppler
5741285|NCT00353444|pulsatility index|pulsatility index
5741286|NCT00353444|vasospasm in head injury|vasospasm in head injury
5741287|NCT00353431|Hyperglycaemia|hyperglycaemia
5741288|NCT00353431|algorithm|algorithm
5741289|NCT00353431|emergency|emergency
5741290|NCT00353431|s.c. insulin therapy|s.c. insulin therapy
5741291|NCT00353431|Emergency patient|emergency patient
5741292|NCT00353405|Adolescents|adolescents
5741293|NCT00353405|Sexually Transmitted Infections|sexually transmitted infections
5741294|NCT00353405|Gonorrhea|gonorrhea
5741295|NCT00353405|Chlamydia Infections|chlamydia infections
5741297|NCT00353366|Post-marketing surveillance (PMS)|post-marketing surveillance (pms)
5741298|NCT00353366|Rotarix|rotarix
5741299|NCT00353366|oral|oral
5741300|NCT00353366|Filipino|filipino
5741301|NCT00353366|Rotavirus|rotavirus
5741302|NCT00353366|Gastroenteritis|gastroenteritis
5741303|NCT00353366|Human Rotavirus (HRV) vaccine|human rotavirus (hrv) vaccine
5741304|NCT00353353|no specific conditions|no specific conditions
5741305|NCT00353340|sodium bicarbonate,|sodium bicarbonate,
5741306|NCT00353340|n-acetylcisteine,|n-acetylcisteine,
5741307|NCT00353340|contrast nephropathy,|contrast nephropathy,
5741308|NCT00353340|cardiac catheterisation|cardiac catheterisation
5741309|NCT00353327|HIV|hiv
5741310|NCT00353327|Passive immunotherapy|passive immunotherapy
5741311|NCT00353301|Carcinoma, Renal Cell|carcinoma, renal cell
5741312|NCT00353301|Receptor, Epidermal Growth Factor|receptor, epidermal growth factor
5741313|NCT00353301|mTOR protein|mtor protein
5741314|NCT00353301|Sirolimus|sirolimus
5741315|NCT00353301|Erlotinib|erlotinib
5741316|NCT00353275|Strict glycemic control|strict glycemic control
5741317|NCT00353249|Cognitive Behavioral Therapy|cognitive behavioral therapy
5741318|NCT00353249|CBT|cbt
5741319|NCT00353249|Homeless Women|homeless women
5741320|NCT00353236|delivery of preterm infant and/or twins|delivery of preterm infant and/or twins
5741321|NCT00353223|Heart Failure|heart failure
5741322|NCT00353223|Functional Impairment|functional impairment
5741323|NCT00353223|Health-Related Quality of Life|health-related quality of life
5741324|NCT00353223|Telemedicine|telemedicine
5741325|NCT00353210|IVF|ivf
5741326|NCT00353210|embryos|embryos
5741327|NCT00353210|research|research
5741328|NCT00353210|donation|donation
5741329|NCT00353210|surplus|surplus
5741330|NCT00353210|stem cells|stem cells
5741331|NCT00353210|abnormal embryo|abnormal embryo
5741332|NCT00353210|screening|screening
5741333|NCT00353197|IVF|ivf
5741334|NCT00353197|embryos|embryos
5741335|NCT00353197|research|research
5741336|NCT00353197|donation|donation
5741337|NCT00353197|surplus|surplus
5741338|NCT00353197|stem cells|stem cells
5741339|NCT00353184|Acute|acute
5741340|NCT00353184|Asthma|asthma
5741341|NCT00353184|Child|child
5741342|NCT00353184|Pediatric|pediatric
5741343|NCT00353184|Emergency|emergency
5741344|NCT00353184|Oral|oral
5741345|NCT00353184|Montelukast|montelukast
5741346|NCT00353184|Forced Expiratory Volume in One Second|forced expiratory volume in one second
5741347|NCT00353184|FEV1|fev1
5741348|NCT00353171|Smoking|smoking
5741349|NCT00353171|PCB|pcb
5741350|NCT00353171|DDE|dde
5741351|NCT00353171|Menstrual Cycle|menstrual cycle
5741352|NCT00353171|NC Infant Feeding Study|nc infant feeding study
5741353|NCT00353158|Phototesting|phototesting
5741354|NCT00353158|UVR/UVA|uvr/uva
5741355|NCT00353158|Sunburn|sunburn
5741356|NCT00353158|Doxycycline|doxycycline
5741357|NCT00353158|Voriconazole|voriconazole
5741358|NCT00353158|Phototoxicity|phototoxicity
5741359|NCT00353158|Healthy Volunteer|healthy volunteer
5741360|NCT00353158|HV|hv
5741361|NCT00353145|Unknown Primary Neoplasms|unknown primary neoplasms
5741362|NCT00353145|UPC|upc
5741363|NCT00353145|Unknown Primary Cancer|unknown primary cancer
5741364|NCT00353145|Questionnaire|questionnaire
5741365|NCT00353145|Gemcitabine|gemcitabine
5741366|NCT00353145|Gemcitabine Hydrochloride|gemcitabine hydrochloride
5741367|NCT00353145|Gemzar|gemzar
5741368|NCT00353145|Oxaliplatin|oxaliplatin
5741369|NCT00353145|Eloxatin|eloxatin
5741370|NCT00353145|Gemox|gemox
5741371|NCT00353119|Palmoplantar pustulosis|palmoplantar pustulosis
5741372|NCT00353119|Psoriasis|psoriasis
5741373|NCT00353119|Etanercept|etanercept
5741374|NCT00353106|Graft-Versus-Host Disease|graft-versus-host disease
5741375|NCT00353106|GVHD|gvhd
5741376|NCT00353106|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5741377|NCT00353106|cGVHD|cgvhd
5741378|NCT00353106|Interview|interview
5741379|NCT00353106|Questionnaire|questionnaire
5741380|NCT00353106|Survey|survey
5741381|NCT00353106|Caregiver|caregiver
5741382|NCT00353093|deep vein thrombosis,D-dimer,ultrasonography|deep vein thrombosis,d-dimer,ultrasonography
5741383|NCT00353080|Prevention of postmenopausal osteoporosis|prevention of postmenopausal osteoporosis
5741384|NCT00353067|unstable angina|unstable angina
5741385|NCT00353067|myocardial infarction|myocardial infarction
5741386|NCT00353067|coronary thrombosis|coronary thrombosis
5741387|NCT00353067|coronary atherosclerosis|coronary atherosclerosis
5741388|NCT00353054|Caltrate|caltrate
5741389|NCT00353054|Lipoproteins|lipoproteins
5741390|NCT00353054|Glucose|glucose
5741391|NCT00353054|Insulin|insulin
5741392|NCT00353054|Blood pressure|blood pressure
5741393|NCT00353054|Body fat|body fat
5741394|NCT00353054|Body weight|body weight
5741395|NCT00353054|Women|women
5741397|NCT00353054|Macronutrients|macronutrients
5741398|NCT00353041|topical|topical
5741399|NCT00353041|anesthetic|anesthetic
5741400|NCT00353041|pain|pain
5741401|NCT00353028|Fluvoxamine Maleate|fluvoxamine maleate
5741402|NCT00353028|Depression|depression
5741403|NCT00353028|Children and Adolescents|children and adolescents
5741404|NCT00353015|Gastrointestinal cancer|gastrointestinal cancer
5741405|NCT00353015|high grade gastrointestinal neuroendocrine carcinoma|high grade gastrointestinal neuroendocrine carcinoma
5741406|NCT00353015|High grade neuroendocrine carcinoma of unknown primary site|high grade neuroendocrine carcinoma of unknown primary site
5741407|NCT00353015|Cisplatin|cisplatin
5741408|NCT00353015|Platinol-AQ|platinol-aq
5741409|NCT00353015|Platinol|platinol
5741411|NCT00353015|CPT-11|cpt-11
5741412|NCT00353015|Irinotecan|irinotecan
5741413|NCT00353002|Pain|pain
5741414|NCT00353002|Ametop|ametop
5741415|NCT00353002|Liposomal Lidocaine|liposomal lidocaine
5741416|NCT00353002|Venous cannulation|venous cannulation
5741417|NCT00352976|Bone Marrow transplant|bone marrow transplant
5741418|NCT00352976|stem cell transplant|stem cell transplant
5741419|NCT00352976|cord blood transplant|cord blood transplant
5741420|NCT00352976|total body irradiation|total body irradiation
5741421|NCT00352976|thymic shielding|thymic shielding
5741422|NCT00352963|Open, phase 3, Infanrix hexa™, Hib-MenC, co-administered|open, phase 3, infanrix hexa™, hib-menc, co-administered
5741423|NCT00352950|NSCLC, Lung cancer|nsclc, lung cancer
5741436|NCT00352885|IL-2 therapy|il-2 therapy
5741437|NCT00352885|Antidepressant|antidepressant
5741438|NCT00352885|Immune system|immune system
5741439|NCT00352885|Neuroendocrine response|neuroendocrine response
5741440|NCT00352872|Pharmacogenetics|pharmacogenetics
5741441|NCT00352872|Toxicity|toxicity
5741442|NCT00352872|Pre-Menopausal|pre-menopausal
5741443|NCT00352872|Women|women
5741444|NCT00352872|Doxorubicin|doxorubicin
5741445|NCT00352872|Cyclophosphamide|cyclophosphamide
5741446|NCT00352872|Breast Cancer|breast cancer
5741447|NCT00352872|Chemotherapy|chemotherapy
5741448|NCT00352859|Cancer|cancer
5741449|NCT00352859|Renal Cell Cancer|renal cell cancer
5741451|NCT00352846|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5741452|NCT00352846|Lymphoma|lymphoma
5741453|NCT00352846|Zoledronic Acid|zoledronic acid
5741454|NCT00352846|Zoledronate|zoledronate
5741455|NCT00352846|Zometa|zometa
5741456|NCT00352846|Vitamin D|vitamin d
5741457|NCT00352846|Calcium Carbonate|calcium carbonate
5741458|NCT00352846|Bone Loss|bone loss
5741459|NCT00352833|gastric cancer|gastric cancer
5741460|NCT00352833|investigational drug|investigational drug
5741461|NCT00352833|adjuvant therapy|adjuvant therapy
5741462|NCT00352833|intraoperative|intraoperative
5741463|NCT00352833|intraperitoneal|intraperitoneal
5741464|NCT00352833|EpCAM-positive tumor|epcam-positive tumor
5741465|NCT00352820|Caregiver|caregiver
5741466|NCT00352820|Brain cancer|brain cancer
5741467|NCT00352820|Glioma|glioma
5741468|NCT00352820|Questionnaire|questionnaire
5741469|NCT00352820|Survey|survey
5741471|NCT00352807|Cataract|cataract
5741472|NCT00352794|Combination chemotherapy|combination chemotherapy
5741473|NCT00352794|Myelofibrosis (MF)|myelofibrosis (mf)
5741474|NCT00352781|nicotine replacement therapy|nicotine replacement therapy
5741475|NCT00352781|smoking cessation|smoking cessation
5741476|NCT00352768|Fluvoxamine Maleate|fluvoxamine maleate
5741477|NCT00352768|OCD|ocd
5741478|NCT00352768|Children and Adolescents|children and adolescents
5741479|NCT00352742|Multiple myeloma|multiple myeloma
5741480|NCT00352742|bortezomib|bortezomib
5741482|NCT00352742|refractory|refractory
5741483|NCT00352742|relapsed|relapsed
5741484|NCT00352742|antiangiogenic|antiangiogenic
5741485|NCT00352729|Burns|burns
5741486|NCT00352729|ACell|acell
5741487|NCT00352729|Donor Site|donor site
5741488|NCT00352703|Oral mucositis|oral mucositis
5741489|NCT00352703|Non-Hodgkin's lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5741490|NCT00352703|conditioning chemotherapy|conditioning chemotherapy
5741491|NCT00352703|autologous PBSCT|autologous pbsct
5741492|NCT00352703|multiple myeloma (MM)|multiple myeloma (mm)
5741493|NCT00352703|Melphalan|melphalan
5741494|NCT00352664|Advanced Cancer|advanced cancer
5741495|NCT00352664|Cancer Pain|cancer pain
5741496|NCT00352664|Donepezil|donepezil
5741497|NCT00352664|Sedation|sedation
5741498|NCT00352664|Placebo|placebo
5741499|NCT00352651|Acute Herpes Zoster (AHZ)|acute herpes zoster (ahz)
5741500|NCT00352651|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5741501|NCT00352651|Pregabalin|pregabalin
5741502|NCT00352651|Lyrica|lyrica
5741503|NCT00352651|Pain|pain
5741504|NCT00352638|colon cancer|colon cancer
5741505|NCT00352638|rectal cancer|rectal cancer
5741514|NCT00352612|clinical trial|clinical trial
5741518|NCT00352599|Neurofibromatosis Type 1|neurofibromatosis type 1
5741520|NCT00352599|Lovastatin|lovastatin
5741521|NCT00352599|statin|statin
5741522|NCT00352586|Classical Conditioning|classical conditioning
5741523|NCT00352586|Learning|learning
5741524|NCT00352586|NMDA|nmda
5741525|NCT00352586|Startle|startle
5741526|NCT00352586|Eyeblink|eyeblink
5741528|NCT00352586|Fear Conditioning|fear conditioning
5741529|NCT00352586|Fear Potentiated Startle|fear potentiated startle
5741530|NCT00352586|Extinction|extinction
5741531|NCT00352586|D-cycloserine|d-cycloserine
5741541|NCT00352547|Immunosuppresant|immunosuppresant
5741542|NCT00352547|Genetic Polymorphism|genetic polymorphism
5741543|NCT00352547|Drug Metabolism|drug metabolism
5741544|NCT00352547|Pharmacogenetics|pharmacogenetics
5741545|NCT00352547|Rapamycin|rapamycin
5741546|NCT00352521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5741547|NCT00352521|adult mixed glioma|adult mixed glioma
5741548|NCT00352521|adult giant cell glioblastoma|adult giant cell glioblastoma
5741549|NCT00352521|adult gliosarcoma|adult gliosarcoma
5741550|NCT00352521|recurrent adult brain tumor|recurrent adult brain tumor
5741551|NCT00352521|adult glioblastoma|adult glioblastoma
5741552|NCT00352521|adult anaplastic ependymoma|adult anaplastic ependymoma
5741553|NCT00352521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5741554|NCT00352521|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5741555|NCT00352508|Internet, dietary advice, saturated fat|internet, dietary advice, saturated fat
5741556|NCT00352495|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5741557|NCT00352495|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5741558|NCT00352495|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5741559|NCT00352495|childhood oligodendroglioma|childhood oligodendroglioma
5741560|NCT00352495|neurofibromatosis type 1|neurofibromatosis type 1
5741561|NCT00352495|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5741562|NCT00352495|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5741563|NCT00352482|Pulmonary Hypertension|pulmonary hypertension
5741564|NCT00352482|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5741565|NCT00352469|Alcoholism|alcoholism
5741566|NCT00352469|Anxiety|anxiety
5741568|NCT00352469|PTSD|ptsd
5741569|NCT00352469|Panic Disorder|panic disorder
5741570|NCT00352469|OCD|ocd
5741571|NCT00352456|Amygdala|amygdala
5741572|NCT00352456|Facial Affect|facial affect
5741573|NCT00352456|Instrumental Learning|instrumental learning
5741574|NCT00352456|Psychopathy|psychopathy
5741575|NCT00352456|Emotion|emotion
5741576|NCT00352456|Orbitofrontal Cortex|orbitofrontal cortex
5741577|NCT00352456|Healthy Volunteer|healthy volunteer
5741578|NCT00352456|HV|hv
5741579|NCT00352443|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5741580|NCT00352443|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5741581|NCT00352443|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5741582|NCT00352443|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5741583|NCT00352443|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5741584|NCT00352443|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5741814|NCT00351832|Type 2 diabetes|type 2 diabetes
5741585|NCT00352443|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5741586|NCT00352443|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5741587|NCT00352443|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5741588|NCT00352443|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5741589|NCT00352443|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5741590|NCT00352443|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5741591|NCT00352443|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5741592|NCT00352443|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5741593|NCT00352443|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5741594|NCT00352443|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5741595|NCT00352443|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5741596|NCT00352443|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5741597|NCT00352443|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5741598|NCT00352443|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5741599|NCT00352443|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5741600|NCT00352443|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5741601|NCT00352443|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5741602|NCT00352443|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5741603|NCT00352443|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5741604|NCT00352443|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5741605|NCT00352443|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5741700|NCT00352131|stage II pancreatic cancer|stage ii pancreatic cancer
5741606|NCT00352443|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5741607|NCT00352443|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5741608|NCT00352443|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5741609|NCT00352443|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5741610|NCT00352443|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5741611|NCT00352443|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5741612|NCT00352443|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5741613|NCT00352430|Nitric Oxide|nitric oxide
5741614|NCT00352430|PDE Inhibitors|pde inhibitors
5741615|NCT00352430|Pulmonary Hypertension|pulmonary hypertension
5741617|NCT00352430|Thalassemia|thalassemia
5741618|NCT00352430|Sickle Cell Anemia|sickle cell anemia
5741619|NCT00352404|Endomicroscopy|endomicroscopy
5741620|NCT00352404|Chromoendoscopy|chromoendoscopy
5741621|NCT00352404|Chromoscopy|chromoscopy
5741622|NCT00352404|Ulcerative Colitis|ulcerative colitis
5741623|NCT00352404|Intraepithelial Neoplasia|intraepithelial neoplasia
5741624|NCT00352391|Non-Small Cell Lung Cancer|non-small cell lung cancer
5741625|NCT00352391|Head And Neck Cancer|head and neck cancer
5741626|NCT00352391|Lung Cancer|lung cancer
5741627|NCT00352391|Bronchoscopy|bronchoscopy
5741628|NCT00352391|Laryngoscopy|laryngoscopy
5741630|NCT00352391|Disease Free Survival|disease free survival
5741631|NCT00352391|Current Smoker|current smoker
5741632|NCT00352391|Former Smoker|former smoker
5741633|NCT00352378|Primary|primary
5741634|NCT00352352|Traditional Chinese Medicine (TCM)|traditional chinese medicine (tcm)
5741635|NCT00352352|Alternative Medicine (AM)|alternative medicine (am)
5741636|NCT00352352|Tongue Acupuncture (TAC)|tongue acupuncture (tac)
5741637|NCT00352352|Autism Spectrum Disorder (ASD)|autism spectrum disorder (asd)
5741638|NCT00352352|Autism|autism
5741639|NCT00352352|Children|children
5741640|NCT00352339|Schizophrenia|schizophrenia
5741641|NCT00352339|Switching|switching
5741642|NCT00352339|Early stage|early stage
5741643|NCT00352339|Risperidone|risperidone
5741644|NCT00352339|Aripirazole|aripirazole
5741645|NCT00352313|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5741646|NCT00352313|adult gliosarcoma|adult gliosarcoma
5741647|NCT00352313|adult mixed glioma|adult mixed glioma
5741648|NCT00352313|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5741649|NCT00352313|recurrent adult brain tumor|recurrent adult brain tumor
5741650|NCT00352313|adult glioblastoma|adult glioblastoma
5741651|NCT00352313|adult giant cell glioblastoma|adult giant cell glioblastoma
5741652|NCT00352287|Visceral fat|visceral fat
5741653|NCT00352287|Impaired glucose tolerance|impaired glucose tolerance
5741654|NCT00352287|Insulin resistance|insulin resistance
5741655|NCT00352287|Growth hormone|growth hormone
5741656|NCT00352287|Thiazolidinedione|thiazolidinedione
5741657|NCT00352261|Barrett's Esophagus|barrett's esophagus
5741658|NCT00352248|Alternative Medicine (AM)|alternative medicine (am)
5741659|NCT00352248|Traditional Chinese Medicine|traditional chinese medicine
5741660|NCT00352248|Tongue Acupuncture|tongue acupuncture
5741661|NCT00352248|Autistic Spectrum Disorder|autistic spectrum disorder
5741662|NCT00352248|Autism|autism
5741663|NCT00352248|Children|children
5741664|NCT00352235|Chronic hepatitis C|chronic hepatitis c
5741665|NCT00352235|KRN7000|krn7000
5741666|NCT00352235|a-GalCer|a-galcer
5741667|NCT00352235|immunotherapy|immunotherapy
5741668|NCT00352235|Natural Killer T cells|natural killer t cells
5741669|NCT00352235|interferon|interferon
5741670|NCT00352222|iliac arteries|iliac arteries
5741671|NCT00352222|implantation|implantation
5741672|NCT00352222|treatment of atherosclerotic disease|treatment of atherosclerotic disease
5741673|NCT00352222|stenosed|stenosed
5741674|NCT00352222|occlusive|occlusive
5863973|NCT00001148|Sampling|sampling
5741675|NCT00352209|Cyclophosphamide|cyclophosphamide
5741676|NCT00352209|Preparative Regimens|preparative regimens
5741677|NCT00352209|Risk Factors|risk factors
5741678|NCT00352209|Chart Review|chart review
5741679|NCT00352209|Incidence|incidence
5741680|NCT00352196|Asperger's Disorder|asperger's disorder
5741681|NCT00352196|Risperidone|risperidone
5741682|NCT00352196|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5741683|NCT00352196|Social Skills|social skills
5741684|NCT00352183|Hyperlipidemia Combined|hyperlipidemia combined
5741685|NCT00352183|Combination of fenofibrate and simvastatin|combination of fenofibrate and simvastatin
5741686|NCT00352170|calcium|calcium
5741687|NCT00352170|vitamin D|vitamin d
5741688|NCT00352170|secondary hyperparathyroidism|secondary hyperparathyroidism
5741689|NCT00352170|osteoporotic fractures|osteoporotic fractures
5741690|NCT00352157|Soy|soy
5741691|NCT00352157|Dermatology|dermatology
5741692|NCT00352157|Skin|skin
5741693|NCT00352157|Hair|hair
5741694|NCT00352157|Finger Nails|finger nails
5741695|NCT00352157|Weight Loss|weight loss
5741696|NCT00352157|Body Mass Index|body mass index
5741697|NCT00352157|Photoaging of Skin|photoaging of skin
5741698|NCT00352157|Skin Wrinkling|skin wrinkling
5741699|NCT00352131|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5741701|NCT00352131|stage III pancreatic cancer|stage iii pancreatic cancer
5741702|NCT00352131|stage IV pancreatic cancer|stage iv pancreatic cancer
5741703|NCT00352131|recurrent pancreatic cancer|recurrent pancreatic cancer
5742377|NCT00349401|pain|pain
5741704|NCT00352118|oral complications of radiation therapy|oral complications of radiation therapy
5736604|NCT00370669|CSME|csme
5741705|NCT00352118|oral complications of chemotherapy|oral complications of chemotherapy
5741706|NCT00352118|mucositis|mucositis
5740663|NCT00355641|RLS|rls
5741707|NCT00352118|xerostomia|xerostomia
5741708|NCT00352118|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5741709|NCT00352118|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5741710|NCT00352118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5741711|NCT00352118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5741712|NCT00352118|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5741713|NCT00352118|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5741714|NCT00352118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5741715|NCT00352118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5741716|NCT00352105|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5741717|NCT00352105|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5741718|NCT00352105|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5741719|NCT00352105|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5741720|NCT00352105|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5741721|NCT00352105|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5741722|NCT00352105|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5741723|NCT00352105|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5741724|NCT00352092|Kidney disease|kidney disease
5741725|NCT00352092|Renal transplant|renal transplant
5741726|NCT00352092|HLA Identical|hla identical
5741727|NCT00352092|Living Donor|living donor
5741728|NCT00352092|Corticosteroid free|corticosteroid free
5741729|NCT00352092|Calcineurin sparing|calcineurin sparing
5741730|NCT00352092|Adults|adults
5741731|NCT00352079|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5741732|NCT00352079|stage 0 bladder cancer|stage 0 bladder cancer
5741733|NCT00352079|stage I bladder cancer|stage i bladder cancer
5741734|NCT00352079|recurrent bladder cancer|recurrent bladder cancer
5741735|NCT00352066|Human Immunodeficiency Virus|human immunodeficiency virus
5741736|NCT00352066|anti-retroviral therapy|anti-retroviral therapy
5741737|NCT00352066|nucleoside analogue|nucleoside analogue
5741738|NCT00352066|reverse transcriptase|reverse transcriptase
5741739|NCT00352066|apricitabine|apricitabine
5741740|NCT00352066|tipranavir|tipranavir
5741741|NCT00352066|bioequivalence|bioequivalence
5741742|NCT00352066|drug-drug interaction|drug-drug interaction
5741743|NCT00352066|pharmacokinetics|pharmacokinetics
5741744|NCT00352053|Phase 3|phase 3
5741745|NCT00352053|Randomized, Double-Blind|randomized, double-blind
5741746|NCT00352053|Control|control
5741747|NCT00352053|Treatment-Experienced|treatment-experienced
5741748|NCT00352053|OBR|obr
5741749|NCT00352053|Optimized background regimen|optimized background regimen
5741750|NCT00352053|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5741751|NCT00352053|HAART|haart
5741752|NCT00352053|HIV|hiv
5741753|NCT00352053|HIV-1|hiv-1
5741754|NCT00352053|AIDS Virus|aids virus
5741755|NCT00352053|Human Immunodeficiency Virus|human immunodeficiency virus
5741756|NCT00352053|Acquired Immune Deficiency Syndrome Virus|acquired immune deficiency syndrome virus
5741757|NCT00352053|Virus|virus
5741758|NCT00352053|Human Immunodeficiency|human immunodeficiency
5741759|NCT00352053|Pediatrics|pediatrics
5741760|NCT00352027|Hodgkin's Disease|hodgkin's disease
5741761|NCT00352014|Monitoring of antiplatelet therapy|monitoring of antiplatelet therapy
5741762|NCT00352014|antiplatelet therapy|antiplatelet therapy
5741763|NCT00352014|platelet function assays|platelet function assays
5741765|NCT00352014|Clopidogrel|clopidogrel
5741766|NCT00352014|elective PCI|elective pci
5741767|NCT00352001|refractory anemia with excess blasts|refractory anemia with excess blasts
5741768|NCT00352001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5741769|NCT00352001|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5741770|NCT00352001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5741771|NCT00352001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5741772|NCT00351988|Lung Cancer|lung cancer
5741773|NCT00351988|Non-Small Cell Lung Cancer|non-small cell lung cancer
5741774|NCT00351988|Breast Cancer|breast cancer
5741775|NCT00351988|Psychosocial|psychosocial
5741776|NCT00351988|Behavioral|behavioral
5741777|NCT00351988|Caregiver|caregiver
5741778|NCT00351988|Interview|interview
5741779|NCT00351988|Questionnaire|questionnaire
5741780|NCT00351988|Minority Caregiver|minority caregiver
5741781|NCT00351988|Non-Minority Caregiver|non-minority caregiver
5741783|NCT00351962|lung neoplasms|lung neoplasms
5741784|NCT00351962|metastatic lung cancer|metastatic lung cancer
5741785|NCT00351962|stereotactic radiation|stereotactic radiation
5741786|NCT00351949|Advanced or metastatic renal cell carcinoma|advanced or metastatic renal cell carcinoma
5741789|NCT00351949|LAG-3|lag-3
5741790|NCT00351949|CD223|cd223
5741791|NCT00351936|Schizophrenia|schizophrenia
5741792|NCT00351936|Diabetes|diabetes
5741793|NCT00351936|Obesity|obesity
5741794|NCT00351936|Olanzapine|olanzapine
5741795|NCT00351936|Insulin Resistance|insulin resistance
5741796|NCT00351910|Major Depressive Disorder|major depressive disorder
5741797|NCT00351910|MDD|mdd
5741798|NCT00351884|Type 2 diabetes|type 2 diabetes
5741799|NCT00351884|vildagliptin|vildagliptin
5741800|NCT00351884|Hemoglobin A1c|hemoglobin a1c
5741801|NCT00351871|HCV|hcv
5741802|NCT00351858|Breast Cancer|breast cancer
5741803|NCT00351858|investigational drug|investigational drug
5741804|NCT00351858|drug therapy|drug therapy
5741805|NCT00351858|Antineoplastic Protocols|antineoplastic protocols
5741806|NCT00351858|Immunotherapy|immunotherapy
5741807|NCT00351858|Metastatic breast cancer|metastatic breast cancer
5741808|NCT00351858|Advanced breast cancer|advanced breast cancer
5741809|NCT00351858|Stage III to IV breast cancer|stage iii to iv breast cancer
5741810|NCT00351858|Hormonal therapy refractory|hormonal therapy refractory
5741811|NCT00351858|Failure of hormonal therapy|failure of hormonal therapy
5741812|NCT00351858|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5741813|NCT00351858|low to moderate Her-2/neu expression|low to moderate her-2/neu expression
5741815|NCT00351832|Vildagliptin|vildagliptin
5741816|NCT00351832|Hemoglobin A1c|hemoglobin a1c
5741817|NCT00351819|Testosterone|testosterone
5741818|NCT00351819|Pain|pain
5741819|NCT00351819|Opioid|opioid
5741820|NCT00351819|Hypogonadism|hypogonadism
5741821|NCT00351806|acute intracerebral infarction|acute intracerebral infarction
5741822|NCT00351780|fractional flow reserve|fractional flow reserve
5741823|NCT00351780|bifurcation|bifurcation
5741824|NCT00351780|stent|stent
5741825|NCT00351767|Diabetes|diabetes
5741826|NCT00351767|Dabetic Feet|dabetic feet
5741827|NCT00351741|Burns|burns
5741828|NCT00351715|Sublingual Methadone|sublingual methadone
5741829|NCT00351715|Cancer related breakthrough pain|cancer related breakthrough pain
5741830|NCT00351715|feasibility study|feasibility study
5741831|NCT00351715|Phase II/open label|phase ii/open label
5741832|NCT00351715|Outpatients|outpatients
5741833|NCT00351715|Safety/ efficacy|safety/ efficacy
5741834|NCT00351715|previously receiving opioids|previously receiving opioids
5741835|NCT00351715|speak English|speak english
5741836|NCT00351702|Preventive therapy|preventive therapy
5741837|NCT00351689|Probiotic bacteria|probiotic bacteria
5741838|NCT00351689|cutaneous immune homeostasis|cutaneous immune homeostasis
5741839|NCT00351689|UV radiation|uv radiation
5741840|NCT00351689|dietary supplement|dietary supplement
5741841|NCT00351676|Drug Therapy|drug therapy
5741842|NCT00351676|Hospitals, Teaching|hospitals, teaching
5741843|NCT00351676|Hospitals, Community|hospitals, community
5741844|NCT00351676|Interprofessional relations|interprofessional relations
5741845|NCT00351676|Patient Care Team|patient care team
5741846|NCT00351676|Pharmacists|pharmacists
5741847|NCT00351676|Pharmacy Service, Hospital|pharmacy service, hospital
5741848|NCT00351676|Comparative Study|comparative study
5741849|NCT00351676|Hospitalization|hospitalization
5741850|NCT00351663|Venous Thrombosis|venous thrombosis
5741851|NCT00351663|Critical Illness|critical illness
5741852|NCT00351663|Blood Coagulation|blood coagulation
5741854|NCT00351650|Imaging|imaging
5741855|NCT00351650|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5741856|NCT00351650|Islet|islet
5741857|NCT00351650|B Cell Mass|b cell mass
5741858|NCT00351650|Pet Scan|pet scan
5741859|NCT00351650|Type 1 Diabetes|type 1 diabetes
5741861|NCT00351650|Pancreas|pancreas
5741862|NCT00351650|Healthy Volunteer|healthy volunteer
5741863|NCT00351650|HV|hv
5741864|NCT00351637|Sublingual methadone|sublingual methadone
5741865|NCT00351637|iatrogenic|iatrogenic
5741866|NCT00351637|treatment related incident breakthrough pain|treatment related incident breakthrough pain
5741867|NCT00351637|feasibility study|feasibility study
5741868|NCT00351637|Phase II/open-label|phase ii/open-label
5741869|NCT00351637|inpatients|inpatients
5741870|NCT00351637|Safety/efficacy|safety/efficacy
5741871|NCT00351637|Cancer related breakthrough pain|cancer related breakthrough pain
5741872|NCT00351637|previously receiving opioids|previously receiving opioids
5741873|NCT00351637|speak English|speak english
5741874|NCT00351624|DHA supplementation|dha supplementation
5741875|NCT00351624|Cognitive function|cognitive function
5741876|NCT00351624|Preschool children|preschool children
5741877|NCT00351624|Attention and behavior|attention and behavior
5741878|NCT00351624|Healthy Children|healthy children
5741879|NCT00351611|epilepsy partial seizure treatment with pregabalin or placebo|epilepsy partial seizure treatment with pregabalin or placebo
5741880|NCT00351611|vision testing|vision testing
5741881|NCT00351598|Tumour Volume|tumour volume
5741882|NCT00351598|Prognostic value|prognostic value
5741883|NCT00351585|Vildagliptin|vildagliptin
5741884|NCT00351585|Type 2 diabetes|type 2 diabetes
5741885|NCT00351585|Insulin secretion|insulin secretion
5741886|NCT00351585|Beta cell|beta cell
5741888|NCT00351559|allograft|allograft
5741889|NCT00351559|rejection|rejection
5741890|NCT00351559|biopsy|biopsy
5741891|NCT00351559|gene|gene
5741892|NCT00351559|expression|expression
5741893|NCT00351559|cardiac|cardiac
5759029|NCT00287820|glucose|glucose
5741894|NCT00351559|heart|heart
5741895|NCT00351559|transplant|transplant
5741896|NCT00351546|Vildagliptin|vildagliptin
5741897|NCT00351546|Type 2 diabetes|type 2 diabetes
5741898|NCT00351546|Insulin sensitivity|insulin sensitivity
5741899|NCT00351546|Insulin action|insulin action
5741900|NCT00351533|Respiratory distress syndrome, adult|respiratory distress syndrome, adult
5741901|NCT00351533|Acute lung injury|acute lung injury
5741902|NCT00351533|Acute respiratory distress syndrome|acute respiratory distress syndrome
5741903|NCT00351533|ARDS, human|ards, human
5741904|NCT00351533|Fish oils|fish oils
5741905|NCT00351533|Fatty Acids, Omega-3|fatty acids, omega-3
5741906|NCT00351533|Docosahexaenoic Acids|docosahexaenoic acids
5741907|NCT00351533|Eicosapentaenoic Acid|eicosapentaenoic acid
5741908|NCT00351520|Anthoponotic Cutaneous leishmaniasis|anthoponotic cutaneous leishmaniasis
5741909|NCT00351520|Glucantime|glucantime
5741910|NCT00351520|Miltefosine|miltefosine
5741911|NCT00351507|Vildagliptin|vildagliptin
5741912|NCT00351507|Type 2 diabetes|type 2 diabetes
5741913|NCT00351494|embolization|embolization
5741914|NCT00351494|contrast enhanced ultrasound|contrast enhanced ultrasound
5741915|NCT00351494|myoma|myoma
5741916|NCT00351494|uterine artery|uterine artery
5741917|NCT00351494|microvascularisation|microvascularisation
5741919|NCT00351481|endometrial receptivity|endometrial receptivity
5741920|NCT00351481|embryo implantation|embryo implantation
5741921|NCT00351481|recurrent implantation failure|recurrent implantation failure
5741922|NCT00351468|eltrombopag olamine|eltrombopag olamine
5741923|NCT00351468|SB-497115-GR|sb-497115-gr
5741924|NCT00351468|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura
5741925|NCT00351468|thrombocytopenia|thrombocytopenia
5741926|NCT00351468|ITP|itp
5741927|NCT00351468|platelets|platelets
5741928|NCT00351455|hernia|hernia
5741929|NCT00351455|incisional hernia|incisional hernia
5741930|NCT00351455|ventral hernia|ventral hernia
5741931|NCT00351455|umbilical hernia|umbilical hernia
5741932|NCT00351442|Host Resistance|host resistance
5741933|NCT00351429|Glaucoma|glaucoma
5741934|NCT00351429|Trabeculectomy|trabeculectomy
5741935|NCT00351429|Sutures|sutures
5741936|NCT00351416|GnRH deficiency|gnrh deficiency
5741937|NCT00351416|GnRH antagonist|gnrh antagonist
5741938|NCT00351416|Letrozole|letrozole
5741939|NCT00351416|GnRH|gnrh
5741940|NCT00351416|FSH|fsh
5741941|NCT00351416|LH|lh
5741942|NCT00351416|Inhibins|inhibins
5741943|NCT00351403|Chronic HCV infection|chronic hcv infection
5741944|NCT00351403|Genotype 1|genotype 1
5741945|NCT00351403|Individually adapted therapy|individually adapted therapy
5741946|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b
5741947|NCT00351403|Ribavirin|ribavirin
5741948|NCT00351403|Sustained viral response (SVR)|sustained viral response (svr)
5741949|NCT00351390|congestive heart failure treatment|congestive heart failure treatment
5741950|NCT00351390|congestive heart failure, prognosis|congestive heart failure, prognosis
5741951|NCT00351390|NT-proBNP testing|nt-probnp testing
5741952|NCT00351377|Autoimmune disease, mycophenolate, GI problems|autoimmune disease, mycophenolate, gi problems
5741953|NCT00351364|atherosclerosis|atherosclerosis
5741954|NCT00351364|inflammation|inflammation
5741955|NCT00351364|leukotriene blockade|leukotriene blockade
5741956|NCT00351364|endothelial function|endothelial function
5741957|NCT00351351|Kidney Stones|kidney stones
5741958|NCT00351351|Renal Calculi|renal calculi
5741959|NCT00351312|Pressure ulcers|pressure ulcers
5741960|NCT00351312|socks|socks
5741961|NCT00351312|foot pressure|foot pressure
5741962|NCT00351299|Delirium|delirium
5741963|NCT00351299|Agitation|agitation
5741964|NCT00351299|Sedation|sedation
5741965|NCT00351299|Dexmedetomidine|dexmedetomidine
5741966|NCT00351299|Surgical|surgical
5741967|NCT00351286|peripheral arterial disease|peripheral arterial disease
5741968|NCT00351286|peripheral vascular disease|peripheral vascular disease
5741969|NCT00351286|claudication|claudication
5741970|NCT00351273|Chlamydia|chlamydia
5741971|NCT00351260|Bifurcation|bifurcation
5741972|NCT00351260|Coronary|coronary
5741973|NCT00351260|Stenosis|stenosis
5741974|NCT00351260|Stent|stent
5741975|NCT00351260|drug elution|drug elution
5741976|NCT00351247|Myocardial Infarction|myocardial infarction
5741977|NCT00351247|Primary PCI|primary pci
5741978|NCT00351247|Postconditioning|postconditioning
5741979|NCT00351247|MRI|mri
5741980|NCT00351234|Diabetes Mellitus Type I,|diabetes mellitus type i,
5741981|NCT00351234|Hypoglycemia,|hypoglycemia,
5741982|NCT00351234|Carnitine|carnitine
5741983|NCT00351208|Spinal cord stimulation|spinal cord stimulation
5742090|NCT00350766|Myocardial Infarction|myocardial infarction
5741984|NCT00351208|Spinal cord stimulation efficacy|spinal cord stimulation efficacy
5741985|NCT00351208|Spinal cord stimulators|spinal cord stimulators
5741986|NCT00351208|Stimulation frequencies|stimulation frequencies
5741991|NCT00351195|Oxaliplatin|oxaliplatin
5741992|NCT00351195|Capecitabine|capecitabine
5741993|NCT00351182|Scrub typhus|scrub typhus
5741994|NCT00351182|Telithromycin|telithromycin
5741995|NCT00351182|Doxycycline|doxycycline
5741996|NCT00351169|Major Depressive Disorder|major depressive disorder
5740990|NCT00354523|MTC|mtc
5741998|NCT00351156|Gaucher Disease|gaucher disease
5741999|NCT00351156|Gaucher Disease, Type 1|gaucher disease, type 1
5742000|NCT00351156|Gaucher Disease, Type 2|gaucher disease, type 2
5742001|NCT00351156|Gaucher Disease, Type 3|gaucher disease, type 3
5742002|NCT00351156|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5742003|NCT00351156|Non-Neuronopathic Gaucher Disease|non-neuronopathic gaucher disease
5742004|NCT00351156|Lysosomal Storage Disease|lysosomal storage disease
5742005|NCT00351156|Metabolism, Inborn Errors|metabolism, inborn errors
5742006|NCT00351156|Metabolic Diseases|metabolic diseases
5742007|NCT00351156|Sphingolipidoses|sphingolipidoses
5742008|NCT00351156|Genetic Diseases, Inborn|genetic diseases, inborn
5742009|NCT00351143|QoL|qol
5742010|NCT00351143|Asthma|asthma
5742011|NCT00351143|asthma compliance enhancement|asthma compliance enhancement
5742012|NCT00351143|Salmeterol/fluticasone|salmeterol/fluticasone
5742013|NCT00351143|Total control|total control
5742014|NCT00351143|SERETIDE|seretide
5742015|NCT00351143|FEV1|fev1
5742016|NCT00351130|Hypertension,|hypertension,
5742017|NCT00351130|stage 1 hypertension,|stage 1 hypertension,
5742018|NCT00351130|stage 2 hypertension,|stage 2 hypertension,
5742019|NCT00351130|valsartan,|valsartan,
5742020|NCT00351130|amlodipine,|amlodipine,
5742021|NCT00351117|St. John's Wort|st. john's wort
5742022|NCT00351117|Selective Serotonin Receptor Inhibitor|selective serotonin receptor inhibitor
5742023|NCT00351117|Microvasculature|microvasculature
5742024|NCT00351117|Natural Health Products|natural health products
5742030|NCT00351078|Cystic fibrosis|cystic fibrosis
5742031|NCT00351078|Nonsense mutation|nonsense mutation
5742032|NCT00351078|Premature stop codon|premature stop codon
5742033|NCT00351078|CF|cf
5742034|NCT00351078|PTC124|ptc124
5742035|NCT00351065|erectile dysfunction, PDE-5 inhibitor|erectile dysfunction, pde-5 inhibitor
5742036|NCT00351052|Pimecrolimus, Atopic Dermatitis, Eczema, Pediatric|pimecrolimus, atopic dermatitis, eczema, pediatric
5742037|NCT00351026|opioid dependence|opioid dependence
5742038|NCT00351026|methadone|methadone
5742039|NCT00351026|HIV|hiv
5742040|NCT00351013|malaria|malaria
5742041|NCT00351013|Plasmodium falciparum|plasmodium falciparum
5742042|NCT00351013|Tropica Nosode|tropica nosode
5742043|NCT00351013|Homeopathy|homeopathy
5742044|NCT00351000|Schizophrenia|schizophrenia
5742045|NCT00351000|Ziprasidone|ziprasidone
5742046|NCT00351000|Diabetes|diabetes
5742047|NCT00351000|Insulin Resistance|insulin resistance
5742048|NCT00350987|Procalcitonin, guidelines, LRTI, non-inferiority|procalcitonin, guidelines, lrti, non-inferiority
5742049|NCT00350987|COLD|cold
5742050|NCT00350961|Cholangiocarcinoma|cholangiocarcinoma
5742051|NCT00350961|Fixed dose rate|fixed dose rate
5742052|NCT00350961|Gemcitabine|gemcitabine
5742053|NCT00350961|Oxaliplatin|oxaliplatin
5742054|NCT00350961|Capecitabine|capecitabine
5742055|NCT00350948|Ovary|ovary
5742056|NCT00350935|fMRI|fmri
5742057|NCT00350935|Visual perception|visual perception
5742058|NCT00350935|Attention|attention
5742059|NCT00350909|drug abuse|drug abuse
5742060|NCT00350896|trapezotrapezoidial|trapezotrapezoidial
5742061|NCT00350896|scaphotrapezial|scaphotrapezial
5742062|NCT00350896|thumb|thumb
5742063|NCT00350896|pain|pain
5742064|NCT00350896|orthoses|orthoses
5789090|NCT00149942|gastrointestinal adverse events|gastrointestinal adverse events
5742065|NCT00350896|Osteoarthritis in the BTOA concerns the trapezometacarpal joint|osteoarthritis in the btoa concerns the trapezometacarpal joint
5742066|NCT00350883|Cognitive Therapy|cognitive therapy
5742067|NCT00350883|Negative Symptoms|negative symptoms
5742068|NCT00350883|Functional Outcomes|functional outcomes
5742069|NCT00350883|Schizophrenia|schizophrenia
5742070|NCT00350883|Schizoaffective Disorder|schizoaffective disorder
5742071|NCT00350870|disulfiram|disulfiram
5742072|NCT00350870|cognitive behavioral therapy|cognitive behavioral therapy
5742073|NCT00350870|contingency management|contingency management
5742074|NCT00350870|drug abuse therapy|drug abuse therapy
5742075|NCT00350870|educational/resource design/development|educational/resource design/development
5742076|NCT00350844|Sickle Cell Disease|sickle cell disease
5742077|NCT00350844|Pulmonary Hypertension|pulmonary hypertension
5742078|NCT00350831|Solid tumor|solid tumor
5742079|NCT00350818|Acute Myelogenous Leukemia|acute myelogenous leukemia
5742080|NCT00350818|Myelodysplastic Syndrome|myelodysplastic syndrome
5742081|NCT00350818|Allogeneic Transplantation|allogeneic transplantation
5742082|NCT00350818|Leukemia|leukemia
5742083|NCT00350818|Azacitidine|azacitidine
5742084|NCT00350818|Vidaza|vidaza
5742085|NCT00350805|Schizophrenia|schizophrenia
5742086|NCT00350805|Time perception|time perception
5742087|NCT00350805|Cortical synchronization|cortical synchronization
5742088|NCT00350805|Electroencephalography|electroencephalography
5742089|NCT00350779|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5742091|NCT00350766|Myocardial Ischemia|myocardial ischemia
5742092|NCT00350766|Ventricular Remodeling|ventricular remodeling
5742093|NCT00350766|Bone Marrow Cell Transplantation|bone marrow cell transplantation
5742095|NCT00350753|Cholangiocarcinoma|cholangiocarcinoma
5742096|NCT00350727|relapsed|relapsed
5742097|NCT00350727|lapatinib|lapatinib
5742098|NCT00350727|Pazopanib|pazopanib
5686261|NCT00552773|CYCLAMEN|cyclamen
5742099|NCT00350727|glioblastoma|glioblastoma
5742100|NCT00350714|HCV (Hepatitis C Virus)|hcv (hepatitis c virus)
5742101|NCT00350714|MBT (Methacetin Breath Test)|mbt (methacetin breath test)
5742102|NCT00350714|Hepatitis C Virus Patients|hepatitis c virus patients
5742103|NCT00350701|DM type 2|dm type 2
5742104|NCT00350701|Hypogonadism|hypogonadism
5742105|NCT00350701|Testosterone|testosterone
5742106|NCT00350701|AndroGel|androgel
5742107|NCT00350688|Bladder,|bladder,
5742108|NCT00350688|Cancer,|cancer,
5742109|NCT00350688|Chemoradiation,|chemoradiation,
5742110|NCT00350688|IMRT,|imrt,
5742111|NCT00350688|tomotherapy|tomotherapy
5742112|NCT00350662|Deferiprone|deferiprone
5742113|NCT00350662|L1|l1
5742114|NCT00350662|Desferrioxamine|desferrioxamine
5742115|NCT00350662|Hemochromatosis|hemochromatosis
5742116|NCT00350662|Iron overload|iron overload
5742117|NCT00350662|Thalassemia|thalassemia
5742118|NCT00350649|behavior modification|behavior modification
5742119|NCT00350649|cognitive behavioral therapy|cognitive behavioral therapy
5742120|NCT00350649|combination therapy|combination therapy
5742121|NCT00350649|drug abuse therapy|drug abuse therapy
5742122|NCT00350649|drug addition|drug addition
5742123|NCT00350649|human therapy evaluation|human therapy evaluation
5742124|NCT00350649|psychotherapy|psychotherapy
5742125|NCT00350649|clinical trial phase II|clinical trial phase ii
5742126|NCT00350649|coping|coping
5742127|NCT00350649|drug and alcohol abstinence|drug and alcohol abstinence
5742128|NCT00350649|longitudinal human study|longitudinal human study
5742129|NCT00350649|outcomes research|outcomes research
5742130|NCT00350649|outpatient care|outpatient care
5742131|NCT00350649|psychological reinforcement|psychological reinforcement
5742132|NCT00350649|therapy compliance|therapy compliance
5742133|NCT00350649|behavior and social research tag|behavior and social research tag
5742134|NCT00350649|human subjects|human subjects
5742135|NCT00350649|neuropsychological test|neuropsychological test
5742136|NCT00350649|patient oriented research|patient oriented research
5742137|NCT00350636|OAB, anticholineric, oxybutynin, urge urinary incontinence|oab, anticholineric, oxybutynin, urge urinary incontinence
5742138|NCT00350623|AIDS|aids
5742139|NCT00350610|cognitive behavior therapy|cognitive behavior therapy
5742140|NCT00350610|computer assisted instruction|computer assisted instruction
5742141|NCT00350610|drug abuse therapy|drug abuse therapy
5742142|NCT00350610|educational resource design and development|educational resource design and development
5742143|NCT00350597|Malignant Melanoma|malignant melanoma
5742144|NCT00350597|Adjuvant Therapy|adjuvant therapy
5742145|NCT00350597|Cytokine Therapy|cytokine therapy
5742146|NCT00350597|Immunologic Testing|immunologic testing
5742147|NCT00350584|Mindfulness|mindfulness
5742148|NCT00350584|Psychoeducation|psychoeducation
5742149|NCT00350584|Telehealth Intervention|telehealth intervention
5742150|NCT00350571|behavior therapy|behavior therapy
5742151|NCT00350571|counseling|counseling
5742152|NCT00350571|drug abuse therapy|drug abuse therapy
5742153|NCT00350571|outpatient care|outpatient care
5742154|NCT00350571|therapy compliance|therapy compliance
5742155|NCT00350571|clinical trial phase I|clinical trial phase i
5742156|NCT00350571|coping|coping
5742157|NCT00350571|outcomes research|outcomes research
5742158|NCT00350571|satisfaction|satisfaction
5742159|NCT00350571|social psychology|social psychology
5742160|NCT00350571|patient oriented research|patient oriented research
5742161|NCT00350532|pain, chronic pain|pain, chronic pain
5742162|NCT00350532|acetylcholine|acetylcholine
5742163|NCT00350532|clonidine|clonidine
5742164|NCT00350532|a2-adrenergic agonists|a2-adrenergic agonists
5742165|NCT00350532|alpha2-adrenergic agonists|alpha2-adrenergic agonists
5742166|NCT00350519|Hemostasis, Surgical|hemostasis, surgical
5742167|NCT00350519|Epoetin alfa|epoetin alfa
5742168|NCT00350519|Surgery|surgery
5742169|NCT00350519|Abdomen|abdomen
5742170|NCT00350519|Pelvis|pelvis
5742171|NCT00350519|PROCRIT|procrit
5742172|NCT00350519|pRBC|prbc
5742173|NCT00350519|Blood transfusion|blood transfusion
5742174|NCT00350519|Packed red blood cell transfusion|packed red blood cell transfusion
5742175|NCT00350480|acute uterine bleeding|acute uterine bleeding
5742176|NCT00350467|Schizophrenia|schizophrenia
5742177|NCT00350467|DSM-IV|dsm-iv
5742178|NCT00350467|PANSS|panss
5742179|NCT00350467|informed consent|informed consent
5742180|NCT00350441|Sildenafil Citrate|sildenafil citrate
5742181|NCT00350441|Cardiopulmonary bypass|cardiopulmonary bypass
5742182|NCT00350441|Open heart surgery|open heart surgery
5742183|NCT00350428|Acute primary angle closure|acute primary angle closure
5742184|NCT00350428|Laser preipheral iridotomy|laser preipheral iridotomy
5742185|NCT00350428|Phacoemulsification|phacoemulsification
5742186|NCT00350415|ulcerative colitis, inflammatory bowel disease|ulcerative colitis, inflammatory bowel disease
5742187|NCT00350402|Parkinson's disease|parkinson's disease
5742188|NCT00350402|PD|pd
5742189|NCT00350402|masked faces|masked faces
5742190|NCT00350402|diminished facial expressivity|diminished facial expressivity
5742191|NCT00350402|diminished facial expression|diminished facial expression
5742192|NCT00350402|high intensity respiratory muscle strength training|high intensity respiratory muscle strength training
5742193|NCT00350402|MST|mst
5742194|NCT00350389|Falls, Older persons|falls, older persons
5742195|NCT00350376|asthma|asthma
5742196|NCT00350376|allergies|allergies
5742197|NCT00350376|Xolair|xolair
5742198|NCT00350376|Advair|advair
5742199|NCT00350350|XEROSTOMIA|xerostomia
5742200|NCT00350350|MOUTH DRYNESS|mouth dryness
5742201|NCT00350350|ELDERLY|elderly
5742202|NCT00350350|ORAL LUBRICANT|oral lubricant
5742203|NCT00350298|Monoclonal antibody,|monoclonal antibody,
5742204|NCT00350298|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5742205|NCT00350285|cannabis|cannabis
5742206|NCT00350285|marijuana|marijuana
5742207|NCT00350272|HIV-1 treatment naive|hiv-1 treatment naive
5742208|NCT00350233|Bone Tumors|bone tumors
5742209|NCT00350233|Bone Cancer|bone cancer
5742210|NCT00350233|Prostate Cancer|prostate cancer
5742211|NCT00350233|lung cancer|lung cancer
5742212|NCT00350220|Single ventricle|single ventricle
5742213|NCT00350220|Bidirectional Glenn|bidirectional glenn
5742214|NCT00350220|Fontan|fontan
5742215|NCT00350220|Congenital cardiac disease|congenital cardiac disease
5742216|NCT00350220|Red blood cell transfusion|red blood cell transfusion
5742217|NCT00350220|oxygen utilization|oxygen utilization
5742218|NCT00350220|lactate level|lactate level
5742219|NCT00350220|hemoglobin level|hemoglobin level
5742220|NCT00350194|Fatty Acids, Omega-3|fatty acids, omega-3
5742221|NCT00350168|Blood pressure|blood pressure
5742222|NCT00350168|Venous pressure|venous pressure
5742223|NCT00350168|Systolic pressure|systolic pressure
5742224|NCT00350168|Diastolic pressure|diastolic pressure
5742225|NCT00350168|Pulse pressure|pulse pressure
5742226|NCT00350155|Video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel|video capsule endoscopy, healthy volunteers, naproxen, omeprazole, lumiracoxib, small bowel
5742227|NCT00350142|Stereotactic Body Radiotherapy (SBRT)|stereotactic body radiotherapy (sbrt)
5742228|NCT00350142|pancreas cancer|pancreas cancer
5742229|NCT00350142|locally advanced|locally advanced
5742230|NCT00350142|local control|local control
5742231|NCT00350142|Gemcitabine|gemcitabine
5742232|NCT00350129|glucose|glucose
5742233|NCT00350129|vasospasm|vasospasm
5742234|NCT00350129|RVA|rva
5742235|NCT00350129|LDF|ldf
5742236|NCT00350129|vasospastic subjects|vasospastic subjects
5742237|NCT00350129|non-vasospastic subjects|non-vasospastic subjects
5742238|NCT00350116|plaque psoriasis|plaque psoriasis
5742239|NCT00350116|Vitamin B12|vitamin b12
5742240|NCT00350090|Anemia|anemia
5742241|NCT00350090|Neoplasms|neoplasms
5742242|NCT00350090|Hemoglobin values|hemoglobin values
5742243|NCT00350077|Burns|burns
5742244|NCT00350064|Metabolic Syndrome|metabolic syndrome
5742245|NCT00350064|Obesity|obesity
5742246|NCT00350064|Exercise|exercise
5742247|NCT00350064|Diabetes|diabetes
5742248|NCT00350064|Physical Activity|physical activity
5742249|NCT00350051|Prostate cancer|prostate cancer
5742250|NCT00350051|Metastatic androgen-independent prostate cancer|metastatic androgen-independent prostate cancer
5742251|NCT00350025|urothelial|urothelial
5742252|NCT00350025|urologic|urologic
5742253|NCT00350025|neoplasm|neoplasm
5742255|NCT00350025|metastatic|metastatic
5742256|NCT00350012|stroke|stroke
5742257|NCT00350012|visual|visual
5742258|NCT00350012|spatial neglect|spatial neglect
5742259|NCT00349999|Vibrio cholerae, Cholera, Bangladesh, esophagogastroduodenoscopy, sub-study|vibrio cholerae, cholera, bangladesh, esophagogastroduodenoscopy, sub-study
5742260|NCT00349973|Schizophrenia|schizophrenia
5742261|NCT00349973|Positive symptoms|positive symptoms
5742262|NCT00349973|Negative symptoms|negative symptoms
5742263|NCT00349973|Cognitive deficits|cognitive deficits
5742264|NCT00349960|Erythropoiesis stimulating agent|erythropoiesis stimulating agent
5742265|NCT00349960|Dosing frequency|dosing frequency
5742266|NCT00349960|Hemodialysis|hemodialysis
5742267|NCT00349960|Therapeutic equivalence|therapeutic equivalence
5742268|NCT00349934|Metastatic breast cancer|metastatic breast cancer
5742269|NCT00349934|IMP321|imp321
5742270|NCT00349934|hLAG-3Ig|hlag-3ig
5742271|NCT00349934|LAG-3|lag-3
5742272|NCT00349934|CD223|cd223
5742273|NCT00349934|Chemotherapy|chemotherapy
5742274|NCT00349934|Paclitaxel|paclitaxel
5742275|NCT00349934|Combination therapy|combination therapy
5742276|NCT00349921|pain|pain
5742277|NCT00349921|chronic pain|chronic pain
5742278|NCT00349921|clonidine|clonidine
5742279|NCT00349921|adenosine|adenosine
5742280|NCT00349921|complex regional pain syndrome|complex regional pain syndrome
5742281|NCT00349921|CRPS|crps
5742282|NCT00349921|a2-adrenergic agonists|a2-adrenergic agonists
5742651|NCT00348088|Untreated|untreated
5742283|NCT00349921|alpha2-adrenergic agonists|alpha2-adrenergic agonists
5742284|NCT00349908|Atherosclerosis,Wide Neck Aneurysm|atherosclerosis,wide neck aneurysm
5742285|NCT00349895|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5742286|NCT00349895|Stent implantation|stent implantation
5742287|NCT00349869|inflammatory arthritis|inflammatory arthritis
5742288|NCT00349869|rheumatoid arthritis|rheumatoid arthritis
5742289|NCT00349869|knee osteoarthritis|knee osteoarthritis
5742290|NCT00349869|arthritis|arthritis
5742292|NCT00349804|temperature|temperature
5742293|NCT00349804|Temperature Homeostasis|temperature homeostasis
5742294|NCT00349791|Natural Menopause|natural menopause
5741274|NCT00353470|PD|pd
5742295|NCT00349765|cardiovascular disease|cardiovascular disease
5742297|NCT00349765|trans fat|trans fat
5742298|NCT00349765|polyunsaturated fat|polyunsaturated fat
5742299|NCT00349765|diet|diet
5742300|NCT00349765|intramyocellular lipid|intramyocellular lipid
5742301|NCT00349752|certolizumab pegol|certolizumab pegol
5742302|NCT00349752|Cimzia|cimzia
5742303|NCT00349752|Crohn's Disease|crohn's disease
5742304|NCT00349752|Inflammatory Bowel Disease|inflammatory bowel disease
5742305|NCT00349739|age related macular degeneration|age related macular degeneration
5742306|NCT00349726|NICHD Neonatal Research Network|nichd neonatal research network
5742307|NCT00349726|Pharmacokinetics|pharmacokinetics
5742308|NCT00349726|Inositol|inositol
5742309|NCT00349726|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5742310|NCT00349726|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5742311|NCT00349726|Prematurity|prematurity
5742312|NCT00349713|Plasmodium falciparum Malaria, Mali, adjuvant|plasmodium falciparum malaria, mali, adjuvant
5742313|NCT00349700|healing|healing
5742314|NCT00349700|skin|skin
5742315|NCT00349700|infection|infection
5742316|NCT00349700|wound therapy|wound therapy
5742317|NCT00349674|Wegener's granulomatosis,|wegener's granulomatosis,
5742318|NCT00349674|microscopic polyangiitis,|microscopic polyangiitis,
5742319|NCT00349674|ANCA-associated vasculitis,|anca-associated vasculitis,
5742320|NCT00349674|methotrexate,|methotrexate,
5742321|NCT00349674|azathioprine|azathioprine
5742322|NCT00349661|clopidogrel|clopidogrel
5742323|NCT00349661|omeprazole|omeprazole
5742324|NCT00349648|subacromial|subacromial
5742325|NCT00349648|impingement|impingement
5742326|NCT00349648|acromioplasty|acromioplasty
5742327|NCT00349648|physiotherapy|physiotherapy
5742328|NCT00349635|Weight loss and diet.|weight loss and diet.
5742329|NCT00349622|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5742331|NCT00349622|ceftriaxone|ceftriaxone
5742332|NCT00349622|cephalosporin antibiotic|cephalosporin antibiotic
5742333|NCT00349622|motor neurons|motor neurons
5742334|NCT00349596|Hypomethylating agent|hypomethylating agent
5742335|NCT00349596|Chemotherapy|chemotherapy
5742336|NCT00349596|Relapsed or refractory ALL|relapsed or refractory all
5742337|NCT00349596|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5742338|NCT00349570|thrombus|thrombus
5742339|NCT00349570|aspiration catheter|aspiration catheter
5742340|NCT00349557|Prostate Cancer|prostate cancer
5742341|NCT00349557|High-Risk Prostate Cancer|high-risk prostate cancer
5742342|NCT00349557|1st line therapy|1st line therapy
5742343|NCT00349544|Neck pain|neck pain
5742344|NCT00349544|Cervicalgia|cervicalgia
5742345|NCT00349544|Quality of life|quality of life
5742346|NCT00349544|Disability|disability
5742347|NCT00349518|Chronic and Advanced Phase CML and|chronic and advanced phase cml and
5742348|NCT00349518|Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance|philadelphia chromosome positive all with imatinib intolerance or resistance
5742349|NCT00349505|previous treatment surgery + 6 cycles of platinum based chemotherapy|previous treatment surgery + 6 cycles of platinum based chemotherapy
5742350|NCT00349492|Small Cell Lung Cancer|small cell lung cancer
5742351|NCT00349492|Extensive Disease|extensive disease
5742352|NCT00349492|Chemotherapy|chemotherapy
5742353|NCT00349492|Randomisation|randomisation
5742354|NCT00349479|stroke|stroke
5742355|NCT00349479|tissue plasminogen activator|tissue plasminogen activator
5742356|NCT00349479|t-PA|t-pa
5742357|NCT00349479|barrier assessment and interactive educational intervention|barrier assessment and interactive educational intervention
5742358|NCT00349479|BA-IEI|ba-iei
5742359|NCT00349466|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5742361|NCT00349466|Dry Eye|dry eye
5742362|NCT00349453|Deferiprone|deferiprone
5742363|NCT00349453|L1|l1
5742364|NCT00349453|Desferrioxamine|desferrioxamine
5742365|NCT00349453|Hemochromatosis|hemochromatosis
5742366|NCT00349453|Iron overload|iron overload
5742367|NCT00349453|Thalassemia|thalassemia
5742368|NCT00349440|Dry eye|dry eye
5742369|NCT00349427|Insulin|insulin
5742370|NCT00349427|BRL49653 /rosiglitazone|brl49653 /rosiglitazone
5742371|NCT00349427|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5742372|NCT00349414|Advanced glaucoma|advanced glaucoma
5742373|NCT00349414|Refractory glaucoma|refractory glaucoma
5742374|NCT00349414|Cyclophotocoagulation|cyclophotocoagulation
5742375|NCT00349414|Transscleral cyclophotocoagulation|transscleral cyclophotocoagulation
5742376|NCT00349414|Micropulse transscleral cyclophotocoagulation|micropulse transscleral cyclophotocoagulation
5742378|NCT00349401|chronic pain|chronic pain
5742379|NCT00349401|morphine|morphine
5742380|NCT00349401|ketorolac|ketorolac
5742381|NCT00349388|Mesalamine|mesalamine
5742382|NCT00349388|Ulcerative Colitis|ulcerative colitis
5742658|NCT00348049|Myopia|myopia
5742383|NCT00349375|Hyperlipidemia Combined, efficacy combination fenofibrate simvastatin|hyperlipidemia combined, efficacy combination fenofibrate simvastatin
5742384|NCT00349323|Community directed treatment,|community directed treatment,
5742385|NCT00349323|soil-transmitted helminth infections,|soil-transmitted helminth infections,
5742387|NCT00349323|Zambia|zambia
5798841|NCT00110877|Human Immunodeficiency Virus|human immunodeficiency virus
5767519|NCT00253981|Leg|leg
5742388|NCT00349284|Hyperlipidemia Combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe|hyperlipidemia combined and features of the metabolic syndrome, efficacy combination fenofibrate ezetimibe
5742389|NCT00349271|Chagas Cardiomyopathy|chagas cardiomyopathy
5742390|NCT00349271|Dilated Cardiomyopathy|dilated cardiomyopathy
5742391|NCT00349271|stem cells|stem cells
5742392|NCT00349271|Therapeutics|therapeutics
5742393|NCT00349271|Randomized Controlled Trials|randomized controlled trials
5742394|NCT00349258|OHSS|ohss
5742395|NCT00349258|PCOS|pcos
5742396|NCT00349258|Previous high response|previous high response
5742397|NCT00349258|GnRH antagonist|gnrh antagonist
5742398|NCT00349258|GnRH agonist|gnrh agonist
5742399|NCT00349258|IVF|ivf
5742400|NCT00349245|Endotracheal|endotracheal
5742401|NCT00349245|Awake fiberoptic intubation|awake fiberoptic intubation
5742402|NCT00349245|Dexmedetomidine|dexmedetomidine
5742403|NCT00349245|Remifentanil|remifentanil
5742404|NCT00349232|childhood obesity|childhood obesity
5742405|NCT00349232|lifestyle intervention|lifestyle intervention
5742406|NCT00349232|school health program|school health program
5742407|NCT00349232|special primary education|special primary education
5742408|NCT00349219|first-line|first-line
5742409|NCT00349219|second-line|second-line
5742410|NCT00349219|targeted therapy|targeted therapy
5742411|NCT00349193|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5742412|NCT00349180|Total Hip Replacement|total hip replacement
5742413|NCT00349180|Enoxaparin|enoxaparin
5742414|NCT00349167|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5742415|NCT00349141|Pandemic influenza|pandemic influenza
5742416|NCT00349128|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5742417|NCT00349102|Non-small-cell lung cancer|non-small-cell lung cancer
5742418|NCT00349102|Breath-hold|breath-hold
5742419|NCT00349102|Radiation pneumonitis|radiation pneumonitis
5742420|NCT00349102|Serum cytokines|serum cytokines
5742421|NCT00349102|LENT-SOMA scale|lent-soma scale
5742422|NCT00349102|Non-metastatic non-small-cell lung cancer|non-metastatic non-small-cell lung cancer
5742423|NCT00349089|Non-small cell lung cancer|non-small cell lung cancer
5742424|NCT00349089|adjuvant therapy|adjuvant therapy
5742425|NCT00349089|clinical feasibility rate|clinical feasibility rate
5742426|NCT00349050|trigeminal neuralgia|trigeminal neuralgia
5742427|NCT00349050|neuropathic pain|neuropathic pain
5742428|NCT00349050|complex regional pain syndrome|complex regional pain syndrome
5742429|NCT00349050|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5742430|NCT00349050|pain|pain
5742431|NCT00349050|chronic pain|chronic pain
5742432|NCT00349050|transcranial magnetic stimulation|transcranial magnetic stimulation
5742433|NCT00349050|TMS|tms
5742434|NCT00349050|laboratory pain assessment|laboratory pain assessment
5742435|NCT00349037|DNA vaccine|dna vaccine
5742436|NCT00349037|influenza|influenza
5742437|NCT00349037|immunogenicity|immunogenicity
5742439|NCT00349037|PMED|pmed
5742440|NCT00349037|efficacy|efficacy
5742441|NCT00349037|challenge virus|challenge virus
5742442|NCT00349024|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5742443|NCT00349024|pain|pain
5680978|NCT00575341|Central Adrenal Insufficiency|central adrenal insufficiency
5680979|NCT00575341|DHEA|dhea
5680980|NCT00575341|Pubes|pubes
5680981|NCT00575328|Sexual Dysfunction|sexual dysfunction
5680982|NCT00575328|Bipolar Disorder|bipolar disorder
5680983|NCT00575315|HIV-HCV Coinfection|hiv-hcv coinfection
5680984|NCT00575315|HIV|hiv
5680985|NCT00575315|Histology|histology
5680986|NCT00575302|IVF|ivf
5680987|NCT00575302|poor responder|poor responder
5680988|NCT00575302|recFSH|recfsh
5742444|NCT00349024|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5742445|NCT00349024|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5742446|NCT00349024|chondrosarcoma|chondrosarcoma
5742447|NCT00349024|osteosarcoma|osteosarcoma
5742448|NCT00349024|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5742449|NCT00349024|Wilms tumor and other childhood kidney tumors|wilms tumor and other childhood kidney tumors
5742450|NCT00349024|neuroblastoma|neuroblastoma
5742451|NCT00349024|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5742452|NCT00349024|childhood large cell lymphoma|childhood large cell lymphoma
5742453|NCT00349024|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5742454|NCT00349024|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5742455|NCT00349024|childhood rhabdomyosarcoma|childhood rhabdomyosarcoma
5742456|NCT00349024|childhood brain stem glioma|childhood brain stem glioma
5742457|NCT00349024|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5742458|NCT00349024|childhood cerebellar astrocytoma|childhood cerebellar astrocytoma
5742459|NCT00349024|childhood cerebral astrocytoma/malignant glioma|childhood cerebral astrocytoma/malignant glioma
5742460|NCT00349024|childhood choroid plexus tumor|childhood choroid plexus tumor
5742461|NCT00349024|childhood craniopharyngioma|childhood craniopharyngioma
5742462|NCT00349024|childhood ependymoma|childhood ependymoma
5742652|NCT00348088|Biomarker|biomarker
5741481|NCT00352742|ATN-224|atn-224
5742463|NCT00349024|childhood medulloblastoma|childhood medulloblastoma
5742464|NCT00349024|childhood meningioma|childhood meningioma
5742465|NCT00349024|childhood oligodendroglioma|childhood oligodendroglioma
5742956|NCT00346736|Acupuncture|acupuncture
5742466|NCT00349024|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5742467|NCT00349024|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5742468|NCT00349024|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5798842|NCT00110877|Treatment Experienced|treatment experienced
5742469|NCT00349024|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5742470|NCT00349024|chordoma|chordoma
5742471|NCT00349024|mucositis|mucositis
5742472|NCT00349024|Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)|ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
5742473|NCT00349011|menopause|menopause
5742474|NCT00349011|genetic counseling|genetic counseling
5742475|NCT00349011|breast cancer|breast cancer
5742476|NCT00349011|tamoxifen|tamoxifen
5742477|NCT00349011|chemoprevention|chemoprevention
5742478|NCT00348998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5742479|NCT00348998|stage IIB prostate cancer|stage iib prostate cancer
5742480|NCT00348998|stage IIA prostate cancer|stage iia prostate cancer
5742481|NCT00348998|stage III prostate cancer|stage iii prostate cancer
5742482|NCT00348998|stage IV prostate cancer|stage iv prostate cancer
5742483|NCT00348972|Glargine|glargine
5742484|NCT00348972|prediabetes|prediabetes
5742485|NCT00348972|impaired glucose tolerance|impaired glucose tolerance
5742486|NCT00348972|impaired fasting glucose|impaired fasting glucose
5742487|NCT00348959|Haematological Malignancies|haematological malignancies
5742488|NCT00348959|Autologous Stem Cell Transplantation|autologous stem cell transplantation
5742489|NCT00348959|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5742490|NCT00348959|Quality of Life|quality of life
5742491|NCT00348959|Life Threatening Illness|life threatening illness
5742492|NCT00348959|Art in Health Care|art in health care
5742493|NCT00348959|Randomised Controlled Trial|randomised controlled trial
5742494|NCT00348959|Mixed Methods Research|mixed methods research
5742495|NCT00348946|Klinefelter syndrome|klinefelter syndrome
5742496|NCT00348946|androgen|androgen
5742497|NCT00348946|androgen oxandrolone|androgen oxandrolone
5742498|NCT00348933|Developmental Delay|developmental delay
5742499|NCT00348933|Mental Retardation|mental retardation
5742501|NCT00348933|Microcephaly|microcephaly
5742502|NCT00348933|Seizures|seizures
5742503|NCT00348920|Aortic Valve|aortic valve
5742504|NCT00348920|Aortic Stenosis|aortic stenosis
5742505|NCT00348920|High Spinal Anesthesia|high spinal anesthesia
5742506|NCT00348920|Total Spinal Anesthesia|total spinal anesthesia
5742507|NCT00348920|Stress Response|stress response
5680989|NCT00575302|Fertilization in Vitro|fertilization in vitro
5680990|NCT00575302|Poor responders|poor responders
5742508|NCT00348920|Inflammatory Mediators|inflammatory mediators
5742509|NCT00348920|Renal Function|renal function
5742510|NCT00348920|Hemodynamic Stability|hemodynamic stability
5742511|NCT00348907|doppler|doppler
5742512|NCT00348907|CIVIQ quality of life|civiq quality of life
5742513|NCT00348907|Hydrotherapy|hydrotherapy
5742514|NCT00348907|anticoagulants|anticoagulants
5742515|NCT00348881|Diphtheria|diphtheria
5742516|NCT00348881|Tetanus|tetanus
5742517|NCT00348881|Pertussis|pertussis
5742518|NCT00348881|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5742519|NCT00348881|Haemophilus influenzae type b|haemophilus influenzae type b
5742520|NCT00348868|HIV Infection|hiv infection
5742521|NCT00348868|Opioid dependence|opioid dependence
5742522|NCT00348868|DSM-IV criteria for opioid dependence|dsm-iv criteria for opioid dependence
5742523|NCT00348855|High Blood Pressure|high blood pressure
5742524|NCT00348855|High cardiovascular risk|high cardiovascular risk
5742525|NCT00348855|Type 2 diabetes|type 2 diabetes
5742526|NCT00348855|Reaching goals|reaching goals
5742527|NCT00348842|Immunotherapy|immunotherapy
5742529|NCT00348829|mitral insufficiency|mitral insufficiency
5742530|NCT00348829|conductance catheter|conductance catheter
5742531|NCT00348829|mitral valve repair|mitral valve repair
5742532|NCT00348816|stage I prostate cancer|stage i prostate cancer
5742533|NCT00348816|stage IIB prostate cancer|stage iib prostate cancer
5742534|NCT00348816|stage IIA prostate cancer|stage iia prostate cancer
5742535|NCT00348816|stage III prostate cancer|stage iii prostate cancer
5742536|NCT00348816|stage IV prostate cancer|stage iv prostate cancer
5742537|NCT00348790|adult grade I meningioma|adult grade i meningioma
5742538|NCT00348790|adult grade II meningioma|adult grade ii meningioma
5742539|NCT00348790|adult grade III meningioma|adult grade iii meningioma
5742540|NCT00348790|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5742541|NCT00348790|adult anaplastic meningioma|adult anaplastic meningioma
5742542|NCT00348790|adult papillary meningioma|adult papillary meningioma
5742543|NCT00348790|adult melanocytic lesion|adult melanocytic lesion
5742544|NCT00348790|recurrent adult brain tumor|recurrent adult brain tumor
5742545|NCT00348777|Visual analogic Scale of pain|visual analogic scale of pain
5742547|NCT00348777|SF-36 quality of life|sf-36 quality of life
5742548|NCT00348777|Hydrotherapy|hydrotherapy
5751619|NCT00313846|opioid|opioid
5742549|NCT00348764|lauromacrogol|lauromacrogol
5742550|NCT00348764|Sclerotherapy|sclerotherapy
5742551|NCT00348738|radiotherapy|radiotherapy
5742552|NCT00348738|clinical trial|clinical trial
5742553|NCT00348738|erythropoietin|erythropoietin
5742554|NCT00348738|cervix cancer|cervix cancer
5742555|NCT00348738|Phase III|phase iii
5742556|NCT00348738|2 Arms|2 arms
5742557|NCT00348725|Treatment of Dyslipidemia and of Type 2 Diabetes Mellitus|treatment of dyslipidemia and of type 2 diabetes mellitus
5742559|NCT00348660|Screening for Hepatitis C in Pregnancy|screening for hepatitis c in pregnancy
5742560|NCT00348647|Prevention|prevention
5742561|NCT00348647|Exercise|exercise
5742562|NCT00348647|Overuse|overuse
5742563|NCT00348647|Anterior knee pain syndrome|anterior knee pain syndrome
5742564|NCT00348647|Exertional lower leg pain|exertional lower leg pain
5742565|NCT00348647|Prospective|prospective
5742566|NCT00348647|Risk factors|risk factors
5742567|NCT00348647|Hip|hip
5742568|NCT00348634|Constipation, Tegaserod, orocecal transit, colonic transit, gastric emptying|constipation, tegaserod, orocecal transit, colonic transit, gastric emptying
5742569|NCT00348621|cataract surgery|cataract surgery
5742570|NCT00348621|refractive correction|refractive correction
5742571|NCT00348621|low vision services|low vision services
5742572|NCT00348621|nursing home|nursing home
5742573|NCT00348621|visual impairment|visual impairment
5742574|NCT00348608|Coronary|coronary
5742575|NCT00348608|Angiography|angiography
5742576|NCT00348608|X-ray|x-ray
5742577|NCT00348608|CAD|cad
5742578|NCT00348595|Prostate Cancer|prostate cancer
5742579|NCT00348569|CT|ct
5742580|NCT00348569|Coronary|coronary
5742581|NCT00348569|Cardiac|cardiac
5742582|NCT00348569|Angiography|angiography
5742583|NCT00348569|X-ray|x-ray
5742584|NCT00348569|CAD|cad
5742585|NCT00348569|Chest pain|chest pain
5742586|NCT00348543|age-related macula degeneration|age-related macula degeneration
5742587|NCT00348543|prophylactic laser treatment|prophylactic laser treatment
5742588|NCT00348543|exudative complication|exudative complication
5742589|NCT00348530|Systolic heart failure; Therapy; Cardiomyopathy|systolic heart failure; therapy; cardiomyopathy
5742590|NCT00348491|Dental surgery|dental surgery
5742591|NCT00348491|acute pain|acute pain
5742592|NCT00348491|lumiracoxib|lumiracoxib
5742593|NCT00348491|celecoxib|celecoxib
5742594|NCT00348491|Moderate to severe pain following dental surgery|moderate to severe pain following dental surgery
5742595|NCT00348478|trachoma|trachoma
5742596|NCT00348478|chlamydia trachomatis|chlamydia trachomatis
5742597|NCT00348478|water|water
5742598|NCT00348478|health education|health education
5742599|NCT00348478|face washing|face washing
5742600|NCT00348465|Brachytherapy|brachytherapy
5742601|NCT00348465|Prostate volume|prostate volume
5742602|NCT00348452|osteoarthritis pain; knee; hip; extended release analgesia; opioid|osteoarthritis pain; knee; hip; extended release analgesia; opioid
5742603|NCT00348426|Food Borne Botulism|food borne botulism
5742604|NCT00348413|Graves ophthalmopathy/therapy|graves ophthalmopathy/therapy
5742605|NCT00348413|Randomized controlled trial|randomized controlled trial
5742606|NCT00348413|Methylprednisolone|methylprednisolone
5742607|NCT00348413|Methotrexate|methotrexate
5742608|NCT00348387|Imovax polio|imovax polio
5742609|NCT00348387|poliomyelitis|poliomyelitis
5742610|NCT00348374|type two diabetes, insulin, HbA1c|type two diabetes, insulin, hba1c
5742611|NCT00348361|Hay fever|hay fever
5742612|NCT00348361|biomarkers|biomarkers
5742613|NCT00348309|apolipoprotein E|apolipoprotein e
5742614|NCT00348309|Alzheimer's disease|alzheimer's disease
5742615|NCT00348309|cognition|cognition
5742616|NCT00348309|rosiglitazone|rosiglitazone
5742617|NCT00348309|adjunctive therapy|adjunctive therapy
5742618|NCT00348296|Scleroderma, Systemic|scleroderma, systemic
5742619|NCT00348270|Cataract|cataract
5742620|NCT00348270|Intraocular lens|intraocular lens
5742621|NCT00348270|Aberration|aberration
5742622|NCT00348270|Wavefront|wavefront
5742623|NCT00348231|diabetes mellitus, biphasic insulin analogue|diabetes mellitus, biphasic insulin analogue
5742624|NCT00348218|Neurovision|neurovision
5742625|NCT00348218|Myopia Therapy|myopia therapy
5742626|NCT00348192|Alzheimer's Disease|alzheimer's disease
5742627|NCT00348192|cognition global functioning|cognition global functioning
5742628|NCT00348192|symptomatic|symptomatic
5742629|NCT00348192|SB-742457|sb-742457
5742630|NCT00348179|Vascular abnormalities|vascular abnormalities
5742631|NCT00348179|Type 1 diabetes|type 1 diabetes
5742632|NCT00348179|Healthy control subjects|healthy control subjects
5742633|NCT00348153|Uveitis|uveitis
5742634|NCT00348153|Adalimumab|adalimumab
5742635|NCT00348153|TNF alpha|tnf alpha
5742636|NCT00348140|adjunctive therapy|adjunctive therapy
5742637|NCT00348140|moderate|moderate
5742638|NCT00348140|Alzheimer's disease|alzheimer's disease
5742639|NCT00348140|apolipoprotein E|apolipoprotein e
5742640|NCT00348140|mild|mild
5742641|NCT00348140|rosiglitazone|rosiglitazone
5742642|NCT00348140|cognition|cognition
5742643|NCT00348127|Neurovision|neurovision
5742644|NCT00348127|Myopia Therapy|myopia therapy
5742646|NCT00348114|transplantation ex-vivo expanded limbal epithelium|transplantation ex-vivo expanded limbal epithelium
5742647|NCT00348114|limbal deficiency|limbal deficiency
5742648|NCT00348101|Patients undergoing major vascular surgery having documented CAD or risk factors for CAD|patients undergoing major vascular surgery having documented cad or risk factors for cad
5742649|NCT00348088|Metastatic|metastatic
5742650|NCT00348088|Melanoma|melanoma
5742653|NCT00348075|Neurovision|neurovision
5742654|NCT00348075|Adult myopia|adult myopia
5742655|NCT00348075|Therapy|therapy
5742656|NCT00348049|LASIK|lasik
5742659|NCT00348036|Major Depression|major depression
5742660|NCT00348036|Trauma|trauma
5742661|NCT00348036|Primary Care|primary care
5742662|NCT00348036|Low-Income Patients|low-income patients
5798843|NCT00110877|TMC114-C214|tmc114-c214
5742663|NCT00348010|osteoarthritis|osteoarthritis
5742664|NCT00348010|knee pain|knee pain
5742665|NCT00348010|extended release analgesia|extended release analgesia
5742666|NCT00348010|opioid|opioid
5742667|NCT00347971|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5742668|NCT00347971|interleukin-21|interleukin-21
5742669|NCT00347971|rituximab|rituximab
5742670|NCT00347971|Immunotherapy|immunotherapy
5742671|NCT00347958|Tetanus,|tetanus,
5742672|NCT00347958|Diphtheria,|diphtheria,
5742673|NCT00347958|Pertussis|pertussis
5742674|NCT00347945|convergence insufficiency, vision therapy, orthoptics|convergence insufficiency, vision therapy, orthoptics
5742675|NCT00347919|GW786034|gw786034
5742676|NCT00347919|Quality of Life|quality of life
5742677|NCT00347919|GW572016|gw572016
5742678|NCT00347919|Lapatinib|lapatinib
5742679|NCT00347919|Pazopanib|pazopanib
5742680|NCT00347919|Metastatic|metastatic
5742681|NCT00347919|Breast cancer|breast cancer
5742682|NCT00347919|Genetics|genetics
5742683|NCT00347919|FISH|fish
5742684|NCT00347919|Advanced|advanced
5742685|NCT00347893|Primary open angle glaucoma|primary open angle glaucoma
5742686|NCT00347893|Ocular hypertension|ocular hypertension
5742687|NCT00347893|Pseudo-exfoliative glaucoma|pseudo-exfoliative glaucoma
5742688|NCT00347893|Pigment Dispersion glaucoma|pigment dispersion glaucoma
5742689|NCT00347893|selective laser trabeculoplasty|selective laser trabeculoplasty
5742690|NCT00347893|intraocular pressure|intraocular pressure
5742691|NCT00347880|Bronchiolitis|bronchiolitis
5742694|NCT00347880|Atrial Natriuretic Peptide|atrial natriuretic peptide
5742695|NCT00347880|Brain Natriuretic Peptide|brain natriuretic peptide
5742696|NCT00347880|Vasopressin|vasopressin
5742697|NCT00347880|ADH|adh
5742698|NCT00347880|Pediatric|pediatric
5742699|NCT00347880|Respiratory Distress|respiratory distress
5742700|NCT00347880|Fluid Balance|fluid balance
5742701|NCT00347867|IUGR|iugr
5742702|NCT00347867|PET|pet
5742703|NCT00347867|Pregnancy|pregnancy
5752733|NCT00309699|mixed-state|mixed-state
5742704|NCT00347867|Viagra|viagra
5742705|NCT00347867|Sildenafil citrate|sildenafil citrate
5742706|NCT00347854|Normal, healthy eyes (other than correction for visual acuity)|normal, healthy eyes (other than correction for visual acuity)
5742707|NCT00347828|Antibiotic prophylaxis|antibiotic prophylaxis
5742708|NCT00347828|Vigamox|vigamox
5742709|NCT00347828|Moxifloxacin|moxifloxacin
5742710|NCT00347828|Zymar|zymar
5742711|NCT00347828|Gatifloxacin|gatifloxacin
5742712|NCT00347828|Preoperative antibiotic|preoperative antibiotic
5742713|NCT00347828|Eye infection|eye infection
5742714|NCT00347789|glaucoma|glaucoma
5742715|NCT00347789|trabeculectomy|trabeculectomy
5742716|NCT00347789|filtering bleb revision|filtering bleb revision
5742717|NCT00347789|intraocular pressure|intraocular pressure
5742718|NCT00347789|needling procedure|needling procedure
5742719|NCT00347789|mitomycin C|mitomycin c
5742720|NCT00347776|trichiasis|trichiasis
5742721|NCT00347776|azithromycin|azithromycin
5742722|NCT00347776|trichiasis surgery|trichiasis surgery
5742723|NCT00347776|topical tetracycline|topical tetracycline
5742725|NCT00347763|chlamydia|chlamydia
5742726|NCT00347763|flies|flies
5742727|NCT00347763|permethrin|permethrin
5742728|NCT00347750|Lopinavir|lopinavir
5742729|NCT00347750|Pharmacokinetic|pharmacokinetic
5742730|NCT00347750|Pharmacodynamic|pharmacodynamic
5742731|NCT00347750|Ethiopian population|ethiopian population
5742732|NCT00347750|Caucasian population|caucasian population
5742733|NCT00347724|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid|chronic low back pain; chronic pain; low back pain; extended-release analgesia; opioid
5742734|NCT00347698|diabetic retinopathy|diabetic retinopathy
5742735|NCT00347698|bevacizumab|bevacizumab
5742736|NCT00347698|photocoagulation|photocoagulation
5742737|NCT00347685|chronic non-malignant pain; chronic pain; non-malignant|chronic non-malignant pain; chronic pain; non-malignant
5742738|NCT00347685|pain; moderate pain; severe pain|pain; moderate pain; severe pain
5742739|NCT00347672|Bird Flu|bird flu
5742740|NCT00347659|Lung volume reduction|lung volume reduction
5742741|NCT00347659|Bronchoscopy|bronchoscopy
5742742|NCT00347659|Emphysema|emphysema
5742743|NCT00347659|COPD|copd
5742744|NCT00347659|NETT|nett
5742745|NCT00347659|Lung disease|lung disease
5742746|NCT00347659|COLD|cold
5742748|NCT00347607|trachoma|trachoma
5742749|NCT00347607|chlamydia trachomatis|chlamydia trachomatis
5742750|NCT00347607|surveillance|surveillance
5742751|NCT00347607|azithromycin|azithromycin
5742752|NCT00347594|Corneal surface topography|corneal surface topography
5742753|NCT00347594|Ocular aberrations|ocular aberrations
5741764|NCT00352014|Aspirin|aspirin
5742754|NCT00347581|convergence insufficiency|convergence insufficiency
5742755|NCT00347581|base-in prism|base-in prism
5742756|NCT00347581|orthoptics|orthoptics
5742757|NCT00347581|vision therapy|vision therapy
5742758|NCT00347568|decision aids|decision aids
5742759|NCT00347568|high risk|high risk
5743947|NCT00342953|saline|saline
5742760|NCT00347568|breast cancer|breast cancer
5742761|NCT00347568|breast cancer prevention|breast cancer prevention
5798844|NCT00110864|diabetes, type 2|diabetes, type 2
5742762|NCT00347555|malaria, falciparum, Plasmodium falciparum malaria, vaccine|malaria, falciparum, plasmodium falciparum malaria, vaccine
5742764|NCT00347542|Diabetes|diabetes
5742765|NCT00347542|Insulin sensitivity|insulin sensitivity
5742766|NCT00347542|Obesity|obesity
5742767|NCT00347529|DNA vaccine, influenza, immunogenicity, tolerability, PMED, pandemic|dna vaccine, influenza, immunogenicity, tolerability, pmed, pandemic
5742768|NCT00347516|IOL formula|iol formula
5742769|NCT00347516|High myopia|high myopia
5742770|NCT00347516|axial length|axial length
5742771|NCT00347477|cardiac arrest|cardiac arrest
5742772|NCT00347477|hypothermia|hypothermia
5742773|NCT00347477|neurologic outcome|neurologic outcome
5742774|NCT00347477|edema|edema
5742775|NCT00347464|Kleinfelter|kleinfelter
5742776|NCT00347451|myopia|myopia
5742777|NCT00347451|optical coherence tomography|optical coherence tomography
5742778|NCT00347438|breast cancer|breast cancer
5742779|NCT00347438|neoadjuvant|neoadjuvant
5742780|NCT00347438|locally advanced|locally advanced
5742781|NCT00347425|Switch Study|switch study
5742782|NCT00347425|Schizophrenia|schizophrenia
5742783|NCT00347425|Atypical Antipsychotics|atypical antipsychotics
5742784|NCT00347412|NSCLC|nsclc
5742785|NCT00347412|Stage IIIb|stage iiib
5742786|NCT00347412|Stage IV|stage iv
5742787|NCT00347412|Non Small Cell Lung Cancer (NSCLC)|non small cell lung cancer (nsclc)
5742788|NCT00347412|NSCLC Stage IIIb with malignant pleural/pericardial effusion|nsclc stage iiib with malignant pleural/pericardial effusion
5742789|NCT00347412|NSCLC Stage IV|nsclc stage iv
5742790|NCT00347399|macular degeneration|macular degeneration
5742791|NCT00347399|antibodies|antibodies
5742792|NCT00347399|angiogenesis inhibitor|angiogenesis inhibitor
5742793|NCT00347386|Infants|infants
5742794|NCT00347386|India|india
5742795|NCT00347386|Zinc|zinc
5742796|NCT00347386|Bacterial illness|bacterial illness
5742797|NCT00347386|Treatment|treatment
5742798|NCT00347373|conjugated linoleic acid|conjugated linoleic acid
5742799|NCT00347373|obesity|obesity
5742800|NCT00347373|body composition|body composition
5742801|NCT00347373|body fat mass|body fat mass
5742802|NCT00347373|lean body mass|lean body mass
5742803|NCT00347360|carvedilol|carvedilol
5742804|NCT00347360|hypertension|hypertension
5742805|NCT00347360|lisinopril|lisinopril
5742806|NCT00347360|factorial|factorial
5742807|NCT00347334|Torticollis|torticollis
5742808|NCT00347334|infant home positioning|infant home positioning
5742809|NCT00347334|head control|head control
5742810|NCT00347321|Percutaneous tracheostomy|percutaneous tracheostomy
5742811|NCT00347321|Endotracheal intubation|endotracheal intubation
5742812|NCT00347321|Mechanical ventilation|mechanical ventilation
5742813|NCT00347321|Cardiac surgery|cardiac surgery
5742814|NCT00347321|Ventilator-free days|ventilator-free days
5742815|NCT00347308|brow ptosis, facial aesthetics, browlift, facelift|brow ptosis, facial aesthetics, browlift, facelift
5742816|NCT00347282|Post enucleation socket syndrome|post enucleation socket syndrome
5733070|NCT00382590|AML|aml
5742817|NCT00347282|Multi-slice computed tomography scan|multi-slice computed tomography scan
5742818|NCT00347282|Prospective studies|prospective studies
5742819|NCT00347282|Tomography, X Ray Computed|tomography, x ray computed
5742820|NCT00347269|Anxiety Disorders|anxiety disorders
5742821|NCT00347269|Post-traumatic Stress Disorder|post-traumatic stress disorder
5742822|NCT00347269|Generalized Anxiety Disorder|generalized anxiety disorder
5742823|NCT00347269|Panic Disorder|panic disorder
5742824|NCT00347269|Social Anxiety Disorder|social anxiety disorder
5742825|NCT00347269|Stress|stress
5742826|NCT00347269|Stress Disorders, Traumatic|stress disorders, traumatic
5742827|NCT00347269|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5742828|NCT00347269|Mental Health Disorders|mental health disorders
5742829|NCT00347230|Intacs ring segments|intacs ring segments
5742830|NCT00347230|Keratoconus|keratoconus
5742831|NCT00347217|Cholesterol|cholesterol
5742832|NCT00347217|rosuvastatin|rosuvastatin
5742833|NCT00347217|LDL-C goal|ldl-c goal
5742834|NCT00347217|observational study|observational study
5742835|NCT00347217|primary prevention|primary prevention
5742836|NCT00347217|secondary prevention|secondary prevention
5742838|NCT00347204|laser vision correction|laser vision correction
5742839|NCT00347204|surface ablation|surface ablation
5742840|NCT00347204|pain|pain
5742841|NCT00347204|wound healing|wound healing
5742842|NCT00347204|corneal haze|corneal haze
5742844|NCT00347191|Intraocular pressure|intraocular pressure
5742845|NCT00347191|Instrumentation|instrumentation
5742846|NCT00347191|Glaucoma|glaucoma
5742847|NCT00347191|Keratoconus|keratoconus
5742848|NCT00347178|Asymptomatic Narrow Angles|asymptomatic narrow angles
5741860|NCT00351650|T1DM|t1dm
5742849|NCT00347178|Primary Angle Closure Suspects|primary angle closure suspects
5742850|NCT00347178|Laser Peripheral Iridotomy|laser peripheral iridotomy
5742851|NCT00347178|Randomised Controlled Trial|randomised controlled trial
5742852|NCT00347165|macular degeneration|macular degeneration
5742853|NCT00347165|angiogenesis|angiogenesis
5742854|NCT00347165|antibodies|antibodies
5742855|NCT00347152|Intellectual disabilities|intellectual disabilities
5742856|NCT00347152|development disabilities|development disabilities
5742857|NCT00347152|behavior disorders|behavior disorders
5742858|NCT00347152|stable epilepsy|stable epilepsy
5742859|NCT00347139|Tolerability|tolerability
5742860|NCT00347139|Pharmacodynamics|pharmacodynamics
5742862|NCT00347139|Pharmacokinetics|pharmacokinetics
5742863|NCT00347139|GW642444|gw642444
5742864|NCT00347139|Asthmatic patients|asthmatic patients
5742865|NCT00347139|Efficacy|efficacy
5742866|NCT00347126|Glaucoma|glaucoma
5742867|NCT00347126|Latanoprost|latanoprost
5742868|NCT00347126|Travoprost|travoprost
5742869|NCT00347126|Intraocular pressure|intraocular pressure
5742870|NCT00347126|Hyperemia|hyperemia
5742871|NCT00347113|P. falciparum|p. falciparum
5742872|NCT00347113|malaria|malaria
5742873|NCT00347113|schistosome infections|schistosome infections
5742874|NCT00347113|soil-transmitted helminths infection|soil-transmitted helminths infection
5742875|NCT00347113|anaemia|anaemia
5742876|NCT00347113|immune response|immune response
5742877|NCT00347113|Tanzania|tanzania
5742878|NCT00347087|Insulin sensitivity|insulin sensitivity
5742879|NCT00347087|chronic heart failure|chronic heart failure
5742880|NCT00347087|metabolism|metabolism
5742881|NCT00347074|Keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life|keratoconus, corneal topography, ocular aberrometry, visual outcome, contact lens wear, quality of life
5742882|NCT00347061|Benign Prostatic Hyperplasiam|benign prostatic hyperplasiam
5742883|NCT00347061|Adrenergic alpha-antagonist|adrenergic alpha-antagonist
5742884|NCT00347048|Ulcerative colitis|ulcerative colitis
5742885|NCT00347048|tacrolimus|tacrolimus
5742886|NCT00347048|FK506|fk506
5742887|NCT00347048|treatment outcome|treatment outcome
5742888|NCT00347022|Multislice computed tomography (MSCT)indications|multislice computed tomography (msct)indications
5742889|NCT00347009|Cirrhosis|cirrhosis
5742890|NCT00347009|Advanced Fibrosis|advanced fibrosis
5742891|NCT00347009|Chronic Hepatitis B|chronic hepatitis b
5742892|NCT00347009|Adefovir Dipivoxil|adefovir dipivoxil
5742893|NCT00346996|diabetes|diabetes
5742894|NCT00346996|insulin|insulin
5742895|NCT00346996|insulin analogues|insulin analogues
5742896|NCT00346996|hypoglycaemia|hypoglycaemia
5742897|NCT00346996|severe hypoglycaemia|severe hypoglycaemia
5742898|NCT00346970|Metabolic Syndrome|metabolic syndrome
5742899|NCT00346970|High Density Lipoprotein|high density lipoprotein
5742900|NCT00346970|Extended-Release Niacin|extended-release niacin
5742901|NCT00346970|Endothelial Function|endothelial function
5742902|NCT00346970|Endothelial Progenitor Cells|endothelial progenitor cells
5742903|NCT00346931|glaucoma|glaucoma
5742904|NCT00346931|cataract|cataract
5742905|NCT00346931|surgery|surgery
5742906|NCT00346931|intraocular pressure|intraocular pressure
5742907|NCT00346931|phacoemulsification|phacoemulsification
5742908|NCT00346931|trabeculotomy|trabeculotomy
5742909|NCT00346918|ADPKD|adpkd
5742910|NCT00346918|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease
5742911|NCT00346918|Sirolimus|sirolimus
5742912|NCT00346918|volumetry|volumetry
5742913|NCT00346905|GERD|gerd
5742914|NCT00346905|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5742915|NCT00346905|Reflux|reflux
5742916|NCT00346905|Enteryx|enteryx
5742917|NCT00346892|Prophylaxis rotavirus|prophylaxis rotavirus
5742918|NCT00346879|fondaparinux for prevention of blood clots|fondaparinux for prevention of blood clots
5742919|NCT00346853|Dark adaptation inhibition|dark adaptation inhibition
5742920|NCT00346853|Stargardt macular dystrophy|stargardt macular dystrophy
5742921|NCT00346853|4-Methylpyrazole (4-MP)|4-methylpyrazole (4-mp)
5742922|NCT00346853|Antizol|antizol
5742923|NCT00346853|Fomepizole|fomepizole
5742924|NCT00346840|Labor induction|labor induction
5742925|NCT00346840|cervical ripening|cervical ripening
5742926|NCT00346840|misoprostol|misoprostol
5742927|NCT00346840|vaginal insert|vaginal insert
5742928|NCT00346814|Retinopathy of prematurity|retinopathy of prematurity
5742929|NCT00346814|antiangiogenic therapy|antiangiogenic therapy
5742930|NCT00346801|Non-Small Cell Lung Cancer|non-small cell lung cancer
5742931|NCT00346801|Lung Cancer|lung cancer
5742932|NCT00346801|Celecoxib|celecoxib
5742933|NCT00346801|Cisplatin|cisplatin
5742934|NCT00346801|Platinol|platinol
5742935|NCT00346801|CPT-11|cpt-11
5742936|NCT00346801|Irinotecan|irinotecan
5742937|NCT00346801|SC-58635|sc-58635
5742938|NCT00346801|Celebrex|celebrex
5742939|NCT00346801|Radiation Therapy|radiation therapy
5742940|NCT00346775|questionnaire|questionnaire
5742941|NCT00346775|nasal spray|nasal spray
5742942|NCT00346775|Seasonal allergic rhinitis|seasonal allergic rhinitis
5742943|NCT00346775|nasal spray questionnaire|nasal spray questionnaire
5742944|NCT00346775|allergic rhinitis|allergic rhinitis
5742945|NCT00346762|Former Plasma Donors|former plasma donors
5742946|NCT00346762|Commercial Plasma Donors|commercial plasma donors
5742947|NCT00346762|Long-Term Nonprogressors|long-term nonprogressors
5742948|NCT00346762|Host Factors|host factors
5742949|NCT00346762|Viral Factors|viral factors
5742951|NCT00346749|Inflammation|inflammation
5742954|NCT00346736|Alternative medicine|alternative medicine
5742955|NCT00346736|Traditional Chinese medicine|traditional chinese medicine
5742957|NCT00346736|Autistic Spectrum Disorder|autistic spectrum disorder
5742958|NCT00346736|Autism|autism
5742959|NCT00346736|Children|children
5742960|NCT00346723|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
5742961|NCT00346710|communication|communication
5742962|NCT00346710|patient experience|patient experience
5742963|NCT00346710|fellowship training|fellowship training
5742964|NCT00346697|AIDS|aids
5742965|NCT00346697|HIV|hiv
5742966|NCT00346697|HAART|haart
5742967|NCT00346697|Lipids|lipids
5742968|NCT00346697|Triglycerides|triglycerides
5742969|NCT00346697|Cholesterol|cholesterol
5742970|NCT00346697|omega-3 fatty acids|omega-3 fatty acids
5742971|NCT00346697|bone turnover|bone turnover
5742972|NCT00346697|inflammation|inflammation
5742973|NCT00346697|insulin resistance|insulin resistance
5742974|NCT00346684|Lymphoma|lymphoma
5742975|NCT00346684|LPHD|lphd
5742976|NCT00346684|Rituximab|rituximab
5742977|NCT00346671|Reiki|reiki
5742978|NCT00346671|Stress|stress
5742979|NCT00346671|CAM|cam
5742980|NCT00346658|Osteoporosis|osteoporosis
5742981|NCT00346658|bone density|bone density
5742982|NCT00346658|magnesium|magnesium
5742983|NCT00346658|vitamin D|vitamin d
5742984|NCT00346645|NON-SMALL CELL LUNG CANCER METASTATIC|non-small cell lung cancer metastatic
5742985|NCT00346632|AML|aml
5742986|NCT00346632|ALL|all
5742987|NCT00346632|MDS|mds
5742988|NCT00346632|CML|cml
5742989|NCT00346632|Kinase Inhibitor|kinase inhibitor
5742990|NCT00346606|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5742991|NCT00346606|Desloratadine|desloratadine
5742992|NCT00346606|Denosin|denosin
5742993|NCT00346606|Levocetirizine|levocetirizine
5742994|NCT00346567|mother-to-child-transmission|mother-to-child-transmission
5742995|NCT00346567|PMTCT|pmtct
5742996|NCT00346567|HIV|hiv
5742997|NCT00346567|resistance|resistance
5742998|NCT00346567|NNRTI|nnrti
5742999|NCT00346554|COPD|copd
5743000|NCT00346554|Sleep disorders|sleep disorders
5743001|NCT00346554|pulmonary rehabilitation|pulmonary rehabilitation
5743002|NCT00346541|glaucoma|glaucoma
5680991|NCT00575276|Pain, Cholecystectomy, Cytokines, Sex Differences|pain, cholecystectomy, cytokines, sex differences
5743003|NCT00346541|polymorphism, genetic|polymorphism, genetic
5743004|NCT00346515|carotid artery|carotid artery
5743005|NCT00346515|carotid stenosis|carotid stenosis
5743006|NCT00346515|carotid stenting|carotid stenting
5743007|NCT00346515|embolic protection|embolic protection
5743008|NCT00346489|Trabeculectomy|trabeculectomy
5743009|NCT00346489|5-fluorouracil|5-fluorouracil
5743010|NCT00346489|Mitomycin C|mitomycin c
5743011|NCT00346476|TB|tb
5743012|NCT00346476|Transmission|transmission
5743013|NCT00346476|Genetic Diversity|genetic diversity
5743014|NCT00346476|Genetic Testing|genetic testing
5743015|NCT00346476|RFLP|rflp
5743016|NCT00346463|Allopurinol|allopurinol
5743017|NCT00346463|Fetal Growth Retardation|fetal growth retardation
5743018|NCT00346463|Oxidative Stress|oxidative stress
5743019|NCT00346463|Placental Insufficiency|placental insufficiency
5743020|NCT00346450|Culture|culture
5743021|NCT00346450|Conjunctiva|conjunctiva
5743023|NCT00346450|pterygium|pterygium
5743024|NCT00346450|ocular surface|ocular surface
5743025|NCT00346437|angina|angina
5743026|NCT00346437|FGF-4|fgf-4
5743027|NCT00346437|angiogenesis|angiogenesis
5743028|NCT00346437|adenovector|adenovector
5743029|NCT00346437|growth factor|growth factor
5743030|NCT00346437|myocardial ischemia|myocardial ischemia
5743031|NCT00346437|revascularization|revascularization
5743032|NCT00346424|occluded central catheter|occluded central catheter
5743033|NCT00346424|central venous access devices dysfunction|central venous access devices dysfunction
5743034|NCT00346424|withdrawal occlusion|withdrawal occlusion
5743035|NCT00346424|Thrombosis|thrombosis
5743036|NCT00346424|Venous thrombosis|venous thrombosis
5743037|NCT00346411|rheumatoid arthritis|rheumatoid arthritis
5743038|NCT00346411|mood|mood
5743039|NCT00346411|adherence|adherence
5743040|NCT00346411|medication|medication
5743041|NCT00346398|asthma|asthma
5743042|NCT00346398|allergen|allergen
5743043|NCT00346398|allergic disease|allergic disease
5743044|NCT00346398|allergen immunotherapy|allergen immunotherapy
5743045|NCT00346398|allergic sensitization|allergic sensitization
5743046|NCT00346398|atopic dermatitis|atopic dermatitis
5743047|NCT00346398|eczema|eczema
5743049|NCT00346398|oral mucosal immunoprophylaxis (OMIP)|oral mucosal immunoprophylaxis (omip)
5743050|NCT00346385|recurrent small cell lung cancer|recurrent small cell lung cancer
5743051|NCT00346385|merkel cell carcinoma|merkel cell carcinoma
5743052|NCT00346385|ovarian cancer|ovarian cancer
5743053|NCT00346372|Ocular Melanoma|ocular melanoma
5752116|NCT00311948|Tobacco|tobacco
5743054|NCT00346372|Optical Coherence Tomography|optical coherence tomography
5743055|NCT00346372|Eye Tumor|eye tumor
5743056|NCT00346372|Choroidal Melanoma|choroidal melanoma
5743057|NCT00346372|Uveal Melanoma|uveal melanoma
5743058|NCT00346359|graft versus host disease|graft versus host disease
5743059|NCT00346359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5798845|NCT00110851|diabetes, type 2|diabetes, type 2
5743060|NCT00346359|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5743948|NCT00342953|silicone|silicone
5743061|NCT00346359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5743062|NCT00346359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5743063|NCT00346359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5743064|NCT00346359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5743065|NCT00346359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5743066|NCT00346359|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5743067|NCT00346359|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5743068|NCT00346359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5743069|NCT00346359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5743070|NCT00346359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5743071|NCT00346359|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5743072|NCT00346359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5743073|NCT00346359|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5743074|NCT00346359|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5743075|NCT00346359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5743076|NCT00346359|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5743077|NCT00346359|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5743078|NCT00346359|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5743079|NCT00346359|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5743080|NCT00346359|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5743081|NCT00346359|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5743082|NCT00346359|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5743083|NCT00346359|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5743084|NCT00346359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5743085|NCT00346346|Immunity|immunity
5743086|NCT00346346|Memory|memory
5743087|NCT00346346|ELISPOT|elispot
5743088|NCT00346346|Malaria|malaria
5743089|NCT00346346|Prospective|prospective
5743090|NCT00346333|Retinitis Pigmentosa, Inherited Retinal Degeneration|retinitis pigmentosa, inherited retinal degeneration
5743091|NCT00346320|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5743092|NCT00346320|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5743093|NCT00346320|adenocarcinoma of the lung|adenocarcinoma of the lung
5743094|NCT00346320|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5743095|NCT00346320|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5743096|NCT00346320|large cell lung cancer|large cell lung cancer
5743097|NCT00346320|squamous cell lung cancer|squamous cell lung cancer
5743098|NCT00346294|Rheumatoid Arthritis|rheumatoid arthritis
5743099|NCT00346294|Device|device
5743100|NCT00346294|Auto-injector|auto-injector
5743101|NCT00346294|SureClick|sureclick
5743102|NCT00346294|Enbrel|enbrel
5743103|NCT00346294|Etanercept|etanercept
5743104|NCT00346281|unresectable pancreatic cancer|unresectable pancreatic cancer
5743105|NCT00346281|brachytherapy|brachytherapy
5743106|NCT00346281|32P|32p
5743107|NCT00346281|BioSilicon|biosilicon
5743108|NCT00346281|locally advanced|locally advanced
5743109|NCT00346281|gemcitabine|gemcitabine
5743110|NCT00346281|intratumourally|intratumourally
5743111|NCT00346281|unresectable|unresectable
5743112|NCT00346255|stage I multiple myeloma|stage i multiple myeloma
5743113|NCT00346255|stage II multiple myeloma|stage ii multiple myeloma
5743114|NCT00346255|stage III multiple myeloma|stage iii multiple myeloma
5743115|NCT00346242|thalassemia|thalassemia
5743116|NCT00346242|zoledronic acid|zoledronic acid
5743117|NCT00346242|skeletal events|skeletal events
5743118|NCT00346229|stage III B breast cancer|stage iii b breast cancer
5743119|NCT00346229|stage III C breast cancer|stage iii c breast cancer
5743120|NCT00346229|stage IV breast cancer|stage iv breast cancer
5743121|NCT00346229|inflammatory breast cancer|inflammatory breast cancer
5743122|NCT00346229|recurrent breast cancer|recurrent breast cancer
5743123|NCT00346177|heart|heart
5743124|NCT00346177|stem Cells|stem cells
5743125|NCT00346177|low EF|low ef
5743126|NCT00346177|heart attack|heart attack
5743127|NCT00346177|cardiomyopathy|cardiomyopathy
5743128|NCT00346177|congestive heart failure|congestive heart failure
5743129|NCT00346177|cardiovascular disease|cardiovascular disease
5743130|NCT00346177|Heart Failure|heart failure
5743131|NCT00346177|Low Ejection Fraction|low ejection fraction
5686262|NCT00552747|fenofibrate|fenofibrate
5768210|NCT00251420|copd|copd
5743132|NCT00346151|renal transplantation|renal transplantation
5743133|NCT00346151|kidney transplantation|kidney transplantation
5743134|NCT00346151|renal allograft recipient|renal allograft recipient
5743135|NCT00346151|anti-rejection drugs|anti-rejection drugs
5743136|NCT00346151|immunosuppression protocol|immunosuppression protocol
5743137|NCT00346151|immunosuppression withdrawal|immunosuppression withdrawal
5743231|NCT00345839|Mimpara|mimpara
5743138|NCT00346125|soft tissue sarcoma|soft tissue sarcoma
5798846|NCT00110838|fish oil|fish oil
5760252|NCT00282295|tetanus|tetanus
5743139|NCT00346125|Malignant fibrous histiocytoma|malignant fibrous histiocytoma
5743140|NCT00346125|Liposarcoma|liposarcoma
5743141|NCT00346125|Fibrosarcoma|fibrosarcoma
5743142|NCT00346125|Leiomyosarcoma|leiomyosarcoma
5743143|NCT00346125|Synovial sarcoma|synovial sarcoma
5743144|NCT00346125|Malignant peripheral nerve sheath tumor (MPNST)|malignant peripheral nerve sheath tumor (mpnst)
5743145|NCT00346125|Epithelioid sarcoma|epithelioid sarcoma
5743146|NCT00346112|ICD|icd
5743147|NCT00346112|distress|distress
5743148|NCT00346112|anxiety|anxiety
5743149|NCT00346112|quality-of-life|quality-of-life
5743150|NCT00346099|NSABP|nsabp
5743151|NCT00346099|panitumumab|panitumumab
5743152|NCT00346099|rectal cancer|rectal cancer
5743153|NCT00346099|colorectal cancer|colorectal cancer
5743154|NCT00346099|oxaliplatin|oxaliplatin
5743155|NCT00346099|capecitabine|capecitabine
5743156|NCT00346099|combined modality therapy|combined modality therapy
5743157|NCT00346099|combined pelvic radiation therapy|combined pelvic radiation therapy
5743158|NCT00346099|Rectal cancer with or without metastasis|rectal cancer with or without metastasis
5743159|NCT00346086|CpG oligonucleotide vaccine|cpg oligonucleotide vaccine
5743160|NCT00346086|ragweed immunotherapy|ragweed immunotherapy
5743161|NCT00346073|Prophylaxis for diphtheria, tetanus, pertussis|prophylaxis for diphtheria, tetanus, pertussis
5743162|NCT00346073|Immunogenicity, booster, dTpa|immunogenicity, booster, dtpa
5743283|NCT00345683|Neisseria meningitidis|neisseria meningitidis
5743163|NCT00346060|Dry age related macular degeneration.|dry age related macular degeneration.
5743164|NCT00346060|Retinal Transplant|retinal transplant
5743165|NCT00346060|Fetal Tissue|fetal tissue
5743166|NCT00346060|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
5743167|NCT00346060|20/200 or worse.|20/200 or worse.
5743168|NCT00346021|Children's behavior towards hat use|children's behavior towards hat use
5743169|NCT00346008|melanoma|melanoma
5743170|NCT00346008|recurrent melanoma|recurrent melanoma
5743171|NCT00346008|stage I melanoma|stage i melanoma
5743172|NCT00346008|stage II melanoma|stage ii melanoma
5743173|NCT00346008|stage III melanoma|stage iii melanoma
5743174|NCT00346008|stage IV melanoma|stage iv melanoma
5743175|NCT00345982|Schizophrenia|schizophrenia
5743176|NCT00345982|Treatment-resistant|treatment-resistant
5743177|NCT00345982|sertindole|sertindole
5743178|NCT00345982|clozapine|clozapine
5743179|NCT00345969|Testosterone Replacement Therapy|testosterone replacement therapy
5743180|NCT00345969|Physical Frailty|physical frailty
5743181|NCT00345969|Hip Fracture|hip fracture
5743182|NCT00345956|Prophylaxis against gastroenteritis caused by Rotavirus|prophylaxis against gastroenteritis caused by rotavirus
5743183|NCT00345943|Eating Disorders|eating disorders
5743184|NCT00345943|Bulimia Nervosa|bulimia nervosa
5743185|NCT00345943|Bulimia|bulimia
5743186|NCT00345943|fMRI|fmri
5743187|NCT00345943|Magnetic Resonance Imaging|magnetic resonance imaging
5743188|NCT00345930|Complementary and alternative medicine|complementary and alternative medicine
5743189|NCT00345930|Complementary therapies|complementary therapies
5743190|NCT00345930|Alternative therapies|alternative therapies
5743191|NCT00345930|Prescription Drugs|prescription drugs
5743192|NCT00345930|Non prescription Drugs|non prescription drugs
5743193|NCT00345930|Liver Disease|liver disease
5743194|NCT00345930|Chemical Ind|chemical ind
5743195|NCT00345930|Phenotype|phenotype
5743196|NCT00345930|Proteomics|proteomics
5743197|NCT00345930|Metabolomics|metabolomics
5743198|NCT00345930|Cholestatic Liver Injury|cholestatic liver injury
5743199|NCT00345930|Hepatocellular Liver Injury|hepatocellular liver injury
5743200|NCT00345930|Mixed Liver Injury|mixed liver injury
5743201|NCT00345930|Matched Case Control Studies|matched case control studies
5743202|NCT00345930|Genotype|genotype
5743203|NCT00345930|Liver Dis|liver dis
5743204|NCT00345930|Chem Ind|chem ind
5743205|NCT00345917|Retinitis Pigmentosa|retinitis pigmentosa
5743206|NCT00345917|Retinal Transplant|retinal transplant
5743207|NCT00345917|Fetal Tissue|fetal tissue
5743208|NCT00345917|Early treatment diabetic retinopathy study|early treatment diabetic retinopathy study
5743209|NCT00345917|20/200 or worse.|20/200 or worse.
5743210|NCT00345904|influenza, vaccine|influenza, vaccine
5743211|NCT00345904|prophylaxis of influenza|prophylaxis of influenza
5743212|NCT00345891|Lung neoplasms|lung neoplasms
5743213|NCT00345891|Family|family
5743214|NCT00345891|Stress|stress
5743215|NCT00345878|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5743217|NCT00345878|Cervical cancer|cervical cancer
5743218|NCT00345878|Human Papillomavirus (HPV)|human papillomavirus (hpv)
5743219|NCT00345878|Double-blind|double-blind
5743220|NCT00345878|AS04|as04
5743221|NCT00345865|Hodgkin lymphoma|hodgkin lymphoma
5743222|NCT00345865|non-Hodgkin lymphoma|non-hodgkin lymphoma
5743223|NCT00345865|HIV-associated lymphoma|hiv-associated lymphoma
5743224|NCT00345852|twin to twin transfusion syndrome|twin to twin transfusion syndrome
5743225|NCT00345852|fetoscopic selective laser photocoagulation|fetoscopic selective laser photocoagulation
5743226|NCT00345852|amnioreduction|amnioreduction
5743227|NCT00345839|Cinacalcet HCl|cinacalcet hcl
5743228|NCT00345839|Cinacalcet|cinacalcet
5743229|NCT00345839|AMG 073|amg 073
5743233|NCT00345839|Hemodialysis|hemodialysis
5743235|NCT00345839|Secondary hyperparathyroidism (HPT)|secondary hyperparathyroidism (hpt)
5743236|NCT00345826|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5743237|NCT00345826|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5743238|NCT00345826|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5743239|NCT00345826|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5743240|NCT00345826|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5743241|NCT00345826|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5743242|NCT00345813|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5743243|NCT00345813|stage I prostate cancer|stage i prostate cancer
5743244|NCT00345813|stage IIB prostate cancer|stage iib prostate cancer
5743245|NCT00345813|stage IIA prostate cancer|stage iia prostate cancer
5743246|NCT00345813|stage III prostate cancer|stage iii prostate cancer
5743247|NCT00345813|stage IV prostate cancer|stage iv prostate cancer
5743248|NCT00345800|Endocrine Evaluation cataplexy|endocrine evaluation cataplexy
5743249|NCT00345800|sodium oxybate (xyrem)|sodium oxybate (xyrem)
5743250|NCT00345787|Osteoarthritic Pain|osteoarthritic pain
5743251|NCT00345774|Pulmonary Hypertension|pulmonary hypertension
5743252|NCT00345774|PH|ph
5743253|NCT00345774|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5743254|NCT00345774|PAH|pah
5743255|NCT00345774|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5743256|NCT00345774|COPD|copd
5743257|NCT00345774|PRX-08066|prx-08066
5743258|NCT00345774|Predix|predix
5743259|NCT00345761|Advanced and/or metastatic colorectal cancer|advanced and/or metastatic colorectal cancer
5743260|NCT00345735|Cancer pain with breakthrough pain episodes|cancer pain with breakthrough pain episodes
5743261|NCT00345722|Strawberry|strawberry
5743262|NCT00345722|Almond|almond
5743263|NCT00345722|Soy protein|soy protein
5743264|NCT00345722|viscous dietary fibre|viscous dietary fibre
5743265|NCT00345722|plant sterols|plant sterols
5743266|NCT00345722|portfolio diet|portfolio diet
5743267|NCT00345722|blood lipids|blood lipids
5743268|NCT00345722|compliance|compliance
5743269|NCT00345722|blood pressure|blood pressure
5743270|NCT00345709|Ovarian Cancer|ovarian cancer
5743271|NCT00345709|Peritoneal Cancer|peritoneal cancer
5743272|NCT00345709|Fallopian Tube Cancer|fallopian tube cancer
5743273|NCT00345709|Elizabeth Registry|elizabeth registry
5743274|NCT00345709|Questionnaire|questionnaire
5743275|NCT00345709|Registry|registry
5743276|NCT00345709|Survey|survey
5743277|NCT00345696|Capecitabine|capecitabine
5743278|NCT00345696|Oxaliplatin|oxaliplatin
5743279|NCT00345696|Bevacizumab|bevacizumab
5743280|NCT00345696|First line|first line
5743281|NCT00345683|H. influenzae type B vaccine|h. influenzae type b vaccine
5743282|NCT00345683|Infants|infants
5743284|NCT00345683|Vaccines, conjugate|vaccines, conjugate
5743285|NCT00345683|Meningococcal vaccines|meningococcal vaccines
5743286|NCT00345683|Prophylaxis|prophylaxis
5743287|NCT00345683|Comparative study|comparative study
5743288|NCT00345683|Safety|safety
5743290|NCT00345670|Lower respiratory tract illness|lower respiratory tract illness
5743291|NCT00345670|RSV and PIV3 infection|rsv and piv3 infection
5743292|NCT00345657|Hyperlipidemia|hyperlipidemia
5743293|NCT00345657|Dyslipidemia|dyslipidemia
5743294|NCT00345657|Niacin|niacin
5743295|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5743296|NCT00345657|Combination lipid therapy|combination lipid therapy
5743297|NCT00345657|Lovastatin|lovastatin
5743298|NCT00345644|Postmenopausal|postmenopausal
5743299|NCT00345631|Closure Device|closure device
5743300|NCT00345631|Angiography|angiography
5743301|NCT00345631|Angioplasty|angioplasty
5743302|NCT00345631|Hemostasis|hemostasis
5743303|NCT00345631|Heart Catheterization|heart catheterization
5743304|NCT00345631|Peripheral Angiography|peripheral angiography
5743305|NCT00345631|Femoral Closure|femoral closure
5743306|NCT00345631|Vascular Closure|vascular closure
5743307|NCT00345631|Coronary Angiography|coronary angiography
5743308|NCT00345618|Deep venous thrombosis|deep venous thrombosis
5743309|NCT00345618|pulmonary embolism|pulmonary embolism
5743310|NCT00345618|anticoagulant drugs|anticoagulant drugs
5743311|NCT00345605|Argininosuccinic Acid Lyase Deficiency|argininosuccinic acid lyase deficiency
5743312|NCT00345605|ASA|asa
5743313|NCT00345579|Prophylaxis|prophylaxis
5743314|NCT00345579|Neisseria meningitidis Vaccines, conjugate|neisseria meningitidis vaccines, conjugate
5743316|NCT00345579|Meningococcal vaccines|meningococcal vaccines
5743317|NCT00345579|H. influenzae type B vaccine|h. influenzae type b vaccine
5752443|NCT00310570|distal|distal
5743318|NCT00345579|Humans|humans
5743319|NCT00345579|Safety|safety
5743320|NCT00345566|cerebral palsy|cerebral palsy
5743321|NCT00345566|protein composition|protein composition
5743322|NCT00345566|gastric emptying rate|gastric emptying rate
5743323|NCT00345566|tube feeding|tube feeding
5743326|NCT00345540|Platinum Resistant Tumors of Ovarian Origin|platinum resistant tumors of ovarian origin
5743327|NCT00345527|Problem gambling|problem gambling
5743328|NCT00345527|Clinically significant anger|clinically significant anger
5743329|NCT00345514|Children|children
5743330|NCT00345514|Self-efficacy|self-efficacy
5743331|NCT00345514|Organization|organization
5743332|NCT00345514|Process of care|process of care
5743333|NCT00345501|contrast media|contrast media
5743334|NCT00345501|contrast nephropathy|contrast nephropathy
5743335|NCT00345475|Birth Defects|birth defects
5743336|NCT00345475|Epilepsy|epilepsy
5743337|NCT00345475|High Risk Pregnancy|high risk pregnancy
5743338|NCT00345462|Influenza, Vaccine, CHMP criteria|influenza, vaccine, chmp criteria
5743339|NCT00345449|cystic fibrosis,|cystic fibrosis,
5743340|NCT00345449|lung disease,|lung disease,
5743341|NCT00345449|lung transplantation,|lung transplantation,
5743342|NCT00345449|decision aid|decision aid
5743343|NCT00345436|Insulin Sensitivity|insulin sensitivity
5743344|NCT00345436|Moderate intensity|moderate intensity
5743345|NCT00345436|Insulin Resistance|insulin resistance
5743346|NCT00345436|Exercise Intervention|exercise intervention
5743347|NCT00345410|obesity and dyslipidemia|obesity and dyslipidemia
5743348|NCT00345397|cecostomy|cecostomy
5743349|NCT00345397|colonoscopy|colonoscopy
5743350|NCT00345397|colostomy|colostomy
5743351|NCT00345397|constipation|constipation
5743352|NCT00345397|endoscopy, gastrointestinal|endoscopy, gastrointestinal
5743353|NCT00345397|fecal incontinence|fecal incontinence
5743354|NCT00345397|percutaneous|percutaneous
5743355|NCT00345397|quality of life|quality of life
5743356|NCT00345397|spinal cord injury|spinal cord injury
5743357|NCT00345384|Dexmedetomidine|dexmedetomidine
5743358|NCT00345384|Sedation|sedation
5743359|NCT00345384|Opioid|opioid
5743360|NCT00345384|Respiratory depression|respiratory depression
5743361|NCT00345371|methamphetamine addiction|methamphetamine addiction
5743362|NCT00345358|Booster vaccination|booster vaccination
5743363|NCT00345358|Catch-up vaccination|catch-up vaccination
5743364|NCT00345358|Pneumococcal vaccine|pneumococcal vaccine
5743365|NCT00345358|Immunogenicity|immunogenicity
5743366|NCT00345358|Safety|safety
5743367|NCT00345358|Pneumococcal disease|pneumococcal disease
5743368|NCT00345345|Neutropenia|neutropenia
5743369|NCT00345345|Monoclonal Antibody Therapy|monoclonal antibody therapy
5743370|NCT00345345|Anti-CD52|anti-cd52
5743371|NCT00345345|T-LGL Leukemia|t-lgl leukemia
5743372|NCT00345345|LGL Leukemia|lgl leukemia
5743373|NCT00345345|Leukemia|leukemia
5743374|NCT00345319|rabies|rabies
5743375|NCT00345319|vaccine|vaccine
5743376|NCT00345319|post-exposure prophylaxis|post-exposure prophylaxis
5743377|NCT00345306|endometrial preparation|endometrial preparation
5743378|NCT00345306|Utrogestan|utrogestan
5743379|NCT00345306|Endometrin|endometrin
5743380|NCT00345293|Prostate Cancer|prostate cancer
5743381|NCT00345280|Cystic fibrosis|cystic fibrosis
5743382|NCT00345280|eye|eye
5743383|NCT00345280|inflammation|inflammation
5743384|NCT00345280|apoptosis|apoptosis
5743385|NCT00345280|C11+|c11+
5743386|NCT00345267|Asthma|asthma
5743387|NCT00345267|Children|children
5743388|NCT00345267|Integrated Care Pathway|integrated care pathway
5743389|NCT00345267|Evidence based medicine|evidence based medicine
5733687|NCT00380172|AMD|amd
5743390|NCT00345267|Prescribing errors|prescribing errors
5743391|NCT00345241|Blepharitis|blepharitis
5743392|NCT00345228|High myopia|high myopia
5743393|NCT00345228|Choroidal neovascularisation|choroidal neovascularisation
5743394|NCT00345228|Lacquer crack|lacquer crack
5743395|NCT00345228|Fundus fluorescein angiography|fundus fluorescein angiography
5743396|NCT00345228|Indocyanine green angiography|indocyanine green angiography
5743397|NCT00345228|Axial length|axial length
5743398|NCT00345215|Urinary Aquaporin 2|urinary aquaporin 2
5743399|NCT00345215|High/low Sodium Diet|high/low sodium diet
5743400|NCT00345215|Fractional Sodium Excretion|fractional sodium excretion
5743401|NCT00345202|HMG-COA reductase inhibition|hmg-coa reductase inhibition
5743402|NCT00345202|GFR|gfr
5743403|NCT00345202|RPF|rpf
5743404|NCT00345202|FE|fe
5743405|NCT00345202|CL|cl
5743406|NCT00345189|Hsp90 inhibitor|hsp90 inhibitor
5743407|NCT00345189|CNF2024|cnf2024
5743408|NCT00345189|Advanced Solid Tumors|advanced solid tumors
5743409|NCT00345176|age-related macular degeneration|age-related macular degeneration
5743410|NCT00345176|AMD|amd
5743412|NCT00345176|zeaxanthin|zeaxanthin
5743413|NCT00345176|docosahexaenoic acid|docosahexaenoic acid
5743414|NCT00345176|eicosapentaenoic acid|eicosapentaenoic acid
5743415|NCT00345163|Glioblastoma Multiforme|glioblastoma multiforme
5743416|NCT00345163|Avastin|avastin
5743418|NCT00345163|GBM|gbm
5743419|NCT00345150|hypertension|hypertension
5743420|NCT00345150|nitric oxide|nitric oxide
5743421|NCT00345150|renal hemodynamics|renal hemodynamics
5686263|NCT00552747|coronary heart disease|coronary heart disease
5686264|NCT00552747|mixed hyperlipidemia|mixed hyperlipidemia
5686265|NCT00552734|Type 1 diabetes|type 1 diabetes
5686266|NCT00552734|Improved glycemic control|improved glycemic control
5686267|NCT00552734|Glucose excursions|glucose excursions
5686268|NCT00552734|Target range glucose levels|target range glucose levels
5686269|NCT00552734|Insulin guidance software|insulin guidance software
5686270|NCT00552734|Advisor|advisor
5686271|NCT00552721|Motor control|motor control
5743422|NCT00345137|Renal hemodynamics|renal hemodynamics
5743423|NCT00345137|Nitric oxide|nitric oxide
5743424|NCT00345124|urinary aquaporin-2|urinary aquaporin-2
5743425|NCT00345124|ENaC|enac
5743426|NCT00345124|fractional sodium excretion|fractional sodium excretion
5743427|NCT00345124|High/low sodium diet|high/low sodium diet
5743428|NCT00345111|Restor IOL versus Conventional IOL|restor iol versus conventional iol
5743429|NCT00345098|Depression, Antidepressive agents|depression, antidepressive agents
5743430|NCT00345098|Clinical Trial|clinical trial
5743431|NCT00345098|Phase III|phase iii
5743432|NCT00345098|Multicenter study|multicenter study
5743433|NCT00345072|Menopause|menopause
5743434|NCT00345072|Decision aids|decision aids
5743435|NCT00345072|Internet|internet
5743436|NCT00345072|Hormone Replacement Therapy|hormone replacement therapy
5743437|NCT00345072|Breast Cancer|breast cancer
5743438|NCT00345072|Cardiovascular Disease|cardiovascular disease
5743439|NCT00345072|Osteoporosis|osteoporosis
5743440|NCT00345059|second line|second line
5743441|NCT00345059|monochemotherapy|monochemotherapy
5743442|NCT00345059|combination chemotherapy|combination chemotherapy
5743443|NCT00345059|platinum refractory|platinum refractory
5743444|NCT00345059|previously treated|previously treated
5743445|NCT00345046|Glaucoma|glaucoma
5743446|NCT00345046|Cataract|cataract
5743447|NCT00345033|Glucose Metabolism|glucose metabolism
5743448|NCT00345020|Deep Lamellar Endotheliam Keratoplasty|deep lamellar endotheliam keratoplasty
5743449|NCT00345007|Retinal detachment|retinal detachment
5743450|NCT00345007|Macular function|macular function
5743451|NCT00345007|Multifocal electrophysiology|multifocal electrophysiology
5743452|NCT00344994|Restless Legs Syndrome|restless legs syndrome
5743453|NCT00344994|Mirapex (pramipexole)|mirapex (pramipexole)
5743454|NCT00344994|Requip(Ropinirole)|requip(ropinirole)
5743455|NCT00344994|Dopamine Agonist|dopamine agonist
5743456|NCT00344981|Cell Cycle Agents|cell cycle agents
5743457|NCT00344955|HMG-COA reductase inhibition|hmg-coa reductase inhibition
5743458|NCT00344955|GFR|gfr
5743459|NCT00344955|RPF|rpf
5743460|NCT00344955|FE|fe
5743461|NCT00344955|CL|cl
5743462|NCT00344916|Renal hemodynamics|renal hemodynamics
5743463|NCT00344916|Nitric oxide|nitric oxide
5743464|NCT00344903|Atherosclerosis|atherosclerosis
5743465|NCT00344903|Heart Failure|heart failure
5743466|NCT00344903|Ventricular Hypertrophy|ventricular hypertrophy
5743467|NCT00344903|Myocardial Infarction|myocardial infarction
5743468|NCT00344903|Screening|screening
5743469|NCT00344903|Hypertension|hypertension
5743470|NCT00344903|Diabetes|diabetes
5743471|NCT00344903|Obesity|obesity
5743472|NCT00344903|Metabolic Syndrome|metabolic syndrome
5743473|NCT00344890|Cervical fusion|cervical fusion
5863974|NCT00001148|p53 Mutation|p53 mutation
5743474|NCT00344890|Anterior Cervical Discectomy and Fusion|anterior cervical discectomy and fusion
5743475|NCT00344890|ACDF|acdf
5743476|NCT00344877|Epilepsy|epilepsy
5743477|NCT00344877|Temporal Lobe Epilepsy|temporal lobe epilepsy
5743478|NCT00344877|Cortical Excitability|cortical excitability
5743479|NCT00344877|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5743480|NCT00344877|Memory Testing|memory testing
5743481|NCT00344877|Seizures|seizures
5743482|NCT00344877|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5743483|NCT00344877|Memory|memory
5743484|NCT00344877|Plasticity|plasticity
5743485|NCT00344864|Contact Lenses Higher Order Aberrations|contact lenses higher order aberrations
5743486|NCT00344851|menstrual cyclicity|menstrual cyclicity
5743487|NCT00344851|insulin resistance|insulin resistance
5743488|NCT00344851|body fat distribution|body fat distribution
5743489|NCT00344851|pancreatic ß-cell function|pancreatic ß-cell function
5743490|NCT00344851|inflammatory markers|inflammatory markers
5743491|NCT00344851|liver function tests|liver function tests
5743492|NCT00344838|LADARWave™|ladarwave™
5743493|NCT00344838|WaveScan Wavefront™ Systems|wavescan wavefront™ systems
5743494|NCT00344825|B- Chronic Lymphocytic Leukemia|b- chronic lymphocytic leukemia
5743495|NCT00344799|Choroidal Melanoma|choroidal melanoma
5743496|NCT00344799|Choroidal Malignant Melanoma|choroidal malignant melanoma
5743497|NCT00344799|Ocular Melanoma|ocular melanoma
5686272|NCT00552721|Spasticity|spasticity
5686273|NCT00552708|COREG CR|coreg cr
5686274|NCT00552695|intravenous catheter|intravenous catheter
5743498|NCT00344799|Uveal Melanoma|uveal melanoma
5743500|NCT00344786|CNF2024|cnf2024
5743501|NCT00344786|Hsp90 inhibitor|hsp90 inhibitor
5743502|NCT00344773|Locally advanced (IIIB) pulmonary adenocarcinoma with EGFR mutation|locally advanced (iiib) pulmonary adenocarcinoma with egfr mutation
5743503|NCT00344773|Metastatic (IV) pulmonary adenocarcinoma with EGFR mutation|metastatic (iv) pulmonary adenocarcinoma with egfr mutation
5743504|NCT00344773|Recurrent pulmonary adenocarcinoma with EGFR mutation|recurrent pulmonary adenocarcinoma with egfr mutation
5743505|NCT00344747|intervention program|intervention program
5743506|NCT00344747|diet|diet
5743507|NCT00344747|physical activity|physical activity
5743508|NCT00344747|adolescents|adolescents
5743509|NCT00344747|obesity|obesity
5743510|NCT00344734|Nitric oxide|nitric oxide
5743511|NCT00344734|Renal hemodynamics|renal hemodynamics
5743512|NCT00344721|Meibomian Gland Syndrome|meibomian gland syndrome
5743514|NCT00344708|Tissue-Cultured Human Amniotic Epithelial Cells onto damaged corneal surface|tissue-cultured human amniotic epithelial cells onto damaged corneal surface
5743515|NCT00344682|memantine|memantine
5743516|NCT00344682|Namenda|namenda
5743517|NCT00344682|augmentation|augmentation
5743518|NCT00344682|add-on|add-on
5743519|NCT00344682|depression|depression
5743520|NCT00344682|MDD (major depressive disorder)|mdd (major depressive disorder)
5743521|NCT00344682|unipolar depression|unipolar depression
5743522|NCT00344682|NMDA|nmda
5743523|NCT00344682|ketamine|ketamine
5743524|NCT00344682|uncompetitive NMDA receptor antagonist|uncompetitive nmda receptor antagonist
5743525|NCT00344669|underweight|underweight
5743526|NCT00344669|preschool|preschool
5743527|NCT00344669|mass deworming|mass deworming
5743528|NCT00344656|Eating Disorders|eating disorders
5743529|NCT00344656|Anorexia Nervosa|anorexia nervosa
5744434|NCT00341471|Sixth Grade|sixth grade
5743530|NCT00344643|Comparison of Daily wear versus Extended wear in bacterial binding and corneal epithelial thickness|comparison of daily wear versus extended wear in bacterial binding and corneal epithelial thickness
5743531|NCT00344617|Choroidal neovascularisation|choroidal neovascularisation
5743532|NCT00344617|Polypoidal choroidal vasculopathy|polypoidal choroidal vasculopathy
5743533|NCT00344617|Intravitreal injection|intravitreal injection
5743534|NCT00344617|Avastin|avastin
5743535|NCT00344604|Patients who have undergone routine LASIK as a primary refractive procedure for myopia, hyperopia, or astigmatism.|patients who have undergone routine lasik as a primary refractive procedure for myopia, hyperopia, or astigmatism.
5743536|NCT00344591|HIV|hiv
5743537|NCT00344591|AIDS|aids
5743538|NCT00344578|Higher Order Abberations|higher order abberations
5743539|NCT00344539|asexual blood stage vaccine, Plasmodium falciparum malaria|asexual blood stage vaccine, plasmodium falciparum malaria
5743540|NCT00344526|AL amyloidosis|al amyloidosis
5743541|NCT00344526|Autologous stem cell transplantation|autologous stem cell transplantation
5743542|NCT00344526|Melphalan|melphalan
5743543|NCT00344526|Dexamethasone|dexamethasone
5743544|NCT00344513|registry|registry
5743545|NCT00344513|OPTIMIZE|optimize
5743546|NCT00344513|Heart failure|heart failure
5743547|NCT00344513|OPTIMIZE-HF|optimize-hf
5743548|NCT00344500|Antipsychotic|antipsychotic
5743549|NCT00344500|Bipolar|bipolar
5743550|NCT00344500|Diabetes|diabetes
5743551|NCT00344500|Mental Illness|mental illness
5743552|NCT00344500|Nutrition|nutrition
5743553|NCT00344500|Obesity|obesity
5743554|NCT00344500|Schizoaffective|schizoaffective
5743555|NCT00344500|Schizophrenia|schizophrenia
5743556|NCT00344500|Weight Gain|weight gain
5743557|NCT00344500|Weight Loss|weight loss
5743558|NCT00344474|Prevention|prevention
5743559|NCT00344474|Addiction|addiction
5743560|NCT00344474|Personality|personality
5743561|NCT00344474|Adolescents|adolescents
5743562|NCT00344474|Binge Drinking|binge drinking
5743563|NCT00344474|Alcohol Abuse|alcohol abuse
5743564|NCT00344474|Comorbidity|comorbidity
5743565|NCT00344474|Depression|depression
5743566|NCT00344474|Anxiety|anxiety
5743567|NCT00344474|Antisocial Behaviour|antisocial behaviour
5743568|NCT00344448|Adhesion Molecule|adhesion molecule
5743569|NCT00344448|Interventional Study|interventional study
5743570|NCT00344448|Immunomodulation|immunomodulation
5743571|NCT00344448|Autoimmunity|autoimmunity
5743572|NCT00344448|Sjogren Syndrome|sjogren syndrome
5743573|NCT00344448|SS|ss
5743574|NCT00344435|Hemophilia|hemophilia
5743575|NCT00344435|Antibody|antibody
5743576|NCT00344435|Mutations|mutations
5743577|NCT00344435|SNP|snp
5743578|NCT00344435|clotting|clotting
5743579|NCT00344422|Anthracyclines|anthracyclines
5743580|NCT00344422|Liposomes|liposomes
5743581|NCT00344422|Liposomal|liposomal
5743582|NCT00344422|Vincristine|vincristine
5743583|NCT00344422|Doxorubicin|doxorubicin
5743585|NCT00344422|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5743586|NCT00344422|DOXIL|doxil
5743587|NCT00344422|drug resistant myeloma|drug resistant myeloma
5743588|NCT00344409|darbepoetin alfa|darbepoetin alfa
5743589|NCT00344409|anemia|anemia
5743590|NCT00344409|cancer patients|cancer patients
5743591|NCT00344409|platinum containing chemotherapy|platinum containing chemotherapy
5743592|NCT00344383|oral contraceptive|oral contraceptive
5743593|NCT00344383|breakthrough bleeding|breakthrough bleeding
5743594|NCT00344383|spotting|spotting
5743595|NCT00344370|Pitavastatin|pitavastatin
5743596|NCT00344370|Type II Diabetes Mellitus|type ii diabetes mellitus
5743597|NCT00344370|Combined Dyslipidemia|combined dyslipidemia
5743598|NCT00344344|Asthma|asthma
5743599|NCT00344344|Cockroach|cockroach
5743600|NCT00344344|Dust Mite|dust mite
5743601|NCT00344344|Extermination|extermination
5743602|NCT00344344|Targeted Cleaning|targeted cleaning
5743603|NCT00344344|Allergy|allergy
5743604|NCT00344344|Prevention|prevention
5743605|NCT00344331|Lysosomal Storage|lysosomal storage
5743606|NCT00344331|Biomarkers|biomarkers
5743607|NCT00344331|Longitudinal|longitudinal
5743608|NCT00344331|Niemann Pick Type C|niemann pick type c
5743609|NCT00344331|NPC|npc
5743610|NCT00344331|Lysosomal Storage Disorder|lysosomal storage disorder
5743612|NCT00344318|Safety|safety
5743613|NCT00344318|Pneumococcal vaccine|pneumococcal vaccine
5743614|NCT00344318|Pneumococcal disease|pneumococcal disease
5743615|NCT00344305|children, FluMist, shedding,|children, flumist, shedding,
5743616|NCT00344292|Polymorphism, Genetic|polymorphism, genetic
5743617|NCT00344292|Coronary Artery Disease|coronary artery disease
5743618|NCT00344292|Coronary Arteriosclerosis|coronary arteriosclerosis
5743619|NCT00344292|Polymorphism, Single Nucleotide|polymorphism, single nucleotide
5743620|NCT00344292|SNPs|snps
5743621|NCT00344279|Coinfection|coinfection
5743622|NCT00344279|AIDS|aids
5743623|NCT00344279|Lymphatic Filariasis|lymphatic filariasis
5743624|NCT00344279|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
5743625|NCT00344279|Albendazole|albendazole
5743631|NCT00344266|Gene Expression|gene expression
5743632|NCT00344266|Adipokines|adipokines
5743633|NCT00344266|Inflammation|inflammation
5743634|NCT00344266|Weight Loss|weight loss
5743635|NCT00344266|Lipid Products|lipid products
5743636|NCT00344253|Uveitis|uveitis
5743637|NCT00344253|Macular Edema|macular edema
5743638|NCT00344253|Interferon|interferon
5743639|NCT00344253|Multiple Sclerosis|multiple sclerosis
5743640|NCT00344253|Encephalomyelitis disseminata (ED)|encephalomyelitis disseminata (ed)
5743641|NCT00344240|type 2 diabetes|type 2 diabetes
5743642|NCT00344240|exercise|exercise
5743643|NCT00344240|activity guidance|activity guidance
5743644|NCT00344240|health education|health education
5743645|NCT00344227|neovascularization|neovascularization
5743646|NCT00344227|age-related macular degeneration|age-related macular degeneration
5743647|NCT00344227|vascular endothelial growth factor (VEGF)|vascular endothelial growth factor (vegf)
5743648|NCT00344227|antigen-binding fragment (Fab)|antigen-binding fragment (fab)
5743649|NCT00344227|antiangiogenesis|antiangiogenesis
5743650|NCT00344227|optical coherence tomography (OCT)|optical coherence tomography (oct)
5743651|NCT00344214|HIV|hiv
5743652|NCT00344214|STDs|stds
5743653|NCT00344214|Methamphetamine|methamphetamine
5743654|NCT00344201|Pterygium|pterygium
5743655|NCT00344201|Fibrin adhesive|fibrin adhesive
5743656|NCT00344201|Conjunctival graft|conjunctival graft
5743657|NCT00344201|Ocular surface reconstruction|ocular surface reconstruction
5743663|NCT00344175|hypercholesterolemia|hypercholesterolemia
5743664|NCT00344175|dyslipidemia|dyslipidemia
5743665|NCT00344175|CHD|chd
5743666|NCT00344175|pitavastatin|pitavastatin
5743667|NCT00344175|simvastatin|simvastatin
5743668|NCT00344175|2 or more risk factors for coronary heart disease|2 or more risk factors for coronary heart disease
5743669|NCT00344175|combined dyslipidemia|combined dyslipidemia
5743670|NCT00344162|Epidemiology|epidemiology
5743671|NCT00344162|Population|population
5743672|NCT00344162|Pregnancy|pregnancy
5743673|NCT00344162|Preeclampsia|preeclampsia
5743674|NCT00344149|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5743675|NCT00344149|Rituximab|rituximab
5743676|NCT00344149|Splenectomy|splenectomy
5743677|NCT00344149|Response|response
5743678|NCT00344149|Treatment|treatment
5743679|NCT00344149|treatment of Idiopathic Thrombocytopenic Purpura|treatment of idiopathic thrombocytopenic purpura
5743680|NCT00344136|Blood Pressure, High|blood pressure, high
5743681|NCT00344136|Stroke|stroke
5743682|NCT00344136|Hypertension|hypertension
5743683|NCT00344136|Diabetes Mellitus|diabetes mellitus
5743684|NCT00344136|Obesity|obesity
5743685|NCT00344136|Cerebrovascular Accident|cerebrovascular accident
5743686|NCT00344136|Atherosclerosis|atherosclerosis
5743687|NCT00344123|HIV|hiv
5743688|NCT00344110|Hypertension, aliskiren, blood pressure, renin|hypertension, aliskiren, blood pressure, renin
5743689|NCT00344097|soy protein|soy protein
5743690|NCT00344097|pain|pain
5743691|NCT00344097|thoracotomy|thoracotomy
5743692|NCT00344084|Leishmania Major|leishmania major
5743693|NCT00344084|Phlebotomus Duboscqi|phlebotomus duboscqi
5743694|NCT00344084|Dermatology|dermatology
5743695|NCT00344084|Vector-Transmitted Disease|vector-transmitted disease
5743696|NCT00344084|Africa|africa
5743697|NCT00344084|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5743698|NCT00344084|CL|cl
5743699|NCT00344071|Clinical|clinical
5743700|NCT00344071|Tissue|tissue
5686275|NCT00552695|emergency department|emergency department
5743701|NCT00344071|Photographs|photographs
5743702|NCT00344071|Women|women
5743703|NCT00344071|Case-Control|case-control
5743704|NCT00344058|pregnancy|pregnancy
5743705|NCT00344058|preeclampsia|preeclampsia
5743706|NCT00344058|treatment|treatment
5743707|NCT00344045|Subjects with postoperative pain after Total Hip Arthroplasty|subjects with postoperative pain after total hip arthroplasty
5743708|NCT00344032|Double-blind|double-blind
5743709|NCT00344032|Human Papillomavirus|human papillomavirus
5743710|NCT00344032|Phase IIIb|phase iiib
5743711|NCT00344032|Controlled|controlled
5743712|NCT00344032|Randomized|randomized
5743713|NCT00344032|India|india
5743714|NCT00344019|Acute coronary syndrome|acute coronary syndrome
5743715|NCT00344019|Percutaneous coronary intervention|percutaneous coronary intervention
5743716|NCT00344019|Peri-procedure myocardial infarction|peri-procedure myocardial infarction
5738641|NCT00362947|LMWH|lmwh
5743717|NCT00344006|Malaria CDA COARTEM Africa pediatrics children|malaria cda coartem africa pediatrics children
5743718|NCT00343993|noninvasive positive pressure ventilation|noninvasive positive pressure ventilation
5743719|NCT00343993|acute lung injury|acute lung injury
5743720|NCT00343993|acute respiratory distress syndrome|acute respiratory distress syndrome
5743721|NCT00343954|sickle cell disease|sickle cell disease
5743722|NCT00343941|HIV-1 infection|hiv-1 infection
5743723|NCT00343941|Tucaresol|tucaresol
5743724|NCT00343941|Viral suppression|viral suppression
5743725|NCT00343915|Persistence|persistence
5743726|NCT00343915|Hepatitis B vaccine|hepatitis b vaccine
5743727|NCT00343902|Hawthorn|hawthorn
5743728|NCT00343902|Crataegus|crataegus
5743729|NCT00343902|Herbs|herbs
5743730|NCT00343889|Diphtheria|diphtheria
5743731|NCT00343889|Tetanus|tetanus
5743732|NCT00343889|Pertussis|pertussis
5743733|NCT00343889|Hepatitis B Hansenula (HB)|hepatitis b hansenula (hb)
5743734|NCT00343889|Haemophilus influenzae type b|haemophilus influenzae type b
5743735|NCT00343889|Haemophilus Influenzae|haemophilus influenzae
5743736|NCT00343876|hs-CRP|hs-crp
5743737|NCT00343876|aspirin|aspirin
5743738|NCT00343876|clopidogrel|clopidogrel
5743739|NCT00343850|idiopathic chronic inflammatory disease of large intestine|idiopathic chronic inflammatory disease of large intestine
5743740|NCT00343850|ulcerative colitis|ulcerative colitis
5743741|NCT00343850|inactive ulcerative colitis|inactive ulcerative colitis
5743742|NCT00343850|chronic disease of large intestine|chronic disease of large intestine
5743743|NCT00343850|medication adherence|medication adherence
5743744|NCT00343850|Asacol|asacol
5743745|NCT00343850|mesalamine|mesalamine
5743746|NCT00343824|Burn wounds - Silver Dressings - Bacterial Control|burn wounds - silver dressings - bacterial control
5743747|NCT00343811|Attention-Deficit/Hyper Activity Disorder|attention-deficit/hyper activity disorder
5743748|NCT00343811|ADHD|adhd
5743749|NCT00343759|Breast cancer|breast cancer
5743750|NCT00343759|Tyrosine kinase inhibitors|tyrosine kinase inhibitors
5743751|NCT00343759|Lapatinib|lapatinib
5743752|NCT00343759|Biologic response modifiers|biologic response modifiers
5743753|NCT00343759|Magnetic resonance imaging|magnetic resonance imaging
5743754|NCT00343759|Treatment-naive, operable|treatment-naive, operable
5743755|NCT00343733|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5743756|NCT00343733|postherpetic neuralgia|postherpetic neuralgia
5743757|NCT00343733|traumatic injury|traumatic injury
5743758|NCT00343733|complex regional pain syndrome|complex regional pain syndrome
5743759|NCT00343733|back pain|back pain
5743760|NCT00343733|neck pain|neck pain
5743761|NCT00343733|fibromyalgia|fibromyalgia
5743762|NCT00343733|chronic pancreatitis|chronic pancreatitis
5743763|NCT00343733|osteoarthritis|osteoarthritis
5743764|NCT00343720|VELCADE|velcade
5743765|NCT00343720|Alimta|alimta
5743766|NCT00343720|locally advanced|locally advanced
5743767|NCT00343720|metastatic|metastatic
5743768|NCT00343720|non-small cell lung cancer|non-small cell lung cancer
5743769|NCT00343720|complete response|complete response
5743770|NCT00343720|partial response|partial response
5743771|NCT00343720|Locally Advanced or Metastatic Non-Small Cell Lung Cancer|locally advanced or metastatic non-small cell lung cancer
5743772|NCT00343707|Social Anxiety Disorder|social anxiety disorder
5743773|NCT00343707|brain imaging|brain imaging
5743774|NCT00343707|Positron Emission Tomography|positron emission tomography
5743775|NCT00343707|antidepressant|antidepressant
5743776|NCT00343681|Influenza|influenza
5743777|NCT00343681|Orthomyxoviridae Infections|orthomyxoviridae infections
5743778|NCT00343681|Orthomyxoviruses|orthomyxoviruses
5743779|NCT00343681|Split-virion influenza vaccine|split-virion influenza vaccine
5743780|NCT00343668|advanced gastric cancer|advanced gastric cancer
5743781|NCT00343668|First-line therapy|first-line therapy
5743783|NCT00343668|irinotecan|irinotecan
5743784|NCT00343655|Hypercholesterolemia|hypercholesterolemia
5743785|NCT00343642|Crohn's disease|crohn's disease
5743786|NCT00343642|Fructooligosaccharide|fructooligosaccharide
5743787|NCT00343642|Inulin|inulin
5743788|NCT00343642|Diet|diet
5743789|NCT00343642|Treatment|treatment
5743790|NCT00343642|Bacterial flora|bacterial flora
5743791|NCT00343642|Oxidative stress|oxidative stress
5743792|NCT00343629|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5743793|NCT00343616|cognitive/functional effects|cognitive/functional effects
5743794|NCT00343616|fatigue|fatigue
5743795|NCT00343616|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5743796|NCT00343616|stage I breast cancer|stage i breast cancer
5743797|NCT00343616|stage II breast cancer|stage ii breast cancer
5743798|NCT00343616|stage IIIA breast cancer|stage iiia breast cancer
5743799|NCT00343603|maculopathy|maculopathy
5743800|NCT00343577|proteinuria|proteinuria
5743801|NCT00343577|ARBs|arbs
5743802|NCT00343577|agalsidase-beta|agalsidase-beta
5743803|NCT00343577|MDRD estimated GFR|mdrd estimated gfr
5743804|NCT00343577|Chronic kidney disease|chronic kidney disease
5743805|NCT00343551|Hypertension, ambulatory blood pressure, missed dose, aliskiren|hypertension, ambulatory blood pressure, missed dose, aliskiren
5743806|NCT00343525|HCV|hcv
5743807|NCT00343525|monoclonal antibody|monoclonal antibody
5743808|NCT00343525|phase 1|phase 1
5743809|NCT00343512|inflammatory breast cancer|inflammatory breast cancer
5743810|NCT00343512|stage II breast cancer|stage ii breast cancer
5743811|NCT00343512|stage IIIA breast cancer|stage iiia breast cancer
5743812|NCT00343512|stage IIIB breast cancer|stage iiib breast cancer
5743813|NCT00343512|stage IIIC breast cancer|stage iiic breast cancer
5743814|NCT00343499|atrial fibrillation|atrial fibrillation
5743815|NCT00343499|valsartan|valsartan
5743816|NCT00343499|sinus rhythm|sinus rhythm
5743903|NCT00343161|Nexium|nexium
5743904|NCT00343135|Skin|skin
5743905|NCT00343135|AUGMENTIN|augmentin
5743817|NCT00343499|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm|persistent atrial fibrillation undergoing electrical cardioversion to restore normal sinus rhythm
5743818|NCT00343486|Overactive Bladder|overactive bladder
5743819|NCT00343473|Fuch's dystrophy|fuch's dystrophy
5743820|NCT00343473|corneal disorders|corneal disorders
5743821|NCT00343473|cornea|cornea
5743822|NCT00343473|lasik|lasik
5743823|NCT00343473|refractive surgery|refractive surgery
5743824|NCT00343460|nausea and vomiting|nausea and vomiting
5743825|NCT00343460|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5743949|NCT00342953|Breast Implants|breast implants
5743826|NCT00343447|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5743827|NCT00343447|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5743828|NCT00343447|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5743829|NCT00343447|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5743830|NCT00343434|stage I breast cancer|stage i breast cancer
5743831|NCT00343434|stage II breast cancer|stage ii breast cancer
5743832|NCT00343434|stage IIIA breast cancer|stage iiia breast cancer
5743833|NCT00343434|stage IIIB breast cancer|stage iiib breast cancer
5743834|NCT00343434|stage IIIC breast cancer|stage iiic breast cancer
5743835|NCT00343434|obesity|obesity
5743836|NCT00343421|Diphtheria|diphtheria
5743837|NCT00343421|Tetanus|tetanus
5743838|NCT00343421|Pertussis|pertussis
5743839|NCT00343421|Poliomyelitis|poliomyelitis
5743840|NCT00343421|Haemophilus influenzae type b|haemophilus influenzae type b
5743841|NCT00343421|Pneumococcal infections|pneumococcal infections
5743842|NCT00343408|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5743843|NCT00343408|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5743844|NCT00343408|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5743845|NCT00343408|recurrent colon cancer|recurrent colon cancer
5743846|NCT00343408|stage III colon cancer|stage iii colon cancer
5743847|NCT00343408|stage IV colon cancer|stage iv colon cancer
5743848|NCT00343408|recurrent rectal cancer|recurrent rectal cancer
5743849|NCT00343408|stage III rectal cancer|stage iii rectal cancer
5743850|NCT00343408|stage IV rectal cancer|stage iv rectal cancer
5743851|NCT00343395|rosiglitazone|rosiglitazone
5743852|NCT00343395|metformin|metformin
5743853|NCT00343395|hs-CRP|hs-crp
5743854|NCT00343395|inflammation|inflammation
5743855|NCT00343382|sexuality and reproductive issues|sexuality and reproductive issues
5743856|NCT00343382|sexual dysfunction|sexual dysfunction
5743857|NCT00343382|recurrent breast cancer|recurrent breast cancer
5743858|NCT00343382|stage I breast cancer|stage i breast cancer
5743859|NCT00343382|stage II breast cancer|stage ii breast cancer
5743860|NCT00343382|stage IIIA breast cancer|stage iiia breast cancer
5743861|NCT00343382|stage IIIB breast cancer|stage iiib breast cancer
5743862|NCT00343382|stage IIIC breast cancer|stage iiic breast cancer
5743863|NCT00343382|stage IV breast cancer|stage iv breast cancer
5743864|NCT00343369|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5743865|NCT00343369|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5743866|NCT00343369|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5743867|NCT00343369|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5743868|NCT00343356|Bladder neoplasm;|bladder neoplasm;
5743869|NCT00343356|Carcinoma;|carcinoma;
5743870|NCT00343356|Epirubicin;|epirubicin;
5743871|NCT00343356|BCG;|bcg;
5743873|NCT00343317|puerperal sepsis|puerperal sepsis
5743874|NCT00343317|HIV infection|hiv infection
5743875|NCT00343317|prophylactic antibiotics|prophylactic antibiotics
5743876|NCT00343304|Stroke.Robot.Ergometer.Group OT|stroke.robot.ergometer.group ot
5743877|NCT00343291|Non-Small Cell Lung Cancer|non-small cell lung cancer
5743878|NCT00343291|Malignant pleural effusions|malignant pleural effusions
5743879|NCT00343278|Valaciclovir Hydrochloride|valaciclovir hydrochloride
5743880|NCT00343278|hemodialysis patient|hemodialysis patient
5743881|NCT00343278|ALDH|aldh
5743882|NCT00343278|pharmacokinetics|pharmacokinetics
5743883|NCT00343278|Japanese|japanese
5743884|NCT00343265|Preterm birth|preterm birth
5743885|NCT00343265|Multiple pregnancy|multiple pregnancy
5743886|NCT00343265|Vaginal progesterone|vaginal progesterone
5743887|NCT00343265|Preterm birth in multiple pregnancy|preterm birth in multiple pregnancy
5743888|NCT00343226|Basiliximab, transplantation, liver, renal function|basiliximab, transplantation, liver, renal function
5743889|NCT00343213|Prognostic value of p16INK4a|prognostic value of p16ink4a
5743890|NCT00343213|CIN 1|cin 1
5743891|NCT00343213|LSIL|lsil
5743893|NCT00343187|Tarceva|tarceva
5743894|NCT00343187|Rash|rash
5743896|NCT00343187|erlotinib|erlotinib
5743897|NCT00343187|Aczone|aczone
5743898|NCT00343187|Dapsone|dapsone
5743899|NCT00343187|Non-small Cell Lung Cancer|non-small cell lung cancer
5743900|NCT00343187|subjects treated with Tarceva for non-small cell lung cancer (NSCLC) who subsequently develop a rash suspected to be related to Tarceva|subjects treated with tarceva for non-small cell lung cancer (nsclc) who subsequently develop a rash suspected to be related to tarceva
5743901|NCT00343174|stroke|stroke
5743902|NCT00343174|vascular diseases|vascular diseases
5743928|NCT00343018|Preschoolers|preschoolers
5743929|NCT00343018|Young Children|young children
5743930|NCT00343018|Eyewitness|eyewitness
5743932|NCT00343005|Blood-Stage|blood-stage
5743933|NCT00343005|Investigational|investigational
5743943|NCT00342966|Tracer Studies|tracer studies
5743944|NCT00342966|Chemoprevention|chemoprevention
5743945|NCT00342966|Selenomethionine|selenomethionine
5743946|NCT00342966|Plasma Selenoproteins|plasma selenoproteins
5743950|NCT00342953|augmentation mammoplasty|augmentation mammoplasty
5743951|NCT00342953|visk|visk
5743952|NCT00342940|influenza|influenza
5743953|NCT00342940|influenza vaccine|influenza vaccine
5743954|NCT00342940|flu|flu
5743955|NCT00342940|vaccination|vaccination
5743956|NCT00342940|immunogenicity|immunogenicity
5743971|NCT00342862|Pregnancy|pregnancy
5743972|NCT00342862|Amevive|amevive
5743973|NCT00342862|alefacept|alefacept
5743974|NCT00342862|Registry|registry
5743975|NCT00342862|Psoriasis|psoriasis
5743976|NCT00342849|Clinical Trial|clinical trial
5743977|NCT00342849|Low-level Lead Poisoning|low-level lead poisoning
5743978|NCT00342849|Chelation|chelation
5743979|NCT00342849|Developmental Assessment|developmental assessment
5743980|NCT00342849|Succimer|succimer
5743981|NCT00342836|Akt|akt
5743982|NCT00342836|Immunohistochemistry|immunohistochemistry
5743983|NCT00342836|Myoinositol|myoinositol
5743984|NCT00342836|Bronchial Specimens|bronchial specimens
5743985|NCT00342836|Phosphorylation|phosphorylation
5743986|NCT00342823|Linkage Analysis|linkage analysis
5743987|NCT00342823|Canidate Gene Analysis|canidate gene analysis
5743988|NCT00342823|Genome Scan|genome scan
5743989|NCT00342823|L. Chagasi|l. chagasi
5743990|NCT00342823|Visceral Leishmania|visceral leishmania
5743991|NCT00342810|Eye Diseases|eye diseases
5743995|NCT00342784|Mutation|mutation
5743996|NCT00342784|Cancer Genetics|cancer genetics
5743997|NCT00342771|Tobacco Use|tobacco use
5743998|NCT00342771|Tumor Biology|tumor biology
5743999|NCT00342771|Biomarker|biomarker
5744000|NCT00342771|Risk Factor|risk factor
5744001|NCT00342771|Health Disparity|health disparity
5744002|NCT00342758|Asthma|asthma
5744003|NCT00342758|Wheeze|wheeze
5744004|NCT00342758|Environment|environment
5744005|NCT00342758|Diet|diet
5744006|NCT00342758|Infection|infection
5744007|NCT00342732|Genetics|genetics
5744008|NCT00342732|Fat Intake|fat intake
5744009|NCT00342732|Pima Indians|pima indians
5744010|NCT00342732|Weight Control|weight control
5744011|NCT00342732|Appetite Control|appetite control
5744012|NCT00342706|Teen Pregnancy|teen pregnancy
5744013|NCT00342706|Short Inter-Pregnancy Intervals|short inter-pregnancy intervals
5744014|NCT00342693|Radiation|radiation
5744015|NCT00342693|Screening|screening
5744039|NCT00342641|Record linkage study|record linkage study
5744040|NCT00342641|Hepatitis C|hepatitis c
5744041|NCT00342628|Antibody|antibody
5744042|NCT00342628|Reactions|reactions
5744043|NCT00342628|Vaccine|vaccine
5744044|NCT00342628|Conjugate Vaccine|conjugate vaccine
5744045|NCT00342628|Typhoid Fever|typhoid fever
5744046|NCT00342628|Trial|trial
5744047|NCT00342628|Safety|safety
5744048|NCT00342628|Immunogenicity|immunogenicity
5744049|NCT00342628|Comparability|comparability
5744050|NCT00342628|DTP|dtp
5744051|NCT00342602|JC Virus|jc virus
5744052|NCT00342602|Opportunistic Infection|opportunistic infection
5744053|NCT00342602|Single Nucleotide Polymorphism|single nucleotide polymorphism
5744054|NCT00342602|Genotype|genotype
5744055|NCT00342602|Sequencing|sequencing
5744061|NCT00342576|Filarial Parasites|filarial parasites
5686276|NCT00552695|pain|pain
5686277|NCT00552682|HIV|hiv
5744062|NCT00342576|Wuchereria Bancrofti|wuchereria bancrofti
5744063|NCT00342576|Brugia Malayi|brugia malayi
5744064|NCT00342576|Diethylcarbamazine (DEC)|diethylcarbamazine (dec)
5744065|NCT00342576|Ivermectin|ivermectin
5744066|NCT00342563|mecamylamine|mecamylamine
5744067|NCT00342563|treatment|treatment
5744068|NCT00342563|alcohol dependence|alcohol dependence
5744069|NCT00342563|smoking|smoking
5744078|NCT00342524|IVIG|ivig
5744079|NCT00342524|Plasmapheresis|plasmapheresis
5744080|NCT00342524|Blood Collection|blood collection
5744081|NCT00342524|Immune Globulin|immune globulin
5744082|NCT00342524|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5744083|NCT00342524|SARS|sars
5744084|NCT00342511|Pap|pap
5744085|NCT00342511|Hybrid Capture 2|hybrid capture 2
5744086|NCT00342511|HSIL|hsil
5744087|NCT00342511|Colposcopy|colposcopy
5744088|NCT00342511|CIN|cin
5744089|NCT00342511|Specimen Collection|specimen collection
5744090|NCT00342498|DNA|dna
5744091|NCT00342498|Hormone|hormone
5744092|NCT00342498|Resistance|resistance
5744093|NCT00342498|Skeleton|skeleton
5744094|NCT00342485|Cellular Immunity|cellular immunity
5744095|NCT00342485|HIV-infected|hiv-infected
5744096|NCT00342485|Immune Deficiency|immune deficiency
5744097|NCT00342485|Cancer|cancer
5744098|NCT00342485|Transplantation|transplantation
5744099|NCT00342472|Esophageal Cancer|esophageal cancer
5744100|NCT00342472|Polycyclic Aromatic Hydrocarbons|polycyclic aromatic hydrocarbons
5744107|NCT00342407|Cancer Risk|cancer risk
5744108|NCT00342407|Cosmic Radiation|cosmic radiation
5744109|NCT00342407|Airlines|airlines
5744110|NCT00342407|Flight Attendants|flight attendants
5744111|NCT00342407|Circadian Rhythm|circadian rhythm
5744112|NCT00342394|Biological Monitoring|biological monitoring
5744113|NCT00342394|Exposure Determinants|exposure determinants
5744114|NCT00342394|Exposure Validation|exposure validation
5744115|NCT00342394|Occupational Exposure|occupational exposure
5744116|NCT00342394|Pesticides|pesticides
5744117|NCT00342394|Agriculture|agriculture
5744118|NCT00342381|Motor fatigue|motor fatigue
5744119|NCT00342381|Cognitive fatigue|cognitive fatigue
5744120|NCT00342368|CPAP|cpap
5744121|NCT00342368|ARDS|ards
5744123|NCT00342368|Hypoxemia|hypoxemia
5744124|NCT00342368|Intubation|intubation
5744141|NCT00342329|Occupational Exposures|occupational exposures
5744142|NCT00342316|Acute Myeloid Leukemia|acute myeloid leukemia
5744143|NCT00342316|Stem Cell Transplantation|stem cell transplantation
5744144|NCT00342316|Reduced Intensity Conditioning|reduced intensity conditioning
5744146|NCT00342316|Relapse|relapse
5744147|NCT00342303|Premature Infants|premature infants
5744148|NCT00342303|Fatty Acid Metabolism|fatty acid metabolism
5744149|NCT00342303|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5744150|NCT00342303|Infant Formula|infant formula
5744151|NCT00342303|Gas-chromatography|gas-chromatography
5744152|NCT00342303|Mass Spectrometry|mass spectrometry
5744153|NCT00342290|Pathophysiological Volume Measurement|pathophysiological volume measurement
5744154|NCT00342290|Power Doppler Ultrasound|power doppler ultrasound
5744155|NCT00342290|Prediction of Adverse Pregnancy Outcome|prediction of adverse pregnancy outcome
5744156|NCT00342290|Subchorionic Hemorrhage|subchorionic hemorrhage
5744157|NCT00342277|Premature Rupture of Membranes|premature rupture of membranes
5744158|NCT00342277|Genetic Risk Factors|genetic risk factors
5744159|NCT00342277|Tissue Specific Expression|tissue specific expression
5744160|NCT00342277|Quantitative Real Time PCR|quantitative real time pcr
5744161|NCT00342277|Preterm Birth|preterm birth
5744162|NCT00342277|Expression Profiling|expression profiling
5744163|NCT00342277|Microarrays|microarrays
5744164|NCT00342264|Lung Cancer|lung cancer
5744165|NCT00342264|Smoking|smoking
5744166|NCT00342264|Diesel Exhaust|diesel exhaust
5744167|NCT00342251|Macular Degeneration|macular degeneration
5744168|NCT00342251|Retinal Images|retinal images
5744169|NCT00342251|Risk Factors|risk factors
5744170|NCT00342251|Linkage Analysis|linkage analysis
5744171|NCT00342251|Gene|gene
5744172|NCT00342251|Mutation|mutation
5744173|NCT00342225|Observation|observation
5744174|NCT00342225|Mothers|mothers
5744175|NCT00342225|Description|description
5744176|NCT00342212|Walking|walking
5744177|NCT00342212|Jogging|jogging
5744178|NCT00342212|Bridging Study|bridging study
5744179|NCT00342212|Data Comparability|data comparability
5744180|NCT00342212|Healthy Adults|healthy adults
5744181|NCT00342212|Healthy Volunteer|healthy volunteer
5744182|NCT00342212|HV|hv
5744183|NCT00342199|Incidence|incidence
5744184|NCT00342199|Prevalence|prevalence
5744185|NCT00342199|Immunity|immunity
5744186|NCT00342199|Bacteriology|bacteriology
5744187|NCT00342199|Pathogenesis|pathogenesis
5744199|NCT00342160|AIDS|aids
5744200|NCT00342160|HIV Infectiousness|hiv infectiousness
5744201|NCT00342160|Immunity|immunity
5744202|NCT00342160|CTL|ctl
5744203|NCT00342160|Epidemiology|epidemiology
5744204|NCT00342147|EBV|ebv
5744205|NCT00342147|NPC|npc
5744206|NCT00342134|Demyelination|demyelination
5744207|NCT00342134|Inflammation|inflammation
5744208|NCT00342134|Immunosuppression|immunosuppression
5744209|NCT00342134|Autoimmunity|autoimmunity
5744210|NCT00342134|Bone Marrow|bone marrow
5744211|NCT00342134|Multiple Sclerosis|multiple sclerosis
5744212|NCT00342121|Cancer|cancer
5744213|NCT00342121|NHL|nhl
5744214|NCT00342121|Pesticides|pesticides
5744215|NCT00342121|Atrazine|atrazine
5744216|NCT00342121|Organophosphates|organophosphates
5744217|NCT00342121|Cancer Risk|cancer risk
5744218|NCT00342121|Normal Control|normal control
5744219|NCT00342095|Autoimmune Diseases|autoimmune diseases
5744220|NCT00342095|Estrogen|estrogen
5744221|NCT00342095|Silica|silica
5744222|NCT00342095|Pesticides|pesticides
5744223|NCT00342095|Major Histocompatibility Complex|major histocompatibility complex
5744224|NCT00342095|Genetic Susceptibility|genetic susceptibility
5744225|NCT00342082|Zidovudine|zidovudine
5744226|NCT00342082|HIV|hiv
5744227|NCT00342082|Cord Blood|cord blood
5744228|NCT00342069|Decision Making|decision making
5744229|NCT00342069|Genetic Counseling|genetic counseling
5744230|NCT00342069|Pregnancy Options|pregnancy options
5744246|NCT00342030|Respiratory|respiratory
5744247|NCT00342030|Polymorphism|polymorphism
5744249|NCT00342030|COPD|copd
5744250|NCT00342030|Prospective|prospective
5744251|NCT00342030|Diet|diet
5744252|NCT00342017|Filarial Infections|filarial infections
5744253|NCT00342017|Helminths|helminths
5744254|NCT00342017|Tuberculosis|tuberculosis
5744255|NCT00342017|Filarial Infection|filarial infection
5744256|NCT00342004|Shanghai|shanghai
5744257|NCT00342004|Residential History|residential history
5744258|NCT00342004|Exposure Assessment|exposure assessment
5744259|NCT00342004|Cohort Study|cohort study
5744260|NCT00342004|Molecular Epidemiology|molecular epidemiology
5744267|NCT00341965|DDE|dde
5744268|NCT00341965|Androgen Levels|androgen levels
5744269|NCT00341965|Farming|farming
5744433|NCT00341471|School|school
5744270|NCT00341965|Antiandrogen|antiandrogen
5744271|NCT00341952|Case-Control Study|case-control study
5744272|NCT00341952|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5744278|NCT00341913|Research|research
5744279|NCT00341913|Repository|repository
5744280|NCT00341913|Registry|registry
5744281|NCT00341913|Surveillance|surveillance
5744282|NCT00341913|Databases|databases
5744283|NCT00341900|Chromosome Translocations|chromosome translocations
5744284|NCT00341900|Cosmic Radiation|cosmic radiation
5744285|NCT00341900|Airline Flight Crew|airline flight crew
5744286|NCT00341900|Airlines|airlines
5744287|NCT00341900|Flight Crew|flight crew
5744288|NCT00341900|Occupational Exposure|occupational exposure
5744289|NCT00341887|Screening|screening
5744290|NCT00341887|AIDS|aids
5744291|NCT00341887|Antiretrovirals|antiretrovirals
5744292|NCT00341887|Military|military
5744293|NCT00341887|Force readiness|force readiness
5744299|NCT00341861|Bladder Cancer|bladder cancer
5744300|NCT00341861|Occupational and Environmental Risks|occupational and environmental risks
5744301|NCT00341861|Lifestyle Factors|lifestyle factors
5744302|NCT00341861|Epidemiology|epidemiology
5744303|NCT00341861|Genetic Susceptibility|genetic susceptibility
5744304|NCT00341848|Apoptosis|apoptosis
5744305|NCT00341848|Environment|environment
5744306|NCT00341848|Infection|infection
5744307|NCT00341848|Inflammation|inflammation
5744308|NCT00341848|Leiomyoma|leiomyoma
5744309|NCT00341848|Uterine Leiomyoma|uterine leiomyoma
5744310|NCT00341848|Uterus|uterus
5744314|NCT00341822|Amniocentesis|amniocentesis
5744315|NCT00341822|Chorionic Villus Sampling|chorionic villus sampling
5744316|NCT00341822|Fertility|fertility
5744317|NCT00341822|Genetic Counseling|genetic counseling
5744318|NCT00341822|Decisional Conflict|decisional conflict
5744319|NCT00341822|Prenatal Testing|prenatal testing
5744320|NCT00341822|Questionnaire|questionnaire
5744321|NCT00341809|Natural Killer Cells|natural killer cells
5744322|NCT00341809|Autoimmune Disease|autoimmune disease
5744323|NCT00341809|Chronic Inflammation|chronic inflammation
5744324|NCT00341809|Two-Locus Interaction|two-locus interaction
5744325|NCT00341809|Allele/Haplotype Analysis|allele/haplotype analysis
5744326|NCT00341796|AIDS|aids
5744327|NCT00341796|HIV|hiv
5744328|NCT00341796|Perinatal|perinatal
5744329|NCT00341796|Transmission|transmission
5744334|NCT00341783|Screening|screening
5744335|NCT00341783|Malaria|malaria
5744336|NCT00341757|Family Reports|family reports
5744337|NCT00341757|Cancer|cancer
5744360|NCT00341692|Risk|risk
5744361|NCT00341692|Genes|genes
5744368|NCT00341666|Immune Regulation|immune regulation
5744369|NCT00341666|Co-Infection|co-infection
5744370|NCT00341666|Filariasis|filariasis
5744371|NCT00341666|Immunology|immunology
5744372|NCT00341666|Filarial Infection|filarial infection
5744373|NCT00341653|Asthma|asthma
5744374|NCT00341653|Pulmonary Function|pulmonary function
5744375|NCT00341653|Air Pollution|air pollution
5744376|NCT00341653|Genetic Polymorphism|genetic polymorphism
5744377|NCT00341653|Environmental Tobacco Agents|environmental tobacco agents
5744378|NCT00341640|Teen Pregnancy|teen pregnancy
5744379|NCT00341627|Bone Tumor|bone tumor
5744380|NCT00341627|Familial Chordoma|familial chordoma
5744381|NCT00341627|Gene Mapping|gene mapping
5744382|NCT00341627|Genetics|genetics
5744383|NCT00341627|Sporadic Chordoma|sporadic chordoma
5744384|NCT00341614|Exercise|exercise
5744385|NCT00341614|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5744386|NCT00341614|Postmenopause|postmenopause
5744387|NCT00341614|Diet|diet
5744388|NCT00341601|Mycobacterium Tuberculosis|mycobacterium tuberculosis
5744389|NCT00341601|TLR-2|tlr-2
5744390|NCT00341601|Recurrent Tuberculosis|recurrent tuberculosis
5744391|NCT00341601|Phenolic Glycolipid|phenolic glycolipid
5744392|NCT00341601|mRNA Expression Profiles|mrna expression profiles
5744398|NCT00341575|Family Systems|family systems
5744399|NCT00341575|Communication|communication
5744400|NCT00341575|Information Diffusion|information diffusion
5744401|NCT00341575|Social Networks|social networks
5744402|NCT00341575|Family Dynamics|family dynamics
5744403|NCT00341562|Gene Expression Profiling|gene expression profiling
5744404|NCT00341562|Vascular Disease|vascular disease
5744410|NCT00341536|Diet|diet
5744411|NCT00341536|Pilot|pilot
5744412|NCT00341536|Cohort|cohort
5744414|NCT00341536|Chronic Disease|chronic disease
5744420|NCT00341510|Risk Behavior|risk behavior
5744421|NCT00341510|Health Status|health status
5744422|NCT00341510|Adolescence|adolescence
5744423|NCT00341510|Positive Health Behaviors|positive health behaviors
5744424|NCT00341510|Social Support|social support
5744425|NCT00341510|Health Behavior|health behavior
5744426|NCT00341510|Survey|survey
5744427|NCT00341497|Leukoplakia|leukoplakia
5744428|NCT00341497|Oral Mucosa|oral mucosa
5744429|NCT00341497|Biomarkers|biomarkers
5744430|NCT00341484|Genetics|genetics
5744431|NCT00341484|Liver Cancer|liver cancer
5744436|NCT00341471|Howard University|howard university
5744437|NCT00341471|D.C.|d.c.
5744438|NCT00341471|Adolescent Pregnancy|adolescent pregnancy
5744439|NCT00341471|Intervention|intervention
5744444|NCT00341445|Environmental Intervention|environmental intervention
5744445|NCT00341445|Indoor Allergens|indoor allergens
5744446|NCT00341445|Environment|environment
5744447|NCT00341432|NRT Study|nrt study
5744477|NCT00341354|Bacterial Infection|bacterial infection
5744478|NCT00341354|Nosocomial Infection|nosocomial infection
5744479|NCT00341354|Trachea|trachea
5744480|NCT00341354|Biofilm|biofilm
5744481|NCT00341354|Mucus Shaver|mucus shaver
5744482|NCT00341341|Smoking|smoking
5744483|NCT00341341|Smoking Cessation|smoking cessation
5744484|NCT00341341|GSTM1|gstm1
5744485|NCT00341341|Glutathione S. Transferase|glutathione s. transferase
5744486|NCT00341341|Lung Cancer|lung cancer
5744487|NCT00341341|Smokers|smokers
5744488|NCT00341341|Genetic Risk Communication|genetic risk communication
5744489|NCT00341328|India|india
5744490|NCT00341328|Pulmonary Tuberculosis|pulmonary tuberculosis
5744491|NCT00341328|Category-I Pulmonary Tuberculosis|category-i pulmonary tuberculosis
5744492|NCT00341328|Immunomodulator|immunomodulator
5744493|NCT00341328|Mycobacterium w|mycobacterium w
5744499|NCT00341302|HIV|hiv
5744500|NCT00341302|AIDS|aids
5744501|NCT00341302|Perinatal|perinatal
5744502|NCT00341302|Transmission|transmission
5744503|NCT00341302|Outcomes|outcomes
5744504|NCT00341289|Submersion|submersion
5744505|NCT00341289|Epidemiology|epidemiology
5744506|NCT00341289|Fatal|fatal
5744507|NCT00341289|Child|child
5744508|NCT00341289|Swim|swim
5744509|NCT00341289|Drowning|drowning
5744510|NCT00341289|Survey|survey
5744521|NCT00341250|Blood Stage|blood stage
5744522|NCT00341250|Investigational|investigational
5744523|NCT00341250|Endemic|endemic
5744524|NCT00341250|Malaria|malaria
5744529|NCT00341224|Aggression|aggression
5744530|NCT00341224|Violence|violence
5744531|NCT00341224|Adolescents|adolescents
5744532|NCT00341224|Randomized Trial|randomized trial
5744533|NCT00341224|Behavioral Intervention|behavioral intervention
5744534|NCT00341211|AIDS|aids
5744535|NCT00341211|Cancer|cancer
5744536|NCT00341211|Epidemiology|epidemiology
5744537|NCT00341211|Immunology|immunology
5744538|NCT00341211|Virology|virology
5744539|NCT00341198|Rheumatoid Arthritis|rheumatoid arthritis
5744540|NCT00341198|Lupus|lupus
5744541|NCT00341198|Scleroderma|scleroderma
5744542|NCT00341198|Sjogren's Syndrome|sjogren's syndrome
5744543|NCT00341198|Farming|farming
5744544|NCT00341198|Autoimmune Disease|autoimmune disease
5744545|NCT00341198|Exposure|exposure
5744546|NCT00341185|Biodosimetry|biodosimetry
5744547|NCT00341185|Dose Reconstruction|dose reconstruction
5744548|NCT00341185|Radioactive Fallout|radioactive fallout
5744549|NCT00341185|Thyroid Screening|thyroid screening
5744550|NCT00341185|Ultrasound|ultrasound
5744551|NCT00341172|Retinitis|retinitis
5744552|NCT00341172|Cytomegalovirus|cytomegalovirus
5744553|NCT00341172|HIV-1|hiv-1
5744554|NCT00341172|Polymorphisms|polymorphisms
5744555|NCT00341172|HAART|haart
5744556|NCT00341159|Breast|breast
5744557|NCT00341159|BRCA1|brca1
5744558|NCT00341159|BRCA2|brca2
5744559|NCT00341159|Inherited|inherited
5744563|NCT00341159|Cancer Susceptibility Alleles|cancer susceptibility alleles
5744565|NCT00341146|Catonese Chinese|catonese chinese
5744566|NCT00341146|Genetic Predisposition|genetic predisposition
5744567|NCT00341146|Genotyping|genotyping
5744568|NCT00341146|Triad analysis|triad analysis
5744569|NCT00341146|Nasopharyngeal Cancer|nasopharyngeal cancer
5744570|NCT00341146|NPC|npc
5744571|NCT00341133|Laterality|laterality
5744572|NCT00341133|Heterotaxy|heterotaxy
5744573|NCT00341133|Holoprosencephaly|holoprosencephaly
5744574|NCT00341133|Genetic Testing|genetic testing
5744575|NCT00341133|Congential Cardiac Malformations|congential cardiac malformations
5744576|NCT00341133|Disturbed Internal Organ Positioning|disturbed internal organ positioning
5744577|NCT00341120|Genotypes|genotypes
5744578|NCT00341120|Mutation|mutation
5744579|NCT00341120|Folate|folate
5744580|NCT00341120|Male Infertility|male infertility
5744581|NCT00341120|Nutrition|nutrition
5744582|NCT00341107|Cancer|cancer
5744583|NCT00341107|Genes|genes
5744584|NCT00341107|Screening|screening
5744585|NCT00341107|Primary Care|primary care
5744586|NCT00341107|Inherited Susceptibility|inherited susceptibility
5744591|NCT00341081|Short Tandem Repeat|short tandem repeat
5744592|NCT00341081|Molecular Epidemiology|molecular epidemiology
5761239|NCT00279227|obesity|obesity
5744593|NCT00341081|Viral Infection|viral infection
5744594|NCT00341081|Mixture Detection|mixture detection
5744595|NCT00341081|Intervention & Education|intervention & education
5744596|NCT00341081|Intervention|intervention
5744597|NCT00341081|Education|education
5744598|NCT00341068|Birth Defects|birth defects
5744599|NCT00341068|Folic Acid|folic acid
5744600|NCT00341068|Gene-Environment Interactions|gene-environment interactions
5744601|NCT00341068|Neural Tube Defects|neural tube defects
5744602|NCT00341068|Cleft Lip|cleft lip
5744603|NCT00341055|Anemia|anemia
5744604|NCT00341055|Hemoglobin|hemoglobin
5744605|NCT00341055|Chemotherapy|chemotherapy
5744606|NCT00341055|Epoetin alfa|epoetin alfa
5744607|NCT00341042|Normal Values|normal values
5744608|NCT00341042|Complete Blood Count|complete blood count
5744609|NCT00341042|HIV|hiv
5744610|NCT00341042|Tuberculosis|tuberculosis
5744611|NCT00341042|Flow Cytometry|flow cytometry
5744612|NCT00341029|Longitudinal Study|longitudinal study
5744613|NCT00341029|Chromosomal Effects|chromosomal effects
5744614|NCT00341029|Sister Chromatid Exchanges|sister chromatid exchanges
5744615|NCT00341029|Micronuclei|micronuclei
5744616|NCT00341029|Stimulants|stimulants
5744617|NCT00341029|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5744618|NCT00341029|ADHD|adhd
5744620|NCT00341003|Plasmodium Falciparum|plasmodium falciparum
5744621|NCT00341003|Hemoglobin E|hemoglobin e
5744622|NCT00341003|Mefloquine|mefloquine
5744623|NCT00341003|Artemisinin|artemisinin
5744624|NCT00341003|Piperaquine|piperaquine
5744625|NCT00341003|Malaria|malaria
5744626|NCT00340990|Tuberculosis|tuberculosis
5744627|NCT00340990|HIV|hiv
5744628|NCT00340990|CD4+ T Cell|cd4+ t cell
5744629|NCT00340990|Interferon-Gamma|interferon-gamma
5744630|NCT00340990|Lymphocyte Proliferation|lymphocyte proliferation
5744631|NCT00340977|Birth Defects|birth defects
5744632|NCT00340977|Cleft Lip and Palate|cleft lip and palate
5744633|NCT00340977|Genetic Susceptibility|genetic susceptibility
5744634|NCT00340964|Photography|photography
5744635|NCT00340964|Self-Esteem|self-esteem
5744636|NCT00340964|Perceived Social Stigma|perceived social stigma
5744637|NCT00340964|Hopefulness|hopefulness
5744638|NCT00340964|Cleft Lip and Palate|cleft lip and palate
5744639|NCT00340964|Hemifacial Microsomia|hemifacial microsomia
5744640|NCT00340964|Treacher Collins Syndrome|treacher collins syndrome
5744641|NCT00340964|Mobius Syndrome|mobius syndrome
5744642|NCT00340964|Apert Syndrome|apert syndrome
5744643|NCT00340964|Videography|videography
5744644|NCT00340964|Craniofacial Differences|craniofacial differences
5744645|NCT00340964|Self -Esteem|self -esteem
5744646|NCT00340951|Regulatory T Cells|regulatory t cells
5744647|NCT00340951|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5744648|NCT00340951|Genetic Polymorphism|genetic polymorphism
5744649|NCT00340951|Innate Immunity|innate immunity
5744650|NCT00340951|Transplantation|transplantation
5744651|NCT00340951|Lung Transplantation|lung transplantation
5744653|NCT00340938|Education|education
5744654|NCT00340938|Problem Solving|problem solving
5744655|NCT00340938|Motivation|motivation
5744656|NCT00340938|Locus of Responsibility|locus of responsibility
5744657|NCT00340912|Skin Biopsy|skin biopsy
5744658|NCT00340899|Perinatal Mortality|perinatal mortality
5744659|NCT00340899|Perinatal Morbidity|perinatal morbidity
5744660|NCT00340899|Preterm Birth|preterm birth
5744661|NCT00340899|Pregnancy Complications|pregnancy complications
5744662|NCT00340899|Pregnancy|pregnancy
5744681|NCT00340847|Genetics|genetics
5744683|NCT00340834|Interferon|interferon
5744684|NCT00340834|RRMS|rrms
5744685|NCT00340834|Multiple Sclerosis|multiple sclerosis
5744686|NCT00340834|Efficacy|efficacy
5744687|NCT00340821|HTLV-I|htlv-i
5744693|NCT00340795|Media Analysis|media analysis
5744694|NCT00340795|Nutrition|nutrition
5744695|NCT00340795|Physical Activity|physical activity
5744696|NCT00340795|After-School|after-school
5744697|NCT00340795|Exercise|exercise
5744698|NCT00340782|Menstrual Cycles|menstrual cycles
5744699|NCT00340782|Early Pregnancy|early pregnancy
5744700|NCT00340782|Reproductive Hormones|reproductive hormones
5744701|NCT00340782|Stress|stress
5744702|NCT00340782|Adrenal Function|adrenal function
5744703|NCT00340769|Cytokines|cytokines
5744704|NCT00340769|Inflammation|inflammation
5744705|NCT00340769|mRNA Stability|mrna stability
5744706|NCT00340769|Pygmy|pygmy
5744707|NCT00340769|Zinc Finger Proteins|zinc finger proteins
5744708|NCT00340769|Ethnic Group|ethnic group
5744709|NCT00340756|GCMS|gcms
5744710|NCT00340756|LCMS-MS|lcms-ms
5744711|NCT00340743|Heterocyclic Aminos|heterocyclic aminos
5744712|NCT00340743|Cruciferous Vegetables|cruciferous vegetables
5744713|NCT00340743|Yogurt|yogurt
5744714|NCT00340743|Chlorophyllin|chlorophyllin
5744715|NCT00340743|Comet Assay|comet assay
5744716|NCT00340743|Diet|diet
5744717|NCT00340743|Healthy Volunteer|healthy volunteer
5744718|NCT00340730|Health Education|health education
5744719|NCT00340730|Mentoring|mentoring
5744720|NCT00340730|Parenting|parenting
5744721|NCT00340730|Social Skills Training|social skills training
5744722|NCT00340730|Violence|violence
5744723|NCT00340730|Intervention|intervention
5744724|NCT00340730|Youth Injury|youth injury
5744725|NCT00340717|Methylation|methylation
5744726|NCT00340717|Genes|genes
5744727|NCT00340717|Screening|screening
5744728|NCT00340717|Prospective|prospective
5744729|NCT00340717|Diagnosis|diagnosis
5744730|NCT00340704|tamsulosin|tamsulosin
5744732|NCT00340704|neurogenic bladder|neurogenic bladder
5744733|NCT00340691|Parasite|parasite
5744734|NCT00340691|Chemotherapy|chemotherapy
5744735|NCT00340691|Wuchereria Bancrofti|wuchereria bancrofti
5744736|NCT00340678|Angiotensin II Receptor Antagonist|angiotensin ii receptor antagonist
5744737|NCT00340678|Therapeutic Trial|therapeutic trial
5744738|NCT00340678|Glomerular Filtration Rate|glomerular filtration rate
5744739|NCT00340678|Kidney Biopsy|kidney biopsy
5744740|NCT00340678|Non-Insulin Dependent Diabetes Mellitus|non-insulin dependent diabetes mellitus
5744741|NCT00340665|Soy|soy
5744742|NCT00340665|Infant Formula|infant formula
5744743|NCT00340665|Sexual Development|sexual development
5744744|NCT00340665|Hormone|hormone
5744745|NCT00340665|Isoflavones|isoflavones
5744746|NCT00340652|Soy|soy
5744747|NCT00340652|Isoflavones|isoflavones
5744748|NCT00340652|Infant Formula|infant formula
5744749|NCT00340652|Sexual Development|sexual development
5744750|NCT00340652|Hormone|hormone
5744751|NCT00340639|Adherence|adherence
5744752|NCT00340639|Chronic Illness|chronic illness
5744753|NCT00340639|Adolescent|adolescent
5744754|NCT00340639|Family|family
5744755|NCT00340639|Self-Regulation|self-regulation
5744756|NCT00340626|Linkage Analysis|linkage analysis
5744757|NCT00340626|Genotyping|genotyping
5744758|NCT00340626|Birth Defects|birth defects
5744759|NCT00340626|Family Study|family study
5744760|NCT00340626|Positional Cloning|positional cloning
5744761|NCT00340613|Type 1 Diabetes|type 1 diabetes
5744762|NCT00340613|Poorly controlled glucose|poorly controlled glucose
5744763|NCT00340613|adolescents|adolescents
5744764|NCT00340600|Cancer|cancer
5744765|NCT00340600|DES|des
5744766|NCT00340600|Endocrine Disrupting Chemicals|endocrine disrupting chemicals
5744767|NCT00340600|In Utero|in utero
5744768|NCT00340587|Zona Pellucida|zona pellucida
5744769|NCT00340587|Human Eggs|human eggs
5744779|NCT00340561|Motor Vehicle|motor vehicle
5744780|NCT00340561|Learning|learning
5744781|NCT00340561|Inexperience|inexperience
5744782|NCT00340548|Genotyping|genotyping
5744783|NCT00340548|Polymorphisms|polymorphisms
5744784|NCT00340548|Co-Infection|co-infection
5744785|NCT00340548|Chemokines|chemokines
5744786|NCT00340548|Associations|associations
5744787|NCT00340548|HIV|hiv
5744788|NCT00340548|HCV|hcv
5744789|NCT00340548|Hepatitis C|hepatitis c
5744790|NCT00340548|Hemophilia|hemophilia
5744794|NCT00340522|Sarcoma|sarcoma
5744795|NCT00340522|Brain Tumor|brain tumor
5744796|NCT00340522|Embryonal Tumor|embryonal tumor
5744797|NCT00340522|Tumor Array|tumor array
5744798|NCT00340522|Childhood Cancer|childhood cancer
5744799|NCT00340522|Plexiform Neurofibromas|plexiform neurofibromas
5744800|NCT00340522|Drug Screening|drug screening
5744801|NCT00340522|Immunohistochemistry|immunohistochemistry
5744802|NCT00340509|Genetics|genetics
5744803|NCT00340509|Population|population
5744804|NCT00340509|CHD Risk|chd risk
5744805|NCT00340509|Epidemiology|epidemiology
5744806|NCT00340509|Gene Mapping|gene mapping
5744807|NCT00340496|Schwannoma|schwannoma
5744808|NCT00340496|Meningioma|meningioma
5744809|NCT00340496|Follow-Up|follow-up
5744810|NCT00340496|Radiation Therapy|radiation therapy
5744811|NCT00340496|Cohort|cohort
5744812|NCT00340483|Smoking Cessation|smoking cessation
5744813|NCT00340483|Young Adults|young adults
5744814|NCT00340483|Quit Smoking|quit smoking
5744815|NCT00340483|Email|email
5744816|NCT00340483|Social Marketing|social marketing
5744817|NCT00340470|Injury|injury
5744818|NCT00340470|Motor Vehicle|motor vehicle
5744819|NCT00340470|Parenting|parenting
5744820|NCT00340470|Randomized Trial|randomized trial
5744821|NCT00340470|Behavioral Intervention|behavioral intervention
5769590|NCT00246363|HIV|hiv
5744827|NCT00340444|Linkage|linkage
5744828|NCT00340444|Covariates|covariates
5744829|NCT00340444|Association|association
5744830|NCT00340444|Fine Mapping|fine mapping
5744831|NCT00340444|Inflammatory Bowel Disease|inflammatory bowel disease
5744832|NCT00340444|Ulcerative Colitis|ulcerative colitis
5744833|NCT00340444|Crohn's Disease|crohn's disease
5744834|NCT00340431|Human|human
5744835|NCT00340431|Clinical Trial|clinical trial
5744836|NCT00340431|Mosquito|mosquito
5744837|NCT00340418|Bronchoalveolar Lavage|bronchoalveolar lavage
5744838|NCT00340418|Acute Rejection|acute rejection
5744839|NCT00340418|Chronic Rejection|chronic rejection
5744840|NCT00340418|Genetic Polymorphisms|genetic polymorphisms
5744841|NCT00340418|Innate Immunity|innate immunity
5744842|NCT00340418|Lung Transplantation|lung transplantation
5744843|NCT00340418|Lung Allograft Rejection|lung allograft rejection
5744844|NCT00340405|Blood|blood
5744845|NCT00340405|Lung Cancer|lung cancer
5744846|NCT00340405|Occupational Exposure|occupational exposure
5744847|NCT00340405|Radon|radon
5744848|NCT00340405|Arsenic|arsenic
5744849|NCT00340392|Mammary Stem Cells|mammary stem cells
5744850|NCT00340392|Breast Cancer|breast cancer
5744851|NCT00340392|Cancer Stem Cells|cancer stem cells
5744852|NCT00340392|Gene Expression Profiling|gene expression profiling
5744853|NCT00340379|Psychotic|psychotic
5744854|NCT00340366|Homocysteine|homocysteine
5744855|NCT00340366|Vitamin B12|vitamin b12
5744856|NCT00340366|Birth Defects|birth defects
5744859|NCT00340366|Irish Individuals|irish individuals
5744860|NCT00340353|Gene Expression|gene expression
5744861|NCT00340353|Drug Sensitivity|drug sensitivity
5744862|NCT00340353|TFE3|tfe3
5744863|NCT00340353|ASPL-TFE3|aspl-tfe3
5744864|NCT00340353|NOD-SCID Mice|nod-scid mice
5744865|NCT00340353|Sarcoma|sarcoma
5744866|NCT00340353|Alveolar Soft Part Sarcoma|alveolar soft part sarcoma
5744867|NCT00340353|ASPS|asps
5744868|NCT00340340|Population-Based Case Control Study|population-based case control study
5744869|NCT00340340|Lung Cancer|lung cancer
5744870|NCT00340340|Epidemiology|epidemiology
5744871|NCT00340340|Smoking|smoking
5744872|NCT00340340|Smokers|smokers
5744873|NCT00340340|Genetics|genetics
5744874|NCT00340327|healthy subjects|healthy subjects
5744875|NCT00340314|symptomatic|symptomatic
5744876|NCT00340314|paroxysmal|paroxysmal
5744877|NCT00340314|atrial fibrillation|atrial fibrillation
5744878|NCT00340301|Polymorphism|polymorphism
5744899|NCT00340223|Immunity|immunity
5744900|NCT00340223|Mutations|mutations
5744901|NCT00340223|Viral Selection|viral selection
5744902|NCT00340223|Disease Progression|disease progression
5744904|NCT00340210|Biomarkers|biomarkers
5744905|NCT00340210|Breast Cancer|breast cancer
5744906|NCT00340210|Etiology|etiology
5744907|NCT00340210|Hormones|hormones
5744908|NCT00340210|Prospective Study|prospective study
5744909|NCT00340184|concurrent|concurrent
5744910|NCT00340184|chemoradiation|chemoradiation
5744911|NCT00340184|paclitaxel|paclitaxel
5744912|NCT00340184|carboplatin|carboplatin
5744913|NCT00340171|Intrauterine Growth Retardation|intrauterine growth retardation
5744914|NCT00340158|Mammary|mammary
5744915|NCT00340158|Diagnosis|diagnosis
5744916|NCT00340158|Aggressive|aggressive
5744917|NCT00340158|Pathology|pathology
5744918|NCT00340158|Epidemiology|epidemiology
5744924|NCT00340119|CHOICE Cohort|choice cohort
5744925|NCT00340119|End Stage Renal Disease|end stage renal disease
5744926|NCT00340119|Epidemiology|epidemiology
5744927|NCT00340119|Prevention|prevention
5744928|NCT00340119|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5744929|NCT00340119|ESRD|esrd
5744930|NCT00340106|Infant Health Study|infant health study
5744931|NCT00340106|Environmental Tobacco Smoke|environmental tobacco smoke
5744932|NCT00340106|Infant Health|infant health
5744955|NCT00340002|Pregnancy|pregnancy
5744956|NCT00340002|Prenatal Diagnosis|prenatal diagnosis
5744962|NCT00339976|Case-Control Study|case-control study
5744963|NCT00339976|Death Certificates|death certificates
5744964|NCT00339976|National Death Index|national death index
5744965|NCT00339976|Cause of Death Information|cause of death information
5744966|NCT00339976|Lead Exposure|lead exposure
5744967|NCT00339976|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5744968|NCT00339976|ALS|als
5744977|NCT00339950|Colorectal adenoma|colorectal adenoma
5744978|NCT00339950|Screening|screening
5744979|NCT00339950|Diet|diet
5744980|NCT00339950|Risk Factors|risk factors
5745011|NCT00339807|Retrovirus|retrovirus
5745012|NCT00339807|Caribbean|caribbean
5745013|NCT00339807|Transmission|transmission
5745014|NCT00339807|Genetic|genetic
5745015|NCT00339807|Viral Markers|viral markers
5745016|NCT00339807|HTLV-1|htlv-1
5745017|NCT00339794|Racial Profiling|racial profiling
5745018|NCT00339794|Genomics|genomics
5745019|NCT00339794|Genetic Testing|genetic testing
5745020|NCT00339794|Family History|family history
5745021|NCT00339794|Family Physician|family physician
5745022|NCT00339781|Fetomaternal Microchimerism|fetomaternal microchimerism
5745023|NCT00339781|Cell Trafficking|cell trafficking
5745024|NCT00339781|Discordant Twins|discordant twins
5745025|NCT00339781|Maternofetal Microchimerism|maternofetal microchimerism
5745026|NCT00339781|Diabetes Type I|diabetes type i
5745027|NCT00339781|Twins|twins
5745028|NCT00339768|Helicobacter Pylori|helicobacter pylori
5745029|NCT00339768|Gastric Cancer Prevention|gastric cancer prevention
5745030|NCT00339768|Precancerous Gastric Lesions|precancerous gastric lesions
5745035|NCT00339729|Children|children
5745036|NCT00339729|Behavior|behavior
5745037|NCT00339729|Epidemiology|epidemiology
5745038|NCT00339729|Lead|lead
5745039|NCT00339729|Learning Disorder|learning disorder
5745040|NCT00339716|Cohort|cohort
5745041|NCT00339716|Radiation|radiation
5745042|NCT00339716|In Utero|in utero
5745043|NCT00339703|Resistin|resistin
5745050|NCT00339690|Intervention|intervention
5745051|NCT00339690|Behaviors|behaviors
5745052|NCT00339690|Test-Kit|test-kit
5745053|NCT00339690|Dust Mites Allergen|dust mites allergen
5745059|NCT00339664|Pharmacokinetics|pharmacokinetics
5745060|NCT00339664|Quantify|quantify
5745061|NCT00339664|HPLC|hplc
5745062|NCT00339664|LC/MS|lc/ms
5745068|NCT00339638|Epidemiology|epidemiology
5745069|NCT00339638|Risk Prediction|risk prediction
5745070|NCT00339638|Biomarkers|biomarkers
5745071|NCT00339638|Nested Case Control|nested case control
5745078|NCT00339599|Atherosclerosis|atherosclerosis
5745079|NCT00339599|Single Nucleotide Polymorphisms|single nucleotide polymorphisms
5745080|NCT00339599|Monocyte Chemotactic Protein-1|monocyte chemotactic protein-1
5745081|NCT00339599|Inflammation|inflammation
5745082|NCT00339599|Eotaxin|eotaxin
5745083|NCT00339586|Non-small cell lung cancer|non-small cell lung cancer
5745084|NCT00339586|tyrosine kinase inhibition|tyrosine kinase inhibition
5745085|NCT00339586|first-line treatment|first-line treatment
5745086|NCT00339586|mutant EGFR-gene|mutant egfr-gene
5745125|NCT00339469|Prevention|prevention
5745126|NCT00339469|Colorectal Neoplasms|colorectal neoplasms
5745127|NCT00339469|Insulin Resistance|insulin resistance
5745128|NCT00339469|Inflammation Obesity|inflammation obesity
5745129|NCT00339469|Adenoma|adenoma
5745130|NCT00339456|Therapy|therapy
5745131|NCT00339456|Africa|africa
5745132|NCT00339456|Structured|structured
5745133|NCT00339456|Interruption|interruption
5745134|NCT00339456|Antiretroviral|antiretroviral
5745136|NCT00339443|Buccal Cells|buccal cells
5745137|NCT00339443|Concordance|concordance
5745138|NCT00339443|DNA Yields|dna yields
5745139|NCT00339443|pH Meter|ph meter
5745140|NCT00339443|Urine pH|urine ph
5745141|NCT00339443|Calibration|calibration
5745142|NCT00339430|Genotyping|genotyping
5745143|NCT00339430|HIV|hiv
5680992|NCT00575263|Pain, Sodium Channel, Dental pulp|pain, sodium channel, dental pulp
5680993|NCT00575250|Osteoporosis/prevention & control|osteoporosis/prevention & control
5680994|NCT00575250|Osteoporosis Prevention and Self-Management Course|osteoporosis prevention and self-management course
5680995|NCT00575250|Patient Education/*trends//Questionnaires|patient education/*trends//questionnaires
5680996|NCT00575250|Adult//Aged//Middle Aged|adult//aged//middle aged
5770554|NCT00242840|HIV-1|hiv-1
5745144|NCT00339430|HPV|hpv
5745145|NCT00339430|HCV|hcv
5745146|NCT00339430|HBV|hbv
5745147|NCT00339417|Lymphatic Filariasis|lymphatic filariasis
5745148|NCT00339417|Chemotherapy|chemotherapy
5745149|NCT00339404|Genotyping|genotyping
5745150|NCT00339404|Linkage Analysis|linkage analysis
5745151|NCT00339404|Cancer|cancer
5745152|NCT00339404|Hereditary Melanoma|hereditary melanoma
5745153|NCT00339391|Adjustment|adjustment
5745154|NCT00339391|Environmental Complexity|environmental complexity
5745155|NCT00339391|Mental Illness|mental illness
5745156|NCT00339391|Non-literate|non-literate
5745157|NCT00339391|West Africa|west africa
5745158|NCT00339391|Stress|stress
5745159|NCT00339391|Knowledge|knowledge
5734870|NCT00376870|PCI|pci
5745160|NCT00339391|Mental Health|mental health
5745161|NCT00339391|AIDS|aids
5745162|NCT00339378|Record Linkage|record linkage
5745163|NCT00339378|Retrospective|retrospective
5745164|NCT00339378|Cohort|cohort
5745165|NCT00339378|Registries|registries
5745166|NCT00339378|Agricultural|agricultural
5745167|NCT00339365|Infants|infants
5745168|NCT00339365|Toddlers|toddlers
5745169|NCT00339365|Attachment|attachment
5745170|NCT00339365|Maltreatment|maltreatment
5745171|NCT00339365|Foster Care|foster care
5745172|NCT00339352|Brain|brain
5745173|NCT00339352|Exposures|exposures
5745174|NCT00339352|Genetics|genetics
5745175|NCT00339352|Glioma|glioma
5745176|NCT00339352|Occupations|occupations
5745177|NCT00339339|Dental Materials|dental materials
5745178|NCT00339339|Resins|resins
5745179|NCT00339339|BisDMA|bisdma
5745180|NCT00339339|Absorption|absorption
5745181|NCT00339339|Systemic|systemic
5745182|NCT00339326|Human Herpes virus 8 (HHV8)|human herpes virus 8 (hhv8)
5745183|NCT00339326|Kaposis sarcoma (KS)|kaposis sarcoma (ks)
5745184|NCT00339326|Kaposi Sarcoma|kaposi sarcoma
5745185|NCT00339326|Karposi Sarcoma-Associated Herpesvirus|karposi sarcoma-associated herpesvirus
5745186|NCT00339326|KSHV|kshv
5745187|NCT00339326|KS|ks
5745188|NCT00339313|Obesity|obesity
5745189|NCT00339313|Etiology|etiology
5745190|NCT00339313|Macronutrient Selection|macronutrient selection
5745191|NCT00339313|Taste Preference|taste preference
5745192|NCT00339313|Mixed Meal Test|mixed meal test
5745193|NCT00339300|Etiology|etiology
5745194|NCT00339300|Brain Cancer|brain cancer
5745195|NCT00339300|Epidemiology|epidemiology
5761542|NCT00278161|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5745196|NCT00339300|Brain Tumors|brain tumors
5745197|NCT00339300|Glioma|glioma
5745202|NCT00339274|Repositories|repositories
5745203|NCT00339274|Pathology|pathology
5745204|NCT00339274|Belarus|belarus
5745205|NCT00339274|Russia|russia
5745231|NCT00339209|Bronchiolitis Obliterans Syndrome|bronchiolitis obliterans syndrome
5745232|NCT00339209|Transplant Rejection|transplant rejection
5745233|NCT00339209|Innate Immunity|innate immunity
5745234|NCT00339209|Lung Transplantation Rejection|lung transplantation rejection
5745236|NCT00339196|MDS High risk|mds high risk
5745237|NCT00339196|Demethylating agents|demethylating agents
5745238|NCT00339196|HDAC Inhibitors|hdac inhibitors
5745239|NCT00339183|Oncology|oncology
5745240|NCT00339183|Cancer|cancer
5745241|NCT00339183|Metastatic Colorectal Cancer|metastatic colorectal cancer
5745242|NCT00339183|EGFr|egfr
5745243|NCT00339183|Panitumumab|panitumumab
5745244|NCT00339183|Clinical Trial|clinical trial
5745245|NCT00339183|Amgen|amgen
5745246|NCT00339170|Schizoaffective Disorder|schizoaffective disorder
5745247|NCT00339170|Schizophrenic Disorders|schizophrenic disorders
5745248|NCT00339170|Psychotic Disorders|psychotic disorders
5745249|NCT00339170|Cognition|cognition
5745250|NCT00339157|IDIOPATHIC JUVENILE ARTHRITIS|idiopathic juvenile arthritis
5745251|NCT00339157|PEDIATRICS|pediatrics
5745252|NCT00339157|ORPHAN DISEASE|orphan disease
5745253|NCT00339157|INTERLEUKIN - 1|interleukin - 1
5745254|NCT00339157|RECEPTORS , INTERLEUKINS|receptors , interleukins
5745255|NCT00339157|ANTAGONISTS|antagonists
5745256|NCT00339144|Solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists|solid tumors (including relapsed disease) that are refractory to standard therapies or for which no effective standard therapy exists
5745257|NCT00339131|radiopharmaceutical|radiopharmaceutical
5745258|NCT00339131|radiation dosimetry|radiation dosimetry
5745259|NCT00339131|iodine|iodine
5745260|NCT00339131|MIBG|mibg
5745261|NCT00339131|iobenguane|iobenguane
5745262|NCT00339131|Ultratrace|ultratrace
5745263|NCT00339131|neuroendocrine tumors|neuroendocrine tumors
5745264|NCT00339105|Acute|acute
5745265|NCT00339105|Coronary|coronary
5745266|NCT00339105|Syndrome|syndrome
5745267|NCT00339105|HyperQ|hyperq
5745268|NCT00339105|High|high
5745269|NCT00339105|Frequency|frequency
5745270|NCT00339105|ECG|ecg
5745271|NCT00339105|chest|chest
5745272|NCT00339105|pain|pain
5745273|NCT00339092|HIV|hiv
5745274|NCT00339092|ART|art
5745275|NCT00339066|Late-Life Depression|late-life depression
5745276|NCT00339053|thoracic aortic aneurysm|thoracic aortic aneurysm
5745277|NCT00339053|immunonutrition|immunonutrition
5745278|NCT00339053|respiratory failure|respiratory failure
5745279|NCT00339053|lenght of stay ICU|lenght of stay icu
5745280|NCT00339040|HPV|hpv
5745281|NCT00339027|child care centers|child care centers
5745282|NCT00339027|community based research|community based research
5745283|NCT00339027|behavioral health|behavioral health
5745284|NCT00339027|health literacy|health literacy
5745285|NCT00339027|unmet healthcare needs|unmet healthcare needs
5745286|NCT00339001|Erythropoietin|erythropoietin
5745287|NCT00339001|Iron|iron
5745288|NCT00339001|Retinopathy of prematurity|retinopathy of prematurity
5745289|NCT00338988|Gastrointestinal|gastrointestinal
5745290|NCT00338988|Capecitabine|capecitabine
5745291|NCT00338988|Oxaliplatin|oxaliplatin
5745292|NCT00338988|Carcinoma of the Gallbladder|carcinoma of the gallbladder
5745293|NCT00338988|Carcinoma of the Intrahepatic or Extrahepatic Biliary Tract|carcinoma of the intrahepatic or extrahepatic biliary tract
5745294|NCT00338988|Xeloda|xeloda
5745295|NCT00338988|Eloxatin|eloxatin
5745296|NCT00338975|Psychotic Disorders|psychotic disorders
5745297|NCT00338975|Schizoaffective Disorder|schizoaffective disorder
5745298|NCT00338975|Cognitive Behavioral Therapy|cognitive behavioral therapy
5745299|NCT00338975|Social Skills Training|social skills training
5745300|NCT00338962|SSRI|ssri
5745301|NCT00338962|treatment|treatment
5745302|NCT00338962|naltrexone|naltrexone
5745303|NCT00338962|alcohol dependence|alcohol dependence
5745304|NCT00338962|Desipramine|desipramine
5745305|NCT00338962|depression|depression
5745306|NCT00338962|PTSD|ptsd
5745307|NCT00338949|Ziprasidone|ziprasidone
5745308|NCT00338949|Olanzapine|olanzapine
5745309|NCT00338949|Risperidone|risperidone
5745310|NCT00338949|Schizoaffective Disorder|schizoaffective disorder
5745311|NCT00338949|Insulin Sensitivity|insulin sensitivity
5745312|NCT00338949|Visceral Adiposity|visceral adiposity
5745313|NCT00338949|Metabolic Syndrome|metabolic syndrome
5745314|NCT00338936|Hypertension|hypertension
5745315|NCT00338936|Valsartan|valsartan
5745316|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide
5745317|NCT00338910|healthy volunteers|healthy volunteers
5745318|NCT00338897|Venous Thromboembolism|venous thromboembolism
5745319|NCT00338897|Prevention|prevention
5745320|NCT00338897|Arthroplasty|arthroplasty
5745321|NCT00338897|Replacement|replacement
5745322|NCT00338897|Hip|hip
5745323|NCT00338897|orthopedic surgery|orthopedic surgery
5745324|NCT00338845|STDs|stds
5745325|NCT00338832|Lifestyle Intervention|lifestyle intervention
5745326|NCT00338832|Schizoaffective Disorder|schizoaffective disorder
5745327|NCT00338819|DVT prevention|dvt prevention
5745328|NCT00338819|Hemodynamic study|hemodynamic study
5745329|NCT00338819|IPC|ipc
5745330|NCT00338819|CECT|cect
5745331|NCT00338806|Prevention|prevention
5745332|NCT00338806|Mood Disorders|mood disorders
5745333|NCT00338806|Unipolar Depression|unipolar depression
5745334|NCT00338793|Tuberculosis;|tuberculosis;
5745335|NCT00338793|Pleural effusion;|pleural effusion;
5745336|NCT00338793|Corticosteroids.|corticosteroids.
5745337|NCT00338780|Chronic Hepatitis B|chronic hepatitis b
5745339|NCT00338780|HBeAg negative|hbeag negative
5745340|NCT00338767|AIDS|aids
5745341|NCT00338767|DOT|dot
5745342|NCT00338767|Directly Observed Therapy|directly observed therapy
5745343|NCT00338715|Effectiveness|effectiveness
5745344|NCT00338715|Pulmonary Vein Isolation Procedure|pulmonary vein isolation procedure
5745345|NCT00338715|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5745346|NCT00338715|Atrial Fibrillation|atrial fibrillation
5745347|NCT00338702|Diabetic|diabetic
5745349|NCT00338702|Ulcer|ulcer
5745350|NCT00338702|Autologous|autologous
5745351|NCT00338702|Platelet|platelet
5745352|NCT00338702|Gel|gel
5745353|NCT00338689|infant formula|infant formula
5745354|NCT00338689|protein content|protein content
5745355|NCT00338689|growth|growth
5745356|NCT00338689|obesity|obesity
5745357|NCT00338689|breast feeding|breast feeding
5745358|NCT00338676|Aortic stenosis|aortic stenosis
5745359|NCT00338676|Elderly|elderly
5745360|NCT00338663|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5745361|NCT00338663|knee immobilization|knee immobilization
5745362|NCT00338663|postoperative pain|postoperative pain
5745363|NCT00338624|lower urinary tract symptoms|lower urinary tract symptoms
5745364|NCT00338624|DITROPAN XL|ditropan xl
5745365|NCT00338624|oxybutynin extended release tablets|oxybutynin extended release tablets
5745366|NCT00338611|vision therapy|vision therapy
5745367|NCT00338611|orthoptics|orthoptics
5745368|NCT00338611|pencil push-up therapy|pencil push-up therapy
5745369|NCT00338598|glycine|glycine
5745370|NCT00338598|treatment|treatment
5745371|NCT00338598|alcohol dependence|alcohol dependence
5745372|NCT00338598|schizophrenia|schizophrenia
5745373|NCT00338585|PAO|pao
5745374|NCT00338585|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5745375|NCT00338585|thrombolysis|thrombolysis
5745376|NCT00338585|blood clot|blood clot
5745377|NCT00338585|leg attack|leg attack
5745378|NCT00338585|alfimeprase|alfimeprase
5745379|NCT00338585|thrombus|thrombus
5745380|NCT00338585|embolism|embolism
5745381|NCT00338585|thromboembolism|thromboembolism
5745382|NCT00338585|claudication|claudication
5745383|NCT00338585|thrombolytic|thrombolytic
5745384|NCT00338585|thrombosis|thrombosis
5745385|NCT00338585|plasminogen activator|plasminogen activator
5745386|NCT00338585|arterial flow|arterial flow
5745387|NCT00338572|Inflammation|inflammation
5745388|NCT00338572|Blood Pressure, High|blood pressure, high
5745389|NCT00338559|Strabismus|strabismus
5745390|NCT00338559|LMA|lma
5745391|NCT00338559|ET Tube|et tube
5745392|NCT00338559|POV|pov
5745393|NCT00338546|Cocaine|cocaine
5745394|NCT00338546|Sympathetic nerve activity|sympathetic nerve activity
5745395|NCT00338546|Blood pressure|blood pressure
5745396|NCT00338546|Cutaneous vasoconstriction|cutaneous vasoconstriction
5745397|NCT00338546|Coronary vasoconstriction|coronary vasoconstriction
5745398|NCT00338533|childhood glaucoma|childhood glaucoma
5745399|NCT00338520|Cerebral malaria, phenylalanine, Tanzania|cerebral malaria, phenylalanine, tanzania
5745400|NCT00338507|Chronic Bronchitis|chronic bronchitis
5745401|NCT00338507|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5745402|NCT00338468|Anemia|anemia
5745403|NCT00338468|Elderly|elderly
5745404|NCT00338468|Hemoglobin level|hemoglobin level
5745405|NCT00338468|Chronic Kidney Disease|chronic kidney disease
5745406|NCT00338455|Congestive heart failure|congestive heart failure
5745407|NCT00338455|cardiac transplantation|cardiac transplantation
5745408|NCT00338455|renal insufficiency|renal insufficiency
5745409|NCT00338455|renal failure|renal failure
5745410|NCT00338455|dialysis|dialysis
5745411|NCT00338455|ultrafiltration|ultrafiltration
5745412|NCT00338455|vasodilator|vasodilator
5745413|NCT00338455|Natrecor (nesiritide)|natrecor (nesiritide)
5745414|NCT00338442|Immune compromised|immune compromised
5745415|NCT00338442|Varicella Zoster Virus ( VZV) Infection|varicella zoster virus ( vzv) infection
5745416|NCT00338442|Pediatric|pediatric
5745417|NCT00338429|sleep onset latency|sleep onset latency
5745418|NCT00338429|bedtime resistance|bedtime resistance
5745419|NCT00338416|Chemotherapy Induced Anemia|chemotherapy induced anemia
5745420|NCT00338416|PROCRIT (Epoetin alfa)|procrit (epoetin alfa)
5745421|NCT00338416|Chemotherapy|chemotherapy
5745422|NCT00338416|Epoetin alfa|epoetin alfa
5743892|NCT00343213|HPV|hpv
5745423|NCT00338403|CPAP pressure of -5cm/water during cold, dry air exposure|cpap pressure of -5cm/water during cold, dry air exposure
5798847|NCT00110838|n-3 fatty acids|n-3 fatty acids
5798848|NCT00110838|n-3 PUFA|n-3 pufa
5745424|NCT00338403|CPAP pressure of 0cm/water during cold, dry air exposure|cpap pressure of 0cm/water during cold, dry air exposure
5745425|NCT00338403|CPAP pressure of 5cm/water during cold, dry air exposure|cpap pressure of 5cm/water during cold, dry air exposure
5745426|NCT00338403|CPAP pressure of 10cm/water during cold, dry air exposure|cpap pressure of 10cm/water during cold, dry air exposure
5745427|NCT00338390|Antiretrovirals|antiretrovirals
5745428|NCT00338390|CD4 cell count|cd4 cell count
5745429|NCT00338390|toxicity|toxicity
5745430|NCT00338377|Melanoma|melanoma
5745431|NCT00338377|Regional nodal disease|regional nodal disease
5745432|NCT00338377|Dendritic Cell Immunization|dendritic cell immunization
5745433|NCT00338377|Lymphodepletion|lymphodepletion
5745434|NCT00338377|Adoptive Cell Transfer|adoptive cell transfer
5745435|NCT00338377|T Cells|t cells
5745436|NCT00338377|Vaccine|vaccine
5745437|NCT00338377|Cyclosphosphamide|cyclosphosphamide
5745439|NCT00338377|Neosar|neosar
5745440|NCT00338377|Dendritic Cells|dendritic cells
5745441|NCT00338377|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5745442|NCT00338377|TIL Cells|til cells
5745443|NCT00338377|MART Peptide|mart peptide
5745444|NCT00338377|Fludarabine|fludarabine
5745445|NCT00338377|Fludarabine Phosphate|fludarabine phosphate
5745446|NCT00338377|Fludara|fludara
5745447|NCT00338377|Proleukin|proleukin
5745448|NCT00338377|IL-2|il-2
5745449|NCT00338377|Interleukin-2|interleukin-2
5745450|NCT00338377|Leptomeningeal disease|leptomeningeal disease
5745451|NCT00338364|Pediatric pain|pediatric pain
5745452|NCT00338364|Pediatric anxiety|pediatric anxiety
5745453|NCT00338364|Painful procedures|painful procedures
5745454|NCT00338338|essential hypertension|essential hypertension
5745455|NCT00338338|Amlodipine|amlodipine
5745456|NCT00338338|blood pressure|blood pressure
5745457|NCT00338338|lacidipine|lacidipine
5745458|NCT00338325|Pediatric Anxiety|pediatric anxiety
5745459|NCT00338325|Pediatric Pain|pediatric pain
5745460|NCT00338312|Natural Menopause|natural menopause
5745461|NCT00338312|HSDD|hsdd
5745462|NCT00338299|Anemia|anemia
5745463|NCT00338299|hemoglobin|hemoglobin
5745464|NCT00338299|chemotherapy|chemotherapy
5745465|NCT00338299|subcutaneous injection|subcutaneous injection
5745466|NCT00338299|Epoetin alfa|epoetin alfa
5745467|NCT00338286|anemia|anemia
5745468|NCT00338286|metastatic breast cancer|metastatic breast cancer
5745469|NCT00338286|Hemoglobin|hemoglobin
5745470|NCT00338286|progression-free survival (PFS)|progression-free survival (pfs)
5745471|NCT00338286|erythropoiesis-stimulating agents (ESA)|erythropoiesis-stimulating agents (esa)
5745472|NCT00338273|Bipolar I disorder with major depressive episode|bipolar i disorder with major depressive episode
5745473|NCT00338247|advanced|advanced
5745474|NCT00338247|TYKERB|tykerb
5745475|NCT00338247|HER2 positive|her2 positive
5745476|NCT00338247|Stage IIIc|stage iiic
5745477|NCT00338247|ErbB2 positive|erbb2 positive
5745478|NCT00338247|GW572016|gw572016
5745479|NCT00338247|metastatic|metastatic
5745480|NCT00338247|Stage IIIb|stage iiib
5745481|NCT00338247|breast cancer|breast cancer
5745482|NCT00338234|anemia|anemia
5745483|NCT00338234|intensive care|intensive care
5745484|NCT00338234|cardiac surgery|cardiac surgery
5745485|NCT00338234|iron metabolism|iron metabolism
5745486|NCT00338234|hepcidin|hepcidin
5745487|NCT00338221|Diarrhea, Malnutrition, Brazil|diarrhea, malnutrition, brazil
5745488|NCT00338208|low vision|low vision
5745489|NCT00338208|glaucoma|glaucoma
5745490|NCT00338195|Caffeine dependence|caffeine dependence
5745491|NCT00338195|Caffeine withdrawal|caffeine withdrawal
5745492|NCT00338182|Solid tumor|solid tumor
5745493|NCT00338156|Left Ventricle Remodelling|left ventricle remodelling
5745494|NCT00338156|Collagen markers|collagen markers
5745495|NCT00338156|Neurohormones|neurohormones
5745496|NCT00338156|Cardiac MRI|cardiac mri
5745497|NCT00338143|Plaque psoriasis|plaque psoriasis
5745498|NCT00338143|Antipsoriatic|antipsoriatic
5745499|NCT00338130|Melanoma|melanoma
5745500|NCT00338130|Phase II|phase ii
5745501|NCT00338130|AZD6244|azd6244
5745502|NCT00338130|temozolomide|temozolomide
5745503|NCT00338117|Dementia|dementia
5745504|NCT00338117|neurodegenerative disorder|neurodegenerative disorder
5745505|NCT00338117|impairment of memory|impairment of memory
5745506|NCT00338117|galantamine|galantamine
5745507|NCT00338117|galanthamine|galanthamine
5745508|NCT00338117|acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5745509|NCT00338117|Mini Mental State Examination score|mini mental state examination score
5745510|NCT00338104|insulin|insulin
5745511|NCT00338104|glargine|glargine
5745512|NCT00338104|intravenous|intravenous
5745513|NCT00338104|subcutaneous|subcutaneous
5745514|NCT00338104|hospital|hospital
5745515|NCT00338104|diabetes|diabetes
5745516|NCT00338104|glucose|glucose
5745517|NCT00338104|inpatient|inpatient
5745518|NCT00338091|Renal Insufficiency,Chronic|renal insufficiency,chronic
5745519|NCT00338091|Disease Progression|disease progression
5745520|NCT00338091|Proteinuria|proteinuria
5745521|NCT00338091|Dose-Response Relationship,Drug|dose-response relationship,drug
5745522|NCT00338091|Benazepril|benazepril
5745523|NCT00338091|Losartan|losartan
5745525|NCT00338052|Contraception|contraception
5745526|NCT00338039|Pancreatic Cancer|pancreatic cancer
5745527|NCT00338039|Cetuximab|cetuximab
5745528|NCT00338039|C225|c225
5745529|NCT00338039|Erbitux|erbitux
5745530|NCT00338039|Gemcitabine|gemcitabine
5745531|NCT00338039|Oxaliplatin|oxaliplatin
5745532|NCT00338039|Eloxatin|eloxatin
5745533|NCT00338039|Capecitabine|capecitabine
5745534|NCT00338039|Xeloda|xeloda
5745535|NCT00338026|Solid Tumors|solid tumors
5745536|NCT00338026|Thallion|thallion
5745537|NCT00338026|TLN-4601|tln-4601
5745538|NCT00338026|Ecopia|ecopia
5745539|NCT00338026|ECO-4601|eco-4601
5745540|NCT00338026|Patients with histologically confirmed solid tumors:|patients with histologically confirmed solid tumors:
5745541|NCT00338026|High Grade Glioma|high grade glioma
5739950|NCT00358098|PET|pet
5745550|NCT00338000|left ventricular hypertrophy|left ventricular hypertrophy
5745551|NCT00338000|epoetin alfa|epoetin alfa
5745552|NCT00337974|cognitive enhancement|cognitive enhancement
5745554|NCT00337974|auditory memory|auditory memory
5745555|NCT00337974|speech|speech
5745556|NCT00337974|computerized|computerized
5745557|NCT00337961|Optic Nerve Sheath Fenestration|optic nerve sheath fenestration
5745558|NCT00337948|Anemia|anemia
5745559|NCT00337948|Epoetin Alfa|epoetin alfa
5745560|NCT00337948|Chemotherapy|chemotherapy
5745561|NCT00337948|Anemia due to Cancer|anemia due to cancer
5745562|NCT00337935|Long Term Care Facilities|long term care facilities
5745563|NCT00337935|subcutaneous injections|subcutaneous injections
5745564|NCT00337935|PROCRIT|procrit
5745565|NCT00337935|Epoetin alfa|epoetin alfa
5745566|NCT00337935|Anemia|anemia
5745567|NCT00337922|EPZICOM|epzicom
5745568|NCT00337922|Lamivudine|lamivudine
5745569|NCT00337922|Abacavir|abacavir
5745570|NCT00337922|pharmacokinetics|pharmacokinetics
5745571|NCT00337922|Japanese|japanese
5745572|NCT00337909|cognitive enhancement|cognitive enhancement
5745573|NCT00337909|memory|memory
5745574|NCT00337909|auditory memory|auditory memory
5755256|NCT00300560|Colistin|colistin
5745575|NCT00337909|speech|speech
5745576|NCT00337909|computerized|computerized
5745577|NCT00337896|vaccine, influenza, A/H5N1, CMI, sub-study|vaccine, influenza, a/h5n1, cmi, sub-study
5745578|NCT00337883|Glioblastoma Multiforme|glioblastoma multiforme
5745579|NCT00337883|glioma|glioma
5745580|NCT00337883|Grade IV glioma|grade iv glioma
5745581|NCT00337870|Pediatric Anxiety|pediatric anxiety
5745582|NCT00337870|Pediatric Pain|pediatric pain
5745583|NCT00337870|Emergency room procedures|emergency room procedures
5745584|NCT00337818|Non-inferiority|non-inferiority
5745585|NCT00337818|Immunogenicity|immunogenicity
5745586|NCT00337818|HPV Vaccine Consistency|hpv vaccine consistency
5745587|NCT00337805|colloid|colloid
5745588|NCT00337805|crystalloid|crystalloid
5745589|NCT00337805|hemodynamics|hemodynamics
5745590|NCT00337805|flow-directed|flow-directed
5745591|NCT00337805|resuscitation|resuscitation
5745592|NCT00337766|Blood Loss|blood loss
5745593|NCT00337766|Postoperative Blood loss|postoperative blood loss
5745594|NCT00337753|Gambling|gambling
5745595|NCT00337714|Central venous catheter,|central venous catheter,
5745596|NCT00337714|bloodstream infections,|bloodstream infections,
5745597|NCT00337714|intensive care unit|intensive care unit
5745598|NCT00337688|Cerebral Palsy|cerebral palsy
5745599|NCT00337688|Spasticity|spasticity
5745600|NCT00337688|Joystick|joystick
5745601|NCT00337688|Wheelchair|wheelchair
5745602|NCT00337688|rehabilitation|rehabilitation
5745604|NCT00337636|INCL|incl
5745605|NCT00337636|LINCL|lincl
5745606|NCT00337636|Batten disease|batten disease
5745607|NCT00337636|Infantile Neuronal Ceroid Lipofuscinosis (INCL)|infantile neuronal ceroid lipofuscinosis (incl)
5745608|NCT00337636|Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)|late infantile neuronal ceroid lipofuscinosis (lincl)
5745609|NCT00337623|Cataracts|cataracts
5745610|NCT00337623|Corticosteroids|corticosteroids
5745611|NCT00337623|Scheimpflug|scheimpflug
5745612|NCT00337623|Lens autofluorescence|lens autofluorescence
5745613|NCT00337597|Normal saline|normal saline
5745614|NCT00337597|Dextrose 5% in water|dextrose 5% in water
5745615|NCT00337597|neurostimulation|neurostimulation
5745616|NCT00337597|Continuous regional analgesia after total knee arthroplasty|continuous regional analgesia after total knee arthroplasty
5745617|NCT00337584|out patient surgery|out patient surgery
5745618|NCT00337584|quality improvement|quality improvement
5745619|NCT00337571|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5745620|NCT00337558|treatment outcomes|treatment outcomes
5745621|NCT00337558|Overactive bladder|overactive bladder
5745622|NCT00337558|Solifenacin succinate|solifenacin succinate
5745623|NCT00337558|urinary incontinence|urinary incontinence
5745624|NCT00337558|urge incontinence|urge incontinence
5745625|NCT00337558|frequency|frequency
5745626|NCT00337545|Metastatic|metastatic
5745627|NCT00337545|Refractory|refractory
5745628|NCT00337519|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5745629|NCT00337519|reduced intensity conditioning|reduced intensity conditioning
5745630|NCT00337519|alemtuzumab|alemtuzumab
5745631|NCT00337519|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5745632|NCT00337506|the efficacy and safety of Velcade plus dexamethasone|the efficacy and safety of velcade plus dexamethasone
5745634|NCT00337480|acute coronary syndrome|acute coronary syndrome
5745635|NCT00337480|cardiovascular risk factors|cardiovascular risk factors
5745636|NCT00337480|smoking habits|smoking habits
5745637|NCT00337480|obesity|obesity
5745638|NCT00337480|sedentary lifestyle|sedentary lifestyle
5745639|NCT00337480|overweight|overweight
5745640|NCT00337480|education|education
5745641|NCT00337480|follow up after hospitalization|follow up after hospitalization
5745642|NCT00337467|HIV-Infected Patients Evidencing Virologic Suppression|hiv-infected patients evidencing virologic suppression
5745643|NCT00337454|Imatinib resistant or intolerant CML|imatinib resistant or intolerant cml
5745644|NCT00337454|Treatment resistant or intolerant Ph+ALL|treatment resistant or intolerant ph+all
5745646|NCT00337441|Anemia|anemia
5745647|NCT00337441|Chronic Diseases|chronic diseases
5745648|NCT00337441|Elderly|elderly
5745649|NCT00337441|Epoetin alfa|epoetin alfa
5745650|NCT00337441|Fatigue|fatigue
5745651|NCT00337441|Quality of life|quality of life
5745652|NCT00337441|Mobility|mobility
5745653|NCT00337402|Gastrostomy|gastrostomy
5745654|NCT00337402|Quality of life|quality of life
5745655|NCT00337389|Metastatic|metastatic
5745656|NCT00337389|Colorectal|colorectal
5745657|NCT00337389|Cancer|cancer
5745658|NCT00337389|CoFactor|cofactor
5745659|NCT00337389|Stage IV|stage iv
5745660|NCT00337350|Schizophrenia|schizophrenia
5745661|NCT00337350|Glucose Metabolism|glucose metabolism
5745662|NCT00337350|Insulin Resistance|insulin resistance
5745663|NCT00337337|Diabetes|diabetes
5745664|NCT00337337|rice|rice
5745665|NCT00337337|fiber|fiber
5745666|NCT00337324|Diabetic neuropathy|diabetic neuropathy
5745667|NCT00337324|Complications of diabetes|complications of diabetes
5745668|NCT00337324|Neuropathies|neuropathies
5745669|NCT00337324|Electromagnetic stimulation|electromagnetic stimulation
5745670|NCT00337324|Neuropathic pain|neuropathic pain
5745671|NCT00337298|Diabetes|diabetes
5745672|NCT00337298|Retinopathy|retinopathy
5745673|NCT00337298|Blood Pressure|blood pressure
5745674|NCT00337298|Amlodipine|amlodipine
5745675|NCT00337298|Lisinopril|lisinopril
5745676|NCT00337285|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5745677|NCT00337285|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5745678|NCT00337285|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5745679|NCT00337272|chronic insomnia|chronic insomnia
5745680|NCT00337259|marginal zone lymphoma|marginal zone lymphoma
5745681|NCT00337259|gemcitabine|gemcitabine
5745682|NCT00337246|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5745683|NCT00337246|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5745684|NCT00337246|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5745685|NCT00337246|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5745686|NCT00337246|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5745687|NCT00337233|fatigue|fatigue
5745688|NCT00337233|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5745689|NCT00337233|recurrent breast cancer|recurrent breast cancer
5745690|NCT00337233|stage I breast cancer|stage i breast cancer
5745691|NCT00337233|stage II breast cancer|stage ii breast cancer
5745692|NCT00337233|stage IIIA breast cancer|stage iiia breast cancer
5745693|NCT00337233|stage IIIB breast cancer|stage iiib breast cancer
5745694|NCT00337233|stage IIIC breast cancer|stage iiic breast cancer
5745695|NCT00337233|stage IV breast cancer|stage iv breast cancer
5745696|NCT00337233|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5745697|NCT00337233|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5745699|NCT00337233|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5745700|NCT00337233|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5745701|NCT00337233|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5745702|NCT00337233|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5745867|NCT00336544|Cethromycin|cethromycin
5745703|NCT00337233|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5745704|NCT00337233|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5745705|NCT00337233|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5745706|NCT00337220|allograft|allograft
5745707|NCT00337220|graft|graft
5745708|NCT00337207|adult glioblastoma|adult glioblastoma
5745709|NCT00337207|adult gliosarcoma|adult gliosarcoma
5745710|NCT00337207|recurrent adult brain tumor|recurrent adult brain tumor
5745711|NCT00337207|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5745712|NCT00337207|adult giant cell glioblastoma|adult giant cell glioblastoma
5745713|NCT00337181|HIV-1|hiv-1
5745714|NCT00337181|Natural History|natural history
5745715|NCT00337181|HIV vaccine|hiv vaccine
5745716|NCT00337181|Thailand|thailand
5745717|NCT00337168|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5761979|NCT00276198|Infants|infants
5745718|NCT00337168|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5744330|NCT00341796|Antiretroviral|antiretroviral
5744331|NCT00341796|Outcomes|outcomes
5744332|NCT00341783|Plasmodium|plasmodium
5744333|NCT00341783|Falciparum|falciparum
5745719|NCT00337168|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5745720|NCT00337168|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5745721|NCT00337168|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5745722|NCT00337155|Recurrent Prostate Cancer|recurrent prostate cancer
5745723|NCT00337155|metastatic Cancer|metastatic cancer
5745724|NCT00337142|gestational diabetes|gestational diabetes
5745725|NCT00337142|newborn|newborn
5745726|NCT00337142|hypoglycemia|hypoglycemia
5745727|NCT00337129|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5745728|NCT00337129|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5745729|NCT00337129|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5745730|NCT00337129|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5745731|NCT00337129|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5745732|NCT00337129|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5745733|NCT00337129|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5745734|NCT00337129|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5745735|NCT00337129|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5745736|NCT00337129|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5745737|NCT00337129|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5745738|NCT00337129|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5745739|NCT00337129|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5745740|NCT00337129|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5745741|NCT00337090|Over Active Bladder|over active bladder
5745742|NCT00337090|Urinary incontinence|urinary incontinence
5745743|NCT00337090|YM178|ym178
5745744|NCT00337090|Symptomatic Over Active Bladder|symptomatic over active bladder
5745745|NCT00337077|Eribulin Mesylate|eribulin mesylate
5745746|NCT00337077|metastatic hormone refractory prostate cancer|metastatic hormone refractory prostate cancer
5745747|NCT00337077|Halichondrin B Analog|halichondrin b analog
5745748|NCT00337064|Breast cancer treatment|breast cancer treatment
5745749|NCT00337064|Partial breast radiation|partial breast radiation
5745750|NCT00337064|Radiation Therapy|radiation therapy
5745751|NCT00337064|Adjuvant Treatment|adjuvant treatment
5745752|NCT00337051|Renal transplantation|renal transplantation
5745753|NCT00337051|renal allograft|renal allograft
5745754|NCT00337051|end-stage renal disease|end-stage renal disease
5745755|NCT00337051|renal failure|renal failure
5745756|NCT00337051|general anaesthesia|general anaesthesia
5745757|NCT00337051|inhaled anaesthetic|inhaled anaesthetic
5745758|NCT00337051|Sevoflurane|sevoflurane
5745759|NCT00337051|ischemia|ischemia
5745760|NCT00337051|reperfusion|reperfusion
5745761|NCT00337051|ischemic lesions|ischemic lesions
5745762|NCT00336973|Plaque Psoriasis|plaque psoriasis
5745763|NCT00336973|Raptiva|raptiva
5745764|NCT00336973|Anti-TNF|anti-tnf
5745765|NCT00336960|stage II rectal cancer|stage ii rectal cancer
5745766|NCT00336960|stage III rectal cancer|stage iii rectal cancer
5745767|NCT00336960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5745768|NCT00336947|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5745769|NCT00336947|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5745770|NCT00336947|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5745771|NCT00336947|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5745772|NCT00336947|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5745773|NCT00336947|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5745774|NCT00336947|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5745775|NCT00336947|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5746060|NCT00335634|Intimacy|intimacy
5745776|NCT00336947|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5745777|NCT00336947|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5745778|NCT00336934|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5745779|NCT00336934|recurrent prostate cancer|recurrent prostate cancer
5745780|NCT00336934|stage I prostate cancer|stage i prostate cancer
5686278|NCT00552682|fibromialgy|fibromialgy
5745781|NCT00336934|stage II prostate cancer|stage ii prostate cancer
5745782|NCT00336934|stage III prostate cancer|stage iii prostate cancer
5745783|NCT00336934|stage IV prostate cancer|stage iv prostate cancer
5745784|NCT00336908|Intensive Care,Neonatal|intensive care,neonatal
5745785|NCT00336908|Parenteral nutrition|parenteral nutrition
5745786|NCT00336908|Fat emulsions,Intravenous|fat emulsions,intravenous
5745787|NCT00336895|Liver transplantation|liver transplantation
5745788|NCT00336895|mycophenolate mofetil|mycophenolate mofetil
5745789|NCT00336895|gastrointestinal|gastrointestinal
5745790|NCT00336895|adverse effects|adverse effects
5745791|NCT00336882|traumatic brain injury|traumatic brain injury
5745792|NCT00336882|propofol|propofol
5745793|NCT00336882|oxidative stress|oxidative stress
5745794|NCT00336882|microdialysis|microdialysis
5745795|NCT00336856|Colon Cancer|colon cancer
5745797|NCT00336843|B-cell non-Hodgkin's lymphoma|b-cell non-hodgkin's lymphoma
5745798|NCT00336843|autologous stem cell transplantation|autologous stem cell transplantation
5745799|NCT00336843|BuCyE regimen|bucye regimen
5745800|NCT00336830|Cardiac Rehabilitation|cardiac rehabilitation
5745801|NCT00336830|Improving Cardiac Rehabilitation Participation|improving cardiac rehabilitation participation
5745803|NCT00336830|coronary artery bypass surgery|coronary artery bypass surgery
5745804|NCT00336817|Liver transplantation|liver transplantation
5745805|NCT00336817|mycophenolate mofetil|mycophenolate mofetil
5745806|NCT00336817|gastrointestinal|gastrointestinal
5745807|NCT00336817|adverse effects|adverse effects
5745808|NCT00336791|Breast Cancer|breast cancer
5745809|NCT00336791|Gene Expression|gene expression
5745810|NCT00336791|Fluorouracil|fluorouracil
5745811|NCT00336791|Cyclophosphamide|cyclophosphamide
5745812|NCT00336791|Doxorubicin|doxorubicin
5745813|NCT00336791|Paclitaxel|paclitaxel
5745814|NCT00336765|solid tumors|solid tumors
5745815|NCT00336752|undisplaced ,unstable wEBER B ankle fractures|undisplaced ,unstable weber b ankle fractures
5745816|NCT00336752|operative intervention|operative intervention
5745817|NCT00336752|non operative intervention|non operative intervention
5745818|NCT00336739|Gastric acidity determination|gastric acidity determination
5745819|NCT00336739|Calcium sensing receptor|calcium sensing receptor
5745820|NCT00336713|depression|depression
5745821|NCT00336713|antidepressive agents|antidepressive agents
5745822|NCT00336713|controlled clinical trial|controlled clinical trial
5745823|NCT00336700|Pancreas|pancreas
5745824|NCT00336700|Cancer|cancer
5745825|NCT00336700|Pancreatic|pancreatic
5745826|NCT00336687|Thrombopenia|thrombopenia
5745827|NCT00336687|Reanimation|reanimation
5745828|NCT00336687|Thrombopenia in reanimation|thrombopenia in reanimation
5745829|NCT00336674|Type 1 diabetes|type 1 diabetes
5745830|NCT00336661|Periodontitis|periodontitis
5745831|NCT00336661|Chronic Periodontitis|chronic periodontitis
5745832|NCT00336661|Gingivitis|gingivitis
5745833|NCT00336661|PERIOWAVE|periowave
5745834|NCT00336661|Photodynamic Disinfection|photodynamic disinfection
5745835|NCT00336648|Pancreatic Neoplasms|pancreatic neoplasms
5745836|NCT00336648|Bevacizumab|bevacizumab
5745837|NCT00336648|Gemcitabine|gemcitabine
5745838|NCT00336648|Radiation Therapy|radiation therapy
5745839|NCT00336648|adenocarcinoma of the pancreatic head|adenocarcinoma of the pancreatic head
5745840|NCT00336648|adenocarcinoma of the uncinate process|adenocarcinoma of the uncinate process
5745841|NCT00336635|smallpox, vaccine, immunity|smallpox, vaccine, immunity
5745842|NCT00336622|Carpal Tunnel Syndrome|carpal tunnel syndrome
5745843|NCT00336622|Splints|splints
5745844|NCT00336596|middle cerebral artery occlusion|middle cerebral artery occlusion
5745845|NCT00336596|intracranial embolism and thrombosis|intracranial embolism and thrombosis
5745846|NCT00336596|ultrasound enhanced thrombolysis|ultrasound enhanced thrombolysis
5745847|NCT00336596|Patients receiving iv thrombolytic therapy (t-PA)|patients receiving iv thrombolytic therapy (t-pa)
5745848|NCT00336583|oxaliplatin|oxaliplatin
5745849|NCT00336583|ESHAOX|eshaox
5745850|NCT00336583|refractory|refractory
5745851|NCT00336583|relapsed|relapsed
5745852|NCT00336583|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5745853|NCT00336570|Oxidative Stress|oxidative stress
5745854|NCT00336570|Endothelial Function|endothelial function
5745855|NCT00336570|Flow Mediated Dilation|flow mediated dilation
5745856|NCT00336557|High-Dose Interferon|high-dose interferon
5745857|NCT00336557|Neutralizing Antibodies|neutralizing antibodies
5745858|NCT00336544|Pneumonia|pneumonia
5745859|NCT00336544|Respiratory|respiratory
5745860|NCT00336544|Infection|infection
5745861|NCT00336544|Infectious|infectious
5745862|NCT00336544|Advanced|advanced
5745863|NCT00336544|Life|life
5745864|NCT00336544|Sciences|sciences
5745865|NCT00336544|Lung|lung
5745866|NCT00336544|Pulmonary|pulmonary
5745868|NCT00336544|Clarithromycin|clarithromycin
5745869|NCT00336544|Biaxin|biaxin
5745870|NCT00336531|prophylactic itraconazole|prophylactic itraconazole
5745871|NCT00336531|Relapsed pediatric solid tumors|relapsed pediatric solid tumors
5745872|NCT00336531|Embryonal brain tumor|embryonal brain tumor
5745873|NCT00336505|Pneumonia|pneumonia
5745874|NCT00336505|Respiratory|respiratory
5745875|NCT00336505|Infection|infection
5744652|NCT00340938|Adherence|adherence
5745876|NCT00336505|Infectious|infectious
5745877|NCT00336505|Advanced|advanced
5745878|NCT00336505|Life|life
5745879|NCT00336505|Sciences|sciences
5745880|NCT00336505|Lung|lung
5762171|NCT00275106|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5762179|NCT00275054|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5762180|NCT00275054|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5762181|NCT00275054|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5762182|NCT00275054|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5762183|NCT00275041|recurrent breast cancer|recurrent breast cancer
5745882|NCT00336505|Cethromycin|cethromycin
5745883|NCT00336505|Restanza|restanza
5745884|NCT00336505|Clarithromycin|clarithromycin
5745885|NCT00336505|Biaxin|biaxin
5745886|NCT00336492|Ulcerative colitis|ulcerative colitis
5745887|NCT00336492|inflammatory bowel disease|inflammatory bowel disease
5745888|NCT00336492|children|children
5745889|NCT00336466|Cardiac bypass surgery|cardiac bypass surgery
5745890|NCT00336453|Influenza|influenza
5745891|NCT00336427|MRSA|mrsa
5745892|NCT00336427|Colonization|colonization
5745893|NCT00336427|Pregnancy|pregnancy
5745894|NCT00336427|Neonates|neonates
5745895|NCT00336414|Juvenile Systemic Lupus Erythematosus nephritis|juvenile systemic lupus erythematosus nephritis
5745896|NCT00336414|randomised actively controlled clinical trial|randomised actively controlled clinical trial
5745897|NCT00336414|cyclophosphamide|cyclophosphamide
5745898|NCT00336414|prednisone|prednisone
5745899|NCT00336414|azathioprine|azathioprine
5745900|NCT00336414|methylprednisolone|methylprednisolone
5745901|NCT00336401|anesthesia|anesthesia
5745902|NCT00336401|non cardiac surgery|non cardiac surgery
5745903|NCT00336401|cardiac outcomes|cardiac outcomes
5745905|NCT00336362|Beta Thalassemia Major|beta thalassemia major
5745906|NCT00336362|Hematopoietic Stem Cell Mobilization|hematopoietic stem cell mobilization
5745907|NCT00336362|Gene Transfer Techniques|gene transfer techniques
5745908|NCT00336349|diabetes mellitus|diabetes mellitus
5745909|NCT00336349|neuropathic pain|neuropathic pain
5745910|NCT00336323|diabetic|diabetic
5745911|NCT00336323|macular|macular
5745912|NCT00336323|edema|edema
5745913|NCT00336323|avastin|avastin
5745914|NCT00336323|bevacizumab|bevacizumab
5745915|NCT00336323|anti-VEGF|anti-vegf
5745916|NCT00336323|retinal thickness|retinal thickness
5745917|NCT00336323|visual acuity|visual acuity
5745919|NCT00336310|Diabetes Mellitus|diabetes mellitus
5745920|NCT00336310|Treatment|treatment
5745921|NCT00336310|Repaglinide|repaglinide
5745922|NCT00336297|screening|screening
5745923|NCT00336297|screening methods|screening methods
5745924|NCT00336297|intimate partner violence|intimate partner violence
5745925|NCT00336284|Telemonitoring|telemonitoring
5745927|NCT00336284|Reduction of office follow-ups|reduction of office follow-ups
5745928|NCT00336271|coffee|coffee
5745929|NCT00336271|caffeine|caffeine
5745930|NCT00336271|healthy subjects|healthy subjects
5745931|NCT00336258|Deep Vein Thrombosis|deep vein thrombosis
5745932|NCT00336258|Cancer|cancer
5745933|NCT00336258|US- Doppler|us- doppler
5745934|NCT00336258|Procoagulant Microparticles|procoagulant microparticles
5745935|NCT00336258|Asymptomatic|asymptomatic
5745936|NCT00336245|Contraception|contraception
5745937|NCT00336245|Women|women
5745938|NCT00336245|HIV/AIDS|hiv/aids
5745939|NCT00336245|IUD|iud
5745940|NCT00336245|IUCD|iucd
5745941|NCT00336232|Vitamin K metabolism|vitamin k metabolism
5745942|NCT00336232|Bone health|bone health
5745943|NCT00336232|Metabolism|metabolism
5745944|NCT00336219|GERD|gerd
5745945|NCT00336219|Pantoprazole|pantoprazole
5745946|NCT00336206|Low dose Alemtuzumab|low dose alemtuzumab
5745947|NCT00336206|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5745948|NCT00336206|B-Cell|b-cell
5745949|NCT00336193|home visitation|home visitation
5745950|NCT00336193|family outcomes|family outcomes
5745951|NCT00336193|competency training|competency training
5745952|NCT00336180|Adolescent|adolescent
5745953|NCT00336180|Adolescent behavior|adolescent behavior
5745954|NCT00336180|Adolescent development|adolescent development
5745955|NCT00336180|Drinking behavior|drinking behavior
5745956|NCT00336180|Health behavior|health behavior
5745957|NCT00336180|Reproductive Behavior|reproductive behavior
5745958|NCT00336180|Sexual Behavior|sexual behavior
5745959|NCT00336180|South Africa|south africa
5745960|NCT00336167|carnitine palmitoyl transferase 2 deficiency|carnitine palmitoyl transferase 2 deficiency
5745961|NCT00336167|Fatty acid oxidation|fatty acid oxidation
5745962|NCT00336167|Mitochondria|mitochondria
5745963|NCT00336128|infant|infant
5745964|NCT00336128|kindergarten|kindergarten
5745965|NCT00336128|obesity|obesity
5745966|NCT00336128|adiposity|adiposity
5745967|NCT00336115|pertussis|pertussis
5745968|NCT00336115|bone marrow transplant|bone marrow transplant
5745970|NCT00336102|hypothyroidism|hypothyroidism
5745971|NCT00336102|stage I breast cancer|stage i breast cancer
5745972|NCT00336102|stage II breast cancer|stage ii breast cancer
5745973|NCT00336102|stage IIIA breast cancer|stage iiia breast cancer
5745974|NCT00336102|stage IIIB breast cancer|stage iiib breast cancer
5745975|NCT00336089|fatigue|fatigue
5745976|NCT00336089|pain|pain
5745977|NCT00336089|cancer survivor|cancer survivor
5745978|NCT00336089|breast cancer in situ|breast cancer in situ
5745979|NCT00336089|inflammatory breast cancer|inflammatory breast cancer
5745980|NCT00336089|stage IA breast cancer|stage ia breast cancer
5745981|NCT00336089|stage IB breast cancer|stage ib breast cancer
5745982|NCT00336089|stage II breast cancer|stage ii breast cancer
5745983|NCT00336089|stage IIIA breast cancer|stage iiia breast cancer
5745984|NCT00336089|stage IIIB breast cancer|stage iiib breast cancer
5745985|NCT00336089|stage IIIC breast cancer|stage iiic breast cancer
5745986|NCT00336089|stage IV breast cancer|stage iv breast cancer
5745987|NCT00336089|recurrent breast cancer|recurrent breast cancer
5745988|NCT00336076|Mast cell disease|mast cell disease
5745989|NCT00336076|Anaphylaxis|anaphylaxis
5745990|NCT00336076|c-kit|c-kit
5745991|NCT00336076|Mutation|mutation
5745992|NCT00336076|Mastocytosis (suspected or proven)|mastocytosis (suspected or proven)
5745993|NCT00336050|Air Pollution|air pollution
5745994|NCT00336050|Pulmonary Function|pulmonary function
5745995|NCT00336011|pacemaker|pacemaker
5745996|NCT00336011|magnetic resonance imaging|magnetic resonance imaging
5745997|NCT00336011|safety|safety
5745998|NCT00335985|polymyositis, dermatomyositis|polymyositis, dermatomyositis
5745999|NCT00335985|High-dose intravenous immunoglobulin|high-dose intravenous immunoglobulin
5746000|NCT00335985|Venoglobulin-IH|venoglobulin-ih
5746001|NCT00335985|Steroid-resistant polymyositis(PM) and dermatomyositis(DM)|steroid-resistant polymyositis(pm) and dermatomyositis(dm)
5746002|NCT00335972|Carotid Endarterectomy patients|carotid endarterectomy patients
5746003|NCT00335959|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5746096|NCT00335478|infection|infection
5746004|NCT00335959|stage I gastric cancer|stage i gastric cancer
5746005|NCT00335959|stage II gastric cancer|stage ii gastric cancer
5746006|NCT00335959|stage III gastric cancer|stage iii gastric cancer
5746007|NCT00335933|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5746008|NCT00335920|Sudden Hearing Loss|sudden hearing loss
5746009|NCT00335920|intratympanic|intratympanic
5746010|NCT00335920|steroids|steroids
5746011|NCT00335907|Clinical trial|clinical trial
5746012|NCT00335907|Controlled clinical trial|controlled clinical trial
5746013|NCT00335907|Shock, Septic|shock, septic
5746014|NCT00335894|Infertility|infertility
5746015|NCT00335894|IVF|ivf
5746016|NCT00335894|ART|art
5746017|NCT00335894|hMG|hmg
5746018|NCT00335881|Prophylaxis for hepatitis B disease|prophylaxis for hepatitis b disease
5746019|NCT00335868|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5746020|NCT00335868|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5746021|NCT00335868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5746022|NCT00335868|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5746023|NCT00335855|Device, influenza|device, influenza
5746024|NCT00335829|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5746025|NCT00335829|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5746026|NCT00335829|advanced adult primary liver cancer|advanced adult primary liver cancer
5746027|NCT00335829|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5746028|NCT00335816|stage II rectal cancer|stage ii rectal cancer
5746029|NCT00335816|stage III rectal cancer|stage iii rectal cancer
5746030|NCT00335816|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5746031|NCT00335751|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5746032|NCT00335751|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5746033|NCT00335751|localized osteosarcoma|localized osteosarcoma
5746034|NCT00335751|metastatic osteosarcoma|metastatic osteosarcoma
5746035|NCT00335751|recurrent osteosarcoma|recurrent osteosarcoma
5746036|NCT00335751|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5746037|NCT00335751|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5746038|NCT00335751|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5746039|NCT00335725|Ovarian stimulation|ovarian stimulation
5746040|NCT00335725|Infertility|infertility
5746041|NCT00335725|ICSI|icsi
5746043|NCT00335712|ONO-5129|ono-5129
5746044|NCT00335712|type 2 diabetes mellitus|type 2 diabetes mellitus
5746045|NCT00335699|Hypercholesterolemia with nondiabetic metabolic syndrome|hypercholesterolemia with nondiabetic metabolic syndrome
5746046|NCT00335686|Mitochondrial toxicity|mitochondrial toxicity
5746047|NCT00335686|Lopinavir-rtv|lopinavir-rtv
5746048|NCT00335686|Nevirapine|nevirapine
5746049|NCT00335686|DNA mitochondrial/DNA nuclear|dna mitochondrial/dna nuclear
5746050|NCT00335660|Idiopathic Detrusor Overactivity|idiopathic detrusor overactivity
5746051|NCT00335660|NK-1 Receptor Antagonist|nk-1 receptor antagonist
5746052|NCT00335660|Neurokinin|neurokinin
5746053|NCT00335660|Urge Incontinence|urge incontinence
5746054|NCT00335647|stage III multiple myeloma|stage iii multiple myeloma
5746055|NCT00335647|refractory multiple myeloma|refractory multiple myeloma
5746056|NCT00335647|stage II multiple myeloma|stage ii multiple myeloma
5746057|NCT00335634|Prostate Cancer|prostate cancer
5744933|NCT00340093|Adherence|adherence
5744934|NCT00340093|Behavioral Intervention|behavioral intervention
5744935|NCT00340093|Adolescence|adolescence
5744936|NCT00340093|Self-Regulation|self-regulation
5744937|NCT00340093|Behavioral Medicine|behavioral medicine
5744938|NCT00340093|Diabetes|diabetes
5744939|NCT00340080|Abacavir|abacavir
5744940|NCT00340080|Pharmacogenetics|pharmacogenetics
5744941|NCT00340080|hypersensitivity|hypersensitivity
5744942|NCT00340080|HLA-B*5701|hla-b*5701
5744943|NCT00340054|brain tumor|brain tumor
5744954|NCT00340002|Fetal Anatomy|fetal anatomy
5746058|NCT00335634|Radical Prostatectomy|radical prostatectomy
5746059|NCT00335634|Sexual Dysfunction|sexual dysfunction
5746061|NCT00335634|Adaptation|adaptation
5746062|NCT00335634|Psychosocial Oncology|psychosocial oncology
5746063|NCT00335621|COPD|copd
5746064|NCT00335621|ipratropium|ipratropium
5746065|NCT00335621|tiotropium|tiotropium
5746066|NCT00335595|colorectal cancer|colorectal cancer
5746067|NCT00335595|Bevacizumab|bevacizumab
5746068|NCT00335595|capecitabine|capecitabine
5746069|NCT00335595|oxaliplatin|oxaliplatin
5746070|NCT00335582|alpha 2 agonists|alpha 2 agonists
5746071|NCT00335582|cardiac events|cardiac events
5746072|NCT00335582|non cardiac surgery|non cardiac surgery
5746073|NCT00335569|Infertility, sterility, hCG, IVF|infertility, sterility, hcg, ivf
5746074|NCT00335543|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5746075|NCT00335543|stage I pancreatic cancer|stage i pancreatic cancer
5746076|NCT00335543|stage II pancreatic cancer|stage ii pancreatic cancer
5746077|NCT00335543|stage III pancreatic cancer|stage iii pancreatic cancer
5746078|NCT00335517|Lumbar surgery|lumbar surgery
5746079|NCT00335517|Surgery L3-S1|surgery l3-s1
5746080|NCT00335517|DepoDur|depodur
5746081|NCT00335517|Post-operative pain|post-operative pain
5746082|NCT00335517|Pain control|pain control
5746084|NCT00335491|small cell lung cancer|small cell lung cancer
5746085|NCT00335491|non-small cell lung cancer|non-small cell lung cancer
5746086|NCT00335491|colon cancer|colon cancer
5746087|NCT00335491|prostate cancer|prostate cancer
5746088|NCT00335491|breast cancer|breast cancer
5746089|NCT00335491|male breast cancer|male breast cancer
5746090|NCT00335491|fatigue|fatigue
5746091|NCT00335491|lymphoma|lymphoma
5746092|NCT00335491|ovarian epithelial cancer|ovarian epithelial cancer
5746093|NCT00335491|bladder cancer|bladder cancer
5746094|NCT00335491|esophageal cancer|esophageal cancer
5746095|NCT00335478|neutropenia|neutropenia
5746097|NCT00335478|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5746098|NCT00335478|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5746099|NCT00335452|platelet aggregation inhibitors|platelet aggregation inhibitors
5746100|NCT00335452|acute coronary disease|acute coronary disease
5746101|NCT00335452|percutaneous coronary|percutaneous coronary
5746102|NCT00335413|Renal autoregulation|renal autoregulation
5746103|NCT00335413|Glomerular filtration rate|glomerular filtration rate
5746104|NCT00335413|Type 1 diabetes|type 1 diabetes
5746105|NCT00335374|Parkinson's disease|parkinson's disease
5746106|NCT00335361|Male Contraceptive Devices|male contraceptive devices
5746107|NCT00335361|Intra Vas Device (IVD)|intra vas device (ivd)
5746108|NCT00335361|Male Sterilization|male sterilization
5746109|NCT00335361|Vasectomy|vasectomy
5746110|NCT00335361|Intra Vas Deferens Occlusion|intra vas deferens occlusion
5746111|NCT00335361|Vas Occlusion|vas occlusion
5746112|NCT00335348|Multiple Myeloma|multiple myeloma
5746113|NCT00335348|Relapse|relapse
5746114|NCT00335348|Bortezomib|bortezomib
5746115|NCT00335348|Dexamethasone|dexamethasone
5746116|NCT00335348|Maintenance|maintenance
5746117|NCT00335335|Coronary|coronary
5746118|NCT00335335|Angiography|angiography
5746119|NCT00335335|X-ray|x-ray
5746120|NCT00335335|CAD|cad
5746121|NCT00335322|Human Immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5746122|NCT00335309|chronic rhinosinusitis|chronic rhinosinusitis
5746123|NCT00335309|sinus irrigation|sinus irrigation
5746124|NCT00335296|PFO|pfo
5746125|NCT00335296|Migraine|migraine
5746126|NCT00335296|Stroke|stroke
5746127|NCT00335296|TIA (transient ischemic attack)|tia (transient ischemic attack)
5746128|NCT00335296|Decompression Illness|decompression illness
5746129|NCT00335270|HIV Type 1|hiv type 1
5746130|NCT00335257|Drospirenone|drospirenone
5746131|NCT00335257|Safety|safety
5746132|NCT00335257|INAS|inas
5746133|NCT00335231|Post-cataract surgery endophthalmitis|post-cataract surgery endophthalmitis
5746134|NCT00335218|Early postmenopausal state|early postmenopausal state
5746135|NCT00335218|Climacteric symptoms|climacteric symptoms
5686279|NCT00552682|chronic fatigue syndrome|chronic fatigue syndrome
5686280|NCT00552682|duloxetine|duloxetine
5686281|NCT00552682|pain|pain
5686282|NCT00552682|treatment experienced|treatment experienced
5702740|NCT00492232|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5702741|NCT00492232|Drug Therapy|drug therapy
5702742|NCT00492219|arthroplasty|arthroplasty
5702743|NCT00492219|replacement|replacement
5746136|NCT00335218|Hormone replacement therapy|hormone replacement therapy
5746137|NCT00335205|ropinirole|ropinirole
5746138|NCT00335205|dopamine|dopamine
5746139|NCT00335205|D2|d2
5735817|NCT00373542|RLS|rls
5746140|NCT00335205|depression|depression
5746141|NCT00335205|bipolar|bipolar
5746142|NCT00335192|Intracellular concentrations|intracellular concentrations
5746143|NCT00335192|Plasma concentration|plasma concentration
5746144|NCT00335192|Abacavir|abacavir
5746145|NCT00335192|Tenofovir|tenofovir
5746146|NCT00335192|Lamivudine (3TC)|lamivudine (3tc)
5746147|NCT00335192|Pharmacokinetic interactions|pharmacokinetic interactions
5746148|NCT00335179|Actinic keratosis|actinic keratosis
5746150|NCT00335179|imiquimod|imiquimod
5746151|NCT00335179|confocal microscopy|confocal microscopy
5746152|NCT00335179|gene microarray|gene microarray
5746153|NCT00335166|Parkinson Disease|parkinson disease
5746154|NCT00335153|severe motor fluctuations|severe motor fluctuations
5746155|NCT00335153|levodopa|levodopa
5746156|NCT00335153|levodopa/carbidopa intestinal gel|levodopa/carbidopa intestinal gel
5746157|NCT00335153|efficacy|efficacy
5746158|NCT00335153|dyskinesia|dyskinesia
5746159|NCT00335153|Parkinson's Disease|parkinson's disease
5746160|NCT00335153|carbidopa|carbidopa
5746161|NCT00335153|DUOPA|duopa
5746162|NCT00335140|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5746163|NCT00335114|cyclosporine, dry eye syndrome, contact lens|cyclosporine, dry eye syndrome, contact lens
5746164|NCT00335101|Coronary Artery Disease (CAD), Renal Impairment, Serum creatinine (SCr), Iodixanol, Ioversol, Iopromide, Contrast Induced Nephropathy (CIN)|coronary artery disease (cad), renal impairment, serum creatinine (scr), iodixanol, ioversol, iopromide, contrast induced nephropathy (cin)
5746165|NCT00335088|Prophylaxis,|prophylaxis,
5746166|NCT00335088|Intraocular surgery|intraocular surgery
5746167|NCT00335088|Lacrimal sac|lacrimal sac
5746168|NCT00335088|Eye lid|eye lid
5746169|NCT00335088|No conditions|no conditions
5746170|NCT00335062|Autoimmune thyroid disease|autoimmune thyroid disease
5746171|NCT00335062|Children and Adolescents|children and adolescents
5746172|NCT00335062|TSH Receptor Antibodies|tsh receptor antibodies
5746173|NCT00335049|myopia progression|myopia progression
5746174|NCT00335049|bifocal|bifocal
5746175|NCT00335036|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5746176|NCT00335036|Ventricular Arrhythmia|ventricular arrhythmia
5746177|NCT00335036|Sudden Cardiac Death|sudden cardiac death
5746178|NCT00335036|Congenital Heart Disease|congenital heart disease
5746179|NCT00335036|Pediatric Electrophysiology|pediatric electrophysiology
5746180|NCT00335023|postpartum hemorrhage|postpartum hemorrhage
5746181|NCT00335023|red blood cell transfusion|red blood cell transfusion
5746182|NCT00335023|health related quality of life|health related quality of life
5746183|NCT00335010|Nitroglycerine|nitroglycerine
5746184|NCT00335010|gastroesophageal anastomosis|gastroesophageal anastomosis
5746185|NCT00335010|microvascular bloodflow|microvascular bloodflow
5746186|NCT00335010|microvascular hemoglobinsaturation|microvascular hemoglobinsaturation
5746187|NCT00334997|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5746946|NCT00331708|Gametocyte|gametocyte
5746188|NCT00334997|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5746189|NCT00334997|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5746190|NCT00334984|childhood fibrosarcoma|childhood fibrosarcoma
5746191|NCT00334984|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5746192|NCT00334984|childhood synovial sarcoma|childhood synovial sarcoma
5746193|NCT00334984|chondrosarcoma|chondrosarcoma
5746194|NCT00334984|localized osteosarcoma|localized osteosarcoma
5746195|NCT00334984|metastatic osteosarcoma|metastatic osteosarcoma
5746196|NCT00334984|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5746197|NCT00334984|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5746198|NCT00334984|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5746199|NCT00334984|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5746200|NCT00334984|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5746201|NCT00334984|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5746202|NCT00334984|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5746203|NCT00334984|childhood angiosarcoma|childhood angiosarcoma
5746204|NCT00334984|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5746205|NCT00334984|childhood leiomyosarcoma|childhood leiomyosarcoma
5746206|NCT00334984|childhood liposarcoma|childhood liposarcoma
5746207|NCT00334984|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5746208|NCT00334984|metastatic childhood malignant fibrous histiocytoma of bone|metastatic childhood malignant fibrous histiocytoma of bone
5746209|NCT00334984|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5746210|NCT00334984|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5746211|NCT00334984|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5746212|NCT00334971|African-American|african-american
5746213|NCT00334971|estradiol|estradiol
5746214|NCT00334971|luteinizing hormone|luteinizing hormone
5746215|NCT00334971|follicle stimulating hormone|follicle stimulating hormone
5746216|NCT00334971|androstenedione|androstenedione
5746217|NCT00334971|aromatase|aromatase
5746218|NCT00334971|inhibins|inhibins
5746219|NCT00334971|ovarian|ovarian
5746220|NCT00334971|Healthy volunteers|healthy volunteers
5746221|NCT00334971|Fragile X|fragile x
5746222|NCT00334945|Fibroblast Growth Factors|fibroblast growth factors
5746223|NCT00334945|Bone development|bone development
5746224|NCT00334932|refractory multiple myeloma|refractory multiple myeloma
5746225|NCT00334932|stage I multiple myeloma|stage i multiple myeloma
5746226|NCT00334932|stage II multiple myeloma|stage ii multiple myeloma
5746227|NCT00334932|stage III multiple myeloma|stage iii multiple myeloma
5746228|NCT00334919|Diabetes|diabetes
5746229|NCT00334919|Pre-Diabetes|pre-diabetes
5746230|NCT00334919|Anti-Inflammatory Diet|anti-inflammatory diet
5746231|NCT00334919|Diet Study|diet study
5746232|NCT00334919|Inflammation|inflammation
5746233|NCT00334919|Diabetic Diet|diabetic diet
5746234|NCT00334906|memantine|memantine
5746235|NCT00334906|Alzheimer's disease|alzheimer's disease
5746237|NCT00334906|moderate Alzheimer's disease|moderate alzheimer's disease
5746238|NCT00334880|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5746239|NCT00334880|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5746240|NCT00334880|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5746241|NCT00334867|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5746242|NCT00334854|childhood synovial sarcoma|childhood synovial sarcoma
5746243|NCT00334854|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5746244|NCT00334854|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5746245|NCT00334854|childhood angiosarcoma|childhood angiosarcoma
5746246|NCT00334854|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5746247|NCT00334854|childhood fibrosarcoma|childhood fibrosarcoma
5746248|NCT00334854|childhood leiomyosarcoma|childhood leiomyosarcoma
5746249|NCT00334854|childhood liposarcoma|childhood liposarcoma
5746250|NCT00334854|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5746251|NCT00334854|localized childhood malignant fibrous histiocytoma of bone|localized childhood malignant fibrous histiocytoma of bone
5746252|NCT00334854|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5746253|NCT00334854|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5746254|NCT00334854|chondrosarcoma|chondrosarcoma
5746255|NCT00334828|Severe sepsis|severe sepsis
5746256|NCT00334828|septic shock|septic shock
5746257|NCT00334828|sepsis|sepsis
5746258|NCT00334776|recurrent melanoma|recurrent melanoma
5746259|NCT00334776|stage IV melanoma|stage iv melanoma
5746260|NCT00334776|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5746261|NCT00334776|iris melanoma|iris melanoma
5746262|NCT00334776|recurrent intraocular melanoma|recurrent intraocular melanoma
5746263|NCT00334776|extraocular extension melanoma|extraocular extension melanoma
5746264|NCT00334763|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5746265|NCT00334763|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5747253|NCT00330460|Osteopenia|osteopenia
5746266|NCT00334763|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5746267|NCT00334763|squamous cell lung cancer|squamous cell lung cancer
5746268|NCT00334750|Glaucoma, Open-Angle Ocular Hypertension Risk factors Canadian|glaucoma, open-angle ocular hypertension risk factors canadian
5746269|NCT00334737|erythropoietin|erythropoietin
5746270|NCT00334737|darbepoetin|darbepoetin
5746271|NCT00334737|transfusions|transfusions
5746272|NCT00334737|neonates|neonates
5746273|NCT00334737|outcomes|outcomes
5746274|NCT00334737|neurodevelopment|neurodevelopment
5746275|NCT00334724|Cardiovascular disease|cardiovascular disease
5746276|NCT00334724|Vascular disease|vascular disease
5746277|NCT00334724|Hypertension|hypertension
5746278|NCT00334724|Home blood pressure measurement|home blood pressure measurement
5746279|NCT00334711|Permanent Neonatal Diabetes|permanent neonatal diabetes
5746280|NCT00334711|Kir6.2|kir6.2
5746281|NCT00334711|KCNJ11|kcnj11
5746282|NCT00334711|Infancy onset diabetes|infancy onset diabetes
5746283|NCT00334711|Sulfonylurea|sulfonylurea
5746284|NCT00334672|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5746285|NCT00334659|HIV-1 Infection|hiv-1 infection
5746286|NCT00334646|cyclophosphamide|cyclophosphamide
5746287|NCT00334646|CINV|cinv
5746288|NCT00334646|Chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5746289|NCT00334633|bacterial vaginosis|bacterial vaginosis
5746290|NCT00334633|tinidazole|tinidazole
5746291|NCT00334620|randomised double-blinded trial|randomised double-blinded trial
5746292|NCT00334620|rehabilitation|rehabilitation
5746293|NCT00334620|radon spa therapy|radon spa therapy
5746294|NCT00334620|long-term effectiveness|long-term effectiveness
5746295|NCT00334607|HRV vaccine|hrv vaccine
5746296|NCT00334607|diarrhoea|diarrhoea
5746297|NCT00334607|rotavirus|rotavirus
5746298|NCT00334594|epithelial mesothelioma|epithelial mesothelioma
5746299|NCT00334594|sarcomatous mesothelioma|sarcomatous mesothelioma
5746300|NCT00334594|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5746301|NCT00334594|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5746302|NCT00334594|stage II malignant mesothelioma|stage ii malignant mesothelioma
5746303|NCT00334594|stage III malignant mesothelioma|stage iii malignant mesothelioma
5746304|NCT00334568|AVANDIA|avandia
5746305|NCT00334568|Alzheimers Disease|alzheimers disease
5746306|NCT00334555|trichomoniasis|trichomoniasis
5746307|NCT00334555|partner notification|partner notification
5746308|NCT00334542|breast cancer|breast cancer
5746309|NCT00334542|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5746310|NCT00334542|breast cancer in situ|breast cancer in situ
5746311|NCT00334542|stage I breast cancer|stage i breast cancer
5746312|NCT00334542|stage II breast cancer|stage ii breast cancer
5746313|NCT00334542|stage IIIA breast cancer|stage iiia breast cancer
5746314|NCT00334542|stage IIIB breast cancer|stage iiib breast cancer
5746315|NCT00334542|stage IIIC breast cancer|stage iiic breast cancer
5746316|NCT00334529|Tamiflu|tamiflu
5746318|NCT00334529|Antiviral|antiviral
5746319|NCT00334529|Neuraminidase Inhibitor|neuraminidase inhibitor
5746320|NCT00334529|Pharmacokinetic Trial|pharmacokinetic trial
5746321|NCT00334529|Healthy Volunteer|healthy volunteer
5746323|NCT00334516|Motor Neuron Disease|motor neuron disease
5746324|NCT00334516|Cognitive Testing|cognitive testing
5746325|NCT00334516|Movement-Related Potential|movement-related potential
5746327|NCT00334516|Neuropsychologic Testing|neuropsychologic testing
5746328|NCT00334516|Primary Lateral Sclerosis|primary lateral sclerosis
5746330|NCT00334516|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5746331|NCT00334516|ALS|als
5746332|NCT00334516|Healthy Volunteer|healthy volunteer
5746333|NCT00334516|HV|hv
5746334|NCT00334503|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
5746335|NCT00334490|Pulmonary Hypertension|pulmonary hypertension
5746336|NCT00334490|Sildenafil|sildenafil
5746337|NCT00334490|Viagra|viagra
5746338|NCT00334490|Cardiac Surgery|cardiac surgery
5746339|NCT00334490|Cardiopulmonary Bypass|cardiopulmonary bypass
5746340|NCT00334477|erectile dysfunction|erectile dysfunction
5746341|NCT00334477|chronic renal dysfunction|chronic renal dysfunction
5746342|NCT00334477|tadalafil|tadalafil
5746343|NCT00334464|warfarin metabolism|warfarin metabolism
5746344|NCT00334464|CYP2C0|cyp2c0
5746345|NCT00334464|anticoagulation|anticoagulation
5746346|NCT00334464|genotyping|genotyping
5746347|NCT00334464|DVT|dvt
5746348|NCT00334464|PE|pe
5746349|NCT00334451|Heart Failure|heart failure
5746350|NCT00334451|Remote Monitoring|remote monitoring
5746351|NCT00334451|Implantable Device|implantable device
5746352|NCT00334438|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5746353|NCT00334438|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5746354|NCT00334438|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5746355|NCT00334438|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5746356|NCT00334438|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5746357|NCT00334399|alpa-glucosidase inhibitor,Biguanide|alpa-glucosidase inhibitor,biguanide
5746358|NCT00334386|Hypertension|hypertension
5746359|NCT00334386|Anti-hypertensive effect|anti-hypertensive effect
5746360|NCT00334386|Diuretic|diuretic
5746361|NCT00334373|Myocardial infarction|myocardial infarction
5746362|NCT00334373|Magnetic Resonance Imaging|magnetic resonance imaging
5746363|NCT00334373|Coronary Angioplasty|coronary angioplasty
5746364|NCT00334334|Streptococcus pneumonia, vaccine|streptococcus pneumonia, vaccine
5746366|NCT00334321|Tomotherapy|tomotherapy
5746367|NCT00334321|Post-Hysterectomy|post-hysterectomy
5746368|NCT00334321|Endometrial Cancer|endometrial cancer
5746369|NCT00334295|Recurrent or metastatic endometrial carcinoma|recurrent or metastatic endometrial carcinoma
5746370|NCT00334282|Metastatic|metastatic
5746371|NCT00334282|Anti-angiogenesis|anti-angiogenesis
5746372|NCT00334282|GW786034|gw786034
5746373|NCT00334282|Pazopanib|pazopanib
5746374|NCT00334269|obesity|obesity
5746375|NCT00334269|physical activity|physical activity
5746376|NCT00334269|daily energy intake|daily energy intake
5746377|NCT00334269|nutrition|nutrition
5746378|NCT00334269|healthy lifestyle|healthy lifestyle
5746379|NCT00334269|Aboriginal|aboriginal
5746380|NCT00334269|body fat|body fat
5746381|NCT00334269|exercise|exercise
5746382|NCT00334269|education|education
5746383|NCT00334269|family|family
5746384|NCT00334269|body mass index|body mass index
5746385|NCT00334269|knowledge|knowledge
5746386|NCT00334269|randomized controlled trial|randomized controlled trial
5746387|NCT00334269|community|community
5746388|NCT00334269|intervention|intervention
5746389|NCT00334269|Six Nations Indian Reserve|six nations indian reserve
5746390|NCT00334269|household|household
5746391|NCT00334269|health counselling|health counselling
5746392|NCT00334256|PMTCT|pmtct
5746393|NCT00334256|Resistance|resistance
5746394|NCT00334256|HIV infection|hiv infection
5746395|NCT00334256|Pregnancy|pregnancy
5746396|NCT00334243|in vitro fertilization|in vitro fertilization
5746397|NCT00334243|infertile|infertile
5746398|NCT00334243|infertility|infertility
5746399|NCT00334243|pregnancy|pregnancy
5746400|NCT00334243|pregnancy rates|pregnancy rates
5746401|NCT00334243|microflare protocol|microflare protocol
5746402|NCT00334243|antagonist protocol|antagonist protocol
5746403|NCT00334243|demi-halt protocol|demi-halt protocol
5746404|NCT00334243|poor responders|poor responders
5746405|NCT00334243|low antral follicle count|low antral follicle count
5746406|NCT00334243|Infertile Patients undergoing in vitro fertilization (IVF)|infertile patients undergoing in vitro fertilization (ivf)
5746407|NCT00334243|Patients with a previous poor response to ovarian stimulation|patients with a previous poor response to ovarian stimulation
5746408|NCT00334243|Patients with an antral follicle count of less than 10|patients with an antral follicle count of less than 10
5746409|NCT00334230|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5746410|NCT00334230|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5746411|NCT00334230|Locomotion|locomotion
5746412|NCT00334230|Cortical Reorganization|cortical reorganization
5746413|NCT00334230|Rehabilitation|rehabilitation
5746414|NCT00334230|fMRI|fmri
5746415|NCT00334230|Stroke|stroke
5746416|NCT00334230|Healthy Volunteer|healthy volunteer
5746418|NCT00334217|Psychology: cognitive aspects|psychology: cognitive aspects
5746419|NCT00334217|Substance-Related Disorders|substance-related disorders
5746420|NCT00334217|treatment efficacy|treatment efficacy
5746421|NCT00334204|Platelet Function Analyser-100 (PFA-100)|platelet function analyser-100 (pfa-100)
5746422|NCT00334204|renal failure|renal failure
5746423|NCT00334204|kidney biopsy|kidney biopsy
5746424|NCT00334204|bleeding|bleeding
5746425|NCT00334204|hematoma|hematoma
5746426|NCT00334191|Cardiac surgery,|cardiac surgery,
5746427|NCT00334191|Cardiopulmonary bypass,|cardiopulmonary bypass,
5746428|NCT00334191|Oxidative stress,|oxidative stress,
5746429|NCT00334191|Acute renal dysfunction,|acute renal dysfunction,
5746430|NCT00334191|Sodium Bicarbonate|sodium bicarbonate
5746431|NCT00334178|Migraine|migraine
5746432|NCT00334178|Migraine prophylaxis|migraine prophylaxis
5746433|NCT00334152|NK-1|nk-1
5746434|NCT00334152|antiemetics|antiemetics
5746435|NCT00334152|casopitant mesylate|casopitant mesylate
5746436|NCT00334152|postoperative nausea and vomiting|postoperative nausea and vomiting
5746437|NCT00334152|ondansetron hydrochloride|ondansetron hydrochloride
5746438|NCT00334152|5HT3|5ht3
5746439|NCT00334152|ZOFRAN|zofran
5746440|NCT00334152|PONV|ponv
5746441|NCT00334139|serum bone markers|serum bone markers
5746442|NCT00334139|bone metastasis|bone metastasis
5746443|NCT00334139|prostate cancer|prostate cancer
5740852|NCT00354965|ABS|abs
5746444|NCT00334139|breast cancer|breast cancer
5746445|NCT00334139|quality of life|quality of life
5746446|NCT00334139|bisphosphonates|bisphosphonates
5746447|NCT00334126|Schizophrenia|schizophrenia
5746448|NCT00334126|Antipsychotic|antipsychotic
5746449|NCT00334126|paliperidone|paliperidone
5746450|NCT00334126|quetiapine|quetiapine
5746451|NCT00334126|Seroquel|seroquel
5746452|NCT00334126|placebo|placebo
5746453|NCT00334113|Diabetes Mellitus|diabetes mellitus
5746454|NCT00334113|Exercise|exercise
5746455|NCT00334113|Obesity|obesity
5746456|NCT00334113|Telemedicine|telemedicine
5746457|NCT00334100|Exercise|exercise
5746458|NCT00334100|multiple sclerosis|multiple sclerosis
5746459|NCT00334100|treadmill|treadmill
5746460|NCT00334087|primary dental prevention|primary dental prevention
5746461|NCT00334087|early childhood caries|early childhood caries
5746462|NCT00334087|prenatal oral care|prenatal oral care
5746464|NCT00334074|MDS|mds
5746465|NCT00334074|CML|cml
5746466|NCT00334074|Relapsed|relapsed
5746467|NCT00334074|Refractory|refractory
5746468|NCT00334074|Chemo treatment|chemo treatment
5746469|NCT00334074|Clofarabine|clofarabine
5746470|NCT00334074|Cytarabine|cytarabine
5746471|NCT00334074|standard or poor cytogenetic risk AML|standard or poor cytogenetic risk aml
5746472|NCT00334074|untreated high-risk (>10% blasts) MDS|untreated high-risk (>10% blasts) mds
5746473|NCT00334074|CML in accelerated phase or blast crisis|cml in accelerated phase or blast crisis
5746474|NCT00334074|Elderly AML patients with risk of anthracycline toxicity|elderly aml patients with risk of anthracycline toxicity
5746476|NCT00334061|Ischemic|ischemic
5746477|NCT00334061|Stroke|stroke
5746478|NCT00334061|Intervention|intervention
5746479|NCT00334061|Neurovascular|neurovascular
5746480|NCT00334061|Thrombus|thrombus
5746481|NCT00334061|Embolectomy|embolectomy
5746482|NCT00334061|Ischemic stroke|ischemic stroke
5746483|NCT00334048|Medication-induced sexual dysfunction|medication-induced sexual dysfunction
5702744|NCT00492219|knee|knee
5746484|NCT00334048|SSRI-induced sexual dysfunction|ssri-induced sexual dysfunction
5746485|NCT00334048|Anorgasmia|anorgasmia
5746486|NCT00334048|Delayed ejaculation|delayed ejaculation
5746487|NCT00334048|Sexual dysfunction|sexual dysfunction
5746488|NCT00334048|Antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
5746489|NCT00334048|Requip|requip
5746490|NCT00334048|Ropinirole|ropinirole
5746491|NCT00334048|Dopamine agonist|dopamine agonist
5746492|NCT00334048|Serotonin reuptake inhibitor|serotonin reuptake inhibitor
5746493|NCT00334048|Sexual dysfunction, physiological, medication-induced|sexual dysfunction, physiological, medication-induced
5746494|NCT00334022|Fuzeon|fuzeon
5746495|NCT00334022|Viral Decay|viral decay
5746496|NCT00334009|Cardiac Surgery|cardiac surgery
5746497|NCT00334009|Cardiopulmonary Bypass|cardiopulmonary bypass
5746498|NCT00334009|COMT-Polymorphism|comt-polymorphism
5746499|NCT00334009|Vasoplegia|vasoplegia
5746500|NCT00334009|Catecholamines|catecholamines
5746501|NCT00334009|Acute Renal Failure|acute renal failure
5746502|NCT00333970|cognition|cognition
5746503|NCT00333970|neuropsychology|neuropsychology
5746504|NCT00333970|Rehabilitation|rehabilitation
5746505|NCT00333970|treatment efficacy|treatment efficacy
5746506|NCT00333970|cognitive remediation|cognitive remediation
5746507|NCT00333957|capsule endoscopy|capsule endoscopy
5746508|NCT00333944|Organophosphorus poisoning|organophosphorus poisoning
5746509|NCT00333944|Atropine|atropine
5746510|NCT00333944|Pralidoxime|pralidoxime
5746511|NCT00333944|Intermediate syndrome.|intermediate syndrome.
5746512|NCT00333931|Impulsive Aggression|impulsive aggression
5746513|NCT00333931|Posttraumatic Stress Disorder|posttraumatic stress disorder
5746514|NCT00333918|Cataract Extraction|cataract extraction
5746515|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5746516|NCT00333905|Exercise|exercise
5746517|NCT00333905|Exercise Therapy|exercise therapy
5746518|NCT00333892|primary HIV infection|primary hiv infection
5746519|NCT00333892|chronic HIV infection|chronic hiv infection
5746520|NCT00333879|Rehabilitation|rehabilitation
5746521|NCT00333879|Sensory Aid|sensory aid
5746523|NCT00333840|STI571|sti571
5746524|NCT00333840|imatinib|imatinib
5746525|NCT00333840|interferon|interferon
5746526|NCT00333840|interferon alpha|interferon alpha
5746527|NCT00333840|cytosine arabinoside|cytosine arabinoside
5746528|NCT00333840|chronic myeloid leukemia|chronic myeloid leukemia
5746529|NCT00333840|Philadelphia chromosome positive|philadelphia chromosome positive
5746530|NCT00333827|Dilated Cardiomyopathy|dilated cardiomyopathy
5746531|NCT00333827|stem cells|stem cells
5746532|NCT00333827|Therapeutics|therapeutics
5746533|NCT00333827|Randomized Controlled Trials|randomized controlled trials
5746534|NCT00333801|Posttraumatic Stress Disorder|posttraumatic stress disorder
5746535|NCT00333801|Veterans|veterans
5746536|NCT00333801|Vocational Rehabilitation|vocational rehabilitation
5746537|NCT00333801|Supported Employment|supported employment
5746538|NCT00333801|Individual Placement and Support|individual placement and support
5746539|NCT00333788|Crohn's Disease|crohn's disease
5746540|NCT00333788|Certolizumab pegol|certolizumab pegol
5746541|NCT00333788|CDP870|cdp870
5746542|NCT00333788|Cimzia|cimzia
5746543|NCT00333762|aging|aging
5746544|NCT00333762|blindness|blindness
5746545|NCT00333762|wheelchairs|wheelchairs
5746546|NCT00333762|spinal cord injury|spinal cord injury
5746547|NCT00333749|children|children
5746548|NCT00333736|Injection site reactions|injection site reactions
5746549|NCT00333736|enfuvirtide administration|enfuvirtide administration
5746550|NCT00333723|Rosiglitazone|rosiglitazone
5746551|NCT00333723|Glyburide|glyburide
5746552|NCT00333723|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5746553|NCT00333723|African American|african american
5746554|NCT00333723|Hispanic|hispanic
5746555|NCT00333710|Rehabilitation|rehabilitation
5746556|NCT00333710|Telecommunication|telecommunication
5746557|NCT00333697|Deep vein thrombosis|deep vein thrombosis
5746558|NCT00333697|Duplex ultrasound|duplex ultrasound
5746559|NCT00333697|Pulmonary embolism|pulmonary embolism
5746560|NCT00333671|Macular oedema|macular oedema
5746561|NCT00333671|Diabetes|diabetes
5746562|NCT00333671|Pathogenesis|pathogenesis
5746563|NCT00333671|Osmolality|osmolality
5746564|NCT00333671|Retinal thickness|retinal thickness
5746565|NCT00333658|psychotherapy, group|psychotherapy, group
5746566|NCT00333658|rehabilitation, vocational|rehabilitation, vocational
5746567|NCT00333658|treatment outcome|treatment outcome
5746568|NCT00333645|Liver transplantation|liver transplantation
5746569|NCT00333645|Invasive fungal infection|invasive fungal infection
5746570|NCT00333645|Invasive aspergillosis|invasive aspergillosis
5746572|NCT00333645|Caspofungin|caspofungin
5746574|NCT00333632|Dexmedetomidine|dexmedetomidine
5746575|NCT00333632|Postoperative care|postoperative care
5746576|NCT00333632|Sedation|sedation
5746577|NCT00333619|sleep disorders|sleep disorders
5746578|NCT00333619|rehabilitation|rehabilitation
5746579|NCT00333619|rehabilitation outcomes|rehabilitation outcomes
5746580|NCT00333593|Dialysis|dialysis
5746581|NCT00333593|Large pore dialyser|large pore dialyser
5746582|NCT00333593|Cytokines|cytokines
5746583|NCT00333593|Noradrenaline|noradrenaline
5746584|NCT00333580|Ethnography|ethnography
5746585|NCT00333580|Psychometrics|psychometrics
5746586|NCT00333580|Qualitative Research|qualitative research
5746587|NCT00333567|arthroscopic knee surgery|arthroscopic knee surgery
5746588|NCT00333567|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5746589|NCT00333567|lumiracoxib|lumiracoxib
5746591|NCT00333567|Ambulatory arthroscopic knee surgery|ambulatory arthroscopic knee surgery
5746593|NCT00333554|docosahexaenoic acid|docosahexaenoic acid
5746594|NCT00333554|omega-3 fatty acid|omega-3 fatty acid
5746595|NCT00333554|fish oil|fish oil
5746596|NCT00333554|pregnancy|pregnancy
5746597|NCT00333554|infancy|infancy
5746598|NCT00333554|prevention|prevention
5746599|NCT00333554|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5746600|NCT00333554|juvenile diabetes|juvenile diabetes
5746601|NCT00333554|T1D|t1d
5746602|NCT00333554|diabetes mellitus|diabetes mellitus
5746603|NCT00333554|Type 1 diabetes TrialNet|type 1 diabetes trialnet
5746605|NCT00333554|dietary supplementation|dietary supplementation
5746606|NCT00333554|nutrition|nutrition
5746607|NCT00333541|Contraceptive behavior|contraceptive behavior
5746608|NCT00333541|Internet Use|internet use
5746609|NCT00333541|Adolescent pregnancy|adolescent pregnancy
5746610|NCT00333541|Unintended pregnancy|unintended pregnancy
5746611|NCT00333528|Chemical Warfare Agents|chemical warfare agents
5746612|NCT00333528|Chemical Nerve Agent Intoxication|chemical nerve agent intoxication
5746613|NCT00333528|Chemical Terrorism|chemical terrorism
5746614|NCT00333515|Chemical nerve agent intoxication|chemical nerve agent intoxication
5746615|NCT00333502|Cancer, Neoplasms, Solid Tumor, Ovarian Cancer, Lung Cancer,|cancer, neoplasms, solid tumor, ovarian cancer, lung cancer,
5746616|NCT00333502|Non Small Cell Lung Cancer, Pancreatic Cancer,|non small cell lung cancer, pancreatic cancer,
5746617|NCT00333502|Breast Cancer, Colon Cancer, Endometrial Cancer,|breast cancer, colon cancer, endometrial cancer,
5746618|NCT00333502|Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,|kidney (renal cell) cancer, melanoma, prostate cancer,
5746619|NCT00333502|Skin Cancer, Thyroid Cancer,|skin cancer, thyroid cancer,
5746620|NCT00333502|Solid Malignancies|solid malignancies
5746621|NCT00333489|valsartan|valsartan
5746622|NCT00333489|amlodipine|amlodipine
5746623|NCT00333489|hypertension|hypertension
5746624|NCT00333437|Scleroderma, Systemic|scleroderma, systemic
5746625|NCT00333424|HIV|hiv
5746626|NCT00333424|Human Immunodeficiency Virus|human immunodeficiency virus
5746627|NCT00333424|Prophylactic vaccine|prophylactic vaccine
5746628|NCT00333398|CSL Influenza Vaccine, influenza, vaccine, immunogenicity|csl influenza vaccine, influenza, vaccine, immunogenicity
5746629|NCT00333385|Ceftazidime|ceftazidime
5746630|NCT00333385|Continuous infusion|continuous infusion
5746631|NCT00333385|Antibiotic course|antibiotic course
5746632|NCT00333333|Thrombocytopenia|thrombocytopenia
5746633|NCT00333333|Small for Gestational Age (SGA)|small for gestational age (sga)
5746634|NCT00333333|Preeclampsia|preeclampsia
5746635|NCT00333320|acute myocardial infarction|acute myocardial infarction
5746636|NCT00333320|postconditioning|postconditioning
5746637|NCT00333320|coronary reserve|coronary reserve
5746638|NCT00333320|ejection fraction|ejection fraction
5746639|NCT00333307|relaxin|relaxin
5746640|NCT00333307|preeclampsia|preeclampsia
5746641|NCT00333281|Healthy Volunteers|healthy volunteers
5746643|NCT00333242|opioid|opioid
5746644|NCT00333242|hyperalgesia|hyperalgesia
5746645|NCT00333242|methadone|methadone
5746646|NCT00333229|Breast Cancer|breast cancer
5746647|NCT00333229|premenopausal|premenopausal
5746648|NCT00333229|Bone Mineral density|bone mineral density
5746649|NCT00333229|Cancer therapy induced bone loss|cancer therapy induced bone loss
5746650|NCT00333229|zoledronic acid|zoledronic acid
5746651|NCT00333203|epimacular membrane|epimacular membrane
5746652|NCT00333190|stem cell transplant|stem cell transplant
5746653|NCT00333190|graft versus host disease|graft versus host disease
5746654|NCT00333190|GVHD|gvhd
5746655|NCT00333190|CD+8 T cell depletion|cd+8 t cell depletion
5746656|NCT00333177|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
5746657|NCT00333177|Schizophreniform Disorder|schizophreniform disorder
5746658|NCT00333177|First-Episode Schizophrenia|first-episode schizophrenia
5746659|NCT00333177|Supported Employment|supported employment
5746660|NCT00333177|Cognitive Remediation|cognitive remediation
5746661|NCT00333177|Health Behavior Training|health behavior training
5746662|NCT00333177|Antipsychotic Medication|antipsychotic medication
5746663|NCT00333164|intracranial arteriosclerosis|intracranial arteriosclerosis
5746664|NCT00333164|cilostazol|cilostazol
5746665|NCT00333164|Platelete aggrigation inhibitors dual antiplatelet therapy|platelete aggrigation inhibitors dual antiplatelet therapy
5746666|NCT00333164|Drug therapy, combination|drug therapy, combination
5746667|NCT00333164|Clinical trials|clinical trials
5746668|NCT00333138|FTY720|fty720
5746670|NCT00333138|Multiple Sclerosis|multiple sclerosis
5746671|NCT00333138|RRMS|rrms
5746672|NCT00333112|Treatment Outcome|treatment outcome
5746673|NCT00333112|Urology|urology
5746674|NCT00333112|Solifenacin succinate|solifenacin succinate
5746675|NCT00333112|Urinary Incontinence|urinary incontinence
5746676|NCT00333099|Enteral nutrition|enteral nutrition
5746677|NCT00333099|immunonutrients|immunonutrients
5771163|NCT00239512|PDA|pda
5746678|NCT00333099|head and neck cancer|head and neck cancer
5746679|NCT00333099|esophageal cancer|esophageal cancer
5746680|NCT00333099|chemoradiotherapy|chemoradiotherapy
5746681|NCT00333099|H&N or esophageal cancer patients with a chemoradiotherapy treatment.|h&n or esophageal cancer patients with a chemoradiotherapy treatment.
5746682|NCT00333086|Endometrial Cancer|endometrial cancer
5746683|NCT00333086|Aromatase inhibitor|aromatase inhibitor
5746684|NCT00333086|Letrozole|letrozole
5746685|NCT00333073|urinary incontinence|urinary incontinence
5746686|NCT00333073|Bulkamid|bulkamid
5746687|NCT00333047|Metastatic breast cancer|metastatic breast cancer
5746688|NCT00333047|Aromatase inhibitor|aromatase inhibitor
5746689|NCT00333047|Letrozole|letrozole
5746690|NCT00333034|Psoriasis|psoriasis
5746691|NCT00333021|Fondaparinux Abdominal surgery Japanese VTE|fondaparinux abdominal surgery japanese vte
5746692|NCT00333008|Diffuse Large B Cell Lymphoma|diffuse large b cell lymphoma
5746693|NCT00333008|CDOP|cdop
5746694|NCT00333008|Dose Dense|dose dense
5746695|NCT00333008|Anne Arbor Stage I-IV|anne arbor stage i-iv
5746696|NCT00333008|Any IPI score|any ipi score
5746697|NCT00332995|HIV Seronegativity|hiv seronegativity
5746698|NCT00332982|best practices, performance improvement, intensive care, measurement|best practices, performance improvement, intensive care, measurement
5746699|NCT00332969|Open label|open label
5746700|NCT00332969|phase II|phase ii
5746701|NCT00332969|disease|disease
5746702|NCT00332969|clinical trial|clinical trial
5746703|NCT00332969|Octreotide|octreotide
5746704|NCT00332969|thymoma|thymoma
5746705|NCT00332969|cancer|cancer
5762966|NCT00271882|Sexual Abuse|sexual abuse
5762967|NCT00271869|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5762968|NCT00271869|graft-versus-host disease|graft-versus-host disease
5762969|NCT00271869|treatment|treatment
5762970|NCT00271856|HIV|hiv
5762971|NCT00271856|Meditation|meditation
5762972|NCT00271856|Stress|stress
5762973|NCT00271856|Randomized Controlled Trial|randomized controlled trial
5746706|NCT00332969|tumor|tumor
5746707|NCT00332943|colorectal polyps|colorectal polyps
5746708|NCT00332943|colorectal cancer|colorectal cancer
5746709|NCT00332943|Virtual colonoscopy|virtual colonoscopy
5746710|NCT00332943|Fecal tagging|fecal tagging
5746711|NCT00332943|MR colonography|mr colonography
5746712|NCT00332930|HIV|hiv
5746713|NCT00332930|Therapeutic vaccine|therapeutic vaccine
5746714|NCT00332917|Parkinson's disease|parkinson's disease
5746715|NCT00332904|betablocker|betablocker
5746716|NCT00332904|aldosterone antagonist|aldosterone antagonist
5746717|NCT00332904|peripheral haemodynamics|peripheral haemodynamics
5746718|NCT00332904|cardiac haemodynamics|cardiac haemodynamics
5746719|NCT00332904|oxygenation|oxygenation
5746720|NCT00332891|Anxiety|anxiety
5746721|NCT00332891|Anti-Anxiety Agents|anti-anxiety agents
5746722|NCT00332891|controlled Clinical Trials|controlled clinical trials
5746723|NCT00332878|Behavioral Intervention|behavioral intervention
5746724|NCT00332878|HIV|hiv
5746725|NCT00332878|HSV2|hsv2
5746726|NCT00332865|Head and neck cancer|head and neck cancer
5746727|NCT00332865|Radiotherapy|radiotherapy
5746728|NCT00332865|Dysphagia|dysphagia
5746729|NCT00332865|Exercise|exercise
5746730|NCT00332865|Deglutition|deglutition
5746731|NCT00332865|Randomized controlled trial|randomized controlled trial
5746732|NCT00332865|Quality of life|quality of life
5746733|NCT00332865|Tube feeding|tube feeding
5746734|NCT00332852|Postive breast cancer|postive breast cancer
5746735|NCT00332852|postmenopausal|postmenopausal
5746736|NCT00332852|disease free survival|disease free survival
5746737|NCT00332852|letrozole|letrozole
5746738|NCT00332852|early adjuvant treatment|early adjuvant treatment
5746739|NCT00332852|primary hormone receptor|primary hormone receptor
5746740|NCT00332839|enteric-coated mycophenolate sodium, everolimus, CNI-free regimen|enteric-coated mycophenolate sodium, everolimus, cni-free regimen
5746741|NCT00332826|Inhaled insulin|inhaled insulin
5746742|NCT00332826|Diabetes Type I and II with Asthma|diabetes type i and ii with asthma
5746743|NCT00332813|HIV Risk Behavior|hiv risk behavior
5746744|NCT00332813|Pregnancy|pregnancy
5746745|NCT00332813|Drug Abuse|drug abuse
5746746|NCT00332800|Stroke-Nutritional Supplementation-Functional Recovery|stroke-nutritional supplementation-functional recovery
5746747|NCT00332787|Major Depressive Disorder|major depressive disorder
5746748|NCT00332735|spinal|spinal
5746749|NCT00332735|anesthesia|anesthesia
5746750|NCT00332735|articaine|articaine
5746751|NCT00332735|bupivacaine|bupivacaine
5746752|NCT00332735|outpatient|outpatient
5746753|NCT00332735|surgery|surgery
5746754|NCT00332735|limbs|limbs
5746755|NCT00332709|Breast cancer|breast cancer
5746756|NCT00332709|postmenopausal|postmenopausal
5746757|NCT00332709|bone mineral density|bone mineral density
5746758|NCT00332709|Zoledronic acid|zoledronic acid
5746759|NCT00332709|Letrozole|letrozole
5746760|NCT00332709|extended adjuvant treatment.|extended adjuvant treatment.
5746761|NCT00332709|Postmenopausal women with primary hormone receptor positive breast cancer|postmenopausal women with primary hormone receptor positive breast cancer
5746762|NCT00332696|bowel obstruction,|bowel obstruction,
5746763|NCT00332696|peritoneal carcinomatosis|peritoneal carcinomatosis
5746764|NCT00332696|Octreotide|octreotide
5745918|NCT00336323|DME|dme
5746765|NCT00332696|inoperable|inoperable
5746766|NCT00332683|Dysphagia|dysphagia
5746767|NCT00332683|spine surgery|spine surgery
5746768|NCT00332683|cuff pressure|cuff pressure
5746769|NCT00332670|(Non-seasonal) Depression|(non-seasonal) depression
5746770|NCT00332670|bright light therapy|bright light therapy
5746771|NCT00332670|randomized controlled trial|randomized controlled trial
5746772|NCT00332670|suprachiasmatic nucleus|suprachiasmatic nucleus
5746773|NCT00332670|HPA-axis|hpa-axis
5746774|NCT00332670|DHEA|dhea
5746775|NCT00332670|melatonin|melatonin
5746776|NCT00332670|actigraphy|actigraphy
5746777|NCT00332670|elderly|elderly
5746778|NCT00332670|self-efficacy|self-efficacy
5746779|NCT00332670|social support|social support
5746780|NCT00332631|Cardiac surgery,|cardiac surgery,
5746781|NCT00332631|Cardiopulmonary bypass,|cardiopulmonary bypass,
5746782|NCT00332631|Oxidative stress,|oxidative stress,
5746783|NCT00332631|Acute renal dysfunction,|acute renal dysfunction,
5746784|NCT00332631|N-acetylcysteine|n-acetylcysteine
5746785|NCT00332618|MULTICENTER|multicenter
5746786|NCT00332618|CONTROLLED|controlled
5746787|NCT00332618|PARALLEL GROUPS|parallel groups
5746788|NCT00332605|Methamphetamine Dependence|methamphetamine dependence
5746789|NCT00332592|Necrotizing Enterocolitis|necrotizing enterocolitis
5746790|NCT00332592|Intragastric microdialysis|intragastric microdialysis
5746791|NCT00332592|Peritoneal microdialysis|peritoneal microdialysis
5746793|NCT00332579|Compulsive Shoplifting|compulsive shoplifting
5746794|NCT00332579|Kleptomania|kleptomania
5746795|NCT00332579|Compulsive Stealing|compulsive stealing
5746796|NCT00332514|pharmacist intervention|pharmacist intervention
5746797|NCT00332514|post-discharge telephone call|post-discharge telephone call
5746798|NCT00332514|black hole|black hole
5746799|NCT00332462|Liver transplantation, Cyclosporine|liver transplantation, cyclosporine
5746800|NCT00332449|early breast feeding|early breast feeding
5746801|NCT00332449|hypoglycemia|hypoglycemia
5746802|NCT00332449|newborn|newborn
5746803|NCT00332410|Voriconazole|voriconazole
5746804|NCT00332410|renal transplant|renal transplant
5746805|NCT00332410|kidney function|kidney function
5746806|NCT00332410|kidneys|kidneys
5746807|NCT00332371|Intensive Care|intensive care
5746808|NCT00332371|Shock, Septic|shock, septic
5746809|NCT00332371|Adsorption|adsorption
5746810|NCT00332371|Sorption Detoxification|sorption detoxification
5746811|NCT00332332|Phase IV|phase iv
5746812|NCT00332332|Psoriasis|psoriasis
5746813|NCT00332332|Inflammation|inflammation
5746814|NCT00332319|spinal cord injury|spinal cord injury
5746815|NCT00332319|urgency|urgency
5746816|NCT00332319|Overactive bladder|overactive bladder
5746817|NCT00332319|neurogenic|neurogenic
5746818|NCT00332319|neurometry|neurometry
5746819|NCT00332319|frequency|frequency
5746820|NCT00332319|urge incontinence|urge incontinence
5746821|NCT00332306|Once daily antiretroviral treatment|once daily antiretroviral treatment
5746822|NCT00332306|Concomitant antituberculosis treatment|concomitant antituberculosis treatment
5746823|NCT00332306|HIV Infections|hiv infections
5746824|NCT00332280|solid tumors|solid tumors
5746825|NCT00332280|clinical benefit|clinical benefit
5746826|NCT00332280|quality of life|quality of life
5746827|NCT00332280|esophageal cancer|esophageal cancer
5746828|NCT00332280|colon cancer|colon cancer
5746829|NCT00332280|pancreatic cancer|pancreatic cancer
5746830|NCT00332280|gastric cancer|gastric cancer
5746831|NCT00332280|liver cancer|liver cancer
5746832|NCT00332280|gall bladder cancer|gall bladder cancer
5746833|NCT00332280|prostate cancer|prostate cancer
5746834|NCT00332280|gynecological cancer|gynecological cancer
5746835|NCT00332280|lung cancer|lung cancer
5746836|NCT00332280|Tumors of GI tract, prostate and gynaecological|tumors of gi tract, prostate and gynaecological
5746837|NCT00332267|Sepsis|sepsis
5746838|NCT00332267|Hypoxia|hypoxia
5746839|NCT00332267|Altitude Sickness|altitude sickness
5746840|NCT00332267|Endotoxin|endotoxin
5746841|NCT00332267|Cytokines|cytokines
5746842|NCT00332267|Cerebral blood flow|cerebral blood flow
5746843|NCT00332267|Cerebral metabolism|cerebral metabolism
5746844|NCT00332267|Reactive oxygen species|reactive oxygen species
5746845|NCT00332254|Anterior cruciate ligament tear|anterior cruciate ligament tear
5746846|NCT00332254|Meniscus tear|meniscus tear
5746847|NCT00332254|Chondral injury|chondral injury
5862867|NCT00001476|Chronic Granulomatous Disease|chronic granulomatous disease
5746848|NCT00332241|Serious behavioral problems in children and adolescents with AD|serious behavioral problems in children and adolescents with ad
5746849|NCT00332241|Behavioral Problems|behavioral problems
5746850|NCT00332228|opiate dependence|opiate dependence
5746851|NCT00332228|heroin dependence|heroin dependence
5746852|NCT00332228|naltrexone|naltrexone
5746853|NCT00332228|cognitive behavioral therapy|cognitive behavioral therapy
5746854|NCT00332215|Cystic Fibrosis|cystic fibrosis
5746855|NCT00332215|Antioxidants|antioxidants
5746856|NCT00332215|Inhalational therapy|inhalational therapy
5746857|NCT00332215|Induced sputum|induced sputum
5746858|NCT00332215|Airway inflammation|airway inflammation
5746860|NCT00332176|Hepatitis C|hepatitis c
5746861|NCT00332176|Celgosivir|celgosivir
5746863|NCT00332176|Genotype 1|genotype 1
5746864|NCT00332176|Treatment-naive|treatment-naive
5746865|NCT00332176|Early viral kinetics|early viral kinetics
5746866|NCT00332163|STEPP|stepp
5746867|NCT00332163|STEP|step
5746868|NCT00332163|STEEP|steep
5746869|NCT00332163|mCRC|mcrc
5746870|NCT00332163|Skin Toxicities|skin toxicities
5746871|NCT00332163|Skin Rash|skin rash
5746872|NCT00332163|Metastatic Colorectal Cancer|metastatic colorectal cancer
5746873|NCT00332163|Anti-EGFr Skin Rash|anti-egfr skin rash
5746874|NCT00332163|colon cancer|colon cancer
5746875|NCT00332163|colorectal cancer|colorectal cancer
5746876|NCT00332163|rectal cancer|rectal cancer
5746877|NCT00332150|parents|parents
5746878|NCT00332150|newborn|newborn
5746879|NCT00332150|clinical trials|clinical trials
5746880|NCT00332111|transplant|transplant
5746881|NCT00332111|pancreas|pancreas
5746882|NCT00332098|Childhood Mood Disorders|childhood mood disorders
5746883|NCT00332098|Family Treatment|family treatment
5746884|NCT00332098|Psychoeducation|psychoeducation
5746885|NCT00332098|Pharmacotherapy|pharmacotherapy
5746886|NCT00332098|Family Functioning|family functioning
5746887|NCT00332098|Psychosocial Intervention|psychosocial intervention
5798849|NCT00110838|omega-3 fatty acids|omega-3 fatty acids
5746888|NCT00332046|fMRI placebo GW679769 Social Anxiety Disorder SAD|fmri placebo gw679769 social anxiety disorder sad
5746889|NCT00332033|Fibroids|fibroids
5746890|NCT00332033|Leiomyoma|leiomyoma
5746891|NCT00332033|Pirfenidone|pirfenidone
5746892|NCT00332033|Misoprostol|misoprostol
5746893|NCT00332033|Non-Surgical|non-surgical
5746894|NCT00332033|Collagen|collagen
5746895|NCT00332033|Uterus|uterus
5746896|NCT00332033|Uterine Fibroids|uterine fibroids
5746897|NCT00332033|Uterine Leiomyoma|uterine leiomyoma
5746898|NCT00331942|Breast|breast
5746899|NCT00331942|Cancer|cancer
5746900|NCT00331942|Associated|associated
5746901|NCT00331942|Antibodies|antibodies
5746902|NCT00331929|Asthma|asthma
5746903|NCT00331929|Allergy|allergy
5746904|NCT00331929|Respiratory|respiratory
5746905|NCT00331929|Pollution|pollution
5746906|NCT00331929|Children|children
5746907|NCT00331929|Air pollution|air pollution
5746908|NCT00331890|Neuroprotection|neuroprotection
5746909|NCT00331890|Acute ischemic stroke|acute ischemic stroke
5746910|NCT00331890|Cerebral infarction|cerebral infarction
5746911|NCT00331877|family|family
5746912|NCT00331877|end-of-life|end-of-life
5746913|NCT00331877|intensive care unit|intensive care unit
5746914|NCT00331864|AMD, ranibizumab|amd, ranibizumab
5746915|NCT00331838|Prevention|prevention
5746916|NCT00331838|Venous Thrombosis|venous thrombosis
5746917|NCT00331838|Orthopedic Surgery|orthopedic surgery
5746918|NCT00331825|Schizophrenia, EPS, risperidone, olanzapine|schizophrenia, eps, risperidone, olanzapine
5746919|NCT00331812|Hypermetabolism|hypermetabolism
5746920|NCT00331812|Mitochondrial abnormalities|mitochondrial abnormalities
5746921|NCT00331812|Oxidant/antioxidant status|oxidant/antioxidant status
5746922|NCT00331799|Depression|depression
5746923|NCT00331799|Pharmacotherapy|pharmacotherapy
5746924|NCT00331799|Duloxetine|duloxetine
5746925|NCT00331786|colon cancer|colon cancer
5746926|NCT00331786|rectal cancer|rectal cancer
5746927|NCT00331773|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5746928|NCT00331773|stage IIB prostate cancer|stage iib prostate cancer
5746929|NCT00331773|stage IIA prostate cancer|stage iia prostate cancer
5746930|NCT00331760|stage I endometrial carcinoma|stage i endometrial carcinoma
5746931|NCT00331760|stage II endometrial carcinoma|stage ii endometrial carcinoma
5746932|NCT00331760|stage III endometrial carcinoma|stage iii endometrial carcinoma
5746933|NCT00331760|endometrial adenoacanthoma|endometrial adenoacanthoma
5746934|NCT00331760|endometrial adenocarcinoma|endometrial adenocarcinoma
5746935|NCT00331760|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5746936|NCT00331760|stage IB cervical cancer|stage ib cervical cancer
5746937|NCT00331760|stage IIA cervical cancer|stage iia cervical cancer
5746938|NCT00331760|stage IIB cervical cancer|stage iib cervical cancer
5746940|NCT00331760|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5746941|NCT00331760|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5746942|NCT00331721|Acute Ischemic Stroke|acute ischemic stroke
5746943|NCT00331708|Malaria|malaria
5746944|NCT00331708|Efficacy|efficacy
5746945|NCT00331708|Pharmacokinetic|pharmacokinetic
5746947|NCT00331708|Molecular markers|molecular markers
5746948|NCT00331708|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5746949|NCT00331708|Artesunate|artesunate
5746950|NCT00331708|Artemisinin|artemisinin
5746951|NCT00331695|Progesterone|progesterone
5746952|NCT00331695|Preterm delivery|preterm delivery
5746953|NCT00331695|Preterm labor|preterm labor
5746954|NCT00331695|Cervical length|cervical length
5746955|NCT00331695|ultrasonography|ultrasonography
5746956|NCT00331669|deep brain stimulation|deep brain stimulation
5746957|NCT00331669|pallidum|pallidum
5746958|NCT00331669|tardive dystonia|tardive dystonia
5746959|NCT00331669|randomized|randomized
5746960|NCT00331669|double blind|double blind
5746961|NCT00331669|multicenter|multicenter
5746962|NCT00331656|noninvasive|noninvasive
5746963|NCT00331656|positive|positive
5746964|NCT00331656|cuirass|cuirass
5746965|NCT00331656|ventilation|ventilation
5746966|NCT00331656|respiratory|respiratory
5746967|NCT00331656|failure|failure
5746968|NCT00331630|stage I breast cancer|stage i breast cancer
5746969|NCT00331630|stage II breast cancer|stage ii breast cancer
5746970|NCT00331630|stage IIIA breast cancer|stage iiia breast cancer
5746971|NCT00331630|stage IIIB breast cancer|stage iiib breast cancer
5746972|NCT00331630|stage IIIC breast cancer|stage iiic breast cancer
5746973|NCT00331565|Bariatric surgery|bariatric surgery
5746974|NCT00331565|Bioavailability|bioavailability
5746975|NCT00331565|Bioequivalence|bioequivalence
5746976|NCT00331565|Atorvastatin|atorvastatin
5746977|NCT00331565|CYP's|cyp's
5746978|NCT00331565|P-gp|p-gp
5746979|NCT00331565|OATP|oatp
5746980|NCT00331539|Cochlear implant|cochlear implant
5746981|NCT00331539|threshold (T) measurement|threshold (t) measurement
5746982|NCT00331539|comfort (C) level|comfort (c) level
5746983|NCT00331539|profound hearing loss|profound hearing loss
5746984|NCT00331539|auditory stimuli|auditory stimuli
5746985|NCT00331539|profound hearing loss patients eligible for the study should be capable of providing reliable|profound hearing loss patients eligible for the study should be capable of providing reliable
5746986|NCT00331539|subjective counted thresholds and has good NRT recordings, implanted with|subjective counted thresholds and has good nrt recordings, implanted with
5746987|NCT00331539|the Nucleus Freedom system|the nucleus freedom system
5746988|NCT00331526|adult glioblastoma|adult glioblastoma
5746989|NCT00331526|adult gliosarcoma|adult gliosarcoma
5746990|NCT00331526|adult giant cell glioblastoma|adult giant cell glioblastoma
5746991|NCT00331487|Glucose Metabolism Disorder|glucose metabolism disorder
5746992|NCT00331487|Dysmetabolic Syndrome|dysmetabolic syndrome
5746993|NCT00331487|Type II Diabetes|type ii diabetes
5746994|NCT00331487|Diabetes Mellitus|diabetes mellitus
5746995|NCT00331487|Lipoatrophic|lipoatrophic
5746996|NCT00331487|Dyslipidemia|dyslipidemia
5746997|NCT00331487|Drug Therapy|drug therapy
5746998|NCT00331474|BCG|bcg
5746999|NCT00331474|HIV|hiv
5747000|NCT00331474|Immune responses|immune responses
5747001|NCT00331474|Delayed vaccination|delayed vaccination
5747002|NCT00331474|Infant morbidity|infant morbidity
5747003|NCT00331474|Nutritional status|nutritional status
5747004|NCT00331474|Morbidity|morbidity
5747005|NCT00331474|Mortality|mortality
5747006|NCT00331448|Treatment Experienced|treatment experienced
5747007|NCT00331448|Lipoatrophy|lipoatrophy
5747008|NCT00331448|Lipohypertrophy|lipohypertrophy
5747009|NCT00331448|Glucose|glucose
5747010|NCT00331448|Cholesterol|cholesterol
5747017|NCT00331435|AMD|amd
5747018|NCT00331435|PCV|pcv
5747019|NCT00331435|PDT|pdt
5747020|NCT00331422|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5747021|NCT00331422|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5747022|NCT00331422|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5747023|NCT00331422|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5747024|NCT00331422|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5747025|NCT00331422|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5747026|NCT00331422|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5747027|NCT00331422|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5741470|NCT00352820|Interview|interview
5747028|NCT00331422|peritoneal cavity cancer|peritoneal cavity cancer
5747029|NCT00331422|fallopian tube cancer|fallopian tube cancer
5747030|NCT00331422|Brenner tumor|brenner tumor
5747031|NCT00331409|stage III renal cell cancer|stage iii renal cell cancer
5747032|NCT00331409|stage IV renal cell cancer|stage iv renal cell cancer
5747033|NCT00331409|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5747034|NCT00331409|recurrent renal cell cancer|recurrent renal cell cancer
5747158|NCT00330772|Transfusion|transfusion
5747035|NCT00331357|acute idiopathic thrombocytopenic purpura|acute idiopathic thrombocytopenic purpura
5747036|NCT00331357|paediatric|paediatric
5747037|NCT00331357|quality of life|quality of life
5747043|NCT00331318|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5747044|NCT00331318|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5747045|NCT00331318|Motor Learning|motor learning
5747046|NCT00331318|Brain Plasticity|brain plasticity
5747047|NCT00331318|Healthy Volunteer|healthy volunteer
5747049|NCT00331305|Exercise|exercise
5747050|NCT00331292|Asthma bronchoscopy|asthma bronchoscopy
5747254|NCT00330460|AMG 162|amg 162
5747051|NCT00331279|polycystic ovary syndrome|polycystic ovary syndrome
5747052|NCT00331279|insulin resistance|insulin resistance
5747053|NCT00331279|cinnamon|cinnamon
5747054|NCT00331253|Indocyanine Green-Mediated Photothrombosis|indocyanine green-mediated photothrombosis
5747055|NCT00331253|Neovascular|neovascular
5747056|NCT00331253|Age-Related Macular Degeneration|age-related macular degeneration
5747057|NCT00331227|flavonoids|flavonoids
5747058|NCT00331227|food supplements|food supplements
5747059|NCT00331227|endothelial function|endothelial function
5747060|NCT00331227|no conditions allowed, healthy volunteers only|no conditions allowed, healthy volunteers only
5747061|NCT00331214|Surgical menopause|surgical menopause
5747062|NCT00331214|HSDD|hsdd
5747063|NCT00331201|NEC|nec
5747064|NCT00331188|Esophageal Variceal Bleeding|esophageal variceal bleeding
5747065|NCT00331188|Portal Hypertension|portal hypertension
5747066|NCT00331188|Hepatic Cirrhosis|hepatic cirrhosis
5747067|NCT00331188|Cirrhosis|cirrhosis
5747068|NCT00331188|Liver Cirrhosis|liver cirrhosis
5747069|NCT00331188|Somatostatin Analog|somatostatin analog
5747070|NCT00331188|Vapreotide|vapreotide
5747071|NCT00331188|Acute Esophageal Variceal Bleeding|acute esophageal variceal bleeding
5747072|NCT00331162|Renal Transplantation|renal transplantation
5747073|NCT00331162|Pancreas Transplantation|pancreas transplantation
5747074|NCT00331162|Graft Rejection|graft rejection
5747075|NCT00331162|Immunosuppression|immunosuppression
5747076|NCT00331162|Kidney failure, chronic|kidney failure, chronic
5747077|NCT00331162|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5747078|NCT00331162|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5747079|NCT00331149|safety|safety
5747080|NCT00331149|efficacy|efficacy
5747081|NCT00331149|L-dopa|l-dopa
5747082|NCT00331149|ropinirole PR|ropinirole pr
5747083|NCT00331149|Parkinson's disease|parkinson's disease
5747084|NCT00331149|ropinirole IR|ropinirole ir
5747085|NCT00331149|adjunctive therapy|adjunctive therapy
5747086|NCT00331149|superiority|superiority
5747087|NCT00331149|REQUIP|requip
5747088|NCT00331149|health outcomes|health outcomes
5747089|NCT00331136|malaria|malaria
5747090|NCT00331136|pyronaridine|pyronaridine
5747091|NCT00331136|artesunate|artesunate
5747092|NCT00331136|falciparum|falciparum
5747093|NCT00331136|ACT|act
5747094|NCT00331123|Surgical menopause|surgical menopause
5747095|NCT00331123|HSDD|hsdd
5747096|NCT00331097|elderly|elderly
5747097|NCT00331097|adjuvant therapy|adjuvant therapy
5747098|NCT00331097|intermediate risk|intermediate risk
5747099|NCT00331097|high risk|high risk
5747100|NCT00331084|prevention of post inflammation in cataract surgery|prevention of post inflammation in cataract surgery
5747101|NCT00331071|Contraception|contraception
5747102|NCT00331071|Hormonal contraception|hormonal contraception
5747103|NCT00331071|Oral contraception|oral contraception
5747104|NCT00331071|Ethinyl estradiol, Progestin, Contraception|ethinyl estradiol, progestin, contraception
5747105|NCT00331071|Transdermal|transdermal
5747314|NCT00330278|Cefazolin|cefazolin
5747106|NCT00331058|Severe Asthma bronchoscopy|severe asthma bronchoscopy
5747108|NCT00331045|cancer|cancer
5747109|NCT00331045|constipation|constipation
5747110|NCT00331032|VivaGel™, sexually transmitted, microbicide, herpes simplex|vivagel™, sexually transmitted, microbicide, herpes simplex
5747111|NCT00331019|Streptococcus Group B|streptococcus group b
5747112|NCT00331019|Pregnancy|pregnancy
5747113|NCT00331006|Blood Coagulation Factor Inhibitors|blood coagulation factor inhibitors
5747114|NCT00330993|mifepristone|mifepristone
5747115|NCT00330993|misoprostol|misoprostol
5747116|NCT00330993|medical abortion|medical abortion
5747117|NCT00330993|buccal administration|buccal administration
5747118|NCT00330980|Cognition|cognition
5747119|NCT00330980|Statins|statins
5747120|NCT00330980|Serotonin|serotonin
5747121|NCT00330980|Cholesterol|cholesterol
5747122|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous
5747123|NCT00330967|Free Fatty Acids|free fatty acids
5747124|NCT00330967|Glucose Clamp Technique|glucose clamp technique
5747125|NCT00330967|Inflammation|inflammation
5747126|NCT00330967|Insulin Resistance|insulin resistance
5747127|NCT00330967|Muscle, Skeletal|muscle, skeletal
5747128|NCT00330967|NF-Kappa B|nf-kappa b
5747129|NCT00330954|viral response genes|viral response genes
5747130|NCT00330902|malaria|malaria
5747131|NCT00330902|subpatent parasitaemia|subpatent parasitaemia
5747132|NCT00330902|dry season|dry season
5747133|NCT00330902|primaquine|primaquine
5747134|NCT00330902|Plasmodium falciparum infection detected by PCR|plasmodium falciparum infection detected by pcr
5747135|NCT00330889|Rheumatoid Arthritis|rheumatoid arthritis
5747136|NCT00330876|pitavastatin|pitavastatin
5747137|NCT00330876|hypercholesterolemia|hypercholesterolemia
5747138|NCT00330876|combined dyslipidemia|combined dyslipidemia
5747139|NCT00330863|Relapse|relapse
5747140|NCT00330863|Prevention|prevention
5747141|NCT00330863|Schizophrenia|schizophrenia
5747142|NCT00330863|Injectable Medication|injectable medication
5747143|NCT00330850|Migraine|migraine
5747144|NCT00330850|Photophobia|photophobia
5747145|NCT00330850|Phonophobia|phonophobia
5747146|NCT00330850|Aura|aura
5747147|NCT00330824|prevention of post inflammation in LASIK surgery|prevention of post inflammation in lasik surgery
5747148|NCT00330811|Pediatrics|pediatrics
5747149|NCT00330811|Non-cardiac Illness|non-cardiac illness
5747150|NCT00330811|B-type Natriuretic Peptide (BNP)|b-type natriuretic peptide (bnp)
5747151|NCT00330798|Photorefractive Keratectomy|photorefractive keratectomy
5747152|NCT00330772|Cardiac Surger|cardiac surger
5747153|NCT00330772|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5747154|NCT00330772|Graft patency|graft patency
5747155|NCT00330772|Aspirin|aspirin
5747156|NCT00330772|Clopidogrel|clopidogrel
5747157|NCT00330772|Hemorrhage|hemorrhage
5747159|NCT00330759|Bone metastases|bone metastases
5747160|NCT00330759|lytic bone lesions|lytic bone lesions
5747161|NCT00330759|advanced cancer|advanced cancer
5747162|NCT00330759|multiple myeloma|multiple myeloma
5747163|NCT00330759|lymphoma|lymphoma
5747164|NCT00330759|solid tumors|solid tumors
5747165|NCT00330759|skeletal related events|skeletal related events
5747166|NCT00330759|skeletal fractures|skeletal fractures
5747167|NCT00330759|spinal cord compressions, radiation to bone|spinal cord compressions, radiation to bone
5747168|NCT00330759|surgery to bone, bisphosphonates|surgery to bone, bisphosphonates
5747169|NCT00330759|denosumab|denosumab
5747170|NCT00330746|elderly|elderly
5747171|NCT00330746|chemotherapy|chemotherapy
5747172|NCT00330746|targeted therapy|targeted therapy
5747173|NCT00330746|combination therapy|combination therapy
5747174|NCT00330746|sequential therapy|sequential therapy
5747175|NCT00330746|randomized phase II|randomized phase ii
5747176|NCT00330746|one year survival|one year survival
5747177|NCT00330733|Cardiovascular Disease|cardiovascular disease
5747178|NCT00330733|Inflammation|inflammation
5747179|NCT00330733|Insulin Resistance|insulin resistance
5747180|NCT00330733|Type 2 DM|type 2 dm
5747181|NCT00330720|Personal Emergency Response System|personal emergency response system
5747182|NCT00330720|Anxiety|anxiety
5747183|NCT00330720|Fear of Falling|fear of falling
5747184|NCT00330720|RCT|rct
5747185|NCT00330707|bladder cancer|bladder cancer
5747186|NCT00330707|BCG|bcg
5747187|NCT00330707|interferon alpha|interferon alpha
5747188|NCT00330694|Physical Therapy|physical therapy
5747189|NCT00330694|Organisation of care|organisation of care
5747190|NCT00330681|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5747191|NCT00330681|free radical scavenger|free radical scavenger
5747192|NCT00330668|Insulin-like Growth Factor Deficiency|insulin-like growth factor deficiency
5747193|NCT00330668|IGF-1|igf-1
5747194|NCT00330668|Short Stature|short stature
5747195|NCT00330655|Binge eating|binge eating
5747196|NCT00330655|Obesity|obesity
5747197|NCT00330655|Eating disorder|eating disorder
5747198|NCT00330642|Streptococcus Group B|streptococcus group b
5747199|NCT00330642|Pregnancy|pregnancy
5747200|NCT00330616|WELLBUTRIN|wellbutrin
5747201|NCT00330616|elderly|elderly
5747202|NCT00330616|depression|depression
5747203|NCT00330616|Pharmacokinetics|pharmacokinetics
5747204|NCT00330603|Cough|cough
5747205|NCT00330603|Gastroesophageal Reflux|gastroesophageal reflux
5747206|NCT00330590|Central Venous|central venous
5747207|NCT00330590|Ultrasonography|ultrasonography
5747208|NCT00330590|Catheterization|catheterization
5747209|NCT00330564|VHL Syndrome|vhl syndrome
5747210|NCT00330564|Von Hippel-Lindau Syndrome|von hippel-lindau syndrome
5747211|NCT00330564|VHL Disease|vhl disease
5747212|NCT00330564|Kidney|kidney
5747213|NCT00330564|Retina|retina
5747214|NCT00330564|Brain|brain
5747215|NCT00330564|Spinal cord|spinal cord
5747216|NCT00330564|Pancreas|pancreas
5747217|NCT00330564|Inner ear|inner ear
5747218|NCT00330564|Cysts|cysts
5747219|NCT00330564|Tumors|tumors
5747220|NCT00330564|Sunitinib Malate|sunitinib malate
5747221|NCT00330564|SU011248|su011248
5747222|NCT00330564|Sutent|sutent
5747223|NCT00330564|VHL|vhl
5747224|NCT00330564|Sunitinib|sunitinib
5747225|NCT00330564|Renal cell carcinoma|renal cell carcinoma
5747226|NCT00330564|Hemangioblastoma|hemangioblastoma
5747227|NCT00330564|Endothelium|endothelium
5747228|NCT00330551|Schizoaffective Disorder, Depressed Type|schizoaffective disorder, depressed type
5747229|NCT00330551|Schizophreniform Disorder|schizophreniform disorder
5747230|NCT00330551|First-episode Schizophrenia|first-episode schizophrenia
5747231|NCT00330551|Injectable Risperidone|injectable risperidone
5747232|NCT00330538|Osteoporosis|osteoporosis
5747233|NCT00330538|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5747234|NCT00330512|regional anestesia|regional anestesia
5747235|NCT00330512|cesarean section|cesarean section
5747236|NCT00330512|hypotention|hypotention
5747237|NCT00330512|newborn|newborn
5747238|NCT00330499|Locally invasive|locally invasive
5747239|NCT00330499|Bladder cancer|bladder cancer
5747240|NCT00330499|Chemoradiotherapy|chemoradiotherapy
5747241|NCT00330499|Efficacy|efficacy
5747242|NCT00330499|Organ conservation|organ conservation
5747243|NCT00330486|Acamprosate|acamprosate
5747244|NCT00330486|Addiction|addiction
5747245|NCT00330486|Alcoholism|alcoholism
5747246|NCT00330486|Alcohol dependence|alcohol dependence
5747247|NCT00330486|Bipolar disorder|bipolar disorder
5747248|NCT00330486|Depression|depression
5747249|NCT00330486|Impulsivity|impulsivity
5747250|NCT00330486|Mania|mania
5747251|NCT00330486|Substance abuse|substance abuse
5747252|NCT00330460|Osteoporosis|osteoporosis
5747255|NCT00330460|Fracture - hip|fracture - hip
5747256|NCT00330460|Postmenopausal|postmenopausal
5747257|NCT00330447|pregnancy|pregnancy
5747258|NCT00330447|in utero|in utero
5747259|NCT00330447|chemotherapy|chemotherapy
5747260|NCT00330447|radiotherapy|radiotherapy
5747262|NCT00330447|offspring|offspring
5747263|NCT00330447|neonatal|neonatal
5747264|NCT00330447|long term|long term
5747265|NCT00330447|follow up|follow up
5747266|NCT00330447|cancer during pregnancy|cancer during pregnancy
5747267|NCT00330447|chemotherapy and radiotherapy during pregnancy|chemotherapy and radiotherapy during pregnancy
5747268|NCT00330447|long term follow up of children|long term follow up of children
5747269|NCT00330434|Alcohol|alcohol
5747270|NCT00330434|Bupropion|bupropion
5747271|NCT00330434|Chlorzoxazone|chlorzoxazone
5747272|NCT00330434|Interaction|interaction
5755653|NCT00299195|Chemoprevention|chemoprevention
5747273|NCT00330434|Induction|induction
5747274|NCT00330434|Depression|depression
5747275|NCT00330434|Smoking|smoking
5747276|NCT00330434|Drinking|drinking
5747277|NCT00330434|Cytochrome P450 Enzyme|cytochrome p450 enzyme
5747278|NCT00330434|CYP2B6|cyp2b6
5747279|NCT00330434|CYP2E1|cyp2e1
5747280|NCT00330434|Pharmacogenetics|pharmacogenetics
5747281|NCT00330434|Pharmacokinetics|pharmacokinetics
5747282|NCT00330434|Pharmacodynamics|pharmacodynamics
5747283|NCT00330434|Boston|boston
5747284|NCT00330434|Tufts University|tufts university
5747285|NCT00330408|Adherence|adherence
5747286|NCT00330408|GP training|gp training
5747287|NCT00330408|Medication Event Monitoring System(MEMS)|medication event monitoring system(mems)
5747288|NCT00330408|Antihypertensive Medication|antihypertensive medication
5747289|NCT00330408|Hypertension|hypertension
5747290|NCT00330356|Dietary Salt|dietary salt
5747291|NCT00330356|Blood Pressure|blood pressure
5747292|NCT00330356|Normotensives|normotensives
5747293|NCT00330343|morphine|morphine
5747294|NCT00330343|naloxone|naloxone
5747295|NCT00330343|pediatrics|pediatrics
5747296|NCT00330343|adverse effects|adverse effects
5747297|NCT00330343|pain|pain
5747298|NCT00330330|Fasting plasma glucose|fasting plasma glucose
5747299|NCT00330330|HbA1c|hba1c
5747300|NCT00330317|Letrozole|letrozole
5747301|NCT00330317|Breast Conserving Surgery|breast conserving surgery
5747302|NCT00330317|NeoAdjuvant|neoadjuvant
5747303|NCT00330317|Early Breast Cancer|early breast cancer
5747304|NCT00330304|Tuberculosis|tuberculosis
5747305|NCT00330304|Child|child
5747307|NCT00330304|prophylaxis|prophylaxis
5747308|NCT00330304|mortality|mortality
5747309|NCT00330291|PTSD|ptsd
5747310|NCT00330291|Xyrem|xyrem
5747311|NCT00330291|Sleep problems|sleep problems
5747312|NCT00330278|Cesarean section|cesarean section
5747313|NCT00330278|Antibiotic prophylaxis|antibiotic prophylaxis
5747315|NCT00330252|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5747316|NCT00330252|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5747317|NCT00330252|Alemtuzumab|alemtuzumab
5747318|NCT00330252|Campath|campath
5747319|NCT00330252|Rituximab|rituximab
5747320|NCT00330252|Rituxan|rituxan
5747321|NCT00330239|Substance Abuse|substance abuse
5747322|NCT00330239|Trauma|trauma
5747323|NCT00330239|Dependence|dependence
5747324|NCT00330226|schizophrenia|schizophrenia
5747325|NCT00330226|bipolar disorder|bipolar disorder
5747326|NCT00330226|atypical antipsychotics|atypical antipsychotics
5747327|NCT00330226|mood stabilizers|mood stabilizers
5747328|NCT00330226|biological markers|biological markers
5747329|NCT00330213|transthoracic|transthoracic
5747330|NCT00330213|echocardiography|echocardiography
5747331|NCT00330213|red wine|red wine
5747332|NCT00330213|cognac|cognac
5747333|NCT00330213|coronary reactivity|coronary reactivity
5747334|NCT00330200|Fasting plasma glucose|fasting plasma glucose
5747335|NCT00330200|HbA1c|hba1c
5747336|NCT00330200|Metabolism|metabolism
5747337|NCT00330187|nicotine dependence|nicotine dependence
5747338|NCT00330187|bupropion SR|bupropion sr
5747339|NCT00330187|smoking cessation|smoking cessation
5747340|NCT00330187|adolescents|adolescents
5747341|NCT00330187|contingency management|contingency management
5747343|NCT00330174|Mood|mood
5747344|NCT00330174|Anxiety|anxiety
5747345|NCT00330174|Acamprosate|acamprosate
5747346|NCT00330148|trypanosomiasis|trypanosomiasis
5747347|NCT00330148|gambiense|gambiense
5747348|NCT00330148|combination drug therapy|combination drug therapy
5747349|NCT00330148|sleeping sickness|sleeping sickness
5747350|NCT00330148|Uganda|uganda
5747351|NCT00330135|hip osteoarthritis|hip osteoarthritis
5747352|NCT00330135|Hyaluronic acid|hyaluronic acid
5747353|NCT00330135|Viscosupplementation|viscosupplementation
5747354|NCT00330135|intra-articular injections|intra-articular injections
5747355|NCT00330122|radius articular displaced fractures|radius articular displaced fractures
5747356|NCT00330122|fore locked plate|fore locked plate
5747357|NCT00330122|external radiocarpal fixer|external radiocarpal fixer
5747358|NCT00330109|glioma|glioma
5747359|NCT00330109|machine learning|machine learning
5747360|NCT00330109|advanced diagnostic imaging|advanced diagnostic imaging
5747468|NCT00329602|ropinirole|ropinirole
5747361|NCT00330096|bone loss, osteoporosis, prevention, hesperidin|bone loss, osteoporosis, prevention, hesperidin
5747362|NCT00330070|8-week treatment|8-week treatment
5747363|NCT00330070|oral tablets|oral tablets
5747364|NCT00330070|persistent moderate to severe asthma|persistent moderate to severe asthma
5747365|NCT00330070|AQLQ|aqlq
5747366|NCT00330070|asthma control|asthma control
5747367|NCT00330070|quality of life|quality of life
5747368|NCT00330018|BMT|bmt
5747369|NCT00330018|CMV|cmv
5747370|NCT00330018|GVHD|gvhd
5747371|NCT00330005|psychotherapy|psychotherapy
5747372|NCT00330005|bipolar disorder|bipolar disorder
5747373|NCT00330005|psychodynamic|psychodynamic
5747374|NCT00330005|psychoeducation|psychoeducation
5747375|NCT00330005|illness management|illness management
5747376|NCT00330005|controlled trial|controlled trial
5747377|NCT00330005|pilot study|pilot study
5680997|NCT00575250|Life Style//|life style//
5747378|NCT00329979|aortic stenosis|aortic stenosis
5747379|NCT00329979|radial|radial
5747380|NCT00329979|femoral|femoral
5747381|NCT00329979|vascular access site|vascular access site
5747382|NCT00329979|embolism|embolism
5747383|NCT00329979|cerebral|cerebral
5747384|NCT00329979|MRI|mri
5747385|NCT00329979|stroke|stroke
5747386|NCT00329966|Influenza|influenza
5747387|NCT00329966|adult|adult
5747388|NCT00329966|elderly|elderly
5747389|NCT00329966|vaccine|vaccine
5747390|NCT00329940|Letrozole|letrozole
5747391|NCT00329940|breast cancer|breast cancer
5747392|NCT00329940|critical musculoskeletal|critical musculoskeletal
5747393|NCT00329940|postmenopausal|postmenopausal
5747394|NCT00329940|rheumatologic tolerance|rheumatologic tolerance
5747395|NCT00329927|Adjuvanted Influenza Vaccine|adjuvanted influenza vaccine
5747396|NCT00329914|Preterm delivery|preterm delivery
5747397|NCT00329914|Prevention|prevention
5747398|NCT00329914|Twins|twins
5747399|NCT00329914|Progesterone|progesterone
5747400|NCT00329901|Meningitis|meningitis
5747401|NCT00329901|healthy subject|healthy subject
5747402|NCT00329901|vaccine|vaccine
5747403|NCT00329888|Endoscopic papillary balloon dilatation|endoscopic papillary balloon dilatation
5747404|NCT00329888|Endoscopic sphincterotomy|endoscopic sphincterotomy
5747405|NCT00329862|Laparoscopic Adjustable Gastric Banding|laparoscopic adjustable gastric banding
5747406|NCT00329862|Truncal Vagotomy|truncal vagotomy
5747407|NCT00329862|Lap Band|lap band
5747408|NCT00329862|Lap Banding|lap banding
5747409|NCT00329862|Obesity Surgery|obesity surgery
5747410|NCT00329862|Bariatric surgery|bariatric surgery
5747411|NCT00329862|Weight Loss Surgery|weight loss surgery
5747412|NCT00329849|Meningitis|meningitis
5747413|NCT00329849|children|children
5747414|NCT00329849|vaccine|vaccine
5747415|NCT00329849|safety|safety
5747416|NCT00329849|efficacy|efficacy
5747417|NCT00329823|Hidradenitis suppurativa, etanercept|hidradenitis suppurativa, etanercept
5747418|NCT00329797|osteoporosis|osteoporosis
5747419|NCT00329797|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5747420|NCT00329797|stage IIB prostate cancer|stage iib prostate cancer
5747421|NCT00329797|stage IIA prostate cancer|stage iia prostate cancer
5747422|NCT00329797|stage III prostate cancer|stage iii prostate cancer
5747423|NCT00329797|stage IV prostate cancer|stage iv prostate cancer
5747424|NCT00329784|peanut allergy|peanut allergy
5747425|NCT00329784|egg allergy|egg allergy
5747426|NCT00329784|eczema|eczema
5747427|NCT00329784|peanut|peanut
5747428|NCT00329784|allergy|allergy
5747429|NCT00329784|allergies|allergies
5747430|NCT00329784|allergic reaction|allergic reaction
5747431|NCT00329784|anaphylaxis|anaphylaxis
5747432|NCT00329784|infants|infants
5747433|NCT00329784|children|children
5747434|NCT00329758|moderate head injury|moderate head injury
5747435|NCT00329758|rosuvastatin|rosuvastatin
5747436|NCT00329758|statin|statin
5747437|NCT00329758|amnesia|amnesia
5747438|NCT00329758|orientation|orientation
5747439|NCT00329745|Rotavirus Gastroenteritis|rotavirus gastroenteritis
5747440|NCT00329745|Human rotavirus vaccine, efficacy, infants|human rotavirus vaccine, efficacy, infants
5747441|NCT00329706|mild cognitive impairment|mild cognitive impairment
5747442|NCT00329706|Alzheimer's disease|alzheimer's disease
5747443|NCT00329706|dementia|dementia
5747446|NCT00329680|Sepsis|sepsis
5747447|NCT00329680|Severe Sepsis|severe sepsis
5747448|NCT00329680|Septic Shock|septic shock
5747449|NCT00329680|Enteral Nutrition|enteral nutrition
5747450|NCT00329680|Antioxidants|antioxidants
5747451|NCT00329680|EPA|epa
5747452|NCT00329680|GLA|gla
5747453|NCT00329680|Nutrition|nutrition
5747454|NCT00329680|Intensive Care|intensive care
5747455|NCT00329680|ICU|icu
5747456|NCT00329667|heart valve|heart valve
5747457|NCT00329667|mitral|mitral
5747458|NCT00329667|aortic|aortic
5747459|NCT00329667|valvular disease|valvular disease
5747460|NCT00329654|Burn wounds, light therapy|burn wounds, light therapy
5747461|NCT00329628|Prevention|prevention
5747462|NCT00329628|Thromboembolism|thromboembolism
5747463|NCT00329615|Cancer cachexia|cancer cachexia
5747464|NCT00329615|Tumor host metabolism|tumor host metabolism
5747465|NCT00329602|Moderate|moderate
5747466|NCT00329602|Restless Legs Syndrome|restless legs syndrome
5747467|NCT00329602|Severe|severe
5747469|NCT00329589|Malignancies of the central nervous system, head and neck area|malignancies of the central nervous system, head and neck area
5747470|NCT00329589|and cervix|and cervix
5747471|NCT00329563|Cardiac Arrest|cardiac arrest
5747472|NCT00329563|Hypothermia|hypothermia
5747473|NCT00329550|Certolizumab pegol|certolizumab pegol
5747474|NCT00329550|Cimzia|cimzia
5747475|NCT00329550|CZP|czp
5747476|NCT00329537|Crohn's Disease|crohn's disease
5747477|NCT00329537|Sargramostim|sargramostim
5747478|NCT00329537|CDAI|cdai
5747479|NCT00329537|Moderately to severely active Crohn's Disease|moderately to severely active crohn's disease
5747480|NCT00329524|Tinnitus|tinnitus
5747481|NCT00329524|TMS|tms
5747482|NCT00329524|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5747483|NCT00329511|pregnancy|pregnancy
5746475|NCT00334061|Penumbra|penumbra
5747484|NCT00329511|hypertension|hypertension
5747485|NCT00329511|compliance|compliance
5747486|NCT00329511|clonidine patch|clonidine patch
5747487|NCT00329511|methyldopa|methyldopa
5747488|NCT00329498|ascorbic acid|ascorbic acid
5747489|NCT00329485|Elevated BNP Levels in CHF patients|elevated bnp levels in chf patients
5747490|NCT00329459|menstrual migraine|menstrual migraine
5747491|NCT00329459|headache|headache
5747492|NCT00329459|early intervention|early intervention
5747493|NCT00329459|dysmenorrhea|dysmenorrhea
5747494|NCT00329446|GAD|gad
5747495|NCT00329446|anxiety|anxiety
5747496|NCT00329433|Deep venous thrombosis|deep venous thrombosis
5747497|NCT00329433|DVT|dvt
5747498|NCT00329433|Heparin induced thrombocytopenia|heparin induced thrombocytopenia
5747499|NCT00329433|HIT|hit
5747500|NCT00329433|Direct thrombin inhibitor|direct thrombin inhibitor
5747501|NCT00329420|Crohn's Disease|crohn's disease
5747502|NCT00329420|CDP870|cdp870
5747503|NCT00329420|Certolizumab pegol|certolizumab pegol
5747504|NCT00329420|CZP|czp
5747505|NCT00329407|Alcoholism|alcoholism
5747506|NCT00329407|Heavy Drinking|heavy drinking
5763791|NCT00268944|Pompe Disease|pompe disease
5763792|NCT00268931|premature birth|premature birth
5763793|NCT00268931|motor skills|motor skills
5763794|NCT00268931|learning|learning
5763795|NCT00268931|reaching|reaching
5747507|NCT00329407|Alcohol Dependence|alcohol dependence
5747508|NCT00329394|Ketamine|ketamine
5747509|NCT00329394|Analgesia|analgesia
5747510|NCT00329394|Alcool-dependent|alcool-dependent
5747511|NCT00329394|carcinological surgery|carcinological surgery
5747512|NCT00329381|Allergic|allergic
5747513|NCT00329381|Asthma|asthma
5747514|NCT00329381|Immunotherapy|immunotherapy
5747515|NCT00329368|Cancer|cancer
5747516|NCT00329368|Vaccine|vaccine
5747517|NCT00329368|Phase I|phase i
5747518|NCT00329368|FolateImmune|folateimmune
5747519|NCT00329368|Recurrent|recurrent
5747520|NCT00329368|Refractory|refractory
5747521|NCT00329368|Experimental|experimental
5747522|NCT00329355|menstrual migraine|menstrual migraine
5747523|NCT00329355|headache|headache
5747524|NCT00329355|early intervention|early intervention
5747525|NCT00329355|dysmenorrhea|dysmenorrhea
5747526|NCT00329342|Low back pain;|low back pain;
5747527|NCT00329342|Return to work;|return to work;
5747528|NCT00329342|Posture|posture
5747529|NCT00329329|Advanced solid malignancies|advanced solid malignancies
5747530|NCT00329316|Pre-term labor|pre-term labor
5747531|NCT00329316|progesterone|progesterone
5747532|NCT00329303|Moderate to severe chronic plaque psoriasis|moderate to severe chronic plaque psoriasis
5747533|NCT00329303|anti TNF α|anti tnf α
5747534|NCT00329303|CDP 870|cdp 870
5747535|NCT00329303|Cimzia®|cimzia®
5747536|NCT00329303|certolizumab pegol|certolizumab pegol
5747537|NCT00329303|retreatment|retreatment
5747538|NCT00329290|pregnancy|pregnancy
5747539|NCT00329290|anticoagulation|anticoagulation
5747540|NCT00329290|enoxaparin|enoxaparin
5747541|NCT00329290|prosthetic heart valves|prosthetic heart valves
5747542|NCT00329277|age-related macular degeneration|age-related macular degeneration
5747543|NCT00329277|preferred retinal locus|preferred retinal locus
5747544|NCT00329277|macular perimetry|macular perimetry
5747545|NCT00329264|GAD|gad
5747546|NCT00329264|anxiety|anxiety
5747547|NCT00329251|HIV|hiv
5747549|NCT00329251|Vaccines|vaccines
5747550|NCT00329251|Immunotherapy|immunotherapy
5747551|NCT00329225|Type 2 Diabetes Mellitus Thiazolidinediones Insulin|type 2 diabetes mellitus thiazolidinediones insulin
5747552|NCT00329212|Pharmacokinetics|pharmacokinetics
5747553|NCT00329212|Bioavailability|bioavailability
5747554|NCT00329212|Therapeutic Equivalency|therapeutic equivalency
5747555|NCT00329199|Depression|depression
5747556|NCT00329199|Adolescents|adolescents
5747557|NCT00329199|Family Therapy|family therapy
5747558|NCT00329199|Primary Care|primary care
5747559|NCT00329199|Family Conflict|family conflict
5747560|NCT00329186|Healthy Subjects|healthy subjects
5747561|NCT00329186|Major Depressive Disorder|major depressive disorder
5747562|NCT00329186|Depression|depression
5747563|NCT00329186|Cytochrome P-450 CYP2D6|cytochrome p-450 cyp2d6
5747564|NCT00329186|Pharmacokinetics|pharmacokinetics
5747565|NCT00329186|Health|health
5747566|NCT00329147|Healthy Subjects|healthy subjects
5862868|NCT00001475|AIDS|aids
5747567|NCT00329147|Major Depressive Disorder|major depressive disorder
5747568|NCT00329147|Depression|depression
5747569|NCT00329121|SCCIS|sccis
5747570|NCT00329121|Bowens disease|bowens disease
5747571|NCT00329121|PEP005|pep005
5747572|NCT00329121|Topical|topical
5747573|NCT00329121|Dermatology|dermatology
5748070|NCT00327210|Behavior|behavior
5747574|NCT00329121|Cutaneous Squamous Cell Carcinoma in situ|cutaneous squamous cell carcinoma in situ
5747575|NCT00329095|Glaucoma|glaucoma
5747576|NCT00329095|Compliance|compliance
5747577|NCT00329069|statin|statin
5747578|NCT00329069|atorvastatin|atorvastatin
5747579|NCT00329069|hypercholesterolemia|hypercholesterolemia
5747580|NCT00329069|coronary artery disease|coronary artery disease
5747581|NCT00329069|monocyte|monocyte
5747582|NCT00329069|collateral formation|collateral formation
5746571|NCT00333645|Prophylaxis|prophylaxis
5747583|NCT00329069|arteriogenesis|arteriogenesis
5747584|NCT00329069|chemotaxis|chemotaxis
5747585|NCT00329069|migration|migration
5747586|NCT00329069|growth factors|growth factors
5747587|NCT00329069|vascular endothelial growth factor A|vascular endothelial growth factor a
5747588|NCT00329069|placenta growth factor 1|placenta growth factor 1
5747589|NCT00329069|hepatocyte growth factor|hepatocyte growth factor
5747590|NCT00329069|monocyte chemotactic protein 1|monocyte chemotactic protein 1
5747591|NCT00329056|Parkinson's disease|parkinson's disease
5747592|NCT00329056|MitoQ|mitoq
5747593|NCT00329056|UPDRS|updrs
5747594|NCT00329043|Prostate Cancer|prostate cancer
5747595|NCT00329043|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5747596|NCT00329043|Ductal Adenocarcinoma of the Prostate|ductal adenocarcinoma of the prostate
5747597|NCT00329043|Hormonal Ablation|hormonal ablation
5747598|NCT00329043|Radical Prostatectomy|radical prostatectomy
5798850|NCT00110838|arrhythmia|arrhythmia
5747599|NCT00329043|LHRH Agonist|lhrh agonist
5747600|NCT00329043|Lupron|lupron
5747601|NCT00329043|Leuprolide|leuprolide
5747603|NCT00329043|SU011248|su011248
5747604|NCT00329030|Large B-Cell Lymphoma|large b-cell lymphoma
5747605|NCT00329030|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5747606|NCT00329017|SNPs|snps
5747607|NCT00329017|single nucleotide polymorphism|single nucleotide polymorphism
5747608|NCT00329017|breast atypia|breast atypia
5747609|NCT00329017|breast epithelial hyperplasia|breast epithelial hyperplasia
5747610|NCT00329017|high risk for breast cancer|high risk for breast cancer
5747611|NCT00329004|Solid Tumors|solid tumors
5747612|NCT00328991|wart|wart
5747613|NCT00328991|common wart|common wart
5747614|NCT00328991|verruca vulgaris|verruca vulgaris
5747615|NCT00328991|verruca plantaris|verruca plantaris
5747616|NCT00328991|plantar wart|plantar wart
5747617|NCT00328991|duct tape|duct tape
5747618|NCT00328991|occlusion therapy|occlusion therapy
5747619|NCT00328978|schizophrenia|schizophrenia
5747620|NCT00328978|schizoaffective disorders|schizoaffective disorders
5747621|NCT00328965|Korean patients|korean patients
5747622|NCT00328965|Type 2 diabetes|type 2 diabetes
5747623|NCT00328965|Endothelial function|endothelial function
5747624|NCT00328965|lacidipine|lacidipine
5747625|NCT00328965|Essential hypertension|essential hypertension
5747626|NCT00328952|schizophrenia|schizophrenia
5747627|NCT00328952|auditory verbal hallucination|auditory verbal hallucination
5747628|NCT00328952|antipsychotic treatment|antipsychotic treatment
5747629|NCT00328939|ARIXTRA|arixtra
5747630|NCT00328939|prevention of DVT|prevention of dvt
5747631|NCT00328926|Hypogonadotropic Hypogonadism (LH <1.2 IU/L)|hypogonadotropic hypogonadism (lh <1.2 iu/l)
5747632|NCT00328926|Placebo|placebo
5747633|NCT00328926|Luveris® 75 IU|luveris® 75 iu
5747634|NCT00328926|Luveris® 25 IU|luveris® 25 iu
5747635|NCT00328926|Recombinant human chorionic gonadotropin (r-hCG)|recombinant human chorionic gonadotropin (r-hcg)
5747636|NCT00328913|satiety|satiety
5747637|NCT00328913|food intake|food intake
5747638|NCT00328913|mood|mood
5747639|NCT00328913|wellness|wellness
5747640|NCT00328913|weight management|weight management
5747641|NCT00328900|Galvanic skin response|galvanic skin response
5747642|NCT00328900|Anesthesia|anesthesia
5747643|NCT00328900|Atropine|atropine
5747644|NCT00328887|Esophageal Neoplasms|esophageal neoplasms
5747645|NCT00328874|Progressive Supranuclear Palsy|progressive supranuclear palsy
5747646|NCT00328874|Coenzyme Q10|coenzyme q10
5747647|NCT00328861|Adoptive Cell Therapy|adoptive cell therapy
5747648|NCT00328861|Cutaneous Melanoma|cutaneous melanoma
5747649|NCT00328861|Clinical Response|clinical response
5747650|NCT00328861|Rate of Repopulation|rate of repopulation
5747651|NCT00328861|Toxicity Profile|toxicity profile
5747652|NCT00328861|Metastatic Melanoma|metastatic melanoma
5747653|NCT00328861|Metastatic Kidney Cancer|metastatic kidney cancer
5747654|NCT00328848|patient care management|patient care management
5747655|NCT00328848|chronic disease|chronic disease
5747657|NCT00328835|Glaucoma|glaucoma
5747658|NCT00328822|Primary insomnia|primary insomnia
5747659|NCT00328822|Quetiapine|quetiapine
5747660|NCT00328822|Randomized controlled trial|randomized controlled trial
5747661|NCT00328822|Double blind|double blind
5747662|NCT00328796|Perineal|perineal
5747663|NCT00328796|repair|repair
5747664|NCT00328796|episiotomies|episiotomies
5747665|NCT00328796|midwives|midwives
5747666|NCT00328796|pain relief|pain relief
5747667|NCT00328796|Episiotomy|episiotomy
5747668|NCT00328783|Breast cancer|breast cancer
5747669|NCT00328783|Active Breathing Control|active breathing control
5747670|NCT00328783|Active Breathing Coordinator|active breathing coordinator
5747671|NCT00328783|ABC|abc
5748071|NCT00327210|Education|education
5747672|NCT00328770|liver transplant|liver transplant
5747673|NCT00328770|hepatocellular carcinoma|hepatocellular carcinoma
5747674|NCT00328770|sirolimus|sirolimus
5747675|NCT00328757|gynecologic cancer|gynecologic cancer
5747676|NCT00328757|cervical cancer|cervical cancer
5747677|NCT00328757|ovarian cancer|ovarian cancer
5747678|NCT00328757|endometrial cancer|endometrial cancer
5747679|NCT00328757|radical abdominal hysterectomy|radical abdominal hysterectomy
5747680|NCT00328757|pelvic lymphadenectomy|pelvic lymphadenectomy
5747681|NCT00328757|surgical staging|surgical staging
5747682|NCT00328757|postoperative feeding|postoperative feeding
5747683|NCT00328757|Early-stage gynecologic cancer patients|early-stage gynecologic cancer patients
5747684|NCT00328744|Weight|weight
5747685|NCT00328744|Dietary intake|dietary intake
5747686|NCT00328744|Energy|energy
5747687|NCT00328744|Hedonics|hedonics
5747688|NCT00328744|Behavioral|behavioral
5747689|NCT00328744|Sensory-specific satiety|sensory-specific satiety
5747690|NCT00328744|Monotony|monotony
5747691|NCT00328731|Allergy|allergy
5747692|NCT00328731|NAET|naet
5747693|NCT00328718|Persistent Asthma|persistent asthma
5747694|NCT00328718|pediatric asthmatic|pediatric asthmatic
5747695|NCT00328718|asthma control|asthma control
5747696|NCT00328705|Sensing|sensing
5747697|NCT00328705|Capture Management|capture management
5747698|NCT00328705|Heart Failure|heart failure
5763953|NCT00268203|expanded access study|expanded access study
5763954|NCT00268203|refractory low-grade non-Hodgkin's Lymphoma|refractory low-grade non-hodgkin's lymphoma
5763956|NCT00268203|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5763959|NCT00268177|Airways|airways
5747699|NCT00328705|ICD Indication|icd indication
5747700|NCT00328692|heart failure|heart failure
5747701|NCT00328692|diuretic|diuretic
5747702|NCT00328692|renal impairment|renal impairment
5747703|NCT00328692|renal function|renal function
5747704|NCT00328679|abdominal|abdominal
5747705|NCT00328679|stomach|stomach
5747706|NCT00328679|dyspepsia|dyspepsia
5747707|NCT00328679|food allergy|food allergy
5747708|NCT00328653|vernal keratoconjunctivitis (VKC), eye, allergy, cyclosporin|vernal keratoconjunctivitis (vkc), eye, allergy, cyclosporin
5747710|NCT00328640|Ischemic stroke|ischemic stroke
5747711|NCT00328627|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5747712|NCT00328627|Drug Therapy|drug therapy
5747713|NCT00328627|Diabetes Mellitus, Non Insulin Dependent|diabetes mellitus, non insulin dependent
5747714|NCT00328627|Glucose Intolerance|glucose intolerance
5747715|NCT00328627|Hyperglycemia|hyperglycemia
5747716|NCT00328614|Locally advanced prostate cancer|locally advanced prostate cancer
5747717|NCT00328614|positive lymph nodes|positive lymph nodes
5747718|NCT00328588|Treatment Efficacy|treatment efficacy
5747719|NCT00328588|Treatment Effectiveness|treatment effectiveness
5747720|NCT00328588|Disease Management|disease management
5747721|NCT00328588|Treatment|treatment
5747722|NCT00328588|Safety|safety
5747723|NCT00328575|Brain metastases|brain metastases
5747724|NCT00328575|Parenchymal|parenchymal
5747725|NCT00328575|Neoplasm|neoplasm
5747726|NCT00328575|IMRT|imrt
5747825|NCT00328198|Refractory|refractory
5747727|NCT00328575|Intensity Modulated Radiation Therapy|intensity modulated radiation therapy
5747728|NCT00328562|Advanced NSCLC|advanced nsclc
5747729|NCT00328562|Non-Small Cell Lung Carcinoma|non-small cell lung carcinoma
5747730|NCT00328562|Stage IV NSCLC|stage iv nsclc
5747731|NCT00328549|Natural History,|natural history,
5747732|NCT00328549|Hepatitis C Infection|hepatitis c infection
5747733|NCT00328549|Ribavirin|ribavirin
5747734|NCT00328549|Pegylated Interferon|pegylated interferon
5747735|NCT00328549|Interferon|interferon
5747736|NCT00328536|flow-mediated vasodilatation|flow-mediated vasodilatation
5747737|NCT00328536|endothelial dysfunction|endothelial dysfunction
5747739|NCT00328536|type 2 diabetes mellitus|type 2 diabetes mellitus
5747740|NCT00328536|postprandial state|postprandial state
5747741|NCT00328510|Stereotactic radiotherapy|stereotactic radiotherapy
5747742|NCT00328484|COPD|copd
5747743|NCT00328484|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5747744|NCT00328484|Exercise|exercise
5747745|NCT00328484|Emphysema|emphysema
5747746|NCT00328484|Chronic Bronchitis|chronic bronchitis
5747747|NCT00328471|patient care management|patient care management
5747748|NCT00328471|cerebrovascular accident|cerebrovascular accident
5747749|NCT00328458|CNS and head and neck cancers|cns and head and neck cancers
5747750|NCT00328458|Histologically confirmed CNS malignancy head and neck|histologically confirmed cns malignancy head and neck
5747751|NCT00328458|there is on standard therapy or|there is on standard therapy or
5747752|NCT00328458|have failed standard therapy|have failed standard therapy
5747753|NCT00328445|Curriculum|curriculum
5747754|NCT00328445|Classroom management|classroom management
5747755|NCT00328445|School-wide climate|school-wide climate
5747756|NCT00328445|Parent involvement|parent involvement
5747757|NCT00328432|early breast cancer|early breast cancer
5747758|NCT00328432|double-blind randomized placebo-controlled|double-blind randomized placebo-controlled
5747759|NCT00328432|RCT|rct
5747760|NCT00328432|pre-surgical model|pre-surgical model
5747761|NCT00328432|DCIS model|dcis model
5747762|NCT00328432|COX-2 inhibitor|cox-2 inhibitor
5747763|NCT00328432|celecoxib|celecoxib
5747764|NCT00328432|Ki-67 placebo|ki-67 placebo
5747765|NCT00328419|Photoprotection,|photoprotection,
5747766|NCT00328419|Parenteral nutrition|parenteral nutrition
5747767|NCT00328419|Oxidant stress|oxidant stress
5747768|NCT00328419|Infant, Premature|infant, premature
5747769|NCT00328393|Hypertension|hypertension
5747770|NCT00328380|Travelers' Diarrhea|travelers' diarrhea
5747771|NCT00328380|Xifaxan|xifaxan
5747772|NCT00328380|Rifaximin|rifaximin
5756167|NCT00297141|T3|t3
5747773|NCT00328380|Escherichia coli|escherichia coli
5747774|NCT00328380|E coli|e coli
5747775|NCT00328380|EAEC|eaec
5747776|NCT00328380|Enteroaggregative E coli|enteroaggregative e coli
5747777|NCT00328380|ETEC|etec
5747778|NCT00328380|Enterotoxigenic E coli|enterotoxigenic e coli
5747779|NCT00328367|schizophrenia|schizophrenia
5747780|NCT00328367|aripiprazole|aripiprazole
5747781|NCT00328367|clozapine|clozapine
5747782|NCT00328341|traumatic brain injury|traumatic brain injury
5747783|NCT00328341|hemorrhagic shock|hemorrhagic shock
5747784|NCT00328341|multisystem trauma|multisystem trauma
5747785|NCT00328341|under resuscitation|under resuscitation
5747786|NCT00328341|tissue oxygen monitoring|tissue oxygen monitoring
5747787|NCT00328315|Myocardial Perfusion SPECT|myocardial perfusion spect
5747788|NCT00328302|Diabetes|diabetes
5747789|NCT00328302|Kidney function|kidney function
5737512|NCT00367133|DME|dme
5747790|NCT00328302|24 ambulatory blood pressure|24 ambulatory blood pressure
5747791|NCT00328302|Kidney biopsy|kidney biopsy
5747792|NCT00328289|Dialysis associated hypotension|dialysis associated hypotension
5747793|NCT00328289|Urea removal|urea removal
5747794|NCT00328263|Bio-K+CL1285|bio-k+cl1285
5747795|NCT00328263|Probiotics|probiotics
5747796|NCT00328263|Antibiotics-associated diarrhea|antibiotics-associated diarrhea
5747797|NCT00328263|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5747798|NCT00328263|Lactobacillus acidophilus|lactobacillus acidophilus
5747799|NCT00328263|Clostridium Difficile|clostridium difficile
5747800|NCT00328250|Internet|internet
5747802|NCT00328250|Insomnia|insomnia
5747803|NCT00328250|Sleep|sleep
5747804|NCT00328237|Cord Blood Transplant|cord blood transplant
5747805|NCT00328237|Umbilical cord blood transplant|umbilical cord blood transplant
5747806|NCT00328237|Transplant|transplant
5747807|NCT00328237|Fludarabine|fludarabine
5747808|NCT00328237|Total Body Irradiation|total body irradiation
5747809|NCT00328237|Cyclophosphamide|cyclophosphamide
5747810|NCT00328224|ritalin|ritalin
5747811|NCT00328224|ADHA|adha
5747812|NCT00328224|dental status|dental status
5747813|NCT00328224|periodontal status|periodontal status
5747814|NCT00328224|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5747815|NCT00328224|Dental trauma|dental trauma
5747816|NCT00328198|CAMPATH|campath
5747817|NCT00328198|Alemtuzumab|alemtuzumab
5747818|NCT00328198|Leukemia|leukemia
5747819|NCT00328198|MabCampath|mabcampath
5747820|NCT00328198|Chronic|chronic
5747821|NCT00328198|Subcutaneous|subcutaneous
5747822|NCT00328198|CLL|cll
5747823|NCT00328198|C-CLL|c-cll
5747824|NCT00328198|Relapsed|relapsed
5747826|NCT00328198|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5747827|NCT00328185|pediatric|pediatric
5747828|NCT00328185|heart disease|heart disease
5747829|NCT00328185|orthotopic heart transplantation|orthotopic heart transplantation
5747830|NCT00328185|allograft fibrosis|allograft fibrosis
5747831|NCT00328159|FAO disorders|fao disorders
5747832|NCT00328159|long-chain FAO enzyme defects|long-chain fao enzyme defects
5747833|NCT00328159|inborn errors of metabolism|inborn errors of metabolism
5747834|NCT00328159|carnitine palmitoyltransferase 1 (CPT1),|carnitine palmitoyltransferase 1 (cpt1),
5747835|NCT00328159|carnitine-acylcarnitine translocase (CAT),|carnitine-acylcarnitine translocase (cat),
5747836|NCT00328159|carnitine palmitoyltransferase 2 (CPT2),|carnitine palmitoyltransferase 2 (cpt2),
5747837|NCT00328159|very-long chain acyl-CoA dehydrogenase (VLCAD),|very-long chain acyl-coa dehydrogenase (vlcad),
5747838|NCT00328159|L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD)|l-3-hydroxy-acyl-coa dehydrogenase (lchad)
5747839|NCT00328159|or trifunctional protein (MTP).|or trifunctional protein (mtp).
5747840|NCT00328146|pediatric|pediatric
5747842|NCT00328146|re-operative surgery|re-operative surgery
5747843|NCT00328133|recombinant Factor VIIa|recombinant factor viia
5747844|NCT00328133|traumatic hemorrhage|traumatic hemorrhage
5747845|NCT00328133|hemorrhagic shock|hemorrhagic shock
5747846|NCT00328133|coagulopathy|coagulopathy
5747847|NCT00328120|Advanced breast cancer|advanced breast cancer
5747848|NCT00328120|Faslodex|faslodex
5747849|NCT00328107|Influenza|influenza
5747850|NCT00328094|Tight|tight
5747851|NCT00328094|Glycemic|glycemic
5747857|NCT00328094|morbidity|morbidity
5747858|NCT00328094|mortality|mortality
5747860|NCT00328081|Weight gain|weight gain
5747861|NCT00328081|Anti-obesity medication|anti-obesity medication
5747862|NCT00328081|Anti-obesity management strategies|anti-obesity management strategies
5747863|NCT00328081|Body Weight|body weight
5747864|NCT00328068|ASAS classification|asas classification
5747865|NCT00328068|ASAS diagnostic criteria|asas diagnostic criteria
5747866|NCT00328068|spondyloarthritis|spondyloarthritis
5747867|NCT00328068|spondyloarthropathy|spondyloarthropathy
5747868|NCT00328068|spondylitis, ankylosing|spondylitis, ankylosing
5747869|NCT00328068|modified New York criteria for AS|modified new york criteria for as
5747870|NCT00328068|ESSG criteria for SpA|essg criteria for spa
5747871|NCT00328068|Amor criteria for SpA|amor criteria for spa
5747872|NCT00328068|arthritis|arthritis
5747873|NCT00328068|enthesitis|enthesitis
5747874|NCT00328068|magnetic resonance imaging|magnetic resonance imaging
5747875|NCT00328055|functional ability|functional ability
5747876|NCT00328055|patient care management|patient care management
5747877|NCT00328055|communication|communication
5747878|NCT00328055|literacy|literacy
5747879|NCT00328042|Self-care|self-care
5747880|NCT00328042|Quality of Life|quality of life
5747881|NCT00328042|Chronic disease|chronic disease
5747882|NCT00328029|Busulfan|busulfan
5747883|NCT00328029|pharmacokinetic|pharmacokinetic
5747884|NCT00328029|respiratory function assessment|respiratory function assessment
5747885|NCT00328029|Busulfan pharmacokinetic and respiratory function tests|busulfan pharmacokinetic and respiratory function tests
5747886|NCT00328016|hypertension|hypertension
5747887|NCT00328016|high blood pressure|high blood pressure
5747888|NCT00328016|meditation|meditation
5747889|NCT00327990|ibandronate|ibandronate
5747890|NCT00327990|osteoporosis|osteoporosis
5747891|NCT00327990|preference|preference
5747892|NCT00327990|case-finding|case-finding
5747893|NCT00327990|post-menopausal|post-menopausal
5747894|NCT00327990|alendronate|alendronate
5747895|NCT00327977|hypoxemia|hypoxemia
5747896|NCT00327977|palliative neonatal surgery|palliative neonatal surgery
5747904|NCT00327951|pediatric|pediatric
5747905|NCT00327951|cardiac|cardiac
5747906|NCT00327951|weight gain pre-operative|weight gain pre-operative
5747907|NCT00327951|trisomy 21|trisomy 21
5747908|NCT00327951|complete atrioventricular canal|complete atrioventricular canal
5747909|NCT00327938|Remifentanil|remifentanil
5747910|NCT00327938|Skin Conductance|skin conductance
5747911|NCT00327938|Anesthesia|anesthesia
5747912|NCT00327938|Analgesics, Opioid|analgesics, opioid
5747913|NCT00327925|Ovarian|ovarian
5747914|NCT00327925|Cancer|cancer
5747915|NCT00327925|Antibodies|antibodies
5747916|NCT00327925|Ovarian Cancer Associated Antibodies|ovarian cancer associated antibodies
5747917|NCT00327912|Obesity|obesity
5747918|NCT00327912|Surgery|surgery
5747919|NCT00327912|Gastric bypass|gastric bypass
5747920|NCT00327912|Biliopancreatic diversion with Duodenal switch|biliopancreatic diversion with duodenal switch
5747921|NCT00327912|Laparoscopy|laparoscopy
5747922|NCT00327899|pediatric|pediatric
5747923|NCT00327899|congestive heart failure|congestive heart failure
5747924|NCT00327899|inotropes|inotropes
5747925|NCT00327886|pediatric|pediatric
5747926|NCT00327886|Glenn operation|glenn operation
5747927|NCT00327886|Cyanosis|cyanosis
5747928|NCT00327873|breathlessness|breathlessness
5747929|NCT00327873|shortness of breath|shortness of breath
5747930|NCT00327873|end-of-life care|end-of-life care
5747931|NCT00327873|hospice|hospice
5747932|NCT00327808|Smokers|smokers
5747933|NCT00327808|Adults|adults
5747934|NCT00327808|Inflammatory markers|inflammatory markers
5747935|NCT00327795|congenital heart disease|congenital heart disease
5747936|NCT00327795|pediatric|pediatric
5747937|NCT00327795|surgical outcomes|surgical outcomes
5747938|NCT00327782|pediatric|pediatric
5747939|NCT00327782|palliative care|palliative care
5747940|NCT00327782|end stage heart failure|end stage heart failure
5747941|NCT00327769|Advanced breast cancer|advanced breast cancer
5747942|NCT00327769|fulvestrant|fulvestrant
5747943|NCT00327769|anastrozole|anastrozole
5747944|NCT00327756|Depression|depression
5747945|NCT00327756|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5747947|NCT00327756|Manic Depressive|manic depressive
5747948|NCT00327756|Bioenergetics|bioenergetics
5747949|NCT00327756|Bipolar Disorder|bipolar disorder
5747950|NCT00327756|Manic Depression|manic depression
5747951|NCT00327743|Cancer Alternative Therapies|cancer alternative therapies
5747952|NCT00327743|Metastatic Breast Cancer|metastatic breast cancer
5747953|NCT00327730|Muscle|muscle
5747954|NCT00327730|Spasm|spasm
5747955|NCT00327730|Back|back
5747956|NCT00327730|Pain|pain
5747957|NCT00327717|Epilepsy|epilepsy
5747958|NCT00327717|Partial seizures|partial seizures
5747959|NCT00327704|Septic Shock|septic shock
5747960|NCT00327691|Major cardiovascular event|major cardiovascular event
5747961|NCT00327691|Major Coronary event|major coronary event
5747962|NCT00327691|Revascularization|revascularization
5747963|NCT00327678|ALL,|all,
5747964|NCT00327678|young patients,|young patients,
5747965|NCT00327678|chemotherapy,|chemotherapy,
5747966|NCT00327678|Mabtera,|mabtera,
5747967|NCT00327678|Imatinib,|imatinib,
5747968|NCT00327678|allogeneic transplant|allogeneic transplant
5747969|NCT00327665|pneumonia|pneumonia
5747970|NCT00327665|pneumococcal vaccine|pneumococcal vaccine
5747971|NCT00327665|elderly subjects|elderly subjects
5747972|NCT00327665|invasive pneumococcal diseases|invasive pneumococcal diseases
5747973|NCT00327665|Prophylaxis|prophylaxis
5747974|NCT00327652|carcinoma|carcinoma
5747975|NCT00327652|liver|liver
5747976|NCT00327652|hepatic|hepatic
5747977|NCT00327652|metastasis|metastasis
5747978|NCT00327652|Listeria|listeria
5747979|NCT00327626|Fasting plasma glucose|fasting plasma glucose
5747980|NCT00327626|HbA1c|hba1c
5747981|NCT00327626|Oral antidiabetic agent(s)|oral antidiabetic agent(s)
5747983|NCT00327613|glaucoma|glaucoma
5747984|NCT00327613|MMP|mmp
5747985|NCT00327613|DNA degradation|dna degradation
5747986|NCT00327613|POAG|poag
5747987|NCT00327613|Healthy subjects|healthy subjects
5747988|NCT00327587|hypertension|hypertension
5747989|NCT00327587|valsartan|valsartan
5747990|NCT00327587|amlodipine|amlodipine
5747991|NCT00327587|HCTZ|hctz
5747992|NCT00327561|Inflammation|inflammation
5747993|NCT00327561|Periodontitis|periodontitis
5747994|NCT00327561|Endothelial function|endothelial function
5747995|NCT00327561|Atherosclerosis|atherosclerosis
5747996|NCT00327561|Controlled trial|controlled trial
5747997|NCT00327509|mRNA|mrna
5747998|NCT00327509|glaucoma|glaucoma
5747999|NCT00327483|Transplant|transplant
5748000|NCT00327483|Medication error|medication error
5748001|NCT00327483|Patient Safety|patient safety
5748002|NCT00327483|Information technology|information technology
5748003|NCT00327470|neovascular age related macular degeneration|neovascular age related macular degeneration
5748004|NCT00327470|choroidal neovascularization|choroidal neovascularization
5748005|NCT00327457|colorectal cancer screening|colorectal cancer screening
5748006|NCT00327457|sigmoidoscopy|sigmoidoscopy
5748007|NCT00327457|colonoscopy|colonoscopy
5748008|NCT00327444|Ovarian neoplasm|ovarian neoplasm
5748009|NCT00327444|Ascites|ascites
5748010|NCT00327444|Angiogenesis inhibitor|angiogenesis inhibitor
5748011|NCT00327444|Vascular Endothelial Growth Factor A|vascular endothelial growth factor a
5748012|NCT00327444|Recombinant fusion protein|recombinant fusion protein
5748013|NCT00327431|Hypertension|hypertension
5748014|NCT00327431|Blood Pressure|blood pressure
5748015|NCT00327431|Psychosocial Factors|psychosocial factors
5748016|NCT00327405|POAG|poag
5748017|NCT00327405|Primary Open Angle Glaucoma|primary open angle glaucoma
5748018|NCT00327405|Trabeculectomy|trabeculectomy
5748019|NCT00327405|Combined Phacotrabeculectomy|combined phacotrabeculectomy
5748020|NCT00327405|Combined Glaucoma Cataract Surgery|combined glaucoma cataract surgery
5748021|NCT00327405|Releasable Suture|releasable suture
5748022|NCT00327405|Ocular Compresssion|ocular compresssion
5748023|NCT00327392|Arthroscopy|arthroscopy
5748024|NCT00327392|AV Shunt|av shunt
5748025|NCT00327392|Bunion|bunion
5748026|NCT00327392|Dilatation and Curettage|dilatation and curettage
5748027|NCT00327392|Esophagogastroduodenoscopy|esophagogastroduodenoscopy
5748028|NCT00327392|Hysteroscopy|hysteroscopy
5748029|NCT00327392|Lithotripsy|lithotripsy
5748030|NCT00327392|Rotator Cuff/ Shoulder|rotator cuff/ shoulder
5748031|NCT00327392|Transesophageal Echocardiography|transesophageal echocardiography
5748032|NCT00327392|Ureteroscopy|ureteroscopy
5748033|NCT00327392|AQUAVAN|aquavan
5748034|NCT00327392|Sedation|sedation
5748035|NCT00327379|Bloodloss|bloodloss
5748036|NCT00327379|Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery|transfusion requirements in patients undergoing elective spinal fusion surgery
5748037|NCT00327366|Menstrual Cycle|menstrual cycle
5748038|NCT00327366|Light Therapy|light therapy
5748039|NCT00327366|Sex Hormones|sex hormones
5748040|NCT00327366|Ovulation|ovulation
5748041|NCT00327353|Asthma|asthma
5748042|NCT00327353|Salmeterol|salmeterol
5748043|NCT00327353|Formoterol|formoterol
5748044|NCT00327353|Airway resistance|airway resistance
5748045|NCT00327340|Metastatic hormone refractory prostate cancer (HRPC)|metastatic hormone refractory prostate cancer (hrpc)
5748047|NCT00327301|Parkinson's disease|parkinson's disease
5748048|NCT00327301|cellular proteome|cellular proteome
5748049|NCT00327301|human leucocytes|human leucocytes
5748050|NCT00327301|vasospasm|vasospasm
5748051|NCT00327301|POAG patients|poag patients
5748052|NCT00327301|Patients with Parkinson's disease|patients with parkinson's disease
5748053|NCT00327301|Healthy subjects|healthy subjects
5748054|NCT00327288|Hormone refractory prostate cancer|hormone refractory prostate cancer
5862869|NCT00001475|Cytokines|cytokines
5680999|NCT00575237|Shoulder pain|shoulder pain
5681001|NCT00575237|Anesthesia|anesthesia
5681002|NCT00575237|Residual CO2|residual co2
5681003|NCT00575237|Postoperative Pain|postoperative pain
5681155|NCT00574509|131Iodine-Anti-B1 Radioimmunotherapy|131iodine-anti-b1 radioimmunotherapy
5773431|NCT00229593|Androgen|androgen
5748055|NCT00327262|chronic myeloid leukemia|chronic myeloid leukemia
5748056|NCT00327262|Ph+|ph+
5748057|NCT00327262|bcr/abl+|bcr/abl+
5748058|NCT00327262|imatinib|imatinib
5748059|NCT00327236|Paraneoplastic Neurologic Syndromes|paraneoplastic neurologic syndromes
5748060|NCT00327223|Metastatic cancer|metastatic cancer
5748061|NCT00327223|Disseminated malignant disease|disseminated malignant disease
5748062|NCT00327210|BGAT|bgat
5748063|NCT00327210|Blood Glucose Awareness Training|blood glucose awareness training
5748064|NCT00327210|Diabetes|diabetes
5748065|NCT00327210|T1DM|t1dm
5748066|NCT00327210|Internet|internet
5748067|NCT00327210|Web|web
5748068|NCT00327210|Intervention|intervention
5748069|NCT00327210|Treatment|treatment
5748073|NCT00327197|bronchoscopy|bronchoscopy
5748074|NCT00327197|Sputum induction|sputum induction
5748075|NCT00327197|Prednisolone|prednisolone
5748076|NCT00327197|Asthma|asthma
5748077|NCT00327197|biomarkers|biomarkers
5748078|NCT00327171|ovarian cancer|ovarian cancer
5748079|NCT00327171|angiogenesis|angiogenesis
5748080|NCT00327171|angiogenesis inhibition|angiogenesis inhibition
5748081|NCT00327171|VEGF-Trap fusion recombinant protein|vegf-trap fusion recombinant protein
5748082|NCT00327171|Cancer and other neoplasms|cancer and other neoplasms
5748083|NCT00327158|Reaming|reaming
5748084|NCT00327158|fracture|fracture
5748085|NCT00327158|emboli|emboli
5748086|NCT00327145|HCTZ|hctz
5748087|NCT00327145|hypertension|hypertension
5748088|NCT00327145|valsartan|valsartan
5748089|NCT00327145|amlodipine|amlodipine
5748090|NCT00327132|Early-stage Lg/Hg Gastric MALT Lymphoma|early-stage lg/hg gastric malt lymphoma
5748091|NCT00327132|Eradication of Helicobacter pylori (Hp)|eradication of helicobacter pylori (hp)
5748092|NCT00327119|EGFR|egfr
5748093|NCT00327119|Fully human|fully human
5748094|NCT00327119|Monoclonal antibody|monoclonal antibody
5748095|NCT00327119|Panitumumab|panitumumab
5748096|NCT00327119|ABX-EGF|abx-egf
5748097|NCT00327119|AMG954|amg954
5748098|NCT00327119|Colorectal Cancer|colorectal cancer
5748099|NCT00327119|Japan|japan
5748100|NCT00327106|hip fracture|hip fracture
5748101|NCT00327106|transfusion|transfusion
5748102|NCT00327106|tranexamic acid|tranexamic acid
5748103|NCT00327106|fondaparinux|fondaparinux
5748104|NCT00327093|Colorectal cancer,|colorectal cancer,
5748105|NCT00327093|immunohistochemistry,|immunohistochemistry,
5748106|NCT00327093|monoclonal antibodies,|monoclonal antibodies,
5748107|NCT00327093|predictive model,|predictive model,
5748108|NCT00327093|antiangiogenic agents,|antiangiogenic agents,
5748109|NCT00327093|medical imaging|medical imaging
5748110|NCT00327093|Colorectal cancer with liver metastases|colorectal cancer with liver metastases
5748111|NCT00327080|HIV|hiv
5748112|NCT00327080|AIDS|aids
5748113|NCT00327080|Pulmonary Hypertension|pulmonary hypertension
5748114|NCT00327080|Blood Flow Studies|blood flow studies
5748115|NCT00327080|Right Heart Catheterization|right heart catheterization
5748116|NCT00327080|HIV Infection|hiv infection
5748117|NCT00327080|HIV Associated Pulmonary Hypertension|hiv associated pulmonary hypertension
5748118|NCT00327080|Healthy Volunteer|healthy volunteer
5748119|NCT00327080|HV|hv
5748120|NCT00327067|Hemoglobin|hemoglobin
5748121|NCT00327067|Iron Supplementation|iron supplementation
5748122|NCT00327067|Donor Retention|donor retention
5748123|NCT00327067|Iron Stores|iron stores
5748124|NCT00327067|Ferritin|ferritin
5748125|NCT00327067|Transferrin Saturation|transferrin saturation
5748126|NCT00327067|Healthy Volunteer|healthy volunteer
5748127|NCT00327067|HV|hv
5748128|NCT00327067|Blood Donors|blood donors
5748129|NCT00327054|Dyslipidaemia|dyslipidaemia
5748130|NCT00327054|Herbal medicine|herbal medicine
5748131|NCT00327054|Home remedy|home remedy
5748132|NCT00327054|Alternative medicine|alternative medicine
5748133|NCT00327054|Metabolic syndrome|metabolic syndrome
5748134|NCT00327041|Aspirin|aspirin
5748135|NCT00327041|Clopidogrel|clopidogrel
5748136|NCT00327041|Balloon Angioplasty|balloon angioplasty
5748137|NCT00327041|Coronary Thrombosis|coronary thrombosis
5748138|NCT00327028|Bronchial asthma|bronchial asthma
5748139|NCT00327028|Phenytoin, Diphenine|phenytoin, diphenine
5748140|NCT00327028|Antiepileptic drugs|antiepileptic drugs
5748141|NCT00327028|Efficacy|efficacy
5748142|NCT00327002|Low HDL|low hdl
5748143|NCT00327002|Metabolic syndrome|metabolic syndrome
5748144|NCT00327002|low HDL Cholesterol in setting of metabolic syndrome|low hdl cholesterol in setting of metabolic syndrome
5748145|NCT00326989|Extracorporal shock wave therapy|extracorporal shock wave therapy
5681156|NCT00574509|Autologous Hematopoietic Stem Cell Transplant|autologous hematopoietic stem cell transplant
5681157|NCT00574509|AHSCT|ahsct
5748146|NCT00326989|Cell therapy|cell therapy
5748147|NCT00326976|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5748148|NCT00326976|Myocardial Revascularization|myocardial revascularization
5748149|NCT00326950|Cancer|cancer
5748150|NCT00326950|Tumors|tumors
5748151|NCT00326950|Phase I|phase i
5748152|NCT00326950|E7389|e7389
5748153|NCT00326924|Transfusion|transfusion
5748154|NCT00326885|Ascites|ascites
5748155|NCT00326885|Epithelial Cancer|epithelial cancer
5748156|NCT00326885|Epithelial Carcinoma|epithelial carcinoma
5748157|NCT00326885|Epithelial Ovarian Cancer|epithelial ovarian cancer
5748158|NCT00326885|Epithelial Ovarian Carcinoma|epithelial ovarian carcinoma
5748159|NCT00326885|Fallopian Tube Cancer|fallopian tube cancer
5748160|NCT00326885|Fallopian Tube Carcinoma|fallopian tube carcinoma
5748161|NCT00326885|Malignant Ascites|malignant ascites
5748162|NCT00326885|Ovarian Cancer|ovarian cancer
5748163|NCT00326885|Ovarian Carcinoma|ovarian carcinoma
5748164|NCT00326885|Ovarian Epithelial Cancer|ovarian epithelial cancer
5748165|NCT00326885|Ovarian Epithelial Carcinoma|ovarian epithelial carcinoma
5748166|NCT00326885|Peritoneal Cancer|peritoneal cancer
5748167|NCT00326885|Peritoneal Carcinoma|peritoneal carcinoma
5748168|NCT00326885|Recurrent Ascites|recurrent ascites
5748169|NCT00326885|Recurrent Malignant Ascites|recurrent malignant ascites
5748170|NCT00326885|Recurrent Symptomatic Malignant Ascites|recurrent symptomatic malignant ascites
5748373|NCT00326066|Surgery|surgery
5748171|NCT00326885|Symptomatic Malignant Ascites|symptomatic malignant ascites
5748172|NCT00326885|Symptomatic Ascites|symptomatic ascites
5748173|NCT00326885|Neoplasms, Glandular and Epithelial|neoplasms, glandular and epithelial
5748174|NCT00326885|Ovarian Neoplasms|ovarian neoplasms
5748298|NCT00326404|Adolescents|adolescents
5748175|NCT00326885|Fallopian Tube Neoplasms|fallopian tube neoplasms
5748176|NCT00326885|Peritoneal Neoplasms|peritoneal neoplasms
5748177|NCT00326859|analgesia strategies|analgesia strategies
5748178|NCT00326859|pain|pain
5748179|NCT00326859|extensive dressing change|extensive dressing change
5748180|NCT00326833|Vitamin B12 deficiency|vitamin b12 deficiency
5748181|NCT00326833|Vitamin B12 absorption|vitamin b12 absorption
5748182|NCT00326833|Holotranscobalamin|holotranscobalamin
5748183|NCT00326820|hypercalcemia of malignancy|hypercalcemia of malignancy
5748184|NCT00326820|stage IV breast cancer|stage iv breast cancer
5748185|NCT00326820|bone metastases|bone metastases
5748186|NCT00326820|recurrent breast cancer|recurrent breast cancer
5748187|NCT00326820|male breast cancer|male breast cancer
5748188|NCT00326807|naltrexone|naltrexone
5748189|NCT00326807|alcohol|alcohol
5748190|NCT00326807|gambling|gambling
5748191|NCT00326807|concurrent|concurrent
5748192|NCT00326794|Nonsurgical proximal humerus fracture|nonsurgical proximal humerus fracture
5748193|NCT00326794|Rehabilitation|rehabilitation
5748194|NCT00326794|Physiotherapy|physiotherapy
5748195|NCT00326794|randomised controlled trial|randomised controlled trial
5748196|NCT00326781|Nicotine nasal spray + counseling|nicotine nasal spray + counseling
5748197|NCT00326781|Transdermal nicotine + counseling|transdermal nicotine + counseling
5748198|NCT00326742|Alcoholism|alcoholism
5748199|NCT00326742|Risk factors|risk factors
5748200|NCT00326742|Adolescence|adolescence
5748201|NCT00326742|Stress test|stress test
5748202|NCT00326742|HPA system|hpa system
5748203|NCT00326742|Family adversity|family adversity
5748204|NCT00326742|Candidate genes|candidate genes
5748205|NCT00326742|Cortisol|cortisol
5748206|NCT00326742|Adrenocorticotrophin|adrenocorticotrophin
5748207|NCT00326729|burns|burns
5748208|NCT00326729|thermal injury|thermal injury
5748209|NCT00326729|hemodynamics|hemodynamics
5748210|NCT00326729|microcirculation|microcirculation
5748211|NCT00326716|HIV-1 infected pregnant women, either treatment naive or on ATV/RTV combined with ZDV/3TC|hiv-1 infected pregnant women, either treatment naive or on atv/rtv combined with zdv/3tc
5748212|NCT00326703|hypoxia|hypoxia
5748213|NCT00326703|hypobaric|hypobaric
5748214|NCT00326703|altitude|altitude
5748215|NCT00326690|Congestive Heart Failure|congestive heart failure
5748216|NCT00326690|Coronary Artery Disease|coronary artery disease
5748217|NCT00326690|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5748218|NCT00326690|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
5748219|NCT00326677|Depression Prevention|depression prevention
5748418|NCT00325936|cilnidipine|cilnidipine
5748224|NCT00326677|Treatment of Depression in Primary Care Patients|treatment of depression in primary care patients
5748226|NCT00326677|Minor Depression|minor depression
5748227|NCT00326651|infertility|infertility
5748228|NCT00326651|pregnancy|pregnancy
5748229|NCT00326651|conception|conception
5748230|NCT00326651|conceive|conceive
5748231|NCT00326651|conceiving|conceiving
5748232|NCT00326651|trying to conceive|trying to conceive
5748233|NCT00326651|get pregnant|get pregnant
5748234|NCT00326651|conception kit|conception kit
5748235|NCT00326651|conception cap|conception cap
5748236|NCT00326651|fertility|fertility
5748237|NCT00326651|Women who are actively trying to become pregnant|women who are actively trying to become pregnant
5748238|NCT00326638|prostate, IMRT, tomotherapy, radiation, cancer|prostate, imrt, tomotherapy, radiation, cancer
5748239|NCT00326612|Seizures|seizures
5748240|NCT00326599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5748241|NCT00326599|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5748242|NCT00326599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5748243|NCT00326599|squamous cell lung cancer|squamous cell lung cancer
5748244|NCT00326573|Diabetes|diabetes
5748245|NCT00326573|Teenagers|teenagers
5748246|NCT00326573|Motivational Interviewing|motivational interviewing
5748247|NCT00326560|Pterygium excision|pterygium excision
5748248|NCT00326560|Cut and paste|cut and paste
5748249|NCT00326560|Tisseel fibrin glue|tisseel fibrin glue
5748250|NCT00326560|Conjunctival autograft|conjunctival autograft
5748251|NCT00326534|Sarcoidosis|sarcoidosis
5748252|NCT00326534|Rickettsia|rickettsia
5748253|NCT00326534|Serological reactions|serological reactions
5748254|NCT00326534|Polymerase chain reaction|polymerase chain reaction
5748255|NCT00326521|Pregnant Women|pregnant women
5748256|NCT00326521|Epidural Anesthesia|epidural anesthesia
5748257|NCT00326521|Fever|fever
5748258|NCT00326521|Chorioamnionitis|chorioamnionitis
5748259|NCT00326521|Intrauterine pressure catheter|intrauterine pressure catheter
5748260|NCT00326521|Pregnancy|pregnancy
5748261|NCT00326508|T Lymphocytes|t lymphocytes
5748262|NCT00326508|IL-2 Conjugate|il-2 conjugate
5748263|NCT00326508|CD25|cd25
5748264|NCT00326508|T Regulatory Cells|t regulatory cells
5748265|NCT00326508|Autoimmunity|autoimmunity
5748266|NCT00326508|Uveitis|uveitis
5748267|NCT00326508|Daclizumab|daclizumab
5748268|NCT00326508|Denileukin Diftitox|denileukin diftitox
5748269|NCT00326508|Immune Tolerance|immune tolerance
5748270|NCT00326508|T Cell|t cell
5748271|NCT00326495|Sorafenib|sorafenib
5748272|NCT00326495|Cetuximab|cetuximab
5748273|NCT00326495|Advanced Cancer|advanced cancer
5748274|NCT00326495|Phase II|phase ii
5747261|NCT00330447|cancer|cancer
5748275|NCT00326495|Colorectal Cancer|colorectal cancer
5748276|NCT00326495|Colon Cancer|colon cancer
5748277|NCT00326495|Rectal Cancer|rectal cancer
5748278|NCT00326495|CRC|crc
5748279|NCT00326495|Metastatic Colorectal Cancer|metastatic colorectal cancer
5748287|NCT00326456|ovarian cancer|ovarian cancer
5748288|NCT00326456|chemotherapy|chemotherapy
5748289|NCT00326456|first-line|first-line
5748290|NCT00326443|Salmonella, vaccine, typhoid fever, S. Typhi|salmonella, vaccine, typhoid fever, s. typhi
5748291|NCT00326430|Social Phobia|social phobia
5748292|NCT00326430|Cognitive Therapy|cognitive therapy
5748293|NCT00326430|Interpersonal Therapy|interpersonal therapy
5748294|NCT00326430|Efficacy|efficacy
5748295|NCT00326430|Process-Outcome|process-outcome
5748296|NCT00326417|Severe Aplastic Anemia|severe aplastic anemia
5748297|NCT00326404|Oral Contraceptives|oral contraceptives
5748299|NCT00326404|Compliance|compliance
5748300|NCT00326391|Attention Deficit Disorder with Hyperactivity, ADHD, Attention Deficit Disorder Adult|attention deficit disorder with hyperactivity, adhd, attention deficit disorder adult
5748301|NCT00326365|mechanical ventilation|mechanical ventilation
5748302|NCT00326365|secretions|secretions
5748303|NCT00326365|viscosity|viscosity
5748304|NCT00326365|homeopathy|homeopathy
5748305|NCT00326365|kalium bichromate|kalium bichromate
5748306|NCT00326365|extubation|extubation
5748307|NCT00326352|Sedation|sedation
5748308|NCT00326352|Propofol|propofol
5748309|NCT00326352|Remifentanil|remifentanil
5748310|NCT00326352|recovery|recovery
5748311|NCT00326339|R935788|r935788
5748312|NCT00326339|Rheumatoid Arthritis|rheumatoid arthritis
5748313|NCT00326339|Syk Kinase|syk kinase
5748314|NCT00326313|Group B streptococci|group b streptococci
5748315|NCT00326313|virulent|virulent
5748316|NCT00326313|morbidity|morbidity
5748317|NCT00326313|mortality|mortality
5748419|NCT00325923|Decision making|decision making
5748710|NCT00324649|HIV-1|hiv-1
5748318|NCT00326300|Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder Adult|attention deficit hyperactivity disorder, adhd, attention deficit disorder adult
5748319|NCT00326287|Community-Acquired Pneumonia|community-acquired pneumonia
5748320|NCT00326287|Cephalosporins|cephalosporins
5748321|NCT00326287|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5748322|NCT00326248|postoperative nausea and vomiting PONV antiemetics NK-1 5HT3 casopitant mesylate ZOFRAN ondansetron hydrochloride|postoperative nausea and vomiting ponv antiemetics nk-1 5ht3 casopitant mesylate zofran ondansetron hydrochloride
5748323|NCT00326235|Opioid withdrawal|opioid withdrawal
5748324|NCT00326235|Buspirone|buspirone
5748325|NCT00326235|Methadone taper|methadone taper
5748326|NCT00326222|Patient Education as a Topic|patient education as a topic
5748327|NCT00326222|Self-Management Program|self-management program
5748328|NCT00326222|Health promotion|health promotion
5748329|NCT00326222|Self Efficacy|self efficacy
5748330|NCT00326222|Quality of life|quality of life
5748332|NCT00326209|Ulcerative colitis|ulcerative colitis
5748333|NCT00326209|Inflammatory bowel disease|inflammatory bowel disease
5748334|NCT00326209|IBD|ibd
5748335|NCT00326196|CABG|cabg
5748336|NCT00326196|Coronary Disease|coronary disease
5748337|NCT00326196|Diabetes|diabetes
5757528|NCT00293384|stage IV breast cancer|stage iv breast cancer
5748339|NCT00326170|Combination Chemotherapy|combination chemotherapy
5748341|NCT00326170|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5748342|NCT00326170|AML|aml
5748343|NCT00326170|Acute myelogenous leukemia|acute myelogenous leukemia
5748344|NCT00326170|valproic acid|valproic acid
5748345|NCT00326170|VPA|vpa
5748346|NCT00326170|Depakene|depakene
5748347|NCT00326170|5-azacytidine|5-azacytidine
5748348|NCT00326170|5-aza|5-aza
5748349|NCT00326170|Azacitidine|azacitidine
5748350|NCT00326170|5-AZC|5-azc
5748351|NCT00326170|Vidaza|vidaza
5748352|NCT00326170|AZA-CR|aza-cr
5748353|NCT00326170|Ladakamycin|ladakamycin
5748354|NCT00326170|NSC-102816|nsc-102816
5748355|NCT00326170|All-trans retinoic acid|all-trans retinoic acid
5748356|NCT00326170|ATRA|atra
5748357|NCT00326170|Tretinoin|tretinoin
5748358|NCT00326170|Vesanoid|vesanoid
5748359|NCT00326157|antifungal primary prophylaxis treatment|antifungal primary prophylaxis treatment
5748360|NCT00326157|allogeneic stem-cell transplantation|allogeneic stem-cell transplantation
5748361|NCT00326157|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation|antifungal primary prophylaxis treatment of high risk patients undergoing allogeneic stem-cell transplantation
5748362|NCT00326144|MDD|mdd
5748363|NCT00326144|Depression|depression
5748364|NCT00326118|Meningococcal serogroup C diseases|meningococcal serogroup c diseases
5748365|NCT00326118|H.influenzae type b diseases|h.influenzae type b diseases
5748366|NCT00326105|MDD|mdd
5748367|NCT00326105|Depression|depression
5748368|NCT00326079|Open angle|open angle
5748369|NCT00326079|Glaucoma|glaucoma
5748370|NCT00326079|Surgery|surgery
5748371|NCT00326066|Open angle|open angle
5748372|NCT00326066|Glaucoma|glaucoma
5748375|NCT00326053|Asthma Reoccurrence|asthma reoccurrence
5748376|NCT00326053|Acute Asthma|acute asthma
5748377|NCT00326053|Patient Discharge|patient discharge
5748378|NCT00326053|Emergency Service, Hospital|emergency service, hospital
5748379|NCT00326053|Asthma Exacerbation|asthma exacerbation
5748380|NCT00326053|Asthma Relapse|asthma relapse
5748381|NCT00326040|Open angle|open angle
5748382|NCT00326040|Glaucoma|glaucoma
5748383|NCT00326040|Refractory|refractory
5748384|NCT00326040|Surgery|surgery
5748385|NCT00326027|GERD|gerd
5748386|NCT00326027|Pantoprazole|pantoprazole
5748387|NCT00326027|NERD|nerd
5748388|NCT00326014|Open angle|open angle
5748389|NCT00326014|Glaucoma|glaucoma
5748390|NCT00326014|Cataract|cataract
5748391|NCT00326014|Surgery|surgery
5748392|NCT00326001|Transvenous Catheter Ablation|transvenous catheter ablation
5748393|NCT00326001|Radiofrequency Catheter Ablation|radiofrequency catheter ablation
5748394|NCT00326001|Atrial flutter|atrial flutter
5748395|NCT00326001|Catheter Ablation|catheter ablation
5748396|NCT00325988|Neuroimmunology|neuroimmunology
5748397|NCT00325988|Demyelinating Disease|demyelinating disease
5748398|NCT00325988|Genetics|genetics
5748399|NCT00325988|Proteins|proteins
5748400|NCT00325975|Smallpox|smallpox
5748401|NCT00325975|Variola|variola
5748402|NCT00325975|Orthopoxvirus|orthopoxvirus
5748403|NCT00325975|Virus|virus
5748404|NCT00325975|Immunogenicity|immunogenicity
5748405|NCT00325975|Smallpox Vaccine|smallpox vaccine
5748406|NCT00325962|Hypertension|hypertension
5748407|NCT00325962|Type 2 Diabetes|type 2 diabetes
5748408|NCT00325962|6R-BH4|6r-bh4
5748409|NCT00325962|BH4|bh4
5748410|NCT00325962|BH4 deficiency|bh4 deficiency
5748411|NCT00325962|sapropterin dihydrochloride|sapropterin dihydrochloride
5748412|NCT00325962|endothelial dysfunction|endothelial dysfunction
5748413|NCT00325962|NO|no
5748414|NCT00325962|Nitric Oxide|nitric oxide
5748415|NCT00325936|metabolic syndrome|metabolic syndrome
5748416|NCT00325936|Hypertension|hypertension
5748417|NCT00325936|CCB|ccb
5748420|NCT00325923|Decision support|decision support
5748421|NCT00325923|Decisional conflict|decisional conflict
5748422|NCT00325923|Menopause|menopause
5748423|NCT00325923|Natural health products|natural health products
5748424|NCT00325923|Herbs|herbs
5748425|NCT00325923|Complementary medicine|complementary medicine
5748426|NCT00325923|Complementary therapies|complementary therapies
5748427|NCT00325910|Diabetes|diabetes
5748428|NCT00325910|Heart Failure|heart failure
5748429|NCT00325910|Mortality|mortality
5748430|NCT00325910|Hospitalization|hospitalization
5748431|NCT00325910|Feasability|feasability
5748432|NCT00325884|coronary artery disease|coronary artery disease
5748433|NCT00325884|bifurcation lesions|bifurcation lesions
5748434|NCT00325884|percutaneous interventions|percutaneous interventions
5748435|NCT00325884|stenting|stenting
5748436|NCT00325884|outcomes|outcomes
5748437|NCT00325884|death|death
5748438|NCT00325884|myocardial infarction|myocardial infarction
5748439|NCT00325858|osteoarthritis pain|osteoarthritis pain
5748440|NCT00325858|knee|knee
5748441|NCT00325858|hip|hip
5748442|NCT00325858|extended-release analgesia|extended-release analgesia
5748443|NCT00325858|opioid|opioid
5742837|NCT00347204|PRK|prk
5748444|NCT00325845|Investigational|investigational
5757570|NCT00293202|etanercept|etanercept
5748445|NCT00325845|Therapeutic|therapeutic
5748446|NCT00325845|Efficacy|efficacy
5748447|NCT00325845|Safety|safety
5748448|NCT00325845|Outcomes|outcomes
5748449|NCT00325845|Lumbar facet joint arthrosis|lumbar facet joint arthrosis
5748450|NCT00325845|Lumbar facet joint arthropathy|lumbar facet joint arthropathy
5748451|NCT00325832|Hypertension|hypertension
5748452|NCT00325832|Blood Pressure|blood pressure
5748453|NCT00325832|Systolic Pressure|systolic pressure
5748454|NCT00325832|Diastolic Pressure|diastolic pressure
5748455|NCT00325832|Blood Pressure Monitoring, Ambulatory|blood pressure monitoring, ambulatory
5748456|NCT00325819|Acetaminophen|acetaminophen
5748457|NCT00325819|Vaccination|vaccination
5748458|NCT00325819|Immunization|immunization
5748459|NCT00325793|nicardipine|nicardipine
5748460|NCT00325793|hypertension|hypertension
5748461|NCT00325793|intracerebral hemorrhage|intracerebral hemorrhage
5748462|NCT00325793|ischemic stroke|ischemic stroke
5748463|NCT00325780|Kowa|kowa
5748464|NCT00325780|Hypercholesterolemia|hypercholesterolemia
5748465|NCT00325780|dyslipidemia|dyslipidemia
5748466|NCT00325780|pitavastatin|pitavastatin
5748467|NCT00325780|NK-104|nk-104
5748468|NCT00325780|Hypercholesterolemia or combined dyslipidemia|hypercholesterolemia or combined dyslipidemia
5748469|NCT00325767|mucociliary clearance|mucociliary clearance
5748470|NCT00325767|beta-adrenergic drugs|beta-adrenergic drugs
5748471|NCT00325767|inhalation|inhalation
5748472|NCT00325767|aerosol|aerosol
5748473|NCT00325754|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5748474|NCT00325754|COPD|copd
5748475|NCT00325741|Lupus|lupus
5748476|NCT00325741|Systemic Lupus Erythematosus|systemic lupus erythematosus
5748477|NCT00325741|Blood Stem Cell Transplantation|blood stem cell transplantation
5748478|NCT00325728|Chronic Insomnia|chronic insomnia
5748479|NCT00325728|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5748480|NCT00325728|Drug Therapy|drug therapy
5748481|NCT00325728|Alzheimer disease|alzheimer disease
5772832|NCT00232336|cocaine|cocaine
5748482|NCT00325702|HIV|hiv
5748483|NCT00325702|prevention|prevention
5748484|NCT00325676|GERD|gerd
5748485|NCT00325676|Pantoprazole|pantoprazole
5748486|NCT00325676|Complete Remission|complete remission
5748487|NCT00325663|acupuncture|acupuncture
5748488|NCT00325663|double-blind|double-blind
5748489|NCT00325663|sham control|sham control
5748490|NCT00325663|osteoarthritis|osteoarthritis
5748491|NCT00325663|pain|pain
5748492|NCT00325650|Prediabetic state|prediabetic state
5748493|NCT00325650|Impaired fasting glucose|impaired fasting glucose
5798852|NCT00110838|human|human
5748494|NCT00325650|Impaired glucose Tolerance|impaired glucose tolerance
5748496|NCT00325637|Ischemic Stroke|ischemic stroke
5748497|NCT00325624|Blood Pressure|blood pressure
5748498|NCT00325624|Diabetes mellitus|diabetes mellitus
5748499|NCT00325624|Hypertension|hypertension
5748500|NCT00325624|Home Care|home care
5748501|NCT00325624|Glucometer|glucometer
5748502|NCT00325611|Palliative care|palliative care
5748503|NCT00325611|End of life care|end of life care
5748504|NCT00325585|Human Immunodeficiency Viruses|human immunodeficiency viruses
5748505|NCT00325585|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5748506|NCT00325585|Substance Abuse|substance abuse
5748507|NCT00325585|Sexually Transmitted Disease, Viral|sexually transmitted disease, viral
5748508|NCT00325585|Intervention Studies|intervention studies
5748509|NCT00325585|Women's Health|women's health
5748510|NCT00325546|Obesity|obesity
5748511|NCT00325533|Blood Pressure, High|blood pressure, high
5748512|NCT00325533|Blacks|blacks
5748513|NCT00325533|African Americans|african americans
5748514|NCT00325507|Renal cell cancer|renal cell cancer
5748515|NCT00325507|requiring IL-2 treatment|requiring il-2 treatment
5748516|NCT00325507|Locally advanced or metastatic renal cell carcinoma|locally advanced or metastatic renal cell carcinoma
5748517|NCT00325494|Pancreatic Cancer|pancreatic cancer
5748518|NCT00325494|Mesothelioma|mesothelioma
5748519|NCT00325494|Ovarian Cancer|ovarian cancer
5748520|NCT00325494|Non-Small Cell Lung Cancer|non-small cell lung cancer
5748521|NCT00325494|Mesothelin|mesothelin
5748522|NCT00325468|bone loss|bone loss
5748523|NCT00325468|osteoporosis|osteoporosis
5748524|NCT00325442|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5748525|NCT00325429|Type 2 diabetes|type 2 diabetes
5748526|NCT00325429|Vildagliptin|vildagliptin
5748527|NCT00325429|HbA1c|hba1c
5748528|NCT00325416|melphalan|melphalan
5748529|NCT00325416|topotecan|topotecan
5748530|NCT00325416|topoisomerase|topoisomerase
5748531|NCT00325416|bone marrow transplant|bone marrow transplant
5748532|NCT00325416|drug sequence|drug sequence
5748533|NCT00325403|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5748534|NCT00325390|SR25990C|sr25990c
5748535|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5748536|NCT00325390|NSTEACS|nsteacs
5748537|NCT00325377|low back pain|low back pain
5748538|NCT00325377|pain|pain
5748539|NCT00325377|magnetism|magnetism
5748540|NCT00325377|electromagnetic fields|electromagnetic fields
5748541|NCT00325377|visual analogue pain scale|visual analogue pain scale
5681004|NCT00575237|Female ASA 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery|female asa 1 and 2 outpatients who were scheduled for elective gynecologic laparoscopic surgery
5748542|NCT00325351|Ovarian cancer|ovarian cancer
5748543|NCT00325351|Ovarian neoplasms, epithelium|ovarian neoplasms, epithelium
5748544|NCT00325338|Allergy|allergy
5748545|NCT00325338|Specific Immunotherapy|specific immunotherapy
5748546|NCT00325338|Ragweed|ragweed
5748547|NCT00325338|Environmental Exposure Chamber|environmental exposure chamber
5748548|NCT00325325|Kidney Transplantation|kidney transplantation
5748549|NCT00325312|Neck Pain|neck pain
5748550|NCT00325312|Complementary Therapies|complementary therapies
5748985|NCT00324142|Bacterial vaginosis|bacterial vaginosis
5748551|NCT00325312|Subcutaneous Carbon Dioxide Insufflations|subcutaneous carbon dioxide insufflations
5748552|NCT00325312|Acute Treatment|acute treatment
5748553|NCT00325273|Lactobacillus rhamnosus|lactobacillus rhamnosus
5748554|NCT00325273|Atopic dermatitis|atopic dermatitis
5748555|NCT00325273|Allergic rhinitis|allergic rhinitis
5748557|NCT00325273|Infant|infant
5748558|NCT00325273|Pregnancy|pregnancy
5748559|NCT00325260|influenza|influenza
5748560|NCT00325260|non-inferiority|non-inferiority
5748561|NCT00325260|Influvac|influvac
5748562|NCT00325260|Agrippal|agrippal
5748563|NCT00325260|healthy subjects|healthy subjects
5748564|NCT00325247|ZINC SUPPLEMENTATION|zinc supplementation
5748565|NCT00325247|ACUTE DIARRHOEA|acute diarrhoea
5748566|NCT00325247|UNDER FIVE CHILDREN|under five children
5748567|NCT00325247|RURAL BANGLADESH|rural bangladesh
5748568|NCT00325221|implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5748569|NCT00325221|telemedicine|telemedicine
5748570|NCT00325221|Home Monitoring|home monitoring
5748571|NCT00325221|psychosomatic|psychosomatic
5748572|NCT00325221|ventricular tachyarrhythmia|ventricular tachyarrhythmia
5748573|NCT00325221|quality of life|quality of life
5748574|NCT00325221|Electric Countershock|electric countershock
5748575|NCT00325182|Alcoholism|alcoholism
5748576|NCT00325169|Cross-over|cross-over
5680998|NCT00575237|Laparoscopic Surgery|laparoscopic surgery
5748577|NCT00325169|Tiotropium|tiotropium
5748578|NCT00325169|Triple|triple
5748579|NCT00325169|COPD|copd
5748580|NCT00325169|SERETIDE 50/500|seretide 50/500
5748581|NCT00325169|Dyspnoea|dyspnoea
5748582|NCT00325169|Impulse oscillometry|impulse oscillometry
5748583|NCT00325169|Plethysmography|plethysmography
5748584|NCT00325117|Type 2 diabetes|type 2 diabetes
5748585|NCT00325117|Vildagliptin|vildagliptin
5748586|NCT00325117|HbA1c|hba1c
5748587|NCT00325104|Multiple Endocrine Neoplasia|multiple endocrine neoplasia
5748588|NCT00325104|Gastrinoma|gastrinoma
5748589|NCT00325104|Prolacinoma|prolacinoma
5748590|NCT00325104|Medullary Thyroid Cancer|medullary thyroid cancer
5748591|NCT00325104|Insulinoma|insulinoma
5748592|NCT00325104|MEN1|men1
5748593|NCT00325104|MEN2A|men2a
5748594|NCT00325104|Familial Primary Hyperparathytoidism|familial primary hyperparathytoidism
5748595|NCT00325091|Writer's Cramp|writer's cramp
5748596|NCT00325091|Electroencephalogram (EEG)|electroencephalogram (eeg)
5748597|NCT00325091|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5748598|NCT00325091|Fine Motor Skills|fine motor skills
5748599|NCT00325091|Focal Hand Dystonia|focal hand dystonia
5748600|NCT00325091|Writer Cramp|writer cramp
5748601|NCT00325091|Healthy Volunteer|healthy volunteer
5748602|NCT00325091|HV|hv
5748603|NCT00325078|Remicade|remicade
5748604|NCT00325078|Crohn's Disease|crohn's disease
5748605|NCT00325078|IBD|ibd
5748606|NCT00325078|CGD Infection|cgd infection
5748607|NCT00325078|Infliximab|infliximab
5748608|NCT00325078|Chorionic Granulomatous Disease|chorionic granulomatous disease
5748609|NCT00325078|CGD|cgd
5748610|NCT00325078|Inflammatory Bowel Disease|inflammatory bowel disease
5748611|NCT00325065|Amygdala|amygdala
5748612|NCT00325065|Emotion|emotion
5748613|NCT00325065|Memory|memory
5748614|NCT00325065|Threat|threat
5748615|NCT00325065|Peptides|peptides
5748616|NCT00325065|Neuropeptides|neuropeptides
5748617|NCT00325065|Oxytocin|oxytocin
5748618|NCT00325065|Vasopressin|vasopressin
5748619|NCT00325065|Mood Disorder|mood disorder
5748620|NCT00325039|Urinary Incontinence, Stress|urinary incontinence, stress
5748621|NCT00325039|Surgery|surgery
5748622|NCT00325026|Preterm gestation|preterm gestation
5748623|NCT00325026|Cervical ripening|cervical ripening
5748624|NCT00325026|Labor induction|labor induction
5748625|NCT00325026|Misoprostol|misoprostol
5748626|NCT00325026|Foley bulb|foley bulb
5748627|NCT00325013|Primary Sclerosing Cholangitis|primary sclerosing cholangitis
5748628|NCT00325013|PSC|psc
5748629|NCT00325013|DHA|dha
5748630|NCT00325013|Docosahexaenoic Acid|docosahexaenoic acid
5748631|NCT00324974|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5748632|NCT00324974|infant|infant
5748633|NCT00324974|lansoprazole oral suspension|lansoprazole oral suspension
5748634|NCT00324974|PPI|ppi
5748635|NCT00324961|adefovir dipivoxil|adefovir dipivoxil
5748636|NCT00324961|e Antigen negative|e antigen negative
5681006|NCT00575224|Genotype 6|genotype 6
5748637|NCT00324961|chronic hepatitis B|chronic hepatitis b
5748638|NCT00324961|Chinese|chinese
5743022|NCT00346450|transplantation|transplantation
5748639|NCT00324948|Female sexual arousal disorder|female sexual arousal disorder
5748640|NCT00324948|Female sexual dysfunction|female sexual dysfunction
5748642|NCT00324922|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5748643|NCT00324896|Parkinson's|parkinson's
5748644|NCT00324896|insomnia|insomnia
5748645|NCT00324896|drug|drug
5748646|NCT00324896|eszopiclone|eszopiclone
5748647|NCT00324896|placebo|placebo
5748648|NCT00324883|sodium intake|sodium intake
5748649|NCT00324883|sodium excretion|sodium excretion
5748650|NCT00324883|chloride excretion|chloride excretion
5748651|NCT00324883|creatinine|creatinine
5748652|NCT00324883|hypertension|hypertension
5748653|NCT00324857|Osteoarthritis, Knee|osteoarthritis, knee
5748654|NCT00324857|race|race
5748655|NCT00324857|ethnicity|ethnicity
5748656|NCT00324857|knee replacement|knee replacement
5748657|NCT00324831|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5748658|NCT00324831|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5748659|NCT00324831|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5748660|NCT00324831|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5748661|NCT00324818|bacterial vaginosis|bacterial vaginosis
5748662|NCT00324818|treatment|treatment
5748663|NCT00324779|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5748664|NCT00324779|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5748665|NCT00324779|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5748666|NCT00324779|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5748667|NCT00324779|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5748668|NCT00324779|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5748669|NCT00324779|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5748670|NCT00324779|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5748671|NCT00324779|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5748672|NCT00324779|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5748673|NCT00324779|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5748751|NCT00324597|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5748674|NCT00324779|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5748675|NCT00324779|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5748676|NCT00324779|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5748678|NCT00324753|screening|screening
5748679|NCT00324753|communication|communication
5748680|NCT00324753|prevention|prevention
5748681|NCT00324727|liver metastases|liver metastases
5748682|NCT00324727|extraocular extension melanoma|extraocular extension melanoma
5748683|NCT00324727|stage IV melanoma|stage iv melanoma
5748684|NCT00324727|recurrent melanoma|recurrent melanoma
5748685|NCT00324727|recurrent intraocular melanoma|recurrent intraocular melanoma
5748686|NCT00324727|metastatic intraocular melanoma|metastatic intraocular melanoma
5748688|NCT00324727|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5748689|NCT00324714|osteoporosis|osteoporosis
5748690|NCT00324714|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5748691|NCT00324714|breast cancer in situ|breast cancer in situ
5748692|NCT00324701|Mental Health|mental health
5748693|NCT00324701|Geriatric Medicine|geriatric medicine
5748694|NCT00324701|Depression|depression
5748695|NCT00324701|Health Service Delivery|health service delivery
5748696|NCT00324701|Aged|aged
5748697|NCT00324688|HIV-1|hiv-1
5748698|NCT00324688|Methadone|methadone
5748699|NCT00324688|HIV-1 infection|hiv-1 infection
5748700|NCT00324675|type 2 diabetes,|type 2 diabetes,
5748701|NCT00324675|glomerular filtration rate,|glomerular filtration rate,
5748702|NCT00324675|renal plasma flow,|renal plasma flow,
5748703|NCT00324675|endothelial dysfunction,|endothelial dysfunction,
5748704|NCT00324675|proteinuria,|proteinuria,
5748705|NCT00324675|diabetic nephropathy|diabetic nephropathy
5748706|NCT00324662|Implantable cardioverter-defibrillator|implantable cardioverter-defibrillator
5748707|NCT00324662|Ventricular tachyarrhythmia|ventricular tachyarrhythmia
5748708|NCT00324662|Supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
5748709|NCT00324662|Electric Countershock|electric countershock
5748711|NCT00324623|stage IV melanoma|stage iv melanoma
5748712|NCT00324623|recurrent melanoma|recurrent melanoma
5748713|NCT00324610|fluoropyrimidines|fluoropyrimidines
5748714|NCT00324610|metastases|metastases
5748715|NCT00324610|pharmacokinetics|pharmacokinetics
5748716|NCT00324610|phase 1-2 study|phase 1-2 study
5748717|NCT00324597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5748718|NCT00324597|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5748719|NCT00324597|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5748720|NCT00324597|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5748721|NCT00324597|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5748722|NCT00324597|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5748723|NCT00324597|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5748724|NCT00324597|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5748725|NCT00324597|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5748726|NCT00324597|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5748727|NCT00324597|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5748728|NCT00324597|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5748729|NCT00324597|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5748730|NCT00324597|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5748731|NCT00324597|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5748732|NCT00324597|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5748733|NCT00324597|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5748734|NCT00324597|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5748735|NCT00324597|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5748736|NCT00324597|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5748737|NCT00324597|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5748738|NCT00324597|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5748739|NCT00324597|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5748740|NCT00324597|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5748741|NCT00324597|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5748742|NCT00324597|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5748743|NCT00324597|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5748744|NCT00324597|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5748745|NCT00324597|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5748746|NCT00324597|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5748747|NCT00324597|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5748748|NCT00324597|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5748749|NCT00324597|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5748750|NCT00324597|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5748973|NCT00324194|Leukemia|leukemia
5748752|NCT00324597|Waldenström macroglobulinemia|waldenström macroglobulinemia
5748753|NCT00324597|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5748754|NCT00324597|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5748755|NCT00324597|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5748756|NCT00324597|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5748757|NCT00324597|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5748758|NCT00324597|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5748759|NCT00324597|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5748760|NCT00324597|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5748761|NCT00324597|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5748762|NCT00324597|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5748763|NCT00324597|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5748764|NCT00324597|adenocarcinoma of the lung|adenocarcinoma of the lung
5748766|NCT00324597|large cell lung cancer|large cell lung cancer
5748767|NCT00324597|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5748768|NCT00324597|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5748769|NCT00324597|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5748770|NCT00324597|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5748771|NCT00324597|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5748772|NCT00324597|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5748773|NCT00324597|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5748774|NCT00324597|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5748775|NCT00324597|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5748776|NCT00324597|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5750654|NCT00317512|HBOC 201|hboc 201
5748777|NCT00324597|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5748778|NCT00324597|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5748779|NCT00324597|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5748780|NCT00324597|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5748781|NCT00324584|type 1 diabetes mellitus|type 1 diabetes mellitus
5748782|NCT00324584|telecare|telecare
5748783|NCT00324584|telemedicine|telemedicine
5748784|NCT00324584|insulin pump therapy|insulin pump therapy
5748785|NCT00324558|Bemiparin|bemiparin
5748786|NCT00324558|small cell lung carcinoma|small cell lung carcinoma
5748787|NCT00324545|Obesity|obesity
5748789|NCT00324545|Heart Disease|heart disease
5748790|NCT00324545|Randomized controlled trial|randomized controlled trial
5748791|NCT00324545|Ischemia.|ischemia.
5748792|NCT00324519|second trimester|second trimester
5748793|NCT00324519|pregnancy termination|pregnancy termination
5748794|NCT00324519|misoprostol|misoprostol
5748795|NCT00324519|foley bulb|foley bulb
5748796|NCT00324493|Severe Hemophilia|severe hemophilia
5748797|NCT00324493|Musculoskeletal Function|musculoskeletal function
5748798|NCT00324493|Factor Replacement|factor replacement
5748799|NCT00324467|NON-HODGKIN'S LYMPHOMA|non-hodgkin's lymphoma
5748800|NCT00324467|POSITRON EMISSION TOMOGRAPHY|positron emission tomography
5748802|NCT00324467|DLBCL|dlbcl
5748803|NCT00324467|R-CHOP|r-chop
5748804|NCT00324467|R-ICE|r-ice
5748805|NCT00324454|motor neuron disease|motor neuron disease
5748806|NCT00324454|amyotrophic lateral sclerosis primary lateral|amyotrophic lateral sclerosis primary lateral
5748807|NCT00324454|sclerosis; progressive muscular atrophy|sclerosis; progressive muscular atrophy
5748808|NCT00324454|cramps|cramps
5748809|NCT00324454|spasticity|spasticity
5748810|NCT00324441|Fibromyalgia|fibromyalgia
5748811|NCT00324441|Rehabilitation|rehabilitation
5748812|NCT00324441|Physical Medicine|physical medicine
5748813|NCT00324441|Whole-Body Hyperthermia|whole-body hyperthermia
5748814|NCT00324441|Water-Filtered Near Infrared|water-filtered near infrared
5748816|NCT00324428|Visceral Pain|visceral pain
5748817|NCT00324428|Analgesia|analgesia
5748818|NCT00324428|Pancreatic Cancer|pancreatic cancer
5748819|NCT00324428|Cancer|cancer
5748820|NCT00324428|Electric stimulation therapy|electric stimulation therapy
5748821|NCT00324428|Electric stimulation|electric stimulation
5748822|NCT00324428|Pain|pain
5748823|NCT00324428|Safety|safety
5748824|NCT00324415|stage I anal cancer|stage i anal cancer
5748825|NCT00324415|stage II anal cancer|stage ii anal cancer
5748826|NCT00324415|stage IIIA anal cancer|stage iiia anal cancer
5748827|NCT00324415|stage IIIB anal cancer|stage iiib anal cancer
5747852|NCT00328094|control|control
5747853|NCT00328094|outcomes|outcomes
5747854|NCT00328094|peripheral vascular disease|peripheral vascular disease
5747855|NCT00328094|infection|infection
5747856|NCT00328094|cardiovascular|cardiovascular
5747859|NCT00328081|Obesity|obesity
5748828|NCT00324415|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5748829|NCT00324415|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5748830|NCT00324415|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5748831|NCT00324402|brain natriuretic peptide|brain natriuretic peptide
5748832|NCT00324402|pregnancy|pregnancy
5748833|NCT00324402|biomarker|biomarker
5748834|NCT00324389|Interferon, Gene Expression in Liver, Lymphocytes, High Density Oligonucleotide Microarray Expression Analysis, African American, Hepatitis C|interferon, gene expression in liver, lymphocytes, high density oligonucleotide microarray expression analysis, african american, hepatitis c
5748835|NCT00324363|exenatide|exenatide
5748836|NCT00324363|diabetes|diabetes
5748837|NCT00324363|Amylin|amylin
5748838|NCT00324363|Lilly|lilly
5748839|NCT00324363|China|china
5748840|NCT00324350|Diabetes Mellitus|diabetes mellitus
5748841|NCT00324350|Fracture|fracture
5748842|NCT00324350|Falls|falls
5748843|NCT00324350|Height Loss|height loss
5748844|NCT00324324|infection|infection
5748845|NCT00324324|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5748846|NCT00324324|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5748847|NCT00324324|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5748848|NCT00324324|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5748849|NCT00324324|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5748850|NCT00324324|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5748851|NCT00324324|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5748852|NCT00324324|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5748853|NCT00324324|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5748854|NCT00324324|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5748855|NCT00324324|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5748856|NCT00324324|primary myelofibrosis|primary myelofibrosis
5748857|NCT00324324|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5748858|NCT00324324|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5748859|NCT00324324|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5748860|NCT00324324|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5748861|NCT00324324|disseminated neuroblastoma|disseminated neuroblastoma
5750748|NCT00317148|Hot Flashes|hot flashes
5748862|NCT00324324|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5748863|NCT00324324|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5748864|NCT00324324|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5748865|NCT00324324|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5748866|NCT00324324|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5748867|NCT00324324|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5748868|NCT00324324|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5748869|NCT00324324|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5748870|NCT00324324|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5748871|NCT00324324|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5748872|NCT00324324|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5748873|NCT00324324|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5748874|NCT00324324|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5748875|NCT00324324|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5748876|NCT00324324|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5748877|NCT00324324|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5748878|NCT00324324|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5748879|NCT00324324|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5748880|NCT00324324|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5748881|NCT00324324|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5748882|NCT00324324|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5748883|NCT00324324|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5748884|NCT00324324|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5748885|NCT00324324|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5748886|NCT00324324|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5748887|NCT00324324|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5748888|NCT00324324|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5748889|NCT00324324|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5748890|NCT00324324|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5748891|NCT00324324|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5748892|NCT00324324|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5748893|NCT00324324|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5748894|NCT00324324|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5748895|NCT00324324|recurrent neuroblastoma|recurrent neuroblastoma
5748896|NCT00324324|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5748897|NCT00324324|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5748898|NCT00324324|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5848265|NCT00035386|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5748899|NCT00324324|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5748900|NCT00324324|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5748901|NCT00324324|refractory hairy cell leukemia|refractory hairy cell leukemia
5748902|NCT00324324|refractory multiple myeloma|refractory multiple myeloma
5748903|NCT00324324|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5748904|NCT00324324|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5748905|NCT00324324|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5748906|NCT00324324|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5748907|NCT00324324|stage I multiple myeloma|stage i multiple myeloma
5748908|NCT00324324|stage II multiple myeloma|stage ii multiple myeloma
5748909|NCT00324324|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5748910|NCT00324324|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5748911|NCT00324324|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5748912|NCT00324324|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5748913|NCT00324324|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5748914|NCT00324324|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5748915|NCT00324324|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5748916|NCT00324324|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5748917|NCT00324324|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5748918|NCT00324324|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5748919|NCT00324324|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5748920|NCT00324324|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5748921|NCT00324324|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5748922|NCT00324324|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5748923|NCT00324324|stage III multiple myeloma|stage iii multiple myeloma
5748924|NCT00324324|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5748925|NCT00324324|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5748926|NCT00324324|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5758385|NCT00290511|R-FND|r-fnd
5748927|NCT00324324|stage IIIA breast cancer|stage iiia breast cancer
5748928|NCT00324324|stage IIIB breast cancer|stage iiib breast cancer
5748930|NCT00324324|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5748931|NCT00324324|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5748932|NCT00324324|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5748933|NCT00324324|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5748934|NCT00324324|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5748935|NCT00324324|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5748936|NCT00324324|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5748937|NCT00324324|stage IV breast cancer|stage iv breast cancer
5748938|NCT00324324|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5748939|NCT00324324|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5748940|NCT00324324|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5748941|NCT00324324|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5748942|NCT00324324|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5748943|NCT00324324|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5748944|NCT00324324|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5748945|NCT00324324|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5748946|NCT00324298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5748947|NCT00324298|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5748948|NCT00324285|Diarrhoea|diarrhoea
5748949|NCT00324285|severe malnutrition|severe malnutrition
5686283|NCT00552682|Fibromialgy in patients with HIV-1 infection|fibromialgy in patients with hiv-1 infection
5686284|NCT00552669|Drug Eluting Stents|drug eluting stents
5686285|NCT00552669|Stents Bare Metal|stents bare metal
5686286|NCT00552669|Stent Thrombosis|stent thrombosis
5686287|NCT00552669|Coronary revascularization|coronary revascularization
5681000|NCT00575237|PDNV|pdnv
5748950|NCT00324285|amylase resistant starch|amylase resistant starch
5748951|NCT00324285|ORS|ors
5748952|NCT00324272|Groin dissection|groin dissection
5748953|NCT00324272|Axilla (or axillary) dissection|axilla (or axillary) dissection
5748954|NCT00324272|Lymph node dissection|lymph node dissection
5748955|NCT00324272|Lymphadenectomy|lymphadenectomy
5748956|NCT00324272|Seroma|seroma
5748957|NCT00324272|Wound drainage|wound drainage
5748958|NCT00324272|Fibrin sealant|fibrin sealant
5748959|NCT00324272|Malignant melanoma|malignant melanoma
5748960|NCT00324272|Squamous cell carcinoma|squamous cell carcinoma
5748961|NCT00324246|vaginal infection|vaginal infection
5748962|NCT00324246|color appearance|color appearance
5748963|NCT00324246|new developed indicator strips (NEW NORMA-SENSE)|new developed indicator strips (new norma-sense)
5748964|NCT00324246|in-vitro|in-vitro
5748965|NCT00324246|vaginal secretion|vaginal secretion
5748966|NCT00324246|elevated pH|elevated ph
5748967|NCT00324233|Residual urine|residual urine
5748968|NCT00324233|Hematuria|hematuria
5748969|NCT00324233|Ultra sound|ultra sound
5765257|NCT00262769|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5765261|NCT00262769|recurrent gallbladder cancer|recurrent gallbladder cancer
5748971|NCT00324207|Type 1 diabetes mellitus|type 1 diabetes mellitus
5748972|NCT00324207|Insulin mRNA|insulin mrna
5748974|NCT00324194|Myelodysplastic Syndromes|myelodysplastic syndromes
5748975|NCT00324194|Phase I|phase i
5748976|NCT00324181|normal-tension glaucoma|normal-tension glaucoma
5748977|NCT00324181|psychopathology|psychopathology
5748978|NCT00324181|Hong Kong|hong kong
5748979|NCT00324168|Bacterial Infections|bacterial infections
5748980|NCT00324168|Eye Diseases|eye diseases
5748981|NCT00324168|Bacterial Keratitis|bacterial keratitis
5748982|NCT00324168|Visual Acuity|visual acuity
5748983|NCT00324155|Stage IIIc N3 (unresectable)|stage iiic n3 (unresectable)
5748984|NCT00324155|Stage IV melanoma|stage iv melanoma
5748986|NCT00324142|Tinidazole|tinidazole
5748987|NCT00324142|Vaginitis|vaginitis
5748988|NCT00324129|Leukemia|leukemia
5748989|NCT00324129|Myelodysplastic Syndromes|myelodysplastic syndromes
5748990|NCT00324129|Phase I|phase i
5748992|NCT00324103|Chronic Infection|chronic infection
5748993|NCT00324103|Clinical Trial|clinical trial
5748994|NCT00324103|Structured Treatment Interruption|structured treatment interruption
5748995|NCT00324077|Chronic phase chronic myelogenous leukemia (CML)|chronic phase chronic myelogenous leukemia (cml)
5748996|NCT00324064|Growth hormone deficiency|growth hormone deficiency
5748997|NCT00324038|OA|oa
5748998|NCT00324038|Elderly|elderly
5748999|NCT00324038|Pain|pain
5749000|NCT00324038|OA of the hips and/or knees|oa of the hips and/or knees
5749001|NCT00324025|Cryptococcal meningitis|cryptococcal meningitis
5749002|NCT00324012|Adrenocortical Carcinoma|adrenocortical carcinoma
5749003|NCT00324012|cisplatin|cisplatin
5749004|NCT00324012|taxotere|taxotere
5749005|NCT00323999|Hysteroscopic resection|hysteroscopic resection
5749006|NCT00323999|Menorrhagia|menorrhagia
5749007|NCT00323999|fibroids|fibroids
5749008|NCT00323999|polyps|polyps
5749009|NCT00323986|COPD|copd
5749010|NCT00323986|tracheotomy|tracheotomy
5749011|NCT00323986|azithromycin|azithromycin
5749012|NCT00323986|exacerbation|exacerbation
5749013|NCT00323986|hospitalisation|hospitalisation
5750749|NCT00317148|Menopause|menopause
5749014|NCT00323986|exhaled breath condensate|exhaled breath condensate
5749015|NCT00323973|Chagas, Heart failure, Cardiomiopathy|chagas, heart failure, cardiomiopathy
5749016|NCT00323960|Juvenile dermatomyositis|juvenile dermatomyositis
5743499|NCT00344786|CLL|cll
5749017|NCT00323960|randomised actively controlled clinical trial|randomised actively controlled clinical trial
5749019|NCT00323960|cyclosporine|cyclosporine
5749020|NCT00323960|methotrexate|methotrexate
5749021|NCT00323960|effectiveness|effectiveness
5749022|NCT00323947|ADHD|adhd
5749023|NCT00323947|Seizures|seizures
5749024|NCT00323947|Methylphenidate|methylphenidate
5749025|NCT00323947|Stimulant|stimulant
5749026|NCT00323934|metastatic solid tumor|metastatic solid tumor
5749027|NCT00323934|aggressive non Hodgkin's Lymphoma|aggressive non hodgkin's lymphoma
5749028|NCT00323934|Phase I|phase i
5749029|NCT00323934|Advanced Solid Tumors|advanced solid tumors
5749030|NCT00323908|Breast Cancer|breast cancer
5749031|NCT00323908|prevention|prevention
5749032|NCT00323908|tissue sampling|tissue sampling
5749033|NCT00323908|polymorphisms|polymorphisms
5749034|NCT00323908|steroid and carcinogen metabolism|steroid and carcinogen metabolism
5686288|NCT00552669|Survival|survival
5686289|NCT00552656|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5749035|NCT00323882|Prostate Cancer|prostate cancer
5749036|NCT00323882|Oncology|oncology
5749037|NCT00323882|Prostate|prostate
5749038|NCT00323882|Cancer|cancer
5749039|NCT00323882|Metastatic|metastatic
5749040|NCT00323882|Hormone|hormone
5749041|NCT00323882|PSA|psa
5749042|NCT00323882|Metastatic Hormone-Refractory Prostate Cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
5749043|NCT00323856|Hemophilia A|hemophilia a
5749044|NCT00323856|Plasma-derived treatment|plasma-derived treatment
5749045|NCT00323856|Factor VIII|factor viii
5749046|NCT00323856|Inhibitor|inhibitor
5749047|NCT00323843|Kidney stone|kidney stone
5749048|NCT00323843|ureteropyeloscopy|ureteropyeloscopy
5749049|NCT00323843|renal pelvic pressure|renal pelvic pressure
5749050|NCT00323830|gastric cancer|gastric cancer
5749051|NCT00323830|radiotherapy|radiotherapy
5749052|NCT00323830|postoperative therapy|postoperative therapy
5749053|NCT00323830|chemotherapy|chemotherapy
5749054|NCT00323804|Maintenance therapy|maintenance therapy
5749055|NCT00323804|Non-responder patients|non-responder patients
5749056|NCT00323804|Ribavirin/peginterferon combination therapy|ribavirin/peginterferon combination therapy
5749057|NCT00323804|Hepatitis C, Chronic|hepatitis c, chronic
5749058|NCT00323791|recurrent renal cell cancer|recurrent renal cell cancer
5749059|NCT00323791|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5749060|NCT00323791|papillary renal cell carcinoma|papillary renal cell carcinoma
5749061|NCT00323791|stage IV renal cell cancer|stage iv renal cell cancer
5749062|NCT00323778|hyalgan|hyalgan
5749063|NCT00323778|knee|knee
5749064|NCT00323778|osteoarthritis|osteoarthritis
5749065|NCT00323778|MRI|mri
5749066|NCT00323765|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5749067|NCT00323765|Cervical Dystonia|cervical dystonia
5749068|NCT00323765|Plasticity|plasticity
5749069|NCT00323765|Healthy Volunteer|healthy volunteer
5749070|NCT00323765|HV|hv
5749071|NCT00323752|Blood loss, Erythropoetin|blood loss, erythropoetin
5749072|NCT00323739|kidney cancer|kidney cancer
5749074|NCT00323713|Chronic renal insufficiency|chronic renal insufficiency
5749075|NCT00323713|CKD stage 4|ckd stage 4
5749076|NCT00323713|CKD stage 5|ckd stage 5
5749077|NCT00323713|Protein intake|protein intake
5749078|NCT00323713|Low protein diet|low protein diet
5749079|NCT00323713|Very low protein diet|very low protein diet
5749080|NCT00323713|Ketoanalogs|ketoanalogs
5749081|NCT00323713|Renal death|renal death
5749082|NCT00323700|ADHD|adhd
5749083|NCT00323700|Effectiveness|effectiveness
5749084|NCT00323700|ODD|odd
5749085|NCT00323687|HIV-1 Infection|hiv-1 infection
5749086|NCT00323674|Hernia Inguinalis|hernia inguinalis
5749087|NCT00323661|Pacing|pacing
5749088|NCT00323661|Rate-adaptive|rate-adaptive
5749089|NCT00323661|Quality of life|quality of life
5749090|NCT00323661|Cognitive performance|cognitive performance
5749091|NCT00323661|Atrial fibrillation|atrial fibrillation
5749092|NCT00323661|Pacemaker sensor|pacemaker sensor
5749093|NCT00323635|nocturia|nocturia
5749094|NCT00323635|urinary incontinence|urinary incontinence
5749095|NCT00323635|overactive bladder|overactive bladder
5749096|NCT00323635|tolterodine|tolterodine
5749097|NCT00323635|sleep|sleep
5749098|NCT00323635|sleep disorder|sleep disorder
5749099|NCT00323635|menopause|menopause
5749100|NCT00323635|midlife women|midlife women
5749101|NCT00323635|psychological tests|psychological tests
5749102|NCT00323609|Kyphoplasty|kyphoplasty
5749103|NCT00323609|Vertebroplasty|vertebroplasty
5749104|NCT00323609|Balloon Kyphoplasty|balloon kyphoplasty
5749105|NCT00323609|Inflatable Bone Tamp|inflatable bone tamp
5749106|NCT00323609|Spine|spine
5749107|NCT00323609|Back Pain|back pain
5749108|NCT00323609|Vertebral Compression Fracture|vertebral compression fracture
5749109|NCT00323609|Vertebral Body Compression Fracture|vertebral body compression fracture
5749110|NCT00323583|Cancer|cancer
5749111|NCT00323583|Pancreatic Cancer|pancreatic cancer
5749237|NCT00323063|male breast cancer|male breast cancer
5749112|NCT00323583|Cancer Alternative Therapies|cancer alternative therapies
5749113|NCT00323583|Living with Cancer|living with cancer
5749114|NCT00323557|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5749115|NCT00323557|Leukemia|leukemia
5749116|NCT00323557|Sargramostim|sargramostim
5749117|NCT00323557|Pneumococcal Pneumonia|pneumococcal pneumonia
5749118|NCT00323557|Pneumococcal Vaccine|pneumococcal vaccine
5749120|NCT00323557|GM-CSF|gm-csf
5749122|NCT00323544|HIV 1|hiv 1
5749123|NCT00323544|HIV 1 infection|hiv 1 infection
5749124|NCT00323531|thoracoscopy|thoracoscopy
5749125|NCT00323531|fibrinolysis|fibrinolysis
5749126|NCT00323531|empyema|empyema
5749127|NCT00323531|children|children
5749128|NCT00323518|oral mucositis|oral mucositis
5749129|NCT00323518|hematologic|hematologic
5749130|NCT00323518|autologous stem cell transplant|autologous stem cell transplant
5749131|NCT00323518|velafermin|velafermin
5749132|NCT00323518|stomatitis|stomatitis
5749133|NCT00323518|oncology - supportive care|oncology - supportive care
5749134|NCT00323518|mouth diseases|mouth diseases
5749135|NCT00323492|HIV 1 Infection|hiv 1 infection
5749136|NCT00323479|breast cancer treatment|breast cancer treatment
5749137|NCT00323479|joint disorders|joint disorders
5749138|NCT00323453|Appendectomy|appendectomy
5749139|NCT00323453|Surgery|surgery
5749140|NCT00323453|Infection|infection
5749141|NCT00323440|Familial Mediterranean fever|familial mediterranean fever
5749142|NCT00323440|Inflammation|inflammation
5749143|NCT00323440|Attacks|attacks
5749144|NCT00323440|Remission|remission
5749145|NCT00323440|RNA|rna
5749146|NCT00323440|Cytokines|cytokines
5749147|NCT00323440|Inflammatory proteins|inflammatory proteins
5749148|NCT00323440|MEFV|mefv
5749149|NCT00323440|mutations|mutations
5749150|NCT00323440|Colchicine|colchicine
5749151|NCT00323440|Treatment|treatment
5749152|NCT00323440|microarray RNA analysis|microarray rna analysis
5749153|NCT00323427|Audiology|audiology
5749154|NCT00323427|Coping behaviors|coping behaviors
5749155|NCT00323427|Counseling|counseling
5749156|NCT00323427|Hearing aids|hearing aids
5749157|NCT00323427|Hearing impairment|hearing impairment
5749158|NCT00323427|Patient-centered care|patient-centered care
5749159|NCT00323427|Psychological adaptation|psychological adaptation
5749160|NCT00323427|Psychological adjustment|psychological adjustment
5749161|NCT00323427|Rehabilitation|rehabilitation
5749162|NCT00323427|Social adjustment|social adjustment
5749163|NCT00323427|Aural Rehabilitation|aural rehabilitation
5749164|NCT00323414|PUFA|pufa
5749165|NCT00323414|NASH|nash
5749166|NCT00323414|Fatty Liver|fatty liver
5749167|NCT00323414|Insulin resistance|insulin resistance
5749168|NCT00323414|Metabolic syndrome|metabolic syndrome
5848266|NCT00035386|OHC|ohc
5765448|NCT00261677|Quality of Life|quality of life
5765449|NCT00261677|hemoglobin|hemoglobin
5765450|NCT00261677|Epoetin alfa|epoetin alfa
5765451|NCT00261638|Mental Health Promotion|mental health promotion
5765452|NCT00261638|Mental Health Index|mental health index
5749169|NCT00323414|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5749170|NCT00323414|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5749171|NCT00323414|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5749172|NCT00323401|Pregnancy|pregnancy
5749173|NCT00323401|Parturition|parturition
5749174|NCT00323401|Depression|depression
5749175|NCT00323401|Randomized|randomized
5749176|NCT00323401|Antenatal classes|antenatal classes
5749177|NCT00323375|Malaria|malaria
5749774|NCT00320827|Apoptosis|apoptosis
5749178|NCT00323375|Aminoquinolines|aminoquinolines
5749179|NCT00323375|Drug Resistance|drug resistance
5749180|NCT00323375|Chloroquine Resistance|chloroquine resistance
5749181|NCT00323362|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5749182|NCT00323362|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5749183|NCT00323349|Glucose Tolerance Test|glucose tolerance test
5749184|NCT00323349|Health Knowledge, Attitudes, Practice|health knowledge, attitudes, practice
5749185|NCT00323349|Motivation|motivation
5749186|NCT00323349|Communication|communication
5749187|NCT00323349|Health Behavior|health behavior
5749188|NCT00323323|Untreated|untreated
5749189|NCT00323323|CD-20 Negative|cd-20 negative
5749190|NCT00323323|Large B-Cell Lymphomas|large b-cell lymphomas
5749191|NCT00323310|disease of the central nervous system (brain or spine)|disease of the central nervous system (brain or spine)
5749192|NCT00323284|Open angle|open angle
5749193|NCT00323284|Glaucoma|glaucoma
5749194|NCT00323284|Cataract|cataract
5749195|NCT00323284|Surgery|surgery
5749196|NCT00323271|Chronic pain|chronic pain
5749197|NCT00323271|Cognitive behavioral therapy|cognitive behavioral therapy
5749198|NCT00323271|Multiple sclerosis|multiple sclerosis
5749199|NCT00323271|Randomized controlled trial|randomized controlled trial
5749200|NCT00323258|Heart disease|heart disease
5749201|NCT00323258|Coronary disease|coronary disease
5749202|NCT00323258|Patient compliance|patient compliance
5749203|NCT00323258|Treatment refusal|treatment refusal
5749204|NCT00323258|Pharmacists|pharmacists
5749205|NCT00323258|Continuity of patient care|continuity of patient care
5749206|NCT00323258|Evidence-based medicine|evidence-based medicine
5749207|NCT00323258|Patient education|patient education
5749208|NCT00323258|Adherence|adherence
5749209|NCT00323245|Randomized clinical trial|randomized clinical trial
5749210|NCT00323245|osteoporosis|osteoporosis
5749211|NCT00323245|urinary incontinence|urinary incontinence
5749213|NCT00323245|education|education
5749214|NCT00323232|DHS, Intertrochanteric|dhs, intertrochanteric
5749215|NCT00323219|Cellulitis, RCT, emergency Department, Double-blind, Equivalence trial, Moxifloxacin, Cefazolin, Probenecid.|cellulitis, rct, emergency department, double-blind, equivalence trial, moxifloxacin, cefazolin, probenecid.
5749216|NCT00323206|melanoma|melanoma
5749217|NCT00323206|electroporation|electroporation
5749218|NCT00323206|IL-12|il-12
5749219|NCT00323206|gene therapy|gene therapy
5749220|NCT00323206|gene transfer|gene transfer
5749221|NCT00323193|Behavioral interventions|behavioral interventions
5749222|NCT00323193|Mental Illness|mental illness
5749223|NCT00323193|Obesity|obesity
5749224|NCT00323193|Psycho-educational interventions|psycho-educational interventions
5686290|NCT00552656|Drug-eluting stents|drug-eluting stents
5748338|NCT00326196|PCI|pci
5749225|NCT00323193|Weight management|weight management
5749226|NCT00323167|Variant Cystic Fibrosis|variant cystic fibrosis
5749227|NCT00323167|Primary Ciliary Dyskinesia|primary ciliary dyskinesia
5749228|NCT00323154|Morphine, analgesia|morphine, analgesia
5749229|NCT00323141|Hernia umbilicalis|hernia umbilicalis
5749230|NCT00323115|immunotherapy|immunotherapy
5749231|NCT00323115|cancer vaccine|cancer vaccine
5749232|NCT00323115|glioblastoma multiforme|glioblastoma multiforme
5749233|NCT00323089|microcoil|microcoil
5749234|NCT00323089|subcentimetre nodules|subcentimetre nodules
5749235|NCT00323063|recurrent breast cancer|recurrent breast cancer
5749236|NCT00323063|stage IV breast cancer|stage iv breast cancer
5749238|NCT00323063|stage IIIA breast cancer|stage iiia breast cancer
5749239|NCT00323063|stage IIIB breast cancer|stage iiib breast cancer
5749240|NCT00323063|stage IIIC breast cancer|stage iiic breast cancer
5749241|NCT00323037|heart failure|heart failure
5749242|NCT00323024|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5749243|NCT00323024|Pulmonary Hypertension|pulmonary hypertension
5749244|NCT00323024|Idiopathic PAH|idiopathic pah
5749245|NCT00323024|PH associated with connective tissue disease (CTD)|ph associated with connective tissue disease (ctd)
5749246|NCT00323024|PH associated with interstitial lung disease (ILD)|ph associated with interstitial lung disease (ild)
5749247|NCT00323024|PH associated with congestive heart failure (CHF)|ph associated with congestive heart failure (chf)
5749248|NCT00323024|PH associated with chronic obstructive pulmonary disease (COPD)|ph associated with chronic obstructive pulmonary disease (copd)
5749249|NCT00322985|T-cell lymphoma|t-cell lymphoma
5749250|NCT00322985|lenalidomide|lenalidomide
5749251|NCT00322972|Bacterial Infections|bacterial infections
5749252|NCT00322972|Chlamydia Infections|chlamydia infections
5749253|NCT00322972|Eye Diseases|eye diseases
5749254|NCT00322959|dendritic cells|dendritic cells
5749255|NCT00322959|Tai-Chi-Chuan|tai-chi-chuan
5749256|NCT00322946|Dengue Fever|dengue fever
5749257|NCT00322946|Dengue Vaccine|dengue vaccine
5749258|NCT00322946|Dengue Virus|dengue virus
5749259|NCT00322946|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5749260|NCT00322946|Dengue Shock Syndrome|dengue shock syndrome
5749261|NCT00322933|intermittent renal replacement therapy|intermittent renal replacement therapy
5749262|NCT00322933|continuous renal replacement therapy|continuous renal replacement therapy
5749263|NCT00322933|acute renal failure|acute renal failure
5749264|NCT00322933|renal recovery|renal recovery
5749265|NCT00322933|mortality|mortality
5749266|NCT00322920|cervical cancer|cervical cancer
5749267|NCT00322920|topotecan|topotecan
5749268|NCT00322920|Stage IVB cervical cancer|stage ivb cervical cancer
5749269|NCT00322920|Persistent or recurrent cervical cancer|persistent or recurrent cervical cancer
5749270|NCT00322907|malaria|malaria
5749271|NCT00322907|treatment|treatment
5749272|NCT00322907|cotrifazid|cotrifazid
5749273|NCT00322907|clinical trial|clinical trial
5749274|NCT00322907|efficacy|efficacy
5749275|NCT00322894|Breast cancer|breast cancer
5749277|NCT00322894|Treatment|treatment
5749278|NCT00322894|Clinico-pathologic|clinico-pathologic
5749279|NCT00322894|Outcomes|outcomes
5749280|NCT00322894|Tissue repository|tissue repository
5749281|NCT00322894|Registry|registry
5749282|NCT00322881|carboplatin|carboplatin
5749283|NCT00322881|paclitaxel|paclitaxel
5749284|NCT00322881|elderly women|elderly women
5749285|NCT00322868|Prescription drugs|prescription drugs
5749286|NCT00322868|Administration, oral|administration, oral
5749287|NCT00322868|Durable medical equipment|durable medical equipment
5749288|NCT00322868|Kinetics|kinetics
5749289|NCT00322842|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5749290|NCT00322842|Multiple Myeloma|multiple myeloma
5749291|NCT00322842|Stem cell mobilization|stem cell mobilization
5749292|NCT00322829|Group B Streptococcus, Strepotococcus agalactiae, detection|group b streptococcus, strepotococcus agalactiae, detection
5749293|NCT00322816|Malaria, Plasmodium falciparum, Gambia, larvicides|malaria, plasmodium falciparum, gambia, larvicides
5749294|NCT00322803|panic disorder|panic disorder
5749295|NCT00322803|proof of concept|proof of concept
5749296|NCT00322777|Major depression|major depression
5749297|NCT00322777|Spirituality|spirituality
5749298|NCT00322777|Randomized clinical trial|randomized clinical trial
5749299|NCT00322764|manic depression|manic depression
5749300|NCT00322764|bipolar disorder|bipolar disorder
5749301|NCT00322764|depression|depression
5749302|NCT00322764|uridine|uridine
5758496|NCT00290186|CP|cp
5749303|NCT00322764|RG2417|rg2417
5749304|NCT00322738|malaria, Plasmodium falciparum, Gambia, larvicides, vector|malaria, plasmodium falciparum, gambia, larvicides, vector
5749306|NCT00322699|Photodynamic Therapy|photodynamic therapy
5749307|NCT00322699|Photofrin|photofrin
5749308|NCT00322699|Photosensitization|photosensitization
5749309|NCT00322699|Photoradiation|photoradiation
5749310|NCT00322686|oglemilast|oglemilast
5749311|NCT00322686|asthma|asthma
5749312|NCT00322686|allergen|allergen
5749313|NCT00322686|prevention|prevention
5749314|NCT00322686|prophylaxis|prophylaxis
5749315|NCT00322686|Allergen-Induced Asthma|allergen-induced asthma
5686291|NCT00552656|Treatment Outcome|treatment outcome
5749316|NCT00322673|acute myeloid leukemia|acute myeloid leukemia
5749318|NCT00322608|Solid Tumors|solid tumors
5749319|NCT00322608|Lymphomas|lymphomas
5749320|NCT00322595|Anxiety|anxiety
5749321|NCT00322595|GAD|gad
5749322|NCT00322582|familial cardiomyopathy|familial cardiomyopathy
5749323|NCT00322582|genetics analysis|genetics analysis
5749324|NCT00322569|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5749325|NCT00322569|Drug eluting stent (DES)|drug eluting stent (des)
5749326|NCT00322556|Immunoglobulin Intravenous|immunoglobulin intravenous
5749327|NCT00322556|Agammaglobulinemia|agammaglobulinemia
5749328|NCT00322556|Hypogammaglobulinemia|hypogammaglobulinemia
5749329|NCT00322556|Common variable immunodeficiency|common variable immunodeficiency
5749330|NCT00322556|Immunoglobulin G|immunoglobulin g
5749331|NCT00322556|Children|children
5749332|NCT00322543|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5749333|NCT00322543|Drug eluting stent (DES)|drug eluting stent (des)
5749334|NCT00322491|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5749335|NCT00322491|Multiple Myeloma|multiple myeloma
5749336|NCT00322491|Stem cell mobilization|stem cell mobilization
5749337|NCT00322465|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole|non-gonococcal urethritis, doxycycline, azithromycin, sexually transmitted, tinidazole
5749338|NCT00322452|NSCLC|nsclc
5749339|NCT00322452|Gefitinib|gefitinib
5749340|NCT00322439|plaque Psoriasis patients|plaque psoriasis patients
5749341|NCT00322439|TNF-inhibitor naïve|tnf-inhibitor naïve
5749342|NCT00322426|Freezing of Gait|freezing of gait
5749343|NCT00322426|Parkinson's Disease|parkinson's disease
5749344|NCT00322426|Sensory Cues|sensory cues
5749345|NCT00322413|Epoetin alfa|epoetin alfa
5749346|NCT00322413|Epoetin omega|epoetin omega
5749347|NCT00322413|Comparative efficacy trial|comparative efficacy trial
5749348|NCT00322413|Renal anemia|renal anemia
5749349|NCT00322400|Clinical trial|clinical trial
5749350|NCT00322400|AMG 706|amg 706
5749351|NCT00322400|Anti-angiogenesis|anti-angiogenesis
5749352|NCT00322400|Locally Recurrent|locally recurrent
5749353|NCT00322400|Metastatic|metastatic
5749354|NCT00322400|Breast Cancer|breast cancer
5749355|NCT00322400|VEGF|vegf
5749356|NCT00322400|Angiogenesis Inhibitor|angiogenesis inhibitor
5749357|NCT00322400|Oral|oral
5749358|NCT00322400|Multi-kinase Inhibitor|multi-kinase inhibitor
5749359|NCT00322400|Anti-tumor|anti-tumor
5749360|NCT00322400|PDGF receptor|pdgf receptor
5749361|NCT00322400|Paclitaxel|paclitaxel
5749362|NCT00322400|Docetaxel|docetaxel
5749363|NCT00322400|Targeted Therapy|targeted therapy
5749364|NCT00322400|Oncology|oncology
5749365|NCT00322400|Amgen|amgen
5749366|NCT00322400|c-Kit|c-kit
5749367|NCT00322387|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5749368|NCT00322387|Multiple Myeloma|multiple myeloma
5749369|NCT00322387|Stem cell mobilization|stem cell mobilization
5749370|NCT00322348|oncology|oncology
5749372|NCT00322348|breast cancer|breast cancer
5749373|NCT00322335|H.influenzae type b Disease|h.influenzae type b disease
5749375|NCT00322322|Hemodialysis|hemodialysis
5749376|NCT00322322|Anaemia|anaemia
5749377|NCT00322322|Erythropoietin responsiveness|erythropoietin responsiveness
5749378|NCT00322309|Cocaine|cocaine
5749379|NCT00322309|Substance Abuse|substance abuse
5749380|NCT00322296|Parapsoriasis|parapsoriasis
5749381|NCT00322296|Cutaneous T-cell lymphoma|cutaneous t-cell lymphoma
5749382|NCT00322296|Mycosis fungoides|mycosis fungoides
5749383|NCT00322296|Bexarotene|bexarotene
5749384|NCT00322296|Retinoids|retinoids
5749385|NCT00322283|oglemilast|oglemilast
5749386|NCT00322283|asthma|asthma
5749387|NCT00322283|exercise|exercise
5749388|NCT00322283|prevention|prevention
5749389|NCT00322283|prophylaxis|prophylaxis
5749390|NCT00322270|Occluded Central Venous Access Devices|occluded central venous access devices
5749391|NCT00322270|Occluded Catheters|occluded catheters
5749392|NCT00322270|Thrombosis|thrombosis
5749393|NCT00322270|thrombosis, catheter|thrombosis, catheter
5749394|NCT00322270|alfimeprase|alfimeprase
5749395|NCT00322270|thrombotic occlusion|thrombotic occlusion
5749396|NCT00322270|thrombosis, CVAD|thrombosis, cvad
5749397|NCT00322270|thrombosis, catheters|thrombosis, catheters
5749398|NCT00322244|Osteoarthritis|osteoarthritis
5749399|NCT00322244|Massage therapy|massage therapy
5749400|NCT00322192|Stroke rehabilitation|stroke rehabilitation
5749401|NCT00322192|Physical Therapy|physical therapy
5749402|NCT00322179|Microarray Analysis|microarray analysis
5749403|NCT00322179|Obesity|obesity
5743872|NCT00343356|Perfusion|perfusion
5749404|NCT00322179|Chronic Hepatitis C|chronic hepatitis c
5749411|NCT00322153|moderate to severe Alzheimer's disease|moderate to severe alzheimer's disease
5749412|NCT00322140|Metastatic|metastatic
5749413|NCT00322140|Triterpenoids|triterpenoids
5749414|NCT00322140|2-Cyano-3,12-Dioxooleana-1,9(11)Dien-28oic Acid|2-cyano-3,12-dioxooleana-1,9(11)dien-28oic acid
5749415|NCT00322140|Dose-Limiting|dose-limiting
5749416|NCT00322140|Pharmacokinetic|pharmacokinetic
5749417|NCT00322140|Solid Tumor|solid tumor
5749418|NCT00322140|Lymphoma|lymphoma
5749426|NCT00322114|prostate cancer|prostate cancer
5686292|NCT00552643|Recalcitrant ulcers|recalcitrant ulcers
5686293|NCT00552643|Chronic wounds|chronic wounds
5686294|NCT00552643|Venous insufficiency wounds|venous insufficiency wounds
5686295|NCT00552643|Ulcers|ulcers
5749427|NCT00322062|Colon cleansing|colon cleansing
5749428|NCT00322049|Dengue, Vaccine, Thailand|dengue, vaccine, thailand
5749429|NCT00322036|Alzheimer Disease|alzheimer disease
5749430|NCT00322036|Dementia|dementia
5749431|NCT00322023|Negative symptoms|negative symptoms
5749433|NCT00322023|Glutamate|glutamate
5749434|NCT00322023|Glycine|glycine
5749435|NCT00322010|mechanical ventilation|mechanical ventilation
5749436|NCT00322010|physical therapy|physical therapy
5749437|NCT00322010|occupational therapy|occupational therapy
5749438|NCT00322010|mobilization|mobilization
5749439|NCT00322010|clinical protocols|clinical protocols
5749440|NCT00322010|ICU acquired weakness|icu acquired weakness
5749441|NCT00322010|critical illness myopathy|critical illness myopathy
5749442|NCT00322010|muscle atrophy|muscle atrophy
5749443|NCT00322010|intensive care unit|intensive care unit
5749444|NCT00322010|randomized controlled trial|randomized controlled trial
5749446|NCT00321997|Age-Related Macular Degeneration|age-related macular degeneration
5749447|NCT00321997|Macular Degeneration|macular degeneration
5749448|NCT00321997|Macugen|macugen
5749449|NCT00321997|pegaptanib sodium|pegaptanib sodium
5749450|NCT00321984|Gastroesophageal Reflux Disease(GERD)|gastroesophageal reflux disease(gerd)
5749451|NCT00321984|Heartburn|heartburn
5749452|NCT00321971|Anxiety|anxiety
5749453|NCT00321971|Mild Cognitive Impairment|mild cognitive impairment
5749455|NCT00321971|Cognitive Impairment|cognitive impairment
5749456|NCT00321971|Alzheimer's Disease|alzheimer's disease
5749457|NCT00321971|Caregiver Burden|caregiver burden
5749458|NCT00321971|Caregiver Stress|caregiver stress
5749459|NCT00321971|Family Dementia Caregiving|family dementia caregiving
5749460|NCT00321971|Spousal Dementia Caregiving|spousal dementia caregiving
5749461|NCT00321958|Barrett Esophagus|barrett esophagus
5749462|NCT00321958|Esophageal Neoplasm|esophageal neoplasm
5749463|NCT00321958|Deglutition disorders|deglutition disorders
5749464|NCT00321958|Cryotherapy|cryotherapy
5749465|NCT00321958|Cryosurgery|cryosurgery
5749466|NCT00321958|GERD|gerd
5749467|NCT00321958|Neoplasm|neoplasm
5749468|NCT00321958|Esophagus|esophagus
5749469|NCT00321958|Endoscopy, Digestive System|endoscopy, digestive system
5749470|NCT00321945|Atrial Fibrillation|atrial fibrillation
5749471|NCT00321945|Atrial Flutter|atrial flutter
5749472|NCT00321945|Angiotensin Converting Enzyme Inhibitor|angiotensin converting enzyme inhibitor
5749473|NCT00321945|Angiotensin Receptor Blocker|angiotensin receptor blocker
5749474|NCT00321906|Rejection in lung transplant|rejection in lung transplant
5749475|NCT00321893|Small cell lung cancer|small cell lung cancer
5749476|NCT00321893|Non-small cell lung cancer|non-small cell lung cancer
5749477|NCT00321893|Budesonide|budesonide
5749478|NCT00321893|Entocort EC|entocort ec
5749479|NCT00321893|Pulmicort Respules|pulmicort respules
5749480|NCT00321893|Rhinocort aqua|rhinocort aqua
5749481|NCT00321893|Aerosol budesonide treatment|aerosol budesonide treatment
5749482|NCT00321893|Smoking|smoking
5749483|NCT00321880|fatigue|fatigue
5749484|NCT00321880|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5749485|NCT00321880|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5749486|NCT00321880|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5749487|NCT00321880|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5749488|NCT00321880|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5749489|NCT00321880|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5749490|NCT00321880|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5749491|NCT00321880|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5749492|NCT00321880|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5749493|NCT00321880|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5749494|NCT00321867|rectocele|rectocele
5749495|NCT00321867|pelvic prolapse|pelvic prolapse
5749497|NCT00321867|surgical repair|surgical repair
5749498|NCT00321828|adenocarcinoma of the colon|adenocarcinoma of the colon
5749499|NCT00321828|stage IV colon cancer|stage iv colon cancer
5749500|NCT00321815|advanced carcinoma non-small cell lung EGFR positive Erlotinib Tarceva PF-3512676 Phase II immunotherapy immune modulator|advanced carcinoma non-small cell lung egfr positive erlotinib tarceva pf-3512676 phase ii immunotherapy immune modulator
5749501|NCT00321802|atrial fibrillation|atrial fibrillation
5749502|NCT00321802|statin therapy|statin therapy
5749503|NCT00321802|CRP levels|crp levels
5749504|NCT00321802|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5749505|NCT00321789|self care|self care
5749506|NCT00321789|social support|social support
5749507|NCT00321763|Influenza|influenza
5749508|NCT00321763|Influenza vaccine|influenza vaccine
5749509|NCT00321750|Oral erosive lichen planus|oral erosive lichen planus
5686296|NCT00552643|Exposed bones|exposed bones
5749510|NCT00321750|pimecrolimus cream|pimecrolimus cream
5749511|NCT00321737|Erosive Esophagitis|erosive esophagitis
5749512|NCT00321711|MDS|mds
5749513|NCT00321711|Myelodysplastic Syndromes|myelodysplastic syndromes
5749514|NCT00321711|Refractory Cytopenias|refractory cytopenias
5749515|NCT00321711|Thrombocytopenia|thrombocytopenia
5749516|NCT00321698|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5749517|NCT00321698|stage II prostate cancer|stage ii prostate cancer
5749518|NCT00321698|stage III prostate cancer|stage iii prostate cancer
5749519|NCT00321672|Analgesics|analgesics
5749520|NCT00321672|Capsaicin|capsaicin
5749521|NCT00321672|Neuropathic pain|neuropathic pain
5749522|NCT00321672|Neuropathy|neuropathy
5749523|NCT00321672|Distal sensory polyneuropathy|distal sensory polyneuropathy
5749524|NCT00321672|Peripheral neuropathy|peripheral neuropathy
5749525|NCT00321672|Dermal assessment|dermal assessment
5749526|NCT00321672|Pain measurement|pain measurement
5749527|NCT00321659|fibromyalgia|fibromyalgia
5749528|NCT00321659|self-management|self-management
5749529|NCT00321659|exercise|exercise
5749530|NCT00321659|patient education|patient education
5749531|NCT00321646|prostate cancer|prostate cancer
5749532|NCT00321646|bevacizumab|bevacizumab
5749533|NCT00321646|docetaxel|docetaxel
5749534|NCT00321646|radical prostatectomy|radical prostatectomy
5749535|NCT00321633|stage IV breast cancer|stage iv breast cancer
5749536|NCT00321633|recurrent breast cancer|recurrent breast cancer
5749537|NCT00321633|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5749538|NCT00321633|BRCA1 mutation carrier|brca1 mutation carrier
5749539|NCT00321633|BRCA2 mutation carrier|brca2 mutation carrier
5749540|NCT00321620|Bone metastases|bone metastases
5749541|NCT00321620|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5749542|NCT00321620|Skeletal|skeletal
5749543|NCT00321620|Fractures|fractures
5749544|NCT00321620|Compressions|compressions
5749545|NCT00321620|Bisphosphonates|bisphosphonates
5749546|NCT00321581|VEGFR2|vegfr2
5749547|NCT00321581|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5749548|NCT00321581|Antiangiogenesis|antiangiogenesis
5749549|NCT00321581|Solid Tumors|solid tumors
5749550|NCT00321581|Childhood Cancer|childhood cancer
5749551|NCT00321581|Solid Tumor|solid tumor
5749552|NCT00321581|Recurrent Solid Tumor|recurrent solid tumor
5749553|NCT00321581|Treatment Resistant Solid Tumor|treatment resistant solid tumor
5749554|NCT00321581|Acute Myelogenous Leukemia|acute myelogenous leukemia
5749555|NCT00321581|AML|aml
5749556|NCT00321568|Multiple Sclerosis|multiple sclerosis
5749557|NCT00321568|Magnetic Resonance|magnetic resonance
5749558|NCT00321568|MRI|mri
5749559|NCT00321568|Magnetic Field|magnetic field
5749560|NCT00321568|MS|ms
5749561|NCT00321555|Biologic Therapy|biologic therapy
5749562|NCT00321555|Monoclonal Antibody|monoclonal antibody
5749563|NCT00321555|Immunotherapy|immunotherapy
5749564|NCT00321555|Pseudomonas Exotoxin|pseudomonas exotoxin
5749565|NCT00321555|Targeted Therapy|targeted therapy
5749566|NCT00321555|Hairy Cell Leukemia|hairy cell leukemia
5749567|NCT00321555|HCL|hcl
5750473|NCT00317928|Ovulation|ovulation
5749568|NCT00321542|Computed tomography|computed tomography
5749569|NCT00321542|Diabetes mellitus|diabetes mellitus
5749570|NCT00321542|Coronary atherosclerosis|coronary atherosclerosis
5749571|NCT00321542|Non-invasive imaging|non-invasive imaging
5749572|NCT00321529|Cervical spine instability|cervical spine instability
5749573|NCT00321529|Penning Study|penning study
5749574|NCT00321516|Bipolar type I Disorder|bipolar type i disorder
5749575|NCT00321503|acid reflux|acid reflux
5749576|NCT00321503|LPR|lpr
5749577|NCT00321503|gastroesophageal reflux|gastroesophageal reflux
5749578|NCT00321503|GERD|gerd
5749579|NCT00321503|pH probe|ph probe
5749580|NCT00321503|proton pump inhibitor|proton pump inhibitor
5749581|NCT00321503|PPI|ppi
5749582|NCT00321490|MDD|mdd
5749583|NCT00321490|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
5749584|NCT00321490|Depression|depression
5749585|NCT00321477|Overactive Bladder|overactive bladder
5749586|NCT00321464|Fractures|fractures
5749587|NCT00321464|Compressions|compressions
5749588|NCT00321464|Bisphosphonates|bisphosphonates
5749589|NCT00321464|Bone metastases|bone metastases
5749590|NCT00321464|Breast cancer|breast cancer
5749591|NCT00321464|Skeletal|skeletal
5749592|NCT00321464|Radiation|radiation
5749593|NCT00321464|Surgery to Bone|surgery to bone
5749594|NCT00321451|insomnia|insomnia
5749595|NCT00321451|cognitive behavior therapy|cognitive behavior therapy
5749596|NCT00321438|HIV-1|hiv-1
5749597|NCT00321438|GW873140|gw873140
5749598|NCT00321438|CCR5 antagonist|ccr5 antagonist
5749599|NCT00321438|experienced|experienced
5749600|NCT00321438|treatment experienced|treatment experienced
5749601|NCT00321412|Crohn's disease|crohn's disease
5749602|NCT00321412|IBD|ibd
5749603|NCT00321412|Inflammatory Bowel Disease|inflammatory bowel disease
5749604|NCT00321412|Fistula|fistula
5749605|NCT00321399|CORONARY ANATOMY|coronary anatomy
5749606|NCT00321399|Coronary Artery Disease|coronary artery disease
5758695|NCT00289289|Pacing|pacing
5749607|NCT00321399|SPECT|spect
5749608|NCT00321399|PET|pet
5749609|NCT00321399|PET/CT|pet/ct
5749610|NCT00321399|CTA|cta
5749611|NCT00321386|Glaucoma|glaucoma
5749612|NCT00321386|Open Angle|open angle
5749613|NCT00321386|Normal Tension|normal tension
5749614|NCT00321373|Influenza|influenza
5749615|NCT00321373|Influenza vaccine|influenza vaccine
5749616|NCT00321360|propofol|propofol
5749617|NCT00321360|sedation|sedation
5749618|NCT00321347|Cancer|cancer
5749619|NCT00321347|Pain|pain
5749620|NCT00321347|Lidocaine|lidocaine
5749621|NCT00321334|non-small cell lung cancer|non-small cell lung cancer
5749622|NCT00321334|Chemotherapy|chemotherapy
5749623|NCT00321334|surgery|surgery
5749624|NCT00321334|neo-adjuvant|neo-adjuvant
5749625|NCT00321334|adjuvant|adjuvant
5749626|NCT00321334|RCT|rct
5749627|NCT00321321|Type 2 diabetes mellitus|type 2 diabetes mellitus
5749628|NCT00321321|Glucose dependent insulinotropic polypeptide|glucose dependent insulinotropic polypeptide
5749629|NCT00321321|Sulfonylurea compounds|sulfonylurea compounds
5749630|NCT00321321|insulin secretion|insulin secretion
5749631|NCT00321321|Sulfonylurea receptor subunit-SUR1|sulfonylurea receptor subunit-sur1
5749632|NCT00321321|Impaired incretin effect|impaired incretin effect
5749633|NCT00321308|advanced carcinoma, non-small cell lung cancer, phase II, pemetrexed, Alimta, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung cancer, phase ii, pemetrexed, alimta, pf-3512676, immunotherapy, immunomodulator
5749634|NCT00321295|Bi-ventricular pacing|bi-ventricular pacing
5749635|NCT00321295|Cardiac Surgery|cardiac surgery
5749636|NCT00321295|Cardiomyopahty|cardiomyopahty
5749637|NCT00321295|Heart Failure|heart failure
5749638|NCT00321282|Atrial Fibrillation|atrial fibrillation
5749639|NCT00321282|Coronary Artery Bypass Graft|coronary artery bypass graft
5749640|NCT00321282|Risk Stratification|risk stratification
5749641|NCT00321269|Home Monitoring|home monitoring
5749642|NCT00321269|Heart Failure|heart failure
5749643|NCT00321269|Depression|depression
5749644|NCT00321256|islet transplantation|islet transplantation
5749645|NCT00321256|brittle diabetes|brittle diabetes
5749646|NCT00321256|severe hypoglycemia|severe hypoglycemia
5765938|NCT00259831|cold|cold
5749647|NCT00321256|type 1 diabetes mellitus|type 1 diabetes mellitus
5749648|NCT00321243|triage|triage
5749649|NCT00321230|Colon cleansing|colon cleansing
5749650|NCT00321217|rheumatoid arthritis|rheumatoid arthritis
5749651|NCT00321217|pharmacogenetics|pharmacogenetics
5749652|NCT00321217|anti-TNF|anti-tnf
5749653|NCT00321217|high throughput genotyping|high throughput genotyping
5749654|NCT00321204|Atrial Fibrillation|atrial fibrillation
5749655|NCT00321204|Atrial Flutter|atrial flutter
5749656|NCT00321204|Cardiac Surgery|cardiac surgery
5749657|NCT00321204|Thiazolidinediones|thiazolidinediones
5749658|NCT00321178|Mycobacterium ulcerans|mycobacterium ulcerans
5749659|NCT00321178|Buruli ulcer|buruli ulcer
5749660|NCT00321178|Ghana|ghana
5749661|NCT00321178|randomized comparison|randomized comparison
5749662|NCT00321178|streptomycin|streptomycin
5749663|NCT00321178|rifampicin|rifampicin
5749664|NCT00321178|clarithromycin|clarithromycin
5749665|NCT00321165|nutrition|nutrition
5749666|NCT00321165|parenteral|parenteral
5749667|NCT00321165|infection|infection
5749668|NCT00321165|katheter|katheter
5749669|NCT00321165|taurolidine|taurolidine
5749670|NCT00321165|acridine orange|acridine orange
5749671|NCT00321165|prevention|prevention
5749672|NCT00321139|biomarkers|biomarkers
5749673|NCT00321139|oxidative stress|oxidative stress
5749674|NCT00321139|intravascular ultrasound|intravascular ultrasound
5749675|NCT00321126|Zinc|zinc
5749676|NCT00321126|Shigella|shigella
5749677|NCT00321126|Children|children
5749678|NCT00321126|Bangladesh|bangladesh
5749679|NCT00321113|MARGINAL KIDNEY|marginal kidney
5749680|NCT00321113|TACROLIMUS|tacrolimus
5749681|NCT00321113|IMMUNOSUPPRESSION|immunosuppression
5749682|NCT00321113|ELDERLY RECEPIENTS|elderly recepients
5749683|NCT00321100|metastatic|metastatic
5749684|NCT00321100|colorectal|colorectal
5749685|NCT00321100|cancer|cancer
5749686|NCT00321100|initial therapy|initial therapy
5749687|NCT00321087|Movement Disorder|movement disorder
5749688|NCT00321074|IMMUNOSUPPRESSION|immunosuppression
5749689|NCT00321074|TACROLIMUS|tacrolimus
5749690|NCT00321074|MARGINAL LIVERS|marginal livers
5749691|NCT00321074|PHARMACOKINETICS|pharmacokinetics
5749692|NCT00321061|HIV Negative|hiv negative
5749693|NCT00321061|Healthy|healthy
5749694|NCT00321061|Immunity|immunity
5749695|NCT00321061|Preventive|preventive
5749696|NCT00321061|Virus|virus
5749697|NCT00321061|Healthy Volunteer|healthy volunteer
5749699|NCT00321048|breast cancer|breast cancer
5749700|NCT00321048|SPECT|spect
5749701|NCT00321048|ABC device|abc device
5749702|NCT00321048|Invasive adenocarcinoma of the left breast|invasive adenocarcinoma of the left breast
5749703|NCT00321048|Ductal Carcinoma In Situ of the left breast|ductal carcinoma in situ of the left breast
5749704|NCT00321035|Glaucoma|glaucoma
5749705|NCT00321035|Pterygium|pterygium
5749706|NCT00321035|collagen matrix|collagen matrix
5749707|NCT00321035|oculusgen|oculusgen
5749708|NCT00321035|ologen|ologen
5749709|NCT00321035|trabeculectomy|trabeculectomy
5749710|NCT00321035|anti scarring|anti scarring
5749711|NCT00321035|prevent recurrence|prevent recurrence
5749712|NCT00321035|tissue engineering|tissue engineering
5749713|NCT00321035|Aeon Astron|aeon astron
5749714|NCT00321022|Transient Ischemic Attack (TIA)|transient ischemic attack (tia)
5749715|NCT00321022|Diagnostic Protocol|diagnostic protocol
5749716|NCT00321022|Observational Medicine|observational medicine
5749717|NCT00321022|Emergency Department Observational Unit|emergency department observational unit
5749718|NCT00321009|Myocardial Infarction|myocardial infarction
5749719|NCT00321009|Left Ventricular Mural Thrombus|left ventricular mural thrombus
5749720|NCT00321009|Low Molecular Weight Heparin|low molecular weight heparin
5749721|NCT00321009|Enoxaparin|enoxaparin
5749722|NCT00321009|Warfarin|warfarin
5749723|NCT00321009|Echocardiograms|echocardiograms
5749724|NCT00320996|Pelvic mass|pelvic mass
5749725|NCT00320983|Cancer|cancer
5749726|NCT00320983|Cervix|cervix
5749727|NCT00320970|TGF-Beta 1|tgf-beta 1
5749728|NCT00320970|Angiotensin II|angiotensin ii
5749729|NCT00320970|Advanced glycation end products|advanced glycation end products
5749730|NCT00320957|Glaucoma|glaucoma
5749731|NCT00320957|Pterygium|pterygium
5749732|NCT00320957|collagen matrix|collagen matrix
5749733|NCT00320957|OculusGen|oculusgen
5749734|NCT00320957|trabeculectomy|trabeculectomy
5749735|NCT00320957|Anti scarring|anti scarring
5749736|NCT00320957|pterygium recurrence|pterygium recurrence
5749737|NCT00320957|tissue engineering|tissue engineering
5749738|NCT00320957|Aeon Astron|aeon astron
5749739|NCT00320957|ologen|ologen
5749740|NCT00320931|Coronary artery disease|coronary artery disease
5749741|NCT00320931|PET CT scan|pet ct scan
5749742|NCT00320931|Stress test|stress test
5749743|NCT00320931|Rubudium|rubudium
5749744|NCT00320918|Unresectable/metastatic cholangiocarcinoma|unresectable/metastatic cholangiocarcinoma
5749745|NCT00320918|Cancer|cancer
5749746|NCT00320918|Chart Review|chart review
5749747|NCT00320905|Cardiac Rehabilitation|cardiac rehabilitation
5749748|NCT00320905|Cognitive functioning|cognitive functioning
5749749|NCT00320905|Cardiovascular disease|cardiovascular disease
5749750|NCT00320892|Death Rattle|death rattle
5749751|NCT00320892|Noise level|noise level
5749752|NCT00320892|Primary Care|primary care
5749753|NCT00320879|diabetes|diabetes
5749754|NCT00320879|microalbuminuria|microalbuminuria
5749755|NCT00320879|angiotensin II receptor blockade|angiotensin ii receptor blockade
5749756|NCT00320879|irbesartan|irbesartan
5749757|NCT00320879|dose-response|dose-response
5749758|NCT00320879|randomized|randomized
5749759|NCT00320879|double-blind|double-blind
5749760|NCT00320879|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5749761|NCT00320879|clinical|clinical
5749762|NCT00320879|hypertension|hypertension
5749763|NCT00320866|Hypodermoclysis|hypodermoclysis
5749764|NCT00320866|Evaluation of Symptoms|evaluation of symptoms
5749765|NCT00320853|Diabetes|diabetes
5749766|NCT00320853|Vitamin D|vitamin d
5749767|NCT00320853|Insulin sensitivity|insulin sensitivity
5749768|NCT00320853|Insulin secretion|insulin secretion
5749769|NCT00320840|preterm infants|preterm infants
5749771|NCT00320840|motherhood|motherhood
5749772|NCT00320840|internal resources|internal resources
5749773|NCT00320840|familial resources|familial resources
5749775|NCT00320827|Death receptor 5|death receptor 5
5749777|NCT00320827|Advanced solid malignancies and lymphomas (without leukemic component)|advanced solid malignancies and lymphomas (without leukemic component)
5749778|NCT00320801|Chronic pain|chronic pain
5749779|NCT00320801|osteoarthritis|osteoarthritis
5749780|NCT00320801|transdermal|transdermal
5749781|NCT00320788|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5749782|NCT00320775|Neovascular Age-Related Macular Degeneration|neovascular age-related macular degeneration
5749783|NCT00320762|Glaucoma|glaucoma
5749784|NCT00320762|Pterygium|pterygium
5749785|NCT00320762|collagen matrix|collagen matrix
5749786|NCT00320762|OculusGen|oculusgen
5749787|NCT00320762|trabeculectomy|trabeculectomy
5749788|NCT00320762|Anti scarring|anti scarring
5749789|NCT00320762|pterygium recurrence|pterygium recurrence
5749790|NCT00320762|tissue engineering|tissue engineering
5749791|NCT00320762|Aeon Astron|aeon astron
5749792|NCT00320749|Advanced Pancreatic Cancer|advanced pancreatic cancer
5749793|NCT00320736|schizophrenia|schizophrenia
5749794|NCT00320736|cognitive function|cognitive function
5749795|NCT00320736|cholinergic medication|cholinergic medication
5749796|NCT00320736|nicotinic receptor agonist|nicotinic receptor agonist
5749797|NCT00320723|schizophrenia|schizophrenia
5749798|NCT00320723|smoking cessation|smoking cessation
5749799|NCT00320723|nicotine|nicotine
5749800|NCT00320723|patch|patch
5749801|NCT00320723|bupropion|bupropion
5749802|NCT00320723|nicotine replacement therapy|nicotine replacement therapy
5749803|NCT00320723|cognitive behavioral therapy|cognitive behavioral therapy
5749804|NCT00320710|Breast cancer|breast cancer
5749805|NCT00320710|zoledronic acid|zoledronic acid
5749806|NCT00320710|bone metastases|bone metastases
5749807|NCT00320697|schizophrenia|schizophrenia
5749808|NCT00320697|smoking cessation|smoking cessation
5749809|NCT00320697|relapse prevention|relapse prevention
5749811|NCT00320697|bupropion|bupropion
5749812|NCT00320697|cognitive behavioral therapy|cognitive behavioral therapy
5765166|NCT00263237|Malabsorption|malabsorption
5749813|NCT00320697|nicotine replacement therapy|nicotine replacement therapy
5749814|NCT00320684|Serotonin Transporter|serotonin transporter
5749815|NCT00320684|Positron-Emission Tomography|positron-emission tomography
5749816|NCT00320671|First-episode|first-episode
5749817|NCT00320671|Schizoaffective Disorder|schizoaffective disorder
5749818|NCT00320671|Schizophreniform Disorder|schizophreniform disorder
5749819|NCT00320671|Psychotic Disorder Not Otherwise Specified NOS|psychotic disorder not otherwise specified nos
5749820|NCT00320671|Aripiprazole|aripiprazole
5749821|NCT00320671|Clozapine|clozapine
5749822|NCT00320671|Risperidone|risperidone
5749823|NCT00320658|Plasmodium falciparum|plasmodium falciparum
5749824|NCT00320632|Major Depressive Disorder|major depressive disorder
5749826|NCT00320619|Aminocaproic Acids|aminocaproic acids
5749827|NCT00320619|Blood Transfusion|blood transfusion
5749828|NCT00320606|immunosuppression withdrawal (IS)|immunosuppression withdrawal (is)
5749829|NCT00320606|anti-rejection drugs|anti-rejection drugs
5749830|NCT00320606|tolerance|tolerance
5749831|NCT00320606|allograft function|allograft function
5749832|NCT00320593|Myopia|myopia
5749833|NCT00320593|Progressive Addition Lenses (PALs)|progressive addition lenses (pals)
5749834|NCT00320593|Single Vision Lenses (SVLs)|single vision lenses (svls)
5749835|NCT00320593|Accommodative lags|accommodative lags
5749836|NCT00320593|Near esophoria|near esophoria
5749837|NCT00320593|Refractive error|refractive error
5749838|NCT00320580|Metrorrhagia|metrorrhagia
5749839|NCT00320580|oral contraception|oral contraception
5749840|NCT00320580|breakthrough bleeding|breakthrough bleeding
5749841|NCT00320580|spotting|spotting
5749842|NCT00320567|osteoporosis|osteoporosis
5749843|NCT00320567|anorexia nervosa|anorexia nervosa
5749844|NCT00320567|pediatric|pediatric
5749845|NCT00320541|Breast Cancer|breast cancer
5749846|NCT00320541|Cancer of Breast|cancer of breast
5749847|NCT00320541|Cancer of the breast|cancer of the breast
5749848|NCT00320541|Breast Neoplasms|breast neoplasms
5749849|NCT00320476|Multiple myeloma|multiple myeloma
5749850|NCT00320450|SB-681323|sb-681323
5749852|NCT00320450|Rheumatoid Arthritis SB-681323 CRP RA|rheumatoid arthritis sb-681323 crp ra
5749853|NCT00320450|Rheumatoid Arthritis|rheumatoid arthritis
5749854|NCT00320450|RA|ra
5749855|NCT00320437|trauma|trauma
5749856|NCT00320437|anxiety|anxiety
5749857|NCT00320437|antenatal|antenatal
5749858|NCT00320437|mothers|mothers
5749859|NCT00320437|children|children
5749860|NCT00320437|Gene x Environment Interaction|gene x environment interaction
5749861|NCT00320424|Xa factor|xa factor
5749862|NCT00320424|VTE|vte
5749863|NCT00320424|MOSLL|mosll
5749864|NCT00320424|pentasaccharide|pentasaccharide
5749865|NCT00320411|Stage IV breast cancer|stage iv breast cancer
5749866|NCT00320411|Herceptin|herceptin
5749867|NCT00320411|metastatic breast cancer|metastatic breast cancer
5749868|NCT00320411|ErbB1|erbb1
5749869|NCT00320411|ErbB2|erbb2
5749870|NCT00320411|trastuzumab|trastuzumab
5749871|NCT00320411|lapatinib|lapatinib
5749872|NCT00320398|Fondaparinux|fondaparinux
5749873|NCT00320398|Hip Replacement Arthroplasty|hip replacement arthroplasty
5749874|NCT00320398|VTE|vte
5749875|NCT00320398|THR|thr
5749876|NCT00320398|MOSLL|mosll
5749877|NCT00320398|pentasaccharide|pentasaccharide
5749878|NCT00320398|Xa factor|xa factor
5749879|NCT00320385|lapatinib|lapatinib
5749881|NCT00320385|ErbB2|erbb2
5749882|NCT00320385|EGFR|egfr
5749883|NCT00320385|ErbB1|erbb1
5749884|NCT00320385|MBC|mbc
5749885|NCT00320385|FISH amplification|fish amplification
5749886|NCT00320385|Metastatic Breast Cancer|metastatic breast cancer
5749887|NCT00320385|dual tyrosine kinase inhibitor|dual tyrosine kinase inhibitor
5749888|NCT00320385|Her-2/neu|her-2/neu
5749889|NCT00320372|Major Depressive Disorder|major depressive disorder
5749890|NCT00320372|Treatment-resistant Depression|treatment-resistant depression
5749891|NCT00320359|First-line Cisplatin|first-line cisplatin
5749892|NCT00320359|Small Cell Lung Cancer|small cell lung cancer
5749893|NCT00320359|topotecan|topotecan
5749894|NCT00320359|etoposide|etoposide
5749895|NCT00320359|Extensive Disease|extensive disease
5749896|NCT00320346|Pandemic|pandemic
5749897|NCT00320346|Influenza|influenza
5749898|NCT00320346|Prevention|prevention
5749899|NCT00320346|Vaccine|vaccine
5750842|NCT00316797|SPECT|spect
5749900|NCT00320346|Prevention of Pandemic Influenza|prevention of pandemic influenza
5749901|NCT00320333|COPD|copd
5749902|NCT00320333|rehabilitation|rehabilitation
5749903|NCT00320333|health services research|health services research
5749904|NCT00320320|No prior chemotherapy|no prior chemotherapy
5749905|NCT00320307|Human Immunodeficiency Virus|human immunodeficiency virus
5749906|NCT00320307|HIV|hiv
5749907|NCT00320307|Abacavir regime|abacavir regime
5749908|NCT00320307|ABC|abc
5749909|NCT00320281|Botox|botox
5749910|NCT00320268|MDD|mdd
5749911|NCT00320268|Quetiapine fumarate, sustained release|quetiapine fumarate, sustained release
5749912|NCT00320268|Depression|depression
5749913|NCT00320255|anticoagulant|anticoagulant
5749914|NCT00320242|Parkinson's disease|parkinson's disease
5686297|NCT00552643|Exposed Tendons|exposed tendons
5749915|NCT00320242|laser cane|laser cane
5749916|NCT00320242|freezing of gait|freezing of gait
5749917|NCT00320242|visual cues|visual cues
5749918|NCT00320229|angioplasty|angioplasty
5749919|NCT00320229|stent|stent
5749920|NCT00320229|abciximab|abciximab
5749921|NCT00320229|Platelet Glycoprotein GPIIb-IIIa Complex|platelet glycoprotein gpiib-iiia complex
5749922|NCT00320229|myocardial infarction|myocardial infarction
5749923|NCT00320216|Psoriasis|psoriasis
5749924|NCT00320216|CNTO 1275|cnto 1275
5749925|NCT00320216|Ustekinumab|ustekinumab
5749926|NCT00320216|Stelara|stelara
5749927|NCT00320216|Interleukin-12|interleukin-12
5749928|NCT00320216|IL-12|il-12
5749929|NCT00320216|Interleukin-23|interleukin-23
5749930|NCT00320216|IL-23|il-23
5749931|NCT00320203|open-angle|open-angle
5749932|NCT00320203|glaucoma|glaucoma
5749933|NCT00320190|Chronic phase CML, with a suboptimal response after treatment with imatinib|chronic phase cml, with a suboptimal response after treatment with imatinib
5749934|NCT00320177|Binge Eating|binge eating
5749935|NCT00320177|Food Intake|food intake
5749936|NCT00320177|Obesity|obesity
5749937|NCT00320177|Melanocortin-4 Receptor Gene|melanocortin-4 receptor gene
5749938|NCT00320177|Child|child
5749939|NCT00320177|Macronutrient Composition|macronutrient composition
5749940|NCT00320164|Healthy Volunteers|healthy volunteers
5749941|NCT00320151|chronic lung disease|chronic lung disease
5749942|NCT00320138|PTSD|ptsd
5749943|NCT00320138|Posttraumatic Stress|posttraumatic stress
5749944|NCT00320138|Acupuncture|acupuncture
5749945|NCT00320138|Randomized Controlled Trial|randomized controlled trial
5749946|NCT00320138|Complementary medicine|complementary medicine
5749947|NCT00320138|Alternative medicine|alternative medicine
5749948|NCT00320138|Chinese medicine|chinese medicine
5749949|NCT00320138|military healthcare|military healthcare
5749950|NCT00320125|Dairy|dairy
5749951|NCT00320125|Calcium|calcium
5749952|NCT00320125|Pregnancy|pregnancy
5749953|NCT00320125|Fetus|fetus
5749954|NCT00320125|Bone mineralization|bone mineralization
5749955|NCT00320112|telemedicine|telemedicine
5749956|NCT00320112|case management|case management
5749957|NCT00320112|insulin|insulin
5749958|NCT00320112|self-care|self-care
5749959|NCT00320099|septic shock|septic shock
5749960|NCT00320099|adrenal insufficiency|adrenal insufficiency
5749961|NCT00320099|glucose control|glucose control
5749962|NCT00320099|mineralocorticoids|mineralocorticoids
5749963|NCT00320073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5749964|NCT00320060|Diabetic nephropathy|diabetic nephropathy
5749965|NCT00320060|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
5749966|NCT00320060|Pyridorin|pyridorin
5749967|NCT00320060|Pyridoxamine|pyridoxamine
5749968|NCT00320047|Binge Eating Disorder|binge eating disorder
5749969|NCT00320034|levalbuterol|levalbuterol
5749970|NCT00320034|asthma|asthma
5749971|NCT00320034|allergen provocation|allergen provocation
5749972|NCT00320034|airway inflammation|airway inflammation
5749973|NCT00320034|clinical trial|clinical trial
5749974|NCT00320021|Diabetic nephropathy|diabetic nephropathy
5749975|NCT00320021|Advanced Glycation Endproduct Inhibitor|advanced glycation endproduct inhibitor
5749976|NCT00320021|Pyridorin|pyridorin
5749977|NCT00320021|Pyridoxamine|pyridoxamine
5749978|NCT00319982|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5739648|NCT00359203|syncope|syncope
5749979|NCT00319982|Left ventricular hypertrophy|left ventricular hypertrophy
5749980|NCT00319982|Diltiazem|diltiazem
5749981|NCT00319969|small cell lung cancer|small cell lung cancer
5749982|NCT00319969|amrubicin|amrubicin
5749983|NCT00319956|premature infant|premature infant
5749984|NCT00319956|respiratory distress syndrome|respiratory distress syndrome
5749985|NCT00319956|mechanical ventilation|mechanical ventilation
5749986|NCT00319943|Cognitive remediation|cognitive remediation
5749987|NCT00319943|Cognitive impairment|cognitive impairment
5749988|NCT00319943|computer|computer
5749989|NCT00319943|training|training
5749990|NCT00319930|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5749992|NCT00319930|ZAP-70|zap-70
5749993|NCT00319930|Hsp90 inhibitor|hsp90 inhibitor
5749994|NCT00319917|Tacrolimus|tacrolimus
5749995|NCT00319917|Rheumatoid Arthritis|rheumatoid arthritis
5749996|NCT00319917|Tacrolimus anhydrous|tacrolimus anhydrous
5749997|NCT00319904|Schizophrenia|schizophrenia
5749998|NCT00319904|DNA|dna
5749999|NCT00319891|Alzheimer's|alzheimer's
5750000|NCT00319891|AD|ad
5750001|NCT00319891|Mild Cognitive Impairment|mild cognitive impairment
5750002|NCT00319891|Dementia|dementia
5750003|NCT00319891|Cognitive remediation|cognitive remediation
5750004|NCT00319891|computer-based training|computer-based training
5750005|NCT00319865|Multiple Myeloma Relapsed|multiple myeloma relapsed
5750006|NCT00319852|Diphteria;|diphteria;
5750007|NCT00319852|Tetanus;|tetanus;
5750008|NCT00319852|Pertussis;|pertussis;
5750009|NCT00319852|Poliomyelitis;|poliomyelitis;
5750010|NCT00319852|acellular|acellular
5750011|NCT00319839|Head cancer|head cancer
5750012|NCT00319839|Neck cancer|neck cancer
5750013|NCT00319839|cetuximab|cetuximab
5750014|NCT00319839|abraxane|abraxane
5750016|NCT00319839|IMC-225|imc-225
5750017|NCT00319839|NSC-714692|nsc-714692
5750018|NCT00319826|Staphylococcus aureus, S. aureus, bacteremia, sepsis|staphylococcus aureus, s. aureus, bacteremia, sepsis
5750019|NCT00319774|End-stage renal disease|end-stage renal disease
5750020|NCT00319774|Hemodialysis|hemodialysis
5750021|NCT00319774|Hypertension|hypertension
5750022|NCT00319774|Hypotension|hypotension
5750023|NCT00319774|Blood volume|blood volume
5750024|NCT00319774|Hypervolemia|hypervolemia
5750025|NCT00319774|Quality of life|quality of life
5750026|NCT00319774|Biofeedback system|biofeedback system
5750027|NCT00319761|glomerulonephritis|glomerulonephritis
5750028|NCT00319761|proteinuria|proteinuria
5750029|NCT00319761|chronic kidney diseases|chronic kidney diseases
5750030|NCT00319748|Breast|breast
5750031|NCT00319748|Ovarian|ovarian
5750032|NCT00319748|Endometrial|endometrial
5750033|NCT00319748|Cervical|cervical
5750034|NCT00319748|Metastatic|metastatic
5750035|NCT00319748|852A|852a
5750036|NCT00319748|IRM|irm
5750037|NCT00319748|Oncology|oncology
5750038|NCT00319748|Metastatic Cervical Cancer|metastatic cervical cancer
5750039|NCT00319748|Metastatic Ovarian Cancer|metastatic ovarian cancer
5750040|NCT00319748|Metastatic Breast Cancer|metastatic breast cancer
5750041|NCT00319748|Metastatic Endometrial Cancer|metastatic endometrial cancer
5750042|NCT00319722|autism|autism
5750043|NCT00319722|pervasive developmental disorder|pervasive developmental disorder
5750044|NCT00319722|evoked potentials|evoked potentials
5750045|NCT00319722|EEG|eeg
5750046|NCT00319722|Coherence|coherence
5750047|NCT00319709|depression|depression
5750048|NCT00319709|antidepressive agents|antidepressive agents
5750049|NCT00319709|controlled clinical trial|controlled clinical trial
5750050|NCT00319696|digital ulcers|digital ulcers
5750051|NCT00319696|systemic sclerosis|systemic sclerosis
5750052|NCT00319696|finger ulcers|finger ulcers
5750053|NCT00319696|bosentan|bosentan
5750054|NCT00319696|open label|open label
5750055|NCT00319683|Cancer|cancer
5750057|NCT00319683|Neoplasms|neoplasms
5750058|NCT00319683|Anticarcinogenic Agents|anticarcinogenic agents
5750059|NCT00319683|Antineoplastic Agents|antineoplastic agents
5750060|NCT00319683|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
5750061|NCT00319670|constipation|constipation
5750062|NCT00319670|pediatric|pediatric
5750063|NCT00319657|Kidney Transplantation|kidney transplantation
5750064|NCT00319657|Blood Stem Cell Transplantation|blood stem cell transplantation
5750065|NCT00319631|Respiratory Distress Syndrome, Adult|respiratory distress syndrome, adult
5750066|NCT00319605|Cross sectional study|cross sectional study
5750067|NCT00319605|acceptability|acceptability
5750068|NCT00319605|levetiracetam|levetiracetam
5750069|NCT00319605|oral solution|oral solution
5750070|NCT00319605|Keppra|keppra
5750071|NCT00319592|Japanese encephalitis|japanese encephalitis
5750072|NCT00319592|ChimeriVax™-JE|chimerivax™-je
5750073|NCT00319592|JE-VAX®|je-vax®
5750074|NCT00319579|living kidney donors|living kidney donors
5750075|NCT00319579|prospective|prospective
5750076|NCT00319579|medical|medical
5750077|NCT00319579|psychosocial|psychosocial
5750078|NCT00319566|Coronary Heart Disease|coronary heart disease
5750079|NCT00319566|Hormone replacement therapy|hormone replacement therapy
5750080|NCT00319566|Estrogen|estrogen
5750081|NCT00319566|Postmenopausal women|postmenopausal women
5750083|NCT00319553|diphtheria|diphtheria
5750085|NCT00319540|Depression|depression
5750086|NCT00319540|psychoeducation|psychoeducation
5750087|NCT00319540|RCT|rct
5750088|NCT00319540|primary health services|primary health services
5750089|NCT00319527|long term outcome|long term outcome
5750090|NCT00319527|living kidney donor|living kidney donor
5750091|NCT00319501|Acute Repetitive Seizures|acute repetitive seizures
5750092|NCT00319501|ARS|ars
5750093|NCT00319501|Diazepam|diazepam
5750094|NCT00319501|Cluster Seizures|cluster seizures
5750095|NCT00319488|Wheezing|wheezing
5750096|NCT00319488|Respiratory Tract Illness|respiratory tract illness
5750097|NCT00319462|point A, cervical cancer, radiotherapy|point a, cervical cancer, radiotherapy
5750098|NCT00319436|parenting intervention|parenting intervention
5750099|NCT00319436|family intervention|family intervention
5750100|NCT00319436|maternal substance abuse|maternal substance abuse
5750101|NCT00319436|mother-child relations|mother-child relations
5750102|NCT00319436|parent-child relations|parent-child relations
5750103|NCT00319423|Hip Osteoarthritis, Exercise therapy, Patient Education|hip osteoarthritis, exercise therapy, patient education
5750104|NCT00319410|Menorrhagia|menorrhagia
5750105|NCT00319410|intrauterine diagnosis|intrauterine diagnosis
5750106|NCT00319410|visual analogue scale|visual analogue scale
5750107|NCT00319397|vascular resistance|vascular resistance
5750108|NCT00319397|vasomotion|vasomotion
5750109|NCT00319397|coronary disorder|coronary disorder
5750110|NCT00319397|hemodynamics|hemodynamics
5750111|NCT00319397|physical fitness|physical fitness
5750112|NCT00319384|congestive heart failure|congestive heart failure
5750113|NCT00319384|heart failure|heart failure
5750114|NCT00319384|ultrafiltration therapy|ultrafiltration therapy
5750115|NCT00319384|fluid overload|fluid overload
5750116|NCT00319371|vasospasm|vasospasm
5750117|NCT00319371|circadian|circadian
5750118|NCT00319371|sleep-disorders|sleep-disorders
5750119|NCT00319358|chronic pancreatitis|chronic pancreatitis
5750120|NCT00319358|antioxidant supplementation|antioxidant supplementation
5750121|NCT00319358|oxidative stress|oxidative stress
5750122|NCT00319345|Traumatic brain injury|traumatic brain injury
5750123|NCT00319345|Intracranial pressure|intracranial pressure
5750124|NCT00319345|Osmotherapy|osmotherapy
5750125|NCT00319345|Glasgow outcome score|glasgow outcome score
5750126|NCT00319345|Mannitol|mannitol
5750127|NCT00319345|Sodium-Lactate|sodium-lactate
5750128|NCT00319332|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5750129|NCT00319332|follicular lymphoma|follicular lymphoma
5750130|NCT00319332|BEXXAR|bexxar
5750131|NCT00319332|ZEVALIN|zevalin
5750132|NCT00319332|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5750133|NCT00319332|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5750134|NCT00319332|Follicular, mixed small-cleaved and large-cell|follicular, mixed small-cleaved and large-cell
5750135|NCT00319332|Diffuse large cell non-Hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma|diffuse large cell non-hodgkin's lymphoma following or concurrent with a diagnosis of follicular lymphoma
5750136|NCT00319319|major depressive disorder,|major depressive disorder,
5750137|NCT00319319|serotonin selective reuptake inhibitor,|serotonin selective reuptake inhibitor,
5750138|NCT00319319|mecamylamine,|mecamylamine,
5750139|NCT00319319|controlled trial,|controlled trial,
5750140|NCT00319319|cigarette smoking|cigarette smoking
5750141|NCT00319306|Respiratory Tract Diseases|respiratory tract diseases
5750142|NCT00319306|Bronchial Diseases|bronchial diseases
5750143|NCT00319306|Anti-asthmatic agents|anti-asthmatic agents
5750144|NCT00319306|Anti-asthmatic drugs|anti-asthmatic drugs
5750145|NCT00319306|Bronchodilators|bronchodilators
5750146|NCT00319280|Osteoarthritis, Knee|osteoarthritis, knee
5750147|NCT00319280|Osteotomy|osteotomy
5750148|NCT00319280|Healing|healing
5750149|NCT00319280|Roentgen Stereometric Analysis|roentgen stereometric analysis
5750150|NCT00319267|bosentan|bosentan
5750151|NCT00319267|children|children
5750152|NCT00319267|pharmacokinetics|pharmacokinetics
5750153|NCT00319267|pulmonary arterial hypertension|pulmonary arterial hypertension
5750154|NCT00319254|Advanced Breast Cancer|advanced breast cancer
5750155|NCT00319241|parenting intervention|parenting intervention
5750156|NCT00319241|substance abuse treatment|substance abuse treatment
5750157|NCT00319241|mother-child relations|mother-child relations
5750158|NCT00319241|parent-child relations|parent-child relations
5750159|NCT00319241|child abuse and neglect|child abuse and neglect
5750160|NCT00319228|AT-III deficiency|at-iii deficiency
5750161|NCT00319228|AT-III concentrate|at-iii concentrate
5750162|NCT00319228|Bleeding disorders|bleeding disorders
5750163|NCT00319228|Blood disorders|blood disorders
5750164|NCT00319215|ramelteon|ramelteon
5750165|NCT00319215|zopiclone|zopiclone
5750167|NCT00319215|memory|memory
5750168|NCT00319215|balance|balance
5750169|NCT00319215|psychomotor|psychomotor
5750170|NCT00319202|Impaired fasting glucose|impaired fasting glucose
5750171|NCT00319202|Abdominal obesity|abdominal obesity
5750172|NCT00319202|HOMA|homa
5750173|NCT00319202|Angiotensin-receptor blocker|angiotensin-receptor blocker
5750174|NCT00319189|Nateglinide|nateglinide
5750175|NCT00319189|Renal|renal
5750176|NCT00319189|Kidney|kidney
5750177|NCT00319189|Transplantation|transplantation
5750178|NCT00319189|Diabets|diabets
5750180|NCT00319176|Pregnancy|pregnancy
5750181|NCT00319176|Enoxaparin|enoxaparin
5750182|NCT00319176|Anticoagulation|anticoagulation
5750183|NCT00319163|oral contraceptive|oral contraceptive
5750184|NCT00319163|therapeutic equivalency|therapeutic equivalency
5750185|NCT00319163|contraceptives, oral, combined|contraceptives, oral, combined
5750186|NCT00319150|Erythropoetin resistance|erythropoetin resistance
5750187|NCT00319150|End Stage Renal Disease on hemodialysis|end stage renal disease on hemodialysis
5750188|NCT00319137|GW274150|gw274150
5750189|NCT00319137|Nitric Oxide|nitric oxide
5750190|NCT00319137|acute migraine|acute migraine
5750191|NCT00319124|Hip Osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life|hip osteoarthritis, muscle strength, range of motion, aerobic capacity, functional capacity, health-related quality of life
5750192|NCT00319111|pulmonary hypertension|pulmonary hypertension
5750193|NCT00319111|bosentan|bosentan
5750194|NCT00319111|BENEFIT|benefit
5750195|NCT00319111|CTEPH|cteph
5751049|NCT00316017|Shock|shock
5750196|NCT00319111|inoperable chronic thromboembolic pulmonary hypertension (CTEPH)|inoperable chronic thromboembolic pulmonary hypertension (cteph)
5750197|NCT00319098|Adjuvanted pandemic influenza candidate vaccine|adjuvanted pandemic influenza candidate vaccine
5750198|NCT00319098|Influenza|influenza
5750199|NCT00319085|Arthroplasty,|arthroplasty,
5750201|NCT00319085|Pre-heating,|pre-heating,
5750202|NCT00319085|Radiostereometric analysis,|radiostereometric analysis,
5750203|NCT00319085|Dual-Energy Radiographic Absorptiometry,|dual-energy radiographic absorptiometry,
5750204|NCT00319046|enzyme replacement therapy|enzyme replacement therapy
5750205|NCT00319046|Type 1 Gaucher Disease|type 1 gaucher disease
5750206|NCT00319046|miglustat|miglustat
5750207|NCT00319033|interstitial lung disease|interstitial lung disease
5750208|NCT00319033|scleroderma|scleroderma
5750209|NCT00319033|bosentan|bosentan
5750210|NCT00319020|bosentan|bosentan
5750211|NCT00319020|pulmonary arterial hypertension|pulmonary arterial hypertension
5750212|NCT00319020|children|children
5750213|NCT00319020|FUTURE 1|future 1
5750214|NCT00318981|Medication trial|medication trial
5750216|NCT00318981|Concerta|concerta
5750217|NCT00318981|Efficacy trial|efficacy trial
5750218|NCT00318968|Acid Reflux|acid reflux
5750219|NCT00318968|Nexium|nexium
5750220|NCT00318968|Esomeprazole|esomeprazole
5750221|NCT00318955|Dexmedetomidine, Sedation, Extubation, Phase 4|dexmedetomidine, sedation, extubation, phase 4
5750222|NCT00318942|Sepsis|sepsis
5750223|NCT00318942|Multiple Trauma|multiple trauma
5750224|NCT00318942|Hypovolemic Shock|hypovolemic shock
5750225|NCT00318929|Treatment Efficacy|treatment efficacy
5750226|NCT00318929|pharmacokinetics|pharmacokinetics
5750227|NCT00318903|Chemotherapy for cancer of the esophagus|chemotherapy for cancer of the esophagus
5750228|NCT00318903|Radiotherapy for cancer of the esophagus|radiotherapy for cancer of the esophagus
5750229|NCT00318903|Surgery for cancer of the esophagus|surgery for cancer of the esophagus
5750230|NCT00318903|Chemotherapy, radiotherapy, surgery for esophageal cancer|chemotherapy, radiotherapy, surgery for esophageal cancer
5750231|NCT00318890|Chemotherapy and Radiotherapy for Head and Neck Cancer|chemotherapy and radiotherapy for head and neck cancer
5750232|NCT00318890|Chemotherapy, Radiotherapy Squamous Cell Carcinoma Head Neck|chemotherapy, radiotherapy squamous cell carcinoma head neck
5750233|NCT00318877|Obesity|obesity
5750234|NCT00318877|Physical activity|physical activity
5750235|NCT00318864|depression|depression
5750236|NCT00318864|cardiovascular risk|cardiovascular risk
5750237|NCT00318864|mechanisms|mechanisms
5750238|NCT00318851|Carotid Artery stenting|carotid artery stenting
5750239|NCT00318851|Stroke|stroke
5750240|NCT00318825|Pain|pain
5750241|NCT00318825|Colonoscopy|colonoscopy
5750242|NCT00318825|Sedation|sedation
5750243|NCT00318812|Randomized controlled trial (RCT)|randomized controlled trial (rct)
5750244|NCT00318812|Prospective Studies|prospective studies
5750245|NCT00318812|ferric oxide, saccharated|ferric oxide, saccharated
5750246|NCT00318812|Peptides|peptides
5750247|NCT00318812|Heme|heme
5750248|NCT00318812|Iron|iron
5750249|NCT00318812|Erythropoietin,|erythropoietin,
5750250|NCT00318812|Recombinant|recombinant
5750251|NCT00318812|Ferritin|ferritin
5750252|NCT00318812|Transferrin|transferrin
5750253|NCT00318812|Treatment Outcome|treatment outcome
5750254|NCT00318799|prevention of unintended pregnancies|prevention of unintended pregnancies
5750256|NCT00318773|PMDD|pmdd
5750257|NCT00318773|sertraline|sertraline
5750258|NCT00318773|antidepressant|antidepressant
5750259|NCT00318773|extended treatment|extended treatment
5750260|NCT00318773|relapse|relapse
5750261|NCT00318760|Drug Cue|drug cue
5750262|NCT00318760|Relapse|relapse
5750263|NCT00318760|Stress|stress
5750264|NCT00318760|Craving|craving
5750368|NCT00318292|paracervical block|paracervical block
5750474|NCT00317902|Anemia|anemia
5750265|NCT00318747|Amb a 1-Immunostimulatory Oligodeoxyribonucleotide Conjugate|amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate
5750266|NCT00318747|AIC|aic
5750267|NCT00318747|Amb a I Protein|amb a i protein
5750268|NCT00318747|Ragweed Allergy|ragweed allergy
5750269|NCT00318747|Hay Fever|hay fever
5750270|NCT00318747|Wheeze|wheeze
5750272|NCT00318747|Tolerance|tolerance
5750273|NCT00318747|Immunostimulatory|immunostimulatory
5750274|NCT00318747|Ragweed Season|ragweed season
5750275|NCT00318747|Asthma|asthma
5750276|NCT00318747|Asthmatics|asthmatics
5750277|NCT00318747|Asthmatic|asthmatic
5750278|NCT00318721|Leishmania donovani|leishmania donovani
5750279|NCT00318721|cluster-randomised control trial|cluster-randomised control trial
5750280|NCT00318721|Long Lasting Impregnated Nets|long lasting impregnated nets
5750281|NCT00318721|Bednets|bednets
5750282|NCT00318721|Sandflies|sandflies
5750283|NCT00318695|Probiotics|probiotics
5750284|NCT00318695|Eczema|eczema
5750285|NCT00318695|Asthma|asthma
5750286|NCT00318695|Allergic Rhinitis|allergic rhinitis
5750287|NCT00318695|Prevention|prevention
5750288|NCT00318695|Immunological responses|immunological responses
5750289|NCT00318682|biopsy|biopsy
5750290|NCT00318682|FIBROSCAN|fibroscan
5750291|NCT00318669|Anxiety|anxiety
5750292|NCT00318669|SAD|sad
5750293|NCT00318669|Social|social
5750294|NCT00318669|Disorder|disorder
5750295|NCT00318656|type 2 diabetes|type 2 diabetes
5750296|NCT00318656|rosiglitazone|rosiglitazone
5750297|NCT00318656|metformin|metformin
5750298|NCT00318656|glimepiride|glimepiride
5750299|NCT00318656|glycemia|glycemia
5750300|NCT00318643|Non-invasive bladder cancer|non-invasive bladder cancer
5750301|NCT00318643|Chemophase|chemophase
5750302|NCT00318643|Intravesical administration|intravesical administration
5750303|NCT00318643|Superficial Bladder Cancer|superficial bladder cancer
5750304|NCT00318630|Asthma AVANDIA Inflammation|asthma avandia inflammation
5750305|NCT00318617|peroxisome proliferator activated receptors,|peroxisome proliferator activated receptors,
5750306|NCT00318617|PPARs,|ppars,
5750307|NCT00318617|Heart Failure,|heart failure,
5750308|NCT00318617|cardiac energetics,|cardiac energetics,
5750309|NCT00318617|MRI,|mri,
5750310|NCT00318617|GW501516X|gw501516x
5750311|NCT00318617|fatty acid metabolism,|fatty acid metabolism,
5686298|NCT00552643|Granulation tissue|granulation tissue
5750312|NCT00318604|plasma circulating DNA|plasma circulating dna
5750313|NCT00318604|hean and neck cancers|hean and neck cancers
5750314|NCT00318604|esophageal cancer|esophageal cancer
5750315|NCT00318604|localized head and neck cancers|localized head and neck cancers
5750316|NCT00318604|localized esophageal cancer|localized esophageal cancer
5750317|NCT00318578|convulsive status epilepticus|convulsive status epilepticus
5750318|NCT00318578|outcome|outcome
5750319|NCT00318578|prognosis factors|prognosis factors
5750320|NCT00318578|seizure duration|seizure duration
5750321|NCT00318578|adult|adult
5750322|NCT00318578|electroencephalogram|electroencephalogram
5750323|NCT00318578|intensive care unit|intensive care unit
5750324|NCT00318565|Heart Disease|heart disease
5750325|NCT00318565|Atrial Flutter|atrial flutter
5750326|NCT00318565|Typical Atrial Flutter|typical atrial flutter
5750327|NCT00318552|Antibiotic Therapy|antibiotic therapy
5750328|NCT00318552|sepsis treatment|sepsis treatment
5750329|NCT00318552|Meropenem|meropenem
5750330|NCT00318539|Obsessive Compulsive Disorder|obsessive compulsive disorder
5750331|NCT00318513|breast cancer|breast cancer
5750332|NCT00318513|lymphedema|lymphedema
5750333|NCT00318513|extremity|extremity
5750334|NCT00318513|women|women
5750335|NCT00318500|Endometriosis|endometriosis
5750336|NCT00318500|Dysmenorrhea|dysmenorrhea
5750337|NCT00318500|Pelvic pain|pelvic pain
5750338|NCT00318500|Dyspareunia|dyspareunia
5750339|NCT00318487|Dental implants|dental implants
5750340|NCT00318474|Proteinuria|proteinuria
5750341|NCT00318474|Immunoglobulin A|immunoglobulin a
5750342|NCT00318448|Child Psychology|child psychology
5750343|NCT00318448|Pediatric Psychology|pediatric psychology
5750344|NCT00318448|Insomnia|insomnia
5750345|NCT00318448|Sleeplessness|sleeplessness
5750346|NCT00318409|Methamphetamine|methamphetamine
5750347|NCT00318409|HIV|hiv
5750348|NCT00318396|THA|tha
5750349|NCT00318383|Vaccine|vaccine
5750350|NCT00318383|Immunogenicity|immunogenicity
5750351|NCT00318383|Randomized Controlled Trial|randomized controlled trial
5750352|NCT00318370|Ovarian Cancer|ovarian cancer
5750353|NCT00318370|Primary Fallopian Tube Cancer|primary fallopian tube cancer
5750354|NCT00318370|Peritoneal Cancer|peritoneal cancer
5750355|NCT00318357|Cardiac Resynchronization therapy (CRT)|cardiac resynchronization therapy (crt)
5750356|NCT00318357|All-cause mortality|all-cause mortality
5750357|NCT00318357|Long-term follow-up|long-term follow-up
5750358|NCT00318331|Glutamine|glutamine
5750359|NCT00318331|Critical Illness|critical illness
5750360|NCT00318331|Enteral Feeding|enteral feeding
5750361|NCT00318331|Blood Volume Analysis|blood volume analysis
5750362|NCT00318318|Premarin,|premarin,
5750363|NCT00318318|HRT,|hrt,
5750364|NCT00318318|RNA,|rna,
5750365|NCT00318318|Gene Expression.|gene expression.
5750366|NCT00318318|Postmenopausal Women|postmenopausal women
5750367|NCT00318292|preemptive analgesia|preemptive analgesia
5750369|NCT00318292|vaginal hysterectomy|vaginal hysterectomy
5750370|NCT00318279|Surgical education|surgical education
5750371|NCT00318279|Vascular anastomosis|vascular anastomosis
5750372|NCT00318279|Simulator|simulator
5750373|NCT00318279|Randomized controlled trial|randomized controlled trial
5750374|NCT00318266|Detection of Bladder Cancer using NMP22 Urine Test Kit|detection of bladder cancer using nmp22 urine test kit
5750375|NCT00318253|Cranberry juice|cranberry juice
5750376|NCT00318253|Antiadhesion|antiadhesion
5750377|NCT00318253|Urinary tract infection|urinary tract infection
5750379|NCT00318240|High Intensity Focused Ultrasound|high intensity focused ultrasound
5750380|NCT00318240|Men|men
5750381|NCT00318240|Locally recurrent prostate cancer.|locally recurrent prostate cancer.
5750382|NCT00318227|Postoperative care|postoperative care
5750383|NCT00318227|Cardiac Surgery|cardiac surgery
5750384|NCT00318227|Blood Transfusion|blood transfusion
5750385|NCT00318214|toe ulcer|toe ulcer
5750386|NCT00318214|heel ulcer|heel ulcer
5750387|NCT00318214|foot ulcer|foot ulcer
5750388|NCT00318214|diabetic feet|diabetic feet
5750389|NCT00318214|diabetic foot|diabetic foot
5750390|NCT00318214|complications of diabetes|complications of diabetes
5750391|NCT00318201|Healthy Subjects|healthy subjects
5750392|NCT00318188|scleroderma|scleroderma
5750393|NCT00318188|HAQ|haq
5751050|NCT00316004|Traumatic|traumatic
5750394|NCT00318188|Intensive care reeducation, readaptation|intensive care reeducation, readaptation
5750395|NCT00318175|Systemic Scleroderma|systemic scleroderma
5750396|NCT00318175|Dermal Sclerosis|dermal sclerosis
5750397|NCT00318175|Bosentan|bosentan
5750398|NCT00318175|Endothelin Receptor Antagonist|endothelin receptor antagonist
5750399|NCT00318175|Rodnan Skin Score|rodnan skin score
5750400|NCT00318162|autism|autism
5750401|NCT00318162|PDD|pdd
5750402|NCT00318162|LDN|ldn
5750403|NCT00318162|naltrexone|naltrexone
5750404|NCT00318136|BRIDGE|bridge
5750405|NCT00318136|NSCLC|nsclc
5750406|NCT00318136|Lung Cancer|lung cancer
5750407|NCT00318136|Avastin|avastin
5750408|NCT00318123|Simplification therapy|simplification therapy
5750409|NCT00318123|Efficacy|efficacy
5750410|NCT00318123|Safety|safety
5750411|NCT00318123|Virological effectiveness|virological effectiveness
5750412|NCT00318123|Immunological effectiveness|immunological effectiveness
5750414|NCT00318110|Metastatic|metastatic
5750415|NCT00318110|Renal|renal
5750416|NCT00318110|Cell|cell
5750417|NCT00318110|Carcinoma|carcinoma
5750418|NCT00318110|Unrelated|unrelated
5750419|NCT00318110|Donor|donor
5750420|NCT00318110|Transplant|transplant
5750421|NCT00318110|stage IV|stage iv
5750422|NCT00318110|clear cell|clear cell
5750423|NCT00318097|McCune Albright Syndrome|mccune albright syndrome
5750424|NCT00318097|Histamine regulation|histamine regulation
5750425|NCT00318084|Gastroesophageal reflux disease|gastroesophageal reflux disease
5750426|NCT00318084|Heartburn|heartburn
5750427|NCT00318084|Acid-related diseases|acid-related diseases
5750428|NCT00318084|Acid reflux disease|acid reflux disease
5750429|NCT00318084|Nexium|nexium
5750430|NCT00318071|Stroke|stroke
5750431|NCT00318071|Ischemic|ischemic
5750432|NCT00318071|Thrombus|thrombus
5750433|NCT00318071|Embolectomy|embolectomy
5750434|NCT00318071|Thrombectomy|thrombectomy
5750435|NCT00318071|Merci|merci
5750436|NCT00318071|Concentric|concentric
5750437|NCT00318071|Embolus|embolus
5750438|NCT00318071|Embolism|embolism
5750439|NCT00318071|Mechanical|mechanical
5750440|NCT00318045|Refractive error|refractive error
5750441|NCT00318045|Asthenopia|asthenopia
5750442|NCT00318032|Randomised control trial|randomised control trial
5750443|NCT00318032|Screening|screening
5750444|NCT00318032|Intensive management|intensive management
5750445|NCT00318032|Diabetes mellitus|diabetes mellitus
5750446|NCT00318032|Type 2 diabetes|type 2 diabetes
5750447|NCT00318019|Energy|energy
5750448|NCT00318019|Energy Level|energy level
5750449|NCT00318006|chronic|chronic
5750450|NCT00318006|nasal|nasal
5750451|NCT00318006|sinus|sinus
5750452|NCT00318006|symptoms|symptoms
5750453|NCT00317980|Cutaneous leishmaniasis|cutaneous leishmaniasis
5750454|NCT00317980|Leishmania braziliensis|leishmania braziliensis
5750455|NCT00317980|Pentavalent antimony|pentavalent antimony
5750456|NCT00317980|Meglumine antimoniate|meglumine antimoniate
5750457|NCT00317967|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5750458|NCT00317967|Statin therapy|statin therapy
5750459|NCT00317967|Regression|regression
5750460|NCT00317967|Heart failure|heart failure
5750461|NCT00317967|Arrhythmias|arrhythmias
5750462|NCT00317967|Sudden cardiac death|sudden cardiac death
5750463|NCT00317954|Diabetic nephropathy|diabetic nephropathy
5750464|NCT00317954|Spironolactone|spironolactone
5750465|NCT00317954|Aldosterone antagonism|aldosterone antagonism
5750466|NCT00317954|Renoprotection|renoprotection
5750467|NCT00317941|Multiple Sclerosis|multiple sclerosis
5750468|NCT00317941|RRMS|rrms
5750469|NCT00317928|Polycystic Ovary Syndrome|polycystic ovary syndrome
5750470|NCT00317928|Metformin|metformin
5750471|NCT00317928|Metabolic Syndrome|metabolic syndrome
5750472|NCT00317928|Hyperandrogenism|hyperandrogenism
5750475|NCT00317902|erythropoetin|erythropoetin
5750476|NCT00317902|Epoetin alfa|epoetin alfa
5750477|NCT00317902|erythropoetin recombinant|erythropoetin recombinant
5750478|NCT00317902|HIV, AIDS|hiv, aids
5750479|NCT00317889|THA|tha
5750481|NCT00317837|Fracture of Femoral Neck|fracture of femoral neck
5750482|NCT00317811|stage I multiple myeloma|stage i multiple myeloma
5750483|NCT00317811|stage II multiple myeloma|stage ii multiple myeloma
5750484|NCT00317811|stage III multiple myeloma|stage iii multiple myeloma
5750485|NCT00317798|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5750486|NCT00317798|stage I multiple myeloma|stage i multiple myeloma
5750487|NCT00317798|stage II multiple myeloma|stage ii multiple myeloma
5750488|NCT00317798|stage III multiple myeloma|stage iii multiple myeloma
5750489|NCT00317798|refractory multiple myeloma|refractory multiple myeloma
5750490|NCT00317785|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5750491|NCT00317785|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5750492|NCT00317785|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5750493|NCT00317785|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5751847|NCT00312923|HIV|hiv
5750494|NCT00317785|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5750495|NCT00317785|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5750496|NCT00317785|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5750497|NCT00317785|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5750498|NCT00317785|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5750499|NCT00317785|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5750500|NCT00317785|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5750501|NCT00317785|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5750502|NCT00317785|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5750503|NCT00317785|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5750504|NCT00317785|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5750505|NCT00317785|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5750506|NCT00317785|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5750507|NCT00317785|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5750508|NCT00317785|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5750509|NCT00317785|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5750510|NCT00317785|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5750511|NCT00317785|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5750512|NCT00317785|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5750513|NCT00317785|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5750514|NCT00317785|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5750515|NCT00317785|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5750516|NCT00317785|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5750517|NCT00317785|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5750518|NCT00317785|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5750519|NCT00317785|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5750520|NCT00317785|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5750521|NCT00317785|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5750522|NCT00317785|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5750523|NCT00317785|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5750524|NCT00317785|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5750525|NCT00317785|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5750526|NCT00317785|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5750527|NCT00317785|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5750528|NCT00317785|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5750529|NCT00317785|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5750530|NCT00317785|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5750531|NCT00317785|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5750532|NCT00317785|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5750533|NCT00317785|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5750534|NCT00317785|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5750535|NCT00317785|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5750536|NCT00317785|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5750537|NCT00317785|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5750538|NCT00317785|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5750539|NCT00317785|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5750540|NCT00317785|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5750541|NCT00317785|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5750542|NCT00317785|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5750543|NCT00317785|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5750544|NCT00317785|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5750545|NCT00317785|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5750546|NCT00317785|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5750547|NCT00317785|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5750548|NCT00317785|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5750549|NCT00317785|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5750550|NCT00317785|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5750551|NCT00317785|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5750552|NCT00317785|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5750553|NCT00317785|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5750554|NCT00317785|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5750555|NCT00317785|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5750556|NCT00317785|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5750557|NCT00317785|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5750558|NCT00317785|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5750559|NCT00317785|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5750560|NCT00317785|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5750561|NCT00317785|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5750562|NCT00317785|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5750563|NCT00317772|Epithelial Ovarian Cancer|epithelial ovarian cancer
5750564|NCT00317772|Peritoneal Cancer|peritoneal cancer
5750565|NCT00317772|Fallopian Tube Cancer|fallopian tube cancer
5750566|NCT00317772|Epidermal Growth Factor|epidermal growth factor
5750567|NCT00317772|Platinum Hypersensitivity|platinum hypersensitivity
5686299|NCT00552643|Polyheal 1|polyheal 1
5750571|NCT00317772|Topotecan|topotecan
5750573|NCT00317759|stage IV melanoma|stage iv melanoma
5750574|NCT00317759|recurrent melanoma|recurrent melanoma
5750575|NCT00317746|HIV/HCV Co-infection|hiv/hcv co-infection
5750576|NCT00317746|Depression|depression
5750577|NCT00317746|Citalopram|citalopram
5750578|NCT00317733|Ketoprofen|ketoprofen
5750579|NCT00317733|Transfersome|transfersome
5750580|NCT00317733|Osteoarthritis, Knee|osteoarthritis, knee
5750581|NCT00317720|Breast Cancer|breast cancer
5750582|NCT00317720|Metastatic Breast Cancer|metastatic breast cancer
5750583|NCT00317720|Trastuzumab|trastuzumab
5750585|NCT00317720|Herceptin|herceptin
5750586|NCT00317707|cardiovascular risk|cardiovascular risk
5750587|NCT00317707|cardiovascular diseases|cardiovascular diseases
5750588|NCT00317707|cardiovascular prevention|cardiovascular prevention
5750589|NCT00317707|polyunsaturated fatty acids|polyunsaturated fatty acids
5750590|NCT00317707|diabetes|diabetes
5750591|NCT00317707|hypertension|hypertension
5750592|NCT00317707|hypercholesterolemia|hypercholesterolemia
5750593|NCT00317707|obesity|obesity
5750594|NCT00317694|Hyperphosphatemia|hyperphosphatemia
5750595|NCT00317694|Phosphate binder|phosphate binder
5750596|NCT00317681|Cutaneous lupus erythematosus|cutaneous lupus erythematosus
5750597|NCT00317681|Tacrolimus ointment|tacrolimus ointment
5750598|NCT00317681|Topical treatment|topical treatment
5750599|NCT00317681|Skin lesions|skin lesions
5750600|NCT00317655|back pain|back pain
5750601|NCT00317642|acute myelogenous leukemia|acute myelogenous leukemia
5750602|NCT00317642|acute myeloid leukemia|acute myeloid leukemia
5750603|NCT00317642|relapsed AML|relapsed aml
5750604|NCT00317642|refractory AML|refractory aml
5750605|NCT00317642|clofarabine|clofarabine
5750606|NCT00317642|cytarabine|cytarabine
5750607|NCT00317642|CLO341|clo341
5750608|NCT00317642|clolar|clolar
5750609|NCT00317629|leishmaniasis|leishmaniasis
5750610|NCT00317629|nitric oxide|nitric oxide
5750611|NCT00317629|treatment|treatment
5750612|NCT00317629|donor|donor
5750613|NCT00317629|controlled trial|controlled trial
5750614|NCT00317616|FALS|fals
5750615|NCT00317616|SOD1|sod1
5750616|NCT00317616|familial|familial
5750617|NCT00317616|genetic testing|genetic testing
5750618|NCT00317616|genetic counseling|genetic counseling
5750620|NCT00317616|C9ORF72|c9orf72
5750621|NCT00317616|TARDBP|tardbp
5750622|NCT00317616|VCP|vcp
5750623|NCT00317616|FUS|fus
5750624|NCT00317616|PFN1|pfn1
5750625|NCT00317603|autologous vaccination|autologous vaccination
5750626|NCT00317603|GM-CSF|gm-csf
5750627|NCT00317603|adenoviral mediated gene transfer|adenoviral mediated gene transfer
5750628|NCT00317603|Stage IV breast cancer|stage iv breast cancer
5750629|NCT00317590|Diagnosis|diagnosis
5750630|NCT00317590|Rapid Diagnostic Test|rapid diagnostic test
5750632|NCT00317590|Attributable Fraction|attributable fraction
5750633|NCT00317590|Threshold|threshold
5750634|NCT00317577|Low-pressure glaucoma|low-pressure glaucoma
5740321|NCT00357058|HV|hv
5750635|NCT00317577|Normal tension glaucoma|normal tension glaucoma
5750636|NCT00317577|Neuroprotection|neuroprotection
5750637|NCT00317577|Brimonidine|brimonidine
5750638|NCT00317577|Visual field progression|visual field progression
5750639|NCT00317564|Birth Defects|birth defects
5750640|NCT00317564|High Risk Pregnancy|high risk pregnancy
5750641|NCT00317564|Multiple Sclerosis|multiple sclerosis
5750642|NCT00317551|Aberration control|aberration control
5750643|NCT00317551|Accommodative facility|accommodative facility
5750644|NCT00317551|Accommodative response|accommodative response
5750645|NCT00317551|Peripheral refraction|peripheral refraction
5750646|NCT00317551|Accommodative convergence to accommodation ratio|accommodative convergence to accommodation ratio
5750647|NCT00317538|Rheumatoid Arthritis|rheumatoid arthritis
5750648|NCT00317538|Switching|switching
5750649|NCT00317538|Structural Damage|structural damage
5750650|NCT00317538|MRI|mri
5750651|NCT00317525|Refractive error|refractive error
5750652|NCT00317525|Asthenopia|asthenopia
5750653|NCT00317512|Hemoglobin Based Oxygen carrier|hemoglobin based oxygen carrier
5750655|NCT00317512|Percutaneous Revascularization|percutaneous revascularization
5750656|NCT00317512|Percutaneous Coronary Intervention|percutaneous coronary intervention
5750657|NCT00317512|Non ST-segment Elevation Myocardial Infarction|non st-segment elevation myocardial infarction
5750658|NCT00317512|Tissue Oxygenation|tissue oxygenation
5750659|NCT00317512|Transluminal Percutaneous Coronary Angioplasty|transluminal percutaneous coronary angioplasty
5750660|NCT00317486|pulmonary arterial hypertension|pulmonary arterial hypertension
5750661|NCT00317486|Eisenmenger physiology|eisenmenger physiology
5750662|NCT00317486|bosentan|bosentan
5750663|NCT00317473|Vaccine|vaccine
5750664|NCT00317473|Phase 1|phase 1
5750665|NCT00317473|Plasmodium falciparum|plasmodium falciparum
5750666|NCT00317473|Malaria|malaria
5750667|NCT00317473|Merozoite surface protein-1|merozoite surface protein-1
5750668|NCT00317473|MSP-1|msp-1
5750669|NCT00317473|Falciparum malaria protein 1|falciparum malaria protein 1
5750670|NCT00317473|FMP-1|fmp-1
5750671|NCT00317473|AS02A|as02a
5750672|NCT00317460|Drug Abuse|drug abuse
5750673|NCT00317460|Drug Addiction|drug addiction
5686300|NCT00552643|Wound care|wound care
5750674|NCT00317460|Drug Dependence|drug dependence
5750675|NCT00317460|Drug Use Disorders|drug use disorders
5750676|NCT00317460|Drug Use Disorder|drug use disorder
5750677|NCT00317460|Substance Abuse|substance abuse
5750678|NCT00317460|Substance Use Disorder|substance use disorder
5750679|NCT00317460|Buprenorphine|buprenorphine
5750680|NCT00317460|Opiate Addiction|opiate addiction
5750681|NCT00317447|Sciatica|sciatica
5750682|NCT00317447|Lower back pain|lower back pain
5750683|NCT00317447|Prednisone|prednisone
5750684|NCT00317447|Randomized, controlled clinical trial|randomized, controlled clinical trial
5750685|NCT00317434|ovarian cancer|ovarian cancer
5750686|NCT00317421|Phosphodiesterase 5|phosphodiesterase 5
5750687|NCT00317421|Sildenafil|sildenafil
5750688|NCT00317421|Hypertension|hypertension
5750689|NCT00317421|Blood pressure|blood pressure
5750690|NCT00317421|Arterial stiffness|arterial stiffness
5750691|NCT00317421|Endothelial function|endothelial function
5750692|NCT00317408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5750693|NCT00317408|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5750694|NCT00317408|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5750695|NCT00317408|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5750696|NCT00317395|Non ST elevation Acute Coronary Syndrome|non st elevation acute coronary syndrome
5750697|NCT00317395|Early invasive strategy|early invasive strategy
5750698|NCT00317395|Percutaneous Coronary Intervention|percutaneous coronary intervention
5750699|NCT00317382|lumbar puncture|lumbar puncture
5750700|NCT00317382|headache|headache
5750701|NCT00317382|traumatic tap|traumatic tap
5750702|NCT00317369|OPC-6535|opc-6535
5750703|NCT00317369|Crohn's disease|crohn's disease
5750704|NCT00317356|OPC-6535|opc-6535
5750705|NCT00317356|ulcerative colitis|ulcerative colitis
5750827|NCT00316875|recurrent breast cancer|recurrent breast cancer
5750706|NCT00317343|Patients candidate to a PCI with a planned anticoagulation regime other than unfractionated heparin in monotherapy|patients candidate to a pci with a planned anticoagulation regime other than unfractionated heparin in monotherapy
5750708|NCT00317317|Acupuncture|acupuncture
5750709|NCT00317317|Pregnant|pregnant
5750710|NCT00317304|Hot flashes|hot flashes
5750711|NCT00317304|vasomotor symptoms|vasomotor symptoms
5750712|NCT00317304|menopause|menopause
5750713|NCT00317304|mindfulness based stress reduction|mindfulness based stress reduction
5750714|NCT00317304|meditation|meditation
5750715|NCT00317291|Acupuncture|acupuncture
5750716|NCT00317291|HIV|hiv
5750717|NCT00317291|AIDS|aids
5750718|NCT00317291|Symptom management|symptom management
5750719|NCT00317291|Non-invasive|non-invasive
5750720|NCT00317291|Complementary Therapies|complementary therapies
5750721|NCT00317291|Treatment Experienced|treatment experienced
5750722|NCT00317278|Massage|massage
5750723|NCT00317278|immune system|immune system
5750724|NCT00317278|preterm infants|preterm infants
5750725|NCT00317265|coronary artery disease|coronary artery disease
5750726|NCT00317265|coronary bypass surgery|coronary bypass surgery
5750727|NCT00317265|complete arterial coronary surgery|complete arterial coronary surgery
5750728|NCT00317265|internal mammary artery|internal mammary artery
5750729|NCT00317252|contrast induced nephropathy|contrast induced nephropathy
5750730|NCT00317252|contrast nephropathy|contrast nephropathy
5750731|NCT00317252|contrast media|contrast media
5750732|NCT00317252|kidney diseases|kidney diseases
5750733|NCT00317252|angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5750735|NCT00317239|Chronic Kidney Disease|chronic kidney disease
5750736|NCT00317239|Iron|iron
5750737|NCT00317226|Anemia|anemia
5750738|NCT00317226|CKD|ckd
5750739|NCT00317226|Chronic Kidney Disease|chronic kidney disease
5750740|NCT00317226|Iron|iron
5750741|NCT00317226|Maintenance Dose|maintenance dose
5750742|NCT00317213|Smoking|smoking
5750743|NCT00317213|Nicotine|nicotine
5750744|NCT00317213|Withdrawal|withdrawal
5750745|NCT00317213|Phospholipids|phospholipids
5750746|NCT00317213|Cell membrane fluidity|cell membrane fluidity
5750747|NCT00317213|Smoking cessation|smoking cessation
5750750|NCT00317148|Quality of Life|quality of life
5750751|NCT00317148|Hot flushes|hot flushes
5750752|NCT00317109|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
5750753|NCT00317109|tetanus|tetanus
5750754|NCT00317109|hepatitis B|hepatitis b
5750755|NCT00317109|pertussis|pertussis
5750756|NCT00317109|Haemophilus influenzae type b|haemophilus influenzae type b
5750757|NCT00317109|meningococcal vaccine|meningococcal vaccine
5750758|NCT00317109|Prophylaxis diphtheria|prophylaxis diphtheria
5750759|NCT00317096|Drug Therapy|drug therapy
5750760|NCT00317096|Maintenance|maintenance
5750761|NCT00317096|rituximab|rituximab
5750762|NCT00317083|Cough Reflex|cough reflex
5750764|NCT00317083|Obesity|obesity
5750765|NCT00317083|Sleep apnea syndrome|sleep apnea syndrome
5750766|NCT00317070|PBS/IC|pbs/ic
5750767|NCT00317070|Painful bladder syndrome including Interstitial cystitis|painful bladder syndrome including interstitial cystitis
5750768|NCT00317057|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5750769|NCT00317057|Outpatient management|outpatient management
5749851|NCT00320450|CRP|crp
5750770|NCT00317057|nurse-lead patient education|nurse-lead patient education
5750771|NCT00317044|Moderate to severe Asthma|moderate to severe asthma
5750772|NCT00317044|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5750773|NCT00317044|esomeprazole|esomeprazole
5750774|NCT00317044|GERD|gerd
5750775|NCT00317031|Alcoholism|alcoholism
5750776|NCT00317031|Drug Therapy|drug therapy
5750777|NCT00317018|depression|depression
5750778|NCT00317018|quality improvement|quality improvement
5750779|NCT00317018|implementation|implementation
5750780|NCT00317018|translation|translation
5750781|NCT00317018|evidence-based practice|evidence-based practice
5750782|NCT00317018|collaborative care|collaborative care
5750783|NCT00317018|adoption|adoption
5750784|NCT00317018|sustainability|sustainability
5750785|NCT00317018|cost-effectiveness|cost-effectiveness
5750786|NCT00317018|rural|rural
5750787|NCT00317005|hemodialysis|hemodialysis
5750788|NCT00317005|chronic uremia|chronic uremia
5750789|NCT00317005|hyperhomocysteinemia|hyperhomocysteinemia
5750790|NCT00317005|folate|folate
5750791|NCT00316992|Insomnia|insomnia
5750792|NCT00316992|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5750793|NCT00316992|Drug Therapy|drug therapy
5750794|NCT00316979|migraine|migraine
5750795|NCT00316979|transcranial magnetic stimulation|transcranial magnetic stimulation
5750796|NCT00316979|repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5750797|NCT00316979|rTMS|rtms
5750798|NCT00316966|Nutritional status, dietary intervention, health care use, costs|nutritional status, dietary intervention, health care use, costs
5750799|NCT00316940|stage I multiple myeloma|stage i multiple myeloma
5750800|NCT00316940|stage II multiple myeloma|stage ii multiple myeloma
5750801|NCT00316940|stage III multiple myeloma|stage iii multiple myeloma
5750802|NCT00316940|refractory multiple myeloma|refractory multiple myeloma
5750803|NCT00316927|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5750804|NCT00316927|stage III prostate cancer|stage iii prostate cancer
5750805|NCT00316927|stage IV prostate cancer|stage iv prostate cancer
5750806|NCT00316914|neurotoxicity|neurotoxicity
5750807|NCT00316914|stage II colon cancer|stage ii colon cancer
5750808|NCT00316914|stage III colon cancer|stage iii colon cancer
5750809|NCT00316914|adenocarcinoma of the colon|adenocarcinoma of the colon
5750810|NCT00316914|stage II rectal cancer|stage ii rectal cancer
5750811|NCT00316914|stage III rectal cancer|stage iii rectal cancer
5750812|NCT00316914|stage IV rectal cancer|stage iv rectal cancer
5750813|NCT00316914|stage IV colon cancer|stage iv colon cancer
5750814|NCT00316914|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5750815|NCT00316901|stage IV renal cell cancer|stage iv renal cell cancer
5750816|NCT00316901|stage IV melanoma|stage iv melanoma
5750817|NCT00316901|recurrent melanoma|recurrent melanoma
5750818|NCT00316901|recurrent renal cell cancer|recurrent renal cell cancer
5750819|NCT00316888|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5750820|NCT00316888|stage I anal cancer|stage i anal cancer
5750821|NCT00316888|stage II anal cancer|stage ii anal cancer
5750822|NCT00316888|stage IIIA anal cancer|stage iiia anal cancer
5750823|NCT00316888|stage IIIB anal cancer|stage iiib anal cancer
5750824|NCT00316888|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5750825|NCT00316888|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5750826|NCT00316875|stage IV breast cancer|stage iv breast cancer
5750828|NCT00316875|male breast cancer|male breast cancer
5750829|NCT00316862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5750830|NCT00316862|stage II esophageal cancer|stage ii esophageal cancer
5750831|NCT00316862|stage III esophageal cancer|stage iii esophageal cancer
5750832|NCT00316836|stage I breast cancer|stage i breast cancer
5750833|NCT00316836|stage II breast cancer|stage ii breast cancer
5750834|NCT00316836|stage IIIA breast cancer|stage iiia breast cancer
5750835|NCT00316823|thyroid cancer|thyroid cancer
5750837|NCT00316810|Alemtuzumab|alemtuzumab
5750838|NCT00316810|Tacrolimus|tacrolimus
5750839|NCT00316810|Pancreas-kidney transplantation|pancreas-kidney transplantation
5750840|NCT00316810|immunosuppression|immunosuppression
5750841|NCT00316810|prevention of acute rejection|prevention of acute rejection
5750843|NCT00316797|Nuclear Medicine|nuclear medicine
5750844|NCT00316784|osteoarthritis; knee; IDEA-033|osteoarthritis; knee; idea-033
5750845|NCT00316745|irinotecan|irinotecan
5750847|NCT00316745|Oxaliplatin|oxaliplatin
5750848|NCT00316745|l-leucovorin|l-leucovorin
5750849|NCT00316745|Fluorouracil|fluorouracil
5750850|NCT00316745|Metastatic colorectal cancer|metastatic colorectal cancer
5750851|NCT00316745|phase III|phase iii
5750852|NCT00316732|Avodart|avodart
5750853|NCT00316732|IPSS|ipss
5750855|NCT00316732|dutasteride|dutasteride
5750856|NCT00316732|EQ-5D|eq-5d
5750857|NCT00316732|Observational|observational
5750858|NCT00316719|treatment naive|treatment naive
5750860|NCT00316719|adefovir|adefovir
5750861|NCT00316719|monotherapy|monotherapy
5750862|NCT00316706|Prophylaxis HPV-16/18 infections and cervical neoplasia|prophylaxis hpv-16/18 infections and cervical neoplasia
5750863|NCT00316693|HPV Vaccine Efficacy|hpv vaccine efficacy
5750864|NCT00316667|epidemiology|epidemiology
5750865|NCT00316667|risk factors|risk factors
5750866|NCT00316654|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5750867|NCT00316654|vaccines, conjugate|vaccines, conjugate
5750868|NCT00316654|immunology|immunology
5750869|NCT00316654|child|child
5750870|NCT00316654|antibody persistence|antibody persistence
5750871|NCT00316628|influenza|influenza
5750872|NCT00316628|elderly|elderly
5750873|NCT00316628|vaccine|vaccine
5750874|NCT00316615|influenza|influenza
5750875|NCT00316615|non elderly adult and elderly|non elderly adult and elderly
5750876|NCT00316615|vaccine|vaccine
5750877|NCT00316602|Atopic dermatitis|atopic dermatitis
5750878|NCT00316602|Smallpox|smallpox
5750879|NCT00316602|Vaccination|vaccination
5750880|NCT00316589|HIV|hiv
5750881|NCT00316589|treatment experienced|treatment experienced
5750882|NCT00316589|treatment vaccinia naive|treatment vaccinia naive
5750883|NCT00316576|Kidney failure, Acute|kidney failure, acute
5750884|NCT00316576|Genetic Polymorphism|genetic polymorphism
5750885|NCT00316576|Angiotensin-converting enzyme|angiotensin-converting enzyme
5750886|NCT00316563|cannabinoids|cannabinoids
5750887|NCT00316563|taste disorders|taste disorders
5750888|NCT00316563|olfaction disorders|olfaction disorders
5750889|NCT00316563|cancer|cancer
5750890|NCT00316563|palliative medicine|palliative medicine
5750891|NCT00316563|caloric intake|caloric intake
5750892|NCT00316563|appetite|appetite
5750893|NCT00316563|reward|reward
5750894|NCT00316563|tetrahydrocannabinol/therapeutic use|tetrahydrocannabinol/therapeutic use
5750895|NCT00316563|anorexia/drug therapy|anorexia/drug therapy
5750896|NCT00316563|quality of life|quality of life
5750897|NCT00316563|chemosensory changes/drug therapy|chemosensory changes/drug therapy
5750898|NCT00316550|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5750899|NCT00316537|diabetes|diabetes
5750900|NCT00316537|foot ulcers|foot ulcers
5750901|NCT00316537|nicotine gel|nicotine gel
5750902|NCT00316537|wound healing|wound healing
5750903|NCT00316524|Smallpox|smallpox
5750904|NCT00316524|Vaccination|vaccination
5750905|NCT00316524|Prevention|prevention
5750906|NCT00316511|advanced solid malignancies|advanced solid malignancies
5750907|NCT00316511|B-cell lymphoma|b-cell lymphoma
5750908|NCT00316511|Aroplatin|aroplatin
5750909|NCT00316511|L-NDDP|l-nddp
5750910|NCT00316511|MTD|mtd
5750911|NCT00316511|advanced solid malignancies or B-cell lymphoma|advanced solid malignancies or b-cell lymphoma
5750912|NCT00316498|Eye Movement|eye movement
5750913|NCT00316498|Niemann Pick C|niemann pick c
5750914|NCT00316485|Bone|bone
5750915|NCT00316485|Microbiology|microbiology
5750916|NCT00316485|Dental Pulp Stem Cell|dental pulp stem cell
5750917|NCT00316485|Wisdom Teeth|wisdom teeth
5750918|NCT00316485|Biopsy|biopsy
5750919|NCT00316485|Third Molar Extraction|third molar extraction
5750920|NCT00316472|Hyperphosphatemia|hyperphosphatemia
5750921|NCT00316472|End Stage Renal Disease|end stage renal disease
5750922|NCT00316472|Renal Osteodystrophy|renal osteodystrophy
5750925|NCT00316459|Pharmacokinetics|pharmacokinetics
5750926|NCT00316394|Preventive Health Care|preventive health care
5750927|NCT00316394|Annual Health Check-up|annual health check-up
5750928|NCT00316394|Primary Care|primary care
5750929|NCT00316394|Reminders|reminders
5750930|NCT00316381|stem cells|stem cells
5750931|NCT00316381|acute myocardial infarction|acute myocardial infarction
5750932|NCT00316381|regeneration|regeneration
5750933|NCT00316381|left ventricular ejection fraction|left ventricular ejection fraction
5750934|NCT00316368|Bi-Ventricular pacing post coronary artery bypass graft|bi-ventricular pacing post coronary artery bypass graft
5750935|NCT00316368|coronary artery bypass graft|coronary artery bypass graft
5750937|NCT00316355|Behavior therapy|behavior therapy
5750938|NCT00316355|Cognitive-behavioral therapy|cognitive-behavioral therapy
5750939|NCT00316355|Stepped care|stepped care
5750940|NCT00316355|Cost-effectiveness|cost-effectiveness
5750941|NCT00316342|Low back pain|low back pain
5750942|NCT00316342|Industrial workers|industrial workers
5750943|NCT00316342|Recurrent back pain|recurrent back pain
5750944|NCT00316342|Back supports|back supports
5750945|NCT00316342|Back health education|back health education
5750946|NCT00316342|Rehabilitation|rehabilitation
5750947|NCT00316316|OCD|ocd
5750948|NCT00316303|Serious Mental Illness|serious mental illness
5750949|NCT00316303|Dual Diagnosis|dual diagnosis
5750950|NCT00316303|Mental Disorders|mental disorders
5750951|NCT00316303|Substance-Related Disorders|substance-related disorders
5750952|NCT00316290|ADHD|adhd
5750953|NCT00316290|Cognitive Behavioral Therapy|cognitive behavioral therapy
5750954|NCT00316290|Parent Training|parent training
5750955|NCT00316277|Opiate Analgesic Dependence|opiate analgesic dependence
5750956|NCT00316264|Respiratory Syncytial Virus|respiratory syncytial virus
5750957|NCT00316264|Premature and under 6 mos. of age|premature and under 6 mos. of age
5862871|NCT00001475|Monoclonal Antibody|monoclonal antibody
5750958|NCT00316264|Chronic Lung Disease over 6 mos. of age|chronic lung disease over 6 mos. of age
5750960|NCT00316264|motavizumab|motavizumab
5750962|NCT00316251|Somatosensory dysfunction|somatosensory dysfunction
5750963|NCT00316212|Coronary Artery Bypass Graft Surgery involving Cardiopulmonary Bypass|coronary artery bypass graft surgery involving cardiopulmonary bypass
5750964|NCT00316186|chemonaive|chemonaive
5750965|NCT00316186|small cell lung cancer|small cell lung cancer
5750015|NCT00319839|erbitux|erbitux
5750966|NCT00316186|untreated|untreated
5750967|NCT00316186|Lung cancer|lung cancer
5750968|NCT00316186|HYCAMTIN|hycamtin
5750969|NCT00316186|first-line|first-line
5750970|NCT00316186|extensive disease|extensive disease
5750971|NCT00316173|HYCAMTIN|hycamtin
5750972|NCT00316173|ovarian cancer|ovarian cancer
5750973|NCT00316173|recurrent|recurrent
5750974|NCT00316173|relapsed|relapsed
5750975|NCT00316173|carboplatin|carboplatin
5750976|NCT00316173|topotecan|topotecan
5750977|NCT00316173|potentially platinum-sensitive|potentially platinum-sensitive
5750978|NCT00316160|sexual dysfunction|sexual dysfunction
5750979|NCT00316160|Depression|depression
5750981|NCT00316147|diphtheria|diphtheria
5750982|NCT00316147|tetanus|tetanus
5750983|NCT00316147|poliomyelitis|poliomyelitis
5750984|NCT00316147|pertussis|pertussis
5750985|NCT00316147|hepatitis B|hepatitis b
5750986|NCT00316147|Prophylaxis|prophylaxis
5750987|NCT00316147|Haemophilus influenza type b diseases|haemophilus influenza type b diseases
5750988|NCT00316134|Pleural Diseases|pleural diseases
5750989|NCT00316134|Pleural Effusion|pleural effusion
5750990|NCT00316134|Pleural Effusion, Malignant|pleural effusion, malignant
5750991|NCT00316134|Pleural Neoplasms|pleural neoplasms
5750992|NCT00316134|Neoplasms, Pleural|neoplasms, pleural
5750993|NCT00316121|One or Two Level Degenerative Disc Disease|one or two level degenerative disc disease
5750994|NCT00316108|Carotid|carotid
5750995|NCT00316108|Carotid Artery Stenting|carotid artery stenting
5750996|NCT00316108|Stent|stent
5750997|NCT00316108|Carotid Endarterectomy|carotid endarterectomy
5750998|NCT00316108|Stroke|stroke
5750999|NCT00316108|Transient Ischemic Attack|transient ischemic attack
5751000|NCT00316108|Stenosis|stenosis
5751001|NCT00316108|Atherosclerotic Disease|atherosclerotic disease
5751002|NCT00001675|Brain Imaging|brain imaging
5751003|NCT00001675|Affect|affect
5751004|NCT00001675|Limbic System|limbic system
5751005|NCT00001675|Cerebral Blood Volume|cerebral blood volume
5751006|NCT00001675|Alcoholism|alcoholism
5751007|NCT00001675|Emotion|emotion
5751008|NCT00001675|Brain|brain
5751009|NCT00001675|Operant|operant
5751010|NCT00001675|Autonomic|autonomic
5751011|NCT00001675|Relapse|relapse
5751012|NCT00001675|Normal Volunteer|normal volunteer
5751013|NCT00001673|Alcoholics|alcoholics
5751014|NCT00001673|Screening|screening
5751015|NCT00001673|Healthy Volunteers|healthy volunteers
5751016|NCT00001673|Violent Abusers|violent abusers
5751017|NCT00001673|Illicit Drug Testing|illicit drug testing
5751018|NCT00001673|Blood Tests|blood tests
5751019|NCT00001673|Normal Volunteer|normal volunteer
5751020|NCT00316069|Erythropoiesis|erythropoiesis
5751021|NCT00316069|Leukapheresis|leukapheresis
5751022|NCT00316069|G-CSF|g-csf
5751023|NCT00316069|Mobilization|mobilization
5751024|NCT00316069|Stem Cells|stem cells
5751025|NCT00316069|Apheresis|apheresis
5751026|NCT00316069|Blood Donation|blood donation
5751027|NCT00316069|Healthy Volunteer|healthy volunteer
5751028|NCT00316069|HV|hv
5751029|NCT00316056|Genetic Literacy|genetic literacy
5751031|NCT00316056|Genetic Knowledge|genetic knowledge
5751032|NCT00316056|Public Understanding of Science|public understanding of science
5751033|NCT00316056|Science Education|science education
5751034|NCT00316056|Healthy Volunteer|healthy volunteer
5751035|NCT00316056|HV|hv
5751036|NCT00316043|Urinary tract infections|urinary tract infections
5751037|NCT00316043|Renal failure|renal failure
5751038|NCT00316043|Renal scarring|renal scarring
5751039|NCT00316043|Prevention|prevention
5751040|NCT00316043|Primary Care|primary care
5751041|NCT00316043|General Practice|general practice
5751042|NCT00316043|Intervention Studies|intervention studies
5751043|NCT00316043|Children|children
5751044|NCT00316030|AML|aml
5751045|NCT00316030|Acute Myeloid Leukemia|acute myeloid leukemia
5751046|NCT00316030|Bexarotene|bexarotene
5751047|NCT00316030|Leukemia|leukemia
5751048|NCT00316017|Trauma|trauma
5751051|NCT00316004|Brain injury|brain injury
5751052|NCT00315991|BG perception|bg perception
5751053|NCT00315991|hypoglycemic awareness|hypoglycemic awareness
5751054|NCT00315991|pediatric T1DM|pediatric t1dm
5751055|NCT00315978|Risk Assessment|risk assessment
5751056|NCT00315978|Decision Support Technique|decision support technique
5751057|NCT00315978|Physician-Patient Relations|physician-patient relations
5751058|NCT00315978|Prevention and Control|prevention and control
5751059|NCT00315965|Diffusion|diffusion
5751060|NCT00315965|Membrane diffusing capacity|membrane diffusing capacity
5751061|NCT00315965|Alveolar capillary gas diffusion|alveolar capillary gas diffusion
5751062|NCT00315965|Transfer factor|transfer factor
5751063|NCT00315965|Nitric oxide diffusion|nitric oxide diffusion
5751064|NCT00315952|type 1 diabetes mellitus|type 1 diabetes mellitus
5751065|NCT00315952|inhaled insulin|inhaled insulin
5751066|NCT00315952|Positron Emission Tomography|positron emission tomography
5751067|NCT00315939|Diabetes|diabetes
5751068|NCT00315939|hypoglycemic episodes|hypoglycemic episodes
5751069|NCT00315926|Cardiac morbidity|cardiac morbidity
5751070|NCT00315926|Melatonin|melatonin
5751071|NCT00315926|Surgery|surgery
5751072|NCT00315926|Postoperative|postoperative
5759261|NCT00286832|PET|pet
5751073|NCT00315913|Labor|labor
5751074|NCT00315913|Dysfunctional Labor|dysfunctional labor
5751075|NCT00315913|Labor Arrest|labor arrest
5751076|NCT00315913|Primary Cesarean Section Prevention|primary cesarean section prevention
5751077|NCT00315900|Seroquel|seroquel
5751078|NCT00315900|Depakote ER|depakote er
5751079|NCT00315900|Nursing Home|nursing home
5751080|NCT00315900|Quetiapine|quetiapine
5751081|NCT00315900|Divalproex ER|divalproex er
5751082|NCT00315900|Agitation|agitation
5751083|NCT00315887|low back pain|low back pain
5751084|NCT00315887|opioid|opioid
5751085|NCT00315887|transdermal|transdermal
5751086|NCT00315874|chronic back pain|chronic back pain
5751087|NCT00315874|opioid|opioid
5751088|NCT00315874|transdermal|transdermal
5751089|NCT00315861|ovarian carcinoma|ovarian carcinoma
5751090|NCT00315861|endometrial carcinoma|endometrial carcinoma
5751091|NCT00315861|cervical carcinoma|cervical carcinoma
5751092|NCT00315861|lung carcinoma|lung carcinoma
5751093|NCT00315848|chronic pain|chronic pain
5751094|NCT00315848|osteoarthritis|osteoarthritis
5751095|NCT00315848|opioid|opioid
5751096|NCT00315848|transdermal|transdermal
5751097|NCT00315835|postoperative pain|postoperative pain
5751098|NCT00315835|opioid|opioid
5751099|NCT00315835|transdermal|transdermal
5751100|NCT00315822|Surgery|surgery
5751101|NCT00315822|colon|colon
5751102|NCT00315809|leprosy, Philippines|leprosy, philippines
5751103|NCT00315796|Mind-Body Intervention|mind-body intervention
5751104|NCT00315796|Distraction|distraction
5751105|NCT00315796|Biophilic|biophilic
5751106|NCT00315796|Cancer|cancer
5751107|NCT00315796|pain|pain
5751108|NCT00315796|Bedscapes|bedscapes
5751109|NCT00315796|procedures|procedures
5751110|NCT00315796|bone marrow aspirate|bone marrow aspirate
5751111|NCT00315796|bone marrow biopsy|bone marrow biopsy
5751112|NCT00315783|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5751113|NCT00315783|echocardiography|echocardiography
5751114|NCT00315783|magnetic resonance imaging|magnetic resonance imaging
5751115|NCT00315770|overweight|overweight
5751116|NCT00315770|Metabolic syndrome|metabolic syndrome
5751117|NCT00315744|moderate asthma|moderate asthma
5751118|NCT00315744|fluticasone|fluticasone
5751119|NCT00315744|children|children
5751120|NCT00315744|salmeterol|salmeterol
5751121|NCT00315744|steroid-sparing|steroid-sparing
5751122|NCT00315744|Asthma|asthma
5751123|NCT00315731|Bexxar|bexxar
5751124|NCT00315731|tositumomab and iodine I 131 tositumomab therapeutic regiment|tositumomab and iodine i 131 tositumomab therapeutic regiment
5751125|NCT00315731|fission|fission
5751126|NCT00315731|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5751127|NCT00315731|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5751128|NCT00315731|pharmacokinetics|pharmacokinetics
5751129|NCT00315731|tellurium|tellurium
5751130|NCT00315718|Hintonia latiflora extract|hintonia latiflora extract
5751231|NCT00315302|Plano lens|plano lens
5751131|NCT00315718|Diabetes mellitus type 2|diabetes mellitus type 2
5751132|NCT00315718|HbA1c|hba1c
5751133|NCT00315718|Safety|safety
5751134|NCT00315718|Liver function tests|liver function tests
5751135|NCT00315705|clofarabine|clofarabine
5751136|NCT00315705|acute leukemia|acute leukemia
5751139|NCT00315705|clolar|clolar
5751140|NCT00315705|CLO218|clo218
5751141|NCT00315692|Ovarian Neoplasms|ovarian neoplasms
5751142|NCT00315679|recurrent aphthous stomatitis|recurrent aphthous stomatitis
5751143|NCT00315679|recurrent mouth ulcers|recurrent mouth ulcers
5751144|NCT00315679|pentoxifylline|pentoxifylline
5751145|NCT00315679|clinical trial|clinical trial
5751146|NCT00315679|double blind|double blind
5751147|NCT00315679|placebo controlled|placebo controlled
5751148|NCT00315679|randomized|randomized
5751149|NCT00315666|Chronic tension-type headache|chronic tension-type headache
5751150|NCT00315653|Bladder Cancer|bladder cancer
5751151|NCT00315653|Cancer of Bladder|cancer of bladder
5751152|NCT00315653|Bladder Tumors|bladder tumors
5751153|NCT00315653|Cancer of the Bladder|cancer of the bladder
5751154|NCT00315653|Neoplasms, Bladder|neoplasms, bladder
5751155|NCT00315640|Elevated IOP due to intravitreal triamcinolone therapy|elevated iop due to intravitreal triamcinolone therapy
5751156|NCT00315627|Islet Transplantation|islet transplantation
5751157|NCT00315614|Islet Transplantation|islet transplantation
5751158|NCT00315601|Telithromycin (drug)|telithromycin (drug)
5751159|NCT00315601|Azithromycin (drug)|azithromycin (drug)
5751160|NCT00315601|Bronchoalveolar lavage (procedure)|bronchoalveolar lavage (procedure)
5751161|NCT00315601|Pharmacokinetics|pharmacokinetics
5751162|NCT00315588|Islet Transplantation|islet transplantation
5751163|NCT00315575|Dementia|dementia
5751164|NCT00315575|brain circulation|brain circulation
5751165|NCT00315575|disease /disorder proneness /risk|disease /disorder proneness /risk
5751166|NCT00315575|neuropathology|neuropathology
5751167|NCT00315575|neurophysiology|neurophysiology
5751168|NCT00315575|aging|aging
5751169|NCT00315575|apolipoprotein E|apolipoprotein e
5751170|NCT00315575|genotype|genotype
5751171|NCT00315575|hemodynamics|hemodynamics
5751172|NCT00315575|memory|memory
5751173|NCT00315575|temporal lobe /cortex|temporal lobe /cortex
5751174|NCT00315562|stroke|stroke
5750215|NCT00318981|ADHD|adhd
5751175|NCT00315562|carotid stenosis|carotid stenosis
5751176|NCT00315562|carotid endarterectomy|carotid endarterectomy
5751178|NCT00315549|Tonsillitis|tonsillitis
5751179|NCT00315549|pharyngitis|pharyngitis
5751180|NCT00315549|penicillin|penicillin
5751181|NCT00315549|telithromycin|telithromycin
5751182|NCT00315549|ketolides|ketolides
5751183|NCT00315549|clinical trials|clinical trials
5751184|NCT00315523|Levocetirizine|levocetirizine
5751185|NCT00315523|Xyzal|xyzal
5751186|NCT00315523|Rhinitis|rhinitis
5751187|NCT00315523|Allergic|allergic
5751188|NCT00315523|Seasonal|seasonal
5751189|NCT00315523|Ragweed|ragweed
5751190|NCT00315510|Ischemia-reperfusion|ischemia-reperfusion
5751191|NCT00315510|Annexin A5|annexin a5
5751192|NCT00315497|Giant Cell Arteritis|giant cell arteritis
5751193|NCT00315484|Anemia|anemia
5751194|NCT00315484|chemotherapy|chemotherapy
5751195|NCT00315484|hemoglobin level|hemoglobin level
5751196|NCT00315484|recombinant human erythropoietin|recombinant human erythropoietin
5751197|NCT00315484|epoetin alfa|epoetin alfa
5751198|NCT00315484|darbepoetin alfa|darbepoetin alfa
5751199|NCT00315471|Vasculitis|vasculitis
5751200|NCT00315458|osteoarthritis|osteoarthritis
5751201|NCT00315458|opioid|opioid
5751202|NCT00315458|transdermal|transdermal
5751203|NCT00315445|chronic back pain|chronic back pain
5751204|NCT00315445|opioid|opioid
5751205|NCT00315445|transdermal|transdermal
5751206|NCT00315432|Natural History, Hepatitis C Infection, HIV Infection, HCV/HIV co-infection Ribavirin, Pegylated Interferon, Interferon|natural history, hepatitis c infection, hiv infection, hcv/hiv co-infection ribavirin, pegylated interferon, interferon
5751207|NCT00315419|Large Granular Lymphocyte Leukemia|large granular lymphocyte leukemia
5751334|NCT00314925|carcinoid|carcinoid
5751208|NCT00315419|Amegakaryocytic Thrombocytopenic Purpura|amegakaryocytic thrombocytopenic purpura
5751209|NCT00315419|Idiopathic Pure Red Cell Aplasia|idiopathic pure red cell aplasia
5751210|NCT00315419|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5751211|NCT00315406|PAN|pan
5751212|NCT00315406|Periarteritis Nodosa|periarteritis nodosa
5751213|NCT00315393|GPA|gpa
5751214|NCT00315393|MPA|mpa
5751215|NCT00315393|WG|wg
5751216|NCT00315380|EGPA|egpa
5751217|NCT00315380|CSS|css
5751218|NCT00315367|Multiple Sclerosis|multiple sclerosis
5751219|NCT00315367|Memory impairment|memory impairment
5751220|NCT00315354|obesity|obesity
5751221|NCT00315354|nutrition|nutrition
5751222|NCT00315328|Amblyopia|amblyopia
5751223|NCT00315328|Atropine|atropine
5751224|NCT00315328|Patching|patching
5751225|NCT00315315|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5751226|NCT00315315|Balloon catheter nasolacrimal duct dilation|balloon catheter nasolacrimal duct dilation
5751227|NCT00315315|Nasolacrimal intubation|nasolacrimal intubation
5751228|NCT00315315|Simple Nasolacrimal duct probing|simple nasolacrimal duct probing
5751229|NCT00315302|Amblyopia|amblyopia
5751230|NCT00315302|Atropine|atropine
5751232|NCT00315289|Nasolacrimal duct obstruction|nasolacrimal duct obstruction
5751233|NCT00315289|Simple probing|simple probing
5751234|NCT00315289|Balloon catheter dilation|balloon catheter dilation
5751235|NCT00315289|Nasolacrimal intubation|nasolacrimal intubation
5751236|NCT00315276|ADHD|adhd
5751237|NCT00315263|DNA|dna
5751238|NCT00315263|Genomics|genomics
5751239|NCT00315263|SNPs|snps
5751240|NCT00315263|Neonatology|neonatology
5751241|NCT00315263|Chronic Lung Disease|chronic lung disease
5751242|NCT00315263|Periventricular Brain Injury|periventricular brain injury
5751243|NCT00315263|Hypoxic Respiratory Failure|hypoxic respiratory failure
5751244|NCT00315250|Parkinson|parkinson
5751245|NCT00315224|Isolated systolic Hypertension|isolated systolic hypertension
5751246|NCT00315224|exercise|exercise
5751247|NCT00315224|pulse pressure|pulse pressure
5751248|NCT00315224|endothelium|endothelium
5751249|NCT00315211|Small Cell Lung Cancer Recurrent|small cell lung cancer recurrent
5751250|NCT00315198|amblyopia|amblyopia
5751251|NCT00315198|patching|patching
5751252|NCT00315198|visual activities|visual activities
5751253|NCT00315185|Advanced Non-small Cell Lung Cancer|advanced non-small cell lung cancer
5751254|NCT00315185|First Line Treatment|first line treatment
5751255|NCT00315172|Adipose Tissue|adipose tissue
5751256|NCT00315172|Weight Gain|weight gain
5751257|NCT00315172|Pediatric|pediatric
5751258|NCT00315172|Body Composition|body composition
5751259|NCT00315172|Thermogenesis|thermogenesis
5751260|NCT00315172|Exercise|exercise
5751261|NCT00315172|Healthy Volunteer|healthy volunteer
5751262|NCT00315172|HV|hv
5751263|NCT00315159|Squamous|squamous
5751264|NCT00315159|Cell|cell
5751265|NCT00315159|Carcinoma|carcinoma
5751266|NCT00315159|Vulva|vulva
5681007|NCT00575224|Novel genoytpe|novel genoytpe
5751267|NCT00315159|Sentinel Node|sentinel node
5751268|NCT00315146|Body Composition|body composition
5751269|NCT00315146|Sarcopenia|sarcopenia
5751270|NCT00315146|Weight loss trials|weight loss trials
5751271|NCT00315146|Intervention studies|intervention studies
5751272|NCT00315146|Elderly|elderly
5751273|NCT00315133|Diabetes mellitus|diabetes mellitus
5751274|NCT00315133|Stem cells|stem cells
5759446|NCT00286091|ADT|adt
5751275|NCT00315133|Autologous stem cell transplantation|autologous stem cell transplantation
5751276|NCT00315133|Autoimmune diseases|autoimmune diseases
5751277|NCT00315120|Randomized controlled trial|randomized controlled trial
5751278|NCT00315120|Low back pain|low back pain
5751279|NCT00315120|Spinal manipulative therapy|spinal manipulative therapy
5751280|NCT00315120|Spinal manipulation|spinal manipulation
5751281|NCT00315120|Osteopathic manipulation|osteopathic manipulation
5751282|NCT00315120|Osteopathic medicine|osteopathic medicine
5751283|NCT00315120|Physical therapy modalities|physical therapy modalities
5751284|NCT00315094|home parenteral nutrition|home parenteral nutrition
5751285|NCT00315081|Schizophrenia|schizophrenia
5751286|NCT00315081|Hyperprolactinemia|hyperprolactinemia
5751288|NCT00315081|Bromocriptin|bromocriptin
5751289|NCT00315068|arrythmia|arrythmia
5751290|NCT00315068|atrial fibrillation|atrial fibrillation
5751291|NCT00315068|proteins|proteins
5751292|NCT00315055|Hepatitis B|hepatitis b
5751293|NCT00315055|Polio|polio
5751294|NCT00315055|Diphtheria|diphtheria
5751295|NCT00315055|Pertussis|pertussis
5751296|NCT00315055|H influenzae type b|h influenzae type b
5751297|NCT00315042|Tonsillitis|tonsillitis
5751298|NCT00315042|pharyngitis|pharyngitis
5751299|NCT00315042|penicillin|penicillin
5751300|NCT00315042|telithromycin|telithromycin
5751301|NCT00315042|ketolides|ketolides
5751302|NCT00315042|clinical trials|clinical trials
5751303|NCT00315029|Implementation|implementation
5751304|NCT00315029|Single embryo transfer|single embryo transfer
5751305|NCT00315029|ICSI|icsi
5751306|NCT00315029|IVF|ivf
5751307|NCT00315029|prevention|prevention
5751308|NCT00315016|albuminuria|albuminuria
5751309|NCT00315016|eplerenone|eplerenone
5751310|NCT00315016|ACE inhibition|ace inhibition
5751311|NCT00315016|renal function|renal function
5751312|NCT00315016|endothelial function|endothelial function
5751313|NCT00315003|Otitis Media|otitis media
5751314|NCT00315003|Suppurative|suppurative
5751315|NCT00315003|Purulent|purulent
5751316|NCT00315003|Ketolide|ketolide
5751317|NCT00315003|Azithromycin|azithromycin
5751318|NCT00315003|Telithromycin|telithromycin
5751319|NCT00315003|Controlled Clinical Trials|controlled clinical trials
5751320|NCT00314990|Venous thrombosis|venous thrombosis
5751321|NCT00314990|Deep-vein thrombosis|deep-vein thrombosis
5751322|NCT00314990|Pulmonary embolism|pulmonary embolism
5751323|NCT00314990|Homocysteine|homocysteine
5751324|NCT00314990|B-vitamins|b-vitamins
5751326|NCT00314990|Vitamin B12|vitamin b12
5751327|NCT00314990|Vitamin B6|vitamin b6
5751328|NCT00314977|Large resectable breast cancer|large resectable breast cancer
5751329|NCT00314977|Locally advanced breast cancer|locally advanced breast cancer
5751330|NCT00314977|Neoadjuvant therapy|neoadjuvant therapy
5751331|NCT00314951|CDAD, Clostridium difficile, diarrhea|cdad, clostridium difficile, diarrhea
5751332|NCT00314951|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5751333|NCT00314925|advanced carcinoma|advanced carcinoma
5751335|NCT00314925|neuroendocrine features|neuroendocrine features
5751336|NCT00314925|oncolytic virus|oncolytic virus
5751337|NCT00314925|phase I study|phase i study
5751338|NCT00314925|dose escalation study|dose escalation study
5751339|NCT00314925|rhabdomyosarcoma|rhabdomyosarcoma
5751340|NCT00314925|alveolar rhabdomyosarcoma|alveolar rhabdomyosarcoma
5751341|NCT00314925|medulloblastoma|medulloblastoma
5751342|NCT00314925|rhabdoid|rhabdoid
5751343|NCT00314925|glioblastoma|glioblastoma
5751344|NCT00314925|ewing's sarcoma|ewing's sarcoma
5751345|NCT00314925|pediatric oncologies|pediatric oncologies
5751346|NCT00314925|neuroblastoma|neuroblastoma
5751347|NCT00314925|wilms' tumor|wilms' tumor
5751348|NCT00314925|retinoblastoma|retinoblastoma
5751349|NCT00314925|Large cell lung cancer|large cell lung cancer
5751350|NCT00314899|Malaria, Plasmodium falciparum, Kenya, immunity|malaria, plasmodium falciparum, kenya, immunity
5751351|NCT00314886|Diet|diet
5751352|NCT00314886|Fiber|fiber
5751353|NCT00314886|Irritable Bowel Syndrome|irritable bowel syndrome
5751354|NCT00314886|Colonic Flora|colonic flora
5751355|NCT00314873|Thymic malignancy|thymic malignancy
5751356|NCT00314873|Thymic Carcinoma|thymic carcinoma
5751357|NCT00314860|Restless Legs Syndrome|restless legs syndrome
5751358|NCT00314847|Myocardial infarction|myocardial infarction
5751359|NCT00314847|Cardiogenic shock|cardiogenic shock
5751360|NCT00314847|Extracorporeal Life Support-Impella|extracorporeal life support-impella
5751361|NCT00314834|hemodialysis|hemodialysis
5751362|NCT00314834|intradialytic parenteral nutrition|intradialytic parenteral nutrition
5751363|NCT00314834|oral supplementation|oral supplementation
5751364|NCT00314834|survival|survival
5751365|NCT00314834|hospitalization|hospitalization
5751366|NCT00314834|serum albumin|serum albumin
5751367|NCT00314834|prealbumin|prealbumin
5751368|NCT00314834|transthyretin|transthyretin
5751369|NCT00314821|bipolar disorder, ropinirole, depression|bipolar disorder, ropinirole, depression
5751370|NCT00314808|primary gliomas|primary gliomas
5751371|NCT00314808|brain tumors|brain tumors
5751372|NCT00314808|vomiting|vomiting
5751373|NCT00314808|appetite suppression|appetite suppression
5751374|NCT00314808|appetite|appetite
5751375|NCT00314795|Drug Therapy|drug therapy
5751376|NCT00314795|pure red cell aplasia|pure red cell aplasia
5751377|NCT00314795|PRCA|prca
5751378|NCT00314795|chronic kidney disease|chronic kidney disease
5751380|NCT00314795|chronic renal failure|chronic renal failure
5751381|NCT00314795|CRF|crf
5751382|NCT00314795|anemia|anemia
5751383|NCT00314795|erythropoietin|erythropoietin
5751384|NCT00314795|EPO|epo
5751385|NCT00314795|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5751386|NCT00314795|ESA|esa
5751387|NCT00314795|hemoglobin|hemoglobin
5751388|NCT00314795|Hb|hb
5751389|NCT00314795|Hgb|hgb
5751390|NCT00314795|red blood cell|red blood cell
5751391|NCT00314795|red blood cell production|red blood cell production
5751392|NCT00314782|metastatic hormone-refractory prostate cancer (HRPC)|metastatic hormone-refractory prostate cancer (hrpc)
5751393|NCT00314769|Transcranial Direct Current Stimulation (TDCS)|transcranial direct current stimulation (tdcs)
5751394|NCT00314769|Motor Learning|motor learning
5751395|NCT00314769|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5751396|NCT00314769|Cortical Re-Organization|cortical re-organization
5751397|NCT00314769|Neuroplasticity|neuroplasticity
5751398|NCT00314769|Neurorehabilitation|neurorehabilitation
5751399|NCT00314769|TBI|tbi
5751400|NCT00314769|Stroke|stroke
5751401|NCT00314769|Healthy Volunteer|healthy volunteer
5751402|NCT00314769|HV|hv
5751403|NCT00314756|imiquimod cream|imiquimod cream
5751404|NCT00314756|nodular basal cell carcinoma|nodular basal cell carcinoma
5751405|NCT00314756|curettage|curettage
5751406|NCT00314743|Patients with Non-Hodgkins Lymphoma or Multiple Myeloma|patients with non-hodgkins lymphoma or multiple myeloma
5751407|NCT00314704|shock|shock
5751408|NCT00314704|hypotension|hypotension
5751409|NCT00314704|circulatory failure|circulatory failure
5751410|NCT00314704|septic shock|septic shock
5751411|NCT00314704|cardiogenic shock|cardiogenic shock
5751412|NCT00314691|fetal DNA|fetal dna
5751413|NCT00314691|prenatal diagnosis|prenatal diagnosis
5751414|NCT00314691|maternal plasma|maternal plasma
5751415|NCT00314691|Diagnostic potential of cell-free fetal DNA circulating in maternal blood|diagnostic potential of cell-free fetal dna circulating in maternal blood
5751416|NCT00314678|Ovarian|ovarian
5751417|NCT00314678|Peritoneal|peritoneal
5751418|NCT00314665|Sarcoidosis|sarcoidosis
5751419|NCT00314665|Chronic Uveitis|chronic uveitis
5751420|NCT00314665|Uveitis|uveitis
5751421|NCT00314665|Thalidomide|thalidomide
5751422|NCT00314652|Osteoarthritis|osteoarthritis
5751423|NCT00314652|chronic pain|chronic pain
5751424|NCT00314652|opioid|opioid
5751425|NCT00314652|transdermal|transdermal
5751426|NCT00314626|Antiviral efficacy|antiviral efficacy
5751427|NCT00314626|Tolerability|tolerability
5751428|NCT00314626|Immunologic response|immunologic response
5751429|NCT00314626|Virologic response|virologic response
5751430|NCT00314626|HIV|hiv
5751431|NCT00314613|Schizophreniform; Schizophrenia; Schizoaffective Disorders|schizophreniform; schizophrenia; schizoaffective disorders
5751432|NCT00314600|Fracture|fracture
5751433|NCT00314600|Forearm|forearm
5751442|NCT00314574|Persistent Asthma|persistent asthma
5751443|NCT00314574|EXTRA|extra
5751444|NCT00314574|Xolair|xolair
5751445|NCT00314574|Difficult Breathing|difficult breathing
5751446|NCT00314561|Rosiglitazone|rosiglitazone
5751447|NCT00314561|Pioglitazone|pioglitazone
5751448|NCT00314561|FMD|fmd
5751449|NCT00314561|PWV|pwv
5751450|NCT00314561|atherosclerosis|atherosclerosis
5751451|NCT00314548|ARDS|ards
5751452|NCT00314548|pulmonary hypertension|pulmonary hypertension
5751453|NCT00314548|prostacyclins|prostacyclins
5751454|NCT00314509|Asthma|asthma
5751455|NCT00314509|Ciclesonide|ciclesonide
5751456|NCT00314509|Formoterol Fumarate|formoterol fumarate
5751848|NCT00312923|lipids|lipids
5751457|NCT00314509|Long-acting beta2-agonists|long-acting beta2-agonists
5751458|NCT00314509|LABA|laba
5751459|NCT00314509|Steroids|steroids
5751460|NCT00314483|Mesenchymal stem cells|mesenchymal stem cells
5751461|NCT00314483|GVHD|gvhd
5751462|NCT00314483|Treatment|treatment
5751463|NCT00314483|Steroid refractory GVHD|steroid refractory gvhd
5751464|NCT00314457|pain control|pain control
5751465|NCT00314457|intra-articular pain control device|intra-articular pain control device
5751466|NCT00314457|ACL repair|acl repair
5751467|NCT00314457|Bankart Repair|bankart repair
5751468|NCT00314444|Psychogenic|psychogenic
5751469|NCT00314444|Psychogenic Movement Disorders|psychogenic movement disorders
5751470|NCT00314431|neonatal chronic lung disease|neonatal chronic lung disease
5751471|NCT00314431|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5751472|NCT00314431|prematurity|prematurity
5751473|NCT00314431|telephone follow up|telephone follow up
5751474|NCT00314431|care coordination|care coordination
5751475|NCT00314431|children with special health care needs|children with special health care needs
5751476|NCT00314418|Colonoscopy|colonoscopy
5751477|NCT00314418|technique|technique
5751479|NCT00314418|duration|duration
5751480|NCT00314418|position|position
5751481|NCT00314418|abdominal pressure|abdominal pressure
5751482|NCT00314405|sentinel lymph node|sentinel lymph node
5751483|NCT00314405|SLN|sln
5751484|NCT00314405|probe|probe
5751485|NCT00314405|breast cancer|breast cancer
5848267|NCT00035386|Obstructive HCM|obstructive hcm
5751486|NCT00314405|lymphoscintigraphy|lymphoscintigraphy
5751487|NCT00314405|methylene blue dye|methylene blue dye
5751488|NCT00314392|Experimental pain|experimental pain
5751489|NCT00314392|Placebo analgesia|placebo analgesia
5751490|NCT00314392|Heart rate variability|heart rate variability
5751491|NCT00314392|Skin conductance|skin conductance
5751493|NCT00314379|Endothelial Function|endothelial function
5751494|NCT00314379|Haptoglobin|haptoglobin
5751495|NCT00314366|stem cell|stem cell
5751496|NCT00314366|autologous|autologous
5751497|NCT00314366|ischemia|ischemia
5751498|NCT00314353|NSABP|nsabp
5751499|NCT00314353|bevacizumab|bevacizumab
5751500|NCT00314353|capecitabine|capecitabine
5751501|NCT00314353|oxaliplatin|oxaliplatin
5751502|NCT00314353|irinotecan|irinotecan
5751503|NCT00314353|rectal cancer|rectal cancer
5751504|NCT00314353|colon cancer|colon cancer
5751505|NCT00314353|colorectal cancer|colorectal cancer
5751506|NCT00314340|Chronic Pain|chronic pain
5751507|NCT00314340|Opioids|opioids
5751508|NCT00314327|first episode|first episode
5751509|NCT00314327|schizophrenia|schizophrenia
5751510|NCT00314327|risperidone|risperidone
5751511|NCT00314314|Bipolar Disorder, memory, executive functioning|bipolar disorder, memory, executive functioning
5751512|NCT00314301|cerebral palsy|cerebral palsy
5751513|NCT00314301|resistance|resistance
5751514|NCT00314301|movement|movement
5751515|NCT00314301|biomechanics|biomechanics
5751516|NCT00314288|Parkinson's Disease|parkinson's disease
5751517|NCT00314288|Dyskinesia|dyskinesia
5751518|NCT00314288|L-dopa-induced dyskinesia|l-dopa-induced dyskinesia
5751519|NCT00314275|Pharmacokinetics|pharmacokinetics
5751520|NCT00314275|Coronary Artery Disease|coronary artery disease
5751521|NCT00314275|PCI|pci
5751522|NCT00314275|Drug Eluting Stent|drug eluting stent
5751523|NCT00314262|Skin Lesions|skin lesions
5751524|NCT00314262|Premalignant Lesion|premalignant lesion
5751525|NCT00314249|Fibromyalgia|fibromyalgia
5751526|NCT00314236|Cartilage repair|cartilage repair
5751527|NCT00314236|Cartilage|cartilage
5751528|NCT00314236|Knee|knee
5751529|NCT00314236|Knee Pain|knee pain
5751530|NCT00314236|Microfracture|microfracture
5751531|NCT00314236|arthroscopy|arthroscopy
5751532|NCT00314236|bone marrow stimulation|bone marrow stimulation
5751533|NCT00314236|Chondrogenesis|chondrogenesis
5751534|NCT00314236|Scaffold|scaffold
5751535|NCT00314236|Chitosan|chitosan
5751536|NCT00314236|A02.165.165|a02.165.165
5751537|NCT00314236|A10.165.382.332|a10.165.382.332
5751538|NCT00314236|G07.574.500.325.377.625.180|g07.574.500.325.377.625.180
5751539|NCT00314236|A10.165.382.400|a10.165.382.400
5751540|NCT00314236|Articular Cartilage Repair|articular cartilage repair
5751541|NCT00314210|Generalised Anxiety Disorder|generalised anxiety disorder
5751542|NCT00314197|automated counseling system|automated counseling system
5751543|NCT00314197|telephone-based intervention|telephone-based intervention
5751544|NCT00314197|behavior change|behavior change
5751545|NCT00314184|Bipolar I disorder.|bipolar i disorder.
5751832|NCT00313014|Butrans|butrans
5751546|NCT00314171|open-angle glaucoma|open-angle glaucoma
5751547|NCT00314171|ocular hypertension|ocular hypertension
5751549|NCT00314132|Encephalitis virus|encephalitis virus
5751550|NCT00314132|ChimeriVax™-JE Vaccine|chimerivax™-je vaccine
5751551|NCT00314119|Tumor Imaging|tumor imaging
5751552|NCT00314119|NF1|nf1
5751553|NCT00314119|Neurofibromatosis|neurofibromatosis
5751554|NCT00314106|Clinical Response|clinical response
5751555|NCT00314106|Stage IV Melanoma|stage iv melanoma
5751556|NCT00314106|Adoptive Cell Therapy|adoptive cell therapy
5751557|NCT00314106|Tumor Infiltrating Lymphocytes|tumor infiltrating lymphocytes
5751558|NCT00314106|Immunologic Response|immunologic response
5752057|NCT00312234|Qigong|qigong
5751559|NCT00314106|Metastatic Melanoma|metastatic melanoma
5751560|NCT00314093|Clinical Response|clinical response
5751561|NCT00314093|Stage IV Melanoma|stage iv melanoma
5751562|NCT00314093|Immunotoxin|immunotoxin
5751563|NCT00314093|T Regulatory Cells|t regulatory cells
5751564|NCT00314093|CD25+ Cells|cd25+ cells
5751565|NCT00314093|Metastatic Melanoma|metastatic melanoma
5751566|NCT00314080|Botulism|botulism
5751567|NCT00314080|Botulinum anti-toxin|botulinum anti-toxin
5751568|NCT00314080|Repetitive nerve stimulation|repetitive nerve stimulation
5751569|NCT00314080|Respiratory failure|respiratory failure
5751570|NCT00314067|Quality of Health Care|quality of health care
5751571|NCT00314067|Primary Health Care|primary health care
5751572|NCT00314067|Education|education
5751573|NCT00314067|E-Learning|e-learning
5751574|NCT00314067|Alcohol-related Disorders|alcohol-related disorders
5751575|NCT00314054|Hepatitis C|hepatitis c
5751576|NCT00314054|Hepatic Impairment|hepatic impairment
5751577|NCT00314054|Healthy Volunteer|healthy volunteer
5751579|NCT00314054|Hepacivirus|hepacivirus
5751580|NCT00314041|Infant|infant
5751581|NCT00314041|Conjugate vaccine|conjugate vaccine
5751582|NCT00314041|Meningococcal|meningococcal
5751583|NCT00314041|Antibody|antibody
5751584|NCT00314041|Immune memory|immune memory
5751585|NCT00314041|Health|health
5751586|NCT00314041|Meningococcal Vaccines|meningococcal vaccines
5776044|NCT00216788|Sucrose|sucrose
5751587|NCT00314028|African American|african american
5751588|NCT00314028|Men|men
5751589|NCT00314028|Sexually Transmitted Diseases|sexually transmitted diseases
5751591|NCT00314002|Massive pulmonary embolism|massive pulmonary embolism
5751592|NCT00314002|Catheter thrombectomy|catheter thrombectomy
5751593|NCT00313976|Multiple Sclerosis|multiple sclerosis
5751594|NCT00313976|Early secondary progressive Multiple Sclerosis|early secondary progressive multiple sclerosis
5751595|NCT00313963|Anemia, Sickle Cell|anemia, sickle cell
5751596|NCT00313963|Magnesium Sulfate|magnesium sulfate
5751597|NCT00313963|pediatric|pediatric
5751598|NCT00313950|measles|measles
5751599|NCT00313950|rubella|rubella
5751600|NCT00313950|mumps|mumps
5751601|NCT00313950|hepatitis A|hepatitis a
5751602|NCT00313924|URGENCY FREQUENCY SYNDROME|urgency frequency syndrome
5751603|NCT00313924|URGE INCONTINENCE|urge incontinence
5751604|NCT00313911|Diphtheria|diphtheria
5751605|NCT00313911|Tetanus|tetanus
5751606|NCT00313911|Pertussis|pertussis
5751607|NCT00313911|Recombinant Hepatitis B|recombinant hepatitis b
5751608|NCT00313911|Poliomyelitis|poliomyelitis
5751609|NCT00313911|Haemophilus influenzae type b|haemophilus influenzae type b
5751610|NCT00313911|Tetanus protein|tetanus protein
5751611|NCT00313898|quality of sexual life, Mild erectile dysfunction|quality of sexual life, mild erectile dysfunction
5751612|NCT00313872|gastric cancer|gastric cancer
5751613|NCT00313872|chemotherapy|chemotherapy
5751614|NCT00313872|irinotecan|irinotecan
5751615|NCT00313872|docetaxel|docetaxel
5751616|NCT00313859|colorectal cancer|colorectal cancer
5751617|NCT00313859|metastatic|metastatic
5751618|NCT00313846|Chronic pain|chronic pain
5751620|NCT00313846|transdermal|transdermal
5751621|NCT00313846|osteoarthritis|osteoarthritis
5751622|NCT00313833|Chronic pain|chronic pain
5751623|NCT00313833|elderly|elderly
5751624|NCT00313833|supervised living|supervised living
5751625|NCT00313833|opioid|opioid
5751626|NCT00313833|transdermal|transdermal
5751627|NCT00313820|Post-stroke pain, pregabalin|post-stroke pain, pregabalin
5751628|NCT00313807|contrast nephropathy|contrast nephropathy
5751629|NCT00313807|renal failure|renal failure
5751630|NCT00313807|Travasol|travasol
5751631|NCT00313781|randomized|randomized
5751632|NCT00313781|non-comparative|non-comparative
5751633|NCT00313781|efficacy|efficacy
5751634|NCT00313768|advanced carcinoma, non-small cell lung, Phase II, paclitaxel, Taxol, carboplatin, Paraplatin, bevacizumab, Avastin, PF-3512676, immunotherapy, immunomodulator|advanced carcinoma, non-small cell lung, phase ii, paclitaxel, taxol, carboplatin, paraplatin, bevacizumab, avastin, pf-3512676, immunotherapy, immunomodulator
5751635|NCT00313755|colonoscopy, narrow band imaging,|colonoscopy, narrow band imaging,
5751636|NCT00313755|high definition endoscopy|high definition endoscopy
5751637|NCT00313755|colorectal cancer|colorectal cancer
5751638|NCT00313755|dysplasia|dysplasia
5751639|NCT00313755|hereditary non-polyposis colorectal cancer|hereditary non-polyposis colorectal cancer
5751640|NCT00313755|Lynch Syndrome|lynch syndrome
5751641|NCT00313755|HNPCC|hnpcc
5752146|NCT00311831|Education|education
5751642|NCT00313729|adult oligodendroglioma|adult oligodendroglioma
5751643|NCT00313729|adult mixed glioma|adult mixed glioma
5751644|NCT00313729|adult diffuse astrocytoma|adult diffuse astrocytoma
5751645|NCT00313729|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5751646|NCT00313729|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5751648|NCT00313716|traumatic brain injury|traumatic brain injury
5751649|NCT00313716|recombinant human erythropoietin|recombinant human erythropoietin
5751651|NCT00313716|erythropoietin|erythropoietin
5751652|NCT00313716|TBI|tbi
5751653|NCT00313716|Epo|epo
5751654|NCT00313703|headache|headache
5751655|NCT00313703|emergency department|emergency department
5751656|NCT00313703|migraine|migraine
5751657|NCT00313703|recurrent headache|recurrent headache
5751658|NCT00313690|Lung Cancer|lung cancer
5751659|NCT00313677|muscular dystrophy|muscular dystrophy
5751660|NCT00313677|MD|md
5751661|NCT00313677|fukutin-related protein gene|fukutin-related protein gene
5751662|NCT00313677|limb girdle|limb girdle
5751663|NCT00313677|FKRP gene|fkrp gene
5751664|NCT00313677|congenital muscular dystrophy|congenital muscular dystrophy
5751665|NCT00313677|childhood onset LGMD|childhood onset lgmd
5751666|NCT00313677|adult onset LGMD|adult onset lgmd
5751667|NCT00313677|POMT1|pomt1
5751668|NCT00313677|POMT2|pomt2
5751669|NCT00313677|POMGnT|pomgnt
5751670|NCT00313677|LARGE|large
5751671|NCT00313677|alpha dystroglycan|alpha dystroglycan
5751672|NCT00313677|dystroglycanopathy|dystroglycanopathy
5751673|NCT00313677|ISPD|ispd
5751674|NCT00313677|DPM|dpm
5751675|NCT00313677|GMPPB|gmppb
5751676|NCT00313677|B3GNT1|b3gnt1
5751677|NCT00313677|B3GALNT2|b3galnt2
5751678|NCT00313677|GTDC2|gtdc2
5751679|NCT00313677|TMEM5|tmem5
5751680|NCT00313677|Fukutin|fukutin
5751681|NCT00313677|DAG1|dag1
5751682|NCT00313677|POMK|pomk
5751683|NCT00313625|stage I multiple myeloma|stage i multiple myeloma
5751684|NCT00313625|stage II multiple myeloma|stage ii multiple myeloma
5751685|NCT00313625|stage III multiple myeloma|stage iii multiple myeloma
5751686|NCT00313625|refractory multiple myeloma|refractory multiple myeloma
5759762|NCT00284479|fatness|fatness
5751687|NCT00313599|recurrent breast cancer|recurrent breast cancer
5751688|NCT00313599|stage IV breast cancer|stage iv breast cancer
5746604|NCT00333554|TrialNet|trialnet
5751689|NCT00313599|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5751690|NCT00313599|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5751691|NCT00313599|recurrent prostate cancer|recurrent prostate cancer
5751692|NCT00313599|stage IV prostate cancer|stage iv prostate cancer
5751693|NCT00313599|recurrent bladder cancer|recurrent bladder cancer
5751694|NCT00313599|stage IV bladder cancer|stage iv bladder cancer
5751695|NCT00313599|recurrent gastric cancer|recurrent gastric cancer
5751696|NCT00313599|stage IV gastric cancer|stage iv gastric cancer
5751697|NCT00313599|recurrent esophageal cancer|recurrent esophageal cancer
5751698|NCT00313599|stage IV esophageal cancer|stage iv esophageal cancer
5751699|NCT00313599|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5751700|NCT00313599|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5751701|NCT00313599|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5751702|NCT00313599|ovarian choriocarcinoma|ovarian choriocarcinoma
5751703|NCT00313599|ovarian dysgerminoma|ovarian dysgerminoma
5751704|NCT00313599|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5751705|NCT00313599|ovarian yolk sac tumor|ovarian yolk sac tumor
5751706|NCT00313599|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5751707|NCT00313599|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5751708|NCT00313599|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5751709|NCT00313599|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5751710|NCT00313599|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5751711|NCT00313599|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5751712|NCT00313599|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5751713|NCT00313599|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5751714|NCT00313573|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5751716|NCT00313573|depression|depression
5751717|NCT00313560|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5751718|NCT00313560|stage I pancreatic cancer|stage i pancreatic cancer
5751719|NCT00313560|stage II pancreatic cancer|stage ii pancreatic cancer
5751720|NCT00313547|Blood pressure|blood pressure
5751721|NCT00313547|Hypertension|hypertension
5751722|NCT00313547|Renin|renin
5751723|NCT00313547|Aldosterone|aldosterone
5751724|NCT00313547|Heart rate variability|heart rate variability
5751725|NCT00313534|recurrent prostate cancer|recurrent prostate cancer
5751726|NCT00313534|stage IIB prostate cancer|stage iib prostate cancer
5751727|NCT00313534|stage IIA prostate cancer|stage iia prostate cancer
5751728|NCT00313534|stage III prostate cancer|stage iii prostate cancer
5751729|NCT00313534|stage I prostate cancer|stage i prostate cancer
5751730|NCT00313521|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5751731|NCT00313521|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5751732|NCT00313508|stage IV melanoma|stage iv melanoma
5751733|NCT00313508|recurrent melanoma|recurrent melanoma
5751734|NCT00313508|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5751735|NCT00313508|recurrent intraocular melanoma|recurrent intraocular melanoma
5751736|NCT00313508|metastatic intraocular melanoma|metastatic intraocular melanoma
5751737|NCT00313508|extraocular extension melanoma|extraocular extension melanoma
5751738|NCT00313508|iris melanoma|iris melanoma
5751739|NCT00313495|Huntington disease, observational, family members, biomarker|huntington disease, observational, family members, biomarker
5751740|NCT00313469|Pharmacokinetics/Pharmacodynamics|pharmacokinetics/pharmacodynamics
5751741|NCT00313469|Elderly|elderly
5751742|NCT00313469|Anticoagulants|anticoagulants
5751743|NCT00313443|Anti-Arrhythmia Agents|anti-arrhythmia agents
5751744|NCT00313443|Amiodarone, chronic treatment|amiodarone, chronic treatment
5751745|NCT00313443|Amiodarone, adverse effects|amiodarone, adverse effects
5751746|NCT00313443|Biopsy, Fine-Needle, Adipose tissue|biopsy, fine-needle, adipose tissue
5751747|NCT00313443|Drug concentrations in tissues|drug concentrations in tissues
5751748|NCT00313443|Drug accumulation in tissues|drug accumulation in tissues
5751749|NCT00313430|Urine concentration ability|urine concentration ability
5751750|NCT00313430|chronic renal insufficiency|chronic renal insufficiency
5751751|NCT00313430|hypertension|hypertension
5751752|NCT00313430|aquaporin2|aquaporin2
5751753|NCT00313430|Patients with chronic renal insufficiency|patients with chronic renal insufficiency
5751754|NCT00313430|Patients with hypertension|patients with hypertension
5751755|NCT00313430|Healthy volunteers|healthy volunteers
5751756|NCT00313417|Creatine|creatine
5751757|NCT00313417|major depressive disorders|major depressive disorders
5760685|NCT00281762|NSAID|nsaid
5751758|NCT00313404|Norovirus|norovirus
5751759|NCT00313404|Gastroenteritis|gastroenteritis
5751760|NCT00313404|Clinical Trial|clinical trial
5751761|NCT00313404|Stomach flu|stomach flu
5751762|NCT00313378|Thoracotomy|thoracotomy
5751763|NCT00313378|Neuropathic pain|neuropathic pain
5751764|NCT00313378|Nerve trauma|nerve trauma
5751765|NCT00313378|Ketamine|ketamine
5750763|NCT00317083|Citric acid|citric acid
5751766|NCT00313378|NMDA receptors|nmda receptors
5751767|NCT00313352|adult|adult
5751768|NCT00313352|cardiac|cardiac
5751769|NCT00313352|transposition of great arteries|transposition of great arteries
5751770|NCT00313352|beta-adrenergic blockers|beta-adrenergic blockers
5751771|NCT00313339|myocardial infarction|myocardial infarction
5751773|NCT00313339|cd34+|cd34+
5751774|NCT00313339|stem cells|stem cells
5751775|NCT00313326|Adaptive Support ventilation|adaptive support ventilation
5751776|NCT00313326|Weaning|weaning
5751777|NCT00313248|Breast Cancer|breast cancer
5751778|NCT00313248|Metastatic Breast Cancer|metastatic breast cancer
5751779|NCT00313235|Dendritic Vaccine|dendritic vaccine
5751780|NCT00313235|Melanoma|melanoma
5751781|NCT00313235|Cyclophosphamide (CPA)|cyclophosphamide (cpa)
5751782|NCT00313222|CTEPH|cteph
5751783|NCT00313222|bosentan|bosentan
5751784|NCT00313209|Roflumilast|roflumilast
5751785|NCT00313209|Salmeterol|salmeterol
5751786|NCT00313209|COPD|copd
5751787|NCT00313209|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5751788|NCT00313196|Pulmonary Hypertension|pulmonary hypertension
5751789|NCT00313196|Sickle Cell Disease|sickle cell disease
5751790|NCT00313196|Sickle cell anemia|sickle cell anemia
5751791|NCT00313196|bosentan|bosentan
5751792|NCT00313196|ASSET|asset
5751793|NCT00313196|ASSET-2|asset-2
5751794|NCT00313183|Type 1 Diabetes|type 1 diabetes
5751795|NCT00313183|pediatric|pediatric
5751796|NCT00313183|pramlintide|pramlintide
5751797|NCT00313183|Symlin|symlin
5751798|NCT00313183|Amylin|amylin
5751799|NCT00313170|oncology|oncology
5751800|NCT00313170|cancer|cancer
5751801|NCT00313170|breast cancer|breast cancer
5751802|NCT00313157|Atrial fibrillation|atrial fibrillation
5751803|NCT00313131|bacterial vaginosis|bacterial vaginosis
5751804|NCT00313131|vaginal candidiasis|vaginal candidiasis
5751805|NCT00313131|trichomoniasis|trichomoniasis
5751806|NCT00313131|vaginitis|vaginitis
5751807|NCT00313131|Ghana|ghana
5751808|NCT00313131|Togo|togo
5751809|NCT00313131|Mali|mali
5751810|NCT00313131|Guinea|guinea
5751811|NCT00313118|oxidative stress parameters|oxidative stress parameters
5751812|NCT00313105|smoking cessation|smoking cessation
5751813|NCT00313105|smokeless tobacco|smokeless tobacco
5751814|NCT00313105|nicotine patch|nicotine patch
5751815|NCT00313105|nicotine buccal tablets|nicotine buccal tablets
5751816|NCT00313105|retreatment|retreatment
5751817|NCT00313105|adherence|adherence
5751818|NCT00313092|OSAS|osas
5751819|NCT00313092|glaucoma|glaucoma
5751821|NCT00313066|CTGF|ctgf
5751822|NCT00313066|fibrogenic cytokine|fibrogenic cytokine
5751824|NCT00313066|pleural fibrosis|pleural fibrosis
5751825|NCT00313040|physical activity|physical activity
5751826|NCT00313040|sedentary|sedentary
5751827|NCT00313040|behavioral medicine|behavioral medicine
5751828|NCT00313040|motivational interviewing|motivational interviewing
5751829|NCT00313014|Low back pain|low back pain
5751830|NCT00313014|opioid|opioid
5751831|NCT00313014|transdermal|transdermal
5751833|NCT00312988|Ovarian cancer|ovarian cancer
5741519|NCT00352599|NF1|nf1
5751834|NCT00312962|Schizoaffective Disorder|schizoaffective disorder
5751835|NCT00312962|Cognitive Remediation|cognitive remediation
5751836|NCT00312962|fMRI|fmri
5751837|NCT00312949|Patient participation|patient participation
5751838|NCT00312949|Patient education|patient education
5751839|NCT00312949|Consumer involvement|consumer involvement
5751840|NCT00312936|Medication adherence|medication adherence
5751841|NCT00312936|Medication compliance|medication compliance
5751842|NCT00312936|Quality of Life|quality of life
5751843|NCT00312936|Stress reduction|stress reduction
5751844|NCT00312936|mindfulness based stress reduction|mindfulness based stress reduction
5751845|NCT00312936|HIV/AIDS|hiv/aids
5751846|NCT00312936|treatment experienced|treatment experienced
5751849|NCT00312923|dyslipidemia|dyslipidemia
5751850|NCT00312923|policosanol|policosanol
5751851|NCT00312923|treatment experienced|treatment experienced
5751852|NCT00312910|Cirrhosis|cirrhosis
5751853|NCT00312910|Probiotics|probiotics
5751854|NCT00312910|Hepatic encephalopathy|hepatic encephalopathy
5751855|NCT00312910|Ammonia|ammonia
5751856|NCT00312897|Adolescents|adolescents
5751857|NCT00312897|Depression|depression
5751858|NCT00312897|Fish Oil|fish oil
5751859|NCT00312897|Omega-3 Fatty Acids|omega-3 fatty acids
5751860|NCT00312897|Psychiatry|psychiatry
5751861|NCT00312884|telemonitoring|telemonitoring
5751862|NCT00312884|heart failure|heart failure
5751863|NCT00312884|randomised|randomised
5751864|NCT00312884|hospitalisation|hospitalisation
5751865|NCT00312884|HomMed|hommed
5751866|NCT00312871|Chronic renal failure|chronic renal failure
5681008|NCT00575224|HCV|hcv
5751867|NCT00312871|Anemia|anemia
5751868|NCT00312871|Renal replacement therapy|renal replacement therapy
5751869|NCT00312871|Epoetin|epoetin
5751870|NCT00312871|Epoetin alfa|epoetin alfa
5751871|NCT00312871|erythropoietin|erythropoietin
5751872|NCT00312871|Chronic kidney failure|chronic kidney failure
5751873|NCT00312871|end-stage renal disease|end-stage renal disease
5751874|NCT00312858|Hepatitis A Virus|hepatitis a virus
5751875|NCT00312845|B-cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5751877|NCT00312832|d4T|d4t
5751878|NCT00312832|TDF|tdf
5751879|NCT00312832|lipoatrophy|lipoatrophy
5751880|NCT00312832|treatment experienced|treatment experienced
5751881|NCT00312832|HIV-infection|hiv-infection
5751882|NCT00312819|Non-small cel lung cancer|non-small cel lung cancer
5751883|NCT00312819|chemotherapy|chemotherapy
5751884|NCT00312819|randomized phaseII|randomized phaseii
5751885|NCT00312819|disulfiram|disulfiram
5751886|NCT00312819|antiangiogenesis|antiangiogenesis
5751887|NCT00312819|placebo|placebo
5751888|NCT00312806|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5751889|NCT00312806|GERD|gerd
5751890|NCT00312806|Pantoprazole|pantoprazole
5751891|NCT00312806|ReQuestTM|requesttm
5751892|NCT00312793|Anterior Cruciate Ligament reconstruction surgery|anterior cruciate ligament reconstruction surgery
5751893|NCT00312780|albuminuria|albuminuria
5751894|NCT00312780|diabetic nephropathy|diabetic nephropathy
5751895|NCT00312780|diabetes|diabetes
5751896|NCT00312767|Agalsidase beta|agalsidase beta
5751897|NCT00312767|alpha Galactosidase A|alpha galactosidase a
5751898|NCT00312767|aGAL|agal
5751899|NCT00312767|rh aGAL|rh agal
5751900|NCT00312767|Fabry|fabry
5751901|NCT00312767|GL3|gl3
5751902|NCT00312767|Fabrazyme|fabrazyme
5751903|NCT00312767|dialysis|dialysis
5751904|NCT00312767|hemodialysis|hemodialysis
5751905|NCT00312741|community-acquired pneumonia|community-acquired pneumonia
5751906|NCT00312741|microbiological tests|microbiological tests
5751907|NCT00312741|urinary antigen|urinary antigen
5751908|NCT00312741|selection of antibiotic treatment|selection of antibiotic treatment
5751909|NCT00312728|Brain Cancer|brain cancer
5751910|NCT00312728|Brain Metastases|brain metastases
5751911|NCT00312728|Avastin|avastin
5751912|NCT00312728|NSCLC|nsclc
5751913|NCT00312728|Lung Cancer|lung cancer
5751914|NCT00312728|PASSPORT|passport
5751915|NCT00312715|Deiodinase|deiodinase
5751916|NCT00312715|Levothyroxine|levothyroxine
5751917|NCT00312715|Liothyronine|liothyronine
5751918|NCT00312715|Lipid Metabolism|lipid metabolism
5751919|NCT00312715|Healthy Volunteer|healthy volunteer
5751920|NCT00312715|HV|hv
5751921|NCT00312702|Vaccine|vaccine
5751922|NCT00312702|Malaria|malaria
5751923|NCT00312702|Liver Stage Antigen-1|liver stage antigen-1
5751924|NCT00312702|Falciparum Malaria Protein-11|falciparum malaria protein-11
5751925|NCT00312702|AS02A|as02a
5751926|NCT00312702|adjuvant|adjuvant
5751927|NCT00312689|congenital|congenital
5751928|NCT00312689|lacrimal|lacrimal
5751929|NCT00312689|stenosis|stenosis
5751930|NCT00312689|bacteria|bacteria
5751931|NCT00312689|microbiological|microbiological
5751932|NCT00312676|Tolerability|tolerability
5751933|NCT00312676|Depakote DR|depakote dr
5751934|NCT00312676|Depakote ER|depakote er
5751935|NCT00312676|Elderly|elderly
5751936|NCT00312676|Conversion|conversion
5751937|NCT00312663|Vaccine|vaccine
5751938|NCT00312663|Phase I/II|phase i/ii
5751939|NCT00312663|Malaria|malaria
5751940|NCT00312663|Liver Stage Antigen -1|liver stage antigen -1
5741629|NCT00352391|NSCLC|nsclc
5751941|NCT00312663|Falciparum Malaria Protein -11|falciparum malaria protein -11
5751942|NCT00312663|AS01B|as01b
5751943|NCT00312663|adjuvant|adjuvant
5751944|NCT00312650|ovarian cancer|ovarian cancer
5751945|NCT00312650|recurrent|recurrent
5751946|NCT00312650|progressive|progressive
5751947|NCT00312637|Breast Cancer Staging|breast cancer staging
5751948|NCT00312624|ICD implantation|icd implantation
5751949|NCT00312624|cardiac MRI|cardiac mri
5751950|NCT00312624|cardiomyopathy|cardiomyopathy
5751951|NCT00312624|ventricular arrhythmias|ventricular arrhythmias
5751952|NCT00312624|LVEF 35% or less|lvef 35% or less
5751953|NCT00312624|indication for ICD implantation as part of standard of care|indication for icd implantation as part of standard of care
5751954|NCT00312611|Gastric pacing device|gastric pacing device
5751955|NCT00312611|Obesity|obesity
5751956|NCT00312598|schizophrenia|schizophrenia
5751957|NCT00312598|BMI|bmi
5751958|NCT00312598|weight|weight
5751959|NCT00312598|aripiprazole|aripiprazole
5751960|NCT00312598|antipsychotic|antipsychotic
5751961|NCT00312598|Mood Disorders with psychotic features|mood disorders with psychotic features
5751962|NCT00312585|pregnancy|pregnancy
5751963|NCT00312585|acupuncture|acupuncture
5751964|NCT00312572|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
5751965|NCT00312559|Parkinson's Disease|parkinson's disease
5751966|NCT00312546|Virus Latency|virus latency
5751967|NCT00312546|Valproic Acid|valproic acid
5751968|NCT00312546|Histone Deacetylase|histone deacetylase
5751969|NCT00312533|knee|knee
5751970|NCT00312533|injection|injection
5751971|NCT00312533|function|function
5751972|NCT00312533|osteoarthritis|osteoarthritis
5751973|NCT00312507|Meconium Aspiration Syndrome|meconium aspiration syndrome
5751974|NCT00312507|Surfactant|surfactant
5751975|NCT00312507|Bronchoalveolar Lavage|bronchoalveolar lavage
5751976|NCT00312507|newborns|newborns
5751977|NCT00312468|AIDS|aids
5751978|NCT00312455|Substance abuse|substance abuse
5751979|NCT00312455|Depression|depression
5750959|NCT00316264|palivizumab|palivizumab
5751980|NCT00312455|Aggression|aggression
5751981|NCT00312442|Prostate cancer after radiation therapy|prostate cancer after radiation therapy
5751982|NCT00312429|Hematological Malignancies|hematological malignancies
5751983|NCT00312429|Leukemia|leukemia
5751985|NCT00312429|Myelodysplasia|myelodysplasia
5751986|NCT00312429|Multiple Myeloma|multiple myeloma
5751987|NCT00312416|Choroidal blood flow|choroidal blood flow
5751988|NCT00312416|Clonidin|clonidin
5751989|NCT00312416|Brimonidin|brimonidin
5751990|NCT00312403|Glaucoma|glaucoma
5751991|NCT00312403|Gene Polymorphism|gene polymorphism
5751992|NCT00312403|Metalloproteinase|metalloproteinase
5751993|NCT00312390|Amblyopia|amblyopia
5751994|NCT00312390|Retinal vessel diameters|retinal vessel diameters
5751995|NCT00312390|Retinal blood flow|retinal blood flow
5751996|NCT00312390|Flicker|flicker
5751997|NCT00312377|Non-small cell lung cancer|non-small cell lung cancer
5751998|NCT00312377|NSCLC|nsclc
5751999|NCT00312364|toe ulcer|toe ulcer
5752000|NCT00312364|heel ulcer|heel ulcer
5752001|NCT00312364|foot ulcer|foot ulcer
5752002|NCT00312364|diabetic feet|diabetic feet
5752003|NCT00312364|diabetic foot|diabetic foot
5752004|NCT00312364|complications of diabetes|complications of diabetes
5752005|NCT00312351|AMD|amd
5752006|NCT00312351|Age-Related Macular Degeneration|age-related macular degeneration
5752007|NCT00312351|Macular Degeneration|macular degeneration
5752008|NCT00312351|Macugen|macugen
5752009|NCT00312351|pegaptanib sodium|pegaptanib sodium
5752010|NCT00312351|ERG|erg
5752011|NCT00312351|specular microscopy|specular microscopy
5752012|NCT00312351|Age-Related Mcular Degeneration (AMD)|age-related mcular degeneration (amd)
5752013|NCT00312325|Optic nerve head blood flow|optic nerve head blood flow
5752014|NCT00312325|Choroidal blood flow|choroidal blood flow
5752015|NCT00312325|Prednisolone|prednisolone
5752016|NCT00312325|Graves´ Ophthalmopathy|graves´ ophthalmopathy
5752017|NCT00312325|optic neuritis|optic neuritis
5752018|NCT00312312|Asthma|asthma
5752019|NCT00312312|Allergic rhinitis|allergic rhinitis
5752020|NCT00312312|Atopy|atopy
5752021|NCT00312312|Exhaled nitric oxide|exhaled nitric oxide
5752022|NCT00312312|Specific immunotherapy|specific immunotherapy
5752023|NCT00312312|Atopic diseases|atopic diseases
5752024|NCT00312299|Double-Blind Method|double-blind method
5752025|NCT00312299|Clinical Trials, Randomized|clinical trials, randomized
5752026|NCT00312299|Lenses, Intraocular|lenses, intraocular
5752027|NCT00312299|Prospective Studies|prospective studies
5752028|NCT00312299|PMMA|pmma
5752029|NCT00312299|Visual acuity|visual acuity
5752030|NCT00312286|Cervical Neoplasms|cervical neoplasms
5752031|NCT00312286|Drug Therapy|drug therapy
5752032|NCT00312286|Human Papillomavirus|human papillomavirus
5752033|NCT00312286|Cervical Human Papillomavirus|cervical human papillomavirus
5752034|NCT00312286|Cervical Dysplasia|cervical dysplasia
5752035|NCT00312286|Chemoprevention|chemoprevention
5752036|NCT00312286|High Risk Cervical Human Papillomavirus|high risk cervical human papillomavirus
5752037|NCT00312286|Atypical Squamous Cells of Undetermined Significance|atypical squamous cells of undetermined significance
5752038|NCT00312286|Low Grade Intraepithelial Lesions|low grade intraepithelial lesions
5752039|NCT00312273|Heart Arrest|heart arrest
5752040|NCT00312273|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5752041|NCT00312273|Aminophylline|aminophylline
5752042|NCT00312273|Bradycardia|bradycardia
5752044|NCT00312273|Emergency Medical Services|emergency medical services
5752045|NCT00312260|Pain|pain
5752046|NCT00312260|Analgesia|analgesia
5752047|NCT00312260|Gabapentin|gabapentin
5752048|NCT00312260|Amitriptyline|amitriptyline
5752049|NCT00312260|Pediatrics|pediatrics
5752050|NCT00312247|Walking|walking
5752051|NCT00312247|Muscle Strength|muscle strength
5752052|NCT00312247|Energy Cost|energy cost
5752053|NCT00312247|Quality of Life|quality of life
5752054|NCT00312234|Muscular Disease|muscular disease
5752055|NCT00312234|Fibromyalgia|fibromyalgia
5752056|NCT00312234|Exercise Therapy|exercise therapy
5752058|NCT00312234|Aerobic Exercise|aerobic exercise
5752059|NCT00312234|pediatrics|pediatrics
5752060|NCT00312221|Osteoarthritis, opioid, transdermal|osteoarthritis, opioid, transdermal
5752061|NCT00312195|Chronic pain|chronic pain
5752062|NCT00312195|opioid|opioid
5752063|NCT00312195|transdermal|transdermal
5752064|NCT00312195|Butrans™ [BTDS]|butrans™ [btds]
5752065|NCT00312169|HIV|hiv
5752066|NCT00312169|NNRTI|nnrti
5752067|NCT00312169|Incomplete virologic suppression|incomplete virologic suppression
5752068|NCT00312169|treatment experienced|treatment experienced
5752069|NCT00312143|De novo Kidney Transplant recipients, enteric-coated mycophenolate sodium|de novo kidney transplant recipients, enteric-coated mycophenolate sodium
5760934|NCT00280540|Valsartan|valsartan
5752070|NCT00312130|Vildaglptin|vildaglptin
5752071|NCT00312130|Pre-diabetes|pre-diabetes
5752072|NCT00312117|contrast induced nephropathy|contrast induced nephropathy
5752073|NCT00312117|sodium bicarbonate|sodium bicarbonate
5752074|NCT00312117|cardiac catheterization|cardiac catheterization
5752075|NCT00312091|Pharmacokinetics|pharmacokinetics
5752076|NCT00312091|Treatment Experienced|treatment experienced
5776600|NCT00213785|ANP|anp
5752077|NCT00312078|Minimal Hepatic Encephalopathy|minimal hepatic encephalopathy
5752078|NCT00312078|Cirrhosis|cirrhosis
5752079|NCT00312065|servocontrolled|servocontrolled
5752080|NCT00312065|radiant warmer|radiant warmer
5752081|NCT00312065|thermistor|thermistor
5752082|NCT00312065|heat shield|heat shield
5752083|NCT00312052|Coronary Artery Disease|coronary artery disease
5752084|NCT00312039|HIV-1|hiv-1
5752085|NCT00312039|treatment experienced|treatment experienced
5752086|NCT00312026|Plaque Psoriasis|plaque psoriasis
5752087|NCT00312026|Hands|hands
5752088|NCT00312026|Feet|feet
5752089|NCT00312026|Hand|hand
5752090|NCT00312013|low molecular weight heparin|low molecular weight heparin
5752091|NCT00312013|nadroparin|nadroparin
5752092|NCT00312013|non-small cell lung cancer|non-small cell lung cancer
5752093|NCT00312013|cancer survival|cancer survival
5752094|NCT00312013|prostate cancer|prostate cancer
5752095|NCT00312013|pancreatic cancer|pancreatic cancer
5752096|NCT00312000|colorectal|colorectal
5752097|NCT00312000|cancer|cancer
5752098|NCT00312000|capecitabine|capecitabine
5752099|NCT00312000|irinotecan|irinotecan
5752100|NCT00312000|oxaliplatin|oxaliplatin
5752101|NCT00311987|Hypercholesterolemia|hypercholesterolemia
5752102|NCT00311987|Thyroid hormone|thyroid hormone
5752103|NCT00311987|Diiodothyropropionic acid|diiodothyropropionic acid
5752104|NCT00311987|Therapy|therapy
5752105|NCT00311974|Dihydralazine|dihydralazine
5752106|NCT00311974|Sympathetic activation|sympathetic activation
5752107|NCT00311974|Fractional sodium excretion|fractional sodium excretion
5752108|NCT00311961|COPD|copd
5752109|NCT00311961|Exacerbations|exacerbations
5752110|NCT00311961|Corticosteroids|corticosteroids
5752111|NCT00311961|Oral|oral
5752112|NCT00311961|Intravenous|intravenous
5752113|NCT00311961|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5752114|NCT00311948|Teen smokers|teen smokers
5752115|NCT00311948|Quithelper|quithelper
5752117|NCT00311948|Tobacco Website|tobacco website
5752118|NCT00311948|Website Intervention|website intervention
5752119|NCT00311948|Tobacco counseling|tobacco counseling
5752120|NCT00311948|Tobacco abstinence|tobacco abstinence
5752121|NCT00311935|Hernia|hernia
5752122|NCT00311935|Inguinal|inguinal
5752123|NCT00311935|Groin|groin
5752124|NCT00311935|Laparoscopic|laparoscopic
5752125|NCT00311935|Open|open
5752126|NCT00311935|Abdominal wall|abdominal wall
5752127|NCT00311922|Diabetes|diabetes
5752128|NCT00311922|Education|education
5752129|NCT00311922|Health Literacy|health literacy
5752130|NCT00311909|Tourette Syndrome|tourette syndrome
5752131|NCT00311909|Deep Brain Stimulation|deep brain stimulation
5752132|NCT00311909|Video assessment|video assessment
5752133|NCT00311909|YGTSS|ygtss
5752134|NCT00311909|TSSL|tssl
5752135|NCT00311896|Cancer|cancer
5752136|NCT00311896|Thrombosis|thrombosis
5752137|NCT00311896|Catheter|catheter
5752138|NCT00311896|Bemiparin|bemiparin
5752139|NCT00311896|Prophylaxis|prophylaxis
5752140|NCT00311883|Cystic Fibrosis|cystic fibrosis
5752141|NCT00311883|Induced sputum|induced sputum
5752142|NCT00311883|Lung inflammation|lung inflammation
5752143|NCT00311857|Cetuximab|cetuximab
5752144|NCT00311831|Pediatrics|pediatrics
5752145|NCT00311831|Gastroenteritis|gastroenteritis
5752150|NCT00311779|Pediculosis capitis|pediculosis capitis
5752151|NCT00311779|Head Lice|head lice
5752152|NCT00311779|Crawlers|crawlers
5752154|NCT00311766|Epidermolysis Bullosa|epidermolysis bullosa
5752155|NCT00311766|cutaneous wound-healing|cutaneous wound-healing
5752156|NCT00311766|chronic wound-healing|chronic wound-healing
5752157|NCT00311766|Thymosin Beta 4|thymosin beta 4
5752158|NCT00311766|laminin-5|laminin-5
5752159|NCT00311753|heparin, thromboprophylaxis, medical patients, acutely ill|heparin, thromboprophylaxis, medical patients, acutely ill
5752160|NCT00311753|Acutely ill non surgical patients|acutely ill non surgical patients
5752161|NCT00311753|Immobilization|immobilization
5752162|NCT00311740|Hypertension,|hypertension,
5752163|NCT00311740|Valsartan,|valsartan,
5752164|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide
5752165|NCT00311727|Cell-Mediated Immune Responses, Influenza, A/H5N1, Vaccine, sub-study|cell-mediated immune responses, influenza, a/h5n1, vaccine, sub-study
5752166|NCT00311714|Influenza, United Kingdom|influenza, united kingdom
5752167|NCT00311701|Influenza, pediatric|influenza, pediatric
5752168|NCT00311688|IL-2|il-2
5752169|NCT00311688|Immunomodulatory Therapies|immunomodulatory therapies
5752170|NCT00311675|influenza, A/H5N1, vaccine|influenza, a/h5n1, vaccine
5752171|NCT00311649|H5N1, Influenza|h5n1, influenza
5752172|NCT00311636|stage I breast cancer|stage i breast cancer
5752173|NCT00311636|stage II breast cancer|stage ii breast cancer
5752174|NCT00311636|stage IIIA breast cancer|stage iiia breast cancer
5752175|NCT00311636|stage IIIB breast cancer|stage iiib breast cancer
5752176|NCT00311636|stage IIIC breast cancer|stage iiic breast cancer
5752177|NCT00311623|stage III prostate cancer|stage iii prostate cancer
5752178|NCT00311623|stage I prostate cancer|stage i prostate cancer
5752179|NCT00311623|stage IIB prostate cancer|stage iib prostate cancer
5752180|NCT00311623|stage IIA prostate cancer|stage iia prostate cancer
5752181|NCT00311623|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5752182|NCT00311610|recurrent colon cancer|recurrent colon cancer
5752183|NCT00311610|stage IV colon cancer|stage iv colon cancer
5752184|NCT00311610|recurrent rectal cancer|recurrent rectal cancer
5752185|NCT00311610|stage IV rectal cancer|stage iv rectal cancer
5752186|NCT00311597|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5752187|NCT00311584|recurrent neuroblastoma|recurrent neuroblastoma
5752189|NCT00311571|spaceflight|spaceflight
5752190|NCT00311571|Weightlessness|weightlessness
5752191|NCT00311571|Countermeasure|countermeasure
5752192|NCT00311558|stage IV melanoma|stage iv melanoma
5752193|NCT00311558|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5752194|NCT00311558|recurrent melanoma|recurrent melanoma
5752195|NCT00311545|recurrent renal cell cancer|recurrent renal cell cancer
5752196|NCT00311545|stage IV renal cell cancer|stage iv renal cell cancer
5752197|NCT00311545|stage III renal cell cancer|stage iii renal cell cancer
5752198|NCT00311519|Subcutaneous hydration|subcutaneous hydration
5752199|NCT00311519|Hylenex|hylenex
5752200|NCT00311519|Hyaluronidase|hyaluronidase
5752201|NCT00311506|Pulmozyme|pulmozyme
5752202|NCT00311493|TBE|tbe
5752203|NCT00311493|vaccine|vaccine
5752204|NCT00311493|adults|adults
5752205|NCT00311480|influenza|influenza
5752206|NCT00311480|pandemic influenza|pandemic influenza
5752207|NCT00311480|influenza vaccine|influenza vaccine
5752208|NCT00311480|adjuvanted influenza vaccine|adjuvanted influenza vaccine
5752209|NCT00311467|renal cell cancer|renal cell cancer
5752210|NCT00311441|TBE, children, vaccine|tbe, children, vaccine
5752211|NCT00311428|Influenza|influenza
5752212|NCT00311428|Children|children
5752213|NCT00311428|Vaccine|vaccine
5752214|NCT00311415|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5752215|NCT00311415|meningococcal vaccines|meningococcal vaccines
5752216|NCT00311415|conjugate|conjugate
5752217|NCT00311415|immunology|immunology
5752219|NCT00311415|antibody persistence|antibody persistence
5752220|NCT00311389|Glaucoma|glaucoma
5752221|NCT00311389|POAG|poag
5752222|NCT00311389|OAG|oag
5752223|NCT00311389|OHT|oht
5752224|NCT00311350|Safety|safety
5752225|NCT00311350|Health|health
5752226|NCT00311350|Pharmacokinetics|pharmacokinetics
5752227|NCT00311350|ileus|ileus
5752228|NCT00311337|VELCADE|velcade
5752229|NCT00311337|bortezomib|bortezomib
5752230|NCT00311337|maintenance treatment|maintenance treatment
5752231|NCT00311337|multiple myeloma|multiple myeloma
5752232|NCT00311337|primary disease|primary disease
5752233|NCT00311324|behavioral intervention|behavioral intervention
5752234|NCT00311311|Kidney transplant|kidney transplant
5752235|NCT00311311|Renal transplant|renal transplant
5752236|NCT00311311|Immunosuppression|immunosuppression
5752237|NCT00311311|Atherosclerosis|atherosclerosis
5752238|NCT00311311|Graft Rejection|graft rejection
5752239|NCT00311298|tuberculosis|tuberculosis
5752240|NCT00311298|hiv|hiv
5752241|NCT00311298|diabetes|diabetes
5752242|NCT00311298|protein-energy|protein-energy
5752243|NCT00311298|micronutrients|micronutrients
5752244|NCT00311285|Electromyography|electromyography
5752245|NCT00311285|Glucocorticoids|glucocorticoids
5752246|NCT00311285|Heart Rate|heart rate
5752247|NCT00311285|Physical workload|physical workload
5752248|NCT00311285|Mental workload|mental workload
5752250|NCT00311285|Laparoscopy|laparoscopy
5752251|NCT00311285|Workload|workload
5752252|NCT00311285|Biomechanics|biomechanics
5752253|NCT00311272|dendritic cells|dendritic cells
5752254|NCT00311272|antigens, neoplasm|antigens, neoplasm
5752255|NCT00311246|Sarcoidosis|sarcoidosis
5752256|NCT00311246|Humira|humira
5752257|NCT00311246|Adalimumab|adalimumab
5752258|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors
5752259|NCT00311233|child|child
5752260|NCT00311233|psychosocial|psychosocial
5752261|NCT00311233|predictors|predictors
5752262|NCT00311233|cohort|cohort
5752263|NCT00311233|recurrent|recurrent
5752264|NCT00311220|tuberculosis|tuberculosis
5752265|NCT00311220|latent tuberculosis|latent tuberculosis
5752266|NCT00311220|tuberculin skin test|tuberculin skin test
5752267|NCT00311220|quantiferon TB-RD1|quantiferon tb-rd1
5752268|NCT00311220|contact screening|contact screening
5752269|NCT00311220|elderly|elderly
5752270|NCT00311207|diagnostic kit|diagnostic kit
5752271|NCT00311207|immunochromatography test|immunochromatography test
5752272|NCT00311207|PCR detection kit|pcr detection kit
5752273|NCT00311207|luminex|luminex
5752274|NCT00311194|Heart failure|heart failure
5752275|NCT00311194|Education|education
5752276|NCT00311194|CD-ROM|cd-rom
5752277|NCT00311194|Randomization|randomization
5752278|NCT00311194|Hospitalization|hospitalization
5752279|NCT00311194|Readmission|readmission
5752280|NCT00311194|Death|death
5752281|NCT00311194|Knowledge|knowledge
5752282|NCT00311181|ICD|icd
5752283|NCT00311181|Defibrillation|defibrillation
5752284|NCT00311181|ULV|ulv
5752285|NCT00311181|Tuned|tuned
5752286|NCT00311155|Olmesartan medoxomil|olmesartan medoxomil
5752287|NCT00311155|Hypertension|hypertension
5752288|NCT00311142|Sleep pattern|sleep pattern
5752289|NCT00311142|newborn|newborn
5686301|NCT00552643|Wound healing|wound healing
5752290|NCT00311142|actigraphy|actigraphy
5752291|NCT00311142|delivery mode|delivery mode
5752292|NCT00311142|Parents' approval|parents' approval
5752293|NCT00311116|Vitamin E|vitamin e
5752294|NCT00311116|Cancer|cancer
5752295|NCT00311116|pediatrics|pediatrics
5752296|NCT00311116|supportive care|supportive care
5752297|NCT00311116|oral mucositis|oral mucositis
5752298|NCT00311116|Bayesian analysis|bayesian analysis
5752299|NCT00311116|N-of-1 trial|n-of-1 trial
5752300|NCT00311116|prophylaxis|prophylaxis
5752301|NCT00311103|Elderly|elderly
5752302|NCT00311103|Disability|disability
5752303|NCT00311103|Musculoskeletal diseases|musculoskeletal diseases
5752304|NCT00311090|Deep Venous Thrombosis|deep venous thrombosis
5752305|NCT00311051|Asthma|asthma
5752306|NCT00311051|Allergens|allergens
5752307|NCT00311051|house dust mites|house dust mites
5752308|NCT00311051|Ramatroban|ramatroban
5752309|NCT00311051|Montelukast|montelukast
5752310|NCT00311051|Bronchial Provocation Tests|bronchial provocation tests
5752311|NCT00311038|ONO-1101|ono-1101
5752312|NCT00311038|Landiolol Hydrochloride|landiolol hydrochloride
5752313|NCT00311038|Multi-slice CT|multi-slice ct
5752314|NCT00311038|Coronary Artery Disease|coronary artery disease
5752315|NCT00311025|stroke|stroke
5752316|NCT00311025|physical therapy|physical therapy
5752317|NCT00311025|rehabilitation|rehabilitation
5752318|NCT00311025|exercise|exercise
5752319|NCT00311025|longterm follow-up|longterm follow-up
5752320|NCT00311012|Hypertension, Aliskiren|hypertension, aliskiren
5752321|NCT00310999|Cervical Vertebrae|cervical vertebrae
5752322|NCT00310999|Intubation, Intratracheal|intubation, intratracheal
5752323|NCT00310999|Laryngoscopes|laryngoscopes
5752324|NCT00310999|Fluoroscopy|fluoroscopy
5752325|NCT00310986|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5752326|NCT00310986|meditation|meditation
5752327|NCT00310986|breathing meditation|breathing meditation
5752328|NCT00310986|Anapanasathi|anapanasathi
5752329|NCT00310986|randomized controlled trial|randomized controlled trial
5752330|NCT00310986|nonpharmacologic treatment|nonpharmacologic treatment
5752331|NCT00310986|complementary and alternative medicine|complementary and alternative medicine
5752333|NCT00310973|Prevention|prevention
5752334|NCT00310973|Risk Behavior Reduction|risk behavior reduction
5752335|NCT00310973|Roma|roma
5752336|NCT00310973|Bulgaria|bulgaria
5752337|NCT00310973|HIV seronegativity|hiv seronegativity
5752338|NCT00310960|infantile esotropia|infantile esotropia
5752339|NCT00310960|acquired non-accommodative esotropia|acquired non-accommodative esotropia
5752340|NCT00310960|acquired partially accommodative esotropia|acquired partially accommodative esotropia
5752341|NCT00310947|Coronary artery disease|coronary artery disease
5752342|NCT00310947|Coronary flow reserve|coronary flow reserve
5752343|NCT00310947|Heart failure|heart failure
5752344|NCT00310947|prospective randomised|prospective randomised
5752345|NCT00310934|heroin dependence|heroin dependence
5752346|NCT00310934|methadone|methadone
5752347|NCT00310934|buprenorphine|buprenorphine
5752348|NCT00310934|contingency management|contingency management
5752349|NCT00310934|relapse prevention|relapse prevention
5752350|NCT00310908|Renal|renal
5752351|NCT00310908|Colic|colic
5752352|NCT00310908|Calculi|calculi
5752356|NCT00310882|breast cancer|breast cancer
5752357|NCT00310882|digitalis like compounds|digitalis like compounds
5752358|NCT00310882|prognostic factor|prognostic factor
5752359|NCT00310869|Preterm Birth|preterm birth
5752360|NCT00310869|Prematurity|prematurity
5752361|NCT00310869|NIDCAP|nidcap
5752362|NCT00310869|Adolescence|adolescence
5752363|NCT00310869|Developmental Care|developmental care
5752364|NCT00310869|Follow-up|follow-up
5752365|NCT00310869|Neurobehavior|neurobehavior
5752366|NCT00310856|meningitis|meningitis
5752367|NCT00310856|children|children
5752368|NCT00310856|vaccine|vaccine
5752369|NCT00310830|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5752370|NCT00310830|Pulmonary hypertension|pulmonary hypertension
5752371|NCT00310830|Sickle Cell Disease|sickle cell disease
5752372|NCT00310830|Sickle cell anemia|sickle cell anemia
5752373|NCT00310830|ASSET|asset
5752374|NCT00310830|ASSET-1|asset-1
5752375|NCT00310817|meningitis|meningitis
5752376|NCT00310817|children|children
5752377|NCT00310817|vaccine|vaccine
5752378|NCT00310804|Influenza|influenza
5752380|NCT00310804|Cell-Derived|cell-derived
5752381|NCT00310804|Egg-Derived|egg-derived
5752382|NCT00310804|Healthy Adults|healthy adults
5752383|NCT00310804|Safety|safety
5752384|NCT00310804|Immunogenicity|immunogenicity
5752385|NCT00310804|Vaccination|vaccination
5752386|NCT00310791|anorexia nervosa|anorexia nervosa
5752387|NCT00310791|adolescents|adolescents
5752388|NCT00310791|dual-energy x-ray absorptiometry|dual-energy x-ray absorptiometry
5752389|NCT00310791|dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5752390|NCT00310791|osteoporosis|osteoporosis
5752391|NCT00310778|High sodium diet|high sodium diet
5752392|NCT00310778|Low sodium diet|low sodium diet
5752393|NCT00310778|Renin-angiotensin system blockers|renin-angiotensin system blockers
5752394|NCT00310778|AT1 receptor (AT1R) antagonist|at1 receptor (at1r) antagonist
5752395|NCT00310778|ACE inhibition|ace inhibition
5752396|NCT00310765|abdominal pain|abdominal pain
5752397|NCT00310765|surgical adhesions|surgical adhesions
5752398|NCT00310726|Mother to Child Transmission of HIV|mother to child transmission of hiv
5752399|NCT00310726|Postnatal HIV transmission|postnatal hiv transmission
5752401|NCT00310726|Breastfeeding|breastfeeding
5752402|NCT00310726|Perinatal HIV Transmission|perinatal hiv transmission
5752403|NCT00310726|HIV Seronegativity|hiv seronegativity
5752404|NCT00310713|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5752405|NCT00310713|vaccines|vaccines
5752406|NCT00310713|conjugate|conjugate
5752407|NCT00310713|immunology|immunology
5752408|NCT00310713|children|children
5752409|NCT00310713|antibody persistence|antibody persistence
5752410|NCT00310700|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5752411|NCT00310700|vaccines, conjugate|vaccines, conjugate
5752412|NCT00310700|immunology|immunology
5752413|NCT00310700|infant|infant
5752414|NCT00310700|antibody persistence|antibody persistence
5752415|NCT00310687|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5752416|NCT00310687|vaccines|vaccines
5752417|NCT00310687|conjugate|conjugate
5752418|NCT00310687|immunology|immunology
5752419|NCT00310687|antibody persistence|antibody persistence
5752420|NCT00310674|Prevention of Meningococcal Meningitis|prevention of meningococcal meningitis
5752421|NCT00310674|meningococcal vaccines|meningococcal vaccines
5752422|NCT00310674|conjugate|conjugate
5752423|NCT00310674|Immunology|immunology
5752424|NCT00310674|infant|infant
5752425|NCT00310661|sarizotan|sarizotan
5752426|NCT00310661|neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
5752427|NCT00310648|Influenza, elderly, vaccine|influenza, elderly, vaccine
5752428|NCT00310635|Prevention of meningococcal infection|prevention of meningococcal infection
5752429|NCT00310622|HyperQ|hyperq
5752430|NCT00310622|Ischemia|ischemia
5752431|NCT00310622|dobutamine|dobutamine
5752432|NCT00310609|Structural abnormalities of the aortic arch and cerebral branches|structural abnormalities of the aortic arch and cerebral branches
5752433|NCT00310596|ECG safety|ecg safety
5752434|NCT00310583|tactile hyperalgesia|tactile hyperalgesia
5752435|NCT00310583|neuropathic pain|neuropathic pain
5752436|NCT00310583|enriched design|enriched design
5752437|NCT00310583|peripheral nerve lesion|peripheral nerve lesion
5752438|NCT00310583|plexus lesion|plexus lesion
5752439|NCT00310583|radicular lesion|radicular lesion
5752440|NCT00310583|spinal lesion|spinal lesion
5752441|NCT00310583|polyneuropathy|polyneuropathy
5752442|NCT00310583|postzosteric neuralgia|postzosteric neuralgia
5752444|NCT00310570|interphalangeal|interphalangeal
5752445|NCT00310570|extensor tendon|extensor tendon
5752446|NCT00310570|avulsion|avulsion
5752447|NCT00310505|visceral leishmaniasis|visceral leishmaniasis
5752448|NCT00310505|amphotericin B|amphotericin b
5752449|NCT00310505|Kala-azar|kala-azar
5752450|NCT00310479|Magnetic Resonance Imaging|magnetic resonance imaging
5752451|NCT00310479|prostate cancer imaging|prostate cancer imaging
5752452|NCT00310479|3T MRS|3t mrs
5752453|NCT00310479|functional imaging|functional imaging
5752454|NCT00310440|Degenerative disc disease|degenerative disc disease
5752455|NCT00310440|P-15 Bone Putty|p-15 bone putty
5752457|NCT00310440|Cervical discectomy|cervical discectomy
5752458|NCT00310440|Cervical spine|cervical spine
5752460|NCT00310427|Alcohol Dependence|alcohol dependence
5752461|NCT00310427|Alcoholism|alcoholism
5752462|NCT00310414|Imaging Studies|imaging studies
5752463|NCT00310414|Botulinum Toxin|botulinum toxin
5752464|NCT00310414|Writer's Cramp|writer's cramp
5752465|NCT00310414|Focal Hand Dystonia|focal hand dystonia
5752467|NCT00310414|Writer Cramp|writer cramp
5752468|NCT00310414|Healthy Volunteer|healthy volunteer
5752469|NCT00310414|HV|hv
5752470|NCT00310401|brain death|brain death
5752471|NCT00310401|organ donor|organ donor
5752472|NCT00310401|pulmonary edema|pulmonary edema
5752473|NCT00310401|albuterol|albuterol
5752475|NCT00310401|lung transplantation|lung transplantation
5752476|NCT00310401|infiltrates|infiltrates
5752477|NCT00310388|Partial Seizures|partial seizures
5752478|NCT00310388|Epilepsy|epilepsy
5752479|NCT00310388|RTG115097|rtg115097
5752480|NCT00310388|Complex Partial Seizures|complex partial seizures
5752481|NCT00310388|Anticonvulsant|anticonvulsant
5752482|NCT00310388|Potassium Channels|potassium channels
5752483|NCT00310388|Epilepsies, Partial|epilepsies, partial
5752484|NCT00310375|Epilepsy|epilepsy
5752485|NCT00310375|Partial Seizures|partial seizures
5752486|NCT00310375|Potassium Channels|potassium channels
5752487|NCT00310375|Anticonvulsant|anticonvulsant
5752488|NCT00310375|Complex Partial Seizures|complex partial seizures
5752489|NCT00310375|Epilepsies, Partial|epilepsies, partial
5761316|NCT00278876|Kit mutation|kit mutation
5752490|NCT00310375|RTG115098|rtg115098
5752491|NCT00310362|telephone|telephone
5752492|NCT00310362|telemedicine|telemedicine
5752493|NCT00310362|mass screening|mass screening
5752494|NCT00310362|patient education|patient education
5752495|NCT00310362|Patient compliance|patient compliance
5752496|NCT00310349|pneumococcal vaccine|pneumococcal vaccine
5763185|NCT00271076|TIA|tia
5752497|NCT00310349|clinical trial|clinical trial
5752498|NCT00310349|Indigenous|indigenous
5752499|NCT00310349|Maternal|maternal
5752500|NCT00310349|Streptococcus pneumoniae|streptococcus pneumoniae
5752501|NCT00310323|sleep apnea|sleep apnea
5752502|NCT00310323|phenotyping|phenotyping
5752503|NCT00310323|cytochrome P450|cytochrome p450
5752504|NCT00310323|drug metabolism|drug metabolism
5752505|NCT00310323|child|child
5752506|NCT00310310|Continuous positive airway pressure|continuous positive airway pressure
5752507|NCT00310310|Patient compliance|patient compliance
5752508|NCT00310310|Self-care|self-care
5752509|NCT00310284|Insomnia|insomnia
5752511|NCT00310271|DNA vaccine, immunotherapy, HSV-2, PMED|dna vaccine, immunotherapy, hsv-2, pmed
5752512|NCT00310245|CD4-guided STI|cd4-guided sti
5752513|NCT00310245|Keywords:|keywords:
5752514|NCT00310245|HAART|haart
5752515|NCT00310245|Clinical outcome|clinical outcome
5752516|NCT00310245|Resistance|resistance
5752517|NCT00310245|Costs|costs
5752518|NCT00310245|Prognostic factors|prognostic factors
5752519|NCT00310245|pulse therapy|pulse therapy
5752520|NCT00310245|treatment experienced|treatment experienced
5752521|NCT00310245|treatment interruption|treatment interruption
5752522|NCT00310232|Quality of Life|quality of life
5752523|NCT00310232|Blood transfusion|blood transfusion
5752524|NCT00310219|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5752525|NCT00310219|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5752526|NCT00310219|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5752527|NCT00310219|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5752528|NCT00310206|Influenza, pandemic, H5N1, vaccine|influenza, pandemic, h5n1, vaccine
5752529|NCT00310167|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5752530|NCT00310167|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5768512|NCT00250172|Reproducibility|reproducibility
5768513|NCT00250172|Healthy Volunteer|healthy volunteer
5768514|NCT00250172|HV|hv
5768523|NCT00250146|Celiac Disease|celiac disease
5768524|NCT00250146|Gluten|gluten
5768525|NCT00250146|Toxicity|toxicity
5768526|NCT00250146|Small bowel morphometry|small bowel morphometry
5768527|NCT00250133|selective decontamination of the digestive tract|selective decontamination of the digestive tract
5768528|NCT00250120|NSCLC|nsclc
5768529|NCT00250120|L9NC|l9nc
5752531|NCT00310167|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5752532|NCT00310167|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5752533|NCT00310167|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5752534|NCT00310167|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5752535|NCT00310167|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5752536|NCT00310167|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5752537|NCT00310167|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5752538|NCT00310167|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5752539|NCT00310167|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5752540|NCT00310167|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5752541|NCT00310167|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5752542|NCT00310167|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5752543|NCT00310167|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5752544|NCT00310167|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5752545|NCT00310167|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5752546|NCT00310167|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5752547|NCT00310167|Marginal zone lymphoma|marginal zone lymphoma
5752548|NCT00310154|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5752549|NCT00310154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5752550|NCT00310154|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5752551|NCT00310154|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5752552|NCT00310154|large cell lung cancer|large cell lung cancer
5752553|NCT00310154|squamous cell lung cancer|squamous cell lung cancer
5752554|NCT00310154|adenocarcinoma of the lung|adenocarcinoma of the lung
5752998|NCT00308269|Refractory|refractory
5752555|NCT00310141|non-small cell lung cancer|non-small cell lung cancer
5752556|NCT00310141|small cell lung cancer|small cell lung cancer
5752557|NCT00310128|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5752558|NCT00310128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5752559|NCT00310128|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5752560|NCT00310128|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5752561|NCT00310128|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5752562|NCT00310128|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5752563|NCT00310128|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5752564|NCT00310128|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5751578|NCT00314054|Phase 1|phase 1
5752565|NCT00310128|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5752566|NCT00310128|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5752567|NCT00310128|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5752568|NCT00310128|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5752569|NCT00310128|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5752570|NCT00310128|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5752571|NCT00310128|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5752572|NCT00310128|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5752573|NCT00310128|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5752574|NCT00310128|contiguous stage II adult Burkitt's lymphoma|contiguous stage ii adult burkitt's lymphoma
5752575|NCT00310128|noncontiguous stage II adult Burkitt's lymphoma|noncontiguous stage ii adult burkitt's lymphoma
5752577|NCT00310128|stage I adult Burkitt's lymphoma|stage i adult burkitt's lymphoma
5752578|NCT00310128|stage III adult Burkitt's lymphoma|stage iii adult burkitt's lymphoma
5752579|NCT00310128|stage IV adult Burkitt's lymphoma|stage iv adult burkitt's lymphoma
5752580|NCT00310128|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5752581|NCT00310128|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5768605|NCT00249691|cocaine dependence|cocaine dependence
5768626|NCT00249496|cocaine|cocaine
5752582|NCT00310128|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5752583|NCT00310128|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5752584|NCT00310128|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5752585|NCT00310128|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5752586|NCT00310128|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5752587|NCT00310128|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5752588|NCT00310128|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5752589|NCT00310128|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5752590|NCT00310128|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5752591|NCT00310128|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5752592|NCT00310128|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5752593|NCT00310128|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5752594|NCT00310128|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5752595|NCT00310128|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5752596|NCT00310128|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5752597|NCT00310128|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5752598|NCT00310128|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5752599|NCT00310115|non-small cell lung cancer|non-small cell lung cancer
5752600|NCT00310115|small cell lung cancer|small cell lung cancer
5752601|NCT00310115|bladder cancer|bladder cancer
5752602|NCT00310115|cervical cancer|cervical cancer
5752603|NCT00310115|esophageal cancer|esophageal cancer
5752605|NCT00310115|renal cell carcinoma|renal cell carcinoma
5752606|NCT00310115|adult primary liver cancer|adult primary liver cancer
5752607|NCT00310115|pancreatic cancer|pancreatic cancer
5752608|NCT00310115|hypopharyngeal cancer|hypopharyngeal cancer
5752609|NCT00310115|lip and oral cavity cancer|lip and oral cavity cancer
5752610|NCT00310115|laryngeal cancer|laryngeal cancer
5752611|NCT00310115|nasopharyngeal cancer|nasopharyngeal cancer
5752612|NCT00310115|oropharyngeal cancer|oropharyngeal cancer
5752613|NCT00310115|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5752885|NCT00308906|child|child
5752614|NCT00310115|adult acute myeloid leukemia|adult acute myeloid leukemia
5752615|NCT00310115|tobacco use disorder|tobacco use disorder
5752616|NCT00310089|stage IIIA breast cancer|stage iiia breast cancer
5752617|NCT00310089|stage IIIB breast cancer|stage iiib breast cancer
5752618|NCT00310089|stage IIIC breast cancer|stage iiic breast cancer
5752619|NCT00310089|inflammatory breast cancer|inflammatory breast cancer
5752620|NCT00310076|carcinoma of the appendix|carcinoma of the appendix
5752621|NCT00310076|stage II colon cancer|stage ii colon cancer
5752622|NCT00310076|stage III colon cancer|stage iii colon cancer
5752623|NCT00310076|stage IV colon cancer|stage iv colon cancer
5752624|NCT00310076|recurrent colon cancer|recurrent colon cancer
5752625|NCT00310076|stage II rectal cancer|stage ii rectal cancer
5752626|NCT00310076|stage III rectal cancer|stage iii rectal cancer
5752627|NCT00310076|stage IV rectal cancer|stage iv rectal cancer
5752628|NCT00310076|recurrent rectal cancer|recurrent rectal cancer
5752629|NCT00310063|nausea and vomiting|nausea and vomiting
5752630|NCT00310063|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5752631|NCT00310050|stage II pancreatic cancer|stage ii pancreatic cancer
5752632|NCT00310050|stage III pancreatic cancer|stage iii pancreatic cancer
5752633|NCT00310050|stage IV pancreatic cancer|stage iv pancreatic cancer
5752634|NCT00310011|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5752635|NCT00310011|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5752636|NCT00310011|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5752637|NCT00310011|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5752638|NCT00310011|stage IV bladder cancer|stage iv bladder cancer
5752639|NCT00310011|recurrent bladder cancer|recurrent bladder cancer
5752640|NCT00309998|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5752641|NCT00309998|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5752642|NCT00309998|adenocarcinoma of the lung|adenocarcinoma of the lung
5752643|NCT00309998|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5752644|NCT00309998|large cell lung cancer|large cell lung cancer
5752645|NCT00309998|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5752646|NCT00309985|metastatic hormone-sensitive prostate cancer|metastatic hormone-sensitive prostate cancer
5752648|NCT00309972|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5752649|NCT00309972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5752650|NCT00309933|cognitive/functional effects|cognitive/functional effects
5752651|NCT00309933|spiritual concerns|spiritual concerns
5752652|NCT00309933|sexuality and reproductive issues|sexuality and reproductive issues
5752653|NCT00309933|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5752654|NCT00309933|cancer survivor|cancer survivor
5752655|NCT00309933|stage I breast cancer|stage i breast cancer
5752656|NCT00309933|stage II breast cancer|stage ii breast cancer
5752657|NCT00309933|stage IIIA breast cancer|stage iiia breast cancer
5752658|NCT00309933|stage IIIB breast cancer|stage iiib breast cancer
5752659|NCT00309933|stage IIIC breast cancer|stage iiic breast cancer
5752660|NCT00309920|stage IIIA breast cancer|stage iiia breast cancer
5752661|NCT00309920|stage IIIC breast cancer|stage iiic breast cancer
5752662|NCT00309894|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5752663|NCT00309894|recurrent prostate cancer|recurrent prostate cancer
5752664|NCT00309881|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5752665|NCT00309881|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5752666|NCT00309881|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5752667|NCT00309881|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5752668|NCT00309881|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5752669|NCT00309868|heart catheterization|heart catheterization
5752670|NCT00309868|echocardiogram|echocardiogram
5752671|NCT00309868|nesiritide|nesiritide
5752672|NCT00309842|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5752673|NCT00309842|primary myelofibrosis|primary myelofibrosis
5752674|NCT00309842|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5752675|NCT00309842|myelodysplastic syndromes|myelodysplastic syndromes
5752676|NCT00309842|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5752677|NCT00309842|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5752678|NCT00309842|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5752679|NCT00309842|recurrent lymphoblastic lymphoma|recurrent lymphoblastic lymphoma
5752680|NCT00309842|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5752681|NCT00309842|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5752682|NCT00309842|recurrent follicular lymphoma|recurrent follicular lymphoma
5752683|NCT00309842|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5752684|NCT00309842|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5752685|NCT00309842|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5752686|NCT00309842|refractory multiple myeloma|refractory multiple myeloma
5752687|NCT00309842|chronic myelogenous leukemia|chronic myelogenous leukemia
5752688|NCT00309842|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5752689|NCT00309842|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5752690|NCT00309842|multiple myeloma|multiple myeloma
5752691|NCT00309842|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5752692|NCT00309842|refractory anemia with excess blasts|refractory anemia with excess blasts
5752693|NCT00309842|refractory anemia|refractory anemia
5752694|NCT00309842|Burkitt lymphoma|burkitt lymphoma
5752695|NCT00309842|childhood large cell lymphoma|childhood large cell lymphoma
5752696|NCT00309842|adult Burkitt lymphoma|adult burkitt lymphoma
5752697|NCT00309842|mantle cell lymphoma|mantle cell lymphoma
5752698|NCT00309842|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5752699|NCT00309842|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5752700|NCT00309816|Exercise stress test|exercise stress test
5752701|NCT00309803|Carotid artery|carotid artery
5752702|NCT00309803|distal protection device|distal protection device
5752703|NCT00309790|exercise stress test|exercise stress test
5752704|NCT00309777|hypercholesterolemia|hypercholesterolemia
5752706|NCT00309777|dyslipidemia|dyslipidemia
5752707|NCT00309777|pitavastatin|pitavastatin
5686302|NCT00552643|Diabetic wounds healing|diabetic wounds healing
5752708|NCT00309777|NK-104|nk-104
5752709|NCT00309777|Primary Hypercholesterolemia or Combined Dyslipidemia|primary hypercholesterolemia or combined dyslipidemia
5752710|NCT00309751|Kowa|kowa
5752711|NCT00309751|Type II Diabetes Mellitus|type ii diabetes mellitus
5752712|NCT00309751|Combined Dyslipidemia|combined dyslipidemia
5763957|NCT00268203|EAP|eap
5752714|NCT00309751|NK-104|nk-104
5752715|NCT00309751|Atorvastatin|atorvastatin
5752716|NCT00309738|Kowa|kowa
5752718|NCT00309738|Hypercholesterolemia|hypercholesterolemia
5752719|NCT00309738|combined dyslipidemia|combined dyslipidemia
5752720|NCT00309738|dyslipidemia|dyslipidemia
5752721|NCT00309738|pitavastatin|pitavastatin
5752722|NCT00309738|NK-104|nk-104
5752723|NCT00309738|simvastatin|simvastatin
5752724|NCT00309725|Alzheimer's Disease|alzheimer's disease
5752725|NCT00309725|cardiac arrhythmias|cardiac arrhythmias
5752726|NCT00309712|diabetes|diabetes
5752727|NCT00309712|combination lipid treatment|combination lipid treatment
5752728|NCT00309712|statin|statin
5752729|NCT00309712|fibrate|fibrate
5752730|NCT00309712|hypercholesteremia|hypercholesteremia
5752731|NCT00309712|mixed dyslipidemia|mixed dyslipidemia
5752732|NCT00309699|Affective psychosis|affective psychosis
5752734|NCT00309699|bipolar disorder|bipolar disorder
5752735|NCT00309699|manic disorder|manic disorder
5752736|NCT00309699|manic-depressive psychosis|manic-depressive psychosis
5752737|NCT00309699|mania|mania
5752738|NCT00309699|manic state|manic state
5752739|NCT00309699|paliperidone|paliperidone
5752740|NCT00309699|paliperidone ER.|paliperidone er.
5752741|NCT00309686|Affective psychosis|affective psychosis
5752742|NCT00309686|bipolar disorder|bipolar disorder
5752743|NCT00309686|manic disorder|manic disorder
5752744|NCT00309686|manic-depressive psychosis|manic-depressive psychosis
5752745|NCT00309686|mania|mania
5752746|NCT00309686|manic state|manic state
5752747|NCT00309686|paliperidone|paliperidone
5752748|NCT00309686|paliperidone ER|paliperidone er
5752749|NCT00309686|adjunctive therapy|adjunctive therapy
5752750|NCT00309673|tuberculosis, tuberculin, childhood, pain|tuberculosis, tuberculin, childhood, pain
5752751|NCT00309660|PPARgamma ligand|ppargamma ligand
5752752|NCT00309660|Rosiglitazone|rosiglitazone
5752753|NCT00309660|Enema|enema
5752754|NCT00309647|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5752755|NCT00309634|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5752756|NCT00309621|Hand Dermatoses,|hand dermatoses,
5752757|NCT00309621|hand dermatitis|hand dermatitis
5752758|NCT00309621|hand eczema|hand eczema
5752759|NCT00309621|chronic hand dermatitis|chronic hand dermatitis
5752760|NCT00309621|retinoid|retinoid
5752761|NCT00309569|Cyclophosphamide|cyclophosphamide
5752762|NCT00309569|Methotrexate|methotrexate
5752763|NCT00309569|Fluorouracil|fluorouracil
5752764|NCT00309569|Epirubicine|epirubicine
5752765|NCT00309569|Breast Cancer|breast cancer
5752766|NCT00309556|Epirubicin|epirubicin
5752767|NCT00309556|Docetaxel|docetaxel
5752768|NCT00309556|Capecitabine|capecitabine
5752769|NCT00309556|Herceptin|herceptin
5752770|NCT00309556|Breast cancer|breast cancer
5752771|NCT00309543|Fluorouracil|fluorouracil
5752772|NCT00309543|Leucovorin|leucovorin
5752773|NCT00309543|Colon cancer|colon cancer
5752774|NCT00309530|Fluorouracil|fluorouracil
5752775|NCT00309530|Levamisol|levamisol
5752776|NCT00309530|Interferon|interferon
5752777|NCT00309530|Colon cancer|colon cancer
5752778|NCT00309517|Fluorouracil|fluorouracil
5752779|NCT00309517|Leucovorin|leucovorin
5752780|NCT00309517|MAb 17-1A|mab 17-1a
5752781|NCT00309517|Rectal cancer|rectal cancer
5752782|NCT00309504|magnetic resonance imaging|magnetic resonance imaging
5752783|NCT00309504|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5752784|NCT00309491|Tamoxifen|tamoxifen
5752785|NCT00309491|Aminoglutethimide|aminoglutethimide
5752786|NCT00309491|Breast cancer|breast cancer
5752787|NCT00309478|Cyclophosphamide|cyclophosphamide
5752788|NCT00309478|Methotrexate|methotrexate
5752789|NCT00309478|Fluorouracil|fluorouracil
5752790|NCT00309478|Goserelin|goserelin
5752791|NCT00309478|Tamoxifen|tamoxifen
5752792|NCT00309478|Breast cancer|breast cancer
5752793|NCT00309465|Diabetes|diabetes
5752794|NCT00309465|Insulin Glargine|insulin glargine
5752795|NCT00309465|Surgery|surgery
5752796|NCT00309452|First episode psychosis|first episode psychosis
5752797|NCT00309452|Specialized care|specialized care
5752798|NCT00309452|Phase-specific treatment|phase-specific treatment
5754737|NCT00302276|fecal fat|fecal fat
5761627|NCT00277875|Endothelial Function|endothelial function
5752800|NCT00309452|Disorders with psychotic features|disorders with psychotic features
5752801|NCT00309426|atherosclerosis|atherosclerosis
5752802|NCT00309413|Schizophrenia and Disorders with Psychotic Features|schizophrenia and disorders with psychotic features
5752803|NCT00309400|History|history
5752804|NCT00309400|Phenylketonuria|phenylketonuria
5752805|NCT00309400|Galactosemia|galactosemia
5752806|NCT00309400|Screening|screening
5752807|NCT00309400|Treatment|treatment
5752808|NCT00309387|Cataract|cataract
5686303|NCT00552643|Post trauma|post trauma
5752809|NCT00309387|Nutritional supplements|nutritional supplements
5752810|NCT00309374|LPS|lps
5752811|NCT00309374|Statins|statins
5752812|NCT00309374|leukocyte mRNA expression profiles|leukocyte mrna expression profiles
5752813|NCT00309361|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5752814|NCT00309335|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5752815|NCT00309322|Soft Tissue Anesthesia (Numbness)|soft tissue anesthesia (numbness)
5752816|NCT00309296|smoking cessation|smoking cessation
5752817|NCT00309296|smoking reduction|smoking reduction
5752818|NCT00309296|nicotine replacement therapy|nicotine replacement therapy
5752819|NCT00309270|Campath-1H, low-dose immunosuppression, T regulatives cells|campath-1h, low-dose immunosuppression, t regulatives cells
5752820|NCT00309231|diabetes mellitus|diabetes mellitus
5752821|NCT00309231|islet transplantation|islet transplantation
5752822|NCT00309218|Pediatric renal transplantation|pediatric renal transplantation
5752823|NCT00309218|Steroid withdrawal|steroid withdrawal
5752824|NCT00309218|Mycophenolate Mofetil|mycophenolate mofetil
5752825|NCT00309218|Cyclosporine A|cyclosporine a
5752826|NCT00309218|Stable graft function|stable graft function
5752827|NCT00309218|children|children
5752828|NCT00309218|renal transplantation|renal transplantation
5752829|NCT00309205|HIV seronegativity|hiv seronegativity
5752830|NCT00309192|Diabetes, Macular Edema, Triamcinolone|diabetes, macular edema, triamcinolone
5752831|NCT00309179|Advanced colorectal cancer|advanced colorectal cancer
5752832|NCT00309127|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5752833|NCT00309127|DM Nephropathy|dm nephropathy
5752834|NCT00309127|Structured care|structured care
5752835|NCT00309114|UTI|uti
5752836|NCT00309114|SCI|sci
5752837|NCT00309114|E coli|e coli
5752838|NCT00309114|Prevention|prevention
5752839|NCT00309101|Tacrolimus|tacrolimus
5752840|NCT00309101|Myasthenia Gravis|myasthenia gravis
5752841|NCT00309088|Tacrolimus|tacrolimus
5752842|NCT00309088|Myasthenia Gravis|myasthenia gravis
5752843|NCT00309075|Stenosis of the calf and/or pedal arteries|stenosis of the calf and/or pedal arteries
5752844|NCT00309062|Allergy|allergy
5752845|NCT00309062|Birch pollen|birch pollen
5752846|NCT00309062|Recombinant|recombinant
5752847|NCT00309036|Allergy|allergy
5752848|NCT00309036|Grass pollen|grass pollen
5752849|NCT00309036|Recombinant|recombinant
5752850|NCT00309023|Advanced Solid Tumors|advanced solid tumors
5752851|NCT00309010|Focal Hand Dystonia|focal hand dystonia
5752852|NCT00309010|Motor Planning|motor planning
5752853|NCT00309010|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5752854|NCT00309010|MRI (Magnetic Resonance Imaging)|mri (magnetic resonance imaging)
5752855|NCT00309010|FHD|fhd
5752856|NCT00309010|Writer's Cramp|writer's cramp
5752857|NCT00309010|Healthy Volunteer|healthy volunteer
5752858|NCT00309010|HV|hv
5752859|NCT00308997|Auditory Hallucinations|auditory hallucinations
5752860|NCT00308997|Schizophrenia|schizophrenia
5752861|NCT00308997|Schizoaffective Disorder|schizoaffective disorder
5752862|NCT00308997|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5752863|NCT00308997|Wernicke's Area|wernicke's area
5752864|NCT00308997|Superior Temporal Gyrus|superior temporal gyrus
5752865|NCT00308984|Pediatrics|pediatrics
5752866|NCT00308984|Intraoperative Awareness|intraoperative awareness
5752867|NCT00308984|Pediatric Anesthesia|pediatric anesthesia
5752868|NCT00308958|cystic fibrosis|cystic fibrosis
5752869|NCT00308958|chest physiotherapy|chest physiotherapy
5752870|NCT00308958|airway clearance|airway clearance
5752871|NCT00308958|bronchiectasis|bronchiectasis
5752872|NCT00308945|Glaucoma|glaucoma
5752873|NCT00308945|Blood flow|blood flow
5752874|NCT00308945|Choroid|choroid
5752875|NCT00308945|Retina|retina
5752876|NCT00308945|Prostaglandin analogues|prostaglandin analogues
5752877|NCT00308932|fluticasone|fluticasone
5752878|NCT00308932|asthma therapy|asthma therapy
5752879|NCT00308932|spacer inhaler|spacer inhaler
5752880|NCT00308932|HFA-134a|hfa-134a
5752881|NCT00308906|infection|infection
5752882|NCT00308906|renal dysfunction|renal dysfunction
5752883|NCT00308906|aminoglycoside|aminoglycoside
5752884|NCT00308906|protein|protein
5752886|NCT00308893|Antidepressants|antidepressants
5752887|NCT00308893|escitalopram|escitalopram
5752888|NCT00308893|Genetic polymorphism|genetic polymorphism
5752889|NCT00308880|Tranexamic acid|tranexamic acid
5752890|NCT00308880|head neck surgery|head neck surgery
5752892|NCT00308867|AK|ak
5752893|NCT00308867|Cryosurgery|cryosurgery
5752894|NCT00308854|AK|ak
5752895|NCT00308854|PDT|pdt
5752999|NCT00308269|Solid Tumors|solid tumors
5753000|NCT00308269|Experimental|experimental
5753001|NCT00308256|Type1 diabetes;|type1 diabetes;
5752896|NCT00308841|"Objective: To evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost IUD"|"objective: to evaluate the efficacy of intrauterine lidocaine instillation in reducing patient discomfort during the removal of a lost iud"
5752897|NCT00308815|Resuscitation|resuscitation
5752898|NCT00308815|Out-of-hospital cardiac arrest|out-of-hospital cardiac arrest
5752899|NCT00308815|cardiac arrest|cardiac arrest
5752900|NCT00308815|CPR|cpr
5752901|NCT00308802|Kidney|kidney
5681009|NCT00575224|Treatment|treatment
5752902|NCT00308802|Transplant|transplant
5752903|NCT00308802|Rejection|rejection
5752904|NCT00308802|Kidney Disease|kidney disease
5752905|NCT00308802|Kidney Failure|kidney failure
5752906|NCT00308802|End Stage Renal Disease|end stage renal disease
5752907|NCT00308789|Continuous Positive Airway Pressure|continuous positive airway pressure
5752908|NCT00308789|Infant,newborn|infant,newborn
5752909|NCT00308789|Artificial respiration|artificial respiration
5752910|NCT00308763|Smoking Cessation|smoking cessation
5752911|NCT00308763|Nicotine Dependence|nicotine dependence
5752912|NCT00308724|Generalized Anxiety Disorder|generalized anxiety disorder
5752913|NCT00308724|Geriatric|geriatric
5752914|NCT00308711|Cervical ripening|cervical ripening
5752915|NCT00308711|Induction of labor|induction of labor
5752916|NCT00308711|Dinoprostone vaginal insert|dinoprostone vaginal insert
5752917|NCT00308711|Cervidil|cervidil
5752918|NCT00308711|Misoprostol vaginal insert|misoprostol vaginal insert
5752919|NCT00308711|Modified Bishop's Score|modified bishop's score
5752920|NCT00308711|PGE2|pge2
5752921|NCT00308711|PGE1|pge1
5752922|NCT00308711|Uterine Hyperstimulation|uterine hyperstimulation
5752923|NCT00308711|Cesarean section|cesarean section
5752924|NCT00308698|recombinant human erythropoietin|recombinant human erythropoietin
5752925|NCT00308698|adiponectin|adiponectin
5752926|NCT00308698|mortality|mortality
5752927|NCT00308685|Asthma|asthma
5752928|NCT00308685|Pediatric asthma|pediatric asthma
5752929|NCT00308633|Cardiac Rehabilitation|cardiac rehabilitation
5752930|NCT00308633|Apoptosis|apoptosis
5752931|NCT00308633|Gene Expression|gene expression
5752932|NCT00308633|Nitric Oxide|nitric oxide
5752933|NCT00308633|Reactive Oxygen Species|reactive oxygen species
5752934|NCT00308633|Coronary Artery Disease|coronary artery disease
5752936|NCT00308620|HIV|hiv
5752937|NCT00308620|chloroquine|chloroquine
5752938|NCT00308620|disease progression|disease progression
5752939|NCT00308620|inflammation|inflammation
5752940|NCT00308620|treatment naive|treatment naive
5752941|NCT00308607|melanoma|melanoma
5752942|NCT00308607|metastatic|metastatic
5752943|NCT00308607|bevacizumab|bevacizumab
5752944|NCT00308594|cervical radiculopathy|cervical radiculopathy
5752945|NCT00308594|dexamethasone|dexamethasone
5752946|NCT00308594|corticosteroid|corticosteroid
5752947|NCT00308594|oral|oral
5752948|NCT00308581|Crohn's Disease|crohn's disease
5752949|NCT00308581|Certolizumab pegol|certolizumab pegol
5752950|NCT00308568|screening colonoscopy|screening colonoscopy
5752951|NCT00308568|adherence|adherence
5752952|NCT00308555|Cannabis|cannabis
5752953|NCT00308555|Morphine|morphine
5752954|NCT00308555|Oxycodone|oxycodone
5752955|NCT00308555|Marijuana|marijuana
5752956|NCT00308555|chronic pain|chronic pain
5752957|NCT00308542|eye diseases|eye diseases
5752958|NCT00308542|diabetic eye problems|diabetic eye problems
5752959|NCT00308529|Carcinoma Small Cell Lung|carcinoma small cell lung
5752960|NCT00308529|Lung Cancer|lung cancer
5752961|NCT00308516|Rectal Cancer|rectal cancer
5752962|NCT00308516|Cancer of the Rectum|cancer of the rectum
5752963|NCT00308516|Colorectal Cancer|colorectal cancer
5752964|NCT00308516|Bevacizumab|bevacizumab
5752965|NCT00308503|Primary Insomnia|primary insomnia
5752966|NCT00308503|Sleep Maintenance Insomnia|sleep maintenance insomnia
5752967|NCT00308503|Awakening|awakening
5752968|NCT00308477|eye diseases|eye diseases
5752969|NCT00308451|chromium|chromium
5752970|NCT00308451|chromium picolinate|chromium picolinate
5752971|NCT00308451|type 2 diabetes mellitus|type 2 diabetes mellitus
5752972|NCT00308451|fructosamine|fructosamine
5752973|NCT00308451|glycemic control|glycemic control
5752974|NCT00308451|OGTT|ogtt
5752975|NCT00308438|Crohn Disease|crohn disease
5752976|NCT00308438|Crohn's Disease|crohn's disease
5752977|NCT00308425|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5752978|NCT00308412|Respiratory Tract Infection|respiratory tract infection
5752979|NCT00308386|Nurse Case Management|nurse case management
5752980|NCT00308386|Diabetes|diabetes
5752981|NCT00308386|Hypertension|hypertension
5752982|NCT00308386|Hyperlipidemia|hyperlipidemia
5752983|NCT00308386|Behavior therapy|behavior therapy
5753396|NCT00306722|AQUAVAN|aquavan
5752984|NCT00308386|Motivational interviewing|motivational interviewing
5752985|NCT00308360|Hostility|hostility
5752986|NCT00308360|Impulsivity|impulsivity
5752987|NCT00308360|Aggression|aggression
5752988|NCT00308334|Domperidone|domperidone
5752989|NCT00308334|breast milk|breast milk
5752990|NCT00308334|breast milk composition|breast milk composition
5752991|NCT00308334|preterm infant|preterm infant
5752993|NCT00308334|nutrition|nutrition
5752994|NCT00308269|Cancer|cancer
5752995|NCT00308269|Phase I|phase i
5752996|NCT00308269|EC145|ec145
5752997|NCT00308269|Recurrent|recurrent
5753006|NCT00308243|Reactive Oxygen Species|reactive oxygen species
5753007|NCT00308243|Inflammation of Lung|inflammation of lung
5753008|NCT00308230|Congenital, BNP|congenital, bnp
5753009|NCT00308217|Heart Disease, Congenital|heart disease, congenital
5753010|NCT00308217|Single Ventricle|single ventricle
5753011|NCT00308217|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5686304|NCT00552643|Post surgery complication|post surgery complication
5753016|NCT00308191|COPD|copd
5753017|NCT00308191|Formoterol|formoterol
5753018|NCT00308191|Tiotropium|tiotropium
5753019|NCT00308178|Abraxane|abraxane
5753020|NCT00308178|dose-dense chemotherapy|dose-dense chemotherapy
5753021|NCT00308178|taxol|taxol
5753022|NCT00308165|Recurrent Primary Malignant Brain Tumors|recurrent primary malignant brain tumors
5753023|NCT00308165|Brain Tumors|brain tumors
5753024|NCT00308165|Neoplasms, Brain|neoplasms, brain
5753025|NCT00308165|Brain Cancer|brain cancer
5753026|NCT00308165|Brain cancer treatment|brain cancer treatment
5753027|NCT00308165|Topotecan|topotecan
5753028|NCT00308152|Colonoscopy|colonoscopy
5753029|NCT00308152|Rehydration|rehydration
5753030|NCT00308152|Sedation|sedation
5753031|NCT00308139|diabetes|diabetes
5753032|NCT00308139|exenatide|exenatide
5753033|NCT00308139|long acting release|long acting release
5753034|NCT00308139|LAR|lar
5753035|NCT00308139|Amylin|amylin
5753036|NCT00308139|Lilly|lilly
5753037|NCT00308126|Abdominal operation|abdominal operation
5753038|NCT00308113|Muscular dystrophy|muscular dystrophy
5753039|NCT00308113|Duchenne|duchenne
5753040|NCT00308113|CoQ10|coq10
5753041|NCT00308113|prednisone|prednisone
5753042|NCT00308100|Liver Transplantation|liver transplantation
5753043|NCT00308087|Sargramostim|sargramostim
5753044|NCT00308087|Leukine|leukine
5753045|NCT00308087|NHL|nhl
5753046|NCT00308074|behavioral problems|behavioral problems
5769016|NCT00248430|stage III multiple myeloma|stage iii multiple myeloma
5753047|NCT00308074|aggression|aggression
5753048|NCT00308074|autism|autism
5753049|NCT00308074|aripiprazole|aripiprazole
5753050|NCT00308061|Plasmodium falciparum|plasmodium falciparum
5753051|NCT00308061|malaria|malaria
5753052|NCT00308061|merozoite surface protein-1|merozoite surface protein-1
5753053|NCT00308048|Interferon|interferon
5753054|NCT00308048|Pegylated interferon|pegylated interferon
5753055|NCT00308048|Pegylated interferon alfa 2b|pegylated interferon alfa 2b
5753056|NCT00308048|Hepatitis C|hepatitis c
5753057|NCT00308048|Genotype 2|genotype 2
5753058|NCT00308048|Genotype 3|genotype 3
5753059|NCT00308048|Rapid virological response|rapid virological response
5753060|NCT00308048|Short treatment|short treatment
5753061|NCT00308048|14 weeks treatment|14 weeks treatment
5753062|NCT00308048|health related quality of life|health related quality of life
5753063|NCT00308048|sick leave|sick leave
5753064|NCT00308048|Injecting drug use|injecting drug use
5753065|NCT00308022|Acute Lung Injury|acute lung injury
5753066|NCT00308022|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5753067|NCT00308022|High Frequency Percussive Ventilation|high frequency percussive ventilation
5753068|NCT00308022|Ventilator Associated Pneumonia|ventilator associated pneumonia
5753069|NCT00308009|Pelvic Organ Prolapse|pelvic organ prolapse
5753070|NCT00308009|Urinary stress incontinence|urinary stress incontinence
5753072|NCT00307996|CoQ10|coq10
5753073|NCT00307996|hemodialysis|hemodialysis
5753074|NCT00307996|oxidative marker|oxidative marker
5753075|NCT00307996|antioxidant|antioxidant
5753076|NCT00307970|fluticasone|fluticasone
5753077|NCT00307970|asthma therapy|asthma therapy
5753078|NCT00307970|spacer inhaler|spacer inhaler
5753079|NCT00307970|HFA-134a|hfa-134a
5753080|NCT00307957|Obstructive Sleep Apnea|obstructive sleep apnea
5753081|NCT00307957|Daytime Sleepiness|daytime sleepiness
5753082|NCT00307957|Pillar Palatal Implants|pillar palatal implants
5753083|NCT00307944|Acid Reflux|acid reflux
5753084|NCT00307944|Obstructive Sleep Apnea|obstructive sleep apnea
5753085|NCT00307944|Daytime Sleepiness|daytime sleepiness
5753086|NCT00307931|Certolizumab pegol|certolizumab pegol
5753087|NCT00307931|Cimzia|cimzia
5753088|NCT00307931|Crohn's disease|crohn's disease
5753089|NCT00307931|Greek patients|greek patients
5753090|NCT00307918|acupuncture, intraocular pressure, glaucoma|acupuncture, intraocular pressure, glaucoma
5753091|NCT00307905|homeopathy|homeopathy
5753092|NCT00307905|pain|pain
5753093|NCT00307905|traumeel s|traumeel s
5753094|NCT00307905|Fracture of neck of femur|fracture of neck of femur
5753095|NCT00307905|Surgical correction of fracture of neck of hip|surgical correction of fracture of neck of hip
5753096|NCT00307892|Homeopathy|homeopathy
5753097|NCT00307892|Traumeel S|traumeel s
5753098|NCT00307892|Arthroscopy|arthroscopy
5753099|NCT00307892|Pain management|pain management
5753100|NCT00307892|Post-operative pain following arthroscopy|post-operative pain following arthroscopy
5753101|NCT00307879|Myocardial infarction|myocardial infarction
5753102|NCT00307879|revascularization|revascularization
5753193|NCT00307463|volume control|volume control
5753103|NCT00307879|granulocyte colony stimulating factor (G-CSF)|granulocyte colony stimulating factor (g-csf)
5862872|NCT00001475|Immunomodulator|immunomodulator
5862873|NCT00001474|Cytokines|cytokines
5753104|NCT00307866|Known or suspected focal liver lesions detected by spiral CT|known or suspected focal liver lesions detected by spiral ct
5753105|NCT00307853|homeopathy|homeopathy
5753107|NCT00307853|traumeel s|traumeel s
5753108|NCT00307853|total knee arthroplasty|total knee arthroplasty
5753109|NCT00307853|total hip arthroplasty|total hip arthroplasty
5753110|NCT00307840|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin D|hemodialysis; secondary hyperparathyroidism; hypercalcemia; hyperphosphatemia; vitamin d
5753111|NCT00307827|Steroid-Refractory|steroid-refractory
5753112|NCT00307827|IVSR-UC|ivsr-uc
5753113|NCT00307827|Ulcerative Colitis|ulcerative colitis
5753114|NCT00307814|Anemia|anemia
5753115|NCT00307814|Low Blood Count|low blood count
5753116|NCT00307814|Chronic Kidney Failure|chronic kidney failure
5753117|NCT00307814|Chronic Kidney Disease|chronic kidney disease
5753118|NCT00307814|epoetin alfa|epoetin alfa
5753119|NCT00307814|recombinant human erythropoietin|recombinant human erythropoietin
5753120|NCT00307801|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5753121|NCT00307788|Psychiatric Comorbidity|psychiatric comorbidity
5753122|NCT00307788|Acupuncture|acupuncture
5753123|NCT00307788|expectancy|expectancy
5753124|NCT00307775|oestradiol, faecal incontinence, post menopausal|oestradiol, faecal incontinence, post menopausal
5753125|NCT00307775|post menopausal women with faecal incontinence|post menopausal women with faecal incontinence
5753126|NCT00307762|Stroke|stroke
5753127|NCT00307762|Physiotherapy|physiotherapy
5753128|NCT00307762|Effectiveness|effectiveness
5753129|NCT00307762|Gait trainer|gait trainer
5753130|NCT00307749|Neuropathy|neuropathy
5753131|NCT00307749|Nerve Conduction|nerve conduction
5753132|NCT00307736|Fluorouracil|fluorouracil
5753133|NCT00307736|bevacizumab|bevacizumab
5753134|NCT00307736|erlotinib|erlotinib
5753135|NCT00307736|external beam radiation therapy|external beam radiation therapy
5753136|NCT00307736|EBRT|ebrt
5753137|NCT00307723|EBRT|ebrt
5753138|NCT00307723|advanced pancreatic cancer|advanced pancreatic cancer
5753139|NCT00307710|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5753140|NCT00307710|Influenza Vaccination|influenza vaccination
5753141|NCT00307710|Trivalent Baculovirus-Expressed Influenza HA vaccine|trivalent baculovirus-expressed influenza ha vaccine
5753142|NCT00307710|Antineoplastic Therapy|antineoplastic therapy
5753143|NCT00307697|Letter intervention|letter intervention
5753144|NCT00307697|Depression|depression
5753145|NCT00307697|Anxiety|anxiety
5753146|NCT00307697|Primary health care|primary health care
5753147|NCT00307684|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5753148|NCT00307684|Adult|adult
5753149|NCT00307684|Long term safety|long term safety
5753150|NCT00307684|Efficacy|efficacy
5753151|NCT00307684|Quality of life|quality of life
5753152|NCT00307671|Systemic necrotizing vasculitides|systemic necrotizing vasculitides
5753153|NCT00307671|corticosteroids; azathioprine; mycophenolate mofetil;|corticosteroids; azathioprine; mycophenolate mofetil;
5753154|NCT00307671|cyclophosphamide|cyclophosphamide
5753155|NCT00307671|Elderly patients|elderly patients
5753156|NCT00307671|Randomized controlled trial|randomized controlled trial
5753157|NCT00307658|ANCA associated Vasculitides|anca associated vasculitides
5753158|NCT00307658|Relapse|relapse
5753159|NCT00307658|intravenous Immunoglobulins|intravenous immunoglobulins
5753160|NCT00307658|Corticosteroid|corticosteroid
5753161|NCT00307658|Immunosuppressant|immunosuppressant
5753162|NCT00307645|ANCA associated systemic vasculitis|anca associated systemic vasculitis
5753163|NCT00307645|Maintenance therapy|maintenance therapy
5753164|NCT00307645|Azathioprine|azathioprine
5753165|NCT00307645|Mycophenolate mofetil|mycophenolate mofetil
5753166|NCT00307632|Contraception|contraception
5753167|NCT00307632|Hormonal patch|hormonal patch
5753168|NCT00307632|Norelgestromine|norelgestromine
5753169|NCT00307632|Ethinyl estradiol|ethinyl estradiol
5753170|NCT00307619|Binge-Eating Disorder|binge-eating disorder
5753171|NCT00307606|Mastectomy|mastectomy
5753172|NCT00307606|Seroma|seroma
5753173|NCT00307606|Breast cancer|breast cancer
5753174|NCT00307606|Glucocorticoid|glucocorticoid
5753175|NCT00307593|Systemic ANCA+ vascularizes|systemic anca+ vascularizes
5753176|NCT00307593|Relapse|relapse
5753177|NCT00307593|Corticosteroids|corticosteroids
5753178|NCT00307593|Immunosuppressant|immunosuppressant
5753180|NCT00307593|Patients with relapsing or refractory forms of ANCA|patients with relapsing or refractory forms of anca
5753181|NCT00307593|associated vasculitides Microscopic polyangiitis|associated vasculitides microscopic polyangiitis
5753183|NCT00307502|protease inhibitors|protease inhibitors
5753184|NCT00307502|non-nucleoside analog reverse transcriptase inhibitors|non-nucleoside analog reverse transcriptase inhibitors
5753185|NCT00307502|pharmacokinetic models|pharmacokinetic models
5753186|NCT00307502|treatment experienced|treatment experienced
5753187|NCT00307502|HIV|hiv
5753188|NCT00307476|Fecal Incontinence|fecal incontinence
5753907|NCT00305201|Pravastatin|pravastatin
5753189|NCT00307476|Fecal Containment Devices|fecal containment devices
5753190|NCT00307476|Skin Integrity|skin integrity
5753191|NCT00307463|end-stage renal disease|end-stage renal disease
5753192|NCT00307463|hemodialysis|hemodialysis
5753194|NCT00307463|ultrafiltration|ultrafiltration
5753195|NCT00307463|inflammation|inflammation
5753196|NCT00307463|cardiovascular disease|cardiovascular disease
5753197|NCT00307463|left ventricular hypertrophy|left ventricular hypertrophy
5753198|NCT00307463|dietary salt restriction|dietary salt restriction
5753199|NCT00307450|Dyskinesias|dyskinesias
5753200|NCT00307450|Parkinson's disease|parkinson's disease
5753201|NCT00307450|Levetiracetam|levetiracetam
5753202|NCT00307450|Treatment|treatment
5753203|NCT00307437|Moderate to Severe Plaque-Type Psoriasis|moderate to severe plaque-type psoriasis
5753204|NCT00307437|interleukin 23|interleukin 23
5753206|NCT00307437|interleukin-12|interleukin-12
5753207|NCT00307437|interleukin-23|interleukin-23
5753208|NCT00307437|CNTO1275|cnto1275
5753209|NCT00307437|biologic|biologic
5753210|NCT00307437|Psoriasis|psoriasis
5753211|NCT00307437|CNTO 1275|cnto 1275
5753212|NCT00307437|IL23|il23
5753213|NCT00307437|interleukin 12|interleukin 12
5753214|NCT00307437|IL-23|il-23
5753215|NCT00307437|IL12|il12
5753216|NCT00307437|ustekinumab|ustekinumab
5753217|NCT00307411|Metabolic syndrome|metabolic syndrome
5753218|NCT00307398|AMD|amd
5753219|NCT00307398|Dry AMD|dry amd
5753220|NCT00307398|Drusen|drusen
5753222|NCT00307385|Motor Recovery|motor recovery
5753223|NCT00307385|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5753224|NCT00307385|Homeostatic Plasticity|homeostatic plasticity
5753225|NCT00307385|Ipsilesional Primary Motor Cortex|ipsilesional primary motor cortex
5753226|NCT00307385|Paretic Fingers Motor Sequence|paretic fingers motor sequence
5753227|NCT00307385|Motor Cortex|motor cortex
5753228|NCT00307385|Motor Function|motor function
5753229|NCT00307385|Motor Learning|motor learning
5753230|NCT00307385|Premotor Cortex|premotor cortex
5753231|NCT00307385|Primary Motor Cortex|primary motor cortex
5753232|NCT00307385|Stroke|stroke
5753233|NCT00307385|Healthy Volunteer|healthy volunteer
5753234|NCT00307385|HV|hv
5753235|NCT00307346|Movement-Related Potential|movement-related potential
5753236|NCT00307346|Electroencephalogram|electroencephalogram
5753237|NCT00307346|Psychogenic Movement Disorders|psychogenic movement disorders
5753238|NCT00307346|Psychogenic Movement Disorder|psychogenic movement disorder
5753239|NCT00307346|Healthy Volunteer|healthy volunteer
5753240|NCT00307346|HV|hv
5753241|NCT00307333|very low birth weight infants|very low birth weight infants
5753242|NCT00307333|heart rate characteristics|heart rate characteristics
5753243|NCT00307320|pregnancy|pregnancy
5753244|NCT00307320|stress|stress
5753245|NCT00307320|anxiety|anxiety
5753246|NCT00307307|atherosclerosis|atherosclerosis
5753247|NCT00307307|HDL cholesterol|hdl cholesterol
5753248|NCT00307307|niacin|niacin
5753249|NCT00307307|MR imaging|mr imaging
5753250|NCT00307294|Prostate|prostate
5753251|NCT00307294|Androgen|androgen
5753252|NCT00307294|AIPC|aipc
5753253|NCT00307294|Doxil|doxil
5753254|NCT00307268|ADHD Effectiveness|adhd effectiveness
5753255|NCT00307255|unspecified adult solid tumor|unspecified adult solid tumor
5753256|NCT00307255|protocol specific|protocol specific
5753257|NCT00307255|Paclitaxel|paclitaxel
5753258|NCT00307255|Abraxane|abraxane
5753259|NCT00307255|Gemcitabine|gemcitabine
5753260|NCT00307255|Gemzar|gemzar
5753261|NCT00307255|Phase I|phase i
5753262|NCT00307255|Lineberger|lineberger
5753263|NCT00307242|Adefovir Dipivoxil|adefovir dipivoxil
5753264|NCT00307242|Lamivudine|lamivudine
5753265|NCT00307242|Hepatitis B|hepatitis b
5753266|NCT00307229|metastatic breast cancer|metastatic breast cancer
5753267|NCT00307229|recurrent breast cancer|recurrent breast cancer
5753268|NCT00307216|First Episode Psychosis|first episode psychosis
5753269|NCT00307216|Early Psychosis|early psychosis
5753270|NCT00307216|Psychosocial Intervention|psychosocial intervention
5753271|NCT00307203|Bupropion|bupropion
5753272|NCT00307203|Zyban|zyban
5753273|NCT00307203|Wellbutrin|wellbutrin
5753274|NCT00307203|Smoking cessation|smoking cessation
5753275|NCT00307203|Schizophrenia|schizophrenia
5753276|NCT00307203|Schizoaffective disorder|schizoaffective disorder
5753277|NCT00307203|Cognitive Behavioral Therapy|cognitive behavioral therapy
5753278|NCT00307190|BED|bed
5753279|NCT00307177|influenza vaccine, baculovirus, immunogenicity, lymphoma|influenza vaccine, baculovirus, immunogenicity, lymphoma
5753280|NCT00307164|Treatment Experienced|treatment experienced
5753282|NCT00307151|Treatment Naive|treatment naive
5753283|NCT00307151|Mother-To-Child Transmission|mother-to-child transmission
5753284|NCT00307151|MTCT|mtct
5753285|NCT00307151|Pediatrics|pediatrics
5753286|NCT00307151|Viral resistance|viral resistance
5753287|NCT00307138|Coronary artery bypass, Off-pump|coronary artery bypass, off-pump
5753288|NCT00307138|Hetastarch|hetastarch
5753289|NCT00307138|Plasma substitutes|plasma substitutes
5753290|NCT00307138|Equivalence|equivalence
5753291|NCT00307125|Organ Transplantation|organ transplantation
5753292|NCT00307125|Graft function/survival|graft function/survival
5753293|NCT00307125|Immunosuppression|immunosuppression
5753294|NCT00307125|anti-CD20 (rituximab)|anti-cd20 (rituximab)
5753399|NCT00306709|obesity|obesity
5753295|NCT00307112|Group A streptococcus, Nicaragua, Rheumatic Heart Disease|group a streptococcus, nicaragua, rheumatic heart disease
5753296|NCT00307099|bacterial diseases|bacterial diseases
5753297|NCT00307073|Pacemaker|pacemaker
5753298|NCT00307073|Managed Ventricular Pacing|managed ventricular pacing
5753299|NCT00307073|Ventricular Pacing|ventricular pacing
5753301|NCT00307047|Angioplasty|angioplasty
5753302|NCT00307047|Total coronary occlusion|total coronary occlusion
5753303|NCT00307047|coronary restenosis|coronary restenosis
5753304|NCT00307047|stent thrombosis|stent thrombosis
5753305|NCT00307034|Primary vaccination|primary vaccination
5761220|NCT00279305|Type 1 diabetes|type 1 diabetes
5753306|NCT00307034|Pneumococcal disease|pneumococcal disease
5753307|NCT00307034|Safety|safety
5753308|NCT00307034|Booster vaccination|booster vaccination
5753309|NCT00307034|Immunogenicity|immunogenicity
5753310|NCT00307034|Pneumococcal vaccine|pneumococcal vaccine
5753311|NCT00307034|Dose comparison|dose comparison
5753312|NCT00307021|Parasitic Diseases|parasitic diseases
5753313|NCT00307021|Malaria, Falciparum|malaria, falciparum
5753314|NCT00307021|Malaria|malaria
5753315|NCT00307021|Coccidiosis|coccidiosis
5753316|NCT00307008|Prophylaxis Invasive pneumococcal diseases and pneumonia|prophylaxis invasive pneumococcal diseases and pneumonia
5753317|NCT00306995|prophylaxis of pandemic influenza|prophylaxis of pandemic influenza
5753318|NCT00306982|Prophylaxis Influenza vaccine|prophylaxis influenza vaccine
5753319|NCT00306969|mycosis fungoides, Sézary Syndrome|mycosis fungoides, sézary syndrome
5753320|NCT00306956|Infant|infant
5753321|NCT00306956|Newborn|newborn
5753322|NCT00306956|pacifier|pacifier
5753323|NCT00306956|dummies|dummies
5753324|NCT00306956|breastfeeding|breastfeeding
5753325|NCT00306956|Sudden Infant Death|sudden infant death
5753326|NCT00306956|SIDS|sids
5753327|NCT00306956|Pacifiers|pacifiers
5753328|NCT00306930|Total Hip Replacement|total hip replacement
5753329|NCT00306930|post-traumatic arthritis|post-traumatic arthritis
5753330|NCT00306917|Total Hip Replacement|total hip replacement
5753331|NCT00306904|Macular|macular
5753332|NCT00306904|Edema|edema
5753333|NCT00306904|Diabetic|diabetic
5753334|NCT00306904|Retinopathy|retinopathy
5753335|NCT00306891|Advanced solid tumours|advanced solid tumours
5753336|NCT00306891|Advanced cancer|advanced cancer
5753337|NCT00306891|tumor|tumor
5753338|NCT00306891|tumour|tumour
5753339|NCT00306891|RECENTIN|recentin
5753340|NCT00306865|Neurotransmitter|neurotransmitter
5753341|NCT00306865|Neuroimaging|neuroimaging
5753342|NCT00306865|Movement Disorder|movement disorder
5753343|NCT00306865|Focal Hand Dystonia|focal hand dystonia
5753344|NCT00306865|FHD|fhd
5753345|NCT00306865|HV|hv
5753346|NCT00306852|Glaucoma|glaucoma
5753347|NCT00306852|Trabeculectomy|trabeculectomy
5753348|NCT00306852|Tube shunt surgery|tube shunt surgery
5753349|NCT00306839|Tissucol|tissucol
5753350|NCT00306839|Tisseel|tisseel
5753351|NCT00306839|Lichtenstein|lichtenstein
5753352|NCT00306839|hernia|hernia
5753353|NCT00306839|inguinal|inguinal
5753354|NCT00306826|Impaired glucose tolerance|impaired glucose tolerance
5753355|NCT00306813|refractory or relapsed multiple myeloma|refractory or relapsed multiple myeloma
5753356|NCT00306813|CC-5013|cc-5013
5753357|NCT00306813|Revlimid|revlimid
5753358|NCT00306813|lenalidomide|lenalidomide
5753359|NCT00306813|RAD|rad
5753360|NCT00306800|Methyl aminolevulinate|methyl aminolevulinate
5753361|NCT00306800|Photodynamic therapy|photodynamic therapy
5753362|NCT00306800|Aktilite CL128 LED light source|aktilite cl128 led light source
5753363|NCT00306800|Multiple Actinic Keratosis|multiple actinic keratosis
5753364|NCT00306787|Herpes simplex|herpes simplex
5753365|NCT00306787|genital herpes|genital herpes
5753366|NCT00306787|famciclovir|famciclovir
5753367|NCT00306787|valacyclovir|valacyclovir
5753368|NCT00306787|Recurrent genital herpes|recurrent genital herpes
5753369|NCT00306774|osteoarthritis|osteoarthritis
5753370|NCT00306774|vitamin D|vitamin d
5753371|NCT00306774|knee pain|knee pain
5753372|NCT00306774|cartilage loss|cartilage loss
5753373|NCT00306774|WOMAC|womac
5753374|NCT00306774|MRI|mri
5753375|NCT00306774|cartilage volume|cartilage volume
5753376|NCT00306774|OA|oa
5753377|NCT00306774|physical function|physical function
5753378|NCT00306774|web-based|web-based
5753379|NCT00306774|internet-based|internet-based
5753380|NCT00306748|Chronic Constipation|chronic constipation
5753381|NCT00306748|Chronic Idiopathic Constipation|chronic idiopathic constipation
5753382|NCT00306748|Constipation|constipation
5753383|NCT00306748|CIC|cic
5753384|NCT00306748|CC|cc
5753385|NCT00306748|MD-1100|md-1100
5753386|NCT00306748|MD-1100 Acetate|md-1100 acetate
5753387|NCT00306748|Microbia|microbia
5753388|NCT00306748|Microbia, Inc.|microbia, inc.
5753389|NCT00306748|linaclotide|linaclotide
5753390|NCT00306748|linaclotide acetate|linaclotide acetate
5753391|NCT00306735|Multiple Myeloma|multiple myeloma
5753392|NCT00306735|Stem Cell Transplantation|stem cell transplantation
5753393|NCT00306735|CINV|cinv
5753394|NCT00306722|Bronchoscopy|bronchoscopy
5753395|NCT00306722|Sedation|sedation
5753397|NCT00306722|fospropofol disodium|fospropofol disodium
5753398|NCT00306722|Flexible bronchoscopy|flexible bronchoscopy
5753400|NCT00306709|behavior change|behavior change
5753401|NCT00306709|cultural adaptations|cultural adaptations
5762156|NCT00275158|Hypertension|hypertension
5753402|NCT00306709|weight loss|weight loss
5753403|NCT00306696|rosiglitazone|rosiglitazone
5753404|NCT00306696|fluid retention|fluid retention
5753405|NCT00306696|Type 2 diabetes|type 2 diabetes
5753406|NCT00306696|diuretics|diuretics
5753407|NCT00306683|Hypothalamic-pituitary lesions|hypothalamic-pituitary lesions
5753408|NCT00306683|Craniopharyngioma|craniopharyngioma
5753409|NCT00306683|Obesity|obesity
5789080|NCT00150020|Renal Transplantation Patients with GI Intolerance with MMF|renal transplantation patients with gi intolerance with mmf
5753410|NCT00306683|Diazoxide|diazoxide
5753411|NCT00306683|Hyperinsulinemia|hyperinsulinemia
5753412|NCT00306683|Pediatric neurosurgery|pediatric neurosurgery
5753413|NCT00306683|Oncology|oncology
5753414|NCT00306683|Pituitary|pituitary
5753415|NCT00306683|Hypothalamus|hypothalamus
5753416|NCT00306670|Acquired Hemophilia A|acquired hemophilia a
5753417|NCT00306670|Anti-Factor VIII antibodies|anti-factor viii antibodies
5753418|NCT00306670|Anti-Factor VIII inhibitors|anti-factor viii inhibitors
5753419|NCT00306670|Hemophilia A|hemophilia a
5753420|NCT00306670|Factor VIII inhibitors|factor viii inhibitors
5753421|NCT00306657|Glaucoma Open-Angle|glaucoma open-angle
5753422|NCT00306657|Normal tension glaucoma progressive|normal tension glaucoma progressive
5753423|NCT00306657|chronic open angle glaucoma progressive|chronic open angle glaucoma progressive
5753424|NCT00306657|optic nerve sheath fenestration|optic nerve sheath fenestration
5753425|NCT00306657|cerebrospinal fluid|cerebrospinal fluid
5753426|NCT00306657|Beta-Trace Protein|beta-trace protein
5753427|NCT00306644|rosiglitazone|rosiglitazone
5753428|NCT00306644|Type 2 diabetes|type 2 diabetes
5753429|NCT00306644|intima media thickness|intima media thickness
5753430|NCT00306644|Insulin resistance|insulin resistance
5753431|NCT00306631|Advanced and Metastatic Breast Cancer|advanced and metastatic breast cancer
5753432|NCT00306605|Emotional experiences|emotional experiences
5753435|NCT00306605|depressive symptomatology|depressive symptomatology
5753436|NCT00306605|NICU|nicu
5753437|NCT00306605|preterm birth|preterm birth
5753438|NCT00306592|Multiple Sclerosis|multiple sclerosis
5753440|NCT00306579|Ischemic Stroke|ischemic stroke
5753441|NCT00306579|Myocardial ischemia|myocardial ischemia
5753442|NCT00306579|Myocardial necrosis|myocardial necrosis
5753443|NCT00306527|Influenza|influenza
5753444|NCT00306527|adult/elderly|adult/elderly
5753445|NCT00306527|flu cell culture|flu cell culture
5753446|NCT00306527|vaccine|vaccine
5753447|NCT00306514|metastatic malignant melanoma of the skin|metastatic malignant melanoma of the skin
5753448|NCT00306501|Training|training
5753449|NCT00306501|Cortical Stimulation|cortical stimulation
5753450|NCT00306501|Sensory Stimulation|sensory stimulation
5753451|NCT00306501|Brain Imaging|brain imaging
5753452|NCT00306501|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5753453|NCT00306501|Swallowing|swallowing
5753454|NCT00306501|Dysphagia|dysphagia
5753455|NCT00306501|Stroke|stroke
5753456|NCT00306501|CVA|cva
5753457|NCT00306501|Cerebral Vascular Accident|cerebral vascular accident
5753458|NCT00306501|Healthy Volunteer|healthy volunteer
5753459|NCT00306501|HV|hv
5753460|NCT00306488|Retinal Pigment Epithelium|retinal pigment epithelium
5753461|NCT00306488|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5753462|NCT00306488|Visual Acuity Decrease|visual acuity decrease
5753463|NCT00306488|Intra-ocular Pressure|intra-ocular pressure
5753464|NCT00306488|Autofluorescence of Retina|autofluorescence of retina
5753465|NCT00306488|Age-Related Macular Degeneration|age-related macular degeneration
5753466|NCT00306488|AMD|amd
5753467|NCT00306475|schizophrenia, cognition, mood stabilizer|schizophrenia, cognition, mood stabilizer
5753468|NCT00306462|Premature Labor|premature labor
5753469|NCT00306462|Premature Birth|premature birth
5753470|NCT00306462|Magnesium sulfate|magnesium sulfate
5753471|NCT00306462|Nifedipine|nifedipine
5753472|NCT00306449|Weight gain|weight gain
5753473|NCT00306449|obesity|obesity
5753474|NCT00306449|overweight|overweight
5753475|NCT00306449|young adults|young adults
5753476|NCT00306449|lipid disorders|lipid disorders
5753477|NCT00306449|insulin resistance|insulin resistance
5753478|NCT00306449|randomized controled study|randomized controled study
5753479|NCT00306436|Diabetes|diabetes
5753480|NCT00306436|renal deficiency|renal deficiency
5753481|NCT00306436|hypertension|hypertension
5753483|NCT00306410|Vitamin D deficiency|vitamin d deficiency
5753484|NCT00306410|HIV/AIDS|hiv/aids
5753485|NCT00306410|HAART|haart
5753486|NCT00306410|T-Lymphocytes, Regulatory|t-lymphocytes, regulatory
5753487|NCT00306410|insulin resistance|insulin resistance
5753488|NCT00306410|bone density|bone density
5753489|NCT00306397|Kidney transplantation|kidney transplantation
5753490|NCT00306397|Steroid free|steroid free
5753491|NCT00306397|Calcineurin inhibitor free|calcineurin inhibitor free
5753492|NCT00306397|Tacrolimus|tacrolimus
5753493|NCT00306397|Sirolimus|sirolimus
5753494|NCT00306384|Glucose Metabolism Disorder|glucose metabolism disorder
5753495|NCT00306384|Dysmetabolic Syndrome|dysmetabolic syndrome
5753496|NCT00306384|Type II Diabetes|type ii diabetes
5753497|NCT00306384|Diabetes Mellitus,|diabetes mellitus,
5753498|NCT00306384|Lipoatrophic|lipoatrophic
5753499|NCT00306384|Dyslipidemia|dyslipidemia
5753500|NCT00306384|Drug Therapy|drug therapy
5753501|NCT00306371|diode|diode
5753502|NCT00306371|laser|laser
5753503|NCT00306371|acne|acne
5753504|NCT00306371|acne scar|acne scar
5753505|NCT00306358|absorption test|absorption test
5753506|NCT00306358|cobalamin|cobalamin
5753507|NCT00306358|holotranscobalamin|holotranscobalamin
5763600|NCT00269802|Ritalin®|ritalin®
5753508|NCT00306358|vitamin B12|vitamin b12
5753509|NCT00306345|Outreach|outreach
5753510|NCT00306345|Major general surgery|major general surgery
5753511|NCT00306345|Intensive care|intensive care
5753512|NCT00306345|Serious adverse events|serious adverse events
5753513|NCT00306332|Allogeneic Stem cell transplantation|allogeneic stem cell transplantation
5753514|NCT00306332|T-cell depletion|t-cell depletion
5753515|NCT00306332|B-cell depletion|b-cell depletion
5753516|NCT00306332|Immunomagnetic selection|immunomagnetic selection
5753517|NCT00306319|Tuberculosis|tuberculosis
5753518|NCT00306293|Recurrent Genital Herpes|recurrent genital herpes
5753519|NCT00306280|Helicobacter pylori|helicobacter pylori
5753520|NCT00306280|phototherapy|phototherapy
5753521|NCT00306280|peptic ulcer|peptic ulcer
5753522|NCT00306280|gastric cancer|gastric cancer
5753523|NCT00306267|Anemia|anemia
5753524|NCT00306267|non-chemotherapy-induced|non-chemotherapy-induced
5753525|NCT00306267|non-radiation therapy-induced|non-radiation therapy-induced
5753526|NCT00306267|cancer|cancer
5753527|NCT00306267|non-myeloid|non-myeloid
5753528|NCT00306241|Cervical neoplasia|cervical neoplasia
5753529|NCT00306241|Cervical cancer|cervical cancer
5753530|NCT00306241|Double-blind|double-blind
5753531|NCT00306241|HPV-16/18 L1 VLP AS04|hpv-16/18 l1 vlp as04
5753532|NCT00306241|HPV|hpv
5753533|NCT00306241|AS04|as04
5753534|NCT00306228|ST elevation acute myocardial infarction|st elevation acute myocardial infarction
5753535|NCT00306228|Thrombolysis|thrombolysis
5753536|NCT00306228|Early routine percutaneous coronary intervention|early routine percutaneous coronary intervention
5753537|NCT00306228|tirofiban|tirofiban
5753538|NCT00306228|paclitaxel|paclitaxel
5753539|NCT00306215|double-blind|double-blind
5753540|NCT00306215|placebo-controlled|placebo-controlled
5753541|NCT00306215|multicenter|multicenter
5753542|NCT00306215|efficacy|efficacy
5753543|NCT00306215|safety|safety
5753544|NCT00306202|Relapsed and Refractory Leukemia|relapsed and refractory leukemia
5753545|NCT00306189|RANKL|rankl
5753546|NCT00306189|RANK|rank
5753547|NCT00306189|denosumab|denosumab
5753548|NCT00306189|AMG 162|amg 162
5753549|NCT00306189|osteoporosis|osteoporosis
5753550|NCT00306189|bone turnover|bone turnover
5753551|NCT00306189|bone mineral density|bone mineral density
5753552|NCT00306189|Japanese|japanese
5753553|NCT00306176|rosiglitazone,exercise,cardiovascular risk factors|rosiglitazone,exercise,cardiovascular risk factors
5753554|NCT00306163|Asthma|asthma
5753555|NCT00306163|AMP|amp
5753556|NCT00306163|Ciclesonide|ciclesonide
5753557|NCT00306163|Fluticasone propionate|fluticasone propionate
5753558|NCT00306150|Prevention of blood loss|prevention of blood loss
5753559|NCT00306150|Blood Loss, Surgical|blood loss, surgical
5753560|NCT00306150|Blood Loss, Postoperative|blood loss, postoperative
5753561|NCT00306124|Dementia|dementia
5753562|NCT00306124|Mild Cognitive Impairment|mild cognitive impairment
5753564|NCT00306124|levodopa|levodopa
5753565|NCT00306124|learning|learning
5753566|NCT00306124|enhancement|enhancement
5753567|NCT00306111|stem cell transplantation|stem cell transplantation
5753568|NCT00306111|stem cell mobilization|stem cell mobilization
5753569|NCT00306111|high-dose therapy|high-dose therapy
5753570|NCT00306098|Transplantation, Islets of Langerhans|transplantation, islets of langerhans
5753571|NCT00306085|Peripheral arterial disease,|peripheral arterial disease,
5753572|NCT00306085|blood marrow cells,|blood marrow cells,
5753573|NCT00306085|therapeutic angiogenesis.|therapeutic angiogenesis.
5753574|NCT00306046|PETScan|petscan
5753575|NCT00306046|Positron-Emission Tomography|positron-emission tomography
5753576|NCT00306046|Bisphosphonate|bisphosphonate
5753577|NCT00306046|Biochemical Markers|biochemical markers
5753578|NCT00306046|Paget's Disease of Bone (monostotic and polyostotic)|paget's disease of bone (monostotic and polyostotic)
5753579|NCT00306033|myasthenia gravis|myasthenia gravis
5753580|NCT00306033|immunoglobulin|immunoglobulin
5753581|NCT00306033|intravenous immunoglobulin|intravenous immunoglobulin
5753582|NCT00306033|treatment|treatment
5753583|NCT00306020|Skin ulcers|skin ulcers
5753584|NCT00306020|Topical morphine|topical morphine
5753585|NCT00306020|Chronic pain|chronic pain
5753586|NCT00306020|Cancer|cancer
5753587|NCT00306007|Pregnancy|pregnancy
5753588|NCT00306007|Unplanned pregnancy|unplanned pregnancy
5753589|NCT00306007|Psychosocial|psychosocial
5753590|NCT00306007|Measure|measure
5753591|NCT00305968|Quality of life|quality of life
5753592|NCT00305968|Gastrointestinal symptoms|gastrointestinal symptoms
5753593|NCT00305968|Health related costs|health related costs
5753594|NCT00305955|amblyopia|amblyopia
5753595|NCT00305955|bilateral amblyopia|bilateral amblyopia
5753596|NCT00305955|refractive error|refractive error
5753597|NCT00305942|Lung Cancer|lung cancer
5753598|NCT00305942|Carcinoma, Small Cell|carcinoma, small cell
5753599|NCT00305929|Treatment of localized prostate cancer|treatment of localized prostate cancer
5681010|NCT00575211|New onset cardiomyopathy|new onset cardiomyopathy
5681011|NCT00575211|Onset of symptoms less than 6 months|onset of symptoms less than 6 months
5681012|NCT00575211|LVEF < 40%|lvef < 40%
5681013|NCT00575198|Chest tubes|chest tubes
5681014|NCT00575198|Trauma|trauma
5681015|NCT00575185|Mono|mono
5753600|NCT00305929|Localized prostate cancer|localized prostate cancer
5753601|NCT00305916|MSCT|msct
5753602|NCT00305916|Idiopathic Cardiomyopathy|idiopathic cardiomyopathy
5753603|NCT00305916|Sinus rhythm|sinus rhythm
5753604|NCT00305903|Dementia,|dementia,
5753605|NCT00305903|Alzheimer's,|alzheimer's,
5753606|NCT00305903|Rivastigmine,|rivastigmine,
5753607|NCT00305903|Memantine|memantine
5753608|NCT00305851|fatigue|fatigue
5753609|NCT00305851|pain|pain
5753610|NCT00305851|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5753611|NCT00305851|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5753612|NCT00305851|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5753613|NCT00305851|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5753614|NCT00305851|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5753615|NCT00305851|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5753616|NCT00305851|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5753617|NCT00305851|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5753618|NCT00305851|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5753619|NCT00305851|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5753620|NCT00305851|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5753621|NCT00305851|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5753622|NCT00305851|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5753623|NCT00305851|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5753624|NCT00305851|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5753626|NCT00305851|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5753627|NCT00305851|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5848268|NCT00035386|Cardiomyopathy|cardiomyopathy
5753628|NCT00305851|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5753629|NCT00305851|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5753630|NCT00305851|disseminated neuroblastoma|disseminated neuroblastoma
5753631|NCT00305851|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5753632|NCT00305851|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5753633|NCT00305851|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5753634|NCT00305851|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5753635|NCT00305851|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5753636|NCT00305851|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5753637|NCT00305851|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5753638|NCT00305851|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5753639|NCT00305851|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5753640|NCT00305851|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5753641|NCT00305851|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5753642|NCT00305851|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5753643|NCT00305851|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5753644|NCT00305851|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5753645|NCT00305851|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5753646|NCT00305851|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5753647|NCT00305851|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5753648|NCT00305851|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5753649|NCT00305851|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5753650|NCT00305851|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5753651|NCT00305851|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5753652|NCT00305851|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5753653|NCT00305851|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5753654|NCT00305851|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5753655|NCT00305851|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5753656|NCT00305851|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5753657|NCT00305851|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5753658|NCT00305851|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5753659|NCT00305851|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5753660|NCT00305851|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5752705|NCT00309777|kowa|kowa
5753661|NCT00305851|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5753662|NCT00305851|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5753663|NCT00305851|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5753664|NCT00305851|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5753665|NCT00305851|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5753666|NCT00305851|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5753667|NCT00305851|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5753668|NCT00305851|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5753669|NCT00305851|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5753670|NCT00305851|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5753671|NCT00305851|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5753672|NCT00305851|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5753673|NCT00305851|recurrent neuroblastoma|recurrent neuroblastoma
5753675|NCT00305851|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5753676|NCT00305851|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5753677|NCT00305851|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5753678|NCT00305851|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5753679|NCT00305851|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5753680|NCT00305851|refractory hairy cell leukemia|refractory hairy cell leukemia
5753681|NCT00305851|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5753682|NCT00305851|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5753683|NCT00305851|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5753684|NCT00305851|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5753685|NCT00305851|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5753686|NCT00305851|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5848269|NCT00035373|Tumor|tumor
5753687|NCT00305851|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5753688|NCT00305851|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5753689|NCT00305851|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5753690|NCT00305851|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5753691|NCT00305851|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5753692|NCT00305851|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5753693|NCT00305851|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5753694|NCT00305851|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5753695|NCT00305851|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5753696|NCT00305851|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5753697|NCT00305851|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5753698|NCT00305851|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5753699|NCT00305851|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5753700|NCT00305851|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5753701|NCT00305851|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5753702|NCT00305851|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5753703|NCT00305851|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5753704|NCT00305851|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5753705|NCT00305851|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5753706|NCT00305851|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5753707|NCT00305851|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5753708|NCT00305851|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5753709|NCT00305851|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5753710|NCT00305851|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5753711|NCT00305851|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5753712|NCT00305851|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5753714|NCT00305851|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5753715|NCT00305851|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5753716|NCT00305851|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5753717|NCT00305851|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5753718|NCT00305851|Ewing sarcoma|ewing sarcoma
5753719|NCT00305851|childhood brain tumor|childhood brain tumor
5753720|NCT00305851|adult brain tumor|adult brain tumor
5753721|NCT00305851|osteosarcoma|osteosarcoma
5753722|NCT00305838|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5753723|NCT00305838|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5753724|NCT00305838|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5753725|NCT00305838|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5753726|NCT00305838|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5752799|NCT00309452|Schizophrenia|schizophrenia
5753727|NCT00305838|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5753728|NCT00305838|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5754734|NCT00302276|caffeine|caffeine
5753733|NCT00305838|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5753734|NCT00305838|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5753735|NCT00305838|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5753736|NCT00305838|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5753737|NCT00305825|recurrent breast cancer|recurrent breast cancer
5753738|NCT00305825|stage IIIA breast cancer|stage iiia breast cancer
5753739|NCT00305825|stage IIIB breast cancer|stage iiib breast cancer
5753740|NCT00305825|stage IIIC breast cancer|stage iiic breast cancer
5753741|NCT00305825|stage IV breast cancer|stage iv breast cancer
5753742|NCT00305812|stage I multiple myeloma|stage i multiple myeloma
5753743|NCT00305812|stage II multiple myeloma|stage ii multiple myeloma
5753744|NCT00305812|stage III multiple myeloma|stage iii multiple myeloma
5753745|NCT00305799|neurotoxicity|neurotoxicity
5753746|NCT00305799|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5753747|NCT00305786|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5753748|NCT00305786|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5753749|NCT00305786|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5753755|NCT00305747|recurrent prostate cancer|recurrent prostate cancer
5753756|NCT00305747|stage I prostate cancer|stage i prostate cancer
5753757|NCT00305747|stage II prostate cancer|stage ii prostate cancer
5753758|NCT00305747|stage III prostate cancer|stage iii prostate cancer
5753759|NCT00305747|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5753760|NCT00305747|stage IV prostate cancer|stage iv prostate cancer
5753761|NCT00305708|thrombocytopenia|thrombocytopenia
5753762|NCT00305708|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5753763|NCT00305708|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5753764|NCT00305708|Diamond-Blackfan anemia|diamond-blackfan anemia
5753765|NCT00305708|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5753766|NCT00305708|Fanconi anemia|fanconi anemia
5753767|NCT00305708|severe congenital neutropenia|severe congenital neutropenia
5753768|NCT00305708|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5753769|NCT00305669|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5753770|NCT00305669|stage I prostate cancer|stage i prostate cancer
5753771|NCT00305669|stage IIB prostate cancer|stage iib prostate cancer
5753772|NCT00305669|stage IIA prostate cancer|stage iia prostate cancer
5753773|NCT00305669|stage III prostate cancer|stage iii prostate cancer
5753774|NCT00305643|Hand-Foot Syndrome|hand-foot syndrome
5753775|NCT00305643|cancer-related problem/condition|cancer-related problem/condition
5753776|NCT00305643|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5753778|NCT00305643|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia
5753779|NCT00305643|stage IV breast cancer|stage iv breast cancer
5753780|NCT00305643|male breast cancer|male breast cancer
5753781|NCT00305643|recurrent breast cancer|recurrent breast cancer
5753782|NCT00305643|stage IV colon cancer|stage iv colon cancer
5753783|NCT00305643|stage IV rectal cancer|stage iv rectal cancer
5753784|NCT00305643|recurrent colon cancer|recurrent colon cancer
5753785|NCT00305643|recurrent rectal cancer|recurrent rectal cancer
5753786|NCT00305643|Celecoxib|celecoxib
5753787|NCT00305643|Celebrex|celebrex
5753788|NCT00305643|Capecitabine|capecitabine
5753790|NCT00305630|Corticosteroids|corticosteroids
5753791|NCT00305630|Triamcinolone|triamcinolone
5753792|NCT00305630|Photodynamic therapy|photodynamic therapy
5753793|NCT00305630|Choroidal neovascularization|choroidal neovascularization
5753794|NCT00305630|Age-related macular degeneration|age-related macular degeneration
5753795|NCT00305617|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5753796|NCT00305617|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5753797|NCT00305591|magnetic resonance imaging|magnetic resonance imaging
5753798|NCT00305591|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5753799|NCT00305591|functional magnetic resonance imaging|functional magnetic resonance imaging
5753800|NCT00305591|cirrhosis|cirrhosis
5753801|NCT00305591|hepatic encephalopathy|hepatic encephalopathy
5753802|NCT00305591|l-ornithine l-aspartate|l-ornithine l-aspartate
5753803|NCT00305578|Bipolar|bipolar
5753804|NCT00305578|Depression|depression
5753805|NCT00305578|Incomplete Response|incomplete response
5753806|NCT00305565|Depression|depression
5762552|NCT00273728|Hydroxyethyl Starch|hydroxyethyl starch
5753807|NCT00305565|Chronic Depression|chronic depression
5753808|NCT00305565|Bipolar Disorder|bipolar disorder
5753809|NCT00305552|Randomized controlled trial|randomized controlled trial
5753810|NCT00305552|Thalidomide vs placebo|thalidomide vs placebo
5753811|NCT00305552|skin sarcoidosis|skin sarcoidosis
5753812|NCT00305552|Thalidomide|thalidomide
5753813|NCT00305539|Giant Cell Arteritis|giant cell arteritis
5753814|NCT00305539|Placebo|placebo
5753815|NCT00305539|Anti-TNF|anti-tnf
5761724|NCT00277381|Adherence|adherence
5753816|NCT00305539|Multicenter-randomized-trial|multicenter-randomized-trial
5753817|NCT00305539|Proved GCA according to ACR criteria (HUNDER et al 1990)|proved gca according to acr criteria (hunder et al 1990)
5753818|NCT00305513|right hemispheric CVA|right hemispheric cva
5753819|NCT00305513|neglect|neglect
5753820|NCT00305513|phasic alert treatment|phasic alert treatment
5753821|NCT00305513|PET scan|pet scan
5753822|NCT00305513|patients post right hemispheric CVA (stroke)|patients post right hemispheric cva (stroke)
5753824|NCT00305500|Escitalopram|escitalopram
5753825|NCT00305487|Hay Fever|hay fever
5753826|NCT00305487|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5753827|NCT00305487|Nasal spray|nasal spray
5753828|NCT00305487|Ciclesonide|ciclesonide
5753829|NCT00305487|Allergic Rhinitis|allergic rhinitis
5753830|NCT00305474|Negative symptoms|negative symptoms
5753831|NCT00305474|neuropsychological deficits|neuropsychological deficits
5753832|NCT00305474|Cognitive function|cognitive function
5753833|NCT00305474|diagnostic|diagnostic
5753834|NCT00305474|prevention|prevention
5753835|NCT00305461|Asthma|asthma
5753836|NCT00305461|Quality of Life|quality of life
5753837|NCT00305461|Ciclesonide|ciclesonide
5753839|NCT00305448|cancer|cancer
5753840|NCT00305448|breast cancer|breast cancer
5753841|NCT00305435|AMG 531, ITP, Phase 2, Japanese|amg 531, itp, phase 2, japanese
5753842|NCT00305409|Crohn's|crohn's
5753843|NCT00305409|TNF-alpha|tnf-alpha
5753844|NCT00305409|Synbiotic|synbiotic
5753845|NCT00305409|Probiotic|probiotic
5753846|NCT00305396|Kidney transplantation|kidney transplantation
5753847|NCT00305396|immunosuppression|immunosuppression
5753848|NCT00305396|sirolimus|sirolimus
5753849|NCT00305396|Thymoglobulin|thymoglobulin
5753850|NCT00305383|Viramidine|viramidine
5753851|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b
5753852|NCT00305383|Valeant|valeant
5753853|NCT00305383|Hepatitis C|hepatitis c
5753854|NCT00305383|Rapid virologic response|rapid virologic response
5753855|NCT00305383|HCV RNA|hcv rna
5753856|NCT00305370|clinical trial|clinical trial
5753857|NCT00305370|aripiprazole|aripiprazole
5753858|NCT00305370|methylphenidate|methylphenidate
5753859|NCT00305370|Bipolar Disorder|bipolar disorder
5848270|NCT00035373|Brain|brain
5753860|NCT00305370|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5753861|NCT00305370|ADHD|adhd
5753862|NCT00305357|Post-Herpetic Neuralgia|post-herpetic neuralgia
5753863|NCT00305357|Acute Herpes Zoster|acute herpes zoster
5753864|NCT00305344|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5753865|NCT00305344|Umbilical Cord|umbilical cord
5753866|NCT00305344|Regeneration|regeneration
5753867|NCT00305344|Insulin|insulin
5753868|NCT00305344|Islets of Langerhans|islets of langerhans
5753869|NCT00305331|Parkinson's disease|parkinson's disease
5753870|NCT00305331|Domperidone|domperidone
5753871|NCT00305331|Peripheral edema|peripheral edema
5753872|NCT00305331|Pramipexole|pramipexole
5753873|NCT00305331|Ropinirole|ropinirole
5753874|NCT00305305|Agenesis Corpus Callosum|agenesis corpus callosum
5753875|NCT00305305|Polymicrogyria|polymicrogyria
5753876|NCT00305305|Dandy-Walker|dandy-walker
5753877|NCT00305305|Brain Malformation|brain malformation
5753878|NCT00305305|Autism|autism
5753879|NCT00305305|Epilepsy|epilepsy
5753880|NCT00305305|Mental Retardation|mental retardation
5753882|NCT00305305|Agenesis of the Corpus Callosum (complete or partial)|agenesis of the corpus callosum (complete or partial)
5753883|NCT00305305|Confirmed by a brain MRI.|confirmed by a brain mri.
5753884|NCT00305305|Aicardi Syndrome.|aicardi syndrome.
5753885|NCT00305266|CIDP|cidp
5753886|NCT00305266|IVIG|ivig
5753887|NCT00305266|gammaglobulin|gammaglobulin
5753888|NCT00305266|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5753889|NCT00305253|maternal mortality|maternal mortality
5753890|NCT00305253|obstetric hemorrhage|obstetric hemorrhage
5753891|NCT00305240|Myocardial Infarction|myocardial infarction
5753892|NCT00305240|Microvolt T Wave Alternans Test|microvolt t wave alternans test
5753893|NCT00305240|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5753894|NCT00305240|Ventricular Arrythmias|ventricular arrythmias
5753895|NCT00305227|urinary tract infection|urinary tract infection
5753896|NCT00305227|cystitis|cystitis
5753897|NCT00305227|Lactobacillus|lactobacillus
5753898|NCT00305227|probiotic|probiotic
5753899|NCT00305227|prevention|prevention
5753900|NCT00305214|Myocardial Infarction|myocardial infarction
5753901|NCT00305214|Microvolt T Wave Alternans Test|microvolt t wave alternans test
5753902|NCT00305214|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5779650|NCT00199108|ALL|all
5753903|NCT00305214|Ventricular Arrhythmia|ventricular arrhythmia
5753904|NCT00305201|Mucocutaneous Lymph Node Syndrome|mucocutaneous lymph node syndrome
5753905|NCT00305201|Kawasaki disease|kawasaki disease
5753906|NCT00305201|Endothelial dysfunction|endothelial dysfunction
5753908|NCT00305201|Statin therapy|statin therapy
5753909|NCT00305188|Neurotoxicity syndromes|neurotoxicity syndromes
5753910|NCT00305188|Paresthesia|paresthesia
5753911|NCT00305188|Oxaliplatin|oxaliplatin
5753912|NCT00305188|Xaliproden|xaliproden
5753913|NCT00305175|Hydroxyurea|hydroxyurea
5753914|NCT00305175|Sickle Cell Anemia|sickle cell anemia
5753915|NCT00305162|Acute Coronary Syndrome (ACS)|acute coronary syndrome (acs)
5753916|NCT00305162|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5753917|NCT00305162|non-ST-segment elevation myocardial infarction (NSTEMI)|non-st-segment elevation myocardial infarction (nstemi)
5753918|NCT00305162|ST-segment elevation myocardial infarction (STEMI)|st-segment elevation myocardial infarction (stemi)
5753919|NCT00305149|Hodgkin Lymphoma|hodgkin lymphoma
5753923|NCT00305149|Tailored therapy|tailored therapy
5753924|NCT00305136|thoracotomy|thoracotomy
5753925|NCT00305136|post-operative pain|post-operative pain
5753926|NCT00305136|chronic pain|chronic pain
5753927|NCT00305136|endogenous analgesia|endogenous analgesia
5753928|NCT00305136|temporal summation|temporal summation
5753929|NCT00305136|central sensitization|central sensitization
5753930|NCT00305136|prediction|prediction
5753931|NCT00305136|Patients Who Should Undergo Thoracotomy|patients who should undergo thoracotomy
5753932|NCT00305123|Pharyngitis, Mali, Group A Streptococcus, Children|pharyngitis, mali, group a streptococcus, children
5753933|NCT00305110|Pain|pain
5753934|NCT00305110|Acute|acute
5753935|NCT00305110|Emergency Department|emergency department
5753937|NCT00305110|Hydromorphone|hydromorphone
5753938|NCT00305110|Dilaudid|dilaudid
5753939|NCT00305110|Adult|adult
5753940|NCT00305097|coffee|coffee
5753941|NCT00305097|caffeine|caffeine
5753942|NCT00305097|glucose tolerance|glucose tolerance
5753943|NCT00305097|body weight|body weight
5753944|NCT00305097|insulin sensitivity|insulin sensitivity
5753945|NCT00305097|randomized controlled trial|randomized controlled trial
5753946|NCT00305084|NGR-hTNF|ngr-htnf
5753947|NCT00305084|doxorubicin|doxorubicin
5753948|NCT00305084|solid tumors|solid tumors
5753949|NCT00305071|pyuria|pyuria
5753950|NCT00305071|urinary tract infections|urinary tract infections
5753951|NCT00305071|Vaccinium macrocarpon|vaccinium macrocarpon
5753952|NCT00305058|Elderly|elderly
5753953|NCT00305058|Hydromorphone|hydromorphone
5753954|NCT00305058|Morphine|morphine
5753955|NCT00305058|Pain|pain
5753956|NCT00305058|Acute|acute
5753957|NCT00305058|Emergency Department|emergency department
5753958|NCT00305045|Major Depressive Disorder|major depressive disorder
5753959|NCT00305045|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5753960|NCT00305045|Treatment resistance|treatment resistance
5753961|NCT00305006|cerebral palsy|cerebral palsy
5753962|NCT00305006|constraint-induced therapy|constraint-induced therapy
5753963|NCT00305006|constraint-induced movement therapy|constraint-induced movement therapy
5753964|NCT00305006|CP|cp
5753965|NCT00305006|hemiplegia|hemiplegia
5753966|NCT00305006|hand|hand
5753967|NCT00305006|forced use|forced use
5753968|NCT00305006|motor control|motor control
5753969|NCT00305006|children|children
5753970|NCT00305006|HABIT|habit
5753971|NCT00305006|Hand-arm bimanual intensive therapy|hand-arm bimanual intensive therapy
5753972|NCT00305006|Bilateral training|bilateral training
5753973|NCT00305006|Bimanual training|bimanual training
5753974|NCT00305006|functional therapy|functional therapy
5753975|NCT00305006|physical therapy|physical therapy
5753976|NCT00305006|occupational therapy|occupational therapy
5753977|NCT00305006|intensive|intensive
5753978|NCT00305006|pediatric|pediatric
5753979|NCT00305006|development|development
5753980|NCT00305006|upper extremity|upper extremity
5753981|NCT00305006|hemiplegic|hemiplegic
5753982|NCT00304993|fenofibrate|fenofibrate
5753983|NCT00304993|niacin|niacin
5753984|NCT00304993|rosiglitazone|rosiglitazone
5753985|NCT00304993|LDL phenotype pattern B|ldl phenotype pattern b
5753986|NCT00304993|small, dense LDL|small, dense ldl
5753987|NCT00304993|insulin resistance|insulin resistance
5753988|NCT00304993|Metabolic Syndrome|metabolic syndrome
5753989|NCT00304967|Cataract|cataract
5753990|NCT00304967|Normal Lenses|normal lenses
5753991|NCT00304967|Lens Crystallines|lens crystallines
5753992|NCT00304967|Dynamic or Quasielastic Light Scattering (DLS)|dynamic or quasielastic light scattering (dls)
5753993|NCT00304967|Eye Examinations|eye examinations
5753994|NCT00304967|Healthy Volunteer|healthy volunteer
5753995|NCT00304967|HV|hv
5753996|NCT00304967|Eye Examination|eye examination
5753997|NCT00304954|Age-Related Macular Degeneration|age-related macular degeneration
5753998|NCT00304954|Rapamycin|rapamycin
5753999|NCT00304954|Remicade|remicade
5754000|NCT00304954|Daclizumab|daclizumab
5754001|NCT00304954|Immunosuppression|immunosuppression
5754002|NCT00304954|Infliximab|infliximab
5754003|NCT00304954|Choroidal Neovascularization|choroidal neovascularization
5762749|NCT00272844|sterols|sterols
5754004|NCT00304954|Sirolimus|sirolimus
5754006|NCT00304954|Ocular Inflammation|ocular inflammation
5754007|NCT00304941|Breast Cancer|breast cancer
5754008|NCT00304941|Family History|family history
5754009|NCT00304941|Pre/Post Menopausal|pre/post menopausal
5754010|NCT00304941|Prevention|prevention
5754011|NCT00304941|Risk-Factor|risk-factor
5754012|NCT00304941|Body-Mass-Index|body-mass-index
5754013|NCT00304941|BRCA1|brca1
5754014|NCT00304941|Insulin|insulin
5754015|NCT00304941|Genetic Counseling|genetic counseling
5778688|NCT00203853|HIV|hiv
5754016|NCT00304941|Penetrance|penetrance
5754017|NCT00304941|Risk Assessment|risk assessment
5754018|NCT00304941|Healthy Volunteer|healthy volunteer
5754019|NCT00304941|HV|hv
5754020|NCT00304915|HIV, depression|hiv, depression
5754021|NCT00304915|patient care management|patient care management
5754022|NCT00304915|patient care team|patient care team
5754023|NCT00304902|MRSA|mrsa
5754024|NCT00304902|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5754123|NCT00304434|Probenecid|probenecid
5754025|NCT00304902|Staphylococcus aureus Bacteremia|staphylococcus aureus bacteremia
5754026|NCT00304889|Clostridium difficile|clostridium difficile
5754027|NCT00304876|Clostridium difficile associated diarrhea|clostridium difficile associated diarrhea
5754028|NCT00304863|CDAD|cdad
5754029|NCT00304863|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5754030|NCT00304850|polyamines|polyamines
5754031|NCT00304850|pain|pain
5754032|NCT00304850|breast cancer|breast cancer
5754033|NCT00304850|mastectomy|mastectomy
5754034|NCT00304850|post operative pain|post operative pain
5754035|NCT00304837|Nonhealing leg ulcers|nonhealing leg ulcers
5754036|NCT00304837|Ischemic rest pain|ischemic rest pain
5754037|NCT00304824|Glaucoma|glaucoma
5754038|NCT00304824|Olfactory functions|olfactory functions
5754039|NCT00304824|Sniffing Sticks Test|sniffing sticks test
5754040|NCT00304811|MRSA|mrsa
5754041|NCT00304811|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5754042|NCT00304798|Transient Ischemic Attack (TIA).|transient ischemic attack (tia).
5754043|NCT00304798|Stroke.|stroke.
5754044|NCT00304798|Hospital admission.|hospital admission.
5754045|NCT00304772|Candida|candida
5754046|NCT00304772|bloodstream infection|bloodstream infection
5754047|NCT00304772|fluconazole|fluconazole
5754048|NCT00304772|micafungin|micafungin
5754049|NCT00304772|randomized controlled trial|randomized controlled trial
5754050|NCT00304759|prostate cancer|prostate cancer
5754051|NCT00304759|localized prostate cancer|localized prostate cancer
5754052|NCT00304759|intermediate risk|intermediate risk
5754053|NCT00304759|prostate specific antigen|prostate specific antigen
5754054|NCT00304759|PSA|psa
5754055|NCT00304759|radiation fractionation|radiation fractionation
5754056|NCT00304759|shorter schedule|shorter schedule
5754057|NCT00304759|quality of life|quality of life
5754058|NCT00304733|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading|neuropathic foot ulcerations - total contact cast - custom -made footwear - off-loading
5754059|NCT00304720|Lymphoma|lymphoma
5754060|NCT00304720|Leukemia|leukemia
5754061|NCT00304694|NPC|npc
5754062|NCT00304694|Induction chemotherapy|induction chemotherapy
5754063|NCT00304694|Therapeutic response|therapeutic response
5754064|NCT00304694|18F-FDG PET|18f-fdg pet
5754065|NCT00304681|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5754066|NCT00304681|OROS* Methylphenidate|oros* methylphenidate
5754067|NCT00304668|HIV-1|hiv-1
5754068|NCT00304668|HIV Seronegativity|hiv seronegativity
5754069|NCT00304655|Schizophrenia|schizophrenia
5754070|NCT00304655|Schizoaffective disorder|schizoaffective disorder
5754071|NCT00304655|Aripiprazole|aripiprazole
5754072|NCT00304642|HIV-1|hiv-1
5754073|NCT00304642|HIV Seronegativity|hiv seronegativity
5754074|NCT00304629|Alzheimer's disease|alzheimer's disease
5754075|NCT00304629|cholinesterase inhibitors|cholinesterase inhibitors
5754076|NCT00304629|galantamine|galantamine
5754077|NCT00304616|Schizophrenia|schizophrenia
5754078|NCT00304616|Aripiprazole|aripiprazole
5754079|NCT00304603|Obesity|obesity
5754080|NCT00304603|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5754081|NCT00304603|Topiramate|topiramate
5754082|NCT00304603|Pharmacogenomics|pharmacogenomics
5754083|NCT00304603|DNA Polymorphism|dna polymorphism
5754084|NCT00304577|Strabismus|strabismus
5754085|NCT00304577|Esotropia|esotropia
5754086|NCT00304577|Surgical techniques|surgical techniques
5754087|NCT00304564|Posturography, Fall Prevention, Geriatrics, Nolwenn Effect|posturography, fall prevention, geriatrics, nolwenn effect
5754088|NCT00304551|CHC with compensated LC|chc with compensated lc
5754089|NCT00304538|diabetes|diabetes
5754090|NCT00304525|Anti-angiogenesis therapy|anti-angiogenesis therapy
5754091|NCT00304525|Kinase inhibitor therapy|kinase inhibitor therapy
5754092|NCT00304525|Raf inhibitor|raf inhibitor
5754093|NCT00304525|Locally Advanced Melanoma|locally advanced melanoma
5754094|NCT00304512|Amicus Therapeutics|amicus therapeutics
5754096|NCT00304512|Galafold|galafold
5754097|NCT00304512|Migalastat|migalastat
5754098|NCT00304512|Substrate|substrate
5754099|NCT00304499|OROS®|oros®
5754100|NCT00304499|middle age|middle age
5754101|NCT00304499|elderly|elderly
5754102|NCT00304499|oxybutynin|oxybutynin
5754103|NCT00304499|urinary incontinenence|urinary incontinenence
5754104|NCT00304499|women|women
5754105|NCT00304473|Schizophrenia|schizophrenia
5754735|NCT00302276|green tea|green tea
5754106|NCT00304460|Serum Protein Levels|serum protein levels
5754107|NCT00304460|Lymphocyte Phenotypes|lymphocyte phenotypes
5754108|NCT00304460|Predictive Analysis|predictive analysis
5754109|NCT00304460|Serum Cytokines|serum cytokines
5754110|NCT00304460|Kidney Cancer|kidney cancer
5761951|NCT00276497|Intervention|intervention
5754111|NCT00304460|Renal Cell Cancer|renal cell cancer
5754112|NCT00304460|Melanoma|melanoma
5754113|NCT00304460|Metastatic Melanoma|metastatic melanoma
5754114|NCT00304447|Leukemia|leukemia
5754115|NCT00304447|Mylotarg|mylotarg
5754116|NCT00304447|Safety|safety
5754117|NCT00304447|Adverse Events|adverse events
5754118|NCT00304434|Adverse effects|adverse effects
5754119|NCT00304434|Antiviral|antiviral
5754120|NCT00304434|Clinical trial|clinical trial
5754121|NCT00304434|Oseltamivir|oseltamivir
5754122|NCT00304434|Pharmacokinetics|pharmacokinetics
5754124|NCT00304421|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5754125|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors
5754126|NCT00304421|Gastric pH|gastric ph
5754127|NCT00304421|Gastric Acid Secretion|gastric acid secretion
5754128|NCT00304408|Clostridium difficile|clostridium difficile
5754129|NCT00304395|Community Acquired Pneumonia|community acquired pneumonia
5754130|NCT00304395|CAP|cap
5754131|NCT00304382|Pneumococcus|pneumococcus
5754132|NCT00304382|Pneumococcal pneumonia|pneumococcal pneumonia
5754133|NCT00304369|Clostridium difficile|clostridium difficile
5754134|NCT00304356|Clostridium difficile Associated Diarrhea|clostridium difficile associated diarrhea
5754136|NCT00304317|calculi|calculi
5754137|NCT00304317|ureteral calculi|ureteral calculi
5754138|NCT00304317|ureter|ureter
5754139|NCT00304304|child care centers|child care centers
5754140|NCT00304304|asthma triggers|asthma triggers
5754141|NCT00304304|community-based research|community-based research
5754142|NCT00304291|Novantrone|novantrone
5754143|NCT00304278|Head and Neck Cancer|head and neck cancer
5754144|NCT00304278|Erlotinib|erlotinib
5754145|NCT00304278|RADPLAT|radplat
5754146|NCT00304265|Pertussis,|pertussis,
5754147|NCT00304265|Diphtheria,|diphtheria,
5754148|NCT00304265|Tetanus,|tetanus,
5754149|NCT00304265|Poliomyelitis|poliomyelitis
5754150|NCT00304239|Methyl aminolevulinate|methyl aminolevulinate
5754151|NCT00304239|Photodynamic therapy|photodynamic therapy
5754152|NCT00304239|Aktilite CL128 LED light source|aktilite cl128 led light source
5754153|NCT00304239|Multiple Actinic Keratosis|multiple actinic keratosis
5754154|NCT00304226|Valsartan,|valsartan,
5754155|NCT00304226|amlodipine,|amlodipine,
5754156|NCT00304226|hydrochlorothiazide|hydrochlorothiazide
5754157|NCT00304213|hypogonadism|hypogonadism
5754158|NCT00304213|testosterone|testosterone
5754159|NCT00304213|aging|aging
5754160|NCT00304213|Total testosterone < 300 ng/dL|total testosterone < 300 ng/dl
5754161|NCT00304213|Bioavailable testosterone < 70 ng/dL|bioavailable testosterone < 70 ng/dl
5754162|NCT00304200|Metastatic Malignant Melanoma|metastatic malignant melanoma
5754163|NCT00304187|Binge-Eating Disorder|binge-eating disorder
5754164|NCT00304161|Depression|depression
5754165|NCT00304161|Parkinson's Disease|parkinson's disease
5754166|NCT00304161|Atomoxetine|atomoxetine
5754167|NCT00304148|Renal Insufficiency Chronic|renal insufficiency chronic
5754168|NCT00304135|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5754169|NCT00304135|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5754170|NCT00304135|unresectable gallbladder cancer|unresectable gallbladder cancer
5754171|NCT00304096|recurrent breast cancer|recurrent breast cancer
5754172|NCT00304096|stage IIIA breast cancer|stage iiia breast cancer
5754173|NCT00304096|stage IIIB breast cancer|stage iiib breast cancer
5754174|NCT00304096|stage IIIC breast cancer|stage iiic breast cancer
5754175|NCT00304096|stage IV breast cancer|stage iv breast cancer
5754176|NCT00304096|male breast cancer|male breast cancer
5754177|NCT00304096|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5754178|NCT00304083|adult neurofibrosarcoma|adult neurofibrosarcoma
5754179|NCT00304083|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5754180|NCT00304083|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5754181|NCT00304083|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5754182|NCT00304083|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5754183|NCT00304083|neurofibromatosis type 1|neurofibromatosis type 1
5754184|NCT00304031|adult glioblastoma|adult glioblastoma
5754185|NCT00304031|adult giant cell glioblastoma|adult giant cell glioblastoma
5754186|NCT00304031|adult gliosarcoma|adult gliosarcoma
5754187|NCT00304018|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5754188|NCT00304018|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5754189|NCT00304018|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5754190|NCT00304018|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5762946|NCT00271986|Anastomotic leakage|anastomotic leakage
5754191|NCT00304018|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5754192|NCT00304018|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5754193|NCT00304018|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5754194|NCT00304018|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5754195|NCT00304018|refractory multiple myeloma|refractory multiple myeloma
5754196|NCT00304018|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5753300|NCT00307047|Stents|stents
5754197|NCT00304018|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5754198|NCT00304018|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5754199|NCT00304018|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5754200|NCT00304018|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5754201|NCT00304018|stage II multiple myeloma|stage ii multiple myeloma
5754202|NCT00304018|stage III multiple myeloma|stage iii multiple myeloma
5754203|NCT00304018|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5754204|NCT00304018|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5754205|NCT00304018|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5754206|NCT00304018|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5754207|NCT00304018|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5754208|NCT00304018|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5754209|NCT00304018|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5754210|NCT00304018|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5754211|NCT00304018|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5754212|NCT00304018|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5754213|NCT00304018|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5754214|NCT00304018|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5754215|NCT00304018|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5754216|NCT00304018|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5754217|NCT00304018|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5754218|NCT00304018|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5754219|NCT00304018|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5754220|NCT00304018|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5754221|NCT00304018|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5754222|NCT00304018|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5754223|NCT00304018|stage I multiple myeloma|stage i multiple myeloma
5754224|NCT00304005|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5754225|NCT00304005|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5754226|NCT00304005|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5754228|NCT00303992|recurrent breast cancer|recurrent breast cancer
5754229|NCT00303979|Systolic Heart Failure|systolic heart failure
5754230|NCT00303979|Quality of Care|quality of care
5754231|NCT00303979|Outcomes|outcomes
5754232|NCT00303979|Evidence-based Guidelines|evidence-based guidelines
5754233|NCT00303979|Recommended Therapies|recommended therapies
5754234|NCT00303940|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5754235|NCT00303940|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5754236|NCT00303940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5754237|NCT00303940|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5754238|NCT00303940|recurrent osteosarcoma|recurrent osteosarcoma
5754239|NCT00303940|recurrent neuroblastoma|recurrent neuroblastoma
5754240|NCT00303940|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5754241|NCT00303940|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5754242|NCT00303940|recurrent childhood liver cancer|recurrent childhood liver cancer
5754243|NCT00303940|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5754244|NCT00303940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5754245|NCT00303940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5754246|NCT00303940|recurrent childhood ependymoma|recurrent childhood ependymoma
5754247|NCT00303940|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5754248|NCT00303940|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5754249|NCT00303940|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5754250|NCT00303940|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5754251|NCT00303940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5754252|NCT00303940|childhood choroid plexus tumor|childhood choroid plexus tumor
5754253|NCT00303940|childhood craniopharyngioma|childhood craniopharyngioma
5754254|NCT00303940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5754255|NCT00303940|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5754256|NCT00303940|childhood oligodendroglioma|childhood oligodendroglioma
5754257|NCT00303940|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5754258|NCT00303940|recurrent childhood brain tumor|recurrent childhood brain tumor
5754259|NCT00303940|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5754260|NCT00303940|childhood grade I meningioma|childhood grade i meningioma
5754261|NCT00303940|childhood grade II meningioma|childhood grade ii meningioma
5863032|NCT00001412|Central Nervous System Function|central nervous system function
5754262|NCT00303940|childhood grade III meningioma|childhood grade iii meningioma
5754263|NCT00303940|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5754264|NCT00303940|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5754265|NCT00303940|childhood teratoma|childhood teratoma
5754266|NCT00303927|recurrent pancreatic cancer|recurrent pancreatic cancer
5754267|NCT00303927|stage IV pancreatic cancer|stage iv pancreatic cancer
5754269|NCT00303914|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5754270|NCT00303914|cognitive/functional effects|cognitive/functional effects
5754271|NCT00303914|recurrent breast cancer|recurrent breast cancer
5754272|NCT00303914|stage I breast cancer|stage i breast cancer
5754273|NCT00303914|stage II breast cancer|stage ii breast cancer
5754274|NCT00303914|stage IIIA breast cancer|stage iiia breast cancer
5754449|NCT00303433|Delirium|delirium
5754275|NCT00303914|stage IIIB breast cancer|stage iiib breast cancer
5754276|NCT00303914|stage IIIC breast cancer|stage iiic breast cancer
5754277|NCT00303914|stage IV breast cancer|stage iv breast cancer
5754278|NCT00303914|recurrent colon cancer|recurrent colon cancer
5754279|NCT00303914|stage I colon cancer|stage i colon cancer
5754280|NCT00303914|stage II colon cancer|stage ii colon cancer
5754282|NCT00303914|stage IV colon cancer|stage iv colon cancer
5754283|NCT00303914|recurrent rectal cancer|recurrent rectal cancer
5754284|NCT00303914|stage I rectal cancer|stage i rectal cancer
5754285|NCT00303914|stage II rectal cancer|stage ii rectal cancer
5754286|NCT00303914|stage III rectal cancer|stage iii rectal cancer
5754287|NCT00303914|stage IV rectal cancer|stage iv rectal cancer
5754288|NCT00303914|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5754289|NCT00303914|limited stage small cell lung cancer|limited stage small cell lung cancer
5754290|NCT00303914|recurrent small cell lung cancer|recurrent small cell lung cancer
5754291|NCT00303914|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5754292|NCT00303914|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5754293|NCT00303914|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5754294|NCT00303914|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5754295|NCT00303914|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5754296|NCT00303914|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5754297|NCT00303914|recurrent prostate cancer|recurrent prostate cancer
5754298|NCT00303914|stage I prostate cancer|stage i prostate cancer
5754299|NCT00303914|stage IIB prostate cancer|stage iib prostate cancer
5754300|NCT00303914|stage IIA prostate cancer|stage iia prostate cancer
5754301|NCT00303914|stage III prostate cancer|stage iii prostate cancer
5754302|NCT00303914|stage IV prostate cancer|stage iv prostate cancer
5754303|NCT00303914|male breast cancer|male breast cancer
5754304|NCT00303914|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5754306|NCT00303901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5754307|NCT00303901|recurrent small cell lung cancer|recurrent small cell lung cancer
5754308|NCT00303901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5754309|NCT00303901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5754310|NCT00303901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5754311|NCT00303901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5754312|NCT00303901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5754313|NCT00303901|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5754314|NCT00303901|limited stage small cell lung cancer|limited stage small cell lung cancer
5754315|NCT00303901|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5754316|NCT00303888|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5754317|NCT00303888|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5754318|NCT00303888|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5754319|NCT00303888|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5754320|NCT00303888|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5754321|NCT00303888|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5754322|NCT00303888|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5754323|NCT00303888|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5754324|NCT00303888|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5754325|NCT00303888|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5754326|NCT00303888|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5862874|NCT00001474|Immunoregulation|immunoregulation
5763164|NCT00271154|Heart Failure|heart failure
5754327|NCT00303888|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5754328|NCT00303888|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5754329|NCT00303888|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5754330|NCT00303888|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5754331|NCT00303875|recurrent prostate cancer|recurrent prostate cancer
5754332|NCT00303875|stage I prostate cancer|stage i prostate cancer
5754333|NCT00303875|stage IIB prostate cancer|stage iib prostate cancer
5754334|NCT00303875|stage IIA prostate cancer|stage iia prostate cancer
5754335|NCT00303875|stage III prostate cancer|stage iii prostate cancer
5754336|NCT00303875|stage IV prostate cancer|stage iv prostate cancer
5754341|NCT00303875|stage IIIB breast cancer|stage iiib breast cancer
5754342|NCT00303875|stage IIIC breast cancer|stage iiic breast cancer
5754343|NCT00303875|stage IV breast cancer|stage iv breast cancer
5754344|NCT00303875|recurrent colon cancer|recurrent colon cancer
5754345|NCT00303875|stage I colon cancer|stage i colon cancer
5754346|NCT00303875|stage II colon cancer|stage ii colon cancer
5754347|NCT00303875|stage III colon cancer|stage iii colon cancer
5754348|NCT00303875|stage IV colon cancer|stage iv colon cancer
5754349|NCT00303875|recurrent rectal cancer|recurrent rectal cancer
5754350|NCT00303875|stage I rectal cancer|stage i rectal cancer
5754351|NCT00303875|stage II rectal cancer|stage ii rectal cancer
5754352|NCT00303875|stage III rectal cancer|stage iii rectal cancer
5754353|NCT00303875|stage IV rectal cancer|stage iv rectal cancer
5754354|NCT00303810|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5754451|NCT00303420|catheter|catheter
5754355|NCT00303810|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5749454|NCT00321971|MCI|mci
5754356|NCT00303810|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5754357|NCT00303810|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5754358|NCT00303810|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5754360|NCT00303784|anemia|anemia
5754361|NCT00303784|osteoporosis|osteoporosis
5754362|NCT00303784|cardiovascular complications|cardiovascular complications
5754363|NCT00303784|recurrent prostate cancer|recurrent prostate cancer
5754364|NCT00303784|stage III prostate cancer|stage iii prostate cancer
5754365|NCT00303784|stage IV prostate cancer|stage iv prostate cancer
5754366|NCT00303784|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5754367|NCT00303771|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5754368|NCT00303771|stage IV rectal cancer|stage iv rectal cancer
5754369|NCT00303771|stage IV colon cancer|stage iv colon cancer
5754370|NCT00303771|adenocarcinoma of the colon|adenocarcinoma of the colon
5754371|NCT00303771|recurrent colon cancer|recurrent colon cancer
5754372|NCT00303771|recurrent rectal cancer|recurrent rectal cancer
5754373|NCT00303758|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5754374|NCT00303758|recurrent pancreatic cancer|recurrent pancreatic cancer
5754375|NCT00303758|stage IV pancreatic cancer|stage iv pancreatic cancer
5754376|NCT00303745|adenocarcinoma of the colon|adenocarcinoma of the colon
5754377|NCT00303745|recurrent colon cancer|recurrent colon cancer
5754378|NCT00303745|stage IV colon cancer|stage iv colon cancer
5848271|NCT00035373|Chemotherapy|chemotherapy
5754379|NCT00303745|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5754380|NCT00303745|recurrent rectal cancer|recurrent rectal cancer
5754381|NCT00303745|stage IV rectal cancer|stage iv rectal cancer
5754382|NCT00303732|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5754383|NCT00303732|recurrent renal cell cancer|recurrent renal cell cancer
5754384|NCT00303732|stage IV renal cell cancer|stage iv renal cell cancer
5754385|NCT00303719|leukemia|leukemia
5754386|NCT00303719|lymphoma|lymphoma
5754387|NCT00303719|myeloma|myeloma
5754392|NCT00303667|NK cells|nk cells
5754393|NCT00303667|natural killer cells|natural killer cells
5754394|NCT00303667|immunotherapy|immunotherapy
5754395|NCT00303667|hematopoietic cell transplant|hematopoietic cell transplant
5754396|NCT00303667|acute myelogenous leukemia|acute myelogenous leukemia
5754397|NCT00303654|recurrent bladder cancer|recurrent bladder cancer
5754398|NCT00303654|stage I bladder cancer|stage i bladder cancer
5754399|NCT00303654|stage II bladder cancer|stage ii bladder cancer
5754400|NCT00303654|stage III bladder cancer|stage iii bladder cancer
5754401|NCT00303654|stage IV bladder cancer|stage iv bladder cancer
5754402|NCT00303641|Cardiopulmonary bypass|cardiopulmonary bypass
5754403|NCT00303641|Inflammatory reaction|inflammatory reaction
5754404|NCT00303628|Rectal cancer|rectal cancer
5754405|NCT00303628|Bevacizumab|bevacizumab
5754406|NCT00303615|ER (-) and PR (-)|er (-) and pr (-)
5754407|NCT00303576|HIV-1|hiv-1
5754408|NCT00303576|HIV Seronegativity|hiv seronegativity
5754409|NCT00303550|skin infection|skin infection
5754410|NCT00303550|complicated skin infection|complicated skin infection
5754411|NCT00303550|skin structure infection|skin structure infection
5754412|NCT00303550|Complicated Skin and Skin Structure Infection|complicated skin and skin structure infection
5754413|NCT00303537|hepatitis|hepatitis
5754414|NCT00303537|metformin|metformin
5754415|NCT00303537|non-alcoholic fatty liver (NAFLD)|non-alcoholic fatty liver (nafld)
5763270|NCT00270725|HIV|hiv
5754416|NCT00303537|non-alcoholic steatohepatitis (NASH)|non-alcoholic steatohepatitis (nash)
5754417|NCT00303537|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5754418|NCT00303511|adult|adult
5754419|NCT00303511|pacemaker|pacemaker
5754420|NCT00303511|bradycardia|bradycardia
5754421|NCT00303511|tachycardia|tachycardia
5754422|NCT00303511|heart failure|heart failure
5754423|NCT00303472|MDS|mds
5754424|NCT00303472|Myelodysplastic Syndromes|myelodysplastic syndromes
5686305|NCT00552643|Recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.|recalcitrant wounds including venous, post-operative and post-traumatic chronic wounds with different etiologies including wounds with exposed bone and tendon.
5686307|NCT00552630|chelation|chelation
5686308|NCT00552604|multiple sclerosis|multiple sclerosis
5754425|NCT00303472|Refractory Cytopenias|refractory cytopenias
5754426|NCT00303472|Thrombocytopenia|thrombocytopenia
5754427|NCT00303459|sildenafil|sildenafil
5754428|NCT00303459|Combination Drug Therapy|combination drug therapy
5754429|NCT00303459|bosentan|bosentan
5754430|NCT00303459|Pulmonary Hypertension|pulmonary hypertension
5754431|NCT00303459|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5754432|NCT00303459|Multicenter Study|multicenter study
5754433|NCT00303459|Antihypertensive Agents|antihypertensive agents
5754434|NCT00303459|Tracleer|tracleer
5754435|NCT00303459|endothelin receptor antagonist|endothelin receptor antagonist
5754436|NCT00303459|Randomized Controlled Trial|randomized controlled trial
5754437|NCT00303459|Phosphodiesterase type 5 inhibitor (PDE5i)|phosphodiesterase type 5 inhibitor (pde5i)
5754438|NCT00303459|Outcome Assessment|outcome assessment
5754439|NCT00303446|Motor Neuron|motor neuron
5754440|NCT00303446|Androgen Receptor|androgen receptor
5754441|NCT00303446|Polyglutamine|polyglutamine
5754442|NCT00303446|X-Linked|x-linked
5754443|NCT00303446|Ligand Dependency|ligand dependency
5754444|NCT00303446|Spinal and Bulbar Muscular Atrophy|spinal and bulbar muscular atrophy
5754446|NCT00303446|Kennedy Disease|kennedy disease
5754447|NCT00303433|Prevention|prevention
5754448|NCT00303433|Post-Operative tates|post-operative tates
5754452|NCT00303420|hemodialysis|hemodialysis
5754453|NCT00303420|dysfunction|dysfunction
5754454|NCT00303420|thrombolytic|thrombolytic
5754455|NCT00303420|alteplase|alteplase
5754456|NCT00303394|Type 2 Diabetes, IL-1, inflammation, glucotoxicity, insulin|type 2 diabetes, il-1, inflammation, glucotoxicity, insulin
5754457|NCT00303368|Neurofibromatosis (NF1)|neurofibromatosis (nf1)
5754458|NCT00303368|Tibial Dysplasia (TD)|tibial dysplasia (td)
5754459|NCT00303355|jugular venous pulse|jugular venous pulse
5754460|NCT00303342|sleep|sleep
5754461|NCT00303342|arousal|arousal
5754462|NCT00303342|stress|stress
5754463|NCT00303342|cortisol|cortisol
5754464|NCT00303342|catecholamines|catecholamines
5754465|NCT00303329|β-thalassemia|β-thalassemia
5754466|NCT00303329|rare chronic anemia|rare chronic anemia
5754467|NCT00303329|iron overload|iron overload
5754468|NCT00303329|deferasirox|deferasirox
5754469|NCT00303329|chronic anemias|chronic anemias
5754470|NCT00303329|transfusional hemosiderosis|transfusional hemosiderosis
5754471|NCT00303316|Diphtheria|diphtheria
5754472|NCT00303316|Tetanus|tetanus
5754473|NCT00303316|Pertussis|pertussis
5754474|NCT00303316|whooping cough|whooping cough
5754475|NCT00303316|Haemophilus influenzae type b|haemophilus influenzae type b
5754476|NCT00303316|Hepatitis B|hepatitis b
5754477|NCT00303316|Poliomyelitis|poliomyelitis
5754478|NCT00303303|Snake envenomation|snake envenomation
5754479|NCT00303303|Antivenins|antivenins
5754480|NCT00303303|Disability evaluation|disability evaluation
5754481|NCT00303303|Activities of daily living|activities of daily living
5754482|NCT00303290|Early Chronic Phase CML|early chronic phase cml
5754483|NCT00303290|Peg Interferon Alpha 2b|peg interferon alpha 2b
5754484|NCT00303290|Peg Intron|peg intron
5754485|NCT00303290|Ara-C|ara-c
5754486|NCT00303290|Cytosine Arabinoside|cytosine arabinoside
5754487|NCT00303277|Alzheimer's disease|alzheimer's disease
5754488|NCT00303277|beta-amyloid|beta-amyloid
5754489|NCT00303277|statins|statins
5754490|NCT00303264|functional dyspepsia|functional dyspepsia
5754491|NCT00303264|cholecystokinin|cholecystokinin
5754492|NCT00303264|CCK|cck
5754493|NCT00303264|gastrointestinal|gastrointestinal
5754494|NCT00303264|intestinal transit|intestinal transit
5754495|NCT00303264|GI motility|gi motility
5754496|NCT00303264|bloating|bloating
5754497|NCT00303264|upper GI discomfort|upper gi discomfort
5754498|NCT00303264|upper GI|upper gi
5754499|NCT00303264|early satiety|early satiety
5754500|NCT00303264|nausea|nausea
5754501|NCT00303264|belching|belching
5754502|NCT00303264|retching|retching
5754503|NCT00303264|vomiting|vomiting
5754504|NCT00303264|GERD|gerd
5754505|NCT00303251|Locally Advanced or Metastatic Melanoma|locally advanced or metastatic melanoma
5754506|NCT00303238|Inflammation|inflammation
5754507|NCT00303238|Interleukin-1|interleukin-1
5754508|NCT00303238|C-reactive protein|c-reactive protein
5754509|NCT00303238|Genotype|genotype
5754510|NCT00303238|Rose Hips|rose hips
5754511|NCT00303238|Blueberry|blueberry
5754512|NCT00303238|Blackberry|blackberry
5754513|NCT00303238|Aframomum melegueta|aframomum melegueta
5754514|NCT00303238|Resveravine|resveravine
5754515|NCT00303225|Biodefense|biodefense
5754516|NCT00303225|Smallpox|smallpox
5754517|NCT00303225|Monkeypox|monkeypox
5754518|NCT00303225|Vaccinia|vaccinia
5754519|NCT00303225|Prophylaxis|prophylaxis
5754520|NCT00303225|Healthy Volunteer|healthy volunteer
5681016|NCT00575185|Mononucleosis|mononucleosis
5754521|NCT00303225|HV|hv
5754522|NCT00303212|heart failure|heart failure
5754523|NCT00303212|CHF|chf
5754524|NCT00303212|telemedicine|telemedicine
5754525|NCT00303212|disease management|disease management
5754526|NCT00303199|Multiple Myeloma|multiple myeloma
5754527|NCT00303199|Arsenic|arsenic
5754528|NCT00303199|Cancer study|cancer study
5754529|NCT00303199|Failed treatment|failed treatment
5754530|NCT00303186|Rheumatoid Arthritis|rheumatoid arthritis
5754531|NCT00303173|Pre-eclampsia|pre-eclampsia
5754532|NCT00303173|hypertension|hypertension
5754533|NCT00303173|blood pressure|blood pressure
5754534|NCT00303173|pregnancy|pregnancy
5754535|NCT00303173|randomized clinical trial|randomized clinical trial
5754536|NCT00303173|guided imagery|guided imagery
5754537|NCT00303173|relaxation|relaxation
5754538|NCT00303173|psychophysiology|psychophysiology
5754539|NCT00303173|mind-body|mind-body
5754540|NCT00303160|heliobacter pylori infection|heliobacter pylori infection
5754541|NCT00303160|reactive oxygen species|reactive oxygen species
5754542|NCT00303160|antioxidants|antioxidants
5754543|NCT00303147|Expressive Writing|expressive writing
5754544|NCT00303147|Written Emotional Expression|written emotional expression
5754545|NCT00303147|Caregiver Stress|caregiver stress
5754546|NCT00303147|Cognition|cognition
5754547|NCT00303134|islet cell|islet cell
5754548|NCT00303134|diabetes|diabetes
5754549|NCT00303134|transplant|transplant
5754550|NCT00303134|immunosuppression|immunosuppression
5754551|NCT00303134|autoimmunity|autoimmunity
5754552|NCT00303134|alloimmunity|alloimmunity
5754553|NCT00303121|Glaucoma|glaucoma
5754554|NCT00303121|Compliance|compliance
5754555|NCT00303121|Therapy|therapy
5754556|NCT00303121|Administration technique|administration technique
5754558|NCT00303082|Bacterial Vaginosis|bacterial vaginosis
5754559|NCT00303082|Premature birth|premature birth
5754560|NCT00303082|Intra-uterine Infection|intra-uterine infection
5754561|NCT00303082|Periventricular leukomalacia|periventricular leukomalacia
5754562|NCT00303069|S. aureus;|s. aureus;
5754563|NCT00303069|Vaccine|vaccine
5754564|NCT00303069|FIM|fim
5754565|NCT00303056|Osteoarthritis|osteoarthritis
5754566|NCT00303056|knee|knee
5754567|NCT00303043|Hemodynamic monitoring|hemodynamic monitoring
5754568|NCT00303043|Mixed venous saturation|mixed venous saturation
5754569|NCT00303043|Critically ill patients|critically ill patients
5754570|NCT00303030|Fecal incontinence|fecal incontinence
5754571|NCT00303030|Biofeedback|biofeedback
5754572|NCT00303030|Patient Satisfaction|patient satisfaction
5754573|NCT00303030|Quality of LifeTreatment Outcome|quality of lifetreatment outcome
5754574|NCT00303030|Injections|injections
5754575|NCT00302991|Observational|observational
5754576|NCT00302991|cross-sectional|cross-sectional
5754577|NCT00302991|health-related quality of life|health-related quality of life
5754578|NCT00302991|adverse effects|adverse effects
5754579|NCT00302991|Baker´s AEP scale validation|baker´s aep scale validation
5754580|NCT00302991|epilepsy|epilepsy
5754581|NCT00302978|Height phobia|height phobia
5754582|NCT00302978|fear of heights|fear of heights
5754583|NCT00302978|specific phobia|specific phobia
5754584|NCT00302965|Plasma|plasma
5754585|NCT00302965|Trauma|trauma
5754586|NCT00302965|Critical Care|critical care
5754587|NCT00302952|Arthritis, Rheumatoid|arthritis, rheumatoid
5770549|NCT00242853|Rheumatoid arthritis|rheumatoid arthritis
5770550|NCT00242853|Exhaled NO|exhaled no
5770551|NCT00242840|protease inhibitor|protease inhibitor
5770552|NCT00242840|ritonavir|ritonavir
5770553|NCT00242840|GW433908|gw433908
5770555|NCT00242840|fosamprenavir|fosamprenavir
5770556|NCT00242788|Colorectal Cancer|colorectal cancer
5770557|NCT00242775|Asthma|asthma
5754588|NCT00302939|Aging|aging
5754589|NCT00302926|Weight loss|weight loss
5754590|NCT00302926|obesity|obesity
5754591|NCT00302926|energy restriction|energy restriction
5754592|NCT00302913|Clopidogrel|clopidogrel
5754593|NCT00302913|Coronary Artery Disease|coronary artery disease
5754594|NCT00302913|Dose-Response Relationship, Drug|dose-response relationship, drug
5754595|NCT00302913|Drug Resistance|drug resistance
5754596|NCT00302913|PCI|pci
5754597|NCT00302900|Blood Donation|blood donation
5754598|NCT00302900|Syncope|syncope
5754599|NCT00302900|Vasovagal Reactions|vasovagal reactions
5754600|NCT00302887|fibromyalgia|fibromyalgia
5754601|NCT00302887|connective tissue manipulation|connective tissue manipulation
5754602|NCT00302887|ultrasound therapy|ultrasound therapy
5754603|NCT00302887|high voltage pulsed galvanic stimulation|high voltage pulsed galvanic stimulation
5754604|NCT00302874|diabetes|diabetes
5754605|NCT00302874|hyperglycemia|hyperglycemia
5754606|NCT00302874|hospital|hospital
5754607|NCT00302874|medicine ward|medicine ward
5754608|NCT00302861|B-Cll|b-cll
5754609|NCT00302848|Venous thromboembolism|venous thromboembolism
5754610|NCT00302848|Drospirenone|drospirenone
5754611|NCT00302835|Analgesics|analgesics
5754612|NCT00302835|Chronic Kidney Failure|chronic kidney failure
5754613|NCT00302822|HIV infections|hiv infections
5754614|NCT00302822|Fuzeon|fuzeon
5754616|NCT00302822|AIDS|aids
5754617|NCT00302822|Treatment Naive|treatment naive
5754618|NCT00302809|Flavonoids|flavonoids
5754619|NCT00302809|Arterial stiffness|arterial stiffness
5754620|NCT00302809|Blood pressure|blood pressure
5754621|NCT00302809|Endothelium|endothelium
5754622|NCT00302809|Inflammation|inflammation
5754623|NCT00302796|Low Back Pain,|low back pain,
5754624|NCT00302783|Education, Medical|education, medical
5754625|NCT00302783|Education, Competency-Based|education, competency-based
5754626|NCT00302783|Multi-Source Feedback|multi-source feedback
5754627|NCT00302783|Communication|communication
5754628|NCT00302783|Professionalism|professionalism
5754629|NCT00302770|Patients with SAD|patients with sad
5754630|NCT00302757|NHL|nhl
5754736|NCT00302276|calcium|calcium
5754631|NCT00302757|low and high grade non-Hodgkin lymphoma|low and high grade non-hodgkin lymphoma
5754632|NCT00302744|Anxiety|anxiety
5754633|NCT00302744|Depression|depression
5754634|NCT00302744|Mood|mood
5754635|NCT00302744|Cancer|cancer
5754636|NCT00302744|Quality of Life|quality of life
5754637|NCT00302744|Psychiatric|psychiatric
5754638|NCT00302744|Psilocybin|psilocybin
5754639|NCT00302744|Alternative|alternative
5754640|NCT00302744|Los Angeles|los angeles
5754641|NCT00302718|Physician Incentive Plan|physician incentive plan
5754642|NCT00302718|Quality of Health Care|quality of health care
5754643|NCT00302718|Reimbursement, Incentive|reimbursement, incentive
5754644|NCT00302718|Randomized Controlled Trial|randomized controlled trial
5754645|NCT00302718|Physicians|physicians
5754646|NCT00302718|Reward|reward
5754647|NCT00302705|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5754648|NCT00302705|Valsartan|valsartan
5754649|NCT00302705|Enalapril|enalapril
5754650|NCT00302705|Missing dose|missing dose
5754651|NCT00302679|Colonoscopy|colonoscopy
5754652|NCT00302679|Sigmoidoscopy|sigmoidoscopy
5754653|NCT00302679|Colon cancer screening|colon cancer screening
5754654|NCT00302679|Pain|pain
5754655|NCT00302679|Screening|screening
5754656|NCT00302666|Contraception, Bleeding pattern|contraception, bleeding pattern
5754657|NCT00302627|bisphosphonates|bisphosphonates
5754658|NCT00302627|vitamin D|vitamin d
5754659|NCT00302627|calcium supplement|calcium supplement
5754660|NCT00302627|corticosteroid therapy|corticosteroid therapy
5754662|NCT00302614|obstructive sleep apnea|obstructive sleep apnea
5754663|NCT00302614|snoring|snoring
5754664|NCT00302614|collapsibility|collapsibility
5754665|NCT00302614|upper airway|upper airway
5754666|NCT00302601|Pulmonary embolism|pulmonary embolism
5754667|NCT00302601|Right heart strain|right heart strain
5754668|NCT00302601|Lung scintigraphy|lung scintigraphy
5754669|NCT00302601|Pulmonary angiography|pulmonary angiography
5754670|NCT00302588|metastatic carcinoma|metastatic carcinoma
5754671|NCT00302588|cervical lymph nodes|cervical lymph nodes
5754672|NCT00302588|unknown primary|unknown primary
5754673|NCT00302588|diagnosis|diagnosis
5754674|NCT00302588|result|result
5754675|NCT00302575|Substance-Related Disorders|substance-related disorders
5754676|NCT00302575|Prisoners|prisoners
5754677|NCT00302562|laryngeal cancer|laryngeal cancer
5754678|NCT00302562|hypopharyngeal cancer|hypopharyngeal cancer
5754679|NCT00302562|CXCR4|cxcr4
5754680|NCT00302562|CXCL12|cxcl12
5754681|NCT00302562|matrix metalloproteinases(MMPs)|matrix metalloproteinases(mmps)
5754682|NCT00302562|metastasis|metastasis
5754683|NCT00302549|Tacrolimus|tacrolimus
5754684|NCT00302549|Cyclophosphamide|cyclophosphamide
5754685|NCT00302549|Treatment|treatment
5754686|NCT00302549|Lupus Nephritis|lupus nephritis
5754687|NCT00302536|Idiopathic Focal Segmental Glomerulosclerosis|idiopathic focal segmental glomerulosclerosis
5754688|NCT00302536|Treatment|treatment
5754689|NCT00302536|Steroids|steroids
5754690|NCT00302523|Idiopathic Membranous Nephropathy|idiopathic membranous nephropathy
5754691|NCT00302523|Treatment|treatment
5754692|NCT00302523|Tacrolimus|tacrolimus
5754693|NCT00302523|Cyclophosphamide|cyclophosphamide
5754694|NCT00302510|lipoprotein glomerulopathy|lipoprotein glomerulopathy
5754695|NCT00302510|treatment|treatment
5754696|NCT00302510|immunoadsorption|immunoadsorption
5754697|NCT00302510|apolipoprotein E|apolipoprotein e
5754698|NCT00302458|healthy volunteers|healthy volunteers
5754699|NCT00302432|smoking reduction|smoking reduction
5754700|NCT00302432|group therapy|group therapy
5754701|NCT00302432|cigarette holders|cigarette holders
5754702|NCT00302432|"Flowers Menthol"|"flowers menthol"
5754703|NCT00302419|Acute myocardial infarction|acute myocardial infarction
5754704|NCT00302419|primary angioplasty|primary angioplasty
5754705|NCT00302419|streptokinase|streptokinase
5754706|NCT00302419|microvasculature|microvasculature
5754707|NCT00302393|healthy volunteers|healthy volunteers
5754708|NCT00302341|Pulmonary disease|pulmonary disease
5754710|NCT00302341|Hypoxemia|hypoxemia
5754711|NCT00302341|AIDS|aids
5754712|NCT00302341|Pneumocystis jiroveci|pneumocystis jiroveci
5754713|NCT00302315|postcesarean physiotherapy|postcesarean physiotherapy
5754714|NCT00302315|incisional pain|incisional pain
5754715|NCT00302315|functional activity|functional activity
5754716|NCT00302315|connective tissue manipulation|connective tissue manipulation
5686309|NCT00552604|muscle stiffness|muscle stiffness
5754717|NCT00302315|transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5754718|NCT00302302|Blood glucose|blood glucose
5754719|NCT00302302|Insulin|insulin
5754722|NCT00302302|GLP-1|glp-1
5754723|NCT00302302|L-arabinose|l-arabinose
5754724|NCT00302302|Appetite|appetite
5754725|NCT00302302|Energy intake|energy intake
5754726|NCT00302289|green tea|green tea
5754727|NCT00302289|caffeine|caffeine
5754728|NCT00302289|tyrosine|tyrosine
5754729|NCT00302289|energy expenditure|energy expenditure
5754730|NCT00302289|energy intake|energy intake
5754731|NCT00302276|Body fat loss|body fat loss
5754732|NCT00302276|energy expenditure|energy expenditure
5754733|NCT00302276|capsaicin|capsaicin
5754738|NCT00302276|fecal energy|fecal energy
5754739|NCT00302263|Green tea|green tea
5754740|NCT00302263|capsaicin|capsaicin
5754741|NCT00302263|tyrosine|tyrosine
5754742|NCT00302263|caffeine|caffeine
5754743|NCT00302263|energy expenditure|energy expenditure
5754744|NCT00302263|catecholamines|catecholamines
5754745|NCT00302250|Cardiovascular|cardiovascular
5754746|NCT00302250|Flow-mediated vasodilation (FMD)|flow-mediated vasodilation (fmd)
5754747|NCT00302250|Pulse perfusion-mediated vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
5754748|NCT00302250|Endothelial function|endothelial function
5754749|NCT00302250|Heart failure|heart failure
5754750|NCT00302237|carotid, stenting, angioplasty|carotid, stenting, angioplasty
5754751|NCT00302224|safety|safety
5754752|NCT00302224|type 2 diabetes|type 2 diabetes
5754754|NCT00302211|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5754755|NCT00302198|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5754756|NCT00302185|Palliative Care|palliative care
5754757|NCT00302185|Acupuncture|acupuncture
5754758|NCT00302185|Symptom Management|symptom management
5754759|NCT00302185|Quality of Life|quality of life
5754761|NCT00302172|solid tumor|solid tumor
5754762|NCT00302172|metastatic|metastatic
5754763|NCT00302172|primary tumor|primary tumor
5754764|NCT00302159|Chemotherapy|chemotherapy
5754765|NCT00302159|Radiation|radiation
5754766|NCT00302159|Brain Tumor|brain tumor
5754767|NCT00302159|GBM|gbm
5754768|NCT00302159|Radiosensitizer|radiosensitizer
5754769|NCT00302159|Glioblastoma|glioblastoma
5754770|NCT00302159|Glioblastoma Multiforme|glioblastoma multiforme
5754771|NCT00302146|Lysosomal Storage Disorder|lysosomal storage disorder
5754772|NCT00302146|Carrier|carrier
5754773|NCT00302146|L-Dopa Uptake|l-dopa uptake
5754774|NCT00302146|Glucocerebrosidase|glucocerebrosidase
5754775|NCT00302146|Pathogenesis|pathogenesis
5754776|NCT00302146|Gaucher Disease|gaucher disease
5754777|NCT00302146|Healthy Volunteer|healthy volunteer
5754778|NCT00302146|HV|hv
5754779|NCT00302133|Alcoholism Bipolar Disorder Pharmacotherapy Naltrexone|alcoholism bipolar disorder pharmacotherapy naltrexone
5754780|NCT00302120|Magnetic Resonance Imaging|magnetic resonance imaging
5754781|NCT00302120|Breast Neoplasms|breast neoplasms
5754782|NCT00302120|Diagnostic Trial|diagnostic trial
5754783|NCT00302107|Mirtazapine|mirtazapine
5754784|NCT00302107|PTSD|ptsd
5754785|NCT00302107|Veterans|veterans
5754786|NCT00302107|antidepressant|antidepressant
5754787|NCT00302081|Hepatitis C, Chronic|hepatitis c, chronic
5754788|NCT00302081|Genotype 2 and Genotype 3|genotype 2 and genotype 3
5754789|NCT00302068|Exercise|exercise
5754790|NCT00302029|Cytomegalovirus, risk factors, seroprevalence|cytomegalovirus, risk factors, seroprevalence
5754791|NCT00302016|Chronic myeloid leukemia|chronic myeloid leukemia
5754792|NCT00302016|AMN 107|amn 107
5754793|NCT00302016|Imatinib resistant or intolerant|imatinib resistant or intolerant
5754794|NCT00302016|nilotinib|nilotinib
5754795|NCT00302016|enact|enact
5754796|NCT00301990|stage IV renal cell cancer|stage iv renal cell cancer
5754797|NCT00301990|recurrent renal cell cancer|recurrent renal cell cancer
5754798|NCT00301990|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5754799|NCT00301951|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5754800|NCT00301951|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5754801|NCT00301951|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5754802|NCT00301951|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5754803|NCT00301951|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5754804|NCT00301951|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5754805|NCT00301951|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5754806|NCT00301951|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5754807|NCT00301951|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5754808|NCT00301951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5754809|NCT00301951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5754810|NCT00301951|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5754811|NCT00301951|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5862875|NCT00001474|Infusion Duration|infusion duration
5686310|NCT00552604|spasticity|spasticity
5754812|NCT00301951|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5754813|NCT00301951|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5754814|NCT00301951|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5754815|NCT00301951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5754816|NCT00301951|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5754817|NCT00301951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5754818|NCT00301951|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5754819|NCT00301951|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5754820|NCT00301951|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5754821|NCT00301951|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5754822|NCT00301951|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5754823|NCT00301951|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5754824|NCT00301951|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5754825|NCT00301951|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5754826|NCT00301951|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5754827|NCT00301951|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5754828|NCT00301951|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5754829|NCT00301951|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5754830|NCT00301951|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5754831|NCT00301951|refractory multiple myeloma|refractory multiple myeloma
5754832|NCT00301951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5754833|NCT00301951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5749880|NCT00320385|GW572016|gw572016
5754834|NCT00301951|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5754835|NCT00301951|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5754836|NCT00301951|stage I multiple myeloma|stage i multiple myeloma
5754837|NCT00301951|stage II multiple myeloma|stage ii multiple myeloma
5754838|NCT00301951|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5754839|NCT00301951|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5754840|NCT00301951|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5754841|NCT00301951|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5755143|NCT00301054|Anaemia|anaemia
5754842|NCT00301951|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5754843|NCT00301951|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5754844|NCT00301951|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5754845|NCT00301951|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5754846|NCT00301951|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5754847|NCT00301951|stage III multiple myeloma|stage iii multiple myeloma
5754848|NCT00301951|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5754849|NCT00301951|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5754850|NCT00301951|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5754851|NCT00301951|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5754852|NCT00301951|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5754853|NCT00301951|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5754854|NCT00301951|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5754855|NCT00301951|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5754856|NCT00301951|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5754857|NCT00301951|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5754858|NCT00301925|stage I breast cancer|stage i breast cancer
5754859|NCT00301925|stage II breast cancer|stage ii breast cancer
5754860|NCT00301925|stage IIIA breast cancer|stage iiia breast cancer
5754861|NCT00301925|male breast cancer|male breast cancer
5754862|NCT00301912|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5754863|NCT00301912|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5754864|NCT00301912|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5754865|NCT00301912|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5754866|NCT00301912|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5754867|NCT00301912|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5754868|NCT00301912|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5754869|NCT00301912|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5754870|NCT00301912|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5754871|NCT00301912|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5754872|NCT00301912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5754873|NCT00301912|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5754874|NCT00301912|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5686311|NCT00552604|pain|pain
5754005|NCT00304954|AMD|amd
5862876|NCT00001474|CD4 Cells|cd4 cells
5754875|NCT00301912|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5754876|NCT00301912|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5754877|NCT00301912|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5754878|NCT00301912|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5754879|NCT00301912|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5754880|NCT00301912|anemia|anemia
5754881|NCT00301912|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5754882|NCT00301912|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5754883|NCT00301912|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5754884|NCT00301912|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5754885|NCT00301912|stage II multiple myeloma|stage ii multiple myeloma
5754886|NCT00301912|stage III multiple myeloma|stage iii multiple myeloma
5754887|NCT00301912|refractory multiple myeloma|refractory multiple myeloma
5754888|NCT00301912|polycythemia vera|polycythemia vera
5754889|NCT00301912|essential thrombocythemia|essential thrombocythemia
5755211|NCT00300742|obesity|obesity
5754890|NCT00301912|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5754891|NCT00301912|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5754892|NCT00301912|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5754893|NCT00301912|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5754894|NCT00301912|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5754895|NCT00301912|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5754896|NCT00301912|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5754897|NCT00301912|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5754898|NCT00301912|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5754899|NCT00301912|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5754901|NCT00301912|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5754902|NCT00301912|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5754903|NCT00301912|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5754904|NCT00301912|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5754905|NCT00301912|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5754906|NCT00301912|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5754907|NCT00301912|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5755045|NCT00301587|nervous system diseases|nervous system diseases
5754908|NCT00301912|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5754909|NCT00301912|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5754910|NCT00301912|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5754911|NCT00301912|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5754912|NCT00301912|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5754913|NCT00301912|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5754914|NCT00301912|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5754915|NCT00301912|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5754916|NCT00301912|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5754917|NCT00301912|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5754918|NCT00301912|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5754919|NCT00301912|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5754920|NCT00301912|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5754921|NCT00301912|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5754922|NCT00301912|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5754923|NCT00301912|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5754924|NCT00301912|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5754925|NCT00301912|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5754926|NCT00301912|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5754927|NCT00301912|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5754928|NCT00301912|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5754929|NCT00301912|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5754930|NCT00301912|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5754931|NCT00301912|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5754932|NCT00301912|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5754933|NCT00301912|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5754934|NCT00301912|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5686312|NCT00552604|treatment|treatment
5754935|NCT00301912|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5862877|NCT00001473|Vasculitis|vasculitis
5754936|NCT00301912|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5754937|NCT00301912|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5754938|NCT00301912|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5754939|NCT00301912|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5754940|NCT00301912|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5754941|NCT00301912|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5754942|NCT00301912|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5754943|NCT00301912|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5754944|NCT00301912|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5754945|NCT00301912|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5754946|NCT00301912|stage I multiple myeloma|stage i multiple myeloma
5754947|NCT00301912|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5754948|NCT00301899|recurrent breast cancer|recurrent breast cancer
5754949|NCT00301899|male breast cancer|male breast cancer
5754950|NCT00301899|stage IIIA breast cancer|stage iiia breast cancer
5754951|NCT00301899|stage IIIB breast cancer|stage iiib breast cancer
5754952|NCT00301899|stage IIIC breast cancer|stage iiic breast cancer
5754953|NCT00301899|stage IV breast cancer|stage iv breast cancer
5754955|NCT00301886|hypercalcemia of malignancy|hypercalcemia of malignancy
5754956|NCT00301886|stage IV breast cancer|stage iv breast cancer
5754957|NCT00301886|bone metastases|bone metastases
5754958|NCT00301886|recurrent breast cancer|recurrent breast cancer
5754959|NCT00301873|osteoporosis|osteoporosis
5754960|NCT00301873|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5754961|NCT00301873|adult giant cell glioblastoma|adult giant cell glioblastoma
5754962|NCT00301873|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5754963|NCT00301873|adult gliosarcoma|adult gliosarcoma
5754964|NCT00301873|adult mixed glioma|adult mixed glioma
5754965|NCT00301873|recurrent adult brain tumor|recurrent adult brain tumor
5754966|NCT00301873|adult glioblastoma|adult glioblastoma
5754967|NCT00301860|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5754968|NCT00301860|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5754969|NCT00301860|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5754970|NCT00301860|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5754971|NCT00301860|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5754972|NCT00301860|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5754973|NCT00301860|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5755047|NCT00301587|Vitamin B|vitamin b
5754974|NCT00301860|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5754975|NCT00301860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5754976|NCT00301860|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5754977|NCT00301860|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5754978|NCT00301860|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5754979|NCT00301860|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5754980|NCT00301847|tumors metastatic to brain|tumors metastatic to brain
5754981|NCT00301847|recurrent renal cell cancer|recurrent renal cell cancer
5754982|NCT00301847|stage IV renal cell cancer|stage iv renal cell cancer
5754983|NCT00301834|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5754984|NCT00301834|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5754985|NCT00301834|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5754986|NCT00301834|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5754987|NCT00301834|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5754988|NCT00301834|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5754989|NCT00301834|Diamond-Blackfan anemia|diamond-blackfan anemia
5754990|NCT00301834|severe congenital neutropenia|severe congenital neutropenia
5754991|NCT00301834|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5754992|NCT00301834|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5754993|NCT00301834|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5754994|NCT00301821|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5754995|NCT00301821|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5754996|NCT00301821|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5754997|NCT00301821|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5754998|NCT00301808|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5754999|NCT00301808|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5755000|NCT00301782|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5686313|NCT00552604|cannabinoids|cannabinoids
5686314|NCT00552591|family risk|family risk
5755001|NCT00301782|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5755002|NCT00301782|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5755003|NCT00301782|testicular choriocarcinoma|testicular choriocarcinoma
5755004|NCT00301782|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5755005|NCT00301782|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5755006|NCT00301782|testicular embryonal carcinoma|testicular embryonal carcinoma
5755007|NCT00301782|testicular yolk sac tumor|testicular yolk sac tumor
5755008|NCT00301782|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5755009|NCT00301782|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5755010|NCT00301782|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5755011|NCT00301782|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5755012|NCT00301782|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5755013|NCT00301782|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5755014|NCT00301782|stage I extragonadal non-seminomatous germ cell tumor|stage i extragonadal non-seminomatous germ cell tumor
5755015|NCT00301782|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5755016|NCT00301782|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5755017|NCT00301782|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5755018|NCT00301782|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5755019|NCT00301782|testicular immature teratoma|testicular immature teratoma
5755020|NCT00301782|testicular mature teratoma|testicular mature teratoma
5755021|NCT00301782|adult teratoma|adult teratoma
5755022|NCT00301730|lung metastases|lung metastases
5755023|NCT00301730|stage IV breast cancer|stage iv breast cancer
5755024|NCT00301730|recurrent breast cancer|recurrent breast cancer
5755025|NCT00301691|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5755026|NCT00301678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5755029|NCT00301652|mycophenolate mofetil|mycophenolate mofetil
5755030|NCT00301652|cyclophosphamide|cyclophosphamide
5755031|NCT00301652|treatment|treatment
5755032|NCT00301626|tobacco|tobacco
5755033|NCT00301626|nicotine|nicotine
5755034|NCT00301626|smoking reduction|smoking reduction
5755035|NCT00301613|Henoch-Schonlein purpura nephritis Mycophenolate mofetil|henoch-schonlein purpura nephritis mycophenolate mofetil
5755036|NCT00301613|Cyclophosphamide|cyclophosphamide
5755037|NCT00301613|treatment|treatment
5755038|NCT00301600|Crescentic IgA nephropathy|crescentic iga nephropathy
5755039|NCT00301600|Mycophenolate mofetil|mycophenolate mofetil
5755040|NCT00301600|Cyclophosphamide|cyclophosphamide
5755041|NCT00301600|treatment|treatment
5755042|NCT00301587|spina bifida|spina bifida
5755043|NCT00301587|birth defects|birth defects
5755044|NCT00301587|folic acid|folic acid
5755048|NCT00301574|Alzheimer's disease|alzheimer's disease
5755049|NCT00301574|Cognitive dysfunction|cognitive dysfunction
5755050|NCT00301561|Antiretroviral treatment|antiretroviral treatment
5755051|NCT00301561|Expanded access|expanded access
5755052|NCT00301561|Africa|africa
5755053|NCT00301561|Treatment Naive|treatment naive
5755054|NCT00301548|antineoplastic protocols|antineoplastic protocols
5755055|NCT00301548|neoadjuvant therapy|neoadjuvant therapy
5755056|NCT00301548|perioperative chemotherapy|perioperative chemotherapy
5755057|NCT00301548|fluorouracil|fluorouracil
5755058|NCT00301535|Coronary Artery Bypass Graft|coronary artery bypass graft
5755059|NCT00301535|memory loss after cardiac surgery|memory loss after cardiac surgery
5755060|NCT00301535|side effects of bypass|side effects of bypass
5755061|NCT00301522|Coronary|coronary
5755062|NCT00301522|Artery|artery
5755063|NCT00301522|Stenosis|stenosis
5755064|NCT00301522|Drug-eluting|drug-eluting
5755065|NCT00301522|stent|stent
5755066|NCT00301522|restenosis|restenosis
5755067|NCT00301522|revascularization|revascularization
5755068|NCT00301483|multiple trauma|multiple trauma
5755069|NCT00301483|bleeding injuries|bleeding injuries
5755070|NCT00301483|gunshot wounds|gunshot wounds
5755071|NCT00301483|stab wounds|stab wounds
5755072|NCT00301483|penetrating injuries|penetrating injuries
5755073|NCT00301483|blunt trauma|blunt trauma
5755074|NCT00301483|multiple wounds|multiple wounds
5755075|NCT00301470|Ureter, obstruction|ureter, obstruction
5755076|NCT00301470|Diagnostic techniques, urological|diagnostic techniques, urological
5755077|NCT00301470|MRI, functional|mri, functional
5755078|NCT00301457|Hormone Sensitive Primary Breast Cancer|hormone sensitive primary breast cancer
5755079|NCT00301457|Adjuvant Treatment|adjuvant treatment
5755080|NCT00301457|Aromatase Inhibitor|aromatase inhibitor
5755081|NCT00301444|phantom limb pain|phantom limb pain
5755082|NCT00301444|limb amputation|limb amputation
5755083|NCT00301431|Fibromyalgia|fibromyalgia
5755084|NCT00301431|Adults|adults
5755085|NCT00301431|Outpatients|outpatients
5755086|NCT00301431|Adult|adult
5755087|NCT00301431|Double-Blind Method|double-blind method
5755088|NCT00301418|Glioblastoma Multiforme|glioblastoma multiforme
5755089|NCT00301418|Anaplastic Astrocytoma|anaplastic astrocytoma
5755090|NCT00301418|High Grade Glial Neoplasms|high grade glial neoplasms
5755091|NCT00301418|Brain Tumor|brain tumor
5755092|NCT00301405|prostatitis|prostatitis
5755093|NCT00301405|pelvic pain|pelvic pain
5755094|NCT00301392|Glucose intolerance|glucose intolerance
5755095|NCT00301392|Diabetes mellitus|diabetes mellitus
5755096|NCT00301392|Statins,HMG-CoA|statins,hmg-coa
5755097|NCT00301379|Cholangiocarcinoma|cholangiocarcinoma
5755098|NCT00301379|Observational|observational
5755099|NCT00301366|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5755100|NCT00301366|alpha 1-Antitrypsin|alpha 1-antitrypsin
5755101|NCT00301366|pulmonary emphysema|pulmonary emphysema
5755102|NCT00301353|early menopause|early menopause
5755103|NCT00301353|isoflavones/phyto-estrogens|isoflavones/phyto-estrogens
5755104|NCT00301353|bone metabolism|bone metabolism
5755105|NCT00301353|bone mineral density|bone mineral density
5755106|NCT00301353|hormones|hormones
5755107|NCT00301249|Diabetes|diabetes
5755108|NCT00301249|Nephropathy|nephropathy
5755109|NCT00301249|Diabetic Nephropathy|diabetic nephropathy
5755110|NCT00301249|Genome Scan|genome scan
5755111|NCT00301249|Genetic Research|genetic research
5755112|NCT00301236|ADHD, children, CADS-T, Dexmethylphenidate-HCl, extended release|adhd, children, cads-t, dexmethylphenidate-hcl, extended release
5755113|NCT00301197|Childhood obesity|childhood obesity
5755114|NCT00301197|intervention|intervention
5755115|NCT00301197|obesity|obesity
5755116|NCT00301197|weight loss|weight loss
5755117|NCT00301197|behavior therapy|behavior therapy
5755118|NCT00301197|peer group|peer group
5755119|NCT00301197|social support network|social support network
5755120|NCT00301197|child|child
5755121|NCT00301197|clinical research|clinical research
5755122|NCT00301197|human subject|human subject
5755123|NCT00301184|HIV Seronegativity|hiv seronegativity
5755124|NCT00301184|HIV Preventive Vaccine|hiv preventive vaccine
5755125|NCT00301184|HIV DNA Vaccine|hiv dna vaccine
5750271|NCT00318747|Immunotherapy|immunotherapy
5755126|NCT00301184|Modified Vaccinia Ankara Vaccine|modified vaccinia ankara vaccine
5755128|NCT00301158|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5755129|NCT00301145|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5755130|NCT00301119|small cell lung cancer|small cell lung cancer
5755131|NCT00301119|non-small cell lung cancer|non-small cell lung cancer
5755132|NCT00301119|smoker lung cancer screening|smoker lung cancer screening
5755133|NCT00301119|low dose spiral CT screening|low dose spiral ct screening
5755134|NCT00301106|stage IV breast cancer|stage iv breast cancer
5755135|NCT00301106|liver metastases|liver metastases
5755136|NCT00301093|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5755137|NCT00301093|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5755138|NCT00301080|pain|pain
5755139|NCT00301080|neurotoxicity|neurotoxicity
5755140|NCT00301080|breast cancer|breast cancer
5755141|NCT00301067|stage IV melanoma|stage iv melanoma
5755142|NCT00301067|recurrent melanoma|recurrent melanoma
5755145|NCT00301054|Rural Area in Ghana|rural area in ghana
5755146|NCT00301041|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5848272|NCT00035373|Anti-Angiogenesis|anti-angiogenesis
5755147|NCT00301041|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5755148|NCT00301041|stage I breast cancer|stage i breast cancer
5755149|NCT00301041|stage II breast cancer|stage ii breast cancer
5755150|NCT00301041|stage IIIA breast cancer|stage iiia breast cancer
5755151|NCT00301028|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5755152|NCT00301028|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5755153|NCT00301028|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5755154|NCT00301028|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5755155|NCT00301028|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5755156|NCT00301002|safety|safety
5755157|NCT00301002|effectiveness|effectiveness
5755158|NCT00301002|Alefacept|alefacept
5755159|NCT00301002|Palmar|palmar
5755160|NCT00301002|Plantar|plantar
5755161|NCT00301002|Pustulosis|pustulosis
5755162|NCT00300976|Blood glucose|blood glucose
5755163|NCT00300976|Blood pressure|blood pressure
5755164|NCT00300976|Lipids|lipids
5755165|NCT00300963|psychosis|psychosis
5755166|NCT00300963|cognition|cognition
5755167|NCT00300950|Pancreas Cancer|pancreas cancer
5755168|NCT00300950|resected pancreas cancer|resected pancreas cancer
5755169|NCT00300950|non-metastatic pancreas cancer|non-metastatic pancreas cancer
5755170|NCT00300911|Natriuretic Peptide, Brain|natriuretic peptide, brain
5755171|NCT00300911|Heart Failure, Congestive|heart failure, congestive
5755172|NCT00300898|contained lumbar herniated disc|contained lumbar herniated disc
5755173|NCT00300898|nucleoplasty|nucleoplasty
5755174|NCT00300898|percutaneous decompression|percutaneous decompression
5755175|NCT00300898|Dekompressor|dekompressor
5686315|NCT00552591|behavior modification|behavior modification
5755176|NCT00300898|intervertebral electrothermal disc decompression|intervertebral electrothermal disc decompression
5755177|NCT00300898|IDET|idet
5755178|NCT00300885|Non-Small Cell Lung Cancer|non-small cell lung cancer
5755179|NCT00300885|NSCLC|nsclc
5755180|NCT00300820|Bipolar Disorder|bipolar disorder
5755181|NCT00300820|Affected Adults and Adult Siblings|affected adults and adult siblings
5755182|NCT00300820|Interest in Genetic Counseling|interest in genetic counseling
5755183|NCT00300820|Bipolar|bipolar
5755184|NCT00300820|Genes|genes
5755185|NCT00300820|Familial|familial
5755186|NCT00300820|Education|education
5755187|NCT00300820|Testing|testing
5755189|NCT00300820|Adult Siblings|adult siblings
5755191|NCT00300807|Monoclonal Antibody|monoclonal antibody
5755192|NCT00300807|failed IFN/RBV treatment|failed ifn/rbv treatment
5755193|NCT00300781|phase 2|phase 2
5755194|NCT00300781|HER2+ breast cancer|her2+ breast cancer
5755195|NCT00300781|monotherapy neratinib|monotherapy neratinib
5755196|NCT00300781|HKI-272|hki-272
5755197|NCT00300781|Neratinib|neratinib
5755198|NCT00300781|Nerlynx|nerlynx
5755199|NCT00300781|PB-272|pb-272
5755200|NCT00300768|onchocerciasis|onchocerciasis
5755201|NCT00300768|onchocerca volvulus|onchocerca volvulus
5755202|NCT00300768|river blindness|river blindness
5755203|NCT00300768|ivermectin|ivermectin
5755204|NCT00300768|moxidectin|moxidectin
5755205|NCT00300755|GERD|gerd
5755206|NCT00300755|Children|children
5755207|NCT00300755|Child|child
5755208|NCT00300755|Child, Preschool|child, preschool
5755209|NCT00300742|drinking|drinking
5755210|NCT00300742|eating|eating
5755212|NCT00300742|alcohol|alcohol
5755213|NCT00300742|binge eating|binge eating
5755214|NCT00300729|Cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5755215|NCT00300729|Celecoxib|celecoxib
5755216|NCT00300729|Carcinoma, non-small-cell lung|carcinoma, non-small-cell lung
5755217|NCT00300729|Antineoplastic agents|antineoplastic agents
5755218|NCT00300729|Therapy, palliative|therapy, palliative
5755219|NCT00300729|Survival|survival
5755220|NCT00300716|Multiple Sclerosis|multiple sclerosis
5755221|NCT00300716|Cognitive impairment|cognitive impairment
5755223|NCT00300716|Placebo|placebo
5755224|NCT00300716|Neuropsychological tests|neuropsychological tests
5755225|NCT00300716|Quality of life|quality of life
5755226|NCT00300716|Fatigue|fatigue
5755227|NCT00300703|Cardiac Arrest|cardiac arrest
5755228|NCT00300690|Lower extremity bypass surgery|lower extremity bypass surgery
5755229|NCT00300690|femoro-popliteal bypass|femoro-popliteal bypass
5755230|NCT00300690|Dacron material|dacron material
5755231|NCT00300690|PTFE material|ptfe material
5755232|NCT00300677|Pharmacokinetics|pharmacokinetics
5755233|NCT00300677|Voriconazole|voriconazole
5755234|NCT00300677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5755235|NCT00300651|Cognitive Behavioral Therapy|cognitive behavioral therapy
5755236|NCT00300651|Schizophrenia|schizophrenia
5755237|NCT00300651|Cognitive Biases|cognitive biases
5755238|NCT00300651|Efficacy|efficacy
5755239|NCT00300638|Alcoholism|alcoholism
5755240|NCT00300638|Emotion|emotion
5755241|NCT00300638|Cognition|cognition
5755242|NCT00300638|Brain scans|brain scans
5755243|NCT00300625|Syncope|syncope
5755244|NCT00300625|Near syncope|near syncope
5755245|NCT00300625|San Francisco Syncope rule|san francisco syncope rule
5755246|NCT00300586|Non-small cell lung cancer ;|non-small cell lung cancer ;
5755247|NCT00300586|metastatic ;|metastatic ;
5755248|NCT00300586|chemotherapy ;|chemotherapy ;
5755249|NCT00300586|erlotinib|erlotinib
5755250|NCT00300573|dexelvucitabine|dexelvucitabine
5755252|NCT00300573|Treatment Experienced|treatment experienced
5755253|NCT00300573|HIV-1|hiv-1
5755254|NCT00300560|ESBL-producing E.coli Infections|esbl-producing e.coli infections
5755255|NCT00300560|ESBL-producing Klebsiella pneumoniae Infections|esbl-producing klebsiella pneumoniae infections
5755257|NCT00300547|colorectal cancer|colorectal cancer
5755258|NCT00300547|polyps|polyps
5755259|NCT00300547|Virtual colonoscopy|virtual colonoscopy
5755260|NCT00300547|synchronous carcinoma|synchronous carcinoma
5755261|NCT00300547|MR colonography|mr colonography
5755262|NCT00300534|Diagnosis|diagnosis
5755263|NCT00300521|hepatocellular carcinoma|hepatocellular carcinoma
5755264|NCT00300521|liver transplantation|liver transplantation
5755265|NCT00300521|adenovirus-thymidine kinase enzyme|adenovirus-thymidine kinase enzyme
5755266|NCT00300521|gene therapy|gene therapy
5755267|NCT00300521|immunosuppression|immunosuppression
5755268|NCT00300508|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5755269|NCT00300495|Atrial fibrillation|atrial fibrillation
5755270|NCT00300495|Lung cancer|lung cancer
5755271|NCT00300495|Pulmonary resection|pulmonary resection
5755272|NCT00300495|Post-operative complications|post-operative complications
5755273|NCT00300482|Dyslipidemia|dyslipidemia
5755274|NCT00300482|Coronary Heart Disease|coronary heart disease
5755275|NCT00300482|Mixed Dyslipidemia|mixed dyslipidemia
5755276|NCT00300469|Mixed Dyslipidemia|mixed dyslipidemia
5755277|NCT00300469|Coronary Heart Disease|coronary heart disease
5755278|NCT00300469|Dyslipidemia|dyslipidemia
5755279|NCT00300456|Dyslipidemia|dyslipidemia
5755280|NCT00300456|Coronary Heart Disease|coronary heart disease
5755281|NCT00300456|Mixed Dyslipidemia|mixed dyslipidemia
5755282|NCT00300417|Flavivirus|flavivirus
5755283|NCT00300417|Mosquito|mosquito
5755284|NCT00300417|Immunity|immunity
5755285|NCT00300417|Preventive|preventive
5755286|NCT00300417|West Nile Fever|west nile fever
5755287|NCT00300417|West Nile Virus|west nile virus
5755288|NCT00300417|Vaccine|vaccine
5755289|NCT00300417|Healthy Volunteer|healthy volunteer
5755290|NCT00300417|HV|hv
5755291|NCT00300404|Schizophrenia|schizophrenia
5755292|NCT00300404|Psychosis|psychosis
5755293|NCT00300404|Depression|depression
5755294|NCT00300404|Affective Disorder|affective disorder
5755295|NCT00300391|Delirium|delirium
5755296|NCT00300391|Mechanical ventilation|mechanical ventilation
5755297|NCT00300391|Intensive care|intensive care
5755298|NCT00300391|Haloperidol|haloperidol
5755299|NCT00300378|Depression|depression
5755300|NCT00300378|Adult|adult
5755301|NCT00300378|Outpatients|outpatients
5755302|NCT00300365|HDL cholesterol|hdl cholesterol
5755303|NCT00300365|Metabolic syndrome|metabolic syndrome
5755304|NCT00300352|Coronary artery disease|coronary artery disease
5755305|NCT00300352|Folic acid|folic acid
5755306|NCT00300352|Endothelial function|endothelial function
5755307|NCT00300300|ACL computer-assisted surgery graft|acl computer-assisted surgery graft
5755308|NCT00300287|Type 2 diabetes|type 2 diabetes
5755309|NCT00300287|Vildagliptin|vildagliptin
5755310|NCT00300274|Everolimus|everolimus
5755311|NCT00300274|heart transplant|heart transplant
5755312|NCT00300274|heart disease|heart disease
5755313|NCT00300274|transplantation|transplantation
5755314|NCT00300274|heart IVUS assessment at 12 months|heart ivus assessment at 12 months
5755315|NCT00300274|rate of graft loss|rate of graft loss
5755316|NCT00300274|acute rejection episodes|acute rejection episodes
5755317|NCT00300274|survival|survival
5755318|NCT00300261|Heart Failure|heart failure
5755319|NCT00300248|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5755320|NCT00300248|Acute Lung Injury|acute lung injury
5755321|NCT00300248|Respiratory Failure|respiratory failure
5755323|NCT00300235|Sickle Cell Anemia|sickle cell anemia
5755324|NCT00300222|dermal assessment|dermal assessment
5755325|NCT00300222|pain measurement|pain measurement
5755326|NCT00300222|diary|diary
5755327|NCT00300222|PHN|phn
5755328|NCT00300222|shingles|shingles
5755329|NCT00300222|neuropathy|neuropathy
5755330|NCT00300222|analgesics|analgesics
5755331|NCT00300222|capsaicin|capsaicin
5755332|NCT00300222|postherpetic neuralgia|postherpetic neuralgia
5755333|NCT00300196|Stroke|stroke
5755334|NCT00300196|Fibrinogen|fibrinogen
5755335|NCT00300196|Reperfusion|reperfusion
5755336|NCT00300196|Thrombolysis|thrombolysis
5755337|NCT00300183|HIV|hiv
5755338|NCT00300183|health services accessibility|health services accessibility
5755339|NCT00300183|health services research|health services research
5755340|NCT00300183|homeless|homeless
5755341|NCT00300183|social support|social support
5755342|NCT00300183|AIDS|aids
5755343|NCT00300183|substance abuse|substance abuse
5755344|NCT00300183|mental health|mental health
5755345|NCT00300183|quality of life|quality of life
5755346|NCT00300183|outreach|outreach
5755347|NCT00300183|harm reduction|harm reduction
5755348|NCT00300170|HIV|hiv
5755349|NCT00300170|race|race
5755350|NCT00300170|unstable housing|unstable housing
5755351|NCT00300170|health services accessibility|health services accessibility
5755352|NCT00300170|health services utilization|health services utilization
5755353|NCT00300170|substance abuse|substance abuse
5755354|NCT00300170|AIDS|aids
5755355|NCT00300170|health services research|health services research
5755356|NCT00300170|social support|social support
5755357|NCT00300170|depression|depression
5755358|NCT00300170|trust|trust
5755359|NCT00300170|discrimination|discrimination
5755360|NCT00300157|Left main coronary artery stenosis, stent, Taxus|left main coronary artery stenosis, stent, taxus
5755361|NCT00300157|Unprotected left main coronary artery disease|unprotected left main coronary artery disease
5755362|NCT00300157|Percutaneous coronary intervention with Taxus stent|percutaneous coronary intervention with taxus stent
5755363|NCT00300131|Bioabsorbable|bioabsorbable
5755364|NCT00300131|Coronary Stent|coronary stent
5755365|NCT00300131|Everolimus|everolimus
5755366|NCT00300131|drug eluting stents|drug eluting stents
5755367|NCT00300131|stents|stents
5755368|NCT00300131|angioplasty|angioplasty
5755369|NCT00300131|coronary artery disease|coronary artery disease
5755370|NCT00300131|total coronary occlusion|total coronary occlusion
5755371|NCT00300131|coronary artery restenosis|coronary artery restenosis
5755372|NCT00300131|stent thrombosis|stent thrombosis
5755373|NCT00300131|vascular disease|vascular disease
5755374|NCT00300131|myocardial ischemia|myocardial ischemia
5755375|NCT00300131|coronary artery stenosis|coronary artery stenosis
5755376|NCT00300105|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 4|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 4
5755377|NCT00300079|Ocular Hypertension Patients|ocular hypertension patients
5686316|NCT00552591|lifestyle change|lifestyle change
5755378|NCT00300066|Glomerular Filtration Rate|glomerular filtration rate
5755379|NCT00300066|Serum Cystatin C|serum cystatin c
5755380|NCT00300066|Body Composition|body composition
5755381|NCT00300066|bioelectrical impedance spectroscopy|bioelectrical impedance spectroscopy
5755382|NCT00300053|angina|angina
5755383|NCT00300040|Amputation|amputation
5755384|NCT00300040|Lower limb|lower limb
5755385|NCT00300040|Critical Limb Ischemia|critical limb ischemia
5755386|NCT00300040|residual limb|residual limb
5755387|NCT00300040|Peripheral Vascular Disease|peripheral vascular disease
5755388|NCT00300040|re-amputation|re-amputation
5755389|NCT00300040|Lower Limb Ischemia|lower limb ischemia
5755390|NCT00300040|PVD|pvd
5755391|NCT00300027|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
5755392|NCT00300014|Post vitrectomy|post vitrectomy
5755393|NCT00300014|Recurrent diabetic vitreous hemorrhage|recurrent diabetic vitreous hemorrhage
5755394|NCT00300014|Intravitreal triamcinolone injection|intravitreal triamcinolone injection
5755395|NCT00300001|Cancer|cancer
5755396|NCT00300001|Symptom Management|symptom management
5755397|NCT00300001|Supportive Symptom Interventions|supportive symptom interventions
5755398|NCT00300001|Symptom Severity|symptom severity
5755399|NCT00300001|quality of life|quality of life
5755400|NCT00300001|Home-based symptom monitoring|home-based symptom monitoring
5755401|NCT00299988|Immunotherapy|immunotherapy
5755402|NCT00299988|Amyloid beta protein|amyloid beta protein
5755403|NCT00299988|Antibodies|antibodies
5755404|NCT00299988|Alzheimer's|alzheimer's
5755405|NCT00299988|Dementia|dementia
5755406|NCT00299975|Randomized Controlled Trials|randomized controlled trials
5755407|NCT00299975|Medicine, Chinese Traditional|medicine, chinese traditional
5755408|NCT00299975|Medicine, Herbal|medicine, herbal
5755409|NCT00299975|Constipation|constipation
5755410|NCT00299962|gene therapy|gene therapy
5755411|NCT00299962|immunotherapy|immunotherapy
5755412|NCT00299936|hepatitis C|hepatitis c
5755413|NCT00299936|chronic hepatitis C|chronic hepatitis c
5755414|NCT00299936|ribavirin|ribavirin
5755415|NCT00299936|WIN-R|win-r
5750572|NCT00317772|EGFR|egfr
5755416|NCT00299923|drug therapy|drug therapy
5755417|NCT00299923|Interferon|interferon
5755419|NCT00299897|AIDS|aids
5755420|NCT00299897|Treatment Resistance|treatment resistance
5755421|NCT00299897|Treatment Failure|treatment failure
5755422|NCT00299897|Mutations|mutations
5755423|NCT00299897|GP120|gp120
5755424|NCT00299897|Entry Inhibitors|entry inhibitors
5755425|NCT00299897|HAART|haart
5755426|NCT00299897|antiretroviral|antiretroviral
5755427|NCT00299897|antiviral|antiviral
5755428|NCT00299897|ARV|arv
5755429|NCT00299897|CCR5|ccr5
5755430|NCT00299897|CXCR4|cxcr4
5755431|NCT00299897|receptors|receptors
5755432|NCT00299897|intracellular fluid|intracellular fluid
5755433|NCT00299897|lipid rafts|lipid rafts
5755434|NCT00299897|cholesterol|cholesterol
5755435|NCT00299897|chemokine|chemokine
5755436|NCT00299897|Treatment Experienced|treatment experienced
5755437|NCT00299884|Randomized|randomized
5755438|NCT00299884|non-blinded|non-blinded
5755439|NCT00299884|prospective|prospective
5755440|NCT00299884|open-label|open-label
5755441|NCT00299884|LDL-C|ldl-c
5755442|NCT00299884|HDL-C|hdl-c
5755443|NCT00299871|Type 2 diabetes|type 2 diabetes
5755444|NCT00299858|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5755445|NCT00299858|Theophylline|theophylline
5755446|NCT00299858|Exercise testing|exercise testing
5755447|NCT00299845|gastroesophageal reflux|gastroesophageal reflux
5755448|NCT00299845|children|children
5755449|NCT00299845|lansoprazole|lansoprazole
5755450|NCT00299845|cytochrome P450 2C19 (CYP2C19)|cytochrome p450 2c19 (cyp2c19)
5755451|NCT00299845|pharmacogenomics|pharmacogenomics
5755452|NCT00299845|genetic polymorphisms|genetic polymorphisms
5755453|NCT00299845|individualized medicine|individualized medicine
5755454|NCT00299845|pharmacokinetics/dynamics|pharmacokinetics/dynamics
5755455|NCT00299832|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
5755457|NCT00299806|Hypertension, aliskiren, blood pressure, rennin|hypertension, aliskiren, blood pressure, rennin
5755458|NCT00299793|Epilepsy|epilepsy
5755459|NCT00299793|Quality of life|quality of life
5755460|NCT00299780|Mobilization|mobilization
5755461|NCT00299780|Stem Cell|stem cell
5755462|NCT00299780|Parathyroid Hormone|parathyroid hormone
5755463|NCT00299754|Low dose misoprostol|low dose misoprostol
5755464|NCT00299754|dinoprostone|dinoprostone
5755465|NCT00299754|cervical priming|cervical priming
5755466|NCT00299741|Sutent|sutent
5755467|NCT00299741|Sunitinib|sunitinib
5755468|NCT00299741|Bone|bone
5755469|NCT00299741|Metastatic|metastatic
5755470|NCT00299741|Hormone-refractory|hormone-refractory
5755471|NCT00299741|Biomarkers|biomarkers
5755472|NCT00299728|NY-ESO-1|ny-eso-1
5755473|NCT00299728|Vaccine|vaccine
5755474|NCT00299728|Adjuvant or metastatic setting|adjuvant or metastatic setting
5755475|NCT00299728|Several tumor types eligible|several tumor types eligible
5755476|NCT00299715|Affective psychosis|affective psychosis
5755477|NCT00299715|mixed-state|mixed-state
5754615|NCT00302822|Truvada|truvada
5755478|NCT00299715|bipolar disorder|bipolar disorder
5755479|NCT00299715|manic disorder|manic disorder
5755480|NCT00299715|manic-depressive|manic-depressive
5755481|NCT00299715|psychosis|psychosis
5755482|NCT00299715|mania|mania
5755483|NCT00299715|manic state|manic state
5755484|NCT00299715|paliperidone|paliperidone
5755485|NCT00299715|paliperidone ER.|paliperidone er.
5755486|NCT00299702|Schizophrenia|schizophrenia
5755487|NCT00299702|Relapse|relapse
5755488|NCT00299702|Remission|remission
5755489|NCT00299702|Treatment Outcome|treatment outcome
5755490|NCT00299702|long-acting injectable|long-acting injectable
5755491|NCT00299689|Melanoma|melanoma
5755492|NCT00299689|Metastatic|metastatic
5755493|NCT00299689|Stage IV|stage iv
5755494|NCT00299689|Ontak|ontak
5755495|NCT00299676|Alzheimer's Disease|alzheimer's disease
5755496|NCT00299676|Dementia|dementia
5755497|NCT00299676|Post Marketing|post marketing
5755498|NCT00299676|Prospective Studies|prospective studies
5755499|NCT00299676|Longitudinal Studies|longitudinal studies
5755500|NCT00299676|New Zealand|new zealand
5755501|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors
5755502|NCT00299676|Observational|observational
5755503|NCT00299676|Outcomes|outcomes
5755504|NCT00299663|group A streptococcal infection|group a streptococcal infection
5755505|NCT00299663|genital tract|genital tract
5755506|NCT00299663|CARRIER|carrier
5755507|NCT00299663|patients with GAS isolation|patients with gas isolation
5755508|NCT00299663|Streptococcus Group A|streptococcus group a
5755509|NCT00299650|ARDS|ards
5755510|NCT00299650|mortality|mortality
5755511|NCT00299650|mechanical ventilation|mechanical ventilation
5755512|NCT00299650|pneumonia|pneumonia
5755513|NCT00299650|muscle relaxants|muscle relaxants
5755514|NCT00299624|venous thromboembolism risk,|venous thromboembolism risk,
5755515|NCT00299624|elderly,|elderly,
5755516|NCT00299624|hypercoagulability|hypercoagulability
5755517|NCT00299624|fibrinolysis|fibrinolysis
5755518|NCT00299624|microparticles|microparticles
5755519|NCT00299611|OCD|ocd
5755520|NCT00299611|Anxiety|anxiety
5755521|NCT00299611|Pharmacotherapy|pharmacotherapy
5755522|NCT00299611|Sertraline|sertraline
5755523|NCT00299611|Levetiracetam|levetiracetam
5755524|NCT00299598|antibacterial|antibacterial
5755525|NCT00299598|composite|composite
5755526|NCT00299598|polyethylenimine|polyethylenimine
5755527|NCT00299598|nanoparticle|nanoparticle
5755528|NCT00299585|dental implant|dental implant
5755529|NCT00299585|dental implantation|dental implantation
5755530|NCT00299585|osseointegration|osseointegration
5755531|NCT00299585|bone cement|bone cement
5755532|NCT00299585|osteoconductivity|osteoconductivity
5755533|NCT00299585|brushite|brushite
5755534|NCT00299585|calcium phosphate|calcium phosphate
5755535|NCT00299585|bone augmentation|bone augmentation
5755536|NCT00299585|primary stability|primary stability
5755537|NCT00299585|immediate implantation|immediate implantation
5755538|NCT00299585|Mandibular Ridge Augmentation|mandibular ridge augmentation
5755539|NCT00299585|Maxillary Ridge Augmentation|maxillary ridge augmentation
5755540|NCT00299585|synthetic implants for rebuilding the alveolar ridge|synthetic implants for rebuilding the alveolar ridge
5755541|NCT00299572|alendronate|alendronate
5755542|NCT00299572|peritoneal dialysis|peritoneal dialysis
5755543|NCT00299572|vascular calcification|vascular calcification
5755544|NCT00299572|bone mineral density|bone mineral density
5755545|NCT00299559|common cold|common cold
5755546|NCT00299559|organic chemicals|organic chemicals
5755547|NCT00299559|menthol|menthol
5755548|NCT00299559|cineole|cineole
5755549|NCT00299559|camphor|camphor
5755550|NCT00299559|etheric oils|etheric oils
5755551|NCT00299559|alternative medicine|alternative medicine
5755552|NCT00299559|smart textiles|smart textiles
5755553|NCT00299546|Rheumatoid Arthritis|rheumatoid arthritis
5755554|NCT00299546|Anti-TNFa agents|anti-tnfa agents
5755555|NCT00299546|subcutaneous injection|subcutaneous injection
5755556|NCT00299520|skin infection|skin infection
5755557|NCT00299520|complicated skin infection|complicated skin infection
5755558|NCT00299520|skin structure infection|skin structure infection
5755559|NCT00299507|exudative AMD|exudative amd
5755560|NCT00299507|age-related macular degeneration (AMD)|age-related macular degeneration (amd)
5755561|NCT00299494|Lymphoma|lymphoma
5755562|NCT00299494|NHL|nhl
5755563|NCT00299481|Tissue Bank|tissue bank
5755564|NCT00299481|Endometrial neoplasm|endometrial neoplasm
5755565|NCT00299481|uterine cervical neoplasm|uterine cervical neoplasm
5755566|NCT00299481|ovarian neoplasm|ovarian neoplasm
5755567|NCT00299481|leiomyoma|leiomyoma
5755568|NCT00299481|DNA|dna
5755569|NCT00299481|RNA|rna
5755570|NCT00299481|Protein|protein
5755571|NCT00299481|Serum|serum
5755572|NCT00299468|hypertension|hypertension
5755573|NCT00299468|home care|home care
5755574|NCT00299468|patient activation|patient activation
5755575|NCT00299468|stages-of-change|stages-of-change
5755576|NCT00299442|behavior|behavior
5755577|NCT00299442|conduct|conduct
5755578|NCT00299442|child|child
5755579|NCT00299442|parenting|parenting
5754721|NCT00302302|GIP|gip
5755580|NCT00299442|self-help|self-help
5755581|NCT00299442|media-based|media-based
5755582|NCT00299429|Stent|stent
5755583|NCT00299429|drug-eluting stent|drug-eluting stent
5755584|NCT00299429|Minimally invasive bypass surgery|minimally invasive bypass surgery
5755585|NCT00299429|left anterior descending|left anterior descending
5755586|NCT00299416|Stroke|stroke
5755587|NCT00299416|Nonhemorrhagic|nonhemorrhagic
5755588|NCT00299416|hypothermia|hypothermia
5755589|NCT00299403|Depressive disorder,|depressive disorder,
5862878|NCT00001473|Remission|remission
5755590|NCT00299403|Antidepressant effect,|antidepressant effect,
5755591|NCT00299403|rTMS,|rtms,
5755592|NCT00299403|ECT,|ect,
5755593|NCT00299403|cognition,|cognition,
5755594|NCT00299403|Saliva cortisol|saliva cortisol
5755595|NCT00299403|noninferiority trial|noninferiority trial
5755596|NCT00299390|Sagopilone|sagopilone
5755597|NCT00299390|Epothilone|epothilone
5755598|NCT00299390|SCLC|sclc
5755599|NCT00299390|Small Cell Lung Cancer|small cell lung cancer
5755600|NCT00299390|Lung Cancer|lung cancer
5755601|NCT00299377|STEMI|stemi
5755602|NCT00299377|infarct size|infarct size
5755603|NCT00299377|primary PCI|primary pci
5755604|NCT00299377|no-reflow|no-reflow
5755605|NCT00299377|ST-elevation myocardial infarction|st-elevation myocardial infarction
5755606|NCT00299364|Climacteric symptoms|climacteric symptoms
5755607|NCT00299364|Black Cohosh|black cohosh
5755608|NCT00299364|Efficacy|efficacy
5755609|NCT00299364|Safety|safety
5755610|NCT00299338|HIV|hiv
5755611|NCT00299338|AIDS|aids
5755612|NCT00299338|CD4|cd4
5755613|NCT00299338|HAART|haart
5755614|NCT00299338|antiretroviral|antiretroviral
5755615|NCT00299338|treatment failure|treatment failure
5755616|NCT00299338|resistance|resistance
5755617|NCT00299338|CCR4|ccr4
5755618|NCT00299338|CXCR5|cxcr5
5755619|NCT00299338|gp120|gp120
5755620|NCT00299338|gp41|gp41
5755621|NCT00299338|cholesterol|cholesterol
5755622|NCT00299338|lipid rafts|lipid rafts
5755623|NCT00299338|intracellular fluid|intracellular fluid
5755624|NCT00299338|receptors|receptors
5755625|NCT00299338|chemokine|chemokine
5755626|NCT00299338|antigens|antigens
5755627|NCT00299338|Treatment Experienced|treatment experienced
5755628|NCT00299312|Loss of Purposeful Hand Use Syndrome|loss of purposeful hand use syndrome
5755629|NCT00299312|Loss of Communication|loss of communication
5755630|NCT00299312|Stereotypic Hand Movements|stereotypic hand movements
5755632|NCT00299312|MECP2 duplication|mecp2 duplication
5755633|NCT00299312|CDKL5 mutation|cdkl5 mutation
5755634|NCT00299312|FOXG1 mutation|foxg1 mutation
5755635|NCT00299286|Ki67|ki67
5755636|NCT00299286|Molecular|molecular
5755637|NCT00299286|antiproliferative|antiproliferative
5755638|NCT00299273|Obesity;|obesity;
5755639|NCT00299273|Low calorie high fat/protein diet;|low calorie high fat/protein diet;
5755640|NCT00299273|Low-carbohydrate diet|low-carbohydrate diet
5755641|NCT00299273|Weight Loss|weight loss
5755642|NCT00299260|cytomegalovirus, glycoprotein B vaccine, allograft|cytomegalovirus, glycoprotein b vaccine, allograft
5755643|NCT00299247|Malaria, Plasmodium falciparum, drug resistance, Colombia|malaria, plasmodium falciparum, drug resistance, colombia
5755644|NCT00299234|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5755645|NCT00299221|immunosuppression|immunosuppression
5755646|NCT00299221|steroid withdrawal|steroid withdrawal
5755647|NCT00299221|rejection|rejection
5755748|NCT00298883|Transplant|transplant
5755648|NCT00299221|coronary disease|coronary disease
5755649|NCT00299221|cytomegalovirus infection|cytomegalovirus infection
5755650|NCT00299208|Malaria|malaria
5755651|NCT00299195|Oral Leukoplakia|oral leukoplakia
5755652|NCT00299195|Benign Neoplasms|benign neoplasms
5755654|NCT00299195|Pan-cyclooxygenase (COX) inhibitor|pan-cyclooxygenase (cox) inhibitor
5755655|NCT00299195|sulindac|sulindac
5755656|NCT00299195|04-099|04-099
5755657|NCT00299182|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5755658|NCT00299182|Lymphoma|lymphoma
5755659|NCT00299182|Mantle Cell Lymphoma|mantle cell lymphoma
5755660|NCT00299182|AMG 531|amg 531
5755661|NCT00299182|Romiplostim|romiplostim
5755662|NCT00299182|Placebo|placebo
5755663|NCT00299182|R-HyperCVAD|r-hypercvad
5755664|NCT00299182|R-Ara-C/MTX|r-ara-c/mtx
5755665|NCT00299182|Cyclophosphamide|cyclophosphamide
5755666|NCT00299182|Cytarabine|cytarabine
5755667|NCT00299182|Dexamethasone|dexamethasone
5755668|NCT00299182|Doxorubicin|doxorubicin
5755669|NCT00299182|Methotrexate|methotrexate
5755670|NCT00299182|Rituximab|rituximab
5755671|NCT00299182|Vincristine|vincristine
5755672|NCT00299182|Decadron|decadron
5755673|NCT00299182|Neosar|neosar
5755675|NCT00299182|Hydroxydaunomycin hydrocholoride|hydroxydaunomycin hydrocholoride
5755676|NCT00299182|Ara-C|ara-c
5755677|NCT00299182|Cytosar|cytosar
5755678|NCT00299182|DepoCyt|depocyt
5755679|NCT00299182|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5755680|NCT00299169|N of 1 trial|n of 1 trial
5755681|NCT00299169|diabetes mellitus|diabetes mellitus
5755682|NCT00299169|HMG CoA Reductase Inhibitors|hmg coa reductase inhibitors
5755683|NCT00299169|cardiovascular disease|cardiovascular disease
5763704|NCT00269399|CDAD|cdad
5755684|NCT00299156|Myelodysplastic Syndrome|myelodysplastic syndrome
5755686|NCT00299156|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5755687|NCT00299156|CMML|cmml
5755688|NCT00299156|Clofarabine|clofarabine
5755689|NCT00299156|Clofarex|clofarex
5755690|NCT00299156|Clolar|clolar
5755691|NCT00299156|Chemotherapy|chemotherapy
5755692|NCT00299143|SIPA|sipa
5755693|NCT00299143|acute coronary syndrome|acute coronary syndrome
5755694|NCT00299130|RA|ra
5755695|NCT00299130|Rituxan|rituxan
5755696|NCT00299130|SERENE|serene
5681017|NCT00575185|Epstein-Barr virus|epstein-barr virus
5781568|NCT00187512|HIV|hiv
5755697|NCT00299117|Smoking cessation|smoking cessation
5755698|NCT00299117|Stress|stress
5755699|NCT00299117|Nicotine dependence|nicotine dependence
5755700|NCT00299117|Complication, postoperative|complication, postoperative
5755701|NCT00299104|Rituxan|rituxan
5755702|NCT00299104|MTX|mtx
5755703|NCT00299104|RA|ra
5755704|NCT00299104|IMAGE|image
5755705|NCT00299104|WA17047|wa17047
5755706|NCT00299091|Therapeutic drug monitoring|therapeutic drug monitoring
5755707|NCT00299091|Treatment Naive|treatment naive
5755708|NCT00299091|Treatment Experienced|treatment experienced
5755710|NCT00299065|Asthma, bronchial|asthma, bronchial
5755711|NCT00299065|Asthma, exercise-induced|asthma, exercise-induced
5755712|NCT00299065|Anti-asthmatic agents|anti-asthmatic agents
5755713|NCT00299052|Tibia|tibia
5755714|NCT00299052|Fracture|fracture
5755715|NCT00299052|DBM|dbm
5755716|NCT00299039|Randomized controlled trial|randomized controlled trial
5755717|NCT00299039|Clinical trial|clinical trial
5755718|NCT00299039|Breast tumor surgery|breast tumor surgery
5755719|NCT00299039|Outpatient surgery|outpatient surgery
5755720|NCT00299039|Analgesia|analgesia
5755721|NCT00299039|Outpatient analgesia|outpatient analgesia
5755722|NCT00299039|Post surgical analgesia|post surgical analgesia
5755723|NCT00299039|≥ 18 and ≤ 70 years of age|≥ 18 and ≤ 70 years of age
5755724|NCT00299039|Elective outpatient breast surgery for:|elective outpatient breast surgery for:
5755725|NCT00299039|lumpectomy/quadrantectomy +/- Sentinel Lymph Node Biopsy|lumpectomy/quadrantectomy +/- sentinel lymph node biopsy
5755726|NCT00299039|lumpectomy/quadrantectomy with Axillary Node Dissection|lumpectomy/quadrantectomy with axillary node dissection
5755727|NCT00299039|simple mastectomy +/- Sentinel Lymph Node Biopsy|simple mastectomy +/- sentinel lymph node biopsy
5755728|NCT00299039|Modified Radical mastectomy|modified radical mastectomy
5755729|NCT00299026|Coronary Artery Disease|coronary artery disease
5755730|NCT00299026|Percutaneous Coronary Intervention|percutaneous coronary intervention
5755731|NCT00299026|Stent Implant|stent implant
5755732|NCT00299026|Drug-coated Stent|drug-coated stent
5755733|NCT00299013|Ulcerative colitis|ulcerative colitis
5755734|NCT00298987|Chronic Myeloid Leukemia Accelerated and Blast Phase|chronic myeloid leukemia accelerated and blast phase
5755735|NCT00298987|Leukemia, Acute, Philadelphia-Positive|leukemia, acute, philadelphia-positive
5755736|NCT00298974|Osteoarthritis of the hip or knee|osteoarthritis of the hip or knee
5755737|NCT00298935|Randomized Controlled Trial|randomized controlled trial
5755738|NCT00298935|Pregnant Women|pregnant women
5755739|NCT00298922|Cystic Fibrosis|cystic fibrosis
5755740|NCT00298922|Burkholderia cepacia complex|burkholderia cepacia complex
5755742|NCT00298896|Squamous Cell|squamous cell
5755743|NCT00298896|Small Cell|small cell
5755744|NCT00298896|Carcinoma|carcinoma
5755745|NCT00298896|Cancer|cancer
5755746|NCT00298896|Small Cell Lung Cancer|small cell lung cancer
5755747|NCT00298883|Renal|renal
5755750|NCT00298870|pulmonary tuberculosis|pulmonary tuberculosis
5755751|NCT00298870|isoniazid|isoniazid
5755752|NCT00298870|arylamine N-acetyltransferase 2|arylamine n-acetyltransferase 2
5755753|NCT00298870|pharmacogenomics|pharmacogenomics
5771733|NCT00237367|EAE|eae
5755754|NCT00298870|genetic polymorphisms|genetic polymorphisms
5755755|NCT00298870|individualized medicine|individualized medicine
5755756|NCT00298870|drug-induced hepatotoxity|drug-induced hepatotoxity
5755758|NCT00298857|Obesity|obesity
5755759|NCT00298857|Pharmacokinetics|pharmacokinetics
5755760|NCT00298844|Type 2 diabetes mellitus|type 2 diabetes mellitus
5755761|NCT00298844|Macrovascular disease|macrovascular disease
5755762|NCT00298844|Diastolic dysfunction|diastolic dysfunction
5755763|NCT00298844|Intima media thickness|intima media thickness
5755764|NCT00298844|Single- photon emission computed tomography (SPECT)|single- photon emission computed tomography (spect)
5755765|NCT00298818|Epilepsy|epilepsy
5755766|NCT00298818|Mental Retardation|mental retardation
5755767|NCT00298818|Developmental Disabilities|developmental disabilities
5755768|NCT00298805|Migraine|migraine
5755769|NCT00298805|Headache|headache
5755770|NCT00298805|Depression|depression
5755771|NCT00298805|Quality of Life|quality of life
5755772|NCT00298792|Cognitive Behavioral Treatment|cognitive behavioral treatment
5755773|NCT00298792|Alcohol Dependence|alcohol dependence
5755774|NCT00298792|Functional Analysis|functional analysis
5755775|NCT00298792|Experience Sampling|experience sampling
5755776|NCT00298792|Interactive Voice Response|interactive voice response
5755777|NCT00298779|patients with advanced solid tumors or Non-Hodgkins's Lymphoma|patients with advanced solid tumors or non-hodgkins's lymphoma
5755778|NCT00298727|Knowledge transfer|knowledge transfer
5755779|NCT00298727|Clinical decision-making|clinical decision-making
5755780|NCT00298727|Outcome measures|outcome measures
5755781|NCT00298714|Hepatitis C, Chronic|hepatitis c, chronic
5755782|NCT00298701|Allergy|allergy
5755783|NCT00298662|Multiple Sclerosis|multiple sclerosis
5755784|NCT00298662|Betaseron-Prograf|betaseron-prograf
5755785|NCT00298662|patients of Multiple Sclerosis|patients of multiple sclerosis
5755786|NCT00298662|Secondary Progressive type|secondary progressive type
5755787|NCT00298662|Relapsing-Remitting type|relapsing-remitting type
5755788|NCT00298649|pesticide safety|pesticide safety
5755789|NCT00298649|migrant and seasonal farmworkers|migrant and seasonal farmworkers
5755790|NCT00298649|Latino/Hispanic|latino/hispanic
5755791|NCT00298649|agricultural health|agricultural health
5755792|NCT00298649|occupational health|occupational health
5755793|NCT00298610|Uncomplicated Malaria|uncomplicated malaria
5755794|NCT00298610|GMP artesunate|gmp artesunate
5755795|NCT00298584|Diagnostic techniques, urological|diagnostic techniques, urological
5755796|NCT00298584|urinary catheterization|urinary catheterization
5755797|NCT00298584|Aspiration|aspiration
5755798|NCT00298584|Neonates|neonates
5755799|NCT00298584|Neonatal Intensive Care Unit|neonatal intensive care unit
5755800|NCT00298584|Infant, Newborn|infant, newborn
5755801|NCT00298584|Infant, Premature|infant, premature
5755802|NCT00298584|Infant, Low-birth weight|infant, low-birth weight
5755803|NCT00298571|Cesarean Delivery|cesarean delivery
5755804|NCT00298571|Post-operative|post-operative
5755805|NCT00298571|Pain|pain
5755806|NCT00298571|Local Anesthetic|local anesthetic
5755807|NCT00298558|cognition disorder|cognition disorder
5755808|NCT00298558|cognitive behavior therapy|cognitive behavior therapy
5755809|NCT00298558|functional ability|functional ability
5755810|NCT00298532|Pediatrics|pediatrics
5755811|NCT00298532|Seizure|seizure
5755812|NCT00298532|Trauma|trauma
5755813|NCT00298532|Respiratory|respiratory
5755814|NCT00298532|Cardiac|cardiac
5755815|NCT00298532|Arrest|arrest
5755816|NCT00298506|Tacrolimus|tacrolimus
5755817|NCT00298506|Mycophenolate mofetil|mycophenolate mofetil
5755818|NCT00298506|Cyclophosphamide|cyclophosphamide
5755819|NCT00298506|Lupus nephritis|lupus nephritis
5755820|NCT00298506|Treatment|treatment
5755821|NCT00298493|ICU|icu
5755823|NCT00298493|Daily sedative interruption|daily sedative interruption
5755824|NCT00298493|Sedation protocols|sedation protocols
5755825|NCT00298480|preterm labor|preterm labor
5755826|NCT00298480|transvaginal ultrasound|transvaginal ultrasound
5755827|NCT00298480|dynamic cervical change|dynamic cervical change
5755828|NCT00298467|ALCL|alcl
5755829|NCT00298467|csALCL|csalcl
5755830|NCT00298467|pcALCL|pcalcl
5755831|NCT00298467|Lymphoma|lymphoma
5755832|NCT00298467|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5755833|NCT00298467|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5755834|NCT00298467|classic systemci Anaplastic Large Cell Lymphoma (csALCL)|classic systemci anaplastic large cell lymphoma (csalcl)
5755835|NCT00298467|primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL)|primary cutaneous anaplastic large cell lymphoma (pcalcl)
5755836|NCT00298454|renal failure|renal failure
5755837|NCT00298454|oliguric|oliguric
5755838|NCT00298454|critically ill|critically ill
5755839|NCT00298454|furosemide|furosemide
5755840|NCT00298441|intravenous iron administration|intravenous iron administration
5755841|NCT00298428|stent|stent
5755842|NCT00298428|percutaneous coronary intervention|percutaneous coronary intervention
5755843|NCT00298428|platelet aggregation|platelet aggregation
5755846|NCT00298428|metabolic syndrome|metabolic syndrome
5755847|NCT00298415|2-years survival|2-years survival
5755848|NCT00298402|macrophage|macrophage
5755850|NCT00298402|CT scan|ct scan
5755851|NCT00298389|macrophage|macrophage
5755852|NCT00298389|phagocytosis|phagocytosis
5755853|NCT00298389|exacerbation|exacerbation
5755854|NCT00298376|Cow’s milk allergy,|cow’s milk allergy,
5755855|NCT00298376|food allergy|food allergy
5755856|NCT00298376|oral tolerance,|oral tolerance,
5755857|NCT00298376|infant,|infant,
5755858|NCT00298376|regulatory T cells,|regulatory t cells,
5755859|NCT00298376|intestinal microflora|intestinal microflora
5755860|NCT00298363|Hepatitis; Hepatitis B virus; Tenofovir|hepatitis; hepatitis b virus; tenofovir
5755861|NCT00298350|Phase 2|phase 2
5755862|NCT00298350|Phase II|phase ii
5755863|NCT00298350|Randomized|randomized
5755864|NCT00298350|Controlled|controlled
5755865|NCT00298350|Comparator|comparator
5755866|NCT00298350|Partially Blind|partially blind
5755867|NCT00298350|Protease Inhibitors|protease inhibitors
5755868|NCT00298350|Integrase Inhibitors|integrase inhibitors
5755869|NCT00298350|Antiviral Agents|antiviral agents
5755870|NCT00298350|Antiretroviral Agents|antiretroviral agents
5755871|NCT00298350|ART|art
5755872|NCT00298350|ARV|arv
5755873|NCT00298350|Highly Activity Antiretroviral Therapy|highly activity antiretroviral therapy
5755874|NCT00298350|HAART|haart
5755875|NCT00298350|Treatment Experienced|treatment experienced
5755876|NCT00298324|GvHD|gvhd
5755877|NCT00298324|graft versus host disease|graft versus host disease
5755878|NCT00298324|extensive|extensive
5755879|NCT00298324|myfortic|myfortic
5755880|NCT00298298|lung cancer|lung cancer
5755881|NCT00298298|non-small cell lung cancere|non-small cell lung cancere
5755882|NCT00298298|vaccine|vaccine
5755883|NCT00298298|immunotherapy|immunotherapy
5755884|NCT00298285|mechanical valve replacement|mechanical valve replacement
5755885|NCT00298285|warfarin|warfarin
5755886|NCT00298246|Neurodevelopmental Disorders|neurodevelopmental disorders
5755887|NCT00298246|Neurological Disorder|neurological disorder
5755888|NCT00298246|Children- Onset|children- onset
5755889|NCT00298246|Children|children
5862879|NCT00001473|Relapse|relapse
5755890|NCT00298246|Pervasive Developmental Disorder|pervasive developmental disorder
5755891|NCT00298246|PDD|pdd
5755892|NCT00298246|Autism|autism
5755893|NCT00298246|Healthy Volunteer|healthy volunteer
5755894|NCT00298246|HV|hv
5755895|NCT00298233|Antibody Response|antibody response
5755896|NCT00298233|Antiviral Efficacy|antiviral efficacy
5755897|NCT00298233|Bird Flu|bird flu
5755898|NCT00298233|Severe Respiratory Distress|severe respiratory distress
5755899|NCT00298233|Viral Replication and Shedding|viral replication and shedding
5755900|NCT00298220|Family Practice|family practice
5755901|NCT00298220|Intervention Studies|intervention studies
5755902|NCT00298220|Prevention and Control|prevention and control
5755904|NCT00298207|hypertension|hypertension
5755905|NCT00298207|adult|adult
5755906|NCT00298207|African Americans|african americans
5755907|NCT00298207|Walking|walking
5755908|NCT00298168|Delayed Graft Function|delayed graft function
5755909|NCT00298142|Cervicogenic Headache|cervicogenic headache
5755910|NCT00298142|Migraine|migraine
5755911|NCT00298142|Tension Type Headache|tension type headache
5755912|NCT00298103|Antibiotic resistant|antibiotic resistant
5755913|NCT00298103|Infection|infection
5755914|NCT00298090|Oxygenation|oxygenation
5755919|NCT00298064|cervical|cervical
5755920|NCT00298064|genomic|genomic
5755921|NCT00298064|DNA|dna
5755922|NCT00298064|markers|markers
5755923|NCT00298064|prognostic|prognostic
5755924|NCT00298064|gene|gene
5755925|NCT00298064|epidermal growth factor|epidermal growth factor
5755926|NCT00298051|Iron-deficiency anemia|iron-deficiency anemia
5755927|NCT00298051|Umbilical cord clamping|umbilical cord clamping
5755928|NCT00298051|Infant|infant
5755929|NCT00298025|Infertility|infertility
5755930|NCT00298025|Cetrotide|cetrotide
5755932|NCT00298025|Recombinant human follicle stimulating hormone (r-hFSH)|recombinant human follicle stimulating hormone (r-hfsh)
5755933|NCT00298025|Human Menopausal Gonadotropin (hMG)|human menopausal gonadotropin (hmg)
5755934|NCT00298025|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
5755935|NCT00298012|Methotrexate|methotrexate
5755936|NCT00298012|Magnetic Resonance Imaging|magnetic resonance imaging
5755937|NCT00298012|Anterior uveitis|anterior uveitis
5755938|NCT00297947|schizophrenia|schizophrenia
5755939|NCT00297947|quetiapine|quetiapine
5755940|NCT00297947|schizoaffective disorder|schizoaffective disorder
5755941|NCT00297934|dual-task|dual-task
5755942|NCT00297934|postural control|postural control
5755943|NCT00297934|cognitive|cognitive
5755944|NCT00297908|Ethanol levels|ethanol levels
5755945|NCT00297908|Dermal absorbtion|dermal absorbtion
5755946|NCT00297895|sentinel lymph node dissection|sentinel lymph node dissection
5755947|NCT00297895|complete lymph node dissection|complete lymph node dissection
5755948|NCT00297895|surgical|surgical
5755949|NCT00297882|Efficacy|efficacy
5755950|NCT00297882|Safety|safety
5755951|NCT00297882|Children|children
5755954|NCT00297830|Heart Transplantation|heart transplantation
5755955|NCT00297830|Liver Transplantation|liver transplantation
5755956|NCT00297830|Immunosuppression|immunosuppression
5755957|NCT00297830|Bone Density/drug effects|bone density/drug effects
5755958|NCT00297830|Alendronate|alendronate
5755959|NCT00297830|Zoledronic acid|zoledronic acid
5755960|NCT00297830|Comparative study|comparative study
5755961|NCT00297830|Humans|humans
5755962|NCT00297817|Meningococcal Disease; Meningococcal Meningitis; Vaccine|meningococcal disease; meningococcal meningitis; vaccine
5755963|NCT00297804|Coronary Artery Disease|coronary artery disease
5755964|NCT00297804|Percutaneous Coronary Intervention|percutaneous coronary intervention
5755965|NCT00297804|Stent Implant|stent implant
5755966|NCT00297804|Drug-coated Stent|drug-coated stent
5755967|NCT00297791|rectal cancer|rectal cancer
5755968|NCT00297791|laparoscopic technique|laparoscopic technique
5755969|NCT00297791|open technique|open technique
5755970|NCT00297791|clinical trial|clinical trial
5755971|NCT00297791|multicenter study|multicenter study
5755972|NCT00297791|randomized controlled trial|randomized controlled trial
5755973|NCT00297791|Tumor Below 15cm|tumor below 15cm
5755974|NCT00297791|curative surgical resection|curative surgical resection
5755975|NCT00297791|no evidence for distant metastases|no evidence for distant metastases
5755976|NCT00297765|Renal Transplantation|renal transplantation
5755977|NCT00297765|Therapeutics|therapeutics
5755978|NCT00297765|Treatment Outcome|treatment outcome
5755979|NCT00297765|Safety|safety
5755984|NCT00297739|Aggression|aggression
5755985|NCT00297739|ADHD|adhd
5755986|NCT00297739|Antipsychotic|antipsychotic
5755987|NCT00297726|Osteoarthritis, Knee|osteoarthritis, knee
5755988|NCT00297726|Osteoarthritis, Hip|osteoarthritis, hip
5755989|NCT00297726|Osteoarthritis, Ankle|osteoarthritis, ankle
5755990|NCT00297726|Arthritis|arthritis
5755991|NCT00297726|Self-Management|self-management
5755992|NCT00297700|Smoking|smoking
5755993|NCT00297700|Dental|dental
5755994|NCT00297700|Cessation|cessation
5755995|NCT00297700|Prevention|prevention
5755996|NCT00297700|Control|control
5755997|NCT00297700|Quitline|quitline
5755998|NCT00297700|5A-Model|5a-model
5755999|NCT00297700|Cost-effective|cost-effective
5756000|NCT00297687|Vaccines|vaccines
5756001|NCT00297687|Healthy Adults|healthy adults
5756002|NCT00297687|Health|health
5756003|NCT00297687|Adult|adult
5756004|NCT00297687|Meningococcal Vaccines|meningococcal vaccines
5756005|NCT00297674|clarithromycin|clarithromycin
5756006|NCT00297674|sepsis|sepsis
5756007|NCT00297674|immunomodulation|immunomodulation
5756008|NCT00297661|Coronary Revascularization|coronary revascularization
5756009|NCT00297661|Sirolimus-eluting stents|sirolimus-eluting stents
5746417|NCT00334230|HV|hv
5756010|NCT00297661|Paclitaxel-eluting stents|paclitaxel-eluting stents
5756011|NCT00297648|Certolizumab pegol|certolizumab pegol
5756012|NCT00297648|Crohn's disease|crohn's disease
5756013|NCT00297648|Mucosal healing|mucosal healing
5756014|NCT00297635|Hyperglycemia|hyperglycemia
5756015|NCT00297635|Insulin Infusion Systems|insulin infusion systems
5756016|NCT00297635|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5756017|NCT00297609|Resuscitation medication errors|resuscitation medication errors
5756018|NCT00297609|critical care|critical care
5756019|NCT00297609|pediatrics|pediatrics
5756020|NCT00297609|clinical decision support systems|clinical decision support systems
5756021|NCT00297609|computerized physician order entry|computerized physician order entry
5756022|NCT00297596|Metastatic|metastatic
5756023|NCT00297596|HER2/neu+|her2/neu+
5756025|NCT00297570|Imatinib|imatinib
5756026|NCT00297570|Pegylated Interferon|pegylated interferon
5756027|NCT00297570|Philadelphia Positive CML|philadelphia positive cml
5756028|NCT00297544|impotence|impotence
5756029|NCT00297544|endothelial function|endothelial function
5756030|NCT00297544|autonomic nervous system|autonomic nervous system
5756031|NCT00297531|Chronic Periodontitis|chronic periodontitis
5756032|NCT00297531|Periodontitis|periodontitis
5756033|NCT00297531|Photodynamic disinfection|photodynamic disinfection
5756034|NCT00297531|PDD|pdd
5756035|NCT00297531|PDT|pdt
5756036|NCT00297531|Periowave|periowave
5756037|NCT00297531|Scaling and Root Planing|scaling and root planing
5756038|NCT00297531|SRP|srp
5756039|NCT00297518|Adult Periodontitis|adult periodontitis
5756040|NCT00297518|Chronic Periodontitis|chronic periodontitis
5756041|NCT00297518|PDD|pdd
5756042|NCT00297518|PDT|pdt
5756043|NCT00297518|Photodynamic Disinfection|photodynamic disinfection
5756044|NCT00297518|SRP|srp
5756045|NCT00297518|Scaling and Root Planing|scaling and root planing
5756046|NCT00297505|Cocaine; citalopram; impulsivity; serotonin|cocaine; citalopram; impulsivity; serotonin
5756047|NCT00297492|Smoking Cessation|smoking cessation
5756048|NCT00297492|Tobacco|tobacco
5756049|NCT00297479|Tobacco Cessation|tobacco cessation
5756050|NCT00297479|Smoking Cessation|smoking cessation
5756051|NCT00297466|tobacco use|tobacco use
5756052|NCT00297466|smoking cessation|smoking cessation
5756053|NCT00297466|emergency department|emergency department
5756054|NCT00297440|Smoking|smoking
5756055|NCT00297440|Exercise|exercise
5756056|NCT00297440|Adolescent|adolescent
5756058|NCT00297427|urinary incontinence|urinary incontinence
5756059|NCT00297414|Mild Cognitive Impairment|mild cognitive impairment
5756060|NCT00297414|Dementia|dementia
5756061|NCT00297414|Galantamine|galantamine
5756062|NCT00297414|Memory disorders|memory disorders
5756063|NCT00297414|Isolated memory impairment|isolated memory impairment
5756064|NCT00297414|Alzheimer's disease|alzheimer's disease
5756065|NCT00297388|schizophrenia|schizophrenia
5756066|NCT00297388|schizoaffective disorder|schizoaffective disorder
5756067|NCT00297388|long-acting risperidone|long-acting risperidone
5756068|NCT00297388|intramuscular injection risperidone|intramuscular injection risperidone
5756069|NCT00297388|risperidone|risperidone
5756070|NCT00297375|treatment|treatment
5756071|NCT00297375|Pain|pain
5756072|NCT00297375|acute|acute
5756073|NCT00297375|migraine|migraine
5756074|NCT00297375|headache|headache
5756075|NCT00297362|Alzheimer Disease|alzheimer disease
5756076|NCT00297362|Dementia|dementia
5756077|NCT00297362|Brain Disease|brain disease
5756078|NCT00297362|Memory Loss|memory loss
5756079|NCT00297362|Caregiver|caregiver
5756080|NCT00297362|Galantamine hydrobromide|galantamine hydrobromide
5756081|NCT00297362|Nervous System Diseases|nervous system diseases
5756082|NCT00297362|Mental Disorders|mental disorders
5756083|NCT00297349|Seizures|seizures
5756084|NCT00297349|Epilepsy|epilepsy
5756085|NCT00297349|Tonic-clonic|tonic-clonic
5756086|NCT00297349|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5756087|NCT00297349|Focal Epilepsy|focal epilepsy
5756088|NCT00297349|Topiramate|topiramate
5756089|NCT00297349|Epilepsy in Children|epilepsy in children
5756090|NCT00297336|Topiramate|topiramate
5756091|NCT00297336|Migraine|migraine
5756092|NCT00297336|Headache|headache
5756093|NCT00297336|Chronic headache|chronic headache
5756094|NCT00297336|Chronic migraine|chronic migraine
5764073|NCT00267839|diabetes|diabetes
5756095|NCT00297323|Seizures|seizures
5756096|NCT00297323|Epilepsy|epilepsy
5756097|NCT00297323|Topiramate|topiramate
5756098|NCT00297323|Epilepsy in Children|epilepsy in children
5756099|NCT00297310|Tacrolimus|tacrolimus
5756100|NCT00297310|Kidney transplantation|kidney transplantation
5756101|NCT00297310|Transplantation|transplantation
5756102|NCT00297310|Kidney failure|kidney failure
5756103|NCT00297310|chronic|chronic
5756104|NCT00297310|P-Glycoprotein|p-glycoprotein
5756105|NCT00297297|Solitary solid and scintigraphically cold thyroid nodules|solitary solid and scintigraphically cold thyroid nodules
5756106|NCT00297284|systemic lupus erythematosus|systemic lupus erythematosus
5756107|NCT00297284|cognitive efficiency|cognitive efficiency
5756108|NCT00297284|cognitive dysfunction|cognitive dysfunction
5756109|NCT00297284|cognition|cognition
5756110|NCT00297284|memory|memory
5756112|NCT00297284|modafinil|modafinil
5756113|NCT00297284|provigil|provigil
5756114|NCT00297271|Dementia|dementia
5756115|NCT00297271|Mild Cognitive Impairment|mild cognitive impairment
5756225|NCT00296972|HAART|haart
5756116|NCT00297271|Patient Registries|patient registries
5756117|NCT00297271|Prospective Studies|prospective studies
5756118|NCT00297271|Longitudinal Studies|longitudinal studies
5756119|NCT00297271|Australia|australia
5756120|NCT00297271|Cholinesterase Inhibitors|cholinesterase inhibitors
5756121|NCT00297271|Observational|observational
5756122|NCT00297271|Non-randomized|non-randomized
5756123|NCT00297258|Sarcoma|sarcoma
5756124|NCT00297258|Synovial sarcoma|synovial sarcoma
5756125|NCT00297258|Pazopanib(GW786034)|pazopanib(gw786034)
5756126|NCT00297258|Adipocytic tumors|adipocytic tumors
5756127|NCT00297258|Leiomyosarcoma|leiomyosarcoma
5756128|NCT00297258|Phase II|phase ii
5756129|NCT00297245|gastrodin|gastrodin
5756130|NCT00297232|Multiple Sclerosis|multiple sclerosis
5756131|NCT00297232|MS|ms
5756132|NCT00297219|Hemodialysis|hemodialysis
5756133|NCT00297219|Coronary artery calcification|coronary artery calcification
5756134|NCT00297219|Adynamic bone disease|adynamic bone disease
5756135|NCT00297219|Dialysate calcium|dialysate calcium
5756136|NCT00297219|Bone mineral density|bone mineral density
5756137|NCT00297219|Bone histomorphometry|bone histomorphometry
5756138|NCT00297206|pharmacokinetics herpes varicella herpes labialis Epstein-Barr virus|pharmacokinetics herpes varicella herpes labialis epstein-barr virus
5756139|NCT00297193|Crohn's Disease|crohn's disease
5756141|NCT00297193|Autologous|autologous
5756142|NCT00297193|EBMT|ebmt
5756143|NCT00297193|ECCO|ecco
5756144|NCT00297180|hunger|hunger
5756145|NCT00297180|obesity|obesity
5756146|NCT00297180|sodium-dependent glucose transporter|sodium-dependent glucose transporter
5756147|NCT00297180|GW869682|gw869682
5756148|NCT00297180|body composition|body composition
5756149|NCT00297180|SGLT2 inhibitor|sglt2 inhibitor
5756150|NCT00297180|weight loss|weight loss
5756151|NCT00297167|CF|cf
5756152|NCT00297167|Cystic Fibrosis|cystic fibrosis
5756153|NCT00297167|EPI|epi
5756154|NCT00297167|Exocrine Pancreatic Insufficiency|exocrine pancreatic insufficiency
5756155|NCT00297167|Pancreatic|pancreatic
5756156|NCT00297167|Enzyme|enzyme
5756157|NCT00297167|PEP|pep
5756158|NCT00297154|Heart failure, congestive|heart failure, congestive
5756268|NCT00296777|Imipramine|imipramine
5756159|NCT00297154|Metabolic Syndrome X|metabolic syndrome x
5756160|NCT00297154|Obesity|obesity
5756161|NCT00297141|Preoperative|preoperative
5756162|NCT00297141|Radiochemotherapy|radiochemotherapy
5756163|NCT00297141|Newly Diagnosed|newly diagnosed
5756164|NCT00297141|Primary Operable|primary operable
5756165|NCT00297141|Locally Advanced|locally advanced
5756166|NCT00297141|Rectal Carcinoma|rectal carcinoma
5756168|NCT00297141|Lower Rectum|lower rectum
5756169|NCT00297141|Middle Rectum|middle rectum
5756170|NCT00297141|ABCSG|abcsg
5756171|NCT00297141|TAKO|tako
5756172|NCT00297141|95|95
5756173|NCT00297141|05|05
5756174|NCT00297128|pilot study|pilot study
5756175|NCT00297128|rectal|rectal
5756176|NCT00297128|cancer|cancer
5756177|NCT00297128|phase II|phase ii
5756178|NCT00297128|preoperative|preoperative
5756179|NCT00297128|chemoradiation|chemoradiation
5756180|NCT00297128|capecitabine|capecitabine
5756181|NCT00297128|cetuximab|cetuximab
5756182|NCT00297128|operable|operable
5756183|NCT00297128|T4|t4
5756184|NCT00297128|ABCSG|abcsg
5756185|NCT00297128|TAKO|tako
5756186|NCT00297128|R03|r03
5756187|NCT00297128|96|96
5756188|NCT00297128|06|06
5756189|NCT00297115|Roflumilast|roflumilast
5756190|NCT00297115|COPD|copd
5756191|NCT00297115|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5756192|NCT00297102|Roflumilast|roflumilast
5756193|NCT00297102|COPD|copd
5756194|NCT00297102|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5756195|NCT00297089|Lung Cancer|lung cancer
5756196|NCT00297089|ABT-751|abt-751
5756197|NCT00297089|NSCLC|nsclc
5756198|NCT00297089|Alimta|alimta
5756199|NCT00297089|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5756200|NCT00297089|pemetrexed|pemetrexed
5755251|NCT00300573|DFC|dfc
5756201|NCT00297076|HIV-1|hiv-1
5756202|NCT00297076|GW873140|gw873140
5756203|NCT00297076|CCR5 antagonist|ccr5 antagonist
5756204|NCT00297076|experienced|experienced
5756205|NCT00297076|Treatment Experienced|treatment experienced
5756206|NCT00297063|rosiglitazone|rosiglitazone
5756207|NCT00297063|vandia|vandia
5756208|NCT00297063|Type 2 diabetes mellitus|type 2 diabetes mellitus
5756209|NCT00297063|diabetes;|diabetes;
5756210|NCT00297050|Influenza Virus|influenza virus
5765107|NCT00263458|HIV|hiv
5756211|NCT00297050|Avian Influenza|avian influenza
5756212|NCT00297050|Normal Volunteers|normal volunteers
5756213|NCT00297050|Neuraminidase Inhibitor|neuraminidase inhibitor
5756214|NCT00297050|Viral Disease|viral disease
5756215|NCT00297050|Healthy Volunteer|healthy volunteer
5756216|NCT00297050|HV|hv
5746590|NCT00333567|COX189|cox189
5756217|NCT00297037|oral lichen planus, pimecrolimus 1% cream|oral lichen planus, pimecrolimus 1% cream
5756218|NCT00296985|Cardiac surgery|cardiac surgery
5756219|NCT00296985|Cellsaver|cellsaver
5756220|NCT00296985|Neurocognitive Function|neurocognitive function
5756221|NCT00296985|Neuronal Protection|neuronal protection
5756222|NCT00296985|Quality of Life|quality of life
5756223|NCT00296972|peg interferon|peg interferon
5756226|NCT00296972|HIV|hiv
5756227|NCT00296972|Chronic Hepatitis C|chronic hepatitis c
5756228|NCT00296972|Treatment Experienced|treatment experienced
5756229|NCT00296959|Dyskinesia|dyskinesia
5756230|NCT00296959|AMPA receptor antagonists|ampa receptor antagonists
5756231|NCT00296946|Sialorrhoea|sialorrhoea
5756232|NCT00296933|Major Depression|major depression
5756233|NCT00296933|Antidepressant|antidepressant
5756234|NCT00296933|Pharmacotherapy|pharmacotherapy
5756235|NCT00296933|Memory functioning|memory functioning
5756236|NCT00296933|Memory Impairment|memory impairment
5756237|NCT00296920|Deep Brain Stimulation|deep brain stimulation
5756238|NCT00296920|Treatment failure|treatment failure
5756239|NCT00296907|cancer|cancer
5756240|NCT00296907|siblings|siblings
5756241|NCT00296907|behavior|behavior
5756242|NCT00296907|psychological adaptation|psychological adaptation
5756243|NCT00296907|intervention|intervention
5756244|NCT00296881|Periodontitis|periodontitis
5756245|NCT00296881|Photodynamic Disinfection|photodynamic disinfection
5756246|NCT00296881|PERIOWAVE|periowave
5756247|NCT00296881|Scaling and Root Planing|scaling and root planing
5756248|NCT00296881|SRP|srp
5756249|NCT00296868|reflex sympathetic dystrophy|reflex sympathetic dystrophy
5756250|NCT00296868|ascorbic acid|ascorbic acid
5756251|NCT00296868|primary prevention|primary prevention
5756252|NCT00296868|radius fractures|radius fractures
5756253|NCT00296855|Peripheral artery disease|peripheral artery disease
5756254|NCT00296842|posttraumatic stress disorder|posttraumatic stress disorder
5756255|NCT00296842|children|children
5756256|NCT00296842|injury|injury
5756257|NCT00296842|road traffic accident|road traffic accident
5756258|NCT00296829|Influenza;|influenza;
5756259|NCT00296829|Orthomyxoviruses;|orthomyxoviruses;
5756260|NCT00296829|Inactivated Split-virion influenza vaccine;|inactivated split-virion influenza vaccine;
5756261|NCT00296829|Elderly.|elderly.
5756262|NCT00296803|metabolic syndrome|metabolic syndrome
5756263|NCT00296777|Major Depression|major depression
5756264|NCT00296777|Dysthymia|dysthymia
5756265|NCT00296777|f-MRI|f-mri
5756266|NCT00296777|Escitalopram|escitalopram
5756267|NCT00296777|Bupropion|bupropion
5756269|NCT00296777|Neuropsychologic test|neuropsychologic test
5756270|NCT00296777|Dichotic listening|dichotic listening
5756271|NCT00296777|EEG|eeg
5756272|NCT00296777|ERP|erp
5756273|NCT00296764|Happy Puppet Syndrome|happy puppet syndrome
5756274|NCT00296764|Developmental Disorders|developmental disorders
5756275|NCT00296725|Major Depression|major depression
5756276|NCT00296725|Dysthymia|dysthymia
5756277|NCT00296725|Depression Not Otherwise Specified|depression not otherwise specified
5756278|NCT00296725|Dichotic Listening|dichotic listening
5756279|NCT00296725|Fluoxetine|fluoxetine
5756280|NCT00296725|Imipramine|imipramine
5756281|NCT00296725|Predictors|predictors
5756282|NCT00296712|Major Depression|major depression
5756283|NCT00296712|Dysthymia|dysthymia
5756284|NCT00296712|Depression NOS|depression nos
5756285|NCT00296712|Escitalopram|escitalopram
5756286|NCT00296712|Bupropion|bupropion
5756287|NCT00296712|Dual Therapy|dual therapy
5756288|NCT00296712|Combination Therapy|combination therapy
5756289|NCT00296699|Atypical Depression|atypical depression
5756290|NCT00296699|Major Depressive Disorder|major depressive disorder
5756291|NCT00296699|Dysthymic Disorder|dysthymic disorder
5756292|NCT00296699|Atypical Features|atypical features
5756293|NCT00296699|Duloxetine|duloxetine
5756294|NCT00296686|Major Depression|major depression
5756295|NCT00296686|Refractory Depression|refractory depression
5756296|NCT00296686|Tranylcypromine|tranylcypromine
5756297|NCT00296686|Dextroamphetamine|dextroamphetamine
5756298|NCT00296686|Triiodothyronine|triiodothyronine
5756299|NCT00296673|Rehabilitation, Side Bridge test, Muscular endurance|rehabilitation, side bridge test, muscular endurance
5756300|NCT00296660|Acute Infection|acute infection
5756301|NCT00296634|H5N1, Influenza, vaccine|h5n1, influenza, vaccine
5764268|NCT00266903|adult|adult
5756302|NCT00296621|glutamine|glutamine
5756303|NCT00296621|nutrition|nutrition
5756304|NCT00296621|children|children
5756305|NCT00296621|pediatrics|pediatrics
5756306|NCT00296621|randomized controlled clinical trial|randomized controlled clinical trial
5756307|NCT00296621|therapy|therapy
5756308|NCT00296621|supplement|supplement
5756309|NCT00296621|oral administration|oral administration
5756310|NCT00296621|handicap|handicap
5756311|NCT00296608|stage II rectal cancer|stage ii rectal cancer
5756312|NCT00296608|stage III rectal cancer|stage iii rectal cancer
5756313|NCT00296608|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5756314|NCT00296556|Ulcerative colitis|ulcerative colitis
5756315|NCT00296556|EP4 agonist|ep4 agonist
5756316|NCT00296556|PGE2|pge2
5756317|NCT00296543|hemodialysis|hemodialysis
5756318|NCT00296543|sudden cardiac death|sudden cardiac death
5756319|NCT00296530|Asthma|asthma
5756320|NCT00296530|Allergic Rhinitis|allergic rhinitis
5756322|NCT00296517|double-blind|double-blind
5756323|NCT00296517|placebo-controlled|placebo-controlled
5756324|NCT00296517|bupropion hydrochloride|bupropion hydrochloride
5756325|NCT00296517|SSRI|ssri
5756326|NCT00296517|comparative study|comparative study
5756327|NCT00296517|non-responder|non-responder
5756328|NCT00296504|antiretroviral therapy naive subjects|antiretroviral therapy naive subjects
5756329|NCT00296504|fosamprenavir|fosamprenavir
5756330|NCT00296504|HIV-1|hiv-1
5756331|NCT00296504|protease inhibitor|protease inhibitor
5756332|NCT00296504|pro-drug|pro-drug
5756333|NCT00296504|antiretroviral therapy|antiretroviral therapy
5756334|NCT00296504|LEXIVA|lexiva
5756335|NCT00296504|AGENERASE|agenerase
5756336|NCT00296504|GW433908|gw433908
5756337|NCT00296504|amprenavir|amprenavir
5756338|NCT00296491|Allergic Rhinitis|allergic rhinitis
5756339|NCT00296491|Asthma|asthma
5756340|NCT00296452|cancer|cancer
5756341|NCT00296452|nutrition|nutrition
5756342|NCT00296426|Adverse Drug Event|adverse drug event
5756343|NCT00296426|Inpatients|inpatients
5756344|NCT00296426|Outcome assessment|outcome assessment
5756345|NCT00296413|epilepsy|epilepsy
5756346|NCT00296413|menstrual cycle|menstrual cycle
5756347|NCT00296413|valproate|valproate
5756350|NCT00296400|Hyperlipidemia|hyperlipidemia
5756351|NCT00296400|Proteinuria|proteinuria
5756352|NCT00296400|Diabetes Mellitus|diabetes mellitus
5756353|NCT00296374|Hyperlipidemia|hyperlipidemia
5756354|NCT00296374|Proteinuria|proteinuria
5756355|NCT00296374|Diabetes Mellitus|diabetes mellitus
5756356|NCT00296361|Tacrolimus|tacrolimus
5756357|NCT00296361|Kidney Transplantation|kidney transplantation
5756358|NCT00296361|Immunosuppression|immunosuppression
5756359|NCT00296361|Adult|adult
5756360|NCT00296361|Treatment Outcomes|treatment outcomes
5756361|NCT00296348|Tacrolimus|tacrolimus
5756362|NCT00296348|Kidney Transplantation|kidney transplantation
5756363|NCT00296348|Child|child
5756364|NCT00296348|Treatment Outcome|treatment outcome
5756365|NCT00296348|Immunosuppression|immunosuppression
5756366|NCT00296335|Stomach cancer|stomach cancer
5756367|NCT00296335|Adjuvant chemotherapy|adjuvant chemotherapy
5756368|NCT00296335|Mitomycin|mitomycin
5756369|NCT00296335|Cisplatin|cisplatin
5756370|NCT00296335|Doxifluridine|doxifluridine
5756371|NCT00296322|stomach cancer|stomach cancer
5756920|NCT00295113|COPD|copd
5756372|NCT00296322|adjuvant chemotherapy|adjuvant chemotherapy
5756373|NCT00296322|mitomycin|mitomycin
5756374|NCT00296322|cisplatin|cisplatin
5756375|NCT00296322|doxifluridine|doxifluridine
5756376|NCT00296309|Tacrolimus|tacrolimus
5756377|NCT00296309|Kidney Transplantation|kidney transplantation
5756378|NCT00296309|Immunosuppression|immunosuppression
5756379|NCT00296309|Adult|adult
5756380|NCT00296309|Treatment Outcomes|treatment outcomes
5756381|NCT00296296|kidney Transplant|kidney transplant
5756382|NCT00296296|Type II Diabetes|type ii diabetes
5756383|NCT00296296|Diabetic Nephropathy|diabetic nephropathy
5756384|NCT00296296|Immunosuppression|immunosuppression
5756385|NCT00296296|Cyclosporin|cyclosporin
5756386|NCT00296296|Tacrolimus|tacrolimus
5756387|NCT00296283|Relatives|relatives
5756388|NCT00296283|Bipolar Disorder|bipolar disorder
5756389|NCT00296283|Psychoeducation|psychoeducation
5756390|NCT00296244|steroid-free immunosuppression|steroid-free immunosuppression
5756391|NCT00296244|liver transplantation|liver transplantation
5756392|NCT00296231|premature infants|premature infants
5756393|NCT00296231|very low birthweight infants|very low birthweight infants
5756394|NCT00296231|high frequency ventilation|high frequency ventilation
5756395|NCT00296231|nasal ventilation|nasal ventilation
5756396|NCT00296205|Multiple Sclerosis|multiple sclerosis
5756397|NCT00296205|Cyclophosphamide|cyclophosphamide
5756398|NCT00296205|autoimmune|autoimmune
5756399|NCT00296192|Rotigotine|rotigotine
5756400|NCT00296192|Rotigotine nasal spray|rotigotine nasal spray
5756401|NCT00296192|Efficacy, safety and tolerability|efficacy, safety and tolerability
5756402|NCT00296192|Parkinson's disease|parkinson's disease
5756403|NCT00296166|Atrial fibrillation|atrial fibrillation
5756404|NCT00296166|Permanent Atrial fibrillation|permanent atrial fibrillation
5756405|NCT00296166|catheter ablation|catheter ablation
5756406|NCT00296166|thoracoscopy|thoracoscopy
5756407|NCT00296166|Arrhythmia|arrhythmia
5756408|NCT00296166|Heart|heart
5756409|NCT00296153|Human immunodeficiency Virus (HIV)|human immunodeficiency virus (hiv)
5756410|NCT00296153|Highly Active Antiviral Therapy (HAART)|highly active antiviral therapy (haart)
5756411|NCT00296153|Ischemic Heart Disease|ischemic heart disease
5756412|NCT00296153|OMACOR|omacor
5756413|NCT00296153|Triglycerides|triglycerides
5756414|NCT00296153|Endothelial function|endothelial function
5756415|NCT00296153|Treatment Experienced|treatment experienced
5756416|NCT00296140|post-stroke depression|post-stroke depression
5756417|NCT00296140|clinical reminder|clinical reminder
5756418|NCT00296140|self-management|self-management
5756419|NCT00296114|Cancer|cancer
5756420|NCT00296114|Pancreas|pancreas
5756421|NCT00296101|Physical Inactivity|physical inactivity
5756422|NCT00296088|Mechanical Ventilation|mechanical ventilation
5756423|NCT00296088|Critical Care|critical care
5756424|NCT00296088|Respiratory Failure|respiratory failure
5756425|NCT00296062|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5756426|NCT00296062|stage III colon cancer|stage iii colon cancer
5756427|NCT00296062|stage IV colon cancer|stage iv colon cancer
5756428|NCT00296062|stage III rectal cancer|stage iii rectal cancer
5756429|NCT00296062|stage IV rectal cancer|stage iv rectal cancer
5756430|NCT00296062|recurrent colon cancer|recurrent colon cancer
5756431|NCT00296062|recurrent rectal cancer|recurrent rectal cancer
5756432|NCT00296049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5756433|NCT00296049|infection|infection
5756434|NCT00296049|neutropenia|neutropenia
5756435|NCT00296049|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5756436|NCT00296036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5756437|NCT00296036|stage I breast cancer|stage i breast cancer
5756438|NCT00296036|stage II breast cancer|stage ii breast cancer
5756439|NCT00296036|stage IIIA breast cancer|stage iiia breast cancer
5756440|NCT00296036|stage IIIB breast cancer|stage iiib breast cancer
5756442|NCT00296036|stage IV breast cancer|stage iv breast cancer
5756443|NCT00296036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5756444|NCT00296023|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5756445|NCT00296023|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5756446|NCT00296023|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5756447|NCT00296023|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5756448|NCT00296023|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5756449|NCT00296023|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5756450|NCT00296023|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5756451|NCT00296023|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5756452|NCT00296023|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5756453|NCT00296023|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5756454|NCT00296023|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5756455|NCT00296023|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5756456|NCT00296023|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5756457|NCT00296023|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5756458|NCT00296023|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5756459|NCT00296023|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5756460|NCT00296023|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5756461|NCT00296023|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5756462|NCT00296023|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5756463|NCT00296023|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5756464|NCT00296023|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5756465|NCT00296023|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5756466|NCT00296023|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5756467|NCT00296023|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5756468|NCT00296023|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5756469|NCT00296023|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5756470|NCT00296023|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5756471|NCT00296023|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5756472|NCT00296023|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5756473|NCT00296023|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5756474|NCT00296023|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5756475|NCT00296023|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5756476|NCT00296023|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5756477|NCT00296023|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5756478|NCT00296023|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5756479|NCT00296023|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5756480|NCT00296023|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5756481|NCT00296023|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5862880|NCT00001473|Toxicity|toxicity
5681018|NCT00575172|type2 diabetes mellitus|type2 diabetes mellitus
5681019|NCT00575172|cardiovascular disease|cardiovascular disease
5756482|NCT00296023|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5756483|NCT00296023|stage II multiple myeloma|stage ii multiple myeloma
5756484|NCT00296023|stage III multiple myeloma|stage iii multiple myeloma
5756485|NCT00296023|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5756486|NCT00296023|primary myelofibrosis|primary myelofibrosis
5756487|NCT00296023|polycythemia vera|polycythemia vera
5756488|NCT00296023|prolymphocytic leukemia|prolymphocytic leukemia
5756489|NCT00296023|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5756490|NCT00296023|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5756491|NCT00296023|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5756492|NCT00296023|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5756493|NCT00296023|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5756494|NCT00296023|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5756495|NCT00296023|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5756496|NCT00296023|refractory anemia with excess blasts|refractory anemia with excess blasts
5756497|NCT00296023|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5756802|NCT00295607|Immunosuppression|immunosuppression
5756498|NCT00296023|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5756499|NCT00296023|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5756500|NCT00296023|Waldenström macroglobulinemia|waldenström macroglobulinemia
5756501|NCT00296023|essential thrombocythemia|essential thrombocythemia
5756502|NCT00296023|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5756503|NCT00296023|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5756504|NCT00296023|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5756505|NCT00296023|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5756506|NCT00296023|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5756507|NCT00296023|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5756508|NCT00296023|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5756509|NCT00296023|stage I multiple myeloma|stage i multiple myeloma
5756510|NCT00296010|stage I breast cancer|stage i breast cancer
5756511|NCT00296010|stage II breast cancer|stage ii breast cancer
5756512|NCT00296010|stage IIIA breast cancer|stage iiia breast cancer
5756513|NCT00295997|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5756514|NCT00295997|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5756515|NCT00295997|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5756516|NCT00295997|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5756517|NCT00295997|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5756518|NCT00295997|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5756519|NCT00295997|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5756520|NCT00295997|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5756521|NCT00295997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5756522|NCT00295997|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5756523|NCT00295997|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5756524|NCT00295997|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5756525|NCT00295997|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5756526|NCT00295997|primary myelofibrosis|primary myelofibrosis
5756527|NCT00295997|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5756528|NCT00295997|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5756529|NCT00295997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5756530|NCT00295997|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5756531|NCT00295997|essential thrombocythemia|essential thrombocythemia
5756532|NCT00295997|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5756533|NCT00295997|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5756534|NCT00295997|polycythemia vera|polycythemia vera
5756535|NCT00295997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5756536|NCT00295997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5756537|NCT00295997|prolymphocytic leukemia|prolymphocytic leukemia
5756538|NCT00295997|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5756539|NCT00295997|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5756540|NCT00295997|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5756541|NCT00295997|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5756542|NCT00295997|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5756543|NCT00295997|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5756544|NCT00295997|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5756545|NCT00295997|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5756546|NCT00295997|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5756547|NCT00295997|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5756548|NCT00295997|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5756549|NCT00295997|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5756550|NCT00295997|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5756551|NCT00295997|refractory multiple myeloma|refractory multiple myeloma
5756552|NCT00295997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5756553|NCT00295997|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5756554|NCT00295997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5756555|NCT00295997|stage II multiple myeloma|stage ii multiple myeloma
5756556|NCT00295997|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5756557|NCT00295997|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5756777|NCT00295685|Reflux|reflux
5756558|NCT00295997|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5756559|NCT00295997|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5756560|NCT00295997|stage III multiple myeloma|stage iii multiple myeloma
5756561|NCT00295997|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5751823|NCT00313066|FGF|fgf
5756562|NCT00295997|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5756563|NCT00295997|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5756564|NCT00295997|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5756565|NCT00295997|recurrent renal cell cancer|recurrent renal cell cancer
5756566|NCT00295997|stage IV renal cell cancer|stage iv renal cell cancer
5756567|NCT00295997|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5756568|NCT00295997|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5756569|NCT00295997|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5756570|NCT00295997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5756571|NCT00295997|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5756572|NCT00295984|classic Kaposi sarcoma|classic kaposi sarcoma
5756573|NCT00295984|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5756574|NCT00295971|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5756575|NCT00295971|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5756576|NCT00295971|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5756577|NCT00295971|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5756578|NCT00295971|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5756579|NCT00295971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5756580|NCT00295971|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5756581|NCT00295971|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5756582|NCT00295971|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5756583|NCT00295971|refractory anemia with excess blasts|refractory anemia with excess blasts
5757029|NCT00294658|thymoma|thymoma
5756584|NCT00295971|severe congenital neutropenia|severe congenital neutropenia
5756585|NCT00295971|congenital amegakaryocytic thrombocytopenia|congenital amegakaryocytic thrombocytopenia
5756586|NCT00295971|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5756587|NCT00295971|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5756588|NCT00295958|recurrent melanoma|recurrent melanoma
5756589|NCT00295958|stage IV melanoma|stage iv melanoma
5756590|NCT00295958|skin cancer|skin cancer
5756591|NCT00295945|pain|pain
5756803|NCT00295607|Adult|adult
5756592|NCT00295945|perioperative/postoperative complications|perioperative/postoperative complications
5756593|NCT00295945|stage III cervical cancer|stage iii cervical cancer
5756594|NCT00295945|recurrent cervical cancer|recurrent cervical cancer
5756595|NCT00295945|stage IB cervical cancer|stage ib cervical cancer
5756596|NCT00295945|stage IIB cervical cancer|stage iib cervical cancer
5756597|NCT00295945|stage IVB cervical cancer|stage ivb cervical cancer
5756598|NCT00295945|stage IA cervical cancer|stage ia cervical cancer
5756599|NCT00295945|stage IIA cervical cancer|stage iia cervical cancer
5756600|NCT00295945|stage IVA cervical cancer|stage iva cervical cancer
5756601|NCT00295945|stage I endometrial carcinoma|stage i endometrial carcinoma
5756602|NCT00295945|stage II endometrial carcinoma|stage ii endometrial carcinoma
5756603|NCT00295945|stage III endometrial carcinoma|stage iii endometrial carcinoma
5686317|NCT00552591|prevention of CHD|prevention of chd
5686318|NCT00552591|health care costs|health care costs
5756604|NCT00295945|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5756605|NCT00295945|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5756606|NCT00295945|stage I uterine sarcoma|stage i uterine sarcoma
5756607|NCT00295945|stage II uterine sarcoma|stage ii uterine sarcoma
5862881|NCT00001473|ANCA|anca
5756608|NCT00295945|stage III uterine sarcoma|stage iii uterine sarcoma
5756609|NCT00295945|stage IV uterine sarcoma|stage iv uterine sarcoma
5756610|NCT00295945|recurrent uterine sarcoma|recurrent uterine sarcoma
5756611|NCT00295945|ovarian sarcoma|ovarian sarcoma
5756612|NCT00295945|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5756613|NCT00295945|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5756614|NCT00295945|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5756615|NCT00295945|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5756616|NCT00295945|ovarian stromal cancer|ovarian stromal cancer
5756618|NCT00295945|stage IA fallopian tube cancer|stage ia fallopian tube cancer
5756619|NCT00295945|stage IB fallopian tube cancer|stage ib fallopian tube cancer
5756620|NCT00295945|stage IC fallopian tube cancer|stage ic fallopian tube cancer
5756621|NCT00295945|stage IIA fallopian tube cancer|stage iia fallopian tube cancer
5756622|NCT00295945|stage IIB fallopian tube cancer|stage iib fallopian tube cancer
5756623|NCT00295945|stage IIC fallopian tube cancer|stage iic fallopian tube cancer
5756624|NCT00295945|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5756625|NCT00295945|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5756626|NCT00295945|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5756627|NCT00295945|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5756628|NCT00295945|stage IA ovarian epithelial cancer|stage ia ovarian epithelial cancer
5756629|NCT00295945|stage IB ovarian epithelial cancer|stage ib ovarian epithelial cancer
5756630|NCT00295945|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5756631|NCT00295945|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5756632|NCT00295945|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5756633|NCT00295945|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5756634|NCT00295945|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5756635|NCT00295945|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5756636|NCT00295945|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5756637|NCT00295945|stage IA ovarian germ cell tumor|stage ia ovarian germ cell tumor
5756638|NCT00295945|stage IB ovarian germ cell tumor|stage ib ovarian germ cell tumor
5756639|NCT00295945|stage IC ovarian germ cell tumor|stage ic ovarian germ cell tumor
5756640|NCT00295945|stage IIA ovarian germ cell tumor|stage iia ovarian germ cell tumor
5756641|NCT00295945|stage IIB ovarian germ cell tumor|stage iib ovarian germ cell tumor
5756642|NCT00295945|stage IIC ovarian germ cell tumor|stage iic ovarian germ cell tumor
5756643|NCT00295945|stage IIIA ovarian germ cell tumor|stage iiia ovarian germ cell tumor
5756644|NCT00295945|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5756645|NCT00295945|stage IIIC ovarian germ cell tumor|stage iiic ovarian germ cell tumor
5756646|NCT00295932|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5756647|NCT00295932|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5756648|NCT00295932|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5756649|NCT00295932|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5756650|NCT00295932|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5756651|NCT00295932|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5756652|NCT00295932|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5756653|NCT00295932|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5756654|NCT00295932|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5756655|NCT00295932|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5756656|NCT00295932|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5756657|NCT00295932|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5756658|NCT00295919|recurrent neuroblastoma|recurrent neuroblastoma
5756659|NCT00295906|melanoma|melanoma
5756660|NCT00295906|skin cancer|skin cancer
5756661|NCT00295893|inflammatory breast cancer|inflammatory breast cancer
5756662|NCT00295893|stage II breast cancer|stage ii breast cancer
5756663|NCT00295893|stage IIIA breast cancer|stage iiia breast cancer
5756664|NCT00295893|stage IIIB breast cancer|stage iiib breast cancer
5756665|NCT00295893|stage IIIC breast cancer|stage iiic breast cancer
5756666|NCT00295893|male breast cancer|male breast cancer
5756667|NCT00295893|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5756668|NCT00295893|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5756669|NCT00295893|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5756670|NCT00295893|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5756671|NCT00295893|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5756672|NCT00295893|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5756673|NCT00295893|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5756674|NCT00295893|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5756675|NCT00295893|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5756676|NCT00295893|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5756677|NCT00295880|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5756678|NCT00295880|adult acute myeloid leukemia|adult acute myeloid leukemia
5756679|NCT00295880|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5756680|NCT00295880|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5756681|NCT00295880|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5756682|NCT00295880|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5756683|NCT00295880|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5756684|NCT00295880|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5756685|NCT00295880|refractory anemia with excess blasts|refractory anemia with excess blasts
5756686|NCT00295880|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5756687|NCT00295880|myelodysplastic syndromes|myelodysplastic syndromes
5756688|NCT00295880|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5756689|NCT00295880|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5756690|NCT00295880|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5756691|NCT00295880|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5756692|NCT00295880|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5756693|NCT00295880|mantle cell lymphoma|mantle cell lymphoma
5756694|NCT00295880|childhood large cell lymphoma|childhood large cell lymphoma
5756695|NCT00295880|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5756696|NCT00295880|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5756697|NCT00295880|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5756698|NCT00295880|refractory anemia|refractory anemia
5756699|NCT00295880|refractory cytopenia|refractory cytopenia
5756700|NCT00295880|childhood acute myeloid leukemia|childhood acute myeloid leukemia
5756701|NCT00295880|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5756702|NCT00295880|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5756703|NCT00295880|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5756704|NCT00295880|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5756705|NCT00295880|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5756706|NCT00295880|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5756707|NCT00295867|stage I breast cancer|stage i breast cancer
5756708|NCT00295867|stage II breast cancer|stage ii breast cancer
5756709|NCT00295867|stage IIIA breast cancer|stage iiia breast cancer
5756710|NCT00295867|stage IIIB breast cancer|stage iiib breast cancer
5756711|NCT00295867|stage IIIC breast cancer|stage iiic breast cancer
5756712|NCT00295854|Interstitial Cystitis|interstitial cystitis
5756715|NCT00295854|MN-001|mn-001
5756716|NCT00295854|Global Response Assessment|global response assessment
5756717|NCT00295854|bladder pain/urgency|bladder pain/urgency
5756718|NCT00295854|O'Leary Sant IC Symptom and Problem Index|o'leary sant ic symptom and problem index
5756719|NCT00295841|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5756720|NCT00295841|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5756721|NCT00295841|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5756722|NCT00295841|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5756723|NCT00295841|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5848596|NCT00034229|Treatment-Resistant|treatment-resistant
5756724|NCT00295841|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5756725|NCT00295841|adult acute basophilic leukemia|adult acute basophilic leukemia
5756726|NCT00295841|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5756727|NCT00295841|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5757030|NCT00294645|Remote Follow Up|remote follow up
5756728|NCT00295841|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5756729|NCT00295841|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5756730|NCT00295841|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5756731|NCT00295841|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5756732|NCT00295841|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5756733|NCT00295841|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5756734|NCT00295841|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5756735|NCT00295841|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5756736|NCT00295828|VEGF|vegf
5756737|NCT00295828|iris neovascularization|iris neovascularization
5756738|NCT00295828|diabetic retinopathy|diabetic retinopathy
5756739|NCT00295828|Macugen|macugen
5756740|NCT00295802|Prostate Cancer|prostate cancer
5756741|NCT00295802|HIFU|hifu
5756742|NCT00295802|EDAP|edap
5756743|NCT00295802|Low Risk, Localized Prostate Cancer|low risk, localized prostate cancer
5756744|NCT00295789|cervical cancer|cervical cancer
5756745|NCT00295789|palliative chemotherapy|palliative chemotherapy
5756746|NCT00295789|recurrent|recurrent
5756747|NCT00295789|persistent|persistent
5756748|NCT00295789|stageⅣb|stageⅳb
5756749|NCT00295789|cisplatin|cisplatin
5756750|NCT00295789|carboplatin|carboplatin
5756751|NCT00295789|paclitaxel|paclitaxel
5756752|NCT00295776|Inclusion Criteria:Minimum of 4 on the Likert Pain Scale.If currently taking TCA and/or Gabapentin, need to have been on stable dose for minimum of 4 weeks.|inclusion criteria:minimum of 4 on the likert pain scale.if currently taking tca and/or gabapentin, need to have been on stable dose for minimum of 4 weeks.
5756753|NCT00295776|Exclusion Criteria:|exclusion criteria:
5756754|NCT00295776|Currently on any antiepilepic drugs (AED), except for Gabapentin.|currently on any antiepilepic drugs (aed), except for gabapentin.
5756755|NCT00295776|Currently taking opioid or unwilling to washout prior to the study,|currently taking opioid or unwilling to washout prior to the study,
5756756|NCT00295776|Pregnant and lactating,|pregnant and lactating,
5756757|NCT00295776|Have active severe systemic disease,|have active severe systemic disease,
5756758|NCT00295776|History of Stevens-Johnson syndrome or TEN,|history of stevens-johnson syndrome or ten,
5756759|NCT00295763|papillary thyroid cancer|papillary thyroid cancer
5756760|NCT00295763|follicular thyroid cancer|follicular thyroid cancer
5756761|NCT00295763|recombinant human TSH|recombinant human tsh
5756762|NCT00295763|Thyrogen|thyrogen
5756763|NCT00295763|thyroid stimulating hormone|thyroid stimulating hormone
5756764|NCT00295763|thyroid remnant ablation|thyroid remnant ablation
5756765|NCT00295763|radioiodine|radioiodine
5756766|NCT00295750|Prostate Cancer|prostate cancer
5756767|NCT00295737|allergic rhinitis|allergic rhinitis
5756768|NCT00295724|bicifadine|bicifadine
5756769|NCT00295724|chronic low back pain|chronic low back pain
5756770|NCT00295711|bicifadine|bicifadine
5756771|NCT00295711|chronic low back pain|chronic low back pain
5756773|NCT00295698|Lymphatic filariasis|lymphatic filariasis
5756774|NCT00295698|Diethylcarbamazine|diethylcarbamazine
5756775|NCT00295698|Interaction|interaction
5756776|NCT00295698|Tanzania|tanzania
5756778|NCT00295685|GERD|gerd
5756779|NCT00295672|Non-Small-Cell Lung,radiotherapy, Chemotherapy, vinorelbine|non-small-cell lung,radiotherapy, chemotherapy, vinorelbine
5756780|NCT00295659|Gestational Diabetes|gestational diabetes
5756781|NCT00295659|Screening|screening
5756782|NCT00295659|Cost-effectiveness|cost-effectiveness
5756783|NCT00295659|obstetrical outcomes|obstetrical outcomes
5756784|NCT00295646|Austrian Breast & Colorectal Cancer Study Group (ABCSG)|austrian breast & colorectal cancer study group (abcsg)
5756786|NCT00295646|Phase 3|phase 3
5756787|NCT00295646|breast cancer|breast cancer
5756788|NCT00295646|anastrozole|anastrozole
5756789|NCT00295646|tamoxifen|tamoxifen
5756790|NCT00295646|zoledronic acid|zoledronic acid
5756791|NCT00295646|premenopausal|premenopausal
5756792|NCT00295646|hormone receptor-positive|hormone receptor-positive
5756793|NCT00295646|Stage I|stage i
5756794|NCT00295646|Stage II|stage ii
5756795|NCT00295646|bone mineral density|bone mineral density
5756797|NCT00295646|bisphosphonate|bisphosphonate
5756798|NCT00295646|zoledronate|zoledronate
5756799|NCT00295620|Hormone receptor positive breast cancer|hormone receptor positive breast cancer
5756800|NCT00295607|Tacrolimus|tacrolimus
5756801|NCT00295607|Liver Transplantation|liver transplantation
5756804|NCT00295607|Treatment Outcome|treatment outcome
5756805|NCT00295594|Tacrolimus|tacrolimus
5756806|NCT00295594|Liver Transplantation|liver transplantation
5756807|NCT00295594|Treatment Outcome|treatment outcome
5756808|NCT00295594|Immunosuppression|immunosuppression
5756809|NCT00295581|Human|human
5756810|NCT00295581|Clinical Trial|clinical trial
5756811|NCT00295581|Mosquito|mosquito
5772931|NCT00231764|GFR|gfr
5756812|NCT00295581|Healthy Volunteer|healthy volunteer
5756813|NCT00295581|HV|hv
5756814|NCT00295568|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5756815|NCT00295568|Motor Learning|motor learning
5756816|NCT00295568|Accuracy|accuracy
5756817|NCT00295568|Tracking Motor Task|tracking motor task
5756818|NCT00295568|Healthy Volunteer|healthy volunteer
5756819|NCT00295568|HV|hv
5756820|NCT00295555|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5756821|NCT00295555|doxazosin|doxazosin
5756822|NCT00295555|alpha1-adrenergic antagonists|alpha1-adrenergic antagonists
5756823|NCT00295555|sympathetic nervous activity|sympathetic nervous activity
5756824|NCT00295555|diabetic nephropathy|diabetic nephropathy
5756825|NCT00295555|essential hypertension|essential hypertension
5756826|NCT00295555|power spectral analysis|power spectral analysis
5756827|NCT00295555|morning surge|morning surge
5756828|NCT00295542|ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5756829|NCT00295542|cardiovascular risk|cardiovascular risk
5756830|NCT00295542|chronotherapy|chronotherapy
5756831|NCT00295542|circadian pattern|circadian pattern
5756832|NCT00295529|Primary health care|primary health care
5756833|NCT00295529|Breast neoplasm|breast neoplasm
5756834|NCT00295529|Education|education
5756835|NCT00295516|Rhesus|rhesus
5756836|NCT00295516|Isoimmunization|isoimmunization
5756837|NCT00295516|Red Cell Alloimmunization|red cell alloimmunization
5756838|NCT00295516|Fetal Hemolytic Anemia|fetal hemolytic anemia
5756839|NCT00295516|Erythroblastosis fetalis|erythroblastosis fetalis
5756840|NCT00295503|mesothelioma|mesothelioma
5756841|NCT00295503|bevacizumab|bevacizumab
5756842|NCT00295503|chemotherapy|chemotherapy
5756843|NCT00295490|double blind randomised controlled trial|double blind randomised controlled trial
5756844|NCT00295490|phase II|phase ii
5765865|NCT00260143|HIV+ men|hiv+ men
5756845|NCT00295490|Devil's Claw|devil's claw
5756846|NCT00295490|osteoarthritis of the knee|osteoarthritis of the knee
5756847|NCT00295490|osteoarthritis of the hip|osteoarthritis of the hip
5756848|NCT00295477|HIV|hiv
5756849|NCT00295477|Treatment Experienced|treatment experienced
5756850|NCT00295464|Antenatal glucocorticoid|antenatal glucocorticoid
5756851|NCT00295464|Premature birth|premature birth
5756852|NCT00295438|robot-based tele-echography|robot-based tele-echography
5756854|NCT00295425|psoriasis|psoriasis
5756855|NCT00295425|randomized clinical trial|randomized clinical trial
5756856|NCT00295425|cyclosporine A|cyclosporine a
5756857|NCT00295425|mycophenolate mofetil|mycophenolate mofetil
5756858|NCT00295425|immunosuppression|immunosuppression
5756859|NCT00295399|cerebrovascular accident|cerebrovascular accident
5756860|NCT00295399|traumatic brain injury|traumatic brain injury
5756861|NCT00295399|stroke|stroke
5756862|NCT00295399|telerehabilitation|telerehabilitation
5756863|NCT00295373|Hypercholesterolemia|hypercholesterolemia
5756864|NCT00295373|Exercise|exercise
5756865|NCT00295373|Statin|statin
5756866|NCT00295373|Rosuvastatin|rosuvastatin
5756867|NCT00295373|TLR4|tlr4
5756868|NCT00295373|Inflammation|inflammation
5756869|NCT00295360|cholestasis|cholestasis
5756870|NCT00295360|BCRP|bcrp
5756871|NCT00295360|multidrug resistance|multidrug resistance
5756872|NCT00295360|duodenum|duodenum
5756873|NCT00295360|bile acids|bile acids
5756874|NCT00295360|ABCG2|abcg2
5756875|NCT00295334|adherence|adherence
5756876|NCT00295334|glycemic control|glycemic control
5756877|NCT00295308|Opioid Dependence|opioid dependence
5756879|NCT00295308|Buprenorphine|buprenorphine
5756880|NCT00295308|Opioid Abstinence|opioid abstinence
5756881|NCT00295308|Relapse|relapse
5756882|NCT00295295|vibration|vibration
5756883|NCT00295295|bone density|bone density
5756884|NCT00295282|Ulcerative Colitis|ulcerative colitis
5756885|NCT00295282|UC|uc
5756886|NCT00295282|Colitis|colitis
5756887|NCT00295256|randomized trial|randomized trial
5756888|NCT00295256|diabetes|diabetes
5756889|NCT00295256|pregnancy|pregnancy
5756890|NCT00295230|respiratory distress syndrome|respiratory distress syndrome
5756891|NCT00295230|very low birth weight infant|very low birth weight infant
5756892|NCT00295230|mechanical ventilation|mechanical ventilation
5756893|NCT00295217|Fibroids|fibroids
5756894|NCT00295217|Uterine Leiomyomas|uterine leiomyomas
5756895|NCT00295217|ExAblate|exablate
5756896|NCT00295217|MrgFUS|mrgfus
5756897|NCT00295204|Syncope|syncope
5756898|NCT00295204|pre-syncope|pre-syncope
5756899|NCT00295204|palpitations|palpitations
5756900|NCT00295191|end-stage renal disease|end-stage renal disease
5756901|NCT00295191|hemodialysis|hemodialysis
5756902|NCT00295191|cardiovascular morbidity and mortality|cardiovascular morbidity and mortality
5756903|NCT00295191|high flux dialyser|high flux dialyser
5756904|NCT00295191|ultrapure dialysate|ultrapure dialysate
5756905|NCT00295191|coronary vascular calcifications|coronary vascular calcifications
5756906|NCT00295191|carotid intima-media thickness|carotid intima-media thickness
5756907|NCT00295191|atherosclerosis|atherosclerosis
5756908|NCT00295152|elderly/aged|elderly/aged
5756909|NCT00295152|occupational therapy|occupational therapy
5756910|NCT00295152|daily activities|daily activities
5756911|NCT00295152|caregivers|caregivers
5756912|NCT00295152|sense of competence|sense of competence
5756913|NCT00295139|treatment|treatment
5756914|NCT00295139|dual diagnosis|dual diagnosis
5756915|NCT00295126|Edentulous|edentulous
5756916|NCT00295126|Tooth Loss|tooth loss
5756917|NCT00295126|APC|apc
5756918|NCT00295126|Autologous platelet concentrate|autologous platelet concentrate
5756919|NCT00295113|Pulmonary arterial pressure|pulmonary arterial pressure
5756922|NCT00295113|pulmonary and cardiac functions|pulmonary and cardiac functions
5756923|NCT00295113|pulmonary arterial pressure measurements|pulmonary arterial pressure measurements
5756924|NCT00295100|Tamoxifen|tamoxifen
5756925|NCT00295100|Prevention|prevention
5756926|NCT00295100|Breast Cancer|breast cancer
5756927|NCT00295100|MRI|mri
5756928|NCT00295087|Premature Ovarian Failure|premature ovarian failure
5756929|NCT00295087|X-Chromosome Inactivation|x-chromosome inactivation
5756930|NCT00295074|traumatic brain injury|traumatic brain injury
5756931|NCT00295074|head injury|head injury
5756932|NCT00295074|concussion|concussion
5756933|NCT00295074|neuropsychologic test|neuropsychologic test
5756934|NCT00295061|alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5756935|NCT00295061|alpha 1-Antitrypsin|alpha 1-antitrypsin
5756936|NCT00295061|pulmonary emphysema|pulmonary emphysema
5756937|NCT00295048|treatment|treatment
5756938|NCT00295048|cognition|cognition
5756939|NCT00295048|schizophrenia|schizophrenia
5756940|NCT00295022|Levocetirizine|levocetirizine
5756941|NCT00295022|Xyzal|xyzal
5756942|NCT00295022|Rhinitis|rhinitis
5756943|NCT00295022|Allergic|allergic
5756944|NCT00295022|Seasonal|seasonal
5756945|NCT00295022|Ragweed|ragweed
5756946|NCT00294996|Metastatic Her2+ Breast cancer|metastatic her2+ breast cancer
5756947|NCT00294996|Myocet|myocet
5765976|NCT00259610|RA|ra
5756948|NCT00294996|liposomal doxorubicin|liposomal doxorubicin
5756949|NCT00294996|trastuzumab|trastuzumab
5756950|NCT00294931|Lung Cancer, Small Cell|lung cancer, small cell
5756951|NCT00294931|Extensive|extensive
5756952|NCT00294918|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
5756953|NCT00294918|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5756954|NCT00294918|Serostim®|serostim®
5756955|NCT00294918|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5756956|NCT00294905|COPD|copd
5756957|NCT00294905|smoking cessation|smoking cessation
5756958|NCT00294905|implementation|implementation
5756959|NCT00294905|patient counseling|patient counseling
5756960|NCT00294905|general practice|general practice
5756961|NCT00294892|HIV|hiv
5756962|NCT00294892|mother to child transmission; MTCT|mother to child transmission; mtct
5756963|NCT00294892|nevirapine resistance|nevirapine resistance
5756964|NCT00294892|pharmacokinetics|pharmacokinetics
5756965|NCT00294892|Treatment Naive|treatment naive
5756966|NCT00294866|End Stage Renal Disease|end stage renal disease
5756967|NCT00294866|Inflammation|inflammation
5756968|NCT00294853|Coronary calcium score|coronary calcium score
5756969|NCT00294853|Coronary artery disease|coronary artery disease
5756970|NCT00294853|Cardiac transplantation|cardiac transplantation
5756971|NCT00294853|Coronary calcium score in heart transplanted patients|coronary calcium score in heart transplanted patients
5756972|NCT00294853|Coronary artery disease in heart transplanted patients|coronary artery disease in heart transplanted patients
5756973|NCT00294827|Liver transplantation|liver transplantation
5756974|NCT00294814|Cardiac Surgery|cardiac surgery
5756985|NCT00294788|probiotic|probiotic
5756986|NCT00294788|HAI|hai
5756987|NCT00294788|immunity|immunity
5756988|NCT00294788|vaccine|vaccine
5756989|NCT00294788|Immune response to influenza vaccine|immune response to influenza vaccine
5756990|NCT00294775|diastolic dysfunction|diastolic dysfunction
5756991|NCT00294775|Reverse Remodelling|reverse remodelling
5756992|NCT00294762|NSCLC|nsclc
5756993|NCT00294762|Erlotinib|erlotinib
5756994|NCT00294762|Tarceva|tarceva
5756995|NCT00294762|Lung Cancer|lung cancer
5756996|NCT00294749|Prostate,|prostate,
5756997|NCT00294749|Infection,|infection,
5756998|NCT00294749|Biopsy,|biopsy,
5756999|NCT00294749|Antibiotic,|antibiotic,
5757000|NCT00294749|Prophylaxis|prophylaxis
5757001|NCT00294736|lung cancer|lung cancer
5757002|NCT00294736|erlotinib|erlotinib
5757003|NCT00294736|NSCLC|nsclc
5757004|NCT00294736|smokers|smokers
5757005|NCT00294710|Hypertension, aliskiren, hydrochlorothiazide, amlodipine|hypertension, aliskiren, hydrochlorothiazide, amlodipine
5757006|NCT00294697|polymorphisms|polymorphisms
5757007|NCT00294697|innate immune response|innate immune response
5757008|NCT00294697|immunomonitoring|immunomonitoring
5757009|NCT00294697|immuno paralysis|immuno paralysis
5757010|NCT00294684|biliary atresia|biliary atresia
5757011|NCT00294684|hepatoportoenterostomy|hepatoportoenterostomy
5757012|NCT00294684|corticosteroids|corticosteroids
5757013|NCT00294671|familial amyloid polyneuropathy|familial amyloid polyneuropathy
5757014|NCT00294671|familial amyloidosis|familial amyloidosis
5757015|NCT00294671|diflunisal|diflunisal
5757016|NCT00294671|amyloidosis|amyloidosis
5757017|NCT00294671|transthyretin|transthyretin
5757018|NCT00294671|peripheral neuropathy|peripheral neuropathy
5757019|NCT00294671|autonomic neuropathy|autonomic neuropathy
5757020|NCT00294671|amyloid cardiomyopathy|amyloid cardiomyopathy
5757021|NCT00294658|myasthenia gravis|myasthenia gravis
5757022|NCT00294658|thymectomy|thymectomy
5757023|NCT00294658|prednisone|prednisone
5757024|NCT00294658|corticosteroid|corticosteroid
5757025|NCT00294658|extended transsternal thymectomy|extended transsternal thymectomy
5757026|NCT00294658|ETTX|ettx
5757027|NCT00294658|MG|mg
5757028|NCT00294658|thymus|thymus
5757044|NCT00294619|Growth hormone deficiency|growth hormone deficiency
5757045|NCT00294606|vasopressor agents|vasopressor agents
5757046|NCT00294606|carotid endarterectomy|carotid endarterectomy
5757047|NCT00294606|cardiac function|cardiac function
5757048|NCT00294606|transesophageal echocardiography|transesophageal echocardiography
5757049|NCT00294606|wall motion abnormalities|wall motion abnormalities
5757050|NCT00294593|Down syndrome|down syndrome
5757051|NCT00294593|folinic acid therapy|folinic acid therapy
5757052|NCT00294593|cognitive functions|cognitive functions
5757053|NCT00294580|Malaria|malaria
5757054|NCT00294580|Cognition|cognition
5757055|NCT00294580|Prevention & control|prevention & control
5757056|NCT00294580|Anemia|anemia
5757057|NCT00294580|Chemoprophylaxis|chemoprophylaxis
5757058|NCT00294580|Mortality|mortality
5757059|NCT00294580|Children|children
5757060|NCT00294580|Randomized controlled trial|randomized controlled trial
5757061|NCT00294580|Education|education
5757062|NCT00294580|Long-term effects|long-term effects
5757063|NCT00294580|The Gambia|the gambia
5686319|NCT00552578|drug dependence|drug dependence
5757064|NCT00294580|Africa, West|africa, west
5757065|NCT00294567|Hypertension|hypertension
5757066|NCT00294567|PCI|pci
5757067|NCT00294567|Calcium Channel Blockers|calcium channel blockers
5757068|NCT00294567|IVUS|ivus
5757069|NCT00294567|Plaque|plaque
5757070|NCT00294554|Parkinson's Disease|parkinson's disease
5757071|NCT00294554|Cognitive Impairment|cognitive impairment
5757072|NCT00294554|Dementia|dementia
5757073|NCT00294554|Memory|memory
5757074|NCT00294541|sickle cell disease|sickle cell disease
5757075|NCT00294541|sickle cell anemia|sickle cell anemia
5757076|NCT00294528|osteoarthritis, knee|osteoarthritis, knee
5757077|NCT00294528|total knee arthroplasty|total knee arthroplasty
5757078|NCT00294528|range of motion|range of motion
5757079|NCT00294528|satisfaction|satisfaction
5757081|NCT00294489|Fibrosis|fibrosis
5757082|NCT00294489|Breath test|breath test
5757083|NCT00294476|IVIg|ivig
5757084|NCT00294476|Cancer|cancer
5757085|NCT00294476|Melanoma|melanoma
5757086|NCT00294463|postmenopause|postmenopause
5757087|NCT00294463|endometrium|endometrium
5757088|NCT00294463|Gene Expression Profiling|gene expression profiling
5757089|NCT00294463|Histology, Comparative|histology, comparative
5757090|NCT00294463|Hormone Replacement Therapy|hormone replacement therapy
5757091|NCT00294463|Hormones|hormones
5757092|NCT00294437|Prostate Cancer|prostate cancer
5757093|NCT00294437|Zometa|zometa
5757094|NCT00294424|Waiting time|waiting time
5757095|NCT00294424|Total hip replacement|total hip replacement
5757096|NCT00294424|Total knee replacement|total knee replacement
5757097|NCT00294424|Quality of life|quality of life
5757098|NCT00294424|The15D|the15d
5757099|NCT00294424|Harris Hip Score|harris hip score
5757100|NCT00294424|Knee Score|knee score
5757101|NCT00294424|Pain measurement|pain measurement
5757102|NCT00294424|Cost-effectiveness|cost-effectiveness
5757103|NCT00294424|Medication|medication
5757106|NCT00294424|Randomized Controlled Trial|randomized controlled trial
5757107|NCT00294398|Asthma, Controller Medications|asthma, controller medications
5757108|NCT00294385|Breast Cancer|breast cancer
5757109|NCT00294385|Docetaxel|docetaxel
5757110|NCT00294359|colorectal neoplasm|colorectal neoplasm
5757111|NCT00294346|Social Anxiety Disorder|social anxiety disorder
5757112|NCT00294346|Social Phobia|social phobia
5757113|NCT00294320|Aldara|aldara
5757114|NCT00294320|Actinic Keratosis|actinic keratosis
5757115|NCT00294307|Nursing Models of Care|nursing models of care
5757116|NCT00294307|Collaborative Care|collaborative care
5757117|NCT00294307|Care Management|care management
5757118|NCT00294307|Transitional Care|transitional care
5757119|NCT00294307|Advanced Practice Nurse Care Interventions|advanced practice nurse care interventions
5757120|NCT00294307|Cognitive Impairment|cognitive impairment
5757121|NCT00294307|Dementia|dementia
5757122|NCT00294307|Delirium|delirium
5757123|NCT00294294|vaccine|vaccine
5757124|NCT00294294|infant|infant
5757125|NCT00294281|Pain|pain
5757126|NCT00294281|Tenderness|tenderness
5757127|NCT00294281|Depression|depression
5757128|NCT00294281|Work Disability|work disability
5757129|NCT00294281|Physical Function|physical function
5757130|NCT00294281|Quality of Life|quality of life
5757131|NCT00294281|Chronic Pain|chronic pain
5757132|NCT00294268|obesity|obesity
5757133|NCT00294268|CBT|cbt
5757134|NCT00294268|motivational enhancement therapy|motivational enhancement therapy
5757135|NCT00294268|weight loss maintenance|weight loss maintenance
5757136|NCT00294255|mixed mania|mixed mania
5757137|NCT00294255|depression|depression
5757138|NCT00294255|irritability|irritability
5757139|NCT00294242|pregnancy|pregnancy
5757140|NCT00294242|membranes sweeping|membranes sweeping
5757141|NCT00294242|prelabor rupture of membranes|prelabor rupture of membranes
5757142|NCT00294229|Low back pain|low back pain
5757143|NCT00294229|Spinal manipulative therapy|spinal manipulative therapy
5757144|NCT00294229|Randomised controlled trial|randomised controlled trial
5757145|NCT00294216|Omacor|omacor
5757146|NCT00294216|Omega-3 PUFA|omega-3 pufa
5757147|NCT00294216|Endarterectomy|endarterectomy
5757148|NCT00294216|Carotid Plaque stability|carotid plaque stability
5757149|NCT00294216|Structural changes|structural changes
5757150|NCT00294216|inflammation|inflammation
5757151|NCT00294203|Digestive System Surgical Procedures|digestive system surgical procedures
5757152|NCT00294203|Post-Operative Care|post-operative care
5757153|NCT00294203|Fatigue|fatigue
5757154|NCT00294203|Quality of Life|quality of life
5757155|NCT00294203|Erythrocyte Transfusion|erythrocyte transfusion
5757156|NCT00294203|Esophagectomy|esophagectomy
5757157|NCT00294203|Gastric Cancer|gastric cancer
5757158|NCT00294203|Hepatectomy|hepatectomy
5757159|NCT00294203|Pancreatic Cancer|pancreatic cancer
5757160|NCT00294203|Rectum|rectum
5757161|NCT00294190|Lung Cancer|lung cancer
5757162|NCT00294190|Extensive stage|extensive stage
5757163|NCT00294190|Small Cell Lung Cancer|small cell lung cancer
5757164|NCT00294177|Trophoblastic Neoplasms|trophoblastic neoplasms
5757165|NCT00294177|Chorionic Gonadotropin|chorionic gonadotropin
5757166|NCT00294177|Molecular Conformation|molecular conformation
5757167|NCT00294164|Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)|human immunodeficiency virus-associated adipose redistribution syndrome (hars)
5757168|NCT00294164|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5757169|NCT00294164|recombinant human growth hormone (r-hGH)|recombinant human growth hormone (r-hgh)
5757170|NCT00294164|Serostim®|serostim®
5757171|NCT00294164|Placebo|placebo
5757172|NCT00294151|breast cancer|breast cancer
5757173|NCT00294151|prostate cancer|prostate cancer
5757174|NCT00294151|vertebral metastasis|vertebral metastasis
5757175|NCT00294151|vertebroplasty|vertebroplasty
5757176|NCT00294151|vertebral metastasis from breast cancer|vertebral metastasis from breast cancer
5757177|NCT00294151|vertebral metastasis from prostate cancer|vertebral metastasis from prostate cancer
5757178|NCT00294125|Medical Food|medical food
5757179|NCT00294125|Botanicals|botanicals
5757180|NCT00294125|Phytochemicals|phytochemicals
5757181|NCT00294112|mesenchymal stem cells|mesenchymal stem cells
5757182|NCT00294099|A/H5N1, Influenza, Vaccine|a/h5n1, influenza, vaccine
5757183|NCT00294086|valsartan,|valsartan,
5757184|NCT00294086|chronic heart failure,|chronic heart failure,
5757185|NCT00294073|femoral block|femoral block
5757186|NCT00294073|fascia iliaca block|fascia iliaca block
5757187|NCT00294073|ACL repair|acl repair
5757188|NCT00294073|post-operative analgesia|post-operative analgesia
5757189|NCT00294073|knee surgery|knee surgery
5757190|NCT00294073|ACL damage|acl damage
5757191|NCT00294073|knee damage|knee damage
5757192|NCT00294060|Pacemaker|pacemaker
5757193|NCT00294060|Bradycardia|bradycardia
5757194|NCT00294047|Vaccine|vaccine
5757195|NCT00294047|Human papillomavirus|human papillomavirus
5757196|NCT00294047|Cervical Cancer|cervical cancer
5757197|NCT00294047|Cervical Infection|cervical infection
5757198|NCT00294034|Registry|registry
5757199|NCT00294034|Pacemaker|pacemaker
5757200|NCT00294034|Diagnostics|diagnostics
5757201|NCT00294008|Schizophrenia|schizophrenia
5757202|NCT00294008|Treatment adherence|treatment adherence
5757203|NCT00294008|Antipsychotic agents|antipsychotic agents
5757204|NCT00294008|Risperidone|risperidone
5757205|NCT00294008|Long-acting injectable|long-acting injectable
5757206|NCT00294008|Risperdal tablet|risperdal tablet
5757207|NCT00294008|Risperidal Consta|risperidal consta
5757208|NCT00293982|Patient satisfaction|patient satisfaction
5757209|NCT00293982|Patient expectations|patient expectations
5757210|NCT00293982|Pediatric emergency department|pediatric emergency department
5757211|NCT00293969|Pain|pain
5757212|NCT00293969|Morphine|morphine
5757213|NCT00293956|hypothyroxinemia|hypothyroxinemia
5757214|NCT00293956|full term infants|full term infants
5757215|NCT00293956|near term infants|near term infants
5757216|NCT00293956|respiratory distress|respiratory distress
5757217|NCT00293956|thyroid disease|thyroid disease
5757218|NCT00293943|Atrial fibrillation|atrial fibrillation
5757219|NCT00293943|Pulmonary vein ablation|pulmonary vein ablation
5757220|NCT00293943|Linear lesions|linear lesions
5757221|NCT00293930|Treatment Outcome|treatment outcome
5757222|NCT00293930|Tacrolimus|tacrolimus
5757223|NCT00293930|Safety|safety
5757224|NCT00293930|Psoriasis|psoriasis
5757225|NCT00293917|Treatment Outcome|treatment outcome
5757226|NCT00293917|Tacrolimus|tacrolimus
5757227|NCT00293917|Safety|safety
5757228|NCT00293917|Psoriasis|psoriasis
5757229|NCT00293904|Allergy|allergy
5757230|NCT00293904|Grass Pollen|grass pollen
5757231|NCT00293904|Systemic Immunotherapy|systemic immunotherapy
5757232|NCT00293891|Treatment Outcome|treatment outcome
5757233|NCT00293891|Tacrolimus|tacrolimus
5757234|NCT00293891|Safety|safety
5757235|NCT00293891|Psoriasis|psoriasis
5757236|NCT00293865|Breast infiltrative cancer|breast infiltrative cancer
5848597|NCT00034229|Bipolar|bipolar
5757237|NCT00293852|Heart failure, Congestive|heart failure, congestive
5757238|NCT00293852|Metabolic Syndrome X|metabolic syndrome x
5757239|NCT00293852|Ambulatory Care|ambulatory care
5757240|NCT00293852|Health behavior|health behavior
5757241|NCT00293839|bladder|bladder
5757242|NCT00293839|overactive|overactive
5757243|NCT00293826|ACR criteria|acr criteria
5757244|NCT00293826|methotrexate|methotrexate
5757245|NCT00293826|DMARDs|dmards
5757246|NCT00293826|patient reported outcomes|patient reported outcomes
5757247|NCT00293826|joint assessment|joint assessment
5757248|NCT00293813|Post Menopausal|post menopausal
5757249|NCT00293813|Osteoporosis|osteoporosis
5757250|NCT00293813|MicroCT|microct
5757251|NCT00293813|Amgen|amgen
5757252|NCT00293813|denosumab|denosumab
5757253|NCT00293813|Extreme CT|extreme ct
5757255|NCT00293813|Fosamax|fosamax
5757256|NCT00293813|Alendronate|alendronate
5757257|NCT00293800|Open-angle|open-angle
5757258|NCT00293800|glaucoma|glaucoma
5757259|NCT00293800|ocular|ocular
5757260|NCT00293800|hypertension|hypertension
5757261|NCT00293787|Open-angle|open-angle
5757262|NCT00293787|glaucoma|glaucoma
5757263|NCT00293787|ocular|ocular
5757264|NCT00293787|hypertension|hypertension
5757265|NCT00293774|Prospective|prospective
5757266|NCT00293774|Conventional therapy|conventional therapy
5757267|NCT00293774|Registry|registry
5757268|NCT00293774|Metal-on-metal|metal-on-metal
5757269|NCT00293774|Ceramic-on-ceramic|ceramic-on-ceramic
5757270|NCT00293774|Hip Arthroplasty|hip arthroplasty
5757271|NCT00293761|open-angle|open-angle
5757272|NCT00293761|glaucoma|glaucoma
5757273|NCT00293761|ocular|ocular
5766663|NCT00256854|Ropinirole|ropinirole
5757274|NCT00293761|hypertension|hypertension
5757275|NCT00293748|Genomics|genomics
5757276|NCT00293748|Statins|statins
5757277|NCT00293748|Coronary Heart Disease|coronary heart disease
5757278|NCT00293748|Stroke|stroke
5757279|NCT00293748|Inflammation|inflammation
5757280|NCT00293748|Gene Expression|gene expression
5757281|NCT00293748|Vascular Risk|vascular risk
5757282|NCT00293748|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5757283|NCT00293748|Atorvastatin|atorvastatin
5757284|NCT00293748|Vascular Disease|vascular disease
5757286|NCT00293735|Preeclampsia|preeclampsia
5757287|NCT00293735|Pregnancy|pregnancy
5757288|NCT00293735|Hypertension|hypertension
5757289|NCT00293735|Eclampsia|eclampsia
5757290|NCT00293735|HELLP Syndrome|hellp syndrome
5757291|NCT00293735|Seizures|seizures
5757292|NCT00293735|Prevention|prevention
5757293|NCT00293722|Arthritis|arthritis
5757294|NCT00293709|Arthritis|arthritis
5757295|NCT00293696|biomarker study|biomarker study
5757296|NCT00293696|Patients with clinically localised prostate cancer|patients with clinically localised prostate cancer
5757297|NCT00293683|cesarean|cesarean
5757298|NCT00293683|closure|closure
5757299|NCT00293683|skin|skin
5757300|NCT00293683|staple|staple
5757301|NCT00293683|absorbable|absorbable
5757302|NCT00293683|metal|metal
5757303|NCT00293644|Pregnancy Complications|pregnancy complications
5757304|NCT00293644|Hyperemesis Gravidarum|hyperemesis gravidarum
5757305|NCT00293644|Diclectin|diclectin
5757306|NCT00293644|doxylamine succinate|doxylamine succinate
5757307|NCT00293644|pyridoxine hydrochloride|pyridoxine hydrochloride
5757308|NCT00293618|Implementation of prediction rules|implementation of prediction rules
5757309|NCT00293618|Decision Support Systems, Clinical|decision support systems, clinical
5757311|NCT00293618|Emesis|emesis
5757312|NCT00293618|Nausea|nausea
5757313|NCT00293618|Vomiting|vomiting
5757314|NCT00293618|Postoperative|postoperative
5757315|NCT00293618|Implementation|implementation
5757316|NCT00293618|prediction rule|prediction rule
5757317|NCT00293618|impact study|impact study
5757318|NCT00293618|decision support|decision support
5757319|NCT00293618|clinical decision support|clinical decision support
5757320|NCT00293605|aseptic loosening|aseptic loosening
5757321|NCT00293605|femoral stem design|femoral stem design
5757322|NCT00293592|Heart surgery|heart surgery
5757323|NCT00293592|Cardiopulmonary bypass|cardiopulmonary bypass
5757324|NCT00293592|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5757325|NCT00293579|head and neck cancer|head and neck cancer
5757326|NCT00293540|metastatic|metastatic
5757327|NCT00293540|secondary|secondary
5757328|NCT00293540|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
5757329|NCT00293527|Metastatic|metastatic
5757330|NCT00293514|standard surgical treatment for air leakage in pulmonary lobectomy|standard surgical treatment for air leakage in pulmonary lobectomy
5757331|NCT00293501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5757332|NCT00293501|stage IV renal cell cancer|stage iv renal cell cancer
5757333|NCT00293501|recurrent renal cell cancer|recurrent renal cell cancer
5757334|NCT00293488|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5757335|NCT00293488|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5757336|NCT00293488|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5848598|NCT00034229|BPD|bpd
5773432|NCT00229593|Progestin|progestin
5773433|NCT00229593|Spermatogenesis|spermatogenesis
5773434|NCT00229593|Gonadotropin suppression|gonadotropin suppression
5773435|NCT00229593|Testosterone|testosterone
5773436|NCT00229593|Nestorone|nestorone
5773437|NCT00229580|Brief Intervention|brief intervention
5757337|NCT00293488|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5757338|NCT00293488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5757339|NCT00293488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5757340|NCT00293488|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5757341|NCT00293488|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5757342|NCT00293488|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5757604|NCT00292994|Insulin resistance|insulin resistance
5757343|NCT00293488|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5757344|NCT00293488|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5757345|NCT00293488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5757346|NCT00293488|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5757347|NCT00293488|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5757348|NCT00293488|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5757349|NCT00293488|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5757350|NCT00293462|mucositis|mucositis
5757351|NCT00293462|radiation toxicity|radiation toxicity
5686320|NCT00552578|substance abuse|substance abuse
5686321|NCT00552578|substance use disorders|substance use disorders
5757352|NCT00293462|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx|recurrent squamous and basal cell carcinoma of the hypopharynx,larynx,lip,nasopharynx
5862882|NCT00001473|Wegener's Granulomatosis|wegener's granulomatosis
5757353|NCT00293462|oropharynx, paranasal sinus and nasal cavity|oropharynx, paranasal sinus and nasal cavity
5757354|NCT00293462|stage I-IV lymphoepithelioma of the nasopharynx|stage i-iv lymphoepithelioma of the nasopharynx
5757355|NCT00293462|stage I-IV lymphoepithelioma of the oropharynx|stage i-iv lymphoepithelioma of the oropharynx
5757356|NCT00293462|Recurrent and stage I-IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent and stage i-iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5757357|NCT00293462|Recurrent and stage I-IV inverted papilloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv inverted papilloma of the paranasal sinus and nasal cavity
5757358|NCT00293462|Recurrent and stage I-IV midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent and stage i-iv midline lethal granuloma of the paranasal sinus and nasal cavity
5757359|NCT00293462|untreated, current,metastatic squamous neck cancer with occult primary|untreated, current,metastatic squamous neck cancer with occult primary
5757360|NCT00293462|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5757361|NCT00293462|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5757362|NCT00293462|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5757739|NCT00292266|Rebif®|rebif®
5757363|NCT00293462|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5757364|NCT00293462|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5757365|NCT00293462|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5757366|NCT00293462|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5757367|NCT00293462|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5757368|NCT00293462|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5757369|NCT00293462|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5757370|NCT00293462|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5757371|NCT00293462|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5757372|NCT00293462|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5757373|NCT00293462|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5757374|NCT00293462|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5757375|NCT00293462|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5757376|NCT00293462|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5757377|NCT00293462|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5757378|NCT00293462|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5757379|NCT00293462|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5757380|NCT00293462|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5757381|NCT00293462|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5757382|NCT00293462|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5798869|NCT00110708|gastrointestinal dysfunction|gastrointestinal dysfunction
5773532|NCT00229138|EC-MPS,|ec-mps,
5773533|NCT00229138|tacrolimus,|tacrolimus,
5757383|NCT00293462|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5757384|NCT00293462|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5757385|NCT00293462|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5757386|NCT00293462|tongue cancer|tongue cancer
5757387|NCT00293436|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5757388|NCT00293436|advanced adult primary liver cancer|advanced adult primary liver cancer
5757389|NCT00293436|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5757390|NCT00293423|adult glioblastoma|adult glioblastoma
5757391|NCT00293423|recurrent adult brain tumor|recurrent adult brain tumor
5757392|NCT00293410|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5757393|NCT00293410|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5757394|NCT00293410|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5757395|NCT00293410|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5757396|NCT00293410|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5757397|NCT00293410|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5757398|NCT00293410|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5757605|NCT00292994|Weight loss|weight loss
5757399|NCT00293410|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5765479|NCT00261547|HLA|hla
5757400|NCT00293410|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5757401|NCT00293410|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5757402|NCT00293410|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5757403|NCT00293410|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5757404|NCT00293410|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5757405|NCT00293410|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5757406|NCT00293410|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5757407|NCT00293410|acute undifferentiated leukemia|acute undifferentiated leukemia
5757408|NCT00293410|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5757409|NCT00293410|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5757410|NCT00293410|adult acute basophilic leukemia|adult acute basophilic leukemia
5757411|NCT00293410|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5757412|NCT00293410|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5757413|NCT00293410|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5757414|NCT00293410|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5757415|NCT00293410|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5757416|NCT00293410|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5757417|NCT00293410|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5757418|NCT00293410|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5757419|NCT00293410|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5757421|NCT00293410|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5757422|NCT00293410|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5757423|NCT00293410|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5757424|NCT00293410|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5757425|NCT00293410|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5757426|NCT00293410|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5757427|NCT00293410|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5757428|NCT00293410|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5757429|NCT00293410|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5757430|NCT00293410|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5757431|NCT00293410|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5757432|NCT00293410|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5757433|NCT00293397|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5757434|NCT00293397|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5757435|NCT00293384|nausea and vomiting|nausea and vomiting
5757436|NCT00293384|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5757437|NCT00293384|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5757438|NCT00293384|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5757439|NCT00293384|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5757440|NCT00293384|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5757441|NCT00293384|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5757442|NCT00293384|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5757443|NCT00293384|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5757444|NCT00293384|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5757445|NCT00293384|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5757446|NCT00293384|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5757447|NCT00293384|primary myelofibrosis|primary myelofibrosis
5757448|NCT00293384|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5757449|NCT00293384|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5757450|NCT00293384|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5757451|NCT00293384|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5757452|NCT00293384|disseminated neuroblastoma|disseminated neuroblastoma
5757453|NCT00293384|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5757454|NCT00293384|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5757455|NCT00293384|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5757456|NCT00293384|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5757457|NCT00293384|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5757458|NCT00293384|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5757607|NCT00292994|Exercise|exercise
5757459|NCT00293384|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5757460|NCT00293384|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5757461|NCT00293384|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5757462|NCT00293384|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5757463|NCT00293384|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5757464|NCT00293384|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5757465|NCT00293384|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5757466|NCT00293384|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5757467|NCT00293384|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5757468|NCT00293384|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5757469|NCT00293384|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5757470|NCT00293384|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5757471|NCT00293384|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5757472|NCT00293384|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5757473|NCT00293384|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5757474|NCT00293384|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5757475|NCT00293384|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5757476|NCT00293384|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5757477|NCT00293384|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5757478|NCT00293384|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5757479|NCT00293384|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5757480|NCT00293384|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5757481|NCT00293384|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5757482|NCT00293384|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5757483|NCT00293384|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5757484|NCT00293384|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5757485|NCT00293384|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5757486|NCT00293384|recurrent neuroblastoma|recurrent neuroblastoma
5757487|NCT00293384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5757488|NCT00293384|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5757489|NCT00293384|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5757490|NCT00293384|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5757491|NCT00293384|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5757492|NCT00293384|refractory hairy cell leukemia|refractory hairy cell leukemia
5757493|NCT00293384|refractory multiple myeloma|refractory multiple myeloma
5757494|NCT00293384|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5757495|NCT00293384|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5757496|NCT00293384|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5757497|NCT00293384|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5757498|NCT00293384|stage I multiple myeloma|stage i multiple myeloma
5757499|NCT00293384|stage II multiple myeloma|stage ii multiple myeloma
5757500|NCT00293384|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5757501|NCT00293384|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5757502|NCT00293384|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5757503|NCT00293384|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5757504|NCT00293384|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5757505|NCT00293384|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5757506|NCT00293384|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5757507|NCT00293384|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5757508|NCT00293384|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5757509|NCT00293384|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5757510|NCT00293384|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5757511|NCT00293384|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5757512|NCT00293384|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5757513|NCT00293384|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5757514|NCT00293384|stage III multiple myeloma|stage iii multiple myeloma
5757515|NCT00293384|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5757516|NCT00293384|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5757517|NCT00293384|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5757518|NCT00293384|stage IIIA breast cancer|stage iiia breast cancer
5757519|NCT00293384|stage IIIB breast cancer|stage iiib breast cancer
5757520|NCT00293384|stage IIIC breast cancer|stage iiic breast cancer
5757521|NCT00293384|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5757522|NCT00293384|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5757523|NCT00293384|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5757524|NCT00293384|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5757525|NCT00293384|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5757526|NCT00293384|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5757527|NCT00293384|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5757529|NCT00293384|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5757530|NCT00293384|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5757531|NCT00293384|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5757532|NCT00293384|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5757533|NCT00293384|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5757534|NCT00293384|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5757535|NCT00293384|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5757536|NCT00293384|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5757537|NCT00293371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5757538|NCT00293371|recurrent prostate cancer|recurrent prostate cancer
5757539|NCT00293371|stage IV prostate cancer|stage iv prostate cancer
5757540|NCT00293358|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5757541|NCT00293358|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5757542|NCT00293358|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5757543|NCT00293358|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5757544|NCT00293358|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5757545|NCT00293332|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5757546|NCT00293332|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5757547|NCT00293332|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5752891|NCT00308867|PDT|pdt
5757549|NCT00293293|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5757550|NCT00293293|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5757551|NCT00293293|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5757552|NCT00293293|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5757553|NCT00293293|peritoneal cavity cancer|peritoneal cavity cancer
5757554|NCT00293280|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5757555|NCT00293280|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5757556|NCT00293280|adenocarcinoma of the lung|adenocarcinoma of the lung
5757557|NCT00293280|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5757558|NCT00293280|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5757559|NCT00293280|large cell lung cancer|large cell lung cancer
5757560|NCT00293280|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5757561|NCT00293280|squamous cell lung cancer|squamous cell lung cancer
5757562|NCT00293267|Treatment Experienced|treatment experienced
5757563|NCT00293254|Treatment Experienced|treatment experienced
5757564|NCT00293241|Pacemaker or ICD replacement|pacemaker or icd replacement
5757565|NCT00293228|Latent tuberculosis|latent tuberculosis
5757566|NCT00293228|biomarkers|biomarkers
5757567|NCT00293228|isoniazid|isoniazid
5757569|NCT00293228|PPD positive individuals|ppd positive individuals
5757571|NCT00293202|malnutrition|malnutrition
5757572|NCT00293202|inflammation|inflammation
5757573|NCT00293202|hemodialysis|hemodialysis
5757574|NCT00293189|hip fracture|hip fracture
5757575|NCT00293189|epidemiology|epidemiology
5757576|NCT00293189|genetics|genetics
5757577|NCT00293189|p2x7|p2x7
5757578|NCT00293176|Cognitive impairment|cognitive impairment
5757579|NCT00293176|Memory Loss|memory loss
5757580|NCT00293150|diastolic heart failure|diastolic heart failure
5757581|NCT00293150|heart failure|heart failure
5757582|NCT00293137|Chronic systolic heart failure|chronic systolic heart failure
5757583|NCT00293137|Heart Failure|heart failure
5757584|NCT00293124|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5757585|NCT00293124|Glivec|glivec
5757586|NCT00293111|Multiple Myeloma|multiple myeloma
5757587|NCT00293111|Relapsed Multiple Myeloma|relapsed multiple myeloma
5757588|NCT00293111|Refractory Multiple Myeloma|refractory multiple myeloma
5757589|NCT00293098|Iron overload|iron overload
5757590|NCT00293098|Thalassemia|thalassemia
5757591|NCT00293098|Iron induced heart disease|iron induced heart disease
5757592|NCT00293098|deferoxamine (Desferal)|deferoxamine (desferal)
5757593|NCT00293098|Deferiprone|deferiprone
5757594|NCT00293085|NSCLC|nsclc
5757595|NCT00293085|Docetaxel|docetaxel
5757596|NCT00293072|Rituximab, ANCA, vasculitis, lupus,|rituximab, anca, vasculitis, lupus,
5757597|NCT00293059|Dysfunctional Uterine Bleeding|dysfunctional uterine bleeding
5757598|NCT00293046|Allergy|allergy
5757599|NCT00293033|Breakthrough Pain in Patients with Cancer|breakthrough pain in patients with cancer
5757600|NCT00293020|Breakthrough Pain in Cancer Patients|breakthrough pain in cancer patients
5757601|NCT00292994|Metabolic Syndrome|metabolic syndrome
5757602|NCT00292994|Hyperlipidemia|hyperlipidemia
5757603|NCT00292994|Type 2 diabetes mellitus|type 2 diabetes mellitus
5756796|NCT00295646|BMD|bmd
5757706|NCT00292370|Paroxetine|paroxetine
5757608|NCT00292994|Hypertension|hypertension
5757609|NCT00292981|C1 Inhibitor|c1 inhibitor
5757610|NCT00292981|Hereditary angioedema|hereditary angioedema
5757611|NCT00292981|Acute HAE attack|acute hae attack
5757612|NCT00292968|Health Behavior|health behavior
5757613|NCT00292968|Prevention|prevention
5757614|NCT00292968|Informatics|informatics
5757615|NCT00292968|Electronic Health Record|electronic health record
5757616|NCT00292955|Cervical Cancer, Cetuximab, Phase II Clinical Trials|cervical cancer, cetuximab, phase ii clinical trials
5757617|NCT00292955|Stage IB2-IVB Carcinoma of the Cervix|stage ib2-ivb carcinoma of the cervix
5757618|NCT00292942|artesunate|artesunate
5757619|NCT00292942|artemisinin|artemisinin
5757620|NCT00292942|falciparum|falciparum
5757621|NCT00292929|artesunate|artesunate
5757622|NCT00292929|artemisinin|artemisinin
5757623|NCT00292929|falciparum|falciparum
5757624|NCT00292916|whole body vibration|whole body vibration
5757625|NCT00292916|exercise|exercise
5757626|NCT00292916|elderly woman|elderly woman
5757627|NCT00292916|Bone Mineral Density|bone mineral density
5757628|NCT00292916|falls|falls
5757629|NCT00292916|higher age|higher age
5757630|NCT00292903|Perinatal Depression|perinatal depression
5757631|NCT00292903|Interpersonal Psychotherapy|interpersonal psychotherapy
5757632|NCT00292890|injection devices|injection devices
5757633|NCT00292890|injection technique|injection technique
5757634|NCT00292890|insulin needles|insulin needles
5757635|NCT00292890|insulin administration|insulin administration
5757636|NCT00292877|1. Eosinophilic bronchitis, 2. Asthma, 3. Steroid dependent asthma, 4. Sputum eosinophils, 5. SB-240563 (Mepolizumab)|1. eosinophilic bronchitis, 2. asthma, 3. steroid dependent asthma, 4. sputum eosinophils, 5. sb-240563 (mepolizumab)
5757637|NCT00292864|Cancer|cancer
5757638|NCT00292864|Carcinoma|carcinoma
5757639|NCT00292864|Adenocarcinoma|adenocarcinoma
5757640|NCT00292864|Tumor|tumor
5757641|NCT00292864|Advanced solid tumors|advanced solid tumors
5757642|NCT00292838|Eosinophilic bronchitis with asthma|eosinophilic bronchitis with asthma
5757643|NCT00292838|Eosinophilic bronchitis without asthma|eosinophilic bronchitis without asthma
5757644|NCT00292825|vasovagal syncope|vasovagal syncope
5757645|NCT00292825|syncope|syncope
5757646|NCT00292825|cardioinhibitory syncope|cardioinhibitory syncope
5757647|NCT00292825|neurocardiogenic syncope|neurocardiogenic syncope
5757648|NCT00292825|pacing|pacing
5757649|NCT00292825|closed loop pacing|closed loop pacing
5757650|NCT00292825|tilt table|tilt table
5757651|NCT00292812|Infant nutrition|infant nutrition
5757652|NCT00292812|Nucleotides|nucleotides
5757653|NCT00292812|Infant formula|infant formula
5757654|NCT00292799|Polycystic ovary syndrome|polycystic ovary syndrome
5757655|NCT00292799|Obesity|obesity
5757656|NCT00292799|metformin|metformin
5757657|NCT00292799|orlistat|orlistat
5757658|NCT00292786|Functional Electrical Stimulation|functional electrical stimulation
5757659|NCT00292786|FES|fes
5757660|NCT00292786|Walking|walking
5757661|NCT00292786|Practice|practice
5757662|NCT00292786|Coordination|coordination
5757663|NCT00292786|Posture|posture
5757664|NCT00292773|Anovulation|anovulation
5757665|NCT00292773|Obesity|obesity
5757666|NCT00292773|bariatric surgery|bariatric surgery
5757667|NCT00292708|Antibiotics|antibiotics
5757668|NCT00292708|Prophylaxis|prophylaxis
5773900|NCT00227474|stage IIIC breast cancer|stage iiic breast cancer
5773901|NCT00227474|stage IV breast cancer|stage iv breast cancer
5773902|NCT00227461|Aphasia|aphasia
5773903|NCT00227461|Stroke|stroke
5757669|NCT00292708|Surgical wound infection|surgical wound infection
5757670|NCT00292656|Allergy|allergy
5757671|NCT00292591|vitamin D|vitamin d
5757672|NCT00292591|cholecalciferol|cholecalciferol
5757673|NCT00292591|pregnancy|pregnancy
5757674|NCT00292591|bone mineral density|bone mineral density
5757675|NCT00292578|Allergy|allergy
5757676|NCT00292578|Sugar Intolerance|sugar intolerance
5757677|NCT00292578|Fatigue|fatigue
5757678|NCT00292552|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5757679|NCT00292552|longitudinal|longitudinal
5757680|NCT00292552|eclipse|eclipse
5757681|NCT00292539|Pacemaker|pacemaker
5757682|NCT00292539|NYHA class|nyha class
5757683|NCT00292539|Ejection fraction|ejection fraction
5757684|NCT00292539|Heart Failure|heart failure
5757685|NCT00292526|Chemotherapy induced cardiotoxicity|chemotherapy induced cardiotoxicity
5757686|NCT00292526|Troponin|troponin
5757687|NCT00292526|Heart failure|heart failure
5757688|NCT00292500|CABG, anastomotic device; myocardial revascularization|cabg, anastomotic device; myocardial revascularization
5757689|NCT00292474|coronary artery disease|coronary artery disease
5757690|NCT00292474|percutaneous coronary interventions|percutaneous coronary interventions
5757691|NCT00292474|stent implant|stent implant
5757692|NCT00292474|drug-coated stent|drug-coated stent
5757693|NCT00292461|Epilepsy|epilepsy
5757694|NCT00292461|seizures|seizures
5757695|NCT00292422|Arthritis, Rheumatoid|arthritis, rheumatoid
5757696|NCT00292422|Methotrexate|methotrexate
5757697|NCT00292422|Antirheumatic Agents|antirheumatic agents
5757698|NCT00292383|Cardiac Pacing, artificial|cardiac pacing, artificial
5757699|NCT00292383|Atrial Fibrillation|atrial fibrillation
5686322|NCT00552578|myofascial pain syndrome|myofascial pain syndrome
5757700|NCT00292383|Heart failure|heart failure
5757701|NCT00292383|Pacemaker leads|pacemaker leads
5757702|NCT00292383|Lead position|lead position
5757703|NCT00292383|Higher degree AV-Block|higher degree av-block
5757704|NCT00292370|Atypical Antipsychotics|atypical antipsychotics
5757705|NCT00292370|Controlled Trial|controlled trial
5757708|NCT00292370|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5757709|NCT00292370|Treatment refractory|treatment refractory
5757710|NCT00292370|Treatment resistant|treatment resistant
5757711|NCT00292344|Travelers' diarrhea|travelers' diarrhea
5757712|NCT00292344|rifaximin|rifaximin
5757713|NCT00292344|loperamide|loperamide
5757714|NCT00292344|enterotoxigenic E. coli|enterotoxigenic e. coli
5757715|NCT00292331|gastric varices|gastric varices
5757716|NCT00292331|liver cirrhosis|liver cirrhosis
5757717|NCT00292331|hepatocelluar carcinoma|hepatocelluar carcinoma
5757718|NCT00292331|rebleeding|rebleeding
5757719|NCT00292331|long-term|long-term
5757720|NCT00292318|adequate relief|adequate relief
5757721|NCT00292318|anorectal manometry|anorectal manometry
5757722|NCT00292318|biofeedback therapy|biofeedback therapy
5757723|NCT00292318|fecal incontinence|fecal incontinence
5757724|NCT00292305|PCI|pci
5757725|NCT00292305|Bifurcation lesion|bifurcation lesion
5757726|NCT00292279|Impact of Omega 3 fatty acid on outcome|impact of omega 3 fatty acid on outcome
5757727|NCT00292279|Omega-3 fatty acid|omega-3 fatty acid
5757728|NCT00292279|Carcinoma surgery|carcinoma surgery
5757729|NCT00292279|Digestive System|digestive system
5757730|NCT00292279|Parenteral Nutrition|parenteral nutrition
5757731|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous
5757732|NCT00292279|Clinical outcome|clinical outcome
5757733|NCT00292279|SIRS|sirs
5757734|NCT00292279|Infectious complication|infectious complication
5757735|NCT00292279|Postoperative hospital stay|postoperative hospital stay
5757736|NCT00292279|Cost of postoperative period|cost of postoperative period
5757737|NCT00292279|Post-operative nutritional cost & total treatment cost|post-operative nutritional cost & total treatment cost
5757738|NCT00292266|Relapsing-remitting Multiple Sclerosis|relapsing-remitting multiple sclerosis
5757742|NCT00292253|MS|ms
5757743|NCT00292240|brief motivational intervention; teens; substance use|brief motivational intervention; teens; substance use
5757744|NCT00292227|advanced-stage idiopathic Parkinson's disease|advanced-stage idiopathic parkinson's disease
5757745|NCT00292214|paracetamol|paracetamol
5757746|NCT00292214|acetaminophen|acetaminophen
5757747|NCT00292214|pharmacokinetic|pharmacokinetic
5757748|NCT00292214|intravenous|intravenous
5757749|NCT00292214|oral|oral
5757750|NCT00292214|analgesia|analgesia
5757751|NCT00292214|pain|pain
5757752|NCT00292214|opioid|opioid
5757753|NCT00292201|Asthma|asthma
5757754|NCT00292201|Statin|statin
5757755|NCT00292188|Phase 4, post-traumatic neuropathic pain, neuropathic pain, Nep, post surgical pain, nerve injury, phantom limb pain, international|phase 4, post-traumatic neuropathic pain, neuropathic pain, nep, post surgical pain, nerve injury, phantom limb pain, international
5757756|NCT00292175|colonoscopy, narrow band imaging (NBI), ulcerative colitis|colonoscopy, narrow band imaging (nbi), ulcerative colitis
5757757|NCT00292162|Chronic Heart Failure|chronic heart failure
5757758|NCT00292162|Atrial Fibrillation|atrial fibrillation
5757759|NCT00292162|Radiofrequency Ablation|radiofrequency ablation
5757760|NCT00292136|Cocaine Dependence|cocaine dependence
5757761|NCT00292136|Drug Relapse|drug relapse
5757762|NCT00292136|Pharmacokinetics|pharmacokinetics
5757763|NCT00292136|EMA|ema
5757764|NCT00292136|Polydrug Abuse|polydrug abuse
5757765|NCT00292110|HIV|hiv
5757766|NCT00292110|Opiate Substitution|opiate substitution
5757767|NCT00292110|Pharmacokinetics|pharmacokinetics
5757768|NCT00292110|ECG|ecg
5757769|NCT00292110|Polydrug Abuse|polydrug abuse
5757770|NCT00292097|Respiratory failure|respiratory failure
5757771|NCT00292097|Tracheostomy|tracheostomy
5757772|NCT00292097|Percutaneous dilatation tracheostomy|percutaneous dilatation tracheostomy
5757773|NCT00292097|Endotracheal Conversion|endotracheal conversion
5757774|NCT00292097|Traumatic brain injury|traumatic brain injury
5757775|NCT00292084|Hepatitis C|hepatitis c
5757776|NCT00292084|Celgosivir|celgosivir
5757777|NCT00292084|HCV|hcv
5757778|NCT00292084|Genotype 1|genotype 1
5757779|NCT00292084|Non-responders|non-responders
5757780|NCT00292084|End of Treatment Response|end of treatment response
5757781|NCT00292084|Sustained Viral Response|sustained viral response
5757782|NCT00292058|Telepsychiatry|telepsychiatry
5757783|NCT00292058|Videoconference|videoconference
5757784|NCT00292058|Psychiatric consultation|psychiatric consultation
5757785|NCT00292058|Equivalence trial|equivalence trial
5757786|NCT00292045|NY-ESO-1 protein, immunization, advanced prostate cancer|ny-eso-1 protein, immunization, advanced prostate cancer
5757787|NCT00292032|cardiac arrest|cardiac arrest
5757788|NCT00292032|diagnosis|diagnosis
5757789|NCT00292032|genetics|genetics
5757790|NCT00292032|testing|testing
5757791|NCT00292006|clinical scaphoid fracture|clinical scaphoid fracture
5757792|NCT00292006|pediatric|pediatric
5757793|NCT00291993|Obstructive sleep apnea|obstructive sleep apnea
5757794|NCT00291993|Vasoactive hormones|vasoactive hormones
5757795|NCT00291993|Blood pressure|blood pressure
5686323|NCT00552578|neuralgia|neuralgia
5757796|NCT00291980|Dialysis|dialysis
5757797|NCT00291980|Pre-dialysis|pre-dialysis
5757798|NCT00291980|Hepatitis B vaccine|hepatitis b vaccine
5757799|NCT00291980|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
5757800|NCT00291954|Dialysis|dialysis
5757801|NCT00291954|Pre-dialysis|pre-dialysis
5757802|NCT00291954|Hepatitis B vaccine|hepatitis b vaccine
5757803|NCT00291954|Prophylaxis hepatitis B infection|prophylaxis hepatitis b infection
5757804|NCT00291941|Dialysis|dialysis
5757805|NCT00291941|Pre-dialysis|pre-dialysis
5757806|NCT00291941|Hepatitis B vaccine|hepatitis b vaccine
5757807|NCT00291941|Prophylaxis|prophylaxis
5757808|NCT00291915|early arthritis, methotrexate, adalimumab|early arthritis, methotrexate, adalimumab
5757809|NCT00291902|CHD|chd
5757810|NCT00291902|coronary heart disease|coronary heart disease
5757811|NCT00291902|atherosclerosis|atherosclerosis
5757812|NCT00291902|inflammation|inflammation
5757813|NCT00291876|HAVRIX™|havrix™
5757815|NCT00291863|end stage renal failure|end stage renal failure
5757816|NCT00291863|peritoneal dialysis|peritoneal dialysis
5757817|NCT00291863|simvastatin|simvastatin
5757818|NCT00291863|endothelium|endothelium
5757819|NCT00291863|vasodilation|vasodilation
5757820|NCT00291850|NSCLC|nsclc
5757821|NCT00291837|ovarian|ovarian
5757822|NCT00291837|CT-2106|ct-2106
5757823|NCT00291824|Cardiovascular risks|cardiovascular risks
5757824|NCT00291824|Motivational interviewing|motivational interviewing
5757825|NCT00291824|Behavior change|behavior change
5757826|NCT00291824|Primary care setting|primary care setting
5757827|NCT00291811|AMD3100|amd3100
5757828|NCT00291811|G-CSF|g-csf
5757829|NCT00291798|pilot study|pilot study
5757830|NCT00291798|exemestane|exemestane
5757831|NCT00291798|endocrinotherapy|endocrinotherapy
5757832|NCT00291798|mamma carcinoma|mamma carcinoma
5757833|NCT00291798|neoadjuvant|neoadjuvant
5757834|NCT00291798|ABCSG|abcsg
5757835|NCT00291798|17|17
5757836|NCT00291785|colorectal cancer|colorectal cancer
5757837|NCT00291785|camptothecin|camptothecin
5757838|NCT00291772|Type 1 Diabetes|type 1 diabetes
5757839|NCT00291772|hypoglycemia|hypoglycemia
5757840|NCT00291772|hyperglycemia|hyperglycemia
5757842|NCT00291733|Levetiracetam|levetiracetam
5757843|NCT00291733|Levodopa-induced dyskinesias|levodopa-induced dyskinesias
5757844|NCT00291733|Parkinson's|parkinson's
5757845|NCT00291720|Aldosterone|aldosterone
5757846|NCT00291720|Spironolactone|spironolactone
5757847|NCT00291720|Chronic Kidney Disease|chronic kidney disease
5757848|NCT00291720|Arterial Stiffness|arterial stiffness
5757849|NCT00291707|head|head
5757850|NCT00291707|neck|neck
5757851|NCT00291707|Cetuximab|cetuximab
5757852|NCT00291707|Pemetrexed|pemetrexed
5757853|NCT00291694|breast atypia|breast atypia
5757854|NCT00291694|double-blind randomized clinical trial|double-blind randomized clinical trial
5757855|NCT00291694|RCT|rct
5757856|NCT00291694|celecoxib|celecoxib
5757857|NCT00291694|COX-2 inhibitor|cox-2 inhibitor
5757858|NCT00291694|placebo|placebo
5757859|NCT00291694|high risk for breast cancer|high risk for breast cancer
5757860|NCT00291694|breast epithelial hyperplasia|breast epithelial hyperplasia
5757861|NCT00291694|ki-67|ki-67
5757862|NCT00291694|chemoprevention|chemoprevention
5757863|NCT00291681|Inflammatory Bowel Disease|inflammatory bowel disease
5757864|NCT00291681|B cell selection|b cell selection
5757865|NCT00291668|Crohn's Disease|crohn's disease
5757866|NCT00291668|CDP870, Certolizumab pegol|cdp870, certolizumab pegol
5757867|NCT00291655|NEWLY DIAGNOSED EPILEPSY|newly diagnosed epilepsy
5757868|NCT00291655|LEVETIRACETAM|levetiracetam
5757869|NCT00291655|KEPPRA|keppra
5757870|NCT00291655|N01175 (NCT00175903)|n01175 (nct00175903)
5757871|NCT00291642|Levocetirizine|levocetirizine
5757872|NCT00291642|Xyzal|xyzal
5757873|NCT00291642|Rhinitis|rhinitis
5757874|NCT00291642|Allergic|allergic
5757875|NCT00291642|Seasonal|seasonal
5757876|NCT00291642|Ragweed|ragweed
5757877|NCT00291629|Myocardial infarction|myocardial infarction
5757878|NCT00291629|revascularization|revascularization
5757879|NCT00291629|drug eluting stents|drug eluting stents
5757880|NCT00291616|chronic hepatitis B, pegylated interferon, thymosin alpha|chronic hepatitis b, pegylated interferon, thymosin alpha
5757881|NCT00291603|dialysis|dialysis
5757882|NCT00291603|Renal Dialysis|renal dialysis
5757883|NCT00291603|inflammation|inflammation
5757884|NCT00291603|quality of life|quality of life
5757885|NCT00291603|End Stage Kidney Failure|end stage kidney failure
5757886|NCT00291590|diabetes|diabetes
5757887|NCT00291590|behavioral change|behavioral change
5757888|NCT00291590|chronic care model|chronic care model
5757889|NCT00291590|stage of change|stage of change
5757890|NCT00291590|Medicaid|medicaid
5757891|NCT00291590|Dual eligible|dual eligible
5757892|NCT00291590|ethnic|ethnic
5757893|NCT00291590|self-care|self-care
5757894|NCT00291577|advanced|advanced
5757895|NCT00291577|sunitinib (Sutent)|sunitinib (sutent)
5757896|NCT00291577|docetaxel|docetaxel
5757897|NCT00291577|Phase 1B|phase 1b
5757898|NCT00291564|Observational|observational
5757899|NCT00291564|Heart Failure|heart failure
5757900|NCT00291564|Continuous Cardiac Resynchronization Therapy|continuous cardiac resynchronization therapy
5757901|NCT00291525|valve|valve
5757902|NCT00291525|prosthesis|prosthesis
5757903|NCT00291525|antithrombotics|antithrombotics
5757904|NCT00291525|randomized|randomized
5757905|NCT00291512|HIV|hiv
5757906|NCT00291512|STDs|stds
5757907|NCT00291512|Methamphetamine abuse|methamphetamine abuse
5757909|NCT00291499|symptomatic OA of the hand|symptomatic oa of the hand
5757911|NCT00291460|respiratory failure|respiratory failure
5757912|NCT00291460|inspiratory muscle training|inspiratory muscle training
5757913|NCT00291434|Head and neck cancer|head and neck cancer
5757914|NCT00291434|Fractionation|fractionation
5757915|NCT00291434|Radiotherapy|radiotherapy
5757916|NCT00291434|Conventional fractionation|conventional fractionation
5757917|NCT00291434|Hyperfractionation|hyperfractionation
5757918|NCT00291434|Accelerated fractionation|accelerated fractionation
5757919|NCT00291421|Alzheimer's Disease|alzheimer's disease
5757920|NCT00291421|Dementia|dementia
5757921|NCT00291421|Brain Disease|brain disease
5757922|NCT00291421|Memory Loss|memory loss
5757923|NCT00291421|Caregiver|caregiver
5757924|NCT00291421|Primary Caregiver|primary caregiver
5757925|NCT00291421|Observation|observation
5757926|NCT00291421|galantamine|galantamine
5757927|NCT00291421|donepezil|donepezil
5757928|NCT00291421|rivastigmine|rivastigmine
5757929|NCT00291421|Quality of life|quality of life
5757930|NCT00291382|Total asthma control|total asthma control
5757931|NCT00291382|airway hyper-responsiveness|airway hyper-responsiveness
5757932|NCT00291382|adult|adult
5757933|NCT00291382|Asthma|asthma
5757934|NCT00291369|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5757935|NCT00291369|Interleukin-2|interleukin-2
5757936|NCT00291369|Interferon alfa|interferon alfa
5757937|NCT00291369|Cytokines|cytokines
5757938|NCT00291369|Survival|survival
5757939|NCT00291356|Diabetes|diabetes
5757940|NCT00291356|sodium dependent glucose transporter|sodium dependent glucose transporter
5757941|NCT00291356|SGLT2|sglt2
5753281|NCT00307164|Uridine|uridine
5757942|NCT00291356|GSK189075|gsk189075
5757943|NCT00291356|GSK189074|gsk189074
5757944|NCT00291356|SGLT1|sglt1
5757945|NCT00291356|GW869683|gw869683
5757946|NCT00291343|hepatitis B|hepatitis b
5757947|NCT00291343|meningococcal vaccine|meningococcal vaccine
5757948|NCT00291343|pertussis|pertussis
5757949|NCT00291343|Prophylaxis diphtheria|prophylaxis diphtheria
5757950|NCT00291343|meningococcal serogroups A and C diseases|meningococcal serogroups a and c diseases
5757951|NCT00291343|tetanus|tetanus
5757952|NCT00291343|Haemophilus influenzae type b|haemophilus influenzae type b
5757953|NCT00291317|pediatric spinal cord injury|pediatric spinal cord injury
5757954|NCT00291317|FES cycling|fes cycling
5757955|NCT00291317|bone mineral density|bone mineral density
5757956|NCT00291317|quality of life|quality of life
5757957|NCT00291304|Magnetic Resonance Imaging|magnetic resonance imaging
5757958|NCT00291304|Pathology|pathology
5757959|NCT00291278|Endometriosis|endometriosis
5757960|NCT00291278|Bone Mineral Density|bone mineral density
5757961|NCT00291278|Osteopenia|osteopenia
5757962|NCT00291278|Osteoporosis|osteoporosis
5757963|NCT00291278|DEXA Scan|dexa scan
5757964|NCT00291278|Menopause|menopause
5757965|NCT00291278|Screening|screening
5757966|NCT00291278|Healthy Volunteer|healthy volunteer
5757967|NCT00291278|HV|hv
5757968|NCT00291265|Bradykinesia|bradykinesia
5757969|NCT00291265|Tremor|tremor
5757970|NCT00291265|Speech|speech
5757971|NCT00291265|Rigidity|rigidity
5757972|NCT00291265|Neurodegeneration|neurodegeneration
5757973|NCT00291265|Parkinson Disease|parkinson disease
5757974|NCT00291265|PD|pd
5757975|NCT00291226|schizophrenia prodrome|schizophrenia prodrome
5757976|NCT00291200|Psychosis|psychosis
5757977|NCT00291200|Basic Symptoms|basic symptoms
5757978|NCT00291174|Ventricular Arrhythmia|ventricular arrhythmia
5757979|NCT00291174|Myocardial Infarction|myocardial infarction
5757980|NCT00291174|Ventricular Dysfunction|ventricular dysfunction
5757981|NCT00291174|Coronary Artery Disease|coronary artery disease
5757982|NCT00291174|Structural Heart Disease|structural heart disease
5757983|NCT00291174|Arrhythmia|arrhythmia
5757984|NCT00291174|Cardiomyopathies|cardiomyopathies
5757985|NCT00291161|Delivery of Health Care, Integrated|delivery of health care, integrated
5757986|NCT00291161|United States Department of Veterans Affairs|united states department of veterans affairs
5757987|NCT00291161|Dementia|dementia
5757988|NCT00291161|Patient Care Management|patient care management
5757989|NCT00291148|Neuropathic pain|neuropathic pain
5757990|NCT00291148|Multiple Sclerosis|multiple sclerosis
5757991|NCT00291148|pregabalin|pregabalin
5757992|NCT00291148|paroxetine|paroxetine
5757993|NCT00291135|breast atypia|breast atypia
5757994|NCT00291135|open label pilot study|open label pilot study
5757995|NCT00291135|letrozole|letrozole
5757996|NCT00291135|fine needle aspiration|fine needle aspiration
5757997|NCT00291135|high risk for breast cancer|high risk for breast cancer
5757998|NCT00291135|breast epithelial hyperplasia|breast epithelial hyperplasia
5757999|NCT00291135|Ki-67|ki-67
5758000|NCT00291135|hormones plus chemoprevention|hormones plus chemoprevention
5758001|NCT00291135|chemoprevention|chemoprevention
5758002|NCT00291122|breast atypia|breast atypia
5758003|NCT00291122|breast epithelial hyperplasia|breast epithelial hyperplasia
5758004|NCT00291122|ki-67|ki-67
5758005|NCT00291122|RTPCR|rtpcr
5758006|NCT00291122|microdissection|microdissection
5758007|NCT00291109|breast atypia|breast atypia
5758008|NCT00291109|breast epithelial hyperplasia|breast epithelial hyperplasia
5758011|NCT00291109|microdissection|microdissection
5758012|NCT00291096|breast atypia|breast atypia
5758013|NCT00291096|fine needle aspiration|fine needle aspiration
5758014|NCT00291096|high risk for breast cancer|high risk for breast cancer
5758015|NCT00291096|breast epithelial hyperplasia|breast epithelial hyperplasia
5758016|NCT00291083|NAF|naf
5758017|NCT00291083|nipple aspirate fluid|nipple aspirate fluid
5758018|NCT00291083|breast atypia|breast atypia
5758019|NCT00291083|high risk for breast cancer|high risk for breast cancer
5758020|NCT00291083|breast epithelial hyperplasia|breast epithelial hyperplasia
5758022|NCT00291083|hormones plus chemoprevention|hormones plus chemoprevention
5758023|NCT00291083|chemoprevention|chemoprevention
5758024|NCT00291070|ADHD|adhd
5758025|NCT00291070|attention|attention
5758026|NCT00291070|insomnia|insomnia
5758027|NCT00291070|hyperactivity|hyperactivity
5758028|NCT00291070|anxiety|anxiety
5758029|NCT00291057|Pediculosis|pediculosis
5758030|NCT00291057|Head Lice|head lice
5758031|NCT00291044|pregnancy, genital herpes|pregnancy, genital herpes
5758032|NCT00291031|nightmare|nightmare
5758033|NCT00291031|sleep disorder|sleep disorder
5758034|NCT00291031|sleep|sleep
5758035|NCT00291031|imagery rehearsal|imagery rehearsal
5758036|NCT00291031|anxiety disorders|anxiety disorders
5758037|NCT00291031|mood disorders|mood disorders
5758038|NCT00291031|personality disorders|personality disorders
5758039|NCT00291018|ProDisc|prodisc
5758040|NCT00291018|ProDisc-C|prodisc-c
5758041|NCT00291018|Spinal Fusion|spinal fusion
5758042|NCT00291018|Anterior cervical diskectomy|anterior cervical diskectomy
5758043|NCT00291018|Cervical spine|cervical spine
5758044|NCT00291018|Disc disease|disc disease
5758045|NCT00291018|Implant|implant
5758047|NCT00291018|Intervertebral disc|intervertebral disc
5758048|NCT00291005|Prostate cancer|prostate cancer
5758049|NCT00291005|HRPC|hrpc
5758050|NCT00291005|AIPC|aipc
5758051|NCT00291005|Hormone refractory|hormone refractory
5758052|NCT00291005|Androgen independent|androgen independent
5758053|NCT00291005|Docetaxel|docetaxel
5758054|NCT00291005|Taxotere|taxotere
5758055|NCT00291005|prednisolone|prednisolone
5758056|NCT00290992|urate oxidase, hyperuricemia, lymphoma, leukemia|urate oxidase, hyperuricemia, lymphoma, leukemia
5758057|NCT00290979|HMR1964, insulin glulisine, Diabetes Mellitus, Type 1|hmr1964, insulin glulisine, diabetes mellitus, type 1
5758058|NCT00290966|docetaxel|docetaxel
5758059|NCT00290966|stomach neoplasm|stomach neoplasm
5758060|NCT00290953|Metastases|metastases
5758061|NCT00290940|Diabetes mellitus, Type 2|diabetes mellitus, type 2
5758062|NCT00290940|High blood sugar|high blood sugar
5758063|NCT00290940|Hyperglycemia|hyperglycemia
5758064|NCT00290940|Antihyperglycemic agents|antihyperglycemic agents
5758065|NCT00290940|CS-917|cs-917
5758066|NCT00290927|HMR1964, insulin glulisine, Diabetes Mellitus, Type 2|hmr1964, insulin glulisine, diabetes mellitus, type 2
5758067|NCT00290888|Rotator Cuff Tear|rotator cuff tear
5758068|NCT00290888|Tendon Repair|tendon repair
5758069|NCT00290888|Acromioplasty|acromioplasty
5758070|NCT00290888|Arthroscopy|arthroscopy
5758071|NCT00290888|Orthopedic Surgery|orthopedic surgery
5758072|NCT00290875|cspine injury|cspine injury
5758073|NCT00290875|radiography|radiography
5758074|NCT00290875|clinical impact|clinical impact
5758075|NCT00290875|dissemination|dissemination
5758076|NCT00290862|Osteoporosis|osteoporosis
5758077|NCT00290862|Spine fracture|spine fracture
5758078|NCT00290862|Back Pain|back pain
5758079|NCT00290862|Vertebroplasty|vertebroplasty
5758080|NCT00290862|Vertebral compression fractures related to osteoporosis|vertebral compression fractures related to osteoporosis
5758081|NCT00290823|Taenia|taenia
5758082|NCT00290823|Seizures|seizures
5758083|NCT00290823|Tapeworm|tapeworm
5758084|NCT00290823|Parasite|parasite
5758085|NCT00290771|imatinib mesylate|imatinib mesylate
5758086|NCT00290771|hydroxyurea|hydroxyurea
5758087|NCT00290771|protein tyrosine kinases|protein tyrosine kinases
5758088|NCT00290771|glioma|glioma
5758089|NCT00290771|glioblastoma multiforme|glioblastoma multiforme
5758090|NCT00290771|recurrent glioblastoma multiforme|recurrent glioblastoma multiforme
5758091|NCT00290771|GBM|gbm
5758092|NCT00290771|MacDonald criteria|macdonald criteria
5758093|NCT00290745|breast cancer in situ|breast cancer in situ
5758094|NCT00290745|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5758095|NCT00290732|stage I breast cancer|stage i breast cancer
5758096|NCT00290732|stage II breast cancer|stage ii breast cancer
5758097|NCT00290732|stage IIIA breast cancer|stage iiia breast cancer
5758098|NCT00290732|stage IIIC breast cancer|stage iiic breast cancer
5758099|NCT00290732|stage IV breast cancer|stage iv breast cancer
5758100|NCT00290732|breast cancer in situ|breast cancer in situ
5758379|NCT00290511|Fludarabine|fludarabine
5758101|NCT00290732|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5686324|NCT00552578|back pain|back pain
5758102|NCT00290719|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5758103|NCT00290719|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5758104|NCT00290719|stage II esophageal cancer|stage ii esophageal cancer
5758105|NCT00290719|stage III esophageal cancer|stage iii esophageal cancer
5758351|NCT00290615|recurrent rectal cancer|recurrent rectal cancer
5758106|NCT00290706|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5758107|NCT00290706|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5758108|NCT00290706|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5758109|NCT00290706|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5758110|NCT00290706|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5758111|NCT00290706|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5758112|NCT00290706|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5758113|NCT00290693|recurrent pancreatic cancer|recurrent pancreatic cancer
5758114|NCT00290693|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5758115|NCT00290693|stage IV pancreatic cancer|stage iv pancreatic cancer
5758116|NCT00290680|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5758117|NCT00290667|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5758118|NCT00290667|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5758119|NCT00290667|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5758120|NCT00290667|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5758121|NCT00290667|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5758122|NCT00290667|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5758123|NCT00290667|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5758124|NCT00290667|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5758185|NCT00290641|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5758125|NCT00290667|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5758126|NCT00290667|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5758127|NCT00290667|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5758128|NCT00290667|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5758129|NCT00290667|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5758130|NCT00290667|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5758131|NCT00290667|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5758132|NCT00290667|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5758133|NCT00290667|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5758134|NCT00290667|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5758135|NCT00290667|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5758136|NCT00290667|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5758137|NCT00290667|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5758138|NCT00290667|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5758139|NCT00290667|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5758140|NCT00290667|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5758141|NCT00290667|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5758142|NCT00290667|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5758143|NCT00290667|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5758144|NCT00290667|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5758145|NCT00290667|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5758146|NCT00290667|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5758147|NCT00290667|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5758148|NCT00290667|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5758149|NCT00290667|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5758150|NCT00290667|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5758151|NCT00290667|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5758152|NCT00290667|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5758153|NCT00290667|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5758154|NCT00290667|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5758155|NCT00290667|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5758156|NCT00290667|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5758157|NCT00290654|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5758158|NCT00290654|breast cancer in situ|breast cancer in situ
5758159|NCT00290641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5758160|NCT00290641|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5758161|NCT00290641|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5862889|NCT00001469|Linkage Analysis|linkage analysis
5758162|NCT00290641|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5758163|NCT00290641|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5758164|NCT00290641|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5758165|NCT00290641|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5758166|NCT00290641|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5758167|NCT00290641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5758168|NCT00290641|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5758169|NCT00290641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5758170|NCT00290641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5758171|NCT00290641|refractory anemia with excess blasts|refractory anemia with excess blasts
5758172|NCT00290641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5758173|NCT00290641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5758174|NCT00290641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5758175|NCT00290641|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5758176|NCT00290641|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5758177|NCT00290641|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5758178|NCT00290641|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5758179|NCT00290641|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5758180|NCT00290641|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5758181|NCT00290641|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5758182|NCT00290641|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5758183|NCT00290641|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5758184|NCT00290641|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5758186|NCT00290641|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5758187|NCT00290641|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5758188|NCT00290641|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5758189|NCT00290641|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5758190|NCT00290641|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5758191|NCT00290641|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5758192|NCT00290641|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5758193|NCT00290641|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5758194|NCT00290641|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5758195|NCT00290641|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5758196|NCT00290641|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5758197|NCT00290641|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5758198|NCT00290641|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5758199|NCT00290641|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5758200|NCT00290641|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5758201|NCT00290641|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5758202|NCT00290641|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5758203|NCT00290641|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5758204|NCT00290641|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5758205|NCT00290641|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5758206|NCT00290641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5758207|NCT00290641|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5758208|NCT00290641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5758209|NCT00290641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5758210|NCT00290641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5758211|NCT00290641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5758212|NCT00290641|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5758213|NCT00290641|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5758214|NCT00290641|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5758215|NCT00290641|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5758216|NCT00290641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5758217|NCT00290641|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5758218|NCT00290641|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5758219|NCT00290641|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5758220|NCT00290641|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5758221|NCT00290641|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5758222|NCT00290641|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5758223|NCT00290641|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5758224|NCT00290641|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5758225|NCT00290641|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5758749|NCT00288964|balloon|balloon
5758226|NCT00290641|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5758227|NCT00290641|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5758228|NCT00290641|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5758229|NCT00290641|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5758230|NCT00290641|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5758231|NCT00290641|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5758232|NCT00290641|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5758233|NCT00290641|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5758234|NCT00290641|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5758235|NCT00290641|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5758236|NCT00290641|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5758237|NCT00290641|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5758238|NCT00290641|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5758239|NCT00290641|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5758240|NCT00290641|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5758241|NCT00290641|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5758243|NCT00290641|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5758244|NCT00290641|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5758245|NCT00290641|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5758246|NCT00290641|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5758247|NCT00290641|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5758248|NCT00290641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5758249|NCT00290628|graft versus host disease|graft versus host disease
5758250|NCT00290628|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5758251|NCT00290628|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5758252|NCT00290628|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5758253|NCT00290628|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5758254|NCT00290628|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5758255|NCT00290628|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5758256|NCT00290628|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5758257|NCT00290628|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5758258|NCT00290628|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5758259|NCT00290628|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5758260|NCT00290628|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5758261|NCT00290628|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5758262|NCT00290628|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5758263|NCT00290628|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5758264|NCT00290628|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5758265|NCT00290628|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5758266|NCT00290628|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5758267|NCT00290628|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5758268|NCT00290628|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5758269|NCT00290628|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5758270|NCT00290628|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5758271|NCT00290628|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5758272|NCT00290628|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5758273|NCT00290628|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5758274|NCT00290628|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5758275|NCT00290628|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5758276|NCT00290628|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5766520|NCT00257465|vaccine|vaccine
5758277|NCT00290628|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5758278|NCT00290628|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5758279|NCT00290628|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5758280|NCT00290628|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5758281|NCT00290628|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5758282|NCT00290628|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5758283|NCT00290628|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5758284|NCT00290628|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5758285|NCT00290628|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5758286|NCT00290628|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5758287|NCT00290628|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5758288|NCT00290628|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5758289|NCT00290628|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5758290|NCT00290628|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5758291|NCT00290628|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5758292|NCT00290628|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5758293|NCT00290628|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5758294|NCT00290628|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5758295|NCT00290628|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5758296|NCT00290628|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5758297|NCT00290628|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5758298|NCT00290628|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5758299|NCT00290628|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5758300|NCT00290628|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5758301|NCT00290628|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5758302|NCT00290628|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5758303|NCT00290628|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5758304|NCT00290628|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5758305|NCT00290628|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5758306|NCT00290628|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5758307|NCT00290628|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5758308|NCT00290628|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5758309|NCT00290628|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5758310|NCT00290628|refractory hairy cell leukemia|refractory hairy cell leukemia
5758311|NCT00290628|refractory multiple myeloma|refractory multiple myeloma
5758312|NCT00290628|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5758313|NCT00290628|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5758314|NCT00290628|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5758315|NCT00290628|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5758316|NCT00290628|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5758317|NCT00290628|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5758318|NCT00290628|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5758319|NCT00290628|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5758320|NCT00290628|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5758321|NCT00290628|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5758322|NCT00290628|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5758323|NCT00290628|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5758324|NCT00290628|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5758325|NCT00290628|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5758326|NCT00290628|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5758327|NCT00290628|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5758328|NCT00290628|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5758329|NCT00290628|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5758330|NCT00290628|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5758331|NCT00290628|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5758332|NCT00290628|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5758333|NCT00290628|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5758334|NCT00290628|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5758335|NCT00290628|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5758336|NCT00290628|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5758337|NCT00290628|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5758338|NCT00290628|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5758339|NCT00290628|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5758340|NCT00290628|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5758341|NCT00290628|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5758342|NCT00290628|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5758343|NCT00290628|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5758344|NCT00290628|Diamond-Blackfan anemia|diamond-blackfan anemia
5758345|NCT00290628|Fanconi anemia|fanconi anemia
5758346|NCT00290628|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5758347|NCT00290615|adenocarcinoma of the colon|adenocarcinoma of the colon
5758348|NCT00290615|recurrent colon cancer|recurrent colon cancer
5758349|NCT00290615|stage IV colon cancer|stage iv colon cancer
5758350|NCT00290615|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5758352|NCT00290615|stage IV rectal cancer|stage iv rectal cancer
5758353|NCT00290602|Acute respiratory distress syndrome|acute respiratory distress syndrome
5758354|NCT00290602|corticosteroids|corticosteroids
5758355|NCT00290602|postoperative complications|postoperative complications
5758357|NCT00290589|low back pain|low back pain
5758358|NCT00290589|emergency department|emergency department
5758359|NCT00290589|corticosteroids|corticosteroids
5758360|NCT00290576|Digestive and Nutritional Effects|digestive and nutritional effects
5758361|NCT00290576|Safety and Growth|safety and growth
5758362|NCT00290576|Feeding Tolerance|feeding tolerance
5758363|NCT00290550|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5758365|NCT00290537|Non-Small Cell Lung Cancer|non-small cell lung cancer
5758366|NCT00290537|Lung Cancer|lung cancer
5758367|NCT00290537|Carboplatin|carboplatin
5758368|NCT00290537|Paclitaxel|paclitaxel
5758369|NCT00290537|ZD6474|zd6474
5758370|NCT00290537|NSCLC|nsclc
5758371|NCT00290524|Oral alimentation following colorectal surgery|oral alimentation following colorectal surgery
5758372|NCT00290524|anastomosis|anastomosis
5753881|NCT00305305|MRI|mri
5758373|NCT00290524|laparoscopy|laparoscopy
5758374|NCT00290524|hospitalization stay|hospitalization stay
5758375|NCT00290511|Follicular Lymphoma|follicular lymphoma
5758376|NCT00290511|Zevalin|zevalin
5758377|NCT00290511|Ibritumomab Tiuxetan|ibritumomab tiuxetan
5758378|NCT00290511|IDEC-Y2B8|idec-y2b8
5758380|NCT00290511|Fludara|fludara
5758381|NCT00290511|Dexamethasone|dexamethasone
5758382|NCT00290511|Mitoxantrone|mitoxantrone
5758383|NCT00290511|Rituximab|rituximab
5758384|NCT00290511|Rituxan|rituxan
5758386|NCT00290511|Fludarabine Phosphate|fludarabine phosphate
5758387|NCT00290511|Decadron|decadron
5758388|NCT00290498|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5758389|NCT00290498|B-Cell Non-Hodgkin's Lymphoma|b-cell non-hodgkin's lymphoma
5758390|NCT00290498|Lymphoma|lymphoma
5758391|NCT00290498|Cyclophosphamide|cyclophosphamide
5758392|NCT00290498|Cytarabine|cytarabine
5758393|NCT00290498|Doxorubicin|doxorubicin
5758394|NCT00290498|Hyper-CVAD|hyper-cvad
5758395|NCT00290498|Methotrexate|methotrexate
5758396|NCT00290498|Prednisone|prednisone
5758397|NCT00290498|Rituximab|rituximab
5758398|NCT00290498|Vincristine|vincristine
5758399|NCT00290498|R-CHOP|r-chop
5758400|NCT00290498|R-HCVAD|r-hcvad
5758401|NCT00290498|Dexamethasone|dexamethasone
5758402|NCT00290498|Decadron|decadron
5758403|NCT00290498|Leucovorin|leucovorin
5758404|NCT00290498|Ara-C|ara-c
5758405|NCT00290498|Cytosar|cytosar
5758406|NCT00290498|Cytoxan|cytoxan
5758407|NCT00290498|DepoCyt|depocyt
5758408|NCT00290498|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5758410|NCT00290498|Hydroxydaunomycin hydrochloride|hydroxydaunomycin hydrochloride
5758411|NCT00290498|Neosar|neosar
5758412|NCT00290485|non-resectable tumor|non-resectable tumor
5758413|NCT00290485|high-risk tumor|high-risk tumor
5758414|NCT00290485|metastasis|metastasis
5758415|NCT00290485|Response Evaluation Criteria in Solid Tumors (RECIST)|response evaluation criteria in solid tumors (recist)
5758416|NCT00290485|Gleevec|gleevec
5758417|NCT00290485|Imatinib mesylate|imatinib mesylate
5758418|NCT00290459|Gynecologic Disease|gynecologic disease
5758419|NCT00290459|Gynecologic Cancer|gynecologic cancer
5758420|NCT00290459|Prognostic Markers|prognostic markers
5758421|NCT00290433|Lymphoma|lymphoma
5758422|NCT00290433|Peripheral T Cell|peripheral t cell
5758423|NCT00290433|HCVIDDOXIL Regimen|hcviddoxil regimen
5758424|NCT00290433|ARA-C|ara-c
5758425|NCT00290433|Cytosar|cytosar
5758426|NCT00290433|DepoCyt|depocyt
5758427|NCT00290433|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5758428|NCT00290433|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5758429|NCT00290433|Doxorubicin hydrochloride|doxorubicin hydrochloride
5758430|NCT00290433|Doxil|doxil
5758431|NCT00290433|Cyclophosphamide|cyclophosphamide
5758432|NCT00290433|Cytoxan|cytoxan
5758433|NCT00290433|Neosar|neosar
5758434|NCT00290433|Dexamethasone|dexamethasone
5758435|NCT00290433|Decadron|decadron
5758436|NCT00290433|Mesna|mesna
5758437|NCT00290433|Methotrexate|methotrexate
5758438|NCT00290433|Vincristine|vincristine
5758439|NCT00290433|G-CSF|g-csf
5758440|NCT00290433|Filgrastim|filgrastim
5758441|NCT00290433|Neupogen|neupogen
5758442|NCT00290420|malaria|malaria
5766742|NCT00256490|FDG|fdg
5758443|NCT00290420|Plasmodium vivax|plasmodium vivax
5758444|NCT00290420|pregnancy|pregnancy
5758445|NCT00290420|chemoprophylaxis|chemoprophylaxis
5758446|NCT00290407|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5758447|NCT00290407|small lymphocytic lymphoma|small lymphocytic lymphoma
5758448|NCT00290407|rituximab|rituximab
5758449|NCT00290407|beta-glucan|beta-glucan
5758450|NCT00290394|Blood Pressure,|blood pressure,
5758451|NCT00290394|rosiglitazone,Diabetes Mellitus, Type 2,|rosiglitazone,diabetes mellitus, type 2,
5758452|NCT00290381|Allergic rhinitis|allergic rhinitis
5758453|NCT00290368|Nasal allergen challenge|nasal allergen challenge
5758454|NCT00290368|Allergic rhinitis|allergic rhinitis
5758455|NCT00290368|Timothy grass pollen|timothy grass pollen
5758456|NCT00290368|inflammatory mediators|inflammatory mediators
5758457|NCT00290329|Safety|safety
5758458|NCT00290329|Meningococcal disease|meningococcal disease
5758459|NCT00290329|Meningitidis serogroups A, C,W & Y diseases|meningitidis serogroups a, c,w & y diseases
5758460|NCT00290329|Meningococcal vaccine|meningococcal vaccine
5758461|NCT00290316|Hepatocellular carcinoma|hepatocellular carcinoma
5758462|NCT00290316|Cholangiocarcinoma|cholangiocarcinoma
5758463|NCT00290316|Metastasis|metastasis
5758464|NCT00290316|Liver neoplasm|liver neoplasm
5758465|NCT00290290|Prevention|prevention
5758466|NCT00290290|Antiseptic Preoperative Scrub|antiseptic preoperative scrub
5758467|NCT00290290|Postoperative Wound Infection|postoperative wound infection
5758468|NCT00290251|Endometrium|endometrium
5758469|NCT00290251|Progesterone|progesterone
5758470|NCT00290251|Estrogen|estrogen
5758471|NCT00290251|Fibroid|fibroid
5758472|NCT00290251|Hysterectomy|hysterectomy
5758473|NCT00290251|Leiomyoma|leiomyoma
5758474|NCT00290251|Uterine Fibroids|uterine fibroids
5758475|NCT00290251|Fibroids|fibroids
5758476|NCT00290238|Chronic Low Back Pain|chronic low back pain
5758477|NCT00290238|Lower Extremity Pain|lower extremity pain
5758478|NCT00290238|Central Sensitization|central sensitization
5758479|NCT00290238|Percutaneous Neuromodulation Therapy|percutaneous neuromodulation therapy
5758480|NCT00290225|Posttraumatic stress disorder|posttraumatic stress disorder
5758481|NCT00290225|depression|depression
5758482|NCT00290225|disaster mental health|disaster mental health
5758484|NCT00290225|Breathwork|breathwork
5758485|NCT00290225|exposure treatments|exposure treatments
5758486|NCT00290212|Women|women
5758487|NCT00290212|Bone density|bone density
5758489|NCT00290212|Dietary Supplements|dietary supplements
5758490|NCT00290212|Vitamin K2|vitamin k2
5758491|NCT00290199|Fetal Membranes, Premature Rupture|fetal membranes, premature rupture
5758492|NCT00290199|Labor, Induced|labor, induced
5758493|NCT00290199|Foley Catheter|foley catheter
5758494|NCT00290186|Cerebral Palsy|cerebral palsy
5758495|NCT00290186|Spastic Cerebral Palsy|spastic cerebral palsy
5758497|NCT00290186|Hyperbaric|hyperbaric
5758498|NCT00290186|HBOT|hbot
5758499|NCT00290173|pre term labor|pre term labor
5758500|NCT00290173|therapy|therapy
5758501|NCT00290173|maintenance|maintenance
5758502|NCT00290160|Hyperkalemia|hyperkalemia
5758503|NCT00290160|Protein|protein
5758504|NCT00290160|Hyperglycemia|hyperglycemia
5758505|NCT00290160|ELBW|elbw
5758506|NCT00290147|Dengue|dengue
5758507|NCT00290147|DNA vaccine|dna vaccine
5758508|NCT00290134|Hypogonadism|hypogonadism
5758509|NCT00290134|Testosterone|testosterone
5758510|NCT00290121|Schizophrenia|schizophrenia
5758511|NCT00290121|Atypical antipsychotics|atypical antipsychotics
5758512|NCT00290121|Weight gain|weight gain
5758513|NCT00290121|Appetite|appetite
5758514|NCT00290121|fMRI|fmri
5758516|NCT00290108|Propofol|propofol
5758517|NCT00290108|hemodynamic|hemodynamic
5758518|NCT00290108|pharmacokinetic|pharmacokinetic
5758519|NCT00290095|Multiple Myeloma|multiple myeloma
5758520|NCT00290095|Quality of Life|quality of life
5758521|NCT00290095|Response Shift|response shift
5758522|NCT00290095|Clinically Important Difference|clinically important difference
5758523|NCT00290082|sedation|sedation
5758524|NCT00290082|midazolam|midazolam
5758525|NCT00290082|loxapine|loxapine
5758526|NCT00290082|agitation|agitation
5758527|NCT00290082|emergency department|emergency department
5758528|NCT00290082|toxicological analysis|toxicological analysis
5758529|NCT00290069|Renal function|renal function
5758530|NCT00290069|Serum creatinine|serum creatinine
5758531|NCT00290069|Immunosuppression|immunosuppression
5758532|NCT00290069|Rejection|rejection
5758533|NCT00290056|CHD|chd
5758534|NCT00290056|Arrhythmia|arrhythmia
5758535|NCT00290056|ICD|icd
5758536|NCT00290056|Omega-3 PUFA|omega-3 pufa
5758537|NCT00290056|Nutrition|nutrition
5758538|NCT00290043|Insulin glulisine|insulin glulisine
5758539|NCT00290043|Diabetes mellitus Type 1|diabetes mellitus type 1
5758540|NCT00290043|Postprandial Period|postprandial period
5758541|NCT00290043|Pharmacokinetics|pharmacokinetics
5758542|NCT00290043|Glucodynamics|glucodynamics
5758543|NCT00290030|acute urinary retention|acute urinary retention
5758544|NCT00290030|International Prostate Symptom Score (IPSS)|international prostate symptom score (ipss)
5758545|NCT00290004|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5681020|NCT00575172|macrovascular event|macrovascular event
5758546|NCT00290004|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5758547|NCT00290004|Leukemia|leukemia
5758548|NCT00290004|Lymphoma|lymphoma
5758549|NCT00290004|Motexafin Gadolinium|motexafin gadolinium
5758550|NCT00290004|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5758551|NCT00290004|Relapsed Small Lymphocytic Lymphoma|relapsed small lymphocytic lymphoma
5758552|NCT00290004|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5758553|NCT00290004|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
5758554|NCT00289978|Multiple Sclerosis|multiple sclerosis
5758555|NCT00289978|FTY720|fty720
5758556|NCT00289978|Fingolimod|fingolimod
5758557|NCT00289965|Alcohol Abuse|alcohol abuse
5758558|NCT00289965|Alcohol Drinking|alcohol drinking
5758559|NCT00289965|Intervention Studies|intervention studies
5758750|NCT00288964|fiber|fiber
5758560|NCT00289965|Computer-Assisted Instruction|computer-assisted instruction
5758561|NCT00289965|College Students|college students
5758562|NCT00289952|HIV infections|hiv infections
5758565|NCT00289952|Peripheral Blood Mononuclear Cells|peripheral blood mononuclear cells
5758566|NCT00289952|Valproic Acid|valproic acid
5758567|NCT00289952|Treatment Experienced|treatment experienced
5758568|NCT00289939|women|women
5758569|NCT00289939|women's health|women's health
5758570|NCT00289939|HIV|hiv
5758571|NCT00289939|risk factors|risk factors
5758572|NCT00289939|risk behaviors|risk behaviors
5758573|NCT00289939|prevention|prevention
5758574|NCT00289939|motivational interviewing|motivational interviewing
5758575|NCT00289939|domestic violence|domestic violence
5758576|NCT00289939|partner violence|partner violence
5758577|NCT00289939|behavioral trial|behavioral trial
5758578|NCT00289939|community justice|community justice
5758579|NCT00289939|criminal justice|criminal justice
5758580|NCT00289926|low libido|low libido
5758581|NCT00289926|lack of wellbeing|lack of wellbeing
5758582|NCT00289913|Hepatitis A virus|hepatitis a virus
5758583|NCT00289861|Schizophrenia|schizophrenia
5758585|NCT00289861|prolactin|prolactin
5758586|NCT00289861|clozapine|clozapine
5758587|NCT00289835|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5758588|NCT00289835|Drug Eluting Stent|drug eluting stent
5758589|NCT00289835|Saphenous Vein Graft|saphenous vein graft
5758590|NCT00289822|chronic heart failure|chronic heart failure
5758591|NCT00289822|myocardial infarction|myocardial infarction
5758592|NCT00289783|Primary and booster vaccination|primary and booster vaccination
5758593|NCT00289783|Neisseria meningitidis|neisseria meningitidis
5758594|NCT00289783|Hib disease|hib disease
5758595|NCT00289783|Meningococcal vaccine|meningococcal vaccine
5758596|NCT00289783|Meningococcal disease|meningococcal disease
5758597|NCT00289783|Children|children
5758598|NCT00289783|Immunogenicity|immunogenicity
5758599|NCT00289783|Safety|safety
5758600|NCT00289783|Infants|infants
5758601|NCT00289770|TWINRIX™ ADULT|twinrix™ adult
5758602|NCT00289770|Hepatitis A|hepatitis a
5758603|NCT00289770|Hepatitis B|hepatitis b
5758604|NCT00289757|Havrix™|havrix™
5758605|NCT00289757|Hepatitis A|hepatitis a
5758606|NCT00289744|Hepatitis A|hepatitis a
5758607|NCT00289744|Hepatitis B|hepatitis b
5758608|NCT00289744|TWINRIX™ ADULT|twinrix™ adult
5758609|NCT00289731|Combined hepatitis A and hepatitis B vaccine|combined hepatitis a and hepatitis b vaccine
5758610|NCT00289731|Hepatitis B|hepatitis b
5758611|NCT00289731|Hepatitis A|hepatitis a
5758612|NCT00289731|Monovalent hepatitis A and hepatitis B vaccines|monovalent hepatitis a and hepatitis b vaccines
5758613|NCT00289718|Combined Hepatitis A and B vaccine|combined hepatitis a and b vaccine
5758614|NCT00289718|Hepatitis A|hepatitis a
5758615|NCT00289718|Hepatitis B|hepatitis b
5758616|NCT00289705|Obesity|obesity
5758617|NCT00289705|Surgery|surgery
5758618|NCT00289705|Adolescent|adolescent
5758619|NCT00289705|Roux-en-Y gastric bypass|roux-en-y gastric bypass
5758620|NCT00289705|Laparoscopic|laparoscopic
5758621|NCT00289666|Sleep Disorder|sleep disorder
5758622|NCT00289666|CPAP|cpap
5758623|NCT00289653|nicotine dependence,|nicotine dependence,
5758624|NCT00289653|transdermal nicotine patch,|transdermal nicotine patch,
5758625|NCT00289653|smoking while receiving nicotine replacement,|smoking while receiving nicotine replacement,
5758626|NCT00289653|comorbidities|comorbidities
5758627|NCT00289640|Stage III (unresectable)|stage iii (unresectable)
5758628|NCT00289640|Stage IV melanoma|stage iv melanoma
5758629|NCT00289627|Previously treated melanoma|previously treated melanoma
5758630|NCT00289627|Unresectable Stage III|unresectable stage iii
5758631|NCT00289627|Stage IV|stage iv
5758632|NCT00289614|contrast induced nephropathy|contrast induced nephropathy
5758633|NCT00289601|aspirin|aspirin
5758634|NCT00289601|clopidogrel|clopidogrel
5758635|NCT00289601|resistance|resistance
5758636|NCT00289601|angioplasty|angioplasty
5758637|NCT00289601|percutaneous coronary intervention|percutaneous coronary intervention
5758638|NCT00289601|myocardial infarction|myocardial infarction
5758639|NCT00289588|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5758640|NCT00289588|Staphylococcus aureus|staphylococcus aureus
5758641|NCT00289588|MRSA|mrsa
5758642|NCT00289588|CA-MRSA|ca-mrsa
5758643|NCT00289575|Femur head aseptic osteonecrosis|femur head aseptic osteonecrosis
5758644|NCT00289575|Bone reconstruction|bone reconstruction
5758645|NCT00289575|Macroporous biphasic calcium phosphate granules|macroporous biphasic calcium phosphate granules
5758647|NCT00289562|leukemia|leukemia
5758648|NCT00289562|B-lymphoblastic leukemia|b-lymphoblastic leukemia
5758649|NCT00289562|lymphoma|lymphoma
5758650|NCT00289562|B-All|b-all
5758651|NCT00289549|CLL|cll
5758652|NCT00289549|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5758653|NCT00289549|leukemia|leukemia
5758654|NCT00289549|Advanced, fludarabine-refractory CLL|advanced, fludarabine-refractory cll
5758751|NCT00288964|respiratory|respiratory
5758752|NCT00288964|oxygenator|oxygenator
5758753|NCT00288964|Heart Failure|heart failure
5749371|NCT00322348|cancer|cancer
5758655|NCT00289523|Major Depressive Disorder, Depressive Disorder, Unipolar Depression, Antidepressants, Electroencephalography|major depressive disorder, depressive disorder, unipolar depression, antidepressants, electroencephalography
5758656|NCT00289497|Charcot|charcot
5758657|NCT00289497|foot|foot
5758658|NCT00289497|ulceration|ulceration
5758659|NCT00289497|neuropathy|neuropathy
5758660|NCT00289484|Mood disorder|mood disorder
5758661|NCT00289471|Sensitivity and specificity|sensitivity and specificity
5758662|NCT00289471|Physician's practice patterns|physician's practice patterns
5758663|NCT00289471|Health Care costs|health care costs
5758664|NCT00289471|Quality of Health Care|quality of health care
5758665|NCT00289458|older adults, falls, arthritis, aquatic, exercise|older adults, falls, arthritis, aquatic, exercise
5758666|NCT00289419|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5758667|NCT00289419|Anesthetics, Local|anesthetics, local
5758668|NCT00289419|Pain, Postoperative|pain, postoperative
5758669|NCT00289406|hypertension|hypertension
5758670|NCT00289380|Nutritional Risk Screening(NRS)|nutritional risk screening(nrs)
5758671|NCT00289380|Malnutrition|malnutrition
5758672|NCT00289380|Overweight|overweight
5758673|NCT00289380|Obesity|obesity
5754095|NCT00304512|AT1001|at1001
5758674|NCT00289380|Clinical nutritional support|clinical nutritional support
5758675|NCT00289380|Clinical outcome|clinical outcome
5758676|NCT00289380|Cost effectiveness|cost effectiveness
5758677|NCT00289380|Complication|complication
5758678|NCT00289380|Infective complications|infective complications
5758679|NCT00289354|chromium|chromium
5758680|NCT00289354|chromium picolinate|chromium picolinate
5758681|NCT00289354|type 2 diabetes mellitus|type 2 diabetes mellitus
5758682|NCT00289354|HbA1c|hba1c
5758683|NCT00289354|hyperglycemia|hyperglycemia
5758684|NCT00289354|cholesterol|cholesterol
5758685|NCT00289302|Heart Failure|heart failure
5758686|NCT00289302|Cardiac pacing|cardiac pacing
5758687|NCT00289302|Cardiac resynchronization therapy|cardiac resynchronization therapy
5758688|NCT00289302|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5758689|NCT00289289|Atrial Fibrillation|atrial fibrillation
5758690|NCT00289289|Atrial Tachyarrhythmia|atrial tachyarrhythmia
5758691|NCT00289289|Arrhythmia|arrhythmia
5758692|NCT00289289|Bradycardia|bradycardia
5758693|NCT00289289|Cardiac Pacemaker|cardiac pacemaker
5758694|NCT00289289|IPG Indication|ipg indication
5758696|NCT00289276|Cardiomyopathy|cardiomyopathy
5758697|NCT00289276|Ventricular Ejection Fraction|ventricular ejection fraction
5758698|NCT00289276|Congestive Heart Failure|congestive heart failure
5758699|NCT00289276|Impedance|impedance
5758700|NCT00289263|metastatic breast cancer|metastatic breast cancer
5758701|NCT00289263|maintenance chemotherapy|maintenance chemotherapy
5758702|NCT00289250|Malaria|malaria
5758703|NCT00289250|Gametocytes|gametocytes
5758704|NCT00289250|Asymptomatic carriers|asymptomatic carriers
5758705|NCT00289237|Lifestyle intervention|lifestyle intervention
5758706|NCT00289237|Behavioural changes|behavioural changes
5758708|NCT00289237|Type 2 diabetes|type 2 diabetes
5758709|NCT00289224|bivalent killed whole cell oral cholera vaccine|bivalent killed whole cell oral cholera vaccine
5758710|NCT00289224|double blind randomized clinical trial|double blind randomized clinical trial
5758711|NCT00289211|Hereditary angioedema|hereditary angioedema
5758712|NCT00289211|HAE|hae
5758713|NCT00289211|C1 esterase inhibitor (human)|c1 esterase inhibitor (human)
5758714|NCT00289211|C1INH-nf|c1inh-nf
5758715|NCT00289198|GW685698X|gw685698x
5758716|NCT00289198|perennial allergic rhinitis|perennial allergic rhinitis
5758717|NCT00289198|allergic rhinitis|allergic rhinitis
5758718|NCT00289185|Coccidiosis|coccidiosis
5758719|NCT00289185|Parasitic Diseases|parasitic diseases
5758720|NCT00289185|Malaria, Falciparum|malaria, falciparum
5758721|NCT00289185|Malaria|malaria
5758722|NCT00289159|aged 18-50|aged 18-50
5758723|NCT00289159|remitting evolution|remitting evolution
5758724|NCT00289159|less than two years of evolution|less than two years of evolution
5758725|NCT00289159|MS patients|ms patients
5758726|NCT00289146|kidney cancer, immunology|kidney cancer, immunology
5758727|NCT00289133|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5758728|NCT00289120|urolithiasis, cola|urolithiasis, cola
5758729|NCT00289107|Total Knee Replacement|total knee replacement
5758730|NCT00289107|Knee Prosthesis|knee prosthesis
5758731|NCT00289081|Total Knee Replacement|total knee replacement
5758732|NCT00289068|cataract surgery|cataract surgery
5758733|NCT00289068|phacoemulsification sleeve|phacoemulsification sleeve
5757910|NCT00291460|COPD|copd
5758734|NCT00289055|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5758735|NCT00289042|atrial fibrillation|atrial fibrillation
5758736|NCT00289042|atrial thrombus|atrial thrombus
5758737|NCT00289042|cardioversion|cardioversion
5758738|NCT00289042|enoxaparin|enoxaparin
5758739|NCT00289042|low molecular weight heparin|low molecular weight heparin
5758740|NCT00289042|transesophageal echocardiography|transesophageal echocardiography
5758741|NCT00289016|gene transfer|gene transfer
5758742|NCT00289016|gene therapy|gene therapy
5758743|NCT00289016|oncolytic virus|oncolytic virus
5758745|NCT00289016|melanoma|melanoma
5758746|NCT00288990|MS|ms
5758747|NCT00288977|Diabetes|diabetes
5758748|NCT00288977|Islet Transplantation|islet transplantation
5758756|NCT00288938|Suspicious mole|suspicious mole
5758757|NCT00288938|Congenital Nevus|congenital nevus
5758758|NCT00288938|Skin Cancer|skin cancer
5758759|NCT00288938|Moles|moles
5758760|NCT00288938|Pigmented lesion|pigmented lesion
5758761|NCT00288938|LCMN|lcmn
5758762|NCT00288912|Self-Care|self-care
5758763|NCT00288912|Telemedicine|telemedicine
5758764|NCT00288912|Pain|pain
5758765|NCT00288912|Veterans|veterans
5758766|NCT00288899|Informed Consent|informed consent
5758767|NCT00288899|Medical Record Systems, computerized|medical record systems, computerized
5758768|NCT00288899|Comprehension|comprehension
5758769|NCT00288899|Anxiety|anxiety
5758770|NCT00288899|Personal Satisfactin|personal satisfactin
5758771|NCT00288886|Compliance|compliance
5758772|NCT00288886|Aftercare|aftercare
5758773|NCT00288886|Reinforcement, social|reinforcement, social
5758774|NCT00288886|Alcoholics Anonymous|alcoholics anonymous
5758775|NCT00288886|Support Groups|support groups
5758776|NCT00288886|Treatment Outcome|treatment outcome
5758777|NCT00288873|Vitamin D deficiency|vitamin d deficiency
5758778|NCT00288873|Secondary hyperparathyroidism|secondary hyperparathyroidism
5758779|NCT00288873|Obesity|obesity
5758780|NCT00288860|telemedicine|telemedicine
5758781|NCT00288860|treatment compliance|treatment compliance
5758783|NCT00288847|Patella Dislocation|patella dislocation
5758784|NCT00288847|Surface EMG|surface emg
5758785|NCT00288847|Gender difference|gender difference
5758786|NCT00288834|stroke|stroke
5758787|NCT00288834|dysphagia|dysphagia
5758788|NCT00288834|rehabilitation|rehabilitation
5758789|NCT00288834|biofeedback|biofeedback
5758790|NCT00288821|Gynaecological malignancy|gynaecological malignancy
5758791|NCT00288821|Diagnostic Accuracy|diagnostic accuracy
5758792|NCT00288821|DWIBS|dwibs
5758793|NCT00288821|Lymph Nodes|lymph nodes
5758794|NCT00288821|Metastasis|metastasis
5758795|NCT00288808|Blood|blood
5758796|NCT00288808|Coagulation|coagulation
5758797|NCT00288808|PT/InR|pt/inr
5758798|NCT00288808|Warfarin|warfarin
5758799|NCT00288808|Mechanical Valve|mechanical valve
5758800|NCT00288795|Fatigue|fatigue
5758801|NCT00288795|Polarity|polarity
5758802|NCT00288795|Massage|massage
5758803|NCT00288782|Mirtazapine|mirtazapine
5758804|NCT00288782|Antidepressant|antidepressant
5758805|NCT00288782|Positron Emission Tomography|positron emission tomography
5758806|NCT00288769|Recurrent aphthous stomatitis|recurrent aphthous stomatitis
5758807|NCT00288769|vitamin B12|vitamin b12
5758808|NCT00288756|arrythmias|arrythmias
5758809|NCT00288730|Heart Failure|heart failure
5758810|NCT00288730|Renal Dysfunction|renal dysfunction
5758811|NCT00288730|Cardiomyopathy|cardiomyopathy
5758812|NCT00288730|Heart Decompensation|heart decompensation
5758813|NCT00288730|Dyspnea Paroxysmal|dyspnea paroxysmal
5758814|NCT00288704|Familial Cold Autoinflammatory Syndrome (FCAS)|familial cold autoinflammatory syndrome (fcas)
5758815|NCT00288704|Muckle-Wells Syndrome (MWS)|muckle-wells syndrome (mws)
5758816|NCT00288704|CIAS1|cias1
5758817|NCT00288704|NLRP-3|nlrp-3
5758818|NCT00288704|PYPAF1|pypaf1
5758819|NCT00288704|Cryopyrin|cryopyrin
5758820|NCT00288704|CAPS|caps
5758821|NCT00288704|Interleukin-1|interleukin-1
5758822|NCT00288691|Treatment-resistant menorrhagia|treatment-resistant menorrhagia
5758823|NCT00288678|Diabetic shared care|diabetic shared care
5758824|NCT00288678|Health manager|health manager
5758825|NCT00288678|Prospective Study|prospective study
5758826|NCT00288678|Health Care Quality, Access, and Evaluation|health care quality, access, and evaluation
5758827|NCT00288665|Myocardial infarction|myocardial infarction
5758828|NCT00288665|aspiration|aspiration
5758829|NCT00288665|thrombectomy|thrombectomy
5758830|NCT00288665|ventricular remodeling|ventricular remodeling
5758831|NCT00288639|Pregabalin for partial seizures|pregabalin for partial seizures
5758832|NCT00288626|hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5758833|NCT00288626|HCT- autologous hematopoietic cell transplant|hct- autologous hematopoietic cell transplant
5758834|NCT00288626|HDIT-high-dose immunosuppressive therapy|hdit-high-dose immunosuppressive therapy
5758835|NCT00288626|BEAM -Carmustine (BCNU), Etoposide (VP-16), Cytarabine (ara-C), and Melphalan|beam -carmustine (bcnu), etoposide (vp-16), cytarabine (ara-c), and melphalan
5758836|NCT00288613|ESRD|esrd
5758837|NCT00288613|Daily Hemodialysis|daily hemodialysis
5758838|NCT00288613|Hemodialysis|hemodialysis
5758839|NCT00288613|Kidney Failure|kidney failure
5758009|NCT00291109|Ki-67|ki-67
5758840|NCT00288613|Kidney Disease|kidney disease
5758841|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5758842|NCT00288600|Hyperbilirubinemia|hyperbilirubinemia
5758843|NCT00288600|Erythroblastosis, Fetal|erythroblastosis, fetal
5758844|NCT00288600|Exchange Transfusion, Whole Blood|exchange transfusion, whole blood
5758845|NCT00288587|Heart Failure|heart failure
5758846|NCT00288587|Congestive Heart Failure|congestive heart failure
5758848|NCT00288574|Depression|depression
5758849|NCT00288561|ARMD, ranibizumab, verteporfin|armd, ranibizumab, verteporfin
5758850|NCT00288535|coronary bifurcation ; PCI; modified T-Stenting; sirolimus stent|coronary bifurcation ; pci; modified t-stenting; sirolimus stent
5758851|NCT00288496|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence|mechanical bowel preparation, colorectal surgery, anastomotic dehiscence
5759617|NCT00285155|behaviour|behaviour
5758852|NCT00288444|Advanced malignancies.|advanced malignancies.
5758854|NCT00288431|sarcoma|sarcoma
5758855|NCT00288418|Colonization of the catheter|colonization of the catheter
5758856|NCT00288418|Catheter related bloodstream infection|catheter related bloodstream infection
5758857|NCT00288405|Intracranial|intracranial
5758858|NCT00288405|Wide-neck|wide-neck
5758859|NCT00288405|Saccular|saccular
5758860|NCT00288405|Aneurysms|aneurysms
5758861|NCT00288379|Asthma|asthma
5758862|NCT00288379|allergen challenge|allergen challenge
5758863|NCT00288379|airway responsiveness|airway responsiveness
5758864|NCT00288379|airway inflammation|airway inflammation
5758865|NCT00288379|Symbicort®|symbicort®
5758866|NCT00288366|schizophrenia|schizophrenia
5758867|NCT00288366|schizoaffective disorder|schizoaffective disorder
5758868|NCT00288366|bipolar disorder|bipolar disorder
5758869|NCT00288366|metabolic syndrome|metabolic syndrome
5758870|NCT00288353|schizophrenia|schizophrenia
5758871|NCT00288353|schizoaffective disorder|schizoaffective disorder
5758872|NCT00288353|bipolar disorder|bipolar disorder
5758873|NCT00288353|metabolic syndrome|metabolic syndrome
5758874|NCT00288340|psychotic disorders|psychotic disorders
5758875|NCT00288340|auditory hallucinations|auditory hallucinations
5758876|NCT00288340|brain structure|brain structure
5758877|NCT00288340|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)|psychiatric disorder with auditory hallucinations (at least one every 20 minutes)
5758967|NCT00287963|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5758878|NCT00288340|schizophrenia/schizoaffective disorder without auditory hallucinations|schizophrenia/schizoaffective disorder without auditory hallucinations
5758879|NCT00288327|diet|diet
5758880|NCT00288327|physical activity|physical activity
5758881|NCT00288327|smoking cessation|smoking cessation
5758882|NCT00288314|PTSD|ptsd
5758883|NCT00288314|MRI, Functional|mri, functional
5758884|NCT00288314|Anxiety|anxiety
5758885|NCT00288314|Working Memory|working memory
5758886|NCT00288314|Processing speed|processing speed
5758887|NCT00288301|diet|diet
5758888|NCT00288301|physical activity|physical activity
5758889|NCT00288301|weight management|weight management
5758890|NCT00288275|Ovarian Cancer|ovarian cancer
5758891|NCT00288275|Fallopian Tube Cancer|fallopian tube cancer
5758892|NCT00288275|Peritoneal Cancer|peritoneal cancer
5758893|NCT00288275|Assay|assay
5758894|NCT00288275|Chemotherapy|chemotherapy
5758895|NCT00288275|Recurrent|recurrent
5758896|NCT00288275|Refractory|refractory
5758897|NCT00288275|Persistent|persistent
5758898|NCT00288275|Chemoresponse|chemoresponse
5758899|NCT00288275|Sensitivity|sensitivity
5758900|NCT00288275|Precision Therapeutics|precision therapeutics
5758901|NCT00288262|hot flashes|hot flashes
5758902|NCT00288262|melatonin|melatonin
5758903|NCT00288262|depression|depression
5758904|NCT00288262|sleep|sleep
5758905|NCT00288262|luteinizing hormone|luteinizing hormone
5758906|NCT00288262|postmenopause|postmenopause
5758907|NCT00288249|Breast Cancer|breast cancer
5758908|NCT00288249|Breast Neoplasms|breast neoplasms
5758909|NCT00288236|Type 2 diabetes mellitus|type 2 diabetes mellitus
5758910|NCT00288210|Myocardial Infarction|myocardial infarction
5758911|NCT00288210|Stents|stents
5758912|NCT00288210|Sirolimus|sirolimus
5758913|NCT00288210|abciximab|abciximab
5758914|NCT00288145|worksite|worksite
5758915|NCT00288145|weight gain prevention (among adults)|weight gain prevention (among adults)
5758916|NCT00288145|obesity (among adults)|obesity (among adults)
5758917|NCT00288145|physical activity|physical activity
5758918|NCT00288145|nutrition|nutrition
5758919|NCT00288132|Diabetes|diabetes
5758920|NCT00288132|self-management|self-management
5758921|NCT00288132|telemedicine|telemedicine
5758922|NCT00288132|retinal|retinal
5758923|NCT00288132|screening|screening
5758924|NCT00288119|Barrett's Esophagus|barrett's esophagus
5758925|NCT00288106|recurrent prostate cancer|recurrent prostate cancer
5758926|NCT00288106|stage I prostate cancer|stage i prostate cancer
5758927|NCT00288106|stage II prostate cancer|stage ii prostate cancer
5758928|NCT00288106|stage III prostate cancer|stage iii prostate cancer
5758929|NCT00288106|stage IV prostate cancer|stage iv prostate cancer
5758930|NCT00288080|stage III prostate cancer|stage iii prostate cancer
5758931|NCT00288080|stage IIB prostate cancer|stage iib prostate cancer
5758932|NCT00288080|stage IIA prostate cancer|stage iia prostate cancer
5758933|NCT00288080|stage IV prostate cancer|stage iv prostate cancer
5758934|NCT00288054|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5758935|NCT00288054|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5758936|NCT00288054|adenocarcinoma of the lung|adenocarcinoma of the lung
5758937|NCT00288054|large cell lung cancer|large cell lung cancer
5758938|NCT00288054|squamous cell lung cancer|squamous cell lung cancer
5758939|NCT00288028|stage I multiple myeloma|stage i multiple myeloma
5758940|NCT00288028|stage II multiple myeloma|stage ii multiple myeloma
5758941|NCT00288028|stage III multiple myeloma|stage iii multiple myeloma
5758942|NCT00288028|refractory multiple myeloma|refractory multiple myeloma
5758943|NCT00288015|adult angiosarcoma|adult angiosarcoma
5758944|NCT00288015|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5758945|NCT00288015|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5758946|NCT00288015|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5758947|NCT00288015|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5758948|NCT00288015|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5758949|NCT00288002|inflammatory breast cancer|inflammatory breast cancer
5758951|NCT00288002|stage IIIA breast cancer|stage iiia breast cancer
5758952|NCT00288002|stage IIIB breast cancer|stage iiib breast cancer
5758953|NCT00288002|stage IIIC breast cancer|stage iiic breast cancer
5758954|NCT00288002|stage IA breast cancer|stage ia breast cancer
5758955|NCT00288002|stage IB breast cancer|stage ib breast cancer
5758956|NCT00288002|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5758957|NCT00288002|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5758958|NCT00288002|HER2-negative breast cancer|her2-negative breast cancer
5758959|NCT00288002|HER2-positive breast cancer|her2-positive breast cancer
5758960|NCT00287989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5758961|NCT00287989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5758962|NCT00287989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5758963|NCT00287976|childhood hepatoblastoma|childhood hepatoblastoma
5758964|NCT00287976|recurrent childhood liver cancer|recurrent childhood liver cancer
5758965|NCT00287963|adenocarcinoma of the lung|adenocarcinoma of the lung
5758966|NCT00287963|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5759054|NCT00287742|dementia|dementia
5758968|NCT00287963|combined type small cell lung cancer|combined type small cell lung cancer
5758969|NCT00287963|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5758970|NCT00287963|large cell lung cancer|large cell lung cancer
5758971|NCT00287963|lymphocyte-like type small cell lung cancer|lymphocyte-like type small cell lung cancer
5758972|NCT00287963|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5758973|NCT00287963|recurrent small cell lung cancer|recurrent small cell lung cancer
5758974|NCT00287963|squamous cell lung cancer|squamous cell lung cancer
5758975|NCT00287950|disseminated neuroblastoma|disseminated neuroblastoma
5758976|NCT00287950|localized resectable neuroblastoma|localized resectable neuroblastoma
5758977|NCT00287950|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5758978|NCT00287950|regional neuroblastoma|regional neuroblastoma
5758979|NCT00287950|stage 4S neuroblastoma|stage 4s neuroblastoma
5758980|NCT00287924|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5758981|NCT00287924|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5758982|NCT00287924|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5758983|NCT00287911|cervical adenocarcinoma|cervical adenocarcinoma
5758984|NCT00287911|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5758985|NCT00287911|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5758986|NCT00287911|stage IB cervical cancer|stage ib cervical cancer
5758987|NCT00287911|stage IIA cervical cancer|stage iia cervical cancer
5758988|NCT00287911|stage IIB cervical cancer|stage iib cervical cancer
5758989|NCT00287911|stage III cervical cancer|stage iii cervical cancer
5758990|NCT00287911|stage IVA cervical cancer|stage iva cervical cancer
5758991|NCT00287898|breast cancer|breast cancer
5758992|NCT00287885|recurrent cervical cancer|recurrent cervical cancer
5758993|NCT00287885|stage III cervical cancer|stage iii cervical cancer
5758994|NCT00287885|stage IVA cervical cancer|stage iva cervical cancer
5758995|NCT00287885|stage IVB cervical cancer|stage ivb cervical cancer
5758996|NCT00287885|stage III endometrial carcinoma|stage iii endometrial carcinoma
5758997|NCT00287885|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5758998|NCT00287885|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5758999|NCT00287885|fallopian tube cancer|fallopian tube cancer
5759000|NCT00287885|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5759001|NCT00287885|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5759002|NCT00287885|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5759003|NCT00287885|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5759004|NCT00287885|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5759005|NCT00287885|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5759006|NCT00287885|recurrent uterine sarcoma|recurrent uterine sarcoma
5759007|NCT00287885|stage III uterine sarcoma|stage iii uterine sarcoma
5759008|NCT00287885|stage IV uterine sarcoma|stage iv uterine sarcoma
5759009|NCT00287885|stage III vaginal cancer|stage iii vaginal cancer
5759010|NCT00287885|recurrent vaginal cancer|recurrent vaginal cancer
5759011|NCT00287885|stage IVA vaginal cancer|stage iva vaginal cancer
5759012|NCT00287885|stage IVB vaginal cancer|stage ivb vaginal cancer
5759013|NCT00287885|stage III vulvar cancer|stage iii vulvar cancer
5759014|NCT00287885|recurrent vulvar cancer|recurrent vulvar cancer
5759015|NCT00287885|stage IV vulvar cancer|stage iv vulvar cancer
5759016|NCT00287885|ovarian sarcoma|ovarian sarcoma
5759017|NCT00287885|ovarian stromal cancer|ovarian stromal cancer
5759018|NCT00287885|peritoneal cavity cancer|peritoneal cavity cancer
5759019|NCT00287872|stage II multiple myeloma|stage ii multiple myeloma
5749776|NCT00320827|Cancer|cancer
5759020|NCT00287872|stage III multiple myeloma|stage iii multiple myeloma
5759021|NCT00287859|fallopian tube cancer|fallopian tube cancer
5759022|NCT00287859|peritoneal cavity cancer|peritoneal cavity cancer
5759023|NCT00287859|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5759024|NCT00287846|desmoid tumor|desmoid tumor
5759025|NCT00287820|schizophrenia|schizophrenia
5759026|NCT00287820|diabetes|diabetes
5759027|NCT00287820|metabolic syndrome|metabolic syndrome
5759028|NCT00287820|hyperglycemia|hyperglycemia
5759030|NCT00287820|insulin|insulin
5759031|NCT00287820|lipids|lipids
5759032|NCT00287820|IL-6|il-6
5759033|NCT00287820|prolactin|prolactin
5759034|NCT00287807|Diabetes mellitus, type 2|diabetes mellitus, type 2
5759035|NCT00287807|Blood Glucose Self-Monitoring|blood glucose self-monitoring
5759036|NCT00287807|life style|life style
5759037|NCT00287794|rheumatoid arthritis|rheumatoid arthritis
5759038|NCT00287794|sleep disturbance|sleep disturbance
5759039|NCT00287781|Migraine|migraine
5759040|NCT00287781|Lidocaine|lidocaine
5759041|NCT00287781|Headache|headache
5759042|NCT00287768|gastric cancer|gastric cancer
5759043|NCT00287768|advanced gastric cancer|advanced gastric cancer
5759045|NCT00287768|docetaxel|docetaxel
5759046|NCT00287768|phase III study|phase iii study
5759047|NCT00287755|gastric cancer|gastric cancer
5759048|NCT00287755|S-1|s-1
5759049|NCT00287755|chemosensitivity|chemosensitivity
5759050|NCT00287755|adjuvant|adjuvant
5759051|NCT00287742|risperidone|risperidone
5759052|NCT00287742|antipsychotic agents|antipsychotic agents
5759053|NCT00287742|Alzheimer's disease|alzheimer's disease
5759055|NCT00287742|psychosis|psychosis
5759056|NCT00287729|Idiopathic|idiopathic
5759057|NCT00287729|Pulmonary|pulmonary
5759058|NCT00287729|Fibrosis|fibrosis
5759059|NCT00287729|Lung|lung
5759060|NCT00287729|Pirfenidone|pirfenidone
5759061|NCT00287729|InterMune|intermune
5759062|NCT00287716|Idiopathic|idiopathic
5759063|NCT00287716|Pulmonary|pulmonary
5759064|NCT00287716|Fibrosis|fibrosis
5759065|NCT00287716|Lung|lung
5759066|NCT00287716|Pirfenidone|pirfenidone
5759067|NCT00287716|InterMune|intermune
5759068|NCT00287703|Major depression|major depression
5759069|NCT00287703|Treatment resistant|treatment resistant
5759070|NCT00287703|PEMF|pemf
5759071|NCT00287703|AQT|aqt
5759072|NCT00287703|Hamilton|hamilton
5759073|NCT00287690|arteries|arteries
5759074|NCT00287690|blood flow|blood flow
5759075|NCT00287690|coronary artery disease|coronary artery disease
5759076|NCT00287690|diet|diet
5759077|NCT00287677|Growth Hormone|growth hormone
5759078|NCT00287677|HIV-1|hiv-1
5759079|NCT00287677|Vaccination|vaccination
5759080|NCT00287677|Thymopoiesis|thymopoiesis
5759081|NCT00287677|HIV-specific responses|hiv-specific responses
5759082|NCT00287677|Treatment Experienced|treatment experienced
5759083|NCT00287664|hepatorenal syndrome|hepatorenal syndrome
5759084|NCT00287664|terlipressin|terlipressin
5759085|NCT00287664|albumin|albumin
5759086|NCT00287664|cirrhosis|cirrhosis
5759087|NCT00287651|Pulsatile intravenous insulin|pulsatile intravenous insulin
5759088|NCT00287651|Oral carbohydrate loading|oral carbohydrate loading
5759089|NCT00287651|Respiratory Quotients|respiratory quotients
5759090|NCT00287651|Hypoglycemia|hypoglycemia
5759091|NCT00287638|Obstructive sleep apnea|obstructive sleep apnea
5759092|NCT00287625|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5759093|NCT00287625|Pulmonary rehabilitation|pulmonary rehabilitation
5759094|NCT00287612|GERD|gerd
5759095|NCT00287612|Hiatal Hernia|hiatal hernia
5759096|NCT00287612|Recurrence|recurrence
5759097|NCT00287599|Surgical wound infections|surgical wound infections
5759098|NCT00287599|Real-time PCR|real-time pcr
5759099|NCT00287599|Rapid identification of bacteria|rapid identification of bacteria
5759100|NCT00287599|Cloning|cloning
5759101|NCT00287599|16S rRNA sequencing|16s rrna sequencing
5759102|NCT00287586|Testosterone Replacement|testosterone replacement
5759103|NCT00287586|Heart Disease|heart disease
5759104|NCT00287586|Vascular Disease|vascular disease
5759105|NCT00287586|Risk Factors for Cardiovascular Disease|risk factors for cardiovascular disease
5759106|NCT00287586|Cholesterol|cholesterol
5759107|NCT00287586|Obesity|obesity
5759108|NCT00287586|Blood pressure|blood pressure
5759109|NCT00287586|Quality of Life|quality of life
5759110|NCT00287534|Early Breast Cancer|early breast cancer
5759111|NCT00287521|open|open
5759112|NCT00287521|angle|angle
5759113|NCT00287521|glaucoma|glaucoma
5759114|NCT00287521|ocular|ocular
5759116|NCT00287508|Carotid stenting|carotid stenting
5759117|NCT00287508|Carotid endarterectomy|carotid endarterectomy
5759118|NCT00287508|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
5759119|NCT00287508|Stroke prevention|stroke prevention
5759120|NCT00287508|cerebral infarction|cerebral infarction
5759121|NCT00287495|AIDS|aids
5759122|NCT00287495|HIV|hiv
5759123|NCT00287495|Antiangiogenesis|antiangiogenesis
5759124|NCT00287495|VEGF|vegf
5759125|NCT00287495|AIDS Malignancy|aids malignancy
5759126|NCT00287495|Kaposi Sarcoma|kaposi sarcoma
5759127|NCT00287495|KS|ks
5759128|NCT00287482|Treatment side effects|treatment side effects
5759130|NCT00287482|Transition|transition
5759131|NCT00287482|Survivorship|survivorship
5759132|NCT00287469|Hepatitis E|hepatitis e
5759133|NCT00287469|clinical hepatitis|clinical hepatitis
5759134|NCT00287469|vaccine|vaccine
5759135|NCT00287469|efficacy|efficacy
5759136|NCT00287469|Nepal|nepal
5759137|NCT00287417|Nucal translucency|nucal translucency
5759138|NCT00287417|Down syndrome|down syndrome
5759139|NCT00287417|MSS|mss
5759140|NCT00287417|Risk assessment|risk assessment
5759141|NCT00287404|type 2 diabetes|type 2 diabetes
5759142|NCT00287404|hyperlipidemia|hyperlipidemia
5759143|NCT00287404|dyslipidemia|dyslipidemia
5759144|NCT00287404|fasting lipids|fasting lipids
5759145|NCT00287404|postprandial lipids|postprandial lipids
5759146|NCT00287404|Non-HDL cholesterol|non-hdl cholesterol
5759147|NCT00287404|NMR lipoanalysis|nmr lipoanalysis
5759148|NCT00287404|ATP III guidelines|atp iii guidelines
5759149|NCT00287391|Insomnia|insomnia
5759150|NCT00287391|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5759151|NCT00287391|Sleep Disturbance|sleep disturbance
5759152|NCT00287352|First episode psychosis|first episode psychosis
5759153|NCT00287339|Cough|cough
5759154|NCT00287339|GERD|gerd
5759155|NCT00287326|Epidural|epidural
5759156|NCT00287326|Bupivacaine|bupivacaine
5759157|NCT00287326|Clonidine|clonidine
5759158|NCT00287313|Unstable INRs|unstable inrs
5759159|NCT00287313|Warfarin|warfarin
5759160|NCT00287313|Vitamin K|vitamin k
5759161|NCT00287300|Malaria|malaria
5759162|NCT00287300|Pregnancy|pregnancy
5759163|NCT00287300|Efficacy|efficacy
5759164|NCT00287300|Azithromycin|azithromycin
5759165|NCT00287300|Artesunate|artesunate
5759166|NCT00287287|Lenalidomide|lenalidomide
5759167|NCT00287287|Clinical Trials phase II|clinical trials phase ii
5759168|NCT00287287|Carcinomas, thyroid|carcinomas, thyroid
5759169|NCT00287287|Radioiodine-Unresponsive Papillary & Follicular Thyroid Carcinomas|radioiodine-unresponsive papillary & follicular thyroid carcinomas
5759170|NCT00287261|myelofibrosis|myelofibrosis
5759171|NCT00287261|D009191|d009191
5759172|NCT00287248|Alzheimer|alzheimer
5759173|NCT00287248|Alzheimer disease|alzheimer disease
5759174|NCT00287248|Alzheimer disease (AD)|alzheimer disease (ad)
5759175|NCT00287235|Hepatic Encephalopathy|hepatic encephalopathy
5759176|NCT00287235|End Stage Liver Disease|end stage liver disease
5759177|NCT00287235|Cirrhosis|cirrhosis
5759178|NCT00287235|MARS|mars
5759179|NCT00287235|Albumin Dialysis|albumin dialysis
5759180|NCT00287222|Inoperable and Metastatic Hepatocellular Carcinoma|inoperable and metastatic hepatocellular carcinoma
5759181|NCT00287209|RASCABG 1 - study|rascabg 1 - study
5759182|NCT00287209|Postoperative atrial fibrillation|postoperative atrial fibrillation
5759183|NCT00287209|Randomized, controlled trial|randomized, controlled trial
5759184|NCT00287209|Amiodarone|amiodarone
5759185|NCT00287196|Melanoma|melanoma
5759186|NCT00287196|Lymph node disease|lymph node disease
5759187|NCT00287196|Adjuvant radiotherapy|adjuvant radiotherapy
5759188|NCT00287196|Lymphoedema|lymphoedema
5759189|NCT00287170|Crohn's Disease|crohn's disease
5759190|NCT00287170|Local Ileal Delivery|local ileal delivery
5759191|NCT00287170|Delayed-Release Formulations|delayed-release formulations
5759192|NCT00287170|6-Mercaptopurine|6-mercaptopurine
5759193|NCT00287170|Calcitriol|calcitriol
5759194|NCT00287157|Traumatic Brain Injury|traumatic brain injury
5759195|NCT00287157|Actigraphy|actigraphy
5759196|NCT00287157|Spasticity, Cognition and Functioning|spasticity, cognition and functioning
5759197|NCT00287144|Hypothyroidism|hypothyroidism
5759198|NCT00287131|melanoma|melanoma
5759199|NCT00287131|metastatic melanoma|metastatic melanoma
5759200|NCT00287131|adoptive immunotherapy|adoptive immunotherapy
5759201|NCT00287131|IL-2|il-2
5759202|NCT00287105|Chemotherapy|chemotherapy
5759203|NCT00287105|Leukemia|leukemia
5759204|NCT00287105|Children|children
5759205|NCT00287105|Philadelphia chromosome|philadelphia chromosome
5759206|NCT00287105|Protein-tyrosine kinase inhibitor|protein-tyrosine kinase inhibitor
5759207|NCT00287092|Haemophilus influenzae type b;|haemophilus influenzae type b;
5759208|NCT00287092|Corynebacterium diphtheriae;|corynebacterium diphtheriae;
5759209|NCT00287092|Clostridium tetani;|clostridium tetani;
5759210|NCT00287092|Bordetella pertussis;|bordetella pertussis;
5759211|NCT00287092|poliovirus types 1, 2 and 3;|poliovirus types 1, 2 and 3;
5759212|NCT00287092|Vero cell;|vero cell;
5759213|NCT00287092|Influenza;|influenza;
5759214|NCT00287092|Diphtheria|diphtheria
5759215|NCT00287053|divalproex sodium|divalproex sodium
5759216|NCT00287053|valproic acid|valproic acid
5759217|NCT00287053|food intake|food intake
5759218|NCT00287053|energy expenditure|energy expenditure
5759219|NCT00287053|posture allocation|posture allocation
5759220|NCT00287053|None, the population of study is healthy|none, the population of study is healthy
5759221|NCT00287040|Breast Cancer|breast cancer
5759222|NCT00287040|Mammography|mammography
5759223|NCT00287027|psychotic disorders|psychotic disorders
5759224|NCT00287027|family burden|family burden
5759225|NCT00287027|long acting injectible antipsychotic medication|long acting injectible antipsychotic medication
5759226|NCT00287014|Rift valley fever, Kenya|rift valley fever, kenya
5759227|NCT00287001|Acquired bilateral nevus of Ota-like macules|acquired bilateral nevus of ota-like macules
5759228|NCT00287001|Postinflammatory hyperpigmentation|postinflammatory hyperpigmentation
5759229|NCT00287001|Cold air cooling|cold air cooling
5759230|NCT00286988|Preventative|preventative
5759231|NCT00286988|Open-Label|open-label
5759232|NCT00286988|Safety/Efficacy|safety/efficacy
5759233|NCT00286975|Leadership skills|leadership skills
5759234|NCT00286975|Management skills|management skills
5759235|NCT00286975|Postgraduate medical education|postgraduate medical education
5759236|NCT00286962|Diabetes mellitus, type 1|diabetes mellitus, type 1
5759237|NCT00286962|insulin infusion systems|insulin infusion systems
5759364|NCT00286455|Lipoatrophic|lipoatrophic
5759238|NCT00286962|continuous intraperitoneal insulin infusion|continuous intraperitoneal insulin infusion
5759239|NCT00286962|cross-over studies|cross-over studies
5759240|NCT00286949|Parkinson's disease|parkinson's disease
5759241|NCT00286949|executive dysfunction|executive dysfunction
5759242|NCT00286949|impairment|impairment
5759243|NCT00286949|motor skills|motor skills
5759244|NCT00286949|cognitive|cognitive
5759245|NCT00286936|Hip fracture|hip fracture
5759246|NCT00286936|delirium|delirium
5759247|NCT00286936|sleep disturbance|sleep disturbance
5759248|NCT00286936|hypnotic|hypnotic
5759249|NCT00286923|migraine|migraine
5759250|NCT00286923|chronic headache|chronic headache
5759251|NCT00286923|hyperexcitability|hyperexcitability
5759252|NCT00286923|Magnetic stimulation|magnetic stimulation
5759254|NCT00286910|NPHS2-gene|nphs2-gene
5759255|NCT00286845|Chemosensitivity|chemosensitivity
5759256|NCT00286845|Acute Myeloid Leukemia|acute myeloid leukemia
5759257|NCT00286845|Apoptosis|apoptosis
5759258|NCT00286845|MiCK Assay|mick assay
5759259|NCT00286832|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5759260|NCT00286832|Diffuse large B-cell lymphoma|diffuse large b-cell lymphoma
5759262|NCT00286832|Prognosis|prognosis
5759263|NCT00286819|early breast cancer,|early breast cancer,
5759264|NCT00286819|Fluorouracil|fluorouracil
5759265|NCT00286793|at-101|at-101
5759266|NCT00286793|at101|at101
5759267|NCT00286793|cancer|cancer
5759268|NCT00286793|hormone refractory|hormone refractory
5759269|NCT00286793|prostate|prostate
5759270|NCT00286793|docetaxel|docetaxel
5759271|NCT00286793|prednisone|prednisone
5759272|NCT00286780|AT101|at101
5759273|NCT00286780|AT-101|at-101
5759274|NCT00286780|cancer|cancer
5759275|NCT00286780|lymphoctic|lymphoctic
5759276|NCT00286780|lukemia|lukemia
5759277|NCT00286780|Rituximab|rituximab
5759278|NCT00286767|Opportunistic Infections|opportunistic infections
5759279|NCT00286767|Immune Restoration Disease|immune restoration disease
5759280|NCT00286767|Mycobacterial Infections|mycobacterial infections
5759281|NCT00286767|HIV-1 Infection|hiv-1 infection
5759282|NCT00286767|HIV|hiv
5759283|NCT00286767|ART Naive|art naive
5759284|NCT00286754|Hypertension|hypertension
5759285|NCT00286754|Behavior modification|behavior modification
5759286|NCT00286754|Randomized controlled trial|randomized controlled trial
5759287|NCT00286754|Treatment effectiveness|treatment effectiveness
5759288|NCT00286754|Telemedicine|telemedicine
5759289|NCT00286754|Prevention|prevention
5759290|NCT00286741|Diabetes|diabetes
5759291|NCT00286741|Hypertension|hypertension
5759292|NCT00286741|Randomized controlled trials|randomized controlled trials
5759293|NCT00286741|cost-effectiveness|cost-effectiveness
5759294|NCT00286741|health services|health services
5759295|NCT00286728|self-help groups|self-help groups
5759296|NCT00286728|referral and consultation|referral and consultation
5759297|NCT00286702|splints|splints
5759298|NCT00286702|Occupational Therapy|occupational therapy
5759299|NCT00286663|AIH, Autoimmune Hepatitis|aih, autoimmune hepatitis
5759300|NCT00286650|Paracetamol|paracetamol
5759301|NCT00286637|OCT|oct
5759302|NCT00286637|CSLO|cslo
5759303|NCT00286637|SLP|slp
5759304|NCT00286637|Perimetry|perimetry
5759305|NCT00286637|electrophysiology|electrophysiology
5759306|NCT00286637|glaucoma|glaucoma
5759307|NCT00286637|macular degeneration|macular degeneration
5759308|NCT00286637|retinopathy|retinopathy
5759309|NCT00286637|diabetes|diabetes
5759310|NCT00286637|macular hole|macular hole
5759311|NCT00286611|Amifostine|amifostine
5759312|NCT00286598|foot ulcer|foot ulcer
5759313|NCT00286598|diabetes mellitus|diabetes mellitus
5759314|NCT00286598|motor activity|motor activity
5759315|NCT00286598|randomized controlled trial|randomized controlled trial
5784643|NCT00171522|PEG|peg
5759316|NCT00286598|prevention|prevention
5759317|NCT00286585|preconditioning|preconditioning
5759318|NCT00286585|cardiac protection|cardiac protection
5759319|NCT00286585|morbidity|morbidity
5759320|NCT00286585|mortality|mortality
5759321|NCT00286585|major non-cardiac surgery|major non-cardiac surgery
5759322|NCT00286585|cardiac mortality and morbidity|cardiac mortality and morbidity
5759323|NCT00286585|high cardiac perioperative risk|high cardiac perioperative risk
5759324|NCT00286572|insulin-dependent diabetes mellitus|insulin-dependent diabetes mellitus
5750082|NCT00319553|Tetanus|tetanus
5759325|NCT00286572|non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
5759326|NCT00286572|coronary artery disease|coronary artery disease
5759327|NCT00286572|long-term mortality|long-term mortality
5759328|NCT00286559|Coronary artery disease|coronary artery disease
5759329|NCT00286559|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5759330|NCT00286559|SPECT|spect
5759331|NCT00286559|Adenosin|adenosin
5759332|NCT00286546|Testosterone|testosterone
5759333|NCT00286546|Major Depression|major depression
5759334|NCT00286546|Men|men
5759335|NCT00286533|Implant|implant
5759336|NCT00286520|Constipation|constipation
5759337|NCT00286520|Fecal incontinence|fecal incontinence
5759338|NCT00286520|Spinal cord injury|spinal cord injury
5759339|NCT00286520|transanal irrigation|transanal irrigation
5759340|NCT00286520|quality of life|quality of life
5759341|NCT00286507|Full thickness macular hole|full thickness macular hole
5759342|NCT00286507|Internal limiting membrane (ILM)|internal limiting membrane (ilm)
5759343|NCT00286507|Vitreo retinal surgery|vitreo retinal surgery
5759344|NCT00286507|Vitrectomy|vitrectomy
5759345|NCT00286494|Glucose Metabolism Disorder|glucose metabolism disorder
5759346|NCT00286494|Dysmetabolic Syndrome|dysmetabolic syndrome
5759347|NCT00286494|Type II Diabetes|type ii diabetes
5759348|NCT00286494|Diabetes Mellitus|diabetes mellitus
5759349|NCT00286494|Lipoatrophic|lipoatrophic
5759350|NCT00286494|Dyslipidemia|dyslipidemia
5759351|NCT00286494|Drug Therapy|drug therapy
5759352|NCT00286481|Hyperlipidemia|hyperlipidemia
5759353|NCT00286481|Drug Therapy|drug therapy
5759354|NCT00286468|Glucose Metabolism Disorder|glucose metabolism disorder
5759355|NCT00286468|Dysmetabolic Syndrome|dysmetabolic syndrome
5759356|NCT00286468|Type II Diabetes|type ii diabetes
5759357|NCT00286468|Diabetes Mellitus|diabetes mellitus
5759358|NCT00286468|Lipoatrophic|lipoatrophic
5759359|NCT00286468|Dyslipidemia|dyslipidemia
5759360|NCT00286468|Drug Therapy|drug therapy
5759361|NCT00286455|Glucose Metabolism Disorder|glucose metabolism disorder
5759362|NCT00286455|Dysmetabolic Syndrome|dysmetabolic syndrome
5759363|NCT00286455|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
5759365|NCT00286455|Dyslipidemia|dyslipidemia
5759366|NCT00286455|Drug Therapy|drug therapy
5759367|NCT00286442|Glucose Metabolism Disorder|glucose metabolism disorder
5759368|NCT00286442|Dysmetabolic Syndrome|dysmetabolic syndrome
5759369|NCT00286442|Type II Diabetes|type ii diabetes
5759370|NCT00286442|Diabetes Mellitus|diabetes mellitus
5759371|NCT00286442|Lipoatrophic|lipoatrophic
5759372|NCT00286442|Dyslipidemia|dyslipidemia
5759373|NCT00286442|Drug Therapy|drug therapy
5759374|NCT00286429|Glucose Metabolism Disorder|glucose metabolism disorder
5759375|NCT00286429|Dysmetabolic Syndrome|dysmetabolic syndrome
5759376|NCT00286429|Type II Diabetes|type ii diabetes
5759377|NCT00286429|Diabetes Mellitus|diabetes mellitus
5759378|NCT00286429|Lipoatrophic|lipoatrophic
5759379|NCT00286429|Dyslipidemia|dyslipidemia
5759380|NCT00286429|Drug Therapy|drug therapy
5759381|NCT00286416|AERD|aerd
5759382|NCT00286416|aspirin|aspirin
5759383|NCT00286416|allergy|allergy
5759384|NCT00286416|omalizumab|omalizumab
5759385|NCT00286403|Acute Tubular Necrosis|acute tubular necrosis
5759386|NCT00286403|antioxidants|antioxidants
5759387|NCT00286403|Fenoldopam|fenoldopam
5759388|NCT00286338|Fluid therapy|fluid therapy
5759389|NCT00286338|Monitoring|monitoring
5759390|NCT00286312|Acute myocardial infarction|acute myocardial infarction
5759391|NCT00286312|Primary angioplasty|primary angioplasty
5759392|NCT00286312|Reperfusion damage|reperfusion damage
5759393|NCT00286312|Atorvastatin|atorvastatin
5759394|NCT00286312|Placebo|placebo
5759395|NCT00286312|Early left ventricular remodelling|early left ventricular remodelling
5759396|NCT00286312|Late left ventricular remodelling|late left ventricular remodelling
5759397|NCT00286312|Cardiac MRI|cardiac mri
5759398|NCT00286312|Statin|statin
5759399|NCT00286312|Transluminal, Percutaneous Coronary|transluminal, percutaneous coronary
5759400|NCT00286312|Angioplasty|angioplasty
5759401|NCT00286299|Schizophrenia|schizophrenia
5759402|NCT00286299|Cardiovascular disease|cardiovascular disease
5759403|NCT00286299|Aerobic capacity|aerobic capacity
5759404|NCT00286299|Mortality|mortality
5759405|NCT00286299|Exercise|exercise
5759406|NCT00286286|Laparoscopy|laparoscopy
5759407|NCT00286286|Laparoscopic Surgical Procedures|laparoscopic surgical procedures
5759408|NCT00286286|Laparoscopic Surgery|laparoscopic surgery
5759409|NCT00286286|Gastric Bypass|gastric bypass
5759410|NCT00286286|Drug Delivery Systems|drug delivery systems
5759411|NCT00286286|Pain Measurement|pain measurement
5784715|NCT00171223|CML|cml
5767541|NCT00253851|DVT|dvt
5759412|NCT00286273|kidney failure, acute|kidney failure, acute
5759413|NCT00286273|venovenous hemofiltration|venovenous hemofiltration
5759414|NCT00286273|hemorrhage|hemorrhage
5759415|NCT00286273|heparin, low-molecular-weight|heparin, low-molecular-weight
5759416|NCT00286273|nadroparin|nadroparin
5759417|NCT00286273|citrates|citrates
5759418|NCT00286260|polyneuropathy|polyneuropathy
5759419|NCT00286260|neuropathic pain|neuropathic pain
5759420|NCT00286260|levetiracetam|levetiracetam
5759421|NCT00286234|triglycerides|triglycerides
5759422|NCT00286234|HDL-cholesterol|hdl-cholesterol
5759423|NCT00286234|insulin resistance|insulin resistance
5759424|NCT00286234|omega-3 fatty acids|omega-3 fatty acids
5759426|NCT00286208|Medical abortion|medical abortion
5759427|NCT00286208|mifepristone|mifepristone
5759428|NCT00286208|misoprostol|misoprostol
5759429|NCT00286182|Heart Failure|heart failure
5759430|NCT00286182|Elderly|elderly
5759431|NCT00286182|Diastolic Dysfunction|diastolic dysfunction
5759432|NCT00286182|Anemia|anemia
5759433|NCT00286182|Ventricular End Diastolic Volume|ventricular end diastolic volume
5759434|NCT00286182|Aged|aged
5759435|NCT00286169|Extensive-disease small-cell lung cancer (ED-SCLC)|extensive-disease small-cell lung cancer (ed-sclc)
5759436|NCT00286156|ADPKD|adpkd
5759437|NCT00286130|metastatic colorectal cancer|metastatic colorectal cancer
5759438|NCT00286130|FOLFOX 6|folfox 6
5759439|NCT00286130|FOLFIRI|folfiri
5759440|NCT00286117|Breast Cancer|breast cancer
5759441|NCT00286104|Ventriculitis|ventriculitis
5759442|NCT00286104|External ventricular catheter|external ventricular catheter
5759443|NCT00286104|Antibiotic-impregnated|antibiotic-impregnated
5759444|NCT00286091|Hormone refractory prostate cancer|hormone refractory prostate cancer
5759445|NCT00286091|androgen independent|androgen independent
5759447|NCT00286091|bone metastasis|bone metastasis
5759448|NCT00286078|Headache|headache
5759449|NCT00286078|Migraine|migraine
5759450|NCT00286078|Refractory|refractory
5759451|NCT00286078|Chronic|chronic
5759452|NCT00286078|Pain|pain
5759453|NCT00286065|Pain|pain
5759454|NCT00286065|Fentanyl|fentanyl
5759455|NCT00286065|Analgesics|analgesics
5759456|NCT00286065|Opioid|opioid
5759457|NCT00286065|Inhalation|inhalation
5759458|NCT00286026|Chlamydia trachomatis|chlamydia trachomatis
5759459|NCT00285961|Fractures of the wrist, forearm, elbow, ankle, foot|fractures of the wrist, forearm, elbow, ankle, foot
5759460|NCT00285961|Distortions of the wrist, elbow, ankle|distortions of the wrist, elbow, ankle
5759461|NCT00285961|Wounds without tendon injuries|wounds without tendon injuries
5759462|NCT00285935|Major Depressive Disorder|major depressive disorder
5759463|NCT00285935|MDD|mdd
5759464|NCT00285935|Neurobiology|neurobiology
5759465|NCT00285935|Selective Serotonin Reuptake Inhibitor|selective serotonin reuptake inhibitor
5759466|NCT00285935|SSRI|ssri
5759467|NCT00285935|Depression|depression
5759468|NCT00285922|myocardial infarction|myocardial infarction
5759469|NCT00285922|electrocardiography|electrocardiography
5759470|NCT00285922|myocardial ischemia|myocardial ischemia
5759471|NCT00285922|emergency medicine|emergency medicine
5759472|NCT00285922|monitoring, physiologic|monitoring, physiologic
5759473|NCT00285909|Moderate alcohol consumption|moderate alcohol consumption
5759474|NCT00285909|Alcohol dehydrogenase 1c polymorphism|alcohol dehydrogenase 1c polymorphism
5759475|NCT00285909|PPAR-gamma activated gene expression|ppar-gamma activated gene expression
5759476|NCT00285896|GLP-1|glp-1
5759477|NCT00285896|fasting|fasting
5759478|NCT00285896|hypoglycaemia|hypoglycaemia
5759479|NCT00285883|Invirase|invirase
5759480|NCT00285883|HIV|hiv
5759481|NCT00285883|DOT|dot
5759482|NCT00285883|Treatment Experienced|treatment experienced
5759483|NCT00285857|duct cytology|duct cytology
5759484|NCT00285844|obesity|obesity
5759485|NCT00285844|insulin resistance|insulin resistance
5759486|NCT00285844|thiazolidinedione|thiazolidinedione
5759487|NCT00285844|weight loss|weight loss
5759488|NCT00285844|adipose tissue|adipose tissue
5759489|NCT00285844|metabolic syndrome|metabolic syndrome
5759490|NCT00285844|diabetes prevention|diabetes prevention
5759491|NCT00285844|cardiovascular disease prevention|cardiovascular disease prevention
5759492|NCT00285805|Rosiglitazone|rosiglitazone
5759493|NCT00285805|Furosemide|furosemide
5759494|NCT00285805|Amiloride|amiloride
5759495|NCT00285805|Epithelial sodium channel|epithelial sodium channel
5759496|NCT00285805|Sodium excretion|sodium excretion
5759497|NCT00285792|Preschool, Physical Activity|preschool, physical activity
5759498|NCT00285766|Depression|depression
5759499|NCT00285753|psychosocial intervention|psychosocial intervention
5759500|NCT00285753|mild cognitive impairment|mild cognitive impairment
5759501|NCT00285753|support group|support group
5759502|NCT00285753|caregivers|caregivers
5759503|NCT00285753|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5759504|NCT00285753|Cognitive Impairment No Dementia (CIND)|cognitive impairment no dementia (cind)
5759505|NCT00285714|3D computer assisted imaging|3d computer assisted imaging
5759506|NCT00285714|maxillofacial surgery|maxillofacial surgery
5759507|NCT00285714|cephalometry|cephalometry
5759508|NCT00285714|normative value|normative value
5759509|NCT00285688|H. Pylori, Clarithromycin resistant, gene|h. pylori, clarithromycin resistant, gene
5759510|NCT00285675|Calcitriol, DN-101, Androgen Independent Prostate Cancer (AIPC), Prostate Cancer, Non Small Cell Lung Cancer (NSCLC)|calcitriol, dn-101, androgen independent prostate cancer (aipc), prostate cancer, non small cell lung cancer (nsclc)
5759511|NCT00285662|IPTi|ipti
5759512|NCT00285662|Malaria|malaria
5759513|NCT00285662|Anemia|anemia
5759514|NCT00285662|Prevention|prevention
5759515|NCT00285662|Infant|infant
5759516|NCT00285662|Artesunate|artesunate
5759518|NCT00285662|Amodiaquine|amodiaquine
5759519|NCT00285662|Papua New Guinea|papua new guinea
5759520|NCT00285649|Spinal Manipulation|spinal manipulation
5759521|NCT00285636|Long Term Follow-Up|long term follow-up
5759522|NCT00285623|Collection of all thromboembolic events,|collection of all thromboembolic events,
5759620|NCT00285142|rosiglitazone|rosiglitazone
5759523|NCT00285623|immunological events and drug interactions leading to thromboembolic events or major|immunological events and drug interactions leading to thromboembolic events or major
5759524|NCT00285623|bleeding after exposure to TachoSil®.|bleeding after exposure to tachosil®.
5759525|NCT00285584|HIV infection|hiv infection
5759526|NCT00285584|Depression|depression
5759527|NCT00285584|Men who have sex with men|men who have sex with men
5759528|NCT00285584|Drug abuse|drug abuse
5759529|NCT00285558|obesity|obesity
5759530|NCT00285558|adolescent|adolescent
5759531|NCT00285558|weight loss|weight loss
5759532|NCT00285558|body mass index|body mass index
5759533|NCT00285558|evaluation studies|evaluation studies
5759534|NCT00285558|peer group|peer group
5759535|NCT00285558|behavior therapy|behavior therapy
5759536|NCT00285558|diet|diet
5759537|NCT00285558|exercise|exercise
5759538|NCT00285558|self efficacy|self efficacy
5759539|NCT00285558|parents|parents
5759540|NCT00285545|Blood Supply|blood supply
5759541|NCT00285545|Mesentery|mesentery
5759542|NCT00285532|Blood Lead|blood lead
5759543|NCT00285532|Pesticides|pesticides
5759544|NCT00285532|Community-based|community-based
5759545|NCT00285532|Sampling Kits|sampling kits
5759546|NCT00285519|Morning hypertension|morning hypertension
5759547|NCT00285506|Healthy Volunteers|healthy volunteers
5759548|NCT00285493|low back pain|low back pain
5759549|NCT00285467|kidney, parathyroid hormone, vitamin d|kidney, parathyroid hormone, vitamin d
5759551|NCT00285428|treatment|treatment
5759552|NCT00285428|NHL|nhl
5759553|NCT00285428|CD20+ B-cell NHL|cd20+ b-cell nhl
5759554|NCT00285428|Lymphoma|lymphoma
5759555|NCT00285415|Advanced endometrial adenocarcinoma, stage III A, B, C|advanced endometrial adenocarcinoma, stage iii a, b, c
5759556|NCT00285402|Migraine|migraine
5759557|NCT00285402|Migraine prophylaxis|migraine prophylaxis
5759558|NCT00285402|Migraine prevention|migraine prevention
5759559|NCT00285402|Chronic migraine treatment|chronic migraine treatment
5759560|NCT00285389|Mantle cell lymphoma|mantle cell lymphoma
5759561|NCT00285389|Chemotherapy|chemotherapy
5759562|NCT00285389|Autologous PBSCT|autologous pbsct
5759563|NCT00285389|Molecular evaluation|molecular evaluation
5759564|NCT00285376|Depression. Genetics, Pharmacogenetics|depression. genetics, pharmacogenetics
5759565|NCT00285363|cancer|cancer
5759566|NCT00285363|quality of life|quality of life
5759567|NCT00285363|adolescents|adolescents
5759568|NCT00285350|myasthenia gravis|myasthenia gravis
5759569|NCT00285337|Myelopathy|myelopathy
5759570|NCT00285337|Laminectomy|laminectomy
5759571|NCT00285337|Laminoplasty|laminoplasty
5759572|NCT00285337|Decompression of Spinal Cord|decompression of spinal cord
5759573|NCT00285337|Cervical Spondylosis|cervical spondylosis
5759574|NCT00285324|Glioma|glioma
5759575|NCT00285324|Glioblastoma Multiforme|glioblastoma multiforme
5759576|NCT00285324|Brain Cancer|brain cancer
5759577|NCT00285324|Diffusion-Weighted Magnetic Resonance Imaging|diffusion-weighted magnetic resonance imaging
5759578|NCT00285324|Brain Tumor|brain tumor
5759579|NCT00285298|proteinuria|proteinuria
5759580|NCT00285298|Kidney failure, chronic|kidney failure, chronic
5759581|NCT00285285|Point-of-care Testing|point-of-care testing
5759582|NCT00285285|Pediatric Emergency Department|pediatric emergency department
5759583|NCT00285285|Length of Stay|length of stay
5759584|NCT00285285|Efficiency|efficiency
5759585|NCT00285259|cytomegalovirus infection|cytomegalovirus infection
5759586|NCT00285259|infectious disease|infectious disease
5759587|NCT00285259|viremia|viremia
5759588|NCT00285259|cytomegalovirus disease|cytomegalovirus disease
5759589|NCT00285259|stem cell transplant|stem cell transplant
5759590|NCT00285259|allogeneic|allogeneic
5759591|NCT00285259|bone marrow transplant|bone marrow transplant
5759592|NCT00285259|hematopoietic cell transplant|hematopoietic cell transplant
5759593|NCT00285259|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5759594|NCT00285259|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5759595|NCT00285259|Acute Myelogenous Leukemia|acute myelogenous leukemia
5759596|NCT00285259|Hodgkin's Lymphoma|hodgkin's lymphoma
5759597|NCT00285259|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5759598|NCT00285259|Myelodysplastic Syndrome|myelodysplastic syndrome
5759599|NCT00285246|combat disorders|combat disorders
5759600|NCT00285246|stress, psychological|stress, psychological
5759601|NCT00285246|somatoform disorders|somatoform disorders
5759602|NCT00285246|life change events|life change events
5758646|NCT00289562|B-cell|b-cell
5759604|NCT00285207|Cervical Intraepithelial Neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5759605|NCT00285207|High-grade Cervical Intraepithelial Neoplasia|high-grade cervical intraepithelial neoplasia
5759606|NCT00285207|High-grade Squamous Intraepithelial Lesions (HSIL)|high-grade squamous intraepithelial lesions (hsil)
5759607|NCT00285207|Human Papilloma Virus (HPV)|human papilloma virus (hpv)
5759608|NCT00285207|High-Grade Cervical Intraepithelial Lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5759609|NCT00285181|persons|persons
5759610|NCT00285168|Osteoporosis|osteoporosis
5759611|NCT00285168|Fractures, Bone|fractures, bone
5759612|NCT00285168|Bone Mineral Density|bone mineral density
5759613|NCT00285155|bupropion|bupropion
5759614|NCT00285155|repeated dose|repeated dose
5759615|NCT00285155|healthy volunteers|healthy volunteers
5759616|NCT00285155|cognitive function|cognitive function
5759621|NCT00285142|insulin secretion|insulin secretion
5759622|NCT00285142|clinical trial|clinical trial
5759623|NCT00285142|healthy|healthy
5759624|NCT00285142|persons|persons
5759625|NCT00285103|Antisense, mRNA antagonist, Bcl-2, CLL|antisense, mrna antagonist, bcl-2, cll
5759626|NCT00285090|Burn Injury|burn injury
5759627|NCT00285090|Calcium|calcium
5759628|NCT00285090|Vitamin D|vitamin d
5759629|NCT00285090|Bone Mineral Density|bone mineral density
5759630|NCT00285077|Alzheimer disease|alzheimer disease
5759631|NCT00285077|nerve growth factors|nerve growth factors
5759632|NCT00285077|Clinical Trial|clinical trial
5759633|NCT00285064|MDCT|mdct
5759634|NCT00285064|viability|viability
5759635|NCT00285051|emesis, nausea,|emesis, nausea,
5759636|NCT00285038|Deep vein thrombosis|deep vein thrombosis
5759637|NCT00285038|Gynecological cancer|gynecological cancer
5759638|NCT00285025|Alzheimer disease|alzheimer disease
5759639|NCT00285025|nerve growth factors|nerve growth factors
5759640|NCT00285025|Clinical Trial|clinical trial
5759641|NCT00285012|smoking cessation|smoking cessation
5759642|NCT00285012|smoking cessation in COPD|smoking cessation in copd
5759643|NCT00284986|GVHD|gvhd
5759644|NCT00284986|Graft vs Host Disease|graft vs host disease
5759645|NCT00284986|Graft versus Host Disease|graft versus host disease
5759646|NCT00284973|malaria|malaria
5759647|NCT00284960|erectile dysfunction|erectile dysfunction
5759648|NCT00284960|metabolic syndrome|metabolic syndrome
5759649|NCT00284960|insulin resistance|insulin resistance
5759650|NCT00284960|etiology|etiology
5759651|NCT00284947|Side effects|side effects
5759652|NCT00284947|calcineurin inhibitors|calcineurin inhibitors
5759653|NCT00284947|maintenance|maintenance
5759654|NCT00284947|basiliximab|basiliximab
5759655|NCT00284947|Kidney maintenance transplant|kidney maintenance transplant
5759656|NCT00284934|Dose optimization|dose optimization
5759657|NCT00284934|immune suppressive regimen|immune suppressive regimen
5759658|NCT00284934|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5759659|NCT00284934|EC-MPS|ec-mps
5759660|NCT00284934|renal transplantation|renal transplantation
5759661|NCT00284934|kidney|kidney
5759662|NCT00284934|transplant|transplant
5759663|NCT00284934|maintenance patients|maintenance patients
5759664|NCT00284934|Renal transplantation in maintenance|renal transplantation in maintenance
5759665|NCT00284921|kidney transplant, hepatitis C, enteric-coated mycophenolate sodium|kidney transplant, hepatitis c, enteric-coated mycophenolate sodium
5759666|NCT00284908|S-Tenatoprazole-Na|s-tenatoprazole-na
5759667|NCT00284908|Pharmacokinetic|pharmacokinetic
5759668|NCT00284908|intragastric pH recording|intragastric ph recording
5759669|NCT00284908|dose-response|dose-response
5759670|NCT00284895|Obesity|obesity
5759671|NCT00284895|Bariatric Surgery|bariatric surgery
5759672|NCT00284895|Weight Loss Surgery|weight loss surgery
5759673|NCT00284895|Asthma|asthma
5759674|NCT00284882|Streptococcus, Fiji, pyoderma, pharyngitis, scabies|streptococcus, fiji, pyoderma, pharyngitis, scabies
5759676|NCT00284869|ethnicity|ethnicity
5759677|NCT00284869|neutrophils|neutrophils
5759679|NCT00284843|Streptococcus, Fiji, pyoderma, scabies, rheumatic disease|streptococcus, fiji, pyoderma, scabies, rheumatic disease
5759680|NCT00284830|Right Ventricular Pacing|right ventricular pacing
5759681|NCT00284830|Persistent Atrial Fibrillation|persistent atrial fibrillation
5759682|NCT00284830|Atrioventricular Conduction|atrioventricular conduction
5759683|NCT00284830|Heart Failure Hospitalization|heart failure hospitalization
5759684|NCT00284830|Cardiovascular Health Care Utilization|cardiovascular health care utilization
5759685|NCT00284830|Sinus-node Disease|sinus-node disease
5759686|NCT00284830|Minimized Ventricular Pacing|minimized ventricular pacing
5759687|NCT00284804|relapsed or refractory Hodgkin's Disease|relapsed or refractory hodgkin's disease
5759688|NCT00284778|lung cancer|lung cancer
5759689|NCT00284778|second line treatment|second line treatment
5759690|NCT00284778|cost-minimization trial|cost-minimization trial
5759691|NCT00284778|Pharmaco-economic study|pharmaco-economic study
5759692|NCT00284778|docetaxel|docetaxel
5759693|NCT00284778|pemetrexed|pemetrexed
5759694|NCT00284752|Prostate|prostate
5759695|NCT00284752|Cancer|cancer
5759696|NCT00284752|Metastatic|metastatic
5759697|NCT00284726|Cytokines in lung transplantation|cytokines in lung transplantation
5759698|NCT00284726|Cold storage solutions|cold storage solutions
5759699|NCT00284726|Ischemic reperfusion injury|ischemic reperfusion injury
5758744|NCT00289016|GM-CSF|gm-csf
5759700|NCT00284700|Helicobacter pylori|helicobacter pylori
5759701|NCT00284700|Iron deficiency anemia|iron deficiency anemia
5759702|NCT00284700|children|children
5759703|NCT00284687|bone marrow transplantation|bone marrow transplantation
5759704|NCT00284687|CMV disease|cmv disease
5759705|NCT00284661|Meniscal repair|meniscal repair
5759706|NCT00284661|Meniscal suturing|meniscal suturing
5759707|NCT00284661|Meniscal tear|meniscal tear
5759708|NCT00284648|Achilles tendon|achilles tendon
5759710|NCT00284648|Non-operative|non-operative
5759711|NCT00284648|Operative|operative
5759712|NCT00284622|HTO|hto
5759714|NCT00284622|Osteoarthritis|osteoarthritis
5759715|NCT00284622|Alignement|alignement
5759716|NCT00284622|Varus gonarthrosis|varus gonarthrosis
5760022|NCT00283439|NHL|nhl
5759717|NCT00284609|Type 2 diabetes,|type 2 diabetes,
5759718|NCT00284609|rehabilitation,|rehabilitation,
5759719|NCT00284609|quality of life,|quality of life,
5759720|NCT00284609|glycaemic control,|glycaemic control,
5759721|NCT00284609|lifestyle intervention,|lifestyle intervention,
5759722|NCT00284609|patient education,|patient education,
5759723|NCT00284609|physical training,|physical training,
5759724|NCT00284609|group visits,|group visits,
5759725|NCT00284609|reminders|reminders
5759726|NCT00284596|Opening wedge high tibial osteotomy|opening wedge high tibial osteotomy
5759727|NCT00284596|Radio Sterometric Analysis|radio sterometric analysis
5759728|NCT00284596|Locking screw fixation|locking screw fixation
5759729|NCT00284583|Morton's Neuroma|morton's neuroma
5759730|NCT00284583|Alcohol|alcohol
5759731|NCT00284583|Steroid|steroid
5759732|NCT00284570|pediatrics|pediatrics
5759733|NCT00284570|congenital heart disease|congenital heart disease
5759734|NCT00284570|cardiac|cardiac
5759735|NCT00284570|cardiopulmonary bypass|cardiopulmonary bypass
5759736|NCT00284570|infection|infection
5759737|NCT00284570|sepsis|sepsis
5759738|NCT00284570|postoperative|postoperative
5759739|NCT00284570|marker for infection|marker for infection
5759740|NCT00284570|inflammation|inflammation
5759741|NCT00284570|cardiac surgery|cardiac surgery
5759742|NCT00284557|Behavioral/Social|behavioral/social
5759743|NCT00284557|Obesity|obesity
5755027|NCT00301652|ANCA|anca
5759744|NCT00284557|Pediatrics|pediatrics
5759745|NCT00284557|Preventive Medicine|preventive medicine
5759746|NCT00284531|cardiac transplantation|cardiac transplantation
5759747|NCT00284531|allograft rejection|allograft rejection
5759748|NCT00284531|anti-CD25|anti-cd25
5759749|NCT00284505|cytokine|cytokine
5759750|NCT00284505|arachnoiditis|arachnoiditis
5759751|NCT00284505|neuropathic pain|neuropathic pain
5759752|NCT00284505|tumor necrosis factor|tumor necrosis factor
5759753|NCT00284492|Women|women
5759754|NCT00284492|Acupuncture|acupuncture
5759755|NCT00284492|Menopause|menopause
5759756|NCT00284492|Hot flashes|hot flashes
5759757|NCT00284492|Health related quality of life|health related quality of life
5759758|NCT00284479|walking intervention|walking intervention
5759759|NCT00284479|cardiovascular risk|cardiovascular risk
5759760|NCT00284479|inflammatory markers|inflammatory markers
5759761|NCT00284479|aerobic fitness|aerobic fitness
5759763|NCT00284466|coronary artery disease|coronary artery disease
5759764|NCT00284466|cardiac catheterization|cardiac catheterization
5759765|NCT00284466|CT coronary angiography|ct coronary angiography
5759766|NCT00284466|coronary angiography|coronary angiography
5759767|NCT00284453|ventricular|ventricular
5759768|NCT00284453|arrhythmias|arrhythmias
5759769|NCT00284453|ICD|icd
5759770|NCT00284453|VT storm|vt storm
5759771|NCT00284453|ICD patients with VT storm|icd patients with vt storm
5759772|NCT00284440|Visual field progression|visual field progression
5759773|NCT00284440|Choroidal blood flow|choroidal blood flow
5759774|NCT00284401|Reversed prosthesis|reversed prosthesis
5759775|NCT00284336|breast cancer|breast cancer
5759776|NCT00284336|elderly|elderly
5759777|NCT00284336|adjuvant chemotherapy|adjuvant chemotherapy
5759778|NCT00284336|Caelyx|caelyx
5759779|NCT00284323|Acute Myocardial Infarction|acute myocardial infarction
5759780|NCT00284323|PCI|pci
5759781|NCT00284323|Adenosine|adenosine
5759782|NCT00284323|Postconditioning|postconditioning
5759783|NCT00284310|Wrist surgery: 4-corner arthrodesis or proximal row carpectomy|wrist surgery: 4-corner arthrodesis or proximal row carpectomy
5759784|NCT00284271|Hodgkin´s Lymphoma|hodgkin´s lymphoma
5759785|NCT00284271|eldery patients|eldery patients
5759786|NCT00284271|primary diagnosis|primary diagnosis
5759787|NCT00284258|Colorectal Cancer|colorectal cancer
5759788|NCT00284245|Chronic Pain|chronic pain
5759789|NCT00284245|Pain|pain
5759790|NCT00284245|Computer Analysis|computer analysis
5759791|NCT00284245|Pain Diagrams|pain diagrams
5759792|NCT00284232|HbA1c|hba1c
5759793|NCT00284232|Self-monitoring blood glucose (SMBG)|self-monitoring blood glucose (smbg)
5759794|NCT00284232|Diabetes treatment|diabetes treatment
5759795|NCT00284232|quality of care|quality of care
5759796|NCT00284219|rTMS, smoking, dopamine, acotinine|rtms, smoking, dopamine, acotinine
5759797|NCT00284206|methamphetamine, cognition, outpatient, risperidone|methamphetamine, cognition, outpatient, risperidone
5759798|NCT00284180|Breast Neoplasms|breast neoplasms
5759799|NCT00284180|Breast Cancer|breast cancer
5759800|NCT00284180|Vinflunine|vinflunine
5759801|NCT00284180|Vinca Alkaloid|vinca alkaloid
5759802|NCT00284180|Javlor|javlor
5759803|NCT00284167|tailored|tailored
5759804|NCT00284167|web-based|web-based
5759805|NCT00284167|weight management|weight management
5759806|NCT00284167|obesity|obesity
5759807|NCT00284167|efficacy|efficacy
5759808|NCT00284154|Extensive stage|extensive stage
5759809|NCT00284154|Relapsed|relapsed
5759810|NCT00284141|lung|lung
5759811|NCT00284141|cancer|cancer
5759812|NCT00284141|non-small-cell lung cancer|non-small-cell lung cancer
5759813|NCT00284141|metastatic|metastatic
5759814|NCT00284141|carcinoma|carcinoma
5759815|NCT00284141|lung neoplasm|lung neoplasm
5759816|NCT00284141|lung diseases|lung diseases
5759817|NCT00284141|angiogenesis|angiogenesis
5759818|NCT00284141|anti-angiogenesis|anti-angiogenesis
5759819|NCT00284141|anti-angiogenesis inhibitors|anti-angiogenesis inhibitors
5759820|NCT00284141|cancer and other neoplasms|cancer and other neoplasms
5759821|NCT00284141|respiratory tract|respiratory tract
5759822|NCT00284141|(lung and bronchial) diseases|(lung and bronchial) diseases
5759823|NCT00284128|Cardiovascular Disease C14|cardiovascular disease c14
5759824|NCT00284128|vascular disease C14.907|vascular disease c14.907
5759825|NCT00284128|hypertension C14.907.489|hypertension c14.907.489
5759826|NCT00284115|Gait trainer|gait trainer
5759827|NCT00284115|Hemiplegia|hemiplegia
5759828|NCT00284115|Rehabilitation|rehabilitation
5759830|NCT00284102|gas exchange|gas exchange
5759831|NCT00284102|dead space|dead space
5759832|NCT00284102|respiratory failure|respiratory failure
5759833|NCT00284102|ALI/ARDS patients|ali/ards patients
5759834|NCT00284089|Subfoveal CNV, AMD, ranibizumab|subfoveal cnv, amd, ranibizumab
5759835|NCT00284063|spinal manipulation, zygapophysial joints|spinal manipulation, zygapophysial joints
5759836|NCT00284050|DME|dme
5759837|NCT00284050|Diabetic macular edema|diabetic macular edema
5759838|NCT00284050|ranibizumab|ranibizumab
5759839|NCT00284050|Diabetic macular edema with center involvement|diabetic macular edema with center involvement
5759840|NCT00284037|obstructive sleep apnea,|obstructive sleep apnea,
5759841|NCT00284037|baroreceptors|baroreceptors
5759842|NCT00284024|breastfeeding|breastfeeding
5759843|NCT00284024|domperidone|domperidone
5759844|NCT00284024|efficacy|efficacy
5759846|NCT00284024|compliance|compliance
5759847|NCT00284011|SAMe|same
5759848|NCT00284011|AdoMet|adomet
5759849|NCT00284011|Methylation|methylation
5759850|NCT00284011|Homocysteine|homocysteine
5759851|NCT00284011|Dietary Supplement|dietary supplement
5759852|NCT00284011|S-Adenosyl-L-Methionine|s-adenosyl-l-methionine
5759853|NCT00283998|Odontoid|odontoid
5759854|NCT00283998|Type II fractures|type ii fractures
5759855|NCT00283998|Elderly patients|elderly patients
5759856|NCT00283998|Surgical vs. conservative treatment|surgical vs. conservative treatment
5759857|NCT00283985|NK/T-cell lymphoma|nk/t-cell lymphoma
5759858|NCT00283985|Lymphoma|lymphoma
5759859|NCT00283985|L-asparaginase|l-asparaginase
5759860|NCT00283985|Nasal NK-cell lymphoma|nasal nk-cell lymphoma
5759861|NCT00283985|Nasal-type NK-cell Lymphoma|nasal-type nk-cell lymphoma
5759862|NCT00283972|Health Outcome Study|health outcome study
5759863|NCT00283959|Amicus Therapeutics|amicus therapeutics
5759864|NCT00283959|AT1001|at1001
5759865|NCT00283959|Galafold|galafold
5759866|NCT00283959|Migalastat|migalastat
5759867|NCT00283959|Substrate|substrate
5759868|NCT00283946|zolpidem|zolpidem
5759869|NCT00283946|sleep initiation and maintenance disorders Hypnotics and sedatives|sleep initiation and maintenance disorders hypnotics and sedatives
5759870|NCT00283946|double-blind study|double-blind study
5759871|NCT00283946|comparative study|comparative study
5759872|NCT00283933|Amicus Therapeutics|amicus therapeutics
5759873|NCT00283933|AT1001|at1001
5759874|NCT00283933|Galafold|galafold
5759875|NCT00283933|Migalastat|migalastat
5759876|NCT00283933|Substrate|substrate
5759877|NCT00283920|Pharmacokinetics|pharmacokinetics
5759878|NCT00283920|Compartmental Analysis|compartmental analysis
5759879|NCT00283920|Distribution Volume|distribution volume
5759880|NCT00283920|Identitiability|identitiability
5759881|NCT00283920|Healthy Volunteer|healthy volunteer
5759882|NCT00283920|HV|hv
5759883|NCT00283907|Electroencephalogram (EEG)|electroencephalogram (eeg)
5759884|NCT00283907|Sense of Agency|sense of agency
5759885|NCT00283907|Coherence|coherence
5759886|NCT00283907|Voluntary Movement|voluntary movement
5759887|NCT00283907|Self-Agency|self-agency
5759888|NCT00283907|Healthy Volunteer|healthy volunteer
5759889|NCT00283907|HV|hv
5759890|NCT00283894|Obesity|obesity
5759891|NCT00283894|Leptin|leptin
5759892|NCT00283894|Sleep Attacks|sleep attacks
5759893|NCT00283894|Energy Metabolism|energy metabolism
5759894|NCT00283894|Healthy Control|healthy control
5759895|NCT00283894|Narcolepsy|narcolepsy
5759896|NCT00283894|Healthy Volunteer|healthy volunteer
5759897|NCT00283894|HV|hv
5759898|NCT00283881|Haptic Skills|haptic skills
5759899|NCT00283881|Implicit Tactile Learning|implicit tactile learning
5759900|NCT00283881|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5862890|NCT00001469|Adenocarcinoma|adenocarcinoma
5759901|NCT00283881|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5759618|NCT00285155|tolerance|tolerance
5759902|NCT00283881|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5759903|NCT00283881|Stroke|stroke
5759904|NCT00283881|Healthy Volunteer|healthy volunteer
5759905|NCT00283881|HV|hv
5759906|NCT00283868|stroke|stroke
5759907|NCT00283868|digital video|digital video
5759908|NCT00283868|SPOTRIAS|spotrias
5759909|NCT00283855|Rheumatoid Arthritis|rheumatoid arthritis
5759910|NCT00283855|Self-Management|self-management
5759911|NCT00283855|Internet|internet
5759912|NCT00283842|neuropathic pain|neuropathic pain
5759913|NCT00283842|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5759915|NCT00283816|Polycystic Ovary Syndrome|polycystic ovary syndrome
5759916|NCT00283816|Overweight Adolescent Girls|overweight adolescent girls
5759917|NCT00283816|Irregular Menstrual Cycles|irregular menstrual cycles
5759918|NCT00283777|insulin|insulin
5759919|NCT00283777|glucose|glucose
5759920|NCT00283777|body weight|body weight
5759921|NCT00283777|chromium|chromium
5759922|NCT00283738|migraine|migraine
5759923|NCT00283738|aura|aura
5759924|NCT00283738|Patent Foramen Ovale (PFO)|patent foramen ovale (pfo)
5759925|NCT00283738|cardiac defects|cardiac defects
5759926|NCT00283738|Heart Septal Defects, Atrial|heart septal defects, atrial
5759927|NCT00283738|Cephalalgia|cephalalgia
5759928|NCT00283725|Dementia|dementia
5759929|NCT00283725|Alzheimer's Disease|alzheimer's disease
5759930|NCT00283725|Acetylcholinesterase inhibitor|acetylcholinesterase inhibitor
5759931|NCT00283725|Galantamine|galantamine
5759932|NCT00283725|Nursing Home Admission|nursing home admission
5759933|NCT00283712|Skin Diseases|skin diseases
5759934|NCT00283712|Autoimmune Diseases|autoimmune diseases
5759935|NCT00283699|neurocysticercosis|neurocysticercosis
5759936|NCT00283699|albendazole|albendazole
5759937|NCT00283699|tape worm|tape worm
5759938|NCT00283686|polycystic kidney disease|polycystic kidney disease
5759939|NCT00283686|polycystic|polycystic
5759940|NCT00283686|kidney|kidney
5759941|NCT00283686|disease|disease
5759942|NCT00283686|adpkd|adpkd
5759943|NCT00283686|halt|halt
5759944|NCT00283686|pkd|pkd
5759945|NCT00283686|blood pressure|blood pressure
5759946|NCT00283686|bp|bp
5759947|NCT00283686|hypertension|hypertension
5759948|NCT00283686|renal|renal
5759949|NCT00283686|renin-angiotensin-aldosterone-system|renin-angiotensin-aldosterone-system
5759950|NCT00283686|RAAS|raas
5759951|NCT00283660|Zinc|zinc
5759952|NCT00283660|Dietary Supplements|dietary supplements
5759953|NCT00283660|Nutritional Supplements|nutritional supplements
5759954|NCT00283660|Child|child
5759955|NCT00283660|Mental Health|mental health
5759956|NCT00283660|School|school
5759957|NCT00283660|Guatemala|guatemala
5759958|NCT00283647|lead exposure|lead exposure
5759959|NCT00283647|magnetic resonance imaging|magnetic resonance imaging
5759960|NCT00283647|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5759961|NCT00283647|functional magnetic resonance|functional magnetic resonance
5759962|NCT00283647|brain development|brain development
5759963|NCT00283621|Aranesp|aranesp
5759964|NCT00283621|Darbepoetin Alfa|darbepoetin alfa
5759965|NCT00283621|Pegfilgrastim|pegfilgrastim
5759966|NCT00283621|Neulasta|neulasta
5759967|NCT00283621|Sarcoma|sarcoma
5759968|NCT00283621|Adriamycin|adriamycin
5759969|NCT00283621|Doxorubicin Hydrocholoride|doxorubicin hydrocholoride
5759970|NCT00283621|Adriamycin PFS|adriamycin pfs
5759971|NCT00283621|Adriamycin RDF|adriamycin rdf
5759972|NCT00283621|Ifosfamide|ifosfamide
5759973|NCT00283608|stage I breast cancer|stage i breast cancer
5759974|NCT00283608|stage II breast cancer|stage ii breast cancer
5759975|NCT00283608|stage IIIA breast cancer|stage iiia breast cancer
5759976|NCT00283608|stage IIIB breast cancer|stage iiib breast cancer
5759977|NCT00283608|stage IIIC breast cancer|stage iiic breast cancer
5759978|NCT00283595|Anorexia Nervosa|anorexia nervosa
5759979|NCT00283595|Eating disorder|eating disorder
5759980|NCT00283595|Bone|bone
5759981|NCT00283595|Growth hormone|growth hormone
5759982|NCT00283595|Osteopenia|osteopenia
5759983|NCT00283595|Osteoporosis|osteoporosis
5759984|NCT00283569|Glioma|glioma
5759985|NCT00283556|High Dose Irinotecan|high dose irinotecan
5759986|NCT00283556|CPT-11|cpt-11
5759987|NCT00283556|Camptosar|camptosar
5759988|NCT00283556|Malignant Glioma|malignant glioma
5759989|NCT00283556|Unresectable|unresectable
5759990|NCT00283543|Glioma|glioma
5759991|NCT00283543|Gliadel Wafer|gliadel wafer
5759992|NCT00283530|Cancer|cancer
5759993|NCT00283530|Cancer receiving chemotherapy|cancer receiving chemotherapy
5759994|NCT00283530|Tumor biopsy|tumor biopsy
5759995|NCT00283517|Risperidone long-acting injection|risperidone long-acting injection
5759996|NCT00283517|Antipsychotic medication|antipsychotic medication
5759997|NCT00283517|Schizophrenia|schizophrenia
5759998|NCT00283517|Treatment retention|treatment retention
5759999|NCT00283517|Observational study|observational study
5760000|NCT00283491|Iron absorption|iron absorption
5760001|NCT00283491|Organic acids|organic acids
5760002|NCT00283491|Lactobacillus|lactobacillus
5760003|NCT00283491|Probiotic|probiotic
5760004|NCT00283478|Advanced stage|advanced stage
5760005|NCT00283478|Lung cancer|lung cancer
5760006|NCT00283465|Anemia|anemia
5760007|NCT00283465|cancer|cancer
5760008|NCT00283465|neoplasm|neoplasm
5760009|NCT00283465|transfusion|transfusion
5760010|NCT00283465|quality of life|quality of life
5760011|NCT00283465|tumor response|tumor response
5760012|NCT00283465|survival|survival
5760013|NCT00283465|chemotherapy|chemotherapy
5760014|NCT00283465|hemoglobin|hemoglobin
5760015|NCT00283465|standard care|standard care
5760016|NCT00283465|epoetin alfa|epoetin alfa
5760017|NCT00283465|epoetin|epoetin
5760018|NCT00283465|erythropoietin|erythropoietin
5760019|NCT00283452|Physical activity maintenance|physical activity maintenance
5760020|NCT00283452|Interactive phone and mail-based intervention|interactive phone and mail-based intervention
5760021|NCT00283452|Older adults|older adults
5760023|NCT00283439|chemotherapy induced thrombocytopenia|chemotherapy induced thrombocytopenia
5760026|NCT00283439|RICE|rice
5760027|NCT00283439|Hodgkin's Lymphoma|hodgkin's lymphoma
5760028|NCT00283439|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5760029|NCT00283439|CHOP|chop
5760030|NCT00283439|ESHAP|eshap
5760031|NCT00283439|DHAP|dhap
5760032|NCT00283439|R-CHOP|r-chop
5760033|NCT00283439|R-ESHAP|r-eshap
5760034|NCT00283439|R-DHAP|r-dhap
5760035|NCT00283413|Covered Stent System|covered stent system
5760036|NCT00283413|Saphenous Vein Graft|saphenous vein graft
5760037|NCT00283413|Coronary Artery Bypass[MeSH]|coronary artery bypass[mesh]
5760038|NCT00283413|Stents[MeSH]|stents[mesh]
5760039|NCT00283400|subarachnoid hemorrhage|subarachnoid hemorrhage
5760041|NCT00283400|human albumin|human albumin
5760042|NCT00283400|HA|ha
5760043|NCT00283400|cerebral vasospasm|cerebral vasospasm
5760044|NCT00283400|aneurysm|aneurysm
5760045|NCT00283400|neuroprotective|neuroprotective
5760046|NCT00283387|Primary Hyperoxaluria|primary hyperoxaluria
5760047|NCT00283374|Metabolic Syndrome|metabolic syndrome
5760048|NCT00283374|Obesity|obesity
5760049|NCT00283374|Nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5760050|NCT00283374|Nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5760051|NCT00283374|Bariatric Surgery|bariatric surgery
5760052|NCT00283348|Renal Transplantation|renal transplantation
5760053|NCT00283348|Immunosuppression|immunosuppression
5760054|NCT00283348|Chronic Rejection|chronic rejection
5760055|NCT00283322|Heparin Induced Thrombocytopenia|heparin induced thrombocytopenia
5760057|NCT00283322|HITT|hitt
5760058|NCT00283322|Thrombosis|thrombosis
5760059|NCT00283322|Thromboembolism|thromboembolism
5760060|NCT00283309|Corticosteroids|corticosteroids
5760061|NCT00283309|Riluzole|riluzole
5760062|NCT00283309|Memantine|memantine
5760063|NCT00283309|Memory|memory
5760064|NCT00283296|manual wheelchair|manual wheelchair
5760065|NCT00283296|assistive technology|assistive technology
5760066|NCT00283296|travel wheelchair|travel wheelchair
5760067|NCT00283283|Influenza|influenza
5760068|NCT00283270|Mental health|mental health
5760069|NCT00283270|Screening|screening
5760070|NCT00283270|Elderly|elderly
5760071|NCT00283270|Chinese|chinese
5760072|NCT00283270|Problem-solving counselling|problem-solving counselling
5760073|NCT00283257|Problem solving|problem solving
5760074|NCT00283257|psychosocial support|psychosocial support
5760075|NCT00283244|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5760076|NCT00283244|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5760077|NCT00283231|Hot Flashes|hot flashes
5760078|NCT00283231|Menopausal Symptoms|menopausal symptoms
5760079|NCT00283231|Paced respiration|paced respiration
5760080|NCT00283231|RESPeRATE|resperate
5760081|NCT00283205|Menopausal Symptoms|menopausal symptoms
5760082|NCT00283205|Hot Flashes|hot flashes
5760083|NCT00283205|Yoga|yoga
5760084|NCT00283192|Menopausal Symptoms|menopausal symptoms
5760085|NCT00283192|Hot flashes|hot flashes
5760086|NCT00283179|Aripiprazole|aripiprazole
5760087|NCT00283179|Risperidone|risperidone
5760088|NCT00283179|Schizophrenia|schizophrenia
5760089|NCT00283179|Schizoaffective disorder|schizoaffective disorder
5760090|NCT00283166|Palliative Care|palliative care
5760091|NCT00283153|Traumatic Brain Injury|traumatic brain injury
5760092|NCT00283153|Stroke|stroke
5760093|NCT00283153|Emotion Recognition|emotion recognition
5760094|NCT00283153|Affect|affect
5760095|NCT00283153|Interventions|interventions
5760096|NCT00283127|Chlamydia trachomatis|chlamydia trachomatis
5760097|NCT00283127|Mass screening|mass screening
5760098|NCT00283127|Home sampling|home sampling
5760099|NCT00283127|Urine test|urine test
5760100|NCT00283114|Lintuzumab|lintuzumab
5760101|NCT00283114|Antigens, CD33|antigens, cd33
5760102|NCT00283114|Antibodies, Monoclonal|antibodies, monoclonal
5760103|NCT00283114|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5760104|NCT00283114|Myelodysplastic Syndromes|myelodysplastic syndromes
5760105|NCT00283114|Hematologic Diseases|hematologic diseases
5760106|NCT00283114|Myeloproliferative Disorders|myeloproliferative disorders
5760107|NCT00283114|Leukemia|leukemia
5760108|NCT00283101|Antigens, CD40|antigens, cd40
5760109|NCT00283101|Antibody, Monoclonal|antibody, monoclonal
5760110|NCT00283101|Leukemia, Lymphocytic, Chronic, B-Cell|leukemia, lymphocytic, chronic, b-cell
5759115|NCT00287521|hypertension|hypertension
5760111|NCT00283101|Hematologic Diseases|hematologic diseases
5760112|NCT00283101|Immunoproliferatic Disorders|immunoproliferatic disorders
5760113|NCT00283101|Lymphatic Diseases|lymphatic diseases
5760114|NCT00283101|Lymphoproliferative Disorders|lymphoproliferative disorders
5760115|NCT00283101|Leukemia|leukemia
5760116|NCT00283088|stroke|stroke
5760117|NCT00283088|hypothermia|hypothermia
5760118|NCT00283088|cooling|cooling
5760119|NCT00283088|tissue plasminogen activator|tissue plasminogen activator
5760120|NCT00283088|tPA|tpa
5760121|NCT00283088|thrombolysis|thrombolysis
5760122|NCT00283075|intraabdominal cancer (carcinomas)|intraabdominal cancer (carcinomas)
5760123|NCT00283075|agarose macrobeads|agarose macrobeads
5760124|NCT00283075|mouse kidney cancer cells|mouse kidney cancer cells
5760125|NCT00283075|cancer cell growth inhibition|cancer cell growth inhibition
5760126|NCT00283023|All selective craniotomy|all selective craniotomy
5760127|NCT00283010|cognitive enhancement|cognitive enhancement
5760129|NCT00283010|auditory memory|auditory memory
5760130|NCT00283010|speech|speech
5760131|NCT00283010|computerized|computerized
5760132|NCT00283010|cognitive decline|cognitive decline
5760133|NCT00282971|Type 2 diabetes melllitus|type 2 diabetes melllitus
5760134|NCT00282893|aneurysm|aneurysm
5760135|NCT00282893|vasospasm|vasospasm
5760136|NCT00282893|subarachnoid hemorrhage|subarachnoid hemorrhage
5760137|NCT00282893|transluminal ballooning|transluminal ballooning
5760138|NCT00282867|stroke|stroke
5760139|NCT00282867|acute ischemic stroke|acute ischemic stroke
5760140|NCT00282867|hyperglycemia|hyperglycemia
5760141|NCT00282867|glucose|glucose
5760142|NCT00282867|insulin|insulin
5760143|NCT00282867|insulin and potassium therapy|insulin and potassium therapy
5760144|NCT00282867|GIK|gik
5760145|NCT00282854|epilepsy|epilepsy
5760146|NCT00282854|Rolandic epilepsy|rolandic epilepsy
5760147|NCT00282841|stroke|stroke
5760148|NCT00282841|ultrasound|ultrasound
5760149|NCT00282841|occlusion|occlusion
5760150|NCT00282841|blockage|blockage
5760151|NCT00282841|contrast solution|contrast solution
5760152|NCT00282828|Social Anxiety Disorder|social anxiety disorder
5760153|NCT00282828|Pharmacotherapy|pharmacotherapy
5760154|NCT00282828|Genetics|genetics
5760155|NCT00282828|Treatment Refractory|treatment refractory
5760156|NCT00282815|obstructive sleep apnea|obstructive sleep apnea
5760158|NCT00282815|OSA|osa
5760159|NCT00282815|CPAP|cpap
5760160|NCT00282815|continuous positive airway pressure|continuous positive airway pressure
5760161|NCT00282802|Parkinson's Disease|parkinson's disease
5760162|NCT00282802|twins|twins
5760163|NCT00282802|SPECT|spect
5760164|NCT00282802|National Academy of Sciences/National Resource Council (NAS/NRC) World War II Veteran Twins Cohort Registry|national academy of sciences/national resource council (nas/nrc) world war ii veteran twins cohort registry
5760165|NCT00282802|NAS/NRC|nas/nrc
5760166|NCT00282802|World War II Veteran Twins|world war ii veteran twins
5760167|NCT00282776|Postpartum Depression|postpartum depression
5760168|NCT00282776|Telephone Care Management|telephone care management
5760169|NCT00282776|Screening for Postpartum Depression|screening for postpartum depression
5760170|NCT00282750|"Surgery[MeSH]"|"surgery[mesh]"
5760171|NCT00282750|"Surgical Sponges[MeSH]"|"surgical sponges[mesh]"
5760172|NCT00282750|"Automatic Data Processing[MeSH]"|"automatic data processing[mesh]"
5760173|NCT00282724|Lamellar ichthyosis|lamellar ichthyosis
5760174|NCT00282724|Liarozole|liarozole
5760175|NCT00282724|Investigator's Global Assessment|investigator's global assessment
5760176|NCT00282724|Scaling|scaling
5760177|NCT00282711|Diagnostic Techniques, Radioisotope|diagnostic techniques, radioisotope
5760178|NCT00282711|Radionuclide Imaging|radionuclide imaging
5760179|NCT00282711|Diagnostic Techniques, Cardiovascular|diagnostic techniques, cardiovascular
5760180|NCT00282711|Heart Function tests|heart function tests
5760181|NCT00282685|Patients with symmetric peripheral diabetic neuropathy|patients with symmetric peripheral diabetic neuropathy
5760182|NCT00282672|Barrett's Esophagus|barrett's esophagus
5760183|NCT00282672|Dysplasia|dysplasia
5760184|NCT00282672|Radiofrequency Ablation|radiofrequency ablation
5760185|NCT00282659|Hemodynamics|hemodynamics
5760186|NCT00282659|Hypertension|hypertension
5760187|NCT00282659|Dyslipidemia|dyslipidemia
5760188|NCT00282659|Diabetes|diabetes
5760189|NCT00282659|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5760190|NCT00282659|Blood Pressure|blood pressure
5760191|NCT00282646|critical limb ischemia|critical limb ischemia
5760192|NCT00282646|peripheral arterial occlusive disease|peripheral arterial occlusive disease
5760193|NCT00282646|[C14.907.137]|[c14.907.137]
5760194|NCT00282633|Cesarean Delivery|cesarean delivery
5760195|NCT00282633|Wound closure|wound closure
5760196|NCT00282633|Suture|suture
5760197|NCT00282633|Alternative therapy|alternative therapy
5760198|NCT00282633|Surgery|surgery
5760199|NCT00282620|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5760200|NCT00282620|Magnesium|magnesium
5760201|NCT00282620|Electrocardiogram|electrocardiogram
5760202|NCT00282620|Ventricular Arrhythmia|ventricular arrhythmia
5760203|NCT00282607|Erectile Dysfunction|erectile dysfunction
5760204|NCT00282594|Intensive Insulin Therapy|intensive insulin therapy
5760205|NCT00282594|General Surgical|general surgical
5760206|NCT00282594|Vascular Surgical|vascular surgical
5760207|NCT00282594|Tight Glycemic Control|tight glycemic control
5760208|NCT00282581|HIV|hiv
5760209|NCT00282581|Smallpox|smallpox
5760210|NCT00282581|MVA|mva
5760211|NCT00282568|Pharmacokinetics|pharmacokinetics
5760212|NCT00282568|Therapy|therapy
5760213|NCT00282568|Immunosuppression|immunosuppression
5760214|NCT00282568|Drugs, Investigational|drugs, investigational
5760215|NCT00282568|Adult|adult
5760216|NCT00282555|Esophagitis, Reflux|esophagitis, reflux
5760217|NCT00282555|S-Tenatoprazole-Na|s-tenatoprazole-na
5760218|NCT00282555|Heartburn|heartburn
5760219|NCT00282555|Esophageal endoscopy|esophageal endoscopy
5760220|NCT00282542|Hepatocytes|hepatocytes
5761610|NCT00277940|Cardiac|cardiac
5760221|NCT00282529|lymphedema, screening, treatment|lymphedema, screening, treatment
5760222|NCT00282516|asthma|asthma
5760223|NCT00282516|telemedicine|telemedicine
5760224|NCT00282516|case management|case management
5760225|NCT00282516|clinic|clinic
5760226|NCT00282516|children|children
5760227|NCT00282516|pediatric|pediatric
5760228|NCT00282503|aGvHD|agvhd
5760229|NCT00282490|Overactive bladder|overactive bladder
5760230|NCT00282490|Children|children
5760231|NCT00282490|Nerve stimulation|nerve stimulation
5760232|NCT00282490|TENS|tens
5760233|NCT00282477|cyclist|cyclist
5760234|NCT00282464|Bipolar I Depression|bipolar i depression
5760235|NCT00282399|Myelodysplastic Syndrome|myelodysplastic syndrome
5760236|NCT00282399|MGI Pharma|mgi pharma
5760237|NCT00282399|Decitabine|decitabine
5760238|NCT00282399|Dacogen|dacogen
5760239|NCT00282360|coronary artery disease|coronary artery disease
5760240|NCT00282360|diabetes mellitus|diabetes mellitus
5760241|NCT00282347|Class IV LN|class iv ln
5760242|NCT00282347|Lupus|lupus
5760243|NCT00282347|LUNAR|lunar
5760244|NCT00282347|LN|ln
5760245|NCT00282334|Telemedicine|telemedicine
5760246|NCT00282334|Blood pressure|blood pressure
5760247|NCT00282334|Quality of life|quality of life
5760248|NCT00282334|Cost-effectiveness|cost-effectiveness
5760249|NCT00282308|RA|ra
5760250|NCT00282308|Rituxan|rituxan
5760251|NCT00282308|SIERRA|sierra
5760253|NCT00282295|pertussis|pertussis
5760254|NCT00282295|Prophylaxis|prophylaxis
5760255|NCT00282295|meningococcus|meningococcus
5760257|NCT00282282|non-myeloablative peripheral blood stem cell|non-myeloablative peripheral blood stem cell
5760258|NCT00282282|PBSCT|pbsct
5760259|NCT00282282|tacrolimus|tacrolimus
5760260|NCT00282282|sirolimus|sirolimus
5760261|NCT00282269|Traumatic Brain Injury|traumatic brain injury
5760262|NCT00282269|Children|children
5760263|NCT00282269|Hypothermia|hypothermia
5760264|NCT00282269|Outcome|outcome
5760265|NCT00282269|Intensive Care|intensive care
5760266|NCT00282269|Magnetic resonance Imaging|magnetic resonance imaging
5760267|NCT00282256|Child|child
5760268|NCT00282256|Pharmacokinetics|pharmacokinetics
5760269|NCT00282256|Immunosuppression Drugs|immunosuppression drugs
5760270|NCT00282256|Hepatic transplant|hepatic transplant
5760271|NCT00282256|Liver Transplantation|liver transplantation
5760272|NCT00282243|Pharmacokinetics|pharmacokinetics
5760273|NCT00282243|Therapy|therapy
5760274|NCT00282243|Immunosuppression|immunosuppression
5760275|NCT00282243|Drugs, Investigational|drugs, investigational
5760276|NCT00282243|Adult|adult
5760277|NCT00282230|Malononitrilamide|malononitrilamide
5760278|NCT00282230|immunosuppression|immunosuppression
5760279|NCT00282230|treatment efficacy|treatment efficacy
5760280|NCT00282230|treatment outcome|treatment outcome
5760281|NCT00282217|Kidney Failure|kidney failure
5760282|NCT00282217|Kidney Transplant|kidney transplant
5760283|NCT00282217|Graft Rejection|graft rejection
5760284|NCT00282217|Kidney Transplantation|kidney transplantation
5760285|NCT00282204|Hypnosis|hypnosis
5760286|NCT00282204|Hypnotherapy|hypnotherapy
5760287|NCT00282204|Childbirth|childbirth
5760288|NCT00282204|Analgesia|analgesia
5760289|NCT00282191|spasticity|spasticity
5760290|NCT00282191|mental retardation|mental retardation
5760291|NCT00282178|Metabolic|metabolic
5760292|NCT00282178|Hypertension|hypertension
5760293|NCT00282178|Abdominal obesity|abdominal obesity
5760294|NCT00282178|Insulin sensitivity|insulin sensitivity
5760295|NCT00282178|Hyperinsulinemic euglycemic clamp|hyperinsulinemic euglycemic clamp
5760296|NCT00282152|Early Stage Parkinson's Disease|early stage parkinson's disease
5760297|NCT00282152|Parkinson's Disease|parkinson's disease
5760298|NCT00282152|Deep Brain Stimulation|deep brain stimulation
5760299|NCT00282152|PD|pd
5760300|NCT00282152|DBS|dbs
5760301|NCT00282126|Calcium balance|calcium balance
5760302|NCT00282113|Probiotic|probiotic
5760303|NCT00282113|Prebiotic|prebiotic
5760304|NCT00282113|NEC|nec
5760305|NCT00282113|Premature infants|premature infants
5760306|NCT00282113|commensal flora|commensal flora
5760307|NCT00282087|early stage|early stage
5760308|NCT00282087|high grade|high grade
5760309|NCT00282087|uterine leiomyosarcoma|uterine leiomyosarcoma
5760310|NCT00282087|adjuvant treatment|adjuvant treatment
5760311|NCT00282061|3 conditions in a within-subject design:|3 conditions in a within-subject design:
5760312|NCT00282061|1-ad-lib sleep wake|1-ad-lib sleep wake
5785595|NCT00167323|Bipolar|bipolar
5760313|NCT00282061|2-forced morning wake-up|2-forced morning wake-up
5760314|NCT00282061|3- ad-lib sleep wake after treatment with melatonin|3- ad-lib sleep wake after treatment with melatonin
5760315|NCT00282035|breast cancer|breast cancer
5760316|NCT00282035|breast tumour|breast tumour
5760318|NCT00282035|female|female
5760319|NCT00282035|breast conserving surgery|breast conserving surgery
5760320|NCT00282035|irradiation|irradiation
5760321|NCT00282035|whole breast irradiation|whole breast irradiation
5760322|NCT00282035|3D CRT accelerated partial breast irradiation|3d crt accelerated partial breast irradiation
5760323|NCT00282035|cosmetic outcome|cosmetic outcome
5760324|NCT00282035|quality of life|quality of life
5760325|NCT00282022|recurrent small cell lung cancer|recurrent small cell lung cancer
5760326|NCT00282022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5760327|NCT00282022|limited stage small cell lung cancer|limited stage small cell lung cancer
5760328|NCT00282009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5760329|NCT00281996|recurrent pancreatic cancer|recurrent pancreatic cancer
5760330|NCT00281996|stage III pancreatic cancer|stage iii pancreatic cancer
5760331|NCT00281996|stage IV pancreatic cancer|stage iv pancreatic cancer
5760332|NCT00281983|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5760333|NCT00281983|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5760334|NCT00281983|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760335|NCT00281983|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5760336|NCT00281983|Waldenström macroglobulinemia|waldenström macroglobulinemia
5760337|NCT00281970|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5760338|NCT00281970|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5760339|NCT00281970|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5760340|NCT00281970|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5760341|NCT00281931|prolymphocytic leukemia|prolymphocytic leukemia
5760342|NCT00281918|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5760343|NCT00281918|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5760344|NCT00281918|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5760345|NCT00281918|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760346|NCT00281918|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5760347|NCT00281905|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5760348|NCT00281905|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5760349|NCT00281905|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5760350|NCT00281905|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5760351|NCT00281905|childhood choroid plexus tumor|childhood choroid plexus tumor
5760352|NCT00281905|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5760353|NCT00281905|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5760354|NCT00281905|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5760355|NCT00281905|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5760356|NCT00281905|childhood oligodendroglioma|childhood oligodendroglioma
5760357|NCT00281905|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5760358|NCT00281905|disseminated neuroblastoma|disseminated neuroblastoma
5760359|NCT00281905|localized resectable neuroblastoma|localized resectable neuroblastoma
5760360|NCT00281905|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5760361|NCT00281905|regional neuroblastoma|regional neuroblastoma
5760362|NCT00281905|stage 4S neuroblastoma|stage 4s neuroblastoma
5760363|NCT00281892|anemia|anemia
5760364|NCT00281892|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5760365|NCT00281892|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5760366|NCT00281892|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5760367|NCT00281892|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5760368|NCT00281892|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760369|NCT00281892|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5760370|NCT00281879|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5760371|NCT00281879|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5760372|NCT00281879|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5760373|NCT00281879|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5760374|NCT00281879|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5760375|NCT00281879|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5760376|NCT00281879|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5760377|NCT00281879|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5760378|NCT00281879|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5760379|NCT00281879|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5760380|NCT00281879|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5760381|NCT00281879|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5785731|NCT00166725|CgA|cga
5759425|NCT00286234|niacin|niacin
5760382|NCT00281879|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5760383|NCT00281879|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5760384|NCT00281879|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5760385|NCT00281879|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5760386|NCT00281879|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5760387|NCT00281879|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5760388|NCT00281879|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5760389|NCT00281879|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5760390|NCT00281879|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5760391|NCT00281879|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5760392|NCT00281879|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5760393|NCT00281879|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5760394|NCT00281879|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5760395|NCT00281879|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5760396|NCT00281879|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5760397|NCT00281879|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5760398|NCT00281879|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5760399|NCT00281879|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5760400|NCT00281879|refractory anemia with excess blasts|refractory anemia with excess blasts
5760401|NCT00281879|refractory anemia|refractory anemia
5760402|NCT00281879|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5760403|NCT00281879|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5760404|NCT00281879|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5760405|NCT00281879|primary myelofibrosis|primary myelofibrosis
5760406|NCT00281879|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5760407|NCT00281879|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5760408|NCT00281879|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5755709|NCT00299091|HIV|hiv
5760409|NCT00281879|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5760410|NCT00281879|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5760411|NCT00281879|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5760412|NCT00281879|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5760413|NCT00281879|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5798870|NCT00110708|autistic disorder|autistic disorder
5760414|NCT00281879|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5760415|NCT00281879|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5760416|NCT00281879|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5760417|NCT00281879|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5760418|NCT00281879|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5760419|NCT00281879|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5760420|NCT00281879|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5760421|NCT00281879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5760422|NCT00281879|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5760423|NCT00281879|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5760424|NCT00281879|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5760425|NCT00281879|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5760426|NCT00281879|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5760427|NCT00281879|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5760428|NCT00281879|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5760429|NCT00281879|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5760430|NCT00281879|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5760431|NCT00281879|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5760432|NCT00281879|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5760433|NCT00281879|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5760434|NCT00281879|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5760435|NCT00281879|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5760436|NCT00281879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5760437|NCT00281879|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5760438|NCT00281879|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5760439|NCT00281879|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5760440|NCT00281879|refractory hairy cell leukemia|refractory hairy cell leukemia
5760441|NCT00281879|refractory multiple myeloma|refractory multiple myeloma
5760442|NCT00281879|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5760443|NCT00281879|stage I multiple myeloma|stage i multiple myeloma
5760444|NCT00281879|stage II multiple myeloma|stage ii multiple myeloma
5760445|NCT00281879|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5760446|NCT00281879|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5760447|NCT00281879|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5760448|NCT00281879|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5760449|NCT00281879|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5760450|NCT00281879|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5760451|NCT00281879|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5760452|NCT00281879|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760453|NCT00281879|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5760454|NCT00281879|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5760455|NCT00281879|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5760456|NCT00281879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5760457|NCT00281879|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5760458|NCT00281879|stage III multiple myeloma|stage iii multiple myeloma
5760459|NCT00281879|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5760460|NCT00281879|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5760461|NCT00281879|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5760462|NCT00281879|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5760463|NCT00281879|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5760464|NCT00281879|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5760465|NCT00281879|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5760466|NCT00281879|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5760467|NCT00281879|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5760468|NCT00281879|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5760469|NCT00281879|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5760470|NCT00281879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5760471|NCT00281879|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5760472|NCT00281879|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5760473|NCT00281879|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5760474|NCT00281879|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5760475|NCT00281879|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5760476|NCT00281879|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5760477|NCT00281879|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5760478|NCT00281879|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5760479|NCT00281879|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5760480|NCT00281879|unusual cancers of childhood|unusual cancers of childhood
5760481|NCT00281879|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5760482|NCT00281866|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5760483|NCT00281866|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5760484|NCT00281866|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5760485|NCT00281866|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5760486|NCT00281866|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5760487|NCT00281866|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5760488|NCT00281866|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5760489|NCT00281866|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5760490|NCT00281866|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5760491|NCT00281866|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5760492|NCT00281866|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5760493|NCT00281866|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5760494|NCT00281866|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5760495|NCT00281866|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5760496|NCT00281853|neurotoxicity|neurotoxicity
5862891|NCT00001469|Micro Satellite|micro satellite
5760497|NCT00281853|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5759603|NCT00285246|utilization|utilization
5760498|NCT00281840|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5760499|NCT00281840|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5760500|NCT00281840|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5760501|NCT00281840|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5760502|NCT00281840|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5760503|NCT00281840|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5760504|NCT00281840|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5760505|NCT00281840|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5760506|NCT00281840|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5760507|NCT00281840|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5760509|NCT00281827|squamous cell lung cancer|squamous cell lung cancer
5760510|NCT00281827|large cell lung cancer|large cell lung cancer
5760511|NCT00281827|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5760512|NCT00281827|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5760513|NCT00281814|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5760514|NCT00281814|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5760515|NCT00281814|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5760516|NCT00281814|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5760517|NCT00281814|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5760518|NCT00281814|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5760519|NCT00281814|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5760520|NCT00281814|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5760521|NCT00281814|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5760522|NCT00281814|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5760523|NCT00281814|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5760524|NCT00281814|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5760525|NCT00281814|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5760526|NCT00281814|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5760527|NCT00281814|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5760590|NCT00281814|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5760528|NCT00281814|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5760529|NCT00281814|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5760530|NCT00281814|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5760531|NCT00281814|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5760532|NCT00281814|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5760533|NCT00281814|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5760534|NCT00281814|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5760535|NCT00281814|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5760536|NCT00281814|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5760537|NCT00281814|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5760538|NCT00281814|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5760539|NCT00281814|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5760540|NCT00281814|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5760541|NCT00281814|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5760542|NCT00281814|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5760543|NCT00281814|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5760544|NCT00281814|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5760545|NCT00281814|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5760546|NCT00281814|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5760547|NCT00281814|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5760548|NCT00281814|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5760549|NCT00281814|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5760550|NCT00281814|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5760551|NCT00281814|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5760552|NCT00281814|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5759709|NCT00284648|Rupture|rupture
5760553|NCT00281814|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5760554|NCT00281814|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5760555|NCT00281814|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5760556|NCT00281814|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5760557|NCT00281814|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5760558|NCT00281814|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5760559|NCT00281814|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5760560|NCT00281814|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5760561|NCT00281814|refractory hairy cell leukemia|refractory hairy cell leukemia
5760562|NCT00281814|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5760563|NCT00281814|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5760564|NCT00281814|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5760565|NCT00281814|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5760566|NCT00281814|stage I multiple myeloma|stage i multiple myeloma
5760567|NCT00281814|stage II multiple myeloma|stage ii multiple myeloma
5760568|NCT00281814|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5760569|NCT00281814|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5760570|NCT00281814|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5760571|NCT00281814|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5760572|NCT00281814|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5760573|NCT00281814|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5760574|NCT00281814|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5760575|NCT00281814|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760576|NCT00281814|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5760577|NCT00281814|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5760578|NCT00281814|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5760579|NCT00281814|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5760580|NCT00281814|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5760581|NCT00281814|stage III multiple myeloma|stage iii multiple myeloma
5760582|NCT00281814|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5760583|NCT00281814|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5760584|NCT00281814|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5760585|NCT00281814|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5760586|NCT00281814|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5760587|NCT00281814|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5760588|NCT00281814|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5760589|NCT00281814|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5760591|NCT00281814|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5760592|NCT00281814|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5760593|NCT00281814|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5760594|NCT00281814|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5760595|NCT00281814|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5760596|NCT00281814|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5760597|NCT00281801|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5760598|NCT00281801|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5760599|NCT00281801|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5760600|NCT00281801|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5760601|NCT00281801|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5760602|NCT00281801|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5760603|NCT00281801|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5760604|NCT00281801|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5760605|NCT00281801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5760606|NCT00281801|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5760607|NCT00281801|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5760608|NCT00281801|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5760609|NCT00281801|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5760610|NCT00281801|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5760611|NCT00281801|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5760612|NCT00281801|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5760613|NCT00281801|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5760614|NCT00281801|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5760615|NCT00281801|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5760616|NCT00281801|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5760617|NCT00281801|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5760618|NCT00281801|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5760619|NCT00281801|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5760620|NCT00281801|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5760621|NCT00281801|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5760622|NCT00281801|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5760623|NCT00281801|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5760624|NCT00281801|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5760625|NCT00281801|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5760626|NCT00281801|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5760627|NCT00281801|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5760628|NCT00281801|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5760629|NCT00281801|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5760630|NCT00281801|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5760631|NCT00281801|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5760632|NCT00281801|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5760633|NCT00281801|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5760634|NCT00281801|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5760635|NCT00281801|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5760636|NCT00281801|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5760637|NCT00281801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5760638|NCT00281801|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5760639|NCT00281801|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5760640|NCT00281801|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5760641|NCT00281801|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5760642|NCT00281801|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5760643|NCT00281801|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5760644|NCT00281801|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5760645|NCT00281801|refractory hairy cell leukemia|refractory hairy cell leukemia
5760646|NCT00281801|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5760647|NCT00281801|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5760648|NCT00281801|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5760649|NCT00281801|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5760650|NCT00281801|stage I multiple myeloma|stage i multiple myeloma
5760651|NCT00281801|stage II multiple myeloma|stage ii multiple myeloma
5760652|NCT00281801|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5760653|NCT00281801|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5760654|NCT00281801|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5760655|NCT00281801|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5760656|NCT00281801|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5760657|NCT00281801|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5760658|NCT00281801|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5760659|NCT00281801|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5760660|NCT00281801|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5760661|NCT00281801|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5760662|NCT00281801|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5760663|NCT00281801|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5760664|NCT00281801|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5760665|NCT00281801|stage III multiple myeloma|stage iii multiple myeloma
5760666|NCT00281801|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5760667|NCT00281801|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5760668|NCT00281801|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5760669|NCT00281801|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5760670|NCT00281801|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5760671|NCT00281801|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5760672|NCT00281801|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5760673|NCT00281801|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5760674|NCT00281801|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5862892|NCT00001469|Hereditary|hereditary
5760675|NCT00281801|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5760676|NCT00281801|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5760677|NCT00281801|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5760678|NCT00281801|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5760679|NCT00281801|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5760680|NCT00281801|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5760681|NCT00281788|stage I esophageal cancer|stage i esophageal cancer
5760682|NCT00281788|stage II esophageal cancer|stage ii esophageal cancer
5760683|NCT00281788|stage III esophageal cancer|stage iii esophageal cancer
5760686|NCT00281762|Urinary concentrating ability|urinary concentrating ability
5760687|NCT00281749|ALZHEIMER'S D-SE|alzheimer's d-se
5760688|NCT00281749|PARKINSON'S D-SE|parkinson's d-se
5760690|NCT00281736|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5760691|NCT00281736|recurrent esophageal cancer|recurrent esophageal cancer
5760692|NCT00281736|stage 0 esophageal cancer|stage 0 esophageal cancer
5760693|NCT00281736|stage I esophageal cancer|stage i esophageal cancer
5760694|NCT00281736|precancerous condition|precancerous condition
5760695|NCT00281723|Aphthous|aphthous
5760696|NCT00281723|oral|oral
5760697|NCT00281710|AQP-2|aqp-2
5760698|NCT00281710|Methylprednisolone|methylprednisolone
5760699|NCT00281710|Urinary concentrating ability|urinary concentrating ability
5760700|NCT00281697|Ribbon 2|ribbon 2
5760701|NCT00281697|Avastin|avastin
5760702|NCT00281697|MBC|mbc
5760703|NCT00281697|Breast cancer|breast cancer
5760704|NCT00281684|Acute Pain|acute pain
5760705|NCT00281684|Dental Pain|dental pain
5760706|NCT00281684|Vanilloid|vanilloid
5760707|NCT00281684|VR1|vr1
5760708|NCT00281684|TRPV1|trpv1
5760709|NCT00281684|Inflammation|inflammation
5760710|NCT00281671|Nesiritide|nesiritide
5760711|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain
5760712|NCT00281671|Heart Defects, Congenital|heart defects, congenital
5760713|NCT00281671|Cardiopulmonary Bypass|cardiopulmonary bypass
5760714|NCT00281671|Diuretics|diuretics
5760715|NCT00281658|ErbB2 positive|erbb2 positive
5760716|NCT00281658|Her2+|her2+
5760717|NCT00281658|metastatic breast cancer|metastatic breast cancer
5760718|NCT00281658|FISH positive|fish positive
5760719|NCT00281658|Stage IV|stage iv
5760720|NCT00281632|Pazopanib|pazopanib
5760721|NCT00281632|Fallopian tube cancer|fallopian tube cancer
5760722|NCT00281632|Ovarian epithelial cancer|ovarian epithelial cancer
5760723|NCT00281632|Peritoneal cancer|peritoneal cancer
5760724|NCT00281619|Pediatric Kidney Transplant|pediatric kidney transplant
5760725|NCT00281619|Kidney Transplant|kidney transplant
5760727|NCT00281619|Mycophenolate mofetil|mycophenolate mofetil
5760728|NCT00281619|Mycophenolic Acid|mycophenolic acid
5760729|NCT00281619|MPA|mpa
5760730|NCT00281606|Lopinavir|lopinavir
5760731|NCT00281606|antiretroviral therapy|antiretroviral therapy
5760732|NCT00281606|cross-over|cross-over
5760733|NCT00281606|tolerability|tolerability
5760734|NCT00281554|Investigational Therapies|investigational therapies
5760735|NCT00281554|Atrial Fibrillation|atrial fibrillation
5760736|NCT00281554|Treatment Efficacy|treatment efficacy
5760737|NCT00281554|Treatment Effectiveness|treatment effectiveness
5760740|NCT00281541|Treatment Efficacy|treatment efficacy
5760741|NCT00281541|Treatment Effectiveness|treatment effectiveness
5760742|NCT00281541|Disease Management|disease management
5760743|NCT00281541|Treatment|treatment
5760744|NCT00281541|Safety|safety
5760745|NCT00281541|Malignant Melanoma|malignant melanoma
5760746|NCT00281528|First Line Metastatic Breast Cancer|first line metastatic breast cancer
5760747|NCT00281502|Hepatic Encephalopathy|hepatic encephalopathy
5760748|NCT00281502|Hepatitis C|hepatitis c
5760749|NCT00281502|Liver Cirrhosis|liver cirrhosis
5760750|NCT00281502|Bacterial Overgrowth|bacterial overgrowth
5760751|NCT00281489|Recall|recall
5760752|NCT00281489|Awareness|awareness
5760753|NCT00281489|BIS|bis
5760754|NCT00281489|Anesthesia|anesthesia
5760755|NCT00281489|Explicit Recall|explicit recall
5760756|NCT00281476|multiple myeloma|multiple myeloma
5760757|NCT00281476|statins|statins
5760758|NCT00281476|bone|bone
5760759|NCT00281463|wheelchair|wheelchair
5760760|NCT00281463|spinal cord injury|spinal cord injury
5760761|NCT00281463|rehabilitation|rehabilitation
5760762|NCT00281437|exercise|exercise
5760763|NCT00281437|adherence|adherence
5760764|NCT00281437|lifestyle|lifestyle
5760765|NCT00281437|choice|choice
5760766|NCT00281437|autonomy|autonomy
5760767|NCT00281424|exercise adherence|exercise adherence
5760768|NCT00281424|cardiac patients|cardiac patients
5760769|NCT00281424|walking|walking
5760770|NCT00281411|Blood Vessel Prosthesis Implantation|blood vessel prosthesis implantation
5760771|NCT00281411|Endovascular aneurysm repair|endovascular aneurysm repair
5760772|NCT00281411|Magnetic Resonance Angiography|magnetic resonance angiography
5760773|NCT00281411|Computed Tomography Angiography|computed tomography angiography
5760774|NCT00281411|Endoleak|endoleak
5760775|NCT00281398|homelessness|homelessness
5760776|NCT00281398|Attitudes of medical trainees towards the homeless|attitudes of medical trainees towards the homeless
5760777|NCT00281385|adherence|adherence
5760778|NCT00281385|lifestyle|lifestyle
5760779|NCT00281385|exercise|exercise
5760780|NCT00281385|pedometer|pedometer
5760781|NCT00281385|training|training
5786325|NCT00163709|AMI|ami
5760040|NCT00283400|SAH|sah
5760782|NCT00281372|sexual dysfunction|sexual dysfunction
5760783|NCT00281372|male|male
5760784|NCT00281372|female|female
5760785|NCT00281372|dental care|dental care
5760786|NCT00281372|need of control|need of control
5760787|NCT00281359|cerebral palsy|cerebral palsy
5760788|NCT00281359|dynamic splinting|dynamic splinting
5760789|NCT00281359|contractures|contractures
5760790|NCT00281359|heat therapy|heat therapy
5760791|NCT00281346|Doppler echocardiography|doppler echocardiography
5760792|NCT00281346|coronary stenosis|coronary stenosis
5760793|NCT00281346|Coronary angiography|coronary angiography
5760794|NCT00281307|Rhinitis|rhinitis
5760795|NCT00281307|Vitamin E|vitamin e
5760796|NCT00281307|Intranasal|intranasal
5760797|NCT00281294|Arthritis, Rheumatoid|arthritis, rheumatoid
5760798|NCT00281281|Extracorporeal Membrane Oxygenation|extracorporeal membrane oxygenation
5760799|NCT00281281|vancomycin|vancomycin
5760800|NCT00281242|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760801|NCT00281242|COPD|copd
5760802|NCT00281229|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760803|NCT00281229|COPD|copd
5760804|NCT00281216|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760805|NCT00281216|COPD|copd
5760806|NCT00281203|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760807|NCT00281203|COPD|copd
5760808|NCT00281190|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760809|NCT00281190|COPD|copd
5760810|NCT00281125|Non-Small Cell Lung Cancer|non-small cell lung cancer
5760811|NCT00281125|Pleural Mesothelioma|pleural mesothelioma
5760813|NCT00281099|Pacing|pacing
5760814|NCT00281099|Heart Failure|heart failure
5760815|NCT00281073|Intra-Cardiac Echocardiography|intra-cardiac echocardiography
5760816|NCT00281073|Cardioversion|cardioversion
5760817|NCT00281060|endovascular|endovascular
5760818|NCT00281060|balloon angioplasty|balloon angioplasty
5760819|NCT00281060|stents|stents
5760820|NCT00281047|Helicobacter pylori (H. pylori)|helicobacter pylori (h. pylori)
5760821|NCT00281047|FP-10|fp-10
5760822|NCT00281047|amoxicillin|amoxicillin
5760823|NCT00281047|clarithromycin|clarithromycin
5760824|NCT00281047|lansoprazole|lansoprazole
5760825|NCT00281034|brain infarction|brain infarction
5760827|NCT00281034|HRQOL|hrqol
5760828|NCT00281034|Japan|japan
5760829|NCT00281034|Post-stroke syndrome|post-stroke syndrome
5760830|NCT00281021|non-small cell lung cancer|non-small cell lung cancer
5760831|NCT00281021|Erlotinib|erlotinib
5760832|NCT00281021|Digoxin|digoxin
5760833|NCT00281008|LDL-cholesterol|ldl-cholesterol
5760834|NCT00281008|apoB-100|apob-100
5760835|NCT00281008|Heterozygous Familial Hypercholesterolemia|heterozygous familial hypercholesterolemia
5760836|NCT00280995|LDL-cholesterol|ldl-cholesterol
5760837|NCT00280995|apoB-100|apob-100
5777462|NCT00210301|MS|ms
5760838|NCT00280995|Homozygous Familial Hypercholesterolemia|homozygous familial hypercholesterolemia
5760839|NCT00280982|dendritic cells, immunotherapy, vaccination, mesothelioma|dendritic cells, immunotherapy, vaccination, mesothelioma
5760840|NCT00280969|HIV infection|hiv infection
5760841|NCT00280969|treatment|treatment
5760842|NCT00280969|efavirenz|efavirenz
5760843|NCT00280969|atazanavir|atazanavir
5760844|NCT00280969|ritonavir|ritonavir
5760845|NCT00280943|All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial|all nc ltc facilities having ten residents with a hip fracture or osteoporosis on the mds will be invited to participate in the trial
5760846|NCT00280930|letrozole|letrozole
5760847|NCT00280930|breast cancer|breast cancer
5760848|NCT00280930|menopause|menopause
5760849|NCT00280917|Rheumatoid Arthritis|rheumatoid arthritis
5760850|NCT00280917|RA|ra
5760851|NCT00280904|Hydrocephalus|hydrocephalus
5760852|NCT00280904|Shunt|shunt
5760853|NCT00280891|head and neck|head and neck
5760854|NCT00280891|cancer|cancer
5760855|NCT00280891|palliation|palliation
5760856|NCT00280891|radiotherapy|radiotherapy
5760857|NCT00280878|Lymphoma|lymphoma
5760858|NCT00280878|CD20+|cd20+
5760859|NCT00280865|Tesaglitazar|tesaglitazar
5760860|NCT00280865|type 2 diabetes|type 2 diabetes
5760861|NCT00280852|anaplastic thyroid cancer|anaplastic thyroid cancer
5760862|NCT00280852|chemotherapy|chemotherapy
5760863|NCT00280852|radiotherapy|radiotherapy
5760864|NCT00280826|OCT|oct
5760865|NCT00280826|Retinal Disease|retinal disease
5760866|NCT00280826|Adhesion Molecule|adhesion molecule
5760867|NCT00280826|Ocular Inflammation|ocular inflammation
5760868|NCT00280826|Raptiva|raptiva
5760869|NCT00280826|Macular Edema|macular edema
5760870|NCT00280826|Uveitis|uveitis
5760871|NCT00280826|Immunosuppression|immunosuppression
5760872|NCT00280813|treatment|treatment
5760873|NCT00280813|dual diagnosis|dual diagnosis
5760874|NCT00280800|randomized|randomized
5760875|NCT00280800|controlled|controlled
5760876|NCT00280800|double blind|double blind
5760877|NCT00280800|effectiveness|effectiveness
5760878|NCT00280800|auto CPAP|auto cpap
5760879|NCT00280800|treatment|treatment
5760880|NCT00280800|sleep apnea|sleep apnea
5760881|NCT00280787|unresectable|unresectable
5760882|NCT00280787|induction|induction
5760883|NCT00280787|radiotherapy|radiotherapy
5760884|NCT00280787|ZD1839|zd1839
5760885|NCT00280774|corticosteroid|corticosteroid
5760886|NCT00280774|prednisone|prednisone
5760887|NCT00280774|memantine|memantine
5760888|NCT00280774|Patients who are taking a corticosteroid for a|patients who are taking a corticosteroid for a
5760889|NCT00280774|pulmonary illness|pulmonary illness
5760890|NCT00280774|rheumatic illness|rheumatic illness
5760891|NCT00280774|kidney transplant|kidney transplant
5760892|NCT00280761|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5760893|NCT00280761|recurrent rectal cancer|recurrent rectal cancer
5760894|NCT00280761|stage II rectal cancer|stage ii rectal cancer
5760895|NCT00280761|stage III rectal cancer|stage iii rectal cancer
5760896|NCT00280761|stage IV rectal cancer|stage iv rectal cancer
5760897|NCT00280748|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5760898|NCT00280748|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5760899|NCT00280748|tumors metastatic to brain|tumors metastatic to brain
5760900|NCT00280735|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5760901|NCT00280735|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5760902|NCT00280735|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5760903|NCT00280722|Randomised|randomised
5760904|NCT00280722|Intervention|intervention
5760905|NCT00280722|Leaflet|leaflet
5760906|NCT00280722|Information|information
5760907|NCT00280722|Awareness|awareness
5760908|NCT00280722|Behaviour|behaviour
5760909|NCT00280722|Research|research
5760910|NCT00280709|Bile duct|bile duct
5760911|NCT00280709|Bile duct obstruction|bile duct obstruction
5760912|NCT00280709|Biliary stent|biliary stent
5760913|NCT00280709|Metal stent|metal stent
5760914|NCT00280709|ERCP|ercp
5760915|NCT00280709|Patency|patency
5760916|NCT00280709|Complication|complication
5760917|NCT00280709|Stent occlusion|stent occlusion
5760918|NCT00280696|Epilepsies, Partial,|epilepsies, partial,
5760919|NCT00280696|Keppra, levetiracetam|keppra, levetiracetam
5760920|NCT00280683|Airway Inflammation|airway inflammation
5760921|NCT00280683|Moderate persistent asthma|moderate persistent asthma
5760922|NCT00280683|Severe Persistent Asthma|severe persistent asthma
5746859|NCT00332189|PKU|pku
5760924|NCT00280592|Prophylaxis|prophylaxis
5760925|NCT00280592|Cranberry|cranberry
5760926|NCT00280592|Neurogenic bladder|neurogenic bladder
5760927|NCT00280553|analgesia|analgesia
5760928|NCT00280553|laparoscopic surgical procedures|laparoscopic surgical procedures
5760929|NCT00280553|length of stay|length of stay
5760930|NCT00280540|Hypertension|hypertension
5760931|NCT00280540|High blood pressure|high blood pressure
5760932|NCT00280540|Blood pressure control|blood pressure control
5760933|NCT00280540|Blood pressure reduction|blood pressure reduction
5760935|NCT00280527|NAFLD|nafld
5760936|NCT00280527|NASH|nash
5760937|NCT00280527|Obesity|obesity
5760938|NCT00280527|Bariatric Surgery|bariatric surgery
5760939|NCT00280527|Weight Reduction|weight reduction
5760940|NCT00280514|abscess|abscess
5760941|NCT00280514|penetration|penetration
5760942|NCT00280514|antibiotics|antibiotics
5760943|NCT00280514|cefpirome|cefpirome
5760944|NCT00280514|moxifloxacin|moxifloxacin
5760945|NCT00280514|abdominal cyst|abdominal cyst
5760946|NCT00280501|Sulpiride|sulpiride
5760947|NCT00280501|Quetiapine|quetiapine
5760948|NCT00280501|Light/dark transition|light/dark transition
5760949|NCT00280501|Choroidal blood flow|choroidal blood flow
5760950|NCT00280488|Motivational Interviewing|motivational interviewing
5760951|NCT00280488|Alcohol Abuse|alcohol abuse
5760952|NCT00280488|Alcohol Dependence|alcohol dependence
5760953|NCT00280488|Emergency Care Setting|emergency care setting
5760954|NCT00280475|Randomized Controlled Trials|randomized controlled trials
5760955|NCT00280475|Brain Neoplasms/Secondary|brain neoplasms/secondary
5760956|NCT00280475|Brain Neoplasms/Radiotherapy|brain neoplasms/radiotherapy
5760957|NCT00280475|Radiosurgery|radiosurgery
5760958|NCT00280462|Nifedipine|nifedipine
5760959|NCT00280462|Choroidal blood flow|choroidal blood flow
5760960|NCT00280462|Choroidal autoregulation|choroidal autoregulation
5760961|NCT00280462|Isometric exercise|isometric exercise
5760962|NCT00280449|people living with HIV|people living with hiv
5760963|NCT00280449|quality of life|quality of life
5760964|NCT00280436|Polysomnography|polysomnography
5760965|NCT00280436|Electroencephalography|electroencephalography
5760966|NCT00280436|Primary Insomnia|primary insomnia
5760967|NCT00280436|Cognition|cognition
5760968|NCT00280436|Sleep|sleep
5760969|NCT00280423|Cognition|cognition
5760970|NCT00280423|Polysomnography|polysomnography
5760971|NCT00280423|Primary Insomnia|primary insomnia
5760972|NCT00280423|Electroencephalography|electroencephalography
5760973|NCT00280423|Sleep|sleep
5760974|NCT00280397|Cancer, solid tumors|cancer, solid tumors
5760975|NCT00280371|COPD|copd
5760976|NCT00280371|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5760977|NCT00280371|formoterol|formoterol
5760978|NCT00280358|Fluticasone|fluticasone
5760979|NCT00280358|Formoterol|formoterol
5760980|NCT00280358|PK Study|pk study
5769138|NCT00247988|Ovarian|ovarian
5760981|NCT00280358|Pharmacokinetics|pharmacokinetics
5760982|NCT00280345|pigmentary glaucoma|pigmentary glaucoma
5760983|NCT00280345|primary open angle glaucoma|primary open angle glaucoma
5760984|NCT00280345|cataract|cataract
5760985|NCT00280345|trabeculectomy|trabeculectomy
5760986|NCT00280345|cataract surgery|cataract surgery
5760987|NCT00280332|colonic adenoma, colonic advanced neoplasm|colonic adenoma, colonic advanced neoplasm
5760988|NCT00280319|randomized controlled trial|randomized controlled trial
5760989|NCT00280319|depression|depression
5760991|NCT00280319|adolescents|adolescents
5760992|NCT00280293|Bipolar Disorder|bipolar disorder
5760993|NCT00280293|Cocaine Dependence|cocaine dependence
5760994|NCT00280293|Dual Diagnosis|dual diagnosis
5760995|NCT00280280|spasticity|spasticity
5760996|NCT00280280|Botox|botox
5760997|NCT00280280|baclofen|baclofen
5760998|NCT00280267|hip fracture|hip fracture
5760999|NCT00280267|testosterone|testosterone
5761000|NCT00280267|muscle weakness|muscle weakness
5761001|NCT00280267|frail elderly|frail elderly
5761002|NCT00280267|aging|aging
5761003|NCT00280254|Heart Failure|heart failure
5761004|NCT00280254|Hemodynamics|hemodynamics
5761005|NCT00280254|Echocardiography|echocardiography
5761006|NCT00280241|Chronic|chronic
5761007|NCT00280241|Lymphocytic|lymphocytic
5761008|NCT00280241|Leukemia|leukemia
5761009|NCT00280241|Fludarabine|fludarabine
5761010|NCT00280241|Cyclophosphamide|cyclophosphamide
5761011|NCT00280241|Rituximab|rituximab
5761012|NCT00280228|ADHD|adhd
5761013|NCT00280228|Oppositional Defiant Disorder|oppositional defiant disorder
5761014|NCT00280228|Conduct Disorder|conduct disorder
5761015|NCT00280228|Substance Use|substance use
5761016|NCT00280228|Drug and Alcohol Use|drug and alcohol use
5761017|NCT00280215|Primary Hyperoxaluria|primary hyperoxaluria
5761018|NCT00280202|Non-small cell lung cancer|non-small cell lung cancer
5761019|NCT00280202|Carcinogenesis|carcinogenesis
5761020|NCT00280202|Genomic changes leading to malignant phenotypes in NSCLC.|genomic changes leading to malignant phenotypes in nsclc.
5761021|NCT00280202|Simultaneous mutagenesis of epithelial cells.|simultaneous mutagenesis of epithelial cells.
5761022|NCT00280202|Chromosomal abnormalities/mutations in bronchial tissues.|chromosomal abnormalities/mutations in bronchial tissues.
5761023|NCT00280202|Detect micrometastases in histologically neg. lymph nodes|detect micrometastases in histologically neg. lymph nodes
5761024|NCT00280189|Radiofrequency ablation|radiofrequency ablation
5761025|NCT00280189|Pulmonary malignancies|pulmonary malignancies
5761026|NCT00280189|Primary lung cancer|primary lung cancer
5761027|NCT00280189|Pulmonary metastasis|pulmonary metastasis
5761028|NCT00280189|Primary lung tumors|primary lung tumors
5761029|NCT00280189|Secondary lung tumors|secondary lung tumors
5761030|NCT00280189|Coagulation necrosis of soft tissue tumors|coagulation necrosis of soft tissue tumors
5761031|NCT00280176|recurrent rectal cancer|recurrent rectal cancer
5761032|NCT00280176|stage II rectal cancer|stage ii rectal cancer
5761033|NCT00280176|stage III rectal cancer|stage iii rectal cancer
5761034|NCT00280176|stage IV rectal cancer|stage iv rectal cancer
5761035|NCT00280176|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5761036|NCT00280163|Genomics, cardiac surgery|genomics, cardiac surgery
5761037|NCT00280150|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5761038|NCT00280150|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5761039|NCT00280150|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5761040|NCT00280150|squamous cell lung cancer|squamous cell lung cancer
5761041|NCT00280137|Quality of Life|quality of life
5761042|NCT00280137|Pediatric Systemic Lupus Erythematosus|pediatric systemic lupus erythematosus
5761043|NCT00280111|rotavirus|rotavirus
5761044|NCT00280111|vaccine|vaccine
5761045|NCT00280111|safety|safety
5761046|NCT00280111|immunogenicity|immunogenicity
5761047|NCT00280111|infants|infants
5761048|NCT00280072|Renal Failure, Acute|renal failure, acute
5761049|NCT00280072|Acute Kidney Failure|acute kidney failure
5761050|NCT00280072|Acute Renal Failure|acute renal failure
5761051|NCT00280072|Acute Tubular Necrosis|acute tubular necrosis
5761052|NCT00280072|Anuria|anuria
5761053|NCT00280072|Renal Dialysis|renal dialysis
5761054|NCT00280072|Acute Kidney Injury|acute kidney injury
5761055|NCT00280059|Epilepsy|epilepsy
5761056|NCT00280059|partial seizures|partial seizures
5761057|NCT00280059|pregabalin monotherapy|pregabalin monotherapy
5761058|NCT00280059|lamotrigine comparator|lamotrigine comparator
5761059|NCT00280059|double-blind and randomized trial|double-blind and randomized trial
5761060|NCT00280033|H5N1, Influenza, vaccine, parent protocol|h5n1, influenza, vaccine, parent protocol
5761061|NCT00280020|sleep disorders|sleep disorders
5761062|NCT00280020|meditation|meditation
5761063|NCT00280020|cognitive behavior therapy|cognitive behavior therapy
5761064|NCT00280007|hepatocellular carcinoma|hepatocellular carcinoma
5761065|NCT00280007|TACE|tace
5761066|NCT00280007|transarterial chemoembolisation|transarterial chemoembolisation
5761067|NCT00280007|portal hypertension|portal hypertension
5761068|NCT00280007|angiogenesis|angiogenesis
5761069|NCT00280007|VEGF|vegf
5761070|NCT00280007|bevacizumab|bevacizumab
5761071|NCT00279994|Intermittent claudication|intermittent claudication
5760317|NCT00282035|DCIS|dcis
5761072|NCT00279994|Exercise therapy|exercise therapy
5761073|NCT00279994|Therapy feedback|therapy feedback
5761074|NCT00279994|Accelerometer|accelerometer
5761075|NCT00279994|Physiotherapy|physiotherapy
5761076|NCT00279994|PAD;|pad;
5761077|NCT00279994|peripheral arterial disease according to Fontaine stage II)|peripheral arterial disease according to fontaine stage ii)
5761078|NCT00279981|Atrial fibrillation|atrial fibrillation
5761079|NCT00279981|Stroke|stroke
5761080|NCT00279981|Pacemaker|pacemaker
5761081|NCT00279981|Implantable Cardiac Defibrillator|implantable cardiac defibrillator
5761082|NCT00279981|Resynchronization systems|resynchronization systems
5761084|NCT00279968|Registry|registry
5761085|NCT00279968|Ventricular tachycardia|ventricular tachycardia
5761086|NCT00279968|Ventricular Fibrillation|ventricular fibrillation
5761087|NCT00279955|Heart Failure, Congestive|heart failure, congestive
5761088|NCT00279955|Implantable Cardioverter-Defibrillators|implantable cardioverter-defibrillators
5761089|NCT00279942|Fibromyalgia|fibromyalgia
5761090|NCT00279942|Dietary Supplements|dietary supplements
5761091|NCT00279942|Rheumatologic Diseases|rheumatologic diseases
5761092|NCT00279942|Complementary and Alternative Medicine|complementary and alternative medicine
5761093|NCT00279851|idiopathic seizure|idiopathic seizure
5761094|NCT00279851|hypoglycemia|hypoglycemia
5761095|NCT00279851|hyperammonemia/hyperinsulinism syndrome|hyperammonemia/hyperinsulinism syndrome
5761096|NCT00279812|Immune response|immune response
5761097|NCT00279812|Selenomethionine|selenomethionine
5761098|NCT00279812|Selenium enriched foods|selenium enriched foods
5761099|NCT00279812|Selenium status|selenium status
5761100|NCT00279812|Selenium biomarkers|selenium biomarkers
5763491|NCT00270062|anemia|anemia
5761101|NCT00279799|Sexually Transmitted Diseases, HIV, condom use, adolescents|sexually transmitted diseases, hiv, condom use, adolescents
5761102|NCT00279786|pediatric|pediatric
5761103|NCT00279773|Acute|acute
5761104|NCT00279773|Myeloid|myeloid
5761105|NCT00279773|Leukemia|leukemia
5761106|NCT00279734|Rheumatoid Arthritis|rheumatoid arthritis
5761107|NCT00279721|thyroid neoplasms|thyroid neoplasms
5761108|NCT00279721|intensity modulated radiation|intensity modulated radiation
5761109|NCT00279721|radiotherapy|radiotherapy
5761110|NCT00279708|Granulomatous Inflammation|granulomatous inflammation
5761111|NCT00279708|Steroid-Sparing|steroid-sparing
5761113|NCT00279708|Sarcoidosis, Pulmonary|sarcoidosis, pulmonary
5761114|NCT00279708|Statins (Atorvastatin)|statins (atorvastatin)
5761116|NCT00279708|Nitric Oxide|nitric oxide
5761117|NCT00279708|Disease Activity|disease activity
5761118|NCT00279708|Quality of Life|quality of life
5761119|NCT00279708|Corticosteroids|corticosteroids
5761120|NCT00279708|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5761121|NCT00279708|Sarcoidosis|sarcoidosis
5761122|NCT00279695|Glaucoma|glaucoma
5761123|NCT00279695|Accommodation|accommodation
5761124|NCT00279695|Ocular Tumors|ocular tumors
5761125|NCT00279695|Age-Related Macular Degeneration|age-related macular degeneration
5761126|NCT00279695|Ultrasound|ultrasound
5761128|NCT00279682|depression|depression
5761129|NCT00279682|suicide|suicide
5761130|NCT00279682|geriatric|geriatric
5761132|NCT00279682|primary care|primary care
5761133|NCT00279669|Retinopathy of Prematurity|retinopathy of prematurity
5761134|NCT00279669|Ultrasound|ultrasound
5761135|NCT00279669|Eye|eye
5761136|NCT00279656|Frail elderly|frail elderly
5761137|NCT00279656|Pharmaceutical services|pharmaceutical services
5761138|NCT00279656|Drug therapy|drug therapy
5761139|NCT00279656|Geriatrics|geriatrics
5761140|NCT00279656|Randomized controlled trial|randomized controlled trial
5761141|NCT00279656|Hospitals, teaching|hospitals, teaching
5761142|NCT00279643|Laser|laser
5761143|NCT00279643|immunohistochemical staining|immunohistochemical staining
5761144|NCT00279643|Laser Hair Removal|laser hair removal
5761145|NCT00279643|follicular stem cells|follicular stem cells
5761146|NCT00279643|keratin 15|keratin 15
5761147|NCT00279630|Tibialis Posterior Tendinopathy|tibialis posterior tendinopathy
5761148|NCT00279578|haemophilia A|haemophilia a
5761149|NCT00279578|thrombelastography|thrombelastography
5761150|NCT00279578|recombinant factor VIII|recombinant factor viii
5761151|NCT00279578|thrombin generation|thrombin generation
5761152|NCT00279565|buprenorphine|buprenorphine
5761153|NCT00279565|methadone|methadone
5761154|NCT00279565|Peg-Intron|peg-intron
5761155|NCT00279565|Rebetol|rebetol
5761156|NCT00279552|Vitamin B12 deficiency|vitamin b12 deficiency
5761157|NCT00279552|Vitamin B12 malabsorption|vitamin b12 malabsorption
5761158|NCT00279552|Intrinsic factor|intrinsic factor
5761159|NCT00279552|Holotranscobalamin|holotranscobalamin
5761160|NCT00279539|Cardiovascular|cardiovascular
5761161|NCT00279539|Gene Therapy|gene therapy
5761162|NCT00279539|DNA|dna
5761163|NCT00279539|Stem Cells|stem cells
5761164|NCT00279539|Congestive Heart Failure|congestive heart failure
5761165|NCT00279539|Coronary Artery Disease|coronary artery disease
5761166|NCT00279539|CHF|chf
5761167|NCT00279539|Cardiomyopathy|cardiomyopathy
5761168|NCT00279526|Depression|depression
5761169|NCT00279526|Health services utilization|health services utilization
5761170|NCT00279526|Elderly|elderly
5761171|NCT00279526|Primary Care|primary care
5761172|NCT00279513|homeopathy|homeopathy
5769315|NCT00247429|anxiety|anxiety
5761173|NCT00279513|hallux valgus|hallux valgus
5761174|NCT00279513|pain|pain
5761175|NCT00279513|traumeel s|traumeel s
5761176|NCT00279487|Patients undergoing total knee replacement who received pain management by the following modality:|patients undergoing total knee replacement who received pain management by the following modality:
5761177|NCT00279487|IV PCA opioid|iv pca opioid
5761178|NCT00279487|Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine|local femoral nerve block with 1.5% mepivacaine & 0.5% ropivacaine
5761179|NCT00279474|cancer patients|cancer patients
5761180|NCT00279474|family|family
5761181|NCT00279474|cognitive behavior|cognitive behavior
5761182|NCT00279474|distress|distress
5761183|NCT00279461|Rheumatoid Arthritis|rheumatoid arthritis
5761184|NCT00279461|Vitamin D|vitamin d
5761185|NCT00279435|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
5761186|NCT00279422|Intravenous, Steroid-Refractory, Ulcerative Colitis|intravenous, steroid-refractory, ulcerative colitis
5761187|NCT00279409|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5761188|NCT00279409|ADHD|adhd
5761189|NCT00279409|Treatment resistant|treatment resistant
5761190|NCT00279409|Partial responder|partial responder
5761191|NCT00279409|Non-responder|non-responder
5761192|NCT00279409|Atypical Antipsychotic|atypical antipsychotic
5761193|NCT00279383|Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures|intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
5761194|NCT00279370|SSRI Exposure|ssri exposure
5761195|NCT00279370|Pregnancy|pregnancy
5763599|NCT00269802|OROS®|oros®
5761196|NCT00279370|Infant Development|infant development
5761197|NCT00279357|NBI|nbi
5761198|NCT00279357|high risk group for adenomas|high risk group for adenomas
5761199|NCT00279331|HIV Seronegativity|hiv seronegativity
5761200|NCT00279331|Men who have Sex with Men|men who have sex with men
5761201|NCT00279331|MSM|msm
5761202|NCT00279331|Peru|peru
5761203|NCT00279331|Ecuador|ecuador
5761204|NCT00279331|Incidence|incidence
5761205|NCT00279331|Prevalence|prevalence
5761206|NCT00279331|Drug resistance, viral|drug resistance, viral
5761208|NCT00279318|Exposures|exposures
5761209|NCT00279318|Diet|diet
5761210|NCT00279318|Toxins|toxins
5761211|NCT00279318|Psychosocial|psychosocial
5761212|NCT00279318|Infectious Agents|infectious agents
5761213|NCT00279318|Bacterial|bacterial
5761214|NCT00279318|Viral|viral
5761215|NCT00279318|Immunizations|immunizations
5761216|NCT00279318|Autoantibody|autoantibody
5761217|NCT00279305|Newly diagnosed type 1 diabetes|newly diagnosed type 1 diabetes
5761218|NCT00279305|New Onset type 1 diabetes|new onset type 1 diabetes
5798873|NCT00110708|abdominal pain|abdominal pain
5761219|NCT00279305|Preservation of insulin secretion|preservation of insulin secretion
5761221|NCT00279305|Juvenile Onset Diabetes|juvenile onset diabetes
5761222|NCT00279305|Insulin Dependent Diabetes|insulin dependent diabetes
5761223|NCT00279305|T1D|t1d
5761224|NCT00279292|Pancreatic neoplasm|pancreatic neoplasm
5761225|NCT00279279|Implantable cardioverter defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5761226|NCT00279279|Sudden Cardiac Death|sudden cardiac death
5761227|NCT00279279|Primary Prevention|primary prevention
5761228|NCT00279266|Diabetic Peripheral Neuropathy|diabetic peripheral neuropathy
5761229|NCT00279266|Peripheral Neuropathy|peripheral neuropathy
5761230|NCT00279266|Diabetes Mellitus|diabetes mellitus
5761231|NCT00279253|clonidine|clonidine
5761232|NCT00279253|glaucoma|glaucoma
5761233|NCT00279240|Impaired glucose tolerance|impaired glucose tolerance
5761234|NCT00279240|Intervention|intervention
5761235|NCT00279240|Prevention|prevention
5761236|NCT00279227|coronary artery disease|coronary artery disease
5761237|NCT00279227|epicardial adipose tissue|epicardial adipose tissue
5761238|NCT00279227|epicardial fat|epicardial fat
5761240|NCT00279201|diabetes|diabetes
5761241|NCT00279201|type 2|type 2
5761242|NCT00279188|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5761243|NCT00279188|Atopy|atopy
5761244|NCT00279188|Inhaled steroids|inhaled steroids
5761245|NCT00279188|Exacerbations|exacerbations
5761246|NCT00279188|Lung function decline|lung function decline
5761247|NCT00279188|Prognosis|prognosis
5761248|NCT00279175|Acute myocardial infarction|acute myocardial infarction
5761249|NCT00279149|Telemedicine|telemedicine
5761250|NCT00279149|TELESTROKE|telestroke
5761251|NCT00279149|symptoms of ischemic stroke since less than 3 hours|symptoms of ischemic stroke since less than 3 hours
5761252|NCT00279136|Bronchial hyperresponsiveness,|bronchial hyperresponsiveness,
5761253|NCT00279136|lung function,|lung function,
5761254|NCT00279136|airway inflammation,|airway inflammation,
5761255|NCT00279136|deep inspiration,|deep inspiration,
5761256|NCT00279136|bronchial biopsies|bronchial biopsies
5761257|NCT00279136|airway smooth muscle|airway smooth muscle
5761259|NCT00279110|Antiretroviral therapy|antiretroviral therapy
5761260|NCT00279110|Heroin dependence|heroin dependence
5761261|NCT00279110|Methadone|methadone
5761262|NCT00279110|Buprenorphine|buprenorphine
5761263|NCT00279097|Intracranial pressure|intracranial pressure
5761264|NCT00279097|High Frequency Chest Wall Oscillation|high frequency chest wall oscillation
5760738|NCT00281554|Safety|safety
5761265|NCT00279097|Neurosurgery|neurosurgery
5761266|NCT00279084|Anaemia|anaemia
5761267|NCT00279084|Chronic kidney disease|chronic kidney disease
5761268|NCT00279084|Type 2 diabetes|type 2 diabetes
5761269|NCT00279084|Randomized trial|randomized trial
5761270|NCT00279071|dystocia|dystocia
5761271|NCT00279071|stimulation|stimulation
5761273|NCT00279071|oxytocin|oxytocin
5761274|NCT00279045|type 2 diabetes monotherapy treatment naive|type 2 diabetes monotherapy treatment naive
5761275|NCT00279032|GW406381|gw406381
5761276|NCT00279032|peripheral nerve injury|peripheral nerve injury
5761277|NCT00279032|patients|patients
5761278|NCT00279032|allodynia|allodynia
5761279|NCT00279032|hyperalgesia|hyperalgesia
5761280|NCT00279032|randomised|randomised
5761281|NCT00279032|placebo-controlled|placebo-controlled
5761282|NCT00279019|GSK233705|gsk233705
5761283|NCT00279019|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5761284|NCT00279019|COPD|copd
5761285|NCT00279006|DES (drug eluting stents)|des (drug eluting stents)
5761286|NCT00279006|CAD (cornary artery disease)|cad (cornary artery disease)
5761287|NCT00279006|stent retrieval|stent retrieval
5761288|NCT00278993|Prostate cancer|prostate cancer
5761289|NCT00278993|metastatic disease|metastatic disease
5761290|NCT00278967|colonoscopy|colonoscopy
5761291|NCT00278967|preparation|preparation
5761292|NCT00278954|Primary Antibody Deficiency|primary antibody deficiency
5761293|NCT00278954|Common variable hypogammaglobulinemia|common variable hypogammaglobulinemia
5761294|NCT00278954|X-linked hypogammaglobulinemia|x-linked hypogammaglobulinemia
5761295|NCT00278954|Hypogammaglobulinemia|hypogammaglobulinemia
5761296|NCT00278954|Immunodeficiency with hyper-IgM|immunodeficiency with hyper-igm
5761297|NCT00278954|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5761298|NCT00278941|Seroquel SR™|seroquel sr™
5761299|NCT00278941|Major Depressive Disorder|major depressive disorder
5761300|NCT00278928|Hypertriglyceridemia|hypertriglyceridemia
5761301|NCT00278928|Infant, Premature|infant, premature
5761302|NCT00278915|Progressive Precocious Puberty|progressive precocious puberty
5761303|NCT00278915|PPP|ppp
5756713|NCT00295854|urgency|urgency
5761305|NCT00278915|MAS|mas
5761306|NCT00278902|ErbB2+ Breast Cancer|erbb2+ breast cancer
5761307|NCT00278902|HER2+ Breast Cancer|her2+ breast cancer
5761308|NCT00278889|Colorectal Cancer|colorectal cancer
5761309|NCT00278889|phase II|phase ii
5761310|NCT00278889|metastatic colorectal cancer|metastatic colorectal cancer
5761311|NCT00278889|AZD2171|azd2171
5761312|NCT00278889|RECENTIN|recentin
5761313|NCT00278876|GIST|gist
5761314|NCT00278876|Imatinib|imatinib
5761315|NCT00278876|Adjuvant therapy|adjuvant therapy
5761317|NCT00278863|Stomach cancer|stomach cancer
5761318|NCT00278863|Palliative chemotherapy|palliative chemotherapy
5761319|NCT00278863|Capecitabine|capecitabine
5761320|NCT00278863|S-1|s-1
5761321|NCT00278850|Vulvar vestibulitis|vulvar vestibulitis
5761322|NCT00278850|Treatment|treatment
5761323|NCT00278850|Education|education
5761324|NCT00278837|Meditation|meditation
5761325|NCT00278837|Stress-reduction|stress-reduction
5761326|NCT00278837|Cognitive-affective behavior learning|cognitive-affective behavior learning
5761327|NCT00278824|Chronic Pain|chronic pain
5761328|NCT00278824|Pain|pain
5761329|NCT00278811|Mental Health Services|mental health services
5761330|NCT00278811|Suicide|suicide
5761331|NCT00278811|Suicide ideation|suicide ideation
5761332|NCT00278798|tracehelectomy|tracehelectomy
5761333|NCT00278798|radical hysterectomy|radical hysterectomy
5761334|NCT00278785|interviews|interviews
5761335|NCT00278785|brief intervention|brief intervention
5761336|NCT00278785|drinking|drinking
5761337|NCT00278785|alcohol|alcohol
5761338|NCT00278785|injuries|injuries
5761339|NCT00278785|wounds|wounds
5761340|NCT00278785|intervention studies|intervention studies
5761341|NCT00278759|rapid viral diagnosis|rapid viral diagnosis
5761342|NCT00278759|respiratory infection|respiratory infection
5761343|NCT00278759|pediatric emergency department|pediatric emergency department
5761344|NCT00278759|febrile respiratory infection|febrile respiratory infection
5761345|NCT00278746|zinc|zinc
5761346|NCT00278746|diarrhea|diarrhea
5761347|NCT00278746|cluster randomization|cluster randomization
5761348|NCT00278746|hospitalization|hospitalization
5761349|NCT00278733|Randomized controlled trial|randomized controlled trial
5761350|NCT00278733|brief intervention|brief intervention
5761351|NCT00278733|university students|university students
5761352|NCT00278733|physician advice|physician advice
5761353|NCT00278733|high risk drinking|high risk drinking
5761354|NCT00278707|Canavan Disease|canavan disease
5761355|NCT00278707|Aspartoacylase Deficiency|aspartoacylase deficiency
5761356|NCT00278707|NAA|naa
5761357|NCT00278707|Acetate|acetate
5761358|NCT00278707|Glyceryltriacetate|glyceryltriacetate
5761361|NCT00278681|diarrhea|diarrhea
5761362|NCT00278681|hospitalization|hospitalization
5761363|NCT00278681|programme|programme
5761365|NCT00278473|Primarily Inattentive|primarily inattentive
5761366|NCT00278473|Hyperactive Impulsive Type|hyperactive impulsive type
5761367|NCT00278473|Combined Type|combined type
5761368|NCT00278473|ADHD|adhd
5769521|NCT00246714|humans|humans
5761369|NCT00278473|Adults|adults
5761370|NCT00278473|Psychological|psychological
5752400|NCT00310726|HIV|hiv
5761371|NCT00278473|Cognitive Behavioral Therapy|cognitive behavioral therapy
5761373|NCT00278460|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5761374|NCT00278460|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5761375|NCT00278460|adenocarcinoma of the lung|adenocarcinoma of the lung
5761376|NCT00278460|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5761377|NCT00278460|large cell lung cancer|large cell lung cancer
5761378|NCT00278460|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5761379|NCT00278460|squamous cell lung cancer|squamous cell lung cancer
5761380|NCT00278447|Alcohol|alcohol
5761381|NCT00278447|Alcohol use|alcohol use
5761382|NCT00278447|Alcohol dependence|alcohol dependence
5761383|NCT00278447|Drug|drug
5761384|NCT00278447|Drug use|drug use
5761385|NCT00278447|Drug dependence|drug dependence
5761386|NCT00278447|Utilization|utilization
5761387|NCT00278447|Hospitalization|hospitalization
5761388|NCT00278447|Primary care|primary care
5761389|NCT00278447|Chronic disease management|chronic disease management
5761390|NCT00278447|Care management|care management
5761391|NCT00278447|Comorbidity|comorbidity
5761392|NCT00278434|cervical cancer|cervical cancer
5761393|NCT00278434|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5761394|NCT00278434|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5761395|NCT00278421|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5761396|NCT00278421|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5761397|NCT00278421|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5761398|NCT00278421|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5761399|NCT00278421|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5761400|NCT00278421|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5761401|NCT00278421|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5761402|NCT00278421|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5761403|NCT00278421|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5761404|NCT00278421|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5761405|NCT00278421|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5761406|NCT00278421|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5761407|NCT00278421|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5761408|NCT00278421|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5761409|NCT00278421|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5761410|NCT00278421|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5761411|NCT00278421|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5761412|NCT00278421|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5761413|NCT00278421|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5761414|NCT00278421|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5761415|NCT00278421|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5761416|NCT00278421|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5761417|NCT00278421|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5761418|NCT00278421|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5761419|NCT00278421|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5761420|NCT00278421|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5761421|NCT00278421|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5761422|NCT00278421|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5761423|NCT00278421|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5761424|NCT00278421|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5761425|NCT00278421|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5761426|NCT00278421|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5761427|NCT00278421|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5761428|NCT00278421|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5761429|NCT00278421|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5761430|NCT00278421|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5761431|NCT00278421|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5761432|NCT00278408|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5761433|NCT00278408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5761434|NCT00278408|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5761435|NCT00278408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5761436|NCT00278408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5786942|NCT00161148|PSC|psc
5761437|NCT00278408|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5761438|NCT00278408|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5761439|NCT00278408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5761440|NCT00278408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5761441|NCT00278408|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5761442|NCT00278408|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5761443|NCT00278408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5761444|NCT00278408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5761445|NCT00278408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5761446|NCT00278408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5761447|NCT00278408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5761448|NCT00278408|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5761449|NCT00278408|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5761450|NCT00278408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5761451|NCT00278408|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5761452|NCT00278408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5761453|NCT00278408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5761454|NCT00278408|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5761455|NCT00278408|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5761456|NCT00278408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5761457|NCT00278408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5761458|NCT00278408|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5756853|NCT00295438|tele-medicine|tele-medicine
5761459|NCT00278408|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5761460|NCT00278408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5761461|NCT00278408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5761462|NCT00278408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5761463|NCT00278408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5761464|NCT00278408|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5761465|NCT00278408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5761466|NCT00278408|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5761467|NCT00278408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5761468|NCT00278408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5761469|NCT00278369|recurrent renal cell cancer|recurrent renal cell cancer
5761470|NCT00278369|stage IV renal cell cancer|stage iv renal cell cancer
5761471|NCT00278369|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5761473|NCT00278304|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5761474|NCT00278304|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5761475|NCT00278304|stage IB cervical cancer|stage ib cervical cancer
5761476|NCT00278304|stage IIA cervical cancer|stage iia cervical cancer
5761477|NCT00278304|stage IIB cervical cancer|stage iib cervical cancer
5761478|NCT00278304|stage III cervical cancer|stage iii cervical cancer
5761479|NCT00278304|stage IVA cervical cancer|stage iva cervical cancer
5761480|NCT00278304|stage IVB cervical cancer|stage ivb cervical cancer
5761481|NCT00278278|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5761482|NCT00278278|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5761483|NCT00278278|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5761484|NCT00278278|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5761485|NCT00278265|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5761488|NCT00278252|recurrent childhood ependymoma|recurrent childhood ependymoma
5761489|NCT00278252|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5761490|NCT00278252|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5761491|NCT00278239|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5761492|NCT00278239|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5761493|NCT00278239|cognitive/functional effects|cognitive/functional effects
5761494|NCT00278239|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5761495|NCT00278226|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5761496|NCT00278213|prolymphocytic leukemia|prolymphocytic leukemia
5761497|NCT00278213|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5761498|NCT00278213|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5761499|NCT00278213|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5761500|NCT00278213|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5761501|NCT00278213|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5769747|NCT00245635|BDD|bdd
5761502|NCT00278213|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5761503|NCT00278200|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5761504|NCT00278187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5761505|NCT00278187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5761506|NCT00278187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5761507|NCT00278174|stage IV renal cell cancer|stage iv renal cell cancer
5761508|NCT00278174|recurrent renal cell cancer|recurrent renal cell cancer
5761509|NCT00278174|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5761510|NCT00278161|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5761511|NCT00278161|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5761512|NCT00278161|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5761513|NCT00278161|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5761514|NCT00278161|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5761515|NCT00278161|small lymphocytic lymphoma|small lymphocytic lymphoma
5761516|NCT00278161|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5761517|NCT00278161|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5761518|NCT00278161|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5761519|NCT00278161|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5761520|NCT00278161|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5761521|NCT00278161|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5761522|NCT00278161|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5761523|NCT00278161|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5761524|NCT00278161|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5761525|NCT00278161|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5761526|NCT00278161|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5761527|NCT00278161|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5761528|NCT00278161|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5761529|NCT00278161|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5761530|NCT00278161|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5761531|NCT00278161|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5761532|NCT00278161|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5761533|NCT00278161|prolymphocytic leukemia|prolymphocytic leukemia
5761534|NCT00278161|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5761535|NCT00278161|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5761536|NCT00278161|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5761537|NCT00278161|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5761538|NCT00278161|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5761539|NCT00278161|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5761540|NCT00278161|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5761541|NCT00278161|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5761543|NCT00278161|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5761544|NCT00278161|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5761545|NCT00278161|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5761546|NCT00278161|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5761547|NCT00278161|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5761548|NCT00278161|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5761549|NCT00278161|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5761550|NCT00278161|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5761551|NCT00278161|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5761552|NCT00278161|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5761553|NCT00278161|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5761554|NCT00278161|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5761555|NCT00278148|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5761556|NCT00278148|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5761557|NCT00278135|Cognition|cognition
5761559|NCT00278135|Nutrition|nutrition
5761560|NCT00278135|Omega-3|omega-3
5761562|NCT00278122|stage III melanoma|stage iii melanoma
5761563|NCT00278122|stage IV melanoma|stage iv melanoma
5761564|NCT00278122|recurrent melanoma|recurrent melanoma
5761567|NCT00278096|disability|disability
5761568|NCT00278096|occupational therapy|occupational therapy
5761569|NCT00278083|Pharmacology|pharmacology
5761570|NCT00278083|Asthma|asthma
5761571|NCT00278083|TNF-alpha|tnf-alpha
5761572|NCT00278070|Metronomic-therapy|metronomic-therapy
5761573|NCT00278070|vinorelbine|vinorelbine
5761574|NCT00278070|Recurrent Breast Cancer|recurrent breast cancer
5761575|NCT00278070|Recurrent Non Small Cell Lung Cancer|recurrent non small cell lung cancer
5761576|NCT00278070|Metastatic prostate cancer|metastatic prostate cancer
5761577|NCT00278057|Blood pressure;|blood pressure;
5761578|NCT00278057|chronic renal failure;|chronic renal failure;
5761579|NCT00278057|diabetes mellitus;|diabetes mellitus;
5761580|NCT00278057|dialysis fluid; glucose;|dialysis fluid; glucose;
5761581|NCT00278057|hemodialysis;|hemodialysis;
5761582|NCT00278057|hypertension;|hypertension;
5761583|NCT00278057|uremia.|uremia.
5761584|NCT00278044|Search as text words in Annotation & Scope Note|search as text words in annotation & scope note
5761585|NCT00278031|Retinoblastoma|retinoblastoma
5761586|NCT00278031|Quality of life|quality of life
5761587|NCT00278005|pediatric|pediatric
5761588|NCT00278005|DiGeorge Syndrome|digeorge syndrome
5761589|NCT00278005|Congenital heart defects|congenital heart defects
5761590|NCT00278005|Infections|infections
5761591|NCT00278005|Cardiac surgery|cardiac surgery
5761592|NCT00277992|Pediatric|pediatric
5761593|NCT00277992|Cardiac|cardiac
5761594|NCT00277992|Norwood operation modification|norwood operation modification
5761595|NCT00277992|GT/Nissen operation|gt/nissen operation
5761596|NCT00277992|Po feed|po feed
5761597|NCT00277992|GT fed|gt fed
5761598|NCT00277979|pediatric|pediatric
5761599|NCT00277979|cardiac|cardiac
5761600|NCT00277979|Infantile Pompe's Disease|infantile pompe's disease
5761601|NCT00277979|3D Echocardiography|3d echocardiography
5761602|NCT00277966|Pediatric|pediatric
5761603|NCT00277966|Cardiac Catheterization|cardiac catheterization
5761604|NCT00277966|Fluoroscopy time|fluoroscopy time
5761605|NCT00277953|Pediatric|pediatric
5761606|NCT00277953|Cardiac|cardiac
5761607|NCT00277953|Tracheal Dimensions|tracheal dimensions
5761609|NCT00277940|Pediatric|pediatric
5761611|NCT00277940|Neoaortic Elastic Properties|neoaortic elastic properties
5761612|NCT00277940|Aortic Arch Reconstruction|aortic arch reconstruction
5761613|NCT00277927|Pediatric|pediatric
5761614|NCT00277927|Cardiac|cardiac
5761615|NCT00277927|Valvar Pulmonary Stenosis|valvar pulmonary stenosis
5761616|NCT00277901|cardiac|cardiac
5761617|NCT00277901|pediatric|pediatric
5761618|NCT00277901|MRI|mri
5761619|NCT00277901|Tetralogy of Fallot TOF|tetralogy of fallot tof
5761620|NCT00277901|Aortic Coarctation|aortic coarctation
5761621|NCT00277888|Dialysis|dialysis
5761622|NCT00277888|Hemodialysis|hemodialysis
5761623|NCT00277888|Catheterization|catheterization
5761624|NCT00277875|Cardiovascular|cardiovascular
5761625|NCT00277875|Flow-Mediated Vasodilation (FMD)|flow-mediated vasodilation (fmd)
5761626|NCT00277875|Pulse Perfusion-Mediated Vasodilation (PPMV)|pulse perfusion-mediated vasodilation (ppmv)
5761628|NCT00277875|Heart Failure|heart failure
5761629|NCT00277875|Local Distensibility|local distensibility
5761630|NCT00277875|Arterial Stiffening|arterial stiffening
5761631|NCT00277875|Augmentation Index (AI)|augmentation index (ai)
5761633|NCT00277875|Isolated Systolic Hypertension|isolated systolic hypertension
5763689|NCT00269477|Meningitis|meningitis
5761634|NCT00277875|Advanced Glycation Endproducts|advanced glycation endproducts
5761635|NCT00277875|Vascular Stiffness|vascular stiffness
5761636|NCT00277862|chronic hepatitis C;|chronic hepatitis c;
5761637|NCT00277862|peg-interferon alfa-2b;|peg-interferon alfa-2b;
5761638|NCT00277862|ribavirin,|ribavirin,
5761639|NCT00277862|rapid virologic response,|rapid virologic response,
5761640|NCT00277862|sustained virological response|sustained virological response
5761641|NCT00277849|Sickle|sickle
5761642|NCT00277849|Hemoglobinopathy|hemoglobinopathy
5761643|NCT00277849|Thalassemia|thalassemia
5761644|NCT00277849|G6PD|g6pd
5761645|NCT00277849|Plasmodium|plasmodium
5761646|NCT00277849|Erythrocyte Variant|erythrocyte variant
5761647|NCT00277849|Hemoglobin Variant|hemoglobin variant
5761648|NCT00277849|Healthy Volunteer|healthy volunteer
5761649|NCT00277849|HV|hv
5761650|NCT00277836|malignant tumor|malignant tumor
5761651|NCT00277823|Depression|depression
5761652|NCT00277823|Adult|adult
5761653|NCT00277823|Outpatients|outpatients
5761654|NCT00277810|Alzheimer's Disease|alzheimer's disease
5761655|NCT00277810|Cholinesterase Inhibitors|cholinesterase inhibitors
5761656|NCT00277810|Outpatients|outpatients
5761657|NCT00277797|Low Back Pain|low back pain
5761658|NCT00277784|Age Related Macular Degeneration|age related macular degeneration
5761659|NCT00277784|Ultrasound|ultrasound
5761660|NCT00277784|OCT|oct
5761661|NCT00277784|Eye|eye
5761662|NCT00277771|technology in weight loss|technology in weight loss
5761663|NCT00277771|standard behavioral therapy for obesity|standard behavioral therapy for obesity
5761664|NCT00277758|Interleukin-2|interleukin-2
5761665|NCT00277745|periodontitis|periodontitis
5761666|NCT00277745|microfluidics|microfluidics
5761667|NCT00277745|saliva diagnostics|saliva diagnostics
5761668|NCT00277706|periodontitis|periodontitis
5761669|NCT00277706|bone regeneration|bone regeneration
5761670|NCT00277706|Parathyroid Hormone|parathyroid hormone
5761671|NCT00277706|moderate to advanced periodontitis|moderate to advanced periodontitis
5761672|NCT00277693|hemodialysis|hemodialysis
5761673|NCT00277693|aldosterone|aldosterone
5761674|NCT00277693|heart failure|heart failure
5761675|NCT00277693|spironolactone|spironolactone
5761676|NCT00277680|uterine fibroids|uterine fibroids
5761677|NCT00277680|leiomyoma|leiomyoma
5761678|NCT00277680|laparoscopy|laparoscopy
5761679|NCT00277680|menorrhagia|menorrhagia
5751820|NCT00313092|MMP|mmp
5761680|NCT00277667|currently experiencing hypomania or mild mania|currently experiencing hypomania or mild mania
5761681|NCT00277654|Bipolar Disorder with Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder|bipolar disorder with concurrent moderately severe anxiety and lifetime panic or generalized anxiety disorder
5761682|NCT00277641|Binge Eating Disorder Associated with Obesity|binge eating disorder associated with obesity
5761684|NCT00277615|Bladder volume|bladder volume
5761685|NCT00277615|Ultrasound|ultrasound
5761686|NCT00277576|DNA vaccine|dna vaccine
5761687|NCT00277576|immunotherapy|immunotherapy
5761688|NCT00277576|Hepatitis B Virus|hepatitis b virus
5761689|NCT00277576|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
5761690|NCT00277563|Carpal Tunnel Syndrome|carpal tunnel syndrome
5761691|NCT00277563|Neuropathic Pain|neuropathic pain
5761692|NCT00277563|Neuromodulation|neuromodulation
5761693|NCT00277563|PEMF|pemf
5761694|NCT00277563|Magnetic Field Therapy|magnetic field therapy
5761695|NCT00277563|Magnetotherapy|magnetotherapy
5761696|NCT00277550|Constipation, Tegaserod, Dyspepsia|constipation, tegaserod, dyspepsia
5761697|NCT00277537|Mannitol|mannitol
5761698|NCT00277524|Pacemaker|pacemaker
5761699|NCT00277524|Defibrillator|defibrillator
5761700|NCT00277524|Cardiac Resynchronization|cardiac resynchronization
5761701|NCT00277524|Dysynchrony|dysynchrony
5761702|NCT00277524|Heart failure|heart failure
5761703|NCT00277524|Arrhythmia|arrhythmia
5761704|NCT00277524|Tachycardia|tachycardia
5761705|NCT00277524|Bradycardia|bradycardia
5761706|NCT00277472|Hypertension|hypertension
5761707|NCT00277472|High blood pressure|high blood pressure
5761708|NCT00277472|diuretics|diuretics
5761709|NCT00277472|valsartan|valsartan
5761710|NCT00277446|Asthma|asthma
5761711|NCT00277446|Soy isoflavones|soy isoflavones
5761712|NCT00277446|Eosinophils|eosinophils
5761713|NCT00277446|Exhaled nitric oxide|exhaled nitric oxide
5761714|NCT00277433|Atopic Dermatitis|atopic dermatitis
5761715|NCT00277433|Eczema|eczema
5757254|NCT00293813|XCT|xct
5761717|NCT00277433|Histamine|histamine
5761718|NCT00277407|NAET|naet
5761719|NCT00277407|Chiropractic procedures|chiropractic procedures
5761720|NCT00277407|Acupuncture/acupressure|acupuncture/acupressure
5761721|NCT00277407|Treatment of Autism by holistic procedures|treatment of autism by holistic procedures
5761722|NCT00277407|Food and Vaccination allergy|food and vaccination allergy
5761723|NCT00277394|Acute, symptomatic and objectively confirmed DVT|acute, symptomatic and objectively confirmed dvt
5761725|NCT00277381|Hypertension|hypertension
5761726|NCT00277381|Telemedicine|telemedicine
5761727|NCT00277368|Epilepsy|epilepsy
5761728|NCT00277368|Headache|headache
5761729|NCT00277368|Seizure|seizure
5761730|NCT00277355|Study of Minocycline in Huntington's Disease|study of minocycline in huntington's disease
5763790|NCT00268944|GSD-II|gsd-ii
5761731|NCT00277342|lipid induced hepatic insulin resistance|lipid induced hepatic insulin resistance
5761732|NCT00277342|polymorphisms liver fatty-acid-binding-protein|polymorphisms liver fatty-acid-binding-protein
5761733|NCT00277342|gluconeogenesis|gluconeogenesis
5761734|NCT00277342|glycogenolysis|glycogenolysis
5761735|NCT00277342|endogenous glucose production|endogenous glucose production
5761736|NCT00277316|Kidney cancer|kidney cancer
5761737|NCT00277316|Metastatic|metastatic
5761738|NCT00277303|Colon Cancer|colon cancer
5761740|NCT00277290|Recurrent|recurrent
5761741|NCT00277290|Platinum-resistant|platinum-resistant
5761742|NCT00277290|Platinum-sensitive|platinum-sensitive
5761743|NCT00277277|Telemedicine|telemedicine
5761744|NCT00277277|Biobehavioral weight loss program|biobehavioral weight loss program
5761745|NCT00277277|Body Mass Index|body mass index
5761746|NCT00277277|Blood Glucose|blood glucose
5761747|NCT00277277|Diabetes Management|diabetes management
5761748|NCT00277251|Crohn's disease|crohn's disease
5761749|NCT00277251|systemic-onset juvenile rheumatoid arthritis|systemic-onset juvenile rheumatoid arthritis
5761750|NCT00277251|juvenile dermatomyositis|juvenile dermatomyositis
5761751|NCT00277251|systemic lupus erythematosus (SLE)|systemic lupus erythematosus (sle)
5761752|NCT00277251|Mixed connective tissue disease (MCTD)|mixed connective tissue disease (mctd)
5761753|NCT00277251|vasculitis|vasculitis
5761755|NCT00277238|Hepatitis c virus|hepatitis c virus
5761756|NCT00277238|Virus diseases|virus diseases
5761757|NCT00277238|Interferon-alpha|interferon-alpha
5761758|NCT00277238|Interferons|interferons
5761759|NCT00277238|Liver diseases|liver diseases
5862893|NCT00001469|Prostate Cancer (hereditary)|prostate cancer (hereditary)
5761760|NCT00277212|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
5761761|NCT00277186|Arthroplasty|arthroplasty
5761762|NCT00277186|Health services research|health services research
5761763|NCT00277186|Intent to treat|intent to treat
5761764|NCT00277186|Randomized|randomized
5761765|NCT00277186|Controlled|controlled
5761766|NCT00277173|Medication Safety|medication safety
5761767|NCT00277173|Adverse Drug Events|adverse drug events
5761768|NCT00277173|Preventable Adverse Drug Events|preventable adverse drug events
5761769|NCT00277173|Culture of Safety|culture of safety
5761770|NCT00277173|Failure Modes and Effects Analysis|failure modes and effects analysis
5761771|NCT00277173|Teambuilding|teambuilding
5761772|NCT00277147|Typhoid Fever|typhoid fever
5761773|NCT00277147|Immunogenicity|immunogenicity
5761774|NCT00277147|Safety|safety
5761775|NCT00277147|Vaccine|vaccine
5761776|NCT00277147|Conjugate|conjugate
5761777|NCT00277147|Healthy Volunteer|healthy volunteer
5761778|NCT00277121|Lipid disorder|lipid disorder
5761779|NCT00277121|Gene mutation|gene mutation
5761780|NCT00277108|postpartum depression|postpartum depression
5761781|NCT00277108|postnatal depression|postnatal depression
5761783|NCT00277095|Urinary Incontinence|urinary incontinence
5761784|NCT00277082|Metastatic or Recurrent Cancer of the Endometrium or the Lung (NSCLC)|metastatic or recurrent cancer of the endometrium or the lung (nsclc)
5761785|NCT00277082|Aerosolized Liposomal 9-Nitro 20|aerosolized liposomal 9-nitro 20
5761786|NCT00277082|Camptothecin (L9NC)|camptothecin (l9nc)
5761787|NCT00277069|Breast metastatic|breast metastatic
5761788|NCT00277056|leukemia|leukemia
5761789|NCT00277043|Taxane|taxane
5761790|NCT00277043|Test Dose|test dose
5761791|NCT00277030|Respiratory Distress Syndrome|respiratory distress syndrome
5761792|NCT00277030|Surfactant|surfactant
5761793|NCT00277030|Nasal CPAP|nasal cpap
5761794|NCT00277017|Combination Therapy|combination therapy
5761795|NCT00277017|5-Fluorouracil|5-fluorouracil
5761796|NCT00277017|Interferon-a Interleukin-2|interferon-a interleukin-2
5761797|NCT00277017|Thalidomide|thalidomide
5761798|NCT00277017|Renal Cell Carcinoma|renal cell carcinoma
5761799|NCT00276991|Prolonged Viral Suppression|prolonged viral suppression
5761800|NCT00276991|HIV Infections|hiv infections
5761801|NCT00276978|Therapy-resistant Depression|therapy-resistant depression
5761802|NCT00276978|add-on therapy depression|add-on therapy depression
5761803|NCT00276965|Bipolar II Depression|bipolar ii depression
5761804|NCT00276952|Gonyautoxins|gonyautoxins
5761805|NCT00276952|Tension-type Headache|tension-type headache
5761806|NCT00276952|Human Treatment|human treatment
5761807|NCT00276939|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5761808|NCT00276939|Diet, Vegetarian|diet, vegetarian
5761809|NCT00276939|Diet, Fat-Restricted|diet, fat-restricted
5761810|NCT00276939|Glycemic Index|glycemic index
5761811|NCT00276926|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5761812|NCT00276926|Eosinophilic leukemias|eosinophilic leukemias
5761813|NCT00276926|STI571 (Gleevec)|sti571 (gleevec)
5761814|NCT00276926|PDGF receptor alpha|pdgf receptor alpha
5761815|NCT00276926|Familiar hypereosinophilia|familiar hypereosinophilia
5761816|NCT00276926|Myeloproliferative disorder (MPD) with eosinophilia|myeloproliferative disorder (mpd) with eosinophilia
5761817|NCT00276926|myeloproliferative disorders/myelodysplastic syndromes|myeloproliferative disorders/myelodysplastic syndromes
5761818|NCT00276900|Postpartum Depression|postpartum depression
5761819|NCT00276900|Recurrent Depression|recurrent depression
5761820|NCT00276887|Somatization Disorder|somatization disorder
5761821|NCT00276887|Multiple Medically Unexplained Symptoms|multiple medically unexplained symptoms
5761822|NCT00276887|Cognitive Behavior Therapy|cognitive behavior therapy
5761823|NCT00276887|Mental Health|mental health
5761824|NCT00276874|Cocaine Addiction|cocaine addiction
5761825|NCT00276874|Cocaine Dependence|cocaine dependence
5761826|NCT00276861|adenocarcinoma of the colon|adenocarcinoma of the colon
5761827|NCT00276861|recurrent colon cancer|recurrent colon cancer
5761828|NCT00276861|stage IV colon cancer|stage iv colon cancer
5761829|NCT00276848|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5761830|NCT00276848|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5761831|NCT00276835|recurrent renal cell cancer|recurrent renal cell cancer
5761832|NCT00276835|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5761833|NCT00276835|stage IV renal cell cancer|stage iv renal cell cancer
5761834|NCT00276835|recurrent melanoma|recurrent melanoma
5761835|NCT00276835|stage IV melanoma|stage iv melanoma
5761836|NCT00276822|stage I breast cancer|stage i breast cancer
5761837|NCT00276822|stage II breast cancer|stage ii breast cancer
5761838|NCT00276822|stage IIIA breast cancer|stage iiia breast cancer
5761839|NCT00276822|stage IIIB breast cancer|stage iiib breast cancer
5761840|NCT00276822|stage IIIC breast cancer|stage iiic breast cancer
5761841|NCT00276822|stage IV breast cancer|stage iv breast cancer
5761842|NCT00276809|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5761843|NCT00276809|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5761844|NCT00276809|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5761845|NCT00276809|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5862942|NCT00001454|Endometrium|endometrium
5761846|NCT00276809|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5761847|NCT00276796|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5761848|NCT00276796|stage III cervical cancer|stage iii cervical cancer
5761849|NCT00276796|recurrent cervical cancer|recurrent cervical cancer
5761850|NCT00276796|cervical adenocarcinoma|cervical adenocarcinoma
5761851|NCT00276796|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5761852|NCT00276796|cervical small cell carcinoma|cervical small cell carcinoma
5761853|NCT00276796|stage IVA cervical cancer|stage iva cervical cancer
5761854|NCT00276796|stage IVB cervical cancer|stage ivb cervical cancer
5761855|NCT00276783|primary central nervous system lymphoma|primary central nervous system lymphoma
5761856|NCT00276783|tumors metastatic to brain|tumors metastatic to brain
5761857|NCT00276783|recurrent adult brain tumor|recurrent adult brain tumor
5761858|NCT00276783|adult giant cell glioblastoma|adult giant cell glioblastoma
5761859|NCT00276783|adult gliosarcoma|adult gliosarcoma
5761860|NCT00276783|adult mixed glioma|adult mixed glioma
5761861|NCT00276783|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5761862|NCT00276783|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5761864|NCT00276770|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5761865|NCT00276770|adult anaplastic ependymoma|adult anaplastic ependymoma
5761866|NCT00276770|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5761867|NCT00276770|adult diffuse astrocytoma|adult diffuse astrocytoma
5761868|NCT00276770|adult glioblastoma|adult glioblastoma
5761869|NCT00276770|adult giant cell glioblastoma|adult giant cell glioblastoma
5761870|NCT00276770|adult gliosarcoma|adult gliosarcoma
5761871|NCT00276770|adult ependymoma|adult ependymoma
5761872|NCT00276770|adult oligodendroglioma|adult oligodendroglioma
5761873|NCT00276770|recurrent adult brain tumor|recurrent adult brain tumor
5761874|NCT00276770|adult mixed glioma|adult mixed glioma
5761875|NCT00276757|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5761876|NCT00276744|recurrent pancreatic cancer|recurrent pancreatic cancer
5761877|NCT00276744|stage III pancreatic cancer|stage iii pancreatic cancer
5761878|NCT00276744|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5761879|NCT00276744|stage I pancreatic cancer|stage i pancreatic cancer
5761880|NCT00276744|stage II pancreatic cancer|stage ii pancreatic cancer
5761881|NCT00276731|localized resectable neuroblastoma|localized resectable neuroblastoma
5762046|NCT00275834|obesity treatment|obesity treatment
5761882|NCT00276731|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5761883|NCT00276731|regional neuroblastoma|regional neuroblastoma
5761884|NCT00276718|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5761885|NCT00276718|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5761886|NCT00276718|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5761887|NCT00276718|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5761889|NCT00276705|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5761890|NCT00276705|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5761891|NCT00276705|advanced adult primary liver cancer|advanced adult primary liver cancer
5761892|NCT00276705|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5761893|NCT00276705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5761894|NCT00276705|stage I childhood liver cancer|stage i childhood liver cancer
5761895|NCT00276705|stage II childhood liver cancer|stage ii childhood liver cancer
5761896|NCT00276705|stage III childhood liver cancer|stage iii childhood liver cancer
5761897|NCT00276705|stage IV childhood liver cancer|stage iv childhood liver cancer
5761966|NCT00276276|topotecan (HYCAMTIN)|topotecan (hycamtin)
5761898|NCT00276692|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5761899|NCT00276679|recurrent neuroblastoma|recurrent neuroblastoma
5761900|NCT00276679|disseminated neuroblastoma|disseminated neuroblastoma
5761901|NCT00276679|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5761902|NCT00276666|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5761903|NCT00276640|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5761904|NCT00276640|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5761905|NCT00276640|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5761906|NCT00276640|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5761907|NCT00276640|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5761908|NCT00276640|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5761909|NCT00276640|childhood oligodendroglioma|childhood oligodendroglioma
5761910|NCT00276640|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5761911|NCT00276640|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5761912|NCT00276640|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5761913|NCT00276627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5761914|NCT00276614|stage IV renal cell cancer|stage iv renal cell cancer
5761915|NCT00276614|recurrent renal cell cancer|recurrent renal cell cancer
5761916|NCT00276614|papillary renal cell carcinoma|papillary renal cell carcinoma
5761917|NCT00276601|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5761918|NCT00276601|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5761919|NCT00276601|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5761920|NCT00276601|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5761921|NCT00276601|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5761922|NCT00276588|adenocarcinoma of the lung|adenocarcinoma of the lung
5761923|NCT00276588|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5761924|NCT00276588|large cell lung cancer|large cell lung cancer
5761925|NCT00276588|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5787474|NCT00158431|knee|knee
5761127|NCT00279695|Eye|eye
5761926|NCT00276588|squamous cell lung cancer|squamous cell lung cancer
5761927|NCT00276588|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5761928|NCT00276588|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5761929|NCT00276575|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5761930|NCT00276549|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5761931|NCT00276549|stage IV prostate cancer|stage iv prostate cancer
5761932|NCT00276536|stage IV melanoma|stage iv melanoma
5761933|NCT00276536|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5761934|NCT00276523|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5761935|NCT00276523|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5761936|NCT00276523|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5761937|NCT00276523|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5761938|NCT00276523|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5761939|NCT00276523|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5761940|NCT00276523|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5761941|NCT00276523|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5761942|NCT00276523|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5761943|NCT00276523|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5761944|NCT00276523|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5761945|NCT00276523|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5757420|NCT00293410|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5761946|NCT00276523|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5761947|NCT00276523|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5846704|NCT00043680|Age-Related Macular Degeneration|age-related macular degeneration
5761948|NCT00276523|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5761949|NCT00276523|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5761952|NCT00276497|Prevention|prevention
5761953|NCT00276445|allergy|allergy
5761954|NCT00276445|Allergy conjunctivitis|allergy conjunctivitis
5761955|NCT00276445|beta-1-3glucan|beta-1-3glucan
5761956|NCT00276445|Th1/Th2|th1/th2
5761957|NCT00276341|cognitive impairment|cognitive impairment
5761958|NCT00276289|nephrolithiasis|nephrolithiasis
5761959|NCT00276289|hypercalciuria|hypercalciuria
5761960|NCT00276289|hypokalemia|hypokalemia
5761961|NCT00276289|thiazide diuretics|thiazide diuretics
5761962|NCT00276276|relapsed|relapsed
5761963|NCT00276276|lung cancer|lung cancer
5761964|NCT00276276|resistant|resistant
5761965|NCT00276276|small cel|small cel
5762070|NCT00275561|Dysphagia|dysphagia
5761967|NCT00276263|Schizophrenia prodrome|schizophrenia prodrome
5761968|NCT00276263|Sarcosine|sarcosine
5761969|NCT00276263|Psychosis|psychosis
5761970|NCT00276263|NMDA receptor|nmda receptor
5761971|NCT00276263|Prevention|prevention
5761972|NCT00276237|Congenital Heart Disease|congenital heart disease
5761973|NCT00276237|Pulmonary Valve Replacement|pulmonary valve replacement
5761974|NCT00276224|iron deficiency schistosomiasis soil transmitted helminths|iron deficiency schistosomiasis soil transmitted helminths
5761975|NCT00276211|MRI diffusion mamma cancer|mri diffusion mamma cancer
5761976|NCT00276198|Clinical trial, controlled|clinical trial, controlled
5761977|NCT00276198|Micronutrients|micronutrients
5761978|NCT00276198|Dietary Supplementation|dietary supplementation
5761980|NCT00276185|spasticity ;|spasticity ;
5761981|NCT00276185|Botulinum toxin ;|botulinum toxin ;
5761982|NCT00276185|Upper limb ;|upper limb ;
5761983|NCT00276185|motor function.|motor function.
5761984|NCT00276185|spastic hemiplegia after stoke|spastic hemiplegia after stoke
5761985|NCT00276159|Leukemia|leukemia
5761986|NCT00276159|Lymphoma|lymphoma
5761987|NCT00276159|Myeloma|myeloma
5761988|NCT00276159|Hematology|hematology
5761989|NCT00276159|852A|852a
5761991|NCT00276159|Oncology|oncology
5761992|NCT00276146|dipyridamole|dipyridamole
5761993|NCT00276146|magnesium|magnesium
5761994|NCT00276146|sickle cell|sickle cell
5761995|NCT00276146|anemia|anemia
5761996|NCT00276146|red blood cells|red blood cells
5761997|NCT00276133|small dense LDL|small dense ldl
5761998|NCT00276120|Breast|breast
5761999|NCT00276120|Cancer|cancer
5762000|NCT00276120|Young|young
5762001|NCT00276120|Women|women
5762002|NCT00276107|Vaccine|vaccine
5762003|NCT00276107|Healthy Infants|healthy infants
5762004|NCT00276094|Urogenital atrophy|urogenital atrophy
5762005|NCT00276094|Vaginal atrophy|vaginal atrophy
5762006|NCT00276094|Vulvar and vaginal atrophy in postmenopausal women|vulvar and vaginal atrophy in postmenopausal women
5762007|NCT00276094|Menopausal symptoms|menopausal symptoms
5762008|NCT00276081|Hot flashes|hot flashes
5770190|NCT00244400|CYP3A|cyp3a
5762009|NCT00276081|postmenopausal|postmenopausal
5762010|NCT00276081|climacteric symptoms|climacteric symptoms
5762011|NCT00276081|hormone replacement therapy|hormone replacement therapy
5762012|NCT00276081|gabapentin|gabapentin
5762013|NCT00276068|Vulvar vestibulitis|vulvar vestibulitis
5762014|NCT00276068|Vulvodynia|vulvodynia
5762015|NCT00276068|Desipramine|desipramine
5762016|NCT00276068|Lidocaine|lidocaine
5762017|NCT00276068|Genetics|genetics
5762018|NCT00276055|Soft Tissue Sarcoma|soft tissue sarcoma
5762019|NCT00276055|Phase I|phase i
5762020|NCT00276055|Gemcitabine|gemcitabine
5762021|NCT00276055|Docetaxel|docetaxel
5762022|NCT00276055|Bevacizumab|bevacizumab
5762023|NCT00276055|vascular endothelial growth factor|vascular endothelial growth factor
5762024|NCT00276042|AOM|aom
5762025|NCT00276029|Asthma|asthma
5762026|NCT00276029|Refractory|refractory
5762027|NCT00276003|Lymphoma-Non Hodgkins|lymphoma-non hodgkins
5762028|NCT00276003|Phase II|phase ii
5762029|NCT00276003|Gemcitabine|gemcitabine
5762030|NCT00276003|Irinotecan|irinotecan
5762031|NCT00275990|coronary thrombectomy|coronary thrombectomy
5762032|NCT00275990|thrombectomy for acute myocardial infarction|thrombectomy for acute myocardial infarction
5762033|NCT00275990|C14.280.647.500|c14.280.647.500
5762034|NCT00275990|C14.907.553.355.500|c14.907.553.355.500
5762035|NCT00275977|"Stem cell"|"stem cell"
5762036|NCT00275977|"autologous bone marrow transplantation"|"autologous bone marrow transplantation"
5762037|NCT00275977|"Myocardial infarction"|"myocardial infarction"
5762038|NCT00275951|Combination|combination
5762039|NCT00275951|Chemotherapy|chemotherapy
5762040|NCT00275951|Gastric cancer|gastric cancer
5762041|NCT00275938|hepatitis B virus|hepatitis b virus
5762042|NCT00275938|e antigen|e antigen
5762043|NCT00275938|interferon|interferon
5762044|NCT00275938|ribavirin|ribavirin
5762045|NCT00275925|partial epilepsy, oxcarbazepine, adults|partial epilepsy, oxcarbazepine, adults
5762048|NCT00275834|antiobesity drugs|antiobesity drugs
5762049|NCT00275834|zonisamide|zonisamide
5762050|NCT00275821|Age-related macular degeneration, ranibizumab|age-related macular degeneration, ranibizumab
5762051|NCT00275795|NST-NAET testing|nst-naet testing
5762052|NCT00275795|Food Ssensitivities|food ssensitivities
5762053|NCT00275795|Eczema|eczema
5762054|NCT00275795|Acne|acne
5762055|NCT00275795|Indigestion|indigestion
5762056|NCT00275769|Arrhythmia|arrhythmia
5762057|NCT00275769|Bradycardia|bradycardia
5762058|NCT00275769|Cardiac Pacemaker Artificial|cardiac pacemaker artificial
5762059|NCT00275756|Ocular Physiology|ocular physiology
5762060|NCT00275756|Brimonidine|brimonidine
5762061|NCT00275756|Timoptic|timoptic
5762062|NCT00275756|Dorzolamide|dorzolamide
5762063|NCT00275756|ocular blood flow|ocular blood flow
5762064|NCT00275756|Regional Blood Flow|regional blood flow
5762065|NCT00275730|indometacine|indometacine
5762066|NCT00275730|retinal blood flow|retinal blood flow
5762067|NCT00275730|choroidal blood flow|choroidal blood flow
5762068|NCT00275561|Eosinophilic Esophagitis|eosinophilic esophagitis
5762069|NCT00275561|Fluticasone|fluticasone
5762071|NCT00275535|kidney transplantation|kidney transplantation
5762072|NCT00275535|immunosuppression|immunosuppression
5762073|NCT00275535|calcineurin inhibitor|calcineurin inhibitor
5762074|NCT00275535|sirolimus|sirolimus
5762075|NCT00275535|chronic allograft nephropathy|chronic allograft nephropathy
5762076|NCT00275509|kidney|kidney
5762077|NCT00275509|transplantation|transplantation
5762078|NCT00275509|positive crossmatch|positive crossmatch
5762079|NCT00275509|antibody mediated rejection|antibody mediated rejection
5762080|NCT00275509|rejection|rejection
5762081|NCT00275509|induction|induction
5762082|NCT00275509|therapy|therapy
5762083|NCT00275509|trial|trial
5762084|NCT00275496|SLND|slnd
5762085|NCT00275496|Sentinel|sentinel
5762086|NCT00275496|Melanoma|melanoma
5762087|NCT00275496|Surgical|surgical
5762088|NCT00275431|cancer|cancer
5762089|NCT00275431|AT-101|at-101
5762090|NCT00275431|AT101|at101
5762091|NCT00275431|B-cell malignancies|b-cell malignancies
5762092|NCT00275431|Non-Hodgkin|non-hodgkin
5762093|NCT00275431|lymphoma|lymphoma
5762094|NCT00275431|lukemia|lukemia
5762095|NCT00275418|Crohn's disease|crohn's disease
5762096|NCT00275418|remission|remission
5762097|NCT00275418|beta carotene|beta carotene
5762098|NCT00275405|Effects of Garlic|effects of garlic
5762100|NCT00275392|Geriatrics|geriatrics
5762101|NCT00275392|Rehabilitation|rehabilitation
5762102|NCT00275392|Vestibular rehabilitation|vestibular rehabilitation
5762103|NCT00275379|Cystitis|cystitis
5762104|NCT00275366|cuff, rotator|cuff, rotator
5762105|NCT00275366|Rotator cuff|rotator cuff
5762106|NCT00275340|Pain|pain
5762107|NCT00275340|Depressive Symptoms|depressive symptoms
5762108|NCT00275340|Coronary Artery Bypass|coronary artery bypass
5762109|NCT00275340|Convalescence|convalescence
5762110|NCT00275340|Quality of Life|quality of life
5762111|NCT00275340|Human Activities|human activities
5762112|NCT00275327|antibiotics|antibiotics
5762113|NCT00275314|transplantation|transplantation
5762114|NCT00275301|Borderline Personality Disorder|borderline personality disorder
5762116|NCT00275301|PET|pet
5761258|NCT00279110|HIV|hiv
5762117|NCT00275301|olanzapine|olanzapine
5762118|NCT00275301|brain|brain
5762119|NCT00275288|Borderline Personality Disorder|borderline personality disorder
5762120|NCT00275288|BPD|bpd
5762121|NCT00275288|amygdala|amygdala
5762122|NCT00275288|facial expression response|facial expression response
5762123|NCT00275288|MRI|mri
5762126|NCT00275262|Bone marrow transplantation|bone marrow transplantation
5762127|NCT00275262|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5762128|NCT00275262|Hodgkin's disease|hodgkin's disease
5762129|NCT00275262|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5762130|NCT00275262|multiple myeloma|multiple myeloma
5762131|NCT00275249|Chronic Pain|chronic pain
5762132|NCT00275236|Idiopthic Restless Legs Syndrome|idiopthic restless legs syndrome
5762133|NCT00275223|adipose tissue|adipose tissue
5762134|NCT00275223|adipocytokines|adipocytokines
5762135|NCT00275210|Oxaliplatin|oxaliplatin
5762136|NCT00275210|Chemotherapy,adjuvant|chemotherapy,adjuvant
5762137|NCT00275210|Colonic Neoplasms|colonic neoplasms
5762138|NCT00275184|Bowel preparation|bowel preparation
5762139|NCT00275184|capsule endoscopy|capsule endoscopy
5762140|NCT00275184|randomised|randomised
5762141|NCT00275184|Citramag|citramag
5762142|NCT00275184|Senna|senna
5762143|NCT00275184|Metoclopramide|metoclopramide
5762144|NCT00275184|Patients referred for Capsule endoscopy|patients referred for capsule endoscopy
5762145|NCT00275184|occult/overt gastrointestinal bleeding|occult/overt gastrointestinal bleeding
5762146|NCT00275184|other suspected small bowel pathology|other suspected small bowel pathology
5762147|NCT00275171|Nontoxic nodular goiter|nontoxic nodular goiter
5762148|NCT00275171|131I therapy|131i therapy
5762149|NCT00275171|thyroid radioiodine uptake|thyroid radioiodine uptake
5762150|NCT00275171|optimal time-interval|optimal time-interval
5762151|NCT00275171|reduced 131I activity|reduced 131i activity
5762152|NCT00275171|goiter reduction|goiter reduction
5762153|NCT00275158|Pre-Eclampsia|pre-eclampsia
5762154|NCT00275158|Glomerular Filtration Rate (GFR)|glomerular filtration rate (gfr)
5762157|NCT00275158|L-Arginine|l-arginine
5762158|NCT00275158|Nitric Oxide|nitric oxide
5762160|NCT00275158|Endothelin|endothelin
5762161|NCT00275158|ADMA|adma
5762162|NCT00275132|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5762163|NCT00275132|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5762164|NCT00275119|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5762165|NCT00275119|stage II pancreatic cancer|stage ii pancreatic cancer
5762166|NCT00275119|stage III pancreatic cancer|stage iii pancreatic cancer
5762167|NCT00275119|recurrent pancreatic cancer|recurrent pancreatic cancer
5762168|NCT00275106|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5762169|NCT00275106|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5762170|NCT00275106|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5762184|NCT00275041|stage IV breast cancer|stage iv breast cancer
5762185|NCT00275041|male breast cancer|male breast cancer
5762186|NCT00275015|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5762187|NCT00275015|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5762188|NCT00275015|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5762189|NCT00275015|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5762190|NCT00275015|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5762191|NCT00275015|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5762192|NCT00275002|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5762193|NCT00275002|recurrent childhood brain tumor|recurrent childhood brain tumor
5762194|NCT00274989|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5762195|NCT00274989|relapsed refractory chronic lymphocytic leukemia|relapsed refractory chronic lymphocytic leukemia
5762196|NCT00274989|previously untreated chronic lymphocytic leukemia|previously untreated chronic lymphocytic leukemia
5762197|NCT00274976|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5762198|NCT00274976|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5762199|NCT00274976|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5762200|NCT00274963|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5762201|NCT00274963|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5762202|NCT00274950|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5762203|NCT00274950|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5762204|NCT00274950|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5762205|NCT00274950|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5762206|NCT00274950|childhood teratoma|childhood teratoma
5762207|NCT00274950|childhood extracranial germ cell tumor|childhood extracranial germ cell tumor
5762208|NCT00274924|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5762209|NCT00274924|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5762210|NCT00274924|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5762211|NCT00274924|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5787772|NCT00156845|echocardiography|echocardiography
5761359|NCT00278694|Oxaliplatin, radiation|oxaliplatin, radiation
5761360|NCT00278681|zinc|zinc
5762212|NCT00274911|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5762213|NCT00274898|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5762214|NCT00274898|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5762215|NCT00274898|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5762216|NCT00274898|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5762217|NCT00274885|neurotoxicity|neurotoxicity
5762218|NCT00274885|carcinoma of the appendix|carcinoma of the appendix
5762219|NCT00274885|recurrent anal cancer|recurrent anal cancer
5762220|NCT00274885|stage I anal cancer|stage i anal cancer
5762221|NCT00274885|stage II anal cancer|stage ii anal cancer
5762222|NCT00274885|stage IIIA anal cancer|stage iiia anal cancer
5762223|NCT00274885|stage IIIB anal cancer|stage iiib anal cancer
5762224|NCT00274885|stage IV anal cancer|stage iv anal cancer
5762225|NCT00274885|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5762226|NCT00274885|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5762227|NCT00274885|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5762228|NCT00274885|localized gallbladder cancer|localized gallbladder cancer
5762229|NCT00274885|recurrent gallbladder cancer|recurrent gallbladder cancer
5762230|NCT00274885|unresectable gallbladder cancer|unresectable gallbladder cancer
5762231|NCT00274885|recurrent gastric cancer|recurrent gastric cancer
5762232|NCT00274885|stage IV gastric cancer|stage iv gastric cancer
5762233|NCT00274885|recurrent colon cancer|recurrent colon cancer
5762234|NCT00274885|recurrent rectal cancer|recurrent rectal cancer
5762235|NCT00274885|recurrent esophageal cancer|recurrent esophageal cancer
5762236|NCT00274885|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5762237|NCT00274885|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5763601|NCT00269802|children|children
5762238|NCT00274885|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5762239|NCT00274885|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5762240|NCT00274885|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5762241|NCT00274885|advanced adult primary liver cancer|advanced adult primary liver cancer
5762242|NCT00274885|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5762243|NCT00274885|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5762244|NCT00274885|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5762245|NCT00274885|recurrent pancreatic cancer|recurrent pancreatic cancer
5762246|NCT00274885|stage I pancreatic cancer|stage i pancreatic cancer
5762247|NCT00274885|stage II pancreatic cancer|stage ii pancreatic cancer
5762248|NCT00274885|stage III pancreatic cancer|stage iii pancreatic cancer
5762249|NCT00274885|recurrent small intestine cancer|recurrent small intestine cancer
5762250|NCT00274885|small intestine adenocarcinoma|small intestine adenocarcinoma
5762251|NCT00274885|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5762252|NCT00274885|small intestine lymphoma|small intestine lymphoma
5762253|NCT00274885|stage IV pancreatic cancer|stage iv pancreatic cancer
5762254|NCT00274885|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5762255|NCT00274885|metastatic gallbladder cancer|metastatic gallbladder cancer
5762256|NCT00274885|stage IA gastric cancer|stage ia gastric cancer
5762257|NCT00274885|stage IB gastric cancer|stage ib gastric cancer
5762258|NCT00274885|stage IIA gastric cancer|stage iia gastric cancer
5762259|NCT00274885|stage IIB gastric cancer|stage iib gastric cancer
5762260|NCT00274885|stage IIIA gastric cancer|stage iiia gastric cancer
5762261|NCT00274885|stage IIIB gastric cancer|stage iiib gastric cancer
5762262|NCT00274885|stage IIIC gastric cancer|stage iiic gastric cancer
5762263|NCT00274885|stage I colon cancer|stage i colon cancer
5762264|NCT00274885|stage IIA colon cancer|stage iia colon cancer
5762265|NCT00274885|stage IIB colon cancer|stage iib colon cancer
5762266|NCT00274885|stage IIIA colon cancer|stage iiia colon cancer
5762267|NCT00274885|stage IIIB colon cancer|stage iiib colon cancer
5762268|NCT00274885|stage IIIC colon cancer|stage iiic colon cancer
5762269|NCT00274885|stage IVA colon cancer|stage iva colon cancer
5762270|NCT00274885|stage IVB colon cancer|stage ivb colon cancer
5762271|NCT00274885|stage I rectal cancer|stage i rectal cancer
5762272|NCT00274885|stage IIA rectal cancer|stage iia rectal cancer
5762273|NCT00274885|stage IIB rectal cancer|stage iib rectal cancer
5762274|NCT00274885|stage IIC rectal cancer|stage iic rectal cancer
5762275|NCT00274885|stage IIIA rectal cancer|stage iiia rectal cancer
5762276|NCT00274885|stage IIIB rectal cancer|stage iiib rectal cancer
5762277|NCT00274885|stage IIIC rectal cancer|stage iiic rectal cancer
5762278|NCT00274885|stage IVA rectal cancer|stage iva rectal cancer
5762279|NCT00274885|stage IVB rectal cancer|stage ivb rectal cancer
5762280|NCT00274885|stage IA esophageal cancer|stage ia esophageal cancer
5762281|NCT00274885|stage IB esophageal cancer|stage ib esophageal cancer
5762282|NCT00274885|stage IIA esophageal cancer|stage iia esophageal cancer
5761472|NCT00278304|cervical adenocarcinoma|cervical adenocarcinoma
5762283|NCT00274885|stage IIB esophageal cancer|stage iib esophageal cancer
5762284|NCT00274885|stage IIIA esophageal cancer|stage iiia esophageal cancer
5762285|NCT00274885|stage IIIB esophageal cancer|stage iiib esophageal cancer
5762286|NCT00274885|stage IIIC esophageal cancer|stage iiic esophageal cancer
5762287|NCT00274885|stage IV esophageal cancer|stage iv esophageal cancer
5762288|NCT00274872|recurrent rectal cancer|recurrent rectal cancer
5762289|NCT00274872|stage IV rectal cancer|stage iv rectal cancer
5762290|NCT00274872|recurrent colon cancer|recurrent colon cancer
5762292|NCT00274872|adenocarcinoma of the colon|adenocarcinoma of the colon
5762293|NCT00274872|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5762294|NCT00274859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5762295|NCT00274846|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5762296|NCT00274846|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5762297|NCT00274846|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5762298|NCT00274846|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5762299|NCT00274846|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5762300|NCT00274846|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5762301|NCT00274846|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5762302|NCT00274846|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5762303|NCT00274833|adult glioblastoma|adult glioblastoma
5762304|NCT00274833|adult giant cell glioblastoma|adult giant cell glioblastoma
5762305|NCT00274833|adult gliosarcoma|adult gliosarcoma
5762306|NCT00274820|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5762307|NCT00274820|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5762308|NCT00274820|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5762309|NCT00274820|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5762310|NCT00274820|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5762311|NCT00274820|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5762466|NCT00274339|Laryngoscopy|laryngoscopy
5779169|NCT00201474|acute psychiatry|acute psychiatry
5779170|NCT00201461|Patent Foramen Ovale|patent foramen ovale
5779171|NCT00201461|STARFlex|starflex
5779172|NCT00201461|CLOSURE I|closure i
5779174|NCT00201461|Stroke|stroke
5762312|NCT00274820|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5762313|NCT00274807|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5762314|NCT00274807|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5762867|NCT00272415|Temodar|temodar
5762315|NCT00274807|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5762316|NCT00274807|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5762317|NCT00274807|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5762318|NCT00274807|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5762319|NCT00274794|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5762320|NCT00274794|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5762321|NCT00274794|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5762322|NCT00274794|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5762323|NCT00274794|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5762324|NCT00274794|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5762325|NCT00274794|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5762326|NCT00274794|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5762327|NCT00274794|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5762328|NCT00274794|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5762329|NCT00274794|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5762330|NCT00274794|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5762331|NCT00274794|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5762332|NCT00274794|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5762333|NCT00274794|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5762334|NCT00274794|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5762335|NCT00274794|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5762336|NCT00274794|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5762337|NCT00274794|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5762338|NCT00274794|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5762339|NCT00274794|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5761558|NCT00278135|Memory|memory
5762340|NCT00274794|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5762341|NCT00274794|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5762342|NCT00274794|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5762343|NCT00274794|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5762344|NCT00274794|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5762345|NCT00274794|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5762346|NCT00274794|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5762347|NCT00274794|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5762348|NCT00274794|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5762349|NCT00274794|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5762350|NCT00274794|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5762351|NCT00274794|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5762352|NCT00274794|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5762353|NCT00274794|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5762354|NCT00274794|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5762355|NCT00274794|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5762356|NCT00274794|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5762357|NCT00274794|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5762358|NCT00274794|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5762359|NCT00274794|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5762360|NCT00274794|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5762361|NCT00274794|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5762362|NCT00274794|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5762363|NCT00274794|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5762364|NCT00274794|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5762365|NCT00274794|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5757814|NCT00291876|Hepatitis A|hepatitis a
5762366|NCT00274794|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5762367|NCT00274794|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5762368|NCT00274794|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5762369|NCT00274781|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5762370|NCT00274781|refractory anemia with excess blasts|refractory anemia with excess blasts
5762371|NCT00274781|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5762372|NCT00274781|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5762373|NCT00274781|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5762374|NCT00274781|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5762375|NCT00274781|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5762376|NCT00274768|stage IV breast cancer|stage iv breast cancer
5762377|NCT00274768|male breast cancer|male breast cancer
5762378|NCT00274768|recurrent breast cancer|recurrent breast cancer
5762379|NCT00274755|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5762380|NCT00274755|adult diffuse astrocytoma|adult diffuse astrocytoma
5762381|NCT00274755|adult glioblastoma|adult glioblastoma
5762382|NCT00274755|adult giant cell glioblastoma|adult giant cell glioblastoma
5762383|NCT00274755|adult gliosarcoma|adult gliosarcoma
5762384|NCT00274755|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5762385|NCT00274755|adult anaplastic ependymoma|adult anaplastic ependymoma
5762386|NCT00274755|adult ependymoma|adult ependymoma
5762387|NCT00274755|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5762388|NCT00274755|adult subependymoma|adult subependymoma
5762389|NCT00274755|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5762390|NCT00274755|adult oligodendroglioma|adult oligodendroglioma
5762391|NCT00274755|adult mixed glioma|adult mixed glioma
5762392|NCT00274742|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5762393|NCT00274742|Cancer immunotherapy|cancer immunotherapy
5762394|NCT00274742|Monoclonal antibody|monoclonal antibody
5762396|NCT00274742|anti-CD3|anti-cd3
5762398|NCT00274742|Blinatumomab|blinatumomab
5762399|NCT00274729|Dietary intervention|dietary intervention
5762400|NCT00274729|High-carbohydrate diet|high-carbohydrate diet
5762401|NCT00274729|High-fat diet|high-fat diet
5762402|NCT00274729|Moderate-fat diet|moderate-fat diet
5762404|NCT00274729|Weight maintenance|weight maintenance
5762405|NCT00274729|Body composition|body composition
5762406|NCT00274729|Glucose metabolism|glucose metabolism
5762407|NCT00274729|Cardiovascular disease|cardiovascular disease
5762408|NCT00274729|Appetite regulation|appetite regulation
5762409|NCT00274729|Energy expenditure|energy expenditure
5762410|NCT00274703|anti IL-5|anti il-5
5762411|NCT00274703|oesophagitis|oesophagitis
5762412|NCT00274703|eosinophils|eosinophils
5762413|NCT00274703|mepolizumab|mepolizumab
5762414|NCT00274703|adults|adults
5762415|NCT00274690|Neurokinin-1 Receptor Antagonist|neurokinin-1 receptor antagonist
5762416|NCT00274690|GW679769|gw679769
5770683|NCT00242242|BCI|bci
5761608|NCT00277953|MRI|mri
5762417|NCT00274690|Post-operative Nausea|post-operative nausea
5762418|NCT00274690|NK-1 Receptor Antagonist|nk-1 receptor antagonist
5762419|NCT00274690|PONV|ponv
5762420|NCT00274690|Post-discharge Nausea and Vomiting|post-discharge nausea and vomiting
5762421|NCT00274690|PDNV|pdnv
5762422|NCT00274690|Vomiting|vomiting
5762423|NCT00274677|Bipolar Disorder|bipolar disorder
5762424|NCT00274664|Amblyopia|amblyopia
5762425|NCT00274664|Occlusion dose monitoring|occlusion dose monitoring
5762426|NCT00274664|Refractive adaptation|refractive adaptation
5762428|NCT00274651|CTCL|ctcl
5762429|NCT00274651|PTCL|ptcl
5762430|NCT00274651|lymphoma|lymphoma
5762431|NCT00274651|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5762432|NCT00274651|Cutaneous T-Cell Lymphomas (CTCL)|cutaneous t-cell lymphomas (ctcl)
5762433|NCT00274651|Peripheral T-Cell Lymphomas (PTCL)|peripheral t-cell lymphomas (ptcl)
5762434|NCT00274651|Other Types of Non-Hodgkin's Lymphoma|other types of non-hodgkin's lymphoma
5762435|NCT00274651|belinostat|belinostat
5762436|NCT00274625|Biomaterials|biomaterials
5762437|NCT00274625|Bariatric Surgery|bariatric surgery
5762438|NCT00274625|Hernia, Prevention of|hernia, prevention of
5762439|NCT00274625|Obesity|obesity
5762440|NCT00274625|Bypass Surgery|bypass surgery
5762441|NCT00274625|Incisional Hernia|incisional hernia
5762442|NCT00274625|Ventral Hernia|ventral hernia
5762443|NCT00274495|Genotype 1|genotype 1
5762444|NCT00274495|Metabolic syndrome|metabolic syndrome
5762445|NCT00274495|Insulin resistance|insulin resistance
5762446|NCT00274469|oncology|oncology
5762447|NCT00274469|cancer|cancer
5762448|NCT00274469|breast cancer|breast cancer
5762449|NCT00274456|Metastatic breast cancer, nab paclitaxel, docetaxel,|metastatic breast cancer, nab paclitaxel, docetaxel,
5762450|NCT00274404|infectious mononucleosis|infectious mononucleosis
5762451|NCT00274404|Epstein-Barr virus|epstein-barr virus
5762452|NCT00274404|valacyclovir|valacyclovir
5762453|NCT00274404|quantitative PCR|quantitative pcr
5762454|NCT00274378|radius fracture|radius fracture
5762455|NCT00274378|fracture fixation|fracture fixation
5762456|NCT00274378|homologous bone transplantation|homologous bone transplantation
5762457|NCT00274365|general practitioners, psychiatry, videoconference|general practitioners, psychiatry, videoconference
5762459|NCT00274352|adalimumab|adalimumab
5762460|NCT00274352|skin diseases|skin diseases
5762461|NCT00274339|Laryngopharyngeal Reflux|laryngopharyngeal reflux
5762462|NCT00274339|Prevacid|prevacid
5762463|NCT00274339|Lifestyle changes|lifestyle changes
5762464|NCT00274339|Reflux Finding Score|reflux finding score
5762465|NCT00274339|Reflux Symptom Index|reflux symptom index
5762467|NCT00274326|Hyponatremia|hyponatremia
5762468|NCT00274313|Cystic Fibrosis|cystic fibrosis
5762469|NCT00274300|DNA vaccine|dna vaccine
5762470|NCT00274300|immunotherapy|immunotherapy
5762471|NCT00274300|Herpes Simplex Virus Type 2 (HSV2)|herpes simplex virus type 2 (hsv2)
5762472|NCT00274300|Particle Mediated Epidermal Delivery|particle mediated epidermal delivery
5762473|NCT00274261|contraception|contraception
5762474|NCT00274235|Malaria|malaria
5762475|NCT00274235|Prevention|prevention
5762476|NCT00274235|Pregnancy|pregnancy
5762477|NCT00274235|Low birthweight|low birthweight
5762478|NCT00274235|Anemia|anemia
5762479|NCT00274235|Africa|africa
5762480|NCT00274222|COPD, nebulized budesonide, systemic corticosteroids|copd, nebulized budesonide, systemic corticosteroids
5762481|NCT00274209|Ulcerative colitis|ulcerative colitis
5762482|NCT00274209|Crohn's disease|crohn's disease
5762483|NCT00274209|Chromoendoscopy|chromoendoscopy
5762484|NCT00274209|Dysplasia|dysplasia
5762485|NCT00274209|Neoplasia|neoplasia
5762486|NCT00274196|fractures, occult|fractures, occult
5762488|NCT00274196|ultrasound examination|ultrasound examination
5762489|NCT00274196|MRI|mri
5762490|NCT00274196|sensitivity|sensitivity
5762491|NCT00274196|specificity|specificity
5762492|NCT00274170|Migraine|migraine
5762493|NCT00274170|Octreotide|octreotide
5762494|NCT00274170|Prochlorperazine|prochlorperazine
5762495|NCT00274157|Peripheral Vascular Disease|peripheral vascular disease
5762496|NCT00274157|Intermittent Claudication|intermittent claudication
5762497|NCT00274157|Catheter-based Arterial Revascularization|catheter-based arterial revascularization
5762498|NCT00274157|Peripheral angioplasty|peripheral angioplasty
5762499|NCT00274157|Peripheral stenting|peripheral stenting
5762500|NCT00274157|Functional capacity|functional capacity
5762501|NCT00274157|Quality of life|quality of life
5762502|NCT00273949|Lactulose|lactulose
5762503|NCT00273949|Prebiotics|prebiotics
5762504|NCT00273949|Nosocomial infection|nosocomial infection
5762505|NCT00273949|children|children
5762506|NCT00273949|infants|infants
5762507|NCT00273910|Disease Free Survival|disease free survival
5762508|NCT00273910|gp 100:209-217 (210m)|gp 100:209-217 (210m)
5762509|NCT00273910|Immunologic Response|immunologic response
5762510|NCT00273910|Adjuvant Therapy|adjuvant therapy
5762511|NCT00273910|Cutaneous Melanoma|cutaneous melanoma
5762512|NCT00273910|Melanoma|melanoma
5762513|NCT00273897|Dementia Treatment|dementia treatment
5762514|NCT00273897|Hand Function|hand function
5762515|NCT00273897|Clinical Trials|clinical trials
5762516|NCT00273897|Dementia|dementia
5762517|NCT00273897|Cortical Syndrome|cortical syndrome
5762518|NCT00273897|CBS|cbs
5762519|NCT00273897|Apraxia|apraxia
5762520|NCT00273884|AML|aml
5762521|NCT00273884|Secondary AML|secondary aml
5762522|NCT00273884|Leukemia|leukemia
5762523|NCT00273871|kidney transplant|kidney transplant
5762524|NCT00273858|Rheumatoid Arthritis|rheumatoid arthritis
5762525|NCT00273858|Ankylosing Spondylitis|ankylosing spondylitis
5762526|NCT00273858|Psoriatic Arthritis|psoriatic arthritis
5762527|NCT00273845|case management|case management
5762528|NCT00273845|substance abuse treatment|substance abuse treatment
5762529|NCT00273845|linkage|linkage
5762530|NCT00273832|Chest pain|chest pain
5762531|NCT00273832|Angina pectoris|angina pectoris
5762532|NCT00273832|Emergency medicine|emergency medicine
5762533|NCT00273832|Spiral computed tomography|spiral computed tomography
5762534|NCT00273832|Length of stay|length of stay
5762535|NCT00273832|Cost analysis|cost analysis
5762536|NCT00273819|Congestive heart failure, LV dysfunction|congestive heart failure, lv dysfunction
5762537|NCT00273806|Behavioral risk factors|behavioral risk factors
5762538|NCT00273806|Primary Care|primary care
5762539|NCT00273806|Health services research|health services research
5762540|NCT00273780|Patient compliance|patient compliance
5762541|NCT00273767|troponin T|troponin t
5762542|NCT00273767|CK-MB|ck-mb
5762543|NCT00273767|protein S-100|protein s-100
5762544|NCT00273767|Cardiopulmonary Bypass|cardiopulmonary bypass
5762545|NCT00273767|Erythropoietin|erythropoietin
5762546|NCT00273754|Obstructive Sleep Apnea (OSA)|obstructive sleep apnea (osa)
5762547|NCT00273754|Tonsillectomy and Adenoidectomy (T&A)|tonsillectomy and adenoidectomy (t&a)
5762548|NCT00273754|Postoperative Complications|postoperative complications
5762549|NCT00273754|Recovery|recovery
5762550|NCT00273741|palliative care|palliative care
5762551|NCT00273741|methylphenidate|methylphenidate
5762553|NCT00273728|shock, septic|shock, septic
5762554|NCT00273728|infusion, intravenous|infusion, intravenous
5762555|NCT00273728|mortality|mortality
5762556|NCT00273715|Comparative|comparative
5762557|NCT00273715|Randomized|randomized
5762558|NCT00273715|Suture|suture
5762559|NCT00273715|Staples, surgical|staples, surgical
5762560|NCT00273715|Skin|skin
5762561|NCT00273715|Surgical procedures, operative|surgical procedures, operative
5762562|NCT00273715|Orthopedics|orthopedics
5762563|NCT00273715|Joint, hip|joint, hip
5762564|NCT00273715|Surgical procedures of Hip, Operative|surgical procedures of hip, operative
5762565|NCT00273702|Gambling|gambling
5762567|NCT00273702|Gamble|gamble
5762568|NCT00273702|Pathological|pathological
5762569|NCT00273676|Community-acquired pneumonia|community-acquired pneumonia
5762570|NCT00273676|Treatment|treatment
5762571|NCT00273676|Antibiotics|antibiotics
5762572|NCT00273663|cerebral blood flow|cerebral blood flow
5763172|NCT00271128|Dyspnea|dyspnea
5762573|NCT00273663|electrical stimulation|electrical stimulation
5762574|NCT00273663|Computed Tomography Scanner, X-Ray|computed tomography scanner, x-ray
5762575|NCT00273663|Brain Mapping|brain mapping
5762576|NCT00273650|Autism|autism
5762577|NCT00273650|Placebo|placebo
5762579|NCT00273650|Controlled|controlled
5762580|NCT00273650|Complementary Alternative Medicine|complementary alternative medicine
5762581|NCT00273650|Vitamin Supplement|vitamin supplement
5762582|NCT00273637|heart failure|heart failure
5762583|NCT00273637|peripartum cardiomyopathy|peripartum cardiomyopathy
5762584|NCT00273637|pregnancy-associated cardiomyopathy|pregnancy-associated cardiomyopathy
5762585|NCT00273637|pregnancy complications|pregnancy complications
5762586|NCT00273637|nonischemic cardiomyopathy|nonischemic cardiomyopathy
5762587|NCT00273624|Therapy-resistant depression|therapy-resistant depression
5762588|NCT00273624|add-on therapy depression|add-on therapy depression
5762589|NCT00273611|vitamin D deficiency|vitamin d deficiency
5762590|NCT00273611|geriatric patients|geriatric patients
5762591|NCT00273598|Scoliosis|scoliosis
5762592|NCT00273598|spinal disease|spinal disease
5762593|NCT00273598|pediatrics|pediatrics
5762594|NCT00273598|Adolescents|adolescents
5762595|NCT00273598|Universal Spinal Instrumentation System|universal spinal instrumentation system
5762596|NCT00273598|Moss Miami Spinal Instrumentation System|moss miami spinal instrumentation system
5762597|NCT00273598|Orthopedic Surgery|orthopedic surgery
5762598|NCT00273585|Fecal occult blood testing|fecal occult blood testing
5762599|NCT00273585|Flexible sigmoidoscopy|flexible sigmoidoscopy
5762600|NCT00273585|Colonoscopy|colonoscopy
5762601|NCT00273585|Self-efficacy|self-efficacy
5762602|NCT00273572|Obesity|obesity
5762603|NCT00273572|Women|women
5762605|NCT00273572|Metabolic syndrome|metabolic syndrome
5762606|NCT00273572|Lifestyle intervention|lifestyle intervention
5762607|NCT00273572|Quality of life|quality of life
5762608|NCT00273559|Renal Transplantation|renal transplantation
5762609|NCT00273546|Head and Neck Cancer|head and neck cancer
5762610|NCT00273546|Induction|induction
5762611|NCT00273546|Chemotherapy|chemotherapy
5762612|NCT00273546|Chemoradiotherapy|chemoradiotherapy
5762613|NCT00273507|Non-small cell lung cancer|non-small cell lung cancer
5762614|NCT00273507|neoadjuvant|neoadjuvant
5762615|NCT00273507|resection|resection
5762616|NCT00273494|N2 disease|n2 disease
5762617|NCT00273494|Non-small cell lung cancer|non-small cell lung cancer
5761782|NCT00277108|PPD|ppd
5762618|NCT00273494|Surgery|surgery
5762619|NCT00273494|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5762620|NCT00273403|HIV|hiv
5762621|NCT00273403|Minority Groups|minority groups
5762622|NCT00273403|Health Services Accessibility|health services accessibility
5762623|NCT00273403|Quality of Life|quality of life
5762624|NCT00273377|Anesthesia|anesthesia
5762625|NCT00273377|Oxygen|oxygen
5762626|NCT00273377|Carbon dioxide|carbon dioxide
5762627|NCT00273377|Hypercapnia|hypercapnia
5762628|NCT00273377|Hypercarbia|hypercarbia
5762629|NCT00273377|Dexamethasone|dexamethasone
5762630|NCT00273377|Steroid|steroid
5762631|NCT00273377|Postoperative nausea and vomiting (PONV)|postoperative nausea and vomiting (ponv)
5762632|NCT00273364|stem cell, autoimmune disease, multiple sclerosis|stem cell, autoimmune disease, multiple sclerosis
5762633|NCT00273351|Parkinson|parkinson
5762634|NCT00273351|family history|family history
5762635|NCT00273351|diagnosis|diagnosis
5762636|NCT00273338|Androgen-independent Prostate Cancer (AIPC)|androgen-independent prostate cancer (aipc)
5762637|NCT00273338|Prostate Cancer|prostate cancer
5762638|NCT00273338|DN-101|dn-101
5762639|NCT00273338|calcitriol|calcitriol
5762640|NCT00273338|Taxotere|taxotere
5762641|NCT00273338|docetaxel|docetaxel
5762642|NCT00273325|NICHD Neonatal Research Network|nichd neonatal research network
5762643|NCT00273325|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5762644|NCT00273325|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5762645|NCT00273325|Prematurity|prematurity
5762646|NCT00273325|Pneumococcal Vaccines|pneumococcal vaccines
5762647|NCT00273325|Vaccines, Conjugate|vaccines, conjugate
5762648|NCT00273325|Immunogenicity|immunogenicity
5762649|NCT00273325|Vaccine Response|vaccine response
5762650|NCT00273325|Heptavalent pneumococcal conjugate vaccine (PCV-7)|heptavalent pneumococcal conjugate vaccine (pcv-7)
5762651|NCT00273325|pneumococcal polysaccharide, type 6B|pneumococcal polysaccharide, type 6b
5762652|NCT00273325|Pneumococcal polysaccharide, type 14|pneumococcal polysaccharide, type 14
5762653|NCT00273325|Pneumococcal polysaccharide, type 19F,|pneumococcal polysaccharide, type 19f,
5762654|NCT00273325|Pneumococcal polysaccharide, 23F|pneumococcal polysaccharide, 23f
5762655|NCT00273325|Pneumococcal polysaccharide, 18C|pneumococcal polysaccharide, 18c
5762657|NCT00273325|Pneumococcal polysaccharide, 9V|pneumococcal polysaccharide, 9v
5762658|NCT00273312|Advanced unresectable metastatic hepatocellular carcinoma|advanced unresectable metastatic hepatocellular carcinoma
5762659|NCT00273312|Liver cancer|liver cancer
5762660|NCT00273299|hypertension|hypertension
5762661|NCT00273299|high blood pressure|high blood pressure
5762662|NCT00273299|valsartan/hydrochlorozide|valsartan/hydrochlorozide
5762663|NCT00273299|severe hypertension|severe hypertension
5762664|NCT00273286|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5762665|NCT00273286|Diabetes Mellitus, Juvenile-Onset|diabetes mellitus, juvenile-onset
5762666|NCT00273286|IDDM|iddm
5762667|NCT00273286|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5762668|NCT00273273|HIV|hiv
5762669|NCT00273273|Atazanavir|atazanavir
5762670|NCT00273273|ritonavir|ritonavir
5762671|NCT00273273|tenofovir|tenofovir
5762672|NCT00273273|Adolescent|adolescent
5762673|NCT00273273|Treatment Experienced|treatment experienced
5762674|NCT00273234|Venous|venous
5762675|NCT00273234|Ulcer|ulcer
5762676|NCT00273234|autologous|autologous
5762677|NCT00273234|platelet|platelet
5762678|NCT00273234|healing|healing
5762679|NCT00273221|Glaucoma|glaucoma
5762680|NCT00273221|Cataract|cataract
5762681|NCT00273208|breast cancer|breast cancer
5762682|NCT00273208|fatigue|fatigue
5762683|NCT00273195|Implantable Cardioverter Defibrillator, Anti-tachycardia pacing (ATP)|implantable cardioverter defibrillator, anti-tachycardia pacing (atp)
5762684|NCT00273182|Heart Failure|heart failure
5762685|NCT00273182|Cardiomyopathy|cardiomyopathy
5762686|NCT00273182|Cardiac pacing|cardiac pacing
5762687|NCT00273182|Cardiac resynchronization therapy|cardiac resynchronization therapy
5762688|NCT00273130|transnasal gastroscopy, stress response, ischaemia|transnasal gastroscopy, stress response, ischaemia
5762689|NCT00273117|transnasal gastroscopy|transnasal gastroscopy
5762690|NCT00273117|tachycardia|tachycardia
5762691|NCT00273117|hypoxemia|hypoxemia
5762692|NCT00273078|Speech,|speech,
5762693|NCT00273078|tongue,|tongue,
5762694|NCT00273078|pressure,|pressure,
5762695|NCT00273078|transducer,|transducer,
5762696|NCT00273078|complete denture|complete denture
5762697|NCT00273065|Local Anesthetic|local anesthetic
5762698|NCT00273065|Neosaxitoxin|neosaxitoxin
5762699|NCT00273052|hypertension|hypertension
5762700|NCT00273039|Social Anxiety Disorder|social anxiety disorder
5762702|NCT00273039|Psychiatry|psychiatry
5762703|NCT00273026|Asthma Advair|asthma advair
5762704|NCT00273013|asthma|asthma
5762705|NCT00273013|allergen challenge|allergen challenge
5762706|NCT00272987|trastuzumab|trastuzumab
5762707|NCT00272987|ErbB2|erbb2
5762708|NCT00272987|paclitaxel|paclitaxel
5762709|NCT00272987|Herceptin|herceptin
5762710|NCT00272987|Taxol|taxol
5762711|NCT00272987|ErbB1|erbb1
5762712|NCT00272987|metastatic breast cancer|metastatic breast cancer
5762713|NCT00272987|Stage IV breast cancer|stage iv breast cancer
5762714|NCT00272987|lapatinib|lapatinib
5788357|NCT00154154|BPD|bpd
5762715|NCT00272974|AE adverse event|ae adverse event
5762716|NCT00272974|DCF data collection forms|dcf data collection forms
5762717|NCT00272974|IRB Institutional Review Board|irb institutional review board
5762718|NCT00272974|SAE serious adverse event|sae serious adverse event
5762719|NCT00272948|Venoocclusive disease|venoocclusive disease
5762720|NCT00272948|Pediatric|pediatric
5762721|NCT00272948|myeloablative conditioning|myeloablative conditioning
5762722|NCT00272948|stem cell transplant|stem cell transplant
5762723|NCT00272935|menopause|menopause
5762724|NCT00272935|vasomotor symptoms|vasomotor symptoms
5762725|NCT00272922|Biomaterials|biomaterials
5762726|NCT00272922|Paraesophageal Hernia|paraesophageal hernia
5762727|NCT00272922|Laparoscopy|laparoscopy
5762728|NCT00272909|Acute Ischemic Stroke|acute ischemic stroke
5762729|NCT00272909|9-Hour window MRI|9-hour window mri
5762730|NCT00272909|Serotonin receptor agonist|serotonin receptor agonist
5762731|NCT00272896|Migraine|migraine
5762733|NCT00272896|Transcranial Doppler|transcranial doppler
5762734|NCT00272896|Headache|headache
5762735|NCT00272883|central core|central core
5762736|NCT00272883|centronuclear|centronuclear
5762737|NCT00272883|multiminicore|multiminicore
5762738|NCT00272883|multicore|multicore
5762739|NCT00272883|minicore|minicore
5762740|NCT00272883|congenital fiber type disproportion|congenital fiber type disproportion
5762741|NCT00272883|myotubular|myotubular
5762742|NCT00272883|nemaline|nemaline
5762743|NCT00272883|congenital myopathy|congenital myopathy
5762744|NCT00272883|neuromuscular|neuromuscular
5762745|NCT00272883|rigid spine|rigid spine
5762746|NCT00272844|cholesterol|cholesterol
5762747|NCT00272844|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
5762748|NCT00272844|mental retardation|mental retardation
5762750|NCT00272844|congenital anomalies|congenital anomalies
5762751|NCT00272831|Diabetic nephropathy|diabetic nephropathy
5762752|NCT00272831|Macroalbuminuria|macroalbuminuria
5762753|NCT00272831|Pletaal|pletaal
5762754|NCT00272818|Colitis|colitis
5762755|NCT00272818|Esophagitis|esophagitis
5762756|NCT00272818|CD23|cd23
5762757|NCT00272805|chronic heart failure|chronic heart failure
5762758|NCT00272805|left ventricular systolic dysfunction|left ventricular systolic dysfunction
5762759|NCT00272779|HIV|hiv
5762760|NCT00272779|Treatment Naive|treatment naive
5762761|NCT00272766|Ocular histoplasmosis|ocular histoplasmosis
5762762|NCT00272766|Macugen|macugen
5762960|NCT00271908|Community|community
5762763|NCT00272766|Photodynamic therapy with Visudyne|photodynamic therapy with visudyne
5762764|NCT00272766|Best-corrected visual acuity scores between 20/40-20/200|best-corrected visual acuity scores between 20/40-20/200
5762765|NCT00272766|classic or occult choroidal neovascularization|classic or occult choroidal neovascularization
5762766|NCT00272740|breast cancer|breast cancer
5762767|NCT00272740|fulvestrant|fulvestrant
5762768|NCT00272740|Faslodex|faslodex
5762769|NCT00272740|hormonotherapy|hormonotherapy
5762770|NCT00272740|aromatase inhibitor failure|aromatase inhibitor failure
5762771|NCT00272740|Advanced breast cancer|advanced breast cancer
5762772|NCT00272727|Asthma|asthma
5762773|NCT00272727|dialog tool|dialog tool
5762774|NCT00272727|compliance|compliance
5762775|NCT00272714|breast pain, tenderness, benign breast conditions|breast pain, tenderness, benign breast conditions
5762776|NCT00272675|Nosocomial infection,|nosocomial infection,
5762777|NCT00272675|Decontamination,|decontamination,
5762778|NCT00272675|Randomized placebo-controlled trial,|randomized placebo-controlled trial,
5762779|NCT00272675|Cardiac surgery,|cardiac surgery,
5762780|NCT00272675|Chlorhexidine,|chlorhexidine,
5762781|NCT00272675|Prevention|prevention
5762782|NCT00272662|anemia|anemia
5762783|NCT00272662|cancer|cancer
5762784|NCT00272662|chemotherapy|chemotherapy
5762785|NCT00272662|chemotherapy induced anemia|chemotherapy induced anemia
5762786|NCT00272662|CIA|cia
5762787|NCT00272662|hemoglobin|hemoglobin
5762788|NCT00272662|Hb|hb
5762789|NCT00272662|Hgb|hgb
5762790|NCT00272662|erythropoietin|erythropoietin
5762791|NCT00272662|EPO|epo
5762792|NCT00272662|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5762793|NCT00272662|ESA|esa
5762794|NCT00272662|Hematide|hematide
5762795|NCT00272662|Omontys|omontys
5762796|NCT00272662|peginesatide|peginesatide
5762797|NCT00272662|red blood cell|red blood cell
5762798|NCT00272662|red blood cell production|red blood cell production
5762799|NCT00272649|Kidney cancer|kidney cancer
5762800|NCT00272649|Renal cancer|renal cancer
5762801|NCT00272636|atrial fibrillation|atrial fibrillation
5762802|NCT00272636|catheter ablation|catheter ablation
5762803|NCT00272636|amiodarone|amiodarone
5762804|NCT00272636|cardioversion|cardioversion
5762805|NCT00272623|Catheter, Indwelling|catheter, indwelling
5762806|NCT00272623|Indwelling Catheter|indwelling catheter
5762807|NCT00272623|Indwelling Catheters|indwelling catheters
5762808|NCT00272623|Implantable Catheters|implantable catheters
5762809|NCT00272623|Catheter, Implantable|catheter, implantable
5762810|NCT00272623|Catheters, Implantable|catheters, implantable
5762811|NCT00272623|Implantable Catheter|implantable catheter
5762812|NCT00272623|In-Dwelling Catheters|in-dwelling catheters
5752992|NCT00308334|neonate|neonate
5762813|NCT00272623|Catheter, In-Dwelling|catheter, in-dwelling
5762814|NCT00272623|Catheters, In-Dwelling|catheters, in-dwelling
5762815|NCT00272623|In Dwelling Catheters|in dwelling catheters
5762816|NCT00272623|In-Dwelling Catheter|in-dwelling catheter
5762817|NCT00272623|Venous Reservoirs|venous reservoirs
5762818|NCT00272623|Reservoir, Venous|reservoir, venous
5762819|NCT00272623|Reservoirs, Venous|reservoirs, venous
5762820|NCT00272623|Venous Reservoir|venous reservoir
5762821|NCT00272623|Vascular Access Ports|vascular access ports
5762822|NCT00272623|Access Port, Vascular|access port, vascular
5762823|NCT00272623|Access Ports, Vascular|access ports, vascular
5762824|NCT00272623|Port, Vascular Access|port, vascular access
5762825|NCT00272623|Ports, Vascular Access|ports, vascular access
5762826|NCT00272623|Vascular Access Port|vascular access port
5762827|NCT00272610|Skin Aging|skin aging
5762828|NCT00272610|Bateman's Purpura|bateman's purpura
5762829|NCT00272597|Psychosis|psychosis
5762830|NCT00272597|schizophrenia|schizophrenia
5762831|NCT00272597|schizoaffective|schizoaffective
5762832|NCT00272597|risperidone|risperidone
5762833|NCT00272584|Psychosis, schizophrenia, schizoaffective, clozapine, risperidone|psychosis, schizophrenia, schizoaffective, clozapine, risperidone
5762834|NCT00272571|ECPT, endothelial progenitor cells|ecpt, endothelial progenitor cells
5762835|NCT00272558|Malignant Pleural Mesothelioma|malignant pleural mesothelioma
5762836|NCT00272558|Chemotherapy|chemotherapy
5762837|NCT00272545|Anorexia Nervosa|anorexia nervosa
5762838|NCT00272545|Bulimia Nervosa|bulimia nervosa
5762839|NCT00272545|Cognitive Behavioral Therapy|cognitive behavioral therapy
5762841|NCT00272519|AIDS|aids
5762842|NCT00272519|Adolescent|adolescent
5762843|NCT00272519|HIV Positive|hiv positive
5762844|NCT00272493|Treatment Experienced|treatment experienced
5762845|NCT00272493|Treatment Naive|treatment naive
5762846|NCT00272480|HAM/TSP|ham/tsp
5762847|NCT00272480|HTLV-I-associated myelopathy|htlv-i-associated myelopathy
5762848|NCT00272480|zidovudine|zidovudine
5762849|NCT00272480|lamivudine|lamivudine
5762850|NCT00272480|antiretroviral therapy|antiretroviral therapy
5762851|NCT00272467|Helicobacter pylori|helicobacter pylori
5762852|NCT00272467|Stomach ulcer|stomach ulcer
5762853|NCT00272467|Rebamipide|rebamipide
5762854|NCT00272467|Omeprazole|omeprazole
5762856|NCT00272454|aspirin|aspirin
5762857|NCT00272454|cerebral infarction|cerebral infarction
5762858|NCT00272428|Prevention trial|prevention trial
5762859|NCT00272428|Antioxydant vitamins and minerals|antioxydant vitamins and minerals
5762860|NCT00272428|Cancer|cancer
5762861|NCT00272428|Ischemic disease|ischemic disease
5762862|NCT00272428|Mortality|mortality
5762863|NCT00272428|Health related quality of life|health related quality of life
5762864|NCT00272415|INO4136g|ino4136g
5762865|NCT00272415|inotek|inotek
5762866|NCT00272415|Parp|parp
5762868|NCT00272402|physician decision support|physician decision support
5762869|NCT00272402|diabetes mellitus|diabetes mellitus
5762870|NCT00272402|electronic medical records|electronic medical records
5762871|NCT00272402|office systems redesign|office systems redesign
5762872|NCT00272376|Myopia|myopia
5762873|NCT00272376|Nearsightedness|nearsightedness
5762874|NCT00272363|Glaucoma|glaucoma
5762875|NCT00272350|Brain|brain
5762876|NCT00272350|Tumor|tumor
5762877|NCT00272350|Therapy|therapy
5762878|NCT00272350|Progression|progression
5762879|NCT00272350|Antiangiogenesis|antiangiogenesis
5762880|NCT00272350|Brain Tumor|brain tumor
5762881|NCT00272350|Malignant Glioma|malignant glioma
5762882|NCT00272337|Cardiovascular diseases|cardiovascular diseases
5762883|NCT00272337|Aspirin|aspirin
5762884|NCT00272337|Atherosclerosis|atherosclerosis
5762885|NCT00272337|Myocardial Infarction|myocardial infarction
5762886|NCT00272324|Colorectal neoplasms|colorectal neoplasms
5762887|NCT00272324|Adenomatous polyps|adenomatous polyps
5762888|NCT00272311|Primary prevention|primary prevention
5762889|NCT00272311|Cardiovascular diseases|cardiovascular diseases
5762890|NCT00272311|Aspirin|aspirin
5762891|NCT00272311|Metabolic Syndrome X|metabolic syndrome x
5762892|NCT00272311|Atherosclerosis|atherosclerosis
5762893|NCT00272285|Serotonin antagonists|serotonin antagonists
5762894|NCT00272285|Randomized controlled trial|randomized controlled trial
5762895|NCT00272285|Combination drug therapy|combination drug therapy
5762896|NCT00272285|Double-blind method|double-blind method
5762897|NCT00272272|Fall Prevention, Music Therapy, Geriatric, Nursing Home|fall prevention, music therapy, geriatric, nursing home
5762898|NCT00272246|dystonia|dystonia
5762899|NCT00272233|Inflammation Mediators [D23.469]|inflammation mediators [d23.469]
5762900|NCT00272233|Cardiovascular Physiologic Phenomena [G09.330.553]|cardiovascular physiologic phenomena [g09.330.553]
5762901|NCT00272220|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5762902|NCT00272220|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5762903|NCT00272220|Randomized Controlled Trials|randomized controlled trials
5762904|NCT00272220|Africa|africa
5762905|NCT00272220|Adherence|adherence
5762906|NCT00272220|Treatment Naive|treatment naive
5762907|NCT00272207|Fibromyalgia|fibromyalgia
5762908|NCT00272207|Cannabinoids|cannabinoids
5762909|NCT00272207|Nabilone|nabilone
5762910|NCT00272207|Cesamet|cesamet
5771185|NCT00239239|Aranesp|aranesp
5762911|NCT00272207|Pain|pain
5762912|NCT00272194|Endotracheal Intubation|endotracheal intubation
5762913|NCT00272194|Supraglottic Airway|supraglottic airway
5762914|NCT00272168|Cognitive behavioral therapy|cognitive behavioral therapy
5762915|NCT00272168|Social Skills training|social skills training
5762916|NCT00272168|Vocational Rehabilitation|vocational rehabilitation
5762917|NCT00272142|mortality|mortality
5762918|NCT00272142|hospitalization|hospitalization
5762919|NCT00272142|diarrhea|diarrhea
5762920|NCT00272142|respiratory infection|respiratory infection
5762921|NCT00272142|low birth weight|low birth weight
5762922|NCT00272142|morbidity|morbidity
5762923|NCT00272116|zinc|zinc
5762924|NCT00272116|diarrhea|diarrhea
5762925|NCT00272116|severe diarrhea|severe diarrhea
5762926|NCT00272116|recurrent diarrhea|recurrent diarrhea
5762927|NCT00272116|acute lower respiratory infection|acute lower respiratory infection
5762928|NCT00272116|pneumonia|pneumonia
5762929|NCT00272103|functional dyspepsia|functional dyspepsia
5762930|NCT00272103|non ulcer dyspepsia|non ulcer dyspepsia
5762931|NCT00272103|drug treatment|drug treatment
5762932|NCT00272051|Neurotoxicity syndromes|neurotoxicity syndromes
5762933|NCT00272051|Paresthesia|paresthesia
5762934|NCT00272051|Oxaliplatin|oxaliplatin
5762935|NCT00272051|Xaliproden|xaliproden
5762936|NCT00272025|Bipolar Depression|bipolar depression
5762937|NCT00272025|Escitalopram|escitalopram
5762938|NCT00272025|Mood Stabilizer|mood stabilizer
5762939|NCT00272025|Atypical Antipsychotic|atypical antipsychotic
5762940|NCT00271999|randomized controlled clinical trial|randomized controlled clinical trial
5762941|NCT00271999|hemodialysis|hemodialysis
5762942|NCT00271999|End Stage Renal Disease|end stage renal disease
5762943|NCT00271986|Peritoneal microdialysis|peritoneal microdialysis
5762944|NCT00271986|Low anterior resection|low anterior resection
5762945|NCT00271986|Recto-sigmoid cancer|recto-sigmoid cancer
5762947|NCT00271960|Pregnancy|pregnancy
5762948|NCT00271960|Birth Weight|birth weight
5762949|NCT00271960|Gestational Age|gestational age
5762950|NCT00271960|Preterm Delivery|preterm delivery
5762951|NCT00271960|HIV Seronegativity|hiv seronegativity
5762952|NCT00271921|eating disorders|eating disorders
5762953|NCT00271921|anorexia nervosa|anorexia nervosa
5762955|NCT00271921|metabolic syndrome|metabolic syndrome
5762956|NCT00271921|visceral adipose tissue|visceral adipose tissue
5762958|NCT00271908|AIDS|aids
5762959|NCT00271908|Adolescent|adolescent
5762961|NCT00271908|Structural Changes|structural changes
5762962|NCT00271908|HIV Seronegativity|hiv seronegativity
5762963|NCT00271882|Adolescent Females|adolescent females
5762964|NCT00271882|HIV positive|hiv positive
5762965|NCT00271882|PTSD|ptsd
5762974|NCT00271856|Complementary Therapies|complementary therapies
5762975|NCT00271856|MBSR|mbsr
5762976|NCT00271856|Not on ART medications|not on art medications
5762977|NCT00271830|renal|renal
5762978|NCT00271830|transplant|transplant
5762979|NCT00271830|sexual dysfunction|sexual dysfunction
5762980|NCT00271830|male|male
5762981|NCT00271830|dialysis free|dialysis free
5762982|NCT00271804|Myelodysplastic syndrome|myelodysplastic syndrome
5762983|NCT00271804|Myelodysplasia|myelodysplasia
5762985|NCT00271804|Velcade|velcade
5762986|NCT00271804|Thalidomide|thalidomide
5762987|NCT00271804|Bortezomib|bortezomib
5762988|NCT00271791|Vestibular Neuronitis|vestibular neuronitis
5762989|NCT00271791|Vestibular Function Tests|vestibular function tests
5762990|NCT00271791|Vestibular Adaptation|vestibular adaptation
5762991|NCT00271791|Steroids|steroids
5762992|NCT00271778|Otitis media suppurative|otitis media suppurative
5762993|NCT00271778|surgery ear|surgery ear
5762994|NCT00271765|Myocardial infarction|myocardial infarction
5762995|NCT00271765|Coronary angioplasty|coronary angioplasty
5762996|NCT00271765|PARP inhibitor|parp inhibitor
5762997|NCT00271765|PARP inhibition|parp inhibition
5762998|NCT00271765|Heart Attack|heart attack
5762999|NCT00271752|Procalcitonin|procalcitonin
5763000|NCT00271752|Sepsis|sepsis
5763001|NCT00271752|Intensive Care Unit|intensive care unit
5763002|NCT00271752|Sepsis and Complications|sepsis and complications
5763003|NCT00271752|Organ Failure|organ failure
5763004|NCT00271739|Telemedicine|telemedicine
5763005|NCT00271739|Diabetes Mellitus|diabetes mellitus
5763006|NCT00271726|distal radius fracture|distal radius fracture
5763007|NCT00271726|extraarticular Colles fracture|extraarticular colles fracture
5763008|NCT00271713|bone structure|bone structure
5763009|NCT00271713|ibandronate|ibandronate
5763010|NCT00271700|Diabetes Mellitus|diabetes mellitus
5763011|NCT00271700|Outcome Assessment (Healthcare)|outcome assessment (healthcare)
5763012|NCT00271700|Inpatients|inpatients
5763013|NCT00271700|Hospital Information Systems|hospital information systems
5763014|NCT00271700|Education|education
5763015|NCT00271687|exercise|exercise
5763016|NCT00271687|exercise therapy|exercise therapy
5763017|NCT00271687|activities of daily living|activities of daily living
5763018|NCT00271687|quality of life|quality of life
5763019|NCT00271661|presbyopia; breast cancer survivors|presbyopia; breast cancer survivors
5763020|NCT00271635|Charcot-Marie-Tooth Disease|charcot-marie-tooth disease
5771280|NCT00238693|transplant|transplant
5762099|NCT00275392|Dizziness|dizziness
5763021|NCT00271635|Hereditary Motor and Sensory Neuropathies|hereditary motor and sensory neuropathies
5763022|NCT00271635|Ascorbic Acid|ascorbic acid
5763023|NCT00271635|Vitamin C|vitamin c
5763032|NCT00271609|AVASTIN|avastin
5763033|NCT00271609|Recurrence|recurrence
5763034|NCT00271609|Chemotherapy|chemotherapy
5763035|NCT00271609|Anti-Angiogenesis|anti-angiogenesis
5763036|NCT00271609|Radiotherapy|radiotherapy
5763037|NCT00271609|Brain Tumor|brain tumor
5763038|NCT00271609|Malignant Glioma|malignant glioma
5763039|NCT00271596|Huntington Disease|huntington disease
5763040|NCT00271596|Citalopram|citalopram
5763041|NCT00271596|Celexa|celexa
5763042|NCT00271596|Chorea|chorea
5763043|NCT00271596|Focus|focus
5763044|NCT00271596|ADD|add
5763045|NCT00271596|ADHD|adhd
5763046|NCT00271596|HD|hd
5763047|NCT00271596|SSRI|ssri
5763048|NCT00271583|emergency contraception|emergency contraception
5763049|NCT00271583|antiprogestin|antiprogestin
5763050|NCT00271557|Heart Failure|heart failure
5763051|NCT00271557|Renal Dysfunction|renal dysfunction
5763052|NCT00271557|Cardiomyopathy|cardiomyopathy
5763053|NCT00271557|Heart Decompensation|heart decompensation
5763054|NCT00271557|Dyspnea Paroxysmal.|dyspnea paroxysmal.
5763055|NCT00271544|heart failure|heart failure
5763056|NCT00271544|cardiac pacing|cardiac pacing
5763057|NCT00271544|left ventricular lead|left ventricular lead
5763058|NCT00271544|cardiac resynchronization therapy|cardiac resynchronization therapy
5763059|NCT00271531|bacterial infection, pneumonia, ventilation, children|bacterial infection, pneumonia, ventilation, children
5763060|NCT00271505|Non-Small Cell Lung Cancer|non-small cell lung cancer
5763061|NCT00271505|Lung Cancer|lung cancer
5763062|NCT00271505|Bevacizumab|bevacizumab
5763063|NCT00271505|Carboplatin|carboplatin
5763064|NCT00271505|Docetaxel|docetaxel
5763065|NCT00271505|Avastin|avastin
5763066|NCT00271505|NSCLC|nsclc
5763477|NCT00270088|Anemia|anemia
5763067|NCT00271505|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5763068|NCT00271505|rhuMAb-VEGF|rhumab-vegf
5763069|NCT00271505|Paraplatin®|paraplatin®
5763070|NCT00271505|Taxotere|taxotere
5763071|NCT00271479|Meningitis|meningitis
5763072|NCT00271479|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5763073|NCT00271479|Neisseria meningitidis|neisseria meningitidis
5763074|NCT00271479|Outbreaks|outbreaks
5763075|NCT00271479|Vaccine|vaccine
5763076|NCT00271479|Africa|africa
5763077|NCT00271479|Uganda|uganda
5763184|NCT00271076|Cerebral Protection Device|cerebral protection device
5763078|NCT00271479|Prevention of Neisseria meningitidis infections|prevention of neisseria meningitidis infections
5763079|NCT00271479|In outbreak contexts in developing countries|in outbreak contexts in developing countries
5763080|NCT00271466|opioid|opioid
5763081|NCT00271466|fentanyl|fentanyl
5763082|NCT00271466|Duragesic|duragesic
5763083|NCT00271466|transdermal|transdermal
5763084|NCT00271466|chronic pain|chronic pain
5763085|NCT00271466|morphine|morphine
5763086|NCT00271453|chronic pain|chronic pain
5763087|NCT00271453|opioid|opioid
5763088|NCT00271453|fentanyl|fentanyl
5763089|NCT00271453|transdermal|transdermal
5763090|NCT00271453|Durogesic|durogesic
5763091|NCT00271453|morphine|morphine
5763092|NCT00271440|chlorhexidine|chlorhexidine
5763093|NCT00271440|neonatal|neonatal
5763094|NCT00271440|skin flora|skin flora
5763095|NCT00271440|skin cleansing|skin cleansing
5763096|NCT00271440|bacterial colonization|bacterial colonization
5763097|NCT00271427|Thyroiditis|thyroiditis
5763098|NCT00271427|Autoimmune|autoimmune
5763099|NCT00271427|Hashimoto's|hashimoto's
5763100|NCT00271427|TPOAb|tpoab
5763101|NCT00271427|Selenium|selenium
5763102|NCT00271414|chronic pain|chronic pain
5763103|NCT00271414|opioid|opioid
5763104|NCT00271414|fentanyl|fentanyl
5763105|NCT00271414|transdermal|transdermal
5763106|NCT00271414|Duragesic|duragesic
5763107|NCT00271414|morphine|morphine
5763108|NCT00271401|Stents|stents
5763109|NCT00271401|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5763110|NCT00271388|Galvanic Vestibular Stimulation|galvanic vestibular stimulation
5763111|NCT00271388|Hemispatial Neglect|hemispatial neglect
5763112|NCT00271388|Stroke|stroke
5763113|NCT00271375|Age|age
5763114|NCT00271375|Caregivers|caregivers
5763115|NCT00271375|Family|family
5763116|NCT00271375|Intervention Studies|intervention studies
5763117|NCT00271362|Exercise|exercise
5763118|NCT00271362|Physical function|physical function
5763119|NCT00271362|Prosthetic mobility|prosthetic mobility
5763120|NCT00271362|Rehabilitation|rehabilitation
5763121|NCT00271349|Eosinophilic Esophagitis|eosinophilic esophagitis
5763122|NCT00271349|Budesonide|budesonide
5763123|NCT00271336|NEC|nec
5763124|NCT00271336|Premature Infants|premature infants
5763125|NCT00271336|TNF|tnf
5763126|NCT00271336|Pentoxifylline|pentoxifylline
5763127|NCT00271297|pelvic floor|pelvic floor
5763128|NCT00271297|exercise therapy|exercise therapy
5763129|NCT00271297|prevention|prevention
5763130|NCT00271297|ultrasonography|ultrasonography
5763131|NCT00271297|risk factors|risk factors
5763132|NCT00271245|cirrhosis|cirrhosis
5763133|NCT00271245|liver disease|liver disease
5763134|NCT00271245|selenium|selenium
5763135|NCT00271245|selenoproteins|selenoproteins
5763136|NCT00271245|selenoprotein P|selenoprotein p
5763137|NCT00271245|biomarkers|biomarkers
5763138|NCT00271232|Heart Failure, Cardiac Resynchronization|heart failure, cardiac resynchronization
5763139|NCT00271219|opiate addiction|opiate addiction
5763140|NCT00271219|opiate dependence|opiate dependence
5763141|NCT00271219|substance abuse|substance abuse
5763143|NCT00271219|substance addiction|substance addiction
5763144|NCT00271219|pregnancy|pregnancy
5763145|NCT00271219|buprenorphine|buprenorphine
5763146|NCT00271219|methadone|methadone
5763147|NCT00271219|fetal|fetal
5763148|NCT00271219|neonatal|neonatal
5763149|NCT00271219|post-partum|post-partum
5763150|NCT00271206|Nicotine Dependence|nicotine dependence
5763151|NCT00271206|Tobacco Dependence|tobacco dependence
5763152|NCT00271180|Cardiac Pacing|cardiac pacing
5763153|NCT00271180|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5763154|NCT00271180|pacemaker|pacemaker
5763155|NCT00271180|Sinus Bradycardia|sinus bradycardia
5763156|NCT00271167|Cardiac surgery|cardiac surgery
5763157|NCT00271167|PARP inhibitor|parp inhibitor
5763158|NCT00271167|PARP inhibition|parp inhibition
5763159|NCT00271167|Bypass surgery|bypass surgery
5763160|NCT00271167|CPB surgery|cpb surgery
5763161|NCT00271167|Cardiopulmonary bypass|cardiopulmonary bypass
5763162|NCT00271167|Coronary revascularization|coronary revascularization
5763163|NCT00271167|Cardiac valve replacement|cardiac valve replacement
5763165|NCT00271154|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5763166|NCT00271154|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5763167|NCT00271141|Parkinson's disease|parkinson's disease
5763168|NCT00271141|Oxidative stress|oxidative stress
5763169|NCT00271141|Marker|marker
5763170|NCT00271128|NT-proBNP|nt-probnp
5763171|NCT00271128|Heart failure|heart failure
5763173|NCT00271115|Kangaroo holding|kangaroo holding
5763174|NCT00271115|Kangaroo care|kangaroo care
5763175|NCT00271115|Maternal stress levels|maternal stress levels
5763176|NCT00271115|Premature birth|premature birth
5763177|NCT00271102|Cystocele, prolapse, anterior repair, colporrhaphy|cystocele, prolapse, anterior repair, colporrhaphy
5763178|NCT00271076|CAD|cad
5763182|NCT00271076|symptomatic|symptomatic
5763183|NCT00271076|asymptomatic|asymptomatic
5763187|NCT00271076|plaque morphology|plaque morphology
5763188|NCT00271063|Refractory or Relapsed Acute Lymphocytic Leukemia|refractory or relapsed acute lymphocytic leukemia
5763189|NCT00271050|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5763190|NCT00271050|external beam radiotherapy (EBRT)|external beam radiotherapy (ebrt)
5763191|NCT00271050|radio-immunotherapy (RIT)|radio-immunotherapy (rit)
5763192|NCT00271050|Zevalin|zevalin
5763193|NCT00271037|Pelvic organ prolapse|pelvic organ prolapse
5763194|NCT00271037|Stress urinary incontinence|stress urinary incontinence
5763195|NCT00271037|Surgery|surgery
5763196|NCT00271037|Colpocleisis|colpocleisis
5763197|NCT00271037|Urinary retention|urinary retention
5763198|NCT00271024|Smoking|smoking
5763199|NCT00271024|Smoking Cessation|smoking cessation
5763200|NCT00270998|Stress urinary incontinence|stress urinary incontinence
5763201|NCT00270985|almonds|almonds
5763202|NCT00270985|pre-diabetes|pre-diabetes
5763203|NCT00270985|inflammatory|inflammatory
5763205|NCT00270972|Venous leg ulcer|venous leg ulcer
5763206|NCT00270972|Venous insufficiency|venous insufficiency
5763207|NCT00270972|OrCel|orcel
5763208|NCT00270959|PTSD|ptsd
5763209|NCT00270946|Venous leg ulcer|venous leg ulcer
5763210|NCT00270946|OrCel|orcel
5763211|NCT00270946|Compression therapy|compression therapy
5763212|NCT00270933|defibrillators|defibrillators
5763213|NCT00270933|LLECG|llecg
5763214|NCT00270933|ventricular tachycardia|ventricular tachycardia
5763215|NCT00270933|ventricular fibrillation|ventricular fibrillation
5763216|NCT00270920|Initiation, Maintenance, Breastfeeding|initiation, maintenance, breastfeeding
5763217|NCT00270907|Metastatic Breast Cancer|metastatic breast cancer
5763218|NCT00270907|Breast Cancer|breast cancer
5763219|NCT00270907|CT-2103|ct-2103
5763220|NCT00270907|Gemcitabine|gemcitabine
5763221|NCT00270907|Xyotax|xyotax
5763222|NCT00270907|Gemzar|gemzar
5763223|NCT00270894|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5763224|NCT00270894|HER2 positive breast cancer|her2 positive breast cancer
5763225|NCT00270894|stage II - III breast cancer|stage ii - iii breast cancer
5763226|NCT00270881|cord blood transplantation|cord blood transplantation
5763227|NCT00270881|myeloablative regimen|myeloablative regimen
5763228|NCT00270881|hematologic malignancies|hematologic malignancies
5763229|NCT00270868|Double guide wire technique|double guide wire technique
5763230|NCT00270868|Difficult selective biliary cannulation|difficult selective biliary cannulation
5763231|NCT00270868|ERCP|ercp
5763232|NCT00270868|Attempts of cannulation|attempts of cannulation
5763233|NCT00270868|Post-ERCP complications.|post-ercp complications.
5763234|NCT00270855|Body Composition|body composition
5763235|NCT00270855|Exercise|exercise
5763236|NCT00270855|Glucose Tolerance|glucose tolerance
5763237|NCT00270855|Insulin Sensitivity|insulin sensitivity
5763238|NCT00270855|Functional Electric Stimulation|functional electric stimulation
5763239|NCT00270842|Education|education
5763240|NCT00270842|Exercise|exercise
5763241|NCT00270842|Gait|gait
5763242|NCT00270842|Peripheral Nervous System|peripheral nervous system
5763243|NCT00270842|Postural Balance|postural balance
5763244|NCT00270842|Self Efficacy|self efficacy
5763245|NCT00270842|Tai Chi Chuan|tai chi chuan
5763246|NCT00270829|renal function|renal function
5763247|NCT00270816|Multiple Sclerosis|multiple sclerosis
5763248|NCT00270816|Interferon-ß-1b|interferon-ß-1b
5763249|NCT00270816|Therapy|therapy
5763250|NCT00270803|Marijuana, FDG, PET, maze, THC, motor coordination.|marijuana, fdg, pet, maze, thc, motor coordination.
5763251|NCT00270790|Head and Neck cancer|head and neck cancer
5763252|NCT00270777|Controlled trial|controlled trial
5763253|NCT00270777|Snake bite|snake bite
5763254|NCT00270777|Safety|safety
5763255|NCT00270777|Antivenom|antivenom
5763256|NCT00270764|HIV/AIDS|hiv/aids
5763257|NCT00270764|Antiretroviral therapy|antiretroviral therapy
5763258|NCT00270764|Quality of life|quality of life
5763259|NCT00270764|South Africa|south africa
5763260|NCT00270764|Treatment Naive|treatment naive
5763261|NCT00270751|Video-Assisted Thoracoscopic Surgery|video-assisted thoracoscopic surgery
5763262|NCT00270751|Spontaneous pneumothorax|spontaneous pneumothorax
5763263|NCT00270751|Pleurectomy|pleurectomy
5763264|NCT00270751|Pleural abrasion|pleural abrasion
5763265|NCT00270751|Minocycline|minocycline
5763266|NCT00270738|urinary incontinence|urinary incontinence
5763267|NCT00270738|transversus abdominis|transversus abdominis
5763268|NCT00270738|pelvic floor muscles|pelvic floor muscles
5763269|NCT00270738|randomized controlled trial|randomized controlled trial
5763271|NCT00270725|AIDS|aids
5763272|NCT00270725|Labor productivity|labor productivity
5763273|NCT00270725|Antiretroviral therapy|antiretroviral therapy
5763274|NCT00270725|South Africa|south africa
5763275|NCT00270712|kidney|kidney
5763276|NCT00270712|transplant|transplant
5763277|NCT00270712|dysfunction|dysfunction
5763278|NCT00270712|chronic|chronic
5763279|NCT00270712|deterioration|deterioration
5763280|NCT00270712|loss of function|loss of function
5763281|NCT00270699|Dengue Vaccine|dengue vaccine
5763282|NCT00270699|Dengue Virus|dengue virus
5763283|NCT00270699|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5763284|NCT00270699|Dengue Shock Syndrome|dengue shock syndrome
5763285|NCT00270686|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5763286|NCT00270686|Stickler Syndrome|stickler syndrome
5763287|NCT00270686|Marfan Syndrome|marfan syndrome
5763288|NCT00270686|Genetics|genetics
5763289|NCT00270686|Aneurysm|aneurysm
5763290|NCT00270673|Lactate|lactate
5763291|NCT00270673|Tissue hypoxia|tissue hypoxia
5763292|NCT00270673|Intensive care|intensive care
5763293|NCT00270673|Goal- directed therapy|goal- directed therapy
5763294|NCT00270660|retraction pockets ear|retraction pockets ear
5763295|NCT00270660|unsafe otitis media|unsafe otitis media
5763296|NCT00270660|otitis media complications|otitis media complications
5763297|NCT00270647|cancer|cancer
5763298|NCT00270647|prostate cancer|prostate cancer
5763299|NCT00270647|colorectal cancer|colorectal cancer
5763300|NCT00270647|cardiovascular disease|cardiovascular disease
5763301|NCT00270647|eye disease|eye disease
5763302|NCT00270647|cognitive decline|cognitive decline
5763303|NCT00270634|Randomized Controlled Trials|randomized controlled trials
5763304|NCT00270634|Immunosuppression|immunosuppression
5763305|NCT00270634|Adult|adult
5763306|NCT00270634|Kidney Transplantation|kidney transplantation
5763307|NCT00270634|Treatment Outcome|treatment outcome
5763308|NCT00270608|Hypertension|hypertension
5763309|NCT00270608|Peripheral vascular disease|peripheral vascular disease
5763310|NCT00270608|Diabetes|diabetes
5763311|NCT00270608|Total body fat percentage|total body fat percentage
5763312|NCT00270556|Treatment Experienced|treatment experienced
5763313|NCT00270543|Stomach Neoplasms|stomach neoplasms
5763314|NCT00270530|Malaria|malaria
5763315|NCT00270530|Placental diseases|placental diseases
5763316|NCT00270530|Birth complications|birth complications
5763317|NCT00270530|Plasmodium falciparum|plasmodium falciparum
5763318|NCT00270530|Zambia|zambia
5763319|NCT00270530|HIV-seropositive|hiv-seropositive
5763320|NCT00270530|HIV|hiv
5763321|NCT00270504|Memokath|memokath
5763322|NCT00270504|Urethral stricture|urethral stricture
5763323|NCT00270504|urethral stent|urethral stent
5763324|NCT00270504|Bulbar urethral stricture|bulbar urethral stricture
5763325|NCT00270478|Erythropoietin Therapy|erythropoietin therapy
5763326|NCT00270478|Fetal Hemoglobin Induction|fetal hemoglobin induction
5763327|NCT00270478|Sickle Cell Disease|sickle cell disease
5763328|NCT00270478|Pulmonary Hypertension|pulmonary hypertension
5763329|NCT00270478|Chronic Kidney Disease|chronic kidney disease
5763330|NCT00270478|SCD|scd
5763331|NCT00270465|HIV-positive|hiv-positive
5763332|NCT00270465|Treatment Interruption|treatment interruption
5763333|NCT00270465|Therapeutic Vaccine|therapeutic vaccine
5763334|NCT00270465|HIV/AIDS|hiv/aids
5763335|NCT00270465|Virologic Response|virologic response
5763336|NCT00270465|HIV Positive|hiv positive
5763337|NCT00270452|Myelodyplastic Syndrome (MDS)|myelodyplastic syndrome (mds)
5788919|NCT00150930|UVB|uvb
5762397|NCT00274742|BiTE|bite
5763338|NCT00270452|Wilm's tumor-1|wilm's tumor-1
5763339|NCT00270452|Proteinase-3|proteinase-3
5763340|NCT00270452|Vaccine Therapy|vaccine therapy
5763341|NCT00270452|Acute Myeloid Leukemia|acute myeloid leukemia
5763342|NCT00270452|Chronic Myeloid Leukemias|chronic myeloid leukemias
5763343|NCT00270452|Myelodysplastic Syndrome|myelodysplastic syndrome
5763344|NCT00270452|MDS|mds
5763345|NCT00270439|Obesity|obesity
5763346|NCT00270439|Omentectomy|omentectomy
5763347|NCT00270439|Diabetes Mellitus Type 2|diabetes mellitus type 2
5763348|NCT00270439|Laparoscopic|laparoscopic
5763349|NCT00270439|Dyslipidemia|dyslipidemia
5763350|NCT00270426|Advanced Chronic Renal Insufficiency|advanced chronic renal insufficiency
5763351|NCT00270426|Benazepril|benazepril
5763352|NCT00270413|breast cancer|breast cancer
5763353|NCT00270413|metastatic|metastatic
5763354|NCT00270413|taxanes|taxanes
5763355|NCT00270413|SU11248|su11248
5763356|NCT00270400|Heart Failure|heart failure
5763357|NCT00270400|Renal Dysfunction|renal dysfunction
5763358|NCT00270400|Cardiomyopathy|cardiomyopathy
5763359|NCT00270400|Heart Decompensation|heart decompensation
5763360|NCT00270400|Dyspnea Paroxsymal.|dyspnea paroxsymal.
5763361|NCT00270387|Acutely Decompensated Congestive Heart Failure|acutely decompensated congestive heart failure
5763362|NCT00270387|Heart Failure|heart failure
5763363|NCT00270387|Renal Impairment|renal impairment
5763364|NCT00270387|Kidney Failure|kidney failure
5763365|NCT00270387|Myocardial Infarction.|myocardial infarction.
5780301|NCT00195936|PTH|pth
5763366|NCT00270374|Congestive heart failure|congestive heart failure
5763367|NCT00270374|CHF|chf
5763368|NCT00270374|Left-sided heart failure|left-sided heart failure
5763369|NCT00270374|Right-sided heart failure|right-sided heart failure
5763370|NCT00270374|Systolic Heart Failure|systolic heart failure
5763371|NCT00270361|Heart Failure|heart failure
5763372|NCT00270361|Renal Dysfunction|renal dysfunction
5763373|NCT00270361|Cardiomyopathy|cardiomyopathy
5763374|NCT00270361|Heart Decompensation|heart decompensation
5763375|NCT00270361|Dyspnea Paroxsymal|dyspnea paroxsymal
5763376|NCT00270361|Outpatient Therapy.|outpatient therapy.
5763377|NCT00270348|Asthma|asthma
5763378|NCT00270348|Safety|safety
5763379|NCT00270348|Pediatrics|pediatrics
5763380|NCT00270322|total knee replacement|total knee replacement
5763381|NCT00270322|orthopedic surgery|orthopedic surgery
5763382|NCT00270322|post operative analgesia|post operative analgesia
5763383|NCT00270322|continuous epidural|continuous epidural
5764487|NCT00265980|Obesity|obesity
5763384|NCT00270322|patients controlled analgesia|patients controlled analgesia
5763385|NCT00270322|morphine|morphine
5763386|NCT00270322|combined spinal epidural anesthesia|combined spinal epidural anesthesia
5763387|NCT00270322|anesthesia|anesthesia
5763388|NCT00270322|analgesia|analgesia
5763389|NCT00270322|epidural marcaine|epidural marcaine
5763390|NCT00270322|epidural fentanyl|epidural fentanyl
5763391|NCT00270322|pain|pain
5763392|NCT00270309|lower urinary tract symptoms, self-management|lower urinary tract symptoms, self-management
5763393|NCT00270296|Treatment Naive|treatment naive
5763394|NCT00270296|MTCT|mtct
5763395|NCT00270296|HIV Seronegativity|hiv seronegativity
5763396|NCT00270283|Anemia|anemia
5763397|NCT00270283|AIDS|aids
5763398|NCT00270283|erythropoietin|erythropoietin
5763399|NCT00270283|epoetin alfa|epoetin alfa
5763400|NCT00270283|Quality of Life|quality of life
5763401|NCT00270283|Zidovudine|zidovudine
5763402|NCT00270283|HIV|hiv
5763403|NCT00270270|erythropoietin|erythropoietin
5763404|NCT00270270|Anemia|anemia
5763405|NCT00270270|Quality of Life|quality of life
5763406|NCT00270270|epoetin alfa|epoetin alfa
5763407|NCT00270270|HIV|hiv
5763408|NCT00270270|Zidovudine|zidovudine
5763409|NCT00270270|AIDS|aids
5763410|NCT00270257|HIV Seronegativity|hiv seronegativity
5763411|NCT00270257|Opiate Addiction|opiate addiction
5763412|NCT00270257|Opiate Dependence|opiate dependence
5763413|NCT00270244|Major Depression|major depression
5763414|NCT00270244|Dysthymic Disorder|dysthymic disorder
5763415|NCT00270244|Adjustment Disorder With Depressed Mood|adjustment disorder with depressed mood
5763416|NCT00270244|Depressive Disorder Not Otherwise Specified|depressive disorder not otherwise specified
5763417|NCT00270244|Adolescent|adolescent
5763418|NCT00270244|Psychotherapy|psychotherapy
5862943|NCT00001454|Normal Volunteer|normal volunteer
5681021|NCT00575159|type 1 Diabetes mellitus, pharmacokinetics,|type 1 diabetes mellitus, pharmacokinetics,
5763419|NCT00270231|within-subjects, crossover, laboratory study|within-subjects, crossover, laboratory study
5763420|NCT00270231|Naltrexone vs. Placebo|naltrexone vs. placebo
5763421|NCT00270218|HIV Seronegativity|hiv seronegativity
5763422|NCT00270218|Adenoviral Vector Vaccine|adenoviral vector vaccine
5763423|NCT00270218|DNA Plasmid Vaccine|dna plasmid vaccine
5763424|NCT00270205|Treatment Experienced|treatment experienced
5763425|NCT00270205|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5763426|NCT00270192|Breastfeeding|breastfeeding
5763427|NCT00270192|exclusive|exclusive
5763428|NCT00270192|education|education
5763429|NCT00270192|counseling|counseling
5763430|NCT00270179|Anemia|anemia
5762487|NCT00274196|hip|hip
5763431|NCT00270179|blood transfusion|blood transfusion
5763432|NCT00270179|epoetin alfa|epoetin alfa
5763433|NCT00270179|erythropoietin|erythropoietin
5763434|NCT00270179|surgery|surgery
5763435|NCT00270179|self-blood donation|self-blood donation
5763436|NCT00270166|cancer|cancer
5763437|NCT00270166|malignancy|malignancy
5763438|NCT00270166|red cell transfusion|red cell transfusion
5763439|NCT00270166|epoetin alfa|epoetin alfa
5763440|NCT00270166|epoetin|epoetin
5763441|NCT00270166|erythropoietin|erythropoietin
5763442|NCT00270166|red blood cells|red blood cells
5763443|NCT00270153|renal transplant, ACE inhibitor|renal transplant, ace inhibitor
5763444|NCT00270140|anemia|anemia
5763445|NCT00270140|blood transfusion|blood transfusion
5763446|NCT00270140|epoetin alfa|epoetin alfa
5763447|NCT00270140|erythropoietin|erythropoietin
5763448|NCT00270140|surgery|surgery
5763449|NCT00270140|blood donation|blood donation
5763450|NCT00270140|blood|blood
5763451|NCT00270127|Anemia|anemia
5763452|NCT00270127|cancer|cancer
5763453|NCT00270127|quality of life|quality of life
5763454|NCT00270127|chemotherapy|chemotherapy
5763455|NCT00270127|hemoglobin|hemoglobin
5763456|NCT00270127|transfusion|transfusion
5763457|NCT00270127|epoetin alfa|epoetin alfa
5763458|NCT00270127|epoetin|epoetin
5763459|NCT00270127|erythropoietin|erythropoietin
5763460|NCT00270114|Anemia|anemia
5763461|NCT00270114|blood transfusion, autologous|blood transfusion, autologous
5763462|NCT00270114|epoetin alfa|epoetin alfa
5763463|NCT00270114|epogen|epogen
5763464|NCT00270114|erythropoietin|erythropoietin
5763465|NCT00270114|orthopedic procedures|orthopedic procedures
5763466|NCT00270114|orthopedic surgery|orthopedic surgery
5763467|NCT00270101|anemia|anemia
5763468|NCT00270101|cancer|cancer
5763469|NCT00270101|quality of life|quality of life
5763470|NCT00270101|chemotherapy|chemotherapy
5763471|NCT00270101|hemoglobin|hemoglobin
5763472|NCT00270101|multiple myeloma|multiple myeloma
5763473|NCT00270101|transfusion|transfusion
5763474|NCT00270101|epoetin alfa|epoetin alfa
5763475|NCT00270101|epoetin|epoetin
5763476|NCT00270101|erythropoietin|erythropoietin
5763478|NCT00270088|blood transfusion|blood transfusion
5763479|NCT00270088|epoetin alfa|epoetin alfa
5763481|NCT00270088|erythropoietin|erythropoietin
5763482|NCT00270088|orthopedic procedures|orthopedic procedures
5763483|NCT00270088|orthopedic surgery|orthopedic surgery
5763485|NCT00270075|erythropoietin|erythropoietin
5763486|NCT00270075|orthopedic procedures|orthopedic procedures
5763487|NCT00270075|orthopedic surgery|orthopedic surgery
5763488|NCT00270075|cardiovascular surgical procedures|cardiovascular surgical procedures
5763489|NCT00270075|Blood transfusion|blood transfusion
5763490|NCT00270075|epoetin alfa|epoetin alfa
5763492|NCT00270062|blood transfusion|blood transfusion
5763493|NCT00270062|epoetin alfa|epoetin alfa
5763494|NCT00270062|erythropoietin|erythropoietin
5763495|NCT00270062|surgery|surgery
5763496|NCT00270062|blood donation|blood donation
5763497|NCT00270062|blood|blood
5763498|NCT00270049|Anemia|anemia
5763499|NCT00270049|cancer|cancer
5763500|NCT00270049|leukemia|leukemia
5763501|NCT00270049|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5763502|NCT00270049|lymphocytic leukemia|lymphocytic leukemia
5763503|NCT00270049|epoetin alfa|epoetin alfa
5763504|NCT00270049|erythropoietin|erythropoietin
5763505|NCT00270049|red blood cells|red blood cells
5763506|NCT00270049|transfusions|transfusions
5763507|NCT00270049|quality of life|quality of life
5763508|NCT00270036|Blood transfusion|blood transfusion
5763509|NCT00270036|epoetin alfa|epoetin alfa
5763510|NCT00270036|epogen|epogen
5763511|NCT00270036|erythropoietin|erythropoietin
5763512|NCT00270036|orthopedic procedures|orthopedic procedures
5763513|NCT00270036|orthopedic surgery|orthopedic surgery
5763514|NCT00270023|Blood transfusion|blood transfusion
5763515|NCT00270023|epoetin alfa|epoetin alfa
5763516|NCT00270023|epogen|epogen
5763517|NCT00270023|erythropoietin|erythropoietin
5763518|NCT00270023|orthopedic procedures|orthopedic procedures
5763519|NCT00270023|orthopedic surgery|orthopedic surgery
5763520|NCT00270023|cardiovascular surgical procedures|cardiovascular surgical procedures
5763521|NCT00270023|breast reduction|breast reduction
5763522|NCT00270010|Anemia|anemia
5763523|NCT00270010|AIDS|aids
5790147|NCT00145561|HIV|hiv
5763524|NCT00270010|HIV|hiv
5763525|NCT00270010|Zidovudine|zidovudine
5763526|NCT00270010|Quality of Life|quality of life
5763527|NCT00270010|erythropoietin|erythropoietin
5763528|NCT00270010|epoetin alfa|epoetin alfa
5763529|NCT00269997|Anemia|anemia
5763530|NCT00269997|chemotherapy|chemotherapy
5763531|NCT00269997|epoetin alfa|epoetin alfa
5763532|NCT00269997|epogen|epogen
5763533|NCT00269997|erythropoietin|erythropoietin
5763534|NCT00269997|neoplasms|neoplasms
5763535|NCT00269997|cancer|cancer
5763536|NCT00269984|Anemia|anemia
5763537|NCT00269984|Blood transfusion|blood transfusion
5763538|NCT00269984|Epoetin alfa|epoetin alfa
5763539|NCT00269984|Erythropoietin|erythropoietin
5763540|NCT00269984|Neoplasm|neoplasm
5789118|NCT00149799|BDD|bdd
5763541|NCT00269984|Epogen|epogen
5763542|NCT00269984|Cancer|cancer
5763543|NCT00269971|hip replacement|hip replacement
5763544|NCT00269971|hip replacement surgery|hip replacement surgery
5763545|NCT00269971|surgery|surgery
5763546|NCT00269971|anemia|anemia
5763547|NCT00269971|transfusions|transfusions
5763548|NCT00269971|blood|blood
5763549|NCT00269971|blood transfusions|blood transfusions
5763550|NCT00269958|hip replacement|hip replacement
5763551|NCT00269958|hip replacement surgery|hip replacement surgery
5763552|NCT00269958|surgery|surgery
5763553|NCT00269958|anemia|anemia
5763554|NCT00269958|transfusions|transfusions
5763555|NCT00269958|blood transfusions|blood transfusions
5763556|NCT00269945|Anemia|anemia
5763557|NCT00269945|AIDS|aids
5763558|NCT00269945|HIV|hiv
5763560|NCT00269945|Quality of Life|quality of life
5763561|NCT00269945|erythropoietin|erythropoietin
5763562|NCT00269945|epoetin alfa|epoetin alfa
5763563|NCT00269932|Bronchitis|bronchitis
5763564|NCT00269932|chronic bronchitis|chronic bronchitis
5763565|NCT00269932|lung diseases|lung diseases
5763566|NCT00269932|respiratory tract infections|respiratory tract infections
5763567|NCT00269932|bronchial diseases|bronchial diseases
5763568|NCT00269932|antibacterial agents|antibacterial agents
5763569|NCT00269932|quinolones|quinolones
5763570|NCT00269932|levofloxacin|levofloxacin
5763571|NCT00269919|Schizophrenia|schizophrenia
5763572|NCT00269919|Risperidone|risperidone
5763573|NCT00269919|Risperidal Consta|risperidal consta
5763574|NCT00269906|Angina, unstable|angina, unstable
5763575|NCT00269906|Angioplasty, transluminal, percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5763576|NCT00269906|Abciximab|abciximab
5763577|NCT00269893|Abciximab|abciximab
5763578|NCT00269893|Angina, unstable|angina, unstable
5763579|NCT00269893|Angioplasty, transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5763580|NCT00269880|Angioplasty, Transluminal, Percutaneous coronary|angioplasty, transluminal, percutaneous coronary
5763581|NCT00269867|Rheumatoid Arthritis|rheumatoid arthritis
5763582|NCT00269867|infliximab|infliximab
5763583|NCT00269867|methotrexate|methotrexate
5763584|NCT00269854|Crohn's Disease|crohn's disease
5763585|NCT00269841|fistulae|fistulae
5763586|NCT00269841|Crohn's Disease|crohn's disease
5763587|NCT00269828|Non-small cell lung cancer|non-small cell lung cancer
5763589|NCT00269828|PS 2|ps 2
5763591|NCT00269828|chemotherapy|chemotherapy
5763592|NCT00269815|ADHD|adhd
5763593|NCT00269815|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5763594|NCT00269815|OROS®|oros®
5763595|NCT00269815|children|children
5763596|NCT00269815|methylphenidate|methylphenidate
5763597|NCT00269802|ADHD|adhd
5763598|NCT00269802|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5763602|NCT00269802|methylphenidate|methylphenidate
5763603|NCT00269789|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5763604|NCT00269789|OROS®|oros®
5763605|NCT00269789|Ritalin®|ritalin®
5763606|NCT00269789|children|children
5763607|NCT00269789|methylphenidate|methylphenidate
5763608|NCT00269789|ADHD|adhd
5763609|NCT00269776|ADHD|adhd
5763610|NCT00269776|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5763611|NCT00269776|OROS|oros
5763612|NCT00269776|children|children
5763613|NCT00269776|methylphenidate|methylphenidate
5763614|NCT00269776|Ritalin|ritalin
5763615|NCT00269763|patch|patch
5763616|NCT00269763|pain|pain
5763617|NCT00269763|fentanyl|fentanyl
5763618|NCT00269763|narcotic|narcotic
5763619|NCT00269763|Cancer|cancer
5763620|NCT00269750|Ditropan®|ditropan®
5763621|NCT00269750|OROS®|oros®
5763622|NCT00269750|urge|urge
5763623|NCT00269750|oxybutynin|oxybutynin
5763624|NCT00269750|mixed urinary incontinence|mixed urinary incontinence
5763625|NCT00269737|fentanyl|fentanyl
5763626|NCT00269737|pain|pain
5763627|NCT00269737|Cancer|cancer
5763628|NCT00269737|patch|patch
5763629|NCT00269724|urinary incontinence|urinary incontinence
5763630|NCT00269724|oxybutynin|oxybutynin
5763631|NCT00269724|OROS®|oros®
5763632|NCT00269685|Septic shock|septic shock
5763633|NCT00269685|catecholamine|catecholamine
5763634|NCT00269685|vasopressin|vasopressin
5763635|NCT00269685|tonometria|tonometria
5681022|NCT00575159|pharmacodynamics|pharmacodynamics
5681023|NCT00575159|Adult male and females,|adult male and females,
5681024|NCT00575146|glioblastoma|glioblastoma
5763636|NCT00269685|lactate|lactate
5763637|NCT00269672|vaccine|vaccine
5763638|NCT00269659|Left Bundle Branch Block|left bundle branch block
5763639|NCT00269659|Regional cardiac function|regional cardiac function
5763640|NCT00269659|Global cardiac function|global cardiac function
5763641|NCT00269659|Mechanical asynchrony|mechanical asynchrony
5763642|NCT00269659|Echocardiography|echocardiography
5763643|NCT00269659|2D echocardiography|2d echocardiography
5763644|NCT00269659|Tissue Doppler Imaging|tissue doppler imaging
5763645|NCT00269659|Real-time 3D echocardiography|real-time 3d echocardiography
5771763|NCT00237250|IGT|igt
5762604|NCT00273572|Arab|arab
5763646|NCT00269659|Cardiovascular Magnetic Resonance Imaging-tagging|cardiovascular magnetic resonance imaging-tagging
5763647|NCT00269646|Diet|diet
5763648|NCT00269646|Low-carbohydrate|low-carbohydrate
5763649|NCT00269646|Insulin|insulin
5763650|NCT00269646|Dietary fiber|dietary fiber
5763651|NCT00269646|Diabetes|diabetes
5763652|NCT00269646|Cardiovascular disease|cardiovascular disease
5763653|NCT00269633|Seasonal Affective Disorder|seasonal affective disorder
5763654|NCT00269620|contraceptive vaginal ring|contraceptive vaginal ring
5763655|NCT00269620|contraceptive patch|contraceptive patch
5763656|NCT00269620|oral contraceptives|oral contraceptives
5763657|NCT00269620|acceptability|acceptability
5763658|NCT00269607|Substance abuse|substance abuse
5763659|NCT00269607|Treatment|treatment
5763660|NCT00269607|Relapse prevention|relapse prevention
5763661|NCT00269607|opioid antagonist|opioid antagonist
5763662|NCT00269594|Skin|skin
5763663|NCT00269594|Picking|picking
5763664|NCT00269594|Pick|pick
5763665|NCT00269594|Neurotic Excoriation|neurotic excoriation
5763666|NCT00269581|migraine|migraine
5763667|NCT00269581|tension headaches|tension headaches
5763668|NCT00269581|chronic daily headaches|chronic daily headaches
5763669|NCT00269568|medical abortion|medical abortion
5763670|NCT00269568|mifepristone|mifepristone
5763671|NCT00269568|misoprostol|misoprostol
5763672|NCT00269555|Prostate|prostate
5763673|NCT00269555|Cancer|cancer
5763674|NCT00269555|Prostate Specific Antigen|prostate specific antigen
5763675|NCT00269555|C04.588.945.440.770|c04.588.945.440.770
5763676|NCT00269542|zinc supplementation|zinc supplementation
5763677|NCT00269542|hospitalisations|hospitalisations
5763678|NCT00269542|children|children
5763679|NCT00269542|mortality|mortality
5763680|NCT00269542|iron folic acid|iron folic acid
5763681|NCT00269529|postoperative pain|postoperative pain
5763682|NCT00269529|knee arthroplasty|knee arthroplasty
5763683|NCT00269529|analgesia|analgesia
5763684|NCT00269529|infiltration|infiltration
5763685|NCT00269529|femoral nerve block|femoral nerve block
5763686|NCT00269516|Parkinson's disease|parkinson's disease
5763687|NCT00269490|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5763690|NCT00269477|Meningococcal infection|meningococcal infection
5763691|NCT00269477|Neisseria meningitidis|neisseria meningitidis
5763692|NCT00269477|Menactra®|menactra®
5763693|NCT00269477|Menomune®|menomune®
5763694|NCT00269425|Cardiovascular disease|cardiovascular disease
5763695|NCT00269425|Nutrition|nutrition
5763696|NCT00269425|Mediterranean diet|mediterranean diet
5763697|NCT00269425|Low fat diet|low fat diet
5763698|NCT00269425|American Heart Association diet|american heart association diet
5763699|NCT00269425|Monounsaturated fats|monounsaturated fats
5763700|NCT00269425|Omega-3 fats|omega-3 fats
5763701|NCT00269425|Outcomes|outcomes
5763702|NCT00269412|Irritable bowel syndrome|irritable bowel syndrome
5763703|NCT00269399|Clostridium difficile-associated Diarrhea (CDAD)|clostridium difficile-associated diarrhea (cdad)
5763705|NCT00269399|C diff|c diff
5763706|NCT00269386|Clarithromycin|clarithromycin
5763707|NCT00269386|Crohn's|crohn's
5763708|NCT00269373|Unknown primary tumor|unknown primary tumor
5763709|NCT00269373|PET-CT|pet-ct
5763710|NCT00269360|Chiropractic|chiropractic
5763711|NCT00269360|Manual Therapies|manual therapies
5763712|NCT00269360|Exercise|exercise
5763713|NCT00269360|Randomized|randomized
5763714|NCT00269360|Clinical Trial|clinical trial
5763715|NCT00269360|Neck Pain|neck pain
5763716|NCT00269347|Chiropractic|chiropractic
5763717|NCT00269347|Manual Therapy|manual therapy
5763718|NCT00269347|Exercise|exercise
5763719|NCT00269347|Randomized|randomized
5763720|NCT00269347|Clinical Trial|clinical trial
5763721|NCT00269347|Back Pain|back pain
5763722|NCT00269334|antidepressant,major depression,CYP2D6,CYP2C19,SSRI|antidepressant,major depression,cyp2d6,cyp2c19,ssri
5763723|NCT00269321|Randomized|randomized
5763724|NCT00269321|Clinical Trial|clinical trial
5763725|NCT00269321|Low Back Pain|low back pain
5763726|NCT00269321|Chiropractic|chiropractic
5763727|NCT00269321|Manual Therapies|manual therapies
5763728|NCT00269321|Exercise|exercise
5763729|NCT00269308|Randomized|randomized
5763730|NCT00269308|Clinical Trial|clinical trial
5763731|NCT00269308|Neck Pain|neck pain
5763732|NCT00269308|Chiropractic|chiropractic
5763733|NCT00269308|Manual Therapies|manual therapies
5763734|NCT00269308|Exercise|exercise
5763735|NCT00269295|Typhoid fever, S typhi, vaccine|typhoid fever, s typhi, vaccine
5763736|NCT00269230|cardiac resynchronization therapy, left ventricular Lead, Heart Failure|cardiac resynchronization therapy, left ventricular lead, heart failure
5763737|NCT00269191|Arcoxia|arcoxia
5763738|NCT00269178|malaria|malaria
5763739|NCT00269178|knowledge attitudes and practice (KAP)|knowledge attitudes and practice (kap)
5763740|NCT00269178|bednets|bednets
5763741|NCT00269178|peer health education|peer health education
5763742|NCT00269139|Behavioral crisis|behavioral crisis
5763743|NCT00269139|Perception of social crisis|perception of social crisis
5763744|NCT00269139|Repetition compulsion|repetition compulsion
5763745|NCT00269139|Intrusive mental events|intrusive mental events
5762701|NCT00273039|Anxiety|anxiety
5763746|NCT00269139|Uncontrollable urges|uncontrollable urges
5763747|NCT00269126|COPD|copd
5763748|NCT00269126|Chronic Bronchitis|chronic bronchitis
5763749|NCT00269126|Emphysema|emphysema
5763750|NCT00269100|Debridement|debridement
5763751|NCT00269087|Chronic Bronchitis|chronic bronchitis
5763752|NCT00269087|COPD|copd
5763753|NCT00269087|Emphysema|emphysema
5763754|NCT00269061|pioglitazone|pioglitazone
5763755|NCT00269061|diabetes|diabetes
5763756|NCT00269061|fluid|fluid
5763758|NCT00269048|Lp-PLA2|lp-pla2
5763759|NCT00269048|SB-480848|sb-480848
5763760|NCT00269035|SB-773812|sb-773812
5763761|NCT00269035|SPECT|spect
5763762|NCT00269035|D2 RO|d2 ro
5763763|NCT00269035|pharmacokinetics|pharmacokinetics
5763764|NCT00269035|schizophrenic patients|schizophrenic patients
5763765|NCT00269035|5HT2A RO|5ht2a ro
5763766|NCT00269022|SB-705498 acute migraine single dose TRPV1 combination inpatient outpatient study|sb-705498 acute migraine single dose trpv1 combination inpatient outpatient study
5763767|NCT00269009|Tobacco use|tobacco use
5763768|NCT00268996|Coronary artery disease|coronary artery disease
5763769|NCT00268996|Lipoprotein-associated Phospholipase A2|lipoprotein-associated phospholipase a2
5763771|NCT00268996|hs-CRP|hs-crp
5763772|NCT00268996|endothelial function|endothelial function
5763773|NCT00268996|intravascular ultrasound|intravascular ultrasound
5763774|NCT00268983|rituximab|rituximab
5763775|NCT00268983|tositumomab and iodine I 131 tositumomab|tositumomab and iodine i 131 tositumomab
5763776|NCT00268983|non-Hodgkins lymphoma|non-hodgkins lymphoma
5763777|NCT00268983|radioimmunotherapy|radioimmunotherapy
5763778|NCT00268983|anti-B1 antibody|anti-b1 antibody
5763779|NCT00268983|Bexxar|bexxar
5763780|NCT00268983|NHL|nhl
5763781|NCT00268983|Tositumomab|tositumomab
5763782|NCT00268970|Advanced non-small cell lung cancer (NSCLC)|advanced non-small cell lung cancer (nsclc)
5763783|NCT00268957|Chronic|chronic
5763784|NCT00268957|Hemodialysis|hemodialysis
5763785|NCT00268957|Kidney|kidney
5763786|NCT00268957|Hyperphosphatemia|hyperphosphatemia
5763787|NCT00268957|Chronic kidney disease|chronic kidney disease
5763788|NCT00268957|Chronic Renal Insufficiency|chronic renal insufficiency
5763789|NCT00268944|Glycogen Storage Disease Type II|glycogen storage disease type ii
5763796|NCT00268918|PTK787|ptk787
5763797|NCT00268918|Metastatic breast cancer|metastatic breast cancer
5763798|NCT00268918|Refractory gynecological cancer|refractory gynecological cancer
5763799|NCT00268892|Prostate Cancer|prostate cancer
5763800|NCT00268892|Androgen ablation therapy|androgen ablation therapy
5763801|NCT00268879|Irritable bowel syndrome|irritable bowel syndrome
5763802|NCT00268879|Constipation-predominant irritable bowel syndrome|constipation-predominant irritable bowel syndrome
5763804|NCT00268853|NHL|nhl
5763805|NCT00268853|large cell|large cell
5763806|NCT00268853|phase II|phase ii
5763807|NCT00268853|CHOP R|chop r
5763808|NCT00268853|CPOP R|cpop r
5763809|NCT00268853|non Hodgkins|non hodgkins
5763810|NCT00268840|Pancreas or biliary cancer|pancreas or biliary cancer
5763811|NCT00268827|Kaletra|kaletra
5763812|NCT00268827|Comparison|comparison
5763813|NCT00268827|Quality of Life|quality of life
5764488|NCT00265980|Energy|energy
5763814|NCT00268827|African American|african american
5763815|NCT00268788|multifocal motor neuropathy|multifocal motor neuropathy
5763816|NCT00268788|subcutaneous|subcutaneous
5763817|NCT00268788|IVIG|ivig
5763818|NCT00268788|gammaglobulin|gammaglobulin
5763819|NCT00268775|community pharmacy services|community pharmacy services
5763820|NCT00268775|patient care|patient care
5763821|NCT00268775|outcome assessment|outcome assessment
5763822|NCT00268775|benzodiazepines therapeutic use|benzodiazepines therapeutic use
5763823|NCT00268762|stroke|stroke
5763824|NCT00268762|thrombin inhibition|thrombin inhibition
5763825|NCT00268762|thrombolysis|thrombolysis
5763826|NCT00268762|bleeding|bleeding
5763827|NCT00268762|outcome|outcome
5763828|NCT00268697|Hyperlipidemia|hyperlipidemia
5763829|NCT00268697|Drug Therapy|drug therapy
5763830|NCT00268658|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5763831|NCT00268658|Arthroplasty, Replacement, Knee|arthroplasty, replacement, knee
5763832|NCT00268658|Arthroscopy|arthroscopy
5763833|NCT00268606|fibromyalgia|fibromyalgia
5763834|NCT00268606|cognitive-behavioral therapy|cognitive-behavioral therapy
5763835|NCT00268606|tailored treatment|tailored treatment
5763836|NCT00268593|heparanase|heparanase
5763837|NCT00268593|angiogenesis|angiogenesis
5681025|NCT00575146|ketogenic diet|ketogenic diet
5763839|NCT00268580|Care map|care map
5763840|NCT00268580|Clinical pathway|clinical pathway
5763841|NCT00268580|Education|education
5763842|NCT00268580|Emergency department|emergency department
5763843|NCT00268554|adenosine|adenosine
5763844|NCT00268554|caffeine|caffeine
5763845|NCT00268554|dipyridamole|dipyridamole
5763846|NCT00268541|exercise|exercise
5763847|NCT00268541|physical activity|physical activity
5763848|NCT00268541|insulin resistance|insulin resistance
5763849|NCT00268541|adipose tissue|adipose tissue
5763850|NCT00268541|gene expression|gene expression
5763851|NCT00268502|fatigue|fatigue
5763852|NCT00268502|depression|depression
5771937|NCT00236691|topiramate|topiramate
5763853|NCT00268502|spiritual concerns|spiritual concerns
5763854|NCT00268502|sexual dysfunction|sexual dysfunction
5763855|NCT00268502|sleep disorders|sleep disorders
5763856|NCT00268502|cancer survivor|cancer survivor
5763857|NCT00268502|stage IA breast cancer|stage ia breast cancer
5763858|NCT00268502|stage IB breast cancer|stage ib breast cancer
5763859|NCT00268502|stage II breast cancer|stage ii breast cancer
5763860|NCT00268502|stage IIIA breast cancer|stage iiia breast cancer
5763861|NCT00268502|stage IIIB breast cancer|stage iiib breast cancer
5763862|NCT00268502|stage IIIC breast cancer|stage iiic breast cancer
5763863|NCT00268489|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5763864|NCT00268489|squamous cell lung cancer|squamous cell lung cancer
5763865|NCT00268489|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5763866|NCT00268489|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5763871|NCT00268463|liver metastases|liver metastases
5763872|NCT00268463|stage IV colon cancer|stage iv colon cancer
5763873|NCT00268463|stage IV rectal cancer|stage iv rectal cancer
5763874|NCT00268463|adenocarcinoma of the colon|adenocarcinoma of the colon
5763875|NCT00268463|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5763876|NCT00268450|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5763877|NCT00268450|stage III bladder cancer|stage iii bladder cancer
5763878|NCT00268450|stage II bladder cancer|stage ii bladder cancer
5763879|NCT00268450|recurrent bladder cancer|recurrent bladder cancer
5763880|NCT00268437|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5763881|NCT00268437|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5763882|NCT00268437|stage III esophageal cancer|stage iii esophageal cancer
5763883|NCT00268437|stage II esophageal cancer|stage ii esophageal cancer
5763884|NCT00268411|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5764353|NCT00266513|Genetics|genetics
5763885|NCT00268411|stage IV pancreatic cancer|stage iv pancreatic cancer
5763886|NCT00268398|adenocarcinoma of the colon|adenocarcinoma of the colon
5763887|NCT00268398|stage IV colon cancer|stage iv colon cancer
5763888|NCT00268398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5763889|NCT00268398|stage IV rectal cancer|stage iv rectal cancer
5763890|NCT00268398|resectable metastases|resectable metastases
5763891|NCT00268372|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5763892|NCT00268372|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5763893|NCT00268359|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5763894|NCT00268359|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5763896|NCT00268359|adult gliosarcoma|adult gliosarcoma
5763897|NCT00268359|recurrent adult brain tumor|recurrent adult brain tumor
5763898|NCT00268359|adult giant cell glioblastoma|adult giant cell glioblastoma
5763899|NCT00268346|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5763900|NCT00268346|recurrent esophageal cancer|recurrent esophageal cancer
5763901|NCT00268346|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5763902|NCT00268346|stage IV esophageal cancer|stage iv esophageal cancer
5763903|NCT00268333|adenocarcinoma of the colon|adenocarcinoma of the colon
5763904|NCT00268333|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5763905|NCT00268333|stage IV colon cancer|stage iv colon cancer
5763906|NCT00268333|stage III colon cancer|stage iii colon cancer
5763907|NCT00268333|stage III rectal cancer|stage iii rectal cancer
5763908|NCT00268333|stage IV rectal cancer|stage iv rectal cancer
5763909|NCT00268320|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator|congestive heart failure, atrial arrhythmia, cardiac resynchronization therapy, implantable cardioverter defibrillator
5763910|NCT00268307|Cell therapy|cell therapy
5763911|NCT00268294|cardiac resynchronization therapy, atrial arrhythmia|cardiac resynchronization therapy, atrial arrhythmia
5763912|NCT00268281|cardiac resynchronization therapy|cardiac resynchronization therapy
5763913|NCT00268255|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5763914|NCT00268255|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5763915|NCT00268255|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5763916|NCT00268255|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5763917|NCT00268255|large cell lung cancer|large cell lung cancer
5763918|NCT00268255|squamous cell lung cancer|squamous cell lung cancer
5763919|NCT00268255|adenocarcinoma of the lung|adenocarcinoma of the lung
5763920|NCT00268242|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5763921|NCT00268242|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5763922|NCT00268242|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5763923|NCT00268242|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5763924|NCT00268242|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5763925|NCT00268242|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5763926|NCT00268242|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5763927|NCT00268242|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5789559|NCT00148031|HCV|hcv
5763928|NCT00268242|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5763929|NCT00268242|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5763930|NCT00268242|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5763931|NCT00268242|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5763932|NCT00268242|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5763933|NCT00268242|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5763934|NCT00268229|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5763935|NCT00268229|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5763936|NCT00268229|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5763937|NCT00268229|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5763938|NCT00268229|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5763939|NCT00268229|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5763940|NCT00268229|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5763941|NCT00268229|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5763942|NCT00268229|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5763943|NCT00268229|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5763944|NCT00268229|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5763945|NCT00268229|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5763946|NCT00268229|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5763947|NCT00268229|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5763948|NCT00268216|mortality|mortality
5763949|NCT00268216|TORCH|torch
5763950|NCT00268216|SERETIDE|seretide
5763951|NCT00268216|ADVAIR|advair
5763952|NCT00268216|COPD|copd
5764354|NCT00266513|Hyper-IGM|hyper-igm
5763958|NCT00268203|relapsed low-grade non-Hodgkin's lymphoma|relapsed low-grade non-hodgkin's lymphoma
5763960|NCT00268177|Pulmonary|pulmonary
5763961|NCT00268177|Obstructive|obstructive
5763962|NCT00268177|Chronic|chronic
5763963|NCT00268177|inflammation|inflammation
5763964|NCT00268177|salmeterol/fluticasone propionate|salmeterol/fluticasone propionate
5763965|NCT00268151|non-small cell lung cancer|non-small cell lung cancer
5763966|NCT00268151|oxaliplatin|oxaliplatin
5763967|NCT00268151|capecitabine|capecitabine
5763968|NCT00268151|XELOX-RT|xelox-rt
5763969|NCT00268138|amine fluoride|amine fluoride
5763970|NCT00268138|white spot lesions|white spot lesions
5763971|NCT00268138|qlf|qlf
5763972|NCT00268125|Breast Neoplasm|breast neoplasm
5763973|NCT00268125|FEC100|fec100
5763974|NCT00268125|Chemotherapy|chemotherapy
5763975|NCT00268125|acupression|acupression
5763976|NCT00268125|bracelet|bracelet
5763977|NCT00268125|nausea|nausea
5763978|NCT00268125|vomiting|vomiting
5763979|NCT00268112|pediatric|pediatric
5763980|NCT00268112|cardiac|cardiac
5763981|NCT00268112|ALCAPA|alcapa
5763982|NCT00268112|Tissue Doppler Imaging|tissue doppler imaging
5763983|NCT00268099|pediatric|pediatric
5763984|NCT00268099|cardiac|cardiac
5763985|NCT00268099|repair of right to left shunt lesions|repair of right to left shunt lesions
5763986|NCT00268099|Tetralogy of Fallot defects|tetralogy of fallot defects
5764489|NCT00265980|Autonomics|autonomics
5763987|NCT00268086|constrictive pericarditis|constrictive pericarditis
5763988|NCT00268086|adult congenital patients|adult congenital patients
5763989|NCT00268086|pulmonary insufficiency|pulmonary insufficiency
5763990|NCT00268073|Pediatric|pediatric
5763992|NCT00268073|neo-aortic insufficience|neo-aortic insufficience
5763993|NCT00268073|Norwood standard Stage I procedure|norwood standard stage i procedure
5763994|NCT00268073|Norwood Sano procedure|norwood sano procedure
5763995|NCT00268060|pediatric|pediatric
5763996|NCT00268060|cardiac|cardiac
5763997|NCT00268060|Long QT Syndrome|long qt syndrome
5763998|NCT00268060|Pacemaker|pacemaker
5763999|NCT00268060|Herg mutation|herg mutation
5764000|NCT00268047|pediatric|pediatric
5764001|NCT00268047|cardiac|cardiac
5764002|NCT00268047|surgery|surgery
5764003|NCT00268047|transplantation|transplantation
5764004|NCT00268047|pulmonary vascular resistance in Fontan patients|pulmonary vascular resistance in fontan patients
5764005|NCT00268034|pediatric|pediatric
5764006|NCT00268034|cardiac|cardiac
5764007|NCT00268034|aneurysms|aneurysms
5764008|NCT00268034|left ventricular aneurysms|left ventricular aneurysms
5764009|NCT00268034|surgical repair for LV aneurysms|surgical repair for lv aneurysms
5764010|NCT00268021|pediatric|pediatric
5764011|NCT00268021|biventricular pacemaker|biventricular pacemaker
5764012|NCT00268021|automated implantable cardioverter defibrillator|automated implantable cardioverter defibrillator
5764013|NCT00268021|AICD|aicd
5764014|NCT00268008|aortic valve replacement|aortic valve replacement
5764015|NCT00268008|mitral valve replacement|mitral valve replacement
5764016|NCT00268008|valvular stenosis|valvular stenosis
5764017|NCT00268008|Ross procedure|ross procedure
5764018|NCT00268008|Homograft valves|homograft valves
5764019|NCT00268008|Bio-prosthetic valves|bio-prosthetic valves
5764020|NCT00268008|Mechanical valves|mechanical valves
5764021|NCT00267995|Pediatric|pediatric
5764022|NCT00267995|cardiac|cardiac
5764023|NCT00267995|Ross procedure|ross procedure
5764024|NCT00267995|Aortic valve replacement|aortic valve replacement
5764025|NCT00267995|Proximal buttressing technique|proximal buttressing technique
5764026|NCT00267982|pediatric|pediatric
5764027|NCT00267982|cardiac|cardiac
5764028|NCT00267982|Radiofrequency Ablation|radiofrequency ablation
5764029|NCT00267982|Ectopic Atrial Tachycardia|ectopic atrial tachycardia
5764030|NCT00267969|Ustekinumab|ustekinumab
5764031|NCT00267969|CNTO1275|cnto1275
5764032|NCT00267969|Plaque type Psoriasis|plaque type psoriasis
5764033|NCT00267969|Interleukin-23|interleukin-23
5764034|NCT00267969|IL-23|il-23
5764035|NCT00267969|Psoriasis|psoriasis
5764036|NCT00267969|Interleukin 12|interleukin 12
5764037|NCT00267969|IL-12|il-12
5764038|NCT00267956|Psoriatic arthritis|psoriatic arthritis
5764039|NCT00267956|CNTO 1275|cnto 1275
5764040|NCT00267956|Ustekinumab|ustekinumab
5764041|NCT00267956|Interleukin-23, IL-12, IL-23|interleukin-23, il-12, il-23
5764042|NCT00267956|Monoclonal antibodies|monoclonal antibodies
5764043|NCT00267930|AFib|afib
5764044|NCT00267930|AF|af
5764052|NCT00267891|Healthy Control Subjects|healthy control subjects
5764053|NCT00267891|Aggression|aggression
5764771|NCT00265148|cognition|cognition
5764054|NCT00267891|Prefrontal Cortex Function|prefrontal cortex function
5764055|NCT00267891|Children and Adolescents|children and adolescents
5764056|NCT00267891|Healthy Volunteer|healthy volunteer
5764057|NCT00267891|HV|hv
5764058|NCT00267865|HIV|hiv
5764059|NCT00267865|AIDS-Related-Primary Central Nervous System Lymphoma|aids-related-primary central nervous system lymphoma
5764060|NCT00267865|High Dose Methotrexate|high dose methotrexate
5764061|NCT00267865|Rituximab|rituximab
5764062|NCT00267865|CNS Lymphoma|cns lymphoma
5764063|NCT00267865|AIDS Related-Primary Central Nervous System Lymphoma|aids related-primary central nervous system lymphoma
5764064|NCT00267865|AR-PCNSL|ar-pcnsl
5764065|NCT00267852|Arthritis|arthritis
5764066|NCT00267839|exercise|exercise
5764067|NCT00267839|intervention|intervention
5764068|NCT00267839|elderly woman|elderly woman
5764069|NCT00267839|risk factors|risk factors
5764070|NCT00267839|health costs|health costs
5764071|NCT00267839|Osteoporosis|osteoporosis
5764072|NCT00267839|cardiovascular diseases|cardiovascular diseases
5764074|NCT00267839|Higher Age|higher age
5764075|NCT00267826|Anti-CD20 antibody treatment|anti-cd20 antibody treatment
5764076|NCT00267826|Atopic dermatitis|atopic dermatitis
5764077|NCT00267826|B cells|b cells
5764078|NCT00267826|Cytokines|cytokines
5764079|NCT00267826|Immunopathology|immunopathology
5764080|NCT00267813|craving|craving
5764081|NCT00267813|nicotine|nicotine
5764082|NCT00267813|imaging|imaging
5764084|NCT00267813|PET|pet
5764085|NCT00267813|smoking|smoking
5764086|NCT00267813|Bupropion|bupropion
5764087|NCT00267800|Lung disease, Interstitial|lung disease, interstitial
5764088|NCT00267800|Sarcoidosis|sarcoidosis
5764089|NCT00267800|Pulmonary fibrosis|pulmonary fibrosis
5764090|NCT00267735|pregnancy|pregnancy
5764091|NCT00267735|repeat cesarean|repeat cesarean
5764092|NCT00267735|vaginal birth after cesarean|vaginal birth after cesarean
5764093|NCT00267696|ovarian cancer|ovarian cancer
5764094|NCT00267696|platinum sensitive cancer|platinum sensitive cancer
5764095|NCT00267696|fallopian tube cancer|fallopian tube cancer
5764096|NCT00267696|peritoneal cancer|peritoneal cancer
5764097|NCT00267670|Fatty Liver Disease|fatty liver disease
5764098|NCT00267670|Liver|liver
5764099|NCT00267670|NASH|nash
5764100|NCT00267670|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5764101|NCT00267670|Nonalcoholic Fatty Liver Disease (NAFLD)|nonalcoholic fatty liver disease (nafld)
5764102|NCT00267670|Pentoxifylline|pentoxifylline
5764103|NCT00267644|Children, dehydration, Ultrasound|children, dehydration, ultrasound
5764104|NCT00267631|children, obesity, emergency medicine|children, obesity, emergency medicine
5764105|NCT00267553|Atamestane|atamestane
5764106|NCT00267553|Breast neoplasms|breast neoplasms
5764107|NCT00267553|Combined hormonal therapy|combined hormonal therapy
5764108|NCT00267553|Complete estrogen blockade|complete estrogen blockade
5764109|NCT00267553|Ductal breast carcinoma|ductal breast carcinoma
5764110|NCT00267553|Estrogen blocker|estrogen blocker
5764112|NCT00267553|Femara®|femara®
5764113|NCT00267553|First line therapy|first line therapy
5764114|NCT00267553|Letrozole|letrozole
5764115|NCT00267553|Lobular breast carcinoma|lobular breast carcinoma
5764116|NCT00267553|Locally advanced breast cancer|locally advanced breast cancer
5764117|NCT00267553|Locally recurrent breast cancer|locally recurrent breast cancer
5764118|NCT00267553|Maximal estrogen inhibition|maximal estrogen inhibition
5764119|NCT00267553|Metastatic breast cancer|metastatic breast cancer
5764120|NCT00267553|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
5764121|NCT00267553|Receptor-positive|receptor-positive
5764122|NCT00267553|Stage IIIA breast cancer|stage iiia breast cancer
5764123|NCT00267553|Stage IIIB breast cancer|stage iiib breast cancer
5764124|NCT00267553|Stage IV breast cancer|stage iv breast cancer
5764125|NCT00267553|Toremifene|toremifene
5764126|NCT00267540|Vitamin D|vitamin d
5764127|NCT00267540|adolescent girls|adolescent girls
5764128|NCT00267540|bone accretion|bone accretion
5764129|NCT00267540|bone turn over|bone turn over
5764130|NCT00267540|vitamin D status|vitamin d status
5764131|NCT00267540|Vitamin D insufficiency in young girls|vitamin d insufficiency in young girls
5764132|NCT00267527|Treatment Experienced|treatment experienced
5764133|NCT00267527|HIV Visceral Obesity|hiv visceral obesity
5764134|NCT00267514|Hemodialysis|hemodialysis
5764135|NCT00267501|Eosinophilic Disorders|eosinophilic disorders
5764136|NCT00267488|Hycamtin|hycamtin
5764137|NCT00267488|endometrial cancer|endometrial cancer
5764138|NCT00267488|topotecan|topotecan
5764139|NCT00267475|eosinophilic esophagitis|eosinophilic esophagitis
5764140|NCT00267475|eosinophilic gastritis|eosinophilic gastritis
5764141|NCT00267475|eosinophilic enteritis|eosinophilic enteritis
5764142|NCT00267475|eosinophilic colitis|eosinophilic colitis
5764143|NCT00267475|eosinophilic gastroenteritis|eosinophilic gastroenteritis
5764144|NCT00267462|pediatric|pediatric
5764145|NCT00267462|cardiac|cardiac
5764146|NCT00267462|hypertrophic Myopathy|hypertrophic myopathy
5764147|NCT00267449|Spectroscopy, Near-Infrared|spectroscopy, near-infrared
5764148|NCT00267449|Mammography|mammography
5764149|NCT00267449|Breast Cancer|breast cancer
5764151|NCT00267436|HIV prevention|hiv prevention
5764152|NCT00267436|HIV positive|hiv positive
5764153|NCT00267436|evidence based interventions|evidence based interventions
5764154|NCT00267436|HIV Seronegativity|hiv seronegativity
5764155|NCT00267423|pediatric|pediatric
5764156|NCT00267423|cardiac|cardiac
5764157|NCT00267423|electrophysiology|electrophysiology
5764158|NCT00267423|epicardial biventricular pacing|epicardial biventricular pacing
5764159|NCT00267410|HIV|hiv
5764160|NCT00267410|Adaptation|adaptation
5764161|NCT00267410|Behavioral interventions|behavioral interventions
5764162|NCT00267410|Seropositive|seropositive
5764163|NCT00267410|MSM|msm
5764164|NCT00267410|HIV Seronegativity|hiv seronegativity
5764165|NCT00267397|infant|infant
5764166|NCT00267397|prenatal|prenatal
5764167|NCT00267397|birth defects|birth defects
5764168|NCT00267397|22Q11 deletion|22q11 deletion
5764169|NCT00267384|Aminoglycosides|aminoglycosides
5764170|NCT00267371|Migraine headache|migraine headache
5764171|NCT00267371|Patent Foramen Ovale|patent foramen ovale
5764172|NCT00267371|Patent Foramen Ovale Closure|patent foramen ovale closure
5764173|NCT00267332|Sedation|sedation
5764174|NCT00267332|Pain|pain
5764175|NCT00267332|modafinil|modafinil
5764176|NCT00267332|opioids|opioids
5764177|NCT00267293|fever treatment|fever treatment
5764179|NCT00267241|ARDS|ards
5764180|NCT00267241|ALI|ali
5764181|NCT00267241|respiratory mechanics|respiratory mechanics
5764182|NCT00267241|gas exchange|gas exchange
5764183|NCT00267241|assisted ventilation|assisted ventilation
5764184|NCT00267228|Anorexia Nervosa|anorexia nervosa
5764185|NCT00267228|Eating disorder|eating disorder
5764186|NCT00267228|Quality of life|quality of life
5764187|NCT00267215|Lumiracoxib|lumiracoxib
5764188|NCT00267215|osteoarthritis|osteoarthritis
5764189|NCT00267202|Allergic Asthma, IgE, immunotherapy, omalizumab|allergic asthma, ige, immunotherapy, omalizumab
5764289|NCT00266812|radiotherapy|radiotherapy
5764190|NCT00267189|Liver transplantation, everolimus, calcineurin inhibitor, renal function|liver transplantation, everolimus, calcineurin inhibitor, renal function
5764191|NCT00267176|Osteoarthritis,|osteoarthritis,
5764192|NCT00267176|hypertension,|hypertension,
5764193|NCT00267176|lumiracoxib,|lumiracoxib,
5764194|NCT00267176|ibuprofen,|ibuprofen,
5764195|NCT00267176|24-hour blood pressure profile|24-hour blood pressure profile
5764196|NCT00267163|Alzheimer's disease|alzheimer's disease
5764197|NCT00267163|Mild Cognitive Impairment|mild cognitive impairment
5764198|NCT00267150|Simultaneous Pancreas-Kidney Transplantation|simultaneous pancreas-kidney transplantation
5764199|NCT00267150|mycophenolate|mycophenolate
5764200|NCT00267150|GI problems|gi problems
5764201|NCT00267137|Pacemaker, Atrial Fibrillation/Therapy|pacemaker, atrial fibrillation/therapy
5764202|NCT00267124|cognitive decline|cognitive decline
5764203|NCT00267124|dementia|dementia
5764204|NCT00267124|neuroimaging|neuroimaging
5764205|NCT00267111|Infant,newborn|infant,newborn
5764206|NCT00267111|Topical anesthesia|topical anesthesia
5764207|NCT00267111|Intramuscular injection|intramuscular injection
5764208|NCT00267098|Atrioventricular block|atrioventricular block
5764209|NCT00267098|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5764210|NCT00267098|Pacemaker|pacemaker
5764211|NCT00267098|Defibrillator|defibrillator
5764212|NCT00267098|NYHA Class I, II or III Heart failure|nyha class i, ii or iii heart failure
5764213|NCT00267085|Chronic Myeloid Leukemia|chronic myeloid leukemia
5764214|NCT00267085|Minimal Residual Disease|minimal residual disease
5764215|NCT00267085|Peptide Vaccine|peptide vaccine
5764216|NCT00267072|Ovarian Cancer|ovarian cancer
5764217|NCT00267059|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5764218|NCT00267059|Lenalidomide|lenalidomide
5764219|NCT00267059|Revlimid|revlimid
5764220|NCT00267059|CLL|cll
5764221|NCT00267046|Sarcoma|sarcoma
5764222|NCT00267046|Soft Tissue Sarcoma|soft tissue sarcoma
5764223|NCT00267046|Oral Mucositis|oral mucositis
5772337|NCT00235001|Tarka|tarka
5764224|NCT00267046|Doxorubicin|doxorubicin
5764225|NCT00267046|Adriamycin|adriamycin
5764226|NCT00267046|Ifosfamide|ifosfamide
5764227|NCT00267046|Palifermin|palifermin
5764228|NCT00267046|Vincristine|vincristine
5764229|NCT00267046|Cisplatin|cisplatin
5764230|NCT00267046|Placebo|placebo
5764231|NCT00267033|Neoplasm Metastasis|neoplasm metastasis
5764232|NCT00267033|Bone Neoplasms|bone neoplasms
5764233|NCT00267033|Pain|pain
5764234|NCT00267033|Radiotherapy|radiotherapy
5764235|NCT00267033|Vertebroplasty|vertebroplasty
5764236|NCT00267033|Combined modality therapy|combined modality therapy
5764237|NCT00267007|Peripheral neuropathy|peripheral neuropathy
5764238|NCT00267007|Chemotherapy-induced|chemotherapy-induced
5764239|NCT00267007|Hemoglobin level|hemoglobin level
5764240|NCT00267007|Cancer|cancer
5764241|NCT00267007|Taxane|taxane
5764242|NCT00267007|Platinum-based chemotherapy|platinum-based chemotherapy
5764243|NCT00266994|Thrombosis|thrombosis
5764244|NCT00266968|pediatric|pediatric
5764245|NCT00266968|cardiac|cardiac
5764246|NCT00266968|single ventricle|single ventricle
5764247|NCT00266955|pediatric|pediatric
5764248|NCT00266955|cardiac|cardiac
5764249|NCT00266955|ADHD|adhd
5764250|NCT00266955|Adderall|adderall
5764251|NCT00266955|Straterra|straterra
5764252|NCT00266942|Fontan procedure|fontan procedure
5764253|NCT00266942|single ventricle physiology|single ventricle physiology
5764254|NCT00266942|intra-atrial|intra-atrial
5764255|NCT00266942|extracardiac technique|extracardiac technique
5764256|NCT00266929|odontoid fx|odontoid fx
5764257|NCT00266929|surgical intervention|surgical intervention
5764258|NCT00266929|conservative treatment|conservative treatment
5764259|NCT00266929|nonunion|nonunion
5764260|NCT00266929|odontoid fractures|odontoid fractures
5764261|NCT00266929|surgical treatment|surgical treatment
5764262|NCT00266916|adult|adult
5764263|NCT00266916|congenital heart disease|congenital heart disease
5764264|NCT00266916|percutaneous occlusion|percutaneous occlusion
5764265|NCT00266916|percutaneous balloon valvotomy|percutaneous balloon valvotomy
5764266|NCT00266916|balloon angioplasty|balloon angioplasty
5764267|NCT00266916|complex cyanotic congenital heart defects (CCHD)|complex cyanotic congenital heart defects (cchd)
5764269|NCT00266903|congenital heart disease|congenital heart disease
5764270|NCT00266903|Eisenmenger's Syndrome|eisenmenger's syndrome
5764271|NCT00266903|Bosentan|bosentan
5764272|NCT00266903|Sitaxsetan|sitaxsetan
5764273|NCT00266903|Sildenafil|sildenafil
5764274|NCT00266877|Lung Cancer|lung cancer
5764275|NCT00266877|HKI-272|hki-272
5764277|NCT00266877|Nerlynx|nerlynx
5764278|NCT00266864|Spinal Cord Injury|spinal cord injury
5764279|NCT00266864|Testosterone Replacement Therapy|testosterone replacement therapy
5764280|NCT00266864|Dual Energy X ray Absorptiometry|dual energy x ray absorptiometry
5764281|NCT00266864|Lean Tissue Mass|lean tissue mass
5764282|NCT00266851|Randomized clinical trial|randomized clinical trial
5764283|NCT00266851|Asthma|asthma
5764284|NCT00266851|Adults|adults
5764285|NCT00266851|Azithromycin|azithromycin
5764286|NCT00266838|Lacrimal Obstruction|lacrimal obstruction
5764287|NCT00266838|Epiphora|epiphora
5764288|NCT00266812|temozolomide|temozolomide
5764290|NCT00266773|Chronic Pain|chronic pain
5764291|NCT00266773|Cognitive Therapy|cognitive therapy
5764292|NCT00266773|Cognitive Behavioral Therapy|cognitive behavioral therapy
5764293|NCT00266773|Recurrence|recurrence
5764294|NCT00266773|Relapse Prevention|relapse prevention
5764295|NCT00266773|Educational Technology|educational technology
5764297|NCT00266773|CST|cst
5764298|NCT00266773|IVR|ivr
5764299|NCT00266773|TIVR|tivr
5764300|NCT00266747|Anxiety|anxiety
5764301|NCT00266747|Anti-Anxiety Agents|anti-anxiety agents
5764302|NCT00266747|Controlled Clinical Trial|controlled clinical trial
5764303|NCT00266734|Adenoviral conjunctivitis|adenoviral conjunctivitis
5764304|NCT00266734|Viral conjunctivitis|viral conjunctivitis
5764305|NCT00266734|conjunctivitis|conjunctivitis
5764306|NCT00266721|Pancrelipase|pancrelipase
5764307|NCT00266721|Abdominal bloating|abdominal bloating
5764308|NCT00266721|Abdominal pain|abdominal pain
5764309|NCT00266721|Eructation|eructation
5764310|NCT00266708|renal transplant|renal transplant
5862944|NCT00001453|Petrosal Sinus Sampling|petrosal sinus sampling
5773448|NCT00229554|health surveys|health surveys
5764311|NCT00266708|post-transplant osteoporosis|post-transplant osteoporosis
5764312|NCT00266682|Bradycardia|bradycardia
5764313|NCT00266669|Raynaud's Phenomenon|raynaud's phenomenon
5764314|NCT00266669|Raynaud's Disease|raynaud's disease
5764315|NCT00266669|Scleroderma|scleroderma
5764316|NCT00266669|Raynaud's Disease Secondary to Scleroderma|raynaud's disease secondary to scleroderma
5764317|NCT00266669|Raynaud's Disease Secondary to Other Autoimmune Disease|raynaud's disease secondary to other autoimmune disease
5764318|NCT00266617|Anemia|anemia
5764319|NCT00266617|chemotherapy|chemotherapy
5764320|NCT00266617|epoetin alfa|epoetin alfa
5764321|NCT00266617|epogen|epogen
5764322|NCT00266617|erythropoietin|erythropoietin
5764323|NCT00266617|neoplasms|neoplasms
5764324|NCT00266617|cancer|cancer
5764325|NCT00266604|Epilepsy|epilepsy
5764326|NCT00266604|seizures|seizures
5764327|NCT00266604|new-onset epilepsy|new-onset epilepsy
5764328|NCT00266604|epilepsy relapse|epilepsy relapse
5764329|NCT00266604|epilepsy monotherapy|epilepsy monotherapy
5764330|NCT00266591|Epilepsy|epilepsy
5764331|NCT00266591|Seizures|seizures
5764332|NCT00266591|Topiramate|topiramate
5764333|NCT00266591|Prophylaxis|prophylaxis
5764334|NCT00266591|Antiepileptic|antiepileptic
5764335|NCT00266591|Epileptic seizures|epileptic seizures
5764336|NCT00266591|Partial seizure disorder|partial seizure disorder
5764337|NCT00266591|Brain disease|brain disease
5764338|NCT00266578|Eosinophilic Esophagitis|eosinophilic esophagitis
5764339|NCT00266552|conduct disorder|conduct disorder
5764340|NCT00266552|oppositional defiant disorder|oppositional defiant disorder
5764341|NCT00266552|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
5764342|NCT00266552|ADHD|adhd
5764343|NCT00266552|risperidone|risperidone
5764344|NCT00266552|antipsychotropic agents|antipsychotropic agents
5764345|NCT00266552|children|children
5764346|NCT00266539|Postoperative pain|postoperative pain
5764347|NCT00266539|patient-controlled analgesia|patient-controlled analgesia
5764348|NCT00266526|Allergy|allergy
5764349|NCT00266526|Birch pollen|birch pollen
5764350|NCT00266526|Recombinant|recombinant
5764351|NCT00266513|CD40 Ligand|cd40 ligand
5764352|NCT00266513|Nemo|nemo
5764355|NCT00266513|Ectodermal Dysplasia|ectodermal dysplasia
5764356|NCT00266513|CVID|cvid
5764357|NCT00266513|Hyper-IgM Syndrome|hyper-igm syndrome
5764358|NCT00266513|Primary Immune Deficiency Disorders|primary immune deficiency disorders
5764359|NCT00266513|Common Variable Immune Deficiency|common variable immune deficiency
5764360|NCT00266500|Adipose Tissue|adipose tissue
5764361|NCT00266500|Weight Gain|weight gain
5764362|NCT00266500|Overweight|overweight
5764363|NCT00266500|Thermogenesis|thermogenesis
5764364|NCT00266500|Deep Body Temperature|deep body temperature
5764365|NCT00266500|Adult|adult
5764366|NCT00266500|Exercise|exercise
5764367|NCT00266487|Homocysteine|homocysteine
5764368|NCT00266487|B vitamins|b vitamins
5764369|NCT00266487|Folic acid|folic acid
5764370|NCT00266487|Randomized trial|randomized trial
5764371|NCT00266487|Secondary prevention|secondary prevention
5764372|NCT00266474|Cystic Fibrosis with Chronic Rhinosinusitis|cystic fibrosis with chronic rhinosinusitis
5764373|NCT00266461|Postoperative Ileus|postoperative ileus
5764374|NCT00266448|MRSA|mrsa
5764375|NCT00266448|eradication|eradication
5764376|NCT00266448|chlorhexidine|chlorhexidine
5759675|NCT00284869|LPS|lps
5764377|NCT00266435|Asymptomatic subjects|asymptomatic subjects
5764378|NCT00266435|Moderate to high risk for cardiovascular event|moderate to high risk for cardiovascular event
5764379|NCT00266396|Total Hip Arthroplasty|total hip arthroplasty
5764381|NCT00266396|Total Knee Arthroplasty|total knee arthroplasty
5764382|NCT00266396|TKA|tka
5764383|NCT00266396|Total Hip Replacement|total hip replacement
5764384|NCT00266396|THR|thr
5764385|NCT00266396|Total Knee Replacement|total knee replacement
5764386|NCT00266396|TKR|tkr
5764387|NCT00266331|Breast cancer|breast cancer
5764388|NCT00266331|Radiation skin protection|radiation skin protection
5764389|NCT00266318|Hepatitis C Nonresponder|hepatitis c nonresponder
5764390|NCT00266318|Genotype 1|genotype 1
5764391|NCT00266318|Interferon Alfacon-1|interferon alfacon-1
5764392|NCT00266318|Consensus Interferon|consensus interferon
5764393|NCT00266318|CIFN|cifn
5764394|NCT00266318|Infergen|infergen
5764395|NCT00266318|Ribavirin|ribavirin
5764396|NCT00266305|n-3 LCPUFA|n-3 lcpufa
5764397|NCT00266305|Infant development|infant development
5764398|NCT00266305|Visual acuity|visual acuity
5764399|NCT00266305|Immune function|immune function
5764400|NCT00266305|Breast milk|breast milk
5764401|NCT00266292|Fish oil|fish oil
5764402|NCT00266292|Polyunsaturated fatty acid|polyunsaturated fatty acid
5764403|NCT00266292|Immune function|immune function
5764404|NCT00266292|Endothelial function|endothelial function
5764405|NCT00266292|Cardiovascular risk factors|cardiovascular risk factors
5764406|NCT00266266|Human Papilloma Virus|human papilloma virus
5764407|NCT00266214|lidocaine patch 5%|lidocaine patch 5%
5764408|NCT00266214|Lidoderm|lidoderm
5764409|NCT00266214|carpal tunnel syndrome|carpal tunnel syndrome
5764410|NCT00266214|pain|pain
5773567|NCT00228995|Anemia|anemia
5764411|NCT00266214|nerve compression injury|nerve compression injury
5764412|NCT00266214|topical analgesic|topical analgesic
5764413|NCT00266201|Heart Defects, Congenital|heart defects, congenital
5764414|NCT00266201|Right Ventricular Dysfunction|right ventricular dysfunction
5764415|NCT00266201|Low Cardiac Output|low cardiac output
5764416|NCT00266201|Biochemical markers|biochemical markers
5764417|NCT00266201|Neurohumoral activity|neurohumoral activity
5764418|NCT00266188|Heart Defects, Congenital|heart defects, congenital
5764419|NCT00266188|Tetralogy of Fallot|tetralogy of fallot
5764420|NCT00266188|Heart Septal Defects, Ventricular|heart septal defects, ventricular
5764421|NCT00266188|Pulmonary Valve Diseases|pulmonary valve diseases
5764422|NCT00266188|Magnetic Resonance Imaging|magnetic resonance imaging
5764423|NCT00266188|Heart Catheterization|heart catheterization
5764424|NCT00266188|Echocardiography|echocardiography
5686325|NCT00552565|IBS, IBS-D, R-verapamil, Arverpamil, Rezular|ibs, ibs-d, r-verapamil, arverpamil, rezular
5764425|NCT00266175|Pulmonary heart disease|pulmonary heart disease
5764426|NCT00266175|Pulmonary hypertension|pulmonary hypertension
5764427|NCT00266175|Stent implantation|stent implantation
5764428|NCT00266175|Balloon dilatation|balloon dilatation
5764429|NCT00266175|Surgery|surgery
5764430|NCT00266162|Heart Defects, Congenital|heart defects, congenital
5764431|NCT00266162|Eisenmenger Complex|eisenmenger complex
5764432|NCT00266162|Hypertension, Pulmonary|hypertension, pulmonary
5764433|NCT00266162|Pulmonary Heart Disease|pulmonary heart disease
5764434|NCT00266162|Pulmonary Circulation|pulmonary circulation
5764435|NCT00266162|Vascular Resistance|vascular resistance
5764436|NCT00266149|Pharmacokinetics|pharmacokinetics
5764437|NCT00266149|Lamotrigine|lamotrigine
5764438|NCT00266149|Oral Contraceptives|oral contraceptives
5764439|NCT00266149|UGT|ugt
5764440|NCT00266149|Glucuronidation.|glucuronidation.
5764441|NCT00266136|AML treatment, de-novo, secondary, high-risk MDS, chemotherapy, autologous SCT, adult|aml treatment, de-novo, secondary, high-risk mds, chemotherapy, autologous sct, adult
5764442|NCT00266123|Kidney Failure|kidney failure
5764443|NCT00266123|Kidney Transplant|kidney transplant
5764444|NCT00266110|stage IV breast cancer|stage iv breast cancer
5764445|NCT00266110|recurrent breast cancer|recurrent breast cancer
5764446|NCT00266097|stage III pancreatic cancer|stage iii pancreatic cancer
5764447|NCT00266097|stage IV pancreatic cancer|stage iv pancreatic cancer
5764448|NCT00266097|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5765061|NCT00263627|Allergovit|allergovit
5764449|NCT00266097|unresectable gallbladder cancer|unresectable gallbladder cancer
5764450|NCT00266097|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5764451|NCT00266097|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5764452|NCT00266097|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5764453|NCT00266097|recurrent pancreatic cancer|recurrent pancreatic cancer
5764454|NCT00266097|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5764455|NCT00266097|recurrent gallbladder cancer|recurrent gallbladder cancer
5764457|NCT00266084|Uterus|uterus
5764458|NCT00266084|Dysplasia|dysplasia
5764459|NCT00266084|Cancer|cancer
5764460|NCT00266084|Collector|collector
5764461|NCT00266071|skin|skin
5764462|NCT00266071|pressure|pressure
5764463|NCT00266071|age|age
5764464|NCT00266058|healthy|healthy
5764465|NCT00266058|controls|controls
5764466|NCT00266058|research|research
5764467|NCT00266058|clinical|clinical
5764468|NCT00266058|study|study
5764469|NCT00266058|pharmacokinetic|pharmacokinetic
5764472|NCT00266058|malaria|malaria
5764473|NCT00266045|Deep Vein Thrombosis|deep vein thrombosis
5764474|NCT00266045|Pulmonary Embolism|pulmonary embolism
5764475|NCT00266045|D-dimer|d-dimer
5764476|NCT00266045|Recurrence|recurrence
5764477|NCT00266045|Duration of Anticoagulation|duration of anticoagulation
5764478|NCT00266045|Vitamin K Antagonists|vitamin k antagonists
5764479|NCT00266019|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5764480|NCT00266019|nonalcoholic fatty liver disease|nonalcoholic fatty liver disease
5764481|NCT00266019|Fatty liver|fatty liver
5764482|NCT00266019|Cirrhosis|cirrhosis
5764483|NCT00266019|Obesity|obesity
5764484|NCT00266019|Weight Reduction|weight reduction
5764485|NCT00266019|Weight Management|weight management
5764486|NCT00265980|Leptin|leptin
5764490|NCT00265980|Neuroendocrine|neuroendocrine
5764491|NCT00265941|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5764492|NCT00265941|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5764493|NCT00265941|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5764494|NCT00265941|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5764495|NCT00265941|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5764496|NCT00265941|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5764497|NCT00265928|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5764498|NCT00265928|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5764499|NCT00265928|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5791099|NCT00140309|TB|tb
5773648|NCT00228449|CKD|ckd
5764500|NCT00265928|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5764501|NCT00265928|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5764502|NCT00265928|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5764503|NCT00265928|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5764504|NCT00265928|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5764505|NCT00265928|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5764506|NCT00265928|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5764507|NCT00265928|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5764508|NCT00265915|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5764509|NCT00265915|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5764510|NCT00265915|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5764511|NCT00265915|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5764512|NCT00265915|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5764513|NCT00265915|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5764514|NCT00265915|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5764515|NCT00265902|Kaposi sarcoma|kaposi sarcoma
5764516|NCT00265889|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5764517|NCT00265889|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5764518|NCT00265889|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5764519|NCT00265876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5764520|NCT00265876|stage III pancreatic cancer|stage iii pancreatic cancer
5764521|NCT00265876|recurrent pancreatic cancer|recurrent pancreatic cancer
5764522|NCT00265876|stage IV pancreatic cancer|stage iv pancreatic cancer
5764523|NCT00265863|malignant ascites|malignant ascites
5764524|NCT00265850|recurrent colon cancer|recurrent colon cancer
5764525|NCT00265850|stage III colon cancer|stage iii colon cancer
5764526|NCT00265850|stage III rectal cancer|stage iii rectal cancer
5764527|NCT00265850|stage IV colon cancer|stage iv colon cancer
5764528|NCT00265850|recurrent rectal cancer|recurrent rectal cancer
5764529|NCT00265850|stage IV rectal cancer|stage iv rectal cancer
5764530|NCT00265850|adenocarcinoma of the colon|adenocarcinoma of the colon
5764531|NCT00265850|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5765062|NCT00263601|Allergovit|allergovit
5764533|NCT00265837|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5764534|NCT00265837|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5764535|NCT00265837|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5764536|NCT00265837|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5764537|NCT00265837|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5764538|NCT00265837|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5764539|NCT00265837|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5764540|NCT00265837|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5764541|NCT00265837|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5764542|NCT00265837|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5764543|NCT00265837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5764544|NCT00265837|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5764545|NCT00265837|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5764546|NCT00265837|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5764547|NCT00265837|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5764548|NCT00265837|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5764549|NCT00265837|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5764550|NCT00265837|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5764551|NCT00265837|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5764552|NCT00265837|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5764553|NCT00265837|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5764554|NCT00265837|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5764555|NCT00265837|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5764556|NCT00265837|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5764557|NCT00265837|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5764558|NCT00265837|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5764559|NCT00265837|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5764560|NCT00265837|stage I multiple myeloma|stage i multiple myeloma
5764561|NCT00265837|stage II multiple myeloma|stage ii multiple myeloma
5764562|NCT00265837|stage III multiple myeloma|stage iii multiple myeloma
5764563|NCT00265837|refractory multiple myeloma|refractory multiple myeloma
5764564|NCT00265837|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5764565|NCT00265837|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5764566|NCT00265837|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5764567|NCT00265837|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5764568|NCT00265837|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5764569|NCT00265837|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5764570|NCT00265837|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5764571|NCT00265837|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5764572|NCT00265837|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5686326|NCT00552552|cancer-related fatigue|cancer-related fatigue
5686327|NCT00552552|self-management|self-management
5686328|NCT00552552|patient education|patient education
5764573|NCT00265837|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5764574|NCT00265837|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5764575|NCT00265837|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5764576|NCT00265837|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5764577|NCT00265837|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5764578|NCT00265837|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5764579|NCT00265837|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5764580|NCT00265837|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5764581|NCT00265837|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5764582|NCT00265837|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5764583|NCT00265837|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5764584|NCT00265837|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5764585|NCT00265837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5764586|NCT00265837|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5764587|NCT00265837|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5764588|NCT00265837|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5764589|NCT00265837|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5764590|NCT00265837|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5764591|NCT00265837|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5764592|NCT00265837|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5764593|NCT00265837|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5764594|NCT00265837|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5764595|NCT00265837|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5764596|NCT00265837|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5764597|NCT00265837|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5764598|NCT00265837|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5764599|NCT00265837|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5764600|NCT00265837|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5764601|NCT00265837|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5764602|NCT00265837|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5764603|NCT00265837|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5764604|NCT00265837|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5764605|NCT00265837|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5764606|NCT00265837|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5764607|NCT00265837|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5764608|NCT00265837|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5764609|NCT00265837|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5764610|NCT00265837|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5764611|NCT00265837|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5764612|NCT00265837|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5764613|NCT00265837|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5764614|NCT00265837|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5764615|NCT00265837|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5764616|NCT00265837|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5764617|NCT00265837|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5764618|NCT00265837|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5764619|NCT00265837|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5764620|NCT00265837|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5764621|NCT00265824|stage IV colon cancer|stage iv colon cancer
5764622|NCT00265824|stage IV rectal cancer|stage iv rectal cancer
5764623|NCT00265824|adenocarcinoma of the colon|adenocarcinoma of the colon
5764624|NCT00265824|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5764625|NCT00265824|chemotherapy|chemotherapy
5681026|NCT00575120|Endothelial Function, MRI, Vascular Biology|endothelial function, mri, vascular biology
5681027|NCT00575081|Physiological Brain Atlas, Brain registry, Brain database|physiological brain atlas, brain registry, brain database
5764626|NCT00265811|stage III colon cancer|stage iii colon cancer
5764627|NCT00265811|adenocarcinoma of the colon|adenocarcinoma of the colon
5764628|NCT00265785|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5764629|NCT00265785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5764630|NCT00265785|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5764631|NCT00265785|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5764632|NCT00265772|enteral nutrition|enteral nutrition
5764633|NCT00265772|steroids|steroids
5764634|NCT00265772|mucosal healing|mucosal healing
5764635|NCT00265759|stage II breast cancer|stage ii breast cancer
5764636|NCT00265759|stage IIIA breast cancer|stage iiia breast cancer
5764637|NCT00265759|stage IIIB breast cancer|stage iiib breast cancer
5764638|NCT00265759|stage IIIC breast cancer|stage iiic breast cancer
5764639|NCT00265759|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5764640|NCT00265746|metformin|metformin
5764641|NCT00265746|gestational diabetes|gestational diabetes
5764642|NCT00265746|lifestyle|lifestyle
5764643|NCT00265733|male breast cancer|male breast cancer
5764644|NCT00265733|recurrent breast cancer|recurrent breast cancer
5764645|NCT00265733|stage IV breast cancer|stage iv breast cancer
5764646|NCT00265720|African Americans|african americans
5764647|NCT00265720|Colorectal Cancer Screening|colorectal cancer screening
5764648|NCT00265720|Colorectal Cancer|colorectal cancer
5764649|NCT00265720|Colorectal Cancer and African Americans|colorectal cancer and african americans
5764650|NCT00265720|Cancer Disparities|cancer disparities
5764651|NCT00265707|Hypertension|hypertension
5764652|NCT00265707|Hypotension|hypotension
5764653|NCT00265681|smokeless tobacco cessation|smokeless tobacco cessation
5764654|NCT00265681|chewing tobacco|chewing tobacco
5764655|NCT00265681|oral tobacco|oral tobacco
5764656|NCT00265681|smokeless tobacco|smokeless tobacco
5764657|NCT00265681|telephone|telephone
5764658|NCT00265681|counseling|counseling
5764659|NCT00265642|Hepatitis C, Chronic|hepatitis c, chronic
5764660|NCT00265642|irbesartan|irbesartan
5764661|NCT00265629|Atrial fibrillation|atrial fibrillation
5764662|NCT00265616|Refractory status epilepticus,|refractory status epilepticus,
5764663|NCT00265616|coma-induction,|coma-induction,
5764664|NCT00265616|treatment,|treatment,
5764665|NCT00265616|propofol,|propofol,
5764666|NCT00265616|barbiturates,|barbiturates,
5764669|NCT00265590|Aniridia|aniridia
5764670|NCT00265590|PAX6|pax6
5764671|NCT00265590|Keratopathy|keratopathy
5764672|NCT00265590|Limbal Stem Cell Deficiency|limbal stem cell deficiency
5764673|NCT00265590|Molecular Genetics|molecular genetics
5764674|NCT00265564|outcomes assessment|outcomes assessment
5764675|NCT00265564|substance use disorders|substance use disorders
5764676|NCT00265564|stress disorders, post-traumatic|stress disorders, post-traumatic
5764677|NCT00265564|screening|screening
5764678|NCT00265551|Schizophrenia|schizophrenia
5764679|NCT00265538|Hypertension|hypertension
5764680|NCT00265538|Diuretics|diuretics
5764681|NCT00265538|Drug Therapy|drug therapy
5764682|NCT00265538|Anti-Hypertensive Agents|anti-hypertensive agents
5764683|NCT00265538|Patient Intervention|patient intervention
5764684|NCT00265525|Randomized Control Trial|randomized control trial
5760025|NCT00283439|ICE|ice
5764686|NCT00265525|Prevention|prevention
5764687|NCT00265525|Rehabilitation|rehabilitation
5764688|NCT00265512|Telemedicine|telemedicine
5764689|NCT00265512|Aftercare|aftercare
5764690|NCT00265499|Coronary Artery Bypass|coronary artery bypass
5764691|NCT00265499|Skeletonization|skeletonization
5764692|NCT00265499|Internal Thoracic Artery|internal thoracic artery
5764693|NCT00265499|Flow|flow
5764694|NCT00265499|Length|length
5764695|NCT00265499|Pain|pain
5764696|NCT00265486|Divers|divers
5764697|NCT00265486|Brain|brain
5764698|NCT00265486|Flow|flow
5764699|NCT00265486|Blood|blood
5764700|NCT00265486|EPO|epo
5764701|NCT00265486|Dive|dive
5764702|NCT00265486|reflex|reflex
5764703|NCT00265460|smoking cessation,|smoking cessation,
5764704|NCT00265460|nicotine,|nicotine,
5764705|NCT00265460|smokeless tobacco,|smokeless tobacco,
5764706|NCT00265460|cigarettes|cigarettes
5764707|NCT00265447|knee osteoarthritis|knee osteoarthritis
5764708|NCT00265447|exercise|exercise
5764709|NCT00265447|aerobic exercise|aerobic exercise
5764710|NCT00265447|strengthening exercise|strengthening exercise
5764711|NCT00265447|exercise prescription|exercise prescription
5764712|NCT00265447|rehabilitation|rehabilitation
5764713|NCT00265447|physical disability|physical disability
5764714|NCT00265447|physical function|physical function
5765211|NCT00262977|aspirin|aspirin
5764715|NCT00265447|physical activity|physical activity
5764716|NCT00265447|physical fitness|physical fitness
5764717|NCT00265421|Suture Techniques|suture techniques
5764718|NCT00265408|Cervicocephalic Arterial Dissection|cervicocephalic arterial dissection
5764719|NCT00265382|Adolescent Subjects|adolescent subjects
5764720|NCT00265356|Positron Emission Tomography (PET)|positron emission tomography (pet)
5764721|NCT00265356|Diagnostic Investigation|diagnostic investigation
5764722|NCT00265356|Colorectal cancer|colorectal cancer
5764723|NCT00265356|Liver metastases|liver metastases
5764724|NCT00265356|Liver surgery|liver surgery
5764725|NCT00265330|Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)|children and adolescents with bipolar i disorder (manic or mixed)
5764726|NCT00265317|Non-small cell lung cancer|non-small cell lung cancer
5764727|NCT00265317|sunitinib|sunitinib
5764728|NCT00265317|erlotinib|erlotinib
5764729|NCT00265317|Phase 2|phase 2
5764730|NCT00265304|Osteoarthritis|osteoarthritis
5686329|NCT00552552|cancer survivors|cancer survivors
5763838|NCT00268580|Asthma|asthma
5764731|NCT00265291|Depression|depression
5764732|NCT00265291|mood disorders|mood disorders
5764733|NCT00265291|affective disorders|affective disorders
5764734|NCT00265291|pharmacogenetics|pharmacogenetics
5764735|NCT00265291|pharmacogenomics|pharmacogenomics
5764736|NCT00265265|Cocaine Dependence|cocaine dependence
5764737|NCT00265252|osteonecrosis|osteonecrosis
5764738|NCT00265252|total hip replacement|total hip replacement
5764739|NCT00265239|Edaravone|edaravone
5764740|NCT00265239|Randomized Control Trial|randomized control trial
5764741|NCT00265239|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5764742|NCT00265239|Coronary Angioplasty|coronary angioplasty
5764743|NCT00265226|India|india
5764744|NCT00265226|Pulmonary Tuberculosis|pulmonary tuberculosis
5764745|NCT00265226|Category-II tuberculosis|category-ii tuberculosis
5764746|NCT00265226|Immunomodulator|immunomodulator
5764747|NCT00265226|Mycobacterium w|mycobacterium w
5764748|NCT00265226|Revised National Tuberculosis Control Programme|revised national tuberculosis control programme
5764749|NCT00265226|Category-II Pulmonary Tuberculosis|category-ii pulmonary tuberculosis
5764750|NCT00265213|breast conservative surgery|breast conservative surgery
5764751|NCT00265213|shoulder functional outcome questionnaire|shoulder functional outcome questionnaire
5764752|NCT00265213|disability questionnaire|disability questionnaire
5764753|NCT00265200|Zometa|zometa
5764754|NCT00265200|bone metastasis|bone metastasis
5764755|NCT00265200|lung cancer|lung cancer
5764756|NCT00265200|non-small cell lung cancer|non-small cell lung cancer
5764757|NCT00265200|small cell lung cancer|small cell lung cancer
5764758|NCT00265200|bone metabolic markers|bone metabolic markers
5764759|NCT00265200|tartrate resistant acid phosphatase|tartrate resistant acid phosphatase
5764760|NCT00265187|child, bronchiolitis,|child, bronchiolitis,
5764761|NCT00265174|SERUM DNA|serum dna
5764762|NCT00265174|LOH|loh
5764763|NCT00265174|METHYLATION|methylation
5764764|NCT00265174|GLIOMA|glioma
5764766|NCT00265161|influenza vaccine|influenza vaccine
5764767|NCT00265161|effectiveness|effectiveness
5764768|NCT00265161|health care worker|health care worker
5764769|NCT00265161|OBSERVATIONAL STUDY|observational study
5764770|NCT00265148|rosiglitazone|rosiglitazone
5764772|NCT00265148|cerebral glucose metabolism|cerebral glucose metabolism
5764773|NCT00265148|positron emission tomography (PET)|positron emission tomography (pet)
5764774|NCT00265148|Alzheimer's Disease|alzheimer's disease
5764775|NCT00265135|Renal cell carcinoma|renal cell carcinoma
5764776|NCT00265135|CNTO 328|cnto 328
5764777|NCT00265135|Infusions|infusions
5764778|NCT00265135|Renal cell cancer|renal cell cancer
5764779|NCT00265122|Crohn Disease|crohn disease
5764780|NCT00265122|Biologic|biologic
5764781|NCT00265122|Infusion|infusion
5764782|NCT00265122|Injection|injection
5764783|NCT00265122|CNTO 1275|cnto 1275
5764784|NCT00265122|Ustekinumab|ustekinumab
5764786|NCT00265122|IL-12p40|il-12p40
5764787|NCT00265109|body dysmorphic disorder|body dysmorphic disorder
5764788|NCT00265109|levetiracetam|levetiracetam
5764789|NCT00265096|Psoriatic Arthritis|psoriatic arthritis
5764790|NCT00265096|Spondyloarthritis|spondyloarthritis
5764791|NCT00265096|Spondyloarthropathy|spondyloarthropathy
5764792|NCT00265096|subcutaneous injection|subcutaneous injection
5764793|NCT00265083|Spondylitis|spondylitis
5764794|NCT00265083|subcutaneous injection|subcutaneous injection
5764795|NCT00265083|Bechterew's Disease|bechterew's disease
5764796|NCT00265083|Spondyloarthritis|spondyloarthritis
5764797|NCT00265083|Spondyloarthropathy|spondyloarthropathy
5764798|NCT00265057|Cancer;|cancer;
5764799|NCT00265057|Tumors;|tumors;
5764800|NCT00265057|Neoplasms;|neoplasms;
5764801|NCT00265057|Anticarcinogenic Agents;|anticarcinogenic agents;
5764802|NCT00265057|Antineoplastic Agents;|antineoplastic agents;
5764803|NCT00265057|Cadherins;|cadherins;
5764804|NCT00265057|Non-Small-Cell Lung Carcinoma;|non-small-cell lung carcinoma;
5764805|NCT00265057|Ovarian Cancer|ovarian cancer
5764806|NCT00265044|Behavior Change|behavior change
5764807|NCT00265044|patient Education|patient education
5764808|NCT00265031|Hodgkin´s Lymphoma|hodgkin´s lymphoma
5764809|NCT00265031|advanced stages|advanced stages
5764810|NCT00265018|Hodgkin´s lymphoma|hodgkin´s lymphoma
5764811|NCT00265018|early stages|early stages
5764812|NCT00265005|alteplase|alteplase
5765304|NCT00262548|Menopause|menopause
5764813|NCT00265005|occluded central venous catheter|occluded central venous catheter
5764814|NCT00265005|occluded arterial catheter|occluded arterial catheter
5764815|NCT00265005|occluded PICC|occluded picc
5764816|NCT00265005|neonates|neonates
5764817|NCT00265005|infants|infants
5764818|NCT00264992|embryo implantation, in vitro fertilization,|embryo implantation, in vitro fertilization,
5764819|NCT00264992|cytokine expression|cytokine expression
5764820|NCT00264979|Colorectal cancer|colorectal cancer
5764821|NCT00264979|Sequential or simultaneous surgery|sequential or simultaneous surgery
5764822|NCT00264979|Synchronous hepatic metastases|synchronous hepatic metastases
5764823|NCT00264966|Mild asthma|mild asthma
5764824|NCT00264953|Hodgkin´s lymphoma|hodgkin´s lymphoma
5764825|NCT00264953|intermediate stages|intermediate stages
5764826|NCT00264927|Inappropriate ADH Syndrome|inappropriate adh syndrome
5764827|NCT00264927|Hyponatremia|hyponatremia
5764828|NCT00264914|Inappropriate ADH Syndrome|inappropriate adh syndrome
5764829|NCT00264914|Hyponatremia|hyponatremia
5764830|NCT00264888|Duchenne muscular dystrophy|duchenne muscular dystrophy
5764831|NCT00264888|Nonsense mutation|nonsense mutation
5764832|NCT00264888|Premature stop codon|premature stop codon
5764833|NCT00264849|Asthma|asthma
5764834|NCT00264849|omalizumab|omalizumab
5764835|NCT00264849|Severe persistent allergic asthma|severe persistent allergic asthma
5764837|NCT00264823|Mental Illness|mental illness
5764838|NCT00264810|Responsive Stimulation|responsive stimulation
5764839|NCT00264810|Brain Stimulator|brain stimulator
5764840|NCT00264810|Epilepsy|epilepsy
5764841|NCT00264810|Seizures|seizures
5764842|NCT00264784|Streptococcus, Group A, Fiji, epidemiology|streptococcus, group a, fiji, epidemiology
5764843|NCT00264771|Fiji, Group A streptococcus, rheumatic, glomerulonephritis|fiji, group a streptococcus, rheumatic, glomerulonephritis
5764844|NCT00264758|randomized controlled clinical trial|randomized controlled clinical trial
5764845|NCT00264758|hemodialysis|hemodialysis
5764846|NCT00264758|end stage renal disease|end stage renal disease
5764847|NCT00264745|Caregiver|caregiver
5764848|NCT00264745|Stroke|stroke
5764849|NCT00264732|cervical lesions|cervical lesions
5764850|NCT00264732|cervical dysplasia|cervical dysplasia
5764851|NCT00264732|Human papilloma virus|human papilloma virus
5764852|NCT00264732|abnormal Pap|abnormal pap
5764853|NCT00264732|High-grade cervical intraepithelial lesions (CIN 2/3)|high-grade cervical intraepithelial lesions (cin 2/3)
5764854|NCT00264719|A drug is administered to initiate breastfeeding|a drug is administered to initiate breastfeeding
5764855|NCT00264680|quality of life|quality of life
5764856|NCT00264680|qolie-10|qolie-10
5764857|NCT00264680|epilepsy|epilepsy
5764858|NCT00264680|lamotrigine|lamotrigine
5764859|NCT00264680|Validation of questionnaire|validation of questionnaire
5764860|NCT00264667|Dyslipidaemia|dyslipidaemia
5764862|NCT00264654|(SAD)|(sad)
5764863|NCT00264654|Anxiety|anxiety
5764864|NCT00264654|Disorder|disorder
5764865|NCT00264641|Hypoglycemia|hypoglycemia
5764866|NCT00264641|Cognitive impairment|cognitive impairment
5764867|NCT00264641|PET|pet
5764868|NCT00264641|CalCAP|calcap
5764869|NCT00264628|NK1-antagonist|nk1-antagonist
5764870|NCT00264628|Depression|depression
5764871|NCT00264628|Fibromyalgia|fibromyalgia
5764872|NCT00264628|GW679769|gw679769
5764873|NCT00264628|Outpatient|outpatient
5764874|NCT00264615|once daily dosing|once daily dosing
5764875|NCT00264615|seizure|seizure
5764876|NCT00264615|pharmacokinetics|pharmacokinetics
5764877|NCT00264615|epilepsy|epilepsy
5764878|NCT00264602|Lymphatic mapping|lymphatic mapping
5764879|NCT00264602|nodal targeting|nodal targeting
5764880|NCT00264602|indocyanine green|indocyanine green
5764881|NCT00264602|near infrared imaging|near infrared imaging
5764882|NCT00264589|vascular function|vascular function
5764883|NCT00264589|cardiac function|cardiac function
5764884|NCT00264589|individualized training|individualized training
5764885|NCT00264589|ultrasonography|ultrasonography
5764886|NCT00264589|body composition|body composition
5764887|NCT00264576|influenza|influenza
5764888|NCT00264576|flu|flu
5764889|NCT00264550|Rheumatoid Arthritis|rheumatoid arthritis
5764890|NCT00264550|Golimumab|golimumab
5764891|NCT00264550|Methotrexate|methotrexate
5764892|NCT00264550|Fully Human anti-TNFa monoclonal antibody|fully human anti-tnfa monoclonal antibody
5764893|NCT00264550|Simpony|simpony
5764894|NCT00264537|Rheumatoid Arthritis|rheumatoid arthritis
5764895|NCT00264537|Methotrexate Naïve|methotrexate naïve
5764896|NCT00264537|subcutaneous injection|subcutaneous injection
5764897|NCT00264524|Rheumatic heart disease, HLA, Genetics, Taiwan|rheumatic heart disease, hla, genetics, taiwan
5764898|NCT00264511|Hyperbaric oxygen|hyperbaric oxygen
5764899|NCT00264511|Crush injury|crush injury
5764900|NCT00264511|Tibial fracture|tibial fracture
5764901|NCT00264511|Gustillo 3|gustillo 3
5764902|NCT00264511|soft tissue injury|soft tissue injury
5764903|NCT00264511|complications|complications
5764904|NCT00264511|outcomes|outcomes
5764905|NCT00264511|randomised controlled trial|randomised controlled trial
5764906|NCT00264498|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5764907|NCT00264498|NSCLC|nsclc
5764908|NCT00264498|Lung Cancer|lung cancer
5764909|NCT00264485|Postoperative pain|postoperative pain
5764910|NCT00264485|patient-controlled analgesia|patient-controlled analgesia
5764911|NCT00264472|Cancer|cancer
5764912|NCT00264472|Tumors|tumors
5764913|NCT00264472|Neoplasms|neoplasms
5764914|NCT00264472|Anticarcinogenic Agents|anticarcinogenic agents
5764915|NCT00264472|Antineoplastic Agents|antineoplastic agents
5764916|NCT00264472|Dihydrouracil Dehydrogenase (NADP)|dihydrouracil dehydrogenase (nadp)
5764917|NCT00264459|Sublingual immunotherapy|sublingual immunotherapy
5764918|NCT00264459|Rhinoconjunctivitis|rhinoconjunctivitis
5764919|NCT00264459|Rhinitis|rhinitis
5764921|NCT00264446|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents;|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents;
5764922|NCT00264446|Dihydrouracil dehydrogenase (NADP); Colorectal Carcinoma; Liver Cancer|dihydrouracil dehydrogenase (nadp); colorectal carcinoma; liver cancer
5773135|NCT00230997|Treatment|treatment
5764923|NCT00264433|Cancer; Tumors; Neoplasms; Anticarcinogenic Agents; Antineoplastic Agents|cancer; tumors; neoplasms; anticarcinogenic agents; antineoplastic agents
5764924|NCT00264433|Cadherins; Non-Small-Cell Lung Carcinoma; Esophageal Cancer; Gastric Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Adrenocortical Carcinoma|cadherins; non-small-cell lung carcinoma; esophageal cancer; gastric cancer; renal cell carcinoma; hepatocellular carcinoma; adrenocortical carcinoma
5764925|NCT00264420|bone metastases|bone metastases
5764926|NCT00264420|breast cancer|breast cancer
5764927|NCT00264420|lung cancer|lung cancer
5764928|NCT00264420|prostate cancer|prostate cancer
5764929|NCT00264420|zoledronic acid|zoledronic acid
5764930|NCT00264420|radiation therapy|radiation therapy
5764931|NCT00264407|Hearing Loss, Central|hearing loss, central
5764932|NCT00264407|Presbycusis|presbycusis
5764933|NCT00264407|Hearing Loss, Sensorineural|hearing loss, sensorineural
5764934|NCT00264407|Hearing Loss, Cochlear|hearing loss, cochlear
5764935|NCT00264407|Hearing Loss, Bilateral|hearing loss, bilateral
5764936|NCT00264407|Sex Steroid Hormones|sex steroid hormones
5764937|NCT00264407|Estradiol|estradiol
5764938|NCT00264394|Computer generated reminder system|computer generated reminder system
5764939|NCT00264394|quality control|quality control
5764940|NCT00264394|dyslipidemia|dyslipidemia
5764941|NCT00264394|antiretroviral therapy|antiretroviral therapy
5764942|NCT00264394|HIV infection|hiv infection
5764943|NCT00264381|Superficial Thrombophlebitis|superficial thrombophlebitis
5764945|NCT00264381|Fragmin|fragmin
5764946|NCT00264381|Ibuprofen|ibuprofen
5764947|NCT00264381|Superficial Thrombus|superficial thrombus
5764948|NCT00264381|Superficial Phlebitis|superficial phlebitis
5764949|NCT00264381|phlebitis|phlebitis
5764950|NCT00264368|Renal replacement therapy|renal replacement therapy
5764951|NCT00264368|CMV disease|cmv disease
5764952|NCT00264355|cyclosporine|cyclosporine
5764953|NCT00264355|metabolites|metabolites
5764954|NCT00264355|metabolic pattern|metabolic pattern
5764955|NCT00264355|genotypes|genotypes
5764956|NCT00264342|Smoking|smoking
5764957|NCT00264342|Tobacco|tobacco
5764958|NCT00264342|Nicotine|nicotine
5764959|NCT00264316|bone marrow cell transfer|bone marrow cell transfer
5764960|NCT00264316|acute myocardial infarction|acute myocardial infarction
5764961|NCT00264316|left ventricular function|left ventricular function
5764962|NCT00264303|Chronic Idiopathic Urticaria|chronic idiopathic urticaria
5764963|NCT00264303|CUTE Levocetirizine Xyzal®|cute levocetirizine xyzal®
5764964|NCT00264290|HIV|hiv
5764965|NCT00264290|CMV|cmv
5764966|NCT00264290|T Cell activation|t cell activation
5764967|NCT00264290|Valganciclovir|valganciclovir
5764968|NCT00264277|D-dimer|d-dimer
5764969|NCT00264277|Recurrence|recurrence
5764970|NCT00264277|Venous Thromboembolism|venous thromboembolism
5764971|NCT00264277|Anticoagulation|anticoagulation
5764972|NCT00264277|Duration|duration
5764973|NCT00264264|Closure device|closure device
5764974|NCT00264264|Stenting|stenting
5764975|NCT00264264|Percutaneous coronary intervention|percutaneous coronary intervention
5764976|NCT00264251|HIV|hiv
5764977|NCT00264251|Body composition|body composition
5764978|NCT00264251|Weight reduction|weight reduction
5764979|NCT00264251|Insulin resistance/sensitivity|insulin resistance/sensitivity
5764980|NCT00264251|Exercise|exercise
5764981|NCT00264251|Diet|diet
5764982|NCT00264251|Visceral adiposity|visceral adiposity
5764983|NCT00264225|osteoarthritis, pain|osteoarthritis, pain
5764984|NCT00264199|Chronic Congestive heart failure|chronic congestive heart failure
5764985|NCT00264199|Ischemic heart disease|ischemic heart disease
5764986|NCT00264199|insulin resistance|insulin resistance
5764987|NCT00264160|AMN107|amn107
5764988|NCT00264160|CML|cml
5764989|NCT00264160|Bcr Abl|bcr abl
5764990|NCT00264160|cytogenetic response|cytogenetic response
5764991|NCT00264160|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5764992|NCT00264160|imatinib mesylate|imatinib mesylate
5764993|NCT00264147|Arcoxia|arcoxia
5764994|NCT00264134|Non-Small Cell Lung Cancer|non-small cell lung cancer
5764995|NCT00264121|congenital, high scrotal|congenital, high scrotal
5764996|NCT00264108|Antineoplastic agents|antineoplastic agents
5764997|NCT00264108|Chemotherapy|chemotherapy
5764998|NCT00264108|Cost-effectiveness|cost-effectiveness
5764999|NCT00264108|Epoetin alfa|epoetin alfa
5765000|NCT00264108|Darbepoetin alfa|darbepoetin alfa
5765001|NCT00264095|Anemia|anemia
5765002|NCT00264095|Blood loss|blood loss
5765004|NCT00264095|Blood transfusion|blood transfusion
5765005|NCT00264095|Erythropoietin|erythropoietin
5765006|NCT00264095|Surgery|surgery
5774229|NCT00225654|stent|stent
5765007|NCT00264095|Surgical blood loss|surgical blood loss
5765008|NCT00264095|Tumor|tumor
5765009|NCT00264095|Cancer|cancer
5765010|NCT00264095|Surgical resection|surgical resection
5765011|NCT00264095|Tumor resection|tumor resection
5765012|NCT00264069|Adherence|adherence
5765013|NCT00264069|Compliance|compliance
5765014|NCT00264069|Schizophrenia|schizophrenia
5765015|NCT00264069|Bipolar Disorder|bipolar disorder
5765016|NCT00264069|Depression|depression
5765017|NCT00264069|Personality Disorders|personality disorders
5765018|NCT00264069|Registry|registry
5764111|NCT00267553|Fareston®|fareston®
5765019|NCT00264056|malignant melanoma|malignant melanoma
5765020|NCT00264056|hyperthermia|hyperthermia
5765021|NCT00264056|chemotherapy|chemotherapy
5765022|NCT00264004|Advanced Solid Tumours|advanced solid tumours
5765023|NCT00264004|phase II|phase ii
5765024|NCT00264004|Hypertension|hypertension
5765025|NCT00264004|RECENTIN|recentin
5765026|NCT00263978|Venous occlusive disease|venous occlusive disease
5765027|NCT00263978|VOD|vod
5765028|NCT00263952|Bee venom allergy|bee venom allergy
5765029|NCT00263952|Specific immunotherapy|specific immunotherapy
5765030|NCT00263939|chronic disease|chronic disease
5765031|NCT00263939|patient education|patient education
5765032|NCT00263939|self-efficacy|self-efficacy
5765033|NCT00263939|self-management|self-management
5765034|NCT00263926|Wasp venom allergy,|wasp venom allergy,
5765035|NCT00263926|specific immunotherapy|specific immunotherapy
5765036|NCT00263900|Influenza A|influenza a
5765037|NCT00263900|Influenza B|influenza b
5765038|NCT00263900|RSV|rsv
5765039|NCT00263887|alpha 1 proteinase inhibitor|alpha 1 proteinase inhibitor
5765040|NCT00263887|alpha1 proteinase inhibitor|alpha1 proteinase inhibitor
5765041|NCT00263887|congenital emphysema|congenital emphysema
5765042|NCT00263887|replacement therapy|replacement therapy
5765043|NCT00263861|neurotoxicity|neurotoxicity
5765044|NCT00263861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5765045|NCT00263822|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5765046|NCT00263822|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5765047|NCT00263822|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5765048|NCT00263822|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5765049|NCT00263822|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5765050|NCT00263822|fallopian tube cancer|fallopian tube cancer
5765051|NCT00263731|lung cancer|lung cancer
5765052|NCT00263731|non-small cell lung cancer|non-small cell lung cancer
5765053|NCT00263731|small cell lung cancer|small cell lung cancer
5765054|NCT00263731|cancer metabolism|cancer metabolism
5765055|NCT00263640|House dust mite|house dust mite
5765056|NCT00263640|Bronchial Asthma|bronchial asthma
5765057|NCT00263640|Allergy|allergy
5765058|NCT00263640|House Dust Mite Allergy|house dust mite allergy
5765059|NCT00263627|specific immunotherapy|specific immunotherapy
5765060|NCT00263627|birch pollen allergy|birch pollen allergy
5765063|NCT00263601|Grass pollen allergy|grass pollen allergy
5765064|NCT00263588|breast cancer|breast cancer
5765065|NCT00263588|brain metastases|brain metastases
5765066|NCT00263588|ErbB2 positive|erbb2 positive
5765067|NCT00263588|HER2 positive|her2 positive
5765068|NCT00263588|neoplasms|neoplasms
5765069|NCT00263588|cancer|cancer
5765070|NCT00263588|lapatinib|lapatinib
5765071|NCT00263588|LAP016A2202|lap016a2202
5765072|NCT00263588|LAP016A|lap016a
5765073|NCT00263588|CLAP016A2202|clap016a2202
5765074|NCT00263588|GW572016|gw572016
5765075|NCT00263575|EN3267|en3267
5765076|NCT00263575|Breakthrough Pain|breakthrough pain
5765077|NCT00263575|Safety Study|safety study
5765078|NCT00263575|Fentanyl Tablets|fentanyl tablets
5765079|NCT00263562|Sickle cell disease|sickle cell disease
5765080|NCT00263562|vaso-occlusive crisis|vaso-occlusive crisis
5765081|NCT00263562|steroid treatment|steroid treatment
5765082|NCT00263549|House dust mite,|house dust mite,
5765084|NCT00263536|Obesity|obesity
5765085|NCT00263536|Adiposity|adiposity
5765086|NCT00263536|Binge Eating|binge eating
5765087|NCT00263536|Social Functioning|social functioning
5765088|NCT00263536|Eating Disorders|eating disorders
5765089|NCT00263536|Prevention|prevention
5765090|NCT00263536|Adolescence|adolescence
5765091|NCT00263536|Adolescent Weight Gain|adolescent weight gain
5765092|NCT00263536|Overweight|overweight
5765093|NCT00263523|Serotonin|serotonin
5765094|NCT00263523|Positron Emission Tomograhy|positron emission tomograhy
5765095|NCT00263523|Brain|brain
5765096|NCT00263523|Neurochemistry|neurochemistry
5765097|NCT00263523|Neurotransmitter|neurotransmitter
5765098|NCT00263523|Healthy Volunteer|healthy volunteer
5765100|NCT00263497|Postinjury chronic pain|postinjury chronic pain
5765101|NCT00263497|Transtibial amputation|transtibial amputation
5765102|NCT00263497|Physical rehabilitation|physical rehabilitation
5765103|NCT00263497|Immediate temporary prosthesis|immediate temporary prosthesis
5765104|NCT00263484|Steroids, Fluorinated|steroids, fluorinated
5765105|NCT00263484|Thalidomide|thalidomide
5765106|NCT00263484|Bisphosphonates|bisphosphonates
5765108|NCT00263458|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5681029|NCT00575042|Primary Biliary Cirrhosis|primary biliary cirrhosis
5681030|NCT00575042|Fenofibrate|fenofibrate
5681031|NCT00575042|Triglide|triglide
5765109|NCT00263458|buprenorphine|buprenorphine
5765110|NCT00263458|opioid dependence|opioid dependence
5765111|NCT00263458|opioid-related disorders|opioid-related disorders
5765112|NCT00263458|integrated care|integrated care
5765113|NCT00263458|primary care|primary care
5765114|NCT00263445|Growth hormone dosing|growth hormone dosing
5765115|NCT00263445|IGF-I|igf-i
5765116|NCT00263419|Diabetes Type 2|diabetes type 2
5765117|NCT00263419|Late Complications|late complications
5765118|NCT00263419|Stress relief management|stress relief management
5765119|NCT00263419|psychosocial stress|psychosocial stress
5765120|NCT00263393|Myocardial Infarction|myocardial infarction
5765121|NCT00263393|Angina Pectoris|angina pectoris
5765122|NCT00263393|Cerebrovascular Accident|cerebrovascular accident
5765123|NCT00263393|Diabetes Mellitus|diabetes mellitus
5765124|NCT00263393|Cluster randomized design|cluster randomized design
5765125|NCT00263393|Community-based intervention trial|community-based intervention trial
5765126|NCT00263393|Primary Healthcare intervention|primary healthcare intervention
5765127|NCT00263393|Lifestyle advice|lifestyle advice
5765128|NCT00263380|COPD|copd
5765129|NCT00263380|cytokines|cytokines
5765130|NCT00263380|corticosteroids|corticosteroids
5765131|NCT00263380|beta agonists|beta agonists
5765132|NCT00263380|synergistic effect|synergistic effect
5765133|NCT00263367|Autism|autism
5765134|NCT00263367|Oxidative Stress|oxidative stress
5765135|NCT00263367|Hyperbaric Oxygen|hyperbaric oxygen
5765136|NCT00263367|Reduced Glutathione|reduced glutathione
5765137|NCT00263367|Lipid Peroxides|lipid peroxides
5765138|NCT00263341|Contraceptive agents|contraceptive agents
5765139|NCT00263341|Female contraception|female contraception
5765140|NCT00263341|Progestins|progestins
5765141|NCT00263328|immunosuppression|immunosuppression
5765142|NCT00263328|JAK3 inhibitor|jak3 inhibitor
5765143|NCT00263328|kidney transplant|kidney transplant
5765144|NCT00263328|tofacitinib|tofacitinib
5765145|NCT00263328|Xeljanz|xeljanz
5765146|NCT00263328|CP-690|cp-690
5765148|NCT00263328|tacromilus|tacromilus
5765149|NCT00263328|mycophenolate mofetil|mycophenolate mofetil
5765150|NCT00263315|aspergillosis|aspergillosis
5765151|NCT00263315|mycosis|mycosis
5765152|NCT00263315|neutropenia|neutropenia
5765153|NCT00263315|primary prevention|primary prevention
5765154|NCT00263315|hematologic diseases|hematologic diseases
5765155|NCT00263315|amphotericin B|amphotericin b
5765156|NCT00263315|AmBisome|ambisome
5765157|NCT00263315|liposomal amphotericin B|liposomal amphotericin b
5765158|NCT00263302|dexamethasone, diuretic, congestive heart failure|dexamethasone, diuretic, congestive heart failure
5765159|NCT00263250|inguinal hernia|inguinal hernia
5765161|NCT00263250|watchful waiting|watchful waiting
5765162|NCT00263250|tension-free hernia repair|tension-free hernia repair
5765163|NCT00263237|T Cell|t cell
5765164|NCT00263237|Lymphocyte|lymphocyte
5765168|NCT00263237|Common Variable Immunodeficiency|common variable immunodeficiency
5765169|NCT00263237|CVID|cvid
5765170|NCT00263237|Gastrointestinal Inflammation|gastrointestinal inflammation
5765171|NCT00263211|Breast Cancer|breast cancer
5765172|NCT00263211|Metastatic|metastatic
5765173|NCT00263211|Platelet|platelet
5765174|NCT00263172|internet|internet
5765175|NCT00263172|weight management|weight management
5765176|NCT00263172|behavior therapy|behavior therapy
5765177|NCT00263172|self-help|self-help
5765178|NCT00263172|commercial program|commercial program
5765179|NCT00263172|obesity|obesity
5765180|NCT00263133|Depression|depression
5765181|NCT00263133|SSRI|ssri
5765182|NCT00263133|Sertraline|sertraline
5765184|NCT00263133|visually evoked potentials|visually evoked potentials
5765185|NCT00263107|telerounding|telerounding
5765186|NCT00263107|minimally invasive surgery|minimally invasive surgery
5765187|NCT00263094|Fasting|fasting
5765188|NCT00263094|Headache|headache
5765189|NCT00263094|Cox 2 Inhibitors|cox 2 inhibitors
5765190|NCT00263094|Pain|pain
5765191|NCT00263094|Prophylaxis|prophylaxis
5765192|NCT00263081|Hyperlipidemia|hyperlipidemia
5765193|NCT00263081|Dyslipidemia|dyslipidemia
5765194|NCT00263081|Drug Therapy|drug therapy
5765195|NCT00263068|IDIOPATHIC RESTLESS LEGS SYNDROME|idiopathic restless legs syndrome
5765196|NCT00263042|Myocardial infarction|myocardial infarction
5765197|NCT00263042|cerebrovascular accident|cerebrovascular accident
5765198|NCT00263042|obesity|obesity
5765199|NCT00262990|Epithelial ovarian cancer|epithelial ovarian cancer
5765200|NCT00262990|fallopian tube cancer|fallopian tube cancer
5765201|NCT00262990|peritoneal cancer|peritoneal cancer
5765202|NCT00262990|primary cancer|primary cancer
5765203|NCT00262990|recurrent cancer|recurrent cancer
5765204|NCT00262990|doxorubicin|doxorubicin
5765205|NCT00262990|taxane chemotherapy|taxane chemotherapy
5765206|NCT00262990|platinum chemotherapy|platinum chemotherapy
5765207|NCT00262990|Patupilone|patupilone
5765208|NCT00262990|taxane platinum resistant|taxane platinum resistant
5765209|NCT00262977|diabetes mellitus|diabetes mellitus
5765210|NCT00262977|cardiovascular diseases|cardiovascular diseases
5765212|NCT00262977|quality of healthcare|quality of healthcare
5765213|NCT00262964|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5765214|NCT00262964|obesity|obesity
5765215|NCT00262964|fatty liver disease|fatty liver disease
5765216|NCT00262951|stage I pancreatic cancer|stage i pancreatic cancer
5765217|NCT00262951|stage II pancreatic cancer|stage ii pancreatic cancer
5765218|NCT00262951|stage III pancreatic cancer|stage iii pancreatic cancer
5765219|NCT00262951|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5765220|NCT00262938|stage I endometrial carcinoma|stage i endometrial carcinoma
5765221|NCT00262938|stage II endometrial carcinoma|stage ii endometrial carcinoma
5686330|NCT00552552|chronic disease|chronic disease
5765222|NCT00262938|weight changes|weight changes
5765223|NCT00262925|MOAD|moad
5765224|NCT00262925|Methotrexate|methotrexate
5765225|NCT00262925|Vincristine|vincristine
5765226|NCT00262925|L-asparaginase|l-asparaginase
5765227|NCT00262925|Dexamethasone|dexamethasone
5765228|NCT00262925|Subcutaneous Campath|subcutaneous campath
5765229|NCT00262899|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5765230|NCT00262899|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5765231|NCT00262899|breast cancer in situ|breast cancer in situ
5765232|NCT00262899|stage IA breast cancer|stage ia breast cancer
5765233|NCT00262899|stage IB breast cancer|stage ib breast cancer
5765234|NCT00262899|stage II breast cancer|stage ii breast cancer
5765235|NCT00262899|stage IIIA breast cancer|stage iiia breast cancer
5765236|NCT00262886|recurrent renal cell cancer|recurrent renal cell cancer
5765237|NCT00262886|stage IV renal cell cancer|stage iv renal cell cancer
5765238|NCT00262873|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5765239|NCT00262873|refractory anemia with excess blasts|refractory anemia with excess blasts
5765240|NCT00262873|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5765241|NCT00262873|refractory anemia|refractory anemia
5765242|NCT00262873|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5765243|NCT00262873|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5765244|NCT00262860|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5765245|NCT00262808|stage II colon cancer|stage ii colon cancer
5765246|NCT00262808|stage III colon cancer|stage iii colon cancer
5765247|NCT00262808|adenocarcinoma of the colon|adenocarcinoma of the colon
5765248|NCT00262795|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5765249|NCT00262795|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5765250|NCT00262795|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5765251|NCT00262795|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5765252|NCT00262795|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5765258|NCT00262769|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5765259|NCT00262769|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5765260|NCT00262769|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5765262|NCT00262769|unresectable gallbladder cancer|unresectable gallbladder cancer
5765263|NCT00262769|metastatic extrahepatic bile duct cancer|metastatic extrahepatic bile duct cancer
5765264|NCT00262769|metastatic gallbladder cancer|metastatic gallbladder cancer
5765265|NCT00262743|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5765266|NCT00262743|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5765267|NCT00262743|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5765268|NCT00262743|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5765269|NCT00262730|adult glioblastoma|adult glioblastoma
5765270|NCT00262730|adult giant cell glioblastoma|adult giant cell glioblastoma
5765271|NCT00262730|adult gliosarcoma|adult gliosarcoma
5765272|NCT00262717|HIV drug resistance testing|hiv drug resistance testing
5765273|NCT00262717|Treatment Experienced|treatment experienced
5765274|NCT00262704|physician intervention|physician intervention
5765275|NCT00262704|diabetes mellitus|diabetes mellitus
5765276|NCT00262704|primary care|primary care
5765277|NCT00262704|quality improvement|quality improvement
5765278|NCT00262704|disease management|disease management
5765279|NCT00262652|sodium pyruvate|sodium pyruvate
5765280|NCT00262652|anti-inflammatory|anti-inflammatory
5765281|NCT00262652|bronchodilation|bronchodilation
5765283|NCT00262652|asthmatics|asthmatics
5765284|NCT00262639|Alcoholism|alcoholism
5765285|NCT00262639|Alcohol Dependence|alcohol dependence
5765286|NCT00262639|Alcohol Withdrawal|alcohol withdrawal
5765287|NCT00262639|Treatment|treatment
5765288|NCT00262639|Pharmacotherapy|pharmacotherapy
5765289|NCT00262613|Sodium Pyruvate|sodium pyruvate
5765290|NCT00262613|COPD|copd
5765291|NCT00262613|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5765292|NCT00262587|Sport|sport
5765293|NCT00262587|Asthma|asthma
5765294|NCT00262587|Treatment|treatment
5765295|NCT00262587|Airway inflammation|airway inflammation
5765296|NCT00262574|endothelial disfunction|endothelial disfunction
5765298|NCT00262574|PCI|pci
5765299|NCT00262574|coronary artery disease|coronary artery disease
5765300|NCT00262561|Intermittent Claudication|intermittent claudication
5765301|NCT00262561|Aspirin resistance|aspirin resistance
5765302|NCT00262561|Clopidogrel resistance|clopidogrel resistance
5765303|NCT00262548|Obesity|obesity
5765305|NCT00262522|Human Immunodeficiency Virus Infections|human immunodeficiency virus infections
5765306|NCT00262509|Rehabilitation|rehabilitation
5765307|NCT00262509|Sensory Aid|sensory aid
5765308|NCT00262496|Botox|botox
5765309|NCT00262496|Overactive bladder|overactive bladder
5765310|NCT00262496|Incontinence|incontinence
5765311|NCT00262496|Spinal Cord Injury|spinal cord injury
5765312|NCT00262470|tachycardia|tachycardia
5765313|NCT00262470|sinus tachycardia|sinus tachycardia
5765314|NCT00262470|postural tachycardia syndrome (POTS)|postural tachycardia syndrome (pots)
5686331|NCT00552539|syphilis|syphilis
5765315|NCT00262457|electrical stimulation|electrical stimulation
5765316|NCT00262457|Pressure Ulcers|pressure ulcers
5765317|NCT00262457|Spinal Cord Injury|spinal cord injury
5765318|NCT00262431|Tracheostomy|tracheostomy
5765319|NCT00262431|Tracheostomy timing|tracheostomy timing
5765320|NCT00262431|Ventilator associated pneumonia|ventilator associated pneumonia
5765321|NCT00262431|Mechanical ventilation|mechanical ventilation
5765322|NCT00262392|heterotopic ossification,|heterotopic ossification,
5765323|NCT00262392|prevention,|prevention,
5765324|NCT00262392|high risk,|high risk,
5765325|NCT00262392|bisphosphonates,|bisphosphonates,
5765326|NCT00262392|radiotherapy|radiotherapy
5765327|NCT00262379|Chronic hepatitis C|chronic hepatitis c
5765328|NCT00262379|peginterferon|peginterferon
5765329|NCT00262379|ribavirin|ribavirin
5765330|NCT00262379|epoetin beta|epoetin beta
5765331|NCT00262340|Asthma|asthma
5765332|NCT00262340|Pediatrics|pediatrics
5765333|NCT00262340|Airway|airway
5765334|NCT00262340|Inflammation|inflammation
5765335|NCT00262327|antiangiogenesis|antiangiogenesis
5765336|NCT00262327|endostatin|endostatin
5765337|NCT00262327|adenovirus|adenovirus
5765338|NCT00262327|gene therapy|gene therapy
5765339|NCT00262327|cancer|cancer
5765340|NCT00262236|Hypertension, Aliskiren, Atenolol, Blood Pressure|hypertension, aliskiren, atenolol, blood pressure
5765341|NCT00262223|Co-morbid alcohol dependence and PTSD|co-morbid alcohol dependence and ptsd
5765342|NCT00262223|Alcohol and other drug use disorders|alcohol and other drug use disorders
5765343|NCT00262223|Treatment outcome|treatment outcome
5765344|NCT00262197|Diabetes mellitus|diabetes mellitus
5765345|NCT00262197|Medical error rates|medical error rates
5765346|NCT00262197|Pharmacotherapy|pharmacotherapy
5765649|NCT00260858|Nutrition|nutrition
5765347|NCT00262184|Post-Menopausal osteopenia|post-menopausal osteopenia
5765348|NCT00262158|smoking status|smoking status
5765349|NCT00262158|cigarette consumption|cigarette consumption
5765350|NCT00262145|glucose|glucose
5765351|NCT00262145|lipid|lipid
5765352|NCT00262145|diabetes|diabetes
5765353|NCT00262145|overweight|overweight
5765354|NCT00262119|Physiological pacing|physiological pacing
5765355|NCT00262119|Antitachycardia pacing therapies|antitachycardia pacing therapies
5765356|NCT00262106|Administration, intravaginal|administration, intravaginal
5765357|NCT00262106|Anti-infective agents|anti-infective agents
5765358|NCT00262106|Double blind method|double blind method
5765359|NCT00262106|Drug evaluation|drug evaluation
5765360|NCT00262106|Female|female
5765361|NCT00262106|Gels|gels
5765362|NCT00262106|HIV infections/prevention and control|hiv infections/prevention and control
5765363|NCT00262106|Microbicide|microbicide
5765364|NCT00262106|Naphthalenesulfonates/administration and dosage|naphthalenesulfonates/administration and dosage
5765365|NCT00262106|Polymers/administration and dosage|polymers/administration and dosage
5765366|NCT00262106|Sexual behavior|sexual behavior
5765367|NCT00262106|Vaginal creams, foams and jellies|vaginal creams, foams and jellies
5765368|NCT00262106|HIV Seronegativity|hiv seronegativity
5765369|NCT00262106|Genital Herpes Infections|genital herpes infections
5782367|NCT00182845|dementia|dementia
5782368|NCT00182845|MCI|mci
5765371|NCT00262093|sFlt1|sflt1
5765372|NCT00262093|PlGF|plgf
5765373|NCT00262093|parity|parity
5765374|NCT00262093|angiogenesis|angiogenesis
5765375|NCT00262054|coronary disease|coronary disease
5765376|NCT00261989|pulse oximetry readings|pulse oximetry readings
5765377|NCT00261989|pediatrics|pediatrics
5765378|NCT00261989|cardiac|cardiac
5765379|NCT00261989|congenital heart disease|congenital heart disease
5765380|NCT00261976|Rheumatoid arthritis|rheumatoid arthritis
5765381|NCT00261976|Crohn's disease|crohn's disease
5765382|NCT00261976|Psoriasis|psoriasis
5765383|NCT00261950|Cinacalcet HCl, Cinacalcet, Amgen (AMG) 073, Sensipar, Mimpara, Calcimimetic|cinacalcet hcl, cinacalcet, amgen (amg) 073, sensipar, mimpara, calcimimetic
5765384|NCT00261924|Thrombocytopenic patients|thrombocytopenic patients
5765385|NCT00261911|Meridia|meridia
5765386|NCT00261911|Sibutramine|sibutramine
5765387|NCT00261911|Obesity|obesity
5765388|NCT00261911|Adolescent|adolescent
5765389|NCT00261911|BMI|bmi
5765390|NCT00261898|Sleep Deprivation|sleep deprivation
5765391|NCT00261898|Obesity|obesity
5765392|NCT00261898|Metabolic Syndrome|metabolic syndrome
5765393|NCT00261898|Hormones|hormones
5765394|NCT00261898|Public Health|public health
5765395|NCT00261898|Overweight|overweight
5765397|NCT00261872|Alcoholism|alcoholism
5765398|NCT00261872|Attention Deficit Disorder|attention deficit disorder
5765399|NCT00261872|ADHD|adhd
5765400|NCT00261859|hazardous drinking|hazardous drinking
5765401|NCT00261846|Leukemia|leukemia
5765611|NCT00260988|Fragmin|fragmin
5765402|NCT00261846|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5765403|NCT00261846|philadelphia chromosome|philadelphia chromosome
5765405|NCT00261846|Philadelphia Positive|philadelphia positive
5765406|NCT00261833|Alpha1-proteinase inhibitor deficiency|alpha1-proteinase inhibitor deficiency
5765407|NCT00261833|Emphysema|emphysema
5765408|NCT00261833|Chronic augmentation and maintenance therapy|chronic augmentation and maintenance therapy
5765409|NCT00261820|Kidney Transplant|kidney transplant
5686332|NCT00552539|educational video|educational video
5686333|NCT00552539|knowledge|knowledge
5765410|NCT00261807|severe|severe
5765411|NCT00261807|skin|skin
5765412|NCT00261807|infections|infections
5765413|NCT00261794|cognition|cognition
5765414|NCT00261794|schizophrenia|schizophrenia
5765415|NCT00261794|treatment|treatment
5765416|NCT00261781|Treadmill|treadmill
5765417|NCT00261781|Walking|walking
5765418|NCT00261781|Exercise|exercise
5765419|NCT00261781|Automaticity|automaticity
5765420|NCT00261781|Quality of Life|quality of life
5765421|NCT00261768|Aging|aging
5765422|NCT00261768|hearing aids|hearing aids
5765423|NCT00261768|hearing loss, sensorineural|hearing loss, sensorineural
5765424|NCT00261768|speech recognition|speech recognition
5765425|NCT00261755|Acupuncture|acupuncture
5765426|NCT00261755|pain relief|pain relief
5765427|NCT00261755|labour|labour
5765428|NCT00261755|randomized controlled trial|randomized controlled trial
5765429|NCT00261755|TENS|tens
5765430|NCT00261742|perianal|perianal
5765431|NCT00261742|dermatitis|dermatitis
5765432|NCT00261742|streptococcus pyogenes|streptococcus pyogenes
5765433|NCT00261729|Paroxetine|paroxetine
5765434|NCT00261729|Prazosin|prazosin
5765435|NCT00261729|Sleep Disorders|sleep disorders
5765436|NCT00261729|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5765437|NCT00261716|clinical trial|clinical trial
5765438|NCT00261716|employment|employment
5765439|NCT00261716|schizoaffective disorder|schizoaffective disorder
5765440|NCT00261716|schizophrenia|schizophrenia
5765441|NCT00261690|Virtual Reality Distraction|virtual reality distraction
5765442|NCT00261677|Anemia|anemia
5765443|NCT00261677|cancer|cancer
5765444|NCT00261677|solid tumor|solid tumor
5765445|NCT00261677|Hodgkin's Disease|hodgkin's disease
5765446|NCT00261677|Acute Lymphocytic Leukemia (ALL)|acute lymphocytic leukemia (all)
5765447|NCT00261677|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5765453|NCT00261638|Taiwan Mental Health Index scale|taiwan mental health index scale
5765454|NCT00261638|psychophysical health|psychophysical health
5765455|NCT00261638|education years over 9 years|education years over 9 years
5765456|NCT00261638|normal people, especially joining Mental Health Foundation Promotions|normal people, especially joining mental health foundation promotions
5765457|NCT00261625|peritoneal dialysis|peritoneal dialysis
5765458|NCT00261625|artery calcification|artery calcification
5765459|NCT00261625|bone mineral density|bone mineral density
5765460|NCT00261612|relapsed or chemotherapy-refractory disease|relapsed or chemotherapy-refractory disease
5765461|NCT00261599|Colonoscopy|colonoscopy
5765462|NCT00261599|Sedation|sedation
5765463|NCT00261599|AQUAVAN|aquavan
5765464|NCT00261599|Fospropofol disodium|fospropofol disodium
5765465|NCT00261599|Colon polyps|colon polyps
5765466|NCT00261599|Endoscopic outcomes|endoscopic outcomes
5765467|NCT00261599|Endoscopic sedation|endoscopic sedation
5765468|NCT00261599|Endoscopy|endoscopy
5765469|NCT00261586|aspirin|aspirin
5765470|NCT00261586|analgesics|analgesics
5765471|NCT00261586|cyclooxygenase activity|cyclooxygenase activity
5765472|NCT00261586|non-steroidal antiinflammatory drugs|non-steroidal antiinflammatory drugs
5763186|NCT00271076|Stroke|stroke
5765473|NCT00261573|"Alzheimer's disease with cerebrovascular disease (mixed dementia)"|"alzheimer's disease with cerebrovascular disease (mixed dementia)"
5765474|NCT00261573|probable vascular dementia|probable vascular dementia
5765476|NCT00261560|ankle sprain|ankle sprain
5765477|NCT00261560|acetaminophen extended release, ibuprofen|acetaminophen extended release, ibuprofen
5765478|NCT00261547|Kidney transplantation|kidney transplantation
5765480|NCT00261534|Chemotherapy|chemotherapy
5765481|NCT00261521|Kidney failure, Chronic|kidney failure, chronic
5765482|NCT00261521|End-stage renal disease|end-stage renal disease
5765483|NCT00261521|Kidney failure|kidney failure
5765484|NCT00261521|Anemia|anemia
5765485|NCT00261521|Dialysis|dialysis
5765486|NCT00261521|Epoetin|epoetin
5765487|NCT00261521|Erythropoetin|erythropoetin
5765488|NCT00261521|Epoetin alfa|epoetin alfa
5765489|NCT00261508|Risperidone|risperidone
5765490|NCT00261508|child development disorders|child development disorders
5765491|NCT00261508|pervasive development disorders|pervasive development disorders
5765492|NCT00261508|autistic disorder|autistic disorder
5765493|NCT00261508|autism|autism
5765494|NCT00261508|developmental disabilities|developmental disabilities
5765495|NCT00261508|antipsychotropic agents|antipsychotropic agents
5765496|NCT00261495|chronic noncancer pain|chronic noncancer pain
5765497|NCT00261495|pain|pain
5765498|NCT00261495|analgesia|analgesia
5765499|NCT00261495|analgesic opioid|analgesic opioid
5765500|NCT00261495|oxycodone|oxycodone
5765501|NCT00261495|hydromorphone|hydromorphone
5765502|NCT00261482|contraception|contraception
5765503|NCT00261482|female contraception|female contraception
5765504|NCT00261482|hormonal contraception|hormonal contraception
5765505|NCT00261482|transdermal contraception|transdermal contraception
5765506|NCT00261482|EVRA|evra
5765507|NCT00261482|estrogen|estrogen
5765508|NCT00261482|progestin|progestin
5765509|NCT00261482|ethinyl estradiol|ethinyl estradiol
5686334|NCT00552539|black|black
5686335|NCT00552539|Hispanic|hispanic
5765510|NCT00261482|norelgestromin|norelgestromin
5765511|NCT00261469|Migraine|migraine
5765512|NCT00261469|Headache|headache
5765519|NCT00261443|Bipolar I Disorder with a recent manic or mixed episode|bipolar i disorder with a recent manic or mixed episode
5765520|NCT00261430|Schizophrenia|schizophrenia
5765521|NCT00261430|acceptance|acceptance
5765522|NCT00261430|motivational enhancement therapy|motivational enhancement therapy
5765523|NCT00261430|long-acting risperidone|long-acting risperidone
5765524|NCT00261430|intramuscular injection|intramuscular injection
5765525|NCT00261430|Treatment Guidebook|treatment guidebook
5765526|NCT00261430|GAIN Acceptance Approach|gain acceptance approach
5765527|NCT00261391|Arteriovenous Malformation|arteriovenous malformation
5765528|NCT00261391|Lymphatic Malformation|lymphatic malformation
5765529|NCT00261391|Gorham|gorham
5765530|NCT00261378|Hepatocellular Carcinoma (HCC)|hepatocellular carcinoma (hcc)
5765531|NCT00261339|Gastroesophageal Reflux|gastroesophageal reflux
5765532|NCT00261339|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5765533|NCT00261339|Pantoprazole|pantoprazole
5765534|NCT00261326|Simvastatin|simvastatin
5765535|NCT00261326|Optic Neuritis|optic neuritis
5765536|NCT00261326|Multiple Sclerosis|multiple sclerosis
5765537|NCT00261313|Breast cancer|breast cancer
5765538|NCT00261313|Doses dense chemotherapy|doses dense chemotherapy
5765539|NCT00261313|Growth factor support|growth factor support
5765540|NCT00261313|Adjuvant Breast Cancer|adjuvant breast cancer
5765541|NCT00261300|Gastric acid|gastric acid
5765542|NCT00261300|GERD|gerd
5766388|NCT00258115|Diabetes|diabetes
5765543|NCT00261300|Gastroesophageal reflux disease|gastroesophageal reflux disease
5765544|NCT00261300|Pantoprazole|pantoprazole
5765545|NCT00261300|Proton pump inhibitor|proton pump inhibitor
5765546|NCT00261287|Hay Fever|hay fever
5765547|NCT00261287|Allergic Rhinitis|allergic rhinitis
5765548|NCT00261287|Perennial Allergic Rhinitis|perennial allergic rhinitis
5765549|NCT00261287|Ciclesonide|ciclesonide
5765550|NCT00261274|transfusion; red blood cells|transfusion; red blood cells
5765551|NCT00261261|children|children
5765552|NCT00261261|anxiety|anxiety
5765553|NCT00261261|behavioral preparation|behavioral preparation
5765554|NCT00261261|family|family
5765555|NCT00261261|surgery|surgery
5765556|NCT00261261|parents|parents
5765557|NCT00261248|Phase 2|phase 2
5765559|NCT00261248|Urinary Tract Infection|urinary tract infection
5765560|NCT00261248|Vaginal Mucosal|vaginal mucosal
5765561|NCT00261235|Rehabilitation, Vocational|rehabilitation, vocational
5765562|NCT00261235|Virtues|virtues
5765563|NCT00261235|Employment, supported|employment, supported
5765564|NCT00261235|veterans|veterans
5765565|NCT00261235|Mentally Ill Persons|mentally ill persons
5765566|NCT00261222|Amodiaquine|amodiaquine
5765567|NCT00261222|Efficacy|efficacy
5765568|NCT00261222|Malaria|malaria
5765569|NCT00261222|Burkina Faso|burkina faso
5765570|NCT00261209|Flexor Tendon Adhesions|flexor tendon adhesions
5765571|NCT00261209|Zone II of the Hand|zone ii of the hand
5765572|NCT00261196|Frozen Shoulder|frozen shoulder
5765573|NCT00261170|smoking|smoking
5765574|NCT00261157|nephrectomy|nephrectomy
5765575|NCT00261157|Safety|safety
5765576|NCT00261157|Laparoscopy|laparoscopy
5765577|NCT00261157|telerounding|telerounding
5765578|NCT00261157|prostatectomy|prostatectomy
5765579|NCT00261131|cerebral palsy|cerebral palsy
5765580|NCT00261131|spasticity|spasticity
5765581|NCT00261131|diplegia|diplegia
5765582|NCT00261118|colitis|colitis
5765583|NCT00261118|rituximab|rituximab
5765584|NCT00261066|Functional outcome|functional outcome
5765585|NCT00261066|Orthopaedic surgery|orthopaedic surgery
5765586|NCT00261040|Osteoarthritis|osteoarthritis
5765587|NCT00261040|Total Hip Arthroplasty|total hip arthroplasty
5765588|NCT00261040|Minimally Invasive Surgery|minimally invasive surgery
5765589|NCT00261027|ovarian cancer|ovarian cancer
5765590|NCT00261014|Recurrent|recurrent
5765591|NCT00261014|Idiopathic|idiopathic
5765592|NCT00261014|Deep Vein Thrombosis|deep vein thrombosis
5765593|NCT00261014|Pulmonary Embolism|pulmonary embolism
5765594|NCT00261014|Clinical Prediction Rule|clinical prediction rule
5765595|NCT00261014|Venous Thromboembolism|venous thromboembolism
5765596|NCT00261014|Risk Factors|risk factors
5765597|NCT00261001|Transcutaneous|transcutaneous
5765598|NCT00261001|Vaccination|vaccination
5765599|NCT00261001|Safety|safety
5765600|NCT00261001|Immunogenicity|immunogenicity
5765602|NCT00261001|Treatment Experienced|treatment experienced
5765603|NCT00260988|Prophylaxis|prophylaxis
5765604|NCT00260988|Thromboembolic disease|thromboembolic disease
5765605|NCT00260988|End stage renal disease|end stage renal disease
5765606|NCT00260988|Hemodialysis|hemodialysis
5765607|NCT00260988|Pharmacokinetics|pharmacokinetics
5765608|NCT00260988|Low Molecular Weight Heparin|low molecular weight heparin
5765610|NCT00260988|Tinzaparin|tinzaparin
5765615|NCT00260988|Oral anticoagulation|oral anticoagulation
5765616|NCT00260988|warfarin|warfarin
5765617|NCT00260988|Coumadin|coumadin
5765618|NCT00260975|breast cancer|breast cancer
5765619|NCT00260975|chemotherapy|chemotherapy
5686336|NCT00552526|Epilepsy|epilepsy
5686337|NCT00552526|Children|children
5686338|NCT00552526|Mental retardation|mental retardation
5686339|NCT00552526|Ketogenic diet|ketogenic diet
5686340|NCT00552526|Diet|diet
5765620|NCT00260975|hormonal therapy|hormonal therapy
5765621|NCT00260975|cognitive function|cognitive function
5765622|NCT00260975|chemo fog|chemo fog
5765623|NCT00260962|Pilot Project,|pilot project,
5765624|NCT00260962|Clinical Trial,|clinical trial,
5765625|NCT00260962|Treatment Outcome,|treatment outcome,
5765626|NCT00260962|Psychopharmacology|psychopharmacology
5765627|NCT00260949|rotator cuff tear|rotator cuff tear
5765628|NCT00260949|arthroscopic repair|arthroscopic repair
5765629|NCT00260936|HIV|hiv
5765630|NCT00260936|AIDS|aids
5765631|NCT00260936|Adolescent Males|adolescent males
5765632|NCT00260936|HIV positive|hiv positive
5765633|NCT00260936|Treatment Naive|treatment naive
5765634|NCT00260936|Treatment Experienced|treatment experienced
5765635|NCT00260923|hypertension|hypertension
5765636|NCT00260923|aliskiren|aliskiren
5765637|NCT00260923|blood pressure|blood pressure
5765638|NCT00260897|avascular necrosis of the femoral head|avascular necrosis of the femoral head
5765639|NCT00260897|genotyping|genotyping
5765640|NCT00260897|linkage analysis|linkage analysis
5765641|NCT00260897|pathogenesis|pathogenesis
5765642|NCT00260897|therapy|therapy
5765643|NCT00260871|lung adenocarcinoma|lung adenocarcinoma
5765644|NCT00260871|genetic epidemiology|genetic epidemiology
5765645|NCT00260871|environmental factors|environmental factors
5765646|NCT00260871|genetic map|genetic map
5765647|NCT00260871|coordination center|coordination center
5765648|NCT00260858|Glycemic index|glycemic index
5765650|NCT00260858|Carbohydrates|carbohydrates
5765651|NCT00260858|Glycemic responses|glycemic responses
5765652|NCT00260858|Methodology|methodology
5765653|NCT00260858|Healthy human subjects|healthy human subjects
5765654|NCT00260832|Acute Myeloid Leukemia|acute myeloid leukemia
5765655|NCT00260832|Dacogen|dacogen
5765656|NCT00260832|Decitabine|decitabine
5765657|NCT00260832|Poor or intermediate-risk cytogenetics|poor or intermediate-risk cytogenetics
5765658|NCT00260819|Hypoxia-induced pulmonary artery hypertension|hypoxia-induced pulmonary artery hypertension
5765659|NCT00260819|High-altitude pulmonary oedema|high-altitude pulmonary oedema
5765660|NCT00260819|ETA receptor antagonist|eta receptor antagonist
5765661|NCT00260793|Ropinirole|ropinirole
5765662|NCT00260793|Parkinson's disease|parkinson's disease
5765663|NCT00260793|dopamine agonist|dopamine agonist
5765664|NCT00260780|sexually transmitted diseases|sexually transmitted diseases
5765665|NCT00260780|Risk Behavior|risk behavior
5765666|NCT00260754|Risk behavior|risk behavior
5765667|NCT00260754|Sexually transmitted diseases|sexually transmitted diseases
5765668|NCT00260741|cannabis|cannabis
5765669|NCT00260741|marijuana|marijuana
5765670|NCT00260741|Multiple Sclerosis|multiple sclerosis
5765671|NCT00260741|Spasticity|spasticity
5765672|NCT00260728|vascular access|vascular access
5765673|NCT00260728|hemodialysis|hemodialysis
5765674|NCT00260715|Risk behavior|risk behavior
5765675|NCT00260715|Sexually Transmitted Diseases|sexually transmitted diseases
5765676|NCT00260702|Phenotype|phenotype
5765677|NCT00260702|Monoclonal|monoclonal
5765678|NCT00260702|Immunoglobulin|immunoglobulin
5765679|NCT00260702|Immunodeficiency|immunodeficiency
5765680|NCT00260702|Dermatitis|dermatitis
5765681|NCT00260702|Job's Syndrome|job's syndrome
5765682|NCT00260702|Hyper-IgE Syndrome|hyper-ige syndrome
5765683|NCT00260702|HIES|hies
5765684|NCT00260689|Immunosuppression|immunosuppression
5765685|NCT00260689|T-cells|t-cells
5765686|NCT00260689|Hematopoiesis|hematopoiesis
5765687|NCT00260689|Autoimmunity|autoimmunity
5765688|NCT00260689|Thrombocytopenia|thrombocytopenia
5765689|NCT00260689|Severe Aplastic Anemia|severe aplastic anemia
5765690|NCT00260689|SAA|saa
5765691|NCT00260676|brain death|brain death
5765692|NCT00260676|lung transplantation|lung transplantation
5765693|NCT00260676|organ donors|organ donors
5765694|NCT00260676|potential organ donors|potential organ donors
5765695|NCT00260663|Hearing Impaired Rehabilitation|hearing impaired rehabilitation
5765696|NCT00260663|Hearing Aids|hearing aids
5765697|NCT00260663|Randomized Controlled Trials|randomized controlled trials
5765698|NCT00260663|Cost Effectiveness|cost effectiveness
5765699|NCT00260663|Quality of life|quality of life
5765700|NCT00260663|Patient Compliance|patient compliance
5765701|NCT00260650|heart failure, congestive|heart failure, congestive
5765702|NCT00260650|self-care|self-care
5765703|NCT00260650|quality of life|quality of life
5765704|NCT00260650|health behavior|health behavior
5765705|NCT00260637|Prostatitis|prostatitis
5765706|NCT00260624|agitation|agitation
5765707|NCT00260624|dementia|dementia
5765708|NCT00260624|Alzheimer's Disease|alzheimer's disease
5765709|NCT00260611|prostate|prostate
5765710|NCT00260598|Non-small cell lung cancer|non-small cell lung cancer
5765711|NCT00260598|Head and neck squamous cell cancer|head and neck squamous cell cancer
5765712|NCT00260598|White light bronchoscopy|white light bronchoscopy
5765713|NCT00260598|Imaging Elastic Scattering Spectroscopy (IESS)|imaging elastic scattering spectroscopy (iess)
5765714|NCT00260598|Fluorescence Bronchoscopy|fluorescence bronchoscopy
5765716|NCT00260598|Helium-Cadmium Laser Bronchoscopy|helium-cadmium laser bronchoscopy
5765717|NCT00260598|Autofluorescence spectra of dysplasia & cancer in situ (CIS)|autofluorescence spectra of dysplasia & cancer in situ (cis)
5765718|NCT00260598|Severe Chronic Obstructive Pulmonary Disorders(COPD)|severe chronic obstructive pulmonary disorders(copd)
5765719|NCT00260585|gastroesophageal reflux disease|gastroesophageal reflux disease
5765720|NCT00260585|GERD|gerd
5765721|NCT00260585|hiatal hernia|hiatal hernia
5765722|NCT00260585|achalasia|achalasia
5765723|NCT00260585|Barrett's metaplasia|barrett's metaplasia
5765724|NCT00260585|Anti-Reflux Surgery|anti-reflux surgery
5765725|NCT00260585|Known/suspected esophageal/gastroesophageal junction tumor|known/suspected esophageal/gastroesophageal junction tumor
5765726|NCT00260585|Esophageal disorders such as Barrett's metaplasia|esophageal disorders such as barrett's metaplasia
5765727|NCT00260585|Symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease
5765728|NCT00260572|GERD|gerd
5765729|NCT00260572|nissen|nissen
5765730|NCT00260572|fundoplication|fundoplication
5765731|NCT00260572|reflux|reflux
5765732|NCT00260572|toupet|toupet
5765733|NCT00260572|QOL|qol
5765734|NCT00260572|dyspepsia|dyspepsia
5765735|NCT00260572|heartburn|heartburn
5765736|NCT00260572|Patients with reflux symptoms for at least 6 months|patients with reflux symptoms for at least 6 months
5765737|NCT00260572|Patients scheduled for lap nissen or toupet fundoplication|patients scheduled for lap nissen or toupet fundoplication
5765738|NCT00260572|Reflux diagnosed by either endoscopy, upper GI, or 24hr. pH (numeric scale used to specify the acidity of gastric contents)|reflux diagnosed by either endoscopy, upper gi, or 24hr. ph (numeric scale used to specify the acidity of gastric contents)
5765739|NCT00260572|On or starting treatment with PPI or pro-motility agents|on or starting treatment with ppi or pro-motility agents
5765740|NCT00260559|Esophagectomy|esophagectomy
5765741|NCT00260559|Esophageal Cancer|esophageal cancer
5765742|NCT00260559|Quality of Life|quality of life
5765743|NCT00260559|Minimally Invasive Esophagectomy|minimally invasive esophagectomy
5765744|NCT00260559|Laparoscopic Transhiatal Esophagectomy|laparoscopic transhiatal esophagectomy
5765745|NCT00260559|Open Esophagectomy|open esophagectomy
5765746|NCT00260559|Karnofsky Score|karnofsky score
5765747|NCT00260559|Dysphagia score|dysphagia score
5765748|NCT00260559|Heartburn Scale|heartburn scale
5765749|NCT00260559|Nutrition Score|nutrition score
5765750|NCT00260546|Ventricular dyssynchrony|ventricular dyssynchrony
5765751|NCT00260520|Low molecular weight heparin|low molecular weight heparin
5765752|NCT00260520|Preeclampsia|preeclampsia
5765753|NCT00260520|Fetal Growth Restriction|fetal growth restriction
5765754|NCT00260520|Thrombophilia|thrombophilia
5765755|NCT00260520|Factor V Leiden|factor v leiden
5765756|NCT00260520|G20210A prothrombin gene mutation|g20210a prothrombin gene mutation
5765757|NCT00260494|Cardiac Surgical Procedures|cardiac surgical procedures
5765758|NCT00260494|open saphenous vein graft harvest wounds|open saphenous vein graft harvest wounds
5765759|NCT00260494|Postoperative Complications|postoperative complications
5765760|NCT00260494|Surgical Wound Infection|surgical wound infection
5765761|NCT00260494|Surgical Wound Dehiscence|surgical wound dehiscence
5765762|NCT00260481|Methamphetamine Dependence|methamphetamine dependence
5765763|NCT00260481|Pharmacotherapy|pharmacotherapy
5765764|NCT00260468|Major depression|major depression
5765765|NCT00260468|Magnetic resonance imaging|magnetic resonance imaging
5765766|NCT00260468|White matter lesions|white matter lesions
5765767|NCT00260468|Perfusion|perfusion
5765768|NCT00260468|Diffusion|diffusion
5765769|NCT00260468|Magnetization transfer|magnetization transfer
5765770|NCT00260468|Vascular risk factors|vascular risk factors
5765771|NCT00260442|sarcopenia|sarcopenia
5765772|NCT00260442|resistance training|resistance training
5765773|NCT00260442|strength training|strength training
5765774|NCT00260442|skeletal muscle|skeletal muscle
5765776|NCT00260442|cholesterol|cholesterol
5765777|NCT00260442|aging|aging
5765778|NCT00260442|cardiovascular disease|cardiovascular disease
5765779|NCT00260442|nutrition|nutrition
5765780|NCT00260442|inflammation|inflammation
5765781|NCT00260442|lipids|lipids
5765782|NCT00260429|Dupuytren's contracture|dupuytren's contracture
5765783|NCT00260429|fixed flexion contracture|fixed flexion contracture
5765784|NCT00260416|Acute myocardial infarction|acute myocardial infarction
5765785|NCT00260416|Symptom duration|symptom duration
5765786|NCT00260416|Primary angioplasty|primary angioplasty
5765787|NCT00260416|Infarct size|infarct size
5765788|NCT00260416|Myocardial scintigraphy|myocardial scintigraphy
5765789|NCT00260390|Dysthymic Disorder|dysthymic disorder
5765790|NCT00260390|HPG hypofunctioning|hpg hypofunctioning
5765791|NCT00260390|Testosterone replacement|testosterone replacement
5765792|NCT00260377|Aspirin treatment|aspirin treatment
5765793|NCT00260377|Aspirin resistance|aspirin resistance
5765794|NCT00260377|Coronary bypass surgery|coronary bypass surgery
5765795|NCT00260364|Recurrent carcinoma of the pancreas|recurrent carcinoma of the pancreas
5765796|NCT00260364|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5792622|NCT00133757|Tobacco|tobacco
5765797|NCT00260364|Stage II carcinoma of the pancreas|stage ii carcinoma of the pancreas
5764836|NCT00264823|HIV|hiv
5765798|NCT00260364|Stage III carcinoma of the pancreas|stage iii carcinoma of the pancreas
5765799|NCT00260364|Stage IVA carcinoma of the pancreas|stage iva carcinoma of the pancreas
5765800|NCT00260364|Stage IVB carcinoma of the pancreas|stage ivb carcinoma of the pancreas
5765801|NCT00260351|rabies;|rabies;
5765802|NCT00260351|rabies post-exposure;|rabies post-exposure;
5765803|NCT00260351|category III|category iii
5765804|NCT00260338|myocardial ischemia|myocardial ischemia
5765805|NCT00260338|stem cell|stem cell
5765806|NCT00260338|mesenchymal|mesenchymal
5765807|NCT00260338|myocardial perfusion|myocardial perfusion
5765808|NCT00260325|pretreatment|pretreatment
5765809|NCT00260325|healthy volunteers|healthy volunteers
5765810|NCT00260312|inactived|inactived
5765811|NCT00260312|polio|polio
5765812|NCT00260312|vaccine|vaccine
5765813|NCT00260312|cuba|cuba
5765814|NCT00260312|trial|trial
5765815|NCT00260312|randomized|randomized
5765816|NCT00260312|eradication|eradication
5765817|NCT00260299|cholesterol defects|cholesterol defects
5765818|NCT00260299|Mevalonic Aciduria|mevalonic aciduria
5765819|NCT00260299|Mevalonate Kinase Deficiency|mevalonate kinase deficiency
5765820|NCT00260299|HIDS|hids
5765821|NCT00260299|Hyperimmunoglobulinemia with periodic fever syndrome|hyperimmunoglobulinemia with periodic fever syndrome
5765823|NCT00260299|Lipid Metabolism, Inborn Errors|lipid metabolism, inborn errors
5765824|NCT00260299|Periodic Fever Syndromes, hereditary|periodic fever syndromes, hereditary
5765825|NCT00260299|mevalonic acid|mevalonic acid
5765826|NCT00260299|mevalonate kinase|mevalonate kinase
5765827|NCT00260299|cholesterol, dietary|cholesterol, dietary
5765828|NCT00260299|Hyper IgD|hyper igd
5765829|NCT00260299|Multiple malformations|multiple malformations
5765830|NCT00260299|Fever|fever
5765831|NCT00260286|LH pulsatility|lh pulsatility
5765832|NCT00260286|energy availability|energy availability
5765833|NCT00260286|exercise|exercise
5765834|NCT00260286|diet|diet
5765835|NCT00260286|gynecological age|gynecological age
5765836|NCT00260273|Preventive Therapy|preventive therapy
5765837|NCT00260273|Psychoses|psychoses
5765838|NCT00260273|Cognitive Behaviour Therapy|cognitive behaviour therapy
5765839|NCT00260247|CYP3A4|cyp3a4
5765840|NCT00260247|Induction|induction
5765841|NCT00260247|Oxcarbazepine|oxcarbazepine
5765842|NCT00260247|Carbamazepine|carbamazepine
5765843|NCT00260247|Quinidine|quinidine
5765844|NCT00260247|Human|human
5765845|NCT00260247|In vivo|in vivo
5765846|NCT00260234|Transplantation, Pancreatic Islets|transplantation, pancreatic islets
5765847|NCT00260234|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5765848|NCT00260234|Insulin Dependent|insulin dependent
5765849|NCT00260234|Islet Transplant|islet transplant
5765850|NCT00260221|Virtual Reality Hypnosis|virtual reality hypnosis
5765851|NCT00260208|Liver transplant, adults, hepatitis C, liver fibrosis, cyclosporine microemulsion, tacrolimus|liver transplant, adults, hepatitis c, liver fibrosis, cyclosporine microemulsion, tacrolimus
5765852|NCT00260195|Trauma|trauma
5765853|NCT00260195|Violence|violence
5765854|NCT00260195|Adolescent|adolescent
5765855|NCT00260195|Schools|schools
5765856|NCT00260195|Cognitive behavioral therapy|cognitive behavioral therapy
5765857|NCT00260182|Depressive Disorder|depressive disorder
5765858|NCT00260182|Family|family
5765859|NCT00260182|Genetics|genetics
5765860|NCT00260169|Treatment Preferences|treatment preferences
5765861|NCT00260169|Public sector|public sector
5765862|NCT00260169|Latino|latino
5765863|NCT00260156|Type 2 diabetes|type 2 diabetes
5765864|NCT00260156|vildagliptin|vildagliptin
5765866|NCT00260143|Treatment Experienced|treatment experienced
5765867|NCT00260130|obesity|obesity
5765868|NCT00260130|food intake|food intake
5765869|NCT00260130|human|human
5760990|NCT00280319|Uganda|uganda
5765871|NCT00260130|beverage|beverage
5765872|NCT00260117|Exercise|exercise
5765873|NCT00260117|Physical activity|physical activity
5765874|NCT00260117|walking|walking
5765875|NCT00260117|running|running
5765876|NCT00260091|Infertility|infertility
5765877|NCT00260091|Advanced maternal age|advanced maternal age
5765878|NCT00260091|Pregnancy|pregnancy
5765879|NCT00260091|Reproductive health|reproductive health
5765880|NCT00260091|Fertility treatment|fertility treatment
5765881|NCT00260091|Reproduction|reproduction
5765882|NCT00260078|Treatment Experienced|treatment experienced
5765883|NCT00260078|Pharmacokinetics|pharmacokinetics
5765885|NCT00260065|Myelodysplastic Syndrome|myelodysplastic syndrome
5765886|NCT00260065|Decitabine|decitabine
5765887|NCT00260065|Dacogen|dacogen
5765888|NCT00260065|MGI Pharma|mgi pharma
5765889|NCT00260052|traumatic brain injury|traumatic brain injury
5765890|NCT00260026|Lung Cancer|lung cancer
5765891|NCT00260013|chronic mental illness|chronic mental illness
5765892|NCT00260000|mild PKU|mild pku
5765893|NCT00260000|Y414C|y414c
5765894|NCT00260000|5,6,7,8-tetrahydrobiopterin, BH4|5,6,7,8-tetrahydrobiopterin, bh4
5765895|NCT00260000|treatment without protein restriction|treatment without protein restriction
5765896|NCT00259987|relapsed adenocarcinoma|relapsed adenocarcinoma
5765897|NCT00259987|esophagus|esophagus
5765898|NCT00259987|tumors|tumors
5765899|NCT00259987|GE junction|ge junction
5765900|NCT00259987|cancer|cancer
5764920|NCT00264459|Asthma|asthma
5765901|NCT00259987|lapatinib|lapatinib
5765902|NCT00259987|gastric cardia|gastric cardia
5765903|NCT00259974|Anti-MAG monoclonal gammopathy|anti-mag monoclonal gammopathy
5765904|NCT00259974|Polyneuropathy|polyneuropathy
5765906|NCT00259948|HR variability, CVA, Myocardial infarction, aerobic exercise training|hr variability, cva, myocardial infarction, aerobic exercise training
5765907|NCT00259935|Any Solid Tumor|any solid tumor
5765908|NCT00259922|constipation|constipation
5765909|NCT00259922|gastrointestinal|gastrointestinal
5765910|NCT00259922|opioids|opioids
5765911|NCT00259922|pain|pain
5765912|NCT00259922|non-cancer pain|non-cancer pain
5765913|NCT00259922|opioid-induced|opioid-induced
5765914|NCT00259922|bowel dysfunction|bowel dysfunction
5765915|NCT00259909|Patient reported outcomes|patient reported outcomes
5765916|NCT00259909|COPD|copd
5765917|NCT00259909|acute exacerbation of chronic obstructive pulmonary disease (AECOPD)|acute exacerbation of chronic obstructive pulmonary disease (aecopd)
5765918|NCT00259896|exenatide|exenatide
5765919|NCT00259896|pharmacokinetics|pharmacokinetics
5765920|NCT00259896|pharmacodynamics|pharmacodynamics
5765921|NCT00259883|depressive episodes|depressive episodes
5765922|NCT00259883|paroxetine|paroxetine
5765923|NCT00259883|PAXIL|paxil
5765924|NCT00259883|depression|depression
5765925|NCT00259883|benzodiazepine|benzodiazepine
5765926|NCT00259883|combination|combination
5765927|NCT00259870|Schizophrenia|schizophrenia
5765928|NCT00259870|PANSS|panss
5765929|NCT00259870|Acute|acute
5765930|NCT00259870|Cognition|cognition
5765931|NCT00259857|Fracture|fracture
5765932|NCT00259857|Bone Mineral Density|bone mineral density
5765933|NCT00259857|DXA|dxa
5765934|NCT00259844|Colorectal|colorectal
5765935|NCT00259844|Liver Metastases|liver metastases
5765936|NCT00259844|Vaccine|vaccine
5769194|NCT00247741|articaine|articaine
5765937|NCT00259844|Colorectal Liver Metastases|colorectal liver metastases
5765939|NCT00259831|influenza|influenza
5765940|NCT00259818|Refractory|refractory
5765941|NCT00259818|Solid Tumors|solid tumors
5765942|NCT00259805|encephalitis|encephalitis
5765943|NCT00259805|epilepsy|epilepsy
5765944|NCT00259805|Rasmussens|rasmussens
5765945|NCT00259805|rituximab|rituximab
5765946|NCT00259805|autoimmune|autoimmune
5765947|NCT00259779|COPD|copd
5765948|NCT00259753|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
5765949|NCT00259740|Multiple Myeloma, Relapsed, Plateau-Phase|multiple myeloma, relapsed, plateau-phase
5765950|NCT00259727|Amprenavir|amprenavir
5765951|NCT00259727|Glucagon|glucagon
5765952|NCT00259727|HIV Protease inhibitors|hiv protease inhibitors
5765953|NCT00259727|Indinavir|indinavir
5765954|NCT00259727|Lopinavir|lopinavir
5765955|NCT00259727|Ritonavir|ritonavir
5765956|NCT00259714|hypertension|hypertension
5765957|NCT00259714|hemodialysis|hemodialysis
5765958|NCT00259714|sodium|sodium
5765959|NCT00259714|dialysate|dialysate
5765960|NCT00259714|hemodynamics|hemodynamics
5765961|NCT00259701|endothelium|endothelium
5765962|NCT00259701|iontophoresis|iontophoresis
5765963|NCT00259701|acetylcholine|acetylcholine
5765964|NCT00259701|nitroglycerin|nitroglycerin
5765965|NCT00259701|vasodilation|vasodilation
5765966|NCT00259688|Preeclampsia|preeclampsia
5765967|NCT00259688|Sleep Apnea|sleep apnea
5765968|NCT00259688|CPAP|cpap
5765969|NCT00259662|cancer--ovarian|cancer--ovarian
5765970|NCT00259662|cancer--endometria|cancer--endometria
5765971|NCT00259662|deep vein thrombosis|deep vein thrombosis
5765972|NCT00259662|statin therapy in perioperative period|statin therapy in perioperative period
5765973|NCT00259623|Cardiac surgery|cardiac surgery
5765974|NCT00259623|Radiofrequency ablation|radiofrequency ablation
5765975|NCT00259623|Atrial fibrillation|atrial fibrillation
5765977|NCT00259610|painful joints|painful joints
5765978|NCT00259610|swollen joints|swollen joints
5765979|NCT00259597|nuclear morphology|nuclear morphology
5765980|NCT00259597|image analysis|image analysis
5765981|NCT00259597|lipid peroxidation|lipid peroxidation
5765982|NCT00259597|diet|diet
5765983|NCT00259597|proliferative breast disease|proliferative breast disease
5765984|NCT00259571|remission|remission
5765985|NCT00259571|mesalazin|mesalazin
5765986|NCT00259571|non-inferiority study|non-inferiority study
5765987|NCT00259571|relapse|relapse
5765988|NCT00259558|Ulcerative Colitis|ulcerative colitis
5765989|NCT00259558|Dose Finding|dose finding
5765990|NCT00259558|Phosphatidylcholine|phosphatidylcholine
5765991|NCT00259545|retarded phosphatidylcholine|retarded phosphatidylcholine
5765992|NCT00259545|chronic active|chronic active
5765993|NCT00259545|steroid|steroid
5765994|NCT00259519|premature or preterm birth|premature or preterm birth
5765995|NCT00259519|chorioamnionitis|chorioamnionitis
5765996|NCT00259519|neonatal sepsis|neonatal sepsis
5765997|NCT00259519|labour|labour
5765998|NCT00259519|Cesarean Section|cesarean section
5765999|NCT00259519|delivery|delivery
5766000|NCT00259519|length of stay|length of stay
5766001|NCT00259519|pregnancy|pregnancy
5766002|NCT00259506|Recurrent depression|recurrent depression
5766003|NCT00259506|Mental Health|mental health
5686341|NCT00552513|timing|timing
5766004|NCT00259493|Coronary Artery Disease|coronary artery disease
5766005|NCT00259493|Coronary Artery Bypass Graft Surgery|coronary artery bypass graft surgery
5766006|NCT00259493|Off-pump CABG|off-pump cabg
5766007|NCT00259493|Cardiac CT|cardiac ct
5766008|NCT00259493|Bypass Graft CT angiography|bypass graft ct angiography
5766009|NCT00259467|Activity, Dementia, Caregiving|activity, dementia, caregiving
5766010|NCT00259454|Caregivers|caregivers
5766011|NCT00259454|in-home care occupational therapy|in-home care occupational therapy
5766012|NCT00259441|Kidney failure|kidney failure
5766013|NCT00259441|Contrast media|contrast media
5766014|NCT00259441|Prevention|prevention
5766015|NCT00259441|Simvastatin|simvastatin
5766016|NCT00259428|Atrial Fibrillation|atrial fibrillation
5766017|NCT00259428|Atrial Flutter|atrial flutter
5766018|NCT00259428|Arrhythmia|arrhythmia
5766019|NCT00259428|Anti-Arrhythmia agents|anti-arrhythmia agents
5766020|NCT00259415|Support groups|support groups
5766021|NCT00259415|Alzheimer's Disease|alzheimer's disease
5766022|NCT00259389|Treatment Experienced|treatment experienced
5766023|NCT00259389|Adherence|adherence
5766024|NCT00259389|Compliance|compliance
5766025|NCT00259389|Directly Observed Therapy|directly observed therapy
5766027|NCT00259389|Treatment Naive|treatment naive
5766028|NCT00259376|Atrial Fibrillation|atrial fibrillation
5766029|NCT00259376|Atrial Flutter|atrial flutter
5766030|NCT00259376|Arrhythmia|arrhythmia
5766031|NCT00259376|Anti-Arrhythmia agents|anti-arrhythmia agents
5766032|NCT00259350|Central venous catheter|central venous catheter
5766033|NCT00259350|Skin disinfection|skin disinfection
5766034|NCT00259350|Antisepsis|antisepsis
5766035|NCT00259350|Nosocomial infection|nosocomial infection
5766036|NCT00259350|Catheter infection|catheter infection
5766037|NCT00259337|Diphteria|diphteria
5766038|NCT00259337|Tetanus|tetanus
5766039|NCT00259337|Polio|polio
5766040|NCT00259337|Acellular Pertussis|acellular pertussis
5766041|NCT00259337|Hib|hib
5766042|NCT00259337|Haemophilus influenzae type B|haemophilus influenzae type b
5766043|NCT00259259|Appetite regulation|appetite regulation
5766044|NCT00259259|Hormones|hormones
5766045|NCT00259259|Energy intake|energy intake
5766046|NCT00259220|Bleeding|bleeding
5766047|NCT00259220|Endoscopy|endoscopy
5766048|NCT00259220|Gastric tube|gastric tube
5766049|NCT00259220|Erythromycin|erythromycin
5766050|NCT00259220|Randomized|randomized
5766051|NCT00259207|Pulmonary valve regurgitation|pulmonary valve regurgitation
5766052|NCT00259207|Valve replacement|valve replacement
5766053|NCT00259207|Hybrid procedure|hybrid procedure
5766054|NCT00259194|Coronary angiography|coronary angiography
5766055|NCT00259194|Complications|complications
5766056|NCT00259194|Observation|observation
5766057|NCT00259181|chlorhexidine gluconate|chlorhexidine gluconate
5766058|NCT00259181|polymethylmethacrylate|polymethylmethacrylate
5766059|NCT00259181|Anti-Bacterial Agents|anti-bacterial agents
5766060|NCT00259168|Postprandial endothelial function|postprandial endothelial function
5766061|NCT00259155|Irritable bowel syndrome, Bacterial overgrowth|irritable bowel syndrome, bacterial overgrowth
5766062|NCT00259142|home management of fever, malaria, Uganda|home management of fever, malaria, uganda
5766063|NCT00259116|Congestive heart failure|congestive heart failure
5766065|NCT00259116|Cardiac hemodynamics|cardiac hemodynamics
5766066|NCT00259103|relaxin|relaxin
5766067|NCT00259103|pregnancy|pregnancy
5766068|NCT00259103|cervical ripening|cervical ripening
5846705|NCT00043680|Photodynamic Therapy|photodynamic therapy
5766069|NCT00259103|normal pregnancy at least at 40 weeks of gestation|normal pregnancy at least at 40 weeks of gestation
5766070|NCT00259038|Carperitide|carperitide
5766071|NCT00259038|Atrial Natriuretic Peptide|atrial natriuretic peptide
5766072|NCT00259038|Treatment efficacy|treatment efficacy
5766073|NCT00259038|Safety|safety
5766074|NCT00259038|Heart failure, Congestive|heart failure, congestive
5766075|NCT00259038|Pulmonary Artery Catheterization|pulmonary artery catheterization
5766077|NCT00259025|Death, sudden, cardiac|death, sudden, cardiac
5766078|NCT00259025|Heart rate variability|heart rate variability
5766079|NCT00259025|Tachycardia, ventricular|tachycardia, ventricular
5766080|NCT00259025|Ventricular premature complexes|ventricular premature complexes
5766081|NCT00259025|Ventricular repolarization|ventricular repolarization
5766082|NCT00259025|Eicosapentaenoic acid|eicosapentaenoic acid
5766083|NCT00259025|Docosahexaenoic acid|docosahexaenoic acid
5766084|NCT00259012|GERD|gerd
5766085|NCT00259012|Infant|infant
5766086|NCT00258999|Skin Cholesterol|skin cholesterol
5766087|NCT00258999|Carotid Plaque|carotid plaque
5766088|NCT00258999|Carotid Intima-Media Thickness|carotid intima-media thickness
5766089|NCT00258986|Living donors|living donors
5766090|NCT00258986|Nephrectomy|nephrectomy
5766091|NCT00258986|Kidney transplantation|kidney transplantation
5766092|NCT00258986|Randomized Controlled Trial|randomized controlled trial
5766093|NCT00258986|Laparoscopy|laparoscopy
5766094|NCT00258973|Hand held Ultrasound|hand held ultrasound
5766095|NCT00258973|Office practice|office practice
5766096|NCT00258973|Atherosclerosis prevention|atherosclerosis prevention
5766097|NCT00258973|Ultrasound training|ultrasound training
5766098|NCT00258960|HER2 positive breast cancer|her2 positive breast cancer
5686342|NCT00552513|intervention|intervention
5686343|NCT00552513|early|early
5686344|NCT00552513|delayed|delayed
5765147|NCT00263328|550|550
5766099|NCT00258960|Metastatic breast cancer|metastatic breast cancer
5766100|NCT00258947|Smallpox|smallpox
5766101|NCT00258947|Orthopoxvirus|orthopoxvirus
5766102|NCT00258947|Poxvirus|poxvirus
5766103|NCT00258947|Vaccina Virus|vaccina virus
5766104|NCT00258947|LISTER Strain|lister strain
5766105|NCT00258947|Bioterrorism|bioterrorism
5766107|NCT00258934|Orthomyxoviruses|orthomyxoviruses
5766108|NCT00258934|Inactivated|inactivated
5766109|NCT00258934|Split-virion influenza vaccine|split-virion influenza vaccine
5766110|NCT00258934|adults|adults
5766111|NCT00258934|Myxovirus Infection|myxovirus infection
5766112|NCT00258934|Orthomyxovirus Infection|orthomyxovirus infection
5766113|NCT00258908|ADACEL™|adacel™
5766114|NCT00258908|Tetanus|tetanus
5766115|NCT00258908|Diphteria|diphteria
5766116|NCT00258908|Acellular pertussis|acellular pertussis
5766117|NCT00258895|DAPTACEL®|daptacel®
5766118|NCT00258895|Pentacel™|pentacel™
5766119|NCT00258895|Diphtheria|diphtheria
5766120|NCT00258895|Tetanus|tetanus
5766121|NCT00258895|Pertussis|pertussis
5766122|NCT00258895|Whooping cough|whooping cough
5766123|NCT00258895|Acellular Pertussis Vaccine Adsorbed|acellular pertussis vaccine adsorbed
5766124|NCT00258882|Tetanus Toxoid,|tetanus toxoid,
5766125|NCT00258882|acellular pertussis,|acellular pertussis,
5766126|NCT00258882|diphtheria toxoid|diphtheria toxoid
5766127|NCT00258869|prospective studies|prospective studies
5766128|NCT00258869|biological assay|biological assay
5766129|NCT00258869|body weights and measures|body weights and measures
5766130|NCT00258869|chemistry, analytical|chemistry, analytical
5766131|NCT00258869|microchip analytical procedures|microchip analytical procedures
5766132|NCT00258869|spectrum analysis, mass|spectrum analysis, mass
5766133|NCT00258869|molecular diagnostic techniques|molecular diagnostic techniques
5766134|NCT00258869|microbiological techniques|microbiological techniques
5769195|NCT00247741|intrathecal|intrathecal
5766135|NCT00258869|drug administration schedule|drug administration schedule
5766136|NCT00258869|data collection|data collection
5766137|NCT00258869|statistics|statistics
5766138|NCT00258869|gene expression profiling|gene expression profiling
5766139|NCT00258869|sequence analysis|sequence analysis
5766140|NCT00258869|human experimentation|human experimentation
5766141|NCT00258869|immunoassay|immunoassay
5766142|NCT00258869|Trauma severity indices|trauma severity indices
5766143|NCT00258869|Glasgow Coma score|glasgow coma score
5766144|NCT00258869|Outcome assessment|outcome assessment
5766145|NCT00258869|mortality|mortality
5766146|NCT00258869|computer models|computer models
5766147|NCT00258869|decision modeling|decision modeling
5766148|NCT00258869|linear models|linear models
5766149|NCT00258869|logistic models|logistic models
5766150|NCT00258869|immunologic model|immunologic model
5766151|NCT00258869|mathematical model|mathematical model
5766152|NCT00258869|non-linear models|non-linear models
5766153|NCT00258869|early diagnosis|early diagnosis
5766154|NCT00258869|diagnosis, computer assisted|diagnosis, computer assisted
5766155|NCT00258869|medical informatics|medical informatics
5766156|NCT00258869|prognosis|prognosis
5766157|NCT00258869|registries|registries
5766158|NCT00258869|computational biology|computational biology
5766159|NCT00258869|systems biology|systems biology
5766160|NCT00258856|Meningitis|meningitis
5766161|NCT00258856|Meningococcal infection|meningococcal infection
5766162|NCT00258856|Neisseria meningitidis|neisseria meningitidis
5766163|NCT00258856|Menactra®|menactra®
5766164|NCT00258856|Menomune®|menomune®
5766165|NCT00258843|IMOVAX;|imovax;
5766166|NCT00258843|poliomyelitis|poliomyelitis
5766167|NCT00258830|Influenza vaccine|influenza vaccine
5766168|NCT00258817|Fluzone®|fluzone®
5766169|NCT00258817|Influenza Virus Vaccine|influenza virus vaccine
5766170|NCT00258791|Psychiatric disorders|psychiatric disorders
5766172|NCT00258791|Headache|headache
5766173|NCT00258791|Ibuprofen|ibuprofen
5766174|NCT00258765|zoledronic acid|zoledronic acid
5766175|NCT00258765|prostate cancer|prostate cancer
5766176|NCT00258765|high risk|high risk
5766178|NCT00258765|docetaxel|docetaxel
5766179|NCT00258752|Prevention|prevention
5766180|NCT00258752|Adolescent|adolescent
5766181|NCT00258726|Measels, Mumps, Varicella, Rubella, vaccine, children|measels, mumps, varicella, rubella, vaccine, children
5766182|NCT00258713|Randomized Controlled Trials|randomized controlled trials
5766183|NCT00258713|Immunosuppression|immunosuppression
5766184|NCT00258713|Adult|adult
5766185|NCT00258713|Chronic Disease|chronic disease
5766186|NCT00258713|Dermatologic Agents|dermatologic agents
5766187|NCT00258713|Female|female
5766188|NCT00258713|Humans|humans
5766189|NCT00258713|Male|male
5766190|NCT00258713|Middle Aged|middle aged
5766191|NCT00258713|Severity of Illness Index|severity of illness index
5766192|NCT00258713|Treatment Outcome|treatment outcome
5766193|NCT00258713|Quality of Life|quality of life
5766194|NCT00258713|Double-Blind Method|double-blind method
5766195|NCT00258687|GVAX|gvax
5765297|NCT00262574|BNP|bnp
5766196|NCT00258687|GM-CSF|gm-csf
5766197|NCT00258687|Adenoviral mediated gene transfer|adenoviral mediated gene transfer
5766198|NCT00258687|Pediatric Melanoma|pediatric melanoma
5766199|NCT00258674|Diabetes|diabetes
5766200|NCT00258674|Care coordination|care coordination
5766201|NCT00258674|Case management|case management
5766202|NCT00258674|Physician profiling|physician profiling
5766203|NCT00258661|Pneumonia|pneumonia
5766204|NCT00258661|Osteopathic|osteopathic
5766205|NCT00258661|Manipulation|manipulation
5766206|NCT00258661|Multi-center|multi-center
5766207|NCT00258661|Elderly|elderly
5766209|NCT00258635|Specific Immunotherapy|specific immunotherapy
5766210|NCT00258622|Peripheral neuropathic pain|peripheral neuropathic pain
5766211|NCT00258622|Neuropathic pain|neuropathic pain
5766212|NCT00258622|Chronic pain|chronic pain
5766213|NCT00258609|Botulinum toxin type A,|botulinum toxin type a,
5766214|NCT00258609|Dysport®,Dysport|dysport®,dysport
5766215|NCT00258609|Migraine without aura,|migraine without aura,
5766216|NCT00258609|Migraine prophylaxis.|migraine prophylaxis.
5766217|NCT00258596|drug-eluting stent|drug-eluting stent
5766218|NCT00258596|chronic total occlusion|chronic total occlusion
5766219|NCT00258596|sirolimus-eluting stent|sirolimus-eluting stent
5766220|NCT00258596|zotarolimus-eluting stent|zotarolimus-eluting stent
5766221|NCT00258596|QCA|qca
5766222|NCT00258583|"Lung[A04.400]"|"lung[a04.400]"
5766223|NCT00258570|"Lung[A04.400]"|"lung[a04.400]"
5766224|NCT00258557|HIV|hiv
5766225|NCT00258557|Anti-Retroviral agents|anti-retroviral agents
5766226|NCT00258557|HIV-1|hiv-1
5766227|NCT00258557|TMC114/r|tmc114/r
5766228|NCT00258557|Treatment naïve patients|treatment naïve patients
5766229|NCT00258544|Lung|lung
5766230|NCT00258544|Fibrosis|fibrosis
5766231|NCT00258544|Idiopathic|idiopathic
5766232|NCT00258544|Microarray|microarray
5766233|NCT00258544|Tissue|tissue
5766234|NCT00258544|Biopsy|biopsy
5766235|NCT00258518|Critically ill patients|critically ill patients
5766236|NCT00258505|Spreading depression|spreading depression
5766237|NCT00258505|Seizures|seizures
5766238|NCT00258505|Blood-brain barrier|blood-brain barrier
5766239|NCT00258492|Restless legs syndrome|restless legs syndrome
5766240|NCT00258492|Insomnia|insomnia
5766241|NCT00258492|Daytime sleepiness|daytime sleepiness
5766242|NCT00258492|Exercise|exercise
5766243|NCT00258479|Nicotine Dependence|nicotine dependence
5766244|NCT00258479|Nicotine Use Disorder|nicotine use disorder
5766245|NCT00258479|Tobacco Dependence|tobacco dependence
5766246|NCT00258466|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5766247|NCT00258466|stage I prostate cancer|stage i prostate cancer
5766248|NCT00258466|stage II prostate cancer|stage ii prostate cancer
5766249|NCT00258466|stage III prostate cancer|stage iii prostate cancer
5766250|NCT00258453|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5766251|NCT00258453|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5766252|NCT00258453|perioperative/postoperative complications|perioperative/postoperative complications
5766254|NCT00258453|childhood craniopharyngioma|childhood craniopharyngioma
5766255|NCT00258440|fatigue|fatigue
5766256|NCT00258440|anemia|anemia
5766257|NCT00258440|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5766258|NCT00258427|Fanconi anemia|fanconi anemia
5766259|NCT00258401|diarrhea|diarrhea
5766260|NCT00258401|radiation toxicity|radiation toxicity
5766261|NCT00258401|recurrent uterine sarcoma|recurrent uterine sarcoma
5766262|NCT00258401|stage I uterine sarcoma|stage i uterine sarcoma
5766263|NCT00258401|stage II uterine sarcoma|stage ii uterine sarcoma
5766264|NCT00258401|stage III uterine sarcoma|stage iii uterine sarcoma
5766265|NCT00258401|stage IV uterine sarcoma|stage iv uterine sarcoma
5766266|NCT00258401|recurrent prostate cancer|recurrent prostate cancer
5766267|NCT00258401|stage I prostate cancer|stage i prostate cancer
5766268|NCT00258401|stage II prostate cancer|stage ii prostate cancer
5766269|NCT00258401|stage III prostate cancer|stage iii prostate cancer
5766270|NCT00258401|stage IV prostate cancer|stage iv prostate cancer
5761372|NCT00278473|CBT|cbt
5766271|NCT00258401|recurrent cervical cancer|recurrent cervical cancer
5766272|NCT00258401|stage 0 cervical cancer|stage 0 cervical cancer
5766273|NCT00258401|stage IA cervical cancer|stage ia cervical cancer
5766274|NCT00258401|stage IB cervical cancer|stage ib cervical cancer
5766275|NCT00258401|stage IIA cervical cancer|stage iia cervical cancer
5766276|NCT00258401|stage IIB cervical cancer|stage iib cervical cancer
5766277|NCT00258401|stage III cervical cancer|stage iii cervical cancer
5766278|NCT00258401|stage IVA cervical cancer|stage iva cervical cancer
5766279|NCT00258401|stage IVB cervical cancer|stage ivb cervical cancer
5766280|NCT00258388|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5766281|NCT00258388|recurrent prostate cancer|recurrent prostate cancer
5766282|NCT00258388|stage IV prostate cancer|stage iv prostate cancer
5766283|NCT00258375|stage IIIA breast cancer|stage iiia breast cancer
5766284|NCT00258375|stage IIIB breast cancer|stage iiib breast cancer
5766285|NCT00258375|stage IIIC breast cancer|stage iiic breast cancer
5766286|NCT00258375|stage IV breast cancer|stage iv breast cancer
5766287|NCT00258375|recurrent breast cancer|recurrent breast cancer
5766288|NCT00258362|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5766289|NCT00258362|stage III endometrial carcinoma|stage iii endometrial carcinoma
5766290|NCT00258362|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5766291|NCT00258336|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5863976|NCT00001148|Circulating Tumor Cells|circulating tumor cells
5766292|NCT00258336|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5766293|NCT00258336|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5766294|NCT00258336|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5766295|NCT00258336|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5766296|NCT00258336|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5766297|NCT00258336|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5766298|NCT00258336|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5766299|NCT00258336|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5766300|NCT00258336|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5766301|NCT00258336|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5766302|NCT00258336|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5766303|NCT00258323|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5766304|NCT00258323|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5766305|NCT00258323|stage II esophageal cancer|stage ii esophageal cancer
5766306|NCT00258323|stage III esophageal cancer|stage iii esophageal cancer
5766307|NCT00258323|stage IV esophageal cancer|stage iv esophageal cancer
5766308|NCT00258310|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5766309|NCT00258310|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5766310|NCT00258310|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5766311|NCT00258310|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5766312|NCT00258310|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5766313|NCT00258310|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5766389|NCT00258115|Inflammation|inflammation
5766314|NCT00258310|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5766315|NCT00258310|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5766316|NCT00258310|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5766317|NCT00258310|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5766318|NCT00258310|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5766319|NCT00258310|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5766320|NCT00258310|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5766321|NCT00258310|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5766322|NCT00258310|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5766323|NCT00258310|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5766324|NCT00258310|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5766325|NCT00258310|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5766326|NCT00258310|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5766327|NCT00258310|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5766328|NCT00258297|stage I esophageal cancer|stage i esophageal cancer
5766329|NCT00258297|stage II esophageal cancer|stage ii esophageal cancer
5766330|NCT00258297|stage III esophageal cancer|stage iii esophageal cancer
5766331|NCT00258297|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5766332|NCT00258297|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5766333|NCT00258284|recurrent prostate cancer|recurrent prostate cancer
5766334|NCT00258284|stage IV prostate cancer|stage iv prostate cancer
5766335|NCT00258284|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5766336|NCT00258271|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5766337|NCT00258271|adult acute basophilic leukemia|adult acute basophilic leukemia
5766338|NCT00258271|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5766339|NCT00258271|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5766340|NCT00258271|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5766341|NCT00258271|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5766342|NCT00258271|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5766343|NCT00258271|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5766344|NCT00258271|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5766345|NCT00258271|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5766346|NCT00258271|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5765396|NCT00261898|Sleep|sleep
5766347|NCT00258271|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5766348|NCT00258271|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5766349|NCT00258258|refractory multiple myeloma|refractory multiple myeloma
5766350|NCT00258245|stage II multiple myeloma|stage ii multiple myeloma
5766351|NCT00258245|stage III multiple myeloma|stage iii multiple myeloma
5681032|NCT00575029|megestrol acetate|megestrol acetate
5681033|NCT00575029|adrenal insufficiency|adrenal insufficiency
5681034|NCT00575029|adrenal suppression|adrenal suppression
5681035|NCT00574990|Interdisciplinary Communication|interdisciplinary communication
5681036|NCT00574990|Safety Management|safety management
5681037|NCT00574990|Management, Medication Therapy|management, medication therapy
5681038|NCT00574990|Cooperative Behavior|cooperative behavior
5681039|NCT00574990|Drug Therapy Management|drug therapy management
5681040|NCT00574990|Physician Nurse Relationships|physician nurse relationships
5681041|NCT00574990|Side Effects|side effects
5681042|NCT00574990|Hospital Information Systems|hospital information systems
5766352|NCT00258245|refractory multiple myeloma|refractory multiple myeloma
5766353|NCT00258245|stage I multiple myeloma|stage i multiple myeloma
5766354|NCT00258232|adenocarcinoma of the colon|adenocarcinoma of the colon
5766355|NCT00258232|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5766356|NCT00258232|recurrent colon cancer|recurrent colon cancer
5766357|NCT00258232|recurrent rectal cancer|recurrent rectal cancer
5766358|NCT00258232|stage IV colon cancer|stage iv colon cancer
5766359|NCT00258232|stage IV rectal cancer|stage iv rectal cancer
5766360|NCT00258206|stage I multiple myeloma|stage i multiple myeloma
5766361|NCT00258206|stage II multiple myeloma|stage ii multiple myeloma
5766362|NCT00258206|stage III multiple myeloma|stage iii multiple myeloma
5766363|NCT00258206|refractory multiple myeloma|refractory multiple myeloma
5766365|NCT00258193|IBS-C|ibs-c
5766366|NCT00258193|Constipation-predominant Irritable Bowel Syndrome|constipation-predominant irritable bowel syndrome
5766367|NCT00258193|Constipation Predominant Irritable Bowel Syndrome|constipation predominant irritable bowel syndrome
5766368|NCT00258193|Irritable Bowel Syndrome|irritable bowel syndrome
5766370|NCT00258193|Transit|transit
5766371|NCT00258193|Scintigraphy|scintigraphy
5766372|NCT00258193|Gastroenterology|gastroenterology
5766373|NCT00258193|Gastrointestinal|gastrointestinal
5766374|NCT00258193|GC|gc
5766375|NCT00258193|MD-1100 Acetate|md-1100 acetate
5766376|NCT00258193|MD-1100|md-1100
5766377|NCT00258193|linaclotide|linaclotide
5766378|NCT00258193|linaclotide acetate|linaclotide acetate
5766379|NCT00258180|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5766380|NCT00258180|gastrointestinal complications|gastrointestinal complications
5766381|NCT00258180|diarrhea|diarrhea
5766382|NCT00258167|Family members|family members
5766383|NCT00258167|Illness burden|illness burden
5766384|NCT00258167|Mental Disorders|mental disorders
5766385|NCT00258167|Family intervention|family intervention
5766386|NCT00258115|Obesity|obesity
5766387|NCT00258115|Metabolic Syndrome|metabolic syndrome
5766390|NCT00258102|levofloxacin|levofloxacin
5766391|NCT00258102|urinary tract infections|urinary tract infections
5766392|NCT00258102|bacterial infections|bacterial infections
5766393|NCT00258102|bacteriuria|bacteriuria
5766394|NCT00258102|urinary anti-infective agents|urinary anti-infective agents
5766395|NCT00258102|urinary infections|urinary infections
5766396|NCT00258102|quinolones|quinolones
5766397|NCT00258089|levofloxacin|levofloxacin
5766398|NCT00258089|urinary tract infections|urinary tract infections
5766399|NCT00258089|bacterial infections|bacterial infections
5766400|NCT00258089|bacteriuria|bacteriuria
5766401|NCT00258089|urinary anti-infective agents|urinary anti-infective agents
5766402|NCT00258089|urinary infections|urinary infections
5766403|NCT00258089|quinolones|quinolones
5766404|NCT00258076|Transdermal contraception|transdermal contraception
5766405|NCT00258076|contraceptive|contraceptive
5766406|NCT00258076|hormonal, steroid contraception|hormonal, steroid contraception
5766407|NCT00258076|ethinyl estradiol|ethinyl estradiol
5766408|NCT00258076|progesterone|progesterone
5766409|NCT00258076|EVRA|evra
5766410|NCT00258063|Transdermal contraception|transdermal contraception
5766411|NCT00258063|contraceptive|contraceptive
5766412|NCT00258063|hormonal, steroid contraception|hormonal, steroid contraception
5766413|NCT00258063|ethinyl estradiol|ethinyl estradiol
5766414|NCT00258063|progesterone|progesterone
5766415|NCT00258063|EVRA|evra
5766416|NCT00258063|CILEST|cilest
5766417|NCT00258063|ORTHO EVRA|ortho evra
5766418|NCT00258050|midazolam|midazolam
5766419|NCT00258050|pharmacokinetics|pharmacokinetics
5766420|NCT00258050|lapatinib|lapatinib
5766421|NCT00258037|Physiotherapy|physiotherapy
5766422|NCT00258037|Stroke|stroke
5766423|NCT00258037|Urinary Incontinence|urinary incontinence
5766424|NCT00258037|quality of Life|quality of life
5863977|NCT00001148|Mutation|mutation
5793036|NCT00131885|Women|women
5766425|NCT00258024|IPT-SP, pregnancy, malaria,Ghana|ipt-sp, pregnancy, malaria,ghana
5766426|NCT00258011|MPS I Disease|mps i disease
5766427|NCT00257985|Familial hemiplegic migraine type 1 and 2|familial hemiplegic migraine type 1 and 2
5766428|NCT00257985|GTN|gtn
5766429|NCT00257985|middle cerebral artery|middle cerebral artery
5766430|NCT00257985|superficial temporal artery|superficial temporal artery
5766431|NCT00257985|headache|headache
5766432|NCT00257985|genotype|genotype
5766433|NCT00257972|Bipolar Mania|bipolar mania
5766434|NCT00257946|Diaphragm|diaphragm
5766435|NCT00257946|Hernia|hernia
5766436|NCT00257946|Congenital|congenital
5766437|NCT00257933|Corticosteroids|corticosteroids
5766438|NCT00257933|Treatment|treatment
5766439|NCT00257933|Pediatric|pediatric
5766440|NCT00257920|Stage 5 Chronic Kidney Disease (CKD)|stage 5 chronic kidney disease (ckd)
5766441|NCT00257907|Latent Tuberculosis|latent tuberculosis
5766442|NCT00257907|PPD|ppd
5766443|NCT00257907|Antigen Specific T-Cells|antigen specific t-cells
5766444|NCT00257907|Lymphocyte Proliferation Assay|lymphocyte proliferation assay
5766445|NCT00257907|HIV|hiv
5766446|NCT00257907|LPA|lpa
5766447|NCT00257894|Baclofen|baclofen
5766448|NCT00257894|Conditioning, Classical|conditioning, classical
5766449|NCT00257894|Nicotine|nicotine
5766450|NCT00257894|Smoking|smoking
5766451|NCT00257881|Tumor|tumor
5766452|NCT00257855|Secondary Progressive Multiple Sclerosis|secondary progressive multiple sclerosis
5766453|NCT00257855|Neuroprotection|neuroprotection
5766454|NCT00257855|Axonal loss|axonal loss
5766455|NCT00257855|Brain atrophy|brain atrophy
5766456|NCT00257855|MRI|mri
5766457|NCT00257855|Lamotrigine|lamotrigine
5766458|NCT00257855|Sodium Channel Blockers|sodium channel blockers
5766459|NCT00257829|Cervical Cancer|cervical cancer
5766460|NCT00257816|Cervical Cancer|cervical cancer
5766461|NCT00257816|Topotecan|topotecan
5766462|NCT00257816|Cisplatin|cisplatin
5766463|NCT00257803|Oxytocin, bolus, postpartum hemorrhage|oxytocin, bolus, postpartum hemorrhage
5766464|NCT00257790|Fever|fever
5766465|NCT00257790|Neutropenia|neutropenia
5766466|NCT00257790|Tobramycin|tobramycin
5766467|NCT00257790|Aminoglycoside|aminoglycoside
5766468|NCT00257790|Penicillin|penicillin
5766469|NCT00257764|Swallowing disorder|swallowing disorder
5766470|NCT00257764|Stroke|stroke
5766471|NCT00257764|Standardized swallowing therapy|standardized swallowing therapy
5766472|NCT00257764|Randomized controlled trial|randomized controlled trial
5766473|NCT00257725|ADHD|adhd
5766474|NCT00257725|Attention-deficit/hyperactivity disorder (ADHD)|attention-deficit/hyperactivity disorder (adhd)
5766475|NCT00257712|Alzheimer's disease|alzheimer's disease
5766476|NCT00257712|cognition disorders|cognition disorders
5766477|NCT00257699|Crohn's Disease|crohn's disease
5766478|NCT00257699|Randomized|randomized
5766479|NCT00257699|Ciprofloxacin|ciprofloxacin
5766480|NCT00257699|Metronidazole|metronidazole
5766481|NCT00257699|Antibiotic|antibiotic
5766482|NCT00257686|Kowa|kowa
5766483|NCT00257686|Hypercholesterolemia|hypercholesterolemia
5766484|NCT00257686|combined|combined
5766485|NCT00257686|dyslipidemia|dyslipidemia
5766486|NCT00257686|elderly|elderly
5766487|NCT00257686|pitavastatin|pitavastatin
5766488|NCT00257686|NK-104|nk-104
5766489|NCT00257673|Cognition|cognition
5766490|NCT00257673|Alzheimer's|alzheimer's
5766491|NCT00257673|Cognitive impairment|cognitive impairment
5766795|NCT00256204|Parkinson's|parkinson's
5766492|NCT00257634|lateral epicondylitis|lateral epicondylitis
5766493|NCT00257634|iontophoresis|iontophoresis
5766494|NCT00257634|dexamethasone|dexamethasone
5766495|NCT00257621|HIV-1 protease inhibitor GW640385 ritonavir RTV|hiv-1 protease inhibitor gw640385 ritonavir rtv
5766496|NCT00257608|NSCLC|nsclc
5766497|NCT00257608|Lung Cancer|lung cancer
5766498|NCT00257608|ATLAS|atlas
5766499|NCT00257608|Avastin|avastin
5766500|NCT00257608|Tarceva|tarceva
5766501|NCT00257595|Perennial Allergic Rhinitis pediatric|perennial allergic rhinitis pediatric
5766502|NCT00257582|cetirizine|cetirizine
5766503|NCT00257582|various type of cutaneous disease accompanied with Pruritus|various type of cutaneous disease accompanied with pruritus
5766504|NCT00257582|pediatrics|pediatrics
5766505|NCT00257569|Atopic|atopic
5766506|NCT00257569|Pediatric|pediatric
5766507|NCT00257569|Dermatitis|dermatitis
5766508|NCT00257543|sickle cell disease|sickle cell disease
5766509|NCT00257543|bone marrow transplant|bone marrow transplant
5766510|NCT00257517|Congenital heart disease|congenital heart disease
5766511|NCT00257517|Single ventricle|single ventricle
5766512|NCT00257517|Infant feeding|infant feeding
5766513|NCT00257478|Treatment Efficacy|treatment efficacy
5766514|NCT00257478|Treatment Effectiveness|treatment effectiveness
5766515|NCT00257478|Disease Management|disease management
5766518|NCT00257465|melanoma|melanoma
5766519|NCT00257465|metastatic|metastatic
5766521|NCT00257465|immunotherapy|immunotherapy
5766522|NCT00257465|autologous|autologous
5766523|NCT00257439|Vitamin B12|vitamin b12
5766524|NCT00257439|Folic Acid|folic acid
5766525|NCT00257426|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5766526|NCT00257426|advanced adult primary liver cancer|advanced adult primary liver cancer
5775784|NCT00218543|ADHD|adhd
5766527|NCT00257426|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5766528|NCT00257426|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5766529|NCT00257400|major depressive disorder|major depressive disorder
5766530|NCT00257400|psychotherapy|psychotherapy
5765609|NCT00260988|Innohep|innohep
5766531|NCT00257400|childhood sexual abuse|childhood sexual abuse
5766532|NCT00257400|trauma|trauma
5766533|NCT00257387|Kidney|kidney
5766534|NCT00257387|Kidney Transplant|kidney transplant
5766535|NCT00257348|Advanced Cervical Carcinoma|advanced cervical carcinoma
5766536|NCT00257348|Recurrent Cervical Carcinoma|recurrent cervical carcinoma
5766537|NCT00257335|Carcinoma of the head and neck|carcinoma of the head and neck
5766538|NCT00257322|Metastatic colon cancer|metastatic colon cancer
5766539|NCT00257322|Metastatic rectal cancer|metastatic rectal cancer
5766540|NCT00257309|Acute myocardial infarction|acute myocardial infarction
5766541|NCT00257309|Elderly|elderly
5766542|NCT00257309|Thrombolysis|thrombolysis
5766543|NCT00257309|Primary angioplasty|primary angioplasty
5766544|NCT00257309|Randomized trial|randomized trial
5766545|NCT00257309|Efficacy|efficacy
5766546|NCT00257309|Safety|safety
5766547|NCT00257283|Chronic renal failure|chronic renal failure
5766548|NCT00257283|Hemodialysis|hemodialysis
5766549|NCT00257283|OMACOR (omega-3-acid ethyl ester 90)|omacor (omega-3-acid ethyl ester 90)
5766550|NCT00257283|intervention study|intervention study
5766551|NCT00257283|cardiovascular events|cardiovascular events
5766552|NCT00257283|mortality|mortality
5766553|NCT00257270|Chronic|chronic
5766554|NCT00257270|Tinnitus|tinnitus
5766555|NCT00257270|Acoustic trauma|acoustic trauma
5766556|NCT00257270|Psychophysics|psychophysics
5766557|NCT00257270|Loudness match|loudness match
5766558|NCT00257270|gabapentin|gabapentin
5766559|NCT00257257|Type 2 diabetes mellitus|type 2 diabetes mellitus
5766560|NCT00257244|Immunity, innate|immunity, innate
5766561|NCT00257244|Inflammation|inflammation
5766562|NCT00257244|Genomics|genomics
5766563|NCT00257244|Proteomics|proteomics
5766564|NCT00257231|Immunity, innate|immunity, innate
5766565|NCT00257231|Inflammation|inflammation
5766566|NCT00257231|Genomics|genomics
5766567|NCT00257231|Proteomics|proteomics
5766568|NCT00257192|Adolescent Subjects With Schizophrenia|adolescent subjects with schizophrenia
5766569|NCT00257179|Tissue factor|tissue factor
5766570|NCT00257179|Lung cancer|lung cancer
5766571|NCT00257179|Tissue factor protein inhibitor|tissue factor protein inhibitor
5766572|NCT00257179|Factor VII|factor vii
5766573|NCT00257179|Factor X|factor x
5766574|NCT00257153|Acute myocardial infarction|acute myocardial infarction
5766575|NCT00257153|primary angioplasty|primary angioplasty
5766576|NCT00257153|myocardial reperfusion|myocardial reperfusion
5766577|NCT00257153|thrombus aspiration|thrombus aspiration
5766578|NCT00257140|Bronchitis|bronchitis
5766579|NCT00257140|chronic bronchitis|chronic bronchitis
5766580|NCT00257140|lung diseases|lung diseases
5766581|NCT00257140|respiratory tract infections|respiratory tract infections
5766582|NCT00257140|bronchial diseases|bronchial diseases
5766583|NCT00257140|antibacterial agents|antibacterial agents
5766584|NCT00257140|quinolones|quinolones
5766585|NCT00257140|levofloxacin|levofloxacin
5766586|NCT00257127|Vaccination|vaccination
5766587|NCT00257114|Multiple Myeloma|multiple myeloma
5766588|NCT00257114|Retreatment|retreatment
5766589|NCT00257114|VELCADE|velcade
5766590|NCT00257088|development|development
5766591|NCT00257088|epidemiology|epidemiology
5766592|NCT00257088|risk factors|risk factors
5766593|NCT00257088|randomized field trials|randomized field trials
5766594|NCT00257075|risperidone|risperidone
5766595|NCT00257075|antipsychotic agents|antipsychotic agents
5766596|NCT00257075|bipolar disorders|bipolar disorders
5766597|NCT00257075|manic episode|manic episode
5766598|NCT00257062|Infectious skin diseases|infectious skin diseases
5766599|NCT00257062|skin diseases|skin diseases
5766600|NCT00257062|bacterial skin diseases|bacterial skin diseases
5766601|NCT00257062|antibacterial agents|antibacterial agents
5766602|NCT00257062|quinolones|quinolones
5766603|NCT00257062|levofloxacin|levofloxacin
5766604|NCT00257049|Pneumonia|pneumonia
5766605|NCT00257049|lung inflammation|lung inflammation
5766606|NCT00257049|bacterial pneumonia|bacterial pneumonia
5766607|NCT00257049|lung diseases|lung diseases
5766608|NCT00257049|respiratory tract infections|respiratory tract infections
5766609|NCT00257049|antibacterial agents|antibacterial agents
5766610|NCT00257049|quinolones|quinolones
5766611|NCT00257049|levofloxacin|levofloxacin
5766612|NCT00257036|Infectious skin diseases|infectious skin diseases
5766613|NCT00257036|skin diseases|skin diseases
5766614|NCT00257036|bacterial skin diseases|bacterial skin diseases
5766615|NCT00257036|cellulitis|cellulitis
5766616|NCT00257036|quinolones|quinolones
5766617|NCT00257036|levofloxacin|levofloxacin
5766618|NCT00257023|Schizophrenia|schizophrenia
5766619|NCT00257023|Risperidone|risperidone
5766620|NCT00257023|Positive and Negative Syndrome Scale (PANSS)|positive and negative syndrome scale (panss)
5766621|NCT00257023|Clinical Global Impression (CGI)|clinical global impression (cgi)
5863978|NCT00001148|Anaplastic Astrocytoma|anaplastic astrocytoma
5766622|NCT00257023|Positron Emission Tomography (PET)|positron emission tomography (pet)
5766623|NCT00257010|Migraine|migraine
5766624|NCT00257010|Almotriptan Malate|almotriptan malate
5766625|NCT00257010|Headache|headache
5766626|NCT00257010|Triptan|triptan
5766627|NCT00256997|Schizophrenia|schizophrenia
5765715|NCT00260598|COPD|copd
5766628|NCT00256997|Risperidone|risperidone
5766629|NCT00256997|Risperdal Consta|risperdal consta
5766630|NCT00256984|Obstructive Defecation Syndrome|obstructive defecation syndrome
5766631|NCT00256984|Colorectal Surgery|colorectal surgery
5766632|NCT00256984|Defecography|defecography
5766633|NCT00256984|Constipation|constipation
5766634|NCT00256984|Rectocele|rectocele
5766635|NCT00256984|Intussusception|intussusception
5766636|NCT00256984|Quality of Life|quality of life
5766637|NCT00256945|biofilm formation|biofilm formation
5766638|NCT00256945|dental plaque|dental plaque
5766639|NCT00256945|surface roughness|surface roughness
5766640|NCT00256945|dental restoration|dental restoration
5766641|NCT00256945|dental materials|dental materials
5766642|NCT00256932|bowel dysfunction|bowel dysfunction
5766643|NCT00256932|constipation|constipation
5766644|NCT00256932|gastrointestinal|gastrointestinal
5766645|NCT00256932|opioids|opioids
5766646|NCT00256932|pain|pain
5766647|NCT00256932|non-cancer pain|non-cancer pain
5766648|NCT00256932|Opioid-induced|opioid-induced
5766649|NCT00256919|GW856553|gw856553
5766650|NCT00256919|biomarkers|biomarkers
5766652|NCT00256919|rheumatoid arthritis|rheumatoid arthritis
5766653|NCT00256906|lateral ventricles|lateral ventricles
5766654|NCT00256906|fetal ventriculomegaly|fetal ventriculomegaly
5766655|NCT00256893|pain intensity|pain intensity
5766656|NCT00256893|numerical rating scale|numerical rating scale
5766657|NCT00256893|fibromyalgia|fibromyalgia
5766658|NCT00256880|Pazopanib(GW786034)|pazopanib(gw786034)
5766659|NCT00256880|Solid Tumors|solid tumors
5766660|NCT00256880|Myeloma|myeloma
5766661|NCT00256867|Type 2 diabetes Type II|type 2 diabetes type ii
5766662|NCT00256854|RLS|rls
5766664|NCT00256854|Restless Legs Syndrome|restless legs syndrome
5766665|NCT00256841|Hypofractionated Chest Radiation|hypofractionated chest radiation
5766666|NCT00256841|Taxotere|taxotere
5766667|NCT00256841|5-FU|5-fu
5766668|NCT00256828|HIV infection|hiv infection
5766669|NCT00256828|Highly active antiretroviral therapy|highly active antiretroviral therapy
5766670|NCT00256828|Treatment Naive|treatment naive
5766671|NCT00256815|Hypofractionated chest radiation|hypofractionated chest radiation
5766672|NCT00256815|Oral Navelbine|oral navelbine
5766673|NCT00256802|Headache|headache
5766674|NCT00256802|migraine|migraine
5766675|NCT00256802|MR-angiography|mr-angiography
5766676|NCT00256802|healthy volunteers|healthy volunteers
5766677|NCT00256802|GTN|gtn
5766678|NCT00256802|Middle cerebral artery|middle cerebral artery
5766679|NCT00256789|NSCLC, Non-Small Cell Lung Cancer,Weekly Radiation, Taxotere|nsclc, non-small cell lung cancer,weekly radiation, taxotere
5766680|NCT00256776|Multiple Myeloma|multiple myeloma
5766681|NCT00256776|Velcade|velcade
5766682|NCT00256776|Autologous transplantation|autologous transplantation
5766683|NCT00256776|Relapse|relapse
5766684|NCT00256776|Disease progress|disease progress
5766685|NCT00256737|Maintenance of healed erosive esophagitis|maintenance of healed erosive esophagitis
5766686|NCT00256724|hypotension|hypotension
5766687|NCT00256724|hypovolemia|hypovolemia
5766688|NCT00256724|dehydration|dehydration
5766689|NCT00256724|sepsis|sepsis
5766690|NCT00256724|blood loss|blood loss
5766691|NCT00256711|Locally advanced or metastatic NSCLC.|locally advanced or metastatic nsclc.
5766692|NCT00256711|Stage IIIb or Stage IV lung cancer|stage iiib or stage iv lung cancer
5766693|NCT00256698|Hormone|hormone
5766694|NCT00256698|receptor|receptor
5766695|NCT00256698|positive|positive
5766696|NCT00256698|breast|breast
5766697|NCT00256698|cancer|cancer
5766698|NCT00256698|first|first
5766699|NCT00256698|relapse|relapse
5766700|NCT00256685|Menopause|menopause
5766701|NCT00256672|Spinal Cord Injury|spinal cord injury
5766702|NCT00256672|TLSO brace|tlso brace
5766703|NCT00256672|Spine curvature|spine curvature
5766704|NCT00256672|Child|child
5766705|NCT00256672|Effectiveness of bracing|effectiveness of bracing
5766706|NCT00256659|Medical inpatients|medical inpatients
5766707|NCT00256659|Social Work|social work
5766708|NCT00256659|Physical therapy|physical therapy
5766710|NCT00256659|Psychiatry|psychiatry
5766711|NCT00256659|Early intervention|early intervention
5766712|NCT00256659|Iatrogenic complications|iatrogenic complications
5766713|NCT00256620|Cardiopulmonary bypass|cardiopulmonary bypass
5766714|NCT00256620|Coronary artery disease|coronary artery disease
5766715|NCT00256620|Cardiac morbidity|cardiac morbidity
5766717|NCT00256620|Neurocognitive function|neurocognitive function
5766718|NCT00256620|Autoregulation|autoregulation
5766719|NCT00256594|Medical Errors|medical errors
5766720|NCT00256594|Medication Errors|medication errors
5766721|NCT00256594|Prescriptions, Drug|prescriptions, drug
5766722|NCT00256581|myocardial perfusion|myocardial perfusion
5766723|NCT00256581|Imaging|imaging
5766724|NCT00256568|Medical Errors|medical errors
5766725|NCT00256568|Medication Errors|medication errors
5863979|NCT00001147|Dopamine|dopamine
5766726|NCT00256568|Prescriptions, Drug|prescriptions, drug
5766727|NCT00256568|Pharmacies|pharmacies
5766728|NCT00256568|Ambulatory Care Facilities|ambulatory care facilities
5766729|NCT00256542|interstitial cystitis|interstitial cystitis
5766730|NCT00256542|pelvic pain|pelvic pain
5765884|NCT00260078|PK|pk
5766731|NCT00256542|urgency|urgency
5766732|NCT00256542|frequency|frequency
5766733|NCT00256542|Pelvic Pain and/or Urgency of Bladder Origin|pelvic pain and/or urgency of bladder origin
5766734|NCT00256529|dysphagia|dysphagia
5766735|NCT00256529|eosinophilic esophagitis|eosinophilic esophagitis
5766736|NCT00256516|Diet Therapy|diet therapy
5766737|NCT00256503|Primary Insomnia|primary insomnia
5766738|NCT00256503|Insomnia|insomnia
5766739|NCT00256503|Sleep|sleep
5766740|NCT00256490|Diffuse large B cells lymphoma|diffuse large b cells lymphoma
5766741|NCT00256490|PET/CT|pet/ct
5766743|NCT00256464|PTSD|ptsd
5766744|NCT00256451|Naltrexone|naltrexone
5766745|NCT00256451|Alcohol|alcohol
5766746|NCT00256438|Depression|depression
5766747|NCT00256438|Transcranial Direct Current Stimulation|transcranial direct current stimulation
5766748|NCT00256425|glioma|glioma
5766749|NCT00256425|brain tumor|brain tumor
5766750|NCT00256425|cognit|cognit
5766751|NCT00256425|neuropsycholog|neuropsycholog
5766752|NCT00256425|attention|attention
5766753|NCT00256425|memory|memory
5766754|NCT00256425|executive function|executive function
5766755|NCT00256425|rehabilitation|rehabilitation
5766756|NCT00256425|remediation|remediation
5766757|NCT00256425|training|training
5766758|NCT00256386|Baseline|baseline
5766759|NCT00256386|Laboratory|laboratory
5766760|NCT00256386|Drug|drug
5766761|NCT00256373|Low Back Pain|low back pain
5766762|NCT00256373|Dynamic Back-Muscle exercise Treatment|dynamic back-muscle exercise treatment
5766763|NCT00256373|Interdisciplinary Treatment|interdisciplinary treatment
5766764|NCT00256373|Roland Morris Disability Questionnaire|roland morris disability questionnaire
5766765|NCT00256373|SF-36|sf-36
5766766|NCT00256373|Low Back Pain Rating Scale|low back pain rating scale
5766767|NCT00256360|breast cancer|breast cancer
5766768|NCT00256360|adjuvant|adjuvant
5766769|NCT00256360|dose dense|dose dense
5766770|NCT00256360|docetaxel|docetaxel
5766771|NCT00256360|pegfilgrastim|pegfilgrastim
5766772|NCT00256334|Colon Cancer|colon cancer
5766773|NCT00256334|Resveratrol|resveratrol
5766774|NCT00256334|Clinical Trial|clinical trial
5766775|NCT00256334|WnT signaling|wnt signaling
5766776|NCT00256334|Grapes|grapes
5766777|NCT00256334|Cancer prevention|cancer prevention
5766778|NCT00256321|Gastric Carcinoma|gastric carcinoma
5766779|NCT00256321|Gastroesophageal junction Carcinoma|gastroesophageal junction carcinoma
5766780|NCT00256308|Head and Neck Cancer|head and neck cancer
5766781|NCT00256308|oxaliplatin|oxaliplatin
5766782|NCT00256308|resected squamous cell carcinoma|resected squamous cell carcinoma
5766783|NCT00256308|Eloxatin™|eloxatin™
5766784|NCT00256295|Cancer of the Head and Neck|cancer of the head and neck
5766785|NCT00256282|Metastatic Melanoma|metastatic melanoma
5766786|NCT00256269|Esophageal Cancer|esophageal cancer
5766787|NCT00256269|Gastroesophageal junction cancer|gastroesophageal junction cancer
5766788|NCT00256269|Oxaliplatin|oxaliplatin
5766789|NCT00256269|Irinotecan|irinotecan
5766790|NCT00256256|type 2 diabetes|type 2 diabetes
5766791|NCT00256256|GLP-1|glp-1
5766792|NCT00256256|PET|pet
5766793|NCT00256256|brain|brain
5766794|NCT00256256|heart|heart
5766796|NCT00256204|Rasagiline Mesylate|rasagiline mesylate
5766797|NCT00256191|taxanes|taxanes
5766798|NCT00256191|multidrug resistance|multidrug resistance
5766799|NCT00256191|mutant tubulin binding|mutant tubulin binding
5766800|NCT00256191|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
5766801|NCT00256178|Hyperlipidemia|hyperlipidemia
5766802|NCT00256178|Drug Therapy|drug therapy
5766803|NCT00256165|Aortic valve replacement|aortic valve replacement
5766804|NCT00256152|Atrial fibrillation|atrial fibrillation
5766805|NCT00256152|Pacemaker|pacemaker
5766806|NCT00256152|AF suppression pacing|af suppression pacing
5766807|NCT00256152|Indications for Pacemaker Implantation due to sinus node or atrio-ventricular node disease|indications for pacemaker implantation due to sinus node or atrio-ventricular node disease
5766808|NCT00256113|depression|depression
5766809|NCT00256113|antidepressive agents|antidepressive agents
5766810|NCT00256113|controlled clinical trial|controlled clinical trial
5766811|NCT00256087|Nosocomial rates in critically ill patients|nosocomial rates in critically ill patients
5766812|NCT00256009|Late abortion|late abortion
5766813|NCT00255983|bronchitis|bronchitis
5766814|NCT00255983|AECB|aecb
5761863|NCT00276783|adult glioblastoma|adult glioblastoma
5766815|NCT00255970|Periodontal Treatment of Intraosseous Vertical Defects|periodontal treatment of intraosseous vertical defects
5766816|NCT00255957|Stroke, HES, Coagulation, Kinetics, Hemorehology|stroke, hes, coagulation, kinetics, hemorehology
5766817|NCT00255944|HIV Prevention|hiv prevention
5766818|NCT00255944|Internet Intervention|internet intervention
5783866|NCT00175786|MRI|mri
5766819|NCT00255944|STDs|stds
5766820|NCT00255931|Heart Failure|heart failure
5766821|NCT00255931|Biofeedback-Relaxation|biofeedback-relaxation
5766822|NCT00255931|Cognitive Behavioral Therapy|cognitive behavioral therapy
5766823|NCT00255918|Evoked Potentials|evoked potentials
5766824|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine
5766825|NCT00255918|DMXB-A|dmxb-a
5766826|NCT00255918|Receptors, Nicotinic|receptors, nicotinic
5766827|NCT00255905|Depression|depression
5766828|NCT00255905|Insomnia|insomnia
5766829|NCT00255892|HIV|hiv
5766830|NCT00255879|Schizophrenia|schizophrenia
5766831|NCT00255879|Neuroleptic|neuroleptic
5766832|NCT00255879|Tardive dyskinesia|tardive dyskinesia
5766833|NCT00255866|Assisted Living Facilities|assisted living facilities
5766834|NCT00255866|Aged|aged
5766835|NCT00255866|Elderly|elderly
5766836|NCT00255866|Caregivers|caregivers
5766837|NCT00255840|Treatment Naive|treatment naive
5766838|NCT00255814|liver metastases|liver metastases
5766839|NCT00255801|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5766840|NCT00255801|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5766841|NCT00255801|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5766842|NCT00255801|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5766843|NCT00255801|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5766844|NCT00255801|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5766845|NCT00255801|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5766846|NCT00255801|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5766847|NCT00255801|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5766848|NCT00255801|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5766849|NCT00255788|recurrent breast cancer|recurrent breast cancer
5766850|NCT00255788|stage IV breast cancer|stage iv breast cancer
5766851|NCT00255788|male breast cancer|male breast cancer
5766852|NCT00255775|non-small cell lung cancer|non-small cell lung cancer
5766853|NCT00255775|small cell lung cancer|small cell lung cancer
5766854|NCT00255749|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5766919|NCT00255749|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5766855|NCT00255749|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5766856|NCT00255749|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5766857|NCT00255749|anemia|anemia
5766858|NCT00255749|extramedullary plasmacytoma|extramedullary plasmacytoma
5766859|NCT00255749|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5767381|NCT00254579|malignant melanoma|malignant melanoma
5766860|NCT00255749|refractory multiple myeloma|refractory multiple myeloma
5766861|NCT00255749|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5766862|NCT00255749|primary systemic amyloidosis|primary systemic amyloidosis
5766863|NCT00255749|stage I multiple myeloma|stage i multiple myeloma
5766864|NCT00255749|stage II multiple myeloma|stage ii multiple myeloma
5766865|NCT00255749|stage III multiple myeloma|stage iii multiple myeloma
5766866|NCT00255749|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5766867|NCT00255749|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5766868|NCT00255749|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5766869|NCT00255749|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5766870|NCT00255749|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5766871|NCT00255749|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5766872|NCT00255749|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5766873|NCT00255749|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5767516|NCT00254007|citalopram|citalopram
5766874|NCT00255749|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5766875|NCT00255749|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5766876|NCT00255749|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5766877|NCT00255749|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5766878|NCT00255749|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5766879|NCT00255749|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5766880|NCT00255749|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5766881|NCT00255749|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5766882|NCT00255749|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5766883|NCT00255749|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5766884|NCT00255749|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5766885|NCT00255749|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5766886|NCT00255749|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5766888|NCT00255749|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5766889|NCT00255749|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5766890|NCT00255749|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5766891|NCT00255749|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5862945|NCT00001453|Corticotropin Releasing Hormone|corticotropin releasing hormone
5766892|NCT00255749|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5766893|NCT00255749|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5766894|NCT00255749|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5766895|NCT00255749|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5766896|NCT00255749|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5766897|NCT00255749|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5766898|NCT00255749|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5766899|NCT00255749|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5766900|NCT00255749|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5766901|NCT00255749|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5766902|NCT00255749|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5766903|NCT00255749|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5766904|NCT00255749|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5766905|NCT00255749|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5766906|NCT00255749|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5766907|NCT00255749|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5766908|NCT00255749|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5766909|NCT00255749|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5766910|NCT00255749|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5766911|NCT00255749|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5766912|NCT00255749|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5766913|NCT00255749|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5766914|NCT00255749|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5766915|NCT00255749|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5766916|NCT00255749|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5766917|NCT00255749|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5766918|NCT00255749|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5767489|NCT00254111|hand pain|hand pain
5766920|NCT00255749|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5766921|NCT00255749|Waldenström macroglobulinemia|waldenström macroglobulinemia
5766922|NCT00255749|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5766923|NCT00255749|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5766924|NCT00255749|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5766925|NCT00255749|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5766926|NCT00255749|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5766927|NCT00255749|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5766928|NCT00255749|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5766929|NCT00255749|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5766930|NCT00255749|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5766931|NCT00255749|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5766932|NCT00255749|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5766933|NCT00255749|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5766934|NCT00255749|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5766935|NCT00255749|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5766936|NCT00255749|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5766937|NCT00255749|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5766938|NCT00255749|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5766939|NCT00255749|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5766940|NCT00255749|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5766941|NCT00255749|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5766942|NCT00255749|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5766943|NCT00255749|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5766944|NCT00255749|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5766945|NCT00255749|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5766946|NCT00255749|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5848599|NCT00034229|Bipolar Depression|bipolar depression
5766948|NCT00255749|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5766949|NCT00255749|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5767509|NCT00254020|cytokines|cytokines
5766950|NCT00255749|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5766951|NCT00255749|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5766952|NCT00255749|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5766953|NCT00255749|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5766954|NCT00255749|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5766955|NCT00255749|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5766956|NCT00255749|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5766957|NCT00255749|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5766958|NCT00255749|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5766959|NCT00255749|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5766960|NCT00255749|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5766961|NCT00255749|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5766962|NCT00255749|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5766963|NCT00255749|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5766964|NCT00255749|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5766965|NCT00255749|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5766966|NCT00255749|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5766967|NCT00255749|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5766968|NCT00255749|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5766969|NCT00255749|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5766970|NCT00255749|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5766971|NCT00255749|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5766972|NCT00255749|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5766973|NCT00255749|refractory hairy cell leukemia|refractory hairy cell leukemia
5766974|NCT00255749|prolymphocytic leukemia|prolymphocytic leukemia
5766975|NCT00255749|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5766976|NCT00255749|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5766977|NCT00255723|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5766978|NCT00255723|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5766979|NCT00255723|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5766980|NCT00255723|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5766981|NCT00255710|graft versus host disease|graft versus host disease
5766982|NCT00255710|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5766983|NCT00255710|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5766984|NCT00255710|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5766985|NCT00255710|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5766986|NCT00255710|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5766987|NCT00255710|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5766988|NCT00255710|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5766989|NCT00255710|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5766990|NCT00255710|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5766991|NCT00255710|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5766992|NCT00255710|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5766993|NCT00255710|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5766994|NCT00255710|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5766995|NCT00255710|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5766996|NCT00255710|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5766997|NCT00255710|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5766998|NCT00255710|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5766999|NCT00255710|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5767000|NCT00255710|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5767001|NCT00255710|stage II multiple myeloma|stage ii multiple myeloma
5767002|NCT00255710|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5767003|NCT00255710|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5762124|NCT00275275|PD|pd
5767004|NCT00255710|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5767005|NCT00255710|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5767006|NCT00255710|stage III multiple myeloma|stage iii multiple myeloma
5767007|NCT00255710|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5767008|NCT00255710|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5767009|NCT00255710|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5767010|NCT00255710|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5767011|NCT00255710|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5767012|NCT00255710|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5767013|NCT00255710|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5767014|NCT00255710|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5767015|NCT00255710|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5775406|NCT00220662|bulimia nervosa|bulimia nervosa
5767016|NCT00255710|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5767017|NCT00255710|refractory anemia with excess blasts|refractory anemia with excess blasts
5767018|NCT00255710|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5767019|NCT00255710|primary systemic amyloidosis|primary systemic amyloidosis
5767020|NCT00255710|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5767021|NCT00255710|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5767022|NCT00255710|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5767023|NCT00255710|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5767024|NCT00255697|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5767025|NCT00255697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5767026|NCT00255684|graft versus host disease|graft versus host disease
5767027|NCT00255684|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5767028|NCT00255684|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5767029|NCT00255684|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5767030|NCT00255684|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5767031|NCT00255684|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5767032|NCT00255684|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5767033|NCT00255684|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5767034|NCT00255684|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5767035|NCT00255684|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5767036|NCT00255684|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5767037|NCT00255684|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5767038|NCT00255684|acute undifferentiated leukemia|acute undifferentiated leukemia
5767039|NCT00255684|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5767040|NCT00255684|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5767041|NCT00255684|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5767287|NCT00254995|Meningococcal disease|meningococcal disease
5767042|NCT00255684|refractory anemia with excess blasts|refractory anemia with excess blasts
5767043|NCT00255684|refractory anemia|refractory anemia
5767044|NCT00255684|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5767045|NCT00255684|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5767046|NCT00255684|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5767047|NCT00255684|primary myelofibrosis|primary myelofibrosis
5767048|NCT00255684|refractory hairy cell leukemia|refractory hairy cell leukemia
5767049|NCT00255684|stage I multiple myeloma|stage i multiple myeloma
5767050|NCT00255684|stage II multiple myeloma|stage ii multiple myeloma
5767051|NCT00255684|stage III multiple myeloma|stage iii multiple myeloma
5767052|NCT00255684|refractory multiple myeloma|refractory multiple myeloma
5767053|NCT00255684|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5767054|NCT00255684|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5767055|NCT00255684|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5767056|NCT00255684|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5767057|NCT00255684|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5767058|NCT00255684|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5767059|NCT00255684|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5767060|NCT00255684|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5767061|NCT00255684|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5767062|NCT00255684|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5767063|NCT00255684|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5767064|NCT00255684|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5767065|NCT00255684|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5767066|NCT00255684|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5767067|NCT00255684|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5767068|NCT00255684|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5767069|NCT00255684|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5767070|NCT00255684|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5767071|NCT00255684|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5767072|NCT00255684|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5681045|NCT00574977|vaccinia|vaccinia
5681046|NCT00574977|virus|virus
5681047|NCT00574977|tumor|tumor
5681048|NCT00574977|melanoma|melanoma
5681049|NCT00574977|breast cancer|breast cancer
5681050|NCT00574977|squamous cell cancer|squamous cell cancer
5681051|NCT00574977|colorectal|colorectal
5681052|NCT00574977|liver|liver
5686345|NCT00552513|acute coronary syndromes|acute coronary syndromes
5681053|NCT00574977|pancreatic|pancreatic
5681054|NCT00574977|adenocarcinoma|adenocarcinoma
5681055|NCT00574951|fallopian tube cancer|fallopian tube cancer
5681056|NCT00574951|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5681057|NCT00574951|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5681058|NCT00574925|H. pylori|h. pylori
5681059|NCT00574912|Type 2 diabetes|type 2 diabetes
5681060|NCT00574912|Insulin Glargine|insulin glargine
5681061|NCT00574912|Endogenous Glucose Production|endogenous glucose production
5767073|NCT00255684|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5767074|NCT00255684|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5767075|NCT00255684|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5767076|NCT00255684|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5767077|NCT00255684|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5767078|NCT00255684|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5767079|NCT00255684|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5767080|NCT00255684|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5767081|NCT00255684|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5767082|NCT00255684|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5767083|NCT00255684|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5767084|NCT00255684|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5767085|NCT00255684|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5767086|NCT00255684|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5767087|NCT00255684|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5767088|NCT00255684|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5767089|NCT00255684|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5767090|NCT00255684|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5767091|NCT00255684|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5767092|NCT00255684|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5767093|NCT00255684|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5767094|NCT00255684|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5767095|NCT00255684|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5767096|NCT00255684|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5767097|NCT00255684|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5767098|NCT00255684|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5767099|NCT00255684|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5767100|NCT00255684|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5767101|NCT00255684|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5767102|NCT00255684|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5767103|NCT00255684|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5767104|NCT00255684|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5767105|NCT00255684|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5767106|NCT00255684|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5767107|NCT00255684|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5767108|NCT00255684|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5767109|NCT00255684|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5862946|NCT00001453|Cushing Syndrome|cushing syndrome
5767110|NCT00255684|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5767111|NCT00255684|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5767112|NCT00255684|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5767113|NCT00255684|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5762291|NCT00274872|stage IV colon cancer|stage iv colon cancer
5767114|NCT00255684|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5767115|NCT00255684|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5767116|NCT00255684|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5767117|NCT00255684|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5767118|NCT00255684|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5767119|NCT00255684|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5767120|NCT00255684|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5767121|NCT00255684|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5767122|NCT00255684|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5767124|NCT00255671|tumors metastatic to brain|tumors metastatic to brain
5686346|NCT00552513|PCI|pci
5686347|NCT00552513|angiography|angiography
5686348|NCT00552513|Non ST-segment elevation myocardial infarction|non st-segment elevation myocardial infarction
5686349|NCT00552513|unstable angina|unstable angina
5686350|NCT00552487|isolated ACTH deficiency|isolated acth deficiency
5686351|NCT00552487|Hashimoto disease|hashimoto disease
5686352|NCT00552487|Hashimoto thyroiditis|hashimoto thyroiditis
5686353|NCT00552487|autoimmune thyroiditis|autoimmune thyroiditis
5686354|NCT00552474|Parkinson disease|parkinson disease
5686355|NCT00552474|Movement disorders|movement disorders
5686356|NCT00552474|Deep Brain Stimulation|deep brain stimulation
5686357|NCT00552474|Libra|libra
5767125|NCT00255671|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5767126|NCT00255671|adult anaplastic ependymoma|adult anaplastic ependymoma
5767127|NCT00255671|adult anaplastic meningioma|adult anaplastic meningioma
5767128|NCT00255671|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5767129|NCT00255671|adult brain stem glioma|adult brain stem glioma
5767130|NCT00255671|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5767131|NCT00255671|adult choroid plexus tumor|adult choroid plexus tumor
5767132|NCT00255671|adult craniopharyngioma|adult craniopharyngioma
5767133|NCT00255671|adult diffuse astrocytoma|adult diffuse astrocytoma
5767134|NCT00255671|adult ependymoblastoma|adult ependymoblastoma
5767135|NCT00255671|adult ependymoma|adult ependymoma
5767136|NCT00255671|adult giant cell glioblastoma|adult giant cell glioblastoma
5767137|NCT00255671|adult gliosarcoma|adult gliosarcoma
5767138|NCT00255671|adult medulloblastoma|adult medulloblastoma
5767139|NCT00255671|adult melanocytic lesion|adult melanocytic lesion
5767140|NCT00255671|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5767141|NCT00255671|adult meningioma|adult meningioma
5767142|NCT00255671|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5767143|NCT00255671|adult oligodendroglioma|adult oligodendroglioma
5767144|NCT00255671|adult papillary meningioma|adult papillary meningioma
5767145|NCT00255671|adult pineoblastoma|adult pineoblastoma
5767146|NCT00255671|adult pineocytoma|adult pineocytoma
5767147|NCT00255671|adult subependymoma|adult subependymoma
5767148|NCT00255671|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5767149|NCT00255671|adult grade I meningioma|adult grade i meningioma
5767150|NCT00255671|adult grade II meningioma|adult grade ii meningioma
5767151|NCT00255671|adult grade III meningioma|adult grade iii meningioma
5767152|NCT00255671|adult mixed glioma|adult mixed glioma
5767153|NCT00255671|recurrent adult brain tumor|recurrent adult brain tumor
5767154|NCT00255671|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5767155|NCT00255671|adult glioblastoma|adult glioblastoma
5767156|NCT00255671|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5767157|NCT00255671|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5767158|NCT00255671|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5767159|NCT00255671|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5767160|NCT00255671|recurrent pituitary tumor|recurrent pituitary tumor
5767161|NCT00255671|TSH producing pituitary tumor|tsh producing pituitary tumor
5767162|NCT00255619|Continuous ambulatory peritoneal dialysis (CAPD)|continuous ambulatory peritoneal dialysis (capd)
5767163|NCT00255619|Peritonitis|peritonitis
5767164|NCT00255619|ANDY-disc® (Fresenius Medical care)|andy-disc® (fresenius medical care)
5767165|NCT00255619|Ultra® (Baxter)|ultra® (baxter)
5767166|NCT00255619|Twin bag System|twin bag system
5767167|NCT00255606|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5767168|NCT00255606|stage IV prostate cancer|stage iv prostate cancer
5767169|NCT00255606|recurrent prostate cancer|recurrent prostate cancer
5767170|NCT00255593|Kidney|kidney
5767171|NCT00255593|Transplantation|transplantation
5767172|NCT00255593|Immunosuppression|immunosuppression
5767173|NCT00255593|Rituximab|rituximab
5767174|NCT00255580|neuropathy|neuropathy
5767175|NCT00255580|cannabis|cannabis
5767176|NCT00255580|marijuana|marijuana
5767178|NCT00255580|DSPN|dspn
5767179|NCT00255567|Visceral Leishmaniasis|visceral leishmaniasis
5767180|NCT00255567|Combination|combination
5767181|NCT00255554|Borderline Personality Disorder|borderline personality disorder
5767183|NCT00255554|Dialectical Behavior Therapy|dialectical behavior therapy
5767184|NCT00255554|DBT|dbt
5767185|NCT00255554|Escitalopram|escitalopram
5767186|NCT00255554|Lexapro|lexapro
5767187|NCT00255528|Pediatric hypertension|pediatric hypertension
5767188|NCT00255502|Pediatric hypertension|pediatric hypertension
5767189|NCT00255450|anemia|anemia
5767190|NCT00255411|Conversion Disorder|conversion disorder
5686358|NCT00552474|l-dopa|l-dopa
5767191|NCT00255411|Somatoform Disorder|somatoform disorder
5767192|NCT00255411|Involuntary Movement|involuntary movement
5767193|NCT00255411|Childhood Abuse|childhood abuse
5767194|NCT00255411|Depression|depression
5767195|NCT00255411|Psychogenic Movement Disorder|psychogenic movement disorder
5767196|NCT00255411|PMD|pmd
5767197|NCT00255411|Non-Epileptic Seizure|non-epileptic seizure
5767199|NCT00255411|Healthy Volunteer|healthy volunteer
5767201|NCT00255398|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5767202|NCT00255398|Minimal Change Disease|minimal change disease
5767203|NCT00255398|Diabetic Nephropathy|diabetic nephropathy
5767204|NCT00255398|Mass Spectrometry|mass spectrometry
5767205|NCT00255398|Proteinuria|proteinuria
5767206|NCT00255398|Idiopathic Nephrotic Syndrome|idiopathic nephrotic syndrome
5767207|NCT00255398|Glomerular Disease|glomerular disease
5767208|NCT00255398|FSG|fsg
5767209|NCT00255398|Kidney Disease|kidney disease
5767210|NCT00255385|Zinc|zinc
5767211|NCT00255385|Iron|iron
5767212|NCT00255385|Probiotics|probiotics
5767213|NCT00255385|Prebiotics|prebiotics
5767214|NCT00255385|Child health|child health
5767215|NCT00255385|Milk fortification|milk fortification
5767216|NCT00255385|Randomized controlled trial|randomized controlled trial
5767217|NCT00255346|targeted therapy|targeted therapy
5767218|NCT00255346|leukemia|leukemia
5767219|NCT00255346|Acute myeloid leukemia (AML)|acute myeloid leukemia (aml)
5767220|NCT00255346|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5767221|NCT00255346|Agnogenic myeloid metaplasia - myelofibrosis (MMM)|agnogenic myeloid metaplasia - myelofibrosis (mmm)
5767222|NCT00255346|Hypereosinophilic syndrome (HES)|hypereosinophilic syndrome (hes)
5767223|NCT00255346|Polycythemia vera (PV)|polycythemia vera (pv)
5767224|NCT00255346|Mastocytosis|mastocytosis
5846706|NCT00043680|Choroidal Neovascularization|choroidal neovascularization
5767226|NCT00255320|healthy volunteers, headache, migraine, hemodynamics, VIP, SPECT, ultrasound|healthy volunteers, headache, migraine, hemodynamics, vip, spect, ultrasound
5767228|NCT00255307|flu|flu
5767229|NCT00255307|respiratory tract infection|respiratory tract infection
5767230|NCT00255255|Asthma|asthma
5767231|NCT00255242|Cystic Fibrosis|cystic fibrosis
5767232|NCT00255242|Airway Inflammation|airway inflammation
5767233|NCT00255242|Cytokines|cytokines
5767234|NCT00255242|Simvastatin|simvastatin
5767235|NCT00255242|HMG-CoA reductase inhibitors|hmg-coa reductase inhibitors
5767236|NCT00255242|Rho GTP-ase|rho gtp-ase
5767237|NCT00255229|irinotecan|irinotecan
5767238|NCT00255229|5FU|5fu
5767239|NCT00255229|amino acids|amino acids
5767240|NCT00255229|heat shock protein|heat shock protein
5767241|NCT00255190|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5767242|NCT00255177|Hepatitis C|hepatitis c
5767243|NCT00255164|Erosive Esophagitis|erosive esophagitis
5767244|NCT00255151|Erosive Esophagitis|erosive esophagitis
5767245|NCT00255138|Cancer|cancer
5767246|NCT00255138|Cognitive Late Effects|cognitive late effects
5767247|NCT00255138|Stimulants|stimulants
5767248|NCT00255138|Atomoxetine|atomoxetine
5767249|NCT00255138|Attention|attention
5767250|NCT00255138|Children|children
5767251|NCT00255125|Estrogen Receptor|estrogen receptor
5767252|NCT00255125|Isoflavones|isoflavones
5767253|NCT00255125|Prostate Neoplasm|prostate neoplasm
5767254|NCT00255125|Soy Supplementation|soy supplementation
5767255|NCT00255112|SAD|sad
5767256|NCT00255112|treatment|treatment
5767257|NCT00255112|cognitive behavior therapy|cognitive behavior therapy
5767258|NCT00255112|family|family
5767259|NCT00255112|children|children
5767260|NCT00255112|anxiety|anxiety
5767261|NCT00255099|HIV|hiv
5767262|NCT00255099|HIV-1|hiv-1
5767263|NCT00255099|TMC125|tmc125
5767264|NCT00255047|Pertussis|pertussis
5767265|NCT00255047|Whooping cough|whooping cough
5767266|NCT00255047|Filamentous Haemagglutinin|filamentous haemagglutinin
5767267|NCT00255047|Fimbriae Types 2 and 3;|fimbriae types 2 and 3;
5767268|NCT00255047|Pertactin|pertactin
5767269|NCT00255047|Diphtheria|diphtheria
5767270|NCT00255047|Tetanus|tetanus
5767271|NCT00255047|Poliovirus Types 1, 2, and 3.|poliovirus types 1, 2, and 3.
5767272|NCT00255034|chronic hepatitis C|chronic hepatitis c
5767273|NCT00255034|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5767274|NCT00255034|ribavirin|ribavirin
5767275|NCT00255034|Australia|australia
5767276|NCT00255021|Diphteria|diphteria
5767277|NCT00255021|Tetanus|tetanus
5767278|NCT00255021|Pertussis|pertussis
5767279|NCT00255021|Poliomyelitis|poliomyelitis
5767280|NCT00255021|Haemophilus influenzae type b|haemophilus influenzae type b
5767281|NCT00255021|acellular|acellular
5767282|NCT00255008|chronic hepatitis C|chronic hepatitis c
5767283|NCT00255008|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5767284|NCT00255008|ribavirin|ribavirin
5767285|NCT00255008|Asia|asia
5767286|NCT00254995|Meningitis|meningitis
5767288|NCT00254995|Menactra vaccine|menactra vaccine
5767289|NCT00254969|Diphteria|diphteria
5767290|NCT00254969|tetanus|tetanus
5767291|NCT00254969|haemophilus influenzae type b|haemophilus influenzae type b
5767292|NCT00254969|poliomyelitis|poliomyelitis
5767293|NCT00254969|pertussis|pertussis
5767294|NCT00254956|Diseases|diseases
5686359|NCT00552474|levodopa|levodopa
5767295|NCT00254956|respiratory tract diseases|respiratory tract diseases
5767296|NCT00254956|respiratory hypersensitivity|respiratory hypersensitivity
5767297|NCT00254956|asthma|asthma
5767298|NCT00254930|learning disorder|learning disorder
5767299|NCT00254930|children|children
5767300|NCT00254930|behaviour disorder|behaviour disorder
5767302|NCT00254917|Pentaxim|pentaxim
5767303|NCT00254904|advanced carcinoma, non-small cell lung, Phase III, Gemcitabine, Gemzar, Cisplatin, Platinol, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, gemcitabine, gemzar, cisplatin, platinol, pf-3512676, immunotherapy, immune modulator
5767304|NCT00254891|advanced carcinoma, non-small cell lung, Phase III, Paclitaxel, Taxol, Carboplatin, Paraplatin, PF-3512676, immunotherapy, immune modulator|advanced carcinoma, non-small cell lung, phase iii, paclitaxel, taxol, carboplatin, paraplatin, pf-3512676, immunotherapy, immune modulator
5767305|NCT00254878|ADHD, Methylphenidate hydrochloride, modified-release|adhd, methylphenidate hydrochloride, modified-release
5767306|NCT00254865|Transdermal contraception|transdermal contraception
5767307|NCT00254865|contraceptive|contraceptive
5767308|NCT00254865|hormonal, steroid contraception|hormonal, steroid contraception
5767309|NCT00254865|ethinyl estradiol|ethinyl estradiol
5767310|NCT00254865|progesterone|progesterone
5767311|NCT00254865|EVRA|evra
5767312|NCT00254865|CILEST|cilest
5767313|NCT00254852|Primary lumbar fusion|primary lumbar fusion
5767314|NCT00254852|Demineralized Bone Matrix|demineralized bone matrix
5767316|NCT00254852|Optecure|optecure
5767317|NCT00254852|Allograft|allograft
5767318|NCT00254852|Autograft|autograft
5767319|NCT00254852|Lumbar fusion|lumbar fusion
5767320|NCT00254852|Interbody fusion|interbody fusion
5767321|NCT00254852|Instrumented fusion|instrumented fusion
5767322|NCT00254852|Non-instrumented fusion|non-instrumented fusion
5767323|NCT00254852|Exactech|exactech
5767324|NCT00254852|Spinal fusion|spinal fusion
5767325|NCT00254839|Oral malodor|oral malodor
5767326|NCT00254839|Dental implants|dental implants
5767327|NCT00254826|Yellow Fever Virus Vaccination|yellow fever virus vaccination
5767328|NCT00254813|Schizophrenia|schizophrenia
5767329|NCT00254813|Schizoaffective disorder|schizoaffective disorder
5767330|NCT00254800|diabetes|diabetes
5767331|NCT00254800|exenatide|exenatide
5767332|NCT00254800|Amylin|amylin
5767333|NCT00254800|Lilly|lilly
5767334|NCT00254787|Schizophrenia|schizophrenia
5767335|NCT00254774|Bipolar Disorder I or II with Rapid Cycling|bipolar disorder i or ii with rapid cycling
5767336|NCT00254761|cannabis|cannabis
5767337|NCT00254761|marijuana|marijuana
5767338|NCT00254761|neuropathy|neuropathy
5767339|NCT00254761|antinociception|antinociception
5767340|NCT00254761|mood|mood
5767341|NCT00254761|cognition|cognition
5767342|NCT00254748|Borderline personality disorder|borderline personality disorder
5767343|NCT00254735|Obsessive Compulsive Disorder (OCD)|obsessive compulsive disorder (ocd)
5767344|NCT00254722|Traumatic Brain Injury|traumatic brain injury
5767345|NCT00254722|Stem Cell|stem cell
5767346|NCT00254709|kidney transplant|kidney transplant
5767347|NCT00254709|elderly|elderly
5767348|NCT00254696|bacterial infection|bacterial infection
5767349|NCT00254683|Rectal Cancer|rectal cancer
5767350|NCT00254683|Positron Emission Tomography|positron emission tomography
5767351|NCT00254683|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5767352|NCT00254683|Computed Tomography|computed tomography
5767353|NCT00254683|Neoadjuvant Therapy|neoadjuvant therapy
5767354|NCT00254683|Chemotherapy|chemotherapy
5767355|NCT00254683|Radiotherapy|radiotherapy
5767356|NCT00254670|Alcohol|alcohol
5767357|NCT00254670|Naltrexone|naltrexone
5767358|NCT00254657|Fibromyalgia|fibromyalgia
5767359|NCT00254657|Fibro|fibro
5767360|NCT00254657|Keppra|keppra
5767361|NCT00254657|Levetiracetam|levetiracetam
5767362|NCT00254644|phonological treatment|phonological treatment
5767363|NCT00254644|language|language
5767364|NCT00254644|fMRI|fmri
5767365|NCT00254631|long bone fracture|long bone fracture
5767366|NCT00254631|open fractures|open fractures
5767367|NCT00254631|closed fractures|closed fractures
5767368|NCT00254631|trauma|trauma
5767369|NCT00254618|ulcerative colitis; pharmacokinetics; pediatrics|ulcerative colitis; pharmacokinetics; pediatrics
5767370|NCT00254605|imaging|imaging
5767371|NCT00254605|adaptive optics scanning laser ophthalmoscope|adaptive optics scanning laser ophthalmoscope
5767372|NCT00254605|optical coherence tomography|optical coherence tomography
5767373|NCT00254605|electroretinography|electroretinography
5767374|NCT00254592|Inflammatory|inflammatory
5767375|NCT00254592|Breast Cancer|breast cancer
5767376|NCT00254592|Female|female
5767377|NCT00254592|Neo-adjuvant|neo-adjuvant
5767378|NCT00254592|HER-2 positive|her-2 positive
5767379|NCT00254592|Hormone receptor|hormone receptor
5767380|NCT00254579|refractory melanoma|refractory melanoma
5767487|NCT00254111|laser|laser
5767488|NCT00254111|device|device
5767382|NCT00254566|Azithromycin SR; Moxifloxacin; Acute exacerbation of chronic bronchitis (AECB)|azithromycin sr; moxifloxacin; acute exacerbation of chronic bronchitis (aecb)
5767383|NCT00254540|Ph2, RCC, SU011248, SUNITINIB|ph2, rcc, su011248, sunitinib
5767384|NCT00254527|Methicillin Resistant Staphylococcus aureus|methicillin resistant staphylococcus aureus
5767385|NCT00254527|Children|children
5767386|NCT00254527|Colonization|colonization
5767387|NCT00254527|Risk Factor|risk factor
5767388|NCT00254501|diabetes|diabetes
5767389|NCT00254475|Valsartan|valsartan
5767390|NCT00254475|simvastatin|simvastatin
5767391|NCT00254475|hypertension|hypertension
5767392|NCT00254475|hypercholesterolemia|hypercholesterolemia
5767393|NCT00254475|angiotensin II receptor blocker|angiotensin ii receptor blocker
5767394|NCT00254462|ADHD|adhd
5767395|NCT00254462|Atomoxetine|atomoxetine
5767396|NCT00254436|Epoetin Alfa|epoetin alfa
5767397|NCT00254436|Epogen|epogen
5767398|NCT00254436|Erythropoietin|erythropoietin
5767399|NCT00254410|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5767400|NCT00254410|Untreated|untreated
5767401|NCT00254410|Fludarabine|fludarabine
5767402|NCT00254410|Fludara|fludara
5767403|NCT00254410|Cyclophosphamide|cyclophosphamide
5767404|NCT00254410|Cytoxan|cytoxan
5767405|NCT00254410|Mitoxantrone|mitoxantrone
5767406|NCT00254410|Novantrone|novantrone
5767407|NCT00254410|Rituximab|rituximab
5767408|NCT00254410|Rituxan|rituxan
5767409|NCT00254410|Pegylated Filgrastim|pegylated filgrastim
5767410|NCT00254410|Neupogen|neupogen
5767411|NCT00254397|Melanoma|melanoma
5767412|NCT00254397|Uveal Melanoma|uveal melanoma
5767413|NCT00254397|Peptide Vaccine|peptide vaccine
5767414|NCT00254397|LHRH-agonist|lhrh-agonist
5767415|NCT00254397|Leuprolide|leuprolide
5767417|NCT00254397|MAGE-3 Peptide|mage-3 peptide
5767418|NCT00254397|MAGE-3|mage-3
5767419|NCT00254397|GP100 Peptide|gp100 peptide
5767420|NCT00254397|Melanoma vaccines|melanoma vaccines
5767421|NCT00254397|Tumor fighting immune cells|tumor fighting immune cells
5767422|NCT00254397|T cells|t cells
5767423|NCT00254397|Skin Cancer|skin cancer
5767424|NCT00254397|Eye Cancer|eye cancer
5767425|NCT00254358|Nicotine|nicotine
5767426|NCT00254358|Dopamine|dopamine
5767427|NCT00254358|IBZM|ibzm
5767428|NCT00254345|biofilm|biofilm
5767429|NCT00254345|adhesion|adhesion
5767430|NCT00254345|liquid polish|liquid polish
5767431|NCT00254345|bonding resin|bonding resin
5767432|NCT00254345|PMMA Polymethylmetacrylate|pmma polymethylmetacrylate
5767433|NCT00254345|provisional crown|provisional crown
5767434|NCT00254345|no antibiotics treatment three months prior to experiment|no antibiotics treatment three months prior to experiment
5767435|NCT00254345|no mouth rinse with oral solutions one month prior to experiment|no mouth rinse with oral solutions one month prior to experiment
5767436|NCT00254332|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5767437|NCT00254332|Sezary Syndrome|sezary syndrome
5767438|NCT00254332|Mycosis Fungoides|mycosis fungoides
5767439|NCT00254332|Denileukin Diftitox|denileukin diftitox
5767440|NCT00254306|Ecstasy|ecstasy
5767441|NCT00254306|D2 Dopamine Receptor|d2 dopamine receptor
5767442|NCT00254306|IBZM|ibzm
5767443|NCT00254306|MDMA|mdma
5767444|NCT00254280|Warts|warts
5767445|NCT00254280|Intense pulsed light|intense pulsed light
5767447|NCT00254280|Recalcitrant hand and foot warts|recalcitrant hand and foot warts
5767448|NCT00254267|Gastrointestinal Stromal Tumor, Imatinib Mesylate Resistance, Phase2 study, AMG 706|gastrointestinal stromal tumor, imatinib mesylate resistance, phase2 study, amg 706
5767449|NCT00254254|diabetes|diabetes
5767450|NCT00254254|adolescents|adolescents
5767451|NCT00254254|exenatide|exenatide
5767452|NCT00254254|Amylin|amylin
5767453|NCT00254254|Lilly|lilly
5767454|NCT00254241|Schizophrenia|schizophrenia
5767455|NCT00254228|Balance|balance
5767456|NCT00254228|Vestibular|vestibular
5767457|NCT00254228|Electrotactile|electrotactile
5767458|NCT00254228|BrainPort|brainport
5767459|NCT00254228|Sensory substitution|sensory substitution
5767460|NCT00254228|Tongue|tongue
5767461|NCT00254215|overweight|overweight
5767462|NCT00254215|obesity|obesity
5767463|NCT00254215|glycemic index|glycemic index
5767464|NCT00254215|glycemic load|glycemic load
5767465|NCT00254215|high protein diet|high protein diet
5767466|NCT00254215|blood cholesterol|blood cholesterol
5767467|NCT00254202|Schizophrenia|schizophrenia
5767468|NCT00254202|Atypical antipsychotic|atypical antipsychotic
5767469|NCT00254202|psychosis|psychosis
5767470|NCT00254189|Ovulation|ovulation
5767471|NCT00254189|Oral Contraceptive|oral contraceptive
5767472|NCT00254176|Neonate|neonate
5767473|NCT00254176|Glutathione|glutathione
5767474|NCT00254176|Cysteine|cysteine
5767475|NCT00254176|Sepsis|sepsis
5767476|NCT00254176|Stable Isotope|stable isotope
5767477|NCT00254137|capecitabine|capecitabine
5767478|NCT00254137|irinotecan|irinotecan
5767479|NCT00254137|cetuximab|cetuximab
5767480|NCT00254137|oxaliplatin|oxaliplatin
5767481|NCT00254137|colorectal cancer|colorectal cancer
5767482|NCT00254124|obesity|obesity
5767483|NCT00254124|type 2 diabetes mellitus|type 2 diabetes mellitus
5767484|NCT00254124|portion control|portion control
5767485|NCT00254111|osteoarthritis|osteoarthritis
5767491|NCT00254085|Type 2 diabtes|type 2 diabtes
5767492|NCT00254085|Postprandial hyperglycemia|postprandial hyperglycemia
5767493|NCT00254085|Insulin treatment|insulin treatment
5767494|NCT00254072|Morbid Obesity|morbid obesity
5767495|NCT00254072|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5767496|NCT00254072|Staple Line Hemorrhage|staple line hemorrhage
5776004|NCT00217139|HCV|hcv
5767497|NCT00254059|OSAHS, OSA, CPAP, polysomnography, overnight oximetry, Obstructive sleep apnea, apnea hypopnea index, AHI, Obstructive Sleep Apnea Hypopnea Syndrome|osahs, osa, cpap, polysomnography, overnight oximetry, obstructive sleep apnea, apnea hypopnea index, ahi, obstructive sleep apnea hypopnea syndrome
5767499|NCT00254046|HIV-1|hiv-1
5767500|NCT00254046|TMC125|tmc125
5767501|NCT00254033|Alzheimer's Disease|alzheimer's disease
5767503|NCT00254033|Brain Reward System|brain reward system
5767504|NCT00254033|Dopamine|dopamine
5767505|NCT00254033|Dextroamphetamine Challenge|dextroamphetamine challenge
5767506|NCT00254033|Methylphenidate|methylphenidate
5767507|NCT00254020|stroke|stroke
5767508|NCT00254020|depression|depression
5767510|NCT00254020|serotonin|serotonin
5767511|NCT00254020|citalopram|citalopram
5767512|NCT00254007|depression|depression
5767513|NCT00254007|traumatic brain injury|traumatic brain injury
5767514|NCT00254007|serotonin transporter|serotonin transporter
5767515|NCT00254007|genetic polymorphisms|genetic polymorphisms
5767517|NCT00253981|Pain, Intractable|pain, intractable
5767518|NCT00253981|Infrared Rays|infrared rays
5767520|NCT00253968|Primary Insomnia|primary insomnia
5767521|NCT00253968|Sleeplessness|sleeplessness
5767522|NCT00253968|Early Awakening|early awakening
5767523|NCT00253968|Chronic Insomnia|chronic insomnia
5767524|NCT00253929|adenosine|adenosine
5767525|NCT00253929|polymorphisms|polymorphisms
5767526|NCT00253929|blood flow|blood flow
5767527|NCT00253929|adenosine A2a receptor|adenosine a2a receptor
5767528|NCT00253929|AMP deaminase|amp deaminase
5767529|NCT00253903|Primary Insomnia|primary insomnia
5767530|NCT00253903|Sleeplessness|sleeplessness
5767531|NCT00253903|Early Awakening|early awakening
5767532|NCT00253903|Chronic Insomnia|chronic insomnia
5767533|NCT00253890|sleep quality|sleep quality
5767534|NCT00253890|methadone|methadone
5767535|NCT00253890|substance use|substance use
5767536|NCT00253877|Osteoarthritis|osteoarthritis
5767537|NCT00253877|Hip Resurfacing|hip resurfacing
5767538|NCT00253864|shoulder surgery|shoulder surgery
5767539|NCT00253864|prospective database|prospective database
5767540|NCT00253864|long term outcome|long term outcome
5767542|NCT00253851|Osteoarthritis|osteoarthritis
5767543|NCT00253851|Total Knee Arthroplasty|total knee arthroplasty
5767544|NCT00253838|revision hip arthroplasty|revision hip arthroplasty
5767545|NCT00253838|bone mineral density|bone mineral density
5767546|NCT00253812|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, FAP|colonoscopy, sigmoidoscopy, chromoendoscopy, autofluorescence, narrow band imaging, colorectal cancer, polyp, adenoma,rectal remnant, fap
5767547|NCT00253786|diabetes|diabetes
5767548|NCT00253786|nephropathy|nephropathy
5767549|NCT00253773|sulfer amino acids|sulfer amino acids
5767550|NCT00253773|redox status|redox status
5767552|NCT00253760|sulfur amino acids|sulfur amino acids
5767553|NCT00253760|glutathione|glutathione
5767554|NCT00253760|aging|aging
5767555|NCT00253734|Influenza|influenza
5767556|NCT00253721|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5767557|NCT00253721|adult brain stem glioma|adult brain stem glioma
5767558|NCT00253721|adult diffuse astrocytoma|adult diffuse astrocytoma
5767559|NCT00253721|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5767560|NCT00253721|adult medulloblastoma|adult medulloblastoma
5767561|NCT00253721|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5767562|NCT00253721|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5767563|NCT00253721|adult oligodendroglioma|adult oligodendroglioma
5767564|NCT00253721|adult pineoblastoma|adult pineoblastoma
5767565|NCT00253721|tumors metastatic to brain|tumors metastatic to brain
5767566|NCT00253721|adult mixed glioma|adult mixed glioma
5767567|NCT00253721|recurrent adult brain tumor|recurrent adult brain tumor
5767568|NCT00253721|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5767569|NCT00253708|depression|depression
5767570|NCT00253708|nausea and vomiting|nausea and vomiting
5767571|NCT00253708|pain|pain
5767572|NCT00253708|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5767573|NCT00253708|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5767574|NCT00253708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5767575|NCT00253708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5767576|NCT00253708|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5767577|NCT00253708|stage III gastric cancer|stage iii gastric cancer
5767578|NCT00253708|stage III esophageal cancer|stage iii esophageal cancer
5767579|NCT00253708|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5767580|NCT00253708|stage III colon cancer|stage iii colon cancer
5767581|NCT00253708|stage IV renal cell cancer|stage iv renal cell cancer
5767582|NCT00253708|stage IV bladder cancer|stage iv bladder cancer
5767583|NCT00253708|stage IV prostate cancer|stage iv prostate cancer
5767584|NCT00253708|stage IV breast cancer|stage iv breast cancer
5767585|NCT00253708|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5767586|NCT00253708|advanced adult primary liver cancer|advanced adult primary liver cancer
5767587|NCT00253708|stage IV melanoma|stage iv melanoma
5767588|NCT00253708|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5767589|NCT00253708|ovarian sarcoma|ovarian sarcoma
5767590|NCT00253708|ovarian stromal cancer|ovarian stromal cancer
5767591|NCT00253708|recurrent small cell lung cancer|recurrent small cell lung cancer
5767592|NCT00253708|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5767593|NCT00253708|recurrent colon cancer|recurrent colon cancer
5767594|NCT00253708|recurrent esophageal cancer|recurrent esophageal cancer
5767595|NCT00253708|recurrent gastric cancer|recurrent gastric cancer
5767596|NCT00253708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5767597|NCT00253708|recurrent bladder cancer|recurrent bladder cancer
5767598|NCT00253708|recurrent breast cancer|recurrent breast cancer
5767599|NCT00253708|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5767600|NCT00253708|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5767601|NCT00253708|recurrent prostate cancer|recurrent prostate cancer
5767602|NCT00253708|recurrent renal cell cancer|recurrent renal cell cancer
5767603|NCT00253708|recurrent melanoma|recurrent melanoma
5767604|NCT00253669|thromboembolism|thromboembolism
5767605|NCT00253669|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5767606|NCT00253669|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5767607|NCT00253669|adult glioblastoma|adult glioblastoma
5767608|NCT00253669|adult giant cell glioblastoma|adult giant cell glioblastoma
5767609|NCT00253669|adult gliosarcoma|adult gliosarcoma
5767610|NCT00253643|prostate cancer|prostate cancer
5767611|NCT00253643|precancerous condition|precancerous condition
5767612|NCT00253591|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5767613|NCT00253591|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5767614|NCT00253591|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5767615|NCT00253591|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5767616|NCT00253565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5767617|NCT00253552|graft versus host disease|graft versus host disease
5767618|NCT00253552|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5767619|NCT00253552|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5767620|NCT00253552|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5767817|NCT00253357|Fluid overload|fluid overload
5767621|NCT00253552|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5767622|NCT00253552|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5767623|NCT00253552|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5767624|NCT00253552|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5767625|NCT00253552|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5767626|NCT00253552|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5767627|NCT00253552|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5767628|NCT00253552|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5767629|NCT00253552|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5767630|NCT00253552|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5767631|NCT00253552|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5767632|NCT00253552|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5767633|NCT00253552|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5767634|NCT00253552|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5767635|NCT00253552|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5767636|NCT00253552|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5767637|NCT00253552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5767638|NCT00253552|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5767639|NCT00253552|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5767640|NCT00253552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5767641|NCT00253552|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5767642|NCT00253552|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5767643|NCT00253552|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5767644|NCT00253552|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5767645|NCT00253552|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5767646|NCT00253552|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5767647|NCT00253552|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5767712|NCT00253552|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5767648|NCT00253552|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5767649|NCT00253552|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5767650|NCT00253552|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5767651|NCT00253552|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5767652|NCT00253552|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5767653|NCT00253552|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5767654|NCT00253552|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5767655|NCT00253552|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5767656|NCT00253552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5767657|NCT00253552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5767658|NCT00253552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5767659|NCT00253552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5767660|NCT00253552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5767661|NCT00253552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5767662|NCT00253552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5767663|NCT00253552|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5767664|NCT00253552|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5767665|NCT00253552|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5767666|NCT00253552|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5767667|NCT00253552|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5767668|NCT00253552|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5767669|NCT00253552|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5767670|NCT00253552|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5767671|NCT00253552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5767672|NCT00253552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5767673|NCT00253552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5767674|NCT00253552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5767675|NCT00253552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5767676|NCT00253552|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5767677|NCT00253552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5767678|NCT00253552|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5767679|NCT00253552|refractory hairy cell leukemia|refractory hairy cell leukemia
5767680|NCT00253552|refractory multiple myeloma|refractory multiple myeloma
5767681|NCT00253552|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5767682|NCT00253552|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5767683|NCT00253552|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5767684|NCT00253552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5767685|NCT00253552|stage I multiple myeloma|stage i multiple myeloma
5767686|NCT00253552|stage II multiple myeloma|stage ii multiple myeloma
5767687|NCT00253552|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5767688|NCT00253552|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5767689|NCT00253552|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5767690|NCT00253552|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5767691|NCT00253552|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5767692|NCT00253552|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5767693|NCT00253552|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5767694|NCT00253552|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5767695|NCT00253552|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5767696|NCT00253552|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5767697|NCT00253552|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5767698|NCT00253552|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5767699|NCT00253552|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5767700|NCT00253552|stage III multiple myeloma|stage iii multiple myeloma
5767701|NCT00253552|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5767702|NCT00253552|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5767703|NCT00253552|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5767704|NCT00253552|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5767705|NCT00253552|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5767706|NCT00253552|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5767707|NCT00253552|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5767708|NCT00253552|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5767709|NCT00253552|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5767710|NCT00253552|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5767711|NCT00253552|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5767713|NCT00253552|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5767714|NCT00253552|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5767715|NCT00253552|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5848600|NCT00034216|Suppressor Cells|suppressor cells
5767716|NCT00253552|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5767717|NCT00253539|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5767718|NCT00253539|breast cancer|breast cancer
5767719|NCT00253513|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5767720|NCT00253513|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5767721|NCT00253513|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5767722|NCT00253513|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5767723|NCT00253513|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5767724|NCT00253513|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5767725|NCT00253513|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5767726|NCT00253513|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5767727|NCT00253513|myelodysplastic syndromes|myelodysplastic syndromes
5767728|NCT00253513|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5767729|NCT00253500|stage II breast cancer|stage ii breast cancer
5767730|NCT00253500|stage I breast cancer|stage i breast cancer
5767731|NCT00253500|stage IIIA breast cancer|stage iiia breast cancer
5767732|NCT00253500|stage IIIB breast cancer|stage iiib breast cancer
5767733|NCT00253487|adult glioblastoma|adult glioblastoma
5767734|NCT00253487|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5767735|NCT00253487|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5767736|NCT00253487|adult giant cell glioblastoma|adult giant cell glioblastoma
5767737|NCT00253487|adult gliosarcoma|adult gliosarcoma
5767738|NCT00253474|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5846707|NCT00043680|Cyclooxygenase 2|cyclooxygenase 2
5767739|NCT00253474|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5767740|NCT00253461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5767741|NCT00253461|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5767742|NCT00253461|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5767743|NCT00253461|recurrent small cell lung cancer|recurrent small cell lung cancer
5767744|NCT00253461|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5767745|NCT00253461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5767746|NCT00253461|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5767747|NCT00253461|tumors metastatic to brain|tumors metastatic to brain
5767748|NCT00253448|adult glioblastoma|adult glioblastoma
5767749|NCT00253448|adult giant cell glioblastoma|adult giant cell glioblastoma
5767750|NCT00253448|adult gliosarcoma|adult gliosarcoma
5767751|NCT00253435|recurrent neuroblastoma|recurrent neuroblastoma
5767752|NCT00253422|recurrent breast cancer|recurrent breast cancer
5767753|NCT00253422|stage IV breast cancer|stage iv breast cancer
5767754|NCT00253422|stage IIIB breast cancer|stage iiib breast cancer
5767755|NCT00253422|stage IIIC breast cancer|stage iiic breast cancer
5767756|NCT00253409|localized malignant mesothelioma|localized malignant mesothelioma
5767758|NCT00253396|clinical trial|clinical trial
5767759|NCT00253396|pain measurement|pain measurement
5767760|NCT00253396|heparin|heparin
5767761|NCT00253396|heparin, low-molecular-weight|heparin, low-molecular-weight
5767762|NCT00253396|Anticoagulants|anticoagulants
5767763|NCT00253383|transitional care planning|transitional care planning
5767764|NCT00253383|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5767765|NCT00253383|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5767766|NCT00253383|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5767767|NCT00253383|stage IV breast cancer|stage iv breast cancer
5767768|NCT00253383|recurrent breast cancer|recurrent breast cancer
5767769|NCT00253383|male breast cancer|male breast cancer
5767770|NCT00253383|stage IIIB anal cancer|stage iiib anal cancer
5767771|NCT00253383|stage IV anal cancer|stage iv anal cancer
5767772|NCT00253383|carcinoma of the appendix|carcinoma of the appendix
5767773|NCT00253383|stage III colon cancer|stage iii colon cancer
5767774|NCT00253383|stage IV colon cancer|stage iv colon cancer
5767775|NCT00253383|stage III rectal cancer|stage iii rectal cancer
5767776|NCT00253383|stage IV rectal cancer|stage iv rectal cancer
5767777|NCT00253383|stage III esophageal cancer|stage iii esophageal cancer
5767778|NCT00253383|stage IV esophageal cancer|stage iv esophageal cancer
5767779|NCT00253383|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5767780|NCT00253383|unresectable gallbladder cancer|unresectable gallbladder cancer
5767781|NCT00253383|stage III gastric cancer|stage iii gastric cancer
5767782|NCT00253383|stage IV gastric cancer|stage iv gastric cancer
5767783|NCT00253383|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5767784|NCT00253383|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5767785|NCT00253383|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5767786|NCT00253383|advanced adult primary liver cancer|advanced adult primary liver cancer
5767787|NCT00253383|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5768382|NCT00250757|prostate|prostate
5776389|NCT00215163|CBT|cbt
5767788|NCT00253383|stage III pancreatic cancer|stage iii pancreatic cancer
5767789|NCT00253383|recurrent small intestine cancer|recurrent small intestine cancer
5767790|NCT00253383|small intestine adenocarcinoma|small intestine adenocarcinoma
5767791|NCT00253383|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5767792|NCT00253383|small intestine lymphoma|small intestine lymphoma
5767794|NCT00253383|stage IV renal cell cancer|stage iv renal cell cancer
5767795|NCT00253383|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5767796|NCT00253383|peripheral primitive neuroectodermal tumor of the kidney|peripheral primitive neuroectodermal tumor of the kidney
5767797|NCT00253383|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5767798|NCT00253383|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5767799|NCT00253383|anterior urethral cancer|anterior urethral cancer
5767800|NCT00253383|posterior urethral cancer|posterior urethral cancer
5767801|NCT00253383|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5767802|NCT00253383|stage IV penile cancer|stage iv penile cancer
5767803|NCT00253383|stage IV prostate cancer|stage iv prostate cancer
5767804|NCT00253383|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5767805|NCT00253383|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5767806|NCT00253383|fallopian tube cancer|fallopian tube cancer
5767807|NCT00253383|ovarian sarcoma|ovarian sarcoma
5767808|NCT00253383|ovarian stromal cancer|ovarian stromal cancer
5767809|NCT00253383|stage IV pancreatic cancer|stage iv pancreatic cancer
5767810|NCT00253370|Sorafenib|sorafenib
5767811|NCT00253370|Docetaxel|docetaxel
5767812|NCT00253370|Cisplatin|cisplatin
5767813|NCT00253370|gastric cancer|gastric cancer
5767814|NCT00253370|gastroesophageal junction adenocarcinoma|gastroesophageal junction adenocarcinoma
5767815|NCT00253357|Heart Failure|heart failure
5767816|NCT00253357|Congestive Heart Failure|congestive heart failure
5767818|NCT00253357|Left sided heart failure|left sided heart failure
5767819|NCT00253357|Pacemaker|pacemaker
5767820|NCT00253357|Defibrillator|defibrillator
5767821|NCT00253344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5767822|NCT00253331|Raynaud's|raynaud's
5767823|NCT00253331|sclerderma|sclerderma
5767824|NCT00253331|systemic sclerosis|systemic sclerosis
5767825|NCT00253331|autoimmune disease|autoimmune disease
5767826|NCT00253318|Neoplasm Metastasis|neoplasm metastasis
5767827|NCT00253318|Breast Cancer|breast cancer
5767828|NCT00253318|Docetaxel|docetaxel
5767829|NCT00253318|RAD001|rad001
5767830|NCT00253318|Taxotere|taxotere
5767831|NCT00253305|tinea unguium|tinea unguium
5767832|NCT00253305|onychomycosis|onychomycosis
5767833|NCT00253292|Burns|burns
5767834|NCT00253292|Trauma|trauma
5767835|NCT00253292|Outcomes|outcomes
5767836|NCT00253292|Quality of Life|quality of life
5767837|NCT00253279|Protein Synthesis Rate|protein synthesis rate
5767838|NCT00253279|Burn Injury|burn injury
5767839|NCT00253279|PET Scan|pet scan
5767840|NCT00253266|Treatment resistant depression|treatment resistant depression
5767841|NCT00253266|Augmentation|augmentation
5767842|NCT00253266|Pharmacogenetics|pharmacogenetics
5767843|NCT00253253|orchidopexy, long-term outcome, congenital|orchidopexy, long-term outcome, congenital
5767844|NCT00253227|Alzheimer's disease|alzheimer's disease
5767845|NCT00253227|dementia|dementia
5767846|NCT00253227|brain disease|brain disease
5767847|NCT00253227|memory loss|memory loss
5767848|NCT00253227|galantamine|galantamine
5767849|NCT00253227|placebo|placebo
5767850|NCT00253214|Alzheimer's disease|alzheimer's disease
5767851|NCT00253214|dementia|dementia
5767852|NCT00253214|galantamine hydrobromide|galantamine hydrobromide
5767853|NCT00253214|controlled-release|controlled-release
5767854|NCT00253214|once-daily dosing|once-daily dosing
5767855|NCT00253201|Alzheimer's disease|alzheimer's disease
5767856|NCT00253201|dementia|dementia
5767857|NCT00253201|brain disease|brain disease
5767858|NCT00253201|memory loss|memory loss
5767859|NCT00253201|galantamine|galantamine
5767860|NCT00253201|placebo|placebo
5767861|NCT00253201|caregiver|caregiver
5767862|NCT00253201|quality of life|quality of life
5767863|NCT00253201|resource utilization|resource utilization
5767864|NCT00253188|Alzheimer's disease|alzheimer's disease
5767865|NCT00253188|dementia|dementia
5767866|NCT00253188|brain disease|brain disease
5767867|NCT00253188|memory loss|memory loss
5767868|NCT00253188|galantamine|galantamine
5767869|NCT00253188|placebo|placebo
5767870|NCT00253188|caregiver|caregiver
5767871|NCT00253188|quality of life|quality of life
5767872|NCT00253188|resource utilization|resource utilization
5767873|NCT00253175|topiramate|topiramate
5767874|NCT00253175|migraine headache|migraine headache
5767875|NCT00253175|migraine prevention|migraine prevention
5767876|NCT00253175|migraine|migraine
5767877|NCT00253162|risperidone|risperidone
5767878|NCT00253162|antipsychotic agents|antipsychotic agents
5767879|NCT00253162|bipolar disorders|bipolar disorders
5767880|NCT00253162|manic episode|manic episode
5767881|NCT00253149|risperidone|risperidone
5767882|NCT00253149|antipsychotic agents|antipsychotic agents
5686360|NCT00552474|neuromodulation|neuromodulation
5686361|NCT00552474|neurostimulation|neurostimulation
5686808|NCT00550511|surgery|surgery
5686362|NCT00552474|Electrical stimulation of the brain|electrical stimulation of the brain
5686363|NCT00552474|STN|stn
5686364|NCT00552474|Subthalamic nucleus|subthalamic nucleus
5686365|NCT00552461|Pulmonary alveolar proteinosis|pulmonary alveolar proteinosis
5686366|NCT00552461|Primary Pulmonary alveolar proteinosis|primary pulmonary alveolar proteinosis
5686367|NCT00552461|Rituximab|rituximab
5702839|NCT00491855|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5702840|NCT00491855|rhuMAb-VEGF|rhumab-vegf
5702841|NCT00491855|Oxaliplatin|oxaliplatin
5702842|NCT00491855|Eloxatin|eloxatin
5702843|NCT00491855|Paclitaxel|paclitaxel
5702844|NCT00491855|Taxol|taxol
5702852|NCT00491816|breast|breast
5686368|NCT00552461|Idiopathic|idiopathic
5686369|NCT00552461|Symptomatic|symptomatic
5686370|NCT00552461|GM-CSF Antibody|gm-csf antibody
5681043|NCT00574990|Documentation|documentation
5767883|NCT00253149|bipolar disorders|bipolar disorders
5767884|NCT00253149|manic episode|manic episode
5767885|NCT00253136|schizophrenia|schizophrenia
5767886|NCT00253136|schizoaffective disorder|schizoaffective disorder
5767887|NCT00253136|psychotic disorder|psychotic disorder
5767888|NCT00253136|risperidone|risperidone
5767889|NCT00253136|long-acting injectable|long-acting injectable
5767890|NCT00253136|intramuscular injection|intramuscular injection
5767891|NCT00253136|antipsychotic agents|antipsychotic agents
5767892|NCT00253123|Dementia|dementia
5767893|NCT00253123|Alzheimer's disease|alzheimer's disease
5767894|NCT00253123|vascular dementia|vascular dementia
5767895|NCT00253123|mixed dementia|mixed dementia
5767896|NCT00253123|risperidone|risperidone
5767897|NCT00253123|nursing home|nursing home
5767898|NCT00253110|Schizophrenia, Psychotic Disorders|schizophrenia, psychotic disorders
5767899|NCT00253110|Haloperidol|haloperidol
5767900|NCT00253110|Risperidone|risperidone
5767901|NCT00253110|Schizoaffective disorder|schizoaffective disorder
5767902|NCT00253097|stroke recurrence|stroke recurrence
5767903|NCT00253097|risk factors|risk factors
5767904|NCT00253097|health behavior|health behavior
5767905|NCT00253097|intervention|intervention
5767906|NCT00253097|tertiary prevention|tertiary prevention
5767907|NCT00253071|Prophylactic treatment|prophylactic treatment
5767908|NCT00253071|Pharmacological treatment|pharmacological treatment
5767909|NCT00253071|Psychological treatment|psychological treatment
5767910|NCT00253058|Allergic|allergic
5767911|NCT00253058|pediatric|pediatric
5767912|NCT00253058|Rhinitis|rhinitis
5767913|NCT00253058|Perennial|perennial
5767914|NCT00253045|Motivational Interviewing|motivational interviewing
5767915|NCT00253045|antiretroviral therapy|antiretroviral therapy
5767916|NCT00253045|medication adherence|medication adherence
5767917|NCT00253045|risk reduction behaviors|risk reduction behaviors
5767918|NCT00253045|women|women
5767920|NCT00253045|AIDS|aids
5767921|NCT00253019|birth control|birth control
5767922|NCT00253019|continuation|continuation
5767923|NCT00253019|abortion|abortion
5767924|NCT00253019|contraception|contraception
5767925|NCT00253006|NO|no
5767926|NCT00253006|mRNA-expression|mrna-expression
5767927|NCT00253006|pathophysiology|pathophysiology
5767928|NCT00253006|painful bladder syndrome|painful bladder syndrome
5767929|NCT00252993|Nausea|nausea
5767930|NCT00252993|Vomiting|vomiting
5767931|NCT00252993|Chronic Functional Vomiting|chronic functional vomiting
5767932|NCT00252993|Functional Vomiting|functional vomiting
5767933|NCT00252993|Cyclic Vomiting|cyclic vomiting
5767934|NCT00252980|Cannabis|cannabis
5767935|NCT00252980|Dependence|dependence
5767936|NCT00252980|Marijuana|marijuana
5767937|NCT00252980|Substance Abuse Treatment|substance abuse treatment
5767938|NCT00252980|Psychotherapy,|psychotherapy,
5767939|NCT00252967|Reactive Oxgen Speers|reactive oxgen speers
5767940|NCT00252967|Atrial Fibrillation|atrial fibrillation
5767941|NCT00252967|Oxidative Stress|oxidative stress
5767942|NCT00252967|Inflammation|inflammation
5767943|NCT00252954|Spinal cord injury|spinal cord injury
5767944|NCT00252954|Neuropathic pain|neuropathic pain
5767182|NCT00255554|BPD|bpd
5767945|NCT00252954|Spasms|spasms
5767946|NCT00252941|prostate cancer|prostate cancer
5767947|NCT00252941|brachytherapy|brachytherapy
5767948|NCT00252941|urethral stenting|urethral stenting
5767949|NCT00252928|sodium dichloroisocyanurate|sodium dichloroisocyanurate
5767950|NCT00252928|water purification|water purification
5767951|NCT00252928|disinfection|disinfection
5767952|NCT00252928|Ghana|ghana
5767953|NCT00252902|tobacco; emergency department; motivation; counseling|tobacco; emergency department; motivation; counseling
5767954|NCT00252889|Metastatic cancer|metastatic cancer
5767955|NCT00252889|Metastatic gastric and esophagus adenocarcinoma|metastatic gastric and esophagus adenocarcinoma
5767956|NCT00252889|Unresectable pancreatic cancer|unresectable pancreatic cancer
5767957|NCT00252889|Unresectable head and neck cancer|unresectable head and neck cancer
5767958|NCT00252889|Cancer of undetermined primary|cancer of undetermined primary
5767959|NCT00252850|Parkinson's Disease|parkinson's disease
5767960|NCT00252850|Gene Transfer|gene transfer
5767961|NCT00252798|Non Small Cell Lung Cancer|non small cell lung cancer
5767962|NCT00252785|Asthma|asthma
5767963|NCT00252746|NSCLC|nsclc
5767964|NCT00252746|Non Small Cell Lung Cancer|non small cell lung cancer
5767965|NCT00252733|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5767966|NCT00252720|Diabetes mellitus type 1|diabetes mellitus type 1
5767967|NCT00252694|Diabetes mellitus type 2|diabetes mellitus type 2
5767968|NCT00252681|randomized|randomized
5767969|NCT00252681|controlled|controlled
5767970|NCT00252681|trial|trial
5767971|NCT00252681|necrotizing|necrotizing
5767972|NCT00252681|enterocolitis|enterocolitis
5767973|NCT00252681|premature|premature
5767974|NCT00252681|infants|infants
5767975|NCT00252681|laparotomy|laparotomy
5767976|NCT00252681|peritoneal|peritoneal
5767977|NCT00252681|drainage|drainage
5767978|NCT00252668|Rheumatoid Arthritis|rheumatoid arthritis
5767979|NCT00252642|Hepatitis C|hepatitis c
5767980|NCT00252642|Interferon|interferon
5767981|NCT00252642|Cirrhosis|cirrhosis
5767982|NCT00252642|Liver Disease|liver disease
5767983|NCT00252642|Portal Hypertension|portal hypertension
5767984|NCT00252642|Portal Pressure|portal pressure
5767985|NCT00252629|Fatigue|fatigue
5767986|NCT00252629|Functional Somatic Syndrome|functional somatic syndrome
5767987|NCT00252629|Gulf War Syndrome|gulf war syndrome
5767988|NCT00252629|Sleep apnea|sleep apnea
5767989|NCT00252629|Upper Airway Resistance Syndrome|upper airway resistance syndrome
5767990|NCT00252616|Mechanical ventilation|mechanical ventilation
5767991|NCT00252616|acute respiratory failure|acute respiratory failure
5767992|NCT00252616|early nutrition|early nutrition
5767993|NCT00252603|Autism|autism
5767994|NCT00252603|Childhood Autism|childhood autism
5767995|NCT00252590|Psychotherapy motivational intervention|psychotherapy motivational intervention
5767996|NCT00252577|Lithium|lithium
5767997|NCT00252577|Pharmacogenetics|pharmacogenetics
5767998|NCT00252551|spondylolisthesis, decompressive surgery, osteosynthesis|spondylolisthesis, decompressive surgery, osteosynthesis
5767999|NCT00252538|Cortisol|cortisol
5768000|NCT00252538|Depression|depression
5768001|NCT00252538|Hepatitis C|hepatitis c
5768002|NCT00252538|Interferon|interferon
5768003|NCT00252538|Polymorphism|polymorphism
5768004|NCT00252538|Serotonin|serotonin
5768005|NCT00252538|Tryptophan|tryptophan
5768006|NCT00252512|Contingency management interventions|contingency management interventions
5768007|NCT00252512|Substance use disorders treatment|substance use disorders treatment
5768008|NCT00252512|Treatment effectiveness|treatment effectiveness
5768009|NCT00252512|Randomized clinical trial|randomized clinical trial
5768010|NCT00252512|Behavioral research|behavioral research
5768011|NCT00252499|beta cell function|beta cell function
5768012|NCT00252499|fenofibrate|fenofibrate
5768013|NCT00252499|non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5768014|NCT00252499|rosiglitazone|rosiglitazone
5768015|NCT00252499|insulin sensitivity|insulin sensitivity
5768017|NCT00252486|Omega-3 Fatty acids|omega-3 fatty acids
5768018|NCT00252434|high-risk sexual behavior|high-risk sexual behavior
5768019|NCT00252434|methamphetamine use|methamphetamine use
5768020|NCT00252434|drug craving|drug craving
5768021|NCT00252434|addiction behaviors|addiction behaviors
5768022|NCT00252421|osteoporosis|osteoporosis
5768023|NCT00252421|bone mineral density|bone mineral density
5768024|NCT00252421|nitrates|nitrates
5768025|NCT00252408|Fracture|fracture
5768026|NCT00252408|Osteoporosis|osteoporosis
5768027|NCT00252408|Bone mineral density|bone mineral density
5768028|NCT00252408|Hormone replacement therapy|hormone replacement therapy
5768029|NCT00252408|Estrogen|estrogen
5768030|NCT00252408|Breast cancer|breast cancer
5768031|NCT00252395|medication error|medication error
5768032|NCT00252395|electronic prescribing|electronic prescribing
5768033|NCT00252395|patient safety|patient safety
5768034|NCT00252382|Lung|lung
5768035|NCT00252382|Squamous Cell|squamous cell
5768036|NCT00252382|Large Cell|large cell
5768037|NCT00252382|Adenocarcinoma|adenocarcinoma
5768038|NCT00252382|Carcinoma|carcinoma
5768039|NCT00252382|Cancer|cancer
5768040|NCT00252356|major depressive disorder|major depressive disorder
5768041|NCT00252356|depression|depression
5768042|NCT00252356|major depressive episode|major depressive episode
5768043|NCT00252356|antidepressive agents|antidepressive agents
5768044|NCT00252343|anxiety disorder|anxiety disorder
5768045|NCT00252330|major depressive disorder|major depressive disorder
5768046|NCT00252330|depression|depression
5768047|NCT00252330|major depressive episode|major depressive episode
5768048|NCT00252330|antidepressive agents|antidepressive agents
5768049|NCT00252317|Aortic stenosis|aortic stenosis
5768050|NCT00252317|ACE-inhibitores|ace-inhibitores
5768051|NCT00252304|Child, severe pneumonia, Zinc, Nepal, therapeutic|child, severe pneumonia, zinc, nepal, therapeutic
5768052|NCT00252291|bronchial|bronchial
5768053|NCT00252291|hyperresponsiveness|hyperresponsiveness
5768054|NCT00252239|stroke|stroke
5768055|NCT00252239|tenecteplase|tenecteplase
5768056|NCT00252239|TNK|tnk
5768057|NCT00252239|ischemic|ischemic
5768058|NCT00252239|tissue plasminogen activator|tissue plasminogen activator
5768059|NCT00252239|tPA|tpa
5768060|NCT00252226|Quetiapine|quetiapine
5768061|NCT00252226|bipolar spectrum disorders|bipolar spectrum disorders
5768062|NCT00252187|Heart failure|heart failure
5768063|NCT00252187|Natriuretic peptides|natriuretic peptides
5768064|NCT00252187|B-type natriuretic peptide|b-type natriuretic peptide
5768065|NCT00252187|Kidney|kidney
5768066|NCT00252187|Nesiritide|nesiritide
5768067|NCT00252187|Natrecor|natrecor
5768068|NCT00252187|CHF|chf
5768069|NCT00252174|MDMA|mdma
5768070|NCT00252174|cancer|cancer
5768071|NCT00252174|anxiety|anxiety
5768072|NCT00252174|psychotherapy|psychotherapy
5768073|NCT00252174|quality of life|quality of life
5768074|NCT00252161|Neoadjuvant Therapy|neoadjuvant therapy
5768075|NCT00252161|Stomach Neoplasms|stomach neoplasms
5768076|NCT00252161|Cisplatin|cisplatin
5768077|NCT00252161|S-1(combination)|s-1(combination)
5768078|NCT00252148|HIV Preventive Vaccine|hiv preventive vaccine
5768079|NCT00252135|Moderate to severe asthma|moderate to severe asthma
5768080|NCT00252109|HIV|hiv
5768081|NCT00252109|Seropositive|seropositive
5768083|NCT00252109|African American|african american
5769193|NCT00247741|lidocaine|lidocaine
5768084|NCT00252109|Popular Opinion Leader|popular opinion leader
5768085|NCT00252096|Diagnosis|diagnosis
5768086|NCT00252096|Chlamydia trachomatis|chlamydia trachomatis
5768087|NCT00252096|Neisseria gonorrhoeae|neisseria gonorrhoeae
5768088|NCT00252096|Nucleic acid amplification test|nucleic acid amplification test
5768090|NCT00252096|Pharynx|pharynx
5768091|NCT00252083|Seropositive|seropositive
5768092|NCT00252083|MSM|msm
5768093|NCT00252083|Hispanic|hispanic
5768094|NCT00252083|Popular Opinion Leader|popular opinion leader
5768095|NCT00252083|HIV|hiv
5768096|NCT00252070|arthritis|arthritis
5768097|NCT00252070|exercise|exercise
5768098|NCT00252070|function|function
5768099|NCT00252070|pain|pain
5768100|NCT00252057|rehospitalization|rehospitalization
5768101|NCT00252057|readmission|readmission
5768102|NCT00252057|adverse events|adverse events
5768103|NCT00252057|discharge|discharge
5768104|NCT00252031|Borderline Personality Disorder|borderline personality disorder
5768105|NCT00252031|BPD|bpd
5768106|NCT00252031|Dialectical Behavior Therapy|dialectical behavior therapy
5768107|NCT00252031|DBT|dbt
5768108|NCT00252018|Nutritional supplement|nutritional supplement
5768109|NCT00252018|Prevention|prevention
5768110|NCT00252018|Endothelial function|endothelial function
5759044|NCT00287768|S-1|s-1
5768112|NCT00251966|Prevention of gastroduodenal lesions|prevention of gastroduodenal lesions
5768113|NCT00251966|erosive oesophagitis|erosive oesophagitis
5768114|NCT00251966|upper GI symptoms|upper gi symptoms
5768115|NCT00251927|Acid reflux disease|acid reflux disease
5768116|NCT00251927|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5768117|NCT00251901|Gastroesophageal reflux disease|gastroesophageal reflux disease
5768118|NCT00251901|GERD|gerd
5768119|NCT00251888|cervix cancer|cervix cancer
5768120|NCT00251888|advanced cervix cancer|advanced cervix cancer
5768121|NCT00251888|radiochemotherapy|radiochemotherapy
5768122|NCT00251888|pelvic radiotherapy|pelvic radiotherapy
5768123|NCT00251888|campto|campto
5768124|NCT00251888|cisplatin|cisplatin
5768125|NCT00251888|irinotecan|irinotecan
5768126|NCT00251888|cisplatyl|cisplatyl
5768127|NCT00251888|maximum dose search|maximum dose search
5768128|NCT00251875|patient portals|patient portals
5768129|NCT00251875|electronic health records|electronic health records
5768130|NCT00251875|family history|family history
5768131|NCT00251875|health maintenance|health maintenance
5768132|NCT00251875|medications|medications
5768133|NCT00251875|diabetes|diabetes
5768134|NCT00251862|Colorectal cancer screening|colorectal cancer screening
5768135|NCT00251862|Shared decision-making|shared decision-making
5768136|NCT00251862|Decision aid|decision aid
5768137|NCT00251849|Intermittent Claudication|intermittent claudication
5768138|NCT00251836|Kidney donation|kidney donation
5768139|NCT00251836|Organ Donation|organ donation
5768140|NCT00251836|Vascular anatomy|vascular anatomy
5768141|NCT00251836|Adrenal Insufficiency|adrenal insufficiency
5768142|NCT00251823|ST-Elevation Myocardial Infarction|st-elevation myocardial infarction
5768143|NCT00251810|general anaesthesia|general anaesthesia
5768144|NCT00251810|depth of hypnosis|depth of hypnosis
5794091|NCT00128050|ICH|ich
5768145|NCT00251810|Cerebral State Monitor|cerebral state monitor
5768146|NCT00251810|CSM|csm
5768147|NCT00251810|Bispectral Index|bispectral index
5768148|NCT00251810|BIS|bis
5768149|NCT00251797|Phase I|phase i
5768150|NCT00251797|Brain cancer|brain cancer
5768151|NCT00251797|Recurrent CNS tumors|recurrent cns tumors
5768152|NCT00251771|Thrombolytic therapy|thrombolytic therapy
5768153|NCT00251771|Postphlebitic syndrome|postphlebitic syndrome
5768154|NCT00251771|Venous thrombosis|venous thrombosis
5768155|NCT00251758|Non-Erosive Gastroesophageal Reflux Disease(GERD),heartburn|non-erosive gastroesophageal reflux disease(gerd),heartburn
5768156|NCT00251745|Non-Erosive Gastroesophageal Reflux Disease (GERD)|non-erosive gastroesophageal reflux disease (gerd)
5768157|NCT00251745|Heartburn|heartburn
5768158|NCT00251732|acid reflux studies|acid reflux studies
5768159|NCT00251732|efficacy of PPI therapy|efficacy of ppi therapy
5768160|NCT00251732|failing PPI therapy|failing ppi therapy
5768161|NCT00251732|GERD|gerd
5768162|NCT00251732|Acid Reflux Disease|acid reflux disease
5768163|NCT00251719|Erosive Esophagitis|erosive esophagitis
5768164|NCT00251706|atrial fibrillation|atrial fibrillation
5768165|NCT00251706|atrial flutter|atrial flutter
5768166|NCT00251706|amiodarone|amiodarone
5768167|NCT00251706|post-operative|post-operative
5768168|NCT00251706|coronary artery bypass surgery|coronary artery bypass surgery
5768169|NCT00251706|valve replacement or repair|valve replacement or repair
5768170|NCT00251693|Erosive Esophagitis|erosive esophagitis
5768171|NCT00251680|Hyperlipidemia|hyperlipidemia
5768172|NCT00251680|Drug Therapy|drug therapy
5768173|NCT00251654|complications|complications
5768174|NCT00251654|adverse events|adverse events
5768175|NCT00251654|regional anesthesia|regional anesthesia
5768176|NCT00251654|adverse effects|adverse effects
5768177|NCT00251628|Tonsils|tonsils
5768178|NCT00251628|Tonsillectomy|tonsillectomy
5768179|NCT00251615|vascular surgery|vascular surgery
5768180|NCT00251615|vascular aging|vascular aging
5768181|NCT00251615|arterial aging|arterial aging
5768182|NCT00251615|surgical tissue|surgical tissue
5768183|NCT00251615|Aging|aging
5768184|NCT00251602|heart rate variability|heart rate variability
5768185|NCT00251602|gene response|gene response
5768186|NCT00251589|Relapsed Non-Small-Cell Lung Cancer|relapsed non-small-cell lung cancer
5768187|NCT00251589|Refractory Non-Small-Cell Lung Cancer|refractory non-small-cell lung cancer
5768189|NCT00251537|Pilot study|pilot study
5768190|NCT00251537|Randomized|randomized
5768191|NCT00251537|Placebo-controlled|placebo-controlled
5768192|NCT00251537|Double-blind|double-blind
5768193|NCT00251537|Effect on viral load|effect on viral load
5768194|NCT00251537|LTB4|ltb4
5768195|NCT00251537|HIV-1 infection|hiv-1 infection
5768196|NCT00251498|Metastatic 1st line NSCLC|metastatic 1st line nsclc
5768197|NCT00251485|Metastatic 1st line colorectal cancer|metastatic 1st line colorectal cancer
5768198|NCT00251459|SAILOR|sailor
5768200|NCT00251459|AMD|amd
5768201|NCT00251459|CNV secondary to AMD|cnv secondary to amd
5768202|NCT00251433|ErbB1|erbb1
5768203|NCT00251433|ErbB2|erbb2
5768204|NCT00251433|trastuzumab (Herceptin)|trastuzumab (herceptin)
5768205|NCT00251433|lapatinib|lapatinib
5768206|NCT00251433|Stage IV breast cancer|stage iv breast cancer
5768207|NCT00251433|metastatic breast cancer|metastatic breast cancer
5768208|NCT00251433|overexpression of ErbB2 receptors|overexpression of erbb2 receptors
5769395|NCT00247130|Ranitidine|ranitidine
5768209|NCT00251433|docetaxel (Taxotere)|docetaxel (taxotere)
5768211|NCT00251420|asthma|asthma
5768212|NCT00251420|QoL|qol
5768213|NCT00251420|Perceived health status|perceived health status
5768214|NCT00251420|Trait anxiety|trait anxiety
5768215|NCT00251407|Advanced solid tumor malignancy|advanced solid tumor malignancy
5768216|NCT00251407|cisplatin|cisplatin
5768217|NCT00251407|CPT-11|cpt-11
5768218|NCT00251407|taxotere|taxotere
5768219|NCT00251394|B-Cell follicular non-Hodgkin's lymphoma|b-cell follicular non-hodgkin's lymphoma
5768220|NCT00251394|Rituxan|rituxan
5768221|NCT00251394|Rituximab|rituximab
5768222|NCT00251394|1018 ISS|1018 iss
5768223|NCT00251394|CD 20 +|cd 20 +
5768224|NCT00251381|Oropharyngeal Neoplasms|oropharyngeal neoplasms
5768225|NCT00251381|Cetuximab|cetuximab
5768226|NCT00251381|Concomitant-boost accelerated radiotherapy|concomitant-boost accelerated radiotherapy
5768227|NCT00251368|leukemia|leukemia
5768228|NCT00251368|9-Aminocamptothecin|9-aminocamptothecin
5768229|NCT00251368|AML|aml
5768230|NCT00251368|ALL|all
5768231|NCT00251368|refractory leukemia|refractory leukemia
5768232|NCT00251368|relapsed leukemia|relapsed leukemia
5768233|NCT00251355|gemcitabine|gemcitabine
5768234|NCT00251355|5-fluorouracil|5-fluorouracil
5768235|NCT00251355|5-FU|5-fu
5768236|NCT00251355|unresectable pancreatic cancer|unresectable pancreatic cancer
5768237|NCT00251355|non-metastatic pancreatic cancer|non-metastatic pancreatic cancer
5768238|NCT00251342|Postnatal depression|postnatal depression
5768239|NCT00251342|Randomized controlled trial|randomized controlled trial
5768240|NCT00251342|Screening|screening
5768241|NCT00251342|Outcome|outcome
5768242|NCT00251342|Edinburgh Postnatal Depression Scale|edinburgh postnatal depression scale
5768243|NCT00251329|Neoadjuvant|neoadjuvant
5768244|NCT00251329|Breast Cancer|breast cancer
5776814|NCT00213005|HIV|hiv
5768245|NCT00251329|pCR|pcr
5768246|NCT00251329|Capecitabine|capecitabine
5768247|NCT00251329|Carboplatin|carboplatin
5768248|NCT00251329|Docetaxel|docetaxel
5768249|NCT00251316|Thyroid Neoplasm|thyroid neoplasm
5768250|NCT00251316|I-131|i-131
5768251|NCT00251316|Radiation Dose|radiation dose
5768252|NCT00251316|Radiation Effect|radiation effect
5768253|NCT00251316|Pharmaceutical Adjuvant|pharmaceutical adjuvant
5768254|NCT00251316|Thyroid Cancer|thyroid cancer
5768255|NCT00251303|Clinical Trial|clinical trial
5768256|NCT00251303|Glutamate Antagonist|glutamate antagonist
5768257|NCT00251303|Pediatrics|pediatrics
5768258|NCT00251303|Basal Ganglia|basal ganglia
5768259|NCT00251303|Neuropsychological|neuropsychological
5768260|NCT00251303|Obsessive Compulsive Disorder|obsessive compulsive disorder
5768261|NCT00251303|OCD|ocd
5768262|NCT00251303|Riluzole|riluzole
5768263|NCT00251303|Rilutek|rilutek
5768264|NCT00251290|transient ischemic attack|transient ischemic attack
5768265|NCT00251290|sleep apnea|sleep apnea
5768266|NCT00251277|Thrombotic Thrombocytopenic Purpura|thrombotic thrombocytopenic purpura
5768267|NCT00251277|TTP|ttp
5768268|NCT00251277|Hematology|hematology
5768269|NCT00251264|Shoulder instability|shoulder instability
5768270|NCT00251264|Traumatic|traumatic
5768271|NCT00251264|Anterior|anterior
5768272|NCT00251264|Unidirectional|unidirectional
5768273|NCT00251264|Open stabilization|open stabilization
5768274|NCT00251264|Arthroscopic|arthroscopic
5768275|NCT00251264|Bankart repair|bankart repair
5768276|NCT00251264|Shoulder instability, traumatic|shoulder instability, traumatic
5768277|NCT00251264|Anterior, unidirectional instability|anterior, unidirectional instability
5768278|NCT00251264|Bankart|bankart
5768279|NCT00251251|Congestive heart failure|congestive heart failure
5768280|NCT00251251|Multicentre randomized controlled trial|multicentre randomized controlled trial
5768281|NCT00251251|Defibrillator|defibrillator
5777824|NCT00208624|cardiac|cardiac
5768282|NCT00251251|Cardiac resynchronization|cardiac resynchronization
5768283|NCT00251251|Sudden death/mortality|sudden death/mortality
5769594|NCT00246350|Massage|massage
5768284|NCT00251251|Hospitalization|hospitalization
5768285|NCT00251251|ICD indication|icd indication
5768286|NCT00251251|NYHA Class II|nyha class ii
5768287|NCT00251251|LVEF </equal to 30%|lvef </equal to 30%
5768288|NCT00251251|QRS >/equal to 120 ms|qrs >/equal to 120 ms
5768289|NCT00251238|Raynaud´s phenomenon|raynaud´s phenomenon
5768290|NCT00251238|Vasospastic attacks|vasospastic attacks
5768291|NCT00251238|Ginkgo biloba|ginkgo biloba
5768292|NCT00251225|prostate|prostate
5768293|NCT00251212|Alcohol|alcohol
5768294|NCT00251212|Violence|violence
5768295|NCT00251212|Alcohol consumption|alcohol consumption
5768296|NCT00251212|Alcohol, drinking|alcohol, drinking
5768297|NCT00251160|Multi-directional instability|multi-directional instability
5768298|NCT00251160|MDI|mdi
5768299|NCT00251160|Ligamentous laxity|ligamentous laxity
5768300|NCT00251160|Multi-directional laxity|multi-directional laxity
5768301|NCT00251160|MDL-AII|mdl-aii
5768302|NCT00251160|Shoulder instability|shoulder instability
5768303|NCT00251160|electrothermal capsulorrhaphy, ETAC|electrothermal capsulorrhaphy, etac
5768304|NCT00251160|inferior capsular shift, ICS|inferior capsular shift, ics
5768305|NCT00251160|capsular redundancy|capsular redundancy
5768306|NCT00251147|rotator cuff|rotator cuff
5768307|NCT00251147|open|open
5768308|NCT00251147|arthroscopic|arthroscopic
5768309|NCT00251147|mini-open|mini-open
5768310|NCT00251147|acromioplasty|acromioplasty
5768311|NCT00251147|quality of life|quality of life
5768312|NCT00251147|shoulder|shoulder
5768313|NCT00251134|myocardial infarction|myocardial infarction
5768314|NCT00251134|omega 3-fatty acids|omega 3-fatty acids
5768315|NCT00251121|Electrophysiological study|electrophysiological study
5768316|NCT00251121|paroxysmal tachycardia|paroxysmal tachycardia
5848601|NCT00034216|T-cells|t-cells
5768317|NCT00251108|'traumatic brain injury'|'traumatic brain injury'
5768318|NCT00251108|'head injury'|'head injury'
5768319|NCT00251108|'brain injuries'|'brain injuries'
5768320|NCT00251108|'exercise therapy'|'exercise therapy'
5768321|NCT00251108|'physical fitness'|'physical fitness'
5768322|NCT00251095|Metastatic Breast Cancer|metastatic breast cancer
5768323|NCT00251082|hormone replacement|hormone replacement
5768324|NCT00251082|vasomotoric symptoms|vasomotoric symptoms
5768325|NCT00251082|bleeding pattern|bleeding pattern
5768326|NCT00251069|glucosamine sulphate, osteoarthritis, cholesterol,|glucosamine sulphate, osteoarthritis, cholesterol,
5768327|NCT00251043|Pregnancy|pregnancy
5768328|NCT00251043|Antepartum Depression|antepartum depression
5768329|NCT00251043|Major Depression|major depression
5768330|NCT00251017|single nucleotide polymorphisms (SNPs)|single nucleotide polymorphisms (snps)
5768331|NCT00251017|personalized medicines|personalized medicines
5768332|NCT00251017|Subjects 16 years of age or older, of either sex.|subjects 16 years of age or older, of either sex.
5768333|NCT00251017|Subjects have a medication including vancomycin|subjects have a medication including vancomycin
5768334|NCT00251004|Renal transplantation, kidney, and organ transplant|renal transplantation, kidney, and organ transplant
5768335|NCT00251004|Renal transplant rejection|renal transplant rejection
5768336|NCT00250991|stroke|stroke
5767498|NCT00254046|HIV|hiv
5768337|NCT00250991|integrilin|integrilin
5768338|NCT00250991|eptifibatide|eptifibatide
5768339|NCT00250991|activase|activase
5768340|NCT00250991|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5768341|NCT00250991|rt-PA|rt-pa
5768342|NCT00250991|recombinant t-PA|recombinant t-pa
5768343|NCT00250991|SPOTRIAS|spotrias
5768344|NCT00250978|Advanced Non Small Cell Lung Cancer|advanced non small cell lung cancer
5768345|NCT00250952|Clinical Practice Variations|clinical practice variations
5768346|NCT00250939|Glycogen Storage Disease Type II|glycogen storage disease type ii
5768347|NCT00250939|GSD-II|gsd-ii
5768348|NCT00250939|Pompe Disease|pompe disease
5768349|NCT00250926|bortezomib|bortezomib
5768350|NCT00250926|dexamethasone|dexamethasone
5768351|NCT00250926|rituximab|rituximab
5768352|NCT00250913|motor activity|motor activity
5768353|NCT00250913|determinants|determinants
5768354|NCT00250913|psychology|psychology
5768355|NCT00250913|health care costs|health care costs
5768356|NCT00250913|quality of life|quality of life
5768357|NCT00250913|Angioplasty|angioplasty
5768358|NCT00250900|Otitis|otitis
5768359|NCT00250900|Antibiotic|antibiotic
5768360|NCT00250900|Prescription|prescription
5768361|NCT00250887|recurrent Glioblastoma, Gefitinib|recurrent glioblastoma, gefitinib
5768362|NCT00250848|Lung Diseases|lung diseases
5768363|NCT00250848|Cancer|cancer
5768364|NCT00250835|Resectable Rectal Cancer|resectable rectal cancer
5768365|NCT00250835|Radiation|radiation
5768366|NCT00250835|Neoadjuvant|neoadjuvant
5768367|NCT00250835|Rectum|rectum
5768368|NCT00250835|GI - Colorectal Neoadjuvant|gi - colorectal neoadjuvant
5768369|NCT00250835|Cancer|cancer
5768370|NCT00250822|Liver|liver
5768371|NCT00250822|hepatocellular|hepatocellular
5768372|NCT00250822|Gem-Ox|gem-ox
5768373|NCT00250822|Cancer|cancer
5768374|NCT00250796|Phase II|phase ii
5768375|NCT00250796|Hepatocellular carcinoma|hepatocellular carcinoma
5768376|NCT00250783|Corpus Uteri|corpus uteri
5768377|NCT00250783|Endometrium|endometrium
5768378|NCT00250783|Cancer|cancer
5768379|NCT00250770|Corpus Uteri|corpus uteri
5768380|NCT00250770|Endometrium|endometrium
5768381|NCT00250770|Cancer|cancer
5768383|NCT00250757|NMR Spectroscopy|nmr spectroscopy
5768384|NCT00250744|delayed nausea and vomiting|delayed nausea and vomiting
5768385|NCT00250744|Emetogenic Chemotherapy|emetogenic chemotherapy
5768386|NCT00250744|Pilot Trial|pilot trial
5768387|NCT00250731|diabetes|diabetes
5768388|NCT00250731|relationship|relationship
5768389|NCT00250731|social support|social support
5768390|NCT00250731|behavior change|behavior change
5768391|NCT00250731|telemedicine|telemedicine
5768392|NCT00250718|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5768393|NCT00250718|Phase II|phase ii
5768394|NCT00250718|Lymphoid malignancies|lymphoid malignancies
5768395|NCT00250705|Aripiprazole|aripiprazole
5768397|NCT00250679|chronic bronchitis|chronic bronchitis
5768398|NCT00250679|emphysema|emphysema
5768399|NCT00250666|Biological Markers|biological markers
5768400|NCT00250666|Procalcitonin|procalcitonin
5768401|NCT00250666|Critical Care|critical care
5768402|NCT00250666|Diagnosis, Differential|diagnosis, differential
5768403|NCT00250666|Prospective Study|prospective study
5768404|NCT00250666|Sepsis|sepsis
5768405|NCT00250666|Antibiotic stewardship|antibiotic stewardship
5768406|NCT00250666|Antimicrobial resistance|antimicrobial resistance
5768407|NCT00250653|depression|depression
5768408|NCT00250653|antidepressive agents|antidepressive agents
5768409|NCT00250653|clinical trial|clinical trial
5768410|NCT00250640|Primary Pulmonary hypertension|primary pulmonary hypertension
5768411|NCT00250627|depression|depression
5768412|NCT00250627|antidepressive agents|antidepressive agents
5768413|NCT00250627|controlled clinical trial|controlled clinical trial
5768414|NCT00250614|depression|depression
5768415|NCT00250614|antidepressive agents|antidepressive agents
5768416|NCT00250614|controlled clinical trial|controlled clinical trial
5768417|NCT00250601|depression|depression
5768418|NCT00250601|antidepressive agents|antidepressive agents
5768419|NCT00250601|controlled clinical trial|controlled clinical trial
5768421|NCT00250588|Child|child
5768422|NCT00250588|Problem-solving|problem-solving
5768423|NCT00250588|Quality of Life|quality of life
5768424|NCT00250588|Barriers to Care|barriers to care
5768425|NCT00250575|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
5768426|NCT00250562|Hypertension|hypertension
5768427|NCT00250562|Angiotensin II receptor blocker|angiotensin ii receptor blocker
5768428|NCT00250562|fixed combination|fixed combination
5768429|NCT00250562|diuretics|diuretics
5768430|NCT00250549|HIV|hiv
5768431|NCT00250549|Prevention|prevention
5768432|NCT00250549|Rapid HIV testing|rapid hiv testing
5768433|NCT00250523|trauma|trauma
5768434|NCT00250523|critical illness|critical illness
5768435|NCT00250523|injury|injury
5768436|NCT00250510|Obesity treatment|obesity treatment
5768437|NCT00250510|Insurance reimbursement|insurance reimbursement
5768438|NCT00250510|Health care utilization|health care utilization
5768439|NCT00250510|Health care costs|health care costs
5768440|NCT00250497|Adolescent|adolescent
5768441|NCT00250497|Girls|girls
5768442|NCT00250497|Physical Activity|physical activity
5768443|NCT00250497|Exercise|exercise
5768444|NCT00250497|Diet|diet
5768445|NCT00250497|Body image|body image
5768446|NCT00250484|analgesia|analgesia
5768447|NCT00250484|electric stimulation therapy|electric stimulation therapy
5768448|NCT00250484|electric stimulation|electric stimulation
5768449|NCT00250484|pain|pain
5768450|NCT00250484|safety|safety
5768451|NCT00250471|GP IIb/IIIa inhibitors|gp iib/iiia inhibitors
5768452|NCT00250471|eptifibatide|eptifibatide
5768453|NCT00250471|Anti-thrombotic agents|anti-thrombotic agents
5768454|NCT00250445|Arcoxia|arcoxia
5768455|NCT00250406|urolithiasis|urolithiasis
5768456|NCT00250406|ureteral stent|ureteral stent
5768457|NCT00250406|triclosan|triclosan
5768458|NCT00250406|drug eluting|drug eluting
5768459|NCT00250393|Parkinson's disease|parkinson's disease
5768460|NCT00250393|monotherapy|monotherapy
5768461|NCT00250380|Aspirin|aspirin
5768462|NCT00250380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5768463|NCT00250367|risperidone|risperidone
5768464|NCT00250367|antipsychotic agents|antipsychotic agents
5768465|NCT00250367|bipolar disorders|bipolar disorders
5768466|NCT00250367|manic episode|manic episode
5768467|NCT00250354|conduct disorder|conduct disorder
5768468|NCT00250354|oppositional deficit disorder|oppositional deficit disorder
5768469|NCT00250354|disruptive behavior disorder not otherwise specified|disruptive behavior disorder not otherwise specified
5768470|NCT00250354|ADHD|adhd
5768471|NCT00250354|risperidone|risperidone
5768472|NCT00250354|antipsychotropic agents|antipsychotropic agents
5768473|NCT00250354|children|children
5768474|NCT00250289|malodor|malodor
5768475|NCT00250289|halitosis|halitosis
5768476|NCT00250289|herbal formulation|herbal formulation
5768477|NCT00250289|natural medicinals|natural medicinals
5863980|NCT00001147|Metanephrine|metanephrine
5681062|NCT00574899|Prostate|prostate
5768478|NCT00250289|slow release delivery system|slow release delivery system
5768479|NCT00250263|rhinitis|rhinitis
5768480|NCT00250263|asthma|asthma
5768481|NCT00250263|atopy|atopy
5768482|NCT00250263|house dust mite|house dust mite
5768483|NCT00250263|immunotherapy|immunotherapy
5768484|NCT00250263|SLIT|slit
5768485|NCT00250237|Post-operative delirium|post-operative delirium
5763770|NCT00268996|palpography|palpography
5768486|NCT00250237|hip fracture|hip fracture
5768487|NCT00250224|Radiotherapy|radiotherapy
5768488|NCT00250224|image guided|image guided
5768489|NCT00250224|marker|marker
5768490|NCT00250211|magnetic resonance imaging, functional|magnetic resonance imaging, functional
5768491|NCT00250211|radiation therapy|radiation therapy
5768492|NCT00250211|temozolomide|temozolomide
5768493|NCT00250211|functional imaging|functional imaging
5768494|NCT00250211|concurrent chemoradiation|concurrent chemoradiation
5768495|NCT00250198|T Cell|t cell
5768496|NCT00250198|Lymphocyte|lymphocyte
5768497|NCT00250198|Lamina Propria|lamina propria
5768498|NCT00250198|Colonoscopy|colonoscopy
5768499|NCT00250198|Placebo|placebo
5768500|NCT00250198|Crohn's Disease|crohn's disease
5768501|NCT00250198|Crohns Disease|crohns disease
5768502|NCT00250185|Ischemia Tolerance|ischemia tolerance
5768503|NCT00250185|Endothelial Function|endothelial function
5768504|NCT00250185|Forearm Blood Flow|forearm blood flow
5768505|NCT00250185|Muscle Recovery|muscle recovery
5768506|NCT00250185|Inflammation|inflammation
5768507|NCT00250185|Healthy Volunteer|healthy volunteer
5768509|NCT00250172|Dosimetry|dosimetry
5768510|NCT00250172|Pharmacokinetics|pharmacokinetics
5768511|NCT00250172|Compartment Analysis|compartment analysis
5768530|NCT00250120|Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin|aerosolized liposomal 9-nitro-20 (s)-camptothecin
5768531|NCT00250094|Phase I|phase i
5768532|NCT00250094|Ovarian Cancer|ovarian cancer
5768533|NCT00250094|Ovary|ovary
5768534|NCT00250094|Cancer|cancer
5768535|NCT00250081|Cerebral Palsy|cerebral palsy
5768536|NCT00250081|Tendon Transfer|tendon transfer
5768537|NCT00250081|Botulinum Toxin Type A|botulinum toxin type a
5768538|NCT00250081|Occupational Therapy|occupational therapy
5768539|NCT00250081|Child|child
5768540|NCT00250068|Phase II|phase ii
5768541|NCT00250068|Aerosol Delivery|aerosol delivery
5768542|NCT00250068|NSCLC|nsclc
5768543|NCT00250068|9-Nitrocamptothecin|9-nitrocamptothecin
5768545|NCT00250055|Non-Invasive diagnosis of cervical tissue|non-invasive diagnosis of cervical tissue
5768546|NCT00250055|Los Alamos/NIH|los alamos/nih
5768547|NCT00250029|Colorectal Cancer|colorectal cancer
5768548|NCT00250029|Pilot Study|pilot study
5768549|NCT00250029|Oxaliplatin|oxaliplatin
5768550|NCT00250016|Endometrium|endometrium
5768551|NCT00250016|Tissue|tissue
5768552|NCT00250016|L9NC|l9nc
5768553|NCT00250003|Elderly|elderly
5768554|NCT00250003|Preventive home visits|preventive home visits
5768555|NCT00249990|Uterus|uterus
5768556|NCT00249990|Recurrent disease|recurrent disease
5768557|NCT00249990|Treatment|treatment
5768558|NCT00249990|9-Nitrocamptothecin|9-nitrocamptothecin
5768559|NCT00249990|Endometrium|endometrium
5768560|NCT00249977|Phase I|phase i
5768561|NCT00249977|solid tumors|solid tumors
5768562|NCT00249977|DNA repair|dna repair
5768563|NCT00249964|Extensive or recurrent small cell lung cancer Phase I|extensive or recurrent small cell lung cancer phase i
5768564|NCT00249964|Paclitaxel, Carboplatin, Temozolomide|paclitaxel, carboplatin, temozolomide
5768565|NCT00249951|nephrocalcinosis|nephrocalcinosis
5768566|NCT00249951|premature infants|premature infants
5768567|NCT00249951|hypocitraturia|hypocitraturia
5768568|NCT00249951|alcaline citrate therapy|alcaline citrate therapy
5768569|NCT00249951|Nephrocalcinosis in premature infants|nephrocalcinosis in premature infants
5768570|NCT00249938|Antilipemic agents|antilipemic agents
5768571|NCT00249938|hyperlipidemia|hyperlipidemia
5768572|NCT00249925|Home modification|home modification
5768573|NCT00249925|Occupational Therapy|occupational therapy
5768574|NCT00249925|Physical Therapy|physical therapy
5768575|NCT00249925|Home care|home care
5768576|NCT00249912|Hyperlipidemia|hyperlipidemia
5768577|NCT00249912|Drug Therapy|drug therapy
5768578|NCT00249899|Hyperlipidemia|hyperlipidemia
5768579|NCT00249899|Drug Therapy|drug therapy
5768580|NCT00249873|Atrial fibrillation|atrial fibrillation
5768581|NCT00249873|Anticoagulant therapy|anticoagulant therapy
5768582|NCT00249873|Thromboembolic prevention|thromboembolic prevention
5768583|NCT00249860|Subjects with chronic hepatitis C who have never previously received interferon therapy.|subjects with chronic hepatitis c who have never previously received interferon therapy.
5768584|NCT00249847|Hot flashes, vasomotor symptoms, estrogen, paroxetine|hot flashes, vasomotor symptoms, estrogen, paroxetine
5768585|NCT00249834|Assisted Reproductive Technology (ART)|assisted reproductive technology (art)
5768586|NCT00249834|Infertility|infertility
5768587|NCT00249834|Ovarian stimulation|ovarian stimulation
5768588|NCT00249808|Candidates for systemic therapy for psoriasis|candidates for systemic therapy for psoriasis
5768589|NCT00249795|Atrial fibrillation|atrial fibrillation
5768590|NCT00249795|Cardiovascular disease|cardiovascular disease
5768591|NCT00249795|angiotensin II blocker|angiotensin ii blocker
5778133|NCT00207181|PDA|pda
5768592|NCT00249782|rosacea, Papulopustular Rosacea,erythema, dapsone|rosacea, papulopustular rosacea,erythema, dapsone
5768593|NCT00249769|Japanese Encephalitis|japanese encephalitis
5768594|NCT00249769|Japanese B Encephalitis|japanese b encephalitis
5768595|NCT00249769|Japanese B Viral Encephalitis|japanese b viral encephalitis
5768596|NCT00249769|Viral Encephalitis, Japanese B|viral encephalitis, japanese b
5768597|NCT00249756|Criminal Justice|criminal justice
5768598|NCT00249743|fall prevention|fall prevention
5768599|NCT00249743|fall risk management|fall risk management
5768600|NCT00249743|RCT|rct
5768601|NCT00249743|cost|cost
5768602|NCT00249717|Contingency management|contingency management
5768603|NCT00249717|Substance abuse treatment|substance abuse treatment
5768604|NCT00249691|cocaine addiction|cocaine addiction
5768608|NCT00249652|End stage liver disease|end stage liver disease
5768609|NCT00249652|End stage renal disease|end stage renal disease
5768610|NCT00249652|Substance-Related Disorders|substance-related disorders
5768611|NCT00249639|Contingency Management|contingency management
5768612|NCT00249639|Substance Abuse Treatment|substance abuse treatment
5768613|NCT00249626|Contingency management|contingency management
5768614|NCT00249626|substance abuse treatment|substance abuse treatment
5768615|NCT00249613|gender-responsive substance abuse treatment|gender-responsive substance abuse treatment
5768616|NCT00249600|contingency management|contingency management
5768617|NCT00249600|substance abuse|substance abuse
5768618|NCT00249574|heroin addiction|heroin addiction
5768619|NCT00249548|contingency management|contingency management
5768620|NCT00249548|substance abuse|substance abuse
5768621|NCT00249535|Substance Abuse|substance abuse
5768622|NCT00249535|Contingency Management|contingency management
5768623|NCT00249522|contingency management|contingency management
5768624|NCT00249522|substance abuse treatment|substance abuse treatment
5768625|NCT00249509|marijuana dependence|marijuana dependence
5768627|NCT00249496|opioids|opioids
5768628|NCT00249496|contingency management|contingency management
5768629|NCT00249496|sexual risk|sexual risk
5768631|NCT00249483|Cocaine Addiction|cocaine addiction
5768632|NCT00249483|Cocaine Dependence|cocaine dependence
5768633|NCT00249470|HIV|hiv
5768634|NCT00249470|HIV risk behaviors|hiv risk behaviors
5768635|NCT00249470|Heroin|heroin
5768636|NCT00249470|Cocaine|cocaine
5768637|NCT00249470|Methadone|methadone
5768638|NCT00249470|Opioid Dependence|opioid dependence
5768639|NCT00249470|Cocaine Abuse|cocaine abuse
5768640|NCT00249470|Contingency management|contingency management
5768641|NCT00249470|alcohol & drug use|alcohol & drug use
5768642|NCT00249470|sexual risk behaviors|sexual risk behaviors
5768643|NCT00249457|Behavior Therapy|behavior therapy
5768644|NCT00249457|Cocaine Abuse|cocaine abuse
5768645|NCT00249457|Cocaine Dependence|cocaine dependence
5768646|NCT00249457|Contingency Management|contingency management
5768647|NCT00249457|Heroin Dependence|heroin dependence
5768648|NCT00249457|Methadone|methadone
5768649|NCT00249457|Opioid Dependence|opioid dependence
5768650|NCT00249444|cocaine dependence|cocaine dependence
5768651|NCT00249444|mirtazipine|mirtazipine
5768652|NCT00249431|Gambling|gambling
5768653|NCT00249431|Alcohol|alcohol
5768654|NCT00249418|Contingency Management|contingency management
5768655|NCT00249418|Substance Abuse Treatment|substance abuse treatment
5768656|NCT00249405|Clinical trial|clinical trial
5768657|NCT00249405|Alcoholism|alcoholism
5768658|NCT00249405|Alcohol|alcohol
5768659|NCT00249405|Pharmacogenetics|pharmacogenetics
5768660|NCT00249405|Citalopram|citalopram
5768661|NCT00249405|Genotype|genotype
5768662|NCT00249405|Therapy compliance|therapy compliance
5768663|NCT00249405|Serotonin inhibitor|serotonin inhibitor
5768664|NCT00249405|Alcoholism/alcohol abuse therapy|alcoholism/alcohol abuse therapy
5768665|NCT00249392|ocular diseases|ocular diseases
5768666|NCT00249392|risk factors|risk factors
5768667|NCT00249392|genetic factors|genetic factors
5768668|NCT00249379|Alcohol dependence|alcohol dependence
5768669|NCT00249379|Acamprosate(drug)|acamprosate(drug)
5768670|NCT00249379|Drug Court|drug court
5768671|NCT00249379|Probation|probation
5768672|NCT00249379|Parole|parole
5768673|NCT00249379|Criminal justice|criminal justice
5768674|NCT00249366|Alcohol withdrawal|alcohol withdrawal
5768675|NCT00249366|Symptom-triggered therapy|symptom-triggered therapy
5768676|NCT00249366|Fixed-schedule therapy|fixed-schedule therapy
5768677|NCT00249366|CIWA-Ar|ciwa-ar
5768678|NCT00249366|Lorazepam (drug)|lorazepam (drug)
5768679|NCT00249353|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5768680|NCT00249353|ADHD|adhd
5768681|NCT00249353|Concerta|concerta
5768682|NCT00249340|behavioral weight loss treatment|behavioral weight loss treatment
5768683|NCT00249340|brief behavioral treatment|brief behavioral treatment
5768684|NCT00249340|commercial weight loss programs|commercial weight loss programs
5768685|NCT00249340|Weight Watchers|weight watchers
5768686|NCT00249327|HIV testing|hiv testing
5768687|NCT00249327|HIV disclosure|hiv disclosure
5768688|NCT00249327|HIV Seronegativity|hiv seronegativity
5768689|NCT00249314|South Asians|south asians
5768690|NCT00249314|European Caucasians|european caucasians
5768691|NCT00249314|ethnic differences|ethnic differences
5768692|NCT00249314|body composition|body composition
5768693|NCT00249314|body fat distribution|body fat distribution
5768694|NCT00249314|adipose tissue|adipose tissue
5768695|NCT00249314|visceral fat|visceral fat
5768696|NCT00249314|myocellular lipids|myocellular lipids
5768697|NCT00249314|skeletal muscle|skeletal muscle
5768698|NCT00249301|Breast Cancer|breast cancer
5768699|NCT00249301|Colon Cancer|colon cancer
5768700|NCT00249301|Pancreatic Cancer|pancreatic cancer
5768701|NCT00249301|Bladder Cancer|bladder cancer
5768702|NCT00249288|Schizophrenia|schizophrenia
5768703|NCT00249288|Negative Symptoms|negative symptoms
5768704|NCT00249288|Folate|folate
5768705|NCT00249275|significant refractive errors|significant refractive errors
5768706|NCT00249275|children|children
5768707|NCT00249275|spectacles|spectacles
5768708|NCT00249275|Africa|africa
5768709|NCT00249249|hypercholesterolemia|hypercholesterolemia
5768710|NCT00249249|dyslipidemia|dyslipidemia
5768711|NCT00249249|kowa|kowa
5768713|NCT00249249|pitavastatin|pitavastatin
5768714|NCT00249249|NK-104|nk-104
5768715|NCT00249236|risperidone|risperidone
5768716|NCT00249236|antipsychotic agents|antipsychotic agents
5768717|NCT00249236|bipolar disorders|bipolar disorders
5768718|NCT00249236|manic episode|manic episode
5768719|NCT00249223|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents|chronic schizophrenia, psychotic disorder, risperidone, long-acting injectable, intramuscular injection, antipsychotic agents
5768720|NCT00249210|Sinusitis|sinusitis
5768721|NCT00249210|respiratory tract diseases|respiratory tract diseases
5768722|NCT00249210|nose diseases|nose diseases
5768723|NCT00249210|respiratory tract infections|respiratory tract infections
5768724|NCT00249210|paranasal sinus diseases|paranasal sinus diseases
5768725|NCT00249210|antibacterial agents|antibacterial agents
5768726|NCT00249210|quinolones|quinolones
5768727|NCT00249210|levofloxacin|levofloxacin
5768728|NCT00249197|skin infection|skin infection
5768729|NCT00249197|bacterial infection|bacterial infection
5768730|NCT00249197|levofloxacin|levofloxacin
5768731|NCT00249197|quinolones|quinolones
5768732|NCT00249197|skin|skin
5768733|NCT00249197|infection|infection
5768734|NCT00249171|acute schizophrenia|acute schizophrenia
5768735|NCT00249171|psychosis|psychosis
5768736|NCT00249171|risperidone|risperidone
5768737|NCT00249171|lorazepam, antipsychotic agents|lorazepam, antipsychotic agents
5768738|NCT00249171|emergency treatment|emergency treatment
5768739|NCT00249158|Dementia|dementia
5768740|NCT00249158|Alzheimer's Disease|alzheimer's disease
5768741|NCT00249158|vascular dementia|vascular dementia
5768742|NCT00249158|mixed dementia|mixed dementia
5768743|NCT00249158|risperidone|risperidone
5768744|NCT00249158|nursing home|nursing home
5768745|NCT00249145|Dementia|dementia
5768746|NCT00249145|Alzheimer's Disease|alzheimer's disease
5768747|NCT00249145|vascular dementia|vascular dementia
5768748|NCT00249145|mixed dementia, risperidone|mixed dementia, risperidone
5768749|NCT00249145|nursing home|nursing home
5768750|NCT00249132|chronic schizophrenia|chronic schizophrenia
5768751|NCT00249132|psychotic disorder|psychotic disorder
5768752|NCT00249132|risperidone|risperidone
5768753|NCT00249132|antipsychotic agents|antipsychotic agents
5768754|NCT00249119|chronic schizophrenia|chronic schizophrenia
5768755|NCT00249119|psychotic disorders|psychotic disorders
5768756|NCT00249119|risperidone|risperidone
5768757|NCT00249119|antipsychotic agents|antipsychotic agents
5768758|NCT00249080|3T MRI|3t mri
5768759|NCT00249080|neurodegenerative disease|neurodegenerative disease
5768760|NCT00249080|Alzheimer's disease|alzheimer's disease
5768761|NCT00249080|spectroscopy|spectroscopy
5768762|NCT00249080|Normal, healthy subject without memory complaint|normal, healthy subject without memory complaint
5768763|NCT00249080|Not pregnant|not pregnant
5768764|NCT00249080|MR compatible|mr compatible
5768765|NCT00249067|Congestive Heart Failure, Left-to-Right Shunt|congestive heart failure, left-to-right shunt
5768766|NCT00249041|Rheumatoid Arthritis, Enbrel liquid, antibodies|rheumatoid arthritis, enbrel liquid, antibodies
5768767|NCT00249015|aerobic exercise|aerobic exercise
5768768|NCT00249015|resistance exercise|resistance exercise
5768769|NCT00249015|physical fitness|physical fitness
5768770|NCT00249015|body composition|body composition
5768771|NCT00249015|quality of life|quality of life
5768772|NCT00249015|rehabilitation|rehabilitation
5768773|NCT00249015|psychosocial oncology|psychosocial oncology
5768774|NCT00249015|adherence|adherence
5768775|NCT00249002|Vascular Access Graft Failure|vascular access graft failure
5768776|NCT00249002|Venous Neointimal Hyperplasia(VNH)|venous neointimal hyperplasia(vnh)
5768777|NCT00249002|Hemodialysis|hemodialysis
5768778|NCT00248989|Skin aging|skin aging
5768779|NCT00248989|Menopausal symptoms|menopausal symptoms
5768780|NCT00248976|Angioplasty|angioplasty
5768781|NCT00248976|Motivating behavior change|motivating behavior change
5768782|NCT00248976|Reducing risk factors|reducing risk factors
5768783|NCT00248976|Enhancing quality of life|enhancing quality of life
5768784|NCT00248976|Improving treatment outcomes|improving treatment outcomes
5768785|NCT00248963|Oral Contraceptive|oral contraceptive
5768786|NCT00248950|Angioplasty|angioplasty
5768787|NCT00248950|Behavior Change|behavior change
5768788|NCT00248937|African-American|african-american
5768789|NCT00248937|Hypertension|hypertension
5768790|NCT00248937|Medication adherence|medication adherence
5768791|NCT00248937|Risk reduction|risk reduction
5768792|NCT00248924|Social service intervention|social service intervention
5768793|NCT00248924|Social support|social support
5768794|NCT00248924|Elderly|elderly
5768795|NCT00248924|Homebound|homebound
5768796|NCT00248924|Quality of life|quality of life
5768797|NCT00248911|Breast cancer|breast cancer
5768798|NCT00248911|Gynecologic cancers|gynecologic cancers
5768799|NCT00248911|Meditation|meditation
5768800|NCT00248911|Stress-reduction|stress-reduction
5768802|NCT00248898|nonagenarians|nonagenarians
5768803|NCT00248898|quality of life|quality of life
5768804|NCT00248898|cardiothoracic surgery|cardiothoracic surgery
5768805|NCT00248898|long term survival|long term survival
5768806|NCT00248885|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5768807|NCT00248885|Perioperative complications|perioperative complications
5768808|NCT00248885|Neurocognitive function|neurocognitive function
5768809|NCT00248885|Quality of life|quality of life
5768810|NCT00248885|Blood pressure|blood pressure
5768811|NCT00248872|African-American|african-american
5768812|NCT00248872|Hypertension|hypertension
5768813|NCT00248872|Medication adherence|medication adherence
5768814|NCT00248872|Risk reduction|risk reduction
5768815|NCT00248859|Coronary artery disease|coronary artery disease
5768816|NCT00248859|Depressive symptoms|depressive symptoms
5768817|NCT00248859|Latino American|latino american
5768818|NCT00248846|Angioplasty patients|angioplasty patients
5768819|NCT00248846|Behavior change|behavior change
5768820|NCT00248846|Physical activity|physical activity
5768821|NCT00248846|Risk reduction|risk reduction
5768822|NCT00248820|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
5768823|NCT00248820|Ultrasound Contrast agent, microbubbles|ultrasound contrast agent, microbubbles
5768824|NCT00248820|Ovarian tumor|ovarian tumor
5768825|NCT00248820|vascularization|vascularization
5768826|NCT00248807|Blood Pressure, Low|blood pressure, low
5768827|NCT00248807|Hypotension, Postural|hypotension, postural
5768828|NCT00248807|Injuries, Spinal Cord|injuries, spinal cord
5768829|NCT00248807|Spinal Cord Transection|spinal cord transection
5768830|NCT00248807|Spinal Cord Trauma|spinal cord trauma
5768831|NCT00248794|Cognitive Impairment|cognitive impairment
5768832|NCT00248794|Rehabilitation|rehabilitation
5768833|NCT00248781|Activities of daily living|activities of daily living
5768835|NCT00248781|Exercise|exercise
5768836|NCT00248781|Weight lifting|weight lifting
5768837|NCT00248768|Depression|depression
5768838|NCT00248768|Parkinson Disease|parkinson disease
5768839|NCT00248768|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5768840|NCT00248755|cystic fibrosis|cystic fibrosis
5768841|NCT00248755|mucociliary clearance|mucociliary clearance
5768842|NCT00248755|nuclear medicine|nuclear medicine
5768843|NCT00248742|IBD, psychological, stress management|ibd, psychological, stress management
5768844|NCT00248703|Disseminating tumor cells,breast cancer,docetaxel,adjuvant|disseminating tumor cells,breast cancer,docetaxel,adjuvant
5768845|NCT00248690|Subarachnoid hemorrhage|subarachnoid hemorrhage
5768846|NCT00248690|Intracranial hypertension|intracranial hypertension
5768847|NCT00248690|Intracranial pressure|intracranial pressure
5768848|NCT00248690|Diagnostic techniques and procedures|diagnostic techniques and procedures
5768849|NCT00248690|Compliance|compliance
5768850|NCT00248690|Treatment outcome|treatment outcome
5768851|NCT00248690|Intensive care, surgical|intensive care, surgical
5768852|NCT00248664|Cystitis, Interstitial|cystitis, interstitial
5768853|NCT00248664|Case-Control Studies|case-control studies
5768854|NCT00248664|Risk Factors|risk factors
5768855|NCT00248651|Bloating|bloating
5768856|NCT00248651|Early Fullness|early fullness
5768857|NCT00248651|Nausea|nausea
5768858|NCT00248651|Upper Abdominal Discomfort|upper abdominal discomfort
5768859|NCT00248651|dyspepsia|dyspepsia
5768860|NCT00248651|stomach pain|stomach pain
5768861|NCT00248651|stomach discomfort|stomach discomfort
5768862|NCT00248625|acute liver failure|acute liver failure
5768863|NCT00248625|hepatic encephalopathy|hepatic encephalopathy
5768864|NCT00248625|acetaminophen toxicity|acetaminophen toxicity
5768865|NCT00248625|N-acetylcysteine|n-acetylcysteine
5768866|NCT00248612|Venlafaxine|venlafaxine
5768867|NCT00248612|Alcoholism|alcoholism
5768868|NCT00248612|Anxiety Disorders|anxiety disorders
5768869|NCT00248612|Alcohol-Use Disorders|alcohol-use disorders
5768870|NCT00248612|Alcohol Abuse|alcohol abuse
5768871|NCT00248612|Alcohol Dependence|alcohol dependence
5768872|NCT00248612|Cognitive Behavioral Treatment|cognitive behavioral treatment
5768873|NCT00248560|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5768874|NCT00248560|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5768875|NCT00248560|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5768876|NCT00248560|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5862947|NCT00001453|Internal Jugular Vein Sampling|internal jugular vein sampling
5768877|NCT00248560|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5768878|NCT00248560|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5768879|NCT00248560|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5768880|NCT00248560|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5768881|NCT00248560|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5768882|NCT00248560|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5768883|NCT00248560|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5769014|NCT00248430|graft versus host disease|graft versus host disease
5768884|NCT00248560|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5768885|NCT00248560|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5768886|NCT00248560|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5768887|NCT00248547|nausea and vomiting|nausea and vomiting
5768888|NCT00248547|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5768889|NCT00248547|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5768890|NCT00248547|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5768891|NCT00248547|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5768892|NCT00248547|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5768893|NCT00248547|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5768894|NCT00248547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5768895|NCT00248547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5768896|NCT00248547|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5768897|NCT00248547|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5768898|NCT00248547|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5768899|NCT00248547|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5768900|NCT00248547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5768901|NCT00248547|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5768902|NCT00248547|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5768903|NCT00248547|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5768904|NCT00248547|disseminated neuroblastoma|disseminated neuroblastoma
5768905|NCT00248547|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5768906|NCT00248547|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5768907|NCT00248547|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5768908|NCT00248547|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5768909|NCT00248547|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5768910|NCT00248547|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5768911|NCT00248547|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5768912|NCT00248547|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5768913|NCT00248547|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5768914|NCT00248547|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5768915|NCT00248547|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5768916|NCT00248547|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5768917|NCT00248547|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5768918|NCT00248547|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5769136|NCT00248014|FUNCTIONAL APPLIANCE|functional appliance
5768919|NCT00248547|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5768920|NCT00248547|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5768921|NCT00248547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5768922|NCT00248547|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5768923|NCT00248547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5768924|NCT00248547|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5768925|NCT00248547|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5768926|NCT00248547|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5768927|NCT00248547|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5768928|NCT00248547|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5768929|NCT00248547|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5768930|NCT00248547|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5768931|NCT00248547|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5768932|NCT00248547|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5768933|NCT00248547|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5768934|NCT00248547|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5768935|NCT00248547|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5768936|NCT00248547|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5768937|NCT00248547|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5768938|NCT00248547|recurrent neuroblastoma|recurrent neuroblastoma
5768939|NCT00248547|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5768940|NCT00248547|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5768941|NCT00248547|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5769015|NCT00248430|stage II multiple myeloma|stage ii multiple myeloma
5768942|NCT00248547|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5768943|NCT00248547|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5768944|NCT00248547|refractory hairy cell leukemia|refractory hairy cell leukemia
5768945|NCT00248547|refractory multiple myeloma|refractory multiple myeloma
5768946|NCT00248547|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5768947|NCT00248547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5768948|NCT00248547|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5768949|NCT00248547|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5768950|NCT00248547|stage I multiple myeloma|stage i multiple myeloma
5768951|NCT00248547|stage II multiple myeloma|stage ii multiple myeloma
5768952|NCT00248547|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5768953|NCT00248547|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5768954|NCT00248547|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5768955|NCT00248547|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5768956|NCT00248547|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5768957|NCT00248547|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5846708|NCT00043680|Macular Degeneration|macular degeneration
5768958|NCT00248547|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5768959|NCT00248547|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5768960|NCT00248547|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5768961|NCT00248547|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5768962|NCT00248547|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5768963|NCT00248547|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5768964|NCT00248547|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5768965|NCT00248547|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5768966|NCT00248547|stage III multiple myeloma|stage iii multiple myeloma
5768967|NCT00248547|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5768968|NCT00248547|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5768969|NCT00248547|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5768970|NCT00248547|stage IIIA breast cancer|stage iiia breast cancer
5768971|NCT00248547|stage IIIB breast cancer|stage iiib breast cancer
5768972|NCT00248547|stage IIIC breast cancer|stage iiic breast cancer
5768973|NCT00248547|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5768974|NCT00248547|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5768082|NCT00252109|MSM|msm
5768975|NCT00248547|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5768976|NCT00248547|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5768977|NCT00248547|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5768978|NCT00248547|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5768979|NCT00248547|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5768980|NCT00248547|stage IV breast cancer|stage iv breast cancer
5768981|NCT00248547|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5768982|NCT00248547|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5768983|NCT00248547|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5768984|NCT00248547|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5768985|NCT00248547|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5768986|NCT00248547|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5768987|NCT00248547|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5768988|NCT00248547|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5768989|NCT00248547|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5768990|NCT00248534|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5768991|NCT00248521|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5768992|NCT00248495|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5768993|NCT00248495|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5768994|NCT00248495|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5768995|NCT00248495|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5768996|NCT00248482|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5768997|NCT00248482|recurrent small cell lung cancer|recurrent small cell lung cancer
5768998|NCT00248469|Community randomised trial|community randomised trial
5769000|NCT00248469|Intervention|intervention
5769001|NCT00248469|Evaluation|evaluation
5769002|NCT00248469|Sexual health education|sexual health education
5769003|NCT00248469|Youth-friendly health services|youth-friendly health services
5769004|NCT00248469|Adolescents|adolescents
5769005|NCT00248469|Behavior change|behavior change
5769008|NCT00248443|Haematology and cancer patients|haematology and cancer patients
5769009|NCT00248443|Acute respiratory failure|acute respiratory failure
5769010|NCT00248443|Bronchoalveolar lavage|bronchoalveolar lavage
5770868|NCT00241085|proteinuria|proteinuria
5769011|NCT00248443|Non invasive diagnostic tools|non invasive diagnostic tools
5769012|NCT00248443|Mechanical ventilation|mechanical ventilation
5769013|NCT00248443|Intensive Care|intensive care
5769017|NCT00248430|refractory multiple myeloma|refractory multiple myeloma
5769018|NCT00248430|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5769019|NCT00248430|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5769020|NCT00248430|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5769021|NCT00248430|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5769022|NCT00248430|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5769023|NCT00248430|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5769024|NCT00248430|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5769025|NCT00248430|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5769026|NCT00248430|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5769027|NCT00248430|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5769028|NCT00248430|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5769029|NCT00248430|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5769030|NCT00248430|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5769031|NCT00248430|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5769032|NCT00248430|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5769033|NCT00248430|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5769034|NCT00248430|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5769035|NCT00248430|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5769036|NCT00248404|colorectal cancer|colorectal cancer
5769037|NCT00248404|ovarian cancer|ovarian cancer
5769038|NCT00248404|lung cancer|lung cancer
5769039|NCT00248404|breast cancer|breast cancer
5769040|NCT00248404|small bowel cancer|small bowel cancer
5769041|NCT00248404|Advanced, recurrent, or metastatic solid tumors of any type|advanced, recurrent, or metastatic solid tumors of any type
5769042|NCT00248404|TS overexpression confirmed by fresh biopsy (RTPCR)|ts overexpression confirmed by fresh biopsy (rtpcr)
5769043|NCT00248404|Suitable for experimental monotherapy|suitable for experimental monotherapy
5769044|NCT00248391|adenoid hypertrophy|adenoid hypertrophy
5769045|NCT00248391|feeding position|feeding position
5769046|NCT00248391|supine|supine
5769047|NCT00248391|upright|upright
5769048|NCT00248391|pneumonia|pneumonia
5769049|NCT00248391|wheezing|wheezing
5769050|NCT00248391|otitis|otitis
5769051|NCT00248391|adenoid|adenoid
5769052|NCT00248391|tonsil|tonsil
5769053|NCT00248391|caries|caries
5769054|NCT00248378|Multiple Sclerosis|multiple sclerosis
5768199|NCT00251459|CNV|cnv
5769055|NCT00248378|Cannabis|cannabis
5769056|NCT00248378|Spasticity|spasticity
5769057|NCT00248378|Tolerability|tolerability
5769058|NCT00248365|Chronic GvHD|chronic gvhd
5769059|NCT00248365|Extensive chronic GvHD|extensive chronic gvhd
5769060|NCT00248365|Resistant chronic GvHD|resistant chronic gvhd
5769061|NCT00248352|Coronary Artery Disease|coronary artery disease
5769062|NCT00248352|Diabetes Mellitus|diabetes mellitus
5769063|NCT00248352|Type 2|type 2
5769064|NCT00248352|Chronic Disease|chronic disease
5769065|NCT00248339|Hepatitis C|hepatitis c
5769066|NCT00248339|Peginterferon|peginterferon
5769067|NCT00248339|Ribavirin|ribavirin
5769068|NCT00248339|Procrit|procrit
5769069|NCT00248339|Epoetin-alpha|epoetin-alpha
5769070|NCT00248326|atrial fibrillation|atrial fibrillation
5769071|NCT00248326|genetics|genetics
5769072|NCT00248326|genetic polymorphisms|genetic polymorphisms
5769073|NCT00248313|Kidney Disease|kidney disease
5769074|NCT00248300|ventilator-associated pneumonia|ventilator-associated pneumonia
5769075|NCT00248300|hospital acquired pneumonia|hospital acquired pneumonia
5769076|NCT00248274|atrial fibrillation|atrial fibrillation
5769077|NCT00248274|genetics|genetics
5769079|NCT00248248|Consolidation|consolidation
5769080|NCT00248248|Ovarian cancer|ovarian cancer
5769081|NCT00248248|DOXIL|doxil
5769082|NCT00248248|Hand-foot syndrome|hand-foot syndrome
5769083|NCT00248235|exercise|exercise
5769084|NCT00248235|rehabilitation|rehabilitation
5769085|NCT00248235|head and neck neoplasms|head and neck neoplasms
5769086|NCT00248222|Exercise|exercise
5778724|NCT00203749|Testing|testing
5769087|NCT00248222|Rehabilitation|rehabilitation
5769088|NCT00248222|Aerobic training|aerobic training
5769089|NCT00248209|Female Orgasmic Disorder|female orgasmic disorder
5769090|NCT00248209|Female Sexual Dysfunction|female sexual dysfunction
5769091|NCT00248170|Breast cancer|breast cancer
5769092|NCT00248170|letrozole|letrozole
5769093|NCT00248170|anastrozole|anastrozole
5769094|NCT00248170|adjuvant|adjuvant
5769095|NCT00248170|postmenopausal|postmenopausal
5769096|NCT00248170|FACE|face
5769097|NCT00248157|Diabetic retinopathy|diabetic retinopathy
5769098|NCT00248157|Octreotide acetate in microspheres|octreotide acetate in microspheres
5769100|NCT00248131|Diabetic retinopathy, octreotide acetate in microspheres|diabetic retinopathy, octreotide acetate in microspheres
5769102|NCT00248118|Double-blind|double-blind
5769103|NCT00248118|Placebo-controlled|placebo-controlled
5769104|NCT00248105|Arthritis|arthritis
5769105|NCT00248105|Physical Activity|physical activity
5769106|NCT00248092|d-Amphetamine|d-amphetamine
5769107|NCT00248092|Diethylpropion|diethylpropion
5769108|NCT00248092|Diethylpropion Hydrochloride|diethylpropion hydrochloride
5769109|NCT00248092|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5769110|NCT00248092|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5769111|NCT00248092|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5769112|NCT00248092|Amphetamine Abuse|amphetamine abuse
5769113|NCT00248092|Amphetamine Dependence|amphetamine dependence
5769114|NCT00248092|Amphetamine Addiction|amphetamine addiction
5769115|NCT00248092|Amphetamine Users|amphetamine users
5769116|NCT00248092|Drug Abuse|drug abuse
5769117|NCT00248092|Drug Addiction|drug addiction
5769118|NCT00248092|Drug Dependence|drug dependence
5769119|NCT00248092|Drug Habituation|drug habituation
5769120|NCT00248092|Drug Use Disorders|drug use disorders
5769121|NCT00248092|Substance Abuse|substance abuse
5769122|NCT00248092|Substance Dependence|substance dependence
5769123|NCT00248092|Substance Use Disorders|substance use disorders
5769124|NCT00248092|Drug Usage|drug usage
5769125|NCT00248092|Substance Addiction|substance addiction
5769126|NCT00248079|Coronary Disease|coronary disease
5769127|NCT00248066|Coronary artery disease|coronary artery disease
5769128|NCT00248066|Restenosis|restenosis
5769129|NCT00248066|Coronary stent restenosis|coronary stent restenosis
5769130|NCT00248053|Familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch|familial adenomatous polyposis patient with 5 or more adenomatous polyps in the colon or ileoanal pouch
5769131|NCT00248040|Kidney transplantation|kidney transplantation
5769132|NCT00248040|Reperfusion Injury|reperfusion injury
5769133|NCT00248040|Survival|survival
5769134|NCT00248027|early intervention,program evaluation|early intervention,program evaluation
5769135|NCT00248014|CLASS II|class ii
5769137|NCT00248014|MANDIBULAR ADVANCEMENT STABILITY|mandibular advancement stability
5769139|NCT00247988|Relapsed|relapsed
5769140|NCT00247975|L-carnitine|l-carnitine
5769141|NCT00247975|Breast cancer|breast cancer
5769142|NCT00247975|Anthracycline Cardiotoxicity|anthracycline cardiotoxicity
5769143|NCT00247975|Primary prevention|primary prevention
5769144|NCT00247975|Anthracycline induced cardiotoxicity|anthracycline induced cardiotoxicity
5769145|NCT00247975|Left Ventricular Ejection Fraction|left ventricular ejection fraction
5769146|NCT00247962|Ankylosing Spondylitis (AS)|ankylosing spondylitis (as)
5769147|NCT00247949|carbon dioxide|carbon dioxide
5769148|NCT00247949|monitoring|monitoring
5769149|NCT00247949|major surgery|major surgery
5769150|NCT00247949|repeated blood gas testing|repeated blood gas testing
5686371|NCT00552448|Pediatric, asthma, pediatric ICU|pediatric, asthma, pediatric icu
5769151|NCT00247949|carbon dioxide monitoring|carbon dioxide monitoring
5769152|NCT00247936|Adenocarcinoma, Esophagectomy|adenocarcinoma, esophagectomy
5769153|NCT00247923|Endometrial polyps.|endometrial polyps.
5769154|NCT00247923|Angiogenesis.|angiogenesis.
5769155|NCT00247923|Asymptomatic.|asymptomatic.
5769156|NCT00247923|Symptoms.|symptoms.
5769157|NCT00247923|Malignancy.|malignancy.
5769158|NCT00247923|Treatment efficiency.|treatment efficiency.
5769159|NCT00247923|Vaginal bleeding.|vaginal bleeding.
5769160|NCT00247910|hypertension, ambulatory BP, office resting BP, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy|hypertension, ambulatory bp, office resting bp, hydrochlorothiazide, stress reduction, self-help, psychotherapy, efficacy
5769161|NCT00247884|Injection drug users|injection drug users
5769162|NCT00247884|pegylated interferon|pegylated interferon
5769163|NCT00247884|ribavirin,|ribavirin,
5769165|NCT00247871|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
5769166|NCT00247858|MRSA, USA300, CMRSA-10, CMRSA-6, soft tissue abscesses|mrsa, usa300, cmrsa-10, cmrsa-6, soft tissue abscesses
5769167|NCT00247845|HIV|hiv
5769168|NCT00247845|Atazanavir|atazanavir
5769169|NCT00247845|quality of life|quality of life
5769170|NCT00247845|Treatment Experienced|treatment experienced
5769171|NCT00247832|Monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain|monitoring, early mobilization, motivation modality, visitation rate, step rates, anxiety, pain
5769172|NCT00247832|Elective lobectomy|elective lobectomy
5769173|NCT00247819|Substance abuse|substance abuse
5769174|NCT00247806|Pilot, pediatric, stem cell transplant, lactose intolerance|pilot, pediatric, stem cell transplant, lactose intolerance
5769176|NCT00247793|preoperative optimization|preoperative optimization
5769177|NCT00247793|preoperative enteral nutritional supplement|preoperative enteral nutritional supplement
5769178|NCT00247793|high risk|high risk
5769179|NCT00247793|cardiac surgery|cardiac surgery
5769180|NCT00247793|arginine|arginine
5769181|NCT00247793|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5769182|NCT00247793|nucleotides|nucleotides
5769183|NCT00247793|glycine|glycine
5769184|NCT00247793|immune enhancing nutritional supplement|immune enhancing nutritional supplement
5769185|NCT00247793|immune enhancing formula|immune enhancing formula
5769186|NCT00247780|Atrial fibrillation|atrial fibrillation
5769187|NCT00247780|Pulmonary vein isolation|pulmonary vein isolation
5769188|NCT00247780|Tissue Doppler echocardiography|tissue doppler echocardiography
5769190|NCT00247754|Therapy|therapy
5769191|NCT00247754|Behaviour|behaviour
5769192|NCT00247741|spinal anesthesia|spinal anesthesia
5769197|NCT00247728|post resection hepatoma|post resection hepatoma
5769198|NCT00247728|adjuvant therapy|adjuvant therapy
5769199|NCT00247728|hepatectomy|hepatectomy
5769200|NCT00247728|hepatoma|hepatoma
5769201|NCT00247715|uninvestigated dyspepsia|uninvestigated dyspepsia
5769202|NCT00247715|cost effectiveness|cost effectiveness
5769203|NCT00247715|acid suppressive medicine|acid suppressive medicine
5769204|NCT00247715|primary care|primary care
5769205|NCT00247715|gastrointestinal complaints|gastrointestinal complaints
5769206|NCT00247715|Gastrointestinal drugs|gastrointestinal drugs
5769207|NCT00247702|CYP2C9|cyp2c9
5769208|NCT00247702|VKORC1|vkorc1
5769209|NCT00247702|polymorphism|polymorphism
5769210|NCT00247702|warfarin|warfarin
5769211|NCT00247689|Ritalin|ritalin
5769212|NCT00247689|Substance Abuse|substance abuse
5769213|NCT00247689|Allelic Variants|allelic variants
5769214|NCT00247689|Genotype|genotype
5769215|NCT00247689|Addiction-Associated Human Gene Variants|addiction-associated human gene variants
5769216|NCT00247689|Methylphenidate|methylphenidate
5769217|NCT00247676|Liver neoplasms, sunitinib, Phase 2|liver neoplasms, sunitinib, phase 2
5769218|NCT00247663|Aromatase inhibitor|aromatase inhibitor
5769219|NCT00247663|letrozole|letrozole
5769220|NCT00247663|breast cancer|breast cancer
5769221|NCT00247650|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate|neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate
5769222|NCT00247637|Mental Health|mental health
5769223|NCT00247637|Psychosis|psychosis
5769224|NCT00247637|Genetics|genetics
5769225|NCT00247637|Heredity|heredity
5769226|NCT00247624|Depression|depression
5769227|NCT00247624|Hypnotics|hypnotics
5769228|NCT00247624|Sleep|sleep
5769229|NCT00247624|Quality of Life|quality of life
5769230|NCT00247624|Insomnia|insomnia
5769231|NCT00247624|Suicide|suicide
5769233|NCT00247611|AIDS|aids
5769234|NCT00247611|Antiretroviral Medication Adherence|antiretroviral medication adherence
5769235|NCT00247585|Alcohol|alcohol
5769236|NCT00247585|Alcohol abuse|alcohol abuse
5769237|NCT00247585|Alcohol consumption|alcohol consumption
5769238|NCT00247585|Unhealthy alcohol use|unhealthy alcohol use
5769239|NCT00247585|Residual effects|residual effects
5769240|NCT00247585|Sleep Stages|sleep stages
5769241|NCT00247585|Respiratory Physiology|respiratory physiology
5769242|NCT00247572|d-Amphetamine|d-amphetamine
5769243|NCT00247572|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5769244|NCT00247572|Attention Deficit Disorders with Hyperactivity|attention deficit disorders with hyperactivity
5769245|NCT00247572|Attention Deficit Hyperactivity Disorders|attention deficit hyperactivity disorders
5769246|NCT00247572|Amphetamine Abuse|amphetamine abuse
5769247|NCT00247572|Amphetamine Dependence|amphetamine dependence
5769248|NCT00247572|Amphetamine Addiction|amphetamine addiction
5769249|NCT00247572|Amphetamine Users|amphetamine users
5769250|NCT00247572|Drug Abuse|drug abuse
5769251|NCT00247572|Drug Addiction|drug addiction
5769252|NCT00247572|Drug Dependence|drug dependence
5769253|NCT00247572|Drug Habituation|drug habituation
5769254|NCT00247572|Drug Use Disorders|drug use disorders
5769255|NCT00247572|Substance Abuse|substance abuse
5769256|NCT00247572|Substance Dependence|substance dependence
5769257|NCT00247572|Substance Use Disorders|substance use disorders
5769258|NCT00247572|Drug Usage|drug usage
5769259|NCT00247572|Substance Addiction|substance addiction
5769260|NCT00247572|Drug Abuse, Intravenous|drug abuse, intravenous
5769261|NCT00247572|Intravenous Drug Abuse|intravenous drug abuse
5769262|NCT00247559|crow's feet|crow's feet
5769263|NCT00247559|cosmesis|cosmesis
5769265|NCT00247546|Falls|falls
5769266|NCT00247546|Accidental falls|accidental falls
5769267|NCT00247546|Prevention|prevention
5769268|NCT00247546|Aged|aged
5769269|NCT00247546|Multifactorial trial|multifactorial trial
5769270|NCT00247533|coronary disease|coronary disease
5769271|NCT00247533|cerebrovascular disorders|cerebrovascular disorders
5769272|NCT00247533|angiography|angiography
5769273|NCT00247533|cerebral ischemia|cerebral ischemia
5769274|NCT00247533|intracranial atherosclerosis|intracranial atherosclerosis
5769275|NCT00247533|Coronary artery disease|coronary artery disease
5769276|NCT00247533|cerebral artery stenosis|cerebral artery stenosis
5769277|NCT00247533|percutaneous coronary balloon angioplasty|percutaneous coronary balloon angioplasty
5769278|NCT00247533|coronary artery bypass surgery|coronary artery bypass surgery
5769279|NCT00247533|ischemic stroke|ischemic stroke
5769280|NCT00247533|electrocardiograph|electrocardiograph
5769281|NCT00247533|electroencephalograph|electroencephalograph
5769282|NCT00247533|Nuclear brain scan|nuclear brain scan
5769283|NCT00247533|cognition decline|cognition decline
5769284|NCT00247533|atrial fibrillation|atrial fibrillation
5769285|NCT00247533|undetermined ischemic stroke|undetermined ischemic stroke
5769286|NCT00247520|Seasonal allergic rhinitis (SAR), rhinoconjunctivitis, allergy|seasonal allergic rhinitis (sar), rhinoconjunctivitis, allergy
5769288|NCT00247507|atherosclerosis|atherosclerosis
5769289|NCT00247507|End-stage renal disease|end-stage renal disease
5769290|NCT00247507|Erythropoietin|erythropoietin
5769291|NCT00247507|Hemodialysis|hemodialysis
5769292|NCT00247507|Oxidative stress|oxidative stress
5770172|NCT00244465|Xyrem|xyrem
5769293|NCT00247507|Pro-inflammation|pro-inflammation
5769294|NCT00247494|HIV-1|hiv-1
5769295|NCT00247494|atherosclerosis|atherosclerosis
5769296|NCT00247494|immunomodulation|immunomodulation
5769297|NCT00247481|Metastatic Breast Cancer|metastatic breast cancer
5769298|NCT00247455|Human nutrition|human nutrition
5769299|NCT00247455|Dietary fibre|dietary fibre
5769300|NCT00247455|Insulin resistance|insulin resistance
5769301|NCT00247455|Obesity|obesity
5769302|NCT00247455|Glucose|glucose
5769303|NCT00247455|Colonic fermentation|colonic fermentation
5769304|NCT00247455|Short chain fatty acids|short chain fatty acids
5769305|NCT00247455|GLP-1|glp-1
5769306|NCT00247455|Appetite|appetite
5769307|NCT00247455|Abdominal fat|abdominal fat
5769308|NCT00247442|Mammography screening|mammography screening
5769309|NCT00247442|Breast cancer screening|breast cancer screening
5769310|NCT00247442|Screening outcomes|screening outcomes
5769311|NCT00247442|Decision aid|decision aid
5769312|NCT00247442|Decision support tool|decision support tool
5769313|NCT00247442|Informed choice|informed choice
5769314|NCT00247429|depression|depression
5769316|NCT00247429|elderly|elderly
5769317|NCT00247416|Untreated|untreated
5769318|NCT00247416|Lung|lung
5769319|NCT00247416|Cancer|cancer
5769320|NCT00247416|non-small cell|non-small cell
5769321|NCT00247416|gemcitabine|gemcitabine
5769322|NCT00247416|gemzar|gemzar
5769323|NCT00247416|carboplatin|carboplatin
5769324|NCT00247416|dexamethasone|dexamethasone
5769325|NCT00247403|Intracranial cancer|intracranial cancer
5769326|NCT00247403|Cancer|cancer
5769328|NCT00247403|2-deoxyglucose|2-deoxyglucose
5769329|NCT00247403|Intracranial metastatic cancer|intracranial metastatic cancer
5769330|NCT00247390|Chronic Insomnia|chronic insomnia
5769331|NCT00247390|Sleep Initiation and Maintenance Disorder|sleep initiation and maintenance disorder
5769332|NCT00247390|Drug Therapy|drug therapy
5769333|NCT00247377|Morbid Obesity|morbid obesity
5769334|NCT00247377|Laparoscopic Gastric Bypass|laparoscopic gastric bypass
5769335|NCT00247377|Laparoscopic Gastric Banding|laparoscopic gastric banding
5769336|NCT00247364|RLS|rls
5769337|NCT00247338|parenteral nutrition|parenteral nutrition
5769338|NCT00247338|low calorie|low calorie
5769339|NCT00247338|low nitrogen|low nitrogen
5769340|NCT00247338|gastrointestinal neoplasms|gastrointestinal neoplasms
5769341|NCT00247338|gastrointestinal diseases|gastrointestinal diseases
5769342|NCT00247338|gastrectomy|gastrectomy
5769343|NCT00247338|colectomy|colectomy
5769344|NCT00247338|rectectomy|rectectomy
5769345|NCT00247338|operations|operations
5686372|NCT00552422|gastroparesis|gastroparesis
5768544|NCT00250055|NIH|nih
5769346|NCT00247325|Kidney failure|kidney failure
5769347|NCT00247325|Contrast media|contrast media
5769348|NCT00247325|Iodixanol|iodixanol
5769349|NCT00247325|Ioxaglate|ioxaglate
5769350|NCT00247312|Prostate cancer|prostate cancer
5769351|NCT00247312|brachytherapy|brachytherapy
5769352|NCT00247312|palladium 103|palladium 103
5769353|NCT00247312|I-125|i-125
5769354|NCT00247299|Vascular lesions|vascular lesions
5769355|NCT00247299|Intense pulse light|intense pulse light
5769356|NCT00247299|phototermolysis|phototermolysis
5769357|NCT00247299|wavelength|wavelength
5769358|NCT00247299|filters|filters
5769359|NCT00247299|non coherent|non coherent
5769360|NCT00247286|urodynamic stress incontinence|urodynamic stress incontinence
5769361|NCT00247286|weighted vaginal cones|weighted vaginal cones
5769362|NCT00247286|pelvic floor biofeedback|pelvic floor biofeedback
5769363|NCT00247286|randomized controlled trial|randomized controlled trial
5769364|NCT00247273|randomized controlled trial, osteoporosis, risedronate|randomized controlled trial, osteoporosis, risedronate
5769365|NCT00247260|HCC|hcc
5769366|NCT00247260|Primary Liver Cancer|primary liver cancer
5769367|NCT00247221|Alcohol|alcohol
5769368|NCT00247221|Substance abuse|substance abuse
5769369|NCT00247221|Adolescent|adolescent
5769370|NCT00247221|Family functioning|family functioning
5769371|NCT00247208|Coronary artery bypass|coronary artery bypass
5769372|NCT00247208|Stents|stents
5769373|NCT00247208|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5769380|NCT00247195|Cultural Congruence|cultural congruence
5769381|NCT00247182|Stepped Care|stepped care
5769382|NCT00247182|Brief Motivational Intervention|brief motivational intervention
5769383|NCT00247182|Minimal Intervention|minimal intervention
5769384|NCT00247182|Treatment response|treatment response
5769385|NCT00247182|College Students|college students
5769386|NCT00247169|cervical intraepithelial neoplasia (CIN)|cervical intraepithelial neoplasia (cin)
5769387|NCT00247169|progesterone|progesterone
5769388|NCT00247156|Autism|autism
5769389|NCT00247156|eye contact|eye contact
5769390|NCT00247156|Noncommunicable|noncommunicable
5769391|NCT00247143|Protease Inhibitor|protease inhibitor
5764667|NCT00265616|efficacy,|efficacy,
5769392|NCT00247143|Antiretroviral Agents|antiretroviral agents
5769393|NCT00247143|Treatment Experienced|treatment experienced
5769396|NCT00247130|Endoscopic treatment|endoscopic treatment
5769397|NCT00247130|Hemostasis|hemostasis
5769398|NCT00247130|Peptic ulcer|peptic ulcer
5769399|NCT00247117|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5769400|NCT00247117|insulin resistance|insulin resistance
5769401|NCT00247117|metformin|metformin
5769402|NCT00247104|Urinary tract infection|urinary tract infection
5769403|NCT00247104|Endometritis|endometritis
5769404|NCT00247104|Respiratory Distress Syndrome|respiratory distress syndrome
5769405|NCT00247104|Necrotizing enterocolitis|necrotizing enterocolitis
5769406|NCT00247104|Intraventricular hemorrhage|intraventricular hemorrhage
5769407|NCT00247104|Latent period|latent period
5769408|NCT00247104|Neonatal infection|neonatal infection
5769409|NCT00247091|HIV|hiv
5769410|NCT00247091|measles|measles
5769413|NCT00247091|Zambia|zambia
5769414|NCT00247078|black|black
5769415|NCT00247078|widow|widow
5769416|NCT00247078|spider|spider
5769417|NCT00247078|antivenom|antivenom
5769418|NCT00247052|post operative pericardial effusion|post operative pericardial effusion
5769419|NCT00247052|NSAID|nsaid
5769420|NCT00247039|neutropenia|neutropenia
5769421|NCT00247039|fever|fever
5769422|NCT00247039|garlic|garlic
5769423|NCT00247039|infection|infection
5769424|NCT00247026|myelodysplasia|myelodysplasia
5769425|NCT00247026|curcumin|curcumin
5769426|NCT00247026|coenzyme Q10|coenzyme q10
5769427|NCT00247026|cytopenia|cytopenia
5769428|NCT00247013|automated telephone system|automated telephone system
5769429|NCT00247013|breast cancer|breast cancer
5769430|NCT00247013|cancer prevention|cancer prevention
5769431|NCT00247013|intervention|intervention
5769432|NCT00247013|mammography|mammography
5769433|NCT00247013|screening|screening
5769434|NCT00247000|Cardiovascular Diseases|cardiovascular diseases
5769435|NCT00247000|Heart Disease|heart disease
5769436|NCT00247000|Heart Failure,Congestive|heart failure,congestive
5769437|NCT00247000|Health Outcomes|health outcomes
5769438|NCT00247000|Disease Management|disease management
5769439|NCT00247000|Telehomecare|telehomecare
5769440|NCT00247000|Home Telehealth|home telehealth
5769441|NCT00246974|bladder cancer|bladder cancer
5769442|NCT00246974|Transitionel cell cancer of the urothelium|transitionel cell cancer of the urothelium
5769443|NCT00246961|Adjuvant|adjuvant
5769444|NCT00246948|Physical therapy|physical therapy
5769445|NCT00246935|COPD|copd
5769446|NCT00246935|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5769447|NCT00246935|Roflumilast|roflumilast
5769448|NCT00246922|Asthma|asthma
5769449|NCT00246922|Roflumilast|roflumilast
5769450|NCT00246922|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5769451|NCT00246909|Gastroesophageal Reflux|gastroesophageal reflux
5686373|NCT00552422|gastroesophageal reflux|gastroesophageal reflux
5769452|NCT00246909|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5769453|NCT00246909|Pantoprazole|pantoprazole
5769454|NCT00246883|Endothelial Progenitor Cells|endothelial progenitor cells
5769455|NCT00246883|Nitric Oxide|nitric oxide
5769456|NCT00246883|Brachial Artery Reactivity|brachial artery reactivity
5769457|NCT00246883|Physical Fitness|physical fitness
5769458|NCT00246883|C-reactive Protein|c-reactive protein
5769459|NCT00246883|Exercise|exercise
5769460|NCT00246883|Vascular Function|vascular function
5769461|NCT00246870|Seizures|seizures
5769462|NCT00246870|Development|development
5769463|NCT00246870|Pediatric|pediatric
5769464|NCT00246870|Benzodiazepine Receptors|benzodiazepine receptors
5769465|NCT00246870|Neurotransmission|neurotransmission
5769466|NCT00246870|Succinic Semialdehyde Dehydrogenase|succinic semialdehyde dehydrogenase
5769467|NCT00246870|Deficiency|deficiency
5769468|NCT00246870|SSADH Deficiency|ssadh deficiency
5769469|NCT00246870|Healthy Volunteer|healthy volunteer
5769470|NCT00246870|HV|hv
5769480|NCT00246844|C-Peptide|c-peptide
5769481|NCT00246844|B Cell|b cell
5769482|NCT00246844|Immunosuppression|immunosuppression
5769483|NCT00246844|Type 1 Diabetes|type 1 diabetes
5769484|NCT00246844|Pancreas Transplant|pancreas transplant
5769485|NCT00246831|fMRI|fmri
5769486|NCT00246831|Self-Agency|self-agency
5769487|NCT00246831|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5769488|NCT00246831|Voluntary Movement|voluntary movement
5769489|NCT00246831|Healthy Volunteer|healthy volunteer
5769490|NCT00246831|HV|hv
5769491|NCT00246818|Mind-Body|mind-body
5769492|NCT00246818|Stress Reduction|stress reduction
5769493|NCT00246818|Complementary Medicine|complementary medicine
5769494|NCT00246818|Quality of Life|quality of life
5769495|NCT00246818|Well-being|well-being
5769496|NCT00246818|Psychoneuroimmunology|psychoneuroimmunology
5769497|NCT00246818|Tai Chi|tai chi
5769498|NCT00246818|Aerobic Exercise|aerobic exercise
5769499|NCT00246818|Cancer Survivor|cancer survivor
5769500|NCT00246805|Permanent atrial fibrillation|permanent atrial fibrillation
5769501|NCT00246805|VVI(R) pacing|vvi(r) pacing
5769502|NCT00246805|rate regularization|rate regularization
5769503|NCT00246792|School-based intervention|school-based intervention
5764765|NCT00265174|MGMT|mgmt
5769505|NCT00246792|ecological intervention|ecological intervention
5769506|NCT00246779|transfusion|transfusion
5769507|NCT00246779|cardiac surgery|cardiac surgery
5769508|NCT00246779|modified ultrafiltration|modified ultrafiltration
5769509|NCT00246779|Cardiopulmonary bypass|cardiopulmonary bypass
5769510|NCT00246766|Maternal's movements recorded by a specific sensor|maternal's movements recorded by a specific sensor
5769511|NCT00246766|Parameters of fetal distress (umbilical and cerebral Doppler) and new-born parameters.|parameters of fetal distress (umbilical and cerebral doppler) and new-born parameters.
5769512|NCT00246753|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5769513|NCT00246753|recurrent prostate cancer|recurrent prostate cancer
5769514|NCT00246753|stage I prostate cancer|stage i prostate cancer
5769515|NCT00246753|stage II prostate cancer|stage ii prostate cancer
5769516|NCT00246753|stage III prostate cancer|stage iii prostate cancer
5769517|NCT00246753|stage IV prostate cancer|stage iv prostate cancer
5769519|NCT00246740|coronary artery bypass grafting|coronary artery bypass grafting
5769520|NCT00246714|endotoxin tolerance|endotoxin tolerance
5769522|NCT00246714|cross-tolerance|cross-tolerance
5769523|NCT00246714|pro and anti-inflammatory cytokines|pro and anti-inflammatory cytokines
5769524|NCT00246701|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5769525|NCT00246701|simvastatin|simvastatin
5769526|NCT00246701|Lovaza|lovaza
5769527|NCT00246701|High triglycerides|high triglycerides
5769528|NCT00246662|Leukemia|leukemia
5769529|NCT00246662|Hematologic|hematologic
5769530|NCT00246662|Blood|blood
5769531|NCT00246662|Cancer|cancer
5769532|NCT00246662|Malignancy|malignancy
5769533|NCT00246662|Myelodysplastic Syndromes|myelodysplastic syndromes
5769534|NCT00246636|Very high triglycerides|very high triglycerides
5769535|NCT00246636|omega-3-acid ethyl esters|omega-3-acid ethyl esters
5769536|NCT00246636|fenofibrate|fenofibrate
5769537|NCT00246636|Lovaza|lovaza
5769538|NCT00246610|Non-randomized open-label single-arm study of Nelfinavir plus Combivir in pregnant females infected with HIV-1 virus.|non-randomized open-label single-arm study of nelfinavir plus combivir in pregnant females infected with hiv-1 virus.
5769539|NCT00246597|Anemia|anemia
5769540|NCT00246597|Breast cancer|breast cancer
5769541|NCT00246597|Hemoglobin|hemoglobin
5769542|NCT00246597|Quality of Life|quality of life
5769543|NCT00246597|Adjuvant Chemotherapy|adjuvant chemotherapy
5769544|NCT00246597|Pure red cell aplasia (PRCA)|pure red cell aplasia (prca)
5769545|NCT00246597|Cognitive and executive function|cognitive and executive function
5769546|NCT00246584|Hypertension|hypertension
5769547|NCT00246584|angiotensin|angiotensin
5769548|NCT00246584|renin|renin
5769549|NCT00246584|aliskiren|aliskiren
5769550|NCT00246558|Tight Achilles Tendon|tight achilles tendon
5769551|NCT00246558|Hyperpronation of the foot|hyperpronation of the foot
5769552|NCT00246519|hypertension|hypertension
5769553|NCT00246519|pharmacogenetics|pharmacogenetics
5769554|NCT00246519|pharmacogenomics|pharmacogenomics
5769555|NCT00246519|beta-blocker|beta-blocker
5769556|NCT00246519|atenolol|atenolol
5769557|NCT00246519|diuretic|diuretic
5769558|NCT00246519|hydrochlorothiazide|hydrochlorothiazide
5769559|NCT00246519|blood pressure|blood pressure
5769560|NCT00246519|metabolic adverse effects|metabolic adverse effects
5769561|NCT00246506|Infertility|infertility
5769562|NCT00246506|Fertility|fertility
5769563|NCT00246506|Reproduction|reproduction
5769564|NCT00246506|Advanced Maternal Age|advanced maternal age
5769565|NCT00246506|Reproductive Medicine|reproductive medicine
5769566|NCT00246506|Reproductive Techniques|reproductive techniques
5769567|NCT00246506|Pregnancy|pregnancy
5769568|NCT00246493|Coronary|coronary
5769569|NCT00246493|Endothelial|endothelial
5769570|NCT00246493|Vascular|vascular
5769571|NCT00246493|Atherosclerosis|atherosclerosis
5769572|NCT00246493|Arterial|arterial
5769573|NCT00246480|Respiratory Syncytial Virus Infections, RSV, elderly|respiratory syncytial virus infections, rsv, elderly
5769574|NCT00246467|plague|plague
5769575|NCT00246454|circadian|circadian
5769576|NCT00246454|advanced sleep phase|advanced sleep phase
5769577|NCT00246454|delayed sleep phase|delayed sleep phase
5769578|NCT00246441|Pharmacotherapy|pharmacotherapy
5769579|NCT00246441|Self medication|self medication
5769580|NCT00246428|Motivational Interviewing|motivational interviewing
5769581|NCT00246428|Alcohol Abuse|alcohol abuse
5769582|NCT00246428|Alcohol Dependence|alcohol dependence
5769583|NCT00246428|Emergency Care Setting|emergency care setting
5769584|NCT00246415|Alcohol Dependence|alcohol dependence
5769585|NCT00246415|Alcohol Abuse|alcohol abuse
5769586|NCT00246415|Memantine|memantine
5769587|NCT00246415|Alcohol Treatment|alcohol treatment
5769588|NCT00246389|muscle spasm|muscle spasm
5769589|NCT00246389|cyclobenzaprine hydrochloride|cyclobenzaprine hydrochloride
5769591|NCT00246363|Hepatitis C|hepatitis c
5769592|NCT00246350|Headaches|headaches
5769593|NCT00246350|Spinal manipulation|spinal manipulation
5769595|NCT00246350|chiropractic|chiropractic
5769596|NCT00246298|Anemia|anemia
5769597|NCT00246298|erythropoetin|erythropoetin
5769598|NCT00246298|Epoetin alfa|epoetin alfa
5769599|NCT00246298|erythropoietin recombinant|erythropoietin recombinant
5769600|NCT00246298|HIV infection|hiv infection
5769601|NCT00246298|HIV|hiv
5769602|NCT00246298|AIDS|aids
5769603|NCT00246285|schizophrenia|schizophrenia
5769604|NCT00246285|antipsychotic agents|antipsychotic agents
5769605|NCT00246285|risperidone|risperidone
5769606|NCT00246285|adolescents|adolescents
5769607|NCT00246272|risperidone|risperidone
5769608|NCT00246272|schizophrenia|schizophrenia
5769609|NCT00246272|rapidly-dissolving|rapidly-dissolving
5769610|NCT00246259|Schizophrenia|schizophrenia
5769611|NCT00246259|Schizoaffective disorder|schizoaffective disorder
5769612|NCT00246259|Schizophreniform disorder|schizophreniform disorder
5769613|NCT00246259|Risperidone|risperidone
5769614|NCT00246259|Risperdal Consta|risperdal consta
5769615|NCT00246246|risperidone|risperidone
5769616|NCT00246246|long-acting injectable|long-acting injectable
5769617|NCT00246246|bipolar disorder|bipolar disorder
5769618|NCT00246246|intramuscular injection|intramuscular injection
5769619|NCT00246233|methylphenidate hydrochloride|methylphenidate hydrochloride
5769620|NCT00246233|oral tablets|oral tablets
5769621|NCT00246233|Major Depressive Disorder|major depressive disorder
5769622|NCT00246220|Attention deficit/hyperactivity disorder|attention deficit/hyperactivity disorder
5769623|NCT00246220|methylphenidate|methylphenidate
5769624|NCT00246220|central nervous system stimulants|central nervous system stimulants
5769625|NCT00246207|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5769626|NCT00246207|once-day oral tablets|once-day oral tablets
5769627|NCT00246194|Schizophrenia|schizophrenia
5769628|NCT00246194|Mental disorder|mental disorder
5769629|NCT00246194|DSM-IV|dsm-iv
5769630|NCT00246194|RISPERDAL CONSTA|risperdal consta
5769631|NCT00246194|Risperidone|risperidone
5769632|NCT00246194|Long-acting risperidone|long-acting risperidone
5769633|NCT00246194|Disorganized|disorganized
5769634|NCT00246194|Catatonic|catatonic
5769635|NCT00246194|Paranoid|paranoid
5769636|NCT00246181|Lung cancer|lung cancer
5769637|NCT00246181|stereotactic body radiotherapy|stereotactic body radiotherapy
5769638|NCT00246168|Rheumatoid arthritis|rheumatoid arthritis
5769639|NCT00246168|NSAID add-on therapy|nsaid add-on therapy
5769640|NCT00246168|tramadol|tramadol
5769641|NCT00246168|acetaminophen|acetaminophen
5769642|NCT00246155|chronic|chronic
5769643|NCT00246155|muscular|muscular
5769644|NCT00246129|Kidney Transplantation|kidney transplantation
5769645|NCT00246129|Kidney Disease|kidney disease
5769646|NCT00246129|Kidney Failure|kidney failure
5769647|NCT00246129|Graft Rejection|graft rejection
5769648|NCT00246116|Lung Cancer|lung cancer
5769649|NCT00246116|Radiation Oncology|radiation oncology
5769650|NCT00246116|Treated with Stereostatic Body Radiation|treated with stereostatic body radiation
5769651|NCT00246103|Valproic Acid|valproic acid
5769652|NCT00246103|Epirubicin|epirubicin
5769653|NCT00246103|Solid Tumor|solid tumor
5769654|NCT00246103|Malignancies|malignancies
5769655|NCT00246077|chronic transfusion therapy|chronic transfusion therapy
5778323|NCT00206037|TomoFix|tomofix
5769656|NCT00246077|quality of life|quality of life
5769657|NCT00246064|Rheumatoid Arthritis|rheumatoid arthritis
5769658|NCT00246064|Infliximab infusions|infliximab infusions
5769659|NCT00246064|Methotrexate|methotrexate
5769660|NCT00246064|Remicade|remicade
5769661|NCT00246051|Police|police
5769662|NCT00246051|Sleep|sleep
5769663|NCT00246051|Fatigue|fatigue
5769664|NCT00246051|Work Hours|work hours
5769665|NCT00246051|Sleep disorder|sleep disorder
5769666|NCT00246051|Performance|performance
5769667|NCT00246038|Abdominal Aortic Aneurysm|abdominal aortic aneurysm
5769668|NCT00246038|Aortic Aneurysm|aortic aneurysm
5769669|NCT00246038|AAA|aaa
5769670|NCT00246038|Endovascular|endovascular
5769671|NCT00246038|Stent Graft|stent graft
5769672|NCT00246038|Endograft|endograft
5769673|NCT00246038|Vascular Prostheses|vascular prostheses
5769674|NCT00246012|Melanoma|melanoma
5769675|NCT00246012|Neoplasm|neoplasm
5769676|NCT00246012|CNTO 95|cnto 95
5769677|NCT00246012|Dacarbazine|dacarbazine
5769678|NCT00246012|Intetumumab|intetumumab
5769679|NCT00245986|Pharmacokinetics|pharmacokinetics
5769680|NCT00245986|Cytochrome P450|cytochrome p450
5769681|NCT00245986|HIV Resistance|hiv resistance
5769682|NCT00245986|Drug Interaction|drug interaction
5769683|NCT00245986|Non-Nucleoside Reverse Transcriptase Inhibitors|non-nucleoside reverse transcriptase inhibitors
5769684|NCT00245986|HIV Positive|hiv positive
5769685|NCT00245986|Healthy Volunteer|healthy volunteer
5769687|NCT00245960|Psoriatic Arthritis|psoriatic arthritis
5769688|NCT00245960|Skin Disease|skin disease
5769689|NCT00245960|Joint Disease|joint disease
5769690|NCT00245947|Crohn's Disease|crohn's disease
5769691|NCT00245947|Inflammation|inflammation
5769692|NCT00245934|Rheumatoid Arthritis|rheumatoid arthritis
5769693|NCT00245921|contraception|contraception
5769694|NCT00245908|Asthma|asthma
5770173|NCT00244465|Misuse|misuse
5769695|NCT00245908|Chlamydia pneumoniae|chlamydia pneumoniae
5770968|NCT00240643|stroke|stroke
5769696|NCT00245908|Chlamydophila pneumoniae|chlamydophila pneumoniae
5769697|NCT00245908|Azithromycin|azithromycin
5769698|NCT00245895|Anemia,|anemia,
5769699|NCT00245895|Prostate Cancer|prostate cancer
5769700|NCT00245882|Telehealth|telehealth
5769701|NCT00245882|Veterans|veterans
5769702|NCT00245882|Glycemic control|glycemic control
5769703|NCT00245882|Active care management|active care management
5769704|NCT00245882|Care coordination|care coordination
5769705|NCT00245869|Contrast-enhanced Ultrasound|contrast-enhanced ultrasound
5769706|NCT00245869|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
5769707|NCT00245869|breast cancer|breast cancer
5769708|NCT00245869|chemotherapy|chemotherapy
5769710|NCT00245856|Upper Extremity Deep-Vein Thrombosis|upper extremity deep-vein thrombosis
5769711|NCT00245856|DVT|dvt
5769712|NCT00245856|Fragmin|fragmin
5769713|NCT00245856|Deep-Vein Thrombosis|deep-vein thrombosis
5769714|NCT00245856|Thrombosis|thrombosis
5769715|NCT00245843|Premature birth|premature birth
5769716|NCT00245843|moderate preterm|moderate preterm
5769717|NCT00245843|late preterm|late preterm
5769718|NCT00245843|Joint attention|joint attention
5769719|NCT00245843|Social interaction|social interaction
5769720|NCT00245843|Child development|child development
5769721|NCT00245843|Parent|parent
5769722|NCT00245843|infant|infant
5769723|NCT00245830|Ischemia/reperfusion of the liver|ischemia/reperfusion of the liver
5769724|NCT00245830|Ischemic Preconditioning|ischemic preconditioning
5769725|NCT00245830|Cadaver organ donor|cadaver organ donor
5769726|NCT00245817|Anxiety. Depression. HRQOL. Psycho-educative intervention|anxiety. depression. hrqol. psycho-educative intervention
5769727|NCT00245791|Complicated Urinary Infection|complicated urinary infection
5769728|NCT00245765|chronic plaque psoriasis, anti TNFα|chronic plaque psoriasis, anti tnfα
5769729|NCT00245765|CDP870, Cimzia|cdp870, cimzia
5769730|NCT00245752|post term pregnancy|post term pregnancy
5769731|NCT00245752|acupuncture|acupuncture
5769732|NCT00245752|induction|induction
5769733|NCT00245739|HIV infections|hiv infections
5769734|NCT00245739|HIV-1|hiv-1
5769735|NCT00245739|TMC114|tmc114
5769736|NCT00245739|Early access|early access
5769737|NCT00245739|Highly antiretroviral treatment experienced patients|highly antiretroviral treatment experienced patients
5769738|NCT00245739|Anti-retroviral agents|anti-retroviral agents
5769739|NCT00245713|Levetiracetam, adult, partial-onset epilepsy, antiepileptic|levetiracetam, adult, partial-onset epilepsy, antiepileptic
5769740|NCT00245687|feeding tube, nutrition, gastric, jejunal|feeding tube, nutrition, gastric, jejunal
5769741|NCT00245661|COPD|copd
5769742|NCT00245661|respiratory|respiratory
5769743|NCT00245661|sleep quality|sleep quality
5769744|NCT00245661|temazepam|temazepam
5769745|NCT00245661|dyspnea|dyspnea
5769746|NCT00245635|Body Dysmorphic Disorder|body dysmorphic disorder
5769748|NCT00245635|BDD treatment|bdd treatment
5769749|NCT00245635|delusionality variant|delusionality variant
5769750|NCT00245635|OCD|ocd
5769751|NCT00245622|Phase 2b Tovaxin|phase 2b tovaxin
5769752|NCT00245622|Clinically Isolated Syndrome (CIS)|clinically isolated syndrome (cis)
5769753|NCT00245622|Relapse-Remitting Multiple Sclerosis (RR-MS)|relapse-remitting multiple sclerosis (rr-ms)
5681063|NCT00574873|Bosutinib|bosutinib
5769754|NCT00245583|Pathological Gambling|pathological gambling
5769755|NCT00245583|Compulsive Gambling|compulsive gambling
5769756|NCT00245583|Gambling|gambling
5769757|NCT00245583|topiramate|topiramate
5769758|NCT00245557|Depression|depression
5769759|NCT00245557|Geriatric|geriatric
5769760|NCT00245557|MRI|mri
5769761|NCT00245557|Sertraline|sertraline
5769762|NCT00245531|endocrine abnormalities|endocrine abnormalities
5769763|NCT00245531|cognitive performance|cognitive performance
5769764|NCT00245518|prostate cancer|prostate cancer
5769765|NCT00245518|soy|soy
5769766|NCT00245518|androgen deprivation|androgen deprivation
5769767|NCT00245518|quality of life|quality of life
5769768|NCT00245518|isoflavones|isoflavones
5769769|NCT00245492|Colonoscopy|colonoscopy
5769770|NCT00245492|Chromoscopy|chromoscopy
5769771|NCT00245492|Prevention|prevention
5769772|NCT00245479|Primary nocturnal enuresis|primary nocturnal enuresis
5769773|NCT00245466|Prostate Cancer|prostate cancer
5769774|NCT00245466|Androgen ablation therapy|androgen ablation therapy
5769775|NCT00245453|pneumonia|pneumonia
5769776|NCT00245453|Spneumoniae|spneumoniae
5769777|NCT00245453|bronchitis|bronchitis
5769778|NCT00245453|telithromycin|telithromycin
5769779|NCT00245453|azithromycin|azithromycin
5769780|NCT00245440|S.pneumonia|s.pneumonia
5769781|NCT00245440|sinusitis|sinusitis
5769782|NCT00245440|ams|ams
5769783|NCT00245440|azithromycin|azithromycin
5769784|NCT00245427|beta-lactam|beta-lactam
5769785|NCT00245427|macrolide|macrolide
5769786|NCT00245427|antibiotics|antibiotics
5769787|NCT00245388|Mixed Dyslipidemia|mixed dyslipidemia
5769788|NCT00245375|Outpatient Surgery for:|outpatient surgery for:
5769789|NCT00245375|inguinal hernia repair|inguinal hernia repair
5769790|NCT00245375|abdominal hernia repair|abdominal hernia repair
5769791|NCT00245375|umbilical hernia repair|umbilical hernia repair
5769792|NCT00245362|cancer vaccine|cancer vaccine
5769793|NCT00245362|pancreatic cancer|pancreatic cancer
5769794|NCT00245362|metastatic pancreatic cancer|metastatic pancreatic cancer
5769795|NCT00245362|unresectable pancreatic cancer|unresectable pancreatic cancer
5769796|NCT00245362|immunotherapy|immunotherapy
5769797|NCT00245349|Head and Neck cancer|head and neck cancer
5769798|NCT00245349|Squamous cell carcinoma|squamous cell carcinoma
5769799|NCT00245349|FLT|flt
5769800|NCT00245349|Fluorothymidine|fluorothymidine
5769801|NCT00245349|F-18|f-18
5769802|NCT00245336|hemostasis|hemostasis
5769804|NCT00245336|hemostatics|hemostatics
5769805|NCT00245336|randomized controlled trial|randomized controlled trial
5769806|NCT00245336|phase 3|phase 3
5769807|NCT00245323|smoking|smoking
5769808|NCT00245310|ICG clearance|icg clearance
5769810|NCT00245310|acute liver failure|acute liver failure
5769811|NCT00245310|prognosis|prognosis
5769812|NCT00245297|Bleeding disorder|bleeding disorder
5769813|NCT00245297|severe Haemophilia A|severe haemophilia a
5769814|NCT00245297|Prophylaxis|prophylaxis
5769815|NCT00245271|Knee|knee
5769816|NCT00245271|Musculoskeletal System|musculoskeletal system
5769817|NCT00245271|Ligament|ligament
5769818|NCT00245271|ACL reconstruction|acl reconstruction
5769819|NCT00245245|hemophilia A|hemophilia a
5769820|NCT00245245|inhibitor|inhibitor
5769821|NCT00245245|treatment|treatment
5769822|NCT00245232|PTSD|ptsd
5769823|NCT00245232|Cognitive therapy|cognitive therapy
5769824|NCT00245232|Rape|rape
5769825|NCT00245206|Antipsychotic|antipsychotic
5769826|NCT00245206|Diabetes|diabetes
5769827|NCT00245206|Hyperlipidemia|hyperlipidemia
5769828|NCT00245206|Stroke|stroke
5769829|NCT00245193|Major Depression|major depression
5769830|NCT00245154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5769831|NCT00245154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5769832|NCT00245141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5769833|NCT00245141|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5769834|NCT00245141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5769835|NCT00245128|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5769836|NCT00245128|polycythemia vera|polycythemia vera
5769837|NCT00245128|essential thrombocythemia|essential thrombocythemia
5769838|NCT00245115|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5769839|NCT00245115|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5769840|NCT00245115|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5769841|NCT00245115|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5769842|NCT00245115|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5769843|NCT00245115|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5769844|NCT00245115|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5769845|NCT00245115|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5769846|NCT00245115|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5769847|NCT00245115|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5769848|NCT00245115|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5769849|NCT00245115|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5769850|NCT00245115|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5769851|NCT00245115|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5769852|NCT00245115|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5769853|NCT00245115|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5769854|NCT00245115|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5769855|NCT00245115|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5769856|NCT00245115|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5769857|NCT00245115|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5769858|NCT00245115|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5862948|NCT00001453|Corticotropin Releasing Hormone Stimulation|corticotropin releasing hormone stimulation
5681064|NCT00574873|imatinib|imatinib
5769859|NCT00245115|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5769860|NCT00245115|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5769861|NCT00245115|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5769862|NCT00245115|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5769863|NCT00245115|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5769864|NCT00245115|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5769865|NCT00245089|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5769866|NCT00245089|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5769867|NCT00245089|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5769868|NCT00245076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5769869|NCT00245050|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5769870|NCT00245050|fallopian tube cancer|fallopian tube cancer
5769871|NCT00245050|peritoneal cavity cancer|peritoneal cavity cancer
5769872|NCT00245050|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5769873|NCT00245050|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5765160|NCT00263250|asymptomatic|asymptomatic
5769874|NCT00245050|stage III endometrial carcinoma|stage iii endometrial carcinoma
5769875|NCT00245050|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5769876|NCT00245050|stage IV breast cancer|stage iv breast cancer
5769877|NCT00245050|male breast cancer|male breast cancer
5769878|NCT00245050|recurrent breast cancer|recurrent breast cancer
5769879|NCT00245037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5769880|NCT00245037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5769881|NCT00245037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5769882|NCT00245037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5769883|NCT00245037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5848602|NCT00034216|CD4+/CD25+ Cells|cd4+/cd25+ cells
5769884|NCT00245037|atypical chronic myeloid leukemia, breakpoint cluster region-Abelson (BCR-ABL) negative|atypical chronic myeloid leukemia, breakpoint cluster region-abelson (bcr-abl) negative
5769885|NCT00245037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5769886|NCT00245037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5769887|NCT00245037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5769888|NCT00245037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5769889|NCT00245037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5769890|NCT00245037|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5769891|NCT00245037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5769892|NCT00245037|stage II multiple myeloma|stage ii multiple myeloma
5769893|NCT00245037|stage III multiple myeloma|stage iii multiple myeloma
5769894|NCT00245037|primary systemic amyloidosis|primary systemic amyloidosis
5769895|NCT00245037|refractory multiple myeloma|refractory multiple myeloma
5769896|NCT00245037|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5769897|NCT00245037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5769898|NCT00245037|primary myelofibrosis|primary myelofibrosis
5769899|NCT00245037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5769900|NCT00245037|essential thrombocythemia|essential thrombocythemia
5769901|NCT00245037|polycythemia vera|polycythemia vera
5769902|NCT00245037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5769903|NCT00245037|acute undifferentiated leukemia|acute undifferentiated leukemia
5769904|NCT00245037|extramedullary plasmacytoma|extramedullary plasmacytoma
5769905|NCT00245037|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5769906|NCT00245037|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5769907|NCT00245037|stage I multiple myeloma|stage i multiple myeloma
5769908|NCT00245037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5769909|NCT00245037|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5769910|NCT00245037|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5769911|NCT00245037|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5769912|NCT00245037|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5769913|NCT00245037|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5769914|NCT00245037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5769915|NCT00245037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5769916|NCT00245037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5769917|NCT00245037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5769918|NCT00245037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5769919|NCT00245037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5769920|NCT00245037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5769921|NCT00245037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5769922|NCT00245037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5769923|NCT00245037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5769924|NCT00245037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5769925|NCT00245037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5769926|NCT00245037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5769927|NCT00245037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5769928|NCT00245037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5769929|NCT00245037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5769930|NCT00245037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5769931|NCT00245037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5769932|NCT00245037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5769933|NCT00245037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5770073|NCT00244842|Severity of Illness Index|severity of illness index
5769934|NCT00245037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5769935|NCT00245037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5769936|NCT00245037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5769937|NCT00245037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5769938|NCT00245037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5769940|NCT00245037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5769941|NCT00245037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5769942|NCT00245037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5769943|NCT00245037|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5769944|NCT00245037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5769945|NCT00245037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5769946|NCT00245037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5769947|NCT00245037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5769948|NCT00245037|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5769949|NCT00245037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5769950|NCT00245037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5769951|NCT00245037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5769952|NCT00245037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5769953|NCT00245037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5769954|NCT00245037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5769955|NCT00245037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5769956|NCT00245037|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5769957|NCT00245037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5769958|NCT00245037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5769959|NCT00245037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5769960|NCT00245037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5769961|NCT00245037|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5769962|NCT00245037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5769963|NCT00245037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5769964|NCT00245037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5769965|NCT00245037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5769966|NCT00245037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5769967|NCT00245037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5769968|NCT00245037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5769969|NCT00245024|breast cancer|breast cancer
5686374|NCT00552409|Diabetes mellitus|diabetes mellitus
5769970|NCT00245024|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5769971|NCT00245024|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5769972|NCT00245024|breast cancer in situ|breast cancer in situ
5769973|NCT00245011|recurrent osteosarcoma|recurrent osteosarcoma
5769974|NCT00245011|metastatic osteosarcoma|metastatic osteosarcoma
5769975|NCT00245011|localized osteosarcoma|localized osteosarcoma
5769976|NCT00244998|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5769977|NCT00244998|stage III prostate cancer|stage iii prostate cancer
5769978|NCT00244998|stage IV prostate cancer|stage iv prostate cancer
5769979|NCT00244985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5769980|NCT00244985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5769981|NCT00244985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5769982|NCT00244985|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5769983|NCT00244985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5769984|NCT00244985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5769985|NCT00244985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5769986|NCT00244985|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5769987|NCT00244985|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5769988|NCT00244985|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5769989|NCT00244985|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5769990|NCT00244959|stage I breast cancer|stage i breast cancer
5769991|NCT00244959|stage II breast cancer|stage ii breast cancer
5769992|NCT00244959|stage IIIA breast cancer|stage iiia breast cancer
5769993|NCT00244959|stage IIIB breast cancer|stage iiib breast cancer
5769994|NCT00244959|stage IIIC breast cancer|stage iiic breast cancer
5769995|NCT00244959|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5769996|NCT00244959|breast cancer in situ|breast cancer in situ
5769997|NCT00244946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5769998|NCT00244946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5769999|NCT00244946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5770000|NCT00244946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5770001|NCT00244946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5770002|NCT00244946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5770003|NCT00244946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5770004|NCT00244946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5770005|NCT00244946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5770006|NCT00244946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5770007|NCT00244946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5770008|NCT00244946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5770009|NCT00244946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5770010|NCT00244946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5770011|NCT00244946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5770012|NCT00244946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5770013|NCT00244946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5770014|NCT00244946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5770015|NCT00244946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5770016|NCT00244946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5770017|NCT00244946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5770018|NCT00244946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5770019|NCT00244946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5770020|NCT00244946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5770021|NCT00244946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5770022|NCT00244946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5770023|NCT00244946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5770024|NCT00244946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5770025|NCT00244946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5770026|NCT00244946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5770027|NCT00244946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5770028|NCT00244946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5770029|NCT00244946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5770030|NCT00244946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5770031|NCT00244946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5770032|NCT00244946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5770033|NCT00244946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5770034|NCT00244946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5769175|NCT00247793|immunonutrition|immunonutrition
5770035|NCT00244946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5770036|NCT00244946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5770037|NCT00244946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5770038|NCT00244946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5770039|NCT00244946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5770040|NCT00244946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5770041|NCT00244946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5770042|NCT00244946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5770043|NCT00244946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5770044|NCT00244946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5862949|NCT00001452|Cushing Syndrome|cushing syndrome
5770045|NCT00244946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5770046|NCT00244946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5770047|NCT00244933|stage IV breast cancer|stage iv breast cancer
5770048|NCT00244933|recurrent breast cancer|recurrent breast cancer
5770049|NCT00244920|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5770050|NCT00244920|stage III prostate cancer|stage iii prostate cancer
5770051|NCT00244907|Bone Resorption|bone resorption
5770052|NCT00244907|Phytoestrogens|phytoestrogens
5770054|NCT00244907|Genistein|genistein
5770055|NCT00244907|Equol|equol
5770056|NCT00244894|fatigue|fatigue
5770057|NCT00244894|recurrent prostate cancer|recurrent prostate cancer
5770058|NCT00244894|stage II prostate cancer|stage ii prostate cancer
5770059|NCT00244894|stage III prostate cancer|stage iii prostate cancer
5770060|NCT00244894|stage IV prostate cancer|stage iv prostate cancer
5770061|NCT00244894|hot flashes|hot flashes
5770062|NCT00244868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5770063|NCT00244868|metastatic cancer|metastatic cancer
5770064|NCT00244842|Randomized Controlled Trials|randomized controlled trials
5770065|NCT00244842|Immunosuppression|immunosuppression
5770066|NCT00244842|Adult|adult
5770067|NCT00244842|Chronic Disease|chronic disease
5770068|NCT00244842|Dermatologic Agents|dermatologic agents
5770070|NCT00244842|Humans|humans
5770071|NCT00244842|Male|male
5770072|NCT00244842|Middle Aged|middle aged
5770171|NCT00244465|Oxybate|oxybate
5770075|NCT00244842|Quality of Life|quality of life
5770076|NCT00244842|Double-Blind Method|double-blind method
5770077|NCT00244829|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5770078|NCT00244829|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5770079|NCT00244829|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5770080|NCT00244829|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5770081|NCT00244829|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5770082|NCT00244829|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5770083|NCT00244829|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5770084|NCT00244803|Human Immunodeficiency Virus|human immunodeficiency virus
5770085|NCT00244803|FRAM 1|fram 1
5770086|NCT00244790|glomerular hyperfiltration|glomerular hyperfiltration
5770087|NCT00244790|proteinuria|proteinuria
5770088|NCT00244777|Seizure|seizure
5770089|NCT00244777|Altered consciousness|altered consciousness
5770090|NCT00244777|Hyponatraemia|hyponatraemia
5770091|NCT00244777|Diarrhoea|diarrhoea
5770092|NCT00244777|Hypo osmolar ORS|hypo osmolar ors
5770093|NCT00244764|Angiogenesis|angiogenesis
5770094|NCT00244764|Renal Cell Carcinoma|renal cell carcinoma
5770095|NCT00244764|Solid tumors|solid tumors
5770096|NCT00244764|Pazopanib(GW786034)|pazopanib(gw786034)
5770097|NCT00244751|Hepatitis C liver fibrosis|hepatitis c liver fibrosis
5770098|NCT00244738|pregnancy|pregnancy
5770099|NCT00244738|post-date|post-date
5770100|NCT00244738|induction of labor|induction of labor
5770101|NCT00244738|castor oil|castor oil
5770102|NCT00244725|deep vein thrombosis|deep vein thrombosis
5770103|NCT00244725|total knee replacement|total knee replacement
5770104|NCT00244725|PE|pe
5770105|NCT00244725|Venous thromboembolism|venous thromboembolism
5770106|NCT00244725|DVT|dvt
5770107|NCT00244725|pulmonary embolism|pulmonary embolism
5770108|NCT00244725|VTE|vte
5770109|NCT00244712|HEAT|heat
5770110|NCT00244712|Antiretroviral-naive|antiretroviral-naive
5770111|NCT00244712|HIV|hiv
5770112|NCT00244712|EPZICOM|epzicom
5770113|NCT00244712|TRUVADA|truvada
5770114|NCT00244712|KALETRA|kaletra
5770115|NCT00244712|once-daily|once-daily
5770116|NCT00244699|youth|youth
5770117|NCT00244699|drug addiction|drug addiction
5770118|NCT00244699|substance abuse|substance abuse
5770119|NCT00244699|mindfulness|mindfulness
5770120|NCT00244699|motivational interviewing|motivational interviewing
5769327|NCT00247403|2DG|2dg
5770121|NCT00244699|brief treatment|brief treatment
5770122|NCT00244699|skills training|skills training
5770123|NCT00244699|group therapy|group therapy
5770124|NCT00244699|emotion regulation|emotion regulation
5770125|NCT00244686|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5770126|NCT00244686|Mepo|mepo
5770127|NCT00244686|HES|hes
5770128|NCT00244686|Compassionate Use|compassionate use
5770129|NCT00244686|Mepolizumab|mepolizumab
5770130|NCT00244673|Vaccination|vaccination
5770131|NCT00244673|DTP|dtp
5770132|NCT00244673|Child mortality|child mortality
5770133|NCT00244673|Sex|sex
5770134|NCT00244673|Non-specific effects|non-specific effects
5770135|NCT00244647|restenosis|restenosis
5770136|NCT00244647|in-stent restenosis|in-stent restenosis
5770137|NCT00244621|Pediatric hypertension|pediatric hypertension
5770138|NCT00244595|Pediatric hypertension|pediatric hypertension
5770139|NCT00244595|Hypertension in children|hypertension in children
5770140|NCT00244582|Central Nervous System|central nervous system
5770141|NCT00244582|Enzyme Replacement Therapy|enzyme replacement therapy
5770142|NCT00244582|Convection|convection
5770143|NCT00244582|Gaucher Disease|gaucher disease
5770144|NCT00244582|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5770145|NCT00244582|Type 2 Gaucher Disease|type 2 gaucher disease
5770146|NCT00244569|Nonalcoholic Fatty Liver Disease|nonalcoholic fatty liver disease
5770147|NCT00244569|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5770148|NCT00244569|Liver Function|liver function
5770149|NCT00244569|Metabolism|metabolism
5770150|NCT00244569|Cirrhosis|cirrhosis
5770151|NCT00244569|Fibrosis|fibrosis
5770152|NCT00244569|Liver|liver
5770153|NCT00244556|Rheumatoid Arthritis|rheumatoid arthritis
5770154|NCT00244543|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
5770155|NCT00244530|Preventive Therapy|preventive therapy
5770156|NCT00244530|Calcium Channel Blockers|calcium channel blockers
5770157|NCT00244530|Kidney Failure, Chronic|kidney failure, chronic
5770158|NCT00244530|Coronary Artery Bypass|coronary artery bypass
5770159|NCT00244530|Heart Valve Prosthesis Implantation|heart valve prosthesis implantation
5770160|NCT00244517|ventricular function|ventricular function
5770161|NCT00244517|diastolic function|diastolic function
5770162|NCT00244517|inhalative anaesthetics|inhalative anaesthetics
5770163|NCT00244491|care transitions|care transitions
5770164|NCT00244491|geriatric|geriatric
5770165|NCT00244491|care coordination|care coordination
5770166|NCT00244491|self-management|self-management
5770168|NCT00244491|patient-centered care|patient-centered care
5770169|NCT00244465|Narcolepsy|narcolepsy
5770170|NCT00244465|Cataplexy|cataplexy
5770174|NCT00244465|Safety|safety
5770175|NCT00244452|Endometriosis|endometriosis
5770176|NCT00244452|Cetrorelix|cetrorelix
5770177|NCT00244452|Hormone|hormone
5770178|NCT00244452|Symptoms relief|symptoms relief
5770179|NCT00244452|Safety|safety
5770180|NCT00244452|Tolerability|tolerability
5770181|NCT00244452|Pharmacodynamic|pharmacodynamic
5770182|NCT00244452|Pharmacokinetic|pharmacokinetic
5770183|NCT00244439|Head Lice|head lice
5770184|NCT00244439|Pediculosis capitis|pediculosis capitis
5770308|NCT00243802|Atrial Fibrillation|atrial fibrillation
5770185|NCT00244426|Prevention of thromboembolic events in patients with non valvular atrial fibrillation|prevention of thromboembolic events in patients with non valvular atrial fibrillation
5770186|NCT00244413|Myotonia|myotonia
5770187|NCT00244413|Paramyotonia Congenita|paramyotonia congenita
5770188|NCT00244413|Thomsen's Disease|thomsen's disease
5770189|NCT00244400|Femur Head Necrosis|femur head necrosis
5770191|NCT00244387|advanced stage idiopathic Parkinson's disease|advanced stage idiopathic parkinson's disease
5770192|NCT00244361|opsoclonus|opsoclonus
5770193|NCT00244361|myoclonus|myoclonus
5770194|NCT00244348|hepatic artery infusion|hepatic artery infusion
5770195|NCT00244348|colorectal cancer|colorectal cancer
5770196|NCT00244348|liver metastasis|liver metastasis
5770197|NCT00244348|oxaliplatin|oxaliplatin
5770198|NCT00244348|5 fluorouracil|5 fluorouracil
5770199|NCT00244335|Post-Traumatic Stress Disorders|post-traumatic stress disorders
5770200|NCT00244335|PTSD|ptsd
5770201|NCT00244309|brachytherapy|brachytherapy
5770202|NCT00244309|urinary symptoms|urinary symptoms
5770203|NCT00244283|Myocardial preconditioning|myocardial preconditioning
5770204|NCT00244283|anesthetics|anesthetics
5770205|NCT00244283|epidural anesthesia|epidural anesthesia
5770206|NCT00244283|sevoflurane|sevoflurane
5770207|NCT00244283|NT proBNP|nt probnp
5770208|NCT00244270|totally implantable vascular access devices|totally implantable vascular access devices
5770209|NCT00244270|thromboembolism|thromboembolism
5770210|NCT00244270|genetic susceptibility to venous thrombosis.|genetic susceptibility to venous thrombosis.
5770211|NCT00244257|idiopathic thrombocytopenia purpura|idiopathic thrombocytopenia purpura
5770212|NCT00244231|Niacin|niacin
5770213|NCT00244231|Hyperlipidemia|hyperlipidemia
5770214|NCT00244218|phenylketonuria|phenylketonuria
5770215|NCT00244218|hyperphenylalaninemia|hyperphenylalaninemia
5770216|NCT00244192|COPD|copd
5770217|NCT00244192|infliximab|infliximab
5770218|NCT00244192|Remicade|remicade
5770219|NCT00244192|inflammation|inflammation
5770220|NCT00244192|cachexia|cachexia
5779028|NCT00202098|ARDS|ards
5769374|NCT00247208|Coronary Restenosis|coronary restenosis
5769375|NCT00247208|Paclitaxel|paclitaxel
5769376|NCT00247195|Major Depression|major depression
5769377|NCT00247195|MDD|mdd
5769378|NCT00247195|Hispanic|hispanic
5769379|NCT00247195|Primary Care|primary care
5770221|NCT00244192|fat-free mass|fat-free mass
5770222|NCT00244192|health status|health status
5770223|NCT00244192|exercise capacity|exercise capacity
5770224|NCT00244179|reactive arthritis|reactive arthritis
5770225|NCT00244179|trial|trial
5770226|NCT00244179|interferon-gamma|interferon-gamma
5770227|NCT00244179|infliximab|infliximab
5770228|NCT00244179|chronic|chronic
5770229|NCT00244179|tnf-blocker|tnf-blocker
5770230|NCT00244166|treatment|treatment
5770231|NCT00244166|ankylosing spondylitis|ankylosing spondylitis
5770232|NCT00244166|prednisolone|prednisolone
5770233|NCT00244166|trial|trial
5770234|NCT00244166|steroid|steroid
5770235|NCT00244153|intraarticular morphine, steroids, arthroscopy|intraarticular morphine, steroids, arthroscopy
5770236|NCT00244140|Ultravist 370|ultravist 370
5770237|NCT00244140|CECT|cect
5770238|NCT00244140|CT Scan|ct scan
5770239|NCT00244114|Hemophilia B|hemophilia b
5770240|NCT00244114|Allergic Reaction|allergic reaction
5770241|NCT00244101|Prematurity|prematurity
5770242|NCT00244101|respiratory distress syndrome|respiratory distress syndrome
5780061|NCT00197184|Twinrix™|twinrix™
5770243|NCT00244101|surfactant|surfactant
5770244|NCT00244101|nasal continuous positive airway pressure|nasal continuous positive airway pressure
5770245|NCT00244088|Abdominal infection|abdominal infection
5770246|NCT00244023|Erectile Dysfunction|erectile dysfunction
5770247|NCT00244023|Testosterone|testosterone
5770248|NCT00244023|Testosterone Therapy|testosterone therapy
5770249|NCT00244023|PDE V Inhibitor|pde v inhibitor
5770250|NCT00244023|Tadalafil|tadalafil
5770251|NCT00244010|Aplastic anemia|aplastic anemia
5770252|NCT00244010|Amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
5770253|NCT00244010|Diamond-Blackfan Anemia|diamond-blackfan anemia
5770254|NCT00244010|Kostmann syndrome|kostmann syndrome
5770255|NCT00244010|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5770256|NCT00244010|Haploidentical stem cell transplant|haploidentical stem cell transplant
5770257|NCT00244010|T-cell depletion|t-cell depletion
5770258|NCT00244010|Partially matched family member donor transplant|partially matched family member donor transplant
5770259|NCT00244010|Refractory cytopenia|refractory cytopenia
5770260|NCT00243997|parents|parents
5770261|NCT00243997|fathers|fathers
5770262|NCT00243997|mothers|mothers
5770263|NCT00243984|metabolic syndrome|metabolic syndrome
5770264|NCT00243984|type 2 diabetes|type 2 diabetes
5770265|NCT00243984|topiramate|topiramate
5770266|NCT00243984|weight loss|weight loss
5770267|NCT00243971|EARLY-STAGE, IDIOPATHIC PARKINSON'S DISEASE|early-stage, idiopathic parkinson's disease
5770268|NCT00243932|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5770270|NCT00243932|Lou Gehrig's disease|lou gehrig's disease
5770272|NCT00243932|coenzyme Q10|coenzyme q10
5770273|NCT00243932|antioxidants|antioxidants
5770274|NCT00243932|free radicals|free radicals
5770275|NCT00243932|mitochondrial dysfunction|mitochondrial dysfunction
5770276|NCT00243919|stroke|stroke
5770277|NCT00243919|locomotor|locomotor
5770278|NCT00243919|exercise|exercise
5770279|NCT00243919|walking|walking
5770280|NCT00243919|training program|training program
5770281|NCT00243919|body weight support training|body weight support training
5770282|NCT00243919|physical therapy|physical therapy
5770283|NCT00243906|acute ischemic stroke|acute ischemic stroke
5770284|NCT00243906|stroke|stroke
5770285|NCT00243906|rt-PA|rt-pa
5770286|NCT00243906|thrombolytic|thrombolytic
5770287|NCT00243906|recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5770288|NCT00243893|giant aneurysms|giant aneurysms
5770289|NCT00243893|arteriovenous malformations|arteriovenous malformations
5770290|NCT00243893|minocycline|minocycline
5770291|NCT00243893|doxycycline|doxycycline
5770292|NCT00243893|BAVM|bavm
5770293|NCT00243880|acute ischemic stroke|acute ischemic stroke
5770294|NCT00243880|lovastatin|lovastatin
5770295|NCT00243880|statin|statin
5770296|NCT00243880|neuroprotection|neuroprotection
5770297|NCT00243880|SPOTRIAS|spotrias
5770298|NCT00243867|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5770299|NCT00243854|Pancreatic Cancer|pancreatic cancer
5770300|NCT00243854|Resectable Pancreatic Cancer|resectable pancreatic cancer
5770301|NCT00243854|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5770302|NCT00243828|Noninvasive Mechanical Ventilation|noninvasive mechanical ventilation
5770303|NCT00243828|Acute Respiratory Failure|acute respiratory failure
5770304|NCT00243828|Intubation|intubation
5770305|NCT00243815|randomized controlled trial|randomized controlled trial
5770306|NCT00243815|prophylactic nonsteroidal antiflammatory drug|prophylactic nonsteroidal antiflammatory drug
5769478|NCT00246844|Transplant|transplant
5769479|NCT00246844|Diabetes|diabetes
5770307|NCT00243815|IUD removal|iud removal
5770309|NCT00243802|Oxidative Stress|oxidative stress
5770310|NCT00243802|Atrial Flutter|atrial flutter
5770311|NCT00243789|Duchenne|duchenne
5770313|NCT00243789|Muscular Dystrophy|muscular dystrophy
5770314|NCT00243789|DMD|dmd
5770315|NCT00243763|Refractory Multiple Myeloma or|refractory multiple myeloma or
5770316|NCT00243763|Relapsed Multiple Myeloma|relapsed multiple myeloma
5770317|NCT00243750|ankylosing spondylitis|ankylosing spondylitis
5770318|NCT00243750|trial|trial
5770319|NCT00243750|methotrexate|methotrexate
5770320|NCT00243737|Malaria|malaria
5770321|NCT00243737|falciparum|falciparum
5770322|NCT00243737|Mefloquine|mefloquine
5770323|NCT00243737|Artesunate|artesunate
5770324|NCT00243737|Artemisinin|artemisinin
5770325|NCT00243724|immunohistochemical|immunohistochemical
5770326|NCT00243724|erosive esophagitis|erosive esophagitis
5770327|NCT00243724|Acid reflux disease|acid reflux disease
5770328|NCT00243698|Contrast-enhanced Ultrasound Sonography|contrast-enhanced ultrasound sonography
5770329|NCT00243698|Ultrasound Contrast agents, microbubbles|ultrasound contrast agents, microbubbles
5770330|NCT00243698|Breast tumors|breast tumors
5770331|NCT00243685|Chemosensitivity|chemosensitivity
5770332|NCT00243685|Chemotherapy|chemotherapy
5770333|NCT00243685|Lung cancer|lung cancer
5770334|NCT00243685|Ovarian Cancer|ovarian cancer
5770335|NCT00243685|Breast Cancer|breast cancer
5770336|NCT00243685|Sarcoma|sarcoma
5770337|NCT00243685|Apoptosis|apoptosis
5770338|NCT00243685|MiCK Assay|mick assay
5770339|NCT00243685|New Technology|new technology
5862950|NCT00001452|Genetics|genetics
5770340|NCT00243685|Patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma|patients with pathological diagnoses of breast, lung, and ovarian adenocarcinomas and soft tissue sarcoma
5770341|NCT00243659|Hemophilia A|hemophilia a
5770342|NCT00243659|bleeding disorder|bleeding disorder
5770343|NCT00243646|Radiation therapy|radiation therapy
5770344|NCT00243646|Brachytherapy|brachytherapy
5770345|NCT00243646|Prostatic neoplasm|prostatic neoplasm
5770346|NCT00243633|focal liver lesions|focal liver lesions
5770347|NCT00243633|contrast-enhanced ultrasound sonography|contrast-enhanced ultrasound sonography
5770348|NCT00243633|cirrhosis|cirrhosis
5770349|NCT00243633|suspected liver metastases|suspected liver metastases
5770350|NCT00243633|suspected liver cirrhosis|suspected liver cirrhosis
5770351|NCT00243620|Chronic leg ulcers; wound healing; wound care; Vacuum Assisted Closure; topical negative Pressure|chronic leg ulcers; wound healing; wound care; vacuum assisted closure; topical negative pressure
5770352|NCT00243607|climacteric symptoms|climacteric symptoms
5770353|NCT00243607|breast cancer|breast cancer
5770354|NCT00243607|hydrotherapy|hydrotherapy
5770355|NCT00243594|Dendritic cells|dendritic cells
5770356|NCT00243594|Immunotherapy|immunotherapy
5770357|NCT00243594|Vaccination|vaccination
5770358|NCT00243594|Melanoma|melanoma
5770359|NCT00243594|Peptides|peptides
5770360|NCT00243594|MRI|mri
5770361|NCT00243594|Scintigraphy|scintigraphy
5770362|NCT00243594|Immune response|immune response
5765822|NCT00260299|MKD|mkd
5770364|NCT00243568|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5770365|NCT00243568|CCR5/CXCR4 mixed tropism|ccr5/cxcr4 mixed tropism
5770366|NCT00243568|R5/X4 mixed tropism|r5/x4 mixed tropism
5770367|NCT00243568|CCR5 inhibitor|ccr5 inhibitor
5770663|NCT00242320|COPD|copd
5770369|NCT00243568|treatment-experienced|treatment-experienced
5770370|NCT00243555|peanut hypersensitivity|peanut hypersensitivity
5770372|NCT00243555|cytokines|cytokines
5770373|NCT00243555|RNA,messenger|rna,messenger
5770374|NCT00243555|monocytes|monocytes
5770375|NCT00243542|Acne, G6PD deficiency, Dapsone|acne, g6pd deficiency, dapsone
5770376|NCT00243529|Dendritic cells|dendritic cells
5770377|NCT00243529|Melanoma|melanoma
5770378|NCT00243529|Vaccine|vaccine
5770379|NCT00243529|Immunotherapy|immunotherapy
5770380|NCT00243529|RNA|rna
5770381|NCT00243529|Peptides|peptides
5770382|NCT00243516|Acute Coronary Syndrome|acute coronary syndrome
5770383|NCT00243516|Emergency Department|emergency department
5770384|NCT00243516|Chest Pain Evaluation Unit|chest pain evaluation unit
5770385|NCT00243516|Overtesting|overtesting
5770386|NCT00243516|Chest Pain Protocol|chest pain protocol
5770387|NCT00243516|Myocardial Infarction|myocardial infarction
5770388|NCT00243516|Medical Malpractice|medical malpractice
5770389|NCT00243503|Breast Cancer Metastatic|breast cancer metastatic
5770390|NCT00243490|Photodynamic therapy|photodynamic therapy
5770391|NCT00243490|Malignant glioma|malignant glioma
5770392|NCT00243490|Photosan|photosan
5770393|NCT00243477|Coronary Artery Bypass|coronary artery bypass
5770394|NCT00243477|Surgery|surgery
5770395|NCT00243425|Major Depressive Disorder;|major depressive disorder;
5770396|NCT00243425|African Americans;|african americans;
5770397|NCT00243425|Disparities;|disparities;
5770398|NCT00243425|Quality Improvement;|quality improvement;
5770399|NCT00243425|Patient Centered Care;|patient centered care;
5770400|NCT00243425|Primary Care;|primary care;
5770401|NCT00243425|Patient-Physician Relationship;|patient-physician relationship;
5770402|NCT00243412|Rituxan|rituxan
5770403|NCT00243412|RA|ra
5770404|NCT00243399|Fanconi anemia|fanconi anemia
5770405|NCT00243399|FA|fa
5770406|NCT00243373|Patient safety|patient safety
5770407|NCT00243373|Medication safety|medication safety
5770408|NCT00243373|Barcode technology|barcode technology
5770409|NCT00243360|Urinary tract infections,|urinary tract infections,
5770410|NCT00243360|antibiotic use,|antibiotic use,
5770411|NCT00243360|long term care facilities|long term care facilities
5770412|NCT00243347|RECENTIN|recentin
5770413|NCT00243334|Ambulatory Care Information Systems|ambulatory care information systems
5770414|NCT00243334|Clinical Decision Support Systems|clinical decision support systems
5770415|NCT00243334|Medication Systems|medication systems
5770416|NCT00243334|Medication Errors|medication errors
5770417|NCT00243334|Reminder Systems|reminder systems
5770418|NCT00243334|Drug Monitoring|drug monitoring
5770419|NCT00243334|Preventive Health Services|preventive health services
5770420|NCT00243334|Time and Motion Studies|time and motion studies
5770421|NCT00243334|Efficiency|efficiency
5770422|NCT00243334|Cost-Benefit Analysis|cost-benefit analysis
5770423|NCT00243321|brachytherapy|brachytherapy
5770424|NCT00243321|intensity-modulated radiation therapy|intensity-modulated radiation therapy
5770425|NCT00243321|prostate specific antigen|prostate specific antigen
5770426|NCT00243308|Anti-inflammatory agents|anti-inflammatory agents
5770427|NCT00243308|unstable plaque|unstable plaque
5770428|NCT00243308|acute coronary syndrome|acute coronary syndrome
5770429|NCT00243295|osteoarthritis|osteoarthritis
5770430|NCT00243295|deformity of knee|deformity of knee
5770431|NCT00243282|Complementary Therapies|complementary therapies
5770432|NCT00243282|Dyspnea|dyspnea
5770433|NCT00243282|Palliative Care|palliative care
5770434|NCT00243282|Meditation|meditation
5770435|NCT00243282|Quality of Life|quality of life
5770436|NCT00243269|nausea, acupressure bands, relaxation|nausea, acupressure bands, relaxation
5770437|NCT00243243|Burns|burns
5770438|NCT00243204|Stage IIIb/IV non-small cell lung cancer|stage iiib/iv non-small cell lung cancer
5770439|NCT00243204|NSCLC|nsclc
5770440|NCT00243204|Lung Cancer|lung cancer
5770441|NCT00243191|newly diagnosed or recurrent|newly diagnosed or recurrent
5770442|NCT00243178|Atrial fibrillation|atrial fibrillation
5770443|NCT00243178|Anticoagulant therapy|anticoagulant therapy
5770444|NCT00243178|Thromboembolic prevention|thromboembolic prevention
5770445|NCT00243165|breast cancer|breast cancer
5770446|NCT00243165|honey|honey
5770447|NCT00243165|myelosuppression|myelosuppression
5770448|NCT00243165|chemotherapy|chemotherapy
5770449|NCT00243152|pain|pain
5770450|NCT00243152|neuropathic|neuropathic
5770451|NCT00243152|face|face
5770452|NCT00243152|trigeminal|trigeminal
5770453|NCT00243139|Oral appliances|oral appliances
5770454|NCT00243139|Obstructive sleep apnea|obstructive sleep apnea
5770455|NCT00243139|Epworth Sleepiness Scale|epworth sleepiness scale
5770456|NCT00243139|SF-36|sf-36
5770457|NCT00243126|HIV prevention|hiv prevention
5770458|NCT00243126|HIV Seronegativity|hiv seronegativity
5770459|NCT00243126|HIV negative|hiv negative
5770460|NCT00243113|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5770461|NCT00243113|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5770462|NCT00243113|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5770463|NCT00243113|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5770464|NCT00243087|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5770465|NCT00243087|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5770466|NCT00243087|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5848604|NCT00034216|Malignancy|malignancy
5770467|NCT00243087|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5770468|NCT00243087|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5770469|NCT00243087|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5770470|NCT00243087|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5770471|NCT00243087|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5770472|NCT00243087|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5770473|NCT00243087|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5770474|NCT00243087|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5770475|NCT00243087|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5770476|NCT00243087|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5770477|NCT00243087|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5770478|NCT00243087|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5770479|NCT00243087|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5770480|NCT00243087|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5770481|NCT00243087|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5770482|NCT00243087|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5770483|NCT00243048|stage I prostate cancer|stage i prostate cancer
5770484|NCT00243048|stage II prostate cancer|stage ii prostate cancer
5770485|NCT00243022|cerebral edema|cerebral edema
5769686|NCT00245986|HV|hv
5770486|NCT00243022|adult glioblastoma|adult glioblastoma
5770487|NCT00243022|adult giant cell glioblastoma|adult giant cell glioblastoma
5770488|NCT00243022|adult gliosarcoma|adult gliosarcoma
5770489|NCT00243022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5770490|NCT00243022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5770491|NCT00243009|recurrent renal cell cancer|recurrent renal cell cancer
5770492|NCT00243009|stage IV renal cell cancer|stage iv renal cell cancer
5770493|NCT00243009|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5770494|NCT00242996|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5770495|NCT00242983|adenocarcinoma of the lung|adenocarcinoma of the lung
5770496|NCT00242983|large cell lung cancer|large cell lung cancer
5770497|NCT00242983|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5770498|NCT00242983|squamous cell lung cancer|squamous cell lung cancer
5770499|NCT00242983|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5770500|NCT00242983|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5770501|NCT00242957|HIV/AIDS|hiv/aids
5770502|NCT00242957|Gender Based Violence|gender based violence
5770503|NCT00242957|Structural Interventions|structural interventions
5770504|NCT00242957|South Africa|south africa
5770505|NCT00242957|HIV Seronegativity|hiv seronegativity
5770506|NCT00242944|Acute coronary syndrome|acute coronary syndrome
5770507|NCT00242944|Hypercholesterolemia|hypercholesterolemia
5770508|NCT00242944|Primary coronary intervention|primary coronary intervention
5770509|NCT00242944|Hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5770510|NCT00242944|coronary plaque|coronary plaque
5770511|NCT00242944|Angioplasty, Transluminal, Percutaneous Coronary|angioplasty, transluminal, percutaneous coronary
5770512|NCT00242944|Ultrasonography, Interventional|ultrasonography, interventional
5770513|NCT00242931|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5770514|NCT00242931|recurrent prostate cancer|recurrent prostate cancer
5770515|NCT00242931|stage IV prostate cancer|stage iv prostate cancer
5770517|NCT00242918|adenocarcinoma|adenocarcinoma
5770518|NCT00242918|prostate cancer|prostate cancer
5770519|NCT00242918|neoadjuvant|neoadjuvant
5770520|NCT00242905|Memory|memory
5770521|NCT00242905|Epilepsy|epilepsy
5770522|NCT00242905|Children|children
5770523|NCT00242905|Magnetic resonance imaging|magnetic resonance imaging
5770524|NCT00242905|Functional magnetic resonance imaging|functional magnetic resonance imaging
5770525|NCT00242892|Deployment stent optimisation|deployment stent optimisation
5770526|NCT00242892|Fractional Flow Reserve|fractional flow reserve
5770527|NCT00242892|Stent|stent
5770528|NCT00242892|Restenosis|restenosis
5770529|NCT00242892|Coronary|coronary
5770530|NCT00242879|treatment-experienced|treatment-experienced
5770532|NCT00242879|protease inhibitor|protease inhibitor
5770533|NCT00242879|ritonavir|ritonavir
5770534|NCT00242879|GW640385|gw640385
5770535|NCT00242879|HIV-1|hiv-1
5770536|NCT00242866|Productivity|productivity
5770537|NCT00242866|Efficacy|efficacy
5770539|NCT00242866|iNOS|inos
5770540|NCT00242866|Safety|safety
5770541|NCT00242866|Nitric Oxide|nitric oxide
5770542|NCT00242866|Pharmacokinetics|pharmacokinetics
5770543|NCT00242866|GW274150|gw274150
5770544|NCT00242866|with aura|with aura
5770545|NCT00242866|Migraine|migraine
5770546|NCT00242866|Prophylaxis|prophylaxis
5770547|NCT00242866|Quality of Life|quality of life
5770548|NCT00242853|iNOS|inos
5770558|NCT00242762|Head and Neck Neoplasms|head and neck neoplasms
5770559|NCT00242762|Cancer of Head and Neck|cancer of head and neck
5770560|NCT00242762|Head and Neck Cancer|head and neck cancer
5770561|NCT00242762|Head Cancer|head cancer
5770562|NCT00242762|Neck Cancer|neck cancer
5770563|NCT00242749|Head and Neck Cancer Disease|head and neck cancer disease
5770564|NCT00242749|Head Cancer|head cancer
5770565|NCT00242749|Neck Cancer|neck cancer
5770566|NCT00242749|Cancer of Head|cancer of head
5770567|NCT00242749|Cancer of Neck|cancer of neck
5770568|NCT00242749|Cancer of the Head|cancer of the head
5770569|NCT00242749|Cancer of the Head and Neck|cancer of the head and neck
5770570|NCT00242749|Cancer of the Neck|cancer of the neck
5770571|NCT00242749|Neoplasms, Head and Neck|neoplasms, head and neck
5770580|NCT00242710|Endometrium|endometrium
5770581|NCT00242710|Uterus|uterus
5770582|NCT00242710|Menopause|menopause
5770583|NCT00242697|coronary artery bypass surgery|coronary artery bypass surgery
5770584|NCT00242697|anesthesia, general|anesthesia, general
5770585|NCT00242697|anesthesia, spinal|anesthesia, spinal
5770586|NCT00242697|heart-lung machine|heart-lung machine
5770587|NCT00242684|Aging|aging
5770588|NCT00242684|Undernutrition|undernutrition
5770589|NCT00242684|Inflammation|inflammation
5770590|NCT00242684|Frail Elderly|frail elderly
5770591|NCT00242671|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea|general anesthesia, hyperventilation, carbon dioxide, isocapnic hyperponea
5770592|NCT00242658|Physical Activity|physical activity
5770593|NCT00242658|Wellness Programs|wellness programs
5770594|NCT00242658|Health Promotion|health promotion
5770595|NCT00242658|Blood Pressure, High|blood pressure, high
5770596|NCT00242645|Doctor-Patient relation|doctor-patient relation
5770597|NCT00242645|Physician-Patient relation|physician-patient relation
5770598|NCT00242645|Diabetes|diabetes
5770599|NCT00242645|Office visits|office visits
5770600|NCT00242645|Comparative Study|comparative study
5770601|NCT00242645|Health behavior|health behavior
5770602|NCT00242645|Randomized controlled trials|randomized controlled trials
5770603|NCT00242645|Health Promotion|health promotion
5770604|NCT00242645|Health Education|health education
5770605|NCT00242645|Computer-tailor information|computer-tailor information
5770606|NCT00242606|Newly diagnosed epilepsy|newly diagnosed epilepsy
5770607|NCT00242606|Initial monotherapy|initial monotherapy
5770608|NCT00242606|Levetiracetam|levetiracetam
5770609|NCT00242606|Lamotrigine|lamotrigine
5770610|NCT00242593|cognition disorders|cognition disorders
5770611|NCT00242593|Alzheimer's disease|alzheimer's disease
5770612|NCT00242593|memory|memory
5770614|NCT00242580|age-related macular degeneration|age-related macular degeneration
5770615|NCT00242580|choroidal neovascularization|choroidal neovascularization
5770616|NCT00242567|zoledronic acid|zoledronic acid
5770617|NCT00242567|bone metastases|bone metastases
5770618|NCT00242567|prostate cancer|prostate cancer
5770619|NCT00242567|hormone-sensitive|hormone-sensitive
5770620|NCT00242554|Prostate Cancer|prostate cancer
5770621|NCT00242554|Bone Metastases|bone metastases
5770622|NCT00242554|Zoledronic acid|zoledronic acid
5770623|NCT00242541|microadenoma|microadenoma
5770624|NCT00242541|macroadenoma|macroadenoma
5770625|NCT00242528|Bone Lesions|bone lesions
5770626|NCT00242528|Multiple Myeloma|multiple myeloma
5770627|NCT00242528|zoledronic acid|zoledronic acid
5681066|NCT00574860|Oral Mucositis|oral mucositis
5797643|NCT00114920|Common Wart(s)|common wart(s)
5770628|NCT00242515|High risk Myelodysplastic Syndrome (MDS)|high risk myelodysplastic syndrome (mds)
5770629|NCT00242502|Hepatocellular Carcinoma|hepatocellular carcinoma
5770630|NCT00242502|Liver Cancer|liver cancer
5770631|NCT00242502|Bevacizumab|bevacizumab
5770632|NCT00242502|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5770633|NCT00242502|rhuMAb-VEGF|rhumab-vegf
5770634|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride
5770635|NCT00242502|OSI-774|osi-774
5770636|NCT00242502|Tarceva|tarceva
5770637|NCT00242502|Erlotinib|erlotinib
5770638|NCT00242502|Avastin|avastin
5770639|NCT00242489|Arcoxia|arcoxia
5770640|NCT00242463|malnutrition|malnutrition
5770641|NCT00242463|anabolic steroids|anabolic steroids
5770642|NCT00242463|intensive care unit|intensive care unit
5770643|NCT00242463|rehabilitation|rehabilitation
5770644|NCT00242450|metoclopramide|metoclopramide
5770645|NCT00242450|feeding|feeding
5770646|NCT00242450|very low birthweightnewborn|very low birthweightnewborn
5770647|NCT00242424|influenza vaccine|influenza vaccine
5770649|NCT00242424|safety|safety
5770650|NCT00242424|immunogenicity|immunogenicity
5770651|NCT00242398|Intensive care unit|intensive care unit
5770652|NCT00242398|Patients with bleeding high risk|patients with bleeding high risk
5766064|NCT00259116|Relaxin|relaxin
5770653|NCT00242398|Intermittent hemodialysis without anticoagulation|intermittent hemodialysis without anticoagulation
5770654|NCT00242398|Blood lost|blood lost
5770655|NCT00242385|Severe congenital Alpha1-Proteinase Inhibitor (Alpha1-PI) deficiency|severe congenital alpha1-proteinase inhibitor (alpha1-pi) deficiency
5770656|NCT00242372|Insulin dependent Type 2 diabetes|insulin dependent type 2 diabetes
5770657|NCT00242346|Hypertension|hypertension
5770658|NCT00242333|COPD|copd
5770659|NCT00242333|COAD|coad
5770660|NCT00242333|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5770661|NCT00242333|emphysema|emphysema
5770662|NCT00242333|chronic bronchitis|chronic bronchitis
5770664|NCT00242320|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5770665|NCT00242320|Roflumilast|roflumilast
5770666|NCT00242307|Asthma|asthma
5770667|NCT00242307|Roflumilast|roflumilast
5770668|NCT00242307|phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5770669|NCT00242294|COPD|copd
5770670|NCT00242294|Phosphodiesterase 4 inhibitor|phosphodiesterase 4 inhibitor
5770671|NCT00242294|Roflumilast|roflumilast
5770672|NCT00242281|Sore Throat|sore throat
5770673|NCT00242281|Pharyngitis|pharyngitis
5770674|NCT00242281|Tonsillitis|tonsillitis
5770675|NCT00242255|Histone|histone
5770676|NCT00242255|Chromatin|chromatin
5770677|NCT00242255|Epigenome|epigenome
5770678|NCT00242255|Senescence|senescence
5770679|NCT00242255|Acetylation|acetylation
5770680|NCT00242255|Aging|aging
5770681|NCT00242255|Tissue Sample|tissue sample
5770682|NCT00242242|Stroke|stroke
5770684|NCT00242242|Healthy Volunteer|healthy volunteer
5770686|NCT00242229|Depression|depression
5770687|NCT00242216|HIV-1 infected people|hiv-1 infected people
5770688|NCT00242216|Antiretroviral treatment-naïve|antiretroviral treatment-naïve
5770689|NCT00242216|Atazanavir|atazanavir
5770690|NCT00242216|Fosamprenavir|fosamprenavir
5770691|NCT00242216|ARV Treatment Naive|arv treatment naive
5770692|NCT00242203|Breast Cancer|breast cancer
5770693|NCT00242203|Neoadjuvant|neoadjuvant
5770694|NCT00242203|Micrometastasis|micrometastasis
5770695|NCT00242190|drug therapy|drug therapy
5770696|NCT00242190|radiotherapy|radiotherapy
5770697|NCT00242190|clinical trial|clinical trial
5770698|NCT00242177|Multiple Sclerosis|multiple sclerosis
5686375|NCT00552409|Type 2 diabetes|type 2 diabetes
5770699|NCT00242177|Relapsing, Remitting|relapsing, remitting
5770700|NCT00242177|Autoimmune disease|autoimmune disease
5770701|NCT00242164|Hemodialysis|hemodialysis
5770702|NCT00242164|Magnesium|magnesium
5770703|NCT00242164|Arrhythmia|arrhythmia
5770704|NCT00242164|QTc interval|qtc interval
5770705|NCT00242164|QT dispersion|qt dispersion
5770706|NCT00242151|Delirium, Confusion, Cardiac Surgery, Organic Brain Injury, Diffusion Weighted Magnetic Resonance Imaging (DW-MRI)|delirium, confusion, cardiac surgery, organic brain injury, diffusion weighted magnetic resonance imaging (dw-mri)
5770707|NCT00242125|Primary biliary Cirrhosis|primary biliary cirrhosis
5770708|NCT00242125|genes|genes
5770709|NCT00242125|DNA|dna
5770710|NCT00242099|liver transplant|liver transplant
5770711|NCT00242099|HHV-6|hhv-6
5770712|NCT00242099|HHV-7|hhv-7
5770713|NCT00242099|Human Herpesvirus-6|human herpesvirus-6
5770714|NCT00242099|Human Herpesvirus-7|human herpesvirus-7
5770715|NCT00242047|Tuberculosis.|tuberculosis.
5770716|NCT00242047|Children.|children.
5770717|NCT00242047|Vaccine.|vaccine.
5770718|NCT00242047|BCG.|bcg.
5770719|NCT00242021|Satiety, ad libitum food intake, fatty acids, hormones|satiety, ad libitum food intake, fatty acids, hormones
5770720|NCT00242008|IDIOPATHIC PARKINSON'S DISEASE|idiopathic parkinson's disease
5770721|NCT00241982|rheumatoid arthritis|rheumatoid arthritis
5770722|NCT00241982|long circulating liposomes|long circulating liposomes
5770723|NCT00241969|nutrition therapy|nutrition therapy
5770724|NCT00241969|preschool children|preschool children
5681067|NCT00574860|Chemoradiation therapy|chemoradiation therapy
5797777|NCT00114517|CAD|cad
5770725|NCT00241969|cystic fibrosis|cystic fibrosis
5770726|NCT00241943|Hepatitis C|hepatitis c
5770727|NCT00241943|Heroin|heroin
5770728|NCT00241943|Populations at risk|populations at risk
5770729|NCT00241943|testing|testing
5770730|NCT00241943|vaccination|vaccination
5770731|NCT00241930|Heroin|heroin
5770732|NCT00241930|HIV|hiv
5770733|NCT00241930|buprenorphine|buprenorphine
5770734|NCT00241930|integration|integration
5770735|NCT00241930|drug treatment|drug treatment
5770736|NCT00241917|hepatitis C|hepatitis c
5770737|NCT00241917|heroin|heroin
5770738|NCT00241917|populations at risk|populations at risk
5770739|NCT00241917|testing|testing
5770740|NCT00241917|vaccination|vaccination
5770741|NCT00241722|bowel dysfunction|bowel dysfunction
5770742|NCT00241722|constipation|constipation
5770743|NCT00241722|gastrointestinal|gastrointestinal
5770744|NCT00241722|opioids|opioids
5770745|NCT00241722|pain|pain
5770746|NCT00241722|non-cancer pain|non-cancer pain
5770747|NCT00241722|opioid-induced|opioid-induced
5770748|NCT00241644|Rotavirus gastroenteritis|rotavirus gastroenteritis
5770749|NCT00241644|HRV vaccine|hrv vaccine
5770750|NCT00241631|COPD|copd
5770751|NCT00241618|Clinical trial|clinical trial
5770752|NCT00241618|Randomized|randomized
5770753|NCT00241618|Treatment|treatment
5770754|NCT00241618|Prospective|prospective
5770755|NCT00241618|Parallel Assignment|parallel assignment
5770756|NCT00241618|Efficacy Safety Study|efficacy safety study
5770758|NCT00241605|AVANDAMET|avandamet
5770759|NCT00241605|Type 2 diabetes|type 2 diabetes
5770760|NCT00241592|Cannabis|cannabis
5770761|NCT00241592|Marijuana|marijuana
5770762|NCT00241592|Vaporization|vaporization
5770763|NCT00241592|Volcano|volcano
5770764|NCT00241592|THC|thc
5770765|NCT00241579|Pain|pain
5770766|NCT00241579|Cannabis|cannabis
5770767|NCT00241579|Analgesic|analgesic
5770768|NCT00241566|Neuropathic pain|neuropathic pain
5770769|NCT00241566|Electric cortical stimulation|electric cortical stimulation
5770770|NCT00241566|Economic Medical evaluation|economic medical evaluation
5770771|NCT00241540|NSAIDs|nsaids
5770772|NCT00241540|Upper GI symptoms|upper gi symptoms
5770773|NCT00241514|NSAIDs|nsaids
5770774|NCT00241514|Upper GI symptoms|upper gi symptoms
5770775|NCT00241475|Cancer of the Prostate|cancer of the prostate
5770776|NCT00241462|Advanced Breast Cancer|advanced breast cancer
5770777|NCT00241449|Locally advanced breast cancer or metastatic breast cancer|locally advanced breast cancer or metastatic breast cancer
5770778|NCT00241423|exenatide|exenatide
5770779|NCT00241423|diabetes|diabetes
5770780|NCT00241423|Amylin|amylin
5770781|NCT00241423|Lilly|lilly
5770782|NCT00241410|Allergy|allergy
5770783|NCT00241410|Specific Immunotherapy|specific immunotherapy
5770784|NCT00241410|Sublingual Immunotherapy|sublingual immunotherapy
5770785|NCT00241397|pain|pain
5770786|NCT00241397|depression|depression
5770787|NCT00241397|anxiety disorder|anxiety disorder
5770788|NCT00241384|Prostatic Cancer|prostatic cancer
5770789|NCT00241384|Brachytherapy|brachytherapy
5770790|NCT00241384|Prostatic neoplasm|prostatic neoplasm
5770791|NCT00241384|Radiation therapy|radiation therapy
5770792|NCT00241371|Multiple Myeloma|multiple myeloma
5770793|NCT00241358|Plerixafor|plerixafor
5770794|NCT00241358|Stem cell transplantation|stem cell transplantation
5770795|NCT00241358|Stem cells|stem cells
5770796|NCT00241358|Mobilization|mobilization
5770797|NCT00241345|post transplant|post transplant
5770922|NCT00240799|osteoarthritis hip|osteoarthritis hip
5681065|NCT00574873|CML|cml
5770798|NCT00241345|Any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at Washington University Medical Center|any patient receiving an allogeneic bone marrow or peripheral blood stem cell transplant at washington university medical center
5770799|NCT00241332|pain|pain
5770800|NCT00241332|hyperalgesia|hyperalgesia
5770801|NCT00241332|drug tolerance|drug tolerance
5770802|NCT00241332|remifentanil|remifentanil
5770803|NCT00241332|fentanyl|fentanyl
5770804|NCT00241332|Anterior Cruciate Ligament|anterior cruciate ligament
5770805|NCT00241332|Posterior Cruciate Ligament|posterior cruciate ligament
5770806|NCT00241332|Medial Collateral Ligament, Knee|medial collateral ligament, knee
5770807|NCT00241319|ocular, allergic conjunctivitis, ophthalmic|ocular, allergic conjunctivitis, ophthalmic
5770808|NCT00241306|aging|aging
5770809|NCT00241306|language|language
5770810|NCT00241306|gender|gender
5770811|NCT00241293|language|language
5770812|NCT00241267|Pulmonary|pulmonary
5770813|NCT00241267|Neoplasms|neoplasms
5770814|NCT00241267|Endobronchial|endobronchial
5770815|NCT00241267|Ultrasonography|ultrasonography
5770816|NCT00241267|Primary|primary
5770817|NCT00241254|Multiple Sclerosis, Chronic Progressive|multiple sclerosis, chronic progressive
5770818|NCT00241254|Cyclophosphamide|cyclophosphamide
5770819|NCT00241254|Methylprednisolone|methylprednisolone
5770820|NCT00241254|Randomized Controlled Trials|randomized controlled trials
5770821|NCT00241254|Double-Blind Study|double-blind study
5770822|NCT00241241|myeloproliferative disorder|myeloproliferative disorder
5780666|NCT00193921|Chemoradiotherapy|chemoradiotherapy
5770823|NCT00241241|polycythemia vera|polycythemia vera
5770824|NCT00241241|interferon|interferon
5770825|NCT00241228|Shock, Septic|shock, septic
5770826|NCT00241228|Renal Failure, Acute|renal failure, acute
5770827|NCT00241228|Venovenous Hemofiltration|venovenous hemofiltration
5770828|NCT00241228|Randomized Controlled Trial|randomized controlled trial
5770829|NCT00241228|Multicenter Study|multicenter study
5770830|NCT00241228|Mortality|mortality
5770831|NCT00241215|Botulinum toxin serotype A|botulinum toxin serotype a
5770832|NCT00241215|Cervicobrachial syndrome|cervicobrachial syndrome
5770833|NCT00241215|Myofascial pain|myofascial pain
5770834|NCT00241215|Cervicothoracic myofascial pain|cervicothoracic myofascial pain
5770835|NCT00241215|Propulsion|propulsion
5770836|NCT00241215|Postural abnormality|postural abnormality
5770837|NCT00241202|signs and symptoms|signs and symptoms
5770838|NCT00241202|self care|self care
5770839|NCT00241202|patient compliance|patient compliance
5770840|NCT00241202|quality of life|quality of life
5770841|NCT00241189|Systemic sclerosis|systemic sclerosis
5770842|NCT00241189|Scleroderma|scleroderma
5770843|NCT00241189|Rapamycin|rapamycin
5770844|NCT00241189|Methotrexate|methotrexate
5770845|NCT00241176|Psychiatric|psychiatric
5770846|NCT00241176|Clinical Trial|clinical trial
5770847|NCT00241176|Pediatrics|pediatrics
5770848|NCT00241176|Tourette's Disorder|tourette's disorder
5770849|NCT00241176|Tic Disorder|tic disorder
5770850|NCT00241150|valsartan|valsartan
5770851|NCT00241150|hypertension|hypertension
5770852|NCT00241150|metabolic syndrome|metabolic syndrome
5770853|NCT00241150|endothelial function|endothelial function
5770854|NCT00241137|hypertension|hypertension
5770855|NCT00241137|valsartan|valsartan
5770856|NCT00241124|hypertension|hypertension
5770857|NCT00241124|valsartan|valsartan
5770858|NCT00241124|morning/evening dosing|morning/evening dosing
5770859|NCT00241124|lisinopril|lisinopril
5770860|NCT00241111|Prostate|prostate
5770862|NCT00241111|bone metastasis|bone metastasis
5770863|NCT00241111|zoledronic acid|zoledronic acid
5770864|NCT00241098|HYPERTENSION|hypertension
5770865|NCT00241098|HEART FAILURE|heart failure
5770866|NCT00241098|PEPTIDE|peptide
5770867|NCT00241098|valsartan|valsartan
5770869|NCT00241085|hypertension|hypertension
5770870|NCT00241085|valsartan|valsartan
5770871|NCT00241085|type 2 diabetes|type 2 diabetes
5770872|NCT00241059|Renal transplantation, maintenance patients, tolerability, EC-MPS|renal transplantation, maintenance patients, tolerability, ec-mps
5770873|NCT00241046|Breast cancer|breast cancer
5770874|NCT00241046|Machine learning techniques|machine learning techniques
5770875|NCT00241046|Aromatase inhibitors|aromatase inhibitors
5770876|NCT00241046|1st line treatment|1st line treatment
5770877|NCT00241046|2nd line treatment|2nd line treatment
5770878|NCT00241020|hepatocellular carcinoma|hepatocellular carcinoma
5770880|NCT00241007|HYPERTENSION, VALSARTAN|hypertension, valsartan
5770881|NCT00240994|End stage renal disease|end stage renal disease
5770882|NCT00240994|Kidney transplantation|kidney transplantation
5770883|NCT00240994|Renal transplantation|renal transplantation
5770884|NCT00240994|Kidney failure|kidney failure
5770885|NCT00240994|Pediatric renal transplant recipients|pediatric renal transplant recipients
5770886|NCT00240994|Alemtuzumab|alemtuzumab
5770887|NCT00240994|Campath|campath
5770888|NCT00240994|Mycophenolate mofetil|mycophenolate mofetil
5770889|NCT00240994|MMF|mmf
5770890|NCT00240994|CellCept|cellcept
5770891|NCT00240994|Tacrolimus|tacrolimus
5770892|NCT00240994|Prograf|prograf
5770893|NCT00240994|Sirolimus|sirolimus
5770894|NCT00240994|Rapamycin|rapamycin
5770895|NCT00240981|Andropause|andropause
5770896|NCT00240981|frailty|frailty
5770897|NCT00240981|hormone replacement therapy|hormone replacement therapy
5770898|NCT00240981|Aging|aging
5770899|NCT00240968|Avian influenza, vaccine, A/H5N1, sub-study|avian influenza, vaccine, a/h5n1, sub-study
5770900|NCT00240955|Renal/Kidney, Transplantation, steroids, EC-MPS|renal/kidney, transplantation, steroids, ec-mps
5770901|NCT00240942|Endometriosis|endometriosis
5770902|NCT00240942|GnRH analog|gnrh analog
5770903|NCT00240942|Aromataseinhibitor|aromataseinhibitor
5770904|NCT00240942|Letrozole|letrozole
5770905|NCT00240903|revaccination, vaccination, influenza, H5N1 vaccine|revaccination, vaccination, influenza, h5n1 vaccine
5770906|NCT00240864|postoperative dental pain|postoperative dental pain
5770907|NCT00240864|acetaminophen|acetaminophen
5770908|NCT00240864|ibuprofen|ibuprofen
5770909|NCT00240851|muscle ache|muscle ache
5770910|NCT00240851|pain|pain
5770911|NCT00240851|soreness|soreness
5770912|NCT00240851|acetaminophen|acetaminophen
5770913|NCT00240838|muscle soreness|muscle soreness
5770914|NCT00240838|pain, acetaminophen|pain, acetaminophen
5770915|NCT00240838|ibuprofen|ibuprofen
5770916|NCT00240825|postoperative dental pain|postoperative dental pain
5770917|NCT00240825|acetaminophen|acetaminophen
5770918|NCT00240825|ibuprofen|ibuprofen
5770919|NCT00240812|nocturnal enuresis|nocturnal enuresis
5770920|NCT00240812|bedwetting|bedwetting
5770921|NCT00240812|ibuprofen|ibuprofen
5770923|NCT00240799|osteoarthritis knee|osteoarthritis knee
5770924|NCT00240799|acetaminophen|acetaminophen
5770925|NCT00240786|osteoarthritis hip|osteoarthritis hip
5770926|NCT00240786|osteoarthritis knee|osteoarthritis knee
5770927|NCT00240786|acetaminophen|acetaminophen
5770928|NCT00240773|osteoarthritis hip|osteoarthritis hip
5770929|NCT00240773|osteoarthritis knee|osteoarthritis knee
5770930|NCT00240773|acetaminophen, naproxen|acetaminophen, naproxen
5770931|NCT00240760|Memantine|memantine
5770932|NCT00240760|Down syndrome|down syndrome
5770933|NCT00240760|Dementia|dementia
5770934|NCT00240760|learning Disability|learning disability
5770935|NCT00240760|Treatment of Dementia|treatment of dementia
5770936|NCT00240734|Anemia|anemia
5770937|NCT00240734|Chronic renal failure|chronic renal failure
5770938|NCT00240734|pre-dialysis|pre-dialysis
5770939|NCT00240734|diabetic|diabetic
5770940|NCT00240721|topiramate|topiramate
5770941|NCT00240721|bipolar disorders|bipolar disorders
5770942|NCT00240721|mood disorders|mood disorders
5770943|NCT00240721|manic state|manic state
5770944|NCT00240721|depression|depression
5770945|NCT00240721|manic-depressive psychoses|manic-depressive psychoses
5770946|NCT00240708|Schizophrenia|schizophrenia
5770947|NCT00240708|intramuscular injection|intramuscular injection
5770948|NCT00240708|antipsychotic agents|antipsychotic agents
5770949|NCT00240708|risperidone|risperidone
5770950|NCT00240708|long-acting injectable|long-acting injectable
5771056|NCT00240110|Cocaine|cocaine
5770951|NCT00240695|Alzheimer's disease|alzheimer's disease
5770952|NCT00240695|Dementia|dementia
5770953|NCT00240695|Brain Disease|brain disease
5770954|NCT00240695|Memory Loss|memory loss
5770955|NCT00240695|galantamine|galantamine
5770956|NCT00240695|Nervous System Diseases|nervous system diseases
5770957|NCT00240695|open-label|open-label
5770958|NCT00240695|elderly|elderly
5770959|NCT00240682|Carcinoma, Squamous Cell|carcinoma, squamous cell
5770960|NCT00240682|Skin|skin
5770961|NCT00240682|cetuximab|cetuximab
5770962|NCT00240682|epidermal growth factor receptor|epidermal growth factor receptor
5770963|NCT00240669|Maxillo facial surgery,|maxillo facial surgery,
5770964|NCT00240669|osteosynthesis,|osteosynthesis,
5770965|NCT00240669|resorbable device|resorbable device
5770966|NCT00240656|aldosterone antagonists, spironolactone, captopril carvedilol|aldosterone antagonists, spironolactone, captopril carvedilol
5770967|NCT00240643|non valvular atrial fibrillation|non valvular atrial fibrillation
5770970|NCT00240630|acute migraine|acute migraine
5770971|NCT00240630|consistency of response|consistency of response
5770972|NCT00240630|satisfaction|satisfaction
5770973|NCT00240630|migraine|migraine
5770974|NCT00240630|early intervention|early intervention
5770975|NCT00240617|consistency of response|consistency of response
5770976|NCT00240617|migraine|migraine
5770977|NCT00240617|satisfaction|satisfaction
5770978|NCT00240617|early intervention|early intervention
5770979|NCT00240604|corticosteroid treatment|corticosteroid treatment
5770980|NCT00240604|inflammatory diseases|inflammatory diseases
5770981|NCT00240591|BEXXAR|bexxar
5770982|NCT00240591|Tositumomab|tositumomab
5770983|NCT00240591|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5770984|NCT00240591|low-grade follicular lymphomas|low-grade follicular lymphomas
5770985|NCT00240578|Long-Term Follow-up|long-term follow-up
5770986|NCT00240578|BEXXAR|bexxar
5770987|NCT00240578|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5770988|NCT00240578|Low-grade lymphoma|low-grade lymphoma
5770989|NCT00240565|BEXXAR|bexxar
5770990|NCT00240565|non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5770991|NCT00240565|tositumomab|tositumomab
5770992|NCT00240565|I-131|i-131
5770993|NCT00240552|protease inhibitor|protease inhibitor
5770994|NCT00240552|Treatment Experienced|treatment experienced
5770995|NCT00240552|amprenavir|amprenavir
5770996|NCT00240552|fosamprenavir|fosamprenavir
5770053|NCT00244907|Calcium|calcium
5770997|NCT00240552|GW433908|gw433908
5770998|NCT00240552|HIV|hiv
5770999|NCT00240552|pro drug|pro drug
5771000|NCT00240539|Hepatitis B|hepatitis b
5771001|NCT00240526|Hepatitis B immunoglobulin|hepatitis b immunoglobulin
5771002|NCT00240526|Hepatitis B antibody persistence|hepatitis b antibody persistence
5771003|NCT00240513|Acne|acne
5771004|NCT00240500|Long-term follow-up|long-term follow-up
5771005|NCT00240500|Hepatitis B antibody persistence|hepatitis b antibody persistence
5771006|NCT00240487|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5771007|NCT00240487|ARDS|ards
5771008|NCT00240487|Nitric Oxide|nitric oxide
5771009|NCT00240461|respiratory|respiratory
5771010|NCT00240461|infection|infection
5771011|NCT00240461|influenza|influenza
5771012|NCT00240396|fracture|fracture
5771013|NCT00240396|Tibia|tibia
5771014|NCT00240396|femur|femur
5771015|NCT00240396|humerus|humerus
5771016|NCT00240396|narcotics|narcotics
5771017|NCT00240396|bimodal|bimodal
5771018|NCT00240396|analgesia|analgesia
5771019|NCT00240396|long-bone|long-bone
5771020|NCT00240396|NSAIDS|nsaids
5771021|NCT00240344|High risk patients|high risk patients
5771022|NCT00240344|Crestor|crestor
5771023|NCT00240344|Rosuvastatin|rosuvastatin
5771024|NCT00240344|LDL cholesterol|ldl cholesterol
5771025|NCT00240344|observational|observational
5771026|NCT00240331|End Stage Renal Failure|end stage renal failure
5771027|NCT00240318|Coronary Artery Disease|coronary artery disease
5771028|NCT00240305|Metabolic Syndrome|metabolic syndrome
5771029|NCT00240305|Dyslipidaemia|dyslipidaemia
5771030|NCT00240292|Ischaemic or non-ischaemic systolic congestive heart failure|ischaemic or non-ischaemic systolic congestive heart failure
5771031|NCT00240279|high blood cholesterol levels|high blood cholesterol levels
5771032|NCT00240266|Metabolic Syndrome|metabolic syndrome
5771033|NCT00240266|Dyslipaemia|dyslipaemia
5771034|NCT00240253|diabetes|diabetes
5771035|NCT00240253|Amylin|amylin
5771036|NCT00240253|Symlin|symlin
5771037|NCT00240253|pramlintide|pramlintide
5771038|NCT00240253|insulin glargine|insulin glargine
5771039|NCT00240227|Alcoholism|alcoholism
5771040|NCT00240227|Cocaine Dependence|cocaine dependence
5771041|NCT00240227|Prazosin|prazosin
5771042|NCT00240227|Substance use disorders|substance use disorders
5771043|NCT00240214|Kidney transplants|kidney transplants
5771044|NCT00240188|Hernia|hernia
5771045|NCT00240188|Incisional|incisional
5771046|NCT00240188|Laparoscopic|laparoscopic
5771047|NCT00240188|Mesh|mesh
5771048|NCT00240188|Repair|repair
5771049|NCT00240188|Ventral|ventral
5771050|NCT00240162|Myeloma|myeloma
5771051|NCT00240162|PTK|ptk
5771052|NCT00240136|Early, severe|early, severe
5771053|NCT00240123|ERCP|ercp
5771054|NCT00240123|EUS|eus
5771055|NCT00240110|Bipolar|bipolar
5771057|NCT00240110|Comorbidity|comorbidity
5771058|NCT00240071|Breast cancer|breast cancer
5771059|NCT00240071|Metastatic breast cancer|metastatic breast cancer
5771060|NCT00240071|Hormonal therapy|hormonal therapy
5771062|NCT00240058|Blood Pressure|blood pressure
5771063|NCT00240058|Nitric Oxide|nitric oxide
5771064|NCT00240058|L-NMMA|l-nmma
5771065|NCT00240058|Phenylephrine|phenylephrine
5771066|NCT00240058|Nitroprusside|nitroprusside
5771067|NCT00240058|Vasoreactivity|vasoreactivity
5771068|NCT00240045|Hepatorenal syndrome|hepatorenal syndrome
5771069|NCT00240045|Refractory ascites|refractory ascites
5771070|NCT00240045|Midodrine|midodrine
5771071|NCT00240045|Octreotide|octreotide
5771072|NCT00240045|Albumin|albumin
5771073|NCT00240045|Cirrhosis|cirrhosis
5771074|NCT00240006|Multiple Sclerosis|multiple sclerosis
5771075|NCT00240006|Copaxone®|copaxone®
5771076|NCT00240006|Shared Solutions®|shared solutions®
5771077|NCT00239980|antineoplastic agent|antineoplastic agent
5771078|NCT00239980|ovarian cancer|ovarian cancer
5771079|NCT00239980|fragmin|fragmin
5771081|NCT00239967|dyslipidemia|dyslipidemia
5771082|NCT00239967|obesity|obesity
5771083|NCT00239928|Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration|long-term study for pegaptanib sodium in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
5771084|NCT00239902|Transplantation, kidney, and organ transplantation|transplantation, kidney, and organ transplantation
5771085|NCT00239889|Forearm fracture|forearm fracture
5771086|NCT00239889|Postmenopausal women|postmenopausal women
5771087|NCT00239889|Pain|pain
5771088|NCT00239889|Grip strength|grip strength
5771089|NCT00239889|Salmon calcitonin|salmon calcitonin
5771090|NCT00239876|Transplantation, kidney, and organ transplant|transplantation, kidney, and organ transplant
5771091|NCT00239863|Transplantation, kidney,organ transplant|transplantation, kidney,organ transplant
5771092|NCT00239850|obesity|obesity
5771093|NCT00239850|lifestyle|lifestyle
5771094|NCT00239850|treatment|treatment
5771095|NCT00239850|Complications|complications
5771096|NCT00239850|endocrine changes|endocrine changes
5771097|NCT00239850|Lipids|lipids
5771098|NCT00239850|C18.654.726.500.495|c18.654.726.500.495
5771099|NCT00239837|Adolescent|adolescent
5771100|NCT00239837|Foster Care|foster care
5771101|NCT00239837|Female|female
5771102|NCT00239824|urinary incontinence|urinary incontinence
5771103|NCT00239824|pelvic floor muscle training|pelvic floor muscle training
5771104|NCT00239824|radical prostatectomy|radical prostatectomy
5771105|NCT00239824|physiotherapy|physiotherapy
5771106|NCT00239811|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
5771107|NCT00239798|Transplantation, kidney, organ transplant|transplantation, kidney, organ transplant
5771108|NCT00239785|Transplantation, kidney, and organ transplant.|transplantation, kidney, and organ transplant.
5771109|NCT00239772|Cognitive Therapy|cognitive therapy
5771110|NCT00239772|PTSD|ptsd
5771111|NCT00239772|Females|females
5771112|NCT00239772|Rape|rape
5771113|NCT00239772|Trauma|trauma
5771114|NCT00239759|Epidemiological study|epidemiological study
5771115|NCT00239746|Nonsteroidal Anti-inflammatories|nonsteroidal anti-inflammatories
5771116|NCT00239746|NSAIDS|nsaids
5771117|NCT00239733|HIV|hiv
5771118|NCT00239733|HCV|hcv
5771119|NCT00239733|Hepatitis C|hepatitis c
5771120|NCT00239733|Thrombocytopenia|thrombocytopenia
5771121|NCT00239720|Psoriatic Arthritis|psoriatic arthritis
5771122|NCT00239720|Arthritis|arthritis
5771123|NCT00239720|Psoriasis|psoriasis
5771124|NCT00239720|Psoriatic|psoriatic
5771125|NCT00239720|PsA|psa
5771126|NCT00239707|insulin sensitivity|insulin sensitivity
5771127|NCT00239707|blood sugar|blood sugar
5771128|NCT00239694|Immune response|immune response
5771129|NCT00239694|Antibody response|antibody response
5771130|NCT00239681|Primary prevention|primary prevention
5771131|NCT00239681|Cardiovascular disease|cardiovascular disease
5771132|NCT00239681|Statin therapy|statin therapy
5771133|NCT00239681|C-reactive protein|c-reactive protein
5771134|NCT00239668|Burns|burns
5771135|NCT00239668|Functional|functional
5771136|NCT00239668|Psychosocial|psychosocial
5771137|NCT00239668|Recovery|recovery
5771138|NCT00239668|Long-term|long-term
5771139|NCT00239668|Pediatric|pediatric
5771140|NCT00239668|Surgical|surgical
5771141|NCT00239668|Outcomes|outcomes
5771142|NCT00239668|Benchmarking|benchmarking
5771143|NCT00239642|Iron|iron
5771144|NCT00239642|Anemia|anemia
5771145|NCT00239642|CKD|ckd
5771146|NCT00239616|Anemia|anemia
5771147|NCT00239616|Pharmacokinetics|pharmacokinetics
5771148|NCT00239603|OV-Watch|ov-watch
5771149|NCT00239603|fertility monitor|fertility monitor
5771150|NCT00239603|ovulation induction|ovulation induction
5771151|NCT00239603|clomiphene citrate|clomiphene citrate
5771152|NCT00239603|anovulation|anovulation
5771153|NCT00239603|infertility|infertility
5771154|NCT00239577|Dengue infection|dengue infection
5771155|NCT00239564|IPX054|ipx054
5771156|NCT00239564|Parkinson disease|parkinson disease
5771157|NCT00239564|Levodopa|levodopa
5771918|NCT00236730|epilepsy|epilepsy
5771158|NCT00239551|gastric stress ulcer|gastric stress ulcer
5771159|NCT00239551|Prevacid|prevacid
5771160|NCT00239551|Prostaglandin|prostaglandin
5766516|NCT00257478|Treatment|treatment
5771161|NCT00239525|Cerebrovascular Accident|cerebrovascular accident
5771162|NCT00239525|Intracranial Hypertension|intracranial hypertension
5771164|NCT00239512|VLBW infants|vlbw infants
5771165|NCT00239512|Indomethacin|indomethacin
5771166|NCT00239512|Ibuprofen|ibuprofen
5771167|NCT00239330|high blood cholesterol levels|high blood cholesterol levels
5771168|NCT00239317|tamsulosin|tamsulosin
5771169|NCT00239317|urinary tract diseases|urinary tract diseases
5771171|NCT00239304|Stage III Head and Neck Cancer|stage iii head and neck cancer
5771172|NCT00239304|Stage IV Head and Neck Cancer|stage iv head and neck cancer
5771173|NCT00239265|tamsulosin|tamsulosin
5771174|NCT00239265|urinary tract diseases|urinary tract diseases
5771175|NCT00239265|female|female
5771176|NCT00239252|Interferon alfacon-1|interferon alfacon-1
5771177|NCT00239252|Virus disease|virus disease
5771179|NCT00239239|Non-myeloid malignancy|non-myeloid malignancy
5771180|NCT00239239|Chemotherapy-induced anemia|chemotherapy-induced anemia
5771181|NCT00239239|Oncology|oncology
5771182|NCT00239239|Clinical Trials|clinical trials
5771183|NCT00239239|Pharmacokinetics|pharmacokinetics
5771184|NCT00239239|Darbepoetin alfa|darbepoetin alfa
5771186|NCT00239239|Amgen|amgen
5771187|NCT00239226|atrial fibrillation|atrial fibrillation
5771188|NCT00239226|interatrial septum|interatrial septum
5771189|NCT00239226|atrial pacing|atrial pacing
5771190|NCT00239226|symptomatic sinus node dysfunction,|symptomatic sinus node dysfunction,
5771191|NCT00239226|pacemaker indication class I|pacemaker indication class i
5771192|NCT00239213|catechins|catechins
5771193|NCT00239213|gargling|gargling
5771194|NCT00239213|healthy volunteers|healthy volunteers
5771195|NCT00239187|Type 2 diabetes|type 2 diabetes
5771196|NCT00239174|obesity|obesity
5771197|NCT00239161|Pyelonephritis|pyelonephritis
5771198|NCT00239148|Type 1 diabetes|type 1 diabetes
5771199|NCT00239135|Actinic Keratosis|actinic keratosis
5771200|NCT00239135|Topical|topical
5771201|NCT00239135|Maximum Tolerated Dose|maximum tolerated dose
5771202|NCT00239135|Solar Keratosis|solar keratosis
5771203|NCT00239135|Sun Spots|sun spots
5771204|NCT00239135|Dermatology|dermatology
5771205|NCT00239122|Cognitive Therapy|cognitive therapy
5771206|NCT00239122|Psychotic Disorders|psychotic disorders
5686376|NCT00552409|Chronic kidney disease|chronic kidney disease
5771207|NCT00239122|Treatment Outcome|treatment outcome
5771208|NCT00239096|alcoholic liver cirrhosis|alcoholic liver cirrhosis
5771209|NCT00239096|ascites|ascites
5771210|NCT00239096|sodium retention|sodium retention
5771211|NCT00239083|MYFORMS, Kidney Transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS), Cyclosporine microemulsion (CsA-ME)|myforms, kidney transplantation, enteric-coated mycophenolate sodium (ec-mps), cyclosporine microemulsion (csa-me)
5771212|NCT00239070|EC-MPS, renal transplantation, de novo patients|ec-mps, renal transplantation, de novo patients
5771213|NCT00239057|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5771214|NCT00239044|Kidney transplant recipients; Enteric-coated Mycophenolate sodium (EC-MPS)|kidney transplant recipients; enteric-coated mycophenolate sodium (ec-mps)
5771215|NCT00239031|Renal transplantation, EC-MPS|renal transplantation, ec-mps
5771216|NCT00239018|Enteric-Coated Mycophenolate Sodium (EC-MPS), de novo, kidney transplantation, long-term safety.|enteric-coated mycophenolate sodium (ec-mps), de novo, kidney transplantation, long-term safety.
5771217|NCT00239005|QoL|qol
5771218|NCT00239005|GI Side Effects|gi side effects
5771219|NCT00239005|MPA|mpa
5771220|NCT00238992|Kidney, de novo transplant, steroid withdrawal, adults, EC-MPS and cyclosporine|kidney, de novo transplant, steroid withdrawal, adults, ec-mps and cyclosporine
5771221|NCT00238979|Renal transplantation, Enteric-coated mycophenolate sodium|renal transplantation, enteric-coated mycophenolate sodium
5771222|NCT00238966|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
5771223|NCT00238953|Kidney transplantation|kidney transplantation
5771224|NCT00238953|enteric-coated mycophenolate sodium|enteric-coated mycophenolate sodium
5771225|NCT00238940|Renal transplantation, Enteric-Coated Mycophenolate Sodium (EC-MPS)|renal transplantation, enteric-coated mycophenolate sodium (ec-mps)
5771226|NCT00238927|asthma|asthma
5771227|NCT00238927|preschool|preschool
5771228|NCT00238927|viral|viral
5771229|NCT00238927|upper respiratory track infection|upper respiratory track infection
5771230|NCT00238927|fluticasone|fluticasone
5771231|NCT00238927|inhaled corticosteroids|inhaled corticosteroids
5771232|NCT00238927|placebo|placebo
5771233|NCT00238927|exacerbations|exacerbations
5771234|NCT00238927|severity|severity
5771235|NCT00238927|safety|safety
5771236|NCT00238927|growth|growth
5771237|NCT00238927|bone mineral density|bone mineral density
5771238|NCT00238927|adrenal function|adrenal function
5771239|NCT00238927|rescue beta2-agonists|rescue beta2-agonists
5771240|NCT00238901|Liver transplant, HCV+, steroid free|liver transplant, hcv+, steroid free
5771241|NCT00238888|asthma|asthma
5771242|NCT00238888|children|children
5771243|NCT00238888|adolescent|adolescent
5771244|NCT00238888|education|education
5771245|NCT00238888|medical review|medical review
5771246|NCT00238888|asthma control|asthma control
5771247|NCT00238888|questionnaire|questionnaire
5771248|NCT00238888|quality of life|quality of life
5771249|NCT00238888|emergency department visit|emergency department visit
5771250|NCT00238888|use of medication|use of medication
5771251|NCT00238888|adherence to treatment|adherence to treatment
5771252|NCT00238875|stereotactic body radiation therapy|stereotactic body radiation therapy
5771253|NCT00238875|T1N0M0 non-small cell lung cancer|t1n0m0 non-small cell lung cancer
5771255|NCT00238862|Diabetes|diabetes
5771256|NCT00238862|Corneal transplant|corneal transplant
5771257|NCT00238862|Neurotrophic keratitis|neurotrophic keratitis
5771258|NCT00238862|Post-bacterial keratitis|post-bacterial keratitis
5771259|NCT00238862|Metaherpetic keratitis|metaherpetic keratitis
5771260|NCT00238849|Non-small cell lung cancer|non-small cell lung cancer
5771261|NCT00238823|cryoablation|cryoablation
5771262|NCT00238823|radiofrequency ablation|radiofrequency ablation
5771263|NCT00238823|pediatrics|pediatrics
5771264|NCT00238823|cardiology|cardiology
5771265|NCT00238810|BNP|bnp
5771266|NCT00238810|Pediatrics|pediatrics
5771267|NCT00238810|Congenital heart disease|congenital heart disease
5771268|NCT00238810|b-type natriuretic peptide|b-type natriuretic peptide
5771269|NCT00238797|Glioblastoma multiforme|glioblastoma multiforme
5771270|NCT00238797|Brain tumour|brain tumour
5771271|NCT00238758|Mood Disorder|mood disorder
5771272|NCT00238745|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5771273|NCT00238732|Vaginal Atrophy|vaginal atrophy
5771274|NCT00238732|Postmenopause|postmenopause
5771275|NCT00238719|Social Anxiety|social anxiety
5771276|NCT00238719|Children Disorders|children disorders
5771277|NCT00238706|Radiofrequency catheter ablation|radiofrequency catheter ablation
5771278|NCT00238706|Atrial fibrillation|atrial fibrillation
5771279|NCT00238706|Randomized trial|randomized trial
5771281|NCT00238693|transplantation of liver, kidney, pancreas|transplantation of liver, kidney, pancreas
5771282|NCT00238680|Overactive bladder|overactive bladder
5771283|NCT00238680|Children|children
5771284|NCT00238680|Bladder rehabilitation|bladder rehabilitation
5771285|NCT00238667|Extracranial carotid artery dissection|extracranial carotid artery dissection
5771286|NCT00238667|Dissection and stroke|dissection and stroke
5771287|NCT00238550|Diabetes|diabetes
5771288|NCT00238550|Pain|pain
5771289|NCT00238550|Peripheral neuropathy|peripheral neuropathy
5771290|NCT00238537|Stroke|stroke
5771291|NCT00238537|Thrombolysis|thrombolysis
5771292|NCT00238537|MRI|mri
5771293|NCT00238537|Echoplanar|echoplanar
5771294|NCT00238537|Penumbra|penumbra
5771295|NCT00238524|painful distal diabetic neuropathy|painful distal diabetic neuropathy
5771296|NCT00238498|Type 2 diabetes|type 2 diabetes
5771297|NCT00238498|vildagliptin|vildagliptin
5771298|NCT00238498|HbA1c|hba1c
5771299|NCT00238485|Bipolar I Disorder|bipolar i disorder
5771300|NCT00238472|Type 2 diabetes|type 2 diabetes
5771301|NCT00238472|nateglinide|nateglinide
5771302|NCT00238459|Immunity to HIV|immunity to hiv
5771303|NCT00238459|Acute Infection|acute infection
5771304|NCT00238459|Treatment Naive|treatment naive
5771305|NCT00238459|Treatment Interruption|treatment interruption
5771306|NCT00238459|Structured Treatment Interruption|structured treatment interruption
5771307|NCT00238459|STI|sti
5771308|NCT00238446|Enteric-coated mycophenolate sodium, heart transplant recipients, long term safety|enteric-coated mycophenolate sodium, heart transplant recipients, long term safety
5771309|NCT00238433|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5771310|NCT00238433|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5771311|NCT00238433|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5771312|NCT00238433|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5771313|NCT00238433|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5771314|NCT00238433|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5771315|NCT00238433|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5771316|NCT00238433|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5771317|NCT00238433|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5771318|NCT00238433|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5771319|NCT00238433|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5771320|NCT00238433|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5771321|NCT00238433|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5771322|NCT00238433|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5771323|NCT00238433|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5771324|NCT00238433|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5771325|NCT00238433|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5771326|NCT00238433|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5771327|NCT00238433|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5771328|NCT00238433|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5771329|NCT00238433|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5771330|NCT00238433|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5771331|NCT00238433|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5771332|NCT00238433|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5766709|NCT00256659|Occupational therapy|occupational therapy
5771333|NCT00238433|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5771334|NCT00238433|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5771335|NCT00238433|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5771336|NCT00238433|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5771337|NCT00238433|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5771338|NCT00238433|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5771339|NCT00238433|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5771340|NCT00238433|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5771341|NCT00238433|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5771342|NCT00238433|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5771343|NCT00238433|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5771413|NCT00238264|childhood oligodendroglioma|childhood oligodendroglioma
5771344|NCT00238433|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5771345|NCT00238433|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5771346|NCT00238433|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5771347|NCT00238433|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5771348|NCT00238433|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5771349|NCT00238433|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5771350|NCT00238433|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5771351|NCT00238433|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5771352|NCT00238433|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5771353|NCT00238433|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5771354|NCT00238433|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5771355|NCT00238433|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5771356|NCT00238433|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5771357|NCT00238433|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5780258|NCT00196131|SAH|sah
5771358|NCT00238433|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5771359|NCT00238433|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5771360|NCT00238407|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5771361|NCT00238407|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5771363|NCT00238407|stage IV esophageal cancer|stage iv esophageal cancer
5771364|NCT00238381|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5771365|NCT00238381|stage 0 rectal cancer|stage 0 rectal cancer
5771366|NCT00238381|stage I rectal cancer|stage i rectal cancer
5771367|NCT00238381|stage II rectal cancer|stage ii rectal cancer
5771368|NCT00238381|stage III rectal cancer|stage iii rectal cancer
5771369|NCT00238381|stage IV rectal cancer|stage iv rectal cancer
5771370|NCT00238381|recurrent rectal cancer|recurrent rectal cancer
5771371|NCT00238368|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5771372|NCT00238368|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5771373|NCT00238368|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5771374|NCT00238368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5771375|NCT00238368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5771376|NCT00238368|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5771377|NCT00238368|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5771378|NCT00238368|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5771379|NCT00238368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5771380|NCT00238368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5771381|NCT00238368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5771382|NCT00238368|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5771383|NCT00238368|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5771384|NCT00238368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5771385|NCT00238368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5771387|NCT00238355|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5771388|NCT00238342|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5771389|NCT00238342|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5771390|NCT00238342|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5771391|NCT00238342|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5771392|NCT00238342|fallopian tube cancer|fallopian tube cancer
5771393|NCT00238342|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5771394|NCT00238342|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5771395|NCT00238342|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5771396|NCT00238342|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5771397|NCT00238342|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5771398|NCT00238329|recurrent melanoma|recurrent melanoma
5771399|NCT00238329|stage IV melanoma|stage iv melanoma
5771400|NCT00238329|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5771401|NCT00238329|extraocular extension melanoma|extraocular extension melanoma
5771402|NCT00238329|iris melanoma|iris melanoma
5771403|NCT00238329|recurrent intraocular melanoma|recurrent intraocular melanoma
5771404|NCT00238316|breast cancer|breast cancer
5771405|NCT00238290|recurrent breast cancer|recurrent breast cancer
5771406|NCT00238290|stage IIIA breast cancer|stage iiia breast cancer
5771407|NCT00238290|stage IIIB breast cancer|stage iiib breast cancer
5771408|NCT00238290|stage IIIC breast cancer|stage iiic breast cancer
5771409|NCT00238290|stage IV breast cancer|stage iv breast cancer
5771410|NCT00238277|adult glioblastoma|adult glioblastoma
5771411|NCT00238277|adult giant cell glioblastoma|adult giant cell glioblastoma
5771412|NCT00238277|adult gliosarcoma|adult gliosarcoma
5848605|NCT00034216|Blood Sample|blood sample
5771414|NCT00238264|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5771415|NCT00238264|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5771416|NCT00238264|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5771417|NCT00238264|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5771418|NCT00238264|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5771419|NCT00238264|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5771420|NCT00238251|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5771421|NCT00238251|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5771422|NCT00238251|tumors metastatic to brain|tumors metastatic to brain
5771423|NCT00238238|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5771424|NCT00238238|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5771425|NCT00238238|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5771426|NCT00238225|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5771427|NCT00238199|stage III pancreatic cancer|stage iii pancreatic cancer
5770516|NCT00242918|High risk|high risk
5771428|NCT00238199|stage IV pancreatic cancer|stage iv pancreatic cancer
5771429|NCT00238173|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5771430|NCT00238173|bone marrow suppression|bone marrow suppression
5771431|NCT00238173|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5771432|NCT00238173|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5771433|NCT00238173|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5771434|NCT00238173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5771435|NCT00238173|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5771436|NCT00238173|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5771437|NCT00238173|recurrent childhood brain tumor|recurrent childhood brain tumor
5771438|NCT00238173|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5771439|NCT00238173|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5771440|NCT00238173|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5771441|NCT00238173|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5771442|NCT00238173|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5771443|NCT00238173|childhood oligodendroglioma|childhood oligodendroglioma
5771444|NCT00238173|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5771445|NCT00238173|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5771446|NCT00238173|recurrent childhood ependymoma|recurrent childhood ependymoma
5771447|NCT00238173|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5771448|NCT00238173|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5771449|NCT00238173|childhood central nervous system germinoma|childhood central nervous system germinoma
5771450|NCT00238173|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5771451|NCT00238173|childhood central nervous system teratoma|childhood central nervous system teratoma
5771452|NCT00238173|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5771453|NCT00238173|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5771454|NCT00238147|stage II esophageal cancer|stage ii esophageal cancer
5771455|NCT00238147|stage III esophageal cancer|stage iii esophageal cancer
5771456|NCT00238108|Sleep disorders|sleep disorders
5771457|NCT00238108|High blood pressure|high blood pressure
5771458|NCT00238082|COPD|copd
5771459|NCT00238082|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5771460|NCT00238082|Emphysema|emphysema
5771461|NCT00238082|Chronic Bronchitis|chronic bronchitis
5771462|NCT00238069|Asthma|asthma
5771463|NCT00238069|Sleep Apnea|sleep apnea
5771464|NCT00238069|Obesity|obesity
5771465|NCT00238069|CPAP|cpap
5771466|NCT00238056|Domperidone, QT, prematurity|domperidone, qt, prematurity
5771467|NCT00238043|Biogeneric Epoetin treatment|biogeneric epoetin treatment
5771468|NCT00238043|Renal anaemia|renal anaemia
5771469|NCT00238043|Chronic Kidney Disease|chronic kidney disease
5771470|NCT00238043|Pure Red Blood Cell Aplasia|pure red blood cell aplasia
5771471|NCT00238043|Hemodialysis|hemodialysis
5771472|NCT00238030|organ donation|organ donation
5771473|NCT00238030|thyroid replacement|thyroid replacement
5771474|NCT00238017|malaria, amodiaquine, artesunate, safety, efficacy|malaria, amodiaquine, artesunate, safety, efficacy
5771475|NCT00238004|Niacin|niacin
5771476|NCT00237965|Skin Self Examination|skin self examination
5771477|NCT00237965|Mole Mapping Diagram|mole mapping diagram
5771478|NCT00237965|Melanoma|melanoma
5771479|NCT00237926|Sleep|sleep
5771480|NCT00237926|Fatigue|fatigue
5771481|NCT00237926|Exercise tolerance|exercise tolerance
5771482|NCT00237926|Quality of life|quality of life
5771483|NCT00237926|Health status|health status
5771484|NCT00237887|Psoriasis|psoriasis
5771485|NCT00237887|adalimumab|adalimumab
5771486|NCT00237874|prodrome|prodrome
5771487|NCT00237874|ultra high risk|ultra high risk
5771488|NCT00237874|aripiprazole|aripiprazole
5771489|NCT00237822|Treatment Adherence|treatment adherence
5771490|NCT00237822|Co-Occurring Disorders|co-occurring disorders
5771491|NCT00237822|Motivational Enhancement Therapy|motivational enhancement therapy
5771492|NCT00237822|Contingency Management|contingency management
5771493|NCT00237822|MEMS Caps|mems caps
5771494|NCT00237796|Behavioral|behavioral
5771495|NCT00237796|Cognitive|cognitive
5771496|NCT00237796|Functioning|functioning
5771497|NCT00237796|Older|older
5771498|NCT00237796|CBT|cbt
5771499|NCT00237796|Rehabilitation|rehabilitation
5771500|NCT00237796|Schizophrenia|schizophrenia
5771501|NCT00237796|Skills|skills
5771502|NCT00237796|Social|social
5771503|NCT00237796|Training|training
5771504|NCT00237783|Renal dialysis|renal dialysis
5771505|NCT00237783|Hypotension|hypotension
5771506|NCT00237783|Dialysis solutions|dialysis solutions
5771507|NCT00237770|Blood Pressure|blood pressure
5771508|NCT00237770|Cardiovascular Autonomic Control|cardiovascular autonomic control
5771509|NCT00237770|Nitric Oxide|nitric oxide
5771510|NCT00237770|NOS Inhibitor|nos inhibitor
5686377|NCT00552409|Diabetic kidney disease|diabetic kidney disease
5686378|NCT00552409|Microalbuminuria|microalbuminuria
5771511|NCT00237770|Orthostatic Hypotension|orthostatic hypotension
5771512|NCT00237770|Spinal Cord Injury|spinal cord injury
5771513|NCT00237770|Tetraplegia|tetraplegia
5771514|NCT00237757|Patient Care Team|patient care team
5771515|NCT00237757|Rehabilitation outcomes|rehabilitation outcomes
5771516|NCT00237757|Treatment outcomes|treatment outcomes
5771517|NCT00237744|Motor Learning|motor learning
5771518|NCT00237744|Rehabilitation|rehabilitation
5771519|NCT00237744|Robotics|robotics
5771520|NCT00237744|Therapeutic Electric Stimulation|therapeutic electric stimulation
5771521|NCT00237731|Acute pain|acute pain
5771522|NCT00237731|Morphine titration|morphine titration
5771523|NCT00237731|Analgesia|analgesia
5771524|NCT00237731|Pre-hospital care|pre-hospital care
5771525|NCT00237705|Headache|headache
5771526|NCT00237705|Concussion|concussion
5771527|NCT00237705|Post concussive syndrome|post concussive syndrome
5771528|NCT00237705|Head trauma|head trauma
5771529|NCT00237692|Telemedicine|telemedicine
5771530|NCT00237692|Adherence|adherence
5771531|NCT00237692|Tailored Nurse Intervention|tailored nurse intervention
5771532|NCT00237692|Home Blood Pressure Monitoring|home blood pressure monitoring
5771533|NCT00237692|cardiovascular disease|cardiovascular disease
5771534|NCT00237679|behavior therapy|behavior therapy
5771535|NCT00237679|combination therapy|combination therapy
5771536|NCT00237679|gastrointestinal disorder chemotherapy|gastrointestinal disorder chemotherapy
5771537|NCT00237679|human therapy evaluation|human therapy evaluation
5771538|NCT00237679|larynx disorder|larynx disorder
5771539|NCT00237679|middle childhood (6-11)|middle childhood (6-11)
5771540|NCT00237679|lansoprazole|lansoprazole
5771541|NCT00237679|reflux esophagitis|reflux esophagitis
5771542|NCT00237679|quality of life|quality of life
5771543|NCT00237679|clinical research|clinical research
5771544|NCT00237679|human subject|human subject
5771545|NCT00237679|laryngoscopy|laryngoscopy
5771546|NCT00237679|patient oriented research|patient oriented research
5771547|NCT00237679|questionnaire|questionnaire
5771548|NCT00237666|Bipolar II Disorder|bipolar ii disorder
5771549|NCT00237666|Major Depressive Episode|major depressive episode
5771550|NCT00237653|Valganciclovir|valganciclovir
5771551|NCT00237653|Cytomegalovirus|cytomegalovirus
5771552|NCT00237653|Cryptogenic inflammatory bowel diseases|cryptogenic inflammatory bowel diseases
5771553|NCT00237653|Crohn Disease|crohn disease
5771554|NCT00237653|colitis, ulcerative|colitis, ulcerative
5771555|NCT00237640|Cinnamon|cinnamon
5771556|NCT00237640|Diabetes mellitus|diabetes mellitus
5771557|NCT00237640|Hyperlipidemia|hyperlipidemia
5771558|NCT00237640|Insulin Resistance|insulin resistance
5771559|NCT00237627|stage IIIA breast cancer|stage iiia breast cancer
5771560|NCT00237627|stage IIIB breast cancer|stage iiib breast cancer
5771561|NCT00237627|stage IIIC breast cancer|stage iiic breast cancer
5771562|NCT00237627|stage IV breast cancer|stage iv breast cancer
5771563|NCT00237627|male breast cancer|male breast cancer
5771564|NCT00237627|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5771565|NCT00237627|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5771566|NCT00237627|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5771567|NCT00237627|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5771568|NCT00237627|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5771569|NCT00237627|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5771570|NCT00237627|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5771571|NCT00237627|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5771572|NCT00237627|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5771573|NCT00237627|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5771574|NCT00237627|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5771575|NCT00237627|mast cell leukemia|mast cell leukemia
5771576|NCT00237627|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5771577|NCT00237627|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5771578|NCT00237627|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5771940|NCT00236691|partial epilepsy|partial epilepsy
5771579|NCT00237627|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5771580|NCT00237627|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5771581|NCT00237627|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5771582|NCT00237627|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5771583|NCT00237627|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5771584|NCT00237627|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5771585|NCT00237627|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5771586|NCT00237627|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5771587|NCT00237627|refractory hairy cell leukemia|refractory hairy cell leukemia
5686379|NCT00552409|Albuminuria|albuminuria
5686380|NCT00552409|Vitamin D|vitamin d
5771588|NCT00237627|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5771589|NCT00237627|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5771590|NCT00237627|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5771591|NCT00237627|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5771592|NCT00237627|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5771593|NCT00237627|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5771594|NCT00237627|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5771595|NCT00237627|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5771596|NCT00237627|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5771597|NCT00237627|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5771598|NCT00237627|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5771599|NCT00237627|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5771600|NCT00237627|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5771601|NCT00237627|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5771602|NCT00237627|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5771603|NCT00237627|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5771604|NCT00237627|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5771605|NCT00237627|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5771606|NCT00237627|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5771607|NCT00237627|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5771608|NCT00237627|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5771609|NCT00237627|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5681068|NCT00574860|Head and neck cancer|head and neck cancer
5681069|NCT00574847|ischemic heart disease|ischemic heart disease
5681070|NCT00574847|mental stress-induced myocardial ischemia|mental stress-induced myocardial ischemia
5681071|NCT00574847|escitalopram|escitalopram
5681072|NCT00574821|Hypertrophic Cardiomyopathy(HCM)|hypertrophic cardiomyopathy(hcm)
5798636|NCT00111527|Quality of life|quality of life
5771610|NCT00237627|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5771611|NCT00237627|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5771612|NCT00237627|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5771613|NCT00237627|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5771614|NCT00237627|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5771615|NCT00237627|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5771616|NCT00237627|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5771617|NCT00237627|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5771618|NCT00237627|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5771619|NCT00237627|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5771620|NCT00237627|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5771621|NCT00237627|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5771622|NCT00237627|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5771623|NCT00237627|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5771624|NCT00237627|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5771625|NCT00237627|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5771626|NCT00237627|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5771627|NCT00237627|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5771628|NCT00237627|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5771629|NCT00237627|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5771630|NCT00237627|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5771631|NCT00237627|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5771632|NCT00237627|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5771633|NCT00237627|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5771634|NCT00237627|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5771635|NCT00237627|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5771636|NCT00237627|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5771637|NCT00237627|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5771638|NCT00237627|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5771639|NCT00237627|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5771640|NCT00237627|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5771641|NCT00237627|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5771642|NCT00237627|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5686381|NCT00552409|Cholecalciferol|cholecalciferol
5686382|NCT00552409|Kidney|kidney
5771643|NCT00237627|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5771644|NCT00237627|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5771645|NCT00237627|intraocular lymphoma|intraocular lymphoma
5771646|NCT00237627|primary central nervous system lymphoma|primary central nervous system lymphoma
5771647|NCT00237627|stage III multiple myeloma|stage iii multiple myeloma
5771648|NCT00237627|stage II multiple myeloma|stage ii multiple myeloma
5771649|NCT00237627|refractory multiple myeloma|refractory multiple myeloma
5771650|NCT00237627|cutaneous B-cell non-Hodgkin lymphoma|cutaneous b-cell non-hodgkin lymphoma
5771651|NCT00237627|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5771652|NCT00237627|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5771653|NCT00237627|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5771654|NCT00237627|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5771655|NCT00237627|recurrent breast cancer|recurrent breast cancer
5771656|NCT00237627|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5771657|NCT00237614|Contrast-induced nephropathy|contrast-induced nephropathy
5771658|NCT00237614|Acute myocardial infarction|acute myocardial infarction
5771659|NCT00237614|Primary coronary angioplasty|primary coronary angioplasty
5771660|NCT00237601|Home birth|home birth
5771661|NCT00237601|Hospital birth|hospital birth
5771662|NCT00237601|Midwifery|midwifery
5771663|NCT00237601|Effectivity|effectivity
5771664|NCT00237601|Efficiency|efficiency
5771665|NCT00237588|Angiotensin II Type I Receptor Blockers|angiotensin ii type i receptor blockers
5771666|NCT00237588|Amlodipine|amlodipine
5771667|NCT00237588|Calcium Channel Blockers|calcium channel blockers
5771668|NCT00237588|Diabetes Mellitus|diabetes mellitus
5771669|NCT00237588|Hypertension|hypertension
5771670|NCT00237588|Insulin Resistance|insulin resistance
5771671|NCT00237588|Losartan|losartan
5771672|NCT00237575|urothelial|urothelial
5771674|NCT00237575|gemcitabine|gemcitabine
5771675|NCT00237575|cisplatin|cisplatin
5771676|NCT00237575|leukine|leukine
5771677|NCT00237575|neupogen|neupogen
5771678|NCT00237575|filgrastim|filgrastim
5771679|NCT00237575|sargramostim|sargramostim
5771680|NCT00237575|metastatic|metastatic
5771681|NCT00237575|Regionally Advanced|regionally advanced
5771682|NCT00237575|Advanced|advanced
5771683|NCT00237549|Type 2 diabetes|type 2 diabetes
5771684|NCT00237549|Screening|screening
5771685|NCT00237549|Intensive treatment|intensive treatment
5771686|NCT00237549|Polypharmacy|polypharmacy
5771687|NCT00237549|Primary care|primary care
5771688|NCT00237536|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5771689|NCT00237536|BPH|bph
5771690|NCT00237536|Enlarged Prostate|enlarged prostate
5771691|NCT00237523|Breast pain|breast pain
5771692|NCT00237523|Mastalgia|mastalgia
5771693|NCT00237523|Cyclic mastalgia|cyclic mastalgia
5771694|NCT00237523|Periodic mastalgia|periodic mastalgia
5771695|NCT00237523|Non-cyclic mastalgia|non-cyclic mastalgia
5771696|NCT00237523|Fibrosis|fibrosis
5771697|NCT00237523|Nodularity|nodularity
5771698|NCT00237523|Cysts|cysts
5771699|NCT00237523|Fibrocystic breast disease|fibrocystic breast disease
5771700|NCT00237523|Fibrocystic breast condition|fibrocystic breast condition
5771701|NCT00237523|Fibocystic breast syndrome|fibocystic breast syndrome
5771702|NCT00237510|Antidepressant induced excessive sweating|antidepressant induced excessive sweating
5771703|NCT00237497|Insomnia|insomnia
5771704|NCT00237497|Center of Pressure|center of pressure
5771705|NCT00237497|Postural Sway|postural sway
5771706|NCT00237497|Drug Therapy|drug therapy
5771707|NCT00237497|Balance and Stability|balance and stability
5771708|NCT00237484|pegylated interferon alfa-2b|pegylated interferon alfa-2b
5771709|NCT00237484|ribavirin|ribavirin
5771710|NCT00237484|infliximab|infliximab
5771711|NCT00237484|chronic hepatitis C|chronic hepatitis c
5771712|NCT00237471|Acute Myocardial Infarction|acute myocardial infarction
5771713|NCT00237471|Hyperglycaemia|hyperglycaemia
5771714|NCT00237471|Insulin Infusion|insulin infusion
5771715|NCT00237419|Ankylosing spondylitis|ankylosing spondylitis
5771716|NCT00237419|Long-term therapy with infliximab|long-term therapy with infliximab
5771717|NCT00237419|Radiographic progression|radiographic progression
5771718|NCT00237406|IVR, methadone|ivr, methadone
5771719|NCT00237406|methadone maintenance|methadone maintenance
5771720|NCT00237393|PTSD|ptsd
5771721|NCT00237393|Posttraumatic stress disorder|posttraumatic stress disorder
5771722|NCT00237393|Treatment|treatment
5771723|NCT00237393|Quetiapine|quetiapine
5771724|NCT00237380|Cystic fibrosis|cystic fibrosis
5771725|NCT00237380|Nonsense mutation|nonsense mutation
5771726|NCT00237380|Premature stop codon|premature stop codon
5771727|NCT00237367|Gastroesophageal Reflux|gastroesophageal reflux
5771728|NCT00237367|GERD|gerd
5771729|NCT00237367|Nighttime heartburn|nighttime heartburn
5771730|NCT00237367|heartburn|heartburn
5771731|NCT00237367|esophagus|esophagus
5771732|NCT00237367|esophageal acid exposure|esophageal acid exposure
5771734|NCT00237367|Aciphex|aciphex
5771735|NCT00237367|Pariet|pariet
5771736|NCT00237367|rabeprazole|rabeprazole
5771737|NCT00237367|Protonix|protonix
5771738|NCT00237367|pantoprazole|pantoprazole
5771739|NCT00237354|Recurrent soft tissue breast carcinoma|recurrent soft tissue breast carcinoma
5771740|NCT00237341|chronic low back pain|chronic low back pain
5771742|NCT00237341|fentanyl|fentanyl
5771743|NCT00237328|Heparin resistance|heparin resistance
5771744|NCT00237328|Blood clotting|blood clotting
5771745|NCT00237328|Heart surgery|heart surgery
5771746|NCT00237328|Cardiopulmonary bypass|cardiopulmonary bypass
5771747|NCT00237315|Urea|urea
5771748|NCT00237315|Inherited metabolic disorders|inherited metabolic disorders
5771749|NCT00237302|pediatric migraine|pediatric migraine
5771750|NCT00237302|migraine headache|migraine headache
5771751|NCT00237302|migraine prophylaxis|migraine prophylaxis
5771752|NCT00237302|migraine prevention|migraine prevention
5771753|NCT00237302|migraine|migraine
5771754|NCT00237289|Manic depression|manic depression
5771755|NCT00237289|Mania|mania
5771756|NCT00237289|Depression|depression
5771757|NCT00237289|Bipolar disorder|bipolar disorder
5771758|NCT00237289|Psychosis|psychosis
5771759|NCT00237276|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, DALM, adenoma, video|colonoscopy, chromoendoscopy, autoflurescence, narrow band imaging, high definition endoscopy, colorectal cancer, colitis, polyp, dalm, adenoma, video
5771760|NCT00237263|Parkinson's disease, end-of -dose wearing-off, entacapone|parkinson's disease, end-of -dose wearing-off, entacapone
5771761|NCT00237250|Pre-diabetes|pre-diabetes
5771762|NCT00237250|vildagliptin|vildagliptin
5771764|NCT00237237|Type 2 diabetes|type 2 diabetes
5771765|NCT00237237|vildagliptin|vildagliptin
5771766|NCT00237224|Breast Cancer, ER and/or PgR positive, Letrozole|breast cancer, er and/or pgr positive, letrozole
5771767|NCT00237211|Aromatase inhibitor|aromatase inhibitor
5798851|NCT00110838|ICD|icd
5771768|NCT00237211|letrozole|letrozole
5771769|NCT00237211|breast cancer|breast cancer
5771770|NCT00237198|Aromatase inhibitor|aromatase inhibitor
5771771|NCT00237198|letrozole|letrozole
5771772|NCT00237198|breast cancer|breast cancer
5771773|NCT00237185|GIST|gist
5771774|NCT00237185|c-kit|c-kit
5771775|NCT00237185|imatinib mesylate|imatinib mesylate
5771776|NCT00237172|GIST|gist
5771777|NCT00237172|Imatinib|imatinib
5771778|NCT00237172|STI571|sti571
5771779|NCT00237172|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5771780|NCT00237159|Prostate cancer|prostate cancer
5771781|NCT00237159|Bone metastasis|bone metastasis
5771782|NCT00237159|Skeletal related event|skeletal related event
5771783|NCT00237146|Prostate cancer|prostate cancer
5771784|NCT00237146|Zoledronic acid|zoledronic acid
5771785|NCT00237146|Bone metastasis|bone metastasis
5771786|NCT00237133|Breast cancer,|breast cancer,
5771787|NCT00237133|Letrozole,|letrozole,
5771788|NCT00237133|Hormonal receptors|hormonal receptors
5771789|NCT00237120|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5771790|NCT00237120|Imatinib|imatinib
5771791|NCT00237120|CML|cml
5771792|NCT00237107|Cytoreduction Surgical Procedures|cytoreduction surgical procedures
5771793|NCT00237107|Curretage|curretage
5771794|NCT00237107|Photochemotherapy|photochemotherapy
5771795|NCT00237094|Diabetes|diabetes
5771796|NCT00237094|Self Management|self management
5771797|NCT00237094|Interdisciplinary team|interdisciplinary team
5771798|NCT00237081|Interstitial Cystitis|interstitial cystitis
5771799|NCT00237081|Painful Bladder Syndrome|painful bladder syndrome
5771800|NCT00237081|Genetics|genetics
5771801|NCT00237081|Risk factors|risk factors
5771802|NCT00237081|Family history|family history
5771803|NCT00237068|Gastroesophageal Reflux|gastroesophageal reflux
5771804|NCT00237055|Children|children
5771805|NCT00237055|Crohn's disease|crohn's disease
5771806|NCT00237055|Inflammatory bowel disease|inflammatory bowel disease
5771807|NCT00237055|Infectious agents|infectious agents
5771809|NCT00237042|Temporomandibular Disorders|temporomandibular disorders
5771810|NCT00237042|TMJ Disorders|tmj disorders
5771811|NCT00237003|women|women
5771812|NCT00237003|incarceration|incarceration
5771813|NCT00237003|alcohol use|alcohol use
5771814|NCT00237003|motivational interviewing|motivational interviewing
5771815|NCT00236990|prostatitis|prostatitis
5771816|NCT00236990|Elmiron|elmiron
5771817|NCT00236990|pentosan polysulfate sodium|pentosan polysulfate sodium
5771818|NCT00236977|CKD|ckd
5771819|NCT00236977|iron|iron
5771820|NCT00236977|anemia|anemia
5771821|NCT00236964|Anemia|anemia
5771822|NCT00236964|Chronic Kidney Disease|chronic kidney disease
5771823|NCT00236951|Anemia|anemia
5771824|NCT00236951|Cancer|cancer
5771825|NCT00236951|Chemotherapy|chemotherapy
5771826|NCT00236938|iron|iron
5771827|NCT00236938|peritoneal dialysis|peritoneal dialysis
5771828|NCT00236938|anemia|anemia
5771829|NCT00236925|Fibromyalgia|fibromyalgia
5771830|NCT00236925|Cortisol|cortisol
5771831|NCT00236925|Hydrocortisone|hydrocortisone
5771832|NCT00236925|Stress|stress
5771833|NCT00236912|complicated appendicitis|complicated appendicitis
5789319|NCT00148915|bone|bone
5771834|NCT00236912|antibiotics|antibiotics
5771835|NCT00236912|appendicitis|appendicitis
5771836|NCT00236912|infection|infection
5771837|NCT00236886|Epilepsy|epilepsy
5771838|NCT00236886|Partial Epilepsy|partial epilepsy
5771839|NCT00236886|Secondary Generalized Epilepsy|secondary generalized epilepsy
5771840|NCT00236886|Primary Generalized Epilepsy|primary generalized epilepsy
5771841|NCT00236886|Tonic-Clonic Seizures|tonic-clonic seizures
5771842|NCT00236886|Topiramate|topiramate
5771843|NCT00236886|Weight Loss|weight loss
5771844|NCT00236873|topiramate|topiramate
5771845|NCT00236873|epilepsy|epilepsy
5771846|NCT00236873|partial epilepsies|partial epilepsies
5771847|NCT00236873|partial epilepsy|partial epilepsy
5771848|NCT00236873|seizures|seizures
5771849|NCT00236873|epileptic seizures|epileptic seizures
5771850|NCT00236873|partial seizure disorder|partial seizure disorder
5771851|NCT00236873|brain diseases|brain diseases
5771852|NCT00236860|partial seizure disorder|partial seizure disorder
5771853|NCT00236860|brain diseases|brain diseases
5771854|NCT00236860|topiramate|topiramate
5771855|NCT00236860|epilepsy|epilepsy
5771856|NCT00236860|partial epilepsies|partial epilepsies
5771857|NCT00236860|partial epilepsy|partial epilepsy
5771858|NCT00236860|seizures|seizures
5771859|NCT00236860|epileptic seizures|epileptic seizures
5771860|NCT00236847|topiramate|topiramate
5771861|NCT00236847|epilepsy|epilepsy
5771862|NCT00236847|partial epilepsy|partial epilepsy
5771863|NCT00236847|seizures|seizures
5771864|NCT00236847|epileptic seizures|epileptic seizures
5771865|NCT00236847|partial seizure disorder|partial seizure disorder
5771866|NCT00236847|brain diseases|brain diseases
5771867|NCT00236834|respiratory tract diseases|respiratory tract diseases
5771868|NCT00236834|levofloxacin|levofloxacin
5771869|NCT00236834|pneumonia|pneumonia
5862951|NCT00001452|Pituitary Adenoma|pituitary adenoma
5771870|NCT00236834|quinolones, hospital-acquired pneumonia|quinolones, hospital-acquired pneumonia
5771871|NCT00236834|lung diseases|lung diseases
5771872|NCT00236821|respiratory tract diseases|respiratory tract diseases
5771873|NCT00236821|pneumonia|pneumonia
5771874|NCT00236821|levofloxacin|levofloxacin
5771875|NCT00236821|community-acquired pneumonia|community-acquired pneumonia
5771876|NCT00236821|lung diseases|lung diseases
5771877|NCT00236821|quinolones|quinolones
5771878|NCT00236808|quinolones, ciprofloxacin|quinolones, ciprofloxacin
5771879|NCT00236808|levofloxacin|levofloxacin
5771880|NCT00236808|chronic bacterial prostatitis|chronic bacterial prostatitis
5771881|NCT00236808|inflammation|inflammation
5771882|NCT00236808|chronic prostatitis|chronic prostatitis
5771883|NCT00236808|prostatitis|prostatitis
5771884|NCT00236808|prostate|prostate
5771885|NCT00236808|antibiotic|antibiotic
5771886|NCT00236795|contraception|contraception
5771887|NCT00236795|hormonal contraception|hormonal contraception
5771888|NCT00236795|oral contraception|oral contraception
5771889|NCT00236795|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception|steroid, ethinyl estradiol, horgestimate, levonorgestrel contraception
5771890|NCT00236795|transdermal.|transdermal.
5771891|NCT00236782|contraception|contraception
5771892|NCT00236782|hormonal contraception|hormonal contraception
5771893|NCT00236782|oral contraception|oral contraception
5771894|NCT00236782|steroid, ethinyl estradiol, progestin contraception|steroid, ethinyl estradiol, progestin contraception
5771895|NCT00236782|transdermal.|transdermal.
5771896|NCT00236769|contraception|contraception
5771897|NCT00236769|transdermal contraception|transdermal contraception
5771898|NCT00236769|hormonal, steroidal contraception|hormonal, steroidal contraception
5771899|NCT00236769|ethinyl estradiol|ethinyl estradiol
5771900|NCT00236769|progesterone|progesterone
5771901|NCT00236756|Epilepsy|epilepsy
5771902|NCT00236756|Seizures|seizures
5771903|NCT00236756|Topiramate|topiramate
5771904|NCT00236756|Prophylaxis|prophylaxis
5767227|NCT00255307|cold|cold
5771905|NCT00236756|Antiepileptic|antiepileptic
5771906|NCT00236756|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5771907|NCT00236756|Seizures, tonic|seizures, tonic
5771908|NCT00236743|topiramate|topiramate
5771909|NCT00236743|epilepsy|epilepsy
5771910|NCT00236743|partial epilepsies|partial epilepsies
5771911|NCT00236743|partial epilepsy|partial epilepsy
5771912|NCT00236743|seizures|seizures
5771913|NCT00236743|epileptic seizures|epileptic seizures
5771914|NCT00236743|partial seizure disorder|partial seizure disorder
5771915|NCT00236743|children|children
5771916|NCT00236743|pediatric|pediatric
5771917|NCT00236730|topiramate|topiramate
5771919|NCT00236730|partial epilepsies|partial epilepsies
5771920|NCT00236730|partial epilepsy|partial epilepsy
5771921|NCT00236730|seizures|seizures
5771922|NCT00236730|epileptic seizures|epileptic seizures
5771923|NCT00236730|partial seizure disorder|partial seizure disorder
5771924|NCT00236730|brain diseases|brain diseases
5771925|NCT00236717|Epilepsy|epilepsy
5771926|NCT00236717|Seizures|seizures
5771927|NCT00236717|Topiramate|topiramate
5771928|NCT00236717|Prophylaxis|prophylaxis
5771929|NCT00236717|Antiepileptic|antiepileptic
5771930|NCT00236704|Epilepsy|epilepsy
5771931|NCT00236704|Seizures|seizures
5771932|NCT00236704|Topiramate|topiramate
5771933|NCT00236704|Prophylaxis|prophylaxis
5771934|NCT00236704|Antiepileptic|antiepileptic
5771935|NCT00236704|Tonic-clonic seizures|tonic-clonic seizures
5771936|NCT00236704|Grand mal seizures|grand mal seizures
5771938|NCT00236691|epilepsy|epilepsy
5771942|NCT00236691|epileptic seizures|epileptic seizures
5771943|NCT00236691|partial seizure disorder|partial seizure disorder
5771944|NCT00236691|brain diseases|brain diseases
5771946|NCT00236678|Rheumatoid arthritis|rheumatoid arthritis
5771947|NCT00236678|Hemoglobin level|hemoglobin level
5771949|NCT00236665|Essential Hypertension|essential hypertension
5771950|NCT00236665|Mild Hypertension|mild hypertension
5771951|NCT00236665|Moderate Hypertension|moderate hypertension
5771952|NCT00236665|High Blood Pressure|high blood pressure
5771953|NCT00236652|Maxillary Sinusitis|maxillary sinusitis
5771954|NCT00236652|Infection|infection
5771955|NCT00236639|Obesity|obesity
5771956|NCT00236639|Hypertension|hypertension
5771957|NCT00236639|Hyperlipidemia|hyperlipidemia
5771958|NCT00236639|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5771959|NCT00236639|Body Mass Index|body mass index
5771960|NCT00236626|Type 2 Diabetes|type 2 diabetes
5771961|NCT00236626|Obesity|obesity
5771962|NCT00236626|Insulin Resistance|insulin resistance
5771963|NCT00236626|Body Mass Index|body mass index
5771964|NCT00236626|Hypertension|hypertension
5771965|NCT00236626|Hyperlipidemia|hyperlipidemia
5771966|NCT00236626|Sulfonylurea|sulfonylurea
5771967|NCT00236626|Topiramate|topiramate
5771968|NCT00236626|Adult-Onset Diabetes Mellitus|adult-onset diabetes mellitus
5771969|NCT00236626|Metabolic Syndrome|metabolic syndrome
5771970|NCT00236613|Obesity|obesity
5771971|NCT00236613|Hypertension|hypertension
5771972|NCT00236613|Hyperlipidemia|hyperlipidemia
5771973|NCT00236613|Body Mass Index|body mass index
5771974|NCT00236600|Obesity|obesity
5771975|NCT00236600|Hypertension|hypertension
5862952|NCT00001452|PPNAD|ppnad
5771976|NCT00236600|Hyperlipidemia|hyperlipidemia
5771977|NCT00236600|Type 2 Diabetes|type 2 diabetes
5771978|NCT00236600|Life style modification|life style modification
5771979|NCT00236587|Schizophrenia|schizophrenia
5771980|NCT00236587|Intramuscular injection|intramuscular injection
5771981|NCT00236587|Antipsychotic agents|antipsychotic agents
5771982|NCT00236587|Long-acting risperidone|long-acting risperidone
5771983|NCT00236574|Dementia|dementia
5771984|NCT00236574|Alzheimer disease|alzheimer disease
5771985|NCT00236574|Mild cognitive impairment|mild cognitive impairment
5771986|NCT00236574|Galantamine hydrobromide|galantamine hydrobromide
5771987|NCT00236574|Memory disorder|memory disorder
5771988|NCT00236561|Migraine|migraine
5771989|NCT00236561|Common Migraine|common migraine
5771990|NCT00236561|Classic Migraine|classic migraine
5771991|NCT00236561|Headache|headache
5771992|NCT00236561|Topiramate|topiramate
5771993|NCT00236561|Propranolol|propranolol
5771994|NCT00236561|Prophylaxis|prophylaxis
5771995|NCT00236561|Prevention|prevention
5771996|NCT00236548|Schizophrenia|schizophrenia
5771997|NCT00236548|schizoaffective disorder|schizoaffective disorder
5771998|NCT00236548|patient compliance|patient compliance
5771999|NCT00236548|long-acting risperidone|long-acting risperidone
5772000|NCT00236548|intramuscular injection|intramuscular injection
5772001|NCT00236548|Treatment Guidebook|treatment guidebook
5772002|NCT00236535|musculoskeletal|musculoskeletal
5772003|NCT00236535|Pain|pain
5772004|NCT00236535|sprained ankle|sprained ankle
5772005|NCT00236535|ligament|ligament
5772006|NCT00236535|sprain|sprain
5772007|NCT00236535|ankle|ankle
5772008|NCT00236522|sinus infection|sinus infection
5772009|NCT00236522|acute bacterial sinusitis|acute bacterial sinusitis
5772010|NCT00236522|sinusitis|sinusitis
5772011|NCT00236522|bacterial sinus infection|bacterial sinus infection
5772012|NCT00236509|Migraine|migraine
5772013|NCT00236509|Common Migraine|common migraine
5772015|NCT00236509|Headache|headache
5772016|NCT00236509|Topiramate|topiramate
5772017|NCT00236509|Prophylaxis|prophylaxis
5772018|NCT00236496|tremor|tremor
5772019|NCT00236496|essential tremor|essential tremor
5772020|NCT00236483|Oral Surgery|oral surgery
5772021|NCT00236483|Analgesics|analgesics
5772022|NCT00236483|Postoperative Pain|postoperative pain
5772023|NCT00236483|dental|dental
5772124|NCT00236210|Lifestyle Modification|lifestyle modification
5772024|NCT00236470|Disruptive behavior disorder|disruptive behavior disorder
5772025|NCT00236470|risperidone|risperidone
5772026|NCT00236470|antipsychotropic agents|antipsychotropic agents
5772027|NCT00236470|child|child
5772028|NCT00236470|adolescent|adolescent
5772029|NCT00236457|Schizophrenia|schizophrenia
5772030|NCT00236457|Intramuscular injection|intramuscular injection
5772031|NCT00236457|Antipsychotic agents|antipsychotic agents
5772032|NCT00236457|Long-acting risperidone|long-acting risperidone
5772033|NCT00236457|Olanzapine|olanzapine
5772034|NCT00236444|Child|child
5772035|NCT00236444|adolescent|adolescent
5772036|NCT00236444|disruptive behavior disorders|disruptive behavior disorders
5772037|NCT00236444|risperidone|risperidone
5772038|NCT00236444|antipsychotropic agents|antipsychotropic agents
5772039|NCT00236431|Mild cognitive impairment|mild cognitive impairment
5772040|NCT00236431|Galantamine hydrobromide|galantamine hydrobromide
5772041|NCT00236431|Memory disorders|memory disorders
5772042|NCT00236418|Epilepsy|epilepsy
5772043|NCT00236418|Seizures|seizures
5686383|NCT00552409|Renal|renal
5772044|NCT00236418|Topiramate|topiramate
5772046|NCT00236418|Antiepileptic|antiepileptic
5772047|NCT00236418|Tonic-clonic seizures|tonic-clonic seizures
5772048|NCT00236418|Grand mal seizures|grand mal seizures
5772049|NCT00236405|Anemia|anemia
5772050|NCT00236405|erythropoetin|erythropoetin
5772051|NCT00236405|quality-of-life outcomes|quality-of-life outcomes
5772052|NCT00236392|Gastroesophageal reflux|gastroesophageal reflux
5772053|NCT00236392|Heartburn|heartburn
5772054|NCT00236392|Rabeprazole|rabeprazole
5772055|NCT00236392|Anti-ulcer agents|anti-ulcer agents
5772056|NCT00236392|GERD|gerd
5772057|NCT00236392|Proton pump inhibitor|proton pump inhibitor
5772058|NCT00236392|GORD|gord
5772059|NCT00236392|Non-Erosive Reflux Disease|non-erosive reflux disease
5772060|NCT00236392|NERD|nerd
5772061|NCT00236379|schizophrenia|schizophrenia
5772062|NCT00236379|blood glucose|blood glucose
5772063|NCT00236379|glucose metabolism|glucose metabolism
5772064|NCT00236379|diabetes mellitus|diabetes mellitus
5772065|NCT00236379|risperidone|risperidone
5772066|NCT00236379|olanzapine|olanzapine
5772067|NCT00236366|Fentanyl|fentanyl
5772068|NCT00236366|opioid analgesics|opioid analgesics
5772069|NCT00236366|osteoarthritis|osteoarthritis
5772070|NCT00236366|arthritis|arthritis
5772071|NCT00236366|transdermal administration|transdermal administration
5772072|NCT00236353|schizophrenia|schizophrenia
5772073|NCT00236353|schizoaffective disorder|schizoaffective disorder
5772074|NCT00236353|long-acting risperidone|long-acting risperidone
5772075|NCT00236353|intramuscular injection|intramuscular injection
5772076|NCT00236340|Amniodrainage|amniodrainage
5772077|NCT00236340|Pregnancy|pregnancy
5772078|NCT00236340|Amniocentesis|amniocentesis
5772079|NCT00236327|Fentanyl|fentanyl
5772080|NCT00236327|Analgesia|analgesia
5772081|NCT00236327|Pain|pain
5772082|NCT00236327|Cancer pain|cancer pain
5772083|NCT00236327|Opioid analgesia|opioid analgesia
5772084|NCT00236327|Transdermal fentanyl|transdermal fentanyl
5772085|NCT00236327|Patient-controlled analgesia|patient-controlled analgesia
5772086|NCT00236301|Hormone|hormone
5772087|NCT00236301|Menopause|menopause
5772088|NCT00236301|Inflammation|inflammation
5772089|NCT00236301|Dose effects|dose effects
5772090|NCT00236301|Apoptosis|apoptosis
5772091|NCT00236288|Cancer treatment and tobacco abuse|cancer treatment and tobacco abuse
5772092|NCT00236275|Comparison of imaging modalities|comparison of imaging modalities
5772093|NCT00236275|predict the effectiveness of neoadjuvant chemotherapy|predict the effectiveness of neoadjuvant chemotherapy
5772094|NCT00236262|SDRA|sdra
5772095|NCT00236262|Distress|distress
5772096|NCT00236262|Expiratory|expiratory
5772097|NCT00236262|Pressure|pressure
5772098|NCT00236262|Ventilatory|ventilatory
5772099|NCT00236249|Double blind method|double blind method
5772100|NCT00236249|Prospective study|prospective study
5772101|NCT00236249|Lidocaine/administration and dosage/therapeutic use|lidocaine/administration and dosage/therapeutic use
5772102|NCT00236249|Anaesthetics local/administration and dosage|anaesthetics local/administration and dosage
5772103|NCT00236249|Opioids/administration and dosage|opioids/administration and dosage
5772104|NCT00236249|Pain, postoperative|pain, postoperative
5772105|NCT00236249|Perioperative care|perioperative care
5772106|NCT00236249|Postoperative care|postoperative care
5772107|NCT00236249|Analgesia, Patient-controlled|analgesia, patient-controlled
5772108|NCT00236249|Length of stay|length of stay
5772109|NCT00236249|Survival analysis|survival analysis
5772110|NCT00236249|Patient satisfaction|patient satisfaction
5772111|NCT00236249|Surgery|surgery
5772112|NCT00236249|Middle age|middle age
5772114|NCT00236249|Aged|aged
5772115|NCT00236223|Primary hip replacement|primary hip replacement
5772116|NCT00236223|Gabapentin|gabapentin
5772117|NCT00236223|Dexamethasone|dexamethasone
5772118|NCT00236223|Ketamine|ketamine
5772119|NCT00236223|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
5772120|NCT00236210|Vascular Intervention Program|vascular intervention program
5772121|NCT00236210|Vascular Disease|vascular disease
5772122|NCT00236210|Coronary Artery Disease|coronary artery disease
5772125|NCT00236210|Modifiable Risk Factors|modifiable risk factors
5772126|NCT00236197|Heartburn|heartburn
5772127|NCT00236197|Rabeprazole|rabeprazole
5772128|NCT00236171|topical therapy|topical therapy
5772129|NCT00236171|Psoriasis Plaque Test|psoriasis plaque test
5772131|NCT00236145|Break through pain|break through pain
5772132|NCT00236145|breakthrough pain|breakthrough pain
5772133|NCT00236093|Sickle Cell|sickle cell
5772134|NCT00236041|Breakthrough Pain|breakthrough pain
5772135|NCT00236041|Cancer|cancer
5772136|NCT00236041|Sickle Cell|sickle cell
5772137|NCT00236041|Severe Burns|severe burns
5772138|NCT00236041|Children|children
5772139|NCT00236041|Adolescents|adolescents
5772140|NCT00236041|Analgesia|analgesia
5772141|NCT00236041|Sickle Cell Disease|sickle cell disease
5772142|NCT00236041|Non-Cancer|non-cancer
5772143|NCT00236028|Early Rheumatoid Arthritis|early rheumatoid arthritis
5772144|NCT00235989|Relapsing multiple sclerosis|relapsing multiple sclerosis
5772145|NCT00235989|interferon beta 1b|interferon beta 1b
5772146|NCT00235989|Betaferon|betaferon
5772123|NCT00236210|Diabetes|diabetes
5772147|NCT00235989|Betaseron|betaseron
5772148|NCT00235976|Neuromuscular Blocking Agent|neuromuscular blocking agent
5772149|NCT00235976|Anesthesia|anesthesia
5772150|NCT00235976|Succinylcholine|succinylcholine
5772151|NCT00235976|Tracheal Intubation|tracheal intubation
5772152|NCT00235976|Adjunct for tracheal intubation|adjunct for tracheal intubation
5772153|NCT00235950|Coronary Heart Disease|coronary heart disease
5772154|NCT00235950|Percutaeous Coronary Intervention (PCI)|percutaeous coronary intervention (pci)
5772155|NCT00235937|Premenopausal|premenopausal
5772156|NCT00235937|Advanced Breast Cancer|advanced breast cancer
5772157|NCT00235937|Metastatic Breast Cancer|metastatic breast cancer
5772158|NCT00235924|menopause|menopause
5772159|NCT00235924|isoflavone|isoflavone
5772160|NCT00235924|endometrial safety|endometrial safety
5772161|NCT00235924|breast innocuity assessment|breast innocuity assessment
5772162|NCT00235924|hot flushes|hot flushes
5772163|NCT00235885|Psoriatic Arthritis|psoriatic arthritis
5772164|NCT00235885|adalimumab|adalimumab
5772165|NCT00235872|Rheumatoid arthritis|rheumatoid arthritis
5772166|NCT00235859|Rheumatoid Arthritis|rheumatoid arthritis
5772167|NCT00235859|adalimumab|adalimumab
5772168|NCT00235846|Endoscopic vein harvesting|endoscopic vein harvesting
5772169|NCT00235846|Saphenous vein|saphenous vein
5772170|NCT00235833|Rheumatoid Arthritis|rheumatoid arthritis
5772171|NCT00235820|Psoriasis|psoriasis
5772172|NCT00235820|adalimumab|adalimumab
5772173|NCT00235807|Audiology|audiology
5772174|NCT00235807|Rehabilitation|rehabilitation
5772175|NCT00235807|Tinnitus|tinnitus
5772176|NCT00235781|Kidney Transplantation|kidney transplantation
5772177|NCT00235781|Antilymphocyte Serum|antilymphocyte serum
5772178|NCT00235781|Induction|induction
5772179|NCT00235781|Graft Rejection|graft rejection
5772180|NCT00235768|Ecstasy|ecstasy
5772181|NCT00235768|MDMA|mdma
5772182|NCT00235768|Cognition|cognition
5772183|NCT00235768|Brain function|brain function
5772184|NCT00235768|Neuroimaging|neuroimaging
5772185|NCT00235755|Partial Seizures|partial seizures
5772186|NCT00235755|Complex Partial Seizures|complex partial seizures
5772187|NCT00235755|Epilepsy|epilepsy
5772188|NCT00235755|Potassium Channels|potassium channels
5772189|NCT00235755|Anticonvulsant|anticonvulsant
5772190|NCT00235729|Opiate addiction|opiate addiction
5772191|NCT00235729|Opiate dependence|opiate dependence
5772192|NCT00235729|Withdrawal symptoms|withdrawal symptoms
5772193|NCT00235716|Alzheimer's Disease|alzheimer's disease
5772194|NCT00235716|clinical trial|clinical trial
5772195|NCT00235716|randomized controlled trial|randomized controlled trial
5772196|NCT00235716|alpha-tocopherol|alpha-tocopherol
5772197|NCT00235716|vitamin E|vitamin e
5772198|NCT00235716|Namenda|namenda
5772199|NCT00235716|memantine|memantine
5772200|NCT00235677|Endoscopic antireflux treatment|endoscopic antireflux treatment
5772201|NCT00235677|GERD|gerd
5772202|NCT00235677|Sham-controlled|sham-controlled
5772203|NCT00235677|Endocinch|endocinch
5772204|NCT00235664|liver transplant recipients|liver transplant recipients
5772205|NCT00235664|intestinal transplant recipients|intestinal transplant recipients
5772206|NCT00235664|multivisceral transplant recipients|multivisceral transplant recipients
5772207|NCT00235651|Lung transplant recipient|lung transplant recipient
5772208|NCT00235625|Alternative Medicine|alternative medicine
5772209|NCT00235625|Psoriasis|psoriasis
5772210|NCT00235625|Turmeric|turmeric
5772211|NCT00235625|Curcumin|curcumin
5772212|NCT00235625|Dermatology|dermatology
5772213|NCT00235599|Growth|growth
5772214|NCT00235599|Hormone|hormone
5772215|NCT00235599|Deficiency|deficiency
5767551|NCT00253760|redox|redox
5772216|NCT00235586|vitamin D deficiency postmenopausal women|vitamin d deficiency postmenopausal women
5772217|NCT00235573|Vitamin B12 absorption|vitamin b12 absorption
5772218|NCT00235573|Holo-transcobalamin|holo-transcobalamin
5772219|NCT00235560|AML|aml
5772220|NCT00235560|Rapamycin|rapamycin
5772221|NCT00235560|Elderly|elderly
5772222|NCT00235560|Elderly patients not eligible for intensive chemotherapy|elderly patients not eligible for intensive chemotherapy
5772223|NCT00235547|abortion|abortion
5772224|NCT00235547|randomized|randomized
5772225|NCT00235547|contraception|contraception
5772226|NCT00235547|pregnancy|pregnancy
5772227|NCT00235547|compliance|compliance
5772228|NCT00235547|continuation|continuation
5772229|NCT00235547|contraceptive patch|contraceptive patch
5772230|NCT00235547|transdermal hormonal contraception|transdermal hormonal contraception
5772231|NCT00235534|abortion|abortion
5772232|NCT00235534|randomized|randomized
5772233|NCT00235534|contraception|contraception
5772234|NCT00235534|pregnancy|pregnancy
5772235|NCT00235534|compliance|compliance
5772236|NCT00235534|continuation|continuation
5772237|NCT00235534|oral contraceptive pills|oral contraceptive pills
5772238|NCT00235521|Pulmonary hypertension|pulmonary hypertension
5772239|NCT00235521|Cardiac Surgery|cardiac surgery
5772240|NCT00235521|Children|children
5772241|NCT00235521|Pediatric Patients|pediatric patients
5772242|NCT00235521|Iloprost|iloprost
5772243|NCT00235521|NO|no
5772244|NCT00235521|nitric oxide|nitric oxide
5771386|NCT00238355|infection|infection
5772245|NCT00235521|Pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old|pulmonary hypertension after cardiac surgery in pediatric patients, 0 - 2 years old
5772246|NCT00235508|Insomnia|insomnia
5772247|NCT00235508|Anxiety|anxiety
5772248|NCT00235508|Generalized Anxiety Disorder|generalized anxiety disorder
5772249|NCT00235495|stroke|stroke
5772250|NCT00235469|PAINFUL DISTAL DIABETIC NEUROPATHY|painful distal diabetic neuropathy
5772251|NCT00235456|oxygen|oxygen
5772252|NCT00235456|surgical complications|surgical complications
5772253|NCT00235456|colo-rectal resections|colo-rectal resections
5772254|NCT00235443|Painful Distal Diabetic Neuropathy|painful distal diabetic neuropathy
5772255|NCT00235417|Bone Marrow Transplantation|bone marrow transplantation
5772256|NCT00235404|Treatment of elderly.|treatment of elderly.
5772257|NCT00235404|Nursing home.|nursing home.
5772258|NCT00235404|Rehabilitation.|rehabilitation.
5772259|NCT00235404|Readmissions.|readmissions.
5772260|NCT00235391|Deferasirox|deferasirox
5772261|NCT00235391|Congenital Anemias|congenital anemias
5772262|NCT00235391|Anemias|anemias
5772263|NCT00235391|Red Blood Cell Disorders|red blood cell disorders
5772264|NCT00235391|Chronic Iron Overload|chronic iron overload
5772265|NCT00235391|Transfusional Iron Overload|transfusional iron overload
5772266|NCT00235391|Iron Chelators|iron chelators
5772267|NCT00235391|Oral Iron Chelators|oral iron chelators
5772268|NCT00235391|Thalassemia|thalassemia
5772269|NCT00235391|Sickle Cell Disease|sickle cell disease
5772270|NCT00235391|Diamond Blackfan Anemia|diamond blackfan anemia
5772271|NCT00235391|Myelofibrosis|myelofibrosis
5772272|NCT00235391|ICL670A|icl670a
5772273|NCT00235378|Lupus|lupus
5772275|NCT00235352|Schizphrenia|schizphrenia
5772276|NCT00235352|Cognition|cognition
5772277|NCT00235352|Negative Symptoms|negative symptoms
5772278|NCT00235339|Oxygen Consumption|oxygen consumption
5772279|NCT00235339|Exercise|exercise
5772280|NCT00235339|Rehabilitation|rehabilitation
5772281|NCT00235326|residents of Walkerton ontario at outbreak|residents of walkerton ontario at outbreak
5772282|NCT00235313|Nicotine replacement therapies|nicotine replacement therapies
5772283|NCT00235313|Smoking|smoking
5772284|NCT00235313|Smoking related diseases|smoking related diseases
5772285|NCT00235313|Saliva cotinine|saliva cotinine
5772286|NCT00235313|Dose adjustment|dose adjustment
5772287|NCT00235313|Smoker; patients with smoking related disease conditions|smoker; patients with smoking related disease conditions
5772288|NCT00235300|Anti-T cells antibodies|anti-t cells antibodies
5772289|NCT00235300|Cadaveric Donor Renal Transplantation|cadaveric donor renal transplantation
5772290|NCT00235300|Acute Renal Allograft Rejection|acute renal allograft rejection
5772291|NCT00235300|Induction Therapy|induction therapy
5772292|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5772293|NCT00235287|type 1 angiotensin receptor antagonists|type 1 angiotensin receptor antagonists
5772294|NCT00235287|blood pressure|blood pressure
5772295|NCT00235274|Schizophrenia|schizophrenia
5772296|NCT00235274|Secretin|secretin
5772297|NCT00235261|Total hip replacement|total hip replacement
5772298|NCT00235261|Pregablin|pregablin
5772299|NCT00235261|Dexamethasone|dexamethasone
5772300|NCT00235261|Multimodal postoperative analgesia.|multimodal postoperative analgesia.
5772301|NCT00235248|TIA/Brain infarct|tia/brain infarct
5772302|NCT00235248|and plaque>4mm in the aortic arch|and plaque>4mm in the aortic arch
5772303|NCT00235248|Or peripheral embolism|or peripheral embolism
5772304|NCT00235248|and plaque>4 mm in the thoracic aorta|and plaque>4 mm in the thoracic aorta
5772305|NCT00235222|Stavudine|stavudine
5772306|NCT00235222|Reduced dose of stavudine|reduced dose of stavudine
5772307|NCT00235222|Viral load|viral load
5772308|NCT00235222|Peripheral neuropathy|peripheral neuropathy
5772309|NCT00235222|Treatment Experienced|treatment experienced
5772310|NCT00235183|plasma|plasma
5772312|NCT00235183|liver transplantation|liver transplantation
5772313|NCT00235131|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5772314|NCT00235105|early ankylosing spondylitis|early ankylosing spondylitis
5772315|NCT00235105|spondyloarthritis|spondyloarthritis
5772316|NCT00235105|trial|trial
5772317|NCT00235105|adalimumab|adalimumab
5772318|NCT00235079|Pericarditis|pericarditis
5772319|NCT00235079|Recurrence|recurrence
5772320|NCT00235079|Therapeutics|therapeutics
5772321|NCT00235079|Prevention|prevention
5772322|NCT00235079|Colchicine|colchicine
5772323|NCT00235053|asthma|asthma
5772324|NCT00235053|candidiasis, oral|candidiasis, oral
5772325|NCT00235053|voice disorders|voice disorders
5772326|NCT00235040|Upper Respiratory Infections|upper respiratory infections
5772327|NCT00235040|Respiratory Tract Infections|respiratory tract infections
5772328|NCT00235040|Tree Number C01.539.739|tree number c01.539.739
5772329|NCT00235040|Tree Number C08.730|tree number c08.730
5772330|NCT00235040|Unique ID D012141|unique id d012141
5772331|NCT00235014|hypertension|hypertension
5772332|NCT00235014|diabetes|diabetes
5772333|NCT00235014|trandolapril|trandolapril
5772334|NCT00235014|verapamil|verapamil
5772335|NCT00235014|albuminuria|albuminuria
5772336|NCT00235001|Hypertension|hypertension
5772338|NCT00234988|Sibutramine|sibutramine
5772339|NCT00234988|Obesity|obesity
5781378|NCT00188617|IRESSA|iressa
5772340|NCT00234975|Lopinavir|lopinavir
5772341|NCT00234975|Ritonavir|ritonavir
5772342|NCT00234975|Phase 4|phase 4
5763204|NCT00270985|CRP|crp
5772344|NCT00234962|HIV Infection|hiv infection
5772348|NCT00234962|Treatment Experienced|treatment experienced
5772349|NCT00234962|Treatment Naive|treatment naive
5772350|NCT00234949|Cefdinir|cefdinir
5772351|NCT00234949|Cephalexin|cephalexin
5772352|NCT00234949|Skin Infection|skin infection
5772353|NCT00234936|rheumatoid arthritis|rheumatoid arthritis
5772354|NCT00234936|adalimumab|adalimumab
5772355|NCT00234936|quality of life|quality of life
5772356|NCT00234923|HIV Infection|hiv infection
5772358|NCT00234923|Lopinavir|lopinavir
5772359|NCT00234923|Ritonavir|ritonavir
5772360|NCT00234923|Treatment Naive|treatment naive
5772361|NCT00234910|Lopinavir|lopinavir
5772362|NCT00234910|Ritonavir|ritonavir
5772363|NCT00234910|Kaletra|kaletra
5772364|NCT00234910|Tenofovir|tenofovir
5772365|NCT00234910|HIV infection|hiv infection
5772366|NCT00234910|Treatment Naive|treatment naive
5772367|NCT00234897|adalimumab|adalimumab
5772368|NCT00234897|rheumatoid arthritis|rheumatoid arthritis
5772369|NCT00234884|rheumatoid arthritis|rheumatoid arthritis
5772370|NCT00234884|adalimumab|adalimumab
5772371|NCT00234871|Hypertension|hypertension
5772372|NCT00234871|Diabetes|diabetes
5772373|NCT00234871|Proteinuria|proteinuria
5772374|NCT00234871|Tarka|tarka
5772375|NCT00234871|Lotrel|lotrel
5772376|NCT00234858|Hypertension|hypertension
5772377|NCT00234858|Metabolic Syndrome|metabolic syndrome
5772378|NCT00234858|Tarka|tarka
5772379|NCT00234858|Hyzaar|hyzaar
5772380|NCT00234832|Obesity|obesity
5772381|NCT00234832|Sibutramine|sibutramine
5772382|NCT00234819|Menopause|menopause
5772383|NCT00234806|telehealth|telehealth
5772384|NCT00234806|telemedicine|telemedicine
5772385|NCT00234793|childhood cancer|childhood cancer
5772386|NCT00234793|intervention|intervention
5772387|NCT00234793|maternal coping|maternal coping
5772388|NCT00234793|problem solving skills|problem solving skills
5772389|NCT00234793|anxiety|anxiety
5772390|NCT00234793|cope|cope
5772391|NCT00234793|problem solving|problem solving
5772392|NCT00234780|acute home care|acute home care
5772393|NCT00234767|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5772394|NCT00234767|ARDS|ards
5772395|NCT00234767|Acute Lung Injury|acute lung injury
5772396|NCT00234767|ALI|ali
5772397|NCT00234767|Cost-effectiveness|cost-effectiveness
5772398|NCT00234767|Pharmacoeconomics|pharmacoeconomics
5772399|NCT00234767|Long-term follow-up|long-term follow-up
5772400|NCT00234754|Incontinence|incontinence
5772401|NCT00234754|Surgery|surgery
5772402|NCT00234754|Trans-vaginal tape|trans-vaginal tape
5772403|NCT00234754|Trans-obturator tape|trans-obturator tape
5772404|NCT00234728|psoriasis|psoriasis
5772405|NCT00234728|hydrogel|hydrogel
5772406|NCT00234728|occlusive dressing|occlusive dressing
5772407|NCT00234728|occlusion|occlusion
5772408|NCT00234728|hydrocortisone|hydrocortisone
5772409|NCT00234728|tacrolimus|tacrolimus
5772410|NCT00234728|Protopic|protopic
5772411|NCT00234728|triamcinolone|triamcinolone
5772412|NCT00234728|calcipotriene|calcipotriene
5772413|NCT00234728|Dovonex|dovonex
5772414|NCT00234728|halobetasol|halobetasol
5772415|NCT00234728|Ultravate|ultravate
5772416|NCT00234715|Breast Cancer|breast cancer
5772417|NCT00234715|Breast Cancer Risk|breast cancer risk
5772418|NCT00234715|Breast Cancer Risk Assessment|breast cancer risk assessment
5772419|NCT00234715|Psychosocial|psychosocial
5772420|NCT00234715|Acceptance|acceptance
5772421|NCT00234676|Parkinson disease|parkinson disease
5772422|NCT00234676|women|women
5772423|NCT00234676|postmenopause|postmenopause
5772424|NCT00234676|estrogen replacement therapy|estrogen replacement therapy
5772425|NCT00234676|clinical trials|clinical trials
5772426|NCT00234663|Cystic fibrosis|cystic fibrosis
5772427|NCT00234663|Nonsense mutation|nonsense mutation
5772428|NCT00234663|Premature stop codon|premature stop codon
5772429|NCT00234650|position change|position change
5772430|NCT00234650|adenoma|adenoma
5772431|NCT00234650|colonoscopy|colonoscopy
5772432|NCT00234637|Alzheimer's disease,|alzheimer's disease,
5772433|NCT00234637|switch,|switch,
5772434|NCT00234637|rivastigmine,|rivastigmine,
5772435|NCT00234637|memantine|memantine
5772436|NCT00234598|Pneumonia|pneumonia
5772437|NCT00234598|Dental Health|dental health
5772438|NCT00234598|Critical Care|critical care
5772439|NCT00234559|Angiogenesis|angiogenesis
5772440|NCT00234559|Post surgical dehisced wounds of the lower extremity|post surgical dehisced wounds of the lower extremity
5772441|NCT00234533|growth|growth
5772442|NCT00234533|child development|child development
5772443|NCT00234533|growth hormone|growth hormone
5772444|NCT00234533|inadequate growth hormone secretion|inadequate growth hormone secretion
5772445|NCT00234533|growth failure|growth failure
5772446|NCT00234468|Locally Advanced Non Small Cell Lung Cancer (Stage IIIA and IIIB)|locally advanced non small cell lung cancer (stage iiia and iiib)
5772447|NCT00234442|Non symptomatic brain metastases|non symptomatic brain metastases
5772448|NCT00234442|Iressa|iressa
5772449|NCT00234429|Colorectal carcinoma advanced disease|colorectal carcinoma advanced disease
5772450|NCT00234416|Pancreatic Cancer|pancreatic cancer
5772451|NCT00234416|EGF-R|egf-r
5772452|NCT00234403|Advanced breast cancer|advanced breast cancer
5772453|NCT00234403|Metastatic breast cancer|metastatic breast cancer
5772454|NCT00234403|ER positive breast cancer|er positive breast cancer
5772455|NCT00234403|PR positive breast cancer|pr positive breast cancer
5772457|NCT00234364|Pergolide|pergolide
5772458|NCT00234364|Ergotamine derivates|ergotamine derivates
5772459|NCT00234364|Valvular heart disease|valvular heart disease
5772460|NCT00234338|Children|children
5772461|NCT00234338|Vaccine|vaccine
5772462|NCT00234338|Prevenar|prevenar
5772463|NCT00234312|Depressive Disorders|depressive disorders
5772464|NCT00234299|Cancer|cancer
5772465|NCT00234299|Prostate|prostate
5772466|NCT00234299|Preventive Therapy|preventive therapy
5772467|NCT00234286|Palliative Care|palliative care
5772468|NCT00234286|Terminal Care|terminal care
5772469|NCT00234286|Hospice Care|hospice care
5772470|NCT00234286|Patient Care Planning|patient care planning
5772471|NCT00234286|Nursing Care Plans|nursing care plans
5772472|NCT00234286|Quality of Health Care|quality of health care
5772473|NCT00234286|Inpatients|inpatients
5772474|NCT00234286|Professional education|professional education
5772475|NCT00234286|Resuscitation orders|resuscitation orders
5772476|NCT00234286|Pastoral Care|pastoral care
5772477|NCT00234273|Adapted Physical Activity|adapted physical activity
5772478|NCT00234273|Quality of life|quality of life
5772479|NCT00234273|cardiovascular risk|cardiovascular risk
5772480|NCT00234273|teaching|teaching
5772481|NCT00234273|Directly Observed Therapy|directly observed therapy
5772482|NCT00234273|Physical activity|physical activity
5772483|NCT00234260|Genetics|genetics
5772484|NCT00234234|Biologics|biologics
5772485|NCT00234208|Complicated parapneumonic effusion|complicated parapneumonic effusion
5772486|NCT00234208|Pleural empyema|pleural empyema
5782435|NCT00182598|opioid|opioid
5772487|NCT00234208|Intervention|intervention
5772488|NCT00234208|Medical thoracoscopy|medical thoracoscopy
5772489|NCT00234208|Chest tube drainage|chest tube drainage
5772490|NCT00234195|Breast Cancer|breast cancer
5772491|NCT00234195|Major Depressive Disorder|major depressive disorder
5772492|NCT00234182|liver cancer|liver cancer
5772493|NCT00234182|hepatectomy|hepatectomy
5772494|NCT00234182|survival|survival
5772495|NCT00234182|recurrence|recurrence
5772496|NCT00234169|Multiple Myeloma|multiple myeloma
5772497|NCT00234169|Lymphoma|lymphoma
5772498|NCT00234156|Fructose|fructose
5772499|NCT00234156|Lipogenesis|lipogenesis
5772500|NCT00234156|Triglycerides|triglycerides
5772501|NCT00234156|Dialysis|dialysis
5772502|NCT00234143|MDS|mds
5772503|NCT00234143|EPO|epo
5772504|NCT00234143|G-CSF|g-csf
5772505|NCT00234143|REGiM|regim
5772506|NCT00234130|Dialysis|dialysis
5772507|NCT00234130|Cytokines|cytokines
5772508|NCT00234130|Triglycerides|triglycerides
5772509|NCT00234130|Insulin|insulin
5772510|NCT00234104|OPC-41061|opc-41061
5772511|NCT00234104|Tolvaptan|tolvaptan
5772512|NCT00234104|Heart Failure|heart failure
5772513|NCT00234104|Edema|edema
5772514|NCT00234104|Extracellular volume expansion|extracellular volume expansion
5772515|NCT00234091|Treatment Naive|treatment naive
5772516|NCT00234091|Treatment Initiation|treatment initiation
5772517|NCT00234091|Infant|infant
5772518|NCT00234091|Preschool Child|preschool child
5772519|NCT00234091|Child|child
5772520|NCT00234091|Zidovudine|zidovudine
5772521|NCT00234091|AZT|azt
5772522|NCT00234091|Retrovir|retrovir
5772523|NCT00234091|3TC|3tc
5772524|NCT00234091|Lamivudine|lamivudine
5772525|NCT00234091|Epivir|epivir
5772526|NCT00234091|Nevirapine|nevirapine
5772527|NCT00234091|NVP|nvp
5772528|NCT00234091|Viramune|viramune
5772529|NCT00234091|Efavirenz|efavirenz
5772530|NCT00234091|EFV|efv
5772531|NCT00234091|Sustiva|sustiva
5772532|NCT00234091|Lopinavir/Ritonavir|lopinavir/ritonavir
5772533|NCT00234091|LPV/r|lpv/r
5772534|NCT00234091|Kaletra|kaletra
5772535|NCT00234091|Nelfinavir|nelfinavir
5772536|NCT00234091|NFV|nfv
5772537|NCT00234091|Viracept|viracept
5772538|NCT00234091|ABC|abc
5772539|NCT00234091|Abacavir|abacavir
5772540|NCT00234091|Ziagen|ziagen
5772541|NCT00234078|OPC-12759|opc-12759
5772542|NCT00234078|Dry eye syndromes|dry eye syndromes
5772543|NCT00234052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5772544|NCT00234052|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5772545|NCT00234052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5772546|NCT00234052|adenocarcinoma of the lung|adenocarcinoma of the lung
5772547|NCT00234052|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5772548|NCT00234052|large cell lung cancer|large cell lung cancer
5772549|NCT00234039|recurrent bladder cancer|recurrent bladder cancer
5772550|NCT00234039|stage 0 bladder cancer|stage 0 bladder cancer
5772551|NCT00234039|stage I bladder cancer|stage i bladder cancer
5790061|NCT00145925|MI|mi
5772552|NCT00234039|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5686384|NCT00552409|Cardiovascular|cardiovascular
5686385|NCT00552409|Clinical trial|clinical trial
5686386|NCT00552409|Placebo|placebo
5686387|NCT00552396|multiple myeloma|multiple myeloma
5686388|NCT00552396|Anti-KIR (1-7F9)|anti-kir (1-7f9)
5686389|NCT00552383|Preterm Infant|preterm infant
5686390|NCT00552383|Behaviour|behaviour
5686391|NCT00552383|Developmental Care|developmental care
5772553|NCT00234026|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5772554|NCT00234026|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5772555|NCT00234026|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5772649|NCT00233376|Antibiotic resistance|antibiotic resistance
5772556|NCT00234026|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5772557|NCT00234026|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5772558|NCT00234026|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5772559|NCT00234000|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5772560|NCT00234000|refractory anemia with excess blasts|refractory anemia with excess blasts
5772561|NCT00234000|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5772562|NCT00234000|refractory anemia|refractory anemia
5772563|NCT00234000|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5772564|NCT00234000|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5772565|NCT00234000|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5772566|NCT00234000|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5772567|NCT00233987|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5772568|NCT00233974|stage IIIA breast cancer|stage iiia breast cancer
5772569|NCT00233974|stage IIIB breast cancer|stage iiib breast cancer
5772570|NCT00233974|stage IIIC breast cancer|stage iiic breast cancer
5772571|NCT00233974|stage IV breast cancer|stage iv breast cancer
5772572|NCT00233961|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5772573|NCT00233922|orbit|orbit
5772574|NCT00233922|orbital|orbital
5772575|NCT00233922|trauma|trauma
5772576|NCT00233922|fractures|fractures
5772577|NCT00233922|facial|facial
5772578|NCT00233909|Leukemia, Myeloid|leukemia, myeloid
5772579|NCT00233909|Relapse|relapse
5772580|NCT00233909|Chemotherapy|chemotherapy
5772581|NCT00233909|Zosuquidar|zosuquidar
5772582|NCT00233909|gemtuzumab ozogamicin (GO)|gemtuzumab ozogamicin (go)
5772583|NCT00233896|Hematopoietic cell transplant|hematopoietic cell transplant
5772584|NCT00233896|Acute graft-vs.-host disease|acute graft-vs.-host disease
5772585|NCT00233896|Gastrointestinal tract|gastrointestinal tract
5772586|NCT00233896|Randomized trial|randomized trial
5772587|NCT00233896|Topical corticosteroid|topical corticosteroid
5772588|NCT00233896|Beclomethasone dipropionate|beclomethasone dipropionate
5772589|NCT00233896|Prednisone|prednisone
5772590|NCT00233896|Survival|survival
5772591|NCT00233857|Acute pain|acute pain
5772592|NCT00233857|postoperative pain|postoperative pain
5772593|NCT00233857|auricular acupuncture|auricular acupuncture
5772594|NCT00233844|Acute pain|acute pain
5772595|NCT00233844|pain on venipuncture|pain on venipuncture
5772596|NCT00233844|"cough-trick"|"cough-trick"
5772597|NCT00233844|distraction|distraction
5772598|NCT00233831|Postoperative pain|postoperative pain
5772599|NCT00233831|analgesia|analgesia
5772600|NCT00233831|total knee arthroplasty|total knee arthroplasty
5772601|NCT00233753|Intracranial|intracranial
5772602|NCT00233753|Wide-neck|wide-neck
5772603|NCT00233753|Saccular|saccular
5772604|NCT00233753|Aneurysms|aneurysms
5772605|NCT00233727|cervical cancer|cervical cancer
5772606|NCT00233727|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5772607|NCT00233727|prevention|prevention
5772608|NCT00233727|cryotherapy|cryotherapy
5772609|NCT00233727|HPV testing|hpv testing
5772610|NCT00233727|cytology|cytology
5772612|NCT00233701|Hydrocephalus|hydrocephalus
5772613|NCT00233636|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5772614|NCT00233636|Inoperable locally advanced Squamous Cell Carcinoma of Head and Neck|inoperable locally advanced squamous cell carcinoma of head and neck
5772615|NCT00233623|Metastatic Colorectal Cancer|metastatic colorectal cancer
5772616|NCT00233610|Casodex monotherapy|casodex monotherapy
5772617|NCT00233597|anemia|anemia
5772618|NCT00233597|iron|iron
5772619|NCT00233584|Children of asthmatic mothers|children of asthmatic mothers
5772620|NCT00233545|cutaneous|cutaneous
5772621|NCT00233545|leishmaniasis|leishmaniasis
5772622|NCT00233545|drug|drug
5772623|NCT00233545|miltefosine|miltefosine
5772624|NCT00233532|Hypertension|hypertension
5772625|NCT00233532|Trandolapril|trandolapril
5772626|NCT00233506|CpG 7909|cpg 7909
5772628|NCT00233493|dermatophytes|dermatophytes
5772629|NCT00233480|Randomized Controlled Trial|randomized controlled trial
5772630|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5772631|NCT00233480|Sympathetic Nervous System|sympathetic nervous system
5772632|NCT00233480|Ventricular Remodeling|ventricular remodeling
5772633|NCT00233480|Chemokines|chemokines
5772634|NCT00233467|antipsychotics|antipsychotics
5772635|NCT00233467|PTSD|ptsd
5772636|NCT00233467|posttraumatic stress disorder|posttraumatic stress disorder
5772637|NCT00233441|Atrial Fibrillation|atrial fibrillation
5772638|NCT00233441|Atrial Flutter|atrial flutter
5772639|NCT00233441|Arrhythmia|arrhythmia
5772640|NCT00233441|Anti-Arrhythmia Agents|anti-arrhythmia agents
5772641|NCT00233428|Healthy volunteers|healthy volunteers
5772642|NCT00233402|Bladder Cancer|bladder cancer
5772643|NCT00233402|Hexvix|hexvix
5772644|NCT00233402|Fluorescence|fluorescence
5772645|NCT00233402|Cystoscopy|cystoscopy
5772646|NCT00233376|Decision support system|decision support system
5772647|NCT00233376|Causal probabilistic network|causal probabilistic network
5772648|NCT00233376|Antibiotics|antibiotics
5773048|NCT00231335|depression|depression
5772650|NCT00233376|Community-acquired infections|community-acquired infections
5772651|NCT00233376|Cross-infections|cross-infections
5772652|NCT00233350|Neuronavigation|neuronavigation
5772653|NCT00233350|Ultrasound|ultrasound
5772654|NCT00233350|Brain tumour surgery|brain tumour surgery
5772655|NCT00233350|Biopsy|biopsy
5772656|NCT00233350|Histopathology|histopathology
5772657|NCT00233350|Intraoperative imaging|intraoperative imaging
5772658|NCT00233350|3D ultrasound imaging|3d ultrasound imaging
5772659|NCT00233337|Malaria, non-immune travelers|malaria, non-immune travelers
5772660|NCT00233324|NICHD Neonatal Research Network|nichd neonatal research network
5772661|NCT00233324|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5772662|NCT00233324|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5772663|NCT00233324|Prematurity|prematurity
5772664|NCT00233324|Mechanical ventilation|mechanical ventilation
5772665|NCT00233324|Surfactant|surfactant
5772666|NCT00233324|Intubation|intubation
5772667|NCT00233324|Neurodevelopmental impairment|neurodevelopmental impairment
5772668|NCT00233324|Pulse oximetry|pulse oximetry
5772669|NCT00233324|Oxygen saturation|oxygen saturation
5772670|NCT00233324|Positive-Pressure Respiration|positive-pressure respiration
5772671|NCT00233311|high fat diet|high fat diet
5772672|NCT00233311|inflammation|inflammation
5772673|NCT00233311|inflammatory markers|inflammatory markers
5772674|NCT00233311|C-reactive protein|c-reactive protein
5772675|NCT00233311|Aging|aging
5772676|NCT00233298|Hypoglycemia|hypoglycemia
5772677|NCT00233298|Blood Sugar|blood sugar
5772678|NCT00233298|Blood Glucose Level|blood glucose level
5772679|NCT00233298|Insulin Sensitivity|insulin sensitivity
5772680|NCT00233298|Metabolism|metabolism
5772681|NCT00233298|Type 2 Diabetes|type 2 diabetes
5772682|NCT00233298|Healthy|healthy
5772683|NCT00233272|Frailty|frailty
5772684|NCT00233272|Disease Processes|disease processes
5772685|NCT00233155|Analgesics|analgesics
5772686|NCT00233155|Capsaicin|capsaicin
5772687|NCT00233155|Neuropathic pain|neuropathic pain
5772688|NCT00233155|Neuropathy|neuropathy
5772689|NCT00233155|PHN|phn
5772690|NCT00233155|Shingles|shingles
5772691|NCT00233142|Diabetes|diabetes
5772692|NCT00233142|Emotions|emotions
5772693|NCT00233142|Blood glucose|blood glucose
5772694|NCT00233142|Expressive Writing|expressive writing
5772695|NCT00233129|Day treatment|day treatment
5772696|NCT00233129|executive function|executive function
5772697|NCT00233129|problem solving|problem solving
5772698|NCT00233129|attention|attention
5772699|NCT00233129|participation|participation
5772700|NCT00233129|TBI|tbi
5772701|NCT00233129|brain injury|brain injury
5772702|NCT00233129|traumatic brain injury|traumatic brain injury
5772703|NCT00233103|Sertraline|sertraline
5772704|NCT00233103|TBI|tbi
5772705|NCT00233103|depression|depression
5772706|NCT00233103|SSRI|ssri
5772707|NCT00233103|brain injury|brain injury
5772708|NCT00233090|Fatigue|fatigue
5772709|NCT00233090|TBI|tbi
5772710|NCT00233090|brain injury|brain injury
5772711|NCT00233090|Modafinil|modafinil
5772712|NCT00233090|traumatic brain injury|traumatic brain injury
5772713|NCT00233077|breast cancer|breast cancer
5772714|NCT00233077|adjuvant treatment|adjuvant treatment
5772715|NCT00233077|racial disparities|racial disparities
5772716|NCT00233051|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5772717|NCT00233051|Emphysema|emphysema
5772718|NCT00233051|Chronic Bronchitis|chronic bronchitis
5772719|NCT00233051|Inhaled Steroid|inhaled steroid
5772720|NCT00233051|Salmeterol|salmeterol
5772722|NCT00233038|Pancreatic adenoma|pancreatic adenoma
5772723|NCT00233038|Ethanol|ethanol
5772724|NCT00233038|Endoscopic ultrasound|endoscopic ultrasound
5772725|NCT00233038|Cyst ablation|cyst ablation
5772726|NCT00233012|Refractory partial-onset seizures|refractory partial-onset seizures
5772727|NCT00233012|Infants aged 1-24 months|infants aged 1-24 months
5772923|NCT00231829|Treatment|treatment
5772728|NCT00233012|Pharmacokinetics|pharmacokinetics
5772729|NCT00233012|Topiramate|topiramate
5772730|NCT00232999|Allergic asthma|allergic asthma
5772731|NCT00232999|Allergen challenge|allergen challenge
5686392|NCT00552383|NIDCAP|nidcap
5772732|NCT00232999|Bronchial hyperresponsiveness|bronchial hyperresponsiveness
5772733|NCT00232960|oral and oropharynx carcinoma|oral and oropharynx carcinoma
5772734|NCT00232960|surgery|surgery
5772735|NCT00232960|postoperative radiotherapy|postoperative radiotherapy
5772736|NCT00232960|molecular analysis|molecular analysis
5772737|NCT00232960|microsatellite instability|microsatellite instability
5772738|NCT00232947|vaccine|vaccine
5772739|NCT00232947|elderly|elderly
5790206|NCT00145275|bisphosphonate|bisphosphonate
5790207|NCT00145275|Low bone mass|low bone mass
5790208|NCT00145262|critical limb ischemia|critical limb ischemia
5772740|NCT00232947|immunogenicity|immunogenicity
5772741|NCT00232947|safety|safety
5772742|NCT00232934|Myeloma|myeloma
5772743|NCT00232934|Thalidomide|thalidomide
5772744|NCT00232934|Diagnosis|diagnosis
5772745|NCT00232934|Elderly patients|elderly patients
5772747|NCT00232882|Blood pressure|blood pressure
5772748|NCT00232882|Antihypertensive drugs|antihypertensive drugs
5772749|NCT00232882|Clinical Pharmacology|clinical pharmacology
5772750|NCT00232882|Autonomic nervous system|autonomic nervous system
5773049|NCT00231335|anxiety|anxiety
5772751|NCT00232882|Renin angiotensin system|renin angiotensin system
5772752|NCT00232882|Oxidative stress|oxidative stress
5772753|NCT00232882|Inflammatory markers|inflammatory markers
5772754|NCT00232843|Peripheral Artery Occlusive Disease|peripheral artery occlusive disease
5772755|NCT00232817|Postoperative pain|postoperative pain
5772756|NCT00232726|Malignant melanoma|malignant melanoma
5772757|NCT00232726|CP-4055|cp-4055
5772758|NCT00232726|Chemotherapy-naïve patients|chemotherapy-naïve patients
5772759|NCT00232726|Phase II|phase ii
5772760|NCT00232726|Chemotherapy-naive patients|chemotherapy-naive patients
5772761|NCT00232726|Metastatic malignant melanoma|metastatic malignant melanoma
5772762|NCT00232713|Birth Defects|birth defects
5772763|NCT00232713|Pregnancy|pregnancy
5772764|NCT00232713|Uterine Fibroids|uterine fibroids
5772765|NCT00232713|Fibroids|fibroids
5772766|NCT00232700|Major depressive disorder|major depressive disorder
5772767|NCT00232700|Repetitive transcranial magnetic stimulation|repetitive transcranial magnetic stimulation
5772768|NCT00232674|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5772769|NCT00232635|RSV|rsv
5772770|NCT00232635|HSCT|hsct
5772771|NCT00232635|HEMATOPOIETIC STEM CELL TRANSPL|hematopoietic stem cell transpl
5772772|NCT00232622|Prosthetic valve thrombosis|prosthetic valve thrombosis
5772773|NCT00232622|Fibrinolysis|fibrinolysis
5772774|NCT00232622|Streptokinase|streptokinase
5772775|NCT00232609|Wheelchair|wheelchair
5772776|NCT00232609|Exercise|exercise
5772777|NCT00232609|Cardiovascular Disease|cardiovascular disease
5772778|NCT00232596|Partial Seizures|partial seizures
5772779|NCT00232596|Anticonvulsant|anticonvulsant
5772780|NCT00232596|Complex Partial Seizures|complex partial seizures
5772781|NCT00232596|Potassium Channels|potassium channels
5772782|NCT00232596|Epilepsy|epilepsy
5772783|NCT00232583|TYpe 2 diabetes mellitus|type 2 diabetes mellitus
5772784|NCT00232583|Newly diagnosed|newly diagnosed
5772785|NCT00232583|Beta-cell function|beta-cell function
5772786|NCT00232570|sleep disturbance|sleep disturbance
5772787|NCT00232570|dementia|dementia
5772788|NCT00232557|Asthma|asthma
5772789|NCT00232557|Disease Management|disease management
5772790|NCT00232557|Telecommunications|telecommunications
5772791|NCT00232557|Health Services|health services
5772792|NCT00232557|Quality of Life|quality of life
5772793|NCT00232557|Patient Compliance|patient compliance
5772794|NCT00232544|sleep apnea, obstructive|sleep apnea, obstructive
5772795|NCT00232544|Quality of Life|quality of life
5772796|NCT00232544|Depression|depression
5772797|NCT00232544|Patient Compliance|patient compliance
5772798|NCT00232518|immune system|immune system
5772799|NCT00232518|infection|infection
5772800|NCT00232518|allergic rhinitis|allergic rhinitis
5772801|NCT00232505|recurrent breast cancer|recurrent breast cancer
5772802|NCT00232505|stage IV breast cancer|stage iv breast cancer
5772803|NCT00232492|Wisdom|wisdom
5772804|NCT00232492|Tooth|tooth
5772805|NCT00232492|Teeth|teeth
5772806|NCT00232492|Third|third
5772807|NCT00232492|Molar|molar
5772808|NCT00232466|Vertebroplasty|vertebroplasty
5772809|NCT00232466|Vertebral fracture|vertebral fracture
5772810|NCT00232466|Actonel|actonel
5772811|NCT00232466|Osteoporotic|osteoporotic
5772812|NCT00232466|vertebral|vertebral
5772813|NCT00232466|fractures|fractures
5772814|NCT00232427|Liver cirrhosis|liver cirrhosis
5772815|NCT00232427|Hemodynamics|hemodynamics
5772817|NCT00232414|bipolar|bipolar
5772818|NCT00232414|with acute depressive episode|with acute depressive episode
5772819|NCT00232401|urine|urine
5772820|NCT00232401|circadian rhythm|circadian rhythm
5772821|NCT00232388|Ejection Fraction <35%|ejection fraction <35%
5772822|NCT00232375|SPIDDM|spiddm
5772823|NCT00232375|LADA|lada
5772824|NCT00232375|GAD antibody|gad antibody
5772825|NCT00232375|Beta cell function|beta cell function
5772826|NCT00232375|Insulin|insulin
5772827|NCT00232349|schizophrenia|schizophrenia
5772828|NCT00232349|galantamine|galantamine
5773024|NCT00231452|age,|age,
5772829|NCT00232349|cholinesterase inhibitors|cholinesterase inhibitors
5772830|NCT00232349|quality of life|quality of life
5772831|NCT00232349|cognition|cognition
5772833|NCT00232336|drug|drug
5772834|NCT00232336|substance|substance
5772835|NCT00232336|abuse|abuse
5772836|NCT00232336|addiction|addiction
5772837|NCT00232336|dependence|dependence
5772838|NCT00232336|quetiapine|quetiapine
5772839|NCT00232336|antipsychotic|antipsychotic
5772840|NCT00232336|treatment|treatment
5772841|NCT00232323|intensive care|intensive care
5772842|NCT00232323|stress|stress
5772843|NCT00232323|education|education
5772844|NCT00232323|simulation|simulation
5772845|NCT00232310|Atrial Fibrillation|atrial fibrillation
5772846|NCT00232310|Atrial Flutter|atrial flutter
5772847|NCT00232310|Electric Countershock|electric countershock
5772848|NCT00232297|Tachycardia, Ventricular|tachycardia, ventricular
5772849|NCT00232297|Ventricular Fibrillation|ventricular fibrillation
5772850|NCT00232297|Defibrillators Implantable|defibrillators implantable
5772851|NCT00232297|Arrhythmia|arrhythmia
5772852|NCT00232297|Anti-arrhythmia agents|anti-arrhythmia agents
5772853|NCT00232258|NK1 Antagonist|nk1 antagonist
5772854|NCT00232258|Inflammatory Bowel Disease|inflammatory bowel disease
5772855|NCT00232258|Mesalamine|mesalamine
5772856|NCT00232232|Atrial mechanical stunning and|atrial mechanical stunning and
5772857|NCT00232232|atrial electrical remodeling|atrial electrical remodeling
5772858|NCT00232206|NSCLC|nsclc
5772859|NCT00232206|Lung|lung
5772860|NCT00232206|Cancer|cancer
5772861|NCT00232206|Metastatic|metastatic
5772862|NCT00232206|Neoadjuvant|neoadjuvant
5772863|NCT00232206|Stage IB Non-Small Cell Lung Cancer (NSCLC)|stage ib non-small cell lung cancer (nsclc)
5772864|NCT00232206|IIA Non-Small Cell Lung Cancer (NSCLC)|iia non-small cell lung cancer (nsclc)
5772865|NCT00232206|IIB Non-Small Cell Lung Cancer (NSCLC)|iib non-small cell lung cancer (nsclc)
5772866|NCT00232206|Some IIIA Non-Small Cell Lung Cancer (NSCLC)|some iiia non-small cell lung cancer (nsclc)
5772867|NCT00232193|Multiple Sclerosis|multiple sclerosis
5772868|NCT00232193|Interferon Beta 1-a|interferon beta 1-a
5772869|NCT00232193|Pulsed steroids|pulsed steroids
5772870|NCT00232180|Open-label|open-label
5772871|NCT00232180|single arm mortality/morbidity trial eplerenone chronic systolic heart failure|single arm mortality/morbidity trial eplerenone chronic systolic heart failure
5772872|NCT00232115|Perioral Dermatitis, pimecrolimus cream|perioral dermatitis, pimecrolimus cream
5772873|NCT00232102|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5772874|NCT00232089|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5772875|NCT00232076|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
5772876|NCT00232063|Atopic Dermatitis, Ciclosporin,|atopic dermatitis, ciclosporin,
5772877|NCT00232050|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
5772878|NCT00232037|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5772879|NCT00232024|Dyspepsia, gastrointestinal, tegaserod|dyspepsia, gastrointestinal, tegaserod
5772880|NCT00232011|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
5772881|NCT00231998|Atopic dermatitis, ASM981, pimecrolimus|atopic dermatitis, asm981, pimecrolimus
5772882|NCT00231985|Habit-reversal Therapy|habit-reversal therapy
5772883|NCT00231985|Behavior Therapy|behavior therapy
5772884|NCT00231985|Supportive Therapy|supportive therapy
5772887|NCT00231959|Depression, Treatment-Resistant|depression, treatment-resistant
5772888|NCT00231946|gonadotropins|gonadotropins
5772889|NCT00231946|hormone therapy|hormone therapy
5772890|NCT00231946|HRT|hrt
5772891|NCT00231946|Antigonadotropin|antigonadotropin
5772892|NCT00231946|Leuprolide|leuprolide
5772893|NCT00231933|Person-centered Care|person-centered care
5772894|NCT00231933|Recovery|recovery
5772895|NCT00231933|Disparities|disparities
5772896|NCT00231933|Culturally Responsive Care|culturally responsive care
5772897|NCT00231933|Psychosis|psychosis
5772898|NCT00231920|Influenza, Vaccine, Infants|influenza, vaccine, infants
5772899|NCT00231907|influenza, vaccine, TIV, LAIV, booster, children|influenza, vaccine, tiv, laiv, booster, children
5772900|NCT00231894|atypical antipsychotics|atypical antipsychotics
5772901|NCT00231894|hyperglycemia|hyperglycemia
5772902|NCT00231894|triglycerides|triglycerides
5772903|NCT00231894|HDL|hdl
5772904|NCT00231894|cholesterol|cholesterol
5772905|NCT00231894|insulin resistance|insulin resistance
5772906|NCT00231894|schizophrenia|schizophrenia
5772907|NCT00231894|verbal memory|verbal memory
5772908|NCT00231881|GORD – Oesophageal sensitivity- Oesophageal permeability|gord – oesophageal sensitivity- oesophageal permeability
5772909|NCT00231868|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5772911|NCT00231868|Radiation Therapy|radiation therapy
5772912|NCT00231868|Chemotherapy|chemotherapy
5772913|NCT00231855|Epithelial Ovarian Cancer|epithelial ovarian cancer
5772914|NCT00231855|Uterine Cancer|uterine cancer
5772915|NCT00231855|Prior Therapy|prior therapy
5772916|NCT00231855|Chemotherapy|chemotherapy
5772917|NCT00231855|Recurrence|recurrence
5772918|NCT00231842|Mixed Mesodermal Tumor|mixed mesodermal tumor
5772919|NCT00231842|MMT|mmt
5772920|NCT00231842|Uterine Cancer|uterine cancer
5772921|NCT00231842|Radiation Therapy|radiation therapy
5772922|NCT00231842|Chemotherapy|chemotherapy
5772924|NCT00231829|Uterine Papillary Serous Carcinoma|uterine papillary serous carcinoma
5772925|NCT00231829|Clear Cell Carcinoma|clear cell carcinoma
5772926|NCT00231829|COX-2 Inhibitors|cox-2 inhibitors
5772927|NCT00231816|Prevention of Herpes Zoster|prevention of herpes zoster
5772928|NCT00231764|Renal transplantation|renal transplantation
5790459|NCT00143728|HIV|hiv
5772929|NCT00231764|Immunosuppression|immunosuppression
5772930|NCT00231764|Daclizumab|daclizumab
5772932|NCT00231751|Hemophilia A|hemophilia a
5772933|NCT00231751|Inhibitors|inhibitors
5772934|NCT00231738|Eicosapentaenoic acid|eicosapentaenoic acid
5772935|NCT00231738|Coronary artery disease|coronary artery disease
5772936|NCT00231712|prospective analysis of immune function,|prospective analysis of immune function,
5772937|NCT00231712|spectratype|spectratype
5772938|NCT00231712|immunoscope|immunoscope
5772939|NCT00231712|TREC analysis|trec analysis
5772941|NCT00231699|Prevention of Hypothermia|prevention of hypothermia
5772942|NCT00231699|Pediatric Patient|pediatric patient
5772943|NCT00231699|Cotton|cotton
5772944|NCT00231699|Plastic wrap|plastic wrap
5772945|NCT00231686|Lung function test|lung function test
5772946|NCT00231686|Physical conditioning, human|physical conditioning, human
5773358|NCT00229879|children|children
5772947|NCT00231686|Physical fitness|physical fitness
5772948|NCT00231686|Quality of life|quality of life
5772949|NCT00231673|Diabetic peripheral polyneuropathy|diabetic peripheral polyneuropathy
5772950|NCT00231673|Electrophysiology|electrophysiology
5772951|NCT00231673|Nerve Conduction Study|nerve conduction study
5772952|NCT00231673|Neurological Examination|neurological examination
5772953|NCT00231673|Quantitative Sensory Testing|quantitative sensory testing
5772954|NCT00231673|Topiramate|topiramate
5772955|NCT00231660|Type 2 Diabetes|type 2 diabetes
5772956|NCT00231660|Obesity|obesity
5772957|NCT00231660|Metformin|metformin
5772958|NCT00231660|Hemoglobin A1c|hemoglobin a1c
5772959|NCT00231660|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5772960|NCT00231647|Obesity|obesity
5772961|NCT00231647|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5772962|NCT00231647|Metformin|metformin
5772963|NCT00231647|Diabetic Diet|diabetic diet
5772964|NCT00231647|Topiramate|topiramate
5772965|NCT00231647|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5772966|NCT00231634|Obesity|obesity
5772967|NCT00231634|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5772968|NCT00231634|HbA1c|hba1c
5772969|NCT00231634|Sulfonylurea|sulfonylurea
5772970|NCT00231634|Topiramate|topiramate
5772971|NCT00231634|Adult-Onset Diabetes Mellitus (AODM)|adult-onset diabetes mellitus (aodm)
5772972|NCT00231621|Obesity|obesity
5772973|NCT00231621|Dyslipidemia|dyslipidemia
5772974|NCT00231621|Hyperlipidemia|hyperlipidemia
5772975|NCT00231621|Triglyceride|triglyceride
5772976|NCT00231621|HDL|hdl
5772977|NCT00231621|LDL|ldl
5772978|NCT00231621|Diabetes|diabetes
5772979|NCT00231608|Obesity|obesity
5772980|NCT00231608|Abdominal Obesity|abdominal obesity
5772981|NCT00231608|Visceral Fat|visceral fat
5772982|NCT00231608|Subcutaneous Fat|subcutaneous fat
5772983|NCT00231608|Dislipidemia|dislipidemia
5772984|NCT00231608|Hypertension|hypertension
5772985|NCT00231608|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5772986|NCT00231595|Migraine|migraine
5772987|NCT00231595|Common Migraine|common migraine
5772988|NCT00231595|Classic Migraine|classic migraine
5772989|NCT00231595|Headache|headache
5772990|NCT00231595|Topiramate|topiramate
5772991|NCT00231595|Prophylaxis|prophylaxis
5772992|NCT00231595|Prevention|prevention
5772993|NCT00231582|High-dose with autologous germ-cell tumors|high-dose with autologous germ-cell tumors
5772994|NCT00231569|LDL-cholesterol|ldl-cholesterol
5772995|NCT00231569|apoB-100|apob-100
5772996|NCT00231569|apoB-48|apob-48
5772997|NCT00231556|Epilepsy|epilepsy
5772998|NCT00231556|Seizures|seizures
5772999|NCT00231556|Parital Epilepsies|parital epilepsies
5773000|NCT00231556|Generalized Epilepsy|generalized epilepsy
5773001|NCT00231556|Tonic-Clonic Epilepsy|tonic-clonic epilepsy
5773002|NCT00231556|Topiramate|topiramate
5773003|NCT00231530|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5773004|NCT00231530|Obesity|obesity
5773005|NCT00231530|Diabetic Diet|diabetic diet
5773006|NCT00231530|Hypertension|hypertension
5773007|NCT00231530|Hyperlipidemia|hyperlipidemia
5773008|NCT00231530|Adult-Onset Diabetes Mellitus(AODM)|adult-onset diabetes mellitus(aodm)
5773009|NCT00231504|Polymorphism P1|polymorphism p1
5773010|NCT00231504|Polymorphism P2|polymorphism p2
5773011|NCT00231504|FSH Receptor|fsh receptor
5773012|NCT00231504|Antral follicle count|antral follicle count
5773013|NCT00231504|FSH receptor polymorphism|fsh receptor polymorphism
5773014|NCT00231491|Overactive bladder|overactive bladder
5773015|NCT00231491|Urgency|urgency
5773016|NCT00231491|Urge incontinence|urge incontinence
5773017|NCT00231491|Botulinum toxin A|botulinum toxin a
5773018|NCT00231491|Quality of life|quality of life
5773019|NCT00231465|elderly|elderly
5773020|NCT00231465|malignant pleural effusion|malignant pleural effusion
5773021|NCT00231452|natural acquired immunity,|natural acquired immunity,
5773022|NCT00231452|clinical malaria,|clinical malaria,
5773023|NCT00231452|P. falciparum,|p. falciparum,
5773025|NCT00231452|exposure,|exposure,
5773026|NCT00231452|neonatal immunology,|neonatal immunology,
5773027|NCT00231452|infants|infants
5773028|NCT00231439|Post-polio syndrome|post-polio syndrome
5773029|NCT00231439|IvIg|ivig
5773030|NCT00231400|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5773031|NCT00231400|GSD-II|gsd-ii
5773032|NCT00231400|Pompe Disease|pompe disease
5773033|NCT00231400|Pompe Disease (late-onset)|pompe disease (late-onset)
5773034|NCT00231400|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5773035|NCT00231400|Glycogenosis II|glycogenosis ii
5773036|NCT00231387|diabetes rosiglitazone plaque|diabetes rosiglitazone plaque
5773037|NCT00231374|cerebrospinal fluid|cerebrospinal fluid
5773038|NCT00231374|pain in cervical spine|pain in cervical spine
5773039|NCT00231374|pain in lumbar spine|pain in lumbar spine
5773040|NCT00231374|myelogram|myelogram
5773041|NCT00231348|Social anxiety disorder|social anxiety disorder
5773042|NCT00231348|social phobia|social phobia
5773043|NCT00231348|positron emission tomography (PET|positron emission tomography (pet
5773044|NCT00231348|regional cerebral blood flow (rCBF)|regional cerebral blood flow (rcbf)
5773045|NCT00231348|nefazodone|nefazodone
5773046|NCT00231348|amygdala|amygdala
5773047|NCT00231335|schizophrenia|schizophrenia
5773050|NCT00231335|negative symptoms|negative symptoms
5773051|NCT00231322|Schistosoma haematobium|schistosoma haematobium
5773052|NCT00231322|haematuria|haematuria
5773053|NCT00231322|ultrasonography|ultrasonography
5773055|NCT00231322|Vesical polyps|vesical polyps
5773056|NCT00231309|G-CSF|g-csf
5773057|NCT00231309|Bone Marrow|bone marrow
5773058|NCT00231309|Hematologic malignancies|hematologic malignancies
5773059|NCT00231309|Non-malignancies|non-malignancies
5773060|NCT00231309|Matched sibling donor|matched sibling donor
5773061|NCT00231309|Allogeneic BMT|allogeneic bmt
5773062|NCT00231296|cryoablation|cryoablation
5773063|NCT00231296|atrial fibrillation|atrial fibrillation
5773064|NCT00231218|vitamin c|vitamin c
5773065|NCT00231218|echinacea|echinacea
5773066|NCT00231218|propolis|propolis
5773067|NCT00231218|upper respiratory tract infection|upper respiratory tract infection
5773068|NCT00231218|common cold|common cold
5773069|NCT00231218|gastroenteritis|gastroenteritis
5773070|NCT00231218|dietary supplement|dietary supplement
5773071|NCT00231218|herbal remedy|herbal remedy
5773072|NCT00231205|viability|viability
5773073|NCT00231205|myocardium|myocardium
5773074|NCT00231205|preejection velocity|preejection velocity
5773076|NCT00231205|echocardiography|echocardiography
5773077|NCT00231205|tissue Doppler|tissue doppler
5773078|NCT00231192|Diabetes|diabetes
5773079|NCT00231192|Adolescents|adolescents
5773080|NCT00231192|Cystic Fibrosis|cystic fibrosis
5681073|NCT00574821|Magnetocardiography (MCG)|magnetocardiography (mcg)
5773081|NCT00231192|Insulin|insulin
5773082|NCT00231192|Repaglinide|repaglinide
5773083|NCT00231179|child, preschool|child, preschool
5773084|NCT00231179|intelligence|intelligence
5773085|NCT00231179|environment|environment
5773086|NCT00231179|home visiting|home visiting
5773087|NCT00231166|dose-finding|dose-finding
5773088|NCT00231166|monoclonal antibody|monoclonal antibody
5773089|NCT00231166|Multiple Myeloma|multiple myeloma
5773090|NCT00231153|catheter site infection|catheter site infection
5773091|NCT00231153|catheter colonization|catheter colonization
5773092|NCT00231153|catheter related blood stream infection|catheter related blood stream infection
5773093|NCT00231153|patients with central venous catheters|patients with central venous catheters
5773094|NCT00231140|ALS, motor neuron disease|als, motor neuron disease
5773095|NCT00231127|COPD|copd
5773096|NCT00231127|Osteoporosis|osteoporosis
5773097|NCT00231127|Osteopenia|osteopenia
5773098|NCT00231127|Glucocorticoids|glucocorticoids
5773099|NCT00231127|GOLD|gold
5773100|NCT00231127|BODE|bode
5773101|NCT00231114|Asthma|asthma
5773102|NCT00231101|Smoking|smoking
5773103|NCT00231101|Schizophrenia|schizophrenia
5773104|NCT00231075|Epithelial ovary cancer F.I.G.O. stages III or IV|epithelial ovary cancer f.i.g.o. stages iii or iv
5773105|NCT00231075|70 years or older|70 years or older
5773106|NCT00231062|sinusitis|sinusitis
5773107|NCT00231062|rhinitis|rhinitis
5773108|NCT00231062|sinus surgery|sinus surgery
5773109|NCT00231062|maxillary|maxillary
5773110|NCT00231062|ethmoid|ethmoid
5773111|NCT00231062|sphenoid|sphenoid
5773112|NCT00231062|frontal|frontal
5773113|NCT00231062|FESS|fess
5773114|NCT00231062|sinuplasty|sinuplasty
5773115|NCT00231049|Genital Herpes|genital herpes
5773116|NCT00231049|HSV-2 Seropositive|hsv-2 seropositive
5773118|NCT00231023|Anterior Subtenon|anterior subtenon
5773119|NCT00231023|Posterior Peribulbar|posterior peribulbar
5773120|NCT00231023|Laser Photocoagulation|laser photocoagulation
5773121|NCT00231023|Diabetes|diabetes
5773122|NCT00231023|Diabetic Retinopathy|diabetic retinopathy
5773123|NCT00231023|Diabetic Macular Edema|diabetic macular edema
5773124|NCT00231023|DME|dme
5773125|NCT00231010|Retnitis Pigmentosa|retnitis pigmentosa
5773126|NCT00231010|Retinal Degeneration|retinal degeneration
5773127|NCT00231010|Retinitis Pigmentosa|retinitis pigmentosa
5773128|NCT00231010|RP|rp
5773129|NCT00231010|Usher Syndrome|usher syndrome
5773130|NCT00231010|USH|ush
5773131|NCT00231010|Bietti Crystalline Dystrophy|bietti crystalline dystrophy
5773132|NCT00231010|BCD|bcd
5773133|NCT00230997|Galantamine|galantamine
5773134|NCT00230997|Dementia with Lewy Bodies|dementia with lewy bodies
5773136|NCT00230984|Chronic Respiratory Failure|chronic respiratory failure
5773137|NCT00230984|Pulmonary Rehabilitation|pulmonary rehabilitation
5773138|NCT00230984|Nutritional Depletion|nutritional depletion
5773139|NCT00230984|Home|home
5773140|NCT00230984|COPD|copd
5773141|NCT00230984|Oral Dietary Supplements|oral dietary supplements
5773142|NCT00230984|Therapeutic Education|therapeutic education
5773143|NCT00230984|Androgens|androgens
5773144|NCT00230984|Exacerbation|exacerbation
5763991|NCT00268073|cardiac|cardiac
5773146|NCT00230971|Intra-Abdominal Infections|intra-abdominal infections
5773147|NCT00230971|Abscess|abscess
5773148|NCT00230958|Viramidine|viramidine
5773149|NCT00230958|Ribavirin|ribavirin
5773150|NCT00230958|Valeant|valeant
5773151|NCT00230958|Hepatitis C|hepatitis c
5773152|NCT00230958|Pegylated interferon alfa-2b|pegylated interferon alfa-2b
5773153|NCT00230932|Veterans|veterans
5773154|NCT00230932|Pain|pain
5773155|NCT00230932|Palliative Care|palliative care
5773156|NCT00230932|Cardiology|cardiology
5773157|NCT00230932|Reproducibility of Results|reproducibility of results
5773158|NCT00230932|Health Personnel|health personnel
5773159|NCT00230932|Heart Failure, Congestive|heart failure, congestive
5773160|NCT00230919|Obesity,|obesity,
5773161|NCT00230919|weight loss,|weight loss,
5773162|NCT00230919|diet counseling|diet counseling
5773163|NCT00230919|low-glycemic load|low-glycemic load
5773164|NCT00230893|Antipsychotics|antipsychotics
5773165|NCT00230893|PTSD|ptsd
5773166|NCT00230893|Post Traumatic Stress Disorder|post traumatic stress disorder
5773167|NCT00230893|monotherapy|monotherapy
5773168|NCT00230893|adjunct therapy|adjunct therapy
5773169|NCT00230880|Contraception behavior|contraception behavior
5773170|NCT00230880|Condoms|condoms
5773171|NCT00230880|Unsafe sex|unsafe sex
5773172|NCT00230880|Pregnancy unwanted|pregnancy unwanted
5773173|NCT00230880|Adolescent pregnancy|adolescent pregnancy
5773174|NCT00230880|Condom use|condom use
5773175|NCT00230880|Unprotected sex|unprotected sex
5773176|NCT00230880|Unintended pregnancy|unintended pregnancy
5773177|NCT00230867|herpes labialis|herpes labialis
5773178|NCT00230867|cold sore|cold sore
5773179|NCT00230867|acyclovir|acyclovir
5773180|NCT00230867|iontophoresis|iontophoresis
5773181|NCT00230867|topical|topical
5773182|NCT00230854|hepatitis C|hepatitis c
5773183|NCT00230854|genotype 1|genotype 1
5783149|NCT00179322|HV|hv
5773184|NCT00230854|non-responders|non-responders
5773185|NCT00230854|viral hepatitis|viral hepatitis
5773186|NCT00230841|croup|croup
5773187|NCT00230841|humidity therapy|humidity therapy
5773188|NCT00230841|pediatrics|pediatrics
5773189|NCT00230815|Oligoanovulatory infertility|oligoanovulatory infertility
5773190|NCT00230815|Follitropin alfa|follitropin alfa
5773191|NCT00230815|Pen device|pen device
5773192|NCT00230815|Gonal-f®|gonal-f®
5773193|NCT00230815|Recombinant Human Choriogonadotropin (r-hCG)|recombinant human choriogonadotropin (r-hcg)
5773194|NCT00230815|Ovidrel®|ovidrel®
5773195|NCT00230802|pregnancy|pregnancy
5773196|NCT00230802|hypothyroidism|hypothyroidism
5773197|NCT00230802|levothyroxine|levothyroxine
5773198|NCT00230750|influenza, elderly, vaccine, H5N1, parent protocol|influenza, elderly, vaccine, h5n1, parent protocol
5773199|NCT00230737|Aged|aged
5773200|NCT00230737|Sleep|sleep
5773201|NCT00230737|Insomnia|insomnia
5773202|NCT00230737|Melatonin|melatonin
5773203|NCT00230737|Neurobehavioral Manifestations|neurobehavioral manifestations
5773204|NCT00230737|Circadian Rhythms|circadian rhythms
5773205|NCT00230737|Human|human
5773206|NCT00230737|Polysomnography|polysomnography
5773207|NCT00230737|Elderly|elderly
5773208|NCT00230724|Exercise maintenance|exercise maintenance
5773209|NCT00230711|Physical activity|physical activity
5773210|NCT00230711|Cancer follow-up care|cancer follow-up care
5773211|NCT00230698|Epilepsy|epilepsy
5773212|NCT00230698|Partial Epilepsies|partial epilepsies
5773213|NCT00230698|Seizures|seizures
5773214|NCT00230698|Topiramate|topiramate
5773215|NCT00230685|Pulmonary arteriovenous malformations|pulmonary arteriovenous malformations
5773216|NCT00230646|cancer recovery|cancer recovery
5773217|NCT00230646|physical activity|physical activity
5773218|NCT00230633|Telangiectasia|telangiectasia
5773219|NCT00230607|alpha Galactosidase A|alpha galactosidase a
5773222|NCT00230607|Fabry|fabry
5773223|NCT00230607|GL3|gl3
5773224|NCT00230607|Fabrazyme|fabrazyme
5773225|NCT00230607|Lysosomal Storage Disorder|lysosomal storage disorder
5773226|NCT00230607|Enzyme Replacement Therapy (ERT)|enzyme replacement therapy (ert)
5773227|NCT00230581|IBS-d, IBS|ibs-d, ibs
5773228|NCT00230568|Mild to Moderate Alzheimer's Disease|mild to moderate alzheimer's disease
5773229|NCT00230568|Hispanic|hispanic
5773230|NCT00230568|Latino|latino
5773231|NCT00230568|Spanish-speaking|spanish-speaking
5773232|NCT00230555|child, preschool|child, preschool
5773233|NCT00230555|environment|environment
5773234|NCT00230555|intelligence|intelligence
5773235|NCT00230542|platinum-sensitive recurrence|platinum-sensitive recurrence
5773236|NCT00230542|carboplatin|carboplatin
5773237|NCT00230542|pemetrexed|pemetrexed
5773238|NCT00230529|Plaque-type Psoriasis|plaque-type psoriasis
5773239|NCT00230529|infliximab|infliximab
5773240|NCT00230529|Remicade|remicade
5773241|NCT00230529|biologics|biologics
5773242|NCT00230516|N/A this study is being conducted with healthy volunteers|n/a this study is being conducted with healthy volunteers
5773243|NCT00230503|Hepatitis B, Chronic|hepatitis b, chronic
5773244|NCT00230503|Hepatitis B Virus|hepatitis b virus
5773245|NCT00230503|Pradefovir Mesylate|pradefovir mesylate
5773246|NCT00230503|Adefovir Dipivoxyl|adefovir dipivoxyl
5773248|NCT00230490|Hepatitis B Virus|hepatitis b virus
5773249|NCT00230490|Pradefovir Mesylate|pradefovir mesylate
5773250|NCT00230490|Adefovir Dipivoxyl|adefovir dipivoxyl
5773251|NCT00230477|Hepatitis B|hepatitis b
5773252|NCT00230464|diabetes|diabetes
5773253|NCT00230464|rate of appearance of glucose|rate of appearance of glucose
5773254|NCT00230464|insulin secretion|insulin secretion
5773255|NCT00230464|glucagon|glucagon
5773256|NCT00230425|Alcohol Abuse|alcohol abuse
5773257|NCT00230425|Anxiety Disorders|anxiety disorders
5773258|NCT00230425|Mood Disorders|mood disorders
5773259|NCT00230412|Kidney Failure, Acute|kidney failure, acute
5773260|NCT00230412|Acute Renal Failure|acute renal failure
5773261|NCT00230412|Kidney Failure|kidney failure
5773262|NCT00230412|Heat-Shock Proteins|heat-shock proteins
5773263|NCT00230412|Children|children
5773264|NCT00230373|Localized scleroderma|localized scleroderma
5773265|NCT00230360|constipation|constipation
5773266|NCT00230360|fecal incontinence|fecal incontinence
5773267|NCT00230360|diagnosis|diagnosis
5773268|NCT00230360|children|children
5773269|NCT00230308|Head and Neck Cancer|head and neck cancer
5773270|NCT00230243|Aspergillosis|aspergillosis
5773271|NCT00230243|CandidiasisMucormycosis|candidiasismucormycosis
5773272|NCT00230243|FusariosisCryptococcosis|fusariosiscryptococcosis
5773273|NCT00230243|Endemic Fungal infections|endemic fungal infections
5773274|NCT00230243|Phaeohyphomycosis|phaeohyphomycosis
5773275|NCT00230217|Relapse|relapse
5773276|NCT00230217|Refracturing|refracturing
5773277|NCT00230217|Leukemia|leukemia
5773278|NCT00230217|Lymphoma|lymphoma
5773279|NCT00230217|Solid Tumor|solid tumor
5773280|NCT00230204|Multiple sclerosis|multiple sclerosis
5773281|NCT00230204|Antibodies|antibodies
5773282|NCT00230204|Serum|serum
5773283|NCT00230204|Infectious agents|infectious agents
5773284|NCT00230204|Immunoglobulin G|immunoglobulin g
5773285|NCT00230204|Immunoglobulin M|immunoglobulin m
5773286|NCT00230191|Oral|oral
5773287|NCT00230191|Mucositis|mucositis
5773288|NCT00230191|Stomatitis|stomatitis
5773289|NCT00230191|Head and Neck Cancer|head and neck cancer
5773290|NCT00230178|Hyperuricemia|hyperuricemia
5773291|NCT00230178|Tumor lysis syndrome|tumor lysis syndrome
5773292|NCT00230178|Leukemia|leukemia
5773293|NCT00230178|Lymphoma|lymphoma
5773294|NCT00230178|Myelodysplastic Syndromes|myelodysplastic syndromes
5773295|NCT00230178|Solid tumor cancers|solid tumor cancers
5773296|NCT00230178|Solid Tumor cancers with hyperuricemia Hyperuricemia (cancer patients only)|solid tumor cancers with hyperuricemia hyperuricemia (cancer patients only)
5773297|NCT00230178|Tumor lysis syndrome (cancer patients only)|tumor lysis syndrome (cancer patients only)
5773298|NCT00230165|Platelets|platelets
5773299|NCT00230165|Erythrocytes|erythrocytes
5773300|NCT00230165|Leukocytes|leukocytes
5773301|NCT00230165|Coagulation|coagulation
5773302|NCT00230165|Thrombosis|thrombosis
5773303|NCT00230126|African Americans|african americans
5773304|NCT00230113|NAFLD|nafld
5773305|NCT00230113|NASH|nash
5773306|NCT00230113|Fatty Liver Disease|fatty liver disease
5773307|NCT00230113|Omega-3 Fatty Acid|omega-3 fatty acid
5773308|NCT00230113|Fish oil|fish oil
5773309|NCT00230100|Gender differences|gender differences
5773310|NCT00230100|Women|women
5773311|NCT00230100|Substance use disorders|substance use disorders
5773312|NCT00230100|Alcohol use disorders|alcohol use disorders
5773313|NCT00230100|Treatment outcomes|treatment outcomes
5773314|NCT00230100|Group therapy|group therapy
5773315|NCT00230087|diabetes|diabetes
5773316|NCT00230087|nafld|nafld
5773317|NCT00230087|nash|nash
5773318|NCT00230087|phlebotomy|phlebotomy
5773319|NCT00230074|Amyotrophic Lateral Sclerosis; ALS|amyotrophic lateral sclerosis; als
5773320|NCT00230061|HIV|hiv
5773321|NCT00230009|child abuse, child neglect, substance use, violence exposure, brief intervention|child abuse, child neglect, substance use, violence exposure, brief intervention
5773322|NCT00229996|endometriosis|endometriosis
5773323|NCT00229996|pelvic pain|pelvic pain
5773324|NCT00229996|treatment|treatment
5773325|NCT00229983|Substance use disorders|substance use disorders
5773326|NCT00229983|Substance abuse|substance abuse
5773327|NCT00229983|Alcohol abuse|alcohol abuse
5773328|NCT00229983|Drug abuse|drug abuse
5773329|NCT00229957|Occupational therapy|occupational therapy
5773330|NCT00229957|Physical therapy techniques|physical therapy techniques
5773331|NCT00229957|Primary health care|primary health care
5773332|NCT00229957|Chronic disease|chronic disease
5773333|NCT00229957|Rehabilitation|rehabilitation
5773334|NCT00229957|Disease management|disease management
5773335|NCT00229957|Self care|self care
5773336|NCT00229944|Azithromycin|azithromycin
5773337|NCT00229944|V. cholerae O1 / O139|v. cholerae o1 / o139
5782331|NCT00182988|coping|coping
5773338|NCT00229944|adults|adults
5773339|NCT00229944|Bangladesh|bangladesh
5773340|NCT00229944|Clinical trial|clinical trial
5773341|NCT00229931|CATARACT EXTRACTION|cataract extraction
5773342|NCT00229931|MACULAR EDEMA|macular edema
5773343|NCT00229931|DIABETES|diabetes
5773344|NCT00229931|FOCAL LASER|focal laser
5773345|NCT00229931|TRIAMCINOLONE|triamcinolone
5773346|NCT00229918|Diabetic macular edema|diabetic macular edema
5773347|NCT00229918|Clinically significant macular edema|clinically significant macular edema
5773348|NCT00229905|pediatric health|pediatric health
5773349|NCT00229905|children|children
5773350|NCT00229905|single case study|single case study
5773351|NCT00229892|pediatric health|pediatric health
5773353|NCT00229892|small incisions|small incisions
5773354|NCT00229892|operations|operations
5773355|NCT00229892|minimally invasive|minimally invasive
5773356|NCT00229879|pediatric health|pediatric health
5773357|NCT00229879|rare tumor|rare tumor
5773361|NCT00229866|pediatric health|pediatric health
5773362|NCT00229866|Feeding difficulty|feeding difficulty
5773363|NCT00229866|discharge with a NG tube|discharge with a ng tube
5773364|NCT00229866|G-tube placement|g-tube placement
5773365|NCT00229866|Nissen fundoplication|nissen fundoplication
5773366|NCT00229853|Children's Healthcare of Atlanta|children's healthcare of atlanta
5773367|NCT00229853|pediatric|pediatric
5773368|NCT00229853|Thoracoscopic Vascular ring|thoracoscopic vascular ring
5773369|NCT00229853|diverticulopexy|diverticulopexy
5773370|NCT00229853|Vascular Ring Division|vascular ring division
5773371|NCT00229840|MRI, fMRI, Epilepsy, Pediatric|mri, fmri, epilepsy, pediatric
5773372|NCT00229827|pediatric health|pediatric health
5773373|NCT00229827|cardiac|cardiac
5773374|NCT00229827|pediatric population|pediatric population
5773375|NCT00229827|congenital heart surgery|congenital heart surgery
5773376|NCT00229827|left to right shunt lesions|left to right shunt lesions
5773377|NCT00229827|heart surgery|heart surgery
5773378|NCT00229827|Atrioventricular canal defects|atrioventricular canal defects
5773379|NCT00229814|Tectal Plate Glioma|tectal plate glioma
5773380|NCT00229814|Tumor|tumor
5773381|NCT00229814|Brain|brain
5773383|NCT00229814|Spectroscopy|spectroscopy
5773384|NCT00229801|Renal Function, MRI|renal function, mri
5773385|NCT00229788|orthotopic heart transplantation|orthotopic heart transplantation
5783335|NCT00178386|cancer|cancer
5773386|NCT00229775|Plasmodium falciparum malaria|plasmodium falciparum malaria
5773387|NCT00229775|malaria|malaria
5773388|NCT00229775|artemether lumafantrine|artemether lumafantrine
5773389|NCT00229775|chloroquine|chloroquine
5773390|NCT00229775|sulfadoxine pyrimethamine|sulfadoxine pyrimethamine
5773391|NCT00229775|Coartem|coartem
5773392|NCT00229762|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded|pneumococcal vaccination coverage with no disease or efficacy outcomes recorded
5773393|NCT00229749|HCV|hcv
5773394|NCT00229723|Head and Neck Squamous Cell Carcinoma|head and neck squamous cell carcinoma
5773395|NCT00229723|Head and Neck Squamous Cell Cancer|head and neck squamous cell cancer
5773396|NCT00229723|Squamous Cell Carcinoma|squamous cell carcinoma
5773397|NCT00229723|Squamous Cell Cancer|squamous cell cancer
5773398|NCT00229710|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5773399|NCT00229710|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5773400|NCT00229697|Breast cancer|breast cancer
5773401|NCT00229697|metastatic breast cancer|metastatic breast cancer
5773402|NCT00229684|Type 2 Diabetes|type 2 diabetes
5773403|NCT00229658|diabetes|diabetes
5773404|NCT00229658|pramlintide|pramlintide
5773405|NCT00229658|Symlin|symlin
5773406|NCT00229658|Amylin|amylin
5773407|NCT00229658|phase 4|phase 4
5773408|NCT00229645|Major Depression|major depression
5773409|NCT00229645|Anxiety|anxiety
5773410|NCT00229632|Friedreich's Ataxia|friedreich's ataxia
5773411|NCT00229632|Idebenone|idebenone
5773412|NCT00229632|Ataxia|ataxia
5773413|NCT00229632|Drug Trial|drug trial
5773414|NCT00229632|Randomized Trial|randomized trial
5773415|NCT00229632|Friedreich Ataxia|friedreich ataxia
5773416|NCT00229632|FA|fa
5773417|NCT00229619|rituxan|rituxan
5773418|NCT00229619|Immunosuppression|immunosuppression
5773419|NCT00229619|Bone Marrow Failure|bone marrow failure
5773420|NCT00229619|Monoclonal Antibody Therapy|monoclonal antibody therapy
5773421|NCT00229619|Diamond Blackfan Anemia (DBA)|diamond blackfan anemia (dba)
5773422|NCT00229619|T -Cells|t -cells
5773423|NCT00229619|B-Cells|b-cells
5773424|NCT00229619|Hematopoiesis|hematopoiesis
5773425|NCT00229619|Moderate Aplastic Anemia (MAA)|moderate aplastic anemia (maa)
5773426|NCT00229619|Diamond-Blackfan Anemia|diamond-blackfan anemia
5773427|NCT00229619|DBA|dba
5773428|NCT00229619|Pure Red Cell Aplasia|pure red cell aplasia
5773429|NCT00229619|PRCA|prca
5773430|NCT00229593|Male contraception|male contraception
5773438|NCT00229580|Motivational Interviewing|motivational interviewing
5773439|NCT00229580|Health Psychology|health psychology
5773440|NCT00229580|Alcohol|alcohol
5773441|NCT00229580|Hepatitis C|hepatitis c
5773442|NCT00229580|Patient Education|patient education
5773443|NCT00229567|ketamine|ketamine
5773444|NCT00229567|lidocaine|lidocaine
5773445|NCT00229567|postoperative ileus|postoperative ileus
5686393|NCT00552383|Family Centred Care|family centred care
5773446|NCT00229567|randomized controlled trial|randomized controlled trial
5773447|NCT00229567|acute postoperative pain|acute postoperative pain
5773449|NCT00229554|questionnaires|questionnaires
5773450|NCT00229541|Medical in-patient rehabilitation|medical in-patient rehabilitation
5773451|NCT00229541|Gainfully employed|gainfully employed
5773452|NCT00229541|Work incapacity|work incapacity
5773453|NCT00229515|Myocardial infarction|myocardial infarction
5773454|NCT00229515|Revascularization|revascularization
5773455|NCT00229515|Stent|stent
5773456|NCT00229515|ST segment elevation|st segment elevation
5773457|NCT00229476|Depression|depression
5773459|NCT00229476|QEEG|qeeg
5773460|NCT00229476|cordance|cordance
5773461|NCT00229476|Zoloft|zoloft
5773462|NCT00229476|sertraline|sertraline
5773463|NCT00229476|placebo|placebo
5773464|NCT00229476|electroencephalogram|electroencephalogram
5773465|NCT00229476|brain|brain
5773466|NCT00229476|antidepressants|antidepressants
5773467|NCT00229463|Depression|depression
5773470|NCT00229463|antidepressant|antidepressant
5773471|NCT00229463|research|research
5773480|NCT00229437|Diabetic Mononeuropathy|diabetic mononeuropathy
5773481|NCT00229437|Diabetic Neuralgia|diabetic neuralgia
5773482|NCT00229437|Mononeuropathy, Diabetic|mononeuropathy, diabetic
5773483|NCT00229437|Neuralgia, Diabetic|neuralgia, diabetic
5773484|NCT00229437|Diabetic Polyneuropathy|diabetic polyneuropathy
5773485|NCT00229437|Drug Therapy|drug therapy
5773486|NCT00229424|lafutidine|lafutidine
5773487|NCT00229424|reflux oesophagitis|reflux oesophagitis
5773488|NCT00229424|Gastroesophageal Reflux|gastroesophageal reflux
5773489|NCT00229424|famotidine|famotidine
5773490|NCT00229424|Double Blind|double blind
5773491|NCT00229424|Controlled Study|controlled study
5773492|NCT00229424|H2 receptor antagonist|h2 receptor antagonist
5773493|NCT00229424|H2-blocker|h2-blocker
5773494|NCT00229411|intensive care|intensive care
5773495|NCT00229411|teamwork|teamwork
5773496|NCT00229411|medical errors|medical errors
5773497|NCT00229411|education|education
5773498|NCT00229411|simulation|simulation
5773499|NCT00229333|Escitalopram|escitalopram
5773500|NCT00229333|Depression|depression
5773501|NCT00229333|Dementia|dementia
5773502|NCT00229333|Treatment|treatment
5773503|NCT00229333|Depressive Syndrome in Alzheimer’s Disease|depressive syndrome in alzheimer’s disease
5773504|NCT00229333|Depressive Syndrome in Vascular Dementia|depressive syndrome in vascular dementia
5773505|NCT00229333|Depressive Syndrome in Mixed Vascular and Alzheimer’s Dementia|depressive syndrome in mixed vascular and alzheimer’s dementia
5773506|NCT00229307|Post traumatic stress disorder|post traumatic stress disorder
5773507|NCT00229268|Healthy Volunteers|healthy volunteers
5773508|NCT00229255|Non-Alcoholic hepatic steatosis|non-alcoholic hepatic steatosis
5773509|NCT00229242|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5773510|NCT00229242|Echocardiography|echocardiography
5773511|NCT00229242|Diastolic function|diastolic function
5773512|NCT00229242|Left ventricular mass regression|left ventricular mass regression
5773513|NCT00229229|Obesity|obesity
5773514|NCT00229229|Cardiovascular Disease|cardiovascular disease
5773515|NCT00229229|Metabolic Syndrome|metabolic syndrome
5773516|NCT00229229|Canada Food Guide|canada food guide
5773517|NCT00229229|Glycemic Index|glycemic index
5773518|NCT00229229|Glycemic Load|glycemic load
5773519|NCT00229203|Myeloma|myeloma
5773520|NCT00229203|Aplidin|aplidin
5773521|NCT00229203|Plitidepsin|plitidepsin
5773522|NCT00229203|PharmaMar|pharmamar
5773523|NCT00229190|Nasal lavage fluid|nasal lavage fluid
5773524|NCT00229190|Eosinophils|eosinophils
5773525|NCT00229190|Reproducibility of results|reproducibility of results
5773526|NCT00229177|ONO-2506|ono-2506
5773527|NCT00229177|stroke|stroke
5773528|NCT00229177|Acute ischemic stroke|acute ischemic stroke
5773529|NCT00229164|Primary Dysmenorrhea,|primary dysmenorrhea,
5773530|NCT00229164|Transcutaneous Electric Nerve Stimulation|transcutaneous electric nerve stimulation
5773531|NCT00229138|De novo kidney recipients,|de novo kidney recipients,
5773534|NCT00229138|efficacy,|efficacy,
5773535|NCT00229138|safety,|safety,
5773536|NCT00229138|glomerular filtration rate|glomerular filtration rate
5773537|NCT00229138|Treatment in de novo kidney recipients|treatment in de novo kidney recipients
5773538|NCT00229125|Alcohol Withdrawal Syndrome|alcohol withdrawal syndrome
5773539|NCT00229125|CIWA-Ar|ciwa-ar
5773540|NCT00229125|Acoustic Startle Procedure|acoustic startle procedure
5773542|NCT00229073|dapoxetine|dapoxetine
5773543|NCT00229073|premature ejaculation|premature ejaculation
5773544|NCT00229073|ejaculation|ejaculation
5773545|NCT00229073|sexual dysfunction|sexual dysfunction
5773546|NCT00229073|orgasmic disorder|orgasmic disorder
5773547|NCT00229073|sexual intercourse|sexual intercourse
5773548|NCT00229060|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5773549|NCT00229060|Appendicitis|appendicitis
5773550|NCT00229060|Cholecystitis|cholecystitis
5773551|NCT00229060|Peritonitis|peritonitis
5773552|NCT00229047|Ischemic Preconditioning|ischemic preconditioning
5773553|NCT00229047|Microvascular Perfusion|microvascular perfusion
5773554|NCT00229047|Inflammation|inflammation
5773555|NCT00229047|Ischemia and Reperfusion|ischemia and reperfusion
5773556|NCT00229047|Chronic Limb Ischemia|chronic limb ischemia
5773557|NCT00229034|Systemic Inflammation|systemic inflammation
5773558|NCT00229034|Microvascular Perfusion|microvascular perfusion
5773559|NCT00229034|Septic Shock|septic shock
5773560|NCT00229021|Complicated Urinary Tract Infection|complicated urinary tract infection
5773561|NCT00229021|Pyelonephritis|pyelonephritis
5773562|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril
5773563|NCT00229008|Nosocomial Pneumonia|nosocomial pneumonia
5773564|NCT00229008|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5773565|NCT00229008|Cephalosporins|cephalosporins
5773566|NCT00229008|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5773568|NCT00228995|Subcutaneous injection|subcutaneous injection
5773569|NCT00228995|PROCRIT|procrit
5773570|NCT00228995|Erythropoietin|erythropoietin
5773571|NCT00228995|Epoetin Alfa|epoetin alfa
5773572|NCT00228995|Hemoglobin Level|hemoglobin level
5773573|NCT00228995|Elderly|elderly
5773574|NCT00228982|Complicated Skin Infections|complicated skin infections
5773575|NCT00228982|Infectious Skin Diseases|infectious skin diseases
5773576|NCT00228982|Bacterial Skin Diseases|bacterial skin diseases
5773577|NCT00228982|Staphylococcal Skin Infections|staphylococcal skin infections
5773578|NCT00228982|Cephalosporin|cephalosporin
5773579|NCT00228956|Breast Cancer|breast cancer
5773580|NCT00228956|Aromatase Inhibitor|aromatase inhibitor
5773581|NCT00228956|Letrozole|letrozole
5773582|NCT00228956|Exemestane|exemestane
5773583|NCT00228943|Breast cancer survivorship|breast cancer survivorship
5773584|NCT00228943|Hot Flashes|hot flashes
5773585|NCT00228943|Serotonin|serotonin
5773586|NCT00228930|Breast Cancer|breast cancer
5773587|NCT00228930|Tamoxifen|tamoxifen
5773588|NCT00228930|Prevention|prevention
5773590|NCT00228904|Pulsatile intravenous insulin|pulsatile intravenous insulin
5773591|NCT00228904|Oral carbohydrate loading|oral carbohydrate loading
5773592|NCT00228904|Respiratory Quotients|respiratory quotients
5773593|NCT00228904|Hypoglycemia|hypoglycemia
5773594|NCT00228904|Diabetic Neuropathy|diabetic neuropathy
5773595|NCT00228904|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5773596|NCT00228891|Pulsatile intravenous insulin|pulsatile intravenous insulin
5773597|NCT00228891|Oral carbohydrate loading|oral carbohydrate loading
5773598|NCT00228891|Respiratory Quotients|respiratory quotients
5773599|NCT00228891|Hypoglycemia|hypoglycemia
5773600|NCT00228891|Diabetic Neuropathy|diabetic neuropathy
5773602|NCT00228878|Pulsatile intravenous insulin|pulsatile intravenous insulin
5773603|NCT00228878|Oral carbohydrate loading|oral carbohydrate loading
5773604|NCT00228878|Respiratory Quotients|respiratory quotients
5773605|NCT00228878|Hypoglycemia|hypoglycemia
5773606|NCT00228878|Diabetes Mellitus, with complications|diabetes mellitus, with complications
5773607|NCT00228865|Pulsatile intravenous insulin|pulsatile intravenous insulin
5773608|NCT00228865|Oral carbohydrate loading|oral carbohydrate loading
5773609|NCT00228865|Mindstream testing|mindstream testing
5773610|NCT00228865|Wechsler Memory Scale II|wechsler memory scale ii
5773611|NCT00228865|Respiratory Quotients|respiratory quotients
5773612|NCT00228865|Hypoglycemia|hypoglycemia
5773613|NCT00228865|Diabetes Mellitus with cognitive impairment|diabetes mellitus with cognitive impairment
5773614|NCT00228865|Diabetes Mellitus with complications|diabetes mellitus with complications
5773615|NCT00228852|Patients with severe T-cell immune deficiency diseases|patients with severe t-cell immune deficiency diseases
5773616|NCT00228839|Recipients of an allogeneic hematopoietic stem cell transplant who have acute GVHD|recipients of an allogeneic hematopoietic stem cell transplant who have acute gvhd
5773617|NCT00228696|late effects|late effects
5773618|NCT00228670|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5773619|NCT00228670|herpesvirus|herpesvirus
5773620|NCT00228670|lung biopsy|lung biopsy
5773621|NCT00228670|Having diagnosed lung disease|having diagnosed lung disease
5773622|NCT00228670|Scheduled to have a lung biopsy as part of the evaluation for your lung disease|scheduled to have a lung biopsy as part of the evaluation for your lung disease
5773623|NCT00228644|oxidative stress|oxidative stress
5773624|NCT00228644|amino acids|amino acids
5773625|NCT00228644|acetaminophen|acetaminophen
5773626|NCT00228644|dietary requirements|dietary requirements
5773627|NCT00228631|sickle|sickle
5773628|NCT00228631|cell|cell
5773629|NCT00228618|oxidative stress|oxidative stress
5773630|NCT00228618|amino acids|amino acids
5773631|NCT00228618|dietary requirements|dietary requirements
5773632|NCT00228605|Pain|pain
5773633|NCT00228605|Sudden Pain|sudden pain
5773634|NCT00228605|Flares|flares
5773635|NCT00228605|noncancer|noncancer
5773636|NCT00228605|low back pain|low back pain
5773637|NCT00228605|neuropathic pain|neuropathic pain
5773638|NCT00228605|osteoarthritis pain|osteoarthritis pain
5773639|NCT00228605|migraine|migraine
5773640|NCT00228605|chronic headache|chronic headache
5773641|NCT00228605|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5773642|NCT00228579|diabetes|diabetes
5773643|NCT00228579|insulin resistance|insulin resistance
5773644|NCT00228488|advanced non-nasopharyngeal head and neck carcinoma|advanced non-nasopharyngeal head and neck carcinoma
5773645|NCT00228462|Schizophrenia|schizophrenia
5773646|NCT00228449|anemia|anemia
5773647|NCT00228449|chronic kidney disease|chronic kidney disease
5773649|NCT00228449|chronic renal failure|chronic renal failure
5773650|NCT00228449|CRF|crf
5773651|NCT00228449|dialysis|dialysis
5773652|NCT00228449|erythropoietin|erythropoietin
5773653|NCT00228449|EPO|epo
5773654|NCT00228449|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5773655|NCT00228449|ESA|esa
5773656|NCT00228449|Hematide™|hematide™
5773657|NCT00228449|hemodialysis|hemodialysis
5773658|NCT00228449|hemoglobin|hemoglobin
5773659|NCT00228449|Hb|hb
5773660|NCT00228449|Hgb|hgb
5773661|NCT00228449|Omontys|omontys
5773662|NCT00228449|peginesatide|peginesatide
5773663|NCT00228449|red blood cell|red blood cell
5773664|NCT00228449|red blood cell production|red blood cell production
5773665|NCT00228436|anemia|anemia
5773666|NCT00228436|chronic kidney disease|chronic kidney disease
5773667|NCT00228436|CKD|ckd
5773668|NCT00228436|chronic renal failure|chronic renal failure
5773669|NCT00228436|CRF|crf
5773670|NCT00228436|dialysis|dialysis
5773671|NCT00228436|erythropoietin|erythropoietin
5773672|NCT00228436|EPO|epo
5773673|NCT00228436|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5773674|NCT00228436|ESA|esa
5773675|NCT00228436|Hematide™|hematide™
5773676|NCT00228436|hemoglobin|hemoglobin
5773677|NCT00228436|Hb|hb
5773678|NCT00228436|Hgb|hgb
5773679|NCT00228436|Omontys|omontys
5773680|NCT00228436|peginesatide|peginesatide
5773681|NCT00228436|red blood cell|red blood cell
5773682|NCT00228436|red blood cell production|red blood cell production
5773683|NCT00228423|Saphenous vein|saphenous vein
5773684|NCT00228423|Intimal hyperplasia|intimal hyperplasia
5773685|NCT00228423|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5773686|NCT00228423|Antiplatelet therapy|antiplatelet therapy
5773687|NCT00228423|Clopidogrel|clopidogrel
5773688|NCT00228423|Saphenous vein graft disease|saphenous vein graft disease
5773689|NCT00228410|Skin Infections|skin infections
5773690|NCT00228410|Skin Disease|skin disease
5773691|NCT00228397|Multiple Sclerosis|multiple sclerosis
5773692|NCT00228371|Epilepsy|epilepsy
5773693|NCT00228371|deep brain stimulation|deep brain stimulation
5773694|NCT00228371|Subthalamic nucleus|subthalamic nucleus
5773695|NCT00228371|Drug resistant epilepsy|drug resistant epilepsy
5773696|NCT00228345|Idiopathic Axonal Polyneuropathy|idiopathic axonal polyneuropathy
5773697|NCT00228345|abnormal OGTT|abnormal ogtt
5773698|NCT00228293|cardiac arrest|cardiac arrest
5773699|NCT00228293|CPR|cpr
5773700|NCT00228280|Apicoectomy|apicoectomy
5773701|NCT00228280|Retrograde|retrograde
5773702|NCT00228280|MTA|mta
5773703|NCT00228267|Chronic Headache|chronic headache
5773704|NCT00228267|Analgesic Rebound Headache|analgesic rebound headache
5773705|NCT00228267|Chronic Daily Headache|chronic daily headache
5773706|NCT00228267|Headache, Intractable|headache, intractable
5773707|NCT00228267|Randomised controlled trial|randomised controlled trial
5773708|NCT00228267|Propofol|propofol
5773709|NCT00228254|acute respiratory infection|acute respiratory infection
5773710|NCT00228254|acute lower respiratory infection|acute lower respiratory infection
5773711|NCT00228254|diarrhea|diarrhea
5773712|NCT00228241|Sick sinus syndrome|sick sinus syndrome
5773713|NCT00228241|AV-block|av-block
5773714|NCT00228228|Multiple Sclerosis|multiple sclerosis
5773715|NCT00228228|T-cell vaccination|t-cell vaccination
5773716|NCT00228228|Autoreactive T cells|autoreactive t cells
5773717|NCT00228215|sleep|sleep
5773718|NCT00228215|neonates|neonates
5773719|NCT00228215|mothers|mothers
5773720|NCT00228215|behavioural intervention|behavioural intervention
5773721|NCT00228202|cytomegalovirus|cytomegalovirus
5773722|NCT00228202|CMV|cmv
5773723|NCT00228202|pregnancy|pregnancy
5773724|NCT00228202|amniotic fluid|amniotic fluid
5773725|NCT00228202|bone marrow|bone marrow
5773726|NCT00228202|transplantation|transplantation
5773727|NCT00228202|viral load|viral load
5773728|NCT00228202|glycoprotein B|glycoprotein b
5773729|NCT00228202|genotyping|genotyping
5773731|NCT00228202|real-time PCR|real-time pcr
5773732|NCT00228202|CMV disease|cmv disease
5773733|NCT00228202|Congenital CMV infection|congenital cmv infection
5773734|NCT00228189|Dendritic cells|dendritic cells
5773735|NCT00228189|Colorectal cancer|colorectal cancer
5773736|NCT00228189|Carcinoembryonic antigen|carcinoembryonic antigen
5773737|NCT00228189|Vaccine|vaccine
5773739|NCT00228176|Metabolic syndrome|metabolic syndrome
5773740|NCT00228176|Carotid Atherosclerosis|carotid atherosclerosis
5773741|NCT00228163|Multiple Sclerosis Relapsing Remitting|multiple sclerosis relapsing remitting
5773742|NCT00228163|Secondary Progressive|secondary progressive
5773743|NCT00228163|Progressive Relapsing|progressive relapsing
5773744|NCT00228150|Parkinson Disease|parkinson disease
5773745|NCT00228150|levodopa|levodopa
5773746|NCT00228150|dopamine agonists|dopamine agonists
5773747|NCT00228124|Prostate cancer|prostate cancer
5773748|NCT00228124|Continuous androgen suppression|continuous androgen suppression
5773749|NCT00228124|Intermittent androgen suppression|intermittent androgen suppression
5773751|NCT00228124|Osteoporosis|osteoporosis
5773752|NCT00228111|Computed tomography|computed tomography
5773753|NCT00228111|wounds and injuries,non penetrating|wounds and injuries,non penetrating
5773754|NCT00228111|algorithms|algorithms
5773755|NCT00228111|Blunt trauma of the thorax and abdomen|blunt trauma of the thorax and abdomen
5773756|NCT00228072|Hyperhidrosis|hyperhidrosis
5773757|NCT00228072|Axillary|axillary
5773758|NCT00228072|Excision|excision
5773759|NCT00228072|Suction-curettage|suction-curettage
5773760|NCT00228072|Outcome|outcome
5773761|NCT00228059|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
5773762|NCT00228046|ADHD|adhd
5773763|NCT00228046|ODD|odd
5773764|NCT00228046|Conduct Disorder|conduct disorder
5773766|NCT00228033|Calcium|calcium
5773767|NCT00228033|Pregnancy|pregnancy
5773768|NCT00228033|Postpartum Depression|postpartum depression
5773769|NCT00228033|Depression|depression
5773770|NCT00228020|pediatric, kidney transplantation, basiliximab|pediatric, kidney transplantation, basiliximab
5773771|NCT00228007|Injection Drug Use|injection drug use
5774257|NCT00225550|Cadherins|cadherins
5773772|NCT00228007|HIV Risk Behavior|hiv risk behavior
5773773|NCT00228007|HIV Seronegativity|hiv seronegativity
5773774|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors
5773775|NCT00227994|Elderly|elderly
5773776|NCT00227994|Stroke|stroke
5773777|NCT00227994|Cognition|cognition
5773778|NCT00227981|Depression Relapse|depression relapse
5773779|NCT00227981|Maintenance Therapy|maintenance therapy
5773780|NCT00227968|Manic-depressive psychosis|manic-depressive psychosis
5773781|NCT00227968|Depression, bipolar|depression, bipolar
5773782|NCT00227955|Major depression|major depression
5773783|NCT00227942|Women|women
5773784|NCT00227942|Menopause|menopause
5773785|NCT00227942|Depression|depression
5773786|NCT00227942|Hot flash|hot flash
5773787|NCT00227942|Insomnia|insomnia
5773788|NCT00227942|Sleep Disruption|sleep disruption
5773789|NCT00227942|Estrogen Replacement Therapy|estrogen replacement therapy
5773790|NCT00227929|Major Depressive Disorder|major depressive disorder
5773791|NCT00227929|MDD|mdd
5773792|NCT00227916|alcohol, marijuana|alcohol, marijuana
5773793|NCT00227890|substance abuse|substance abuse
5773794|NCT00227877|alcohol abuse|alcohol abuse
5773795|NCT00227877|substance abuse|substance abuse
5773796|NCT00227877|substance related disorders|substance related disorders
5773797|NCT00227864|marijuana|marijuana
5773798|NCT00227864|sexual risk|sexual risk
5773799|NCT00227838|substance abuse|substance abuse
5773800|NCT00227825|Behavioral Intervention|behavioral intervention
5773801|NCT00227812|cocaine dependence|cocaine dependence
5773802|NCT00227786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5773803|NCT00227786|tobacco use disorder|tobacco use disorder
5773804|NCT00227773|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5773805|NCT00227773|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5773806|NCT00227773|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5773807|NCT00227773|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5773808|NCT00227773|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5773809|NCT00227773|gastrinoma|gastrinoma
5773810|NCT00227773|insulinoma|insulinoma
5773811|NCT00227773|WDHA syndrome|wdha syndrome
5773812|NCT00227773|glucagonoma|glucagonoma
5773813|NCT00227773|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5773814|NCT00227773|somatostatinoma|somatostatinoma
5773815|NCT00227747|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5773816|NCT00227747|stage II rectal cancer|stage ii rectal cancer
5773817|NCT00227747|stage III rectal cancer|stage iii rectal cancer
5773818|NCT00227734|stage IV colon cancer|stage iv colon cancer
5773819|NCT00227734|stage IV rectal cancer|stage iv rectal cancer
5773820|NCT00227734|recurrent colon cancer|recurrent colon cancer
5773821|NCT00227734|recurrent rectal cancer|recurrent rectal cancer
5773822|NCT00227721|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5773823|NCT00227721|peritoneal cavity cancer|peritoneal cavity cancer
5773824|NCT00227708|adenocarcinoma of the lung|adenocarcinoma of the lung
5773825|NCT00227708|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5773826|NCT00227708|large cell lung cancer|large cell lung cancer
5773827|NCT00227708|squamous cell lung cancer|squamous cell lung cancer
5773828|NCT00227708|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5769007|NCT00248469|HIV|hiv
5773829|NCT00227708|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5773830|NCT00227708|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5773831|NCT00227695|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5773832|NCT00227695|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5773833|NCT00227695|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5773834|NCT00227695|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5773835|NCT00227695|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5773836|NCT00227695|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5791287|NCT00139113|hepatitis A vaccine|hepatitis a vaccine
5791288|NCT00139074|Bipolar I Disorder (DSM-IV 296.01, DSM-IV 296.4, DSM-IV 296.61)|bipolar i disorder (dsm-iv 296.01, dsm-iv 296.4, dsm-iv 296.61)
5791289|NCT00139048|informed choice|informed choice
5773837|NCT00227695|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5772886|NCT00231972|MSM|msm
5773838|NCT00227695|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5773839|NCT00227695|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5773840|NCT00227695|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5773841|NCT00227695|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5773842|NCT00227695|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5773843|NCT00227695|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5773844|NCT00227695|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5773845|NCT00227695|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5773846|NCT00227695|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5773847|NCT00227695|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5773848|NCT00227695|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5773850|NCT00227669|uterine leiomyosarcoma|uterine leiomyosarcoma
5773851|NCT00227669|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5773852|NCT00227669|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5773853|NCT00227669|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5773854|NCT00227669|stage III uterine sarcoma|stage iii uterine sarcoma
5773855|NCT00227669|stage IV uterine sarcoma|stage iv uterine sarcoma
5773856|NCT00227669|recurrent uterine sarcoma|recurrent uterine sarcoma
5773857|NCT00227669|adult leiomyosarcoma|adult leiomyosarcoma
5773858|NCT00227656|stage IV breast cancer|stage iv breast cancer
5773859|NCT00227656|recurrent breast cancer|recurrent breast cancer
5773860|NCT00227656|male breast cancer|male breast cancer
5773861|NCT00227656|tumors metastatic to brain|tumors metastatic to brain
5773862|NCT00227630|epithelial mesothelioma|epithelial mesothelioma
5773863|NCT00227630|sarcomatous mesothelioma|sarcomatous mesothelioma
5773864|NCT00227630|localized malignant mesothelioma|localized malignant mesothelioma
5773865|NCT00227630|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5773866|NCT00227617|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5773867|NCT00227617|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5773868|NCT00227617|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5773869|NCT00227617|gastrinoma|gastrinoma
5773870|NCT00227617|insulinoma|insulinoma
5773871|NCT00227617|WDHA syndrome|wdha syndrome
5773872|NCT00227617|glucagonoma|glucagonoma
5773873|NCT00227617|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5773874|NCT00227617|somatostatinoma|somatostatinoma
5773875|NCT00227617|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5773876|NCT00227617|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5773877|NCT00227565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5773878|NCT00227539|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5773879|NCT00227539|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5773880|NCT00227539|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5773881|NCT00227539|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5773882|NCT00227526|Colon|colon
5773883|NCT00227526|Surgery|surgery
5773884|NCT00227526|Prehabilitation|prehabilitation
5773885|NCT00227526|Exercise|exercise
5773886|NCT00227500|Hyperlipidaemia|hyperlipidaemia
5773887|NCT00227500|Lipid metabolism|lipid metabolism
5773888|NCT00227500|Glucose metabolism|glucose metabolism
5773889|NCT00227500|HMG CoA reductase inhibitors|hmg coa reductase inhibitors
5773890|NCT00227500|Lipodystrophy|lipodystrophy
5773891|NCT00227500|Cardiovascular disease|cardiovascular disease
5773892|NCT00227500|Treatment Experienced|treatment experienced
5773893|NCT00227500|HIV|hiv
5773894|NCT00227487|autism|autism
5773895|NCT00227487|intestine|intestine
5773896|NCT00227487|disaccharidases|disaccharidases
5773897|NCT00227487|inflammation|inflammation
5773898|NCT00227487|permeability|permeability
5773899|NCT00227474|stage IIIB breast cancer|stage iiib breast cancer
5774001|NCT00226746|Gemcitabine|gemcitabine
5773904|NCT00227448|Ischemic|ischemic
5773905|NCT00227448|Stroke|stroke
5773906|NCT00227422|Neisseria meningitidis serogroups A & C diseases|neisseria meningitidis serogroups a & c diseases
5846709|NCT00043680|AMD|amd
5773907|NCT00227422|Hib diseases|hib diseases
5773908|NCT00227409|Repeated chelation therapy|repeated chelation therapy
5773909|NCT00227409|Progressive renal insufficiency|progressive renal insufficiency
5773910|NCT00227409|Body lead burden|body lead burden
5773911|NCT00227409|Long-term outcome|long-term outcome
5773912|NCT00227409|Glomerular filtration rate|glomerular filtration rate
5773914|NCT00227383|gastroparesis|gastroparesis
5773915|NCT00227383|electroacupuncture|electroacupuncture
5773916|NCT00227370|Acute rejection|acute rejection
5773917|NCT00227370|Non-CMV infections|non-cmv infections
5773918|NCT00227370|Resistance|resistance
5773919|NCT00227357|HIV|hiv
5773920|NCT00227357|AIDS|aids
5773921|NCT00227357|Buprenorphine|buprenorphine
5773922|NCT00227357|Methadone|methadone
5773923|NCT00227357|Primary care|primary care
5773924|NCT00227357|dual diagnosis|dual diagnosis
5773925|NCT00227357|ptsd|ptsd
5773926|NCT00227331|Pneumonia|pneumonia
5773927|NCT00227305|Schizophrenia|schizophrenia
5773928|NCT00227305|Bipolar I Disorder|bipolar i disorder
5773929|NCT00227292|Low back pain|low back pain
5773930|NCT00227292|Depression|depression
5773931|NCT00227279|Grass pollen allergy|grass pollen allergy
5773932|NCT00227279|Hayfever|hayfever
5773933|NCT00227279|Allergen immunotherapy|allergen immunotherapy
5773934|NCT00227279|Specific immunotherapy|specific immunotherapy
5773935|NCT00227266|Spinal Muscular Atrophy (SMA)|spinal muscular atrophy (sma)
5773936|NCT00227266|SMA Type 2|sma type 2
5773937|NCT00227266|SMA Type 3|sma type 3
5773938|NCT00227253|Phenotype|phenotype
5773939|NCT00227253|Growth|growth
5773940|NCT00227253|Genotype|genotype
5773941|NCT00227253|Chromosome 18|chromosome 18
5773942|NCT00227201|African-American|african-american
5773943|NCT00227201|Hypertension|hypertension
5773944|NCT00227201|Complementary medicine|complementary medicine
5773945|NCT00227201|Medication adherence|medication adherence
5773946|NCT00227175|African American|african american
5773947|NCT00227175|Hypertension|hypertension
5773948|NCT00227175|Medication adherence|medication adherence
5773949|NCT00227175|Risk reduction|risk reduction
5773950|NCT00227162|Asthma|asthma
5773951|NCT00227162|Behavior change|behavior change
5773952|NCT00227162|Physical activity|physical activity
5773953|NCT00227162|Risk reduction|risk reduction
5773954|NCT00227149|C06.552.380.705.440|c06.552.380.705.440
5773955|NCT00227136|5Hydroxytryptamine|5hydroxytryptamine
5773956|NCT00227136|Chromogranin A|chromogranin a
5773957|NCT00227136|5HIAA|5hiaa
5773958|NCT00227136|carcinoid|carcinoid
5773959|NCT00227123|Bipolar, cocaine, methamphetamine,quetiapine,risperidone|bipolar, cocaine, methamphetamine,quetiapine,risperidone
5773960|NCT00227110|NASH, IGT, T2DM|nash, igt, t2dm
5773961|NCT00227097|therapeutic education|therapeutic education
5773962|NCT00227097|thrombi embolic disease|thrombi embolic disease
5773963|NCT00227084|Mammary glands|mammary glands
5773964|NCT00227084|hemostasis|hemostasis
5773965|NCT00227084|Mammaplasty|mammaplasty
5773966|NCT00227071|accidental falls|accidental falls
5773967|NCT00227071|osteoporosis|osteoporosis
5773968|NCT00227071|risk factors|risk factors
5773969|NCT00227058|allergic rhinitis|allergic rhinitis
5773970|NCT00227045|Kidney Transplantation|kidney transplantation
5773971|NCT00227032|adult giant cell glioblastoma|adult giant cell glioblastoma
5773972|NCT00227032|adult gliosarcoma|adult gliosarcoma
5773973|NCT00227032|adult glioblastoma|adult glioblastoma
5773974|NCT00227032|recurrent adult brain tumor|recurrent adult brain tumor
5773979|NCT00226902|Diabetes|diabetes
5773980|NCT00226902|Hemoglobin|hemoglobin
5773981|NCT00226902|Dialysis|dialysis
5773982|NCT00226902|Vascular reactivity|vascular reactivity
5773983|NCT00226889|Scleroderma|scleroderma
5773984|NCT00226889|Fibrosis|fibrosis
5773985|NCT00226889|Therapy|therapy
5773986|NCT00226889|Bosentan|bosentan
5773987|NCT00226889|Endothelin-1|endothelin-1
5773988|NCT00226876|dreaming|dreaming
5773989|NCT00226876|anaesthesia|anaesthesia
5773990|NCT00226876|electroencephalography|electroencephalography
5773991|NCT00226876|bispectral index|bispectral index
5773992|NCT00226876|awareness|awareness
5773993|NCT00226824|Tourette's disorder|tourette's disorder
5773995|NCT00226772|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5773996|NCT00226772|ACL reconstruction|acl reconstruction
5773997|NCT00226759|Anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5773998|NCT00226759|ACL reconstruction|acl reconstruction
5773999|NCT00226746|Pancreatic Cancer|pancreatic cancer
5774000|NCT00226746|Hyperfractionated Radiation Therapy|hyperfractionated radiation therapy
5774002|NCT00226746|Paclitaxel|paclitaxel
5774003|NCT00226746|Carcinoma, Pancreatic Ductal|carcinoma, pancreatic ductal
5774004|NCT00226733|Coronary Artery Bypass (E04.928.220.520.220)|coronary artery bypass (e04.928.220.520.220)
5774005|NCT00226733|Exercise Test [E01.370.370.380.250]|exercise test [e01.370.370.380.250]
5774006|NCT00226733|Echocardiography [E01.370.370.380.220]|echocardiography [e01.370.370.380.220]
5774007|NCT00226733|Quality of Life [K01.752.400.750]|quality of life [k01.752.400.750]
5774008|NCT00226720|alcoholism|alcoholism
5774009|NCT00226720|Alcohol dependence|alcohol dependence
5769164|NCT00247884|HCV|hcv
5774010|NCT00226720|Detoxification|detoxification
5774011|NCT00226720|Abstinence maintain|abstinence maintain
5774012|NCT00226720|Efficacy|efficacy
5774013|NCT00226720|Ambulatory detoxification|ambulatory detoxification
5774014|NCT00226707|Chronic hand dermatitis, pimecrolimus, dermatitis|chronic hand dermatitis, pimecrolimus, dermatitis
5774015|NCT00226694|Alcoholism|alcoholism
5774016|NCT00226694|Stress|stress
5774017|NCT00226694|Gender Differences|gender differences
5774018|NCT00226694|Addiction|addiction
5774019|NCT00226694|Alcohol Dependence|alcohol dependence
5774020|NCT00226668|peritumoral brain edema|peritumoral brain edema
5774021|NCT00226668|edema|edema
5774022|NCT00226668|malignant brain tumor|malignant brain tumor
5774023|NCT00226668|astrocytoma|astrocytoma
5774024|NCT00226668|brain tumor|brain tumor
5774025|NCT00226668|dexamethasone|dexamethasone
5774026|NCT00226668|Decadron|decadron
5774027|NCT00226655|peritumoral brain edema|peritumoral brain edema
5774028|NCT00226655|edema|edema
5686394|NCT00552383|Neurodevelopmental Outcome, preterm infant|neurodevelopmental outcome, preterm infant
5774029|NCT00226655|malignant brain tumor|malignant brain tumor
5774030|NCT00226655|astrocytoma|astrocytoma
5774031|NCT00226655|brain tumor|brain tumor
5774032|NCT00226655|dexamethasone|dexamethasone
5774033|NCT00226655|Decadron|decadron
5774034|NCT00226642|depression|depression
5774035|NCT00226642|primary care|primary care
5774036|NCT00226616|Zinc|zinc
5774037|NCT00226616|cholera|cholera
5774038|NCT00226616|children|children
5774039|NCT00226616|Bangladesh|bangladesh
5774040|NCT00226603|groin injury|groin injury
5774041|NCT00226603|football|football
5774042|NCT00226603|prevention|prevention
5774043|NCT00226603|traing programme|traing programme
5774044|NCT00226603|cluster randomized study|cluster randomized study
5774045|NCT00226590|non-small cell lung cancer|non-small cell lung cancer
5774046|NCT00226590|carcinoma|carcinoma
5774047|NCT00226590|unresectable|unresectable
5774048|NCT00226590|Stage IIIA|stage iiia
5774049|NCT00226590|Stage IIIB|stage iiib
5774050|NCT00226590|thoracic radiation|thoracic radiation
5774051|NCT00226577|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5774052|NCT00226577|resectable|resectable
5774053|NCT00226577|NSCLC|nsclc
5774054|NCT00226525|Restenosis, skin metal allergy|restenosis, skin metal allergy
5774055|NCT00226473|malignant Melanoma|malignant melanoma
5774056|NCT00226473|Chemotherapy|chemotherapy
5774057|NCT00226473|Metastasis|metastasis
5774058|NCT00226473|standard palliative care|standard palliative care
5774059|NCT00226473|best supportive care|best supportive care
5774060|NCT00226447|Chronic Hepatitis B|chronic hepatitis b
5774061|NCT00226447|Pegylated Interferon|pegylated interferon
5774062|NCT00226447|Lamivudine|lamivudine
5774063|NCT00226434|HIV infection|hiv infection
5774064|NCT00226434|Tuberculosis|tuberculosis
5774065|NCT00226434|Paradoxical reaction|paradoxical reaction
5774066|NCT00226434|Treatment Naive|treatment naive
5774067|NCT00226421|opioid|opioid
5774068|NCT00226421|oxymorphone|oxymorphone
5774069|NCT00226421|chronic pain|chronic pain
5774070|NCT00226421|randomized, double-blind trial|randomized, double-blind trial
5774071|NCT00226421|low back pain|low back pain
5774072|NCT00226408|melanoma,adjuvant therapy,stageIII Interferon|melanoma,adjuvant therapy,stageiii interferon
5774073|NCT00226408|high dose|high dose
5783984|NCT00175227|prevention|prevention
5774074|NCT00226395|oxymorphone|oxymorphone
5774075|NCT00226395|acute pain|acute pain
5774076|NCT00226395|abdominal surgery|abdominal surgery
5774077|NCT00226395|opioids|opioids
5774078|NCT00226382|Chronic Hepatitis B|chronic hepatitis b
5774079|NCT00226382|Pegylated Interferon-alfa-2a|pegylated interferon-alfa-2a
5774080|NCT00226382|Pegasys|pegasys
5774081|NCT00226369|Pediatric|pediatric
5774082|NCT00226369|Cardiopulmonary bypass|cardiopulmonary bypass
5774083|NCT00226369|Congenital heart disease|congenital heart disease
5774084|NCT00226369|Reperfusion injury|reperfusion injury
5774085|NCT00226330|Patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study GALLANT 6.|patients diagnosed with type 2 diabetes who have participated in and completed the randomized, double-blind, parallel-group, multi-center study gallant 6.
5774086|NCT00226304|Focal Brain Lesions|focal brain lesions
5774087|NCT00226304|AIDS|aids
5774088|NCT00226304|Lymphoma|lymphoma
5774090|NCT00226304|FDG-PET|fdg-pet
5774091|NCT00226304|HIV Infection|hiv infection
5774092|NCT00226304|Brain Lesion|brain lesion
5774093|NCT00226291|EBM|ebm
5774094|NCT00226291|evidence based medicine|evidence based medicine
5774095|NCT00226291|informationist|informationist
5774096|NCT00226291|clinical medical librarian|clinical medical librarian
5774097|NCT00226265|Cardiac surgery patients|cardiac surgery patients
5774098|NCT00226265|Quality of Life|quality of life
5774099|NCT00226265|Recall bias|recall bias
5774100|NCT00226265|Aortic valve replacement|aortic valve replacement
5774101|NCT00226265|Mitral valve replacement|mitral valve replacement
5774102|NCT00226265|Tricuspid valve replacement|tricuspid valve replacement
5774103|NCT00226265|Coronary artery bypass graft surgery|coronary artery bypass graft surgery
5774104|NCT00226252|Wheelchair|wheelchair
5774105|NCT00226252|Propulsion|propulsion
5774106|NCT00226252|Biomechanics|biomechanics
5774107|NCT00226239|head|head
5774108|NCT00226239|neck|neck
5774109|NCT00226200|Allergic|allergic
5774110|NCT00226200|Non allergic|non allergic
5774111|NCT00226187|Fatty acids|fatty acids
5774112|NCT00226187|Human milk|human milk
5774113|NCT00226187|Infant development|infant development
5774114|NCT00226187|Very low birthweight infants|very low birthweight infants
5774115|NCT00226174|Curcuminoids|curcuminoids
5774116|NCT00226174|Oral Lichen Planus|oral lichen planus
5774117|NCT00226148|Implant|implant
5774118|NCT00226148|Immediate placement|immediate placement
5774119|NCT00226148|Molar tooth|molar tooth
5774120|NCT00226135|Bipolar disorder|bipolar disorder
5774121|NCT00226135|Treatment|treatment
5774122|NCT00226135|Long-term|long-term
5774123|NCT00226135|Lithium|lithium
5774124|NCT00226135|Lamotrigine|lamotrigine
5686395|NCT00552344|CDP 870|cdp 870
5694863|NCT00519181|HTLV|htlv
5774125|NCT00226135|Randomised Clinical Trial|randomised clinical trial
5774126|NCT00226122|Enuresis|enuresis
5774127|NCT00226122|Nocturnal|nocturnal
5774128|NCT00226122|Monosymptomatic|monosymptomatic
5774129|NCT00226122|DDAVP|ddavp
5774130|NCT00226122|Indomethacin|indomethacin
5774131|NCT00226122|Randomized|randomized
5774132|NCT00226109|Alcoholism|alcoholism
5774133|NCT00226109|cardiomyopathy|cardiomyopathy
5774134|NCT00226109|skeletal muscle|skeletal muscle
5774135|NCT00226109|spironolactone|spironolactone
5774136|NCT00226109|Na,K-pumps|na,k-pumps
5774137|NCT00226109|Magnesium|magnesium
5774138|NCT00226096|Clinical Trial|clinical trial
5774139|NCT00226096|Blood Pressure|blood pressure
5774140|NCT00226096|CVA (Cerebrovascular Accident)|cva (cerebrovascular accident)
5774141|NCT00226070|selfrated health,|selfrated health,
5774142|NCT00226070|SF-36,|sf-36,
5774143|NCT00226070|rehabilitation,|rehabilitation,
5774144|NCT00226070|total hip replacement,|total hip replacement,
5774145|NCT00226070|patients above 65|patients above 65
5774146|NCT00226057|Atopic dermatitis|atopic dermatitis
5774147|NCT00226057|Raptiva|raptiva
5774148|NCT00226044|Omeprazole, suppository, infants|omeprazole, suppository, infants
5774149|NCT00226031|Osteoporosis|osteoporosis
5774150|NCT00226031|Wrist fractures|wrist fractures
5774151|NCT00226031|Knowledge translation|knowledge translation
5774152|NCT00226031|Implementation|implementation
5774153|NCT00226031|Educational reminder|educational reminder
5774154|NCT00226005|pancreas|pancreas
5774155|NCT00226005|adenocarcinoma|adenocarcinoma
5774157|NCT00226005|metastatic|metastatic
5774158|NCT00226005|advanced cancer|advanced cancer
5774159|NCT00226005|Phase II|phase ii
5774160|NCT00226005|growth factor|growth factor
5774161|NCT00226005|VEGF|vegf
5774162|NCT00226005|angiogenesis|angiogenesis
5774163|NCT00225979|Acromegaly|acromegaly
5774164|NCT00225979|Untreated|untreated
5774165|NCT00225979|Newly diagnosed|newly diagnosed
5774166|NCT00225979|Octreotide LAR|octreotide lar
5774167|NCT00225979|Pituitary surgery|pituitary surgery
5774168|NCT00225966|Urinary urgency-frequency|urinary urgency-frequency
5774169|NCT00225927|invasive breast cancer|invasive breast cancer
5774170|NCT00225927|in situ breast cancer|in situ breast cancer
5774171|NCT00225927|radioguided seed localization|radioguided seed localization
5774172|NCT00225927|nonpalpable tumour|nonpalpable tumour
5774173|NCT00225927|needle localization|needle localization
5774174|NCT00225927|margin status|margin status
5774175|NCT00225914|Menopause|menopause
5774176|NCT00225914|Hormone Therapy|hormone therapy
5774177|NCT00225914|Paxil|paxil
5774178|NCT00225914|Hot Flash|hot flash
5774179|NCT00225914|Sleep Disturbance|sleep disturbance
5774180|NCT00225914|Night Sweats|night sweats
5774181|NCT00225914|Antidepressants|antidepressants
5774182|NCT00225888|Diabetes|diabetes
5774183|NCT00225888|Nutrition|nutrition
5774184|NCT00225888|Digital photography|digital photography
5774185|NCT00225888|Self-management|self-management
5774186|NCT00225875|Autoimmune thrombocytopenic purpura|autoimmune thrombocytopenic purpura
5774187|NCT00225875|Rituximab|rituximab
5774189|NCT00225862|Restless Legs Syndrome|restless legs syndrome
5774190|NCT00225849|Aspirin|aspirin
5774191|NCT00225849|Primary prevention|primary prevention
5774192|NCT00225836|Dysmenorrhoea|dysmenorrhoea
5774193|NCT00225836|Women|women
5774194|NCT00225836|Pain|pain
5774195|NCT00225836|TENS|tens
5774196|NCT00225823|Seasonal Allergic Rhinitis Intranasal Corticosteroid|seasonal allergic rhinitis intranasal corticosteroid
5774197|NCT00225797|chronic pain|chronic pain
5774198|NCT00225797|lower back|lower back
5774199|NCT00225797|opioid|opioid
5774200|NCT00225797|efficacy|efficacy
5774201|NCT00225797|safety|safety
5774202|NCT00225784|Stage I, II, III pancreatic adenocarcinoma|stage i, ii, iii pancreatic adenocarcinoma
5774203|NCT00225784|Radiographically measurable disease|radiographically measurable disease
5774204|NCT00225758|breast cancer|breast cancer
5774205|NCT00225758|endocrine therapy|endocrine therapy
5774206|NCT00225758|drug resistance|drug resistance
5774207|NCT00225758|lapatinib|lapatinib
5774208|NCT00225758|epidermal growth factor receptor|epidermal growth factor receptor
5774209|NCT00225745|Ghrelin|ghrelin
5774210|NCT00225693|coronary artery|coronary artery
5774211|NCT00225693|restenosis|restenosis
5774212|NCT00225693|patency|patency
5774213|NCT00225693|drug eluting|drug eluting
5774214|NCT00225693|stent|stent
5774217|NCT00225680|drug eluting|drug eluting
5774218|NCT00225680|patency|patency
5774219|NCT00225680|restenosis|restenosis
5774220|NCT00225667|Atrial Fibrillation|atrial fibrillation
5774221|NCT00225667|Arrhythmia|arrhythmia
5774222|NCT00225667|Pacemaker, Artificial|pacemaker, artificial
5774223|NCT00225667|Atrial High Rate Episodes|atrial high rate episodes
5774224|NCT00225667|Electrophysiology|electrophysiology
5774225|NCT00225667|Renin-Angiotensin System|renin-angiotensin system
5774226|NCT00225667|Hypertension|hypertension
5774227|NCT00225667|Cardiac Remodeling|cardiac remodeling
5774228|NCT00225654|coronary artery|coronary artery
5774230|NCT00225654|drug eluting|drug eluting
5774231|NCT00225654|patency|patency
5774232|NCT00225654|restenosis|restenosis
5774233|NCT00225641|Follow-up|follow-up
5774234|NCT00225628|Computerized clinical decision support|computerized clinical decision support
5774235|NCT00225628|Patient Safety|patient safety
5774236|NCT00225628|Quality of Care|quality of care
5774237|NCT00225628|Electronic Medical Records|electronic medical records
5774238|NCT00225628|Chronic Disease Management|chronic disease management
5774239|NCT00225628|Drug Monitoring|drug monitoring
5774240|NCT00225628|Guideline Adherence|guideline adherence
5774241|NCT00225628|Reminder Systems|reminder systems
5774242|NCT00225615|Phenylalanine Hydroxylase|phenylalanine hydroxylase
5774243|NCT00225602|Schizophrenia|schizophrenia
5774244|NCT00225602|Assertive community treatment|assertive community treatment
5774245|NCT00225589|Hypercholesteremia|hypercholesteremia
5774246|NCT00225576|medication errors|medication errors
5774247|NCT00225576|adverse drug events|adverse drug events
5774248|NCT00225576|electronic health records|electronic health records
5774249|NCT00225563|Electronic medical records|electronic medical records
5774250|NCT00225563|Electronic prescribing|electronic prescribing
5774251|NCT00225563|Quality measures|quality measures
5774252|NCT00225550|Cancer;|cancer;
5774253|NCT00225550|Tumors;|tumors;
5774254|NCT00225550|Neoplasms;|neoplasms;
5774255|NCT00225550|Anticarcinogenic Agents;|anticarcinogenic agents;
5774256|NCT00225550|Antineoplastic Agents;|antineoplastic agents;
5774260|NCT00225537|methylumbelliferone|methylumbelliferone
5774261|NCT00225537|liver|liver
5774262|NCT00225537|hepatitis|hepatitis
5774263|NCT00225537|viral|viral
5774264|NCT00225537|heparvit|heparvit
5774265|NCT00225537|hiv|hiv
5774266|NCT00225537|aids|aids
5774267|NCT00225524|Depression|depression
5774268|NCT00225511|Depression|depression
5774269|NCT00225485|Depression|depression
5774270|NCT00225459|Religious psychology|religious psychology
5774271|NCT00225459|Anxiety disorder|anxiety disorder
5774272|NCT00225459|Mood disorder|mood disorder
5774273|NCT00225459|Suicide|suicide
5774274|NCT00225446|Orthognathic surgery.|orthognathic surgery.
5774275|NCT00225446|optic repositioning system.|optic repositioning system.
5774276|NCT00225433|infertility|infertility
5774277|NCT00225433|in vitro fertilization|in vitro fertilization
5774278|NCT00225420|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5774279|NCT00225420|stage I prostate cancer|stage i prostate cancer
5774280|NCT00225420|stage II prostate cancer|stage ii prostate cancer
5774281|NCT00225420|stage III prostate cancer|stage iii prostate cancer
5774282|NCT00225420|stage IV prostate cancer|stage iv prostate cancer
5774283|NCT00225407|Cannabis|cannabis
5774284|NCT00225407|Tetrahydrocannabinol|tetrahydrocannabinol
5774285|NCT00225407|Pharmacokinetics|pharmacokinetics
5774286|NCT00225407|Psychomotor tests|psychomotor tests
5774287|NCT00225407|Event related potentials|event related potentials
5774288|NCT00225394|CMV|cmv
5774289|NCT00225394|Kidney Transplant|kidney transplant
5774290|NCT00225394|Pancreas Transplant|pancreas transplant
5774291|NCT00225394|Ganciclovir-resistance|ganciclovir-resistance
5774292|NCT00225394|Valganciclovir|valganciclovir
5774293|NCT00225394|CMV Disease|cmv disease
5774294|NCT00225381|Oxygen consumption|oxygen consumption
5774295|NCT00225381|CO2 production|co2 production
5774296|NCT00225381|Indirect calorimetry|indirect calorimetry
5774297|NCT00225381|Non steady state|non steady state
5774298|NCT00225381|Anesthesia monitoring|anesthesia monitoring
5774299|NCT00225381|Critical events during anesthesia|critical events during anesthesia
5774300|NCT00225381|Acid base balance|acid base balance
5774301|NCT00225381|Metabolism during anesthesia|metabolism during anesthesia
5774302|NCT00225368|Malaria|malaria
5774303|NCT00225368|All-cause mortality|all-cause mortality
5774304|NCT00225368|Africa|africa
5774305|NCT00225368|Burkina Faso|burkina faso
5774306|NCT00225355|Angina pectoris|angina pectoris
5774307|NCT00225355|Metabolic syndrome|metabolic syndrome
5774308|NCT00225355|Ischaemic heart disease|ischaemic heart disease
5774309|NCT00225342|Angina|angina
5774310|NCT00225342|Ischaemic heart disease|ischaemic heart disease
5774311|NCT00225342|Diabetes|diabetes
5774312|NCT00225329|RCT|rct
5774313|NCT00225329|intervention study|intervention study
5774314|NCT00225329|labour management|labour management
5774315|NCT00225329|assessment|assessment
5774316|NCT00225316|RCT|rct
5774317|NCT00225316|intervention study|intervention study
5774319|NCT00225316|substance use|substance use
5774320|NCT00225316|pregnancy|pregnancy
5774321|NCT00225303|HIV infection|hiv infection
5774322|NCT00225303|TMC125|tmc125
5774323|NCT00225303|Non-Nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5774324|NCT00225303|Protease inhibitor|protease inhibitor
5774325|NCT00225303|TMC125-C227|tmc125-c227
5774326|NCT00225290|Phase III|phase iii
5774327|NCT00225290|Hepatocellular Carcinoma|hepatocellular carcinoma
5791746|NCT00136903|Mesenchymal stem cells|mesenchymal stem cells
5791747|NCT00136903|Adult stem cells|adult stem cells
5791772|NCT00136825|cocaine|cocaine
5774328|NCT00225277|Glucose Metabolism Disorder|glucose metabolism disorder
5774329|NCT00225277|Dysmetabolic Syndrome|dysmetabolic syndrome
5774330|NCT00225277|Type II Diabetes|type ii diabetes
5686396|NCT00552344|Certolizumab Pegol|certolizumab pegol
5774331|NCT00225277|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5774332|NCT00225277|Dyslipidemia|dyslipidemia
5774333|NCT00225277|Drug Therapy|drug therapy
5774334|NCT00225277|Atherosclerosis|atherosclerosis
5774335|NCT00225264|Glucose Metabolism Disorder|glucose metabolism disorder
5774336|NCT00225264|Dysmetabolic Syndrome|dysmetabolic syndrome
5774337|NCT00225264|Type II Diabetes|type ii diabetes
5774338|NCT00225264|Diabetes Mellitus, Lipoatrophic|diabetes mellitus, lipoatrophic
5774339|NCT00225264|Dyslipidemia|dyslipidemia
5774340|NCT00225264|Drug Therapy|drug therapy
5774341|NCT00225251|Dysthymic Disorder|dysthymic disorder
5774342|NCT00225251|Dysthymia|dysthymia
5774343|NCT00225251|Depression|depression
5774344|NCT00225251|Chronic Depression|chronic depression
5774346|NCT00225238|colonoscopy prep|colonoscopy prep
5774347|NCT00225212|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5774348|NCT00225212|diffuse large cell lymphoma|diffuse large cell lymphoma
5774349|NCT00225212|mantle cell lymphoma|mantle cell lymphoma
5774350|NCT00225212|transformed lymphoma|transformed lymphoma
5774351|NCT00225212|other subtypes of B cell lymphoma|other subtypes of b cell lymphoma
5774352|NCT00225212|recurrent lymphoma|recurrent lymphoma
5774353|NCT00225173|nodular sclerosis|nodular sclerosis
5774354|NCT00225173|lymphocyte rich|lymphocyte rich
5774355|NCT00225173|lymphocyte depleted|lymphocyte depleted
5774356|NCT00225173|mixed cellularity|mixed cellularity
5774357|NCT00225160|HIV|hiv
5774358|NCT00225160|poly neuropathy|poly neuropathy
5774359|NCT00225160|acetyl L-carnitine|acetyl l-carnitine
5774360|NCT00225160|treatment naïve|treatment naïve
5774361|NCT00225160|combination antiretroviral therapy|combination antiretroviral therapy
5774362|NCT00225160|Lipid abnormalities|lipid abnormalities
5774363|NCT00225108|Deep vein thrombosis|deep vein thrombosis
5774364|NCT00225108|bleeding|bleeding
5774365|NCT00225095|meniscectomy|meniscectomy
5774366|NCT00225095|Chondrogen|chondrogen
5774367|NCT00225095|Mesenchymal Stem Cells|mesenchymal stem cells
5774368|NCT00225095|Osiris|osiris
5774369|NCT00225082|Lipoatrophy|lipoatrophy
5774370|NCT00225082|Mitochondrial function|mitochondrial function
5774371|NCT00225082|Nucleoside analogue switch|nucleoside analogue switch
5774372|NCT00225082|Treatment Experienced|treatment experienced
5774373|NCT00225069|Facial blushing|facial blushing
5774374|NCT00225069|Sympathectomy|sympathectomy
5774375|NCT00225017|Atazanavir|atazanavir
5774376|NCT00225017|Endothelial function|endothelial function
5774377|NCT00225017|Treatment Experienced|treatment experienced
5774378|NCT00225004|Colles Fracture|colles fracture
5774379|NCT00225004|Osteoporosis|osteoporosis
5774380|NCT00225004|BMD|bmd
5774381|NCT00225004|Quality assurance|quality assurance
5774382|NCT00224991|osteoporosis|osteoporosis
5774383|NCT00224991|fall frequency|fall frequency
5774384|NCT00224991|medical treatment|medical treatment
5774385|NCT00224991|compliance|compliance
5774386|NCT00224991|quality of life|quality of life
5774387|NCT00224991|systematic education|systematic education
5774388|NCT00224965|nicotine dependence|nicotine dependence
5774389|NCT00224952|seizures|seizures
5774390|NCT00224952|Epilepsy|epilepsy
5774391|NCT00224926|Tinea Capitis|tinea capitis
5774392|NCT00224913|osteoarthritis|osteoarthritis
5774393|NCT00224913|quadriceps|quadriceps
5774394|NCT00224913|inhibition|inhibition
5774395|NCT00224913|functional outcome|functional outcome
5774396|NCT00224913|electrical stimulation|electrical stimulation
5774397|NCT00224900|Perinatally-acquired HIV infection|perinatally-acquired hiv infection
5774398|NCT00224900|Life Skills|life skills
5774399|NCT00224900|Focus Group|focus group
5774400|NCT00224900|Young adolescents|young adolescents
5774401|NCT00224900|Caregivers|caregivers
5774402|NCT00224874|Acute Graft vs Host Disease|acute graft vs host disease
5774403|NCT00224874|GVHD|gvhd
5774404|NCT00224822|Psychiatry|psychiatry
5774405|NCT00224822|Antipsychotic|antipsychotic
5774406|NCT00224822|Psychopharmacology|psychopharmacology
5774407|NCT00224822|Clinical Trial|clinical trial
5774408|NCT00224822|Open Label|open label
5774409|NCT00224822|Schizophrenia|schizophrenia
5774410|NCT00224822|Schizoaffective Disorder|schizoaffective disorder
5774411|NCT00224822|Bipolar Disorder|bipolar disorder
5774412|NCT00224822|Metabolic Syndrome|metabolic syndrome
5774413|NCT00224796|Wound closure|wound closure
5774414|NCT00224796|Foot salvage|foot salvage
5774415|NCT00224796|Accelerated healing|accelerated healing
5774416|NCT00224796|Amputation Wounds of the Diabetic Foot|amputation wounds of the diabetic foot
5774417|NCT00224757|Echocardiography|echocardiography
5774418|NCT00224744|Vulvar Neoplasms|vulvar neoplasms
5774419|NCT00224744|Skin Neoplasms|skin neoplasms
5774420|NCT00224744|Ultracision|ultracision
5774421|NCT00224744|Lymphadenectomy|lymphadenectomy
5774422|NCT00224731|Attention disorder with hyperactivity|attention disorder with hyperactivity
5774423|NCT00224731|sleep|sleep
5774424|NCT00224731|stimulants|stimulants
5774425|NCT00224731|actigraphy|actigraphy
5774426|NCT00224718|Abdominal aortic aneurysm|abdominal aortic aneurysm
5774427|NCT00224718|Endograft|endograft
5774428|NCT00224718|Open repair|open repair
5774429|NCT00224718|Endovascular repair|endovascular repair
5774430|NCT00224718|AAA|aaa
5774431|NCT00224705|Albumin dialysis|albumin dialysis
5774432|NCT00224705|MARS system|mars system
5774433|NCT00224705|Extracorporeal artificial liver support|extracorporeal artificial liver support
5774434|NCT00224705|Fulminant hepatitis|fulminant hepatitis
5774435|NCT00224705|Subfulminant hepatitis|subfulminant hepatitis
5774436|NCT00224705|Acute liver failure|acute liver failure
5774437|NCT00224692|Mucositis|mucositis
5774438|NCT00224692|Pain|pain
5774439|NCT00224692|Morphine|morphine
5774440|NCT00224692|Ketamine|ketamine
5774441|NCT00224679|Colon cancer|colon cancer
5774442|NCT00224679|Aspirin|aspirin
5774443|NCT00224679|Adenomas|adenomas
5774444|NCT00224679|Prevention|prevention
5774445|NCT00224666|Cortex stimulation ,Rebel neuropathic pains|cortex stimulation ,rebel neuropathic pains
5774447|NCT00224653|Respiration. Respiration, artificial.|respiration. respiration, artificial.
5774448|NCT00224653|Ventilation. Pressure controlled. Volume controlled.|ventilation. pressure controlled. volume controlled.
5774449|NCT00224640|Iron-chelating treatment|iron-chelating treatment
5774450|NCT00224627|Randomized study|randomized study
5774451|NCT00224627|Capsule endoscopy|capsule endoscopy
5774452|NCT00224627|Push enteroscopy|push enteroscopy
5774453|NCT00224627|Occult gastrointestinal bleeding|occult gastrointestinal bleeding
5774454|NCT00224627|Endoscopy|endoscopy
5774455|NCT00224614|stem cell transplantation|stem cell transplantation
5774456|NCT00224614|reduced-intensity conditioning regimen|reduced-intensity conditioning regimen
5774457|NCT00224614|acute myeloid leukemia|acute myeloid leukemia
5774458|NCT00224601|Colorectal cancer|colorectal cancer
5774463|NCT00224601|Indigo carmine|indigo carmine
5774464|NCT00224601|Colorectal Neoplasms|colorectal neoplasms
5774465|NCT00224601|Hereditary Nonpolyposis|hereditary nonpolyposis
5774466|NCT00224588|Ketamine|ketamine
5774467|NCT00224588|Chronic post thoracotomy pain|chronic post thoracotomy pain
5774468|NCT00224588|NMDA|nmda
5774469|NCT00224588|Post operative|post operative
5774470|NCT00224575|Veterans|veterans
5774471|NCT00224562|TNF alpha antagonists|tnf alpha antagonists
5774472|NCT00224562|infections|infections
5774473|NCT00224562|lymphoma|lymphoma
5774474|NCT00224562|safety|safety
5774475|NCT00224549|Resistant hypertension|resistant hypertension
5774476|NCT00224549|Combined diuretic therapy|combined diuretic therapy
5774477|NCT00224549|Combined RAS blockers|combined ras blockers
5801235|NCT00103012|HV|hv
5784382|NCT00172588|adenomyosis|adenomyosis
5774478|NCT00224536|Myocardial infarction|myocardial infarction
5774479|NCT00224536|Bone marrow cells|bone marrow cells
5774480|NCT00224536|Intracoronary|intracoronary
5774481|NCT00224523|perennial allergic rhinitis|perennial allergic rhinitis
5774482|NCT00224523|nasal biopsy|nasal biopsy
5774483|NCT00224523|GW685698X|gw685698x
5774484|NCT00224510|bipolar disorder bipolar depression lamotrigine|bipolar disorder bipolar depression lamotrigine
5774485|NCT00224497|Alzheimer's disease|alzheimer's disease
5774486|NCT00224497|cognition global functioning|cognition global functioning
5774487|NCT00224497|symptomatic|symptomatic
5774488|NCT00224497|B-742457|b-742457
5774489|NCT00224484|Herpes Simplex vaccine|herpes simplex vaccine
5774490|NCT00224484|Safety|safety
5774491|NCT00224484|Adolescents|adolescents
5774492|NCT00224484|Immunogenicity|immunogenicity
5774493|NCT00224471|Adolescents|adolescents
5774494|NCT00224471|Immunogenicity|immunogenicity
5774495|NCT00224471|Safety|safety
5774496|NCT00224471|Herpes Simplex vaccine|herpes simplex vaccine
5774497|NCT00224458|Treatment Experienced|treatment experienced
5774498|NCT00224458|HIV-1|hiv-1
5774499|NCT00224445|Treatment Naive|treatment naive
5774500|NCT00224445|HIV-1|hiv-1
5774501|NCT00224432|Atopic Dermatitis|atopic dermatitis
5774502|NCT00224432|SCORAD|scorad
5774503|NCT00224432|probiotics|probiotics
5774504|NCT00224432|cytokines|cytokines
5774505|NCT00224432|Infant|infant
5774506|NCT00224419|Smoking cessation|smoking cessation
5774507|NCT00224419|Pregnancy|pregnancy
5774508|NCT00224419|Nicotine replacement therapy|nicotine replacement therapy
5774509|NCT00224419|Motivational interviewing|motivational interviewing
5774510|NCT00224406|Lung transplantation|lung transplantation
5774511|NCT00224406|Reperfusion Injury|reperfusion injury
5774512|NCT00224406|Survival|survival
5774513|NCT00224393|Amyloidosis|amyloidosis
5774514|NCT00224393|Enbrel|enbrel
5774515|NCT00224380|Serious mental illness|serious mental illness
5774516|NCT00224380|medication adherence|medication adherence
5774519|NCT00224367|ambulation|ambulation
5774520|NCT00224354|LYMPHOCYTIC|lymphocytic
5774521|NCT00224354|B-LEUKEMIA|b-leukemia
5774523|NCT00224341|Pacemaker|pacemaker
5774524|NCT00224341|Atrial Fibrillation|atrial fibrillation
5774525|NCT00224341|Prevention pacing|prevention pacing
5774526|NCT00224341|Algorithms|algorithms
5774527|NCT00224341|Sick sinus syndrome + Atrial Fibrillation|sick sinus syndrome + atrial fibrillation
5774528|NCT00224328|Tissue Oxygen Saturation|tissue oxygen saturation
5774529|NCT00224328|Peripheral Arterial Disease|peripheral arterial disease
5774530|NCT00224328|Critical Limb Ischemia|critical limb ischemia
5774531|NCT00224328|Near-infrared Spectroscopy|near-infrared spectroscopy
5774532|NCT00224315|Schizophrenia,|schizophrenia,
5773601|NCT00228878|Diabetes|diabetes
5774533|NCT00224315|schizoaffective disorder,|schizoaffective disorder,
5774534|NCT00224315|treatment resistancy|treatment resistancy
5774535|NCT00224315|clozapine,|clozapine,
5774536|NCT00224315|ziprasidone|ziprasidone
5774537|NCT00224315|risperidone|risperidone
5774538|NCT00224315|combination|combination
5774539|NCT00224302|Schizophrenia,|schizophrenia,
5774540|NCT00224302|schizoaffective disorder,|schizoaffective disorder,
5774541|NCT00224302|major depressive episode,|major depressive episode,
5774542|NCT00224302|combination,|combination,
5774543|NCT00224302|duloxetine|duloxetine
5774544|NCT00224289|Latanoprost|latanoprost
5774545|NCT00224289|Glaucoma|glaucoma
5774546|NCT00224289|Intraocular pressure|intraocular pressure
5774547|NCT00224263|Traditional Chinese Medicine|traditional chinese medicine
5774549|NCT00224237|Latino patients|latino patients
5774550|NCT00224237|Health practices|health practices
5774551|NCT00224237|Culture influences|culture influences
5774552|NCT00224224|Clinical performance|clinical performance
5774553|NCT00224224|Continuity of care|continuity of care
5774554|NCT00224224|Utilization of resources|utilization of resources
5774555|NCT00224185|Healthy individuals|healthy individuals
5774556|NCT00224185|smokers|smokers
5774557|NCT00224185|ex-smokers|ex-smokers
5774558|NCT00224185|non-smokers|non-smokers
5774559|NCT00224172|Pre-hospitalization characteristics|pre-hospitalization characteristics
5774560|NCT00224172|Post-hospitalization characteristics|post-hospitalization characteristics
5774561|NCT00224172|Psychosocial measures|psychosocial measures
5774562|NCT00224172|Predict re-hospitalization|predict re-hospitalization
5774563|NCT00224159|Statin therapy|statin therapy
5774564|NCT00224159|Dietary behavior|dietary behavior
5774565|NCT00224159|Attitudes and beliefs|attitudes and beliefs
5774566|NCT00224159|Self efficacy|self efficacy
5774567|NCT00224146|Oxytrol(r)|oxytrol(r)
5774568|NCT00224146|transdermal oxybutynin|transdermal oxybutynin
5774569|NCT00224146|overactive bladder|overactive bladder
5774570|NCT00224133|benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
5774571|NCT00224120|Benign prostatic hyperplasia, alpha blocker|benign prostatic hyperplasia, alpha blocker
5774572|NCT00224107|Benign prostatic hyperplasia, BPH, alpha blocker|benign prostatic hyperplasia, bph, alpha blocker
5774573|NCT00224094|Menopause|menopause
5681075|NCT00574808|Prevention of Cardiovascular Disease|prevention of cardiovascular disease
5848028|NCT00036595|Coherence|coherence
5681076|NCT00574808|Chronic Disease Management|chronic disease management
5681077|NCT00574808|Chronic Disease Prevention|chronic disease prevention
5774574|NCT00224094|Testosterone|testosterone
5774575|NCT00224094|Androgens|androgens
5774576|NCT00224094|Sex Hormone Binding Globulin|sex hormone binding globulin
5774577|NCT00224094|Thyroid function|thyroid function
5774578|NCT00224094|Cortisol|cortisol
5774579|NCT00224081|iron deficiency anemia|iron deficiency anemia
5774580|NCT00224081|ferritin|ferritin
5774581|NCT00224081|hemodialysis|hemodialysis
5774582|NCT00224081|sodium ferric gluconate|sodium ferric gluconate
5774583|NCT00224081|epoetin alfa|epoetin alfa
5774584|NCT00224068|Iron deficiency|iron deficiency
5774585|NCT00224068|Sodium ferric gluconate|sodium ferric gluconate
5774586|NCT00224068|anemia|anemia
5774587|NCT00224068|cancer chemotherapy|cancer chemotherapy
5774588|NCT00224068|epoetin alfa|epoetin alfa
5774589|NCT00224068|Anemia/drug therapy|anemia/drug therapy
5774590|NCT00224068|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5774591|NCT00224068|Hematinics/administration & dosage/pharmacology|hematinics/administration & dosage/pharmacology
5774592|NCT00224068|Antineoplastic Agents/adverse effects|antineoplastic agents/adverse effects
5774593|NCT00224068|Erythropoietin, Recombinant/therapeutic use/adverse effects|erythropoietin, recombinant/therapeutic use/adverse effects
5774594|NCT00224055|Iron deficiency|iron deficiency
5774595|NCT00224055|Anemia|anemia
5774596|NCT00224055|Chronic kidney disease|chronic kidney disease
5774597|NCT00224055|Sodium Ferric Gluconate|sodium ferric gluconate
5774598|NCT00224055|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5774599|NCT00224055|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
5774600|NCT00224042|Iron deficiency|iron deficiency
5774601|NCT00224042|Anemia|anemia
5774602|NCT00224042|Chronic kidney disease|chronic kidney disease
5774603|NCT00224042|Erythropoietic agents|erythropoietic agents
5774604|NCT00224042|Sodium Ferric Gluconate|sodium ferric gluconate
5774605|NCT00224042|Anemia, Iron-Deficiency/drug therapy/etiology|anemia, iron-deficiency/drug therapy/etiology
5774606|NCT00224042|Kidney Failure, Chronic/blood/complications/therapy|kidney failure, chronic/blood/complications/therapy
5774607|NCT00224042|Erythropoietin, Recombinant/adverse effects/therapeutic use|erythropoietin, recombinant/adverse effects/therapeutic use
5774609|NCT00223990|Plasmodium|plasmodium
5774610|NCT00223990|falciparum|falciparum
5774611|NCT00223990|malaria|malaria
5774612|NCT00223990|vaccine|vaccine
5774613|NCT00223990|AS02A adjuvant|as02a adjuvant
5774614|NCT00223990|FMP1|fmp1
5774615|NCT00223990|Merozoite surface protein-1|merozoite surface protein-1
5774616|NCT00223977|Anemia.|anemia.
5774617|NCT00223964|Iron Deficiency|iron deficiency
5774618|NCT00223964|Anemia in Pediatric Hemodialysis|anemia in pediatric hemodialysis
5681074|NCT00574808|Primary care|primary care
5774619|NCT00223951|Healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic|healthy volunteers, safety, ocular, allergic conjunctivitis, ophthalmic
5774620|NCT00223925|Stem cell transplantation|stem cell transplantation
5774621|NCT00223925|Allogeneic transplantation|allogeneic transplantation
5774622|NCT00223912|Cardiovascular Disease|cardiovascular disease
5774623|NCT00223912|Exercise|exercise
5774624|NCT00223912|Functional electrical stimulation|functional electrical stimulation
5774625|NCT00223912|hemostasis|hemostasis
5774626|NCT00223912|Spinal cord injury|spinal cord injury
5774627|NCT00223899|Melanoma|melanoma
5774628|NCT00223899|Electroporation|electroporation
5774629|NCT00223899|IL-2|il-2
5774630|NCT00223873|Penile Vibratory Stimulation|penile vibratory stimulation
5774631|NCT00223873|Muscles Spasticity|muscles spasticity
5774632|NCT00223873|Spasms|spasms
5774633|NCT00223873|Ferti Care Vibrator|ferti care vibrator
5774634|NCT00223873|Antispasmotic treatment|antispasmotic treatment
5774635|NCT00223860|Hypogonadal|hypogonadal
5774636|NCT00223860|Hypothalamus|hypothalamus
5774637|NCT00223860|Pituitary|pituitary
5774638|NCT00223860|Spinal Cord Injury|spinal cord injury
5774639|NCT00223860|Testes|testes
5774640|NCT00223860|Testosterone|testosterone
5774641|NCT00223847|Aphasia rehabilitation|aphasia rehabilitation
5774642|NCT00223847|Aphasia therapy|aphasia therapy
5774643|NCT00223847|Constraint therapy|constraint therapy
5774644|NCT00223847|Language therapy|language therapy
5774645|NCT00223834|Counseling|counseling
5774646|NCT00223834|Motivation|motivation
5774647|NCT00223834|Psychotherapy, brief|psychotherapy, brief
5774648|NCT00223821|Behavior Therapy|behavior therapy
5774649|NCT00223821|Behavioral Medicine|behavioral medicine
5774650|NCT00223821|Behavioral Research|behavioral research
5774651|NCT00223821|Behavioral Sciences|behavioral sciences
5774652|NCT00223821|Combined Modality Therapy|combined modality therapy
5774653|NCT00223821|Drug Therapy|drug therapy
5774654|NCT00223821|Overactive bladder|overactive bladder
5774655|NCT00223821|Treatment Outcome|treatment outcome
5774656|NCT00223821|Urge incontinence|urge incontinence
5774657|NCT00223821|Urinary incontinence|urinary incontinence
5774658|NCT00223808|Rehabilitation|rehabilitation
5774659|NCT00223808|Robotics|robotics
5774660|NCT00223795|Cane|cane
5774661|NCT00223795|Gait|gait
5774662|NCT00223795|Obesity|obesity
5774663|NCT00223795|Osteoarthritis|osteoarthritis
5774664|NCT00223795|Walking Aids|walking aids
5774665|NCT00223782|Diabetes|diabetes
5774666|NCT00223782|Peripheral Neuropathy|peripheral neuropathy
5774667|NCT00223782|Walking|walking
5774668|NCT00223769|oxandrolone|oxandrolone
5774669|NCT00223769|oxandrin|oxandrin
5774670|NCT00223769|lean body mass|lean body mass
5774671|NCT00223769|functional recovery|functional recovery
5774672|NCT00223769|resistance training|resistance training
5774673|NCT00223756|Vision, Low|vision, low
5774674|NCT00223743|essential tremor|essential tremor
5774675|NCT00223743|zonisamide|zonisamide
5774676|NCT00223743|clinical trial|clinical trial
5774677|NCT00223730|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5774678|NCT00223730|Bone Marrow Transplant|bone marrow transplant
5774679|NCT00223730|Citrulline|citrulline
5774680|NCT00223730|Urea Cycle|urea cycle
5774681|NCT00223730|Hepatic Injury|hepatic injury
5774682|NCT00223730|Allogeneic PBSCT|allogeneic pbsct
5774683|NCT00223730|Matched-Unrelated PBSCT|matched-unrelated pbsct
5774684|NCT00223717|Supine Hypertension|supine hypertension
5774685|NCT00223717|Hypertension|hypertension
5774686|NCT00223717|Treatment|treatment
5774687|NCT00223717|Autonomic failure|autonomic failure
5774688|NCT00223717|Pure autonomic failure|pure autonomic failure
5774689|NCT00223717|Multiple System Atrophy|multiple system atrophy
5774690|NCT00223717|Shy-Drager Syndrome|shy-drager syndrome
5774691|NCT00223704|Coronary Artery Bypass|coronary artery bypass
5774692|NCT00223704|Blood Transfusion|blood transfusion
5774693|NCT00223704|Bradykinin Receptor Antagonism|bradykinin receptor antagonism
5774694|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents
5774695|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents
5774696|NCT00223691|orthostatic hypotension|orthostatic hypotension
5774697|NCT00223691|autonomic failure|autonomic failure
5774698|NCT00223665|Intermittent Hormone Therapy|intermittent hormone therapy
5774699|NCT00223665|Intermittent Androgen Suppression|intermittent androgen suppression
5774700|NCT00223665|Biochemical Relapsed Prostate Cancer|biochemical relapsed prostate cancer
5774701|NCT00223665|Androgen Deprivation Therapy|androgen deprivation therapy
5774702|NCT00223665|Localized Prostate Cancer|localized prostate cancer
5774703|NCT00223652|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5774704|NCT00223652|Telephone psychotherapy|telephone psychotherapy
5774706|NCT00223652|Primary Care Clinic|primary care clinic
5774707|NCT00223652|Treatment for Depression|treatment for depression
5774708|NCT00223639|alcoholism /alcohol abuse|alcoholism /alcohol abuse
5774709|NCT00223639|alcoholism antagonist|alcoholism antagonist
5774710|NCT00223639|anticonvulsant|anticonvulsant
5774711|NCT00223639|cognition|cognition
5774712|NCT00223639|neuropharmacology|neuropharmacology
5774713|NCT00223639|substance abuse related behavior|substance abuse related behavior
5783697|NCT00176462|Leukemia|leukemia
5774714|NCT00223639|craving|craving
5774715|NCT00223639|euphoria|euphoria
5774716|NCT00223639|relapse /recurrence|relapse /recurrence
5774717|NCT00223639|patient oriented research|patient oriented research
5774718|NCT00223626|Cocaine Addiction|cocaine addiction
5774719|NCT00223626|Cocaine Dependence|cocaine dependence
5774720|NCT00223613|diabetes|diabetes
5774721|NCT00223613|juvenile diabetes|juvenile diabetes
5774722|NCT00223613|insulin deficiency|insulin deficiency
5774723|NCT00223600|lipids|lipids
5774724|NCT00223600|lipoproproteins|lipoproproteins
5774725|NCT00223600|growth|growth
5774726|NCT00223600|neurological development|neurological development
5774727|NCT00223600|vascular wall|vascular wall
5774728|NCT00223600|blood pressure|blood pressure
5774729|NCT00223600|nutrient intake|nutrient intake
5774730|NCT00223587|driving|driving
5774731|NCT00223587|memory|memory
5774732|NCT00223561|adult|adult
5774733|NCT00223548|prophylaxis|prophylaxis
5774734|NCT00223548|contrast-induced nephropathy|contrast-induced nephropathy
5774735|NCT00223548|mesna|mesna
5774736|NCT00223548|acute renal failure|acute renal failure
5774737|NCT00223535|Schizophrenia|schizophrenia
5774738|NCT00223535|Cognitive Remediation|cognitive remediation
5774739|NCT00223535|Social Skills Training|social skills training
5774740|NCT00223535|Psychosocial|psychosocial
5774741|NCT00223522|Schizophrenia|schizophrenia
5774742|NCT00223522|Schizoaffective|schizoaffective
5774743|NCT00223522|MEMS|mems
5774744|NCT00223522|adherence to antipsychotic medication|adherence to antipsychotic medication
5774745|NCT00223509|mixed mania|mixed mania
5774746|NCT00223509|lamotrigine|lamotrigine
5774747|NCT00223496|Bipolar Depression|bipolar depression
5774748|NCT00223496|Refractory|refractory
5774749|NCT00223483|Hematologic Diseases|hematologic diseases
5774750|NCT00223483|Genomics|genomics
5774751|NCT00223483|Cytokines|cytokines
5774752|NCT00223483|Chemokines|chemokines
5774755|NCT00223457|multiple sclerosis|multiple sclerosis
5774756|NCT00223457|compliance|compliance
5784666|NCT00171405|aliskiren|aliskiren
5774757|NCT00223457|adherence|adherence
5774758|NCT00223457|disease modifying therapy|disease modifying therapy
5774759|NCT00223457|depression|depression
5774761|NCT00223457|quality of life|quality of life
5774762|NCT00223444|alcohol|alcohol
5774763|NCT00223444|GABA|gaba
5774764|NCT00223444|genetic variation|genetic variation
5774765|NCT00223418|aripiprazole|aripiprazole
5774766|NCT00223418|olanzapine|olanzapine
5774767|NCT00223418|vocational|vocational
5774768|NCT00223418|learning|learning
5774769|NCT00223418|cognition|cognition
5774770|NCT00223418|cognitive|cognitive
5774771|NCT00223405|enamel wear against ceramic crowns|enamel wear against ceramic crowns
5774772|NCT00223379|Apical Periodontitis, Root Canal Therapy, Apical Preparation|apical periodontitis, root canal therapy, apical preparation
5774773|NCT00223366|Pain in teeth|pain in teeth
5774774|NCT00223353|Biomechanics|biomechanics
5774775|NCT00223353|Gait|gait
5774776|NCT00223353|Balance|balance
5774777|NCT00223340|patient activation|patient activation
5774778|NCT00223340|primary care|primary care
5774779|NCT00223340|diabetes|diabetes
5774780|NCT00223340|cardiovascular risk|cardiovascular risk
5774781|NCT00223327|pain|pain
5774782|NCT00223327|Normal pulp and normal periodontal status|normal pulp and normal periodontal status
5774783|NCT00223327|Chronic apical periodontitis of pulpal origin|chronic apical periodontitis of pulpal origin
5774784|NCT00223314|HIV|hiv
5774785|NCT00223314|Sexually Transmitted Diseases|sexually transmitted diseases
5774786|NCT00223314|Pregnancy|pregnancy
5774787|NCT00223314|HIV Seronegativity|hiv seronegativity
5774788|NCT00223275|Bipolar Disorder|bipolar disorder
5774789|NCT00223275|Alcohol Dependence|alcohol dependence
5774790|NCT00223275|Dual Diagnosis|dual diagnosis
5774791|NCT00223275|Naltrexone|naltrexone
5774792|NCT00223210|bipolar disorder|bipolar disorder
5774793|NCT00223210|cocaine dependence|cocaine dependence
5774794|NCT00223210|quetiapine|quetiapine
5774795|NCT00223197|Bipolar with depression|bipolar with depression
5774895|NCT00222794|Schizo-Affective Disorder|schizo-affective disorder
5774796|NCT00223197|Recurrent major depressive disorder|recurrent major depressive disorder
5774797|NCT00223197|substance abuse dependence|substance abuse dependence
5774798|NCT00223171|Stage T3 T4|stage t3 t4
5774799|NCT00223171|PSA > 20|psa > 20
5774801|NCT00223158|Thyroid cancer|thyroid cancer
5774802|NCT00223158|Hypothyroidism|hypothyroidism
5774803|NCT00223158|Whole Body Scintigraphy|whole body scintigraphy
5774804|NCT00223158|Liothyronine|liothyronine
5774805|NCT00223158|TSH elevation|tsh elevation
5774806|NCT00223145|Prostate adenocarcinoma|prostate adenocarcinoma
5774807|NCT00223145|Gleason score <= 6 and PSA 10-20|gleason score <= 6 and psa 10-20
5774808|NCT00223145|Gleason score = 7 and PSA <=20|gleason score = 7 and psa <=20
5774809|NCT00223132|bariatric surgery|bariatric surgery
5774810|NCT00223132|body contouring|body contouring
5774811|NCT00223132|skin laxity|skin laxity
5774812|NCT00223132|plastic surgery|plastic surgery
5774813|NCT00223132|suture granuloma|suture granuloma
5774814|NCT00223132|absorbable sutures|absorbable sutures
5774815|NCT00223119|perineal trauma|perineal trauma
5783798|NCT00176059|Th1|th1
5774816|NCT00223119|perineal laceration|perineal laceration
5774817|NCT00223119|persistent perineal pain|persistent perineal pain
5774818|NCT00223106|urge incontinence|urge incontinence
5774819|NCT00223106|urinary incontinence|urinary incontinence
5774820|NCT00223106|vault prolapse|vault prolapse
5774821|NCT00223106|stess incontinence|stess incontinence
5774822|NCT00223106|mixed incontinence|mixed incontinence
5774823|NCT00223106|urine leakage|urine leakage
5774824|NCT00223106|enterocele|enterocele
5774825|NCT00223106|rectocele|rectocele
5774826|NCT00223106|cystocele|cystocele
5774827|NCT00223093|renal transplantation, TAIZ-moncytes|renal transplantation, taiz-moncytes
5774828|NCT00223080|HIV Seronegativity|hiv seronegativity
5774829|NCT00223067|renal transplantation|renal transplantation
5774830|NCT00223067|TAIZ|taiz
5774831|NCT00223054|cyclosporin A|cyclosporin a
5774832|NCT00223054|Tacrolimus|tacrolimus
5774833|NCT00223054|Everolimus|everolimus
5774834|NCT00223054|Sirolimus|sirolimus
5774835|NCT00223054|Fluvastatin|fluvastatin
5774836|NCT00223041|renal transplantation|renal transplantation
5774837|NCT00223041|cardiovasculary disease|cardiovasculary disease
5774838|NCT00223041|statin|statin
5774839|NCT00223028|fluvastain|fluvastain
5774840|NCT00223028|sirolimus|sirolimus
5774841|NCT00223028|mycophenolat mofetil|mycophenolat mofetil
5774842|NCT00223028|renal transplantation|renal transplantation
5774843|NCT00223015|renal transplantation|renal transplantation
5774844|NCT00223015|pharmacokinetics|pharmacokinetics
5774845|NCT00223015|Fluvastatin|fluvastatin
5774846|NCT00223015|Mycophenolat mofetil|mycophenolat mofetil
5774847|NCT00223015|tacrolimus|tacrolimus
5774848|NCT00222989|GERD|gerd
5774849|NCT00222989|PPI|ppi
5774850|NCT00222989|Functional heartburn|functional heartburn
5774851|NCT00222963|Obesity|obesity
5774852|NCT00222963|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5774853|NCT00222963|Children|children
5774855|NCT00222963|Adenotonsillectomy|adenotonsillectomy
5774856|NCT00222950|plant sterols, serum, aortic valve cusps|plant sterols, serum, aortic valve cusps
5774857|NCT00222937|Voice Problems|voice problems
5774858|NCT00222937|Voice Disorders|voice disorders
5774859|NCT00222924|Mitochondria|mitochondria
5774860|NCT00222911|plantar fasciitis|plantar fasciitis
5774861|NCT00222911|heel pain|heel pain
5774862|NCT00222911|heel spur|heel spur
5774863|NCT00222911|night splint|night splint
5774864|NCT00222911|arch support|arch support
5774865|NCT00222911|foot orthosis|foot orthosis
5774866|NCT00222911|physical therapy|physical therapy
5774867|NCT00222898|Pancreatic Cyst|pancreatic cyst
5774868|NCT00222898|PANDA Study|panda study
5774869|NCT00222885|PET imaging|pet imaging
5774870|NCT00222885|Skeletal muscle|skeletal muscle
5774871|NCT00222885|In vivo insulin-stimulated tissue perfusion|in vivo insulin-stimulated tissue perfusion
5774872|NCT00222885|Glucose transport|glucose transport
5774873|NCT00222885|Glucose phosphorylation|glucose phosphorylation
5774874|NCT00222872|Endocrine System Diseases|endocrine system diseases
5774875|NCT00222872|MusculoSkeletal System Diseases|musculoskeletal system diseases
5774876|NCT00222872|Hormone|hormone
5774877|NCT00222872|Postmenopausal Women|postmenopausal women
5774878|NCT00222859|HIV|hiv
5774879|NCT00222859|HCV|hcv
5774880|NCT00222846|Clinical trial|clinical trial
5774881|NCT00222846|Behavioral research|behavioral research
5774882|NCT00222846|Patient compliance|patient compliance
5774883|NCT00222833|Schizophrenia|schizophrenia
5774884|NCT00222833|Schizoaffective disorder|schizoaffective disorder
5774885|NCT00222833|Aripiprazole|aripiprazole
5774886|NCT00222833|Obese|obese
5774887|NCT00222833|Overweight|overweight
5774888|NCT00222833|Heart Health|heart health
5774889|NCT00222833|Antipsychotic|antipsychotic
5774890|NCT00222833|Heart Health Factors|heart health factors
5774891|NCT00222833|Cardiovascular Health Indices|cardiovascular health indices
5774892|NCT00222833|Cardiovascular health|cardiovascular health
5774893|NCT00222807|schizophrenia, psychosis, type 2 diabetes mellitus|schizophrenia, psychosis, type 2 diabetes mellitus
5774894|NCT00222794|Schizophrenia|schizophrenia
5775284|NCT00221182|Pain|pain
5774896|NCT00222794|Negative Symptoms|negative symptoms
5774897|NCT00222794|Atomoxetine|atomoxetine
5774898|NCT00222794|Strattera|strattera
5774899|NCT00222781|Skeletal muscle|skeletal muscle
5774900|NCT00222781|Triple-tracer PET imaging|triple-tracer pet imaging
5774901|NCT00222768|Adipose tissue|adipose tissue
5774902|NCT00222768|PET imaging|pet imaging
5774903|NCT00222755|Mood disorders-bipolar|mood disorders-bipolar
5774904|NCT00222755|Disease management|disease management
5774905|NCT00222755|Quality of care|quality of care
5774906|NCT00222742|hypothermia|hypothermia
5774907|NCT00222742|pediatric TBI|pediatric tbi
5774908|NCT00222729|head|head
5774909|NCT00222729|neck|neck
5774910|NCT00222716|Treatment adherence|treatment adherence
5774911|NCT00222716|HIV|hiv
5774912|NCT00222716|Self-efficacy|self-efficacy
5774913|NCT00222716|Treatment Experienced|treatment experienced
5774914|NCT00222703|nicotine addiction|nicotine addiction
5774915|NCT00222703|relapse|relapse
5774916|NCT00222703|smoking|smoking
5774917|NCT00222703|chronic disorders|chronic disorders
5774918|NCT00222703|randomized controlled trial|randomized controlled trial
5774919|NCT00222703|intervention|intervention
5774920|NCT00222690|qualitative interview|qualitative interview
5774921|NCT00222690|symptom triggers|symptom triggers
5774922|NCT00222690|activity and participation|activity and participation
5774923|NCT00222677|venous thromboembolism|venous thromboembolism
5774924|NCT00222677|deep vein thrombosis|deep vein thrombosis
5774925|NCT00222677|pulmonary embolism|pulmonary embolism
5774926|NCT00222677|antithrombotic agents|antithrombotic agents
5774927|NCT00222664|hepatitis B|hepatitis b
5774928|NCT00222664|hepatocellular carcinoma|hepatocellular carcinoma
5774929|NCT00222664|prevention|prevention
5774930|NCT00222664|vaccination|vaccination
5774931|NCT00222651|pulmonary embolism|pulmonary embolism
5774932|NCT00222651|right ventricular dysfunction|right ventricular dysfunction
5774933|NCT00222651|thrombolysis|thrombolysis
5774934|NCT00222651|echocardiography|echocardiography
5774935|NCT00222638|Oral anticoagulants|oral anticoagulants
5774936|NCT00222638|Influenza virus|influenza virus
5774937|NCT00222638|Influenza vaccine|influenza vaccine
5774938|NCT00222638|Pharmacological interference|pharmacological interference
5774939|NCT00222625|Intracerebral Hemorrhage|intracerebral hemorrhage
5774940|NCT00222625|Oral Anticoagulants|oral anticoagulants
5774941|NCT00222625|Antiplatelet Agents|antiplatelet agents
5774942|NCT00222625|Recombinant Activated Factor VII|recombinant activated factor vii
5774943|NCT00222573|clopidogrel|clopidogrel
5774944|NCT00222573|metoprolol|metoprolol
5774945|NCT00222573|myocardial infarction|myocardial infarction
5774946|NCT00222573|randomised trial|randomised trial
5774947|NCT00222560|physical activity counselling|physical activity counselling
5774948|NCT00222560|physical activity behavior change intervention|physical activity behavior change intervention
5774949|NCT00222560|prevention|prevention
5774950|NCT00222560|collaborative health care|collaborative health care
5774951|NCT00222560|physical inactivity|physical inactivity
5774952|NCT00222560|motivation|motivation
5774954|NCT00222560|randomized controlled trial|randomized controlled trial
5774955|NCT00222534|Respiratory Insufficiency|respiratory insufficiency
5774956|NCT00222534|Alkalosis|alkalosis
5774957|NCT00222521|Cystic Fibrosis|cystic fibrosis
5774958|NCT00222521|Diabetes|diabetes
5774959|NCT00222508|Cystic Fibrosis|cystic fibrosis
5774960|NCT00222508|Diabetes|diabetes
5774961|NCT00222508|Complications|complications
5774962|NCT00222495|Psychotic Disorders in adolescents|psychotic disorders in adolescents
5774963|NCT00222495|Schizophrenia in adolescents|schizophrenia in adolescents
5774964|NCT00222495|Schizophreniform Disorders in adolescents|schizophreniform disorders in adolescents
5774965|NCT00222495|Schizoaffective Disorders in adolescents|schizoaffective disorders in adolescents
5774966|NCT00222482|Borderline Personality Disorder|borderline personality disorder
5774967|NCT00222469|pancreatic cancer|pancreatic cancer
5774968|NCT00222469|unresectable pancreatic cancer|unresectable pancreatic cancer
5774969|NCT00222469|metastatic pancreatic cancer|metastatic pancreatic cancer
5774970|NCT00222469|bevacizumab|bevacizumab
5774971|NCT00222469|oxaliplatin|oxaliplatin
5774972|NCT00222469|gemcitabine|gemcitabine
5774973|NCT00222469|1st line treatment|1st line treatment
5774974|NCT00222469|first line treatment|first line treatment
5774975|NCT00222469|locally advanced (unresectable) pancreatic cancer|locally advanced (unresectable) pancreatic cancer
5774976|NCT00222456|preterm infants|preterm infants
5774977|NCT00222456|early intervention|early intervention
5774979|NCT00222456|behavioral problems|behavioral problems
5774980|NCT00222456|parenting stress|parenting stress
5774981|NCT00222443|Recurrent solid tumors|recurrent solid tumors
5774982|NCT00222443|recurrent lymphomas|recurrent lymphomas
5774983|NCT00222443|Pediatrics|pediatrics
5774984|NCT00222443|Adolescents|adolescents
5774985|NCT00222430|Fluoroscopy|fluoroscopy
5774986|NCT00222430|Femoral Artery|femoral artery
5774987|NCT00222430|Arterial Vascular Access|arterial vascular access
5774988|NCT00222404|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5774989|NCT00222404|Pharmacogenomic|pharmacogenomic
5774990|NCT00222378|Crohn's disease|crohn's disease
5774991|NCT00222378|ulcerative colitis|ulcerative colitis
5774992|NCT00222378|cytomegalovirus|cytomegalovirus
5774993|NCT00222378|Epstein Bar Virus|epstein bar virus
5774994|NCT00222378|Human Herpes virus 6|human herpes virus 6
5774995|NCT00222365|homeopathy|homeopathy
5774996|NCT00222365|assessment|assessment
5774997|NCT00222365|pain|pain
5774998|NCT00222365|ligamentoplasty|ligamentoplasty
5774999|NCT00222352|Unstable Angina|unstable angina
5775000|NCT00222352|Non-ST-segment Myocardial Infarction|non-st-segment myocardial infarction
5775001|NCT00222352|Myocardial Necrosis|myocardial necrosis
5775003|NCT00222339|Stroke|stroke
5775004|NCT00222339|Hand function|hand function
5775005|NCT00222339|Task-specific training|task-specific training
5775006|NCT00222326|Hysterectomy,|hysterectomy,
5775007|NCT00222326|Prolapse,|prolapse,
5775008|NCT00222326|Pelvic floor muscles,|pelvic floor muscles,
5775009|NCT00222326|Bladder,|bladder,
5775010|NCT00222326|Bowel.|bowel.
5775011|NCT00222300|Total hip replacement|total hip replacement
5775012|NCT00222300|Strength training|strength training
5775013|NCT00222300|Gait analysis|gait analysis
5775014|NCT00222287|Feldenkrais Method|feldenkrais method
5686398|NCT00552344|Crohn's Disease|crohn's disease
5686399|NCT00552344|Crohn Disease|crohn disease
5775015|NCT00222287|movement class|movement class
5775016|NCT00222287|balance|balance
5775017|NCT00222287|Four square step test|four square step test
5775018|NCT00222287|Activities Specific Balance Confidence Scale|activities specific balance confidence scale
5775019|NCT00222287|systems theory|systems theory
5775020|NCT00222274|fibromyalgia|fibromyalgia
5775021|NCT00222274|pain|pain
5775022|NCT00222274|biofeedback|biofeedback
5775023|NCT00222274|heart rate variability|heart rate variability
5775024|NCT00222261|antiplatelet therapy|antiplatelet therapy
5775025|NCT00222261|aspirin non-responders|aspirin non-responders
5775026|NCT00222261|aspirin resistance|aspirin resistance
5775027|NCT00222261|clopidogrel|clopidogrel
5775028|NCT00222261|coronary heart disease|coronary heart disease
5775029|NCT00222261|stable angina pectoris|stable angina pectoris
5775030|NCT00222248|Stress urinary incontinence|stress urinary incontinence
5775031|NCT00222248|Pelvic floor muscle training|pelvic floor muscle training
5775032|NCT00222248|Bladder training|bladder training
5775033|NCT00222248|Older women|older women
5775034|NCT00222235|schizophrenia|schizophrenia
5775035|NCT00222235|schizoaffective disorder|schizoaffective disorder
5775036|NCT00222235|negative symptoms|negative symptoms
5775037|NCT00222235|cognitive impairments|cognitive impairments
5775038|NCT00222222|severe sepsis|severe sepsis
5775039|NCT00222222|prognostic markers|prognostic markers
5775040|NCT00222222|polymorphisms|polymorphisms
5775041|NCT00222222|SIRS|sirs
5775042|NCT00222209|Experimental study|experimental study
5775043|NCT00222209|chronic pain|chronic pain
5775044|NCT00222209|operant learning|operant learning
5775045|NCT00222209|comorbidity|comorbidity
5775046|NCT00222209|stress|stress
5775047|NCT00222209|Fibromyalgia w visceral hypersensitivity|fibromyalgia w visceral hypersensitivity
5775048|NCT00222209|Fibromyalgia w/o visceral hypersensitivity|fibromyalgia w/o visceral hypersensitivity
5775049|NCT00222196|atherosclerosis|atherosclerosis
5775050|NCT00222196|quality of life|quality of life
5775051|NCT00222196|pain-score|pain-score
5775053|NCT00222183|Lupus erythematodes|lupus erythematodes
5775054|NCT00222183|Elidel|elidel
5775055|NCT00222183|Pimecrolimus|pimecrolimus
5775056|NCT00222183|Chronic discoid lupus erythematosus (dLE)|chronic discoid lupus erythematosus (dle)
5775057|NCT00222183|subacute cutaneous lupus erythematosus (scLE)|subacute cutaneous lupus erythematosus (scle)
5775058|NCT00222131|Epigastric Pain|epigastric pain
5775059|NCT00222131|Non-Ulcer Dyspepsia (NUD)|non-ulcer dyspepsia (nud)
5775060|NCT00222092|post-ERCP pancreatitis|post-ercp pancreatitis
5775061|NCT00222092|prophylaxis|prophylaxis
5775062|NCT00222092|prognosis|prognosis
5775063|NCT00222092|natural course|natural course
5775064|NCT00222092|molecular markers|molecular markers
5775065|NCT00222066|Aspiration|aspiration
5775066|NCT00222066|Fetal ovarian cyst|fetal ovarian cyst
5775067|NCT00222066|Ovarian torsion|ovarian torsion
5775068|NCT00222053|Myeloma|myeloma
5775069|NCT00222053|Autologous transplantation|autologous transplantation
5775070|NCT00222053|Maintenance therapy|maintenance therapy
5775071|NCT00222053|Thalidomide|thalidomide
5775072|NCT00222040|Stroke|stroke
5775073|NCT00222040|thrombolysis|thrombolysis
5775074|NCT00222040|ultrasound|ultrasound
5775075|NCT00222040|microbubbles|microbubbles
5775076|NCT00222040|alteplase|alteplase
5775077|NCT00222027|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5775078|NCT00222027|adult patient|adult patient
5775079|NCT00222027|chemotherapy|chemotherapy
5775080|NCT00222027|stem cell transplantation|stem cell transplantation
5775081|NCT00222027|Young adult patients|young adult patients
5775082|NCT00222014|Refractory ascites|refractory ascites
5775083|NCT00222014|Cirrhosis|cirrhosis
5775084|NCT00222014|Paracentesesis|paracentesesis
5775085|NCT00221988|Elderly|elderly
5775086|NCT00221988|Epilepsy|epilepsy
5775087|NCT00221988|Cognition|cognition
5775088|NCT00221988|Health Outcome|health outcome
5775089|NCT00221962|ADHD|adhd
5775090|NCT00221923|Primary open angle glaucoma|primary open angle glaucoma
5775091|NCT00221923|African American|african american
5775092|NCT00221923|Glaucoma/pathology|glaucoma/pathology
5775093|NCT00221923|Glaucoma/ physiopathology|glaucoma/ physiopathology
5775094|NCT00221923|Nerve Fibers/pathology|nerve fibers/pathology
5775095|NCT00221923|Risk factor glaucoma|risk factor glaucoma
5775096|NCT00221897|Primary open angle glaucoma|primary open angle glaucoma
5775097|NCT00221897|Glaucoma/pathology|glaucoma/pathology
5775098|NCT00221897|Glaucoma/physiopathology|glaucoma/physiopathology
5775099|NCT00221897|Nerve Fibers/pathology|nerve fibers/pathology
5775100|NCT00221897|Risk factors glaucoma|risk factors glaucoma
5775101|NCT00221845|Ramipril|ramipril
5775102|NCT00221845|Hypertension|hypertension
5775103|NCT00221845|Chronic renal failure|chronic renal failure
5775104|NCT00221845|Disease progression|disease progression
5775105|NCT00221845|Left ventricular hypertrophy|left ventricular hypertrophy
5775106|NCT00221845|Intima media thickness|intima media thickness
5775107|NCT00221845|Cardiovascular disease|cardiovascular disease
5775108|NCT00221845|Biomarkers|biomarkers
5800948|NCT00104390|allergy|allergy
5775109|NCT00221845|Gene polymorphisms|gene polymorphisms
5775110|NCT00221832|Long QT Syndrome|long qt syndrome
5775111|NCT00221832|Hypertrophic cardiomyopathy|hypertrophic cardiomyopathy
5775112|NCT00221832|arrhythmogenic right ventricular dysplasia|arrhythmogenic right ventricular dysplasia
5775113|NCT00221832|Short QT Syndrome|short qt syndrome
5775114|NCT00221832|Brugada Syndrome|brugada syndrome
5775115|NCT00221819|Humidification|humidification
5775116|NCT00221819|Heat and moisture exchanger|heat and moisture exchanger
5775117|NCT00221819|Heated humidifier, non invasive ventilation|heated humidifier, non invasive ventilation
5775118|NCT00221806|Arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, Doppler echography|arteritis, femoro popliteal bypass, endothelialised prosthesis, saphenous vein graft, permeability, doppler echography
5775119|NCT00221793|Parkinson|parkinson
5775120|NCT00221793|deep subthalamic stimulation|deep subthalamic stimulation
5775121|NCT00221793|pharmacological treatment|pharmacological treatment
5775122|NCT00221780|Heart failure|heart failure
5775123|NCT00221780|Cardiomyopathy, dilated|cardiomyopathy, dilated
5775124|NCT00221780|Coronary disease|coronary disease
5775125|NCT00221780|Cardiac Pacing, Artificial|cardiac pacing, artificial
5775126|NCT00221780|Hemodynamics|hemodynamics
5775127|NCT00221780|Randomized Controlled Trials|randomized controlled trials
5775128|NCT00221780|Single-Blind Study|single-blind study
5775129|NCT00221767|Neurogenic bladder|neurogenic bladder
5775130|NCT00221767|electric stimulation therapy|electric stimulation therapy
5775131|NCT00221767|urinary tract infection|urinary tract infection
5775132|NCT00221767|urinary incontinence|urinary incontinence
5775133|NCT00221767|spinal cord injuries|spinal cord injuries
5775134|NCT00221767|spinal nerve roots|spinal nerve roots
5775135|NCT00221767|nonRandomized Controlled Trials|nonrandomized controlled trials
5775137|NCT00221754|HIV,|hiv,
5775138|NCT00221754|protease inhibitors|protease inhibitors
5775139|NCT00221754|pravastatin|pravastatin
5775140|NCT00221754|Treatment Experienced|treatment experienced
5775141|NCT00221741|Heart surgery|heart surgery
5775142|NCT00221741|Blood Loss, Surgical|blood loss, surgical
5775144|NCT00221741|Blood Transfusion|blood transfusion
5775145|NCT00221741|Cohort Studies|cohort studies
5775146|NCT00221728|Kidney Neoplasms|kidney neoplasms
5775147|NCT00221728|Surgery|surgery
5775148|NCT00221728|Catheter Ablation|catheter ablation
5775149|NCT00221728|Randomized controlled trials|randomized controlled trials
5775150|NCT00221728|Kidney Failure, Chronic|kidney failure, chronic
5775151|NCT00221715|arteritis|arteritis
5775152|NCT00221715|lower limb ischemia|lower limb ischemia
5775153|NCT00221715|femoropopliteal artery bypass|femoropopliteal artery bypass
5775154|NCT00221715|blood vessel prothesis implantation|blood vessel prothesis implantation
5775155|NCT00221715|saphenous vein|saphenous vein
5775156|NCT00221715|vascular permeability|vascular permeability
5775157|NCT00221715|doppler ultrasonography|doppler ultrasonography
5775158|NCT00221715|randomized clinical trials|randomized clinical trials
5775159|NCT00221715|efficacy study|efficacy study
5775160|NCT00221702|Melanoma|melanoma
5775161|NCT00221702|Neoplasm metastasis|neoplasm metastasis
5775162|NCT00221702|Interferon alfa-2b|interferon alfa-2b
5775163|NCT00221702|Adjuvants|adjuvants
5775164|NCT00221702|Randomized clinical trial|randomized clinical trial
5775165|NCT00221702|Disease-free survival time|disease-free survival time
5775166|NCT00221702|Safety|safety
5775167|NCT00221702|Drug toxicity|drug toxicity
5775168|NCT00221702|Quality of life|quality of life
5775169|NCT00221689|Severe brain injury|severe brain injury
5775170|NCT00221689|Coma|coma
5775171|NCT00221689|Hypertonia|hypertonia
5775172|NCT00221689|Dysautonomia|dysautonomia
5775173|NCT00221689|Baclofen|baclofen
5775174|NCT00221689|Randomized Controlled Trials|randomized controlled trials
5775175|NCT00221676|influenza vaccine|influenza vaccine
5775176|NCT00221676|general practitioner|general practitioner
5775177|NCT00221663|Cardiac surgery|cardiac surgery
5775178|NCT00221663|Aortic valve replacement|aortic valve replacement
5775179|NCT00221663|Minimally invasive surgery|minimally invasive surgery
5775180|NCT00221663|Perioperative course|perioperative course
5775181|NCT00221650|Hepatitis C, Chronic|hepatitis c, chronic
5775182|NCT00221650|HCV infection|hcv infection
5775183|NCT00221650|HIV infection|hiv infection
5775184|NCT00221650|Treatment Failure|treatment failure
5775185|NCT00221650|PEG interferon|peg interferon
5775186|NCT00221650|Interferons/therapeutic use|interferons/therapeutic use
5775187|NCT00221650|Interferon Alfa-2a/adverse effects|interferon alfa-2a/adverse effects
5775188|NCT00221650|Ribavirin/therapeutic use|ribavirin/therapeutic use
5775189|NCT00221650|Ribavirin/adverse effects|ribavirin/adverse effects
5775190|NCT00221650|Drug Therapy, Combination|drug therapy, combination
5775191|NCT00221650|Treatment Experienced|treatment experienced
5775192|NCT00221650|Treatment Naive|treatment naive
5775193|NCT00221637|Neuralgia|neuralgia
5775194|NCT00221637|Valproate|valproate
5775195|NCT00221637|Anticonvulsant Drugs|anticonvulsant drugs
5775196|NCT00221637|Pain Measurement|pain measurement
5775197|NCT00221637|Randomized Controlled Trials|randomized controlled trials
5775198|NCT00221624|Hepatitis C, chronic|hepatitis c, chronic
5775199|NCT00221624|HCV infection|hcv infection
5775200|NCT00221624|Treatment failure|treatment failure
5775201|NCT00221624|PEG Interferon|peg interferon
5775202|NCT00221624|(Interferons/therapeutic use|(interferons/therapeutic use
5775203|NCT00221624|Interferon Alfa-2a/adverse effects)|interferon alfa-2a/adverse effects)
5775204|NCT00221624|ribavirin|ribavirin
5775205|NCT00221624|(Ribavirin/therapeutic use|(ribavirin/therapeutic use
5775458|NCT00220454|estradiol|estradiol
5775206|NCT00221624|Ribavirin/adverse effects)|ribavirin/adverse effects)
5775207|NCT00221624|Amantadine|amantadine
5775208|NCT00221624|Drug Therapy, Combination|drug therapy, combination
5775209|NCT00221520|Sedation, mechanical ventilation|sedation, mechanical ventilation
5775210|NCT00221507|Vaccination|vaccination
5775211|NCT00221507|Prevention & Control|prevention & control
5775212|NCT00221494|depression|depression
5775213|NCT00221481|Bipolar|bipolar
5775214|NCT00221481|Alcohol|alcohol
5775215|NCT00221468|Adolescents|adolescents
5775216|NCT00221455|Diabetes Mellitus|diabetes mellitus
5775217|NCT00221455|Chronic disease management|chronic disease management
5775218|NCT00221455|Patient portal|patient portal
5775219|NCT00221455|Patient empowerment|patient empowerment
5775220|NCT00221442|Adults|adults
5775221|NCT00221442|Binge eating disorder|binge eating disorder
5775222|NCT00221442|Blood draw|blood draw
5775223|NCT00221442|E.Coli enterprotoxin|e.coli enterprotoxin
5775224|NCT00221442|Eating disorders|eating disorders
5775225|NCT00221442|Electrocardiogram|electrocardiogram
5775226|NCT00221442|Females|females
5775227|NCT00221442|Males|males
5775228|NCT00221442|Physical exam|physical exam
5775229|NCT00221442|Psychiatric evaluation|psychiatric evaluation
5775230|NCT00221442|Questionnaire|questionnaire
5775231|NCT00221429|child|child
5775232|NCT00221429|adolescent|adolescent
5775233|NCT00221416|child|child
5775234|NCT00221416|adolescent|adolescent
5775235|NCT00221403|child|child
5775236|NCT00221403|adolescent|adolescent
5775237|NCT00221403|bipolar disorder|bipolar disorder
5775238|NCT00221390|stroke|stroke
5775239|NCT00221390|Chronic stroke with hemiparesis|chronic stroke with hemiparesis
5775240|NCT00221377|intubation|intubation
5775247|NCT00221364|Azithromycin|azithromycin
5775249|NCT00221351|acute bronchitis|acute bronchitis
5775250|NCT00221351|upper respiratory tract infection|upper respiratory tract infection
5775251|NCT00221351|pneumonia|pneumonia
5775252|NCT00221351|lower respiratory tract infection|lower respiratory tract infection
5775253|NCT00221338|gabapentin|gabapentin
5775254|NCT00221338|pain|pain
5775255|NCT00221338|surgery|surgery
5775256|NCT00221338|delirium|delirium
5775257|NCT00221338|cognitive decline|cognitive decline
5775258|NCT00221325|Phase I Clinical Trial|phase i clinical trial
5775259|NCT00221325|Pharmacokinetics|pharmacokinetics
5775260|NCT00221325|Pharmacodynamics|pharmacodynamics
5775261|NCT00221325|CNS Lymphoma|cns lymphoma
5775262|NCT00221325|Ocular Lymphoma|ocular lymphoma
5775263|NCT00221312|Perimenopausal bone loss|perimenopausal bone loss
5775264|NCT00221299|Osteoporosis|osteoporosis
5775265|NCT00221299|Steroids|steroids
5775266|NCT00221299|Prednisone|prednisone
5775267|NCT00221286|chronic hepatitis B|chronic hepatitis b
5775268|NCT00221286|human immunodeficiency virus|human immunodeficiency virus
5775269|NCT00221286|pegylated interferon|pegylated interferon
5775270|NCT00221286|tenofovir DF|tenofovir df
5775271|NCT00221286|emtricitabine|emtricitabine
5775272|NCT00221260|Analgesia|analgesia
5775273|NCT00221260|anesthesia|anesthesia
5775274|NCT00221247|cerebral palsy; acupuncture|cerebral palsy; acupuncture
5775275|NCT00221234|Diabetes|diabetes
5775276|NCT00221234|Physical Activity|physical activity
5775277|NCT00221221|breast cancer survivors|breast cancer survivors
5775278|NCT00221221|physical activity|physical activity
5775279|NCT00221221|health promotion|health promotion
5775280|NCT00221208|Diabetes|diabetes
5775281|NCT00221208|Resistance Training|resistance training
5775282|NCT00221182|Angina|angina
5775283|NCT00221182|Heart diseases|heart diseases
5775285|NCT00221182|Vascular diseases|vascular diseases
5775286|NCT00221169|Non-small cell lung cancer|non-small cell lung cancer
5775287|NCT00221169|Positron emission tomography|positron emission tomography
5775288|NCT00221169|Gross tumor volume|gross tumor volume
5775289|NCT00221169|Radiation therapy|radiation therapy
5775290|NCT00221156|Abnormal Glucose Tolerance|abnormal glucose tolerance
5775291|NCT00221156|coronary artery disease|coronary artery disease
5775292|NCT00221156|diabetes mellitus|diabetes mellitus
5775293|NCT00221156|clinical outcome|clinical outcome
5775294|NCT00221143|Ulcer/ gangrene|ulcer/ gangrene
5775295|NCT00221143|Leg diseases|leg diseases
5775297|NCT00221143|Vascular diseases|vascular diseases
5775298|NCT00221143|Chronic limb ischemia|chronic limb ischemia
5775299|NCT00221143|Peripheral artery disease|peripheral artery disease
5775300|NCT00221130|Regenerative medicine|regenerative medicine
5775301|NCT00221130|Periodontal tissue|periodontal tissue
5775302|NCT00221117|Spinal Cord Injuries|spinal cord injuries
5775303|NCT00221104|stroke|stroke
5775304|NCT00221104|brain ischemia|brain ischemia
5775305|NCT00221104|cerebrovascular accident|cerebrovascular accident
5775306|NCT00221104|statin|statin
5775307|NCT00221104|hydroxymethylglutaryl-CoA reductase inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5784358|NCT00172783|TB|tb
5775308|NCT00221104|cholesterol|cholesterol
5775309|NCT00221104|hypercholesterolemia|hypercholesterolemia
5775310|NCT00221104|hyperlipidemia|hyperlipidemia
5775311|NCT00221104|multicenter studies|multicenter studies
5775312|NCT00221104|prospective studies|prospective studies
5775313|NCT00221104|endpoint determination|endpoint determination
5775314|NCT00221104|randomized controlled trials|randomized controlled trials
5775315|NCT00221104|recurrence|recurrence
5775316|NCT00221104|pravastatin|pravastatin
5775317|NCT00221091|idiopathic normal pressure hydrocephalus|idiopathic normal pressure hydrocephalus
5775318|NCT00221091|shunt|shunt
5775319|NCT00221078|Cerebrovascular Accident|cerebrovascular accident
5775320|NCT00221078|Stroke|stroke
5775321|NCT00221065|Sleep Apnea Syndromes|sleep apnea syndromes
5775322|NCT00221065|Cerebrovascular Accident|cerebrovascular accident
5775323|NCT00221039|ECP|ecp
5775324|NCT00221039|Photopheresis|photopheresis
5775325|NCT00221039|CTCL|ctcl
5775326|NCT00221039|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5775327|NCT00221039|Mycosis Fungoides|mycosis fungoides
5775328|NCT00221013|Acute Renal Failure|acute renal failure
5775329|NCT00221013|Continuous Renal Replacement Therapy|continuous renal replacement therapy
5775330|NCT00221013|Continuous Veno-Venous Haemofiltration|continuous veno-venous haemofiltration
5775331|NCT00221013|Continuous Veno-Venous Haemodiafiltration|continuous veno-venous haemodiafiltration
5775332|NCT00221013|Renal Replacement Therapy|renal replacement therapy
5775333|NCT00221000|Rheumatoid Arthritis|rheumatoid arthritis
5775334|NCT00220987|Hyperglycemia in the critically ill patient|hyperglycemia in the critically ill patient
5775335|NCT00220987|Intensive Insulin Therapy|intensive insulin therapy
5775336|NCT00220987|Conventional insulin therapy|conventional insulin therapy
5775337|NCT00220987|Hypoglycaemia|hypoglycaemia
5775338|NCT00220961|Impaired Glucose Tolerance|impaired glucose tolerance
5775339|NCT00220961|Type 2 Diabetes|type 2 diabetes
5775340|NCT00220961|Prevention|prevention
5775341|NCT00220961|Pioglitazone|pioglitazone
5775342|NCT00220948|discogenic pain|discogenic pain
5775443|NCT00220493|MS|ms
5775343|NCT00220948|myoelectric activity|myoelectric activity
5775344|NCT00220935|Randomized controlled clinical trial|randomized controlled clinical trial
5775345|NCT00220922|Copaxone|copaxone
5775346|NCT00220909|Gastric erosions|gastric erosions
5775347|NCT00220909|Proton pump inhibitors|proton pump inhibitors
5775348|NCT00220896|Delirium|delirium
5775349|NCT00220896|Prevention|prevention
5775350|NCT00220896|Donepezil|donepezil
5775351|NCT00220883|Functional Dyspepsia|functional dyspepsia
5775352|NCT00220883|Electrogastrography|electrogastrography
5775353|NCT00220870|schizophrenia|schizophrenia
5775354|NCT00220870|shared decision making|shared decision making
5775355|NCT00220870|compliance|compliance
5775356|NCT00220870|maintenance therapy|maintenance therapy
5775357|NCT00220857|Rabeprazole|rabeprazole
5775358|NCT00220857|Nonsteroidal Antiinflammatory Drugs|nonsteroidal antiinflammatory drugs
5775359|NCT00220857|Gastric erosions|gastric erosions
5775360|NCT00220831|Diabetes|diabetes
5775361|NCT00220831|MI|mi
5775362|NCT00220831|CVD disease|cvd disease
5775363|NCT00220818|Pediatric GERD|pediatric gerd
5775364|NCT00220818|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
5775365|NCT00220818|lansoprazole|lansoprazole
5775366|NCT00220792|Primary breast cancer|primary breast cancer
5775367|NCT00220792|support groups|support groups
5775368|NCT00220792|mood disturbance|mood disturbance
5775369|NCT00220766|Primary Immune Deficiency|primary immune deficiency
5775370|NCT00220766|IGIV|igiv
5775371|NCT00220766|Immunoglobulin G|immunoglobulin g
5775372|NCT00220753|Dog allergy|dog allergy
5775373|NCT00220753|Pet allergy|pet allergy
5775374|NCT00220753|Air cleaners|air cleaners
5775375|NCT00220753|HEPA filters|hepa filters
5775376|NCT00220753|Air filtration|air filtration
5775377|NCT00220753|Can f1|can f1
5775378|NCT00220753|Asthma|asthma
5775379|NCT00220753|Children|children
5775380|NCT00220753|Adolescents|adolescents
5775381|NCT00220753|Indoor environment|indoor environment
5775382|NCT00220753|Indoor allergy|indoor allergy
5775383|NCT00220753|Perennial allergy|perennial allergy
5775384|NCT00220740|Immunoglobulin G|immunoglobulin g
5775385|NCT00220727|Idiopathic (Immune) Thrombocytopenic Purpura|idiopathic (immune) thrombocytopenic purpura
5775386|NCT00220727|Immunoglobulin G|immunoglobulin g
5775387|NCT00220714|schizophrenia|schizophrenia
5775388|NCT00220714|first-episode|first-episode
5775389|NCT00220714|patient compliance|patient compliance
5770371|NCT00243555|chemokines|chemokines
5775390|NCT00220714|long-acting risperidone|long-acting risperidone
5775392|NCT00220701|Dysthymic Disorder|dysthymic disorder
5775393|NCT00220701|Depression|depression
5775394|NCT00220701|Chronic Depression|chronic depression
5775395|NCT00220701|Escitalopram|escitalopram
5775396|NCT00220688|nausea|nausea
5775397|NCT00220688|vomiting|vomiting
5775398|NCT00220688|palliative|palliative
5775399|NCT00220688|acupressure|acupressure
5775400|NCT00220675|Malignant extradural spinal cord compression|malignant extradural spinal cord compression
5775401|NCT00220675|Erythropoietin|erythropoietin
5775402|NCT00220675|Neuroprotectant|neuroprotectant
5686400|NCT00552344|CD Induction|cd induction
5686401|NCT00552344|Induction|induction
5775403|NCT00220675|Radiotherapy|radiotherapy
5775404|NCT00220675|Palliation|palliation
5775405|NCT00220662|anorexia nervosa|anorexia nervosa
5775407|NCT00220662|readiness and motivation|readiness and motivation
5775408|NCT00220649|solid tumors or adenocarcinoma of the exocrine pancreas|solid tumors or adenocarcinoma of the exocrine pancreas
5775409|NCT00220636|Major Depression|major depression
5775410|NCT00220636|Depression|depression
5775411|NCT00220636|Unipolar Depression|unipolar depression
5775412|NCT00220636|Treatment Resistant Depression|treatment resistant depression
5775413|NCT00220636|Adjunctive treatment|adjunctive treatment
5775414|NCT00220623|major depression|major depression
5775415|NCT00220623|psychotherapy|psychotherapy
5775416|NCT00220623|antidepressant medications|antidepressant medications
5775417|NCT00220623|clincial trial|clincial trial
5775418|NCT00220597|group therapy|group therapy
5775419|NCT00220597|sexual revictimization|sexual revictimization
5775420|NCT00220597|risky sex|risky sex
5775421|NCT00220597|addiction|addiction
5775422|NCT00220571|AMI|ami
5775423|NCT00220571|stent|stent
5775424|NCT00220571|PTCA|ptca
5775425|NCT00220571|abciximab|abciximab
5775426|NCT00220571|reteplase|reteplase
5775427|NCT00220571|combo therapy|combo therapy
5775428|NCT00220558|Percutaneous Transluminal Coronary Angioplasty|percutaneous transluminal coronary angioplasty
5775429|NCT00220558|Bare metal stents|bare metal stents
5775430|NCT00220558|drug eluting stents|drug eluting stents
5775431|NCT00220545|Polycystic ovarY|polycystic ovary
5775432|NCT00220545|Laparoscopic ovarian diathermy|laparoscopic ovarian diathermy
5775433|NCT00220545|Induction of ovulation|induction of ovulation
5775434|NCT00220545|Clomiphene citrate|clomiphene citrate
5775435|NCT00220532|Randomised placebo controlled intervention trial|randomised placebo controlled intervention trial
5775436|NCT00220532|Folic acid|folic acid
5775437|NCT00220532|Riboflavin|riboflavin
5775438|NCT00220532|cervical cancer|cervical cancer
5775439|NCT00220506|provigil|provigil
5775440|NCT00220506|fatigue|fatigue
5775441|NCT00220506|Multiple Sclerosis|multiple sclerosis
5775442|NCT00220506|cognition|cognition
5775448|NCT00220493|Relapsing remitting|relapsing remitting
5775449|NCT00220493|Secondary progressive|secondary progressive
5775450|NCT00220493|Primary progressive|primary progressive
5775451|NCT00220467|MCI|mci
5775452|NCT00220467|aging|aging
5775453|NCT00220467|cognition|cognition
5775454|NCT00220467|exercise|exercise
5775455|NCT00220467|aerobic|aerobic
5775456|NCT00220467|insulin|insulin
5775457|NCT00220454|cognition|cognition
5775459|NCT00220454|cortisol|cortisol
5775460|NCT00220454|postmenopause|postmenopause
5775462|NCT00220441|exercise|exercise
5775463|NCT00220441|cognition|cognition
5775464|NCT00220441|insulin|insulin
5775465|NCT00220441|aging|aging
5775466|NCT00220441|aerobic|aerobic
5775467|NCT00220428|T cell|t cell
5775468|NCT00220350|arousal|arousal
5775469|NCT00220350|sex offender|sex offender
5775470|NCT00220350|suppression of arousal|suppression of arousal
5775471|NCT00220350|pedohilia|pedohilia
5775472|NCT00220350|leuprolide acetate|leuprolide acetate
5775473|NCT00220324|Contraception|contraception
5775474|NCT00220285|Antigen|antigen
5775475|NCT00220285|CD20|cd20
5775476|NCT00220272|Parkinson Disease|parkinson disease
5775477|NCT00220272|5-fluorodopa|5-fluorodopa
5775478|NCT00220259|Cystic Fibrosis, inhaled corticosteroids|cystic fibrosis, inhaled corticosteroids
5775479|NCT00220246|Hereditary colorectal cancer|hereditary colorectal cancer
5775480|NCT00220246|Microsatellite instability|microsatellite instability
5775481|NCT00220246|Chromosomal instability|chromosomal instability
5775482|NCT00220207|Diabetes|diabetes
5775483|NCT00220207|Health Education|health education
5775484|NCT00220207|Information Technology|information technology
5775485|NCT00220207|African Americans|african americans
5775486|NCT00220207|Disease Management|disease management
5775487|NCT00220207|Internet|internet
5775488|NCT00220207|Patient Education|patient education
5775489|NCT00220181|Nutritional status|nutritional status
5775490|NCT00220181|Bowel symptoms|bowel symptoms
5775491|NCT00220181|Radical radiotherapy to pelvis|radical radiotherapy to pelvis
5775492|NCT00220181|Gynaecological, urological or rectal cancer|gynaecological, urological or rectal cancer
5775493|NCT00220090|Irritable Bowel Syndrome|irritable bowel syndrome
5775494|NCT00220090|Cholecystokinin|cholecystokinin
5775495|NCT00220090|Dexloxiglumide|dexloxiglumide
5775496|NCT00220090|Randomized/withdrawal|randomized/withdrawal
5775497|NCT00219999|Hepatitis|hepatitis
5775498|NCT00219999|Hepacivirus|hepacivirus
5775499|NCT00219999|B Lymphocytes|b lymphocytes
5775500|NCT00219999|Chemokines|chemokines
5775501|NCT00219999|Antibodies|antibodies
5775502|NCT00219986|Treatment Experienced|treatment experienced
5775503|NCT00219986|HIV|hiv
5775504|NCT00219973|venous thromboembolism|venous thromboembolism
5775505|NCT00219973|deep vein thrombosis|deep vein thrombosis
5775506|NCT00219973|pulmonary embolism|pulmonary embolism
5775507|NCT00219973|bleeding|bleeding
5686402|NCT00552344|Clinical response|clinical response
5686403|NCT00552344|Clinical remission|clinical remission
5686404|NCT00552292|metabolic syndrome|metabolic syndrome
5686405|NCT00552292|hypertension|hypertension
5686406|NCT00552292|obesity|obesity
5686407|NCT00552292|dyslipidemia|dyslipidemia
5775508|NCT00219973|low-molecular-weight heparin|low-molecular-weight heparin
5775509|NCT00219973|cancer|cancer
5775510|NCT00219973|surgery|surgery
5775511|NCT00219960|Hypertension|hypertension
5775512|NCT00219960|Blood Pressure|blood pressure
5775513|NCT00219960|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5775514|NCT00219960|Complementary and Alternative Medicine|complementary and alternative medicine
5775515|NCT00219960|Herbal|herbal
5775516|NCT00219960|North American Ginseng|north american ginseng
5775517|NCT00219960|Panax Quinquefolius|panax quinquefolius
5775518|NCT00219947|HIV Infection|hiv infection
5775519|NCT00219947|Acute HIV Infection|acute hiv infection
5775520|NCT00219947|Primary HIV Infection|primary hiv infection
5775521|NCT00219947|Acute Seroconversion Syndrome|acute seroconversion syndrome
5775522|NCT00219934|New HIV Infection|new hiv infection
5775523|NCT00219934|Acute HIV Infection|acute hiv infection
5775524|NCT00219934|Primary HIV Infection|primary hiv infection
5775525|NCT00219934|Acute Seroconversion Syndrome|acute seroconversion syndrome
5775526|NCT00219921|total hip replacement|total hip replacement
5775527|NCT00219921|pain treatment|pain treatment
5775528|NCT00219908|Multiple sclerosis|multiple sclerosis
5775529|NCT00219908|Mitoxantrone|mitoxantrone
5775530|NCT00219908|Methylprednisolone|methylprednisolone
5775531|NCT00219908|Interferon beta1b|interferon beta1b
5775532|NCT00219908|Relapse|relapse
5775534|NCT00219908|EDSS|edss
5775535|NCT00219895|Cystic Fibrosis|cystic fibrosis
5775536|NCT00219895|Anti-inflammatory Agents|anti-inflammatory agents
5775537|NCT00219895|Ibuprofen|ibuprofen
5775538|NCT00219882|Cystic Fibrosis|cystic fibrosis
5775539|NCT00219882|curcuminoids|curcuminoids
5775540|NCT00219882|turmeric root extract|turmeric root extract
5775541|NCT00219882|nasal potential difference (NPD)|nasal potential difference (npd)
5775542|NCT00219882|sweat chloride|sweat chloride
5775543|NCT00219869|Post|post
5775544|NCT00219869|Traumatic|traumatic
5775545|NCT00219869|Headache|headache
5775546|NCT00219869|Cognitive|cognitive
5775547|NCT00219856|Propofol|propofol
5775548|NCT00219856|Hepatectomy|hepatectomy
5775549|NCT00219856|Oxidative stress|oxidative stress
5775550|NCT00219843|Stage III and IV melanoma|stage iii and iv melanoma
5775551|NCT00219830|Cardiac Rehabilitation|cardiac rehabilitation
5775553|NCT00219830|Acute Myocardial Infarction|acute myocardial infarction
5775554|NCT00219830|Secondary Prevention|secondary prevention
5775555|NCT00219817|Anorexia|anorexia
5775556|NCT00219817|Cachexia|cachexia
5775557|NCT00219791|methotrexate|methotrexate
5775558|NCT00219791|delayed elimination|delayed elimination
5775559|NCT00219791|renal insufficiency|renal insufficiency
5775560|NCT00219791|CPG2|cpg2
5775561|NCT00219791|Voraxaze|voraxaze
5775562|NCT00219765|CML|cml
5775563|NCT00219765|Acute Phase|acute phase
5775564|NCT00219765|Imatinib mesylate|imatinib mesylate
5775565|NCT00219765|Cytarabine|cytarabine
5775566|NCT00219765|Daunorubicine|daunorubicine
5775567|NCT00219752|CML - ederly patients - Imatinib mesylate|cml - ederly patients - imatinib mesylate
5775568|NCT00219739|CML|cml
5775569|NCT00219739|Imatinib|imatinib
5775570|NCT00219739|Interferon|interferon
5775571|NCT00219739|Cytarabine|cytarabine
5775572|NCT00219726|CML|cml
5775573|NCT00219726|Imatinib mesylate|imatinib mesylate
5775574|NCT00219726|Stem cell transplantation|stem cell transplantation
5775575|NCT00219713|Nitrous oxide and oxygen|nitrous oxide and oxygen
5775576|NCT00219713|Pain|pain
5775577|NCT00219713|Bone marrow biopsy|bone marrow biopsy
5775578|NCT00219713|Bone marrow aspiration|bone marrow aspiration
5775579|NCT00219700|NSAID-PC|nsaid-pc
5775580|NCT00219700|IBU-PC|ibu-pc
5775581|NCT00219687|Heart arrest|heart arrest
5775582|NCT00219687|Cardiopulmonary resuscitation|cardiopulmonary resuscitation
5775583|NCT00219687|Dispatcher|dispatcher
5775584|NCT00219674|education|education
5775585|NCT00219674|training, defibrillators|training, defibrillators
5775586|NCT00219674|home defibrillators|home defibrillators
5775587|NCT00219674|automated external defibrillators|automated external defibrillators
5775588|NCT00219674|psychological adjustment|psychological adjustment
5775589|NCT00219661|randomised control trial|randomised control trial
5775590|NCT00219661|intensive care unit|intensive care unit
5775591|NCT00219661|mechanical ventilation|mechanical ventilation
5775592|NCT00219661|ventilator-associated pneumonia|ventilator-associated pneumonia
5775593|NCT00219661|drainage of subglottic secretions|drainage of subglottic secretions
5775594|NCT00219557|Randomized Phase 2 Study of AG-013736 in Combination with Gemcitabine versus Gemcitabine Alone in Advanced Pancreatic Cancer|randomized phase 2 study of ag-013736 in combination with gemcitabine versus gemcitabine alone in advanced pancreatic cancer
5775595|NCT00219531|functional MRI|functional mri
5775596|NCT00219531|pain perception|pain perception
5775597|NCT00219531|anxiety|anxiety
5775600|NCT00219518|Pelvic floor dyssynergia|pelvic floor dyssynergia
5775601|NCT00219518|Anismus|anismus
5775602|NCT00219505|Diarrhea-predominant irritable bowel syndrome|diarrhea-predominant irritable bowel syndrome
5775603|NCT00219505|Acupuncture|acupuncture
5775604|NCT00219505|abdominal pain|abdominal pain
5775605|NCT00219492|NCCP, mast cell, esophagus|nccp, mast cell, esophagus
5775606|NCT00219479|seizure prophylaxis|seizure prophylaxis
5775607|NCT00219479|enteral nutrition|enteral nutrition
5775608|NCT00219453|Pilot Projects|pilot projects
5792901|NCT00132366|Healthy Volunteer|healthy volunteer
5792902|NCT00132366|HV|hv
5792915|NCT00132340|Spasmodic Torticollis|spasmodic torticollis
5792916|NCT00132340|Treatment|treatment
5792917|NCT00132340|Physiology|physiology
5792918|NCT00132340|Surgery|surgery
5792919|NCT00132340|Cervical Dystonia|cervical dystonia
5792920|NCT00132327|Lyme Disease|lyme disease
5792921|NCT00132327|Borrelia Burgdorferi|borrelia burgdorferi
5792922|NCT00132327|Inflammation|inflammation
5792923|NCT00132327|Skin|skin
5792924|NCT00132327|Host Response|host response
5792925|NCT00132327|Erythema Migrans Rash|erythema migrans rash
5792927|NCT00132327|HV|hv
5775609|NCT00219453|Injections, Jet|injections, jet
5775610|NCT00219453|Injections, Jet/instrumentation|injections, jet/instrumentation
5775611|NCT00219453|Equipment Contamination/prevention and control|equipment contamination/prevention and control
5775612|NCT00219453|Blood-Borne Pathogens|blood-borne pathogens
5775613|NCT00219453|Disease Transmission, Horizontal|disease transmission, horizontal
5775614|NCT00219427|Low vision|low vision
5775615|NCT00219401|Pneumococcal vaccine|pneumococcal vaccine
5775616|NCT00219401|Antibody responses|antibody responses
5775617|NCT00219401|Cellular immunology|cellular immunology
5775618|NCT00219401|Th1/Th2 immune responses|th1/th2 immune responses
5775619|NCT00219401|Paediatric|paediatric
5775620|NCT00219401|Neonatal|neonatal
5775621|NCT00219401|Infectious diseases|infectious diseases
5775622|NCT00219401|Papua New Guinea|papua new guinea
5775623|NCT00219388|Safety|safety
5775624|NCT00219388|Efficacy|efficacy
5775625|NCT00219388|Levosimendan|levosimendan
5775626|NCT00219388|Dobutamine|dobutamine
5775627|NCT00219388|Intravenous|intravenous
5775628|NCT00219388|Invasive hemodynamics|invasive hemodynamics
5775629|NCT00219388|Decompensated Heart Failure|decompensated heart failure
5775630|NCT00219375|sivelestat sodium hydrate|sivelestat sodium hydrate
5775631|NCT00219375|acute lung injury|acute lung injury
5775632|NCT00219375|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5775633|NCT00219375|Elaspol|elaspol
5775634|NCT00219375|Acute Lung Injury (ALI) Associated With Systemic Inflammatory Response Syndrome (SIRS)|acute lung injury (ali) associated with systemic inflammatory response syndrome (sirs)
5775635|NCT00219362|HIV-1 infection|hiv-1 infection
5775636|NCT00219362|therapeutic vaccine|therapeutic vaccine
5775637|NCT00219362|Treatment Experienced|treatment experienced
5775638|NCT00219349|Anxiety Disorders|anxiety disorders
5775639|NCT00219349|Anxiety Neuroses|anxiety neuroses
5775640|NCT00219349|Behavior Therapy, Cognitive|behavior therapy, cognitive
5775641|NCT00219349|Escitalopram|escitalopram
5775642|NCT00219336|Prevent Alcohol Exposed Pregnancies|prevent alcohol exposed pregnancies
5775643|NCT00219336|Reduced Alcohol Used|reduced alcohol used
5775644|NCT00219336|Self-Guided Motivational Intervention|self-guided motivational intervention
5775645|NCT00219336|Effective Contraception|effective contraception
5775646|NCT00219336|Contraception|contraception
5775647|NCT00219336|College Students|college students
5775648|NCT00219323|Asthma, IgE, Omalizumab|asthma, ige, omalizumab
5775649|NCT00219310|Recurrent Genital Herpes (RGH), famciclovir, episodic treatment, suppressive treatment, Polymerase Chain Reaction (PCR).|recurrent genital herpes (rgh), famciclovir, episodic treatment, suppressive treatment, polymerase chain reaction (pcr).
5775651|NCT00219297|EPO906|epo906
5775652|NCT00219297|Brain cancer|brain cancer
5775653|NCT00219297|Brain metastasis|brain metastasis
5775654|NCT00219297|Lung cancer|lung cancer
5775655|NCT00219297|Lung metastasis|lung metastasis
5775656|NCT00219297|Brain metastasis from non-small cell lung cancer|brain metastasis from non-small cell lung cancer
5775657|NCT00219284|Parkinson's disease, tremor|parkinson's disease, tremor
5775658|NCT00219271|Prostate cancer|prostate cancer
5775659|NCT00219271|molecular staging|molecular staging
5775660|NCT00219271|antitumor potential|antitumor potential
5775661|NCT00219245|Traumatic brain injury, head trauma, rivastigmine, cognitive deficits|traumatic brain injury, head trauma, rivastigmine, cognitive deficits
5775662|NCT00219232|Alzheimer's disease|alzheimer's disease
5775663|NCT00219232|Dementia|dementia
5775664|NCT00219219|zoledronic acid|zoledronic acid
5775665|NCT00219219|prostate cancer|prostate cancer
5775666|NCT00219219|SRE|sre
5775667|NCT00219193|Hypertension, aliskiren, blood pressure, valsartan, HCTZ|hypertension, aliskiren, blood pressure, valsartan, hctz
5775668|NCT00219180|Hypertension, Aliskiren|hypertension, aliskiren
5775669|NCT00219167|hypertension|hypertension
5775670|NCT00219167|aliskiren|aliskiren
5686408|NCT00552292|hyperglycemia|hyperglycemia
5775671|NCT00219167|age|age
5775672|NCT00219128|Hypertension, aliskiren, blood pressure, placebo|hypertension, aliskiren, blood pressure, placebo
5775673|NCT00219115|Hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide|hypertension, aliskiren, blood pressure, irbesartan, amlodipine, hydrochlorothiazide
5775674|NCT00219102|Hypertension,|hypertension,
5775676|NCT00219102|aliskiren,|aliskiren,
5775677|NCT00219102|blood pressure,|blood pressure,
5775678|NCT00219102|valsartan,|valsartan,
5775679|NCT00219102|hydrochlorothiazide|hydrochlorothiazide
5775680|NCT00219089|Hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril|hypertension, aliskiren, blood pressure, diabetes mellitus, ramipril
5775681|NCT00219076|Hypertension, aliskiren, blood pressure, amlodipine|hypertension, aliskiren, blood pressure, amlodipine
5775682|NCT00219063|Hypertension, aliskiren, blood pressure, Ramipril, hydrochlorothiazide|hypertension, aliskiren, blood pressure, ramipril, hydrochlorothiazide
5775683|NCT00219037|Hypertension, blood pressure, aliskiren|hypertension, blood pressure, aliskiren
5775684|NCT00219024|Hypertension, aliskiren, blood pressure, hydrochlorothiazide (HCTZ).|hypertension, aliskiren, blood pressure, hydrochlorothiazide (hctz).
5775685|NCT00219011|Aliskiren, heart failure,hypertension|aliskiren, heart failure,hypertension
5775686|NCT00218998|Exercise|exercise
5775687|NCT00218998|Exercise therapy|exercise therapy
5775688|NCT00218985|Aerobic capacity|aerobic capacity
5775689|NCT00218985|Exercise training|exercise training
5775690|NCT00218985|CABG|cabg
5775691|NCT00218985|Endothelial function|endothelial function
5775692|NCT00218972|Hypertension|hypertension
5775693|NCT00218972|endurance training|endurance training
5775694|NCT00218972|endothelial function|endothelial function
5775695|NCT00218972|left ventricular function|left ventricular function
5775696|NCT00218972|Echocardiography|echocardiography
5775697|NCT00218972|Quality of life|quality of life
5775698|NCT00218972|Essential hypertension grade 1 - 2|essential hypertension grade 1 - 2
5775699|NCT00218959|PTSD|ptsd
5775700|NCT00218959|trauma treatment|trauma treatment
5775701|NCT00218959|refugees|refugees
5775702|NCT00218959|randomized controlled|randomized controlled
5775703|NCT00218946|pain|pain
5775704|NCT00218946|infant, premature|infant, premature
5775705|NCT00218946|intubation, gastrointestinal|intubation, gastrointestinal
5775706|NCT00218946|Neonatal nursing|neonatal nursing
5775707|NCT00218933|Interval training|interval training
5775708|NCT00218933|Endothelial dysfunction|endothelial dysfunction
5775709|NCT00218933|Aerobic capacity|aerobic capacity
5775710|NCT00218933|Exercise|exercise
5775711|NCT00218920|aerobic capacity|aerobic capacity
5775712|NCT00218920|endothelial function|endothelial function
5775713|NCT00218920|exercise|exercise
5775714|NCT00218907|HIV prevention|hiv prevention
5775715|NCT00218907|HIV counseling|hiv counseling
5775716|NCT00218907|HIV testing|hiv testing
5775717|NCT00218907|Emergency Medicine|emergency medicine
5775718|NCT00218907|HIV Seronegativity|hiv seronegativity
5775719|NCT00218894|Effect|effect
5775720|NCT00218894|Balance|balance
5775721|NCT00218894|Gait|gait
5775722|NCT00218894|Falls|falls
5775723|NCT00218881|HIV prevention|hiv prevention
5775724|NCT00218881|HIV screening|hiv screening
5775725|NCT00218881|Emergency Medicine|emergency medicine
5775726|NCT00218881|HIV counseling and Testing|hiv counseling and testing
5775727|NCT00218881|HIV Seronegativity|hiv seronegativity
5775728|NCT00218868|Cytodiagnosis|cytodiagnosis
5775729|NCT00218868|Skin Scrape|skin scrape
5775730|NCT00218868|Touch Imprint|touch imprint
5775731|NCT00218868|Papanicolaou|papanicolaou
5775732|NCT00218868|May-Grunvald-Giemsa|may-grunvald-giemsa
5775733|NCT00218855|Multiple Myeloma|multiple myeloma
5775734|NCT00218855|Phase 3, randomised, double blind study|phase 3, randomised, double blind study
5775735|NCT00218855|thalidomide|thalidomide
5775736|NCT00218842|exercise|exercise
5775737|NCT00218842|functioning|functioning
5775738|NCT00218842|frail elderly|frail elderly
5775739|NCT00218829|Photodynamic treatment|photodynamic treatment
5775740|NCT00218829|Basal cell carcinoma|basal cell carcinoma
5775741|NCT00218829|DMSO|dmso
5775742|NCT00218790|Sleep|sleep
5775743|NCT00218790|Renal failure|renal failure
5775744|NCT00218790|Dialysis|dialysis
5775745|NCT00218777|Chronic tic disorder|chronic tic disorder
5775746|NCT00218777|Motor tics|motor tics
5775747|NCT00218777|Vocal tics|vocal tics
5775748|NCT00218751|Child abuse|child abuse
5775749|NCT00218751|Neglect|neglect
5775750|NCT00218751|Home Visitation|home visitation
5775751|NCT00218751|Program Evaluation|program evaluation
5775752|NCT00218725|Cognitive Therapy|cognitive therapy
5775753|NCT00218725|Suicide|suicide
5775754|NCT00218725|Addictions|addictions
5775755|NCT00218725|Substance Abuse|substance abuse
5775757|NCT00218712|AIDS|aids
5775759|NCT00218712|Cognitive-Behavioral|cognitive-behavioral
5775760|NCT00218712|HIV Seronegativity|hiv seronegativity
5775761|NCT00218699|HIV|hiv
5775762|NCT00218699|MSM Men Who Have Sex with Men|msm men who have sex with men
5775763|NCT00218699|Men Who Have Sex With Men|men who have sex with men
5775764|NCT00218699|Cognitive-Behavioral|cognitive-behavioral
5775765|NCT00218699|HIV Counseling and Testing|hiv counseling and testing
5775766|NCT00218699|HIV Seronegativity|hiv seronegativity
5775767|NCT00218686|HIV|hiv
5775768|NCT00218686|injection drug use|injection drug use
5775769|NCT00218686|social networks|social networks
5775772|NCT00218673|social networks|social networks
5775773|NCT00218621|Buprenorphine|buprenorphine
5775774|NCT00218621|Methadone|methadone
5775775|NCT00218608|Cocaine Abuse|cocaine abuse
5775776|NCT00218582|12 step groups|12 step groups
5775777|NCT00218582|self help|self help
5775778|NCT00218582|psychiatric day treatment|psychiatric day treatment
5775779|NCT00218582|co-occurring disorders|co-occurring disorders
5775780|NCT00218582|dual diagnosis|dual diagnosis
5775781|NCT00218569|Alcohol Dependence|alcohol dependence
5775782|NCT00218569|Cocaine Dependence|cocaine dependence
5775783|NCT00218556|Hepatitis C, Depressive Symptoms|hepatitis c, depressive symptoms
5775785|NCT00218543|Cocaine Abuse|cocaine abuse
5775786|NCT00218517|cannabis use disorder|cannabis use disorder
5775787|NCT00218491|Cocaine Dependence|cocaine dependence
5775788|NCT00218465|Drugs, Investigational|drugs, investigational
5775789|NCT00218465|Therapies for Relapse to Nicotine|therapies for relapse to nicotine
5775790|NCT00218465|Relapse Prevention|relapse prevention
5775791|NCT00218465|Nicotine Cessation Therapies|nicotine cessation therapies
5775792|NCT00218465|Smoking Cessation|smoking cessation
5775793|NCT00218465|Nicotine Dependence|nicotine dependence
5775794|NCT00218452|Tobacco use cessation|tobacco use cessation
5775795|NCT00218439|Smoking|smoking
5775796|NCT00218413|Vaccine|vaccine
5775797|NCT00218413|Immunogenicity|immunogenicity
5775798|NCT00218413|Randomized Controlled Trial|randomized controlled trial
5775799|NCT00218413|Addiction|addiction
5775800|NCT00218387|Cocaine Dependence|cocaine dependence
5775801|NCT00218374|Opiate Addiction|opiate addiction
5775802|NCT00218374|Opiate Dependence|opiate dependence
5775803|NCT00218361|Behavioral economics|behavioral economics
5775804|NCT00218361|Drug self administration|drug self administration
5775805|NCT00218361|Opioid|opioid
5775806|NCT00218348|Cocaine Abuse|cocaine abuse
5775807|NCT00218348|Dextro-Amphetamine Sulfate|dextro-amphetamine sulfate
5775808|NCT00218335|HIV prevention Intervention, injection drug user,peer-oriented, randomized controlled trial, social network|hiv prevention intervention, injection drug user,peer-oriented, randomized controlled trial, social network
5775810|NCT00218296|Nicotine Dependence|nicotine dependence
5775811|NCT00218296|Tobacco Dependence|tobacco dependence
5775812|NCT00218283|Nicotine Dependence|nicotine dependence
5775813|NCT00218283|Tobacco Dependence|tobacco dependence
5775814|NCT00218270|Smokeless tobacco, harm reduction|smokeless tobacco, harm reduction
5775815|NCT00218257|Cocaine|cocaine
5775816|NCT00218244|Brand Switching, smokeless tobacco use|brand switching, smokeless tobacco use
5775817|NCT00218231|schizophrenia|schizophrenia
5775818|NCT00218231|tobacco dependence|tobacco dependence
5775819|NCT00218231|nicotine|nicotine
5775820|NCT00218218|Nicotine Dependence|nicotine dependence
5775821|NCT00218218|Tobacco Dependence|tobacco dependence
5775822|NCT00218205|Epirubicin|epirubicin
5775823|NCT00218205|Estramustine Phosphate|estramustine phosphate
5775824|NCT00218205|Celecoxib|celecoxib
5775825|NCT00218205|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5775826|NCT00218192|hepatitis c|hepatitis c
5775827|NCT00218192|injection drug use|injection drug use
5775828|NCT00218179|Lung Cancer|lung cancer
5775829|NCT00218179|Cotinine|cotinine
5775830|NCT00218179|NNAL|nnal
5775831|NCT00218179|Carcinogens|carcinogens
5775832|NCT00218179|Case-control|case-control
5775833|NCT00218179|SNPs|snps
5775834|NCT00218166|cocaine|cocaine
5775837|NCT00218153|nicotine dependence|nicotine dependence
5775838|NCT00218140|tobacco|tobacco
5775839|NCT00218127|Heroin dependence|heroin dependence
5775840|NCT00218114|ADHD, disruptive behavior disorder, marijuana abuse|adhd, disruptive behavior disorder, marijuana abuse
5775841|NCT00218101|opioid dependence|opioid dependence
5775842|NCT00218075|Cocaine addiction|cocaine addiction
5775843|NCT00218075|cocaine treatment|cocaine treatment
5775844|NCT00218036|Cocaine Abuse|cocaine abuse
5775845|NCT00218036|Opiate Abuse|opiate abuse
5775846|NCT00218023|cocaine|cocaine
5775847|NCT00218023|cocaine addiction|cocaine addiction
5775848|NCT00218023|cocaine abuse|cocaine abuse
5775849|NCT00218023|relapse prevention|relapse prevention
5775850|NCT00218010|methadone|methadone
5775851|NCT00218010|lactation|lactation
5775852|NCT00218010|breastfeeding|breastfeeding
5775853|NCT00218010|maternal opioid dependency|maternal opioid dependency
5775854|NCT00217997|cocaine abuse|cocaine abuse
5775855|NCT00217997|Cocaine-Related Disorders|cocaine-related disorders
5775856|NCT00217984|Tobacco use disorder|tobacco use disorder
5775857|NCT00217984|Alcohol dependence|alcohol dependence
5775858|NCT00217971|cannabis dependence|cannabis dependence
5775859|NCT00217971|dronabinol|dronabinol
5775860|NCT00217971|treatment|treatment
5775861|NCT00217932|Behavioral Disorders|behavioral disorders
5775862|NCT00217854|asthma, corticosteroids|asthma, corticosteroids
5775863|NCT00217841|MRSA|mrsa
5775864|NCT00217763|Dementia|dementia
5775865|NCT00217763|Alzheimer's disease|alzheimer's disease
5775866|NCT00217724|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5775867|NCT00217724|pain|pain
5775868|NCT00217711|stage III colon cancer|stage iii colon cancer
5775869|NCT00217711|stage IV colon cancer|stage iv colon cancer
5775870|NCT00217711|stage III rectal cancer|stage iii rectal cancer
5775871|NCT00217711|stage IV rectal cancer|stage iv rectal cancer
5775872|NCT00217698|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5775873|NCT00217698|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5775874|NCT00217698|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5775875|NCT00217698|adenocarcinoma of the lung|adenocarcinoma of the lung
5775876|NCT00217698|large cell lung cancer|large cell lung cancer
5775877|NCT00217698|squamous cell lung cancer|squamous cell lung cancer
5775878|NCT00217672|stage IV breast cancer|stage iv breast cancer
5775879|NCT00217672|recurrent breast cancer|recurrent breast cancer
5775880|NCT00217659|male breast cancer|male breast cancer
5775881|NCT00217659|recurrent breast cancer|recurrent breast cancer
5775882|NCT00217659|stage IV breast cancer|stage iv breast cancer
5775883|NCT00217620|adult angiosarcoma|adult angiosarcoma
5775884|NCT00217620|adult leiomyosarcoma|adult leiomyosarcoma
5775885|NCT00217620|adult liposarcoma|adult liposarcoma
5775886|NCT00217620|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5775887|NCT00217620|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5775888|NCT00217620|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5775889|NCT00217620|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5775890|NCT00217607|adult angiosarcoma|adult angiosarcoma
5775891|NCT00217607|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5775892|NCT00217607|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5775893|NCT00217607|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5775894|NCT00217594|Immunosuppression|immunosuppression
5775895|NCT00217594|T Cells|t cells
5775896|NCT00217594|Hematopoiesis|hematopoiesis
5775897|NCT00217594|Anti-CD52|anti-cd52
5775898|NCT00217594|Monoclonal Antibody Therapy|monoclonal antibody therapy
5775899|NCT00217581|recurrent gastric cancer|recurrent gastric cancer
5775900|NCT00217581|stage III gastric cancer|stage iii gastric cancer
5775901|NCT00217581|stage IV gastric cancer|stage iv gastric cancer
5775902|NCT00217581|recurrent esophageal cancer|recurrent esophageal cancer
5775903|NCT00217581|stage III esophageal cancer|stage iii esophageal cancer
5775904|NCT00217581|stage IV esophageal cancer|stage iv esophageal cancer
5775905|NCT00217581|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5775906|NCT00217568|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5862953|NCT00001452|Carney Complex|carney complex
5775907|NCT00217568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5775908|NCT00217568|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5775909|NCT00217568|peritoneal cavity cancer|peritoneal cavity cancer
5775910|NCT00217555|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5775911|NCT00217555|fallopian tube cancer|fallopian tube cancer
5775912|NCT00217555|peritoneal cavity cancer|peritoneal cavity cancer
5775913|NCT00217529|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5775914|NCT00217529|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5775915|NCT00217529|peritoneal cavity cancer|peritoneal cavity cancer
5775916|NCT00217529|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5775917|NCT00217529|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5775918|NCT00217529|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5775919|NCT00217529|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5775920|NCT00217529|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5775922|NCT00217529|fallopian tube cancer|fallopian tube cancer
5775923|NCT00217529|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5775924|NCT00217516|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5775925|NCT00217516|stage I prostate cancer|stage i prostate cancer
5775926|NCT00217516|stage II prostate cancer|stage ii prostate cancer
5775927|NCT00217503|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5775928|NCT00217490|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5775929|NCT00217477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5775930|NCT00217464|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5775931|NCT00217464|recurrent prostate cancer|recurrent prostate cancer
5775932|NCT00217451|Malaria|malaria
5775933|NCT00217451|Fosmidomycin|fosmidomycin
5775934|NCT00217451|Clindamycin|clindamycin
5775935|NCT00217451|Gabon|gabon
5775936|NCT00217425|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5775937|NCT00217425|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5775938|NCT00217425|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5775939|NCT00217425|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5775940|NCT00217425|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5775941|NCT00217425|peripheral T-cell lymphoma|peripheral t-cell lymphoma
5775942|NCT00217386|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5775943|NCT00217386|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5775944|NCT00217386|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5848606|NCT00034138|immunotherapy|immunotherapy
5775052|NCT00222196|biomarkers|biomarkers
5775945|NCT00217386|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5775947|NCT00217347|Gastroesophageal reflux|gastroesophageal reflux
5775948|NCT00217347|Dyspepsia|dyspepsia
5775949|NCT00217347|Esophageal Capsule Endoscopy|esophageal capsule endoscopy
5775950|NCT00217334|Hypertension|hypertension
5775951|NCT00217334|Cardiovascular diseases|cardiovascular diseases
5775952|NCT00217334|Randomized controlled trial|randomized controlled trial
5775953|NCT00217334|Cluster randomization|cluster randomization
5775954|NCT00217334|Primary care|primary care
5775955|NCT00217321|Parkinson's disease|parkinson's disease
5775956|NCT00217321|Parkinson disease|parkinson disease
5775957|NCT00217321|Registry|registry
5775958|NCT00217321|quality of life|quality of life
5775959|NCT00217321|database|database
5775960|NCT00217295|Relapsing-remitting multiple sclerosis|relapsing-remitting multiple sclerosis
5775961|NCT00217295|Brain atrophy|brain atrophy
5775962|NCT00217295|Disease progression|disease progression
5775963|NCT00217269|Restenosis|restenosis
5775964|NCT00217256|Restenosis|restenosis
5775965|NCT00217243|Pain|pain
5775966|NCT00217243|Magnetoencephalography|magnetoencephalography
5775967|NCT00217243|Median|median
5775968|NCT00217243|Ulnar|ulnar
5775969|NCT00217243|Causalgia|causalgia
5775970|NCT00217243|Complex regional pain syndrome|complex regional pain syndrome
5775971|NCT00217243|Evoked fields|evoked fields
5775972|NCT00217243|Nerve injury|nerve injury
5775973|NCT00217243|Neuropathic pain|neuropathic pain
5775974|NCT00217217|non-pharmaceutical|non-pharmaceutical
5775975|NCT00217217|alternative|alternative
5775976|NCT00217217|imaging|imaging
5775977|NCT00217217|magnetic resonance imaging|magnetic resonance imaging
5775978|NCT00217217|low field magnetic stimulation|low field magnetic stimulation
5775979|NCT00217217|bipolar disorder|bipolar disorder
5775980|NCT00217217|depression|depression
5775981|NCT00217217|bipolar depression|bipolar depression
5775982|NCT00217204|Cystic fibrosis|cystic fibrosis
5775983|NCT00217204|Pancreatic insufficiency|pancreatic insufficiency
5775984|NCT00217204|Steatorrhea|steatorrhea
5775985|NCT00217204|Fat malabsorption|fat malabsorption
5775986|NCT00217204|Pancrelipase|pancrelipase
5775987|NCT00217191|Premature Infants|premature infants
5775988|NCT00217191|Patent ductus arteriosus|patent ductus arteriosus
5775989|NCT00217191|Renal function|renal function
5775990|NCT00217191|Ibuprofen|ibuprofen
5775991|NCT00217178|Atherosclerosis|atherosclerosis
5775992|NCT00217178|CV Risk Factors|cv risk factors
5775993|NCT00217178|Homocysteine|homocysteine
5775994|NCT00217178|CV disease|cv disease
5775995|NCT00217178|Cardiovascular disease|cardiovascular disease
5775996|NCT00217165|bipolar|bipolar
5775997|NCT00217165|mania|mania
5775998|NCT00217165|depression|depression
5775999|NCT00217165|taurine|taurine
5776000|NCT00217165|alternative|alternative
5776001|NCT00217152|Kidney Transplant|kidney transplant
5776002|NCT00217139|Hepatitis C|hepatitis c
5776003|NCT00217139|Celgosivir|celgosivir
5776005|NCT00217139|Genotype 1|genotype 1
5776006|NCT00217139|Non-responders|non-responders
5776007|NCT00217139|Early Viral Response|early viral response
5776008|NCT00217139|EVR|evr
5776009|NCT00217035|parenteral nutrition|parenteral nutrition
5776010|NCT00217035|burn injury|burn injury
5776011|NCT00217035|stable isotopes|stable isotopes
5776012|NCT00217035|Proline Metabolic Kinetics|proline metabolic kinetics
5776013|NCT00217035|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
5776014|NCT00217035|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5776112|NCT00216541|cancer|cancer
5776015|NCT00217035|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5776016|NCT00217022|Lymphocytic Colitis|lymphocytic colitis
5776017|NCT00217022|diarrhea|diarrhea
5776018|NCT00217022|budesonide|budesonide
5776019|NCT00216996|parenteral nutrition|parenteral nutrition
5776020|NCT00216996|burn injury|burn injury
5776021|NCT00216996|stable isotopes|stable isotopes
5776022|NCT00216996|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5776023|NCT00216996|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5776024|NCT00216983|parenteral nutrition|parenteral nutrition
5776025|NCT00216983|burn injury|burn injury
5776026|NCT00216983|stable isotopes|stable isotopes
5776027|NCT00216983|Proline Metabolic Kinetics|proline metabolic kinetics
5776028|NCT00216983|Ornithine Metabolic Kinetics|ornithine metabolic kinetics
5776029|NCT00216983|Glutamate Metabolic Kinetics|glutamate metabolic kinetics
5776030|NCT00216983|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5776031|NCT00216970|parenteral nutrition|parenteral nutrition
5776032|NCT00216970|burn injury|burn injury
5776033|NCT00216970|stable isotopes|stable isotopes
5776034|NCT00216970|Arginine Metabolic Kinetics|arginine metabolic kinetics
5776035|NCT00216970|Nitric Oxide Formation|nitric oxide formation
5776036|NCT00216970|Glutamine Metabolic Kinetics|glutamine metabolic kinetics
5776037|NCT00216944|Intubation|intubation
5776038|NCT00216944|premedication|premedication
5776039|NCT00216905|Patients with alcoholism according to ICD-10 after detoxification|patients with alcoholism according to icd-10 after detoxification
5776040|NCT00216866|Embolism|embolism
5776041|NCT00216866|Thrombosis|thrombosis
5681078|NCT00574808|Chronic Care Model|chronic care model
5771080|NCT00239980|dalteparin|dalteparin
5776042|NCT00216814|antiangiogenic effects of bcg treatment and prognosis|antiangiogenic effects of bcg treatment and prognosis
5776355|NCT00215280|ivermectin|ivermectin
5776043|NCT00216801|Upper Tract Transitional Cell (TCC)|upper tract transitional cell (tcc)
5776045|NCT00216788|Barrett's esophagus|barrett's esophagus
5776046|NCT00216788|Esophagitis|esophagitis
5776047|NCT00216788|GERD|gerd
5776048|NCT00216788|Reflux|reflux
5776049|NCT00216788|Esophagus|esophagus
5776050|NCT00216788|Esomeprazole|esomeprazole
5776051|NCT00216762|Urticaria|urticaria
5776052|NCT00216762|Hives|hives
5776053|NCT00216749|Cerebral Infarction Prevention|cerebral infarction prevention
5776054|NCT00216749|Cilostazol|cilostazol
5776055|NCT00216736|Migraine|migraine
5776056|NCT00216736|Headache|headache
5776057|NCT00216736|Rebound headache|rebound headache
5776058|NCT00216723|Aripiprazole|aripiprazole
5776059|NCT00216723|Schizophrenia|schizophrenia
5776060|NCT00216723|Bipolar Disorder|bipolar disorder
5776061|NCT00216710|Child abuse|child abuse
5776062|NCT00216710|Neglect|neglect
5776063|NCT00216710|Home visitation|home visitation
5776064|NCT00216710|Program evaluation|program evaluation
5776065|NCT00216697|Multiple myeloma|multiple myeloma
5776066|NCT00216697|Proteasome inhibitor|proteasome inhibitor
5776067|NCT00216697|Ubiquitin|ubiquitin
5776068|NCT00216697|Boronic acids|boronic acids
5776069|NCT00216697|Bortezomib|bortezomib
5776070|NCT00216684|Fentanyl, Chronic intractable pain, Japanese patients|fentanyl, chronic intractable pain, japanese patients
5776071|NCT00216671|Schizophrenia|schizophrenia
5776072|NCT00216671|intramuscular injection|intramuscular injection
5776073|NCT00216671|antipsychotic agents|antipsychotic agents
5776074|NCT00216671|long-acting risperidone|long-acting risperidone
5776075|NCT00216658|Fentanyl|fentanyl
5776076|NCT00216658|Cancer pain|cancer pain
5776077|NCT00216658|Japanese patients|japanese patients
5776078|NCT00216645|Müllerian Carcinoma|müllerian carcinoma
5776079|NCT00216645|Doxil|doxil
5776080|NCT00216645|Japanese Patients|japanese patients
5776081|NCT00216632|Schizophrenia, Schizoaffective disorder|schizophrenia, schizoaffective disorder
5776082|NCT00216632|antipsychotic agents|antipsychotic agents
5776083|NCT00216632|long-acting risperidone|long-acting risperidone
5776084|NCT00216632|intramuscular injection|intramuscular injection
5776085|NCT00216619|chronic migraine|chronic migraine
5776086|NCT00216619|Topiramate|topiramate
5776087|NCT00216619|migraine|migraine
5776088|NCT00216619|headache|headache
5776089|NCT00216619|chronic headache|chronic headache
5776090|NCT00216606|Chronic migraine|chronic migraine
5776091|NCT00216606|Migraine|migraine
5776092|NCT00216606|Headache|headache
5776093|NCT00216606|Migraine headache|migraine headache
5776094|NCT00216606|Topiramate|topiramate
5776095|NCT00216593|dementia|dementia
5776096|NCT00216593|cognition function|cognition function
5776097|NCT00216593|Alzheimer disease|alzheimer disease
5776098|NCT00216593|behavioral symptoms|behavioral symptoms
5776099|NCT00216593|galantamine hydrobromide|galantamine hydrobromide
5776100|NCT00216580|Schizophrenia|schizophrenia
5776101|NCT00216580|Intramuscular injection|intramuscular injection
5776102|NCT00216580|Antipsychotic agents|antipsychotic agents
5776103|NCT00216580|Long-acting risperidone|long-acting risperidone
5776104|NCT00216580|Schizophreniform disorders|schizophreniform disorders
5776105|NCT00216580|Schizoaffective disorder|schizoaffective disorder
5776106|NCT00216567|Benign rolandic epilepsy|benign rolandic epilepsy
5776107|NCT00216567|Topiramate|topiramate
5776108|NCT00216554|Bipolar|bipolar
5776109|NCT00216554|risperidone|risperidone
5776110|NCT00216554|Adjunctive therapy|adjunctive therapy
5776111|NCT00216541|Anemia|anemia
5776114|NCT00216541|chemotherapy|chemotherapy
5776115|NCT00216541|hemoglobin|hemoglobin
5776116|NCT00216541|standard care|standard care
5776117|NCT00216541|epoetin alfa|epoetin alfa
5776118|NCT00216541|epoetin|epoetin
5776119|NCT00216541|erythropoietin|erythropoietin
5776120|NCT00216528|Schizophrenia|schizophrenia
5776121|NCT00216528|risperidone|risperidone
5776122|NCT00216528|Intramuscular injection, long-acting risperidone|intramuscular injection, long-acting risperidone
5776123|NCT00216515|Alzheimer's disease|alzheimer's disease
5776124|NCT00216515|galantamine|galantamine
5776125|NCT00216515|attention|attention
5776126|NCT00216515|executive function|executive function
5776127|NCT00216502|Alzheimer's disease|alzheimer's disease
5776128|NCT00216502|Dementia|dementia
5776129|NCT00216502|galantamine|galantamine
5776130|NCT00216502|placebo|placebo
5776131|NCT00216502|Caregiver|caregiver
5776132|NCT00216502|Brain disease|brain disease
5776133|NCT00216502|Memory loss|memory loss
5776134|NCT00216489|gastroesophageal reflux|gastroesophageal reflux
5776135|NCT00216489|heartburn|heartburn
5776136|NCT00216489|rabeprazole|rabeprazole
5776137|NCT00216489|GERD|gerd
5776138|NCT00216489|anti-ulcer agents|anti-ulcer agents
5776139|NCT00216489|proton pump inhibitor|proton pump inhibitor
5776140|NCT00216476|Schizophrenia, relapse prevention|schizophrenia, relapse prevention
5776141|NCT00216476|Antipsychotic agents|antipsychotic agents
5785129|NCT00169195|rituximab|rituximab
5775248|NCT00221351|cough|cough
5776142|NCT00216476|Long-acting risperidone|long-acting risperidone
5776143|NCT00216476|Quetiapine|quetiapine
5776144|NCT00216476|Aripiprazole|aripiprazole
5776145|NCT00216463|LDL-cholesterol|ldl-cholesterol
5776146|NCT00216463|apoB-100|apob-100
5776147|NCT00216463|apoB-48|apob-48
5776148|NCT00216450|rabeprazole|rabeprazole
5776149|NCT00216450|proton pump inhibitor|proton pump inhibitor
5776150|NCT00216450|Helicobacter infections|helicobacter infections
5776151|NCT00216450|Helicobacter pylori|helicobacter pylori
5776152|NCT00216450|H pylori|h pylori
5776153|NCT00216450|bacterial infections|bacterial infections
5776154|NCT00216437|Liver cancer|liver cancer
5776155|NCT00216424|Colon cancer|colon cancer
5776156|NCT00216424|Rectal cancer|rectal cancer
5776157|NCT00216398|acromegaly|acromegaly
5776158|NCT00216398|growth hormone|growth hormone
5776159|NCT00216385|Tuberculosis|tuberculosis
5776160|NCT00216385|Treatment|treatment
5776161|NCT00216385|Quinolone|quinolone
5776162|NCT00216385|Short course chemotherapy|short course chemotherapy
5776163|NCT00216372|carcinomatosis|carcinomatosis
5776164|NCT00216359|Treatment Experienced|treatment experienced
5776165|NCT00216333|tuberculosis|tuberculosis
5776166|NCT00216333|fixed dose combination|fixed dose combination
5776168|NCT00216333|shot-course chemotherapy|shot-course chemotherapy
5776169|NCT00216320|electrical stimulation|electrical stimulation
5776170|NCT00216294|Obsessive Compulsive Disorder|obsessive compulsive disorder
5776171|NCT00216294|RG 1068 (Synthetic Human Secretin)|rg 1068 (synthetic human secretin)
5776172|NCT00216281|Schizophrenia|schizophrenia
5776173|NCT00216281|Clozapine|clozapine
5776174|NCT00216281|Atomoxetine|atomoxetine
5776175|NCT00216255|Persistent Developmental Stuttering|persistent developmental stuttering
5776176|NCT00216242|influenza|influenza
5776177|NCT00216242|vaccine|vaccine
5776178|NCT00216242|efficacy|efficacy
5776179|NCT00216242|safety|safety
5776180|NCT00216242|immunogenicity|immunogenicity
5776181|NCT00216229|combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5776182|NCT00216229|hepatitis B virus|hepatitis b virus
5776183|NCT00216229|immunity|immunity
5776184|NCT00216203|Non-Small Cell Lung Cancer|non-small cell lung cancer
5776185|NCT00216190|Sedation, ICU, Anesthesia, Dexmedetomidine, Midazolam|sedation, icu, anesthesia, dexmedetomidine, midazolam
5776186|NCT00216164|Lymphoma|lymphoma
5776187|NCT00216151|Multiple Myeloma|multiple myeloma
5776188|NCT00216151|Bisphosphonates|bisphosphonates
5776189|NCT00216138|Head and Neck Cancer|head and neck cancer
5776190|NCT00216125|Non-Small Cell Lung Cancer|non-small cell lung cancer
5776191|NCT00216112|Ovarian Cancer|ovarian cancer
5776192|NCT00216099|Prostate Cancer|prostate cancer
5776193|NCT00216086|Rectal Cancer|rectal cancer
5776194|NCT00216073|Breast Cancer|breast cancer
5776195|NCT00216047|Breast Cancer|breast cancer
5776196|NCT00216034|Gastric Cancer|gastric cancer
5776197|NCT00216034|TS-1|ts-1
5776199|NCT00216034|Disease-free survival|disease-free survival
5776200|NCT00216034|Overall survival|overall survival
5776201|NCT00216021|Breast Cancer|breast cancer
5776202|NCT00215995|esophageal cancer|esophageal cancer
5776203|NCT00215995|esophagogastric cancer|esophagogastric cancer
5776204|NCT00215995|gastric cancer|gastric cancer
5776205|NCT00215982|advanced|advanced
5776206|NCT00215982|colon|colon
5776207|NCT00215982|rectal|rectal
5776208|NCT00215969|Pre-eclampsia|pre-eclampsia
5776209|NCT00215969|Pregnancy|pregnancy
5776210|NCT00215969|Hypercoagulation|hypercoagulation
5776211|NCT00215969|Screening|screening
5776212|NCT00215969|Cardiovascular complications|cardiovascular complications
5776213|NCT00215956|Topotecan|topotecan
5776214|NCT00215956|Rectal Neoplasms|rectal neoplasms
5776215|NCT00215956|Radiosensitizing|radiosensitizing
5776216|NCT00215943|hematologic malignancy|hematologic malignancy
5776217|NCT00215930|malignant pleural effusion|malignant pleural effusion
5776218|NCT00215917|Schizophrenia|schizophrenia
5776219|NCT00215917|NMDA|nmda
5776220|NCT00215917|D-serine|d-serine
5776221|NCT00215891|Treatment Experienced|treatment experienced
5776222|NCT00215852|Alferon LDO|alferon ldo
5776223|NCT00215852|Low Dose Oral Interferon|low dose oral interferon
5776224|NCT00215852|Alfa-n3|alfa-n3
5776225|NCT00215852|Human Leukocyte Derived|human leukocyte derived
5776227|NCT00215852|Asymptomatic HIV|asymptomatic hiv
5776228|NCT00215852|Treatment Experienced|treatment experienced
5776229|NCT00215839|Treatment Experienced|treatment experienced
5776230|NCT00215826|SARS|sars
5776231|NCT00215826|Alferon LDO|alferon ldo
5776232|NCT00215826|Low Dose Oral Interferon ALFA-n3|low dose oral interferon alfa-n3
5776233|NCT00215826|Human Leukocyte Derived|human leukocyte derived
5776234|NCT00215826|Exposure to SARS|exposure to sars
5776235|NCT00215826|Possible SARS|possible sars
5776236|NCT00215813|Chronic Fatigue Syndrome|chronic fatigue syndrome
5776237|NCT00215813|CFS|cfs
5776238|NCT00215813|ME|me
5776239|NCT00215813|Ampligen|ampligen
5776240|NCT00215813|poly I:poly C12U|poly i:poly c12u
5776241|NCT00215813|Rintatolimod|rintatolimod
5785230|NCT00168662|Infant mortality|infant mortality
5776242|NCT00215800|Chronic Fatigue Syndrome|chronic fatigue syndrome
5776243|NCT00215800|Myalgic Encephalomyelitis|myalgic encephalomyelitis
5776244|NCT00215800|CFS|cfs
5776245|NCT00215800|Ampligen|ampligen
5848607|NCT00034138|monoclonal|monoclonal
5776246|NCT00215800|Poly I:ploy C12U|poly i:ploy c12u
5776248|NCT00215787|Gastroesophageal Reflux|gastroesophageal reflux
5776249|NCT00215774|Atrial fibrillation|atrial fibrillation
5776250|NCT00215761|Atrial fibrillation|atrial fibrillation
5776251|NCT00215761|Preventive stimulation|preventive stimulation
5776252|NCT00215761|Pacemaker|pacemaker
5776253|NCT00215748|Elderly|elderly
5776254|NCT00215748|Weekly|weekly
5776255|NCT00215735|diabetes|diabetes
5776256|NCT00215735|Ulcer|ulcer
5776257|NCT00215735|APC|apc
5776258|NCT00215709|elderly|elderly
5776259|NCT00215683|Prostate Cancer|prostate cancer
5776260|NCT00215683|Androgen ablation therapy|androgen ablation therapy
5776261|NCT00215670|AMD|amd
5776262|NCT00215670|Macugen|macugen
5776263|NCT00215670|Pharmacokinetics|pharmacokinetics
5776264|NCT00215670|Age-Related Macular Degeneration|age-related macular degeneration
5776265|NCT00215670|PK|pk
5776266|NCT00215644|Esophagus|esophagus
5776267|NCT00215644|Gastric|gastric
5776268|NCT00215644|Adenocarcinoma|adenocarcinoma
5776269|NCT00215644|EGFR|egfr
5776270|NCT00215644|matuzumab|matuzumab
5776271|NCT00215644|EMD 72000|emd 72000
5776272|NCT00215644|randomized|randomized
5776273|NCT00215644|Epirubicin|epirubicin
5776274|NCT00215644|cisplatin|cisplatin
5776275|NCT00215644|capecitabine|capecitabine
5776276|NCT00215644|Metastatic Esophago-Gastric cancer|metastatic esophago-gastric cancer
5776277|NCT00215631|prostate cancer|prostate cancer
5776278|NCT00215631|radiotherapy|radiotherapy
5776279|NCT00215631|erectile dysfunction|erectile dysfunction
5776280|NCT00215631|tadalafil|tadalafil
5776281|NCT00215605|Advanced Malignancies|advanced malignancies
5776282|NCT00215605|Solid Tumor|solid tumor
5776283|NCT00215605|Medullary Thyroid Cancer|medullary thyroid cancer
5776284|NCT00215566|IBS|ibs
5776285|NCT00215566|IBS-c|ibs-c
5776286|NCT00215540|Double-blind|double-blind
5776287|NCT00215540|Low Birth Weight|low birth weight
5776288|NCT00215540|Surfactant|surfactant
5776289|NCT00215540|Placebo-Controlled|placebo-controlled
5776290|NCT00215540|Premature Birth|premature birth
5776291|NCT00215527|mucopolysaccharidosis|mucopolysaccharidosis
5776292|NCT00215527|Hurler-Scheie|hurler-scheie
5776293|NCT00215527|Scheie|scheie
5776294|NCT00215527|laronidase|laronidase
5776295|NCT00215527|spinal cord compression|spinal cord compression
5776296|NCT00215527|central nervous system|central nervous system
5776297|NCT00215527|enzyme replacement therapy|enzyme replacement therapy
5776298|NCT00215527|intrathecal|intrathecal
5776299|NCT00215527|LA Biomed|la biomed
5776300|NCT00215514|adjuvant chemoradiation|adjuvant chemoradiation
5776301|NCT00215514|GE junction|ge junction
5776302|NCT00215514|epirubicin|epirubicin
5776303|NCT00215501|advanced solid tumor malignancy|advanced solid tumor malignancy
5776304|NCT00215501|capecitabine|capecitabine
5776305|NCT00215501|continuous infusion|continuous infusion
5776306|NCT00215501|5-FU|5-fu
5776307|NCT00215501|irinotecan|irinotecan
5776308|NCT00215501|5-fluorouracil|5-fluorouracil
5776309|NCT00215501|cisplatin|cisplatin
5776310|NCT00215462|gastric adenocarcinoma|gastric adenocarcinoma
5776311|NCT00215462|esophageal adenocarcinoma|esophageal adenocarcinoma
5776312|NCT00215462|vinorelbine|vinorelbine
5776313|NCT00215449|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5776314|NCT00215449|COPD|copd
5776315|NCT00215449|formoterol|formoterol
5776316|NCT00215449|formoterol fumarate|formoterol fumarate
5776317|NCT00215436|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5776318|NCT00215436|COPD|copd
5776319|NCT00215436|formoterol|formoterol
5776320|NCT00215423|COPD|copd
5776321|NCT00215423|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5776322|NCT00215423|Formoterol Fumarate|formoterol fumarate
5776323|NCT00215423|Formoterol|formoterol
5776324|NCT00215410|Asthma|asthma
5776325|NCT00215410|Formoterol|formoterol
5776326|NCT00215410|Fumarate|fumarate
5776327|NCT00215397|Asthma|asthma
5776328|NCT00215397|Formoterol|formoterol
5776329|NCT00215397|Fumarate|fumarate
5776330|NCT00215384|COPD|copd
5776331|NCT00215384|formoterol|formoterol
5776332|NCT00215371|Asthma|asthma
5776333|NCT00215371|Pediatric|pediatric
5776334|NCT00215371|Formoterol Fumarate|formoterol fumarate
5776335|NCT00215371|Foradil|foradil
5776336|NCT00215358|Asthma|asthma
5776337|NCT00215358|Formoterol|formoterol
5776338|NCT00215358|Fumarate|fumarate
5776339|NCT00215358|Foradil|foradil
5776340|NCT00215345|Celecoxib|celecoxib
5776341|NCT00215345|Taxotere|taxotere
5776342|NCT00215345|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5776343|NCT00215332|arthroplasty|arthroplasty
5776344|NCT00215332|lumbar|lumbar
5776345|NCT00215332|disc|disc
5776346|NCT00215319|Degenerative disc disease at up to 2 levels (L2-S1)|degenerative disc disease at up to 2 levels (l2-s1)
5681079|NCT00574808|Outreach Facilitation|outreach facilitation
5776347|NCT00215306|arthroplasty|arthroplasty
5776348|NCT00215306|lumbar|lumbar
5776349|NCT00215306|spine|spine
5776350|NCT00215293|fusion|fusion
5776351|NCT00215293|cervical|cervical
5776352|NCT00215293|spine|spine
5776353|NCT00215280|Mansonella perstans|mansonella perstans
5776354|NCT00215280|microfilaraemia|microfilaraemia
5776356|NCT00215280|albendazole|albendazole
5776357|NCT00215280|Uganda|uganda
5776358|NCT00215267|Schistosoma mansoni|schistosoma mansoni
5776359|NCT00215267|hepatosplenomegaly|hepatosplenomegaly
5776360|NCT00215267|malaria|malaria
5776361|NCT00215267|Uganda|uganda
5776362|NCT00215254|quetiapine|quetiapine
5776363|NCT00215254|social anxiety disorder|social anxiety disorder
5776364|NCT00215254|antipsychotic|antipsychotic
5776365|NCT00215254|pilot study|pilot study
5776366|NCT00215241|PTSD|ptsd
5776367|NCT00215241|sertraline|sertraline
5776368|NCT00215241|risperidone|risperidone
5776369|NCT00215241|antidepressant|antidepressant
5776370|NCT00215241|antipsychotic|antipsychotic
5776371|NCT00215241|anxiety|anxiety
5776372|NCT00215241|trauma|trauma
5776373|NCT00215215|Vagus Nerve Stimulation Therapy|vagus nerve stimulation therapy
5776374|NCT00215215|Epilepsies, Partial|epilepsies, partial
5776375|NCT00215215|Seizures|seizures
5776376|NCT00215215|Antiepileptic Drugs|antiepileptic drugs
5776377|NCT00215215|Refractory Partial Seizures|refractory partial seizures
5776378|NCT00215202|Adrenocortical Cancer|adrenocortical cancer
5776379|NCT00215202|Iressa|iressa
5776380|NCT00215202|Adrenal Cancer|adrenal cancer
5776381|NCT00215189|health|health
5776382|NCT00215189|mental illness|mental illness
5776383|NCT00215189|fitness|fitness
5776384|NCT00215176|atypical depression|atypical depression
5776385|NCT00215176|psychostimulants|psychostimulants
5776386|NCT00215176|modafinil|modafinil
5776387|NCT00215163|PTSD|ptsd
5776388|NCT00215163|Anxiety|anxiety
5776390|NCT00215163|Exposure|exposure
5776391|NCT00215163|Paroxetine|paroxetine
5776392|NCT00215163|Paroxetine-CR|paroxetine-cr
5776393|NCT00215150|anxiety disorder|anxiety disorder
5776394|NCT00215150|SAD|sad
5776395|NCT00215150|ziprasidone|ziprasidone
5776396|NCT00215150|sertraline|sertraline
5776397|NCT00215150|antidepressant|antidepressant
5776398|NCT00215150|antipsychotic|antipsychotic
5776400|NCT00215137|SSRI|ssri
5776401|NCT00215137|escitalopram|escitalopram
5776402|NCT00215137|relapse|relapse
5776403|NCT00215111|childhood obesity|childhood obesity
5776404|NCT00215111|weight management|weight management
5776405|NCT00215111|dietary interventions|dietary interventions
5776406|NCT00215111|cardiovascular disease risk factors|cardiovascular disease risk factors
5776407|NCT00215098|pediatric health|pediatric health
5776408|NCT00215098|cardiac|cardiac
5786342|NCT00163579|premature birth|premature birth
5776409|NCT00215098|congenital heart surgery|congenital heart surgery
5776410|NCT00215098|post-operative chylous effusions|post-operative chylous effusions
5776411|NCT00215098|heart defects|heart defects
5776412|NCT00215098|children|children
5776413|NCT00215085|pediatric health|pediatric health
5776414|NCT00215085|cardiac|cardiac
5776415|NCT00215085|cardiac tumor|cardiac tumor
5776416|NCT00215085|children|children
5776417|NCT00215072|Death after heart surgery|death after heart surgery
5776418|NCT00215072|surgical mortality|surgical mortality
5776419|NCT00215072|post-operative mortality|post-operative mortality
5776420|NCT00215072|pediatric health|pediatric health
5776421|NCT00215072|cardiac|cardiac
5776422|NCT00215059|angiogenic related growth factor|angiogenic related growth factor
5776423|NCT00215046|vinblastine|vinblastine
5776424|NCT00215046|methotrexate|methotrexate
5776425|NCT00215033|Epstein-Barr virus|epstein-barr virus
5776426|NCT00215033|pediatric health|pediatric health
5776427|NCT00215033|cardiac|cardiac
5776428|NCT00215033|heart transplant|heart transplant
5776429|NCT00215033|lymphoproliferative disease|lymphoproliferative disease
5776430|NCT00215033|post-transplant|post-transplant
5776431|NCT00215033|pediatric transplant|pediatric transplant
5776432|NCT00215020|Isoprostanes|isoprostanes
5776433|NCT00214981|ADHD|adhd
5776434|NCT00214981|Attention Deficit/Hyperactivity Disorder|attention deficit/hyperactivity disorder
5776435|NCT00214929|Pulmonary Embolism|pulmonary embolism
5776436|NCT00214929|Therapy|therapy
5776437|NCT00214929|Home Nursing|home nursing
5776438|NCT00214929|Economics|economics
5776439|NCT00214916|Tight glycemic control with|tight glycemic control with
5776440|NCT00214916|intensive insulin treatment|intensive insulin treatment
5776441|NCT00214916|versus conventional glycemic control|versus conventional glycemic control
5776442|NCT00214916|in infant or child in ICU|in infant or child in icu
5776443|NCT00214903|Postmenopause|postmenopause
5776445|NCT00214890|HIV|hiv
5776446|NCT00214890|nucleoside pharmacology|nucleoside pharmacology
5776447|NCT00214890|drug-drug interaction|drug-drug interaction
5776448|NCT00214890|Treatment Naive|treatment naive
5776449|NCT00214890|Drug resistance|drug resistance
5776450|NCT00214890|Drug pharmacokinetics|drug pharmacokinetics
5776451|NCT00214877|methylene blue for cognitive dysfunction in bipolar disorder|methylene blue for cognitive dysfunction in bipolar disorder
5776452|NCT00214864|Metastatic Breast Cancer|metastatic breast cancer
5776453|NCT00214864|Taxotere (docetaxel)|taxotere (docetaxel)
5776454|NCT00214864|Xeloda (capecitabine)|xeloda (capecitabine)
5776455|NCT00214851|Familial Cold Urticaria|familial cold urticaria
5776456|NCT00214851|Kineret (anakinra)|kineret (anakinra)
5776457|NCT00214851|Interleukin 1 beta|interleukin 1 beta
5793790|NCT00129207|pharmacodynamics|pharmacodynamics
5793791|NCT00129207|VELCADE|velcade
5793792|NCT00129207|Ketoconazole|ketoconazole
5793793|NCT00129207|CYP 3A4|cyp 3a4
5793794|NCT00129207|Solid Tumor|solid tumor
5793795|NCT00129207|Advanced Solid Tumors|advanced solid tumors
5793796|NCT00129194|HIV|hiv
5793797|NCT00129194|Treatment Experienced|treatment experienced
5793798|NCT00129181|parkinson|parkinson
5793799|NCT00129181|brain imaging|brain imaging
5793800|NCT00129181|diagnosis|diagnosis
5793801|NCT00129168|Leukemia, Myeloid|leukemia, myeloid
5793802|NCT00129168|Relapse|relapse
5793803|NCT00129168|Chemotherapy|chemotherapy
5793804|NCT00129168|Zosuquidar|zosuquidar
5793805|NCT00129168|Daunorubicin|daunorubicin
5793806|NCT00129168|Cytarabine|cytarabine
5793807|NCT00129168|Acute|acute
5793808|NCT00129168|AML|aml
5793809|NCT00129168|Adult AML|adult aml
5793810|NCT00129155|Allogenic stem cell transplantation|allogenic stem cell transplantation
5793811|NCT00129155|Treosulfan|treosulfan
5776747|NCT00213174|pediatrics|pediatrics
5776458|NCT00214851|C-Reactive Protein|c-reactive protein
5776459|NCT00214851|Serum Amyloid A protein|serum amyloid a protein
5776460|NCT00214838|cancer, atiprimod|cancer, atiprimod
5776461|NCT00214812|HIV Seronegativity|hiv seronegativity
5776462|NCT00214812|HIV|hiv
5776463|NCT00214786|Diabetes Mellitus|diabetes mellitus
5776464|NCT00214786|Hypoglycemia|hypoglycemia
5776465|NCT00214786|Hyperglycemia|hyperglycemia
5776466|NCT00214760|Hip prosthesis|hip prosthesis
5776467|NCT00214760|Centralizer|centralizer
5776468|NCT00214760|Uncemented|uncemented
5776469|NCT00214747|HIV Seronegativity|hiv seronegativity
5776470|NCT00214747|HIV|hiv
5776471|NCT00214708|Tuberculosis|tuberculosis
5776472|NCT00214708|Screening|screening
5776473|NCT00214708|Heaf|heaf
5776474|NCT00214708|BCG|bcg
5776475|NCT00214682|Depression|depression
5776476|NCT00214682|Cognition|cognition
5776477|NCT00214682|Depressive disorder|depressive disorder
5767177|NCT00255580|HIV|hiv
5776478|NCT00214682|Mental health literacy|mental health literacy
5776479|NCT00214682|Older adults|older adults
5776480|NCT00214682|Randomzed controlled trial|randomzed controlled trial
5776481|NCT00214669|ethnicity|ethnicity
5776482|NCT00214669|primary care|primary care
5776483|NCT00214669|education|education
5776484|NCT00214656|Cardiac surgical procedures|cardiac surgical procedures
5786453|NCT00162994|prevention|prevention
5776485|NCT00214656|Surgical blood loss|surgical blood loss
5776486|NCT00214656|Surgical haemostasis|surgical haemostasis
5776487|NCT00214656|Factor VIIa|factor viia
5776488|NCT00214656|Anaesthesia|anaesthesia
5776489|NCT00214643|Malaria|malaria
5776490|NCT00214643|Fosmidomycin|fosmidomycin
5776491|NCT00214643|Clindamycin|clindamycin
5776492|NCT00214643|Chemotherapy|chemotherapy
5776493|NCT00214643|Gabon|gabon
5776494|NCT00214617|hypercholesterolemia|hypercholesterolemia
5776495|NCT00214617|HMG CoA Reductase Inhibtors|hmg coa reductase inhibtors
5776496|NCT00214617|tracer kinetics|tracer kinetics
5776497|NCT00214617|Apolipoproteins|apolipoproteins
5776498|NCT00214591|Type 2 diabetes|type 2 diabetes
5776499|NCT00214578|Schizophrenia|schizophrenia
5776500|NCT00214565|Type 2 diabetes|type 2 diabetes
5776501|NCT00214552|GERD|gerd
5776502|NCT00214552|Gastroesophageal reflux disease|gastroesophageal reflux disease
5776503|NCT00214552|Asthma symptoms|asthma symptoms
5776504|NCT00214539|Asthma|asthma
5776505|NCT00214539|Bronchial Thermoplasty|bronchial thermoplasty
5776506|NCT00214526|Asthma|asthma
5776507|NCT00214526|Bronchial Thermoplasty|bronchial thermoplasty
5776508|NCT00214526|Airway Hyperresponsiveness|airway hyperresponsiveness
5776509|NCT00214500|Amicus Therapeutics|amicus therapeutics
5776510|NCT00214500|AT1001|at1001
5776511|NCT00214500|Galafold|galafold
5776512|NCT00214500|Migalastat|migalastat
5776513|NCT00214500|Substrate|substrate
5776514|NCT00214487|Myopia Progression|myopia progression
5776515|NCT00214487|Myopia Control|myopia control
5776516|NCT00214487|Bifocal Contact Lenses|bifocal contact lenses
5776517|NCT00214487|Esophoria|esophoria
5776518|NCT00214487|Fixation Disparity|fixation disparity
5776519|NCT00214474|Disease Management|disease management
5776520|NCT00214474|Health Literacy|health literacy
5776521|NCT00214474|Telephone Care|telephone care
5776522|NCT00214474|Group Medical Visits|group medical visits
5776523|NCT00214474|Type 2 Diabetes|type 2 diabetes
5776524|NCT00214474|Access to Care|access to care
5776525|NCT00214474|Technology|technology
5776526|NCT00214474|Language Barriers|language barriers
5776527|NCT00214461|Clostridium difficile|clostridium difficile
5776528|NCT00214448|Multiple genetic conditions will be studied|multiple genetic conditions will be studied
5776529|NCT00214435|HIV infection|hiv infection
5776530|NCT00214435|AIDS|aids
5785534|NCT00167531|physiotherapy|physiotherapy
5775650|NCT00219297|EPO|epo
5776533|NCT00214435|Treatment Experienced|treatment experienced
5776534|NCT00214422|Prostate|prostate
5776535|NCT00214422|Radiation|radiation
5776536|NCT00214422|Cancer|cancer
5776537|NCT00214422|Prostate Cancer|prostate cancer
5776538|NCT00214383|pediatric asthma|pediatric asthma
5776539|NCT00214370|pediatric|pediatric
5776540|NCT00214370|acute leukemia/lymphoma|acute leukemia/lymphoma
5776541|NCT00214344|dying|dying
5776542|NCT00214227|patient who will undergo definitive radiotherapy|patient who will undergo definitive radiotherapy
5776543|NCT00214175|low grade gliomas and benign CNS lesions|low grade gliomas and benign cns lesions
5776544|NCT00214045|Bladder cancer surveillance|bladder cancer surveillance
5776545|NCT00214045|Voiding dysfunction|voiding dysfunction
5776546|NCT00214045|Cystoscopy|cystoscopy
5776547|NCT00214032|lymphedema of the arm in breast cancer survivors|lymphedema of the arm in breast cancer survivors
5776548|NCT00213980|bone mineral density|bone mineral density
5776549|NCT00213980|postmenopausal women|postmenopausal women
5776550|NCT00213967|Influenza vaccine|influenza vaccine
5776551|NCT00213954|Nerve block anaesthesia|nerve block anaesthesia
5776552|NCT00213954|ultrasound-guidance|ultrasound-guidance
5776553|NCT00213941|transient tachypnoea of the newborn|transient tachypnoea of the newborn
5776554|NCT00213941|surfactant deficiency|surfactant deficiency
5776555|NCT00213941|persistant pulmonary hypertension of the neonate|persistant pulmonary hypertension of the neonate
5776556|NCT00213941|lung maturity tests|lung maturity tests
5776557|NCT00213915|L-arginine|l-arginine
5776748|NCT00213174|injury|injury
5776558|NCT00213915|exercise capacity|exercise capacity
5776559|NCT00213915|renal function|renal function
5776560|NCT00213915|nitric oxide|nitric oxide
5776561|NCT00213915|exercise capacity using a maximal exercise test|exercise capacity using a maximal exercise test
5776562|NCT00213915|urinary elimination of a saline load using blood and urinary samples|urinary elimination of a saline load using blood and urinary samples
5776563|NCT00213902|Heart failure|heart failure
5776564|NCT00213902|Diastolic|diastolic
5776565|NCT00213902|functionClonidine|functionclonidine
5776566|NCT00213902|Left ventricular diastolic dysfunction with preserved ejection fraction|left ventricular diastolic dysfunction with preserved ejection fraction
5776567|NCT00213889|Facial clefting|facial clefting
5776568|NCT00213889|twist|twist
5776569|NCT00213889|craniofacial development genes|craniofacial development genes
5776570|NCT00213889|Human cleft lip and palate|human cleft lip and palate
5776571|NCT00213889|cleft lip and palate|cleft lip and palate
5776572|NCT00213876|Brain tumours|brain tumours
5776573|NCT00213876|oligodendrogliomas|oligodendrogliomas
5776575|NCT00213876|SAGE|sage
5776576|NCT00213876|Presence of molecular abnormalities statistically linked to survival or response to chemotherapy|presence of molecular abnormalities statistically linked to survival or response to chemotherapy
5776577|NCT00213863|porous titanium implants|porous titanium implants
5776578|NCT00213863|thyroplasty|thyroplasty
5776579|NCT00213863|vocal cord paralysis|vocal cord paralysis
5776580|NCT00213863|male or female more than 18 years old|male or female more than 18 years old
5776581|NCT00213850|Interrupter technique|interrupter technique
5776582|NCT00213850|Respiratory resistance|respiratory resistance
5776584|NCT00213837|porous titanium implants|porous titanium implants
5776585|NCT00213837|thyroplasty|thyroplasty
5776586|NCT00213837|vocal cord paralysis|vocal cord paralysis
5776587|NCT00213837|male or female more than 18 years old|male or female more than 18 years old
5776588|NCT00213824|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5776589|NCT00213824|Nogo gene|nogo gene
5776590|NCT00213824|reticulon genes|reticulon genes
5776591|NCT00213811|Bardet-Biedl syndrome, retinitis pigmentosa, obesity, genes|bardet-biedl syndrome, retinitis pigmentosa, obesity, genes
5776592|NCT00213798|Lung cancer|lung cancer
5776593|NCT00213798|plasma DNA|plasma dna
5776594|NCT00213798|allelotyping|allelotyping
5776595|NCT00213798|follow-up|follow-up
5776596|NCT00213798|Prospective Study|prospective study
5776597|NCT00213798|Non-Small Cell Lung Cancer|non-small cell lung cancer
5776598|NCT00213798|Small Cell Lung Cancer|small cell lung cancer
5776599|NCT00213785|AreET1|areet1
5776601|NCT00213785|BNP pronostic markers of stroke|bnp pronostic markers of stroke
5776602|NCT00213772|Porphyria cutanea tarda|porphyria cutanea tarda
5776603|NCT00213772|hepatitis C|hepatitis c
5776604|NCT00213772|hemochromatosis|hemochromatosis
5776605|NCT00213759|neutropenia|neutropenia
5776606|NCT00213759|prematurity|prematurity
5776607|NCT00213759|nosocomial infection|nosocomial infection
5776608|NCT00213759|G-CSF|g-csf
5776609|NCT00213746|Coronary Arteriosclerosis|coronary arteriosclerosis
5776610|NCT00213746|Heart Failure, Congestive|heart failure, congestive
5776611|NCT00213746|Myocardial Infarction|myocardial infarction
5776612|NCT00213746|Myocardial Revascularization|myocardial revascularization
5776613|NCT00213746|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5776614|NCT00213746|Dobutamine|dobutamine
5776615|NCT00213746|Myocardial Stunning|myocardial stunning
5776616|NCT00213746|Myocardial Hibernation|myocardial hibernation
5776617|NCT00213733|Lung cancer patients|lung cancer patients
5776618|NCT00213733|non-small cell lung cancer|non-small cell lung cancer
5776619|NCT00213733|molecular marker|molecular marker
5776825|NCT00212953|Trauma|trauma
5776620|NCT00213733|lymph node completed resected|lymph node completed resected
5776621|NCT00213733|Lung cancer samples and paired lymph node resected|lung cancer samples and paired lymph node resected
5776622|NCT00213720|Hyperthyroidism|hyperthyroidism
5776623|NCT00213720|atrial fibrillation|atrial fibrillation
5776624|NCT00213720|quality of life|quality of life
5776625|NCT00213720|radioiodine treatment|radioiodine treatment
5776626|NCT00213707|Dendritic cells|dendritic cells
5776627|NCT00213707|liver transplantation|liver transplantation
5776628|NCT00213707|hepatitis C virus|hepatitis c virus
5776629|NCT00213707|quasispecies|quasispecies
5776630|NCT00213707|virological markers|virological markers
5776631|NCT00213707|biochemical markers|biochemical markers
5776632|NCT00213707|immunological markers|immunological markers
5776633|NCT00213707|clinical markers|clinical markers
5776634|NCT00213681|Pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure|pulmonary edema, respiratory failure, pressure support ventilation, continuous positive pressure
5776635|NCT00213668|glutamine|glutamine
5776636|NCT00213668|premature neonate|premature neonate
5776637|NCT00213668|gastric emptying|gastric emptying
5776638|NCT00213642|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide
5776639|NCT00213642|Radionuclide Imaging|radionuclide imaging
5776640|NCT00213642|Cisplatin|cisplatin
5776641|NCT00213642|Kidney failure|kidney failure
5776642|NCT00213642|Drug Toxicity|drug toxicity
5776643|NCT00213642|Cancer|cancer
5776644|NCT00213629|myositis|myositis
5776645|NCT00213629|cDNA arrays|cdna arrays
5776646|NCT00213629|Genes, T-Cell Receptor beta|genes, t-cell receptor beta
5776647|NCT00213616|bilateral vocal cord paralysis|bilateral vocal cord paralysis
5776648|NCT00213616|reinnervation|reinnervation
5776649|NCT00213616|phrenic nerve|phrenic nerve
5776650|NCT00213603|precancerous lesions|precancerous lesions
5776651|NCT00213603|Lung cancer|lung cancer
5776652|NCT00213603|Follow-up|follow-up
5776653|NCT00213603|Randomized study|randomized study
5776654|NCT00213603|Autofluorescence endoscopy|autofluorescence endoscopy
5776655|NCT00213603|precancerous conditions|precancerous conditions
5776656|NCT00213577|overactive neurogenic bladder|overactive neurogenic bladder
5776657|NCT00213499|Mechanical ventilation|mechanical ventilation
5776658|NCT00213499|Weaning|weaning
5776659|NCT00213499|Noninvasive ventilation|noninvasive ventilation
5776660|NCT00213499|Acute on chronic respiratory failure|acute on chronic respiratory failure
5776661|NCT00213473|acquired haemophilia|acquired haemophilia
5776662|NCT00213434|prospective|prospective
5776663|NCT00213434|randomized|randomized
5776664|NCT00213434|polysomnography|polysomnography
5776665|NCT00213434|orthodontic appliance, removable|orthodontic appliance, removable
5776666|NCT00213408|Arrhythmia|arrhythmia
5776667|NCT00213408|atrial flutter|atrial flutter
5776668|NCT00213408|catheter ablation|catheter ablation
5776669|NCT00213395|Noninvasive ventilation|noninvasive ventilation
5786662|NCT00161382|HIV|hiv
5776670|NCT00213395|Acute hypercapnic respiratory failure|acute hypercapnic respiratory failure
5776671|NCT00213395|Cephalic mask|cephalic mask
5776672|NCT00213395|Facial Mask|facial mask
5776673|NCT00213382|swallowing|swallowing
5776674|NCT00213382|ventilation|ventilation
5776675|NCT00213382|pressure|pressure
5776676|NCT00213382|EMG|emg
5776677|NCT00213382|cortical magnetic stimulation|cortical magnetic stimulation
5776678|NCT00213382|Brain Mapping|brain mapping
5776679|NCT00213369|aspiration|aspiration
5776680|NCT00213369|stroke|stroke
5776681|NCT00213369|motor evoked potential|motor evoked potential
5776682|NCT00213369|cortical evoked potential|cortical evoked potential
5776683|NCT00213369|neuromodulation|neuromodulation
5776684|NCT00213356|spinal cord injuries - anal sphincter - evoked potentials|spinal cord injuries - anal sphincter - evoked potentials
5776685|NCT00213343|aspiration|aspiration
5776686|NCT00213343|phrenic nerve|phrenic nerve
5776687|NCT00213343|magnetic stimulation|magnetic stimulation
5776688|NCT00213330|cerebral activity|cerebral activity
5776689|NCT00213330|rectal distension|rectal distension
5776690|NCT00213330|colitis ulcerative|colitis ulcerative
5776691|NCT00213330|irritable bowel syndrome|irritable bowel syndrome
5776692|NCT00213330|magnetic resonance imaging|magnetic resonance imaging
5776693|NCT00213317|sacral magnetic stimulation|sacral magnetic stimulation
5776694|NCT00213317|fecal incontinence|fecal incontinence
5776695|NCT00213317|constipation|constipation
5776696|NCT00213304|organ transplantation|organ transplantation
5776697|NCT00213304|immunosuppression|immunosuppression
5776698|NCT00213304|vaccine|vaccine
5776699|NCT00213304|varicella|varicella
5776700|NCT00213304|pediatrics|pediatrics
5776701|NCT00213291|chronic kidney failure|chronic kidney failure
5776702|NCT00213291|darbepoetin|darbepoetin
5776703|NCT00213291|pediatrics|pediatrics
5776704|NCT00213291|anemia|anemia
5776705|NCT00213278|glioma|glioma
5776706|NCT00213278|brain tumour|brain tumour
5776707|NCT00213278|cancer|cancer
5776708|NCT00213278|pediatrics|pediatrics
5776709|NCT00213278|vinblastine sulfate|vinblastine sulfate
5776710|NCT00213265|organ transplantation|organ transplantation
5776711|NCT00213265|immunosuppression|immunosuppression
5776712|NCT00213265|vaccine|vaccine
5785752|NCT00166660|MRI|mri
5776713|NCT00213265|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5776714|NCT00213265|pediatrics|pediatrics
5776826|NCT00212940|Treatment Naive|treatment naive
5776715|NCT00213252|asthma, randomized trial, pediatrics|asthma, randomized trial, pediatrics
5776716|NCT00213239|spinal puncture|spinal puncture
5776717|NCT00213239|remifentanil|remifentanil
5776718|NCT00213239|propofol|propofol
5776719|NCT00213239|anesthesia|anesthesia
5776720|NCT00213239|dose finding|dose finding
5776721|NCT00213239|pediatrics|pediatrics
5776722|NCT00213226|bronchiolitis|bronchiolitis
5776723|NCT00213226|pediatrics|pediatrics
5776724|NCT00213226|corticosteroids|corticosteroids
5776725|NCT00213213|sucrose|sucrose
5776726|NCT00213213|analgesia|analgesia
5776727|NCT00213213|pain|pain
5776728|NCT00213213|neonates|neonates
5776729|NCT00213213|diabetes|diabetes
5776730|NCT00213200|pain|pain
5776731|NCT00213200|analgesia|analgesia
5776732|NCT00213200|morphine|morphine
5776733|NCT00213200|amethocaine|amethocaine
5776734|NCT00213200|neonate|neonate
5776735|NCT00213187|Juvenile Rheumatoid Arthritis,|juvenile rheumatoid arthritis,
5776736|NCT00213187|Randomized Control Trial,|randomized control trial,
5776737|NCT00213187|attention placebo,|attention placebo,
5776738|NCT00213187|exercise testing,|exercise testing,
5776739|NCT00213187|aerobics,|aerobics,
5776740|NCT00213187|Qi Gong,|qi gong,
5776741|NCT00213187|exercise video,|exercise video,
5776742|NCT00213187|activities of daily living,|activities of daily living,
5776743|NCT00213187|quality of life,|quality of life,
5776744|NCT00213187|economy of walking,|economy of walking,
5776745|NCT00213187|fitness|fitness
5776746|NCT00213187|pediatrics|pediatrics
5776749|NCT00213174|arm fractures|arm fractures
5776750|NCT00213174|trauma|trauma
5776751|NCT00213174|playground surfaces|playground surfaces
5776752|NCT00213174|fractures|fractures
5776753|NCT00213161|anemia|anemia
5776754|NCT00213161|iron deficiency|iron deficiency
5776755|NCT00213161|iron drops|iron drops
5776756|NCT00213161|iron supplement|iron supplement
5776757|NCT00213161|malnutrition|malnutrition
5776758|NCT00213161|pediatrics|pediatrics
5776759|NCT00213122|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5776760|NCT00213109|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5776761|NCT00213096|Contraceptive agents|contraceptive agents
5776762|NCT00213096|female|female
5776763|NCT00213083|Microbicide|microbicide
5776765|NCT00213083|AIDS|aids
5776766|NCT00213083|STIs|stis
5776767|NCT00213083|STDs|stds
5776768|NCT00213083|Efficacy|efficacy
5776770|NCT00213083|Women|women
5776771|NCT00213083|South Africa|south africa
5776772|NCT00213083|seroconversion|seroconversion
5776773|NCT00213083|condom|condom
5776774|NCT00213083|safe-sex|safe-sex
5776775|NCT00213083|vaginal intercourse|vaginal intercourse
5776776|NCT00213083|prevention|prevention
5776777|NCT00213083|HIV Seronegativity|hiv seronegativity
5776778|NCT00213070|alpha-glucosidase inhibitor,Insulin|alpha-glucosidase inhibitor,insulin
5776779|NCT00213057|Microbicides|microbicides
5776780|NCT00213057|HIV prevention|hiv prevention
5776781|NCT00213057|sexually transmitted infections|sexually transmitted infections
5776782|NCT00213057|carrageenan|carrageenan
5776783|NCT00213057|sero-concordant couples|sero-concordant couples
5776784|NCT00213057|HIV Seronegativity|hiv seronegativity
5776786|NCT00213044|Microbicides|microbicides
5776787|NCT00213044|HIV prevention|hiv prevention
5776788|NCT00213044|HIV-positive women|hiv-positive women
5776790|NCT00213044|carrageenan|carrageenan
5776791|NCT00213044|HIV|hiv
5776792|NCT00213031|microbicides|microbicides
5776793|NCT00213031|HIV prevention|hiv prevention
5776794|NCT00213031|sexually transmitted infections|sexually transmitted infections
5776795|NCT00213031|female-initiated protection|female-initiated protection
5776796|NCT00213031|carrageenan|carrageenan
5776797|NCT00213031|expanded safety trial|expanded safety trial
5776798|NCT00213031|HIV Seronegativity|hiv seronegativity
5776799|NCT00213031|HIV|hiv
5776800|NCT00213018|microbicides|microbicides
5776801|NCT00213018|HIV prevention|hiv prevention
5776802|NCT00213018|sexually transmitted infections|sexually transmitted infections
5776803|NCT00213018|female-initiated protection|female-initiated protection
5776804|NCT00213018|carrageenan|carrageenan
5776805|NCT00213018|expanded safety trial|expanded safety trial
5776806|NCT00213018|HIV Seronegativity|hiv seronegativity
5776807|NCT00213018|HIV|hiv
5776808|NCT00213005|Microbicides|microbicides
5776809|NCT00213005|HIV prevention|hiv prevention
5776810|NCT00213005|HIV positive|hiv positive
5776811|NCT00213005|carrageenan|carrageenan
5776812|NCT00213005|safety trial|safety trial
5776813|NCT00213005|Treatment Experienced|treatment experienced
5776815|NCT00212992|defibrillation|defibrillation
5776816|NCT00212992|ventricular fibrillation|ventricular fibrillation
5776817|NCT00212992|heart arrest|heart arrest
5776818|NCT00212979|glomerular filtration rate|glomerular filtration rate
5776819|NCT00212979|cystatin C|cystatin c
5776820|NCT00212979|creatinine|creatinine
5776821|NCT00212966|psychosocial|psychosocial
5776822|NCT00212953|Chest Pain,|chest pain,
5776823|NCT00212953|Shortness of breath,|shortness of breath,
5776824|NCT00212953|Injury,|injury,
5776830|NCT00212901|Angiotensin converting enzyme inhibitors|angiotensin converting enzyme inhibitors
5776831|NCT00212901|Angiotensin receptor antagonists|angiotensin receptor antagonists
5776832|NCT00212888|HIV|hiv
5776833|NCT00212888|Vaccination|vaccination
5776834|NCT00212875|Chronic Kidney disease|chronic kidney disease
5776835|NCT00212875|anemia|anemia
5776836|NCT00212862|Anemia|anemia
5776837|NCT00212862|Cancer|cancer
5776838|NCT00212862|Epoetin alfa|epoetin alfa
5776839|NCT00212862|Darbepoetin alfa|darbepoetin alfa
5776840|NCT00212862|Registry|registry
5776841|NCT00212849|Articular Cartilage Lesions|articular cartilage lesions
5776842|NCT00212849|Patellar lesions|patellar lesions
5776843|NCT00212849|Trochlear lesions|trochlear lesions
5776844|NCT00212849|Patellofemoral joint|patellofemoral joint
5776845|NCT00212849|Carticel|carticel
5776846|NCT00212849|Autologous Chondrocyte Implantation|autologous chondrocyte implantation
5776847|NCT00212823|Migraine|migraine
5776848|NCT00212810|Migraine|migraine
5776849|NCT00212810|Headache|headache
5776850|NCT00212810|Migraine Headache|migraine headache
5776851|NCT00212758|Short stature|short stature
5776852|NCT00212758|children|children
5776853|NCT00212758|kidney failure, chronic|kidney failure, chronic
5776854|NCT00212758|Growth|growth
5776855|NCT00212745|Behavior Therapy|behavior therapy
5776856|NCT00212745|Relaxation Techniques|relaxation techniques
5776857|NCT00212732|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
5776858|NCT00212719|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
5776859|NCT00212706|ONO-8025, KRP-197, overactive bladder, antimuscarinic|ono-8025, krp-197, overactive bladder, antimuscarinic
5776860|NCT00212693|ONO-2506PO, Parkinson's disease|ono-2506po, parkinson's disease
5776861|NCT00212680|ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia|ono-1101,landiolol hydrochloride, postoperative, supraventricular tachyarrhythmia
5776862|NCT00212667|ONO-5920, osteoporosis, bisphosphonate|ono-5920, osteoporosis, bisphosphonate
5776863|NCT00212654|ONO-1101|ono-1101
5776864|NCT00212654|Landiolol Hydrochloride|landiolol hydrochloride
5776865|NCT00212654|Postoperative|postoperative
5776866|NCT00212654|supraventricular tachyarrhythmia|supraventricular tachyarrhythmia
5776867|NCT00212628|ONO-5920|ono-5920
5776868|NCT00212628|osteoporosis|osteoporosis
5776869|NCT00212628|bisphosphonate|bisphosphonate
5776870|NCT00212615|Colorectal neoplasm|colorectal neoplasm
5776871|NCT00212615|Capecitabine (Xeloda)|capecitabine (xeloda)
5776872|NCT00212615|Oxaliplatin (Eloxatin)|oxaliplatin (eloxatin)
5776873|NCT00212615|Advanced disease|advanced disease
5776874|NCT00212615|Metastatic disease|metastatic disease
5776875|NCT00212615|First-line treatment|first-line treatment
5776876|NCT00212615|Phase II study|phase ii study
5776877|NCT00212602|ONO-7436, Aprepitant, Vomiting, Nausea|ono-7436, aprepitant, vomiting, nausea
5776878|NCT00212589|Patients preference|patients preference
5776879|NCT00212589|Colorectal cancer|colorectal cancer
5776880|NCT00212589|Capecitabine|capecitabine
5776881|NCT00212589|Fluorouracil + folinic acid|fluorouracil + folinic acid
5776882|NCT00212589|Cross-over study|cross-over study
5776883|NCT00212576|Child development|child development
5776884|NCT00212576|Language Development|language development
5776885|NCT00212576|Parenting|parenting
5776886|NCT00212537|Asthma and normal|asthma and normal
5776887|NCT00212485|Hemophilia|hemophilia
5776888|NCT00212485|Factor Deficiency|factor deficiency
5776889|NCT00212485|synovitis|synovitis
5776890|NCT00212485|sonogram|sonogram
5776891|NCT00212459|Bleeding logs|bleeding logs
5776892|NCT00212459|Factor Infusions|factor infusions
5776893|NCT00212446|Tocolysis|tocolysis
5776894|NCT00212446|Electrical Pacemaker|electrical pacemaker
5776895|NCT00212433|colorectal neoplasia|colorectal neoplasia
5776896|NCT00212433|CT colonography|ct colonography
5776897|NCT00212433|faecal tagging|faecal tagging
5776898|NCT00212420|fistula; enterocutaneous; nutrition;enteral; parenteral; TPN|fistula; enterocutaneous; nutrition;enteral; parenteral; tpn
5776899|NCT00212407|Cord blood transplantation|cord blood transplantation
5776900|NCT00212407|bone marrow transplantation|bone marrow transplantation
5776901|NCT00212394|Tourniquet|tourniquet
5776902|NCT00212394|paresis|paresis
5776903|NCT00212381|cervical dysplasia, diindolylmethane, pap smear|cervical dysplasia, diindolylmethane, pap smear
5776904|NCT00212329|Type 1 Diabetes|type 1 diabetes
5776905|NCT00212329|Juvenile Onset Diabetes|juvenile onset diabetes
5776906|NCT00212329|Insulin Dependent Diabetes|insulin dependent diabetes
5776908|NCT00212316|Huntington's Disease|huntington's disease
5776909|NCT00212316|phenylbutyrate|phenylbutyrate
5776910|NCT00212316|HDAC inhibitors|hdac inhibitors
5776911|NCT00212316|transcription|transcription
5776912|NCT00212303|type 2 diabetes|type 2 diabetes
5776913|NCT00212303|hypertension|hypertension
5776914|NCT00212303|exercise training|exercise training
5776915|NCT00212303|cardiac, peripheral|cardiac, peripheral
5776916|NCT00212303|body composition|body composition
5776917|NCT00212303|physical fitness|physical fitness
5776918|NCT00212303|inflammation|inflammation
5776919|NCT00212290|impaired glucose tolerance|impaired glucose tolerance
5776920|NCT00212264|urinary incontinence|urinary incontinence
5786000|NCT00165347|PTK|ptk
5776921|NCT00212264|therapy|therapy
5776922|NCT00212264|prostatectomy|prostatectomy
5776923|NCT00212264|prostate cancer|prostate cancer
5776924|NCT00212251|obesity|obesity
5776925|NCT00212251|postpartum period|postpartum period
5776926|NCT00212251|exercise|exercise
5776927|NCT00212251|diet|diet
5776928|NCT00212251|motivation|motivation
5776929|NCT00212238|obesity|obesity
5776930|NCT00212238|weight loss|weight loss
5776931|NCT00212238|Internet|internet
5776932|NCT00212238|cognitive behavior therapy|cognitive behavior therapy
5776933|NCT00212238|computer assisted patient care|computer assisted patient care
5776934|NCT00212238|human therapy evaluation|human therapy evaluation
5776936|NCT00212238|clinical trial|clinical trial
5776937|NCT00212238|nutrient intake activity|nutrient intake activity
5776938|NCT00212238|outcomes research|outcomes research
5776939|NCT00212238|personal log /diary|personal log /diary
5776940|NCT00212238|reinforcer|reinforcer
5776941|NCT00212238|self care|self care
5776942|NCT00212238|social support network|social support network
5776943|NCT00212238|weight control|weight control
5776944|NCT00212238|behavioral /social science research tag|behavioral /social science research tag
5776945|NCT00212238|clinical research|clinical research
5776946|NCT00212238|human subject|human subject
5776947|NCT00212238|questionnaire|questionnaire
5776948|NCT00212225|gastric disease|gastric disease
5776949|NCT00212225|H. pylori|h. pylori
5776950|NCT00212225|children|children
5776951|NCT00212225|Helicobacter pylori|helicobacter pylori
5776952|NCT00212225|child|child
5776953|NCT00212225|epidemiology|epidemiology
5776954|NCT00212212|selenium supplements|selenium supplements
5776955|NCT00212212|selenate|selenate
5776956|NCT00212212|selenomethionine|selenomethionine
5776957|NCT00212212|biomarkers|biomarkers
5776958|NCT00212212|plasma selenium concentration|plasma selenium concentration
5776959|NCT00212212|plasma glutathione peroxidase|plasma glutathione peroxidase
5776960|NCT00212212|selenoprotein P|selenoprotein p
5776961|NCT00212199|Obesity Treatment|obesity treatment
5776962|NCT00212199|Effectiveness of weight management treatment|effectiveness of weight management treatment
5776963|NCT00212199|Counseling for weight management|counseling for weight management
5776964|NCT00212173|Adolescent|adolescent
5776965|NCT00212173|Weight Management|weight management
5776966|NCT00212173|Obesity Treatment|obesity treatment
5776967|NCT00212173|Behavioral Treatment|behavioral treatment
5776968|NCT00212147|cobalamin|cobalamin
5776969|NCT00212147|anesthesia|anesthesia
5776970|NCT00212147|cognition|cognition
5776971|NCT00212134|cataract surgery|cataract surgery
5776972|NCT00212134|intraocular lens|intraocular lens
5776973|NCT00212134|contact lens|contact lens
5776974|NCT00212134|infants|infants
5776975|NCT00212134|aphakia|aphakia
5776976|NCT00212121|breast cancer|breast cancer
5776977|NCT00212121|radiotherapy|radiotherapy
5776978|NCT00212121|microarrays|microarrays
5776979|NCT00212108|celecoxib, NPC, gefitinib|celecoxib, npc, gefitinib
5776980|NCT00212095|breast cancer|breast cancer
5776981|NCT00212095|docetaxel|docetaxel
5776982|NCT00212095|gene expression|gene expression
5776983|NCT00212095|proteomics|proteomics
5776984|NCT00212082|breast cancer|breast cancer
5776985|NCT00212082|chemotherapy response|chemotherapy response
5776986|NCT00212082|gene expression profiles|gene expression profiles
5776987|NCT00212082|proteomics|proteomics
5776988|NCT00212069|breast cancer|breast cancer
5776989|NCT00212069|serum proteomics|serum proteomics
5776990|NCT00212069|gemcitabine|gemcitabine
5776991|NCT00212069|carboplatin|carboplatin
5776992|NCT00212069|chemotherapy sensitivity|chemotherapy sensitivity
5776993|NCT00212056|Acute myocardial infarction|acute myocardial infarction
5776994|NCT00212056|Atrial natriuretic peptide|atrial natriuretic peptide
5776995|NCT00212056|Data mining|data mining
5776996|NCT00212056|Randomized clinical trial|randomized clinical trial
5776997|NCT00212056|SNPs|snps
5776998|NCT00212043|randomised phase II trial gemcitabine and carboplatin|randomised phase ii trial gemcitabine and carboplatin
5776999|NCT00212030|Acute myocardial infarction|acute myocardial infarction
5777000|NCT00212030|Data mining|data mining
5777001|NCT00212030|Nicorandil|nicorandil
5777002|NCT00212030|Randomized clinical trial|randomized clinical trial
5777003|NCT00212030|SNPs|snps
5777004|NCT00212017|IGT|igt
5777005|NCT00212017|Myocardial Infarction|myocardial infarction
5777006|NCT00212017|alpha-glucosidase inhibitor|alpha-glucosidase inhibitor
5777007|NCT00212017|re-infarction prevention|re-infarction prevention
5777008|NCT00212004|diabetes mellitus|diabetes mellitus
5777009|NCT00212004|myocardial infarction|myocardial infarction
5777010|NCT00212004|pioglitazone|pioglitazone
5777011|NCT00211978|PhosLo (Calcium acetate)|phoslo (calcium acetate)
5777012|NCT00211965|Knee replacement surgery|knee replacement surgery
5777013|NCT00211965|hip replacement surgery|hip replacement surgery
5777014|NCT00211965|nosocomial infections|nosocomial infections
5777015|NCT00211965|Arthroplasty|arthroplasty
5777016|NCT00211939|PhosLo (Calcium acetate)|phoslo (calcium acetate)
5777017|NCT00211939|Renagel (sevelamer, polyallylamine HCL)|renagel (sevelamer, polyallylamine hcl)
5777018|NCT00211939|kidney dialysis|kidney dialysis
5777019|NCT00211939|hyperphosphatemia|hyperphosphatemia
5777020|NCT00211939|Kidney failure|kidney failure
5777022|NCT00211926|Staphylococcus aureus vaccine|staphylococcus aureus vaccine
5777023|NCT00211887|Multiple Sclerosis|multiple sclerosis
5777024|NCT00211887|Clinical trial|clinical trial
5777025|NCT00211887|treatment trial|treatment trial
5777026|NCT00211887|autoimmune disease|autoimmune disease
5777027|NCT00211887|Relapsing Remitting|relapsing remitting
5777028|NCT00211887|MS Treatment|ms treatment
5777029|NCT00211887|interferon beta-1a|interferon beta-1a
5777030|NCT00211887|glatiramer acetate|glatiramer acetate
5771939|NCT00236691|partial epilepsies|partial epilepsies
5777031|NCT00211874|Congestive heart failure|congestive heart failure
5777032|NCT00211874|nurse management|nurse management
5777033|NCT00211874|effectiveness trial|effectiveness trial
5777034|NCT00211874|quality improvement|quality improvement
5777035|NCT00211874|minority communities|minority communities
5777036|NCT00211874|disease management|disease management
5777037|NCT00211848|Chemical Compounds-drugs|chemical compounds-drugs
5777038|NCT00211848|Human Subjects- adults|human subjects- adults
5777039|NCT00211848|Gastrointestinal System-liver|gastrointestinal system-liver
5777040|NCT00211848|Pathology|pathology
5777042|NCT00211835|traumatic brain injury|traumatic brain injury
5777043|NCT00211835|depression|depression
5777044|NCT00211835|cognitive behavioral therapy|cognitive behavioral therapy
5777045|NCT00211835|supportive psychotherapy|supportive psychotherapy
5777046|NCT00211835|psychotherapy|psychotherapy
5777047|NCT00211822|Pathological Gambling|pathological gambling
5777048|NCT00211822|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5777049|NCT00211822|Go No-go|go no-go
5777050|NCT00211822|Monetary incentives delay|monetary incentives delay
5777051|NCT00211822|fMRI|fmri
5777052|NCT00211809|Body Dysmorphic Disorder|body dysmorphic disorder
5777053|NCT00211809|SRIs|sris
5777054|NCT00211809|Cognitive Behavioral Therapy|cognitive behavioral therapy
5777055|NCT00211796|autism|autism
5777056|NCT00211796|divalproex sodium ER|divalproex sodium er
5777057|NCT00211796|aggression|aggression
5777058|NCT00211796|irritability|irritability
5777059|NCT00211783|autism|autism
5777060|NCT00211783|fMRI|fmri
5777061|NCT00211783|response inhibition|response inhibition
5777062|NCT00211783|face processing|face processing
5777063|NCT00211783|linguistic processing|linguistic processing
5777064|NCT00211770|Autism|autism
5777065|NCT00211770|Functional Behavioral Assessment|functional behavioral assessment
5777066|NCT00211770|Citalopram|citalopram
5777067|NCT00211757|autism|autism
5777068|NCT00211757|aggression|aggression
5777069|NCT00211757|irritability|irritability
5777070|NCT00211757|divalproex sodium|divalproex sodium
5777071|NCT00211744|OCD|ocd
5777072|NCT00211744|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5777073|NCT00211744|OCD treatment|ocd treatment
5777074|NCT00211731|Acute stroke|acute stroke
5777075|NCT00211731|recurrent stroke preventive measures|recurrent stroke preventive measures
5777076|NCT00211731|racial disparities|racial disparities
5777077|NCT00211718|shoulder pain|shoulder pain
5777078|NCT00211718|arthritis|arthritis
5777079|NCT00211718|intra-articular botulinum toxin a|intra-articular botulinum toxin a
5777080|NCT00211718|joint pain|joint pain
5777081|NCT00211705|Hyperlipidemia|hyperlipidemia
5777082|NCT00211705|coronary heart disease|coronary heart disease
5777083|NCT00211705|prevention|prevention
5777084|NCT00211705|stroke|stroke
5777085|NCT00211705|pravastatin|pravastatin
5777086|NCT00211692|Hepatitis C|hepatitis c
5777087|NCT00211692|interferon alfa|interferon alfa
5777088|NCT00211692|ribavirin|ribavirin
5777089|NCT00211692|interferon alfacon-1|interferon alfacon-1
5777090|NCT00211692|antiviral therapy|antiviral therapy
5777091|NCT00211679|Joint pain|joint pain
5777092|NCT00211679|Knee Pain|knee pain
5777093|NCT00211679|Arthritis|arthritis
5777094|NCT00211679|Intra-articular Botulinum Toxin Type A|intra-articular botulinum toxin type a
5777095|NCT00211666|Hypertension|hypertension
5777096|NCT00211666|blood pressure|blood pressure
5777097|NCT00211666|self management|self management
5777098|NCT00211666|nurse management|nurse management
5777099|NCT00211666|racial disparities|racial disparities
5777100|NCT00211666|cardiovascular disease|cardiovascular disease
5777101|NCT00211653|Kidney failure|kidney failure
5777102|NCT00211653|Thoracic surgery|thoracic surgery
5777103|NCT00211653|Acetylcysteine|acetylcysteine
5777104|NCT00211614|Obstructive Sleep Apnea|obstructive sleep apnea
5777105|NCT00211614|Gastroesophageal Reflux|gastroesophageal reflux
5777106|NCT00211614|Proton Pump Inhibitor|proton pump inhibitor
5777107|NCT00211614|Lansoprazole (Prevacid)|lansoprazole (prevacid)
5777108|NCT00211614|Quality of Life|quality of life
5777109|NCT00211588|cognition|cognition
5777110|NCT00211562|weight gain|weight gain
5777111|NCT00211562|weight gain supplementation|weight gain supplementation
5777112|NCT00211562|antioxidants|antioxidants
5777113|NCT00211562|olanzapine|olanzapine
5777114|NCT00211549|Osteoarthritis|osteoarthritis
5777115|NCT00211536|Diabetes|diabetes
5777116|NCT00211536|Implantable Insulin Pump|implantable insulin pump
5777117|NCT00211536|Intraperitoneal Insulin Delivery|intraperitoneal insulin delivery
5777118|NCT00211523|acne|acne
5777119|NCT00211523|acne vulgaris|acne vulgaris
5777120|NCT00211523|MBI 226|mbi 226
5777121|NCT00211523|Propionibacterium acnes|propionibacterium acnes
5777122|NCT00211523|lesion counts|lesion counts
5777124|NCT00211523|inflammatory|inflammatory
5777125|NCT00211523|non-inflammatory|non-inflammatory
5777126|NCT00211523|topical|topical
5777127|NCT00211510|Diabetes|diabetes
5777128|NCT00211510|Continuous Glucose Monitoring|continuous glucose monitoring
5777129|NCT00211510|Glycemic Control|glycemic control
5777130|NCT00211497|acne vulgaris|acne vulgaris
5777131|NCT00211497|acne|acne
5777132|NCT00211497|Propionibacterium acnes|propionibacterium acnes
5777133|NCT00211497|topical|topical
5777134|NCT00211497|inflammatory|inflammatory
5777135|NCT00211497|non-inflammatory|non-inflammatory
5777136|NCT00211497|lesion counts|lesion counts
5777137|NCT00211497|lesions|lesions
5777138|NCT00211458|Age-Related Macular Degeneration|age-related macular degeneration
5777139|NCT00211419|Exudative Age-Related Macular Degeneration|exudative age-related macular degeneration
5777141|NCT00211380|cognition|cognition
5777142|NCT00211380|schizophrenia|schizophrenia
5777143|NCT00211380|schizoaffective disorder|schizoaffective disorder
5777144|NCT00211367|Radiation Retinopathy|radiation retinopathy
5777145|NCT00211341|Pregnancy|pregnancy
5777146|NCT00211341|Mortality|mortality
5777147|NCT00211341|Maternal|maternal
5777148|NCT00211341|Vitamin A|vitamin a
5777149|NCT00211302|Cognition|cognition
5777150|NCT00211302|Schizophrenia|schizophrenia
5777151|NCT00211302|Schizoaffective disorder|schizoaffective disorder
5777152|NCT00211289|Educational Interventions|educational interventions
5777153|NCT00211289|Heart Failure|heart failure
5777154|NCT00211289|Compliance|compliance
5777155|NCT00211263|Bipolar Disorder|bipolar disorder
5777156|NCT00211250|Depakote Er and Valproic Acid|depakote er and valproic acid
5777157|NCT00211237|Balloon Kyphoplasty|balloon kyphoplasty
5777158|NCT00211237|Cancer|cancer
5777159|NCT00211237|Vertebral Compression Fracture|vertebral compression fracture
5777160|NCT00211237|Back Pain|back pain
5777161|NCT00211237|Spine|spine
5777162|NCT00211224|multiple system atrophy|multiple system atrophy
5777163|NCT00211224|progressive supranuclear palsy|progressive supranuclear palsy
5777164|NCT00211224|riluzole|riluzole
5777165|NCT00211224|MSA|msa
5777166|NCT00211224|PSP|psp
5777167|NCT00211211|Osteopenia|osteopenia
5777168|NCT00211211|Osteoporosis|osteoporosis
5777169|NCT00211211|Multiple Myeloma|multiple myeloma
5777170|NCT00211211|Osteolytic Metastatic Tumors|osteolytic metastatic tumors
5777171|NCT00211211|Vertebral Compression Fracture|vertebral compression fracture
5777174|NCT00211198|Cutaneous|cutaneous
5777175|NCT00211198|T-cell lymphoma|t-cell lymphoma
5777176|NCT00211198|ONTAK|ontak
5777177|NCT00211198|CD25|cd25
5777178|NCT00211172|Acute Myocardial Infarction (AMI)|acute myocardial infarction (ami)
5777179|NCT00211172|Heart Attack|heart attack
5777180|NCT00211172|Adherence|adherence
5777181|NCT00211172|Beta-blocker|beta-blocker
5777182|NCT00211172|Behavior change|behavior change
5777183|NCT00211159|Alzheimer's disease|alzheimer's disease
5777184|NCT00211159|Omega-3 fatty acid|omega-3 fatty acid
5777185|NCT00211159|Dietary supplementation|dietary supplementation
5777186|NCT00211159|Cognition|cognition
5777187|NCT00211159|Safety|safety
5777188|NCT00211146|Anemia, erythropoetin, PROCRIT, deep vein thrombosis, thrombovascular event|anemia, erythropoetin, procrit, deep vein thrombosis, thrombovascular event
5777189|NCT00211133|Anemia|anemia
5777190|NCT00211133|Breast Cancer|breast cancer
5777191|NCT00211133|Breast Tumor|breast tumor
5777192|NCT00211133|Quality of Life|quality of life
5777193|NCT00211133|Women|women
5777194|NCT00211133|Female|female
5777195|NCT00211133|Chemotherapy|chemotherapy
5777196|NCT00211133|Hemoglobin|hemoglobin
5777197|NCT00211133|Survival|survival
5777198|NCT00211133|Epoetin|epoetin
5777199|NCT00211133|Epoetin alfa|epoetin alfa
5777200|NCT00211133|erythropoietin|erythropoietin
5777201|NCT00211120|Anemia|anemia
5777202|NCT00211120|Low Blood Count|low blood count
5777203|NCT00211120|Chronic Kidney Failure|chronic kidney failure
5777204|NCT00211120|Chronic Kidney Disease|chronic kidney disease
5777205|NCT00211107|dapoxetine|dapoxetine
5777206|NCT00211107|rapid ejaculation|rapid ejaculation
5777207|NCT00211107|premature ejaculation|premature ejaculation
5777208|NCT00211107|ejaculation|ejaculation
5777209|NCT00211107|sexual dysfunction|sexual dysfunction
5777210|NCT00211107|orgasmic disorder|orgasmic disorder
5777211|NCT00211107|sexual intercourse|sexual intercourse
5777212|NCT00211094|dapoxetine|dapoxetine
5777213|NCT00211094|premature ejaculation|premature ejaculation
5777214|NCT00211094|ejaculation|ejaculation
5777215|NCT00211094|sexual dysfunction|sexual dysfunction
5777216|NCT00211094|orgasmic disorder|orgasmic disorder
5777217|NCT00211094|sexual intercourse|sexual intercourse
5777218|NCT00211081|Congenital Heart Disease|congenital heart disease
5777219|NCT00211081|Spironolactone|spironolactone
5777220|NCT00211081|>17 years old|>17 years old
5777221|NCT00211081|undergone Fontan procedure|undergone fontan procedure
5777222|NCT00211081|endothelial function|endothelial function
5777223|NCT00211068|Pure red-cell aplasia|pure red-cell aplasia
5803021|NCT00096564|Urge|urge
5777224|NCT00211068|Chronic kidney failure|chronic kidney failure
5777225|NCT00211068|Epoetin alfa (Eprex)|epoetin alfa (eprex)
5777226|NCT00211068|Erythropoietin|erythropoietin
5777227|NCT00211068|Kidney disease|kidney disease
5777228|NCT00211068|Anemia|anemia
5777229|NCT00211055|Critically Ill|critically ill
5777230|NCT00211055|Intensive Care Unit|intensive care unit
5777231|NCT00211055|Blood transfusion|blood transfusion
5777232|NCT00211055|Blood loss|blood loss
5777233|NCT00211055|Pediatric|pediatric
5777234|NCT00211055|Children|children
5777235|NCT00211055|Anemia, Pediatric Intensive Care Unit|anemia, pediatric intensive care unit
5777237|NCT00211055|Transfusion|transfusion
5777238|NCT00211042|Pure red-cell aplasia|pure red-cell aplasia
5777239|NCT00211042|Anemia|anemia
5777240|NCT00211042|Red blood cells|red blood cells
5777241|NCT00211042|Epoetin alfa (Eprex)|epoetin alfa (eprex)
5777242|NCT00211042|Anti-erythropoietin antibodies|anti-erythropoietin antibodies
5777243|NCT00211042|Recombinant human erythropoietin|recombinant human erythropoietin
5777244|NCT00211029|Anemia, Hemoglobin, Red Blood Cells, Epoetin alfa|anemia, hemoglobin, red blood cells, epoetin alfa
5777245|NCT00211029|Epoetin|epoetin
5777246|NCT00211029|erythropoietin|erythropoietin
5777446|NCT00210470|IRX-2|irx-2
5777247|NCT00211029|Red Cell Aplasia, Pure Red Cell Aplasia|red cell aplasia, pure red cell aplasia
5777248|NCT00211029|Chronic Renal Failure|chronic renal failure
5777249|NCT00211029|Kidney Failure|kidney failure
5777250|NCT00211016|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5777251|NCT00211003|Hospital-Acquired Pneumonia|hospital-acquired pneumonia
5777252|NCT00211003|Mechanical Ventilation|mechanical ventilation
5777253|NCT00210990|Complicated Urinary Tract Infections|complicated urinary tract infections
5777254|NCT00210990|Pyelonephritis|pyelonephritis
5777255|NCT00210977|Anemia|anemia
5777256|NCT00210977|Erythropoietin|erythropoietin
5777257|NCT00210977|Epoetin alfa|epoetin alfa
5777258|NCT00210977|Erythropoietin receptor agonist (ERA) therapy|erythropoietin receptor agonist (era) therapy
5777259|NCT00210977|Anti-erythropoietin antibodies (anti-EPO Ab)|anti-erythropoietin antibodies (anti-epo ab)
5777260|NCT00210977|Recombinant human erythropoietin|recombinant human erythropoietin
5777261|NCT00210977|Pure red cell aplasia|pure red cell aplasia
5777262|NCT00210977|Darbepoetin|darbepoetin
5777263|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril
5777264|NCT00210964|Nosocominal Pneumonia|nosocominal pneumonia
5777265|NCT00210964|Ventilator-Associated Pneumonia|ventilator-associated pneumonia
5777266|NCT00210964|Cephalosporins|cephalosporins
5777267|NCT00210964|Methicillin-Resistant Staphylococcus Aureus|methicillin-resistant staphylococcus aureus
5777268|NCT00210951|Epoetin alfa|epoetin alfa
5777269|NCT00210951|Erythropoietin|erythropoietin
5777270|NCT00210951|Red Cell Aplasia, Pure|red cell aplasia, pure
5777271|NCT00210951|Chronic Renal Failure|chronic renal failure
5777272|NCT00210938|Complicated Intra-Abdominal Infections|complicated intra-abdominal infections
5777273|NCT00210938|Appendicitis|appendicitis
5777274|NCT00210938|Cholecystitis|cholecystitis
5777275|NCT00210938|Peritonitis|peritonitis
5777276|NCT00210925|alcoholism|alcoholism
5777277|NCT00210925|alcohol dependence|alcohol dependence
5777278|NCT00210925|medication treatment.|medication treatment.
5777279|NCT00210912|prevention|prevention
5777280|NCT00210912|Migraine|migraine
5777281|NCT00210912|chronic|chronic
5777282|NCT00210912|headache|headache
5777283|NCT00210899|Complicated Skin Infections|complicated skin infections
5777284|NCT00210899|Infectious Skin Diseases|infectious skin diseases
5777285|NCT00210899|Bacterial Skin Diseases|bacterial skin diseases
5777286|NCT00210899|Staphylococcal Skin Infections|staphylococcal skin infections
5777287|NCT00210899|Cephalosporin|cephalosporin
5777288|NCT00210886|complicated urinary tract infection|complicated urinary tract infection
5777289|NCT00210886|urinary tract infection|urinary tract infection
5777290|NCT00210886|acute pyelonephritis|acute pyelonephritis
5777291|NCT00210886|pyelonephritis|pyelonephritis
5777292|NCT00210886|kidney infection|kidney infection
5777293|NCT00210886|bladder infection|bladder infection
5777294|NCT00210873|Migraine|migraine
5777295|NCT00210873|headache|headache
5777296|NCT00210873|chronic|chronic
5777297|NCT00210873|prevention|prevention
5777298|NCT00210860|chronic|chronic
5777299|NCT00210860|headache|headache
5777300|NCT00210860|prevention|prevention
5777301|NCT00210860|Migraine|migraine
5777302|NCT00210847|peripheral neuropathy|peripheral neuropathy
5777303|NCT00210847|Diabetic neuropathy|diabetic neuropathy
5777304|NCT00210847|pain|pain
5777305|NCT00210847|diabetes|diabetes
5777306|NCT00210847|extremities|extremities
5777307|NCT00210847|neuropathy|neuropathy
5777308|NCT00210847|diabetic|diabetic
5777309|NCT00210834|PROCRIT, Erythropoietin, Epoetin alfa, Hemoglobin level|procrit, erythropoietin, epoetin alfa, hemoglobin level
5777310|NCT00210821|migraine|migraine
5777311|NCT00210821|headache|headache
5777312|NCT00210821|analgesics|analgesics
5777313|NCT00210821|prophylaxis|prophylaxis
5777314|NCT00210821|prevention|prevention
5777315|NCT00210808|Binge-Eating Disorder|binge-eating disorder
5777316|NCT00210808|medication treatment|medication treatment
5777317|NCT00210808|obesity|obesity
5686409|NCT00552292|cardiovascular complications|cardiovascular complications
5777318|NCT00210808|bingeing|bingeing
5777319|NCT00210795|Anemia|anemia
5777320|NCT00210795|Subcutaneous injection|subcutaneous injection
5777321|NCT00210795|PROCRIT|procrit
5777322|NCT00210795|Erythropoietin|erythropoietin
5777323|NCT00210795|Epoetin Alfa|epoetin alfa
5777324|NCT00210795|Hemoglobin Level|hemoglobin level
5777325|NCT00210795|Elderly|elderly
5777326|NCT00210782|epilepsy|epilepsy
5777327|NCT00210782|seizures|seizures
5777328|NCT00210782|epileptic seizures|epileptic seizures
5777329|NCT00210782|complex partial seizures|complex partial seizures
5777330|NCT00210782|generalized tonic-clonic seizures|generalized tonic-clonic seizures
5777332|NCT00210769|extended release|extended release
5777333|NCT00210769|oral administration|oral administration
5777334|NCT00210769|antipsychotic agents|antipsychotic agents
5777335|NCT00210769|dementia praecox|dementia praecox
5777336|NCT00210769|mental disorders|mental disorders
5777337|NCT00210769|paliperidone|paliperidone
5777338|NCT00210769|PANSS|panss
5777339|NCT00210756|Anemia|anemia
5777340|NCT00210756|pharmacokinetics|pharmacokinetics
5777341|NCT00210756|erythropoetin|erythropoetin
5777342|NCT00210756|Epoetin alfa|epoetin alfa
5777343|NCT00210756|erythropoetin recombinant|erythropoetin recombinant
5777344|NCT00210756|Critical care|critical care
5777345|NCT00210756|critical illness, intensive care,|critical illness, intensive care,
5777346|NCT00210743|Anemia|anemia
5777347|NCT00210743|chronic kidney disease|chronic kidney disease
5777348|NCT00210743|erythropoetin, Epoetin alfa|erythropoetin, epoetin alfa
5777349|NCT00210743|erythropoetin recombinant|erythropoetin recombinant
5777350|NCT00210743|pre-dialysis|pre-dialysis
5777351|NCT00210730|Anemia|anemia
5777352|NCT00210730|Neoplasm|neoplasm
5777353|NCT00210730|Hemoglobin Level|hemoglobin level
5777354|NCT00210717|schizophrenia|schizophrenia
5777355|NCT00210717|intramuscular injection|intramuscular injection
5777356|NCT00210717|antipsychotic agents|antipsychotic agents
5777357|NCT00210717|risperidone|risperidone
5777358|NCT00210717|paliperidone palmitate|paliperidone palmitate
5777359|NCT00210717|dementia praecox|dementia praecox
5777360|NCT00210717|mental disorders|mental disorders
5777361|NCT00210717|PANSS|panss
5777362|NCT00210704|dapoxetine|dapoxetine
5777363|NCT00210704|premature ejaculation|premature ejaculation
5777364|NCT00210704|ejaculation|ejaculation
5777365|NCT00210704|sexual dysfunction|sexual dysfunction
5777366|NCT00210704|orgasmic disorder|orgasmic disorder
5777367|NCT00210704|sexual intercourse|sexual intercourse
5777368|NCT00210691|Schizophrenia|schizophrenia
5777369|NCT00210691|intramuscular injection|intramuscular injection
5777370|NCT00210691|psychotropic agents|psychotropic agents
5777371|NCT00210691|long-acting risperidone|long-acting risperidone
5777372|NCT00210678|Erectile Dysfunction|erectile dysfunction
5777373|NCT00210678|Dapoxetine|dapoxetine
5777374|NCT00210678|Premature ejaculation|premature ejaculation
5777375|NCT00210678|Ejaculation|ejaculation
5777376|NCT00210678|Sexual dysfunction|sexual dysfunction
5777377|NCT00210678|Orgasmic disorder|orgasmic disorder
5777378|NCT00210665|Sarcoma|sarcoma
5777379|NCT00210665|Soft tissue sarcoma|soft tissue sarcoma
5777380|NCT00210665|Standard care|standard care
5777381|NCT00210665|Trabectedin|trabectedin
5777382|NCT00210665|Antitumor agent|antitumor agent
5777383|NCT00210665|Safety|safety
5777384|NCT00210652|Epilepsy|epilepsy
5777385|NCT00210652|Refractory partial epilepsy|refractory partial epilepsy
5777386|NCT00210652|seizure disorder|seizure disorder
5777387|NCT00210652|antiepileptic drugs|antiepileptic drugs
5777388|NCT00210639|Musculoskeletal Diseases|musculoskeletal diseases
5777389|NCT00210639|Musculoskeletal Disorders|musculoskeletal disorders
5777390|NCT00210639|Childhood Disease|childhood disease
5777391|NCT00210639|Bone Diseases|bone diseases
5777392|NCT00210639|Joint Diseases|joint diseases
5777393|NCT00210639|Levofloxacin|levofloxacin
5777394|NCT00210639|Quinolones|quinolones
5777395|NCT00210639|Bacterial infections|bacterial infections
5777396|NCT00210626|Anemia, erythropoetin, Epoetin alfa, erythropoetin recombinant, Critical care, critical illness, intensive care|anemia, erythropoetin, epoetin alfa, erythropoetin recombinant, critical care, critical illness, intensive care
5777397|NCT00210613|dapoxetine|dapoxetine
5777398|NCT00210613|premature ejaculation|premature ejaculation
5777399|NCT00210613|sexual dysfunction|sexual dysfunction
5777400|NCT00210613|orgasmic disorder|orgasmic disorder
5777401|NCT00210613|sexual intercourse|sexual intercourse
5777402|NCT00210613|ejaculation|ejaculation
5777403|NCT00210600|Anemia|anemia
5777404|NCT00210600|Hemoglobin level|hemoglobin level
5777405|NCT00210587|Anemia|anemia
5777406|NCT00210587|Neoplasms|neoplasms
5777407|NCT00210587|hemoglobin level|hemoglobin level
5777408|NCT00210574|childhood absence epilepsy|childhood absence epilepsy
5777409|NCT00210574|epilepsy|epilepsy
5777410|NCT00210574|seizures|seizures
5777411|NCT00210574|absence seizures|absence seizures
5777412|NCT00210561|Pain|pain
5777413|NCT00210561|Acute Low Back Pain|acute low back pain
5777414|NCT00210561|Back|back
5777415|NCT00210561|Lower back|lower back
5686410|NCT00552279|HPV|hpv
5777416|NCT00210548|schizophrenia|schizophrenia
5777417|NCT00210548|intramuscular injection|intramuscular injection
5777418|NCT00210548|antipsychotic agents|antipsychotic agents
5777623|NCT00209443|Omniscan|omniscan
5777419|NCT00210548|dementia praecox|dementia praecox
5777420|NCT00210548|paliperidone palmitate|paliperidone palmitate
5777421|NCT00210548|mental disorders|mental disorders
5777422|NCT00210548|PANSS.|panss.
5777423|NCT00210535|Topiramate|topiramate
5777424|NCT00210535|Migraine|migraine
5777425|NCT00210535|Migraine headache|migraine headache
5777426|NCT00210535|Migraine prevention|migraine prevention
5777427|NCT00210535|Pediatric|pediatric
5777428|NCT00210522|RWJ-333369|rwj-333369
5777430|NCT00210522|Epilepsy|epilepsy
5777431|NCT00210522|Refractory partial epilepsy|refractory partial epilepsy
5777432|NCT00210522|Seizure disorder|seizure disorder
5777433|NCT00210522|Antiepileptic drugs|antiepileptic drugs
5777434|NCT00210509|aura|aura
5777435|NCT00210509|Migraine|migraine
5777436|NCT00210509|pain|pain
5777437|NCT00210509|headache|headache
5777438|NCT00210496|Migraine headache|migraine headache
5777439|NCT00210496|Topiramate, Almotriptan malate|topiramate, almotriptan malate
5777440|NCT00210483|pain|pain
5777441|NCT00210483|Migraine|migraine
5777442|NCT00210483|aura|aura
5777443|NCT00210483|headache|headache
5777444|NCT00210470|Head and Neck Cancer|head and neck cancer
5777445|NCT00210470|Immunotherapy|immunotherapy
5777447|NCT00210470|Mouth Cancer|mouth cancer
5777448|NCT00210470|Throat Cancer|throat cancer
5777449|NCT00210418|Malnutrition|malnutrition
5777450|NCT00210418|Infant nutrition|infant nutrition
5777451|NCT00210418|Food, fortified|food, fortified
5777452|NCT00210418|Growth|growth
5777453|NCT00210418|Randomized controlled trials|randomized controlled trials
5777454|NCT00210418|Evaluation studies|evaluation studies
5777455|NCT00210418|Haiti|haiti
5777456|NCT00210405|Anemia|anemia
5777457|NCT00210405|Infant nutrition|infant nutrition
5777458|NCT00210405|Dietary supplements|dietary supplements
5777459|NCT00210405|Randomized controlled trials|randomized controlled trials
5777460|NCT00210405|Evaluation studies|evaluation studies
5777461|NCT00210405|Haiti|haiti
5777463|NCT00210301|cognition|cognition
5777464|NCT00210301|attention|attention
5777465|NCT00210301|fatigue|fatigue
5777466|NCT00210288|Healthy Volunteer|healthy volunteer
5777467|NCT00210288|Shigella|shigella
5777468|NCT00210288|Oral Vaccine|oral vaccine
5777469|NCT00210288|Double Blind|double blind
5777470|NCT00210288|Placebo|placebo
5777471|NCT00210288|Immunogenicity|immunogenicity
5777472|NCT00210288|Safety|safety
5777473|NCT00210249|Cancer|cancer
5777474|NCT00210249|elderly|elderly
5777475|NCT00210249|geriatric evaluation|geriatric evaluation
5777476|NCT00210249|safety|safety
5777477|NCT00210249|chemotherapy|chemotherapy
5777478|NCT00210236|Breast neoplasms|breast neoplasms
5777479|NCT00210236|Local recurrence|local recurrence
5777480|NCT00210236|Survival|survival
5777481|NCT00210236|Surgery|surgery
5777482|NCT00210223|Radiofrequency|radiofrequency
5777483|NCT00210223|Percutaneous technique|percutaneous technique
5777484|NCT00210223|breast cancer|breast cancer
5777485|NCT00210223|tolerance|tolerance
5777486|NCT00210210|Post-operative-pain|post-operative-pain
5777487|NCT00210210|Breast cancer|breast cancer
5777488|NCT00210210|Morphine|morphine
5777489|NCT00210210|Analgesia|analgesia
5777490|NCT00210197|Hypercoagulability|hypercoagulability
5777491|NCT00210197|Plasma coagulation parameters|plasma coagulation parameters
5777492|NCT00210197|Breast cancer|breast cancer
5777493|NCT00210184|Chemotherapy|chemotherapy
5777494|NCT00210184|gastric cancer|gastric cancer
5777495|NCT00210184|geriatric evaluation|geriatric evaluation
5777496|NCT00210184|efficacy|efficacy
5777497|NCT00210184|safety|safety
5777498|NCT00210171|Carcinoma|carcinoma
5777499|NCT00210171|Stage IIIA Non Small Cell Lung|stage iiia non small cell lung
5777500|NCT00210171|Stage IIIB Non-Small-Cell Lung|stage iiib non-small-cell lung
5777501|NCT00210171|Concomitant chemo-radiotherapy|concomitant chemo-radiotherapy
5777502|NCT00210171|Consolidation chemotherapy|consolidation chemotherapy
5777503|NCT00210158|Current opioid treatment|current opioid treatment
5777504|NCT00210158|Nitrous oxide|nitrous oxide
5777505|NCT00210158|Chronic pain|chronic pain
5777506|NCT00210158|Opioid therapy|opioid therapy
5777507|NCT00210158|Postoperative hyperalgesia|postoperative hyperalgesia
5777508|NCT00210158|Acute opioid tolerance|acute opioid tolerance
5777509|NCT00210145|Aesthetic care,|aesthetic care,
5777510|NCT00210145|Mastectomy,|mastectomy,
5777511|NCT00210145|Breast cancer,|breast cancer,
5777512|NCT00210145|Quality of life,|quality of life,
5777513|NCT00210145|Body image,|body image,
5777514|NCT00210145|Psychological adjustment|psychological adjustment
5777515|NCT00210132|Thoracic surgery|thoracic surgery
5777516|NCT00210132|postoperative pain|postoperative pain
5777517|NCT00210132|ropivacaine|ropivacaine
5777518|NCT00210132|inter pleural analgesia|inter pleural analgesia
5777519|NCT00210119|Chronic myeloid leukemia|chronic myeloid leukemia
5777520|NCT00210119|imatinib mesylate|imatinib mesylate
5776583|NCT00213850|Normal adults|normal adults
5777521|NCT00210119|zoledronate|zoledronate
5777522|NCT00210119|molecular response|molecular response
5777523|NCT00210106|Radiofrequency ablation|radiofrequency ablation
5777524|NCT00210106|Colorectal cancer|colorectal cancer
5777525|NCT00210106|Liver metastases|liver metastases
5777526|NCT00210041|Genital Neoplasms, Male|genital neoplasms, male
5777527|NCT00210028|Breast Neoplasms|breast neoplasms
5777528|NCT00210028|Zarnestra|zarnestra
5777529|NCT00210028|Tamoxifen|tamoxifen
5777530|NCT00210028|estrogen receptor|estrogen receptor
5777531|NCT00210028|progesterone receptor|progesterone receptor
5777532|NCT00210002|Neoplasms|neoplasms
5777533|NCT00210002|Solid|solid
5777534|NCT00210002|Anemia|anemia
5777535|NCT00210002|darbepoetin alfa|darbepoetin alfa
5777536|NCT00210002|ferric saccharose|ferric saccharose
5777537|NCT00210002|Venofer®|venofer®
5777538|NCT00210002|Aranesp®|aranesp®
5777539|NCT00209989|Glioblastoma Multiforme|glioblastoma multiforme
5777540|NCT00209989|Zarnestra|zarnestra
5777541|NCT00209989|Radiation therapy|radiation therapy
5777542|NCT00209963|Primary insomnia|primary insomnia
5777543|NCT00209950|Primary insomnia|primary insomnia
5777544|NCT00209937|Primary insomnia|primary insomnia
5777545|NCT00209924|Primary insomnia|primary insomnia
5777546|NCT00209911|atrial volume|atrial volume
5777547|NCT00209911|ventricular volume|ventricular volume
5777548|NCT00209911|atrial function|atrial function
5777549|NCT00209911|ventricular function|ventricular function
5777550|NCT00209911|magnetic resonance imaging|magnetic resonance imaging
5777551|NCT00209911|cardioversion|cardioversion
5777552|NCT00209911|natriuretic peptides|natriuretic peptides
5777553|NCT00209898|Chronic hepatits C|chronic hepatits c
5777554|NCT00209898|peginterferon|peginterferon
5777555|NCT00209898|ribavirin|ribavirin
5777556|NCT00209898|inmate|inmate
5777557|NCT00209898|fast initiation procedure|fast initiation procedure
5777558|NCT00209846|Primary insomnia|primary insomnia
5777559|NCT00209820|low back pain|low back pain
5777560|NCT00209820|randomized clinical trial|randomized clinical trial
5777561|NCT00209820|Nordic walking|nordic walking
5777562|NCT00209820|supervision|supervision
5777563|NCT00209820|Advice to stay active|advice to stay active
5777564|NCT00209807|major depression|major depression
5777565|NCT00209807|pain|pain
5777566|NCT00209807|escitalopram|escitalopram
5777567|NCT00209807|reboxetine|reboxetine
5777568|NCT00209807|visceral sensitivity|visceral sensitivity
5777569|NCT00209807|somatic sensitivity|somatic sensitivity
5777570|NCT00209768|pediatric intensive care|pediatric intensive care
5777571|NCT00209768|critically ill children|critically ill children
5777572|NCT00209768|in-line filtration|in-line filtration
5777573|NCT00209768|prospective randomized study|prospective randomized study
5777574|NCT00209768|complications|complications
5777576|NCT00209768|SIRS|sirs
5777577|NCT00209768|thrombosis|thrombosis
5777578|NCT00209768|organ failure|organ failure
5777579|NCT00209755|chronic hepatitis C|chronic hepatitis c
5862954|NCT00001451|Bone Marrow Transplantation|bone marrow transplantation
5681080|NCT00574782|cholesterol, coronary heart disease|cholesterol, coronary heart disease
5681081|NCT00574782|rosuvastatin|rosuvastatin
5681082|NCT00574782|LDL-C goal|ldl-c goal
5681083|NCT00574782|hypercholesterolemia|hypercholesterolemia
5681084|NCT00574769|RAD001|rad001
5681085|NCT00574769|mTOR inhibition|mtor inhibition
5681086|NCT00574769|docetaxel|docetaxel
5681087|NCT00574769|bevacizumab|bevacizumab
5681088|NCT00574769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5787404|NCT00158678|IMRT|imrt
5777580|NCT00209742|Colorectal Cancer,UFT,LV,Krestin,adjuvant therapy,phase III|colorectal cancer,uft,lv,krestin,adjuvant therapy,phase iii
5777581|NCT00209729|Docetaxel|docetaxel
5777583|NCT00209729|Elderly Patients|elderly patients
5777584|NCT00209729|Gastric cancer|gastric cancer
5777585|NCT00209664|Irinotecan, S-1, Phase II, gastric cancer|irinotecan, s-1, phase ii, gastric cancer
5777586|NCT00209651|Irinotecan, S-1, Phase II, colorectal cancer,|irinotecan, s-1, phase ii, colorectal cancer,
5777587|NCT00209638|Irinotecan,|irinotecan,
5777588|NCT00209638|S-1,|s-1,
5777589|NCT00209638|Phase I/II,|phase i/ii,
5777590|NCT00209638|gastric cancer|gastric cancer
5777591|NCT00209625|Irinotecan, leucovorin, fluorouracil, PhaseI/II, colorectal cancer,|irinotecan, leucovorin, fluorouracil, phasei/ii, colorectal cancer,
5777592|NCT00209599|Colonoscopy|colonoscopy
5777593|NCT00209599|Seadation|seadation
5777594|NCT00209586|Bronchoscopy|bronchoscopy
5777595|NCT00209586|Sedation|sedation
5777596|NCT00209573|Colonoscopy|colonoscopy
5777597|NCT00209573|Sedation|sedation
5777598|NCT00209560|AQUAVAN® Injection|aquavan® injection
5777599|NCT00209560|Midazolam|midazolam
5777600|NCT00209560|Minor surgical procedures|minor surgical procedures
5777601|NCT00209560|Sedation|sedation
5777602|NCT00209547|AQUAVAN® Injection|aquavan® injection
5777603|NCT00209547|Midazolam|midazolam
5777604|NCT00209547|Angioplasty|angioplasty
5777605|NCT00209547|Coronary catheterization|coronary catheterization
5777606|NCT00209521|Coronary Artery Bypass Surgery|coronary artery bypass surgery
5777607|NCT00209521|AQUAVAN® Injection|aquavan® injection
5686411|NCT00552279|cervical cancer|cervical cancer
5777608|NCT00209521|DISOPRIVAN® Injectable Emulsion.|disoprivan® injectable emulsion.
5777609|NCT00209521|ischemic coronary artery disease|ischemic coronary artery disease
5777610|NCT00209508|Parkinson's Disease|parkinson's disease
5777611|NCT00209508|SPECT Scanning|spect scanning
5777612|NCT00209495|Abdominal hysterectomy|abdominal hysterectomy
5777613|NCT00209495|Pregabalin|pregabalin
5777614|NCT00209495|Dexamethasone|dexamethasone
5777615|NCT00209495|Multimodal postoperative analgesia|multimodal postoperative analgesia
5777616|NCT00209456|Lewy Body Dementia|lewy body dementia
5777617|NCT00209456|non-DLB dementia|non-dlb dementia
5777618|NCT00209456|Dopamine Transporter|dopamine transporter
5777619|NCT00209456|Striatal Uptake|striatal uptake
5772611|NCT00233701|NPH|nph
5777621|NCT00209443|Occlusion|occlusion
5777622|NCT00209443|Diagnostic Imaging|diagnostic imaging
5777624|NCT00209443|Magnetic Resonance Angiography|magnetic resonance angiography
5777625|NCT00209443|Contrast Media|contrast media
5777626|NCT00209430|Iodixanol|iodixanol
5777627|NCT00209430|Iopamidol|iopamidol
5777628|NCT00209430|coronary angiography|coronary angiography
5777629|NCT00209430|Contrast media-induced nephropathy|contrast media-induced nephropathy
5777630|NCT00209417|Iodixanol|iodixanol
5777631|NCT00209417|Iopamidol|iopamidol
5777632|NCT00209417|computed tomography|computed tomography
5777633|NCT00209417|Patients with pre-existing renal impairment and diabetes|patients with pre-existing renal impairment and diabetes
5777634|NCT00209404|MDCT|mdct
5777635|NCT00209404|Coronary Artery|coronary artery
5777636|NCT00209404|Heart Rate|heart rate
5777637|NCT00209404|Image Quality|image quality
5777638|NCT00209404|Diagnostic Quality|diagnostic quality
5777639|NCT00209391|Renal Artery Stenosis|renal artery stenosis
5777640|NCT00209391|Occlusion|occlusion
5777641|NCT00209391|Diagnostic Imaging|diagnostic imaging
5777642|NCT00209391|Omniscan|omniscan
5777643|NCT00209391|Magnetic Resonance Angiography|magnetic resonance angiography
5777644|NCT00209391|Contrast Media|contrast media
5777645|NCT00209378|Continuous venovenous hemofiltration (CVVH)|continuous venovenous hemofiltration (cvvh)
5777646|NCT00209378|Continuous renal replacement therapy (CRRT)|continuous renal replacement therapy (crrt)
5777647|NCT00209378|Acute Kidney Injury|acute kidney injury
5777648|NCT00209378|Regional citrate anticoagulation|regional citrate anticoagulation
5777649|NCT00209378|filter survival|filter survival
5777650|NCT00209378|trisodium citrate|trisodium citrate
5777651|NCT00209378|bleeding complication|bleeding complication
5777652|NCT00209378|Hemofiltration|hemofiltration
5777653|NCT00209352|Varicella Zoster Virus Infection|varicella zoster virus infection
5777654|NCT00209352|VZV infection|vzv infection
5777656|NCT00209352|Allogeneic Bone Marrow Transplantation|allogeneic bone marrow transplantation
5777657|NCT00209352|Allogeneic Hematopoietic Cell Transplantation|allogeneic hematopoietic cell transplantation
5777658|NCT00209339|Mitral Valve Insufficiency|mitral valve insufficiency
5777659|NCT00209339|Mitral Valve Regurgitation|mitral valve regurgitation
5777660|NCT00209339|Mitral Valve Incompetence|mitral valve incompetence
5777661|NCT00209339|Mitral Regurgitation|mitral regurgitation
5777662|NCT00209339|Mitral Insufficiency|mitral insufficiency
5777663|NCT00209339|Mitral Valve|mitral valve
5777664|NCT00209339|MR|mr
5777665|NCT00209339|Mitral Valve Prolapse|mitral valve prolapse
5777666|NCT00209339|E2E - Edge to Edge|e2e - edge to edge
5777667|NCT00209339|Alfieri Technique|alfieri technique
5777668|NCT00209339|MitraClip|mitraclip
5777669|NCT00209339|Functional MR|functional mr
5777670|NCT00209339|Degenerative MR|degenerative mr
5777671|NCT00209339|Echocardiogram|echocardiogram
5777672|NCT00209339|CAD - Coronary Artery Disease|cad - coronary artery disease
5777673|NCT00209339|Heart Failure|heart failure
5777674|NCT00209339|Heart Attack|heart attack
5777675|NCT00209339|EVEREST|everest
5777676|NCT00209339|EVEREST I|everest i
5777677|NCT00209339|EVEREST II|everest ii
5777678|NCT00209313|HIV-1|hiv-1
5777679|NCT00209313|HSV-2|hsv-2
5777680|NCT00209313|Coinfection|coinfection
5777681|NCT00209313|Africa|africa
5777682|NCT00209313|Cameroon|cameroon
5777683|NCT00209300|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
5777684|NCT00209287|Ulcerative Colitis for Maintenance of Remission|ulcerative colitis for maintenance of remission
5777685|NCT00209274|Mitral Valve Insufficiency|mitral valve insufficiency
5777686|NCT00209274|Mitral Valve Regurgitation|mitral valve regurgitation
5777687|NCT00209274|Mitral Valve Incompetence|mitral valve incompetence
5777688|NCT00209274|Mitral Regurgitation|mitral regurgitation
5777689|NCT00209274|Mitral Insufficiency|mitral insufficiency
5777690|NCT00209274|Mitral Valve|mitral valve
5777691|NCT00209274|MR|mr
5777692|NCT00209274|Mitral Valve Prolapse|mitral valve prolapse
5777693|NCT00209274|Edge to Edge (E2E)|edge to edge (e2e)
5777694|NCT00209274|Alfieri Technique|alfieri technique
5777695|NCT00209274|MitraClip|mitraclip
5777696|NCT00209274|Functional MR|functional mr
5777697|NCT00209274|Degenerative MR|degenerative mr
5777698|NCT00209274|Echocardiogram|echocardiogram
5777699|NCT00209274|CAD - Coronary Artery Disease|cad - coronary artery disease
5777700|NCT00209274|Heart Failure|heart failure
5777701|NCT00209274|Heart Attack|heart attack
5776789|NCT00213044|safety|safety
5777702|NCT00209274|EVEREST|everest
5777703|NCT00209274|EVEREST I|everest i
5777704|NCT00209274|EVEREST II|everest ii
5777705|NCT00209274|REALISM|realism
5777706|NCT00209235|Pseudohypoparathyroidism Type 1A (PHP 1A)|pseudohypoparathyroidism type 1a (php 1a)
5848608|NCT00034138|antibody|antibody
5777707|NCT00209235|Albright Hereditary Osteodystrophy|albright hereditary osteodystrophy
5777708|NCT00209235|Growth Hormone Deficiency|growth hormone deficiency
5777709|NCT00209222|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5777710|NCT00209222|younger patients|younger patients
5777711|NCT00209222|chemotherapy|chemotherapy
5777712|NCT00209222|high dose therapy|high dose therapy
5777713|NCT00209222|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
5777714|NCT00209222|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
5777715|NCT00209222|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
5777814|NCT00208650|pediatrics|pediatrics
5777717|NCT00209209|Elderly patients|elderly patients
5777718|NCT00209209|Chemotherapy|chemotherapy
5777719|NCT00209209|Maintenance therapy|maintenance therapy
5777720|NCT00209209|C04.557.386.480.300.725.500|c04.557.386.480.300.725.500
5777721|NCT00209209|C15.604.515.569.480.300.725.500|c15.604.515.569.480.300.725.500
5777722|NCT00209209|C20.683.515.761.480.300.725.500|c20.683.515.761.480.300.725.500
5777723|NCT00209196|pediatric|pediatric
5777724|NCT00209196|transplantation|transplantation
5777725|NCT00209196|psychosocial|psychosocial
5777726|NCT00209196|kidney transplant recipient|kidney transplant recipient
5777727|NCT00209196|liver transplant recipient|liver transplant recipient
5777728|NCT00209196|heart transplant recipient|heart transplant recipient
5777729|NCT00209196|lung transplant recipient|lung transplant recipient
5777730|NCT00209196|heart-lung transplant recipient|heart-lung transplant recipient
5777731|NCT00209144|Inflammation|inflammation
5777732|NCT00209144|Thrombosis|thrombosis
5777733|NCT00209144|Hyperglycemia|hyperglycemia
5777734|NCT00209144|Myocardial Infarction|myocardial infarction
5777735|NCT00209144|Angioplasty|angioplasty
5777736|NCT00209131|urolithiasis|urolithiasis
5777737|NCT00209118|Hepatitis C|hepatitis c
5777738|NCT00209118|Interferon-alpha associated side effects|interferon-alpha associated side effects
5777739|NCT00209118|Antidepressants|antidepressants
5777740|NCT00209118|Prevention|prevention
5777741|NCT00209105|Child Abuse|child abuse
5777742|NCT00209105|Hypothalamic-Pituitary-Adrenal Axis|hypothalamic-pituitary-adrenal axis
5777743|NCT00209105|Brain Imaging|brain imaging
5777744|NCT00209105|Depression|depression
5777745|NCT00209092|Breast Cancer|breast cancer
5777746|NCT00209079|Gastric Adenocarcinoma|gastric adenocarcinoma
5777747|NCT00209066|Major Depressive Disorder|major depressive disorder
5777748|NCT00209066|Electroconvulsive Therapy|electroconvulsive therapy
5777751|NCT00209040|Acoustic startle|acoustic startle
5777752|NCT00209027|schizophrenia|schizophrenia
5777753|NCT00209027|reward|reward
5777754|NCT00209027|fMRI|fmri
5777755|NCT00209014|B-Cell Lymphoma|b-cell lymphoma
5777756|NCT00209014|Hodgkin's Disease|hodgkin's disease
5777757|NCT00209001|Breast Cancer|breast cancer
5777758|NCT00208988|Health literacy|health literacy
5777759|NCT00208988|Physician-Patient Relationship|physician-patient relationship
5777760|NCT00208988|Prostate Cancer|prostate cancer
5777761|NCT00208975|Lymphoma|lymphoma
5777762|NCT00208962|Hematologic Diseases|hematologic diseases
5777763|NCT00208949|Hematologic Diseases|hematologic diseases
5777764|NCT00208936|Esophageal Diseases|esophageal diseases
5777765|NCT00208923|Hematologic Malignancies|hematologic malignancies
5777766|NCT00208910|Anxiety|anxiety
5777767|NCT00208910|Mental Health|mental health
5777768|NCT00208897|Early Life Stress|early life stress
5777769|NCT00208897|HPA-axis|hpa-axis
5777770|NCT00208897|CRF|crf
5777771|NCT00208884|pediatric|pediatric
5777772|NCT00208884|orthotopic heart transplantation|orthotopic heart transplantation
5777773|NCT00208884|graft failure|graft failure
5777774|NCT00208871|Stereoscopic digital mammography|stereoscopic digital mammography
5777775|NCT00208871|Breast cancer detection|breast cancer detection
5777776|NCT00208871|Reduced rate of recall|reduced rate of recall
5777777|NCT00208871|Focal abnormalities detection|focal abnormalities detection
5777778|NCT00208832|Medication Compliance|medication compliance
5777779|NCT00208832|Health Literacy|health literacy
5777780|NCT00208819|Alzheimer's Disease|alzheimer's disease
5777781|NCT00208819|Geriatric|geriatric
5777782|NCT00208819|Dementia|dementia
5777783|NCT00208819|Agitation|agitation
5777784|NCT00208819|Behavioral Disturbances|behavioral disturbances
5777785|NCT00208819|Psychosis|psychosis
5777786|NCT00208806|Dilated Cardiomyopathy|dilated cardiomyopathy
5777787|NCT00208806|Pediatric|pediatric
5777788|NCT00208806|Bi-ventricular Pacemaker|bi-ventricular pacemaker
5777789|NCT00208793|colonic polyps|colonic polyps
5777790|NCT00208793|adenomatous polyps|adenomatous polyps
5777791|NCT00208793|colon cancer prevention|colon cancer prevention
5777792|NCT00208793|dietary supplements|dietary supplements
5777793|NCT00208780|Oxidative Stress|oxidative stress
5777794|NCT00208780|Endothelium|endothelium
5777795|NCT00208767|Angiotensin receptor blockade|angiotensin receptor blockade
5777796|NCT00208767|Oxidative stress|oxidative stress
5777797|NCT00208767|Endothelial dysfunction|endothelial dysfunction
5777798|NCT00208754|heart defects|heart defects
5777799|NCT00208754|cardiology|cardiology
5777800|NCT00208754|adults who have congenital heart defects|adults who have congenital heart defects
5777801|NCT00208741|Social Anxiety Disorder|social anxiety disorder
5777802|NCT00208741|Mental Health|mental health
5777803|NCT00208728|pediatric|pediatric
5777804|NCT00208728|congenital heart disease|congenital heart disease
5777805|NCT00208728|cardiac surgery|cardiac surgery
5777806|NCT00208715|Depression|depression
5777807|NCT00208702|Major Depressive Disorder|major depressive disorder
5777808|NCT00208702|Mental Health|mental health
5777809|NCT00208702|Depression|depression
5777810|NCT00208689|pediatric|pediatric
5777811|NCT00208689|congenital heart disease|congenital heart disease
5777812|NCT00208676|heart defects|heart defects
5777813|NCT00208676|pediatrics|pediatrics
5777818|NCT00208637|insulin sensitivity|insulin sensitivity
5777819|NCT00208637|cardiovascular risk|cardiovascular risk
5777820|NCT00208637|diabetes prevention|diabetes prevention
5777821|NCT00208637|diet modification|diet modification
5777822|NCT00208624|arrhythmia|arrhythmia
5777823|NCT00208624|pediatrics|pediatrics
5777825|NCT00208598|Maori|maori
5777826|NCT00208598|Body Composition|body composition
5777827|NCT00208598|DEXA|dexa
5777828|NCT00208598|Cardiovascular disease|cardiovascular disease
5777829|NCT00208598|Diabetes|diabetes
5777830|NCT00208572|Traumatic Brain Injury; Anxiety Disorders; SRI Treatment|traumatic brain injury; anxiety disorders; sri treatment
5777831|NCT00208559|Autism|autism
5777832|NCT00208559|Pervasive Developmental Disorder|pervasive developmental disorder
5777833|NCT00208559|Ziprasidone|ziprasidone
5777834|NCT00208559|Adolescents|adolescents
5777835|NCT00208546|capecitabine|capecitabine
5777836|NCT00208546|oxaliplatin|oxaliplatin
5777837|NCT00208546|bevacizumab|bevacizumab
5777838|NCT00208546|cetuximab|cetuximab
5778254|NCT00206466|taxotere|taxotere
5777839|NCT00208546|advanced colorectal cancer|advanced colorectal cancer
5777840|NCT00208533|Autism|autism
5777841|NCT00208533|Pervasive developmental disorder|pervasive developmental disorder
5777842|NCT00208533|Aripiprazole|aripiprazole
5777843|NCT00208533|Antipsychotic medication|antipsychotic medication
5777844|NCT00208533|Adolescents|adolescents
5777845|NCT00208520|Epilepsy|epilepsy
5777846|NCT00208520|Valproate|valproate
5777847|NCT00208520|Levetiracetam|levetiracetam
5777848|NCT00208520|Lamotrigine|lamotrigine
5777849|NCT00208520|Carbamazepine|carbamazepine
5777850|NCT00208507|Joint Diseases|joint diseases
5787700|NCT00157183|cystic fibrosis|cystic fibrosis
5777851|NCT00208507|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5777852|NCT00208494|Non-Inflammatory Degenerative Joint Disease|non-inflammatory degenerative joint disease
5777853|NCT00208468|Hip|hip
5777854|NCT00208468|Cementless|cementless
5777855|NCT00208455|Arthroplasty|arthroplasty
5777856|NCT00208455|Replacement|replacement
5777857|NCT00208455|Hip|hip
5777858|NCT00208455|Conservative|conservative
5777859|NCT00208455|Anatomic|anatomic
5777860|NCT00208455|Cementless|cementless
5777861|NCT00208442|Hip|hip
5777862|NCT00208442|Cemented|cemented
5777863|NCT00208429|Hip|hip
5777864|NCT00208429|Cementless|cementless
5777865|NCT00208416|Hip|hip
5777866|NCT00208416|Surgical Technique|surgical technique
5777867|NCT00208403|Hip|hip
5777868|NCT00208403|Cement|cement
5777869|NCT00208390|Hip|hip
5777870|NCT00208390|Cementless|cementless
5777871|NCT00208377|Hip|hip
5777872|NCT00208377|Conservative|conservative
5777873|NCT00208377|Metal-on-Metal|metal-on-metal
5777874|NCT00208377|Resurfacing|resurfacing
5777875|NCT00208364|Hip|hip
5777876|NCT00208364|Cementless|cementless
5777877|NCT00208364|Metal-on-Metal|metal-on-metal
5777878|NCT00208351|Hip|hip
5777879|NCT00208351|Cemented|cemented
5777880|NCT00208338|Rotator cuff tear repair|rotator cuff tear repair
5777881|NCT00208312|Lexiscan|lexiscan
5777882|NCT00208312|Regadenoson|regadenoson
5777883|NCT00208312|Adenoscan®|adenoscan®
5777884|NCT00208312|Adenosine|adenosine
5777885|NCT00208312|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
5777886|NCT00208312|Reversible Perfusion Defect|reversible perfusion defect
5777887|NCT00208299|Lexiscan|lexiscan
5777888|NCT00208299|Regadenoson|regadenoson
5777889|NCT00208299|Adenoscan®|adenoscan®
5777890|NCT00208299|Adenosine|adenosine
5777891|NCT00208299|SPECT Myocardial Perfusion Imaging|spect myocardial perfusion imaging
5777892|NCT00208299|Reversible Perfusion Defect|reversible perfusion defect
5777893|NCT00208273|Postmenopausal breast cancer, radiohormonotherapy sequences|postmenopausal breast cancer, radiohormonotherapy sequences
5777894|NCT00208273|ER+ and/or PgR+,|er+ and/or pgr+,
5777895|NCT00208273|Postmenopausal Breast cancer,|postmenopausal breast cancer,
5777896|NCT00208273|Adjuvant setting|adjuvant setting
5777897|NCT00208234|asthma|asthma
5777898|NCT00208221|Hypertension|hypertension
5777899|NCT00208221|Diabetes|diabetes
5777900|NCT00208221|Microalbuminuria|microalbuminuria
5777901|NCT00208221|Blood pressure|blood pressure
5777902|NCT00208208|Posttraumatic Stress Disorder|posttraumatic stress disorder
5777903|NCT00208208|Post-traumatic Stress Disorder|post-traumatic stress disorder
5777904|NCT00208208|PTSD|ptsd
5777905|NCT00208208|Geodon|geodon
5777906|NCT00208208|Ziprasidone|ziprasidone
5777907|NCT00208195|Bipolar Disorder|bipolar disorder
5777908|NCT00208195|Mania|mania
5777909|NCT00208195|Substance Abuse|substance abuse
5777910|NCT00208195|Substance Dependence|substance dependence
5777911|NCT00208195|Comorbid|comorbid
5777912|NCT00208169|Comorbid substance abuse/dependence|comorbid substance abuse/dependence
5777913|NCT00208169|Comorbid diagnoses|comorbid diagnoses
5777914|NCT00208169|Substance abuse and/or dependence|substance abuse and/or dependence
5777915|NCT00208156|Depression|depression
5777916|NCT00208156|Major Depression|major depression
5777917|NCT00208156|Psychotic Major Depression|psychotic major depression
5777919|NCT00208156|Psychosis|psychosis
5777920|NCT00208143|Cocaine Abuse|cocaine abuse
5778529|NCT00204503|Depression|depression
5777921|NCT00208143|Cocaine Dependence|cocaine dependence
5777922|NCT00208143|Amphetamine Abuse|amphetamine abuse
5777923|NCT00208143|Amphetamine Dependence|amphetamine dependence
5777924|NCT00208143|Schizophrenia|schizophrenia
5777925|NCT00208143|Comorbid|comorbid
5777926|NCT00208143|Schizoaffective Disorder|schizoaffective disorder
5777927|NCT00208130|PTSD|ptsd
5777928|NCT00208130|trauma|trauma
5777929|NCT00208117|depression|depression
5777930|NCT00208117|inflammation|inflammation
5777931|NCT00208117|heart disease|heart disease
5777932|NCT00208117|randomized clinical trial|randomized clinical trial
5777933|NCT00208117|sertraline|sertraline
5777934|NCT00208117|simvastatin|simvastatin
5777935|NCT00208117|placebo|placebo
5777936|NCT00208104|Hypertension|hypertension
5777937|NCT00208104|African Americans|african americans
5777938|NCT00208104|Adherence|adherence
5777939|NCT00208104|Motivational Interviewing|motivational interviewing
5777940|NCT00208091|Myloboc|myloboc
5777941|NCT00208091|Botulinum Toxin Type B|botulinum toxin type b
5777942|NCT00208091|Focal Dystonia|focal dystonia
5777943|NCT00208091|Musicians|musicians
5777944|NCT00208091|Muscle Relaxants|muscle relaxants
5777945|NCT00208091|Motor Impairments|motor impairments
5777946|NCT00208091|Motor Performance|motor performance
5777948|NCT00208091|Abnormal Postures|abnormal postures
5777949|NCT00208078|Hypercapnia|hypercapnia
5777950|NCT00208078|Non-Invasive Ventilation|non-invasive ventilation
5777951|NCT00208065|migraine|migraine
5777952|NCT00208065|biological markers|biological markers
5777953|NCT00208065|rhinosinusitis|rhinosinusitis
5777954|NCT00208065|CGRP|cgrp
5777955|NCT00208065|histamine|histamine
5777956|NCT00208065|VIP|vip
5777957|NCT00208039|Prematurity|prematurity
5777958|NCT00208039|Lung Disease|lung disease
5777959|NCT00208039|Hyaline Membrane|hyaline membrane
5777960|NCT00208039|Surfactant|surfactant
5777961|NCT00208013|resting energy expenditure|resting energy expenditure
5777962|NCT00208013|cachexia|cachexia
5777963|NCT00208013|advanced cancer|advanced cancer
5777964|NCT00208013|advanced cancer patients|advanced cancer patients
5777965|NCT00207987|controlled hypotension|controlled hypotension
5777966|NCT00207974|Hyperuricemia, Anserine, Pharmacokinetic|hyperuricemia, anserine, pharmacokinetic
5777967|NCT00207948|Human Immunodeficiency Virus|human immunodeficiency virus
5777968|NCT00207948|Protease Inhibitors|protease inhibitors
5777969|NCT00207948|Pharmacogenetics|pharmacogenetics
5777970|NCT00207948|Genes, MDR1, Cytochrome P-450 enzymes|genes, mdr1, cytochrome p-450 enzymes
5777971|NCT00207948|Pharmacokinetics|pharmacokinetics
5777972|NCT00207948|Pediatrics|pediatrics
5777973|NCT00207948|Treatment Experienced|treatment experienced
5777974|NCT00207935|Seizures|seizures
5777975|NCT00207935|Depakote|depakote
5777976|NCT00207935|Developmental Delay|developmental delay
5777977|NCT00207935|Mental Retardation|mental retardation
5777978|NCT00207935|Swallow|swallow
5777979|NCT00207922|cytokine|cytokine
5777980|NCT00207922|T-cell|t-cell
5777981|NCT00207922|chemokine|chemokine
5777982|NCT00207922|graft-versus-host disease|graft-versus-host disease
5777983|NCT00207909|Acute Renal Failure|acute renal failure
5777984|NCT00207909|Contiuous Veno Venous Hemofiltration|contiuous veno venous hemofiltration
5777985|NCT00207896|Pediatric Intensive Care|pediatric intensive care
5777986|NCT00207896|Neuroendocrine Dysfunction|neuroendocrine dysfunction
5777987|NCT00207883|Vascular Access|vascular access
5777988|NCT00207883|Ultrasound|ultrasound
5777989|NCT00207883|Pediatric|pediatric
5777990|NCT00207883|Pediatric intensive care patient|pediatric intensive care patient
5777991|NCT00207870|Type II Supracondylar Fracture|type ii supracondylar fracture
5777992|NCT00207870|Orthopaedics|orthopaedics
5777993|NCT00207857|Duchenne's Muscular Dystrophy|duchenne's muscular dystrophy
5777994|NCT00207857|Scoliosis|scoliosis
5777995|NCT00207844|Selenium|selenium
5777996|NCT00207844|Oxidative stress|oxidative stress
5777997|NCT00207844|Septic shock|septic shock
5777998|NCT00207844|Sodium selenite|sodium selenite
5777999|NCT00207831|rectal cancer|rectal cancer
5778000|NCT00207831|neoadjuvant therapy|neoadjuvant therapy
5778001|NCT00207831|UFT|uft
5778002|NCT00207831|radiochemotherapy|radiochemotherapy
5778003|NCT00207818|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care|tissue engineered wound dressing; autologous skin substitute; biological dressing; wound care
5777140|NCT00211419|AMD|amd
5778004|NCT00207792|Granulocyte colony stimulating factor|granulocyte colony stimulating factor
5778005|NCT00207779|central venous catheter|central venous catheter
5778006|NCT00207779|catheter related bloodstream infection|catheter related bloodstream infection
5778007|NCT00207779|heparin|heparin
5795319|NCT00123214|Weight|weight
5778008|NCT00207766|Crohn's Disease|crohn's disease
5778009|NCT00207766|infusions|infusions
5778010|NCT00207753|ascaris|ascaris
5778011|NCT00207753|trichuris|trichuris
5778012|NCT00207753|strongyloides|strongyloides
5778013|NCT00207753|hookworm|hookworm
5778014|NCT00207753|head lice|head lice
5778016|NCT00207740|Severe Persistent Asthma|severe persistent asthma
5778017|NCT00207740|Subcutaneous injections|subcutaneous injections
5778018|NCT00207740|Immunology disorder|immunology disorder
5778019|NCT00207740|Breathlesness|breathlesness
5778020|NCT00207727|Multiple Sclerosis|multiple sclerosis
5778021|NCT00207714|Rheumatoid Arthritis|rheumatoid arthritis
5778022|NCT00207714|CNTO 148|cnto 148
5778023|NCT00207714|Methotrexate|methotrexate
5778024|NCT00207714|Joint pain|joint pain
5778025|NCT00207714|Arthritis|arthritis
5778026|NCT00207701|Ankylosing Spondylitis|ankylosing spondylitis
5778027|NCT00207701|infusion|infusion
5778028|NCT00207688|Ulcerative Colitis|ulcerative colitis
5778029|NCT00207688|Infliximab|infliximab
5778030|NCT00207688|Remicade|remicade
5778031|NCT00207688|Safety|safety
5778032|NCT00207675|Crohn's Disease|crohn's disease
5778033|NCT00207675|pediatric Crohn's Disease|pediatric crohn's disease
5778034|NCT00207662|Crohn's Disease|crohn's disease
5778035|NCT00207649|shared decision-making|shared decision-making
5778036|NCT00207649|prostate cancer screening|prostate cancer screening
5778037|NCT00207649|evidence-based medicine|evidence-based medicine
5778038|NCT00207649|computer-assisted learning tools|computer-assisted learning tools
5778039|NCT00207649|standardized patients|standardized patients
5778040|NCT00207649|randomized controlled trial|randomized controlled trial
5778041|NCT00207649|educational intervention|educational intervention
5778042|NCT00207649|patient education|patient education
5778043|NCT00207649|physician education|physician education
5778044|NCT00207636|Computer-Assisted Decision Making|computer-assisted decision making
5778045|NCT00207636|Workplace|workplace
5778046|NCT00207636|Screening|screening
5778047|NCT00207623|arthritis|arthritis
5778048|NCT00207623|self management|self management
5778049|NCT00207623|patient education|patient education
5787910|NCT00156221|Autism|autism
5778050|NCT00207610|Anemia|anemia
5778051|NCT00207610|Postpartum|postpartum
5778052|NCT00207610|iron|iron
5778053|NCT00207610|supplements|supplements
5778054|NCT00207571|computer|computer
5778055|NCT00207571|video|video
5778056|NCT00207571|partner notification|partner notification
5778057|NCT00207519|overweight|overweight
5778058|NCT00207519|obesity|obesity
5778059|NCT00207519|adolescent|adolescent
5778060|NCT00207506|Latino|latino
5778061|NCT00207506|Lay Health|lay health
5778062|NCT00207506|Access|access
5778063|NCT00207506|Prevention|prevention
5778064|NCT00207506|HIV Seronegativity|hiv seronegativity
5778065|NCT00207506|HIV|hiv
5778066|NCT00207493|sexually transmitted disease|sexually transmitted disease
5778067|NCT00207493|structural intervention|structural intervention
5778068|NCT00207493|behavioral intervention|behavioral intervention
5778069|NCT00207467|patient-delivered partner treatment|patient-delivered partner treatment
5778070|NCT00207467|partner referral|partner referral
5778071|NCT00207467|sexually transmitted diseases|sexually transmitted diseases
5778072|NCT00207454|Partner Referral|partner referral
5778073|NCT00207454|Social Cognitive Intervention|social cognitive intervention
5778074|NCT00207454|Partner Delivered Medication|partner delivered medication
5778075|NCT00207441|arthritis|arthritis
5778076|NCT00207441|chronic disease|chronic disease
5778077|NCT00207441|self management|self management
5778078|NCT00207441|self efficacy|self efficacy
5778079|NCT00207428|Bronchial asthma|bronchial asthma
5778080|NCT00207428|Carbamazepine|carbamazepine
5778081|NCT00207428|Efficacy|efficacy
5778082|NCT00207415|arthritis|arthritis
5778083|NCT00207415|self management|self management
5778084|NCT00207402|Hepatitis C|hepatitis c
5778085|NCT00207402|Insulin resistance|insulin resistance
5778086|NCT00207389|Incretins:GIP , GLP-1|incretins:gip , glp-1
5778087|NCT00207389|Gastric bypass surgery|gastric bypass surgery
5778088|NCT00207389|Laparoscopic gastric bypass surgery|laparoscopic gastric bypass surgery
5778089|NCT00207389|Postprandial expression of GIP|postprandial expression of gip
5778090|NCT00207363|Hepatitis C|hepatitis c
5778091|NCT00207350|Brain Tumor|brain tumor
5778092|NCT00207337|COPD (Chronic Obstructive Pulmonary Disease)|copd (chronic obstructive pulmonary disease)
5778093|NCT00207337|Emphysema|emphysema
5778094|NCT00207337|Minimally invasive|minimally invasive
5778095|NCT00207311|Hepatitis C|hepatitis c
5778096|NCT00207311|Fatty Liver|fatty liver
5778097|NCT00207311|NASH|nash
5778098|NCT00207311|Steatohepatitis|steatohepatitis
5778099|NCT00207285|Police|police
5778100|NCT00207285|Sleep|sleep
5778101|NCT00207285|Fatigue|fatigue
5778102|NCT00207285|Work Hours|work hours
5778103|NCT00207285|Sleep disorder|sleep disorder
5778104|NCT00207285|Performance|performance
5778105|NCT00207272|Hypocaloric MCT oil liquid diet|hypocaloric mct oil liquid diet
5778106|NCT00207272|Hypocaloric LCT oil liquid diet|hypocaloric lct oil liquid diet
5778107|NCT00207272|Visceral and omental adipose tissue|visceral and omental adipose tissue
5778108|NCT00207272|Subcutaneous abdominal adipose tissue|subcutaneous abdominal adipose tissue
5778109|NCT00207272|Gastric bypass surgery|gastric bypass surgery
5778110|NCT00207259|Prostate Cancer|prostate cancer
5778111|NCT00207259|Reiki|reiki
5778112|NCT00207259|Relaxation Response|relaxation response
5773054|NCT00231322|Uganda|uganda
5778114|NCT00207259|Feasibility|feasibility
5778115|NCT00207233|Weight loss|weight loss
5778116|NCT00207233|MCT oil hypocaloric liquid diet|mct oil hypocaloric liquid diet
5778117|NCT00207233|LCT oil hypocaloric liquid diet|lct oil hypocaloric liquid diet
5778118|NCT00207233|Gastric Bypass|gastric bypass
5778119|NCT00207220|heart failure|heart failure
5778120|NCT00207220|preserved ejection fraction|preserved ejection fraction
5778121|NCT00207220|vascular stiffness|vascular stiffness
5778122|NCT00207207|Alternate Site|alternate site
5778123|NCT00207207|Blood Glucose Testing|blood glucose testing
5778124|NCT00207207|Blood Sugar Testing|blood sugar testing
5778125|NCT00207207|Hemoglobin A1C|hemoglobin a1c
5778126|NCT00207181|Cancer prevention|cancer prevention
5778127|NCT00207181|Physical activity|physical activity
5778128|NCT00207181|Self-report|self-report
5778129|NCT00207181|Paper diary|paper diary
5778130|NCT00207181|Electronic|electronic
5778131|NCT00207181|Computerized|computerized
5778132|NCT00207181|Measurement|measurement
5778134|NCT00207181|Accelerometer|accelerometer
5778135|NCT00207142|Treatment Naive|treatment naive
5778136|NCT00207142|HIV-1 infected treatment naive patients|hiv-1 infected treatment naive patients
5778137|NCT00207116|Metastatic Non Small Cell Lung Cancer|metastatic non small cell lung cancer
5778138|NCT00207103|Advanced metastatic or solid tumors|advanced metastatic or solid tumors
5778139|NCT00207077|Advanced Solid Tumors|advanced solid tumors
5778140|NCT00207064|first-episode|first-episode
5778141|NCT00207064|altanserin|altanserin
5778142|NCT00207064|5-HT2A receptors|5-ht2a receptors
5778144|NCT00207064|fMRI|fmri
5778145|NCT00207064|PPI|ppi
5778146|NCT00207064|P300|p300
5778147|NCT00207064|P50 gating|p50 gating
5778148|NCT00207064|endophenotypes|endophenotypes
5778149|NCT00207064|vulnerability indicators|vulnerability indicators
5778150|NCT00207064|quetiapine|quetiapine
5778151|NCT00207051|Advanced Gastrointestinal Malignancies|advanced gastrointestinal malignancies
5778152|NCT00207038|Asthma|asthma
5778153|NCT00207038|Airway inflammation|airway inflammation
5778154|NCT00207038|Sport|sport
5778155|NCT00207025|Patients with advanced solid tumors|patients with advanced solid tumors
5778156|NCT00206999|Psychophysiology|psychophysiology
5778157|NCT00206999|PPI|ppi
5778158|NCT00206999|P50 suppression|p50 suppression
5778159|NCT00206999|Imipramine|imipramine
5778160|NCT00206986|Schizophrenia|schizophrenia
5778161|NCT00206986|Information processing|information processing
5778162|NCT00206986|PPI|ppi
5778163|NCT00206986|P50 gating|p50 gating
5778164|NCT00206986|P300|p300
5778165|NCT00206986|mismatch negativity|mismatch negativity
5778166|NCT00206986|clonidine|clonidine
5778167|NCT00206960|drug-naive|drug-naive
5778168|NCT00206960|epidepride|epidepride
5768712|NCT00249249|KRE|kre
5778169|NCT00206960|single tomography|single tomography
5778170|NCT00206960|D2 receptor|d2 receptor
5778171|NCT00206960|information processing|information processing
5778172|NCT00206960|PPI|ppi
5778173|NCT00206960|antipsychotic treatment|antipsychotic treatment
5778174|NCT00206960|MRI|mri
5778175|NCT00206960|fMRI|fmri
5778176|NCT00206960|cognitive disturbances|cognitive disturbances
5778177|NCT00206947|Cognitive deficits|cognitive deficits
5778178|NCT00206947|Cholinergic Augmentation|cholinergic augmentation
5778179|NCT00206947|Schizophrenia|schizophrenia
5778180|NCT00206934|PPI|ppi
5778181|NCT00206934|P50 suppression|p50 suppression
5778182|NCT00206934|P300|p300
5778183|NCT00206934|mismatch negativity|mismatch negativity
5778184|NCT00206934|escitalopram|escitalopram
5778185|NCT00206921|Telangiectasia|telangiectasia
5778186|NCT00206921|Skin redness|skin redness
5778187|NCT00206882|sunburn|sunburn
5778188|NCT00206882|corticosteroids|corticosteroids
5778189|NCT00206791|bone substitutes|bone substitutes
5778190|NCT00206791|Bone Replacement Materials|bone replacement materials
5778191|NCT00206791|bone void filler|bone void filler
5778192|NCT00206791|Grafting, Bone|grafting, bone
5778193|NCT00206791|Bone Cysts|bone cysts
5778194|NCT00206778|Mixed mania|mixed mania
5778195|NCT00206778|Bipolar Disorder|bipolar disorder
5778196|NCT00206765|panic|panic
5778197|NCT00206739|Malaria|malaria
5778198|NCT00206739|Anemia|anemia
5778199|NCT00206739|IPTi|ipti
5778200|NCT00206739|Intermittent Preventive Treatment in Infants|intermittent preventive treatment in infants
5778201|NCT00206739|Sulfadoxine-Pyrimethamine|sulfadoxine-pyrimethamine
5778202|NCT00206739|Chemoprophylaxis|chemoprophylaxis
5778203|NCT00206739|Ghana|ghana
5778204|NCT00206713|Crohn Disease|crohn disease
5778205|NCT00206674|Morbus Crohn|morbus crohn
5778206|NCT00206674|Sargramostim|sargramostim
5778207|NCT00206674|Phase III|phase iii
5778208|NCT00206674|Placebo Controlled|placebo controlled
5778209|NCT00206661|Crohn Disease|crohn disease
5778210|NCT00206609|Cancer|cancer
5778211|NCT00206609|palliative care|palliative care
5778212|NCT00206609|dyspnoea|dyspnoea
5778213|NCT00206609|oxygen|oxygen
5778214|NCT00206570|Schizophrenia|schizophrenia
5778215|NCT00206570|Gender differences|gender differences
5778216|NCT00206570|Hormones|hormones
5778217|NCT00206570|Estradiol|estradiol
5778220|NCT00206557|Mental Illness|mental illness
5778221|NCT00206557|Hormone Therapy|hormone therapy
5778222|NCT00206557|Post-menopausal|post-menopausal
5778223|NCT00206557|SERM|serm
5778224|NCT00206557|Raloxifene|raloxifene
5778225|NCT00206544|Bipolar Affective Disorder|bipolar affective disorder
5778226|NCT00206544|Mania|mania
5778227|NCT00206544|Anti-Estrogen|anti-estrogen
5778228|NCT00206544|Schizoaffective Disorder|schizoaffective disorder
5778229|NCT00206544|Mood|mood
5778230|NCT00206531|HIV-1|hiv-1
5778231|NCT00206531|Naive T-cells|naive t-cells
5778232|NCT00206531|CD31|cd31
5778233|NCT00206531|Treatment Naive|treatment naive
5778234|NCT00206518|Breast|breast
5778235|NCT00206518|Cancer|cancer
5778236|NCT00206518|Taxotere|taxotere
5778237|NCT00206518|AC|ac
5778238|NCT00206518|Validation|validation
5778239|NCT00206518|Neoadjuvant|neoadjuvant
5778240|NCT00206505|Breast|breast
5778241|NCT00206505|Cancer|cancer
5778242|NCT00206505|Neoadjuvant|neoadjuvant
5778243|NCT00206505|Taxotere|taxotere
5778244|NCT00206492|Breast|breast
5778245|NCT00206492|Cancer|cancer
5778246|NCT00206492|Neoadjuvant|neoadjuvant
5778247|NCT00206492|HER2|her2
5778248|NCT00206492|Overexpressing|overexpressing
5778249|NCT00206466|neoadjuvant|neoadjuvant
5778250|NCT00206466|chemosensitivity|chemosensitivity
5778251|NCT00206466|chemotherapy|chemotherapy
5778252|NCT00206466|breast cancer|breast cancer
5778253|NCT00206466|tumor|tumor
5778255|NCT00206466|AC|ac
5778256|NCT00206453|Breast|breast
5778257|NCT00206453|Cancer|cancer
5778258|NCT00206453|Gene|gene
5778259|NCT00206453|Expression|expression
5778260|NCT00206453|Taxotere|taxotere
5778261|NCT00206440|chemotherapy|chemotherapy
5778262|NCT00206440|nausea|nausea
5778263|NCT00206440|vomiting|vomiting
5778264|NCT00206440|breast cancer|breast cancer
5778265|NCT00206427|Advanced|advanced
5778266|NCT00206427|Breast|breast
5778267|NCT00206427|Cancer|cancer
5778268|NCT00206427|Neoadjuvant|neoadjuvant
5778269|NCT00206427|HER2|her2
5778270|NCT00206414|HORMONE RECEPTOR POSITIVE BREAST CANCER|hormone receptor positive breast cancer
5778271|NCT00206401|Adolescents|adolescents
5778272|NCT00206401|Lantus|lantus
5778273|NCT00206388|NEUROBLASTOMA|neuroblastoma
5778274|NCT00206388|RECURRENT|recurrent
5778275|NCT00206388|REFRACTORY|refractory
5778276|NCT00206388|CORTICAL|cortical
5778277|NCT00206388|BONE|bone
5778278|NCT00206375|Hypothyroidism|hypothyroidism
5778279|NCT00206375|Growth hormone|growth hormone
5778280|NCT00206362|Depression|depression
5778281|NCT00206362|Socioeconomic status|socioeconomic status
5778282|NCT00206362|Type 1 diabetes mellitus|type 1 diabetes mellitus
5778283|NCT00206362|Children|children
5778284|NCT00206362|Adolescents|adolescents
5778285|NCT00206349|Depression|depression
5778286|NCT00206349|Socioeconomic status|socioeconomic status
5778287|NCT00206349|Type 1 diabetes mellitus|type 1 diabetes mellitus
5778288|NCT00206349|Children|children
5778289|NCT00206349|Adolescents|adolescents
5778290|NCT00206297|Type 1 diabetes|type 1 diabetes
5778291|NCT00206297|hypoglycemia|hypoglycemia
5778292|NCT00206297|hyperglycemia|hyperglycemia
5778293|NCT00206284|GERD without erosive esophagitis|gerd without erosive esophagitis
5778294|NCT00206271|whiplash injuries|whiplash injuries
5778295|NCT00206271|neck pain|neck pain
5778296|NCT00206271|exercise movement techniques|exercise movement techniques
5778297|NCT00206271|immobilisation|immobilisation
5778298|NCT00206258|type 1 diabetes|type 1 diabetes
5778299|NCT00206258|hypoglycemia|hypoglycemia
5778300|NCT00206258|hyperglycemia|hyperglycemia
5778301|NCT00206245|GERD with erosive esophagitis|gerd with erosive esophagitis
5778302|NCT00206232|Diastolic Heart Failure|diastolic heart failure
5778303|NCT00206219|Squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5778304|NCT00206193|termination of pregnancy|termination of pregnancy
5778305|NCT00206141|Bipolar disorder|bipolar disorder
5778306|NCT00206141|bipolar depression|bipolar depression
5778307|NCT00206141|depression|depression
5778308|NCT00206128|Schizophrenia|schizophrenia
5778309|NCT00206115|Schizophrenic disorder|schizophrenic disorder
5778310|NCT00206102|Schizophrenia|schizophrenia
5778311|NCT00206102|Schizoaffective Disorder|schizoaffective disorder
5778312|NCT00206089|Prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery|prevention of venous thromboembolic events in patients undergoing elective hip replacement or hip fracture surgery
5778313|NCT00206076|Liver transplantation|liver transplantation
5778314|NCT00206076|Calcineurin inhibitor withdraw|calcineurin inhibitor withdraw
5778315|NCT00206076|mycophenolate mofetil|mycophenolate mofetil
5778316|NCT00206076|Immunosuppression side effects|immunosuppression side effects
5778317|NCT00206076|Graft rejection|graft rejection
5778318|NCT00206037|Tibia osteotomy|tibia osteotomy
5778319|NCT00206037|Bone healing|bone healing
5778320|NCT00206037|Bone filler|bone filler
5778321|NCT00206037|Equine Protein|equine protein
5778322|NCT00206037|COLLOSS E|colloss e
5778325|NCT00206011|fractures|fractures
5778326|NCT00206011|endoscopic|endoscopic
5778327|NCT00206011|Helkimo Dysfunction index|helkimo dysfunction index
5778328|NCT00205998|Locking Compression Plate|locking compression plate
5778329|NCT00205998|Conservative treatment|conservative treatment
5778330|NCT00205998|Surgical treatment|surgical treatment
5778331|NCT00205998|Radius fractures|radius fractures
5778332|NCT00205998|AO 23|ao 23
5778333|NCT00205985|Return to work|return to work
5778334|NCT00205985|Scaphoid fracture|scaphoid fracture
5778335|NCT00205985|Operative treatment|operative treatment
5778336|NCT00205985|Activity level|activity level
5778337|NCT00205972|Fractures|fractures
5778338|NCT00205972|Humerus|humerus
5778339|NCT00205972|Conservative treatment|conservative treatment
5778340|NCT00205972|Operative treatment|operative treatment
5778341|NCT00205959|Humerus|humerus
5778342|NCT00205959|Fractures|fractures
5778343|NCT00205959|Locking Plates|locking plates
5778344|NCT00205959|Nail System|nail system
5778345|NCT00205946|Reward Processing|reward processing
5778346|NCT00205946|Wellbutrin|wellbutrin
5778347|NCT00205946|Bupropion|bupropion
5778348|NCT00205933|Depression|depression
5778349|NCT00205933|Bipolar Disorder|bipolar disorder
5778350|NCT00205933|Reward Processing|reward processing
5778351|NCT00205920|emphysema|emphysema
5778352|NCT00205920|pulmonary emphysema|pulmonary emphysema
5778353|NCT00205920|COPD|copd
5778354|NCT00205920|COLD|cold
5778355|NCT00205920|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5778356|NCT00205907|BLVR|blvr
5778357|NCT00205907|emphysema|emphysema
5778358|NCT00205907|COPD|copd
5778359|NCT00205907|COLD|cold
5778360|NCT00205907|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5778361|NCT00205907|pulmonary emphysema|pulmonary emphysema
5778362|NCT00205894|Headache|headache
5778363|NCT00205894|Chronic headache|chronic headache
5778364|NCT00205894|Migraine|migraine
5778365|NCT00205894|Pain|pain
5778366|NCT00205894|Cluster headache|cluster headache
5778367|NCT00205881|HiResolution Bionic Ear|hiresolution bionic ear
5778368|NCT00205881|severe to profound hearing loss|severe to profound hearing loss
5778369|NCT00205881|bilateral implantation|bilateral implantation
5778370|NCT00205868|Back Pain|back pain
5778371|NCT00205868|Low Back Pain|low back pain
5778372|NCT00205868|Chronic Pain|chronic pain
5778373|NCT00205868|Spinal Cord Stimulation|spinal cord stimulation
5778374|NCT00205855|Pain|pain
5778375|NCT00205855|Chronic Pain|chronic pain
5778376|NCT00205855|Neurostimulation|neurostimulation
5778377|NCT00205829|Chronic headaches|chronic headaches
5778378|NCT00205829|greater occipital nerve stimulation|greater occipital nerve stimulation
5778379|NCT00205816|Bacterial Infections|bacterial infections
5778380|NCT00205803|Infant Vaccine|infant vaccine
5778381|NCT00205777|Osteoporosis|osteoporosis
5778383|NCT00205764|Multiple Myeloma|multiple myeloma
5778384|NCT00205764|first line tretment|first line tretment
5778385|NCT00205764|high dose chemotherapy|high dose chemotherapy
5778386|NCT00205764|stem cell transplantation|stem cell transplantation
5778387|NCT00205764|maintenance therapy|maintenance therapy
5778388|NCT00205751|Multiple Myeloma|multiple myeloma
5778389|NCT00205751|first line treatment|first line treatment
5778390|NCT00205751|thalidomide|thalidomide
5778391|NCT00205751|melphalan|melphalan
5778392|NCT00205738|Schizophrenia|schizophrenia
5778393|NCT00205738|BMI|bmi
5778394|NCT00205738|T2DM|t2dm
5778395|NCT00205725|Schizophrenia|schizophrenia
5778396|NCT00205725|BMI|bmi
5778397|NCT00205725|T2DM|t2dm
5778398|NCT00205712|NMDA antagonist-induced psychosis|nmda antagonist-induced psychosis
5778399|NCT00205712|Children|children
5778400|NCT00205712|Memory Impairment|memory impairment
5778401|NCT00205712|Decreased cognitive function|decreased cognitive function
5778402|NCT00205712|Increased memory impairment|increased memory impairment
5778403|NCT00205699|Antipsychotic treatment|antipsychotic treatment
5778404|NCT00205699|Insulin action/secretion|insulin action/secretion
5778405|NCT00205699|Abdominal fat mass, total body fat|abdominal fat mass, total body fat
5778406|NCT00205699|Aggression|aggression
5778407|NCT00205699|Resting metabolic rates|resting metabolic rates
5778408|NCT00205686|Aging, dhea, bone density, muscle mass, insulin action|aging, dhea, bone density, muscle mass, insulin action
5778409|NCT00205660|Schizophrenia|schizophrenia
5778410|NCT00205660|Obesity|obesity
5778411|NCT00205660|Hyperglycemia|hyperglycemia
5778412|NCT00205660|Dyslipidemia|dyslipidemia
5778413|NCT00205660|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5778414|NCT00205647|Chronic Bronchitis|chronic bronchitis
5778415|NCT00205647|N-acetylcysteine (NAC)|n-acetylcysteine (nac)
5778416|NCT00205647|Quality of Life|quality of life
5778417|NCT00205647|Mucus|mucus
5778418|NCT00205634|Cystic Fibrosis (CF)|cystic fibrosis (cf)
5778419|NCT00205634|Macrolide antiobiotics|macrolide antiobiotics
5795708|NCT00121771|Malaria|malaria
5778420|NCT00205634|airway inflammation|airway inflammation
5778421|NCT00205621|Alzheimer's disease|alzheimer's disease
5778422|NCT00205621|amyloid|amyloid
5778423|NCT00205621|PET|pet
5778424|NCT00205621|PIB|pib
5778426|NCT00205608|schizophrenia|schizophrenia
5778427|NCT00205608|microglia|microglia
5778428|NCT00205608|PET|pet
5778429|NCT00205595|microglia|microglia
5778430|NCT00205595|PET|pet
5778431|NCT00205595|PK11195|pk11195
5778432|NCT00205582|Traumatic Brain Injury|traumatic brain injury
5778433|NCT00205582|PET|pet
5778434|NCT00205582|microglia|microglia
5778435|NCT00205569|brain injury, acute rehabilitation|brain injury, acute rehabilitation
5778436|NCT00205556|online hemodiafiltration|online hemodiafiltration
5778437|NCT00205556|low flux hemodialysis|low flux hemodialysis
5778438|NCT00205556|cardiovascular disease|cardiovascular disease
5778439|NCT00205556|endothelial dysfunction|endothelial dysfunction
5778440|NCT00205556|uremic toxicity|uremic toxicity
5778441|NCT00205556|quality of life|quality of life
5778442|NCT00205556|nutritional status|nutritional status
5778443|NCT00205543|obstructive sleep apnea|obstructive sleep apnea
5778444|NCT00205543|airway obstruction|airway obstruction
5778445|NCT00205543|sleep-disordered breathing|sleep-disordered breathing
5778446|NCT00205530|brain injury, family treatment|brain injury, family treatment
5778447|NCT00205504|Inflammatory markers, oral contraceptions, obesity, metabolic syndrome X|inflammatory markers, oral contraceptions, obesity, metabolic syndrome x
5778448|NCT00205491|depression after brain injury|depression after brain injury
5778449|NCT00205491|traumatic brain injury|traumatic brain injury
5778450|NCT00205491|Venlafaxine|venlafaxine
5778451|NCT00205426|Pulmonary hypertension in lung transplant recipients|pulmonary hypertension in lung transplant recipients
5778452|NCT00205413|surveillance for lung cancer|surveillance for lung cancer
5778453|NCT00205387|echocardiography|echocardiography
5778454|NCT00205387|cardiac elastography|cardiac elastography
5778455|NCT00205387|Normal volunteers|normal volunteers
5778456|NCT00205309|intubated patients|intubated patients
5778457|NCT00205283|HIV|hiv
5778458|NCT00205270|Pre or post-lung transplant|pre or post-lung transplant
5778459|NCT00205270|Healthy|healthy
5778460|NCT00205231|HIV|hiv
5778461|NCT00205192|Heart Failure|heart failure
5778462|NCT00205192|Cardiac resynchronization|cardiac resynchronization
5778463|NCT00205192|echocardiography|echocardiography
5778464|NCT00205166|adenosine tracer scans|adenosine tracer scans
5778465|NCT00205166|coronary artery disease|coronary artery disease
5778466|NCT00205166|caffeine|caffeine
5778467|NCT00205153|hypertension in African Americans|hypertension in african americans
5778468|NCT00205127|Cardiac PET imaging|cardiac pet imaging
5778469|NCT00205127|Radiopharmaceutical tracers|radiopharmaceutical tracers
5778470|NCT00205101|Transforaminal lumbar interbody fusion|transforaminal lumbar interbody fusion
5778471|NCT00205101|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5778472|NCT00205101|Isthmic spondylolisthesis, degenerative spondylolisthesis|isthmic spondylolisthesis, degenerative spondylolisthesis
5778473|NCT00205101|Pseudoarthritis|pseudoarthritis
5778474|NCT00205101|Severe Foraminal Stenosis|severe foraminal stenosis
5778475|NCT00205049|acute alcoholic hepatitis|acute alcoholic hepatitis
5778476|NCT00204997|Cervical Cancer|cervical cancer
5778477|NCT00204997|Squamous Cell|squamous cell
5778478|NCT00204997|Laparoscopy|laparoscopy
5778479|NCT00204997|Ovarian Function|ovarian function
5778480|NCT00204984|arterial stiffness|arterial stiffness
5778481|NCT00204984|echocardiography|echocardiography
5778482|NCT00204984|nesiritide|nesiritide
5778483|NCT00204958|bone marrow transplant (BMT)|bone marrow transplant (bmt)
5778484|NCT00204958|hematopoietic stem cell transplant (HSCT)|hematopoietic stem cell transplant (hsct)
5778485|NCT00204945|arterial stiffness|arterial stiffness
5778486|NCT00204945|echocardiography|echocardiography
5778487|NCT00204945|nesiritide|nesiritide
5778488|NCT00204945|high heart pressures|high heart pressures
5778489|NCT00204945|cardiac catheterization|cardiac catheterization
5778490|NCT00204919|osteoporosis|osteoporosis
5778491|NCT00204919|vitamin D deficiency|vitamin d deficiency
5778492|NCT00204867|colorectal|colorectal
5778493|NCT00204867|polyps|polyps
5778494|NCT00204763|manometry catheters|manometry catheters
5778495|NCT00204763|diffuse esophageal spasm or hypertensive LES|diffuse esophageal spasm or hypertensive les
5778496|NCT00204763|incontinence|incontinence
5778497|NCT00204750|lower esophageal ring|lower esophageal ring
5778498|NCT00204750|dysphagia|dysphagia
5778499|NCT00204750|electrosurgical incision|electrosurgical incision
5778500|NCT00204750|bougie dilation|bougie dilation
5778501|NCT00204750|GERD|gerd
5778502|NCT00204711|patients having outpatient surgery with sedation|patients having outpatient surgery with sedation
5778503|NCT00204711|patients having procedures with sedation|patients having procedures with sedation
5778504|NCT00204672|Asthma|asthma
5778505|NCT00204659|Rituximab|rituximab
5778506|NCT00204659|CHOP|chop
5778507|NCT00204659|DLBCL|dlbcl
5778508|NCT00204659|gastric lymphoma|gastric lymphoma
5778509|NCT00204594|mRNA|mrna
5778510|NCT00204594|vaccination|vaccination
5778511|NCT00204594|melanoma|melanoma
5778512|NCT00204581|Melanoma|melanoma
5778513|NCT00204581|Soft tissue metastases|soft tissue metastases
5778514|NCT00204581|Interleukin-2|interleukin-2
5686412|NCT00552279|papillomavirus|papillomavirus
5686413|NCT00552279|Human papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5686414|NCT00552266|Methylphenidate|methylphenidate
5686415|NCT00552266|Trichotillomania|trichotillomania
5686416|NCT00552266|Attention deficit|attention deficit
5686417|NCT00552214|Nucleic acid test|nucleic acid test
5686418|NCT00552214|HIV-1|hiv-1
5686419|NCT00552214|hepatitis|hepatitis
5686420|NCT00552214|HBV|hbv
5686421|NCT00552214|HCV|hcv
5686422|NCT00552214|TMA|tma
5778515|NCT00204555|nodular basal cell carcinoma|nodular basal cell carcinoma
5778516|NCT00204555|Imiquimod|imiquimod
5778517|NCT00204555|topical treatment|topical treatment
5778518|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic
5778519|NCT00204555|Antineoplastic Agents|antineoplastic agents
5778520|NCT00204555|Interferon Inducers|interferon inducers
5778521|NCT00204542|actinic keratosis|actinic keratosis
5778522|NCT00204542|diclofenac sodium|diclofenac sodium
5778523|NCT00204529|malignant melanoma|malignant melanoma
5778524|NCT00204529|adjuvant therapy|adjuvant therapy
5778525|NCT00204529|Adjuvants, Immunologic|adjuvants, immunologic
5778526|NCT00204516|vaccination|vaccination
5778527|NCT00204516|mRNA|mrna
5778528|NCT00204503|Bipolar I or II|bipolar i or ii
5778530|NCT00204503|Alcohol Abuse or Dependence|alcohol abuse or dependence
5778531|NCT00204503|Mental Health Issues|mental health issues
5778533|NCT00204490|isoflavones|isoflavones
5778534|NCT00204490|phytoestrogens|phytoestrogens
5778535|NCT00204490|prevention|prevention
5778536|NCT00204490|mammographic density|mammographic density
5778537|NCT00204490|bone density|bone density
5778538|NCT00204477|soy diet|soy diet
5778539|NCT00204477|breast cancer|breast cancer
5778540|NCT00204477|ovarian hormones|ovarian hormones
5778541|NCT00204477|breast density|breast density
5778542|NCT00204477|prevention|prevention
5778543|NCT00204464|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5778544|NCT00204464|Exercise|exercise
5778545|NCT00204451|emergency contraception|emergency contraception
5778546|NCT00204451|follicle|follicle
5778547|NCT00204451|ovulation|ovulation
5778548|NCT00204451|blood pressure|blood pressure
5778549|NCT00204451|Fertility Control|fertility control
5778550|NCT00204451|Inhibition of fertilization|inhibition of fertilization
5778551|NCT00204438|female contraception|female contraception
5778552|NCT00204438|oral contraceptive|oral contraceptive
5778553|NCT00204438|emergency contraceptive|emergency contraceptive
5778554|NCT00204438|ovary|ovary
5778555|NCT00204438|follicle|follicle
5778556|NCT00204438|ovulation|ovulation
5778557|NCT00204425|Osteoporosis|osteoporosis
5778558|NCT00204425|Bone|bone
5778559|NCT00204425|Exercise|exercise
5778560|NCT00204425|Soy|soy
5778561|NCT00204425|Isoflavone|isoflavone
5778562|NCT00204425|Phytoestrogen|phytoestrogen
5778563|NCT00204425|Menopause|menopause
5778564|NCT00204425|Lipids|lipids
5778565|NCT00204412|Cholesterol|cholesterol
5778566|NCT00204412|High density lipoprotein|high density lipoprotein
5778567|NCT00204412|Low density lipoprotein|low density lipoprotein
5778568|NCT00204412|Triglyceride|triglyceride
5778569|NCT00204412|Glucose|glucose
5778570|NCT00204412|Exercise|exercise
5778571|NCT00204412|Fitness|fitness
5778572|NCT00204412|Flax|flax
5778573|NCT00204412|Lignan|lignan
5778574|NCT00204412|Phytoestrogen|phytoestrogen
5778575|NCT00204412|bone|bone
5778576|NCT00204386|Posttraumatic Stress Disorder|posttraumatic stress disorder
5778577|NCT00204360|epilepsy|epilepsy
5778578|NCT00204347|risperidone|risperidone
5778579|NCT00204334|Kidney transplantation|kidney transplantation
5778580|NCT00204334|anemia|anemia
5778581|NCT00204334|vascular endothelium|vascular endothelium
5778582|NCT00204334|monocytes|monocytes
5778583|NCT00204334|apoptosis|apoptosis
5778584|NCT00204321|rejection|rejection
5778585|NCT00204321|vesselwall function|vesselwall function
5778586|NCT00204321|endothelial cell function|endothelial cell function
5778587|NCT00204321|monocytes|monocytes
5778589|NCT00204308|Pregnancy|pregnancy
5778590|NCT00204308|Mother-to-child transmission of HIV|mother-to-child transmission of hiv
5778591|NCT00204308|Drug resistance|drug resistance
5778592|NCT00204308|Nevirapine resistance|nevirapine resistance
5778593|NCT00204308|NNRTI resistance|nnrti resistance
5778594|NCT00204295|Brain neoplasms|brain neoplasms
5778595|NCT00204295|Positron-Emission Tomography|positron-emission tomography
5778596|NCT00204295|Amino Acids|amino acids
5778597|NCT00204295|Magnetic Resonance Imaging|magnetic resonance imaging
5778598|NCT00204282|Diabetes prevention|diabetes prevention
5778599|NCT00204269|Hypogonadism|hypogonadism
5778600|NCT00204269|Testosterone|testosterone
5777655|NCT00209352|Oral Acyclovir|oral acyclovir
5778601|NCT00204269|Substitution|substitution
5778602|NCT00204256|chronic kidney disease|chronic kidney disease
5778603|NCT00204256|anemia|anemia
5778604|NCT00204256|intravenous iron|intravenous iron
5778605|NCT00204256|recombinant human erythropoetin|recombinant human erythropoetin
5778606|NCT00204243|naltrexone implant|naltrexone implant
5778607|NCT00204243|methadone|methadone
5778608|NCT00204243|inmates|inmates
5778609|NCT00204243|randomized controlled trial|randomized controlled trial
5778610|NCT00204230|Kidney Failure, Chronic|kidney failure, chronic
5778611|NCT00204230|Kidney Transplantation|kidney transplantation
5778612|NCT00204217|cardiac arrest|cardiac arrest
5778613|NCT00204217|resuscitation|resuscitation
5778614|NCT00204217|ventilation|ventilation
5778615|NCT00204217|impedance|impedance
5778616|NCT00204204|multiple trauma|multiple trauma
5778617|NCT00204204|traffic accident|traffic accident
5778618|NCT00204204|outcome|outcome
5778619|NCT00204204|safety|safety
5778620|NCT00204204|injury severity|injury severity
5778621|NCT00204191|kidney transplantation|kidney transplantation
5778622|NCT00204191|Immunosuppression|immunosuppression
5778623|NCT00204191|Cyclosporine|cyclosporine
5778624|NCT00204191|Tacrolimus|tacrolimus
5778625|NCT00204178|Kidney transplantation|kidney transplantation
5778626|NCT00204178|Reperfusion injury|reperfusion injury
5778627|NCT00204152|Early onset depression|early onset depression
5778628|NCT00204152|early adversity|early adversity
5778629|NCT00204126|exercise testing|exercise testing
5778630|NCT00204126|treadmill|treadmill
5778631|NCT00204126|incomplete spinal cord injury|incomplete spinal cord injury
5778632|NCT00204126|novel methods|novel methods
5778633|NCT00204113|spinal cord injury|spinal cord injury
5778634|NCT00204113|standing|standing
5778636|NCT00204113|functional electrical stimulation|functional electrical stimulation
5778637|NCT00204100|paraplegia|paraplegia
5778638|NCT00204100|spinal cord injury|spinal cord injury
5778639|NCT00204100|functional electrical stimulation|functional electrical stimulation
5778641|NCT00204100|exercise|exercise
5778642|NCT00204100|cardiopulmonary fitness|cardiopulmonary fitness
5778643|NCT00204087|Schizophrenia|schizophrenia
5778644|NCT00204087|Psychosis|psychosis
5778645|NCT00204087|Prodrome|prodrome
5778646|NCT00204087|Early Initial Prodromal State|early initial prodromal state
5778647|NCT00204087|Early Intervention|early intervention
5778648|NCT00204087|Cognitive Behavioral Therapy|cognitive behavioral therapy
5778649|NCT00204074|Migraine|migraine
5778650|NCT00204074|Menstrual cycle|menstrual cycle
5778651|NCT00204074|17 beta-estradiol|17 beta-estradiol
5778652|NCT00204074|Transdermal administration|transdermal administration
5778653|NCT00204061|schizophrenia|schizophrenia
5778654|NCT00204061|psychosis|psychosis
5779065|NCT00201981|dry eye|dry eye
5778655|NCT00204061|ultra high risk|ultra high risk
5778656|NCT00204061|prodromal state|prodromal state
5778657|NCT00204061|early intervention|early intervention
5778658|NCT00204061|amisulpride|amisulpride
5778659|NCT00204048|Hospitalists|hospitalists
5778660|NCT00204035|Training early achievers for careers in health|training early achievers for careers in health
5778661|NCT00204022|Lupus nephritis|lupus nephritis
5778662|NCT00204022|Treatment|treatment
5778663|NCT00204022|Maintenance therapy|maintenance therapy
5778664|NCT00204022|Mycophenolate mofetil|mycophenolate mofetil
5778665|NCT00204022|Azathioprine|azathioprine
5778666|NCT00204009|children and adolescents|children and adolescents
5778667|NCT00204009|epidemiology|epidemiology
5778668|NCT00203996|polycystic ovary syndrome|polycystic ovary syndrome
5778669|NCT00203996|metabolic syndrome|metabolic syndrome
5778670|NCT00203996|obstructive sleep apnea|obstructive sleep apnea
5778671|NCT00203996|impaired glucose tolerance|impaired glucose tolerance
5778672|NCT00203996|insulin resistance|insulin resistance
5778673|NCT00203970|Thrombosis|thrombosis
5778674|NCT00203970|Low Molecular Weight Heparin|low molecular weight heparin
5778675|NCT00203957|Parkinson's Disease|parkinson's disease
5778676|NCT00203944|Adoption|adoption
5778677|NCT00203944|Stress Response|stress response
5778678|NCT00203944|Child Development|child development
5778679|NCT00203931|Non-small cell lung cancer|non-small cell lung cancer
5778680|NCT00203918|Prostate Cancer|prostate cancer
5778681|NCT00203918|Cost-Effectiveness Analysis|cost-effectiveness analysis
5778682|NCT00203918|Utility Assessment|utility assessment
5778683|NCT00203905|Head and Neck Cancer|head and neck cancer
5778684|NCT00203892|Adenocarcinoma|adenocarcinoma
5778685|NCT00203892|Pancreas|pancreas
5778686|NCT00203879|metastatic melanoma|metastatic melanoma
5778687|NCT00203866|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5778690|NCT00203853|medication adherance|medication adherance
5778691|NCT00203853|pillbox|pillbox
5778692|NCT00203853|wristwatch|wristwatch
5778693|NCT00203840|Sleep Disorders|sleep disorders
5778694|NCT00203827|Sleep Disorders|sleep disorders
5778695|NCT00203814|Malaria|malaria
5778696|NCT00203814|Efficacy|efficacy
5778697|NCT00203814|Pharmacokinetic|pharmacokinetic
5778698|NCT00203814|Gametocyte|gametocyte
5778699|NCT00203814|Molecular markers|molecular markers
5778700|NCT00203814|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5777749|NCT00209066|Platelet Activation|platelet activation
5778701|NCT00203814|Artesunate|artesunate
5778702|NCT00203814|Artemisinin|artemisinin
5778703|NCT00203801|Malaria|malaria
5778704|NCT00203801|Efficacy|efficacy
5778705|NCT00203801|Pharmacokinetic|pharmacokinetic
5778706|NCT00203801|Gametocyte|gametocyte
5778707|NCT00203801|Molecular markers|molecular markers
5778708|NCT00203801|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5778709|NCT00203801|Artesunate|artesunate
5778710|NCT00203801|Artemisinin|artemisinin
5778711|NCT00203788|work outcome|work outcome
5778712|NCT00203788|supported employment|supported employment
5778713|NCT00203788|social skills training|social skills training
5778714|NCT00203788|risperidone|risperidone
5778715|NCT00203788|cognition|cognition
5778716|NCT00203788|first-episode schizophrenia|first-episode schizophrenia
5778717|NCT00203762|Pragmatic cluster non-randomized controlled trial|pragmatic cluster non-randomized controlled trial
5778718|NCT00203762|antiretroviral treatment|antiretroviral treatment
5778719|NCT00203762|tuberculosis|tuberculosis
5778720|NCT00203762|childhood immunization|childhood immunization
5778721|NCT00203762|primary care|primary care
5778722|NCT00203762|resource-restricted settings|resource-restricted settings
5778725|NCT00203749|Counseling|counseling
5778726|NCT00203736|Malaria|malaria
5778728|NCT00203736|Pharmacokinetic|pharmacokinetic
5778729|NCT00203736|Gametocyte|gametocyte
5778730|NCT00203736|Molecular Markers|molecular markers
5778731|NCT00203736|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5778732|NCT00203736|Artesunate|artesunate
5778733|NCT00203736|Artemisinin|artemisinin
5778734|NCT00203723|mood disorder|mood disorder
5778735|NCT00203723|affective disorder|affective disorder
5778736|NCT00203723|depression|depression
5778737|NCT00203723|treatment-resistant|treatment-resistant
5778738|NCT00203710|Concentric Retriever Device|concentric retriever device
5778739|NCT00203710|embolectomy|embolectomy
5778740|NCT00203710|acute ischemic stroke|acute ischemic stroke
5778741|NCT00203710|treatment|treatment
5778742|NCT00203697|Eric Kleerup|eric kleerup
5778743|NCT00203697|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5778744|NCT00203671|renal|renal
5778745|NCT00203671|transplant|transplant
5778746|NCT00203671|kidney|kidney
5778747|NCT00203671|rejection|rejection
5778748|NCT00203671|MMF|mmf
5778749|NCT00203671|Mycophenolate Mofetil|mycophenolate mofetil
5778750|NCT00203671|outcomes|outcomes
5778751|NCT00203671|Kidney Transplantation|kidney transplantation
5778752|NCT00203645|Problem gambling|problem gambling
5778753|NCT00203645|Self-help manual|self-help manual
5778754|NCT00203645|Motivation enhancement|motivation enhancement
5778755|NCT00203645|Telephone support|telephone support
5778756|NCT00203645|Treatment|treatment
5778757|NCT00203645|Pathological gambling|pathological gambling
5778758|NCT00203632|diabetes mellitus|diabetes mellitus
5778759|NCT00203632|endothelium|endothelium
5778760|NCT00203632|thiazolidinediones|thiazolidinediones
5778761|NCT00203632|atherosclerosis|atherosclerosis
5778762|NCT00203593|exercise|exercise
5778763|NCT00203593|total peripheral resistance|total peripheral resistance
5778764|NCT00203593|venoconstriction|venoconstriction
5778765|NCT00203593|blood volume expansion|blood volume expansion
5778766|NCT00203593|orthostatic tolerance|orthostatic tolerance
5778767|NCT00203580|venous thromboembolism|venous thromboembolism
5778768|NCT00203580|low-molecular-weight heparin|low-molecular-weight heparin
5778769|NCT00203567|bipolar depression|bipolar depression
5778770|NCT00203567|carbamazepine ER|carbamazepine er
5778771|NCT00203567|Equetro|equetro
5778772|NCT00203554|osteoporosis|osteoporosis
5778773|NCT00203554|vertebra|vertebra
5778774|NCT00203554|fracture|fracture
5778775|NCT00203554|pain|pain
5778776|NCT00203554|percutaneous|percutaneous
5778777|NCT00203554|vertebroplasty|vertebroplasty
5778778|NCT00203554|polymethylmetacrylate|polymethylmetacrylate
5778779|NCT00203528|divalproex sodium|divalproex sodium
5778780|NCT00203528|risperidone|risperidone
5778781|NCT00203528|dual diagnosis|dual diagnosis
5778782|NCT00203528|substance use|substance use
5778783|NCT00203528|bipolar|bipolar
5778784|NCT00203515|Urinary Catheterization|urinary catheterization
5778785|NCT00203502|Operable and Locally advanced Breast Cancer|operable and locally advanced breast cancer
5778787|NCT00203476|niacin|niacin
5778788|NCT00203476|colestipol|colestipol
5778789|NCT00203476|hyperlipidemia|hyperlipidemia
5778790|NCT00203476|adjunct therapy|adjunct therapy
5778791|NCT00203476|zetia|zetia
5778792|NCT00203463|topiramate|topiramate
5778793|NCT00203463|PTSD|ptsd
5778794|NCT00203463|posttraumatic stress disorder|posttraumatic stress disorder
5778795|NCT00203463|topamax|topamax
5778796|NCT00203450|obesity|obesity
5778797|NCT00203450|zonisamide|zonisamide
5778798|NCT00203450|zonegran|zonegran
5778799|NCT00203450|psychotropic weight gain|psychotropic weight gain
5778800|NCT00203450|psychotropic|psychotropic
5778801|NCT00203385|divalproex sodium, depakote, ptsd, long-term ptsd treatments|divalproex sodium, depakote, ptsd, long-term ptsd treatments
5778802|NCT00203333|Epilepsy|epilepsy
5778803|NCT00203281|renal transplantation|renal transplantation
5778804|NCT00203268|migraine|migraine
5686423|NCT00552214|HIV Seronegativity|hiv seronegativity
5778805|NCT00203268|cutaneous allodynia|cutaneous allodynia
5778806|NCT00203255|Menstrually-Associated Migraine|menstrually-associated migraine
5778807|NCT00203229|Double-Blind|double-blind
5778808|NCT00203229|Placebo-Controlled|placebo-controlled
5778809|NCT00203203|Autologous|autologous
5778810|NCT00203203|Cardiac|cardiac
5778811|NCT00203203|Stem Cell|stem cell
5778812|NCT00203203|Transplant|transplant
5778813|NCT00203047|Multiple Sclerosis|multiple sclerosis
5778814|NCT00203047|brain atrophy|brain atrophy
5778815|NCT00203047|Glatiramer Acetate|glatiramer acetate
5778816|NCT00203047|Copaxone|copaxone
5778817|NCT00203047|Steroids|steroids
5778818|NCT00203047|Prednisone|prednisone
5778819|NCT00202969|Stomach cancer|stomach cancer
5778820|NCT00202943|TCRFVR, LAUP, Snorer|tcrfvr, laup, snorer
5778821|NCT00202930|neuroblastoma|neuroblastoma
5778822|NCT00202930|Opsoclonus-myoclonus|opsoclonus-myoclonus
5778823|NCT00202930|rituximab|rituximab
5778824|NCT00202917|haploidentical transplantation|haploidentical transplantation
5778825|NCT00202917|immunomagnetic cell sorting|immunomagnetic cell sorting
5778826|NCT00202917|allogeneic hematopoietic cell transplantation|allogeneic hematopoietic cell transplantation
5778827|NCT00202917|dose reduced conditioning|dose reduced conditioning
5778828|NCT00202904|ezetimibe|ezetimibe
5778830|NCT00202904|hypercholesterolemia|hypercholesterolemia
5778831|NCT00202904|coronary heart disease|coronary heart disease
5778832|NCT00202891|pyoderma|pyoderma
5778833|NCT00202891|sisomicin|sisomicin
5778834|NCT00202891|nadifloxacin|nadifloxacin
5778835|NCT00202878|hypercholesterolemia|hypercholesterolemia
5778836|NCT00202878|myocardial infarction|myocardial infarction
5778837|NCT00202878|cholesterol|cholesterol
5778838|NCT00202878|randomized controlled trials|randomized controlled trials
5778839|NCT00202878|acute coronary syndrome|acute coronary syndrome
5778840|NCT00202878|angina|angina
5778841|NCT00202813|CVC|cvc
5778842|NCT00202813|central venous catheter|central venous catheter
5778843|NCT00202813|infection|infection
5778844|NCT00202813|bloodstream infection|bloodstream infection
5778845|NCT00202813|catheter infection|catheter infection
5778846|NCT00202813|pediatric|pediatric
5778847|NCT00202813|children|children
5778848|NCT00202813|antibiotic impregnated catheters|antibiotic impregnated catheters
5778849|NCT00202800|Pancreatic Cancer|pancreatic cancer
5778850|NCT00202800|Gemcitabine/Etoposide|gemcitabine/etoposide
5778851|NCT00202800|Ras-mutation|ras-mutation
5778852|NCT00202787|colorectal cancer|colorectal cancer
5778853|NCT00202787|cetuximab|cetuximab
5778854|NCT00202787|FOLFOX4|folfox4
5778855|NCT00202774|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil|colorectal cancer, capecitabine, oxaliplatin, 5-fluorouracil
5778856|NCT00202761|Cerebral palsy|cerebral palsy
5778857|NCT00202761|Functional training|functional training
5778858|NCT00202761|preschool children|preschool children
5778859|NCT00202761|Gross Motor Functional Classification Level|gross motor functional classification level
5778860|NCT00202761|Gross motor functional Measure test|gross motor functional measure test
5778861|NCT00202761|Pediatric Evaluation of Disability Inventory|pediatric evaluation of disability inventory
5778862|NCT00202761|Parental Stress Index|parental stress index
5778863|NCT00202748|metabolic syndrome|metabolic syndrome
5778864|NCT00202748|lifestyle|lifestyle
5778865|NCT00202748|obesity|obesity
5778866|NCT00202735|shoulder dislocation|shoulder dislocation
5778867|NCT00202735|anterior|anterior
5778868|NCT00202735|traumatic|traumatic
5778869|NCT00202735|primary|primary
5778870|NCT00202735|first time|first time
5778871|NCT00202735|initial|initial
5778872|NCT00202735|immobilization|immobilization
5778873|NCT00202735|external|external
5778874|NCT00202735|rotation|rotation
5778875|NCT00202722|Remifentanil, parenteral opioids, obstetric analgesia, IVPCA|remifentanil, parenteral opioids, obstetric analgesia, ivpca
5778876|NCT00202709|Anxiety disorder|anxiety disorder
5778877|NCT00202709|Thought Field Therapy|thought field therapy
5778878|NCT00202709|Psychotherapy|psychotherapy
5778879|NCT00202709|Agoraphobia|agoraphobia
5778880|NCT00202709|Social Phobia|social phobia
5778881|NCT00202709|Post Traumatic Stress Disorder|post traumatic stress disorder
5778883|NCT00202683|Anoxemia|anoxemia
5778884|NCT00202683|Mitochondria|mitochondria
5778885|NCT00202683|Reflex|reflex
5778886|NCT00202683|Genetic research|genetic research
5778887|NCT00202670|coronary artery disease|coronary artery disease
5778888|NCT00202670|stress myocardial scintigraphy|stress myocardial scintigraphy
5778889|NCT00202670|stress echocardiography|stress echocardiography
5778890|NCT00202657|parkinson's disease|parkinson's disease
5778891|NCT00202657|pergolide|pergolide
5778892|NCT00202657|heart valve disease|heart valve disease
5778893|NCT00202631|tetraplegia|tetraplegia
5778894|NCT00202631|quadriplegia|quadriplegia
5778895|NCT00202631|spinal cord injury|spinal cord injury
5778896|NCT00202631|functional electrical stimulation|functional electrical stimulation
5778897|NCT00202631|abdominal stimulation|abdominal stimulation
5778898|NCT00202618|Hypertension|hypertension
5778899|NCT00202618|Type 2 diabetes mellitus|type 2 diabetes mellitus
5778900|NCT00202618|Microalbuminuria|microalbuminuria
5778901|NCT00202618|Amlodipine|amlodipine
5778902|NCT00202618|Calcium channel blocker|calcium channel blocker
5778903|NCT00202618|Valsartan|valsartan
5778904|NCT00202618|Angiotensin type 2 receptor blocker|angiotensin type 2 receptor blocker
5778905|NCT00202527|Sleep apnea|sleep apnea
5778906|NCT00202527|Hypertension|hypertension
5778907|NCT00202527|CPAP|cpap
5778908|NCT00202514|alcoholism|alcoholism
5778909|NCT00202514|alcohol related disorders|alcohol related disorders
5778910|NCT00202514|mood disorders|mood disorders
5778911|NCT00202514|anticonvulsants|anticonvulsants
5778912|NCT00202514|divalproex sodium|divalproex sodium
5778913|NCT00202488|anemia, iron-deficiency|anemia, iron-deficiency
5778914|NCT00202488|Helicobacter pylori|helicobacter pylori
5778915|NCT00202475|Dubble eerythrocytapheresis|dubble eerythrocytapheresis
5778916|NCT00202462|testosterone|testosterone
5778917|NCT00202462|depression|depression
5778918|NCT00202462|subsyndromal depression|subsyndromal depression
5778919|NCT00202462|quality of life|quality of life
5778920|NCT00202449|Prazosin|prazosin
5778921|NCT00202449|Paroxetine|paroxetine
5778922|NCT00202449|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5778923|NCT00202449|Sleep Disorders|sleep disorders
5778924|NCT00202423|Multiple sclerosis|multiple sclerosis
5778925|NCT00202423|Cannabinoids|cannabinoids
5778927|NCT00202423|fMRI|fmri
5778928|NCT00202423|TMS|tms
5778929|NCT00202410|Multiple Sclerosis|multiple sclerosis
5778930|NCT00202410|Tuberculosis vaccine|tuberculosis vaccine
5778931|NCT00202410|Therapy|therapy
5778932|NCT00202397|cerebellar ataxia|cerebellar ataxia
5778933|NCT00202397|deep cerebellar nuclei (DCN)|deep cerebellar nuclei (dcn)
5778934|NCT00202397|small-conductance calcium-activated potassium(SK)channels|small-conductance calcium-activated potassium(sk)channels
5778936|NCT00202397|Sporadic ataxia|sporadic ataxia
5778937|NCT00202397|Multiple system atrophy type C|multiple system atrophy type c
5778938|NCT00202384|Multiple Sclerosis|multiple sclerosis
5778939|NCT00202384|microarrays|microarrays
5778940|NCT00202371|MDS, Fatigue, RBC transfusion|mds, fatigue, rbc transfusion
5778941|NCT00202358|perioperative|perioperative
5778942|NCT00202358|beta-blockers|beta-blockers
5778943|NCT00202358|inflammation|inflammation
5778944|NCT00202358|outcomes|outcomes
5778945|NCT00202345|Creatinine Clearance|creatinine clearance
5778946|NCT00202345|Hemoglobin|hemoglobin
5778947|NCT00202345|Iron sucrose|iron sucrose
5778948|NCT00202345|Oral iron therapy|oral iron therapy
5778949|NCT00202345|Ferritin|ferritin
5778950|NCT00202345|Transferrin saturation|transferrin saturation
5778952|NCT00202319|sedation|sedation
5778953|NCT00202319|mechanical ventilation|mechanical ventilation
5778954|NCT00202319|sedation protocols|sedation protocols
5778955|NCT00202319|critical care|critical care
5778956|NCT00202319|intensive care outcomes|intensive care outcomes
5778957|NCT00202319|staffing|staffing
5778958|NCT00202306|at risk mental state|at risk mental state
5778959|NCT00202306|prodrome|prodrome
5778960|NCT00202306|ultra high risk|ultra high risk
5778961|NCT00202306|first episode psychosis|first episode psychosis
5778962|NCT00202306|schizophrenia|schizophrenia
5778963|NCT00202306|bipolar disorder|bipolar disorder
5778964|NCT00202293|Bipolar|bipolar
5778965|NCT00202293|Mania|mania
5778966|NCT00202293|Drug treatment|drug treatment
5778967|NCT00202293|First episode|first episode
5778968|NCT00202293|Psychosis|psychosis
5778969|NCT00202293|Therapy|therapy
5778970|NCT00202293|Antipsychotic|antipsychotic
5778971|NCT00202267|leg ulcer, compression, bandage, APBI, venous insufficiency|leg ulcer, compression, bandage, apbi, venous insufficiency
5778972|NCT00202254|Mulitple Sclerosis|mulitple sclerosis
5778973|NCT00202254|MS|ms
5778974|NCT00202241|HIV|hiv
5778975|NCT00202241|AIDS|aids
5778976|NCT00202241|testosterone|testosterone
5778977|NCT00202241|anabolic steroid|anabolic steroid
5778978|NCT00202241|body composition|body composition
5778979|NCT00202241|lipodystrophy|lipodystrophy
5778980|NCT00202241|MRI|mri
5778981|NCT00202241|BIA|bia
5778982|NCT00202241|skinfold measurements|skinfold measurements
5778983|NCT00202241|protease inhibitors|protease inhibitors
5778985|NCT00202228|HIV/AIDS|hiv/aids
5778986|NCT00202228|Lactic Acidosis|lactic acidosis
5778987|NCT00202228|Supplementation|supplementation
5778988|NCT00202228|Lactate Clearance|lactate clearance
5778989|NCT00202228|Mitochondrial Toxicity|mitochondrial toxicity
5778990|NCT00202228|HAART|haart
5778991|NCT00202215|Day hospital treatment|day hospital treatment
5778992|NCT00202202|personality disorder|personality disorder
5778993|NCT00202202|user satisfaction|user satisfaction
5778994|NCT00202189|COPD|copd
5778995|NCT00202189|Pulmicort|pulmicort
5778996|NCT00202189|Budesonide|budesonide
5778997|NCT00202189|Chronic|chronic
5778998|NCT00202189|Obstructive|obstructive
5778999|NCT00202189|Pulmonary|pulmonary
5779000|NCT00202189|Disease|disease
5779001|NCT00202189|Exercise|exercise
5779002|NCT00202189|Emphysema|emphysema
5779003|NCT00202176|Chronic|chronic
5779004|NCT00202176|Obstructive|obstructive
5779005|NCT00202176|Pulmonary|pulmonary
5779006|NCT00202176|Disease|disease
5779007|NCT00202176|COPD|copd
5779008|NCT00202176|Atrovent|atrovent
5686424|NCT00552201|kidney transplantation|kidney transplantation
5779009|NCT00202176|Ipratropium|ipratropium
5779010|NCT00202176|Bromide|bromide
5779011|NCT00202176|Exercise|exercise
5779012|NCT00202176|Dyspnea|dyspnea
5779013|NCT00202163|ED|ed
5779014|NCT00202163|DHEA|dhea
5779015|NCT00202163|testosterone|testosterone
5779016|NCT00202150|Advanced chronic diseases|advanced chronic diseases
5779017|NCT00202150|Heart failure|heart failure
5779018|NCT00202150|Chronic obstructive lung disease|chronic obstructive lung disease
5779019|NCT00202150|primary care|primary care
5779020|NCT00202150|Chronic Care|chronic care
5779021|NCT00202137|Home Blood Pressure, Hypertension, Blood Pressure Control|home blood pressure, hypertension, blood pressure control
5779022|NCT00202111|Clinical Trial|clinical trial
5779023|NCT00202111|Colonic Neoplasms|colonic neoplasms
5779024|NCT00202111|Laparoscopic Surgery|laparoscopic surgery
5779025|NCT00202111|Morbidity|morbidity
5779026|NCT00202111|Port Site Metastasis|port site metastasis
5779027|NCT00202111|Disease-Free Survival|disease-free survival
5779029|NCT00202098|mechanical ventilation|mechanical ventilation
5779030|NCT00202098|variable ventilation|variable ventilation
5779031|NCT00202098|chaotic ventilation|chaotic ventilation
5779032|NCT00202072|lung|lung
5779033|NCT00202072|airway|airway
5779035|NCT00202072|mucus|mucus
5779036|NCT00202059|Breast cancer|breast cancer
5779037|NCT00202059|Bone mineral density|bone mineral density
5779038|NCT00202059|Chemotherapy|chemotherapy
5779039|NCT00202046|Breast cancer|breast cancer
5779040|NCT00202046|Lymphedema|lymphedema
5779041|NCT00202046|Quality of life|quality of life
5779043|NCT00202033|comprehensive|comprehensive
5779044|NCT00202033|diabetes|diabetes
5779045|NCT00202033|education|education
5779046|NCT00202033|program|program
5779047|NCT00202020|Cerebral infarction|cerebral infarction
5779048|NCT00202020|Prevention|prevention
5779049|NCT00202020|Cilostazol|cilostazol
5779050|NCT00202020|Aspirin|aspirin
5779051|NCT00202020|Stroke|stroke
5779052|NCT00202020|Clinical trial|clinical trial
5779053|NCT00202007|Aripiprazole|aripiprazole
5779054|NCT00202007|Schizophrenia|schizophrenia
5779055|NCT00202007|Clinical trial|clinical trial
5779056|NCT00202007|Risperidone|risperidone
5779057|NCT00201994|Sodium|sodium
5779058|NCT00201994|SIADH|siadh
5779059|NCT00201994|Vasopressin|vasopressin
5779061|NCT00201994|Cirrhosis|cirrhosis
5779062|NCT00201994|salt|salt
5779063|NCT00201994|water|water
5779064|NCT00201994|electrolyte|electrolyte
5779066|NCT00201981|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5779067|NCT00201955|dry eye|dry eye
5779068|NCT00201955|keratoconjunctivitis sicca|keratoconjunctivitis sicca
5779069|NCT00201942|Breast Cancer|breast cancer
5779070|NCT00201942|Diagnosis|diagnosis
5779071|NCT00201942|PET|pet
5779072|NCT00201942|Positronic Emission Tomography|positronic emission tomography
5779073|NCT00201942|fluorodeoxyglucose|fluorodeoxyglucose
5779074|NCT00201929|breast cancer|breast cancer
5779075|NCT00201929|decision aid|decision aid
5779076|NCT00201929|Decision Board|decision board
5779077|NCT00201929|information transfer|information transfer
5779078|NCT00201916|prostate cancer|prostate cancer
5779079|NCT00201916|prostate specific antigen|prostate specific antigen
5779081|NCT00201916|radiation fractionation|radiation fractionation
5779082|NCT00201903|venous thromboembolism|venous thromboembolism
5779083|NCT00201903|brain tumours|brain tumours
5779084|NCT00201903|glioma|glioma
5779085|NCT00201903|tissue factor|tissue factor
5779086|NCT00201903|blood coagulation|blood coagulation
5779087|NCT00201903|tumour progression|tumour progression
5779088|NCT00201903|low molecular weight heparin|low molecular weight heparin
5779089|NCT00201890|Breast Cancer|breast cancer
5779090|NCT00201890|Lymphedema|lymphedema
5779091|NCT00201890|Treatment|treatment
5779092|NCT00201890|Massage|massage
5779093|NCT00201890|Randomized|randomized
5779094|NCT00201890|DLT therapy|dlt therapy
5779095|NCT00201890|Quality of Life|quality of life
5779096|NCT00201890|Decongestive Therapy|decongestive therapy
5779097|NCT00201890|Breast Cancer related Lymphedema|breast cancer related lymphedema
5779098|NCT00201877|Relapsed/Refractory|relapsed/refractory
5779099|NCT00201877|NHL|nhl
5779100|NCT00201877|Follicular|follicular
5779101|NCT00201877|Mantle Cell|mantle cell
5779102|NCT00201877|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5779103|NCT00201864|Postmenopausal|postmenopausal
5779104|NCT00201864|Women|women
5779105|NCT00201851|Asian|asian
5779106|NCT00201851|Premenopausal|premenopausal
5779107|NCT00201851|Women|women
5779108|NCT00201851|Oophorectomy|oophorectomy
5779109|NCT00201838|Advanced Stage|advanced stage
5779110|NCT00201838|Chemotherapy Naive|chemotherapy naive
5779111|NCT00201825|Previously Untreated|previously untreated
5779112|NCT00201825|Advanced|advanced
5779113|NCT00201812|Advanced Solid Tumors|advanced solid tumors
5779114|NCT00201799|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5779115|NCT00201786|Corticosteroids|corticosteroids
5779116|NCT00201773|Post-Menopause|post-menopause
5779117|NCT00201773|Neoadjuvant Therapy|neoadjuvant therapy
5779118|NCT00201760|metastatic|metastatic
5779119|NCT00201747|Advanced|advanced
5779120|NCT00201734|Adenocarcinoma|adenocarcinoma
5779121|NCT00201721|Previously Untreated|previously untreated
5779122|NCT00201708|Adjuvant Trial|adjuvant trial
5779123|NCT00201708|Dose-Dense|dose-dense
5779124|NCT00201708|Axillary Node-Positive|axillary node-positive
5779125|NCT00201695|Untreated Patients|untreated patients
5779126|NCT00201695|Symptomatic|symptomatic
5779127|NCT00201682|Leukemia|leukemia
5779128|NCT00201682|Lymphoma|lymphoma
5779129|NCT00201669|Aggressive|aggressive
5779130|NCT00201669|Clofarabine|clofarabine
5779131|NCT00201656|PPROM|pprom
5779132|NCT00201656|Cerclage|cerclage
5779133|NCT00201656|Preterm Premature Rupture of the Membranes with Cerclage|preterm premature rupture of the membranes with cerclage
5779134|NCT00201643|Preterm Labor|preterm labor
5779135|NCT00201643|Preterm delivery|preterm delivery
5779136|NCT00201630|Prostate|prostate
5779137|NCT00201630|cancer|cancer
5779138|NCT00201630|Brachytherapy|brachytherapy
5779139|NCT00201630|Alpha Blocker|alpha blocker
5779140|NCT00201617|Unilateral hearing loss|unilateral hearing loss
5779141|NCT00201617|Unilateral deafness|unilateral deafness
5779142|NCT00201617|Bone anchored hearing aid|bone anchored hearing aid
5779143|NCT00201591|Coronary artery disease|coronary artery disease
5779144|NCT00201591|Exercise training|exercise training
5779146|NCT00201591|Randomized|randomized
5779147|NCT00201591|echocardiography|echocardiography
5779148|NCT00201591|Aerobic Exercise|aerobic exercise
5779149|NCT00201578|Herbal Drugs|herbal drugs
5779150|NCT00201578|Alternative medicine|alternative medicine
5779151|NCT00201565|pulse wave velocity|pulse wave velocity
5779152|NCT00201565|cardiovascular disease|cardiovascular disease
5779153|NCT00201539|analgesics, opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
5779154|NCT00201539|humans|humans
5779155|NCT00201539|morphine/therapeutic use*|morphine/therapeutic use*
5779156|NCT00201539|neoplasms|neoplasms
5779157|NCT00201539|pain/drugtherapy|pain/drugtherapy
5779158|NCT00201526|Bipolar Disorder|bipolar disorder
5779159|NCT00201513|Muscle, Skeletal|muscle, skeletal
5779160|NCT00201513|Neuromuscular control|neuromuscular control
5779161|NCT00201513|Stability|stability
5779162|NCT00201513|Exercise|exercise
5779163|NCT00201513|Anticipatory muscle control|anticipatory muscle control
5779164|NCT00201474|brief depressive episodes|brief depressive episodes
5779165|NCT00201474|affective disorders|affective disorders
5779166|NCT00201474|EEG and QEEG|eeg and qeeg
5779167|NCT00201474|epilepsy|epilepsy
5779173|NCT00201461|Septal Closure System|septal closure system
5779175|NCT00201461|Cerebrovascular Accident|cerebrovascular accident
5779176|NCT00201461|Transient Ischemic Attack|transient ischemic attack
5779177|NCT00201461|Heart Septal Defects, Atrial|heart septal defects, atrial
5779178|NCT00201448|CMV, cytomegalovirus, vaccine, Towne strain|cmv, cytomegalovirus, vaccine, towne strain
5779179|NCT00201435|Breast|breast
5779180|NCT00201435|Cancer|cancer
5779181|NCT00201435|Paclitaxel|paclitaxel
5779182|NCT00201435|Docetaxel|docetaxel
5779183|NCT00201435|Qulaity of life|qulaity of life
5779184|NCT00201422|MALT lymphoma|malt lymphoma
5779185|NCT00201422|diffuse large B-cell lymphoma,|diffuse large b-cell lymphoma,
5779186|NCT00201422|stomach|stomach
5779187|NCT00201422|Helicobacter pylori|helicobacter pylori
5779188|NCT00201422|antibiotic therapy|antibiotic therapy
5779189|NCT00201396|A Multicenter Phase III Trial|a multicenter phase iii trial
5779190|NCT00201396|Induction Chemotherapy|induction chemotherapy
5779191|NCT00201396|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5779192|NCT00201396|Stage IV Nasopharyngeal Carcinoma (NPC)|stage iv nasopharyngeal carcinoma (npc)
5779193|NCT00201396|randomization|randomization
5779194|NCT00201396|disease-free survival|disease-free survival
5779195|NCT00201370|cervical neoplasia;|cervical neoplasia;
5779196|NCT00201370|human papillomavirus,|human papillomavirus,
5779197|NCT00201370|PCR,|pcr,
5779198|NCT00201370|risk factors,|risk factors,
5779199|NCT00201370|Taiwan|taiwan
5779200|NCT00201357|hormone-refractory prostate cancer|hormone-refractory prostate cancer
5779202|NCT00201357|quality of life|quality of life
5779203|NCT00201344|Radiotherapy|radiotherapy
5779204|NCT00201344|Adjuvant chemotherapy|adjuvant chemotherapy
5779205|NCT00201344|Chemtherapy|chemtherapy
5779206|NCT00201344|Nasopharyngeal Carcinoma|nasopharyngeal carcinoma
5779207|NCT00201292|Metabolic syndrome|metabolic syndrome
5779208|NCT00201292|Diabetes|diabetes
5779209|NCT00201292|Insulin resistance|insulin resistance
5779210|NCT00201292|pharmacogenetics|pharmacogenetics
5779211|NCT00201201|Older Adults|older adults
5779212|NCT00201201|Primary Care|primary care
5779213|NCT00201201|Hypertension|hypertension
5779214|NCT00201201|Adherence|adherence
5779215|NCT00201136|Behavioral intervention|behavioral intervention
5779216|NCT00201136|Lifestyle modification|lifestyle modification
5779217|NCT00201136|Guidelines|guidelines
5779218|NCT00201110|African Americans|african americans
5779219|NCT00201058|urban|urban
5779220|NCT00201058|adolescents|adolescents
5779221|NCT00201058|African American|african american
5779222|NCT00201058|web-based|web-based
5779223|NCT00201058|computer tailoring|computer tailoring
5779224|NCT00201058|school based|school based
5779225|NCT00201045|Hypertension management|hypertension management
5779226|NCT00201045|Pharmacist management|pharmacist management
5779227|NCT00201045|Physician pharmacist collaboration|physician pharmacist collaboration
5779228|NCT00201045|Blood pressure control|blood pressure control
5779229|NCT00200954|prospective|prospective
5779230|NCT00200954|intervention|intervention
5779231|NCT00200954|randomised|randomised
5779232|NCT00200954|probiotics|probiotics
5779233|NCT00200954|atopy|atopy
5779234|NCT00200941|Restless Legs Syndrome|restless legs syndrome
5779235|NCT00200941|Topiramate|topiramate
5779236|NCT00200941|Actigraphy|actigraphy
5779237|NCT00200941|Polysomnography|polysomnography
5779238|NCT00200928|prospective|prospective
5779239|NCT00200928|randomised|randomised
5779240|NCT00200928|intervention|intervention
5779241|NCT00200928|BCG|bcg
5779242|NCT00200928|atopy|atopy
5779243|NCT00200902|Major depressive disorder|major depressive disorder
5779244|NCT00200902|MDD|mdd
5779245|NCT00200902|Antidepressant|antidepressant
5779252|NCT00200876|Positron-Emission Tomography|positron-emission tomography
5779253|NCT00200876|Endorphins|endorphins
5779254|NCT00200876|Pain Relief|pain relief
5779255|NCT00200876|Opioid Receptors|opioid receptors
5779256|NCT00200876|Stress|stress
5779257|NCT00200876|Analgesia|analgesia
5779258|NCT00200863|light|light
5779259|NCT00200863|wavelength|wavelength
5779260|NCT00200863|action spectrum|action spectrum
5779261|NCT00200863|circadian|circadian
5779262|NCT00200863|melatonin|melatonin
5779268|NCT00200850|Mites, House Dust|mites, house dust
5779269|NCT00200837|oral mucosal pain|oral mucosal pain
5779270|NCT00200837|oral inflammations|oral inflammations
5779271|NCT00200837|anisillo|anisillo
5779272|NCT00200837|cordonsillo|cordonsillo
5779273|NCT00200837|Piperaceae|piperaceae
5779274|NCT00200837|oral ulcers|oral ulcers
5779275|NCT00200837|oral tumors|oral tumors
5779276|NCT00200837|mucosal pain|mucosal pain
5779277|NCT00200837|mucosal inflammations|mucosal inflammations
5779278|NCT00200837|cordoncillo|cordoncillo
5779279|NCT00200824|isoflavones|isoflavones
5779280|NCT00200824|soy|soy
5779281|NCT00200824|postmenopausal|postmenopausal
5779282|NCT00200824|men|men
5779283|NCT00200824|prostate|prostate
5779284|NCT00200824|breast|breast
5779285|NCT00200824|bone|bone
5779286|NCT00200798|Milk Thistle|milk thistle
5779287|NCT00200798|Silymarin|silymarin
5779288|NCT00200798|pharmacokinetics|pharmacokinetics
5779289|NCT00200798|drug interactions|drug interactions
5779290|NCT00200798|Normal volunteers|normal volunteers
5779291|NCT00200785|garlic|garlic
5779292|NCT00200759|Vaccinium macrocarpon|vaccinium macrocarpon
5779293|NCT00200759|Antioxidants|antioxidants
5779294|NCT00200759|Drug Interactions|drug interactions
5779295|NCT00200746|Hepatitis|hepatitis
5779296|NCT00200746|Liver Diseases|liver diseases
5779297|NCT00200746|Alcoholism|alcoholism
5779298|NCT00200746|Arginine|arginine
5779299|NCT00200733|acupuncture|acupuncture
5779300|NCT00200733|patient narratives|patient narratives
5779301|NCT00200733|qualitative methods|qualitative methods
5779302|NCT00200720|Diet|diet
5789039|NCT00150150|adverse effects|adverse effects
5779303|NCT00200720|Carbohydrates|carbohydrates
5779304|NCT00200720|Weight Loss|weight loss
5779305|NCT00200707|Cell therapy|cell therapy
5779306|NCT00200707|bone marrow mononuclear cells|bone marrow mononuclear cells
5779307|NCT00200707|myocardial infarction|myocardial infarction
5779308|NCT00200694|Proteinuria|proteinuria
5779309|NCT00200694|ACEI|acei
5779310|NCT00200694|ARB|arb
5779311|NCT00200694|diuretics|diuretics
5779312|NCT00200694|blood pressure|blood pressure
5779313|NCT00200694|renal failure|renal failure
5779314|NCT00200681|Secretory Multiple Myeloma|secretory multiple myeloma
5779315|NCT00200681|First line treatment|first line treatment
5779316|NCT00200681|Velcade®|velcade®
5779317|NCT00200681|autograft|autograft
5779318|NCT00200681|Newly diagnosed secretory Multiple Myeloma (MM)|newly diagnosed secretory multiple myeloma (mm)
5779319|NCT00200642|Gastroesophageal reflux. PPI. Radiofrequency|gastroesophageal reflux. ppi. radiofrequency
5779320|NCT00200629|Women|women
5779321|NCT00200629|Diagnostic Testing|diagnostic testing
5779322|NCT00200629|Radionuclide Imaging|radionuclide imaging
5779323|NCT00200629|Stress Testing|stress testing
5779324|NCT00200629|Adenosine|adenosine
5779325|NCT00200616|Urinary tract infection|urinary tract infection
5779326|NCT00200616|Vesico-renal reflux|vesico-renal reflux
5779327|NCT00200616|Child|child
5779328|NCT00200616|Antimicrobial prophylaxis|antimicrobial prophylaxis
5779329|NCT00200616|Recurrence of urinary tract infection|recurrence of urinary tract infection
5779330|NCT00200603|Calcium phosphate ceramic|calcium phosphate ceramic
5779331|NCT00200603|tibial osteotomy|tibial osteotomy
5779332|NCT00200603|osteoarthritis|osteoarthritis
5779333|NCT00200590|prostaglandin|prostaglandin
5779334|NCT00200590|analgesia|analgesia
5779335|NCT00200590|congenital|congenital
5779336|NCT00200590|heart|heart
5779337|NCT00200590|defect|defect
5779338|NCT00200590|induced|induced
5779339|NCT00200577|Adjuvant therapy|adjuvant therapy
5779340|NCT00200577|immunotherapy|immunotherapy
5686425|NCT00552201|Tacrolimus|tacrolimus
5779341|NCT00200577|TIL|til
5779342|NCT00200577|melanoma|melanoma
5779343|NCT00200564|Pediatrics|pediatrics
5779344|NCT00200564|ketamine|ketamine
5779345|NCT00200564|postoperative analgesia|postoperative analgesia
5779346|NCT00200564|nalbuphine|nalbuphine
5779347|NCT00200564|Postoperative analgesia in children|postoperative analgesia in children
5779348|NCT00200538|frontotemporal dementia|frontotemporal dementia
5779349|NCT00200538|Mémantine|mémantine
5779350|NCT00200538|Patients with frontotemporal dementia|patients with frontotemporal dementia
5779351|NCT00200499|Nebivolol|nebivolol
5779352|NCT00200499|Hypertension|hypertension
5779353|NCT00200499|Beta-Blocker|beta-blocker
5779354|NCT00200486|genetic microarray|genetic microarray
5779355|NCT00200486|head and neck cancer|head and neck cancer
5779356|NCT00200473|Nebivolol|nebivolol
5779357|NCT00200473|Hypertension|hypertension
5779358|NCT00200473|Beta-Blockers|beta-blockers
5779359|NCT00200460|Nebivolol|nebivolol
5779360|NCT00200460|Hypertension|hypertension
5779361|NCT00200460|Beta-Blocker|beta-blocker
5779362|NCT00200447|Parkinson|parkinson
5779363|NCT00200447|brain imaging|brain imaging
5779364|NCT00200434|Nebivolol|nebivolol
5779366|NCT00200434|Hypertension|hypertension
5779367|NCT00200421|Nebivolol|nebivolol
5779368|NCT00200421|Atenolol|atenolol
5779369|NCT00200421|Exercise|exercise
5779370|NCT00200421|Hypertension|hypertension
5779371|NCT00200408|cancer of head and neck|cancer of head and neck
5779372|NCT00200408|smoking|smoking
5779375|NCT00200369|Antiretroviral therapy|antiretroviral therapy
5779376|NCT00200369|Protease inhibitor|protease inhibitor
5779377|NCT00200369|Lopinavir|lopinavir
5779378|NCT00200343|Chronic hepatitis C, Ursodeoxycholic acid|chronic hepatitis c, ursodeoxycholic acid
5779379|NCT00200330|weight loss|weight loss
5779380|NCT00200330|physical activity|physical activity
5779381|NCT00200330|diet|diet
5779382|NCT00200330|home environment|home environment
5779383|NCT00200317|Exercise|exercise
5779384|NCT00200317|Internet|internet
5779385|NCT00200317|Print|print
5779386|NCT00200317|Randomized Controlled Trial|randomized controlled trial
5779387|NCT00200317|Exercise Intervention|exercise intervention
5779388|NCT00200304|Obesity|obesity
5779389|NCT00200304|Weight loss|weight loss
5779390|NCT00200304|Internet|internet
5779391|NCT00200278|Exercise|exercise
5779392|NCT00200278|Intervention studies|intervention studies
5779393|NCT00200278|Decision-making|decision-making
5779394|NCT00200278|computer assisted Expert systems|computer assisted expert systems
5779395|NCT00200278|telephone|telephone
5779396|NCT00200252|oxytocin|oxytocin
5779397|NCT00200252|third stage|third stage
5779398|NCT00200252|dose|dose
5779399|NCT00200252|route|route
5779400|NCT00200252|blood loss|blood loss
5779401|NCT00200226|pain/discomfort|pain/discomfort
5779402|NCT00200226|cervical dilatation|cervical dilatation
5779403|NCT00200226|side effects|side effects
5779404|NCT00200200|BEVACIZUMAB (AVASTIN)|bevacizumab (avastin)
5779405|NCT00200200|DEXAMETHASONE|dexamethasone
5681089|NCT00574769|recurrent prostate cancer|recurrent prostate cancer
5779406|NCT00200200|FLOXURIDINE|floxuridine
5779407|NCT00200200|FLUOROURACIL|fluorouracil
5779408|NCT00200200|IRINOTECAN (CPT-11) CAMPTOSAR|irinotecan (cpt-11) camptosar
5779409|NCT00200200|LEUCOVORIN|leucovorin
5779410|NCT00200200|OXALIPLATIN|oxaliplatin
5779411|NCT00200200|Colon|colon
5779412|NCT00200200|Rectal|rectal
5779413|NCT00200200|04-086|04-086
5779414|NCT00200200|Adjuvant postoperative chemo for CLM|adjuvant postoperative chemo for clm
5779415|NCT00200187|Prostatectomy|prostatectomy
5779416|NCT00200187|Anesthesia|anesthesia
5779417|NCT00200187|Blood Loss|blood loss
5779418|NCT00200174|Breast cancer|breast cancer
5779419|NCT00200174|estrogen|estrogen
5779420|NCT00200174|postmenopausal|postmenopausal
5779421|NCT00200148|Pancreaticoduodenectomy|pancreaticoduodenectomy
5779422|NCT00200148|Hepatectomy|hepatectomy
5779423|NCT00200148|Major Hepatic resection|major hepatic resection
5779424|NCT00200148|Acute Normovolemic Hemodilution|acute normovolemic hemodilution
5779425|NCT00200135|motorcycle accident|motorcycle accident
5779426|NCT00200135|helmet|helmet
5779427|NCT00200135|traumatic brain injury|traumatic brain injury
5779428|NCT00200135|financial burden|financial burden
5779429|NCT00200096|Cancer|cancer
5779430|NCT00200096|Fatigue|fatigue
5779431|NCT00200083|Obesity|obesity
5779432|NCT00200083|Morbid Obesity|morbid obesity
5779433|NCT00200083|SHAPE|shape
5779434|NCT00200083|IGS|igs
5779435|NCT00200083|Implantable Gastric Stimulator|implantable gastric stimulator
5779436|NCT00200070|Angina Pectoris Pain|angina pectoris pain
5779437|NCT00200057|Fecal Incontinence|fecal incontinence
5779438|NCT00200057|InterStim|interstim
5779439|NCT00200044|GERD|gerd
5779440|NCT00200018|Obesity|obesity
5779441|NCT00200018|Morbid obesity|morbid obesity
5779442|NCT00200018|Diabetes|diabetes
5779443|NCT00200005|Slow transit constipation|slow transit constipation
5779444|NCT00200005|Fecal incontinence|fecal incontinence
5779445|NCT00200005|Constipation|constipation
5779446|NCT00200005|Idiopathic slow transit constipation|idiopathic slow transit constipation
5779447|NCT00200005|Chronic constipation|chronic constipation
5779448|NCT00199992|acute wounds|acute wounds
5779449|NCT00199992|wounds|wounds
5779450|NCT00199992|platelets|platelets
5779451|NCT00199992|platelet gel|platelet gel
5779452|NCT00199979|Antiretroviral Therapy|antiretroviral therapy
5779453|NCT00199979|Nevirapine|nevirapine
5779454|NCT00199979|HIV Viral Load|hiv viral load
5779455|NCT00199979|Adherence|adherence
5779456|NCT00199979|Quality of Life|quality of life
5779457|NCT00199979|Resistance Mutations|resistance mutations
5779458|NCT00199966|Bipolar Disorder; Pediatric Bipolar Disorder; Depakote ER|bipolar disorder; pediatric bipolar disorder; depakote er
5779459|NCT00199953|Postnasal drainage|postnasal drainage
5779460|NCT00199953|Extraesophageal reflux|extraesophageal reflux
5779461|NCT00199940|Schizophrenia|schizophrenia
5779462|NCT00199940|Pediatric psychotic disorders|pediatric psychotic disorders
5779463|NCT00199940|Ziprasidone|ziprasidone
5779464|NCT00199914|Diathermy|diathermy
5779465|NCT00199914|Short-wave therapy|short-wave therapy
5779466|NCT00199914|Osteoarthritis|osteoarthritis
5779467|NCT00199914|Knee|knee
5779469|NCT00199901|Randomized Controlled Trial|randomized controlled trial
5779470|NCT00199901|Double-Blind|double-blind
5779471|NCT00199901|Cancer Vaccine|cancer vaccine
5779472|NCT00199901|NY-ESO-1 protein, human|ny-eso-1 protein, human
5779473|NCT00199901|ISCOMATRIX, immunological adjuvant|iscomatrix, immunological adjuvant
5779474|NCT00199888|Kidney Cancer|kidney cancer
5779475|NCT00199888|Renal Cancer|renal cancer
5779476|NCT00199888|Neoplasms, Kidney|neoplasms, kidney
5779477|NCT00199888|cG250|cg250
5779481|NCT00199875|renal cell carcinoma|renal cell carcinoma
5779482|NCT00199875|advanced renal cancer|advanced renal cancer
5779483|NCT00199875|cG250|cg250
5779484|NCT00199875|^90Y|^90y
5779485|NCT00199862|huA33|hua33
5779486|NCT00199862|antibody|antibody
5779487|NCT00199862|colorectal cancer|colorectal cancer
5779488|NCT00199862|Iodine 124|iodine 124
5779489|NCT00199862|124I|124i
5779490|NCT00199862|03-124|03-124
5779491|NCT00199849|NY-ESO-1|ny-eso-1
5779493|NCT00199836|cancer vaccine|cancer vaccine
5779494|NCT00199836|NY-ESO-1b peptide|ny-eso-1b peptide
5779495|NCT00199836|CpG 7909|cpg 7909
5779496|NCT00199836|Montanide ISA-51|montanide isa-51
5779497|NCT00199836|LAGE-1|lage-1
5779498|NCT00199836|immune response|immune response
5779499|NCT00199836|safety|safety
5779500|NCT00199823|Myocardial infarction|myocardial infarction
5779501|NCT00199823|bone marrow cells|bone marrow cells
5779502|NCT00199823|cell transplantation|cell transplantation
5779503|NCT00199810|Cardiac output|cardiac output
5779504|NCT00199810|Preeclamptic women|preeclamptic women
5779505|NCT00199810|systemic vascular resistance|systemic vascular resistance
5779506|NCT00199810|blood pressure|blood pressure
5779507|NCT00199797|Colorectal Cancer|colorectal cancer
5779508|NCT00199797|huA33|hua33
5779509|NCT00199797|antibody|antibody
5779510|NCT00199797|chemotherapy|chemotherapy
5779511|NCT00199784|Hemodynamic|hemodynamic
5779512|NCT00199784|Hypotension|hypotension
5779513|NCT00199784|Spinal|spinal
5779514|NCT00199784|Anesthesia|anesthesia
5779515|NCT00199784|Healthy pregnant women for elective cesarean section|healthy pregnant women for elective cesarean section
5779516|NCT00199771|Cardiac Surgery|cardiac surgery
5779517|NCT00199771|Infant|infant
5779518|NCT00199771|Infant, Newborn|infant, newborn
5779519|NCT00199771|Hypertonic Solutions|hypertonic solutions
5779520|NCT00199771|Saline Solution, Hypertonic|saline solution, hypertonic
5779521|NCT00199771|Capillary leak|capillary leak
5779522|NCT00199771|Inflammation Mediators|inflammation mediators
5779523|NCT00199758|Non small cell lung carcinoma|non small cell lung carcinoma
5779524|NCT00199758|Cisplatin|cisplatin
5779525|NCT00199758|Gemcitabine|gemcitabine
5779526|NCT00199758|Paclitaxel|paclitaxel
5779527|NCT00199745|statin|statin
5779528|NCT00199745|statins|statins
5779529|NCT00199745|statin therapy|statin therapy
5779530|NCT00199745|adverse events|adverse events
5779531|NCT00199745|side effect|side effect
5779532|NCT00199745|Myotoxicity|myotoxicity
5779533|NCT00199745|atorvastatin|atorvastatin
5779534|NCT00199745|Atorvastatin Therapy|atorvastatin therapy
5779535|NCT00199732|Chronic hepatitis B|chronic hepatitis b
5779536|NCT00199732|CCC DNA kinetics|ccc dna kinetics
5779537|NCT00199732|Total HBV DNA kinetics|total hbv dna kinetics
5779538|NCT00199732|Adefovir-Dipovixil|adefovir-dipovixil
5779539|NCT00199732|Peg interferon alpha 2a|peg interferon alpha 2a
5779540|NCT00199719|drug monitoring|drug monitoring
5779541|NCT00199719|ribavirin-pharmacokinetic|ribavirin-pharmacokinetic
5779542|NCT00199719|pharmacodynamics|pharmacodynamics
5779543|NCT00199719|chronic hepatitis C|chronic hepatitis c
5779544|NCT00199719|non 2 non 3 genotype|non 2 non 3 genotype
5779545|NCT00199706|Intracranial Pressure|intracranial pressure
5779546|NCT00199706|Intracranial Hypertension|intracranial hypertension
5779547|NCT00199706|Hypertonic Solutions|hypertonic solutions
5779548|NCT00199706|Saline Solutions, Hypertonic|saline solutions, hypertonic
5779549|NCT00199693|Hemodynamic and respiratory changes and pregnancy|hemodynamic and respiratory changes and pregnancy
5779550|NCT00199693|Healthy pregnant women|healthy pregnant women
5779551|NCT00199680|PETscan, cervical cancer|petscan, cervical cancer
5779552|NCT00199667|MMF, Monitoring, area under curve (AUC), kidney transplantation|mmf, monitoring, area under curve (auc), kidney transplantation
5779553|NCT00199654|colorectal cancer stage II and III|colorectal cancer stage ii and iii
5779554|NCT00199628|fetomaternal tissular alloimmunization|fetomaternal tissular alloimmunization
5779555|NCT00199628|Mothers having a child suffering from:|mothers having a child suffering from:
5779556|NCT00199628|neonatal membranous glomerulonephritis|neonatal membranous glomerulonephritis
5779557|NCT00199628|unexplained neonatal tubular defect|unexplained neonatal tubular defect
5779558|NCT00199628|unexplained thrombotic microangiopathy|unexplained thrombotic microangiopathy
5779559|NCT00199628|neonatal hemochromatosis|neonatal hemochromatosis
5779560|NCT00199615|lung cancer, 18 FDG, PET|lung cancer, 18 fdg, pet
5779561|NCT00199589|Spastic equinovarus|spastic equinovarus
5779562|NCT00199589|Botox|botox
5779563|NCT00199589|Ankle foot orthosis|ankle foot orthosis
5779564|NCT00199576|Corticosteroids|corticosteroids
5779565|NCT00199576|Laryngotracheal injury|laryngotracheal injury
5779567|NCT00199563|Viagra|viagra
5779568|NCT00199563|sildenafil|sildenafil
5779569|NCT00199550|Transurethral Resection of Prostate|transurethral resection of prostate
5779570|NCT00199550|TURP|turp
5779571|NCT00199524|ureteroscopy|ureteroscopy
5779572|NCT00199524|stone free|stone free
5779573|NCT00199511|Brain Tumor|brain tumor
5779574|NCT00199511|Intracranial Pressure|intracranial pressure
5779575|NCT00199511|Osmolarity|osmolarity
5779576|NCT00199511|Seric|seric
5779577|NCT00199511|Hypertonic Solution|hypertonic solution
5779578|NCT00199498|Permanent Pacemaker Implantation- Lead Position|permanent pacemaker implantation- lead position
5779579|NCT00199485|prostate cancer|prostate cancer
5779580|NCT00199485|Luteinizing Hormone Releasing Hormone|luteinizing hormone releasing hormone
5779581|NCT00199485|LHRH|lhrh
5779582|NCT00199459|calculi|calculi
5779583|NCT00199459|proteomics|proteomics
5779584|NCT00199446|Sleep -Sleep Disorder|sleep -sleep disorder
5779585|NCT00199446|Sleep- Restless Legs Syndrome|sleep- restless legs syndrome
5779586|NCT00199446|Clinical Trial|clinical trial
5779587|NCT00199433|Parkinson's Disease|parkinson's disease
5779588|NCT00199433|Movement Disorder|movement disorder
5779589|NCT00199433|Neurology,|neurology,
5779590|NCT00199433|Clinical Trial|clinical trial
5779591|NCT00199420|levodopa|levodopa
5779592|NCT00199420|end of dose wearing off|end of dose wearing off
5779593|NCT00199420|OFF time|off time
5779594|NCT00199407|Parkinson's disease|parkinson's disease
5779595|NCT00199407|levodopa|levodopa
5779596|NCT00199407|end of dose wearing off|end of dose wearing off
5779597|NCT00199407|OFF time|off time
5779598|NCT00199394|KW-6002 (istradefylline)|kw-6002 (istradefylline)
5779599|NCT00199394|Entacapone|entacapone
5779600|NCT00199394|Placebo|placebo
5779601|NCT00199394|Parkinson's Disease|parkinson's disease
5779602|NCT00199394|Motor Response Complications|motor response complications
5779603|NCT00199394|Levodopa Therapy|levodopa therapy
5779604|NCT00199381|Parkinson's Disease|parkinson's disease
5779605|NCT00199381|levodopa|levodopa
5779606|NCT00199381|end of dose wearing off|end of dose wearing off
5779607|NCT00199381|OFF time|off time
5779608|NCT00199368|Parkinson's disease|parkinson's disease
5779609|NCT00199368|levodopa|levodopa
5779610|NCT00199368|end of dose wearing off|end of dose wearing off
5779611|NCT00199368|OFF time|off time
5779612|NCT00199355|Parkinson's Disease|parkinson's disease
5779613|NCT00199355|levodopa|levodopa
5779614|NCT00199355|end of dose wearing off|end of dose wearing off
5779615|NCT00199355|OFF time|off time
5779616|NCT00199342|Melanoma|melanoma
5779617|NCT00199342|Monoclonal Antibody|monoclonal antibody
5779618|NCT00199342|Anti-GD-3|anti-gd-3
5779619|NCT00199329|ondansetron|ondansetron
5779621|NCT00199316|patient who recieve kidney surgery and Patient controlled anesthesia with spinal morphine, intrathecal|patient who recieve kidney surgery and patient controlled anesthesia with spinal morphine, intrathecal
5779622|NCT00199303|NMDAreceptor antagonist, dextromethorphan|nmdareceptor antagonist, dextromethorphan
5779623|NCT00199303|pain, post-operative|pain, post-operative
5779624|NCT00199303|opioid consumption, morphine|opioid consumption, morphine
5779625|NCT00199290|Trafermin|trafermin
5779626|NCT00199290|Periodontitis|periodontitis
5779627|NCT00199264|antifungal oral therapy|antifungal oral therapy
5779628|NCT00199264|efficacy acute candidiasis vulvaginitis|efficacy acute candidiasis vulvaginitis
5779629|NCT00199251|URTICARIA, WHEALS, FLARE, ANTIHISTAMINE, ANTIHISTAMINE|urticaria, wheals, flare, antihistamine, antihistamine
5779630|NCT00199238|ANTIHISTAMINE|antihistamine
5779631|NCT00199238|RUPATADINE|rupatadine
5779632|NCT00199238|WHEAL|wheal
5779633|NCT00199238|FLARE|flare
5779634|NCT00199238|DERMATOLOGY|dermatology
5779635|NCT00199225|Thorough study QT/QTc|thorough study qt/qtc
5779636|NCT00199225|Cardiac repolarization|cardiac repolarization
5779637|NCT00199225|QT prolongation|qt prolongation
5779638|NCT00199212|HER-2 positive|her-2 positive
5779639|NCT00199212|metastatic breast cancer patients|metastatic breast cancer patients
5779640|NCT00199173|colorectal cancer|colorectal cancer
5779641|NCT00199173|liver metastasis|liver metastasis
5779642|NCT00199173|intraarterial hepatic injection|intraarterial hepatic injection
5779643|NCT00199173|yttrium loaded microspheres|yttrium loaded microspheres
5788533|NCT00153361|HIV|hiv
5779644|NCT00199173|colorectal neoplasm metastatic to the liver|colorectal neoplasm metastatic to the liver
5779645|NCT00199160|local recurrence and or metastatic disease|local recurrence and or metastatic disease
5779646|NCT00199160|Previously treated with platinum|previously treated with platinum
5779647|NCT00199160|carcinoma of the head and neck|carcinoma of the head and neck
5779648|NCT00199134|neoadjuvant treatment|neoadjuvant treatment
5779649|NCT00199108|CNS relapse|cns relapse
5779651|NCT00199108|Treatment|treatment
5779653|NCT00199095|Elderly|elderly
5779654|NCT00199095|Chemotherapy|chemotherapy
5779655|NCT00199082|High-grade NHL|high-grade nhl
5779656|NCT00199082|De novo|de novo
5779657|NCT00199082|Mature B-ALL|mature b-all
5779658|NCT00199082|Burkitt'S NHL|burkitt's nhl
5779659|NCT00199082|Chemotherapy|chemotherapy
5779660|NCT00199082|Rituximab|rituximab
5779661|NCT00199082|Primary mediastinal diffuse large cell lymphoma|primary mediastinal diffuse large cell lymphoma
5774548|NCT00224263|Lingzhi|lingzhi
5779662|NCT00199082|B-precursor lymphoblastic lymphoma|b-precursor lymphoblastic lymphoma
5779664|NCT00199069|Treatment|treatment
5779665|NCT00199069|De Novo|de novo
5779666|NCT00199069|Adult|adult
5779667|NCT00199056|ALL|all
5779668|NCT00199056|Treatment|treatment
5779669|NCT00199056|De Novo|de novo
5779670|NCT00199056|Adult|adult
5779671|NCT00199030|Relapse|relapse
5779672|NCT00199030|T-ALL|t-all
5779673|NCT00199030|T-LBL|t-lbl
5779674|NCT00199030|MabCampath|mabcampath
5779675|NCT00199030|Minimal residual disease|minimal residual disease
5779785|NCT00198588|thrombosis|thrombosis
5779676|NCT00199030|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
5779677|NCT00199017|T-LBL|t-lbl
5779678|NCT00199017|Treatment|treatment
5779679|NCT00199017|De novo|de novo
5779680|NCT00199017|Chemotherapy|chemotherapy
5779681|NCT00199017|Adult|adult
5779682|NCT00199017|Lymphoma, lymphoblastic, T-cell|lymphoma, lymphoblastic, t-cell
5779683|NCT00199004|ALL|all
5779684|NCT00199004|Treatment|treatment
5779685|NCT00199004|De novo|de novo
5779686|NCT00199004|Minimal residual disease|minimal residual disease
5779687|NCT00199004|Rituximab|rituximab
5779688|NCT00199004|Adult|adult
5779689|NCT00198991|ALL|all
5779690|NCT00198991|Treatment|treatment
5779691|NCT00198991|de novo|de novo
5779692|NCT00198991|Minimal residual disease|minimal residual disease
5779693|NCT00198991|Adult|adult
5779694|NCT00198978|ALL|all
5779695|NCT00198978|Treatment|treatment
5779696|NCT00198978|Elderly|elderly
5779697|NCT00198978|De novo|de novo
5779698|NCT00198939|drug prevention|drug prevention
5779699|NCT00198939|adolescence|adolescence
5779700|NCT00198939|middle school|middle school
5779701|NCT00198939|randomized trial|randomized trial
5779702|NCT00198939|family therapy|family therapy
5779703|NCT00198939|cognitive-behavioral|cognitive-behavioral
5779704|NCT00198939|efficacy|efficacy
5779705|NCT00198939|selected youth|selected youth
5779706|NCT00198939|indicated youth|indicated youth
5779707|NCT00198887|newborn|newborn
5779708|NCT00198887|operations research|operations research
5779709|NCT00198887|newborn survival|newborn survival
5779710|NCT00198887|Neonatal illness/mortality|neonatal illness/mortality
5779711|NCT00198887|Delivery complications|delivery complications
5779712|NCT00198874|drug abuse|drug abuse
5779713|NCT00198874|drug dependence|drug dependence
5779714|NCT00198874|treatment|treatment
5779715|NCT00198874|randomized trial|randomized trial
5779716|NCT00198874|stage II study|stage ii study
5779717|NCT00198874|adolescents|adolescents
5779718|NCT00198874|young adults|young adults
5779719|NCT00198874|efficacy study|efficacy study
5779720|NCT00198861|HIV Epidemiology|hiv epidemiology
5779721|NCT00198861|Neurology|neurology
5779722|NCT00198861|Neuropsychological|neuropsychological
5779723|NCT00198861|HIV Risk Factors|hiv risk factors
5779724|NCT00198861|Cognitive Risk Factors|cognitive risk factors
5779725|NCT00198861|HIV|hiv
5779726|NCT00198848|Iron deficiency anemia|iron deficiency anemia
5779727|NCT00198848|Adolescent girls|adolescent girls
5779728|NCT00198848|India|india
5779729|NCT00198835|malnutrition|malnutrition
5779730|NCT00198835|anemia|anemia
5779731|NCT00198835|infants|infants
5779732|NCT00198835|children|children
5779733|NCT00198835|India|india
5779734|NCT00198822|Maternal mortality|maternal mortality
5779735|NCT00198822|Infant mortality|infant mortality
5779736|NCT00198822|Vitamin A|vitamin a
5779737|NCT00198822|Beta-carotene|beta-carotene
5779738|NCT00198822|Micronutrients|micronutrients
5779739|NCT00198822|Bangladesh|bangladesh
5779740|NCT00198822|Neonatal mortality|neonatal mortality
5779741|NCT00198731|maternal health|maternal health
5779742|NCT00198731|Bangladesh|bangladesh
5779743|NCT00198731|care seeking|care seeking
5779744|NCT00198718|Vitamin A supplementation|vitamin a supplementation
5779746|NCT00198718|Mother to child transmission of HIV|mother to child transmission of hiv
5779747|NCT00198718|Breastfeeding|breastfeeding
5779748|NCT00198692|amputation|amputation
5779749|NCT00198692|depression|depression
5779750|NCT00198692|pain|pain
5779751|NCT00198692|anxiety|anxiety
5779752|NCT00198692|self-management|self-management
5779753|NCT00198692|secondary conditions|secondary conditions
5779754|NCT00198679|skin cleansing|skin cleansing
5779755|NCT00198679|Bangladesh|bangladesh
5779756|NCT00198679|Skin Flora|skin flora
5779757|NCT00198679|Newborn|newborn
5779758|NCT00198679|infectious disease|infectious disease
5779759|NCT00198679|chlorhexidine|chlorhexidine
5779760|NCT00198666|Pneumonia|pneumonia
5779761|NCT00198666|zinc|zinc
5779762|NCT00198653|Hypothermia|hypothermia
5779763|NCT00198653|Newborn|newborn
5779764|NCT00198653|India|india
5779765|NCT00198653|Maternal/Child Health|maternal/child health
5779766|NCT00198653|Infant|infant
5779767|NCT00198653|Kangaroo Mother Care|kangaroo mother care
5779768|NCT00198640|animal antibiotics|animal antibiotics
5779769|NCT00198640|human antibiotics|human antibiotics
5779770|NCT00198627|Neonatal bacterial infection|neonatal bacterial infection
5779771|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists
5779772|NCT00198614|Carvedilol|carvedilol
5779773|NCT00198614|Metoprolol|metoprolol
5779774|NCT00198614|Coronary Artery Bypass|coronary artery bypass
5779775|NCT00198614|Atrial Fibrillation|atrial fibrillation
5779776|NCT00198601|meningitis|meningitis
5779777|NCT00198601|neonatal deaths|neonatal deaths
5779778|NCT00198601|gentamicin|gentamicin
5779779|NCT00198601|Uniject|uniject
5779780|NCT00198601|aminoglycoside|aminoglycoside
5779781|NCT00198588|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5779782|NCT00198588|argatroban|argatroban
5779783|NCT00198588|cardiac surgery|cardiac surgery
5779784|NCT00198588|acute coronary syndrome|acute coronary syndrome
5779787|NCT00198588|anticoagulation|anticoagulation
5779788|NCT00198575|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5779789|NCT00198575|cardiovascular surgery|cardiovascular surgery
5779790|NCT00198575|percutaneous coronary intervention|percutaneous coronary intervention
5779791|NCT00198562|Antihypertensive therapy|antihypertensive therapy
5779792|NCT00198562|Home blood pressure|home blood pressure
5779793|NCT00198562|Systolic blood pressure|systolic blood pressure
5779794|NCT00198562|Morning blood pressure|morning blood pressure
5779795|NCT00198562|Calcium antagonist|calcium antagonist
5779796|NCT00198562|Angiotensin receptor antagonist|angiotensin receptor antagonist
5779797|NCT00198549|Adjuvants, Anesthesia|adjuvants, anesthesia
5779798|NCT00198549|hyaluronate lyase|hyaluronate lyase
5779799|NCT00198523|Cataract Extraction|cataract extraction
5779800|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents
5779801|NCT00198523|Steroids|steroids
5779802|NCT00198484|Adjuvants, Anesthesia|adjuvants, anesthesia
5779803|NCT00198484|Spreading Factor|spreading factor
5779804|NCT00198445|Cataract Extraction|cataract extraction
5779805|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal
5779806|NCT00198393|stage IIIB/IV NSCLC|stage iiib/iv nsclc
5779807|NCT00198393|patients with performance status 2 or 3.|patients with performance status 2 or 3.
5779808|NCT00198380|Adenocarcinoma, Bronchiolo-Alveolar|adenocarcinoma, bronchiolo-alveolar
5789528|NCT00148161|Stuttering|stuttering
5779809|NCT00198367|operable and resectable stage IIIA (T1-3, N2) NSCLC|operable and resectable stage iiia (t1-3, n2) nsclc
5779810|NCT00198341|Post-surgical Non-small cell lung cancer|post-surgical non-small cell lung cancer
5779811|NCT00198328|Squamous Cell Carcinoma|squamous cell carcinoma
5779812|NCT00198328|carcinoma|carcinoma
5779813|NCT00198328|head and neck cancer|head and neck cancer
5779814|NCT00198328|larynx|larynx
5779815|NCT00198328|electroporation|electroporation
5779816|NCT00198328|medpulser|medpulser
5779817|NCT00198328|bleomycin|bleomycin
5779818|NCT00198328|cancer|cancer
5779819|NCT00198328|Locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx|locally recurrent or second primary squamous cell carcinoma of the base of the tongue, posterior lateral pharyngeal wall, hypopharynx, or larynx
5779820|NCT00198315|Squamous Cell Carcinoma|squamous cell carcinoma
5779821|NCT00198315|Carcinoma|carcinoma
5779822|NCT00198315|Head and Neck Cancer|head and neck cancer
5779823|NCT00198315|Oral|oral
5779824|NCT00198315|Soft Palate|soft palate
5779825|NCT00198315|Cancer|cancer
5779826|NCT00198315|Medpulser|medpulser
5779827|NCT00198315|Electroporation|electroporation
5779828|NCT00198315|Local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil|local recurrent or second primary squamous cell carcinoma of anterior oral cavity, soft palate, or tonsil
5779829|NCT00198302|staphylococcus aureus|staphylococcus aureus
5779830|NCT00198302|bacteremia|bacteremia
5779831|NCT00198302|sepsis|sepsis
5779832|NCT00198289|Cystic Fibrosis|cystic fibrosis
5779833|NCT00198289|Staphylococcus aureus|staphylococcus aureus
5779834|NCT00198289|lungs|lungs
5779835|NCT00198276|cancer|cancer
5779836|NCT00198276|cutaneous|cutaneous
5779837|NCT00198276|subcutaneous|subcutaneous
5779838|NCT00198276|MedPulser|medpulser
5779839|NCT00198276|bleomycin|bleomycin
5779840|NCT00198276|electroporation|electroporation
5779841|NCT00198276|Cutaneous or subcutaneous cancer|cutaneous or subcutaneous cancer
5779842|NCT00198263|head and neck cancer|head and neck cancer
5779843|NCT00198263|cancer|cancer
5779844|NCT00198263|bleomycin|bleomycin
5779845|NCT00198263|medpulser|medpulser
5779846|NCT00198263|electroporation|electroporation
5686426|NCT00552201|P450 3A5 cytochrome|p450 3a5 cytochrome
5686427|NCT00552201|genotype|genotype
5779847|NCT00198263|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors|primary oral cavity, primary pharyngeal, primary laryngeal, salivary gland, limited recurrent and second primary tumors
5779848|NCT00198250|Breast cancer survivorship|breast cancer survivorship
5779849|NCT00198250|hot flashes|hot flashes
5779850|NCT00198250|treatment|treatment
5779851|NCT00198237|Breast Cancer|breast cancer
5779852|NCT00198237|Stage II Breast Cancer|stage ii breast cancer
5779853|NCT00198237|Stage III Breast Cancer|stage iii breast cancer
5779854|NCT00198224|immunosuppression|immunosuppression
5779855|NCT00198185|Full Thickness Tendon Defect of Rotator Cuff|full thickness tendon defect of rotator cuff
5779856|NCT00198172|Germ Cell Tumor|germ cell tumor
5779857|NCT00198172|Refractory Germ Cell Tumors|refractory germ cell tumors
5779858|NCT00198172|Cisplatin plus Epirubicin Salvage Chemotherapy|cisplatin plus epirubicin salvage chemotherapy
5779859|NCT00198159|Refractory Germ Cell Tumors|refractory germ cell tumors
5779860|NCT00198159|Germ Cell Tumors|germ cell tumors
5779861|NCT00198133|Thymoma|thymoma
5779862|NCT00198133|Thymic Carcinoma|thymic carcinoma
5779863|NCT00198120|Autistic Disorder|autistic disorder
5779864|NCT00198120|cycloserine|cycloserine
5779865|NCT00198120|pharmacology|pharmacology
5779866|NCT00198120|glutamatergic agents|glutamatergic agents
5779867|NCT00198120|communication|communication
5779868|NCT00198120|social interaction|social interaction
5779869|NCT00198120|Double-Blind Method|double-blind method
5779870|NCT00198107|Children|children
5779871|NCT00198107|Adolescents|adolescents
5779872|NCT00198107|Aripiprazole|aripiprazole
5779873|NCT00198107|Cycloserine|cycloserine
5779874|NCT00198107|Aggression|aggression
5779875|NCT00198107|Irritability|irritability
5779876|NCT00198107|Self-Injurious Behavior|self-injurious behavior
5779877|NCT00198107|Social Interaction|social interaction
5779878|NCT00198107|Antipsychotics|antipsychotics
5779879|NCT00198107|Pharmacology|pharmacology
5779880|NCT00198107|Glutamatergic Agents|glutamatergic agents
5779881|NCT00198081|celecoxib for pancreas lesions|celecoxib for pancreas lesions
5779882|NCT00198068|Pregnancy outcomes|pregnancy outcomes
5779883|NCT00198068|Systemic lupus erythematosus|systemic lupus erythematosus
5779884|NCT00198068|Antiphospholipid syndrome|antiphospholipid syndrome
5779885|NCT00198055|Aggression|aggression
5779886|NCT00198055|Behavioral symptoms|behavioral symptoms
5779887|NCT00198042|ACL|acl
5779888|NCT00198042|Tunnel|tunnel
5779889|NCT00198042|Widening|widening
5779890|NCT00198029|Osteoarthritis|osteoarthritis
5779891|NCT00198029|Hyaluronan|hyaluronan
5779892|NCT00198029|Carpometacarpal|carpometacarpal
5779893|NCT00198029|Outcomes|outcomes
5779894|NCT00198016|coronary fistulas.|coronary fistulas.
5779895|NCT00198016|coils embolization.|coils embolization.
5779896|NCT00198003|hip arthritis|hip arthritis
5779897|NCT00198003|total hip arthroplasty|total hip arthroplasty
5779898|NCT00198003|expectations|expectations
5779899|NCT00198003|education|education
5779900|NCT00197990|total hip arthroplasty|total hip arthroplasty
5779901|NCT00197990|expectations|expectations
5779902|NCT00197990|satisfaction|satisfaction
5779903|NCT00197990|quality of life|quality of life
5779904|NCT00197977|knee arthritis|knee arthritis
5779905|NCT00197977|total knee arthroplasty|total knee arthroplasty
5779906|NCT00197977|expectations|expectations
5779907|NCT00197977|education|education
5779908|NCT00197964|Self-management|self-management
5779909|NCT00197964|Self-efficacy|self-efficacy
5779910|NCT00197964|Quality of life|quality of life
5779911|NCT00197964|Resource utilization|resource utilization
5779912|NCT00197951|Psychiatric symptoms associated to alcoholism recovery|psychiatric symptoms associated to alcoholism recovery
5779913|NCT00197951|Alcoholism treatment|alcoholism treatment
5779914|NCT00197951|Alcohol craving|alcohol craving
5779915|NCT00197951|Relapse to heavy drinking|relapse to heavy drinking
5779916|NCT00197951|Abuse of other substances during alcoholism recovery|abuse of other substances during alcoholism recovery
5779917|NCT00197925|breast cancer|breast cancer
5779918|NCT00197925|dendritic cells|dendritic cells
5779919|NCT00197925|vaccine|vaccine
5779920|NCT00197912|dendritic cell|dendritic cell
5779921|NCT00197912|cancer vaccine|cancer vaccine
5779922|NCT00197912|cyclophosphamide|cyclophosphamide
5779923|NCT00197912|melanoma|melanoma
5779924|NCT00197873|colorectal cancer|colorectal cancer
5779925|NCT00197873|probiotics|probiotics
5779926|NCT00197873|chemotherapy|chemotherapy
5779927|NCT00197873|prevention|prevention
5779928|NCT00197873|adverse effects|adverse effects
5779929|NCT00197873|diarrhoea|diarrhoea
5779930|NCT00197860|dendritic cell|dendritic cell
5779931|NCT00197860|vaccine|vaccine
5779932|NCT00197860|renal cell carcinoma|renal cell carcinoma
5779933|NCT00197834|Depakote|depakote
5779934|NCT00197834|Agitation|agitation
5779935|NCT00197834|Dementia|dementia
5779936|NCT00197834|Atypical antipsychotic|atypical antipsychotic
5779937|NCT00197834|Behavioral Symptoms|behavioral symptoms
5779938|NCT00197834|Psychiatric Symptoms|psychiatric symptoms
5779939|NCT00197834|Psychological Symptoms|psychological symptoms
5779940|NCT00197834|Geriatric|geriatric
5779941|NCT00197834|Behavioral and Psychological Symptoms|behavioral and psychological symptoms
5779942|NCT00197808|Streptococcus pneumoniae|streptococcus pneumoniae
5779943|NCT00197808|Neisseria meningitidis|neisseria meningitidis
5779944|NCT00197756|HIV|hiv
5779945|NCT00197756|Breastfeeding|breastfeeding
5779946|NCT00197756|Vitamins|vitamins
5779947|NCT00197756|Tanzania|tanzania
5779948|NCT00197756|Children|children
5779949|NCT00197743|HIV|hiv
5779950|NCT00197743|Multivitamins|multivitamins
5779951|NCT00197743|Pregnancy outcomes|pregnancy outcomes
5779952|NCT00197743|Tanzania|tanzania
5779953|NCT00197743|Women|women
5779954|NCT00197730|Birth Outcomes|birth outcomes
5779955|NCT00197730|Nutrition|nutrition
5779956|NCT00197730|HIV|hiv
5779957|NCT00197730|AIDS|aids
5779958|NCT00197730|Vitamins|vitamins
5779959|NCT00197730|Multivitamins|multivitamins
5779960|NCT00197730|Maternal and child health outcomes|maternal and child health outcomes
5779961|NCT00197730|Tanzania|tanzania
5779962|NCT00197730|Africa|africa
5779963|NCT00197704|Tuberculosis|tuberculosis
5779964|NCT00197704|HIV|hiv
5779966|NCT00197704|multivitamins|multivitamins
5779967|NCT00197691|HIV infected mothers|hiv infected mothers
5779968|NCT00197691|Infants at risk of HIV-infection|infants at risk of hiv-infection
5779969|NCT00197691|Infant lower respiratory tract disease|infant lower respiratory tract disease
5779970|NCT00197691|Infant bloodstream infection|infant bloodstream infection
5779971|NCT00197678|HIV|hiv
5779972|NCT00197678|AIDS|aids
5779973|NCT00197678|Multivitamins|multivitamins
5779974|NCT00197678|Pregnancy Outcomes|pregnancy outcomes
5779975|NCT00197678|Women|women
5779976|NCT00197678|Tanzania|tanzania
5779977|NCT00197678|Africa|africa
5780172|NCT00196625|Lopinavir|lopinavir
5779978|NCT00197652|Prevention of Mother-Infant HIV Transmission|prevention of mother-infant hiv transmission
5779979|NCT00197639|indinavir, HIV, ritonavir, pharmacokinetics, Thailand|indinavir, hiv, ritonavir, pharmacokinetics, thailand
5779980|NCT00197561|HIV|hiv
5779981|NCT00197561|Selenium|selenium
5779982|NCT00197561|Nutrition|nutrition
5779983|NCT00197561|Women|women
5779984|NCT00197561|Pregnancy|pregnancy
5779985|NCT00197561|Tanzania|tanzania
5779986|NCT00197561|Maternal and child health outcomes|maternal and child health outcomes
5779987|NCT00197561|HIV/AIDS|hiv/aids
5779988|NCT00197561|Pregnancy Outcome|pregnancy outcome
5779989|NCT00197548|Women|women
5779990|NCT00197548|Pregnancy Outcomes|pregnancy outcomes
5779991|NCT00197548|Nutrition|nutrition
5779992|NCT00197548|Vitamins|vitamins
5779993|NCT00197548|Tanzania|tanzania
5779994|NCT00197548|Maternal and Child Health Outcomes|maternal and child health outcomes
5779995|NCT00197522|breast cancer|breast cancer
5779996|NCT00197522|vaccination|vaccination
5779997|NCT00197522|dendritic cells|dendritic cells
5779998|NCT00197522|HER-2|her-2
5779999|NCT00197522|CD34+ stem cells|cd34+ stem cells
5780000|NCT00197509|Long-Term Care|long-term care
5780001|NCT00197509|Clinical Protocols|clinical protocols
5780003|NCT00197483|Pergolide|pergolide
5780004|NCT00197483|Dopamine D1|dopamine d1
5780005|NCT00197483|Schizophrenia|schizophrenia
5780006|NCT00197483|Cognitive disturbance|cognitive disturbance
5780007|NCT00197483|Negative symptoms|negative symptoms
5780008|NCT00197444|esophageal cancer|esophageal cancer
5780009|NCT00197444|Nedaplatin|nedaplatin
5780010|NCT00197444|5-FU|5-fu
5780011|NCT00197444|chemotherapy|chemotherapy
5780012|NCT00197444|radiation|radiation
5780013|NCT00197444|chemoradiotherapy|chemoradiotherapy
5780014|NCT00197418|H. pylori infection|h. pylori infection
5780015|NCT00197392|Ventriculostomy|ventriculostomy
5780016|NCT00197392|EVD|evd
5780017|NCT00197379|androgenetic alopecia|androgenetic alopecia
5780018|NCT00197379|roxitromycin|roxitromycin
5780019|NCT00197379|apoptosis|apoptosis
5780020|NCT00197366|pregnancy|pregnancy
5780021|NCT00197366|HIV-positive|hiv-positive
5780022|NCT00197366|HIV resistance|hiv resistance
5780023|NCT00197366|HIV|hiv
5780024|NCT00197353|Anesthesia, Epidural|anesthesia, epidural
5780025|NCT00197353|Pharmacology|pharmacology
5780026|NCT00197353|Dose-Response Relationship, Drug|dose-response relationship, drug
5780028|NCT00197353|Photoplethysmography|photoplethysmography
5780029|NCT00197340|Pre-Eclampsia|pre-eclampsia
5780030|NCT00197340|Fetal Growth Retardation|fetal growth retardation
5780031|NCT00197340|Anesthesia, Epidural|anesthesia, epidural
5780032|NCT00197340|Placental Circulation|placental circulation
5780033|NCT00197340|Dose-Response Relationship, Drug|dose-response relationship, drug
5780034|NCT00197327|Labor Pain|labor pain
5780035|NCT00197327|Analgesia, Obstetrical|analgesia, obstetrical
5780036|NCT00197327|Pharmacology|pharmacology
5780037|NCT00197327|Treatment Outcome|treatment outcome
5780038|NCT00197314|Urinary stress incontinence|urinary stress incontinence
5780039|NCT00197314|Randomized trial|randomized trial
5780040|NCT00197314|circular muscle training|circular muscle training
5780041|NCT00197314|pelvic floor training|pelvic floor training
5780042|NCT00197314|bioequivalence|bioequivalence
5780043|NCT00197301|Intranasal vaccination, Influenza|intranasal vaccination, influenza
5779080|NCT00201916|PSA|psa
5780044|NCT00197288|Prophylaxis: Influenza virus infection|prophylaxis: influenza virus infection
5780045|NCT00197275|Haemophilus influenzae type b|haemophilus influenzae type b
5780046|NCT00197275|diphtheria|diphtheria
5780047|NCT00197275|tetanus|tetanus
5780048|NCT00197275|Prophylaxis diphtheria|prophylaxis diphtheria
5780049|NCT00197275|pertussis|pertussis
5780050|NCT00197275|hepatitis B|hepatitis b
5780051|NCT00197275|meningococcal serogroups A & C diseases|meningococcal serogroups a & c diseases
5780052|NCT00197262|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5780053|NCT00197262|GW685698X|gw685698x
5780054|NCT00197262|allergic rhinitis|allergic rhinitis
5780055|NCT00197262|Hayfever|hayfever
5780056|NCT00197249|Hepatitis A & B|hepatitis a & b
5780057|NCT00197249|Typhoid|typhoid
5780058|NCT00197236|Hepatitis A|hepatitis a
5780059|NCT00197197|HIV-1 GW873140 CCR5 antagonist treatment experienced|hiv-1 gw873140 ccr5 antagonist treatment experienced
5780060|NCT00197184|Combined hepatitis A and B vaccine|combined hepatitis a and b vaccine
5780062|NCT00197145|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
5774978|NCT00222456|outcome|outcome
5780063|NCT00197132|Insulin resistance vasodilatory response|insulin resistance vasodilatory response
5780064|NCT00197119|Hepatitis B|hepatitis b
5780065|NCT00197119|TWINRIX™ Adult|twinrix™ adult
5780066|NCT00197119|Hepatitis A|hepatitis a
5780067|NCT00197119|TWINRIX™ Junior|twinrix™ junior
5780068|NCT00197106|salmeterol/fluticasone combination|salmeterol/fluticasone combination
5780069|NCT00197106|Asthma|asthma
5780070|NCT00197106|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5780071|NCT00197106|Children|children
5780072|NCT00197106|symptom control|symptom control
5780073|NCT00197093|Schizophrenia|schizophrenia
5780074|NCT00197093|safety|safety
5780075|NCT00197093|tolerability|tolerability
5780076|NCT00197093|pharmacokinetics|pharmacokinetics
5780077|NCT00197080|Restless Legs Syndrome|restless legs syndrome
5780078|NCT00197080|RLS|rls
5780079|NCT00196989|Efficacy|efficacy
5780080|NCT00196989|PPARpan|pparpan
5780081|NCT00196989|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5780082|NCT00196989|Phase IIb|phase iib
5780083|NCT00196989|Safety|safety
5780084|NCT00196989|Pharmacokinetics|pharmacokinetics
5780085|NCT00196989|GW677954|gw677954
5780086|NCT00196989|Pharmacodynamics|pharmacodynamics
5780087|NCT00196989|Tolerability|tolerability
5780088|NCT00196989|Dose-Ranging|dose-ranging
5780089|NCT00196976|Safety|safety
5780090|NCT00196976|Meningococcal vaccine|meningococcal vaccine
5780091|NCT00196976|Dose selection|dose selection
5780092|NCT00196976|Toddlers|toddlers
5780093|NCT00196976|Immunogenicity|immunogenicity
5780094|NCT00196976|Conjugate vaccine|conjugate vaccine
5780095|NCT00196976|Reactogenicity|reactogenicity
5780096|NCT00196976|Children|children
5780097|NCT00196937|HPV Vaccine Safety|hpv vaccine safety
5780098|NCT00196898|Parkinson´s disease|parkinson´s disease
5780099|NCT00196898|fibrotic valvular heart fibrosis|fibrotic valvular heart fibrosis
5780100|NCT00196898|ergot dopamine agonists|ergot dopamine agonists
5780101|NCT00196898|non-ergot dopamine agonists|non-ergot dopamine agonists
5780102|NCT00196885|cancer cachexia|cancer cachexia
5780103|NCT00196885|muscle wasting|muscle wasting
5780104|NCT00196885|weight loss|weight loss
5780105|NCT00196885|proteolysis|proteolysis
5780106|NCT00196872|dose dense sequence|dose dense sequence
5780107|NCT00196872|dose dense combination|dose dense combination
5780108|NCT00196872|node positive disease|node positive disease
5780109|NCT00196859|Early Breast Cancer in elderly Patients|early breast cancer in elderly patients
5780110|NCT00196859|Ibandronate plus/minus Capecitabine in elderly patients|ibandronate plus/minus capecitabine in elderly patients
5780111|NCT00196846|hormone insensitive breast cancer|hormone insensitive breast cancer
5780112|NCT00196846|Prevention of Chemotherapy induced ovarian failure|prevention of chemotherapy induced ovarian failure
5780113|NCT00196846|P.O.F.|p.o.f.
5780114|NCT00196846|GnRH-Agonist Goserelin|gnrh-agonist goserelin
5780115|NCT00196833|Breast Cancer in Pregnancy|breast cancer in pregnancy
5780116|NCT00196833|Prospective and Retrospective Register|prospective and retrospective register
5780117|NCT00196833|Study|study
5780118|NCT00196820|Metastatic breast cancer|metastatic breast cancer
5780119|NCT00196820|HER2 negative, medium-risk, metastatic breast cancer|her2 negative, medium-risk, metastatic breast cancer
5780120|NCT00196807|prostate cancer screening|prostate cancer screening
5780121|NCT00196807|medical decision making|medical decision making
5780122|NCT00196807|informed decision making|informed decision making
5780123|NCT00196807|patient education|patient education
5780124|NCT00196807|male|male
5780125|NCT00196794|Pseudomembranous Colitis|pseudomembranous colitis
5780126|NCT00196794|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5780127|NCT00196794|C. difficile|c. difficile
5780128|NCT00196794|CDAD|cdad
5780129|NCT00196781|prostate cancer treatment|prostate cancer treatment
5780130|NCT00196781|medical decision making|medical decision making
5780131|NCT00196781|informed decision making|informed decision making
5780132|NCT00196781|shared decision making|shared decision making
5780133|NCT00196781|decision aid|decision aid
5780134|NCT00196781|patient education|patient education
5788941|NCT00150891|acute rejection|acute rejection
5780135|NCT00196768|relapsed|relapsed
5780136|NCT00196768|acute promyelocytic leukemia|acute promyelocytic leukemia
5780137|NCT00196768|arsenic|arsenic
5780138|NCT00196742|alpha Galactosidase A|alpha galactosidase a
5780139|NCT00196742|aGAL (alpha-galactosidase)|agal (alpha-galactosidase)
5780140|NCT00196742|Fabry|fabry
5780141|NCT00196742|GL3 (globotriaosylceramide)|gl3 (globotriaosylceramide)
5780142|NCT00196742|Anderson-Fabry Disease|anderson-fabry disease
5780143|NCT00196742|angiokeratomas|angiokeratomas
5780144|NCT00196742|GLA deficiency (gene deficiency)|gla deficiency (gene deficiency)
5780145|NCT00196742|errors in metabolism|errors in metabolism
5780146|NCT00196716|alpha Galactosidase A|alpha galactosidase a
5780147|NCT00196716|aGAL|agal
5780148|NCT00196716|rh aGAL|rh agal
5780149|NCT00196716|Fabry|fabry
5780150|NCT00196716|GL3|gl3
5780151|NCT00196716|Fabrazyme|fabrazyme
5780152|NCT00196703|Aphasia|aphasia
5780153|NCT00196703|Memantine|memantine
5780154|NCT00196703|Constraint-induced language therapy|constraint-induced language therapy
5780155|NCT00196703|Event-related potentials|event-related potentials
5780156|NCT00196690|Aphasia|aphasia
5780157|NCT00196690|Donepezil|donepezil
5780158|NCT00196664|Chronic Hepatitis C|chronic hepatitis c
5780160|NCT00196664|Depression|depression
5780161|NCT00196651|HIV infection|hiv infection
5780162|NCT00196651|AIDS Vaccines|aids vaccines
5780163|NCT00196651|ALVAC vaccine|alvac vaccine
5780164|NCT00196651|Interleukin-2|interleukin-2
5780165|NCT00196651|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5780166|NCT00196638|HIV infections|hiv infections
5780167|NCT00196638|Primary acute infection|primary acute infection
5780168|NCT00196638|Interferon-alpha|interferon-alpha
5780169|NCT00196625|HIV infections|hiv infections
5780170|NCT00196625|Salvage therapy|salvage therapy
5780171|NCT00196625|Amprenavir|amprenavir
5780174|NCT00196612|HIV Infections|hiv infections
5780175|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5780176|NCT00196612|Treatment simplification|treatment simplification
5780177|NCT00196599|HIV infections|hiv infections
5780178|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5780179|NCT00196586|Chronic Hepatitis C|chronic hepatitis c
5780180|NCT00196586|HIV infection|hiv infection
5780181|NCT00196586|Interleukin-2|interleukin-2
5780182|NCT00196586|Pegylated interferon alpha 2 a|pegylated interferon alpha 2 a
5780183|NCT00196586|ribavirin|ribavirin
5780184|NCT00196573|Rotator Cuff|rotator cuff
5780185|NCT00196573|Tendinosis|tendinosis
5780186|NCT00196573|Impingement Syndrome|impingement syndrome
5780187|NCT00196573|Partial Thickness Tears|partial thickness tears
5780188|NCT00196573|Rotator Cuff Tendinosis|rotator cuff tendinosis
5780189|NCT00196573|Partial Thickness Rotator Cuff Tears|partial thickness rotator cuff tears
5780190|NCT00196560|Immobilization in External Rotation|immobilization in external rotation
5780191|NCT00196560|Acute primary anterior shoulder dislocation|acute primary anterior shoulder dislocation
5780192|NCT00196547|Asthma|asthma
5780193|NCT00196547|Respiratory viral infections|respiratory viral infections
5780194|NCT00196547|Exacerbations|exacerbations
5681090|NCT00574769|stage IV prostate cancer|stage iv prostate cancer
5780195|NCT00196547|Pediatric|pediatric
5780196|NCT00196547|Leukotriene receptor antagonists|leukotriene receptor antagonists
5780197|NCT00196547|School|school
5780198|NCT00196508|Childbirth|childbirth
5780199|NCT00196482|growth|growth
5780200|NCT00196482|oral feeding|oral feeding
5780201|NCT00196482|nutrition|nutrition
5780202|NCT00196456|Photodynamic lasertherapy|photodynamic lasertherapy
5780203|NCT00196456|Periodontol disease|periodontol disease
5780204|NCT00196417|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5780205|NCT00196417|HIT|hit
5780206|NCT00196417|unfractionated heparin|unfractionated heparin
5780207|NCT00196417|UFH|ufh
5780208|NCT00196417|low-molecular-weight heparin|low-molecular-weight heparin
5780209|NCT00196417|LMWH|lmwh
5780210|NCT00196417|thrombosis prophylaxis|thrombosis prophylaxis
5780211|NCT00196417|HIT-antibody|hit-antibody
5780212|NCT00196404|overactive bladder|overactive bladder
5780213|NCT00196404|urge incontinence|urge incontinence
5780214|NCT00196404|urinary incontinence|urinary incontinence
5780215|NCT00196391|secondary amenorrhea|secondary amenorrhea
5780216|NCT00196391|progesterone|progesterone
5780217|NCT00196378|vaginal atrophy|vaginal atrophy
5780218|NCT00196378|vaginal dryness|vaginal dryness
5780219|NCT00196378|vaginal itching|vaginal itching
5780220|NCT00196378|vaginal pain|vaginal pain
5780222|NCT00196365|cyclic pelvic pain|cyclic pelvic pain
5780223|NCT00196365|dysmenorrhea|dysmenorrhea
5780224|NCT00196352|oral contraceptives|oral contraceptives
5780225|NCT00196352|birth control|birth control
5780226|NCT00196352|ethinyl estradiol|ethinyl estradiol
5780227|NCT00196352|pregnancy prevention|pregnancy prevention
5780228|NCT00196339|prostate cancer|prostate cancer
5780229|NCT00196339|hot flashes|hot flashes
5780230|NCT00196339|hot flushes|hot flushes
5780231|NCT00196339|vasomotor symptoms|vasomotor symptoms
5780232|NCT00196326|pregnancy prevention|pregnancy prevention
5780233|NCT00196326|oral contraceptives|oral contraceptives
5686428|NCT00552188|Atherosclerosis|atherosclerosis
5780234|NCT00196313|cyclic pelvic pain|cyclic pelvic pain
5780235|NCT00196313|dysmenorrhea|dysmenorrhea
5780236|NCT00196313|oral contraceptives|oral contraceptives
5780237|NCT00196300|Assessment, Risk|assessment, risk
5780238|NCT00196300|Autonomic nervous system|autonomic nervous system
5780239|NCT00196300|Aged|aged
5780240|NCT00196287|Assessment, risk|assessment, risk
5780241|NCT00196287|autonomic nervous system|autonomic nervous system
5780242|NCT00196287|Gender|gender
5780243|NCT00196274|AUTONOMIC NERVOUS SYSTEM|autonomic nervous system
5780244|NCT00196274|Assessment, Risk|assessment, risk
5780245|NCT00196261|Assessment, Risk|assessment, risk
5780246|NCT00196261|Autonomic nervous system|autonomic nervous system
5780247|NCT00196235|Assessment, Risk|assessment, risk
5780248|NCT00196235|Diabetes mellitus|diabetes mellitus
5780249|NCT00196235|Autonomic nervous system|autonomic nervous system
5780250|NCT00196209|atrial fibrillation|atrial fibrillation
5780251|NCT00196209|catheter ablation|catheter ablation
5780252|NCT00196196|Hydrocephalus|hydrocephalus
5780253|NCT00196196|Codman Hakim Programmable Valve|codman hakim programmable valve
5780254|NCT00196196|Programmable Valve|programmable valve
5780255|NCT00196196|Shunt System|shunt system
5780256|NCT00196131|morphine|morphine
5780257|NCT00196131|head injury|head injury
5780259|NCT00196118|Pulmonary Embolism|pulmonary embolism
5780260|NCT00196118|Venous Thromboembolism|venous thromboembolism
5780261|NCT00196118|Inferior Vena Cava Filter|inferior vena cava filter
5780262|NCT00196118|IVC|ivc
5780263|NCT00196118|PE|pe
5780264|NCT00196105|Stents|stents
5780265|NCT00196105|Stent-graft|stent-graft
5780266|NCT00196105|Minimally invasive|minimally invasive
5780267|NCT00196105|Biliary Tract Cancer|biliary tract cancer
5780268|NCT00196105|Pancreatic Cancer|pancreatic cancer
5780269|NCT00196105|Jaundice|jaundice
5780270|NCT00196105|Biliary Tract Neoplasms|biliary tract neoplasms
5780271|NCT00196105|Pancreatic Neoplasms|pancreatic neoplasms
5780272|NCT00196105|Jaundice, Obstructive|jaundice, obstructive
5780273|NCT00196105|Zilver|zilver
5780274|NCT00196079|coronary artery|coronary artery
5780275|NCT00196079|stenosis|stenosis
5780276|NCT00196079|drug eluting stent|drug eluting stent
5780277|NCT00196079|stent|stent
5780278|NCT00196053|Intrathecal pain management|intrathecal pain management
5780279|NCT00196053|constant flow pump|constant flow pump
5780280|NCT00196014|Registered Nurses|registered nurses
5780281|NCT00196014|Workload|workload
5780282|NCT00196014|Clinical staff nurses that are currently working|clinical staff nurses that are currently working
5780283|NCT00196001|Adrenal sufficiency|adrenal sufficiency
5780284|NCT00196001|Low-dose ACTH stimulation|low-dose acth stimulation
5780285|NCT00196001|G proteins|g proteins
5780286|NCT00195988|immunosuppression,|immunosuppression,
5780287|NCT00195988|steroid avoidance,|steroid avoidance,
5780288|NCT00195988|liver transplantation,|liver transplantation,
5780289|NCT00195988|children|children
5780290|NCT00195975|Abdominal Pain|abdominal pain
5780291|NCT00195975|Functional Gastrointestinal Disorders|functional gastrointestinal disorders
5780292|NCT00195975|Stress|stress
5780293|NCT00195975|Anxiety|anxiety
5780294|NCT00195975|Autonomic Nervous System|autonomic nervous system
5780295|NCT00195962|Breastfeeding|breastfeeding
5780296|NCT00195962|Post-partum mothers of healthy breast-fed newborns|post-partum mothers of healthy breast-fed newborns
5780297|NCT00195949|Pyloric Stenosis|pyloric stenosis
5780298|NCT00195949|Laparoscopy|laparoscopy
5780299|NCT00195949|Idiopathic Hypertrophic Pyloric Stenosis|idiopathic hypertrophic pyloric stenosis
5780300|NCT00195936|Cinacalcet|cinacalcet
5780302|NCT00195936|XLH|xlh
5780303|NCT00195936|children and adolescents with hypophosphatemic rickets (XLH)|children and adolescents with hypophosphatemic rickets (xlh)
5780304|NCT00195923|appendicitis|appendicitis
5780305|NCT00195923|perforation|perforation
5780306|NCT00195910|Acute|acute
5780307|NCT00195910|Pain|pain
5780308|NCT00195910|Emergency Department|emergency department
5780309|NCT00195910|Morphine|morphine
5780310|NCT00195910|Hydromorphone|hydromorphone
5780311|NCT00195910|Dilaudid|dilaudid
5780312|NCT00195910|oligoanalgesia|oligoanalgesia
5780313|NCT00195897|Lymphoma|lymphoma
5780314|NCT00195897|Anthracyclines|anthracyclines
5780315|NCT00195897|Heart Failure|heart failure
5780316|NCT00195897|Radionuclide|radionuclide
5770613|NCT00242580|AMD|amd
5780317|NCT00195897|Magnetic Resonance Imaging|magnetic resonance imaging
5780318|NCT00195897|Troponin|troponin
5780319|NCT00195897|Natriuretic Peptide, Brain|natriuretic peptide, brain
5780320|NCT00195884|Diabetes Mellitus|diabetes mellitus
5780321|NCT00195884|Type 2 Diabetes|type 2 diabetes
5780322|NCT00195884|Aerobic|aerobic
5780323|NCT00195884|Resistance|resistance
5780324|NCT00195884|weight training|weight training
5780325|NCT00195884|Exercise|exercise
5780326|NCT00195871|Non-Hodgkin|non-hodgkin
5780327|NCT00195871|Lymphoma|lymphoma
5780328|NCT00195871|Lymphoblastic|lymphoblastic
5780329|NCT00195858|Youth|youth
5780330|NCT00195858|Exercise|exercise
5780331|NCT00195858|Physical Activity|physical activity
5780332|NCT00195858|Aerobic|aerobic
5686429|NCT00552084|Fish Oil|fish oil
5780333|NCT00195858|Resistance|resistance
5780334|NCT00195858|Overweight|overweight
5780335|NCT00195858|obese|obese
5780336|NCT00195858|Canada|canada
5780337|NCT00195858|Sigal|sigal
5780338|NCT00195819|ankylosing spondylitis|ankylosing spondylitis
5780339|NCT00195819|adalimumab|adalimumab
5780340|NCT00195806|Migraine|migraine
5780341|NCT00195806|Depakote ER|depakote er
5780342|NCT00195806|Divalproex sodium|divalproex sodium
5780343|NCT00195793|Hyperlipidemia|hyperlipidemia
5780344|NCT00195793|fenofibrate|fenofibrate
5780345|NCT00195793|ezetimibe|ezetimibe
5780346|NCT00195793|atorvastatin|atorvastatin
5780347|NCT00195780|Bipolar I Disorder|bipolar i disorder
5780348|NCT00195780|Depakote|depakote
5780349|NCT00195767|Bipolar I Disorder|bipolar i disorder
5780350|NCT00195767|Depakote ER|depakote er
5780351|NCT00195767|divalproex sodium|divalproex sodium
5780352|NCT00195754|Migraines|migraines
5780353|NCT00195754|Depakote ER|depakote er
5780354|NCT00195754|divalproex sodium|divalproex sodium
5780355|NCT00195741|Migraine|migraine
5780356|NCT00195741|Depakote ER|depakote er
5780357|NCT00195728|Hydrocodone/Acetaminophen|hydrocodone/acetaminophen
5780358|NCT00195728|Vicodin CR|vicodin cr
5780359|NCT00195702|Rheumatoid Arthritis|rheumatoid arthritis
5780360|NCT00195663|Early Rheumatoid Arthritis|early rheumatoid arthritis
5780361|NCT00195650|Rheumatoid Arthritis|rheumatoid arthritis
5780362|NCT00195637|GNE Gene|gne gene
5780363|NCT00195637|Alpha-Dystroglycan|alpha-dystroglycan
5780364|NCT00195637|Sialic Acid|sialic acid
5780365|NCT00195637|Glycosylation|glycosylation
5780366|NCT00195637|Dystroglycanopathy|dystroglycanopathy
5780367|NCT00195637|Hereditary Inclusion Body Myopathy|hereditary inclusion body myopathy
5780368|NCT00195637|Immune Globulin|immune globulin
5780370|NCT00195624|Immunosuppression|immunosuppression
5780371|NCT00195624|T-cells|t-cells
5780372|NCT00195624|Hematopoiesis|hematopoiesis
5780373|NCT00195624|Autoimmunity|autoimmunity
5780374|NCT00195624|Thrombocytopenia|thrombocytopenia
5780375|NCT00195624|Severe Aplastic Anemia|severe aplastic anemia
5780377|NCT00195611|Middle Ear Infection|middle ear infection
5780378|NCT00195598|Panic Disorders|panic disorders
5780379|NCT00195585|Colon Cancer|colon cancer
5780380|NCT00195572|Gastric Cancer|gastric cancer
5780381|NCT00195572|Advanced/Recurrent Gastric Cancer|advanced/recurrent gastric cancer
5780382|NCT00195559|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
5780383|NCT00195559|Hormone Therapy|hormone therapy
5780384|NCT00195546|Menopause|menopause
5780385|NCT00195533|Leukemia|leukemia
5780386|NCT00195533|Lymphoma|lymphoma
5780387|NCT00195533|Myeloma|myeloma
5780388|NCT00195520|Menopause|menopause
5780389|NCT00195520|Sleep Disorder|sleep disorder
5780390|NCT00195520|Hot Flashes|hot flashes
5780391|NCT00195507|Psoriasis|psoriasis
5780392|NCT00195494|Rheumatoid Arthritis|rheumatoid arthritis
5780393|NCT00195481|Kidney|kidney
5780394|NCT00195481|Transplant|transplant
5780395|NCT00195468|Kidney Failure|kidney failure
5780396|NCT00195468|Transplant|transplant
5780397|NCT00195455|Postmenopause|postmenopause
5780398|NCT00195442|Hemophilia A|hemophilia a
5780400|NCT00195429|Transplant|transplant
5780401|NCT00195416|Ankylosing Spondylitis|ankylosing spondylitis
5780402|NCT00195403|Rheumatoid Arthritis|rheumatoid arthritis
5780403|NCT00195390|Vaccine|vaccine
5780404|NCT00195390|heptavalent pneumococcal conjugate vaccine|heptavalent pneumococcal conjugate vaccine
5780405|NCT00195364|Rheumatoid Arthritis|rheumatoid arthritis
5780406|NCT00195351|Complicated intra-abdominal infection|complicated intra-abdominal infection
5780407|NCT00195351|Appendicitis with abscess|appendicitis with abscess
5780408|NCT00195351|Perforated diverticulitis|perforated diverticulitis
5780409|NCT00195351|Purulent peritonitis|purulent peritonitis
5780410|NCT00195351|Complicated cholecystitis|complicated cholecystitis
5780411|NCT00195338|Rheumatoid Arthritis|rheumatoid arthritis
5780412|NCT00195325|Advanced Malignant Solid Tumors|advanced malignant solid tumors
5780413|NCT00195312|HIV|hiv
5780414|NCT00195312|Vaccine|vaccine
5780415|NCT00195312|Treatment Experienced|treatment experienced
5780416|NCT00195299|Carcinoma|carcinoma
5780417|NCT00195299|Head|head
5780418|NCT00195299|Neck|neck
5780419|NCT00195286|Urinary Infections|urinary infections
5780420|NCT00195273|Kidney|kidney
5780421|NCT00195273|Transplant|transplant
5780422|NCT00195260|Solid tumors|solid tumors
5780424|NCT00195247|Advanced malignant solid tumors|advanced malignant solid tumors
5780425|NCT00195234|HIV|hiv
5780426|NCT00195234|Treatment Experienced|treatment experienced
5780427|NCT00195221|Hemophilia B|hemophilia b
5780428|NCT00195208|Gastroesophageal Reflux Disease (GERD)|gastroesophageal reflux disease (gerd)
5780429|NCT00195195|Transplantation|transplantation
5780430|NCT00195182|Hypertension|hypertension
5780431|NCT00195182|African-American|african-american
5780432|NCT00195182|Perceived Racism|perceived racism
5780433|NCT00195182|Psychological Stress|psychological stress
5780434|NCT00195182|Medication Adherence|medication adherence
5780435|NCT00195169|Myocardial Infarction|myocardial infarction
5780436|NCT00195169|Social support|social support
5789232|NCT00149357|VTE|vte
5780437|NCT00195156|Solid Tumor Malignancies|solid tumor malignancies
5780438|NCT00195143|Parkinson's disease|parkinson's disease
5780439|NCT00195143|GABA|gaba
5780440|NCT00195143|Subthalamic nucleus|subthalamic nucleus
5780441|NCT00195143|Adeno-associated virus|adeno-associated virus
5780442|NCT00195143|AAV|aav
5780443|NCT00195143|Gene therapy|gene therapy
5780444|NCT00195130|prognosis|prognosis
5780445|NCT00195130|risk of death|risk of death
5780446|NCT00195130|morbidity|morbidity
5780447|NCT00195130|mortality|mortality
5780448|NCT00195130|quality of life|quality of life
5780449|NCT00195117|Asthma|asthma
5780450|NCT00195117|Behavior change|behavior change
5780451|NCT00195117|Physical activity|physical activity
5780452|NCT00195117|Risk reduction|risk reduction
5780453|NCT00195104|Myelodysplastic Syndrome|myelodysplastic syndrome
5780454|NCT00195078|head and neck cancer|head and neck cancer
5780455|NCT00195078|squamous cell carcinoma of the oral cavity|squamous cell carcinoma of the oral cavity
5780456|NCT00195078|squamous cell carcinoma of the oropharynx|squamous cell carcinoma of the oropharynx
5780457|NCT00195078|squamous cell carcinoma of the larynx|squamous cell carcinoma of the larynx
5780458|NCT00195078|squamous cell carcinoma of the hypopharynx|squamous cell carcinoma of the hypopharynx
5797644|NCT00114907|Tea|tea
5780459|NCT00195065|Asthma|asthma
5780460|NCT00195065|Behavior change|behavior change
5780461|NCT00195065|Physical activity|physical activity
5780462|NCT00195065|Risk reduction|risk reduction
5780463|NCT00195052|epilepsy|epilepsy
5780464|NCT00195052|optical imaging|optical imaging
5780465|NCT00195052|optical mapping|optical mapping
5780466|NCT00195039|Prostate Cancer|prostate cancer
5780467|NCT00195000|Acute Myeloid Leukemia|acute myeloid leukemia
5780468|NCT00195000|Myelodysplastic Syndrome|myelodysplastic syndrome
5780469|NCT00194987|Alloimmune thrombocytopenia|alloimmune thrombocytopenia
5780470|NCT00194987|Fetal alloimmune thrombocytopenia|fetal alloimmune thrombocytopenia
5780471|NCT00194974|pregnancy|pregnancy
5780472|NCT00194974|chronic hypertension|chronic hypertension
5780473|NCT00194974|Toxemia|toxemia
5780474|NCT00194974|Blood Pressure|blood pressure
5780475|NCT00194961|Chronic Kidney Disease|chronic kidney disease
5780476|NCT00194961|Growth Failure|growth failure
5780477|NCT00194961|Cytokines|cytokines
5780478|NCT00194961|leptin|leptin
5780479|NCT00194935|Ovarian Cancer|ovarian cancer
5780480|NCT00194935|Cancer of the Ovary|cancer of the ovary
5780481|NCT00194896|type 2 diabetes mellitus|type 2 diabetes mellitus
5780482|NCT00194896|autoantibodies|autoantibodies
5780483|NCT00194896|islet proteins|islet proteins
5780484|NCT00194896|rosiglitazone|rosiglitazone
5780485|NCT00194896|glyburide|glyburide
5780486|NCT00194896|c-peptide|c-peptide
5780487|NCT00194883|Recombinant Human Growth Hormone|recombinant human growth hormone
5780488|NCT00194883|Leptin|leptin
5780489|NCT00194883|Cytokines|cytokines
5780490|NCT00194883|Chronic Renal Insufficiency|chronic renal insufficiency
5780491|NCT00194883|Children|children
5780492|NCT00194870|EEG|eeg
5780493|NCT00194870|DBS|dbs
5780494|NCT00194857|anemia|anemia
5780495|NCT00194857|dose reduction|dose reduction
5780496|NCT00194857|neutropenia|neutropenia
5780497|NCT00194857|hepatitis C virus|hepatitis c virus
5780498|NCT00194857|human immunodeficiency virus|human immunodeficiency virus
5780499|NCT00194844|caring|caring
5780500|NCT00194844|miscarriage|miscarriage
5780501|NCT00194844|grief|grief
5780502|NCT00194844|couples|couples
5780503|NCT00194844|counseling|counseling
5780504|NCT00194805|Internet|internet
5780505|NCT00194805|Diabetes|diabetes
5780506|NCT00194805|Education|education
5780507|NCT00194805|Social Support|social support
5780508|NCT00194766|Breast cancer|breast cancer
5780509|NCT00194766|Soft tissue sarcoma|soft tissue sarcoma
5780510|NCT00194753|Breast cancer|breast cancer
5780511|NCT00194740|Breast cancer|breast cancer
5780512|NCT00194727|Breast cancer|breast cancer
5780513|NCT00194701|heart failure|heart failure
5780514|NCT00194701|sleep|sleep
5780515|NCT00194701|exercise|exercise
5780516|NCT00194701|heart rate variability|heart rate variability
5780517|NCT00194688|ammonia|ammonia
5780518|NCT00194675|androgen deficiency|androgen deficiency
5780519|NCT00194675|testosterone|testosterone
5780520|NCT00194675|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5780521|NCT00194675|hypogonadism|hypogonadism
5780522|NCT00194675|prostate|prostate
5780523|NCT00194675|BPH|bph
5780524|NCT00194649|Glycosphingolipids (GSL)|glycosphingolipids (gsl)
5780525|NCT00194636|Prostatitis|prostatitis
5780526|NCT00194636|Chronic Male Pelvic Pain Syndrome|chronic male pelvic pain syndrome
5780527|NCT00194623|prostatitis|prostatitis
5780528|NCT00194597|Prostatitis|prostatitis
5780529|NCT00194584|children|children
5780530|NCT00194584|chronic illness|chronic illness
5780531|NCT00194584|parent education|parent education
5780532|NCT00194584|parent support|parent support
5780533|NCT00194571|breast cancer,|breast cancer,
5780534|NCT00194571|child functioning,|child functioning,
5780535|NCT00194571|parenting,|parenting,
5780536|NCT00194571|self-efficacy,|self-efficacy,
5780537|NCT00194571|psychoeducational intervention|psychoeducational intervention
5779652|NCT00199095|ALL|all
5780538|NCT00194571|counseling|counseling
5780539|NCT00194558|Diabetes|diabetes
5780540|NCT00194558|Health Education|health education
5780541|NCT00194558|Information Technology|information technology
5780542|NCT00194558|Disease Management|disease management
5780543|NCT00194558|Internet|internet
5780544|NCT00194558|Patient Education|patient education
5780545|NCT00194545|HIV-1|hiv-1
5780546|NCT00194545|pediatric adherence|pediatric adherence
5780547|NCT00194545|medication diaries|medication diaries
5780548|NCT00194545|HAART|haart
5780549|NCT00194545|Treatment Naive|treatment naive
5780550|NCT00194532|UTI|uti
5780551|NCT00194519|HIV infection|hiv infection
5780552|NCT00194519|HIV transmission|hiv transmission
5780553|NCT00194519|genital herpes|genital herpes
5780554|NCT00194519|sexual intercourse|sexual intercourse
5780555|NCT00194519|sexual transmitted infection|sexual transmitted infection
5780556|NCT00194519|acyclovir|acyclovir
5780557|NCT00194519|HIV Seronegativity|hiv seronegativity
5780558|NCT00194519|Treatment Naive|treatment naive
5780559|NCT00194519|HIV-discordant couples|hiv-discordant couples
5780560|NCT00194519|HIV serodiagnosis|hiv serodiagnosis
5780561|NCT00194506|Diabetes|diabetes
5780562|NCT00194506|Health Education|health education
5780563|NCT00194506|Information Technology|information technology
5780564|NCT00194506|Disease Management|disease management
5780565|NCT00194506|Internet|internet
5780566|NCT00194506|Patient Education|patient education
5780568|NCT00194493|Quality of Life|quality of life
5780569|NCT00194493|Signs and Symptoms|signs and symptoms
5780570|NCT00194493|Computers|computers
5780571|NCT00194493|Patient-Reported Outcomes|patient-reported outcomes
5780572|NCT00194480|Hepatitis C, peg-Interferon, drug abuse|hepatitis c, peg-interferon, drug abuse
5780573|NCT00194454|Depressive symptoms|depressive symptoms
5780574|NCT00194454|Behavior and behavior mechanisms|behavior and behavior mechanisms
5780575|NCT00194454|Recovery|recovery
5780576|NCT00194441|cerebral circulation|cerebral circulation
5780577|NCT00194441|monitoring, physiologic|monitoring, physiologic
5780578|NCT00194441|informatics|informatics
5780579|NCT00194441|nursing care|nursing care
5780580|NCT00194441|physiologic variability|physiologic variability
5780582|NCT00194441|quality adjusted life years|quality adjusted life years
5780583|NCT00194428|Obesity,|obesity,
5780584|NCT00194428|Metabolic Syndrome,|metabolic syndrome,
5780586|NCT00194402|cholesterol|cholesterol
5780587|NCT00194402|dyslipidemia|dyslipidemia
5780588|NCT00194402|hypercholesterolemia|hypercholesterolemia
5780589|NCT00194402|C-reactive protein|c-reactive protein
5780590|NCT00194363|breast cancer|breast cancer
5780591|NCT00194363|breast cancer survivors|breast cancer survivors
5780592|NCT00194363|lymphedema|lymphedema
5780593|NCT00194363|strength training|strength training
5780594|NCT00194363|breast cancer survivorship|breast cancer survivorship
5780595|NCT00194350|Infertility|infertility
5780596|NCT00194350|Factor V Leiden|factor v leiden
5780597|NCT00194337|stage I breast cancer|stage i breast cancer
5780598|NCT00194337|stage II breast cancer|stage ii breast cancer
5780599|NCT00194337|stage IIIA breast cancer|stage iiia breast cancer
5780600|NCT00194337|stage IIIB breast cancer|stage iiib breast cancer
5780601|NCT00194337|stage IIIC breast cancer|stage iiic breast cancer
5780602|NCT00194337|stage IV breast cancer|stage iv breast cancer
5780603|NCT00194311|HPV|hpv
5780604|NCT00194311|Pregnancy|pregnancy
5780605|NCT00194298|diabetic foot disease|diabetic foot disease
5780606|NCT00194298|osteomyelitis|osteomyelitis
5780607|NCT00194298|charcot|charcot
5780608|NCT00194298|neuropathy|neuropathy
5780609|NCT00194298|hypoxia|hypoxia
5780610|NCT00194298|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
5780611|NCT00194298|Positron Emission Tomography Imaging|positron emission tomography imaging
5780612|NCT00194285|Prosthesis|prosthesis
5780613|NCT00194285|[18 F] Fluorodeoxyglucose|[18 f] fluorodeoxyglucose
5780614|NCT00194285|Positron Emission Tomography Imaging|positron emission tomography imaging
5780615|NCT00194272|Ectopic pregnancy|ectopic pregnancy
5780616|NCT00194272|Methotrexate|methotrexate
5780617|NCT00194233|Endometriosis|endometriosis
5780618|NCT00194220|Infertility|infertility
5780619|NCT00194220|Oxidative stress|oxidative stress
5780620|NCT00194207|Ectopic pregnancy|ectopic pregnancy
5780621|NCT00194194|BMI|bmi
5780622|NCT00194194|RMR|rmr
5780623|NCT00194194|Personal Computer|personal computer
5780624|NCT00194181|dialysis|dialysis
5780625|NCT00194181|fibrin|fibrin
5780626|NCT00194181|sheath|sheath
5780627|NCT00194181|clot|clot
5780628|NCT00194181|tpa|tpa
5780629|NCT00194168|ectopic pregnancy|ectopic pregnancy
5780630|NCT00194155|cytomegalovirus|cytomegalovirus
5780631|NCT00194155|pregnancy|pregnancy
5780632|NCT00194155|placenta|placenta
5780633|NCT00194142|Pregnancy|pregnancy
5780634|NCT00194142|Cytomegalovirus|cytomegalovirus
5780635|NCT00194090|pain|pain
5780636|NCT00194090|osteoarthritis|osteoarthritis
5780637|NCT00194051|obesity|obesity
5780638|NCT00194051|gait biomechanics|gait biomechanics
5780639|NCT00194051|knee osteoarthritis|knee osteoarthritis
5780640|NCT00194038|Bipolar Disorder|bipolar disorder
5780641|NCT00194038|Geriatric Psychiatry|geriatric psychiatry
5686430|NCT00552071|Acromegaly|acromegaly
5780642|NCT00194038|Aripiprazole|aripiprazole
5780643|NCT00194025|Schizophrenia|schizophrenia
5780644|NCT00194025|Anticonvulsants|anticonvulsants
5780645|NCT00194025|Valproic Acid|valproic acid
5780646|NCT00194025|Valproate|valproate
5780647|NCT00194012|bipolar disorder|bipolar disorder
5780648|NCT00193999|Nasogastric Tubes|nasogastric tubes
5780649|NCT00193999|Nausea|nausea
5780650|NCT00193999|Vomiting|vomiting
5780651|NCT00193999|Cardiac surgery|cardiac surgery
5780652|NCT00193986|Prepulse|prepulse
5780653|NCT00193986|Defibrillator|defibrillator
5780654|NCT00193973|Lymphoma|lymphoma
5780655|NCT00193973|PCNSL|pcnsl
5780656|NCT00193973|Primary CNS lymphoma|primary cns lymphoma
5780657|NCT00193960|Seton surgery, glaucoma, Ahmed valve, intraocular pressure|seton surgery, glaucoma, ahmed valve, intraocular pressure
5780658|NCT00193934|Women's Health|women's health
5780659|NCT00193934|Multidisciplinary, multicentre prospective study|multidisciplinary, multicentre prospective study
5780660|NCT00193934|Cancer:mechanisms of growth, invasion, metastases|cancer:mechanisms of growth, invasion, metastases
5780661|NCT00193934|Figo Stages cervical cancer|figo stages cervical cancer
5780662|NCT00193934|Advances in diagnosis using radiological methods|advances in diagnosis using radiological methods
5780663|NCT00193934|Quantitative Magnetic Resonance Imaging|quantitative magnetic resonance imaging
5780664|NCT00193934|Patient Management Strategies|patient management strategies
5780665|NCT00193934|Selecting patients for therapy|selecting patients for therapy
5780668|NCT00193921|palliative radiotherapy|palliative radiotherapy
5780669|NCT00193921|Quality of life|quality of life
5780670|NCT00193908|Skin care|skin care
5780671|NCT00193908|Radiotherapy|radiotherapy
5780672|NCT00193895|Skin cancer|skin cancer
5780673|NCT00193895|radiotherapy|radiotherapy
5780674|NCT00193895|chemotherapy|chemotherapy
5780675|NCT00193895|surgery|surgery
5780676|NCT00193882|Oesophageal|oesophageal
5780677|NCT00193882|Dysphagia|dysphagia
5780678|NCT00193882|Palliation|palliation
5780679|NCT00193882|Quality of Life|quality of life
5780680|NCT00193882|Radiotherapy|radiotherapy
5780681|NCT00193882|Chemotherapy|chemotherapy
5780682|NCT00193869|Radiotherapy|radiotherapy
5780683|NCT00193869|Dose fractionation|dose fractionation
5780684|NCT00193856|Prostate Cancer|prostate cancer
5780685|NCT00193856|Androgen Deprivation|androgen deprivation
5780686|NCT00193856|Hormone Therapy|hormone therapy
5780687|NCT00193856|RadiotherapyBisphosphonate|radiotherapybisphosphonate
5780688|NCT00193856|Prostate Specific Antigen (PSA)|prostate specific antigen (psa)
5780689|NCT00193843|Oral cancer|oral cancer
5780690|NCT00193843|Head and neck surgery|head and neck surgery
5780691|NCT00193843|Accelerated radiotherapy|accelerated radiotherapy
5780692|NCT00193843|Chemo-radiotherapy|chemo-radiotherapy
5780693|NCT00193830|Cervical Cancer|cervical cancer
5780694|NCT00193830|High Dose Rate (HDR) Brachytherapy|high dose rate (hdr) brachytherapy
5780695|NCT00193830|Low Dose Rate (LDR) Brachytherapy|low dose rate (ldr) brachytherapy
5780696|NCT00193830|Acute Toxicities|acute toxicities
5780697|NCT00193830|Late Radiation Sequelae|late radiation sequelae
5780698|NCT00193817|Cancer|cancer
5780699|NCT00193817|Esophagus|esophagus
5780700|NCT00193817|Lymphadenectomy|lymphadenectomy
5780701|NCT00193804|Cervical Cancer|cervical cancer
5780702|NCT00193804|FIGO STAGE IIB|figo stage iib
5790454|NCT00143780|Vaccine|vaccine
5780703|NCT00193804|CHEMORADIATION|chemoradiation
5780704|NCT00193804|Intensity Modulated Radiation Therapy(IMRT)|intensity modulated radiation therapy(imrt)
5780705|NCT00193804|Conventional Radiation Therapy|conventional radiation therapy
5780706|NCT00193804|Cancer of the Cervix|cancer of the cervix
5780707|NCT00193804|Cervix Cancer|cervix cancer
5780708|NCT00193791|Carcinoma Cervix|carcinoma cervix
5780709|NCT00193791|FIGO Stage IIIB|figo stage iiib
5780710|NCT00193791|Radiation therapy|radiation therapy
5780711|NCT00193791|Chemoradiation|chemoradiation
5780712|NCT00193791|Treatment related toxicities|treatment related toxicities
5780713|NCT00193791|Cervical Cancer|cervical cancer
5780714|NCT00193791|Cervix Cancer|cervix cancer
5780715|NCT00193778|Metastatic breast cancer|metastatic breast cancer
5780716|NCT00193778|Locoregional treatment|locoregional treatment
5780717|NCT00193778|Survival|survival
5780718|NCT00193765|neck dissection|neck dissection
5780719|NCT00193765|survival|survival
5780720|NCT00193765|early oral cancer|early oral cancer
5780721|NCT00193765|Early oral cavity squamous cancer with node negative neck|early oral cavity squamous cancer with node negative neck
5780722|NCT00193752|FDG-PET Imaging|fdg-pet imaging
5780723|NCT00193752|Cervical Cancer|cervical cancer
5780724|NCT00193752|Post-treatment evaluation|post-treatment evaluation
5780725|NCT00193752|Para-aortic Nodal Staging|para-aortic nodal staging
5780726|NCT00193752|Extended field Radiation|extended field radiation
5780727|NCT00193752|Extended field IMRT|extended field imrt
5780728|NCT00193739|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5780729|NCT00193739|Surgery|surgery
5780730|NCT00193739|Cervix cancer|cervix cancer
5780731|NCT00193739|Concurrent chemoradiation|concurrent chemoradiation
5780732|NCT00193726|Estrogen|estrogen
5780733|NCT00193726|Priming|priming
5780734|NCT00193726|Adjuvant chemotherapy|adjuvant chemotherapy
5780735|NCT00193726|Breast cancer|breast cancer
5686431|NCT00552071|Octreotide LAR|octreotide lar
5780736|NCT00193713|double-blind study in the treatment of schizophrenia|double-blind study in the treatment of schizophrenia
5780737|NCT00193700|Hypogonadism|hypogonadism
5780738|NCT00193687|open-label study in the treatment of schizophrenia|open-label study in the treatment of schizophrenia
5780739|NCT00193674|Pregnancy|pregnancy
5780740|NCT00193674|Immunology|immunology
5780741|NCT00193674|Unexplained recurrent miscarriage|unexplained recurrent miscarriage
5780742|NCT00193661|Hypogonadism|hypogonadism
5780743|NCT00193648|FSGS|fsgs
5780744|NCT00193648|Pharmacokinetics|pharmacokinetics
5780745|NCT00193648|Rosiglitazone|rosiglitazone
5780746|NCT00193648|PPAR-gamma agonist|ppar-gamma agonist
5780747|NCT00193648|Adalimumab|adalimumab
5780748|NCT00193648|TNF-alpha antagonist|tnf-alpha antagonist
5780749|NCT00193648|Steroid and immunosuppressive drug resistance|steroid and immunosuppressive drug resistance
5780750|NCT00193648|Resistant primary FSGS|resistant primary fsgs
5780751|NCT00193635|Congenital uropathies|congenital uropathies
5780752|NCT00193635|Mycophenolate mofetil|mycophenolate mofetil
5780753|NCT00193635|GFR|gfr
5780754|NCT00193635|Iothalamate clearance|iothalamate clearance
5780755|NCT00193635|Urine cytometry|urine cytometry
5780756|NCT00193635|Children|children
5780757|NCT00193635|Congenital urological abnormalities which represent stuctural defects in the genitourinary system|congenital urological abnormalities which represent stuctural defects in the genitourinary system
5780758|NCT00193609|Neoplasms, Unknown Primary|neoplasms, unknown primary
5780759|NCT00193596|Neoplasms, Unknown Primary|neoplasms, unknown primary
5780760|NCT00193492|Lymphoma|lymphoma
5780761|NCT00193492|Bevacizumab|bevacizumab
5780762|NCT00193492|Rituximab|rituximab
5780763|NCT00193453|Lung Cancer|lung cancer
5780764|NCT00193336|NSCLC Lung Cancer|nsclc lung cancer
5780765|NCT00193336|Non Small Cell Lung Cancer|non small cell lung cancer
5780766|NCT00193297|Ovary Cancer|ovary cancer
5780767|NCT00193258|Recurrent clear cell renal cell carcinoma|recurrent clear cell renal cell carcinoma
5780768|NCT00193258|Bevacizumab|bevacizumab
5780769|NCT00193258|Erlotinib|erlotinib
5780770|NCT00193258|Imatinib|imatinib
5780771|NCT00193219|Colon Cancer|colon cancer
5780772|NCT00193206|Locally Advanced Breast Cancer|locally advanced breast cancer
5780773|NCT00193206|Inflammatory Breast Cancer|inflammatory breast cancer
5780774|NCT00193206|Breast Cancer|breast cancer
5780775|NCT00193206|Abraxane|abraxane
5780776|NCT00193206|nab Paclitaxel|nab paclitaxel
5780777|NCT00193206|Epirubicin|epirubicin
5780778|NCT00193206|Gemcitabine|gemcitabine
5780779|NCT00193206|Gemzar|gemzar
5780780|NCT00193180|Breast Cancer|breast cancer
5780781|NCT00193154|Kidney Cancer|kidney cancer
5780782|NCT00193128|Esophagus Cancer|esophagus cancer
5780783|NCT00193037|Breast Cancer|breast cancer
5780784|NCT00192998|Affective disorder|affective disorder
5780785|NCT00192998|Alzheimer dementia|alzheimer dementia
5780786|NCT00192998|healthy controls|healthy controls
5780787|NCT00192972|Catheter ablation|catheter ablation
5780788|NCT00192972|Atrial fibrillation|atrial fibrillation
5780789|NCT00192959|Anaesthesia|anaesthesia
5780790|NCT00192959|Surgery|surgery
5780791|NCT00192959|Postoperative|postoperative
5780792|NCT00192959|Neuropsychological test|neuropsychological test
5780793|NCT00192946|Cardiac resynchronization|cardiac resynchronization
5780794|NCT00192946|Heart failure|heart failure
5780795|NCT00192946|open heart surgery|open heart surgery
5780796|NCT00192946|surgery|surgery
5780797|NCT00192881|Percutaneous coronary intervention|percutaneous coronary intervention
5780798|NCT00192881|Balloon angioplasty|balloon angioplasty
5780799|NCT00192881|Restenosis|restenosis
5780800|NCT00192881|Stents|stents
5780801|NCT00192868|primary PCI|primary pci
5780802|NCT00192868|distal protection|distal protection
5780803|NCT00192868|drug eluting stent|drug eluting stent
5780804|NCT00192868|restenosis|restenosis
5780805|NCT00192855|schizophrenia|schizophrenia
5780806|NCT00192855|negative symptoms|negative symptoms
5780807|NCT00192855|entacapone|entacapone
5780808|NCT00192842|carcinoma|carcinoma
5780809|NCT00192842|pancreas|pancreas
5780810|NCT00192842|gemcitabine|gemcitabine
5780811|NCT00192842|curcumin|curcumin
5780812|NCT00192829|Lung cancer|lung cancer
5780813|NCT00192829|Thrombosis|thrombosis
5780814|NCT00192829|Hypercoagulable|hypercoagulable
5780815|NCT00192803|niddm|niddm
5780816|NCT00192803|ace2|ace2
5780817|NCT00192803|NIDDM patients|niddm patients
5780818|NCT00192790|Therma,pain, Silent myocardial ischemia, catastrophizing|therma,pain, silent myocardial ischemia, catastrophizing
5780819|NCT00192777|Solid Tumors|solid tumors
5780820|NCT00192777|Bone Metastases|bone metastases
5780821|NCT00192777|Radiotherapy|radiotherapy
5780823|NCT00192777|Concurrent|concurrent
5780824|NCT00192777|Radiosensitization|radiosensitization
5780825|NCT00192764|large cell lymphoma|large cell lymphoma
5780826|NCT00192764|CHOP|chop
5780827|NCT00192764|cyclophosphamide|cyclophosphamide
5780828|NCT00192764|high-dose|high-dose
5780829|NCT00192751|Schizophrenia|schizophrenia
5780830|NCT00192751|Major depression|major depression
5780831|NCT00192751|Bipolar disorder|bipolar disorder
5780832|NCT00192751|Compliance|compliance
5780833|NCT00192751|Relapse prevention|relapse prevention
5780834|NCT00192738|telephone,|telephone,
5780835|NCT00192738|internal medicine,|internal medicine,
5780836|NCT00192738|readmission,|readmission,
5780837|NCT00192738|patients' satisfaction|patients' satisfaction
5780838|NCT00192725|bipolar disorder|bipolar disorder
5780839|NCT00192725|acute mania|acute mania
5780840|NCT00192725|tryptophan depletion|tryptophan depletion
5780841|NCT00192725|placebo controlled add-on|placebo controlled add-on
5780842|NCT00192725|Bipolar disorder- manic type|bipolar disorder- manic type
5780843|NCT00192712|carcinoma|carcinoma
5780844|NCT00192712|pancreas|pancreas
5780845|NCT00192712|chemotherapy|chemotherapy
5780846|NCT00192712|radiotherapy|radiotherapy
5780847|NCT00192699|Osteoarthritis|osteoarthritis
5780848|NCT00192673|Asparaginase|asparaginase
5780849|NCT00192673|intramuscular administration|intramuscular administration
5780850|NCT00192673|Silent antibodies|silent antibodies
5780851|NCT00192673|Childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5780852|NCT00192673|Side effects|side effects
5780853|NCT00192673|5-year EFS|5-year efs
5780854|NCT00192660|HIV|hiv
5780855|NCT00192660|Metabolic abnormality|metabolic abnormality
5780856|NCT00192660|Lipodystrophy|lipodystrophy
5780857|NCT00192660|Cardiovascular disease|cardiovascular disease
5780858|NCT00192660|Treatment Naive|treatment naive
5780859|NCT00192660|Treatment Experienced|treatment experienced
5780860|NCT00192660|HIV Infections|hiv infections
5780861|NCT00192634|HIV|hiv
5780862|NCT00192634|Antiretroviral therapy|antiretroviral therapy
5780863|NCT00192634|nucleoside analogue reverse transcriptase|nucleoside analogue reverse transcriptase
5780865|NCT00192634|Treatment Experienced|treatment experienced
5780866|NCT00192621|HIV negative healthy subjects|hiv negative healthy subjects
5780867|NCT00192621|Lipid metabolism|lipid metabolism
5780868|NCT00192621|Glucose metabolism|glucose metabolism
5780869|NCT00192621|Metabolic abnormality|metabolic abnormality
5780870|NCT00192621|Lipodystrophy|lipodystrophy
5780972|NCT00190437|Antibiotics|antibiotics
5780871|NCT00192621|Cardiovascular disease|cardiovascular disease
5780872|NCT00192621|Treatment Naive|treatment naive
5780873|NCT00192621|HIV|hiv
5780976|NCT00190437|Intensive Care|intensive care
5781175|NCT00189579|Carboplatin|carboplatin
5780874|NCT00192608|Pharmacokinetics, atazanavir, saquinavir, ritonavir, HIV|pharmacokinetics, atazanavir, saquinavir, ritonavir, hiv
5780875|NCT00192595|Hepatitis B|hepatitis b
5780876|NCT00192595|HIV|hiv
5780877|NCT00192595|Treatment Naive|treatment naive
5780878|NCT00192582|Motivational interview|motivational interview
5780879|NCT00192582|Care plan|care plan
5780880|NCT00192582|Relapse prevention|relapse prevention
5780881|NCT00192582|Psychoeducation|psychoeducation
5780882|NCT00192582|Indigenous mental health|indigenous mental health
5780883|NCT00192569|Acute Hepatitis C|acute hepatitis c
5780884|NCT00192556|tuberculosis|tuberculosis
5780885|NCT00192556|nutrition|nutrition
5780886|NCT00192556|directly observed therapy|directly observed therapy
5780887|NCT00192556|Timor Leste|timor leste
5780888|NCT00192556|cost-effectiveness|cost-effectiveness
5780889|NCT00192543|dialysis|dialysis
5780890|NCT00192543|omega-3 fatty acids|omega-3 fatty acids
5780891|NCT00192543|antioxidants|antioxidants
5780892|NCT00192543|cardiovascular markers|cardiovascular markers
5780893|NCT00192543|Mortality|mortality
5780894|NCT00192543|End-stage renal disease|end-stage renal disease
5780895|NCT00191971|Transitional cell carcinoma of urothelium|transitional cell carcinoma of urothelium
5780896|NCT00191282|diabetes|diabetes
5780897|NCT00191282|MI|mi
5780898|NCT00191282|heart attack|heart attack
5780899|NCT00191269|after|after
5780900|NCT00191269|anthracycline|anthracycline
5780901|NCT00191269|taxane|taxane
5780902|NCT00191269|regimen|regimen
5780903|NCT00191243|breast cancer|breast cancer
5780904|NCT00191113|syndrome|syndrome
5780905|NCT00191113|Turner|turner
5780906|NCT00191113|Turner's|turner's
5780907|NCT00191113|height|height
5780908|NCT00191113|growth|growth
5780909|NCT00191113|growth hormone|growth hormone
5780910|NCT00191113|somatropin|somatropin
5780911|NCT00191113|short stature|short stature
5780912|NCT00191113|short|short
5780913|NCT00191113|hearing|hearing
5780914|NCT00191113|glucose metabolism|glucose metabolism
5780915|NCT00190671|Advanced Breast Cancer|advanced breast cancer
5780916|NCT00190580|CKD|ckd
5780917|NCT00190580|chronic kidney disease|chronic kidney disease
5780918|NCT00190580|hypertension|hypertension
5780919|NCT00190580|angiotensin II receptor blocker|angiotensin ii receptor blocker
5780920|NCT00190580|cardiovascular disease|cardiovascular disease
5780921|NCT00190580|valsartan|valsartan
5780923|NCT00190554|esophageal cancer|esophageal cancer
5780924|NCT00190554|squamous cell carcinoma|squamous cell carcinoma
5780925|NCT00190554|esophagectomy|esophagectomy
5780926|NCT00190554|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5780927|NCT00190554|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma
5780928|NCT00190541|Rectal Cancer|rectal cancer
5780929|NCT00190541|Lymph Node Dissection|lymph node dissection
5780930|NCT00190541|Rectal Surgery|rectal surgery
5780931|NCT00190541|Autonomic Nerves|autonomic nerves
5780002|NCT00197509|Sit-To-Stand|sit-to-stand
5780932|NCT00190541|Stage II, III lower rectal cancer|stage ii, iii lower rectal cancer
5780933|NCT00190528|cervical cancer|cervical cancer
5780934|NCT00190528|drug therapy|drug therapy
5780935|NCT00190528|cisplatin|cisplatin
5780936|NCT00190528|bleomycin|bleomycin
5780937|NCT00190528|mitomycin|mitomycin
5780938|NCT00190528|vincristine|vincristine
5780939|NCT00190515|adjuvant chemotherapy|adjuvant chemotherapy
5780940|NCT00190515|Stage III colorectal cancer|stage iii colorectal cancer
5780941|NCT00190515|5-FU+l-LV|5-fu+l-lv
5780942|NCT00190515|UFT+LV|uft+lv
5780943|NCT00190515|randomized controlled trial|randomized controlled trial
5780944|NCT00190502|Type 1 diabetes mellitus|type 1 diabetes mellitus
5780945|NCT00190502|Immune intervention|immune intervention
5780946|NCT00190502|Polyclonal antibodies|polyclonal antibodies
5780947|NCT00190502|Type 1 diabetes of recent onset|type 1 diabetes of recent onset
5780948|NCT00190502|C-peptide level 0.3 pmol/l or higher|c-peptide level 0.3 pmol/l or higher
5780949|NCT00190502|Positivity of at least one marker of autoimmunity (diabetes)|positivity of at least one marker of autoimmunity (diabetes)
5780950|NCT00190489|metastatic breast cancer|metastatic breast cancer
5780951|NCT00190489|drug therapy|drug therapy
5780952|NCT00190489|doxorubicin|doxorubicin
5780953|NCT00190489|docetaxel|docetaxel
5780954|NCT00190476|Elderly|elderly
5780955|NCT00190476|advanced|advanced
5780956|NCT00190476|non-small-cell lung cancer|non-small-cell lung cancer
5780957|NCT00190476|cisplatin|cisplatin
5780958|NCT00190476|docetaxel|docetaxel
5780960|NCT00190476|combination|combination
5780961|NCT00190476|chemotherapy|chemotherapy
5780962|NCT00190476|randomized trial|randomized trial
5780963|NCT00190463|aspergillosis|aspergillosis
5780964|NCT00190463|antifungal therapy|antifungal therapy
5780965|NCT00190463|empirical antifungal treatment|empirical antifungal treatment
5780966|NCT00190450|Huntington|huntington
5780967|NCT00190450|graft|graft
5780968|NCT00190450|cellular therapy|cellular therapy
5780969|NCT00190450|striatum|striatum
5780970|NCT00190437|Chronic Obstructive Lung Disease (COLD)|chronic obstructive lung disease (cold)
5780971|NCT00190437|Randomized Clinical Trial|randomized clinical trial
5780973|NCT00190437|Acute Exacerbation|acute exacerbation
5780974|NCT00190437|Mechanical|mechanical
5780975|NCT00190437|Ventilation|ventilation
5780977|NCT00190437|Length of Stay|length of stay
5780978|NCT00190437|Mortality|mortality
5780979|NCT00190424|Glioblastoma|glioblastoma
5780980|NCT00190424|Immunotherapy|immunotherapy
5780981|NCT00190411|Arteries|arteries
5780982|NCT00190411|ultrasonography|ultrasonography
5780983|NCT00190411|Ehlers Danlos syndrome|ehlers danlos syndrome
5780984|NCT00190411|Cardiovascular disease|cardiovascular disease
5780985|NCT00190411|beta adrenergic antagonists|beta adrenergic antagonists
5780986|NCT00190398|Prospective|prospective
5780987|NCT00190398|Randomised|randomised
5780989|NCT00190398|Blinded End-point|blinded end-point
5780990|NCT00190398|PROBE Study|probe study
5780991|NCT00190398|Ischemic stroke|ischemic stroke
5780992|NCT00190385|Cirrhosis|cirrhosis
5780993|NCT00190385|Hepatocellular carcinoma|hepatocellular carcinoma
5780994|NCT00190385|Screening|screening
5780995|NCT00190385|Randomized|randomized
5780996|NCT00190385|HBV|hbv
5780997|NCT00190385|HCV|hcv
5790739|NCT00142129|Velcade|velcade
5780998|NCT00190385|alcohol|alcohol
5780999|NCT00190385|hemochromatosis|hemochromatosis
5781000|NCT00190372|Alzheimer's disease training programme|alzheimer's disease training programme
5781001|NCT00190372|educational programme caregivers carers dementia treatment|educational programme caregivers carers dementia treatment
5781002|NCT00190372|Dementia Cognitive disorder|dementia cognitive disorder
5781003|NCT00190359|heart failure|heart failure
5781004|NCT00190359|hormones|hormones
5781005|NCT00190359|growth substances|growth substances
5781006|NCT00190346|Acute respiratory distress|acute respiratory distress
5781007|NCT00190346|with hypercapnia|with hypercapnia
5781008|NCT00190346|with hypoxemia|with hypoxemia
5781009|NCT00190346|requiring NIV|requiring niv
5781010|NCT00190333|pulmonary hypertension|pulmonary hypertension
5781011|NCT00190333|6 minutes walking test|6 minutes walking test
5781012|NCT00190333|serotonin|serotonin
5781013|NCT00190333|primary or associated pulmonary hypertension|primary or associated pulmonary hypertension
5781014|NCT00190320|Fetal macrosomia|fetal macrosomia
5781015|NCT00190320|Neonatal traumatism|neonatal traumatism
5781016|NCT00190320|Maternal morbidity|maternal morbidity
5781017|NCT00190307|Long term antiplatelet therapy|long term antiplatelet therapy
5781018|NCT00190307|Scheduled surgery|scheduled surgery
5781019|NCT00190294|Pregnancy Complications|pregnancy complications
5781020|NCT00190281|FUNCTIONAL STUDY|functional study
5781021|NCT00190281|CONTRAST-ENHANCED US|contrast-enhanced us
5781023|NCT00190268|multiple sclerosis|multiple sclerosis
5781024|NCT00190268|fatigue|fatigue
5781025|NCT00190268|3,4-diaminopyridine|3,4-diaminopyridine
5781026|NCT00190255|gastrointestinal haemorrhage|gastrointestinal haemorrhage
5781027|NCT00190255|stomach ulcer|stomach ulcer
5781028|NCT00190255|anti-inflammatory agents, non-steroidal|anti-inflammatory agents, non-steroidal
5781029|NCT00190255|CYP2C9 protein, human|cyp2c9 protein, human
5781030|NCT00190255|genotype|genotype
5781031|NCT00190255|pharmacogenetics|pharmacogenetics
5781032|NCT00190242|HIV|hiv
5781033|NCT00190242|hepatitis A|hepatitis a
5781034|NCT00190242|vaccine|vaccine
5781035|NCT00190242|HBV and/or HCV co-infection|hbv and/or hcv co-infection
5781036|NCT00190229|Vasculitis|vasculitis
5781037|NCT00190229|Cyclophosphamide|cyclophosphamide
5781038|NCT00190229|Renal failure|renal failure
5781039|NCT00190216|Resistant depression|resistant depression
5781040|NCT00190216|Transcranial Magnetic Stimulation,|transcranial magnetic stimulation,
5781041|NCT00190216|Neuroimaging|neuroimaging
5781042|NCT00190203|Malignant middle cerebral artery infarction|malignant middle cerebral artery infarction
5781043|NCT00190203|Decompressive surgery|decompressive surgery
5781044|NCT00190203|Hemicraniectomy|hemicraniectomy
5781045|NCT00190203|Brain edema|brain edema
5781046|NCT00190190|Macular hole|macular hole
5781047|NCT00190190|internal limiting membrane|internal limiting membrane
5781048|NCT00190190|retina|retina
5781049|NCT00190190|surgery|surgery
5781050|NCT00190164|Macular hole|macular hole
5781051|NCT00190164|Vitrectomy|vitrectomy
5781052|NCT00190164|positioning|positioning
5781053|NCT00190164|retina|retina
5781054|NCT00190164|surgery|surgery
5781055|NCT00190151|ciprofloxacin|ciprofloxacin
5781056|NCT00190151|commensal flora|commensal flora
5781057|NCT00190151|resistance|resistance
5781058|NCT00190151|Pharmacokinetic|pharmacokinetic
5781059|NCT00190138|Bi-ventricular pacing|bi-ventricular pacing
5775921|NCT00217529|Brenner tumor|brenner tumor
5781060|NCT00190138|ventricular resynchronization|ventricular resynchronization
5781061|NCT00190138|baroreflex sensitivity|baroreflex sensitivity
5781062|NCT00190138|heart rate variability|heart rate variability
5781063|NCT00190125|Hemodialysis|hemodialysis
5781064|NCT00190125|Malnutrition|malnutrition
5781065|NCT00190125|Inflammation|inflammation
5781066|NCT00190099|In-stent restenosis,|in-stent restenosis,
5781067|NCT00190099|Drug eluting stent,|drug eluting stent,
5781068|NCT00190099|dexamethasone,|dexamethasone,
5781069|NCT00190099|Acute coronary syndrome|acute coronary syndrome
5781070|NCT00190073|Epidermal nerves;protein gene product 9.5; ethanol|epidermal nerves;protein gene product 9.5; ethanol
5781071|NCT00190060|Frailty|frailty
5781072|NCT00190060|Muscle strength|muscle strength
5781073|NCT00190060|Physical performance|physical performance
5781074|NCT00190060|Bone mineral density|bone mineral density
5781075|NCT00190060|Quality of life|quality of life
5781076|NCT00190047|Cerebral Ischemia|cerebral ischemia
5781077|NCT00190047|Ischemic Brain Injury|ischemic brain injury
5781078|NCT00190047|Brain Infarction|brain infarction
5781079|NCT00190047|Brain Ischemia|brain ischemia
5781080|NCT00190034|Acetylcysteine|acetylcysteine
5781081|NCT00190034|cardiac surgery|cardiac surgery
5781082|NCT00190034|cardiopulmonary bypass|cardiopulmonary bypass
5781083|NCT00190034|acute renal insufficiency|acute renal insufficiency
5781084|NCT00190021|Alzheimer's type dementia|alzheimer's type dementia
5781085|NCT00190021|donepezil|donepezil
5781086|NCT00190021|double-blind|double-blind
5781087|NCT00190008|tardive dyskinesia|tardive dyskinesia
5781088|NCT00190008|piracetam|piracetam
5781089|NCT00189995|schizophrenia|schizophrenia
5781090|NCT00189995|aggression|aggression
5781091|NCT00189995|clozapine|clozapine
5781092|NCT00189995|efficacy|efficacy
5781093|NCT00189995|double-blind|double-blind
5781094|NCT00189982|Factor VIII Deficiency|factor viii deficiency
5781095|NCT00189930|Treatment Experienced|treatment experienced
5781096|NCT00189904|HIV|hiv
5781097|NCT00189878|chronic idiopathic urticaria|chronic idiopathic urticaria
5781098|NCT00189878|methotrexate|methotrexate
5781099|NCT00189852|Telecare|telecare
5781100|NCT00189852|chronic|chronic
5781101|NCT00189852|older people|older people
5781102|NCT00189852|heart failure|heart failure
5781103|NCT00189839|Tacrolimus|tacrolimus
5781104|NCT00189839|Kidney transplantation|kidney transplantation
5781105|NCT00189839|Transplantation, kidney|transplantation, kidney
5781106|NCT00189839|Renal Transplantation|renal transplantation
5781107|NCT00189839|Transplantation, renal|transplantation, renal
5781108|NCT00189826|Tacrolimus|tacrolimus
5781109|NCT00189826|Liver transplantation|liver transplantation
5781110|NCT00189813|Irritable Bowel Syndrome|irritable bowel syndrome
5781111|NCT00189813|Diarrhea|diarrhea
5781112|NCT00189813|Nasea®|nasea®
5781113|NCT00189813|Irribow®|irribow®
5781114|NCT00189813|ramosetron|ramosetron
5781115|NCT00189800|Solifenacin|solifenacin
5781116|NCT00189800|tolterodine|tolterodine
5781117|NCT00189800|randomized controlled trial|randomized controlled trial
5781118|NCT00189800|double-blind method|double-blind method
5781119|NCT00189787|Tacrolimus|tacrolimus
5781120|NCT00189787|Immunosuppressant|immunosuppressant
5781121|NCT00189787|Anti-asthmatic drug|anti-asthmatic drug
5781122|NCT00189787|Administration, inhalation|administration, inhalation
5781123|NCT00189774|nateglinide|nateglinide
5781124|NCT00189774|pioglitazone|pioglitazone
5781125|NCT00189774|combination drug therapy|combination drug therapy
5781126|NCT00189774|treatment|treatment
5781127|NCT00189761|Tacrolimus|tacrolimus
5781128|NCT00189761|Immunosuppression|immunosuppression
5781129|NCT00189761|Bone Marrow Transplantation|bone marrow transplantation
5686432|NCT00552071|Ultrasound guidance|ultrasound guidance
5686433|NCT00552058|CDP 870|cdp 870
5781130|NCT00189761|Graft versus Host Disease|graft versus host disease
5781131|NCT00189748|Tacrolimus|tacrolimus
5781132|NCT00189748|Immunosuppression|immunosuppression
5781133|NCT00189748|Bone Marrow Transplantation|bone marrow transplantation
5781134|NCT00189748|Graft versus Host Disease|graft versus host disease
5781135|NCT00189735|Treatment Efficacy|treatment efficacy
5781136|NCT00189735|Treatment Effectiveness|treatment effectiveness
5781137|NCT00189735|Anti-rejection therapy|anti-rejection therapy
5781138|NCT00189735|Immunosuppression|immunosuppression
5781139|NCT00189735|Antirejection|antirejection
5781140|NCT00189735|Malononitrilamide|malononitrilamide
5781141|NCT00189722|Tacrolimus|tacrolimus
5781142|NCT00189722|Immunosuppressant|immunosuppressant
5781143|NCT00189722|Anti-asthmatic drug|anti-asthmatic drug
5781144|NCT00189722|Administration, inhalation|administration, inhalation
5781145|NCT00189709|micafungin|micafungin
5781146|NCT00189709|fluconazole|fluconazole
5781147|NCT00189709|invasive candidiasis|invasive candidiasis
5781148|NCT00189709|candidemia|candidemia
5781149|NCT00189696|Irritable Bowel Syndrome, Diarrhea|irritable bowel syndrome, diarrhea
5781150|NCT00189618|Peripheral vascular disease|peripheral vascular disease
5781151|NCT00189618|Peripheral arterial disease|peripheral arterial disease
5781152|NCT00189618|Walking Capacity|walking capacity
5781153|NCT00189618|Aspirin|aspirin
5781154|NCT00189618|Clopidogrel|clopidogrel
5781155|NCT00189605|Plasma disc decompression|plasma disc decompression
5781156|NCT00189605|Intradiscal Pressure|intradiscal pressure
5781157|NCT00189605|Steroid Injection|steroid injection
5781158|NCT00189605|Epidural Steroid Injection|epidural steroid injection
5781159|NCT00189605|Selective Nerve Root Injection|selective nerve root injection
5781161|NCT00189605|Radicular Pain|radicular pain
5781162|NCT00189605|Coblation|coblation
5781163|NCT00189605|SNRI|snri
5781164|NCT00189592|plantar fascia|plantar fascia
5781165|NCT00189592|plantar fasciitis|plantar fasciitis
5781166|NCT00189592|Coblation|coblation
5781167|NCT00189592|fasciotomy|fasciotomy
5781168|NCT00189592|conventional surgical fasciotomy|conventional surgical fasciotomy
5781169|NCT00189592|heel spur|heel spur
5781170|NCT00189592|heel pain|heel pain
5781171|NCT00189592|aponeurosis|aponeurosis
5781172|NCT00189592|plasma based radiofrequency|plasma based radiofrequency
5781173|NCT00189592|angiogenesis|angiogenesis
5781174|NCT00189579|HERCEPTIN|herceptin
5781178|NCT00189566|Relapse within 6 months|relapse within 6 months
5781179|NCT00189566|Previously received taxane derivative|previously received taxane derivative
5781180|NCT00189553|Extra-ovarian papillary serous tumors|extra-ovarian papillary serous tumors
5781181|NCT00189553|Relapse over 6 months|relapse over 6 months
5781182|NCT00189553|Previously received taxane derivative|previously received taxane derivative
5781183|NCT00189540|Ischemic ulcers|ischemic ulcers
5781184|NCT00189540|Critical Limb Ischemia|critical limb ischemia
5781185|NCT00189514|obesity|obesity
5781186|NCT00189514|weight loss|weight loss
5781187|NCT00189514|Amylin|amylin
5781188|NCT00189514|pramlintide|pramlintide
5781189|NCT00189501|Chronic Kidney Disease, CKD,|chronic kidney disease, ckd,
5781190|NCT00189501|Secondary Hyperparathyroidism, HPT|secondary hyperparathyroidism, hpt
5781191|NCT00189488|Hematological Malignancies|hematological malignancies
5781192|NCT00189488|Graft-versus-host-disease|graft-versus-host-disease
5781193|NCT00189488|Oral Mucositis|oral mucositis
5790924|NCT00141037|Organ Rejection|organ rejection
5781194|NCT00189488|Allogeneic Transplantation|allogeneic transplantation
5781195|NCT00189475|Cold|cold
5781196|NCT00189475|Upper Respiratory Infection|upper respiratory infection
5781197|NCT00189462|Ear Infections|ear infections
5781198|NCT00189462|Otitis Media|otitis media
5781199|NCT00189449|Allergic Rhinitis|allergic rhinitis
5781200|NCT00189449|Allergy|allergy
5781201|NCT00189449|Growth|growth
5781202|NCT00189436|Asthma|asthma
5781203|NCT00189423|Heart Arrest|heart arrest
5781204|NCT00189423|Cardiac Arrest|cardiac arrest
5781205|NCT00189423|Cardiopulmonary Resuscitation|cardiopulmonary resuscitation
5781206|NCT00189423|Impedance Threshold Device|impedance threshold device
5781207|NCT00189423|Active Compression Decompression|active compression decompression
5781208|NCT00189423|ResQPOD|resqpod
5781209|NCT00189423|ResQPump|resqpump
5781210|NCT00189423|Survival|survival
5781211|NCT00189423|Out-of-hospital|out-of-hospital
5781212|NCT00189423|Prehospital|prehospital
5781213|NCT00189423|ResQCPR System|resqcpr system
5781214|NCT00189397|Parthenium dermatitis|parthenium dermatitis
5781215|NCT00189384|Neonatal sepsis|neonatal sepsis
5781216|NCT00189384|Neonatal pneumonia|neonatal pneumonia
5781217|NCT00189384|Bacterial infections|bacterial infections
5781218|NCT00189384|Young infants|young infants
5781219|NCT00189384|Neonate|neonate
5781220|NCT00189384|Community|community
5781221|NCT00189384|Developing country|developing country
5781222|NCT00189358|cancer|cancer
5781223|NCT00189358|cancer alternative therapies|cancer alternative therapies
5781224|NCT00189358|ovarian cancer|ovarian cancer
5781225|NCT00189358|tyrosine kinase inhibitor|tyrosine kinase inhibitor
5781226|NCT00189345|Cancer|cancer
5790039|NCT00146003|eczema|eczema
5781227|NCT00189345|Cancer alternative therapies|cancer alternative therapies
5781228|NCT00189345|ovarian cancer|ovarian cancer
5781229|NCT00189332|Oncology|oncology
5781230|NCT00189332|Melanoma|melanoma
5781231|NCT00189319|Tambocor|tambocor
5781232|NCT00189319|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5781233|NCT00189319|Quality of Life|quality of life
5781234|NCT00189306|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
5781235|NCT00189306|Aldara|aldara
5781236|NCT00189293|External Ano-Genital Warts|external ano-genital warts
5781237|NCT00189293|Ablative Therapy|ablative therapy
5781238|NCT00189293|Aldara|aldara
5781239|NCT00189280|Aldara, sBCC|aldara, sbcc
5781240|NCT00189267|Aldara|aldara
5781241|NCT00189267|Actinic Keratosis|actinic keratosis
5781242|NCT00189267|Graft Recipients|graft recipients
5781243|NCT00189254|1 year follow up|1 year follow up
5781244|NCT00189241|Aldara|aldara
5781245|NCT00189241|Superficial Basal Cell Carcinoma|superficial basal cell carcinoma
5781246|NCT00189241|Long-Term Study|long-term study
5781247|NCT00189215|coronary artery disease|coronary artery disease
5781248|NCT00189215|cardiopulmonary bypass|cardiopulmonary bypass
5781249|NCT00189215|cognition disorders|cognition disorders
5781250|NCT00189189|prevention|prevention
5781251|NCT00189189|oppositional defiant disorder|oppositional defiant disorder
5781252|NCT00189189|conduct disorder|conduct disorder
5781253|NCT00189163|Hepatitis C|hepatitis c
5781254|NCT00189163|Genotype 1|genotype 1
5781255|NCT00189163|Insulin Resistance|insulin resistance
5781256|NCT00189163|Pioglitazone|pioglitazone
5781257|NCT00189150|Valganciclovir|valganciclovir
5776167|NCT00216333|DOT|dot
5781259|NCT00189150|Pharmacokinetic|pharmacokinetic
5781260|NCT00189150|Interaction|interaction
5781261|NCT00189150|MPA|mpa
5781262|NCT00189124|Systemic Lupus Erythematosus|systemic lupus erythematosus
5781263|NCT00189124|Dehydroepiandrosterone (DHEA)|dehydroepiandrosterone (dhea)
5781264|NCT00189124|DHEA|dhea
5781265|NCT00189124|SLE|sle
5781266|NCT00189124|Lupus|lupus
5781267|NCT00189111|peripheral arterial disease|peripheral arterial disease
5781268|NCT00189111|computed tomography|computed tomography
5781269|NCT00189111|cardiac asymptomatic|cardiac asymptomatic
5781270|NCT00189111|dobutamine magnetic resonance imaging|dobutamine magnetic resonance imaging
5781271|NCT00189085|Metabolic syndrome|metabolic syndrome
5781272|NCT00189072|gabapentin|gabapentin
5781273|NCT00189072|neuropathic pain|neuropathic pain
5781274|NCT00189072|driving|driving
5781275|NCT00189072|attention|attention
5781276|NCT00189059|neuropathic pain|neuropathic pain
5781280|NCT00189059|amitriptyline|amitriptyline
5781281|NCT00189046|driving, chronic pain, attention|driving, chronic pain, attention
5781282|NCT00189033|Irritable Bowel Syndrome|irritable bowel syndrome
5781283|NCT00189033|Diet Therapy|diet therapy
5781284|NCT00189033|Dietary Fiber|dietary fiber
5781285|NCT00189033|Randomized Controlled Trial|randomized controlled trial
5781286|NCT00189033|Family Practice|family practice
5781287|NCT00189020|pneumococcal conjugate vaccination|pneumococcal conjugate vaccination
5781288|NCT00189020|nasopharyngeal carriage|nasopharyngeal carriage
5781289|NCT00189020|herd immunity|herd immunity
5781290|NCT00189020|antipneumococcal antibodies|antipneumococcal antibodies
5781291|NCT00189020|respiratory tract infections|respiratory tract infections
5781292|NCT00189020|National infant vaccination program|national infant vaccination program
5781293|NCT00189007|allopurinol|allopurinol
5781294|NCT00189007|neuroprotection|neuroprotection
5781295|NCT00189007|reperfusion injury|reperfusion injury
5781296|NCT00189007|fetal hypoxia|fetal hypoxia
5781297|NCT00189007|post hypoxic-ischemic reperfusion damage|post hypoxic-ischemic reperfusion damage
5781298|NCT00188994|Myocardial Protection|myocardial protection
5781299|NCT00188994|Myocardial Metabolism|myocardial metabolism
5781300|NCT00188994|Ventricular Function|ventricular function
5781301|NCT00188994|Cardiovascular Disease|cardiovascular disease
5781302|NCT00188994|Cardioplegic Additives|cardioplegic additives
5781303|NCT00188981|psychosis|psychosis
5781304|NCT00188981|high risk|high risk
5781305|NCT00188981|prodrome|prodrome
5781306|NCT00188981|Multiple Complex Developmental Disorder|multiple complex developmental disorder
5781307|NCT00188968|Xanthines|xanthines
5781308|NCT00188968|Reintubation|reintubation
5781309|NCT00188968|Nasal Intermittent Ventilation|nasal intermittent ventilation
5781310|NCT00188968|Nasal continous positive airway pressure|nasal continous positive airway pressure
5781311|NCT00188955|pediatric|pediatric
5781312|NCT00188955|chronic allograft nephropathy|chronic allograft nephropathy
5781313|NCT00188955|chronic rejection|chronic rejection
5781314|NCT00188955|interstitial fibrosis|interstitial fibrosis
5781315|NCT00188942|Magnetic Resonance Imaging|magnetic resonance imaging
5781316|NCT00188942|Diagnostic Imaging|diagnostic imaging
5781317|NCT00188942|Mood Disorders|mood disorders
5781318|NCT00188942|Major Depressive Disorder|major depressive disorder
5781319|NCT00188942|Antipsychotic|antipsychotic
5781320|NCT00188942|Olanzapine|olanzapine
5781321|NCT00188942|Fluoxetine|fluoxetine
5781322|NCT00188916|Bronchial blockers|bronchial blockers
5781323|NCT00188916|Lung isolation|lung isolation
5780399|NCT00195429|Kidney|kidney
5781324|NCT00188916|Thoracic Anesthesia|thoracic anesthesia
5781325|NCT00188903|Cardiac Surgery|cardiac surgery
5781326|NCT00188903|Diastolic Dysfunction|diastolic dysfunction
5781327|NCT00188903|Atrial Fibrillation|atrial fibrillation
5781328|NCT00188890|Lung Cancer|lung cancer
5781329|NCT00188890|Mesothelioma|mesothelioma
5781330|NCT00188890|Asbestos|asbestos
5781331|NCT00188890|Screening|screening
5781332|NCT00188890|Early Diagnosis|early diagnosis
5781333|NCT00188851|HIV|hiv
5781334|NCT00188851|salvage regimen|salvage regimen
5781335|NCT00188851|virologic failure|virologic failure
5781336|NCT00188851|treatment interruption|treatment interruption
5781337|NCT00188851|ARV experienced|arv experienced
5781338|NCT00188838|Bipolar Disorder|bipolar disorder
5781339|NCT00188838|Psychosocial Factors|psychosocial factors
5781340|NCT00188838|Mania|mania
5781341|NCT00188838|Depression|depression
5781342|NCT00188838|Social Adjustment|social adjustment
5781343|NCT00188838|Coping Skills|coping skills
5781344|NCT00188825|Lung|lung
5781345|NCT00188825|Transplant|transplant
5781346|NCT00188825|Rejection|rejection
5781347|NCT00188825|BOS|bos
5781348|NCT00188812|dementia|dementia
5781349|NCT00188812|stroke|stroke
5781350|NCT00188773|n-acetylcysteine,|n-acetylcysteine,
5781351|NCT00188773|free fatty acid,|free fatty acid,
5781352|NCT00188773|glucose stimulated insulin secretion,|glucose stimulated insulin secretion,
5781353|NCT00188773|insulin resistance syndrome|insulin resistance syndrome
5781354|NCT00188773|antioxidant therapy|antioxidant therapy
5781355|NCT00188773|Insulin Resistance|insulin resistance
5781356|NCT00188760|Breast Transillumination Spectroscopy|breast transillumination spectroscopy
5781357|NCT00188760|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5781358|NCT00188760|Breast Cancer Risk|breast cancer risk
5781359|NCT00188747|Coagulopathy|coagulopathy
5781360|NCT00188747|Cardiac Surgery|cardiac surgery
5781361|NCT00188747|Point of Care|point of care
5781362|NCT00188747|Monitoring|monitoring
5781363|NCT00188734|Lung Cancer|lung cancer
5781364|NCT00188734|Eary Diagnosis|eary diagnosis
5781365|NCT00188734|Screening|screening
5781366|NCT00188721|Breast Cancer Risk|breast cancer risk
5781367|NCT00188721|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5781565|NCT00187551|Salvage Therapy|salvage therapy
5781368|NCT00188721|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5781369|NCT00188682|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5781370|NCT00188682|Transillumination Breast Spectroscopy|transillumination breast spectroscopy
5781371|NCT00188682|Breast Cancer Risk|breast cancer risk
5781372|NCT00188643|Bipolar Disorder, Depression, Anticonvulsants, Antidepressants|bipolar disorder, depression, anticonvulsants, antidepressants
5781373|NCT00188630|Cardiac Surgery|cardiac surgery
5781374|NCT00188630|Acute Renal Failure|acute renal failure
5781375|NCT00188630|N-acetylcysteine|n-acetylcysteine
5781376|NCT00188630|Cardiopulmonary bypass|cardiopulmonary bypass
5781377|NCT00188617|LUNG CANCER|lung cancer
5781379|NCT00188617|GEFITINIB|gefitinib
5781380|NCT00188617|STAGE 1A & 1B|stage 1a & 1b
5781381|NCT00188617|NEOADJUVANT|neoadjuvant
5781382|NCT00188617|PHASE 2|phase 2
5781383|NCT00188591|Optical Transillumination Spectroscopy|optical transillumination spectroscopy
5781384|NCT00188591|Breast Cancer Risk|breast cancer risk
5781385|NCT00188500|epilepsy|epilepsy
5781386|NCT00188500|atkins diet|atkins diet
5781387|NCT00188396|Major Depressive Disorder|major depressive disorder
5781388|NCT00188396|Women's Mental Health|women's mental health
5781389|NCT00188396|Hormones|hormones
5781390|NCT00188396|Citalopram|citalopram
5781391|NCT00188396|Antidepressive agents|antidepressive agents
5781392|NCT00188396|Mental Health|mental health
5781393|NCT00188383|Hyperalgesia|hyperalgesia
5781394|NCT00188383|Quantitative Sensory Testing|quantitative sensory testing
5781395|NCT00188383|Pain|pain
5781396|NCT00188383|Opioid use|opioid use
5781397|NCT00188383|Elderly|elderly
5781398|NCT00188344|laparoscopic myotomy|laparoscopic myotomy
5781399|NCT00188344|pneumatic dilatation|pneumatic dilatation
5781400|NCT00188344|motility disorder|motility disorder
5781401|NCT00188344|dysphasia|dysphasia
5781402|NCT00188344|health-related quality of life|health-related quality of life
5781403|NCT00188331|cognitive function|cognitive function
5781404|NCT00188331|fatigue|fatigue
5781405|NCT00188331|colorectal cancer|colorectal cancer
5781406|NCT00188331|chemotherapy|chemotherapy
5781407|NCT00188331|cognitive impairment|cognitive impairment
5781408|NCT00188305|Risk counselling|risk counselling
5781409|NCT00188305|Health education|health education
5781410|NCT00188305|Prevention|prevention
5781411|NCT00188305|Behavioral|behavioral
5781412|NCT00188305|Screening|screening
5781413|NCT00188305|Intervention|intervention
5781414|NCT00188305|Telephone vs in person|telephone vs in person
5781415|NCT00188292|Human Papillomavirus|human papillomavirus
5781416|NCT00188292|Anal|anal
5781417|NCT00188292|Cancer screening|cancer screening
5781418|NCT00188292|Immunodeficiency|immunodeficiency
5781419|NCT00188292|HIV|hiv
5781421|NCT00188279|scan|scan
5781422|NCT00188279|lung|lung
5781423|NCT00188279|follow-up|follow-up
5781424|NCT00188253|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5781425|NCT00188253|PET scan|pet scan
5781426|NCT00188253|MRI|mri
5781427|NCT00188253|EBV virus|ebv virus
5781428|NCT00188240|hepatitis C|hepatitis c
5781429|NCT00188240|insulin resistance|insulin resistance
5781430|NCT00188240|antiviral therapy|antiviral therapy
5781431|NCT00188227|Bone marrow puncture|bone marrow puncture
5781432|NCT00188227|Pain|pain
5781433|NCT00188214|perfusion|perfusion
5781434|NCT00188214|CT|ct
5781435|NCT00188214|CAT|cat
5781436|NCT00188214|non-small|non-small
5781437|NCT00188214|lung|lung
5781438|NCT00188201|Hepatitis C|hepatitis c
5781439|NCT00188201|neucognitive functions|neucognitive functions
5781440|NCT00188201|neuropsychological testing|neuropsychological testing
5781441|NCT00188201|antiviral treatment|antiviral treatment
5781442|NCT00188188|Endothelial|endothelial
5781443|NCT00188188|Dysfunction|dysfunction
5781444|NCT00188188|Systemic|systemic
5781445|NCT00188188|Lupus|lupus
5781446|NCT00188149|Hodgkin's Lymphoma|hodgkin's lymphoma
5781447|NCT00188149|Chemotherapy|chemotherapy
5781448|NCT00188149|Radiation therapy|radiation therapy
5781449|NCT00188149|PET|pet
5781450|NCT00188136|AML, allogeneic transplantation, high-risk, karyotype|aml, allogeneic transplantation, high-risk, karyotype
5781451|NCT00188123|Myocardial infarction|myocardial infarction
5781452|NCT00188123|MRI late enhancement|mri late enhancement
5781453|NCT00188123|Atrial fibrillation|atrial fibrillation
5781454|NCT00188110|Water-Enema Computed Tomography|water-enema computed tomography
5781455|NCT00188110|colon tumor|colon tumor
5781456|NCT00188110|coloscopy|coloscopy
5781457|NCT00188110|suspicion of colon tumor|suspicion of colon tumor
5781458|NCT00188110|coloscopy or surgery|coloscopy or surgery
5781459|NCT00188071|medical abortion|medical abortion
5781460|NCT00188071|analgesia|analgesia
5781461|NCT00188058|Acute respiratory distress syndrome|acute respiratory distress syndrome
5781462|NCT00188058|Positive end-expiratory pressure|positive end-expiratory pressure
5781463|NCT00188058|Acute lung injury|acute lung injury
5781464|NCT00188058|Mechanical ventilation|mechanical ventilation
5781465|NCT00188058|Randomized controlled trial|randomized controlled trial
5781566|NCT00187551|Drug Resistance, Multiple|drug resistance, multiple
5781661|NCT00187161|Large cell lymphoma|large cell lymphoma
5781466|NCT00188045|Portal hypertension, alcoholic cirrhosis, Hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol|portal hypertension, alcoholic cirrhosis, hepatic venous pressure gradient, hemodynamic, spironolactone, propranolol
5781467|NCT00188032|pulmonary embolism|pulmonary embolism
5781468|NCT00188032|clinical practice|clinical practice
5781469|NCT00188032|quality of health care|quality of health care
5781470|NCT00188032|diagnostic criteria|diagnostic criteria
5781471|NCT00188032|Computer-Assisted Decision Support|computer-assisted decision support
5781472|NCT00188032|reminders|reminders
5781473|NCT00188006|cardiopulmonary bypass, inflammatory response|cardiopulmonary bypass, inflammatory response
5781474|NCT00188006|neurologic injury|neurologic injury
5781475|NCT00188006|neurocognitive deficit|neurocognitive deficit
5781476|NCT00188006|biomaterials|biomaterials
5781477|NCT00188006|coronary artery bypass surgery|coronary artery bypass surgery
5781478|NCT00187993|growth hormone deficiency|growth hormone deficiency
5781479|NCT00187993|growth hormone|growth hormone
5781480|NCT00187993|energy expenditure|energy expenditure
5781481|NCT00187993|body composition|body composition
5781482|NCT00187954|women|women
5781483|NCT00187954|chest pain|chest pain
5781484|NCT00187954|microvascular dysfunction|microvascular dysfunction
5781485|NCT00187954|retinal photography|retinal photography
5781486|NCT00187954|Retinal vascular function|retinal vascular function
5781487|NCT00187941|transplant|transplant
5781488|NCT00187941|renal|renal
5781489|NCT00187941|Cellcept|cellcept
5781490|NCT00187941|therapeutic drug level|therapeutic drug level
5781492|NCT00187941|MPA|mpa
5781493|NCT00187941|immunosuppression|immunosuppression
5781494|NCT00187928|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5781495|NCT00187928|Obsessions|obsessions
5781496|NCT00187928|Compulsions|compulsions
5781497|NCT00187928|Adjunctive treatment|adjunctive treatment
5781498|NCT00187915|Renal transplant|renal transplant
5781499|NCT00187915|Cellcept|cellcept
5781500|NCT00187915|Therapeutic drug level|therapeutic drug level
5781501|NCT00187915|Mycophenolate mofetil (MMF)|mycophenolate mofetil (mmf)
5781502|NCT00187915|Mycophenolate Acid (MPA)|mycophenolate acid (mpa)
5781503|NCT00187915|Oral Bioavailability|oral bioavailability
5781504|NCT00187915|Immunosuppression|immunosuppression
5781505|NCT00187902|Sexually Transmitted Diseases|sexually transmitted diseases
5781506|NCT00187902|Chlamydia trachomatis|chlamydia trachomatis
5781507|NCT00187902|Neisseria gonorrhoeae|neisseria gonorrhoeae
5781508|NCT00187889|Microvascular Disease|microvascular disease
5781509|NCT00187889|Women|women
5781510|NCT00187889|Ischemic Heart Disease|ischemic heart disease
5781511|NCT00187889|WISE|wise
5781512|NCT00187850|Pulp capping|pulp capping
5781513|NCT00187850|partial pulpotomy|partial pulpotomy
5781514|NCT00187850|Exposure of the pulp|exposure of the pulp
5781515|NCT00187837|Stepwise excavation|stepwise excavation
5781516|NCT00187824|prospective|prospective
5781517|NCT00187824|observational|observational
5781518|NCT00187824|hormonal|hormonal
5781519|NCT00187824|inflammatory|inflammatory
5781520|NCT00187824|vioenergetic|vioenergetic
5781522|NCT00187824|sepsis|sepsis
5781523|NCT00187811|Angioplasty,|angioplasty,
5781524|NCT00187811|Restenosis,|restenosis,
5781525|NCT00187811|Photodynamic therapy|photodynamic therapy
5781526|NCT00187798|Healthy Control Twins|healthy control twins
5781527|NCT00187785|Hispanic|hispanic
5781528|NCT00187785|communication|communication
5781529|NCT00187772|domestic violence|domestic violence
5781530|NCT00187772|preschoolers|preschoolers
5781531|NCT00187772|trauma|trauma
5781532|NCT00187772|intervention|intervention
5781533|NCT00187759|Abscess|abscess
5781534|NCT00187759|Antibitoics|antibitoics
5781535|NCT00187759|Methicillin-resistant Staphylococcus aureus|methicillin-resistant staphylococcus aureus
5781536|NCT00187746|Healthy Control|healthy control
5781537|NCT00187733|L-carnitine|l-carnitine
5781538|NCT00187720|Healthy Control|healthy control
5781539|NCT00187681|Healthy controls|healthy controls
5781540|NCT00187668|Healthy Cohort|healthy cohort
5781541|NCT00187655|Healthy volunteers willing to be dosed with cefotaxime|healthy volunteers willing to be dosed with cefotaxime
5781542|NCT00187616|adverse events|adverse events
5781543|NCT00187616|clinical trial methodology|clinical trial methodology
5781544|NCT00187603|tobacco|tobacco
5781545|NCT00187603|cessation|cessation
5781546|NCT00187603|smoking|smoking
5781547|NCT00187603|smoking cessation|smoking cessation
5781548|NCT00187590|HIV|hiv
5798635|NCT00111527|Catheter ablation|catheter ablation
5798637|NCT00111527|Echocardiography|echocardiography
5776399|NCT00215137|OCD|ocd
5798638|NCT00111514|Leishmaniasis|leishmaniasis
5798639|NCT00111514|Subunit vaccine|subunit vaccine
5798640|NCT00111514|therapeutic|therapeutic
5798641|NCT00111514|T-cell|t-cell
5781549|NCT00187590|case management|case management
5781550|NCT00187577|Alopecia areata|alopecia areata
5781551|NCT00187577|Eyelash growth|eyelash growth
5781552|NCT00187577|Latanoprost|latanoprost
5781553|NCT00187577|Bimatoprost|bimatoprost
5781554|NCT00187564|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5781555|NCT00187564|lipoic acid|lipoic acid
5781556|NCT00187564|oxidative stress|oxidative stress
5781557|NCT00187551|enfuvirtide|enfuvirtide
5781558|NCT00187551|T20|t20
5781559|NCT00187551|Fuzeon|fuzeon
5781560|NCT00187551|Treatment|treatment
5781561|NCT00187551|Interruption|interruption
5781562|NCT00187551|Resistance|resistance
5781563|NCT00187551|HIV Drug Resistance|hiv drug resistance
5781564|NCT00187551|Antiretroviral Agents|antiretroviral agents
5781567|NCT00187551|Human Immunodeficiency virus|human immunodeficiency virus
5781569|NCT00187512|Antiretroviral Agents|antiretroviral agents
5781570|NCT00187512|Drug Resistance, Multiple|drug resistance, multiple
5781571|NCT00187512|Long Term Non Progression|long term non progression
5781572|NCT00187512|Long Term Non Progressor|long term non progressor
5781573|NCT00187512|Elite Suppression|elite suppression
5781574|NCT00187512|Elite Suppressor|elite suppressor
5781575|NCT00187512|Natural History|natural history
5781576|NCT00187512|Observational|observational
5781577|NCT00187499|Asthma|asthma
5781578|NCT00187499|Corticosteroid|corticosteroid
5781579|NCT00187499|Gene expression|gene expression
5781580|NCT00187486|Glioblastoma Multiforme|glioblastoma multiforme
5781581|NCT00187486|Gliosarcoma|gliosarcoma
5781582|NCT00187486|GBM|gbm
5781583|NCT00187486|GS|gs
5781584|NCT00187486|Tarceva|tarceva
5781585|NCT00187486|Temodar|temodar
5781586|NCT00187486|Radiation|radiation
5781587|NCT00187486|Newly Diagnosed|newly diagnosed
5781588|NCT00187473|hepatitis C|hepatitis c
5781589|NCT00187473|HCV|hcv
5781590|NCT00187473|natural history|natural history
5781591|NCT00187460|Acute myocardial infarction|acute myocardial infarction
5781592|NCT00187460|Congestive heart failure|congestive heart failure
5781593|NCT00187460|Quality of care|quality of care
5781594|NCT00187460|Reperfusion|reperfusion
5781595|NCT00187460|Report cards|report cards
5781596|NCT00187460|Quality indicators|quality indicators
5781597|NCT00187447|prematurity|prematurity
5781598|NCT00187447|chronic lung disease|chronic lung disease
5781599|NCT00187447|necrotizing enterocolitis|necrotizing enterocolitis
5781600|NCT00187447|indomethacin|indomethacin
5781601|NCT00187447|ductus arteriosus|ductus arteriosus
5781602|NCT00187434|premature infant|premature infant
5781603|NCT00187434|supporting extubation|supporting extubation
5781604|NCT00187421|coronary disease|coronary disease
5781605|NCT00187421|angiography|angiography
5781606|NCT00187421|intraoperative care|intraoperative care
5781607|NCT00187421|vascular patency|vascular patency
5781608|NCT00187408|Thrombosis|thrombosis
5781609|NCT00187408|Pulmonary Embolism|pulmonary embolism
5781610|NCT00187408|Low Molecular Weight Heparin|low molecular weight heparin
5781611|NCT00187408|Tibial Fractures|tibial fractures
5781612|NCT00187395|hypertension|hypertension
5781613|NCT00187395|blood pressure|blood pressure
5781614|NCT00187395|pregnancy|pregnancy
5781615|NCT00187382|antenatal corticosteroids|antenatal corticosteroids
5781616|NCT00187382|preterm birth|preterm birth
5781617|NCT00187382|multiple versus single doses|multiple versus single doses
5686434|NCT00552058|Certolizumab Pegol|certolizumab pegol
5781618|NCT00187382|follow-up|follow-up
5781619|NCT00187369|twins|twins
5781620|NCT00187369|twin births|twin births
5781621|NCT00187369|multiples|multiples
5781622|NCT00187356|Coronary Bypass Surgery|coronary bypass surgery
5781623|NCT00187356|Coronary Artery Disease|coronary artery disease
5781624|NCT00187356|Angiography|angiography
5781625|NCT00187356|Arterial Grafts|arterial grafts
5781626|NCT00187356|Radial Artery|radial artery
5781627|NCT00187356|Saphenous Vein|saphenous vein
5781628|NCT00187343|Radiotherapy|radiotherapy
5781629|NCT00187343|IMRT|imrt
5781630|NCT00187330|cardiopulmonary bypass|cardiopulmonary bypass
5781631|NCT00187330|renal insufficiency|renal insufficiency
5781632|NCT00187330|cardiac surgery|cardiac surgery
5781633|NCT00187330|n-acetylcysteine|n-acetylcysteine
5781634|NCT00187317|Exercise|exercise
5781635|NCT00187317|Rehabilitation|rehabilitation
5781636|NCT00187317|Postural Balance|postural balance
5781637|NCT00187317|Accidental Falls|accidental falls
5781638|NCT00187317|Geriatrics|geriatrics
5781639|NCT00187291|T-Wave Alternans|t-wave alternans
5781640|NCT00187291|ICD|icd
5781641|NCT00187291|Primary Prevention|primary prevention
5781642|NCT00187278|Standard pacing indication|standard pacing indication
5781643|NCT00187252|Ventricular Dyssynchrony|ventricular dyssynchrony
5781644|NCT00187239|ICDs|icds
5781645|NCT00187239|Ventricular pacing|ventricular pacing
5781646|NCT00187239|Patient has been implanted with a dual chamber SJM ICD with AICS for 1 month (± 2 weeks).|patient has been implanted with a dual chamber sjm icd with aics for 1 month (± 2 weeks).
5781647|NCT00187239|At the time of enrollment, patient is paced in the RV ≤25% of the time as determined by the device diagnostics.|at the time of enrollment, patient is paced in the rv ≤25% of the time as determined by the device diagnostics.
5781649|NCT00187226|Brain neoplasm|brain neoplasm
5781650|NCT00187226|Brain cancer|brain cancer
5781651|NCT00187226|Neoplasm intracranial|neoplasm intracranial
5781652|NCT00187213|Ventricular Dyssynchrony|ventricular dyssynchrony
5781653|NCT00187174|Brain tumors|brain tumors
5781654|NCT00187174|Soft Tissue Sarcomas|soft tissue sarcomas
5781655|NCT00187174|Refractory solid tumors|refractory solid tumors
5781656|NCT00187174|Recurrent or Refractory Rhabdomyosarcomatous Soft Tissue and Non-Rhabdomyosarcoma Soft Tissue Sarcomas|recurrent or refractory rhabdomyosarcomatous soft tissue and non-rhabdomyosarcoma soft tissue sarcomas
5781657|NCT00187161|Mature B-Cell Leukemia|mature b-cell leukemia
5781658|NCT00187161|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5781659|NCT00187161|Burkitt's lymphoma|burkitt's lymphoma
5781660|NCT00187161|Small noncleaved cell non Hodgkin lymphoma|small noncleaved cell non hodgkin lymphoma
5781662|NCT00187148|Vaccine|vaccine
5781663|NCT00187148|Prevention|prevention
5781664|NCT00187148|HIV|hiv
5781665|NCT00187148|AIDS|aids
5781666|NCT00187135|Pain Management|pain management
5781667|NCT00187135|Bone Marrow Aspiration|bone marrow aspiration
5781668|NCT00187122|Non-Hodgkin|non-hodgkin
5781669|NCT00187122|Lymphoma|lymphoma
5781670|NCT00187109|Thrombocytopenia|thrombocytopenia
5781671|NCT00187109|Platelets|platelets
5781672|NCT00187109|Thrombopoietin|thrombopoietin
5781673|NCT00187096|Leukemia|leukemia
5781674|NCT00187096|Myeloid|myeloid
5781675|NCT00187096|Acute|acute
5781676|NCT00187083|Leukemia|leukemia
5781677|NCT00187083|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5781678|NCT00187083|Refractory Acute Lymphoblastic Leukemia|refractory acute lymphoblastic leukemia
5781679|NCT00187083|Relapsed Acute Lymphoblastic Leukemia|relapsed acute lymphoblastic leukemia
5781680|NCT00187057|Ataxia|ataxia
5781681|NCT00187057|alphafetoprotein|alphafetoprotein
5781682|NCT00187044|Vaccine|vaccine
5681091|NCT00574769|prostate cancer|prostate cancer
5781683|NCT00187044|Prevention|prevention
5781685|NCT00187044|AIDS|aids
5781686|NCT00187031|Wilms Tumor|wilms tumor
5781687|NCT00187018|Collagen Disease|collagen disease
5781688|NCT00187005|Leukemia|leukemia
5781689|NCT00186992|Sarcoma|sarcoma
5781690|NCT00186992|radiation therapy|radiation therapy
5781691|NCT00186992|Other musculoskeletal tumors|other musculoskeletal tumors
5781692|NCT00186979|Refractory Childhood Solid Tumors|refractory childhood solid tumors
5781693|NCT00186953|Ultrasound|ultrasound
5781694|NCT00186953|Abdominal tumors|abdominal tumors
5781695|NCT00186953|Pelvic tumors|pelvic tumors
5781696|NCT00186940|leukemia|leukemia
5781697|NCT00186927|Vaccine|vaccine
5781698|NCT00186927|Sendai virus vaccine|sendai virus vaccine
5781699|NCT00186914|Bone marrow transplant|bone marrow transplant
5781700|NCT00186914|bone marrow stromal cells|bone marrow stromal cells
5781701|NCT00186914|allogeneic transplant|allogeneic transplant
5781702|NCT00186914|Osteodysplasia|osteodysplasia
5781703|NCT00186914|Osteogenesis imperfecta|osteogenesis imperfecta
5781704|NCT00186914|Gene marking|gene marking
5781705|NCT00186914|Stromal cell|stromal cell
5781706|NCT00186901|Bone Density|bone density
5781707|NCT00186888|Cancer of the Eye|cancer of the eye
5781708|NCT00186888|Eye Enucleation|eye enucleation
5781709|NCT00186875|Leukemia|leukemia
5781710|NCT00186875|Lymphoblastic|lymphoblastic
5781711|NCT00186875|Acute|acute
5781712|NCT00186875|Lymphoma|lymphoma
5781713|NCT00186875|Non-Hodgkin's|non-hodgkin's
5686435|NCT00552058|CIMZIA ®|cimzia ®
5806394|NCT00089414|MRMD|mrmd
5781714|NCT00186862|Neuroblastoma|neuroblastoma
5781715|NCT00186862|Immunotherapy|immunotherapy
5781716|NCT00186862|Gene therapy|gene therapy
5781717|NCT00186849|Neuroblastoma|neuroblastoma
5781718|NCT00186836|Hepatitis A|hepatitis a
5781719|NCT00186836|Hepatitis B|hepatitis b
5781720|NCT00186836|Hemodialysis|hemodialysis
5781721|NCT00186836|Vaccine|vaccine
5781722|NCT00186823|Haploidentical stem cell transplant|haploidentical stem cell transplant
5781723|NCT00186823|Allogeneic stem cell transplant|allogeneic stem cell transplant
5781724|NCT00186823|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5781850|NCT00185159|Microalbuminuria|microalbuminuria
5781725|NCT00186823|Bone marrow transplantHigh risk hematologic malignancies|bone marrow transplanthigh risk hematologic malignancies
5781727|NCT00186810|Sickle Cell|sickle cell
5781728|NCT00186797|Aplastic Anemia|aplastic anemia
5781729|NCT00186784|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5781730|NCT00186784|TMS|tms
5781731|NCT00186771|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5781732|NCT00186771|Paired Pulse|paired pulse
5781733|NCT00186758|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5781734|NCT00186758|TMS|tms
5781735|NCT00186745|Venous thrombosis|venous thrombosis
5781736|NCT00186745|Pulmonary embolism|pulmonary embolism
5781737|NCT00186745|Kidney failure|kidney failure
5781738|NCT00186745|Anticoagulants|anticoagulants
5781739|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight
5781740|NCT00186732|wound closure|wound closure
5781741|NCT00186732|Pfannenstiel incision|pfannenstiel incision
5781742|NCT00186732|surgical staples|surgical staples
5781743|NCT00186732|subcuticular suture|subcuticular suture
5781744|NCT00186719|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5781745|NCT00186719|Smoking Related Disease|smoking related disease
5781746|NCT00186719|Immune System Changes|immune system changes
5781747|NCT00186706|Selenium|selenium
5781748|NCT00186706|Chronic Obstructive Pulmonaary Disease|chronic obstructive pulmonaary disease
5781749|NCT00186706|Cardiovascular Disease|cardiovascular disease
5781750|NCT00186706|Anti-oxidant|anti-oxidant
5781751|NCT00186706|Pulmonary|pulmonary
5781752|NCT00186693|Airway remodeling|airway remodeling
5781753|NCT00186693|Asthma|asthma
5781754|NCT00186693|Hyper-responsiveness|hyper-responsiveness
5781755|NCT00186641|chronic Graft vs Host Disease|chronic graft vs host disease
5781756|NCT00186537|Insulin resistance|insulin resistance
5781757|NCT00186537|Insulin resistance syndrome|insulin resistance syndrome
5781758|NCT00186537|dyslipidemia|dyslipidemia
5781759|NCT00186537|atherogenic dyslipidemia|atherogenic dyslipidemia
5782363|NCT00182871|HT|ht
5781760|NCT00186537|triglyceride/HDL-C ratio|triglyceride/hdl-c ratio
5781761|NCT00186420|Prostate Cancer|prostate cancer
5781762|NCT00186420|Taxotere|taxotere
5781763|NCT00186368|Prostate cancer|prostate cancer
5781764|NCT00186368|Gene expression|gene expression
5781765|NCT00186368|tumor markers|tumor markers
5781766|NCT00186368|microarray analysis|microarray analysis
5781767|NCT00186329|Vasodilation|vasodilation
5782454|NCT00182559|conversion|conversion
5781768|NCT00186329|Congestive heart failure|congestive heart failure
5781769|NCT00186329|Renal insufficiency|renal insufficiency
5781770|NCT00186329|Diuresis|diuresis
5781771|NCT00186329|Serum creatinine|serum creatinine
5781772|NCT00186199|voiding patterns|voiding patterns
5781773|NCT00186199|flow rate|flow rate
5781774|NCT00186199|ultrasound|ultrasound
5781775|NCT00186173|Obesity|obesity
5781776|NCT00186173|Physical activity|physical activity
5781777|NCT00186134|Physical Activity|physical activity
5781778|NCT00186134|Walking|walking
5781779|NCT00186134|Primary Schools|primary schools
5781780|NCT00186134|Transportation|transportation
5781781|NCT00186108|Oral Triamcinalone|oral triamcinalone
5781782|NCT00186108|Prostate Cancer|prostate cancer
5781783|NCT00186095|Amyloidosis|amyloidosis
5781784|NCT00186095|nonmyeloablative|nonmyeloablative
5781785|NCT00186095|hematopoietic|hematopoietic
5781786|NCT00186095|cell transplantation|cell transplantation
5781787|NCT00186030|HIV|hiv
5781788|NCT00186030|AIDS|aids
5781789|NCT00186030|PTSD|ptsd
5781790|NCT00186030|Prevention|prevention
5781791|NCT00185978|obesity prevention|obesity prevention
5781792|NCT00185978|preadolescents|preadolescents
5781793|NCT00185978|schools|schools
5781794|NCT00185965|non-Hodgkin|non-hodgkin
5781795|NCT00185965|lymphoma|lymphoma
5781796|NCT00185965|mycosis|mycosis
5781797|NCT00185965|fungoides|fungoides
5781798|NCT00185939|dog bites|dog bites
5781799|NCT00185939|infection|infection
5781800|NCT00185939|prophylactic antibiotics|prophylactic antibiotics
5781801|NCT00185939|cost effectiveness|cost effectiveness
5781802|NCT00185783|Sepsis|sepsis
5781803|NCT00185783|Adrenal Insufficiency|adrenal insufficiency
5781804|NCT00185783|Hydrocortisone|hydrocortisone
5781805|NCT00185783|Gene Expression|gene expression
5781806|NCT00185783|Microarray|microarray
5781807|NCT00185783|RNA|rna
5781808|NCT00185783|Critically Ill|critically ill
5781809|NCT00185770|Obesity prevention|obesity prevention
5781810|NCT00185770|Television|television
5781811|NCT00185770|Screen time|screen time
5781813|NCT00185770|Preadolescents|preadolescents
5781814|NCT00185705|Insulin resistance|insulin resistance
5781815|NCT00185705|obesity|obesity
5781816|NCT00185705|hypertension|hypertension
5781817|NCT00185705|adolescents|adolescents
5781818|NCT00185705|telmisartan|telmisartan
5781819|NCT00185705|lifestyle intervention|lifestyle intervention
5781820|NCT00185562|Osteoarthritis|osteoarthritis
5781821|NCT00185549|Cystic Fibrosis;|cystic fibrosis;
5781822|NCT00185549|patient education,|patient education,
5781823|NCT00185549|Internet|internet
5781824|NCT00185536|Taste|taste
5781825|NCT00185536|preschool children|preschool children
5781826|NCT00185536|fast food|fast food
5781827|NCT00185484|Oral contraception|oral contraception
5781828|NCT00185445|Non Hodgkin Lymphoma|non hodgkin lymphoma
5781829|NCT00185393|Follicular Non Hodgkin lymphoma|follicular non hodgkin lymphoma
5781830|NCT00185354|FC patch|fc patch
5781831|NCT00185354|comparator study|comparator study
5781832|NCT00185341|Endometriosis associated pelvic pain|endometriosis associated pelvic pain
5781833|NCT00185328|Postmenopause|postmenopause
5781834|NCT00185302|Non-resectable metastatic melanoma|non-resectable metastatic melanoma
5781835|NCT00185276|Structural abnormalities of the infrarenal aorta and peripheral arteries|structural abnormalities of the infrarenal aorta and peripheral arteries
5781836|NCT00185263|angina|angina
5781837|NCT00185263|FGF-4|fgf-4
5781838|NCT00185263|angiogenesis|angiogenesis
5781839|NCT00185263|adenovector|adenovector
5781840|NCT00185263|growth factor|growth factor
5781841|NCT00185263|myocardial ischemia|myocardial ischemia
5781842|NCT00185263|revascularization|revascularization
5781843|NCT00185250|Cardiomyopathy|cardiomyopathy
5781844|NCT00185250|idiopathic chronic heart failure|idiopathic chronic heart failure
5781846|NCT00185250|Enterovirus|enterovirus
5781847|NCT00185250|Parvovirus|parvovirus
5781848|NCT00185237|Menopause|menopause
5781849|NCT00185198|Partial androgen deficiency of aging males (PADAM)|partial androgen deficiency of aging males (padam)
5781851|NCT00185133|Treatment of high blood pressure in mild to severe hypertensive patients|treatment of high blood pressure in mild to severe hypertensive patients
5781852|NCT00185120|Hypertension|hypertension
5781853|NCT00185120|angiotensin receptor blocker|angiotensin receptor blocker
5781854|NCT00185120|calcium channel blocker|calcium channel blocker
5781855|NCT00185120|angiotensin converting enzyme inhibitor hydroclorothiazide|angiotensin converting enzyme inhibitor hydroclorothiazide
5781856|NCT00185107|Safety|safety
5781857|NCT00185107|Efficacy|efficacy
5781858|NCT00185107|WelChol®|welchol®
5781859|NCT00185107|Zocor®|zocor®
5781860|NCT00185107|Zetia®|zetia®
5781861|NCT00185081|colon cancer|colon cancer
5781862|NCT00185081|radioimmunoscintigraphy|radioimmunoscintigraphy
5781863|NCT00185081|colon-specific antigen,|colon-specific antigen,
5781864|NCT00185081|radioimmunotherapy,|radioimmunotherapy,
5781865|NCT00185081|radioimmunodetection|radioimmunodetection
5781866|NCT00185068|Systolic hypertension, Angiotensin receptor blocker|systolic hypertension, angiotensin receptor blocker
5781867|NCT00185055|olmesartan|olmesartan
5781868|NCT00185055|valsartan|valsartan
5781869|NCT00185055|irbesartan|irbesartan
5781870|NCT00185055|renin-angiotensin-aldosterone system|renin-angiotensin-aldosterone system
5781871|NCT00185042|Atherosclerosis, intravascular ultrasound|atherosclerosis, intravascular ultrasound
5781872|NCT00185029|prostate|prostate
5781873|NCT00185029|ferumoxtran-10|ferumoxtran-10
5781874|NCT00185029|lymph nodes|lymph nodes
5781875|NCT00185029|USPIO|uspio
5781876|NCT00185016|intimate partner abuse|intimate partner abuse
5781877|NCT00185016|gender|gender
5781878|NCT00185016|education|education
5681158|NCT00574496|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5781880|NCT00185016|family doctor|family doctor
5781881|NCT00185016|health care utilisation|health care utilisation
5781882|NCT00185016|abused women|abused women
5781883|NCT00185003|Endotoxemia|endotoxemia
5781884|NCT00185003|vascular potassium channels|vascular potassium channels
5781885|NCT00185003|cytokine|cytokine
5781886|NCT00185003|norepinephrine|norepinephrine
5781887|NCT00185003|regional blood flow,|regional blood flow,
5781888|NCT00185003|inflammation,|inflammation,
5781889|NCT00185003|ion channels,|ion channels,
5781890|NCT00185003|nitric oxide synthase,|nitric oxide synthase,
5781891|NCT00185003|pharmacology.|pharmacology.
5781892|NCT00184990|Endotoxemia|endotoxemia
5781893|NCT00184990|Aminoguanidine|aminoguanidine
5781894|NCT00184977|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5781895|NCT00184977|Randomized Controlled Trial|randomized controlled trial
5781896|NCT00184977|Family Practice|family practice
5781897|NCT00184977|Respiratory Function Tests|respiratory function tests
5781898|NCT00184977|Health Status|health status
5781899|NCT00184951|HIV|hiv
5781900|NCT00184938|opioids|opioids
5781901|NCT00184938|ischemic preconditioning|ischemic preconditioning
5781902|NCT00184938|morphine|morphine
5781903|NCT00184899|free fatty acids|free fatty acids
5781904|NCT00184899|vasodilation|vasodilation
5781905|NCT00184899|sympathetic activity|sympathetic activity
5781906|NCT00184873|randomized controlled trial|randomized controlled trial
5686436|NCT00552058|Crohn's disease|crohn's disease
5781907|NCT00184873|health-counseling|health-counseling
5781908|NCT00184873|multi-center study|multi-center study
5781910|NCT00184847|adenosine|adenosine
5781911|NCT00184847|caffeine|caffeine
5781912|NCT00184847|ischemic preconditioning|ischemic preconditioning
5781913|NCT00184834|colorectal|colorectal
5781914|NCT00184834|liver|liver
5781915|NCT00184834|metastases|metastases
5781916|NCT00184834|health-related quality of life|health-related quality of life
5781917|NCT00184834|surgery|surgery
5781918|NCT00184821|Diabetes|diabetes
5781919|NCT00184821|Ischemia|ischemia
5781920|NCT00184821|Annexin A5 scintigraphy|annexin a5 scintigraphy
5781921|NCT00184795|Hot flashes|hot flashes
5781922|NCT00184782|colorectal cancer|colorectal cancer
5781923|NCT00184782|liver metastases|liver metastases
5781924|NCT00184782|metabolic activity|metabolic activity
5781925|NCT00184587|prophylactic|prophylactic
5781926|NCT00184587|episodic|episodic
5781927|NCT00184587|cluster|cluster
5781928|NCT00184587|candesartan|candesartan
5781929|NCT00184587|angiotensin II receptor blocker|angiotensin ii receptor blocker
5781930|NCT00184587|randomized placebo controlled parallel study|randomized placebo controlled parallel study
5781931|NCT00184587|headache diary|headache diary
5781932|NCT00184535|Low back pain|low back pain
5781933|NCT00184535|Neuromuscular control|neuromuscular control
5781934|NCT00184535|Anticipatory motor control|anticipatory motor control
5781935|NCT00184535|Musculoskeletal Physiologic Processes|musculoskeletal physiologic processes
5781936|NCT00184535|Muscle, Skeletal|muscle, skeletal
5781937|NCT00184535|Ultrasonography|ultrasonography
5781938|NCT00184535|Electromyography|electromyography
5781939|NCT00184522|Gastroesophageal Reflux|gastroesophageal reflux
5781940|NCT00184522|Esomeprazole|esomeprazole
5781941|NCT00184522|Drug treatment|drug treatment
5776785|NCT00213057|HIV|hiv
5781942|NCT00184509|schizophrenia|schizophrenia
5781943|NCT00184509|psychosocial treatment|psychosocial treatment
5781944|NCT00184509|outcome|outcome
5781945|NCT00184496|Analgesics, Opioid/pharmacokinetics|analgesics, opioid/pharmacokinetics
5781946|NCT00184496|Humans|humans
5781947|NCT00184496|Methadone/therapeutic use|methadone/therapeutic use
5781948|NCT00184496|Neoplasms/complications|neoplasms/complications
5781949|NCT00184496|pain/drug therapy|pain/drug therapy
5781950|NCT00184483|Surgery|surgery
5781951|NCT00184483|Lichtenstein|lichtenstein
5781952|NCT00184483|Prolene Hernia System|prolene hernia system
5781953|NCT00184483|Postoperative pain|postoperative pain
5781954|NCT00184483|Recurrence|recurrence
5781955|NCT00184470|Adult|adult
5781956|NCT00184470|Child|child
5781957|NCT00184470|Hospitalization/statistics & numerical data|hospitalization/statistics & numerical data
5781958|NCT00184470|Retrospective studies|retrospective studies
5781959|NCT00184457|Cardiac heart failure|cardiac heart failure
5781960|NCT00184457|Leg press|leg press
5782364|NCT00182871|andropause|andropause
5781961|NCT00184457|Maximal strength training|maximal strength training
5781962|NCT00184457|Serum testosterone|serum testosterone
5781963|NCT00184457|Work economy|work economy
5781964|NCT00184444|angina pectoris|angina pectoris
5781965|NCT00184444|hyperoxia|hyperoxia
5781966|NCT00184444|endurance training|endurance training
5781967|NCT00184444|stroke volume|stroke volume
5783056|NCT00179660|Revlimid|revlimid
5781968|NCT00184444|cardiac perfusion|cardiac perfusion
5781969|NCT00184431|Cerebrovascular Accident|cerebrovascular accident
5781970|NCT00184431|Physical Therapy Techniques|physical therapy techniques
5781971|NCT00184431|Musculoskeletal Equilibrium|musculoskeletal equilibrium
5781972|NCT00184431|Rehabilitation|rehabilitation
5781973|NCT00184418|Immunity|immunity
5681092|NCT00574769|Metastatic, androgen independent prostate cancer|metastatic, androgen independent prostate cancer
5681093|NCT00574743|ERL080A, Heart Transplantation, Mycophenolate, EC-MPS|erl080a, heart transplantation, mycophenolate, ec-mps
5681094|NCT00574717|hyperopia|hyperopia
5791702|NCT00137280|Obesity|obesity
5781974|NCT00184418|Immune System|immune system
5781975|NCT00184418|Cytokines|cytokines
5781976|NCT00184418|Psychophysiology|psychophysiology
5781977|NCT00184418|Psychoneuroimmunology|psychoneuroimmunology
5781978|NCT00184405|Parents with psychiatric or addictive problems|parents with psychiatric or addictive problems
5781979|NCT00184392|Sinus surgery|sinus surgery
5781980|NCT00184392|endoscopic|endoscopic
5781981|NCT00184392|postoperative care|postoperative care
5781982|NCT00184392|debridement|debridement
5781983|NCT00184392|randomized|randomized
5781984|NCT00184392|acute recurrent rhinosinusitis|acute recurrent rhinosinusitis
5781985|NCT00184392|chronic rhinosinusitis|chronic rhinosinusitis
5781986|NCT00184392|nasal polyps|nasal polyps
5781987|NCT00184392|Chronic rhinosinusitis with nasal polyps|chronic rhinosinusitis with nasal polyps
5781988|NCT00184392|Chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps
5781989|NCT00184379|Family|family
5781990|NCT00184379|Coping Skills|coping skills
5781991|NCT00184379|Psychoeducation|psychoeducation
5781992|NCT00184379|Stress, Psychological|stress, psychological
5781993|NCT00184379|Health Education|health education
5781994|NCT00184366|drug therapy|drug therapy
5781995|NCT00184366|efalizumab|efalizumab
5686437|NCT00552058|Induction|induction
5781996|NCT00184353|brain metastasis|brain metastasis
5781997|NCT00184353|signal to noise ratio|signal to noise ratio
5781998|NCT00184353|spectral resolution|spectral resolution
5781999|NCT00184340|eTherapy supplementary|etherapy supplementary
5782000|NCT00184327|Severe and longstanding psychiatric symptoms in children|severe and longstanding psychiatric symptoms in children
5782001|NCT00184301|Eating disorders|eating disorders
5782002|NCT00184301|Anorexia nervosa|anorexia nervosa
5782003|NCT00184301|Bulimia nervosa|bulimia nervosa
5782004|NCT00184301|Personality disorders|personality disorders
5782005|NCT00184301|In-patient treatment|in-patient treatment
5782006|NCT00184301|out-patient treatment|out-patient treatment
5782007|NCT00184301|group therapy|group therapy
5782009|NCT00184288|choline|choline
5782010|NCT00184288|metastasis|metastasis
5782011|NCT00184288|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5782012|NCT00184288|treatment response|treatment response
5782013|NCT00184275|Brain metastasis|brain metastasis
5782014|NCT00184275|HR MAS spectroscopy|hr mas spectroscopy
5782015|NCT00184275|Tissue micro array|tissue micro array
5782016|NCT00184275|DNA micro array|dna micro array
5782017|NCT00184249|Catheter ablation|catheter ablation
5782018|NCT00184249|Heart/surgery|heart/surgery
5782019|NCT00184249|Cardial surgical procedures|cardial surgical procedures
5782020|NCT00184236|Exercise Training|exercise training
5782021|NCT00184236|Cardiovascular diseases|cardiovascular diseases
5782022|NCT00184236|Risk factors|risk factors
5782023|NCT00184223|Motivational Interviewing|motivational interviewing
5782024|NCT00184223|Substance abuse|substance abuse
5782025|NCT00184223|Acuteley admitted psychiatric patients|acuteley admitted psychiatric patients
5782026|NCT00184223|Emergency Services, Psychiatric|emergency services, psychiatric
5782027|NCT00184210|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5782028|NCT00184197|Injection|injection
5782029|NCT00184197|Headache|headache
5782030|NCT00184197|Cervical muscles|cervical muscles
5782031|NCT00184184|Emergency Services, Psychiatric|emergency services, psychiatric
5782032|NCT00184184|Tobacco use cessation|tobacco use cessation
5782033|NCT00184184|Coffee use cessation|coffee use cessation
5782034|NCT00184184|substance use detection|substance use detection
5782035|NCT00184184|Substance Abuse Detection|substance abuse detection
5782036|NCT00184171|Microscopic colitis|microscopic colitis
5782037|NCT00184171|Drug treatment|drug treatment
5782038|NCT00184171|Diarrhoea|diarrhoea
5782039|NCT00184158|Cubital tunnel|cubital tunnel
5782040|NCT00184158|treatment|treatment
5782041|NCT00184158|nerve compression|nerve compression
5782042|NCT00184145|Specific (Animal) Phobia|specific (animal) phobia
5782044|NCT00184145|Exposure therapy|exposure therapy
5782045|NCT00184132|Intensive care units|intensive care units
5782046|NCT00184132|Emergency services, psychiatric|emergency services, psychiatric
5782047|NCT00184132|Interior Design and Furnishings|interior design and furnishings
5782048|NCT00184132|Intensive Care|intensive care
5782049|NCT00184119|Emergency services, psychiatric|emergency services, psychiatric
5782050|NCT00184119|Intensive care units|intensive care units
5782051|NCT00184119|Hospitals, psychiatric|hospitals, psychiatric
5782052|NCT00184119|Aggression|aggression
5782053|NCT00184119|Violence|violence
5782054|NCT00184106|Phobic disorders|phobic disorders
5782055|NCT00184106|Therapy, cognitive|therapy, cognitive
5782056|NCT00184106|Paroxetine|paroxetine
5782057|NCT00184093|Cervical Carcinoma|cervical carcinoma
5782058|NCT00183976|Diffuse mixed NHL|diffuse mixed nhl
5782059|NCT00183976|Diffuse or follicular large B-cell NHL|diffuse or follicular large b-cell nhl
5782060|NCT00183976|Immunoblastic NHL|immunoblastic nhl
5784626|NCT00171574|lisinopril|lisinopril
5782061|NCT00183976|Burkitt or Burkitt-like lymphomas|burkitt or burkitt-like lymphomas
5782062|NCT00183898|Gastroesophageal Junction Cancer|gastroesophageal junction cancer
5782063|NCT00183872|Gastroesophageal cancer|gastroesophageal cancer
5782064|NCT00183872|Gastric Adenocarcinoma|gastric adenocarcinoma
5782065|NCT00183872|Gastroesophageal Junction Adenocarcinoma|gastroesophageal junction adenocarcinoma
5782066|NCT00183859|solid tumor|solid tumor
5782067|NCT00183859|phase I|phase i
5782068|NCT00183859|phase one|phase one
5782069|NCT00183846|pancreas|pancreas
5782070|NCT00183846|stomach|stomach
5782071|NCT00183846|common bile duct cancer|common bile duct cancer
5782072|NCT00183846|ampulla of Vater cancer|ampulla of vater cancer
5782073|NCT00183833|phase 1|phase 1
5782074|NCT00183833|phase I|phase i
5782075|NCT00183833|phase one|phase one
5782076|NCT00183833|colon cancer|colon cancer
5782077|NCT00183833|colorectal cancer|colorectal cancer
5782078|NCT00183820|Testicular|testicular
5782079|NCT00183820|Extra gonadal germ cell neoplasm|extra gonadal germ cell neoplasm
5782080|NCT00183794|Primary Peritoneal|primary peritoneal
5782081|NCT00183781|HIV|hiv
5782082|NCT00183781|Telephone intervention|telephone intervention
5782083|NCT00183768|Cognitive Behavioral Treatment For Depression|cognitive behavioral treatment for depression
5782084|NCT00183768|Antidepressant Psychopharmacology|antidepressant psychopharmacology
5782085|NCT00183768|HIV Risk Behavior|hiv risk behavior
5782086|NCT00183768|Injection Drug Use|injection drug use
5782087|NCT00183755|Reward Processing|reward processing
5686438|NCT00552058|Clinical remission|clinical remission
5782088|NCT00183755|Anhedonia|anhedonia
5782089|NCT00183755|Major Depressive Disorder|major depressive disorder
5782090|NCT00183755|Depression|depression
5782091|NCT00183742|Phase 1|phase 1
5782092|NCT00183742|Phase I|phase i
5782093|NCT00183742|Phase one|phase one
5782094|NCT00183742|Solid tumor|solid tumor
5772274|NCT00235378|SLE|sle
5782095|NCT00183729|Major depressive disorder|major depressive disorder
5782096|NCT00183729|Rehabilitating|rehabilitating
5782097|NCT00183729|Elderly|elderly
5782098|NCT00183729|Apathy|apathy
5782099|NCT00183716|PTSD|ptsd
5782100|NCT00183716|Physical Abuse|physical abuse
5782101|NCT00183716|Sexual Abuse|sexual abuse
5782102|NCT00183716|Women|women
5782103|NCT00183716|Trauma|trauma
5782104|NCT00183716|Group Therapy|group therapy
5782105|NCT00183716|Substance Abuse|substance abuse
5782106|NCT00183703|Depression, Bipolar|depression, bipolar
5782107|NCT00183703|Manic-Depressive Psychosis|manic-depressive psychosis
5782108|NCT00183690|PTSD|ptsd
5782109|NCT00183690|Anxiety Disorder|anxiety disorder
5782110|NCT00183690|Trauma|trauma
5782111|NCT00183690|Adolescents|adolescents
5782112|NCT00183690|Cognitive Behavioral Therapy|cognitive behavioral therapy
5782113|NCT00183677|Brain Bioenergetic Metabolism|brain bioenergetic metabolism
5782114|NCT00183677|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5782115|NCT00183677|Major Depressive Disorder|major depressive disorder
5782116|NCT00183677|Treatment Response|treatment response
5782117|NCT00183651|Suicide|suicide
5782118|NCT00183651|Women|women
5782119|NCT00183651|Emotions|emotions
5782120|NCT00183651|Psychotherapy, Group|psychotherapy, group
5782121|NCT00183638|Internet|internet
5782122|NCT00183638|Interactive Computer Program|interactive computer program
5782123|NCT00183638|HIV Prevention|hiv prevention
5782124|NCT00183625|Antipsychotic Agents|antipsychotic agents
5782125|NCT00183625|Employment|employment
5782126|NCT00183612|Child|child
5782127|NCT00183612|Adolescent|adolescent
5782129|NCT00183612|Olanzapine|olanzapine
5782130|NCT00183612|Pharmacokinetics|pharmacokinetics
5782131|NCT00183612|Pharmacology|pharmacology
5782132|NCT00183599|Brief interventions|brief interventions
5782133|NCT00183599|Motivational Enhancement Therapy|motivational enhancement therapy
5782134|NCT00183599|Cognitive Behavioral Therapy|cognitive behavioral therapy
5782135|NCT00183586|Treatment outcomes study|treatment outcomes study
5782136|NCT00183586|Anorexia|anorexia
5782137|NCT00183586|Anorexia nervosa|anorexia nervosa
5782138|NCT00183573|STDs|stds
5782139|NCT00183573|Sexual Behavior|sexual behavior
5782140|NCT00183573|Health Behavior|health behavior
5782141|NCT00183573|HIV Seronegativity|hiv seronegativity
5782142|NCT00183560|Depression Recurrence|depression recurrence
5782143|NCT00183560|Drug Therapy|drug therapy
5782144|NCT00183560|Cognitive Therapy|cognitive therapy
5782145|NCT00183560|Relapse|relapse
5782146|NCT00183560|Antidepressants|antidepressants
5782147|NCT00183547|Postpartum Depression|postpartum depression
5782148|NCT00183547|Postpartum Period|postpartum period
5782149|NCT00183547|Indians, North American|indians, north american
5782150|NCT00183547|Adolescent|adolescent
5782151|NCT00183547|Female|female
5782152|NCT00183547|CBT|cbt
5782153|NCT00183521|Hyperventilation|hyperventilation
5782154|NCT00183521|Breathing Exercises|breathing exercises
5782155|NCT00183521|Carbon Dioxide|carbon dioxide
5782156|NCT00183521|Panic Attack|panic attack
5782157|NCT00183508|PTSD|ptsd
5782158|NCT00183508|Occupational Health|occupational health
5782159|NCT00183508|Trauma|trauma
5782160|NCT00183508|Job|job
5782161|NCT00183508|CBT|cbt
5782162|NCT00183495|Depression, Bipolar|depression, bipolar
5785602|NCT00167310|Placebos|placebos
5782163|NCT00183495|Manic-Depressive Psychosis|manic-depressive psychosis
5782164|NCT00183482|Parents|parents
5782165|NCT00183482|Child|child
5782166|NCT00183482|Stress|stress
5782167|NCT00183482|CBT|cbt
5782168|NCT00183469|Lamotrigine|lamotrigine
5782169|NCT00183469|Divalproex|divalproex
5782170|NCT00183469|Antidepressant|antidepressant
5782171|NCT00183456|Sex Education|sex education
5782172|NCT00183456|Peer Group|peer group
5782173|NCT00183456|Social Identity Theory|social identity theory
5782174|NCT00183456|HIV Seronegativity|hiv seronegativity
5782175|NCT00183456|Intervention|intervention
5782176|NCT00183456|women|women
5782177|NCT00183456|Social Networks|social networks
5782178|NCT00183456|Peer Education|peer education
5782179|NCT00183443|Mania|mania
5782180|NCT00183443|Manic-depressive|manic-depressive
5782181|NCT00183443|Psychotic disorder|psychotic disorder
5782182|NCT00183430|Prazosin|prazosin
5782183|NCT00183430|Sleep Disorders|sleep disorders
5782184|NCT00183417|Adolescent|adolescent
5782185|NCT00183417|CBT|cbt
5782186|NCT00183404|Drug Treatment|drug treatment
5782187|NCT00183404|Child|child
5782188|NCT00183404|Olanzapine|olanzapine
5782189|NCT00183391|ADHD|adhd
5782190|NCT00183391|Child|child
5782191|NCT00183391|Adolescent|adolescent
5782192|NCT00183391|School|school
5782193|NCT00183378|Alzheimer's Disease|alzheimer's disease
5782194|NCT00183378|Insomnia|insomnia
5782195|NCT00183378|Sleep Problems|sleep problems
5782196|NCT00183378|Elderly|elderly
5782197|NCT00183378|Caregivers|caregivers
5782198|NCT00183365|Family|family
5782199|NCT00183365|Parenting|parenting
5782200|NCT00183365|Depression|depression
5782201|NCT00183365|Group Intervention|group intervention
5782202|NCT00183352|Women|women
5782203|NCT00183352|Mood|mood
5782204|NCT00183352|Menarche|menarche
5782205|NCT00183352|Menstruation|menstruation
5782206|NCT00183339|Autism|autism
5782207|NCT00183326|Posttraumatic Stress Disorder|posttraumatic stress disorder
5782208|NCT00183326|Domestic Violence|domestic violence
5782209|NCT00183326|Children|children
5782210|NCT00183326|Cognitive Behavioral Therapy|cognitive behavioral therapy
5782212|NCT00183313|Mental Health|mental health
5782213|NCT00183313|Primary health care|primary health care
5782214|NCT00183313|Case management|case management
5782215|NCT00183300|Post-traumatic stress disorder|post-traumatic stress disorder
5782216|NCT00183300|PTSD|ptsd
5782217|NCT00183300|Prolonged Exposure|prolonged exposure
5782218|NCT00183300|Cognitive-Behavior Therapy|cognitive-behavior therapy
5782219|NCT00183274|Generalized Anxiety Disorder|generalized anxiety disorder
5782220|NCT00183274|Chronic Mediation Treatment|chronic mediation treatment
5782221|NCT00183274|Double-Blind|double-blind
5782222|NCT00183274|Placebo Controlled|placebo controlled
5782223|NCT00183274|Venlafaxine XR|venlafaxine xr
5782224|NCT00183274|Relapse|relapse
5782225|NCT00183261|Treatment Interruption|treatment interruption
5782226|NCT00183261|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5782227|NCT00183261|Acute Infection|acute infection
5782228|NCT00183261|Acute Retroviral Syndrome|acute retroviral syndrome
5782229|NCT00183248|kidney|kidney
5782230|NCT00183248|kidney transplant|kidney transplant
5782231|NCT00183248|kidney transplantation|kidney transplantation
5782232|NCT00183248|transplant|transplant
5782233|NCT00183248|transplantation|transplantation
5782234|NCT00183248|renal|renal
5782236|NCT00183248|renal transplantation|renal transplantation
5782237|NCT00183248|kidney disease|kidney disease
5782238|NCT00183248|chronic|chronic
5782239|NCT00183248|renal failure|renal failure
5782240|NCT00183248|kidney failure|kidney failure
5782241|NCT00183235|Alcohol dependence|alcohol dependence
5782242|NCT00183235|Alcoholism|alcoholism
5782243|NCT00183235|Craving|craving
5782244|NCT00183222|Alcohol dependence|alcohol dependence
5782245|NCT00183222|Alcoholism|alcoholism
5782246|NCT00183222|Craving|craving
5782247|NCT00183209|Substance use disorders|substance use disorders
5782248|NCT00183209|Parent child relationship|parent child relationship
5782249|NCT00183196|Alcohol dependence|alcohol dependence
5782250|NCT00183196|Alcoholism|alcoholism
5782251|NCT00183196|Heavy drinking|heavy drinking
5782252|NCT00183183|Alcohol Abuse|alcohol abuse
5782253|NCT00183183|Harm Reduction|harm reduction
5782254|NCT00183183|Motivational Interviewing|motivational interviewing
5782255|NCT00183183|Emergency Department|emergency department
5782256|NCT00183183|Risky Drinking|risky drinking
5782257|NCT00183183|Prevention|prevention
5782258|NCT00183170|Alcohol abuse|alcohol abuse
5782259|NCT00183170|Alcoholic beverages (beer)|alcoholic beverages (beer)
5782260|NCT00183170|Residual effects|residual effects
5782261|NCT00183170|Psychomotor performance|psychomotor performance
5681095|NCT00574717|ocular refraction|ocular refraction
5681096|NCT00574717|infant|infant
5782262|NCT00183170|Psychomotor vigilance test|psychomotor vigilance test
5782748|NCT00181506|lung cancer|lung cancer
5782263|NCT00183170|Neurobehavioral Evaluation System|neurobehavioral evaluation system
5782264|NCT00183170|Family history of alcohol use|family history of alcohol use
5782265|NCT00183170|Alcoholic Consumption|alcoholic consumption
5782266|NCT00183170|Unhealthy alcohol use|unhealthy alcohol use
5782267|NCT00183170|Alcohol|alcohol
5782268|NCT00183157|High risk drinking|high risk drinking
5782269|NCT00183157|Alcohol dependence|alcohol dependence
5782270|NCT00183157|Alcohol related injury|alcohol related injury
5782271|NCT00183144|contingency management|contingency management
5782272|NCT00183144|reinforcement|reinforcement
5782273|NCT00183144|employment|employment
5782274|NCT00183144|Therapeutic Workplace|therapeutic workplace
5782275|NCT00183131|Alcohol|alcohol
5782276|NCT00183131|Alcohol abuse|alcohol abuse
5782277|NCT00183131|Alcohol dependence|alcohol dependence
5782278|NCT00183131|Alcohol consumption|alcohol consumption
5782279|NCT00183131|Unhealthy alcohol use|unhealthy alcohol use
5782280|NCT00183131|Screening|screening
5782281|NCT00183131|Brief Intervention|brief intervention
5782282|NCT00183131|Effectiveness|effectiveness
5782283|NCT00183131|Electronic intervention|electronic intervention
5782284|NCT00183131|Web-based intervention|web-based intervention
5782285|NCT00183131|College students|college students
5782287|NCT00183118|Russia|russia
5782288|NCT00183118|Prevention|prevention
5782289|NCT00183118|Behavioral intervention|behavioral intervention
5782290|NCT00183118|Alcohol dependence|alcohol dependence
5782291|NCT00183105|Alcohol|alcohol
5782292|NCT00183105|Alcohol abuse|alcohol abuse
5782293|NCT00183105|Alcohol dependence|alcohol dependence
5782294|NCT00183105|Utilization|utilization
5782295|NCT00183105|Alcohol consumption|alcohol consumption
5791141|NCT00140101|stents|stents
5782296|NCT00183105|Unhealthy alcohol use|unhealthy alcohol use
5782297|NCT00183105|Hospitalization|hospitalization
5782298|NCT00183105|Screening|screening
5782299|NCT00183105|Brief Intervention|brief intervention
5782300|NCT00183105|Motivational Interviewing|motivational interviewing
5782301|NCT00183105|Randomized trial|randomized trial
5782302|NCT00183105|Effectiveness|effectiveness
5782303|NCT00183105|Unhealthy alcohol use (Risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)|unhealthy alcohol use (risky alcohol consumption amounts, problem alcohol use, hazardous alcohol use, alcohol abuse and alcohol dependence)
5782304|NCT00183092|dementia|dementia
5782305|NCT00183092|spongiform encephalopathy|spongiform encephalopathy
5782306|NCT00183092|nervous system disorder|nervous system disorder
5782307|NCT00183092|acridine|acridine
5782308|NCT00183092|prion|prion
5782309|NCT00183092|neuropharmacologic agent|neuropharmacologic agent
5782310|NCT00183079|Depression|depression
5782311|NCT00183079|Alcohol Use|alcohol use
5782312|NCT00183079|Motivational Interviewing|motivational interviewing
5782313|NCT00183053|Hospitalization|hospitalization
5782314|NCT00183053|Fall Risk|fall risk
5782315|NCT00183053|Frailty|frailty
5782316|NCT00183040|andropause|andropause
5782317|NCT00183040|hormone therapy|hormone therapy
5782319|NCT00183027|Dietary restriction|dietary restriction
5782320|NCT00183027|Caloric restriction|caloric restriction
5782321|NCT00183014|behavior therapy|behavior therapy
5782322|NCT00183014|exercise|exercise
5782323|NCT00183014|gait|gait
5782324|NCT00183014|physical activity|physical activity
5782325|NCT00183001|nutritional supplement|nutritional supplement
5782326|NCT00183001|dietary supplement|dietary supplement
5782327|NCT00183001|vitamin therapy|vitamin therapy
5782328|NCT00183001|Vitamin K deficiency|vitamin k deficiency
5782329|NCT00183001|bone density|bone density
5777172|NCT00211211|Back Pain|back pain
5782330|NCT00182988|communication behavior|communication behavior
5782332|NCT00182988|functional ability|functional ability
5782333|NCT00182988|quality of life|quality of life
5782334|NCT00182988|caregiving|caregiving
5782335|NCT00182975|Metabolic syndrome|metabolic syndrome
5782336|NCT00182962|Activities of Daily Living|activities of daily living
5782337|NCT00182962|Low-income|low-income
5782338|NCT00182962|geriatric medicine|geriatric medicine
5782339|NCT00182962|computer assisted patient care|computer assisted patient care
5782340|NCT00182949|Epidemiology|epidemiology
5782341|NCT00182949|Genetics|genetics
5782342|NCT00182949|Aging|aging
5782343|NCT00182949|Sardinian Population|sardinian population
5782344|NCT00182949|Cardiovascular Diseases|cardiovascular diseases
5782345|NCT00182949|Personality Traits|personality traits
5782346|NCT00182949|Frailty|frailty
5782347|NCT00182936|Cognition disorder|cognition disorder
5782348|NCT00182936|organic brain syndrome|organic brain syndrome
5782349|NCT00182936|patient care management|patient care management
5782350|NCT00182936|long term care|long term care
5782351|NCT00182936|extended care facility|extended care facility
5782352|NCT00182923|Blood pressure|blood pressure
5782353|NCT00182923|genetics|genetics
5782354|NCT00182897|caregiver|caregiver
5782355|NCT00182897|home health care|home health care
5782357|NCT00182884|Hospital acquired complications|hospital acquired complications
5782358|NCT00182884|adverse effects|adverse effects
5782359|NCT00182884|Cognitive Impairment|cognitive impairment
5782360|NCT00182884|Aging|aging
5782361|NCT00182871|geriatric medicine|geriatric medicine
5782362|NCT00182871|hormone therapy|hormone therapy
5782370|NCT00182845|Adverse Effects|adverse effects
5782371|NCT00182845|Hospital Acquired Complications|hospital acquired complications
5782372|NCT00182845|Cognitive Impairment|cognitive impairment
5782373|NCT00182845|Aging|aging
5782374|NCT00182832|Physician Behavior|physician behavior
5786510|NCT00162734|Ribavirin|ribavirin
5782375|NCT00182832|Hospital Acquired Complications|hospital acquired complications
5782377|NCT00182832|Mild Cognitive Impairment|mild cognitive impairment
5782378|NCT00182819|adult oligodendroglioma|adult oligodendroglioma
5782379|NCT00182819|adult diffuse astrocytoma|adult diffuse astrocytoma
5782380|NCT00182819|adult mixed glioma|adult mixed glioma
5782381|NCT00182806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5782382|NCT00182806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5782383|NCT00182806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5782384|NCT00182806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5782385|NCT00182793|stage IIIB breast cancer|stage iiib breast cancer
5782386|NCT00182793|stage IIIC breast cancer|stage iiic breast cancer
5782387|NCT00182793|stage IV breast cancer|stage iv breast cancer
5782388|NCT00182793|inflammatory breast cancer|inflammatory breast cancer
5782389|NCT00182793|male breast cancer|male breast cancer
5782390|NCT00182793|recurrent breast cancer|recurrent breast cancer
5782391|NCT00182793|invasive ductal breast carcinoma with predominant intraductal component|invasive ductal breast carcinoma with predominant intraductal component
5782392|NCT00182793|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5782393|NCT00182793|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5782394|NCT00182793|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5782395|NCT00182793|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5782396|NCT00182793|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5782397|NCT00182793|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5782398|NCT00182793|invasive lobular breast carcinoma with predominant in situ component|invasive lobular breast carcinoma with predominant in situ component
5782399|NCT00182793|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5782400|NCT00182793|comedo ductal breast carcinoma|comedo ductal breast carcinoma
5782401|NCT00182780|fatigue|fatigue
5782402|NCT00182780|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5782403|NCT00182754|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5782404|NCT00182754|malignant ascites|malignant ascites
5782405|NCT00182741|recurrent prostate cancer|recurrent prostate cancer
5782406|NCT00182741|stage IV prostate cancer|stage iv prostate cancer
5782407|NCT00182728|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5782408|NCT00182728|stage I breast cancer|stage i breast cancer
5782409|NCT00182728|stage II breast cancer|stage ii breast cancer
5782410|NCT00182715|adenocarcinoma of the colon|adenocarcinoma of the colon
5782411|NCT00182715|stage IV colon cancer|stage iv colon cancer
5782412|NCT00182715|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5782413|NCT00182715|stage IV rectal cancer|stage iv rectal cancer
5782414|NCT00182650|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5782415|NCT00182650|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5782416|NCT00182650|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5782417|NCT00182637|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5782418|NCT00182637|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5782419|NCT00182637|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5782420|NCT00182637|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5782421|NCT00182637|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5782422|NCT00182637|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5782423|NCT00182637|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5782424|NCT00182637|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5782425|NCT00182637|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5782426|NCT00182637|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5782428|NCT00182624|Magnetic Resonance Imaging|magnetic resonance imaging
5782429|NCT00182624|Spectroscopy|spectroscopy
5782430|NCT00182611|stage III gastric cancer|stage iii gastric cancer
5782431|NCT00182611|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5782432|NCT00182598|buprenorphine|buprenorphine
5782433|NCT00182598|computer|computer
5782434|NCT00182598|treatment|treatment
5782436|NCT00182598|heroin|heroin
5782437|NCT00182585|HIV|hiv
5782438|NCT00182585|hepatitis|hepatitis
5782439|NCT00182585|STDs|stds
5782440|NCT00182585|adolescents|adolescents
5782441|NCT00182585|addiction|addiction
5782442|NCT00182585|treatment|treatment
5782443|NCT00182585|prevention|prevention
5782848|NCT00180674|Coumarin|coumarin
5782444|NCT00182585|HIV and related risk behavior among youth in drug treatment|hiv and related risk behavior among youth in drug treatment
5782445|NCT00182572|heroin|heroin
5782446|NCT00182572|opiate|opiate
5782447|NCT00182572|addiction|addiction
5782448|NCT00182572|adolescent|adolescent
5782449|NCT00182572|treatment|treatment
5782450|NCT00182559|kidney|kidney
5782451|NCT00182559|transplantation|transplantation
5782452|NCT00182559|tacrolimus|tacrolimus
5782453|NCT00182559|cyclosporine|cyclosporine
5782455|NCT00182546|Pulmonary Embolism|pulmonary embolism
5782456|NCT00182546|DVT|dvt
5782457|NCT00182546|Venous Thrombosis|venous thrombosis
5782458|NCT00182546|D dimer|d dimer
5782459|NCT00182546|DD|dd
5782460|NCT00182546|Thrombosis|thrombosis
5782461|NCT00182546|Diagnosis|diagnosis
5782462|NCT00182533|Generalized social phobia|generalized social phobia
5782463|NCT00182533|Comorbid panic disorder with agoraphobia|comorbid panic disorder with agoraphobia
5782464|NCT00182533|Comorbid obsessive compulsive disorder|comorbid obsessive compulsive disorder
5782465|NCT00182533|Comorbid generalized anxiety disorder|comorbid generalized anxiety disorder
5782466|NCT00182533|Comorbid major depressive disorder/Dysthymia|comorbid major depressive disorder/dysthymia
5782467|NCT00182520|Treatment Refractory Obsessive Compulsive Disorder|treatment refractory obsessive compulsive disorder
5782468|NCT00182494|Schizophrenia, Diabetes, Weight gain, Antipsychotic drugs|schizophrenia, diabetes, weight gain, antipsychotic drugs
5782469|NCT00182481|asthma treatment|asthma treatment
5782470|NCT00182481|induced sputum cell counts|induced sputum cell counts
5782471|NCT00182481|asthma exacerbations|asthma exacerbations
5782472|NCT00182481|eosinophilic bronchitis|eosinophilic bronchitis
5782473|NCT00182481|non-eosinophilic bronchitis|non-eosinophilic bronchitis
5782474|NCT00182468|Domestic violence|domestic violence
5782475|NCT00182468|Spouse Abuse|spouse abuse
5782476|NCT00182455|Treatment Refractory Generalized Social Phobia|treatment refractory generalized social phobia
5782477|NCT00182442|Cognitive deficits|cognitive deficits
5782478|NCT00182442|Psychosocial functioning|psychosocial functioning
5782479|NCT00182442|Quality of Life|quality of life
5782480|NCT00182429|Antibiotic associated diarrhea|antibiotic associated diarrhea
5782481|NCT00182429|C. difficile|c. difficile
5782482|NCT00182429|Metronidazole|metronidazole
5782483|NCT00182429|Rifampin|rifampin
5782484|NCT00182416|pacemakers|pacemakers
5782485|NCT00182416|atrial fibrillation|atrial fibrillation
5782486|NCT00182416|stroke|stroke
5782487|NCT00182416|cardiovascular death|cardiovascular death
5782488|NCT00182403|Unfractionated Heparin|unfractionated heparin
5782489|NCT00182403|Low Molecular Weight Heparin|low molecular weight heparin
5782490|NCT00182403|Venous Thromboembolism|venous thromboembolism
5782491|NCT00182403|APTT|aptt
5782492|NCT00182403|Treatment|treatment
5782493|NCT00182390|ELBW premature infants|elbw premature infants
5782494|NCT00182390|neonatal transfusion|neonatal transfusion
5782495|NCT00182390|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5782496|NCT00182390|periventricular leukomalacia|periventricular leukomalacia
5782497|NCT00182390|ventriculomegaly|ventriculomegaly
5782498|NCT00182390|retinopathy of prematurity|retinopathy of prematurity
5782499|NCT00182377|patients undergoing cardiac surgery requiring cardiopulmonary bypass|patients undergoing cardiac surgery requiring cardiopulmonary bypass
5782500|NCT00182364|Critically Ill|critically ill
5782501|NCT00182364|Deep Venous Thrombosis|deep venous thrombosis
5782502|NCT00182364|Randomized Control Trial|randomized control trial
5782503|NCT00182364|Pilot Study|pilot study
5782504|NCT00182351|deep vein thrombosis|deep vein thrombosis
5782505|NCT00182351|d-dimer|d-dimer
5782506|NCT00182351|serial compression ultrasound|serial compression ultrasound
5782507|NCT00182338|cardiovascular outcomes|cardiovascular outcomes
5782508|NCT00182338|congestive heart failure|congestive heart failure
5782509|NCT00182338|Peritoneal Membrane transport properties|peritoneal membrane transport properties
5782510|NCT00182338|Arterial stiffening|arterial stiffening
5782511|NCT00182338|Inflammatory markers|inflammatory markers
5782512|NCT00182325|medical record|medical record
5782513|NCT00182325|pregnancy|pregnancy
5782514|NCT00182325|Internet|internet
5782515|NCT00182312|preterm infants|preterm infants
5782516|NCT00182312|very low birthweight|very low birthweight
5782517|NCT00182312|apnea of prematurity|apnea of prematurity
5782518|NCT00182312|methylxanthines|methylxanthines
5782519|NCT00182312|developmental disabilities|developmental disabilities
5782520|NCT00182286|Diabetes|diabetes
5782521|NCT00182286|Continuity of Care|continuity of care
5782522|NCT00182286|Patient Perspective|patient perspective
5782523|NCT00182286|Health Service Organization|health service organization
5782524|NCT00182273|Benign paroxysmal positional vertigo|benign paroxysmal positional vertigo
5782525|NCT00182273|Canalith repositioning maneuver|canalith repositioning maneuver
5782526|NCT00182273|Dizziness|dizziness
5782527|NCT00182273|Primary Care|primary care
5782528|NCT00182247|deep vein thrombosis|deep vein thrombosis
5782530|NCT00182247|pulmonary embolism|pulmonary embolism
5782531|NCT00182247|PE|pe
5782532|NCT00182247|venous thromboembolism|venous thromboembolism
5782533|NCT00182247|VTE|vte
5782534|NCT00182247|d-dimer|d-dimer
5782535|NCT00182247|IPG|ipg
5782849|NCT00180674|Warfarin|warfarin
5782536|NCT00182234|unmet supportive care needs|unmet supportive care needs
5782537|NCT00182221|Pulmonary Embolism|pulmonary embolism
5782538|NCT00182221|Deep Vein Thrombosis|deep vein thrombosis
5782539|NCT00182221|MDA D-Dimer Testing|mda d-dimer testing
5782540|NCT00182221|Diagnostic Algorithm|diagnostic algorithm
5782541|NCT00182208|PTS|pts
5782542|NCT00182208|Post phlebitic Syndrome|post phlebitic syndrome
5782543|NCT00182208|Activities of Daily Living|activities of daily living
5782544|NCT00182208|Quality of Life|quality of life
5782545|NCT00182182|Heart Failure|heart failure
5782546|NCT00182182|Family physicians|family physicians
5782547|NCT00182182|academic detailing|academic detailing
5782548|NCT00182182|process of care|process of care
5782549|NCT00182169|Severe heart failure|severe heart failure
5782550|NCT00182169|Growth hormone|growth hormone
5782551|NCT00182169|exercise capacity|exercise capacity
5782552|NCT00182169|quality of life|quality of life
5782553|NCT00182169|cardiac function|cardiac function
5782554|NCT00182156|hemodialysis|hemodialysis
5782555|NCT00182156|platelet function analyzer|platelet function analyzer
5782556|NCT00182156|bioimpedance|bioimpedance
5782557|NCT00182156|pulse wave velocity|pulse wave velocity
5782558|NCT00182156|end stage renal disease|end stage renal disease
5782559|NCT00182143|Critically Ill|critically ill
5782560|NCT00182143|Deep Venous ThromboEmbolism|deep venous thromboembolism
5782561|NCT00182143|Randomized Controlled Trial|randomized controlled trial
5782562|NCT00182130|rectal cancer|rectal cancer
5782563|NCT00182130|surgery|surgery
5782564|NCT00182130|physician behaviour|physician behaviour
5782565|NCT00182130|knowledge translation|knowledge translation
5782566|NCT00182117|bleeding|bleeding
5782567|NCT00182117|end stage renal disease|end stage renal disease
5782568|NCT00182117|antiplatelet therapy|antiplatelet therapy
5782569|NCT00182117|anticoagulant therapy|anticoagulant therapy
5782570|NCT00182117|hemodialysis|hemodialysis
5686439|NCT00552058|Clinical response|clinical response
5781684|NCT00187044|HIV|hiv
5782571|NCT00182104|Fontan procedure|fontan procedure
5782572|NCT00182104|Anticoagulation|anticoagulation
5782573|NCT00182104|Thrombosis|thrombosis
5782574|NCT00182104|Thromboembolism|thromboembolism
5782575|NCT00182104|Prevention|prevention
5782576|NCT00182091|Acromegaly|acromegaly
5782577|NCT00182091|Growth Hormone Deficiency|growth hormone deficiency
5782578|NCT00182091|Cardiovascular Risk|cardiovascular risk
5782579|NCT00182091|Pituitary|pituitary
5782580|NCT00182091|Hypothalamic|hypothalamic
5782581|NCT00182078|sertraline|sertraline
5782582|NCT00182078|children|children
5782583|NCT00182078|adolescents|adolescents
5782584|NCT00182078|posttraumatic stress disorder|posttraumatic stress disorder
5782585|NCT00182078|depression|depression
5782586|NCT00182078|prevention|prevention
5782587|NCT00182078|burns|burns
5782588|NCT00182078|injuries|injuries
5782589|NCT00182065|Heart failure|heart failure
5782590|NCT00182065|Functional decline|functional decline
5782591|NCT00182065|Cognitive impairment|cognitive impairment
5782592|NCT00182065|Neuropsychiatric health|neuropsychiatric health
5782593|NCT00182065|Longitudinal|longitudinal
5782594|NCT00182065|Long-term care|long-term care
5782595|NCT00182065|Elderly|elderly
5782596|NCT00182052|rosiglitazone|rosiglitazone
5782597|NCT00182052|Avandia|avandia
5782598|NCT00182052|androgen dependant prostate cancer|androgen dependant prostate cancer
5782599|NCT00182039|randomized controlled trial|randomized controlled trial
5782600|NCT00182039|blinded|blinded
5782601|NCT00182039|noncardiac surgery|noncardiac surgery
5782602|NCT00182039|cardiovascular events|cardiovascular events
5782603|NCT00182026|diabetes|diabetes
5782604|NCT00182026|community intervention|community intervention
5782605|NCT00182026|self-management|self-management
5782606|NCT00182026|prevention|prevention
5782607|NCT00182000|OCD|ocd
5782608|NCT00181987|ADHD|adhd
5782610|NCT00181987|children|children
5782611|NCT00181987|Concerta|concerta
5782612|NCT00181974|burns|burns
5782613|NCT00181974|hemostasis|hemostasis
5782614|NCT00181974|skin graft|skin graft
5782615|NCT00181974|Surgical Hemostasis|surgical hemostasis
5782616|NCT00181974|Grafting, Skin|grafting, skin
5782617|NCT00181961|antidepressant-induced sexual dysfunction|antidepressant-induced sexual dysfunction
5782618|NCT00181948|ADHD|adhd
5782619|NCT00181948|children|children
5782620|NCT00181948|stimulant non-responders|stimulant non-responders
5782621|NCT00181948|Strattera|strattera
5782622|NCT00181935|bipolar disorder|bipolar disorder
5782623|NCT00181935|preschoolers|preschoolers
5782624|NCT00181935|risperdal|risperdal
5782625|NCT00181935|zyprexa|zyprexa
5782626|NCT00181922|bipolar disorder|bipolar disorder
5782627|NCT00181922|children|children
5782628|NCT00181922|ziprasidone|ziprasidone
5782629|NCT00181922|mania|mania
5782630|NCT00181909|Pregnancy|pregnancy
5782631|NCT00181909|Smoking cessation|smoking cessation
5782632|NCT00181896|depression|depression
5782633|NCT00181896|bipolar disorder|bipolar disorder
5782634|NCT00181896|children|children
5782635|NCT00181896|bupropion SR|bupropion sr
5782636|NCT00181883|children|children
5782637|NCT00181883|bipolar disorder|bipolar disorder
5782638|NCT00181883|quetiapine|quetiapine
5782639|NCT00181883|preschoolers|preschoolers
5782640|NCT00181870|bipolar disorder|bipolar disorder
5782641|NCT00181870|children|children
5782642|NCT00181870|mania|mania
5782643|NCT00181870|Equetro|equetro
5782644|NCT00181857|ADHD NOS|adhd nos
5782645|NCT00181857|familial risk|familial risk
5782646|NCT00181857|children|children
5782647|NCT00181844|bipolar disorder|bipolar disorder
5782648|NCT00181844|lamotrigine|lamotrigine
5782649|NCT00181844|children|children
5782650|NCT00181844|mania|mania
5782651|NCT00181831|SPECT|spect
5782652|NCT00181831|bipolar disorder|bipolar disorder
5782654|NCT00181831|children|children
5782655|NCT00181818|Smoking cessation|smoking cessation
5782656|NCT00181818|Bupropion SR|bupropion sr
5782657|NCT00181818|Hospital intervention|hospital intervention
5782658|NCT00181818|Myocardial infarction|myocardial infarction
5782659|NCT00181818|Unstable angina|unstable angina
5782660|NCT00181805|GER|ger
5782661|NCT00181792|ADHD|adhd
5782662|NCT00181792|smoking|smoking
5782663|NCT00181792|familial risk|familial risk
5782664|NCT00181779|mania|mania
5782665|NCT00181779|Abilify|abilify
5782666|NCT00181779|children|children
5782667|NCT00181779|bipolar disorder|bipolar disorder
5782668|NCT00181766|ADHD NOS|adhd nos
5782669|NCT00181766|Adults|adults
5782670|NCT00181766|Strattera (atomoxetine)|strattera (atomoxetine)
5782671|NCT00181766|Open-Label|open-label
5782672|NCT00181753|glutamine metabolic kinetics|glutamine metabolic kinetics
5782673|NCT00181753|glutamate metabolic kinetics|glutamate metabolic kinetics
5782674|NCT00181753|enteral nutrition|enteral nutrition
5782675|NCT00181753|parenteral nutrition|parenteral nutrition
5782676|NCT00181753|burn injury|burn injury
5782677|NCT00181753|stable isotopes|stable isotopes
5782678|NCT00181740|ADHD NOS|adhd nos
5782679|NCT00181740|Adults|adults
5782680|NCT00181740|Concerta|concerta
5782681|NCT00181740|Open-Label|open-label
5782682|NCT00181727|bipolar disorder|bipolar disorder
5782683|NCT00181727|mania|mania
5782684|NCT00181727|depakote ER|depakote er
5782685|NCT00181727|children|children
5782686|NCT00181714|cigarette smoking|cigarette smoking
5782687|NCT00181714|ADHD|adhd
5782688|NCT00181714|adolescents|adolescents
5782689|NCT00181714|Concerta|concerta
5782690|NCT00181701|Ovarian cancer|ovarian cancer
5782691|NCT00181701|Epithelial carcinoma of mullerian origin|epithelial carcinoma of mullerian origin
5782692|NCT00181701|Intraperitoneal paclitaxel|intraperitoneal paclitaxel
5782693|NCT00181701|Intraperitoneal carboplatin|intraperitoneal carboplatin
5782694|NCT00181701|Primary peritoneal carcinoma|primary peritoneal carcinoma
5782695|NCT00181701|Tubal carcinoma|tubal carcinoma
5782696|NCT00181688|Iressa|iressa
5782697|NCT00181688|ZD1839|zd1839
5782698|NCT00181688|Anastrozole|anastrozole
5782699|NCT00181688|Arimidex|arimidex
5782700|NCT00181675|Adult|adult
5782701|NCT00181675|ADHD|adhd
5782702|NCT00181675|galantamine|galantamine
5782703|NCT00181675|double-blind|double-blind
5782704|NCT00181662|Curcumin|curcumin
5782705|NCT00181662|Piperine|piperine
5782706|NCT00181662|Silybin|silybin
5782707|NCT00181662|Healthy volunteer|healthy volunteer
5782708|NCT00181662|Female|female
5782709|NCT00181649|Lactation|lactation
5782710|NCT00181649|Breastfeeding|breastfeeding
5782711|NCT00181649|Adoptive mothers|adoptive mothers
5782712|NCT00181649|Prolactin|prolactin
5782713|NCT00181649|Relative lactation insufficiency|relative lactation insufficiency
5782714|NCT00181623|Lactation|lactation
5782715|NCT00181623|Breastfeeding|breastfeeding
5782716|NCT00181623|Prolactin|prolactin
5782717|NCT00181623|Primary lactation insufficiency|primary lactation insufficiency
5782719|NCT00181610|Breastfeeding|breastfeeding
5782720|NCT00181610|Premature infants|premature infants
5782721|NCT00181610|Prolactin|prolactin
5782722|NCT00181610|Primary lactation insufficiency|primary lactation insufficiency
5782723|NCT00181597|Trilostane|trilostane
5782724|NCT00181597|Androgen-independent prostate cancer|androgen-independent prostate cancer
5782725|NCT00181584|Androgen deprivation therapy|androgen deprivation therapy
5782726|NCT00181584|bone loss|bone loss
5782727|NCT00181584|prostate cancer|prostate cancer
5782728|NCT00181584|Zoledronic Acid|zoledronic acid
5782729|NCT00181584|Zometa|zometa
5782730|NCT00181571|ADHD|adhd
5782731|NCT00181571|Adults|adults
5782732|NCT00181571|Concerta|concerta
5782733|NCT00181571|Double-Blind|double-blind
5782734|NCT00181558|Prostate Cancer|prostate cancer
5782735|NCT00181558|bone metastases|bone metastases
5782736|NCT00181558|Atrasentan|atrasentan
5782737|NCT00181558|Zometa|zometa
5782738|NCT00181558|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5782739|NCT00181545|Non-small cell lung carcinoma|non-small cell lung carcinoma
5782740|NCT00181545|radiotherapy|radiotherapy
5782741|NCT00181545|mean lung dose|mean lung dose
5782742|NCT00181532|NSCLC|nsclc
5782743|NCT00181532|cox-2-inhibitor|cox-2-inhibitor
5782744|NCT00181532|radiosensitizer|radiosensitizer
5782745|NCT00181532|radiotherapy|radiotherapy
5782746|NCT00181506|radiotherapy|radiotherapy
5782747|NCT00181506|radiation dose|radiation dose
5782749|NCT00181363|Breast cancer|breast cancer
5782750|NCT00181363|Breast conserving surgery|breast conserving surgery
5782751|NCT00181363|Radiotherapy|radiotherapy
5782752|NCT00181363|Pendulous breasts|pendulous breasts
5782753|NCT00181350|brain tumor|brain tumor
5782754|NCT00181350|fractionated stereotactic radiotherapy|fractionated stereotactic radiotherapy
5782755|NCT00181350|fixationsystems|fixationsystems
5782756|NCT00181350|repositioning|repositioning
5782757|NCT00181311|vaginal hysterectomy|vaginal hysterectomy
5782758|NCT00181311|abdominal hysterectomy|abdominal hysterectomy
5782759|NCT00181311|complications|complications
5782760|NCT00181311|physical well being|physical well being
5782761|NCT00181311|mental well being|mental well being
5782762|NCT00181298|Memantine|memantine
5782763|NCT00181298|SLE|sle
5782764|NCT00181298|Anti NR2|anti nr2
5782765|NCT00181298|ANAM|anam
5782766|NCT00181298|Cognitive functioning|cognitive functioning
5782767|NCT00181272|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5782768|NCT00181272|undifferentiated asthma/COPD|undifferentiated asthma/copd
5782769|NCT00181246|Neuropathic pain|neuropathic pain
5782770|NCT00181246|Efficacy|efficacy
5782771|NCT00181207|COPD|copd
5782772|NCT00181194|Asthma|asthma
5782773|NCT00181181|Hypertension|hypertension
5782774|NCT00181168|thyroid cancer|thyroid cancer
5782775|NCT00181168|PET scan|pet scan
5782776|NCT00181168|recombinant thyrotropin|recombinant thyrotropin
5782777|NCT00181168|thyroglobulin|thyroglobulin
5782778|NCT00181168|Thyroid cancer, differentiated epithelial|thyroid cancer, differentiated epithelial
5782779|NCT00181155|metabolism|metabolism
5782780|NCT00181155|congestive heart failure|congestive heart failure
5782781|NCT00181155|allopurinol|allopurinol
5782782|NCT00181155|Adenosine triphosphate (ATP)|adenosine triphosphate (atp)
5686440|NCT00552045|epilepsy|epilepsy
5781879|NCT00185016|attitude|attitude
5782783|NCT00181142|Induciton therapy, Daclizumab, Thymoglobulin, lung transplantation|induciton therapy, daclizumab, thymoglobulin, lung transplantation
5782784|NCT00181129|Fatigue|fatigue
5782785|NCT00181129|Cancer treatment|cancer treatment
5782786|NCT00181116|Epilepsy|epilepsy
5782787|NCT00181116|Benign rolandic|benign rolandic
5782788|NCT00181116|Levetiracetam|levetiracetam
5782789|NCT00181090|Epilepsy|epilepsy
5782790|NCT00181090|Ketosis|ketosis
5782791|NCT00181090|Atkins|atkins
5782792|NCT00181090|seizures|seizures
5782793|NCT00181077|preeclampsia, hypertonic saline, diuresis|preeclampsia, hypertonic saline, diuresis
5782794|NCT00181064|headache|headache
5782795|NCT00181064|Atkins|atkins
5782796|NCT00181064|ketosis|ketosis
5782797|NCT00181064|intractable|intractable
5782798|NCT00181038|Oro-Pharyngeal Carcinoma Surgery|oro-pharyngeal carcinoma surgery
5782799|NCT00181025|Limbs’ girdle|limbs’ girdle
5782800|NCT00181012|Cancer Related Visceral Pain Resistant to Morphinics|cancer related visceral pain resistant to morphinics
5782801|NCT00180947|Soft parts tissue|soft parts tissue
5782802|NCT00180921|Adenoid cystic carcinoma of the head and neck|adenoid cystic carcinoma of the head and neck
5782803|NCT00180908|Osteosarcoma|osteosarcoma
5782804|NCT00180895|Burkitt lymphoma|burkitt lymphoma
5782805|NCT00180895|B-cell non Hodgkin lymphoma|b-cell non hodgkin lymphoma
5782806|NCT00180895|B-cell ALL|b-cell all
5782807|NCT00180895|Refractory|refractory
5782808|NCT00180895|Relapse|relapse
5782809|NCT00180895|Rituximab|rituximab
5782810|NCT00180895|Children|children
5782811|NCT00180869|cancer|cancer
5782812|NCT00180869|peroperative transfusion|peroperative transfusion
5782813|NCT00180869|allogeneic red blood cell concentrate|allogeneic red blood cell concentrate
5782814|NCT00180869|leuko-reduced red blood cell concentrate|leuko-reduced red blood cell concentrate
5782815|NCT00180856|Lung metastasis|lung metastasis
5782816|NCT00180856|Lung cancer|lung cancer
5782817|NCT00180856|Radiofrequency ablation|radiofrequency ablation
5782818|NCT00180791|Brain PNET|brain pnet
5782819|NCT00180765|Leukocytes|leukocytes
5782820|NCT00180765|Eosinophils|eosinophils
5782821|NCT00180765|Neutrophils|neutrophils
5782822|NCT00180765|Chronic Obstructive Airway Disease|chronic obstructive airway disease
5782823|NCT00180765|Apoptosis|apoptosis
5782824|NCT00180765|Signal Transduction|signal transduction
5782825|NCT00180739|MR guided FUS|mr guided fus
5782826|NCT00180739|Uterine Fibroids|uterine fibroids
5782827|NCT00180739|Fertility|fertility
5782828|NCT00180739|Pregnancy|pregnancy
5782829|NCT00180726|asthma, inflammatory, corticosteroid|asthma, inflammatory, corticosteroid
5782830|NCT00180713|Pulmonary hypertension|pulmonary hypertension
5782831|NCT00180713|Simvastatin|simvastatin
5782832|NCT00180713|Statins|statins
5782834|NCT00180700|Stress|stress
5782835|NCT00180700|Psychoneuroimmunology|psychoneuroimmunology
5782836|NCT00180700|stress management|stress management
5782837|NCT00180700|hypnosis|hypnosis
5782838|NCT00180700|Johrei|johrei
5782839|NCT00180700|psychological intervention|psychological intervention
5782840|NCT00180687|Pain|pain
5782841|NCT00180687|Nebulisation|nebulisation
5782842|NCT00180687|Cholecystectomy|cholecystectomy
5782843|NCT00180687|Laparoscopic|laparoscopic
5782844|NCT00180687|Bupivacaine|bupivacaine
5782845|NCT00180687|Local Anaesthetic|local anaesthetic
5782846|NCT00180674|Hepatic fibrosis|hepatic fibrosis
5782847|NCT00180674|anticoagulation|anticoagulation
5782850|NCT00180674|Chronic hepatitis C virus infection|chronic hepatitis c virus infection
5782851|NCT00180661|Severe asthma|severe asthma
5782852|NCT00180661|corticosteroid responsiveness|corticosteroid responsiveness
5782853|NCT00180648|Short Bowel Syndrome|short bowel syndrome
5782854|NCT00180648|Intestinal Failure|intestinal failure
5782855|NCT00180648|Glucagon Like Peptide 2|glucagon like peptide 2
5782856|NCT00180648|Parenteral Nutrition|parenteral nutrition
5782858|NCT00180635|Aminoguanidine|aminoguanidine
5782859|NCT00180635|Nitric oxide|nitric oxide
5782860|NCT00180518|Carotid artery disease|carotid artery disease
5782861|NCT00180518|High risk|high risk
5782862|NCT00180518|High surgical risk|high surgical risk
5782863|NCT00180505|Peripheral Artery Disease|peripheral artery disease
5782864|NCT00180505|Restenosis Rate|restenosis rate
5782865|NCT00180505|Patency Rates|patency rates
5782866|NCT00180505|Self-Expandable Nitinol Stents|self-expandable nitinol stents
5782867|NCT00180505|Stent Fractures|stent fractures
5782868|NCT00180492|Atherosclerotic disease|atherosclerotic disease
5782869|NCT00180479|Everolimus|everolimus
5782870|NCT00180466|drug eluting stents|drug eluting stents
5782871|NCT00180466|stents|stents
5782872|NCT00180466|angioplasty|angioplasty
5782873|NCT00180466|coronary artery disease|coronary artery disease
5782874|NCT00180466|total coronary occlusion|total coronary occlusion
5782875|NCT00180466|coronary artery restenosis|coronary artery restenosis
5782876|NCT00180466|stent thrombosis|stent thrombosis
5782877|NCT00180466|vascular disease|vascular disease
5782878|NCT00180466|myocardial ischemia|myocardial ischemia
5782879|NCT00180466|coronary artery stenosis|coronary artery stenosis
5782880|NCT00180453|Cardiovascular disease|cardiovascular disease
5686441|NCT00552045|localization-related epilepsy|localization-related epilepsy
5686442|NCT00552045|idiopathic generalized epilepsy|idiopathic generalized epilepsy
5686443|NCT00552045|infantile spasms|infantile spasms
5686444|NCT00552045|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5686445|NCT00552045|polymicrogyria|polymicrogyria
5782881|NCT00180453|Ischemia|ischemia
5782882|NCT00180414|heart failure|heart failure
5782883|NCT00180388|cardiovascular system|cardiovascular system
5782884|NCT00180388|veins|veins
5782885|NCT00180388|saphenous vein|saphenous vein
5782886|NCT00180336|Heart Failure|heart failure
5782887|NCT00180336|Tachycardia|tachycardia
5782888|NCT00180336|Atrial Fibrillation|atrial fibrillation
5782889|NCT00180336|Atrial Flutter|atrial flutter
5782890|NCT00180336|Ventricular Fibrillation|ventricular fibrillation
5782891|NCT00180310|drug eluting stents|drug eluting stents
5782892|NCT00180310|stents|stents
5782893|NCT00180310|angioplasty|angioplasty
5782894|NCT00180310|coronary artery disease|coronary artery disease
5782895|NCT00180310|total coronary occlusion|total coronary occlusion
5782896|NCT00180310|coronary artery restenosis|coronary artery restenosis
5782897|NCT00180310|stent thrombosis|stent thrombosis
5782898|NCT00180310|vascular disease|vascular disease
5782899|NCT00180310|myocardial ischemia|myocardial ischemia
5782900|NCT00180310|coronary artery stenosis|coronary artery stenosis
5782901|NCT00180284|Pacemaker leads|pacemaker leads
5782902|NCT00180284|Electrodes, implantable|electrodes, implantable
5782903|NCT00180284|Cardiac pacing, aritificial|cardiac pacing, aritificial
5782904|NCT00180271|Defibrillator|defibrillator
5782905|NCT00180271|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5782906|NCT00180271|MADIT|madit
5782907|NCT00180258|Cardiac Resynchronization Therapy (CRT)|cardiac resynchronization therapy (crt)
5782908|NCT00180258|Heart Failure|heart failure
5782909|NCT00180258|Defibrillator|defibrillator
5782910|NCT00180258|Pacemaker|pacemaker
5782911|NCT00180245|Radiation therapy|radiation therapy
5782912|NCT00180245|F-18-FDG|f-18-fdg
5782913|NCT00180219|G08.520.769.550.408|g08.520.769.550.408
5782914|NCT00180219|G08.520.769.550.490|g08.520.769.550.490
5782915|NCT00180219|G08.520.769.550.520|g08.520.769.550.520
5782916|NCT00180206|Arthritis|arthritis
5782917|NCT00180206|Hip|hip
5782918|NCT00180206|Hip arthroplasty|hip arthroplasty
5782919|NCT00180206|Hip resurfacing arthroplasty|hip resurfacing arthroplasty
5782920|NCT00180193|Radiotherapy|radiotherapy
5782921|NCT00180193|F-18-OMFD|f-18-omfd
5782922|NCT00180180|head-and-neck cancer|head-and-neck cancer
5782923|NCT00180180|radiation therapy|radiation therapy
5782924|NCT00180180|F-18-FMISO|f-18-fmiso
5782925|NCT00180167|Chemotherapy|chemotherapy
5782926|NCT00180167|elderly|elderly
5782927|NCT00180154|radiation therapy|radiation therapy
5782928|NCT00180154|F-18-FDG|f-18-fdg
5782929|NCT00180154|NSCLC|nsclc
5782930|NCT00180141|Atopic dermatitis on both lower arm.|atopic dermatitis on both lower arm.
5782931|NCT00180128|acute promyelocytic leukemia|acute promyelocytic leukemia
5782932|NCT00180128|risk adapted therapy|risk adapted therapy
5782933|NCT00180115|acute myeloid leukemia|acute myeloid leukemia
5782934|NCT00180115|cytarabine postremission dosage|cytarabine postremission dosage
5782935|NCT00180115|risk adapted treatment strategy|risk adapted treatment strategy
5782936|NCT00180115|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5782937|NCT00180115|autologous stem cell transplantation|autologous stem cell transplantation
5782938|NCT00180102|acute myeloid leukemia|acute myeloid leukemia
5782939|NCT00180102|risk adapted treatment|risk adapted treatment
5782940|NCT00180102|early allogeneic stem cell transplantation|early allogeneic stem cell transplantation
5782941|NCT00180102|autologous stem cell transplantation|autologous stem cell transplantation
5782942|NCT00180089|graft-versus-host disease|graft-versus-host disease
5782943|NCT00180089|budesonide|budesonide
5783728|NCT00176319|ageing|ageing
5782944|NCT00180089|stem cell transplantation|stem cell transplantation
5782945|NCT00180076|collagenous colitis|collagenous colitis
5782946|NCT00180076|microscopic colitis|microscopic colitis
5782947|NCT00180076|budesonide|budesonide
5782948|NCT00180050|lymphocytic colitis|lymphocytic colitis
5782949|NCT00180050|microscopic colitis|microscopic colitis
5782950|NCT00180050|budesonide|budesonide
5782951|NCT00180037|Parkinson's disease|parkinson's disease
5782952|NCT00180037|Coenzyme Q10|coenzyme q10
5782953|NCT00180037|Treatment|treatment
5782954|NCT00180037|Neuroprotection|neuroprotection
5782955|NCT00180024|AT1-receptor|at1-receptor
5782956|NCT00180024|AT2-receptor|at2-receptor
5782957|NCT00180024|human pharmacology|human pharmacology
5782958|NCT00180011|omalizumab|omalizumab
5782959|NCT00180011|severe asthma|severe asthma
5782960|NCT00180011|moderate asthma|moderate asthma
5782961|NCT00180011|injectable asthma medication|injectable asthma medication
5782962|NCT00180011|Xolair|xolair
5782963|NCT00179998|Cystic fibrosis|cystic fibrosis
5782964|NCT00179998|Infants|infants
5782965|NCT00179998|Children|children
5807330|NCT00088387|AD|ad
5782966|NCT00179998|Pulmozyme|pulmozyme
5782967|NCT00179998|Pulmonary function|pulmonary function
5782968|NCT00179998|Computed tomography|computed tomography
5782969|NCT00179985|Developmental Care|developmental care
5782970|NCT00179985|Neonatal Intensive Care Unit (NICU)|neonatal intensive care unit (nicu)
5782971|NCT00179972|Pulse oximetry|pulse oximetry
5782972|NCT00179972|Pulse oximetry sensors|pulse oximetry sensors
5782973|NCT00179972|Skin Integrity|skin integrity
5782974|NCT00179972|Prematurity|prematurity
5782975|NCT00179972|Neonatal Intensive Care Unit|neonatal intensive care unit
5782976|NCT00179972|Infant, premature|infant, premature
5782977|NCT00179933|developmental care|developmental care
5782978|NCT00179933|Neonatal Intensive Care Unit|neonatal intensive care unit
5782979|NCT00179894|ADHD|adhd
5782980|NCT00179894|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5782981|NCT00179881|Brain stem glioma|brain stem glioma
5782982|NCT00179868|cancer|cancer
5782983|NCT00179868|leukemia|leukemia
5782984|NCT00179868|stem cell transplant|stem cell transplant
5782985|NCT00179868|complications|complications
5782986|NCT00179855|graft versus host disease|graft versus host disease
5782988|NCT00179855|extracorporeal photopheresis|extracorporeal photopheresis
5782989|NCT00179855|allogeneic transplantation|allogeneic transplantation
5782990|NCT00179829|leukemia|leukemia
5782991|NCT00179829|acute lymphocytic leukemia|acute lymphocytic leukemia
5782992|NCT00179829|chronic myelogenous leukemia|chronic myelogenous leukemia
5782993|NCT00179829|acute myelogenous leukemia|acute myelogenous leukemia
5782994|NCT00179816|wilm's tumor|wilm's tumor
5782995|NCT00179816|stem cell transplantation|stem cell transplantation
5782996|NCT00179816|solid tumor|solid tumor
5782997|NCT00179803|brain tumor|brain tumor
5782998|NCT00179803|medulloblastoma|medulloblastoma
5782999|NCT00179803|germ cell tumor|germ cell tumor
5783000|NCT00179803|CNS tumor|cns tumor
5783001|NCT00179803|glioblastoma|glioblastoma
5783002|NCT00179803|astrocytoma|astrocytoma
5783003|NCT00179803|pineoblastoma|pineoblastoma
5783004|NCT00179803|rhabdoid tumor|rhabdoid tumor
5783005|NCT00179803|supratentorial PNET|supratentorial pnet
5783006|NCT00179803|high grade astrocytoma|high grade astrocytoma
5783007|NCT00179790|cancer|cancer
5783008|NCT00179790|hemoglobinopathy|hemoglobinopathy
5783009|NCT00179790|immune deficiency|immune deficiency
5783010|NCT00179790|photopheresis|photopheresis
5783011|NCT00179790|ECP|ecp
5783012|NCT00179790|extracorporeal photopheresis|extracorporeal photopheresis
5783013|NCT00179777|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5799956|NCT00107887|TST|tst
5783014|NCT00179777|Genetic Predisposition to Disease|genetic predisposition to disease
5783015|NCT00179777|Infant Nutrition|infant nutrition
5783016|NCT00179777|Primary Prevention|primary prevention
5783017|NCT00179764|Patients with recurrent solid tumors|patients with recurrent solid tumors
5783018|NCT00179764|Patients with malignant melanoma|patients with malignant melanoma
5783019|NCT00179764|Patients with hematological malignancies|patients with hematological malignancies
5783020|NCT00179764|Acute lymphoblastic leukemia (ALL)|acute lymphoblastic leukemia (all)
5783021|NCT00179764|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5783022|NCT00179751|cc-5013|cc-5013
5783023|NCT00179751|revlimid|revlimid
5783024|NCT00179751|pancreatic cancer|pancreatic cancer
5783025|NCT00179738|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5783026|NCT00179725|cc-5013|cc-5013
5783027|NCT00179725|revlimid|revlimid
5783028|NCT00179725|ovarian cancer|ovarian cancer
5783029|NCT00179725|celgene|celgene
5783030|NCT00179712|cc-5013|cc-5013
5783031|NCT00179712|revlimid|revlimid
5783032|NCT00179712|ovarian cancer|ovarian cancer
5783033|NCT00179712|celgene|celgene
5783034|NCT00179699|cc-5013|cc-5013
5783035|NCT00179699|Non Small Cell Lung Cancer|non small cell lung cancer
5783036|NCT00179699|revlimid|revlimid
5783037|NCT00179699|celgene|celgene
5783038|NCT00179699|cc5013|cc5013
5783039|NCT00179686|celgene|celgene
5783040|NCT00179686|cc-5013|cc-5013
5783041|NCT00179686|NSCLC|nsclc
5783042|NCT00179686|CC5013|cc5013
5783043|NCT00179686|Revlimid|revlimid
5783044|NCT00179686|Non-Small Cell Lung Cancer|non-small cell lung cancer
5783045|NCT00179673|NHL|nhl
5783046|NCT00179673|CC5013|cc5013
5783047|NCT00179673|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5783048|NCT00179673|revlimid|revlimid
5783049|NCT00179673|cc-5013|cc-5013
5783050|NCT00179673|celgene|celgene
5783051|NCT00179660|celgene|celgene
5783052|NCT00179660|cc-5013|cc-5013
5783053|NCT00179660|CC5013|cc5013
5783054|NCT00179660|NHL|nhl
5783055|NCT00179660|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5783057|NCT00179647|Multiple Myeloma|multiple myeloma
5783058|NCT00179647|MM|mm
5783059|NCT00179647|Revlimid|revlimid
5783060|NCT00179647|CC5013|cc5013
5783061|NCT00179647|celgene|celgene
5783062|NCT00179647|cc-5013|cc-5013
5783063|NCT00179647|relapsed/refractory|relapsed/refractory
5783064|NCT00179647|lenalidomide|lenalidomide
5783065|NCT00179647|dexamethasone|dexamethasone
5783066|NCT00179647|Decadron|decadron
5783067|NCT00179634|Mastectomy|mastectomy
5807914|NCT00088179|CABG|cabg
5783068|NCT00179634|Randomized Controlled Trial|randomized controlled trial
5783069|NCT00179634|Imagery|imagery
5783070|NCT00179621|MDS|mds
5783071|NCT00179621|transfusion dependent|transfusion dependent
5783072|NCT00179621|anaemia|anaemia
5783073|NCT00179621|cytogenetic abnormality 5q-|cytogenetic abnormality 5q-
5783074|NCT00179621|erythroid response|erythroid response
5783075|NCT00179621|leukaemia|leukaemia
5783076|NCT00179621|CC-5013|cc-5013
5783077|NCT00179621|Celgene|celgene
5783078|NCT00179621|revlimid|revlimid
5783079|NCT00179621|lenalidomide|lenalidomide
5783080|NCT00179608|CC-5013|cc-5013
5783081|NCT00179608|CC5013|cc5013
5783082|NCT00179608|celgene|celgene
5783083|NCT00179608|Melanoma|melanoma
5783084|NCT00179608|Revlimid|revlimid
5783085|NCT00179608|Metastatic Malignant Melanoma|metastatic malignant melanoma
5783086|NCT00179608|Lenalidomide|lenalidomide
5783087|NCT00179595|nitric oxide, volumetric oxygen consumption|nitric oxide, volumetric oxygen consumption
5783088|NCT00179582|IBS|ibs
5783089|NCT00179582|Functional bowel disorder|functional bowel disorder
5783090|NCT00179582|Diarrhea|diarrhea
5783091|NCT00179582|probiotic|probiotic
5783092|NCT00179556|Hot flashes|hot flashes
5783093|NCT00179556|Menopausal symptoms|menopausal symptoms
5783094|NCT00179556|Soybean germ|soybean germ
5783095|NCT00179556|Aglycones|aglycones
5783096|NCT00179556|Menopause|menopause
5783097|NCT00179517|Seizure|seizure
5783098|NCT00179517|Epilepsy|epilepsy
5783099|NCT00179517|Testosterone|testosterone
5783100|NCT00179517|Hormone|hormone
5783101|NCT00179517|Sexual Dysfunction|sexual dysfunction
5783102|NCT00179517|Hypogonadism|hypogonadism
5783103|NCT00179517|Men|men
5783104|NCT00179491|coronary artery bypass grafting surgery|coronary artery bypass grafting surgery
5783105|NCT00179478|Multiple sclerosis|multiple sclerosis
5783106|NCT00179478|Interferon Beta|interferon beta
5783107|NCT00179478|MRI|mri
5783108|NCT00179478|Optic neuritis|optic neuritis
5783109|NCT00179478|Transverse Myelitis|transverse myelitis
5783110|NCT00179465|Treatment|treatment
5783111|NCT00179465|fMRI|fmri
5783112|NCT00179465|Cognition|cognition
5783113|NCT00179465|Brain development|brain development
5783114|NCT00179452|epilepsy, yoga|epilepsy, yoga
5783115|NCT00179439|PSC|psc
5783116|NCT00179439|IBD|ibd
5783117|NCT00179439|CFTR|cftr
5783118|NCT00179426|Seizure Disorder|seizure disorder
5783119|NCT00179426|Hypogonadism|hypogonadism
5783120|NCT00179426|Sexual Function|sexual function
5783121|NCT00179426|Epilepsy|epilepsy
5783122|NCT00179413|hepatitis C|hepatitis c
5783123|NCT00179413|cirrhosis|cirrhosis
5783124|NCT00179413|interferon|interferon
5783125|NCT00179413|colchicine|colchicine
5783126|NCT00179387|Neoplasms|neoplasms
5783127|NCT00179387|Needs Assessment|needs assessment
5783128|NCT00179387|Adaptation Psychological|adaptation psychological
5783129|NCT00179387|Minority Groups|minority groups
5783130|NCT00179387|Psychotherapy, Group|psychotherapy, group
5783131|NCT00179387|Program Evaluation|program evaluation
5783132|NCT00179387|Spirituality|spirituality
5783133|NCT00179387|Spiritual Therapies|spiritual therapies
5783134|NCT00179374|Medication adherence|medication adherence
5783135|NCT00179374|Self-care behaviors|self-care behaviors
5783136|NCT00179374|Telephonic intervention|telephonic intervention
5783137|NCT00179374|Diabetes|diabetes
5783138|NCT00179374|Nutrition|nutrition
5783139|NCT00179374|Exercise|exercise
5783140|NCT00179335|Regular lopinavir/ritonavir or Efavirenz use|regular lopinavir/ritonavir or efavirenz use
5783141|NCT00179335|Age >/= 55 y or </= 35 y|age >/= 55 y or </= 35 y
5783142|NCT00179335|HIV+|hiv+
5783143|NCT00179322|Sleep Architecture|sleep architecture
5783144|NCT00179322|Sleep Measures|sleep measures
5783145|NCT00179322|Speech Articulation|speech articulation
5783146|NCT00179322|Cerebral Perfusion|cerebral perfusion
5783147|NCT00179322|Neuroimaging|neuroimaging
5783148|NCT00179322|Healthy Volunteer|healthy volunteer
5783151|NCT00179309|MUC-1|muc-1
5783152|NCT00179309|Immunotherapy|immunotherapy
5783153|NCT00179309|GM-CSF|gm-csf
5783154|NCT00179309|Vaccine|vaccine
5783155|NCT00179309|Breast Cancer|breast cancer
5783156|NCT00179309|Metastatic Breast Cancer|metastatic breast cancer
5783157|NCT00179257|Failure to Escitalopram|failure to escitalopram
5783158|NCT00179244|Treatment Resistant Depression|treatment resistant depression
5783159|NCT00179192|End Stage Renal Disease|end stage renal disease
5783160|NCT00179192|ESRD|esrd
5783161|NCT00179192|Chronic Maintenance Hemodialysis|chronic maintenance hemodialysis
5783162|NCT00179127|Pediatrics|pediatrics
5783163|NCT00179127|Diabetes|diabetes
5783164|NCT00179127|Emergency Care|emergency care
5783165|NCT00179127|Endocrinology|endocrinology
5783166|NCT00179127|Critical Care|critical care
5783167|NCT00179114|Spasticity|spasticity
5783168|NCT00179114|Developmental Disabilities|developmental disabilities
5783169|NCT00179114|Intrathecal baclofen (ITB)|intrathecal baclofen (itb)
5783170|NCT00179114|Botulinum Toxin Type A (Botox)|botulinum toxin type a (botox)
5783171|NCT00179101|Parkinson's Disease|parkinson's disease
5783172|NCT00179101|Depression|depression
5783173|NCT00179101|Quality of Life|quality of life
5686446|NCT00552045|periventricular heterotopias|periventricular heterotopias
5782318|NCT00183040|HRT|hrt
5783174|NCT00179101|Deep Brain Stimulation|deep brain stimulation
5783175|NCT00179088|Weight-Bearing|weight-bearing
5783176|NCT00179088|Total Hip Replacement|total hip replacement
5783177|NCT00179088|Non-cemented|non-cemented
5783178|NCT00179088|Randomized|randomized
5783179|NCT00179088|Fiber-Metal-Taper-Stem|fiber-metal-taper-stem
5783181|NCT00179088|Osteoarthritis|osteoarthritis
5783182|NCT00179075|T-Lymphocyte Subsets|t-lymphocyte subsets
5783183|NCT00179062|major depression with psychotic features|major depression with psychotic features
5783184|NCT00179062|bipolar disorder with psychotic features|bipolar disorder with psychotic features
5783185|NCT00179049|T-Lymphocyte Subsets|t-lymphocyte subsets
5783186|NCT00179036|Blood supply|blood supply
5783187|NCT00179036|Mesentery|mesentery
5783188|NCT00179023|OBESITY|obesity
5783189|NCT00179023|RESTING ENERGY EXPENDITURE|resting energy expenditure
5783190|NCT00179023|SYMPATHETIC NERVOUS SYSTEM|sympathetic nervous system
5783191|NCT00179023|HYPERTENSION|hypertension
5783192|NCT00179023|AUTONOMIC FAILURE|autonomic failure
5783193|NCT00179010|Adenosine|adenosine
5783194|NCT00179010|AMP|amp
5783195|NCT00179010|Microdialysis|microdialysis
5783196|NCT00179010|Blood Flow|blood flow
5783197|NCT00178997|Blood supply|blood supply
5783198|NCT00178997|Mesentery|mesentery
5783199|NCT00178984|Blood supply|blood supply
5783200|NCT00178984|Mesentery|mesentery
5783201|NCT00178919|Endothelial Nitric Oxide|endothelial nitric oxide
5783202|NCT00178919|L-NMMA|l-nmma
5783203|NCT00178919|Trimethaphan|trimethaphan
5783204|NCT00178919|Autonomic Nervous System|autonomic nervous system
5783205|NCT00178919|Nitric Oxide Inhibition|nitric oxide inhibition
5783206|NCT00178906|depression|depression
5783207|NCT00178906|suicide|suicide
5783208|NCT00178906|voice|voice
5783209|NCT00178880|depression|depression
5783210|NCT00178880|MRI|mri
5783211|NCT00178880|imaging|imaging
5783212|NCT00178841|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5783213|NCT00178841|CTCL|ctcl
5783214|NCT00178841|Mycosis Fungoides|mycosis fungoides
5783215|NCT00178841|Sezary Syndrome|sezary syndrome
5783216|NCT00178841|Bexarotene|bexarotene
5783217|NCT00178841|Targretin|targretin
5783218|NCT00178841|Rosiglitazone|rosiglitazone
5783219|NCT00178841|Avandia|avandia
5783220|NCT00178828|Depression|depression
5783221|NCT00178828|antidepressant|antidepressant
5783222|NCT00178828|SSRI|ssri
5783223|NCT00178802|breast cancer|breast cancer
5783224|NCT00178802|endometrial cancer|endometrial cancer
5783225|NCT00178802|cervical cancer|cervical cancer
5783226|NCT00178802|ovarian cancer|ovarian cancer
5783227|NCT00178789|Deep Venous Thrombosis|deep venous thrombosis
5783228|NCT00178789|Blood Clot|blood clot
5783229|NCT00178789|Lower Extremity|lower extremity
5778143|NCT00207064|MRI|mri
5783230|NCT00178789|Sonography|sonography
5783231|NCT00178776|Group|group
5783232|NCT00178776|Therapy|therapy
5783233|NCT00178776|Cocaine|cocaine
5783234|NCT00178776|Drugs|drugs
5783235|NCT00178776|Trial|trial
5783236|NCT00178776|Outcome|outcome
5783237|NCT00178776|Study|study
5783238|NCT00178776|Feasibility|feasibility
5783239|NCT00178776|Transtheoretical|transtheoretical
5783240|NCT00178776|Stages|stages
5783241|NCT00178776|Motivation|motivation
5783242|NCT00178776|Change|change
5783243|NCT00178763|Cancer|cancer
5783244|NCT00178763|Pancreatic Cancer|pancreatic cancer
5783245|NCT00178763|Pancreas|pancreas
5783246|NCT00178763|Neoplasms|neoplasms
5783247|NCT00178750|Epidural placement|epidural placement
5783248|NCT00178750|CompuFlo®|compuflo®
5783249|NCT00178724|spinal cord injury|spinal cord injury
5783250|NCT00178724|SCI|sci
5783251|NCT00178724|traumatic spinal cord injury|traumatic spinal cord injury
5783252|NCT00178724|acute spinal cord injury|acute spinal cord injury
5783253|NCT00178724|paralysis|paralysis
5783254|NCT00178711|Traumatic Brain Injury|traumatic brain injury
5783255|NCT00178711|Hypothermia|hypothermia
5783256|NCT00178698|thermochemotherapy|thermochemotherapy
5783257|NCT00178698|fever range whole body|fever range whole body
5783259|NCT00178698|gemcitabine|gemcitabine
5783729|NCT00176293|prostate|prostate
5783260|NCT00178698|daily low dose interferon alpha|daily low dose interferon alpha
5783261|NCT00178685|Self-determination|self-determination
5783262|NCT00178685|motivation|motivation
5783263|NCT00178685|adherence|adherence
5783264|NCT00178685|competence|competence
5783265|NCT00178685|autonomy|autonomy
5783266|NCT00178685|tobacco dependence|tobacco dependence
5783267|NCT00178685|Tobacco use and dependence|tobacco use and dependence
5783268|NCT00178685|Behavior change|behavior change
5783269|NCT00178672|CVA|cva
5783270|NCT00178672|TIA|tia
5783271|NCT00178672|Carotid disease|carotid disease
5783273|NCT00178672|Neurology|neurology
5783274|NCT00178672|Carotid Stenting|carotid stenting
5783275|NCT00178659|Traumatic Brain Injury|traumatic brain injury
5783276|NCT00178659|TBI (Traumatic Brain Injury)|tbi (traumatic brain injury)
5783277|NCT00178659|Proteomics|proteomics
5782376|NCT00182832|MCI|mci
5783278|NCT00178646|Stroke|stroke
5783279|NCT00178646|Brain Injuries|brain injuries
5783280|NCT00178646|Spasticity|spasticity
5783281|NCT00178646|Botulinum Toxins|botulinum toxins
5783282|NCT00178633|Obesity|obesity
5783283|NCT00178633|Insulin Resistance|insulin resistance
5783284|NCT00178633|Free Fatty Acids|free fatty acids
5783285|NCT00178633|Heart Failure|heart failure
5783286|NCT00178620|Heart Disease|heart disease
5783287|NCT00178620|Heart Attack|heart attack
5783288|NCT00178620|Myocardial Infarction|myocardial infarction
5783289|NCT00178620|Thrombolytic Therapy|thrombolytic therapy
5783290|NCT00178620|Emergency Medicine|emergency medicine
5783291|NCT00178607|Inhibitors|inhibitors
5783292|NCT00178594|Hereditary Bleeding disorder|hereditary bleeding disorder
5783293|NCT00178594|Thrombotic Disorder|thrombotic disorder
5783294|NCT00178581|Trauma|trauma
5783295|NCT00178581|Critical Illness|critical illness
5783296|NCT00178581|Shock|shock
5783297|NCT00178581|Enteral Nutrition|enteral nutrition
5783298|NCT00178581|Glutamine|glutamine
5783299|NCT00178568|Caregiving|caregiving
5783300|NCT00178568|Spousal|spousal
5783301|NCT00178568|Sleep disturbances|sleep disturbances
5783302|NCT00178568|Progressive dementia|progressive dementia
5783303|NCT00178568|Stress|stress
5783304|NCT00178568|Health outcomes|health outcomes
5783305|NCT00178568|Intervention|intervention
5783306|NCT00178568|Affective self-management|affective self-management
5783307|NCT00178568|Caregivers M01.526.485.200|caregivers m01.526.485.200
5783308|NCT00178568|Spouses F01.829.263.500.660|spouses f01.829.263.500.660
5783309|NCT00178568|Alzheimer's disease C10.574.945.249|alzheimer's disease c10.574.945.249
5783310|NCT00178568|Parkinson's disease C10.574.812|parkinson's disease c10.574.812
5783311|NCT00178568|Sleep disorder C10.886.425.800.800|sleep disorder c10.886.425.800.800
5783312|NCT00178555|Endotracheal Intubation, Video Laryngoscopy|endotracheal intubation, video laryngoscopy
5783313|NCT00178542|von Willebrand Disease|von willebrand disease
5783314|NCT00178542|Healthy Women and Women with von Willebrand Disease|healthy women and women with von willebrand disease
5783315|NCT00178529|Stroke|stroke
5783316|NCT00178529|Caregivers|caregivers
5783317|NCT00178516|male|male
5783318|NCT00178516|infertility|infertility
5783319|NCT00178490|Neurocognitive Function|neurocognitive function
5783320|NCT00178464|sickle cell disease|sickle cell disease
5783321|NCT00178464|hemoglobin SS disease|hemoglobin ss disease
5783322|NCT00178464|hemoglobin S Beta-0 Thalassemia|hemoglobin s beta-0 thalassemia
5783323|NCT00178464|silent infarction in sickle cell disease|silent infarction in sickle cell disease
5783324|NCT00178464|overt stroke in sickle cell disease|overt stroke in sickle cell disease
5783325|NCT00178464|aspirin|aspirin
5783326|NCT00178464|transcranial Doppler ultrasound|transcranial doppler ultrasound
5783327|NCT00178464|neurocognitive testing|neurocognitive testing
5783328|NCT00178438|capsule endoscopy in small bowel|capsule endoscopy in small bowel
5783329|NCT00178425|mycophenolate mofetil hydrochloride|mycophenolate mofetil hydrochloride
5783330|NCT00178425|pharmacokinetics|pharmacokinetics
5783331|NCT00178425|tacrolimus|tacrolimus
5783332|NCT00178412|Hospitalized elders|hospitalized elders
5783333|NCT00178412|Family caregivers|family caregivers
5783334|NCT00178412|Acute care|acute care
5783336|NCT00178386|education|education
5783337|NCT00178386|learning|learning
5783338|NCT00178386|brain tumor|brain tumor
5783339|NCT00178386|school|school
5783340|NCT00178373|cancer-related fatigue|cancer-related fatigue
5783341|NCT00178373|chemotherapy|chemotherapy
5783342|NCT00178373|modafinil|modafinil
5783343|NCT00178360|Huntington's Disease, Music Therapy, quality of life|huntington's disease, music therapy, quality of life
5783344|NCT00178321|Sleep|sleep
5783345|NCT00178321|Criticall Ill|criticall ill
5783346|NCT00178321|Children|children
5783347|NCT00178321|Earplugs|earplugs
5783348|NCT00178217|Botulinum Toxin|botulinum toxin
5783349|NCT00178217|Music Therapy|music therapy
5783350|NCT00178217|Cerebral Palsy|cerebral palsy
5783351|NCT00178217|Procedural Support|procedural support
5783352|NCT00178204|delta sleep|delta sleep
5783353|NCT00178204|Cancer-related fatigue|cancer-related fatigue
5783354|NCT00178204|Sleep Disturbance|sleep disturbance
5783355|NCT00178204|chemotherapy|chemotherapy
5783356|NCT00178178|anterior cruciate ligament reconstruction|anterior cruciate ligament reconstruction
5783357|NCT00178178|Pain Care 3000|pain care 3000
5783358|NCT00178178|Catheter Placement|catheter placement
5783359|NCT00178178|Pain|pain
5783360|NCT00178178|Breg, Inc|breg, inc
5783361|NCT00178165|Family Caregivers|family caregivers
5783362|NCT00178165|Dementia|dementia
5783363|NCT00178165|Alzheimer Disease|alzheimer disease
5783364|NCT00178165|Randomized Controlled Trial|randomized controlled trial
5783365|NCT00178165|Intervention Studies|intervention studies
5783366|NCT00178139|Music Therapy|music therapy
5783367|NCT00178139|Mechanical ventilation|mechanical ventilation
5783368|NCT00178139|Weaning from mechanical ventilation|weaning from mechanical ventilation
5783369|NCT00178139|complementary and alternative therapy|complementary and alternative therapy
5783370|NCT00178126|pressure ulcer|pressure ulcer
5783371|NCT00178113|Prostatic Intraepithelial Neoplasia|prostatic intraepithelial neoplasia
5783372|NCT00178113|Prostate-Specific Antigen|prostate-specific antigen
5783373|NCT00178113|lycopene|lycopene
5783374|NCT00178100|Depression|depression
5783375|NCT00178100|Elderly|elderly
5783376|NCT00178100|Late Life|late life
5783377|NCT00178087|late-life depression|late-life depression
5783378|NCT00178087|mild cognitive impairment|mild cognitive impairment
5783379|NCT00178087|dementia|dementia
5783380|NCT00178074|depression|depression
5783381|NCT00178074|imaging|imaging
5783382|NCT00178074|PET|pet
5783383|NCT00178074|elderly|elderly
5783384|NCT00178074|late life|late life
5783385|NCT00178074|sleep deprivation|sleep deprivation
5783386|NCT00178048|primary insomnia|primary insomnia
5783387|NCT00178048|insomnia|insomnia
5783388|NCT00178048|depression|depression
5783389|NCT00178048|late life|late life
5783390|NCT00178048|elderly|elderly
5783391|NCT00178048|sleep disorders|sleep disorders
5783392|NCT00178035|Depression|depression
5783393|NCT00178035|Unipolar Depression|unipolar depression
5783394|NCT00178035|Elderly depression|elderly depression
5783395|NCT00178035|Late-Life|late-life
5783396|NCT00178022|tbi|tbi
5783397|NCT00178022|intervention|intervention
5783398|NCT00178022|depression|depression
5783399|NCT00178022|anxiety|anxiety
5783400|NCT00178009|computer-assisted instruction|computer-assisted instruction
5783401|NCT00178009|instruction (video)|instruction (video)
5783402|NCT00177996|depression|depression
5783403|NCT00177996|anxiety|anxiety
5783404|NCT00177983|Schizophrenia|schizophrenia
5783405|NCT00177983|Relapse|relapse
5783406|NCT00177983|Psychological distress|psychological distress
5783407|NCT00177957|Gram negative bacteremia|gram negative bacteremia
5783408|NCT00177944|invasive fungal infection|invasive fungal infection
5783409|NCT00177931|Liver transplant|liver transplant
5783410|NCT00177931|cefepime|cefepime
5783411|NCT00177931|antibiotics|antibiotics
5783412|NCT00177918|Lung Transplant|lung transplant
5783413|NCT00177892|Sleep fragmentation|sleep fragmentation
5783414|NCT00177892|Intermittent hypoxia|intermittent hypoxia
5783415|NCT00177892|Obstructive Sleep Apnea|obstructive sleep apnea
5783416|NCT00177892|Metabolic Syndrome|metabolic syndrome
5783417|NCT00177892|Insulin resistance|insulin resistance
5783418|NCT00177879|website|website
5783419|NCT00177879|comparison|comparison
5783420|NCT00177853|Locally advanced pancreatic cancer|locally advanced pancreatic cancer
5783421|NCT00177853|invasion of major arteries and veins around pancreas|invasion of major arteries and veins around pancreas
5783422|NCT00177853|No prior radiation or chemo|no prior radiation or chemo
5783423|NCT00177840|cancer-related fatigue|cancer-related fatigue
5783424|NCT00177840|acupuncture|acupuncture
5783425|NCT00177840|breast cancer|breast cancer
5783426|NCT00177814|pipercillin|pipercillin
5783427|NCT00177814|gram negative bacteria infections|gram negative bacteria infections
5783428|NCT00177788|liver transplant|liver transplant
5783429|NCT00177788|voriconazole prophylaxis|voriconazole prophylaxis
5783430|NCT00177788|liver transplantation|liver transplantation
5783431|NCT00177788|voriconazole|voriconazole
5783432|NCT00177749|invasive fungal infections|invasive fungal infections
5783433|NCT00177736|ventilator associated pneumonia|ventilator associated pneumonia
5783434|NCT00177723|receiving antibiotic Linezolid clinically|receiving antibiotic linezolid clinically
5783436|NCT00177671|Dementia|dementia
5783437|NCT00177671|Alzheimer's Disease|alzheimer's disease
5783438|NCT00177671|Cognitive|cognitive
5783439|NCT00177671|Donepezil|donepezil
5783440|NCT00177671|Memory|memory
5783441|NCT00177671|Function|function
5783442|NCT00177671|Elderly|elderly
5783443|NCT00177671|Late-Life|late-life
5783444|NCT00177658|Salmonella|salmonella
5783445|NCT00177645|cystic fibrosis|cystic fibrosis
5783446|NCT00177645|mucus clearance|mucus clearance
5783447|NCT00177619|Prostatic neoplasms|prostatic neoplasms
5783448|NCT00177619|Bisphosphonates|bisphosphonates
5783449|NCT00177619|Hypogonadism|hypogonadism
5783450|NCT00177606|withdrawal|withdrawal
5783451|NCT00177606|life-sustaining|life-sustaining
5783452|NCT00177606|treatments|treatments
5783453|NCT00177606|UNOS|unos
5783454|NCT00177606|organ donation|organ donation
5783455|NCT00177580|schizophrenia|schizophrenia
5783456|NCT00177580|schizoaffective disorder|schizoaffective disorder
5783457|NCT00177580|positive symptoms|positive symptoms
5783458|NCT00177580|negative symptoms|negative symptoms
5784023|NCT00175097|lipids|lipids
5783459|NCT00177580|cognitive functioning|cognitive functioning
5783460|NCT00177580|pravastatin|pravastatin
5783461|NCT00177567|Bipolar Disorder|bipolar disorder
5783462|NCT00177567|Manic Depression|manic depression
5783463|NCT00177567|Elderly|elderly
5783464|NCT00177567|Late-Life|late-life
5783465|NCT00177554|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5783466|NCT00177541|urge incontinence|urge incontinence
5783467|NCT00177541|biofeedback|biofeedback
5783468|NCT00177541|pelvic floor muscle training|pelvic floor muscle training
5783469|NCT00177541|behavior modification|behavior modification
5783470|NCT00177528|Elderly|elderly
5783471|NCT00177515|emergency contraception|emergency contraception
5783472|NCT00177515|folic acid|folic acid
5783473|NCT00177515|education|education
5783474|NCT00177515|preventive health|preventive health
5783475|NCT00177489|Family Caregivers|family caregivers
5783476|NCT00177489|Dementia|dementia
5783477|NCT00177489|Alzheimer Disease|alzheimer disease
5783478|NCT00177489|Randomized Controlled Trial|randomized controlled trial
5783479|NCT00177489|Intervention Studies|intervention studies
5783480|NCT00177463|L-carnosine|l-carnosine
5783481|NCT00177463|Bipolar I disorder|bipolar i disorder
5783482|NCT00177463|Cognitive enhancement|cognitive enhancement
5783483|NCT00177424|Rehabilitation|rehabilitation
5783484|NCT00177411|Endocrine System Diseases|endocrine system diseases
5783485|NCT00177411|MusculoSkeletal System Diseases|musculoskeletal system diseases
5783486|NCT00177411|Hormone|hormone
5783487|NCT00177411|Postmenopausal Women|postmenopausal women
5783488|NCT00177398|Type 2 diabetes|type 2 diabetes
5783489|NCT00177398|Hyperglycemia|hyperglycemia
5783490|NCT00177398|Enteral nutrition|enteral nutrition
5783491|NCT00177385|Sleep|sleep
5783492|NCT00177385|Sleep Hygiene|sleep hygiene
5783493|NCT00177385|Modest sleep deprivation|modest sleep deprivation
5783494|NCT00177385|Healthy Aging and sleep|healthy aging and sleep
5783495|NCT00177385|Health Promotion|health promotion
5783496|NCT00177359|gait impairment|gait impairment
5783497|NCT00177333|Abortion, Induced|abortion, induced
5783498|NCT00177333|Doxycycline|doxycycline
5783499|NCT00177333|Antibiotic Prophylaxis|antibiotic prophylaxis
5783500|NCT00177333|Vomiting|vomiting
5783501|NCT00177333|Abortion, Therapeutic|abortion, therapeutic
5783502|NCT00177320|Rheumatic Disorders|rheumatic disorders
5783503|NCT00177320|Computer Use|computer use
5783504|NCT00177307|colon|colon
5783505|NCT00177307|rectum|rectum
5783507|NCT00177294|Remission|remission
5783508|NCT00177294|Escitalopram|escitalopram
5783509|NCT00177294|Interpersonal Psychotherapy|interpersonal psychotherapy
5783510|NCT00177294|Psychotherapy|psychotherapy
5783511|NCT00177294|Caregiving|caregiving
5783512|NCT00177294|Late-Life|late-life
5783513|NCT00177268|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5783514|NCT00177268|Sezary Syndrome|sezary syndrome
5783515|NCT00177268|Mycosis Fungoides|mycosis fungoides
5783516|NCT00177268|Blood/tissue banking|blood/tissue banking
5783517|NCT00177268|eczema|eczema
5783518|NCT00177268|atopic dermatitis|atopic dermatitis
5783519|NCT00177255|gastric|gastric
5783520|NCT00177255|stomach|stomach
5783521|NCT00177255|esophagus|esophagus
5783522|NCT00177255|esophageal|esophageal
5783523|NCT00177242|pancreas|pancreas
5783524|NCT00177242|pancreatic|pancreatic
5783525|NCT00177216|Primary Insomnia|primary insomnia
5783526|NCT00177216|Insomnia|insomnia
5783527|NCT00177216|Placebo-Controlled|placebo-controlled
5783528|NCT00177216|Double-Blind|double-blind
5783529|NCT00177216|Polysomnography|polysomnography
5783530|NCT00177216|PET Studies|pet studies
5783531|NCT00177216|Escitalopram|escitalopram
5783532|NCT00177216|Zolpidem|zolpidem
5783533|NCT00177203|Insomnia|insomnia
5783534|NCT00177203|Sleep Disorders|sleep disorders
5783535|NCT00177203|Sleeplessness|sleeplessness
5778382|NCT00205777|Postmenopause|postmenopause
5783536|NCT00177203|Chronic Insomnia|chronic insomnia
5783537|NCT00177203|Sleep Studies|sleep studies
5783538|NCT00177203|Disorders of Initiating and Maintaining Sleep|disorders of initiating and maintaining sleep
5783539|NCT00177203|Primary Care|primary care
5783540|NCT00177190|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5783541|NCT00177190|Sezary Syndrome|sezary syndrome
5783542|NCT00177190|Mycosis Fungoides|mycosis fungoides
5783543|NCT00177190|Immune Responses|immune responses
5783544|NCT00177177|L-carnosine|l-carnosine
5783545|NCT00177177|Schizophrenia|schizophrenia
5783546|NCT00177177|Schizoaffective disorder|schizoaffective disorder
5783547|NCT00177177|Cognitive enhancement|cognitive enhancement
5783548|NCT00177164|Bipolar I Disorder|bipolar i disorder
5783549|NCT00177164|Risperidone Consta - Long Acting Injection|risperidone consta - long acting injection
5783550|NCT00177164|Oral second generation antipsychotic agents|oral second generation antipsychotic agents
5783551|NCT00177138|Campath Study|campath study
5783552|NCT00177138|Pancreas After Kidney Transplantation|pancreas after kidney transplantation
5783553|NCT00177138|Alemtuzumab|alemtuzumab
5783554|NCT00177112|Cystoscopy|cystoscopy
5783555|NCT00177047|stem cell transplantation|stem cell transplantation
5783564|NCT00176956|Post Pediatric Heart Transplant|post pediatric heart transplant
5783565|NCT00176930|stem cell transplant|stem cell transplant
5783566|NCT00176930|chronic leukemia|chronic leukemia
5783568|NCT00176930|irradiation|irradiation
5783569|NCT00176930|chemotherapy|chemotherapy
5783570|NCT00176917|stem cell transplant|stem cell transplant
5783571|NCT00176917|storage disease|storage disease
5783572|NCT00176917|errors of metabolism|errors of metabolism
5783573|NCT00176904|Inborn errors|inborn errors
5783574|NCT00176904|Storage disease|storage disease
5783575|NCT00176904|errors of metabolism|errors of metabolism
5783576|NCT00176904|stem cell transplant|stem cell transplant
5783577|NCT00176891|Laronidase ERT|laronidase ert
5783578|NCT00176891|Stem cell transplant|stem cell transplant
5783579|NCT00176891|storage disease|storage disease
5783580|NCT00176891|inborn errors of metabolism|inborn errors of metabolism
5783581|NCT00176891|hurler syndrome|hurler syndrome
5783582|NCT00176891|glycosaminoglycans|glycosaminoglycans
5783583|NCT00176891|enzyme replacement|enzyme replacement
5681097|NCT00574717|vision|vision
5783584|NCT00176878|Stem cell transplant|stem cell transplant
5783585|NCT00176878|T-cell depletion|t-cell depletion
5783587|NCT00176878|bone marrow failure disorders|bone marrow failure disorders
5783588|NCT00176865|Stem cell transplant|stem cell transplant
5783589|NCT00176865|immunodeficiency|immunodeficiency
5783590|NCT00176865|donor lymphocyte infusion|donor lymphocyte infusion
5783599|NCT00176839|Stem Cell transplant|stem cell transplant
5783600|NCT00176839|retransplant|retransplant
5783601|NCT00176839|hematological malignancies|hematological malignancies
5783602|NCT00176826|Stem Cell Transplant|stem cell transplant
5783604|NCT00176826|immune deficiencies|immune deficiencies
5783605|NCT00176826|Busulfan pharmacokinetics|busulfan pharmacokinetics
5783606|NCT00176826|Non-Malignant Hematological Disorders|non-malignant hematological disorders
5783607|NCT00176722|Spine Surgery|spine surgery
5783608|NCT00176722|Intraocular Pressure|intraocular pressure
5783609|NCT00176722|lumbar or thoracic Spine Surgery in the prone position|lumbar or thoracic spine surgery in the prone position
5783610|NCT00176722|and its association with visual change|and its association with visual change
5783611|NCT00176696|general anesthesia|general anesthesia
5783612|NCT00176696|pain|pain
5783613|NCT00176696|depth of anesthesia|depth of anesthesia
5783614|NCT00176683|intubation|intubation
5783615|NCT00176683|capnography|capnography
5783616|NCT00176670|presurgical anxiety, children,|presurgical anxiety, children,
5783617|NCT00176657|cardiac surgery|cardiac surgery
5783618|NCT00176657|transfusion|transfusion
5783619|NCT00176644|prostate cancer|prostate cancer
5783620|NCT00176631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5783621|NCT00176631|recurrent prostate cancer|recurrent prostate cancer
5783622|NCT00176631|stage IV prostate cancer|stage iv prostate cancer
5783623|NCT00176618|Aberrant Crypt Foci|aberrant crypt foci
5783624|NCT00176605|prostate cancer|prostate cancer
5783625|NCT00176605|recurrent prostate cancer|recurrent prostate cancer
5783626|NCT00176605|stage IV prostate cancer|stage iv prostate cancer
5783627|NCT00176592|Multiple Sclerosis|multiple sclerosis
5783628|NCT00176592|Brain|brain
5783629|NCT00176592|Betaseron|betaseron
5783630|NCT00176592|Copaxone|copaxone
5783631|NCT00176592|MRI|mri
5783632|NCT00176579|osteoporosis|osteoporosis
5783633|NCT00176579|stage I prostate cancer|stage i prostate cancer
5783634|NCT00176566|oral leukoplakia|oral leukoplakia
5783635|NCT00176553|methotrexate neurotoxicity|methotrexate neurotoxicity
5783636|NCT00176540|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5783637|NCT00176540|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5783638|NCT00176540|fatigue|fatigue
5783639|NCT00176527|recurrent prostate cancer|recurrent prostate cancer
5783640|NCT00176527|stage IV prostate cancer|stage iv prostate cancer
5783641|NCT00176514|mucositis|mucositis
5783642|NCT00176501|recurrent renal cell cancer|recurrent renal cell cancer
5783643|NCT00176501|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5783644|NCT00176501|stage IV renal cell cancer|stage iv renal cell cancer
5783645|NCT00176488|recurrent breast cancer|recurrent breast cancer
5783646|NCT00176488|stage II breast cancer|stage ii breast cancer
5783647|NCT00176488|stage IIIA breast cancer|stage iiia breast cancer
5783648|NCT00176488|stage IIIB breast cancer|stage iiib breast cancer
5783649|NCT00176488|stage IV breast cancer|stage iv breast cancer
5783650|NCT00176488|male breast cancer|male breast cancer
5783651|NCT00176475|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5783652|NCT00176475|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5783653|NCT00176475|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5783654|NCT00176475|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5783655|NCT00176475|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5783656|NCT00176475|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5783657|NCT00176475|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5783658|NCT00176475|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5783659|NCT00176475|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5783660|NCT00176475|refractory hairy cell leukemia|refractory hairy cell leukemia
5783661|NCT00176475|prolymphocytic leukemia|prolymphocytic leukemia
5783662|NCT00176475|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5783663|NCT00176475|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5783664|NCT00176475|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5783665|NCT00176475|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5783666|NCT00176475|refractory multiple myeloma|refractory multiple myeloma
5783667|NCT00176475|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5783668|NCT00176475|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5783669|NCT00176475|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5783670|NCT00176475|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5783671|NCT00176475|stage II multiple myeloma|stage ii multiple myeloma
5783672|NCT00176475|stage III multiple myeloma|stage iii multiple myeloma
5783673|NCT00176475|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5783674|NCT00176475|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5783675|NCT00176475|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5783676|NCT00176475|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5783677|NCT00176475|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5783678|NCT00176475|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5783679|NCT00176475|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5783680|NCT00176475|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5783681|NCT00176475|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5783682|NCT00176475|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5783683|NCT00176475|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5783684|NCT00176475|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5783685|NCT00176475|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5783686|NCT00176475|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5783687|NCT00176475|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5783688|NCT00176475|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5783689|NCT00176475|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5783690|NCT00176475|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5783691|NCT00176475|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5783692|NCT00176475|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5783693|NCT00176475|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5783694|NCT00176475|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5783695|NCT00176475|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5783696|NCT00176462|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5783699|NCT00176449|Nicotine Use Disorder|nicotine use disorder
5783700|NCT00176449|Tobacco Dependence|tobacco dependence
5783701|NCT00176449|Tobacco-Use Disorder|tobacco-use disorder
5783702|NCT00176449|Smoking Cessation|smoking cessation
5783704|NCT00176436|Support group|support group
5783705|NCT00176436|Exercise|exercise
5783706|NCT00176436|Atomoxetine|atomoxetine
5783707|NCT00176423|schizophrenia|schizophrenia
5783708|NCT00176423|acetylcholine|acetylcholine
5783709|NCT00176423|cognitive impairments|cognitive impairments
5783710|NCT00176423|attention|attention
5783711|NCT00176423|processing speed|processing speed
5783712|NCT00176423|sensory gating|sensory gating
5783713|NCT00176423|eye-tracking|eye-tracking
5783714|NCT00176410|aortic valve stenosis|aortic valve stenosis
5783715|NCT00176410|statin therapy|statin therapy
5783716|NCT00176397|left main coronary artery|left main coronary artery
5783717|NCT00176397|coronary artery disease|coronary artery disease
5783718|NCT00176384|chronic heart failure|chronic heart failure
5783719|NCT00176384|exercise training|exercise training
5783720|NCT00176371|Physical fitness|physical fitness
5783722|NCT00176345|endothelial function|endothelial function
5783723|NCT00176332|chronic heart failure|chronic heart failure
5783724|NCT00176332|rosuvastatin|rosuvastatin
5783725|NCT00176332|endothelial function|endothelial function
5783726|NCT00176332|skeletal muscle|skeletal muscle
5783727|NCT00176319|heart failure|heart failure
5783730|NCT00176293|prostate cancer|prostate cancer
5783732|NCT00176293|dexamethasone|dexamethasone
5783733|NCT00176293|metastatic|metastatic
5783734|NCT00176293|hormone refractory|hormone refractory
5783735|NCT00176280|Renal|renal
5783736|NCT00176280|Carcinoma|carcinoma
5783737|NCT00176280|Renal Cell Carcinoma|renal cell carcinoma
5783738|NCT00176280|RCC|rcc
5783739|NCT00176280|Leukine|leukine
5786511|NCT00162734|Combination|combination
5783740|NCT00176280|Dexamethasone|dexamethasone
5783741|NCT00176280|Gemcitabine|gemcitabine
5783742|NCT00176280|5 Fluorouracil|5 fluorouracil
5783743|NCT00176280|5 FU|5 fu
5783744|NCT00176280|Metastatic|metastatic
5783745|NCT00176267|head and neck|head and neck
5783746|NCT00176267|squamous cell carcinoma|squamous cell carcinoma
5783747|NCT00176267|squamous cell|squamous cell
5783748|NCT00176267|carcinoma|carcinoma
5783749|NCT00176267|paclitaxel|paclitaxel
5783750|NCT00176267|carboplatin|carboplatin
5783751|NCT00176267|radiotherapy|radiotherapy
5783752|NCT00176267|induction therapy|induction therapy
5783753|NCT00176254|head and neck|head and neck
5783754|NCT00176254|squamous cell carcinoma|squamous cell carcinoma
5783755|NCT00176254|squamous cell|squamous cell
5783756|NCT00176254|carcinoma|carcinoma
5783757|NCT00176254|paclitaxel|paclitaxel
5783758|NCT00176254|carboplatin|carboplatin
5783759|NCT00176254|radiotherapy|radiotherapy
5783760|NCT00176254|induction therapy|induction therapy
5783761|NCT00176241|head and neck|head and neck
5783762|NCT00176241|Gemcitabine|gemcitabine
5783763|NCT00176241|Paclitaxel|paclitaxel
5783764|NCT00176241|radiation|radiation
5783765|NCT00176241|low-dose radiation|low-dose radiation
5783766|NCT00176241|recurrent|recurrent
5783767|NCT00176241|metastatic|metastatic
5783768|NCT00176189|FPD, all-ceramic|fpd, all-ceramic
5783769|NCT00176176|cerebral circulation|cerebral circulation
5783770|NCT00176163|Fibromyalgia|fibromyalgia
5782857|NCT00180635|COPD|copd
5783771|NCT00176163|Back pain|back pain
5783772|NCT00176163|Behavior Therapy|behavior therapy
5783773|NCT00176163|Operant learning|operant learning
5783774|NCT00176163|Tetrahydrocannabinol|tetrahydrocannabinol
5783775|NCT00176150|anorexia nervosa|anorexia nervosa
5773994|NCT00226824|tic|tic
5783776|NCT00176150|multidrug resistance|multidrug resistance
5783777|NCT00176150|cholesterol metabolism|cholesterol metabolism
5783778|NCT00176137|multimodality treatment|multimodality treatment
5783779|NCT00176124|leukocyte depletion, autologous transfusion,|leukocyte depletion, autologous transfusion,
5783780|NCT00176124|infection|infection
5783781|NCT00176124|bacterial infection|bacterial infection
5783782|NCT00176124|sepsis, antibiotics|sepsis, antibiotics
5783783|NCT00176111|peripheral nerve stimulation|peripheral nerve stimulation
5783784|NCT00176111|saline|saline
5783785|NCT00176111|local anesthestics|local anesthestics
5783786|NCT00176111|regional anesthestia|regional anesthestia
5783787|NCT00176111|nerve damage|nerve damage
5783788|NCT00176098|Cataract surgery|cataract surgery
5783789|NCT00176098|Hypnosis|hypnosis
5783790|NCT00176098|C11.510.245|c11.510.245
5783791|NCT00176098|F04.754.424.771|f04.754.424.771
5783792|NCT00176098|Suggestion|suggestion
5783793|NCT00176059|immunoglobulins, intravenous|immunoglobulins, intravenous
5783794|NCT00176059|kidney transplantation|kidney transplantation
5783795|NCT00176059|acute rejection|acute rejection
5783796|NCT00176059|chronic rejection|chronic rejection
5783797|NCT00176059|regulatory autoantibodies|regulatory autoantibodies
5783799|NCT00176059|Th2|th2
5783800|NCT00176059|B Cell|b cell
5783801|NCT00176059|Monokines|monokines
5783802|NCT00176059|Cytokine promoter gene polymorphisms|cytokine promoter gene polymorphisms
5783803|NCT00176046|breast cancer|breast cancer
5783804|NCT00176046|mistletoe|mistletoe
5783805|NCT00176046|complementary therapy|complementary therapy
5783806|NCT00176046|quality of life|quality of life
5783807|NCT00176046|immune function|immune function
5783808|NCT00176046|breast cancer (UICC stage I/II)|breast cancer (uicc stage i/ii)
5783809|NCT00176033|ritonavir|ritonavir
5783810|NCT00176033|lopinavir|lopinavir
5783811|NCT00176033|HIV Infections|hiv infections
5783812|NCT00176020|nicotinic acid|nicotinic acid
5783813|NCT00176020|flush symptom|flush symptom
5783814|NCT00176020|pharmacodynamic|pharmacodynamic
5783815|NCT00176020|pharmacokinetic|pharmacokinetic
5783816|NCT00175994|voriconazole|voriconazole
5783817|NCT00175994|genotype|genotype
5783818|NCT00175994|bioavailability|bioavailability
5783819|NCT00175994|metabolic clearance|metabolic clearance
5783820|NCT00175955|Neuroleptic-induced tardive dyskinesia|neuroleptic-induced tardive dyskinesia
5783821|NCT00175955|Keppra, Levetiracetam|keppra, levetiracetam
5783822|NCT00175942|acute myocardial infarction|acute myocardial infarction
5783823|NCT00175942|ventricular fibrillation|ventricular fibrillation
5783824|NCT00175942|coagulation|coagulation
5783826|NCT00175929|Epilepsy|epilepsy
5783827|NCT00175929|Focal Epilepsy|focal epilepsy
5783828|NCT00175929|Partial Onset Seizures|partial onset seizures
5783829|NCT00175929|Brivaracetam|brivaracetam
5783830|NCT00175916|Brivaracetam|brivaracetam
5783831|NCT00175916|Epilepsy|epilepsy
5783832|NCT00175916|long term|long term
5784316|NCT00173069|P50I|p50i
5783833|NCT00175903|Newly Diagnosed Epilepsy|newly diagnosed epilepsy
5783834|NCT00175903|Levetiracetam|levetiracetam
5783835|NCT00175903|Keppra|keppra
5783836|NCT00175903|Carbamazepine|carbamazepine
5783837|NCT00175903|Valproate|valproate
5783838|NCT00175890|Partial Onset Seizure|partial onset seizure
5783839|NCT00175890|levetiracetam|levetiracetam
5783840|NCT00175890|Video Electroencephalogram|video electroencephalogram
5783841|NCT00175890|Keppra|keppra
5783842|NCT00175877|Rheumatoid Arthritis|rheumatoid arthritis
5783843|NCT00175877|CDP870|cdp870
5783844|NCT00175877|Certolizumab Pegol|certolizumab pegol
5783845|NCT00175877|Cimzia|cimzia
5783846|NCT00175864|Partial Onset, Primary Generalized Seizures, Seletracetam|partial onset, primary generalized seizures, seletracetam
5783847|NCT00175851|Partial onset, primary generalized seizures, seletracetam|partial onset, primary generalized seizures, seletracetam
5783848|NCT00175838|Primary Thrombocythmeia|primary thrombocythmeia
5783849|NCT00175838|Hydroxyurea|hydroxyurea
5783850|NCT00175838|Randomised|randomised
5783851|NCT00175838|Thrombosis|thrombosis
5783852|NCT00175838|Haemorrhage|haemorrhage
5783853|NCT00175825|Epilepsy: partial onset seizures|epilepsy: partial onset seizures
5783854|NCT00175825|brivaracetam|brivaracetam
5783855|NCT00175812|Acute myelogenous leukemia|acute myelogenous leukemia
5783856|NCT00175812|Differentiation|differentiation
5783857|NCT00175812|All trans retinoic acid|all trans retinoic acid
5783858|NCT00175812|Valproic acid|valproic acid
5783859|NCT00175812|Theophyllamin|theophyllamin
5783860|NCT00175799|Observational study of physiological status at entry into PICU as a predictor of outcome, comparison of two commonly used scores (PRISM and PIM)|observational study of physiological status at entry into picu as a predictor of outcome, comparison of two commonly used scores (prism and pim)
5783861|NCT00175799|Data from children admitted to a Paediatric Intensive Care unit|data from children admitted to a paediatric intensive care unit
5783862|NCT00175786|Glaucoma|glaucoma
5783863|NCT00175786|Normal Tensions Glaucoma|normal tensions glaucoma
5782987|NCT00179855|ECP|ecp
5783864|NCT00175786|Neuroradiology|neuroradiology
5783865|NCT00175786|Tumor|tumor
5783867|NCT00175786|Magnetic Resonance Imaging|magnetic resonance imaging
5783868|NCT00175786|Compressive Lesion|compressive lesion
5783869|NCT00175773|Orthostatic stress|orthostatic stress
5783870|NCT00175760|TTG|ttg
5783872|NCT00175760|comparison study|comparison study
5783873|NCT00175747|dysplasia|dysplasia
5783874|NCT00175747|lung cancer|lung cancer
5783875|NCT00175747|chemoprevention|chemoprevention
5783876|NCT00175734|Vascular Reactivity|vascular reactivity
5783877|NCT00175734|Anemia Correction Therapy|anemia correction therapy
5783878|NCT00175734|Hemodialysis patients|hemodialysis patients
5783879|NCT00175734|Diabetic and non-diabetic patients|diabetic and non-diabetic patients
5783880|NCT00175734|Diabetes in Hemodialysis patients|diabetes in hemodialysis patients
5783881|NCT00175721|Combined Clinic|combined clinic
5783882|NCT00175721|Chronic Kidney Disease|chronic kidney disease
5783883|NCT00175721|Diabetes|diabetes
5783884|NCT00175708|Evaluation of an outcome tool|evaluation of an outcome tool
5783885|NCT00175708|clubfoot|clubfoot
5783886|NCT00175708|foot pressure profiles|foot pressure profiles
5783887|NCT00175708|pedobarographs|pedobarographs
5783888|NCT00175682|Autonomic Dysreflexia|autonomic dysreflexia
5783889|NCT00175682|SCI|sci
5783890|NCT00175682|Vibrostimulation|vibrostimulation
5783891|NCT00175682|Ejaculation|ejaculation
5783892|NCT00175669|Randomized control trial; placebo-control study|randomized control trial; placebo-control study
5783893|NCT00175656|Femur fracture|femur fracture
5783894|NCT00175656|titanium elastic nails|titanium elastic nails
5783895|NCT00175643|actinic keratoses|actinic keratoses
5783896|NCT00175643|imiquimod|imiquimod
5783897|NCT00175643|pre-malignant|pre-malignant
5783898|NCT00175643|squamous cell carcinoma|squamous cell carcinoma
5783899|NCT00175643|immunosuppression|immunosuppression
5783900|NCT00175630|ACL reconstruction|acl reconstruction
5783901|NCT00175630|morphine sparing|morphine sparing
5783902|NCT00175630|preemptive analgesia|preemptive analgesia
5783903|NCT00175630|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
5783904|NCT00175604|Botox|botox
5783905|NCT00175604|torticollis|torticollis
5783906|NCT00175604|Congenital Muscular Torticollis (CMT)|congenital muscular torticollis (cmt)
5783907|NCT00175591|Femur fracture|femur fracture
5783908|NCT00175591|morphine sparing|morphine sparing
5783909|NCT00175591|preemptive analgesia|preemptive analgesia
5783910|NCT00175591|Post-operative pain and post- operative opioid use|post-operative pain and post- operative opioid use
5783911|NCT00175578|Early stage (0/I) non-small cell lung cancer|early stage (0/i) non-small cell lung cancer
5783912|NCT00175565|inflammation|inflammation
5783913|NCT00175565|trial|trial
5783914|NCT00175565|fluticasone|fluticasone
5783915|NCT00175552|Depression|depression
5783916|NCT00175552|Adolescents|adolescents
5783918|NCT00175552|Knowledge translation|knowledge translation
5783919|NCT00175552|Psychotherapy|psychotherapy
5783920|NCT00175539|sexual dysfunction|sexual dysfunction
5783921|NCT00175539|group treatment|group treatment
5783922|NCT00175513|Psychosis|psychosis
5783923|NCT00175513|early psychosis|early psychosis
5783924|NCT00175513|first episode psychosis|first episode psychosis
5783925|NCT00175513|schizophrenia|schizophrenia
5783926|NCT00175513|schizoaffective|schizoaffective
5783927|NCT00175513|schizophreniform|schizophreniform
5783928|NCT00175513|bipolar disorder|bipolar disorder
5783930|NCT00175513|valacyclovir.|valacyclovir.
5783931|NCT00175500|Post-Arthroplasty Hip Dislocation|post-arthroplasty hip dislocation
5783932|NCT00175487|Osteoarthritis/Avascular Necrosis|osteoarthritis/avascular necrosis
5783933|NCT00175487|Hip|hip
5787085|NCT00160511|Nerve Pain|nerve pain
5783934|NCT00175435|Topical Immune Modulator|topical immune modulator
5783935|NCT00175435|resiquimod gel|resiquimod gel
5783936|NCT00175435|Hepatitis B booster response|hepatitis b booster response
5783937|NCT00175435|Vaccine Evaluation|vaccine evaluation
5783938|NCT00175435|Prevention of Hepatitis B disease|prevention of hepatitis b disease
5783939|NCT00175422|Prevention|prevention
5783940|NCT00175422|Randomized controlled trial|randomized controlled trial
5783941|NCT00175422|Community education|community education
5783942|NCT00175422|Shaken Baby Syndrome|shaken baby syndrome
5783943|NCT00175422|Crying|crying
5783944|NCT00175422|Colic|colic
5783945|NCT00175409|Pain Response|pain response
5783946|NCT00175396|ASCENDE-RT|ascende-rt
5783947|NCT00175383|Prostate cancer, LHRH, hormone therapy, testosterone level|prostate cancer, lhrh, hormone therapy, testosterone level
5783948|NCT00175370|Vancomycin|vancomycin
5783949|NCT00175370|Coagulase Negative Staphylococcus|coagulase negative staphylococcus
5783950|NCT00175370|Central Venous Catheter|central venous catheter
5783951|NCT00175370|Bloodstream infection|bloodstream infection
5783952|NCT00175370|CNS bloodstream infection|cns bloodstream infection
5783953|NCT00175357|Opiate addiction|opiate addiction
5783954|NCT00175357|medical heroin|medical heroin
5783955|NCT00175357|methadoneRCT|methadonerct
5783956|NCT00175344|Breast cancer|breast cancer
5783957|NCT00175344|scar massage|scar massage
5783958|NCT00175344|breast conserving surgery|breast conserving surgery
5783959|NCT00175344|scar pain|scar pain
5681098|NCT00574691|Closure Device|closure device
5783960|NCT00175344|quality of life|quality of life
5783961|NCT00175344|Breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.|breast cancer treated with breast conserving surgery with or without axillary dissection or sentinel node sampling.
5783962|NCT00175318|Motivational interviewing|motivational interviewing
5783963|NCT00175318|behavioural modification|behavioural modification
5783965|NCT00175305|Prader-Willi Syndrome|prader-willi syndrome
5783966|NCT00175305|Somatostatin|somatostatin
5783967|NCT00175305|Ghrelin|ghrelin
5783968|NCT00175305|Obesity|obesity
5783969|NCT00175305|Hyperphagia|hyperphagia
5783970|NCT00175305|Hyperphagia in Prader-Willi syndrome|hyperphagia in prader-willi syndrome
5783971|NCT00175279|coronary disease|coronary disease
5783972|NCT00175279|heart failure|heart failure
5783973|NCT00175279|quality improvement|quality improvement
5783974|NCT00175279|knowledge translation|knowledge translation
5783975|NCT00175279|opinion leaders|opinion leaders
5783976|NCT00175266|islet|islet
5783977|NCT00175266|transplantation|transplantation
5783978|NCT00175253|islet|islet
5783979|NCT00175253|transplantation|transplantation
5783980|NCT00175240|Coronary disease|coronary disease
5783981|NCT00175240|quality improvement|quality improvement
5783982|NCT00175240|knowledge translation|knowledge translation
5783983|NCT00175227|contrast-induced nephropathy|contrast-induced nephropathy
5783985|NCT00175227|renal failure|renal failure
5783986|NCT00175227|cardiac angiogram|cardiac angiogram
5783987|NCT00175214|osteoporosis|osteoporosis
5783988|NCT00175214|wrist fractures|wrist fractures
5783989|NCT00175214|quality improvement|quality improvement
5783990|NCT00175214|knowledge translation|knowledge translation
5783992|NCT00175188|DEXA|dexa
5783993|NCT00175188|Osteoarthritis|osteoarthritis
5783994|NCT00175188|Finger implant|finger implant
5783995|NCT00175188|Micromotion|micromotion
5783996|NCT00175188|Bone density|bone density
5783997|NCT00175188|Cement|cement
5783998|NCT00175175|osteoporosis treatment|osteoporosis treatment
5783999|NCT00175175|osteoporosis testing|osteoporosis testing
5784000|NCT00175175|hip fracture|hip fracture
5784001|NCT00175175|quality improvement|quality improvement
5784002|NCT00175162|RSA|rsa
5784003|NCT00175162|DEXA|dexa
5784004|NCT00175162|Genoarthrosis|genoarthrosis
5784005|NCT00175162|Knee Arthroplasty|knee arthroplasty
5784006|NCT00175162|Micromotion of polyethylene liner|micromotion of polyethylene liner
5784007|NCT00175162|Cement|cement
5784008|NCT00175149|CKD 3-4|ckd 3-4
5784009|NCT00175136|RSA|rsa
5784010|NCT00175136|DEXA|dexa
5784011|NCT00175136|Gonarthrosis|gonarthrosis
5784012|NCT00175136|Knee Arthroplasty|knee arthroplasty
5784013|NCT00175136|Micromotion of polyethylen liner|micromotion of polyethylen liner
5784014|NCT00175136|Stem arthroplasty design|stem arthroplasty design
5784015|NCT00175123|Myelomeningocele|myelomeningocele
5784016|NCT00175123|Neurogenic Bladder|neurogenic bladder
5784017|NCT00175123|Intervention|intervention
5784018|NCT00175123|Botulinum A toxin|botulinum a toxin
5784019|NCT00175123|Oxybutynin|oxybutynin
5784020|NCT00175110|pre-hypertension|pre-hypertension
5784021|NCT00175110|mild hypertension|mild hypertension
5784022|NCT00175097|soy protein|soy protein
5784024|NCT00175097|lipoproteins|lipoproteins
5784025|NCT00175097|apolipoproteins|apolipoproteins
5784026|NCT00175097|cholesterol|cholesterol
5784027|NCT00175097|endothelial function|endothelial function
5784028|NCT00175058|Heart Attack|heart attack
5784029|NCT00175045|Intravenous|intravenous
5784030|NCT00175045|gastric acid secretion|gastric acid secretion
5784031|NCT00175045|Lansoprazole|lansoprazole
5784032|NCT00175045|Esophagitis|esophagitis
5784034|NCT00175032|Low dose aspirin|low dose aspirin
5784035|NCT00175032|Peptic Ulcer|peptic ulcer
5784036|NCT00175032|gastric ulcer|gastric ulcer
5784037|NCT00175032|duodenal ulcer|duodenal ulcer
5784038|NCT00175032|NSAIDs|nsaids
5784039|NCT00175019|uric acid|uric acid
5784040|NCT00175019|xanthine oxidase|xanthine oxidase
5784041|NCT00175019|hyperuricemia|hyperuricemia
5784042|NCT00175019|tophi|tophi
5784043|NCT00175019|Drug Therapy|drug therapy
5784044|NCT00175006|Hyperuricemia|hyperuricemia
5784045|NCT00175006|Tophi|tophi
5784046|NCT00175006|Tophus|tophus
5784047|NCT00175006|Drug Therapy|drug therapy
5784048|NCT00174993|Glucose Metabolism Disorder|glucose metabolism disorder
5784049|NCT00174993|Dysmetabolic Syndrome|dysmetabolic syndrome
5784050|NCT00174993|Type II Diabetes; Diabetes Mellitus|type ii diabetes; diabetes mellitus
5784051|NCT00174993|Lipoatrophic|lipoatrophic
5784052|NCT00174993|Dyslipidemia|dyslipidemia
5784053|NCT00174993|Drug Therapy|drug therapy
5784054|NCT00174980|Oxycyte|oxycyte
5784055|NCT00174980|perfluorocarbon oxygen carrier|perfluorocarbon oxygen carrier
5784056|NCT00174980|brain oxygen tension|brain oxygen tension
5784057|NCT00174967|Uric Acid|uric acid
5784058|NCT00174967|xanthine oxidase|xanthine oxidase
5784059|NCT00174967|tophi|tophi
5784060|NCT00174967|Drug Therapy|drug therapy
5784061|NCT00174954|Gout|gout
5784062|NCT00174954|Tophus|tophus
5784063|NCT00174954|MRI|mri
5783180|NCT00179088|Hip|hip
5784064|NCT00174941|Uric acid|uric acid
5784065|NCT00174941|xanthine oxidase|xanthine oxidase
5784066|NCT00174941|tophi|tophi
5784067|NCT00174941|Drug Therapy|drug therapy
5784068|NCT00174928|Pediatric GERD|pediatric gerd
5784069|NCT00174928|Pediatric Gastroesophageal Reflux Disease|pediatric gastroesophageal reflux disease
5784070|NCT00174928|Neonates|neonates
5784071|NCT00174928|lansoprazole|lansoprazole
5784072|NCT00174915|Uric Acid, gout, xanthine oxidase, febuxostat, tophi|uric acid, gout, xanthine oxidase, febuxostat, tophi
5784073|NCT00174902|Randomized controlled trial|randomized controlled trial
5784074|NCT00174902|Blood platelets|blood platelets
5784075|NCT00174902|Hemostasis|hemostasis
5784076|NCT00174902|Stress, psychological|stress, psychological
5784077|NCT00174902|Adrenergic beta-antagonists|adrenergic beta-antagonists
5784078|NCT00174902|Aspirin|aspirin
5784079|NCT00174902|Endothelium|endothelium
5784080|NCT00174902|Arteriosclerosis|arteriosclerosis
5784081|NCT00174889|Schizophrenia|schizophrenia
5784082|NCT00174889|Pregnenolone|pregnenolone
5784083|NCT00174889|Neurosteroids|neurosteroids
5784084|NCT00174876|depression|depression
5784085|NCT00174850|anxiety|anxiety
5784086|NCT00174850|sexual dysfunction|sexual dysfunction
5784087|NCT00174850|ssri|ssri
5784088|NCT00174837|Tirapazamine|tirapazamine
5784089|NCT00174837|Head and Neck Cancer|head and neck cancer
5784090|NCT00174837|Cisplatin|cisplatin
5784091|NCT00174837|Radiation|radiation
5784092|NCT00174824|Diabetes|diabetes
5784093|NCT00174824|Diabetic Retinopathy|diabetic retinopathy
5784094|NCT00174811|acute otitis media|acute otitis media
5784095|NCT00174811|controlled clinical trial|controlled clinical trial
5784096|NCT00174811|telithromycin|telithromycin
5784097|NCT00174811|cefuroxime axetil|cefuroxime axetil
5784098|NCT00174811|middle ear infections|middle ear infections
5784099|NCT00174811|tympanocentecis|tympanocentecis
5784100|NCT00174798|Cystometry NK1 Antagonist SSR240600C|cystometry nk1 antagonist ssr240600c
5784101|NCT00174785|Mortality, Hospitalization|mortality, hospitalization
5784102|NCT00174746|Glucocorticosteroid; Dose response; Bronchospasm|glucocorticosteroid; dose response; bronchospasm
5784103|NCT00174733|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
5784104|NCT00174720|Glucocorticosteroid. Bronchospasm|glucocorticosteroid. bronchospasm
5784105|NCT00174603|depression|depression
5784106|NCT00174603|psychosis|psychosis
5784107|NCT00174590|depression|depression
5784108|NCT00174538|codeine|codeine
5784109|NCT00174538|pain|pain
5784110|NCT00174538|CYP2D6|cyp2d6
5784111|NCT00174538|genotype|genotype
5784112|NCT00174538|morphine|morphine
5784113|NCT00174538|sickle cell|sickle cell
5784114|NCT00174538|pharmacokinetic|pharmacokinetic
5784115|NCT00174525|Alzheimer's Caregivers|alzheimer's caregivers
5784116|NCT00174525|Alzheimer disease|alzheimer disease
5784117|NCT00174499|Tooth stain|tooth stain
5784118|NCT00174213|iliotibial tract|iliotibial tract
5784119|NCT00174161|Premenstrual Syndrome,Health Related Quality of Life|premenstrual syndrome,health related quality of life
5784120|NCT00174135|Sarcopenia|sarcopenia
5784121|NCT00174135|exercise|exercise
5784122|NCT00174122|Emergency department|emergency department
5784123|NCT00174122|Blood culture|blood culture
5784124|NCT00174122|Antimicrobial therapy|antimicrobial therapy
5784317|NCT00173069|MRS|mrs
5784125|NCT00174109|arecoline, oral cancer, MAP2, cell migration|arecoline, oral cancer, map2, cell migration
5784126|NCT00174096|laryngeal cancer|laryngeal cancer
5784127|NCT00174096|hypopharyngeal cancer|hypopharyngeal cancer
5784128|NCT00174096|CXCR4|cxcr4
5784129|NCT00174096|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
5784130|NCT00174096|metastasis|metastasis
5784131|NCT00174083|Tuberculosis, TB-ELISPOT, active tuberculosis latent infection interferon|tuberculosis, tb-elispot, active tuberculosis latent infection interferon
5784132|NCT00174070|Respiratory failure|respiratory failure
5784133|NCT00174070|Community|community
5784134|NCT00174057|Graves' ophthalmopathy|graves' ophthalmopathy
5784135|NCT00174057|real time PCR|real time pcr
5784136|NCT00174057|cytokines|cytokines
5784137|NCT00174057|Tsh receptor|tsh receptor
5784138|NCT00174031|baseball|baseball
5784139|NCT00174031|injury|injury
5784140|NCT00174018|subacrominal space|subacrominal space
5784141|NCT00174005|muscle|muscle
5784142|NCT00174005|tendon|tendon
5784143|NCT00173992|Stroke|stroke
5784144|NCT00173992|Balance|balance
5784145|NCT00173992|Proactive control|proactive control
5784146|NCT00173992|Reactive control|reactive control
5784147|NCT00173992|Recovery|recovery
5784148|NCT00173992|Training|training
5784149|NCT00173992|Fall|fall
5784150|NCT00173979|muscle|muscle
5784151|NCT00173979|tendon|tendon
5784152|NCT00173953|H. pylori、immune response、lymphocytic subsets、cytokine|h. pylori、immune response、lymphocytic subsets、cytokine
5784153|NCT00173940|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on|chronic diseases, such as hypertension, diabetes, obesity, chronic renal failure, and so on
5784154|NCT00173927|extracranial atherosclerosis|extracranial atherosclerosis
5784155|NCT00173927|imaging|imaging
5784156|NCT00173927|biomarkers|biomarkers
5784157|NCT00173914|1. Transplant vasculopathy|1. transplant vasculopathy
5783258|NCT00178698|cisplatin|cisplatin
5784158|NCT00173914|2. Endothelial dysfunction|2. endothelial dysfunction
5784159|NCT00173914|3. Myocardial perfusion imaging|3. myocardial perfusion imaging
5784160|NCT00173914|4. Intravascular vascular ultrasound|4. intravascular vascular ultrasound
5784161|NCT00173901|ceftazidime|ceftazidime
5784162|NCT00173901|safety|safety
5784163|NCT00173901|infection|infection
5784164|NCT00173888|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
5784165|NCT00173875|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
5784166|NCT00173862|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
5784167|NCT00173849|oral cancer|oral cancer
5784168|NCT00173849|CXCR4|cxcr4
5784169|NCT00173849|stromal-cell-derived factor-1(SDF-1)|stromal-cell-derived factor-1(sdf-1)
5784170|NCT00173849|metastasis|metastasis
5784171|NCT00173836|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5784172|NCT00173836|Saliva|saliva
5784173|NCT00173836|Swallowing|swallowing
5784174|NCT00173836|Videofluoroscopy|videofluoroscopy
5784175|NCT00173836|Radiation|radiation
5784176|NCT00173810|stroke|stroke
5784177|NCT00173810|movement|movement
5784178|NCT00173810|psychomterics|psychomterics
5784179|NCT00173797|depression|depression
5784180|NCT00173797|psychometrics|psychometrics
5784181|NCT00173784|psychometrics|psychometrics
5784182|NCT00173784|activities of daily living|activities of daily living
5784183|NCT00173771|stroke|stroke
5784184|NCT00173771|activities of daily living|activities of daily living
5784185|NCT00173771|psychometrics|psychometrics
5784186|NCT00173758|IL-15|il-15
5784187|NCT00173758|IL-15 receptor|il-15 receptor
5784188|NCT00173758|decidual natural killer cells|decidual natural killer cells
5784189|NCT00173758|endometrium|endometrium
5784190|NCT00173745|cerebral palsy|cerebral palsy
5784191|NCT00173745|drooling|drooling
5784192|NCT00173745|botulinum toxin|botulinum toxin
5784193|NCT00173732|Preimplantation genetic diagnosis (PGD)|preimplantation genetic diagnosis (pgd)
5784194|NCT00173732|single cell|single cell
5784195|NCT00173732|Multiple displacement amplification (MDA)|multiple displacement amplification (mda)
5784196|NCT00173719|Hemiplegia|hemiplegia
5784197|NCT00173719|Assisstive device|assisstive device
5784198|NCT00173719|Walking|walking
5784199|NCT00173719|Dynamic equilibrium|dynamic equilibrium
5784200|NCT00173719|Reaction time|reaction time
5784201|NCT00173719|Attention|attention
5784202|NCT00173719|Dual task|dual task
5784203|NCT00173706|L-Carnitine|l-carnitine
5784204|NCT00173706|hemodialysis|hemodialysis
5784205|NCT00173706|cardiac complications|cardiac complications
5784206|NCT00173706|impaired exercise and functional capacities|impaired exercise and functional capacities
5784207|NCT00173706|muscle symptoms|muscle symptoms
5784208|NCT00173706|intradialytic hypotension|intradialytic hypotension
5784209|NCT00173706|erythropoietin-resistant anemia|erythropoietin-resistant anemia
5784334|NCT00172913|Wavefront Aberration|wavefront aberration
5784210|NCT00173693|CEA, Osteoporosis, Fracture, Prevention, Exercise|cea, osteoporosis, fracture, prevention, exercise
5784211|NCT00173615|ECMO|ecmo
5784213|NCT00173602|Peritoneal Dialysis|peritoneal dialysis
5784214|NCT00173563|Immunology|immunology
5784215|NCT00173550|Menopause, premature|menopause, premature
5784216|NCT00173550|Hysterectomy|hysterectomy
5784217|NCT00173550|Ovariectomy|ovariectomy
5784314|NCT00173069|Schizophrenia|schizophrenia
5784218|NCT00173550|Estrogen Replacement Therapy|estrogen replacement therapy
5784219|NCT00173550|Knowledge|knowledge
5784220|NCT00173550|Perception|perception
5784221|NCT00173550|Attitude|attitude
5784222|NCT00173537|idiopathic pulmonary artery hypertension|idiopathic pulmonary artery hypertension
5784223|NCT00173524|EGFR Non-small cell lung cancer|egfr non-small cell lung cancer
5784224|NCT00173498|atopic dermatitis, skin test|atopic dermatitis, skin test
5784225|NCT00173485|peritonitis, peritoneal dialysis, dialysate|peritonitis, peritoneal dialysis, dialysate
5784226|NCT00173472|colorectal cancer, MSI, TS, DPD, EGFR, chemotherapy.|colorectal cancer, msi, ts, dpd, egfr, chemotherapy.
5784227|NCT00173446|Normal part of the adrenal gland|normal part of the adrenal gland
5784228|NCT00173433|tuberculosis|tuberculosis
5784229|NCT00173433|relapse|relapse
5784230|NCT00173433|reinfection|reinfection
5784231|NCT00173433|reactivation|reactivation
5784232|NCT00173433|dormancy|dormancy
5784233|NCT00173433|tuberculin skin test|tuberculin skin test
5784234|NCT00173420|Normal Controls|normal controls
5784235|NCT00173407|Ovarian endometrioid carcinoma|ovarian endometrioid carcinoma
5784236|NCT00173407|invasion|invasion
5784237|NCT00173407|IGFBP-3|igfbp-3
5784238|NCT00173407|transfection|transfection
5784239|NCT00173407|signal transduction|signal transduction
5784240|NCT00173407|PTEN|pten
5784241|NCT00173407|methylation|methylation
5784242|NCT00173394|ovarian cancer|ovarian cancer
5784243|NCT00173394|immunotherapy|immunotherapy
5784244|NCT00173394|mesothelin|mesothelin
5784245|NCT00173394|normal volunteer|normal volunteer
5784246|NCT00173381|lymphangiogenesis|lymphangiogenesis
5784247|NCT00173381|head and neck squamous cell carcinoma (HNSCC)|head and neck squamous cell carcinoma (hnscc)
5784248|NCT00173381|vascular endothelial growth factor-C (VEGF-C)|vascular endothelial growth factor-c (vegf-c)
5784249|NCT00173381|cyclooxygenase-2 (COX-2)|cyclooxygenase-2 (cox-2)
5784250|NCT00173381|interleukin-6 (IL-6)|interleukin-6 (il-6)
5784251|NCT00173368|Sphincterotomy|sphincterotomy
5784252|NCT00173368|needle knife|needle knife
5784253|NCT00173368|hemorrhage|hemorrhage
5784254|NCT00173368|complication|complication
5774518|NCT00224367|hip|hip
5784255|NCT00173355|pediatric Dermatofibrosarcoma Protuberans|pediatric dermatofibrosarcoma protuberans
5784256|NCT00173342|Right bundle branch block|right bundle branch block
5784257|NCT00173342|Electrocardiography|electrocardiography
5784258|NCT00173342|Ion channel|ion channel
5784259|NCT00173329|HIV|hiv
5784260|NCT00173316|vascular endothelial growth factor-C|vascular endothelial growth factor-c
5784261|NCT00173316|VEGF-CR|vegf-cr
5784262|NCT00173316|lymphangiogenesis|lymphangiogenesis
5784263|NCT00173316|host inflammatory responses|host inflammatory responses
5784264|NCT00173316|oral carcinogenesis|oral carcinogenesis
5784265|NCT00173316|oral cancers|oral cancers
5784266|NCT00173316|oral premalignant lesions|oral premalignant lesions
5784267|NCT00173303|Breast neoplasms|breast neoplasms
5784268|NCT00173303|Breast radiography|breast radiography
5784269|NCT00173303|Cancer screening|cancer screening
5784270|NCT00173290|Cervical cancer|cervical cancer
5784271|NCT00173290|Breast cancer|breast cancer
5784272|NCT00173290|T lymphocyte|t lymphocyte
5784273|NCT00173290|NK receptor|nk receptor
5784274|NCT00173277|colorectal cancer screening|colorectal cancer screening
5784275|NCT00173277|colonoscopy|colonoscopy
5784276|NCT00173238|atherosclerosis|atherosclerosis
5784277|NCT00173238|optical coherence tomography|optical coherence tomography
5784278|NCT00173238|polarization|polarization
5784279|NCT00173238|phase retardation|phase retardation
5784280|NCT00173238|birefringence|birefringence
5784281|NCT00173225|nociceptin|nociceptin
5784282|NCT00173225|sunstance P|sunstance p
5784283|NCT00173225|asthma|asthma
5784284|NCT00173225|COPD|copd
5784285|NCT00173225|cough|cough
5784286|NCT00173212|adenomyosis|adenomyosis
5784287|NCT00173212|cell proliferation|cell proliferation
5784288|NCT00173212|Immunocytochemistry|immunocytochemistry
5784289|NCT00173186|ventricular septal defect|ventricular septal defect
5784290|NCT00173186|aortic regurgitation|aortic regurgitation
5784291|NCT00173173|Gifted dance students|gifted dance students
5784292|NCT00173173|eating disorders|eating disorders
5784293|NCT00173173|prevalence|prevalence
5784294|NCT00173173|risk factors|risk factors
5784295|NCT00173173|BITE|bite
5784296|NCT00173160|Eating disorders|eating disorders
5784297|NCT00173160|risk factors|risk factors
5784298|NCT00173160|prospective study|prospective study
5784299|NCT00173160|case-controled study|case-controled study
5784300|NCT00173160|outcome|outcome
5784301|NCT00173160|gifted dance students|gifted dance students
5784302|NCT00173134|diabetes|diabetes
5784303|NCT00173134|erectile dysfunction|erectile dysfunction
5784304|NCT00173134|erectile dysfunction related quality of life|erectile dysfunction related quality of life
5681101|NCT00574691|Hemostasis|hemostasis
5681102|NCT00574691|Heart Catheterization|heart catheterization
5681103|NCT00574691|Coronary Angiography|coronary angiography
5681104|NCT00574678|Screening tool for cancer|screening tool for cancer
5681105|NCT00574665|Type 2 Diabetes|type 2 diabetes
5681106|NCT00574665|Endothelial Function|endothelial function
5681107|NCT00574665|Fibrinolytic Balance|fibrinolytic balance
5784305|NCT00173121|enterovirus, environment, aerosol, air|enterovirus, environment, aerosol, air
5784306|NCT00173108|Prematurity|prematurity
5784307|NCT00173108|Early intervention|early intervention
5784308|NCT00173108|Neurodevelopment|neurodevelopment
5784309|NCT00173108|Cost-effectiveness|cost-effectiveness
5784310|NCT00173082|primary aldosteronism|primary aldosteronism
5784311|NCT00173082|Insulin resistance|insulin resistance
5784312|NCT00173082|Metabolic syndrome|metabolic syndrome
5784313|NCT00173082|OGTT|ogtt
5784318|NCT00173069|Niacin|niacin
5784319|NCT00173069|Candidate Genes|candidate genes
5784320|NCT00173056|Peritoneal dialysis|peritoneal dialysis
5784321|NCT00173017|N95 mask|n95 mask
5784322|NCT00173017|medical staff|medical staff
5784323|NCT00173017|hypoxemia|hypoxemia
5784324|NCT00173017|hypercapnia|hypercapnia
5784325|NCT00173017|neurological study|neurological study
5784326|NCT00172965|Optic coherence tomography|optic coherence tomography
5784327|NCT00172965|oral cancer|oral cancer
5787479|NCT00158418|cement|cement
5784328|NCT00172965|oral precancers|oral precancers
5784329|NCT00172952|high myopia, genomic|high myopia, genomic
5784330|NCT00172926|Physical Constitution|physical constitution
5784331|NCT00172926|Disease Pattern|disease pattern
5784332|NCT00172926|Laboratory Data|laboratory data
5784333|NCT00172926|Integrative Chinese Medicine and Western Medicine|integrative chinese medicine and western medicine
5784335|NCT00172913|LASIK|lasik
5784336|NCT00172913|Contrast Sensitivity|contrast sensitivity
5784337|NCT00172913|Visual Performance|visual performance
5784338|NCT00172913|Ablation Profile|ablation profile
5784339|NCT00172900|Diffusion tensor imaging|diffusion tensor imaging
5784340|NCT00172900|MR spectroscopy|mr spectroscopy
5784341|NCT00172900|dementia|dementia
5784342|NCT00172900|white matter|white matter
5784343|NCT00172887|Psychiatrists|psychiatrists
5793056|NCT00131807|HIV|hiv
5784344|NCT00172874|cross-cultural,|cross-cultural,
5784345|NCT00172874|eating disorders,|eating disorders,
5784346|NCT00172874|EDI,|edi,
5784347|NCT00172874|psychometrics|psychometrics
5784348|NCT00172861|gastric cancer, cyclooxygenase-2, microarray|gastric cancer, cyclooxygenase-2, microarray
5784349|NCT00172835|pleural effusion|pleural effusion
5784350|NCT00172835|procalcitonin|procalcitonin
5784351|NCT00172822|appendicitis|appendicitis
5784352|NCT00172809|Chronic Hepatitis C|chronic hepatitis c
5784353|NCT00172809|End stage renal disease|end stage renal disease
5784354|NCT00172809|Hemodialysis|hemodialysis
5784355|NCT00172809|Interferon|interferon
5784356|NCT00172809|Pegylated interferon|pegylated interferon
5784357|NCT00172796|Metabolic syndrome|metabolic syndrome
5784359|NCT00172783|PPD|ppd
5784360|NCT00172783|ELISPOT|elispot
5784361|NCT00172783|BCG|bcg
5784362|NCT00172757|MSI, TS, Colorectal Cancer, DM.|msi, ts, colorectal cancer, dm.
5784363|NCT00172744|stem cells|stem cells
5784364|NCT00172744|periodontal cells|periodontal cells
5784365|NCT00172744|mechanical stress|mechanical stress
5784366|NCT00172744|differentiation|differentiation
5784367|NCT00172744|periodontal ligament|periodontal ligament
5784368|NCT00172692|Chewing efficiency,|chewing efficiency,
5784369|NCT00172692|Gum chewing|gum chewing
5784370|NCT00172692|Chewing velocity|chewing velocity
5784371|NCT00172692|Occlusal surface area|occlusal surface area
5784372|NCT00172692|EMG|emg
5784373|NCT00172692|Jaw movement|jaw movement
5784374|NCT00172679|Tai Chi|tai chi
5784375|NCT00172679|NK Cells|nk cells
5784376|NCT00172679|T lymphocytes|t lymphocytes
5784377|NCT00172679|Exercise|exercise
5784378|NCT00172666|SLE|sle
5784379|NCT00172666|healthy subjects|healthy subjects
5784380|NCT00172653|shoulder, reliability, validity|shoulder, reliability, validity
5784381|NCT00172614|metabolic syndrome|metabolic syndrome
5784383|NCT00172588|apoptosis|apoptosis
5784384|NCT00172588|flowcytometry|flowcytometry
5784385|NCT00172575|Lung neoplasms|lung neoplasms
5784386|NCT00172575|Magnetic resonance imaging|magnetic resonance imaging
5784387|NCT00172562|acute myeloid leukemia|acute myeloid leukemia
5784388|NCT00172562|age and sex matched normal subjects|age and sex matched normal subjects
5784389|NCT00172562|dynamic MRI|dynamic mri
5784390|NCT00172562|bone marrow perfusion|bone marrow perfusion
5784391|NCT00172562|tumor angiogenesis|tumor angiogenesis
5784392|NCT00172497|aggressive acts|aggressive acts
5784393|NCT00172484|cerebrovascular accident|cerebrovascular accident
5784394|NCT00172484|stroke center|stroke center
5784395|NCT00172484|stroke team|stroke team
5784396|NCT00172484|intensive care of stroke|intensive care of stroke
5784397|NCT00172484|rehabilitation of stroke|rehabilitation of stroke
5784398|NCT00172419|statin, inflammation, FDG, positron emission tomography|statin, inflammation, fdg, positron emission tomography
5784399|NCT00172393|EV71,|ev71,
5784400|NCT00172393|CNS,|cns,
5784401|NCT00172393|Outcome,|outcome,
5784402|NCT00172393|Neurological,|neurological,
5784403|NCT00172393|Psychiatric|psychiatric
5784404|NCT00172367|Urothelial carcinoma|urothelial carcinoma
5784405|NCT00172367|Lycopene|lycopene
5784406|NCT00172367|uremia|uremia
5784407|NCT00172367|prevention|prevention
5784408|NCT00172367|biomarker|biomarker
5784409|NCT00172367|progression|progression
5784410|NCT00172367|anti-oxidant|anti-oxidant
5784411|NCT00172328|Hepatitis B|hepatitis b
5784412|NCT00172328|vaccine|vaccine
5784413|NCT00172315|acquired immunodeficiency syndrome|acquired immunodeficiency syndrome
5784414|NCT00172315|lipodystrophy|lipodystrophy
5784415|NCT00172315|MR spectroscopy|mr spectroscopy
5784416|NCT00172289|pulse wave velocity|pulse wave velocity
5784417|NCT00172289|sympathetic nerve activity|sympathetic nerve activity
5784418|NCT00172289|spinal cord injury|spinal cord injury
5784419|NCT00172289|cerebrovascular accident|cerebrovascular accident
5784420|NCT00172263|Immunology|immunology
5784421|NCT00172237|eye-head coordination|eye-head coordination
5784422|NCT00172237|proprioception|proprioception
5784423|NCT00172237|cervical spine with degenerative disease|cervical spine with degenerative disease
5784424|NCT00172237|degenerated cervical spine|degenerated cervical spine
5784425|NCT00172224|osteoporosis|osteoporosis
5784426|NCT00172224|compression fracture|compression fracture
5784427|NCT00172224|bone marrow perfusion|bone marrow perfusion
5784428|NCT00172224|MR spectroscopy|mr spectroscopy
5784429|NCT00172224|hormone therapy|hormone therapy
5784430|NCT00172211|Physioneal|physioneal
5784431|NCT00172211|Peritoneal dialysis|peritoneal dialysis
5784432|NCT00172211|Oxidative stress|oxidative stress
5784433|NCT00172211|insulin resistance|insulin resistance
5784434|NCT00172198|w-3 fish oil|w-3 fish oil
5784435|NCT00172198|Nutrition|nutrition
5784436|NCT00172198|immune|immune
5784437|NCT00172198|intensive care|intensive care
5784438|NCT00172198|patients|patients
5784439|NCT00172185|Short Bowel Syndrome|short bowel syndrome
5784440|NCT00172185|Parenteral Nutrition|parenteral nutrition
5784441|NCT00172185|SBS|sbs
5784442|NCT00172185|Teduglutide|teduglutide
5784443|NCT00172172|Post-menopausal|post-menopausal
5784444|NCT00172172|Osteoporosis|osteoporosis
5784445|NCT00172172|Parathyroid Hormone|parathyroid hormone
5783556|NCT00177047|chemotherapy|chemotherapy
5783557|NCT00177047|multiple myeloma|multiple myeloma
5783558|NCT00177047|autologous|autologous
5783559|NCT00177034|Keratinocyte|keratinocyte
5783560|NCT00177008|Schizophrenia|schizophrenia
5783561|NCT00177008|Schizoaffective Disorder|schizoaffective disorder
5783562|NCT00177008|Social Anxiety Disorder|social anxiety disorder
5783563|NCT00176982|treatment of alopecia areata|treatment of alopecia areata
5783567|NCT00176930|acute leukemia|acute leukemia
5784446|NCT00172172|PTH|pth
5784447|NCT00172172|ALX1-11|alx1-11
5784448|NCT00172159|Colorectal cancer|colorectal cancer
5784449|NCT00172159|Chemotherapy|chemotherapy
5784450|NCT00172159|Surgery|surgery
5784451|NCT00172159|Liver metastasis|liver metastasis
5784452|NCT00172146|Hemiplegia|hemiplegia
5784453|NCT00172146|Regular cane|regular cane
5784454|NCT00172146|Volitional stepping|volitional stepping
5784455|NCT00172146|Dynamic equilibrium|dynamic equilibrium
5784456|NCT00172146|Attention|attention
5784457|NCT00172146|Dual task|dual task
5784458|NCT00172133|Post-menopausal|post-menopausal
5784459|NCT00172133|Osteoporosis|osteoporosis
5784460|NCT00172133|Parathyroid Hormone|parathyroid hormone
5784461|NCT00172133|PTH|pth
5784462|NCT00172133|ALX1-11|alx1-11
5784463|NCT00172120|Post-menopausal|post-menopausal
5784465|NCT00172120|Parathyroid Hormone|parathyroid hormone
5784466|NCT00172120|PTH|pth
5784467|NCT00172120|ALX1-11|alx1-11
5784468|NCT00172107|Post-menopausal|post-menopausal
5784469|NCT00172107|Osteoporosis|osteoporosis
5784470|NCT00172107|Parathyroid Hormone|parathyroid hormone
5784471|NCT00172107|PTH|pth
5784472|NCT00172107|ALX1-11|alx1-11
5784473|NCT00172094|Migraine|migraine
5784474|NCT00172081|Post-menopausal|post-menopausal
5784475|NCT00172081|Osteoporosis|osteoporosis
5784476|NCT00172081|Parathyroid Hormone|parathyroid hormone
5784477|NCT00172081|PTH|pth
5784478|NCT00172081|ALX1-11|alx1-11
5784479|NCT00172068|Primary breast cancer|primary breast cancer
5784480|NCT00172068|Bone metastases|bone metastases
5784481|NCT00172068|Minimal residual disease|minimal residual disease
5801338|NCT00102622|biologic therapy|biologic therapy
5801339|NCT00102622|platinum-resistant|platinum-resistant
5801340|NCT00102622|platinum-refractory ovarian cancer|platinum-refractory ovarian cancer
5801341|NCT00102622|platinum-resistant ovarian cancer|platinum-resistant ovarian cancer
5784482|NCT00172068|Bisphosphonates|bisphosphonates
5784483|NCT00172055|Zoledronic acid|zoledronic acid
5784484|NCT00172055|Zometa|zometa
5784485|NCT00172055|prostate cancer|prostate cancer
5784486|NCT00172055|osteoporosis|osteoporosis
5784487|NCT00172042|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5784488|NCT00172042|Bisphosphonates|bisphosphonates
5784489|NCT00172042|Zoledronic acid|zoledronic acid
5784490|NCT00172042|Bone metastases|bone metastases
5784491|NCT00172042|Prevention of bone metastases|prevention of bone metastases
5784492|NCT00172029|Zoledronic acid|zoledronic acid
5784493|NCT00172029|Radiotherapy|radiotherapy
5784494|NCT00172029|Bone pain|bone pain
5784495|NCT00172029|Breast cancer|breast cancer
5681108|NCT00574652|HCV+|hcv+
5784496|NCT00172016|Zoledronic acid|zoledronic acid
5784497|NCT00172016|SRE|sre
5784498|NCT00172016|Prostate cancer|prostate cancer
5784499|NCT00172003|Renal Cell Cancer|renal cell cancer
5784500|NCT00172003|Bone metastasis|bone metastasis
5784501|NCT00172003|Skeletal related event|skeletal related event
5784502|NCT00172003|Renal Cell Cancer patients with bone metastasis|renal cell cancer patients with bone metastasis
5784503|NCT00171990|genital herpes|genital herpes
5784504|NCT00171990|herpes|herpes
5784505|NCT00171990|famciclovir|famciclovir
5784506|NCT00171977|GIST|gist
5784507|NCT00171977|Imatinib|imatinib
5784508|NCT00171977|Postoperative Adjuvant|postoperative adjuvant
5784509|NCT00171964|Pain|pain
5784510|NCT00171964|Bone metastasis|bone metastasis
5784511|NCT00171964|Analgesic consumption|analgesic consumption
5784512|NCT00171964|Cancer patients|cancer patients
5784513|NCT00171964|Cancer patients with painful bone metastasis|cancer patients with painful bone metastasis
5784514|NCT00171951|Cushing's disease|cushing's disease
5784515|NCT00171951|ACTH|acth
5784516|NCT00171951|Cortisol|cortisol
5784517|NCT00171951|ACTH dependent Cushing's disease|acth dependent cushing's disease
5784518|NCT00171938|Glioblastoma|glioblastoma
5784519|NCT00171938|Brain tumors|brain tumors
5784520|NCT00171938|Imatinib|imatinib
5784521|NCT00171938|PDGFR|pdgfr
5784522|NCT00171925|Multiple Myeloma|multiple myeloma
5784523|NCT00171925|Stage I|stage i
5784524|NCT00171925|Zoledronic acid|zoledronic acid
5784525|NCT00171925|Progression|progression
5784526|NCT00171912|Imatinib mesylate|imatinib mesylate
5784527|NCT00171912|tyrosine kinases|tyrosine kinases
5784315|NCT00173069|PPI|ppi
5784528|NCT00171912|imatinib sensitivity|imatinib sensitivity
5784529|NCT00171912|Diverse malignancies either associated with|diverse malignancies either associated with
5784530|NCT00171912|or thought to be associated with|or thought to be associated with
5784531|NCT00171912|activated tyrosine kinase enzymes|activated tyrosine kinase enzymes
5784532|NCT00171912|including hypereosinophilic syndrome|including hypereosinophilic syndrome
5787480|NCT00158405|HIV|hiv
5784533|NCT00171912|systemic mastocytosis|systemic mastocytosis
5784534|NCT00171912|chronic myelomonocytic leukaemia,|chronic myelomonocytic leukaemia,
5784535|NCT00171912|dermatofibrosarcoma protuberans and other diseases.|dermatofibrosarcoma protuberans and other diseases.
5784536|NCT00171912|Not included:|not included:
5784537|NCT00171912|patients with chronic myeloid leukemia,|patients with chronic myeloid leukemia,
5784538|NCT00171912|some other types of leukemias (abl-mutated)|some other types of leukemias (abl-mutated)
5784539|NCT00171912|some types of gastrointestinal stromal tumours (c-KIT-positive),|some types of gastrointestinal stromal tumours (c-kit-positive),
5784540|NCT00171912|some systemic mastocytosis (if c-KIT D816V mutation),|some systemic mastocytosis (if c-kit d816v mutation),
5784541|NCT00171912|brain,|brain,
5784542|NCT00171912|prostate,|prostate,
5784543|NCT00171912|breast or lung cancers.|breast or lung cancers.
5784544|NCT00171899|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5784545|NCT00171899|Complete cytogenetic response|complete cytogenetic response
5784546|NCT00171899|Imatinib mesylate|imatinib mesylate
5784547|NCT00171899|Major molecular response|major molecular response
5784548|NCT00171899|Chronic phase Ph+ Chronic Myelogenous Leukemia|chronic phase ph+ chronic myelogenous leukemia
5784549|NCT00171886|Acromegaly|acromegaly
5784550|NCT00171886|Otreotide|otreotide
5784551|NCT00171886|Tumor reduction|tumor reduction
5784552|NCT00171873|Double blind|double blind
5784553|NCT00171873|Phase III|phase iii
5784554|NCT00171873|Disease|disease
5784555|NCT00171873|Clinical trial|clinical trial
5784556|NCT00171873|Octreotide|octreotide
5784557|NCT00171873|Neuroendocrine tumor|neuroendocrine tumor
5784558|NCT00171873|Cancer|cancer
5784559|NCT00171873|Tumor|tumor
5784560|NCT00171873|Midgut|midgut
5784561|NCT00171860|Hypereosinophilic syndrome|hypereosinophilic syndrome
5784562|NCT00171860|Imatinib|imatinib
5784563|NCT00171847|Breast cancer|breast cancer
5784564|NCT00171847|Metastatic|metastatic
5784565|NCT00171847|Trastuzumab|trastuzumab
5784566|NCT00171847|Letrozole|letrozole
5784568|NCT00171834|EPO906|epo906
5784569|NCT00171834|Brain metastasis|brain metastasis
5784570|NCT00171834|Lung cancer|lung cancer
5784571|NCT00171834|Lung metastasis|lung metastasis
5784572|NCT00171834|NSCLC|nsclc
5784573|NCT00171821|Thalassemia|thalassemia
5784574|NCT00171821|Myelodysplastic Syndrome|myelodysplastic syndrome
5784575|NCT00171821|MDS|mds
5784576|NCT00171821|Sickle cell|sickle cell
5784577|NCT00171821|Diamond-Blackfan anemia|diamond-blackfan anemia
5784578|NCT00171821|Transfusion|transfusion
5784579|NCT00171821|Anemia|anemia
5784580|NCT00171821|Fanconi|fanconi
5784581|NCT00171821|Chelation|chelation
5784582|NCT00171821|Deferasirox|deferasirox
5784583|NCT00171808|Endometrial Cancer|endometrial cancer
5784584|NCT00171808|Aromatase inhibitor|aromatase inhibitor
5784585|NCT00171808|Advanced or recurrent|advanced or recurrent
5784586|NCT00171808|hormone receptor positive|hormone receptor positive
5784587|NCT00171795|Traumatic brain injury,|traumatic brain injury,
5784588|NCT00171795|cognitive impairment,|cognitive impairment,
5784589|NCT00171795|rivastigmine|rivastigmine
5784590|NCT00171782|HYPERTENSION|hypertension
5784591|NCT00171782|VALSARTAN|valsartan
5784592|NCT00171782|VALSARTAN AND HYDROCHLOROTHIAZIDE|valsartan and hydrochlorothiazide
5784593|NCT00171782|RISK FACTORS|risk factors
5784594|NCT00171756|hypertension|hypertension
5784595|NCT00171756|valsartan|valsartan
5784596|NCT00171743|Adults|adults
5784597|NCT00171743|Post transplant diabetes|post transplant diabetes
5784598|NCT00171730|Acromegaly|acromegaly
5784599|NCT00171730|Pasireotide|pasireotide
5784600|NCT00171730|GH|gh
5784602|NCT00171717|Cyclosporine, liver transplantation, maintenance, diabetes|cyclosporine, liver transplantation, maintenance, diabetes
5784603|NCT00171704|Breast Cancer|breast cancer
5784604|NCT00171704|Letrozole|letrozole
5784605|NCT00171704|Bone Mineral Density|bone mineral density
5784606|NCT00171704|Bone Markers|bone markers
5784607|NCT00171704|Serum lipid|serum lipid
5784608|NCT00171704|Postmenopausal|postmenopausal
5784609|NCT00171691|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5784610|NCT00171678|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5784611|NCT00171665|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
5784612|NCT00171652|Hand osteoarthritis, Topical NSAID, Diclofenac sodium|hand osteoarthritis, topical nsaid, diclofenac sodium
5784613|NCT00171626|Knee osteoarthritis, Topical NSAID, Diclofenac sodium|knee osteoarthritis, topical nsaid, diclofenac sodium
5784614|NCT00171613|Obesity|obesity
5784615|NCT00171600|valsartan|valsartan
5784616|NCT00171600|lisinopril|lisinopril
5784617|NCT00171600|albuminuria|albuminuria
5784618|NCT00171600|diabetic nephropathy|diabetic nephropathy
5784978|NCT00169845|mortality|mortality
5783731|NCT00176293|doxil|doxil
5784619|NCT00171587|Metastatic solid tumors|metastatic solid tumors
5784620|NCT00171587|PTK787/ZK 222584|ptk787/zk 222584
5784621|NCT00171587|Vatalanib|vatalanib
5784622|NCT00171587|Capecitabine|capecitabine
5784623|NCT00171587|VEGF (vascular endothelial growth factor)|vegf (vascular endothelial growth factor)
5784624|NCT00171587|Histologically confirmed metastatic solid tumors|histologically confirmed metastatic solid tumors
5784625|NCT00171574|valsartan|valsartan
5784627|NCT00171574|antiproteinuric|antiproteinuric
5784628|NCT00171574|diabetic nephropathy|diabetic nephropathy
5784629|NCT00171561|hypertension|hypertension
5784630|NCT00171561|diabetes|diabetes
5784631|NCT00171561|albuminuria|albuminuria
5784632|NCT00171561|valsartan|valsartan
5784633|NCT00171561|hydrochlorothiazide|hydrochlorothiazide
5784634|NCT00171561|amlodipine|amlodipine
5784635|NCT00171548|Metabolic syndrome, cardiovascular risk reduction|metabolic syndrome, cardiovascular risk reduction
5784636|NCT00171535|hypertension|hypertension
5784637|NCT00171535|high blood pressure|high blood pressure
5784638|NCT00171535|valsartan|valsartan
5784639|NCT00171535|amlodipine|amlodipine
5784640|NCT00171522|Constipation|constipation
5784641|NCT00171522|Tegaserod|tegaserod
5784642|NCT00171522|Polyethylene Glycol 3350|polyethylene glycol 3350
5784644|NCT00171509|Liver transplant, adults, once a day administration, Immunosuppressants|liver transplant, adults, once a day administration, immunosuppressants
5784645|NCT00171496|Kidney transplant, adults, NODM, immunosuppressants|kidney transplant, adults, nodm, immunosuppressants
5784646|NCT00171483|GERD|gerd
5784647|NCT00171483|PPI|ppi
5784648|NCT00171483|heartburn|heartburn
5784649|NCT00171483|regurgitation|regurgitation
5784650|NCT00171470|dyspepsia|dyspepsia
5784651|NCT00171470|hearburn|hearburn
5784652|NCT00171470|female|female
5784653|NCT00171470|PPI|ppi
5784654|NCT00171457|functional heartburn|functional heartburn
5784655|NCT00171457|dyspepsia|dyspepsia
5784656|NCT00171457|male|male
5784657|NCT00171457|female|female
5784658|NCT00171457|visceral sensitivity|visceral sensitivity
5784659|NCT00171444|hypertension,|hypertension,
5784660|NCT00171444|valsartan+hydrochlorothiazide|valsartan+hydrochlorothiazide
5784661|NCT00171431|IBS-C|ibs-c
5784662|NCT00171431|female|female
5784663|NCT00171418|GERD|gerd
5784664|NCT00171418|PPI|ppi
5784665|NCT00171405|hypertension|hypertension
5784667|NCT00171405|hydrochlorothiazide|hydrochlorothiazide
5784668|NCT00171392|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium, tacrolimus.
5784669|NCT00171379|Kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.|kidney transplantation; acute rejection; gastrointestinal adverse events; quality of life; mycophenolate sodium.
5784670|NCT00171366|amlodipine|amlodipine
5784671|NCT00171366|benazepril|benazepril
5784672|NCT00171366|hypertension|hypertension
5784673|NCT00171366|diastolic|diastolic
5784674|NCT00171353|arterial hypertension|arterial hypertension
5784675|NCT00171353|albuminuria|albuminuria
5784676|NCT00171353|valsartan|valsartan
5784677|NCT00171340|Bone Loss|bone loss
5784678|NCT00171340|Osteopenia|osteopenia
5784679|NCT00171340|Breast cancer|breast cancer
5784680|NCT00171340|letrozole|letrozole
5784681|NCT00171340|zoledronic acid|zoledronic acid
5784682|NCT00171340|postmenopausal|postmenopausal
5784683|NCT00171327|arterial hypertension|arterial hypertension
5784684|NCT00171327|dyslipidemia|dyslipidemia
5784685|NCT00171327|valsartan|valsartan
5809222|NCT00086086|CHF|chf
5784686|NCT00171327|fluvastatin|fluvastatin
5784687|NCT00171314|breast cancer|breast cancer
5784688|NCT00171314|letrozole|letrozole
5784689|NCT00171314|zoledronic acid|zoledronic acid
5784690|NCT00171314|adjuvant|adjuvant
5784691|NCT00171314|postmenopausal|postmenopausal
5784692|NCT00171301|Transfusional hemosiderosis|transfusional hemosiderosis
5784693|NCT00171301|Beta-thalassemia major|beta-thalassemia major
5784695|NCT00171301|iron overload|iron overload
5784696|NCT00171301|rare anemia|rare anemia
5784697|NCT00171301|iron overload due to transfusion|iron overload due to transfusion
5784698|NCT00171288|Dyslipidemia, ezetimibe, inflammatory markers, fluvastatin|dyslipidemia, ezetimibe, inflammatory markers, fluvastatin
5784699|NCT00171275|Coronary disease|coronary disease
5784700|NCT00171275|Myocardial infarction|myocardial infarction
5784701|NCT00171275|Statins|statins
5784702|NCT00171262|Dyslipidemia, chronic renal disease, fluvastatin|dyslipidemia, chronic renal disease, fluvastatin
5784703|NCT00171249|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5784704|NCT00171249|CML|cml
5784705|NCT00171249|Philadelphia Chromosome|philadelphia chromosome
5784706|NCT00171249|Accelerated phase|accelerated phase
5784707|NCT00171249|Acute Myelogenous Leukemia|acute myelogenous leukemia
5784708|NCT00171249|AML|aml
5784823|NCT00170742|phase III,|phase iii,
5784709|NCT00171249|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5784710|NCT00171249|ALL|all
5784711|NCT00171249|Imatinib mesylate|imatinib mesylate
5784712|NCT00171236|Heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia
5784713|NCT00171236|mixed dyslipidemia|mixed dyslipidemia
5793445|NCT00130338|Stroke|stroke
5784714|NCT00171223|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5784716|NCT00171223|Philadelphia Chromosome|philadelphia chromosome
5784717|NCT00171223|Accelerated phase|accelerated phase
5784718|NCT00171223|Acute Myelogenous Leukemia|acute myelogenous leukemia
5784719|NCT00171223|AML|aml
5784720|NCT00171223|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5784721|NCT00171223|ALL|all
5784722|NCT00171223|Imatinib mesylate|imatinib mesylate
5784723|NCT00171210|β-thalassemia|β-thalassemia
5784724|NCT00171210|iron overload|iron overload
5784725|NCT00171210|deferasirox|deferasirox
5784726|NCT00171184|Overactive bladder, Darifenacin, M3 muscarinic receptor antagonist, elderly population|overactive bladder, darifenacin, m3 muscarinic receptor antagonist, elderly population
5784727|NCT00171171|Thalassemia (beta-thal. major)|thalassemia (beta-thal. major)
5784728|NCT00171171|Transfusional hemosiderosis|transfusional hemosiderosis
5784729|NCT00171171|Deferasirox|deferasirox
5784730|NCT00171171|Beta-thalassemia major patients|beta-thalassemia major patients
5784731|NCT00171171|Unable to be chelated with deferoxamine or deferiprone|unable to be chelated with deferoxamine or deferiprone
5784732|NCT00171158|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5784733|NCT00171158|CML|cml
5784734|NCT00171158|Philadelphia Chromosome|philadelphia chromosome
5784735|NCT00171158|Blast crisis|blast crisis
5784736|NCT00171158|Imatinib mesylate|imatinib mesylate
5784737|NCT00171145|Overactive Bladder, incontinence, antimuscarinic, warning time, darifenacin|overactive bladder, incontinence, antimuscarinic, warning time, darifenacin
5784738|NCT00171132|Postmenopausal|postmenopausal
5784739|NCT00171132|women|women
5784740|NCT00171132|overweight|overweight
5784741|NCT00171132|hypertension|hypertension
5784742|NCT00171132|impaired|impaired
5784743|NCT00171132|exercise|exercise
5784744|NCT00171132|capacity|capacity
5784745|NCT00171132|valsartan|valsartan
5784746|NCT00171132|atenolol|atenolol
5784747|NCT00171132|hydrochlorothiazide|hydrochlorothiazide
5784748|NCT00171119|HYPERTENSION|hypertension
5784749|NCT00171119|DIABETES MELLITUS TYPE II|diabetes mellitus type ii
5784750|NCT00171119|VALSARTAN|valsartan
5784751|NCT00171119|BENAZAPRIL|benazapril
5784752|NCT00171106|diastolic dysfunction|diastolic dysfunction
5784753|NCT00171106|heart failure|heart failure
5784754|NCT00171106|exercise tolerance|exercise tolerance
5784755|NCT00171106|valsartan|valsartan
5784756|NCT00171093|HYPERTENSION|hypertension
5784757|NCT00171093|HYPERCHOLESTEROLEMIA|hypercholesterolemia
5784758|NCT00171093|BLOOD PRESSURE|blood pressure
5784759|NCT00171093|CHOLESTEROL|cholesterol
5784760|NCT00171093|VALSARTAN|valsartan
5784761|NCT00171093|SIMVASTATIN|simvastatin
5784762|NCT00171080|Hypertension|hypertension
5784763|NCT00171080|Valsartan|valsartan
5784764|NCT00171080|Dialysis|dialysis
5784765|NCT00171080|Renal Disease|renal disease
5784766|NCT00171067|Microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination|microalbuminuria, urinary albumin excretion, urinary albumin creatinine ratio, hypertension, valsartan, lisinopril, combination
5784767|NCT00171054|hypertension|hypertension
5784768|NCT00171054|postmenopausal|postmenopausal
5784769|NCT00171054|valsartan|valsartan
5784770|NCT00171054|amlodipine|amlodipine
5784771|NCT00171054|hydrochlorothiazide|hydrochlorothiazide
5784772|NCT00171041|PEDIATRIC HYPERTENSION|pediatric hypertension
5784773|NCT00171041|PEDIATRIC|pediatric
5784774|NCT00171041|VALSARTAN|valsartan
5784775|NCT00171028|PEDIATRIC HYPERTENSION|pediatric hypertension
5784776|NCT00171028|PEDIATRIC|pediatric
5784777|NCT00171028|VALSARTAN|valsartan
5784778|NCT00171015|VALSARTAN|valsartan
5784779|NCT00171015|HYDROCHLOROTHIAZIDE|hydrochlorothiazide
5784780|NCT00171015|OLMESARTAN|olmesartan
5784781|NCT00171015|HYPERTENSION|hypertension
5784782|NCT00171002|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
5784783|NCT00170989|hypertension|hypertension
5784784|NCT00170989|high blood pressure|high blood pressure
5784785|NCT00170989|valsartan|valsartan
5784786|NCT00170989|hydrochlorothiazide|hydrochlorothiazide
5784787|NCT00170976|HYPERTENSION, VALSARTAN, AMLODIPINE< SAFETY|hypertension, valsartan, amlodipine< safety
5784788|NCT00170963|Hypertension, high blood pressure, valsartan, amlodipine|hypertension, high blood pressure, valsartan, amlodipine
5784789|NCT00170950|cardiovascular morbidity|cardiovascular morbidity
5784790|NCT00170950|cardiovascular mortality|cardiovascular mortality
5784791|NCT00170950|benazepril|benazepril
5784792|NCT00170950|amlodipine|amlodipine
5784793|NCT00170950|high risk population|high risk population
5784794|NCT00170937|METABOLIC SYNDROME, VALSARTAN, HYDROCHLOROTHIAZIDE, HYPERTENSION,|metabolic syndrome, valsartan, hydrochlorothiazide, hypertension,
5784795|NCT00170924|Hypertension, High Blood Pressure, Diastolic Dysfunction,|hypertension, high blood pressure, diastolic dysfunction,
5784796|NCT00170924|Heart Disease|heart disease
5784797|NCT00170911|Osteoporosis|osteoporosis
5784798|NCT00170911|Postmenopausal women|postmenopausal women
5784799|NCT00170911|Cathepsin K inhibitor|cathepsin k inhibitor
5784800|NCT00170898|Musculoskeletal pain|musculoskeletal pain
5784801|NCT00170898|cyclooxygenase-2 inhibitors|cyclooxygenase-2 inhibitors
5784802|NCT00170898|lumiracoxib|lumiracoxib
5784803|NCT00170898|naproxen|naproxen
5784804|NCT00170885|acute rejection|acute rejection
5784805|NCT00170885|renal function|renal function
5784806|NCT00170885|everolimus|everolimus
5784807|NCT00170885|cyclosporine microemulsion|cyclosporine microemulsion
5784808|NCT00170872|Osteoarthritis|osteoarthritis
5784809|NCT00170872|Rheumatoid Arthritis|rheumatoid arthritis
5784810|NCT00170872|Cox-2|cox-2
5784811|NCT00170872|lumiracoxib|lumiracoxib
5784812|NCT00170859|everolimus|everolimus
5784813|NCT00170859|cyclosporine microemulsion|cyclosporine microemulsion
5784814|NCT00170859|renal function|renal function
5787585|NCT00157859|Falciparum|falciparum
5784815|NCT00170846|Renal transplantation, everolimus, calcineurin inhibitors, GFR|renal transplantation, everolimus, calcineurin inhibitors, gfr
5784816|NCT00170833|Renal/Kidney, transplantation, everolimus, calcineurin sparing|renal/kidney, transplantation, everolimus, calcineurin sparing
5784817|NCT00170820|Renal transplantation, maintenance, switch, everolimus, CNI-free|renal transplantation, maintenance, switch, everolimus, cni-free
5784818|NCT00170794|cardiac transplantation, everolimus, cyclosporine microemulsion, GFR|cardiac transplantation, everolimus, cyclosporine microemulsion, gfr
5784819|NCT00170781|Pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin|pain, acute gout, arthritis, cyclooxygenase-2 inhibitors, lumiracoxib, indomethacin
5784820|NCT00170768|Darifenacin, oxybutynin, cognition, memory|darifenacin, oxybutynin, cognition, memory
5784821|NCT00170755|Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment|overactive bladder, incontinence, antimuscarinic, darifenacin, long-term treatment
5784822|NCT00170742|Open label,|open label,
5784824|NCT00170742|disease,|disease,
5784825|NCT00170742|clinical trial,|clinical trial,
5784826|NCT00170742|octreotide,|octreotide,
5784827|NCT00170742|proliferative diabetic retinopathy, lasercoagulation|proliferative diabetic retinopathy, lasercoagulation
5784828|NCT00170729|Prednisolone acetate,|prednisolone acetate,
5784829|NCT00170729|efficacy,|efficacy,
5784830|NCT00170729|cataract,|cataract,
5784831|NCT00170729|eye drops,|eye drops,
5784833|NCT00170729|inflammation|inflammation
5784834|NCT00170716|Motor Cortex Electrical Stimulation|motor cortex electrical stimulation
5784835|NCT00170716|Ischemic Stroke|ischemic stroke
5784836|NCT00170716|Upper Extremity Hemiparesis|upper extremity hemiparesis
5784837|NCT00170716|Rehabilitation|rehabilitation
5784838|NCT00170716|Motor Recovery|motor recovery
5784839|NCT00170716|Functional MRI|functional mri
5784840|NCT00170703|Cortical Electrical Stimulation|cortical electrical stimulation
5784841|NCT00170703|Ischemic Stroke|ischemic stroke
5784842|NCT00170703|Broca's Aphasia|broca's aphasia
5784843|NCT00170703|Speech Rehabilitation|speech rehabilitation
5784844|NCT00170703|Functional MRI|functional mri
5784845|NCT00170664|Ovarian neoplasms|ovarian neoplasms
5784846|NCT00170664|paclitaxel, carboplatin|paclitaxel, carboplatin
5784847|NCT00170664|clinical trials, phase II|clinical trials, phase ii
5784848|NCT00170664|first-line chemotherapy|first-line chemotherapy
5784849|NCT00170664|weekly therapy schedule|weekly therapy schedule
5784850|NCT00170638|Tuberculosis, children, infants|tuberculosis, children, infants
5784851|NCT00170625|platin-resistant|platin-resistant
5784852|NCT00170612|Pneumococcal infections|pneumococcal infections
5784853|NCT00170612|Fiji|fiji
5784854|NCT00170612|infants|infants
5784855|NCT00170612|vaccine|vaccine
5784856|NCT00170586|Underglove, polyvinylidene fluoride, acrylic polymer|underglove, polyvinylidene fluoride, acrylic polymer
5784857|NCT00170573|biweekly schedule of PLD - Ovarian cancer - pegylated liposomal doxorubicin -quality of life - Toxic skin reactions|biweekly schedule of pld - ovarian cancer - pegylated liposomal doxorubicin -quality of life - toxic skin reactions
5784858|NCT00170560|hospital, acquired, infections, mortality|hospital, acquired, infections, mortality
5784859|NCT00170547|inactivated, trivalent, influenza, vaccine, Fluzone|inactivated, trivalent, influenza, vaccine, fluzone
5784860|NCT00170534|India, male, sexually transmitted infection, STI, STD|india, male, sexually transmitted infection, sti, std
5784861|NCT00170521|group A streptococci, pharyngitis, epidemiology, Streptococcus pyogenes, children, Nicaragua|group a streptococci, pharyngitis, epidemiology, streptococcus pyogenes, children, nicaragua
5784862|NCT00170508|Influenza, sub-study|influenza, sub-study
5784863|NCT00170495|respiratory illness, influenza, bronchitis, pneumonia, cold|respiratory illness, influenza, bronchitis, pneumonia, cold
5784865|NCT00170482|inactivated|inactivated
5784866|NCT00170482|influenza vaccine|influenza vaccine
5784867|NCT00170482|sub-study|sub-study
5784868|NCT00170482|trivalent|trivalent
5784869|NCT00170469|Anthrax|anthrax
5784870|NCT00170456|Anthrax vaccine|anthrax vaccine
5784871|NCT00170443|Influenza, Baculovirus, Immunogenicity, Geriatrics|influenza, baculovirus, immunogenicity, geriatrics
5784872|NCT00170430|HIV-1, sexually transmitted diseases, females, Kenya|hiv-1, sexually transmitted diseases, females, kenya
5784873|NCT00170404|HIV Infections, Tuberculosis, Malnutrition, Tanzania|hiv infections, tuberculosis, malnutrition, tanzania
5784874|NCT00170391|Insomnia|insomnia
5784875|NCT00170391|Sleep|sleep
5784876|NCT00170391|PSG|psg
5784877|NCT00170391|Behavioural treatment|behavioural treatment
5784878|NCT00170378|Enoxaparin|enoxaparin
5784879|NCT00170378|Safety|safety
5784880|NCT00170365|Stress|stress
5784881|NCT00170365|Yoga|yoga
5784882|NCT00170352|hyperbaric oxygen|hyperbaric oxygen
5784883|NCT00170352|cerebral metabolism|cerebral metabolism
5784884|NCT00170352|hyperoxia|hyperoxia
5784885|NCT00170352|traumatic brain injury|traumatic brain injury
5784886|NCT00170339|Opiate Dependence|opiate dependence
5681099|NCT00574691|Angiography|angiography
5784887|NCT00170339|Methadone Maintenance|methadone maintenance
5784888|NCT00170339|Osteoporosis|osteoporosis
5784889|NCT00170339|Hypogonadism|hypogonadism
5784890|NCT00170326|Permanent Pacing artificial internal|permanent pacing artificial internal
5784891|NCT00170313|Heart Failure|heart failure
5784892|NCT00170313|Primary Prevention of Sudden Cardiac Death|primary prevention of sudden cardiac death
5784893|NCT00170313|Secondary Prevention of Sudden Cardiac Death|secondary prevention of sudden cardiac death
5784894|NCT00170313|Cardiac Desynchronization|cardiac desynchronization
5784895|NCT00170313|CRT-D|crt-d
5784896|NCT00170313|Cardiac Dyssynchrony|cardiac dyssynchrony
5784897|NCT00170300|Cardiac resynchronisation therapy (CRT therapy),|cardiac resynchronisation therapy (crt therapy),
5784898|NCT00170300|all-cause mortality,|all-cause mortality,
5784899|NCT00170300|quality of life assesment,|quality of life assesment,
5784900|NCT00170300|echocardiographic left ventricular function,|echocardiographic left ventricular function,
5784901|NCT00170300|CRT and neurohormonal activation,|crt and neurohormonal activation,
5784902|NCT00170300|CRT and health economics|crt and health economics
5784903|NCT00170287|Unstable Ventricular Tachycardia|unstable ventricular tachycardia
5784904|NCT00170274|Indication for cardiac pacing|indication for cardiac pacing
5784905|NCT00170274|Atrial Arrhythmia|atrial arrhythmia
5784906|NCT00170274|Indication for the implantation of a pacemaker according to the German guidelines|indication for the implantation of a pacemaker according to the german guidelines
5784907|NCT00170274|Documented (ECG) atrial tachyarrhythmia within the last three months before enrollment|documented (ecg) atrial tachyarrhythmia within the last three months before enrollment
5784908|NCT00170261|Syncope of uncertain etiology|syncope of uncertain etiology
5784909|NCT00170261|Repeated presyncopes|repeated presyncopes
5784910|NCT00170248|Asthma|asthma
5784911|NCT00170248|Primary Care|primary care
5784912|NCT00170248|Computer-Based Decision Support|computer-based decision support
5784913|NCT00170248|Outcome Evaluation|outcome evaluation
5784914|NCT00170235|Breast cancer|breast cancer
5784915|NCT00170235|Prehabilitation|prehabilitation
5784916|NCT00170235|Rehabilitation|rehabilitation
5784917|NCT00170235|Exercise|exercise
5784918|NCT00170222|Acute bronchitis|acute bronchitis
5784919|NCT00170222|antibiotics|antibiotics
5784920|NCT00170209|Tuberculosis|tuberculosis
5784921|NCT00170209|Children|children
5784922|NCT00170196|pneumonia|pneumonia
5784923|NCT00170196|corticosteroids|corticosteroids
5784924|NCT00170183|Heart failure|heart failure
5784925|NCT00170183|Renal dysfunction|renal dysfunction
5784926|NCT00170170|cytomegalovirus|cytomegalovirus
5784927|NCT00170105|Age 18 years or older|age 18 years or older
5784928|NCT00170105|No cognitive impairment or altered mental status|no cognitive impairment or altered mental status
5784929|NCT00170105|Stable|stable
5784930|NCT00170105|No aphasia|no aphasia
5784931|NCT00170105|English-speaking|english-speaking
5784932|NCT00170053|Kidney Transplantation|kidney transplantation
5784933|NCT00170001|supraesophageal reflux|supraesophageal reflux
5784934|NCT00170001|laryngopharyngeal symptoms|laryngopharyngeal symptoms
5784935|NCT00170001|pharynx|pharynx
5784936|NCT00170001|esophagus|esophagus
5784937|NCT00169988|clinical high risk|clinical high risk
5784938|NCT00169988|attenuated positive symptoms|attenuated positive symptoms
5784939|NCT00169988|attenuated negative symptoms|attenuated negative symptoms
5784940|NCT00169988|cognition|cognition
5784941|NCT00169988|functional status|functional status
5784942|NCT00169988|prodromal psychosis|prodromal psychosis
5784943|NCT00169962|acute disease|acute disease
5784944|NCT00169949|early intervention|early intervention
5784945|NCT00169949|social functioning|social functioning
5681109|NCT00574652|cryoglobulinemia|cryoglobulinemia
5681110|NCT00574652|Vasculitis|vasculitis
5681111|NCT00574652|IL-2 treatment|il-2 treatment
5681112|NCT00574652|safety and efficacy|safety and efficacy
5794614|NCT00126087|aging|aging
5784946|NCT00169949|role functioning|role functioning
5784947|NCT00169949|cognition|cognition
5784948|NCT00169910|Renal Transplantation|renal transplantation
5784950|NCT00169910|Mycophenolate Mofetil|mycophenolate mofetil
5784951|NCT00169910|Cardiovascular Disease|cardiovascular disease
5784952|NCT00169897|COPD|copd
5784953|NCT00169897|Exercise|exercise
5784954|NCT00169897|Self-management|self-management
5784955|NCT00169897|Rehabilitation|rehabilitation
5784956|NCT00169897|Quality of life|quality of life
5784957|NCT00169897|Health economy|health economy
5784958|NCT00169897|Cost effectiveness|cost effectiveness
5784959|NCT00169897|Health care utilization|health care utilization
5784960|NCT00169884|Deliberate Self-Harm,|deliberate self-harm,
5784961|NCT00169884|cognitive-behavioural therapy,|cognitive-behavioural therapy,
5784962|NCT00169884|integrative approach|integrative approach
5784963|NCT00169858|Hepatitis B|hepatitis b
5784964|NCT00169858|Vaccination|vaccination
5784965|NCT00169858|Engerix-B|engerix-b
5784966|NCT00169858|Immunogenicity|immunogenicity
5784967|NCT00169858|Long-term immunity|long-term immunity
5784968|NCT00169858|Booster dose|booster dose
5784969|NCT00169858|Safety|safety
5784970|NCT00169845|chemoprevention trial|chemoprevention trial
5784971|NCT00169845|antioxidant|antioxidant
5793769|NCT00129259|T1D|t1d
5784972|NCT00169845|alpha-tocopherol|alpha-tocopherol
5784973|NCT00169845|beta-carotene|beta-carotene
5784974|NCT00169845|second primary cancer|second primary cancer
5784975|NCT00169845|head and neck cancer|head and neck cancer
5784976|NCT00169845|adverse effect of radiation therapy|adverse effect of radiation therapy
5784977|NCT00169845|quality of life|quality of life
5784979|NCT00169845|cancer free survival|cancer free survival
5784980|NCT00169845|cancer recurrence|cancer recurrence
5784981|NCT00169832|Atherosclerosis progression|atherosclerosis progression
5784982|NCT00169832|Ischemic heart disease|ischemic heart disease
5784983|NCT00169832|Saphenous vein graft|saphenous vein graft
5784984|NCT00169832|Metabolic risk factors|metabolic risk factors
5784985|NCT00169832|Rosiglitazone|rosiglitazone
5784986|NCT00169819|Same day discharge|same day discharge
5784987|NCT00169819|Trans-radial|trans-radial
5787586|NCT00157859|Vivax|vivax
5784988|NCT00169819|Coronary artery stenting|coronary artery stenting
5784989|NCT00169819|Abciximab bolus|abciximab bolus
5784990|NCT00169806|Randall's Plaque|randall's plaque
5784991|NCT00169806|Kidney stones|kidney stones
5784993|NCT00169793|Nephrolithiasis|nephrolithiasis
5784994|NCT00169780|Renal Calculi|renal calculi
5784995|NCT00169780|Radiology|radiology
5784996|NCT00169780|High Reslolution CT|high reslolution ct
5784997|NCT00169767|Enlarged Prostate|enlarged prostate
5784999|NCT00169754|Nephrolithiasis|nephrolithiasis
5785000|NCT00169754|Renal Calculi|renal calculi
5785001|NCT00169754|Perc|perc
5785002|NCT00169754|Attached Stones|attached stones
5785003|NCT00169741|Nephrolithiasis|nephrolithiasis
5785004|NCT00169741|Renal Calculi|renal calculi
5785005|NCT00169728|allogeneic haematopoietic stem cell transplantation|allogeneic haematopoietic stem cell transplantation
5785006|NCT00169728|bone marrow transplantation|bone marrow transplantation
5785007|NCT00169728|children|children
5785008|NCT00169728|vaccination|vaccination
5785009|NCT00169728|invasive pneumococcal disease|invasive pneumococcal disease
5785010|NCT00169728|tetanus|tetanus
5785011|NCT00169728|diphtheria|diphtheria
5785012|NCT00169728|poliomyelitis|poliomyelitis
5785013|NCT00169728|pertussis|pertussis
5785014|NCT00169728|Hepatitis B|hepatitis b
5785015|NCT00169728|Haemophilus influenzae type B infection|haemophilus influenzae type b infection
5785016|NCT00169715|Kidney stones|kidney stones
5785017|NCT00169715|renal Calculi|renal calculi
5785019|NCT00169715|Caliceal Diverticula|caliceal diverticula
5785020|NCT00169702|Schizophrenia, weight management programme|schizophrenia, weight management programme
5785021|NCT00169689|schizophrenia, rTMS|schizophrenia, rtms
5785022|NCT00169676|Prostate Cancer|prostate cancer
5785023|NCT00169663|Brushite Kidney Stones|brushite kidney stones
5785024|NCT00169663|Nephrolithiasis|nephrolithiasis
5801884|NCT00100698|HIV|hiv
5785025|NCT00169650|UPJ Obstruction|upj obstruction
5785026|NCT00169650|Renal Obstruction|renal obstruction
5785027|NCT00169650|Delayed Renal Flow|delayed renal flow
5785028|NCT00169637|Short bowel syndrome|short bowel syndrome
5785029|NCT00169637|Growth hormone|growth hormone
5785030|NCT00169637|Children|children
5785031|NCT00169624|Diabetes,|diabetes,
5785032|NCT00169624|coronary endothelial dysfunction,|coronary endothelial dysfunction,
5785033|NCT00169624|metformin,|metformin,
5785034|NCT00169624|glyclazide,|glyclazide,
5785035|NCT00169624|MRI.|mri.
5785036|NCT00169611|Neurofibromatosis type 1|neurofibromatosis type 1
5681113|NCT00574639|Type 1 Diabetes|type 1 diabetes
5785037|NCT00169611|Attention deficit with hyperactivity disorder school difficulties|attention deficit with hyperactivity disorder school difficulties
5785038|NCT00169611|methylphenidate|methylphenidate
5785039|NCT00169598|Lymphoma|lymphoma
5785040|NCT00169598|positron emission tomography|positron emission tomography
5785041|NCT00169598|stem cell transplantation|stem cell transplantation
5785042|NCT00169598|therapeutic impact|therapeutic impact
5785043|NCT00169585|diagnostic-therapeutic pathway|diagnostic-therapeutic pathway
5785044|NCT00169585|PSA|psa
5785045|NCT00169585|DRE|dre
5785046|NCT00169585|Levofloxacin|levofloxacin
5785047|NCT00169572|Nausea|nausea
5785048|NCT00169572|Vomiting|vomiting
5785049|NCT00169572|Emesis|emesis
5785050|NCT00169572|Chemotherapy-induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5785051|NCT00169572|CINV|cinv
5785052|NCT00169559|triglycerides|triglycerides
5785053|NCT00169559|Hypertriglyceridemia|hypertriglyceridemia
5785054|NCT00169559|cholesterol|cholesterol
5785055|NCT00169559|LDL|ldl
5785056|NCT00169559|HDL|hdl
5785057|NCT00169546|Asthma|asthma
5785058|NCT00169546|inhaled corticosteroids|inhaled corticosteroids
5785059|NCT00169533|safety|safety
5785060|NCT00169533|tolerating lapatinib|tolerating lapatinib
5785061|NCT00169533|Lapatinib|lapatinib
5785062|NCT00169520|Safety|safety
5785063|NCT00169520|tolerability|tolerability
5785064|NCT00169520|dose limiting toxicity|dose limiting toxicity
5785065|NCT00169520|solid tumors|solid tumors
5785066|NCT00169520|docetaxel|docetaxel
5785067|NCT00169468|B Lymphoma|b lymphoma
5785068|NCT00169468|Velcade|velcade
5785069|NCT00169468|Chemotherapy|chemotherapy
5785070|NCT00169416|chicken pox|chicken pox
5785071|NCT00169416|varicella|varicella
5785072|NCT00169416|VZV|vzv
5686447|NCT00552045|malformations of cortical development|malformations of cortical development
5785073|NCT00169416|pharmacokinetics|pharmacokinetics
5785074|NCT00169403|Idiopathic dystonia|idiopathic dystonia
5785075|NCT00169403|deep brain stimulation|deep brain stimulation
5785076|NCT00169403|globus pallidus|globus pallidus
5785077|NCT00169403|generalised Idiopathic dystonia|generalised idiopathic dystonia
5785078|NCT00169390|smoking|smoking
5785079|NCT00169390|pregnancy|pregnancy
5785080|NCT00169390|newborns|newborns
5785081|NCT00169390|monoamine oxidases|monoamine oxidases
5785082|NCT00169377|Obsessive compulsive disorder|obsessive compulsive disorder
5785083|NCT00169377|deep brain stimulation|deep brain stimulation
5785084|NCT00169377|subthalamic nucleus|subthalamic nucleus
5785085|NCT00169364|Parkinson's disease|parkinson's disease
5785086|NCT00169364|parkin mutation|parkin mutation
5785087|NCT00169364|Juvenile parkinson's disease|juvenile parkinson's disease
5785088|NCT00169364|positron emission tomography|positron emission tomography
5785089|NCT00169338|Dystonia|dystonia
5785090|NCT00169338|deep brain stimulation|deep brain stimulation
5785091|NCT00169338|globus pallidus|globus pallidus
5785092|NCT00169338|Post-anoxic dystonia|post-anoxic dystonia
5785093|NCT00169325|basal ganglia|basal ganglia
5785094|NCT00169325|loss of psychic self-activation|loss of psychic self-activation
5785095|NCT00169312|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5785096|NCT00169299|Menopause|menopause
5785097|NCT00169299|Vasomotor|vasomotor
5785098|NCT00169299|Black cohosh|black cohosh
5785099|NCT00169299|Herbs|herbs
5785100|NCT00169299|Hot flashes|hot flashes
5785101|NCT00169299|HT|ht
5785102|NCT00169299|CAM|cam
5785103|NCT00169273|Obesity|obesity
5785104|NCT00169273|Depression|depression
5785105|NCT00169273|Behavioral|behavioral
5785106|NCT00169273|Cognitive|cognitive
5785107|NCT00169273|Treatment|treatment
5785108|NCT00169260|smoking|smoking
5785109|NCT00169260|tobacco|tobacco
5785110|NCT00169260|behavior therapy|behavior therapy
5785111|NCT00169247|larynx cancer|larynx cancer
5785112|NCT00169247|hypopharynx cancer|hypopharynx cancer
5785113|NCT00169247|larynx preservation|larynx preservation
5785114|NCT00169247|concomitant radiochemotherapy|concomitant radiochemotherapy
5785116|NCT00169247|cetuximab|cetuximab
5785117|NCT00169247|randomized trial|randomized trial
5785118|NCT00169234|Pneumococcal disease|pneumococcal disease
5785119|NCT00169234|Vaccination|vaccination
5785120|NCT00169234|Immunization|immunization
5785121|NCT00169234|PPV23|ppv23
5785122|NCT00169234|PCV7|pcv7
5785123|NCT00169208|relapsed/refractory.|relapsed/refractory.
5785124|NCT00169208|lymphoma, follicular|lymphoma, follicular
5785125|NCT00169208|rituximab|rituximab
5785126|NCT00169208|chemotherapy|chemotherapy
5785127|NCT00169195|B-cell lymphoma|b-cell lymphoma
5785128|NCT00169195|Salvage Therapy|salvage therapy
5785130|NCT00169195|oxaliplatine|oxaliplatine
5785131|NCT00169195|gemcitabine|gemcitabine
5785132|NCT00169182|Larynx cancer|larynx cancer
5785133|NCT00169182|Hypopharynx cancer|hypopharynx cancer
5785134|NCT00169182|Chemotherapy|chemotherapy
5785135|NCT00169182|Randomized trial|randomized trial
5785136|NCT00169182|Larynx preservation|larynx preservation
5785137|NCT00169169|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5785138|NCT00169169|Rituximab|rituximab
5785139|NCT00169169|Autotransplant|autotransplant
5785140|NCT00169156|T-cell angioimmunoblastic lymphoma|t-cell angioimmunoblastic lymphoma
5785141|NCT00169156|Rituximab|rituximab
5785142|NCT00169143|Diffuse large B cell lymphoma|diffuse large b cell lymphoma
5785143|NCT00169143|Pegfilgrastim|pegfilgrastim
5785144|NCT00169143|Autotransplant|autotransplant
5785145|NCT00169130|lymphoma|lymphoma
5785146|NCT00169130|autologous stem cell transplant|autologous stem cell transplant
5785147|NCT00169130|chemotherapy|chemotherapy
5785148|NCT00169130|BCL2|bcl2
5785149|NCT00169117|Mosquito nets|mosquito nets
5785150|NCT00169117|Malaria prevention|malaria prevention
5785151|NCT00169117|Songs|songs
5785152|NCT00169117|Posters|posters
5785153|NCT00169117|Net repair|net repair
5785155|NCT00169104|Breast cancer|breast cancer
5785156|NCT00169104|Her-2/neu|her-2/neu
5785157|NCT00169104|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5785158|NCT00169104|Trastuzumab|trastuzumab
5785159|NCT00169104|Vinorelbine|vinorelbine
5785160|NCT00169104|Antibody-dependent cellular cytotoxicity|antibody-dependent cellular cytotoxicity
5785161|NCT00169104|Effector cells|effector cells
5785162|NCT00169091|Clozapine|clozapine
5785163|NCT00169091|Haloperidol|haloperidol
5785164|NCT00169091|Schizophrenia|schizophrenia
5785165|NCT00169078|Transmission intensity|transmission intensity
5785166|NCT00169078|Insecticide-treated materials|insecticide-treated materials
5785167|NCT00169078|antimalarial drug resistance|antimalarial drug resistance
5785168|NCT00169065|Clozapine|clozapine
5785169|NCT00169065|olanzapine|olanzapine
5785170|NCT00169052|geriatric,|geriatric,
5785172|NCT00169052|serious mental illness|serious mental illness
5785173|NCT00169052|SMI|smi
5785174|NCT00169039|Clozapine|clozapine
5785175|NCT00169039|Chlorpromazine|chlorpromazine
5686448|NCT00552045|phenome|phenome
5686449|NCT00552045|genome|genome
5686450|NCT00552045|genotype|genotype
5686451|NCT00552045|phenotype|phenotype
5686452|NCT00552006|PTSD|ptsd
5686453|NCT00552006|Treatment|treatment
5686454|NCT00552006|Randomized Controlled Clinical Trial|randomized controlled clinical trial
5686455|NCT00552006|Combat|combat
5686456|NCT00552006|Child Soldiers|child soldiers
5785176|NCT00169039|Schizophrenia|schizophrenia
5785177|NCT00169039|Biochemistry|biochemistry
5785178|NCT00169026|Clozapine|clozapine
5785179|NCT00169026|Atypical Antipsychotic|atypical antipsychotic
5785180|NCT00169026|Conventional antipsychotic|conventional antipsychotic
5785181|NCT00169026|Schizophrenia|schizophrenia
5785182|NCT00169026|Dual Diagnosis|dual diagnosis
5785183|NCT00169026|Substance Abuse|substance abuse
5785184|NCT00169026|Alcohol Abuse|alcohol abuse
5785185|NCT00169000|breast cancer|breast cancer
5785186|NCT00169000|capecitabine|capecitabine
5785187|NCT00169000|docetaxel|docetaxel
5785188|NCT00169000|pharmacokinetic/pharmacodynamic|pharmacokinetic/pharmacodynamic
5785189|NCT00169000|bcl-2|bcl-2
5785190|NCT00169000|bax|bax
5785191|NCT00168987|oral nutritional supplement|oral nutritional supplement
5785192|NCT00168987|eicosapentanoic acid|eicosapentanoic acid
5785193|NCT00168987|gastroenterological tumors|gastroenterological tumors
5785194|NCT00168987|muscle function|muscle function
5785195|NCT00168987|quality of life|quality of life
5785196|NCT00168987|body composition|body composition
5785197|NCT00168961|liver cirrhosis Child B or C|liver cirrhosis child b or c
5785198|NCT00168948|Intermittent preventive treatment|intermittent preventive treatment
5785199|NCT00168948|IPTi|ipti
5785200|NCT00168948|Malaria control|malaria control
5785201|NCT00168948|Ghana|ghana
5785202|NCT00168922|recurrent SCLC|recurrent sclc
5785203|NCT00168909|osteoporosis|osteoporosis
5785204|NCT00168909|frailty|frailty
5785205|NCT00168909|falls|falls
5785206|NCT00168896|SCLC|sclc
5785207|NCT00168883|NSCLC|nsclc
5785208|NCT00168883|curative non-treatable NSCLC UICC stage IIIB and IV|curative non-treatable nsclc uicc stage iiib and iv
5785209|NCT00168870|metastatic ocular melanoma|metastatic ocular melanoma
5785210|NCT00168766|Combination therapy for multiple sclerosis|combination therapy for multiple sclerosis
5785211|NCT00168753|Extended dosing|extended dosing
5785212|NCT00168753|alefacept|alefacept
5785213|NCT00168740|rituximab|rituximab
5785214|NCT00168740|Rituxan|rituxan
5785215|NCT00168740|B-cell lymphoma|b-cell lymphoma
5785216|NCT00168740|low-grade|low-grade
5785217|NCT00168740|follicular|follicular
5785218|NCT00168740|anti-CD20 monoclonal antibody|anti-cd20 monoclonal antibody
5785219|NCT00168727|Radioimmunotherapy|radioimmunotherapy
5785220|NCT00168727|Antigens, CD20|antigens, cd20
5785221|NCT00168714|AVONEX|avonex
5785222|NCT00168714|Pregnancy|pregnancy
5785223|NCT00168701|Multiple Sclerosis|multiple sclerosis
5785224|NCT00168701|MRI|mri
5785225|NCT00168688|micronutrient supplementation|micronutrient supplementation
5785226|NCT00168688|pregnancy|pregnancy
5785227|NCT00168688|birth weight|birth weight
5785228|NCT00168688|perinatal mortality|perinatal mortality
5785229|NCT00168662|Non-specific effects of vaccines|non-specific effects of vaccines
5785231|NCT00168662|Child mortality|child mortality
5785232|NCT00168662|Mortality|mortality
5785233|NCT00168662|Morbidity|morbidity
5785234|NCT00168662|Measles vaccine|measles vaccine
5785235|NCT00168662|Measles|measles
5785236|NCT00168662|Immunisation|immunisation
5785237|NCT00168662|Low income country|low income country
5785238|NCT00168662|Guinea-Bissau|guinea-bissau
5785239|NCT00168662|Bandim Health Project|bandim health project
5785240|NCT00168662|Immunology|immunology
5785241|NCT00168649|Vitamin A|vitamin a
5785242|NCT00168649|Endotoxin|endotoxin
5785243|NCT00168649|TNF-alfa|tnf-alfa
5785244|NCT00168636|Vitamin A|vitamin a
5785245|NCT00168636|Mortality|mortality
5785246|NCT00168636|Morbidity|morbidity
5785247|NCT00168636|OPV|opv
5785248|NCT00168636|Sex|sex
5785249|NCT00168623|Vitamin A|vitamin a
5785250|NCT00168623|Vaccines|vaccines
5785251|NCT00168623|Mortality|mortality
5785252|NCT00168623|Morbidity|morbidity
5785253|NCT00168610|Vitamin A|vitamin a
5785254|NCT00168610|BCG|bcg
5785255|NCT00168610|Infant mortality|infant mortality
5785256|NCT00168610|Morbidity|morbidity
5785257|NCT00168610|Low-income country|low-income country
5785258|NCT00168610|Mortality|mortality
5785259|NCT00168597|Vitamin A|vitamin a
5785260|NCT00168597|BCG|bcg
5785261|NCT00168597|Infant mortality|infant mortality
5785262|NCT00168597|Morbidity|morbidity
5785263|NCT00168597|Low-income country|low-income country
5785264|NCT00168584|Vitamin A|vitamin a
5785265|NCT00168584|Mortality|mortality
5785266|NCT00168584|Morbidity|morbidity
5794059|NCT00128245|KCS|kcs
5785267|NCT00168584|Doses|doses
5785268|NCT00168584|OPV|opv
5785269|NCT00168571|Measles vaccine|measles vaccine
5785270|NCT00168571|Measles|measles
5785271|NCT00168571|Measles antibodies|measles antibodies
5785272|NCT00168571|Immunisation|immunisation
5785273|NCT00168571|Low income country|low income country
5785274|NCT00168571|Guinea-Bissau|guinea-bissau
5785275|NCT00168571|Bandim Health Project|bandim health project
5785276|NCT00168571|Measles antibody level|measles antibody level
5785277|NCT00168558|Non-specific effects of vaccines|non-specific effects of vaccines
5785278|NCT00168558|Infant mortality|infant mortality
5785279|NCT00168558|Child mortality|child mortality
5785280|NCT00168558|Mortality|mortality
5785281|NCT00168558|Morbidity|morbidity
5785282|NCT00168558|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
5785283|NCT00168558|Measles vaccine|measles vaccine
5785284|NCT00168558|Measles|measles
5785285|NCT00168558|Immunisation|immunisation
5785286|NCT00168558|Low income country|low income country
5785287|NCT00168558|Guinea-Bissau|guinea-bissau
5785288|NCT00168558|Bandim Health Project|bandim health project
5785289|NCT00168558|Immunology|immunology
5785290|NCT00168545|Non-specific effects of vaccines|non-specific effects of vaccines
5785291|NCT00168545|Immunology|immunology
5785292|NCT00168545|Cytokines|cytokines
5785293|NCT00168545|Infant mortality|infant mortality
5785294|NCT00168545|Child mortality|child mortality
5785295|NCT00168545|Mortality|mortality
5785296|NCT00168545|Morbidity|morbidity
5785297|NCT00168545|Diphtheria-tetanus-pertussis vaccine|diphtheria-tetanus-pertussis vaccine
5785298|NCT00168545|Measles vaccine|measles vaccine
5785299|NCT00168545|Measles|measles
5785300|NCT00168545|Immunisation|immunisation
5785301|NCT00168545|Low income country|low income country
5785302|NCT00168545|Guinea-Bissau|guinea-bissau
5785303|NCT00168545|Bandim Health Project|bandim health project
5785304|NCT00168545|Immunology of measles and DTP vaccination|immunology of measles and dtp vaccination
5785305|NCT00168532|Prophylactic antibiotics|prophylactic antibiotics
5785306|NCT00168532|Measles|measles
5785307|NCT00168532|Pneumonia|pneumonia
5785308|NCT00168532|Post-measles pneumonia|post-measles pneumonia
5785309|NCT00168532|Low income country|low income country
5785310|NCT00168532|Guinea-Bissau|guinea-bissau
5785311|NCT00168532|Bandim Health Project|bandim health project
5785312|NCT00168519|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5785313|NCT00168519|Blood Glucose|blood glucose
5785314|NCT00168519|Exercise|exercise
5785315|NCT00168519|Muscle Contraction|muscle contraction
5785316|NCT00168519|Nitric Oxide|nitric oxide
5785317|NCT00168519|Nitrates|nitrates
5785318|NCT00168506|panic disorder|panic disorder
5785319|NCT00168506|cardiac risk|cardiac risk
5785320|NCT00168493|Major Depression|major depression
5785321|NCT00168493|Cardiac disease|cardiac disease
5785322|NCT00168402|Axillary Hyperhidrosis|axillary hyperhidrosis
5785323|NCT00168376|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5785324|NCT00168376|Depression|depression
5785325|NCT00168311|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5785326|NCT00168311|Schizophrenia|schizophrenia
5785327|NCT00168311|Negative Symptoms|negative symptoms
5785328|NCT00168285|Exercise|exercise
5785329|NCT00168285|Pulmonary rehabilitation|pulmonary rehabilitation
5785330|NCT00168285|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5785331|NCT00168285|Connective tissue disorders|connective tissue disorders
5802210|NCT00099541|NTX|ntx
5785332|NCT00168272|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5785333|NCT00168272|Depression|depression
5785334|NCT00168259|Treatment Naive|treatment naive
5785335|NCT00168259|HIV|hiv
5785336|NCT00168246|HIV|hiv
5785337|NCT00168233|Treatment Naive|treatment naive
5785338|NCT00168233|HIV|hiv
5785339|NCT00168220|Treatment Experienced|treatment experienced
5785340|NCT00168220|HIV|hiv
5785341|NCT00168207|Treatment Experienced|treatment experienced
5785342|NCT00168207|HIV|hiv
5785343|NCT00168194|HIV|hiv
5785344|NCT00168181|salagen|salagen
5785345|NCT00168181|gland transfer|gland transfer
5785346|NCT00168181|randomized|randomized
5785347|NCT00168181|xerostomia|xerostomia
5785348|NCT00168168|G-CSF|g-csf
5785349|NCT00168168|Filgrastim|filgrastim
5785350|NCT00168168|Engraftment time|engraftment time
5785351|NCT00168168|Autologus transplant|autologus transplant
5785352|NCT00168155|resectable liver metastases|resectable liver metastases
5785353|NCT00168155|colorectal adenocarcinoma|colorectal adenocarcinoma
5785354|NCT00168155|survival|survival
5785355|NCT00168155|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5785356|NCT00168142|Helical tomotherapy|helical tomotherapy
5785357|NCT00168142|Megavoltage imaging|megavoltage imaging
5785358|NCT00168129|tomotherapy|tomotherapy
5785359|NCT00168129|bone metastases|bone metastases
5785360|NCT00168129|radiotherapy|radiotherapy
5785361|NCT00168129|intensity modulated|intensity modulated
5785362|NCT00168116|nasopharynx|nasopharynx
5785363|NCT00168116|xerostomia|xerostomia
5785364|NCT00168116|prevention|prevention
5785365|NCT00168103|C1 Inhibitor|c1 inhibitor
5785366|NCT00168103|Hereditary angioedema|hereditary angioedema
5686457|NCT00552006|Dissemination|dissemination
5785367|NCT00168103|Acute HAE attack|acute hae attack
5785368|NCT00168090|von Willebrand Factor|von willebrand factor
5785369|NCT00168090|Blood Coagulation Disorders|blood coagulation disorders
5785370|NCT00168090|Factor VIII|factor viii
5785371|NCT00168077|Prothrombin Complex Concentrate|prothrombin complex concentrate
5785372|NCT00168077|Anticoagulant reversal|anticoagulant reversal
5785373|NCT00168064|Mycosis Fungoides|mycosis fungoides
5785374|NCT00168064|Nitrogen Mustard|nitrogen mustard
5785375|NCT00168064|Cutaneous T-Cell Lymphoma|cutaneous t-cell lymphoma
5785376|NCT00168064|CTCL - Mycosis Fungoides|ctcl - mycosis fungoides
5785377|NCT00168051|Hemophilia A|hemophilia a
5785378|NCT00168038|Chronic Immune Thrombocytopenic Purpura|chronic immune thrombocytopenic purpura
5785379|NCT00168038|Chronic Idiopathic Thrombocytopenic Purpura|chronic idiopathic thrombocytopenic purpura
5785380|NCT00168038|Werlhofs Disease|werlhofs disease
5785381|NCT00168038|Autoimmune Thrombocytopenia|autoimmune thrombocytopenia
5785382|NCT00168038|Immunglobulin Intravenous|immunglobulin intravenous
5785383|NCT00168038|Chronic ITP|chronic itp
5785384|NCT00168038|Platelet count|platelet count
5785385|NCT00168038|Thrombocytopenia|thrombocytopenia
5785386|NCT00168025|Immunoglobulin Intravenous|immunoglobulin intravenous
5785387|NCT00168025|Agammaglobulinemia|agammaglobulinemia
5785388|NCT00168025|Hypogammaglobulinemia|hypogammaglobulinemia
5785593|NCT00167336|Reliability|reliability
5785389|NCT00168025|Common variable immunodeficiency|common variable immunodeficiency
5785390|NCT00168025|Immunoglobulin G|immunoglobulin g
5785391|NCT00168025|Children|children
5785392|NCT00168012|Immunoglobulin intravenous|immunoglobulin intravenous
5785393|NCT00168012|Agammaglobulinemia|agammaglobulinemia
5785394|NCT00168012|Hypogammaglobulinemia|hypogammaglobulinemia
5785395|NCT00168012|Common variable immunodeficiency|common variable immunodeficiency
5785396|NCT00168012|Immunoglobulin G|immunoglobulin g
5785397|NCT00168012|Children|children
5785398|NCT00167999|Bacterial Infections|bacterial infections
5785399|NCT00167986|Bacterial Infections|bacterial infections
5785400|NCT00167973|Hemophilia B|hemophilia b
5785401|NCT00167960|Bacterial Infections|bacterial infections
5785403|NCT00167947|Transplant|transplant
5785404|NCT00167934|Diabetes|diabetes
5785405|NCT00167934|Metabolic|metabolic
5785406|NCT00167895|osteoarthritis|osteoarthritis
5785407|NCT00167895|knee|knee
5785408|NCT00167895|platelet concentrate|platelet concentrate
5785409|NCT00167882|Crohn's disease|crohn's disease
5785410|NCT00167882|Ulcerative colitis|ulcerative colitis
5785411|NCT00167882|Inflammatory bowel disease|inflammatory bowel disease
5785412|NCT00167882|azathioprine|azathioprine
5785413|NCT00167882|6-mercaptopurine|6-mercaptopurine
5785414|NCT00167882|5-aminosalicylate|5-aminosalicylate
5785415|NCT00167882|metabolism|metabolism
5785416|NCT00167869|hypertension|hypertension
5785417|NCT00167869|blood pressure|blood pressure
5785418|NCT00167869|dairy peptides|dairy peptides
5785419|NCT00167869|bioactive peptides|bioactive peptides
5785420|NCT00167869|randomized controlled trial|randomized controlled trial
5785421|NCT00167856|Burning pain|burning pain
5785422|NCT00167856|Clinical trial|clinical trial
5785424|NCT00167856|Pain|pain
5785425|NCT00167856|Spinal cord injury|spinal cord injury
5785426|NCT00167856|Venalafaxine|venalafaxine
5785427|NCT00167856|Neuropathic Pain|neuropathic pain
5785428|NCT00167843|Malaria|malaria
5785429|NCT00167843|Anemia|anemia
5785430|NCT00167843|Children|children
5785431|NCT00167843|Gabon|gabon
5785432|NCT00167843|Intermittent preventive treatment|intermittent preventive treatment
5785433|NCT00167830|Pediatric Overweight,|pediatric overweight,
5785434|NCT00167830|African American;|african american;
5785435|NCT00167830|Adolescent;|adolescent;
5785436|NCT00167830|Intervention,|intervention,
5785437|NCT00167830|Teasing;|teasing;
5785438|NCT00167830|Self-esteem|self-esteem
5785439|NCT00167830|Quality of Life|quality of life
5785440|NCT00167830|Metabolic syndrome|metabolic syndrome
5785441|NCT00167830|Insulin resistance|insulin resistance
5785442|NCT00167830|Diabetes|diabetes
5785443|NCT00167830|Nutrition|nutrition
5785444|NCT00167830|Motivation|motivation
5785445|NCT00167830|Culture|culture
5785447|NCT00167830|Cardiorespiratory fitness|cardiorespiratory fitness
5785448|NCT00167830|Resistance Training|resistance training
5785449|NCT00167830|Compliance|compliance
5785450|NCT00167817|Schizophrenia|schizophrenia
5785451|NCT00167817|Smoking|smoking
5785452|NCT00167817|Metabolic|metabolic
5785453|NCT00167817|Health|health
5785454|NCT00167817|Glucose|glucose
5785455|NCT00167817|Lipids|lipids
5785456|NCT00167804|Exposure Therapy|exposure therapy
5785457|NCT00167804|Post Traumatic Stress Disorder|post traumatic stress disorder
5785458|NCT00167804|Treatment Outcome|treatment outcome
5785459|NCT00167804|Veterans|veterans
5785460|NCT00167804|Virtual Reality|virtual reality
5780423|NCT00195247|Tumors|tumors
5785461|NCT00167791|transplant|transplant
5785462|NCT00167791|desensitization|desensitization
5785463|NCT00167791|kidney transplant|kidney transplant
5785464|NCT00167778|Amputation|amputation
5785465|NCT00167778|Amputee|amputee
5785466|NCT00167778|Artificial limbs|artificial limbs
5785467|NCT00167778|Gait|gait
5785468|NCT00167778|Locomotion|locomotion
5785469|NCT00167778|Walking|walking
5785470|NCT00167765|stroke, ischemic|stroke, ischemic
5785471|NCT00167765|acute ischemic stroke|acute ischemic stroke
5785472|NCT00167739|Malaria|malaria
5785473|NCT00167739|Quinine|quinine
5785474|NCT00167739|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5785475|NCT00167739|Gabon|gabon
5785476|NCT00167713|Malaria|malaria
5785477|NCT00167713|Fever|fever
5785478|NCT00167713|Ibuprofen|ibuprofen
5785479|NCT00167713|Gabon|gabon
5785480|NCT00167700|atopic disease|atopic disease
5785481|NCT00167700|probiotics|probiotics
5785482|NCT00167700|gut microbiota|gut microbiota
5785483|NCT00167700|allergy|allergy
5785484|NCT00167700|nutrition|nutrition
5785485|NCT00167700|growth|growth
5785486|NCT00167700|allergic rhinitis|allergic rhinitis
5785487|NCT00167700|atopic sensitization|atopic sensitization
5785488|NCT00167700|risk-markers of life-style related diseases|risk-markers of life-style related diseases
5785489|NCT00167687|Alcoholism|alcoholism
5785490|NCT00167687|Randomized Controlled Trial|randomized controlled trial
5785491|NCT00167674|breastmilk|breastmilk
5785492|NCT00167674|HIV-1|hiv-1
5785493|NCT00167674|antiretroviral|antiretroviral
5785494|NCT00167674|mother-to-child|mother-to-child
5785495|NCT00167674|transmission|transmission
5785496|NCT00167661|living or deceased donor renal transplant recipient|living or deceased donor renal transplant recipient
5785497|NCT00167635|Irritable Bowel Syndrome|irritable bowel syndrome
5785498|NCT00167635|Cognitive-behavioral intervention|cognitive-behavioral intervention
5785499|NCT00167635|Psychological distress|psychological distress
5785500|NCT00167635|Quality of life|quality of life
5785501|NCT00167622|Guillain Barré|guillain barré
5785502|NCT00167622|Mechanical ventilation, invasive|mechanical ventilation, invasive
5785503|NCT00167622|Mechanical ventilation, non invasive|mechanical ventilation, non invasive
5785504|NCT00167622|Pneumonia|pneumonia
5785505|NCT00167609|myotonic dystrophy|myotonic dystrophy
5785506|NCT00167609|hypersomnia|hypersomnia
5785507|NCT00167609|dehydroepiandrosterone|dehydroepiandrosterone
5785508|NCT00167596|near infrared spectroscopy|near infrared spectroscopy
5785509|NCT00167596|tissue oxygenation|tissue oxygenation
5785510|NCT00167596|organ dysfunction|organ dysfunction
5785511|NCT00167596|mortality|mortality
5785512|NCT00167583|Ocular Behcet`s disease|ocular behcet`s disease
5785513|NCT00167583|Panuveitis|panuveitis
5785514|NCT00167583|Posterior Uveitis|posterior uveitis
5785515|NCT00167583|Retinal vasculitis|retinal vasculitis
5785516|NCT00167583|Treatment|treatment
5785517|NCT00167583|Interferon-alpha|interferon-alpha
5785518|NCT00167583|Cyclosporin A|cyclosporin a
5785519|NCT00167570|Artificial Limbs|artificial limbs
5785520|NCT00167570|Amputees|amputees
5785521|NCT00167570|Computer-Aided Design|computer-aided design
5785522|NCT00167557|Liver Transplantation|liver transplantation
5785523|NCT00167544|Bronchopulmonary Dysplasia|bronchopulmonary dysplasia
5785524|NCT00167544|Encephalomalacia|encephalomalacia
5785525|NCT00167544|Brain injury|brain injury
5785526|NCT00167544|Neurosensory impairment|neurosensory impairment
5785527|NCT00167544|Corticosteroids|corticosteroids
5785528|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents
5785529|NCT00167544|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
5785530|NCT00167544|Premature Birth|premature birth
5785531|NCT00167544|Magnetic Resonance Imaging|magnetic resonance imaging
5785533|NCT00167531|health outcomes|health outcomes
5785535|NCT00167531|rehabilitation|rehabilitation
5785536|NCT00167531|treadmill|treadmill
5785537|NCT00167518|Diabetic macular oedema|diabetic macular oedema
5785538|NCT00167518|Triamcinolone acetate|triamcinolone acetate
5785539|NCT00167518|Intravitreal injection|intravitreal injection
5785540|NCT00167518|Clinical trial|clinical trial
5785541|NCT00167518|Laser treatment|laser treatment
5785542|NCT00167505|adolescents|adolescents
5785543|NCT00167505|sexual health|sexual health
5785544|NCT00167505|HIV|hiv
5785545|NCT00167505|STD|std
5785546|NCT00167505|pregnancy prevention|pregnancy prevention
5785547|NCT00167505|abstinence education|abstinence education
5681115|NCT00574639|Exercise|exercise
5681116|NCT00574626|NHL|nhl
5681117|NCT00574626|Non Hodgkins Lymphoma|non hodgkins lymphoma
5681119|NCT00574626|Bone Marrow Transplant|bone marrow transplant
5681120|NCT00574626|PBSCT|pbsct
5681121|NCT00574626|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5681122|NCT00574626|PSCT|psct
5785548|NCT00167505|HIV Seronegativity|hiv seronegativity
5785549|NCT00167505|human immunodeficiency virus|human immunodeficiency virus
5785550|NCT00167479|Bipolar Anxiety|bipolar anxiety
5785551|NCT00167479|Bipolar Disorder|bipolar disorder
5785552|NCT00167479|Anxiety|anxiety
5785553|NCT00167479|Panic Disorder|panic disorder
5785554|NCT00167479|Generalized Anxiety Disorder|generalized anxiety disorder
5785555|NCT00167479|GAD|gad
5785556|NCT00167479|Risperidone|risperidone
5785558|NCT00167479|Placebo Controlled|placebo controlled
5785559|NCT00167466|periodontal disease|periodontal disease
5785560|NCT00167466|toothbrush|toothbrush
5785561|NCT00167466|titanium dioxide semiconductor|titanium dioxide semiconductor
5686458|NCT00552006|Narrative Exposure Therapy|narrative exposure therapy
5785562|NCT00167466|mild-to-moderate periodontal disease|mild-to-moderate periodontal disease
5785563|NCT00167466|adult patients 18 to 70 years of age|adult patients 18 to 70 years of age
5785564|NCT00167453|Nervous system disease|nervous system disease
5785565|NCT00167453|movement disorder|movement disorder
5785566|NCT00167453|exercise|exercise
5785567|NCT00167453|balance|balance
5785568|NCT00167453|education|education
5785569|NCT00167440|cardiac index|cardiac index
5785570|NCT00167440|cardiac output|cardiac output
5785571|NCT00167440|indwelling central venous catheter|indwelling central venous catheter
5785572|NCT00167440|indwelling arterial catheter|indwelling arterial catheter
5785573|NCT00167414|conformal radiotherapy|conformal radiotherapy
5785574|NCT00167388|anemia|anemia
5785575|NCT00167388|prematurity|prematurity
5785576|NCT00167388|blood flow velocity|blood flow velocity
5785577|NCT00167388|superior mesenteric artery|superior mesenteric artery
5785578|NCT00167388|intestinal blood flow in premature infants|intestinal blood flow in premature infants
5785579|NCT00167375|Insomnia|insomnia
5785580|NCT00167375|polysomnography|polysomnography
5785581|NCT00167375|sleep onset|sleep onset
5785582|NCT00167375|time series analysis|time series analysis
5785583|NCT00167362|Schizophrenia|schizophrenia
5785584|NCT00167362|Cognition|cognition
5785585|NCT00167362|Enhancement|enhancement
5785586|NCT00167362|Randomized|randomized
5785587|NCT00167349|cardiac surgery|cardiac surgery
5785588|NCT00167349|cardiopulmonary bypass|cardiopulmonary bypass
5785589|NCT00167349|cytokines|cytokines
5785590|NCT00167336|Computer|computer
5785591|NCT00167336|Kinematics|kinematics
5785592|NCT00167336|Instrument development|instrument development
5785594|NCT00167336|Cumulative Trauma Disorder|cumulative trauma disorder
5785596|NCT00167323|Alcoholism|alcoholism
5785597|NCT00167310|Omega-3 fatty acids|omega-3 fatty acids
5785598|NCT00167310|Statins|statins
5785599|NCT00167310|Antipsychotic drug|antipsychotic drug
5785600|NCT00167310|Antidepressant drug|antidepressant drug
5785601|NCT00167310|Antimanic drug|antimanic drug
5785603|NCT00167310|Double-blind method|double-blind method
5785604|NCT00167310|Bipolar (depressed phase)|bipolar (depressed phase)
5785605|NCT00167297|atomoxetine|atomoxetine
5785606|NCT00167297|cannabis dependence|cannabis dependence
5785607|NCT00167297|treatment|treatment
5785608|NCT00167284|chronic care model, diabetes, community, diabetes education|chronic care model, diabetes, community, diabetes education
5785609|NCT00167271|Cognitive therapy|cognitive therapy
5785610|NCT00167245|Topiramate|topiramate
5785611|NCT00167245|alcoholism|alcoholism
5785612|NCT00167245|cocaine dependence|cocaine dependence
5785613|NCT00167232|naltrexone|naltrexone
5785614|NCT00167232|cocaine dependence|cocaine dependence
5785615|NCT00167232|alcohol dependence|alcohol dependence
5785616|NCT00167232|psychosocial treatment|psychosocial treatment
5785617|NCT00167219|Stem cell transplant|stem cell transplant
5785618|NCT00167219|long term survival|long term survival
5785619|NCT00167219|retinoic acid|retinoic acid
5785620|NCT00167206|Stem Cell Transplant|stem cell transplant
5785621|NCT00167206|Thymic Shielding|thymic shielding
5785622|NCT00167206|Total Body Irradiation|total body irradiation
5785623|NCT00167206|Chemotherapy|chemotherapy
5785624|NCT00167180|donor lymphocyte infusions|donor lymphocyte infusions
5785625|NCT00167180|BMT|bmt
5785626|NCT00167180|bone marrow transplant|bone marrow transplant
5785627|NCT00167167|Donor Lymphocyte Infusion|donor lymphocyte infusion
5785628|NCT00167167|relapse|relapse
5785629|NCT00167167|post-transplant|post-transplant
5785630|NCT00167154|suicidality|suicidality
5785631|NCT00167154|antipsychotic|antipsychotic
5785632|NCT00167154|antidepressant|antidepressant
5785633|NCT00167154|treatment|treatment
5785634|NCT00167141|male fertility|male fertility
5785635|NCT00167141|semen parameters|semen parameters
5785636|NCT00167128|Auditory Processing Disorder|auditory processing disorder
5785637|NCT00167128|speech-in-noise intelligibility|speech-in-noise intelligibility
5785638|NCT00167115|Alcohol|alcohol
5785639|NCT00167115|Type 2 diabetes mellitus|type 2 diabetes mellitus
5785640|NCT00167115|Plama glucose|plama glucose
5785641|NCT00167115|HDL cholesterol|hdl cholesterol
5785642|NCT00167102|Alopecia Areata|alopecia areata
5785643|NCT00167089|Stroke|stroke
5785644|NCT00167089|Hemiplegia|hemiplegia
5785645|NCT00167089|Gait|gait
5785646|NCT00167089|Ambulation training|ambulation training
5785647|NCT00167089|Neurologic physical therapy|neurologic physical therapy
5785648|NCT00167076|Stroke|stroke
5785649|NCT00167076|Foot pressure|foot pressure
5785650|NCT00167076|Walking speed|walking speed
5785651|NCT00167076|Gait|gait
5785652|NCT00167063|Stroke|stroke
5785653|NCT00167063|Fall|fall
5785654|NCT00167063|Fall prediction|fall prediction
5785655|NCT00167063|Clinical manifestations|clinical manifestations
5785656|NCT00167063|Frequent faller|frequent faller
5785657|NCT00167037|Hemiplegia|hemiplegia
5785658|NCT00167037|Waist pulling perturbation|waist pulling perturbation
5785659|NCT00167037|Reactive balance strategy|reactive balance strategy
5785660|NCT00167037|Trajectory of center of pressure|trajectory of center of pressure
5686459|NCT00552006|Africa|africa
5785661|NCT00167037|Parameters of center of pressure|parameters of center of pressure
5785662|NCT00167024|prostate cancer, DNA repair gene, genetic polymorphism|prostate cancer, dna repair gene, genetic polymorphism
5785663|NCT00167011|coronary artery|coronary artery
5785664|NCT00166998|Breast neoplasms|breast neoplasms
5785665|NCT00166998|diagnosis|diagnosis
5785666|NCT00166985|endometrial cancer, MRI, Doppler sonography, angiogenesis|endometrial cancer, mri, doppler sonography, angiogenesis
5785667|NCT00166972|metastasis, survival, malignancy, female, trophinin|metastasis, survival, malignancy, female, trophinin
5785668|NCT00166959|Stroke patients|stroke patients
5785669|NCT00166959|Falls|falls
5785670|NCT00166959|Reliability|reliability
5785671|NCT00166959|Validity|validity
5785672|NCT00166933|minimal erythema dose|minimal erythema dose
5785673|NCT00166933|UVB|uvb
5785674|NCT00166933|normal|normal
5785675|NCT00166907|Stroke|stroke
5785676|NCT00166907|Balance|balance
5785677|NCT00166907|Proactive control|proactive control
5785678|NCT00166907|Reactive control|reactive control
5785679|NCT00166907|Recovery|recovery
5785680|NCT00166907|Training|training
5785681|NCT00166907|Fall|fall
5785682|NCT00166894|pleural effusion|pleural effusion
5785683|NCT00166894|TREM-1|trem-1
5785684|NCT00166881|Combination, Chemotherapy, Inoperable Gastric Cancer|combination, chemotherapy, inoperable gastric cancer
5785685|NCT00166868|Biliary atresia, cholangitis, probiotics, prophylaxis|biliary atresia, cholangitis, probiotics, prophylaxis
5785686|NCT00166855|angiogenesis|angiogenesis
5785687|NCT00166855|bone marrow perfusion|bone marrow perfusion
5785688|NCT00166855|dynamic MRI|dynamic mri
5785689|NCT00166855|multiple myeloma|multiple myeloma
5785690|NCT00166855|prognosis|prognosis
5785691|NCT00166842|Pharmacokinetics|pharmacokinetics
5785692|NCT00166842|Sirolimus|sirolimus
5785693|NCT00166842|Cyclosporine|cyclosporine
5785694|NCT00166842|Tacrolimus|tacrolimus
5785695|NCT00166842|Immunosuppressive Agents|immunosuppressive agents
5785696|NCT00166842|Immunosuppression|immunosuppression
5785697|NCT00166842|Transplantation|transplantation
5785698|NCT00166842|Kidney Transplantation|kidney transplantation
5785699|NCT00166829|Tacrolimus|tacrolimus
5785700|NCT00166829|Sirolimus|sirolimus
5785701|NCT00166829|Mycophenolic acid|mycophenolic acid
5785702|NCT00166829|Immunosuppressive Agents|immunosuppressive agents
5785703|NCT00166829|Immunosuppression|immunosuppression
5785704|NCT00166829|Kidney Transplantation|kidney transplantation
5785705|NCT00166829|Transplantation|transplantation
5785706|NCT00166816|Sirolimus|sirolimus
5785707|NCT00166816|Tacrolimus|tacrolimus
5785708|NCT00166816|Cyclosporine|cyclosporine
5785709|NCT00166816|Pharmacokinetics|pharmacokinetics
5785710|NCT00166816|Immunosuppressive Agents|immunosuppressive agents
5785711|NCT00166816|Immunosuppression|immunosuppression
5785712|NCT00166816|Kidney Transplantation|kidney transplantation
5785713|NCT00166816|Transplantation|transplantation
5785714|NCT00166803|Diabetes Mellitus, PPARγ agonist, FDG PET|diabetes mellitus, pparγ agonist, fdg pet
5785715|NCT00166790|Human Chorionic Gonadotropin|human chorionic gonadotropin
5785716|NCT00166790|Dual Polarization Interferometry,|dual polarization interferometry,
5785717|NCT00166790|Gestational Trophoblastic Neoplasms|gestational trophoblastic neoplasms
5785718|NCT00166764|Psychiatric Disorders|psychiatric disorders
5785719|NCT00166764|Evaluation of Mental Health Index|evaluation of mental health index
5785720|NCT00166751|Videofluoroscopic examination,|videofluoroscopic examination,
5785721|NCT00166751|ultrasound|ultrasound
5785722|NCT00166751|laryngeal elevation|laryngeal elevation
5785723|NCT00166751|dysphagia|dysphagia
5785724|NCT00166738|Schizophrenia|schizophrenia
5785725|NCT00166738|multiple genes|multiple genes
5785726|NCT00166738|array-comparative genomic hybridization (CGH)|array-comparative genomic hybridization (cgh)
5785727|NCT00166738|genomic DNA|genomic dna
5785728|NCT00166738|Chinese Han People|chinese han people
5785729|NCT00166725|HRPC|hrpc
5785730|NCT00166725|octreotide LAR|octreotide lar
5785732|NCT00166712|Kidney Transplant|kidney transplant
5795379|NCT00122902|HIV|hiv
5785733|NCT00166712|Living Donor Kidney Transplant Recipients|living donor kidney transplant recipients
5785734|NCT00166699|ultrasonography|ultrasonography
5785735|NCT00166699|obesity|obesity
5785736|NCT00166699|Cesarean Section|cesarean section
5785737|NCT00166699|Anesthesia|anesthesia
5785738|NCT00166699|Epidural|epidural
5785739|NCT00166686|Cancer|cancer
5785740|NCT00166686|Clonidine|clonidine
5785741|NCT00166686|Neurocognitive sequelae|neurocognitive sequelae
5785742|NCT00166673|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5785743|NCT00166673|Type 1 Diabetes|type 1 diabetes
5785744|NCT00166673|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5785745|NCT00166673|Electronic Data Collection|electronic data collection
5785746|NCT00166660|Preterm infants|preterm infants
5785747|NCT00166660|Developmental Care|developmental care
5785748|NCT00166660|NIDCAP|nidcap
5785749|NCT00166660|Fetal Growth Restriction|fetal growth restriction
5785750|NCT00166660|Neurobehavior|neurobehavior
5785751|NCT00166660|APIB|apib
5785753|NCT00166660|EEG|eeg
5785754|NCT00166660|Parent Stress|parent stress
5785756|NCT00166647|Chemotherapy|chemotherapy
5785757|NCT00166647|Hematological disorder|hematological disorder
5785758|NCT00166634|Hypertension|hypertension
5785759|NCT00166634|ABPM|abpm
5785760|NCT00166634|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5785761|NCT00166621|Autism|autism
5785762|NCT00166621|Neuroplasticity|neuroplasticity
5785763|NCT00166608|acetaminophen toxicity|acetaminophen toxicity
5785764|NCT00166608|liver damage|liver damage
5785765|NCT00166608|tylenol overdose|tylenol overdose
5785766|NCT00166595|Risperidone|risperidone
5785767|NCT00166595|Autism|autism
5785768|NCT00166595|Pervasive Developmental Disorder (PDD)|pervasive developmental disorder (pdd)
5785769|NCT00166582|pediatric asthma, medication adherence, adolescents|pediatric asthma, medication adherence, adolescents
5785770|NCT00166569|Polycystic Ovary Syndrome|polycystic ovary syndrome
5785771|NCT00166543|locally advanced breast carcinoma|locally advanced breast carcinoma
5785772|NCT00166543|locally recurrent inoperable breast carcinoma|locally recurrent inoperable breast carcinoma
5785773|NCT00166543|progressive metastatic breast carcinoma|progressive metastatic breast carcinoma
5785774|NCT00166517|Gastrointestinal Rotavirus|gastrointestinal rotavirus
5785775|NCT00166439|C04.557.386|c04.557.386
5785776|NCT00166387|Hemophilia|hemophilia
5785777|NCT00166387|Inhibitors|inhibitors
5785778|NCT00166361|Extrinsic ureteral obstruction|extrinsic ureteral obstruction
5785779|NCT00166361|Memokath 051 Ureteral Stent|memokath 051 ureteral stent
5785780|NCT00166361|JJ Stent|jj stent
5785781|NCT00166361|Stent|stent
5785782|NCT00166348|Cognitive Rehabilitation|cognitive rehabilitation
5785783|NCT00166322|IBZM-SPECT|ibzm-spect
5785784|NCT00166322|Amphetamine Challenge|amphetamine challenge
5785785|NCT00166322|Schizophrenia|schizophrenia
5785786|NCT00166322|dopaminergic neurotransmission|dopaminergic neurotransmission
5785787|NCT00166322|Persons at risk for the development of schizophrenia|persons at risk for the development of schizophrenia
5785788|NCT00166322|healthy subjects|healthy subjects
5785789|NCT00166309|Hemophilia A|hemophilia a
5785790|NCT00166309|Inhibitors|inhibitors
5785791|NCT00166296|Major depressive disorder, chemically induced.|major depressive disorder, chemically induced.
5785792|NCT00166296|Peginterferon alfa-2a.|peginterferon alfa-2a.
5785793|NCT00166296|Escitalopram.|escitalopram.
5786001|NCT00165347|Relapsed multiple myeloma|relapsed multiple myeloma
5785794|NCT00166296|Chronic hepatitis C, psychology.|chronic hepatitis c, psychology.
5785795|NCT00166296|Prophylactic treatment.|prophylactic treatment.
5785796|NCT00166283|memory|memory
5785797|NCT00166283|learning|learning
5785798|NCT00166283|Multiple Sclerosis|multiple sclerosis
5785799|NCT00166283|Cognition|cognition
5785800|NCT00166283|treatment|treatment
5785801|NCT00166283|therapy|therapy
5785802|NCT00166270|Fibroids|fibroids
5785803|NCT00166270|ExAblate|exablate
5785804|NCT00166270|MrgFus|mrgfus
5785805|NCT00166270|Uterine Fibroids|uterine fibroids
5785806|NCT00166257|Paradoxical embolism, Patent foramen ovale,|paradoxical embolism, patent foramen ovale,
5785807|NCT00166244|Mycophenolate mofetil|mycophenolate mofetil
5785808|NCT00166244|Therapeutic Drug Monitoring|therapeutic drug monitoring
5785809|NCT00166244|Adult kidney transplantation|adult kidney transplantation
5785810|NCT00166244|Paediatric kidney transplantation|paediatric kidney transplantation
5785811|NCT00166231|Innocent heart murmurs|innocent heart murmurs
5785812|NCT00166231|Chest pain|chest pain
5785813|NCT00166231|pediatric Cardiology|pediatric cardiology
5785814|NCT00166231|Somatization|somatization
5785815|NCT00166231|life stress|life stress
5785816|NCT00166218|pediatrics|pediatrics
5785817|NCT00166218|cardiac defects|cardiac defects
5785818|NCT00166205|Obesity, Morbid|obesity, morbid
5785819|NCT00166205|Obesity|obesity
5785820|NCT00166205|Body Weight|body weight
5785821|NCT00166192|Melasma|melasma
5785822|NCT00166192|Jessner's solution|jessner's solution
5785823|NCT00166192|Trichloroacetic acid (TCA)|trichloroacetic acid (tca)
5785825|NCT00166166|hyperlipidaemia|hyperlipidaemia
5785826|NCT00166166|EDHF|edhf
5785827|NCT00166166|FMD|fmd
5785828|NCT00166153|cardiac transplantation|cardiac transplantation
5785829|NCT00166153|pediatrics|pediatrics
5785830|NCT00166153|cardiology|cardiology
5785831|NCT00166153|drug metabolism|drug metabolism
5785832|NCT00166140|pediatrics|pediatrics
5785833|NCT00166140|cardiac|cardiac
5785834|NCT00166140|surgery|surgery
5785835|NCT00166127|heart failure|heart failure
5785836|NCT00166127|cardiac surgery|cardiac surgery
5785837|NCT00166127|pharmacokinetics|pharmacokinetics
5785838|NCT00166127|pharmacodynamics|pharmacodynamics
5785839|NCT00166114|platelet function|platelet function
5785840|NCT00166114|childhood abuse|childhood abuse
5785841|NCT00166114|depression|depression
5785842|NCT00166114|antidepressants|antidepressants
5785843|NCT00166114|immune function|immune function
5785844|NCT00166114|stress response|stress response
5785845|NCT00166101|pediatric|pediatric
5785846|NCT00166101|cardiac surgery|cardiac surgery
5785847|NCT00166088|Oxidative Stress|oxidative stress
5785848|NCT00166088|Diet, Mediterranean|diet, mediterranean
5785849|NCT00166075|Suicidality|suicidality
5785850|NCT00166075|PTSD|ptsd
5785851|NCT00166075|depression|depression
5780822|NCT00192777|Xeloda|xeloda
5785852|NCT00166062|intimate partner violence|intimate partner violence
5785853|NCT00166062|perpetration|perpetration
5686460|NCT00551993|laparoscopy|laparoscopy
5686461|NCT00551993|robot|robot
5686462|NCT00551993|vaginal prolapse|vaginal prolapse
5686463|NCT00551993|sacrocolpopexy|sacrocolpopexy
5686464|NCT00551993|sacral colpopexy|sacral colpopexy
5785018|NCT00169715|Tic|tic
5785854|NCT00166049|Heart failure|heart failure
5785855|NCT00166049|Family partnership|family partnership
5785856|NCT00166049|Patient family education|patient family education
5785857|NCT00166023|pediatric|pediatric
5785858|NCT00166023|cardiology|cardiology
5785859|NCT00166010|drug|drug
5785860|NCT00166010|pediatrics|pediatrics
5785861|NCT00166010|cardiac|cardiac
5785862|NCT00166010|Children with Cardiac Ventricular Failure|children with cardiac ventricular failure
5785863|NCT00165997|pediatrics|pediatrics
5785864|NCT00165997|cardiology|cardiology
5785865|NCT00165997|Radiofrequency ablation|radiofrequency ablation
5785866|NCT00165997|structurally normal heart|structurally normal heart
5785867|NCT00165984|cardiac|cardiac
5785868|NCT00165984|hypoplastic|hypoplastic
5785869|NCT00165984|pediatric|pediatric
5785870|NCT00165984|hypoplastic heart ventricle|hypoplastic heart ventricle
5785871|NCT00165971|Cognitive decline|cognitive decline
5785872|NCT00165971|Inflammation|inflammation
5785873|NCT00165971|Monitoring|monitoring
5785874|NCT00165971|Recovery|recovery
5785875|NCT00165971|Bispectral index|bispectral index
5785876|NCT00165958|Epidermal cyst|epidermal cyst
5785877|NCT00165958|Epidermoid cyst|epidermoid cyst
5785878|NCT00165958|Sebaceous cyst|sebaceous cyst
5785879|NCT00165958|Pilar cyst|pilar cyst
5785880|NCT00165945|pediatric, cardiology, diagnostic imaging using MRI|pediatric, cardiology, diagnostic imaging using mri
5785881|NCT00165932|tachycardia|tachycardia
5785882|NCT00165932|pediatrics|pediatrics
5785883|NCT00165919|Hepatitis C|hepatitis c
5785885|NCT00165919|Immunopathogenesis|immunopathogenesis
5785886|NCT00165919|HIV-1|hiv-1
5785887|NCT00165906|neonates|neonates
5785888|NCT00165906|cardiac|cardiac
5785889|NCT00165906|non-cardiac|non-cardiac
5785890|NCT00165906|surgery|surgery
5785891|NCT00165906|anticoagulation|anticoagulation
5785892|NCT00165893|low back pain|low back pain
5785893|NCT00165893|DDD|ddd
5785894|NCT00165841|non-erosive symptomatic GERD|non-erosive symptomatic gerd
5785895|NCT00165841|GERD|gerd
5785896|NCT00165828|Epilepsy|epilepsy
5785897|NCT00165802|Cancer|cancer
5785898|NCT00165802|malignant tumors|malignant tumors
5785899|NCT00165763|Vascular Dementia|vascular dementia
5785900|NCT00165737|Dementia cerebrovascular disease|dementia cerebrovascular disease
5785901|NCT00165698|Postmenopausal|postmenopausal
5785902|NCT00165698|osteoporosis|osteoporosis
5785903|NCT00165672|24-hour esophageal pH monitoring|24-hour esophageal ph monitoring
5785904|NCT00165672|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
5785905|NCT00165672|NERD|nerd
5785906|NCT00165672|proton pump inhibitor|proton pump inhibitor
5785907|NCT00165672|rabeprazole|rabeprazole
5785908|NCT00165646|non-erosive gastroesophageal reflux disease|non-erosive gastroesophageal reflux disease
5785909|NCT00165646|NERD|nerd
5785910|NCT00165646|proton pump inhibitor|proton pump inhibitor
5785911|NCT00165646|rabeprazole|rabeprazole
5785912|NCT00165633|Hepatocellular|hepatocellular
5785913|NCT00165633|Carcinoma|carcinoma
5785914|NCT00165633|Hepatitis C Virus|hepatitis c virus
5785915|NCT00165633|Hepatitis B Virus|hepatitis b virus
5785916|NCT00165633|recurrence|recurrence
5785917|NCT00165633|Vitamin K2|vitamin k2
5785918|NCT00165633|E0167|e0167
5785919|NCT00165594|gastric cancer|gastric cancer
5785920|NCT00165594|Phase I|phase i
5785921|NCT00165594|Phase IIa|phase iia
5785922|NCT00165594|E7070|e7070
5785923|NCT00165594|Indisulam|indisulam
5785924|NCT00165594|Pharmacogenomic|pharmacogenomic
5785925|NCT00165594|2C19|2c19
5785926|NCT00165581|Intracavitary brachytherapy|intracavitary brachytherapy
5785927|NCT00165581|radiation therapy|radiation therapy
5785929|NCT00165581|Stage II breast cancer|stage ii breast cancer
5785930|NCT00165568|Positron emission tomography|positron emission tomography
5785932|NCT00165568|bevacizumab|bevacizumab
5785933|NCT00165568|5fluorouracil|5fluorouracil
5785934|NCT00165568|Metastatic colorectal cancer|metastatic colorectal cancer
5785935|NCT00165555|cisplatin|cisplatin
5785936|NCT00165555|pleurectomy|pleurectomy
5785937|NCT00165555|decortication|decortication
5785938|NCT00165555|heated cisplatin|heated cisplatin
5785939|NCT00165542|A-protein level|a-protein level
5785940|NCT00165542|brain tumor|brain tumor
5785941|NCT00165516|Extrapleural pneumonectomy|extrapleural pneumonectomy
5785942|NCT00165516|cisplatin|cisplatin
5785943|NCT00165516|heated cisplatin|heated cisplatin
5785944|NCT00165503|pleurectomy|pleurectomy
5785945|NCT00165503|decortication|decortication
5785946|NCT00165503|cisplatin|cisplatin
5785947|NCT00165503|ALIMTA|alimta
5785948|NCT00165490|adenocarcinoma of esophagus|adenocarcinoma of esophagus
5686465|NCT00551980|Headache|headache
5686466|NCT00551980|Cervical Pain|cervical pain
5785949|NCT00165490|squamous cell carcinoma of esophagus|squamous cell carcinoma of esophagus
5785950|NCT00165490|combination chemotherapy|combination chemotherapy
5785951|NCT00165490|cisplatin|cisplatin
5785952|NCT00165490|irinotecan|irinotecan
5785953|NCT00165490|radiation therapy|radiation therapy
5785954|NCT00165490|resectable esophageal cancer|resectable esophageal cancer
5785955|NCT00165477|Glioblastoma|glioblastoma
5780922|NCT00190580|KVT|kvt
5785956|NCT00165477|Gliosarcoma|gliosarcoma
5785957|NCT00165477|Malignant Gliomas|malignant gliomas
5785958|NCT00165477|Radiation Therapy|radiation therapy
5785960|NCT00165477|Lenalidomide|lenalidomide
5785961|NCT00165464|Esophageal Cancer|esophageal cancer
5785962|NCT00165464|Gastric Cancer|gastric cancer
5785963|NCT00165464|GE Junction|ge junction
5785964|NCT00165464|Cisplatin|cisplatin
5785965|NCT00165464|Taxotere|taxotere
5785966|NCT00165464|CPT-11|cpt-11
5785967|NCT00165464|Irinotecan|irinotecan
5785968|NCT00165451|Relapsed tumors|relapsed tumors
5785969|NCT00165451|Progressive Poor Prognosis Tumors|progressive poor prognosis tumors
5785970|NCT00165451|Thalidomide|thalidomide
5785971|NCT00165451|Celecoxib|celecoxib
5785972|NCT00165451|Etoposide|etoposide
5785973|NCT00165451|Cyclophosphamide|cyclophosphamide
5785974|NCT00165438|Pulmonary function|pulmonary function
5785975|NCT00165438|Bleomycin-based chemotherapy|bleomycin-based chemotherapy
5785976|NCT00165438|mediastinal irradiation|mediastinal irradiation
5785977|NCT00165425|Cardiac screening|cardiac screening
5785978|NCT00165425|Cardiac stress test|cardiac stress test
5785979|NCT00165425|Echocardiogram|echocardiogram
5785980|NCT00165412|Breast screening|breast screening
5785981|NCT00165412|Breast MRI|breast mri
5785982|NCT00165412|Mammogram|mammogram
5785983|NCT00165412|Mammography|mammography
5785984|NCT00165399|Prostate cancer|prostate cancer
5785985|NCT00165399|PSA level|psa level
5785986|NCT00165399|docetaxel|docetaxel
5785987|NCT00165399|estramustine|estramustine
5785988|NCT00165399|hormone therapy|hormone therapy
5785989|NCT00165399|androgen withdrawal|androgen withdrawal
5785990|NCT00165386|MRI-guided bone marrow biopsy|mri-guided bone marrow biopsy
5785991|NCT00165373|pediatric solid tumors|pediatric solid tumors
5785992|NCT00165373|rhEndostatin|rhendostatin
5786401|NCT00163371|Pediatric|pediatric
5785993|NCT00165360|low-grade glioma|low-grade glioma
5785994|NCT00165360|astrocytoma|astrocytoma
5785995|NCT00165360|oligodendroglioma|oligodendroglioma
5785996|NCT00165360|oligoastrocytoma|oligoastrocytoma
5785997|NCT00165360|temozolomide|temozolomide
5785998|NCT00165360|mixed oligoastrocytoma|mixed oligoastrocytoma
5785999|NCT00165347|Multiple myeloma|multiple myeloma
5786002|NCT00165347|Refractory Multiple myeloma|refractory multiple myeloma
5786004|NCT00165334|Non-small cell lung cancer|non-small cell lung cancer
5786005|NCT00165334|Cetuximab|cetuximab
5786006|NCT00165334|Vinorelbine|vinorelbine
5786007|NCT00165334|Navelbine|navelbine
5786008|NCT00165334|Previously untreated lung cancer|previously untreated lung cancer
5786009|NCT00165308|Hodgkin's disease|hodgkin's disease
5786010|NCT00165308|breast cancer prevention|breast cancer prevention
5786011|NCT00165308|tamoxifen|tamoxifen
5786012|NCT00165295|sildenafil citrate|sildenafil citrate
5786013|NCT00165295|Viagra|viagra
5786014|NCT00165295|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5786015|NCT00165282|Meditation|meditation
5786016|NCT00165282|Mindfulness meditation|mindfulness meditation
5786017|NCT00165282|Bone Marrow Transplant|bone marrow transplant
5786018|NCT00165282|Stem Cell Transplant|stem cell transplant
5786019|NCT00165269|Hodgkin's Disease Stage IA-IIA|hodgkin's disease stage ia-iia
5786020|NCT00165269|mantle irradiation|mantle irradiation
5786021|NCT00165256|Ductal carcinoma in situ|ductal carcinoma in situ
5786022|NCT00165256|DCIS|dcis
5786023|NCT00165256|wide excision|wide excision
5786024|NCT00165243|Axillary Dissection|axillary dissection
5786025|NCT00165243|Tangential Radiation|tangential radiation
5786026|NCT00165243|Breast Cancer|breast cancer
5786027|NCT00165230|thalidomide|thalidomide
5786028|NCT00165230|temodar|temodar
5786029|NCT00165230|metastatic neuroendocrine tumor|metastatic neuroendocrine tumor
5786030|NCT00165230|unresectable neuroendocrine tumor|unresectable neuroendocrine tumor
5786031|NCT00165217|capecitabine|capecitabine
5786032|NCT00165217|thalidomide|thalidomide
5786033|NCT00165217|colorectal cancer|colorectal cancer
5786034|NCT00165204|Tibolone|tibolone
5786035|NCT00165204|High risk women|high risk women
5786036|NCT00165204|Oophorectomy|oophorectomy
5786037|NCT00165204|Breast Density|breast density
5786039|NCT00165191|doxorubicin|doxorubicin
5786040|NCT00165191|cisplatin|cisplatin
5786041|NCT00165191|5-fluorouracil|5-fluorouracil
5786042|NCT00165191|stomach cancer|stomach cancer
5786043|NCT00165191|esophagus cancer|esophagus cancer
5786044|NCT00165178|Acute lymphoblastic leukemia in children|acute lymphoblastic leukemia in children
5786045|NCT00165178|High Risk ALL|high risk all
5786046|NCT00165178|Standard Risk ALL|standard risk all
5786047|NCT00165178|E. coli asparaginase|e. coli asparaginase
5794795|NCT00125424|AQUAVAN|aquavan
5786048|NCT00165152|Genetic testing|genetic testing
5786049|NCT00165152|BRCA1 gene|brca1 gene
5786050|NCT00165152|BRCA2 gene|brca2 gene
5786051|NCT00165152|Counseling interventions|counseling interventions
5786052|NCT00165152|Genetic counseling|genetic counseling
5786053|NCT00165139|Stem cell transplant|stem cell transplant
5786054|NCT00165139|High-risk pediatric tumors|high-risk pediatric tumors
5786055|NCT00165126|dosimetric analysis|dosimetric analysis
5786056|NCT00165126|vaginal cuff brachytherapy|vaginal cuff brachytherapy
5786057|NCT00165100|DAT|dat
5781022|NCT00190281|PERFUSION|perfusion
5786058|NCT00165100|imaging modality|imaging modality
5786059|NCT00165087|childhood ALL|childhood all
5786060|NCT00165087|standard risk|standard risk
5786061|NCT00165087|high risk|high risk
5786062|NCT00165087|infant/high risk|infant/high risk
5786063|NCT00165074|Prematurity|prematurity
5786064|NCT00165074|Lung Disease|lung disease
5786065|NCT00165074|Hyaline Membrane|hyaline membrane
5786066|NCT00165074|Surfactant|surfactant
5786067|NCT00165035|Percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5786068|NCT00165035|Drug eluting stent (DES)|drug eluting stent (des)
5786069|NCT00165009|Bleeding Peptic Ulcer|bleeding peptic ulcer
5786070|NCT00165009|Endoscopic treatment|endoscopic treatment
5786071|NCT00164996|upper endoscopy|upper endoscopy
5786072|NCT00164996|local pharyngeal anaesthesia|local pharyngeal anaesthesia
5786073|NCT00164996|ultrathin endoscope|ultrathin endoscope
5786074|NCT00164944|Colonoscopy|colonoscopy
5786075|NCT00164944|First degree relatives|first degree relatives
5786076|NCT00164931|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5786077|NCT00164931|Omeprazole|omeprazole
5786078|NCT00164931|Scheduled second endoscopy|scheduled second endoscopy
5786079|NCT00164905|Peptic ulcer hemorrhage|peptic ulcer hemorrhage
5786080|NCT00164905|Doppler ultrasound|doppler ultrasound
5786081|NCT00164879|Obstructing|obstructing
5786082|NCT00164879|Left-sided|left-sided
5786083|NCT00164879|Colorectal neoplasms|colorectal neoplasms
5786084|NCT00164879|Obstructing left-sided colorectal cancers|obstructing left-sided colorectal cancers
5786085|NCT00164866|Peptic ulcer|peptic ulcer
5786086|NCT00164866|IVPPI prior endoscopy|ivppi prior endoscopy
5786088|NCT00164788|24 hours pH monitoring|24 hours ph monitoring
5786089|NCT00164775|Functional dyspepsia, refractory, antidepressant|functional dyspepsia, refractory, antidepressant
5786090|NCT00164762|HIV|hiv
5786091|NCT00164762|drug resistance|drug resistance
5786092|NCT00164762|nevirapine|nevirapine
5786093|NCT00164762|anti-retroviral drugs|anti-retroviral drugs
5786094|NCT00164762|mother-to-child transmission|mother-to-child transmission
5786095|NCT00164762|Treatment Naive|treatment naive
5786096|NCT00164762|pregnancy|pregnancy
5786097|NCT00164749|dementia|dementia
5786098|NCT00164749|cognition|cognition
5786099|NCT00164749|memory|memory
5786100|NCT00164749|neurodegenerative disease|neurodegenerative disease
5786101|NCT00164749|brain|brain
5786102|NCT00164736|HIV|hiv
5786103|NCT00164736|Clinical trial|clinical trial
5786104|NCT00164736|breastfeeding|breastfeeding
5786105|NCT00164736|mother-to-child-transmission|mother-to-child-transmission
5786106|NCT00164736|nutrition|nutrition
5786107|NCT00164736|HIV Seronegativity|hiv seronegativity
5786108|NCT00164723|Capsule Endoscopy|capsule endoscopy
5786109|NCT00164710|antimalarials|antimalarials
5786110|NCT00164697|Child Development|child development
5786111|NCT00164697|Parenting|parenting
5786112|NCT00164697|Child Rearing|child rearing
5786113|NCT00164697|Parent-Child Relations|parent-child relations
5786114|NCT00164684|batterers|batterers
5786115|NCT00164684|prevention|prevention
5786116|NCT00164684|African American|african american
5786117|NCT00164684|Latino|latino
5786118|NCT00164671|Male condoms|male condoms
5786119|NCT00164671|Female condoms|female condoms
5786120|NCT00164671|Self-efficacy|self-efficacy
5786121|NCT00164658|family history|family history
5786122|NCT00164658|familial risk|familial risk
5786123|NCT00164658|behavior change|behavior change
5786124|NCT00164645|Emotional outcomes|emotional outcomes
5786125|NCT00164645|health outcomes|health outcomes
5786126|NCT00164645|traumatic brain injury|traumatic brain injury
5786127|NCT00164645|caregiving|caregiving
5786128|NCT00164619|controlled clinical trial|controlled clinical trial
5786129|NCT00164619|behavioral intervention|behavioral intervention
5786130|NCT00164619|prevention intervention|prevention intervention
5786132|NCT00164606|child abuse|child abuse
5786133|NCT00164606|prevention|prevention
5786134|NCT00164593|Youth Violence|youth violence
5786135|NCT00164593|Prevention|prevention
5786136|NCT00164580|Homosexuality, Male|homosexuality, male
5786137|NCT00164580|Adolescents|adolescents
5786138|NCT00164580|Minority Groups|minority groups
5786140|NCT00164580|Community Surveys|community surveys
5786141|NCT00164580|HIV Seronegativity|hiv seronegativity
5786142|NCT00164580|HIV|hiv
5786143|NCT00164567|partner abuse|partner abuse
5786144|NCT00164567|screening|screening
5786145|NCT00164567|intimate partner violence|intimate partner violence
5786146|NCT00164554|treatment|treatment
5786147|NCT00164554|control|control
5786148|NCT00164541|dating violence|dating violence
5681114|NCT00574639|Alprazolam|alprazolam
5786149|NCT00164541|violence against women|violence against women
5786150|NCT00164515|obesity, mobility limitations, women, physical activity|obesity, mobility limitations, women, physical activity
5786151|NCT00164463|tuberculosis|tuberculosis
5786152|NCT00164463|TB|tb
5786153|NCT00164450|tuberculosis|tuberculosis
5786154|NCT00164450|TB|tb
5786155|NCT00164450|pharmacokinetics|pharmacokinetics
5786156|NCT00164450|children|children
5786157|NCT00164437|screening|screening
5786158|NCT00164437|community healt education|community healt education
5786159|NCT00164437|decision making|decision making
5786160|NCT00164437|computer-assisted decision making|computer-assisted decision making
5786161|NCT00164424|HSV2|hsv2
5786162|NCT00164424|genital ulcer|genital ulcer
5786163|NCT00164424|HIV|hiv
5786164|NCT00164424|South Africa|south africa
5786165|NCT00164424|Treatment|treatment
5786166|NCT00164424|Acyclovir|acyclovir
5786167|NCT00164424|Prevention|prevention
5786168|NCT00164411|Diptheria-Tetanus vaccine|diptheria-tetanus vaccine
5786169|NCT00164411|Pneumococcal vaccine|pneumococcal vaccine
5786170|NCT00164411|Adverse events following vaccination|adverse events following vaccination
5786171|NCT00164411|Immunization|immunization
5786172|NCT00164411|Immunogenicity|immunogenicity
5786173|NCT00164398|HIV|hiv
5786174|NCT00164385|HIV/AIDS|hiv/aids
5786175|NCT00164372|IV Drug users|iv drug users
5786176|NCT00164372|HIV|hiv
5786177|NCT00164372|hepatitis C virus|hepatitis c virus
5786178|NCT00164372|HIV Seronegativity|hiv seronegativity
5786179|NCT00164359|malaria, falciparum|malaria, falciparum
5786180|NCT00164359|antimalarials|antimalarials
5786181|NCT00164346|fetal alcohol syndrome (FAS)|fetal alcohol syndrome (fas)
5786182|NCT00164346|alcohol-related neurodevelopmental disorder (ARND)|alcohol-related neurodevelopmental disorder (arnd)
5786183|NCT00164281|TB|tb
5786184|NCT00164281|Tuberculosis|tuberculosis
5786185|NCT00164281|INH|inh
5786186|NCT00164281|Isoniazid|isoniazid
5786187|NCT00164281|Preventive therapy|preventive therapy
5786188|NCT00164281|HIV|hiv
5786189|NCT00164281|AIDS|aids
5786190|NCT00164281|Botswana|botswana
5786191|NCT00164281|LTBI|ltbi
5786192|NCT00164281|Latent TB Infection|latent tb infection
5786193|NCT00164268|Intimate partner violence|intimate partner violence
5786194|NCT00164268|Sexual violence|sexual violence
5787167|NCT00160056|Diabetes|diabetes
5786195|NCT00164268|Cultural intervention|cultural intervention
5786196|NCT00164268|Native Hawaiian|native hawaiian
5786197|NCT00164255|malaria|malaria
5786198|NCT00164255|birthweight|birthweight
5786199|NCT00164255|placental malaria|placental malaria
5786200|NCT00164255|intermittent protective treatment|intermittent protective treatment
5786201|NCT00164255|sulfadoxine/ pyrimethamine|sulfadoxine/ pyrimethamine
5786202|NCT00164255|artesuate|artesuate
5786203|NCT00164255|combination therapy|combination therapy
5786204|NCT00164255|Pregnancy|pregnancy
5786205|NCT00164242|Tardive dyskinesia|tardive dyskinesia
5786206|NCT00164242|Galantamine|galantamine
5786207|NCT00164242|Cholinesterase inhibitors|cholinesterase inhibitors
5786208|NCT00164229|treatment|treatment
5786210|NCT00164216|malaria|malaria
5786211|NCT00164216|combination therapy|combination therapy
5786212|NCT00164216|mefloquine|mefloquine
5786213|NCT00164216|artesunate|artesunate
5786214|NCT00164216|Peru|peru
5786215|NCT00164216|malaria, uncomplicated|malaria, uncomplicated
5786216|NCT00164190|Myocardial Infarction|myocardial infarction
5786217|NCT00164190|Thrombolysis|thrombolysis
5786218|NCT00164190|Angioplasty|angioplasty
5786219|NCT00164190|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5786220|NCT00164177|virtual colonoscopy|virtual colonoscopy
5786221|NCT00164177|colonoscopy preparation|colonoscopy preparation
5786222|NCT00164177|bowel prep|bowel prep
5786223|NCT00164164|colonoscopy preparation|colonoscopy preparation
5786224|NCT00164164|prep|prep
5786225|NCT00164151|colonoscopy preparation|colonoscopy preparation
5786226|NCT00164151|prep|prep
5786227|NCT00164138|Incontinence|incontinence
5786228|NCT00164138|physiotherapy|physiotherapy
5786229|NCT00164138|treatment|treatment
5786230|NCT00164138|pelvic floor muscle function|pelvic floor muscle function
5786231|NCT00164138|coughing|coughing
5786232|NCT00164138|forced expirations|forced expirations
5786233|NCT00164138|lung disease|lung disease
5786234|NCT00164112|Cooperstown Cocktail|cooperstown cocktail
5786235|NCT00164112|Drug Metabolizing Enzymes|drug metabolizing enzymes
5786236|NCT00164112|Drug Interactions|drug interactions
5786237|NCT00164112|Phenotyping|phenotyping
5786238|NCT00164099|Coronary Artery Bypass|coronary artery bypass
5786239|NCT00164099|Postoperative Complications|postoperative complications
5786240|NCT00164099|Probiotics|probiotics
5786241|NCT00164099|Surgical Wound infection|surgical wound infection
5786242|NCT00164099|cystitis|cystitis
5786243|NCT00164099|bacteremia|bacteremia
5786244|NCT00164099|pneumonia|pneumonia
5786245|NCT00164099|Enterocolitis, Pseudomembranous|enterocolitis, pseudomembranous
5786246|NCT00164073|HCV and microarray|hcv and microarray
5786247|NCT00164073|HCV|hcv
5786248|NCT00164060|HCV|hcv
5786249|NCT00164060|HIV co-infection|hiv co-infection
5786250|NCT00164047|Nitrous Oxide|nitrous oxide
5786251|NCT00164047|Anaesthesia|anaesthesia
5786252|NCT00164047|Anesthesia|anesthesia
5786253|NCT00164047|Recovery|recovery
5786254|NCT00164047|Quality|quality
5786255|NCT00164034|Trauma|trauma
5786256|NCT00164034|Wounds|wounds
5786257|NCT00164034|Injuries|injuries
5786258|NCT00164021|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication|gastroesophageal reflux, gastric reflux, acid reflux, lung transplantation, physiotherapy, anti-reflux medication
5786259|NCT00163995|Chronic Liver Disease|chronic liver disease
5786260|NCT00163982|HVPG > 12 mmHg|hvpg > 12 mmhg
5786261|NCT00163969|Pain|pain
5786262|NCT00163969|Wind-up|wind-up
5786263|NCT00163969|opioid|opioid
5786264|NCT00163969|ketamine|ketamine
5786265|NCT00163969|pre-emptive|pre-emptive
5786266|NCT00163956|IVC filters|ivc filters
5786267|NCT00163956|failed retrieval|failed retrieval
5786268|NCT00163943|Metabolic syndrome|metabolic syndrome
5786269|NCT00163943|Sympathetic nervous system activity|sympathetic nervous system activity
5786270|NCT00163943|Insulin sensitivity|insulin sensitivity
5786271|NCT00163943|weight loss|weight loss
5786272|NCT00163943|aerobic exercise|aerobic exercise
5786273|NCT00163930|Uterine Fibroids|uterine fibroids
5786274|NCT00163930|embolisation|embolisation
5786275|NCT00163930|pain management|pain management
5786276|NCT00163917|Hypnosis|hypnosis
5786277|NCT00163917|Analgesia|analgesia
5786278|NCT00163904|Heart Failure|heart failure
5786279|NCT00163904|Inflammatory mediators|inflammatory mediators
5786280|NCT00163904|insulin sensitivity|insulin sensitivity
5786281|NCT00163904|overweight|overweight
5786282|NCT00163904|high monounsaturated diet|high monounsaturated diet
5786283|NCT00163891|Respiratory Therapy|respiratory therapy
5786284|NCT00163891|Postoperative Care|postoperative care
5786285|NCT00163891|Treatment Outcome|treatment outcome
5786286|NCT00163878|Sensory Stimulation Programs|sensory stimulation programs
5786287|NCT00163865|Boredom|boredom
5786288|NCT00163865|Adolescent|adolescent
5786289|NCT00163865|Mental illness|mental illness
5786290|NCT00163865|Depression|depression
5786291|NCT00163865|Anxiety|anxiety
5786292|NCT00163852|Cystic fibrosis|cystic fibrosis
5786293|NCT00163852|Metabolic alkalosis|metabolic alkalosis
5786294|NCT00163852|Hypercapnia|hypercapnia
5786295|NCT00163852|Salt replacement|salt replacement
5786296|NCT00163839|Dietary Intervention|dietary intervention
5787271|NCT00159341|nasal|nasal
5786297|NCT00163839|Pseudoallergen free diet|pseudoallergen free diet
5786298|NCT00163826|cervical spine injury|cervical spine injury
5786299|NCT00163826|multiple trauma|multiple trauma
5786300|NCT00163813|Mechanically-ventilated|mechanically-ventilated
5786301|NCT00163813|medical-surgical critically ill patients|medical-surgical critically ill patients
5786302|NCT00163813|reduced gastric motility|reduced gastric motility
5786303|NCT00163800|Outcome predictors|outcome predictors
5786304|NCT00163800|Acute brain injury|acute brain injury
5786305|NCT00163787|mobility|mobility
5786306|NCT00163787|falls|falls
5786307|NCT00163787|activity level|activity level
5786308|NCT00163761|Lymphoma|lymphoma
5786309|NCT00163748|Lymphoma|lymphoma
5786310|NCT00163735|Food allergy|food allergy
5786311|NCT00163735|wine|wine
5786312|NCT00163735|milk allergy|milk allergy
5786313|NCT00163735|egg allergy|egg allergy
5786314|NCT00163735|nut allergy|nut allergy
5786315|NCT00163735|fish allergy|fish allergy
5786316|NCT00163709|Atrial natriuretic factor.|atrial natriuretic factor.
5786317|NCT00163709|Biochemistry.|biochemistry.
5786318|NCT00163709|Cardiac failure.|cardiac failure.
5786319|NCT00163709|Randomised trials.|randomised trials.
5786320|NCT00163709|Hormones.|hormones.
5786321|NCT00163709|Systolic heart failure.|systolic heart failure.
5786322|NCT00163709|Diastolic heart failure.|diastolic heart failure.
5786323|NCT00163709|Ischaemic cardiomyopathy.|ischaemic cardiomyopathy.
5786324|NCT00163709|Ventricular hypertrophy.|ventricular hypertrophy.
5786326|NCT00163696|MBNW|mbnw
5786327|NCT00163696|Ventilation|ventilation
5786328|NCT00163696|small airways|small airways
5786329|NCT00163696|Lung Transplant recipients (Bronchiolitis Obliterans syndrome)|lung transplant recipients (bronchiolitis obliterans syndrome)
5786330|NCT00163683|Dietary Intervention|dietary intervention
5786331|NCT00163657|Hepatitis C Virus|hepatitis c virus
5786332|NCT00163657|Immunosuppressive Agents|immunosuppressive agents
5786333|NCT00163644|Hematological malignancies.|hematological malignancies.
5786334|NCT00163644|Bone- marrow/ haemopoetic transplant|bone- marrow/ haemopoetic transplant
5786335|NCT00163644|Exercise|exercise
5786336|NCT00163618|tick-borne encephalitis|tick-borne encephalitis
5786337|NCT00163605|Sinus augmentation|sinus augmentation
5786338|NCT00163605|Alloplastic bone substitute|alloplastic bone substitute
5786339|NCT00163605|Hydroxyl apatite|hydroxyl apatite
5786340|NCT00163592|Vascular reconstruction|vascular reconstruction
5786341|NCT00163592|Polytetraflouroethylene (PTFE) prosthesis|polytetraflouroethylene (ptfe) prosthesis
5786343|NCT00163579|cerclage|cerclage
5786344|NCT00163579|tocolysis|tocolysis
5786345|NCT00163579|drug therapy|drug therapy
5786346|NCT00163566|libido|libido
5786347|NCT00163566|depression strength|depression strength
5786348|NCT00163566|testosterone|testosterone
5775758|NCT00218712|MSM|msm
5786349|NCT00163566|dihydrotestosterone|dihydrotestosterone
5786350|NCT00163553|spinal surgery|spinal surgery
5786351|NCT00163553|pethidine|pethidine
5786352|NCT00163553|analgesia|analgesia
5786353|NCT00163540|tick-borne encephalitis|tick-borne encephalitis
5786354|NCT00163527|Asthma|asthma
5786355|NCT00163527|Roflumilast|roflumilast
5786356|NCT00163527|Corticosteroids|corticosteroids
5786357|NCT00163514|Allergy|allergy
5786358|NCT00163514|Perennial Allergic Rhinitis|perennial allergic rhinitis
5786359|NCT00163514|Allergic Rhinitis|allergic rhinitis
5786360|NCT00163514|Hay Fever|hay fever
5786361|NCT00163501|Allergy|allergy
5786362|NCT00163501|Perennial Allergic Rhinitis|perennial allergic rhinitis
5786363|NCT00163501|Allergic Rhinitis|allergic rhinitis
5786364|NCT00163501|Hay Fever|hay fever
5786365|NCT00163488|Allergy|allergy
5786366|NCT00163488|Perennial Allergic Rhinitis|perennial allergic rhinitis
5786367|NCT00163488|Allergic Rhinitis|allergic rhinitis
5786368|NCT00163488|Hay Fever|hay fever
5786369|NCT00163475|Asthma|asthma
5786370|NCT00163475|Roflumilast|roflumilast
5786371|NCT00163462|Asthma|asthma
5786372|NCT00163462|Ciclesonide|ciclesonide
5786373|NCT00163462|Child|child
5786374|NCT00163462|Fluticasone propionate|fluticasone propionate
5786375|NCT00163462|Pediatric|pediatric
5786376|NCT00163449|Asthma|asthma
5786377|NCT00163449|Ciclesonide|ciclesonide
5786378|NCT00163449|Child|child
5786379|NCT00163449|Pediatric|pediatric
5786380|NCT00163436|Asthma|asthma
5786381|NCT00163436|Ciclesonide|ciclesonide
5786382|NCT00163423|Asthma|asthma
5786383|NCT00163423|Ciclesonide|ciclesonide
5786384|NCT00163423|Fluticasone propionate|fluticasone propionate
5786385|NCT00163410|Asthma|asthma
5786386|NCT00163410|Ciclesonide|ciclesonide
5786387|NCT00163410|Child|child
5786388|NCT00163410|Fluticasone propionate|fluticasone propionate
5786389|NCT00163410|Pediatric|pediatric
5786390|NCT00163397|Asthma|asthma
5786391|NCT00163397|Ciclesonide|ciclesonide
5786392|NCT00163397|Budesonide|budesonide
5786393|NCT00163384|Asthma|asthma
5786394|NCT00163384|Ciclesonide|ciclesonide
5786395|NCT00163384|Budesonide|budesonide
5786396|NCT00163371|Asthma|asthma
5786397|NCT00163371|Ciclesonide|ciclesonide
5786398|NCT00163371|Child|child
5786399|NCT00163371|Fluticasone propionate|fluticasone propionate
5786400|NCT00163371|HPA-axis|hpa-axis
5786402|NCT00163371|Linear growth rate|linear growth rate
5786403|NCT00163358|Asthma|asthma
5786404|NCT00163358|Ciclesonide|ciclesonide
5786405|NCT00163358|Fluticasone propionate|fluticasone propionate
5786406|NCT00163358|Salmeterol|salmeterol
5786407|NCT00163345|Asthma|asthma
5786408|NCT00163345|Ciclesonide|ciclesonide
5786409|NCT00163345|Small Airways|small airways
5786410|NCT00163332|Asthma|asthma
5786411|NCT00163332|Ciclesonide|ciclesonide
5786509|NCT00162734|Alpha|alpha
5786412|NCT00163332|Fluticasone propionate|fluticasone propionate
5786413|NCT00163319|Asthma|asthma
5786414|NCT00163319|Ciclesonide|ciclesonide
5786415|NCT00163319|Fluticasone propionate|fluticasone propionate
5786416|NCT00163306|Gastroesophageal Reflux|gastroesophageal reflux
5786417|NCT00163306|Gastroesophageal Reflux Disease|gastroesophageal reflux disease
5786418|NCT00163306|Pantoprazole|pantoprazole
5786419|NCT00163293|Asthma|asthma
5786420|NCT00163293|Ciclesonide|ciclesonide
5786421|NCT00163293|Exacerbation|exacerbation
5786422|NCT00163280|Mucositis|mucositis
5786423|NCT00163280|Peripheral blood stem cell transplant|peripheral blood stem cell transplant
5786424|NCT00163267|peripheral arterial intervention|peripheral arterial intervention
5786425|NCT00163267|atherosclerosis|atherosclerosis
5786426|NCT00163267|platelets|platelets
5786427|NCT00163267|Age above 18|age above 18
5786428|NCT00163254|Chronic limb ischemia|chronic limb ischemia
5786429|NCT00163254|Intervention|intervention
5786430|NCT00163254|Restenosis|restenosis
5786431|NCT00163254|Patients above 18 years|patients above 18 years
5786432|NCT00163228|C05.550.114.606.500|c05.550.114.606.500
5786433|NCT00163228|C05.550.114.606.508|c05.550.114.606.508
5786434|NCT00163176|cell proliferation|cell proliferation
5786435|NCT00163176|PET|pet
5786436|NCT00163176|radiotherapy|radiotherapy
5786437|NCT00163124|chiropractic|chiropractic
5786438|NCT00163124|spinal manipulation|spinal manipulation
5786439|NCT00163124|low back pain|low back pain
5786440|NCT00163072|transdermal|transdermal
5786441|NCT00163072|Megace|megace
5786442|NCT00163072|pharmacokinetics|pharmacokinetics
5786443|NCT00163033|phase I study|phase i study
5786444|NCT00163020|Preterm Birth|preterm birth
5786445|NCT00163020|Preterm Delivery|preterm delivery
5786446|NCT00163020|Multiple gestation|multiple gestation
5786447|NCT00163020|17-alpha-hydroxyprogesterone caproate|17-alpha-hydroxyprogesterone caproate
5786448|NCT00163020|Progesterone|progesterone
5786449|NCT00162994|recurrent otitis media|recurrent otitis media
5786450|NCT00162994|adenoidectomy|adenoidectomy
5786451|NCT00162994|tympanostomy|tympanostomy
5786452|NCT00162994|young children|young children
5786454|NCT00162994|quality of life|quality of life
5786455|NCT00162968|polyneuropathies|polyneuropathies
5786456|NCT00162968|pain|pain
5686467|NCT00551980|Cognitive treatment|cognitive treatment
5686468|NCT00551980|Relaxation|relaxation
5686469|NCT00551980|Exercise|exercise
5686470|NCT00551967|clinical outcomes|clinical outcomes
5686471|NCT00551967|radiographic outcomes|radiographic outcomes
5686472|NCT00551967|total hip arthroplasty|total hip arthroplasty
5686473|NCT00551967|survivorship|survivorship
5786457|NCT00162968|drug effects|drug effects
5786458|NCT00162968|escitalopram|escitalopram
5786459|NCT00162968|serotonin uptake inhibitors|serotonin uptake inhibitors
5786460|NCT00162955|untreated adult Non-Hodgkin's Lymphoma|untreated adult non-hodgkin's lymphoma
5786461|NCT00162955|CHOP protocol|chop protocol
5786462|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5786463|NCT00162955|Cardiomyopathy|cardiomyopathy
5786464|NCT00162942|Crohn's Disease|crohn's disease
5786465|NCT00162929|metastatic breast cancer|metastatic breast cancer
5786466|NCT00162929|locally recurrent breast cancer|locally recurrent breast cancer
5786467|NCT00162916|Traumatic Brain Injury|traumatic brain injury
5786468|NCT00162916|Depression|depression
5786469|NCT00162916|Antidepressant medication|antidepressant medication
5786470|NCT00162916|Double-Blind Study|double-blind study
5781420|NCT00188279|ct|ct
5786471|NCT00162916|Brain Injuries|brain injuries
5786472|NCT00162916|Antidepressive Agents|antidepressive agents
5786474|NCT00162916|Double-Blind Method|double-blind method
5786475|NCT00162903|Preterm infant, Patent ductus arteriosus, Nitric oxide,Endothelin-1|preterm infant, patent ductus arteriosus, nitric oxide,endothelin-1
5786476|NCT00162890|degenerated cervical spine|degenerated cervical spine
5786477|NCT00162890|assessment|assessment
5786478|NCT00162890|physical therapy|physical therapy
5786479|NCT00162877|rabeprazole, omeprazole, CYP2C19, H. pylori, PK/PD|rabeprazole, omeprazole, cyp2c19, h. pylori, pk/pd
5786481|NCT00162864|COPD|copd
5786482|NCT00162864|montelukast sodium|montelukast sodium
5786483|NCT00162864|leukotriene modifier|leukotriene modifier
5786484|NCT00162864|older adults|older adults
5786485|NCT00162825|Psoriasis, T cell, inflammation, CD7, cytokine|psoriasis, t cell, inflammation, cd7, cytokine
5786486|NCT00162812|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5786487|NCT00162812|early breast cancer|early breast cancer
5786488|NCT00162812|inflammatory breast cancer|inflammatory breast cancer
5786489|NCT00162799|insulin resistance and inflamation|insulin resistance and inflamation
5786490|NCT00162799|insulin sensitibity|insulin sensitibity
5786491|NCT00162799|obesity-induced insuline resistence|obesity-induced insuline resistence
5786492|NCT00162799|obesity-diabetes link|obesity-diabetes link
5786493|NCT00162799|salicylate|salicylate
5786494|NCT00162799|insulin resistance in obesity health adults|insulin resistance in obesity health adults
5786495|NCT00162786|Driving performance|driving performance
5786496|NCT00162786|Antihistamine|antihistamine
5786497|NCT00162773|asthma|asthma
5786498|NCT00162747|Pre-term infants|pre-term infants
5786499|NCT00162747|skin infections|skin infections
5786500|NCT00162747|infant skin|infant skin
5786501|NCT00162747|Aquaphor|aquaphor
5786502|NCT00162747|sunflower seed oil|sunflower seed oil
5786503|NCT00162747|nutrition|nutrition
5786504|NCT00162747|skin care|skin care
5786505|NCT00162734|Chronic Hepatitis C|chronic hepatitis c
5786506|NCT00162734|Liver|liver
5786507|NCT00162734|Pegylated|pegylated
5786508|NCT00162734|Interferon|interferon
5786512|NCT00162734|Nonresponder|nonresponder
5786514|NCT00162734|Infergen|infergen
5786515|NCT00162734|SVR|svr
5786516|NCT00162721|Uterine sarcoma non metastatic|uterine sarcoma non metastatic
5786517|NCT00162708|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5786518|NCT00162708|Radiotherapy|radiotherapy
5786519|NCT00162708|Chemotherapy|chemotherapy
5786520|NCT00162682|HIV|hiv
5786521|NCT00162682|Highly Active Antiretroviral Therapy|highly active antiretroviral therapy
5786522|NCT00162682|Monitoring|monitoring
5786523|NCT00162682|Viral load|viral load
5786524|NCT00162682|CD4|cd4
5786525|NCT00162682|Thailand|thailand
5786526|NCT00162682|Future Drug Options|future drug options
5786527|NCT00162682|Resistance|resistance
5786528|NCT00162682|Developing Country|developing country
5786529|NCT00162682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5786530|NCT00162669|Hepatocellular carcinoma, advanced, bevacizumab, phase II, VGEF, neovascularization|hepatocellular carcinoma, advanced, bevacizumab, phase ii, vgef, neovascularization
5786531|NCT00162656|B-Cell Lymphoma|b-cell lymphoma
5786532|NCT00162643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5786533|NCT00162643|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5786534|NCT00162643|Protease Inhibitors|protease inhibitors
5786535|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5786536|NCT00162630|Hip fracture, pain, regional anaesthesia, analgesia|hip fracture, pain, regional anaesthesia, analgesia
5786537|NCT00162617|Hip fracture|hip fracture
5786538|NCT00162617|Rehabilitation|rehabilitation
5786539|NCT00162617|Transfusion|transfusion
5786540|NCT00162617|Outcome|outcome
5786541|NCT00162604|Prophylactic antibiotic|prophylactic antibiotic
5786542|NCT00162604|Postoperative infections|postoperative infections
5786543|NCT00162604|Uterine prolapse grade I - II|uterine prolapse grade i - ii
5786544|NCT00162604|cystocele|cystocele
5786545|NCT00162604|rectocele|rectocele
5786546|NCT00162604|enterocele|enterocele
5786547|NCT00162604|defects of the perineal body|defects of the perineal body
5786548|NCT00162591|Bispectral index|bispectral index
5786549|NCT00162591|sedation|sedation
5786550|NCT00162591|remifentanyl|remifentanyl
5786551|NCT00162591|Bronchoalveolar lavage|bronchoalveolar lavage
5786552|NCT00162591|Intensive care|intensive care
5786553|NCT00162591|Nociceptive stimuli|nociceptive stimuli
5786554|NCT00162591|Sedated patient|sedated patient
5786555|NCT00162591|BIS variation|bis variation
5786556|NCT00162578|pneumococcal meningitis|pneumococcal meningitis
5786557|NCT00162578|intensive care unit|intensive care unit
5786558|NCT00162578|vancomycin|vancomycin
5786559|NCT00162578|dexamethasone|dexamethasone
5786560|NCT00162578|drug diffusion in cerebrospinal fluid|drug diffusion in cerebrospinal fluid
5786561|NCT00162565|Heart Failure, Congestive|heart failure, congestive
5786562|NCT00162565|beta-Adrenergic Blockers|beta-adrenergic blockers
5786563|NCT00162552|multicenter-randomized-trial|multicenter-randomized-trial
5786564|NCT00162552|pentoxifyllinE|pentoxifylline
5786565|NCT00162552|placebo|placebo
5786566|NCT00162552|cirrhosis|cirrhosis
5781521|NCT00187824|immune|immune
5786567|NCT00162552|liver failure|liver failure
5786568|NCT00162552|cytokine|cytokine
5786569|NCT00162539|foetal thyroid mensuration|foetal thyroid mensuration
5786570|NCT00162500|Metastatic solid tumors|metastatic solid tumors
5786571|NCT00162474|Healthy Volunteers|healthy volunteers
5786572|NCT00162461|Healthy Volunteers|healthy volunteers
5786573|NCT00162448|Patients requiring dual-chamber pacemakers or defibrillators|patients requiring dual-chamber pacemakers or defibrillators
5786574|NCT00162396|Albuterol|albuterol
5786575|NCT00162396|β2 Adrenergic receptor|β2 adrenergic receptor
5786576|NCT00162396|Polymorphism|polymorphism
5786577|NCT00162240|Metabolics Diabetes New Onset|metabolics diabetes new onset
5786578|NCT00162214|Advanced Solid Tumors|advanced solid tumors
5786579|NCT00162123|ipilimumab|ipilimumab
5786580|NCT00162123|previously treated|previously treated
5786581|NCT00162019|Factor VIII Deficiency|factor viii deficiency
5786582|NCT00162006|Chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura
5786583|NCT00161993|Gammaglobulin|gammaglobulin
5786584|NCT00161980|Axillary wound|axillary wound
5786585|NCT00161980|Seroma|seroma
5786586|NCT00161980|Fistulae|fistulae
5786587|NCT00161967|tick-borne encephalitis|tick-borne encephalitis
5786588|NCT00161954|Tick-Borne Encephalitis|tick-borne encephalitis
5786589|NCT00161941|Meningococcal Vaccine|meningococcal vaccine
5786590|NCT00161941|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
5786591|NCT00161941|Neisseria Meningitidis|neisseria meningitidis
5786592|NCT00161928|Meningococcal Vaccine|meningococcal vaccine
5786593|NCT00161928|Meningococcal Meningitis, Serogroup C|meningococcal meningitis, serogroup c
5786594|NCT00161928|Neisseria Meningitidis|neisseria meningitidis
5786595|NCT00161915|Liver cirrhosis|liver cirrhosis
5786596|NCT00161902|Arthroplasty|arthroplasty
5786597|NCT00161902|Hip Prosthesis|hip prosthesis
5786598|NCT00161902|Cement Free Hip Prosthesis|cement free hip prosthesis
5786599|NCT00161902|Femur Head Necrosis|femur head necrosis
5786600|NCT00161902|Coxarthrosis|coxarthrosis
5786601|NCT00161876|tick-borne encephalitis|tick-borne encephalitis
5786602|NCT00161837|Influenza|influenza
5786603|NCT00161837|Vaccine|vaccine
5786604|NCT00161746|Tick-Borne Encephalitis|tick-borne encephalitis
5786605|NCT00161733|Cardiopulmonary bypass|cardiopulmonary bypass
5786606|NCT00161733|Median sternotomy|median sternotomy
5786607|NCT00161733|Fibrin sealant|fibrin sealant
5786608|NCT00161733|Clot|clot
5786609|NCT00161733|Cardiac surgery|cardiac surgery
5786610|NCT00161720|Severe Congenital Protein C Deficiency|severe congenital protein c deficiency
5786611|NCT00161694|pain control|pain control
5786612|NCT00161681|Levonorgestrel|levonorgestrel
5786613|NCT00161681|ethinyl estradiol|ethinyl estradiol
5786614|NCT00161681|premenstrual syndrome|premenstrual syndrome
5786615|NCT00161681|menstrual cycle related symptoms|menstrual cycle related symptoms
5786616|NCT00161668|Leukemia|leukemia
5786617|NCT00161655|Psoriasis|psoriasis
5786618|NCT00161655|Arthritis|arthritis
5786619|NCT00161642|Malignant Tumors|malignant tumors
5786620|NCT00161629|Distal Radius Fractures|distal radius fractures
5786621|NCT00161616|Open Diaphyseal Tibia Fractures|open diaphyseal tibia fractures
5786622|NCT00161603|Angioplasty|angioplasty
5786623|NCT00161603|Behavior change|behavior change
5786624|NCT00161603|Physical activity|physical activity
5786625|NCT00161603|Risk reduction|risk reduction
5786626|NCT00161590|NK cell lymphoma|nk cell lymphoma
5786627|NCT00161590|Null cell lymphoma|null cell lymphoma
5786628|NCT00161577|Ketorolac|ketorolac
5786629|NCT00161564|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5786630|NCT00161564|ITP|itp
5786631|NCT00161564|Non-Malignant Hematology|non-malignant hematology
5786632|NCT00161551|Cardiac Pacing, artificial|cardiac pacing, artificial
5686474|NCT00551928|Multiple Myeloma|multiple myeloma
5786633|NCT00161551|Atrial Fibrillation|atrial fibrillation
5786634|NCT00161551|Heart Failure|heart failure
5786635|NCT00161551|Pacemaker leads|pacemaker leads
5786636|NCT00161551|Pacing Mode|pacing mode
5786637|NCT00161538|Cardiac Pacing, artificial|cardiac pacing, artificial
5786638|NCT00161538|Atrial fibrillation|atrial fibrillation
5786639|NCT00161538|Pacemaker leads|pacemaker leads
5786640|NCT00161538|Lead positions|lead positions
5786641|NCT00161525|Subretinal Hemorrhage, Perfluorocarbon gas|subretinal hemorrhage, perfluorocarbon gas
5786642|NCT00161486|Male contraception|male contraception
5786643|NCT00161486|Prostate|prostate
5786644|NCT00161486|Acyline|acyline
5786645|NCT00161486|Androgen replacement|androgen replacement
5786646|NCT00161473|double-blind|double-blind
5786647|NCT00161473|treatment|treatment
5786648|NCT00161473|prazosin|prazosin
5786649|NCT00161460|Colorectal cancer|colorectal cancer
5786650|NCT00161460|Mass screening|mass screening
5786651|NCT00161447|Male contraception|male contraception
5786652|NCT00161447|testosterone|testosterone
5786653|NCT00161447|acyline|acyline
5786654|NCT00161434|HIV-1|hiv-1
5786655|NCT00161421|Male Contraception|male contraception
5786656|NCT00161421|Testosterone|testosterone
5786657|NCT00161421|Hypogonadism|hypogonadism
5786658|NCT00161408|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation|schizophrenia, first episode, cognitive behavioural therapy, psychoeducation
5786659|NCT00161395|fertility|fertility
5786660|NCT00161395|pregnancy|pregnancy
5786661|NCT00161382|HIV Seronegativity|hiv seronegativity
5786664|NCT00161369|asymmetric dimethylarginine|asymmetric dimethylarginine
5786665|NCT00161369|atherosclerosis|atherosclerosis
5786666|NCT00161369|cardiovascular event|cardiovascular event
5786667|NCT00161369|hemodialysis|hemodialysis
5786668|NCT00161343|HIV|hiv
5786669|NCT00161343|Prevention Intervention|prevention intervention
5786670|NCT00161343|Female|female
5786671|NCT00161343|Adolescents|adolescents
5786672|NCT00161343|STD|std
5786673|NCT00161343|HIV Seronegativity|hiv seronegativity
5786674|NCT00161330|urinary tract infection,|urinary tract infection,
5786675|NCT00161330|antibiotic treatment|antibiotic treatment
5786676|NCT00161330|childhood|childhood
5786677|NCT00161330|amoxicilline/clavulanic acid|amoxicilline/clavulanic acid
5786678|NCT00161330|ceftriaxone|ceftriaxone
5786679|NCT00161330|renal ultrasonography|renal ultrasonography
5786680|NCT00161330|renal scintigraphy|renal scintigraphy
5786681|NCT00161291|Carcinoma of the breast|carcinoma of the breast
5786682|NCT00161291|Breast cancer|breast cancer
5786683|NCT00161252|Prostate Cancer|prostate cancer
5786684|NCT00161239|T-Cell Lymphomas|t-cell lymphomas
5786685|NCT00161226|endometrial cancer|endometrial cancer
5786686|NCT00161213|recurrent pancreatic cancer|recurrent pancreatic cancer
5786687|NCT00161213|stage IV pancreatic cancer|stage iv pancreatic cancer
5786688|NCT00161213|stage III pancreatic cancer|stage iii pancreatic cancer
5786689|NCT00161213|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5786690|NCT00161213|stage II pancreatic cancer|stage ii pancreatic cancer
5786691|NCT00161200|Esophageal Metaplasia|esophageal metaplasia
5786692|NCT00161187|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5786693|NCT00161187|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5786694|NCT00161187|prolymphocytic leukemia|prolymphocytic leukemia
5786695|NCT00161187|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5786696|NCT00161187|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5786697|NCT00161187|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5786698|NCT00161187|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5786699|NCT00161187|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5786700|NCT00161187|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5786701|NCT00161187|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5786702|NCT00161187|stage I multiple myeloma|stage i multiple myeloma
5786703|NCT00161187|stage II multiple myeloma|stage ii multiple myeloma
5786704|NCT00161187|stage III multiple myeloma|stage iii multiple myeloma
5786705|NCT00161187|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5786706|NCT00161187|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5786707|NCT00161187|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5786708|NCT00161187|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5786709|NCT00161187|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5786710|NCT00161187|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5786711|NCT00161187|adult nasal type extranodal NK/T-cell lymphoma|adult nasal type extranodal nk/t-cell lymphoma
5786712|NCT00161187|childhood nasal type extranodal NK/T-cell lymphoma|childhood nasal type extranodal nk/t-cell lymphoma
5786713|NCT00161187|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5786714|NCT00161187|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5786715|NCT00161187|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5786716|NCT00161187|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5786717|NCT00161187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5786718|NCT00161187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5786719|NCT00161187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5786720|NCT00161187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5786721|NCT00161187|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5862955|NCT00001451|Bone Marrow Donor|bone marrow donor
5786722|NCT00161187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5786723|NCT00161187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5786724|NCT00161187|recurrent renal cell cancer|recurrent renal cell cancer
5786725|NCT00161187|stage IV renal cell cancer|stage iv renal cell cancer
5786726|NCT00161187|recurrent bladder cancer|recurrent bladder cancer
5786727|NCT00161187|stage IV bladder cancer|stage iv bladder cancer
5786728|NCT00161187|recurrent prostate cancer|recurrent prostate cancer
5786729|NCT00161187|stage IV prostate cancer|stage iv prostate cancer
5786730|NCT00161187|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5786731|NCT00161187|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5786732|NCT00161187|recurrent gastric cancer|recurrent gastric cancer
5786733|NCT00161187|stage IV gastric cancer|stage iv gastric cancer
5786734|NCT00161187|recurrent pancreatic cancer|recurrent pancreatic cancer
5786735|NCT00161187|stage IV pancreatic cancer|stage iv pancreatic cancer
5786736|NCT00161187|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5786738|NCT00161187|recurrent childhood liver cancer|recurrent childhood liver cancer
5786739|NCT00161187|recurrent colon cancer|recurrent colon cancer
5786740|NCT00161187|stage IV colon cancer|stage iv colon cancer
5786741|NCT00161187|recurrent rectal cancer|recurrent rectal cancer
5786742|NCT00161187|stage IV rectal cancer|stage iv rectal cancer
5786743|NCT00161187|recurrent breast cancer|recurrent breast cancer
5786744|NCT00161187|stage IV breast cancer|stage iv breast cancer
5786745|NCT00161187|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5786746|NCT00161187|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5786747|NCT00161187|recurrent small cell lung cancer|recurrent small cell lung cancer
5786748|NCT00161187|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5786749|NCT00161187|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5786750|NCT00161187|recurrent cervical cancer|recurrent cervical cancer
5786751|NCT00161187|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5786752|NCT00161187|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5786753|NCT00161187|chondrosarcoma|chondrosarcoma
5786754|NCT00161187|recurrent osteosarcoma|recurrent osteosarcoma
5786755|NCT00161187|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5786756|NCT00161187|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5786757|NCT00161187|ovarian sarcoma|ovarian sarcoma
5786758|NCT00161187|recurrent uterine sarcoma|recurrent uterine sarcoma
5786759|NCT00161187|stage IV uterine sarcoma|stage iv uterine sarcoma
5786760|NCT00161187|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5786761|NCT00161187|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5786762|NCT00161187|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5786763|NCT00161187|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5786764|NCT00161187|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5786765|NCT00161187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5786766|NCT00161187|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5786767|NCT00161187|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5786768|NCT00161187|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5786769|NCT00161187|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5786770|NCT00161187|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5786771|NCT00161187|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5786772|NCT00161187|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5786773|NCT00161187|advanced adult primary liver cancer|advanced adult primary liver cancer
5786774|NCT00161187|ovarian stromal cancer|ovarian stromal cancer
5786775|NCT00161187|stage IA cervical cancer|stage ia cervical cancer
5786776|NCT00161187|stage IB cervical cancer|stage ib cervical cancer
5786777|NCT00161187|stage IIA cervical cancer|stage iia cervical cancer
5786778|NCT00161187|stage IIB cervical cancer|stage iib cervical cancer
5786779|NCT00161187|stage III cervical cancer|stage iii cervical cancer
5786780|NCT00161187|stage IVA cervical cancer|stage iva cervical cancer
5786781|NCT00161187|stage IVB cervical cancer|stage ivb cervical cancer
5786782|NCT00161187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5786783|NCT00161187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5786784|NCT00161187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5786785|NCT00161187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5786786|NCT00161187|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5786787|NCT00161187|stage I endometrial carcinoma|stage i endometrial carcinoma
5786788|NCT00161187|stage II endometrial carcinoma|stage ii endometrial carcinoma
5786789|NCT00161187|stage III endometrial carcinoma|stage iii endometrial carcinoma
5786790|NCT00161187|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5786791|NCT00161187|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5786792|NCT00161187|stage III childhood liver cancer|stage iii childhood liver cancer
5786793|NCT00161187|stage IV childhood liver cancer|stage iv childhood liver cancer
5786794|NCT00161187|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5786795|NCT00161187|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5786796|NCT00161187|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5786797|NCT00161187|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5786798|NCT00161187|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5786799|NCT00161187|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5786800|NCT00161187|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5786801|NCT00161187|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5786802|NCT00161187|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5781812|NCT00185770|Schools|schools
5786803|NCT00161187|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5786804|NCT00161187|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5786806|NCT00161187|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5786807|NCT00161187|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5786808|NCT00161187|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5786809|NCT00161187|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5786810|NCT00161187|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5786811|NCT00161187|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5786812|NCT00161187|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5786813|NCT00161187|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5786814|NCT00161187|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5786815|NCT00161187|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5786816|NCT00161187|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5786817|NCT00161187|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5786818|NCT00161187|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5786819|NCT00161187|localized osteosarcoma|localized osteosarcoma
5786820|NCT00161187|metastatic osteosarcoma|metastatic osteosarcoma
5786821|NCT00161187|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5786822|NCT00161187|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5786823|NCT00161187|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5786824|NCT00161187|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5786825|NCT00161187|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5786826|NCT00161187|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5786827|NCT00161187|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5786828|NCT00161187|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5786829|NCT00161187|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5786830|NCT00161187|limited stage small cell lung cancer|limited stage small cell lung cancer
5786831|NCT00161187|refractory multiple myeloma|refractory multiple myeloma
5786832|NCT00161187|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5786833|NCT00161187|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5787282|NCT00159315|Asthma Patients|asthma patients
5786834|NCT00161187|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5786835|NCT00161187|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5786836|NCT00161187|stage I bladder cancer|stage i bladder cancer
5786837|NCT00161187|stage II bladder cancer|stage ii bladder cancer
5786838|NCT00161187|stage III bladder cancer|stage iii bladder cancer
5786839|NCT00161187|male breast cancer|male breast cancer
5786840|NCT00161187|stage I breast cancer|stage i breast cancer
5786841|NCT00161187|stage II breast cancer|stage ii breast cancer
5786842|NCT00161187|stage IIIA breast cancer|stage iiia breast cancer
5786843|NCT00161187|stage IIIB breast cancer|stage iiib breast cancer
5786844|NCT00161187|stage IIIC breast cancer|stage iiic breast cancer
5786845|NCT00161187|stage I colon cancer|stage i colon cancer
5786846|NCT00161187|stage II colon cancer|stage ii colon cancer
5786847|NCT00161187|stage III colon cancer|stage iii colon cancer
5786848|NCT00161187|stage I gastric cancer|stage i gastric cancer
5786849|NCT00161187|stage II gastric cancer|stage ii gastric cancer
5786850|NCT00161187|stage III gastric cancer|stage iii gastric cancer
5786851|NCT00161187|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5786852|NCT00161187|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5786853|NCT00161187|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5786854|NCT00161187|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5786038|NCT00165204|Bone Density|bone density
5786856|NCT00161187|stage II pancreatic cancer|stage ii pancreatic cancer
5786857|NCT00161187|stage III pancreatic cancer|stage iii pancreatic cancer
5786858|NCT00161187|stage I prostate cancer|stage i prostate cancer
5786859|NCT00161187|stage II prostate cancer|stage ii prostate cancer
5786860|NCT00161187|stage III prostate cancer|stage iii prostate cancer
5786862|NCT00161187|stage II rectal cancer|stage ii rectal cancer
5786863|NCT00161187|stage III rectal cancer|stage iii rectal cancer
5786864|NCT00161187|stage I renal cell cancer|stage i renal cell cancer
5786865|NCT00161187|stage II renal cell cancer|stage ii renal cell cancer
5786866|NCT00161187|stage III renal cell cancer|stage iii renal cell cancer
5786867|NCT00161187|stage I uterine sarcoma|stage i uterine sarcoma
5786868|NCT00161187|stage II uterine sarcoma|stage ii uterine sarcoma
5786869|NCT00161187|stage III uterine sarcoma|stage iii uterine sarcoma
5786870|NCT00161187|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5786871|NCT00161187|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5786872|NCT00161187|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5786873|NCT00161187|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5786874|NCT00161187|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5786875|NCT00161187|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5786876|NCT00161187|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5786877|NCT00161187|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5786878|NCT00161187|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5786879|NCT00161187|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5786880|NCT00161187|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5786881|NCT00161187|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5786882|NCT00161187|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5786883|NCT00161187|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5786884|NCT00161187|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5786885|NCT00161187|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5786886|NCT00161187|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5786887|NCT00161187|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5786888|NCT00161187|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5786889|NCT00161187|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5786890|NCT00161187|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5786891|NCT00161187|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5786892|NCT00161187|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5786893|NCT00161187|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5786894|NCT00161187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5787007|NCT00160927|endothelial function|endothelial function
5786895|NCT00161187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5786896|NCT00161187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5786897|NCT00161187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5786898|NCT00161187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5786899|NCT00161187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5786900|NCT00161187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5786901|NCT00161187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5786902|NCT00161187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5786903|NCT00161187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5786904|NCT00161187|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5786905|NCT00161187|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5786906|NCT00161187|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5786907|NCT00161187|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5786908|NCT00161187|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5786909|NCT00161187|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5786910|NCT00161187|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5786911|NCT00161187|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5786912|NCT00161187|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5786913|NCT00161187|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5786914|NCT00161187|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5786915|NCT00161187|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5786916|NCT00161187|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5786917|NCT00161187|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5786918|NCT00161187|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5786919|NCT00161187|Burkitt lymphoma|burkitt lymphoma
5786139|NCT00164580|Community Participation|community participation
5786920|NCT00161187|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5786921|NCT00161187|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5786922|NCT00161187|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5786923|NCT00161187|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5786924|NCT00161187|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5786925|NCT00161187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5786926|NCT00161187|childhood renal cell carcinoma|childhood renal cell carcinoma
5786927|NCT00161187|stage IA melanoma|stage ia melanoma
5786928|NCT00161187|stage IB melanoma|stage ib melanoma
5786929|NCT00161187|stage IIA melanoma|stage iia melanoma
5786930|NCT00161187|stage IIB melanoma|stage iib melanoma
5786931|NCT00161187|stage IIC melanoma|stage iic melanoma
5786932|NCT00161187|stage IIIA melanoma|stage iiia melanoma
5786933|NCT00161187|stage IIIB melanoma|stage iiib melanoma
5786934|NCT00161187|stage IIIC melanoma|stage iiic melanoma
5786935|NCT00161187|stage IV melanoma|stage iv melanoma
5786936|NCT00161187|recurrent melanoma|recurrent melanoma
5786937|NCT00161174|testicular cancer|testicular cancer
5786938|NCT00161174|cardiovascular morbidity|cardiovascular morbidity
5786939|NCT00161174|cardiovascular risk factors|cardiovascular risk factors
5786940|NCT00161174|pharmacogenomic determinants|pharmacogenomic determinants
5786941|NCT00161161|ADHD; MRI; genetics|adhd; mri; genetics
5786943|NCT00161148|Liver biochemistry|liver biochemistry
5786944|NCT00161148|Probiotics|probiotics
5786945|NCT00161148|Pruritus|pruritus
5786947|NCT00161135|PDD-NOS, MCDD|pdd-nos, mcdd
5786948|NCT00161109|22q11.2 deletion syndrome|22q11.2 deletion syndrome
5786949|NCT00161109|Psychopathology|psychopathology
5786950|NCT00161109|Psychiatry|psychiatry
5786951|NCT00161109|Neuropsychology|neuropsychology
5786952|NCT00161109|Psychiophysiology|psychiophysiology
5786953|NCT00161109|Autism|autism
5786954|NCT00161109|Psychosis|psychosis
5786955|NCT00161109|Deletion size|deletion size
5786956|NCT00161109|Candidate genes|candidate genes
5786957|NCT00161109|Psychiatric symptoms|psychiatric symptoms
5786958|NCT00161109|Neuropsychological impairments|neuropsychological impairments
5786959|NCT00161109|Psychophysiological performance|psychophysiological performance
5786960|NCT00161096|on-demand therapy|on-demand therapy
5786961|NCT00161096|pantoprazole|pantoprazole
5786962|NCT00161096|gastro-oesophageal reflux disease|gastro-oesophageal reflux disease
5786963|NCT00161096|proton pump inhibitor|proton pump inhibitor
5786964|NCT00161096|acid suppression|acid suppression
5786965|NCT00161096|intermittent|intermittent
5786966|NCT00161083|ursodeoxycholic acid|ursodeoxycholic acid
5786967|NCT00161083|gallstone|gallstone
5786968|NCT00161083|complications|complications
5786969|NCT00161083|pancreatitis|pancreatitis
5786970|NCT00161083|gallbladder motility|gallbladder motility
5786971|NCT00161083|colic|colic
5786972|NCT00161070|secondary prevention|secondary prevention
5786973|NCT00161070|TIA / minor stroke|tia / minor stroke
5786974|NCT00161070|atherosclerotic origin|atherosclerotic origin
5786975|NCT00161070|TIA (Transient Ischemic Attack)|tia (transient ischemic attack)
5786976|NCT00161070|prevention & control|prevention & control
5786977|NCT00161057|Schizophrenia|schizophrenia
5786978|NCT00161057|Medication-naive|medication-naive
5786979|NCT00161057|Functional MRI|functional mri
5786980|NCT00161057|Working memory|working memory
5786981|NCT00161057|Language lateralization|language lateralization
5786982|NCT00161057|schizoaffective disorder|schizoaffective disorder
5786983|NCT00161057|psychotic disorder Not Otherwise Specified|psychotic disorder not otherwise specified
5786984|NCT00161005|Acute myocardial infarction|acute myocardial infarction
5786985|NCT00161005|Fibrinolysis|fibrinolysis
5786986|NCT00161005|Health effects /Quality of life|health effects /quality of life
5786987|NCT00160992|Adoptive cell transfer|adoptive cell transfer
5786988|NCT00160992|peptide vaccination|peptide vaccination
5786989|NCT00160992|melanoma|melanoma
5786990|NCT00160992|immunosuppression and homeostatic proliferation|immunosuppression and homeostatic proliferation
5786991|NCT00160966|kidney transplantation|kidney transplantation
5786992|NCT00160966|polyoma virus associated transplant nephropathy|polyoma virus associated transplant nephropathy
5786993|NCT00160966|tacrolimus|tacrolimus
5786994|NCT00160966|mycophenolate mofetil|mycophenolate mofetil
5786995|NCT00160966|everolimus|everolimus
5786996|NCT00160966|cyclosporin A|cyclosporin a
5786997|NCT00160966|BK virus PCR|bk virus pcr
5786998|NCT00160966|viruria screening|viruria screening
5786999|NCT00160966|BK polyomavirus|bk polyomavirus
5787000|NCT00160966|immunosuppression|immunosuppression
5787001|NCT00160940|gene expression|gene expression
5787002|NCT00160940|viral hepatitis|viral hepatitis
5787003|NCT00160940|autoimmune disease|autoimmune disease
5787004|NCT00160927|microcirculation|microcirculation
5787005|NCT00160927|Laser doppler flowmetry|laser doppler flowmetry
5787008|NCT00160914|Childhood obesity|childhood obesity
5787009|NCT00160901|Breast cancer|breast cancer
5787010|NCT00160901|Chemotherapy|chemotherapy
5787011|NCT00160901|Phytotherapy|phytotherapy
5787012|NCT00160901|Nutritional counseling|nutritional counseling
5795913|NCT00120965|CPR|cpr
5787013|NCT00160875|esophageal|esophageal
5787014|NCT00160875|esophagus|esophagus
5787015|NCT00160875|irinotecan|irinotecan
5787017|NCT00160875|cisplatin|cisplatin
5787018|NCT00160849|Treatment Experienced|treatment experienced
5787019|NCT00160836|Tissue diagnosis|tissue diagnosis
5787020|NCT00160823|Colon cleansing|colon cleansing
5787022|NCT00160823|Cost-effectiveness|cost-effectiveness
5787023|NCT00160810|distal|distal
5787024|NCT00160810|radius|radius
5787025|NCT00160810|fractures|fractures
5787026|NCT00160745|endothelium, NO, renal, statins|endothelium, no, renal, statins
5787027|NCT00160732|Islet Cell Transplant|islet cell transplant
5787028|NCT00160732|Human islet cell infusion|human islet cell infusion
5787029|NCT00160732|Juvenile-onset diabetes|juvenile-onset diabetes
5787030|NCT00160693|Rheumatoid Arthritis|rheumatoid arthritis
5787031|NCT00160693|America College of Rheumatology|america college of rheumatology
5787032|NCT00160693|Disease modifying anti-rheumatic drug|disease modifying anti-rheumatic drug
5787033|NCT00160693|Certolizumab Pegol (CDP870)|certolizumab pegol (cdp870)
5787034|NCT00160680|Persistent Allergic Rhinitis|persistent allergic rhinitis
5787035|NCT00160680|HDM|hdm
5787036|NCT00160680|Parietaria|parietaria
5787037|NCT00160680|sneezing|sneezing
5787038|NCT00160680|rhinorrhea|rhinorrhea
5787039|NCT00160680|ocular pruritus|ocular pruritus
5787040|NCT00160680|Rhinasthma|rhinasthma
5787041|NCT00160680|inflammatory cells|inflammatory cells
5787043|NCT00160680|ATAREAL|atareal
5787044|NCT00160680|Xyzal|xyzal
5787045|NCT00160680|Levocetirizine|levocetirizine
5787046|NCT00160667|Post-herpetic Neuralgia (PHN)|post-herpetic neuralgia (phn)
5787047|NCT00160667|Brivaracetam|brivaracetam
5787048|NCT00160654|Epilepsy|epilepsy
5787049|NCT00160654|Partial Onset Seizures|partial onset seizures
5787050|NCT00160654|Keppra|keppra
5787051|NCT00160654|Levetiracetam|levetiracetam
5787052|NCT00160641|Rheumatoid Arthritis|rheumatoid arthritis
5787053|NCT00160641|CDP870|cdp870
5787054|NCT00160641|Certolizumab Pegol|certolizumab pegol
5787055|NCT00160641|Cimzia|cimzia
5787056|NCT00160628|Epilepsy|epilepsy
5787057|NCT00160628|Partial Onset Seizures|partial onset seizures
5787058|NCT00160628|Keppra|keppra
5787059|NCT00160628|Levetiracetam|levetiracetam
5787060|NCT00160615|Epilepsy, partial|epilepsy, partial
5787061|NCT00160615|Keppra|keppra
5787062|NCT00160615|Levetiracetam|levetiracetam
5787063|NCT00160602|Rheumatoid Arthritis|rheumatoid arthritis
5787064|NCT00160602|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
5787065|NCT00160589|Allergic Rhinits, Symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), LEADER, Xyzal, Levocetirizine|allergic rhinits, symptoms (sneezing, rhinorrhea, nasal/ocular pruritus, nasal congestion), leader, xyzal, levocetirizine
5787066|NCT00160576|Idiopathic Parkinson's Disease, levodopa induced dyskinesia,|idiopathic parkinson's disease, levodopa induced dyskinesia,
5787067|NCT00160576|Levetiracetam, Keppra|levetiracetam, keppra
5787068|NCT00160563|Pediatry|pediatry
5787069|NCT00160563|EPAAC|epaac
5787070|NCT00160563|atopic Children|atopic children
5787071|NCT00160563|prevention of asthma|prevention of asthma
5787072|NCT00160563|Levocetirizine|levocetirizine
5787073|NCT00160563|Xyzal|xyzal
5787074|NCT00160550|Idiopathic Generalized Epilepsy, tonic-clonic seizures|idiopathic generalized epilepsy, tonic-clonic seizures
5787075|NCT00160550|Levetiracetam, Keppra|levetiracetam, keppra
5787168|NCT00160056|adrenal receptor|adrenal receptor
5787076|NCT00160537|Seasonal Allergic Rhinitis (SAR), Grass pollen, SAR Symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)|seasonal allergic rhinitis (sar), grass pollen, sar symptoms (sneezing, rhinorrhea, nasal / ocular pruritus, nasal congestion)
5787077|NCT00160537|POPULAR, Xyzal, Levocetirizine|popular, xyzal, levocetirizine
5787078|NCT00160524|Certolizumab Pegol|certolizumab pegol
5787079|NCT00160524|Cimzia|cimzia
5787080|NCT00160524|CDP870|cdp870
5787081|NCT00160524|CZP|czp
5787082|NCT00160511|Postherpetic Neuralgia (PHN)|postherpetic neuralgia (phn)
5787083|NCT00160511|Levetiracetam|levetiracetam
5787084|NCT00160511|Keppra|keppra
5787086|NCT00160498|Lercanidipine, calcium antagonist, hypertension, obesity|lercanidipine, calcium antagonist, hypertension, obesity
5787087|NCT00160485|Gestational Diabetes|gestational diabetes
5787088|NCT00160485|Pregnancy|pregnancy
5787089|NCT00160485|Glyburide|glyburide
5787090|NCT00160485|Insulin|insulin
5787091|NCT00160472|vasopressin|vasopressin
5787092|NCT00160472|ovarian|ovarian
5787093|NCT00160472|neoplasm|neoplasm
5787094|NCT00160459|Fibroid Uterus|fibroid uterus
5787095|NCT00160459|Leiomyoma|leiomyoma
5787096|NCT00160459|Uterine Fibroids|uterine fibroids
5787097|NCT00160459|asoprisnil|asoprisnil
5787098|NCT00160446|Pelvic pain|pelvic pain
5787099|NCT00160446|Dysmenorrhea|dysmenorrhea
5787100|NCT00160446|Dyspareunia|dyspareunia
5787101|NCT00160446|Infertility|infertility
5787102|NCT00160446|Asoprisnil|asoprisnil
5787103|NCT00160433|Pelvic pain|pelvic pain
5787104|NCT00160433|Dysmenorrhea|dysmenorrhea
5787105|NCT00160433|Dyspareunia|dyspareunia
5787106|NCT00160433|Infertility|infertility
5787107|NCT00160433|asoprisnil|asoprisnil
5787108|NCT00160420|Pelvic pain|pelvic pain
5787109|NCT00160420|Dysmenorrhea|dysmenorrhea
5787110|NCT00160420|Dyspareunia|dyspareunia
5787111|NCT00160420|Infertility|infertility
5787112|NCT00160420|asoprisnil|asoprisnil
5787113|NCT00160407|nonalcoholic steatohepatitis|nonalcoholic steatohepatitis
5787114|NCT00160407|enzyme inhibitors|enzyme inhibitors
5787116|NCT00160407|obesity|obesity
5787117|NCT00160407|insulin resistance|insulin resistance
5681123|NCT00574613|Skin fibrosis|skin fibrosis
5681124|NCT00574613|systemic scleroderma|systemic scleroderma
5681125|NCT00574613|systemic sclerosis|systemic sclerosis
5681126|NCT00574613|P144|p144
5787118|NCT00160394|Mild to Moderate|mild to moderate
5787119|NCT00160381|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5787120|NCT00160381|Excessive Uterine Bleeding|excessive uterine bleeding
5787121|NCT00160381|Uterine Hemorrhage|uterine hemorrhage
5787122|NCT00160381|asoprisnil|asoprisnil
5787123|NCT00160368|Hypertension, potassium salts|hypertension, potassium salts
5787124|NCT00160355|Wiskott-Aldrich Syndrome|wiskott-aldrich syndrome
5787125|NCT00160355|Immunodeficiency|immunodeficiency
5787126|NCT00160355|Haploidentical transplantation|haploidentical transplantation
5787127|NCT00160342|Hormone replacement therapy, hot flushes, postmenopause|hormone replacement therapy, hot flushes, postmenopause
5787128|NCT00160303|Prolotherapy|prolotherapy
5787129|NCT00160303|Lateral Epicondylitis|lateral epicondylitis
5787130|NCT00160303|Tennis Elbow|tennis elbow
5787131|NCT00160303|Corticosteroid Therapy|corticosteroid therapy
5787132|NCT00160290|lactulose|lactulose
5782211|NCT00183326|CBT|cbt
5787133|NCT00160290|randomised clinical trial|randomised clinical trial
5787134|NCT00160290|hemorrhoids|hemorrhoids
5787135|NCT00160290|anal fissures|anal fissures
5787136|NCT00160277|Efficacy and safety of moxonidine in Indian hypertensives|efficacy and safety of moxonidine in indian hypertensives
5787137|NCT00160264|lactulose; randomised clinical trial; osteopenia; postmenopause|lactulose; randomised clinical trial; osteopenia; postmenopause
5787138|NCT00160251|PEG-Intron|peg-intron
5787139|NCT00160251|Ribavirin|ribavirin
5787140|NCT00160251|Protease Inhibitor|protease inhibitor
5787141|NCT00160238|Meniere's disease|meniere's disease
5787142|NCT00160238|Vestibular neurotomy|vestibular neurotomy
5787143|NCT00160225|blood pressure, diabetic nephropathy, proteinuria|blood pressure, diabetic nephropathy, proteinuria
5787144|NCT00160212|blood pressure|blood pressure
5787145|NCT00160199|To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea|to collect additional data on 300 and 400 mg doses of prometrium in women with secondary amenorrhea
5787146|NCT00160173|Post menopausal vasomotor symptoms|post menopausal vasomotor symptoms
5787147|NCT00160160|comparator trial|comparator trial
5787148|NCT00160160|hypertension|hypertension
5787149|NCT00160160|diabetes|diabetes
5787150|NCT00160160|blood pressure|blood pressure
5787151|NCT00160134|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic|congestive heart failure, adenosine receptor blocker, cardiac hemodynamic
5787152|NCT00160095|larynx carcinoma|larynx carcinoma
5787153|NCT00160095|Tumor hypoxia|tumor hypoxia
5787154|NCT00160095|microregional imaging|microregional imaging
5787155|NCT00160095|hypoxia modifying treatment|hypoxia modifying treatment
5787156|NCT00160082|Post Polio Syndrome|post polio syndrome
5787157|NCT00160082|PPS|pps
5787158|NCT00160082|Poliomyelitis|poliomyelitis
5787159|NCT00160082|Paralylic Polio|paralylic polio
5787160|NCT00160082|Late effects of polio|late effects of polio
5787161|NCT00160082|Late onset polio sequele|late onset polio sequele
5787162|NCT00160082|Xepol|xepol
5787163|NCT00160082|IvIg|ivig
5787164|NCT00160082|Intravenous Immunoglobuline|intravenous immunoglobuline
5787165|NCT00160069|Stage IIIB or stage IV non-small-cell lung cancer.|stage iiib or stage iv non-small-cell lung cancer.
5787166|NCT00160056|Hypoglycemia unawareness|hypoglycemia unawareness
5787169|NCT00160056|adrenerg respons|adrenerg respons
5787170|NCT00160056|adrenergic beta-agonists|adrenergic beta-agonists
5787171|NCT00160056|salbutamol|salbutamol
5787172|NCT00160017|Quality assurance health care|quality assurance health care
5787173|NCT00160017|Diabetes|diabetes
5787174|NCT00160017|Breakthrough collaborative (IHI)|breakthrough collaborative (ihi)
5787175|NCT00160017|Evaluation|evaluation
5787176|NCT00160004|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5787177|NCT00160004|Exercise|exercise
5787178|NCT00160004|Fatigue|fatigue
5787179|NCT00160004|Quality-of-life|quality-of-life
5787587|NCT00157859|Papua|papua
5787180|NCT00159991|Coronary artery bypass grafting|coronary artery bypass grafting
5787181|NCT00159991|Total arterial revascularization|total arterial revascularization
5787182|NCT00159991|Internal mammary artery grafting|internal mammary artery grafting
5787183|NCT00159991|Radial artery grafting|radial artery grafting
5787184|NCT00159978|head and neck cancer|head and neck cancer
5787185|NCT00159978|hypoxia|hypoxia
5787186|NCT00159978|tumor cell proliferation|tumor cell proliferation
5787187|NCT00159978|PET|pet
5787188|NCT00159965|nonepileptic seizure|nonepileptic seizure
5787189|NCT00159965|pseudoseizure|pseudoseizure
5787190|NCT00159965|conversion disorder|conversion disorder
5787191|NCT00159965|psychogenic|psychogenic
5787192|NCT00159965|Depression|depression
5787193|NCT00159965|Anxiety|anxiety
5787194|NCT00159965|Abuse|abuse
5787195|NCT00159965|post-traumatic stress disorder|post-traumatic stress disorder
5787196|NCT00159965|sertraline|sertraline
5787197|NCT00159965|serotonin|serotonin
5787198|NCT00159965|randomized controlled trial|randomized controlled trial
5787199|NCT00159952|Sepsis|sepsis
5787200|NCT00159952|Septic shock|septic shock
5787201|NCT00159952|Hyperglycemia|hyperglycemia
5787202|NCT00159952|Fibrinolysis|fibrinolysis
5787203|NCT00159952|PAI 1|pai 1
5787204|NCT00159939|ARDS|ards
5787205|NCT00159939|prone position|prone position
5787206|NCT00159926|systemic inflammatory response syndrome|systemic inflammatory response syndrome
5787207|NCT00159926|coronary artery bypass grafting|coronary artery bypass grafting
5787208|NCT00159926|cell saver|cell saver
5787209|NCT00159926|interleukins|interleukins
5787210|NCT00159926|tumor necrosis factor alfa|tumor necrosis factor alfa
5787211|NCT00159900|Impotence|impotence
5787212|NCT00159874|children|children
5787213|NCT00159627|heart failure, congestive|heart failure, congestive
5787214|NCT00159627|diuretic|diuretic
5787215|NCT00159614|renal insufficiency|renal insufficiency
5787216|NCT00159614|diuretic|diuretic
5787217|NCT00159614|heart failure, congestive|heart failure, congestive
5787218|NCT00159601|Quality of Life|quality of life
5787219|NCT00159601|Mental health|mental health
5787220|NCT00159601|Children|children
5787221|NCT00159601|Adolescents|adolescents
5787222|NCT00159601|Normal population|normal population
5787223|NCT00159588|Medication-overuse headache|medication-overuse headache
5787224|NCT00159588|preventative medication|preventative medication
5787225|NCT00159588|controls|controls
5787226|NCT00159588|follow-up|follow-up
5787228|NCT00159588|abrupt withdrawal|abrupt withdrawal
5787229|NCT00159575|Polycystic ovarian syndrome|polycystic ovarian syndrome
5787230|NCT00159575|Clinical pregnancy rate|clinical pregnancy rate
5787231|NCT00159575|Oligo- or anovulation|oligo- or anovulation
5787232|NCT00159562|Bipolar Disorder|bipolar disorder
5787233|NCT00159562|Psycho-education|psycho-education
5787234|NCT00159549|Patient education|patient education
5787235|NCT00159536|PCOS|pcos
5787236|NCT00159536|metformin|metformin
5787237|NCT00159536|pregnancy|pregnancy
5787238|NCT00159536|preeclampsia|preeclampsia
5787239|NCT00159536|diabetes|diabetes
5787240|NCT00159536|preterm delivery|preterm delivery
5787241|NCT00159523|Prevention|prevention
5787242|NCT00159523|Probiotics|probiotics
5787243|NCT00159523|Allergy|allergy
5787244|NCT00159523|Hypersensitivity|hypersensitivity
5787245|NCT00159510|sepsis, methylene blue, nitric oxide, acute lung injury|sepsis, methylene blue, nitric oxide, acute lung injury
5787246|NCT00159497|THA|tha
5787247|NCT00159484|phase 1|phase 1
5787248|NCT00159484|phase one|phase one
5787249|NCT00159484|phase I|phase i
5787250|NCT00159432|colorectal|colorectal
5787251|NCT00159432|cancer|cancer
5787252|NCT00159419|Osteogenesis Imperfecta|osteogenesis imperfecta
5787253|NCT00159419|Fractures|fractures
5787254|NCT00159419|Pediatric|pediatric
5787255|NCT00159419|Osteoporosis|osteoporosis
5787256|NCT00159419|Juvenile Pagets|juvenile pagets
5787257|NCT00159406|BPH treatment|bph treatment
5787258|NCT00159406|Laser Prostatectomy|laser prostatectomy
5787259|NCT00159406|Treatment of enlarged Prostates|treatment of enlarged prostates
5787260|NCT00159406|BPH|bph
5787261|NCT00159393|Kidney stones|kidney stones
5787262|NCT00159393|nephrolithotripsy percutaneous|nephrolithotripsy percutaneous
5787263|NCT00159380|Asthma|asthma
5787264|NCT00159367|Neuromuscular electrical stimulation|neuromuscular electrical stimulation
5787265|NCT00159354|FDG−PET|fdg−pet
5787266|NCT00159354|pulmonary inflammation,|pulmonary inflammation,
5787267|NCT00159354|smoking,|smoking,
5787268|NCT00159354|COPD|copd
5787269|NCT00159354|steroid intervention|steroid intervention
5787270|NCT00159341|cigarette smoke|cigarette smoke
5787273|NCT00159341|cytokines|cytokines
5787274|NCT00159341|chemokines|chemokines
5787275|NCT00159341|nasal fluid|nasal fluid
5787276|NCT00159341|filter paper|filter paper
5787277|NCT00159328|Magnetic Resonance Guided Focused Ultrasound|magnetic resonance guided focused ultrasound
5787278|NCT00159328|Gonadotrophin Releasing Hormone Agonist|gonadotrophin releasing hormone agonist
5787279|NCT00159328|Uterine Fibroids|uterine fibroids
5787280|NCT00159315|Healthy Volunteers (smokers)|healthy volunteers (smokers)
5787281|NCT00159315|Healthy Volunteers (Non-smokers)|healthy volunteers (non-smokers)
5787588|NCT00157859|Chloroquine|chloroquine
5787283|NCT00159315|COPD Patients|copd patients
5787284|NCT00159289|Mild to moderate Chronic Obstructive Pulmonary Disease (COPD)|mild to moderate chronic obstructive pulmonary disease (copd)
5787285|NCT00159289|Volunteers (healthy non-smokers)|volunteers (healthy non-smokers)
5787286|NCT00159289|Volunteers (current or ex-smokers)|volunteers (current or ex-smokers)
5787287|NCT00159263|Asthma|asthma
5787288|NCT00159263|Glucocorticoid|glucocorticoid
5787289|NCT00159263|Long-acting beta2-adrenoceptor|long-acting beta2-adrenoceptor
5787290|NCT00159263|Inhaled corticosteroids|inhaled corticosteroids
5787291|NCT00159250|Duchenne muscular dystrophy;|duchenne muscular dystrophy;
5787292|NCT00159250|antisense oligonucleotides;|antisense oligonucleotides;
5787293|NCT00159250|gene restoration;|gene restoration;
5787294|NCT00159250|deletion|deletion
5787295|NCT00159224|HIV|hiv
5787296|NCT00159224|Simplification|simplification
5787297|NCT00159224|Monotherapy|monotherapy
5787298|NCT00159224|Treatment Naive|treatment naive
5787299|NCT00159224|HIV-1 infection|hiv-1 infection
5787300|NCT00159211|type 2 diabetes|type 2 diabetes
5787301|NCT00159198|Amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5796982|NCT00117091|RA|ra
5787302|NCT00159198|Frontotemporal dementia|frontotemporal dementia
5787304|NCT00159198|Linkage studies|linkage studies
5787305|NCT00159198|Genetic epidemiology|genetic epidemiology
5787306|NCT00159185|Arthroplasty, Replacement, Hip|arthroplasty, replacement, hip
5787307|NCT00159185|Epidemiology|epidemiology
5787308|NCT00159172|Advanced parkinson disease|advanced parkinson disease
5787309|NCT00159172|Stimulation|stimulation
5787310|NCT00159172|Motor Cortex|motor cortex
5787311|NCT00159172|Parkinson disease C10.574.812|parkinson disease c10.574.812
5787312|NCT00159172|Electric Stimulation Therapy E02.831.580.438|electric stimulation therapy e02.831.580.438
5787313|NCT00159172|Neuronavigation E05.873.249|neuronavigation e05.873.249
5787314|NCT00159159|Cardiac Transplant|cardiac transplant
5787315|NCT00159159|ciclosporine|ciclosporine
5787316|NCT00159159|immunosuppressive|immunosuppressive
5787317|NCT00159146|Major Depression|major depression
5787318|NCT00159146|Pindolol|pindolol
5787319|NCT00159146|Venlafaxine|venlafaxine
5787320|NCT00159146|Augmentation|augmentation
5787321|NCT00159146|Major depression (DSM-IVR)|major depression (dsm-ivr)
5787322|NCT00159133|Schizophrenia|schizophrenia
5787323|NCT00159133|first episode|first episode
5787324|NCT00159133|prodrome based early intervention|prodrome based early intervention
5787325|NCT00159133|antipsychotics - benzodiazepine|antipsychotics - benzodiazepine
5787326|NCT00159133|maintenance treatment|maintenance treatment
5787327|NCT00159133|drug discontinuation|drug discontinuation
5787328|NCT00159120|Schizophrenia|schizophrenia
5787329|NCT00159120|first episode|first episode
5787330|NCT00159120|neuroleptic maintenance treatment|neuroleptic maintenance treatment
5787331|NCT00159120|drug discontinuation|drug discontinuation
5787332|NCT00159120|prodrome based early intervention|prodrome based early intervention
5787333|NCT00159107|alcoholism|alcoholism
5787334|NCT00159107|abstinence enhancement|abstinence enhancement
5787335|NCT00159107|psychotherapy|psychotherapy
5787336|NCT00159107|cognitive behavior therapy vs. supportive counseling|cognitive behavior therapy vs. supportive counseling
5787337|NCT00159107|Acamprosate vs. Placebo|acamprosate vs. placebo
5787338|NCT00159107|multi-center study|multi-center study
5787339|NCT00159081|Schizophrenia|schizophrenia
5787340|NCT00159081|first episode|first episode
5787341|NCT00159081|long-term treatment|long-term treatment
5787342|NCT00159081|typical vs. atypical neuroleptics|typical vs. atypical neuroleptics
5787343|NCT00159003|drug metabolism and disposition enzymes|drug metabolism and disposition enzymes
5787344|NCT00158990|major depression|major depression
5787345|NCT00158990|bipolar disorder|bipolar disorder
5787346|NCT00158990|unipolar depression|unipolar depression
5787347|NCT00158990|sertraline|sertraline
5787348|NCT00158990|triiodothyronine|triiodothyronine
5787349|NCT00158977|heart failure|heart failure
5787350|NCT00158977|atrial fibrillation|atrial fibrillation
5787351|NCT00158977|cardiac resynchronization therapy defibrillator|cardiac resynchronization therapy defibrillator
5787352|NCT00158964|left ventricular lead|left ventricular lead
5787353|NCT00158964|pacing|pacing
5787354|NCT00158964|heart failure|heart failure
5787355|NCT00158951|Left Ventricular Lead|left ventricular lead
5787356|NCT00158951|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5787357|NCT00158951|Congestive Heart Failure|congestive heart failure
5787358|NCT00158938|Artificial Cardiac Pacemaker|artificial cardiac pacemaker
5787359|NCT00158938|Implanted Electrodes|implanted electrodes
5787360|NCT00158925|Artificial Cardiac Pacing|artificial cardiac pacing
5787361|NCT00158925|Implanted Electrodes|implanted electrodes
5787362|NCT00158899|HDLc|hdlc
5787363|NCT00158899|high-density lipoprotein|high-density lipoprotein
5787364|NCT00158899|Dyslipidemia|dyslipidemia
5787365|NCT00158886|oral topotecan rectal cancer pelvic radiation|oral topotecan rectal cancer pelvic radiation
5787366|NCT00158873|ICU mechanical ventilation analgesia sedation|icu mechanical ventilation analgesia sedation
5787367|NCT00158860|VALTREX®|valtrex®
5787368|NCT00158860|valaciclovir|valaciclovir
5787369|NCT00158860|genital herpes|genital herpes
5787370|NCT00158860|HSV-2|hsv-2
5787371|NCT00158860|suppression|suppression
5787478|NCT00158418|randomized trial|randomized trial
5787372|NCT00158847|COPD inflammation sputum lung function biopsy|copd inflammation sputum lung function biopsy
5787373|NCT00158834|Children|children
5787374|NCT00158834|Asthma|asthma
5787375|NCT00158834|bronchial hyperresponsiveness|bronchial hyperresponsiveness
5787376|NCT00158834|symptoms|symptoms
5787378|NCT00158821|Antiretroviral|antiretroviral
5787379|NCT00158821|Treatment Experienced|treatment experienced
5787380|NCT00158821|HIV-1|hiv-1
5787381|NCT00158782|Cancer GW786034 Lapatinib Pazopanib|cancer gw786034 lapatinib pazopanib
5787382|NCT00158769|Hepatic Impairment|hepatic impairment
5787383|NCT00158769|GR270773|gr270773
5787384|NCT00158769|Emulsion|emulsion
5787385|NCT00158756|Diphtheria|diphtheria
5787386|NCT00158756|Pertussis|pertussis
5787387|NCT00158756|Prophylaxis|prophylaxis
5787388|NCT00158756|Hepatitis B diseases|hepatitis b diseases
5787389|NCT00158756|Tetanus|tetanus
5787390|NCT00158743|Pre-eclampsia|pre-eclampsia
5787391|NCT00158743|Hypertension|hypertension
5787392|NCT00158743|Endogenous digitalis-like factor|endogenous digitalis-like factor
5787393|NCT00158743|Anti-digoxin antibody|anti-digoxin antibody
5787394|NCT00158743|Digibind|digibind
5787395|NCT00158717|Chronic Hepatitis B|chronic hepatitis b
5787396|NCT00158704|Chronic Hepatitis B|chronic hepatitis b
5787397|NCT00158691|Head and Neck cancer|head and neck cancer
5787398|NCT00158691|Radiotherapy|radiotherapy
5787399|NCT00158691|Xerostomia|xerostomia
5787400|NCT00158691|Randomized trial|randomized trial
5787401|NCT00158678|oral cancer|oral cancer
5804075|NCT00092170|Acute pelvic infections|acute pelvic infections
5804076|NCT00092157|High cholesterol|high cholesterol
5804077|NCT00092105|Rhinitis, Allergic|rhinitis, allergic
5804078|NCT00092053|Postmenopausal|postmenopausal
5804079|NCT00092053|Osteoporosis|osteoporosis
5804080|NCT00092235|cGVHD-associated graft-versus-tumor effects (GVT)|cgvhd-associated graft-versus-tumor effects (gvt)
5804081|NCT00092235|Allo-HSCT controls|allo-hsct controls
5804082|NCT00092235|Leukapheresis|leukapheresis
5787402|NCT00158678|oropharynx cancer|oropharynx cancer
5787403|NCT00158678|hypopharynx cancer|hypopharynx cancer
5787405|NCT00158665|Influenza|influenza
5787406|NCT00158665|Vaccination|vaccination
5787407|NCT00158665|Immunization|immunization
5787408|NCT00158665|Flu|flu
5787409|NCT00158665|Immunogenicity|immunogenicity
5787410|NCT00158652|Head and neck squamous cell carcinoma|head and neck squamous cell carcinoma
5787411|NCT00158652|Radiotherapy|radiotherapy
5787412|NCT00158652|Chemotherapy|chemotherapy
5787413|NCT00158639|Blood Pressure Monitoring, home|blood pressure monitoring, home
5787414|NCT00158639|Pharmaceutical services|pharmaceutical services
5787415|NCT00158639|Self care|self care
5787416|NCT00158626|physical therapy|physical therapy
5787417|NCT00158626|physiotherapy|physiotherapy
5787418|NCT00158626|pelvic organ prolapse|pelvic organ prolapse
5787419|NCT00158600|Glycogen Storage Disease Type II|glycogen storage disease type ii
5787420|NCT00158600|GSD-II|gsd-ii
5787421|NCT00158600|Pompe Disease|pompe disease
5787422|NCT00158587|Vivax|vivax
5787423|NCT00158587|Treatment|treatment
5787424|NCT00158587|Primaquine|primaquine
5787425|NCT00158587|Asia|asia
5787426|NCT00158574|intermittent preventive treatment|intermittent preventive treatment
5787427|NCT00158574|malaria|malaria
5787428|NCT00158574|efficacy|efficacy
5787429|NCT00158574|safety|safety
5787430|NCT00158574|drug options|drug options
5787431|NCT00158561|vivax|vivax
5787432|NCT00158561|treatment|treatment
5787433|NCT00158561|Asia|asia
5787434|NCT00158548|Falciparum|falciparum
5787435|NCT00158548|Vivax|vivax
5787436|NCT00158548|Treatment|treatment
5787437|NCT00158548|Asia|asia
5787438|NCT00158535|Liver Transplantation|liver transplantation
5787439|NCT00158535|Hepatitis C|hepatitis c
5787440|NCT00158535|HIV Infections|hiv infections
5787441|NCT00158522|Acute hepatitis C|acute hepatitis c
5787442|NCT00158522|Genotype 4|genotype 4
5787443|NCT00158522|Pegylated Interferon|pegylated interferon
5787444|NCT00158522|Egypt|egypt
5787445|NCT00158509|Valacyclovir|valacyclovir
5787446|NCT00158509|HIV-1|hiv-1
5787447|NCT00158509|HSV-2|hsv-2
5787448|NCT00158509|genital shedding|genital shedding
5787449|NCT00158509|herpes genitalis|herpes genitalis
5787450|NCT00158509|HIV infection|hiv infection
5787451|NCT00158496|Chronic Hepatitis C|chronic hepatitis c
5787452|NCT00158496|Genotype 4|genotype 4
5787453|NCT00158496|Pegylated Interferon|pegylated interferon
5787454|NCT00158496|Ribavirin|ribavirin
5787455|NCT00158496|Egypt|egypt
5787456|NCT00158483|Genital herpes|genital herpes
5787457|NCT00158483|Cofactors of sexual transmission|cofactors of sexual transmission
5787458|NCT00158483|Syndromic treatment|syndromic treatment
5787459|NCT00158483|Genital viral load|genital viral load
5787460|NCT00158483|Ulcer|ulcer
5787461|NCT00158470|HIV infection|hiv infection
5787462|NCT00158470|injecting drug users|injecting drug users
5787463|NCT00158470|HAART|haart
5787464|NCT00158470|once daily regimen|once daily regimen
5787465|NCT00158470|Treatment Naive|treatment naive
5787466|NCT00158457|Simplification regimen|simplification regimen
5788151|NCT00155129|nociceptin|nociceptin
5787467|NCT00158457|HIV infection|hiv infection
5787468|NCT00158457|Once a day|once a day
5787469|NCT00158457|Naive patients|naive patients
5787470|NCT00158457|Sub-saharian Africa|sub-saharian africa
5787471|NCT00158457|Treatment Naive|treatment naive
5787472|NCT00158431|osteoarthritis|osteoarthritis
5787473|NCT00158431|randomized trial|randomized trial
5787475|NCT00158431|quality of life|quality of life
5787476|NCT00158418|osteoarthritis|osteoarthritis
5787477|NCT00158418|shoulder|shoulder
5787481|NCT00158405|Structured treatment interruption|structured treatment interruption
5787482|NCT00158405|HAART|haart
5787483|NCT00158405|Sub-saharian africa|sub-saharian africa
5787484|NCT00158405|Treatment Interruption|treatment interruption
5787485|NCT00158405|Treatment Naive|treatment naive
5787486|NCT00158366|Weight Loss|weight loss
5787487|NCT00158353|Mentors|mentors
5787488|NCT00158353|Self-esteem|self-esteem
5787489|NCT00158353|Adolescent|adolescent
5787490|NCT00158353|Mental health|mental health
5787491|NCT00158353|Social support|social support
5796330|NCT00119496|Asthma|asthma
5787492|NCT00158353|Substance use|substance use
5787493|NCT00158353|Violence|violence
5787494|NCT00158353|Exercise|exercise
5787495|NCT00158353|Nutrition|nutrition
5787496|NCT00158353|Sexual behavior|sexual behavior
5787497|NCT00158353|Female|female
5787498|NCT00158340|Binge Eating|binge eating
5787499|NCT00158340|Overeating|overeating
5787500|NCT00158340|Compulsive Eating|compulsive eating
5787501|NCT00158340|Hyperphagia|hyperphagia
5787502|NCT00158327|Primary Health Care|primary health care
5787503|NCT00158314|Pathological gambling|pathological gambling
5787504|NCT00158314|Gambler's anonymous|gambler's anonymous
5787505|NCT00158314|Cognitive behavioral therapy|cognitive behavioral therapy
5787507|NCT00158301|Child|child
5787508|NCT00158301|Adolescent|adolescent
5787509|NCT00158301|CBT|cbt
5787510|NCT00158301|Drug Therapy|drug therapy
5787511|NCT00158288|Substance Use Disorders|substance use disorders
5787512|NCT00158275|Cognitive behavioral therapy|cognitive behavioral therapy
5787513|NCT00158275|Problem solving therapy|problem solving therapy
5787514|NCT00158275|CBT|cbt
5787515|NCT00158262|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5787516|NCT00158262|Prevention|prevention
5787517|NCT00158262|Propranolol|propranolol
5787518|NCT00158262|Psychophysiology|psychophysiology
5787519|NCT00158249|citicoline, drug abuse, marijuana|citicoline, drug abuse, marijuana
5787520|NCT00158236|Opiate Addiction|opiate addiction
5787521|NCT00158236|Opiate Dependence|opiate dependence
5787522|NCT00158223|Schizophrenia|schizophrenia
5787523|NCT00158223|Clozapine|clozapine
5787524|NCT00158223|Treatment|treatment
5787525|NCT00158223|Combination|combination
5787526|NCT00158223|Unresponsive|unresponsive
5787527|NCT00158223|Schizoaffective Disorders|schizoaffective disorders
5787528|NCT00158197|Adherence|adherence
5787529|NCT00158197|Amphetamine-Related Disorders|amphetamine-related disorders
5787530|NCT00158197|Behavior Therapy|behavior therapy
5787531|NCT00158197|Contingency management|contingency management
5787532|NCT00158197|Drug Counseling|drug counseling
5787533|NCT00158197|health behaviors|health behaviors
5787534|NCT00158197|methamphetamine|methamphetamine
5787535|NCT00158197|sexual risk behaviors|sexual risk behaviors
5787536|NCT00158197|substance dependence|substance dependence
5787537|NCT00158184|Opiate|opiate
5787538|NCT00158184|Opioid|opioid
5787539|NCT00158184|Abuse Liability|abuse liability
5787540|NCT00158184|Abuse Potential|abuse potential
5787541|NCT00158171|smoking addiction|smoking addiction
5787542|NCT00158158|smoking addiction|smoking addiction
5787543|NCT00158132|cocaine|cocaine
5787544|NCT00158119|strength training|strength training
5787545|NCT00158119|power training|power training
5787546|NCT00158119|exercise training|exercise training
5787547|NCT00158119|functional performance tasks|functional performance tasks
5787548|NCT00158106|functional communicative ability|functional communicative ability
5787549|NCT00158106|cost effectiveness|cost effectiveness
5787550|NCT00158106|service user preferences|service user preferences
5787551|NCT00158067|Epilepsy|epilepsy
5787552|NCT00158067|Neurostimulation|neurostimulation
5787553|NCT00158054|depression|depression
5787554|NCT00158054|acute coronary syndrome|acute coronary syndrome
5787555|NCT00158054|clinical trials|clinical trials
5787556|NCT00158041|Amifostine|amifostine
5787557|NCT00158041|Mucositis|mucositis
5787558|NCT00158041|Nausea|nausea
5787559|NCT00158041|Hypotension|hypotension
5787560|NCT00158041|Rash|rash
5787561|NCT00158028|Schizotypal Personality Disorder|schizotypal personality disorder
5787562|NCT00158028|Risperidone|risperidone
5787563|NCT00158028|Treatment|treatment
5787564|NCT00158028|Cognitive|cognitive
5787565|NCT00158015|Echocardiography|echocardiography
5787566|NCT00158015|tissue Doppler Imaging|tissue doppler imaging
5787567|NCT00158015|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5787568|NCT00158002|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
5787569|NCT00158002|Prophylaxis|prophylaxis
5787570|NCT00157989|Infant, Premature|infant, premature
5787571|NCT00157976|Macular Degeneration|macular degeneration
5787572|NCT00157976|AMD|amd
5787573|NCT00157976|Visual Acuity|visual acuity
5787574|NCT00157950|Human Papilloma Virus|human papilloma virus
5787575|NCT00157885|Falciparum|falciparum
5787576|NCT00157885|Vivax|vivax
5787577|NCT00157885|Papua|papua
5787578|NCT00157885|Amodiaquine|amodiaquine
5787579|NCT00157885|Artekin|artekin
5787580|NCT00157885|Artemisinin Combination Therapy|artemisinin combination therapy
5787581|NCT00157885|Dihydroartemisinin|dihydroartemisinin
5787582|NCT00157885|Piperaquine|piperaquine
5787583|NCT00157885|Lumefantrine|lumefantrine
5787584|NCT00157885|Artemether|artemether
5787589|NCT00157859|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5787590|NCT00157846|Heart Failure|heart failure
5787591|NCT00157846|LVEF < 35%|lvef < 35%
5787592|NCT00157846|Bradycardia|bradycardia
5787593|NCT00157833|Coartemether|coartemether
5787594|NCT00157833|Artekin|artekin
5787595|NCT00157833|Papua|papua
5787596|NCT00157833|Uncomplicated malaria|uncomplicated malaria
5787597|NCT00157820|Defibrillators, Implantable|defibrillators, implantable
5787272|NCT00159341|whole blood|whole blood
5787598|NCT00157820|Atrial Fibrillation|atrial fibrillation
5848706|NCT00034008|Neonatal intensive care|neonatal intensive care
5681128|NCT00574613|soluble collagen|soluble collagen
5787599|NCT00157820|Ventricular Tachyarrhythmias|ventricular tachyarrhythmias
5787601|NCT00157807|Persistent Atrial Fibrillation|persistent atrial fibrillation
5787602|NCT00157807|Permanent Atrial Fibrillation|permanent atrial fibrillation
5787603|NCT00157807|Mitral Valve Defect|mitral valve defect
5787604|NCT00157807|Tricuspid Valve Defect|tricuspid valve defect
5787605|NCT00157807|Aortic Valve Defect|aortic valve defect
5787606|NCT00157794|Sinus Node Disease|sinus node disease
5787607|NCT00157794|Pacemaker|pacemaker
5787608|NCT00157794|Dual Chamber Pacemaker|dual chamber pacemaker
5787609|NCT00157781|Atrial Fibrillation|atrial fibrillation
5787610|NCT00157781|Atrial Tachyarrhythmia|atrial tachyarrhythmia
5787611|NCT00157781|Pacing|pacing
5787612|NCT00157781|Electrophysiology|electrophysiology
5787613|NCT00157768|Acute myocardial infarction|acute myocardial infarction
5787614|NCT00157768|Non-sustained ventricular tachycardia|non-sustained ventricular tachycardia
5787615|NCT00157768|Left ventricular dysfunction|left ventricular dysfunction
5787616|NCT00157768|Implantable cardioverter defibrillator|implantable cardioverter defibrillator
5787618|NCT00157768|Risk-stratification|risk-stratification
5787619|NCT00157755|Nausea and Vomiting|nausea and vomiting
5787620|NCT00157742|Angina Pectoris|angina pectoris
5787621|NCT00157742|Spinal Cord Stimulation (SCS)|spinal cord stimulation (scs)
5787622|NCT00157742|Percutaneous Myocardial Revascularisation (PMR)|percutaneous myocardial revascularisation (pmr)
5787623|NCT00157742|Refractory Angina Pectoris|refractory angina pectoris
5787625|NCT00157729|antihypertensive agents|antihypertensive agents
5787626|NCT00157729|diabetes mellitus type 2|diabetes mellitus type 2
5787627|NCT00157729|metabolic syndrome|metabolic syndrome
5787628|NCT00157716|Coronary|coronary
5787629|NCT00157716|surgery|surgery
5787630|NCT00157716|ischemia|ischemia
5787631|NCT00157716|reperfusion injury|reperfusion injury
5787632|NCT00157716|cardiac|cardiac
5787633|NCT00157716|heart|heart
5787634|NCT00157716|neurological|neurological
5787635|NCT00157716|cardiopulmonary bypass|cardiopulmonary bypass
5787636|NCT00157716|cardioprotection|cardioprotection
5787637|NCT00157703|Malignant glioma|malignant glioma
5787638|NCT00157703|Glioblastoma multiforme|glioblastoma multiforme
5787639|NCT00157703|GBM|gbm
5787640|NCT00157703|Gliosarcoma|gliosarcoma
5787641|NCT00157703|Anaplastic astrocytoma|anaplastic astrocytoma
5787642|NCT00157703|Brain cancer|brain cancer
5787643|NCT00157703|Brain tumor|brain tumor
5787644|NCT00157703|Glioma|glioma
5787645|NCT00157703|recurrent/progressive malignant glioma|recurrent/progressive malignant glioma
5787646|NCT00157690|Alendronate|alendronate
5787647|NCT00157690|Bisphosphonates|bisphosphonates
5787648|NCT00157690|Cystic Fibrosis|cystic fibrosis
5787649|NCT00157690|Osteoporosis|osteoporosis
5787650|NCT00157677|deep vein thrombosis|deep vein thrombosis
5787651|NCT00157677|pulmonary embolism|pulmonary embolism
5787652|NCT00157677|D-dimer testing|d-dimer testing
5787653|NCT00157651|end stage renal disease|end stage renal disease
5787654|NCT00157651|thrombosis|thrombosis
5787655|NCT00157651|bleeding|bleeding
5787656|NCT00157638|pharmacist|pharmacist
5787657|NCT00157638|physician|physician
5787658|NCT00157638|primary care|primary care
5787659|NCT00157638|collaboration|collaboration
5787660|NCT00157638|therapeutics|therapeutics
5787661|NCT00157625|urinary infections, catheters, bacteriuria, trial|urinary infections, catheters, bacteriuria, trial
5787662|NCT00157612|pneumonia|pneumonia
5787663|NCT00157612|lower respiratory tract infection|lower respiratory tract infection
5787664|NCT00157612|clinical pathway|clinical pathway
5787665|NCT00157612|nursing home|nursing home
5787666|NCT00157612|long-term care|long-term care
5787667|NCT00157612|randomized control trial|randomized control trial
5787668|NCT00157599|deep vein thrombosis|deep vein thrombosis
5787669|NCT00157599|DVT|dvt
5787670|NCT00157573|Asymptomatic|asymptomatic
5787671|NCT00157573|Clinical trial|clinical trial
5787672|NCT00157573|Phase II|phase ii
5787673|NCT00157573|GM-CSF|gm-csf
5787674|NCT00157573|Immunotherapy|immunotherapy
5787675|NCT00157547|Depression|depression
5787676|NCT00157547|Quantitative EEG (QEEG)|quantitative eeg (qeeg)
5787677|NCT00157547|Antidepressants|antidepressants
5787678|NCT00157534|Hepatitis C|hepatitis c
5787679|NCT00157534|Celgosivir|celgosivir
5787680|NCT00157534|HCV|hcv
5787681|NCT00157534|Genotype 1|genotype 1
5787682|NCT00157378|first episode,|first episode,
5787683|NCT00157378|schizophrenia,|schizophrenia,
5787684|NCT00157378|atypical neuroleptics,|atypical neuroleptics,
5787685|NCT00157378|negative symptoms|negative symptoms
5787686|NCT00157326|High Blood Pressure|high blood pressure
5787687|NCT00157313|Schizophrenia|schizophrenia
5787688|NCT00157313|First episode psychosis|first episode psychosis
5787689|NCT00157313|Psychosocial intervention|psychosocial intervention
5787690|NCT00157300|erythropoietin|erythropoietin
5787691|NCT00157300|kidney transplantation|kidney transplantation
5787692|NCT00157300|delayed graft function|delayed graft function
5787693|NCT00157274|Alemtuzumab|alemtuzumab
5787694|NCT00157274|Mycosis fungoides|mycosis fungoides
5786861|NCT00161187|stage I rectal cancer|stage i rectal cancer
5787695|NCT00157274|Sezary|sezary
5787696|NCT00157222|Charcot|charcot
5787697|NCT00157222|Diabetic|diabetic
5787698|NCT00157222|osteoporosis|osteoporosis
5787699|NCT00157196|Carcinoma, Non-Small-Cell Lung, L-BLP25, Tecemotide|carcinoma, non-small-cell lung, l-blp25, tecemotide
5787701|NCT00157183|hypoxia|hypoxia
5787702|NCT00157183|oxygen|oxygen
5787703|NCT00157183|noninvasive ventilation|noninvasive ventilation
5787704|NCT00157183|quality of life|quality of life
5787705|NCT00157170|exercise|exercise
5787706|NCT00157170|self efficacy|self efficacy
5787707|NCT00157170|quality of life|quality of life
5787708|NCT00157170|HIV|hiv
5787709|NCT00157157|Factor VIII Deficiency|factor viii deficiency
5787710|NCT00157144|Lung Transplantation|lung transplantation
5787711|NCT00157144|Heart Transplantation|heart transplantation
5787712|NCT00157131|autologous sheet skin grafts|autologous sheet skin grafts
5787713|NCT00157131|FS 4IU VH S/D|fs 4iu vh s/d
5787714|NCT00157131|skin grafts|skin grafts
5787715|NCT00157131|burn|burn
5787716|NCT00157118|Severe congenital protein C deficiency|severe congenital protein c deficiency
5787717|NCT00157079|PID|pid
5787718|NCT00157079|Immunodeficiency|immunodeficiency
5787719|NCT00157079|Immune Thrombocytopenic Purpura (ITP)|immune thrombocytopenic purpura (itp)
5787720|NCT00157079|Kawasaki syndrome|kawasaki syndrome
5787721|NCT00157066|Latent tuberculosis infection|latent tuberculosis infection
5787722|NCT00157066|Active tuberculosis infection|active tuberculosis infection
5787723|NCT00157053|Factor VIII Deficiency|factor viii deficiency
5787724|NCT00157040|Factor VIII Deficiency|factor viii deficiency
5787725|NCT00157027|Treatment Experienced|treatment experienced
5787726|NCT00157027|HIV-1 Positive by ELISA Assay|hiv-1 positive by elisa assay
5787727|NCT00157027|Confirmed by Western Blot|confirmed by western blot
5787728|NCT00157027|Refractory or intolerant to HAART|refractory or intolerant to haart
5787729|NCT00157014|Antirejection|antirejection
5787730|NCT00157014|Treatment Outcome|treatment outcome
5787731|NCT00157014|Immunosuppression|immunosuppression
5787732|NCT00157014|Treatment Effectiveness|treatment effectiveness
5787733|NCT00157014|Anti-rejection therapy|anti-rejection therapy
5787734|NCT00156988|burns|burns
5787735|NCT00156988|partial thickness|partial thickness
5787736|NCT00156988|cerium flamazine|cerium flamazine
5787737|NCT00156988|randomised clinical trial|randomised clinical trial
5787738|NCT00156975|Oxaliplatin|oxaliplatin
5787739|NCT00156975|Capecitabine|capecitabine
5787740|NCT00156975|Chemotherapy|chemotherapy
5787741|NCT00156975|Resection|resection
5787742|NCT00156975|Liver metastases|liver metastases
5787743|NCT00156975|Liver resection|liver resection
5787744|NCT00156975|Adjuvant|adjuvant
5787745|NCT00156962|Epogen|epogen
5787746|NCT00156962|Procrit|procrit
5787747|NCT00156962|Chronic Kidney Disease|chronic kidney disease
5787748|NCT00156962|Anemia Treatment|anemia treatment
5787749|NCT00156949|Epogen|epogen
5787750|NCT00156949|Procrit|procrit
5787751|NCT00156949|Chronic Kidney Disease|chronic kidney disease
5787752|NCT00156949|Anemia Treatment for Dialysis Patients|anemia treatment for dialysis patients
5787753|NCT00156923|Alcohol dependence|alcohol dependence
5787754|NCT00156897|Non-insulin-dependent diabetes mellitus|non-insulin-dependent diabetes mellitus
5787755|NCT00156897|NIDDM|niddm
5787756|NCT00156897|Type II diabetes|type ii diabetes
5787757|NCT00156897|Obesity|obesity
5787758|NCT00156897|Lipase inhibitor|lipase inhibitor
5787759|NCT00156884|prostate cancer|prostate cancer
5787760|NCT00156884|cisplatin|cisplatin
5787761|NCT00156884|strontium-89|strontium-89
5787762|NCT00156884|phase II|phase ii
5787763|NCT00156871|transplant|transplant
5787764|NCT00156871|fatigue|fatigue
5787765|NCT00156871|exercise|exercise
5787766|NCT00156871|Malignant disease|malignant disease
5787767|NCT00156858|pharmacokinetics|pharmacokinetics
5787768|NCT00156858|transplantation|transplantation
5787769|NCT00156858|busulfan|busulfan
5787770|NCT00156845|coronary artery disease|coronary artery disease
5787771|NCT00156845|ischemia|ischemia
5787773|NCT00156845|cardiac imaging|cardiac imaging
5787774|NCT00156845|heart disease|heart disease
5787775|NCT00156845|myocardial contrast enhancement|myocardial contrast enhancement
5787776|NCT00156845|myocardial perfusion|myocardial perfusion
5787777|NCT00156845|wall motion|wall motion
5787778|NCT00156845|ultrasound contrast agent|ultrasound contrast agent
5787779|NCT00156819|Asthma|asthma
5787780|NCT00156819|Asthma Control|asthma control
5787781|NCT00156806|aloe|aloe
5787782|NCT00156806|radiation dermatitis|radiation dermatitis
5787783|NCT00156806|radiation therapy|radiation therapy
5787784|NCT00156793|coronary artery disease|coronary artery disease
5787785|NCT00156793|ischemia|ischemia
5787786|NCT00156793|echocardiography|echocardiography
5787787|NCT00156793|cardiac imaging|cardiac imaging
5787788|NCT00156793|heart disease|heart disease
5787789|NCT00156793|myocardial contrast enhancement|myocardial contrast enhancement
5787790|NCT00156793|myocardial perfusion|myocardial perfusion
5787791|NCT00156793|wall motion|wall motion
5787792|NCT00156793|ultrasound contrast agent|ultrasound contrast agent
5787793|NCT00156780|ultrasound contrast agent|ultrasound contrast agent
5797040|NCT00116935|KIT|kit
5787794|NCT00156780|pharmacokinetics|pharmacokinetics
5787795|NCT00156780|congestive heart failure|congestive heart failure
5787796|NCT00156780|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5787800|NCT00156741|Refined ventricular pacing|refined ventricular pacing
5787801|NCT00156728|Pacemaker artificial, congestive heart failure and atrial fibrillation|pacemaker artificial, congestive heart failure and atrial fibrillation
5787803|NCT00156715|Seroquel|seroquel
5787804|NCT00156715|Schizophrenia|schizophrenia
5787805|NCT00156715|Dual Diagnosis|dual diagnosis
5787806|NCT00156715|Substance Abuse|substance abuse
5787807|NCT00156715|Alcohol Abuse|alcohol abuse
5787809|NCT00156702|Adolescents|adolescents
5787810|NCT00156702|Motivational Interviewing|motivational interviewing
5787811|NCT00156689|polyneuropathy|polyneuropathy
5787812|NCT00156676|Disability|disability
5787813|NCT00156676|Gait|gait
5787814|NCT00156676|Multiple Sclerosis|multiple sclerosis
5787815|NCT00156676|Rehabilitation|rehabilitation
5787816|NCT00156676|Robot|robot
5787817|NCT00156663|Women|women
5787818|NCT00156663|Veterans|veterans
5787819|NCT00156663|Delivery of Healthcare|delivery of healthcare
5787820|NCT00156663|Intervention Studies|intervention studies
5787821|NCT00156663|United States Department of Veterans Affairs|united states department of veterans affairs
5787822|NCT00156663|Women's Health|women's health
5787823|NCT00156650|Male contraception|male contraception
5787824|NCT00156650|Testosterone|testosterone
5787825|NCT00156637|schizophrenia|schizophrenia
5787826|NCT00156637|quality of health care|quality of health care
5787827|NCT00156637|quality indicators|quality indicators
5787829|NCT00156624|Intervention|intervention
5787830|NCT00156624|Peripheral Vascular Disease|peripheral vascular disease
5787831|NCT00156624|Drug|drug
5787832|NCT00156624|Restenosis|restenosis
5787833|NCT00156624|18 years and above|18 years and above
5787834|NCT00156611|peripheral vascular disease|peripheral vascular disease
5787835|NCT00156611|intervention|intervention
5787836|NCT00156611|restenosis|restenosis
5787837|NCT00156611|Age above 18 years|age above 18 years
5787838|NCT00156598|metal ion concentration|metal ion concentration
5787839|NCT00156585|cerebral metastases|cerebral metastases
5787840|NCT00156585|dynamic contrast enhanced magnetic resonance imaging|dynamic contrast enhanced magnetic resonance imaging
5787841|NCT00156585|DCE-MRI|dce-mri
5787842|NCT00156585|gamma knife|gamma knife
5787843|NCT00156559|immunization|immunization
5787844|NCT00156559|vaccine|vaccine
5787845|NCT00156559|low birth weight infant|low birth weight infant
5787846|NCT00156559|premature infant|premature infant
5787847|NCT00156546|Urinary tract infections|urinary tract infections
5787848|NCT00156546|Children|children
5787849|NCT00156546|Antibiotic prophylaxis|antibiotic prophylaxis
5787850|NCT00156546|Renal scintigraphy|renal scintigraphy
5787851|NCT00156546|Vesico ureteral reflux|vesico ureteral reflux
5787852|NCT00156533|Insomnia|insomnia
5787853|NCT00156533|Sleep|sleep
5787854|NCT00156533|zolpidem|zolpidem
5787855|NCT00156533|Ambien|ambien
5787856|NCT00156533|Hypnotics|hypnotics
5787857|NCT00156455|Children|children
5787858|NCT00156455|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5787859|NCT00156455|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5787860|NCT00156455|Single Ventricle Physiology|single ventricle physiology
5787861|NCT00156442|Obstructive Sleep Apnea Syndrome|obstructive sleep apnea syndrome
5787862|NCT00156442|Cleft lip/palate|cleft lip/palate
5787863|NCT00156442|Children|children
5787864|NCT00156429|genetic testing|genetic testing
5787865|NCT00156416|menopause|menopause
5787866|NCT00156416|hot flash|hot flash
5787867|NCT00156416|night sweat|night sweat
5787868|NCT00156416|meditation|meditation
5787869|NCT00156416|breast cancer|breast cancer
5788152|NCT00155103|Hepatitis B|hepatitis b
5787870|NCT00156403|pancreatitis, hereditary|pancreatitis, hereditary
5787871|NCT00156403|trypsinogen, cationic|trypsinogen, cationic
5787872|NCT00156403|pilot study|pilot study
5787873|NCT00156377|Mupirocin|mupirocin
5787874|NCT00156377|Staphylococcus aureus|staphylococcus aureus
5787875|NCT00156377|Nasal Cavity|nasal cavity
5787876|NCT00156377|Preventive measures|preventive measures
5787877|NCT00156364|Diabetic Nephropathy|diabetic nephropathy
5787878|NCT00156364|Kidney Transplant|kidney transplant
5787879|NCT00156364|Pancreas Transplant|pancreas transplant
5787880|NCT00156364|Renal Interstitium|renal interstitium
5787881|NCT00156364|Diabetes Mellitus|diabetes mellitus
5787882|NCT00156364|Cyclosporine|cyclosporine
5787883|NCT00156364|Tacrolimus|tacrolimus
5787884|NCT00156351|African Americans|african americans
5787885|NCT00156351|Women|women
5787886|NCT00156351|Internet|internet
5787887|NCT00156351|Telephone Counseling|telephone counseling
5787888|NCT00156338|Fluid therapy|fluid therapy
5787889|NCT00156325|Bipolar Disorder|bipolar disorder
5787890|NCT00156325|Depression|depression
5787891|NCT00156325|Hypomania|hypomania
5787892|NCT00156325|Mood Stabilizer|mood stabilizer
5787893|NCT00156299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5787894|NCT00156299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5787021|NCT00160823|Quality|quality
5787895|NCT00156299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5848817|NCT00033163|Antiviral Agents|antiviral agents
5787896|NCT00156299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5787897|NCT00156299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5787898|NCT00156299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5787899|NCT00156299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5787900|NCT00156299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5787901|NCT00156299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5787902|NCT00156299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5787903|NCT00156299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5787904|NCT00156299|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5787905|NCT00156299|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5787906|NCT00156299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5787907|NCT00156247|psoriasis|psoriasis
5787908|NCT00156247|etanercept|etanercept
5787909|NCT00156247|acitretin|acitretin
5787912|NCT00156221|Developmental Disorders|developmental disorders
5787913|NCT00156208|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5787914|NCT00156208|Excessive Uterine Bleeding|excessive uterine bleeding
5787915|NCT00156208|Uterine Hemorrhage|uterine hemorrhage
5787916|NCT00156208|asoprisnil|asoprisnil
5787917|NCT00156195|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5787918|NCT00156195|Excessive Uterine Bleeding|excessive uterine bleeding
5787919|NCT00156195|Uterine Hemorrhage|uterine hemorrhage
5787920|NCT00156195|asoprisnil|asoprisnil
5787921|NCT00156182|Fibroid Uterus|fibroid uterus
5787922|NCT00156182|Leiomyoma|leiomyoma
5787923|NCT00156182|Uterine Fibroids|uterine fibroids
5787924|NCT00156182|asoprisnil|asoprisnil
5787925|NCT00156156|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5787926|NCT00156156|Excessive Uterine Bleeding|excessive uterine bleeding
5787927|NCT00156156|Uterine Hemorrhage|uterine hemorrhage
5787928|NCT00156130|Breast Cancer|breast cancer
5787929|NCT00156130|Lumpectomy|lumpectomy
5787930|NCT00156130|Radiotherapy|radiotherapy
5787931|NCT00156130|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5787932|NCT00156130|Long Term Outcomes|long term outcomes
5787933|NCT00156052|Breast Cancer|breast cancer
5787934|NCT00156052|Hypofractionated Radiotherapy|hypofractionated radiotherapy
5787935|NCT00156052|Lumpectomy|lumpectomy
5787936|NCT00156039|Breast Cancer|breast cancer
5787937|NCT00156039|Follow-up Strategy|follow-up strategy
5787938|NCT00156039|Follow-up Care|follow-up care
5787939|NCT00156039|Family Physician|family physician
5787940|NCT00156039|Oncologist|oncologist
5787941|NCT00156026|CIN 1|cin 1
5787942|NCT00156026|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5787943|NCT00156026|cervix|cervix
5787944|NCT00156026|cancer|cancer
5787945|NCT00156026|loop electrosurgical excision procedure|loop electrosurgical excision procedure
5787946|NCT00156026|LEEP|leep
5787947|NCT00156026|expectant management|expectant management
5787948|NCT00156026|human papilloma virus|human papilloma virus
5787949|NCT00156026|HPV|hpv
5787950|NCT00156026|colposcopy|colposcopy
5787951|NCT00156013|B-Cell NHL|b-cell nhl
5787952|NCT00156000|Preterm Delivery|preterm delivery
5787953|NCT00156000|Multifetal pregnancy|multifetal pregnancy
5787954|NCT00156000|Preterm Birth|preterm birth
5787955|NCT00156000|17-alpha Hydroxyprogesterone Caproate|17-alpha hydroxyprogesterone caproate
5787956|NCT00156000|Markers of Preterm Birth|markers of preterm birth
5787957|NCT00155987|Severe diffuse TBI refractory intracranial hypertension.|severe diffuse tbi refractory intracranial hypertension.
5787958|NCT00155974|Influenza|influenza
5787959|NCT00155974|Vaccination|vaccination
5787960|NCT00155974|Hard-to-Reach Populations|hard-to-reach populations
5787961|NCT00155974|Urban|urban
5787962|NCT00155974|Disadvantaged|disadvantaged
5787963|NCT00155961|Androgens|androgens
5787964|NCT00155961|Metabolic syndrome|metabolic syndrome
5787965|NCT00155961|Bone mineral density|bone mineral density
5787966|NCT00155961|Body composition|body composition
5787967|NCT00155961|Questionnaire|questionnaire
5787968|NCT00155948|Ultrasonography|ultrasonography
5787969|NCT00155948|Cervical Multifidus|cervical multifidus
5787970|NCT00155935|ovarian cancer|ovarian cancer
5787971|NCT00155935|immunotherapy|immunotherapy
5787972|NCT00155935|folate receptor|folate receptor
5787973|NCT00155935|Chemotherapy|chemotherapy
5787974|NCT00155922|Diabetes mellitus|diabetes mellitus
5787975|NCT00155922|Monocyte|monocyte
5787976|NCT00155922|Gene expression|gene expression
5787977|NCT00155922|Monocyte gene expression|monocyte gene expression
5787978|NCT00155909|Radiation Pneumonitis|radiation pneumonitis
5787979|NCT00155909|Radiotherapy Planning, Computer-Assisted|radiotherapy planning, computer-assisted
5787980|NCT00155896|BRCA1 gene, BRCA2 gene, DHPLC, genetic diagnosis|brca1 gene, brca2 gene, dhplc, genetic diagnosis
5787981|NCT00155870|laparoscopic assisted vaginal hysterectomy leiomyoma|laparoscopic assisted vaginal hysterectomy leiomyoma
5686475|NCT00551928|Lenalidomide|lenalidomide
5686476|NCT00551928|High dose Melphalan|high dose melphalan
5686477|NCT00551928|Mobilization|mobilization
5686478|NCT00551928|CD34|cd34
5686479|NCT00551902|Glaucoma|glaucoma
5787982|NCT00155870|adenomyosis|adenomyosis
5787983|NCT00155870|quality of life|quality of life
5787984|NCT00155857|glaucoma, genetic|glaucoma, genetic
5787985|NCT00155831|Premature infants|premature infants
5787986|NCT00155831|Kicking|kicking
5681222|NCT00574262|acute ischemic stroke|acute ischemic stroke
5787987|NCT00155831|Stepping|stepping
5787988|NCT00155831|Walking|walking
5787989|NCT00155831|Motor development|motor development
5787990|NCT00155831|Kinematics|kinematics
5787991|NCT00155818|DISC1|disc1
5787992|NCT00155818|Schizophrenia|schizophrenia
5787993|NCT00155818|Chromosome 1q|chromosome 1q
5787994|NCT00155818|Polymorphism detection|polymorphism detection
5787995|NCT00155818|Association study|association study
5787996|NCT00155818|Balanced translocation|balanced translocation
5787997|NCT00155818|DHPLC|dhplc
5787998|NCT00155805|Gastroesophageal reflux disease|gastroesophageal reflux disease
5787999|NCT00155805|reflux esophagitis|reflux esophagitis
5788000|NCT00155805|nonerosive reflux disease|nonerosive reflux disease
5788001|NCT00155805|Barrett’s esophagus|barrett’s esophagus
5788002|NCT00155805|hiatus hernia|hiatus hernia
5788003|NCT00155805|lower esophageal sphincter pressure|lower esophageal sphincter pressure
5788004|NCT00155805|24 hours esophageal pH monitor|24 hours esophageal ph monitor
5788005|NCT00155805|Helicobacter pylori|helicobacter pylori
5788006|NCT00155792|ervical cancer, human papillomavirus, immunotherapy|ervical cancer, human papillomavirus, immunotherapy
5788007|NCT00155779|adult respiratory distress syndrome|adult respiratory distress syndrome
5788008|NCT00155779|angiotensin-converting enzyme|angiotensin-converting enzyme
5788009|NCT00155779|polymorphism|polymorphism
5788010|NCT00155766|cervical cancer, immunotherapy, DC|cervical cancer, immunotherapy, dc
5788011|NCT00155753|pathological myopia, genomic|pathological myopia, genomic
5788012|NCT00155740|ovarian cancer|ovarian cancer
5788013|NCT00155740|tumor marker|tumor marker
5788014|NCT00155740|mesothelin|mesothelin
5788015|NCT00155727|colorectal cancer, laparoscopic colectomy|colorectal cancer, laparoscopic colectomy
5788016|NCT00155714|pulmonary arterial hypertension|pulmonary arterial hypertension
5788017|NCT00155714|type-5 phosphodiesterase Inhibitors|type-5 phosphodiesterase inhibitors
5788018|NCT00155714|Sildenafil|sildenafil
5788019|NCT00155701|DISC1|disc1
5788020|NCT00155701|Schizophrenia|schizophrenia
5788021|NCT00155701|Chromosome 1q|chromosome 1q
5788022|NCT00155701|Polymorphism detection|polymorphism detection
5788023|NCT00155701|Association study|association study
5788024|NCT00155701|Balanced translocation|balanced translocation
5788025|NCT00155701|DHPLC|dhplc
5788026|NCT00155688|Schizophrenia|schizophrenia
5788027|NCT00155688|linkage|linkage
5788028|NCT00155688|Taiwan|taiwan
5788029|NCT00155688|Han Chinese population|han chinese population
5788030|NCT00155662|work hardening|work hardening
5788031|NCT00155662|chronic low back pain over 3 months|chronic low back pain over 3 months
5788032|NCT00155649|schizophrenia|schizophrenia
5788033|NCT00155649|vulnerability gene|vulnerability gene
5788034|NCT00155649|positional cloning|positional cloning
5788035|NCT00155649|subtype definition|subtype definition
5788036|NCT00155649|endophenotype|endophenotype
5788037|NCT00155649|genetic marker|genetic marker
5788038|NCT00155649|genetic linkage|genetic linkage
5788039|NCT00155649|candidate genes|candidate genes
5788040|NCT00155636|Schizophrenia|schizophrenia
5788041|NCT00155623|H. pylori, 13C-urea breath test, serology, epidemiology|h. pylori, 13c-urea breath test, serology, epidemiology
5788042|NCT00155610|diabetic cystopathy|diabetic cystopathy
5788043|NCT00155610|bladder|bladder
5788044|NCT00155610|voiding dysfunction|voiding dysfunction
5788045|NCT00155610|current perception test|current perception test
5788046|NCT00155597|physical therapy|physical therapy
5788047|NCT00155597|post surgery|post surgery
5788048|NCT00155584|warts|warts
5788049|NCT00155584|photodynamic therapy|photodynamic therapy
5788050|NCT00155584|5-ALA|5-ala
5788051|NCT00155571|betel nut|betel nut
5788052|NCT00155571|periodontitis|periodontitis
5788053|NCT00155571|periodontal microbiology|periodontal microbiology
5788153|NCT00155103|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5788054|NCT00155558|Colorectal Cancer, Maximum tolerated dose|colorectal cancer, maximum tolerated dose
5788055|NCT00155545|functional scoliosis|functional scoliosis
5788056|NCT00155545|idiopathic scoliosis|idiopathic scoliosis
5788057|NCT00155545|leg length discrepancy|leg length discrepancy
5788058|NCT00155545|motion analysis|motion analysis
5788059|NCT00155545|biomechanics|biomechanics
5788060|NCT00155532|Peripheral neuropathy;systemic lupus erythematosus|peripheral neuropathy;systemic lupus erythematosus
5788061|NCT00155519|Schizophrenia|schizophrenia
5788062|NCT00155519|Latent Schizophrenia|latent schizophrenia
5788063|NCT00155519|Schizotypal Disorder|schizotypal disorder
5788064|NCT00155519|Psychopathology|psychopathology
5788065|NCT00155519|Neuropsychological Function|neuropsychological function
5788066|NCT00155519|Family History|family history
5788067|NCT00155519|Nosology|nosology
5788068|NCT00155519|basic symptoms|basic symptoms
5788069|NCT00155506|Schizophrenia|schizophrenia
5788072|NCT00155506|candidate gene|candidate gene
5788073|NCT00155506|one proband, normal parents and one normal sibling|one proband, normal parents and one normal sibling
5788074|NCT00155480|thoracic aorta|thoracic aorta
5788075|NCT00155480|finite element mesh|finite element mesh
5788076|NCT00155467|CT|ct
5788077|NCT00155467|children|children
5788079|NCT00155454|Diabetic retinopathy|diabetic retinopathy
5788080|NCT00155454|Vitrectomy|vitrectomy
5788081|NCT00155454|Postoperative vitreous hemorrahge|postoperative vitreous hemorrahge
5788082|NCT00155454|Intravitreal gas injection|intravitreal gas injection
5788083|NCT00155441|sleep disorder|sleep disorder
5788084|NCT00155441|peritoneal dialysis|peritoneal dialysis
5788085|NCT00155441|cognitive-behavioral therapy|cognitive-behavioral therapy
5788086|NCT00155441|sleep disorder:C23.888.592.796|sleep disorder:c23.888.592.796
5788087|NCT00155441|peritoneal dialysis: F03.870.664|peritoneal dialysis: f03.870.664
5788089|NCT00155428|rapid prototyping|rapid prototyping
5788090|NCT00155428|computed tomograpgy|computed tomograpgy
5788091|NCT00155415|Colonoscopy|colonoscopy
5788092|NCT00155415|Polyethylene glycol(PEG)|polyethylene glycol(peg)
5788093|NCT00155415|Colon neoplasm|colon neoplasm
5788094|NCT00155415|Colon cleansing|colon cleansing
5788095|NCT00155415|Timing|timing
5788096|NCT00155402|fibrin glue|fibrin glue
5788097|NCT00155402|corneal perforation|corneal perforation
5788098|NCT00155402|pterygium|pterygium
5788099|NCT00155402|conjunctiva|conjunctiva
5788100|NCT00155402|corneal ulcer|corneal ulcer
5788101|NCT00155389|Helicobacter pylori|helicobacter pylori
5788102|NCT00155389|Gastric cancer|gastric cancer
5788103|NCT00155389|single nucleotide polymorphism|single nucleotide polymorphism
5788104|NCT00155350|atherosclerosis|atherosclerosis
5788105|NCT00155350|calcification|calcification
5788106|NCT00155350|coronary|coronary
5788107|NCT00155350|inflammation|inflammation
5788108|NCT00155350|insulin|insulin
5788109|NCT00155350|plaque|plaque
5788110|NCT00155350|Coronary calcification|coronary calcification
5788111|NCT00155350|Plaque vulnerability|plaque vulnerability
5788112|NCT00155337|leukoplakia|leukoplakia
5788113|NCT00155337|erythroleukoplakia|erythroleukoplakia
5788114|NCT00155337|photodynamic therapy|photodynamic therapy
5788115|NCT00155324|plantar fasciitis|plantar fasciitis
5788116|NCT00155324|ultrasonographic examination|ultrasonographic examination
5788117|NCT00155311|orthodontic tooth movement|orthodontic tooth movement
5788118|NCT00155311|OPG|opg
5788119|NCT00155311|RANKL|rankl
5788120|NCT00155285|heart diseases|heart diseases
5788121|NCT00155285|congenital|congenital
5788122|NCT00155272|Hepatocellular Carcinoma|hepatocellular carcinoma
5788123|NCT00155272|Radiotherapy|radiotherapy
5788124|NCT00155272|Thalidomide|thalidomide
5788125|NCT00155272|Dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5788126|NCT00155259|Breast Cancer , Neoadjuvant Chemotherapy|breast cancer , neoadjuvant chemotherapy
5788127|NCT00155246|CKD, pentoxifylline|ckd, pentoxifylline
5788128|NCT00155233|analgeisa|analgeisa
5788129|NCT00155233|postoperatve|postoperatve
5788130|NCT00155233|side effects|side effects
5788131|NCT00155207|Schizophrenia|schizophrenia
5788132|NCT00155207|endophenotype|endophenotype
5788133|NCT00155207|risk genetic mutation|risk genetic mutation
5788134|NCT00155207|vulnerability genes|vulnerability genes
5788135|NCT00155207|affected sib-pairs|affected sib-pairs
5788136|NCT00155207|case-control design|case-control design
5788137|NCT00155207|animal model|animal model
5788138|NCT00155207|functional validity|functional validity
5788139|NCT00155207|genetic epidemiological analysis|genetic epidemiological analysis
5788140|NCT00155181|Epstein-Barr virus|epstein-barr virus
5788141|NCT00155181|Nasopharyngeal carcinoma|nasopharyngeal carcinoma
5788142|NCT00155181|Carcinogenesis|carcinogenesis
5788143|NCT00155168|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
5788144|NCT00155168|SMN1/SMN2 gene|smn1/smn2 gene
5788145|NCT00155168|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
5788146|NCT00155168|multiplex PCR|multiplex pcr
5788147|NCT00155168|gene dose|gene dose
5788148|NCT00155168|carrier test|carrier test
5788149|NCT00155129|migraine|migraine
5788150|NCT00155129|CGRP|cgrp
5788154|NCT00155103|Polymorphism, Genetic|polymorphism, genetic
5788155|NCT00155090|Magnetic resonance imaging,|magnetic resonance imaging,
5788156|NCT00155090|breast disease|breast disease
5788157|NCT00155077|cervical cancer, chemoradiotherapy, angiogenesis|cervical cancer, chemoradiotherapy, angiogenesis
5788158|NCT00155064|Primary aldosteronism|primary aldosteronism
5788159|NCT00155064|kallikrein|kallikrein
5788160|NCT00155064|aldosterone|aldosterone
5788161|NCT00155064|captopril|captopril
5788162|NCT00155038|Breast neoplasms|breast neoplasms
5788163|NCT00155038|breast radiography|breast radiography
5788164|NCT00155038|young women.|young women.
5788165|NCT00155025|Prostatic neoplasms|prostatic neoplasms
5788166|NCT00155025|Family history|family history
5788167|NCT00154999|hyperbilirubinemia|hyperbilirubinemia
5788168|NCT00154999|free radicals|free radicals
5788169|NCT00154999|Health neonate|health neonate
5686480|NCT00551902|trabeculectomy|trabeculectomy
5788170|NCT00154986|invasion|invasion
5788171|NCT00154986|migration|migration
5788172|NCT00154986|metastasis|metastasis
5788174|NCT00154986|transfection|transfection
5788175|NCT00154986|signal transduction.|signal transduction.
5788176|NCT00154973|oral precancers|oral precancers
5788177|NCT00154973|oral cancer|oral cancer
5788178|NCT00154973|hypoxia-inducible factor|hypoxia-inducible factor
5811818|NCT00003724|lung metastases|lung metastases
5788179|NCT00154960|Spinal muscular atrophy (SMA)|spinal muscular atrophy (sma)
5788180|NCT00154960|SMN1/SMN2 gene|smn1/smn2 gene
5846710|NCT00043680|Age Related Macular Degeneration|age related macular degeneration
5788181|NCT00154960|denaturing high-performance liquid chromatography (DHPLC)|denaturing high-performance liquid chromatography (dhplc)
5788183|NCT00154960|gene dose|gene dose
5788184|NCT00154960|carrier test|carrier test
5788185|NCT00154960|screen|screen
5788186|NCT00154960|stool|stool
5788187|NCT00154960|microsatellite|microsatellite
5788188|NCT00154895|minocycline|minocycline
5788189|NCT00154895|pleurodesis|pleurodesis
5788190|NCT00154895|thoracoscopy|thoracoscopy
5788191|NCT00154895|primary spontaneous pneumothorax|primary spontaneous pneumothorax
5788192|NCT00154895|clinical trial|clinical trial
5788193|NCT00154882|Breast Cancer|breast cancer
5788194|NCT00154882|First-line|first-line
5788195|NCT00154869|Patients with dual chronic hepatitis B and C|patients with dual chronic hepatitis b and c
5788196|NCT00154856|osteogenesis|osteogenesis
5788197|NCT00154856|Ilizarov fixator|ilizarov fixator
5788198|NCT00154856|motion analysis|motion analysis
5788199|NCT00154856|FEM|fem
5788200|NCT00154856|bone stress|bone stress
5788201|NCT00154843|Lycopene|lycopene
5788202|NCT00154843|BPH|bph
5788203|NCT00154843|PSA|psa
5788204|NCT00154843|IPSS|ipss
5788205|NCT00154817|radiotherapy|radiotherapy
5788206|NCT00154817|dynamic contrast enhanced MRI|dynamic contrast enhanced mri
5788207|NCT00154817|hepatocellular carcinoma|hepatocellular carcinoma
5788208|NCT00154804|Concurrent Chemoradiotherapy|concurrent chemoradiotherapy
5788209|NCT00154804|Esophageal Cancer|esophageal cancer
5788210|NCT00154791|Pancreatic adenocarcinoma|pancreatic adenocarcinoma
5788211|NCT00154791|Oxaliplatin|oxaliplatin
5788212|NCT00154791|Gemcitabine|gemcitabine
5788213|NCT00154791|5-FU|5-fu
5788214|NCT00154778|Combination,Chemotherapy,Advanced Gastric Cancer|combination,chemotherapy,advanced gastric cancer
5788215|NCT00154752|Rectal cancer, CCRT, Pelvic lymphadenoectomy.|rectal cancer, ccrt, pelvic lymphadenoectomy.
5788216|NCT00154739|Combination, Chemotherapy,non-small cell lung cancer|combination, chemotherapy,non-small cell lung cancer
5788217|NCT00154726|Paclitaxel-HDFL,Locally Advanced and Recurrent/Metastatic Gastric Cancer|paclitaxel-hdfl,locally advanced and recurrent/metastatic gastric cancer
5788218|NCT00154713|colorectal cancer|colorectal cancer
5788219|NCT00154713|dendritic cell|dendritic cell
5788220|NCT00154713|CEA|cea
5788221|NCT00154713|IL-2|il-2
5788222|NCT00154700|Combination,Chemotherapy,Esophageal Cancer|combination,chemotherapy,esophageal cancer
5788223|NCT00154687|Combination, Chemotherapy,transitional cell carcinoma|combination, chemotherapy,transitional cell carcinoma
5788224|NCT00154661|glomerulonephritis|glomerulonephritis
5788225|NCT00154648|MRA|mra
5788226|NCT00154648|DSA|dsa
5788227|NCT00154648|gadovist|gadovist
5788228|NCT00154648|angiography|angiography
5788229|NCT00154635|Alzheimer's disease|alzheimer's disease
5788230|NCT00154635|Fo-ti|fo-ti
5788231|NCT00154635|Chinese herbs|chinese herbs
5788232|NCT00154622|musculoskeletal disorder, work hardening, return to work|musculoskeletal disorder, work hardening, return to work
5788233|NCT00154596|etiology|etiology
5788234|NCT00154596|transmission|transmission
5788235|NCT00154596|vasculitis|vasculitis
5788236|NCT00154596|household|household
5788237|NCT00154596|etiology of disease|etiology of disease
5788238|NCT00154583|cervical cancer|cervical cancer
5788239|NCT00154583|human papillomavirus|human papillomavirus
5788240|NCT00154583|cancer vaccine|cancer vaccine
5788241|NCT00154583|normal volunteer|normal volunteer
5788242|NCT00154570|reflux esophagitis|reflux esophagitis
5788243|NCT00154570|24 hour esophageal pH|24 hour esophageal ph
5788244|NCT00154570|electrogastrography (EGG)|electrogastrography (egg)
5788245|NCT00154570|Running Spectral Analysis (RSA)|running spectral analysis (rsa)
5788246|NCT00154557|Judo, Performance, Injury|judo, performance, injury
5788247|NCT00154518|orthodontic tooth movement|orthodontic tooth movement
5788248|NCT00154518|matrix metalloproteinase|matrix metalloproteinase
5788249|NCT00154518|Orthodontics|orthodontics
5788250|NCT00154505|Scoliosis|scoliosis
5788251|NCT00154505|Spinal Cord Injury|spinal cord injury
5788252|NCT00154505|Lateral Trunk Support|lateral trunk support
5788253|NCT00154505|Radiography|radiography
5788254|NCT00154492|Active variceal bleeding in patients with advanced cirrhosis|active variceal bleeding in patients with advanced cirrhosis
5788255|NCT00154479|Cervical cancer|cervical cancer
5788256|NCT00154479|Human papillomavirus|human papillomavirus
5788257|NCT00154479|Human leukocyte antigen|human leukocyte antigen
5788258|NCT00154479|immunologic response|immunologic response
5788259|NCT00154479|healthy volunteers|healthy volunteers
5788260|NCT00154466|Myocardial infarction, stem cell, cardiac rehabilitation|myocardial infarction, stem cell, cardiac rehabilitation
5788261|NCT00154453|Aging|aging
5788262|NCT00154453|Orbicularis oculi|orbicularis oculi
5788263|NCT00154453|Blepharoplasty|blepharoplasty
5788264|NCT00154453|Myosin heavy chain (MHC)|myosin heavy chain (mhc)
5788265|NCT00154440|primary gastric MALT lymphoma|primary gastric malt lymphoma
5788832|NCT00151411|Anovulation|anovulation
5788266|NCT00154440|Helicobacter pylori|helicobacter pylori
5788267|NCT00154440|eradication therapy|eradication therapy
5788268|NCT00154440|radiation|radiation
5788269|NCT00154440|marginal zone B-cell lymphoma|marginal zone b-cell lymphoma
5788270|NCT00154440|Mucosa-associated Lymphoid Tissue|mucosa-associated lymphoid tissue
5788271|NCT00154440|B-cell Non-Hodgkin's Lymphoma of the stomach|b-cell non-hodgkin's lymphoma of the stomach
5788272|NCT00154440|primary gastric lymphoma|primary gastric lymphoma
5788273|NCT00154388|adenocarcinoma|adenocarcinoma
5788274|NCT00154388|leiomyosarcoma|leiomyosarcoma
5788275|NCT00154388|angiosarcoma|angiosarcoma
5788276|NCT00154388|synovial sarcoma|synovial sarcoma
5788277|NCT00154388|myelodysplastic syndrome/HES|myelodysplastic syndrome/hes
5788278|NCT00154388|CMML|cmml
5788279|NCT00154388|multiple myeloma|multiple myeloma
5788280|NCT00154388|embryonal rhabdomyosarcoma|embryonal rhabdomyosarcoma
5788281|NCT00154388|endometrial sarcoma|endometrial sarcoma
5788282|NCT00154388|adenoid cystic carcinoma|adenoid cystic carcinoma
5788283|NCT00154388|fibromatosis|fibromatosis
5788284|NCT00154388|ductal invasive breast carcinoma|ductal invasive breast carcinoma
5788285|NCT00154388|chondrosarcoma|chondrosarcoma
5788286|NCT00154388|pleural tumor|pleural tumor
5788287|NCT00154388|brenner tumor|brenner tumor
5788288|NCT00154388|ewing sarcoma|ewing sarcoma
5788289|NCT00154388|round cell tumor|round cell tumor
5788290|NCT00154388|seminoma|seminoma
5788291|NCT00154388|thymic carcinoma|thymic carcinoma
5788292|NCT00154388|malignant melanoma|malignant melanoma
5788293|NCT00154388|fibrosarcoma breast|fibrosarcoma breast
5788294|NCT00154388|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans
5788295|NCT00154388|DFSP|dfsp
5788296|NCT00154388|ovarian stromal tumor|ovarian stromal tumor
5788297|NCT00154388|osteosarcoma|osteosarcoma
5788298|NCT00154388|chorioideal melanoma|chorioideal melanoma
5788299|NCT00154388|hemangiopericytoma|hemangiopericytoma
5788300|NCT00154388|myelofibrosis|myelofibrosis
5788301|NCT00154388|liposarcoma|liposarcoma
5788303|NCT00154388|small cell lung carcinoma|small cell lung carcinoma
5788304|NCT00154388|hypereosinophilic syndrome|hypereosinophilic syndrome
5788305|NCT00154388|chronic myelo-monocytic leukemia|chronic myelo-monocytic leukemia
5788306|NCT00154388|neurofibrosarcoma|neurofibrosarcoma
5788307|NCT00154388|mesothelioma|mesothelioma
5788308|NCT00154388|malignant mesenchymoma|malignant mesenchymoma
5788309|NCT00154388|malignant schwannoma|malignant schwannoma
5788310|NCT00154388|mast cell leukemia / mastocytosis|mast cell leukemia / mastocytosis
5788311|NCT00154388|renal cell carcinoma|renal cell carcinoma
5788312|NCT00154388|malignant histocytoma|malignant histocytoma
5788313|NCT00154388|chordoma|chordoma
5788314|NCT00154375|Open label|open label
5788315|NCT00154375|Imatinib mesylate|imatinib mesylate
5788316|NCT00154375|hydroxyurea|hydroxyurea
5788317|NCT00154375|temozolomide|temozolomide
5788318|NCT00154375|resistant|resistant
5788319|NCT00154375|protein tyrosine kinases|protein tyrosine kinases
5788320|NCT00154375|adenocarcinoma|adenocarcinoma
5788321|NCT00154375|glioblastoma multiforme|glioblastoma multiforme
5788322|NCT00154375|astrocytoma|astrocytoma
5788323|NCT00154375|brain tumor|brain tumor
5788324|NCT00154375|brain cancer|brain cancer
5788325|NCT00154362|Oxcarbazepine, conduct disorder, adolescents|oxcarbazepine, conduct disorder, adolescents
5788326|NCT00154349|Ph+ALL|ph+all
5788327|NCT00154349|imatinib mesylate|imatinib mesylate
5788328|NCT00154336|Rheumatoid arthritis, imatinib, methotrexate|rheumatoid arthritis, imatinib, methotrexate
5788329|NCT00154323|Oxcarbazepine, bipolar disorder|oxcarbazepine, bipolar disorder
5788330|NCT00154310|Renal transplantation, everolimus, immunosuppressants, CNI-free|renal transplantation, everolimus, immunosuppressants, cni-free
5788331|NCT00154297|Renal transplantation|renal transplantation
5788332|NCT00154297|everolimus|everolimus
5788333|NCT00154297|immunosuppressants|immunosuppressants
5788334|NCT00154297|wound-healing|wound-healing
5788335|NCT00154284|Renal transplantation,|renal transplantation,
5788336|NCT00154284|everolimus,|everolimus,
5788337|NCT00154284|immunosuppressants,|immunosuppressants,
5788338|NCT00154284|basiliximab,|basiliximab,
5788429|NCT00153894|Breast cancer survivor|breast cancer survivor
5788430|NCT00153894|Insulin levels|insulin levels
5788339|NCT00154284|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization|cyclosporine microemulsion discontinuation, cyclosporine microemulsion minimization
5788340|NCT00154271|Hypertension (HTN)|hypertension (htn)
5788341|NCT00154271|High Sensitivity C-Reactive Protein|high sensitivity c-reactive protein
5788342|NCT00154258|Schizophrenia, treatment-resistant, clozapine|schizophrenia, treatment-resistant, clozapine
5788343|NCT00154245|Enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine|enteric-coated mycophenolate sodium, transplantation, de novo, cyclosporine
5788344|NCT00154232|Renal transplantation, DGF, basiliximab, EC-MPS, cyclosporine|renal transplantation, dgf, basiliximab, ec-mps, cyclosporine
5681127|NCT00574613|orphan drug|orphan drug
5788345|NCT00154219|Osteoarthritis, Hip, Lumiracoxib, Efficacy, Safety|osteoarthritis, hip, lumiracoxib, efficacy, safety
5788346|NCT00154206|Enteric-coated mycophenolate sodium,|enteric-coated mycophenolate sodium,
5788347|NCT00154206|de novo,|de novo,
5788348|NCT00154206|renal transplantation,|renal transplantation,
5788349|NCT00154206|pediatric|pediatric
5788350|NCT00154206|De novo pediatric renal transplantation|de novo pediatric renal transplantation
5788932|NCT00150904|hepatitis C|hepatitis c
5862956|NCT00001451|Marrow Transplant|marrow transplant
5788351|NCT00154193|Heart transplant, lung transplant, renal function, cyclosporine C2 Levels|heart transplant, lung transplant, renal function, cyclosporine c2 levels
5788352|NCT00154180|Perimenopause|perimenopause
5788353|NCT00154180|Coronary Disease|coronary disease
5788354|NCT00154180|Estrogen Replacement Therapy|estrogen replacement therapy
5788355|NCT00154180|Hormone Replacement Therapy|hormone replacement therapy
5788356|NCT00154154|borderline personality disorder|borderline personality disorder
5788358|NCT00154154|treatment|treatment
5788359|NCT00154154|dialectical behavior therapy|dialectical behavior therapy
5788361|NCT00154154|general Psychiatric management|general psychiatric management
5788362|NCT00154154|GPM|gpm
5788363|NCT00154154|suicide|suicide
5788364|NCT00154154|parasuicide|parasuicide
5788365|NCT00154154|randomized control trials|randomized control trials
5788366|NCT00154128|temporomandibular disorder|temporomandibular disorder
5788367|NCT00154128|craniomandibular disorder|craniomandibular disorder
5788368|NCT00154128|occlusal appliance|occlusal appliance
5788369|NCT00154128|clinical trial|clinical trial
5788370|NCT00154115|heart failure|heart failure
5788371|NCT00154115|levosimendan|levosimendan
5788372|NCT00154115|cardiac surgery|cardiac surgery
5788373|NCT00154102|Metastatic colorectal cancer|metastatic colorectal cancer
5788374|NCT00154102|EGFR|egfr
5788375|NCT00154102|Irinotecan|irinotecan
5788376|NCT00154102|cetuximab|cetuximab
5788377|NCT00154102|first-line treatment|first-line treatment
5788378|NCT00154089|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5788379|NCT00154089|CIN|cin
5788380|NCT00154089|HPV|hpv
5788381|NCT00154050|restenosis|restenosis
5788382|NCT00154050|intima hyperproliferation|intima hyperproliferation
5788384|NCT00154050|pain-free walking distance|pain-free walking distance
5788385|NCT00154037|vascular reactivity|vascular reactivity
5788386|NCT00154037|venodilation|venodilation
5788387|NCT00154037|pulse wave velocity|pulse wave velocity
5788388|NCT00154024|venoconstriction|venoconstriction
5788389|NCT00154024|venodilation|venodilation
5788390|NCT00154024|pleiotropic effects|pleiotropic effects
5788391|NCT00154011|vascular reactivity, venodilation|vascular reactivity, venodilation
5788392|NCT00153998|Cetuximab|cetuximab
5788393|NCT00153998|Oxaliplatin|oxaliplatin
5788394|NCT00153998|Irinotecan|irinotecan
5788395|NCT00153998|5-FU|5-fu
5788396|NCT00153998|Chemotherapy|chemotherapy
5788397|NCT00153998|Resection|resection
5788398|NCT00153998|Liver resection|liver resection
5788399|NCT00153998|Neoadjuvant|neoadjuvant
5788400|NCT00153985|Hemoglobinopathies|hemoglobinopathies
5788401|NCT00153985|Sickle cell anemia|sickle cell anemia
5788402|NCT00153985|sickle cell-hemoglobin C disease|sickle cell-hemoglobin c disease
5788403|NCT00153985|sickle cell-B-thalassemia|sickle cell-b-thalassemia
5788404|NCT00153985|transfusion-dependant thalassemia|transfusion-dependant thalassemia
5788405|NCT00153985|allogeneic transplant|allogeneic transplant
5788406|NCT00153985|nonmyeloablative transplant|nonmyeloablative transplant
5788407|NCT00153985|Stem cell transfusion|stem cell transfusion
5788408|NCT00153985|graft vs. host disease|graft vs. host disease
5788409|NCT00153972|Parkinson's disease|parkinson's disease
5788410|NCT00153972|Fluoro-Dopa-PET|fluoro-dopa-pet
5788411|NCT00153972|Dopamine agonists|dopamine agonists
5788412|NCT00153972|Cabergoline|cabergoline
5788413|NCT00153972|Surrogate marker|surrogate marker
5788414|NCT00153972|Dopamine turnover|dopamine turnover
5788415|NCT00153946|Free Radical Scavenger|free radical scavenger
5788416|NCT00153946|Selective Thrombin Inhibitor|selective thrombin inhibitor
5788417|NCT00153946|Acute ischemic stroke (nonlacunar and noncardioembolic)|acute ischemic stroke (nonlacunar and noncardioembolic)
5788418|NCT00153933|Multiple Myeloma|multiple myeloma
5788419|NCT00153933|bortezomib|bortezomib
5788420|NCT00153933|Revlimid|revlimid
5788421|NCT00153933|CC-5013|cc-5013
5788422|NCT00153920|multiple myeloma|multiple myeloma
5788423|NCT00153920|Velcade|velcade
5788424|NCT00153920|bortezomib|bortezomib
5788425|NCT00153907|Xeloda|xeloda
5788426|NCT00153907|Navelbine|navelbine
5788427|NCT00153907|capecitabine|capecitabine
5788428|NCT00153907|metastatic breast cancer|metastatic breast cancer
5788431|NCT00153894|exercise regimen|exercise regimen
5788432|NCT00153894|endurance training|endurance training
5788433|NCT00153894|strength training|strength training
5788434|NCT00153881|Esophageal Cancer|esophageal cancer
5788435|NCT00153881|Trimodality|trimodality
5788436|NCT00153881|Capecitabine|capecitabine
5788437|NCT00153881|Xeloda|xeloda
5788438|NCT00153881|Gastro-esophageal Neoplasm|gastro-esophageal neoplasm
5788439|NCT00153881|Carcinoma of the Esophagus|carcinoma of the esophagus
5788440|NCT00153868|Anemia|anemia
5686481|NCT00551902|anterior chamber maintainer|anterior chamber maintainer
5788441|NCT00153868|Cancer|cancer
5788442|NCT00153868|Quality of life|quality of life
5788443|NCT00153868|Web-based|web-based
5788444|NCT00153868|Aranesp|aranesp
5788445|NCT00153868|Darbepoetin alfa|darbepoetin alfa
5788446|NCT00153855|etiology|etiology
5788447|NCT00153855|pathology|pathology
5788448|NCT00153842|NSCLC|nsclc
5788449|NCT00153842|Bexarotene|bexarotene
5788450|NCT00153842|Targretin|targretin
5788451|NCT00153829|Chronic Disease|chronic disease
5788452|NCT00153829|Quality of Life|quality of life
5788453|NCT00153816|Colorectal neoplasms|colorectal neoplasms
5788454|NCT00153816|Adenomatous polyps|adenomatous polyps
5788455|NCT00153803|Erlotinib|erlotinib
5788457|NCT00153803|Web based|web based
5788458|NCT00153803|Stage III NSCLC|stage iii nsclc
5788459|NCT00153790|green tea|green tea
5788460|NCT00153790|weight|weight
5788461|NCT00153790|women|women
5788462|NCT00153777|HIV prevention|hiv prevention
5788463|NCT00153777|Randomized controlled trial|randomized controlled trial
5788464|NCT00153777|Women|women
5788465|NCT00153777|Sexually transmitted infections|sexually transmitted infections
5788466|NCT00153777|HIV Seronegativity|hiv seronegativity
5788467|NCT00153764|supplement|supplement
5788468|NCT00153764|omega-3 fatty acid|omega-3 fatty acid
5788469|NCT00153764|Homocysteine|homocysteine
5788470|NCT00153764|LDL cholesterol|ldl cholesterol
5788471|NCT00153751|Traditional Chinese Medicine|traditional chinese medicine
5788472|NCT00153738|LDL-C, phytosterol|ldl-c, phytosterol
5788473|NCT00153712|Non-NSAID|non-nsaid
5788474|NCT00153712|Non-Hp Bleeding Peptic Ulcer|non-hp bleeding peptic ulcer
5788475|NCT00153699|Side effects|side effects
5788476|NCT00153699|Topiramate|topiramate
5788477|NCT00153686|Capsule Endoscopy|capsule endoscopy
5788478|NCT00153686|Mesenteric angiogram|mesenteric angiogram
5788479|NCT00153673|celecoxib|celecoxib
5788480|NCT00153673|arthritis|arthritis
5788481|NCT00153673|ulcer healing|ulcer healing
5788482|NCT00153634|Cystic fibrosis|cystic fibrosis
5788483|NCT00153634|Antibiotic susceptibility testing|antibiotic susceptibility testing
5788484|NCT00153634|Pseudomonas aeruginosa|pseudomonas aeruginosa
5788485|NCT00153634|Chronic bronchitis|chronic bronchitis
5788488|NCT00153621|Chronic Kidney Failure|chronic kidney failure
5788490|NCT00153621|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5788491|NCT00153621|AIDS-Associated Nephropathy|aids-associated nephropathy
5788492|NCT00153595|Allergic rhinitis|allergic rhinitis
5788493|NCT00153595|EWO1|ewo1
5788494|NCT00153556|Haemophilus influenza type B|haemophilus influenza type b
5788495|NCT00153556|Carrier state|carrier state
5788496|NCT00153556|Bacterial Vaccines|bacterial vaccines
5788497|NCT00153556|Anti-PRP antibody|anti-prp antibody
5788498|NCT00153556|Antibody avidity|antibody avidity
5788499|NCT00153556|Serum bacteriocidal antibody|serum bacteriocidal antibody
5788500|NCT00153556|American Indians/Alaska Natives|american indians/alaska natives
5788501|NCT00153556|Case control study|case control study
5788502|NCT00153556|Adult vaccines|adult vaccines
5788503|NCT00153530|primary central nervous system lymphoma|primary central nervous system lymphoma
5788504|NCT00153517|Bacterial Vaginosis|bacterial vaginosis
5788505|NCT00153517|Metronidazole|metronidazole
5788507|NCT00153504|AIDS|aids
5788508|NCT00153504|Homeless|homeless
5788509|NCT00153504|Homelessness|homelessness
5788510|NCT00153504|Housing|housing
5788511|NCT00153504|HIV seropositive|hiv seropositive
5788512|NCT00153504|HIV risk behavior|hiv risk behavior
5788513|NCT00153491|malaria|malaria
5788514|NCT00153491|artemether-lumefantrine|artemether-lumefantrine
5788515|NCT00153491|co-artem|co-artem
5788516|NCT00153491|Tanzania|tanzania
5788517|NCT00153491|adherence|adherence
5788518|NCT00153478|Alcohol-Exposed Pregnancy|alcohol-exposed pregnancy
5788519|NCT00153478|Binge drinking|binge drinking
5788520|NCT00153478|Frequent drinking|frequent drinking
5788521|NCT00153478|Unintended pregnancy|unintended pregnancy
5788522|NCT00153478|Fetal Alcohol Syndrome|fetal alcohol syndrome
5788523|NCT00153465|Parent training|parent training
5788524|NCT00153465|Child maltreatment|child maltreatment
5788525|NCT00153465|Motivation|motivation
5788526|NCT00153465|Program attrition|program attrition
5788527|NCT00153439|parenting|parenting
5788528|NCT00153439|motivation|motivation
5788529|NCT00153439|child maltreatment|child maltreatment
5788530|NCT00153439|program attrition|program attrition
5788531|NCT00153400|CVD risk|cvd risk
5788532|NCT00153361|HIV Seronegativity|hiv seronegativity
5788534|NCT00153335|Health Risk Assessment|health risk assessment
5788535|NCT00153335|Behavior Change|behavior change
5788536|NCT00153335|Patient-Provider Interaction|patient-provider interaction
5788537|NCT00153335|Employee Health|employee health
5788538|NCT00153335|Absenteeism|absenteeism
5788539|NCT00153335|Tobacco Use|tobacco use
5788540|NCT00153335|Substance Use|substance use
5788541|NCT00153335|Diet|diet
5788542|NCT00153335|Exercise|exercise
5788543|NCT00153335|Medication Adherence|medication adherence
5788544|NCT00153322|Childhood Obesity|childhood obesity
5788545|NCT00153322|Community-based Participatory Research|community-based participatory research
5788546|NCT00153322|School intervention|school intervention
5788547|NCT00153322|Parental Involvement|parental involvement
5788548|NCT00153309|arthritis|arthritis
5788549|NCT00153309|exercise|exercise
5788550|NCT00153309|physical activity|physical activity
5788551|NCT00153309|physical function|physical function
5788552|NCT00153309|pain|pain
5788553|NCT00153296|Bronchial asthma|bronchial asthma
5788554|NCT00153296|Carbamazepine|carbamazepine
5788555|NCT00153296|Antiepileptic drugs|antiepileptic drugs
5788556|NCT00153296|Efficacy|efficacy
5788557|NCT00153283|Bronchial asthma|bronchial asthma
5788558|NCT00153283|Gabapentin|gabapentin
5788560|NCT00153283|Efficacy|efficacy
5788561|NCT00153270|Bronchial asthma|bronchial asthma
5788562|NCT00153270|Sodium valproate|sodium valproate
5788563|NCT00153270|Antiepileptic drug|antiepileptic drug
5788564|NCT00153270|Efficacy|efficacy
5788565|NCT00153244|Bronchial asthma|bronchial asthma
5788566|NCT00153244|Lamotrigine|lamotrigine
5788567|NCT00153244|Antiepileptic drug|antiepileptic drug
5788568|NCT00153244|Efficacy|efficacy
5788569|NCT00153218|Metastatic Breast Cancer|metastatic breast cancer
5788570|NCT00153218|Her2neu|her2neu
5788571|NCT00153218|trastuzumab|trastuzumab
5788572|NCT00153205|medication errors|medication errors
5788573|NCT00153205|medical records systems, computerized|medical records systems, computerized
5788574|NCT00153205|patient safety|patient safety
5788575|NCT00153192|Marinol|marinol
5788576|NCT00153192|Dronabinol|dronabinol
5788577|NCT00153192|Cannabinoid|cannabinoid
5788578|NCT00153192|Chronic Pain|chronic pain
5788579|NCT00153179|insulin resistance|insulin resistance
5788580|NCT00153179|insulin signaling|insulin signaling
5788581|NCT00153179|endothelium-dependent vasodilation|endothelium-dependent vasodilation
5788582|NCT00153166|peripheral arterial disease|peripheral arterial disease
5788583|NCT00153166|intermittent claudication|intermittent claudication
5788584|NCT00152945|intestinal lipoprotein|intestinal lipoprotein
5788585|NCT00152945|very low density lipoprotein|very low density lipoprotein
5788586|NCT00152945|free fatty acids|free fatty acids
5788587|NCT00152945|Apo B48 and Apo B100|apo b48 and apo b100
5788589|NCT00152945|Intestinal lipoprotein production|intestinal lipoprotein production
5788590|NCT00152932|Glaucoma|glaucoma
5788591|NCT00152932|Intraocular pressure|intraocular pressure
5788592|NCT00152932|Ocular blood flow|ocular blood flow
5788593|NCT00152932|Laser-Doppler Flowmetry|laser-doppler flowmetry
5788595|NCT00152893|blood sugar > 6.1 mmol/l|blood sugar > 6.1 mmol/l
5788596|NCT00152893|triglycerides > 2 mmol/l|triglycerides > 2 mmol/l
5788597|NCT00152893|total cholesterol > 5.5 mmol/l or HDL < 0.9 mmol/l|total cholesterol > 5.5 mmol/l or hdl < 0.9 mmol/l
5788598|NCT00152880|Hepatitis B, apoptosis|hepatitis b, apoptosis
5788599|NCT00152867|quality of life|quality of life
5788600|NCT00152867|dexamethasone|dexamethasone
5788601|NCT00152867|emesis|emesis
5788602|NCT00152854|cancer pain|cancer pain
5788603|NCT00152854|acetaminophen|acetaminophen
5788604|NCT00152854|opioids|opioids
5788605|NCT00152815|HIV|hiv
5788606|NCT00152815|non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5788607|NCT00152802|liver transplant|liver transplant
5788608|NCT00152802|antibody response|antibody response
5788609|NCT00152802|opsonophagocytic assay|opsonophagocytic assay
5788610|NCT00152802|pneumococcal conjugate vaccine|pneumococcal conjugate vaccine
5788611|NCT00152802|pneumococcal polysaccharide vaccine|pneumococcal polysaccharide vaccine
5788612|NCT00152776|menopausal symptoms|menopausal symptoms
5788613|NCT00152776|complementary medicine|complementary medicine
5788614|NCT00152763|health anxiety|health anxiety
5788615|NCT00152750|Tourette's Syndrome|tourette's syndrome
5788616|NCT00152750|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5788617|NCT00152750|Children|children
5788618|NCT00152750|Sleep disorders|sleep disorders
5788619|NCT00152750|Aggression|aggression
5788620|NCT00152737|Intermittent Claudication|intermittent claudication
5788621|NCT00152737|Peripheral Vascular Diseases|peripheral vascular diseases
5788622|NCT00152737|Blood Gas Monitoring, Transcutaneous|blood gas monitoring, transcutaneous
5788623|NCT00152737|Surgery|surgery
5788624|NCT00152724|Physiology|physiology
5788625|NCT00152724|Microcirculation|microcirculation
5788626|NCT00152724|Laser-Doppler Flowmetry|laser-doppler flowmetry
5788627|NCT00152659|Epilepsy|epilepsy
5788628|NCT00152659|Tumor|tumor
5788629|NCT00152659|Surgery|surgery
5788630|NCT00152659|Brain|brain
5788631|NCT00152633|endothelium, hypertension, retina, AT1|endothelium, hypertension, retina, at1
5789396|NCT00148668|taxotere|taxotere
5788632|NCT00152620|Inflammatory Bowel Disease (IBD)|inflammatory bowel disease (ibd)
5788633|NCT00152607|Liver Transplantation|liver transplantation
5788634|NCT00152607|Living Donors|living donors
5788635|NCT00152607|End Stage Liver Disease|end stage liver disease
5788636|NCT00152581|HCV, genotype 1, treatment, HCV kinetics, T-cells|hcv, genotype 1, treatment, hcv kinetics, t-cells
5788637|NCT00152568|Car Seat Check|car seat check
5788638|NCT00152555|SLE,|sle,
5788639|NCT00152555|exercize,|exercize,
5788640|NCT00152555|physical therapy,|physical therapy,
5788641|NCT00152555|Systemic lupus erythematosus|systemic lupus erythematosus
5788642|NCT00152555|relaxation therapy|relaxation therapy
5788643|NCT00152542|Inhaled nitric oxide,|inhaled nitric oxide,
5787808|NCT00156702|Smoking|smoking
5788644|NCT00152542|Lung recruitment,|lung recruitment,
5788645|NCT00152542|Ventilatory approach,|ventilatory approach,
5788646|NCT00152542|Neurodevelopmental outcomes,|neurodevelopmental outcomes,
5788647|NCT00152542|School age children|school age children
5788648|NCT00152529|Depression, educational site for depression|depression, educational site for depression
5788649|NCT00152516|Partial Onset Seizures|partial onset seizures
5788650|NCT00152516|levetiracetam|levetiracetam
5788651|NCT00152516|Epilepsy|epilepsy
5788652|NCT00152516|Keppra|keppra
5788653|NCT00152503|Epilepsy, Partial Onset Seizures, Seletracetam|epilepsy, partial onset seizures, seletracetam
5788654|NCT00152490|Crohn's disease, CDP870, CDAI, clinical response, remission,|crohn's disease, cdp870, cdai, clinical response, remission,
5788655|NCT00152490|Certolizumab Pegol, Cimzia|certolizumab pegol, cimzia
5788656|NCT00152477|Non-small-cell-lung cancer|non-small-cell-lung cancer
5788657|NCT00152477|carboplatin|carboplatin
5788658|NCT00152477|paclitaxel|paclitaxel
5788659|NCT00152477|VEGF|vegf
5788660|NCT00152477|monoclonal antibody|monoclonal antibody
5788661|NCT00152464|EPAAC|epaac
5788662|NCT00152464|Atopic children|atopic children
5788663|NCT00152464|Asthma|asthma
5788664|NCT00152464|XYZAL|xyzal
5788665|NCT00152464|Levocetirizine|levocetirizine
5788666|NCT00152451|Epilepsy: partial onset seizures, seletracetam|epilepsy: partial onset seizures, seletracetam
5788667|NCT00152438|Vasomotor symptoms|vasomotor symptoms
5788668|NCT00152438|Menopause|menopause
5788669|NCT00152425|Crohn's disease, CDP870, CDAI, clinical response, remission, Certolizumab Pegol, Cimzia|crohn's disease, cdp870, cdai, clinical response, remission, certolizumab pegol, cimzia
5788670|NCT00152412|Allergic Rhinitis, safety, levocetirizine, children|allergic rhinitis, safety, levocetirizine, children
5788671|NCT00152412|Xyzal|xyzal
5788672|NCT00152399|Peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin|peptic ulcer bleeding, upper intestinal bleeding, endoscopy, somatostatin
5788673|NCT00152386|Rheumatoid Arthritis, CDP870|rheumatoid arthritis, cdp870
5788674|NCT00152386|Certolizumab pegol, Cimzia|certolizumab pegol, cimzia
5788675|NCT00152373|Epilepsy, Partial Onset Seizures; Keppra; Levetiracetam|epilepsy, partial onset seizures; keppra; levetiracetam
5788677|NCT00152360|weight loss|weight loss
5788678|NCT00152360|cardiovascular risk factors|cardiovascular risk factors
5788679|NCT00152360|Obesity and obesity related pathology|obesity and obesity related pathology
5788680|NCT00152334|Efficacy study|efficacy study
5788681|NCT00152334|assessment of patient outcomes following treatment|assessment of patient outcomes following treatment
5788682|NCT00152321|osteoporosis|osteoporosis
5788683|NCT00152321|wrist fractures|wrist fractures
5788684|NCT00152321|quality improvement|quality improvement
5788685|NCT00152321|knowledge translation|knowledge translation
5788686|NCT00152295|Postmenopausal|postmenopausal
5788687|NCT00152295|Amenorrhea|amenorrhea
5788688|NCT00152295|Hormone replacement therapy|hormone replacement therapy
5788689|NCT00152295|HRT|hrt
5788690|NCT00152295|asoprisnil|asoprisnil
5788691|NCT00152295|Estrogen Replacement Therapy, postmenopause|estrogen replacement therapy, postmenopause
5788692|NCT00152282|Postmenopausal|postmenopausal
5788693|NCT00152282|Amenorrhea|amenorrhea
5788694|NCT00152282|Hormone replacement therapy|hormone replacement therapy
5788695|NCT00152282|HRT|hrt
5788696|NCT00152282|asoprisnil|asoprisnil
5788697|NCT00152269|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5788698|NCT00152269|Excessive Uterine Bleeding|excessive uterine bleeding
5788699|NCT00152269|Uterine Hemorrhage|uterine hemorrhage
5788700|NCT00152269|asoprisnil|asoprisnil
5788701|NCT00152256|Symptomatic Uterine Fibroids|symptomatic uterine fibroids
5788702|NCT00152256|Excessive Uterine Bleeding|excessive uterine bleeding
5788703|NCT00152256|Uterine Hemorrhage|uterine hemorrhage
5788704|NCT00152243|Stomach Cancer|stomach cancer
5788705|NCT00152230|Colorectal Cancer|colorectal cancer
5788706|NCT00152217|Stomach cancer|stomach cancer
5788707|NCT00152204|Use-Effectiveness|use-effectiveness
5788708|NCT00152204|Cost Effectiveness|cost effectiveness
5788709|NCT00152204|Patient Acceptance of Health Care|patient acceptance of health care
5788710|NCT00152204|Drug Resistance|drug resistance
5788711|NCT00152204|Delivery of Health Care|delivery of health care
5788712|NCT00152191|Breast Cancer|breast cancer
5788713|NCT00152178|Breast Cancer|breast cancer
5788714|NCT00152165|spinal motion|spinal motion
5788715|NCT00152165|tantalum beads|tantalum beads
5788716|NCT00152165|DYNESYS Stabilization system|dynesys stabilization system
5788717|NCT00152165|spinal fusion|spinal fusion
5788718|NCT00152165|Radiostereometric Analysis following spinal fusion|radiostereometric analysis following spinal fusion
5788812|NCT00151580|Ribavirin / Interferon|ribavirin / interferon
5788719|NCT00152165|Radiostereometric Analysis following surgery with DYNESYS Stabilization System|radiostereometric analysis following surgery with dynesys stabilization system
5788720|NCT00152152|spinal motion|spinal motion
5788721|NCT00152152|tantalum beads|tantalum beads
5788722|NCT00152139|High risk hematologic malignancies|high risk hematologic malignancies
5788723|NCT00152139|Allogeneic stem cell transplant|allogeneic stem cell transplant
5788724|NCT00152139|Matched unrelated donor transplantation|matched unrelated donor transplantation
5788725|NCT00152139|Unmanipulated stem cell graft|unmanipulated stem cell graft
5788726|NCT00152139|Bone marrow transplantation|bone marrow transplantation
5788727|NCT00152126|Autologous stem cell transplantation|autologous stem cell transplantation
5788728|NCT00152126|CD133 cell selection|cd133 cell selection
5788729|NCT00152126|CliniMACS device|clinimacs device
5788730|NCT00152126|Tumor marker|tumor marker
5788731|NCT00152126|Tumor purging|tumor purging
5788732|NCT00152113|Sickle Cell Anemia|sickle cell anemia
5788733|NCT00152113|Stem Cell Transplantation|stem cell transplantation
5788933|NCT00150904|virologic|virologic
5788734|NCT00152113|Haploidentical stem cell transplant|haploidentical stem cell transplant
5788735|NCT00152113|T cell depletion|t cell depletion
5788736|NCT00152113|CliniMACS device|clinimacs device
5788737|NCT00152100|Severe combined immunodeficiency|severe combined immunodeficiency
5788739|NCT00152100|Haploidentical|haploidentical
5788740|NCT00152087|Liver cancer|liver cancer
5788741|NCT00152087|Brachytherapy|brachytherapy
5788742|NCT00152074|Blood pressure|blood pressure
5788743|NCT00152074|Sodium|sodium
5788744|NCT00152074|Dietary|dietary
5788745|NCT00152074|Hypertension or prehypertension|hypertension or prehypertension
5788747|NCT00152061|Antiretroviral Drug Resistance|antiretroviral drug resistance
5788748|NCT00152061|Treatment Experienced|treatment experienced
5788749|NCT00151905|bronchiolitis|bronchiolitis
5788750|NCT00151905|hypertonic saline|hypertonic saline
5788751|NCT00151879|partial seizures with or without secondary generalization|partial seizures with or without secondary generalization
5788752|NCT00151866|Thrombopenia|thrombopenia
5788753|NCT00151866|Platelet transfusion|platelet transfusion
5788754|NCT00151866|Increment|increment
5788755|NCT00151866|Transfusion reactions|transfusion reactions
5788756|NCT00151866|Bleeding complication|bleeding complication
5788757|NCT00151853|CPB|cpb
5788758|NCT00151853|oral anticoagulant therapy|oral anticoagulant therapy
5788759|NCT00151853|plasma|plasma
5788760|NCT00151853|PCC|pcc
5788761|NCT00151840|Purpura, Thrombocytopenic, Idiopathic|purpura, thrombocytopenic, idiopathic
5788762|NCT00151840|ITP|itp
5788763|NCT00151840|Immunoglobulin, Intravenous|immunoglobulin, intravenous
5788765|NCT00151801|multiple sclerosis|multiple sclerosis
5788766|NCT00151801|estroprogestins|estroprogestins
5788767|NCT00151801|interferon-beta|interferon-beta
5788768|NCT00151801|sex hormones|sex hormones
5788769|NCT00151801|MRI|mri
5788770|NCT00151775|Treatment of hypertension or high blood pressure in children ages 1-16 years.|treatment of hypertension or high blood pressure in children ages 1-16 years.
5788771|NCT00151762|Open label, Diabetes Mellitus|open label, diabetes mellitus
5788772|NCT00151762|Long term safety study, extension study|long term safety study, extension study
5788773|NCT00151749|Diabetes mellitus|diabetes mellitus
5788774|NCT00151736|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5788775|NCT00151736|CLL|cll
5788776|NCT00151736|Leukemia|leukemia
5788777|NCT00151723|endogenous subclinical hyperthyroidism|endogenous subclinical hyperthyroidism
5788778|NCT00151697|diabetes|diabetes
5788779|NCT00151697|failing oral treatment|failing oral treatment
5788780|NCT00151697|weight gain|weight gain
5788781|NCT00151684|Obesity|obesity
5788782|NCT00151684|Hyperinsulinism|hyperinsulinism
5788783|NCT00151684|Diazoxide|diazoxide
5788784|NCT00151671|Surgery|surgery
5788785|NCT00151671|Liver Cancer|liver cancer
5788786|NCT00151671|Cirrhosis|cirrhosis
5788787|NCT00151671|Nutrition|nutrition
5788788|NCT00151658|Coronary complex lesions|coronary complex lesions
5788789|NCT00151658|Restenosis|restenosis
5788790|NCT00151658|Drug eluting stents|drug eluting stents
5788791|NCT00151645|Immunotherapy|immunotherapy
5788792|NCT00151645|Renal cell carcinoma|renal cell carcinoma
5788793|NCT00151645|Metastasis|metastasis
5788794|NCT00151645|Lymphokine activated killers|lymphokine activated killers
5788795|NCT00151645|Cell therapy|cell therapy
5788796|NCT00151632|Immunosuppression|immunosuppression
5788797|NCT00151632|Liver transplantation|liver transplantation
5788798|NCT00151632|Acute graft rejection|acute graft rejection
5788799|NCT00151632|Treatment combination|treatment combination
5788800|NCT00151619|Calcium channel blockers|calcium channel blockers
5788801|NCT00151619|Heart failure|heart failure
5788802|NCT00151619|Hemodynamics|hemodynamics
5788803|NCT00151606|Infection prevention|infection prevention
5788804|NCT00151606|Isolation|isolation
5788805|NCT00151606|Resistant bacteria|resistant bacteria
5788806|NCT00151606|MRSA colonization|mrsa colonization
5788807|NCT00151593|Cold storage|cold storage
5788808|NCT00151593|Liver transplantation|liver transplantation
5788809|NCT00151593|Preservation solution|preservation solution
5788810|NCT00151580|Hepatitis C|hepatitis c
5788811|NCT00151580|Viral recurrence|viral recurrence
5788813|NCT00151567|Ureterolithiasis|ureterolithiasis
5788814|NCT00151567|Alpha1-blocker|alpha1-blocker
5788815|NCT00151567|Lower ureteral stone|lower ureteral stone
5788816|NCT00151554|Anxiety|anxiety
5788817|NCT00151554|Intensive Care Unit (ICU)|intensive care unit (icu)
5788818|NCT00151554|Preoperative Information|preoperative information
5788819|NCT00151554|Randomized Controlled Trial (RCT)|randomized controlled trial (rct)
5788820|NCT00151554|Chronic heart disease|chronic heart disease
5788821|NCT00151541|Acne Vulgaris|acne vulgaris
5788822|NCT00151541|Acne|acne
5788823|NCT00151541|Dermatology|dermatology
5788824|NCT00151541|Dapsone|dapsone
5788825|NCT00151541|Dapsone Topical Gel|dapsone topical gel
5686482|NCT00551902|anterior chamber infusion|anterior chamber infusion
5681129|NCT00574613|durometer|durometer
5788826|NCT00151515|Alopecia, Balding|alopecia, balding
5788827|NCT00151476|Familial adenomatous polyposis|familial adenomatous polyposis
5788828|NCT00151476|celecoxib|celecoxib
5788829|NCT00151476|IRA|ira
5788830|NCT00151476|IPAA|ipaa
5788831|NCT00151411|Polycystic Ovary Syndrome (PCOS)|polycystic ovary syndrome (pcos)
5788833|NCT00151411|Elevated Testosterone|elevated testosterone
5788834|NCT00151346|Epidural|epidural
5788835|NCT00151346|Labour pain|labour pain
5788836|NCT00151346|Pregnant women|pregnant women
5788837|NCT00151346|Epidural anesthesia|epidural anesthesia
5788838|NCT00151346|Labour, Obstetric|labour, obstetric
5788839|NCT00151346|labor pain|labor pain
5788840|NCT00151346|labor, obstetric|labor, obstetric
5788841|NCT00151346|labor analgesia|labor analgesia
5788842|NCT00151320|diffuse large B cell|diffuse large b cell
5788843|NCT00151320|mantle cell lymphoma|mantle cell lymphoma
5788844|NCT00151307|Heart surgery|heart surgery
5788845|NCT00151307|Cerebral oxygen saturation|cerebral oxygen saturation
5788846|NCT00151307|Neuropsychological function|neuropsychological function
5788847|NCT00151294|Depression (mild to moderate)|depression (mild to moderate)
5788848|NCT00151294|Affective symptoms|affective symptoms
5788849|NCT00151294|Emotional lability|emotional lability
5788850|NCT00151294|Multiple Sclerosis|multiple sclerosis
5788851|NCT00151281|relapsed mantle cell lymphoma|relapsed mantle cell lymphoma
5788852|NCT00151268|Batten Disease|batten disease
5788853|NCT00151268|Late Infantile Neuronal Lipofuscinosis|late infantile neuronal lipofuscinosis
5788854|NCT00151268|LINCL|lincl
5788855|NCT00151255|age > 60 years|age > 60 years
5788856|NCT00151229|isolated systolic hypertension|isolated systolic hypertension
5788857|NCT00151229|valsartan|valsartan
5788858|NCT00151229|target blood pressure|target blood pressure
5788859|NCT00151216|Batten Disease|batten disease
5783964|NCT00175318|maternal counseling|maternal counseling
5788860|NCT00151216|Late Infantile Neuronal Ceroid Lipofuscinosis|late infantile neuronal ceroid lipofuscinosis
5788861|NCT00151216|LINCL|lincl
5788862|NCT00151203|newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5788863|NCT00151177|ischemic stroke|ischemic stroke
5788864|NCT00151177|CPAP ventilation|cpap ventilation
5788865|NCT00151164|transplantation tolerance|transplantation tolerance
5788866|NCT00151164|thymus|thymus
5788867|NCT00151164|bone marrow|bone marrow
5788868|NCT00151164|pediatric heart transplantation|pediatric heart transplantation
5788869|NCT00151151|pregnancy prevention|pregnancy prevention
5788870|NCT00151151|STD prevention|std prevention
5788871|NCT00151151|adolescents|adolescents
5788872|NCT00151151|motivational interviewing|motivational interviewing
5788873|NCT00151151|abstinence|abstinence
5788874|NCT00151151|contraception|contraception
5788875|NCT00151151|transtheoretical model|transtheoretical model
5788876|NCT00151151|sexual behavior|sexual behavior
5788877|NCT00151138|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology|cerebral blood flow, positron emission tomography, magnetic resonance imaging, neuropsychology
5788878|NCT00151125|Von Willebrand Disease|von willebrand disease
5788879|NCT00151125|Bleeding|bleeding
5788880|NCT00151125|Coagulation|coagulation
5788881|NCT00151125|Hemostatic agent|hemostatic agent
5788882|NCT00151112|nerve block|nerve block
5788883|NCT00151112|regional anesthesia|regional anesthesia
5788884|NCT00151112|injuries|injuries
5788885|NCT00151112|diverse malformations|diverse malformations
5788886|NCT00151099|preoperative nutrition|preoperative nutrition
5788887|NCT00151099|postoperative nausea and vomiting|postoperative nausea and vomiting
5788888|NCT00151099|Dysgnathia|dysgnathia
5788889|NCT00151099|anesthesia|anesthesia
5788890|NCT00151073|Zometa|zometa
5788891|NCT00151073|Prostate Cancer|prostate cancer
5788892|NCT00151073|Metastatic Prostate Cancer|metastatic prostate cancer
5788893|NCT00151034|Urothelial Cancer|urothelial cancer
5788894|NCT00151034|Herceptin|herceptin
5788895|NCT00151034|Advanced Urothelial Cancer|advanced urothelial cancer
5788896|NCT00151021|Diabetes|diabetes
5788897|NCT00151021|Pedometer|pedometer
5788898|NCT00151021|Behavioral|behavioral
5788899|NCT00151008|psoriasis|psoriasis
5788900|NCT00151008|bexarotene|bexarotene
5788901|NCT00151008|narrow band|narrow band
5788902|NCT00151008|UVB|uvb
5788903|NCT00150982|psoriasis|psoriasis
5788904|NCT00150982|alefacept|alefacept
5788905|NCT00150969|vitamin K|vitamin k
5788906|NCT00150969|bone mineral density|bone mineral density
5788907|NCT00150969|post-menopausal women|post-menopausal women
5788908|NCT00150969|randomized double blind placebo controlled trial|randomized double blind placebo controlled trial
5788909|NCT00150969|osteoporosis|osteoporosis
5788910|NCT00150969|women's health|women's health
5788911|NCT00150943|Renal artery stenosis|renal artery stenosis
5788912|NCT00150943|Stent|stent
5788913|NCT00150943|Renal failure|renal failure
5788914|NCT00150943|Atorvastatin|atorvastatin
5788915|NCT00150943|Hypertension|hypertension
5788916|NCT00150943|Atherosclerosis|atherosclerosis
5788917|NCT00150930|psoriasis|psoriasis
5788918|NCT00150930|ultraviolet|ultraviolet
5797786|NCT00114517|CVD|cvd
5788078|NCT00155467|congenital|congenital
5788920|NCT00150930|phototherapy|phototherapy
5788921|NCT00150930|home care|home care
5788922|NCT00150930|narrowband|narrowband
5788923|NCT00150917|Breast cancer|breast cancer
5788924|NCT00150917|Genetics|genetics
5788925|NCT00150917|Psychotherapy|psychotherapy
5788926|NCT00150917|Group counselling|group counselling
5788927|NCT00150917|Randomized control trial|randomized control trial
5788928|NCT00150917|Risk counselling|risk counselling
5788929|NCT00150917|Women's mental health|women's mental health
5788930|NCT00150917|Familial breast cancer|familial breast cancer
5788931|NCT00150904|HIV|hiv
5788935|NCT00150904|HIV / Hepatitis C coinfection|hiv / hepatitis c coinfection
5788936|NCT00150891|Th1|th1
5788937|NCT00150891|Th2|th2
5788938|NCT00150891|B cell|b cell
5788939|NCT00150891|monokines|monokines
5788940|NCT00150891|kidney transplantation|kidney transplantation
5848818|NCT00033163|Hepatitis B|hepatitis b
5788942|NCT00150891|chronic rejection|chronic rejection
5788943|NCT00150878|Reduced-intensity conditioning|reduced-intensity conditioning
5788944|NCT00150878|Fludarabine|fludarabine
5788945|NCT00150878|Acute myeloid Leukemia|acute myeloid leukemia
5788946|NCT00150878|Treatment-related mortality|treatment-related mortality
5788947|NCT00150865|ropivacaine|ropivacaine
5788948|NCT00150865|posterior lumbar plexus block|posterior lumbar plexus block
5788949|NCT00150865|hip arthroplasy|hip arthroplasy
5788950|NCT00150865|analgesia|analgesia
5788951|NCT00150865|postoperative|postoperative
5788952|NCT00150852|Gastrostomy|gastrostomy
5788953|NCT00150852|Wound infection|wound infection
5788954|NCT00150852|Antibiotic prophylaxis|antibiotic prophylaxis
5788955|NCT00150839|Depressive Disorder, Major|depressive disorder, major
5788956|NCT00150839|Venlafaxine|venlafaxine
5788957|NCT00150839|Mirtazapine|mirtazapine
5788958|NCT00150839|Double-blind RCT|double-blind rct
5788959|NCT00150839|Magnetic resonance imaging|magnetic resonance imaging
5788960|NCT00150839|Hippocampal volume|hippocampal volume
5788961|NCT00150826|microvascular disease|microvascular disease
5788962|NCT00150826|women|women
5788963|NCT00150826|renin angiotensin system|renin angiotensin system
5788964|NCT00150826|WISE|wise
5788965|NCT00150826|ischemic heart disease|ischemic heart disease
5788966|NCT00150813|Monotherapy|monotherapy
5788967|NCT00150813|Epilepsy|epilepsy
5788968|NCT00150813|Keppra|keppra
5788969|NCT00150813|Levetiracetam|levetiracetam
5788970|NCT00150800|Brivaracetam|brivaracetam
5788971|NCT00150800|Epilepsy|epilepsy
5788972|NCT00150800|Partial Onset Seizures|partial onset seizures
5788973|NCT00150800|open label|open label
5788974|NCT00150787|Monotherapy, epilepsy|monotherapy, epilepsy
5788975|NCT00150787|Levetiracetam|levetiracetam
5788976|NCT00150787|Keppra|keppra
5788977|NCT00150774|Idiopathic Generalized Epilepsy, Myoclonic seizures|idiopathic generalized epilepsy, myoclonic seizures
5788978|NCT00150774|Keppra - Levetiracetam|keppra - levetiracetam
5788979|NCT00150761|Nasal histamine provocation, facial thermography, levocetirizine, cetirizine,|nasal histamine provocation, facial thermography, levocetirizine, cetirizine,
5788980|NCT00150761|Xyzal, Zyrtec|xyzal, zyrtec
5788981|NCT00150748|Generalized Epilepsy, Primary Generalized Seizures|generalized epilepsy, primary generalized seizures
5788982|NCT00150748|Keppra, Levetiracetam|keppra, levetiracetam
5788983|NCT00150735|Monotherapy, epilepsy, Levetiracetam, Keppra.|monotherapy, epilepsy, levetiracetam, keppra.
5788984|NCT00150722|atherosclerosis|atherosclerosis
5788985|NCT00150722|endothelial function|endothelial function
5788987|NCT00150722|Niacin|niacin
5788988|NCT00150722|statins|statins
5788989|NCT00150722|Stable Atherosclerotic Vascular Disease|stable atherosclerotic vascular disease
5788990|NCT00150709|Epilepsy, Pediatric , partial onset epilepsy,|epilepsy, pediatric , partial onset epilepsy,
5788991|NCT00150709|Levetiracetam (Keppra®)|levetiracetam (keppra®)
5788992|NCT00150696|Osteoporosis|osteoporosis
5788993|NCT00150696|Spinal Cord Injury|spinal cord injury
5788994|NCT00150683|Spinal Cord Injury.|spinal cord injury.
5788995|NCT00150683|Osteoporosis.|osteoporosis.
5788996|NCT00150683|Standing.|standing.
5788997|NCT00150683|Vibration.|vibration.
5788998|NCT00150670|Stomach cancer|stomach cancer
5788999|NCT00150644|Fibroid Uterus|fibroid uterus
5789000|NCT00150644|Leiomyoma|leiomyoma
5789001|NCT00150644|Uterine Fibroids|uterine fibroids
5789002|NCT00150644|Hysterectomy|hysterectomy
5789003|NCT00150644|Asoprisnil|asoprisnil
5789004|NCT00150631|Hypertension|hypertension
5789005|NCT00150631|Prevention|prevention
5789006|NCT00150631|Offspring|offspring
5789007|NCT00150631|Prevent or delay development of hypertension|prevent or delay development of hypertension
5789008|NCT00150527|antidepressive agents|antidepressive agents
5789009|NCT00150514|nasal biopsy grasspollen sublingual immunotherapy|nasal biopsy grasspollen sublingual immunotherapy
5789010|NCT00150488|PBS|pbs
5789011|NCT00150488|Painful Bladder Syndrome|painful bladder syndrome
5789012|NCT00150488|Interstitial Cystitis|interstitial cystitis
5789013|NCT00150488|chrondroitin sulfate|chrondroitin sulfate
5789014|NCT00150475|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5789015|NCT00150462|Hematological|hematological
5789016|NCT00150462|Proteasome|proteasome
5778532|NCT00204490|soy|soy
5789017|NCT00150462|Myeloma|myeloma
5789018|NCT00150462|Lymphoma|lymphoma
5789019|NCT00150371|(D006937)|(d006937)
5789020|NCT00150345|Neutropenia|neutropenia
5789021|NCT00150345|Fever of unknown origin|fever of unknown origin
5789022|NCT00150345|Empirical treatment|empirical treatment
5789023|NCT00150345|Voriconazole|voriconazole
5789024|NCT00150189|Pain|pain
5789025|NCT00150189|Procedural Pain|procedural pain
5789026|NCT00150189|Sucrose|sucrose
5789027|NCT00150189|Infant|infant
5789028|NCT00150189|Newborn|newborn
5789029|NCT00150163|Androgens|androgens
5789030|NCT00150163|Bone|bone
5789031|NCT00150163|Muscle|muscle
5789091|NCT00149942|Kidney and liver transplantation patients experiencing GI AEs with current MMF treatment|kidney and liver transplantation patients experiencing gi aes with current mmf treatment
5789092|NCT00149929|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
5789093|NCT00149916|Renal Transplant, adults, immunosuppressants|renal transplant, adults, immunosuppressants
5789094|NCT00149890|pediatric|pediatric
5789095|NCT00149890|liver transplantation|liver transplantation
5789096|NCT00149890|Simulect|simulect
5789097|NCT00149890|Basiliximab|basiliximab
5789098|NCT00149890|ciclosporin microemulsion|ciclosporin microemulsion
5789099|NCT00149890|steroid reduction|steroid reduction
5789100|NCT00149890|pediatric liver transplantation|pediatric liver transplantation
5789101|NCT00149877|Chronic constipation, tegaserod|chronic constipation, tegaserod
5789394|NCT00148668|herceptin|herceptin
5789102|NCT00149864|Renal Transplant, adults, immunosuppressant|renal transplant, adults, immunosuppressant
5789103|NCT00149851|GERD, heartburn, regurgitation, reflux disease|gerd, heartburn, regurgitation, reflux disease
5789104|NCT00149838|Electric Stimulation|electric stimulation
5789105|NCT00149838|Magnetic Stimulation|magnetic stimulation
5789106|NCT00149838|Prefrontal Cortex|prefrontal cortex
5789108|NCT00149825|Major Depressive Disorder|major depressive disorder
5789109|NCT00149825|Insomnia|insomnia
5789110|NCT00149825|Sleep|sleep
5789111|NCT00149825|Mental Health|mental health
5789112|NCT00149812|Depression|depression
5789113|NCT00149812|Child disruptive behavior|child disruptive behavior
5789114|NCT00149812|Family functioning|family functioning
5784212|NCT00173615|CPR|cpr
5789115|NCT00149799|Body Dysmorphic Disorder|body dysmorphic disorder
5789116|NCT00149799|Escitalopram|escitalopram
5789117|NCT00149799|Lexapro|lexapro
5789119|NCT00149799|Body Image|body image
5789120|NCT00149786|Anorexia Nervosa|anorexia nervosa
5789121|NCT00149786|Adolescents|adolescents
5789122|NCT00149786|Family therapy|family therapy
5789123|NCT00149786|Individual therapy|individual therapy
5789124|NCT00149773|Cognitive therapy|cognitive therapy
5789125|NCT00149773|Suicide|suicide
5789127|NCT00149773|Death ideation|death ideation
5789128|NCT00149773|Primary care|primary care
5789129|NCT00149760|Cognitive Behavior Therapy|cognitive behavior therapy
5789130|NCT00149760|Treatment Outcome|treatment outcome
5805399|NCT00090103|BPH|bph
5789131|NCT00149760|Health Care Utilization|health care utilization
5789132|NCT00149760|Somatization Disorder|somatization disorder
5789133|NCT00149760|Somatoform Disorder|somatoform disorder
5789134|NCT00149747|Sleep|sleep
5789135|NCT00149747|Exercise|exercise
5789136|NCT00149747|Older Adults|older adults
5789137|NCT00149734|Schizophrenia|schizophrenia
5789138|NCT00149734|Ondansetron|ondansetron
5789139|NCT00149734|P50 sensory gating|p50 sensory gating
5789140|NCT00149734|Evoked potentials|evoked potentials
5789141|NCT00149734|5-HT3 receptors|5-ht3 receptors
5789142|NCT00149734|Atypical antipsychotics|atypical antipsychotics
5789143|NCT00149721|hydrocephalus|hydrocephalus
5789144|NCT00149721|pituitary function|pituitary function
5789145|NCT00149721|shunting|shunting
5789146|NCT00149708|Growth hormone|growth hormone
5789147|NCT00149708|Deficiency|deficiency
5789148|NCT00149708|Cardiovascular risk|cardiovascular risk
5789149|NCT00149708|Body composition|body composition
5789150|NCT00149695|Obesity, beverages, weight loss, body mass index, diet|obesity, beverages, weight loss, body mass index, diet
5789151|NCT00149682|Obesity|obesity
5789152|NCT00149669|Behavior Therapy|behavior therapy
5789153|NCT00149669|Cocaine|cocaine
5789154|NCT00149669|Cocaine (IV)|cocaine (iv)
5789155|NCT00149669|Cocaine Abuse|cocaine abuse
5789156|NCT00149669|Cocaine Dependence|cocaine dependence
5789157|NCT00149669|Contingency management|contingency management
5789158|NCT00149669|HIV risk behaviors|hiv risk behaviors
5789159|NCT00149669|Heroin|heroin
5789160|NCT00149669|Naltrexone|naltrexone
5789161|NCT00149669|Opioid Dependence|opioid dependence
5789162|NCT00149669|sexual risk behaviors|sexual risk behaviors
5789163|NCT00149656|Treatment Naive|treatment naive
5789164|NCT00149656|Multivitamins|multivitamins
5789165|NCT00149656|Selenium|selenium
5789166|NCT00149656|Supplementation|supplementation
5789167|NCT00149656|HIV Disease Progression|hiv disease progression
5789168|NCT00149643|Cannabis|cannabis
5789169|NCT00149643|MDD|mdd
5789170|NCT00149630|Opioid Dependence|opioid dependence
5789171|NCT00149630|Substance Related Disorders|substance related disorders
5789172|NCT00149617|Marijuana|marijuana
5789173|NCT00149617|Mood Disorder|mood disorder
5789174|NCT00149604|metabolic syndrome|metabolic syndrome
5789175|NCT00149604|hormone therapy|hormone therapy
5789176|NCT00149604|abdominal adiposity|abdominal adiposity
5789177|NCT00149604|lipolysis|lipolysis
5789178|NCT00149591|Myocardial infarction|myocardial infarction
5789179|NCT00149591|Viability|viability
5789180|NCT00149591|Coronary angioplasty|coronary angioplasty
5789181|NCT00149591|Prevention|prevention
5789182|NCT00149591|Prognosis|prognosis
5789183|NCT00149578|pancreatic cancer|pancreatic cancer
5789184|NCT00149578|gemcitabine|gemcitabine
5789185|NCT00149578|oxaliplatin|oxaliplatin
5789186|NCT00149578|5-Fluorouracil|5-fluorouracil
5789187|NCT00149578|radiation|radiation
5789188|NCT00149552|Treatment Naive|treatment naive
5789189|NCT00149552|Treatment Experienced|treatment experienced
5681159|NCT00574496|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5681160|NCT00574496|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5681161|NCT00574496|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5681162|NCT00574496|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5681163|NCT00574496|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5681164|NCT00574496|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5789190|NCT00149461|Asthma Action Plans|asthma action plans
5789191|NCT00149461|African Americans|african americans
5789192|NCT00149461|Latinos|latinos
5789193|NCT00149461|Health Literacy|health literacy
5789194|NCT00149461|Asthma Education|asthma education
5789195|NCT00149422|NT-proBNP|nt-probnp
5789196|NCT00149396|Colorectal cancer metastases to liver|colorectal cancer metastases to liver
5789197|NCT00149396|Colorectal Cancer|colorectal cancer
5789198|NCT00149396|Colorectal Carcinoma|colorectal carcinoma
5789199|NCT00149396|Colorectal Tumors|colorectal tumors
5789200|NCT00149396|Colorectal Neoplasms|colorectal neoplasms
5789201|NCT00149396|Rectum Cancer|rectum cancer
5789202|NCT00149396|Rectum tumors|rectum tumors
5789203|NCT00149396|Rectum carcinoma|rectum carcinoma
5789204|NCT00149396|Colon cancer|colon cancer
5789205|NCT00149396|Colon tumors|colon tumors
5789206|NCT00149396|Colon carcinoma|colon carcinoma
5789207|NCT00149396|Rectum Neoplasms|rectum neoplasms
5789208|NCT00149396|Colon Neoplasms|colon neoplasms
5789209|NCT00149396|Liver Neoplasms|liver neoplasms
5789210|NCT00149396|Hepatic Neoplasms|hepatic neoplasms
5789211|NCT00149396|Liver Tumors|liver tumors
5789212|NCT00149396|Liver cancer|liver cancer
5789213|NCT00149396|Hepatic Cancer|hepatic cancer
5789214|NCT00149396|Hepatic tumors|hepatic tumors
5789215|NCT00149396|metastatic to the liver|metastatic to the liver
5789216|NCT00149383|randomized controlled trial|randomized controlled trial
5789218|NCT00149383|Plasmodium falciparum|plasmodium falciparum
5789219|NCT00149383|thiazolidinediones|thiazolidinediones
5789220|NCT00149383|rosiglitazone|rosiglitazone
5789221|NCT00149383|atovaquone-proguanil|atovaquone-proguanil
5789222|NCT00149370|breast hypertrophy|breast hypertrophy
5789223|NCT00149370|breast reduction surgery|breast reduction surgery
5789224|NCT00149370|health-related quality of life|health-related quality of life
5789225|NCT00149370|Health Utilities Index|health utilities index
5789226|NCT00149370|HUI|hui
5789227|NCT00149370|prospective|prospective
5789228|NCT00149370|SF-36|sf-36
5789229|NCT00149370|quality-adjusted life years|quality-adjusted life years
5789231|NCT00149357|venous thromboembolism|venous thromboembolism
5789233|NCT00149357|thrombophilia|thrombophilia
5789234|NCT00149357|fetal loss|fetal loss
5789235|NCT00149344|cost-utility analysis;|cost-utility analysis;
5789236|NCT00149344|breast reduction;|breast reduction;
5789237|NCT00149344|vertical scar mammoplasty;|vertical scar mammoplasty;
5789238|NCT00149344|pedicle reduction mammoplasty|pedicle reduction mammoplasty
5789239|NCT00149331|Diabetes, Insulin, Education|diabetes, insulin, education
5789240|NCT00149305|Gouty diathesis|gouty diathesis
5789241|NCT00149305|Acid uric nephrolithiasis|acid uric nephrolithiasis
5789242|NCT00149279|stomach neoplasms|stomach neoplasms
5789243|NCT00149279|lymph node excision|lymph node excision
5789244|NCT00149279|abdominal aorta|abdominal aorta
5789245|NCT00149266|stomach neoplasms|stomach neoplasms
5789246|NCT00149266|lymph node resection|lymph node resection
5789247|NCT00149266|cardia|cardia
5789248|NCT00149266|thoracotomy|thoracotomy
5789249|NCT00149253|Abdominal hysterectomy,|abdominal hysterectomy,
5789250|NCT00149253|Etoricoxib,|etoricoxib,
5789251|NCT00149253|morphine consumption,|morphine consumption,
5789252|NCT00149253|pre-emptive analgesia|pre-emptive analgesia
5789253|NCT00149240|DYSPORT|dysport
5789254|NCT00149240|botulinum toxin A|botulinum toxin a
5789255|NCT00149240|myofascial pain syndrome|myofascial pain syndrome
5789256|NCT00149227|High risk hypertension|high risk hypertension
5789257|NCT00149227|Ischemic heart disease|ischemic heart disease
5789258|NCT00149227|Angiotensin receptor blockers|angiotensin receptor blockers
5789259|NCT00149227|Cardiovascular mortality- morbidity|cardiovascular mortality- morbidity
5789260|NCT00149227|KYOTO HEART Study|kyoto heart study
5789261|NCT00149201|gastric cancer|gastric cancer
5789262|NCT00149201|peritoneal metastasis|peritoneal metastasis
5789263|NCT00149201|randomized trial|randomized trial
5789264|NCT00149201|5-FU|5-fu
5798042|NCT00113724|taxane|taxane
5789265|NCT00149201|MTX|mtx
5789266|NCT00149188|Growth Hormone|growth hormone
5789267|NCT00149175|Alzheimer's disease|alzheimer's disease
5789268|NCT00149175|Dementia|dementia
5789269|NCT00149175|Phenotype-genotype correlations|phenotype-genotype correlations
5789270|NCT00149175|Candidate genes|candidate genes
5789271|NCT00149175|Related disorders|related disorders
5789272|NCT00149162|Controlled|controlled
5789273|NCT00149162|Multicenter|multicenter
5789274|NCT00149162|International|international
5789275|NCT00149162|Randomized study|randomized study
5789276|NCT00149162|Direct individual benefit|direct individual benefit
5789277|NCT00149162|complete remission after chemotherapy|complete remission after chemotherapy
5789278|NCT00149162|non allogeneic transplanted|non allogeneic transplanted
5789279|NCT00149149|Reduction in NSAID related gut damage|reduction in nsaid related gut damage
5789280|NCT00149136|Acute Lymphocytic Leukemia,|acute lymphocytic leukemia,
5789281|NCT00149136|Ph+,|ph+,
5789282|NCT00149136|elderly patients,|elderly patients,
5789283|NCT00149136|Imatinib|imatinib
5789284|NCT00149123|Burn|burn
5789285|NCT00149123|adrenal insufficiency|adrenal insufficiency
5789286|NCT00149123|hydrocortisone|hydrocortisone
5789287|NCT00149123|short corticotropin test|short corticotropin test
5789288|NCT00149110|Sleep deprivation|sleep deprivation
5789289|NCT00149110|Exercise|exercise
5789290|NCT00149110|Light therapy|light therapy
5789291|NCT00149110|Major depression|major depression
5789292|NCT00149110|Bipolar depression|bipolar depression
5789293|NCT00149110|Sleep-wake cycle|sleep-wake cycle
5789294|NCT00149084|The tailored H. pylori eradication therapy|the tailored h. pylori eradication therapy
5789295|NCT00149084|CYP2C19 genotype|cyp2c19 genotype
5789296|NCT00149084|23S rRNA|23s rrna
5789297|NCT00149084|clarithromycin|clarithromycin
5789298|NCT00149084|Lansoprazole|lansoprazole
5789299|NCT00149084|Amoxicillin|amoxicillin
5789300|NCT00149084|H. pylori infection|h. pylori infection
5789395|NCT00148668|navelbine|navelbine
5789301|NCT00149071|Transcranial magnetic stimulation (TMS)|transcranial magnetic stimulation (tms)
5789302|NCT00149071|Major depression|major depression
5789303|NCT00149071|treatment resistant major depression|treatment resistant major depression
5789304|NCT00149058|acute myocardial infarction|acute myocardial infarction
5789306|NCT00149045|familial peripheral Neuropathy Anticipation|familial peripheral neuropathy anticipation
5789307|NCT00149032|Metastatic solid tumor|metastatic solid tumor
5789308|NCT00149006|Metastatic solid tumor|metastatic solid tumor
5789309|NCT00149006|Mismatch allogeneic cell mediated immunotherapy|mismatch allogeneic cell mediated immunotherapy
5789310|NCT00148993|Tumor cell vaccine|tumor cell vaccine
5789311|NCT00148980|Myelodysplastic syndrome (MDS)|myelodysplastic syndrome (mds)
5789312|NCT00148980|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5789313|NCT00148980|Demineralized bone matrix (DBM)|demineralized bone matrix (dbm)
5789314|NCT00148980|Bone marrow microenvironment|bone marrow microenvironment
5789315|NCT00148967|right ventricular pacing|right ventricular pacing
5789316|NCT00148967|implantable cardioverter defibrillator|implantable cardioverter defibrillator
5789317|NCT00148915|Osteoporosis|osteoporosis
5789318|NCT00148915|bisphosphonates|bisphosphonates
5789320|NCT00148902|tumor|tumor
5789321|NCT00148889|cervical dystonia|cervical dystonia
5789323|NCT00148889|deep brain stimulation|deep brain stimulation
5789324|NCT00148889|pallidal stimulation|pallidal stimulation
5789325|NCT00148889|globus pallidus internus|globus pallidus internus
5789326|NCT00148876|Progression after treatment with Trastuzumab|progression after treatment with trastuzumab
5789327|NCT00148876|Metastatic Breast Cancer|metastatic breast cancer
5789328|NCT00148876|Palliative Study|palliative study
5789329|NCT00148863|Hepatitis C, Chronic|hepatitis c, chronic
5789330|NCT00148863|Interferon Alfa-2a|interferon alfa-2a
5789331|NCT00148863|Ribavirin|ribavirin
5789332|NCT00148863|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5789333|NCT00148850|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5789334|NCT00148850|pioglitazone|pioglitazone
5789335|NCT00148850|HIV infections|hiv infections
5789336|NCT00148850|Treatment Experienced|treatment experienced
5789337|NCT00148837|Hepatitis C, Chronic|hepatitis c, chronic
5789338|NCT00148837|Fibrosis|fibrosis
5789339|NCT00148837|Interferon Alfa-2b|interferon alfa-2b
5789340|NCT00148837|Ribavirin|ribavirin
5789341|NCT00148837|Prazosin|prazosin
5789342|NCT00148824|HIV infections|hiv infections
5789343|NCT00148824|Pneumococcal vaccines|pneumococcal vaccines
5789344|NCT00148824|Treatment Experienced|treatment experienced
5789345|NCT00148824|Treatment Naive|treatment naive
5789346|NCT00148798|Cetuximab|cetuximab
5789347|NCT00148798|Non small cell lung cancer|non small cell lung cancer
5789348|NCT00148798|Lung cancer|lung cancer
5789349|NCT00148798|Cisplatin/vinorelbine|cisplatin/vinorelbine
5789350|NCT00148798|Monoclonal antibody|monoclonal antibody
5789351|NCT00148798|Erbitux|erbitux
5789352|NCT00148785|Antiretroviral drugs|antiretroviral drugs
5789353|NCT00148785|Pharmacokinetic|pharmacokinetic
5789354|NCT00148785|Indinavir|indinavir
5789355|NCT00148785|Ritonavir|ritonavir
5789356|NCT00148785|Fosamprenavir|fosamprenavir
5789357|NCT00148772|Prostate Cancer|prostate cancer
5789358|NCT00148772|Rising PSA|rising psa
5789359|NCT00148772|Erlotinib|erlotinib
5789360|NCT00148772|Tarceva|tarceva
5789361|NCT00148772|Androgen Deprivation Therapy|androgen deprivation therapy
5789362|NCT00148772|Hormone Therapy|hormone therapy
5862613|NCT00001566|Ewing's Sarcoma|ewing's sarcoma
5789363|NCT00148772|Rising Prostate Specific Antigen (PSA)|rising prostate specific antigen (psa)
5789364|NCT00148772|Non-Metastatic Prostate Cancer|non-metastatic prostate cancer
5789365|NCT00148759|Sex differences|sex differences
5789366|NCT00148759|Pharmacokinetic|pharmacokinetic
5789367|NCT00148759|Lopinavir/ritonavir|lopinavir/ritonavir
5789368|NCT00148759|Treatment Experienced|treatment experienced
5789369|NCT00148759|HIV-infection|hiv-infection
5789370|NCT00148746|atopic dermatitis, atopy|atopic dermatitis, atopy
5789371|NCT00148733|Child|child
5789372|NCT00148733|pneumonia|pneumonia
5789373|NCT00148733|Zinc|zinc
5789374|NCT00148733|clinical trial|clinical trial
5789375|NCT00148733|Nepal|nepal
5789376|NCT00148733|nutrition|nutrition
5789377|NCT00148733|therapeutic|therapeutic
5789378|NCT00148720|Invasive Breast Cancer|invasive breast cancer
5789379|NCT00148720|Operable Breast Cancer|operable breast cancer
5789380|NCT00148720|Capecitabine|capecitabine
5789381|NCT00148707|Metastatic Breast Cancer|metastatic breast cancer
5789382|NCT00148707|HER2-negative Breast Cancer|her2-negative breast cancer
5789383|NCT00148707|CT-2103|ct-2103
5789384|NCT00148707|Xyotax|xyotax
5789385|NCT00148694|Cisplatin|cisplatin
5789386|NCT00148694|Early Stage Breast Cancer|early stage breast cancer
5789387|NCT00148694|ER Negative Breast Cancer|er negative breast cancer
5789388|NCT00148694|PR Negative Breast Cancer|pr negative breast cancer
5789389|NCT00148694|HER-2 Negative Breast Cancer|her-2 negative breast cancer
5789390|NCT00148681|HER-2 Positive breast cancer|her-2 positive breast cancer
5789391|NCT00148681|herceptin|herceptin
5789392|NCT00148681|navelbine|navelbine
5789393|NCT00148668|HER-2 Positive Breast Cancer|her-2 positive breast cancer
5789397|NCT00148668|carboplatin|carboplatin
5789398|NCT00148668|Early stage Breast Cancer|early stage breast cancer
5789399|NCT00148655|educational intervention|educational intervention
5789400|NCT00148655|decision board|decision board
5789401|NCT00148655|DCIS|dcis
5789402|NCT00148642|ventilator-associated pneumonia|ventilator-associated pneumonia
5789403|NCT00148642|nosocomial pneumonia|nosocomial pneumonia
5789405|NCT00148629|Birth weight|birth weight
5789406|NCT00148629|Neonatal Mortality|neonatal mortality
5789407|NCT00148629|Tanzania|tanzania
5789408|NCT00148629|Pregnancy|pregnancy
5789409|NCT00148616|Memantine|memantine
5789410|NCT00148616|Negative Syndrome|negative syndrome
5789411|NCT00148616|Schizophrenia|schizophrenia
5789412|NCT00148616|Cognitive impairment|cognitive impairment
5789413|NCT00148603|dyspepsia|dyspepsia
5789414|NCT00148603|eosinophilic gastroenteritis|eosinophilic gastroenteritis
5789415|NCT00148603|montelukast|montelukast
5789416|NCT00148590|Memantine|memantine
5789417|NCT00148590|Negative syndrome|negative syndrome
5789418|NCT00148590|Schizophrenia|schizophrenia
5789419|NCT00148590|Cognitive impairment|cognitive impairment
5789420|NCT00148590|Glutamate|glutamate
5789421|NCT00148577|Pain Relief, TENS, Acupuncture Points|pain relief, tens, acupuncture points
5789422|NCT00148564|weight gain|weight gain
5789423|NCT00148564|schizophrenia|schizophrenia
5789424|NCT00148564|atypical antipsychotics|atypical antipsychotics
5789425|NCT00148551|AMD|amd
5789426|NCT00148551|Triamcinolone|triamcinolone
5789427|NCT00148551|Macular Degeneration|macular degeneration
5789428|NCT00148538|Type 1 Diabetes|type 1 diabetes
5789429|NCT00148538|Resistance Exercise|resistance exercise
5789430|NCT00148538|Aerobic Exercise|aerobic exercise
5789431|NCT00148538|Exercise & Disease|exercise & disease
5789432|NCT00148538|Exercise|exercise
5789433|NCT00148538|Diabetes|diabetes
5789434|NCT00148525|automated telephony, cancer prevention, healthy diet|automated telephony, cancer prevention, healthy diet
5789435|NCT00148473|Cervical ripening.|cervical ripening.
5789436|NCT00148473|Induction of labor.|induction of labor.
5789437|NCT00148473|Misoprostol.|misoprostol.
5789438|NCT00148447|negative symptoms|negative symptoms
5789439|NCT00148447|depression|depression
5789440|NCT00148447|ssri|ssri
5789441|NCT00148447|schizophrenia|schizophrenia
5789442|NCT00148434|hypertension|hypertension
5789443|NCT00148434|guidelines|guidelines
5789444|NCT00148434|patient empowerment|patient empowerment
5789445|NCT00148434|anxiety|anxiety
5789446|NCT00148421|Non-myeloid malignancy|non-myeloid malignancy
5789447|NCT00148421|Chemotherapy-induced anemia|chemotherapy-induced anemia
5789448|NCT00148408|Asthma|asthma
5789449|NCT00148408|Placebo|placebo
5789450|NCT00148408|Education|education
5789451|NCT00148382|Obesity|obesity
5789452|NCT00148382|Pharmacokinetics|pharmacokinetics
5789453|NCT00148382|Pharmacodynamics|pharmacodynamics
5789454|NCT00148356|drug eluting stents|drug eluting stents
5789455|NCT00148356|stents|stents
5789456|NCT00148356|angioplasty|angioplasty
5789457|NCT00148356|coronary artery disease|coronary artery disease
5789458|NCT00148356|total coronary occlusion|total coronary occlusion
5789459|NCT00148356|coronary artery restenosis|coronary artery restenosis
5789460|NCT00148356|stent thrombosis|stent thrombosis
5789461|NCT00148356|vascular disease|vascular disease
5789462|NCT00148356|myocardial ischemia|myocardial ischemia
5789463|NCT00148356|coronary artery stenosis|coronary artery stenosis
5789464|NCT00148343|hemiplegia|hemiplegia
5789465|NCT00148343|hemiparesis|hemiparesis
5789466|NCT00148343|stroke|stroke
5789467|NCT00148343|foot-drop|foot-drop
5789468|NCT00148343|electrical stimulation|electrical stimulation
5789469|NCT00148343|ankle-foot-orthosis|ankle-foot-orthosis
5789470|NCT00148330|Diabetic macular oedema|diabetic macular oedema
5789471|NCT00148330|Triamcinolone acetate|triamcinolone acetate
5789472|NCT00148330|Intravitreal injection|intravitreal injection
5789473|NCT00148330|Clinical trial|clinical trial
5789474|NCT00148330|Laser treatment|laser treatment
5789475|NCT00148304|Decision-making|decision-making
5789476|NCT00148304|Insulin|insulin
5789477|NCT00148304|Preference|preference
5789478|NCT00148304|Treatment Variation|treatment variation
5789479|NCT00148304|Provider|provider
5789480|NCT00148304|Patient|patient
5789481|NCT00148278|Catecholamines|catecholamines
5789482|NCT00148278|Septic shock|septic shock
5789483|NCT00148265|Diabetic macular oedema|diabetic macular oedema
5789484|NCT00148265|Triamcinolone acetate|triamcinolone acetate
5789485|NCT00148265|Intravitreal injection|intravitreal injection
5789486|NCT00148265|Clinical trial|clinical trial
5789487|NCT00148265|Laser treatment|laser treatment
5789488|NCT00148252|Calcineurin|calcineurin
5789489|NCT00148252|reduction|reduction
5789490|NCT00148252|immunosuppression|immunosuppression
5789491|NCT00148252|cyclosporine A|cyclosporine a
5789492|NCT00148252|mycophenolate mofetil|mycophenolate mofetil
5789494|NCT00148239|Caregiving|caregiving
5789495|NCT00148239|Aging|aging
5789496|NCT00148239|Disability|disability
5789497|NCT00148239|Paralysis|paralysis
5789498|NCT00148226|Decision Aid|decision aid
5789499|NCT00148226|Faecal Occult Blood Test|faecal occult blood test
5789500|NCT00148226|Colorectal Cancer Screening|colorectal cancer screening
5789501|NCT00148226|Informed Decision-making|informed decision-making
5789502|NCT00148213|differentiated thyroid carcinoma|differentiated thyroid carcinoma
5789503|NCT00148213|thyroglobulin|thyroglobulin
5789504|NCT00148213|immunoassay|immunoassay
5789505|NCT00148213|thyroidectomy|thyroidectomy
5789506|NCT00148213|radioiodine therapy|radioiodine therapy
5789507|NCT00148200|female sexual dysfunction|female sexual dysfunction
5789508|NCT00148200|desire|desire
5789509|NCT00148200|arousal|arousal
5789510|NCT00148200|lubrification|lubrification
5789511|NCT00148200|orgasm|orgasm
5789512|NCT00148200|satisfaction|satisfaction
5789513|NCT00148200|pain|pain
5789514|NCT00148187|Medication adherence|medication adherence
5789515|NCT00148187|Patient compliance|patient compliance
5789516|NCT00148187|Kidney transplant|kidney transplant
5789517|NCT00148187|Organ rejection|organ rejection
5789518|NCT00148187|Allograft loss|allograft loss
5789519|NCT00148187|Drug monitoring|drug monitoring
5789520|NCT00148174|Medication adherence|medication adherence
5789521|NCT00148174|Patient compliance|patient compliance
5789522|NCT00148174|Kidney transplant|kidney transplant
5789523|NCT00148174|Organ rejection|organ rejection
5789524|NCT00148174|Allograft loss|allograft loss
5789525|NCT00148174|Drug monitoring|drug monitoring
5789526|NCT00148161|Magnetoencephalography|magnetoencephalography
5789529|NCT00148161|Non stuttering|non stuttering
5789530|NCT00148148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5789531|NCT00148148|Caspofungin|caspofungin
5789532|NCT00148148|Liposomal Amphotericin B|liposomal amphotericin b
5789533|NCT00148135|Carcinoma of Unknown Primary Site (CUP)|carcinoma of unknown primary site (cup)
5789534|NCT00148122|Squamous cell cancer of the oral cavity and pharynx|squamous cell cancer of the oral cavity and pharynx
5789535|NCT00148109|Unresectable/metastatic high grade soft tissue bony sarcoma|unresectable/metastatic high grade soft tissue bony sarcoma
5789536|NCT00148096|asthma|asthma
5789537|NCT00148096|house dust mite|house dust mite
5789538|NCT00148096|allergy|allergy
5789539|NCT00148096|housing|housing
5789540|NCT00148096|avoidance|avoidance
5789541|NCT00148096|humidity|humidity
5789542|NCT00148083|Schizophrenia|schizophrenia
5789543|NCT00148083|Cognition|cognition
5789544|NCT00148083|Clinical Trial|clinical trial
5789545|NCT00148057|Diet|diet
5789546|NCT00148057|Dietary fat|dietary fat
5789547|NCT00148057|Breast cancer|breast cancer
5789548|NCT00148057|Prevention|prevention
5789549|NCT00148031|behavior modification|behavior modification
5789550|NCT00148031|health care service utilization|health care service utilization
5789551|NCT00148031|hepatitis C,|hepatitis c,
5789552|NCT00148031|injection drug use|injection drug use
5789553|NCT00148031|therapy compliance|therapy compliance
5789554|NCT00148031|alcoholism|alcoholism
5789555|NCT00148031|alcohol abuse|alcohol abuse
5789556|NCT00148031|prevention|prevention
5789557|NCT00148031|drug abuse|drug abuse
5789558|NCT00148031|liver disorder|liver disorder
5789560|NCT00148031|methadone|methadone
5789561|NCT00148018|Hodgkin disease|hodgkin disease
5789562|NCT00148018|Bortezomib|bortezomib
5789563|NCT00148018|Relapse|relapse
5789564|NCT00148018|Lymphoma|lymphoma
5789565|NCT00147966|active disease despite concomitant methotrexate|active disease despite concomitant methotrexate
5789566|NCT00147953|NHL|nhl
5812176|NCT00004132|radiation toxicity|radiation toxicity
5789567|NCT00147953|Lymphoma|lymphoma
5789568|NCT00147953|Radiotherapy|radiotherapy
5789569|NCT00147953|Rituximab|rituximab
5789570|NCT00147953|Palliative treatment|palliative treatment
5789571|NCT00147940|Allergy|allergy
5789572|NCT00147927|email|email
5789573|NCT00147927|internet|internet
5789574|NCT00147927|health promotion|health promotion
5789575|NCT00147927|behavior change|behavior change
5789576|NCT00147927|health status|health status
5789577|NCT00147927|work productivity|work productivity
5789578|NCT00147927|healthcare cost|healthcare cost
5789579|NCT00147927|employee|employee
5789580|NCT00147914|Acute bacterial sinusitis|acute bacterial sinusitis
5789581|NCT00147901|CLL|cll
5789582|NCT00147901|Immunochemotherapy|immunochemotherapy
5789583|NCT00147888|Mucosal congestion|mucosal congestion
5789584|NCT00147888|Acoustic rhinometry|acoustic rhinometry
5789585|NCT00147888|Physiology|physiology
5789586|NCT00147875|Lymphoma|lymphoma
5789587|NCT00147875|Gemcitabine|gemcitabine
5789588|NCT00147875|Advanced stages Hodgkin's lymphoma|advanced stages hodgkin's lymphoma
5789589|NCT00147875|Elderly|elderly
5789590|NCT00147862|Tranexamic Acid|tranexamic acid
5789591|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents
5789592|NCT00147862|Head and Neck Neoplasms|head and neck neoplasms
5789593|NCT00147862|Thromboelastography|thromboelastography
5789594|NCT00147849|knowledge translation|knowledge translation
5789595|NCT00147849|health care utilization|health care utilization
5789596|NCT00147849|economic analysis|economic analysis
5789597|NCT00147836|type 2 diabetes mellitus|type 2 diabetes mellitus
5789598|NCT00147836|therapy|therapy
5789599|NCT00147836|sulfonylureas|sulfonylureas
5789600|NCT00147836|metformin|metformin
5789601|NCT00147836|insulin|insulin
5789602|NCT00147823|Bone formation|bone formation
5789603|NCT00147823|Bone lesions|bone lesions
5789604|NCT00147823|Benign bone lesion|benign bone lesion
5789605|NCT00147810|telephone outreach|telephone outreach
5789606|NCT00147810|asthma care|asthma care
5789607|NCT00147797|Atherosclerosis|atherosclerosis
5789608|NCT00147797|intima media thickness|intima media thickness
5789609|NCT00147797|aortic stiffness|aortic stiffness
5789610|NCT00147797|HIV infection|hiv infection
5789611|NCT00147797|Dyslipidemia|dyslipidemia
5789612|NCT00147797|Treatment Experienced|treatment experienced
5789613|NCT00147784|Chronical Hepatitis C treatment|chronical hepatitis c treatment
5789614|NCT00147784|Methadone Maintenance Treatment|methadone maintenance treatment
5789615|NCT00147784|Pegylated Interferon and Ribavirin|pegylated interferon and ribavirin
5789616|NCT00147784|14 weeks treatment|14 weeks treatment
5789617|NCT00147784|Genotype 2 and 3|genotype 2 and 3
5789618|NCT00147771|localized scleroderma|localized scleroderma
5789620|NCT00147771|imiquimod|imiquimod
5789621|NCT00147771|pediatrics|pediatrics
5789622|NCT00147758|Diabetes Mellitus|diabetes mellitus
5789623|NCT00147745|Mechanism of action insulin sensitivity|mechanism of action insulin sensitivity
5789624|NCT00147732|larynx carcinoma|larynx carcinoma
5789625|NCT00147732|radiotherapy|radiotherapy
5789626|NCT00147732|carbogen|carbogen
5789627|NCT00147732|nicotinamide|nicotinamide
5789628|NCT00147719|Diabetes Mellitus|diabetes mellitus
5789629|NCT00147706|Electronic Health Record|electronic health record
5789630|NCT00147706|Patient Portal|patient portal
5789631|NCT00147706|Chronic Diseases|chronic diseases
5789632|NCT00147693|Dementia|dementia
5789633|NCT00147693|Alzheimer Disease|alzheimer disease
5789634|NCT00147693|Lewy-Body|lewy-body
5789635|NCT00147693|Cost*|cost*
5789636|NCT00147693|Community (dwelling)|community (dwelling)
5789637|NCT00147693|Caregiver(s)|caregiver(s)
5789638|NCT00147693|Institutionalization|institutionalization
5789639|NCT00147693|Quality of life|quality of life
5789640|NCT00147693|Randomized Control Trail|randomized control trail
5789641|NCT00147693|Vascular dementia|vascular dementia
5789642|NCT00147680|Uterine Papillary Serous Carcinoma (UPSC)|uterine papillary serous carcinoma (upsc)
5789643|NCT00147667|COPD|copd
5789644|NCT00147667|EXACERBATIONS|exacerbations
5789645|NCT00147667|AIRWAY INFLAMMATION|airway inflammation
5789646|NCT00147537|non-small cell lung cancer|non-small cell lung cancer
5789647|NCT00147537|chemotherapy|chemotherapy
5789648|NCT00147537|figitumumab|figitumumab
5789649|NCT00147537|insulin-like growth 1 factor receptor|insulin-like growth 1 factor receptor
5789650|NCT00147537|IGF-IR|igf-ir
5789651|NCT00147537|monoclonal antibody|monoclonal antibody
5789652|NCT00147498|oral JAK inhibitor|oral jak inhibitor
5789653|NCT00147498|clinical trial|clinical trial
5789654|NCT00147498|joint diseases|joint diseases
5789655|NCT00147498|anti-Inflammatory agents|anti-inflammatory agents
5789656|NCT00147498|rheumatic diseases|rheumatic diseases
5789657|NCT00147498|DMARD|dmard
5789658|NCT00147498|Antirheumatic Agents|antirheumatic agents
5789659|NCT00147498|Autoimmune Diseases|autoimmune diseases
5789660|NCT00147498|Immune System Diseases|immune system diseases
5789661|NCT00147472|Head and neck|head and neck
5789662|NCT00147472|Cancer|cancer
5789663|NCT00147472|Diagnosis|diagnosis
5789664|NCT00147472|Fluorodeoxyglucose|fluorodeoxyglucose
5789665|NCT00147472|Positron-Emission Tomography|positron-emission tomography
5798400|NCT00112515|depression|depression
5788746|NCT00152061|HIV|hiv
5789666|NCT00147472|PET|pet
5789667|NCT00147472|Oncology|oncology
5789668|NCT00147459|hepatitis B virus|hepatitis b virus
5789669|NCT00147459|vaccine|vaccine
5789670|NCT00147459|booster|booster
5789671|NCT00147459|liver transplantation|liver transplantation
5789672|NCT00147446|Stress|stress
5789673|NCT00147446|Stress Management|stress management
5789674|NCT00147446|Behavioral Medicine|behavioral medicine
5789675|NCT00147446|Multiple Sclerosis|multiple sclerosis
5789676|NCT00147446|Psychoneuroimmunology|psychoneuroimmunology
5789677|NCT00147433|free thyroxine|free thyroxine
5789678|NCT00147433|pregnancy|pregnancy
5789679|NCT00147433|fetal brain development|fetal brain development
5789680|NCT00147433|thyroid stimulating hormone|thyroid stimulating hormone
5789682|NCT00147420|Tibet|tibet
5789683|NCT00147420|Third Stage Labor|third stage labor
5789684|NCT00147420|Post Partum Hemorrhage|post partum hemorrhage
5789685|NCT00147420|Misoprostol|misoprostol
5789686|NCT00147420|Zhi Byed 11|zhi byed 11
5789687|NCT00147420|Global Network|global network
5789688|NCT00147394|Risperidone|risperidone
5789689|NCT00147394|Autism|autism
5789690|NCT00147394|PDD|pdd
5789691|NCT00147394|Pervasive Developmental Disorder|pervasive developmental disorder
5789692|NCT00147381|Campath-1H|campath-1h
5789693|NCT00147381|Alemtuzumab|alemtuzumab
5789694|NCT00147381|Tacrolimus|tacrolimus
5789695|NCT00147381|renal transplantation|renal transplantation
5789696|NCT00147381|immunosuppression|immunosuppression
5789697|NCT00147381|prevention of acute rejection|prevention of acute rejection
5789698|NCT00147368|falciparum|falciparum
5789699|NCT00147368|malaria|malaria
5789700|NCT00147368|arginine|arginine
5789701|NCT00147355|rIL-2-toxicity|ril-2-toxicity
5789702|NCT00147355|interleukin-2 therapy|interleukin-2 therapy
5789703|NCT00147355|HIV|hiv
5789704|NCT00147355|Toxicity substudy of ESPRIT|toxicity substudy of esprit
5789705|NCT00147342|exercise|exercise
5789706|NCT00147342|hypoglycemia|hypoglycemia
5789707|NCT00147342|Diabetes Mellitus, Type I|diabetes mellitus, type i
5789708|NCT00147342|glucose monitoring|glucose monitoring
5789709|NCT00147316|acute stroke|acute stroke
5789710|NCT00147316|thrombolytic therapy|thrombolytic therapy
5789711|NCT00147316|tissue plasminogen activator|tissue plasminogen activator
5789713|NCT00147290|Tachycardia|tachycardia
5789714|NCT00147290|CRT-D|crt-d
5789715|NCT00147277|ATP|atp
5789716|NCT00147277|Thachy|thachy
5789717|NCT00147277|FVT|fvt
5789718|NCT00147264|insulin resistance, myocellular lipids, adipose tissue|insulin resistance, myocellular lipids, adipose tissue
5789719|NCT00147251|lowering LDL and BP below current targets|lowering ldl and bp below current targets
5789720|NCT00147251|LDL cholesterol treatment|ldl cholesterol treatment
5789721|NCT00147251|blood pressure treatment|blood pressure treatment
5789722|NCT00147251|carotid intimal medial thickness|carotid intimal medial thickness
5789723|NCT00147251|prevent progression of CVD|prevent progression of cvd
5789724|NCT00147238|Bladder Cancer|bladder cancer
5789725|NCT00147238|Genitourinary Cancer|genitourinary cancer
5789726|NCT00147238|Prostate Cancer|prostate cancer
5789727|NCT00147238|MR Lymphangiography|mr lymphangiography
5789728|NCT00147238|Ferumoxtran-10|ferumoxtran-10
5789729|NCT00147238|SPIO|spio
5789730|NCT00147238|Ultra-small superparamagnetic agent iron oxide|ultra-small superparamagnetic agent iron oxide
5789731|NCT00147225|Advanced Cancer|advanced cancer
5789732|NCT00147225|Advanced Malignancy|advanced malignancy
5789733|NCT00147225|Solid Tumors|solid tumors
5789734|NCT00147225|Thrombocytopenia|thrombocytopenia
5789735|NCT00147225|AMG 531|amg 531
5789736|NCT00147225|Romiplostim|romiplostim
5789737|NCT00147225|Carboplatin|carboplatin
5789738|NCT00147225|Paraplatin|paraplatin
5789739|NCT00147225|Platelets|platelets
5789740|NCT00147225|Adriamycin|adriamycin
5789741|NCT00147225|Doxorubicin|doxorubicin
5789742|NCT00147225|Rubex|rubex
5789743|NCT00147225|Ifosfamide|ifosfamide
5789744|NCT00147225|Ifex|ifex
5789745|NCT00147212|Advanced Prostate Cancer|advanced prostate cancer
5789746|NCT00147212|Prostate Cancer|prostate cancer
5789747|NCT00147212|Trabectedin|trabectedin
5789748|NCT00147212|ET 743|et 743
5789749|NCT00147212|Yondelis|yondelis
5789750|NCT00147199|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5789751|NCT00147147|gastric neoplasm|gastric neoplasm
5789752|NCT00147147|gastrectomy|gastrectomy
5789753|NCT00147147|adjuvant chemotherapy|adjuvant chemotherapy
5789754|NCT00147147|randomized trial|randomized trial
5789755|NCT00147147|T3 and T4 carcinoma of the stomach/Gastric Neoplasm|t3 and t4 carcinoma of the stomach/gastric neoplasm
5789756|NCT00147134|colorectal cancer|colorectal cancer
5789757|NCT00147134|laparoscopic surgery|laparoscopic surgery
5789758|NCT00147134|randomized controlled trial|randomized controlled trial
5789759|NCT00147134|oncological outcome|oncological outcome
5789760|NCT00147121|Rituximab|rituximab
5789761|NCT00147121|CHOP|chop
5789762|NCT00147121|Bi-weekly|bi-weekly
5789763|NCT00147121|low-grade B-cell lymphoma|low-grade b-cell lymphoma
5789764|NCT00147121|advanced stage|advanced stage
5789765|NCT00147121|follicular lymphoma|follicular lymphoma
5789766|NCT00147121|G-CSF|g-csf
5789767|NCT00147121|Untreated stage III/IV low-grade B-cell lymphoma|untreated stage iii/iv low-grade b-cell lymphoma
5789768|NCT00147108|Breast Cancer|breast cancer
5789769|NCT00147095|macrophages|macrophages
5789770|NCT00147095|neutrophils|neutrophils
5789772|NCT00147082|chemokine|chemokine
5789773|NCT00147082|chemokine receptor|chemokine receptor
5789774|NCT00147082|neutrophil|neutrophil
5789775|NCT00147082|lymphocyte|lymphocyte
5789776|NCT00147082|monocyte|monocyte
5789777|NCT00147069|sputum|sputum
5789778|NCT00147069|macrophage|macrophage
5789779|NCT00147069|neutrophil|neutrophil
5789780|NCT00147056|Brain tumor|brain tumor
5789781|NCT00147056|Brain Lesions|brain lesions
5789782|NCT00147056|Brain Cancer|brain cancer
5789783|NCT00147056|ExAblate|exablate
5789784|NCT00147043|Adult stem cells|adult stem cells
5789785|NCT00147043|Liver disease|liver disease
5789786|NCT00147043|CD34 positive cells|cd34 positive cells
5789787|NCT00147030|Hypoxia|hypoxia
5789788|NCT00147030|Ischaemia|ischaemia
5789789|NCT00147030|Encephalopathy|encephalopathy
5789790|NCT00147030|Neonatal|neonatal
5789791|NCT00147030|Hypothermia|hypothermia
5789792|NCT00147030|Perinatal|perinatal
5789793|NCT00147030|Cooling|cooling
5789794|NCT00147030|Whole/Total Body|whole/total body
5789795|NCT00147017|macrophage|macrophage
5789796|NCT00147017|inflammation|inflammation
5789797|NCT00147017|COPD|copd
5789798|NCT00147004|Septic shock|septic shock
5789799|NCT00147004|Steroids|steroids
5789800|NCT00147004|Hydrocortisone|hydrocortisone
5789801|NCT00147004|Mortality|mortality
5789802|NCT00147004|Reversal of shock|reversal of shock
5789803|NCT00147004|Adrenal insufficiency|adrenal insufficiency
5789804|NCT00146952|Hemineglects|hemineglects
5789805|NCT00146926|Propofol|propofol
5789806|NCT00146926|pain|pain
5789807|NCT00146926|general anesthesia|general anesthesia
5789808|NCT00146926|prevention|prevention
5789809|NCT00146913|Chronic myeloid leukaemia|chronic myeloid leukaemia
5789810|NCT00146913|resistant|resistant
5789811|NCT00146913|refractory|refractory
5789812|NCT00146913|Imatinib mesylate|imatinib mesylate
5789813|NCT00146900|Traumatic Events|traumatic events
5784832|NCT00170729|tolerability,|tolerability,
5789814|NCT00146900|Post-traumatic Stress Disorder|post-traumatic stress disorder
5789815|NCT00146900|Treatment (psychological)|treatment (psychological)
5789816|NCT00146900|Treatment (pharmacological)|treatment (pharmacological)
5789817|NCT00146900|Prevention|prevention
5789818|NCT00146900|SSRIs|ssris
5789819|NCT00146887|Coronary CT|coronary ct
5789820|NCT00146887|sensitivity|sensitivity
5789821|NCT00146887|specificity|specificity
5789822|NCT00146809|Multi-System-Atrophy|multi-system-atrophy
5789823|NCT00146809|Minocycline|minocycline
5789824|NCT00146796|Malaria|malaria
5789825|NCT00146796|Diagnosis|diagnosis
5789827|NCT00146796|Africa|africa
5789828|NCT00146796|Tanzania|tanzania
5789829|NCT00146783|intermittent preventive treatment|intermittent preventive treatment
5789830|NCT00146783|malaria|malaria
5789831|NCT00146783|pregnancy|pregnancy
5789832|NCT00146783|efficacy|efficacy
5789833|NCT00146783|safety|safety
5789834|NCT00146731|malaria|malaria
5789835|NCT00146731|pregnancy|pregnancy
5789836|NCT00146731|treatment|treatment
5789837|NCT00146731|Africa|africa
5789840|NCT00146718|drug resistance|drug resistance
5789841|NCT00146718|antimalarials|antimalarials
5789842|NCT00146705|chronic HBV|chronic hbv
5789843|NCT00146705|Peginterferon|peginterferon
5789844|NCT00146705|long term follow-up|long term follow-up
5789845|NCT00146692|Malaria|malaria
5789846|NCT00146692|Cost|cost
5789847|NCT00146692|Treatment|treatment
5789848|NCT00146692|Diagnosis|diagnosis
5789849|NCT00146692|Africa|africa
5789850|NCT00146692|Ghana|ghana
5789851|NCT00146679|Heart failure|heart failure
5789852|NCT00146679|Ventricular arrhythmias|ventricular arrhythmias
5789853|NCT00146679|ICD|icd
5789854|NCT00146679|Psychoeducational intervention|psychoeducational intervention
5789855|NCT00146666|Peak walking time|peak walking time
5789856|NCT00146666|Absolute claudication distance|absolute claudication distance
5789857|NCT00146666|Claudication onset time|claudication onset time
5789858|NCT00146666|Initial claudication distance|initial claudication distance
5789859|NCT00146666|Intermittent compression|intermittent compression
5789860|NCT00146653|pediatrics|pediatrics
5789861|NCT00146653|cardiopulmonary bypass|cardiopulmonary bypass
5789862|NCT00146653|surgery|surgery
5789863|NCT00146640|active disease|active disease
5789864|NCT00146640|morning stiffness of joints|morning stiffness of joints
5789865|NCT00146640|nighttime application of prednisone|nighttime application of prednisone
5789866|NCT00146640|modified release prednisone|modified release prednisone
5789867|NCT00146627|Human African Trypanosomiasis|human african trypanosomiasis
5789868|NCT00146627|Combination|combination
5789869|NCT00146627|Trypanosoma brucei gambiense Human African Trypanosomiasis|trypanosoma brucei gambiense human african trypanosomiasis
5789870|NCT00146614|Graft versus Host Disease|graft versus host disease
5789871|NCT00146614|GVHD|gvhd
5789872|NCT00146614|Stem Cell Transplantation|stem cell transplantation
5789873|NCT00146614|Tacrolimus|tacrolimus
5789874|NCT00146614|Sirolimus|sirolimus
5789875|NCT00146614|Methotrexate|methotrexate
5789876|NCT00146614|allogeneic stem cell transplantation|allogeneic stem cell transplantation
5789877|NCT00146601|Fulvestrant|fulvestrant
5789878|NCT00146601|Advanced breast cancer|advanced breast cancer
5789879|NCT00146601|Invasive breast cancer|invasive breast cancer
5789880|NCT00146601|Stage IV Breast Cancer|stage iv breast cancer
5789881|NCT00146601|Hormone Receptor-Positive Breast Cancer|hormone receptor-positive breast cancer
5789882|NCT00146588|Breast cancer|breast cancer
5789883|NCT00146588|cytoxan|cytoxan
5789884|NCT00146588|epirubicin|epirubicin
5789885|NCT00146588|capecitabine|capecitabine
5789886|NCT00146562|adjuvant chemotherapy|adjuvant chemotherapy
5789887|NCT00146562|G-CSF|g-csf
5789888|NCT00146562|pegfilgrastim|pegfilgrastim
5789889|NCT00146562|darbepoetin alfa|darbepoetin alfa
5789890|NCT00146549|HER2-positive Breast cancer|her2-positive breast cancer
5789891|NCT00146549|HER2 overexpressing|her2 overexpressing
5789892|NCT00146549|trastuzumab|trastuzumab
5789893|NCT00146549|Herceptin|herceptin
5789894|NCT00146549|vinorelbine|vinorelbine
5789895|NCT00146549|Navelbine|navelbine
5789896|NCT00146549|Taxotere|taxotere
5789897|NCT00146549|taxol|taxol
5789899|NCT00146536|LCIS|lcis
5789900|NCT00146536|DCIS|dcis
5789901|NCT00146536|adjacent ipsilateral infiltrating carcinoma|adjacent ipsilateral infiltrating carcinoma
5789902|NCT00146536|core needle biopsy|core needle biopsy
5789903|NCT00146536|Lobular neoplasia of the breast|lobular neoplasia of the breast
5789904|NCT00146523|Psychotic Major Depression|psychotic major depression
5789905|NCT00146523|PMD|pmd
5789906|NCT00146523|Depression|depression
5789907|NCT00146523|Major Depression|major depression
5789908|NCT00146523|Psychosis|psychosis
5789909|NCT00146510|weight control|weight control
5789910|NCT00146510|compliance|compliance
5789911|NCT00146510|physical activity|physical activity
5789912|NCT00146510|nutrition|nutrition
5789913|NCT00146510|Health Behavior|health behavior
5789914|NCT00146510|Patient Compliance|patient compliance
5789915|NCT00146497|Respiratory distress syndrome (RDS)|respiratory distress syndrome (rds)
5789916|NCT00146497|Premature infants|premature infants
5789917|NCT00146497|Chronic lung disease (CLD)|chronic lung disease (cld)
5789918|NCT00146497|Bronchoalveolar lavage fluid (BALF)|bronchoalveolar lavage fluid (balf)
5789919|NCT00146497|Cytokines|cytokines
5789920|NCT00146484|Diabetes Mellitus, Type 1|diabetes mellitus, type 1
5789921|NCT00146484|Child|child
5789922|NCT00146484|Adolescent|adolescent
5789923|NCT00146484|Disease Management|disease management
5789924|NCT00146484|Newly Diagnosed|newly diagnosed
5789925|NCT00146484|Hemoglobin A, Glycosylated|hemoglobin a, glycosylated
5789926|NCT00146471|alcohol withdrawal|alcohol withdrawal
5789927|NCT00146471|detoxification|detoxification
5789928|NCT00146471|Inpatients|inpatients
5789929|NCT00146471|alcohol dependence according to DSM-IV/ICD-10|alcohol dependence according to dsm-iv/icd-10
5789930|NCT00146471|withdrawal symptoms|withdrawal symptoms
5789931|NCT00146458|Cervical cancer|cervical cancer
5789932|NCT00146458|FDG-PET|fdg-pet
5789933|NCT00146458|Lymph node metastasis|lymph node metastasis
5789934|NCT00146458|Radiotherapy|radiotherapy
5789935|NCT00146458|Chemotherapy|chemotherapy
5789936|NCT00146445|IV drug users|iv drug users
5789937|NCT00146419|Treatment Experienced|treatment experienced
5789938|NCT00146419|Treatment Naive|treatment naive
5806012|NCT00089739|Uveitis|uveitis
5789939|NCT00146406|Adolescent Health|adolescent health
5789940|NCT00146406|Sexually Transmitted Disease|sexually transmitted disease
5789941|NCT00146406|Sexual Behavior|sexual behavior
5789942|NCT00146393|exercise|exercise
5789943|NCT00146393|physical activity|physical activity
5789944|NCT00146393|physical conditioning|physical conditioning
5789945|NCT00146393|pain|pain
5789946|NCT00146393|physical function|physical function
5789947|NCT00146380|Prevention Mother-to-Child HIV transmission|prevention mother-to-child hiv transmission
5789948|NCT00146380|HIV Seronegativity|hiv seronegativity
5789949|NCT00146367|arthritis|arthritis
5789950|NCT00146367|osteoarthritis|osteoarthritis
5789951|NCT00146367|rheumatoid arthritis|rheumatoid arthritis
5789952|NCT00146367|rheumatic disease|rheumatic disease
5789953|NCT00146367|exercise|exercise
5789954|NCT00146367|physical activity|physical activity
5789955|NCT00146367|physical function|physical function
5789956|NCT00146367|disability|disability
5789957|NCT00146354|Electronic Medical Record|electronic medical record
5789958|NCT00146354|Electronic Results Tracking|electronic results tracking
5789959|NCT00146354|Patient Safety|patient safety
5789960|NCT00146354|Post-Discharge Test Results|post-discharge test results
5789961|NCT00146315|Primary Health Care|primary health care
5789962|NCT00146315|Family Practice|family practice
5789963|NCT00146315|Family Physician|family physician
5789964|NCT00146315|Exercise|exercise
5789965|NCT00146315|Coronary Heart Disease|coronary heart disease
5789966|NCT00146315|Randomized Controlled Trials|randomized controlled trials
5789967|NCT00146315|Multicenter Studies|multicenter studies
5789968|NCT00146302|Non-specific effects of vaccines|non-specific effects of vaccines
5789969|NCT00146302|Infant mortality|infant mortality
5789970|NCT00146302|Morbidity|morbidity
5789971|NCT00146302|Low income country|low income country
5789973|NCT00146302|Vaccine policy|vaccine policy
5790035|NCT00146029|Patients who participated in UMCC 9900/9901 (Phase II Studies of Tailored-Dose Docetaxel in Metastatic Breast Cancer)|patients who participated in umcc 9900/9901 (phase ii studies of tailored-dose docetaxel in metastatic breast cancer)
5790036|NCT00146016|Chronic Hepatitis C|chronic hepatitis c
5790037|NCT00146016|Amantadine|amantadine
5790038|NCT00146016|Triple therapy|triple therapy
5790040|NCT00146003|atopic dermatitis|atopic dermatitis
5790041|NCT00146003|efalizumab|efalizumab
5790042|NCT00145990|methacholine PC20|methacholine pc20
5790043|NCT00145990|dosimeter|dosimeter
5790045|NCT00145977|osteoporosis|osteoporosis
5790046|NCT00145977|bone density|bone density
5790047|NCT00145977|women|women
5790048|NCT00145977|endocrine|endocrine
5790049|NCT00145977|musculoskeletal|musculoskeletal
5790050|NCT00145977|metabolic|metabolic
5790051|NCT00145964|Biliary Cirrhosis, Primary|biliary cirrhosis, primary
5790052|NCT00145964|genes|genes
5790053|NCT00145964|autoimmune disease|autoimmune disease
5790054|NCT00145938|Portopulmonary hypertension|portopulmonary hypertension
5790055|NCT00145938|PTPH|ptph
5790056|NCT00145938|pulmonary hypertension|pulmonary hypertension
5790057|NCT00145938|high blood pressure in the pulmonary arteries|high blood pressure in the pulmonary arteries
5790058|NCT00145925|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5790059|NCT00145925|Blood Pressure|blood pressure
5790060|NCT00145925|Stroke|stroke
5790062|NCT00145912|Depression in adolescents and young adults, depression web-base activity|depression in adolescents and young adults, depression web-base activity
5790063|NCT00145886|low bone turnover; sclerosing bone disorders,|low bone turnover; sclerosing bone disorders,
5790064|NCT00145886|osteopetrosis|osteopetrosis
5790065|NCT00145873|heart failure|heart failure
5790066|NCT00145873|nesiritide|nesiritide
5790067|NCT00145873|heart disease|heart disease
5790068|NCT00145873|cardiovascular disease|cardiovascular disease
5790069|NCT00145860|Colorectal Cancer|colorectal cancer
5790070|NCT00145847|alcohol|alcohol
5790071|NCT00145847|schizophrenia|schizophrenia
5790072|NCT00145847|naltrexone|naltrexone
5790073|NCT00145834|psychosocial factors|psychosocial factors
5790074|NCT00145834|breastfeeding|breastfeeding
5790075|NCT00145834|postnatal intervention|postnatal intervention
5790076|NCT00145834|health visitor|health visitor
5790077|NCT00145808|Ulcerative colitis|ulcerative colitis
5790078|NCT00145795|HIV|hiv
5790079|NCT00145795|HAART (Highly Active Anti-Retroviral Therapy) partial immune response|haart (highly active anti-retroviral therapy) partial immune response
5790080|NCT00145795|no immune response|no immune response
5790081|NCT00145795|Treatment Experienced|treatment experienced
5790082|NCT00145782|multiphasic screening|multiphasic screening
5790083|NCT00145782|primary health care|primary health care
5790084|NCT00145782|randomized controlled trial|randomized controlled trial
5790085|NCT00145782|Risk factors|risk factors
5790086|NCT00145769|rectal cancer|rectal cancer
5790087|NCT00145769|radiotherapy|radiotherapy
5790088|NCT00145769|chemotherapy|chemotherapy
5790089|NCT00145769|chemoradiation|chemoradiation
5790090|NCT00145769|adjuvant therapy|adjuvant therapy
5790091|NCT00145756|Sodium Chloride|sodium chloride
5790092|NCT00145756|Blood Pressure|blood pressure
5790093|NCT00145756|Cardiovascular Diseases|cardiovascular diseases
5790094|NCT00145756|Clinical Trial|clinical trial
5790095|NCT00145743|Quality of Life|quality of life
5790096|NCT00145743|Breast Cancer|breast cancer
5790097|NCT00145743|Referee's Report|referee's report
5790098|NCT00145743|Diagnostics|diagnostics
5790099|NCT00145743|Therapy|therapy
5790100|NCT00145730|osteoarthritis hip|osteoarthritis hip
5790101|NCT00145730|arthroplasty|arthroplasty
5790102|NCT00145730|ectopic bone formation|ectopic bone formation
5790103|NCT00145730|non-steroidal anti-inflammatory drugs|non-steroidal anti-inflammatory drugs
5790104|NCT00145730|disability|disability
5790105|NCT00145717|Phytosterols|phytosterols
5790106|NCT00145717|Cholesterol|cholesterol
5790107|NCT00145717|China|china
5790108|NCT00145717|Randomized controlled trial|randomized controlled trial
5790109|NCT00145704|osteopenia|osteopenia
5790110|NCT00145704|growth hormone deficiency|growth hormone deficiency
5790111|NCT00145704|pediatric malignancy|pediatric malignancy
5790112|NCT00145678|borderline|borderline
5790113|NCT00145678|alcohol|alcohol
5790114|NCT00145678|substance|substance
5790115|NCT00145678|psychodynamic|psychodynamic
5790116|NCT00145678|psychotherapy|psychotherapy
5790117|NCT00145678|psychoanalytic|psychoanalytic
5790118|NCT00145665|FLT-PET|flt-pet
5790119|NCT00145665|colorectal liver metastases|colorectal liver metastases
5790120|NCT00145665|proliferation|proliferation
5790121|NCT00145665|proliferation markers|proliferation markers
5790122|NCT00145665|recurrence|recurrence
5790123|NCT00145652|erythropoetin|erythropoetin
5790124|NCT00145652|adjuvant iron therapy|adjuvant iron therapy
5790125|NCT00145652|anemia|anemia
5790126|NCT00145652|cancer|cancer
5790127|NCT00145639|Osteosarcoma|osteosarcoma
5785115|NCT00169247|cisplatin|cisplatin
5790128|NCT00145639|Treatment, Carboplatin|treatment, carboplatin
5790129|NCT00145626|Stem cell transplantation|stem cell transplantation
5790130|NCT00145626|Stem cell transplant|stem cell transplant
5790131|NCT00145626|Haploidentical transplant|haploidentical transplant
5790132|NCT00145613|Haploidentical stem cell transplant|haploidentical stem cell transplant
5686483|NCT00551889|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5686484|NCT00551863|alcohol, drugs, aggression, substance use disorder treatment|alcohol, drugs, aggression, substance use disorder treatment
5686485|NCT00551850|epidermal growth factor inhibitor|epidermal growth factor inhibitor
5686486|NCT00551850|solid tumors|solid tumors
5686487|NCT00551850|advanced cancer|advanced cancer
5686488|NCT00551837|Lung Transplantation|lung transplantation
5686489|NCT00551837|Kidney Transplnatation|kidney transplnatation
5790133|NCT00145613|High risk hematologic malignancies|high risk hematologic malignancies
5790134|NCT00145613|Allogeneic stem cell transplant|allogeneic stem cell transplant
5790135|NCT00145613|Mismatched family member stem cell donor|mismatched family member stem cell donor
5790137|NCT00145600|Hodgkin Disease|hodgkin disease
5780585|NCT00194428|BMI|bmi
5790138|NCT00145587|Osteopetrosis|osteopetrosis
5790139|NCT00145587|Autosomal recessive bone disease|autosomal recessive bone disease
5790140|NCT00145587|Haploidentical stem cell transplantation|haploidentical stem cell transplantation
5790141|NCT00145587|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5790142|NCT00145587|T-cell depletion methodology|t-cell depletion methodology
5790143|NCT00145587|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5790144|NCT00145574|Pediatric|pediatric
5790145|NCT00145574|hypercholesterolemia|hypercholesterolemia
5790146|NCT00145574|colesevelam|colesevelam
5790148|NCT00145548|COPD|copd
5790149|NCT00145535|Glaucoma|glaucoma
5790150|NCT00145535|Glaucoma, open angle|glaucoma, open angle
5790151|NCT00145535|Intraocular Pressure|intraocular pressure
5790152|NCT00145535|Trabeculoplasty|trabeculoplasty
5790153|NCT00145535|laser|laser
5790154|NCT00145535|laser, surgery|laser, surgery
5790155|NCT00145522|Menopause, IGF-1, HRT|menopause, igf-1, hrt
5790156|NCT00145418|Non small Cell Lung Cancer Stage IIIb and IV|non small cell lung cancer stage iiib and iv
5790157|NCT00145405|Acromegaly|acromegaly
5790158|NCT00145405|somatostatin analogues|somatostatin analogues
5790159|NCT00145405|lanreotide|lanreotide
5790160|NCT00145405|octreotide|octreotide
5790161|NCT00145405|GH|gh
5790162|NCT00145405|IGF-I|igf-i
5790163|NCT00145405|injection site|injection site
5790164|NCT00145392|Polycystic ovary syndrome|polycystic ovary syndrome
5790165|NCT00145392|growth hormone|growth hormone
5790166|NCT00145392|insulin resistance|insulin resistance
5790167|NCT00145392|overweight|overweight
5790168|NCT00145392|glucose metabolism|glucose metabolism
5790169|NCT00145379|type 1 diabetes mellitus|type 1 diabetes mellitus
5790170|NCT00145379|insulin resistance|insulin resistance
5790171|NCT00145379|metformin|metformin
5790172|NCT00145379|randomized, controlled study|randomized, controlled study
5790173|NCT00145366|Benign nontoxic and toxic goiter|benign nontoxic and toxic goiter
5790174|NCT00145366|rhTSH|rhtsh
5790175|NCT00145366|131I|131i
5790176|NCT00145366|goiter reduction|goiter reduction
5790177|NCT00145366|131I kinetic|131i kinetic
5790178|NCT00145366|thyroid size|thyroid size
5790179|NCT00145366|patient satisfaction|patient satisfaction
5790180|NCT00145366|adverse effects|adverse effects
5790181|NCT00145366|BRT|brt
5790182|NCT00145366|Graves' disease|graves' disease
5790183|NCT00145353|type 1 diabetes mellitus|type 1 diabetes mellitus
5790184|NCT00145353|hypoglycaemia|hypoglycaemia
5790185|NCT00145353|insulin profiles|insulin profiles
5790186|NCT00145353|growth hormone|growth hormone
5790187|NCT00145353|cortisol|cortisol
5790188|NCT00145353|glucagon|glucagon
5790189|NCT00145340|polycystic ovary syndrome (PCOS)|polycystic ovary syndrome (pcos)
5790190|NCT00145340|PPARgamma|ppargamma
5790191|NCT00145340|growth hormone|growth hormone
5790192|NCT00145340|insulin resistance|insulin resistance
5790193|NCT00145340|pioglitazone|pioglitazone
5790194|NCT00145340|glucose metabolism|glucose metabolism
5790195|NCT00145340|microarray|microarray
5790196|NCT00145327|Osteoporosis, Zoledronic Acid|osteoporosis, zoledronic acid
5790197|NCT00145314|Metastatic colorectal cancer|metastatic colorectal cancer
5790198|NCT00145314|FLOX|flox
5790199|NCT00145314|Cetuximab|cetuximab
5790200|NCT00145301|Osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety|osteoarthritis, lumiracoxib, retention on treatment, efficacy, safety
5790201|NCT00145288|hirsutism|hirsutism
5790202|NCT00145288|type 2 diabetes|type 2 diabetes
5790203|NCT00145288|polycystic ovary syndrome|polycystic ovary syndrome
5790204|NCT00145288|metabolism|metabolism
5790205|NCT00145275|zoledronic acid|zoledronic acid
5790209|NCT00145262|bone marrow mononuclear cells|bone marrow mononuclear cells
5790210|NCT00145262|angiogenesis|angiogenesis
5790211|NCT00145262|vasculogenesis|vasculogenesis
5790212|NCT00145262|Arteriosclerosis Obliterans (ASO)|arteriosclerosis obliterans (aso)
5790213|NCT00145262|Ischemic ulcers|ischemic ulcers
5790214|NCT00145249|Bacterial infections, HIV infection, cryptococcal meningitis|bacterial infections, hiv infection, cryptococcal meningitis
5790215|NCT00145236|Nebivolol|nebivolol
5790216|NCT00145236|Beta-Blocker|beta-blocker
5790217|NCT00145223|Wuchereria bancrofti, filariasis, Egypt|wuchereria bancrofti, filariasis, egypt
5790218|NCT00145210|Nebivolol|nebivolol
5790219|NCT00145197|breast cancer|breast cancer
5790220|NCT00145197|adjuvant treatment|adjuvant treatment
5790221|NCT00145197|racial disparities|racial disparities
5790222|NCT00145197|Early-Stage Breast Cancer|early-stage breast cancer
5790223|NCT00145184|multivitamin, supplements, tuberculosis, Tanzania|multivitamin, supplements, tuberculosis, tanzania
5790228|NCT00145145|Melanoma|melanoma
5790229|NCT00145145|Vaccine|vaccine
5790230|NCT00145145|Peptide|peptide
5790231|NCT00145145|MAGE|mage
5790232|NCT00145145|CpG|cpg
5790233|NCT00145132|depression|depression
5790234|NCT00145132|β-CIT-SPECT|β-cit-spect
5790235|NCT00145132|SERT|sert
5790236|NCT00145132|DAT|dat
5790237|NCT00145132|neurophysiology|neurophysiology
5790238|NCT00145132|LDAEP|ldaep
5790239|NCT00145132|escitalopram|escitalopram
5790240|NCT00145132|SSRI|ssri
5790241|NCT00145119|Acute myocardial infarction|acute myocardial infarction
5790242|NCT00145119|Cardiac arrhythmias|cardiac arrhythmias
5790243|NCT00145119|Left ventricular dysfunction|left ventricular dysfunction
5790244|NCT00145119|Implantable loop recorder|implantable loop recorder
5790245|NCT00145119|Risk stratifiers|risk stratifiers
5790246|NCT00145106|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination|acne, tazarotene, minocycline, maintenance, retinoid, efficacy, combination
5790247|NCT00145093|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5790248|NCT00145093|Chromium|chromium
5790249|NCT00145093|Saccharomyces cerevisiae|saccharomyces cerevisiae
5790250|NCT00145028|Neoplasms|neoplasms
5790251|NCT00145028|Carboplatin|carboplatin
5790252|NCT00145028|optimal exposure|optimal exposure
5790254|NCT00145015|Intervention|intervention
5790255|NCT00145015|Adults|adults
5790256|NCT00145015|Colorectal cancer|colorectal cancer
5790257|NCT00145015|Nutrition|nutrition
5790258|NCT00145015|Fish|fish
5790259|NCT00145015|n-3 fatty acids|n-3 fatty acids
5790260|NCT00145015|Apoptosis|apoptosis
5790261|NCT00145015|Ulcerative colitis|ulcerative colitis
5790262|NCT00145015|Polyps|polyps
5790263|NCT00145015|Gastro-intestinal tract|gastro-intestinal tract
5790264|NCT00145002|ATLL|atll
5790265|NCT00145002|chemotherapy|chemotherapy
5790266|NCT00145002|phase III study|phase iii study
5790267|NCT00145002|VCAP-AMP-VECP|vcap-amp-vecp
5790268|NCT00145002|biweekly-CHOP|biweekly-chop
5790269|NCT00144989|Small-cell lung cancer|small-cell lung cancer
5790270|NCT00144989|Limited-Stage Small-Cell Lung Cancer|limited-stage small-cell lung cancer
5790271|NCT00144989|Combined modality therapy|combined modality therapy
5790272|NCT00144989|chemotherapy|chemotherapy
5790273|NCT00144989|radiotherapy|radiotherapy
5790274|NCT00144989|Irinotecan|irinotecan
5790275|NCT00144989|Cisplatin|cisplatin
5790276|NCT00144976|Head and Neck Neoplasms|head and neck neoplasms
5790277|NCT00144976|Tarceva|tarceva
5790278|NCT00144976|ENT|ent
5790279|NCT00144911|exacerbations|exacerbations
5790280|NCT00144911|breathing|breathing
5790281|NCT00144911|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5790282|NCT00144898|Breast cancer|breast cancer
5790283|NCT00144898|sentinel node resection|sentinel node resection
5790284|NCT00144898|survival|survival
5790285|NCT00144898|Breast cancer unifocal N0|breast cancer unifocal n0
5790286|NCT00144885|Endocarditis|endocarditis
5790287|NCT00144885|RMI|rmi
5790288|NCT00144885|Impact measure|impact measure
5790289|NCT00144872|Absence Seizures|absence seizures
5790290|NCT00144872|EEG|eeg
5790291|NCT00144872|LTG|ltg
5790292|NCT00144872|Typical Absence Epilepsy|typical absence epilepsy
5790293|NCT00144872|Epilepsy|epilepsy
5790294|NCT00144872|LAMICTAL|lamictal
5790295|NCT00144859|P38 map kinase|p38 map kinase
5790296|NCT00144859|CRP|crp
5790297|NCT00144859|COPD|copd
5790298|NCT00144859|safety|safety
5790299|NCT00144846|wheezing|wheezing
5790300|NCT00144846|bronchospasm|bronchospasm
5790301|NCT00144846|albuterol sulfate HFA|albuterol sulfate hfa
5790302|NCT00144833|Protease inhibitors-experienced HIV-1 infected patients|protease inhibitors-experienced hiv-1 infected patients
5790303|NCT00144833|Highly-resistant HIV-1|highly-resistant hiv-1
5790304|NCT00144833|Dual boosted Pis|dual boosted pis
5790305|NCT00144833|fosamprenavir|fosamprenavir
5790306|NCT00144833|lopinavir|lopinavir
5790307|NCT00144820|Hyaluronan|hyaluronan
5790308|NCT00144820|Gonarthrosis|gonarthrosis
5790309|NCT00144820|Osteoarthritis,knee|osteoarthritis,knee
5790310|NCT00144820|Double-blinded|double-blinded
5790311|NCT00144820|Placebo controlled|placebo controlled
5790312|NCT00144820|Randomised|randomised
5790313|NCT00144807|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5790314|NCT00144807|rituximab|rituximab
5790315|NCT00144807|chemotherapy|chemotherapy
5790316|NCT00144807|autologous stem cell transplant|autologous stem cell transplant
5790317|NCT00144794|Hurler's Syndrome|hurler's syndrome
5790318|NCT00144794|Hurler-Scheie Syndrome|hurler-scheie syndrome
5790319|NCT00144794|Scheie Syndrome|scheie syndrome
5790320|NCT00144755|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5790321|NCT00144755|rituximab|rituximab
5790322|NCT00144755|chemotherapy|chemotherapy
5790323|NCT00144755|erythropoetin|erythropoetin
5790324|NCT00144755|darbepoetin alfa|darbepoetin alfa
5790325|NCT00144716|Vector Control|vector control
5790326|NCT00144716|repellent|repellent
5790327|NCT00144716|ITN's|itn's
5790328|NCT00144716|malaria|malaria
5790329|NCT00144716|Amazon|amazon
5790330|NCT00144703|Graft versus host disease|graft versus host disease
5790332|NCT00144703|Stem cell transplantation|stem cell transplantation
5790333|NCT00144703|sirolimus|sirolimus
5790334|NCT00144703|tacrolimus|tacrolimus
5790335|NCT00144690|Epilepsy refractory partial seizures|epilepsy refractory partial seizures
5790336|NCT00144677|Graft versus Host Disease|graft versus host disease
5790337|NCT00144677|GVHD|gvhd
5790338|NCT00144677|sirolimus|sirolimus
5790339|NCT00144677|tacrolimus|tacrolimus
5790340|NCT00144677|Stem cell transplant|stem cell transplant
5790341|NCT00144443|Aerobiology|aerobiology
5790342|NCT00144443|Asthma|asthma
5790343|NCT00144443|Indoor Fungi|indoor fungi
5790344|NCT00144443|Allergen|allergen
5790345|NCT00144443|Home Remediation|home remediation
5790346|NCT00144430|chronic graft versus host disease|chronic graft versus host disease
5790347|NCT00144430|graft|graft
5790348|NCT00144430|host|host
5790349|NCT00144430|transplant|transplant
5790350|NCT00144430|stem cell|stem cell
5790351|NCT00144430|pediatric|pediatric
5790352|NCT00144430|GVH0313|gvh0313
5790353|NCT00144430|leukemia|leukemia
5790354|NCT00144417|tuberculosis|tuberculosis
5790355|NCT00144417|TB|tb
5790356|NCT00144417|treatment|treatment
5790357|NCT00144417|efficacy|efficacy
5790358|NCT00144417|safety|safety
5790359|NCT00144378|gastric cancer|gastric cancer
5790360|NCT00144378|metastatic|metastatic
5790361|NCT00144378|irinotecan|irinotecan
5790362|NCT00144365|HIV|hiv
5790363|NCT00144365|Africa|africa
5790364|NCT00144365|Adherence|adherence
5790365|NCT00144365|HIV viral load|hiv viral load
5790366|NCT00144365|Sexual behavior|sexual behavior
5790367|NCT00144365|Voluntary counseling and testing|voluntary counseling and testing
5790368|NCT00144352|Malaria|malaria
5790369|NCT00144352|HIV|hiv
5790370|NCT00144352|AIDS|aids
5790371|NCT00144352|drug efficacy|drug efficacy
5790372|NCT00144352|Kenya|kenya
5790373|NCT00144352|Africa|africa
5790374|NCT00144352|Sulfadoxine pyirmethamine|sulfadoxine pyirmethamine
5790375|NCT00144352|fansidar|fansidar
5790376|NCT00144313|vaccine|vaccine
5790377|NCT00144313|hepatitis B|hepatitis b
5790378|NCT00144313|immune memory|immune memory
5790379|NCT00144144|Hypertension|hypertension
5790380|NCT00144144|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5790381|NCT00144144|Calcium Channel Blocker|calcium channel blocker
5790382|NCT00144144|Angiotensin II type 1 Receptor Blocker|angiotensin ii type 1 receptor blocker
5790383|NCT00144131|Chemotherapy, Anemia|chemotherapy, anemia
5790384|NCT00144131|Aranesp®, rHuEPO|aranesp®, rhuepo
5790385|NCT00144131|Chemotherapy Induced Anemia|chemotherapy induced anemia
5790386|NCT00144131|non-myeloid malignancy|non-myeloid malignancy
5790387|NCT00144131|Non-Myeloid Malignancies|non-myeloid malignancies
5790388|NCT00144131|Chemotherapy|chemotherapy
5862614|NCT00001566|Immunotherapy|immunotherapy
5790389|NCT00144092|autologous and allogeneic stem cell transplantation|autologous and allogeneic stem cell transplantation
5790390|NCT00144092|low grade lymphoma|low grade lymphoma
5790391|NCT00144092|mantle cell|mantle cell
5790392|NCT00144079|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5790393|NCT00144079|radiotherapy|radiotherapy
5790394|NCT00144079|radioiodine therapy|radioiodine therapy
5790395|NCT00144079|thyroidectomy|thyroidectomy
5790396|NCT00144040|Antibiotics|antibiotics
5790397|NCT00144040|Respiratory Infections|respiratory infections
5790398|NCT00144040|Quality Assurance, Healthcare|quality assurance, healthcare
5790399|NCT00144040|Professional Education|professional education
5790400|NCT00144040|Emergency Services, Medical|emergency services, medical
5790401|NCT00144040|Education, Patient|education, patient
5790402|NCT00144027|patient non-adherence|patient non-adherence
5790403|NCT00144027|intervention studies|intervention studies
5790405|NCT00144014|Ischaemic|ischaemic
5790406|NCT00144014|Stroke|stroke
5790407|NCT00144001|Epilepsy|epilepsy
5790408|NCT00144001|Pharmacoepidemiology|pharmacoepidemiology
5790409|NCT00144001|Quality of Care|quality of care
5790410|NCT00144001|Outcomes|outcomes
5790697|NCT00142311|Clinics|clinics
5790411|NCT00143988|Blood Pressure|blood pressure
5790412|NCT00143988|Heart Rate|heart rate
5790413|NCT00143988|Sexual Activity|sexual activity
5790414|NCT00143975|Acute myeloid leukemia|acute myeloid leukemia
5790415|NCT00143975|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5790416|NCT00143975|refractory disease|refractory disease
5790417|NCT00143962|Weight Loss|weight loss
5790418|NCT00143949|diabetes|diabetes
5790419|NCT00143949|nephropathy|nephropathy
5790420|NCT00143949|kidney|kidney
5790421|NCT00143949|retinopathy|retinopathy
5790422|NCT00143936|Weight Loss|weight loss
5789493|NCT00148239|SCI|sci
5790423|NCT00143923|Cardiovascular Diseases|cardiovascular diseases
5790424|NCT00143923|Ethnic Groups|ethnic groups
5790425|NCT00143923|Risk Factors|risk factors
5790426|NCT00143923|Sleep disordered breathing|sleep disordered breathing
5790427|NCT00143923|Environmental exposures|environmental exposures
5790428|NCT00143923|Cognitive Function|cognitive function
5790429|NCT00143910|Medication adherence|medication adherence
5790430|NCT00143910|Patient compliance|patient compliance
5790431|NCT00143910|Kidney transplant|kidney transplant
5790432|NCT00143910|Organ rejection|organ rejection
5790433|NCT00143910|Allograft loss|allograft loss
5790434|NCT00143910|Drug monitoring|drug monitoring
5790435|NCT00143858|Peripheral Pulse Volume|peripheral pulse volume
5790436|NCT00143832|fMRI|fmri
5790437|NCT00143819|psoriasis|psoriasis
5790438|NCT00143819|dry skin|dry skin
5790439|NCT00143819|eczema|eczema
5790440|NCT00143819|atopic dermatitis|atopic dermatitis
5790441|NCT00143806|psoriasis|psoriasis
5790442|NCT00143806|cyclosporine|cyclosporine
5790443|NCT00143806|transition|transition
5790444|NCT00143806|alefacept|alefacept
5790445|NCT00143793|natruretic peptides|natruretic peptides
5790446|NCT00143793|NT-proBNP|nt-probnp
5790447|NCT00143793|new biomarkers|new biomarkers
5791131|NCT00140179|mania|mania
5790448|NCT00143793|congestive heart failure|congestive heart failure
5790450|NCT00143793|acute myocardial infarction|acute myocardial infarction
5790451|NCT00143793|lung embolism|lung embolism
5790452|NCT00143780|Bone Marrow Transplant|bone marrow transplant
5790453|NCT00143780|Pneumonia|pneumonia
5790455|NCT00143780|Conjugate Vaccine|conjugate vaccine
5790456|NCT00143780|Polysaccharide Vaccine|polysaccharide vaccine
5790457|NCT00143767|Magnetic Resonance Imaging|magnetic resonance imaging
5790458|NCT00143741|Kidney Disease, Lipitor, Atorvastatin, Allosensitization|kidney disease, lipitor, atorvastatin, allosensitization
5790460|NCT00143728|Treatment Experienced|treatment experienced
5790461|NCT00143715|Vitamin K1 (phytonadione)|vitamin k1 (phytonadione)
5790462|NCT00143715|Randomized controlled trial|randomized controlled trial
5790463|NCT00143715|Warfarin|warfarin
5790464|NCT00143715|Coagulopathy|coagulopathy
5790465|NCT00143715|Bleeding|bleeding
5790466|NCT00143715|Thrombosis|thrombosis
5790467|NCT00143715|Warfarin associated coagulopathy defined as an INR of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study|warfarin associated coagulopathy defined as an inr of 4.5 and 10.0 (for entry into randomized tria) or greater than 10.0 (for entry into parallel cohort study
5790468|NCT00143715|Warfarin associated coagulopathy|warfarin associated coagulopathy
5790469|NCT00143702|Elevated Lactic Acid|elevated lactic acid
5790470|NCT00143676|Hyperlipidemia|hyperlipidemia
5790471|NCT00143676|Dyslipidemia|dyslipidemia
5790472|NCT00143676|Drug Therapy|drug therapy
5790473|NCT00143663|Hypercholesterolemia|hypercholesterolemia
5790474|NCT00143663|Hyperlipidemia|hyperlipidemia
5790475|NCT00143663|Drug Therapy|drug therapy
5790476|NCT00143650|Upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans|upper airway, irritation inflammation, discomfort, house dust, damp buildings, climate chamber, humans
5790477|NCT00143637|Office dust|office dust
5790478|NCT00143637|Glucan|glucan
5790479|NCT00143637|dose-response|dose-response
5790480|NCT00143637|lung function|lung function
5790481|NCT00143637|peak expiratory flow|peak expiratory flow
5790482|NCT00143637|inflammation|inflammation
5790483|NCT00143637|perception|perception
5790484|NCT00143624|Treatment Experienced|treatment experienced
5790485|NCT00143624|HIV Metabolic Syndrome|hiv metabolic syndrome
5790486|NCT00143624|Atherosclerosis in HIV|atherosclerosis in hiv
5790487|NCT00143611|Shock, Septic|shock, septic
5790488|NCT00143611|Sepsis Syndrome|sepsis syndrome
5790489|NCT00143611|Respiratory Insufficiency|respiratory insufficiency
5790490|NCT00143611|SIRS (Systemic Inflammatory Response Syndrome)|sirs (systemic inflammatory response syndrome)
5790491|NCT00143611|Respiratory Failure|respiratory failure
5790492|NCT00143611|Drug Therapy|drug therapy
5790493|NCT00143598|Postphlebitic Syndrome|postphlebitic syndrome
5790494|NCT00143598|Post-Thrombotic Syndrome|post-thrombotic syndrome
5790495|NCT00143598|Elastic Stockings|elastic stockings
5790496|NCT00143598|Stockings, Compression|stockings, compression
5790497|NCT00143598|Randomized Controlled Trials|randomized controlled trials
5790498|NCT00143598|Quality of Life|quality of life
5790499|NCT00143585|angiogenesis|angiogenesis
5790500|NCT00143585|VEGF|vegf
5790501|NCT00143572|Hematologic Diseases|hematologic diseases
5790502|NCT00143572|Anemia, Sickle Cell|anemia, sickle cell
5790503|NCT00143559|Allogeneic stem cell transplantation|allogeneic stem cell transplantation
5790504|NCT00143559|Haploidentical stem cell transplant|haploidentical stem cell transplant
5790505|NCT00143559|Mismatched family member stem cell donor transplant|mismatched family member stem cell donor transplant
5790506|NCT00143559|Bone marrow transplant|bone marrow transplant
5790507|NCT00143559|High risk hematological malignancies|high risk hematological malignancies
5790508|NCT00143559|T-cell depletion methodology|t-cell depletion methodology
5790509|NCT00143559|Miltenyi Biotec CliniMACS stem cell selection device|miltenyi biotec clinimacs stem cell selection device
5790510|NCT00143546|Hepatic Veno-occlusive Disease|hepatic veno-occlusive disease
5799437|NCT00109642|Emotion|emotion
5790511|NCT00143533|Solid Tumors|solid tumors
5790512|NCT00143520|Placebo and active control dose response study of rivoglitazone in type 2 diabetics|placebo and active control dose response study of rivoglitazone in type 2 diabetics
5790513|NCT00143468|gas exchange|gas exchange
5790514|NCT00143468|respiratory mechanics|respiratory mechanics
5790515|NCT00143429|Primary Open Angle Glaucoma|primary open angle glaucoma
5790516|NCT00143312|Invasive Fungal Infection, Allogenic Stem Cell Transplant, prophylaxis, leukemia, voriconazole|invasive fungal infection, allogenic stem cell transplant, prophylaxis, leukemia, voriconazole
5790517|NCT00143130|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica|phase 4, open label, seizures, epilepsy, add-on therapy, pregabalin, lyrica
5790518|NCT00143091|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
5790519|NCT00143078|Obesity|obesity
5790520|NCT00143078|Reproduction|reproduction
5790521|NCT00143078|Weight Loss|weight loss
5790522|NCT00143078|Reproductive System|reproductive system
5790523|NCT00143065|Antigens, CD5|antigens, cd5
5790524|NCT00143065|Antigens, CD19|antigens, cd19
5790525|NCT00143065|Antigens, CD20|antigens, cd20
5790526|NCT00143052|Hirsutism|hirsutism
5790527|NCT00143052|Bone status|bone status
5790528|NCT00143052|Androgens|androgens
5790529|NCT00143052|insulin|insulin
5790531|NCT00143039|Severe Symmetrical IUGR|severe symmetrical iugr
5790532|NCT00143039|Tandem Mass Spectrometry|tandem mass spectrometry
5790533|NCT00143039|Nonimmune Hydrops|nonimmune hydrops
5790534|NCT00143039|Severe Symmetrical Intrauterine Growth Restriction|severe symmetrical intrauterine growth restriction
5790535|NCT00143026|Parkinson's disease, levodopa, motor fluctuations|parkinson's disease, levodopa, motor fluctuations
5790536|NCT00143013|type 2 diabetes|type 2 diabetes
5790537|NCT00143013|microarray|microarray
5790538|NCT00143013|skeletal muscle|skeletal muscle
5790539|NCT00143013|bioinformatics|bioinformatics
5790540|NCT00143000|Hepatitis C Virus|hepatitis c virus
5790541|NCT00143000|Genotype 2|genotype 2
5790542|NCT00143000|Genotype 3|genotype 3
5790543|NCT00142987|Tegaserod, IBS-C, women, mixed bowel habit|tegaserod, ibs-c, women, mixed bowel habit
5790544|NCT00142974|Diabetes, tegaserod, gastropathy|diabetes, tegaserod, gastropathy
5790545|NCT00142961|cannabis abuse|cannabis abuse
5790546|NCT00142961|atomoxetine|atomoxetine
5790547|NCT00142961|ADHD|adhd
5790548|NCT00142948|Heroin Abuse|heroin abuse
5790549|NCT00142948|Heroin Addiction|heroin addiction
5790550|NCT00142935|HIV Prevention|hiv prevention
5790551|NCT00142935|Opioid-Related Disorders|opioid-related disorders
5790552|NCT00142935|Medication Assisted Treatment|medication assisted treatment
5790553|NCT00142935|Methadone|methadone
5790554|NCT00142922|Adherence|adherence
5790555|NCT00142922|self-care|self-care
5790556|NCT00142922|Behavioral intervention|behavioral intervention
5790557|NCT00142922|Diabetes|diabetes
5790558|NCT00142909|Opioid dependence|opioid dependence
5790559|NCT00142896|Opiate Addiction|opiate addiction
5790560|NCT00142896|Opiate Dependence|opiate dependence
5790561|NCT00142883|addiction, crack, cocaine|addiction, crack, cocaine
5790562|NCT00142870|marijuana|marijuana
5790563|NCT00142870|treatment|treatment
5790564|NCT00142844|cocaine|cocaine
5790565|NCT00142831|nicotine dependence|nicotine dependence
5790566|NCT00142818|Alcohol Abuse|alcohol abuse
5790567|NCT00142818|Cocaine Abuse|cocaine abuse
5790568|NCT00142805|ketones|ketones
5790569|NCT00142805|Apolipoprotein E|apolipoprotein e
5790570|NCT00142805|ApoE genotype|apoe genotype
5790571|NCT00142805|cognitive function|cognitive function
5790572|NCT00142805|glucose metabolism|glucose metabolism
5790573|NCT00142792|stroke|stroke
5790574|NCT00142792|recovery of function|recovery of function
5790575|NCT00142792|functional electrical stimulation (FES)|functional electrical stimulation (fes)
5790576|NCT00142779|Cocaine Addiction|cocaine addiction
5790577|NCT00142779|Cocaine Dependence|cocaine dependence
5790578|NCT00142779|Opiate Addiction|opiate addiction
5790579|NCT00142779|Opiate Dependence|opiate dependence
5790580|NCT00142766|Sedation|sedation
5790581|NCT00142766|Mechanical ventilation|mechanical ventilation
5790582|NCT00142766|Critical illness|critical illness
5790583|NCT00142766|Analgesic|analgesic
5790584|NCT00142766|Opioid Withdrawal|opioid withdrawal
5790585|NCT00142766|Benzodiazepine Withdrawal|benzodiazepine withdrawal
5790586|NCT00142766|Nurse|nurse
5790587|NCT00142753|Hepatitis B vaccines|hepatitis b vaccines
5790588|NCT00142753|HIV-infected adolescents|hiv-infected adolescents
5790589|NCT00142753|Hepatitis B infection|hepatitis b infection
5790590|NCT00142740|Hepatitis B vaccines|hepatitis b vaccines
5790591|NCT00142740|HIV-infected adolescents|hiv-infected adolescents
5790592|NCT00142740|Hepatitis B infection (negative)|hepatitis b infection (negative)
5790593|NCT00142740|HIV vaccine trial|hiv vaccine trial
5790594|NCT00142714|sexual response|sexual response
5790595|NCT00142714|sexual dysfunction in females|sexual dysfunction in females
5790596|NCT00142714|spinal cord injury|spinal cord injury
5790597|NCT00142636|Chronic Kideny Disease|chronic kideny disease
5790598|NCT00142636|Hypertension|hypertension
5790599|NCT00142610|alpha tocopherol|alpha tocopherol
5790600|NCT00142610|vitamin E|vitamin e
5790601|NCT00142610|ascorbate|ascorbate
5790602|NCT00142610|vitamin C|vitamin c
5789681|NCT00147433|IQ|iq
5790603|NCT00142610|antioxidant|antioxidant
5790604|NCT00142610|allergic|allergic
5790605|NCT00142610|asthma|asthma
5790606|NCT00142597|acupuncture|acupuncture
5790607|NCT00142597|analgesia|analgesia
5790608|NCT00142597|pain|pain
5790609|NCT00142597|fibromyalgia|fibromyalgia
5790610|NCT00142597|fMRI|fmri
5790611|NCT00142597|PET|pet
5790612|NCT00142584|safety and tolerability study|safety and tolerability study
5790613|NCT00142584|hypertension|hypertension
5790614|NCT00142584|beta-blockers|beta-blockers
5790615|NCT00142571|Sarcoma, Soft Tissue|sarcoma, soft tissue
5790616|NCT00142571|Gemcitabine|gemcitabine
5790617|NCT00142571|Docetaxel|docetaxel
5790618|NCT00142558|Arcoxia|arcoxia
5790619|NCT00142532|Acupuncture|acupuncture
5790620|NCT00142532|Pain|pain
5790621|NCT00142532|Lung Cancer|lung cancer
5790622|NCT00142532|Thoracotomy|thoracotomy
5790623|NCT00142532|Surgery|surgery
5790624|NCT00142519|Pain|pain
5790625|NCT00142519|Analgesics|analgesics
5790626|NCT00142519|Retroperitoneal lymph node dissection|retroperitoneal lymph node dissection
5790627|NCT00142506|Prostate Cancer|prostate cancer
5790628|NCT00142506|Cancer of the Prostate|cancer of the prostate
5790629|NCT00142506|Prostate Neoplasms|prostate neoplasms
5790630|NCT00142506|Prostatic Cancer|prostatic cancer
5790631|NCT00142506|Viagra|viagra
5790632|NCT00142506|05-007|05-007
5790633|NCT00142493|Episodic Memory|episodic memory
5790635|NCT00142493|Amnesia, Temporary|amnesia, temporary
5790636|NCT00142480|locally advanced biliary adenocarcinoma|locally advanced biliary adenocarcinoma
5790637|NCT00142480|unresectable biliary adenocarcinoma|unresectable biliary adenocarcinoma
5790638|NCT00142480|gallbladder adenocarcinoma|gallbladder adenocarcinoma
5790639|NCT00142480|capecitabine|capecitabine
5790640|NCT00142480|oxaliplatin|oxaliplatin
5790641|NCT00142480|bevacizumab|bevacizumab
5790642|NCT00142480|Biliary tract adenocarcinoma|biliary tract adenocarcinoma
5790643|NCT00142467|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5790644|NCT00142467|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
5790645|NCT00142467|gemcitabine|gemcitabine
5790646|NCT00142467|oxaliplatin|oxaliplatin
5790647|NCT00142467|bevacizumab|bevacizumab
5790648|NCT00142467|Avastin|avastin
5790649|NCT00142454|Malignant melanoma|malignant melanoma
5790650|NCT00142454|Stages IIB-III|stages iib-iii
5790651|NCT00142441|Pulsed dye laser|pulsed dye laser
5790652|NCT00142441|Keloids|keloids
5790653|NCT00142441|Hypertrophic scars|hypertrophic scars
5790654|NCT00142441|Pulse width|pulse width
5790655|NCT00142441|Pulse duration|pulse duration
5790656|NCT00142428|Hepatocellular carcinoma|hepatocellular carcinoma
5790657|NCT00142428|cetuximab|cetuximab
5790658|NCT00142428|Unresectable hepatocellular carcinoma|unresectable hepatocellular carcinoma
5790659|NCT00142428|Metastatic hepatocellular carcinoma|metastatic hepatocellular carcinoma
5790660|NCT00142415|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5790661|NCT00142415|Clear Cell Renal Cell Carcinoma (CCRCC)|clear cell renal cell carcinoma (ccrcc)
5790662|NCT00142415|Lutetium-177|lutetium-177
5790663|NCT00142415|177-Lu|177-lu
5790664|NCT00142415|cG250|cg250
5790665|NCT00142415|DOTA-cG250|dota-cg250
5790666|NCT00142415|Monoclonal Antibody|monoclonal antibody
5790667|NCT00142402|Multiple Sclerosis|multiple sclerosis
5790668|NCT00142402|Memory|memory
5790669|NCT00142402|New Learning|new learning
5790670|NCT00142402|Fatigue|fatigue
5790671|NCT00142389|gestational immunization,|gestational immunization,
5790672|NCT00142389|infant antibody,|infant antibody,
5790673|NCT00142389|cord antibody|cord antibody
5790674|NCT00142363|Parkinson's disease|parkinson's disease
5790675|NCT00142363|Parkin|parkin
5790676|NCT00142363|Epilepsy|epilepsy
5790677|NCT00142363|Phenotype-genotype correlations|phenotype-genotype correlations
5790678|NCT00142363|Ionic channels|ionic channels
5790679|NCT00142350|gastric cancer|gastric cancer
5790680|NCT00142350|5-fluorouracil|5-fluorouracil
5790681|NCT00142350|irinotecan|irinotecan
5790682|NCT00142350|cisplatin|cisplatin
5790684|NCT00142350|advanced or recurrent gastric cancer|advanced or recurrent gastric cancer
5790685|NCT00142337|zidovudine|zidovudine
5790686|NCT00142337|didanosine|didanosine
5790687|NCT00142337|Prevention of mother to child transmission of HIV|prevention of mother to child transmission of hiv
5790688|NCT00142337|nevirapine|nevirapine
5790689|NCT00142337|Thailand|thailand
5790690|NCT00142337|Resistance|resistance
5790691|NCT00142337|HIV|hiv
5790692|NCT00142337|Postpartum period|postpartum period
5790693|NCT00142324|Dementia|dementia
5790694|NCT00142311|Parkinson's disease|parkinson's disease
5790695|NCT00142311|Parkin mutations|parkin mutations
5790696|NCT00142311|Metabolic explorations|metabolic explorations
5790698|NCT00142311|Genetics|genetics
5790699|NCT00142285|pneumonia|pneumonia
5790700|NCT00142285|zinc|zinc
5790701|NCT00142285|treatment|treatment
5790702|NCT00142285|efficacy|efficacy
5790703|NCT00142285|children|children
5790704|NCT00142272|Ciprofloxacin|ciprofloxacin
5790705|NCT00142272|children|children
5790706|NCT00142272|V.cholerae O1 and O139|v.cholerae o1 and o139
5790707|NCT00142272|drug resistance|drug resistance
5789771|NCT00147095|lymphocytes|lymphocytes
5790708|NCT00142272|Bangladesh|bangladesh
5790709|NCT00142259|deep brain stimulation|deep brain stimulation
5790710|NCT00142259|internal globus pallidus|internal globus pallidus
5790711|NCT00142259|dystonia|dystonia
5790712|NCT00142246|malaria|malaria
5790713|NCT00142246|anaemia|anaemia
5790714|NCT00142246|school performance|school performance
5790715|NCT00142246|education|education
5790716|NCT00142246|intermittent preventive treatment|intermittent preventive treatment
5790717|NCT00142246|schools|schools
5790718|NCT00142233|EUROPAC 2, ANTOX (vers)1.2, MGCT (Magnesiocard)|europac 2, antox (vers)1.2, mgct (magnesiocard)
5790719|NCT00142233|Hereditary Pancreatitis|hereditary pancreatitis
5790720|NCT00142233|idiopathic chronic pancreatitis|idiopathic chronic pancreatitis
5790721|NCT00142207|malaria|malaria
5790722|NCT00142207|pregnancy|pregnancy
5790723|NCT00142207|intermittent preventive treatment|intermittent preventive treatment
5790724|NCT00142207|insecticide-treated nets|insecticide-treated nets
5790725|NCT00142194|Atrial Fibrillation|atrial fibrillation
5790726|NCT00142194|Oxidative stress|oxidative stress
5790727|NCT00142194|Cardiology|cardiology
5790728|NCT00142181|Lymphoplasmacytic lymphoma|lymphoplasmacytic lymphoma
5790729|NCT00142181|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5790730|NCT00142181|Antibody|antibody
5790731|NCT00142181|Campath-1H|campath-1h
5790732|NCT00142168|CC-5103 (lenalidomide)|cc-5103 (lenalidomide)
5790733|NCT00142168|rituximab|rituximab
5790734|NCT00142168|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5790735|NCT00142155|monoclonal antibody|monoclonal antibody
5790736|NCT00142155|Fc gamma RIII receptor expression|fc gamma riii receptor expression
5790737|NCT00142155|rituximab|rituximab
5790738|NCT00142129|bortezomib|bortezomib
5790740|NCT00142129|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5790741|NCT00142116|thalidomide|thalidomide
5790742|NCT00142116|rituximab|rituximab
5790743|NCT00142116|Waldenstrom's|waldenstrom's
5790744|NCT00142103|Hepatitis c virus|hepatitis c virus
5790745|NCT00142103|HCV|hcv
5790746|NCT00142103|Liver|liver
5790747|NCT00142090|Brain Concussion|brain concussion
5790748|NCT00142090|Post-Concussion Syndrome|post-concussion syndrome
5790749|NCT00142090|Closed Head Injury|closed head injury
5790750|NCT00142090|Traumatic Brain Injury|traumatic brain injury
5790751|NCT00142090|Hypertonic Saline Solution|hypertonic saline solution
5790752|NCT00142077|Influenza|influenza
5790753|NCT00142077|Electronic health record|electronic health record
5790754|NCT00142077|Behavior modification|behavior modification
5790755|NCT00142064|Topical analgesia|topical analgesia
5790756|NCT00142064|Urinary catheterization|urinary catheterization
5790757|NCT00142064|FlACC Pain Scale|flacc pain scale
5790758|NCT00142064|Lidocaine jelly|lidocaine jelly
5790759|NCT00142051|sickle cell disease|sickle cell disease
5790760|NCT00142051|pain crisis|pain crisis
5790761|NCT00142051|vaso-occlusive crisis|vaso-occlusive crisis
5790762|NCT00142051|nitric oxide|nitric oxide
5790763|NCT00142038|gastric cancer|gastric cancer
5790764|NCT00142038|metastatic|metastatic
5790765|NCT00142038|locally advanced|locally advanced
5790766|NCT00142038|docetaxel|docetaxel
5790767|NCT00142038|capecitabine|capecitabine
5790768|NCT00142025|Bronchial asthma|bronchial asthma
5790769|NCT00142025|Oxcarbazepine|oxcarbazepine
5790770|NCT00142025|Antiepileptic drug|antiepileptic drug
5790771|NCT00142025|Efficacy|efficacy
5790772|NCT00142012|School-based|school-based
5790773|NCT00142012|Obesity|obesity
5790774|NCT00142012|Prevention|prevention
5790775|NCT00141999|vaccine|vaccine
5790776|NCT00141999|hepatitis|hepatitis
5790777|NCT00141986|vitamin D|vitamin d
5790778|NCT00141986|type 1 diabetes|type 1 diabetes
5790779|NCT00141986|prevention trial|prevention trial
5790780|NCT00141973|Procalcitonin|procalcitonin
5790781|NCT00141973|Sepsis|sepsis
5790782|NCT00141973|Corticosteroids|corticosteroids
5790783|NCT00141960|Treatment efficacy|treatment efficacy
5790784|NCT00141960|Treatment effectiveness|treatment effectiveness
5790785|NCT00141960|Gastrointestinal Diseases|gastrointestinal diseases
5790786|NCT00141960|Reflux, Gastroesophageal|reflux, gastroesophageal
5790787|NCT00141960|GERD|gerd
5790788|NCT00141947|bexarotene|bexarotene
5790789|NCT00141947|schizophrenia|schizophrenia
5790790|NCT00141947|psychopathology|psychopathology
5790791|NCT00141947|cognitive impairment|cognitive impairment
5790792|NCT00141947|quality of life|quality of life
5790793|NCT00141947|open lable trial|open lable trial
5790794|NCT00141934|Rheumatoid Arthritis|rheumatoid arthritis
5790795|NCT00141934|RA|ra
5790796|NCT00141934|ACR20 endpoint|acr20 endpoint
5790797|NCT00141934|Tender/swollen joints|tender/swollen joints
5790798|NCT00141934|Improvement in pain|improvement in pain
5790991|NCT00140660|chemotherapy|chemotherapy
5790799|NCT00141934|Health assessment questionnaire|health assessment questionnaire
5790800|NCT00141934|Profile of mood states|profile of mood states
5790801|NCT00141921|Immunex|immunex
5790802|NCT00141921|Amgen|amgen
5790803|NCT00141921|Pediatric,|pediatric,
5790804|NCT00141921|plaque psoriasis|plaque psoriasis
5790805|NCT00141921|clinical trial|clinical trial
5789898|NCT00146536|ALH|alh
5790806|NCT00141908|Hydroxyprogesterone Caproate, twins, preterm delivery|hydroxyprogesterone caproate, twins, preterm delivery
5790807|NCT00141895|Intrauterine fetal death, 2nd trimester, induction|intrauterine fetal death, 2nd trimester, induction
5790808|NCT00141869|Sensory Processing|sensory processing
5790809|NCT00141869|Magnetoencephalogram|magnetoencephalogram
5790810|NCT00141869|Tourete Syndrome|tourete syndrome
5790811|NCT00141869|Trigeminal Nerve|trigeminal nerve
5790812|NCT00141869|Tics|tics
5790813|NCT00141869|TS|ts
5790814|NCT00141869|Healthy Volunteer|healthy volunteer
5790815|NCT00141869|HV|hv
5790816|NCT00141856|Dis Management|dis management
5790817|NCT00141856|Heart Decompensation|heart decompensation
5790818|NCT00141856|Hearts|hearts
5790819|NCT00141856|Veteran (M01.930)|veteran (m01.930)
5790820|NCT00141843|Hemophilia A|hemophilia a
5790821|NCT00141830|Rheumatoid Arthritis|rheumatoid arthritis
5790822|NCT00141817|Gastrointestinal Reflux Disease|gastrointestinal reflux disease
5790824|NCT00141804|immunosuppression|immunosuppression
5790825|NCT00141804|prevention of acute rejection|prevention of acute rejection
5790826|NCT00141791|Asthma|asthma
5790827|NCT00141791|Anti-Asthmatic Agents|anti-asthmatic agents
5790828|NCT00141791|Receptors|receptors
5790829|NCT00141791|Tumor Necrosis Factor|tumor necrosis factor
5790830|NCT00141778|atrial fibrillation|atrial fibrillation
5790831|NCT00141778|cardiac surgery|cardiac surgery
5790832|NCT00141752|Cerebrovascular Accident|cerebrovascular accident
5790833|NCT00141752|Deglutition Disorders|deglutition disorders
5790835|NCT00141752|dysphagia|dysphagia
5790836|NCT00141752|screening|screening
5790837|NCT00141739|Stem Cell Transplantation|stem cell transplantation
5790838|NCT00141739|Graft-Versus-Host Disease|graft-versus-host disease
5790839|NCT00141739|prophylaxis|prophylaxis
5790840|NCT00141726|Enbrel|enbrel
5790841|NCT00141726|Stem Cell Transplantation|stem cell transplantation
5790842|NCT00141726|Lung Injury|lung injury
5790843|NCT00141687|External cephalic version|external cephalic version
5790844|NCT00141687|Cesarean section|cesarean section
5790845|NCT00141687|pregnancy|pregnancy
5790846|NCT00141687|labour|labour
5790847|NCT00141687|Breech pregnancy|breech pregnancy
5790848|NCT00141674|Blood transfusion|blood transfusion
5790849|NCT00141674|Age of blood|age of blood
5790850|NCT00141674|Traumatic Brain Injury|traumatic brain injury
5790851|NCT00141674|Cerebral Oxygen Extraction Ratio|cerebral oxygen extraction ratio
5790852|NCT00141674|Age of transfused blood in traumatic brain injury|age of transfused blood in traumatic brain injury
5790853|NCT00141661|Interventional, Alzheimer, Safety and Tolerability|interventional, alzheimer, safety and tolerability
5790854|NCT00141648|Osteolymphoma|osteolymphoma
5790855|NCT00141648|Chemotherapy|chemotherapy
5790856|NCT00141648|Radiotherapy|radiotherapy
5790857|NCT00141648|Lymphoma|lymphoma
5790858|NCT00141635|Quality of Life|quality of life
5790859|NCT00141635|Breast Cancer|breast cancer
5790860|NCT00141635|Referee's Report|referee's report
5790861|NCT00141635|Diagnostics|diagnostics
5790862|NCT00141635|Therapy|therapy
5790863|NCT00141622|Endothelial dysfunction|endothelial dysfunction
5790864|NCT00141622|ADMA|adma
5790865|NCT00141622|DDAH|ddah
5790866|NCT00141622|Sodium|sodium
5790867|NCT00141609|End-stage renal failure|end-stage renal failure
5790868|NCT00141609|Haemodialysis|haemodialysis
5790869|NCT00141609|Sodium|sodium
5790870|NCT00141609|Blood Pressure|blood pressure
5790871|NCT00141596|Resistant Hypertension|resistant hypertension
5790872|NCT00141596|Extracellular Fluid Volume|extracellular fluid volume
5790873|NCT00141583|Renin-angiotensin system|renin-angiotensin system
5790874|NCT00141583|ACE Inhibitor|ace inhibitor
5790875|NCT00141583|Angiotensin Receptor Blocker|angiotensin receptor blocker
5790876|NCT00141570|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5790877|NCT00141557|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5790878|NCT00141544|Menopause; Postmenopause; Estrogen; Hormone Therapy|menopause; postmenopause; estrogen; hormone therapy
5790879|NCT00141531|Bladder cancer|bladder cancer
5790880|NCT00141531|Superficial|superficial
5790881|NCT00141531|Carcinoma in situ|carcinoma in situ
5790882|NCT00141531|Intravesical instillation|intravesical instillation
5790883|NCT00141531|Chemotherapy|chemotherapy
5790884|NCT00141531|Adjuvant|adjuvant
5790885|NCT00141518|Health economics,Quality of life|health economics,quality of life
5790886|NCT00141505|drug interaction|drug interaction
5790887|NCT00141505|pharmacokinetics|pharmacokinetics
5790888|NCT00141505|valproate|valproate
5790889|NCT00141505|bipolar|bipolar
5790890|NCT00141492|Type 2 diabetes|type 2 diabetes
5790891|NCT00141492|hypogonadism|hypogonadism
5790892|NCT00141492|testosterone|testosterone
5790893|NCT00141492|glycosylated hemoglobin A1C|glycosylated hemoglobin a1c
5791286|NCT00139113|hepatitis A|hepatitis a
5790894|NCT00141479|Treatment interruption on reinitiation|treatment interruption on reinitiation
5790895|NCT00141479|Schizophrenia|schizophrenia
5790896|NCT00141479|Schizoaffective disorder|schizoaffective disorder
5790897|NCT00141466|Hereditary colorectal cancer|hereditary colorectal cancer
5790898|NCT00141466|Microsatellite instability|microsatellite instability
5789978|NCT00146276|bladder cancer|bladder cancer
5789979|NCT00146276|cystectomy|cystectomy
5789980|NCT00146276|gemcitabine|gemcitabine
5789981|NCT00146276|adjuvant chemotherapy|adjuvant chemotherapy
5790899|NCT00141466|Physician roles|physician roles
5790900|NCT00141466|Health care implementation|health care implementation
5790901|NCT00141466|Intervention|intervention
5790902|NCT00141453|angiotensin II type I receptor blockers|angiotensin ii type i receptor blockers
5790903|NCT00141453|diabetic nephropathy|diabetic nephropathy
5790904|NCT00141453|end-stage renal disease|end-stage renal disease
5790905|NCT00141453|renal failure|renal failure
5790906|NCT00141453|type 2 diabetes|type 2 diabetes
5790907|NCT00141453|olmesartan medoxomil|olmesartan medoxomil
5790908|NCT00141440|gas exchange|gas exchange
5790909|NCT00141440|pressure support ventilation|pressure support ventilation
5790910|NCT00141440|respiratory mechanics|respiratory mechanics
5790911|NCT00141440|COPD patients|copd patients
5790912|NCT00141297|Advanced cancer|advanced cancer
5790913|NCT00141271|Bipolar I Disorder|bipolar i disorder
5790914|NCT00141115|Substance-induced anxiety disorder|substance-induced anxiety disorder
5790915|NCT00141102|GI events in high risk GI arthritis patients|gi events in high risk gi arthritis patients
5790916|NCT00141089|Male patients, chronic constipation, tegaserod|male patients, chronic constipation, tegaserod
5790917|NCT00141076|obesity|obesity
5790918|NCT00141076|glycemic index|glycemic index
5790919|NCT00141076|insulin resistance|insulin resistance
5790920|NCT00141076|cardiovascular disease|cardiovascular disease
5790921|NCT00141076|diabetes|diabetes
5790922|NCT00141063|ADHD, children|adhd, children
5790923|NCT00141050|ADHD, children|adhd, children
5790925|NCT00141037|Corticosteroids|corticosteroids
5790926|NCT00141037|Child|child
5790927|NCT00141037|Adolescent|adolescent
5790928|NCT00141037|Immunosuppression|immunosuppression
5790929|NCT00141037|Steroids|steroids
5790930|NCT00141024|HIV Seronegativity|hiv seronegativity
5790931|NCT00141024|HIV Preventive Vaccine|hiv preventive vaccine
5790932|NCT00141011|Stroke|stroke
5790933|NCT00141011|Fibrinogen|fibrinogen
5790934|NCT00141011|Reperfusion|reperfusion
5790935|NCT00141011|Thrombolysis|thrombolysis
5790936|NCT00140998|Turner syndrome|turner syndrome
5790937|NCT00140998|Hypogonadism|hypogonadism
5790938|NCT00140998|GH|gh
5790939|NCT00140998|Estrogen|estrogen
5790940|NCT00140998|Estrogen Patches|estrogen patches
5790941|NCT00140998|IGF-I|igf-i
5790942|NCT00140998|Body Composition|body composition
5790943|NCT00140998|Protein Metabolism|protein metabolism
5790944|NCT00140998|Lipolysis|lipolysis
5790945|NCT00140972|Arcoxia|arcoxia
5790946|NCT00140894|Osteoarthritis|osteoarthritis
5790947|NCT00140894|Cancer Pain|cancer pain
5790948|NCT00140868|Colonic Pseudo-Obstruction|colonic pseudo-obstruction
5790949|NCT00140868|Large bowel obstruction|large bowel obstruction
5790950|NCT00140868|Stents|stents
5790951|NCT00140868|Laparotomy|laparotomy
5790952|NCT00140868|Palliative Surgery|palliative surgery
5790953|NCT00140868|Surgery, Palliative|surgery, palliative
5790954|NCT00140868|Palliative Therapy|palliative therapy
5790955|NCT00140855|synovial sarcoma|synovial sarcoma
5790956|NCT00140855|immunotherapy|immunotherapy
5790957|NCT00140855|cancer-testis antigen|cancer-testis antigen
5790958|NCT00140855|cancer-germ cell antigen|cancer-germ cell antigen
5790959|NCT00140855|soft tissue sarcoma|soft tissue sarcoma
5790960|NCT00140855|SYT-SSX chromosomal translocation|syt-ssx chromosomal translocation
5790961|NCT00140842|Obesity, adolescent, ghrelin, growth hormone, cortisol|obesity, adolescent, ghrelin, growth hormone, cortisol
5790962|NCT00140829|Cerebellar ataxias|cerebellar ataxias
5790963|NCT00140829|Spastic paraplegias|spastic paraplegias
5790964|NCT00140829|Mutations spectrum|mutations spectrum
5790965|NCT00140829|Linkage studies|linkage studies
5790966|NCT00140829|Genetic counselling|genetic counselling
5790967|NCT00140790|Cardiorenal syndrome|cardiorenal syndrome
5790968|NCT00140790|Renal dysfunction|renal dysfunction
5790969|NCT00140790|Cardiovascular events|cardiovascular events
5790970|NCT00140790|Valsartan|valsartan
5790971|NCT00140764|Genitourinary symptoms|genitourinary symptoms
5790972|NCT00140751|HIV-1|hiv-1
5790973|NCT00140751|Treatment simplification|treatment simplification
5790974|NCT00140751|Lopinavir/ritonavir|lopinavir/ritonavir
5790975|NCT00140751|Treatment Experienced|treatment experienced
5790976|NCT00140751|HIV Seropositivity|hiv seropositivity
5790977|NCT00140725|HBeAg-positive|hbeag-positive
5790978|NCT00140725|chronic|chronic
5790979|NCT00140725|Hepatitis B|hepatitis b
5790980|NCT00140725|lamivudine|lamivudine
5790981|NCT00140725|seroconversion|seroconversion
5790982|NCT00140725|Chronic Hepatitis B|chronic hepatitis b
5790983|NCT00140712|RLS|rls
5790984|NCT00140712|PLMS|plms
5790985|NCT00140712|Adolescent|adolescent
5790986|NCT00140712|Periodic Limb Movements of Sleep|periodic limb movements of sleep
5790987|NCT00140712|Ropinirole|ropinirole
5790988|NCT00140699|Children, Hearing loss, Balance control, Sensory inputs|children, hearing loss, balance control, sensory inputs
5790989|NCT00140660|lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5790990|NCT00140660|rituximab|rituximab
5790992|NCT00140647|atherosclerosis|atherosclerosis
5790993|NCT00140647|carotid artery|carotid artery
5790994|NCT00140647|ramipril|ramipril
5790995|NCT00140647|rosiglitazone|rosiglitazone
5790996|NCT00140647|impaired glucose tolerance|impaired glucose tolerance
5790997|NCT00140647|impaired fasting glucose|impaired fasting glucose
5790998|NCT00140647|diabetes prevention|diabetes prevention
5790999|NCT00140621|cardiac fabry disease|cardiac fabry disease
5791000|NCT00140608|sinus|sinus
5791001|NCT00140595|Lymphoma, diffuse large B-cell|lymphoma, diffuse large b-cell
5791002|NCT00140595|rituximab|rituximab
5791003|NCT00140595|chemotherapy|chemotherapy
5791004|NCT00140582|lymphoma|lymphoma
5791005|NCT00140582|follicular|follicular
5791006|NCT00140582|maintenance|maintenance
5791007|NCT00140569|follicular lymphoma|follicular lymphoma
5791008|NCT00140569|CHVP + interferon|chvp + interferon
5791009|NCT00140569|fludarabine|fludarabine
5791010|NCT00140569|autotransplant|autotransplant
5791011|NCT00140556|head and neck cancer|head and neck cancer
5791012|NCT00140556|targeted therapy|targeted therapy
5791013|NCT00140556|bevacizumab|bevacizumab
5791014|NCT00140556|erlotinib|erlotinib
5791015|NCT00140556|Tarceva|tarceva
5791017|NCT00140556|concurrent chemotherapy|concurrent chemotherapy
5791018|NCT00140556|pharynx cancer|pharynx cancer
5791019|NCT00140556|tonsil cancer|tonsil cancer
5791020|NCT00140556|hyperfractionation|hyperfractionation
5791021|NCT00140556|angiogenesis|angiogenesis
5791022|NCT00140556|epidermal growth factor|epidermal growth factor
5791023|NCT00140556|vascular endothelial growth factor|vascular endothelial growth factor
5791024|NCT00140556|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5791025|NCT00140556|cancer of the head and neck|cancer of the head and neck
5791488|NCT00138047|zinc|zinc
5791026|NCT00140556|upper aerodigestive tract neoplasms|upper aerodigestive tract neoplasms
5791027|NCT00140556|pharynx neoplasms|pharynx neoplasms
5791028|NCT00140543|simultaneous pancreas/kidney transplantation|simultaneous pancreas/kidney transplantation
5791029|NCT00140543|Immunosuppression|immunosuppression
5791030|NCT00140517|Plasmodium falciparum|plasmodium falciparum
5791032|NCT00140517|pregnancy|pregnancy
5791033|NCT00140517|resistance|resistance
5791034|NCT00140504|Adverse drug event|adverse drug event
5791035|NCT00140504|Patient safety|patient safety
5791036|NCT00140504|Internet portal|internet portal
5791037|NCT00140504|PatientSite|patientsite
5791038|NCT00140504|Preventive health|preventive health
5791039|NCT00140504|Primary care|primary care
5791040|NCT00140491|Non-Arteritic Anterior Ischemic Optic Neuropathy|non-arteritic anterior ischemic optic neuropathy
5791041|NCT00140491|Visual Field Defect|visual field defect
5791042|NCT00140491|Neuroplasticity|neuroplasticity
5791043|NCT00140491|Rehabilitation|rehabilitation
5791044|NCT00140478|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5791045|NCT00140478|Prostate Cancer|prostate cancer
5791046|NCT00140478|Mifepristone|mifepristone
5791047|NCT00140478|RU-486|ru-486
5791048|NCT00140452|ALS|als
5791049|NCT00140439|asthma|asthma
5791050|NCT00140439|emergency department|emergency department
5791051|NCT00140439|compliance|compliance
5791052|NCT00140439|randomized clinical trial|randomized clinical trial
5791053|NCT00140426|Anorexia Nervosa|anorexia nervosa
5791054|NCT00140426|Risperidone|risperidone
5791055|NCT00140426|Atypical Neuroleptics|atypical neuroleptics
5791056|NCT00140426|Dopamine|dopamine
5791057|NCT00140426|Leptin|leptin
5791058|NCT00140426|Body Image|body image
5791059|NCT00140426|Adolescents|adolescents
5791060|NCT00140413|Optic Nerve Hypoplasia|optic nerve hypoplasia
5791061|NCT00140400|Prostate|prostate
5791062|NCT00140400|Cancer|cancer
5791063|NCT00140400|Advanced prostate cancer|advanced prostate cancer
5791064|NCT00140400|Metastatic|metastatic
5791065|NCT00140400|Hormone-refractory|hormone-refractory
5791066|NCT00140400|GVAX|gvax
5791067|NCT00140400|Vaccine|vaccine
5791068|NCT00140400|Allogeneic cells|allogeneic cells
5791069|NCT00140387|Prostate|prostate
5791070|NCT00140387|Cancer|cancer
5791071|NCT00140387|GVAX|gvax
5791072|NCT00140387|Metastatic|metastatic
5791073|NCT00140387|Vaccine|vaccine
5791074|NCT00140387|Allogeneic cells|allogeneic cells
5791075|NCT00140374|Prostate|prostate
5791076|NCT00140374|Cancer|cancer
5791077|NCT00140374|Vaccine|vaccine
5791078|NCT00140374|GVAX|gvax
5791079|NCT00140374|Allogeneic cells|allogeneic cells
5791080|NCT00140361|malaria|malaria
5791081|NCT00140361|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5791082|NCT00140361|sulfadoxine-pyrimethamine plus artsunate|sulfadoxine-pyrimethamine plus artsunate
5791083|NCT00140361|lumefantrine plus artemether|lumefantrine plus artemether
5791084|NCT00140361|combination therapy|combination therapy
5791085|NCT00140348|Prostate|prostate
5791086|NCT00140348|Cancer|cancer
5791087|NCT00140348|Advanced Prostate Cancer|advanced prostate cancer
5791088|NCT00140348|Metastatic|metastatic
5791089|NCT00140348|Hormone-refractory|hormone-refractory
5791090|NCT00140348|GVAX|gvax
5791091|NCT00140348|Vaccine|vaccine
5791092|NCT00140348|Allogeneic cells|allogeneic cells
5791093|NCT00140335|handwashing|handwashing
5792051|NCT00135694|HCV|hcv
5791094|NCT00140335|communicable diseases|communicable diseases
5791095|NCT00140335|health education|health education
5791096|NCT00140322|falls|falls
5791097|NCT00140322|injury|injury
5791098|NCT00140322|elderly|elderly
5791100|NCT00140309|Pulmonary Tuberculosis|pulmonary tuberculosis
5791101|NCT00140309|Tuberculosis|tuberculosis
5791102|NCT00140309|Pulmonary TB|pulmonary tb
5791103|NCT00140283|Effectiveness|effectiveness
5791104|NCT00140283|Educational intervention|educational intervention
5791105|NCT00140283|Primary health care|primary health care
5791106|NCT00140257|Myocardial Infarction|myocardial infarction
5791108|NCT00140244|lipodystrophy|lipodystrophy
5791109|NCT00140244|insulin resistance|insulin resistance
5791110|NCT00140244|hyperlipidemia|hyperlipidemia
5791111|NCT00140244|metabolic syndrome|metabolic syndrome
5791112|NCT00140231|leptin|leptin
5791113|NCT00140231|fasting|fasting
5791114|NCT00140231|reproductive|reproductive
5791115|NCT00140231|neuroendocrine|neuroendocrine
5791116|NCT00140231|immune function|immune function
5791117|NCT00140231|energy deficiency associated with short-term fasting|energy deficiency associated with short-term fasting
5791118|NCT00140218|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5791120|NCT00140218|oxidative stress|oxidative stress
5791121|NCT00140218|neuroprotection|neuroprotection
5791122|NCT00140205|leptin|leptin
5791123|NCT00140205|fasting|fasting
5791124|NCT00140205|pharmacokinetics|pharmacokinetics
5791125|NCT00140192|creatine metabolism|creatine metabolism
5791126|NCT00140192|schizophrenia|schizophrenia
5791127|NCT00140192|energy metabolism|energy metabolism
5791128|NCT00140179|valnoctamide|valnoctamide
5791129|NCT00140179|teratogenicity|teratogenicity
5791130|NCT00140179|double-blind|double-blind
5791132|NCT00140166|schizophrenia|schizophrenia
5791133|NCT00140166|niacinamide|niacinamide
5791134|NCT00140153|androgel|androgel
5791135|NCT00140153|female sexuale dysfunction|female sexuale dysfunction
5791136|NCT00140153|controlled double-blind|controlled double-blind
5791137|NCT00140153|testosterone|testosterone
5791138|NCT00140140|Breast cancer|breast cancer
5791139|NCT00140114|Vaginal, sublingual, misoprostol, cervical ripening|vaginal, sublingual, misoprostol, cervical ripening
5791140|NCT00140101|drug eluting stents|drug eluting stents
5791142|NCT00140101|angioplasty|angioplasty
5791143|NCT00140101|coronary artery disease|coronary artery disease
5791144|NCT00140101|total coronary occlusion|total coronary occlusion
5791145|NCT00140101|coronary artery restenosis|coronary artery restenosis
5791146|NCT00140101|stent thrombosis|stent thrombosis
5791147|NCT00140101|vascular disease|vascular disease
5791148|NCT00140101|myocardial ischemia|myocardial ischemia
5791149|NCT00140101|coronary artery stenosis|coronary artery stenosis
5791150|NCT00140088|Needlestick pain|needlestick pain
5791151|NCT00140088|Venipuncture pain|venipuncture pain
5791152|NCT00140010|aneurysm|aneurysm
5791153|NCT00140010|autoregulation|autoregulation
5791154|NCT00140010|erythropoietion|erythropoietion
5791155|NCT00140010|stroke|stroke
5791156|NCT00140010|subarachnoid hemorrhage|subarachnoid hemorrhage
5791157|NCT00140010|vasospasm|vasospasm
5791158|NCT00139997|Major Depression|major depression
5791159|NCT00139997|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
5791160|NCT00139984|Hypertension|hypertension
5791161|NCT00139984|Ambulatory blood pressure monitoring|ambulatory blood pressure monitoring
5791162|NCT00139984|Blood pressure|blood pressure
5791163|NCT00139984|Risk assessment|risk assessment
5791164|NCT00139958|Acute coronary syndrome|acute coronary syndrome
5791165|NCT00139958|HIV infection|hiv infection
5791166|NCT00139958|Prognosis|prognosis
5791167|NCT00139958|Coronary heart disease|coronary heart disease
5791168|NCT00139958|Revascularization|revascularization
5791169|NCT00139919|Decreasing Titration Study|decreasing titration study
5791170|NCT00139919|Schizophrenia|schizophrenia
5791171|NCT00139919|Bipolar|bipolar
5791172|NCT00139919|Pharmacokinetic|pharmacokinetic
5791173|NCT00139906|Titration Study|titration study
5791174|NCT00139906|Schizophrenia|schizophrenia
5791175|NCT00139906|BID dosing|bid dosing
5791176|NCT00139906|Pharmacokinetic|pharmacokinetic
5791177|NCT00139841|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5791178|NCT00139841|Rituximab Refractory|rituximab refractory
5791179|NCT00139841|Rituximab Failure|rituximab failure
5791180|NCT00139841|Indolent Non-Hodgkins Lymphoma|indolent non-hodgkins lymphoma
5791181|NCT00139828|haemophilia B|haemophilia b
5791182|NCT00139828|factor IX|factor ix
5791183|NCT00139828|Product Surveillance, Postmarketing|product surveillance, postmarketing
5791184|NCT00139828|plasma products|plasma products
5791185|NCT00139815|unstable angina|unstable angina
5791186|NCT00139815|acute coronary syndrome|acute coronary syndrome
5791187|NCT00139815|fondaparinux sodium|fondaparinux sodium
5791188|NCT00139815|non ST segment elevation myocardial infarction|non st segment elevation myocardial infarction
5791189|NCT00139815|myocardial infarction|myocardial infarction
5791190|NCT00139776|Chronic treatment osteoarthritis, Celecoxib, Continuous Use, Intermittent Use|chronic treatment osteoarthritis, celecoxib, continuous use, intermittent use
5791285|NCT00139139|immune globulin|immune globulin
5791191|NCT00139737|Open-label extension Ziprasidone study in Schizophrenia|open-label extension ziprasidone study in schizophrenia
5791192|NCT00139633|esophageal cancer, chemotherapy, radiation|esophageal cancer, chemotherapy, radiation
5791193|NCT00139620|advanced cancer, solid tumor|advanced cancer, solid tumor
5791194|NCT00139594|Bipolar disorder, manic episode/treatment/licarbazepine|bipolar disorder, manic episode/treatment/licarbazepine
5791195|NCT00139581|Atopic dermatitis, children, infants, pimecrolimus, bid, od|atopic dermatitis, children, infants, pimecrolimus, bid, od
5791196|NCT00139568|Chronic constipation|chronic constipation
5791197|NCT00139568|5-HT,5-HT4,|5-ht,5-ht4,
5791198|NCT00139568|functional GI|functional gi
5791199|NCT00139568|China|china
5791200|NCT00139568|tegaserod|tegaserod
5791201|NCT00139555|Hypertension|hypertension
5791202|NCT00139555|Left ventricular hypertrophy|left ventricular hypertrophy
5791203|NCT00139542|human|human
5791204|NCT00139542|ventricular fibrillation|ventricular fibrillation
5791205|NCT00139542|out-of-hospital|out-of-hospital
5791206|NCT00139542|cardiac arrest|cardiac arrest
5791207|NCT00139542|automated external defibrillators (AED)|automated external defibrillators (aed)
5791208|NCT00139542|defibrillators|defibrillators
5791209|NCT00139542|electrick countershock|electrick countershock
5791210|NCT00139542|cardiopulmonary resuscitation|cardiopulmonary resuscitation
5791211|NCT00139490|Blood Pressure, High|blood pressure, high
5791213|NCT00139451|Delayed Growth|delayed growth
5791214|NCT00139451|Energy Expenditure|energy expenditure
5791216|NCT00139451|Nutrition|nutrition
5791217|NCT00139451|Short Stature|short stature
5791218|NCT00139399|Coronary artery bypass|coronary artery bypass
5791219|NCT00139399|Coronary arteries|coronary arteries
5791220|NCT00139399|Atherosclerosis|atherosclerosis
5791221|NCT00139399|Angiography|angiography
5791222|NCT00139399|Blood flow|blood flow
5791489|NCT00138047|HIV|hiv
5791223|NCT00139386|Drug-eluting stent|drug-eluting stent
5791224|NCT00139386|Candesartan|candesartan
5791225|NCT00139386|Randomized control study|randomized control study
5791226|NCT00139386|Coronary Angioplasty|coronary angioplasty
5791227|NCT00139373|Progressive supranuclear palsy|progressive supranuclear palsy
5791228|NCT00139373|Frontal lobe|frontal lobe
5791229|NCT00139373|Oculomotor testing|oculomotor testing
5791230|NCT00139373|Neuropsychological scores|neuropsychological scores
5791231|NCT00139373|Motor disability (UPDRS)|motor disability (updrs)
5791232|NCT00139373|Distractibility|distractibility
5791233|NCT00139321|Gait disorders|gait disorders
5791234|NCT00139321|Postural instability|postural instability
5791235|NCT00139321|parkinsonian syndrome|parkinsonian syndrome
5791236|NCT00139321|Gait initiation|gait initiation
5791237|NCT00139321|Parkinson's disease|parkinson's disease
5791238|NCT00139321|Adults|adults
5791239|NCT00139308|Tourette's syndrome|tourette's syndrome
5791240|NCT00139308|High frequency stimulation|high frequency stimulation
5791241|NCT00139308|Globus pallidus|globus pallidus
5791242|NCT00139308|Thalamus|thalamus
5791243|NCT00139295|musculoskeletal|musculoskeletal
5791244|NCT00139295|osteoarthritis of the knee|osteoarthritis of the knee
5791245|NCT00139282|wet AMD|wet amd
5791246|NCT00139282|macular degeneration|macular degeneration
5791247|NCT00139269|Advanced Squamous Cell Carcinoma|advanced squamous cell carcinoma
5791248|NCT00139269|Squamous cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5791249|NCT00139269|SSCHN|sschn
5791250|NCT00139269|Docetaxel|docetaxel
5791251|NCT00139256|Glucocorticoid|glucocorticoid
5791252|NCT00139256|Antepartum Betamethasone Treatment|antepartum betamethasone treatment
5791253|NCT00139256|Elective Cesarean Section|elective cesarean section
5791254|NCT00139256|Respiratory Distress in Infants|respiratory distress in infants
5791255|NCT00139243|squamous cell carcinoma|squamous cell carcinoma
5791256|NCT00139243|Taxotere|taxotere
5791257|NCT00139243|carcinoma of head/neck|carcinoma of head/neck
5791258|NCT00139243|Cisplatin|cisplatin
5791259|NCT00139243|5-Fluorouracil|5-fluorouracil
5791260|NCT00139243|Leucovorin|leucovorin
5791261|NCT00139230|Squamous Cell Carcinoma of Head and Neck|squamous cell carcinoma of head and neck
5791262|NCT00139230|Compressed TPFL|compressed tpfl
5791263|NCT00139230|Taxotere|taxotere
5791264|NCT00139230|Growth Factor Support|growth factor support
5862615|NCT00001566|Tumor Vaccine|tumor vaccine
5791265|NCT00139217|Persistent pulmonary hypertension|persistent pulmonary hypertension
5791266|NCT00139217|Non-invasive inhaled nitric oxide|non-invasive inhaled nitric oxide
5791269|NCT00139204|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5791270|NCT00139204|PET scan|pet scan
5791271|NCT00139204|C11-methionine|c11-methionine
5791272|NCT00139204|positron emission tomography|positron emission tomography
5791273|NCT00139191|Prostate Cancer|prostate cancer
5791274|NCT00139191|positron emission tomography|positron emission tomography
5791275|NCT00139191|carbon 11 acetate|carbon 11 acetate
5791276|NCT00139191|PET|pet
5791277|NCT00139191|fatty acid synthase|fatty acid synthase
5791278|NCT00139191|FAS|fas
5791279|NCT00139165|Collagenous colitis|collagenous colitis
5791280|NCT00139165|Budesonide treatment|budesonide treatment
5791281|NCT00139165|Diarrhea|diarrhea
5791282|NCT00139152|moderate to severe allergic asthma|moderate to severe allergic asthma
5791283|NCT00139139|hepatitis A|hepatitis a
5791284|NCT00139139|hepatitis A vaccine|hepatitis a vaccine
5791290|NCT00139048|shared decision making|shared decision making
5791291|NCT00139048|decision aid|decision aid
5790404|NCT00144014|Acute|acute
5791292|NCT00139048|mammography screening|mammography screening
5791293|NCT00139048|decision support|decision support
5791294|NCT00139035|glucose intolerance|glucose intolerance
5791295|NCT00139035|insulin|insulin
5791296|NCT00139035|microvascular function|microvascular function
5791297|NCT00139035|genotyping|genotyping
5791298|NCT00139035|CYP3A5|cyp3a5
5791299|NCT00139035|pharmacokinetics|pharmacokinetics
5791300|NCT00139035|renal transplantation|renal transplantation
5791301|NCT00139022|sleep apnea, home monitoring, CPAP|sleep apnea, home monitoring, cpap
5791302|NCT00139009|intracellular concentration|intracellular concentration
5791303|NCT00139009|cyclosporine A|cyclosporine a
5791304|NCT00139009|renal biopsies|renal biopsies
5791305|NCT00139009|heart biopsies|heart biopsies
5791306|NCT00139009|Renal transplant recipients|renal transplant recipients
5791307|NCT00138996|cardiac arrest|cardiac arrest
5791308|NCT00138996|resuscitation|resuscitation
5791309|NCT00138996|quality|quality
5791310|NCT00138996|feedback|feedback
5791311|NCT00138996|training|training
5791312|NCT00138983|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
5791314|NCT00138983|prevention|prevention
5791315|NCT00138983|randomized double-blind, double placebo controlled trial|randomized double-blind, double placebo controlled trial
5791316|NCT00138983|alendronate versus alfacalcidol|alendronate versus alfacalcidol
5791317|NCT00138970|Cadaveric donor|cadaveric donor
5791318|NCT00138970|Calcineurine free|calcineurine free
5791319|NCT00138957|Laparoscopic parastomal hernia repair|laparoscopic parastomal hernia repair
5791320|NCT00138957|Intraperitoneally|intraperitoneally
5791321|NCT00138957|Mesh|mesh
5791322|NCT00138957|Quality of life|quality of life
5791490|NCT00138047|children|children
5791323|NCT00138957|Postoperative pain|postoperative pain
5791324|NCT00138957|Recurrence|recurrence
5791325|NCT00138944|Essential hypertension|essential hypertension
5791326|NCT00138931|Cardiomyopathy|cardiomyopathy
5791327|NCT00138931|Arrhythmia|arrhythmia
5791328|NCT00138931|Muscular Dystrophy|muscular dystrophy
5791329|NCT00138918|Prostate Cancer|prostate cancer
5791330|NCT00138918|Clusterin|clusterin
5791331|NCT00138918|Neoadjuvant|neoadjuvant
5791332|NCT00138918|Phase II|phase ii
5791333|NCT00138905|Base station, EMF, human exposure study,Well-being,cognitive|base station, emf, human exposure study,well-being,cognitive
5791334|NCT00138892|Quality of life|quality of life
5791335|NCT00138892|waiting time|waiting time
5791336|NCT00138892|total joint replacement|total joint replacement
5791337|NCT00138879|Citrulline|citrulline
5791338|NCT00138879|Parenteral Nutrition|parenteral nutrition
5791339|NCT00138879|functioning intestinal mass|functioning intestinal mass
5791340|NCT00138879|small bowel permeability and absorption|small bowel permeability and absorption
5791341|NCT00138879|Granulomatous Enteritis|granulomatous enteritis
5791342|NCT00138866|Spinal cord injury|spinal cord injury
5791347|NCT00138840|Crohn's disease|crohn's disease
5791348|NCT00138840|Gastroenterology|gastroenterology
5791349|NCT00138827|Radiotherapy|radiotherapy
5791350|NCT00138827|Mucositis|mucositis
5791351|NCT00138827|Xerostomia|xerostomia
5791352|NCT00138814|Neoplasm recurrence, local|neoplasm recurrence, local
5791353|NCT00138814|Radiotherapy dosage|radiotherapy dosage
5791354|NCT00138814|Cosmesis|cosmesis
5791355|NCT00138814|Mastectomy, segmental|mastectomy, segmental
5791356|NCT00138801|Neuroborreliosis|neuroborreliosis
5791357|NCT00138788|Radiotherapy|radiotherapy
5791358|NCT00138788|Qualify of life|qualify of life
5791359|NCT00138788|Neoplasm metastasis of the brain|neoplasm metastasis of the brain
5791360|NCT00138775|D-serine|d-serine
5791361|NCT00138775|Negative symptoms|negative symptoms
5791362|NCT00138775|Cognition|cognition
5791363|NCT00138775|Schizophrenia|schizophrenia
5791364|NCT00138775|Amino acid|amino acid
5791365|NCT00138736|MBL-deficient|mbl-deficient
5791366|NCT00138736|chemotherapy|chemotherapy
5791367|NCT00138736|neutropenia|neutropenia
5791368|NCT00138736|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia
5791369|NCT00138710|obesity|obesity
5800883|NCT00104559|HIV|hiv
5791370|NCT00138710|Hypogonadotrophic hypogonadism|hypogonadotrophic hypogonadism
5791371|NCT00138710|aromatase inhibition|aromatase inhibition
5791372|NCT00138697|Agammaglobulinemia|agammaglobulinemia
5791373|NCT00138697|Hypogammaglobulinemia|hypogammaglobulinemia
5791374|NCT00138697|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5791375|NCT00138684|insulin resistance|insulin resistance
5791376|NCT00138684|iron overload|iron overload
5791377|NCT00138684|phlebotomy|phlebotomy
5791378|NCT00138684|hepatic iron overload|hepatic iron overload
5791379|NCT00138658|NSCLC|nsclc
5791380|NCT00138658|custirsen sodium|custirsen sodium
5791381|NCT00138658|OGX-011|ogx-011
5791652|NCT00137488|high risk group selection|high risk group selection
5791382|NCT00138658|Stage IIIB or IV advanced non-small cell lung cancer|stage iiib or iv advanced non-small cell lung cancer
5791383|NCT00138632|Wet Age-related macular degeneration|wet age-related macular degeneration
5791384|NCT00138632|PTK787|ptk787
5791385|NCT00138619|Type 2 diabetes|type 2 diabetes
5791386|NCT00138619|vildagliptin|vildagliptin
5791387|NCT00138606|Type 2 diabetes|type 2 diabetes
5791388|NCT00138606|vildagliptin|vildagliptin
5791389|NCT00138593|Type 2 diabetes|type 2 diabetes
5791390|NCT00138593|vildagliptin|vildagliptin
5791391|NCT00138580|Type 2 diabetes|type 2 diabetes
5791392|NCT00138580|vildagliptin|vildagliptin
5791393|NCT00138567|Type 2 diabetes|type 2 diabetes
5791394|NCT00138567|vildagliptin|vildagliptin
5791395|NCT00138554|Type 2 diabetes|type 2 diabetes
5791396|NCT00138554|vildagliptin|vildagliptin
5791397|NCT00138541|type 2 diabetes|type 2 diabetes
5791398|NCT00138541|vildagliptin|vildagliptin
5791399|NCT00138528|Metabolic Syndrome, fluvastatin|metabolic syndrome, fluvastatin
5791400|NCT00138515|Type 2 diabetes|type 2 diabetes
5791401|NCT00138515|vildagliptin|vildagliptin
5791402|NCT00138502|Candidiasis, Funguria|candidiasis, funguria
5791403|NCT00138489|Malaria, Papua New Guinea, infants, children|malaria, papua new guinea, infants, children
5791404|NCT00138476|Norovirus, calicivirus, gastroenteritis, Norwalk virus, challenge|norovirus, calicivirus, gastroenteritis, norwalk virus, challenge
5791405|NCT00138463|West Nile Virus, Neuroinvasive Disease|west nile virus, neuroinvasive disease
5791406|NCT00138450|Schistosomiasis, S. haematobium, morbidity, Kenya|schistosomiasis, s. haematobium, morbidity, kenya
5791408|NCT00138437|Colombia|colombia
5791409|NCT00138424|Vistide®, Cidofovir, renal transplant, BK Virus Nephropathy|vistide®, cidofovir, renal transplant, bk virus nephropathy
5791410|NCT00138411|anthrax, Bacillus anthracis, monoclonal antibody, ETI-204|anthrax, bacillus anthracis, monoclonal antibody, eti-204
5791411|NCT00138398|Influenza, T cell, vaccine, Congestive heart failure|influenza, t cell, vaccine, congestive heart failure
5791412|NCT00138385|inactivated, attenuated, influenza vaccine, FluMist, Fluzone|inactivated, attenuated, influenza vaccine, flumist, fluzone
5791414|NCT00138372|immunity|immunity
5807019|NCT00088686|Vanilloid Receptor (VR)|vanilloid receptor (vr)
5791415|NCT00138372|MSP-1|msp-1
5791416|NCT00138372|Kenya|kenya
5791417|NCT00138372|infants|infants
5791418|NCT00138359|T solium, cysticercus, pig triquina, solitaria, intestinal parasites, Niclosamide, tapeworms, Taeniasis|t solium, cysticercus, pig triquina, solitaria, intestinal parasites, niclosamide, tapeworms, taeniasis
5791419|NCT00138346|hydatid disease, Echinococcus granulosus, tapeworm|hydatid disease, echinococcus granulosus, tapeworm
5791420|NCT00138333|Thimerosal, mercury levels, low birth weight, Argentina|thimerosal, mercury levels, low birth weight, argentina
5791421|NCT00138320|Herpes Simplex, vaccine, antibodies, mother|herpes simplex, vaccine, antibodies, mother
5791422|NCT00138307|malaria, children, naturally acquired immunity, Ghana|malaria, children, naturally acquired immunity, ghana
5791423|NCT00138294|influenza vaccine|influenza vaccine
5791424|NCT00138294|live attenuated influenza vaccine (LAIV or FluMist)|live attenuated influenza vaccine (laiv or flumist)
5791425|NCT00138294|inactivated influenza vaccine (IIV)|inactivated influenza vaccine (iiv)
5791426|NCT00138294|School-based influenza vaccination program|school-based influenza vaccination program
5791427|NCT00138294|children|children
5791428|NCT00138294|herd protection|herd protection
5791429|NCT00138281|influenza, vaccine, respiratory virus, Fluzone, FluMist|influenza, vaccine, respiratory virus, fluzone, flumist
5791430|NCT00138268|umbilical cord blood, vaccine, pregnant women|umbilical cord blood, vaccine, pregnant women
5791431|NCT00138242|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5791432|NCT00138242|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5791433|NCT00138242|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5791434|NCT00138242|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5791435|NCT00138242|fallopian tube cancer|fallopian tube cancer
5791436|NCT00138242|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5791437|NCT00138229|recurrent melanoma|recurrent melanoma
5791438|NCT00138229|stage IV melanoma|stage iv melanoma
5791439|NCT00138216|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5791440|NCT00138216|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5791441|NCT00138216|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5791442|NCT00138216|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5791443|NCT00138216|recurrent childhood brain tumor|recurrent childhood brain tumor
5800984|NCT00104299|MPA|mpa
5791444|NCT00138216|recurrent childhood ependymoma|recurrent childhood ependymoma
5791445|NCT00138216|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5791446|NCT00138216|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5791447|NCT00138216|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5791448|NCT00138216|childhood oligodendroglioma|childhood oligodendroglioma
5791449|NCT00138216|childhood craniopharyngioma|childhood craniopharyngioma
5791450|NCT00138216|childhood choroid plexus tumor|childhood choroid plexus tumor
5791451|NCT00138216|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5791452|NCT00138216|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5791453|NCT00138216|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5791454|NCT00138216|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5791653|NCT00137475|IMRT|imrt
5791455|NCT00138216|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5791456|NCT00138216|childhood grade I meningioma|childhood grade i meningioma
5791457|NCT00138216|childhood grade II meningioma|childhood grade ii meningioma
5791458|NCT00138216|childhood grade III meningioma|childhood grade iii meningioma
5813534|NCT00081926|CML|cml
5791459|NCT00138216|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5791460|NCT00138216|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5791461|NCT00138164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5791462|NCT00138164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5791463|NCT00138164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5791464|NCT00138164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5791465|NCT00138164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5791466|NCT00138151|recurrent cervical cancer|recurrent cervical cancer
5791467|NCT00138151|stage IVB cervical cancer|stage ivb cervical cancer
5791468|NCT00138125|stage IV breast cancer|stage iv breast cancer
5791469|NCT00138125|recurrent breast cancer|recurrent breast cancer
5791470|NCT00138112|Streptococcal Sepsis|streptococcal sepsis
5791471|NCT00138112|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5791472|NCT00138112|Hematologic Malignancies|hematologic malignancies
5791473|NCT00138112|Streptococci|streptococci
5791474|NCT00138112|Transplant|transplant
5791475|NCT00138099|Critically ill patients (ICU)|critically ill patients (icu)
5791476|NCT00138099|Deep Venous Thromboembolism prevention|deep venous thromboembolism prevention
5791477|NCT00138099|Renal Failure|renal failure
5791478|NCT00138099|Critically ill|critically ill
5791479|NCT00138086|lymphoma|lymphoma
5791480|NCT00138086|chemotherapy|chemotherapy
5791481|NCT00138086|Zevalin ( Yttrium-90 Ibritumomab Tiuxetan)|zevalin ( yttrium-90 ibritumomab tiuxetan)
5791482|NCT00138073|pulmonary artery catheter|pulmonary artery catheter
5791483|NCT00138073|waveform interpretation|waveform interpretation
5791484|NCT00138073|computer-based learning|computer-based learning
5791485|NCT00138073|medical education|medical education
5791486|NCT00138060|genotypic profile|genotypic profile
5791487|NCT00138060|metastatic colorectal cancer|metastatic colorectal cancer
5791491|NCT00138034|Open infarct-related artery within 72 hours of thrombolysis|open infarct-related artery within 72 hours of thrombolysis
5791492|NCT00138021|Serious mental illness|serious mental illness
5791493|NCT00138021|Supported Employment|supported employment
5791494|NCT00138021|Cognitive remediation|cognitive remediation
5791495|NCT00138021|Cognitive impairments|cognitive impairments
5791496|NCT00138008|prostate cancer|prostate cancer
5791497|NCT00138008|radical prostatectomy|radical prostatectomy
5791498|NCT00138008|PSA failure|psa failure
5791500|NCT00138008|radiation|radiation
5791501|NCT00138008|endocrinotherapy|endocrinotherapy
5791502|NCT00137995|Lymphoma|lymphoma
5791503|NCT00137995|Chemotherapy|chemotherapy
5791504|NCT00137995|rituximab|rituximab
5791505|NCT00137982|Ectopic pregnancy|ectopic pregnancy
5791506|NCT00137982|Surgical treatment|surgical treatment
5791507|NCT00137982|Medical treatment|medical treatment
5791508|NCT00137982|Fertility|fertility
5791509|NCT00137969|Rituxan|rituxan
5791510|NCT00137969|SLE|sle
5791511|NCT00137969|Lupus|lupus
5791512|NCT00137956|Endobronchial Valve|endobronchial valve
5791513|NCT00137956|Endobronchial Valve ProcedureEBV|endobronchial valve procedureebv
5791514|NCT00137956|EBV Procedure|ebv procedure
5791515|NCT00137956|Endobronchial Lung Volume Reduction|endobronchial lung volume reduction
5791516|NCT00137956|Lung Volume Reduction|lung volume reduction
5791517|NCT00137943|Parent-child communication|parent-child communication
5791518|NCT00137943|Primary prevention|primary prevention
5791519|NCT00137943|sexual risk prevention|sexual risk prevention
5791520|NCT00137943|HIV|hiv
5791521|NCT00137930|Prophylaxis of rotavirus gastroenteritis|prophylaxis of rotavirus gastroenteritis
5791522|NCT00137917|Prophylaxis meningococcal serogroup B disease|prophylaxis meningococcal serogroup b disease
5791523|NCT00137904|multiple sclerosis|multiple sclerosis
5791524|NCT00137904|fatigue|fatigue
5791525|NCT00137904|sleep disorders|sleep disorders
5791526|NCT00137891|Multinodular goiter|multinodular goiter
5791527|NCT00137852|Esophageal Cancer|esophageal cancer
5791528|NCT00137852|Resectable Esophageal Cancer|resectable esophageal cancer
5791529|NCT00137852|Radiation Therapy|radiation therapy
5791530|NCT00137852|Celecoxib|celecoxib
5791531|NCT00137852|Irinotecan|irinotecan
5791532|NCT00137852|Cisplatin|cisplatin
5791533|NCT00137839|Tarceva|tarceva
5791534|NCT00137839|Erlotinib|erlotinib
5791535|NCT00137839|OSI-774|osi-774
5791536|NCT00137839|Adenocarcinoma|adenocarcinoma
5791537|NCT00137839|Advanced Lung Cancer|advanced lung cancer
5791538|NCT00137826|Mesothelioma|mesothelioma
5791539|NCT00137826|Avastin|avastin
5791540|NCT00137826|Bevacizumab|bevacizumab
5791541|NCT00137826|Tarceva|tarceva
5791542|NCT00137826|OSI-774|osi-774
5791543|NCT00137826|Erlotinib|erlotinib
5791544|NCT00137813|Bevacizumab|bevacizumab
5791545|NCT00137813|Docetaxel|docetaxel
5791546|NCT00137813|AvaTax|avatax
5791547|NCT00137813|Metastatic Esophagogastric Cancer|metastatic esophagogastric cancer
5791548|NCT00137800|Non-Small Cell Lung Cancer|non-small cell lung cancer
5791549|NCT00137800|Elderly Cancer Patients|elderly cancer patients
5791550|NCT00137800|Tarceva|tarceva
5791551|NCT00137800|Erlotinib|erlotinib
5791552|NCT00137800|OSI-774|osi-774
5791553|NCT00137800|Stage IIIB or IV Non-Small Cell Lung Cancer|stage iiib or iv non-small cell lung cancer
5791554|NCT00137787|febrile neutropenia|febrile neutropenia
5791555|NCT00137787|hematologic disease|hematologic disease
5791556|NCT00137774|Metastatic Neuroendocrine Tumor|metastatic neuroendocrine tumor
5791557|NCT00137774|Advanced Neuroendocrine tumor|advanced neuroendocrine tumor
5791558|NCT00137774|Bevacizumab|bevacizumab
5791559|NCT00137774|Temozolomide|temozolomide
5791560|NCT00137761|Pancreatic Carcinoma|pancreatic carcinoma
5791561|NCT00137761|Iressa|iressa
5791562|NCT00137761|Docetaxel|docetaxel
5791563|NCT00137748|Lung transplantation|lung transplantation
5791564|NCT00137735|carpal tunnel syndrome|carpal tunnel syndrome
5791565|NCT00137735|gabapentin|gabapentin
5791566|NCT00137722|Asthma|asthma
5791567|NCT00137722|Disease Management|disease management
5791568|NCT00137722|Outcomes|outcomes
5791569|NCT00137722|Utilization|utilization
5791570|NCT00137709|epilepsy|epilepsy
5791571|NCT00137709|hormone|hormone
5791573|NCT00137696|vaccine|vaccine
5791574|NCT00137696|immunogenicity|immunogenicity
5791575|NCT00137683|screening|screening
5791576|NCT00137683|prevention|prevention
5791577|NCT00137683|community health education|community health education
5791578|NCT00137670|Intervention studies|intervention studies
5791579|NCT00137670|HIV|hiv
5791580|NCT00137657|HIV|hiv
5791581|NCT00137657|malaria|malaria
5791582|NCT00137657|E. Coli|e. coli
5791583|NCT00137657|S. pneumoniae|s. pneumoniae
5791584|NCT00137657|drug resistance|drug resistance
5791585|NCT00137657|antifolate|antifolate
5791586|NCT00137657|opportunistic infections|opportunistic infections
5791587|NCT00137657|Africa|africa
5791588|NCT00137657|Kenya|kenya
5791589|NCT00137657|East Africa|east africa
5807165|NCT00088530|Pixantrone|pixantrone
5791590|NCT00137644|Adolescent|adolescent
5791591|NCT00137644|*HIV Infections/ pc [Prevention & Control]|*hiv infections/ pc [prevention & control]
5791592|NCT00137644|Male|male
5791593|NCT00137644|Humans|humans
5791594|NCT00137644|Risk-Taking|risk-taking
5791596|NCT00137644|Sexual Behavior|sexual behavior
5791597|NCT00137644|HIV|hiv
5791598|NCT00137644|HIV Seronegativity|hiv seronegativity
5791599|NCT00137631|Adult|adult
5791600|NCT00137631|HIV Infections / pc [Prevention & Control]|hiv infections / pc [prevention & control]
5791601|NCT00137631|Homosexuality, Male|homosexuality, male
5791602|NCT00137631|Humans|humans
5791603|NCT00137631|Male|male
5791604|NCT00137631|Risk-Taking|risk-taking
5791605|NCT00137631|Safe Sex|safe sex
5791606|NCT00137631|Sexual Behavior|sexual behavior
5791607|NCT00137631|HIV|hiv
5791608|NCT00137618|Prostatic neoplasm|prostatic neoplasm
5791609|NCT00137618|Prostate cancer|prostate cancer
5791610|NCT00137618|Informed decision making|informed decision making
5791611|NCT00137618|Prostate cancer screening|prostate cancer screening
5791612|NCT00137618|Prostate specific antigen|prostate specific antigen
5791613|NCT00137605|HIV|hiv
5791614|NCT00137605|HIV Infections|hiv infections
5791615|NCT00137592|screening|screening
5791616|NCT00137592|community health education|community health education
5791617|NCT00137579|Influenza Vaccines|influenza vaccines
5791618|NCT00137579|Acenocoumarol|acenocoumarol
5791619|NCT00137579|Drug Administration Routes|drug administration routes
5791620|NCT00137579|Anticoagulants|anticoagulants
5791621|NCT00137566|malaria|malaria
5791622|NCT00137566|treatment|treatment
5791623|NCT00137566|paracetamol|paracetamol
5791624|NCT00137566|chloroquine|chloroquine
5791625|NCT00137566|Guinea-Bissau|guinea-bissau
5791626|NCT00137566|children|children
5791627|NCT00137566|P.falciparum|p.falciparum
5791628|NCT00137553|Children|children
5791629|NCT00137553|malaria|malaria
5791630|NCT00137553|sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5791631|NCT00137553|Guinea-Bissau|guinea-bissau
5791632|NCT00137553|treatment|treatment
5791633|NCT00137540|First line ablation therapy|first line ablation therapy
5791634|NCT00137527|Cardiac Surgery|cardiac surgery
5791635|NCT00137527|Cardiopulmonary Bypass|cardiopulmonary bypass
5791636|NCT00137527|Cerebral Oxygenation|cerebral oxygenation
5791637|NCT00137527|Neurologic Dysfunction|neurologic dysfunction
5791638|NCT00137527|Neurocognitive Dysfunction|neurocognitive dysfunction
5791639|NCT00137527|Neurological manifestations|neurological manifestations
5791640|NCT00137527|Memory loss|memory loss
5791641|NCT00137527|Delirium|delirium
5791642|NCT00137527|Coronary Artery Bypass|coronary artery bypass
5791643|NCT00137514|malaria|malaria
5791644|NCT00137514|Plasmodium falciparum|plasmodium falciparum
5791645|NCT00137514|chloroquine|chloroquine
5791646|NCT00137514|amodiaquine|amodiaquine
5791647|NCT00137514|treatment|treatment
5791648|NCT00137514|Guinea-Bissau|guinea-bissau
5791649|NCT00137514|children|children
5791650|NCT00137488|non-enhancing lesion|non-enhancing lesion
5791651|NCT00137488|low grade glioma|low grade glioma
5791654|NCT00137475|head and neck cancer|head and neck cancer
5791655|NCT00137475|parotid sparing|parotid sparing
5791656|NCT00137436|First-line treatment of metastatic hormone-refractory prostate cancer SUTENT in combination with docetaxel and prednisone|first-line treatment of metastatic hormone-refractory prostate cancer sutent in combination with docetaxel and prednisone
5791657|NCT00137384|Magnetoencephalogram|magnetoencephalogram
5791658|NCT00137384|Functional Connectivity|functional connectivity
5791659|NCT00137384|Electroencephalogram (EEG)|electroencephalogram (eeg)
5791660|NCT00137384|Focal Hand Dystonia|focal hand dystonia
5791661|NCT00137384|Spectral Analysis|spectral analysis
5791662|NCT00137384|Healthy Volunteer|healthy volunteer
5791663|NCT00137384|HV|hv
5791664|NCT00137371|Postmenopause|postmenopause
5791665|NCT00137371|Vaginitis|vaginitis
5791666|NCT00137358|Cervical|cervical
5791667|NCT00137358|Uterine|uterine
5791668|NCT00137358|Para-aortic|para-aortic
5791669|NCT00137358|Nodes|nodes
5791670|NCT00137358|IMRT|imrt
5791671|NCT00137358|Cancer|cancer
5791672|NCT00137345|Randomized controlled trial|randomized controlled trial
5791673|NCT00137345|Clinical Trial Phase III|clinical trial phase iii
5791674|NCT00137345|Drug therapy|drug therapy
5791675|NCT00137345|Immunosuppression|immunosuppression
5791676|NCT00137345|Treatment outcome|treatment outcome
5791678|NCT00137345|Kidney function tests|kidney function tests
5791679|NCT00137332|Arrhythmia|arrhythmia
5791680|NCT00137332|antiarrhythmic|antiarrhythmic
5791681|NCT00137332|programmed electrical stimulation|programmed electrical stimulation
5791682|NCT00137319|inspiratory impedance threshold device|inspiratory impedance threshold device
5791683|NCT00137319|blood pressure regulation|blood pressure regulation
5791684|NCT00137319|head-up tilt test|head-up tilt test
5791685|NCT00137319|tilt table testing|tilt table testing
5791686|NCT00137319|burn injury|burn injury
5791687|NCT00137319|Burns|burns
5791688|NCT00137306|Guideline Adherence|guideline adherence
5791689|NCT00137306|Quality Assurance, Health Care|quality assurance, health care
5807240|NCT00002630|stage III multiple myeloma|stage iii multiple myeloma
5807241|NCT00002627|stage II breast cancer|stage ii breast cancer
5807242|NCT00002627|stage IIIA breast cancer|stage iiia breast cancer
5807243|NCT00002627|stage IIIB breast cancer|stage iiib breast cancer
5791690|NCT00137293|Arrhythmia, syncope, antiarrhythmic|arrhythmia, syncope, antiarrhythmic
5791691|NCT00137280|Randomized Controlled Trial|randomized controlled trial
5791692|NCT00137280|Quality of Health Care|quality of health care
5791693|NCT00137280|Health Services Research|health services research
5791695|NCT00137280|Medical Informatics Computing|medical informatics computing
5791696|NCT00137280|Services, Mental Health|services, mental health
5791697|NCT00137280|Medicine, Evidenced-Based|medicine, evidenced-based
5791698|NCT00137280|Quality Assurance, Healthcare|quality assurance, healthcare
5791699|NCT00137280|Quality Indicators, Health Care|quality indicators, health care
5791700|NCT00137280|Veterans|veterans
5791701|NCT00137280|Unemployment|unemployment
5791703|NCT00137280|Quality Improvement|quality improvement
5791704|NCT00137267|Schizophrenia / disorders w psychotic features|schizophrenia / disorders w psychotic features
5791705|NCT00137267|Substance-related disorders|substance-related disorders
5791706|NCT00137267|Community Mental Health Services|community mental health services
5791707|NCT00137267|Case Management|case management
5791708|NCT00137267|Health Education|health education
5791709|NCT00137254|Severe burns|severe burns
5791710|NCT00137254|Hyperinsulinemia|hyperinsulinemia
5791711|NCT00137254|Insulin|insulin
5791712|NCT00137254|Muscle protein kinetics|muscle protein kinetics
5791713|NCT00137254|Immune function|immune function
5791714|NCT00137254|Exercise|exercise
5791715|NCT00137241|health literacy|health literacy
5791716|NCT00137241|screening|screening
5791717|NCT00137241|cancer|cancer
5791718|NCT00137241|health disparities|health disparities
5791719|NCT00137228|Hand Edema|hand edema
5791720|NCT00137228|Figure of eight method|figure of eight method
5791721|NCT00137228|Measuring edema in burn patients|measuring edema in burn patients
5791722|NCT00137215|burns|burns
5791723|NCT00137215|donor site care|donor site care
5791724|NCT00137215|Silverlon dressing|silverlon dressing
5791725|NCT00137202|pruritus|pruritus
5791726|NCT00137202|burn wound|burn wound
5791727|NCT00137189|Motivation|motivation
5791728|NCT00137189|Music Therapy|music therapy
5791729|NCT00137189|Psychotherapy|psychotherapy
5791730|NCT00137176|Clinically Isolated Syndrome|clinically isolated syndrome
5791732|NCT00137163|donor site care|donor site care
5791733|NCT00137163|Dermafill dressing|dermafill dressing
5791734|NCT00137124|Essential hypertension|essential hypertension
5791735|NCT00137111|Leukemia|leukemia
5791736|NCT00137085|procedural sedation|procedural sedation
5791737|NCT00136955|Weekly Irinotecan(60mg/sqm, D1, 8, 15) in combination with Cisplatin (60mg/sqm, D1), Squamous Cell Carcinoma Of The Uterine Cervix|weekly irinotecan(60mg/sqm, d1, 8, 15) in combination with cisplatin (60mg/sqm, d1), squamous cell carcinoma of the uterine cervix
5791738|NCT00136929|AMI|ami
5791739|NCT00136929|MI|mi
5791740|NCT00136929|Acute myocardial infarction (AMI), (MI)|acute myocardial infarction (ami), (mi)
5791741|NCT00136903|Graft vs Host Disease|graft vs host disease
5791742|NCT00136903|GVHD|gvhd
5791743|NCT00136903|Graft Versus Host Disease|graft versus host disease
5791744|NCT00136903|Bone marrow transplant|bone marrow transplant
5791745|NCT00136903|Stem cells|stem cells
5792050|NCT00135694|hepatitis C|hepatitis c
5791748|NCT00136903|Leukemia|leukemia
5791749|NCT00136903|Lymphoma|lymphoma
5791750|NCT00136890|Positron-Emission Tomography|positron-emission tomography
5791751|NCT00136890|PET Scan|pet scan
5791752|NCT00136890|Lung Cancer|lung cancer
5791753|NCT00136890|Thoracic Surgery|thoracic surgery
5791754|NCT00136890|Diagnostic|diagnostic
5791755|NCT00136890|Randomized Controlled Trial|randomized controlled trial
5791756|NCT00136890|Oncology|oncology
5791757|NCT00136877|recurrent tonsillitis|recurrent tonsillitis
5791758|NCT00136877|streptococcus|streptococcus
5791759|NCT00136877|tonsillectomy|tonsillectomy
5791760|NCT00136877|prevention|prevention
5791761|NCT00136864|Positron-Emission Tomography|positron-emission tomography
5791762|NCT00136864|PET Scan|pet scan
5791763|NCT00136864|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5791764|NCT00136864|Diagnosis|diagnosis
5791765|NCT00136864|Radiation Oncology|radiation oncology
5791766|NCT00136864|Lung Cancer|lung cancer
5791767|NCT00136864|Randomized Controlled Trial|randomized controlled trial
5791768|NCT00136864|Oncology|oncology
5791770|NCT00136851|Hypertension|hypertension
5791771|NCT00136838|tobacco use|tobacco use
5791773|NCT00136825|treatment|treatment
5791774|NCT00136812|tobacco|tobacco
5791775|NCT00136799|Mixed Dyslipidemia|mixed dyslipidemia
5791776|NCT00136799|high cholesterol|high cholesterol
5791777|NCT00136799|adults|adults
5791778|NCT00136799|fluvastatin|fluvastatin
5791779|NCT00136786|tobacco use|tobacco use
5791780|NCT00136773|Albuminuria|albuminuria
5791781|NCT00136773|Type 2 diabetes mellitus|type 2 diabetes mellitus
5791782|NCT00136773|Hypertension|hypertension
5791783|NCT00136760|tobacco|tobacco
5791784|NCT00136747|tobacco use|tobacco use
5791785|NCT00136734|ADHD|adhd
5791786|NCT00136734|Cocaine dependence|cocaine dependence
5791787|NCT00136734|treatment|treatment
5791788|NCT00136734|methylphenidate|methylphenidate
5791789|NCT00136721|Parkinson's disease|parkinson's disease
5791790|NCT00136721|phenotype-genotype correlations|phenotype-genotype correlations
5791791|NCT00136721|mutations spectrum|mutations spectrum
5791792|NCT00136721|candidate genes|candidate genes
5791793|NCT00136708|Global Network|global network
5791794|NCT00136708|Neonatal mortality|neonatal mortality
5791795|NCT00136708|Asphyxia|asphyxia
5791796|NCT00136708|Maternal and child health|maternal and child health
5791797|NCT00136708|International|international
5791798|NCT00136708|Zambia|zambia
5791799|NCT00136708|Pakistan|pakistan
5791800|NCT00136708|India|india
5791801|NCT00136708|Democratic Republic of Congo|democratic republic of congo
5791802|NCT00136708|Uruguay|uruguay
5791803|NCT00136708|Guatemala|guatemala
5791804|NCT00136708|Argentina|argentina
5791805|NCT00136708|Neonatal resuscitation|neonatal resuscitation
5791806|NCT00136695|Aging|aging
5791807|NCT00136682|Major abdominal or pelvic surgery|major abdominal or pelvic surgery
5791808|NCT00136682|Patient-Controlled Epidural Analgesia (PCEA)|patient-controlled epidural analgesia (pcea)
5791809|NCT00136682|Length of hospital stay after surgery|length of hospital stay after surgery
5791810|NCT00136669|Acupuncture|acupuncture
5791811|NCT00136669|Pain|pain
5791812|NCT00136669|Pancreatic Neoplasms|pancreatic neoplasms
5791813|NCT00136656|infant|infant
5791814|NCT00136656|children|children
5791815|NCT00136656|pyelonephritis|pyelonephritis
5791816|NCT00136656|Renal scars|renal scars
5791817|NCT00136656|DMSA scan|dmsa scan
5791818|NCT00136643|microbicide|microbicide
5791819|NCT00136643|Women|women
5791820|NCT00136643|Prevention|prevention
5791821|NCT00136643|HIV|hiv
5791822|NCT00136643|STIs|stis
5791823|NCT00136643|HIV Seronegativity|hiv seronegativity
5791824|NCT00136643|prevention of sexually transmitted infections including HIV.|prevention of sexually transmitted infections including hiv.
5791825|NCT00136630|dominant spinocerebellar degenerations|dominant spinocerebellar degenerations
5791826|NCT00136630|new rate scales|new rate scales
5791827|NCT00136630|natural history|natural history
5791828|NCT00136630|molecular biology|molecular biology
5791829|NCT00136630|candidate genes|candidate genes
5791830|NCT00136617|Short Alcohol Withdrawal Scale|short alcohol withdrawal scale
5791831|NCT00136617|Documentation|documentation
5791834|NCT00136591|follicular lymphoma|follicular lymphoma
5791835|NCT00136591|bortezomib|bortezomib
5791837|NCT00136578|solid tumors|solid tumors
5791838|NCT00136578|dose limiting toxicity|dose limiting toxicity
5791839|NCT00136578|carboplatin|carboplatin
5791840|NCT00136578|tolerability|tolerability
5791842|NCT00136565|peripheral T-cell lymphomas|peripheral t-cell lymphomas
5791843|NCT00136565|bortezomib|bortezomib
5791844|NCT00136565|ACVBP regimen|acvbp regimen
5791845|NCT00136552|lymphoma|lymphoma
5791846|NCT00136552|follicular|follicular
5791847|NCT00136552|B-cell|b-cell
5791848|NCT00136552|rituximab|rituximab
5791849|NCT00136552|interferon|interferon
5791850|NCT00136539|Breast Cancer|breast cancer
5791851|NCT00136539|Early Stage Breast Cancer|early stage breast cancer
5791852|NCT00136539|HER2-positive|her2-positive
5791853|NCT00136539|HER2-positive breast cancer|her2-positive breast cancer
5791854|NCT00136539|Herceptin|herceptin
5791855|NCT00136539|Taxol|taxol
5791856|NCT00136539|Stage II Breast Cancer|stage ii breast cancer
5791857|NCT00136539|Stage III Breast Cancer|stage iii breast cancer
5791858|NCT00136526|Prostate Cancer|prostate cancer
5791859|NCT00136526|Hormone refractory prostate cancer|hormone refractory prostate cancer
5791860|NCT00136526|Metastatic prostate cancer|metastatic prostate cancer
5791861|NCT00136513|Safety|safety
5791862|NCT00136513|tolerability|tolerability
5791863|NCT00136513|dose limiting toxicity|dose limiting toxicity
5791864|NCT00136513|solid tumors|solid tumors
5791865|NCT00136500|genetics|genetics
5791866|NCT00136500|biomarkers|biomarkers
5791867|NCT00136500|pre-symptomatic|pre-symptomatic
5791868|NCT00136500|natural history|natural history
5791869|NCT00136487|Prostate Cancer|prostate cancer
5791870|NCT00136487|Cancer of Prostate|cancer of prostate
5791871|NCT00136487|Cancer of the Prostate|cancer of the prostate
5791872|NCT00136487|Prostate-Specific Antigen|prostate-specific antigen
5791873|NCT00136474|Lymphoma|lymphoma
5791874|NCT00136474|Radiation therapy|radiation therapy
5791875|NCT00136474|Amifostine|amifostine
5791876|NCT00136461|AML|aml
5791877|NCT00136461|acute myelogenous leukemia|acute myelogenous leukemia
5791878|NCT00136461|MDS|mds
5791879|NCT00136461|myelodysplastic syndrome|myelodysplastic syndrome
5791880|NCT00136461|bryostatin 1|bryostatin 1
5791881|NCT00136461|all-trans retinoic acid|all-trans retinoic acid
5791882|NCT00136461|ATRA|atra
5791883|NCT00136448|AML|aml
5791884|NCT00136448|acute myelogenous leukemia|acute myelogenous leukemia
5791885|NCT00136448|cytarabine|cytarabine
5791886|NCT00136448|interleukin-2|interleukin-2
5791887|NCT00136435|ALL|all
5791888|NCT00136435|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5791889|NCT00136435|chemotherapy|chemotherapy
5791890|NCT00136435|asparaginase|asparaginase
5791891|NCT00136422|AML|aml
5791892|NCT00136422|acute myelogenous leukemia|acute myelogenous leukemia
5791893|NCT00136422|MDS|mds
5791894|NCT00136422|myelodysplasia|myelodysplasia
5791895|NCT00136422|vaccine|vaccine
5791897|NCT00136409|agnogenic myeloid metaplasia with myelofibrosis|agnogenic myeloid metaplasia with myelofibrosis
5791898|NCT00136409|CMML|cmml
5791899|NCT00136409|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5791900|NCT00136409|imatinib mesylate|imatinib mesylate
5791901|NCT00136409|Gleevec|gleevec
5792100|NCT00135577|opioids|opioids
5791902|NCT00136396|Steroid-refractory Chronic Graft vs. Host Disease|steroid-refractory chronic graft vs. host disease
5791903|NCT00136396|Chronic Graft vs. Host Disease|chronic graft vs. host disease
5791904|NCT00136396|GVHD|gvhd
5791905|NCT00136396|steroid-refractory|steroid-refractory
5791906|NCT00136396|rituximab|rituximab
5791907|NCT00136370|Chlorhexidine|chlorhexidine
5791908|NCT00136370|Prevention|prevention
5791909|NCT00136370|Neonatal sepsis|neonatal sepsis
5791910|NCT00136370|Peripartum infections|peripartum infections
5791911|NCT00136357|posttraumatic stress|posttraumatic stress
5791912|NCT00136357|mind-body techniques|mind-body techniques
5791913|NCT00136357|war|war
5791914|NCT00136357|adolescents|adolescents
5791915|NCT00136344|cataract surgery|cataract surgery
5791916|NCT00136344|phacoemulsification|phacoemulsification
5791917|NCT00136344|post-operative endophthalmitis|post-operative endophthalmitis
5791918|NCT00136331|Pandemic|pandemic
5791919|NCT00136331|Influenza|influenza
5791920|NCT00136331|Prevention|prevention
5791921|NCT00136331|Vaccine|vaccine
5791922|NCT00136331|Prevention of Pandemic Influenza|prevention of pandemic influenza
5791923|NCT00136318|Pegasys-Induced depression|pegasys-induced depression
5791924|NCT00136305|pediatric asthma|pediatric asthma
5791925|NCT00136305|asthma action plans|asthma action plans
5791926|NCT00136305|patient education|patient education
5791927|NCT00136305|medication adherence|medication adherence
5791928|NCT00136292|Gram-Positive Infection|gram-positive infection
5791929|NCT00136279|adolescent behavior|adolescent behavior
5791930|NCT00136279|sexual behavior|sexual behavior
5791931|NCT00136279|smoking|smoking
5791932|NCT00136279|parents|parents
5791933|NCT00136279|communication|communication
5791934|NCT00136279|health education|health education
5791935|NCT00136279|schools|schools
5791936|NCT00136279|Sexual initiation|sexual initiation
5791937|NCT00136266|Adherence|adherence
5791938|NCT00136266|Supplements|supplements
5791939|NCT00136266|Iron|iron
5791940|NCT00136266|Iron deficiency|iron deficiency
5791941|NCT00136266|Anemia|anemia
5791942|NCT00136266|Vitamins|vitamins
5791943|NCT00136266|Minerals|minerals
5791944|NCT00136227|screening,|screening,
5791945|NCT00136227|community health education,|community health education,
5791946|NCT00136227|decision making,|decision making,
5791947|NCT00136227|computer-assisted decision making|computer-assisted decision making
5791948|NCT00136201|Peritonitis|peritonitis
5791949|NCT00136201|Community-Acquired Infections|community-acquired infections
5791950|NCT00136201|Cross Infection|cross infection
5791951|NCT00136188|Prediabetes|prediabetes
5791952|NCT00136188|Metabolic Syndrome|metabolic syndrome
5791953|NCT00136188|Healthy Controls|healthy controls
5791954|NCT00136188|Endothelial function|endothelial function
5791955|NCT00136175|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5791956|NCT00136110|ALS|als
5791957|NCT00136110|Sodium Valproate|sodium valproate
5791958|NCT00136110|randomised trial|randomised trial
5791959|NCT00136110|Amyotrophic Lateral Sclerosis (ALS)|amyotrophic lateral sclerosis (als)
5791960|NCT00136097|colonisation of the catheter|colonisation of the catheter
5791961|NCT00136084|Leukemia,Erythroblastic, Acute|leukemia,erythroblastic, acute
5791962|NCT00136084|Erythroblastic Leukemia, Acute|erythroblastic leukemia, acute
5791963|NCT00136084|Leukemia, Myeloid, Acute|leukemia, myeloid, acute
5791964|NCT00136084|Myeloid Leukemia, Acute|myeloid leukemia, acute
5791965|NCT00136071|Stress Urinary Incontinence,|stress urinary incontinence,
5791966|NCT00136071|TOT,|tot,
5791967|NCT00136071|TVT-O|tvt-o
5791968|NCT00136058|osteoporosis|osteoporosis
5791969|NCT00136058|hip fracture|hip fracture
5791970|NCT00136045|Idiopathic RLS|idiopathic rls
5791971|NCT00136032|Growth Hormone|growth hormone
5791972|NCT00136032|Cardiovascular risk|cardiovascular risk
5791973|NCT00136032|Pituitary|pituitary
5791974|NCT00136032|Hypothalamic|hypothalamic
5791975|NCT00136032|GH Deficiency|gh deficiency
5791976|NCT00136032|Pituitary Tumor|pituitary tumor
5791977|NCT00136032|Pituitary Disease|pituitary disease
5791978|NCT00136019|Epilepsy with partial seizures|epilepsy with partial seizures
5791979|NCT00136006|Epidemiology|epidemiology
5791980|NCT00136006|Lung health|lung health
5791981|NCT00136006|lung function|lung function
5807535|NCT00005805|fatigue|fatigue
5791982|NCT00136006|COPD|copd
5791983|NCT00135993|Idiopathic Restless Leg syndrome|idiopathic restless leg syndrome
5791984|NCT00135967|membranous nephropathy|membranous nephropathy
5791985|NCT00135967|mycophenolate mofetil|mycophenolate mofetil
5791986|NCT00135967|cyclophosphamide|cyclophosphamide
5791987|NCT00135967|prednisone|prednisone
5791988|NCT00135954|membranous nephropathy|membranous nephropathy
5791989|NCT00135954|cyclophosphamide|cyclophosphamide
5791990|NCT00135954|prednisone|prednisone
5791991|NCT00135941|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5791992|NCT00135928|ST-elevation myocardial infarction|st-elevation myocardial infarction
5791993|NCT00135928|granulocyte-colony stimulating factor angiogenesis|granulocyte-colony stimulating factor angiogenesis
5791994|NCT00135928|stem cells|stem cells
5791995|NCT00135902|Preterm birth|preterm birth
5791996|NCT00135902|Progesterone|progesterone
5791997|NCT00135902|Omega-3 fatty acid|omega-3 fatty acid
5791998|NCT00135902|Pregnancy|pregnancy
5792099|NCT00135590|Body composition|body composition
5791999|NCT00135889|Total Knee Arthroplasty secondary to osteoarthritis|total knee arthroplasty secondary to osteoarthritis
5792000|NCT00135876|deep vein thrombosis|deep vein thrombosis
5792001|NCT00135876|pulmonary embolism|pulmonary embolism
5792002|NCT00135876|glioma|glioma
5792003|NCT00135876|fragmin|fragmin
5792004|NCT00135876|anticoagulant|anticoagulant
5792005|NCT00135876|prophylaxis|prophylaxis
5792006|NCT00135876|dalteparin|dalteparin
5792007|NCT00135850|Gene therapy|gene therapy
5792008|NCT00135850|VEGF|vegf
5792009|NCT00135850|Stem cells|stem cells
5792010|NCT00135850|myocardial ischemia|myocardial ischemia
5792011|NCT00135850|angiogenesis|angiogenesis
5792012|NCT00135837|Age related Macula Degeneration,|age related macula degeneration,
5792013|NCT00135837|AMD,|amd,
5792014|NCT00135837|choroidal neovascularisation (CNV),|choroidal neovascularisation (cnv),
5792015|NCT00135837|occult CNV lesion,|occult cnv lesion,
5792016|NCT00135837|verteporfin for injection,|verteporfin for injection,
5792017|NCT00135837|photodynamic therapy (PDT)|photodynamic therapy (pdt)
5792018|NCT00135824|Artificial eye drops|artificial eye drops
5792019|NCT00135824|tolerability|tolerability
5792020|NCT00135824|healthy volunteers|healthy volunteers
5792021|NCT00135824|povidone|povidone
5792022|NCT00135824|healthy subjects|healthy subjects
5792023|NCT00135811|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5792024|NCT00135798|Hepatitis C|hepatitis c
5792025|NCT00135798|Ribavirin|ribavirin
5792026|NCT00135798|PegInterferon alfa2b|peginterferon alfa2b
5792027|NCT00135772|nicotine dependence|nicotine dependence
5792028|NCT00135759|opiate dependence|opiate dependence
5792029|NCT00135746|tobacco|tobacco
5792030|NCT00135733|Lichen Planus|lichen planus
5792031|NCT00135733|Mucosal lichen planus|mucosal lichen planus
5792032|NCT00135733|Alefacept|alefacept
5792033|NCT00135733|T-cell mediated|t-cell mediated
5792034|NCT00135733|subcutaneous medication|subcutaneous medication
5792035|NCT00135733|Autoimmune disease|autoimmune disease
5792036|NCT00135720|Pemphigus Vulgaris|pemphigus vulgaris
5792037|NCT00135720|Chronic Pemphigus|chronic pemphigus
5792038|NCT00135720|Etanercept|etanercept
5792039|NCT00135720|Enbrel|enbrel
5792040|NCT00135720|anti-TNF-alpha|anti-tnf-alpha
5792041|NCT00135720|TNF-alpha antagonist|tnf-alpha antagonist
5792042|NCT00135720|biologic|biologic
5792043|NCT00135720|immunomodulator|immunomodulator
5792044|NCT00135720|subcutaneous medication|subcutaneous medication
5792045|NCT00135707|Antioxidants|antioxidants
5792046|NCT00135707|Preeclampsia|preeclampsia
5792047|NCT00135707|Pregnancy|pregnancy
5792048|NCT00135707|Hypertension|hypertension
5792049|NCT00135694|hepatitis|hepatitis
5792052|NCT00135694|liver|liver
5792053|NCT00135694|liver disease|liver disease
5792054|NCT00135694|liver transplant|liver transplant
5792055|NCT00135694|liver transplantation|liver transplantation
5792056|NCT00135694|transplant|transplant
5792057|NCT00135694|hepatic|hepatic
5792058|NCT00135694|hepatic transplantation|hepatic transplantation
5792059|NCT00135694|immunosuppression|immunosuppression
5792060|NCT00135694|rejection|rejection
5792061|NCT00135668|children|children
5792062|NCT00135668|sodium nitroprusside|sodium nitroprusside
5792063|NCT00135668|controlled hypotension|controlled hypotension
5792064|NCT00135668|dose-response|dose-response
5792065|NCT00135668|pharmacokinetics|pharmacokinetics
5792066|NCT00135668|pharmacodynamics|pharmacodynamics
5792067|NCT00135668|safety|safety
5792068|NCT00135668|efficacy|efficacy
5792069|NCT00135655|macular edema|macular edema
5792070|NCT00135655|post cataract extraction|post cataract extraction
5792071|NCT00135655|cystoid macular edema|cystoid macular edema
5792072|NCT00135655|post cataract extraction macular edema|post cataract extraction macular edema
5792073|NCT00135642|Hayfever|hayfever
5792074|NCT00135642|Subcutaneous Immunotherapy|subcutaneous immunotherapy
5792075|NCT00135642|Grass pollen immunotherapy|grass pollen immunotherapy
5792076|NCT00135642|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5792078|NCT00135629|Sublingual Immunotherapy|sublingual immunotherapy
5792079|NCT00135629|Grass pollen immunotherapy|grass pollen immunotherapy
5792080|NCT00135629|Late cutaneous response|late cutaneous response
5792081|NCT00135629|Intradermal allergen challenge|intradermal allergen challenge
5792082|NCT00135629|Seasonal Allergic Rhinoconjunctivitis|seasonal allergic rhinoconjunctivitis
5792083|NCT00135616|urinary incontinence|urinary incontinence
5792084|NCT00135616|stress incontinence|stress incontinence
5792085|NCT00135616|urethra|urethra
5792086|NCT00135616|gynaecologic surgical procedures|gynaecologic surgical procedures
5792087|NCT00135616|suburethral sling|suburethral sling
5792088|NCT00135603|appendicitis.|appendicitis.
5792089|NCT00135603|adult.|adult.
5792091|NCT00135603|antibiotic therapy.|antibiotic therapy.
5792092|NCT00135603|CT scanning.|ct scanning.
5792093|NCT00135603|randomized trial|randomized trial
5792094|NCT00135603|safety|safety
5792095|NCT00135590|Protein pulse-feeding|protein pulse-feeding
5792096|NCT00135590|Nutritional supplementation|nutritional supplementation
5792097|NCT00135590|Protein-energy malnutrition|protein-energy malnutrition
5792098|NCT00135590|Elderly subjects|elderly subjects
5792101|NCT00135577|constipation|constipation
5792102|NCT00135577|opioid-induced bowel dysfunction|opioid-induced bowel dysfunction
5792103|NCT00135564|Haemophilus Influenzae type b/Meningococcal (vaccine)|haemophilus influenzae type b/meningococcal (vaccine)
5792104|NCT00135564|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
5792105|NCT00135551|Hypertension|hypertension
5792106|NCT00135551|Multicenter clinical trial|multicenter clinical trial
5792108|NCT00135551|Combination therapy|combination therapy
5792109|NCT00135551|Benidipine|benidipine
5792110|NCT00135551|Essential Hypertension|essential hypertension
5792111|NCT00135538|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5792112|NCT00135538|Intermittent Positive-Pressure Ventilation|intermittent positive-pressure ventilation
5792113|NCT00135538|Rehabilitation|rehabilitation
5792114|NCT00135525|Generalized Anxiety Disorder|generalized anxiety disorder
5792115|NCT00135512|MDD|mdd
5792116|NCT00135499|Lymphoma|lymphoma
5792117|NCT00135499|chemotherapy|chemotherapy
5792118|NCT00135499|rituximab|rituximab
5792119|NCT00135486|Haemophilus Influenzae type b/Meningococcal vaccine|haemophilus influenzae type b/meningococcal vaccine
5792120|NCT00135486|Prophylaxis meningococcal serogroup C disease, Hib diseases|prophylaxis meningococcal serogroup c disease, hib diseases
5792121|NCT00135473|Severe sepsis|severe sepsis
5792122|NCT00135473|septic shock|septic shock
5792123|NCT00135473|volume substitution|volume substitution
5792124|NCT00135473|intensive insulin therapy|intensive insulin therapy
5792125|NCT00135473|colloids|colloids
5792126|NCT00135473|crystalloids|crystalloids
5792127|NCT00135473|outcome|outcome
5792128|NCT00135473|safety|safety
5792129|NCT00135460|HIV|hiv
5792130|NCT00135460|Lipoatrophy|lipoatrophy
5792131|NCT00135460|Lipodystrophy|lipodystrophy
5792132|NCT00135460|Treatment Naive|treatment naive
5792133|NCT00135460|HIV Infections|hiv infections
5792134|NCT00135460|Hypercholesterolemia|hypercholesterolemia
5792135|NCT00135447|HIV/AIDS|hiv/aids
5792136|NCT00135447|Treatment Experienced|treatment experienced
5792137|NCT00135408|Unresectable Stage III or IV Malignant Melanoma|unresectable stage iii or iv malignant melanoma
5792138|NCT00135395|HIV/AIDS|hiv/aids
5792139|NCT00135395|Treatment Experienced|treatment experienced
5792140|NCT00135382|HIV/AIDS|hiv/aids
5792141|NCT00135369|HIV-AIDS|hiv-aids
5792142|NCT00135356|HIV infections|hiv infections
5792143|NCT00135343|HIV/AIDS|hiv/aids
5792144|NCT00135330|diabetes|diabetes
5792145|NCT00135330|exenatide|exenatide
5792146|NCT00135330|rosiglitazone|rosiglitazone
5792147|NCT00135330|Amylin|amylin
5792148|NCT00135330|Lilly|lilly
5792149|NCT00135317|oncology|oncology
5792150|NCT00135317|darbepoetin alfa|darbepoetin alfa
5792151|NCT00135317|Aranesp®|aranesp®
5792152|NCT00135317|Amgen|amgen
5792153|NCT00135317|Non-myeloid malignancy|non-myeloid malignancy
5792154|NCT00135304|Vitamin D|vitamin d
5792155|NCT00135304|Sensipar®|sensipar®
5792156|NCT00135304|Cinacalcet HCl|cinacalcet hcl
5792157|NCT00135304|Chronic Kidney Disease|chronic kidney disease
5792158|NCT00135291|transfusion-induced immunomodulation|transfusion-induced immunomodulation
5792159|NCT00135291|leukoreduction|leukoreduction
5792160|NCT00135291|surgical site infections|surgical site infections
5791268|NCT00139204|Prostate cancer|prostate cancer
5792161|NCT00135291|nosocomial infections|nosocomial infections
5792162|NCT00135291|transfusion|transfusion
5792163|NCT00135291|Infection|infection
5792164|NCT00135291|Sepsis|sepsis
5792165|NCT00135291|Hemorrhage|hemorrhage
5792166|NCT00135278|Neuroprotection|neuroprotection
5792167|NCT00135278|inflammation|inflammation
5792168|NCT00135278|cytokines|cytokines
5792169|NCT00135278|CSF|csf
5792170|NCT00135265|smoking cessation|smoking cessation
5792171|NCT00135265|adolescents|adolescents
5792172|NCT00135252|developing chronic lung disease|developing chronic lung disease
5792173|NCT00135239|back|back
5792174|NCT00135239|Lower Mechanical Back Pain|lower mechanical back pain
5792175|NCT00135239|Rehabilitation|rehabilitation
5792176|NCT00135226|Diabetes Mellitus|diabetes mellitus
5792177|NCT00135226|Cardiovascular Disease|cardiovascular disease
5792178|NCT00135226|Aspirin|aspirin
5792179|NCT00135226|Omega-3 fatty acids|omega-3 fatty acids
5792180|NCT00135226|Primary prevention|primary prevention
5792181|NCT00135226|Randomized Controlled Trial|randomized controlled trial
5792182|NCT00135226|Type 1 Diabetes Mellitus|type 1 diabetes mellitus
5792183|NCT00135226|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5792184|NCT00135226|n-3 fatty acid|n-3 fatty acid
5792185|NCT00135213|passive smoking|passive smoking
5792186|NCT00135213|pediatric practice|pediatric practice
5792187|NCT00135213|smoking cessation|smoking cessation
5792188|NCT00135174|Pacemaker|pacemaker
5792189|NCT00135174|routine|routine
5792190|NCT00135174|follow-up|follow-up
5792191|NCT00135174|complications|complications
5792192|NCT00135174|Quality of Life|quality of life
5792193|NCT00135161|neoplasms (squamous cell carcinoma of the head and neck region)|neoplasms (squamous cell carcinoma of the head and neck region)
5792194|NCT00135135|Cancer|cancer
5792195|NCT00135135|Childhood Tumor|childhood tumor
5792196|NCT00135135|Neoplasms|neoplasms
5792197|NCT00135122|migraine|migraine
5792198|NCT00135122|analgesics|analgesics
5792199|NCT00135122|tension type headache|tension type headache
5792200|NCT00135070|Diabetes Mellitus|diabetes mellitus
5792201|NCT00135044|taurine|taurine
5792202|NCT00135044|intestinal failure|intestinal failure
5792203|NCT00135044|HPN|hpn
5792204|NCT00135044|hepatobiliary complications|hepatobiliary complications
5792205|NCT00135044|chronic intestinal failure (CIF)|chronic intestinal failure (cif)
5792206|NCT00135005|GIST|gist
5792207|NCT00135005|AMN107|amn107
5792208|NCT00135005|Gastrointestinal Stromal Tumors|gastrointestinal stromal tumors
5792209|NCT00134992|Prednisolone acetate|prednisolone acetate
5792210|NCT00134992|eye drops|eye drops
5792211|NCT00134992|tolerability|tolerability
5792212|NCT00134992|Healthy volunteers|healthy volunteers
5792213|NCT00134979|COPD, formoterol,|copd, formoterol,
5792214|NCT00134966|Parkinson's disease, levodopa, dyskinesia|parkinson's disease, levodopa, dyskinesia
5792215|NCT00134953|Mild cognitive impairment|mild cognitive impairment
5792216|NCT00134953|Alzheimer's disease|alzheimer's disease
5792217|NCT00134953|Dementia|dementia
5792218|NCT00134953|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5792219|NCT00134940|Transplantation, heart|transplantation, heart
5792220|NCT00134940|Organ transplant|organ transplant
5792221|NCT00134914|opiate dependence|opiate dependence
5792222|NCT00134901|Cocaine dependence|cocaine dependence
5792223|NCT00134901|treatment|treatment
5792224|NCT00134901|memantine|memantine
5792225|NCT00134888|Opioid Dependence|opioid dependence
5792226|NCT00134875|opioid dependence|opioid dependence
5792227|NCT00134849|hypertension|hypertension
5792228|NCT00134823|Parent Experience of Care|parent experience of care
5792230|NCT00134823|Medication Errors|medication errors
5792231|NCT00134823|Abnormal Lab Values|abnormal lab values
5792232|NCT00134823|Guideline Adherence|guideline adherence
5792233|NCT00134810|Myofascial pain syndrome|myofascial pain syndrome
5792234|NCT00134797|GFR|gfr
5792235|NCT00134797|serum creatinine|serum creatinine
5792236|NCT00134784|parkinson|parkinson
5792237|NCT00134784|brain imaging|brain imaging
5792238|NCT00134771|Infants whose birthweight is less than the 20th centile for gestational age (UK standards)|infants whose birthweight is less than the 20th centile for gestational age (uk standards)
5792239|NCT00134771|Infants who are formula fed from birth|infants who are formula fed from birth
5792240|NCT00134771|Singletons|singletons
5792241|NCT00134771|Infants free from major congenital disease|infants free from major congenital disease
5792242|NCT00134758|Treatment of adenomas of the duodenum in FAP patients.|treatment of adenomas of the duodenum in fap patients.
5792243|NCT00134758|Adenoma|adenoma
5792244|NCT00134745|Turner Syndrome|turner syndrome
5792245|NCT00134745|Hormonal replacement therapy|hormonal replacement therapy
5792246|NCT00134745|Bone mineralization|bone mineralization
5792247|NCT00134745|Uterine size|uterine size
5792248|NCT00134745|aortic root dilatation|aortic root dilatation
5792249|NCT00134732|Prophylaxis of Rotavirus Gastroenteritis|prophylaxis of rotavirus gastroenteritis
5792250|NCT00134719|Invasive Hib & N. meningitidis diseases|invasive hib & n. meningitidis diseases
5792251|NCT00134706|Prostate Cancer|prostate cancer
5792252|NCT00134706|Cancer of the prostate|cancer of the prostate
5792253|NCT00134706|Cancer of prostate|cancer of prostate
5792254|NCT00134706|Docetaxel|docetaxel
5686490|NCT00551837|Chroinic Kidney Disease|chroinic kidney disease
5792255|NCT00134706|Carboplatin|carboplatin
5792256|NCT00134693|SB-681323 rheumatoid arthritis CRP biomarkers|sb-681323 rheumatoid arthritis crp biomarkers
5792257|NCT00134680|estrogen receptor positive|estrogen receptor positive
5792258|NCT00134680|progesterone receptor positive|progesterone receptor positive
5792259|NCT00134680|ErbB2 positive|erbb2 positive
5792260|NCT00134680|metastatic breast cancer|metastatic breast cancer
5792261|NCT00134667|AMD|amd
5792262|NCT00134667|Age-Related Macular Degeneration|age-related macular degeneration
5792263|NCT00134667|Macular Degeneration|macular degeneration
5792264|NCT00134667|Macugen|macugen
5792265|NCT00134667|Photodynamic Therapy|photodynamic therapy
5792266|NCT00134667|PDT|pdt
5792267|NCT00134667|Visudyne|visudyne
5792268|NCT00134667|pegaptanib sodium|pegaptanib sodium
5792270|NCT00134667|Predominantly Classic|predominantly classic
5846711|NCT00043667|Interleukin 2|interleukin 2
5792271|NCT00134667|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5792272|NCT00134654|Androgen-independent prostate cancer|androgen-independent prostate cancer
5792273|NCT00134654|Premarin|premarin
5792274|NCT00134654|conjugated estrogen|conjugated estrogen
5792275|NCT00134641|soft tissue sarcoma|soft tissue sarcoma
5792276|NCT00134641|metastatic soft tissue sarcoma|metastatic soft tissue sarcoma
5792277|NCT00134641|gemcitabine|gemcitabine
5792278|NCT00134641|vinorelbine|vinorelbine
5792279|NCT00134628|Hyperbaric Oxygenation|hyperbaric oxygenation
5792280|NCT00134628|Radiation injuries|radiation injuries
5792281|NCT00134628|Prophylaxis|prophylaxis
5792282|NCT00134628|Proctitis|proctitis
5792283|NCT00134628|Cystitis|cystitis
5792284|NCT00134628|Enteritis|enteritis
5792285|NCT00134628|Osteoradionecrosis|osteoradionecrosis
5792286|NCT00134615|decision-making|decision-making
5792287|NCT00134615|patient activation|patient activation
5792288|NCT00134615|empowerment|empowerment
5792289|NCT00134615|mental health|mental health
5792290|NCT00134615|Depression|depression
5792291|NCT00134615|Anxiety|anxiety
5795720|NCT00121719|lymphomas|lymphomas
5792292|NCT00134615|Other Psychiatric Disorder|other psychiatric disorder
5792293|NCT00134602|HIV infection, antiretroviral therapy, adherence, pediatric|hiv infection, antiretroviral therapy, adherence, pediatric
5792294|NCT00134589|Academic Detailing|academic detailing
5792295|NCT00134589|Decision Aid|decision aid
5792296|NCT00134589|Colorectal Cancer Screening|colorectal cancer screening
5792297|NCT00134589|RECTAL NEOPLASMS|rectal neoplasms
5792298|NCT00134589|COLONIC POLYPS|colonic polyps
5792299|NCT00134563|Multiple Sclerosis|multiple sclerosis
5792300|NCT00134563|Relapsing Remitting|relapsing remitting
5792301|NCT00134563|Secondary Progressive|secondary progressive
5792302|NCT00134563|Progressive Relapsing|progressive relapsing
5792303|NCT00134550|Diabetes Mellitus|diabetes mellitus
5792304|NCT00134550|Foot ulcers|foot ulcers
5792305|NCT00134550|Complication|complication
5792306|NCT00134550|Foot Ulcer, Diabetic|foot ulcer, diabetic
5792307|NCT00134537|Degenerative Disc Disease of the lumbar spine|degenerative disc disease of the lumbar spine
5792308|NCT00134524|Magnetics|magnetics
5792309|NCT00134524|Electromagnetics|electromagnetics
5792310|NCT00134524|Diabetic neuropathy|diabetic neuropathy
5792311|NCT00134524|Pain|pain
5792312|NCT00134472|Hypothermia, induced|hypothermia, induced
5792313|NCT00134472|Traumatic Brain injuries|traumatic brain injuries
5792314|NCT00134472|Anesthesia|anesthesia
5792315|NCT00134472|Neuro-intensive care|neuro-intensive care
5792316|NCT00134472|neurochemistry|neurochemistry
5792317|NCT00134459|Depression|depression
5792318|NCT00134459|Bipolar Disorder|bipolar disorder
5792319|NCT00134446|post traumatic stress disorder|post traumatic stress disorder
5792320|NCT00134446|PTSD|ptsd
5792321|NCT00134446|trauma|trauma
5792322|NCT00134446|transcranial magnetic stimulation|transcranial magnetic stimulation
5792323|NCT00134446|randomized clinical trial|randomized clinical trial
5792324|NCT00134433|Coronary Artery Disease, Diffuse|coronary artery disease, diffuse
5792325|NCT00134433|Coronary Artery Disease, Deemed Inoperable|coronary artery disease, deemed inoperable
5792326|NCT00134420|Growth Hormone|growth hormone
5792327|NCT00134420|Chromosomes, Human, Pair 18|chromosomes, human, pair 18
5792328|NCT00134420|Child|child
5792329|NCT00134407|Nutrition|nutrition
5792330|NCT00134407|Postoperative|postoperative
5792331|NCT00134407|oral|oral
5792332|NCT00134407|jejunal|jejunal
5792333|NCT00134407|feeding|feeding
5792334|NCT00134407|Surgery|surgery
5792335|NCT00134407|major|major
5792336|NCT00134407|abdominal|abdominal
5792337|NCT00134407|adult|adult
5792338|NCT00134394|psoriasis|psoriasis
5792339|NCT00134394|tacrolimus|tacrolimus
5792340|NCT00134394|etanercept|etanercept
5792341|NCT00134381|Normal volunteer study|normal volunteer study
5792342|NCT00134368|vitiligo|vitiligo
5792343|NCT00134368|etanercept|etanercept
5792344|NCT00134355|antiangiogenesis therapy|antiangiogenesis therapy
5792345|NCT00134355|vatalanib|vatalanib
5792346|NCT00134342|tuberculosis|tuberculosis
5792347|NCT00134342|tuberculin test|tuberculin test
5792348|NCT00134342|immunologic tests|immunologic tests
5792349|NCT00134342|Latent tuberculosis|latent tuberculosis
5686491|NCT00551837|Influenza|influenza
5792350|NCT00134342|end stage renal disease|end stage renal disease
5792351|NCT00134342|solid organ transplantation|solid organ transplantation
5792352|NCT00134342|bone marrow transplantation|bone marrow transplantation
5792353|NCT00134342|rheumatologic disease|rheumatologic disease
5792354|NCT00134316|sexual dysfunction|sexual dysfunction
5792355|NCT00134251|Parkinson's disease|parkinson's disease
5792356|NCT00134251|adjunctive to L-dopa therapy|adjunctive to l-dopa therapy
5792357|NCT00134251|Advanced stage Parkinson's disease|advanced stage parkinson's disease
5792358|NCT00134225|Musculoskeletal abnormality|musculoskeletal abnormality
5792359|NCT00134225|Musculoskeletal physiology|musculoskeletal physiology
5792360|NCT00134225|Musculoskeletal disease|musculoskeletal disease
5792361|NCT00134225|Musculoskeletal dysfunction|musculoskeletal dysfunction
5787303|NCT00159198|Mutations spectrum|mutations spectrum
5792362|NCT00134212|Splanchnic perfusion, hepatic damage, oxidative stress.|splanchnic perfusion, hepatic damage, oxidative stress.
5792364|NCT00134186|Renal cell carcinoma|renal cell carcinoma
5792365|NCT00134186|Motexafin gadolinium|motexafin gadolinium
5792367|NCT00134160|Hypertension|hypertension
5792368|NCT00134160|Cardiovascular Diseases|cardiovascular diseases
5792369|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5792370|NCT00134160|Calcium Channel Blockers|calcium channel blockers
5792371|NCT00134160|Combination Drug Therapy|combination drug therapy
5792372|NCT00134160|Diabetes Mellitus Type 2|diabetes mellitus type 2
5792373|NCT00134134|hidradenitis suppurativa|hidradenitis suppurativa
5792374|NCT00134134|efalizumab|efalizumab
5792375|NCT00134134|biologic|biologic
5792377|NCT00134095|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5792378|NCT00134095|stage II gastric cancer|stage ii gastric cancer
5792379|NCT00134095|stage III gastric cancer|stage iii gastric cancer
5792380|NCT00134095|stage IV gastric cancer|stage iv gastric cancer
5792381|NCT00134082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5792382|NCT00134056|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5792383|NCT00134056|stage IV prostate cancer|stage iv prostate cancer
5792384|NCT00134056|recurrent prostate cancer|recurrent prostate cancer
5792386|NCT00134017|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5792387|NCT00134017|refractory anemia with excess blasts|refractory anemia with excess blasts
5792388|NCT00134017|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5792389|NCT00134017|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5792390|NCT00134017|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5792391|NCT00134017|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5792392|NCT00134017|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5792393|NCT00134017|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5792394|NCT00134017|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5792395|NCT00134017|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5792396|NCT00134017|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5792397|NCT00134017|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5792398|NCT00134017|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5792399|NCT00134017|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5792400|NCT00134017|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5792401|NCT00134017|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5792402|NCT00134017|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5862616|NCT00001566|Interleukin-2|interleukin-2
5792403|NCT00134017|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5792404|NCT00134017|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5792405|NCT00134017|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5792406|NCT00134017|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5792407|NCT00134017|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5792408|NCT00134017|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5792409|NCT00134017|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5792410|NCT00134017|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5792411|NCT00134017|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5792412|NCT00134017|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5792413|NCT00134017|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5792414|NCT00134017|stage II multiple myeloma|stage ii multiple myeloma
5792415|NCT00134017|stage III multiple myeloma|stage iii multiple myeloma
5792477|NCT00134017|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5792416|NCT00134017|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5792417|NCT00134017|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5792418|NCT00134017|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5792419|NCT00134017|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5792420|NCT00134017|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5792421|NCT00134017|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5792422|NCT00134017|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5792423|NCT00134017|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5792424|NCT00134017|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5792425|NCT00134017|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5792426|NCT00134017|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5792427|NCT00134017|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5792429|NCT00134017|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5792430|NCT00134017|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5792431|NCT00134017|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5792432|NCT00134017|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5792433|NCT00134017|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5792434|NCT00134017|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5792435|NCT00134017|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5792436|NCT00134017|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5792437|NCT00134017|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5792438|NCT00134017|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5792439|NCT00134017|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5792440|NCT00134017|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5792441|NCT00134017|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5792442|NCT00134017|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5792443|NCT00134017|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5792444|NCT00134017|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5792445|NCT00134017|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5792446|NCT00134017|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5792447|NCT00134017|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5792448|NCT00134017|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5792449|NCT00134017|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5792450|NCT00134017|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5792451|NCT00134017|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5792452|NCT00134017|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5792453|NCT00134017|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5792454|NCT00134017|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5792455|NCT00134017|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5792456|NCT00134017|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5792457|NCT00134017|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5792458|NCT00134017|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5792459|NCT00134017|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5792460|NCT00134017|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5792461|NCT00134017|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5792462|NCT00134017|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5792463|NCT00134017|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5792464|NCT00134017|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5792465|NCT00134017|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5792466|NCT00134017|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5792467|NCT00134017|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5792468|NCT00134017|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5792469|NCT00134017|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5792470|NCT00134017|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5792471|NCT00134017|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5792472|NCT00134017|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5792473|NCT00134017|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5792475|NCT00134017|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5792476|NCT00134017|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5792478|NCT00134004|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5792479|NCT00134004|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5792480|NCT00134004|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5792481|NCT00134004|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5792482|NCT00134004|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5801501|NCT00102115|PDT|pdt
5792483|NCT00134004|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5792484|NCT00134004|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5792485|NCT00134004|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5792486|NCT00134004|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5792487|NCT00134004|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5792488|NCT00134004|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5792489|NCT00134004|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5792490|NCT00134004|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5792491|NCT00134004|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5792492|NCT00134004|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5792493|NCT00134004|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5792494|NCT00134004|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5792495|NCT00134004|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5792496|NCT00134004|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5792497|NCT00134004|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5792498|NCT00134004|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5792499|NCT00134004|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5792500|NCT00134004|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5792501|NCT00134004|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5792502|NCT00134004|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5792503|NCT00134004|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5792504|NCT00134004|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5792505|NCT00134004|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5792574|NCT00133965|Supportive Care|supportive care
5796192|NCT00120029|exercise|exercise
5792506|NCT00134004|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5792507|NCT00134004|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5792508|NCT00134004|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5792509|NCT00134004|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5792510|NCT00134004|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5792511|NCT00134004|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5792512|NCT00134004|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5792513|NCT00134004|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5792514|NCT00134004|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5792515|NCT00134004|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5792516|NCT00134004|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5792517|NCT00134004|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5792518|NCT00134004|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5792519|NCT00134004|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5792520|NCT00134004|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5862617|NCT00001564|Rhabdomyosarcoma|rhabdomyosarcoma
5792521|NCT00134004|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5792522|NCT00134004|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5792523|NCT00134004|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5792524|NCT00134004|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5792525|NCT00134004|refractory multiple myeloma|refractory multiple myeloma
5792526|NCT00134004|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5792527|NCT00134004|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5792528|NCT00134004|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5792529|NCT00134004|stage I multiple myeloma|stage i multiple myeloma
5792530|NCT00134004|stage II multiple myeloma|stage ii multiple myeloma
5792531|NCT00134004|stage III multiple myeloma|stage iii multiple myeloma
5792532|NCT00134004|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5792533|NCT00134004|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5792534|NCT00134004|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5792535|NCT00134004|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5792536|NCT00134004|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5792537|NCT00134004|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5792619|NCT00133783|IVF treatment patients|ivf treatment patients
5792538|NCT00134004|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5791731|NCT00137163|burns|burns
5792539|NCT00134004|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5792540|NCT00134004|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5792541|NCT00134004|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5792542|NCT00134004|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5792543|NCT00134004|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5792544|NCT00134004|polycythemia vera|polycythemia vera
5792545|NCT00134004|essential thrombocythemia|essential thrombocythemia
5792546|NCT00134004|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5787600|NCT00157820|Clinical Trial|clinical trial
5792547|NCT00134004|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5792548|NCT00134004|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5792549|NCT00134004|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5792550|NCT00134004|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5792551|NCT00134004|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5792552|NCT00134004|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5792553|NCT00134004|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5792554|NCT00134004|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5846713|NCT00043667|Anti-CD25|anti-cd25
5792555|NCT00134004|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5792556|NCT00134004|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5792557|NCT00134004|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5792558|NCT00134004|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5792559|NCT00134004|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5792560|NCT00134004|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5792561|NCT00133991|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5792562|NCT00133991|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5792563|NCT00133991|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5792564|NCT00133991|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5792565|NCT00133991|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5792566|NCT00133991|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5792567|NCT00133991|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5792569|NCT00133978|antioxidants|antioxidants
5792570|NCT00133978|glutamine|glutamine
5792571|NCT00133978|organ failure|organ failure
5792572|NCT00133965|Advanced Cancer|advanced cancer
5792573|NCT00133965|Dignity Care|dignity care
5792575|NCT00133965|Quality of Life|quality of life
5792576|NCT00133965|Psychotherapy|psychotherapy
5792577|NCT00133965|Palliative Care|palliative care
5792578|NCT00133939|Proportional assisted ventilation|proportional assisted ventilation
5792579|NCT00133939|Pressure support ventilation|pressure support ventilation
5792580|NCT00133939|Synchronism during mechanical ventilation|synchronism during mechanical ventilation
5792581|NCT00133939|Patients undergoing partial mechanical ventilation|patients undergoing partial mechanical ventilation
5792582|NCT00133926|Periodontal disease|periodontal disease
5792583|NCT00133926|Pregnancy|pregnancy
5792584|NCT00133926|Pre-term birth|pre-term birth
5792585|NCT00133926|Fetal growth|fetal growth
5792586|NCT00133926|Pre-eclampsia|pre-eclampsia
5792587|NCT00133926|Infant, Low Birth Weight|infant, low birth weight
5792588|NCT00133913|metastatic colorectal cancer|metastatic colorectal cancer
5792589|NCT00133900|hormone refractory prostate cancer|hormone refractory prostate cancer
5792590|NCT00133887|Squamous cell carcinoma|squamous cell carcinoma
5792591|NCT00133887|kidney transplant recipients|kidney transplant recipients
5792592|NCT00133887|rapamycin|rapamycin
5792593|NCT00133887|Skin cancers in kidney transplant recipients|skin cancers in kidney transplant recipients
5792594|NCT00133874|topical antibacterial|topical antibacterial
5792595|NCT00133874|topical antibiotic|topical antibiotic
5792596|NCT00133874|impetigo|impetigo
5792597|NCT00133861|cerebral palsy children|cerebral palsy children
5792598|NCT00133861|Botulinum toxin|botulinum toxin
5792599|NCT00133848|impetigo|impetigo
5792600|NCT00133848|topical antibacterial|topical antibacterial
5792601|NCT00133848|topical antibiotic|topical antibiotic
5792602|NCT00133835|Randomized controlled trial|randomized controlled trial
5792603|NCT00133835|Lithotripsy|lithotripsy
5792604|NCT00133835|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5792605|NCT00133835|Abdominal pain|abdominal pain
5792606|NCT00133822|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5792607|NCT00133822|Sertraline|sertraline
5792608|NCT00133822|Risperidone|risperidone
5792609|NCT00133809|Type 1 Diabetes|type 1 diabetes
5792610|NCT00133809|Islet Transplantation|islet transplantation
5792611|NCT00133809|Immunology|immunology
5792612|NCT00133796|Breast Cancer|breast cancer
5792613|NCT00133796|Advanced Breast Cancer|advanced breast cancer
5792614|NCT00133783|Intermedin|intermedin
5792615|NCT00133783|estradiol|estradiol
5792616|NCT00133783|female hypertension|female hypertension
5792617|NCT00133783|Premenopausal and postmenopausal women|premenopausal and postmenopausal women
5791841|NCT00136578|Safety|safety
5792618|NCT00133783|Surgically-induced menopause women|surgically-induced menopause women
5792620|NCT00133770|IV pantoprazole|iv pantoprazole
5792621|NCT00133770|Esophagitis|esophagitis
5792623|NCT00133757|Nicotine|nicotine
5792624|NCT00133757|Bupropion|bupropion
5792625|NCT00133757|Cue-reactivity|cue-reactivity
5792627|NCT00133744|pregnancy|pregnancy
5792628|NCT00133744|vitamins|vitamins
5792629|NCT00133744|minerals|minerals
5792630|NCT00133744|supplements|supplements
5792631|NCT00133744|mortality|mortality
5792632|NCT00133744|prenatal|prenatal
5792633|NCT00133744|perinatal|perinatal
5792634|NCT00133744|anemia|anemia
5792635|NCT00133744|birthweight|birthweight
5792636|NCT00133744|preterm|preterm
5792638|NCT00133744|micronutrients|micronutrients
5792639|NCT00133744|Stillbirths|stillbirths
5792640|NCT00133744|Early neonatal deaths|early neonatal deaths
5792641|NCT00133718|Type 2 diabetes mellitus|type 2 diabetes mellitus
5792642|NCT00133718|Cardiovascular|cardiovascular
5792643|NCT00133718|Coronary artery disease|coronary artery disease
5792644|NCT00133718|Glycemic control|glycemic control
5792645|NCT00133718|Treatment|treatment
5792646|NCT00133718|Diabetes Mellitus|diabetes mellitus
5792647|NCT00133705|A benign tumor derived from smooth uterine muscle tissue.|a benign tumor derived from smooth uterine muscle tissue.
5808022|NCT00003225|recurrent colon cancer|recurrent colon cancer
5792648|NCT00133692|Hypertension|hypertension
5783272|NCT00178672|Stroke|stroke
5792649|NCT00133692|Coronary Artery Disease|coronary artery disease
5792651|NCT00133692|Diabetes|diabetes
5792652|NCT00133692|Verapamil SR|verapamil sr
5792653|NCT00133692|Trandolapril|trandolapril
5792654|NCT00133692|Atenolol|atenolol
5792655|NCT00133692|HCTZ|hctz
5792656|NCT00133679|Chronic lung disease|chronic lung disease
5792657|NCT00133679|Nitric oxide|nitric oxide
5792658|NCT00133679|cyclic guanosine monophosphate|cyclic guanosine monophosphate
5792659|NCT00133679|phosphodiesterase inhibitor|phosphodiesterase inhibitor
5792660|NCT00133653|Hypertension; Job Strain; Marital Strain; Blood Pressure|hypertension; job strain; marital strain; blood pressure
5792661|NCT00133640|Vitamin D|vitamin d
5792662|NCT00133640|Elderly|elderly
5792663|NCT00133640|Hip fracture|hip fracture
5792664|NCT00133640|Falls|falls
5792665|NCT00133640|Physical Therapy|physical therapy
5792666|NCT00133640|Disability|disability
5792667|NCT00133627|Allergic|allergic
5792668|NCT00133627|Conjunctivitis|conjunctivitis
5792669|NCT00133627|Ketotifen|ketotifen
5792670|NCT00133627|Histamine|histamine
5792671|NCT00133588|influenza, vaccine, proteomic profiling, elderly|influenza, vaccine, proteomic profiling, elderly
5792672|NCT00133575|MVA, smallpox, Acambis|mva, smallpox, acambis
5794555|NCT00126256|metastatic|metastatic
5792673|NCT00133562|Malnutrition, pediatric, Brazil, alanyl-glutamine|malnutrition, pediatric, brazil, alanyl-glutamine
5792674|NCT00133549|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly|pneumococcal vaccine, 23-valent polysaccharide vaccine, elderly
5792675|NCT00133536|H5N1, Influenza, children|h5n1, influenza, children
5792676|NCT00133523|FLU-VACS, influenza, vaccine|flu-vacs, influenza, vaccine
5792677|NCT00133510|children, immunocompromised, influenza, liver transplant|children, immunocompromised, influenza, liver transplant
5792678|NCT00133497|cytomegalovirus, vaccine, women, children, parent protocol|cytomegalovirus, vaccine, women, children, parent protocol
5792679|NCT00133484|Anthrax, rPA|anthrax, rpa
5792680|NCT00133471|Influenza, vaccine, A/H9N2, MF59, adjuvant|influenza, vaccine, a/h9n2, mf59, adjuvant
5792681|NCT00133458|Albenza, Subarachnoid cysticercosis|albenza, subarachnoid cysticercosis
5792682|NCT00133445|Pentavalent vaccine, Pediarix, DTaP-Hep B-IPV vaccine|pentavalent vaccine, pediarix, dtap-hep b-ipv vaccine
5792683|NCT00133432|Pneumonia, acute respiratory infections, zinc, Tanzania, children, infants, hospitalization|pneumonia, acute respiratory infections, zinc, tanzania, children, infants, hospitalization
5862618|NCT00001564|Ewing's Sarcoma|ewing's sarcoma
5792684|NCT00133419|micronutrient, supplementation, Africa, children, HIV|micronutrient, supplementation, africa, children, hiv
5792685|NCT00133406|Brazil, Child Nutrition Disorders, Deficiency Diseases|brazil, child nutrition disorders, deficiency diseases
5792686|NCT00133367|Hematologic malignancy|hematologic malignancy
5792687|NCT00133367|Cord blood transfusion|cord blood transfusion
5792688|NCT00133367|Graft versus host disease|graft versus host disease
5792689|NCT00133367|tacrolimus|tacrolimus
5792690|NCT00133367|sirolimus|sirolimus
5792691|NCT00133354|Puberty|puberty
5792692|NCT00133354|Growth hormone deficiency|growth hormone deficiency
5792693|NCT00133354|aromatase inhibitors|aromatase inhibitors
5792694|NCT00133354|estrogen|estrogen
5792695|NCT00133354|bone mineral density|bone mineral density
5792696|NCT00133354|short stature|short stature
5792697|NCT00133341|Allergic contact dermatitis,patch testing, dilution series|allergic contact dermatitis,patch testing, dilution series
5792698|NCT00133328|stroke|stroke
5792699|NCT00133328|myocardial infarction|myocardial infarction
5792700|NCT00133328|angina|angina
5792701|NCT00133328|renal damage|renal damage
5792702|NCT00133302|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5792703|NCT00133302|intermediate-grade lymphoma|intermediate-grade lymphoma
5792704|NCT00133302|high-grade lymphoma|high-grade lymphoma
5792705|NCT00133302|CHOP protocol|chop protocol
5792706|NCT00133302|granulocyte-colony stimulating factor|granulocyte-colony stimulating factor
5792707|NCT00133276|Hepatitis C|hepatitis c
5792708|NCT00133276|Peg-interferon|peg-interferon
5792709|NCT00133276|Psychiatric side-effects|psychiatric side-effects
5792710|NCT00133263|Randomized controlled trial|randomized controlled trial
5792711|NCT00133263|Primary Care|primary care
5792712|NCT00133224|Advanced Prostate Cancer|advanced prostate cancer
5792713|NCT00133224|HRPC|hrpc
5792714|NCT00133224|Prostate|prostate
5792715|NCT00133224|Cancer|cancer
5792716|NCT00133224|Metastatic|metastatic
5792717|NCT00133224|Hormone-refractory|hormone-refractory
5792718|NCT00133224|GVAX|gvax
5792719|NCT00133224|Chemotherapy|chemotherapy
5792720|NCT00133224|Taxotere|taxotere
5792722|NCT00133224|Prednisone|prednisone
5792723|NCT00133224|Vaccine|vaccine
5792724|NCT00133224|Allogeneic cells|allogeneic cells
5792725|NCT00133211|Paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5792726|NCT00133211|Heart arrhythmia|heart arrhythmia
5792727|NCT00133211|Ablation|ablation
5792728|NCT00133211|Drug treatment|drug treatment
5792729|NCT00133172|Treatment Efficacy|treatment efficacy
5792730|NCT00133172|Treatment Effectiveness|treatment effectiveness
5792731|NCT00133172|Anti-rejection therapy|anti-rejection therapy
5792732|NCT00133172|Immunosuppression|immunosuppression
5792733|NCT00133172|Antirejection|antirejection
5792734|NCT00133172|Renal Transplantation|renal transplantation
5792735|NCT00133172|Transplantation, Renal|transplantation, renal
5792736|NCT00133172|Transplantation, Kidney|transplantation, kidney
5792737|NCT00133172|Grafting, Kidney|grafting, kidney
5792739|NCT00133159|Specific Immunotherapy|specific immunotherapy
5792740|NCT00133146|Allergy|allergy
5792741|NCT00133146|Specific Immunotherapy|specific immunotherapy
5792742|NCT00133133|Postoperative pain|postoperative pain
5792743|NCT00133133|Open cholecystectomy|open cholecystectomy
5792744|NCT00133133|Capsaicin|capsaicin
5792745|NCT00133094|Hypercholesterolemia|hypercholesterolemia
5792746|NCT00133094|Decision Support Systems, Clinical|decision support systems, clinical
5792747|NCT00133081|epilepsy|epilepsy
5792748|NCT00133081|antiepileptic drugs|antiepileptic drugs
5792749|NCT00133081|side effects|side effects
5792750|NCT00133081|quality of life|quality of life
5792751|NCT00133068|High Blood Pressure|high blood pressure
5792752|NCT00133068|Health Behaviors|health behaviors
5792753|NCT00133068|Patient Compliance|patient compliance
5792754|NCT00133055|parenting|parenting
5792755|NCT00133055|sleep problems|sleep problems
5792756|NCT00133055|behavior problems|behavior problems
5792757|NCT00133055|brief intervention|brief intervention
5792758|NCT00133055|self-help|self-help
5792759|NCT00133055|preschool-age children|preschool-age children
5792760|NCT00133055|psychosocial|psychosocial
5792761|NCT00133042|anti-IgE, omalizumab|anti-ige, omalizumab
5792762|NCT00133016|Induction of labor|induction of labor
5792763|NCT00132990|Cervical dystonia|cervical dystonia
5792764|NCT00132990|Deep brain stimulation|deep brain stimulation
5792765|NCT00132977|Cardiac Resynchronization Therapy|cardiac resynchronization therapy
5792766|NCT00132977|Heart Failure|heart failure
5792767|NCT00132977|Mechanical Dyssynchrony|mechanical dyssynchrony
5792768|NCT00132964|pediatric|pediatric
5792769|NCT00132964|ankle fractures|ankle fractures
5792770|NCT00132964|randomized controlled trial|randomized controlled trial
5792771|NCT00132964|management|management
5792772|NCT00132925|allergic rhinitis|allergic rhinitis
5792773|NCT00132912|Platelets|platelets
5792774|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5792775|NCT00132912|Protease-Activated Receptor 1|protease-activated receptor 1
5792776|NCT00132912|Hemorrhage|hemorrhage
5792777|NCT00132899|Crohn's Disease|crohn's disease
5792778|NCT00132899|multi-centre randomized placebo-controlled|multi-centre randomized placebo-controlled
5792779|NCT00132899|infliximab|infliximab
5792780|NCT00132899|methotrexate|methotrexate
5681165|NCT00574496|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5681166|NCT00574496|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5681167|NCT00574496|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5681168|NCT00574496|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5681169|NCT00574496|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5681170|NCT00574483|Renal cell carcinoma|renal cell carcinoma
5681171|NCT00574457|Atherosclerosis|atherosclerosis
5681172|NCT00574457|Cardiovascular Risk Prevention|cardiovascular risk prevention
5681173|NCT00574457|Carotid Ultrasound|carotid ultrasound
5792781|NCT00132899|inflammatory bowel disease|inflammatory bowel disease
5792782|NCT00132873|Narcolepsy|narcolepsy
5792783|NCT00132873|Cataplexy|cataplexy
5792785|NCT00132847|Adolescent|adolescent
5792786|NCT00132847|Urban Health|urban health
5792787|NCT00132821|Nicotine dependence|nicotine dependence
5792788|NCT00132821|Sleep disorders|sleep disorders
5792789|NCT00132821|smoking cessation|smoking cessation
5792790|NCT00132821|Relapse|relapse
5792791|NCT00132808|Postmenopausal osteoporosis|postmenopausal osteoporosis
5792792|NCT00132808|osteopenia|osteopenia
5792793|NCT00132808|zoledronic acid|zoledronic acid
5792794|NCT00132808|Osteopenia (osteoporosis prevention)|osteopenia (osteoporosis prevention)
5801613|NCT00101907|AMG 706|amg 706
5792795|NCT00132795|Cognitive Therapy|cognitive therapy
5792796|NCT00132795|Recurrence|recurrence
5792797|NCT00132795|Prevention|prevention
5792798|NCT00132795|Educational Technology|educational technology
5792799|NCT00132756|Hormone Refractory|hormone refractory
5792800|NCT00132756|Taxane Refractory|taxane refractory
5792801|NCT00132704|Lung cancer metastases to the CNS (adenocarcinomas)|lung cancer metastases to the cns (adenocarcinomas)
5792802|NCT00132704|Melanoma metastases to the CNS|melanoma metastases to the cns
5792803|NCT00132704|Breast cancer metastases to the CNS (ductal carcinomas)|breast cancer metastases to the cns (ductal carcinomas)
5792804|NCT00132704|Central nervous system gliomas|central nervous system gliomas
5792805|NCT00132704|Colorectal cancers (adenocarcinomas)|colorectal cancers (adenocarcinomas)
5792806|NCT00132704|Ovarian cancers (papillary serous carcinomas)|ovarian cancers (papillary serous carcinomas)
5792900|NCT00132366|SSADH|ssadh
5792807|NCT00132704|Endometrial cancers (endometrioid carcinomas)|endometrial cancers (endometrioid carcinomas)
5792808|NCT00132704|Cervical cancers (squamous cell carcinomas)|cervical cancers (squamous cell carcinomas)
5792809|NCT00132704|Sarcomas (liposarcomas and leiomyosarcomas)|sarcomas (liposarcomas and leiomyosarcomas)
5792810|NCT00132704|Thoracic mesotheliomas|thoracic mesotheliomas
5792811|NCT00132704|Colorectal cancers metastatic to the liver|colorectal cancers metastatic to the liver
5792812|NCT00132704|Primary adenocarcinomas of the lung|primary adenocarcinomas of the lung
5792813|NCT00132704|Primary squamous cell carcinomas of the lung|primary squamous cell carcinomas of the lung
5792814|NCT00132704|Pancreatic Cancers-adenocarcinoma|pancreatic cancers-adenocarcinoma
5792815|NCT00132691|uveitis|uveitis
5792816|NCT00132691|non-infectious intermediate uveitis|non-infectious intermediate uveitis
5792817|NCT00132691|non-infectious posterior uveitis|non-infectious posterior uveitis
5792818|NCT00132691|non-infectious panuveitis|non-infectious panuveitis
5792819|NCT00132678|Mood episodes|mood episodes
5792820|NCT00132678|Bipolar 1 disorder|bipolar 1 disorder
5792821|NCT00132678|Intramuscular Injectable|intramuscular injectable
5792822|NCT00132678|risperidone|risperidone
5792823|NCT00132678|safety and efficacy|safety and efficacy
5792824|NCT00132665|non-small cell lung cancer|non-small cell lung cancer
5792825|NCT00132665|elderly patients|elderly patients
5792826|NCT00132665|carboplatin|carboplatin
5792827|NCT00132665|chemoradiotherapy|chemoradiotherapy
5792828|NCT00132639|pulmonary neoplasm|pulmonary neoplasm
5792829|NCT00132639|preoperative chemotherapy|preoperative chemotherapy
5792830|NCT00132639|cisplatin, docetaxel|cisplatin, docetaxel
5792831|NCT00132639|randomized trial|randomized trial
5792832|NCT00132639|clinical stage IB or II nonsmall cell lung cancer|clinical stage ib or ii nonsmall cell lung cancer
5792833|NCT00132626|parkinson|parkinson
5792834|NCT00132626|diagnosis|diagnosis
5792835|NCT00132613|pulmonary neoplasm|pulmonary neoplasm
5792836|NCT00132613|malignant pericardial effusion|malignant pericardial effusion
5792837|NCT00132613|pericardial drainage|pericardial drainage
5792838|NCT00132613|randomized trial|randomized trial
5792839|NCT00132613|bleomycin|bleomycin
5792840|NCT00132613|intrapericardial instillation|intrapericardial instillation
5792841|NCT00132600|Allergic contact dermatitis|allergic contact dermatitis
5792842|NCT00132600|Patch testing|patch testing
5792843|NCT00132600|bacitracin|bacitracin
5792844|NCT00132587|Knee arthroplasty|knee arthroplasty
5792845|NCT00132587|Femoral loosening|femoral loosening
5792846|NCT00132587|Total Knee Arthroplasty|total knee arthroplasty
5792847|NCT00132574|acne, dairy|acne, dairy
5792849|NCT00132548|Children|children
5792850|NCT00132548|Intermittent preventive treatment|intermittent preventive treatment
5792851|NCT00132548|Senegal|senegal
5792852|NCT00132535|Malaria in pregnancy|malaria in pregnancy
5792854|NCT00132535|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5792855|NCT00132535|Chloroquine|chloroquine
5792857|NCT00132535|Viral load|viral load
5792858|NCT00132535|birth weight|birth weight
5792859|NCT00132535|anaemia|anaemia
5792860|NCT00132522|EpCAM|epcam
5792861|NCT00132522|monoclonal-antibody|monoclonal-antibody
5792862|NCT00132522|targeted therapy|targeted therapy
5792863|NCT00132522|colorectal|colorectal
5792864|NCT00132522|prostate|prostate
5792865|NCT00132522|non-small cell lung cancer|non-small cell lung cancer
5792866|NCT00132522|ovarian|ovarian
5792867|NCT00132522|solid tumor|solid tumor
5792868|NCT00132509|rt-PA|rt-pa
5792869|NCT00132509|thrombolysis|thrombolysis
5792870|NCT00132509|Acute ischemic stroke|acute ischemic stroke
5792871|NCT00132496|GERD|gerd
5792872|NCT00132483|Physical activity|physical activity
5792873|NCT00132483|cerebral infarct|cerebral infarct
5792874|NCT00132457|Chlamydia|chlamydia
5792875|NCT00132457|screening|screening
5792876|NCT00132457|Sexually transmitted disease|sexually transmitted disease
5792877|NCT00132444|HIV|hiv
5792878|NCT00132444|topical microbicides|topical microbicides
5792879|NCT00132431|calcimimetic|calcimimetic
5792880|NCT00132431|cinacalcet|cinacalcet
5792881|NCT00132431|hemodialysis|hemodialysis
5792882|NCT00132431|secondary hyperparathyroidism|secondary hyperparathyroidism
5792883|NCT00132431|chronic kidney disease|chronic kidney disease
5801646|NCT00101777|HV|hv
5792884|NCT00132418|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)|rheumatoid arthritis and at least 1 qualifying comorbid condition (diabetes, chronic pulmonary disease, recent infection)
5792885|NCT00132418|RA|ra
5792886|NCT00132418|rheumatoid arthritis|rheumatoid arthritis
5792887|NCT00132405|Needlestick pain|needlestick pain
5792888|NCT00132405|Venipuncture pain|venipuncture pain
5792889|NCT00132405|Procedural pain|procedural pain
5792890|NCT00132392|Arthroplasty|arthroplasty
5792891|NCT00132392|Total knee arthroplasty|total knee arthroplasty
5792892|NCT00132392|Capsaicin|capsaicin
5792893|NCT00132392|Pain|pain
5792894|NCT00132392|Analgesia|analgesia
5792895|NCT00132366|Neurotransmission|neurotransmission
5792896|NCT00132366|Cortical Excitability|cortical excitability
5792897|NCT00132366|GABA|gaba
5792898|NCT00132366|Seizures|seizures
5792899|NCT00132366|Succinic Semialdehyde Dehydrogenase Deficiency|succinic semialdehyde dehydrogenase deficiency
5792928|NCT00132301|multi-site clinical trial|multi-site clinical trial
5792929|NCT00132301|prostate|prostate
5792930|NCT00132301|radical prostatectomy|radical prostatectomy
5792931|NCT00132301|randomized|randomized
5792932|NCT00132288|Aging|aging
5792933|NCT00132288|Frailty|frailty
5792934|NCT00132288|Sedentary|sedentary
5792935|NCT00132288|Falls|falls
5792936|NCT00132288|Physical Activity|physical activity
5792937|NCT00132275|bacterial|bacterial
5792938|NCT00132275|sinusitis|sinusitis
5792939|NCT00132275|treatment|treatment
5792940|NCT00132275|diagnosis|diagnosis
5792941|NCT00132275|guideline|guideline
5792942|NCT00132275|acute bacterial sinusitis|acute bacterial sinusitis
5792943|NCT00132262|Screening and Brief Intervention|screening and brief intervention
5792944|NCT00132262|Ethnic Differences|ethnic differences
5792945|NCT00132262|Trauma Center|trauma center
5792946|NCT00132249|Traumatic Brain Injury|traumatic brain injury
5792947|NCT00132249|Penetrating head wound|penetrating head wound
5792948|NCT00132249|Closed head trauma|closed head trauma
5792949|NCT00132249|Vietnam Veteran|vietnam veteran
5792950|NCT00132236|smoking cessation|smoking cessation
5783586|NCT00176878|TLI|tli
5792951|NCT00132236|nicotine sublingual tablets|nicotine sublingual tablets
5792952|NCT00132236|behaviour support|behaviour support
5792953|NCT00132236|smoking reduction|smoking reduction
5792954|NCT00132236|quality of life|quality of life
5792955|NCT00132236|COPD|copd
5792956|NCT00132236|weight|weight
5792957|NCT00132223|magnetic imaging|magnetic imaging
5792958|NCT00132223|angiography|angiography
5792959|NCT00132223|contrast agent|contrast agent
5792960|NCT00132223|signal/noise ratio|signal/noise ratio
5792961|NCT00132223|contrast/noise ratio|contrast/noise ratio
5792962|NCT00132223|vessel|vessel
5792963|NCT00132210|acute hepatitis C|acute hepatitis c
5792964|NCT00132210|HIV|hiv
5792965|NCT00132210|pegylated interferon|pegylated interferon
5792966|NCT00132197|Functional somatic symptoms|functional somatic symptoms
5792967|NCT00132197|Cognitive behavioral therapy|cognitive behavioral therapy
5792968|NCT00132197|somatization disorder|somatization disorder
5792969|NCT00132197|SF-36|sf-36
5792970|NCT00132197|cost-effectiveness|cost-effectiveness
5792971|NCT00132197|Medically unexplained symptoms|medically unexplained symptoms
5792972|NCT00132184|Vitamin D|vitamin d
5792973|NCT00132184|Crohns Disease|crohns disease
5792974|NCT00132171|Helicobacter pylori|helicobacter pylori
5792975|NCT00132171|Eradication|eradication
5792976|NCT00132171|Sequential therapy|sequential therapy
5792977|NCT00132171|Standard therapy|standard therapy
5794952|NCT00124852|cognition|cognition
5792978|NCT00132145|Vascular diseases|vascular diseases
5792979|NCT00132145|Computerized decision support systems|computerized decision support systems
5792980|NCT00132145|Shared care|shared care
5792981|NCT00132145|Patient motivation|patient motivation
5792982|NCT00132145|Quality of care|quality of care
5792983|NCT00132132|BMI|bmi
5792984|NCT00132132|obesity|obesity
5792985|NCT00132132|behavioral intervention|behavioral intervention
5792986|NCT00132132|longterm randomized controlled trial|longterm randomized controlled trial
5792987|NCT00132132|exercise|exercise
5792988|NCT00132132|empowerment|empowerment
5792989|NCT00132132|nutrition|nutrition
5792990|NCT00132093|Left ventricular remodelling|left ventricular remodelling
5792991|NCT00132093|Acute myocardial infarction|acute myocardial infarction
5792992|NCT00132093|Left ventricular dysfunction|left ventricular dysfunction
5792993|NCT00132093|Eplerenone|eplerenone
5792994|NCT00132093|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5792995|NCT00132054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5792996|NCT00132054|recurrent small cell lung cancer|recurrent small cell lung cancer
5792997|NCT00132041|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5792998|NCT00132041|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5792999|NCT00132015|Waldenström macroglobulinemia|waldenström macroglobulinemia
5793000|NCT00132015|multicentric Castleman disease|multicentric castleman disease
5793001|NCT00132015|unicentric Castleman disease|unicentric castleman disease
5793002|NCT00132015|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5792229|NCT00134823|Quality Improvement|quality improvement
5793003|NCT00132015|polycythemia vera|polycythemia vera
5793004|NCT00132015|essential thrombocythemia|essential thrombocythemia
5793005|NCT00132015|hairy cell leukemia|hairy cell leukemia
5793006|NCT00132015|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5793007|NCT00132015|adult Burkitt lymphoma|adult burkitt lymphoma
5793008|NCT00132015|adult diffuse large cell lymphoma|adult diffuse large cell lymphoma
5793009|NCT00132015|adult diffuse mixed cell lymphoma|adult diffuse mixed cell lymphoma
5793010|NCT00132015|adult diffuse small cleaved cell lymphoma|adult diffuse small cleaved cell lymphoma
5793011|NCT00132015|adult immunoblastic large cell lymphoma|adult immunoblastic large cell lymphoma
5793012|NCT00132015|adult lymphoblastic lymphoma|adult lymphoblastic lymphoma
5793013|NCT00132015|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5788088|NCT00155428|biomodel|biomodel
5793014|NCT00132015|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5793015|NCT00132015|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5793017|NCT00132015|marginal zone lymphoma|marginal zone lymphoma
5793018|NCT00132015|small lymphocytic lymphoma|small lymphocytic lymphoma
5793019|NCT00132015|precancerous condition|precancerous condition
5793020|NCT00131963|stage One A (IA) breast cancer|stage one a (ia) breast cancer
5793021|NCT00131963|stage Two (II) breast cancer|stage two (ii) breast cancer
5793022|NCT00131963|stage Three A (IIIA) breast cancer|stage three a (iiia) breast cancer
5793023|NCT00131963|stage Three B(IIIB) breast cancer|stage three b(iiib) breast cancer
5793024|NCT00131963|stage Three C(IIIC) breast cancer|stage three c(iiic) breast cancer
5793025|NCT00131963|stage One B (IB) breast cancer|stage one b (ib) breast cancer
5793026|NCT00131950|breast cancer|breast cancer
5793027|NCT00131924|recurrent breast cancer|recurrent breast cancer
5793028|NCT00131924|stage IV breast cancer|stage iv breast cancer
5793029|NCT00131898|IMRT+Surgery versus Surgery For Sarcoma|imrt+surgery versus surgery for sarcoma
5793030|NCT00131885|Menstruation|menstruation
5793031|NCT00131885|Complementary Therapies|complementary therapies
5793032|NCT00131885|Pharmacokinetics|pharmacokinetics
5793033|NCT00131885|Hypericum|hypericum
5793034|NCT00131885|St. John's wort|st. john's wort
5793035|NCT00131885|Levonorgestrel|levonorgestrel
5793037|NCT00131872|vascular access graft|vascular access graft
5793038|NCT00131872|hemodialysis|hemodialysis
5793039|NCT00131872|dialysis|dialysis
5793040|NCT00131872|end stage renal disease|end stage renal disease
5793041|NCT00131859|Perinatal brain injury|perinatal brain injury
5793042|NCT00131859|Diffusion-tensor imaging|diffusion-tensor imaging
5793043|NCT00131846|Thiazide diuretics|thiazide diuretics
5793044|NCT00131846|Essential hypertension|essential hypertension
5793045|NCT00131846|Type 2 diabetes|type 2 diabetes
5793046|NCT00131846|Randomized clinical trial|randomized clinical trial
5793047|NCT00131846|Cost-effectiveness|cost-effectiveness
5793048|NCT00131833|salmonella|salmonella
5793049|NCT00131833|typhoid vaccine|typhoid vaccine
5793050|NCT00131833|enteric fever|enteric fever
5793051|NCT00131820|Salmonella|salmonella
5793052|NCT00131820|typhoid vaccine|typhoid vaccine
5793053|NCT00131820|enteric fever|enteric fever
5793054|NCT00131820|socioeconomic costs|socioeconomic costs
5793055|NCT00131807|Blood Pressure|blood pressure
5793057|NCT00131807|Antiretroviral therapy|antiretroviral therapy
5793058|NCT00131794|Malaria|malaria
5793059|NCT00131794|BCG vaccine|bcg vaccine
5793060|NCT00131794|Guinea Bissau|guinea bissau
5793061|NCT00131781|Borderline personality disorder|borderline personality disorder
5793062|NCT00131781|Controlled trials|controlled trials
5793063|NCT00131781|Cognitive Therapy|cognitive therapy
5793064|NCT00131781|Supportive Therapy|supportive therapy
5793066|NCT00131781|impulsivity|impulsivity
5793067|NCT00131768|osteoarthritis of the ankle|osteoarthritis of the ankle
5793068|NCT00131768|musculoskeletal|musculoskeletal
5793069|NCT00131755|type 1 diabetes|type 1 diabetes
5793070|NCT00131755|beta cell rest|beta cell rest
5793071|NCT00131755|diazoxide|diazoxide
5793072|NCT00131755|insulin secretion|insulin secretion
5793073|NCT00131729|Amblyopia|amblyopia
5793074|NCT00131729|Occlusion therapy|occlusion therapy
5793075|NCT00131729|Compliance|compliance
5793076|NCT00131729|Risk factors|risk factors
5793077|NCT00131716|prevention|prevention
5793078|NCT00131716|recurrence|recurrence
5793080|NCT00131716|anaemia|anaemia
5793081|NCT00131703|Screening|screening
5793082|NCT00131703|Treatment|treatment
5793083|NCT00131703|Amodiaquine|amodiaquine
5793084|NCT00131703|Sulphadoxine-pyrimethamine|sulphadoxine-pyrimethamine
5793085|NCT00131703|Malaria in pregnancy|malaria in pregnancy
5793086|NCT00131690|Caffeine|caffeine
5793087|NCT00131690|Coffee|coffee
5793088|NCT00131690|Randomized|randomized
5793089|NCT00131690|Birth weight|birth weight
5793090|NCT00131651|renal|renal
5793091|NCT00131651|cancer|cancer
5793092|NCT00131651|advanced|advanced
5793093|NCT00131651|unresectable|unresectable
5793094|NCT00131651|metastatic|metastatic
5793095|NCT00131651|recurrent|recurrent
5793096|NCT00131651|anti-angiogenic|anti-angiogenic
5793097|NCT00131651|targeted|targeted
5793098|NCT00131651|ATN-161|atn-161
5793099|NCT00131651|Recurrent renal cell cancer|recurrent renal cell cancer
5793100|NCT00131651|Renal clear cell carcinoma|renal clear cell carcinoma
5793101|NCT00131651|Advanced Renal Cell Cancer|advanced renal cell cancer
5793102|NCT00131638|Oncology|oncology
5793103|NCT00131638|KGF|kgf
5793104|NCT00131638|Palifermin|palifermin
5793105|NCT00131638|Oral mucositis|oral mucositis
5793106|NCT00131638|Clinical Trial|clinical trial
5793107|NCT00131638|Amgen|amgen
5793108|NCT00131638|head and neck|head and neck
5793109|NCT00131625|Exclusive breast-feeding|exclusive breast-feeding
5793110|NCT00131625|Mortality|mortality
5793111|NCT00131625|Morbidity|morbidity
5793112|NCT00131625|Nutrition|nutrition
5793113|NCT00131625|Low income country|low income country
5793114|NCT00131612|adjuvant therapy|adjuvant therapy
5793115|NCT00131612|epirubicin|epirubicin
5793116|NCT00131612|uridine glucuronosyl/transferase 2B7|uridine glucuronosyl/transferase 2b7
5793117|NCT00131612|pharmacogenetics|pharmacogenetics
5793118|NCT00131599|5-fluorouracil|5-fluorouracil
5793119|NCT00131599|thymidylate synthase|thymidylate synthase
5793120|NCT00131599|pharmacogenetics|pharmacogenetics
5793121|NCT00131586|platinum analogues|platinum analogues
5793122|NCT00131586|cisplatin, carboplatin, oxaliplatin|cisplatin, carboplatin, oxaliplatin
5793123|NCT00131586|proteomics|proteomics
5793124|NCT00131586|hemoglobin|hemoglobin
5793125|NCT00131573|Urgency-Frequency|urgency-frequency
5793126|NCT00131573|Syndrome|syndrome
5793127|NCT00131573|Urinary|urinary
5793128|NCT00131573|Refractory|refractory
5793129|NCT00131573|Stimulation|stimulation
5793130|NCT00131573|Nerve|nerve
5793131|NCT00131573|Neuromodulation|neuromodulation
5793132|NCT00131573|Microstimulator|microstimulator
5793133|NCT00131573|bion|bion
5793134|NCT00131573|Pudendal|pudendal
5793135|NCT00131573|Overactive bladder|overactive bladder
5793136|NCT00131560|HIV, gene therapy, leukapheresis, autologous CD4 T cell, lentivector|hiv, gene therapy, leukapheresis, autologous cd4 t cell, lentivector
5793137|NCT00131547|Obesity|obesity
5793138|NCT00131547|Obstructive Sleep Apnea|obstructive sleep apnea
5793139|NCT00131534|Complex trauma|complex trauma
5793140|NCT00131534|Trauma recovery|trauma recovery
5793141|NCT00131534|Resiliency|resiliency
5793142|NCT00131534|Posttraumatic stress|posttraumatic stress
5793143|NCT00131534|Individual psychotherapy|individual psychotherapy
5793144|NCT00131534|Group psychotherapy|group psychotherapy
5793145|NCT00131521|mucus obstruction, ventilator management|mucus obstruction, ventilator management
5793146|NCT00131508|Hemoglobin S Disease|hemoglobin s disease
5793147|NCT00131508|Sickle Cell Anemia|sickle cell anemia
5793148|NCT00131495|Low Libido|low libido
5793149|NCT00131495|Low Desire|low desire
5793150|NCT00131495|Distress|distress
5793151|NCT00131482|Chrysalin|chrysalin
5793152|NCT00131482|TP508|tp508
5793153|NCT00131482|Fracture|fracture
5793154|NCT00131482|Wrist|wrist
5793155|NCT00131482|Healing|healing
5793156|NCT00131469|Osteogenesis Imperfecta|osteogenesis imperfecta
5793157|NCT00131469|Brittle Bone Disease|brittle bone disease
5793158|NCT00131469|Fragility Fractures|fragility fractures
5793159|NCT00131456|cannabis dependence|cannabis dependence
5793160|NCT00131456|depression|depression
5793161|NCT00131456|treatment|treatment
5793162|NCT00131456|venlafaxine|venlafaxine
5793163|NCT00131443|Basilar/Hemiplegic Migraine|basilar/hemiplegic migraine
5793164|NCT00131443|Prophylaxis|prophylaxis
5793165|NCT00131417|severe|severe
5793166|NCT00131417|malnutrition|malnutrition
5793167|NCT00131417|ready-to-use-therapeutic-food|ready-to-use-therapeutic-food
5793168|NCT00131417|children|children
5793169|NCT00131417|Uganda|uganda
5793170|NCT00131378|Visceral obesity|visceral obesity
5793171|NCT00131378|Growth hormone|growth hormone
5793172|NCT00131378|Cardiovascular risk|cardiovascular risk
5793173|NCT00131378|Insulin resistance|insulin resistance
5793174|NCT00131365|fibroids|fibroids
5793175|NCT00131365|Uterine Fibroids|uterine fibroids
5793176|NCT00131365|ExAblate|exablate
5793177|NCT00131365|MrgFUS|mrgfus
5793178|NCT00131352|Osteoarthritis of the knee|osteoarthritis of the knee
5793179|NCT00131352|Musculoskeletal|musculoskeletal
5793180|NCT00131339|panic disorder|panic disorder
5793181|NCT00131339|cognitive behavioral therapy|cognitive behavioral therapy
5793182|NCT00131339|D-cycloserine|d-cycloserine
5793183|NCT00131339|medication|medication
5793184|NCT00131339|treatment trial|treatment trial
5793185|NCT00131339|placebo-controlled|placebo-controlled
5793186|NCT00131339|double-blind|double-blind
5793187|NCT00131339|randomized|randomized
5793188|NCT00131326|osteoarthritis of the hip|osteoarthritis of the hip
5793189|NCT00131326|Musculoskeletal Diseases|musculoskeletal diseases
5793190|NCT00131313|Leukemia|leukemia
5793191|NCT00131313|Cancer|cancer
5793192|NCT00131313|Nipent|nipent
5793193|NCT00131313|Rituxan|rituxan
5793194|NCT00131313|Cytoxan|cytoxan
5793195|NCT00131300|Osteoarthritis of the shoulder|osteoarthritis of the shoulder
5793196|NCT00131300|Musculoskeletal|musculoskeletal
5793197|NCT00131287|Agaricus Blazei Murill|agaricus blazei murill
5793198|NCT00131287|type II DM|type ii dm
5793199|NCT00131287|insulin index|insulin index
5793200|NCT00131274|Pulmonary Fibrosis|pulmonary fibrosis
5793201|NCT00131274|Respiratory Diseases|respiratory diseases
5793202|NCT00131274|Interstitial Lung Disease|interstitial lung disease
5793203|NCT00131274|Usual Interstitial Pneumonia|usual interstitial pneumonia
5793204|NCT00131261|Multiple Myeloma|multiple myeloma
5793205|NCT00131261|Neoplasms|neoplasms
5793206|NCT00131235|Malaria|malaria
5793208|NCT00131235|Pregnancy|pregnancy
5793209|NCT00131235|Prevention|prevention
5793210|NCT00131235|Preterm birth|preterm birth
5793211|NCT00131235|Low birth weight|low birth weight
5793212|NCT00131235|Sub-Saharan Africa|sub-saharan africa
5793213|NCT00131222|Infant|infant
5793214|NCT00131222|Malnutrition|malnutrition
5793215|NCT00131222|Sub-Saharan Africa|sub-saharan africa
5793216|NCT00131222|Treatment|treatment
5793217|NCT00131222|Growth|growth
5793218|NCT00131222|Haemoglobin|haemoglobin
5793219|NCT00131222|Fortified spread|fortified spread
5793220|NCT00131222|Food supplement|food supplement
5793221|NCT00131209|Infant|infant
5793222|NCT00131209|Sub-Saharan Africa|sub-saharan africa
5793223|NCT00131209|Complementary feeding|complementary feeding
5793224|NCT00131209|Malnutrition|malnutrition
5793225|NCT00131209|Growth|growth
5793226|NCT00131209|Fortified spread|fortified spread
5793227|NCT00131209|Haemoglobin|haemoglobin
5793228|NCT00131196|pneumonia|pneumonia
5793229|NCT00131196|peritonitis|peritonitis
5793230|NCT00131196|sepsis|sepsis
5793231|NCT00131196|outcome|outcome
5793232|NCT00131196|genomics|genomics
5793233|NCT00131183|Angina Pectoris|angina pectoris
5793234|NCT00131183|Arteriosclerosis|arteriosclerosis
5793235|NCT00131183|Testosterone|testosterone
5793236|NCT00131157|Pulmonary Disease, Chronic Obstructive|pulmonary disease, chronic obstructive
5793237|NCT00131157|Family Practice|family practice
5793238|NCT00131157|Spirometry|spirometry
5793239|NCT00131157|Decision Support Systems|decision support systems
5793240|NCT00131157|Feedback|feedback
5793241|NCT00131144|Diabetic retinopathy,Octreotide Acetate in Microspheres|diabetic retinopathy,octreotide acetate in microspheres
5793242|NCT00131131|physical activity|physical activity
5793243|NCT00131131|cholelithiasis|cholelithiasis
5793244|NCT00131131|pregnancy complication|pregnancy complication
5793245|NCT00131118|Osteogenesis Imperfecta, Brittle bone disease, bisphosphonate, children|osteogenesis imperfecta, brittle bone disease, bisphosphonate, children
5793246|NCT00131105|Healthy|healthy
5793247|NCT00131105|Caregivers|caregivers
5793248|NCT00131105|Aging|aging
5793249|NCT00131092|exercise|exercise
5793250|NCT00131092|aging|aging
5793251|NCT00131092|physical activity|physical activity
5793252|NCT00131079|Primary Health Care|primary health care
5793253|NCT00131079|Physicians, Family|physicians, family
5793254|NCT00131079|Family Practice|family practice
5793255|NCT00131079|Health Promotion|health promotion
5793256|NCT00131079|Randomized Controlled Trials|randomized controlled trials
5793257|NCT00131079|Multicenter Studies|multicenter studies
5793258|NCT00131079|Physical Fitness|physical fitness
5793259|NCT00131079|Quality of Life|quality of life
5793260|NCT00131066|Previously enrolled on a MEDI-507 for psoriasis|previously enrolled on a medi-507 for psoriasis
5793261|NCT00131053|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5793262|NCT00131053|newly diagnosed|newly diagnosed
5793263|NCT00131053|BCR-ABL-negative|bcr-abl-negative
5793264|NCT00131040|Cardiopulmonary|cardiopulmonary
5793265|NCT00131040|Surgery|surgery
5793266|NCT00131040|leukocyte|leukocyte
5793267|NCT00131040|inflammation|inflammation
5793268|NCT00131040|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5793269|NCT00131027|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5793270|NCT00131027|newly diagnosed|newly diagnosed
5793271|NCT00131027|BCR-ABL-negative|bcr-abl-negative
5793272|NCT00131014|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5794953|NCT00124852|depression|depression
5793273|NCT00131014|Hodgkin's disease|hodgkin's disease
5793274|NCT00131014|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5793275|NCT00131014|Lymphoproliferative disorder|lymphoproliferative disorder
5793276|NCT00131014|Genetics|genetics
5793277|NCT00131001|Carotid artery stenosis|carotid artery stenosis
5793278|NCT00131001|cost effectiveness|cost effectiveness
5793279|NCT00131001|magnetic resonance angiography|magnetic resonance angiography
5793280|NCT00131001|computed tomography angiography|computed tomography angiography
5793281|NCT00131001|digital subtraction angiography|digital subtraction angiography
5793282|NCT00130988|Somatoform Disorders|somatoform disorders
5793283|NCT00130988|Medically unexplained symptoms|medically unexplained symptoms
5793284|NCT00130988|Physician-Patient Relations|physician-patient relations
5793285|NCT00130988|Primary Health Care|primary health care
5793286|NCT00130988|Family Physician|family physician
5793287|NCT00130988|psychosocial therapy|psychosocial therapy
5793288|NCT00130988|re-attribution of symptoms|re-attribution of symptoms
5793289|NCT00130988|cluster randomised controlled trial|cluster randomised controlled trial
5793290|NCT00130975|Atrial fibrillation.|atrial fibrillation.
5793291|NCT00130975|Cardioversion.|cardioversion.
5793292|NCT00130975|Recurrence.|recurrence.
5793293|NCT00130975|Candesartan.|candesartan.
5793598|NCT00129753|Lymphoma|lymphoma
5793294|NCT00130962|Intermetatarsal neuroma|intermetatarsal neuroma
5793295|NCT00130962|Morton's neuroma|morton's neuroma
5793296|NCT00130962|ALGRX 4975|algrx 4975
5793297|NCT00130962|capsaicin|capsaicin
5793298|NCT00130949|Acute lateral epicondylitis|acute lateral epicondylitis
5793299|NCT00130949|Tennis elbow|tennis elbow
5793300|NCT00130949|Capsaicin|capsaicin
5793302|NCT00130936|epirubicin|epirubicin
5793303|NCT00130936|solid tumors|solid tumors
5793304|NCT00130923|Risperidone|risperidone
5793305|NCT00130923|Schizophrenia|schizophrenia
5793306|NCT00130923|Substance Use Disorder|substance use disorder
5793307|NCT00130923|Alcohol Use Disorder|alcohol use disorder
5793308|NCT00130923|Treatment|treatment
5793309|NCT00130923|Schizoaffective Disorder|schizoaffective disorder
5793311|NCT00130910|Helminthiasis|helminthiasis
5793312|NCT00130910|Co-infection|co-infection
5793313|NCT00130910|Intestinal immune activation|intestinal immune activation
5793314|NCT00130910|Treatment Naive|treatment naive
5793315|NCT00130884|levosimendan|levosimendan
5788360|NCT00154154|DBT|dbt
5793317|NCT00130884|oral administration|oral administration
5793318|NCT00130871|levosimendan|levosimendan
5793319|NCT00130871|weaning|weaning
5793320|NCT00130871|cardio-pulmonary bypass|cardio-pulmonary bypass
5793321|NCT00130858|Sarcoma, Soft Tissue|sarcoma, soft tissue
5793322|NCT00130845|Diabetic retinopathy, Octreotide Acetate in Microspheres|diabetic retinopathy, octreotide acetate in microspheres
5793323|NCT00130819|Drug Dependence|drug dependence
5793324|NCT00130819|Opiate Dependence|opiate dependence
5793325|NCT00130819|Human Immunodeficiency Viruses|human immunodeficiency viruses
5793326|NCT00130819|Buprenorphine|buprenorphine
5793327|NCT00130780|Multi-modality treatment for lung cancer|multi-modality treatment for lung cancer
5793328|NCT00130780|Carcinoma, Squamous Cell|carcinoma, squamous cell
5793329|NCT00130780|Bevacizumab|bevacizumab
5793330|NCT00130780|BEACON|beacon
5793331|NCT00130780|05-052|05-052
5793332|NCT00130767|Prostate|prostate
5793333|NCT00130767|apoptosis|apoptosis
5793334|NCT00130767|finasteride kinetics|finasteride kinetics
5793335|NCT00130728|NSCLC|nsclc
5793336|NCT00130728|Avastin|avastin
5793337|NCT00130728|Tarceva|tarceva
5793338|NCT00130728|Lung Cancer|lung cancer
5793339|NCT00130715|Patients undergoing a variety of abdominal surgical procedures|patients undergoing a variety of abdominal surgical procedures
5793340|NCT00130702|AML|aml
5793341|NCT00130702|acute myelogenous leukemia|acute myelogenous leukemia
5793342|NCT00130702|gefitinib|gefitinib
5793343|NCT00130702|Iressa|iressa
5793344|NCT00130689|Esophageal Cancer|esophageal cancer
5793345|NCT00130689|Gastric Cancer|gastric cancer
5793346|NCT00130689|Metastatic Esophageal Cancer|metastatic esophageal cancer
5793347|NCT00130689|Metastatic Gastric Cancer|metastatic gastric cancer
5793348|NCT00130689|Cetuximab|cetuximab
5793349|NCT00130689|Metastatic Esophageal and Gastric Cancer|metastatic esophageal and gastric cancer
5793350|NCT00130676|PMD|pmd
5793351|NCT00130676|Psychotic Major Depression|psychotic major depression
5793352|NCT00130676|Depression|depression
5793353|NCT00130676|Major Depression|major depression
5793354|NCT00130676|Psychosis|psychosis
5793355|NCT00130650|IV|iv
5793356|NCT00130650|cannulation|cannulation
5793357|NCT00130650|Injections, Intravenous|injections, intravenous
5793358|NCT00130637|Anterior Uveitis|anterior uveitis
5793359|NCT00130637|Arthritis, Juvenile Idiopathic|arthritis, juvenile idiopathic
5793360|NCT00130637|Daclizumab|daclizumab
5793361|NCT00130637|Iritis|iritis
5793362|NCT00130637|Immunosuppression|immunosuppression
5793363|NCT00130637|Chronic Inflammatory Eye-Disease|chronic inflammatory eye-disease
5793364|NCT00130637|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5793365|NCT00130624|Falls|falls
5793366|NCT00130624|Elderly|elderly
5793367|NCT00130624|multidisciplinary assessment|multidisciplinary assessment
5793368|NCT00130611|heart failure|heart failure
5793369|NCT00130611|cost effectiveness|cost effectiveness
5793370|NCT00130611|BNP|bnp
5793371|NCT00130611|private practice|private practice
5793372|NCT00130611|Acute dyspnoea|acute dyspnoea
5793373|NCT00130598|contrast nephropathy|contrast nephropathy
5793374|NCT00130598|contrast media|contrast media
5793375|NCT00130598|renal dysfunction|renal dysfunction
5793376|NCT00130585|Folate|folate
5793377|NCT00130585|Bioavailability|bioavailability
5793378|NCT00130585|Stable isotopes|stable isotopes
5793379|NCT00130559|Respiratory failure|respiratory failure
5793380|NCT00130559|BNP|bnp
5793381|NCT00130546|coronary artery disease|coronary artery disease
5793382|NCT00130546|coronary intervention|coronary intervention
5793383|NCT00130546|drug eluting stent implantation|drug eluting stent implantation
5793384|NCT00130546|Cypher - Stent|cypher - stent
5793385|NCT00130546|Sirolimus|sirolimus
5793386|NCT00130546|Taxus - Stent|taxus - stent
5793387|NCT00130546|Paclitaxel|paclitaxel
5793388|NCT00130533|Triple-Negative Early Breast Cancer|triple-negative early breast cancer
5793389|NCT00130533|Maintenance Adjuvant Chemotherapy|maintenance adjuvant chemotherapy
5793390|NCT00130533|Capecitabine|capecitabine
5793391|NCT00130533|Basal-like genotype|basal-like genotype
5793392|NCT00130533|Triple-Negative|triple-negative
5794837|NCT00125281|Fatigue|fatigue
5793393|NCT00130520|advanced ovarian cancer|advanced ovarian cancer
5793394|NCT00130520|refractory ovarian cancer|refractory ovarian cancer
5793395|NCT00130520|primary peritoneal cancer|primary peritoneal cancer
5793396|NCT00130507|HER2 positive breast cancer.|her2 positive breast cancer.
5793397|NCT00130507|Progression to trastuzumab and taxanes.|progression to trastuzumab and taxanes.
5793398|NCT00130494|Non-symptomatic bone metastases.|non-symptomatic bone metastases.
5793399|NCT00130481|Diabetes|diabetes
5793400|NCT00130481|Children|children
5793401|NCT00130481|Adolescents|adolescents
5793402|NCT00130481|Arterial Compliance|arterial compliance
5793403|NCT00130481|Physiology Cardiovascular Endothelium|physiology cardiovascular endothelium
5793404|NCT00130442|phase II|phase ii
5793405|NCT00130442|metastatic melanoma|metastatic melanoma
5793406|NCT00130442|dacarbazine|dacarbazine
5793407|NCT00130442|combination|combination
5793408|NCT00130442|PI-88|pi-88
5793409|NCT00130429|dementia|dementia
5793410|NCT00130429|memory|memory
5788456|NCT00153803|Tarceva|tarceva
5793412|NCT00130429|paired associated learning|paired associated learning
5793413|NCT00130416|behavior|behavior
5793414|NCT00130416|randomized trial|randomized trial
5793415|NCT00130416|communication|communication
5793416|NCT00130416|patient|patient
5793417|NCT00130416|internet|internet
5793418|NCT00130416|coaching|coaching
5793419|NCT00130416|self-efficacy|self-efficacy
5793420|NCT00130416|nurse|nurse
5793421|NCT00130416|primary care|primary care
5793422|NCT00130416|physician|physician
5793423|NCT00130416|screening|screening
5793424|NCT00130416|survey|survey
5793425|NCT00130416|pain|pain
5793426|NCT00130416|mobility|mobility
5793427|NCT00130416|disability|disability
5793428|NCT00130416|depression|depression
5793429|NCT00130390|Crohn's Disease|crohn's disease
5793430|NCT00130377|Stem Cell|stem cell
5793431|NCT00130377|Heart|heart
5793432|NCT00130377|Lung|lung
5793433|NCT00130377|Vascular|vascular
5793434|NCT00130377|cell therapy registry|cell therapy registry
5793435|NCT00130364|Atopic dermatitis|atopic dermatitis
5793436|NCT00130364|T-cell|t-cell
5793437|NCT00130364|pimecrolimus|pimecrolimus
5793438|NCT00130364|children|children
5793439|NCT00130364|facial|facial
5793440|NCT00130364|Facial atopic dermatitis|facial atopic dermatitis
5793441|NCT00130351|asthma, formoterol multi-dose dry powder inhaler (MDDPI)|asthma, formoterol multi-dose dry powder inhaler (mddpi)
5793442|NCT00130338|Dementia|dementia
5793443|NCT00130338|Vascular|vascular
5793444|NCT00130338|Rivastigmine|rivastigmine
5793446|NCT00130338|Memory loss|memory loss
5793447|NCT00130325|ELISPOT,|elispot,
5793448|NCT00130325|tuberculosis,|tuberculosis,
5793449|NCT00130325|Mycobacterium tuberculosis|mycobacterium tuberculosis
5793450|NCT00130325|Isoniazid|isoniazid
5793451|NCT00130325|Clinical trial|clinical trial
5793452|NCT00130312|Diabetes|diabetes
5793453|NCT00130312|Diabetic Nephropathy|diabetic nephropathy
5793454|NCT00130312|Proteinuria|proteinuria
5793455|NCT00130286|Lipodystrophy|lipodystrophy
5793457|NCT00130286|Growth hormone|growth hormone
5793458|NCT00130286|Rosiglitazone|rosiglitazone
5793459|NCT00130286|Visceral fat|visceral fat
5793460|NCT00130286|Metabolic syndrome|metabolic syndrome
5793461|NCT00130286|Treatment Experienced|treatment experienced
5793462|NCT00130286|Visceral fat accumulation|visceral fat accumulation
5793463|NCT00130286|fat accumulation|fat accumulation
5793464|NCT00130286|HIV-Associated Metabolic Syndrome|hiv-associated metabolic syndrome
5793465|NCT00130273|HIV|hiv
5793466|NCT00130273|AIDS|aids
5793467|NCT00130273|Problem Solving|problem solving
5793468|NCT00130273|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5793469|NCT00130273|Patient Compliance|patient compliance
5793470|NCT00130260|Staphylococcus aureus|staphylococcus aureus
5793471|NCT00130260|Vaccine|vaccine
5793472|NCT00130260|Randomized Controlled Trial|randomized controlled trial
5793473|NCT00130247|Brazil|brazil
5793474|NCT00130247|Philippines|philippines
5793475|NCT00130247|Tuberculosis|tuberculosis
5793476|NCT00130247|Uganda|uganda
5793477|NCT00130234|urticaria|urticaria
5793478|NCT00130234|hives|hives
5793479|NCT00130234|Xolair|xolair
5793480|NCT00130221|Chlorhexidine|chlorhexidine
5793481|NCT00130221|Blood stream infections|blood stream infections
5793482|NCT00130221|central venous catheter associated|central venous catheter associated
5793483|NCT00130221|Nosocomial infection|nosocomial infection
5793484|NCT00130221|Bacteremia|bacteremia
5793485|NCT00130221|sepsis|sepsis
5793486|NCT00130221|Pneumonia|pneumonia
5793487|NCT00130221|Urinary tract infection|urinary tract infection
5793488|NCT00130221|Clostridium Difficile|clostridium difficile
5793489|NCT00130221|intensive care unit|intensive care unit
5793490|NCT00130221|catheter|catheter
5793491|NCT00130221|nosocomial pneumonia|nosocomial pneumonia
5793492|NCT00130221|Infection control|infection control
5793493|NCT00130208|Diabetes|diabetes
5793494|NCT00130208|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5793495|NCT00130208|Albuminuria|albuminuria
5793496|NCT00130208|Diabetic Nephropathy|diabetic nephropathy
5793497|NCT00130195|acute lymphoblastic leukemia|acute lymphoblastic leukemia
5793498|NCT00130195|BCR-ABL|bcr-abl
5793499|NCT00130195|Philadelphia-chromosome|philadelphia-chromosome
5793500|NCT00130195|newly diagnosed|newly diagnosed
5793501|NCT00130182|lung disease|lung disease
5793502|NCT00130169|Cancer|cancer
5793503|NCT00130169|malignant tumors|malignant tumors
5793504|NCT00130156|Blood pressure|blood pressure
5793506|NCT00130156|DBP|dbp
5792626|NCT00133757|Craving|craving
5793507|NCT00130117|leptin|leptin
5793508|NCT00130117|hypothalamic amenorrhea|hypothalamic amenorrhea
5793509|NCT00130117|exercise-induced amenorrhea|exercise-induced amenorrhea
5793510|NCT00130117|neuroendocrine function|neuroendocrine function
5793511|NCT00130117|bone metabolism|bone metabolism
5793512|NCT00130104|digital block|digital block
5793513|NCT00130104|regional anesthesia|regional anesthesia
5793514|NCT00130104|finger repair|finger repair
5793515|NCT00130104|Fingers|fingers
5793516|NCT00130104|Anesthesia, Conduction|anesthesia, conduction
5793517|NCT00130091|unilateral|unilateral
5793519|NCT00130091|hydrocele|hydrocele
5793520|NCT00130091|pediatric|pediatric
5793521|NCT00130091|clonidine|clonidine
5793522|NCT00130091|nerve block|nerve block
5793523|NCT00130078|HIV Seronegativity|hiv seronegativity
5793524|NCT00130078|HIV transmission|hiv transmission
5793525|NCT00130065|Malaria|malaria
5793526|NCT00130065|Pregnancy|pregnancy
5793527|NCT00130065|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5793528|NCT00130065|Folic acid|folic acid
5793529|NCT00130065|Folate|folate
5793530|NCT00130039|Infarction, Cerebral|infarction, cerebral
5793531|NCT00130039|cilostazol|cilostazol
5793532|NCT00130039|stenosis|stenosis
5793533|NCT00130039|atherosclerosis|atherosclerosis
5793534|NCT00130039|clopidogrel|clopidogrel
5793535|NCT00130013|Children|children
5793536|NCT00130013|Non-severe pneumonia|non-severe pneumonia
5793537|NCT00130013|Oral amoxicillin|oral amoxicillin
5793538|NCT00130000|h5g.1|h5g.1
5793539|NCT00130000|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5793540|NCT00130000|SHEPHERD|shepherd
5793541|NCT00130000|PNH|pnh
5793542|NCT00129987|Asthma|asthma
5793543|NCT00129974|Lung cancer|lung cancer
5793544|NCT00129974|Phase II|phase ii
5793545|NCT00129974|Drug Therapy|drug therapy
5793546|NCT00129961|Kidney|kidney
5793547|NCT00129961|Transplant|transplant
5793548|NCT00129961|Skin Cancer|skin cancer
5793549|NCT00129948|Acute myeloid leukemia|acute myeloid leukemia
5793550|NCT00129948|AML|aml
5793551|NCT00129948|refractory|refractory
5793552|NCT00129948|relapsed|relapsed
5793553|NCT00129935|HER2 negative breast cancer|her2 negative breast cancer
5793554|NCT00129935|Node positive breast cancer|node positive breast cancer
5793555|NCT00129935|Adjuvant treatment|adjuvant treatment
5793556|NCT00129935|Oral chemotherapy|oral chemotherapy
5793557|NCT00129922|Axillary node positive breast cancer.|axillary node positive breast cancer.
5793558|NCT00129922|Sequential drug administration.|sequential drug administration.
5793559|NCT00129922|Weekly paclitaxel.|weekly paclitaxel.
5793560|NCT00129909|hypertension|hypertension
5793561|NCT00129909|family physicians|family physicians
5793562|NCT00129909|fixed dose combination therapy|fixed dose combination therapy
5793563|NCT00129909|cluster randomized controlled trial|cluster randomized controlled trial
5793564|NCT00129896|Her2neu positive breast cancer.|her2neu positive breast cancer.
5793565|NCT00129896|Neoadjuvant treatment.|neoadjuvant treatment.
5793566|NCT00129883|quality of care|quality of care
5793567|NCT00129883|antibiotic use|antibiotic use
5793568|NCT00129883|intervention|intervention
5793569|NCT00129883|lower respiratory tract infections|lower respiratory tract infections
5793570|NCT00129883|Community acquired Pneumonia|community acquired pneumonia
5793571|NCT00129883|Acute Exacerbation of Chronic Bronchitis or COPD|acute exacerbation of chronic bronchitis or copd
5793572|NCT00129844|Motexafin Gadolinium|motexafin gadolinium
5793573|NCT00129844|non-small cell, lung cancer|non-small cell, lung cancer
5793574|NCT00129844|Lung cancer|lung cancer
5793575|NCT00129844|cancer of the lung|cancer of the lung
5793576|NCT00129844|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5793577|NCT00129831|COPD, indacaterol, PK|copd, indacaterol, pk
5793578|NCT00129818|Genital herpes|genital herpes
5793579|NCT00129818|viral shedding|viral shedding
5793580|NCT00129818|famciclovir|famciclovir
5793581|NCT00129818|Symptomatic genital herpes|symptomatic genital herpes
5793582|NCT00129818|Asymptomatic genital herpes|asymptomatic genital herpes
5793583|NCT00129792|Blood Glucose|blood glucose
5793584|NCT00129792|Cholesterol|cholesterol
5793585|NCT00129792|Weight Loss|weight loss
5793587|NCT00129792|Complementary Therapies|complementary therapies
5793589|NCT00129766|Respiratory Syncytial Virus (RSV)|respiratory syncytial virus (rsv)
5793590|NCT00129766|motavizumab|motavizumab
5793591|NCT00129766|palivizumab|palivizumab
5793592|NCT00129766|Synagis|synagis
5793593|NCT00129753|Campath-1H Monoclonal Antibody|campath-1h monoclonal antibody
5793594|NCT00129753|Alemtuzumab|alemtuzumab
5793595|NCT00129753|Campath|campath
5793596|NCT00129753|Campath-1H|campath-1h
5793597|NCT00129753|Relapsed and Resistant Classical Hodgkin's Disease|relapsed and resistant classical hodgkin's disease
5793599|NCT00129740|Chronic phase CML|chronic phase cml
5793600|NCT00129740|Newly diagnosed chronic phase CML|newly diagnosed chronic phase cml
5793601|NCT00129740|AMN107|amn107
5793602|NCT00129727|Carboplatin|carboplatin
5793603|NCT00129727|Paclitaxel|paclitaxel
5793604|NCT00129727|Bevacizumab|bevacizumab
5793605|NCT00129727|Ovarian|ovarian
5793606|NCT00129727|Cancer|cancer
5793607|NCT00129714|cervical radiculopathy conservative treatment|cervical radiculopathy conservative treatment
5793608|NCT00129701|phone consultation in secondary care|phone consultation in secondary care
5793609|NCT00129688|febrile neutropenia|febrile neutropenia
5793610|NCT00129688|once-daily|once-daily
5793611|NCT00129688|amikacin|amikacin
5793612|NCT00129688|cloxacillin|cloxacillin
5793613|NCT00129688|children|children
5793614|NCT00129675|parkinson|parkinson
5793615|NCT00129675|diagnosis|diagnosis
5793616|NCT00129662|Pictorial action plan|pictorial action plan
5793617|NCT00129649|Telephone reminder|telephone reminder
5793618|NCT00129636|post consultation letter|post consultation letter
5793620|NCT00129610|panic disorder|panic disorder
5793621|NCT00129610|Virtual Reality Therapy|virtual reality therapy
5793622|NCT00129610|Cognitive Behavior Therapy|cognitive behavior therapy
5793623|NCT00129610|cognition|cognition
5793624|NCT00129610|spatial cognition|spatial cognition
5793625|NCT00129610|PANIC DISORDER WITH AGORAPHOBIA|panic disorder with agoraphobia
5793626|NCT00129597|Ketalar|ketalar
5793627|NCT00129597|NMDA|nmda
5793628|NCT00129597|mastectomy|mastectomy
5793629|NCT00129597|postoperative chronic pain|postoperative chronic pain
5793630|NCT00129597|Chronic pain after mastectomy for breast cancer|chronic pain after mastectomy for breast cancer
5793631|NCT00129584|Endobronchial Valve (EBV) Procedure|endobronchial valve (ebv) procedure
5793632|NCT00129584|Bronchoscopic Lung Volume Reduction|bronchoscopic lung volume reduction
5793633|NCT00129545|Atrial Fibrillation|atrial fibrillation
5793635|NCT00129545|A Fib|a fib
5793636|NCT00129545|Stroke|stroke
5793637|NCT00129545|Coumadin|coumadin
5793638|NCT00129545|Warfarin|warfarin
5793639|NCT00129545|Blood thinning medication|blood thinning medication
5793640|NCT00129545|transient ischemic attack (TIA)|transient ischemic attack (tia)
5793641|NCT00129545|WATCHMAN|watchman
5793642|NCT00129545|Left atrial appendage|left atrial appendage
5793643|NCT00129545|LAA isolation|laa isolation
5793644|NCT00129545|LAA occlusion|laa occlusion
5793645|NCT00129532|HIV transmission|hiv transmission
5793646|NCT00129519|BCC curettage|bcc curettage
5793647|NCT00129506|medical abortion|medical abortion
5808683|NCT00087529|PPMS|ppms
5793648|NCT00129506|methotrexate|methotrexate
5793649|NCT00129506|misoprostol|misoprostol
5793650|NCT00129493|Practice guidelines|practice guidelines
5793651|NCT00129493|Hypertension|hypertension
5793652|NCT00129493|Primary health care|primary health care
5793653|NCT00129493|Patient-centered care|patient-centered care
5793654|NCT00129493|Healthcare quality|healthcare quality
5793655|NCT00129493|Office visits|office visits
5793656|NCT00129493|Self-efficacy|self-efficacy
5793657|NCT00129493|Self care|self care
5793658|NCT00129493|Guideline adherence|guideline adherence
5793659|NCT00129493|Patient noncompliance|patient noncompliance
5793660|NCT00129480|veterans|veterans
5793661|NCT00129480|pain and chronic disease|pain and chronic disease
5793662|NCT00129480|disease management|disease management
5793663|NCT00129480|depression|depression
5793664|NCT00129480|primary health care|primary health care
5793665|NCT00129480|practice guidelines|practice guidelines
5793666|NCT00129480|guideline adherence|guideline adherence
5793667|NCT00129480|narcotics|narcotics
5793668|NCT00129480|patient compliance|patient compliance
5793669|NCT00129480|randomized controlled trial|randomized controlled trial
5793670|NCT00129467|Depression|depression
5793671|NCT00129467|Hospice Care|hospice care
5793672|NCT00129467|Antidepressive Agents|antidepressive agents
5793673|NCT00129467|Methylphenidate|methylphenidate
5793674|NCT00129467|Central Nervous System Stimulant|central nervous system stimulant
5793676|NCT00129467|Caregiver Burden|caregiver burden
5793677|NCT00129467|Cancer|cancer
5793678|NCT00129454|Telemedicine|telemedicine
5793679|NCT00129454|Cognitive Behavior Therapy|cognitive behavior therapy
5793680|NCT00129454|Utilization|utilization
5793681|NCT00129454|Randomized Control Trial|randomized control trial
5793682|NCT00129454|Gulf War Illness|gulf war illness
5793683|NCT00129454|Symptom-Based Illness|symptom-based illness
5793684|NCT00129454|Multisymptom Illness|multisymptom illness
5793685|NCT00129454|High utilization|high utilization
5793686|NCT00129441|schizophrenia|schizophrenia
5793687|NCT00129428|UVB|uvb
5793688|NCT00129428|keloid|keloid
5793689|NCT00129428|scleroderma|scleroderma
5793690|NCT00129428|acne keloidalis nuchae|acne keloidalis nuchae
5793691|NCT00129428|scars|scars
5793692|NCT00129428|granuloma annulare|granuloma annulare
5793693|NCT00129415|UVA1|uva1
5793694|NCT00129415|UVB|uvb
5793695|NCT00129415|atopic dermatitis|atopic dermatitis
5793696|NCT00129415|psoriasis|psoriasis
5793697|NCT00129415|alopecia|alopecia
5793698|NCT00129415|mycosis fungoides (CTCL)|mycosis fungoides (ctcl)
5793699|NCT00129415|urticaria|urticaria
5793700|NCT00129415|inflammatory dermatoses|inflammatory dermatoses
5793701|NCT00129415|stretch marks|stretch marks
5793702|NCT00129402|cholesterol|cholesterol
5793703|NCT00129402|drugs|drugs
5793704|NCT00129402|hypercholesterolemia|hypercholesterolemia
5793705|NCT00129402|adolescent|adolescent
5793706|NCT00129402|randomized controlled trials|randomized controlled trials
5793707|NCT00129389|Node negative, high risk breast cancer.|node negative, high risk breast cancer.
5793708|NCT00129389|Prognostic gene profile.|prognostic gene profile.
5686492|NCT00551824|esophageal stricture|esophageal stricture
5686493|NCT00551811|SB-656933-AAA,|sb-656933-aaa,
5686494|NCT00551811|ozone challenge|ozone challenge
5686495|NCT00551811|single dose,|single dose,
5681140|NCT00574574|inflammation|inflammation
5686496|NCT00551798|Hodgkin's Disease|hodgkin's disease
5686497|NCT00551798|Malignant lymphomas high grade|malignant lymphomas high grade
5686498|NCT00551798|Chemoresistance|chemoresistance
5686499|NCT00551798|MIBI|mibi
5686500|NCT00551798|PGP|pgp
5686501|NCT00551798|MRP1|mrp1
5686502|NCT00551798|Tumor response|tumor response
5793709|NCT00129389|Saint Gallen high risk criteria.|saint gallen high risk criteria.
5793710|NCT00129389|Weekly paclitaxel.|weekly paclitaxel.
5793711|NCT00129376|Stage II and IIIA breast Cancer.|stage ii and iiia breast cancer.
5793712|NCT00129376|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5793713|NCT00129376|Weekly docetaxel.|weekly docetaxel.
5793714|NCT00129363|Adolescent|adolescent
5793715|NCT00129363|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
5793716|NCT00129363|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
5793717|NCT00129363|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
5793718|NCT00129363|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
5793719|NCT00129363|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
5793720|NCT00129363|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
5793721|NCT00129363|Age Factors|age factors
5793722|NCT00129363|Carbazoles/therapeutic use|carbazoles/therapeutic use
5793723|NCT00129363|Carbazoles/administration & dosage|carbazoles/administration & dosage
5793724|NCT00129363|Child|child
5793725|NCT00129363|Child, Preschool|child, preschool
5793726|NCT00129363|Drug Administration Schedule|drug administration schedule
5793727|NCT00129363|Female|female
5793728|NCT00129363|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
5793729|NCT00129363|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
5793730|NCT00129363|Heart Failure, Congestive/blood|heart failure, congestive/blood
5793731|NCT00129363|Human|human
5793732|NCT00129363|Infant|infant
5793733|NCT00129363|Infant, Newborn|infant, newborn
5793734|NCT00129363|Male|male
5793735|NCT00129363|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
5793736|NCT00129363|Placebos|placebos
5793737|NCT00129363|Propanolamines/therapeutic use|propanolamines/therapeutic use
5793738|NCT00129363|Propanolamines/administration & dosage|propanolamines/administration & dosage
5793739|NCT00129363|Prospective Studies|prospective studies
5793740|NCT00129363|Support, Non-U.S. Gov't|support, non-u.s. gov't
5793741|NCT00129363|Treatment Outcome|treatment outcome
5793742|NCT00129363|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
5793743|NCT00129363|Ventricular Dysfunction/complications|ventricular dysfunction/complications
5793744|NCT00129363|Ventricular Dysfunction/blood|ventricular dysfunction/blood
5793745|NCT00129363|Ventricular Function/drug effects|ventricular function/drug effects
5793746|NCT00129363|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
5793747|NCT00129350|End Stage Fibrotic Lung Disease|end stage fibrotic lung disease
5793748|NCT00129337|monoclonal antibody|monoclonal antibody
5793749|NCT00129337|phase 1|phase 1
5793750|NCT00129337|solid tumor|solid tumor
5793751|NCT00129337|anti-angiogenesis|anti-angiogenesis
5793752|NCT00129337|refractory advanced solid tumor malignancy|refractory advanced solid tumor malignancy
5793753|NCT00129324|HOME|home
5793754|NCT00129324|Environmental Exposure|environmental exposure
5793755|NCT00129324|Neurobehavior|neurobehavior
5793756|NCT00129324|Child Development|child development
5793757|NCT00129324|Lead Exposure|lead exposure
5793758|NCT00129324|Child Injury|child injury
5793759|NCT00129324|Adolescence|adolescence
5793760|NCT00129324|Adiposity|adiposity
5793761|NCT00129324|Neuroimaging|neuroimaging
5793762|NCT00129311|Tobacco|tobacco
5793763|NCT00129298|cocaine abuse|cocaine abuse
5681174|NCT00574457|Handheld ultrasound|handheld ultrasound
5681175|NCT00574457|Office Practice|office practice
5681176|NCT00574457|Carotid Intima Media Thickness|carotid intima media thickness
5681177|NCT00574457|Carotid Plaque|carotid plaque
5803242|NCT00096083|insulinoma|insulinoma
5793764|NCT00129298|opiate dependent|opiate dependent
5793765|NCT00129298|tiagabine|tiagabine
5793766|NCT00129298|methadone|methadone
5793767|NCT00129285|cocaine|cocaine
5793768|NCT00129272|adolescents, cigarettes, smoking, tobacco|adolescents, cigarettes, smoking, tobacco
5793770|NCT00129259|type 1 diabetes|type 1 diabetes
5793771|NCT00129259|type 1 diabetes mellitus|type 1 diabetes mellitus
5793772|NCT00129259|juvenile diabetes|juvenile diabetes
5792856|NCT00132535|HIV|hiv
5793773|NCT00129259|autoimmune diabetes|autoimmune diabetes
5793774|NCT00129259|autoimmune|autoimmune
5793775|NCT00129259|anti-CD3 mAb|anti-cd3 mab
5793776|NCT00129259|mAb hOKT3g1(Ala-Ala)|mab hokt3g1(ala-ala)
5793777|NCT00129259|teplizumab|teplizumab
5793778|NCT00129246|Tobacco|tobacco
5793779|NCT00129246|Smoking|smoking
5793780|NCT00129246|Weight|weight
5793781|NCT00129246|Weight perception|weight perception
5793782|NCT00129246|Naltrexone|naltrexone
5793783|NCT00129246|Bupropion|bupropion
5793784|NCT00129233|cardiovascular disease|cardiovascular disease
5793785|NCT00129233|rennin-angiotensin system|rennin-angiotensin system
5793786|NCT00129233|calcium channel blocker|calcium channel blocker
5793787|NCT00129233|impaired glucose tolerance|impaired glucose tolerance
5793788|NCT00129220|Manic or mixed episode associated with bipolar I disorder|manic or mixed episode associated with bipolar i disorder
5793789|NCT00129207|pharmacokinetic|pharmacokinetic
5793812|NCT00129155|Haematological malignancies|haematological malignancies
5793813|NCT00129155|allogeneic stem cell transplantation in patients with hematological malignancies|allogeneic stem cell transplantation in patients with hematological malignancies
5793814|NCT00129142|Prostate cancer|prostate cancer
5793815|NCT00129142|Bone Loss|bone loss
5793816|NCT00129142|Osteoporosis|osteoporosis
5793817|NCT00129142|Fractures|fractures
5793818|NCT00129142|Androgen Deprivation Therapy|androgen deprivation therapy
5793819|NCT00129129|Immunogenicity|immunogenicity
5793820|NCT00129129|Primary & booster vaccination|primary & booster vaccination
5793821|NCT00129129|Infants|infants
5793822|NCT00129129|Meningococcal vaccine|meningococcal vaccine
5793824|NCT00129129|Children|children
5793825|NCT00129129|Hib disease|hib disease
5793826|NCT00129129|Meningococcal disease|meningococcal disease
5793827|NCT00129116|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
5793828|NCT00129116|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
5793829|NCT00129077|Pediatric critical care|pediatric critical care
5793830|NCT00129077|neuromuscular blocking agents|neuromuscular blocking agents
5793831|NCT00129077|corneal abrasions|corneal abrasions
5793832|NCT00129064|Referrals|referrals
5793833|NCT00129064|Quality of care|quality of care
5793834|NCT00129064|Ambulatory care|ambulatory care
5793835|NCT00129064|Electronic medical record|electronic medical record
5793836|NCT00129064|Referral communication|referral communication
5793837|NCT00129051|tomotherapy|tomotherapy
5793838|NCT00129051|metastatic carcinoma|metastatic carcinoma
5793839|NCT00129025|conformal hypofractionated radiotherapy|conformal hypofractionated radiotherapy
5793840|NCT00129025|localized prostate cancer|localized prostate cancer
5793841|NCT00129012|radiation therapy|radiation therapy
5793842|NCT00129012|carcinoma|carcinoma
5793843|NCT00129012|non-small cell lung|non-small cell lung
5793844|NCT00128999|radiation therapy|radiation therapy
5793845|NCT00128986|radiotherapy|radiotherapy
5793846|NCT00128986|brain|brain
5793868|NCT00128947|Immunosuppresant|immunosuppresant
5793869|NCT00128947|Pharmacogenetics|pharmacogenetics
5793870|NCT00128947|Glucuronidation|glucuronidation
5793871|NCT00128947|Metabolism|metabolism
5793872|NCT00128947|UGT|ugt
5793873|NCT00128934|Premenstrual Syndrome (PMS)|premenstrual syndrome (pms)
5793874|NCT00128934|Hormone Therapy|hormone therapy
5793875|NCT00128921|Multiple Myeloma|multiple myeloma
5793876|NCT00128908|HIV-1|hiv-1
5793877|NCT00128908|HAART|haart
5808859|NCT00086632|ovarex|ovarex
5793878|NCT00128908|sequential HAART|sequential haart
5793879|NCT00128908|resistance|resistance
5793881|NCT00128908|Treatment Experienced|treatment experienced
5793882|NCT00128895|Wegener's granulomatosis, ANCA, vasculitis, proteinase 3|wegener's granulomatosis, anca, vasculitis, proteinase 3
5793883|NCT00128895|ANCA-associated vasculitis|anca-associated vasculitis
5793884|NCT00128895|ANCA|anca
5793885|NCT00128882|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5793886|NCT00128882|Treatment|treatment
5793887|NCT00128882|Anti-D|anti-d
5793888|NCT00128882|Subcutaneous|subcutaneous
5794838|NCT00125281|Cirrhosis|cirrhosis
5793889|NCT00128882|Clinical evaluation|clinical evaluation
5793890|NCT00128882|Platelet count|platelet count
5793891|NCT00128882|IVIG|ivig
5793892|NCT00128869|Manipulation|manipulation
5793893|NCT00128869|Mobilization|mobilization
5793894|NCT00128869|Neck Pain|neck pain
5793895|NCT00128869|Physical Therapy|physical therapy
5793896|NCT00128856|Neoadjuvant chemotherapy.|neoadjuvant chemotherapy.
5793897|NCT00128856|Stage III disease.|stage iii disease.
5793898|NCT00128843|Metastatic breast cancer|metastatic breast cancer
5793899|NCT00128843|First line of hormone treatment|first line of hormone treatment
5793900|NCT00128843|Postmenopausal women|postmenopausal women
5793901|NCT00128843|Positive hormone receptor tumours|positive hormone receptor tumours
5793902|NCT00128830|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5793903|NCT00128830|HIV-1 infection|hiv-1 infection
5793905|NCT00128830|Etravirine|etravirine
5793906|NCT00128830|Enfuvirtide|enfuvirtide
5793907|NCT00128830|Antiretroviral therapy|antiretroviral therapy
5793908|NCT00128817|neoplasm|neoplasm
5793909|NCT00128817|larynx|larynx
5793910|NCT00128817|surgery|surgery
5793911|NCT00128817|radiotherapy|radiotherapy
5793912|NCT00128817|chemotherapy|chemotherapy
5793913|NCT00128804|vitamin A|vitamin a
5793914|NCT00128804|beta Carotene|beta carotene
5793915|NCT00128804|diet|diet
5793916|NCT00128804|nutrition|nutrition
5793917|NCT00128804|nutritional requirements|nutritional requirements
5793918|NCT00128791|myocardial infarction|myocardial infarction
5793919|NCT00128791|angioplasty|angioplasty
5793920|NCT00128791|nitric oxide|nitric oxide
5793921|NCT00128791|prevention|prevention
5793922|NCT00128791|acute myocardial infarction|acute myocardial infarction
5793923|NCT00128778|Breast cancer|breast cancer
5793924|NCT00128778|Metastases|metastases
5793925|NCT00128778|Maintenance treatment|maintenance treatment
5793926|NCT00128765|chronic obstructive pulmonary disease (COPD)|chronic obstructive pulmonary disease (copd)
5793927|NCT00128765|self-management|self-management
5793928|NCT00128765|practice nurse|practice nurse
5793929|NCT00128765|cost-effectiveness|cost-effectiveness
5793930|NCT00128765|randomized controlled trial|randomized controlled trial
5793931|NCT00128752|vitamin A|vitamin a
5793932|NCT00128752|beta Carotene|beta carotene
5793933|NCT00128752|diet|diet
5793934|NCT00128752|nutrition|nutrition
5793935|NCT00128752|nutritional requirements|nutritional requirements
5793936|NCT00128726|continuous combined oral contraceptive|continuous combined oral contraceptive
5793937|NCT00128726|endometrial and ovarian suppression|endometrial and ovarian suppression
5793938|NCT00128713|Blood Transfusion|blood transfusion
5793939|NCT00128713|Blood Platelets|blood platelets
5793940|NCT00128700|adult glioblastoma|adult glioblastoma
5793941|NCT00128700|adult giant cell glioblastoma|adult giant cell glioblastoma
5793942|NCT00128700|adult gliosarcoma|adult gliosarcoma
5793943|NCT00128661|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5793944|NCT00128661|cervical cancer|cervical cancer
5793945|NCT00128661|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5793946|NCT00128635|adult glioblastoma|adult glioblastoma
5793947|NCT00128635|adult gliosarcoma|adult gliosarcoma
5793948|NCT00128635|adult giant cell glioblastoma|adult giant cell glioblastoma
5793949|NCT00128635|recurrent adult brain tumor|recurrent adult brain tumor
5793950|NCT00128622|male breast cancer|male breast cancer
5793951|NCT00128622|recurrent breast cancer|recurrent breast cancer
5793952|NCT00128622|stage IV breast cancer|stage iv breast cancer
5793953|NCT00128622|recurrent colon cancer|recurrent colon cancer
5793954|NCT00128622|stage IV colon cancer|stage iv colon cancer
5793955|NCT00128622|recurrent rectal cancer|recurrent rectal cancer
5793956|NCT00128622|stage IV rectal cancer|stage iv rectal cancer
5793957|NCT00128622|recurrent pancreatic cancer|recurrent pancreatic cancer
5793958|NCT00128622|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5793959|NCT00128622|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5793960|NCT00128622|recurrent small cell lung cancer|recurrent small cell lung cancer
5793961|NCT00128622|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5793962|NCT00128622|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5793963|NCT00128622|stage IV pancreatic cancer|stage iv pancreatic cancer
5793964|NCT00128596|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5793965|NCT00128596|advanced adult primary liver cancer|advanced adult primary liver cancer
5793966|NCT00128596|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5808917|NCT00003091|recurrent melanoma|recurrent melanoma
5808918|NCT00002953|stage IV breast cancer|stage iv breast cancer
5808919|NCT00002922|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5808920|NCT00002922|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5793967|NCT00128583|stage III melanoma|stage iii melanoma
5793968|NCT00128570|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5793969|NCT00128557|Vitamin A|vitamin a
5793970|NCT00128557|Newborn health|newborn health
5793971|NCT00128557|Infant Mortality|infant mortality
5793972|NCT00128557|Supplementation|supplementation
5793973|NCT00128557|Micronutrients|micronutrients
5793974|NCT00128557|Bangladesh|bangladesh
5793975|NCT00128531|Phase III|phase iii
5793976|NCT00128531|open label|open label
5793977|NCT00128531|multiple dose|multiple dose
5793978|NCT00128531|safety study|safety study
5793979|NCT00128531|pharmacokinetic study|pharmacokinetic study
5793980|NCT00128531|efficacy study|efficacy study
5793981|NCT00128518|Hypertension - Drugs - Blood pressure response - Responders - pharmacogenetics|hypertension - drugs - blood pressure response - responders - pharmacogenetics
5793982|NCT00128505|PMD|pmd
5793983|NCT00128505|Depression|depression
5793984|NCT00128505|Psychosis|psychosis
5793985|NCT00128505|Psychotic Major Depression|psychotic major depression
5793986|NCT00128505|Major Depression|major depression
5793987|NCT00128492|cystic fibrosis|cystic fibrosis
5793988|NCT00128492|Pseudomonas aeruginosa|pseudomonas aeruginosa
5793989|NCT00128479|PMD|pmd
5793990|NCT00128479|Psychotic Depression|psychotic depression
5793991|NCT00128479|Psychosis|psychosis
5793992|NCT00128479|Major Depression|major depression
5793993|NCT00128479|Depression|depression
5793994|NCT00128479|Psychotic Major Depression|psychotic major depression
5793065|NCT00131781|suicide|suicide
5793995|NCT00128466|bubonic plague|bubonic plague
5793996|NCT00128466|pneumonic plague|pneumonic plague
5793997|NCT00128466|septicemic plague|septicemic plague
5793998|NCT00128466|Yersinia pestis|yersinia pestis
5793999|NCT00128466|Pasteurella pestis|pasteurella pestis
5794000|NCT00128453|Pericarditis|pericarditis
5794001|NCT00128453|Recurrence|recurrence
5794002|NCT00128453|Therapeutics|therapeutics
5794003|NCT00128453|Prevention|prevention
5794004|NCT00128453|Colchicine|colchicine
5794005|NCT00128427|Postpericardiotomy Syndrome|postpericardiotomy syndrome
5794006|NCT00128427|Pericarditis|pericarditis
5794007|NCT00128427|Prevention|prevention
5794008|NCT00128427|Colchicine|colchicine
5794009|NCT00128427|Recurrence|recurrence
5794010|NCT00128414|Pericarditis|pericarditis
5794011|NCT00128414|Recurrence|recurrence
5794012|NCT00128414|Therapeutics|therapeutics
5794013|NCT00128414|Prevention|prevention
5794014|NCT00128414|Colchicine|colchicine
5794015|NCT00128401|Cognitive|cognitive
5794016|NCT00128401|Behavioral|behavioral
5794017|NCT00128401|Adolescent|adolescent
5794018|NCT00128401|Therapy|therapy
5794019|NCT00128401|Extinction|extinction
5794020|NCT00128401|Social Phobia|social phobia
5794021|NCT00128388|panic disorder,|panic disorder,
5794022|NCT00128388|psychodynamic psychotherapy,|psychodynamic psychotherapy,
5794023|NCT00128388|efficacy trial|efficacy trial
5794024|NCT00128375|Smoking Cessation|smoking cessation
5794025|NCT00128375|Work-site|work-site
5794026|NCT00128375|Incentives|incentives
5794027|NCT00128375|Cost Effectiveness|cost effectiveness
5794028|NCT00128375|Health Behavior|health behavior
5794030|NCT00128362|Sentinel node|sentinel node
5794031|NCT00128362|Axillary sampling|axillary sampling
5794032|NCT00128362|Operable breast cancer|operable breast cancer
5794033|NCT00128336|Weight|weight
5794034|NCT00128336|Diet|diet
5794035|NCT00128336|exercise|exercise
5794036|NCT00128336|maintenance|maintenance
5794037|NCT00128323|Children|children
5794038|NCT00128323|oropharyngeal candidiasis|oropharyngeal candidiasis
5794039|NCT00128323|GV solution|gv solution
5794040|NCT00128323|nystatin drops|nystatin drops
5794041|NCT00128310|Drug-resistant metastatic breast cancer|drug-resistant metastatic breast cancer
5794042|NCT00128297|Breast cancer patients with symptomatic bone metastases|breast cancer patients with symptomatic bone metastases
5794043|NCT00128284|gastroparesis|gastroparesis
5794044|NCT00128284|Digestive|digestive
5794045|NCT00128284|Gastrointestinal|gastrointestinal
5794046|NCT00128284|Stomach|stomach
5794047|NCT00128284|Motility|motility
5794048|NCT00128284|Non-Invasive|non-invasive
5794049|NCT00128284|Capsule|capsule
5794051|NCT00128284|Device|device
5794052|NCT00128284|Digestive System Diseases|digestive system diseases
5794053|NCT00128271|HCV|hcv
5794054|NCT00128271|monoclonal antibody|monoclonal antibody
5794055|NCT00128271|phase 1|phase 1
5794056|NCT00128258|Stem Cell|stem cell
5794057|NCT00128258|Heart Failure|heart failure
5794058|NCT00128258|Bone Marrow|bone marrow
5794060|NCT00128245|dry eye|dry eye
5794061|NCT00128245|pimecrolimus|pimecrolimus
5794062|NCT00128245|Keratoconjunctivitis sicca (dry eye syndrome)|keratoconjunctivitis sicca (dry eye syndrome)
5794063|NCT00128232|Acromegaly|acromegaly
5794064|NCT00128232|untreated|untreated
5794065|NCT00128232|newly diagnosed|newly diagnosed
5794066|NCT00128232|octreotide LAR|octreotide lar
5794067|NCT00128219|Group B Streptococcus, women, vaccine|group b streptococcus, women, vaccine
5794068|NCT00128206|LTBI, tuberculosis, rifampin, isoniazid, prisoners|ltbi, tuberculosis, rifampin, isoniazid, prisoners
5794069|NCT00128193|leprosy, Mycobacterium leprae, Hansen's Disease, skin test, Nepal|leprosy, mycobacterium leprae, hansen's disease, skin test, nepal
5794070|NCT00128180|hantaviruses, methylprednisolone, cardiopulmonary syndrome|hantaviruses, methylprednisolone, cardiopulmonary syndrome
5794071|NCT00128154|Chromium|chromium
5794072|NCT00128154|Chromium picolinate|chromium picolinate
5794073|NCT00128154|Blood Glucose|blood glucose
5794074|NCT00128154|Cholesterol|cholesterol
5794075|NCT00128154|Complementary Therapies|complementary therapies
5794076|NCT00128128|Vaccinium macrocarpon|vaccinium macrocarpon
5794077|NCT00128128|Cranberry|cranberry
5794078|NCT00128128|Complementary Therapies|complementary therapies
5794079|NCT00128102|Advanced malignant pleural mesothelioma|advanced malignant pleural mesothelioma
5794080|NCT00128089|Obesity|obesity
5794081|NCT00128089|Dietary treatment|dietary treatment
5794082|NCT00128089|Fasting as medical therapy|fasting as medical therapy
5794083|NCT00128076|shoulder surgery|shoulder surgery
5794084|NCT00128076|rotator cuff|rotator cuff
5794085|NCT00128076|arthroscopic repair|arthroscopic repair
5794086|NCT00128076|mini-open repair|mini-open repair
5794087|NCT00128063|HIV-1|hiv-1
5794088|NCT00128063|succinylated human serum albumin|succinylated human serum albumin
5794089|NCT00128063|Treatment Naive|treatment naive
5794090|NCT00128050|Spontaneous intracerebral hemorrhage|spontaneous intracerebral hemorrhage
5794092|NCT00128050|intracerebral rebleeding|intracerebral rebleeding
5794093|NCT00128050|cerebral hematoma evacuation|cerebral hematoma evacuation
5794094|NCT00128050|cerebral hematoma volume|cerebral hematoma volume
5794095|NCT00128037|pulmonary neoplasm|pulmonary neoplasm
5794096|NCT00128037|preoperative chemoradiotherapy|preoperative chemoradiotherapy
5794097|NCT00128037|surgical resection|surgical resection
5794098|NCT00128037|superior sulcus tumor|superior sulcus tumor
5794099|NCT00128037|chest wall invasion|chest wall invasion
5794100|NCT00128037|mytomicin C|mytomicin c
5794101|NCT00128037|vindesine|vindesine
5794102|NCT00128037|cisplatin|cisplatin
5794103|NCT00128024|randomized prospective study|randomized prospective study
5794104|NCT00128024|lipid-lowering therapy with any available statins|lipid-lowering therapy with any available statins
5794105|NCT00128024|multicenter study|multicenter study
5794106|NCT00128024|Japanese|japanese
5794107|NCT00128024|acute myocardial infarction|acute myocardial infarction
5794108|NCT00128024|primary percutaneous coronary intervention|primary percutaneous coronary intervention
5794109|NCT00128011|watery diarrhea|watery diarrhea
5794110|NCT00128011|cholera vaccine|cholera vaccine
5794111|NCT00127998|malaria|malaria
5794112|NCT00127998|Plasmodium falciparum|plasmodium falciparum
5794113|NCT00127998|drug resistance|drug resistance
5794114|NCT00127998|antimalarials|antimalarials
5794115|NCT00127998|genotype|genotype
5794116|NCT00127998|treatment outcome|treatment outcome
5794117|NCT00127985|multiple organ dysfunction syndrome|multiple organ dysfunction syndrome
5794118|NCT00127985|corticosteroids|corticosteroids
5794119|NCT00127985|mortality|mortality
5794120|NCT00127972|nevirapine|nevirapine
5794121|NCT00127972|efavirenz|efavirenz
5794122|NCT00127972|hiv-1|hiv-1
5794123|NCT00127972|Treatment Experienced|treatment experienced
5794124|NCT00127959|HIV-1|hiv-1
5794125|NCT00127959|HBV|hbv
5794126|NCT00127959|treatment|treatment
5794128|NCT00127959|emtricitabine|emtricitabine
5794129|NCT00127959|Treatment Naive|treatment naive
5794130|NCT00127959|HIV-1 infection|hiv-1 infection
5794131|NCT00127959|Hepatitis B virus infection|hepatitis b virus infection
5794132|NCT00127907|Out-of-hospital cardiac arrest - Vasopressin - Epinephrine|out-of-hospital cardiac arrest - vasopressin - epinephrine
5794133|NCT00127881|Refractory or intolerant to Mycosis Fungoides and sezary syndrome|refractory or intolerant to mycosis fungoides and sezary syndrome
5794134|NCT00127881|Cutaneous T-cell Lymphoma|cutaneous t-cell lymphoma
5794135|NCT00127881|To evaluate the efficacy and safety of zanolimumab in Mycosis Fungoides and sezary syndrome|to evaluate the efficacy and safety of zanolimumab in mycosis fungoides and sezary syndrome
5794136|NCT00127868|Tinea Capitis|tinea capitis
5794137|NCT00127868|Children|children
5794138|NCT00127868|Pediatric|pediatric
5794139|NCT00127868|Treatment|treatment
5794140|NCT00127868|Therapy|therapy
5794141|NCT00127868|Adjunctive|adjunctive
5794142|NCT00127868|Selenium Sulfide|selenium sulfide
5794143|NCT00127868|Ciclopirox|ciclopirox
5794144|NCT00127868|Shampoo|shampoo
5794145|NCT00127855|Invasive bacterial disease caused by Hib|invasive bacterial disease caused by hib
5794146|NCT00127855|Neisseria meningitidis serogroups C & Y|neisseria meningitidis serogroups c & y
5794147|NCT00127842|Psoriatic Arthritis|psoriatic arthritis
5794148|NCT00127842|PsA|psa
5809084|NCT00086190|depression|depression
5794149|NCT00127842|Commercial product|commercial product
5794150|NCT00127842|American College of Rheumatology|american college of rheumatology
5794151|NCT00127842|ACR/PASI|acr/pasi
5794152|NCT00127829|Solid Tumors|solid tumors
5794153|NCT00127816|brachytherapy|brachytherapy
5794154|NCT00127816|implant radiotherapy|implant radiotherapy
5794155|NCT00127803|Clostridium difficile|clostridium difficile
5794156|NCT00127790|Insomnia|insomnia
5794157|NCT00127790|Sleep|sleep
5794158|NCT00127790|Pain|pain
5794159|NCT00127790|Pain, Chronic|pain, chronic
5794160|NCT00127790|Behavior Therapy|behavior therapy
5794161|NCT00127790|CBT|cbt
5794162|NCT00127790|CBT-I|cbt-i
5794163|NCT00127790|cognitive-behavioral|cognitive-behavioral
5794164|NCT00127777|HCV genotype 1|hcv genotype 1
5794165|NCT00127777|peginterferon alfa-2a|peginterferon alfa-2a
5794166|NCT00127777|ribavirin|ribavirin
5794167|NCT00127777|amantadine|amantadine
5794168|NCT00127777|treatment-naive|treatment-naive
5794169|NCT00127764|pemphigus|pemphigus
5794170|NCT00127764|dexamethasone|dexamethasone
5794171|NCT00127764|glucocorticoids|glucocorticoids
5794172|NCT00127764|pulse|pulse
5794173|NCT00127764|therapy|therapy
5794174|NCT00127764|randomised|randomised
5794175|NCT00127764|placebo-controlled|placebo-controlled
5794176|NCT00127751|Risk factor reduction|risk factor reduction
5794177|NCT00127751|cardiovascular disease prevention|cardiovascular disease prevention
5794178|NCT00127738|Hypertension|hypertension
5794179|NCT00127738|Renal artery stenosis|renal artery stenosis
5794180|NCT00127738|Kidney disease|kidney disease
5794181|NCT00127738|Renal vascular disease|renal vascular disease
5794182|NCT00127738|Atherosclerosis|atherosclerosis
5794183|NCT00127725|tibia|tibia
5794184|NCT00127725|fracture|fracture
5794185|NCT00127725|PEMF|pemf
5794186|NCT00127725|electromagnetic|electromagnetic
5794187|NCT00127725|non-union|non-union
5794188|NCT00127725|revision|revision
5794189|NCT00127725|Diaphyseal fractures of the tibia|diaphyseal fractures of the tibia
5794190|NCT00127712|amiodarone|amiodarone
5794191|NCT00127712|atrial fibrillation|atrial fibrillation
5794192|NCT00127712|surgical procedures, thoracic|surgical procedures, thoracic
5794193|NCT00127699|Umbilical cord|umbilical cord
5794194|NCT00127699|Triple dye|triple dye
5794195|NCT00127699|Infant care|infant care
5794196|NCT00127686|cough|cough
5794197|NCT00127686|nocturnal cough|nocturnal cough
5794198|NCT00127686|upper respiratory tract infection|upper respiratory tract infection
5794199|NCT00127686|sleep quality|sleep quality
5794200|NCT00127686|childhood cough|childhood cough
5794201|NCT00127686|Dextromethorphan|dextromethorphan
5794202|NCT00127686|Honey|honey
5794203|NCT00127673|Antidepressants|antidepressants
5794204|NCT00127673|Cognitive behavior therapy|cognitive behavior therapy
5794205|NCT00127660|Behavior|behavior
5794206|NCT00127621|ICU patients needing prolonged ventilatory support|icu patients needing prolonged ventilatory support
5794207|NCT00127595|carcinoma of the urothelial tract|carcinoma of the urothelial tract
5794208|NCT00127582|Myotonic dystrophy type 1|myotonic dystrophy type 1
5794209|NCT00127582|Sudden cardiac death|sudden cardiac death
5794210|NCT00127582|Ventricular tachyarrhythmias|ventricular tachyarrhythmias
5794211|NCT00127582|Bradyarrhythmias|bradyarrhythmias
5794212|NCT00127569|HIV infections|hiv infections
5794213|NCT00127569|Giant Lymph Node Hyperplasia|giant lymph node hyperplasia
5794214|NCT00127569|Herpesvirus 8, Human|herpesvirus 8, human
5794215|NCT00127569|Rituximab (Mabthera)|rituximab (mabthera)
5794216|NCT00127569|Antibodies, Monoclonal|antibodies, monoclonal
5794217|NCT00127556|Transfusion|transfusion
5794218|NCT00127556|Safety|safety
5794219|NCT00127543|Medication Education|medication education
5794220|NCT00127543|Pediatric|pediatric
5794221|NCT00127530|Walking Ability|walking ability
5794223|NCT00127517|Palliative Care|palliative care
5794224|NCT00127517|Advanced Cancer|advanced cancer
5794225|NCT00127517|Palliative Cancer Care|palliative cancer care
5794226|NCT00127504|Onchocerciasis|onchocerciasis
5794227|NCT00127504|Wolbachia|wolbachia
5794229|NCT00127491|Acute Lung Injury|acute lung injury
5794230|NCT00127491|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5794231|NCT00127491|Mechanical Ventilation|mechanical ventilation
5794232|NCT00127491|Esophageal Pressures|esophageal pressures
5794233|NCT00127491|Randomized Controlled Trial|randomized controlled trial
5794234|NCT00127478|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5794235|NCT00127478|Adenocarcinoma of the Prostate|adenocarcinoma of the prostate
5794236|NCT00127465|Medical Informatics|medical informatics
5794237|NCT00127465|Patient education|patient education
5794238|NCT00127465|Social support|social support
5794239|NCT00127465|Cancer|cancer
5794240|NCT00127465|Anxiety|anxiety
5794241|NCT00127452|alpha-linolenic acid|alpha-linolenic acid
5794242|NCT00127452|cardiovascular diseases|cardiovascular diseases
5794243|NCT00127452|coronary heart disease|coronary heart disease
5794244|NCT00127452|coronary patients|coronary patients
5794246|NCT00127452|dietary intervention|dietary intervention
5794247|NCT00127452|dietary supplementation|dietary supplementation
5794248|NCT00127452|docosahexaenoic acid|docosahexaenoic acid
5794249|NCT00127452|eicosapentaenoic acid|eicosapentaenoic acid
5794250|NCT00127452|EPA|epa
5794251|NCT00127452|fish oil|fish oil
5794252|NCT00127452|fish fatty acids|fish fatty acids
5794253|NCT00127452|human subjects|human subjects
5794254|NCT00127452|ischaemic heart disease|ischaemic heart disease
5794255|NCT00127452|margarine|margarine
5794256|NCT00127452|marine fatty acids|marine fatty acids
5794257|NCT00127452|mortality|mortality
5794258|NCT00127452|myocardial infarction|myocardial infarction
5794259|NCT00127452|n-3 fatty acids|n-3 fatty acids
5794260|NCT00127452|n-3 polyunsaturated fatty acids|n-3 polyunsaturated fatty acids
5794261|NCT00127452|n-3 PUFA|n-3 pufa
5794262|NCT00127452|omega-3 fatty acids|omega-3 fatty acids
5794263|NCT00127452|omega-3 polyunsaturated fatty acids|omega-3 polyunsaturated fatty acids
5794264|NCT00127452|prevention|prevention
5794265|NCT00127452|randomized controlled trial|randomized controlled trial
5794266|NCT00127452|secondary prevention|secondary prevention
5794267|NCT00127439|Ambulatory Disability|ambulatory disability
5794268|NCT00127439|Disability Ambulation|disability ambulation
5794269|NCT00127439|Locomotion Disorders|locomotion disorders
5794270|NCT00127439|Motor Activity|motor activity
5794271|NCT00127439|Rehabilitation|rehabilitation
5794272|NCT00127439|Spinal Cord Injury|spinal cord injury
5794273|NCT00127413|Chronic pain|chronic pain
5794274|NCT00127413|Co-morbid|co-morbid
5794275|NCT00127413|Intervention|intervention
5795703|NCT00121823|Malaria|malaria
5794276|NCT00127413|Posttraumatic Stress Disorder|posttraumatic stress disorder
5794277|NCT00127413|Treatment|treatment
5794278|NCT00127400|anger|anger
5794279|NCT00127400|intermittent|intermittent
5794280|NCT00127400|explosive|explosive
5794281|NCT00127387|Bone metastasis|bone metastasis
5794282|NCT00127387|Radiation therapy|radiation therapy
5794283|NCT00127387|Lung cancer|lung cancer
5794284|NCT00127387|Prostate cancer|prostate cancer
5794285|NCT00127387|Advanced lung cancer receiving radiation therapy|advanced lung cancer receiving radiation therapy
5794286|NCT00127387|Advanced prostate cancer receiving radiation therapy|advanced prostate cancer receiving radiation therapy
5794287|NCT00127387|Any cancer with bone mets receiving radiation therapy|any cancer with bone mets receiving radiation therapy
5794288|NCT00127374|Overweight; self-esteem; depression|overweight; self-esteem; depression
5794289|NCT00127361|doula|doula
5794290|NCT00127361|caregivers|caregivers
5794291|NCT00127361|labor support|labor support
5794292|NCT00127361|being with woman|being with woman
5794293|NCT00127361|continuous labor support|continuous labor support
5794294|NCT00127361|maternal outcomes|maternal outcomes
5794295|NCT00127361|Parturition|parturition
5794296|NCT00127335|rhabdomyolysis,|rhabdomyolysis,
5794297|NCT00127335|myositis,|myositis,
5794298|NCT00127335|myopathy,|myopathy,
5794299|NCT00127335|statin side effects,|statin side effects,
5794300|NCT00127335|fatty acid oxidation|fatty acid oxidation
5794301|NCT00127335|Statin induced Muscle toxicity|statin induced muscle toxicity
5794302|NCT00127322|Heart Failure, Congestive|heart failure, congestive
5794303|NCT00127322|survival|survival
5794304|NCT00127322|patient admission|patient admission
5794305|NCT00127309|hangover|hangover
5794306|NCT00127309|hangover symptoms|hangover symptoms
5794308|NCT00127270|Overactive Bladder|overactive bladder
5794309|NCT00127270|Bladder hyperactivity|bladder hyperactivity
5794310|NCT00127270|Urge Incontinence|urge incontinence
5794311|NCT00127270|Incontinence|incontinence
5794312|NCT00127270|Bladder|bladder
5794313|NCT00127257|Constipation|constipation
5794314|NCT00127257|Biofeedback|biofeedback
5794315|NCT00127257|Dyssynergia|dyssynergia
5794316|NCT00127257|Pelvic floor dyssynergia|pelvic floor dyssynergia
5794317|NCT00127257|Outlet dysfunction|outlet dysfunction
5794318|NCT00127231|Controlled Clinical Trials, Randomized|controlled clinical trials, randomized
5794319|NCT00127231|Alcohol Consumption|alcohol consumption
5794320|NCT00127231|Behavioral Research|behavioral research
5794322|NCT00127231|Alcohol Abuse|alcohol abuse
5794323|NCT00127218|atherosclerotic plaque|atherosclerotic plaque
5794324|NCT00127218|MRI|mri
5794325|NCT00127218|inflammatory markers|inflammatory markers
5794326|NCT00127218|statins|statins
5794327|NCT00127205|stage I breast cancer|stage i breast cancer
5794328|NCT00127205|stage II breast cancer|stage ii breast cancer
5794329|NCT00127205|stage IIIA breast cancer|stage iiia breast cancer
5794330|NCT00127205|stage IIIB breast cancer|stage iiib breast cancer
5794331|NCT00127205|stage IIIC breast cancer|stage iiic breast cancer
5794332|NCT00127127|Solid tumors|solid tumors
5794333|NCT00127114|Behavioral disturbance|behavioral disturbance
5794334|NCT00127114|Frontotemporal dementia|frontotemporal dementia
5794335|NCT00127114|Dementia|dementia
5794336|NCT00127114|Amantadine|amantadine
5794337|NCT00127114|Behavioral disturbance due to frontotemporal dementia|behavioral disturbance due to frontotemporal dementia
5794338|NCT00127088|Patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate|patients with localized gleason 7 pt2a-pt2b adenocarcinoma of the prostate
5798853|NCT00110838|Patients with an implantable cardioverter defibrillator|patients with an implantable cardioverter defibrillator
5798854|NCT00110812|Treatment Naive|treatment naive
5798855|NCT00110812|IL-2|il-2
5794339|NCT00127075|Multiple sclerosis. Relapses. Post partum. Pregnancy. Delivery. Hormones. Progesterone. Estradiol. Clinical trial. Prevention.|multiple sclerosis. relapses. post partum. pregnancy. delivery. hormones. progesterone. estradiol. clinical trial. prevention.
5794340|NCT00127062|Exposure to Oxford Street|exposure to oxford street
5794341|NCT00127062|Exposure to Hyde Park|exposure to hyde park
5794342|NCT00127049|Patients with relapsed non-seminomatous germ-cell tumors (NSGCT)|patients with relapsed non-seminomatous germ-cell tumors (nsgct)
5794343|NCT00127036|colon|colon
5794344|NCT00127036|adenocarcinoma|adenocarcinoma
5794345|NCT00127036|adenocarcinoma-colon|adenocarcinoma-colon
5794346|NCT00127036|adenocarcinoma-rectum|adenocarcinoma-rectum
5794347|NCT00127023|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5794348|NCT00127010|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5794349|NCT00126997|Prophylaxis measles, mumps, rubella and chickenpox|prophylaxis measles, mumps, rubella and chickenpox
5794351|NCT00126984|Reactogenicity|reactogenicity
5794352|NCT00126984|Immunogenicity|immunogenicity
5794353|NCT00126984|Meningococcal vaccine|meningococcal vaccine
5794354|NCT00126984|Dose selection|dose selection
5794355|NCT00126984|Conjugate vaccine|conjugate vaccine
5794356|NCT00126971|malaria|malaria
5794357|NCT00126971|pregnancy|pregnancy
5794358|NCT00126971|Plasmodium falciparum|plasmodium falciparum
5794359|NCT00126971|antimalarials|antimalarials
5794360|NCT00126971|pharmacokinetics|pharmacokinetics
5794361|NCT00126971|treatment outcome|treatment outcome
5794362|NCT00126971|safety|safety
5794363|NCT00126958|superficial urothelial cell carcinoma|superficial urothelial cell carcinoma
5794364|NCT00126958|urinary analysis|urinary analysis
5794365|NCT00126958|Loss of heterozygosity|loss of heterozygosity
5794366|NCT00126958|FGFR3 mutation|fgfr3 mutation
5794367|NCT00126958|follow-up|follow-up
5794368|NCT00126945|Meningococcal serogroups A, C, W-135, Y disease|meningococcal serogroups a, c, w-135, y disease
5794369|NCT00126906|Malaria|malaria
5794370|NCT00126906|Pregnancy|pregnancy
5794372|NCT00126893|Leukemia|leukemia
5794373|NCT00126893|AML|aml
5794374|NCT00126893|CC401|cc401
5794375|NCT00126893|CC-401|cc-401
5794376|NCT00126893|Celgene|celgene
5794377|NCT00126893|High Risk Myeloid Leukemia|high risk myeloid leukemia
5794954|NCT00124852|elderly|elderly
5794378|NCT00126893|Myeloid Leukemia|myeloid leukemia
5794379|NCT00126880|Human Immunodeficiency Virus|human immunodeficiency virus
5794380|NCT00126880|anti-retroviral therapy|anti-retroviral therapy
5794381|NCT00126880|nucleoside analogue|nucleoside analogue
5794382|NCT00126880|reverse transcriptase|reverse transcriptase
5794383|NCT00126880|lamivudine|lamivudine
5794384|NCT00126880|resistance mutation|resistance mutation
5794385|NCT00126880|Treatment Experienced|treatment experienced
5794386|NCT00126867|thymidylate synthase polymers|thymidylate synthase polymers
5794387|NCT00126867|rapecitabine|rapecitabine
5794388|NCT00126867|adjuvant|adjuvant
5794389|NCT00126867|colon cancer|colon cancer
5794390|NCT00126867|toxicity|toxicity
5794391|NCT00126867|Stage II colon cancer|stage ii colon cancer
5794392|NCT00126867|Stage III colon cancer|stage iii colon cancer
5794393|NCT00126867|adenocarcinoma of the colon|adenocarcinoma of the colon
5794394|NCT00126854|brachytherapy|brachytherapy
5794395|NCT00126854|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5794396|NCT00126841|radiotherapy planning CT/MR fusion|radiotherapy planning ct/mr fusion
5794397|NCT00126828|radiotherapy, conformal|radiotherapy, conformal
5794398|NCT00126828|lung neoplasm|lung neoplasm
5794399|NCT00126828|radiotherapy dosage|radiotherapy dosage
5794400|NCT00126815|prostate cancer|prostate cancer
5794401|NCT00126815|prostate specific antigen|prostate specific antigen
5794402|NCT00126815|radiotherapy|radiotherapy
5794403|NCT00126815|mathematical modeling|mathematical modeling
5794404|NCT00126802|tomotherapy|tomotherapy
5794405|NCT00126802|MRSZ|mrsz
5794407|NCT00126789|Pain Cancer|pain cancer
5794408|NCT00126789|Chronic Pain|chronic pain
5794409|NCT00126776|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5794410|NCT00126776|case management|case management
5794411|NCT00126776|self management|self management
5794412|NCT00126763|Chronic Pain|chronic pain
5794413|NCT00126763|Pain|pain
5794414|NCT00126750|Myocardial Infarction|myocardial infarction
5794415|NCT00126750|Comorbidities|comorbidities
5794416|NCT00126750|Guidelines|guidelines
5794417|NCT00126750|Computer Assisted Instruction|computer assisted instruction
5794418|NCT00126750|Physician Practice Instruction|physician practice instruction
5794419|NCT00126750|Online Systems|online systems
5794420|NCT00126737|Elderly|elderly
5794421|NCT00126737|Exercise|exercise
5794422|NCT00126737|lean body mass|lean body mass
5794423|NCT00126737|muscle strength|muscle strength
5794424|NCT00126737|Nutrition program|nutrition program
5794425|NCT00126737|Pain control|pain control
5794426|NCT00126737|stair climb|stair climb
5794427|NCT00126737|walking distance|walking distance
5794428|NCT00126737|weight loss|weight loss
5794429|NCT00126724|tgAAC94|tgaac94
5794430|NCT00126724|Rheumatoid arthritis|rheumatoid arthritis
5794431|NCT00126724|Inflammatory arthritis|inflammatory arthritis
5794432|NCT00126724|Arthritis|arthritis
5794433|NCT00126724|Gene therapy|gene therapy
5794434|NCT00126724|AAV|aav
5794435|NCT00126698|Bacteriuria|bacteriuria
5794436|NCT00126698|Urinary Catheter|urinary catheter
5794437|NCT00126698|Urinary tract infection|urinary tract infection
5794438|NCT00126698|Prophylaxis|prophylaxis
5794439|NCT00126698|Urinary catheter removal|urinary catheter removal
5794440|NCT00126685|stage IV melanoma|stage iv melanoma
5784992|NCT00169793|Obesity|obesity
5794441|NCT00126685|recurrent melanoma|recurrent melanoma
5794442|NCT00126672|angiomyolipoma|angiomyolipoma
5794443|NCT00126646|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5794444|NCT00126646|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5794445|NCT00126646|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5794446|NCT00126646|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5794447|NCT00126646|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5794448|NCT00126646|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5794449|NCT00126646|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5794450|NCT00126646|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5794451|NCT00126646|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5794452|NCT00126646|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5794453|NCT00126646|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5794454|NCT00126646|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5794455|NCT00126646|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5794456|NCT00126646|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5794457|NCT00126646|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5794458|NCT00126646|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5794459|NCT00126646|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5794460|NCT00126646|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5794461|NCT00126646|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5794462|NCT00126646|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5794463|NCT00126646|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5794583|NCT00126178|Renal|renal
5794464|NCT00126646|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5794465|NCT00126646|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5793588|NCT00129779|COPD|copd
5794466|NCT00126646|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5794467|NCT00126646|prolymphocytic leukemia|prolymphocytic leukemia
5794468|NCT00126633|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5794469|NCT00126633|stage IV pancreatic cancer|stage iv pancreatic cancer
5794470|NCT00126620|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5794471|NCT00126581|A Phase II Randomized Study of OSI-774|a phase ii randomized study of osi-774
5794472|NCT00126555|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5794473|NCT00126555|recurrent skin cancer|recurrent skin cancer
5794474|NCT00126555|non-melanomatous skin cancer|non-melanomatous skin cancer
5794475|NCT00126555|Radiation|radiation
5794476|NCT00126555|ZD1839|zd1839
5794477|NCT00126555|Iressa|iressa
5794478|NCT00126555|Gefitinib|gefitinib
5794479|NCT00126516|silent brain infarction|silent brain infarction
5794480|NCT00126516|cognitive decline|cognitive decline
5794481|NCT00126516|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers
5794482|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors
5794483|NCT00126516|hypertension|hypertension
5794484|NCT00126477|quality of life|quality of life
5794485|NCT00126477|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5789527|NCT00148161|Auditory cortex|auditory cortex
5794486|NCT00126477|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5794487|NCT00126477|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5794488|NCT00126477|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5794489|NCT00126477|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5794490|NCT00126477|childhood lymphoblastic lymphoma|childhood lymphoblastic lymphoma
5794491|NCT00126477|childhood large cell lymphoma|childhood large cell lymphoma
5794492|NCT00126477|childhood small noncleaved cell lymphoma|childhood small noncleaved cell lymphoma
5794493|NCT00126477|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5794494|NCT00126477|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5794495|NCT00126477|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5794496|NCT00126464|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5794497|NCT00126464|breast cancer in situ|breast cancer in situ
5794498|NCT00126438|Heart Failure|heart failure
5794499|NCT00126438|nuclear cardiology|nuclear cardiology
5794500|NCT00126438|sympathetic innervation|sympathetic innervation
5794501|NCT00126438|123I-mIBG|123i-mibg
5794502|NCT00126425|Heart Failure|heart failure
5794503|NCT00126425|nuclear cardiology|nuclear cardiology
5794504|NCT00126425|sympathetic innervation|sympathetic innervation
5794505|NCT00126425|123I-mIBG|123i-mibg
5794506|NCT00126412|Phaeochromocytoma|phaeochromocytoma
5794507|NCT00126412|Neuroblastoma|neuroblastoma
5794508|NCT00126412|diagnosis|diagnosis
5794509|NCT00126412|123I-mIBG|123i-mibg
5794510|NCT00126399|rosacea|rosacea
5794511|NCT00126399|acne rosacea|acne rosacea
5794512|NCT00126386|tumor induced hypercalcemia|tumor induced hypercalcemia
5794513|NCT00126386|malignant bone pain|malignant bone pain
5794514|NCT00126386|bisphosphonates|bisphosphonates
5794515|NCT00126386|cancer|cancer
5794516|NCT00126386|palliative|palliative
5794517|NCT00126386|Zometa|zometa
5794518|NCT00126386|palliative patient|palliative patient
5794519|NCT00126386|treatment in community|treatment in community
5794520|NCT00126373|Crohn disease|crohn disease
5794521|NCT00126373|TNF-alpha|tnf-alpha
5794522|NCT00126360|Breast Cancer|breast cancer
5794523|NCT00126360|Timing of Radiotherapy|timing of radiotherapy
5794524|NCT00126360|Local Control|local control
5794525|NCT00126347|betaine|betaine
5794526|NCT00126347|serine|serine
5794527|NCT00126347|folic acid|folic acid
5794528|NCT00126347|methionine load|methionine load
5794529|NCT00126347|homocysteine|homocysteine
5794530|NCT00126347|cardiovascular health|cardiovascular health
5794531|NCT00126347|vascular function|vascular function
5794532|NCT00126347|human|human
5794533|NCT00126334|Myocardial Infarction|myocardial infarction
5794534|NCT00126334|Anemia|anemia
5794535|NCT00126334|Erythrocyte Transfusion|erythrocyte transfusion
5794536|NCT00126321|AML, relapsed|aml, relapsed
5794537|NCT00126321|cladribine|cladribine
5794538|NCT00126321|chemotherapy|chemotherapy
5794540|NCT00126308|Lipodystrophy|lipodystrophy
5794541|NCT00126308|Intervention|intervention
5794542|NCT00126308|Poly-L-lactic acid|poly-l-lactic acid
5794543|NCT00126308|HIV facial lipoatrophy|hiv facial lipoatrophy
5794544|NCT00126308|Treatment Experienced|treatment experienced
5795704|NCT00121823|PCR|pcr
5794545|NCT00126282|obsessive-compulsive disorder|obsessive-compulsive disorder
5794546|NCT00126282|behavior therapy|behavior therapy
5794547|NCT00126282|D-Cycloserine|d-cycloserine
5794548|NCT00126282|medication|medication
5794549|NCT00126282|treatment trial|treatment trial
5794550|NCT00126282|placebo-controlled|placebo-controlled
5794551|NCT00126282|double-blind|double-blind
5794552|NCT00126282|randomized|randomized
5794553|NCT00126269|Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis|patients with carcinoma of unknown primary and a predicted favorable prognosis
5794554|NCT00126256|Colorectal cancer|colorectal cancer
5793675|NCT00129467|Pain|pain
5794556|NCT00126256|chemotherapy|chemotherapy
5794557|NCT00126256|randomized trial|randomized trial
5794558|NCT00126243|AIDS related Lymphoma|aids related lymphoma
5794559|NCT00126243|chemotherapy|chemotherapy
5794560|NCT00126243|rituximab|rituximab
5794561|NCT00126230|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine|hormone-refractory advanced prostate cancer who achieve a response or a stabilization to docetaxel-estramustine
5794562|NCT00126217|Non-specific effects of vaccines|non-specific effects of vaccines
5794563|NCT00126217|Infant mortality|infant mortality
5794564|NCT00126217|Morbidity|morbidity
5794565|NCT00126217|Low income country|low income country
5794566|NCT00126217|Malaria|malaria
5794567|NCT00126217|BCG|bcg
5794568|NCT00126217|immunisation|immunisation
5794569|NCT00126217|BCG revaccination|bcg revaccination
5794570|NCT00126217|Tuberculin|tuberculin
5794571|NCT00126217|Mortality|mortality
5794572|NCT00126204|endoleak|endoleak
5794573|NCT00126204|doxycycline|doxycycline
5794574|NCT00126204|matrix metalloproteinase|matrix metalloproteinase
5794575|NCT00126204|inflammation|inflammation
5794576|NCT00126204|endograft|endograft
5794577|NCT00126204|circulating markers|circulating markers
5794578|NCT00126191|Burkitt Lymphoma|burkitt lymphoma
5794579|NCT00126191|atypical Burkitt lymphoma|atypical burkitt lymphoma
5794580|NCT00126191|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5794581|NCT00126191|rituximab|rituximab
5794582|NCT00126178|Kidney Cancer|kidney cancer
5794584|NCT00126178|Immunotherapy|immunotherapy
5794585|NCT00126178|Vaccine|vaccine
5794586|NCT00126165|prostate cancer|prostate cancer
5794587|NCT00126165|radiotherapy|radiotherapy
5794588|NCT00126165|hypofraction|hypofraction
5794589|NCT00126165|radiosensitivity|radiosensitivity
5794590|NCT00126165|image-guidance|image-guidance
5794591|NCT00126152|Falls|falls
5794592|NCT00126152|Exercise|exercise
5794593|NCT00126152|Fall Risk Factors|fall risk factors
5794594|NCT00126152|Older Adults|older adults
5794595|NCT00126139|stroke, ischemic|stroke, ischemic
5794596|NCT00126139|stenosis, internal carotid artery|stenosis, internal carotid artery
5794597|NCT00126139|Acute ischemic stroke|acute ischemic stroke
5794598|NCT00126139|Stenosis of extracranial internal carotid artery|stenosis of extracranial internal carotid artery
5794599|NCT00126126|Artificial Limbs|artificial limbs
5794600|NCT00126126|Evidence based medicine|evidence based medicine
5794601|NCT00126126|Exercise|exercise
5794602|NCT00126126|Outcomes research|outcomes research
5794603|NCT00126126|Physical therapy|physical therapy
5794604|NCT00126113|Audiologic rehabilitation|audiologic rehabilitation
5794605|NCT00126113|Counseling|counseling
5794606|NCT00126100|Stem Cells|stem cells
5794607|NCT00126087|dopamine|dopamine
5794608|NCT00126087|NMDA receptor|nmda receptor
5794609|NCT00126087|brain imaging|brain imaging
5794610|NCT00126087|neuroplasticity|neuroplasticity
5809418|NCT00002657|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5809419|NCT00002657|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5794611|NCT00126087|learning|learning
5794612|NCT00126087|transcranial direct current stimulation|transcranial direct current stimulation
5794613|NCT00126087|rehabilitation|rehabilitation
5794615|NCT00126074|Atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm|atrial fibrillation, atrial flutter, anti-arrhythmic agents, conversion to normal sinus rhythm
5794616|NCT00126061|Atrial fibrillation|atrial fibrillation
5794617|NCT00126061|atrial flutter|atrial flutter
5794618|NCT00126061|anti-arrhythmic agents|anti-arrhythmic agents
5794619|NCT00126061|conversion to normal sinus rhythm|conversion to normal sinus rhythm
5794620|NCT00126048|Atopy|atopy
5794621|NCT00126048|Statin|statin
5794622|NCT00126048|Asthma|asthma
5794623|NCT00126048|methacholine|methacholine
5794624|NCT00126048|FEV1|fev1
5794625|NCT00126035|Acute Migraine|acute migraine
5794626|NCT00126035|Device|device
5794627|NCT00126035|Migraid|migraid
5794628|NCT00126035|Treatment|treatment
5794629|NCT00126035|Aura|aura
5794630|NCT00126022|Atrial fibrillation|atrial fibrillation
5794631|NCT00126022|atrial flutter|atrial flutter
5794632|NCT00126022|anti-arrhythmic agents|anti-arrhythmic agents
5794633|NCT00126022|conversion to normal sinus rhythm|conversion to normal sinus rhythm
5794634|NCT00125996|ANAEMIA|anaemia
5794635|NCT00125996|Iron Deficiency|iron deficiency
5794636|NCT00125983|Birth Control Pills|birth control pills
5794637|NCT00125983|Oral Contraceptives|oral contraceptives
5794638|NCT00125983|Contraceptive Patch|contraceptive patch
5794639|NCT00125983|Pharmacokinetics|pharmacokinetics
5794640|NCT00125983|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5794641|NCT00125983|Protease Inhibitor|protease inhibitor
5794642|NCT00125983|Treatment Experienced|treatment experienced
5794643|NCT00125983|Treatment Naive|treatment naive
5794644|NCT00125983|Contraception|contraception
5794645|NCT00125970|HIV Seronegativity|hiv seronegativity
5794646|NCT00125970|HIV Preventive Vaccine|hiv preventive vaccine
5794647|NCT00125957|depression|depression
5794648|NCT00125957|serotonin|serotonin
5794649|NCT00125957|norepinephrine|norepinephrine
5686503|NCT00551785|Hypoactive Sexual Desire Disorder|hypoactive sexual desire disorder
5686504|NCT00551785|Menopause|menopause
5686505|NCT00551785|Androgen|androgen
5686506|NCT00551772|Bio-availability, healthy elderly volunteers|bio-availability, healthy elderly volunteers
5794650|NCT00125957|SSRI|ssri
5794651|NCT00125957|Wellbutrin|wellbutrin
5794652|NCT00125957|bupropion|bupropion
5794653|NCT00125957|executive function|executive function
5794654|NCT00125957|residual symptoms|residual symptoms
5794655|NCT00125931|bipolar disorder|bipolar disorder
5794656|NCT00125931|mania|mania
5794657|NCT00125931|manic state|manic state
5794658|NCT00125931|opiate|opiate
5794659|NCT00125931|kappa|kappa
5794660|NCT00125918|Hypertension, Pulmonary; Pulmonary Heart Disease|hypertension, pulmonary; pulmonary heart disease
5794661|NCT00125905|Primary Care|primary care
5794662|NCT00125905|Smoking Cessation|smoking cessation
5794663|NCT00125905|Stages of Change Model|stages of change model
5794664|NCT00125905|Health Education|health education
5794665|NCT00125905|Clinical Practice guideline|clinical practice guideline
5794666|NCT00125879|Glycogen Storage Disease Type II|glycogen storage disease type ii
5794667|NCT00125879|GSD-II|gsd-ii
5794668|NCT00125879|Pompe Disease|pompe disease
5794669|NCT00125879|Pompe Disease (Late-onset)|pompe disease (late-onset)
5794670|NCT00125879|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5794671|NCT00125879|Glycogenosis 2|glycogenosis 2
5794672|NCT00125879|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5794673|NCT00125866|randomised double blind trial|randomised double blind trial
5794674|NCT00125866|blood pressure|blood pressure
5794675|NCT00125866|cocoa flavonoids|cocoa flavonoids
5794676|NCT00125853|blood pressure|blood pressure
5794677|NCT00125853|insulin sensitivity|insulin sensitivity
5794678|NCT00125853|beta blockers|beta blockers
5794679|NCT00125853|randomised double blind crossover trial|randomised double blind crossover trial
5794680|NCT00125840|CLO151|clo151
5794681|NCT00125840|Clolar|clolar
5794682|NCT00125840|Pediatric ALL and AML|pediatric all and aml
5794683|NCT00125840|Adult ALL and AML and MDS|adult all and aml and mds
5794684|NCT00125827|CLO152|clo152
5794685|NCT00125827|Clolar|clolar
5794686|NCT00125814|Interferon Alfa-2b|interferon alfa-2b
5794687|NCT00125814|HIV infections|hiv infections
5794688|NCT00125788|sickle cell disease|sickle cell disease
5794689|NCT00125788|sickle cell anemia|sickle cell anemia
5794690|NCT00125788|L-glutamine|l-glutamine
5794691|NCT00125788|Sickle Cell Anemia (homozygous)|sickle cell anemia (homozygous)
5794692|NCT00125788|Sickle ß0-Thalassemia|sickle ß0-thalassemia
5794693|NCT00125749|Dendritic|dendritic
5794694|NCT00125749|Vaccine|vaccine
5794695|NCT00125749|Melanoma|melanoma
5794696|NCT00125749|Stage IV metastatic melanoma|stage iv metastatic melanoma
5794697|NCT00125723|Phase 4 Clinical Trial|phase 4 clinical trial
5794698|NCT00125723|Chemotherapy|chemotherapy
5794699|NCT00125723|Neulasta®|neulasta®
5794700|NCT00125723|Oncology|oncology
5809521|NCT00085904|IL-18|il-18
5794701|NCT00125723|Malignancy|malignancy
5794702|NCT00125710|cryogenic analysis|cryogenic analysis
5794703|NCT00125710|oncogenes|oncogenes
5794704|NCT00125697|malignant glioma|malignant glioma
5794705|NCT00125697|spectroscopy|spectroscopy
5794706|NCT00125697|magnetic resonance|magnetic resonance
5794707|NCT00125684|transdermal morphine|transdermal morphine
5794708|NCT00125684|cancer|cancer
5794709|NCT00125684|pain|pain
5794710|NCT00125684|bioavailability|bioavailability
5794711|NCT00125684|pharmacokinetics|pharmacokinetics
5794712|NCT00125684|cancer related pain|cancer related pain
5794714|NCT00125684|currently taking opioids|currently taking opioids
5794715|NCT00125671|Warfarin and Antiplatelet Vascular Evaluation|warfarin and antiplatelet vascular evaluation
5794716|NCT00125671|Peripheral vascular disease|peripheral vascular disease
5794717|NCT00125671|Atherosclerosis|atherosclerosis
5794718|NCT00125671|cardiovascular events|cardiovascular events
5794719|NCT00125671|Ischemia|ischemia
5794720|NCT00125671|oral anticoagulants|oral anticoagulants
5794721|NCT00125671|low ankle-brachial index|low ankle-brachial index
5794722|NCT00125671|moderate intensity warfarin|moderate intensity warfarin
5794723|NCT00125671|International normalized ratio [INR]|international normalized ratio [inr]
5794724|NCT00125658|biomechanics|biomechanics
5794725|NCT00125658|Cerebrovascular Accident|cerebrovascular accident
5794726|NCT00125658|electromyography|electromyography
5794727|NCT00125658|muscular weakness|muscular weakness
5794728|NCT00125658|recovery of function|recovery of function
5794729|NCT00125658|reflex variability stroke|reflex variability stroke
5794730|NCT00125658|upper-extremity kinematics|upper-extremity kinematics
5794731|NCT00125645|AMI|ami
5794732|NCT00125645|Left ventricular function|left ventricular function
5794733|NCT00125645|Myocardial performance index|myocardial performance index
5794734|NCT00125645|Acute myocardial infarction (AMI)|acute myocardial infarction (ami)
5794735|NCT00125632|Reading|reading
5794736|NCT00125632|Rehabilitation|rehabilitation
5794737|NCT00125632|Treatment Outcomes|treatment outcomes
5794738|NCT00125632|Low vision|low vision
5794739|NCT00125619|biomechanics|biomechanics
5794740|NCT00125619|stroke|stroke
5794741|NCT00125619|electromyography|electromyography
5794742|NCT00125619|Gait disability stroke|gait disability stroke
5794743|NCT00125619|locomotor therapy|locomotor therapy
5794744|NCT00125619|muscular weakness|muscular weakness
5794745|NCT00125619|reflex variability stroke|reflex variability stroke
5794746|NCT00125606|AML|aml
5794747|NCT00125606|allogeneic HSCT|allogeneic hsct
5794748|NCT00125606|reduced intensity conditioning|reduced intensity conditioning
5794749|NCT00125606|randomized trail|randomized trail
5794750|NCT00125593|Kidney Disease, Chronic|kidney disease, chronic
5794751|NCT00125593|LDL cholesterol|ldl cholesterol
5794752|NCT00125593|simvastatin|simvastatin
5794753|NCT00125593|ezetimibe|ezetimibe
5794754|NCT00125593|cardiovascular disease|cardiovascular disease
5794755|NCT00125593|atherosclerosis|atherosclerosis
5794756|NCT00125580|Obesity|obesity
5794757|NCT00125580|Childhood Obesity|childhood obesity
5794758|NCT00125580|Infant Sleep|infant sleep
5794759|NCT00125580|Infant growth|infant growth
5794760|NCT00125580|Infant feeding|infant feeding
5794761|NCT00125554|Clinical trial|clinical trial
5794762|NCT00125554|double-blind|double-blind
5794763|NCT00125554|randomized placebo-controlled trial|randomized placebo-controlled trial
5794764|NCT00125554|metyrapone|metyrapone
5794765|NCT00125554|Major Depression|major depression
5794766|NCT00125541|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
5794767|NCT00125541|Hereditary Angioedema Type I or II, Acquired Angioedema|hereditary angioedema type i or ii, acquired angioedema
5794768|NCT00125528|chronic pain|chronic pain
5794769|NCT00125528|low back pain|low back pain
5794770|NCT00125528|D-cycloserine|d-cycloserine
5794771|NCT00125515|Heroin|heroin
5794772|NCT00125515|Opiates|opiates
5794773|NCT00125515|naltrexone|naltrexone
5794774|NCT00125515|memantine|memantine
5794775|NCT00125502|CMV, Cytomegalovirus, vaccine, women, postpartum|cmv, cytomegalovirus, vaccine, women, postpartum
5794776|NCT00125489|chloroquine, malaria, sulfadoxine/pyrimethamine, Malawi|chloroquine, malaria, sulfadoxine/pyrimethamine, malawi
5794777|NCT00125476|Postmenopause|postmenopause
5794778|NCT00125463|Hypertension|hypertension
5794779|NCT00125463|clinical trial|clinical trial
5794780|NCT00125463|Candesartan Antihypertensive Survival Evaluation in Japan trial|candesartan antihypertensive survival evaluation in japan trial
5794781|NCT00125463|candesartan cilexetil|candesartan cilexetil
5794782|NCT00125463|amlodipine besilate|amlodipine besilate
5794783|NCT00125450|Acute Bronchiolitis|acute bronchiolitis
5794784|NCT00125450|Chest Physiotherapy|chest physiotherapy
5794785|NCT00125450|Forced Expiratory Techniques|forced expiratory techniques
5794786|NCT00125450|Double Blind Trial|double blind trial
5794787|NCT00125450|Children|children
5794788|NCT00125450|Pediatric|pediatric
5794789|NCT00125450|RESPIRATORY SYNCYTIAL VIRUS|respiratory syncytial virus
5794790|NCT00125437|aldosterone antagonists|aldosterone antagonists
5794791|NCT00125437|spironolactone|spironolactone
5794792|NCT00125437|left ventricular remodeling|left ventricular remodeling
5794793|NCT00125424|Colonoscopy|colonoscopy
5794794|NCT00125424|Sedation|sedation
5794796|NCT00125424|(fospropofol disodium)|(fospropofol disodium)
5794797|NCT00125424|Endoscopic sedation|endoscopic sedation
5794798|NCT00125424|Endoscopic outcomes|endoscopic outcomes
5794799|NCT00125424|Endoscopy|endoscopy
5794800|NCT00125411|satraplatin|satraplatin
5794801|NCT00125411|docetaxel|docetaxel
5794802|NCT00125411|cancer|cancer
5794803|NCT00125411|Phase I|phase i
5794804|NCT00125411|advanced solid tumors|advanced solid tumors
5794805|NCT00125398|AQUAVAN|aquavan
5794806|NCT00125398|GPI 15715|gpi 15715
5794808|NCT00125398|Sedation|sedation
5794809|NCT00125385|IPF|ipf
5794810|NCT00125385|Idiopathic|idiopathic
5794811|NCT00125385|Pulmonary|pulmonary
5794812|NCT00125385|Fibrosis|fibrosis
5794813|NCT00125372|tarceva|tarceva
5794814|NCT00125372|targretin|targretin
5794815|NCT00125372|non-small cell lung cancer|non-small cell lung cancer
5794816|NCT00125372|carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
5794817|NCT00125372|nsclc|nsclc
5794818|NCT00125359|tarceva|tarceva
5794819|NCT00125359|targretin|targretin
5794820|NCT00125359|non-small cell lung cancer|non-small cell lung cancer
5794821|NCT00125359|Carcinoma, non-small cell lung cancer|carcinoma, non-small cell lung cancer
5794822|NCT00125359|NSCLC|nsclc
5794823|NCT00125346|Tobramycin Inhalation Powder|tobramycin inhalation powder
5794824|NCT00125333|atopic dermatitis, eczema|atopic dermatitis, eczema
5794825|NCT00125320|Treatment|treatment
5794826|NCT00125307|SLE|sle
5794827|NCT00125307|glomerulonephritis|glomerulonephritis
5794828|NCT00125307|immunosuppressive therapy|immunosuppressive therapy
5794829|NCT00125307|type V (membranous) lupus nephritis|type v (membranous) lupus nephritis
5794830|NCT00125294|cancer pain|cancer pain
5681178|NCT00574444|transvaginal peritoneoscopy|transvaginal peritoneoscopy
5681180|NCT00574431|Intensive care unit|intensive care unit
5681181|NCT00574431|Early enteral nutrition|early enteral nutrition
5681182|NCT00574431|Nutritional management protocol|nutritional management protocol
5681183|NCT00574418|Fibroid Tumor|fibroid tumor
5681184|NCT00574418|Fibroid Uterus|fibroid uterus
5681185|NCT00574418|Fibroids, Uterine|fibroids, uterine
5681186|NCT00574418|Fibromyoma|fibromyoma
5681187|NCT00574418|Uterine Neoplasms|uterine neoplasms
5681188|NCT00574405|Insulin pump|insulin pump
5681189|NCT00574405|Beta cell|beta cell
5681190|NCT00574392|skin disorders|skin disorders
5681191|NCT00574379|Allergic Rhinitis|allergic rhinitis
5681192|NCT00574379|Mountain Cedar Pollen|mountain cedar pollen
5681193|NCT00574379|Pollen Allergy|pollen allergy
5681194|NCT00574379|Rhinoconjunctivitis|rhinoconjunctivitis
5681195|NCT00574366|recurrent breast cancer|recurrent breast cancer
5681196|NCT00574366|stage IV breast cancer|stage iv breast cancer
5681197|NCT00574366|male breast cancer|male breast cancer
5681198|NCT00574353|colorectal cancer|colorectal cancer
5681200|NCT00574340|Type 2 Diabetes|type 2 diabetes
5681201|NCT00574340|Endothelial Function|endothelial function
5681202|NCT00574340|Fibrinolytic Balance|fibrinolytic balance
5681203|NCT00574340|Hypoglycemia|hypoglycemia
5681205|NCT00574327|Registry|registry
5681206|NCT00574327|Barrett's Esophagus|barrett's esophagus
5681207|NCT00574314|women|women
5681209|NCT00574301|Image Guided Vacuum Assisted Biopsy|image guided vacuum assisted biopsy
5681210|NCT00574301|Radiofrequency Ablation|radiofrequency ablation
5681211|NCT00574301|Breast Conservation Therapy|breast conservation therapy
5681212|NCT00574301|Mastectomy|mastectomy
5681213|NCT00574301|MRI|mri
5681214|NCT00574288|Multiple Myeloma|multiple myeloma
5681215|NCT00574288|Daratumumab|daratumumab
5681216|NCT00574288|Safety|safety
5681217|NCT00574288|HuMax-CD38|humax-cd38
5681218|NCT00574288|Dose-escalation|dose-escalation
5681219|NCT00574275|metastatic pancreatic cancer|metastatic pancreatic cancer
5681220|NCT00574275|angiogenesis inhibitor|angiogenesis inhibitor
5681221|NCT00574275|gemcitabine|gemcitabine
5681223|NCT00574262|clinical pathway|clinical pathway
5681224|NCT00574262|quality of care|quality of care
5681225|NCT00574262|secondary prevention|secondary prevention
5681227|NCT00574249|Moderate Psoriasis|moderate psoriasis
5794831|NCT00125294|breakthrough pain|breakthrough pain
5794832|NCT00125294|methadone|methadone
5794833|NCT00125294|dose titration|dose titration
5794834|NCT00125294|sublingual route of administration|sublingual route of administration
5794835|NCT00125294|Cancer related pain|cancer related pain
5794836|NCT00125294|currently taking narcotics|currently taking narcotics
5794839|NCT00125281|S-Adenosyl Methionine|s-adenosyl methionine
5794840|NCT00125281|Primary Biliary Cirrhosis|primary biliary cirrhosis
5794841|NCT00125281|Pruritus|pruritus
5794842|NCT00125281|Symptomatic Releif|symptomatic releif
5794843|NCT00125281|Serum Liver-Related Enzymes|serum liver-related enzymes
5794844|NCT00125281|PBC|pbc
5794845|NCT00125281|Liver Disease|liver disease
5794846|NCT00125268|painful|painful
5794847|NCT00125268|peripheral|peripheral
5794848|NCT00125268|neuropathy|neuropathy
5794849|NCT00125268|light|light
5794850|NCT00125268|therapy|therapy
5794851|NCT00125242|Aphasia|aphasia
5794852|NCT00125242|Language therapy|language therapy
5794853|NCT00125242|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5794854|NCT00125242|Speech-language pathology|speech-language pathology
5794855|NCT00125229|Hypertonic Saline|hypertonic saline
5794856|NCT00125229|Mannitol|mannitol
5794857|NCT00125229|Intracranial hypertension|intracranial hypertension
5794858|NCT00125229|Cerebral blood flow|cerebral blood flow
5794859|NCT00125229|Traumatic brain injury|traumatic brain injury
5794860|NCT00125216|Aphasia|aphasia
5794861|NCT00125216|Language Therapy|language therapy
5794862|NCT00125216|Rehabilitation of speech and language disorders|rehabilitation of speech and language disorders
5794863|NCT00125216|Speech-language pathology|speech-language pathology
5794864|NCT00125203|ALS|als
5794865|NCT00125203|Lou Gehrig's Disease|lou gehrig's disease
5794866|NCT00125203|Motor Neuron Disease|motor neuron disease
5794867|NCT00125203|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5794868|NCT00125203|Sialorrhea|sialorrhea
5794869|NCT00125203|Hypersalivation|hypersalivation
5794870|NCT00125203|Excessive Drooling|excessive drooling
5794871|NCT00125203|Myobloc|myobloc
5794872|NCT00125203|botulinum toxin type B|botulinum toxin type b
5794873|NCT00125203|Clostridium botulinum B toxin|clostridium botulinum b toxin
5794874|NCT00125203|botulinum B toxin|botulinum b toxin
5794875|NCT00125203|botulinum neurotoxin B|botulinum neurotoxin b
5794876|NCT00125203|NeuroBloc|neurobloc
5794877|NCT00125190|Primary IGF-1 Deficiency|primary igf-1 deficiency
5794878|NCT00125190|IGF-1|igf-1
5794879|NCT00125177|pelvic muscle therapy|pelvic muscle therapy
5794880|NCT00125177|urinary incontinence therapy|urinary incontinence therapy
5794881|NCT00125177|stress incontinence intervention|stress incontinence intervention
5794882|NCT00125177|incontinence intervention|incontinence intervention
5794883|NCT00125177|Incontinence|incontinence
5794884|NCT00125177|SUI|sui
5794885|NCT00125177|Stress Incontinence|stress incontinence
5794886|NCT00125164|Primary IGF-1 Deficiency|primary igf-1 deficiency
5794887|NCT00125151|MeSH: angioneurotic edema, complement 1 inactivators|mesh: angioneurotic edema, complement 1 inactivators
5794888|NCT00125151|Hereditary angioedema type I or II, Acquired angioedema|hereditary angioedema type i or ii, acquired angioedema
5794889|NCT00125125|Dyslipidemia, adults, fluvastatin|dyslipidemia, adults, fluvastatin
5794890|NCT00125112|binge eating|binge eating
5794891|NCT00125112|weight loss|weight loss
5794892|NCT00125112|obesity|obesity
5809654|NCT00085917|HIV|hiv
5794893|NCT00125099|Acute Infection|acute infection
5794894|NCT00125099|Treatment Experienced|treatment experienced
5794895|NCT00125099|Treatment Interruption|treatment interruption
5794896|NCT00125099|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5794897|NCT00125086|wounds|wounds
5794898|NCT00125086|healing|healing
5794899|NCT00125086|Acute wounds healing by secondary intention|acute wounds healing by secondary intention
5794900|NCT00125073|Standard Care|standard care
5794901|NCT00125073|Nutritional Counseling|nutritional counseling
5794902|NCT00125060|Aorta|aorta
5794903|NCT00125060|Atherosclerosis|atherosclerosis
5794904|NCT00125060|MRI|mri
5794905|NCT00125060|statin|statin
5794906|NCT00125060|inflammatory markers|inflammatory markers
5794907|NCT00125047|Salmonellosis|salmonellosis
5794908|NCT00125047|typhoid vaccine|typhoid vaccine
5794909|NCT00125047|enteric fever|enteric fever
5794910|NCT00125034|FOLFOX-4|folfox-4
5794911|NCT00125034|Cetuximab|cetuximab
5794912|NCT00125034|First-line mCRC|first-line mcrc
5794913|NCT00125034|EGFR positive|egfr positive
5794914|NCT00125034|metastatic CRC|metastatic crc
5794915|NCT00125021|Second Line Therapy|second line therapy
5794916|NCT00125021|Gemcitabine Refractory|gemcitabine refractory
5794917|NCT00125021|Pancreatic Cancer|pancreatic cancer
5794918|NCT00125021|Capecitabine|capecitabine
5794919|NCT00125021|Tarceva|tarceva
5794920|NCT00125021|OSI-774|osi-774
5794921|NCT00125021|Metastatic Pancreatic Cancer|metastatic pancreatic cancer
5794922|NCT00125008|Salmonella|salmonella
5794923|NCT00125008|Typhoid vaccine|typhoid vaccine
5794924|NCT00125008|enteric fever|enteric fever
5794925|NCT00124969|End-stage renal disease, hemodialysis|end-stage renal disease, hemodialysis
5790044|NCT00145990|asthma|asthma
5794926|NCT00124943|Prevention of Instent Restenosis|prevention of instent restenosis
5794927|NCT00124930|olanzapine|olanzapine
5794928|NCT00124930|haldol|haldol
5794929|NCT00124930|cancer|cancer
5794930|NCT00124930|nausea|nausea
5794931|NCT00124930|second line treatment|second line treatment
5794932|NCT00124930|refractory nausea|refractory nausea
5794933|NCT00124917|Prostate Cancer|prostate cancer
5794934|NCT00124917|MRI|mri
5794935|NCT00124917|Fiducial Marker|fiducial marker
5794936|NCT00124917|IMRT|imrt
5681228|NCT00574249|Severe Psoriasis|severe psoriasis
5794937|NCT00124904|Biofeedback|biofeedback
5794938|NCT00124904|Incontinence|incontinence
5794939|NCT00124891|Arrhythmias|arrhythmias
5794941|NCT00124878|STDs|stds
5794942|NCT00124878|Male circumcision|male circumcision
5794943|NCT00124878|HIV+ males|hiv+ males
5794944|NCT00124878|HIV-negative males|hiv-negative males
5794945|NCT00124878|Female partners|female partners
5794946|NCT00124878|STDs such as the following:|stds such as the following:
5794947|NCT00124878|HPV|hpv
5794948|NCT00124878|HSV-2|hsv-2
5794949|NCT00124878|HIV Seronegativity|hiv seronegativity
5794950|NCT00124865|Campylobacter|campylobacter
5794951|NCT00124865|Bacterial enteritis|bacterial enteritis
5794955|NCT00124839|Dissociation|dissociation
5794956|NCT00124839|Flashbacks|flashbacks
5794957|NCT00124839|Self-injurious behavior|self-injurious behavior
5794958|NCT00124826|stroke|stroke
5794959|NCT00124826|cerebrovascular disease|cerebrovascular disease
5794960|NCT00124826|hyperglycemia|hyperglycemia
5794961|NCT00124826|magnetic resonance imaging|magnetic resonance imaging
5794962|NCT00124826|acute ischemic stroke|acute ischemic stroke
5794963|NCT00124800|tinnitus|tinnitus
5794964|NCT00124774|hernia|hernia
5794965|NCT00124774|nucleoplasty|nucleoplasty
5794966|NCT00124774|radicular pain|radicular pain
5794967|NCT00124774|Contained lumbar herniated disc|contained lumbar herniated disc
5794968|NCT00124761|Radiosurgery|radiosurgery
5794969|NCT00124761|Brain metastases|brain metastases
5794970|NCT00124761|Whole Brain Radiotherapy|whole brain radiotherapy
5794971|NCT00124761|Neurosurgery|neurosurgery
5794972|NCT00124761|Solitary Brain Metastases|solitary brain metastases
5794973|NCT00124761|Adult Tumours Metastatic to Brain|adult tumours metastatic to brain
5794974|NCT00124748|CML|cml
5794975|NCT00124748|Philadelphia positive|philadelphia positive
5794976|NCT00124748|Bcr-abl|bcr-abl
5794977|NCT00124748|imatinib mesylate|imatinib mesylate
5794978|NCT00124748|Chronic myeloid leukemia (CML) in chronic phase|chronic myeloid leukemia (cml) in chronic phase
5794979|NCT00124709|Atopic, dermatitis, asthma, children, modification|atopic, dermatitis, asthma, children, modification
5794980|NCT00124709|Atopic dermatitis/atopy|atopic dermatitis/atopy
5794981|NCT00124696|cocaine dependence|cocaine dependence
5794982|NCT00124683|nicotine dependence|nicotine dependence
5794983|NCT00124657|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5794984|NCT00124657|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5794985|NCT00124657|adult glioblastoma|adult glioblastoma
5794986|NCT00124657|adult giant cell glioblastoma|adult giant cell glioblastoma
5794987|NCT00124657|adult gliosarcoma|adult gliosarcoma
5794988|NCT00124657|adult mixed glioma|adult mixed glioma
5794989|NCT00124657|childhood mixed glioma|childhood mixed glioma
5794245|NCT00127452|DHA|dha
5794990|NCT00124657|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5794991|NCT00124657|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5794992|NCT00124657|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5794993|NCT00124657|childhood oligodendroglioma|childhood oligodendroglioma
5794994|NCT00124657|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5794995|NCT00124644|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5794996|NCT00124644|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5794997|NCT00124644|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5794998|NCT00124644|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5794999|NCT00124618|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5795000|NCT00124618|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5795001|NCT00124579|stage I multiple myeloma|stage i multiple myeloma
5795002|NCT00124579|stage II multiple myeloma|stage ii multiple myeloma
5795003|NCT00124579|stage III multiple myeloma|stage iii multiple myeloma
5795004|NCT00124579|refractory multiple myeloma|refractory multiple myeloma
5795005|NCT00124566|Irofulven|irofulven
5795006|NCT00124566|Docetaxel|docetaxel
5795007|NCT00124566|Taxotere|taxotere
5795008|NCT00124553|Type 2 diabetes|type 2 diabetes
5795009|NCT00124553|cardiovascular risk|cardiovascular risk
5795010|NCT00124553|glycaemic control|glycaemic control
5795011|NCT00124553|dietary modification|dietary modification
5795012|NCT00124540|Misoprostol|misoprostol
5795013|NCT00124540|Active management|active management
5795014|NCT00124540|Postpartum hemorrhage|postpartum hemorrhage
5795015|NCT00124540|Maternal morbidity|maternal morbidity
5795016|NCT00124540|Anemia|anemia
5795017|NCT00124540|Developing countries|developing countries
5795018|NCT00124527|Irofulven, Thyroid Cancer|irofulven, thyroid cancer
5795019|NCT00124514|SLE|sle
5795020|NCT00124514|Lupus|lupus
5795021|NCT00124514|Ovarian damage|ovarian damage
5795023|NCT00124501|Biofeedback|biofeedback
5795024|NCT00124488|radiotherapy planning|radiotherapy planning
5795025|NCT00124488|computer assisted radiotherapy|computer assisted radiotherapy
5795026|NCT00124488|conformal|conformal
5795027|NCT00124475|Chronic Hand Dermatitis|chronic hand dermatitis
5795125|NCT00124046|Surgical Section of the Filum Terminale|surgical section of the filum terminale
5795126|NCT00124046|Occult Tethered Cord Syndrome|occult tethered cord syndrome
5795028|NCT00124436|Patients who have been enrolled in study protocol BAP089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed|patients who have been enrolled in study protocol bap089, and whose severe chronic hand dermatitis responded with mild or moderate disease, or who relapsed
5795029|NCT00124423|brachytherapy megavoltage CT imaging|brachytherapy megavoltage ct imaging
5795030|NCT00124410|prostate cancer|prostate cancer
5795031|NCT00124410|androgen suppression therapy (hormone therapy)|androgen suppression therapy (hormone therapy)
5795032|NCT00124410|osteoporosis|osteoporosis
5795033|NCT00124384|primary insomnia, stimulants, cognitive behavioral therapy|primary insomnia, stimulants, cognitive behavioral therapy
5795034|NCT00124371|coronary artery bypass surgery|coronary artery bypass surgery
5795035|NCT00124371|risk factors|risk factors
5796193|NCT00120029|diet|diet
5795036|NCT00124371|nurse-led secondary prevention|nurse-led secondary prevention
5795037|NCT00124371|prehabilitation|prehabilitation
5795038|NCT00124371|waiting period|waiting period
5795039|NCT00124358|Drug Abuse|drug abuse
5795040|NCT00124358|Drug Addiction|drug addiction
5795041|NCT00124358|Drug Dependence|drug dependence
5795042|NCT00124358|Drug Use Disorders|drug use disorders
5795043|NCT00124358|Drug Use Disorder|drug use disorder
5795044|NCT00124358|Substance Abuse|substance abuse
5795045|NCT00124358|Substance Use Disorder|substance use disorder
5795046|NCT00124358|Buprenorphine|buprenorphine
5795047|NCT00124358|Opiate Addiction|opiate addiction
5795048|NCT00124358|Substance-related disorders|substance-related disorders
5795049|NCT00124358|HIV|hiv
5795050|NCT00124345|temperature|temperature
5795051|NCT00124345|humidity|humidity
5795052|NCT00124345|non invasive mechanical ventilation|non invasive mechanical ventilation
5795053|NCT00124319|Biomechanics|biomechanics
5795054|NCT00124319|Neuromuscular|neuromuscular
5795055|NCT00124319|Lower limb|lower limb
5795056|NCT00124319|Injury|injury
5795057|NCT00124319|ACL|acl
5795058|NCT00124319|Anterior Cruciate Ligament injury|anterior cruciate ligament injury
5795059|NCT00124306|painful bladder syndrome|painful bladder syndrome
5795060|NCT00124306|interstitial cystitis|interstitial cystitis
5795061|NCT00124306|newly diagnosed|newly diagnosed
5795062|NCT00124280|Lung cancer|lung cancer
5795063|NCT00124280|non-small cell|non-small cell
5795064|NCT00124280|everolimus|everolimus
5795065|NCT00124280|Non-small cell lung cancer (NSCLC)|non-small cell lung cancer (nsclc)
5795066|NCT00124267|Cerebral|cerebral
5795067|NCT00124267|malaria|malaria
5795068|NCT00124267|intra-rectal|intra-rectal
5795069|NCT00124267|quinine|quinine
5795070|NCT00124267|children|children
5795071|NCT00124267|Uganda|uganda
5795072|NCT00124267|efficacy|efficacy
5795073|NCT00124267|safety|safety
5795074|NCT00124254|Metacarpophalangeal Joint|metacarpophalangeal joint
5795075|NCT00124254|Arthroplasty|arthroplasty
5795076|NCT00124254|Outcomes|outcomes
5795077|NCT00124254|Michigan Hand Outcomes Questionnaire|michigan hand outcomes questionnaire
5795078|NCT00124254|Joint Replacement|joint replacement
5795079|NCT00124228|Cirrhosis|cirrhosis
5795080|NCT00124228|Infection|infection
5795082|NCT00124228|Renal failure|renal failure
5795083|NCT00124215|Hepatitis|hepatitis
5795084|NCT00124215|HCV|hcv
5795085|NCT00124215|vaccine|vaccine
5795086|NCT00124215|Hepatitis C Infection|hepatitis c infection
5795087|NCT00124202|a fatty meal|a fatty meal
5795088|NCT00124202|ERCP|ercp
5795089|NCT00124189|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5795090|NCT00124189|T-cell prolymphocytic leukemia|t-cell prolymphocytic leukemia
5795091|NCT00124189|Chronic lymphoproliferative diseases|chronic lymphoproliferative diseases
5795092|NCT00124189|Telomerase|telomerase
5795093|NCT00124189|Telomerase Inhibition|telomerase inhibition
5795095|NCT00124176|Levalbuterol|levalbuterol
5795096|NCT00124176|Albuterol|albuterol
5795097|NCT00124176|Children|children
5795098|NCT00124163|CT Virtual Colonoscopy|ct virtual colonoscopy
5795099|NCT00124163|Optical Colonoscopy|optical colonoscopy
5795100|NCT00124163|Stool Tagging|stool tagging
5795101|NCT00124163|Patient Preparation|patient preparation
5795102|NCT00124150|subarachnoid hemorrhage|subarachnoid hemorrhage
5795103|NCT00124150|magnesium sulfate|magnesium sulfate
5795104|NCT00124137|Ultrafiltration|ultrafiltration
5795105|NCT00124137|acute decompensated heart failure|acute decompensated heart failure
5795106|NCT00124137|fluid overload|fluid overload
5795107|NCT00124137|pulmonary congestion|pulmonary congestion
5795108|NCT00124111|clinical trial|clinical trial
5795109|NCT00124111|pegfilgrastim|pegfilgrastim
5795110|NCT00124111|haematopoietic growth factor|haematopoietic growth factor
5795111|NCT00124111|neutropenia|neutropenia
5795112|NCT00124111|CMF|cmf
5795113|NCT00124111|Cancer|cancer
5795114|NCT00124098|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5795115|NCT00124098|anemia, clinical trial|anemia, clinical trial
5795116|NCT00124098|darbepoetin alfa|darbepoetin alfa
5795117|NCT00124098|Aranesp®|aranesp®
5795118|NCT00124098|Amgen|amgen
5795119|NCT00124072|Myocardial infarction|myocardial infarction
5795120|NCT00124072|Coronary heart disease|coronary heart disease
5795121|NCT00124072|Cholesterol|cholesterol
5795122|NCT00124072|Stroke|stroke
5795123|NCT00124059|alcohol dependence|alcohol dependence
5795124|NCT00124046|Urinary Incontinence in Children|urinary incontinence in children
5795127|NCT00124046|Urodynamic Scale|urodynamic scale
5795128|NCT00124046|Enuresis-Specific Quality of Life Scale|enuresis-specific quality of life scale
5795129|NCT00124033|Cholecystectomy|cholecystectomy
5795130|NCT00124033|Cholangiopancreatography, Endoscopic Retrograde|cholangiopancreatography, endoscopic retrograde
5795131|NCT00124007|HIV Seronegativity|hiv seronegativity
5795132|NCT00124007|HIV Preventive Vaccine|hiv preventive vaccine
5795134|NCT00123994|Hydrotherapy|hydrotherapy
5795135|NCT00123994|Exercise|exercise
5795136|NCT00123994|Joint pain|joint pain
5795137|NCT00123994|Disability|disability
5795138|NCT00123981|Off-pump Coronary Artery By-pass Grafting|off-pump coronary artery by-pass grafting
5796398|NCT00119106|Prevention|prevention
5795139|NCT00123981|Randomization|randomization
5795140|NCT00123981|stroke|stroke
5795141|NCT00123981|myocardial infarction|myocardial infarction
5795142|NCT00123981|mortality|mortality
5795143|NCT00123981|graft patency|graft patency
5795144|NCT00123981|quality of life|quality of life
5795145|NCT00123968|HIV Seronegativity|hiv seronegativity
5795146|NCT00123968|HIV Preventive Vaccine|hiv preventive vaccine
5795147|NCT00123942|CD2+ Lymphoproliferative disorder|cd2+ lymphoproliferative disorder
5795148|NCT00123929|breast cancer|breast cancer
5795149|NCT00123929|neoadjuvant chemotherapy|neoadjuvant chemotherapy
5795150|NCT00123929|genetic signature|genetic signature
5795151|NCT00123929|doxorubicin|doxorubicin
5795152|NCT00123929|docetaxel|docetaxel
5795153|NCT00123916|Chagas Disease|chagas disease
5795154|NCT00123916|Trypanosomiasis|trypanosomiasis
5795155|NCT00123916|Benznidazole|benznidazole
5795156|NCT00123916|Chronic Heart disease|chronic heart disease
5795157|NCT00123916|Trypanosoma Cruzi|trypanosoma cruzi
5795158|NCT00123903|hypertension|hypertension
5795159|NCT00123903|urine albumin:creatinine ratio|urine albumin:creatinine ratio
5795160|NCT00123903|microalbuminuria|microalbuminuria
5795161|NCT00123890|HIV-1 GW873140 CCR5 antagonist experienced|hiv-1 gw873140 ccr5 antagonist experienced
5795162|NCT00123877|Breast|breast
5795163|NCT00123877|Cancer|cancer
5795164|NCT00123877|Metastasis|metastasis
5795165|NCT00123864|intensity modulated radiation therapy|intensity modulated radiation therapy
5795166|NCT00123864|parotid|parotid
5795167|NCT00123864|nasopharyngeal carcinoma|nasopharyngeal carcinoma
5795168|NCT00123851|Colorectal|colorectal
5795169|NCT00123851|Metastatic Colorectal Cancer|metastatic colorectal cancer
5795170|NCT00123851|Oxaliplatin|oxaliplatin
5795171|NCT00123851|Tarceva|tarceva
5795172|NCT00123851|Capecitabine|capecitabine
5795173|NCT00123851|Xeloda|xeloda
5795174|NCT00123838|Prostate|prostate
5795175|NCT00123838|Cancer|cancer
5795176|NCT00123838|Radiotherapy|radiotherapy
5795177|NCT00123838|Neoplasm|neoplasm
5794371|NCT00126906|HIV|hiv
5795178|NCT00123838|Localization|localization
5795179|NCT00123838|Tracking|tracking
5795180|NCT00123838|Cancer of Prostate|cancer of prostate
5795181|NCT00123838|Neoplasms, Prostate|neoplasms, prostate
5795182|NCT00123825|Gallbladder|gallbladder
5809842|NCT00002864|stage II breast cancer|stage ii breast cancer
5809843|NCT00002864|stage III breast cancer|stage iii breast cancer
5809844|NCT00002838|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5809845|NCT00002838|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5809846|NCT00002838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5795183|NCT00123825|Biliary Tract|biliary tract
5795184|NCT00123825|Cholangiocarcinoma|cholangiocarcinoma
5795185|NCT00123812|quality assurance|quality assurance
5795186|NCT00123812|frequency of port films|frequency of port films
5795187|NCT00123799|positron emission tomography|positron emission tomography
5795188|NCT00123799|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5795189|NCT00123799|sentinel lymph node biopsy|sentinel lymph node biopsy
5795190|NCT00123786|positron emission tomography|positron emission tomography
5795191|NCT00123786|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5795192|NCT00123786|tomography scanners, x-ray computed|tomography scanners, x-ray computed
5795193|NCT00123773|positron emission tomography|positron emission tomography
5795194|NCT00123773|fluorodeoxyglucose F18|fluorodeoxyglucose f18
5795195|NCT00123773|Tomography scanners, x-ray computed|tomography scanners, x-ray computed
5795196|NCT00123760|Positron-Emission Tomography|positron-emission tomography
5795197|NCT00123760|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5795198|NCT00123760|Tomography scanners, X-Ray computed|tomography scanners, x-ray computed
5795199|NCT00123747|Positron Emission Tomography|positron emission tomography
5795200|NCT00123747|Fluorodeoxyglucose F18|fluorodeoxyglucose f18
5795201|NCT00123747|Tomography scanners, X-Ray Computed|tomography scanners, x-ray computed
5795203|NCT00123708|Dystonia|dystonia
5795204|NCT00123708|Movement Disorders|movement disorders
5795205|NCT00123708|Walking|walking
5795207|NCT00123708|Resistance|resistance
5795208|NCT00123708|Gait|gait
5795209|NCT00123708|Cerebral Palsy|cerebral palsy
5795210|NCT00123708|CP|cp
5795211|NCT00123695|Subarachnoid hemorrhage|subarachnoid hemorrhage
5795212|NCT00123695|Takotsubo cardiomyopathy|takotsubo cardiomyopathy
5795213|NCT00123695|Cardiac abnormalities|cardiac abnormalities
5795214|NCT00123695|outcome|outcome
5795215|NCT00123682|Smoking Cessation|smoking cessation
5795216|NCT00123682|Care Management|care management
5795217|NCT00123682|Substance Use Disorder QUERI|substance use disorder queri
5795218|NCT00123682|Primary Care|primary care
5795219|NCT00123682|Regional Expansion|regional expansion
5795220|NCT00123682|Telephone|telephone
5795221|NCT00123669|Cancer of the Breast|cancer of the breast
5795222|NCT00123669|Neoplasm|neoplasm
5795317|NCT00123214|Diet|diet
5795223|NCT00123656|Eosinophilic esophagitis|eosinophilic esophagitis
5795224|NCT00123656|esomeprazole|esomeprazole
5795225|NCT00123656|fluticasone|fluticasone
5795226|NCT00123643|thiazolidinedione|thiazolidinedione
5795227|NCT00123643|sulfonylurea|sulfonylurea
5795228|NCT00123643|endothelial function|endothelial function
5795229|NCT00123630|eosinophilic esophagitis|eosinophilic esophagitis
5795230|NCT00123630|omalizumab|omalizumab
5795231|NCT00123617|Chest pain|chest pain
5795232|NCT00123617|Women|women
5795233|NCT00123617|Syndrome X|syndrome x
5795234|NCT00123617|Cardiac rehabilitation|cardiac rehabilitation
5795235|NCT00123617|Psychological morbidity|psychological morbidity
5795236|NCT00123617|Cardiovascular risk factors|cardiovascular risk factors
5795237|NCT00123604|beta-blockers|beta-blockers
5795238|NCT00123604|endothelial function|endothelial function
5795239|NCT00123565|Coronary Disease|coronary disease
5795240|NCT00123552|Uganda, malaria, combination antimalarial therapy|uganda, malaria, combination antimalarial therapy
5795241|NCT00123487|Accelerated Phase Chronic Myeloid Leukemia|accelerated phase chronic myeloid leukemia
5795242|NCT00123487|Lymphoid Blast Phase Chronic Myeloid Leukemia|lymphoid blast phase chronic myeloid leukemia
5795243|NCT00123487|Myeloid Blast Phase Chronic Myeloid Leukemia|myeloid blast phase chronic myeloid leukemia
5795244|NCT00123487|Philadelphia Positive Acute Lymphoblastic Leukemia|philadelphia positive acute lymphoblastic leukemia
5795245|NCT00123474|Chronic Phase Chronic Myelogenous Leukemia|chronic phase chronic myelogenous leukemia
5795246|NCT00123448|Mirror Neurons|mirror neurons
5795247|NCT00123448|fMRI|fmri
5795248|NCT00123448|Premotor Cortex|premotor cortex
5795249|NCT00123448|gesture|gesture
5795250|NCT00123448|Healthy Volunteer|healthy volunteer
5795252|NCT00123435|Behavioral Research|behavioral research
5795253|NCT00123435|Nutritional management|nutritional management
5795254|NCT00123435|Physical activity|physical activity
5795255|NCT00123435|Prevention|prevention
5795256|NCT00123435|Randomized control trial|randomized control trial
5795257|NCT00123435|walking program|walking program
5795258|NCT00123435|Weight loss|weight loss
5795259|NCT00123435|World wide web|world wide web
5795260|NCT00123422|Breathing exercise|breathing exercise
5795261|NCT00123422|Exercise Therapy|exercise therapy
5795262|NCT00123422|Helium|helium
5795263|NCT00123422|Oxygen inhalation therapy|oxygen inhalation therapy
5795264|NCT00123422|Pulmonary emphysema|pulmonary emphysema
5795265|NCT00123422|Pulmonary ventilation|pulmonary ventilation
5795266|NCT00123422|Rehabilitation|rehabilitation
5795267|NCT00123409|Primary Care|primary care
5795268|NCT00123409|Telephone|telephone
5795269|NCT00123409|Quality of Life|quality of life
5795270|NCT00123396|Bioterrorism|bioterrorism
5795271|NCT00123396|Education, Medical, Continuing|education, medical, continuing
5795272|NCT00123396|Internet|internet
5795273|NCT00123383|Modafinil|modafinil
5795274|NCT00123383|Cocaine Dependence|cocaine dependence
5795275|NCT00123383|Randomised placebo-controlled trial|randomised placebo-controlled trial
5795276|NCT00123370|Modafinil|modafinil
5795277|NCT00123370|Amphetamine Dependence|amphetamine dependence
5785931|NCT00165568|PET|pet
5795278|NCT00123370|Randomised placebo-controlled trial|randomised placebo-controlled trial
5795280|NCT00123344|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation
5795281|NCT00123344|antitachycardia pacing therapies|antitachycardia pacing therapies
5795282|NCT00123344|prevention algorithms|prevention algorithms
5795283|NCT00123331|Heart transplantation|heart transplantation
5795284|NCT00123331|Renal failure|renal failure
5795285|NCT00123331|Cyclosporine|cyclosporine
5795286|NCT00123331|Rapamycin|rapamycin
5795287|NCT00123318|Gastric cancer|gastric cancer
5795288|NCT00123318|Radiotherapy|radiotherapy
5795289|NCT00123318|Chemotherapy|chemotherapy
5795290|NCT00123318|Chemoradiation|chemoradiation
5795291|NCT00123305|Stroke|stroke
5795292|NCT00123305|Acute Ischemic Stroke|acute ischemic stroke
5795293|NCT00123292|arterial occlusion|arterial occlusion
5795294|NCT00123292|thromboembolism|thromboembolism
5795295|NCT00123292|Acute Peripheral Arterial Occlusion|acute peripheral arterial occlusion
5795296|NCT00123279|diabetic macular edema|diabetic macular edema
5795297|NCT00123279|macular hole|macular hole
5795298|NCT00123279|vitreomacular traction syndrome|vitreomacular traction syndrome
5795299|NCT00123266|stroke|stroke
5795300|NCT00123266|vertebrobasilar|vertebrobasilar
5795301|NCT00123266|basilar|basilar
5795302|NCT00123266|Acute vertebrobasilar artery occlusion|acute vertebrobasilar artery occlusion
5795303|NCT00123253|HIV|hiv
5795304|NCT00123253|Lipodystrophy|lipodystrophy
5795305|NCT00123253|Abdominal fat accumulation|abdominal fat accumulation
5795306|NCT00123253|Growth hormone releasing factor/Growth hormone releasing hormone|growth hormone releasing factor/growth hormone releasing hormone
5795307|NCT00123253|Treatment Experienced|treatment experienced
5817212|NCT00080275|Stroke|stroke
5795308|NCT00123240|overweight|overweight
5795309|NCT00123240|obese|obese
5795310|NCT00123240|diet|diet
5795311|NCT00123227|Randomised controlled trial|randomised controlled trial
5795312|NCT00123227|Rosiglitazone|rosiglitazone
5795313|NCT00123227|Cardiovascular magnetic resonance|cardiovascular magnetic resonance
5795314|NCT00123227|Diabetes Mellitus|diabetes mellitus
5795315|NCT00123227|Vascular Diseases|vascular diseases
5795316|NCT00123227|Hypertension|hypertension
5795318|NCT00123214|Chronic sleep deprivation|chronic sleep deprivation
5795320|NCT00123214|Cognitive impairment|cognitive impairment
5795321|NCT00123214|Lipids|lipids
5795322|NCT00123214|Inflammation|inflammation
5795323|NCT00123214|Resting metabolic rate|resting metabolic rate
5795324|NCT00123214|Weight Gain|weight gain
5795325|NCT00123214|Percent Body Fat|percent body fat
5795326|NCT00123214|Hyperlipidemia|hyperlipidemia
5795327|NCT00123201|efficacy & safety, migraine headache, placebo-controlled|efficacy & safety, migraine headache, placebo-controlled
5795328|NCT00123201|migraine headache with or without aura|migraine headache with or without aura
5795428|NCT00122642|catheterization|catheterization
5795329|NCT00123175|Endometrial Hyperplasia without atypia|endometrial hyperplasia without atypia
5795330|NCT00123162|Sildenafil|sildenafil
5795331|NCT00123149|Anemia|anemia
5795332|NCT00123149|Rheumatoid arthritis|rheumatoid arthritis
5795333|NCT00123149|Hemoglobin level|hemoglobin level
5795334|NCT00123136|pulsed magnetic field therapy|pulsed magnetic field therapy
5795335|NCT00123136|diabetic peripheral neuropathy|diabetic peripheral neuropathy
5795336|NCT00123136|neuromodulation|neuromodulation
5795337|NCT00123136|diabetic peripheral neuropathic pain|diabetic peripheral neuropathic pain
5795338|NCT00123136|sleep benefit|sleep benefit
5795339|NCT00123136|diabetic peripheral neuropathic functioning|diabetic peripheral neuropathic functioning
5795340|NCT00123123|Ventilator-associated pneumonia|ventilator-associated pneumonia
5795341|NCT00123097|Facial Neoplasms|facial neoplasms
5795342|NCT00123097|Head and Neck Neoplasms|head and neck neoplasms
5795343|NCT00123097|Head Injuries, Penetrating|head injuries, penetrating
5795344|NCT00123097|Birth Injuries|birth injuries
5795345|NCT00123084|Parkinson's disease|parkinson's disease
5795346|NCT00123084|Swallowing difficulties|swallowing difficulties
5795347|NCT00123084|speech|speech
5795348|NCT00123084|voice|voice
5795349|NCT00123058|Hypertension|hypertension
5795350|NCT00123058|Cariovascular Diseases|cariovascular diseases
5795351|NCT00123058|Health Illiteracy|health illiteracy
5795352|NCT00122980|Blood Diseases|blood diseases
5795353|NCT00122954|Fatty Acids, Omega-3|fatty acids, omega-3
5795354|NCT00122954|Fish Oils|fish oils
5795355|NCT00122954|Complementary Therapies|complementary therapies
5795356|NCT00122941|multiple|multiple
5795357|NCT00122941|micronutrients|micronutrients
5795358|NCT00122941|supplementation|supplementation
5795360|NCT00122941|children|children
5795361|NCT00122941|randomised|randomised
5795362|NCT00122941|trial|trial
5795363|NCT00122941|mortality|mortality
5795364|NCT00122941|morbidity|morbidity
5795365|NCT00122941|growth|growth
5795366|NCT00122941|Uganda|uganda
5795367|NCT00122928|Worksite|worksite
5795368|NCT00122928|Workplace|workplace
5795369|NCT00122928|Return on Investment|return on investment
5795370|NCT00122928|Financial Impact|financial impact
5795371|NCT00122915|Motor Cortex Stimulation|motor cortex stimulation
5795372|NCT00122915|Pain treatment|pain treatment
5795373|NCT00122915|Central post-stroke pain (CPSP)|central post-stroke pain (cpsp)
5795374|NCT00122915|Trigeminal neuropathic pain (TGN)|trigeminal neuropathic pain (tgn)
5795375|NCT00122915|Facial pain|facial pain
5795376|NCT00122915|Neurostimuation|neurostimuation
5795377|NCT00122915|Cortical lead|cortical lead
5795378|NCT00122915|Neuropathic pain|neuropathic pain
5795380|NCT00122902|AIDS|aids
5795381|NCT00122902|Spirituality|spirituality
5795382|NCT00122889|Drug Interactions|drug interactions
5795383|NCT00122889|Pharmacokinetics|pharmacokinetics
5795384|NCT00122889|Garlic|garlic
5795385|NCT00122889|Complementary Therapies|complementary therapies
5795386|NCT00122889|Complementary and Alternative Medicine|complementary and alternative medicine
5795387|NCT00122876|Hepatocellular Carcinoma|hepatocellular carcinoma
5795388|NCT00122876|HCC|hcc
5795389|NCT00122876|Photodynamic therapy|photodynamic therapy
5795390|NCT00122876|Talaporfin Sodium (LS11)|talaporfin sodium (ls11)
5795391|NCT00122876|Light emitting diodes (LEDs)|light emitting diodes (leds)
5795392|NCT00122876|Litx|litx
5795393|NCT00122876|Light Infusion Technology|light infusion technology
5795394|NCT00122811|Aged|aged
5795395|NCT00122811|Hypertension|hypertension
5795396|NCT00122811|Stroke|stroke
5795397|NCT00122798|Stroke, stroke treatment, atrial fibrillation, medication, rehabilitation|stroke, stroke treatment, atrial fibrillation, medication, rehabilitation
5795399|NCT00122785|wheezing|wheezing
5795400|NCT00122785|dexamethasone|dexamethasone
5795401|NCT00122785|young children|young children
5795402|NCT00122759|Mechanical ventilation|mechanical ventilation
5795403|NCT00122759|Agitation|agitation
5795404|NCT00122746|Cervical Cancer|cervical cancer
5795405|NCT00122746|AIDS|aids
5795406|NCT00122746|External Beam Radiotherapy|external beam radiotherapy
5795407|NCT00122746|Brachytherapy|brachytherapy
5795408|NCT00122746|Cisplatin|cisplatin
5795409|NCT00122733|Mechanical ventilation|mechanical ventilation
5795410|NCT00122733|Agitation|agitation
5795411|NCT00122733|Difficult weaning|difficult weaning
5795412|NCT00122720|colorectal cancer|colorectal cancer
5795413|NCT00122720|erythropoietin|erythropoietin
5795414|NCT00122720|rehabilitation|rehabilitation
5795415|NCT00122720|physical capacity|physical capacity
5795416|NCT00122707|catheter-related infection|catheter-related infection
5795417|NCT00122707|mechanical complications of catheters|mechanical complications of catheters
5795418|NCT00122694|carbon monoxide|carbon monoxide
5795419|NCT00122694|COPD|copd
5795420|NCT00122694|inflammation|inflammation
5795421|NCT00122694|sputum induction|sputum induction
5795422|NCT00122694|stable COPD|stable copd
5795423|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors
5795424|NCT00122668|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5795425|NCT00122668|HIV infections|hiv infections
5795426|NCT00122655|HIV infections|hiv infections
5795427|NCT00122655|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5795429|NCT00122642|Catheters, Indwelling|catheters, indwelling
5795430|NCT00122629|Hepatitis C, Chronic|hepatitis c, chronic
5795431|NCT00122629|peginterferon alfa-2b|peginterferon alfa-2b
5795432|NCT00122629|ribavirin|ribavirin
5795433|NCT00122629|Amantadine|amantadine
5795434|NCT00122616|HIV infections|hiv infections
5795435|NCT00122616|peginterferon alfa-2a|peginterferon alfa-2a
5795436|NCT00122616|Treatment Failure|treatment failure
5795437|NCT00122616|Hepatitis C, Chronic|hepatitis c, chronic
5795438|NCT00122616|Treatment Experienced|treatment experienced
5795439|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors
5795440|NCT00122603|HIV infections|hiv infections
5795441|NCT00122603|Atazanavir|atazanavir
5795442|NCT00122603|Saquinavir|saquinavir
5795443|NCT00122603|Fosamprenavir|fosamprenavir
5795444|NCT00122603|ritonavir|ritonavir
5795445|NCT00122603|Treatment Naive|treatment naive
5795446|NCT00122590|protease inhibitors|protease inhibitors
5795447|NCT00122590|nelfinavir|nelfinavir
5795448|NCT00122590|lopinavir|lopinavir
5795449|NCT00122590|indinavir|indinavir
5795450|NCT00122590|Pharmacokinetics|pharmacokinetics
5795451|NCT00122577|HIV infections|hiv infections
5795452|NCT00122577|Treatment Failure|treatment failure
5795453|NCT00122577|tenofovir|tenofovir
5795454|NCT00122577|atazanavir|atazanavir
5795455|NCT00122564|HIV Vaccines|hiv vaccines
5795456|NCT00122564|HIV Seronegativity|hiv seronegativity
5795457|NCT00122551|HIV infections|hiv infections
5795458|NCT00122538|HAART|haart
5795459|NCT00122538|once-daily|once-daily
5795460|NCT00122538|child|child
5795461|NCT00122538|africa|africa
5795462|NCT00122538|HIV|hiv
5795463|NCT00122538|AIDS|aids
5795464|NCT00122538|Treatment Naive|treatment naive
5795465|NCT00122525|HIV|hiv
5795466|NCT00122525|Male circumcision|male circumcision
5795467|NCT00122525|Prevention|prevention
5795468|NCT00122525|HSV-2|hsv-2
5795469|NCT00122525|Africa|africa
5795470|NCT00122525|Sexual behavior|sexual behavior
5795471|NCT00122512|AE adverse event|ae adverse event
5795472|NCT00122512|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5795473|NCT00122512|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5795474|NCT00122512|ART antiretroviral therapy|art antiretroviral therapy
5795475|NCT00122512|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5795477|NCT00122512|DMC Data Monitoring Committee|dmc data monitoring committee
5795478|NCT00122512|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5795479|NCT00122512|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5795480|NCT00122512|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5795481|NCT00122512|ICH International Conference of Harmonisation|ich international conference of harmonisation
5795482|NCT00122512|IND Investigational New Drug Application|ind investigational new drug application
5795483|NCT00122512|IRB Institutional Review Board|irb institutional review board
5795484|NCT00122512|IU international units|iu international units
5795485|NCT00122512|mg milligram(s)|mg milligram(s)
5795486|NCT00122512|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5795487|NCT00122512|PCR polymerase chain reaction|pcr polymerase chain reaction
5795488|NCT00122512|SAE serious adverse event|sae serious adverse event
5795489|NCT00122512|TDF tenofovir disoproxil fumarate, GS-4331-05, PMPA prodrug|tdf tenofovir disoproxil fumarate, gs-4331-05, pmpa prodrug
5795490|NCT00122512|µg microgram|µg microgram
5795491|NCT00122512|ULN upper limit of the normal range|uln upper limit of the normal range
5795492|NCT00122512|WB Western Blot|wb western blot
5795493|NCT00122512|Human Immunodeficiency Virus|human immunodeficiency virus
5795494|NCT00122512|HIV Seronegativity|hiv seronegativity
5795495|NCT00122499|Prostate cancer|prostate cancer
5795496|NCT00122499|Radiotherapy|radiotherapy
5795497|NCT00122499|Erectile dysfunction|erectile dysfunction
5795499|NCT00122486|AE adverse event|ae adverse event
5795500|NCT00122486|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5795501|NCT00122486|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5795502|NCT00122486|ART antiretroviral therapy|art antiretroviral therapy
5795503|NCT00122486|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5795504|NCT00122486|DCF data collection forms|dcf data collection forms
5795505|NCT00122486|DMC Data Monitoring Committee|dmc data monitoring committee
5795506|NCT00122486|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5795507|NCT00122486|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5795508|NCT00122486|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5795509|NCT00122486|ICH International Conference of Harmonisation|ich international conference of harmonisation
5795510|NCT00122486|IND Investigational New Drug Application|ind investigational new drug application
5795511|NCT00122486|IRB Institutional Review Board|irb institutional review board
5795512|NCT00122486|IU international units|iu international units
5795513|NCT00122486|mg milligram(s)|mg milligram(s)
5795514|NCT00122486|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5795515|NCT00122486|PCR polymerase chain reaction|pcr polymerase chain reaction
5795516|NCT00122486|SAE serious adverse event|sae serious adverse event
5795517|NCT00122486|µg microgram|µg microgram
5795615|NCT00122135|values inventory|values inventory
5795518|NCT00122486|ULN upper limit of the normal range|uln upper limit of the normal range
5795519|NCT00122486|WB Western Blot|wb western blot
5795520|NCT00122486|Human Immunodeficiency Virus|human immunodeficiency virus
5795521|NCT00122473|Dermatofibrosarcoma|dermatofibrosarcoma
5795522|NCT00122473|Imatinib|imatinib
5795523|NCT00122473|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5795524|NCT00122460|Head and Neck Cancer|head and neck cancer
5795525|NCT00122447|Prediabetic state|prediabetic state
5795526|NCT00122447|Cardiovascular disease|cardiovascular disease
5795527|NCT00122447|Diabetes|diabetes
5795528|NCT00122447|Glucose intolerance|glucose intolerance
5795529|NCT00122421|diabetes|diabetes
5795530|NCT00122421|quality of care|quality of care
5795531|NCT00122421|pharmacist recommendations|pharmacist recommendations
5795532|NCT00122408|ventilator-associated pneumonia|ventilator-associated pneumonia
5795533|NCT00122408|probiotic|probiotic
5795534|NCT00122408|mechanical ventilation|mechanical ventilation
5795535|NCT00122408|intensive care|intensive care
5795536|NCT00122395|Domestic violence|domestic violence
5795537|NCT00122395|Screening|screening
5795538|NCT00122395|Emergency department|emergency department
5795539|NCT00122382|abatacept, methotrexate, erosive RA|abatacept, methotrexate, erosive ra
5795541|NCT00122369|Biopsy|biopsy
5795542|NCT00122369|Hypnosis|hypnosis
5795543|NCT00122369|Relaxation|relaxation
5795544|NCT00122369|Anxiety|anxiety
5795545|NCT00122369|Pain|pain
5795546|NCT00122369|Medical and Surgical Procedures|medical and surgical procedures
5795547|NCT00122343|Endometrial|endometrial
5795548|NCT00122343|Cancer|cancer
5795549|NCT00122317|transfusion dependent|transfusion dependent
5795550|NCT00122317|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5795551|NCT00122317|hemolytic|hemolytic
5795552|NCT00122291|preoperative|preoperative
5795553|NCT00122291|chemotherapy|chemotherapy
5816587|NCT00022386|anemia|anemia
5795554|NCT00122291|radiation therapy|radiation therapy
5795555|NCT00122291|rectal cancer|rectal cancer
5795556|NCT00122291|transmural rectal wall invasion|transmural rectal wall invasion
5795557|NCT00122291|nodal metastasis|nodal metastasis
5795558|NCT00122278|migraine, emergency department, dexamethasone|migraine, emergency department, dexamethasone
5795559|NCT00122278|Migraine with or without aura or probable migraine without aura as defined by ICHD, 2nd edition|migraine with or without aura or probable migraine without aura as defined by ichd, 2nd edition
5795560|NCT00122265|prostate cancer|prostate cancer
5795561|NCT00122265|radiotherapy|radiotherapy
5795562|NCT00122265|radiation toxicity|radiation toxicity
5795563|NCT00122265|single nucleotide polymorphism|single nucleotide polymorphism
5795564|NCT00122252|prostate cancer|prostate cancer
5795565|NCT00122252|radiotherapy|radiotherapy
5795566|NCT00122252|biological imaging|biological imaging
5795567|NCT00122239|radiotherapy|radiotherapy
5795568|NCT00122239|radiation toxicity|radiation toxicity
5795569|NCT00122239|single nucleotide polymorphism|single nucleotide polymorphism
5795570|NCT00122239|breast carcinoma|breast carcinoma
5795571|NCT00122239|prostate carcinoma|prostate carcinoma
5795572|NCT00122239|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5795573|NCT00122239|lung carcinoma (non-small cell)|lung carcinoma (non-small cell)
5795575|NCT00122226|HIV-associated lipodystrophy syndrome|hiv-associated lipodystrophy syndrome
5795576|NCT00122213|Prevention|prevention
5795577|NCT00122213|Retirement|retirement
5795578|NCT00122213|Physical activity|physical activity
5795579|NCT00122213|Diet|diet
5795580|NCT00122213|Weight gain|weight gain
5795581|NCT00122213|Body composition|body composition
5795582|NCT00122187|cancer|cancer
5795583|NCT00122187|colonoscopy|colonoscopy
5795584|NCT00122187|mass screening|mass screening
5795585|NCT00122187|colorectal cancer|colorectal cancer
5795586|NCT00122187|colorectal carcinoma|colorectal carcinoma
5795587|NCT00122187|reminder systems|reminder systems
5795588|NCT00122187|rectal cancers|rectal cancers
5795589|NCT00122187|colorectal tumor|colorectal tumor
5795590|NCT00122187|guidelines|guidelines
5795591|NCT00122187|CRC secondary prevention|crc secondary prevention
5795592|NCT00122187|colorectal neoplasms|colorectal neoplasms
5795593|NCT00122187|colonic neoplasms|colonic neoplasms
5795594|NCT00122187|colonic diseases|colonic diseases
5795595|NCT00122187|hemoccult testing|hemoccult testing
5795596|NCT00122174|Caregivers|caregivers
5795597|NCT00122174|Stress|stress
5795598|NCT00122174|Coping|coping
5795599|NCT00122174|Immune|immune
5795600|NCT00122174|Relaxation|relaxation
5795601|NCT00122174|Biofeedback|biofeedback
5795602|NCT00122174|Bioinstrumentation|bioinstrumentation
5795603|NCT00122174|Homecare|homecare
5795604|NCT00122161|Drug therapy|drug therapy
5795605|NCT00122161|Practice guidelines|practice guidelines
5795606|NCT00122161|Reminder systems|reminder systems
5795607|NCT00122161|Ambulatory care|ambulatory care
5795608|NCT00122161|Hypertension|hypertension
5795609|NCT00122161|Clinical protocols|clinical protocols
5795610|NCT00122161|Quality Assurance, Health Care|quality assurance, health care
5795611|NCT00122148|Quality of health care|quality of health care
5795612|NCT00122148|Feedback|feedback
5795613|NCT00122135|end-of-life care|end-of-life care
5795614|NCT00122135|clinical decision-making|clinical decision-making
5795616|NCT00122135|racial disparities|racial disparities
5795617|NCT00122109|Posttraumatic Stress Disorder|posttraumatic stress disorder
5795618|NCT00122109|Anger Management|anger management
5795619|NCT00122109|Telemedicine modality|telemedicine modality
5795620|NCT00122096|neurosurgery|neurosurgery
5795621|NCT00122096|COX-2|cox-2
5795622|NCT00122096|inflammation|inflammation
5795623|NCT00122096|pain|pain
5795624|NCT00122083|Depression|depression
5795625|NCT00122083|Students|students
5795626|NCT00122083|Health education|health education
5795627|NCT00122070|Borderline Personality Disorder|borderline personality disorder
5795628|NCT00122070|Personality Disorder|personality disorder
5795629|NCT00122070|Quetiapine|quetiapine
5795630|NCT00122070|Atypical Antipsychotics|atypical antipsychotics
5795631|NCT00122070|Seroquel|seroquel
5795632|NCT00122070|Antipsychotics|antipsychotics
5795633|NCT00122057|ventilator-associated tracheobronchitis|ventilator-associated tracheobronchitis
5795634|NCT00122057|nosocomial tracheobronchitis|nosocomial tracheobronchitis
5795635|NCT00122044|childhood|childhood
5795636|NCT00122044|cerebral palsy|cerebral palsy
5795637|NCT00122044|dystonia|dystonia
5795638|NCT00122044|secondary|secondary
5795639|NCT00122044|trihexyphenidyl|trihexyphenidyl
5795640|NCT00122044|pediatric dystonia|pediatric dystonia
5795641|NCT00122031|Major Depression|major depression
5795642|NCT00122031|Treatment Refractory Major Depression|treatment refractory major depression
5795643|NCT00122018|Kidney failure|kidney failure
5795644|NCT00122018|Cardiac Surgery|cardiac surgery
5795645|NCT00122018|Fenoldopam|fenoldopam
5795646|NCT00122018|N-acetylcysteine|n-acetylcysteine
5795647|NCT00122005|Metastatic|metastatic
5795648|NCT00122005|Prostate|prostate
5795649|NCT00122005|Advanced|advanced
5795650|NCT00122005|Cancer|cancer
5795651|NCT00122005|GVAX|gvax
5686507|NCT00551759|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5686508|NCT00551759|chemoradiotherapy|chemoradiotherapy
5686509|NCT00551759|oxaliplatin|oxaliplatin
5686510|NCT00551759|cetuximab|cetuximab
5686511|NCT00551759|docetaxel|docetaxel
5686512|NCT00551746|purple grape juice|purple grape juice
5686513|NCT00551746|antioxidants|antioxidants
5686514|NCT00551746|platelet aggregation|platelet aggregation
5686515|NCT00551746|anti-thrombotic|anti-thrombotic
5686516|NCT00551733|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5686517|NCT00551733|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5686518|NCT00551733|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5686520|NCT00551720|HIV positive|hiv positive
5686521|NCT00551720|AIDS|aids
5686522|NCT00551720|smoking cessation|smoking cessation
5686523|NCT00551720|smoking|smoking
5686524|NCT00551720|smoking counseling|smoking counseling
5686525|NCT00551707|CombinatoRx|combinatorx
5686526|NCT00551707|CRx-102|crx-102
5686527|NCT00551707|Rheumatoid Arthritis|rheumatoid arthritis
5686528|NCT00551707|Prednisolone|prednisolone
5686529|NCT00551707|Dipyridamole|dipyridamole
5686530|NCT00551707|ACR20|acr20
5686531|NCT00551694|GSK256073A|gsk256073a
5686876|NCT00550186|bladder retention|bladder retention
5686532|NCT00551681|cardiac resynchronisation therapy|cardiac resynchronisation therapy
5686533|NCT00551681|epicardial lead|epicardial lead
5686534|NCT00551681|coronary sinus|coronary sinus
5686535|NCT00551655|Human Immunodeficiency Viruses|human immunodeficiency viruses
5686536|NCT00551655|Glomerular Filtration Rate|glomerular filtration rate
5686537|NCT00551655|Tenofovir|tenofovir
5686538|NCT00551655|Treatment Experienced|treatment experienced
5686539|NCT00551642|Preemie, Inhaled Nitric Oxide|preemie, inhaled nitric oxide
5686540|NCT00551603|epoetinum beta once-weekly|epoetinum beta once-weekly
5686541|NCT00551603|darbepoetinum once-fortnightly|darbepoetinum once-fortnightly
5686542|NCT00551603|anemia correction|anemia correction
5686543|NCT00551603|hemoglobin stability|hemoglobin stability
5686544|NCT00551590|diabetes mellitus|diabetes mellitus
5686545|NCT00551590|DPP-4 inhibitor|dpp-4 inhibitor
5686546|NCT00551590|sitagliptin|sitagliptin
5686547|NCT00551590|exendin(9-39)|exendin(9-39)
5686548|NCT00551590|GLP-1|glp-1
5686549|NCT00551577|Ovarian neoplasms,|ovarian neoplasms,
5681179|NCT00574431|Critical care|critical care
5795652|NCT00122005|Vaccine|vaccine
5795653|NCT00121992|High risk node negative breast cancer|high risk node negative breast cancer
5795654|NCT00121992|Disease-Free survival|disease-free survival
5795655|NCT00121992|Quality of life|quality of life
5795656|NCT00121979|HIV|hiv
5795657|NCT00121979|treatment-experienced|treatment-experienced
5795658|NCT00121979|lamivudine|lamivudine
5795659|NCT00121979|3TC|3tc
5795660|NCT00121966|Type 2 diabetes|type 2 diabetes
5795661|NCT00121966|Insulin Aspart|insulin aspart
5795662|NCT00121966|Insulin NPH|insulin nph
5795663|NCT00121966|Metformin|metformin
5795664|NCT00121966|Rosiglitazone|rosiglitazone
5795665|NCT00121953|Endometriosis|endometriosis
5795666|NCT00121953|Peritoneal fluid|peritoneal fluid
5795667|NCT00121953|Cytokines|cytokines
5795668|NCT00121953|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5795669|NCT00121940|Chronic Disease|chronic disease
5795670|NCT00121940|Nurses|nurses
5795671|NCT00121940|Caregivers|caregivers
5795672|NCT00121940|Support Groups|support groups
5795673|NCT00121927|intractable|intractable
5795674|NCT00121927|ketogenic|ketogenic
5795675|NCT00121927|ketosis|ketosis
5795676|NCT00121927|Atkins|atkins
5795677|NCT00121914|Carcinoma, Hepatocellular,|carcinoma, hepatocellular,
5795678|NCT00121914|percutaneous ethanol instillation|percutaneous ethanol instillation
5795679|NCT00121914|long-acting somatostatin|long-acting somatostatin
5795680|NCT00121901|Pancreatitis|pancreatitis
5795681|NCT00121901|Cholangiopancreatograpy, Endoscopic Retrograde/adverse|cholangiopancreatograpy, endoscopic retrograde/adverse
5795682|NCT00121901|Nitroglycerin|nitroglycerin
5795683|NCT00121901|Randomized Controlled Trial,|randomized controlled trial,
5795684|NCT00121888|post traumatic stress disorder|post traumatic stress disorder
5795685|NCT00121888|Prolonged Exposure Therapy|prolonged exposure therapy
5795686|NCT00121888|pharmacotherapy|pharmacotherapy
5795687|NCT00121888|double-blind|double-blind
5795688|NCT00121888|Anxiety Disorder|anxiety disorder
5795689|NCT00121875|short stature|short stature
5795690|NCT00121875|insulin resistance|insulin resistance
5795691|NCT00121875|body composition|body composition
5795692|NCT00121875|Turner syndrome|turner syndrome
5795693|NCT00121875|intramyocellular lipid|intramyocellular lipid
5795694|NCT00121875|glucose tolerance|glucose tolerance
5795695|NCT00121862|Leishmaniasis|leishmaniasis
5795696|NCT00121862|Subunit Vaccine|subunit vaccine
5795697|NCT00121862|Prevention|prevention
5795698|NCT00121862|T cell|t cell
5795699|NCT00121849|Leishmaniasis,|leishmaniasis,
5795700|NCT00121849|Subunit Vaccine,|subunit vaccine,
5795701|NCT00121849|Prevention,|prevention,
5795702|NCT00121849|T cell|t cell
5795705|NCT00121823|Vaccines|vaccines
5795706|NCT00121823|Acceptability|acceptability
5795707|NCT00121797|Postpartum Period|postpartum period
5795709|NCT00121771|Vaccines|vaccines
5795710|NCT00121771|Safety|safety
5795711|NCT00121771|Immunogenicity|immunogenicity
5795712|NCT00121758|HIV Vaccines|hiv vaccines
5795713|NCT00121758|HIV Seronegativity|hiv seronegativity
5795714|NCT00121745|gene transfer|gene transfer
5795715|NCT00121745|cell cycle control|cell cycle control
5795716|NCT00121745|cancer gene therapy|cancer gene therapy
5795717|NCT00121745|pathotropic targeting|pathotropic targeting
5795718|NCT00121745|tumor targeted retroviral vector|tumor targeted retroviral vector
5795719|NCT00121719|Resistant and refractory solid tumors|resistant and refractory solid tumors
5795721|NCT00121719|hodgkins disease|hodgkins disease
5795722|NCT00121719|non-hodgkins lymphoma|non-hodgkins lymphoma
5795723|NCT00121719|neoplasms|neoplasms
5795724|NCT00121693|Fall prevention|fall prevention
5795725|NCT00121693|posturography|posturography
5795726|NCT00121693|music therapy|music therapy
5795727|NCT00121680|cancer|cancer
5795728|NCT00121654|Angina pectoris|angina pectoris
5795729|NCT00121654|Spinal cord stimulation|spinal cord stimulation
5795730|NCT00121654|Refractory angina pectoris|refractory angina pectoris
5795731|NCT00121628|Thyroid cancer|thyroid cancer
5795732|NCT00121628|Advanced thyroid cancer|advanced thyroid cancer
5795733|NCT00121628|Metastatic thyroid cancer|metastatic thyroid cancer
5795734|NCT00121628|Medullary thyroid cancer|medullary thyroid cancer
5795735|NCT00121628|Follicular thyroid cancer|follicular thyroid cancer
5795736|NCT00121628|Papillary thyroid cancer|papillary thyroid cancer
5795737|NCT00121628|Hurthle cell thyroid cancer|hurthle cell thyroid cancer
5795738|NCT00121628|Thyroid cancer treatments|thyroid cancer treatments
5795739|NCT00121628|Differentiated thyroid cancer and medullary thyroid cancer|differentiated thyroid cancer and medullary thyroid cancer
5795740|NCT00121615|Clinical Trials|clinical trials
5795741|NCT00121602|Hemodialysis|hemodialysis
5795742|NCT00121602|Darbepoetin Alfa|darbepoetin alfa
5795743|NCT00121602|Clinical Trials|clinical trials
5795744|NCT00121602|Nephrology|nephrology
5795745|NCT00121602|Amgen|amgen
5795746|NCT00121602|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5795747|NCT00121589|AMD|amd
5795748|NCT00121589|Macular Pigment|macular pigment
5795749|NCT00121589|Serum Lutein Levels|serum lutein levels
5795750|NCT00121589|Vitamin Supplementation|vitamin supplementation
5795751|NCT00121589|Carotenoids|carotenoids
5795752|NCT00121589|Lutein|lutein
5795753|NCT00121589|Zeaxanthin|zeaxanthin
5795754|NCT00121589|DHA|dha
5795755|NCT00121589|Age Related Macular Degeneration|age related macular degeneration
5795756|NCT00121563|Cytokines|cytokines
5795757|NCT00121563|Inflammation|inflammation
5795758|NCT00121563|Pain|pain
5795759|NCT00121563|Injury|injury
5795760|NCT00121563|Peripheral|peripheral
5795761|NCT00121563|Wisdom Teeth|wisdom teeth
5795762|NCT00121563|Third Molar Extraction|third molar extraction
5686550|NCT00551577|Neoadjuvant Therapy,|neoadjuvant therapy,
5794940|NCT00124878|HIV|hiv
5795763|NCT00121550|Coronary heart disease|coronary heart disease
5795764|NCT00121550|Clarithromycin|clarithromycin
5795765|NCT00121550|Macrolides|macrolides
5795766|NCT00121550|Cardiovascular mortality|cardiovascular mortality
5795767|NCT00121550|Chlamydia pneumoniae|chlamydia pneumoniae
5795768|NCT00121537|wounds-open|wounds-open
5795769|NCT00121524|cardiac arrest|cardiac arrest
5795770|NCT00121524|resuscitation|resuscitation
5795771|NCT00121524|epinephrine|epinephrine
5795772|NCT00121524|intravenous|intravenous
5795773|NCT00121524|survival|survival
5795774|NCT00121511|photoaging|photoaging
5795775|NCT00121511|Actinic Keratoses|actinic keratoses
5795776|NCT00121511|Efudex|efudex
5795777|NCT00121511|5 fluorouracil|5 fluorouracil
5795778|NCT00121498|Pain|pain
5795779|NCT00121498|Hysterectomy|hysterectomy
5795780|NCT00121498|Preemptive|preemptive
5795781|NCT00121498|Lidocaine|lidocaine
5795782|NCT00121485|Heart-assist devices|heart-assist devices
5795783|NCT00121472|Heart-assist devices|heart-assist devices
5795784|NCT00121459|Diaphragm|diaphragm
5795785|NCT00121459|HIV prevention|hiv prevention
5795786|NCT00121459|Southern/South Africa, Zimbabwe|southern/south africa, zimbabwe
5795787|NCT00121459|female-controlled methods|female-controlled methods
5795788|NCT00121459|Replens|replens
5795789|NCT00121459|STI prevention|sti prevention
5795790|NCT00121459|HIV Seronegativity|hiv seronegativity
5795791|NCT00121446|Heart Attack|heart attack
5795792|NCT00121446|ST Elevation Myocardial Infarction|st elevation myocardial infarction
5795794|NCT00121446|percutaneous coronary intervention|percutaneous coronary intervention
5795795|NCT00121446|Acute Myocardial Infarction|acute myocardial infarction
5795796|NCT00121420|Brain Neoplasms/secondary|brain neoplasms/secondary
5795797|NCT00121420|Brain neoplasms/radiotherapy|brain neoplasms/radiotherapy
5795798|NCT00121420|Brain metastasis|brain metastasis
5795799|NCT00121420|Neoplasm metastasis|neoplasm metastasis
5795800|NCT00121420|Cranial irradiation|cranial irradiation
5795801|NCT00121420|Radiosurgery|radiosurgery
5795802|NCT00121420|Lung Neoplasms|lung neoplasms
5795803|NCT00121420|Breast Neoplasms|breast neoplasms
5795804|NCT00121420|Kidney Neoplasms|kidney neoplasms
5795806|NCT00121420|Radiotherapy|radiotherapy
5795807|NCT00121420|Carcinoma, non-small cell lung|carcinoma, non-small cell lung
5795808|NCT00121407|Age Related Macular Degeneration (AMD)|age related macular degeneration (amd)
5795809|NCT00121407|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5795810|NCT00121407|Visudyne|visudyne
5795811|NCT00121394|Chlorhexidine|chlorhexidine
5795812|NCT00121394|Vaginal wash|vaginal wash
5795813|NCT00121394|Neonatal mortality|neonatal mortality
5795814|NCT00121394|Sepsis|sepsis
5795815|NCT00121394|Global Network|global network
5795816|NCT00121394|Maternal and child health|maternal and child health
5795817|NCT00121394|Women's Health|women's health
5795818|NCT00121394|International|international
5795819|NCT00121394|Pakistan|pakistan
5795820|NCT00121381|Atopic dermatitis|atopic dermatitis
5795821|NCT00121381|T-cell|t-cell
5795822|NCT00121381|pimecrolimus|pimecrolimus
5795823|NCT00121381|children|children
5795824|NCT00121381|topical corticosteroids|topical corticosteroids
5795825|NCT00121368|Global Network|global network
5795826|NCT00121368|Maternal and child health|maternal and child health
5795827|NCT00121368|International|international
5795828|NCT00121368|Women's health|women's health
5795829|NCT00121368|Tobacco|tobacco
5795830|NCT00121368|Smoking|smoking
5795831|NCT00121368|Africa|africa
5795832|NCT00121368|Latin America|latin america
5795833|NCT00121368|South America|south america
5795834|NCT00121368|Guatemala|guatemala
5795835|NCT00121368|Zambia|zambia
5795836|NCT00121368|India|india
5795837|NCT00121368|Argentina|argentina
5795838|NCT00121368|Democratic Republic of the Congo|democratic republic of the congo
5795839|NCT00121329|Pain with procedures|pain with procedures
5795840|NCT00121316|Atopic dermatitis|atopic dermatitis
5795841|NCT00121316|pimecrolimus|pimecrolimus
5795842|NCT00121303|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5795843|NCT00121303|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5795844|NCT00121303|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5795845|NCT00121303|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5795846|NCT00121303|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5798856|NCT00110812|rIL-2|ril-2
5798857|NCT00110799|thrombopoietin|thrombopoietin
5795847|NCT00121303|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5795848|NCT00121303|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5795849|NCT00121303|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5795850|NCT00121303|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5795851|NCT00121303|refractory anemia with excess blasts|refractory anemia with excess blasts
5795852|NCT00121303|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5795853|NCT00121303|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5795854|NCT00121303|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5795855|NCT00121303|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5795856|NCT00121303|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5795857|NCT00121303|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5795858|NCT00121303|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5795859|NCT00121303|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5795860|NCT00121303|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5795861|NCT00121277|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5795862|NCT00121212|stage I prostate cancer|stage i prostate cancer
5795863|NCT00121212|stage IIB prostate cancer|stage iib prostate cancer
5795864|NCT00121212|stage IIA prostate cancer|stage iia prostate cancer
5795865|NCT00121212|stage III prostate cancer|stage iii prostate cancer
5795866|NCT00121186|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5795867|NCT00121186|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5795868|NCT00121186|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5795869|NCT00121186|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5795870|NCT00121186|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5795871|NCT00121186|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5791031|NCT00140517|malaria|malaria
5795872|NCT00121186|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5795874|NCT00121173|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5795875|NCT00121173|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5795876|NCT00121160|immune response to vaccines|immune response to vaccines
5795877|NCT00121160|stress management|stress management
5795878|NCT00121160|breast cancer|breast cancer
5795880|NCT00121147|pseudoexfoliation|pseudoexfoliation
5795881|NCT00121134|Bevacizumab|bevacizumab
5795882|NCT00121134|Metronomic Chemotherapy|metronomic chemotherapy
5795883|NCT00121134|Breast Cancer Stages II-III|breast cancer stages ii-iii
5795884|NCT00121134|Invasive breast cancer stages II-III|invasive breast cancer stages ii-iii
5795885|NCT00121121|HIV Vaccines|hiv vaccines
5795886|NCT00121121|HIV Seronegativity|hiv seronegativity
5795887|NCT00121095|prostate cancer|prostate cancer
5795888|NCT00121069|specific phobia|specific phobia
5795889|NCT00121069|anxiety|anxiety
5795890|NCT00121069|SSRI|ssri
5795891|NCT00121069|clinical trial|clinical trial
5795892|NCT00121069|escitalopram|escitalopram
5795893|NCT00121043|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5795894|NCT00121043|Interleukin-1 (IL-1), r-metHuIL-1ra|interleukin-1 (il-1), r-methuil-1ra
5795895|NCT00121043|Autoimmune, Kineret®|autoimmune, kineret®
5795896|NCT00121043|Anakinra, Immunex|anakinra, immunex
5795897|NCT00121043|Amgen, Clinical Trials|amgen, clinical trials
5795898|NCT00121030|uterine cancer|uterine cancer
5795899|NCT00121030|ovarian cancer|ovarian cancer
5795900|NCT00121030|darbepoetin alfa|darbepoetin alfa
5795901|NCT00121030|Amgen|amgen
5795902|NCT00121030|Gynecological Malignancies|gynecological malignancies
5795903|NCT00121017|HCV Infection|hcv infection
5795904|NCT00121017|Treatment Naive|treatment naive
5795905|NCT00121004|Advance Directive|advance directive
5795906|NCT00121004|Living Will|living will
5795907|NCT00121004|Terminal Illness|terminal illness
5795908|NCT00120991|Coronary artery bypass grafting|coronary artery bypass grafting
5795909|NCT00120991|OPCAB|opcab
5795910|NCT00120978|Clinical Trial; C-reactive protein; fluticasone; salmeterol|clinical trial; c-reactive protein; fluticasone; salmeterol
5795911|NCT00120965|Cardiac arrest|cardiac arrest
5795912|NCT00120965|OOH-cardiac arrest|ooh-cardiac arrest
5795914|NCT00120965|Chest compressions|chest compressions
5795915|NCT00120965|Chest compression device|chest compression device
5795917|NCT00120952|Osteoarthritis|osteoarthritis
5795918|NCT00120952|Hip arthroplasty|hip arthroplasty
5795919|NCT00120952|DEXA|dexa
5795920|NCT00120952|Titanium|titanium
5795921|NCT00120952|Cobalt chromium|cobalt chromium
5795922|NCT00120952|Bone cement|bone cement
5795923|NCT00120939|Lung Cancer|lung cancer
5795924|NCT00120939|Breast Cancer|breast cancer
5795925|NCT00120939|Prostate Cancer|prostate cancer
5795926|NCT00120939|Ovarian Cancer|ovarian cancer
5795927|NCT00120939|Head and Neck Cancer|head and neck cancer
5795928|NCT00120939|Gastrointestinal Cancer|gastrointestinal cancer
5795929|NCT00120939|Metastatic Cancer|metastatic cancer
5810479|NCT00084097|IgE|ige
5795930|NCT00120939|Advanced Cancer|advanced cancer
5795931|NCT00120939|Genitourinary Cancer|genitourinary cancer
5795932|NCT00120939|Glioblastoma Multiforme|glioblastoma multiforme
5795933|NCT00120939|Recurrent Cancer|recurrent cancer
5795934|NCT00120939|Colon Cancer|colon cancer
5795935|NCT00120939|Gastric Cancer|gastric cancer
5795936|NCT00120939|Stomach Cancer|stomach cancer
5795937|NCT00120939|Pancreatic Cancer|pancreatic cancer
5795938|NCT00120939|Esophageal Cancer|esophageal cancer
5795939|NCT00120939|Throat Cancer|throat cancer
5795940|NCT00120939|Bladder Cancer|bladder cancer
5795133|NCT00123994|TaiChi|taichi
5795941|NCT00120939|Kidney Cancer|kidney cancer
5795942|NCT00120939|Renal Cancer|renal cancer
5795943|NCT00120939|Cervical Cancer|cervical cancer
5795944|NCT00120939|Endometrial Cancer|endometrial cancer
5795945|NCT00120939|Colorectal Cancer|colorectal cancer
5795946|NCT00120926|Premature neonate|premature neonate
5795947|NCT00120926|Parenteral nutrition|parenteral nutrition
5795948|NCT00120926|Growth|growth
5795949|NCT00120926|Amino Acids|amino acids
5795950|NCT00120926|Nutrition|nutrition
5795951|NCT00120913|Breakthrough bleeding while taking continuously dosed oral contraceptives|breakthrough bleeding while taking continuously dosed oral contraceptives
5795952|NCT00120900|COX-2 inhibitor|cox-2 inhibitor
5795953|NCT00120900|Knee osteoarthritis|knee osteoarthritis
5795954|NCT00120887|Atherosclerosis, SLE, statins|atherosclerosis, sle, statins
5795955|NCT00120874|Alzheimer's disease|alzheimer's disease
5795956|NCT00120874|caregiver training|caregiver training
5795957|NCT00120874|caregiver counseling|caregiver counseling
5795958|NCT00120874|individualized management|individualized management
5795959|NCT00120874|memantine|memantine
5795960|NCT00120874|dementia|dementia
5795961|NCT00120861|Genotype-1|genotype-1
5795962|NCT00120861|Previously failed treatment|previously failed treatment
5795963|NCT00120848|HPV vaccine efficacy|hpv vaccine efficacy
5795964|NCT00120848|Prophylaxis HPV 16/18 infections|prophylaxis hpv 16/18 infections
5795965|NCT00120835|Genotype-1|genotype-1
5795966|NCT00120835|Treatment-Naive|treatment-naive
5795967|NCT00120822|Malaria|malaria
5795968|NCT00120822|Pregnancy|pregnancy
5795969|NCT00120822|Folic acid|folic acid
5795970|NCT00120822|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5795971|NCT00120809|Malaria|malaria
5795972|NCT00120809|Pregnancy|pregnancy
5795973|NCT00120809|Multigravidae|multigravidae
5795974|NCT00120809|Intermittent preventative treatment|intermittent preventative treatment
5795975|NCT00120809|Sulfadoxine-pyrimethamine|sulfadoxine-pyrimethamine
5795976|NCT00120796|Hepatitis B|hepatitis b
5681229|NCT00574249|Chronic Plaque Psoriasis|chronic plaque psoriasis
5795977|NCT00120796|Hepatitis B Vaccines|hepatitis b vaccines
5795978|NCT00120796|Lamivudine|lamivudine
5795979|NCT00120783|Treatment Failure|treatment failure
5795980|NCT00120783|HIV infections|hiv infections
5795981|NCT00120770|AE adverse event|ae adverse event
5795982|NCT00120770|AIDS acquired immunodeficiency syndrome|aids acquired immunodeficiency syndrome
5795983|NCT00120770|ALT (SGPT) alanine aminotransferase|alt (sgpt) alanine aminotransferase
5795984|NCT00120770|ART antiretroviral therapy|art antiretroviral therapy
5795985|NCT00120770|AST (SGOT) aspartate aminotransferase|ast (sgot) aspartate aminotransferase
5795986|NCT00120770|DCF data collection forms|dcf data collection forms
5795987|NCT00120770|DMC Data Monitoring Committee|dmc data monitoring committee
5795988|NCT00120770|FDA (U.S.) Food and Drug Administration|fda (u.s.) food and drug administration
5795989|NCT00120770|GCP Good Clinical Practice guidelines|gcp good clinical practice guidelines
5795990|NCT00120770|HB sAg Hepatitis B surface antigen|hb sag hepatitis b surface antigen
5795991|NCT00120770|ICH International Conference of Harmonisation|ich international conference of harmonisation
5795992|NCT00120770|IND Investigational New Drug Application|ind investigational new drug application
5795993|NCT00120770|IRB Institutional Review Board|irb institutional review board
5795994|NCT00120770|IU international units|iu international units
5796399|NCT00119106|Tenofovir|tenofovir
5795995|NCT00120770|mg milligram(s)|mg milligram(s)
5795996|NCT00120770|mm3 cubic millimeter(s)|mm3 cubic millimeter(s)
5795997|NCT00120770|PCR polymerase chain reaction|pcr polymerase chain reaction
5795998|NCT00120770|SAE serious adverse event|sae serious adverse event
5795999|NCT00120770|µg microgram|µg microgram
5796000|NCT00120770|ULN upper limit of the normal range|uln upper limit of the normal range
5796001|NCT00120770|WB Western Blot|wb western blot
5796002|NCT00120770|Human Immunodeficiency Virus|human immunodeficiency virus
5796003|NCT00120770|Neisseria gonorrhoeae|neisseria gonorrhoeae
5796004|NCT00120770|Chlamydia trachomatis|chlamydia trachomatis
5796005|NCT00120770|HIV Seronegativity|hiv seronegativity
5796006|NCT00120757|Osteoporosis|osteoporosis
5796007|NCT00120731|Recurrent nephrolithiasis|recurrent nephrolithiasis
5796008|NCT00120731|Potassium Citrate|potassium citrate
5796009|NCT00120731|Hypercalciuria|hypercalciuria
5796010|NCT00120731|Distal Renal Tubular Acidosis|distal renal tubular acidosis
5796011|NCT00120731|Nephrolithiasis in children|nephrolithiasis in children
5796012|NCT00120705|anemia|anemia
5796013|NCT00120705|darbepoetin alfa|darbepoetin alfa
5796014|NCT00120705|Amgen|amgen
5796015|NCT00120705|Non-myeloid Malignancies|non-myeloid malignancies
5796016|NCT00120692|breast cancer|breast cancer
5796017|NCT00120692|darbepoetin alfa|darbepoetin alfa
5796018|NCT00120692|Amgen|amgen
5798858|NCT00110799|platelets|platelets
5796019|NCT00120679|non-small cell lung cancer|non-small cell lung cancer
5796020|NCT00120679|darbepoetin alfa|darbepoetin alfa
5796021|NCT00120679|Amgen|amgen
5796022|NCT00120666|Exercise|exercise
5796023|NCT00120666|Stimulation|stimulation
5796024|NCT00120666|Nerve|nerve
5796025|NCT00120666|Electrical|electrical
5796026|NCT00120666|Muscle|muscle
5796027|NCT00120666|Healthy Volunteer|healthy volunteer
5796029|NCT00120653|Reglan|reglan
5795251|NCT00123448|HV|hv
5796030|NCT00120653|Prolactin|prolactin
5796031|NCT00120653|MDS|mds
5796032|NCT00120653|Metoclopramide|metoclopramide
5796033|NCT00120653|Myelodysplastic Syndrome|myelodysplastic syndrome
5796034|NCT00120640|Premature birth|premature birth
5796035|NCT00120640|Premature labor|premature labor
5796036|NCT00120640|Progesterone|progesterone
5796037|NCT00120627|Randomized Controlled Trial|randomized controlled trial
5796038|NCT00120627|Intervention Study|intervention study
5796039|NCT00120627|Mindfulness|mindfulness
5796040|NCT00120627|Complementary Therapy|complementary therapy
5796041|NCT00120627|Mind-Body Relations (Metaphysics)|mind-body relations (metaphysics)
5796042|NCT00120627|Spiritual Therapy|spiritual therapy
5796043|NCT00120627|Meditation|meditation
5796044|NCT00120627|Qualitative Analysis|qualitative analysis
5796045|NCT00120614|Premature Infant|premature infant
5796046|NCT00120614|Premature Birth|premature birth
5796047|NCT00120614|Parenting Interventions|parenting interventions
5796048|NCT00120614|NICU Interventional studies|nicu interventional studies
5796049|NCT00120614|Parental coping|parental coping
5796050|NCT00120614|Low birthweight infant|low birthweight infant
5796051|NCT00120614|Coping Behavior|coping behavior
5796052|NCT00120614|Infant, Premature|infant, premature
5796053|NCT00120601|treatment|treatment
5796054|NCT00120601|alcohol|alcohol
5796055|NCT00120601|dependence|dependence
5796056|NCT00120601|medication|medication
5796057|NCT00120588|brain protection|brain protection
5796058|NCT00120588|white matter injury|white matter injury
5796059|NCT00120588|neurodevelopmental sequelae|neurodevelopmental sequelae
5796060|NCT00120588|magnesium sulfate|magnesium sulfate
5796061|NCT00120588|intraventricular hemorrhage|intraventricular hemorrhage
5796062|NCT00120575|Hemofiltration|hemofiltration
5796064|NCT00120562|weight loss surgery|weight loss surgery
5796065|NCT00120562|gastric bypass surgery|gastric bypass surgery
5796066|NCT00120549|Assisted Hatching|assisted hatching
5796067|NCT00120549|Cleavage Stage, Ovum|cleavage stage, ovum
5796068|NCT00120549|Embryo Transfer|embryo transfer
5796069|NCT00120549|Pregnancy|pregnancy
5796070|NCT00120549|Embryo Implantation|embryo implantation
5796071|NCT00120536|Type 2 diabetes|type 2 diabetes
5796072|NCT00120536|vildagliptin|vildagliptin
5796073|NCT00120523|Atopic dermatitis, children, infants, pimecrolimus|atopic dermatitis, children, infants, pimecrolimus
5796074|NCT00120510|Treatment Naive|treatment naive
5796076|NCT00120497|short stature|short stature
5796077|NCT00120497|intrauterine growth restriction|intrauterine growth restriction
5796078|NCT00120497|insulin resistance|insulin resistance
5796079|NCT00120497|intramyocellular lipid|intramyocellular lipid
5796080|NCT00120497|small for gestational age|small for gestational age
5796081|NCT00120497|glucose tolerance|glucose tolerance
5796082|NCT00120484|Circadian Rhythm|circadian rhythm
5796083|NCT00120484|Biological Clock|biological clock
5796084|NCT00120484|Complementary and Alternative Medicine|complementary and alternative medicine
5796085|NCT00120471|Perinatal Transmission|perinatal transmission
5796086|NCT00120471|MTCT|mtct
5796087|NCT00120471|HIV Seronegativity|hiv seronegativity
5796088|NCT00120458|Black Cohosh|black cohosh
5796089|NCT00120458|Cimicifuga|cimicifuga
5796090|NCT00120458|Anxiety|anxiety
5796091|NCT00120458|Women|women
5796092|NCT00120458|Complementary and Alternative Medicine|complementary and alternative medicine
5796865|NCT00117533|ribavirin|ribavirin
5796093|NCT00120445|retinal detachment|retinal detachment
5796094|NCT00120445|pneumatic retinopexy|pneumatic retinopexy
5796095|NCT00120432|single dose|single dose
5796096|NCT00120432|mydriatic drug|mydriatic drug
5796097|NCT00120432|pupillary dilation|pupillary dilation
5796098|NCT00120419|HIV-1 infection|hiv-1 infection
5796099|NCT00120419|immunomodulatory therapy|immunomodulatory therapy
5796100|NCT00120419|Treatment Naive|treatment naive
5796101|NCT00120406|Peripheral Arterial Disease (PAD)|peripheral arterial disease (pad)
5796102|NCT00120406|Peripheral Vascular Disease|peripheral vascular disease
5796103|NCT00120406|Drug-Eluting Stent|drug-eluting stent
5796104|NCT00120406|Drug-Coated Stent|drug-coated stent
5796105|NCT00120393|Treatment Experienced|treatment experienced
5796106|NCT00120380|Idiopathic pulmonary arterial hypertension|idiopathic pulmonary arterial hypertension
5796107|NCT00120367|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5796108|NCT00120367|HIV infections|hiv infections
5796109|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors
5796110|NCT00120354|Hepatitis B Virus|hepatitis b virus
5796111|NCT00120354|Antiviral Resistance|antiviral resistance
5796112|NCT00120354|Drug Withdrawal|drug withdrawal
5796113|NCT00120354|Immune Response|immune response
5796114|NCT00120354|Hepatitis B Surface Antigen|hepatitis b surface antigen
5796115|NCT00120354|Liver Biopsy|liver biopsy
5796116|NCT00120354|Hepatitis B|hepatitis b
5796117|NCT00120328|serum creatinine|serum creatinine
5796118|NCT00120328|end stage renal disease|end stage renal disease
5796119|NCT00120328|cardiovascular mortality|cardiovascular mortality
5796120|NCT00120328|cardiovascular morbidity|cardiovascular morbidity
5796121|NCT00120328|non-cardiovascular mortality|non-cardiovascular mortality
5796122|NCT00120328|non-cardiovascular morbidity|non-cardiovascular morbidity
5796123|NCT00120315|dyspepsia|dyspepsia
5796124|NCT00120315|discontinuation|discontinuation
5686551|NCT00551577|Docetaxel,|docetaxel,
5796125|NCT00120315|Primary health care|primary health care
5796126|NCT00120315|Helicobacter pylori|helicobacter pylori
5796127|NCT00120315|Proton Pump Inhibitor|proton pump inhibitor
5796128|NCT00120315|Histamine-2-receptor-antagonist|histamine-2-receptor-antagonist
5796129|NCT00120302|Randomised|randomised
5796130|NCT00120302|Placebo-controlled|placebo-controlled
5796131|NCT00120302|Elidel|elidel
5796132|NCT00120302|Quality of Life|quality of life
5796133|NCT00120302|Atopic Eczema|atopic eczema
5796134|NCT00120276|Functional Mitral Regurgitation (FMR)|functional mitral regurgitation (fmr)
5796135|NCT00120276|Ischemic Mitral Regurgitation|ischemic mitral regurgitation
5796136|NCT00120276|Less invasive repair|less invasive repair
5796137|NCT00120276|Surgical MV repair|surgical mv repair
5796138|NCT00120276|Mitral Valve Repair|mitral valve repair
5796139|NCT00120276|Heart Failure|heart failure
5796140|NCT00120276|Left Ventricular Dysfunction|left ventricular dysfunction
5796141|NCT00120263|Plasma Exchange|plasma exchange
5796142|NCT00120263|Myeloma|myeloma
5796143|NCT00120263|Acute renal failure|acute renal failure
5796144|NCT00120263|Light Chains|light chains
5796145|NCT00120263|Bence Jones Proteins|bence jones proteins
5796146|NCT00120263|Kidney Function|kidney function
5796147|NCT00120250|PTSD|ptsd
5796148|NCT00120250|Sleep disturbance|sleep disturbance
5796149|NCT00120250|Eszopiclone|eszopiclone
5796150|NCT00120250|Double-blind|double-blind
5796151|NCT00120250|Crossover|crossover
5796152|NCT00120237|Postpartum hemorrhage|postpartum hemorrhage
5796153|NCT00120237|Misoprostol|misoprostol
5796154|NCT00120237|Maternal morbidity|maternal morbidity
5796155|NCT00120237|Developing countries|developing countries
5796156|NCT00120237|Traditional birth attendants|traditional birth attendants
5796157|NCT00120224|Mifepristone|mifepristone
5796158|NCT00120224|Medical abortion|medical abortion
5796159|NCT00120224|Ultrasound|ultrasound
5796161|NCT00120198|elderly|elderly
5796162|NCT00120185|HIV Infections|hiv infections
5796163|NCT00120185|Interleukin-2|interleukin-2
5796164|NCT00120172|colorectal|colorectal
5796165|NCT00120172|metastatic|metastatic
5796166|NCT00120172|elderly|elderly
5796167|NCT00120172|metastatic colorectal cancer|metastatic colorectal cancer
5796168|NCT00120159|Necrotizing Enterocolitis|necrotizing enterocolitis
5796169|NCT00120133|Osteoporosis|osteoporosis
5796170|NCT00120133|Bisphosphonates|bisphosphonates
5796171|NCT00120133|Atorvastatin|atorvastatin
5796172|NCT00120120|Radiculopathy|radiculopathy
5796173|NCT00120120|Back Pain|back pain
5796174|NCT00120120|Lumbar Pain|lumbar pain
5796175|NCT00120120|CC-5013|cc-5013
5796176|NCT00120120|Revlimid|revlimid
5796177|NCT00120120|Lenalidomide|lenalidomide
5796178|NCT00120094|Syncope|syncope
5796179|NCT00120094|Electrocardiographic monitoring|electrocardiographic monitoring
5796180|NCT00120081|Vaccine|vaccine
5796181|NCT00120081|Hookworm|hookworm
5796182|NCT00120081|Phase 1|phase 1
5796183|NCT00120081|Human Hookworm Infection|human hookworm infection
5796184|NCT00120081|Na-ASP-2|na-asp-2
5796185|NCT00120042|Abortion|abortion
5796186|NCT00120042|Retained placenta|retained placenta
5796187|NCT00120042|Hemorrhage|hemorrhage
5796188|NCT00120042|Postpartum ultrasound|postpartum ultrasound
5796189|NCT00120029|weight loss|weight loss
5796190|NCT00120029|survivorship|survivorship
5796191|NCT00120029|breast ductal lavage|breast ductal lavage
5796194|NCT00120016|cancer prevention|cancer prevention
5796195|NCT00120016|diet|diet
5796196|NCT00120016|nutrition|nutrition
5796197|NCT00120016|polyunsaturated fat|polyunsaturated fat
5796198|NCT00120016|olive oil|olive oil
5796199|NCT00120003|Acute stroke|acute stroke
5796200|NCT00120003|Elevated blood pressure|elevated blood pressure
5796201|NCT00120003|Blood pressure lowering treatment|blood pressure lowering treatment
5796202|NCT00119990|vasopressin|vasopressin
5796203|NCT00119990|icodextrin|icodextrin
5796204|NCT00119990|cardiac output|cardiac output
5796205|NCT00119977|cartilage thickness|cartilage thickness
5796207|NCT00119977|DEXA|dexa
5796208|NCT00119977|ultra sound|ultra sound
5796209|NCT00119977|MRI|mri
5796210|NCT00119977|osteoarthritis|osteoarthritis
5796211|NCT00119977|periacetabular osteotomy|periacetabular osteotomy
5796212|NCT00119951|Behavioral|behavioral
5796213|NCT00119938|Disease management|disease management
5796214|NCT00119938|Patient access to records|patient access to records
5796215|NCT00119938|Medical records systems, computerized|medical records systems, computerized
5796216|NCT00119938|Questionnaires|questionnaires
5796217|NCT00119938|Physician-patient relations|physician-patient relations
5796218|NCT00119938|Medical records|medical records
5796219|NCT00119925|infertility|infertility
5796220|NCT00119925|guideline|guideline
5796221|NCT00119925|health care implementation|health care implementation
5796222|NCT00119925|intervention|intervention
5796223|NCT00119925|gynecology|gynecology
5796224|NCT00119912|screening|screening
5796225|NCT00119912|flexible sigmoidoscopy|flexible sigmoidoscopy
5796226|NCT00119912|fecal occult blood|fecal occult blood
5796227|NCT00119912|cancer|cancer
5796228|NCT00119912|colon|colon
5796229|NCT00119912|rectum|rectum
5817155|NCT00080392|PAD|pad
5796230|NCT00119899|Colorectal Cancer;|colorectal cancer;
5796231|NCT00119899|Liver;|liver;
5796232|NCT00119899|Metastases;|metastases;
5796233|NCT00119899|Resection;|resection;
5796234|NCT00119899|Fluorodeoxyglucose;|fluorodeoxyglucose;
5796235|NCT00119899|Tomography;|tomography;
5796236|NCT00119899|Positron-Emission|positron-emission
5796237|NCT00119873|HIV Preventive Vaccine|hiv preventive vaccine
5796238|NCT00119873|AIDS Vaccines|aids vaccines
5796239|NCT00119873|Adenoviridae|adenoviridae
5796240|NCT00119847|Stents, myocardial infarction|stents, myocardial infarction
5796241|NCT00119834|Heart Failure|heart failure
5796242|NCT00119834|Intermacs|intermacs
5796243|NCT00119834|Pedimacs|pedimacs
5796244|NCT00119834|Mechanical Circulatory Support|mechanical circulatory support
5796245|NCT00119834|Ventricular Assist Device|ventricular assist device
5796246|NCT00119769|HIV|hiv
5796247|NCT00119769|immune stimulation|immune stimulation
5796248|NCT00119769|lipodystrophy|lipodystrophy
5796249|NCT00119769|growth hormone|growth hormone
5796250|NCT00119769|recombinant growth hormone|recombinant growth hormone
5796251|NCT00119769|Treatment Experienced|treatment experienced
5796252|NCT00119756|Schizophrenia|schizophrenia
5796253|NCT00119756|Intramuscular injection|intramuscular injection
5796254|NCT00119756|Deltoid muscle|deltoid muscle
5796255|NCT00119756|Gluteus muscle|gluteus muscle
5796256|NCT00119756|Paliperidone palmitate|paliperidone palmitate
5796257|NCT00119743|Prophylaxis pneumococcal vaccine|prophylaxis pneumococcal vaccine
5796258|NCT00119730|Fludarabine|fludarabine
5796259|NCT00119730|Mitoxantrone|mitoxantrone
5796260|NCT00119730|Rituximab|rituximab
5796261|NCT00119730|Zevalin|zevalin
5796262|NCT00119730|Mantle Cell Lymphoma|mantle cell lymphoma
5796263|NCT00119730|Relapsed Mantle Cell Lymphoma|relapsed mantle cell lymphoma
5796264|NCT00119717|acute|acute
5796265|NCT00119717|ischemic|ischemic
5796266|NCT00119717|stroke|stroke
5805293|NCT00090337|pain|pain
5796267|NCT00119717|randomized|randomized
5796268|NCT00119717|device|device
5796269|NCT00119717|treatment|treatment
5796271|NCT00119665|Postmenopausal symptoms|postmenopausal symptoms
5796272|NCT00119665|Hot Flashes|hot flashes
5796273|NCT00119665|Postmenopausal Hot Flashes|postmenopausal hot flashes
5796274|NCT00119652|Bipolar disorder|bipolar disorder
5796275|NCT00119652|bipolar depression|bipolar depression
5796276|NCT00119652|depression|depression
5796277|NCT00119626|Stroke, Acute|stroke, acute
5796278|NCT00119626|Cerebrovascular Stroke|cerebrovascular stroke
5796279|NCT00119613|Oncology|oncology
5796280|NCT00119613|Clinical Trial|clinical trial
5796281|NCT00119613|Hemoglobin|hemoglobin
5796282|NCT00119613|Darbepoetin alfa|darbepoetin alfa
5796283|NCT00119613|Survival|survival
5796284|NCT00119613|Carboplatin|carboplatin
5796285|NCT00119613|Cisplatin|cisplatin
5796286|NCT00119613|Etoposide|etoposide
5796287|NCT00119613|Extensive Stage Small Cell Lung Cancer|extensive stage small cell lung cancer
5796288|NCT00119600|Non-myeloid malignancy|non-myeloid malignancy
5796289|NCT00119600|Clinical Trial|clinical trial
5796290|NCT00119587|Hemodialysis|hemodialysis
5796291|NCT00119587|darbepoetin alfa|darbepoetin alfa
5796292|NCT00119587|Clinical Trial|clinical trial
5796293|NCT00119587|Amgen|amgen
5796294|NCT00119574|Randomized Controlled Trial|randomized controlled trial
5796295|NCT00119574|Quality of Health Care|quality of health care
5796296|NCT00119574|Health Services Research|health services research
5796297|NCT00119574|Guidelines|guidelines
5796298|NCT00119574|Medical Informatics Computing|medical informatics computing
5796299|NCT00119574|Services, Mental Health|services, mental health
5796300|NCT00119574|Medicine, Evidence-Based|medicine, evidence-based
5796301|NCT00119574|Quality Assurance, Healthcare|quality assurance, healthcare
5796302|NCT00119574|Quality Indicators, Health Care|quality indicators, health care
5796303|NCT00119574|Veterans|veterans
5796304|NCT00119561|Caregiver|caregiver
5796305|NCT00119561|Dementia|dementia
5796306|NCT00119561|Alzheimer Disease|alzheimer disease
5796307|NCT00119561|Telephone|telephone
5796308|NCT00119561|Randomized Controlled Trials|randomized controlled trials
5796309|NCT00119548|HIV Rapid Testing|hiv rapid testing
5796310|NCT00119548|Cost-effectiveness|cost-effectiveness
5796311|NCT00119548|HIV Seronegativity|hiv seronegativity
5796312|NCT00119535|Diabetes mellitus|diabetes mellitus
5796313|NCT00119535|Diabetic retinopathy|diabetic retinopathy
5796314|NCT00119535|Organizational change|organizational change
5796315|NCT00119535|Quality improvement|quality improvement
5796316|NCT00119535|Quasi-experimental|quasi-experimental
5796317|NCT00119522|wheelchairs|wheelchairs
5796318|NCT00119522|falls|falls
5796319|NCT00119522|spinal cord injury|spinal cord injury
5796320|NCT00119522|accidental falls|accidental falls
5796321|NCT00119522|safety|safety
5796322|NCT00119509|Cervix Neoplasms|cervix neoplasms
5796323|NCT00119509|Vaginal smears|vaginal smears
5796324|NCT00119509|Papillomavirus - Human|papillomavirus - human
5796325|NCT00119496|Corticosteroid|corticosteroid
5796326|NCT00119496|Rosiglitazone|rosiglitazone
5796327|NCT00119496|Theophylline|theophylline
5796328|NCT00119496|Beclomethasone|beclomethasone
5796329|NCT00119496|Inflammation|inflammation
5795540|NCT00122369|Breast|breast
5796331|NCT00119496|Smoking|smoking
5796332|NCT00119496|Pulmonary|pulmonary
5796334|NCT00119483|testosterone|testosterone
5796335|NCT00119483|hypogonadal|hypogonadal
5796336|NCT00119483|aging|aging
5796338|NCT00119483|quality og life|quality og life
5796339|NCT00119483|Muscle strength|muscle strength
5796340|NCT00119483|Aging male|aging male
5796341|NCT00119457|antithrombotic agents|antithrombotic agents
5796342|NCT00119457|anticoagulants|anticoagulants
5796343|NCT00119457|prophylaxis|prophylaxis
5796344|NCT00119457|embolism|embolism
5796345|NCT00119457|deep vein thrombosis|deep vein thrombosis
5796346|NCT00119457|hip fracture|hip fracture
5796347|NCT00119444|PET|pet
5796348|NCT00119444|Periacetabular osteotomy|periacetabular osteotomy
5796349|NCT00119431|Hereditary angioedema type I (MeSH: angioneurotic edema, complement 1 inactivators)|hereditary angioedema type i (mesh: angioneurotic edema, complement 1 inactivators)
5796350|NCT00119418|hot flash|hot flash
5796351|NCT00119418|menopause|menopause
5796352|NCT00119418|herbal medicine|herbal medicine
5796353|NCT00119418|kampo|kampo
5796354|NCT00119418|alternative medicine|alternative medicine
5796355|NCT00119405|Lipoatrophy|lipoatrophy
5796356|NCT00119405|Mitochondria|mitochondria
5796357|NCT00119405|Treatment Naive|treatment naive
5796358|NCT00119379|lipoatrophy|lipoatrophy
5796359|NCT00119379|mitochondria|mitochondria
5796360|NCT00119379|HIV|hiv
5796361|NCT00119379|treatment experienced|treatment experienced
5796362|NCT00119340|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5796363|NCT00119340|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5796364|NCT00119340|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5796365|NCT00119340|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5862619|NCT00001564|Immunotherapy|immunotherapy
5796366|NCT00119314|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5796367|NCT00119314|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5796368|NCT00119301|recurrent osteosarcoma|recurrent osteosarcoma
5796369|NCT00119210|Tobacco use cessation|tobacco use cessation
5796370|NCT00119210|Bupropion|bupropion
5796372|NCT00119210|Puerperium|puerperium
5796373|NCT00119197|watery diarrhea|watery diarrhea
5796374|NCT00119197|cholera vaccine|cholera vaccine
5796375|NCT00119184|anesthesia|anesthesia
5796376|NCT00119184|breech|breech
5796377|NCT00119184|external cephalic version|external cephalic version
5796378|NCT00119184|spinal|spinal
5796379|NCT00119184|success|success
5796380|NCT00119184|anesthesia,spinal|anesthesia,spinal
5796381|NCT00119171|Safety|safety
5796382|NCT00119171|tolerability|tolerability
5796383|NCT00119171|dose limiting toxicity|dose limiting toxicity
5796384|NCT00119171|solid tumors|solid tumors
5796385|NCT00119171|capecitabine|capecitabine
5796386|NCT00119158|THerapy for acute moderate to severe flares|therapy for acute moderate to severe flares
5796387|NCT00119145|antimalarial drugs|antimalarial drugs
5796388|NCT00119145|efficacy|efficacy
5796389|NCT00119145|safety|safety
5796390|NCT00119145|trial|trial
5796391|NCT00119132|intermittent preventive treatment|intermittent preventive treatment
5796392|NCT00119132|effectiveness|effectiveness
5796393|NCT00119132|malaria|malaria
5796394|NCT00119119|Hepatitis C|hepatitis c
5796395|NCT00119119|Liver Cirrhosis|liver cirrhosis
5796396|NCT00119119|Tocopherols|tocopherols
5796397|NCT00119106|HIV|hiv
5796400|NCT00119106|HIV Seronegativity|hiv seronegativity
5796401|NCT00119093|Antiretroviral therapy|antiretroviral therapy
5796402|NCT00119093|HIV|hiv
5796403|NCT00119093|Adherence|adherence
5796404|NCT00119093|Viral Load|viral load
5796405|NCT00119093|Opportunistic illness|opportunistic illness
5796406|NCT00119080|Meningococcal carriage|meningococcal carriage
5796407|NCT00119080|Conjugate vaccine|conjugate vaccine
5796408|NCT00119067|Anthrax|anthrax
5796409|NCT00119067|Vaccine|vaccine
5796410|NCT00119067|Immunogenicity|immunogenicity
5796411|NCT00119067|Reactogenicity|reactogenicity
5796412|NCT00119054|Hypertension|hypertension
5796413|NCT00119054|Diabetes Mellitus|diabetes mellitus
5796414|NCT00119054|Telemedicine|telemedicine
5796415|NCT00119054|Nursing Care|nursing care
5796416|NCT00119041|Diabetes Mellitus|diabetes mellitus
5796417|NCT00119041|Telemedicine|telemedicine
5796418|NCT00119041|Referral|referral
5796419|NCT00119041|Consultation|consultation
5796420|NCT00119028|Quality Improvement|quality improvement
5796421|NCT00119028|Cluster Randomized Trial|cluster randomized trial
5796422|NCT00119028|Care Model|care model
5796423|NCT00119015|perennial allergic rhinitis|perennial allergic rhinitis
5796424|NCT00119002|randomized clinical trial|randomized clinical trial
5796425|NCT00119002|placebo-controlled|placebo-controlled
5796426|NCT00119002|double-blind|double-blind
5796427|NCT00119002|double-masked|double-masked
5796428|NCT00119002|infant|infant
5796429|NCT00119002|dexamethasone|dexamethasone
5796430|NCT00119002|wheezing|wheezing
5796431|NCT00118989|Curcumin|curcumin
5796432|NCT00118989|chemoprevention|chemoprevention
5796433|NCT00118989|adenomatous polyps|adenomatous polyps
5796434|NCT00118989|colorectal cancer|colorectal cancer
5796435|NCT00118976|diabetic nephropathy|diabetic nephropathy
5796436|NCT00118976|type 1 diabetes|type 1 diabetes
5796437|NCT00118976|albuminuria|albuminuria
5796438|NCT00118976|hypertension|hypertension
5796439|NCT00118924|Dengue Vaccine|dengue vaccine
5796440|NCT00118924|Tick-Borne Illnesses|tick-borne illnesses
5796441|NCT00118924|Flavivirus|flavivirus
5796442|NCT00118911|Adult|adult
5796443|NCT00118911|ADHD|adhd
5796445|NCT00118911|CBT|cbt
5796446|NCT00118911|Relaxation Techniques|relaxation techniques
5796447|NCT00118911|Education|education
5796448|NCT00118898|Treatment Naive|treatment naive
5796449|NCT00118885|Shingles|shingles
5796450|NCT00118885|depression|depression
5796451|NCT00118885|varicella zoster virus|varicella zoster virus
5796452|NCT00118885|alternative medicine|alternative medicine
5796453|NCT00118885|psychoneuroimmunology|psychoneuroimmunology
5796454|NCT00118872|Growth and Development|growth and development
5796455|NCT00118872|Pakistan|pakistan
5796456|NCT00118872|Weaning|weaning
5796457|NCT00118872|Probiotics|probiotics
5796458|NCT00118872|Infant|infant
5796459|NCT00118872|Lactobacillus GG|lactobacillus gg
5796460|NCT00118859|Back Pain|back pain
5796461|NCT00118859|Integrative Care|integrative care
5796462|NCT00118859|Acupuncture|acupuncture
5796463|NCT00118859|Chiropractic|chiropractic
5796464|NCT00118859|Exercise|exercise
5796465|NCT00118859|Massage Therapy|massage therapy
5796466|NCT00118859|Mind-Body Therapy|mind-body therapy
5796467|NCT00118859|Nutritional Counseling|nutritional counseling
5796468|NCT00118859|Complementary Therapies|complementary therapies
5796469|NCT00118859|Complementary and Alternative Medicine|complementary and alternative medicine
5796471|NCT00118846|Complementary and Alternative Medicine|complementary and alternative medicine
5796472|NCT00118846|CAM|cam
5796473|NCT00118833|Social Anxiety Disorder|social anxiety disorder
5796474|NCT00118833|Social Phobia|social phobia
5796475|NCT00118833|Generalized Anxiety Disorder|generalized anxiety disorder
5796476|NCT00118833|Hypericum|hypericum
5796477|NCT00118833|St. John's wort|st. john's wort
5796478|NCT00118833|Medicine, Herbal|medicine, herbal
5796479|NCT00118833|Complementary Therapies|complementary therapies
5796480|NCT00118820|Dry socket|dry socket
5796481|NCT00118820|Third molar|third molar
5796482|NCT00118820|Infection|infection
5796483|NCT00118820|postop-infection|postop-infection
5796484|NCT00118820|Antibiotic efficacy|antibiotic efficacy
5796587|NCT00118469|Adolescent|adolescent
5796485|NCT00118820|Infection characterized by pus,erythema,edema and pain|infection characterized by pus,erythema,edema and pain
5796486|NCT00118807|malaria treatment|malaria treatment
5796487|NCT00118807|artemisinin based combination therapy|artemisinin based combination therapy
5796488|NCT00118807|Plasmodium falciparum|plasmodium falciparum
5796489|NCT00118807|pragmatic trial|pragmatic trial
5796490|NCT00118807|effectiveness|effectiveness
5796491|NCT00118794|uncomplicated malaria|uncomplicated malaria
5796492|NCT00118794|G6PD deficiency|g6pd deficiency
5796493|NCT00118794|haemolytic anaemia|haemolytic anaemia
5796494|NCT00118794|Lapdap|lapdap
5796495|NCT00118794|Artemsinin based combination treatment|artemsinin based combination treatment
5796496|NCT00118794|compliance|compliance
5796497|NCT00118794|pragmatic trials|pragmatic trials
5796498|NCT00118781|ventilator-associated pneumonia|ventilator-associated pneumonia
5796499|NCT00118781|VAP|vap
5796500|NCT00118781|pneumonia|pneumonia
5796501|NCT00118781|ICU infection|icu infection
5796502|NCT00118768|Genotype-1, Chronic Hepatitis C|genotype-1, chronic hepatitis c
5796503|NCT00118729|Ragweed|ragweed
5796504|NCT00118729|GW685698X|gw685698x
5796505|NCT00118729|seasonal allergic rhinitis|seasonal allergic rhinitis
5796506|NCT00118729|onset|onset
5796507|NCT00118716|asthma|asthma
5796508|NCT00118716|bronchospasm|bronchospasm
5796509|NCT00118703|nonallergic rhinitis|nonallergic rhinitis
5796510|NCT00118703|GW685698X|gw685698x
5796511|NCT00118703|VMR|vmr
5796512|NCT00118703|vasomotor rhinitis|vasomotor rhinitis
5796513|NCT00118690|bronchospasm|bronchospasm
5796514|NCT00118690|asthma|asthma
5796515|NCT00118677|HIV Infections|hiv infections
5796516|NCT00118664|Septic Shock|septic shock
5796517|NCT00118664|Thrombocytopenia|thrombocytopenia
5796518|NCT00118664|Multiple Organ Failure|multiple organ failure
5796519|NCT00118664|Pediatric|pediatric
5796520|NCT00118651|pneumonia|pneumonia
5796521|NCT00118651|chest x-ray|chest x-ray
5796522|NCT00118651|diagnosis|diagnosis
5796523|NCT00118638|Non-myeloid malignancy|non-myeloid malignancy
5796524|NCT00118638|Darbepoetin alfa|darbepoetin alfa
5796525|NCT00118638|Clinical Trial|clinical trial
5796526|NCT00118625|Allergy|allergy
5796527|NCT00118625|Specific Immunotherapy|specific immunotherapy
5796528|NCT00118625|Adjuvant|adjuvant
5796529|NCT00118625|Allergy Vaccination|allergy vaccination
5796530|NCT00118625|Allergenicity|allergenicity
5796531|NCT00118612|Allergy|allergy
5796532|NCT00118612|Specific Immunotherapy|specific immunotherapy
5796533|NCT00118612|Allergy Vaccination|allergy vaccination
5796534|NCT00118612|Allergenicity|allergenicity
5796535|NCT00118586|Neuroanatomy|neuroanatomy
5796536|NCT00118586|Brain Damage|brain damage
5796537|NCT00118586|Dystonia|dystonia
5796538|NCT00118586|Pathology|pathology
5796539|NCT00118586|Brain Imaging|brain imaging
5796540|NCT00118586|Spasmodic Dysphonia|spasmodic dysphonia
5796541|NCT00118586|SD|sd
5796542|NCT00118586|Focal Dystonia|focal dystonia
5796543|NCT00118586|Healthy Volunteer|healthy volunteer
5796544|NCT00118586|HV|hv
5796545|NCT00118573|abdominal aortic aneurysm|abdominal aortic aneurysm
5796546|NCT00118573|randomized controlled trial|randomized controlled trial
5796547|NCT00118573|endovascular aneurysm repair|endovascular aneurysm repair
5796548|NCT00118560|Collateral Circulation|collateral circulation
5796549|NCT00118560|Exercise Therapy|exercise therapy
5796550|NCT00118560|Microcirculation|microcirculation
5796551|NCT00118560|Oxygen|oxygen
5796552|NCT00118560|Positron-emission tomography|positron-emission tomography
5796553|NCT00118560|Walking|walking
5796554|NCT00118547|Adherence|adherence
5796555|NCT00118547|Medication|medication
5796556|NCT00118547|Multiple Sclerosis|multiple sclerosis
5796557|NCT00118534|addictive disorders|addictive disorders
5796558|NCT00118534|clinical trial|clinical trial
5796559|NCT00118534|cost effectiveness|cost effectiveness
5796560|NCT00118534|mental health|mental health
5796561|NCT00118534|military or environmental exposure|military or environmental exposure
5796562|NCT00118534|multi-site trial|multi-site trial
5796563|NCT00118534|nicotine|nicotine
5796564|NCT00118534|nicotine replacement|nicotine replacement
5796565|NCT00118534|post traumatic stress|post traumatic stress
5796566|NCT00118534|post traumatic stress disorder|post traumatic stress disorder
5796567|NCT00118534|psychiatric|psychiatric
5796568|NCT00118534|psychological|psychological
5796570|NCT00118534|smoking cessation|smoking cessation
5796571|NCT00118534|smoking cessation medications|smoking cessation medications
5796572|NCT00118534|substance abuse|substance abuse
5796573|NCT00118521|Anterior Knee Pain|anterior knee pain
5796574|NCT00118495|female sexual dysfunction|female sexual dysfunction
5796575|NCT00118495|FSD|fsd
5796576|NCT00118495|arousal|arousal
5796577|NCT00118495|orgasm|orgasm
5796578|NCT00118495|desire|desire
5796579|NCT00118495|Zestra|zestra
5796580|NCT00118495|Mixed FSD|mixed fsd
5796581|NCT00118495|Hypoactive sexual desire disorder|hypoactive sexual desire disorder
5796582|NCT00118495|Sexual arousal disorder|sexual arousal disorder
5796583|NCT00118495|Orgasmic disorder|orgasmic disorder
5796584|NCT00118482|vasovagal syncope|vasovagal syncope
5796585|NCT00118482|randomized clinical trial|randomized clinical trial
5796586|NCT00118482|quality of life|quality of life
5796588|NCT00118469|CBT|cbt
5796589|NCT00118469|Parents|parents
5796590|NCT00118456|Advanced cancers|advanced cancers
5796591|NCT00118456|EGFR|egfr
5796592|NCT00118456|Her2|her2
5796593|NCT00118456|VEGFR|vegfr
5796594|NCT00118443|Suicide Prevention|suicide prevention
5796595|NCT00118443|Depression|depression
5796596|NCT00118443|Adolescent|adolescent
5796597|NCT00118443|Students|students
5796598|NCT00118443|School Teachers|school teachers
5796599|NCT00118430|Back Pain|back pain
5796600|NCT00118430|Knee Pain|knee pain
5796601|NCT00118430|Hip Pain|hip pain
5796602|NCT00118430|Stepped Care|stepped care
5796603|NCT00118430|Antidepressant|antidepressant
5796604|NCT00118430|Relaxation Techniques|relaxation techniques
5796605|NCT00118430|Exercise|exercise
5796606|NCT00118417|Selective serotonin reuptake inhibitor|selective serotonin reuptake inhibitor
5796607|NCT00118417|Anxiety|anxiety
5796608|NCT00118417|Pharmacotherapy|pharmacotherapy
5796609|NCT00118417|Cognitive behavioral therapy|cognitive behavioral therapy
5796610|NCT00118417|CBT|cbt
5796611|NCT00118404|Cognitive therapy|cognitive therapy
5796612|NCT00118404|Antidepressants|antidepressants
5796613|NCT00118404|Psychotherapy|psychotherapy
5796614|NCT00118391|Pathological Gambling|pathological gambling
5796615|NCT00118391|CBT|cbt
5796616|NCT00118391|CM|cm
5796617|NCT00118378|HIV|hiv
5796618|NCT00118378|AIDS|aids
5796619|NCT00118378|Modafinil|modafinil
5796620|NCT00118378|Depression|depression
5796621|NCT00118339|oral complications|oral complications
5796622|NCT00118339|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5796623|NCT00118339|stage I multiple myeloma|stage i multiple myeloma
5796624|NCT00118339|stage II multiple myeloma|stage ii multiple myeloma
5796625|NCT00118339|stage III multiple myeloma|stage iii multiple myeloma
5796626|NCT00118326|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5796627|NCT00118326|disseminated neuroblastoma|disseminated neuroblastoma
5796628|NCT00118326|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5796629|NCT00118326|recurrent neuroblastoma|recurrent neuroblastoma
5796630|NCT00118326|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5846714|NCT00043667|Anti-Tac|anti-tac
5796631|NCT00118326|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5796632|NCT00118326|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5796633|NCT00118326|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5796634|NCT00118326|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5796635|NCT00118326|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5795805|NCT00121420|Melanoma|melanoma
5796636|NCT00118326|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5796637|NCT00118326|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5796638|NCT00118326|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5796639|NCT00118326|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5796640|NCT00118326|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5796641|NCT00118326|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5796642|NCT00118326|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5796643|NCT00118326|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5796644|NCT00118326|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5796645|NCT00118326|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5796647|NCT00118313|stage III melanoma|stage iii melanoma
5796648|NCT00118313|stage IV melanoma|stage iv melanoma
5796649|NCT00118300|stage III cervical cancer|stage iii cervical cancer
5796650|NCT00118300|stage IVA cervical cancer|stage iva cervical cancer
5796651|NCT00118300|recurrent cervical cancer|recurrent cervical cancer
5796652|NCT00118300|stage III endometrial carcinoma|stage iii endometrial carcinoma
5796653|NCT00118300|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5796654|NCT00118300|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5796655|NCT00118300|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5796656|NCT00118300|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5796657|NCT00118300|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5796659|NCT00118300|stage IVA vaginal cancer|stage iva vaginal cancer
5796660|NCT00118300|recurrent vaginal cancer|recurrent vaginal cancer
5796661|NCT00118300|ovarian sarcoma|ovarian sarcoma
5796662|NCT00118300|ovarian stromal cancer|ovarian stromal cancer
5796663|NCT00118300|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5796664|NCT00118300|stage IB cervical cancer|stage ib cervical cancer
5796665|NCT00118300|stage IIA cervical cancer|stage iia cervical cancer
5796666|NCT00118300|stage IIB cervical cancer|stage iib cervical cancer
5796667|NCT00118300|stage II vaginal cancer|stage ii vaginal cancer
5796668|NCT00118300|stage I vaginal cancer|stage i vaginal cancer
5796669|NCT00118274|stage II melanoma|stage ii melanoma
5796670|NCT00118274|stage III melanoma|stage iii melanoma
5796671|NCT00118274|stage IV melanoma|stage iv melanoma
5796672|NCT00118261|stage IV rectal cancer|stage iv rectal cancer
5796673|NCT00118261|stage IV colon cancer|stage iv colon cancer
5796674|NCT00118261|recurrent rectal cancer|recurrent rectal cancer
5796675|NCT00118261|recurrent colon cancer|recurrent colon cancer
5796676|NCT00118222|adult mixed glioma|adult mixed glioma
5796677|NCT00118222|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5796678|NCT00118222|recurrent adult brain tumor|recurrent adult brain tumor
5796679|NCT00118222|adult giant cell glioblastoma|adult giant cell glioblastoma
5796680|NCT00118222|adult gliosarcoma|adult gliosarcoma
5796681|NCT00118196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5796682|NCT00118196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5796683|NCT00118196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5796684|NCT00118196|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5796685|NCT00118131|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5797163|NCT00116532|Open Label|open label
5796686|NCT00118131|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5796687|NCT00118131|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5796688|NCT00118105|recurrent colon cancer|recurrent colon cancer
5796689|NCT00118105|stage IV colon cancer|stage iv colon cancer
5796690|NCT00118105|recurrent rectal cancer|recurrent rectal cancer
5796691|NCT00118105|stage IV rectal cancer|stage iv rectal cancer
5796692|NCT00118105|liver metastases|liver metastases
5796693|NCT00118066|prostate cancer|prostate cancer
5796694|NCT00118066|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5796695|NCT00118053|inflammatory breast cancer|inflammatory breast cancer
5796696|NCT00118053|stage II breast cancer|stage ii breast cancer
5796697|NCT00118053|stage IIIA breast cancer|stage iiia breast cancer
5796698|NCT00118053|stage IIIB breast cancer|stage iiib breast cancer
5796699|NCT00118053|stage IIIC breast cancer|stage iiic breast cancer
5796700|NCT00118027|Malaria in pregnancy|malaria in pregnancy
5796702|NCT00118027|Low birth weight|low birth weight
5796703|NCT00118014|Trichotillomania|trichotillomania
5796704|NCT00118014|Habit Reversal Training|habit reversal training
5796705|NCT00118014|Sertraline|sertraline
5796706|NCT00118014|Zoloft|zoloft
5796707|NCT00118001|Psychotherapy|psychotherapy
5796708|NCT00118001|Generalized Anxiety Disorder|generalized anxiety disorder
5796709|NCT00118001|randomized-controlled trial|randomized-controlled trial
5796710|NCT00118001|worry exposure|worry exposure
5796711|NCT00118001|applied relaxation|applied relaxation
5796712|NCT00117975|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5796713|NCT00117975|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5795916|NCT00120952|RSA|rsa
5796714|NCT00117975|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5796715|NCT00117975|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5796716|NCT00117975|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5796717|NCT00117975|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5796718|NCT00117975|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5796719|NCT00117975|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5796720|NCT00117975|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5796721|NCT00117975|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5796722|NCT00117975|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5796723|NCT00117975|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5796724|NCT00117962|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5796725|NCT00117962|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5796726|NCT00117962|squamous cell lung cancer|squamous cell lung cancer
5796727|NCT00117962|large cell lung cancer|large cell lung cancer
5796728|NCT00117962|adenocarcinoma of the lung|adenocarcinoma of the lung
5796729|NCT00117962|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5796730|NCT00117949|Prostate Cancer|prostate cancer
5796731|NCT00117949|Androgen ablation therapy|androgen ablation therapy
5796732|NCT00117936|Angiogenesis|angiogenesis
5796733|NCT00117936|No-option heart patients|no-option heart patients
5796734|NCT00117936|Blocked coronary artery|blocked coronary artery
5796735|NCT00117936|Revascularization|revascularization
5796738|NCT00117923|Warts|warts
5796739|NCT00117923|Adults|adults
5796740|NCT00117923|Common Warts|common warts
5796741|NCT00117923|Resiquimod|resiquimod
5796742|NCT00117910|Aged, Granulocyte Colony-Stimulating Factor|aged, granulocyte colony-stimulating factor
5796743|NCT00117910|Combined Modality Therapy, Neutropenia|combined modality therapy, neutropenia
5796744|NCT00117910|pegfilgrastim, Neulasta®|pegfilgrastim, neulasta®
5796745|NCT00117910|FEC-100, Antineoplastic Agents|fec-100, antineoplastic agents
5796746|NCT00117910|Breast Cancer, Female|breast cancer, female
5796747|NCT00117897|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5796748|NCT00117897|R-CHOP-14|r-chop-14
5796749|NCT00117897|pegfilgrastim|pegfilgrastim
5796750|NCT00117897|neutropenia, clinical trial|neutropenia, clinical trial
5796751|NCT00117897|haematopoietic growth factor|haematopoietic growth factor
5796752|NCT00117884|Papillomavirus infections;|papillomavirus infections;
5796753|NCT00117884|Cervix Dysplasia|cervix dysplasia
5796754|NCT00117871|Warts|warts
5796755|NCT00117871|Adults|adults
5796756|NCT00117871|Common Warts|common warts
5796757|NCT00117871|Resiquimod|resiquimod
5796758|NCT00117858|Frontal Lobe|frontal lobe
5796759|NCT00117858|Language|language
5796760|NCT00117858|Behavior|behavior
5796761|NCT00117858|Degenerative Diseases|degenerative diseases
5796762|NCT00117858|Pick's Disease|pick's disease
5796763|NCT00117858|Frontotemporal Dementia|frontotemporal dementia
5796765|NCT00117845|Denileukin Diftitox (Ontak)|denileukin diftitox (ontak)
5796766|NCT00117845|Recombinant Immunotoxin|recombinant immunotoxin
5796767|NCT00117845|Human T-Cell Lymphotropic Virus (HTLV1)|human t-cell lymphotropic virus (htlv1)
5796768|NCT00117845|CD25 Positive|cd25 positive
5796769|NCT00117845|IL-2R|il-2r
5796770|NCT00117845|ATL|atl
5796771|NCT00117845|Ontak|ontak
5796772|NCT00117845|Adult T-Cell Leukemia|adult t-cell leukemia
5796773|NCT00117845|Lymphoproliferative Disorders|lymphoproliferative disorders
5796774|NCT00117832|allergic rhinitis|allergic rhinitis
5796775|NCT00117819|parkinson|parkinson
5796776|NCT00117819|family history|family history
5796777|NCT00117819|diagnosis|diagnosis
5796779|NCT00117806|Depression|depression
5796780|NCT00117806|Employment, supported|employment, supported
5796781|NCT00117806|Health Service/ut|health service/ut
5796782|NCT00117806|Humans|humans
5796783|NCT00117806|Outcomes|outcomes
5796784|NCT00117806|Quality of life|quality of life
5796785|NCT00117806|Veterans/rh (rehabilitation)|veterans/rh (rehabilitation)
5796786|NCT00117806|Workplace|workplace
5796787|NCT00117806|Spinal Cord Injuries|spinal cord injuries
5796788|NCT00117793|Amputee|amputee
5796789|NCT00117793|Artificial limbs|artificial limbs
5796790|NCT00117793|Gait|gait
5796791|NCT00117793|Walking|walking
5796792|NCT00117767|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
5796793|NCT00117754|Terbinafine, Tinea capitis, pediatric, antifungal|terbinafine, tinea capitis, pediatric, antifungal
5796794|NCT00117741|Opiate Dependence|opiate dependence
5796795|NCT00117741|DBT|dbt
5846715|NCT00043667|Anti-IL-2R|anti-il-2r
5811093|NCT00005088|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5811094|NCT00005088|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5796796|NCT00117741|Dialectical Behavior Therapy|dialectical behavior therapy
5796797|NCT00117741|Drug Counseling|drug counseling
5796798|NCT00117741|Therapy, Cognitive Behavior|therapy, cognitive behavior
5796799|NCT00117728|Non-nucleoside reverse transcriptase inhibitor|non-nucleoside reverse transcriptase inhibitor
5686552|NCT00551577|Neoplasm, Residual|neoplasm, residual
5796028|NCT00120666|HV|hv
5796800|NCT00117728|Drug Resistance|drug resistance
5796801|NCT00117728|HIV Seronegativity|hiv seronegativity
5796802|NCT00117728|Treatment Naive|treatment naive
5796803|NCT00117715|Developmental regulation of CYPs 1A2, 2D6, 3A4|developmental regulation of cyps 1a2, 2d6, 3a4
5796804|NCT00117715|Ontogeny|ontogeny
5796805|NCT00117715|pharmacokinetics|pharmacokinetics
5796806|NCT00117715|drug biotransformation|drug biotransformation
5796807|NCT00117715|enzymatic biotransformation of drugs|enzymatic biotransformation of drugs
5796808|NCT00117702|GvHD|gvhd
5796809|NCT00117702|Tacrolimus|tacrolimus
5796810|NCT00117702|Everolimus|everolimus
5796811|NCT00117702|Stem cell transplantation|stem cell transplantation
5796812|NCT00117689|Anti-T cell antibodies|anti-t cell antibodies
5796813|NCT00117689|Primary Liver Transplantation and Renal Dysfunction|primary liver transplantation and renal dysfunction
5796814|NCT00117689|Liver Transplant Rejection|liver transplant rejection
5796815|NCT00117689|Induction Therapy with reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
5796816|NCT00117689|Primary Liver Transplantation|primary liver transplantation
5796817|NCT00117689|Primary Transplant Rejection|primary transplant rejection
5796818|NCT00117689|Transplantation, Liver|transplantation, liver
5796819|NCT00117689|Rejection, Transplant|rejection, transplant
5796820|NCT00117676|tenofovir|tenofovir
5796821|NCT00117676|adefovir|adefovir
5796822|NCT00117676|hepatitis B virus|hepatitis b virus
5796823|NCT00117676|HBeAg Negative|hbeag negative
5796824|NCT00117663|Randomized controlled trial|randomized controlled trial
5796825|NCT00117663|Mammography|mammography
5796827|NCT00117663|hormone replacement therapy|hormone replacement therapy
5796828|NCT00117663|breast density|breast density
5796829|NCT00117663|mammography performance|mammography performance
5796830|NCT00117663|Breast Carcinoma|breast carcinoma
5796831|NCT00117650|leg pain|leg pain
5796832|NCT00117650|gene transfer|gene transfer
5796833|NCT00117650|angiogenesis|angiogenesis
5796834|NCT00117650|Phase 2|phase 2
5796835|NCT00117650|Genzyme|genzyme
5796836|NCT00117650|peripheral arterial disease|peripheral arterial disease
5796837|NCT00117637|Renal Cell Cancer|renal cell cancer
5796838|NCT00117637|RCC|rcc
5796839|NCT00117637|Cancer|cancer
5796840|NCT00117624|Non-myeloid malignancy|non-myeloid malignancy
5796841|NCT00117624|Darbepoetin alfa|darbepoetin alfa
5796842|NCT00117624|Clinical Trial|clinical trial
5796843|NCT00117611|chronic sinusitis|chronic sinusitis
5796844|NCT00117598|Lymphoma|lymphoma
5796845|NCT00117585|Aging|aging
5796846|NCT00117585|Blood pressure|blood pressure
5796847|NCT00117585|Hypotension|hypotension
5796848|NCT00117585|Orthostatic|orthostatic
5796849|NCT00117585|Rehabilitation|rehabilitation
5797041|NCT00116935|PDGFRA|pdgfra
5796850|NCT00117572|Cancer of the Pharynx (Nasopharynx, Oropharynx, Hypopharynx)|cancer of the pharynx (nasopharynx, oropharynx, hypopharynx)
5796851|NCT00117572|Cancer of the Nasal Cavity and Paranasal Sinuses|cancer of the nasal cavity and paranasal sinuses
5796852|NCT00117559|Psychotherapy,group|psychotherapy,group
5796853|NCT00117559|Rehabilitation|rehabilitation
5796854|NCT00117559|Telecommunications|telecommunications
5796855|NCT00117546|CAPACITY trial|capacity trial
5796856|NCT00117546|preeclampsia|preeclampsia
5796857|NCT00117546|plasma volume|plasma volume
5796858|NCT00117546|sympathetic activity|sympathetic activity
5796859|NCT00117546|hypertension|hypertension
5796860|NCT00117546|cardiovascular system|cardiovascular system
5796861|NCT00117533|chronic hepatitis B;|chronic hepatitis b;
5796862|NCT00117533|chronic hepatitis delta;|chronic hepatitis delta;
5796863|NCT00117533|treatment;|treatment;
5796864|NCT00117533|pegylated interferon alfa-2b;|pegylated interferon alfa-2b;
5796866|NCT00117520|caffeine, endurance, postural stability, elderly|caffeine, endurance, postural stability, elderly
5796867|NCT00117507|MDS|mds
5796868|NCT00117507|Myelodysplastic Syndrome|myelodysplastic syndrome
5796869|NCT00117507|ICL-670|icl-670
5796870|NCT00117507|ICL-670 and Myelodysplastic Syndrome|icl-670 and myelodysplastic syndrome
5796871|NCT00117494|Hyperlipidemia|hyperlipidemia
5796872|NCT00117494|HIV infections|hiv infections
5796873|NCT00117494|STATINS, HMG-COA|statins, hmg-coa
5796874|NCT00117494|Protease Inhibitor|protease inhibitor
5796875|NCT00117494|Treatment Experienced|treatment experienced
5796876|NCT00117481|endometriosis|endometriosis
5796877|NCT00117481|pelvic pain|pelvic pain
5796878|NCT00117481|hormonal treatment|hormonal treatment
5796879|NCT00117468|luteal phase replacement|luteal phase replacement
5796880|NCT00117468|oocyte donation|oocyte donation
5796881|NCT00117468|infertility|infertility
5796882|NCT00117468|progesterone|progesterone
5796883|NCT00117455|ICE|ice
5796884|NCT00117455|BEAM|beam
5796885|NCT00117455|PBPC transplant|pbpc transplant
5796886|NCT00117442|solid tumour|solid tumour
5796887|NCT00117442|unknown primary tumour|unknown primary tumour
5796888|NCT00117442|carboplatin|carboplatin
5796889|NCT00117442|paclitaxel|paclitaxel
5796890|NCT00117429|HIV-1|hiv-1
5796891|NCT00117429|therapeutic vaccination|therapeutic vaccination
5796892|NCT00117429|cellular immunity|cellular immunity
5796893|NCT00117429|humoral immunity|humoral immunity
5796075|NCT00120510|TB|tb
5796894|NCT00117429|HAART|haart
5796895|NCT00117429|chronic HIV-1 infection|chronic hiv-1 infection
5796896|NCT00117429|Treatment Experienced|treatment experienced
5796897|NCT00117429|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5796899|NCT00117403|anti-oxidant|anti-oxidant
5796900|NCT00117403|biomarkers|biomarkers
5796901|NCT00117403|alpha-tocopherol|alpha-tocopherol
5796902|NCT00117403|CoQ|coq
5796903|NCT00117377|Atopic dermatitis, pimecrolimus, cellular, molecular|atopic dermatitis, pimecrolimus, cellular, molecular
5796904|NCT00117364|chronic ulcer|chronic ulcer
5796905|NCT00117364|poor healing|poor healing
5796906|NCT00117364|The patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study|the patients with a poorly healed wound, in which skin graft is clinically indicated, are included in this study
5796907|NCT00117351|Adenocarcinoma|adenocarcinoma
5796908|NCT00117351|Bronchiolo-Alveolar|bronchiolo-alveolar
5796909|NCT00117351|Carcinoma, Bronchioloalveolar|carcinoma, bronchioloalveolar
5796910|NCT00117351|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5796911|NCT00117351|Carcinoma, Bronchiolo-Alveolar|carcinoma, bronchiolo-alveolar
5796912|NCT00117325|Vasomotor Rhinitis|vasomotor rhinitis
5796913|NCT00117325|VMR|vmr
5796914|NCT00117325|nonallergic rhinitis|nonallergic rhinitis
5796915|NCT00117325|GW685698X|gw685698x
5796916|NCT00117312|Prostate Cancer|prostate cancer
5796917|NCT00117312|Androgen ablation therapy|androgen ablation therapy
5796918|NCT00117299|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5796919|NCT00117299|GIST|gist
5796920|NCT00117299|Sarcoma|sarcoma
5796921|NCT00117299|PTK787|ptk787
5796923|NCT00117299|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5796924|NCT00117299|Tyrosine kinase|tyrosine kinase
5796925|NCT00117299|VEGF|vegf
5796926|NCT00117299|Vascular endothelial growth factor|vascular endothelial growth factor
5796927|NCT00117299|VEGFR|vegfr
5796928|NCT00117299|Vascular endothelial growth factor receptor|vascular endothelial growth factor receptor
5796929|NCT00117299|KDR|kdr
5796930|NCT00117299|KIT|kit
5796931|NCT00117299|c-KIT|c-kit
5796932|NCT00117299|Platelet derived growth factor receptor|platelet derived growth factor receptor
5796934|NCT00117286|Prostate Cancer|prostate cancer
5796935|NCT00117286|Androgen ablation therapy|androgen ablation therapy
5796936|NCT00117260|osteopenia|osteopenia
5796937|NCT00117260|bone mineral density|bone mineral density
5796938|NCT00117260|amenorrhea|amenorrhea
5796939|NCT00117260|adolescents|adolescents
5796940|NCT00117247|Heart Failure|heart failure
5796941|NCT00117234|chronic heart failure|chronic heart failure
5796942|NCT00117234|congestive heart failure|congestive heart failure
5796943|NCT00117234|low hemoglobin|low hemoglobin
5796944|NCT00117234|anemia|anemia
5796945|NCT00117234|CHF|chf
5796946|NCT00117234|Symptomatic Congestive Heart Failure (CHF)|symptomatic congestive heart failure (chf)
5796947|NCT00117221|Magnetic Resonance Imaging|magnetic resonance imaging
5796948|NCT00117221|Functional Imaging|functional imaging
5796949|NCT00117221|Cerebral Blood Flow|cerebral blood flow
5796950|NCT00117221|BOLD Effect|bold effect
5796951|NCT00117221|Sleep|sleep
5796952|NCT00117208|cystic fibrosis|cystic fibrosis
5796953|NCT00117195|parkinson|parkinson
5796954|NCT00117195|diagnosis|diagnosis
5796955|NCT00117195|screening|screening
5796956|NCT00117169|Pulmonary embolism|pulmonary embolism
5796957|NCT00117169|multi-detector helical computed tomography clinical probability|multi-detector helical computed tomography clinical probability
5796958|NCT00117169|clinical score|clinical score
5796959|NCT00117156|Fludarabine|fludarabine
5796960|NCT00117156|Rituximab|rituximab
5796961|NCT00117156|Marginal Zone Lymphoma|marginal zone lymphoma
5796962|NCT00117156|MALT lymphoma|malt lymphoma
5797565|NCT00115141|Adults|adults
5796963|NCT00117143|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5796964|NCT00117143|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5796966|NCT00117143|Thrombocytopenia|thrombocytopenia
5796967|NCT00117130|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
5796968|NCT00117130|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
5796969|NCT00117130|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
5796970|NCT00117130|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
5796971|NCT00117130|Patient preference, Subject preference|patient preference, subject preference
5796972|NCT00117117|Chemotherapy induced anemia|chemotherapy induced anemia
5796973|NCT00117117|Amgen|amgen
5796974|NCT00117117|Aranesp®|aranesp®
5796975|NCT00117117|darbepoetin alfa|darbepoetin alfa
5796976|NCT00117104|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5796977|NCT00117104|Kidney Disease, Dialysis|kidney disease, dialysis
5796978|NCT00117104|Aranesp®, rHuEPO|aranesp®, rhuepo
5796979|NCT00117104|Anemia, Hemoglobin|anemia, hemoglobin
5796980|NCT00117104|Dosing, Amgen|dosing, amgen
5796981|NCT00117091|Rheumatoid Arthritis|rheumatoid arthritis
5796983|NCT00117091|Anakinra (Kineret®)|anakinra (kineret®)
5796984|NCT00117078|Kidney disease, Renal, CKD (Chronic Kidney Disease)|kidney disease, renal, ckd (chronic kidney disease)
5796985|NCT00117078|CRI (Chronic Renal Insufficiency), Pre-dialysis, Amgen|cri (chronic renal insufficiency), pre-dialysis, amgen
5796986|NCT00117078|Aranesp®, Darbepoetin alfa, QW dosing|aranesp®, darbepoetin alfa, qw dosing
5817720|NCT00079911|HIV|hiv
5787617|NCT00157768|ICD|icd
5796987|NCT00117078|Q2W dosing, Q4W dosing|q2w dosing, q4w dosing
5796988|NCT00117078|Patient preference, Subject preference|patient preference, subject preference
5796989|NCT00117065|Kidney transplant, Renal transplant|kidney transplant, renal transplant
5796990|NCT00117065|Aranesp®, Darbepoetin alfa|aranesp®, darbepoetin alfa
5796991|NCT00117065|Amgen, Q2W dosing, Q4W dosing|amgen, q2w dosing, q4w dosing
5796992|NCT00117052|Clinical trial|clinical trial
5796993|NCT00117052|Amgen|amgen
5796994|NCT00117052|Secondary HyperParaThyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5796995|NCT00117052|Dialysis|dialysis
5796996|NCT00117052|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5796997|NCT00117052|KDOQI|kdoqi
5796998|NCT00117052|Cinacalcet|cinacalcet
5796999|NCT00117039|anemia|anemia
5797000|NCT00117039|fatigue|fatigue
5797001|NCT00117039|Aranesp®|aranesp®
5797002|NCT00117039|clinical trial|clinical trial
5797003|NCT00117026|Diabetes Complications|diabetes complications
5797004|NCT00117026|benfotiamine|benfotiamine
5797005|NCT00117026|type 1 diabetes|type 1 diabetes
5797006|NCT00117026|elevated urinary albumin excretion|elevated urinary albumin excretion
5797007|NCT00117026|nerve function|nerve function
5797008|NCT00117026|advanced glycation end products|advanced glycation end products
5797009|NCT00117013|Phase I|phase i
5797010|NCT00117013|Antiangiogenesis|antiangiogenesis
5797011|NCT00117013|Targeted Therapy|targeted therapy
5797012|NCT00117013|Chronic Schedule|chronic schedule
5797013|NCT00117013|VEGF|vegf
5797014|NCT00117013|Cancer|cancer
5797015|NCT00117013|Metastatic Solid Tumor|metastatic solid tumor
5797016|NCT00117000|testosterone|testosterone
5797017|NCT00117000|food, formulated|food, formulated
5797018|NCT00117000|malnutrition|malnutrition
5797019|NCT00117000|undernutrition|undernutrition
5797020|NCT00117000|aging|aging
5797021|NCT00117000|aged|aged
5797022|NCT00117000|aged, 80 and over|aged, 80 and over
5797023|NCT00117000|frail elderly|frail elderly
5797024|NCT00116987|physiologic pacing|physiologic pacing
5797025|NCT00116987|ventricular pacing|ventricular pacing
5797026|NCT00116987|hospitalizations|hospitalizations
5797027|NCT00116974|Dental scaling|dental scaling
5797028|NCT00116948|Osteoarthrosis|osteoarthrosis
5797029|NCT00116948|RSA|rsa
5797030|NCT00116948|DEXA|dexa
5797031|NCT00116948|Hip arthroplasty|hip arthroplasty
5797032|NCT00116948|Metal ion|metal ion
5797033|NCT00116948|Inflammatory response|inflammatory response
5797034|NCT00116948|Gait analysis|gait analysis
5797035|NCT00116935|Gastrointestinal stromal tumor|gastrointestinal stromal tumor
5797036|NCT00116935|GIST|gist
5797037|NCT00116935|Sarcoma|sarcoma
5797038|NCT00116935|Imatinib|imatinib
5797039|NCT00116935|Adjuvant therapy|adjuvant therapy
5797042|NCT00116935|Receptor tyrosine kinase|receptor tyrosine kinase
5797043|NCT00116935|Tyrosine kinase inhibitor|tyrosine kinase inhibitor
5797044|NCT00116922|Diabetes|diabetes
5797045|NCT00116922|Prevention.|prevention.
5797046|NCT00116922|Rosiglitazone|rosiglitazone
5797047|NCT00116922|Metformin|metformin
5797048|NCT00116922|Lifestyle|lifestyle
5797049|NCT00116922|Impaired glucose Tolerance|impaired glucose tolerance
5797050|NCT00116883|GW685698X|gw685698x
5797051|NCT00116883|perennial allergic rhinitis|perennial allergic rhinitis
5797052|NCT00116883|pediatric|pediatric
5797053|NCT00116883|intranasal corticosteroid|intranasal corticosteroid
5797054|NCT00116883|HPA axis function|hpa axis function
5797055|NCT00116870|CAD|cad
5797056|NCT00116870|familial hypercholesterolemia|familial hypercholesterolemia
5797057|NCT00116844|viral shedding|viral shedding
5797058|NCT00116844|Recurrent|recurrent
5797059|NCT00116844|herpes|herpes
5797060|NCT00116844|genital herpes|genital herpes
5797061|NCT00116831|atheroma|atheroma
5797062|NCT00116831|IVUS|ivus
5797063|NCT00116831|Intravascular ultrasound|intravascular ultrasound
5797064|NCT00116831|atherosclerosis|atherosclerosis
5797065|NCT00116818|perennial allergic rhinitis|perennial allergic rhinitis
5797066|NCT00116818|intranasal corticosteroid|intranasal corticosteroid
5797067|NCT00116818|HPA axis function|hpa axis function
5797068|NCT00116818|GW685698X|gw685698x
5797069|NCT00116805|tenofovir|tenofovir
5797070|NCT00116805|adefovir|adefovir
5797071|NCT00116805|hepatitis B|hepatitis b
5797072|NCT00116805|HBeAg Positive|hbeag positive
5797073|NCT00116792|CAD|cad
5797074|NCT00116792|Diabetes Mellitus|diabetes mellitus
5797075|NCT00116792|Restenosis|restenosis
5797076|NCT00116792|ppar gamma|ppar gamma
5797077|NCT00116792|glitazone|glitazone
5797078|NCT00116779|Prostate Cancer|prostate cancer
5797079|NCT00116779|Androgen ablation therapy|androgen ablation therapy
5797080|NCT00116766|mosquitoes|mosquitoes
5797081|NCT00116766|malaria|malaria
5797082|NCT00116766|vector control|vector control
5797083|NCT00116766|plant-based|plant-based
5797084|NCT00116753|Prostate Cancer|prostate cancer
5797085|NCT00116753|Androgen ablation therapy|androgen ablation therapy
5797086|NCT00116740|Serotonin|serotonin
5797087|NCT00116740|5-HT2c|5-ht2c
5797088|NCT00116740|Satiety|satiety
5797089|NCT00116740|Obesity|obesity
5797090|NCT00116740|Appetite suppressant|appetite suppressant
5686553|NCT00551564|total body water|total body water
5797091|NCT00116740|Weight Loss|weight loss
5797092|NCT00116740|Overweight|overweight
5797093|NCT00116727|Rheumatoid Arthritis|rheumatoid arthritis
5797095|NCT00116714|rheumatoid arthritis|rheumatoid arthritis
5797096|NCT00116714|RA|ra
5797097|NCT00116714|DMARD|dmard
5797098|NCT00116701|Chronic Kidney Disease (CKD)|chronic kidney disease (ckd)
5797099|NCT00116701|Haemoglobin (Hb)|haemoglobin (hb)
5797100|NCT00116701|Erthropoetin (EPO)|erthropoetin (epo)
5797101|NCT00116701|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5797102|NCT00116701|Recombinant Human Erthropoetic (rHuEPO)|recombinant human erthropoetic (rhuepo)
5797103|NCT00116701|Anaemia|anaemia
5797104|NCT00116701|Darbepoetin Alfa, Aranesp®|darbepoetin alfa, aranesp®
5797105|NCT00116701|Haemodialysis|haemodialysis
5797106|NCT00116701|Clinical Trial|clinical trial
5797107|NCT00116688|Immune (Idiopathic) Thrombocytopenic Purpura (ITP)|immune (idiopathic) thrombocytopenic purpura (itp)
5797108|NCT00116688|Thrombocytopenic|thrombocytopenic
5797109|NCT00116675|Common Wart(s)|common wart(s)
5797110|NCT00116675|Pediatric|pediatric
5797111|NCT00116675|Wart(s)|wart(s)
5797112|NCT00116675|Children|children
5797113|NCT00116675|3M Pharmaceuticals|3m pharmaceuticals
5797114|NCT00116675|Resiquimod|resiquimod
5797115|NCT00116662|Wart(s)|wart(s)
5797116|NCT00116662|Common Wart(s)|common wart(s)
5797117|NCT00116662|Children|children
5797118|NCT00116662|Pediatric|pediatric
5797119|NCT00116662|3M Pharmaceuticals|3m pharmaceuticals
5797120|NCT00116662|Resiquimod|resiquimod
5797121|NCT00116649|actinic keratosis lesions large head torso extremities|actinic keratosis lesions large head torso extremities
5797124|NCT00116636|Treatment Naive|treatment naive
5797125|NCT00116610|small cell lung cancer|small cell lung cancer
5797126|NCT00116610|resistant|resistant
5797127|NCT00116610|refractory|refractory
5797128|NCT00116610|platinum|platinum
5797129|NCT00116610|chemotherapy|chemotherapy
5797130|NCT00116610|second-line|second-line
5797131|NCT00116610|relapse|relapse
5797132|NCT00116610|sensitive|sensitive
5797133|NCT00116597|Active Specific Immunotherapy|active specific immunotherapy
5797134|NCT00116597|Intranodal|intranodal
5797135|NCT00116597|Cancer|cancer
5797136|NCT00116597|Melanoma stages IIb to IV|melanoma stages iib to iv
5797137|NCT00116597|Gene Therapy|gene therapy
5797138|NCT00116597|Recombinant Vaccinia virus|recombinant vaccinia virus
5797139|NCT00116597|HLA-A2|hla-a2
5797140|NCT00116597|Mart-1/Melan-A, Gp-100, tyrosinase|mart-1/melan-a, gp-100, tyrosinase
5797141|NCT00116597|Clinical Trial|clinical trial
5797142|NCT00116597|Phase I/II|phase i/ii
5797143|NCT00116584|heliox|heliox
5797144|NCT00116584|bronchiolitis|bronchiolitis
5797145|NCT00116584|racemic epinephrine|racemic epinephrine
5797146|NCT00116571|Benign Prostatic Hyperplasia (BPH)|benign prostatic hyperplasia (bph)
5797147|NCT00116571|Photodynamic Therapy (PDT)|photodynamic therapy (pdt)
5797148|NCT00116571|Lower Urinary Tract Symptoms (LUTS)|lower urinary tract symptoms (luts)
5797149|NCT00116558|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5797150|NCT00116558|ALS|als
5797151|NCT00116558|Lou Gehrig's disease|lou gehrig's disease
5797152|NCT00116558|nutrition|nutrition
5797153|NCT00116558|NIPPV|nippv
5797154|NCT00116558|non-invasive positive pressure ventilation|non-invasive positive pressure ventilation
5797155|NCT00116558|percutaneous endoscopic gastrostomy|percutaneous endoscopic gastrostomy
5797156|NCT00116558|PEG|peg
5797157|NCT00116545|IDDM|iddm
5797158|NCT00116545|Insulin|insulin
5797159|NCT00116545|cardiovascular disease|cardiovascular disease
5797160|NCT00116532|Obsessive Compulsive Disorder|obsessive compulsive disorder
5797161|NCT00116532|Escitalopram|escitalopram
5797162|NCT00116532|SSRI|ssri
5797164|NCT00116506|Metastatic Colorectal Cancer|metastatic colorectal cancer
5797165|NCT00116506|Bevacizumab|bevacizumab
5797166|NCT00116506|Erlotinib|erlotinib
5797167|NCT00116506|FOLFOX|folfox
5797168|NCT00116493|severe anemia|severe anemia
5797169|NCT00116493|anthelminthic|anthelminthic
5797170|NCT00116493|multivitamins|multivitamins
5797171|NCT00116493|pregnancy|pregnancy
5797172|NCT00116493|children|children
5797173|NCT00116493|Pakistan|pakistan
5797174|NCT00116480|Postpartum Haemorrhage|postpartum haemorrhage
5797175|NCT00116480|Misoprostol|misoprostol
5797176|NCT00116467|AML|aml
5797177|NCT00116467|Acute Myelogenous Leukemia|acute myelogenous leukemia
5797178|NCT00116467|GVAX|gvax
5797179|NCT00116467|Vaccine|vaccine
5797180|NCT00116467|Stem Cell Transplant|stem cell transplant
5797181|NCT00116467|Autologous|autologous
5797182|NCT00116454|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5811413|NCT00083395|MRI|mri
5797183|NCT00116454|Viral Hepatitis, Alcoholic Hepatitis|viral hepatitis, alcoholic hepatitis
5797184|NCT00116441|Multiple Myeloma|multiple myeloma
5797185|NCT00116441|Cancer|cancer
5797186|NCT00116441|PSCT|psct
5797187|NCT00116441|Peripheral Stem Cell Transplant|peripheral stem cell transplant
5797188|NCT00116441|Chemotherapy|chemotherapy
5797189|NCT00116441|GVAX|gvax
5797190|NCT00116428|Atrial Fibrillation|atrial fibrillation
5797191|NCT00116428|Paroxysmal Atrial Fibrillation|paroxysmal atrial fibrillation
5797192|NCT00116415|HIV/AIDS|hiv/aids
5797193|NCT00116402|COPD|copd
5797194|NCT00116402|Chronic Obstructive|chronic obstructive
5797195|NCT00116402|Pulmonary Disease|pulmonary disease
5797196|NCT00116402|Inhaled Corticosteroids|inhaled corticosteroids
5797197|NCT00116402|Airway Inflammation|airway inflammation
5797198|NCT00116402|Bronchoscopy|bronchoscopy
5797199|NCT00116389|pancreatic cancer|pancreatic cancer
5797200|NCT00116389|cancer of the pancreas|cancer of the pancreas
5797201|NCT00116389|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5797202|NCT00116389|pancreatic neoplasms|pancreatic neoplasms
5797203|NCT00116389|Metastatic pancreatic cancer (Stage IV)|metastatic pancreatic cancer (stage iv)
5797204|NCT00116389|Stage IV Adenocarcinoma of the Pancreas|stage iv adenocarcinoma of the pancreas
5797205|NCT00116376|GBM|gbm
5797206|NCT00116376|recurrent/relapse|recurrent/relapse
5797207|NCT00116376|EGFR|egfr
5797208|NCT00116376|VEGFR|vegfr
5797209|NCT00116363|gene therapy|gene therapy
5797210|NCT00116363|melanoma|melanoma
5797211|NCT00116363|adenovirus|adenovirus
5797212|NCT00116363|in-transit melanoma|in-transit melanoma
5797213|NCT00116363|metastatic melanoma|metastatic melanoma
5797214|NCT00116350|Postpartum hemorrhage|postpartum hemorrhage
5797215|NCT00116350|Misoprostol|misoprostol
5797216|NCT00116350|Developing countries|developing countries
5797217|NCT00116350|Maternal morbidity|maternal morbidity
5797218|NCT00116350|Randomized controlled trial|randomized controlled trial
5797219|NCT00116337|spinal cord injury|spinal cord injury
5797220|NCT00116337|paralysis|paralysis
5797221|NCT00116337|cough|cough
5797223|NCT00116337|thoracic spinal cord injury|thoracic spinal cord injury
5797225|NCT00116324|Leukotriene receptor antagonist|leukotriene receptor antagonist
5797226|NCT00116324|Hypertonic saline challenge|hypertonic saline challenge
5797227|NCT00116311|Adenosine receptors|adenosine receptors
5797228|NCT00116311|asthma|asthma
5797229|NCT00116311|sputum|sputum
5797230|NCT00116311|peripheral blood|peripheral blood
5797231|NCT00116311|healthy|healthy
5797232|NCT00116298|Antivirals|antivirals
5797233|NCT00116298|HIV|hiv
5797234|NCT00116285|allergy|allergy
5797235|NCT00116285|skin prick test|skin prick test
5797236|NCT00116285|allergoid|allergoid
5797237|NCT00116285|allergenicity|allergenicity
5797238|NCT00116285|specific immunotherapy|specific immunotherapy
5797239|NCT00116272|pregnancy|pregnancy
5797240|NCT00116272|Autoimmune Disease|autoimmune disease
5797241|NCT00116259|clinical trial|clinical trial
5797242|NCT00116259|aripiprazole|aripiprazole
5797243|NCT00116259|Bipolar Disorder|bipolar disorder
5797244|NCT00116259|Attention-Deficit Hyperactivity Disorder|attention-deficit hyperactivity disorder
5797245|NCT00116259|ADHD|adhd
5797246|NCT00116246|Labour|labour
5797247|NCT00116246|vaginal delivery|vaginal delivery
5797248|NCT00116246|primigravida|primigravida
5797249|NCT00116246|McRobert's Manoeuvre|mcrobert's manoeuvre
5797250|NCT00116246|operative delivery|operative delivery
5797251|NCT00116233|post operative adhesions|post operative adhesions
5797252|NCT00116220|Prostate Cancer|prostate cancer
5797253|NCT00116220|Total Androgen Suppression|total androgen suppression
5797254|NCT00116220|endorectal coil MRI|endorectal coil mri
5797255|NCT00116220|External Beam Radiation Therapy|external beam radiation therapy
5797256|NCT00116220|Prostate Cancer- High Risk, clinically Organ-Confined|prostate cancer- high risk, clinically organ-confined
5797257|NCT00116207|Type 1 Diabetes|type 1 diabetes
5797258|NCT00116207|Oxidative Stress|oxidative stress
5797259|NCT00116207|Diabetic Complications|diabetic complications
5797260|NCT00116207|Neuropathy|neuropathy
5797261|NCT00116194|exercise|exercise
5797262|NCT00116194|activities of daily living|activities of daily living
5797263|NCT00116194|ADL|adl
5798778|NCT00111098|Anemia|anemia
5797264|NCT00116194|loss of mobility|loss of mobility
5797265|NCT00116194|risk of disability|risk of disability
5797266|NCT00116194|physical activity|physical activity
5797267|NCT00116194|mobility disability|mobility disability
5797268|NCT00116155|Hormone Refractory Metastatic Prostate Cancer|hormone refractory metastatic prostate cancer
5797269|NCT00116142|Prostate Cancer|prostate cancer
5797270|NCT00116142|Hormone Refractory|hormone refractory
5797271|NCT00116142|Metastatic|metastatic
5797272|NCT00116142|Localized|localized
5797273|NCT00116142|Locally Advanced|locally advanced
5797274|NCT00116142|Prostate Cancer - High Risk Localized or Locally Advanced|prostate cancer - high risk localized or locally advanced
5797275|NCT00116129|Fibromyalgia|fibromyalgia
5797276|NCT00116129|Treatment|treatment
5797277|NCT00116129|Growth hormone|growth hormone
5797278|NCT00116129|IGF-1|igf-1
5811437|NCT00006269|diarrhea|diarrhea
5797279|NCT00116129|MK-0677|mk-0677
5797280|NCT00116129|Oral growth hormone secretagogue|oral growth hormone secretagogue
5797281|NCT00116116|HIV/AIDS|hiv/aids
5797282|NCT00116103|Treatment Effectiveness|treatment effectiveness
5797283|NCT00116103|Treatment Efficacy|treatment efficacy
5797284|NCT00116103|Investigational, Therapies|investigational, therapies
5797285|NCT00116103|Asthma|asthma
5797286|NCT00116103|Antiasthmatics|antiasthmatics
5797287|NCT00116103|Antiasthmatic agents|antiasthmatic agents
5797288|NCT00116090|Uveitis|uveitis
5797289|NCT00116090|Immunosuppression|immunosuppression
5797290|NCT00116090|Cancer|cancer
5797291|NCT00116090|Infections|infections
5797292|NCT00116090|Mortality|mortality
5797293|NCT00116090|Ocular Inflammatory Disease|ocular inflammatory disease
5797294|NCT00116090|Scleritis|scleritis
5797295|NCT00116090|Mucous Membranes Pemphigoid|mucous membranes pemphigoid
5797296|NCT00116077|PET|pet
5797297|NCT00116077|[C-11] NNC-112|[c-11] nnc-112
5797298|NCT00116077|[F-18] Fallypride|[f-18] fallypride
5797299|NCT00116077|Dopamine Receptors|dopamine receptors
5797300|NCT00116077|Mood Disorders|mood disorders
5797301|NCT00116077|DA Receptors|da receptors
5797302|NCT00116077|Major Depressive Disorder|major depressive disorder
5797303|NCT00116077|Bipolar Disorder|bipolar disorder
5797304|NCT00116077|MDD|mdd
5797305|NCT00116077|Bipolar Depression|bipolar depression
5797306|NCT00116077|Healthy Volunteer|healthy volunteer
5797307|NCT00116077|HV|hv
5797308|NCT00116064|intranasal|intranasal
5797309|NCT00116064|lorazepam|lorazepam
5797310|NCT00116064|paediatric|paediatric
5797311|NCT00116064|convulsions|convulsions
5797312|NCT00116051|RSA|rsa
5797313|NCT00116051|DEXA|dexa
5797314|NCT00116051|Osteoarthritis|osteoarthritis
5797315|NCT00116051|Hip arthroplasty|hip arthroplasty
5797316|NCT00116038|RSA|rsa
5797317|NCT00116038|Osteoarthritis|osteoarthritis
5797318|NCT00116038|Hip arthroplasty|hip arthroplasty
5797319|NCT00116038|DEXA|dexa
5797320|NCT00116012|acute coronary syndrome|acute coronary syndrome
5797321|NCT00116012|rNAPc2|rnapc2
5797322|NCT00116012|unstable angina|unstable angina
5797323|NCT00116012|Non-STE myocardial infarction|non-ste myocardial infarction
5797324|NCT00116012|ST elevation|st elevation
5797325|NCT00116012|cardiac enzymes|cardiac enzymes
5797326|NCT00116012|acute coronary syndromes|acute coronary syndromes
5797327|NCT00116012|factor VIIa|factor viia
5797328|NCT00116012|tissue factor|tissue factor
5797329|NCT00116012|nematode anticoagulant protein c2|nematode anticoagulant protein c2
5797330|NCT00116012|anticoagulants|anticoagulants
5797331|NCT00116012|thrombin inhibitors|thrombin inhibitors
5797332|NCT00116012|thrombosis|thrombosis
5797333|NCT00115999|PAO|pao
5797334|NCT00115999|acute peripheral arterial occlusion|acute peripheral arterial occlusion
5797335|NCT00115999|thrombolysis|thrombolysis
5797336|NCT00115999|blood clot|blood clot
5797337|NCT00115999|leg attack|leg attack
5797338|NCT00115999|alfimeprase|alfimeprase
5797339|NCT00115999|thrombus|thrombus
5797340|NCT00115999|embolism|embolism
5797341|NCT00115999|thromboembolism|thromboembolism
5797342|NCT00115999|claudication|claudication
5797343|NCT00115999|thrombolytic|thrombolytic
5797344|NCT00115999|thrombosis|thrombosis
5797345|NCT00115999|plasminogen activator|plasminogen activator
5797346|NCT00115999|arterial flow|arterial flow
5797347|NCT00115986|A/H5N1, Influenza, Vaccine, parent protocol|a/h5n1, influenza, vaccine, parent protocol
5797348|NCT00115973|Pump|pump
5797349|NCT00115973|Diabetes|diabetes
5797350|NCT00115960|IL-12|il-12
5797351|NCT00115960|IL-15|il-15
5797352|NCT00115960|HIV Seronegativity|hiv seronegativity
5797353|NCT00115960|HIV Preventive Vaccine|hiv preventive vaccine
5797354|NCT00115921|Home-based care|home-based care
5797355|NCT00115921|Malaria|malaria
5797356|NCT00115921|Africa|africa
5797357|NCT00115908|Hepatitis C|hepatitis c
5797358|NCT00115895|radioiodine|radioiodine
5797359|NCT00115895|serum thyroglobulin|serum thyroglobulin
5797360|NCT00115895|whole body radioiodine scanning|whole body radioiodine scanning
5797361|NCT00115882|Adolescent|adolescent
5797362|NCT00115882|smoking|smoking
5797363|NCT00115882|smoking cessation|smoking cessation
5797364|NCT00115882|counseling|counseling
5797365|NCT00115869|smoking prevention|smoking prevention
5797366|NCT00115869|tobacco use prevention|tobacco use prevention
5797367|NCT00115869|adolescent tobacco use|adolescent tobacco use
5797368|NCT00115869|prevention intervention|prevention intervention
5797369|NCT00115856|Arterial Disease|arterial disease
5797370|NCT00115843|Atrial fibrillation|atrial fibrillation
5797371|NCT00115843|Arrhythmia|arrhythmia
5797372|NCT00115843|Tachycardia|tachycardia
5797373|NCT00115804|Fibromyalgia|fibromyalgia
5797374|NCT00115804|Juvenile|juvenile
5797375|NCT00115791|Atrial Flutters|atrial flutters
5797376|NCT00115791|Atrial Fibrillations|atrial fibrillations
5797377|NCT00115791|RSD1235|rsd1235
5797378|NCT00115778|Hypogammaglobulinemia|hypogammaglobulinemia
5797379|NCT00115778|Lung Transplantation|lung transplantation
5797380|NCT00115765|Panitumumab Advanced Colorectal Cancer Evaluation Study (PACCE Study)|panitumumab advanced colorectal cancer evaluation study (pacce study)
5797381|NCT00115765|Colorectal, Colon, Rectal Cancer, Metastatic Colorectal|colorectal, colon, rectal cancer, metastatic colorectal
5797382|NCT00115765|Cancer|cancer
5797383|NCT00115765|EGFr, Clinical Trial|egfr, clinical trial
5797384|NCT00115765|Panitumumab, ABX-EGF|panitumumab, abx-egf
5797385|NCT00115765|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5797386|NCT00115765|Metastatic Colorectal Cancer|metastatic colorectal cancer
5797387|NCT00115765|Oncology|oncology
5797388|NCT00115752|Single Nucleotide Polymorphism|single nucleotide polymorphism
5797389|NCT00115752|Analgesic Efficacy|analgesic efficacy
5797390|NCT00115752|Oral Surgery Model|oral surgery model
5797391|NCT00115752|Cyclooxygenase Inhibitor|cyclooxygenase inhibitor
5797392|NCT00115752|Gene Expression Profile|gene expression profile
5797393|NCT00115752|Wisdom Teeth|wisdom teeth
5797394|NCT00115752|Third Molar Extraction|third molar extraction
5797395|NCT00115739|Anaplastic Thyroid Cancer|anaplastic thyroid cancer
5797396|NCT00115726|anesthesia|anesthesia
5797397|NCT00115726|hypotension|hypotension
5797398|NCT00115726|furosemide|furosemide
5797399|NCT00115726|blood pressure|blood pressure
5797400|NCT00115726|peripheral edema|peripheral edema
5797401|NCT00115726|diuretic|diuretic
5797402|NCT00115726|surgery|surgery
5797403|NCT00115726|congestive heart failure|congestive heart failure
5797404|NCT00115713|Aerobic Exercise|aerobic exercise
5797405|NCT00115713|Weight Lifting|weight lifting
5797406|NCT00115713|Breast Cancer|breast cancer
5797407|NCT00115713|Quality of Life|quality of life
5797408|NCT00115700|Radiotherapy|radiotherapy
5797409|NCT00115700|Chemotherapy|chemotherapy
5797410|NCT00115700|Rituximab|rituximab
5797411|NCT00115700|Randomised Trial|randomised trial
5797412|NCT00115700|Stage I-II low grade follicular lymphoma|stage i-ii low grade follicular lymphoma
5797413|NCT00115687|nicotine addiction|nicotine addiction
5797414|NCT00115661|Peroxisome Proliferator-Activated Receptors|peroxisome proliferator-activated receptors
5797415|NCT00115661|treatment of endometriosis|treatment of endometriosis
5797417|NCT00115648|MTCT|mtct
5797418|NCT00115648|Infants|infants
5797419|NCT00115648|africa|africa
5797421|NCT00115635|Hormonal refractory, chemotherapy, docetaxel, gemcitabine|hormonal refractory, chemotherapy, docetaxel, gemcitabine
5797422|NCT00115622|GW685698X|gw685698x
5797423|NCT00115622|once daily|once daily
5797424|NCT00115622|mountain cedar|mountain cedar
5797425|NCT00115622|allergic rhinitis|allergic rhinitis
5797426|NCT00115622|fluticasone furoate|fluticasone furoate
5797427|NCT00115609|HIV infections|hiv infections
5797428|NCT00115609|tuberculosis|tuberculosis
5797429|NCT00115609|tuberculosis agents|tuberculosis agents
5797430|NCT00115609|Anti HIV agents|anti hiv agents
5797431|NCT00115609|Treatment Naive|treatment naive
5797432|NCT00115596|Procedure|procedure
5797433|NCT00115596|Training|training
5797434|NCT00115596|Simulation|simulation
5797435|NCT00115596|Pediatrics|pediatrics
5797436|NCT00115596|Curriculum|curriculum
5797437|NCT00115596|Evaluation|evaluation
5797438|NCT00115570|Diabetes,Insulin-Dependent, pediatric,rapid acting injection|diabetes,insulin-dependent, pediatric,rapid acting injection
5797439|NCT00115557|translational research|translational research
5797440|NCT00115557|prevention|prevention
5797441|NCT00115557|primary care|primary care
5797442|NCT00115557|practice-based research network|practice-based research network
5797443|NCT00115544|neonatal|neonatal
5797444|NCT00115544|jaundice|jaundice
5797445|NCT00115544|hyperbilirubinemia|hyperbilirubinemia
5797542|NCT00115193|Oncology|oncology
5797446|NCT00115531|Elderly, influenza, vaccine, parent protocol|elderly, influenza, vaccine, parent protocol
5797447|NCT00115505|stage IA breast cancer|stage ia breast cancer
5797448|NCT00115505|stage II breast cancer|stage ii breast cancer
5797449|NCT00115505|stage IB breast cancer|stage ib breast cancer
5797450|NCT00115505|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5797451|NCT00115505|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5797452|NCT00115505|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5797453|NCT00115505|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5797454|NCT00115492|Breathing|breathing
5797455|NCT00115492|Exacerbation|exacerbation
5797456|NCT00115492|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5797457|NCT00115479|critical illness|critical illness
5797458|NCT00115479|intensive care|intensive care
5797459|NCT00115479|outcome|outcome
5797460|NCT00115479|insulin|insulin
5797461|NCT00115479|blood glucose|blood glucose
5797462|NCT00115466|ASCs (adult stem cells derived from adipose tissue)|ascs (adult stem cells derived from adipose tissue)
5797463|NCT00115466|Fistula|fistula
5797464|NCT00115466|Cell Therapy|cell therapy
5797465|NCT00115466|Complex perianal fistula|complex perianal fistula
5797466|NCT00115453|glioblastoma|glioblastoma
5797467|NCT00115453|boron neutron capture therapy|boron neutron capture therapy
5797468|NCT00115453|boronophenylalanine|boronophenylalanine
5797469|NCT00115453|brain tumor|brain tumor
5797470|NCT00115440|glioblastoma|glioblastoma
5797471|NCT00115440|anaplastic astrocytoma|anaplastic astrocytoma
5797472|NCT00115440|boron neutron capture therapy|boron neutron capture therapy
5846716|NCT00043667|Uveitis|uveitis
5797473|NCT00115440|radiation therapy|radiation therapy
5797474|NCT00115440|boronophenylalanine|boronophenylalanine
5797475|NCT00115427|Bilateral, Idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
5797476|NCT00115414|Neulasta®|neulasta®
5797477|NCT00115414|Chemotherapy|chemotherapy
5797479|NCT00115414|Amgen|amgen
5797480|NCT00019500|breast cancer|breast cancer
5797481|NCT00115401|Walking|walking
5797482|NCT00115401|Compensation|compensation
5797483|NCT00115401|Leg Weakness|leg weakness
5797484|NCT00115401|Orthotics|orthotics
5797485|NCT00115401|Joint Impairment|joint impairment
5797486|NCT00115401|Healthy Volunteer|healthy volunteer
5797487|NCT00115401|HV|hv
5797488|NCT00115401|Joint Inmpairment|joint inmpairment
5797489|NCT00115388|Pelvic inflammatory disease|pelvic inflammatory disease
5797490|NCT00115388|Chlamydia trachomatis|chlamydia trachomatis
5796701|NCT00118027|Anaemia|anaemia
5797491|NCT00115388|Screening|screening
5797492|NCT00115375|THROMBOSIS|thrombosis
5797493|NCT00115375|PLATELET AGGREGATION|platelet aggregation
5797494|NCT00115375|Pediatrics|pediatrics
5797495|NCT00115362|functional dyspepsia;|functional dyspepsia;
5797496|NCT00115362|Serotonin Uptake Inhibitors;|serotonin uptake inhibitors;
5797497|NCT00115362|Antidepressive Agents.|antidepressive agents.
5797498|NCT00115336|Blood Diseases|blood diseases
5797499|NCT00115336|Sickle Cell Anemia|sickle cell anemia
5797500|NCT00115310|dermal assessment|dermal assessment
5797501|NCT00115310|pain measurement|pain measurement
5797502|NCT00115310|diary|diary
5797503|NCT00115310|PHN|phn
5797504|NCT00115310|shingles|shingles
5797505|NCT00115310|neuropathy|neuropathy
5797506|NCT00115310|analgesics|analgesics
5797507|NCT00115310|capsaicin|capsaicin
5797508|NCT00115310|postherpetic neuralgia|postherpetic neuralgia
5797509|NCT00115284|Asthma|asthma
5797510|NCT00115284|Education, Medical, Continuing|education, medical, continuing
5797511|NCT00115284|American Board of Internal Medicine|american board of internal medicine
5797512|NCT00115284|Recertification|recertification
5792568|NCT00133978|randomized trial|randomized trial
5797513|NCT00115284|Continuous Professional Development|continuous professional development
5797515|NCT00115271|Micronutrients|micronutrients
5797516|NCT00115271|Supplementation|supplementation
5797517|NCT00115271|Pregnancy|pregnancy
5797518|NCT00115271|Birth weight|birth weight
5797519|NCT00115271|Infant mortality|infant mortality
5797520|NCT00115258|Nutrition, Parenteral|nutrition, parenteral
5797521|NCT00115258|Body Composition|body composition
5797522|NCT00115258|Energy Expenditure|energy expenditure
5797523|NCT00115232|cardiovascular disease|cardiovascular disease
5797524|NCT00115232|metabolic syndrome|metabolic syndrome
5797525|NCT00115232|hypercholesterolemia|hypercholesterolemia
5797526|NCT00115232|child|child
5797527|NCT00115232|family history|family history
5797528|NCT00115232|inflammation|inflammation
5797529|NCT00115219|Rheumatoid Arthritis, RA|rheumatoid arthritis, ra
5797530|NCT00115219|Enbrel® (etanercept)|enbrel® (etanercept)
5797531|NCT00115219|Clinical Trials, Amgen|clinical trials, amgen
5797532|NCT00115219|Immunex, Methotrexate (MTX)|immunex, methotrexate (mtx)
5797533|NCT00115219|Rheumatoid Arthritis (RA)|rheumatoid arthritis (ra)
5797534|NCT00115206|Non Small Cell Lung Cancer|non small cell lung cancer
5797535|NCT00115206|NSCLC|nsclc
5797536|NCT00115206|Fever|fever
5797537|NCT00115206|Neutropenia|neutropenia
5797538|NCT00115206|Neulasta®|neulasta®
5797539|NCT00115206|Quality of Life|quality of life
5797540|NCT00115206|Chemotherapy|chemotherapy
5797541|NCT00115206|Amgen|amgen
5797544|NCT00115193|Mantle cell|mantle cell
5797545|NCT00115193|Diffuse large B-cell|diffuse large b-cell
5797546|NCT00115193|Chemotherapy|chemotherapy
5797547|NCT00115193|RCHOP|rchop
5797548|NCT00115193|Neulasta®|neulasta®
5797549|NCT00115193|Neutropenia|neutropenia
5797550|NCT00115193|Pegfilgrastim|pegfilgrastim
5797551|NCT00115193|Amgen|amgen
5797552|NCT00115180|analgesia|analgesia
5797553|NCT00115180|adult|adult
5797554|NCT00115180|opioid|opioid
5797555|NCT00115180|Long Bone Fractures|long bone fractures
5797556|NCT00115167|Oncology|oncology
5797557|NCT00115167|Cancer-related anemia|cancer-related anemia
5797558|NCT00115154|Actinic Keratosis|actinic keratosis
5797559|NCT00115154|AK|ak
5797560|NCT00115154|3M Pharmaceuticals|3m pharmaceuticals
5797561|NCT00115154|Aldara|aldara
5797562|NCT00115154|Imiquimod|imiquimod
5797563|NCT00115154|Actinic Keratosis (AK)|actinic keratosis (ak)
5797564|NCT00115141|Wart(s)|wart(s)
5797566|NCT00115141|Common Wart(s)|common wart(s)
5797567|NCT00115128|normal PBPC donors|normal pbpc donors
5797568|NCT00115115|Donor dopamine|donor dopamine
5797569|NCT00115115|Immediate graft function|immediate graft function
5797570|NCT00115115|Kidney transplantation|kidney transplantation
5797571|NCT00115102|Atypical odontalgia|atypical odontalgia
5797572|NCT00115102|capsaicin|capsaicin
5797573|NCT00115102|pain|pain
5797574|NCT00115102|neuropathic pain|neuropathic pain
5797575|NCT00115089|Allergic Rhinitis|allergic rhinitis
5797576|NCT00115089|Nasal Spray|nasal spray
5797577|NCT00115089|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5797578|NCT00115076|skin|skin
5797579|NCT00115076|psoriasis|psoriasis
5797580|NCT00115063|obesity|obesity
5797581|NCT00115063|Low Calorie Diet|low calorie diet
5797582|NCT00115063|Obesity Pharmacotherapy|obesity pharmacotherapy
5797583|NCT00115063|Pragmatic Clinical Trial|pragmatic clinical trial
5797584|NCT00115050|HIV infections|hiv infections
5797585|NCT00115050|Antiretroviral|antiretroviral
5797586|NCT00115050|TMC114|tmc114
5797587|NCT00115050|Ritonavir|ritonavir
5797588|NCT00115050|Safety, TMC114-C209|safety, tmc114-c209
5797589|NCT00115037|Alcoholism|alcoholism
5797590|NCT00115037|alcohol abuse|alcohol abuse
5797591|NCT00115037|therapy|therapy
5797592|NCT00115037|drug resistance|drug resistance
5797593|NCT00115037|naltrexone|naltrexone
5797594|NCT00115037|patient care management|patient care management
5797595|NCT00115037|human subject|human subject
5797596|NCT00115024|cardiovascular disease|cardiovascular disease
5797597|NCT00115024|CVD|cvd
5797598|NCT00115024|estrogen|estrogen
5797599|NCT00115024|cholesterol|cholesterol
5797600|NCT00115024|LDL|ldl
5797601|NCT00115024|lipids|lipids
5797602|NCT00115024|postmenopausal|postmenopausal
5797603|NCT00115011|Skin Picking|skin picking
5797604|NCT00115011|Escitalopram|escitalopram
5797605|NCT00115011|Lexapro|lexapro
5797606|NCT00115011|Body Focused Repetitive Behaviors|body focused repetitive behaviors
5797607|NCT00115011|Obsessive Compulsive Spectrum Disorders|obsessive compulsive spectrum disorders
5797608|NCT00114985|Total Androgen Suppression|total androgen suppression
5797609|NCT00114985|Simulation|simulation
5797610|NCT00114985|3-D Conformal External Beam Radiation Therapy|3-d conformal external beam radiation therapy
5797611|NCT00114985|Intra-rectal immobilization device|intra-rectal immobilization device
5797612|NCT00114985|Quality of Life Assessment Questionnaire|quality of life assessment questionnaire
5797613|NCT00114985|Rectal Bleeding|rectal bleeding
5797614|NCT00114985|Late effects|late effects
5797615|NCT00114972|Three-vessel coronary artery disease|three-vessel coronary artery disease
5797616|NCT00114972|Left main coronary artery disease|left main coronary artery disease
5797618|NCT00114959|ChemGenex Pharmaceuticals|chemgenex pharmaceuticals
5797619|NCT00114959|ChemGenex|chemgenex
5797620|NCT00114959|Chronic Myeloid Leukemia|chronic myeloid leukemia
5797621|NCT00114959|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
5797622|NCT00114959|Leukemia|leukemia
5797623|NCT00114959|Myeloid Leukemia|myeloid leukemia
5797624|NCT00114959|Chronic Phase|chronic phase
5797625|NCT00114959|Accelerated Phase|accelerated phase
5797626|NCT00114959|Blast Phase|blast phase
5797627|NCT00114959|Myeloid, Leukemia, Chronic, Accelerated Phase|myeloid, leukemia, chronic, accelerated phase
5797628|NCT00114959|Myeloid, Leukemia, Chronic|myeloid, leukemia, chronic
5797629|NCT00114959|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5797630|NCT00114959|Leukemia, Myeloid, Chronic-Phase|leukemia, myeloid, chronic-phase
5797631|NCT00114959|Leukemia, Myeloid, Chronic Phase|leukemia, myeloid, chronic phase
5807325|NCT00088387|T181|t181
5797632|NCT00114959|Leukemia, Myeloid, Accelerated-Phase|leukemia, myeloid, accelerated-phase
5797633|NCT00114959|Myeloid, Leukemia, Chronic, Chronic Phase|myeloid, leukemia, chronic, chronic phase
5797634|NCT00114959|Leukemia, Myeloid, Accelerated Phase|leukemia, myeloid, accelerated phase
5797635|NCT00114959|Homoharringtonine|homoharringtonine
5797636|NCT00114959|Omacetaxine|omacetaxine
5797637|NCT00114946|Metastatic Colorectal Cancer OASIS|metastatic colorectal cancer oasis
5797639|NCT00114933|AIDS|aids
5797640|NCT00114933|Treatment Experienced|treatment experienced
5797641|NCT00114920|Wart(s)|wart(s)
5797642|NCT00114920|Adults|adults
5797645|NCT00114907|Oxidative stress markers|oxidative stress markers
5797646|NCT00114907|cardiovascular disease|cardiovascular disease
5797647|NCT00114907|polyphenolics|polyphenolics
5797648|NCT00114907|double blind|double blind
5797649|NCT00114907|Ischaemic cardiac disease|ischaemic cardiac disease
5797650|NCT00114894|Jellyfish|jellyfish
5797651|NCT00114894|Stings|stings
5797652|NCT00114894|Marine|marine
5797653|NCT00114894|Envenomation|envenomation
5797654|NCT00114894|Jellyfish stings|jellyfish stings
5797655|NCT00114881|Children|children
5797656|NCT00114881|Urban Health|urban health
5797657|NCT00114881|Pregnancy|pregnancy
5797658|NCT00114881|Asthma|asthma
5797659|NCT00114868|vitamin A|vitamin a
5797660|NCT00114868|mortality|mortality
5797661|NCT00114868|newborn|newborn
5797662|NCT00114868|liveborn infants|liveborn infants
5797663|NCT00114855|Hypocol|hypocol
5797664|NCT00114855|Red yeast rice|red yeast rice
5798231|NCT00113152|Diastolic Dysfunction|diastolic dysfunction
5797665|NCT00114855|Patients with mild Type IIa, Type IIb or IV hyperlipidaemia (LDL-cholesterol >3.0 mmol/L< 6.0 mmol/L.|patients with mild type iia, type iib or iv hyperlipidaemia (ldl-cholesterol >3.0 mmol/l< 6.0 mmol/l.
5797666|NCT00114855|Mildly elevated blood glucose|mildly elevated blood glucose
5797667|NCT00114842|colorectal polyps|colorectal polyps
5797668|NCT00114842|colorectal cancer|colorectal cancer
5797669|NCT00114842|Virtual colonoscopy|virtual colonoscopy
5797670|NCT00114842|Fecal tagging|fecal tagging
5797671|NCT00114842|MR colonography|mr colonography
5797672|NCT00114829|Colorectal cancer|colorectal cancer
5797673|NCT00114829|Colorectal tumor|colorectal tumor
5797674|NCT00114829|Dynamic contrast uptake|dynamic contrast uptake
5797675|NCT00114829|MR colonography|mr colonography
5846717|NCT00043667|Daclizumab|daclizumab
5811719|NCT00002567|bone marrow ablation|bone marrow ablation
5797676|NCT00114816|breast cancer|breast cancer
5797677|NCT00114816|chemotherapy|chemotherapy
5797678|NCT00114816|adjuvant|adjuvant
5797679|NCT00114816|capecitabine|capecitabine
5797680|NCT00114816|docetaxel|docetaxel
5797681|NCT00114803|bone mineral density|bone mineral density
5797682|NCT00114803|osteoporosis|osteoporosis
5797683|NCT00114803|osteopenia|osteopenia
5797684|NCT00114803|children|children
5797685|NCT00114803|adolescents|adolescents
5797686|NCT00114803|DXA|dxa
5797687|NCT00114790|head and neck cancer|head and neck cancer
5797688|NCT00114790|boron neutron capture therapy|boron neutron capture therapy
5797689|NCT00114790|radiation therapy|radiation therapy
5797690|NCT00114790|boronophenylalanine|boronophenylalanine
5797691|NCT00114764|Acute myeloid leukaemia|acute myeloid leukaemia
5797692|NCT00114764|Pegfilgrastim|pegfilgrastim
5797693|NCT00114764|Neulasta®|neulasta®
5797694|NCT00114764|Neutropenia|neutropenia
5797695|NCT00114764|Induction chemotherapy|induction chemotherapy
5797696|NCT00114764|Consolidation|consolidation
5797697|NCT00114738|Proteasome Inhibition|proteasome inhibition
5797698|NCT00114738|NF-Kappa-B|nf-kappa-b
5797699|NCT00114738|Gene Expression Signature|gene expression signature
5797700|NCT00114738|Cyclin D1|cyclin d1
5797701|NCT00114738|Translational Studies|translational studies
5797702|NCT00114738|Lymphoma|lymphoma
5797703|NCT00114738|Mantle Cell Lymphoma|mantle cell lymphoma
5797704|NCT00114738|MCL|mcl
5797705|NCT00114725|In Vitro Fertilization|in vitro fertilization
5797706|NCT00114725|Intracytoplasmic Sperm Injection|intracytoplasmic sperm injection
5797707|NCT00114725|Oocytes|oocytes
5797708|NCT00114725|Zona Pellucida|zona pellucida
5797709|NCT00114725|Oolemma|oolemma
5797710|NCT00114725|Fertilization|fertilization
5792738|NCT00133159|Allergy|allergy
5797711|NCT00114725|Preimplantation Embryo Development|preimplantation embryo development
5797712|NCT00114712|Birth Defects|birth defects
5797713|NCT00114712|Pregnancy|pregnancy
5797714|NCT00114712|Ribavirin|ribavirin
5797715|NCT00114712|Hepatitis C|hepatitis c
5797717|NCT00114699|Treatment Naive|treatment naive
5797718|NCT00114686|Bipolar I Disorder|bipolar i disorder
5797719|NCT00114686|Alcohol Dependency|alcohol dependency
5797720|NCT00114673|Uneven skin color|uneven skin color
5797721|NCT00114673|Wrinkles|wrinkles
5797722|NCT00114673|Wrinkles and uneven skin color in the area around the eyes|wrinkles and uneven skin color in the area around the eyes
5797723|NCT00114660|striae gravidarum|striae gravidarum
5797724|NCT00114660|stretch marks|stretch marks
5797725|NCT00114660|cocoa butter|cocoa butter
5797726|NCT00114660|prevention|prevention
5797729|NCT00114634|SLOS|slos
5797730|NCT00114634|RSH syndrome|rsh syndrome
5681230|NCT00574249|Severe Chronic Plaque Psoriasis|severe chronic plaque psoriasis
5681231|NCT00574210|Seasonal Allergic Rhinitis (SAR)|seasonal allergic rhinitis (sar)
5681232|NCT00574210|Environmental Exposure Chamber (EEC)|environmental exposure chamber (eec)
5681233|NCT00574210|Therapeutic Uses|therapeutic uses
5797731|NCT00114634|ABC Checklist|abc checklist
5797732|NCT00114634|Cholesterol supplementation|cholesterol supplementation
5797733|NCT00114634|Egg yolk|egg yolk
5797734|NCT00114634|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5797735|NCT00114621|PA|pa
5797736|NCT00114621|Phase I|phase i
5797737|NCT00114621|Phase 2|phase 2
5797738|NCT00114621|Safety|safety
5797739|NCT00114621|Immunogenicity|immunogenicity
5797740|NCT00114608|Electrical foot stimulation|electrical foot stimulation
5797741|NCT00114608|Intermittent pneumatic compression|intermittent pneumatic compression
5797742|NCT00114608|Venous thromboembolism|venous thromboembolism
5797743|NCT00114608|Immobilization|immobilization
5798015|NCT00113815|Epilepsy|epilepsy
5797744|NCT00114608|Total hip replacement|total hip replacement
5797745|NCT00114608|Prolonged travel|prolonged travel
5797746|NCT00114608|Venous thromboembolic disease (VTE)|venous thromboembolic disease (vte)
5797747|NCT00114608|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5797748|NCT00114608|Pulmonary embolism (PE)|pulmonary embolism (pe)
5797749|NCT00114595|eicosapentaenoic acid|eicosapentaenoic acid
5797750|NCT00114595|tardive dyskinesia|tardive dyskinesia
5797751|NCT00114595|omega-3|omega-3
5797752|NCT00114595|schizophrenia|schizophrenia
5797753|NCT00114582|family style dinner|family style dinner
5797754|NCT00114582|quality of life|quality of life
5797755|NCT00114582|nutritional status|nutritional status
5797756|NCT00114582|nursing home residents|nursing home residents
5797757|NCT00114569|children|children
5797758|NCT00114569|status epilepticus|status epilepticus
5797759|NCT00114569|lorazepam|lorazepam
5797760|NCT00114569|safety|safety
5797761|NCT00114569|pharmacokinetics|pharmacokinetics
5797762|NCT00114569|status epilepticus in children|status epilepticus in children
5797763|NCT00114556|osteoporosis|osteoporosis
5797764|NCT00114556|liver transplantation|liver transplantation
5797765|NCT00114543|NICHD Neonatal Research Network|nichd neonatal research network
5797766|NCT00114543|Bilirubin|bilirubin
5797767|NCT00114543|Phototherapy|phototherapy
5797768|NCT00114543|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5797769|NCT00114543|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5797770|NCT00114543|Prematurity|prematurity
5797771|NCT00114543|Neurodevelopmental outcome|neurodevelopmental outcome
5797772|NCT00114530|systemic sclerosis|systemic sclerosis
5797773|NCT00114530|hematopoietic stem cell transplant|hematopoietic stem cell transplant
5811768|NCT00083356|Pain|pain
5797774|NCT00114530|clinical trial|clinical trial
5797775|NCT00114530|global rank composite score|global rank composite score
5797776|NCT00114517|atherosclerosis|atherosclerosis
5797778|NCT00114517|cardiac computed tomography|cardiac computed tomography
5797779|NCT00114517|cardiovascular disease|cardiovascular disease
5797780|NCT00114517|carotid artery intima-media thickness|carotid artery intima-media thickness
5797781|NCT00114517|cognitive function|cognitive function
5797782|NCT00114517|computed tomography|computed tomography
5797783|NCT00114517|coronary artery calcium|coronary artery calcium
5797784|NCT00114517|coronary artery disease|coronary artery disease
5796933|NCT00117299|PDGFR|pdgfr
5797785|NCT00114517|coronary artery lesions|coronary artery lesions
5797787|NCT00114517|estrogen|estrogen
5797788|NCT00114517|estrogen therapy|estrogen therapy
5797790|NCT00114517|postmenopausal|postmenopausal
5797791|NCT00114517|subclinical vascular disease|subclinical vascular disease
5797792|NCT00114517|timing hypothesis|timing hypothesis
5797793|NCT00114517|ultrasonography|ultrasonography
5797794|NCT00114504|atherosclerosis|atherosclerosis
5797795|NCT00114504|inflammation|inflammation
5797796|NCT00114504|statins|statins
5797797|NCT00114504|PET|pet
5797798|NCT00114504|carotid ultrasonography|carotid ultrasonography
5797799|NCT00114491|Aortic Stenosis|aortic stenosis
5797800|NCT00114491|Statins|statins
5797801|NCT00114491|Hypercholesterolemia|hypercholesterolemia
5797802|NCT00114478|Bronchiolitis|bronchiolitis
5797803|NCT00114478|disposition|disposition
5797804|NCT00114478|pediatric|pediatric
5797805|NCT00114478|epinephrine|epinephrine
5792848|NCT00132548|Malaria|malaria
5797807|NCT00114465|Randomized|randomized
5797808|NCT00114465|Double-Blind|double-blind
5797809|NCT00114465|Probiotic|probiotic
5797810|NCT00114465|Remission|remission
5797811|NCT00114465|Crohn's Disease|crohn's disease
5797812|NCT00114452|Acute Myocardial Infarction|acute myocardial infarction
5797813|NCT00114452|Heart Attack|heart attack
5797814|NCT00114452|Cardiovascular Disease|cardiovascular disease
5797815|NCT00114452|Stem cells|stem cells
5797816|NCT00114452|Congestive Heart Failure|congestive heart failure
5797817|NCT00114452|Heart Attack Repair|heart attack repair
5797818|NCT00114439|cannabis withdrawal|cannabis withdrawal
5797819|NCT00114439|lithium|lithium
5797820|NCT00114439|Cannabis withdrawal syndrome|cannabis withdrawal syndrome
5797821|NCT00114426|randomized controlled trial; COPD|randomized controlled trial; copd
5797822|NCT00114413|Exhaled Nitric Oxide|exhaled nitric oxide
5797824|NCT00114413|Urban Health|urban health
5797825|NCT00114413|Child|child
5797826|NCT00114413|Adolescent|adolescent
5797827|NCT00114400|cardiovascular disease|cardiovascular disease
5797828|NCT00114400|CVD|cvd
5797829|NCT00114387|vitamin E|vitamin e
5797830|NCT00114374|Acute Stress Disorder|acute stress disorder
5797831|NCT00114374|Posttraumatic Stress Disorder|posttraumatic stress disorder
5797832|NCT00114374|Escitalopram|escitalopram
5797833|NCT00114374|Double-Blind|double-blind
5797834|NCT00114361|HBeAg-negative|hbeag-negative
5797835|NCT00114361|chronic|chronic
5797836|NCT00114361|hepatitis B|hepatitis b
5797837|NCT00114361|viral|viral
5797838|NCT00114348|non-B ALL|non-b all
5797839|NCT00114348|relapse|relapse
5797840|NCT00114348|treatment|treatment
5797841|NCT00114348|Relapsed non-B ALL or non-B non-Hodgkin lymphoma|relapsed non-b all or non-b non-hodgkin lymphoma
5797842|NCT00114335|low molecular weight heparin|low molecular weight heparin
5797843|NCT00114335|unfractionated heparin|unfractionated heparin
5797844|NCT00114309|High grade recurrent glioma|high grade recurrent glioma
5797845|NCT00114309|Phase II|phase ii
5797846|NCT00114309|Multi-Center|multi-center
5797847|NCT00114309|Open label|open label
5797848|NCT00114309|Multiple dose|multiple dose
5797849|NCT00114309|Brain Cancer|brain cancer
5797850|NCT00114309|Brain Tumor|brain tumor
5797851|NCT00114309|GBM|gbm
5797852|NCT00114309|glioma|glioma
5797853|NCT00114296|breast cancer|breast cancer
5797854|NCT00114270|breast cancer|breast cancer
5797855|NCT00114270|osteoporosis|osteoporosis
5797856|NCT00114257|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5797857|NCT00114257|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5797858|NCT00114257|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5797859|NCT00114257|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5797860|NCT00114257|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5797861|NCT00114257|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5797862|NCT00114257|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5797863|NCT00114257|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5797864|NCT00114257|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5797865|NCT00114257|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5797866|NCT00114257|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5797867|NCT00114257|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5797868|NCT00114257|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5797869|NCT00114257|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5797870|NCT00114257|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5797871|NCT00114257|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5797872|NCT00114257|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5797873|NCT00114257|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5797874|NCT00114257|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5797875|NCT00114257|primary myelofibrosis|primary myelofibrosis
5797876|NCT00114257|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5797877|NCT00114257|essential thrombocythemia|essential thrombocythemia
5797878|NCT00114257|polycythemia vera|polycythemia vera
5797879|NCT00114257|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5797880|NCT00114257|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5797881|NCT00114257|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5797882|NCT00114257|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5797883|NCT00114257|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5797884|NCT00114257|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5797885|NCT00114257|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5797886|NCT00114257|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5797887|NCT00114257|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5797888|NCT00114257|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5797889|NCT00114257|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5797890|NCT00114257|adult acute basophilic leukemia|adult acute basophilic leukemia
5797891|NCT00114257|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5797892|NCT00114231|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5797893|NCT00114231|stage I rectal cancer|stage i rectal cancer
5797894|NCT00114205|malignant pleural effusion|malignant pleural effusion
5797895|NCT00114192|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5797896|NCT00114192|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5797897|NCT00114192|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5797898|NCT00114192|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5797899|NCT00114166|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5797900|NCT00114166|fallopian tube cancer|fallopian tube cancer
5798144|NCT00113360|Everolimus|everolimus
5797901|NCT00114166|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5797902|NCT00114153|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5797903|NCT00114153|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5797904|NCT00114153|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5797905|NCT00114153|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5797906|NCT00114153|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5797907|NCT00114153|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5797908|NCT00114140|adult diffuse astrocytoma|adult diffuse astrocytoma
5797909|NCT00114140|adult oligodendroglioma|adult oligodendroglioma
5797910|NCT00114140|adult mixed glioma|adult mixed glioma
5797911|NCT00114127|social anxiety disorder|social anxiety disorder
5797912|NCT00114127|social phobia|social phobia
5797913|NCT00114127|duloxetine|duloxetine
5797914|NCT00114127|serotonin norepinephrine reuptake inhibitor|serotonin norepinephrine reuptake inhibitor
5797916|NCT00114127|double blind|double blind
5797917|NCT00114114|Testosterone|testosterone
5797918|NCT00114114|Bone turnover|bone turnover
5797919|NCT00114114|Aging|aging
5797920|NCT00114114|Body composition|body composition
5797921|NCT00114114|Hypogonadism|hypogonadism
5797922|NCT00114114|Sexual function|sexual function
5797923|NCT00114088|Hysterectomy,|hysterectomy,
5797924|NCT00114088|Endometrial ablation,|endometrial ablation,
5797925|NCT00114088|Ovulatory dysfunctional uterine bleeding,|ovulatory dysfunctional uterine bleeding,
5797926|NCT00114088|Anovulatory dysfucntional uterine bleeding,|anovulatory dysfucntional uterine bleeding,
5797928|NCT00114088|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5797929|NCT00114075|gait|gait
5797930|NCT00114075|walking|walking
5797931|NCT00114075|orthopedic surgery|orthopedic surgery
5797932|NCT00114075|orthopaedic surgery|orthopaedic surgery
5797933|NCT00114062|uveitis|uveitis
5797934|NCT00114062|macular edema|macular edema
5798458|NCT00112242|Melanoma|melanoma
5797935|NCT00114062|uveitis associated macular edema|uveitis associated macular edema
5797936|NCT00114049|Dental Pain|dental pain
5797937|NCT00114049|Dental Surgery|dental surgery
5797938|NCT00114049|Cox-2 inhibitor|cox-2 inhibitor
5797939|NCT00114036|Antibiotic prophylaxis|antibiotic prophylaxis
5797940|NCT00114036|Surgical wound infections|surgical wound infections
5797942|NCT00114023|Imiquimod 5% cream|imiquimod 5% cream
5797943|NCT00114023|3M Pharmaceuticals|3m pharmaceuticals
5797944|NCT00114023|Aldara|aldara
5797945|NCT00114023|Actinic Keratosis|actinic keratosis
5797946|NCT00114010|B Cells|b cells
5797947|NCT00114010|T Cells|t cells
5797948|NCT00114010|Erythrocyte Stage|erythrocyte stage
5797949|NCT00114010|Antibody|antibody
5797950|NCT00114010|Immunogenicity|immunogenicity
5797951|NCT00114010|Healthy Volunteer|healthy volunteer
5797952|NCT00113997|Anticoagulant|anticoagulant
5797953|NCT00113997|Antidote|antidote
5797954|NCT00113997|Pharmacokinetics|pharmacokinetics
5797955|NCT00113997|Pharmacodynamics|pharmacodynamics
5797956|NCT00113997|Healthy Volunteer|healthy volunteer
5797957|NCT00113997|HV|hv
5797958|NCT00113984|Monoclonal Antibody|monoclonal antibody
5797960|NCT00113984|Cytokines|cytokines
5797961|NCT00113984|Immunotherapy|immunotherapy
5797962|NCT00113984|Elispot Assay|elispot assay
5797963|NCT00113984|Prostate Cancer|prostate cancer
5797964|NCT00113984|Metastatic Prostate Cancer|metastatic prostate cancer
5797965|NCT00113971|study of epratuzumab in systemic lupus erythematosus|study of epratuzumab in systemic lupus erythematosus
5797966|NCT00113971|systemic lupus erythematosus|systemic lupus erythematosus
5797967|NCT00113971|SLE|sle
5797968|NCT00113958|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5797969|NCT00113958|secondary hyperparathyroidism (SHPT)|secondary hyperparathyroidism (shpt)
5797970|NCT00113958|hemodialysis|hemodialysis
5797971|NCT00113958|biPTH|bipth
5797972|NCT00113958|AMG 073, Amgen|amg 073, amgen
5797973|NCT00113945|End Stage Renal Disease (ESRD)|end stage renal disease (esrd)
5797974|NCT00113945|secondary hyperparathyroidism|secondary hyperparathyroidism
5797975|NCT00113945|hemodialysis, biPTH|hemodialysis, bipth
5797976|NCT00113945|AMG 073, Amgen|amg 073, amgen
5797978|NCT00113919|Myeloma, MM|myeloma, mm
5797979|NCT00113906|melatonin,|melatonin,
5797980|NCT00113906|fatigue,|fatigue,
5797981|NCT00113906|sleep quality,|sleep quality,
5797982|NCT00113906|circadian,|circadian,
5797983|NCT00113906|postoperative|postoperative
5797984|NCT00113906|Postoperative fatigue|postoperative fatigue
5797985|NCT00113906|postoperative sleep disturbance|postoperative sleep disturbance
5797986|NCT00113906|general wellbeing|general wellbeing
5797987|NCT00113893|Myelodysplastic syndromes|myelodysplastic syndromes
5797988|NCT00113893|p38 MAP kinase|p38 map kinase
5797989|NCT00113893|Bone marrow diseases|bone marrow diseases
5797990|NCT00113893|SCIO-469|scio-469
5797991|NCT00113867|IVF|ivf
5797992|NCT00113867|in vitro fertilization|in vitro fertilization
5797993|NCT00113867|hormones|hormones
5797994|NCT00113867|stress|stress
5797995|NCT00113867|memory|memory
5797996|NCT00113867|Cognitive Function|cognitive function
5797997|NCT00113867|adoption|adoption
5797998|NCT00113854|cerebral|cerebral
5797999|NCT00113854|malaria|malaria
5798000|NCT00113854|children|children
5798001|NCT00113854|mannitol|mannitol
5798002|NCT00113854|adjunct|adjunct
5798003|NCT00113854|therapy|therapy
5798004|NCT00113854|Uganda|uganda
5798005|NCT00113841|Multiple Myeloma|multiple myeloma
5798006|NCT00113841|Diferuloylmethane Derivative|diferuloylmethane derivative
5798007|NCT00113841|Curcumin|curcumin
5798008|NCT00113841|Bioperine|bioperine
5798009|NCT00113828|Non-Myeloablative|non-myeloablative
5798010|NCT00113828|Stem Cell Transplantation|stem cell transplantation
5798011|NCT00113828|T-cell Depletion|t-cell depletion
5798012|NCT00113828|HLA-Matched|hla-matched
5798013|NCT00113815|Partial seizure disorder|partial seizure disorder
5798014|NCT00113815|Topiramate|topiramate
5798016|NCT00113815|Infants|infants
5798017|NCT00113802|Epratuzumab (hLL2- anti-CD22 humanized antibody)|epratuzumab (hll2- anti-cd22 humanized antibody)
5798018|NCT00113802|Waldenstrom's Macroglobulinemia|waldenstrom's macroglobulinemia
5798019|NCT00113802|Waldenstrom Macroglobulinemia|waldenstrom macroglobulinemia
5798020|NCT00113802|Hematologic Disease|hematologic disease
5798021|NCT00113802|Hematologic Diseases|hematologic diseases
5798022|NCT00113802|Paraproteinemias|paraproteinemias
5798023|NCT00113802|Vascular Hemostatic Disorders|vascular hemostatic disorders
5798024|NCT00113802|Lymphoproliferative Disorders|lymphoproliferative disorders
5798025|NCT00113789|ovarian cancer|ovarian cancer
5798026|NCT00113789|topotecan|topotecan
5798027|NCT00113789|neutropenia|neutropenia
5798028|NCT00113789|Neulasta®|neulasta®
5798029|NCT00113776|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
5798030|NCT00113776|Colorectal, Rectal Cancer, EGFr|colorectal, rectal cancer, egfr
5798031|NCT00113776|Metastatic, Cancer, ABX-EGF|metastatic, cancer, abx-egf
5798032|NCT00113776|Panitumumab, Clinical Trial|panitumumab, clinical trial
5798033|NCT00113776|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5798034|NCT00113763|Metastatic Colorectal Cancer, Colon|metastatic colorectal cancer, colon
5798035|NCT00113763|Colorectal, Rectal Cancer, Cancer|colorectal, rectal cancer, cancer
5798036|NCT00113763|Metastatic, EGFr, Clinical Trial|metastatic, egfr, clinical trial
5798037|NCT00113763|Panitumumab, ABX-EGF|panitumumab, abx-egf
5798038|NCT00113763|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5798040|NCT00113750|Allergoid|allergoid
5798041|NCT00113750|Specific Immunotherapy|specific immunotherapy
5798043|NCT00113724|multi-drug resistance|multi-drug resistance
5798044|NCT00113724|mutant tubulin binding|mutant tubulin binding
5798045|NCT00113724|Advanced malignancies|advanced malignancies
5798046|NCT00113724|Hodgkin's or Non-Hodgkin's Lymphoma|hodgkin's or non-hodgkin's lymphoma
5798047|NCT00113659|Asthma|asthma
5798048|NCT00113659|Probiotics|probiotics
5798049|NCT00113659|Prevention|prevention
5798050|NCT00113659|Eczema|eczema
5798051|NCT00113646|Non-Myeloablative|non-myeloablative
5798052|NCT00113646|T-cell Depleted|t-cell depleted
5798053|NCT00113646|Mismatched|mismatched
5798054|NCT00113646|Stem Cell Transplantation|stem cell transplantation
5798055|NCT00113633|Asthma|asthma
5798056|NCT00113633|Emergency|emergency
5798057|NCT00113633|Primary Care|primary care
5798058|NCT00113633|Children|children
5798059|NCT00113620|distal symmetrical|distal symmetrical
5798061|NCT00113620|lower extremities|lower extremities
5798062|NCT00113620|dextromethorphan|dextromethorphan
5798063|NCT00113607|Ovarian cancer|ovarian cancer
5798064|NCT00113607|Trabectedin|trabectedin
5798065|NCT00113607|Yondelis|yondelis
5798066|NCT00113607|Advanced Relapsed Ovarian Cancer|advanced relapsed ovarian cancer
5798067|NCT00113607|DOXIL|doxil
5798068|NCT00113607|CAELYX|caelyx
5798069|NCT00113581|EMD 72000|emd 72000
5798070|NCT00113581|matuzumab|matuzumab
5798071|NCT00113581|Esophageal adenocarcinoma|esophageal adenocarcinoma
5798072|NCT00113581|Gastric adenocarcinoma|gastric adenocarcinoma
5798073|NCT00113568|Menorrhagia|menorrhagia
5798074|NCT00113568|Heavy Menstrual Bleeding|heavy menstrual bleeding
5798075|NCT00113555|urinary incontinence|urinary incontinence
5798076|NCT00113542|Psoriasis|psoriasis
5798077|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate
5798078|NCT00113516|Lung Neoplasms|lung neoplasms
5798079|NCT00113503|Inflammatory Bowel Disease, Crohn's disease, Crohn's Colitis|inflammatory bowel disease, crohn's disease, crohn's colitis
5798080|NCT00113490|motavizumab, palivizumab, synagis|motavizumab, palivizumab, synagis
5798081|NCT00113490|Rezield, MEDI-524|rezield, medi-524
5798083|NCT00113477|CoQ10|coq10
5798084|NCT00113477|Coenzyme Q10|coenzyme q10
5798085|NCT00113477|selen|selen
5798086|NCT00113477|selenoprotein|selenoprotein
5798087|NCT00113477|selenoproteins|selenoproteins
5798088|NCT00113477|adverse events|adverse events
5798089|NCT00113477|adverse effects|adverse effects
5798090|NCT00113477|AE|ae
5798091|NCT00113477|myalgia|myalgia
5798092|NCT00113477|muscle|muscle
5798093|NCT00113477|statin therapy|statin therapy
5798094|NCT00113477|Indication for statin therapy|indication for statin therapy
5798095|NCT00113464|SCID (Severe Combined Immunodeficiency)|scid (severe combined immunodeficiency)
5798096|NCT00113464|TREC (T cell Receptor Excision Circle)|trec (t cell receptor excision circle)
5798097|NCT00113464|Bone Marrow Transplant|bone marrow transplant
5798098|NCT00113464|Dried Blood Spots|dried blood spots
5798099|NCT00113464|Early Detection|early detection
5798100|NCT00113464|T Cell Immunodeficiency Diseases|t cell immunodeficiency diseases
5798101|NCT00113464|Immunodeficiency Diseases|immunodeficiency diseases
5798102|NCT00113464|Primary Immunodeficiency|primary immunodeficiency
5798103|NCT00113464|T Cell Immunodeficiency Disease|t cell immunodeficiency disease
5798104|NCT00113464|Severe Combined Immunodeficiency|severe combined immunodeficiency
5798105|NCT00113464|SCID|scid
5798106|NCT00113451|radial artery|radial artery
5798107|NCT00113451|angina pectoris|angina pectoris
5798108|NCT00113451|infarction|infarction
5798109|NCT00113451|bypass|bypass
5798110|NCT00113451|angiography|angiography
5798111|NCT00113438|cancer|cancer
5798112|NCT00113438|tumor|tumor
5798113|NCT00113438|imageable|imageable
5798114|NCT00113438|CA4P|ca4p
5798115|NCT00113438|Combretastatin|combretastatin
5798116|NCT00113438|Combretastatin A4 Phosphate|combretastatin a4 phosphate
5798117|NCT00113438|Combretastatin A-4 Phosphate|combretastatin a-4 phosphate
5798118|NCT00113438|Carboplatin|carboplatin
5798119|NCT00113438|Paclitaxel|paclitaxel
5798120|NCT00113438|carbo|carbo
5798121|NCT00113438|taxol|taxol
5798122|NCT00113425|non-ablative laser|non-ablative laser
5798123|NCT00113425|acne|acne
5798124|NCT00113425|photosensitizer|photosensitizer
5798125|NCT00113425|photodynamic therapy|photodynamic therapy
5798126|NCT00113412|HIV|hiv
5798127|NCT00113412|Treatment Experienced|treatment experienced
5798128|NCT00113399|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5798129|NCT00113399|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5798130|NCT00113399|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5798131|NCT00113399|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5798132|NCT00113399|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5798133|NCT00113399|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5798134|NCT00113386|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5798135|NCT00113386|adenocarcinoma of the lung|adenocarcinoma of the lung
5798136|NCT00113386|large cell lung cancer|large cell lung cancer
5798137|NCT00113386|squamous cell lung cancer|squamous cell lung cancer
5798138|NCT00113386|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5798139|NCT00113360|Neuroendocrine Carcinoma|neuroendocrine carcinoma
5798140|NCT00113360|Low Grade Neuroendocrine Carcinoma|low grade neuroendocrine carcinoma
5798141|NCT00113360|Neuroendocrine Carcinoid|neuroendocrine carcinoid
5798142|NCT00113360|Islet Cell Carcinoma|islet cell carcinoma
5798143|NCT00113360|RAD001|rad001
5798145|NCT00113360|Octreotide Depot|octreotide depot
5798146|NCT00113360|Sandostatin LAR|sandostatin lar
5798147|NCT00113360|Octreotide long-acting release (LAR)|octreotide long-acting release (lar)
5798148|NCT00113360|Octreotide LAR|octreotide lar
5798149|NCT00113347|Head and Neck Cancer|head and neck cancer
5798150|NCT00113347|Squamous Cell Carcinoma|squamous cell carcinoma
5798151|NCT00113347|Erlotinib|erlotinib
5798152|NCT00113347|Docetaxel|docetaxel
5798153|NCT00113347|Radiation|radiation
5798154|NCT00113347|Radiotherapy|radiotherapy
5798155|NCT00113347|Concomitant Boost Radiation|concomitant boost radiation
5798156|NCT00113334|Head and Neck Cancer|head and neck cancer
5798157|NCT00113334|Thrombospondin Analogue|thrombospondin analogue
5798159|NCT00113334|Antiangiogenic agent|antiangiogenic agent
5798160|NCT00113334|Lung|lung
5798161|NCT00113334|Skin|skin
5798162|NCT00113334|Thyroid|thyroid
5798163|NCT00113321|Myelodysplastic Syndrome|myelodysplastic syndrome
5798164|NCT00113321|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5798165|NCT00113321|Azacytidine Failure|azacytidine failure
5798166|NCT00113321|Decitabine|decitabine
5798167|NCT00113308|Rheumatoid Arthritis|rheumatoid arthritis
5798168|NCT00113308|COX-2 Inhibitor|cox-2 inhibitor
5798169|NCT00113295|generalized anxiety disorder|generalized anxiety disorder
5798170|NCT00113295|pharmacotherapy|pharmacotherapy
5798171|NCT00113295|treatment refractory|treatment refractory
5798172|NCT00113295|double-blind|double-blind
5798173|NCT00113282|Treatment failure|treatment failure
5798174|NCT00113282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5798175|NCT00113282|Interleukin-2|interleukin-2
5798176|NCT00113282|Treatment Experienced|treatment experienced
5798177|NCT00113269|Treatment Effectiveness|treatment effectiveness
5798178|NCT00113269|Treatment Efficacy|treatment efficacy
5798179|NCT00113269|Anti-rejection therapy|anti-rejection therapy
5798180|NCT00113269|Immunosuppression|immunosuppression
5798181|NCT00113269|Therapy, antirejection|therapy, antirejection
5798182|NCT00113269|Renal Transplantation|renal transplantation
5798183|NCT00113269|Transplantation, Kidney|transplantation, kidney
5798184|NCT00113269|Transplantation, Renal|transplantation, renal
5798185|NCT00113269|Grafting, Kidney|grafting, kidney
5798186|NCT00113256|rubitecan|rubitecan
5798187|NCT00113256|Orathecin|orathecin
5798188|NCT00113256|9-nitrocamptothecin|9-nitrocamptothecin
5798189|NCT00113256|gemcitabine|gemcitabine
5798190|NCT00113256|Gemzar|gemzar
5798191|NCT00113256|pancreatic cancer|pancreatic cancer
5798192|NCT00113256|adenocarcinoma|adenocarcinoma
5798193|NCT00113256|RFS 2000|rfs 2000
5798194|NCT00113230|Rectal Cancer|rectal cancer
5798195|NCT00113230|Bevacizumab|bevacizumab
5798196|NCT00113230|RHUMAB VEGF|rhumab vegf
5798197|NCT00113230|Avastin|avastin
5798198|NCT00113230|Capecitabine|capecitabine
5798199|NCT00113230|Neoadjuvant Concurrent Capecitabine|neoadjuvant concurrent capecitabine
5798200|NCT00113230|Xeloda|xeloda
5798201|NCT00113230|Radiation|radiation
5798202|NCT00113230|Radiotherapy|radiotherapy
5798203|NCT00113230|Radiation Therapy|radiation therapy
5798204|NCT00113230|XRT|xrt
5798205|NCT00113217|Renal Cell Carcinoma|renal cell carcinoma
5798206|NCT00113217|Kidney Cancer|kidney cancer
5798207|NCT00113217|Bevacizumab|bevacizumab
5798208|NCT00113217|Avastin|avastin
5798209|NCT00113217|RCC|rcc
5798210|NCT00113204|Multiple myeloma|multiple myeloma
5798211|NCT00113204|Relapsed|relapsed
5798212|NCT00113204|Relapsed refractory|relapsed refractory
5798213|NCT00113204|Hematologic cancer|hematologic cancer
5798214|NCT00113204|hematologic disease|hematologic disease
5798215|NCT00113204|plasma cells|plasma cells
5798216|NCT00113191|late onset sepsis|late onset sepsis
5798217|NCT00113191|premature infants|premature infants
5798218|NCT00113191|staphylococcus|staphylococcus
5798219|NCT00113191|candida|candida
5798220|NCT00113191|prevention|prevention
5798221|NCT00113178|atrial flutter|atrial flutter
5798222|NCT00113178|cryoablation|cryoablation
5798223|NCT00113165|partial seizures|partial seizures
5798224|NCT00113165|Epilepsy|epilepsy
5798225|NCT00113165|antiepileptic drugs|antiepileptic drugs
5798226|NCT00113165|anticonvulsants|anticonvulsants
5798227|NCT00113165|LAMICTAL|lamictal
5798228|NCT00113165|seizures|seizures
5798229|NCT00113165|lamotrigine|lamotrigine
5798230|NCT00113152|Cardiac Arrhythmias|cardiac arrhythmias
5798232|NCT00113152|Pulmonary Hypertension|pulmonary hypertension
5798233|NCT00113152|Sickle Cell Anemia|sickle cell anemia
5798234|NCT00113152|Sudden Death|sudden death
5798235|NCT00113152|Thalassemia|thalassemia
5798236|NCT00113126|Scheduled treatment interruptions|scheduled treatment interruptions
5798237|NCT00113126|STI|sti
5798238|NCT00113113|rubitecan|rubitecan
5798239|NCT00113113|Orathecin|orathecin
5798240|NCT00113113|9-nitrocamptothecin|9-nitrocamptothecin
5798241|NCT00113113|solid tumors|solid tumors
5798242|NCT00113113|organ dysfunction|organ dysfunction
5798243|NCT00113113|renal dysfunction|renal dysfunction
5798244|NCT00113113|hepatic dysfunction|hepatic dysfunction
5798245|NCT00113113|RFS 2000|rfs 2000
5798246|NCT00113100|skin|skin
5798247|NCT00113100|estrogen|estrogen
5798248|NCT00113100|sun damage|sun damage
5798249|NCT00113100|Photodamaged Skin|photodamaged skin
5798250|NCT00113061|Coronary Heart Disease Risk Reduction|coronary heart disease risk reduction
5798251|NCT00113048|CD52 Expressing Hematologic Malignancies|cd52 expressing hematologic malignancies
5798252|NCT00113035|Glycogen Storage Disease Type II|glycogen storage disease type ii
5798253|NCT00113035|GSD-II|gsd-ii
5798254|NCT00113035|Pompe Disease|pompe disease
5798255|NCT00113035|Pompe Disease (Late-Onset)|pompe disease (late-onset)
5798256|NCT00113035|Glycogen Storage Disease Type II (GSD-II)|glycogen storage disease type ii (gsd-ii)
5798257|NCT00113035|Acid Maltase Deficiency|acid maltase deficiency
5798258|NCT00113035|Glycogenosis 2|glycogenosis 2
5798259|NCT00113022|Depression|depression
5798260|NCT00113022|Glutamate|glutamate
5798261|NCT00113022|Ampakine|ampakine
5798262|NCT00113022|Treatment|treatment
5798263|NCT00113022|Memory|memory
5798264|NCT00113022|Major Depressive Disorder|major depressive disorder
5798265|NCT00113022|AMPA Receptor Activation|ampa receptor activation
5798266|NCT00113022|BDNF|bdnf
5798267|NCT00113009|Peripheral arterial disease|peripheral arterial disease
5798268|NCT00112996|neurotoxicity|neurotoxicity
5798269|NCT00112996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5798476|NCT00112216|SB AS-2 adjuvant|sb as-2 adjuvant
5798270|NCT00112996|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5798271|NCT00112983|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5798272|NCT00112983|adult acute myeloid leukemia|adult acute myeloid leukemia
5798273|NCT00112957|fallopian tube cancer|fallopian tube cancer
5798274|NCT00112957|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5798275|NCT00112957|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5798276|NCT00112957|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5798277|NCT00112957|peritoneal cavity cancer|peritoneal cavity cancer
5798278|NCT00112931|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5798279|NCT00112931|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5798280|NCT00112931|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5798281|NCT00112931|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5798282|NCT00112931|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5798283|NCT00112931|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5798284|NCT00112931|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5798285|NCT00112931|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5798286|NCT00112931|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5798287|NCT00112931|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5798288|NCT00112931|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5798289|NCT00112931|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5798290|NCT00112918|stage II colon cancer|stage ii colon cancer
5798291|NCT00112918|stage III colon cancer|stage iii colon cancer
5798292|NCT00112892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5798293|NCT00112775|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5798294|NCT00112775|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5798295|NCT00112775|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5798296|NCT00112749|stage I breast cancer|stage i breast cancer
5798297|NCT00112749|stage II breast cancer|stage ii breast cancer
5798298|NCT00112749|breast cancer in situ|breast cancer in situ
5798299|NCT00112749|fatigue|fatigue
5798300|NCT00112710|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5798301|NCT00112710|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5798302|NCT00112697|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5798303|NCT00112697|stage IV pancreatic cancer|stage iv pancreatic cancer
5798304|NCT00112658|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5798305|NCT00112658|stage IV pancreatic cancer|stage iv pancreatic cancer
5798306|NCT00112645|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5798307|NCT00112645|recurrent neuroblastoma|recurrent neuroblastoma
5798308|NCT00112645|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5798309|NCT00112645|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5798776|NCT00111124|etanercept|etanercept
5798310|NCT00112632|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5798311|NCT00112619|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5798312|NCT00112619|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5798313|NCT00112619|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5846718|NCT00043667|Inflammatory Eye DIsease|inflammatory eye disease
5798314|NCT00112619|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5798315|NCT00112619|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5798316|NCT00112619|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5798317|NCT00112619|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5798318|NCT00112619|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5798319|NCT00112619|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5798320|NCT00112619|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5798321|NCT00112619|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5798322|NCT00112619|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5798323|NCT00112619|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5798324|NCT00112619|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5798325|NCT00112619|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5798326|NCT00112619|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5798327|NCT00112619|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5798328|NCT00112619|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5798330|NCT00112619|childhood grade II meningioma|childhood grade ii meningioma
5798331|NCT00112619|childhood grade III meningioma|childhood grade iii meningioma
5798332|NCT00112619|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5798333|NCT00112619|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5798334|NCT00112619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5798335|NCT00112619|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5798336|NCT00112619|childhood choroid plexus tumor|childhood choroid plexus tumor
5798337|NCT00112619|childhood craniopharyngioma|childhood craniopharyngioma
5798338|NCT00112619|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5798339|NCT00112619|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5798340|NCT00112619|recurrent childhood ependymoma|recurrent childhood ependymoma
5798341|NCT00112619|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5798342|NCT00112619|childhood oligodendroglioma|childhood oligodendroglioma
5798343|NCT00112619|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5798344|NCT00112619|leptomeningeal metastases|leptomeningeal metastases
5798345|NCT00112619|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5798346|NCT00112619|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5798347|NCT00112619|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5798348|NCT00112619|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5798349|NCT00112619|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5798350|NCT00112619|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5798351|NCT00112619|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5798352|NCT00112619|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5798353|NCT00112619|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5798354|NCT00112619|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5798355|NCT00112619|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5798356|NCT00112619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5798357|NCT00112619|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5798358|NCT00112619|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5798360|NCT00112619|secondary central nervous system Hodgkin lymphoma|secondary central nervous system hodgkin lymphoma
5798361|NCT00112619|secondary central nervous system non-Hodgkin lymphoma|secondary central nervous system non-hodgkin lymphoma
5798362|NCT00112593|HIV|hiv
5798363|NCT00112593|Lymphoma|lymphoma
5798364|NCT00112593|Leukemia|leukemia
5798365|NCT00112580|recurrent pancreatic cancer|recurrent pancreatic cancer
5798366|NCT00112580|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5798367|NCT00112580|stage IV pancreatic cancer|stage iv pancreatic cancer
5798368|NCT00112567|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5798369|NCT00112567|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5798370|NCT00112567|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5798371|NCT00112567|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5798372|NCT00112567|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5798373|NCT00112567|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5798374|NCT00112567|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5798375|NCT00112567|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5798376|NCT00112567|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5846719|NCT00043654|Antidepressant|antidepressant
5798377|NCT00112567|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5798378|NCT00112567|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5798379|NCT00112567|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5798380|NCT00112567|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5798381|NCT00112554|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5798382|NCT00112554|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5798383|NCT00112554|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5798384|NCT00112554|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5798385|NCT00112554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5798386|NCT00112554|adult acute basophilic leukemia|adult acute basophilic leukemia
5798387|NCT00112554|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5686554|NCT00551564|T2DM,|t2dm,
5797638|NCT00114933|HIV|hiv
5798388|NCT00112554|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5798389|NCT00112554|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5798390|NCT00112554|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5798391|NCT00112554|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5798392|NCT00112554|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5798393|NCT00112554|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5798394|NCT00112554|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5798395|NCT00112554|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5798396|NCT00112554|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5798397|NCT00112528|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5798398|NCT00112528|recurrent pancreatic cancer|recurrent pancreatic cancer
5798399|NCT00112528|stage IV pancreatic cancer|stage iv pancreatic cancer
5798401|NCT00112515|cognitive/functional effects|cognitive/functional effects
5798403|NCT00112515|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5798404|NCT00112502|adult giant cell glioblastoma|adult giant cell glioblastoma
5798405|NCT00112502|adult gliosarcoma|adult gliosarcoma
5798406|NCT00112502|adult glioblastoma|adult glioblastoma
5798407|NCT00112489|recurrent uterine sarcoma|recurrent uterine sarcoma
5798408|NCT00112489|stage III uterine sarcoma|stage iii uterine sarcoma
5798409|NCT00112489|stage IV uterine sarcoma|stage iv uterine sarcoma
5798410|NCT00112489|uterine carcinosarcoma|uterine carcinosarcoma
5798411|NCT00112424|Superior cavo-pulmonary anastomosis|superior cavo-pulmonary anastomosis
5798412|NCT00112424|Glenn operation|glenn operation
5798413|NCT00112424|Congenital heart defects|congenital heart defects
5798414|NCT00112424|Cardiac magnetic resonance imaging|cardiac magnetic resonance imaging
5798415|NCT00112398|Head injuries|head injuries
5798416|NCT00112398|Prehospital|prehospital
5798417|NCT00112398|Advanced Interventions|advanced interventions
5798418|NCT00112385|dermatomyositis|dermatomyositis
5798419|NCT00112385|etanercept|etanercept
5798420|NCT00112385|tumor necrosis factor alpha|tumor necrosis factor alpha
5798421|NCT00112372|unresectable|unresectable
5798422|NCT00112372|metastatic|metastatic
5798423|NCT00112372|cancer|cancer
5798424|NCT00112372|recurrent|recurrent
5798425|NCT00112372|malignancies|malignancies
5798426|NCT00112372|progressive|progressive
5798427|NCT00112359|Cystic Fibrosis|cystic fibrosis
5798428|NCT00112359|Pseudomonas aeruginosa|pseudomonas aeruginosa
5798429|NCT00112359|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5798430|NCT00112346|Non-Small Lung Cancer|non-small lung cancer
5798431|NCT00112333|Dyspepsia, fMRI|dyspepsia, fmri
5798432|NCT00112320|Pulmonary Valve Regurgitation|pulmonary valve regurgitation
5798433|NCT00112320|Right Ventricular Dysfunction|right ventricular dysfunction
5798434|NCT00112320|Heart Diseases|heart diseases
5798435|NCT00112307|MRI|mri
5798436|NCT00112307|Brachytherapy|brachytherapy
5798437|NCT00112307|Carcinoma|carcinoma
5798438|NCT00112307|Cervix|cervix
5798439|NCT00112307|Uterus|uterus
5798440|NCT00112307|Vagina|vagina
5798441|NCT00112307|Vulva|vulva
5798442|NCT00112307|Carcinoma of the cervix|carcinoma of the cervix
5798443|NCT00112307|Carcinoma of the uterus|carcinoma of the uterus
5798444|NCT00112307|Carcinoma of the vagina|carcinoma of the vagina
5798445|NCT00112307|Carcinoma of the vulva|carcinoma of the vulva
5798446|NCT00112294|Non-Small Cell Lung Cancer|non-small cell lung cancer
5798447|NCT00112281|"shock, cardiogenic, myocardial infarction"|"shock, cardiogenic, myocardial infarction"
5798448|NCT00112268|randomized controlled trial|randomized controlled trial
5798449|NCT00112268|primary health care|primary health care
5798450|NCT00112268|smoking cessation|smoking cessation
5798451|NCT00112255|Chlamydia trachomatis|chlamydia trachomatis
5798452|NCT00112255|Chlamydia infections|chlamydia infections
5798453|NCT00112255|Randomized controlled trials|randomized controlled trials
5798454|NCT00112255|Contact tracing|contact tracing
5798455|NCT00112255|Family practice|family practice
5798456|NCT00112242|Immunotherapy|immunotherapy
5798457|NCT00112242|Vaccination|vaccination
5798459|NCT00112242|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5798460|NCT00112242|MAGE-A10 peptide|mage-a10 peptide
5798461|NCT00112242|NY-ESO-1 peptide|ny-eso-1 peptide
5798462|NCT00112242|Montanide|montanide
5798463|NCT00112229|Immunotherapy|immunotherapy
5798464|NCT00112229|Vaccination|vaccination
5798465|NCT00112229|Melanoma|melanoma
5798466|NCT00112229|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5798467|NCT00112229|Tyrosinase peptide|tyrosinase peptide
5798469|NCT00112229|Montanide|montanide
5798470|NCT00112216|Immunotherapy|immunotherapy
5798471|NCT00112216|Vaccination|vaccination
5798472|NCT00112216|Melanoma|melanoma
5798473|NCT00112216|Melan-A/Mart-1 peptide|melan-a/mart-1 peptide
5798474|NCT00112216|Flu peptide|flu peptide
5798475|NCT00112216|Mage-A10 peptide|mage-a10 peptide
5798477|NCT00112216|Montanide adjuvant|montanide adjuvant
5798478|NCT00112203|Abdominal Symptom Relief|abdominal symptom relief
5798479|NCT00112203|Fullness|fullness
5686555|NCT00551564|Healthy Obese,|healthy obese,
5686556|NCT00551564|Insulin Resistance,|insulin resistance,
5686557|NCT00551564|Rosiglitazone maleate,|rosiglitazone maleate,
5686558|NCT00551564|Glucose Disposal,|glucose disposal,
5686559|NCT00551564|hyperinsulinemic-euglycemic clamp,|hyperinsulinemic-euglycemic clamp,
5798480|NCT00112203|Bloating|bloating
5798481|NCT00112203|Indigestion|indigestion
5798482|NCT00112203|Functional dyspepsia|functional dyspepsia
5798483|NCT00112190|Functional dyspepsia|functional dyspepsia
5798484|NCT00112190|Abdominal Symptom relief|abdominal symptom relief
5798485|NCT00112190|Fullness|fullness
5798486|NCT00112190|Bloating|bloating
5798487|NCT00112190|Indigestion|indigestion
5798488|NCT00112177|Functional dyspepsia|functional dyspepsia
5798489|NCT00112177|Abdominal Symptom relief|abdominal symptom relief
5798490|NCT00112177|Fullness|fullness
5798491|NCT00112177|Bloating|bloating
5798492|NCT00112177|Indigestion|indigestion
5798493|NCT00112164|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5798494|NCT00112151|andropause|andropause
5798495|NCT00112151|hypogonadism|hypogonadism
5798496|NCT00112151|AndroGel|androgel
5798497|NCT00112151|exercise|exercise
5798498|NCT00112151|PRT|prt
5798499|NCT00112151|Testosterone|testosterone
5798500|NCT00112151|T supplementation|t supplementation
5798501|NCT00112138|gabapentin|gabapentin
5798502|NCT00112138|hot flashes or flushes|hot flashes or flushes
5798503|NCT00112138|menopause|menopause
5798504|NCT00112125|cardiac contractility modulation|cardiac contractility modulation
5798505|NCT00112125|heart failure|heart failure
5798506|NCT00112125|cardiopulmonary exercise test|cardiopulmonary exercise test
5798507|NCT00112125|chronic heart disease|chronic heart disease
5798508|NCT00112112|cancer, pediatric, influenza, vaccine|cancer, pediatric, influenza, vaccine
5798509|NCT00112099|gastric neoplasm|gastric neoplasm
5798510|NCT00112099|gastrectomy|gastrectomy
5798511|NCT00112099|splenectomy|splenectomy
5798512|NCT00112099|randomized trial|randomized trial
5798513|NCT00112099|T2, T3 and T4 carcinoma in the proximal third of the stomach|t2, t3 and t4 carcinoma in the proximal third of the stomach
5798514|NCT00112086|ovarian neoplasms|ovarian neoplasms
5798516|NCT00112086|neoadjuvant therapy|neoadjuvant therapy
5798517|NCT00112086|interval cytoreductive surgery|interval cytoreductive surgery
5798518|NCT00112073|Alzheimer's disease|alzheimer's disease
5798519|NCT00112073|immunotherapy|immunotherapy
5798520|NCT00112073|beta amyloid|beta amyloid
5798521|NCT00112060|Talotrexin|talotrexin
5798522|NCT00112060|PT-523|pt-523
5798523|NCT00112060|Non-Small Cell Lung Carcinoma (NSCLC)|non-small cell lung carcinoma (nsclc)
5798524|NCT00112047|Human Immunodeficiency Virus|human immunodeficiency virus
5798525|NCT00112034|Multiple Sclerosis|multiple sclerosis
5798526|NCT00112034|Relapsing-Remitting|relapsing-remitting
5798527|NCT00112034|AVONEX|avonex
5798528|NCT00112034|Combination|combination
5798529|NCT00112034|Methotrexate|methotrexate
5798530|NCT00112034|IV Methylprednisolone|iv methylprednisolone
5798531|NCT00112034|IVMP|ivmp
5798532|NCT00112034|ACT|act
5798533|NCT00112034|MTX|mtx
5798534|NCT00112021|obesity|obesity
5798535|NCT00112021|weight loss|weight loss
5798536|NCT00112021|Amylin|amylin
5798537|NCT00112021|pramlintide|pramlintide
5798538|NCT00112021|Symlin|symlin
5798539|NCT00112008|Anemia|anemia
5798540|NCT00111995|Chronic Renal Failure (CRF)|chronic renal failure (crf)
5798541|NCT00111995|Anemia|anemia
5798542|NCT00111982|bilateral, idiopathic Parkinson's Disease|bilateral, idiopathic parkinson's disease
5798543|NCT00111969|Heart failure|heart failure
5798544|NCT00111969|Immune modulation therapy|immune modulation therapy
5798545|NCT00111969|Inflammation|inflammation
5798546|NCT00111969|Chronic systolic heart failure|chronic systolic heart failure
5798547|NCT00111956|TNF|tnf
5798548|NCT00111956|metabolic syndrome|metabolic syndrome
5798549|NCT00111956|inflammation|inflammation
5798550|NCT00111956|CRP|crp
5798551|NCT00111956|adiponectin|adiponectin
5798552|NCT00111943|Anti-Infective Agents, Local|anti-infective agents, local
5798553|NCT00111943|HIV Seronegativity|hiv seronegativity
5798554|NCT00111943|Tenofovir|tenofovir
5798555|NCT00111943|Vaginal gel|vaginal gel
5798556|NCT00111943|Microbicide|microbicide
5798557|NCT00111943|Vaginal Microbicide|vaginal microbicide
5798558|NCT00111943|PMPA|pmpa
5798559|NCT00111930|dehydroepiandrosterone|dehydroepiandrosterone
5798560|NCT00111930|DHEAS|dheas
5798561|NCT00111930|bone mineral density|bone mineral density
5798562|NCT00111930|body composition|body composition
5798563|NCT00111930|lean mass|lean mass
5798564|NCT00111930|fat mass|fat mass
5798565|NCT00111930|bone mass|bone mass
5798566|NCT00111930|decreased DHEAS levels|decreased dheas levels
5798567|NCT00111917|Chronic Beryllium Disease|chronic beryllium disease
5798568|NCT00111917|Berylliosis|berylliosis
5798569|NCT00111917|Beryllium Disease|beryllium disease
5798570|NCT00111917|CBD|cbd
5798571|NCT00111917|Infliximab|infliximab
5797823|NCT00114413|Lung|lung
5798572|NCT00111904|stage III pancreatic cancer|stage iii pancreatic cancer
5798573|NCT00111904|recurrent pancreatic cancer|recurrent pancreatic cancer
5798574|NCT00111904|stage IV pancreatic cancer|stage iv pancreatic cancer
5798575|NCT00111878|Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3)|respiratory syncytial virus (rsv) and parainfluenza virus type 3 (piv3)
5798576|NCT00111865|physical exercise|physical exercise
5798577|NCT00111865|quality of life|quality of life
5798578|NCT00111865|lymphoma|lymphoma
5798579|NCT00111852|Desmoteplase|desmoteplase
5798580|NCT00111852|Acute Ischemic Stroke|acute ischemic stroke
5798581|NCT00111852|Stroke, Acute|stroke, acute
5798582|NCT00111839|Lung cancer|lung cancer
5798583|NCT00111826|Intermittent Claudication|intermittent claudication
5798584|NCT00111826|Peripheral Arterial Disease|peripheral arterial disease
5798585|NCT00111826|Immune modulation therapy|immune modulation therapy
5798586|NCT00111826|Inflammation|inflammation
5798587|NCT00111800|NIDDM|niddm
5798588|NCT00111787|breast cancer|breast cancer
5798589|NCT00111774|Colon Cancer, Rectal Cancer|colon cancer, rectal cancer
5798590|NCT00111774|Colorectal Carcinoma, EGFr|colorectal carcinoma, egfr
5798591|NCT00111774|Metastatic Cancer, ABX-EGF|metastatic cancer, abx-egf
5798592|NCT00111774|Panitumumab, Abgenix|panitumumab, abgenix
5798593|NCT00111774|Clinical Trial, Immunex, Amgen|clinical trial, immunex, amgen
5798594|NCT00111774|Metastatic Colorectal|metastatic colorectal
5798595|NCT00111761|Immunex|immunex
5798596|NCT00111761|Panitumumab|panitumumab
5798597|NCT00111761|ABX-EGF|abx-egf
5798598|NCT00111761|Abgenix|abgenix
5798599|NCT00111748|Myeloma|myeloma
5798600|NCT00111683|Myelodysplastic Syndrome[Refractory Anemia with|myelodysplastic syndrome[refractory anemia with
5798727|NCT00111254|collagen|collagen
5798601|NCT00111683|Excess Blasts-1 or 2 (WHO Classification)]|excess blasts-1 or 2 (who classification)]
5798602|NCT00111683|Chronic Myelogenous Leukemia in blast crisis|chronic myelogenous leukemia in blast crisis
5798605|NCT00111657|Tophaceous gout|tophaceous gout
5798606|NCT00111657|Allergy to allopurinol|allergy to allopurinol
5798607|NCT00111657|Post-transplant gout|post-transplant gout
5798608|NCT00111618|vascular disrupting agent|vascular disrupting agent
5798609|NCT00111618|safety|safety
5798610|NCT00111618|tolerability|tolerability
5798611|NCT00111618|efficacy|efficacy
5798612|NCT00111618|hormone refractory prostate cancer|hormone refractory prostate cancer
5798613|NCT00111605|AIDS Vaccines|aids vaccines
5798614|NCT00111605|HIV Vaccines|hiv vaccines
5798615|NCT00111605|HIV Preventive Vaccine|hiv preventive vaccine
5798616|NCT00111605|HIV Seronegativity|hiv seronegativity
5798617|NCT00111592|BPH|bph
5798618|NCT00111592|benign prostatic hyperplasia|benign prostatic hyperplasia
5798619|NCT00111566|Percutaneous Coronary Intervention (PCI)|percutaneous coronary intervention (pci)
5798620|NCT00111566|Glycoprotein IIb/IIIa blockade|glycoprotein iib/iiia blockade
5798621|NCT00111566|Ischemic complications following PCI|ischemic complications following pci
5798622|NCT00111553|Leishmaniasis|leishmaniasis
5798623|NCT00111553|Subunit vaccine|subunit vaccine
5798624|NCT00111553|Therapeutic|therapeutic
5798625|NCT00111553|T cell|t cell
5798626|NCT00111553|Antimony|antimony
5798627|NCT00111540|exenatide|exenatide
5798628|NCT00111540|diabetes|diabetes
5798629|NCT00111540|Amylin|amylin
5798630|NCT00111540|exendin-4|exendin-4
5798631|NCT00111527|Heart failure|heart failure
5798632|NCT00111527|Atrial fibrillation|atrial fibrillation
5798633|NCT00111527|Cardiac resynchronization|cardiac resynchronization
5798634|NCT00111527|Cardiac pacing|cardiac pacing
5798642|NCT00111514|pentavalent antimony|pentavalent antimony
5798643|NCT00111501|smoking|smoking
5798644|NCT00111501|tobacco|tobacco
5798645|NCT00111488|atrial fibrillation|atrial fibrillation
5798646|NCT00111475|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5798647|NCT00111475|Idiopathic Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura
5798648|NCT00111475|Thrombocytopenic|thrombocytopenic
5798649|NCT00111475|Thrombocytopenia|thrombocytopenia
5798650|NCT00111475|ITP|itp
5798651|NCT00111462|non-myeloid malignancy|non-myeloid malignancy
5798652|NCT00111462|chemotherapy-induced anemia|chemotherapy-induced anemia
5798653|NCT00111449|Psoriasis, adults|psoriasis, adults
5798654|NCT00111449|skin, Phase 3|skin, phase 3
5798655|NCT00111449|clinical trial, Amgen|clinical trial, amgen
5798656|NCT00111449|etanercept, Enbrel®|etanercept, enbrel®
5798657|NCT00111449|moderate, severe|moderate, severe
5798658|NCT00111436|Psoriasis, adults, skin|psoriasis, adults, skin
5798659|NCT00111436|Phase 3, clinical trial|phase 3, clinical trial
5798660|NCT00111436|Amgen, etanercept|amgen, etanercept
5798661|NCT00111436|Enbrel®, moderate|enbrel®, moderate
5798662|NCT00111436|severe, extension|severe, extension
5798777|NCT00111111|Psoriasis|psoriasis
5798663|NCT00111423|Rheumatoid Arthritis, Inflammation|rheumatoid arthritis, inflammation
5798664|NCT00111423|Pegsunercept, PEG sTNF-RI|pegsunercept, peg stnf-ri
5798665|NCT00111423|Autoimmune, Amgen|autoimmune, amgen
5798874|NCT00110708|gastrointestinal problems associated with autism|gastrointestinal problems associated with autism
5798875|NCT00110708|immune globulin|immune globulin
5798876|NCT00110708|immunoglobulin|immunoglobulin
5798877|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5798974|NCT00110305|Efavirenz|efavirenz
5797915|NCT00114127|SNRI|snri
5798878|NCT00110708|Intestinal Mucosa/immunology/pathology|intestinal mucosa/immunology/pathology
5798879|NCT00110708|Administration, Oral|administration, oral
5798880|NCT00110708|Autistic Disorder/*drug therapy|autistic disorder/*drug therapy
5798881|NCT00110708|Child Behavior/*drug effects|child behavior/*drug effects
5798882|NCT00110708|Constipation/drug therapy|constipation/drug therapy
5798883|NCT00110708|Diarrhea/drug therapy|diarrhea/drug therapy
5798884|NCT00110708|Gastrointestinal Agents/*therapeutic use|gastrointestinal agents/*therapeutic use
5798885|NCT00110695|NSABP|nsabp
5798886|NCT00110695|Abraxis|abraxis
5798887|NCT00110695|Abraxane|abraxane
5798888|NCT00110695|Locally advanced breast cancer|locally advanced breast cancer
5798889|NCT00110695|Fluorouracil|fluorouracil
5798890|NCT00110695|Epirubicin|epirubicin
5798891|NCT00110695|Cyclophosphamide|cyclophosphamide
5798892|NCT00110695|FEC|fec
5798893|NCT00110682|Actinic Keratosis|actinic keratosis
5798894|NCT00110682|Cryotherapy|cryotherapy
5798895|NCT00110682|Imiquimod|imiquimod
5798896|NCT00110669|Muscular dystrophy, Duchenne and Beckers|muscular dystrophy, duchenne and beckers
5798897|NCT00110669|Beckers Muscular dystrophy|beckers muscular dystrophy
5798898|NCT00110656|Kidney transplant|kidney transplant
5798899|NCT00110643|Acne|acne
5798900|NCT00110643|laser|laser
5798901|NCT00110630|nicotine dependence|nicotine dependence
5798902|NCT00110617|Sickle Cell Disease|sickle cell disease
5798903|NCT00110617|Iron Overload from Repeated Blood Transfusions|iron overload from repeated blood transfusions
5798904|NCT00110617|Iron Overload|iron overload
5798905|NCT00110617|Blood Transfusions|blood transfusions
5798906|NCT00110604|Folic acid|folic acid
5798907|NCT00110604|Atherosclerosis|atherosclerosis
5798908|NCT00110604|Cognitive function|cognitive function
5798910|NCT00110604|Inflammation|inflammation
5798911|NCT00110604|Hemostasis|hemostasis
5798912|NCT00110604|Arterial stiffness|arterial stiffness
5798913|NCT00110578|Treatment Naive|treatment naive
5798914|NCT00110578|Treatment Experienced|treatment experienced
5798915|NCT00110565|Magnetics|magnetics
5798916|NCT00110565|Pulsed Magnetic Pad|pulsed magnetic pad
5798917|NCT00110565|Magnetic Field|magnetic field
5798918|NCT00110565|Electromagnetic Field|electromagnetic field
5798919|NCT00110565|Women|women
5798920|NCT00110565|Pulsed Magnetic Field|pulsed magnetic field
5798921|NCT00110539|Medicine, Herbal|medicine, herbal
5798923|NCT00110539|Complementary and Alternative Medicine|complementary and alternative medicine
5798924|NCT00110539|Physicians|physicians
5798925|NCT00110526|Prostate Cancer|prostate cancer
5798926|NCT00110526|Radiation Therapy|radiation therapy
5798927|NCT00110526|Local recurrence|local recurrence
5798928|NCT00110526|Gene Therapy|gene therapy
5798929|NCT00110513|Antithrombin Deficiency, Congenital or Hereditary|antithrombin deficiency, congenital or hereditary
5798930|NCT00110513|Antithrombin III Deficiency|antithrombin iii deficiency
5798931|NCT00110513|ATIII|atiii
5798932|NCT00110513|Hereditary Antithrombin Deficiency (HD)|hereditary antithrombin deficiency (hd)
5798933|NCT00110500|Diabetes|diabetes
5798934|NCT00110500|Neuropathy|neuropathy
5798935|NCT00110487|Endometriosis|endometriosis
5798936|NCT00110474|Glucosamine sulfate|glucosamine sulfate
5798937|NCT00110474|Osteoarthritis|osteoarthritis
5798938|NCT00110474|Acetaminophen|acetaminophen
5798939|NCT00110474|Paracetamol|paracetamol
5798940|NCT00110474|Clinical trial|clinical trial
5798941|NCT00110461|Aripiprazole|aripiprazole
5798942|NCT00110461|Bipolar I Disorder, Manic or Mixed Episode with or without Psychotic Features|bipolar i disorder, manic or mixed episode with or without psychotic features
5798943|NCT00110448|type 2 diabetes|type 2 diabetes
5798944|NCT00110448|coronary heart diseases|coronary heart diseases
5798945|NCT00110448|primary prevention|primary prevention
5798946|NCT00110448|atherosclerosis|atherosclerosis
5798947|NCT00110448|aspirin|aspirin
5798948|NCT00110422|Metabolic Syndrome|metabolic syndrome
5798949|NCT00110396|Multiple Sclerosis|multiple sclerosis
5798950|NCT00110396|Relapsing forms of multiple sclerosis|relapsing forms of multiple sclerosis
5798951|NCT00110344|Cancer|cancer
5798952|NCT00110331|Encephalopathy|encephalopathy
5798953|NCT00110331|Neuroimaging|neuroimaging
5798954|NCT00110331|Cognition|cognition
5798955|NCT00110331|Neuroinflammation|neuroinflammation
5798956|NCT00110331|Opportunistic Infections|opportunistic infections
5798957|NCT00110331|HIV|hiv
5798958|NCT00110331|Central Nervous System Disease|central nervous system disease
5798959|NCT00110331|Bipolar Disorder|bipolar disorder
5798960|NCT00110331|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5798961|NCT00110331|ADHD|adhd
5798962|NCT00110331|Major Depression|major depression
5798963|NCT00110331|Psychosis|psychosis
5798964|NCT00110318|Tennis Elbow|tennis elbow
5798965|NCT00110318|Physical Therapy Techniques|physical therapy techniques
5798966|NCT00110318|Evidence-Based Medicine|evidence-based medicine
5798967|NCT00110318|Primary Health Care|primary health care
5812498|NCT00082823|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5812499|NCT00082797|adult glioblastoma|adult glioblastoma
5812500|NCT00082797|adult giant cell glioblastoma|adult giant cell glioblastoma
5812501|NCT00082797|adult gliosarcoma|adult gliosarcoma
5812502|NCT00082758|recurrent neuroblastoma|recurrent neuroblastoma
5812503|NCT00082732|stage I prostate cancer|stage i prostate cancer
5812504|NCT00082732|stage II prostate cancer|stage ii prostate cancer
5812505|NCT00082732|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5813508|NCT00003239|Ara-C|ara-c
5798968|NCT00110305|Human Immunodeficiency Virus Type 1|human immunodeficiency virus type 1
5798969|NCT00110305|Human immunodeficiency virus (HIV)|human immunodeficiency virus (hiv)
5798970|NCT00110305|Antiretroviral|antiretroviral
5798971|NCT00110305|Antiviral|antiviral
5798972|NCT00110305|ARV|arv
5798973|NCT00110305|TMC278|tmc278
5798979|NCT00110305|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5798980|NCT00110305|Emtricitabine|emtricitabine
5798981|NCT00110292|Public health|public health
5798982|NCT00110292|Primary care|primary care
5798983|NCT00110292|Parenting education|parenting education
5798984|NCT00110292|Child rearing|child rearing
5798985|NCT00110292|Parenting newsletters|parenting newsletters
5798986|NCT00110292|Child development|child development
5798987|NCT00110292|Language delay|language delay
5798988|NCT00110279|Bird Flu|bird flu
5798989|NCT00110266|ICL670|icl670
5798990|NCT00110266|Deferasirox|deferasirox
5798991|NCT00110266|Iron chelation|iron chelation
5798992|NCT00110266|Chelator|chelator
5798993|NCT00110266|Desferal|desferal
5798994|NCT00110240|Type 2 diabetes|type 2 diabetes
5798995|NCT00110240|vildagliptin|vildagliptin
5798996|NCT00110227|Complementary Therapies|complementary therapies
5798997|NCT00110227|Tai Chi|tai chi
5798998|NCT00110201|Acute renal failure|acute renal failure
5798999|NCT00110201|Nesiritide|nesiritide
5808948|NCT00086554|Surgery|surgery
5799000|NCT00110201|Cardiovascular surgery|cardiovascular surgery
5799001|NCT00110188|prostate|prostate
5799002|NCT00110188|cancer|cancer
5799003|NCT00110175|Cortical Reorganization|cortical reorganization
5799004|NCT00110175|Motor Function|motor function
5799005|NCT00110175|Somatosensory Stimulation|somatosensory stimulation
5799006|NCT00110175|Rehabilitation|rehabilitation
5799007|NCT00110175|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5799008|NCT00110175|Direct Current Stimulation|direct current stimulation
5799009|NCT00110175|Stroke|stroke
5799010|NCT00110175|Healthy Volunteer|healthy volunteer
5799011|NCT00110162|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5799012|NCT00110162|stage I prostate cancer|stage i prostate cancer
5799013|NCT00110162|stage IIB prostate cancer|stage iib prostate cancer
5799014|NCT00110162|stage IIA prostate cancer|stage iia prostate cancer
5799015|NCT00110162|stage III prostate cancer|stage iii prostate cancer
5799016|NCT00110162|stage IV prostate cancer|stage iv prostate cancer
5799017|NCT00110162|recurrent prostate cancer|recurrent prostate cancer
5799018|NCT00110149|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5799019|NCT00110149|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5799020|NCT00110149|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5799021|NCT00110149|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5799022|NCT00110149|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5799023|NCT00110149|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5799024|NCT00110149|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5799025|NCT00110149|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5799026|NCT00110149|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5799027|NCT00110149|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5799028|NCT00110149|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5799029|NCT00110149|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5799030|NCT00110149|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5799031|NCT00110149|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5799032|NCT00110149|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5799033|NCT00110149|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5799034|NCT00110149|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5799035|NCT00110149|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5799036|NCT00110149|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5799037|NCT00110149|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5846476|NCT00044291|Toremifene|toremifene
5799038|NCT00110149|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5799039|NCT00110149|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5799040|NCT00110149|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5799041|NCT00110136|recurrent breast cancer|recurrent breast cancer
5799042|NCT00110136|stage I breast cancer|stage i breast cancer
5799043|NCT00110136|stage II breast cancer|stage ii breast cancer
5799044|NCT00110136|stage IIIA breast cancer|stage iiia breast cancer
5799045|NCT00110136|stage IIIB breast cancer|stage iiib breast cancer
5799046|NCT00110136|breast cancer in situ|breast cancer in situ
5799047|NCT00110136|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5799048|NCT00110136|hot flashes|hot flashes
5799049|NCT00110123|liver metastases|liver metastases
5799050|NCT00110123|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5799051|NCT00110123|iris melanoma|iris melanoma
5799052|NCT00110123|extraocular extension melanoma|extraocular extension melanoma
5799053|NCT00110123|recurrent intraocular melanoma|recurrent intraocular melanoma
5799054|NCT00110123|metastatic intraocular melanoma|metastatic intraocular melanoma
5799055|NCT00110110|intraocular retinoblastoma|intraocular retinoblastoma
5799056|NCT00110084|recurrent breast cancer|recurrent breast cancer
5799057|NCT00110084|stage IV breast cancer|stage iv breast cancer
5799058|NCT00110058|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5799378|NCT00109785|male breast cancer|male breast cancer
5799059|NCT00110058|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5799060|NCT00110058|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5799061|NCT00110058|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5799062|NCT00110058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5799063|NCT00110045|infection|infection
5799064|NCT00110045|ataxia-telangiectasia|ataxia-telangiectasia
5799065|NCT00110045|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5799066|NCT00110045|acute undifferentiated leukemia|acute undifferentiated leukemia
5799067|NCT00110045|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5799068|NCT00110045|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5799069|NCT00110045|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5799070|NCT00110045|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5799072|NCT00110045|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5799073|NCT00110045|essential thrombocythemia|essential thrombocythemia
5799074|NCT00110045|polycythemia vera|polycythemia vera
5799075|NCT00110045|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5799076|NCT00110045|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5799077|NCT00110045|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5799078|NCT00110045|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5799079|NCT00110045|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5799080|NCT00110045|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5799081|NCT00110045|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5799082|NCT00110045|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5799083|NCT00110045|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5799084|NCT00110045|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5799085|NCT00110045|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5799086|NCT00110045|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5799087|NCT00110045|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5799088|NCT00110045|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5799089|NCT00110045|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5799090|NCT00110045|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5799091|NCT00110045|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5799092|NCT00110045|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5799093|NCT00110045|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5799094|NCT00110045|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5799095|NCT00110045|refractory hairy cell leukemia|refractory hairy cell leukemia
5799096|NCT00110045|prolymphocytic leukemia|prolymphocytic leukemia
5799438|NCT00109642|Guanfacine|guanfacine
5799097|NCT00110045|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5799098|NCT00110045|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5799099|NCT00110045|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5799100|NCT00110045|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5799101|NCT00110045|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5799102|NCT00110045|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5799103|NCT00110045|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5799104|NCT00110045|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5799105|NCT00110045|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5846477|NCT00044291|Letrozole|letrozole
5799106|NCT00110045|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5799107|NCT00110045|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5799108|NCT00110045|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5799109|NCT00110045|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5799110|NCT00110045|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5799111|NCT00110045|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5799112|NCT00110045|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5799113|NCT00110045|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5799114|NCT00110045|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5799115|NCT00110045|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5799116|NCT00110045|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5799117|NCT00110045|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5799118|NCT00110045|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5799119|NCT00110045|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5799120|NCT00110045|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5799121|NCT00110045|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5799308|NCT00109993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5799122|NCT00110045|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5799123|NCT00110045|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5799124|NCT00110045|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5799125|NCT00110045|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5799126|NCT00110045|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5799127|NCT00110045|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5799128|NCT00110045|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5799129|NCT00110045|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5799130|NCT00110045|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5799131|NCT00110045|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5799132|NCT00110045|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5799133|NCT00110045|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5799134|NCT00110045|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5799135|NCT00110045|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5799136|NCT00110045|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5799137|NCT00110045|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5799138|NCT00110045|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5799139|NCT00110045|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5799140|NCT00110045|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5799141|NCT00110045|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5799142|NCT00110045|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5799143|NCT00110045|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5799144|NCT00110045|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5799145|NCT00110045|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5799146|NCT00110045|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5799147|NCT00110045|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5799148|NCT00110045|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5799149|NCT00110045|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5799150|NCT00110045|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5799151|NCT00110045|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5799152|NCT00110045|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5799153|NCT00110045|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5799154|NCT00110045|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5799155|NCT00110045|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5799156|NCT00110045|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5799157|NCT00110045|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5799158|NCT00110045|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5799159|NCT00110045|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5799160|NCT00110045|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5799161|NCT00110045|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5799162|NCT00110045|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5799163|NCT00110045|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5799164|NCT00110045|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5799165|NCT00110045|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5799166|NCT00110045|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5799167|NCT00110045|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5799168|NCT00110045|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5799169|NCT00110045|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5799170|NCT00110045|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5799171|NCT00110045|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5806759|NCT00088764|Stress|stress
5799172|NCT00110045|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5799173|NCT00110045|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5799174|NCT00110045|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5799175|NCT00110045|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5799741|NCT00108563|Interferon-alpha|interferon-alpha
5799176|NCT00110045|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5799177|NCT00110045|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5799179|NCT00110045|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5799180|NCT00110045|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5799181|NCT00110045|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5799182|NCT00110045|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5799379|NCT00109772|CRPS|crps
5799183|NCT00110045|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5799184|NCT00110045|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5799185|NCT00110045|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5799186|NCT00110045|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5799187|NCT00110045|intraocular lymphoma|intraocular lymphoma
5799188|NCT00110045|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5799189|NCT00110045|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5799190|NCT00110045|extramedullary plasmacytoma|extramedullary plasmacytoma
5799192|NCT00110045|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5799193|NCT00110045|stage I multiple myeloma|stage i multiple myeloma
5799194|NCT00110045|stage II multiple myeloma|stage ii multiple myeloma
5799195|NCT00110045|stage III multiple myeloma|stage iii multiple myeloma
5799196|NCT00110045|primary systemic amyloidosis|primary systemic amyloidosis
5799197|NCT00110045|refractory multiple myeloma|refractory multiple myeloma
5799198|NCT00110045|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5799199|NCT00110045|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5799200|NCT00110045|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5799201|NCT00110045|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5799202|NCT00110045|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5799203|NCT00110045|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5799204|NCT00110045|disseminated neuroblastoma|disseminated neuroblastoma
5799205|NCT00110045|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5799206|NCT00110045|recurrent neuroblastoma|recurrent neuroblastoma
5799207|NCT00110045|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5799208|NCT00110045|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5799209|NCT00110045|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5799210|NCT00110045|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5799211|NCT00110045|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5799212|NCT00110045|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5799213|NCT00110045|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5799214|NCT00110045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5799215|NCT00110045|stage IIIA breast cancer|stage iiia breast cancer
5799216|NCT00110045|stage IIIB breast cancer|stage iiib breast cancer
5799217|NCT00110045|stage IIIC breast cancer|stage iiic breast cancer
5799218|NCT00110045|stage IV breast cancer|stage iv breast cancer
5799219|NCT00110045|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5799220|NCT00110045|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5799221|NCT00110045|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5799222|NCT00110045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5799350|NCT00109941|recurrent pancreatic cancer|recurrent pancreatic cancer
5799223|NCT00110045|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5799224|NCT00110045|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5799225|NCT00110045|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5799226|NCT00110045|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5846478|NCT00044291|Aromatase inhibitor|aromatase inhibitor
5799227|NCT00110006|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5799228|NCT00110006|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5799229|NCT00110006|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5799230|NCT00110006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5799231|NCT00110006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5799232|NCT00110006|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5799233|NCT00110006|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5799234|NCT00110006|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5798359|NCT00112619|meningeal leukemia|meningeal leukemia
5799235|NCT00110006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5799236|NCT00110006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5799237|NCT00110006|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5799238|NCT00110006|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5799239|NCT00110006|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5799240|NCT00110006|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5799241|NCT00110006|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5799242|NCT00110006|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5799243|NCT00109993|graft versus host disease|graft versus host disease
5799244|NCT00109993|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5799245|NCT00109993|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5799246|NCT00109993|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5799247|NCT00109993|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5799248|NCT00109993|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5799249|NCT00109993|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5799250|NCT00109993|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5794350|NCT00126984|Safety|safety
5799251|NCT00109993|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5799252|NCT00109993|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5799253|NCT00109993|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5799254|NCT00109993|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5799255|NCT00109993|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5799256|NCT00109993|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5799257|NCT00109993|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5799258|NCT00109993|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5799259|NCT00109993|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5799260|NCT00109993|disseminated neuroblastoma|disseminated neuroblastoma
5799261|NCT00109993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5862621|NCT00001564|Fusion Protein|fusion protein
5799262|NCT00109993|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5799263|NCT00109993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5799264|NCT00109993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5799265|NCT00109993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5799266|NCT00109993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5799267|NCT00109993|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5799268|NCT00109993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5799269|NCT00109993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5799270|NCT00109993|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5799271|NCT00109993|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5799272|NCT00109993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5799273|NCT00109993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5799274|NCT00109993|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5799275|NCT00109993|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5799276|NCT00109993|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5799277|NCT00109993|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5799278|NCT00109993|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5799279|NCT00109993|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5799280|NCT00109993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5799281|NCT00109993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5799282|NCT00109993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5799283|NCT00109993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5799284|NCT00109993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5799285|NCT00109993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5799286|NCT00109993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5799287|NCT00109993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5799288|NCT00109993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5799289|NCT00109993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5799290|NCT00109993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5799291|NCT00109993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5799292|NCT00109993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5799293|NCT00109993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5799294|NCT00109993|recurrent neuroblastoma|recurrent neuroblastoma
5799295|NCT00109993|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5799296|NCT00109993|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5799297|NCT00109993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5799298|NCT00109993|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5799299|NCT00109993|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5799300|NCT00109993|refractory multiple myeloma|refractory multiple myeloma
5799301|NCT00109993|refractory hairy cell leukemia|refractory hairy cell leukemia
5799302|NCT00109993|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5799303|NCT00109993|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5799304|NCT00109993|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5799305|NCT00109993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5799306|NCT00109993|stage I multiple myeloma|stage i multiple myeloma
5799307|NCT00109993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5799309|NCT00109993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5799310|NCT00109993|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5799311|NCT00109993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5799312|NCT00109993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5799313|NCT00109993|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5799314|NCT00109993|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5799315|NCT00109993|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5799316|NCT00109993|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5799317|NCT00109993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5799318|NCT00109993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5799319|NCT00109993|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5799320|NCT00109993|stage III multiple myeloma|stage iii multiple myeloma
5799321|NCT00109993|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5799322|NCT00109993|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5799323|NCT00109993|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5799324|NCT00109993|stage IIIA breast cancer|stage iiia breast cancer
5799325|NCT00109993|stage IIIB breast cancer|stage iiib breast cancer
5799326|NCT00109993|stage IIIC breast cancer|stage iiic breast cancer
5799327|NCT00109993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5799328|NCT00109993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5799329|NCT00109993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5799330|NCT00109993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5799331|NCT00109993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5799332|NCT00109993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5799333|NCT00109993|stage IV breast cancer|stage iv breast cancer
5799334|NCT00109993|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5799335|NCT00109993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5799336|NCT00109993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5799337|NCT00109993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5799338|NCT00109993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5799339|NCT00109993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5799340|NCT00109993|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5799341|NCT00109993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5799342|NCT00109980|Complementary Therapies|complementary therapies
5799343|NCT00109980|Plants, Medicinal|plants, medicinal
5799344|NCT00109980|Dominican Republic|dominican republic
5799345|NCT00109980|Hispanic Americans|hispanic americans
5799346|NCT00109954|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5799347|NCT00109954|advanced adult primary liver cancer|advanced adult primary liver cancer
5799348|NCT00109954|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5799349|NCT00109954|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5799351|NCT00109941|stage III pancreatic cancer|stage iii pancreatic cancer
5799352|NCT00109941|stage IV pancreatic cancer|stage iv pancreatic cancer
5799353|NCT00109928|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5799354|NCT00109928|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5799355|NCT00109928|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5799356|NCT00109928|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5799357|NCT00109928|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5799358|NCT00109928|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5799359|NCT00109928|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5799360|NCT00109928|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5798515|NCT00112086|laparoscopy|laparoscopy
5799361|NCT00109928|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5799362|NCT00109889|extramedullary plasmacytoma|extramedullary plasmacytoma
5799363|NCT00109889|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5799364|NCT00109876|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5799365|NCT00109863|recurrent melanoma|recurrent melanoma
5799366|NCT00109863|stage IV melanoma|stage iv melanoma
5799367|NCT00109850|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5799368|NCT00109850|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5799369|NCT00109850|stage III esophageal cancer|stage iii esophageal cancer
5799370|NCT00109837|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5799371|NCT00109837|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5799372|NCT00109837|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5799373|NCT00109798|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5799374|NCT00109798|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5799375|NCT00109785|stage IIIA breast cancer|stage iiia breast cancer
5799376|NCT00109785|stage IIIB breast cancer|stage iiib breast cancer
5799377|NCT00109785|stage IIIC breast cancer|stage iiic breast cancer
5799384|NCT00109772|Complex Regional Pain Syndrome|complex regional pain syndrome
5799385|NCT00109772|Reflex Sympathy Dystrophy Syndrome|reflex sympathy dystrophy syndrome
5799386|NCT00109772|Lenalidomide|lenalidomide
5799387|NCT00109772|CRPS Type I|crps type i
5799388|NCT00109772|Celgene|celgene
5799389|NCT00109759|allergy|allergy
5799390|NCT00109759|allergoid|allergoid
5799391|NCT00109759|specific immunotherapy|specific immunotherapy
5799392|NCT00109759|ragweed|ragweed
5799393|NCT00109746|HIV|hiv
5799394|NCT00109746|Treatment Experienced|treatment experienced
5799395|NCT00109746|Anti-Retroviral Agents|anti-retroviral agents
5799396|NCT00109746|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5799397|NCT00109746|Picolinic acid|picolinic acid
5799398|NCT00109746|Dietary Supplements|dietary supplements
5799399|NCT00109733|Childhood-onset growth hormone deficiency (COGHD)|childhood-onset growth hormone deficiency (coghd)
5799400|NCT00109733|Saizen®|saizen®
5799401|NCT00109720|Diabetes|diabetes
5799402|NCT00109720|Self Management|self management
5799403|NCT00109720|Type 2 diabetes|type 2 diabetes
5799404|NCT00109707|CML in blast crisis|cml in blast crisis
5799405|NCT00109707|CML in chronic phase|cml in chronic phase
5799406|NCT00109707|CML in accelerated phase|cml in accelerated phase
5799407|NCT00109707|Gleevec resistance|gleevec resistance
5799408|NCT00109707|Gleevec intolerant|gleevec intolerant
5799409|NCT00109707|Gleevec and CML|gleevec and cml
5799410|NCT00109707|imatinib resistance|imatinib resistance
5799411|NCT00109707|imatinib intolerant|imatinib intolerant
5799412|NCT00109707|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5799413|NCT00109707|Systemic Mastocytosis|systemic mastocytosis
5799414|NCT00109707|Chronic eosinophilic syndrome|chronic eosinophilic syndrome
5799415|NCT00109707|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5799416|NCT00109707|HES|hes
5799417|NCT00109707|CEL|cel
5799418|NCT00109707|CML|cml
5799419|NCT00109707|SM|sm
5799420|NCT00109707|Ph+ ALL refractory to standard therapy|ph+ all refractory to standard therapy
5799421|NCT00109707|Ph+ALL relapsed|ph+all relapsed
5799422|NCT00109707|AMN107A|amn107a
5799423|NCT00109681|ACTIVE|active
5799424|NCT00109681|iloprost|iloprost
5799425|NCT00109681|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5799426|NCT00109681|pulmonary arterial hypertension|pulmonary arterial hypertension
5799427|NCT00109655|Superficial Transitional Cell Carcinoma|superficial transitional cell carcinoma
5799428|NCT00109655|Bacillus Calmette-Guerin (BCG)|bacillus calmette-guerin (bcg)
5799429|NCT00109655|Superficial Bladder Cancer|superficial bladder cancer
5799430|NCT00109655|Gene Therapy|gene therapy
5799431|NCT00109655|Vaccine|vaccine
5799432|NCT00109655|Adenovirus|adenovirus
5799433|NCT00109655|Carcinoma in situ|carcinoma in situ
5799434|NCT00109642|Amygdala|amygdala
5799435|NCT00109642|Orbitofrontal Cortex|orbitofrontal cortex
5799436|NCT00109642|Yohimbine|yohimbine
5799439|NCT00109642|Norepinephrine|norepinephrine
5799440|NCT00109642|Healthy Volunteer|healthy volunteer
5799441|NCT00109629|HIV-Negative|hiv-negative
5799442|NCT00109629|Healthy|healthy
5799443|NCT00109629|Immunity|immunity
5799444|NCT00109629|Preventive|preventive
5799445|NCT00109629|Virus|virus
5799446|NCT00109629|Healthy Volunteer|healthy volunteer
5799447|NCT00109616|neonatal mortality|neonatal mortality
5799448|NCT00109616|chlorhexidine|chlorhexidine
5799449|NCT00109616|newborn cleansing|newborn cleansing
5799450|NCT00109616|umbilical cord care|umbilical cord care
5799451|NCT00109616|community-based trial|community-based trial
5799452|NCT00109616|prevention trial|prevention trial
5799453|NCT00109616|omphalitis|omphalitis
5799454|NCT00109603|Treatment Experienced|treatment experienced
5799455|NCT00109603|TDF|tdf
5799456|NCT00109590|HIV Seronegativity|hiv seronegativity
5799457|NCT00109590|Treatment Naive|treatment naive
5799458|NCT00109590|Pregnancy|pregnancy
5799459|NCT00109590|Perinatal Transmission|perinatal transmission
5799460|NCT00109590|Vertical Transmission|vertical transmission
5799461|NCT00109590|Mother-To-Child Transmission|mother-to-child transmission
5799462|NCT00109590|MTCT|mtct
5799463|NCT00109577|bipolar disorder|bipolar disorder
5799464|NCT00109577|mood disorders|mood disorders
5799465|NCT00109577|manic depression|manic depression
5799466|NCT00109577|nutrition|nutrition
5799467|NCT00109564|AAMI|aami
5799468|NCT00109564|Memory Impairment|memory impairment
5799469|NCT00109564|Decline in Cognitive Function|decline in cognitive function
5799470|NCT00109564|Age Associated Memory Impairment|age associated memory impairment
5799471|NCT00109551|zinc|zinc
5799472|NCT00109551|child mortality|child mortality
5799473|NCT00109551|child morbidity|child morbidity
5799474|NCT00109551|community trial|community trial
5799475|NCT00109551|prevention trial|prevention trial
5799476|NCT00109551|dietary supplement|dietary supplement
5799477|NCT00109538|Lonafarnib|lonafarnib
5799478|NCT00109525|NICHD Neonatal Research Network|nichd neonatal research network
5799479|NCT00109525|Fungal Infection|fungal infection
5799480|NCT00109525|Mycosis|mycosis
5799481|NCT00109525|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5799482|NCT00109525|Prematurity|prematurity
5799483|NCT00109525|Clinical Judgement|clinical judgement
5799484|NCT00109525|Polymerase chain reaction (PCR) testing|polymerase chain reaction (pcr) testing
5799485|NCT00109525|Beta-glucan assay|beta-glucan assay
5799486|NCT00109525|Mass Spectrometry|mass spectrometry
5799487|NCT00109525|Lumbar puncture|lumbar puncture
5799489|NCT00109512|pelvic pain|pelvic pain
5799490|NCT00109512|painful periods|painful periods
5799491|NCT00109512|dysmenorrhea|dysmenorrhea
5799492|NCT00109512|painful menstruation|painful menstruation
5799493|NCT00109512|GnRH|gnrh
5799494|NCT00109512|agonist|agonist
5799495|NCT00109512|antagonist|antagonist
5799496|NCT00109512|menstrual pain|menstrual pain
5799497|NCT00109499|Wet Age-Related Macular Degeneration|wet age-related macular degeneration
5799498|NCT00109499|Age-Related Maculopathies|age-related maculopathies
5799499|NCT00109486|GW685698X|gw685698x
5799500|NCT00109486|seasonal allergic rhinitis|seasonal allergic rhinitis
5799501|NCT00109486|perennial allergic rhinitis|perennial allergic rhinitis
5799502|NCT00109486|knemometry|knemometry
5799503|NCT00109486|children|children
5799504|NCT00109473|Pediatric Crohn's disease|pediatric crohn's disease
5799505|NCT00109473|Pediatric|pediatric
5799506|NCT00109473|Crohn's Disease|crohn's disease
5799507|NCT00024635|Screening|screening
5799508|NCT00024635|Anxiety|anxiety
5799511|NCT00024635|Natural History|natural history
5799512|NCT00024635|HV|hv
5799513|NCT00024635|Healthy Volunteer|healthy volunteer
5799514|NCT00024635|Normal Control|normal control
5799515|NCT00024635|Mood Disorder|mood disorder
5799516|NCT00024635|PTSD|ptsd
5799517|NCT00024635|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5799518|NCT00109460|Tobacco|tobacco
5799519|NCT00109434|exercise|exercise
5799520|NCT00109434|hypoglycemia|hypoglycemia
5799521|NCT00109434|Diabetes Mellitus, Type I|diabetes mellitus, type i
5799522|NCT00109434|glucose monitoring|glucose monitoring
5799523|NCT00109421|adolescent|adolescent
5799524|NCT00109421|female|female
5799525|NCT00109421|community-based|community-based
5799526|NCT00109421|social network|social network
5799527|NCT00109421|HIV/STI intervention|hiv/sti intervention
5799528|NCT00109421|High HIV-risk African American adolescent females|high hiv-risk african american adolescent females
5799529|NCT00109395|Lorazepam|lorazepam
5799530|NCT00109395|Midazolam|midazolam
5799531|NCT00109395|Best Pharmaceuticals for Children Act|best pharmaceuticals for children act
5799532|NCT00109395|Critically ill|critically ill
5799533|NCT00109395|pediatrics|pediatrics
5799534|NCT00109395|mechanical ventilation|mechanical ventilation
5799535|NCT00109395|sedation|sedation
5799536|NCT00109382|Transient Ischemic Attack|transient ischemic attack
5799537|NCT00109382|Stroke|stroke
5799538|NCT00109382|Stroke Prevention|stroke prevention
5799539|NCT00109382|Recurrence|recurrence
5799540|NCT00109382|Neuroprotection|neuroprotection
5799541|NCT00109382|Antiplatelet Therapy|antiplatelet therapy
5799542|NCT00109382|Statins|statins
5799543|NCT00109369|Chronic Disease|chronic disease
5799544|NCT00109369|Multi-Hospital Information Systems|multi-hospital information systems
5799545|NCT00109369|Clinical Decision Support Systems|clinical decision support systems
5799546|NCT00109369|Reminder Systems|reminder systems
5799547|NCT00109369|Registries|registries
5799548|NCT00109369|Quality of Healthcare|quality of healthcare
5853035|NCT00002210|Delavirdine|delavirdine
5799549|NCT00109369|Guideline Adherence|guideline adherence
5799550|NCT00109369|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5799551|NCT00109369|Technology Assessment, Biomedical|technology assessment, biomedical
5799552|NCT00109369|Primary Health Care|primary health care
5799553|NCT00109369|Hypercholesterolemia|hypercholesterolemia
5799554|NCT00109369|Hypertension|hypertension
5799555|NCT00109369|Hyperglycemia|hyperglycemia
5799556|NCT00109356|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5799557|NCT00109356|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5799558|NCT00109356|Small Lymphocytic Leukemia|small lymphocytic leukemia
5798922|NCT00110539|Dietary Supplements|dietary supplements
5799559|NCT00109330|Prevention of Diphtheria, Tetanus, Pertussis|prevention of diphtheria, tetanus, pertussis
5799560|NCT00109317|Moderate Plaque Psoriasis|moderate plaque psoriasis
5799561|NCT00109317|Severe Plaque Psoriasis|severe plaque psoriasis
5799562|NCT00109317|Topical|topical
5799563|NCT00109304|Venezuelan Equine Encephalitis|venezuelan equine encephalitis
5799565|NCT00109304|Vaccine|vaccine
5799566|NCT00109304|Provide protective immunity against VEE subtypes IA/B|provide protective immunity against vee subtypes ia/b
5799567|NCT00109291|anemia|anemia
5799568|NCT00109291|chronic kidney disease|chronic kidney disease
5799569|NCT00109291|CKD|ckd
5799570|NCT00109291|chronic renal failure|chronic renal failure
5799571|NCT00109291|CRF|crf
5799572|NCT00109291|dialysis|dialysis
5799573|NCT00109291|erythropoietin|erythropoietin
5799574|NCT00109291|EPO|epo
5799575|NCT00109291|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5799576|NCT00109291|ESA|esa
5799577|NCT00109291|Hematide™|hematide™
5799578|NCT00109291|hemoglobin|hemoglobin
5799579|NCT00109291|Hb|hb
5799580|NCT00109291|Hgb|hgb
5799581|NCT00109291|Omontys|omontys
5799582|NCT00109291|peginesatide|peginesatide
5799583|NCT00109291|red blood cell|red blood cell
5799584|NCT00109291|red blood cell production|red blood cell production
5799585|NCT00109278|Prevention of Measles|prevention of measles
5799586|NCT00109265|Advanced Breast Cancer|advanced breast cancer
5794713|NCT00125684|stable baseline pain|stable baseline pain
5799587|NCT00109265|Metastatic Breast Cancer|metastatic breast cancer
5799589|NCT00109252|Plaque Psoriasis|plaque psoriasis
5799590|NCT00109252|Topical|topical
5799591|NCT00109239|Metastatic Breast Cancer|metastatic breast cancer
5799592|NCT00109239|Metastatic|metastatic
5799593|NCT00109239|Cancer|cancer
5799594|NCT00109226|Metastatic Colorectal Cancer|metastatic colorectal cancer
5799595|NCT00109226|Cancer|cancer
5799596|NCT00109213|Spinal Stenosis|spinal stenosis
5799597|NCT00109213|Lumbar Spine|lumbar spine
5799598|NCT00109213|Decompression|decompression
5799599|NCT00109213|Fusion|fusion
5799600|NCT00109213|Spondylolisthesis|spondylolisthesis
5799601|NCT00109213|Prospective, randomized clinical trial|prospective, randomized clinical trial
5799602|NCT00109200|Allergic Asthma|allergic asthma
5799603|NCT00109200|Severe Allergic Asthma|severe allergic asthma
5799604|NCT00109187|Moderate Persistent Asthma|moderate persistent asthma
5799605|NCT00109187|Severe Persistent Asthma|severe persistent asthma
5799613|NCT00109083|Migraine|migraine
5799614|NCT00109083|Headaches|headaches
5799615|NCT00109083|Migraine headaches|migraine headaches
5799616|NCT00109083|Head pain|head pain
5799617|NCT00109070|Metastatic|metastatic
5799618|NCT00109057|Cancer|cancer
5799619|NCT00109057|Advanced malignancies|advanced malignancies
5799620|NCT00109044|Depression|depression
5799621|NCT00109044|Major Depressive Disorder|major depressive disorder
5799622|NCT00109044|Escitalopram|escitalopram
5799623|NCT00109031|Cancer|cancer
5799624|NCT00109031|Oncology|oncology
5799625|NCT00109018|Risk Assessment|risk assessment
5799626|NCT00109018|Coronary Heart Disease|coronary heart disease
5799627|NCT00109018|Vascular Function|vascular function
5799628|NCT00109018|Nitric Oxide Metabolites|nitric oxide metabolites
5799629|NCT00109018|Blood Tests|blood tests
5799630|NCT00109018|Nitrite|nitrite
5799631|NCT00109018|Flow-Mediated Dilation|flow-mediated dilation
5799632|NCT00109018|Biomarker|biomarker
5799633|NCT00109018|Endothelial Dysfunction|endothelial dysfunction
5799634|NCT00109018|Coronary Artery Disease|coronary artery disease
5799635|NCT00109018|CAD|cad
5799636|NCT00109018|Coronary Artery Disease At Risk|coronary artery disease at risk
5799637|NCT00109018|Healthy Volunteer|healthy volunteer
5799638|NCT00109005|Response Rate|response rate
5799639|NCT00109005|Toxicity|toxicity
5799640|NCT00109005|Progression-Free Survival|progression-free survival
5799641|NCT00109005|Overall Survival|overall survival
5799642|NCT00109005|Pharmacokinetic|pharmacokinetic
5799643|NCT00109005|Ocular Melanoma|ocular melanoma
5799644|NCT00108992|topical NSAID|topical nsaid
5799645|NCT00108992|topical diclofenac|topical diclofenac
5799646|NCT00108979|Depression|depression
5853238|NCT00002179|Zidovudine|zidovudine
5799647|NCT00108979|Major Depressive Disorder|major depressive disorder
5799648|NCT00108979|Escitalopram|escitalopram
5799649|NCT00108953|Cancer|cancer
5799650|NCT00108953|Liver Cancer|liver cancer
5799651|NCT00108953|Hepatocellular carcinoma|hepatocellular carcinoma
5799652|NCT00108953|HCC|hcc
5799653|NCT00108940|stroke|stroke
5799654|NCT00108940|ischemic stroke|ischemic stroke
5799655|NCT00108940|siblings|siblings
5799656|NCT00108927|Clinical trial|clinical trial
5799657|NCT00108927|Diabetes|diabetes
5799658|NCT00108927|Quality Improvement|quality improvement
5799659|NCT00108914|Perennial allergic rhinitis|perennial allergic rhinitis
5799660|NCT00108914|pediatric|pediatric
5799661|NCT00108901|prevention|prevention
5799662|NCT00108901|children|children
5799663|NCT00108901|diabetes|diabetes
5799664|NCT00108901|overweight|overweight
5799666|NCT00108901|metabolic syndrome|metabolic syndrome
5799667|NCT00108901|exercise|exercise
5799668|NCT00108901|insulin resistance|insulin resistance
5799669|NCT00108901|female|female
5799670|NCT00108901|male|male
5799671|NCT00108901|black, African-American|black, african-american
5799672|NCT00108901|white, Caucasian|white, caucasian
5799673|NCT00108901|cognition|cognition
5799674|NCT00108901|executive function|executive function
5799675|NCT00108875|Peptide vaccine therapy|peptide vaccine therapy
5799676|NCT00108875|Survivin|survivin
5799677|NCT00108862|Treatment Naive|treatment naive
5799678|NCT00108862|TB|tb
5799679|NCT00108862|HIV|hiv
5799680|NCT00108862|Antiretroviral Agents|antiretroviral agents
5799681|NCT00108862|Strategy Study|strategy study
5799682|NCT00108836|GAD|gad
5799683|NCT00108836|Anxiety|anxiety
5799684|NCT00108836|XBD173|xbd173
5799685|NCT00108836|Generalized Anxiety Disorder|generalized anxiety disorder
5799686|NCT00108810|Pain|pain
5800995|NCT00104156|Knee pain|knee pain
5799687|NCT00108810|Osteoarthritis|osteoarthritis
5799689|NCT00108810|Mild to Moderate Osteoarthritis (OA) Pain of the Knee|mild to moderate osteoarthritis (oa) pain of the knee
5799690|NCT00108784|reduced-energy-density diet|reduced-energy-density diet
5799691|NCT00108784|fat-restricted diet|fat-restricted diet
5799692|NCT00108784|fruit|fruit
5799693|NCT00108784|vegetables|vegetables
5799694|NCT00108784|ad libitum intake|ad libitum intake
5799695|NCT00108784|weight loss|weight loss
5799696|NCT00108784|obesity|obesity
5799697|NCT00108771|Pain|pain
5794807|NCT00125398|ICU|icu
5799698|NCT00108771|Chronic Pain|chronic pain
5799699|NCT00108771|Osteoarthritis Pain|osteoarthritis pain
5799700|NCT00108771|Osteoarthritis|osteoarthritis
5799701|NCT00108706|Acute Stroke|acute stroke
5799702|NCT00108706|Cerebrovascular Accident|cerebrovascular accident
5799703|NCT00108706|Ischaemic Stroke|ischaemic stroke
5799704|NCT00108706|Candesartan|candesartan
5799705|NCT00108706|Angiotensin Receptor Blocker|angiotensin receptor blocker
5799706|NCT00108680|Hemiparesis|hemiparesis
5799707|NCT00108680|Rehabilitation|rehabilitation
5799708|NCT00108680|Reaching|reaching
5799709|NCT00108680|Interlimb Coupling|interlimb coupling
5799710|NCT00108680|Cortical Excitability|cortical excitability
5799711|NCT00108680|Stroke|stroke
5799712|NCT00108667|Parkinson's Disease|parkinson's disease
5799713|NCT00108667|AMPA Antagonist|ampa antagonist
5799714|NCT00108667|Dyskinesias|dyskinesias
5799715|NCT00108667|Glutamate Antagonist|glutamate antagonist
5799716|NCT00108667|Parkinson Disease|parkinson disease
5799718|NCT00108654|HIV-Negative|hiv-negative
5799719|NCT00108654|Healthy|healthy
5799720|NCT00108654|Immunity|immunity
5799721|NCT00108654|Preventive|preventive
5799722|NCT00108654|Virus|virus
5799723|NCT00108654|Healthy Volunteer|healthy volunteer
5799724|NCT00108628|Imagery|imagery
5799725|NCT00108628|Nightmares|nightmares
5799726|NCT00108628|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5799727|NCT00108628|Psychotherapy|psychotherapy
5799728|NCT00108602|sleep apnea|sleep apnea
5799729|NCT00108602|stroke|stroke
5799730|NCT00108602|ventilatory control|ventilatory control
5799731|NCT00108589|s-adenosylmethionine|s-adenosylmethionine
5799732|NCT00108589|fatty liver|fatty liver
5799733|NCT00108589|obesity|obesity
5799734|NCT00108589|Non-alcoholic steatohepatitis|non-alcoholic steatohepatitis
5799735|NCT00108576|anticonvulsant|anticonvulsant
5799736|NCT00108576|anxiety|anxiety
5799737|NCT00108576|divalproex|divalproex
5799738|NCT00108576|PTSD|ptsd
5799739|NCT00108563|Hepatitis C|hepatitis c
5799742|NCT00108563|Citalopram|citalopram
5799743|NCT00108563|ribavirin|ribavirin
5799744|NCT00108563|antidepressive agents|antidepressive agents
5799745|NCT00108550|analgesia|analgesia
5799746|NCT00108550|antidepressant agents|antidepressant agents
5799747|NCT00108550|back pain|back pain
5799748|NCT00108550|pain|pain
5799749|NCT00108537|smoking|smoking
5799750|NCT00108537|nicotine|nicotine
5799751|NCT00108537|drug therapy|drug therapy
5799752|NCT00108537|smoking cessation|smoking cessation
5799753|NCT00108524|anti-obesity agents|anti-obesity agents
5799754|NCT00108524|diet therapy|diet therapy
5799755|NCT00108524|diet, reducing|diet, reducing
5799756|NCT00108524|obesity|obesity
5799757|NCT00108524|overweight|overweight
5799758|NCT00108524|risk factors|risk factors
5799759|NCT00108524|weight loss|weight loss
5799760|NCT00108511|hypertriglyceridemia|hypertriglyceridemia
5799761|NCT00108511|lipoproteins|lipoproteins
5799762|NCT00108511|triglycerides|triglycerides
5799763|NCT00108511|serum GPI-PLD (glycosylphosphatidylinositol-specific phospholipase D)|serum gpi-pld (glycosylphosphatidylinositol-specific phospholipase d)
5799764|NCT00108498|sleep apnea|sleep apnea
5799765|NCT00108498|mirtazapine|mirtazapine
5799766|NCT00108498|sleep|sleep
5799767|NCT00108485|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5799768|NCT00108485|Kidney Failure, Chronic|kidney failure, chronic
5799769|NCT00108485|Hyperlipidemia|hyperlipidemia
5799770|NCT00108485|Randomized Controlled Trials|randomized controlled trials
5799771|NCT00108459|Obesity|obesity
5799772|NCT00108459|Type 2 Diabetes|type 2 diabetes
5799773|NCT00108459|Hyperlipidemia|hyperlipidemia
5799774|NCT00108459|Insulin resistance|insulin resistance
5799775|NCT00108446|Irritable Bowel Syndrome|irritable bowel syndrome
5799776|NCT00108446|visceral hypersensitivity|visceral hypersensitivity
5799777|NCT00108446|cutaneous hypersensitivity|cutaneous hypersensitivity
5799778|NCT00108446|lidocaine|lidocaine
5799779|NCT00108420|Prazosin|prazosin
5799780|NCT00108420|Stress Disorders, Post-traumatic|stress disorders, post-traumatic
5799781|NCT00108407|Alcohol Abuse/Dependence|alcohol abuse/dependence
5799782|NCT00108407|Alcohol Use Disorders|alcohol use disorders
5799783|NCT00108407|Cannabis Abuse/Dependence|cannabis abuse/dependence
5799784|NCT00108407|Depression|depression
5799785|NCT00108407|Dual diagnosis|dual diagnosis
5799786|NCT00108407|Dysthymia|dysthymia
5799787|NCT00108407|Stimulant Abuse/Dependence|stimulant abuse/dependence
5799788|NCT00108407|Substance Use Disorders|substance use disorders
5799790|NCT00108394|Dialysis|dialysis
5799791|NCT00108394|Clinical Trials|clinical trials
5799792|NCT00108394|Bone Diseases, Metabolic|bone diseases, metabolic
5799793|NCT00108394|adynamic bone disease|adynamic bone disease
5799794|NCT00108394|low bone turnover|low bone turnover
5799795|NCT00108381|chronic back pain|chronic back pain
5799796|NCT00108381|cognitive-behavioral|cognitive-behavioral
5799797|NCT00108381|pain|pain
5799798|NCT00108381|stages of change|stages of change
5799799|NCT00108368|schizophrenia|schizophrenia
5799800|NCT00108368|cognition|cognition
5799801|NCT00108368|antipsychotic medication|antipsychotic medication
5799802|NCT00108368|information processing|information processing
5799803|NCT00108368|social cognition|social cognition
5799804|NCT00108368|Psychotic|psychotic
5799805|NCT00108355|albumin|albumin
5799806|NCT00108355|ascites|ascites
5799807|NCT00108355|paracentesis|paracentesis
5799808|NCT00108342|nicotine|nicotine
5799809|NCT00108342|drug therapy|drug therapy
5799810|NCT00108342|Smoking Cessation|smoking cessation
5799811|NCT00108329|aging|aging
5799812|NCT00108329|exercise|exercise
5799813|NCT00108329|metabolic syndrome|metabolic syndrome
5799814|NCT00108329|insulin resistance|insulin resistance
5799815|NCT00108316|Depressive Disorder|depressive disorder
5799817|NCT00108316|Serotonin|serotonin
5799818|NCT00108303|schizophrenia|schizophrenia
5799820|NCT00108290|chemotherapy|chemotherapy
5799821|NCT00108290|hormone therapy|hormone therapy
5799822|NCT00108290|surgery|surgery
5799823|NCT00108290|PSA|psa
5799824|NCT00108290|Gleason score|gleason score
5799825|NCT00108277|Anxiety|anxiety
5799826|NCT00108277|Breathing Training|breathing training
5799827|NCT00108277|Respiratory Dysregulation|respiratory dysregulation
5799828|NCT00108264|Prostatic Neoplasms|prostatic neoplasms
5799829|NCT00108264|Neoplasm Metastasis|neoplasm metastasis
5799830|NCT00108264|Immunotherapy|immunotherapy
5799831|NCT00108264|Active|active
5799832|NCT00108264|Dendritic Cells|dendritic cells
5799833|NCT00108251|controlled clinical trial|controlled clinical trial
5799834|NCT00108251|Diastole|diastole
5799835|NCT00108251|Echocardiography|echocardiography
5799836|NCT00108251|exercise tolerance|exercise tolerance
5799837|NCT00108251|Heart Failure, Congestive|heart failure, congestive
5799838|NCT00108251|Receptors, Aldosterone|receptors, aldosterone
5799839|NCT00108238|endothelial function|endothelial function
5799840|NCT00108238|hormone replacement therapy|hormone replacement therapy
5799841|NCT00108238|coronary flow reserve|coronary flow reserve
5799842|NCT00108238|posmenopausal women|posmenopausal women
5799843|NCT00108238|women's cardiovascular heatlh|women's cardiovascular heatlh
5799844|NCT00108225|Cholesterol|cholesterol
5799845|NCT00108225|Creatinine Clearance|creatinine clearance
5799846|NCT00108225|Diabetes|diabetes
5799847|NCT00108225|Glycohemoglobin|glycohemoglobin
5799848|NCT00108225|High Protein Diet|high protein diet
5799849|NCT00108212|Diet|diet
5799850|NCT00108212|triglyceride|triglyceride
5799851|NCT00108212|inflammation|inflammation
5799852|NCT00108212|Genetic polymorphism|genetic polymorphism
5799853|NCT00108199|Schizophrenia|schizophrenia
5799854|NCT00108199|vocational rehabilitation|vocational rehabilitation
5799855|NCT00108199|neuropsychology|neuropsychology
5799856|NCT00108186|cyclooxygenase 2|cyclooxygenase 2
5799857|NCT00108186|lung cancer|lung cancer
5799858|NCT00108186|lymphocytes|lymphocytes
5799859|NCT00108186|non small cell|non small cell
5799860|NCT00108186|therapeutics|therapeutics
5799861|NCT00108173|Position Emission Tomography (PET)|position emission tomography (pet)
5799862|NCT00108173|Nicotine dependence|nicotine dependence
5799863|NCT00108173|functional magnetic resonance imaging|functional magnetic resonance imaging
5799864|NCT00108173|cigarette cues|cigarette cues
5799865|NCT00108160|mupirocin|mupirocin
5799866|NCT00108160|prevention and control|prevention and control
5799867|NCT00108160|s. aureus|s. aureus
5799868|NCT00108147|Aged|aged
5799869|NCT00108147|Congestive Heart Failure|congestive heart failure
5799870|NCT00108147|Exercise|exercise
5799871|NCT00108134|Superficial basal cell carcinoma|superficial basal cell carcinoma
5799872|NCT00108134|basal cell carcinoma|basal cell carcinoma
5799874|NCT00108134|BCC|bcc
5799875|NCT00108134|PEP005|pep005
5799876|NCT00108134|Topical|topical
5799877|NCT00108134|Dermatology|dermatology
5799878|NCT00108121|Nodular basal cell carcinoma|nodular basal cell carcinoma
5799879|NCT00108121|basal cell carcinoma|basal cell carcinoma
5852747|NCT00002265|Zidovudine|zidovudine
5799880|NCT00108121|nBCC|nbcc
5799881|NCT00108121|BCC|bcc
5799882|NCT00108121|PEP005|pep005
5799883|NCT00108121|Topical|topical
5799884|NCT00108121|Dermatology|dermatology
5799885|NCT00108108|Lymphocytic Leukemia|lymphocytic leukemia
5799886|NCT00108095|emesis|emesis
5799887|NCT00108095|nausea|nausea
5799888|NCT00108095|post operative nausea and vomiting|post operative nausea and vomiting
5799889|NCT00108095|vomiting|vomiting
5799890|NCT00108095|PONV|ponv
5799891|NCT00108082|left ventricular hypertrophy (LVH)|left ventricular hypertrophy (lvh)
5799892|NCT00108082|echocardiogram|echocardiogram
5799893|NCT00108082|left ventricular mass regression|left ventricular mass regression
5799894|NCT00108082|cardiac MRI|cardiac mri
5799895|NCT00108082|left ventricular mass index (LVMI)hypertension|left ventricular mass index (lvmi)hypertension
5799896|NCT00108069|Brain|brain
5799897|NCT00108069|Tumor|tumor
5799898|NCT00108069|Malignant|malignant
5799899|NCT00108069|Therapy|therapy
5799900|NCT00108069|Progression|progression
5799901|NCT00108069|Chemotherapy|chemotherapy
5799902|NCT00108069|Antiangiogenesis|antiangiogenesis
5799903|NCT00108069|Radiation|radiation
5799904|NCT00108069|Malignant Brain Tumor|malignant brain tumor
5799905|NCT00108069|Malignant Glioma|malignant glioma
5799906|NCT00108069|Glioma|glioma
5799907|NCT00108056|Brain|brain
5799908|NCT00108056|Tumor|tumor
5799910|NCT00108056|Therapy|therapy
5799911|NCT00108056|Progression|progression
5799912|NCT00108056|Malignant Brain Tumor|malignant brain tumor
5799913|NCT00108056|Malignant Glioma|malignant glioma
5799914|NCT00108056|Glioma|glioma
5799915|NCT00108043|Functional Electrical Stimulation|functional electrical stimulation
5799916|NCT00108043|Gait|gait
5799917|NCT00108043|Blood pressure|blood pressure
5799918|NCT00108043|Orthostatic Hypotension|orthostatic hypotension
5799919|NCT00108043|Cardiovascular responses|cardiovascular responses
5799920|NCT00108043|Near-infra red spectroscopy|near-infra red spectroscopy
5799921|NCT00108030|PBWST training|pbwst training
5681234|NCT00574210|Antihistamine Drug|antihistamine drug
5681235|NCT00574210|Ragweed Pollen|ragweed pollen
5681236|NCT00574197|Heart Transplant|heart transplant
5681237|NCT00574197|gastrointestinal|gastrointestinal
5681238|NCT00574197|Cellcept|cellcept
5681239|NCT00574197|Myfortic|myfortic
5681240|NCT00574197|GI|gi
5799922|NCT00108030|Strength training|strength training
5799923|NCT00108030|6-min walking endurance|6-min walking endurance
5799924|NCT00108030|Cardiovascular fitness|cardiovascular fitness
5799925|NCT00108030|Psychosocial attributes|psychosocial attributes
5799926|NCT00108017|Ocular hypertension (excessive pressure in the eye)|ocular hypertension (excessive pressure in the eye)
5799927|NCT00108004|Diabetes|diabetes
5799928|NCT00108004|Amylin|amylin
5799929|NCT00108004|Symlin|symlin
5799930|NCT00108004|pramlintide acetate|pramlintide acetate
5799931|NCT00107991|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf|clinical trial; efficacy; etanercept; hidradenitis suppurativa; quality of life; safety; tnf
5799932|NCT00107978|cSSSI (complicated Skin and Skin Structure Infections)|csssi (complicated skin and skin structure infections)
5799933|NCT00107978|Staph (Staphylococcus)|staph (staphylococcus)
5799934|NCT00107978|MRSA (Methicillin-resistant Staphylococcus Aureus)|mrsa (methicillin-resistant staphylococcus aureus)
5799935|NCT00107965|Actinic Keratosis|actinic keratosis
5799936|NCT00107965|Solar Keratosis|solar keratosis
5799937|NCT00107965|AK|ak
5799938|NCT00107965|Sun spots|sun spots
5799939|NCT00107965|PEP005|pep005
5799940|NCT00107965|Topical|topical
5799941|NCT00107965|Dermatology|dermatology
5799942|NCT00107952|Nosocomial pneumonia|nosocomial pneumonia
5799943|NCT00107952|MRSA|mrsa
5799944|NCT00107939|bipolar disorder|bipolar disorder
5799945|NCT00107939|manic episode|manic episode
5799946|NCT00107939|treatment|treatment
5799947|NCT00107939|licarbazepine|licarbazepine
5799948|NCT00107926|bipolar disorder|bipolar disorder
5799949|NCT00107926|manic episode|manic episode
5799950|NCT00107926|treatment|treatment
5799951|NCT00107926|licarbazepine|licarbazepine
5799952|NCT00107913|Immune Thrombocytopenic Purpura|immune thrombocytopenic purpura
5799953|NCT00107900|Deep Vein Thrombosis,|deep vein thrombosis,
5799954|NCT00107900|Anticoagulant,|anticoagulant,
5799955|NCT00107900|Venous thromboembolic|venous thromboembolic
5799957|NCT00107887|isoniazid|isoniazid
5799958|NCT00107887|HAART|haart
5799959|NCT00107887|Brazil|brazil
5799960|NCT00107887|HIV|hiv
5799961|NCT00107874|Maternal|maternal
5799962|NCT00107874|morbidity|morbidity
5799963|NCT00107874|mortality|mortality
5799964|NCT00107874|pregnancy|pregnancy
5799965|NCT00107874|postpartum hemorrhage|postpartum hemorrhage
5799966|NCT00107874|Cesarean Section|cesarean section
5799967|NCT00107848|Pediatric Narcolepsy|pediatric narcolepsy
5799968|NCT00107848|Pediatric OSA|pediatric osa
5799969|NCT00107848|CPAP|cpap
5799970|NCT00107848|Pediatric Narcolepsy or OSAHS|pediatric narcolepsy or osahs
5799971|NCT00107835|Pain|pain
5799972|NCT00107822|Pain|pain
5799973|NCT00107809|Pediatric Obstructive sleep Apnea|pediatric obstructive sleep apnea
5799974|NCT00107809|Excessive sleepiness|excessive sleepiness
5799976|NCT00107809|Pediatric OSAHS|pediatric osahs
5799977|NCT00107796|Pediatric Narcolepsy|pediatric narcolepsy
5799978|NCT00107796|Excessive sleepiness|excessive sleepiness
5799979|NCT00107783|Arthritis|arthritis
5799980|NCT00107783|Homogentisic Acid|homogentisic acid
5799981|NCT00107783|Corneal Damage|corneal damage
5799982|NCT00107783|Tyrosine|tyrosine
5799983|NCT00107783|Alkaptonuria|alkaptonuria
5799984|NCT00107783|Photophobia|photophobia
5799985|NCT00107783|Nitisinone|nitisinone
5799986|NCT00107770|ALS|als
5799987|NCT00107770|histone deacetylase inhibition|histone deacetylase inhibition
5799988|NCT00107770|open label|open label
5799989|NCT00107770|safety study|safety study
5799990|NCT00107770|sodium phenylbutyrate|sodium phenylbutyrate
5799991|NCT00107757|pediatric|pediatric
5799992|NCT00107757|Seasonal allergic rhinitis|seasonal allergic rhinitis
5799993|NCT00107744|Blood Pressure; Lipids; Dietary Protein|blood pressure; lipids; dietary protein
5799994|NCT00107731|Bipolar I Disorder|bipolar i disorder
5799995|NCT00107731|Manic Depressive Disorder|manic depressive disorder
5799996|NCT00107731|Manic Depression|manic depression
5799997|NCT00107718|IL-18|il-18
5799998|NCT00107718|treatment naive|treatment naive
5799999|NCT00107718|Phase 2|phase 2
5800000|NCT00107718|melanoma|melanoma
5800001|NCT00107705|allergy|allergy
5800002|NCT00107705|skin prick test|skin prick test
5800004|NCT00107705|allergenicity|allergenicity
5800005|NCT00107705|specific immunotherapy|specific immunotherapy
5800006|NCT00107692|Child Obesity|child obesity
5800007|NCT00107692|Physical activity|physical activity
5800008|NCT00107692|community intervention study|community intervention study
5800009|NCT00107692|competence|competence
5800010|NCT00107692|diet and nutrition|diet and nutrition
5800011|NCT00107692|Nutrition|nutrition
5800012|NCT00107679|Treatment Experienced|treatment experienced
5800014|NCT00107679|HPV|hpv
5800015|NCT00107679|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5800016|NCT00107679|Papillomavirus, Human|papillomavirus, human
5800017|NCT00107666|Coronary artery bypass grafting|coronary artery bypass grafting
5800018|NCT00107666|Heart valve prosthesis implantation|heart valve prosthesis implantation
5800019|NCT00107666|Cardiopulmonary bypass|cardiopulmonary bypass
5800020|NCT00107666|Oxidative stress|oxidative stress
5800021|NCT00107666|Inflammation|inflammation
5800022|NCT00107666|Endotoxemia|endotoxemia
5800023|NCT00107640|At-risk drinking|at-risk drinking
5800024|NCT00107640|Alcohol education|alcohol education
5800025|NCT00107640|Effectiveness|effectiveness
5800026|NCT00107640|Cost-effectiveness|cost-effectiveness
5800027|NCT00107627|Gynaecological Cancer|gynaecological cancer
5800028|NCT00107627|Surgical Staples|surgical staples
5800029|NCT00107627|Subcuticular Sutures|subcuticular sutures
5800030|NCT00107614|Waldenstrom|waldenstrom
5800031|NCT00107601|Glucose|glucose
5800032|NCT00107601|Glucose Control|glucose control
5800033|NCT00107601|Insulin|insulin
5800034|NCT00107601|Insulin therapy|insulin therapy
5800035|NCT00107601|Critically ill|critically ill
5800036|NCT00107601|Intensive Care|intensive care
5800037|NCT00107588|marijuana dependence|marijuana dependence
5800038|NCT00107588|self-efficacy|self-efficacy
5800039|NCT00107588|coping skills|coping skills
5800040|NCT00107588|attendance|attendance
5800041|NCT00107588|marijuana abstinence|marijuana abstinence
5800042|NCT00107575|tobacco|tobacco
5800043|NCT00107575|alcohol|alcohol
5800044|NCT00107562|risk behavior|risk behavior
5800045|NCT00107562|social networks|social networks
5800046|NCT00107562|behavior|behavior
5800047|NCT00107549|Treatment Experienced|treatment experienced
5800048|NCT00107549|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5800049|NCT00107523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5800050|NCT00107523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5800051|NCT00107523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5800052|NCT00107523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5800053|NCT00107523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5800054|NCT00107523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5800055|NCT00107523|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5800056|NCT00107510|stage II breast cancer|stage ii breast cancer
5800057|NCT00107510|stage IIIA breast cancer|stage iiia breast cancer
5800058|NCT00107510|stage IIIB breast cancer|stage iiib breast cancer
5800059|NCT00107510|stage IIIC breast cancer|stage iiic breast cancer
5800060|NCT00107510|male breast cancer|male breast cancer
5800061|NCT00107497|stage I breast cancer|stage i breast cancer
5800062|NCT00107497|stage II breast cancer|stage ii breast cancer
5800063|NCT00107484|stage IV breast cancer|stage iv breast cancer
5800064|NCT00107484|stage I breast cancer|stage i breast cancer
5800065|NCT00107484|stage II breast cancer|stage ii breast cancer
5800066|NCT00107484|stage IIIA breast cancer|stage iiia breast cancer
5800067|NCT00107484|stage IIIB breast cancer|stage iiib breast cancer
5800068|NCT00107484|stage IIIC breast cancer|stage iiic breast cancer
5800070|NCT00107471|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5800071|NCT00107458|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5800072|NCT00107458|recurrent childhood brain tumor|recurrent childhood brain tumor
5800073|NCT00107458|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5800074|NCT00107458|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5800075|NCT00107458|recurrent childhood ependymoma|recurrent childhood ependymoma
5800076|NCT00107458|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5800077|NCT00107458|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5800078|NCT00107458|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5800079|NCT00107458|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5800080|NCT00107458|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5800081|NCT00107458|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5800082|NCT00107458|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5800083|NCT00107458|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5800084|NCT00107458|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5800085|NCT00107458|childhood grade I meningioma|childhood grade i meningioma
5795202|NCT00123708|Spasticity|spasticity
5800087|NCT00107458|childhood grade III meningioma|childhood grade iii meningioma
5800088|NCT00107458|childhood craniopharyngioma|childhood craniopharyngioma
5800089|NCT00107458|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5800090|NCT00107419|chondrosarcoma|chondrosarcoma
5800091|NCT00107393|recurrent breast cancer|recurrent breast cancer
5800092|NCT00107393|stage IV breast cancer|stage iv breast cancer
5800093|NCT00107380|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5800094|NCT00107380|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5800095|NCT00107380|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5800096|NCT00107380|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5800097|NCT00107367|tumors metastatic to brain|tumors metastatic to brain
5800098|NCT00107354|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5800099|NCT00107354|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5800100|NCT00107354|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5800101|NCT00107354|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5800102|NCT00107354|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5800103|NCT00107354|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5800104|NCT00107354|refractory anemia with excess blasts|refractory anemia with excess blasts
5800105|NCT00107354|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5800106|NCT00107354|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5800107|NCT00107354|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5800108|NCT00107354|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5800109|NCT00107354|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5800110|NCT00107354|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5800111|NCT00107354|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5800112|NCT00107354|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5800113|NCT00107354|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5800114|NCT00107354|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5800115|NCT00107354|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5800116|NCT00107354|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5800944|NCT00104403|CINV|cinv
5800117|NCT00107354|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5800118|NCT00107341|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5800119|NCT00107341|stage IV esophageal cancer|stage iv esophageal cancer
5800120|NCT00107341|recurrent esophageal cancer|recurrent esophageal cancer
5800121|NCT00107315|recurrent colon cancer|recurrent colon cancer
5800122|NCT00107315|stage IV colon cancer|stage iv colon cancer
5800123|NCT00107315|recurrent rectal cancer|recurrent rectal cancer
5800124|NCT00107315|stage IV rectal cancer|stage iv rectal cancer
5800125|NCT00107289|metastatic pheochromocytoma|metastatic pheochromocytoma
5800126|NCT00107289|recurrent pheochromocytoma|recurrent pheochromocytoma
5800127|NCT00107289|regional pheochromocytoma|regional pheochromocytoma
5800128|NCT00107289|recurrent neuroblastoma|recurrent neuroblastoma
5800129|NCT00107289|04-148|04-148
5800130|NCT00107276|stage IV breast cancer|stage iv breast cancer
5800131|NCT00107276|recurrent breast cancer|recurrent breast cancer
5800132|NCT00107263|osteoporosis|osteoporosis
5800133|NCT00107263|stage I breast cancer|stage i breast cancer
5790834|NCT00141752|stroke|stroke
5800134|NCT00107263|stage II breast cancer|stage ii breast cancer
5800135|NCT00107263|stage IIIA breast cancer|stage iiia breast cancer
5800136|NCT00107250|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5800137|NCT00107250|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5800138|NCT00107250|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5800139|NCT00107250|stage IV colon cancer|stage iv colon cancer
5800140|NCT00107250|stage IV rectal cancer|stage iv rectal cancer
5800141|NCT00107250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5800142|NCT00107237|adult glioblastoma|adult glioblastoma
5800143|NCT00107237|recurrent adult brain tumor|recurrent adult brain tumor
5800144|NCT00107237|adult giant cell glioblastoma|adult giant cell glioblastoma
5800145|NCT00107237|adult gliosarcoma|adult gliosarcoma
5800146|NCT00107211|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5800147|NCT00107211|breast cancer in situ|breast cancer in situ
5800148|NCT00107185|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5800149|NCT00107185|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5800150|NCT00107185|childhood oligodendroglioma|childhood oligodendroglioma
5800151|NCT00107172|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5800152|NCT00107159|recurrent melanoma|recurrent melanoma
5800153|NCT00107159|stage III melanoma|stage iii melanoma
5800154|NCT00107159|stage IV melanoma|stage iv melanoma
5800155|NCT00107120|Major Depressive Disorder|major depressive disorder
5800157|NCT00107120|Adolescents|adolescents
5800158|NCT00107120|Escitalopram|escitalopram
5800159|NCT00107120|Pediatrics|pediatrics
5800160|NCT00107107|Diabetes|diabetes
5800161|NCT00107107|Amylin|amylin
5800162|NCT00107107|pramlintide|pramlintide
5800163|NCT00107107|Symlin|symlin
5800164|NCT00107094|Breast Cancer|breast cancer
5800165|NCT00107094|Adriamycin|adriamycin
5800166|NCT00107094|Cyclophosphamide|cyclophosphamide
5800167|NCT00107094|Abraxane|abraxane
5800183|NCT00107029|HIV infection|hiv infection
5800184|NCT00107029|CD8+ T-cells|cd8+ t-cells
5800185|NCT00107029|HIV-1 genotype|hiv-1 genotype
5800186|NCT00107016|Breast Cancer|breast cancer
5800187|NCT00107016|Cancer of the Breast|cancer of the breast
5800188|NCT00107016|Neo-adjuvant|neo-adjuvant
5800189|NCT00107016|Primary breast cancer|primary breast cancer
5800190|NCT00107016|postmenopausal|postmenopausal
5800191|NCT00107016|pre-operative|pre-operative
5800192|NCT00107003|Brain|brain
5800193|NCT00107003|Tumor|tumor
5800194|NCT00107003|Surgery|surgery
5800195|NCT00107003|Therapy|therapy
5800196|NCT00107003|Trial|trial
5800197|NCT00107003|Brain Tumor|brain tumor
5800198|NCT00107003|Glioblastoma Multiforme|glioblastoma multiforme
5800199|NCT00107003|GBM|gbm
5800200|NCT00107003|Gliosarcoma|gliosarcoma
5800201|NCT00107003|GS|gs
5800209|NCT00106964|Hepatitis B vaccines|hepatitis b vaccines
5800210|NCT00106964|HIV-infected adolescents|hiv-infected adolescents
5800211|NCT00106964|Hepatitis B infection (negative)|hepatitis b infection (negative)
5800212|NCT00106951|Surveillance|surveillance
5800213|NCT00106951|coronary heart disease|coronary heart disease
5800214|NCT00106951|neighborhood SES|neighborhood ses
5800215|NCT00106938|Carotid stenting|carotid stenting
5800216|NCT00106938|Carotid endarterectomy|carotid endarterectomy
5800217|NCT00106938|Carotid artery disease with severe narrowing of the artery|carotid artery disease with severe narrowing of the artery
5800218|NCT00106938|Stroke prevention|stroke prevention
5800225|NCT00106912|Genetic|genetic
5800226|NCT00106912|Stroke|stroke
5800227|NCT00106912|Heart|heart
5800228|NCT00106912|Lysosomal|lysosomal
5800229|NCT00106912|Glycolipid|glycolipid
5800230|NCT00106912|Fabry Disease|fabry disease
5800231|NCT00106899|neuroimaging|neuroimaging
5800232|NCT00106899|brain metabolism|brain metabolism
5800233|NCT00106899|biomarkers|biomarkers
5800234|NCT00106899|cognition disorder|cognition disorder
5800235|NCT00106899|Mild Cognitive Impairment|mild cognitive impairment
5800236|NCT00106886|homocysteine|homocysteine
5800237|NCT00106886|folic acid|folic acid
5800238|NCT00106886|micronutrients|micronutrients
5800239|NCT00106886|multivitamins|multivitamins
5800240|NCT00106886|vitamin supplements|vitamin supplements
5800241|NCT00106860|Anxiety|anxiety
5800242|NCT00106860|Generalized Anxiety Disorder|generalized anxiety disorder
5800243|NCT00106847|plaque-type psoriasis|plaque-type psoriasis
5800244|NCT00106847|psoriasis|psoriasis
5800245|NCT00106847|drug safety|drug safety
5800246|NCT00106847|drug efficacy|drug efficacy
5800247|NCT00106847|maintenance therapy|maintenance therapy
5800248|NCT00106847|induction therapy|induction therapy
5800249|NCT00106847|remicade|remicade
5800250|NCT00106834|Psoriasis|psoriasis
5800251|NCT00106834|Infliximab|infliximab
5800252|NCT00106834|Remicade|remicade
5800253|NCT00106808|Type 2 Diabetes|type 2 diabetes
5800254|NCT00106795|Antiretrovirals|antiretrovirals
5800255|NCT00106795|Adipocytes|adipocytes
5800256|NCT00106795|Skeletal Muscle|skeletal muscle
5800257|NCT00106795|Fatigue|fatigue
5800258|NCT00106795|HIV|hiv
5800259|NCT00106795|AIDS|aids
5800260|NCT00106795|Lymphocytes|lymphocytes
5800261|NCT00106795|Lipodystrophy|lipodystrophy
5800262|NCT00106795|HIV Positive|hiv positive
5800263|NCT00106795|Healthy Volunteer|healthy volunteer
5800264|NCT00106795|HV|hv
5800265|NCT00106782|Electrical|electrical
5800266|NCT00106782|Stimulation|stimulation
5800267|NCT00106782|Dystonia|dystonia
5800268|NCT00106782|Brain|brain
5800269|NCT00106782|Focal Hand Dystonia|focal hand dystonia
5800270|NCT00106782|FHD|fhd
5800271|NCT00106769|Flavivirus|flavivirus
5800272|NCT00106769|Mosquito|mosquito
5800273|NCT00106769|Immunity|immunity
5800274|NCT00106769|Preventive|preventive
5800275|NCT00106769|Virus|virus
5800276|NCT00106769|West Nile Fever|west nile fever
5800277|NCT00106769|Healthy Volunteer|healthy volunteer
5800278|NCT00106769|HV|hv
5800279|NCT00106756|Exudation|exudation
5800280|NCT00106756|Avascular Retina|avascular retina
5800281|NCT00106756|Retina Fold|retina fold
5800282|NCT00106743|Usher Syndrome|usher syndrome
5800283|NCT00106743|Retinitis Pigmentosa|retinitis pigmentosa
5800284|NCT00106743|Congenital Deafness|congenital deafness
5800285|NCT00106717|Cancer pain|cancer pain
5800286|NCT00106717|Quality of life|quality of life
5800287|NCT00106717|Narrative medicine|narrative medicine
5800288|NCT00106717|Pain relief|pain relief
5800289|NCT00106691|neoplasia|neoplasia
5800290|NCT00106691|chemoprevention|chemoprevention
5800291|NCT00106691|cancer|cancer
5800294|NCT00106691|Chemoprophylaxis|chemoprophylaxis
5800295|NCT00106691|Intraepithelial Prostatic Neoplasia|intraepithelial prostatic neoplasia
5800296|NCT00106691|Neoplasia, Prostatic Intraepithelial|neoplasia, prostatic intraepithelial
5800297|NCT00106678|HIV|hiv
5800298|NCT00106678|Antiretroviral therapy (ART)|antiretroviral therapy (art)
5800299|NCT00106678|HAART|haart
5800300|NCT00106678|Adherence|adherence
5800301|NCT00106678|Barriers|barriers
5800302|NCT00106665|ICU acquired weakness|icu acquired weakness
5800303|NCT00106665|Critical care polyneuropathy|critical care polyneuropathy
5800304|NCT00106665|Critical care myopathy|critical care myopathy
5800305|NCT00106652|autism|autism
5800306|NCT00106652|neurodevelopment|neurodevelopment
5800307|NCT00106652|neurotoxicology|neurotoxicology
5800308|NCT00106652|perinatology|perinatology
5800309|NCT00106652|teratology|teratology
5800310|NCT00106639|tofacitinib|tofacitinib
5800311|NCT00106639|CP-690550|cp-690550
5800312|NCT00106639|kidney transplant|kidney transplant
5800313|NCT00106626|Advanced solid tumors including MPM and NSCLC|advanced solid tumors including mpm and nsclc
5800314|NCT00106613|Renal Cell Carcinoma|renal cell carcinoma
5800315|NCT00106613|Metastatic Cancer|metastatic cancer
5800316|NCT00106613|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5800317|NCT00106600|Relapsed|relapsed
5800318|NCT00106600|Refractory|refractory
5800319|NCT00106587|in stent restenosis|in stent restenosis
5800320|NCT00106587|paclitaxel coated balloon catheter|paclitaxel coated balloon catheter
5800321|NCT00106587|paccocath|paccocath
5800322|NCT00106587|drug eluting balloon|drug eluting balloon
5800323|NCT00106561|spironolactone|spironolactone
5800324|NCT00106561|proteinuria|proteinuria
5800325|NCT00106561|angiotensin converting enzyme inhibitor|angiotensin converting enzyme inhibitor
5800326|NCT00106561|angiotensin receptor blocker|angiotensin receptor blocker
5800327|NCT00106561|renin angiotensin aldosterone system|renin angiotensin aldosterone system
5800328|NCT00106561|aldosterone|aldosterone
5800329|NCT00106509|Clostridium Enterocolitis|clostridium enterocolitis
5800330|NCT00106509|Pseudomembranous Colitis|pseudomembranous colitis
5800331|NCT00106509|Clostridium difficile-associated diarrhea|clostridium difficile-associated diarrhea
5800332|NCT00106509|C. difficile|c. difficile
5800333|NCT00106509|CDAD|cdad
5800334|NCT00106496|Treatment Effectiveness|treatment effectiveness
5800335|NCT00106496|Treatment Efficacy|treatment efficacy
5800336|NCT00106496|Immunomodulator, Topical|immunomodulator, topical
5800337|NCT00106496|Tacrolimus, Topical|tacrolimus, topical
5800338|NCT00106496|Dermatitis, Atopic|dermatitis, atopic
5800339|NCT00106496|Eczema, Atopic|eczema, atopic
5800340|NCT00106496|Atopic Dermatitis|atopic dermatitis
5800341|NCT00106483|Cardiovascular Diseases|cardiovascular diseases
5800342|NCT00106483|Coronary Disease|coronary disease
5800343|NCT00106483|Heart Diseases|heart diseases
5800344|NCT00106470|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5800345|NCT00106431|romidepsin|romidepsin
5800346|NCT00106418|Prostate Cancer|prostate cancer
5800347|NCT00106418|Androgen independent metastatic prostate cancer patients with rising PSA|androgen independent metastatic prostate cancer patients with rising psa
5800348|NCT00106418|romidepsin|romidepsin
5800349|NCT00106405|Bipolar I Disorder|bipolar i disorder
5800350|NCT00106405|Mania|mania
5800351|NCT00106405|Memantine HCl|memantine hcl
5800352|NCT00106392|Treatment effectiveness|treatment effectiveness
5800353|NCT00106392|Treatment efficacy|treatment efficacy
5800354|NCT00106392|Investigational, Therapies|investigational, therapies
5800355|NCT00106392|Immunosuppressant|immunosuppressant
5800356|NCT00106392|Erectile dysfunction|erectile dysfunction
5800357|NCT00106392|Prostatectomy|prostatectomy
5800358|NCT00106379|HIV-1|hiv-1
5800359|NCT00106379|Treatment Naive|treatment naive
5800360|NCT00106379|Treatment Experienced|treatment experienced
5800361|NCT00106366|Diabetes, Type 2|diabetes, type 2
5800362|NCT00106353|Pediatric Tumors|pediatric tumors
5800363|NCT00106340|type 2 diabetes|type 2 diabetes
5800364|NCT00106340|vildagliptin|vildagliptin
5800365|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone
5800366|NCT00106314|DHEA|dhea
5800367|NCT00106314|Crohn's disease|crohn's disease
5820787|NCT00076986|GBM|gbm
5799509|NCT00024635|Mood|mood
5799510|NCT00024635|Diagnostic Testing|diagnostic testing
5800368|NCT00106314|C-reactive protein|c-reactive protein
5800369|NCT00106314|CRP|crp
5800370|NCT00106314|Crohn's Disease Activity Index|crohn's disease activity index
5800371|NCT00106314|CDAI|cdai
5800372|NCT00106314|Inflammatory Bowel Disease Questionnaire|inflammatory bowel disease questionnaire
5800373|NCT00106314|IBDQ|ibdq
5800374|NCT00106301|FK228|fk228
5800375|NCT00106301|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5800376|NCT00106288|Candidaemia|candidaemia
5800377|NCT00106288|Micafungin|micafungin
5800378|NCT00106275|Fibromyalgia|fibromyalgia
5800379|NCT00106275|Meditation|meditation
5800380|NCT00106275|Stress, Psychological|stress, psychological
5800381|NCT00106275|Monitoring, Ambulatory|monitoring, ambulatory
5800382|NCT00106275|Electrocardiographie, Ambulatory|electrocardiographie, ambulatory
5800383|NCT00106275|Psychophysiology|psychophysiology
5800384|NCT00106262|advanced cervical cancer|advanced cervical cancer
5800385|NCT00106262|metastatic cervical cancer|metastatic cervical cancer
5800386|NCT00106249|TMS, Supplementary Motor Area, Obsessive-Compulsive Disorder|tms, supplementary motor area, obsessive-compulsive disorder
5800387|NCT00106236|Exercise|exercise
5800388|NCT00106236|Fitness Club|fitness club
5800389|NCT00106236|Randomized Controlled Trial|randomized controlled trial
5800390|NCT00106236|Cardiovascular Risk Factor|cardiovascular risk factor
5800391|NCT00106236|Overweight|overweight
5800392|NCT00106236|Inactivity|inactivity
5800393|NCT00106223|Cognitive Behavioral Therapy|cognitive behavioral therapy
5800395|NCT00106223|BDD|bdd
5800396|NCT00106223|Body dysmorphic disorder|body dysmorphic disorder
5800397|NCT00106210|Child|child
5800398|NCT00106197|Sleep, REM|sleep, rem
5800399|NCT00106197|Antidepressant|antidepressant
5800400|NCT00106197|Adolescent|adolescent
5800401|NCT00106197|Cortisol|cortisol
5800402|NCT00106184|rituximab|rituximab
5800403|NCT00106184|myositis|myositis
5800404|NCT00106184|dermatomyositis|dermatomyositis
5800405|NCT00106184|polymyositis|polymyositis
5800406|NCT00106184|refractory|refractory
5800407|NCT00106184|Juvenile Dermatomyositis|juvenile dermatomyositis
5800408|NCT00106171|HIV|hiv
5800409|NCT00106171|Acute/Early Seroconverters|acute/early seroconverters
5800410|NCT00106171|Acute Infection|acute infection
5800411|NCT00106171|Treatment Naive|treatment naive
5800412|NCT00106171|Primary HIV Infection|primary hiv infection
5800413|NCT00106158|cancer/testis antigen|cancer/testis antigen
5800414|NCT00106158|cancer vaccine|cancer vaccine
5800415|NCT00106158|recombinant protein|recombinant protein
5800416|NCT00106145|Advanced Breast Cancer|advanced breast cancer
5800417|NCT00106145|Solid Tumors|solid tumors
5800418|NCT00106145|Advanced Solid Tumors|advanced solid tumors
5800419|NCT00106132|Macular Edema|macular edema
5800420|NCT00106132|Steroid|steroid
5800421|NCT00106132|Fluorescein Angiogram|fluorescein angiogram
5800422|NCT00106132|Ocular Coherence Tomography|ocular coherence tomography
5800423|NCT00106132|Laser|laser
5800424|NCT00106132|Retinal Vein Occlusion|retinal vein occlusion
5800425|NCT00106119|Levothyroxine|levothyroxine
5800426|NCT00106119|Liothyronine|liothyronine
5800427|NCT00106119|Lipid Metabolism|lipid metabolism
5800428|NCT00106119|Gluconeogensis|gluconeogensis
5800429|NCT00106119|Thyrotropin Releasing Hormone|thyrotropin releasing hormone
5800431|NCT00106119|Replacement Thyroid Hormone Therapy|replacement thyroid hormone therapy
5800432|NCT00106119|Thyroidectomy|thyroidectomy
5800433|NCT00106119|Near Total Thyroidectomy|near total thyroidectomy
5800434|NCT00106106|Alcoholism|alcoholism
5800435|NCT00106106|Acamprosate|acamprosate
5800436|NCT00106106|Withdrawal|withdrawal
5800437|NCT00106106|Glutamate|glutamate
5800438|NCT00106106|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5800439|NCT00106106|Alcohol Dependence|alcohol dependence
5800440|NCT00106106|Healthy Volunteer|healthy volunteer
5800441|NCT00106106|HV|hv
5800442|NCT00106093|Alcohol|alcohol
5800443|NCT00106093|Alcohol Treatment|alcohol treatment
5800444|NCT00106093|DNA|dna
5800445|NCT00106093|Treatment|treatment
5800446|NCT00106093|Alcohol Dependence|alcohol dependence
5800447|NCT00106093|Alcoholism|alcoholism
5800448|NCT00106093|Alcohol Drinking Related Problems|alcohol drinking related problems
5800449|NCT00106080|Communication|communication
5800450|NCT00106080|Palliative Care|palliative care
5800451|NCT00106067|aging|aging
5800452|NCT00106067|behavioral research|behavioral research
5800453|NCT00106067|quality of life|quality of life
5800454|NCT00106067|end of life|end of life
5800455|NCT00106067|family relations|family relations
5800456|NCT00106067|supportive care|supportive care
5800457|NCT00106067|advanced care|advanced care
5800458|NCT00106067|bereavement|bereavement
5800459|NCT00106041|end of life care|end of life care
5800460|NCT00106041|evaluation studies|evaluation studies
5800461|NCT00106041|quality of death and dying|quality of death and dying
5800462|NCT00106041|palliative care|palliative care
5800463|NCT00106041|coordination of care|coordination of care
5800464|NCT00106041|satisfaction with care|satisfaction with care
5800465|NCT00106041|healthcare cost|healthcare cost
5799611|NCT00109161|Multiple Sclerosis, MS, CNS, Daclizumab|multiple sclerosis, ms, cns, daclizumab
5799612|NCT00109148|Obesity and obesity-related medical conditions|obesity and obesity-related medical conditions
5800466|NCT00106041|utilization of healthcare resources|utilization of healthcare resources
5800467|NCT00106041|caregivers|caregivers
5800468|NCT00106041|veterans|veterans
5800469|NCT00106028|Primary disease: Osteogenesis Imperfecta|primary disease: osteogenesis imperfecta
5800470|NCT00106015|inherited pure red cell aplasia|inherited pure red cell aplasia
5800471|NCT00105963|abuse|abuse
5800472|NCT00105950|ErbB2 overexpressing|erbb2 overexpressing
5800473|NCT00105950|ErbB1 expressing|erbb1 expressing
5800474|NCT00105950|relapsed breast cancer|relapsed breast cancer
5800475|NCT00105950|refractory inflammatory breast cancer|refractory inflammatory breast cancer
5800476|NCT00105937|Cancer|cancer
5800477|NCT00105937|Pain|pain
5800478|NCT00105911|Cognitive Behavioral Therapy|cognitive behavioral therapy
5800479|NCT00105898|Diabetes mellitus|diabetes mellitus
5800480|NCT00105898|Hypertension|hypertension
5800481|NCT00105898|Telemedicine|telemedicine
5800482|NCT00105898|Case management|case management
5795574|NCT00122226|HIV|hiv
5800483|NCT00105885|Telephone|telephone
5800484|NCT00105885|Telemedicine|telemedicine
5800485|NCT00105885|Psychopharmacology|psychopharmacology
5800486|NCT00105872|insomnia|insomnia
5800487|NCT00105872|cognitive behavior therapy|cognitive behavior therapy
5800488|NCT00105820|Evaluation|evaluation
5800489|NCT00105820|Quality improvement|quality improvement
5800490|NCT00105820|Cluster randomized trial|cluster randomized trial
5800491|NCT00105820|Care model|care model
5800492|NCT00105820|Collaborative care|collaborative care
5800493|NCT00105820|Informatics|informatics
5800494|NCT00105794|advance directives|advance directives
5800495|NCT00105794|advance directive adherence|advance directive adherence
5800496|NCT00105794|patient-centered care|patient-centered care
5800497|NCT00105794|patient satisfaction|patient satisfaction
5800498|NCT00105794|coercion|coercion
5800499|NCT00105794|informed consent|informed consent
5800500|NCT00105794|commitment of mentally ill|commitment of mentally ill
5800501|NCT00105794|physician-patient relations|physician-patient relations
5800502|NCT00105781|Nurses|nurses
5800503|NCT00105781|Telephone|telephone
5800504|NCT00105781|Counseling|counseling
5800505|NCT00105781|Exercise|exercise
5800506|NCT00105755|Activity Cycles|activity cycles
5800507|NCT00105755|Amputation|amputation
5800508|NCT00105755|Prevention|prevention
5800509|NCT00105755|Temperature|temperature
5800510|NCT00105729|Self-help groups|self-help groups
5800511|NCT00105729|Referral and consultation|referral and consultation
5800512|NCT00105716|hypertension|hypertension
5800513|NCT00105716|adherence|adherence
5800514|NCT00105716|cardiovascular diseases|cardiovascular diseases
5800515|NCT00105703|Nurse practitioners|nurse practitioners
5800516|NCT00105703|Case management|case management
5800517|NCT00105677|Racial/ethnic health disparities|racial/ethnic health disparities
5800518|NCT00105677|Attitudes|attitudes
5800519|NCT00105677|Osteoarthritis Management|osteoarthritis management
5800520|NCT00105677|Patient Perceptions|patient perceptions
5800521|NCT00105664|Outcomes Assessment|outcomes assessment
5800522|NCT00105664|Primary Health Care|primary health care
5800523|NCT00105664|Group Process|group process
5800524|NCT00105638|Intervention studies|intervention studies
5800525|NCT00105638|Health Care Costs|health care costs
5800526|NCT00105638|Telephone|telephone
5800527|NCT00105638|Caregivers|caregivers
5800528|NCT00105625|Geriatrics|geriatrics
5800529|NCT00105625|Nutrition|nutrition
5800530|NCT00105625|Immune function|immune function
5800531|NCT00105625|Infection|infection
5800532|NCT00105625|Rehabilitation|rehabilitation
5800533|NCT00105625|Inpatient|inpatient
5800534|NCT00105612|Informed Consent|informed consent
5800535|NCT00105612|Memory Aid|memory aid
5800536|NCT00105586|Anxiety|anxiety
5800537|NCT00105586|Elderly|elderly
5800538|NCT00105586|Aged|aged
5800539|NCT00105586|Serotonin Reuptake Inhibitors|serotonin reuptake inhibitors
5800540|NCT00105586|SSRI|ssri
5800541|NCT00105586|SERT|sert
5800542|NCT00105573|Mother-Child Relations|mother-child relations
5800543|NCT00105573|Infant|infant
5800544|NCT00105573|Child Development|child development
5800545|NCT00105573|Poverty|poverty
5800546|NCT00105560|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5800547|NCT00105560|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5800548|NCT00105560|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5800549|NCT00105547|Alzheimer's|alzheimer's
5800550|NCT00105547|Dementia|dementia
5800551|NCT00105547|Dementia of Alzheimer Type|dementia of alzheimer type
5800552|NCT00105534|Bacterial Conjunctivitis|bacterial conjunctivitis
5800553|NCT00105534|Pink Eye|pink eye
5800554|NCT00105534|Conjunctivitis|conjunctivitis
5800555|NCT00105534|Eye Infection|eye infection
5800996|NCT00104156|Arthritis|arthritis
5800556|NCT00105534|Eye Discharge|eye discharge
5800557|NCT00105521|Parkinson's Disease|parkinson's disease
5800558|NCT00105521|Dyskinesia|dyskinesia
5800559|NCT00105521|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
5800560|NCT00105508|Parkinson's Disease|parkinson's disease
5800561|NCT00105508|Dyskinesia|dyskinesia
5800562|NCT00105508|Dyskinesia associated with dopaminergic treatment|dyskinesia associated with dopaminergic treatment
5800563|NCT00105495|Iron Overload|iron overload
5800564|NCT00105495|Thalassemia|thalassemia
5800565|NCT00105495|Haemosiderosis|haemosiderosis
5800567|NCT00105495|Deferiprone|deferiprone
5800568|NCT00105495|Chelation|chelation
5800569|NCT00105482|Tobacco|tobacco
5800570|NCT00105482|Smoking|smoking
5800571|NCT00105482|Weight|weight
5800572|NCT00105482|Weight perception|weight perception
5800573|NCT00105482|Naltrexone|naltrexone
5800574|NCT00105469|Bacterial Conjunctivitis|bacterial conjunctivitis
5800575|NCT00105469|Pink Eye|pink eye
5800576|NCT00105469|Conjunctivitis|conjunctivitis
5800577|NCT00105469|Eye Infection|eye infection
5800578|NCT00105456|HER2-Positive Metastatic Breast Cancer|her2-positive metastatic breast cancer
5800579|NCT00105456|HER2|her2
5800580|NCT00105443|Liver Cancer|liver cancer
5800581|NCT00105443|Cancer|cancer
5800582|NCT00105430|Surgery|surgery
5800583|NCT00105430|Treatment|treatment
5800584|NCT00105430|Physiology|physiology
5800586|NCT00105430|Neurosurgery|neurosurgery
5800587|NCT00105430|Generalized Primary Dystonia|generalized primary dystonia
5800588|NCT00105417|Immune Reconstitution|immune reconstitution
5800589|NCT00105417|Thymus|thymus
5800590|NCT00105417|Cytokines|cytokines
5800592|NCT00105404|Steroid|steroid
5800593|NCT00105404|Diabetic Macular Edema|diabetic macular edema
5800594|NCT00105404|DME|dme
5800595|NCT00105378|health care services research|health care services research
5800596|NCT00105378|frail elderly|frail elderly
5800597|NCT00105378|intermediate care|intermediate care
5800598|NCT00105378|patient centered care|patient centered care
5800599|NCT00105378|comprehensive health care|comprehensive health care
5800600|NCT00105378|geriatric nursing|geriatric nursing
5800601|NCT00105378|Behavioral symptoms|behavioral symptoms
5800602|NCT00105365|lateral wedge inserts|lateral wedge inserts
5800603|NCT00105365|shoe inserts|shoe inserts
5800604|NCT00105352|Type 1 Diabetes Study Group|type 1 diabetes study group
5800605|NCT00105352|TrialNet|trialnet
5800606|NCT00105352|type 1 diabetes|type 1 diabetes
5800607|NCT00105352|juvenile onset diabetes|juvenile onset diabetes
5800608|NCT00105339|consent form, vaccine trial|consent form, vaccine trial
5800609|NCT00105339|Simplified consent form|simplified consent form
5800610|NCT00105326|Schizophrenia|schizophrenia
5800611|NCT00105326|Schizophrenia-related insomnia|schizophrenia-related insomnia
5800612|NCT00105326|insomnia|insomnia
5800613|NCT00105326|paliperidone|paliperidone
5800614|NCT00105326|placebo|placebo
5800615|NCT00105326|polysomnography|polysomnography
5800616|NCT00105287|cancer|cancer
5800617|NCT00105287|pain|pain
5800618|NCT00105287|Breakthrough Pain in cancer patients|breakthrough pain in cancer patients
5800619|NCT00105274|Velocardiofacial Syndrome|velocardiofacial syndrome
5800620|NCT00105274|Susceptibility Genes|susceptibility genes
5853239|NCT00002179|Lymph Nodes|lymph nodes
5800621|NCT00105274|Neuroimaging|neuroimaging
5800622|NCT00105274|22q11.2|22q11.2
5800623|NCT00105274|Psychosis|psychosis
5800624|NCT00105274|Mircodeletion|mircodeletion
5800625|NCT00105274|DiGeorge Syndrome|digeorge syndrome
5800626|NCT00105274|22q11.2 Syndrome|22q11.2 syndrome
5800627|NCT00105248|acute repiratory infections|acute repiratory infections
5800628|NCT00105248|antibiotic therapy|antibiotic therapy
5800629|NCT00105248|patient-centred communication|patient-centred communication
5800630|NCT00105248|randomized controlled trial|randomized controlled trial
5800631|NCT00105235|transplantation|transplantation
5800632|NCT00105235|liver transplant|liver transplant
5800633|NCT00105235|rejection|rejection
5800634|NCT00105235|tolerance|tolerance
5800635|NCT00105235|antibody induction|antibody induction
5800636|NCT00105222|Cycle Ergometer|cycle ergometer
5800637|NCT00105222|Exercise Physiology|exercise physiology
5800638|NCT00105222|Nitric Oxide|nitric oxide
5800639|NCT00105222|Sodium Nitrite|sodium nitrite
5800640|NCT00105222|Healthy Volunteers|healthy volunteers
5800641|NCT00105222|Normal Volunteer|normal volunteer
5800642|NCT00105222|Healthy Volunteer|healthy volunteer
5800643|NCT00105222|HV|hv
5800644|NCT00105209|Platelets|platelets
5800645|NCT00105196|Single or recurrent|single or recurrent
5800646|NCT00105196|non-psychotic episode of Major Depressive Disorder|non-psychotic episode of major depressive disorder
5800647|NCT00105183|pulmonary transplantation|pulmonary transplantation
5800648|NCT00105183|Pulmonary Allograft Rejection|pulmonary allograft rejection
5800649|NCT00105170|Monoclonal antibody|monoclonal antibody
5800650|NCT00105170|Advanced solid tumors|advanced solid tumors
5800651|NCT00105170|Tumors|tumors
5800652|NCT00105170|hCBE-11|hcbe-11
5800653|NCT00105144|Treatment Effectiveness|treatment effectiveness
5800654|NCT00105144|Treatment Efficacy|treatment efficacy
5800655|NCT00105144|Investigational, Therapies|investigational, therapies
5800656|NCT00105144|Antifungal, Systemic|antifungal, systemic
5800657|NCT00105144|Antibiotics, Antifungal|antibiotics, antifungal
5799819|NCT00108290|Prostate cancer|prostate cancer
5800658|NCT00105144|Micafungin|micafungin
5800659|NCT00105131|Parkinson's Disease|parkinson's disease
5800660|NCT00105131|Movement Disorders|movement disorders
5800661|NCT00105131|Tremor|tremor
5800662|NCT00105131|Alpha-Synuclein|alpha-synuclein
5800663|NCT00105131|Lewy Bodies|lewy bodies
5800664|NCT00105131|Parkinson Disease|parkinson disease
5800665|NCT00105131|PD|pd
5800666|NCT00105131|Movement Disorder|movement disorder
5800667|NCT00105131|Healthy Volunteer|healthy volunteer
5800668|NCT00105131|HV|hv
5800669|NCT00105118|Cognition|cognition
5800670|NCT00105118|Alpha|alpha
5800671|NCT00105118|Schizophrenia|schizophrenia
5800672|NCT00105118|Functional Connectivity|functional connectivity
5800673|NCT00105118|Oscillatory Potential|oscillatory potential
5800674|NCT00105105|Alzheimers|alzheimers
5800675|NCT00105105|cognition|cognition
5800676|NCT00105105|acetyl cholinesterase inhibitor|acetyl cholinesterase inhibitor
5800677|NCT00105105|GR-II antagonist|gr-ii antagonist
5800678|NCT00105066|Metabolic Syndrome|metabolic syndrome
5800679|NCT00105066|triglycerides|triglycerides
5800680|NCT00105066|HDL|hdl
5800681|NCT00105066|LDL|ldl
5800682|NCT00105066|High Blood Pressure|high blood pressure
5800683|NCT00105066|High Cholesterol|high cholesterol
5800684|NCT00105066|High Blood Sugar|high blood sugar
5800686|NCT00105040|epilepsy|epilepsy
5800687|NCT00105040|levetiracetam|levetiracetam
5800688|NCT00105040|Keppra|keppra
5800689|NCT00105040|cognition|cognition
5800690|NCT00105040|behavior|behavior
5800691|NCT00105040|pediatry|pediatry
5800692|NCT00105027|macular edema|macular edema
5800693|NCT00105027|central retinal vein occlusion (CRVO)|central retinal vein occlusion (crvo)
5800694|NCT00105027|branch retinal vein occlusion (BRVO)|branch retinal vein occlusion (brvo)
5800695|NCT00104988|stage IV melanoma|stage iv melanoma
5800696|NCT00104975|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5800697|NCT00104975|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5800698|NCT00104975|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5800699|NCT00104975|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5800700|NCT00104975|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5800701|NCT00104975|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5800702|NCT00104975|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5800703|NCT00104975|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5800704|NCT00104975|refractory anemia with excess blasts|refractory anemia with excess blasts
5800705|NCT00104975|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5800706|NCT00104975|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5800945|NCT00104403|Emesis|emesis
5800707|NCT00104975|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5800708|NCT00104975|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5800709|NCT00104975|primary myelofibrosis|primary myelofibrosis
5800710|NCT00104975|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5800711|NCT00104975|essential thrombocythemia|essential thrombocythemia
5800712|NCT00104975|polycythemia vera|polycythemia vera
5800713|NCT00104975|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5800714|NCT00104975|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5800715|NCT00104975|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5800716|NCT00104975|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5800717|NCT00104975|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5800933|NCT00104442|mood swings|mood swings
5800718|NCT00104975|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5800719|NCT00104975|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5800720|NCT00104975|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5800721|NCT00104975|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5800722|NCT00104975|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5800723|NCT00104975|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5800724|NCT00104975|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5800725|NCT00104975|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5800726|NCT00104975|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5800727|NCT00104975|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5800728|NCT00104975|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5800729|NCT00104975|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5800730|NCT00104949|adult synovial sarcoma|adult synovial sarcoma
5800731|NCT00104949|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5800732|NCT00104949|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5800733|NCT00104949|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5800734|NCT00104936|adult grade I meningioma|adult grade i meningioma
5686560|NCT00551551|Pelvic floor|pelvic floor
5686561|NCT00551551|Kegel exercises|kegel exercises
5686562|NCT00551551|Quality of Life|quality of life
5686563|NCT00551551|Pelvic Pain|pelvic pain
5686564|NCT00551538|Diabetes|diabetes
5686565|NCT00551538|Diabetic|diabetic
5686566|NCT00551538|Insulin|insulin
5686567|NCT00551538|Glargine|glargine
5800997|NCT00104156|Qigong|qigong
5800735|NCT00104923|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5800736|NCT00104923|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5800737|NCT00104923|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5800738|NCT00104923|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5800739|NCT00104923|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5821124|NCT00076609|HCC|hcc
5800740|NCT00104923|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5800741|NCT00104923|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5800742|NCT00104923|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5800743|NCT00104923|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5800744|NCT00104923|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5800745|NCT00104923|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5800746|NCT00104923|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5800747|NCT00104923|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5800748|NCT00104923|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5800749|NCT00104923|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5800750|NCT00104923|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5800751|NCT00104923|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5800752|NCT00104923|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5800753|NCT00104923|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5800754|NCT00104923|refractory multiple myeloma|refractory multiple myeloma
5800755|NCT00104923|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5800756|NCT00104923|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5800757|NCT00104923|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5800758|NCT00104923|primary myelofibrosis|primary myelofibrosis
5800759|NCT00104923|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5800760|NCT00104923|essential thrombocythemia|essential thrombocythemia
5800761|NCT00104923|polycythemia vera|polycythemia vera
5800762|NCT00104923|stage II multiple myeloma|stage ii multiple myeloma
5800763|NCT00104923|stage III multiple myeloma|stage iii multiple myeloma
5800764|NCT00104923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5800765|NCT00104923|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5800766|NCT00104923|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5800767|NCT00104923|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5800768|NCT00104923|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5800769|NCT00104923|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5800770|NCT00104923|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5800946|NCT00104403|Nausea|nausea
5800771|NCT00104923|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5800772|NCT00104897|recurrent melanoma|recurrent melanoma
5800773|NCT00104897|stage IV melanoma|stage iv melanoma
5800774|NCT00104884|stage III melanoma|stage iii melanoma
5800775|NCT00104884|stage IV melanoma|stage iv melanoma
5800776|NCT00104884|Depsipeptide|depsipeptide
5800777|NCT00104871|National Thyroid Cancer Treatment Cooperative Study Group|national thyroid cancer treatment cooperative study group
5800778|NCT00104871|NTCTCSG|ntctcsg
5800779|NCT00104871|bortezomib|bortezomib
5800780|NCT00104871|velcade|velcade
5800781|NCT00104871|metastatic differentiated thyroid carcinoma|metastatic differentiated thyroid carcinoma
5800782|NCT00104871|Differentiated thyroid carcinoma|differentiated thyroid carcinoma
5800783|NCT00104871|follicular epithelial thyroid cells|follicular epithelial thyroid cells
5800785|NCT00104871|oxyphilic cell|oxyphilic cell
5800786|NCT00104871|Hurthle cell|hurthle cell
5800787|NCT00104871|insular cell|insular cell
5800788|NCT00104871|columnar cell|columnar cell
5800789|NCT00104871|tall cell|tall cell
5800790|NCT00104845|stage II melanoma|stage ii melanoma
5800791|NCT00104845|stage III melanoma|stage iii melanoma
5800792|NCT00104845|stage IV melanoma|stage iv melanoma
5800793|NCT00104845|recurrent melanoma|recurrent melanoma
5800794|NCT00104819|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5800795|NCT00104819|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5686568|NCT00551538|Lispro|lispro
5800796|NCT00104819|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5800797|NCT00104806|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5800798|NCT00104806|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5800799|NCT00104806|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5800800|NCT00104806|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5800801|NCT00104806|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5800802|NCT00104806|refractory anemia with excess blasts|refractory anemia with excess blasts
5800803|NCT00104806|refractory anemia|refractory anemia
5800804|NCT00104806|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5800805|NCT00104806|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5800806|NCT00104806|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5800807|NCT00104806|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5800808|NCT00104793|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5800809|NCT00104780|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5800810|NCT00104780|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5800811|NCT00104780|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5800812|NCT00104767|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5800813|NCT00104767|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5800814|NCT00104767|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5800815|NCT00104754|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5800934|NCT00104429|HIV infections|hiv infections
5800816|NCT00104754|limited stage small cell lung cancer|limited stage small cell lung cancer
5800817|NCT00104754|recurrent small cell lung cancer|recurrent small cell lung cancer
5800818|NCT00104741|stage IIB prostate cancer|stage iib prostate cancer
5800819|NCT00104741|stage IIA prostate cancer|stage iia prostate cancer
5800820|NCT00104741|stage III prostate cancer|stage iii prostate cancer
5800821|NCT00104728|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5800822|NCT00104728|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5800823|NCT00104728|stage IA non-small cell lung cancer|stage ia non-small cell lung cancer
5800824|NCT00104728|stage IB non-small cell lung cancer|stage ib non-small cell lung cancer
5800825|NCT00104715|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5800826|NCT00104715|recurrent prostate cancer|recurrent prostate cancer
5800827|NCT00104715|stage IV prostate cancer|stage iv prostate cancer
5800828|NCT00104702|stage I breast cancer|stage i breast cancer
5800829|NCT00104702|stage II breast cancer|stage ii breast cancer
5800830|NCT00104689|stage IV colon cancer|stage iv colon cancer
5800831|NCT00104689|stage IV rectal cancer|stage iv rectal cancer
5800832|NCT00104689|adenocarcinoma of the colon|adenocarcinoma of the colon
5800833|NCT00104689|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5800834|NCT00104676|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5800835|NCT00104676|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5800836|NCT00104676|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5800837|NCT00104676|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5800838|NCT00104676|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5800839|NCT00104676|testicular choriocarcinoma|testicular choriocarcinoma
5800840|NCT00104676|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5800841|NCT00104676|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5800842|NCT00104676|testicular embryonal carcinoma|testicular embryonal carcinoma
5800843|NCT00104676|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5800844|NCT00104676|testicular yolk sac tumor|testicular yolk sac tumor
5800845|NCT00104676|stage II extragonadal non-seminomatous germ cell tumor|stage ii extragonadal non-seminomatous germ cell tumor
5800846|NCT00104676|stage III extragonadal non-seminomatous germ cell tumor|stage iii extragonadal non-seminomatous germ cell tumor
5800847|NCT00104676|testicular immature teratoma|testicular immature teratoma
5800848|NCT00104676|testicular mature teratoma|testicular mature teratoma
5800849|NCT00104676|adult teratoma|adult teratoma
5800850|NCT00104663|Creutzfeldt-Jakob disease|creutzfeldt-jakob disease
5800851|NCT00104663|inherited|inherited
5800852|NCT00104663|sporadic|sporadic
5800853|NCT00104663|acquired|acquired
5800854|NCT00104663|new variant CJD|new variant cjd
5800855|NCT00104650|Bone Metastases|bone metastases
5800856|NCT00104650|AMG 162|amg 162
5800857|NCT00104650|Bisphosphonates|bisphosphonates
5800858|NCT00104650|Solid Tumor Carcinomas|solid tumor carcinomas
5800859|NCT00104650|Advanced|advanced
5800860|NCT00104637|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5800861|NCT00104637|Emphysema|emphysema
5800862|NCT00104637|Phosphodiesterase inhibitors|phosphodiesterase inhibitors
5800863|NCT00104637|Sildenafil|sildenafil
5800864|NCT00104637|Exercise testing|exercise testing
5800865|NCT00104637|Quality of life|quality of life
5800866|NCT00104624|stage IV breast cancer|stage iv breast cancer
5800867|NCT00104624|recurrent breast cancer|recurrent breast cancer
5800868|NCT00104611|Major Depressive Disorder|major depressive disorder
5800869|NCT00104611|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5800870|NCT00104611|rTMS|rtms
5800871|NCT00104611|Non-invasive Neuromodulation|non-invasive neuromodulation
5800872|NCT00104611|Antidepressant|antidepressant
5800873|NCT00104585|Parkinson's disease|parkinson's disease
5800875|NCT00104585|gene|gene
5800876|NCT00104585|environment|environment
5800877|NCT00104585|early-onset Parkinson's disease|early-onset parkinson's disease
5800878|NCT00104572|Estrogen|estrogen
5800879|NCT00104572|Glucose Tolerance|glucose tolerance
5800880|NCT00104572|Bone Density|bone density
5800881|NCT00104572|Quality-of-Life|quality-of-life
5800882|NCT00104572|Sarcopenia|sarcopenia
5800884|NCT00104559|Informed Consent|informed consent
5800885|NCT00104546|Dysmenorrhea|dysmenorrhea
5800886|NCT00104546|Acupuncture|acupuncture
5800887|NCT00104546|Vitamin K|vitamin k
5800888|NCT00104546|Medicine, Chinese Traditional|medicine, chinese traditional
5800889|NCT00104546|Women|women
5800890|NCT00104546|Menstruation|menstruation
5800891|NCT00104546|Pain, Menstrual|pain, menstrual
5800892|NCT00104546|China|china
5800893|NCT00104533|Static magnetic therapy|static magnetic therapy
5800902|NCT00104507|Satiety|satiety
5800903|NCT00104507|Obesity|obesity
5800904|NCT00104507|Appetite suppressant|appetite suppressant
5800905|NCT00104507|Weight Loss|weight loss
5800906|NCT00104507|Overweight|overweight
5800907|NCT00104494|Cystic Fibrosis|cystic fibrosis
5800908|NCT00104494|Zinc supplementation|zinc supplementation
5800909|NCT00104494|Nutrition|nutrition
5800910|NCT00104494|Zinc absorption|zinc absorption
5800911|NCT00104494|Zinc excretion|zinc excretion
5800912|NCT00104494|Zinc status|zinc status
5800913|NCT00104481|cognitive behavior therapy|cognitive behavior therapy
5800914|NCT00104481|coping|coping
5800915|NCT00104481|smoking cessation|smoking cessation
5800916|NCT00104481|acceptance|acceptance
5800917|NCT00104481|expectancies|expectancies
5800918|NCT00104481|quit smoking|quit smoking
5800919|NCT00104481|quitting smoking|quitting smoking
5800920|NCT00104468|Single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia|single-arm, open-label, multi-center, dose escalation, continuous infusion, multi-dose, acute myeloid leukemia
5800921|NCT00104468|Acute myelogenous leukemia (AML) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies|acute myelogenous leukemia (aml) that has been refractory to prior therapy and/or is unlikely to benefit from known therapies
5800923|NCT00104455|Punch Biopsy|punch biopsy
5800924|NCT00104455|Dose Response|dose response
5800925|NCT00104455|Healthy People Programs|healthy people programs
5800926|NCT00104442|Alzheimer's disease|alzheimer's disease
5800927|NCT00104442|memory loss|memory loss
5800928|NCT00104442|dementia|dementia
5800929|NCT00104442|senility|senility
5800930|NCT00104442|forgetful|forgetful
5800931|NCT00104442|geriatric|geriatric
5800932|NCT00104442|behavior|behavior
5800935|NCT00104429|therapy naive|therapy naive
5800936|NCT00104416|antiepileptic drugs|antiepileptic drugs
5800937|NCT00104416|seizures|seizures
5800938|NCT00104416|primary generalized tonic-clonic seizures|primary generalized tonic-clonic seizures
5800939|NCT00104416|Epilepsy|epilepsy
5800940|NCT00104416|lamotrigine|lamotrigine
5800941|NCT00104416|anticonvulsants|anticonvulsants
5800942|NCT00104416|LAMICTAL|lamictal
5800943|NCT00104403|Vomiting|vomiting
5800947|NCT00104403|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5800949|NCT00104390|skin prick test|skin prick test
5800950|NCT00104390|allergoid|allergoid
5800951|NCT00104390|allergenicity|allergenicity
5800952|NCT00104390|specific immunotherapy|specific immunotherapy
5800953|NCT00104377|Allergy|allergy
5800954|NCT00104377|Allergoid|allergoid
5800955|NCT00104377|Specific Immunotherapy|specific immunotherapy
5800956|NCT00104338|Investigational Therapies|investigational therapies
5800957|NCT00104338|Treatment Effectiveness|treatment effectiveness
5800958|NCT00104338|Treatment Efficacy|treatment efficacy
5800959|NCT00104338|Immunosuppressant|immunosuppressant
5800960|NCT00104338|BK Nephropathy|bk nephropathy
5800961|NCT00104338|Polyomavirus, BK|polyomavirus, bk
5800962|NCT00104338|Human Polyomavirus BK|human polyomavirus bk
5800963|NCT00104338|Polyomavirus hominis 1|polyomavirus hominis 1
5800972|NCT00104312|Knee Osteoarthritis|knee osteoarthritis
5800973|NCT00104312|Muscle|muscle
5800974|NCT00104312|Cytokine|cytokine
5800975|NCT00104312|Mobility|mobility
5800976|NCT00104312|Function|function
5800977|NCT00104299|ANCA|anca
5800978|NCT00104299|Vasculitis|vasculitis
5800979|NCT00104299|Wegener's Granulomatosis|wegener's granulomatosis
5800980|NCT00104299|microscopic polyangiitis|microscopic polyangiitis
5800981|NCT00104299|ANCA-positive|anca-positive
5800982|NCT00104299|ANCA-associated|anca-associated
5800983|NCT00104299|ANCA-associated vasculitis|anca-associated vasculitis
5800985|NCT00104273|Dementia, Alzheimer's Disease|dementia, alzheimer's disease
5800986|NCT00104247|Phenylalanine Hydroxylase|phenylalanine hydroxylase
5800987|NCT00104195|Anxiety|anxiety
5800988|NCT00104195|Adolescence|adolescence
5800989|NCT00104195|Generalized Anxiety Disorder|generalized anxiety disorder
5800990|NCT00104169|Anemia|anemia
5800991|NCT00104169|Frailty|frailty
5800168|NCT00107081|children|children
5800169|NCT00107081|oral antibiotics|oral antibiotics
5800170|NCT00107081|outpatient treatment|outpatient treatment
5800171|NCT00107081|fever and neutropenia|fever and neutropenia
5800172|NCT00107068|Stroke|stroke
5800173|NCT00107068|Exercise|exercise
5800174|NCT00107068|Aerobic|aerobic
5800175|NCT00107068|PRT|prt
5800176|NCT00107068|Walking ability|walking ability
5800177|NCT00107055|Herniated nucleus pulposus|herniated nucleus pulposus
5800178|NCT00107055|Lumbosacral radiculopathy|lumbosacral radiculopathy
5800179|NCT00107055|Anti-TNF alpha|anti-tnf alpha
5800180|NCT00107055|Tumor necrosis factor alpha|tumor necrosis factor alpha
5800181|NCT00107042|Hepatitis B|hepatitis b
5800182|NCT00107042|HIV vaccine trial|hiv vaccine trial
5800992|NCT00104169|Epoetin|epoetin
5800993|NCT00104169|Erythropoietin|erythropoietin
5801000|NCT00104156|Breathing Exercises|breathing exercises
5801001|NCT00104130|prostate|prostate
5801002|NCT00104104|Z-MAX, multiple myeloma, zoledronic acid, bone metastases|z-max, multiple myeloma, zoledronic acid, bone metastases
5801003|NCT00104091|Gross Total Resection|gross total resection
5801004|NCT00104091|Convection Enhanced Delivery|convection enhanced delivery
5801005|NCT00104091|Recurrent Glioblastoma Multiforme|recurrent glioblastoma multiforme
5801006|NCT00104065|oral mucositis|oral mucositis
5801007|NCT00104065|oncology - supportive care|oncology - supportive care
5801008|NCT00104065|mouth diseases|mouth diseases
5801009|NCT00104039|Amygdala|amygdala
5801010|NCT00104039|Orbital Frontal Cortex|orbital frontal cortex
5801011|NCT00104039|Serotonin|serotonin
5801012|NCT00104039|Orbitofrontal Cortex|orbitofrontal cortex
5801013|NCT00104039|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5801014|NCT00104039|ADHD|adhd
5801015|NCT00104039|Anti-Social Behavior|anti-social behavior
5801016|NCT00104039|Healthy Volunteer|healthy volunteer
5801017|NCT00104039|HV|hv
5801018|NCT00104026|Periodontal Disease|periodontal disease
5801019|NCT00104026|Dilantin|dilantin
5801020|NCT00104026|Cyclosporin|cyclosporin
5801021|NCT00104026|Calcium-Channel Blockers|calcium-channel blockers
5801022|NCT00104026|Genetics|genetics
5801023|NCT00104026|Hereditary Gingival Fibromatosis|hereditary gingival fibromatosis
5801024|NCT00104026|HGF|hgf
5801025|NCT00104026|Gingival Overgrowth|gingival overgrowth
5801026|NCT00104026|Gum Overgrowth|gum overgrowth
5801027|NCT00104000|Neuromuscular|neuromuscular
5801028|NCT00104000|Elevation|elevation
5801029|NCT00104000|Current|current
5801030|NCT00104000|Videofluoroscopy|videofluoroscopy
5801031|NCT00104000|Nasoendoscopy|nasoendoscopy
5801032|NCT00104000|Healthy Volunteer|healthy volunteer
5801033|NCT00104000|HV|hv
5801034|NCT00103987|Panic Disorder|panic disorder
5801035|NCT00103987|Norepinephrine|norepinephrine
5801036|NCT00103987|Yohimbine|yohimbine
5801037|NCT00103987|Genes|genes
5801038|NCT00103987|Pathophysiology|pathophysiology
5801039|NCT00103987|Noradrenergic Mechanisms|noradrenergic mechanisms
5801040|NCT00103987|PET Imaging|pet imaging
5801041|NCT00103987|PD|pd
5801042|NCT00103987|Healthy Volunteer|healthy volunteer
5801043|NCT00103987|HV|hv
5801044|NCT00103974|multiple sclerosis|multiple sclerosis
5801045|NCT00103974|relapsing-remitting|relapsing-remitting
5801046|NCT00103974|secondary progressive|secondary progressive
5801047|NCT00103961|Acute Infection|acute infection
5801048|NCT00103961|HIV|hiv
5801049|NCT00103961|AIDS|aids
5801050|NCT00103961|Acute HIV|acute hiv
5801051|NCT00103961|Early HIV|early hiv
5801052|NCT00103935|diabetes|diabetes
5801053|NCT00103935|exenatide|exenatide
5801054|NCT00103935|long acting release|long acting release
5801055|NCT00103935|Amylin|amylin
5801056|NCT00103935|Lilly|lilly
5801057|NCT00103922|smokers cough|smokers cough
5801058|NCT00103896|High-risk youth|high-risk youth
5801059|NCT00103896|HIV infected youth|hiv infected youth
5801060|NCT00103896|Community mobilization|community mobilization
5801061|NCT00103896|HIV serosurveys|hiv serosurveys
5801062|NCT00103883|HIV|hiv
5801063|NCT00103883|Detuned Assay|detuned assay
5801064|NCT00103883|Enzyme Immunoassay (EIA)|enzyme immunoassay (eia)
5801065|NCT00103883|HIV Incidence|hiv incidence
5801066|NCT00103883|Laboratory assay|laboratory assay
5801067|NCT00103883|Sensitive/Less sensitive Assay|sensitive/less sensitive assay
5801068|NCT00103883|Acute Infection|acute infection
5801069|NCT00103870|Music Therapy|music therapy
5827598|NCT00062452|Airway|airway
5801070|NCT00103870|Electric Stimulation|electric stimulation
5801071|NCT00103870|Electric Shock|electric shock
5801072|NCT00103870|Analgesics|analgesics
5801073|NCT00103870|Distraction|distraction
5801074|NCT00103844|Chronic Phase Philadelphia chromosome Positive (Ph+) chronic myeloid leukemia|chronic phase philadelphia chromosome positive (ph+) chronic myeloid leukemia
5801075|NCT00103831|NSCLC - non-small cell lung cancer|nsclc - non-small cell lung cancer
5801076|NCT00103805|language acquisition|language acquisition
5801077|NCT00103805|plasticity|plasticity
5801078|NCT00103805|stroke recovery|stroke recovery
5801079|NCT00103805|associative learning|associative learning
5801080|NCT00103792|Induction therapy|induction therapy
5801081|NCT00103792|ANCA-associated vasculitis|anca-associated vasculitis
5801082|NCT00103792|Wegener's granulomatosis|wegener's granulomatosis
5801083|NCT00103792|microscopic polyangiitis|microscopic polyangiitis
5801084|NCT00103792|mycophenolate mofetil|mycophenolate mofetil
5801085|NCT00103792|cyclophosphamide|cyclophosphamide
5801086|NCT00103779|Antigens, CD40|antigens, cd40
5801087|NCT00103779|Antibody, Monoclonal|antibody, monoclonal
5801088|NCT00103779|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5801089|NCT00103779|Lymphoma, B-Cell|lymphoma, b-cell
5801090|NCT00103779|Hematologic Diseases|hematologic diseases
5801091|NCT00103779|Immunoproliferative Disorders|immunoproliferative disorders
5801092|NCT00103779|Lymphatic Diseases|lymphatic diseases
5801093|NCT00103779|Lymphoproliferative Disorders|lymphoproliferative disorders
5801094|NCT00103779|Lymphoma|lymphoma
5801095|NCT00103766|Alteplase|alteplase
5801096|NCT00103766|Empyema|empyema
5801097|NCT00103766|Complicated Parapneumonic Effusion|complicated parapneumonic effusion
5801285|NCT00102856|plasticity|plasticity
5801098|NCT00103753|Randomized Controlled Trial|randomized controlled trial
5801099|NCT00103753|Deferiprone|deferiprone
5801100|NCT00103753|Deferoxamine|deferoxamine
5801101|NCT00103753|Iron chelation|iron chelation
5801102|NCT00103753|Beta Thalassemia Major|beta thalassemia major
5862626|NCT00001561|Multiple Myeloma|multiple myeloma
5801103|NCT00103740|Zoledronic acid, risedronate, Paget's disease of bone|zoledronic acid, risedronate, paget's disease of bone
5801104|NCT00103727|paranoid|paranoid
5801105|NCT00103727|catatonic|catatonic
5801106|NCT00103727|undifferentiated types|undifferentiated types
5801107|NCT00103727|disorganized|disorganized
5801108|NCT00103714|lung disease|lung disease
5801109|NCT00103701|Chronic myelogenous leukemia (CML) chronic, accelerated, blast phase|chronic myelogenous leukemia (cml) chronic, accelerated, blast phase
5801110|NCT00103701|Philadelphia chromosome positive acute (Ph+ALL)|philadelphia chromosome positive acute (ph+all)
5801111|NCT00103675|Acupuncture|acupuncture
5801112|NCT00103636|Phlebitis/etiology|phlebitis/etiology
5801113|NCT00103636|Infusions|infusions
5801114|NCT00103636|Intravenous/adverse effects|intravenous/adverse effects
5801115|NCT00103636|Randomised controlled trial|randomised controlled trial
5801116|NCT00103636|Phlebitis/prevention|phlebitis/prevention
5801117|NCT00103636|Adult|adult
5801118|NCT00103636|Time factors|time factors
5801119|NCT00103623|Advanced|advanced
5801120|NCT00103623|Symptomatic|symptomatic
5801121|NCT00103623|Prostate|prostate
5801122|NCT00103623|Cancer|cancer
5801123|NCT00103623|Advanced Symptomatic Prostate Cancer|advanced symptomatic prostate cancer
5801124|NCT00103610|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5801125|NCT00103610|Stem cell mobilization|stem cell mobilization
5801126|NCT00103597|Orthostatic hypotension|orthostatic hypotension
5801127|NCT00103597|Parkinson's Disease|parkinson's disease
5801128|NCT00103545|Ovarian Cancer|ovarian cancer
5801129|NCT00103545|ACA 125|aca 125
5801130|NCT00103545|6 or 9 vaccinations|6 or 9 vaccinations
5801132|NCT00103545|Fallopian tube cancer|fallopian tube cancer
5801133|NCT00103545|Peritoneal cancer|peritoneal cancer
5801134|NCT00103532|motivational enhancement|motivational enhancement
5801135|NCT00103532|health behaviors|health behaviors
5801136|NCT00103532|risk behaviors|risk behaviors
5801137|NCT00103519|Heart Failure, DITPA|heart failure, ditpa
5801138|NCT00103506|Multiple Myeloma|multiple myeloma
5801139|NCT00103506|Doxil|doxil
5801140|NCT00103506|Caelyx|caelyx
5801141|NCT00103506|Doxorubicin|doxorubicin
5801142|NCT00103506|Velcade|velcade
5801143|NCT00103506|Bortezomib|bortezomib
5801144|NCT00103454|allergic rhinitis|allergic rhinitis
5801145|NCT00103454|GW685698X|gw685698x
5801146|NCT00103454|Perennial Allergic Rhinitis|perennial allergic rhinitis
5801147|NCT00103428|chemotherapy|chemotherapy
5801148|NCT00103428|prostate cancer|prostate cancer
5801149|NCT00103428|cancer|cancer
5801150|NCT00103428|metastatic|metastatic
5801151|NCT00103428|hormone refractory|hormone refractory
5801152|NCT00103428|chemotherapy naive|chemotherapy naive
5801153|NCT00103428|dose escalation|dose escalation
5801154|NCT00103415|Depression|depression
5801155|NCT00103415|Exercise|exercise
5801157|NCT00103402|Prostatitis|prostatitis
5853431|NCT00002147|Liposomes|liposomes
5801158|NCT00103402|Non-bacterial Prostatitis|non-bacterial prostatitis
5801159|NCT00103402|Prostatodynia|prostatodynia
5801160|NCT00103402|Alfuzosin|alfuzosin
5801161|NCT00103402|Alpha-adrenergic blocker|alpha-adrenergic blocker
5801162|NCT00103389|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5801163|NCT00103389|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5801164|NCT00103389|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5801165|NCT00103376|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5801166|NCT00103376|recurrent prostate cancer|recurrent prostate cancer
5801167|NCT00103363|non-small cell lung cancer|non-small cell lung cancer
5801168|NCT00103363|small cell lung cancer|small cell lung cancer
5801169|NCT00103350|myocardial infarction|myocardial infarction
5801170|NCT00103350|infarct size|infarct size
5801171|NCT00103350|angioplasty|angioplasty
5801172|NCT00103350|percutaneous coronary intervention|percutaneous coronary intervention
5801173|NCT00103350|Acute Myocardial Infarction|acute myocardial infarction
5801174|NCT00103298|recurrent colon cancer|recurrent colon cancer
5801175|NCT00103298|stage IV colon cancer|stage iv colon cancer
5801176|NCT00103298|recurrent rectal cancer|recurrent rectal cancer
5801177|NCT00103298|stage IV rectal cancer|stage iv rectal cancer
5801178|NCT00103298|liver metastases|liver metastases
5801179|NCT00103246|skin cancer|skin cancer
5801180|NCT00103246|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5801181|NCT00103246|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5801182|NCT00103246|recurrent skin cancer|recurrent skin cancer
5801183|NCT00103246|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5801184|NCT00103246|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5801185|NCT00103246|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5801186|NCT00103246|actinic keratosis|actinic keratosis
5801187|NCT00103246|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5801188|NCT00103246|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5801189|NCT00103246|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5801190|NCT00103233|stage IV breast cancer|stage iv breast cancer
5801191|NCT00103233|recurrent breast cancer|recurrent breast cancer
5862627|NCT00001561|Vaccine|vaccine
5801192|NCT00103207|bronchioalveolar carcinoma (BAC)|bronchioalveolar carcinoma (bac)
5801193|NCT00103207|adenocarcinoma with BAC features|adenocarcinoma with bac features
5801194|NCT00103207|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5801195|NCT00103207|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5801196|NCT00103207|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5801197|NCT00103207|cetuximab|cetuximab
5801198|NCT00103181|stage II breast cancer|stage ii breast cancer
5801199|NCT00103181|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5801200|NCT00103181|breast cancer in situ|breast cancer in situ
5801201|NCT00103181|stage IA breast cancer|stage ia breast cancer
5801202|NCT00103181|stage IB breast cancer|stage ib breast cancer
5801203|NCT00103168|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5801204|NCT00103155|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5801205|NCT00103142|liver metastases|liver metastases
5801206|NCT00103142|adenocarcinoma of the colon|adenocarcinoma of the colon
5801207|NCT00103142|recurrent colon cancer|recurrent colon cancer
5801208|NCT00103142|stage IV colon cancer|stage iv colon cancer
5801209|NCT00103142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5801210|NCT00103142|recurrent rectal cancer|recurrent rectal cancer
5801211|NCT00103142|stage IV rectal cancer|stage iv rectal cancer
5801212|NCT00103142|lung metastases|lung metastases
5801213|NCT00103116|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5801214|NCT00103116|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5801215|NCT00103116|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5801216|NCT00103116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5801217|NCT00103116|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5801218|NCT00103103|recurrent gastric cancer|recurrent gastric cancer
5801219|NCT00103103|stage IV gastric cancer|stage iv gastric cancer
5801220|NCT00103103|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5801221|NCT00103051|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5801222|NCT00103025|Vasodilation|vasodilation
5801223|NCT00103025|Hypotension|hypotension
5801224|NCT00103025|Hypertension|hypertension
5801225|NCT00103025|EDRF|edrf
5801226|NCT00103025|Methemoglobinemia|methemoglobinemia
5801227|NCT00103025|Healthy Volunteer|healthy volunteer
5801228|NCT00103025|HV|hv
5801229|NCT00103012|Antiretrovirals|antiretrovirals
5801230|NCT00103012|Protease Inhibitors|protease inhibitors
5801231|NCT00103012|Herbal Supplements|herbal supplements
5801232|NCT00103012|Drug Interactions|drug interactions
5801233|NCT00103012|Metabolism|metabolism
5801234|NCT00103012|Healthy Volunteer|healthy volunteer
5801236|NCT00102999|Learning|learning
5801237|NCT00102999|PAS|pas
5801238|NCT00102999|Upper Limb|upper limb
5801239|NCT00102999|TMS|tms
5801240|NCT00102999|Somatosensory|somatosensory
5801241|NCT00102999|Dystonia|dystonia
5801242|NCT00102999|Upper Limb Dystonia|upper limb dystonia
5801243|NCT00102999|Healthy Volunteer|healthy volunteer
5801244|NCT00102999|HV|hv
5801245|NCT00102986|Kaletra|kaletra
5801246|NCT00102986|Treatment Experienced|treatment experienced
5801247|NCT00102973|Ovary|ovary
5801248|NCT00102960|Infant|infant
5801249|NCT00102960|Perinatal|perinatal
5801250|NCT00102960|HIV|hiv
5801251|NCT00102960|Disease Transmission, Vertical|disease transmission, vertical
5801252|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents
5801253|NCT00102960|Treatment Interruption|treatment interruption
5801254|NCT00102960|Treatment Naive|treatment naive
5801255|NCT00102960|Acute Infection|acute infection
5801256|NCT00102960|Mother-to-Child Transmission|mother-to-child transmission
5801257|NCT00102947|renal impairment|renal impairment
5801259|NCT00102947|Cubist|cubist
5801260|NCT00102947|complicated skin and skin structure infections|complicated skin and skin structure infections
5801261|NCT00102934|HIV|hiv
5801262|NCT00102934|Drug Resistance|drug resistance
5801263|NCT00102934|Viral Fitness|viral fitness
5801264|NCT00102934|HIV Specific Immunity|hiv specific immunity
5801265|NCT00102934|T Cell Activation|t cell activation
5801266|NCT00102934|Drug Resistant Viremia|drug resistant viremia
5801267|NCT00102934|Treatment Experienced|treatment experienced
5801268|NCT00102921|Crohn Disease|crohn disease
5801269|NCT00102921|oral medication|oral medication
5801270|NCT00102908|Bone Metabolism|bone metabolism
5801271|NCT00102908|Osteopenia|osteopenia
5801272|NCT00102908|Osteoporosis|osteoporosis
5801273|NCT00102908|Treatment Experienced|treatment experienced
5801274|NCT00102882|genotype|genotype
5801275|NCT00102882|Salmeterol|salmeterol
5801276|NCT00102882|ADVAIR|advair
5801277|NCT00102869|language acquisition|language acquisition
5801278|NCT00102869|plasticity|plasticity
5801279|NCT00102869|stroke recovery|stroke recovery
5801280|NCT00102869|aphasia treatment|aphasia treatment
5801281|NCT00102869|naming|naming
5801282|NCT00102869|levodopa|levodopa
5801283|NCT00102869|stroke|stroke
5801284|NCT00102856|language acquisition|language acquisition
5801286|NCT00102856|stroke recovery|stroke recovery
5801287|NCT00102856|associative learning|associative learning
5801288|NCT00102843|folic acid|folic acid
5801289|NCT00102843|betaine|betaine
5801290|NCT00102843|homocysteine|homocysteine
5801291|NCT00102843|cardiovascular disease prevention|cardiovascular disease prevention
5801293|NCT00102843|Cardiovascular health|cardiovascular health
5801294|NCT00102830|Solid Tumor|solid tumor
5801295|NCT00102830|Metastatic Cancer|metastatic cancer
5801296|NCT00102830|Advanced Solid Tumors|advanced solid tumors
5801297|NCT00102817|Growth Hormone Disorder|growth hormone disorder
5801298|NCT00102791|Sickle Cell Anemia|sickle cell anemia
5801299|NCT00102778|HIV infected|hiv infected
5801300|NCT00102778|therapy-naive subjects|therapy-naive subjects
5801301|NCT00102765|asthma exacerbation|asthma exacerbation
5801302|NCT00102765|asthma|asthma
5801303|NCT00102752|Pancreas|pancreas
5801304|NCT00102752|Cancer|cancer
5801305|NCT00102752|Metastatic|metastatic
5801306|NCT00102752|Glufosfamide|glufosfamide
5801307|NCT00102752|Advanced|advanced
5801309|NCT00102752|Tumor|tumor
5801310|NCT00102752|Advanced Solid Tumors|advanced solid tumors
5801311|NCT00102752|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5801312|NCT00102739|thrombopoietin|thrombopoietin
5801313|NCT00102739|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5801314|NCT00102739|platelets|platelets
5801315|NCT00102739|chronic thrombocytopenia|chronic thrombocytopenia
5801316|NCT00102726|chemotherapy|chemotherapy
5801317|NCT00102726|thrombopoietin|thrombopoietin
5801318|NCT00102726|platelets|platelets
5801319|NCT00102726|chemotherapy induced|chemotherapy induced
5801320|NCT00102713|Partial Seizures|partial seizures
5801321|NCT00102700|cancer|cancer
5801323|NCT00102700|advanced solid tumor|advanced solid tumor
5801324|NCT00102700|pancreas|pancreas
5801325|NCT00102700|pancreatic cancer|pancreatic cancer
5801326|NCT00102700|cancer of the pancreas|cancer of the pancreas
5801327|NCT00102674|cangrelor|cangrelor
5801328|NCT00102674|clopidogrel|clopidogrel
5801329|NCT00102635|apoptotic activity|apoptotic activity
5801330|NCT00102635|4-HPR|4-hpr
5801331|NCT00102635|FTI|fti
5801332|NCT00102635|Fenretinide|fenretinide
5801333|NCT00102635|SCH66336|sch66336
5801334|NCT00102635|Farnesyl Transferase Inhibitor|farnesyl transferase inhibitor
5801335|NCT00102635|HNC|hnc
5801336|NCT00102622|Ovary|ovary
5801337|NCT00102622|ovarian cancer|ovarian cancer
5801342|NCT00102622|paclitaxel|paclitaxel
5801343|NCT00102622|tgDCC-E1A|tgdcc-e1a
5801344|NCT00102622|E1A|e1a
5801345|NCT00102622|Taxol|taxol
5801346|NCT00102609|Doxorubicin|doxorubicin
5801347|NCT00102609|Adriamycin|adriamycin
5801348|NCT00102609|Trabectedin|trabectedin
5801349|NCT00102609|Yondelis|yondelis
5801350|NCT00102609|Ecteinascidin 743|ecteinascidin 743
5801351|NCT00102609|Filgrastim, Antineoplastic|filgrastim, antineoplastic
5801352|NCT00102609|Antineoplastic Agents|antineoplastic agents
5801353|NCT00102609|Pharmacologic Actions|pharmacologic actions
5801354|NCT00102609|Alkylating Agents|alkylating agents
5801355|NCT00102596|Ethanol|ethanol
5801356|NCT00102596|Alcohol Responsive|alcohol responsive
5801357|NCT00102596|Movement Disorder|movement disorder
5801358|NCT00102596|Gas Chromatography|gas chromatography
5801359|NCT00102596|Bioavailability|bioavailability
5801360|NCT00102596|Pharmacokinetics|pharmacokinetics
5800566|NCT00105495|Cardiac|cardiac
5801361|NCT00102596|Essential Tremor|essential tremor
5801363|NCT00102583|Lacrimal Gland|lacrimal gland
5801364|NCT00102583|Tear Deficiency|tear deficiency
5801365|NCT00102583|Keratitis Sicca|keratitis sicca
5801366|NCT00102583|GVHD|gvhd
5801367|NCT00102583|Ocular GVHD|ocular gvhd
5801368|NCT00102583|Ocular Graft Vs Host Disease|ocular graft vs host disease
5801369|NCT00102570|Pediatric|pediatric
5801370|NCT00102570|Atopic|atopic
5801371|NCT00102570|Asthma|asthma
5801372|NCT00102570|Rhinitis|rhinitis
5801373|NCT00102570|Outpatient|outpatient
5801374|NCT00102570|Allergy|allergy
5801375|NCT00102570|Pediatric Allergy|pediatric allergy
5801376|NCT00102570|Food Allergy|food allergy
5801377|NCT00102570|Stinging Insect Allergy|stinging insect allergy
5801378|NCT00102570|Atopic Dermatitis|atopic dermatitis
5801379|NCT00102570|Insect Sting|insect sting
5801380|NCT00102557|Vesiculobullous|vesiculobullous
5801381|NCT00102557|Mucosal Lesions|mucosal lesions
5801382|NCT00102557|Oral Health|oral health
5801383|NCT00102557|Dermatology|dermatology
5801384|NCT00102557|Plaquenil|plaquenil
5801385|NCT00102557|Oral Lichen Planus|oral lichen planus
5801386|NCT00102557|Mouth Lesions|mouth lesions
5801387|NCT00102557|Oral Lesions|oral lesions
5801393|NCT00102531|Osteosarcoma|osteosarcoma
5801394|NCT00102531|relapsed|relapsed
5801395|NCT00102531|progressive|progressive
5801396|NCT00102531|metastatic|metastatic
5801397|NCT00102531|lung|lung
5801398|NCT00102518|Open Label|open label
5801399|NCT00102518|Aripiprazole|aripiprazole
5801400|NCT00102518|Bipolar I Disorder, Manic or Mixed Episode|bipolar i disorder, manic or mixed episode
5801401|NCT00102505|Non-Small Cell Lung Cancer|non-small cell lung cancer
5801402|NCT00102505|Lung Cancer|lung cancer
5801403|NCT00102505|Metastatic lung cancer|metastatic lung cancer
5801404|NCT00102505|Inoperable lung cancer|inoperable lung cancer
5801405|NCT00102505|Advanced lung cancer|advanced lung cancer
5801406|NCT00102505|Large-cell lung cancer|large-cell lung cancer
5801407|NCT00102505|Adenocarcinoma, lung|adenocarcinoma, lung
5801408|NCT00102505|Squamous cell carcinoma, lung|squamous cell carcinoma, lung
5801409|NCT00102505|Squamous cell lung cancer|squamous cell lung cancer
5801410|NCT00102505|Large cell carcinoma, lung|large cell carcinoma, lung
5801411|NCT00102505|Bronchogenic|bronchogenic
5801412|NCT00102492|Major Depressive Disorder|major depressive disorder
5801413|NCT00102492|Major Depression|major depression
5801414|NCT00102492|Mood Disorders|mood disorders
5801415|NCT00102492|Major Depressive Episode|major depressive episode
5801416|NCT00102479|Pharmacokinetics,|pharmacokinetics,
5801417|NCT00102479|Aripiprazole|aripiprazole
5801418|NCT00102479|acute mania in pediatric populations|acute mania in pediatric populations
5801419|NCT00102466|type 2 diabetes|type 2 diabetes
5801420|NCT00102466|vildagliptin|vildagliptin
5801421|NCT00102453|Duchenne|duchenne
5801422|NCT00102453|Genetics|genetics
5801423|NCT00102440|uric Acid|uric acid
5801424|NCT00102440|xanthine oxidase|xanthine oxidase
5801425|NCT00102440|tophi|tophi
5801426|NCT00102440|Drug Therapy|drug therapy
5801427|NCT00102427|Anxiety|anxiety
5801428|NCT00102427|Panic|panic
5801429|NCT00102427|Generalized Anxiety Disorder|generalized anxiety disorder
5801430|NCT00102414|Ovarian cancer|ovarian cancer
5801431|NCT00102414|Recurrence or progression|recurrence or progression
5801432|NCT00102414|Gemcitabine plus Carboplatin vs Carboplatin|gemcitabine plus carboplatin vs carboplatin
5801433|NCT00102401|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5801435|NCT00102401|Lung disease, obstructive|lung disease, obstructive
5801436|NCT00102401|Self-care|self-care
5801437|NCT00102401|Self-management|self-management
5801438|NCT00102401|Patient education|patient education
5801439|NCT00102388|type 2 diabetes|type 2 diabetes
5801440|NCT00102388|vildagliptin|vildagliptin
5801441|NCT00102375|Ovarian Cancer|ovarian cancer
5801442|NCT00102375|first-line|first-line
5801443|NCT00102375|Topotecan|topotecan
5801444|NCT00102362|behavioral intervention|behavioral intervention
5801445|NCT00102349|behavioral intervention|behavioral intervention
5801446|NCT00102336|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5801447|NCT00102336|pre-splenectomy|pre-splenectomy
5801449|NCT00102336|Thrombopenia|thrombopenia
5801450|NCT00102323|immune (idiopathic) thrombocytopenic purpura|immune (idiopathic) thrombocytopenic purpura
5801451|NCT00102323|post-splenectomy|post-splenectomy
5801452|NCT00102323|ITP|itp
5801453|NCT00102323|Thrombopenia|thrombopenia
5801454|NCT00102310|Nausea|nausea
5801455|NCT00102310|Indigestion|indigestion
5801456|NCT00102310|Bloating|bloating
5801457|NCT00102310|Functional Dyspepsia|functional dyspepsia
5801458|NCT00102310|Fullness after Meals|fullness after meals
5801459|NCT00102297|Incipient Nephropathy|incipient nephropathy
5853432|NCT00002147|Doxorubicin|doxorubicin
5801460|NCT00102297|Type 1 or Type 2 Diabetes|type 1 or type 2 diabetes
5801461|NCT00102284|language acquisition|language acquisition
5801462|NCT00102284|plasticity|plasticity
5801463|NCT00102284|stroke recovery|stroke recovery
5801464|NCT00102284|associative learning|associative learning
5801465|NCT00102271|Sodium Nitrite|sodium nitrite
5801467|NCT00102271|Ascorbic Acid|ascorbic acid
5801468|NCT00102271|Hypoxic Gas|hypoxic gas
5801469|NCT00102271|Forearm Blood Flow|forearm blood flow
5801470|NCT00102271|Healthy Volunteer|healthy volunteer
5801471|NCT00102271|HV|hv
5801472|NCT00102258|Short Stature|short stature
5801473|NCT00102258|Constitutional Delay of Growth and Development|constitutional delay of growth and development
5801474|NCT00102258|Body Composition|body composition
5801475|NCT00102258|Energy Expenditure|energy expenditure
5801476|NCT00102258|Dietary Supplements|dietary supplements
5801477|NCT00102258|Constitutional Delay of Growth|constitutional delay of growth
5801478|NCT00102258|CDGM|cdgm
5801479|NCT00102245|Hemoglobin|hemoglobin
5801480|NCT00102245|Hemoglobinapathies|hemoglobinapathies
5801481|NCT00102245|Human Genome|human genome
5801482|NCT00102245|Recombinant DNA Technology|recombinant dna technology
5801483|NCT00102245|Sequencing|sequencing
5801484|NCT00102245|Erythrocyte|erythrocyte
5801485|NCT00102232|phosphatidylcholine|phosphatidylcholine
5801486|NCT00102232|choline|choline
5801487|NCT00102232|homocysteine|homocysteine
5801488|NCT00102232|cardiovascular disease prevention|cardiovascular disease prevention
5801489|NCT00102232|human|human
5801490|NCT00102232|cardiovascular health|cardiovascular health
5801491|NCT00102206|Treatment Experienced|treatment experienced
5801492|NCT00102206|Child|child
5801493|NCT00102193|Ulcerative Colitis, Apheresis|ulcerative colitis, apheresis
5801494|NCT00102141|Postmenopausal|postmenopausal
5801495|NCT00102141|vasomotor symptoms|vasomotor symptoms
5801496|NCT00102141|essential hypertension|essential hypertension
5801497|NCT00102115|Macular disease|macular disease
5801498|NCT00102115|Wet AMD|wet amd
5801499|NCT00102115|AMD|amd
5801500|NCT00102115|Age-Related Macular Disease|age-related macular disease
5801502|NCT00102115|Photodynamic Therapy|photodynamic therapy
5801503|NCT00102102|Substance P|substance p
5801504|NCT00102102|Neurokinin|neurokinin
5801505|NCT00102102|Tachykinin|tachykinin
5801506|NCT00102102|Anxiety|anxiety
5801507|NCT00102102|Neuroreceptor Imaging|neuroreceptor imaging
5801508|NCT00102102|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5801509|NCT00102102|PTSD|ptsd
5801510|NCT00102102|Healthy Volunteer|healthy volunteer
5801511|NCT00102102|HV|hv
5801512|NCT00102089|HIV-Negative|hiv-negative
5801513|NCT00102089|Healthy|healthy
5801514|NCT00102089|Immunity|immunity
5801515|NCT00102089|Preventive|preventive
5801516|NCT00102089|Virus|virus
5801517|NCT00102089|Healthy Volunteer|healthy volunteer
5801518|NCT00102089|HV|hv
5801519|NCT00102076|Minimal|minimal
5801520|NCT00102076|Risk|risk
5801521|NCT00102076|Regulations|regulations
5801522|NCT00102076|Parents|parents
5801523|NCT00102076|IRB|irb
5801524|NCT00102076|Surgery|surgery
5801525|NCT00102076|Assent Requirement|assent requirement
5801526|NCT00102063|Schizophrenia|schizophrenia
5801527|NCT00102063|Aripiprazole|aripiprazole
5801528|NCT00102050|NM-702 tablets|nm-702 tablets
5801529|NCT00102050|intermittent claudication|intermittent claudication
5801530|NCT00102050|peripheral|peripheral
5801531|NCT00102050|arterial|arterial
5801532|NCT00102050|vascular|vascular
5801533|NCT00102050|peripheral arterial disease|peripheral arterial disease
5801534|NCT00102024|Metastatic Colorectal Adenocarcinoma|metastatic colorectal adenocarcinoma
5801535|NCT00102024|Anti TAG-72|anti tag-72
5801536|NCT00102024|Monoclonal Antibody|monoclonal antibody
5801538|NCT00102011|rectal cancer|rectal cancer
5801539|NCT00101998|OBD (Induced Bowel Dysfunction)|obd (induced bowel dysfunction)
5801540|NCT00101998|cancer pain|cancer pain
5801541|NCT00101998|pain medication|pain medication
5801725|NCT00101387|Acupuncture|acupuncture
5801542|NCT00101998|constipation|constipation
5801543|NCT00101998|bowel|bowel
5801544|NCT00101998|bowel dysfunction|bowel dysfunction
5801545|NCT00101985|Quality of Life|quality of life
5801546|NCT00101985|Irritable bowel syndrome|irritable bowel syndrome
5801547|NCT00101985|IBS|ibs
5801548|NCT00101985|SB223412|sb223412
5801549|NCT00101985|Qol|qol
5801550|NCT00101972|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5801551|NCT00101972|adenocarcinoma of the colon|adenocarcinoma of the colon
5801552|NCT00101972|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5801553|NCT00101972|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5801554|NCT00101972|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5801555|NCT00101972|adenocarcinoma of the lung|adenocarcinoma of the lung
5801556|NCT00101972|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5801557|NCT00101972|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5801558|NCT00101972|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5801559|NCT00101972|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5846479|NCT00044291|Receptor-positive|receptor-positive
5801560|NCT00101972|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5801561|NCT00101972|cervical adenocarcinoma|cervical adenocarcinoma
5801562|NCT00101972|endometrial adenocarcinoma|endometrial adenocarcinoma
5801563|NCT00101972|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5801564|NCT00101972|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5686569|NCT00551525|stage IIB prostate cancer|stage iib prostate cancer
5801565|NCT00101972|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5801566|NCT00101972|small intestine adenocarcinoma|small intestine adenocarcinoma
5801568|NCT00101972|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5801569|NCT00101972|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5801570|NCT00101972|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5801571|NCT00101972|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5801572|NCT00101972|stage IV bladder cancer|stage iv bladder cancer
5801573|NCT00101972|stage IV breast cancer|stage iv breast cancer
5801574|NCT00101972|stage IV colon cancer|stage iv colon cancer
5801575|NCT00101972|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5801576|NCT00101972|stage IV esophageal cancer|stage iv esophageal cancer
5801577|NCT00101972|stage IV gastric cancer|stage iv gastric cancer
5801578|NCT00101972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5801579|NCT00101972|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5801580|NCT00101972|stage IV prostate cancer|stage iv prostate cancer
5801581|NCT00101972|stage IV rectal cancer|stage iv rectal cancer
5801582|NCT00101972|stage IV renal cell cancer|stage iv renal cell cancer
5801583|NCT00101972|stage IV salivary gland cancer|stage iv salivary gland cancer
5801584|NCT00101972|stage IVA cervical cancer|stage iva cervical cancer
5801585|NCT00101972|stage IVA vaginal cancer|stage iva vaginal cancer
5801586|NCT00101972|stage IVB cervical cancer|stage ivb cervical cancer
5801587|NCT00101972|stage IVB vaginal cancer|stage ivb vaginal cancer
5801588|NCT00101972|recurrent bladder cancer|recurrent bladder cancer
5801589|NCT00101972|recurrent breast cancer|recurrent breast cancer
5801590|NCT00101972|recurrent cervical cancer|recurrent cervical cancer
5801591|NCT00101972|recurrent colon cancer|recurrent colon cancer
5802241|NCT00099463|Immunity|immunity
5801592|NCT00101972|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5801593|NCT00101972|recurrent esophageal cancer|recurrent esophageal cancer
5801594|NCT00101972|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5801595|NCT00101972|recurrent gallbladder cancer|recurrent gallbladder cancer
5801596|NCT00101972|recurrent gastric cancer|recurrent gastric cancer
5801597|NCT00101972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5801598|NCT00101972|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5801599|NCT00101972|recurrent pancreatic cancer|recurrent pancreatic cancer
5801600|NCT00101972|recurrent prostate cancer|recurrent prostate cancer
5801601|NCT00101972|recurrent rectal cancer|recurrent rectal cancer
5801602|NCT00101972|recurrent renal cell cancer|recurrent renal cell cancer
5801603|NCT00101972|recurrent salivary gland cancer|recurrent salivary gland cancer
5801604|NCT00101972|recurrent small intestine cancer|recurrent small intestine cancer
5801605|NCT00101972|recurrent vaginal cancer|recurrent vaginal cancer
5801606|NCT00101972|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5801607|NCT00101972|unresectable gallbladder cancer|unresectable gallbladder cancer
5801608|NCT00101972|stage IV pancreatic cancer|stage iv pancreatic cancer
5801610|NCT00101946|Crohn's Disease|crohn's disease
5801611|NCT00101933|Deep brain stimulation, DBS, SANTE|deep brain stimulation, dbs, sante
5801612|NCT00101907|Advanced Cancer|advanced cancer
5801614|NCT00101907|Panitumumab|panitumumab
5801615|NCT00101907|Gemcitabine-Cisplatin|gemcitabine-cisplatin
5801616|NCT00101894|AMG 706|amg 706
5801617|NCT00101894|Panitumumab|panitumumab
5801618|NCT00101881|Cardiac arrest|cardiac arrest
5801619|NCT00101881|Defibrillation|defibrillation
5801620|NCT00101881|Biphasic defibrillation|biphasic defibrillation
5801621|NCT00101881|Monophasic defibrillation|monophasic defibrillation
5801622|NCT00101881|Ventricular fibrillation|ventricular fibrillation
5801623|NCT00101868|Aged|aged
5801624|NCT00101868|Hospitalists|hospitalists
5801625|NCT00101868|Outcome and process assessment (health care)|outcome and process assessment (health care)
5801626|NCT00101868|Human|human
5801627|NCT00101868|Hospitals, teaching|hospitals, teaching
5801628|NCT00101868|Physicians, family|physicians, family
5801629|NCT00101868|Medical records|medical records
5801630|NCT00101868|Quality assurance, health care|quality assurance, health care
5801631|NCT00101868|Medical errors|medical errors
5801632|NCT00101855|prevention|prevention
5801633|NCT00101855|internet|internet
5801634|NCT00101855|quality of care|quality of care
5801635|NCT00101829|Autoimmune Diseases|autoimmune diseases
5801636|NCT00101816|Myeloid blast phase Chronic Myeloid Leukemia (CML)|myeloid blast phase chronic myeloid leukemia (cml)
5801637|NCT00101803|type 2 diabetes|type 2 diabetes
5801638|NCT00101803|vildagliptin|vildagliptin
5801639|NCT00101790|low back pain|low back pain
5801640|NCT00101790|pamidronate|pamidronate
5801641|NCT00101777|Anxiety|anxiety
5801642|NCT00101777|Ventilation|ventilation
5801643|NCT00101777|Panic Disorder|panic disorder
5801644|NCT00101777|Children|children
5801645|NCT00101777|Healthy Volunteer|healthy volunteer
5801647|NCT00101777|Normal Control|normal control
5801649|NCT00101764|CRVO|crvo
5801650|NCT00101764|BRVO|brvo
5801651|NCT00101764|Uveitis|uveitis
5801652|NCT00101764|Choroidal Neovascularization|choroidal neovascularization
5801653|NCT00101764|Age-Related Macular Degeneration (AMD)|age-related macular degeneration (amd)
5808681|NCT00087555|Pain|pain
5801655|NCT00101764|Central Retinal Vein Occlusion|central retinal vein occlusion
5801656|NCT00101764|Branch Retinal Vein Occlusion|branch retinal vein occlusion
5801657|NCT00101764|Inflammation|inflammation
5801658|NCT00101764|Age Related Macular Degeneration|age related macular degeneration
5801659|NCT00101764|Retinal Disorder|retinal disorder
5801660|NCT00101738|MPA|mpa
5801661|NCT00101738|Kidney Transplantation|kidney transplantation
5801662|NCT00101738|Acute rejection|acute rejection
5801663|NCT00101738|Kidney function|kidney function
5801664|NCT00101725|Diarrhea|diarrhea
5801665|NCT00101725|IBS|ibs
5801666|NCT00101725|Irritable Bowel Syndrome|irritable bowel syndrome
5801667|NCT00101725|Abdominal pain|abdominal pain
5801668|NCT00101712|type 2 diabetes|type 2 diabetes
5801669|NCT00101712|vildagliptin|vildagliptin
5801670|NCT00101699|Women|women
5801671|NCT00101699|Soy Foods|soy foods
5801672|NCT00101699|Middle Aged|middle aged
5801673|NCT00101673|type 2 diabetes|type 2 diabetes
5801674|NCT00101673|vildagliptin|vildagliptin
5801675|NCT00101660|Chronic phase Philadelphia chromosome chronic myeloid leukemia (Ph+CML)|chronic phase philadelphia chromosome chronic myeloid leukemia (ph+cml)
5801676|NCT00101647|Chronic myelogenous leukemia (CML): Accelerated phase|chronic myelogenous leukemia (cml): accelerated phase
5801677|NCT00101634|Schizophrenia|schizophrenia
5801678|NCT00101634|Paliperidone palmitate|paliperidone palmitate
5801679|NCT00101634|R092670|r092670
5801680|NCT00101634|antipsychotic|antipsychotic
5801681|NCT00101621|cancer|cancer
5801682|NCT00101621|pain|pain
5801683|NCT00101621|Cancers, Pain|cancers, pain
5801684|NCT00101608|urothelium|urothelium
5801685|NCT00101595|Lymphoid blast phase chronic myeloid leukemia|lymphoid blast phase chronic myeloid leukemia
5801686|NCT00101595|Philadelphia chromosome positive acute lymphoblastic leukemia|philadelphia chromosome positive acute lymphoblastic leukemia
5801687|NCT00101582|SCCHN|scchn
5801688|NCT00101582|Palifermin|palifermin
5801689|NCT00101582|Mucositis|mucositis
5801690|NCT00101582|Oral Cavity|oral cavity
5801691|NCT00101582|Oropharynx|oropharynx
5801692|NCT00101582|Nasopharynx|nasopharynx
5801693|NCT00101582|Hypopharynx|hypopharynx
5801694|NCT00101582|Larynx|larynx
5801695|NCT00101582|Mouth Pain|mouth pain
5801696|NCT00101582|Mouth Sores|mouth sores
5801697|NCT00101582|Radiation Therapy|radiation therapy
5801698|NCT00101582|Radiotherapy|radiotherapy
5801699|NCT00101582|Radiochemotherapy|radiochemotherapy
5801700|NCT00101582|Concurrent Chemotherapy|concurrent chemotherapy
5801701|NCT00101582|Xerostomia|xerostomia
5801702|NCT00101582|Stomatitis|stomatitis
5801703|NCT00101582|Mucosa|mucosa
5801704|NCT00101582|KGF|kgf
5801705|NCT00101582|rHuKGF|rhukgf
5801706|NCT00101582|Keratinocyte Growth Factor|keratinocyte growth factor
5801707|NCT00101582|HNC|hnc
5801708|NCT00101582|Head and Neck Cancer|head and neck cancer
5801709|NCT00101582|Oral Mucositis|oral mucositis
5801710|NCT00101543|Gait Training|gait training
5801711|NCT00101543|Motor learning|motor learning
5801712|NCT00101543|Electrical stimulation|electrical stimulation
5801713|NCT00101543|Body Weight supported Treadmill Training|body weight supported treadmill training
5801714|NCT00101543|Cerebrovascular Accident|cerebrovascular accident
5801715|NCT00101465|Heart Failure|heart failure
5801716|NCT00101452|Depression|depression
5801717|NCT00101452|Antidepressive Agents|antidepressive agents
5801718|NCT00101452|Complementary Therapies|complementary therapies
5801719|NCT00101439|Primary Hypercholesterolemia|primary hypercholesterolemia
5801720|NCT00101426|Diabetic sensorimotor polyneuropathy|diabetic sensorimotor polyneuropathy
5801722|NCT00101413|NSCLC|nsclc
5801723|NCT00101400|Cancer|cancer
5801724|NCT00101387|Aged|aged
5801726|NCT00101374|Immunomodulatory Drug|immunomodulatory drug
5801727|NCT00101374|Antiviral|antiviral
5801728|NCT00101374|Ki67+|ki67+
5801729|NCT00101374|Immune Activation|immune activation
5801730|NCT00101374|T Cell Proliferation|t cell proliferation
5801731|NCT00101374|HIV|hiv
5801732|NCT00101374|Activated CD4+T-cell|activated cd4+t-cell
5801733|NCT00101374|Proliferation|proliferation
5801734|NCT00101361|dermatologic|dermatologic
5801735|NCT00101361|skin|skin
5801736|NCT00101361|clinical trial|clinical trial
5801737|NCT00101361|androgen/anabolic|androgen/anabolic
5801738|NCT00101335|hypopharyngeal cancer|hypopharyngeal cancer
5801739|NCT00101335|lip and oral cavity cancer|lip and oral cavity cancer
5801740|NCT00101335|nasopharyngeal cancer|nasopharyngeal cancer
5801741|NCT00101335|oropharyngeal cancer|oropharyngeal cancer
5801742|NCT00101335|tongue cancer|tongue cancer
5801743|NCT00101335|oral leukoplakia|oral leukoplakia
5801744|NCT00101309|recurrent neuroblastoma|recurrent neuroblastoma
5846480|NCT00044291|First line therapy|first line therapy
5801745|NCT00101309|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5801746|NCT00101283|advanced malignant mesothelioma|advanced malignant mesothelioma
5801747|NCT00101283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5801748|NCT00101257|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5801749|NCT00101257|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5801750|NCT00101257|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5800894|NCT00104533|Pain|pain
5800895|NCT00104533|Analgesia|analgesia
5800896|NCT00104533|Opioids|opioids
5800897|NCT00104520|Cystic Fibrosis|cystic fibrosis
5800898|NCT00104520|Pseudomonas aeruginosa|pseudomonas aeruginosa
5800899|NCT00104520|Pulmonary Cystic Fibrosis|pulmonary cystic fibrosis
5800900|NCT00104507|Serotonin|serotonin
5800901|NCT00104507|5-HT2c|5-ht2c
5801751|NCT00101257|peritoneal cavity cancer|peritoneal cavity cancer
5801752|NCT00101192|recurrent cervical cancer|recurrent cervical cancer
5801753|NCT00101192|cervical adenocarcinoma|cervical adenocarcinoma
5801754|NCT00101192|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5801755|NCT00101192|cervical small cell carcinoma|cervical small cell carcinoma
5801756|NCT00101192|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5801757|NCT00101192|stage III cervical cancer|stage iii cervical cancer
5801758|NCT00101192|stage IVA cervical cancer|stage iva cervical cancer
5801759|NCT00101192|stage IVB cervical cancer|stage ivb cervical cancer
5801760|NCT00101166|recurrent melanoma|recurrent melanoma
5801761|NCT00101166|stage III melanoma|stage iii melanoma
5801762|NCT00101166|stage IV melanoma|stage iv melanoma
5801763|NCT00101153|adult acute basophilic leukemia|adult acute basophilic leukemia
5801764|NCT00101153|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5801765|NCT00101153|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5801766|NCT00101153|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5801767|NCT00101153|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5801768|NCT00101153|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5801769|NCT00101153|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5801770|NCT00101153|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5801771|NCT00101153|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5801772|NCT00101153|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5801773|NCT00101153|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5801774|NCT00101153|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5801775|NCT00101153|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5801776|NCT00101153|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5862628|NCT00001561|Idiotype-Specific Immunity|idiotype-specific immunity
5801777|NCT00101153|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5801778|NCT00101153|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5801779|NCT00101140|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5801780|NCT00101140|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5801781|NCT00101140|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5801782|NCT00101140|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5801783|NCT00101140|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5801784|NCT00101140|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5801785|NCT00101140|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5801786|NCT00101140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5802024|NCT00100269|free radicals|free radicals
5801787|NCT00101140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5801788|NCT00101140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5801789|NCT00101140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5796898|NCT00117403|dementia|dementia
5801790|NCT00101140|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5801791|NCT00101127|recurrent uterine sarcoma|recurrent uterine sarcoma
5801792|NCT00101127|stage III uterine sarcoma|stage iii uterine sarcoma
5801793|NCT00101127|stage IV uterine sarcoma|stage iv uterine sarcoma
5801794|NCT00101127|uterine leiomyosarcoma|uterine leiomyosarcoma
5801795|NCT00101101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5801796|NCT00101101|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5802077|NCT00100126|Pharyngitis|pharyngitis
5801797|NCT00101101|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5801798|NCT00101101|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5801799|NCT00101101|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5801800|NCT00101075|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5801801|NCT00101075|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5801802|NCT00101075|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5801803|NCT00101075|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5801804|NCT00101075|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5801805|NCT00101075|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5801806|NCT00101075|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5801807|NCT00101075|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5801808|NCT00101075|recurrent salivary gland cancer|recurrent salivary gland cancer
5801809|NCT00101075|stage III salivary gland cancer|stage iii salivary gland cancer
5801810|NCT00101075|stage IV salivary gland cancer|stage iv salivary gland cancer
5801811|NCT00101062|stage IIIA breast cancer|stage iiia breast cancer
5801812|NCT00101062|stage IIIB breast cancer|stage iiib breast cancer
5801813|NCT00101062|stage IIIC breast cancer|stage iiic breast cancer
5801814|NCT00101062|stage IV breast cancer|stage iv breast cancer
5801815|NCT00101062|recurrent breast cancer|recurrent breast cancer
5801816|NCT00101010|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5801817|NCT00101010|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5801818|NCT00101010|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5801819|NCT00101010|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5801820|NCT00100997|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5801821|NCT00100997|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5801822|NCT00100997|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5801823|NCT00100971|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5801824|NCT00100971|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5801825|NCT00100971|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5801826|NCT00100971|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5801827|NCT00100971|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5801828|NCT00100971|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5801829|NCT00100958|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5801830|NCT00100945|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5801831|NCT00100945|stage II esophageal cancer|stage ii esophageal cancer
5801832|NCT00100919|Kinesithesia|kinesithesia
5801833|NCT00100919|Sensorimotor Function|sensorimotor function
5801834|NCT00100919|Somatosensory|somatosensory
5801835|NCT00100919|Muscle Spindles|muscle spindles
5801836|NCT00100919|Sensory Feedback|sensory feedback
5801837|NCT00100919|Healthy Volunteer|healthy volunteer
5801839|NCT00100906|stage IV renal cell cancer|stage iv renal cell cancer
5801840|NCT00100906|recurrent renal cell cancer|recurrent renal cell cancer
5801841|NCT00100906|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5801842|NCT00100893|breast cancer|breast cancer
5801843|NCT00100867|Perinatal Transmission|perinatal transmission
5801844|NCT00100867|Mother-to-Child Transmission|mother-to-child transmission
5801845|NCT00100854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5801846|NCT00100854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5801847|NCT00100854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5801848|NCT00100828|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5801849|NCT00100828|recurrent thyroid cancer|recurrent thyroid cancer
5801850|NCT00100815|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5801851|NCT00100815|recurrent pancreatic cancer|recurrent pancreatic cancer
5801852|NCT00100815|stage IV pancreatic cancer|stage iv pancreatic cancer
5801853|NCT00100802|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5801854|NCT00100802|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5801856|NCT00100789|stage IV|stage iv
5801857|NCT00100789|squamous cell carcinoma|squamous cell carcinoma
5801858|NCT00100789|hypopharynx|hypopharynx
5801859|NCT00100789|larynx|larynx
5801861|NCT00100789|oral cavity|oral cavity
5801862|NCT00100789|nasopharynx|nasopharynx
5801863|NCT00100789|oropharynx|oropharynx
5801864|NCT00100789|paranasal|paranasal
5801865|NCT00100789|nasal cavity|nasal cavity
5801866|NCT00100789|metastatic|metastatic
5801867|NCT00100789|neck cancer|neck cancer
5801868|NCT00100737|non-hodgkins lymphoma|non-hodgkins lymphoma
5801869|NCT00100737|interleukin-2|interleukin-2
5801870|NCT00100737|rituximab|rituximab
5801871|NCT00100737|CD20+ follicular B-cell non-hodgkins lymphoma (grade I, II,III)|cd20+ follicular b-cell non-hodgkins lymphoma (grade i, ii,iii)
5801873|NCT00100724|rPA102|rpa102
5801874|NCT00100724|vaccine|vaccine
5801875|NCT00100711|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5801876|NCT00100711|Small Lymphocytic Lymphoma|small lymphocytic lymphoma
5801877|NCT00100711|Leukemia|leukemia
5801878|NCT00100711|Lymphoma|lymphoma
5801879|NCT00100711|Motexafin Gadolinium|motexafin gadolinium
5801880|NCT00100711|Relapsed Chronic Lymphocytic Leukemia|relapsed chronic lymphocytic leukemia
5801881|NCT00100711|Relapsed Chronic Lymphocycic Lymphoma|relapsed chronic lymphocycic lymphoma
5801882|NCT00100711|Refractory Chronic Lymphocytic Leukemia|refractory chronic lymphocytic leukemia
5801883|NCT00100711|Refractory Small Lymphocytic Lymphoma|refractory small lymphocytic lymphoma
5801885|NCT00100698|lipodystrophy|lipodystrophy
5801886|NCT00100698|growth hormone|growth hormone
5801887|NCT00100698|visceral fat|visceral fat
5801888|NCT00100698|IGF-I|igf-i
5801889|NCT00100698|Treatment Experienced|treatment experienced
5801890|NCT00100685|Kidney|kidney
5801891|NCT00100685|renal|renal
5801892|NCT00100685|cancer|cancer
5801893|NCT00100685|carcinoma|carcinoma
5801894|NCT00100685|cell|cell
5801895|NCT00100685|metastatic|metastatic
5801896|NCT00100685|metastatic renal cell carcinoma|metastatic renal cell carcinoma
5801897|NCT00100685|RCC|rcc
5801898|NCT00100672|LErafAON-ETU|lerafaon-etu
5801899|NCT00100672|Signal transduction|signal transduction
5801900|NCT00100672|Neoplasm|neoplasm
5801901|NCT00100672|Cancer|cancer
5801902|NCT00100672|NeoPharm|neopharm
5801903|NCT00100672|Liposomes|liposomes
5801904|NCT00100672|Antisense|antisense
5801905|NCT00100672|Anti-cancer|anti-cancer
5801906|NCT00100672|Advanced neoplasm|advanced neoplasm
5801907|NCT00100672|Advanced cancer|advanced cancer
5801908|NCT00100672|Chemotherapy|chemotherapy
5801909|NCT00100672|Refractory cancer|refractory cancer
5801910|NCT00100672|Metastatic cancer|metastatic cancer
5801911|NCT00100659|pediatric|pediatric
5801912|NCT00100659|hepatitis|hepatitis
5801913|NCT00100659|children|children
5801914|NCT00100659|HCV|hcv
5801915|NCT00100659|PEG|peg
5801916|NCT00100659|PEG-2a|peg-2a
5801917|NCT00100659|peginterferon alfa-2a|peginterferon alfa-2a
5801918|NCT00100659|Pegylated Interferon|pegylated interferon
5801919|NCT00100659|RV|rv
5801920|NCT00100659|ribavirin|ribavirin
5801921|NCT00100659|Pegasys|pegasys
5801922|NCT00100659|CHC|chc
5801923|NCT00100659|chronic hepatitis C|chronic hepatitis c
5801924|NCT00100659|chronic hepatitis C virus|chronic hepatitis c virus
5801925|NCT00100659|hepatitis c|hepatitis c
5801926|NCT00100659|pediatric hepatitis|pediatric hepatitis
5801927|NCT00100659|pediatric HCV|pediatric hcv
5801928|NCT00100646|Treatment Interruption|treatment interruption
5801929|NCT00100646|Treatment Naive|treatment naive
5801930|NCT00100633|Hepatitis B Vaccine|hepatitis b vaccine
5801931|NCT00100633|Treatment Experienced|treatment experienced
5801932|NCT00100633|Treatment Naive|treatment naive
5801933|NCT00100620|Corticosteroid induced osteoporosis|corticosteroid induced osteoporosis
5801934|NCT00100620|prevention|prevention
5801935|NCT00100620|treatment|treatment
5801936|NCT00100620|zoledronic acid|zoledronic acid
5801937|NCT00100607|osteoporosis/osteopenia, BMD, postmenopausal|osteoporosis/osteopenia, bmd, postmenopausal
5801938|NCT00100594|Treatment Naive|treatment naive
5801939|NCT00100581|Treatment Naive|treatment naive
5801940|NCT00100568|Treatment Naive|treatment naive
5801941|NCT00100555|Osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
5801942|NCT00100542|Treatment Experienced|treatment experienced
5801944|NCT00100542|Psychopathology|psychopathology
5801945|NCT00100542|Anti-Retroviral Agents|anti-retroviral agents
5801947|NCT00100542|Adolescent|adolescent
5801948|NCT00100529|Facial Imaging|facial imaging
5801949|NCT00100529|Genetics|genetics
5801950|NCT00100529|Growth|growth
5801951|NCT00100529|Development|development
5801952|NCT00100529|Diagnostics|diagnostics
5801953|NCT00100529|Craniofacial Dysmorphologies|craniofacial dysmorphologies
5801954|NCT00100529|Facial Features|facial features
5801955|NCT00100516|Renal|renal
5801956|NCT00100516|Allografts|allografts
5801957|NCT00100516|Nephrectomy|nephrectomy
5801958|NCT00100516|Pneumoperitoneum|pneumoperitoneum
5801959|NCT00100516|LaparoscopIC|laparoscopic
5801960|NCT00100516|Kidney Donation|kidney donation
5801961|NCT00100503|Rehabilitation|rehabilitation
5801962|NCT00100503|Forced Use|forced use
5801963|NCT00100503|Hemiplegia|hemiplegia
5801964|NCT00100503|Magnetic Resonance Imaging|magnetic resonance imaging
5801965|NCT00100503|TMS|tms
5801966|NCT00100503|Cerebral Palsy|cerebral palsy
5801967|NCT00100503|Spastic Hemiplegia|spastic hemiplegia
5801968|NCT00100503|Healthy Volunteer|healthy volunteer
5801969|NCT00100503|HV|hv
5801970|NCT00100477|Multiple Myeloma|multiple myeloma
5801971|NCT00100477|Lymphoma|lymphoma
5801972|NCT00100477|Leukemia|leukemia
5801973|NCT00100477|Etoposide|etoposide
5801974|NCT00100477|Drug Therapy|drug therapy
5801975|NCT00100477|Clinical Trials|clinical trials
5801976|NCT00100464|Serotonin|serotonin
5801977|NCT00100464|Sleep Apnea Syndrome|sleep apnea syndrome
5801978|NCT00100464|Pharyngeal Muscles|pharyngeal muscles
5801979|NCT00100451|Adipose tissue|adipose tissue
5801980|NCT00100451|Aging|aging
5801981|NCT00100451|Exercise|exercise
5801982|NCT00100451|Lipolysis|lipolysis
5801983|NCT00100451|Estrogens|estrogens
5801984|NCT00100425|Irritable Bowel Syndrome|irritable bowel syndrome
5801985|NCT00100425|Visceral Hypersensitivity|visceral hypersensitivity
5801986|NCT00100425|Visceral Pain|visceral pain
5801987|NCT00100399|influenza, flu, Fluarix, vaccine, GSK, immunogenicity|influenza, flu, fluarix, vaccine, gsk, immunogenicity
5801988|NCT00100386|Hand hygiene, antibiotic resistance, contact precautions|hand hygiene, antibiotic resistance, contact precautions
5801989|NCT00100373|Respiratory Syncytial Virus Infections|respiratory syncytial virus infections
5801990|NCT00100360|Gonadal Steroids|gonadal steroids
5801991|NCT00100360|GnRH Agonist|gnrh agonist
5801992|NCT00100360|Depression|depression
5801993|NCT00100360|Menstrual Cycle|menstrual cycle
5801994|NCT00100360|Menstrually Related Mood Disorder|menstrually related mood disorder
5801995|NCT00100360|MRMD|mrmd
5801996|NCT00100360|Healthy Volunteer|healthy volunteer
5801997|NCT00100360|HV|hv
5801998|NCT00100347|non-Hodgkin lymphoma|non-hodgkin lymphoma
5801999|NCT00100347|non-Hodgkin’s lymphoma|non-hodgkin’s lymphoma
5802000|NCT00100347|NHL|nhl
5802001|NCT00100347|MetAP2|metap2
5802002|NCT00100347|Solid Tumors|solid tumors
5802004|NCT00100321|Tumor Antigen Identification|tumor antigen identification
5802005|NCT00100321|Standard Treatment|standard treatment
5802006|NCT00100321|Tissue Acquisition|tissue acquisition
5802007|NCT00100321|Surgery|surgery
5802008|NCT00100321|Adjuvant Chemotherapy|adjuvant chemotherapy
5802009|NCT00100321|Pancreatic Cancer|pancreatic cancer
5802010|NCT00100321|Pancreatic Tumor|pancreatic tumor
5802011|NCT00100308|sepsis|sepsis
5802012|NCT00100308|Randomized clinical trial|randomized clinical trial
5802013|NCT00100308|Heparin|heparin
5802014|NCT00100308|Therapy|therapy
5802015|NCT00100295|Adolescent|adolescent
5802016|NCT00100295|Child|child
5802017|NCT00100295|Phytotherapy|phytotherapy
5802018|NCT00100282|Mild-moderate Alzheimer's disease|mild-moderate alzheimer's disease
5802019|NCT00100269|Male infertility|male infertility
5802020|NCT00100269|sperm|sperm
5802021|NCT00100269|pregnancy|pregnancy
5802022|NCT00100269|IVF (in vitro fertilisation)|ivf (in vitro fertilisation)
5802023|NCT00100269|oxidative stress|oxidative stress
5802025|NCT00100269|DNA damage|dna damage
5802026|NCT00100256|Advanced or recurrent stage IIIb or IV non small cell lung cancer|advanced or recurrent stage iiib or iv non small cell lung cancer
5802027|NCT00100256|Disseminated or recurrent small cell lung cancer|disseminated or recurrent small cell lung cancer
5802028|NCT00100243|androgen-independent|androgen-independent
5802029|NCT00100243|prostate cancer|prostate cancer
5802030|NCT00100230|retina|retina
5802031|NCT00100230|electroretinography|electroretinography
5802032|NCT00100230|clinical trial|clinical trial
5802033|NCT00100230|docosahexaenoic acid|docosahexaenoic acid
5802034|NCT00100230|omega-3 fatty acid|omega-3 fatty acid
5802035|NCT00100230|x-linked inheritance|x-linked inheritance
5802036|NCT00100217|Training|training
5802037|NCT00100217|Critical Care|critical care
5802038|NCT00100217|Heart Failure|heart failure
5802039|NCT00100217|Pulmonary Hypertension|pulmonary hypertension
5802040|NCT00100217|Infectious Diseases|infectious diseases
5802041|NCT00100204|Head and Neck Radiation|head and neck radiation
5802042|NCT00100204|Diabetes|diabetes
5802043|NCT00100204|Sarcoidosis|sarcoidosis
5802044|NCT00100204|Sjogren's Syndrome|sjogren's syndrome
5802045|NCT00100204|Caries|caries
5802046|NCT00100204|Healthy Volunteer|healthy volunteer
5802047|NCT00100204|HV|hv
5802048|NCT00100204|Saliva Sample|saliva sample
5802049|NCT00100191|hysterectomy|hysterectomy
5802050|NCT00100191|fibroids|fibroids
5802051|NCT00100191|uterine artery embolization|uterine artery embolization
5802052|NCT00100191|therapeutic embolization|therapeutic embolization
5802053|NCT00100191|uterus|uterus
5802054|NCT00100191|menorrhagia|menorrhagia
5802055|NCT00100178|immunosuppressive therapy|immunosuppressive therapy
5802056|NCT00100178|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
5802057|NCT00100178|TrialNet|trialnet
5802058|NCT00100178|POPPII|poppii
5802059|NCT00100178|POPPII-1|poppii-1
5802060|NCT00100165|Schizophrenia|schizophrenia
5802061|NCT00100152|Relapsed or refractory T-cell ALL acute lymphoblastic/leukemia|relapsed or refractory t-cell all acute lymphoblastic/leukemia
5802062|NCT00100152|Relapsed/refractory T-cell acute Lymphoblastic/leukemia|relapsed/refractory t-cell acute lymphoblastic/leukemia
5802063|NCT00100152|Acute/chronic myelogenous leukemia|acute/chronic myelogenous leukemia
5802064|NCT00100152|Poor-risk myelodysplasia|poor-risk myelodysplasia
5802065|NCT00100139|Neoplasm|neoplasm
5802066|NCT00100139|Cancer|cancer
5802067|NCT00100139|NeoPharm|neopharm
5802068|NCT00100139|Liposomes|liposomes
5802071|NCT00100139|Anti-cancer|anti-cancer
5802072|NCT00100139|Advanced neoplasm|advanced neoplasm
5802073|NCT00100139|Advanced cancer|advanced cancer
5802074|NCT00100139|Chemotherapy|chemotherapy
5802075|NCT00100139|Refractory cancer|refractory cancer
5802076|NCT00100139|Metastatic cancer|metastatic cancer
5802078|NCT00100126|Strep throat|strep throat
5802079|NCT00100113|cocaine dependence|cocaine dependence
5802080|NCT00100100|cocaine dependence|cocaine dependence
5802081|NCT00100087|macular degeneration|macular degeneration
5802082|NCT00100087|brachytherapy|brachytherapy
5802083|NCT00100087|choroidal neovascularization|choroidal neovascularization
5802084|NCT00100087|retinal degeneration|retinal degeneration
5802085|NCT00100087|retinal diseases|retinal diseases
5802086|NCT00100061|Cranberry|cranberry
5802087|NCT00100061|Vaccinium macrocarpon|vaccinium macrocarpon
5802088|NCT00100035|Caregivers|caregivers
5802089|NCT00100035|Complementary Therapies|complementary therapies
5802090|NCT00100009|Steroid|steroid
5802091|NCT00100009|Inflammation|inflammation
5802092|NCT00100009|Choroidal Neovascularization|choroidal neovascularization
5801292|NCT00102843|human|human
5802093|NCT00100009|Intravitreal Injection|intravitreal injection
5802094|NCT00100009|Verteporfin|verteporfin
5802095|NCT00100009|Age-Related Macular Degeneration|age-related macular degeneration
5802096|NCT00100009|Photodynamic Therapy|photodynamic therapy
5802097|NCT00100009|Age Related Macular Degeneration|age related macular degeneration
5802098|NCT00100009|AMD|amd
5802099|NCT00099996|Sitosterolemia|sitosterolemia
5802100|NCT00099996|Sitosterol|sitosterol
5802101|NCT00099996|Ezetimibe|ezetimibe
5802102|NCT00099996|Absorption|absorption
5802103|NCT00099996|Intestine|intestine
5802104|NCT00099996|Cholesterol|cholesterol
5802105|NCT00099996|Atherosclerosis|atherosclerosis
5802106|NCT00099996|Homozygous Sitosterolemia|homozygous sitosterolemia
5802107|NCT00099983|PTSD|ptsd
5802108|NCT00099970|Solid tumors|solid tumors
5802109|NCT00099970|Metastatic melanoma|metastatic melanoma
5802110|NCT00099957|type 2 diabetes|type 2 diabetes
5802111|NCT00099957|vildagliptin|vildagliptin
5802112|NCT00099944|type 2 diabetes|type 2 diabetes
5802113|NCT00099944|vildagliptin|vildagliptin
5802114|NCT00099931|type 2 diabetes|type 2 diabetes
5802115|NCT00099931|vildagliptin|vildagliptin
5802116|NCT00099918|type 2 diabetes|type 2 diabetes
5802117|NCT00099918|vildagliptin|vildagliptin
5802118|NCT00099905|type 2 diabetes|type 2 diabetes
5802119|NCT00099905|vildagliptin|vildagliptin
5802120|NCT00099892|type 2 diabetes|type 2 diabetes
5802121|NCT00099892|vildagliptin|vildagliptin
5802122|NCT00099866|type 2 diabetes|type 2 diabetes
5802123|NCT00099866|vildagliptin|vildagliptin
5802124|NCT00099853|type 2 diabetes|type 2 diabetes
5802125|NCT00099853|vildagliptin|vildagliptin
5802126|NCT00099840|common cold|common cold
5802127|NCT00099840|pharyngitis|pharyngitis
5802128|NCT00099840|tonsillitis|tonsillitis
5802129|NCT00099840|rhinosinusitis|rhinosinusitis
5802130|NCT00099840|tracheo-bronchitis|tracheo-bronchitis
5802131|NCT00099840|otitis media|otitis media
5802132|NCT00099840|acute exacerbations of asthma|acute exacerbations of asthma
5802133|NCT00099840|acute exacerbations of chronic pulmonary disease|acute exacerbations of chronic pulmonary disease
5802134|NCT00099840|community acquired pneumonia|community acquired pneumonia
5802135|NCT00099827|Depression|depression
5802136|NCT00099814|tooth movement|tooth movement
5802137|NCT00099814|orthodontics|orthodontics
5802138|NCT00099814|force|force
5802139|NCT00099814|humans|humans
5802140|NCT00099814|clinical trial|clinical trial
5802242|NCT00099463|Preventive|preventive
5802141|NCT00099801|Kidney, Transplantation, Rejection, Immunosuppression|kidney, transplantation, rejection, immunosuppression
5802142|NCT00099788|Acute Coronary Syndrome|acute coronary syndrome
5802143|NCT00099788|Myocardial Infarction|myocardial infarction
5802144|NCT00099788|Heart Attack|heart attack
5802146|NCT00099788|Chest pain|chest pain
5681241|NCT00574197|GI symptoms with Mycophenolate Mofetil after heart transplant|gi symptoms with mycophenolate mofetil after heart transplant
5681243|NCT00574184|Erectile Dysfunction|erectile dysfunction
5681244|NCT00574158|ozone|ozone
5681245|NCT00574158|inflammatory airway disease|inflammatory airway disease
5802147|NCT00099788|Ischemia|ischemia
5802148|NCT00099788|Non-ST Elevation Acute Coronary Syndrome|non-st elevation acute coronary syndrome
5802149|NCT00099775|Mycoses|mycoses
5802150|NCT00099775|Candida|candida
5802151|NCT00099775|Echinocandin|echinocandin
5802152|NCT00099775|Immunocompromised Host|immunocompromised host
5802153|NCT00099775|Invasive Fungal Infection|invasive fungal infection
5802154|NCT00099775|Fungal Infection|fungal infection
5802155|NCT00099762|Tumor Induced Osteomalacia|tumor induced osteomalacia
5802156|NCT00099762|FGF-23|fgf-23
5802157|NCT00099762|Phosphatonin|phosphatonin
5802158|NCT00099762|Hypophosphatemia|hypophosphatemia
5802159|NCT00099762|Oncogenic Osteomalacia|oncogenic osteomalacia
5802160|NCT00099762|Phosphaturic Mesenchymal Tumor|phosphaturic mesenchymal tumor
5802161|NCT00099762|TIO|tio
5802162|NCT00099762|Osteogenic Osteomalacia|osteogenic osteomalacia
5802163|NCT00099762|OOM|oom
5802164|NCT00099749|Kidney, immunosuppression, transplant, rejection|kidney, immunosuppression, transplant, rejection
5802165|NCT00099736|Kidney, transplantation, rejection, immunosuppression|kidney, transplantation, rejection, immunosuppression
5802166|NCT00099723|Hepatic steatosis|hepatic steatosis
5802167|NCT00099723|adult-onset diabetes|adult-onset diabetes
5802168|NCT00099723|Non-alcoholic fatty liver disease|non-alcoholic fatty liver disease
5802170|NCT00099710|Turmeric|turmeric
5802171|NCT00099710|Curry|curry
5802172|NCT00099710|NSAID|nsaid
5802173|NCT00099710|anti-inflammatory|anti-inflammatory
5802174|NCT00099710|Cholesterol|cholesterol
5802175|NCT00099710|anti-oxidant|anti-oxidant
5802176|NCT00099697|abdominal fat|abdominal fat
5802177|NCT00099697|dehydroepiandrosterone|dehydroepiandrosterone
5802178|NCT00099697|Insulin sensitivity|insulin sensitivity
5802179|NCT00099684|Treatment Experienced|treatment experienced
5802180|NCT00099671|Treatment Experienced|treatment experienced
5802181|NCT00099658|MTCT|mtct
5802182|NCT00099645|Mifepristone|mifepristone
5802183|NCT00099645|Mifeprex|mifeprex
5802184|NCT00099645|RU486|ru486
5802185|NCT00099645|VGX-410|vgx-410
5802186|NCT00099645|Abortion Pill|abortion pill
5802187|NCT00099645|Investigational Drug|investigational drug
5802188|NCT00099632|Treatment Naive|treatment naive
5802189|NCT00099619|exenatide|exenatide
5802190|NCT00099619|exendin-4|exendin-4
5802191|NCT00099619|diabetes|diabetes
5802192|NCT00099619|Amylin|amylin
5802193|NCT00099619|Lilly|lilly
5802194|NCT00099593|Cutaneous T-cell lymphoma (CTCL)|cutaneous t-cell lymphoma (ctcl)
5802195|NCT00099593|Sezary Syndrome|sezary syndrome
5802196|NCT00099593|Mycosis Fungoides|mycosis fungoides
5802197|NCT00099593|Vaccine|vaccine
5855187|NCT00000974|Pentamidine|pentamidine
5802198|NCT00099580|Congestive Heart Failure|congestive heart failure
5802199|NCT00099580|AC2592|ac2592
5802200|NCT00099580|GLP-1|glp-1
5802201|NCT00099580|Amylin|amylin
5802202|NCT00099580|metabolic abnormality|metabolic abnormality
5802203|NCT00099567|Metabolic Syndrome|metabolic syndrome
5802204|NCT00099567|Alzheimer's Disease|alzheimer's disease
5802205|NCT00099567|Cognitive Impairment|cognitive impairment
5802206|NCT00099567|Inflammation|inflammation
5802207|NCT00099541|Lung Cancer|lung cancer
5802208|NCT00099541|Bone Metastases|bone metastases
5802209|NCT00099541|Bone Markers|bone markers
5802211|NCT00099541|zoledronic acid|zoledronic acid
5802212|NCT00099541|Registry|registry
5802213|NCT00099541|Unresectable Stage IV Non Small-cell Lung Cancer (NSCLC)|unresectable stage iv non small-cell lung cancer (nsclc)
5802214|NCT00099541|Unresectable Stage IIIB NSCLC with Pleural Effusion|unresectable stage iiib nsclc with pleural effusion
5802215|NCT00099528|Post-herpetic neuralgia|post-herpetic neuralgia
5802216|NCT00099528|Shingles|shingles
5802217|NCT00099528|Herpes Zoster|herpes zoster
5802218|NCT00099528|Neuropathic pain|neuropathic pain
5802219|NCT00099528|Neuralgia|neuralgia
5802220|NCT00099528|Anti-TNF agents|anti-tnf agents
5802221|NCT00099528|Inflammatory cytokines|inflammatory cytokines
5802222|NCT00099528|Hyperalgesia|hyperalgesia
5802223|NCT00099528|Allodynia|allodynia
5802224|NCT00099528|Irritable nociceptor|irritable nociceptor
5802225|NCT00099502|Relapsing multiple sclerosis|relapsing multiple sclerosis
5802226|NCT00099502|interferon beta 1b|interferon beta 1b
5802227|NCT00099502|Betaferon|betaferon
5802228|NCT00099502|Betaseron|betaseron
5802229|NCT00099489|Chronic Inflammatory Demyelinating Polyradiculoneuropathy|chronic inflammatory demyelinating polyradiculoneuropathy
5802230|NCT00099489|CIDP|cidp
5802231|NCT00099489|IVIg|ivig
5802232|NCT00099489|AVONEX|avonex
5802233|NCT00099476|Epicatechin|epicatechin
5802234|NCT00099476|Polyphenols|polyphenols
5802235|NCT00099476|Chocolate|chocolate
5802236|NCT00099476|Insulin Resistance|insulin resistance
5802237|NCT00099476|Endothelial Dysfunction|endothelial dysfunction
5802238|NCT00099476|Hypertension|hypertension
5802239|NCT00099463|Coronavirus|coronavirus
5802240|NCT00099463|Healthy|healthy
5802244|NCT00099463|Healthy Volunteer|healthy volunteer
5802246|NCT00099450|bleeding|bleeding
5802247|NCT00099450|blood transfusion|blood transfusion
5802248|NCT00099450|surgeries|surgeries
5802249|NCT00099437|Advanced Breast Cancer|advanced breast cancer
5802250|NCT00099437|Metastatic Breast Cancer|metastatic breast cancer
5802251|NCT00099424|exercise training|exercise training
5802252|NCT00099424|resistance training|resistance training
5802253|NCT00099424|endurance training|endurance training
5802254|NCT00099424|Boeck's Sarcoid|boeck's sarcoid
5802255|NCT00099424|Besnier-Boeck Disease|besnier-boeck disease
5802256|NCT00099385|social development|social development
5802257|NCT00099385|risk behaviors|risk behaviors
5802258|NCT00099385|social emotional education|social emotional education
5802259|NCT00099385|classroom instruction|classroom instruction
5802260|NCT00099372|sacrocolpopexy|sacrocolpopexy
5802261|NCT00099372|abdominal sacrocolpopexy|abdominal sacrocolpopexy
5802262|NCT00099372|surgical procedure, prolapse|surgical procedure, prolapse
5802263|NCT00099372|pelvic organ prolapse|pelvic organ prolapse
5802264|NCT00099372|urinary incontinence|urinary incontinence
5802265|NCT00099372|stress urinary incontinence|stress urinary incontinence
5802266|NCT00099359|HIV|hiv
5802267|NCT00099359|Perinatal|perinatal
5802268|NCT00099359|Prevention|prevention
5802269|NCT00099359|Transmission|transmission
5802270|NCT00099359|Nevirapine|nevirapine
5802271|NCT00099359|Epivir|epivir
5802272|NCT00099359|Zidovudine|zidovudine
5802273|NCT00099359|Nelfinavir|nelfinavir
5802274|NCT00099359|ZDV|zdv
5802275|NCT00099359|NVP|nvp
5802276|NCT00099359|3TC|3tc
5802277|NCT00099359|NFV|nfv
5802278|NCT00099359|Viracept|viracept
5802279|NCT00099359|Viramune|viramune
5802280|NCT00099359|HIV Seronegativity|hiv seronegativity
5802281|NCT00099359|Treatment Naive|treatment naive
5802282|NCT00099333|exenatide|exenatide
5802283|NCT00099333|exendin-4|exendin-4
5802284|NCT00099333|Amylin|amylin
5802285|NCT00099333|Eli Lilly|eli lilly
5802286|NCT00099333|diabetes|diabetes
5802287|NCT00099320|exenatide|exenatide
5802288|NCT00099320|exendin-4|exendin-4
5802289|NCT00099320|diabetes|diabetes
5802290|NCT00099320|Amylin|amylin
5802291|NCT00099320|Lilly|lilly
5802292|NCT00099307|White Matter|white matter
5802293|NCT00099307|Grey Matter|grey matter
5802294|NCT00099307|Brain|brain
5802295|NCT00099307|Disability|disability
5802296|NCT00099307|Lesions|lesions
5802297|NCT00099307|Multiple Sclerosis|multiple sclerosis
5802298|NCT00099307|MS|ms
5802299|NCT00099307|Healthy Volunteer|healthy volunteer
5802300|NCT00099307|HV|hv
5802301|NCT00099294|Pancreas|pancreas
5802302|NCT00099294|Cancer|cancer
5802303|NCT00099294|Pancreatic Adenocarcinoma|pancreatic adenocarcinoma
5802304|NCT00099294|Metastatic|metastatic
5802305|NCT00099294|Glufosfamide|glufosfamide
5802306|NCT00099281|Metastatic breast cancer|metastatic breast cancer
5855573|NCT00000911|Viremia|viremia
5802307|NCT00099268|Parkinson's disease, levodopa therapy, dyskinesia|parkinson's disease, levodopa therapy, dyskinesia
5802308|NCT00099255|Keyword?|keyword?
5802309|NCT00099255|Primary Cutaneous Anaplastic Large Cell Lymphoma|primary cutaneous anaplastic large cell lymphoma
5802310|NCT00099255|Large Cell Transformation of Mycosis Fungoides|large cell transformation of mycosis fungoides
5802311|NCT00099255|Lymphomatoid Papulosis|lymphomatoid papulosis
5802313|NCT00099242|Dementia|dementia
5802314|NCT00099229|bipolar disorder|bipolar disorder
5802315|NCT00099229|manic episode|manic episode
5802316|NCT00099229|treatment|treatment
5802317|NCT00099229|licarbazepine|licarbazepine
5802318|NCT00099216|Dementia,vascular,rivastigmine,stroke,memory loss|dementia,vascular,rivastigmine,stroke,memory loss
5802319|NCT00099190|cancer|cancer
5802320|NCT00099190|solid tumor|solid tumor
5802321|NCT00099190|advanced solid tumor|advanced solid tumor
5802322|NCT00099164|preterm birth|preterm birth
5802323|NCT00099164|pregnancy|pregnancy
5802324|NCT00099164|multifetal|multifetal
5802325|NCT00099164|Progesterone|progesterone
5802326|NCT00099151|Longevity|longevity
5802327|NCT00099151|Dietary restriction|dietary restriction
5802328|NCT00099151|Physical activity|physical activity
5802329|NCT00099151|Weight Loss|weight loss
5802330|NCT00099151|Diabetes|diabetes
5802331|NCT00099138|Diet|diet
5802332|NCT00099138|Caloric Restriction|caloric restriction
5802333|NCT00099138|Exercise|exercise
5802334|NCT00099138|Energy Metabolism|energy metabolism
5802335|NCT00099138|Primary Aging|primary aging
5802336|NCT00099138|Secondary Aging|secondary aging
5802337|NCT00099125|adult giant cell glioblastoma|adult giant cell glioblastoma
5802338|NCT00099125|adult gliosarcoma|adult gliosarcoma
5802339|NCT00099125|adult glioblastoma|adult glioblastoma
5802340|NCT00099112|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5802341|NCT00099112|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5802342|NCT00099112|actinic keratosis|actinic keratosis
5802343|NCT00099099|Longevity|longevity
5802344|NCT00099099|Calorie restriction|calorie restriction
5802345|NCT00099099|Physical activity|physical activity
5802346|NCT00099099|Weight loss|weight loss
5802766|NCT00097409|Persistent|persistent
5802347|NCT00099086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5802348|NCT00099086|stage IIB prostate cancer|stage iib prostate cancer
5802349|NCT00099086|stage IIA prostate cancer|stage iia prostate cancer
5802350|NCT00099086|stage III prostate cancer|stage iii prostate cancer
5802351|NCT00099086|stage IV prostate cancer|stage iv prostate cancer
5802352|NCT00099060|adult giant cell glioblastoma|adult giant cell glioblastoma
5802353|NCT00099060|adult gliosarcoma|adult gliosarcoma
5802354|NCT00099060|recurrent adult brain tumor|recurrent adult brain tumor
5802355|NCT00099008|breast cancer|breast cancer
5802356|NCT00099008|endometrial cancer|endometrial cancer
5802357|NCT00098995|stage IB cervical cancer|stage ib cervical cancer
5802358|NCT00098995|stage IIA cervical cancer|stage iia cervical cancer
5802359|NCT00098995|stage IIB cervical cancer|stage iib cervical cancer
5802360|NCT00098995|stage III cervical cancer|stage iii cervical cancer
5802361|NCT00098995|stage IVA cervical cancer|stage iva cervical cancer
5802362|NCT00098995|cervical adenocarcinoma|cervical adenocarcinoma
5802363|NCT00098995|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5802364|NCT00098995|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5802365|NCT00098982|stage III colon cancer|stage iii colon cancer
5802366|NCT00098982|stage IV colon cancer|stage iv colon cancer
5802367|NCT00098982|stage III rectal cancer|stage iii rectal cancer
5802368|NCT00098982|stage IV rectal cancer|stage iv rectal cancer
5802369|NCT00098982|recurrent colon cancer|recurrent colon cancer
5802370|NCT00098982|recurrent rectal cancer|recurrent rectal cancer
5802371|NCT00098969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5802372|NCT00098943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5802373|NCT00098943|stage IV renal cell cancer|stage iv renal cell cancer
5802374|NCT00098943|recurrent renal cell cancer|recurrent renal cell cancer
5802375|NCT00098943|stage IV colon cancer|stage iv colon cancer
5802376|NCT00098943|recurrent colon cancer|recurrent colon cancer
5802377|NCT00098943|anaplastic thyroid cancer|anaplastic thyroid cancer
5802378|NCT00098943|insular thyroid cancer|insular thyroid cancer
5802379|NCT00098943|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5802380|NCT00098943|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5802381|NCT00098943|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5802382|NCT00098943|recurrent thyroid cancer|recurrent thyroid cancer
5802383|NCT00098943|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5801648|NCT00101764|AMD|amd
5802384|NCT00098943|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5802385|NCT00098943|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5802386|NCT00098943|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5802387|NCT00098943|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5802388|NCT00098943|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5815186|NCT00004107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815187|NCT00004107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815189|NCT00004100|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815190|NCT00004087|stage IV colon cancer|stage iv colon cancer
5815191|NCT00004087|stage IV pancreatic cancer|stage iv pancreatic cancer
5815192|NCT00004087|recurrent pancreatic cancer|recurrent pancreatic cancer
5815193|NCT00004087|stage IV rectal cancer|stage iv rectal cancer
5815194|NCT00004087|recurrent colon cancer|recurrent colon cancer
5802389|NCT00098943|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5802390|NCT00098943|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5802391|NCT00098943|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5802604|NCT00098059|cold sores|cold sores
5802392|NCT00098943|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5802393|NCT00098943|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5802394|NCT00098943|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5802395|NCT00098943|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5802396|NCT00098943|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5802397|NCT00098943|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5802398|NCT00098943|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5802399|NCT00098943|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5802400|NCT00098943|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5802401|NCT00098943|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5802402|NCT00098943|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5862629|NCT00001561|Immune Transfer|immune transfer
5802403|NCT00098943|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5802404|NCT00098943|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5802405|NCT00098943|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5802406|NCT00098943|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5802407|NCT00098943|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5802408|NCT00098943|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5802409|NCT00098943|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5802410|NCT00098943|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5802479|NCT00098566|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5802411|NCT00098943|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5802412|NCT00098943|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5802413|NCT00098943|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5802414|NCT00098943|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5802415|NCT00098943|metastatic parathyroid cancer|metastatic parathyroid cancer
5802416|NCT00098943|recurrent parathyroid cancer|recurrent parathyroid cancer
5802417|NCT00098943|recurrent salivary gland cancer|recurrent salivary gland cancer
5802418|NCT00098943|stage IV salivary gland cancer|stage iv salivary gland cancer
5802419|NCT00098917|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5802420|NCT00098917|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5802421|NCT00098917|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5802422|NCT00098878|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5802423|NCT00098878|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5802424|NCT00098878|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5802425|NCT00098878|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5802426|NCT00098878|fallopian tube cancer|fallopian tube cancer
5802427|NCT00098878|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5802428|NCT00098852|recurrent thyroid cancer|recurrent thyroid cancer
5802429|NCT00098852|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5802430|NCT00098852|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5802431|NCT00098852|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5802432|NCT00098852|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5802433|NCT00098800|ovarian epithelial cancer|ovarian epithelial cancer
5802434|NCT00098800|BRCA1 mutation carrier|brca1 mutation carrier
5802435|NCT00098800|BRCA2 mutation carrier|brca2 mutation carrier
5802436|NCT00098787|recurrent colon cancer|recurrent colon cancer
5802437|NCT00098787|stage IV colon cancer|stage iv colon cancer
5802438|NCT00098787|recurrent rectal cancer|recurrent rectal cancer
5802439|NCT00098787|stage IV rectal cancer|stage iv rectal cancer
5802440|NCT00098787|adenocarcinoma of the colon|adenocarcinoma of the colon
5802441|NCT00098787|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5802442|NCT00098774|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5802444|NCT00098761|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5802445|NCT00098761|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5802446|NCT00098761|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5802447|NCT00098761|recurrent childhood ependymoma|recurrent childhood ependymoma
5802448|NCT00098761|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5802449|NCT00098761|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5802450|NCT00098761|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5802451|NCT00098761|childhood choroid plexus tumor|childhood choroid plexus tumor
5802452|NCT00098761|childhood craniopharyngioma|childhood craniopharyngioma
5802453|NCT00098761|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5802454|NCT00098761|childhood grade I meningioma|childhood grade i meningioma
5802455|NCT00098761|childhood grade II meningioma|childhood grade ii meningioma
5802456|NCT00098761|childhood grade III meningioma|childhood grade iii meningioma
5802457|NCT00098761|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5802458|NCT00098761|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5802459|NCT00098735|Kidney,Transplantation, rejection, immunosuppression|kidney,transplantation, rejection, immunosuppression
5802461|NCT00098709|labor, obstetric|labor, obstetric
5802462|NCT00098709|fetal monitoring|fetal monitoring
5802463|NCT00098709|oximetry|oximetry
5802464|NCT00098709|fetal heart rate|fetal heart rate
5802465|NCT00098709|cardiotocography|cardiotocography
5802466|NCT00098683|refractory anemia with excess blasts|refractory anemia with excess blasts
5802467|NCT00098683|refractory anemia|refractory anemia
5802468|NCT00098683|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5681246|NCT00574158|polymorphisms|polymorphisms
5681247|NCT00574145|fatigue|fatigue
5681248|NCT00574145|depression|depression
5681249|NCT00574145|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5681250|NCT00574145|stage I breast cancer|stage i breast cancer
5802469|NCT00098683|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5802470|NCT00098683|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5802471|NCT00098683|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5802472|NCT00098566|quality of life|quality of life
5802473|NCT00098566|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5802474|NCT00098566|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5802475|NCT00098566|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5802476|NCT00098566|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5802477|NCT00098566|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5802478|NCT00098566|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5802663|NCT00097851|combination|combination
5802480|NCT00098566|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5802481|NCT00098566|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5802482|NCT00098566|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5802483|NCT00098566|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5802485|NCT00098566|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5802486|NCT00098566|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5802487|NCT00098566|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5802488|NCT00098566|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5802489|NCT00098566|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5802490|NCT00098553|stage IV melanoma|stage iv melanoma
5802491|NCT00098553|recurrent melanoma|recurrent melanoma
5802492|NCT00098514|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5802493|NCT00098462|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5802494|NCT00098462|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5802495|NCT00098462|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5802496|NCT00098436|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5802497|NCT00098436|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5802498|NCT00098436|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5802499|NCT00098436|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5802500|NCT00098436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5857909|NCT00018031|HIV|hiv
5802501|NCT00098436|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5802502|NCT00098436|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5802701|NCT00097721|breast neoplasm|breast neoplasm
5802503|NCT00098436|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5802504|NCT00098436|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5793301|NCT00130936|phase I|phase i
5802505|NCT00098436|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5802506|NCT00098384|Travelers’ diarrhea|travelers’ diarrhea
5802507|NCT00098384|rifaximin|rifaximin
5802508|NCT00098384|prophylaxis|prophylaxis
5802509|NCT00098384|enterotoxigenic E. coli|enterotoxigenic e. coli
5802510|NCT00098358|Leukotrienes|leukotrienes
5802511|NCT00098358|inflammation|inflammation
5802512|NCT00098345|Caprelsa (vandetanib)|caprelsa (vandetanib)
5802513|NCT00098345|ZD6474|zd6474
5802514|NCT00098332|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5802515|NCT00098332|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5802516|NCT00098332|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5802517|NCT00098332|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5802518|NCT00098332|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5802519|NCT00098332|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5802520|NCT00098332|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5802521|NCT00098332|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5802522|NCT00098319|Cleft palate|cleft palate
5802523|NCT00098319|Cleft lip|cleft lip
5802524|NCT00098319|Folic acid|folic acid
5802525|NCT00098319|Global Network|global network
5802526|NCT00098319|Maternal and child health|maternal and child health
5802527|NCT00098319|International|international
5822742|NCT00072917|diet|diet
5802528|NCT00098319|Women's health|women's health
5802529|NCT00098319|Brazil|brazil
5802530|NCT00098319|Brasil|brasil
5802531|NCT00098319|Latin America|latin america
5802532|NCT00098319|ECLAMC|eclamc
5802533|NCT00098319|Congenital defects|congenital defects
5802534|NCT00098319|Pregnancy|pregnancy
5802535|NCT00098293|Aids|aids
5802536|NCT00098293|HIV|hiv
5802537|NCT00098280|H5g1|h5g1
5802538|NCT00098280|PNH|pnh
5802539|NCT00098280|TRIUMPH|triumph
5802540|NCT00098280|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5802541|NCT00098267|Bacteria|bacteria
5802542|NCT00098267|Biofilm Formation|biofilm formation
5802543|NCT00098267|Secretory Antibodies|secretory antibodies
5802544|NCT00098267|Teeth|teeth
5802545|NCT00098267|Health and Disease|health and disease
5802546|NCT00098254|Non-Small Cell|non-small cell
5802547|NCT00098254|Molecular|molecular
5802548|NCT00098254|Targeted|targeted
5802549|NCT00098254|Therapies|therapies
5802550|NCT00098254|Cancer|cancer
5802551|NCT00098254|Non-Small Cell Lung Cancer|non-small cell lung cancer
5802552|NCT00098254|NSCLC|nsclc
5802553|NCT00098241|pediatric|pediatric
5802554|NCT00098241|renal|renal
5802555|NCT00098241|transplant recipients|transplant recipients
5802556|NCT00098241|de novo|de novo
5802557|NCT00098241|De novo renal pediatric transplant|de novo renal pediatric transplant
5802558|NCT00098228|COPD, adults, QAB149|copd, adults, qab149
5802559|NCT00098215|Residency training|residency training
5802560|NCT00098202|Global Network|global network
5802561|NCT00098202|Micronutrients|micronutrients
5802562|NCT00098202|Zinc|zinc
5802563|NCT00098202|Maternal and child health|maternal and child health
5802564|NCT00098202|Women's health|women's health
5802565|NCT00098202|International|international
5802566|NCT00098202|Guatemala|guatemala
5802567|NCT00098202|Nutrition|nutrition
5802568|NCT00098202|Corn|corn
5802569|NCT00098202|Maize|maize
5802570|NCT00098189|Safety, psoriasis, adverse event, SAE, extension|safety, psoriasis, adverse event, sae, extension
5802571|NCT00098163|HIV Seronegativity|hiv seronegativity
5802572|NCT00098163|HIV Preventive Vaccine|hiv preventive vaccine
5802573|NCT00098150|Safety, atopic dermatitis, adverse event, SAE, extension|safety, atopic dermatitis, adverse event, sae, extension
5802574|NCT00098137|atrial fibrillation|atrial fibrillation
5802575|NCT00098137|angiotensin II|angiotensin ii
5802576|NCT00098137|angiotensin receptor antagonist|angiotensin receptor antagonist
5802577|NCT00098137|drug|drug
5802578|NCT00098137|controlled clinical trial|controlled clinical trial
5802579|NCT00098124|NSRI|nsri
5802580|NCT00098124|milnacipran|milnacipran
5802581|NCT00098124|fibromyalgia|fibromyalgia
5802582|NCT00098111|Crohn's disease|crohn's disease
5802583|NCT00098111|inflammatory bowel disease|inflammatory bowel disease
5802584|NCT00098111|IMURAN|imuran
5802585|NCT00098111|azathioprine|azathioprine
5802586|NCT00098098|Botulinum|botulinum
5802587|NCT00098098|Recombinant Botulinum Vaccine|recombinant botulinum vaccine
5801855|NCT00100789|Recurrent|recurrent
5802588|NCT00098098|botulinum neurotoxins|botulinum neurotoxins
5802589|NCT00098085|Lung cancer|lung cancer
5802590|NCT00098085|Non-small cell lung cancer|non-small cell lung cancer
5802591|NCT00098085|Pulmonary|pulmonary
5802592|NCT00098085|Immunotherapy|immunotherapy
5802593|NCT00098085|Vaccine|vaccine
5802594|NCT00098072|Cytometry|cytometry
5802595|NCT00098072|Genes|genes
5802596|NCT00098072|Hypertension|hypertension
5802597|NCT00098072|Lung|lung
5802598|NCT00098072|Proteomics|proteomics
5802906|NCT00097097|Zambia|zambia
5802599|NCT00098072|Primary Pulmonary Hypertenion|primary pulmonary hypertenion
5802601|NCT00098072|Healthy Volunteers|healthy volunteers
5802602|NCT00098072|HV|hv
5802605|NCT00098059|fever blisters|fever blisters
5802606|NCT00098059|children|children
5802607|NCT00098059|Famvir|famvir
5802608|NCT00098059|famciclovir|famciclovir
5802609|NCT00098046|chickenpox|chickenpox
5802610|NCT00098046|herpes zoster|herpes zoster
5802611|NCT00098046|children|children
5802612|NCT00098046|Famvir|famvir
5802613|NCT00098046|varicella zoster virus|varicella zoster virus
5802614|NCT00098033|clinical|clinical
5802615|NCT00098033|pharmacodynamics|pharmacodynamics
5802616|NCT00098033|investigational drug clofarabine|investigational drug clofarabine
5802617|NCT00098033|AML, ALL, CML-accelerated phase, CML-blastic phase|aml, all, cml-accelerated phase, cml-blastic phase
5802618|NCT00098033|Chronic Myelogenous Leukemia - accelerated phase|chronic myelogenous leukemia - accelerated phase
5802619|NCT00098033|Chronic Myelogenous Leukemia - blastic phase|chronic myelogenous leukemia - blastic phase
5802620|NCT00098020|Glomerulosclerosis|glomerulosclerosis
5802621|NCT00098020|Proteinuria|proteinuria
5802622|NCT00098020|Fibrosis|fibrosis
5802623|NCT00098020|Chronic Kidney Disease|chronic kidney disease
5802624|NCT00098020|Nephrotic Syndrome|nephrotic syndrome
5802625|NCT00098007|Heart transplantation|heart transplantation
5802626|NCT00098007|Everolimus|everolimus
5802627|NCT00098007|De novo heart transplant patients|de novo heart transplant patients
5802628|NCT00097994|Menopause|menopause
5802629|NCT00097994|Quality of Life|quality of life
5822848|NCT00072735|HV|hv
5802630|NCT00097994|Health Services|health services
5802631|NCT00097994|Complementary Therapies|complementary therapies
5802632|NCT00097981|Multiple myeloma|multiple myeloma
5802633|NCT00097981|Newly diagnosed multiple myeloma|newly diagnosed multiple myeloma
5802634|NCT00097981|Thalidomide|thalidomide
5802635|NCT00097981|Dexamethasone|dexamethasone
5802636|NCT00097981|DOXIL|doxil
5802637|NCT00097981|Pegylated liposomal hydrochloride doxorubicin injection|pegylated liposomal hydrochloride doxorubicin injection
5802638|NCT00097968|transplant, heart, adult, everolimus|transplant, heart, adult, everolimus
5802639|NCT00097968|allograft rejection|allograft rejection
5802640|NCT00097955|diabetes|diabetes
5802641|NCT00097955|nephropathy|nephropathy
5802642|NCT00097955|hypertension|hypertension
5802643|NCT00097955|aliskiren|aliskiren
5802644|NCT00097955|losartan|losartan
5802645|NCT00097942|memantine|memantine
5802646|NCT00097942|adjunctive therapy|adjunctive therapy
5802647|NCT00097942|schizophrenia|schizophrenia
5802648|NCT00097929|Relapsed Diffuse Large B-cell Lymphoma|relapsed diffuse large b-cell lymphoma
5802649|NCT00097916|memantine HCl|memantine hcl
5802650|NCT00097916|Dementia|dementia
5802651|NCT00097916|Agitation|agitation
5802652|NCT00097916|Alzheimer Disease|alzheimer disease
5802653|NCT00097903|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5802654|NCT00097903|Solid Tumors|solid tumors
5802655|NCT00097903|Oral|oral
5802656|NCT00097890|Lysosomes|lysosomes
5802657|NCT00097890|Storage|storage
5802658|NCT00097890|Glycolipid|glycolipid
5802659|NCT00097890|Fabry Disease|fabry disease
5802660|NCT00097890|Stroke|stroke
5802661|NCT00097877|Type 2 Diabetes|type 2 diabetes
5802662|NCT00097851|second-line|second-line
5802664|NCT00097851|chemotherapy|chemotherapy
5802665|NCT00097851|anti-angiogenic|anti-angiogenic
5802666|NCT00097838|HIV Seronegativity|hiv seronegativity
5802667|NCT00097838|HIV Preventive Vaccine|hiv preventive vaccine
5802668|NCT00097825|Male Osteoporosis|male osteoporosis
5802669|NCT00097812|osteoporosis, osteopenia, post-menopausal, zoledronic acid|osteoporosis, osteopenia, post-menopausal, zoledronic acid
5802671|NCT00097786|Diabetes type 2|diabetes type 2
5802672|NCT00097786|valsartan|valsartan
5802673|NCT00097786|nateglinide|nateglinide
5802674|NCT00097773|Lung Diseases|lung diseases
5802675|NCT00097773|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5802676|NCT00097760|Multiple Sclerosis|multiple sclerosis
5802677|NCT00097760|MS|ms
5802678|NCT00097747|anemia|anemia
5802679|NCT00097747|chronic kidney disease|chronic kidney disease
5802680|NCT00097747|CKD|ckd
5802681|NCT00097747|chronic renal failure|chronic renal failure
5802682|NCT00097747|CRF|crf
5802683|NCT00097747|erythropoietin|erythropoietin
5802684|NCT00097747|EPO|epo
5802685|NCT00097747|erythropoiesis stimulating agent|erythropoiesis stimulating agent
5802686|NCT00097747|ESA|esa
5802687|NCT00097747|Hematide™|hematide™
5802688|NCT00097747|hemoglobin|hemoglobin
5802689|NCT00097747|Hb|hb
5802690|NCT00097747|Hgb|hgb
5802691|NCT00097747|Omontys|omontys
5801943|NCT00100542|Treatment Naive|treatment naive
5802692|NCT00097747|peginesatide|peginesatide
5802693|NCT00097747|red blood cell|red blood cell
5802694|NCT00097747|red blood cell production|red blood cell production
5802695|NCT00097734|diverticulitis|diverticulitis
5802696|NCT00097734|Invanz|invanz
5802697|NCT00097734|Ertapenem|ertapenem
5802698|NCT00097734|acute attacks|acute attacks
5802699|NCT00097734|sigmoid diverticulitis|sigmoid diverticulitis
5802700|NCT00097734|Acute attacks of sigmoid diverticulitis|acute attacks of sigmoid diverticulitis
5802702|NCT00097721|breast cancer|breast cancer
5802703|NCT00097721|breast tumor|breast tumor
5802704|NCT00097708|Double Blind, Placebo controlled, Safety and Efficacy|double blind, placebo controlled, safety and efficacy
5802705|NCT00097708|Generalized Anxiety Disorder|generalized anxiety disorder
5802706|NCT00097695|Hereditary Angioedema|hereditary angioedema
5802707|NCT00097695|C1 inhibitor deficiency|c1 inhibitor deficiency
5802709|NCT00097695|Icatibant|icatibant
5802710|NCT00097695|Bradykinin antagonist|bradykinin antagonist
5802711|NCT00097695|acute attack|acute attack
5802712|NCT00097695|subcutaneous|subcutaneous
5802713|NCT00097682|Financial Ties|financial ties
5802714|NCT00097682|Institution|institution
5802715|NCT00097682|Research Doctor|research doctor
5802716|NCT00097682|Oncology|oncology
5802717|NCT00097682|Attitudes|attitudes
5802718|NCT00097682|Cancer|cancer
5802719|NCT00097682|Survey|survey
5802720|NCT00097669|VITATOPS|vitatops
5802721|NCT00097669|stroke|stroke
5802722|NCT00097669|prevention|prevention
5802723|NCT00097669|multivitamins|multivitamins
5802724|NCT00097669|homocysteine|homocysteine
5802725|NCT00097643|exercise|exercise
5802726|NCT00097643|health promotion|health promotion
5802727|NCT00097643|independent living|independent living
5802728|NCT00097643|affective aspects|affective aspects
5802729|NCT00097630|mechanical ventilation|mechanical ventilation
5802730|NCT00097630|delirium|delirium
5802731|NCT00097630|sedation scoring|sedation scoring
5802732|NCT00097630|cognitive impairment|cognitive impairment
5802733|NCT00097630|ventilation weaning|ventilation weaning
5802734|NCT00097604|Sleep|sleep
5802735|NCT00097604|Aged|aged
5802736|NCT00097604|Valerian|valerian
5802737|NCT00097604|Complementary Therapies|complementary therapies
5802738|NCT00097604|Medicine, Herbal|medicine, herbal
5802739|NCT00097565|Follicular Non-Hodgkin's Lymphoma|follicular non-hodgkin's lymphoma
5802740|NCT00097539|Pediatric growth disorders|pediatric growth disorders
5802741|NCT00097526|Growth Hormone Deficiency|growth hormone deficiency
5802742|NCT00097513|Pubertal Growth Hormone Deficiency|pubertal growth hormone deficiency
5802743|NCT00097500|diabetes|diabetes
5802744|NCT00097500|exenatide|exenatide
5802745|NCT00097500|exendin-4|exendin-4
5802746|NCT00097500|Amylin|amylin
5802747|NCT00097500|Lilly|lilly
5802748|NCT00097487|Metastatic Breast Cancer|metastatic breast cancer
5802749|NCT00097474|Cortisol|cortisol
5802750|NCT00097474|Jet Lag|jet lag
5802751|NCT00097474|Healthy Volunteer|healthy volunteer
5802752|NCT00097474|HV|hv
5802753|NCT00097461|Employee Health|employee health
5802754|NCT00097461|Insurance Benefit|insurance benefit
5802755|NCT00097461|Fringe Benefit|fringe benefit
5802756|NCT00097461|Health Status|health status
5802757|NCT00097461|Socioeconomic Factors|socioeconomic factors
5802758|NCT00097448|sudden hearing loss|sudden hearing loss
5802759|NCT00097448|unilateral sudden sensorineural hearing loss|unilateral sudden sensorineural hearing loss
5802760|NCT00097448|sudden sensorineural hearing loss|sudden sensorineural hearing loss
5802761|NCT00097448|sudden unilateral hearing loss|sudden unilateral hearing loss
5802762|NCT00097422|CDAD, diarrhea|cdad, diarrhea
5802763|NCT00097422|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5802764|NCT00097409|ovarian cancer|ovarian cancer
5802765|NCT00097409|platinum/taxane-refractory chemotherapy|platinum/taxane-refractory chemotherapy
5797959|NCT00113984|Vaccine|vaccine
5802769|NCT00097396|recombinant plague vaccine|recombinant plague vaccine
5802771|NCT00097396|plague vaccine|plague vaccine
5802772|NCT00097396|Protection against pneumonic plague|protection against pneumonic plague
5802773|NCT00097370|Mepolizumab|mepolizumab
5802774|NCT00097370|Open-label|open-label
5802775|NCT00097370|Anti-IL-5|anti-il-5
5802776|NCT00097370|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5802777|NCT00097370|Hypereosinophilia|hypereosinophilia
5802778|NCT00097357|Prevention of deep vein thrombosis and pulmonary embolism|prevention of deep vein thrombosis and pulmonary embolism
5802779|NCT00097357|Preventive therapy|preventive therapy
5802780|NCT00097344|Aromatase inhibitor|aromatase inhibitor
5802781|NCT00097344|Atamestane|atamestane
5802782|NCT00097344|Breast neoplasms|breast neoplasms
5802783|NCT00097344|Combined hormonal therapy|combined hormonal therapy
5802784|NCT00097344|Complete estrogen blockade|complete estrogen blockade
5802785|NCT00097344|Ductal breast carcinoma|ductal breast carcinoma
5802786|NCT00097344|Estrogen blocker|estrogen blocker
5802787|NCT00097344|Fareston®|fareston®
5802788|NCT00097344|Femara®|femara®
5802789|NCT00097344|First line therapy|first line therapy
5802790|NCT00097344|Letrozole|letrozole
5802791|NCT00097344|Lobular breast carcinoma|lobular breast carcinoma
5802792|NCT00097344|Locally advanced breast cancer|locally advanced breast cancer
5802793|NCT00097344|Locally recurrent breast cancer|locally recurrent breast cancer
5802794|NCT00097344|Maximal estrogen inhibition|maximal estrogen inhibition
5802795|NCT00097344|Metastatic breast cancer|metastatic breast cancer
5802796|NCT00097344|Neoplasms, Hormone-dependent|neoplasms, hormone-dependent
5802797|NCT00097344|Receptor-positive|receptor-positive
5802798|NCT00097344|Stage IIIA breast cancer|stage iiia breast cancer
5802799|NCT00097344|Stage IIIB breast cancer|stage iiib breast cancer
5802800|NCT00097344|Stage IV breast cancer|stage iv breast cancer
5802801|NCT00097344|Toremifene|toremifene
5802802|NCT00097331|multiple sclerosis|multiple sclerosis
5802803|NCT00097331|relapsing|relapsing
5802804|NCT00097331|remitting|remitting
5802805|NCT00097331|Relapsing-Remitting MS (RRMS)|relapsing-remitting ms (rrms)
5802806|NCT00097318|Ischemic|ischemic
5802808|NCT00097318|Inflammation|inflammation
5802809|NCT00097318|Clinical Trial|clinical trial
5802810|NCT00097318|Stroke|stroke
5802811|NCT00097305|Mental Health|mental health
5802812|NCT00097305|Psychotherapy|psychotherapy
5802813|NCT00097292|"at risk for developing type 1 diabetes"|"at risk for developing type 1 diabetes"
5802814|NCT00097292|T1DM|t1dm
5802815|NCT00097292|T1D|t1d
5802816|NCT00097292|juvenile diabetes|juvenile diabetes
5802817|NCT00097292|Type 1 Diabetes TrialNet|type 1 diabetes trialnet
5802818|NCT00097292|TrialNet|trialnet
5802819|NCT00097266|Bipolar Mania|bipolar mania
5802820|NCT00097253|Aromatherapy|aromatherapy
5802821|NCT00097253|Smell|smell
5802822|NCT00097240|FOLLOW|follow
5802823|NCT00097240|Psoriasis|psoriasis
5802824|NCT00097240|Pregnancy|pregnancy
5802825|NCT00097227|NSCLC|nsclc
5802826|NCT00097227|non-small|non-small
5802827|NCT00097227|lung|lung
5802828|NCT00097227|IIIb|iiib
5802829|NCT00097227|IV|iv
5802830|NCT00097227|Carboplatin|carboplatin
5802831|NCT00097227|Paclitaxel|paclitaxel
5802832|NCT00097227|Cetuximab|cetuximab
5802833|NCT00097227|Stage IIIB Non-Small Cell Lung Cancer|stage iiib non-small cell lung cancer
5802834|NCT00097227|Stage IV Non-Small Cell Lung Cancer|stage iv non-small cell lung cancer
5802835|NCT00097214|NSCLC|nsclc
5802836|NCT00097214|Non-small|non-small
5802837|NCT00097214|Lung|lung
5802838|NCT00097214|IIIB|iiib
5802839|NCT00097214|IV|iv
5802840|NCT00097214|Carboplatin|carboplatin
5802841|NCT00097214|Cetuximab|cetuximab
5802842|NCT00097214|Stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5802843|NCT00097214|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5802844|NCT00097188|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5802845|NCT00097175|Major Depressive Disorder|major depressive disorder
5802846|NCT00097175|Serotonin|serotonin
5802847|NCT00097175|Functional MRI|functional mri
5802848|NCT00097175|Genotype|genotype
5802849|NCT00097175|Negative Affect|negative affect
5802850|NCT00097175|MDD|mdd
5802851|NCT00097175|Healthy Volunteer|healthy volunteer
5802852|NCT00097175|HV|hv
5802853|NCT00097162|Anisometropia|anisometropia
5802854|NCT00097162|Strabismus|strabismus
5802855|NCT00097162|Cortical Suppression|cortical suppression
5802856|NCT00097162|Impaired Vision|impaired vision
5802857|NCT00097162|Cortical Plasticity|cortical plasticity
5802858|NCT00097162|Amblyopia|amblyopia
5802859|NCT00097162|Adult Amblyopia|adult amblyopia
5802860|NCT00097149|Congenital birth defects|congenital birth defects
5802861|NCT00097149|Cleft lip|cleft lip
5802862|NCT00097149|Cleft palate|cleft palate
5802863|NCT00097149|Global Network|global network
5802864|NCT00097149|Neurodevelopmental outcome|neurodevelopmental outcome
5802865|NCT00097149|Maternal and child health|maternal and child health
5802866|NCT00097149|International|international
5802867|NCT00097149|Women's health|women's health
5802868|NCT00097149|Brazil|brazil
5802869|NCT00097149|Brasil|brasil
5802871|NCT00097149|ECLAMC|eclamc
5802872|NCT00097149|Argentina|argentina
5802873|NCT00097149|Bolivia|bolivia
5802874|NCT00097149|Chile|chile
5802875|NCT00097149|Colombia|colombia
5802876|NCT00097149|Ecuador|ecuador
5802877|NCT00097149|Venezuela|venezuela
5802878|NCT00097123|Acute postpartum hemorrhage|acute postpartum hemorrhage
5802879|NCT00097123|PPH|pph
5802880|NCT00097123|Misoprostol|misoprostol
5802881|NCT00097123|Global Network|global network
5802882|NCT00097123|Uterotonics|uterotonics
5802883|NCT00097123|India|india
5802884|NCT00097123|Maternal and child health|maternal and child health
5802885|NCT00097123|International|international
5802886|NCT00097123|Women's health|women's health
5802887|NCT00097110|Vitamin C|vitamin c
5802888|NCT00097110|Vitamin E|vitamin e
5802889|NCT00097110|Preeclampsia|preeclampsia
5802890|NCT00097110|Antioxidants|antioxidants
5802891|NCT00097110|Global Network|global network
5802892|NCT00097110|Preterm birth|preterm birth
5802893|NCT00097110|Low birth weight infants|low birth weight infants
5802894|NCT00097110|Brazil|brazil
5802895|NCT00097110|Brasil|brasil
5802896|NCT00097110|Maternal and child health|maternal and child health
5802897|NCT00097110|International|international
5802898|NCT00097110|Women's health|women's health
5686570|NCT00551525|stage IIA prostate cancer|stage iia prostate cancer
5686571|NCT00551525|stage III prostate cancer|stage iii prostate cancer
5686572|NCT00551525|stage IV prostate cancer|stage iv prostate cancer
5686573|NCT00551512|cancer|cancer
5686574|NCT00551512|solid tumors|solid tumors
5681242|NCT00574184|ED|ed
5802899|NCT00097097|Asphyxia|asphyxia
5802900|NCT00097097|Neonatal mortality|neonatal mortality
5802901|NCT00097097|Neonatal morbidity|neonatal morbidity
5802902|NCT00097097|Hypoxic ischemic encephalopathy|hypoxic ischemic encephalopathy
5802903|NCT00097097|Neurodevelopmental impairment|neurodevelopmental impairment
5857910|NCT00018031|Hepatitis C|hepatitis c
5802904|NCT00097097|Neonatal resuscitation|neonatal resuscitation
5802905|NCT00097097|Global Network|global network
5802907|NCT00097097|Africa|africa
5802908|NCT00097097|Cerebral palsy|cerebral palsy
5802909|NCT00097097|Child health|child health
5802910|NCT00097097|International|international
5802911|NCT00097071|Diabetes, Type 1|diabetes, type 1
5802912|NCT00097058|Aging|aging
5802913|NCT00097058|Menopause|menopause
5802914|NCT00097058|Estrogen Replacement Therapy|estrogen replacement therapy
5802915|NCT00097058|Cognitive Decline|cognitive decline
5802916|NCT00097045|Hepatitis C|hepatitis c
5802917|NCT00097045|HCV|hcv
5802918|NCT00097045|Omega Interferon|omega interferon
5802919|NCT00097045|Interferon|interferon
5802920|NCT00097045|HCV genotype 1|hcv genotype 1
5802921|NCT00097032|Bipolar I Disorder|bipolar i disorder
5802922|NCT00097032|risperidone|risperidone
5802923|NCT00097032|quetiapine|quetiapine
5802924|NCT00097032|sedation|sedation
5802925|NCT00097032|cognition|cognition
5802926|NCT00097019|Recurrent ovarian cancer|recurrent ovarian cancer
5802927|NCT00097019|Refractory ovarian cancer|refractory ovarian cancer
5802928|NCT00096993|Omnitarg|omnitarg
5802929|NCT00096993|Cancer|cancer
5802930|NCT00096993|Platinum-Resistant|platinum-resistant
5802931|NCT00096967|Metastatic breast cancer|metastatic breast cancer
5802932|NCT00096967|Metastatic colorectal cancer|metastatic colorectal cancer
5802933|NCT00096954|Omalizumab (Xolair)|omalizumab (xolair)
5802934|NCT00096954|Atopic Asthma|atopic asthma
5802935|NCT00096941|Advanced solid cancers|advanced solid cancers
5802936|NCT00096941|HER2|her2
5802937|NCT00096941|EGFR|egfr
5802938|NCT00096928|Plaque Psoriasis|plaque psoriasis
5802939|NCT00096928|RESPONSE|response
5802940|NCT00096928|Raptiva|raptiva
5681251|NCT00574145|stage II breast cancer|stage ii breast cancer
5681252|NCT00574145|stage IIIA breast cancer|stage iiia breast cancer
5802941|NCT00096928|efalizumab|efalizumab
5802942|NCT00096915|chronic kidney disease, CKD|chronic kidney disease, ckd
5802943|NCT00096915|renal failure|renal failure
5802944|NCT00096915|anemia|anemia
5802945|NCT00096915|hemodialysis|hemodialysis
5802946|NCT00096915|peritoneal dialysis|peritoneal dialysis
5802947|NCT00096915|Aranesp®, Darbepoetin Alfa|aranesp®, darbepoetin alfa
5802948|NCT00096902|Orthostatic Intolerance|orthostatic intolerance
5802949|NCT00096902|Hypnosis|hypnosis
5802950|NCT00096902|Cold Pressor|cold pressor
5802951|NCT00096902|Isometric Exercise|isometric exercise
5802952|NCT00096902|Behavior|behavior
5802953|NCT00096902|Neurocardiogenic Syncope|neurocardiogenic syncope
5802954|NCT00096876|Parkinsonian syndrome|parkinsonian syndrome
5802955|NCT00096863|Delirium|delirium
5802956|NCT00096863|Cognition Disorders|cognition disorders
5802957|NCT00096863|Antipsychotics|antipsychotics
5802958|NCT00096863|Mechanical Ventilation|mechanical ventilation
5802959|NCT00096863|Critical Illness|critical illness
5802960|NCT00096850|HIV Seronegativity|hiv seronegativity
5802961|NCT00096850|Antitubercular agents|antitubercular agents
5802962|NCT00096837|Myeloma|myeloma
5802963|NCT00096837|Multiple Myeloma|multiple myeloma
5802964|NCT00096837|Relapsed Multiple Myeloma|relapsed multiple myeloma
5802965|NCT00096837|Refractory Multiple Myeloma|refractory multiple myeloma
5802966|NCT00096824|Acute Infection|acute infection
5802967|NCT00096824|Treatment Naive|treatment naive
5802968|NCT00096798|Fatty Acids, Omega-3|fatty acids, omega-3
5802969|NCT00096798|Antidepressive Agents|antidepressive agents
5802970|NCT00096798|Eicosapentanoic Acid|eicosapentanoic acid
5802971|NCT00096785|chronic hepatitis B infection|chronic hepatitis b infection
5802972|NCT00096772|Genetic Testing|genetic testing
5802973|NCT00096772|Genomics|genomics
5802974|NCT00096772|Human Genetic Factors|human genetic factors
5802978|NCT00096759|Relaxation Techniques|relaxation techniques
5802979|NCT00096746|Treatment Experienced|treatment experienced
5802980|NCT00096733|Living donors|living donors
5802981|NCT00096733|Organ procurement|organ procurement
5802982|NCT00096733|Liver transplantation|liver transplantation
5802983|NCT00096733|Hepatitis C|hepatitis c
5802984|NCT00096733|Hepatocellular carcinoma|hepatocellular carcinoma
5802985|NCT00096733|Hepatectomy|hepatectomy
5802986|NCT00096733|Liver regeneration|liver regeneration
5802987|NCT00096733|Graft rejection|graft rejection
5802245|NCT00099463|HV|hv
5802988|NCT00096733|Quality of life|quality of life
5802989|NCT00096733|Informed consent|informed consent
5802990|NCT00096720|parkinson|parkinson
5802991|NCT00096720|brain imaging|brain imaging
5802992|NCT00096720|diagnosis|diagnosis
5802993|NCT00096707|advanced solid tumors|advanced solid tumors
5802995|NCT00096707|docetaxel|docetaxel
5802996|NCT00096707|2-deoxy-D-glucose (2DG)|2-deoxy-d-glucose (2dg)
5802997|NCT00096707|phase 1|phase 1
5802998|NCT00096694|Intrauterine Device|intrauterine device
5803000|NCT00096694|Contraceptive|contraceptive
5803001|NCT00096694|Levonorgestrel|levonorgestrel
5803002|NCT00096668|Breast cancer|breast cancer
5803003|NCT00096668|TOCOSOL Paclitaxel|tocosol paclitaxel
5803004|NCT00096655|Ulcerative colitis|ulcerative colitis
5803005|NCT00096655|Infliximab|infliximab
5803006|NCT00096655|Remicade|remicade
5803007|NCT00096642|cognitive behavioral therapy|cognitive behavioral therapy
5803008|NCT00096642|depression|depression
5803009|NCT00096642|group therapy|group therapy
5803010|NCT00096642|parenting|parenting
5803011|NCT00096642|children and adolescents|children and adolescents
5803012|NCT00096629|recurrent renal cell cancer|recurrent renal cell cancer
5803013|NCT00096629|stage I renal cell cancer|stage i renal cell cancer
5803014|NCT00096629|stage II renal cell cancer|stage ii renal cell cancer
5803015|NCT00096629|stage III renal cell cancer|stage iii renal cell cancer
5803017|NCT00096603|Moderate to severe plaque psoriasis|moderate to severe plaque psoriasis
5803018|NCT00096590|thromboembolism|thromboembolism
5803019|NCT00096590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803020|NCT00096564|Mirror Neuron|mirror neuron
5803022|NCT00096564|Statistical Parametric Mapping|statistical parametric mapping
5803023|NCT00096564|Healthy Volunteer|healthy volunteer
5803025|NCT00096551|Biochemical Failure|biochemical failure
5803026|NCT00096551|Immunotherapy|immunotherapy
5803027|NCT00096551|TRICOM|tricom
5803028|NCT00096551|Pox-virus|pox-virus
5803029|NCT00096551|Fowlpox|fowlpox
5803030|NCT00096551|Prostate Cancer|prostate cancer
5803031|NCT00096538|classic Kaposi sarcoma|classic kaposi sarcoma
5803032|NCT00096538|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5803033|NCT00096525|recurrent renal cell cancer|recurrent renal cell cancer
5803034|NCT00096525|stage III renal cell cancer|stage iii renal cell cancer
5803035|NCT00096525|stage IV renal cell cancer|stage iv renal cell cancer
5803036|NCT00096486|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5803037|NCT00096486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5862630|NCT00001561|Myeloma Immunoglobulin|myeloma immunoglobulin
5681253|NCT00574145|stage IIIB breast cancer|stage iiib breast cancer
5681254|NCT00574145|stage IIIC breast cancer|stage iiic breast cancer
5681255|NCT00574145|recurrent breast cancer|recurrent breast cancer
5681256|NCT00574119|heart failure|heart failure
5681257|NCT00574119|positron emission tomography|positron emission tomography
5823142|NCT00071760|pediatrics|pediatrics
5803038|NCT00096486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5803039|NCT00096473|Alzheimer's Disease|alzheimer's disease
5803040|NCT00096473|dementia|dementia
5803041|NCT00096473|acetylcholinesterase|acetylcholinesterase
5803042|NCT00096473|donepezil|donepezil
5803043|NCT00096473|Aricept|aricept
5803044|NCT00096473|memory loss|memory loss
5803045|NCT00096473|Severe dementia of the Alzheimer's type|severe dementia of the alzheimer's type
5803046|NCT00096421|Critical illness|critical illness
5803047|NCT00096421|Critical care|critical care
5803048|NCT00096421|Hyperglycemia|hyperglycemia
5803049|NCT00096421|Intensive care|intensive care
5803050|NCT00096421|Intensive Care Units|intensive care units
5803051|NCT00096421|Insulin resistance|insulin resistance
5803052|NCT00096421|Intensive insulin therapy|intensive insulin therapy
5803053|NCT00096421|Conventional insulin therapy|conventional insulin therapy
5803054|NCT00096408|Endometrial|endometrial
5803055|NCT00096408|Endometrium|endometrium
5803056|NCT00096408|Uterus|uterus
5803057|NCT00096408|Cancer|cancer
5803058|NCT00096408|Carcinoma|carcinoma
5803059|NCT00096408|Adenocarcinoma|adenocarcinoma
5803060|NCT00096408|Stage 1|stage 1
5803061|NCT00096408|Hysterectomy|hysterectomy
5803062|NCT00096408|Laparoscopy|laparoscopy
5803063|NCT00096408|Abdominal|abdominal
5803064|NCT00096408|Total|total
5803065|NCT00096408|Surgery|surgery
5803066|NCT00096408|Quality of Life|quality of life
5803067|NCT00096408|Disease-free survival|disease-free survival
5803069|NCT00096382|recurrent melanoma|recurrent melanoma
5803070|NCT00096369|breast cancer|breast cancer
5803071|NCT00096369|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5803072|NCT00096369|breast cancer in situ|breast cancer in situ
5803073|NCT00096356|fatigue|fatigue
5803074|NCT00096356|stage I breast cancer|stage i breast cancer
5803075|NCT00096356|stage II breast cancer|stage ii breast cancer
5803076|NCT00096356|stage IIIA breast cancer|stage iiia breast cancer
5803077|NCT00096356|stage IIIB breast cancer|stage iiib breast cancer
5803078|NCT00096356|stage IIIC breast cancer|stage iiic breast cancer
5803079|NCT00096356|stage IV breast cancer|stage iv breast cancer
5803080|NCT00096343|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5803081|NCT00096343|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5803082|NCT00096343|stage II breast cancer|stage ii breast cancer
5803083|NCT00096343|stage IIIA breast cancer|stage iiia breast cancer
5803084|NCT00096343|stage IIIB breast cancer|stage iiib breast cancer
5803085|NCT00096343|inflammatory breast cancer|inflammatory breast cancer
5803086|NCT00096330|colon cancer|colon cancer
5803087|NCT00096330|rectal cancer|rectal cancer
5803088|NCT00096317|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803089|NCT00096304|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5803090|NCT00096304|recurrent prostate cancer|recurrent prostate cancer
5803091|NCT00096304|stage IV prostate cancer|stage iv prostate cancer
5803092|NCT00096291|stage II breast cancer|stage ii breast cancer
5803093|NCT00096291|stage IIIA breast cancer|stage iiia breast cancer
5803094|NCT00096291|stage IIIB breast cancer|stage iiib breast cancer
5803095|NCT00096291|stage IIIC breast cancer|stage iiic breast cancer
5803096|NCT00096239|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5803097|NCT00096239|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5803098|NCT00096239|fallopian tube cancer|fallopian tube cancer
5803099|NCT00096226|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5803100|NCT00096226|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5803101|NCT00096213|chondrosarcoma|chondrosarcoma
5803102|NCT00096187|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
5803103|NCT00096187|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5803104|NCT00096187|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
5803105|NCT00096174|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5803106|NCT00096174|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5803107|NCT00096174|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5803108|NCT00096174|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5803109|NCT00096135|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5803110|NCT00096135|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5803111|NCT00096135|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5803112|NCT00096135|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5803113|NCT00096096|graft versus host disease|graft versus host disease
5803114|NCT00096096|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5803115|NCT00096096|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5803116|NCT00096096|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5803117|NCT00096096|refractory multiple myeloma|refractory multiple myeloma
5803118|NCT00096096|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5803119|NCT00096096|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5803120|NCT00096096|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5803121|NCT00096096|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5803122|NCT00096096|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5803123|NCT00096096|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5803124|NCT00096096|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5803125|NCT00096096|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5803126|NCT00096096|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5803127|NCT00096096|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5803128|NCT00096096|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5803129|NCT00096096|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5803130|NCT00096096|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5803131|NCT00096096|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5803132|NCT00096096|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5803133|NCT00096096|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5803134|NCT00096096|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5803135|NCT00096096|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5803136|NCT00096096|refractory anemia with excess blasts|refractory anemia with excess blasts
5803137|NCT00096096|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5803138|NCT00096096|refractory hairy cell leukemia|refractory hairy cell leukemia
5803139|NCT00096096|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5803140|NCT00096096|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5803141|NCT00096096|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5803142|NCT00096096|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5803143|NCT00096096|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5803144|NCT00096096|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5803145|NCT00096096|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5803146|NCT00096096|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5803147|NCT00096096|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5802460|NCT00098709|pregnancy|pregnancy
5803148|NCT00096096|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5803149|NCT00096096|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5803150|NCT00096096|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5803151|NCT00096096|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5803152|NCT00096096|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5803153|NCT00096096|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5803154|NCT00096096|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5803155|NCT00096096|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5803156|NCT00096096|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5803157|NCT00096096|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5803158|NCT00096096|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5803159|NCT00096096|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5803160|NCT00096096|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5803161|NCT00096096|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5803162|NCT00096096|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5803229|NCT00096083|stage IV gastric cancer|stage iv gastric cancer
5803163|NCT00096096|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5803164|NCT00096096|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5803165|NCT00096096|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5803166|NCT00096096|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5803167|NCT00096096|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5803168|NCT00096096|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5803169|NCT00096096|stage I multiple myeloma|stage i multiple myeloma
5803170|NCT00096096|stage II multiple myeloma|stage ii multiple myeloma
5803171|NCT00096096|stage III multiple myeloma|stage iii multiple myeloma
5803172|NCT00096096|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5803173|NCT00096096|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5803174|NCT00096096|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5803175|NCT00096096|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5803176|NCT00096096|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5803177|NCT00096096|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5803178|NCT00096096|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5803179|NCT00096096|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5803180|NCT00096096|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5803181|NCT00096096|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5803182|NCT00096096|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5803183|NCT00096096|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5803184|NCT00096096|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5803185|NCT00096096|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5803186|NCT00096096|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5803187|NCT00096096|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5803188|NCT00096096|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5803189|NCT00096096|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5803190|NCT00096096|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5803191|NCT00096096|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5803192|NCT00096096|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5803193|NCT00096096|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5803194|NCT00096096|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5803195|NCT00096096|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5803196|NCT00096096|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5803197|NCT00096096|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5803198|NCT00096096|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5803199|NCT00096096|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5803200|NCT00096096|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5803201|NCT00096096|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5803202|NCT00096096|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5803203|NCT00096096|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5803204|NCT00096096|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5803205|NCT00096096|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5803206|NCT00096096|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5803207|NCT00096096|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5686575|NCT00551499|Sleep Apnea, CRT|sleep apnea, crt
5686576|NCT00551486|Pyrosequencing|pyrosequencing
5686577|NCT00551486|BRAFV600E mutation|brafv600e mutation
5686578|NCT00551486|Thyroid incidentaloma|thyroid incidentaloma
5686579|NCT00551486|Ultrasound-guided fine-needle aspiration biopsy|ultrasound-guided fine-needle aspiration biopsy
5803208|NCT00096083|advanced adult primary liver cancer|advanced adult primary liver cancer
5803209|NCT00096083|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5803210|NCT00096083|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5803211|NCT00096083|liver metastases|liver metastases
5803212|NCT00096083|adenocarcinoma of the colon|adenocarcinoma of the colon
5803213|NCT00096083|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5803214|NCT00096083|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5803215|NCT00096083|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5803216|NCT00096083|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5803217|NCT00096083|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5803218|NCT00096083|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5803219|NCT00096083|carcinoma of the appendix|carcinoma of the appendix
5803220|NCT00096083|recurrent gallbladder cancer|recurrent gallbladder cancer
5803221|NCT00096083|unresectable gallbladder cancer|unresectable gallbladder cancer
5803222|NCT00096083|recurrent colon cancer|recurrent colon cancer
5803223|NCT00096083|stage IV colon cancer|stage iv colon cancer
5803224|NCT00096083|recurrent esophageal cancer|recurrent esophageal cancer
5803225|NCT00096083|stage IV esophageal cancer|stage iv esophageal cancer
5803226|NCT00096083|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5803227|NCT00096083|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5815870|NCT00004002|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5815871|NCT00004002|small intestine lymphoma|small intestine lymphoma
5815872|NCT00004002|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803228|NCT00096083|recurrent gastric cancer|recurrent gastric cancer
5803231|NCT00096083|stage IV rectal cancer|stage iv rectal cancer
5803232|NCT00096083|small intestine adenocarcinoma|small intestine adenocarcinoma
5803233|NCT00096083|recurrent small intestine cancer|recurrent small intestine cancer
5803234|NCT00096083|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5803235|NCT00096083|recurrent pheochromocytoma|recurrent pheochromocytoma
5803236|NCT00096083|metastatic pheochromocytoma|metastatic pheochromocytoma
5803237|NCT00096083|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5803238|NCT00096083|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5803239|NCT00096083|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5803240|NCT00096083|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5803241|NCT00096083|recurrent pancreatic cancer|recurrent pancreatic cancer
5803243|NCT00096083|WDHA syndrome|wdha syndrome
5803245|NCT00096083|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5803246|NCT00096083|somatostatinoma|somatostatinoma
5803247|NCT00096083|stage IV pancreatic cancer|stage iv pancreatic cancer
5803248|NCT00096083|intraocular melanoma|intraocular melanoma
5803249|NCT00096083|conjunctival melanoma|conjunctival melanoma
5803250|NCT00096083|iris melanoma|iris melanoma
5803251|NCT00096083|recurrent melanoma|recurrent melanoma
5803252|NCT00096083|stage IV melanoma|stage iv melanoma
5803253|NCT00096057|recurrent breast cancer|recurrent breast cancer
5803254|NCT00096057|stage IIIA breast cancer|stage iiia breast cancer
5803255|NCT00096057|stage IIIB breast cancer|stage iiib breast cancer
5803256|NCT00096057|stage IIIC breast cancer|stage iiic breast cancer
5803257|NCT00096057|stage IV breast cancer|stage iv breast cancer
5803258|NCT00096044|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5803259|NCT00096031|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5803260|NCT00096031|recurrent esophageal cancer|recurrent esophageal cancer
5803261|NCT00096031|stage IV esophageal cancer|stage iv esophageal cancer
5803262|NCT00096018|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5803263|NCT00096018|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5803264|NCT00096018|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5803265|NCT00096018|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5803266|NCT00096018|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5803267|NCT00095992|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5803268|NCT00095992|advanced adult primary liver cancer|advanced adult primary liver cancer
5803269|NCT00095992|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5803270|NCT00095992|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5803271|NCT00095953|recurrent melanoma|recurrent melanoma
5803272|NCT00095953|stage IV melanoma|stage iv melanoma
5803273|NCT00095927|radiation toxicity|radiation toxicity
5803274|NCT00095927|chemotherapeutic agent toxicity|chemotherapeutic agent toxicity
5686580|NCT00551473|pharmacodynamics,|pharmacodynamics,
5803275|NCT00095927|mucositis|mucositis
5803276|NCT00095927|xerostomia|xerostomia
5803277|NCT00095927|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5803278|NCT00095927|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5803279|NCT00095927|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5803280|NCT00095927|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5803281|NCT00095927|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5803282|NCT00095927|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5803283|NCT00095927|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5803284|NCT00095927|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5803285|NCT00095927|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5803286|NCT00095927|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5803287|NCT00095927|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5803288|NCT00095927|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5803289|NCT00095927|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5803290|NCT00095927|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5803291|NCT00095927|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5846481|NCT00044291|Estrogen blocker|estrogen blocker
5803292|NCT00095927|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5803293|NCT00095927|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5803409|NCT00095329|sirolimus|sirolimus
5803294|NCT00095914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803295|NCT00095901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5803296|NCT00095901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5803383|NCT00095420|Interpersonal Relationships|interpersonal relationships
5803297|NCT00095901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5803298|NCT00095901|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5803299|NCT00095875|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5862631|NCT00001560|AIDS|aids
5803300|NCT00095875|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5803301|NCT00095875|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5803302|NCT00095875|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5803303|NCT00095875|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5803304|NCT00095875|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5803305|NCT00095875|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5803306|NCT00095875|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5803307|NCT00095862|recurrent breast cancer|recurrent breast cancer
5803308|NCT00095862|stage IV breast cancer|stage iv breast cancer
5803309|NCT00095862|male breast cancer|male breast cancer
5803310|NCT00095862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803311|NCT00095836|recurrent thyroid cancer|recurrent thyroid cancer
5803312|NCT00095836|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5803313|NCT00095836|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5803314|NCT00095836|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5803315|NCT00095836|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5803316|NCT00095836|anaplastic thyroid cancer|anaplastic thyroid cancer
5803317|NCT00095836|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5803318|NCT00095810|Psychosis, Parkinson's Disease|psychosis, parkinson's disease
5803319|NCT00095771|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5803320|NCT00095771|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5803321|NCT00095732|Pancreatic Insufficiency|pancreatic insufficiency
5803322|NCT00095732|Cystic Fibrosis|cystic fibrosis
5803323|NCT00095732|Enzymes|enzymes
5803324|NCT00095719|Acute agitation in patients diagnosed with Dementia|acute agitation in patients diagnosed with dementia
5803325|NCT00095706|Metastatic breast cancer|metastatic breast cancer
5803326|NCT00095706|HER2|her2
5803327|NCT00095706|Trastuzumab|trastuzumab
5803328|NCT00095706|Herceptin|herceptin
5803329|NCT00095706|VEGF|vegf
5803331|NCT00095706|Avastin|avastin
5803332|NCT00095680|Multiple Myeloma|multiple myeloma
5803333|NCT00095680|SCIO-469|scio-469
5803334|NCT00095680|Bortezomib|bortezomib
5686581|NCT00551473|tolerance|tolerance
5803335|NCT00095680|p38 MAP kinase|p38 map kinase
5803336|NCT00095654|diabetes prevention|diabetes prevention
5803337|NCT00095654|ramipril|ramipril
5803338|NCT00095654|rosiglitazone|rosiglitazone
5803339|NCT00095654|impaired glucose tolerance|impaired glucose tolerance
5803340|NCT00095654|isolated impaired fasting glucose|isolated impaired fasting glucose
5803341|NCT00095654|Isolated Impaired Glucose Tolerance|isolated impaired glucose tolerance
5803342|NCT00095589|bladder cancer|bladder cancer
5803343|NCT00095589|stage 0 bladder cancer|stage 0 bladder cancer
5803344|NCT00095589|stage I bladder cancer|stage i bladder cancer
5803345|NCT00095589|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5803346|NCT00095550|Moderate Hypertension|moderate hypertension
5803347|NCT00095537|Solid tumors|solid tumors
5803348|NCT00095537|cancer|cancer
5803349|NCT00095537|HER-2-expressing tumors|her-2-expressing tumors
5803350|NCT00095524|Patient weight change|patient weight change
5803351|NCT00095524|changes in metabolic status|changes in metabolic status
5803352|NCT00095511|Bipolar Mania|bipolar mania
5803353|NCT00095498|arthritis|arthritis
5803354|NCT00095498|joint pain|joint pain
5803355|NCT00095498|Methotrexate|methotrexate
5803356|NCT00095485|Activity Level|activity level
5803357|NCT00095485|Musculoskeletal|musculoskeletal
5803358|NCT00095485|Healthy Volunteer|healthy volunteer
5803359|NCT00095485|Physical Activity|physical activity
5803360|NCT00095472|Blood Flow|blood flow
5803361|NCT00095472|Nitric Oxide|nitric oxide
5803362|NCT00095472|Vascular Function|vascular function
5803363|NCT00095472|Vasodilation|vasodilation
5803364|NCT00095472|Vaso-Occlusive Pain Crisis|vaso-occlusive pain crisis
5803365|NCT00095472|Sickle Cell Disease|sickle cell disease
5803366|NCT00095459|Raf-Kinase Inhibitor|raf-kinase inhibitor
5803367|NCT00095459|Combinatorial Therapy|combinatorial therapy
5803368|NCT00095459|Pathway Profiling|pathway profiling
5803369|NCT00095459|VEGFR|vegfr
5803370|NCT00095459|Bevacizumab|bevacizumab
5803371|NCT00095459|Sorafenib|sorafenib
5803372|NCT00095459|Advanced Solid Tumors|advanced solid tumors
5803373|NCT00095459|Angiogenesis|angiogenesis
5803374|NCT00095459|Targeted Therapy|targeted therapy
5803375|NCT00095459|VEGF|vegf
5803376|NCT00095459|Cancer|cancer
5803377|NCT00095459|Solid Tumor|solid tumor
5803378|NCT00095459|Metastatic Uresectable Solid Tumors|metastatic uresectable solid tumors
5803379|NCT00095446|Diabetes Mellitus|diabetes mellitus
5803380|NCT00095446|Diabetes|diabetes
5803381|NCT00095433|AMD|amd
5803382|NCT00095433|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5803384|NCT00095420|Child|child
5803385|NCT00095407|Social Cognition|social cognition
5803386|NCT00095407|Semantic Memory|semantic memory
5803387|NCT00095407|Prefrontal Cortex|prefrontal cortex
5803388|NCT00095407|Temporal Cortex|temporal cortex
5803389|NCT00095407|Conceptual Self|conceptual self
5803390|NCT00095394|Severe Hypertension|severe hypertension
5803391|NCT00095381|Leukemia, Lymphocytic, T-Cell|leukemia, lymphocytic, t-cell
5803392|NCT00095381|Entry Term Lymphocytic Leukemia, T-Cell|entry term lymphocytic leukemia, t-cell
5803393|NCT00095381|T-Cell Leukemia|t-cell leukemia
5803394|NCT00095381|T-Lymphocytic Leukemia|t-lymphocytic leukemia
5803395|NCT00095381|Leukemia, Lymphocytic, T Cell|leukemia, lymphocytic, t cell
5803396|NCT00095381|T Lymphocytic Leukemia|t lymphocytic leukemia
5803397|NCT00095381|BCX-1777|bcx-1777
5803398|NCT00095381|forodesine hydrochloride|forodesine hydrochloride
5803399|NCT00095381|BioCryst|biocryst
5803400|NCT00095368|Pharyngitis|pharyngitis
5803401|NCT00095368|Tonsillitis|tonsillitis
5803402|NCT00095355|BDNF|bdnf
5803403|NCT00095355|Lithium|lithium
5803404|NCT00095355|Divalproex|divalproex
5803405|NCT00095355|Huntington Disease|huntington disease
5803406|NCT00095355|HD|hd
5803407|NCT00095329|relapsing-remitting MS|relapsing-remitting ms
5803408|NCT00095329|nonresponsive to standard of care MS|nonresponsive to standard of care ms
5803410|NCT00095316|candidiasis, caspofungin, fungal infection, prophylaxis|candidiasis, caspofungin, fungal infection, prophylaxis
5803411|NCT00095303|BSFT|bsft
5803412|NCT00095303|Family Therapy|family therapy
5803413|NCT00095303|Adolescents|adolescents
5803414|NCT00095303|Substance Abuse|substance abuse
5803415|NCT00095290|Albuminuria|albuminuria
5803416|NCT00095290|Hypertension|hypertension
5803417|NCT00095290|Elevated Cardiovascular Risk|elevated cardiovascular risk
5803418|NCT00095290|Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk|albuminuria in hypertensive subjects at elevated cardiovascular risk
5803419|NCT00095277|non-myeloid malignancies|non-myeloid malignancies
5803420|NCT00095277|myeloma|myeloma
5803421|NCT00095277|Anemia of Cancer|anemia of cancer
5803422|NCT00095264|Myelodysplastic Syndrome|myelodysplastic syndrome
5803423|NCT00095251|Delirium|delirium
5803424|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives
5803425|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists
5803426|NCT00095251|efficacy of sedation|efficacy of sedation
5803427|NCT00095251|cognitive impairment|cognitive impairment
5803428|NCT00095225|Recurrent or refractory non-small cell lung cancer|recurrent or refractory non-small cell lung cancer
5803429|NCT00095212|HIV|hiv
5803430|NCT00095212|women|women
5803431|NCT00095212|androgen|androgen
5803432|NCT00095212|Treatment Experienced|treatment experienced
5803433|NCT00095199|Recurrent or Progressive Non-Small Cell Lung Cancer|recurrent or progressive non-small cell lung cancer
5803434|NCT00095199|Second-line therapy|second-line therapy
5803435|NCT00095199|Docetaxel|docetaxel
5803436|NCT00095199|Pemetrexed|pemetrexed
5803437|NCT00095199|Cetuximab|cetuximab
5803438|NCT00095199|Failed platinum-based therapy|failed platinum-based therapy
5803439|NCT00095199|NSCLC|nsclc
5803440|NCT00095186|Cancer|cancer
5803441|NCT00095186|Metastatic|metastatic
5803442|NCT00095186|Kidney|kidney
5803443|NCT00095186|Refractive|refractive
5803444|NCT00095186|Lactoferrin|lactoferrin
5803445|NCT00095186|Oral|oral
5803446|NCT00095173|Juvenile Idiopathic Arthritis|juvenile idiopathic arthritis
5803447|NCT00095160|Solid Organ Tumors|solid organ tumors
5803448|NCT00095121|Hepatitis B|hepatitis b
5803449|NCT00095121|Children|children
5803450|NCT00095121|Pediatric|pediatric
5803451|NCT00095121|Adefovir Dipivoxil|adefovir dipivoxil
5803452|NCT00095108|Metastatic Melanoma|metastatic melanoma
5803453|NCT00095108|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5803454|NCT00095095|Spine|spine
5803455|NCT00095095|Lumbar spine|lumbar spine
5803456|NCT00095095|Spinal fusion|spinal fusion
5803457|NCT00095095|Low back pain|low back pain
5803458|NCT00095095|Fusion cage|fusion cage
5803459|NCT00095095|Posterior lumbar interbody fusion|posterior lumbar interbody fusion
5803460|NCT00095095|Bioresorbable|bioresorbable
5803461|NCT00095095|Peek|peek
5803462|NCT00095082|Diabetes Mellitus, Type I|diabetes mellitus, type i
5803463|NCT00095056|Type 2 Diabetes Mellitus and Chronic Renal Insufficiency|type 2 diabetes mellitus and chronic renal insufficiency
5803464|NCT00095030|Diabetes|diabetes
5803465|NCT00095017|Arcoxia|arcoxia
5803466|NCT00094991|Type 2 diabetes|type 2 diabetes
5803467|NCT00094978|Apoptosis|apoptosis
5803468|NCT00094978|Toxicity|toxicity
5803469|NCT00094978|Pharmacokinetic|pharmacokinetic
5803470|NCT00094978|Gene Induction|gene induction
5803471|NCT00094978|Maximally Tolerated Dose|maximally tolerated dose
5803472|NCT00094978|Small Cell Lung Cancer|small cell lung cancer
5803473|NCT00094978|SCLC|sclc
5803474|NCT00094978|Non-Small Cell Lung Cancer|non-small cell lung cancer
5803476|NCT00094978|Esophageal Cancer|esophageal cancer
5803477|NCT00094978|Pleural Mesothelioma|pleural mesothelioma
5803478|NCT00094965|Advanced Gastrointestinal tumors and normal to severely abnormal renal function|advanced gastrointestinal tumors and normal to severely abnormal renal function
5803479|NCT00094952|Mild Cognitive Impairment|mild cognitive impairment
5803480|NCT00094952|Alzheimer's disease|alzheimer's disease
5803481|NCT00094952|magnetic resonance imaging|magnetic resonance imaging
5803482|NCT00094952|cerebrospinal fluid (CSF) biomarkers|cerebrospinal fluid (csf) biomarkers
5803483|NCT00094939|mild cognitive impairment|mild cognitive impairment
5803484|NCT00094939|Alzheimer disease|alzheimer disease
5803485|NCT00094939|magnetic resonance imaging|magnetic resonance imaging
5803486|NCT00094939|CSF tau protein|csf tau protein
5803487|NCT00094939|Hippocampus|hippocampus
5803488|NCT00094926|Risperidal CONSTA|risperidal consta
5803489|NCT00094926|Bipolar disorder|bipolar disorder
5803490|NCT00094926|mood episodes|mood episodes
5803491|NCT00094926|Safety and efficacy, adjuvant therapy|safety and efficacy, adjuvant therapy
5803492|NCT00094913|Aging|aging
5803493|NCT00094913|Mild Cognitive Impairment|mild cognitive impairment
5803494|NCT00094913|Alzheimer disease, preclinical|alzheimer disease, preclinical
5803495|NCT00094913|Hippocampal formation|hippocampal formation
5803496|NCT00094913|Glucose metabolism|glucose metabolism
5803497|NCT00094900|Muckle Wells Syndrome|muckle wells syndrome
5803498|NCT00094900|NOMID|nomid
5803499|NCT00094900|Adult Stills Disease|adult stills disease
5803500|NCT00094900|Familial Mediterranean|familial mediterranean
5803501|NCT00094900|Treatment Trial/Fever|treatment trial/fever
5803502|NCT00094900|Autoinflammatory Disease|autoinflammatory disease
5803503|NCT00094887|Blood Flow|blood flow
5803504|NCT00094887|Nitric Oxide|nitric oxide
5803505|NCT00094887|Pain Crisis|pain crisis
5803506|NCT00094887|Sickle Cell Anemia|sickle cell anemia
5803507|NCT00094887|Vaso-Occlusive Crisis|vaso-occlusive crisis
5803508|NCT00094887|Sickle Cell Disease|sickle cell disease
5803509|NCT00094887|SCD|scd
5803510|NCT00094874|pelvic pain, bladder pain, urgency, frequency, nocturia|pelvic pain, bladder pain, urgency, frequency, nocturia
5803511|NCT00094861|dysphagia|dysphagia
5803512|NCT00094861|palifermin, KGF|palifermin, kgf
5803513|NCT00094861|chemoradiotherapy|chemoradiotherapy
5803514|NCT00094861|NSCLC, non-small cell lung cancer|nsclc, non-small cell lung cancer
5803515|NCT00094861|lung cancer|lung cancer
5803516|NCT00094861|supportive care|supportive care
5803517|NCT00094861|clinical trial|clinical trial
5803518|NCT00094861|consolidation chemotherapy|consolidation chemotherapy
5803519|NCT00094861|radiotherapy|radiotherapy
5803520|NCT00094835|Lung cancer, Non-small cell lung cancer, NSCLC|lung cancer, non-small cell lung cancer, nsclc
5803521|NCT00094835|Clinical Trial, Panitumumab, AMG 706|clinical trial, panitumumab, amg 706
5803522|NCT00094835|Anti-angiogenesis|anti-angiogenesis
5803523|NCT00094835|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5803524|NCT00094835|Stage IIIB, Stage IV, Unresectable|stage iiib, stage iv, unresectable
5823049|NCT00072605|HV|hv
5803525|NCT00094822|Metastatic Cancer|metastatic cancer
5803526|NCT00094822|Neulasta®|neulasta®
5803527|NCT00094822|pegfilgrastim|pegfilgrastim
5803528|NCT00094809|Neulasta®|neulasta®
5803529|NCT00094809|pegfilgrastim|pegfilgrastim
5803530|NCT00094809|Advanced|advanced
5803531|NCT00094809|Chemotherapy|chemotherapy
5803532|NCT00094796|Insulin Resistance|insulin resistance
5803533|NCT00094796|Brachial Artery Reactivity|brachial artery reactivity
5803534|NCT00094796|Endothelial Progenitor Cells|endothelial progenitor cells
5803535|NCT00094796|Metabolic Stress Test|metabolic stress test
5803536|NCT00094796|Mitochondrial Function|mitochondrial function
5803537|NCT00094796|Type 2 Diabetes|type 2 diabetes
5803538|NCT00094796|T2DM|t2dm
5803539|NCT00094796|Pre-Diabetes|pre-diabetes
5803540|NCT00094783|Magnetic Resonance Imaging|magnetic resonance imaging
5803541|NCT00094783|Interventional MRI|interventional mri
5803542|NCT00094783|Arterial Stenosis|arterial stenosis
5803543|NCT00094783|Revascularization|revascularization
5803544|NCT00094783|Lllac Artery Stenosis|lllac artery stenosis
5803545|NCT00094783|Peripheral Arterial Disease|peripheral arterial disease
5803546|NCT00094783|Cardiovascular Disease|cardiovascular disease
5803547|NCT00094731|Aging|aging
5803548|NCT00094731|Memory|memory
5803549|NCT00094731|Mental Recall|mental recall
5803550|NCT00094731|Mental Processes|mental processes
5803551|NCT00094718|Chimeric Virus Vaccine|chimeric virus vaccine
5803552|NCT00094718|West Nile Virus|west nile virus
5803553|NCT00094718|Dengue Virus|dengue virus
5803554|NCT00094705|Dengue Vaccine|dengue vaccine
5803555|NCT00094705|Dengue Virus|dengue virus
5803556|NCT00094705|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5803557|NCT00094705|Dengue Shock Syndrome|dengue shock syndrome
5803558|NCT00094692|Amblyopia|amblyopia
5803559|NCT00094692|Patching|patching
5803560|NCT00094692|Spectacles|spectacles
5803561|NCT00094653|melanoma|melanoma
5803562|NCT00094653|metastatic melanoma|metastatic melanoma
5803563|NCT00094653|skin cancer|skin cancer
5803564|NCT00094601|Positron Emission Tomograhy|positron emission tomograhy
5803565|NCT00094601|[18F] FDOPA|[18f] fdopa
5803566|NCT00094601|[11C] NNC-112|[11c] nnc-112
5803567|NCT00094601|Dopamine|dopamine
5794539|NCT00126308|HIV|hiv
5803568|NCT00094601|Molecular Imaging|molecular imaging
5803569|NCT00094601|Dopamine D1 Receptor|dopamine d1 receptor
5803570|NCT00094601|PET|pet
5803571|NCT00094601|Parkinson's Disease|parkinson's disease
5803572|NCT00094601|Cognition|cognition
5803573|NCT00094601|Parkinson Disease|parkinson disease
5803574|NCT00094601|PD|pd
5803575|NCT00094601|Healthy Volunteer|healthy volunteer
5803576|NCT00094601|HV|hv
5803577|NCT00094575|Abdominal|abdominal
5803578|NCT00094575|Aortic Aneurysm|aortic aneurysm
5803579|NCT00094575|cost of AAA repair|cost of aaa repair
5803580|NCT00094575|Endovascular Repair|endovascular repair
5803581|NCT00094575|Grafts|grafts
5803582|NCT00094575|Long-term survival|long-term survival
5803583|NCT00094575|secondary outcomes|secondary outcomes
5803584|NCT00094562|Cancer|cancer
5803585|NCT00094562|Cancer Cachexia|cancer cachexia
5803586|NCT00094562|Weight Loss|weight loss
5803587|NCT00094562|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5803588|NCT00094562|Chronic Heart Failure|chronic heart failure
5803589|NCT00094562|Rheumatoid Arthritis|rheumatoid arthritis
5803590|NCT00094536|Menorrhagia|menorrhagia
5803591|NCT00094536|Excessive Uterine Bleeding|excessive uterine bleeding
5803592|NCT00094536|Cryoablation|cryoablation
5803593|NCT00094536|Menstrual disorder|menstrual disorder
5803594|NCT00094536|Endometrial ablation|endometrial ablation
5803595|NCT00094536|Abnormal uterine bleeding|abnormal uterine bleeding
5803596|NCT00094536|Dysfunctional uterine bleeding|dysfunctional uterine bleeding
5803597|NCT00094523|fosamprenavir LEXIVA non-inferiority safety tolerability|fosamprenavir lexiva non-inferiority safety tolerability
5803598|NCT00094510|Prefrontal GABA|prefrontal gaba
5803599|NCT00094510|Stress|stress
5803600|NCT00094510|Emotion Recognition|emotion recognition
5803601|NCT00094510|Differential Reward|differential reward
5803602|NCT00094510|Gabapentin|gabapentin
5803603|NCT00094510|GABA|gaba
5803604|NCT00094510|Prefrontal Cortex|prefrontal cortex
5803605|NCT00094510|Emotional Processing|emotional processing
5803606|NCT00094510|Healthy Humans|healthy humans
5803607|NCT00094510|Healthy Volunteer|healthy volunteer
5803608|NCT00094510|HV|hv
5803609|NCT00094484|Sensipar®|sensipar®
5803610|NCT00094484|Mimpara®|mimpara®
5803611|NCT00094484|Cinacalcet|cinacalcet
5803612|NCT00094484|Calcimimetic|calcimimetic
5803613|NCT00094484|Chronic Kidney Disease|chronic kidney disease
5803614|NCT00094458|Crohn's Disease|crohn's disease
5803615|NCT00094458|infliximab|infliximab
5803616|NCT00094458|azathioprine|azathioprine
5803617|NCT00094458|Remicade|remicade
5803618|NCT00094458|SONIC|sonic
5803619|NCT00094445|Pancreatic Cancer|pancreatic cancer
5803620|NCT00094445|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5803621|NCT00094445|Alternative therapy|alternative therapy
5803622|NCT00094445|Pancreas|pancreas
5803623|NCT00094445|Pancreatic Neoplasm|pancreatic neoplasm
5686582|NCT00551473|H2 antagonist,|h2 antagonist,
5686583|NCT00551473|AH23844,|ah23844,
5803024|NCT00096564|HV|hv
5803624|NCT00094445|Cancer of the pancreas|cancer of the pancreas
5803625|NCT00094432|depressed|depressed
5803626|NCT00094419|Complementary Therapies|complementary therapies
5803627|NCT00094406|Lung Permeability|lung permeability
5803628|NCT00094406|Endotoxin Tolerance|endotoxin tolerance
5803629|NCT00094406|Bronchoscopy|bronchoscopy
5803630|NCT00094406|Carbon Monoxide Inhalation|carbon monoxide inhalation
5803631|NCT00094393|Ageing|ageing
5803632|NCT00094393|Atherosclerosis|atherosclerosis
5803633|NCT00094393|Lamin A|lamin a
5803634|NCT00094393|Lipodystrophy|lipodystrophy
5803635|NCT00094393|Growth Impairment|growth impairment
5803636|NCT00094393|Premature Aging|premature aging
5803637|NCT00094393|Hutchinson-Gilford Progeria Syndrome|hutchinson-gilford progeria syndrome
5803638|NCT00094393|HGPS|hgps
5803639|NCT00094380|SLE|sle
5803640|NCT00094380|Lupus|lupus
5803641|NCT00094380|Systemic Lupus Erythematosus|systemic lupus erythematosus
5803642|NCT00094380|Lupus Nephritis|lupus nephritis
5803643|NCT00094367|1592U89|1592u89
5803644|NCT00094367|GR109714|gr109714
5803645|NCT00094367|abacavir|abacavir
5803646|NCT00094367|lamivudine|lamivudine
5803647|NCT00094367|fixed-dose combination|fixed-dose combination
5803648|NCT00094367|once-daily|once-daily
5803649|NCT00094367|twice-daily|twice-daily
5803650|NCT00094367|HIV infection|hiv infection
5803651|NCT00094367|naive|naive
5803652|NCT00094354|HIV infected former Plasma Donors|hiv infected former plasma donors
5803653|NCT00094354|Needs assessment|needs assessment
5803654|NCT00094354|HIV-related stigma and discrimination|hiv-related stigma and discrimination
5803655|NCT00094354|In-depth interview|in-depth interview
5803656|NCT00094354|Focus Groups|focus groups
5803657|NCT00094341|Arthritis|arthritis
5803658|NCT00094341|Rheumatology|rheumatology
5803659|NCT00094328|Testotoxicosis|testotoxicosis
5803660|NCT00094328|Familial Male-limited Precocious Puberty (FMPP)|familial male-limited precocious puberty (fmpp)
5803661|NCT00094302|Heart Failure|heart failure
5803662|NCT00094302|Diastolic Heart Failure|diastolic heart failure
5803663|NCT00094302|Preserved Ejection Fraction|preserved ejection fraction
5803664|NCT00094172|Early Multiple Sclerosis|early multiple sclerosis
5803665|NCT00094172|MS|ms
5803666|NCT00094172|Clinically Isolated Syndrome|clinically isolated syndrome
5803667|NCT00094146|Primary Insulin Hypersecretion|primary insulin hypersecretion
5803668|NCT00094146|PIH|pih
5803670|NCT00094133|cancer survivor|cancer survivor
5803671|NCT00094133|stage IA breast cancer|stage ia breast cancer
5803672|NCT00094133|stage IB breast cancer|stage ib breast cancer
5803673|NCT00094133|stage II breast cancer|stage ii breast cancer
5803674|NCT00094133|stage IIIA breast cancer|stage iiia breast cancer
5803675|NCT00094133|stage IIIB breast cancer|stage iiib breast cancer
5803676|NCT00094133|stage IIIC breast cancer|stage iiic breast cancer
5803677|NCT00094133|stage IV breast cancer|stage iv breast cancer
5803678|NCT00094133|breast cancer in situ|breast cancer in situ
5803679|NCT00094133|inflammatory breast cancer|inflammatory breast cancer
5803680|NCT00094133|hot flashes|hot flashes
5803681|NCT00094120|Age-Related Macular Degeneration - Wet Type|age-related macular degeneration - wet type
5803682|NCT00094107|melanoma|melanoma
5803683|NCT00094107|antiangiogenesis|antiangiogenesis
5803684|NCT00094081|squamous cell carcinoma|squamous cell carcinoma
5803685|NCT00094081|oropharynx|oropharynx
5803686|NCT00094081|oral cavity|oral cavity
5803687|NCT00094081|larynx|larynx
5803688|NCT00094081|hypopharynx|hypopharynx
5803689|NCT00091468|Age-Related Memory Loss|age-related memory loss
5803690|NCT00091468|Nicotine|nicotine
5803691|NCT00091468|Mild Cognitive Impairment (MCI)|mild cognitive impairment (mci)
5803692|NCT00094068|Gray Matter|gray matter
5803693|NCT00094068|White Matter|white matter
5803694|NCT00094068|Cerebral Blood Flow|cerebral blood flow
5803695|NCT00094068|Cerebral Blood Volume|cerebral blood volume
5803696|NCT00094068|Lesion|lesion
5803698|NCT00094068|Multiple Sclerosis|multiple sclerosis
5803699|NCT00094068|Perfusion|perfusion
5803700|NCT00094068|Imaging|imaging
5803701|NCT00094068|Sildenafil|sildenafil
5803702|NCT00094068|MS|ms
5803703|NCT00094068|Healthy Volunteer|healthy volunteer
5803704|NCT00094068|HV|hv
5803705|NCT00094042|Socioeconomic Factors|socioeconomic factors
5803706|NCT00094042|Dietary Supplementation|dietary supplementation
5803707|NCT00094003|Liver metastases|liver metastases
5803708|NCT00094003|Colorectal cancer|colorectal cancer
5803709|NCT00094003|Gastric cancer|gastric cancer
5803710|NCT00094003|Esophagus cancer|esophagus cancer
5803711|NCT00094003|Breast cancer|breast cancer
5803712|NCT00094003|Lung cancer|lung cancer
5803713|NCT00094003|Skin cancer|skin cancer
5803714|NCT00094003|Renal Cancer|renal cancer
5803715|NCT00094003|Liver metastasis|liver metastasis
5803716|NCT00093990|Myeloid leukemia acute disease|myeloid leukemia acute disease
5803717|NCT00093990|Tipifarnib|tipifarnib
5803718|NCT00093990|Bone marrow aspirate|bone marrow aspirate
5803719|NCT00093977|Chronic Kidney Disease|chronic kidney disease
5803720|NCT00093977|Dialysis|dialysis
5686584|NCT00551473|lavoltidine,|lavoltidine,
5686585|NCT00551473|gastroesophageal reflux disease (GERD), pharmacokinetics,|gastroesophageal reflux disease (gerd), pharmacokinetics,
5686586|NCT00551460|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5686587|NCT00551460|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5803721|NCT00093977|Anemia|anemia
5803722|NCT00093977|Nephrology|nephrology
5803723|NCT00093964|Brain cancer|brain cancer
5803724|NCT00093964|Brain tumor|brain tumor
5803725|NCT00093951|Alzheimer disease|alzheimer disease
5803728|NCT00093951|GABA(B)receptor antagonist|gaba(b)receptor antagonist
5803729|NCT00093938|Vaccinium macrocarpon|vaccinium macrocarpon
5803730|NCT00093938|Asymptomatic Bacteriuria|asymptomatic bacteriuria
5803731|NCT00093925|Postoperative hypertension|postoperative hypertension
5803732|NCT00093912|Perioperative Hypertension|perioperative hypertension
5803733|NCT00093899|Mixed Hyperlipidemia|mixed hyperlipidemia
5803734|NCT00093886|Preoperative hypertension|preoperative hypertension
5803736|NCT00093873|antiangiogenesis|antiangiogenesis
5803737|NCT00093873|Solid Tumors|solid tumors
5803738|NCT00093847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors
5803739|NCT00093847|S-adenosyl Methionine|s-adenosyl methionine
5803740|NCT00093847|SSRI|ssri
5803741|NCT00093847|SAMe|same
5803742|NCT00093834|stage IV breast cancer|stage iv breast cancer
5803743|NCT00093834|recurrent breast cancer|recurrent breast cancer
5803744|NCT00093808|recurrent breast cancer|recurrent breast cancer
5803745|NCT00093808|stage IV breast cancer|stage iv breast cancer
5803746|NCT00093808|male breast cancer|male breast cancer
5803747|NCT00093795|stage II breast cancer|stage ii breast cancer
5803748|NCT00093795|stage IIIA breast cancer|stage iiia breast cancer
5803749|NCT00093795|stage IIIC breast cancer|stage iiic breast cancer
5803750|NCT00093769|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5803751|NCT00093769|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5803752|NCT00093769|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5803753|NCT00093769|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5803754|NCT00093769|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5803755|NCT00093769|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5803756|NCT00093769|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5803757|NCT00093730|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803758|NCT00093704|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5803759|NCT00093704|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5803760|NCT00093704|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5803761|NCT00093704|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5803762|NCT00093704|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5803763|NCT00093704|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5803764|NCT00093678|pain|pain
5803765|NCT00093678|cachexia|cachexia
5803766|NCT00093678|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5803767|NCT00093678|recurrent uterine sarcoma|recurrent uterine sarcoma
5803768|NCT00093678|stage III uterine sarcoma|stage iii uterine sarcoma
5803769|NCT00093678|stage IV uterine sarcoma|stage iv uterine sarcoma
5803770|NCT00093678|ovarian sarcoma|ovarian sarcoma
5803771|NCT00093678|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5803772|NCT00093678|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5803773|NCT00093678|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5803775|NCT00093678|stage III melanoma|stage iii melanoma
5803776|NCT00093678|stage IV melanoma|stage iv melanoma
5803777|NCT00093678|chondrosarcoma|chondrosarcoma
5803778|NCT00093678|metastatic osteosarcoma|metastatic osteosarcoma
5803779|NCT00093678|recurrent osteosarcoma|recurrent osteosarcoma
5803780|NCT00093678|classic Kaposi sarcoma|classic kaposi sarcoma
5803781|NCT00093678|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5803782|NCT00093678|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5803783|NCT00093678|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5803784|NCT00093678|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5803785|NCT00093678|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5803786|NCT00093678|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5803787|NCT00093678|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5803788|NCT00093678|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5803789|NCT00093678|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5803790|NCT00093678|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5803791|NCT00093678|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5823245|NCT00071435|EEG|eeg
5803792|NCT00093678|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5803793|NCT00093678|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5803794|NCT00093678|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5803795|NCT00093678|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5803796|NCT00093678|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5803797|NCT00093678|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5803798|NCT00093678|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5803799|NCT00093678|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5803800|NCT00093678|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5803801|NCT00093678|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5803802|NCT00093678|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5803803|NCT00093678|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5803804|NCT00093678|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5803805|NCT00093678|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5803806|NCT00093678|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5803808|NCT00093678|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5803809|NCT00093678|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5803810|NCT00093678|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5803811|NCT00093678|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5803812|NCT00093678|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5803813|NCT00093678|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5803814|NCT00093678|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5803815|NCT00093678|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5803816|NCT00093678|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5803817|NCT00093678|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5803818|NCT00093678|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5803819|NCT00093678|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5803820|NCT00093678|primary central nervous system lymphoma|primary central nervous system lymphoma
5803821|NCT00093678|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5803822|NCT00093678|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5803823|NCT00093678|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5803824|NCT00093678|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5803825|NCT00093678|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5803826|NCT00093678|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5803827|NCT00093678|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5858754|NCT00011245|Myelography|myelography
5803828|NCT00093678|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5803829|NCT00093678|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5803830|NCT00093678|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5803831|NCT00093678|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5803832|NCT00093678|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5803833|NCT00093678|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5803834|NCT00093678|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5803835|NCT00093678|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5803836|NCT00093678|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5803837|NCT00093678|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5803838|NCT00093678|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5803839|NCT00093678|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5803840|NCT00093678|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5803841|NCT00093678|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5803842|NCT00093678|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5803843|NCT00093678|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5803844|NCT00093665|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5803845|NCT00093665|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5803846|NCT00093665|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5803847|NCT00093665|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5803848|NCT00093665|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5803849|NCT00093665|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5803850|NCT00093652|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5803851|NCT00093652|recurrent esophageal cancer|recurrent esophageal cancer
5803852|NCT00093652|stage II esophageal cancer|stage ii esophageal cancer
5803853|NCT00093652|stage III esophageal cancer|stage iii esophageal cancer
5803854|NCT00093652|stage IV esophageal cancer|stage iv esophageal cancer
5803855|NCT00093652|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5803856|NCT00093639|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5803857|NCT00093639|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5803858|NCT00093600|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5803859|NCT00093600|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5803860|NCT00093600|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5789972|NCT00146302|BCG|bcg
5803861|NCT00093600|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5803862|NCT00093600|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5803863|NCT00093600|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5803864|NCT00093587|graft versus host disease|graft versus host disease
5803865|NCT00093587|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5803866|NCT00093587|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5803867|NCT00093587|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5803868|NCT00093587|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5803869|NCT00093587|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5803870|NCT00093587|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5803871|NCT00093587|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5803872|NCT00093587|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5803873|NCT00093561|prostate cancer|prostate cancer
5803874|NCT00093548|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5803875|NCT00093548|advanced adult primary liver cancer|advanced adult primary liver cancer
5803876|NCT00093548|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5803877|NCT00093548|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5803878|NCT00093522|recurrent renal cell cancer|recurrent renal cell cancer
5804048|NCT00092950|Compliance|compliance
5803879|NCT00093522|stage IV renal cell cancer|stage iv renal cell cancer
5803880|NCT00093509|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5803881|NCT00093509|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5803882|NCT00093509|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5803883|NCT00093509|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5803884|NCT00093483|adult acute basophilic leukemia|adult acute basophilic leukemia
5803885|NCT00093483|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5803886|NCT00093483|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5803887|NCT00093483|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5803888|NCT00093483|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5803889|NCT00093483|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5803890|NCT00093483|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5803891|NCT00093483|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5803892|NCT00093483|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5803893|NCT00093483|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5803894|NCT00093483|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5803895|NCT00093483|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5803896|NCT00093483|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5803897|NCT00093483|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5803898|NCT00093483|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5803899|NCT00093483|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5803900|NCT00093483|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5803901|NCT00093457|recurrent prostate cancer|recurrent prostate cancer
5803902|NCT00093457|stage IV prostate cancer|stage iv prostate cancer
5803903|NCT00093457|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5803904|NCT00093444|advanced adult primary liver cancer|advanced adult primary liver cancer
5803906|NCT00093444|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5803907|NCT00093444|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5803908|NCT00093405|recurrent renal cell cancer|recurrent renal cell cancer
5803909|NCT00093405|stage IV renal cell cancer|stage iv renal cell cancer
5803910|NCT00093405|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5803911|NCT00093379|stage II anal cancer|stage ii anal cancer
5803912|NCT00093379|stage IIIA anal cancer|stage iiia anal cancer
5803913|NCT00093379|stage IIIB anal cancer|stage iiib anal cancer
5803914|NCT00093379|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5803915|NCT00093379|Capecitabine|capecitabine
5803916|NCT00093379|Xeloda|xeloda
5803917|NCT00093379|Oxaliplatin|oxaliplatin
5803918|NCT00093379|Eloxatin|eloxatin
5803919|NCT00093379|Radiotherapy|radiotherapy
5803920|NCT00093379|XRT|xrt
5803244|NCT00096083|glucagonoma|glucagonoma
5803921|NCT00093366|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5803922|NCT00093366|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5803923|NCT00093366|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5803924|NCT00093366|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5803925|NCT00093366|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5803926|NCT00093366|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5803927|NCT00093353|diarrhea|diarrhea
5803928|NCT00093353|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5803929|NCT00093353|disseminated neuroblastoma|disseminated neuroblastoma
5803930|NCT00093353|recurrent neuroblastoma|recurrent neuroblastoma
5803931|NCT00093314|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5803932|NCT00093314|B-cell Lymphoma|b-cell lymphoma
5803933|NCT00093860|Adrenaline|adrenaline
5803934|NCT00093860|Norepinephrine|norepinephrine
5803935|NCT00093860|Sympathetic Nervous System|sympathetic nervous system
5803936|NCT00093860|Fainting|fainting
5803937|NCT00093860|Hypotension|hypotension
5803938|NCT00093860|Beta-Adrenoceptors|beta-adrenoceptors
5803939|NCT00093860|Neurocardiogenic Syncope|neurocardiogenic syncope
5803940|NCT00093860|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5803941|NCT00093860|Sympathoadrenal Imbalance|sympathoadrenal imbalance
5803942|NCT00093860|SAI|sai
5803943|NCT00093860|Children|children
5803944|NCT00093301|Shock|shock
5803945|NCT00093301|Levosimendan|levosimendan
5803946|NCT00093301|Inotropes|inotropes
5803947|NCT00093301|Dobutamine|dobutamine
5803948|NCT00093301|Heart failure|heart failure
5803949|NCT00093301|Sepsis|sepsis
5803950|NCT00093288|MDD|mdd
5803951|NCT00093288|bupropion|bupropion
5803952|NCT00093288|Depression|depression
5803953|NCT00093262|Postoperative Hypertension|postoperative hypertension
5803954|NCT00093249|Pre-operative hypertension|pre-operative hypertension
5803955|NCT00093223|In-Stent Restenosis|in-stent restenosis
5803956|NCT00093184|ST-Segment Elevation|st-segment elevation
5803957|NCT00093184|Acute Myocardial Infarction|acute myocardial infarction
5803958|NCT00093184|PCI|pci
5804049|NCT00092950|Breast Cancer Survivor|breast cancer survivor
5803959|NCT00093184|Percutaneous Coronary Intervention|percutaneous coronary intervention
5803960|NCT00093158|Acute Coronary Syndromes|acute coronary syndromes
5803961|NCT00093145|Advanced Breast Cancer|advanced breast cancer
5803962|NCT00002543|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5803963|NCT00002543|recurrent childhood brain tumor|recurrent childhood brain tumor
5803964|NCT00002543|recurrent neuroblastoma|recurrent neuroblastoma
5803965|NCT00002543|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5803966|NCT00002543|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5803967|NCT00002543|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5803968|NCT00002543|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5846482|NCT00044291|Metastatic breast cancer|metastatic breast cancer
5803969|NCT00002524|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5803970|NCT00002524|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5803971|NCT00002524|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5803972|NCT00002524|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5803973|NCT00002524|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5803974|NCT00002524|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5803975|NCT00002524|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5803976|NCT00093132|Non-Small Cell Lung Cancer (stage II or III)|non-small cell lung cancer (stage ii or iii)
5803977|NCT00093132|NSCLC|nsclc
5803978|NCT00093132|Squamous Cell Lung Cancer|squamous cell lung cancer
5803979|NCT00093132|adenocarcinoma of the lung|adenocarcinoma of the lung
5803980|NCT00093132|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5803981|NCT00093132|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5803982|NCT00093132|carcinoma, non-small cell lung|carcinoma, non-small cell lung
5803983|NCT00093119|Metastatic Melanoma|metastatic melanoma
5803984|NCT00093093|Viramidine|viramidine
5803985|NCT00093093|Ribavirin|ribavirin
5803986|NCT00093093|Valeant|valeant
5803987|NCT00093093|Hepatitis C|hepatitis c
5803988|NCT00093093|Pegylated interferon alfa-2a|pegylated interferon alfa-2a
5803989|NCT00093080|Metastatic and/or unresectable soft tissue or|metastatic and/or unresectable soft tissue or
5803990|NCT00093067|Gram-positive bacterial infections|gram-positive bacterial infections
5803991|NCT00093067|Staph Aureus|staph aureus
5803992|NCT00093067|endocarditis|endocarditis
5803993|NCT00093067|bacteremia|bacteremia
5803994|NCT00093067|Cubist|cubist
5803995|NCT00093054|Vaccinium macrocarpon|vaccinium macrocarpon
5803996|NCT00093041|Head and neck cancer|head and neck cancer
5803997|NCT00093041|squamous cell carcinoma of the head and neck|squamous cell carcinoma of the head and neck
5803998|NCT00093028|Myeloma|myeloma
5803999|NCT00093028|Revlimid|revlimid
5804000|NCT00093028|bortezomib|bortezomib
5804001|NCT00093028|CC-5013|cc-5013
5804002|NCT00093028|Dexamethasone|dexamethasone
5804003|NCT00091520|Congestive heart failure|congestive heart failure
5804004|NCT00091520|Nesiritide|nesiritide
5804005|NCT00093002|Early Breast Cancer|early breast cancer
5804006|NCT00093002|neoadjuvant therapy|neoadjuvant therapy
5804007|NCT00093002|hormonal treatment|hormonal treatment
5804008|NCT00093002|newly diagnosed breast cancer|newly diagnosed breast cancer
5804009|NCT00093002|Estrogen Receptor Positive Breast Cancer|estrogen receptor positive breast cancer
5804010|NCT00093002|treatment naïve|treatment naïve
5804011|NCT00093002|neoadjuvant treatment|neoadjuvant treatment
5804012|NCT00093002|neoadjuvant setting|neoadjuvant setting
5804013|NCT00093002|invasive breast cancer|invasive breast cancer
5804014|NCT00092976|Hemophilia A|hemophilia a
5804015|NCT00092898|Sitosterolemia|sitosterolemia
5804016|NCT00092846|High Blood Cholesterol Levels|high blood cholesterol levels
5804017|NCT00092820|Homozygous Sitosterolemia|homozygous sitosterolemia
5804018|NCT00092807|Homozygous Sitosterolemia|homozygous sitosterolemia
5804019|NCT00092781|Arcoxia|arcoxia
5804020|NCT00092768|Arcoxia|arcoxia
5804021|NCT00092755|Arcoxia|arcoxia
5804022|NCT00092742|Arcoxia|arcoxia
5804023|NCT00092703|Arcoxia|arcoxia
5804024|NCT00092664|Primary hypercholesterolemia|primary hypercholesterolemia
5804025|NCT00092651|Primary hypercholesterolemia|primary hypercholesterolemia
5804026|NCT00092573|Mixed hyperlipidemia (high cholesterol and high triglycerides)|mixed hyperlipidemia (high cholesterol and high triglycerides)
5804027|NCT00092560|mixed hyperlipidemia|mixed hyperlipidemia
5804028|NCT00092560|high cholesterol|high cholesterol
5804029|NCT00092560|high triglycerides|high triglycerides
5804030|NCT00092508|Ulcerative Colitis Remission|ulcerative colitis remission
5804031|NCT00092508|ulcerative|ulcerative
5804032|NCT00092508|colitis|colitis
5804033|NCT00092508|remission|remission
5804034|NCT00092508|relapse|relapse
5804035|NCT00092508|Asacol®|asacol®
5804036|NCT00092508|maintain|maintain
5804037|NCT00092508|maintenance|maintenance
5804038|NCT00092508|flare|flare
5804039|NCT00092508|rectal|rectal
5804040|NCT00092508|bleeding|bleeding
5804041|NCT00092508|bowel|bowel
5804042|NCT00092300|dental surgery|dental surgery
5804043|NCT00092300|molar removal|molar removal
5804044|NCT00092950|Exercise|exercise
5804045|NCT00092950|Pedometer|pedometer
5804046|NCT00092950|Physician Prescription|physician prescription
5804050|NCT00092950|Breast Cancer Risk|breast cancer risk
5804051|NCT00092937|Chronic Granulomatous Disease|chronic granulomatous disease
5804052|NCT00092937|Nonmyeloablative|nonmyeloablative
5804053|NCT00092937|CD34 Positive Cells|cd34 positive cells
5804054|NCT00092937|Donor Engraftment|donor engraftment
5804055|NCT00092937|Myeloid Chimerism|myeloid chimerism
5804056|NCT00092638|Elevated Cholesterol|elevated cholesterol
5804057|NCT00092625|Elevated Cholesterol|elevated cholesterol
5804058|NCT00092612|Elevated Cholesterol|elevated cholesterol
5804059|NCT00092599|Elevated Cholesterol|elevated cholesterol
5804060|NCT00092378|Bunionectomy|bunionectomy
5804061|NCT00092339|dental surgery|dental surgery
5804062|NCT00092339|molar removal|molar removal
5804063|NCT00092326|dental surgery|dental surgery
5804065|NCT00092313|dental surgery|dental surgery
5804066|NCT00092313|molar removal|molar removal
5804067|NCT00092287|Carcinoid Syndrome|carcinoid syndrome
5804068|NCT00092287|Neuroendocrine Tumuors|neuroendocrine tumuors
5804069|NCT00092274|Follicular Lymphoma|follicular lymphoma
5804070|NCT00092274|Non Hodgkin´s Lymphoma|non hodgkin´s lymphoma
5804071|NCT00092001|Non-small cell lung cancer, carcinoma, sunitinib, Phase 2|non-small cell lung cancer, carcinoma, sunitinib, phase 2
5804072|NCT00092196|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5804073|NCT00092183|Chemotherapy-Induced Nausea and Vomiting|chemotherapy-induced nausea and vomiting
5804074|NCT00092170|Intra-abdominal infections|intra-abdominal infections
5804083|NCT00092235|Chronic Graft-Versus-Host Disease|chronic graft-versus-host disease
5804096|NCT00091988|Urinary Incontinence|urinary incontinence
5804103|NCT00091949|diabetes|diabetes
5804104|NCT00091949|pioglitazone|pioglitazone
5804105|NCT00091949|insulin resistance|insulin resistance
5804106|NCT00091936|Treatment Naive|treatment naive
5804107|NCT00091936|Directly Observed Therapy|directly observed therapy
5804110|NCT00091910|Anemia|anemia
5804111|NCT00091910|Epoetin alfa|epoetin alfa
5804112|NCT00091910|Erythropoietin|erythropoietin
5804113|NCT00091910|Blood transfusion|blood transfusion
5804114|NCT00091910|Intensive care units|intensive care units
5804115|NCT00091858|Cancer-related anemia|cancer-related anemia
5804116|NCT00091845|West Nile Fever Myelitis|west nile fever myelitis
5804117|NCT00091845|West Nile Fever Encephalitis|west nile fever encephalitis
5804118|NCT00091845|West Nile Fever Meningitis|west nile fever meningitis
5804119|NCT00091845|West Nile Fever Meningoencephalitis|west nile fever meningoencephalitis
5804120|NCT00091832|Breast Cancer|breast cancer
5804121|NCT00091832|Cancer|cancer
5804122|NCT00091819|staph|staph
5804123|NCT00091819|MRSA|mrsa
5804124|NCT00091819|cSSSI|csssi
5804125|NCT00091806|Targeted Therapy|targeted therapy
5804126|NCT00091806|Solid tumors|solid tumors
5804127|NCT00091806|ABX-EGF, panitumumab|abx-egf, panitumumab
5804128|NCT00091806|EGFr|egfr
5804129|NCT00091806|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5804130|NCT00091806|Monoclonal Antibody|monoclonal antibody
5804131|NCT00091793|Osteoporosis|osteoporosis
5804132|NCT00091793|Postmenopausal|postmenopausal
5804133|NCT00091897|RITUXAN|rituxan
5804134|NCT00091897|GABA|gaba
5804135|NCT00091897|B Cells|b cells
5804136|NCT00091897|Humanized Monoclonal Antibodies|humanized monoclonal antibodies
5804137|NCT00091897|GAD|gad
5804138|NCT00091897|Stiff Person Syndrome|stiff person syndrome
5804139|NCT00091897|SPS|sps
5804140|NCT00091884|HIV|hiv
5804141|NCT00091884|Immune Recovery|immune recovery
5804142|NCT00091884|Reactivation|reactivation
5800994|NCT00104169|EPO|epo
5804143|NCT00091884|Anti-Viral Medication|anti-viral medication
5804144|NCT00091884|HAART|haart
5804145|NCT00091884|CMV Retinitis|cmv retinitis
5804146|NCT00091884|Retinal Disease|retinal disease
5804154|NCT00091741|Treatment Experienced|treatment experienced
5804155|NCT00091741|Complementary Therapies|complementary therapies
5804156|NCT00091728|epidemiology|epidemiology
5804157|NCT00091728|relative risk|relative risk
5804158|NCT00091728|cervical ectopy|cervical ectopy
5804159|NCT00091728|hormonal contraceptives|hormonal contraceptives
5804160|NCT00091728|sexually transmitted infections|sexually transmitted infections
5804161|NCT00091715|Pulmonary arterial hypertension|pulmonary arterial hypertension
5804162|NCT00091715|PAH|pah
5804163|NCT00091715|PPH|pph
5804164|NCT00091715|bosentan|bosentan
5804165|NCT00091715|early|early
5804166|NCT00091702|FluMist|flumist
5804167|NCT00091702|Influenza Vaccine|influenza vaccine
5804168|NCT00091702|Adolescent|adolescent
5804169|NCT00091702|Treatment Experienced|treatment experienced
5804170|NCT00091689|Advanced Metastatic Melanoma|advanced metastatic melanoma
5804171|NCT00091676|follicular|follicular
5804172|NCT00091676|lymphoma|lymphoma
5804173|NCT00091676|Non-Hodgkins|non-hodgkins
5804174|NCT00091676|idiotype|idiotype
5804176|NCT00091676|indolent follicular Non-Hodgkins Lymphoma|indolent follicular non-hodgkins lymphoma
5804177|NCT00091676|tumor-derived|tumor-derived
5804178|NCT00091676|B-cell|b-cell
5804179|NCT00091676|cancer|cancer
5807017|NCT00088686|Acute Pain|acute pain
5804180|NCT00091663|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5804181|NCT00004905|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804182|NCT00004905|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5816659|NCT00009841|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5816660|NCT00009841|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5816661|NCT00009841|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5816662|NCT00009841|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5816663|NCT00009841|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5816664|NCT00009841|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5816665|NCT00009841|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5816699|NCT00006487|limited stage small cell lung cancer|limited stage small cell lung cancer
5816700|NCT00006458|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5816701|NCT00006458|squamous cell lung cancer|squamous cell lung cancer
5816702|NCT00006458|large cell lung cancer|large cell lung cancer
5816703|NCT00006458|adenocarcinoma of the lung|adenocarcinoma of the lung
5816704|NCT00006458|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5816705|NCT00006376|stage II bladder cancer|stage ii bladder cancer
5816706|NCT00006376|stage III bladder cancer|stage iii bladder cancer
5816707|NCT00006376|recurrent bladder cancer|recurrent bladder cancer
5816708|NCT00006376|stage IV bladder cancer|stage iv bladder cancer
5816709|NCT00006376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5816710|NCT00006376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5816711|NCT00006376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5816712|NCT00006376|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5816713|NCT00006371|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5816714|NCT00006371|stage IV prostate cancer|stage iv prostate cancer
5816715|NCT00006371|recurrent prostate cancer|recurrent prostate cancer
5816716|NCT00006370|stage IV breast cancer|stage iv breast cancer
5816717|NCT00006370|recurrent breast cancer|recurrent breast cancer
5816718|NCT00006370|recurrent small cell lung cancer|recurrent small cell lung cancer
5816719|NCT00006370|male breast cancer|male breast cancer
5816720|NCT00006369|stage IV breast cancer|stage iv breast cancer
5816721|NCT00006369|recurrent breast cancer|recurrent breast cancer
5816722|NCT00006368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804183|NCT00004905|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5804184|NCT00004905|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5804185|NCT00004905|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5804186|NCT00004905|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5804187|NCT00004209|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5804188|NCT00004209|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5804189|NCT00004195|stage I colon cancer|stage i colon cancer
5804190|NCT00004195|stage II colon cancer|stage ii colon cancer
5804191|NCT00004195|stage III colon cancer|stage iii colon cancer
5804192|NCT00004195|stage IV colon cancer|stage iv colon cancer
5804193|NCT00004195|stage I rectal cancer|stage i rectal cancer
5804194|NCT00004195|stage II rectal cancer|stage ii rectal cancer
5804195|NCT00004195|stage III rectal cancer|stage iii rectal cancer
5804196|NCT00004195|stage IV rectal cancer|stage iv rectal cancer
5804197|NCT00004195|recurrent colon cancer|recurrent colon cancer
5804198|NCT00004195|recurrent rectal cancer|recurrent rectal cancer
5804199|NCT00004194|graft versus host disease|graft versus host disease
5804200|NCT00004184|stage III melanoma|stage iii melanoma
5804201|NCT00004184|stage IV melanoma|stage iv melanoma
5804202|NCT00004184|recurrent melanoma|recurrent melanoma
5804203|NCT00004172|stage IV breast cancer|stage iv breast cancer
5804204|NCT00004172|stage IIIA breast cancer|stage iiia breast cancer
5804205|NCT00004172|recurrent breast cancer|recurrent breast cancer
5804206|NCT00004172|stage IIIB breast cancer|stage iiib breast cancer
5804210|NCT00091624|Lenalidomide|lenalidomide
5804211|NCT00091624|Multiple myeloma|multiple myeloma
5804212|NCT00091598|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5804213|NCT00091572|Metastatic Melanoma|metastatic melanoma
5804214|NCT00091559|CTCL|ctcl
5804215|NCT00004089|anaplastic thyroid cancer|anaplastic thyroid cancer
5804216|NCT00004083|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5804217|NCT00004083|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5804218|NCT00004014|recurrent prostate cancer|recurrent prostate cancer
5804219|NCT00003956|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804220|NCT00003956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804221|NCT00003956|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804222|NCT00003956|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804223|NCT00003956|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804224|NCT00003956|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804225|NCT00003956|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804226|NCT00003956|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5804227|NCT00003956|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804228|NCT00003956|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804229|NCT00003956|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804230|NCT00003956|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804231|NCT00003956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804232|NCT00003956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804233|NCT00003956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804234|NCT00003956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804235|NCT00003956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804236|NCT00003956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804237|NCT00003956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804238|NCT00003956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804239|NCT00003956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804240|NCT00003956|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804241|NCT00003956|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804242|NCT00003956|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5804243|NCT00003956|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5804244|NCT00003956|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5804245|NCT00003956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804246|NCT00003956|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804247|NCT00003956|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804248|NCT00003956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5804249|NCT00003956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804250|NCT00003956|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5804251|NCT00003956|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5804252|NCT00003956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804253|NCT00003956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804254|NCT00003956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804255|NCT00003858|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5804256|NCT00003858|stage I prostate cancer|stage i prostate cancer
5804257|NCT00003858|stage IIB prostate cancer|stage iib prostate cancer
5804258|NCT00003858|stage IIA prostate cancer|stage iia prostate cancer
5804259|NCT00003858|stage III prostate cancer|stage iii prostate cancer
5804260|NCT00003858|stage IV prostate cancer|stage iv prostate cancer
5804261|NCT00003842|recurrent adult brain tumor|recurrent adult brain tumor
5804262|NCT00003842|adult glioblastoma|adult glioblastoma
5804263|NCT00003842|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5804264|NCT00003842|adult giant cell glioblastoma|adult giant cell glioblastoma
5804265|NCT00003842|adult gliosarcoma|adult gliosarcoma
5804266|NCT00003780|stage II pancreatic cancer|stage ii pancreatic cancer
5804267|NCT00003780|stage III pancreatic cancer|stage iii pancreatic cancer
5804268|NCT00003780|stage IV pancreatic cancer|stage iv pancreatic cancer
5804269|NCT00003775|recurrent adult brain tumor|recurrent adult brain tumor
5804270|NCT00003775|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5804271|NCT00003775|adult mixed glioma|adult mixed glioma
5804272|NCT00003714|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5804273|NCT00003714|advanced adult primary liver cancer|advanced adult primary liver cancer
5804274|NCT00003714|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5804275|NCT00003714|liver metastases|liver metastases
5804276|NCT00003711|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804277|NCT00091611|Clinical Response|clinical response
5804278|NCT00091611|Intravenous|intravenous
5804279|NCT00091611|Intra-Arterial|intra-arterial
5804280|NCT00091611|Lymphodepletion|lymphodepletion
5804281|NCT00091611|Traffic of Cells|traffic of cells
5804282|NCT00091611|T-Cell Transfer|t-cell transfer
5804283|NCT00091611|Renal Cell Carcinoma|renal cell carcinoma
5804284|NCT00091611|Metastatic Renal Cell Cancer|metastatic renal cell cancer
5804285|NCT00091507|Acute Coronary Syndrome|acute coronary syndrome
5804286|NCT00091481|Stage V Chronic Kidney Disease|stage v chronic kidney disease
5804287|NCT00091442|Breast Cancer|breast cancer
5804288|NCT00091442|Advanced breast cancer|advanced breast cancer
5804289|NCT00091442|Breast Tumors|breast tumors
5804290|NCT00091442|Cancer of Breast|cancer of breast
5804291|NCT00091442|Human Mammary Carcinoma|human mammary carcinoma
5804292|NCT00091442|Mammary Neoplasms, Human|mammary neoplasms, human
5804294|NCT00091442|Docetaxel|docetaxel
5804295|NCT00004057|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804296|NCT00004057|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804297|NCT00004057|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804298|NCT00004057|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804299|NCT00004057|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804300|NCT00004057|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804301|NCT00004057|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804302|NCT00004057|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804303|NCT00004057|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804304|NCT00004057|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804305|NCT00004057|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804306|NCT00004057|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804307|NCT00004057|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804308|NCT00004057|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804309|NCT00004057|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804310|NCT00004057|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5804311|NCT00004057|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804312|NCT00004057|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804313|NCT00004057|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804314|NCT00004057|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804315|NCT00004036|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5804316|NCT00004036|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804317|NCT00004036|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5804318|NCT00004036|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804319|NCT00004036|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5808686|NCT00087529|Rituxan|rituxan
5804320|NCT00004036|extramedullary plasmacytoma|extramedullary plasmacytoma
5804321|NCT00004036|refractory multiple myeloma|refractory multiple myeloma
5804322|NCT00004036|Waldenström macroglobulinemia|waldenström macroglobulinemia
5804323|NCT00004036|stage III multiple myeloma|stage iii multiple myeloma
5804324|NCT00004036|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5804325|NCT00004036|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5804326|NCT00004036|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804327|NCT00004036|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5804328|NCT00004036|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5804329|NCT00004036|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5804330|NCT00004036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804331|NCT00004036|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5804332|NCT00004036|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5804333|NCT00004036|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5803697|NCT00094068|MRI|mri
5804334|NCT00004036|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5804335|NCT00004036|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5804336|NCT00004036|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5804337|NCT00004036|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5804338|NCT00004036|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5799789|NCT00108394|Uremia|uremia
5804340|NCT00004036|primary myelofibrosis|primary myelofibrosis
5804341|NCT00004036|essential thrombocythemia|essential thrombocythemia
5804342|NCT00004036|untreated hairy cell leukemia|untreated hairy cell leukemia
5804343|NCT00004036|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5804344|NCT00004036|refractory hairy cell leukemia|refractory hairy cell leukemia
5804345|NCT00004036|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5804346|NCT00004036|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5804347|NCT00004036|acute undifferentiated leukemia|acute undifferentiated leukemia
5804348|NCT00004036|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5804349|NCT00004036|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5804350|NCT00004036|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5804351|NCT00004036|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5804352|NCT00004036|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5804353|NCT00004036|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5804354|NCT00004036|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5804355|NCT00004036|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5804356|NCT00004036|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5804357|NCT00004036|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804358|NCT00004036|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804359|NCT00004036|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804360|NCT00004036|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804361|NCT00004036|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5804362|NCT00004036|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804363|NCT00004036|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804364|NCT00004036|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804365|NCT00004036|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804366|NCT00004036|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804367|NCT00004036|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804368|NCT00004036|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804369|NCT00004036|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804370|NCT00004036|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804371|NCT00004036|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804372|NCT00004036|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804373|NCT00004036|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804374|NCT00004036|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804375|NCT00004036|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5804376|NCT00004036|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804377|NCT00004036|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804378|NCT00004036|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5804379|NCT00004036|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5804380|NCT00004036|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5804381|NCT00004036|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5804382|NCT00004036|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5804383|NCT00004036|prolymphocytic leukemia|prolymphocytic leukemia
5804384|NCT00004036|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5814798|NCT00081835|Cornea|cornea
5804385|NCT00004036|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5804386|NCT00004036|primary systemic amyloidosis|primary systemic amyloidosis
5804387|NCT00004036|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5804388|NCT00004036|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5804389|NCT00004036|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804390|NCT00004036|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804391|NCT00004036|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804392|NCT00004036|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805100|NCT00002730|recurrent neuroblastoma|recurrent neuroblastoma
5804393|NCT00004036|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804394|NCT00004036|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5804395|NCT00004036|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5846872|NCT00042536|Opiate Receptor|opiate receptor
5804396|NCT00004036|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5803774|NCT00093678|recurrent melanoma|recurrent melanoma
5804397|NCT00004036|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5804398|NCT00004036|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804399|NCT00004036|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804400|NCT00004036|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804401|NCT00004022|stage III melanoma|stage iii melanoma
5804402|NCT00004022|stage IV melanoma|stage iv melanoma
5804403|NCT00004022|recurrent melanoma|recurrent melanoma
5804404|NCT00003673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804405|NCT00003671|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5804406|NCT00003671|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5804407|NCT00003666|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5804408|NCT00003666|squamous cell lung cancer|squamous cell lung cancer
5804409|NCT00003666|large cell lung cancer|large cell lung cancer
5804410|NCT00003666|adenocarcinoma of the lung|adenocarcinoma of the lung
5804411|NCT00003666|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5804412|NCT00003634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5804413|NCT00003634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5804414|NCT00003634|fallopian tube cancer|fallopian tube cancer
5804415|NCT00003634|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5804416|NCT00003625|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5804417|NCT00003599|non-small cell lung cancer|non-small cell lung cancer
5804418|NCT00003599|small cell lung cancer|small cell lung cancer
5804419|NCT00003591|stage I pancreatic cancer|stage i pancreatic cancer
5804420|NCT00003591|stage II pancreatic cancer|stage ii pancreatic cancer
5804421|NCT00003591|stage III pancreatic cancer|stage iii pancreatic cancer
5804422|NCT00003591|recurrent pancreatic cancer|recurrent pancreatic cancer
5804423|NCT00003591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5804424|NCT00003587|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5804425|NCT00003587|squamous cell lung cancer|squamous cell lung cancer
5804426|NCT00003587|large cell lung cancer|large cell lung cancer
5804427|NCT00003587|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5804428|NCT00003587|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5804429|NCT00003587|adenocarcinoma of the lung|adenocarcinoma of the lung
5804430|NCT00003564|recurrent adult brain tumor|recurrent adult brain tumor
5804431|NCT00003564|adult glioblastoma|adult glioblastoma
5804432|NCT00003564|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5804433|NCT00003564|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5804434|NCT00003564|adult mixed glioma|adult mixed glioma
5804435|NCT00003564|adult giant cell glioblastoma|adult giant cell glioblastoma
5804436|NCT00003564|adult gliosarcoma|adult gliosarcoma
5804437|NCT00003551|stage III renal cell cancer|stage iii renal cell cancer
5804438|NCT00003551|stage IV renal cell cancer|stage iv renal cell cancer
5804439|NCT00003551|recurrent renal cell cancer|recurrent renal cell cancer
5804440|NCT00003546|stage I pancreatic cancer|stage i pancreatic cancer
5804441|NCT00003546|stage II pancreatic cancer|stage ii pancreatic cancer
5804442|NCT00003546|stage III pancreatic cancer|stage iii pancreatic cancer
5804443|NCT00003546|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5804444|NCT00003451|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5804445|NCT00003451|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804446|NCT00003451|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5804447|NCT00003451|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804448|NCT00003451|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5804449|NCT00003451|extramedullary plasmacytoma|extramedullary plasmacytoma
5804450|NCT00003451|refractory multiple myeloma|refractory multiple myeloma
5804451|NCT00003451|Waldenström macroglobulinemia|waldenström macroglobulinemia
5804452|NCT00003451|stage III multiple myeloma|stage iii multiple myeloma
5804453|NCT00003451|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5804454|NCT00003451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804455|NCT00003451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5804456|NCT00003451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5804457|NCT00003451|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5804458|NCT00003451|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804459|NCT00003451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5804460|NCT00003451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5804461|NCT00003451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5804462|NCT00003451|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5804463|NCT00003451|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5804464|NCT00003451|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5804465|NCT00003451|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5804466|NCT00003451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5804467|NCT00003451|polycythemia vera|polycythemia vera
5804468|NCT00003451|primary myelofibrosis|primary myelofibrosis
5804469|NCT00003451|essential thrombocythemia|essential thrombocythemia
5804470|NCT00003451|untreated hairy cell leukemia|untreated hairy cell leukemia
5804471|NCT00003451|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5804472|NCT00003451|refractory hairy cell leukemia|refractory hairy cell leukemia
5804474|NCT00003451|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5804475|NCT00003451|acute undifferentiated leukemia|acute undifferentiated leukemia
5804476|NCT00003451|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5804477|NCT00003451|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5804478|NCT00003451|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5804479|NCT00003451|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5804480|NCT00003451|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5804481|NCT00003451|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5804482|NCT00003451|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5804483|NCT00003451|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5804484|NCT00003451|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5804485|NCT00003451|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804486|NCT00003451|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804487|NCT00003451|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804488|NCT00003451|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804489|NCT00003451|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5804490|NCT00003451|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804491|NCT00003451|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804492|NCT00003451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804493|NCT00003451|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804494|NCT00003451|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804495|NCT00003451|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804496|NCT00003451|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804497|NCT00003451|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804498|NCT00003451|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804499|NCT00003451|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804500|NCT00003451|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804501|NCT00003451|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804502|NCT00003451|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804503|NCT00003451|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5804504|NCT00003451|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804505|NCT00003451|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804506|NCT00003451|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5804507|NCT00003451|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5804508|NCT00003451|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5804509|NCT00003451|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5681258|NCT00574119|magnetic resonance imaging|magnetic resonance imaging
5681259|NCT00574119|myocardial energetics|myocardial energetics
5681260|NCT00574119|myocardial perfusion|myocardial perfusion
5681261|NCT00574106|Cancer|cancer
5681262|NCT00574106|Tumors|tumors
5804510|NCT00003451|prolymphocytic leukemia|prolymphocytic leukemia
5804511|NCT00003451|primary systemic amyloidosis|primary systemic amyloidosis
5804512|NCT00003451|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5804513|NCT00003451|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5804514|NCT00003451|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804515|NCT00003451|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804516|NCT00003451|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804517|NCT00003451|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5804518|NCT00003451|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804519|NCT00003451|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5804520|NCT00003451|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5804521|NCT00003451|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5804522|NCT00003451|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5804595|NCT00003331|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5804523|NCT00003451|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804524|NCT00003451|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804525|NCT00003451|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804526|NCT00003451|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5804527|NCT00003441|stage IV colon cancer|stage iv colon cancer
5804528|NCT00003441|stage IV rectal cancer|stage iv rectal cancer
5804529|NCT00003441|recurrent colon cancer|recurrent colon cancer
5804530|NCT00003441|recurrent rectal cancer|recurrent rectal cancer
5824021|NCT00069914|Flu|flu
5803905|NCT00093444|liver metastases|liver metastases
5804531|NCT00003441|adenocarcinoma of the colon|adenocarcinoma of the colon
5804532|NCT00003441|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5804533|NCT00003441|6-hydroxymethylacylfulvene|6-hydroxymethylacylfulvene
5804535|NCT00003441|Irofulven|irofulven
5804536|NCT00003430|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5804537|NCT00003430|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804538|NCT00003430|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5804539|NCT00003430|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5804540|NCT00003430|recurrent laryngeal cancer|recurrent laryngeal cancer
5804541|NCT00003430|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5804542|NCT00003430|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5804543|NCT00003428|stage IV breast cancer|stage iv breast cancer
5804544|NCT00003428|recurrent breast cancer|recurrent breast cancer
5804545|NCT00003353|primary systemic amyloidosis|primary systemic amyloidosis
5804546|NCT00003344|stage II colon cancer|stage ii colon cancer
5804547|NCT00003344|stage III colon cancer|stage iii colon cancer
5804548|NCT00003344|stage II rectal cancer|stage ii rectal cancer
5804549|NCT00003344|stage III rectal cancer|stage iii rectal cancer
5804550|NCT00003344|recurrent colon cancer|recurrent colon cancer
5804551|NCT00003344|recurrent rectal cancer|recurrent rectal cancer
5804552|NCT00003339|recurrent intraocular melanoma|recurrent intraocular melanoma
5804553|NCT00003339|stage III melanoma|stage iii melanoma
5804554|NCT00003339|stage IV melanoma|stage iv melanoma
5804555|NCT00003339|recurrent melanoma|recurrent melanoma
5804556|NCT00003331|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5804557|NCT00003331|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804558|NCT00003331|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5804559|NCT00003331|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804560|NCT00003331|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5804561|NCT00003331|extramedullary plasmacytoma|extramedullary plasmacytoma
5804562|NCT00003331|refractory multiple myeloma|refractory multiple myeloma
5804563|NCT00003331|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5804564|NCT00003331|stage III multiple myeloma|stage iii multiple myeloma
5804565|NCT00003331|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5804566|NCT00003331|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804567|NCT00003331|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5804568|NCT00003331|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5804569|NCT00003331|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5804570|NCT00003331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804571|NCT00003331|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5804572|NCT00003331|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5804573|NCT00003331|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5804574|NCT00003331|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5681263|NCT00574093|combination therapy|combination therapy
5681264|NCT00574093|Lucentis|lucentis
5681265|NCT00574093|Visudyne|visudyne
5681266|NCT00574054|Familial Dementia|familial dementia
5681267|NCT00574054|Semantic Dementia|semantic dementia
5804575|NCT00003331|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5804576|NCT00003331|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5804577|NCT00003331|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5804578|NCT00003331|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5804579|NCT00003331|polycythemia vera|polycythemia vera
5804580|NCT00003331|primary myelofibrosis|primary myelofibrosis
5804581|NCT00003331|essential thrombocythemia|essential thrombocythemia
5804582|NCT00003331|untreated hairy cell leukemia|untreated hairy cell leukemia
5804583|NCT00003331|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5804584|NCT00003331|refractory hairy cell leukemia|refractory hairy cell leukemia
5804585|NCT00003331|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5804586|NCT00003331|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5804587|NCT00003331|acute undifferentiated leukemia|acute undifferentiated leukemia
5804588|NCT00003331|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5804589|NCT00003331|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5804590|NCT00003331|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5804591|NCT00003331|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5804592|NCT00003331|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5804593|NCT00003331|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5804594|NCT00003331|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5804596|NCT00003331|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5804597|NCT00003331|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804598|NCT00003331|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804599|NCT00003331|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804600|NCT00003331|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804601|NCT00003331|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5805516|NCT00003260|recurrent rectal cancer|recurrent rectal cancer
5804602|NCT00003331|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804603|NCT00003331|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804604|NCT00003331|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804605|NCT00003331|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804606|NCT00003331|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804607|NCT00003331|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804608|NCT00003331|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804609|NCT00003331|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804610|NCT00003331|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804611|NCT00003331|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804612|NCT00003331|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804613|NCT00003331|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804614|NCT00003331|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804615|NCT00003331|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5804616|NCT00003331|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804617|NCT00003331|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804618|NCT00003331|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5804619|NCT00003331|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5804620|NCT00003331|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5804621|NCT00003331|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5804622|NCT00003331|prolymphocytic leukemia|prolymphocytic leukemia
5804623|NCT00003331|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5804624|NCT00003331|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5804625|NCT00003331|primary systemic amyloidosis|primary systemic amyloidosis
5804626|NCT00003331|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5804627|NCT00003331|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5804628|NCT00003331|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804629|NCT00003331|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804630|NCT00003331|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804631|NCT00003331|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5804632|NCT00003331|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804633|NCT00003331|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5804634|NCT00003331|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5804635|NCT00003331|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5804636|NCT00003331|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5804637|NCT00003331|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804638|NCT00003331|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804639|NCT00003331|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804640|NCT00003288|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5804641|NCT00003263|localized malignant mesothelioma|localized malignant mesothelioma
5804643|NCT00091533|Mirror Neuron System|mirror neuron system
5804645|NCT00091533|Somatosensory Cortex|somatosensory cortex
5804646|NCT00091533|Rehabilitation|rehabilitation
5804647|NCT00091533|Healthy Volunteer|healthy volunteer
5804648|NCT00091533|HV|hv
5804649|NCT00091429|Angina|angina
5804650|NCT00091429|Chest Pain|chest pain
5804651|NCT00091429|Coronary Artery Disease|coronary artery disease
5804652|NCT00091429|Heart Disease|heart disease
5804653|NCT00003257|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5804654|NCT00003257|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5804655|NCT00003257|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5804656|NCT00003257|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5804657|NCT00003257|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5804658|NCT00003257|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5804659|NCT00003257|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5804660|NCT00003252|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804661|NCT00003252|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5804817|NCT00090727|pancreatic cancer|pancreatic cancer
5804662|NCT00003248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5804663|NCT00003248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5804097|NCT00091988|Weight Loss|weight loss
5804098|NCT00091988|Obesity|obesity
5804099|NCT00091988|Motivation|motivation
5804100|NCT00091975|Chronic Kidney Disease|chronic kidney disease
5804101|NCT00091949|stroke|stroke
5804102|NCT00091949|heart attack|heart attack
5804664|NCT00003248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5804665|NCT00003248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5804666|NCT00003248|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5804667|NCT00003241|recurrent childhood brain tumor|recurrent childhood brain tumor
5804668|NCT00003241|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5804669|NCT00003241|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5804670|NCT00003241|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5804671|NCT00003241|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5804672|NCT00003241|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5804673|NCT00003241|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5804674|NCT00003241|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5804675|NCT00003241|recurrent childhood ependymoma|recurrent childhood ependymoma
5804676|NCT00003223|lip and oral cavity cancer|lip and oral cavity cancer
5804677|NCT00091416|HIV Seronegativity|hiv seronegativity
5804678|NCT00091416|HIV Preventive Vaccine|hiv preventive vaccine
5804679|NCT00091390|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5804680|NCT00091390|stage IIB prostate cancer|stage iib prostate cancer
5804681|NCT00091390|stage IIA prostate cancer|stage iia prostate cancer
5804682|NCT00091390|stage III prostate cancer|stage iii prostate cancer
5804683|NCT00091377|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5804684|NCT00091377|fallopian tube cancer|fallopian tube cancer
5804685|NCT00091377|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5804686|NCT00091351|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5804687|NCT00091351|adult angiosarcoma|adult angiosarcoma
5804688|NCT00091351|adult epithelioid sarcoma|adult epithelioid sarcoma
5804689|NCT00091351|adult fibrosarcoma|adult fibrosarcoma
5804690|NCT00091351|adult leiomyosarcoma|adult leiomyosarcoma
5804691|NCT00091351|adult liposarcoma|adult liposarcoma
5804692|NCT00091351|adult neurofibrosarcoma|adult neurofibrosarcoma
5804693|NCT00091351|adult synovial sarcoma|adult synovial sarcoma
5804694|NCT00091351|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5804695|NCT00091351|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5804696|NCT00091351|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5804697|NCT00091351|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5804698|NCT00091338|recurrent melanoma|recurrent melanoma
5804699|NCT00091338|stage IV melanoma|stage iv melanoma
5804700|NCT00091325|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804701|NCT00091312|stage II colon cancer|stage ii colon cancer
5804702|NCT00091312|adenocarcinoma of the colon|adenocarcinoma of the colon
5804703|NCT00091299|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804704|NCT00091286|recurrent colon cancer|recurrent colon cancer
5804705|NCT00091286|stage IIB colon cancer|stage iib colon cancer
5804706|NCT00091286|stage IIIA colon cancer|stage iiia colon cancer
5804707|NCT00091286|stage IIIB colon cancer|stage iiib colon cancer
5804708|NCT00091286|stage IIIC colon cancer|stage iiic colon cancer
5804709|NCT00091286|stage IVA colon cancer|stage iva colon cancer
5804710|NCT00091286|stage IVB colon cancer|stage ivb colon cancer
5804711|NCT00091286|recurrent rectal cancer|recurrent rectal cancer
5804712|NCT00091286|stage IIB rectal cancer|stage iib rectal cancer
5804713|NCT00091286|stage IIIA rectal cancer|stage iiia rectal cancer
5804714|NCT00091286|stage IIIB rectal cancer|stage iiib rectal cancer
5804715|NCT00091286|stage IIIC rectal cancer|stage iiic rectal cancer
5804716|NCT00091286|stage IVA rectal cancer|stage iva rectal cancer
5804717|NCT00091286|stage IVB rectal cancer|stage ivb rectal cancer
5804718|NCT00091273|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5804719|NCT00091273|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5804720|NCT00091273|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5804721|NCT00091273|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5804722|NCT00091273|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5804723|NCT00091260|primary systemic amyloidosis|primary systemic amyloidosis
5804724|NCT00091247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804725|NCT00091234|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5804726|NCT00091234|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5804727|NCT00091234|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5804728|NCT00091234|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5804208|NCT00091624|CC5013|cc5013
5804729|NCT00091234|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5804730|NCT00091234|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5804731|NCT00091234|adult acute basophilic leukemia|adult acute basophilic leukemia
5804732|NCT00091234|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5804733|NCT00091234|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5804734|NCT00091234|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5804735|NCT00091234|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5804736|NCT00091234|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5804737|NCT00091234|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5804738|NCT00091234|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5804739|NCT00091234|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5804740|NCT00091234|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5846873|NCT00042536|Male Impotence|male impotence
5804741|NCT00091234|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5804742|NCT00091169|fatigue|fatigue
5804743|NCT00091169|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804744|NCT00091169|levocarnitine|levocarnitine
5804745|NCT00091169|depression|depression
5804746|NCT00091169|pain|pain
5804747|NCT00091169|carnitine deficiency|carnitine deficiency
5804748|NCT00091156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5804749|NCT00091156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5804750|NCT00091143|recurrent melanoma|recurrent melanoma
5804751|NCT00091143|stage III melanoma|stage iii melanoma
5804752|NCT00091143|stage IV melanoma|stage iv melanoma
5804753|NCT00091104|stage IV melanoma|stage iv melanoma
5804754|NCT00091104|recurrent melanoma|recurrent melanoma
5804755|NCT00091091|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5804756|NCT00091091|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5804757|NCT00091091|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5804758|NCT00091091|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5804759|NCT00091091|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5804760|NCT00091052|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804761|NCT00091039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5804762|NCT00091039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5804763|NCT00090987|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5804764|NCT00090987|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5804765|NCT00090974|stage I breast cancer|stage i breast cancer
5804766|NCT00090974|stage II breast cancer|stage ii breast cancer
5804767|NCT00090974|stage IIIA breast cancer|stage iiia breast cancer
5804768|NCT00090961|pulmonary complications|pulmonary complications
5804769|NCT00090961|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5804770|NCT00090961|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5804771|NCT00090961|squamous cell lung cancer|squamous cell lung cancer
5804772|NCT00090961|large cell lung cancer|large cell lung cancer
5804773|NCT00090961|adenocarcinoma of the lung|adenocarcinoma of the lung
5804774|NCT00090961|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5804775|NCT00090961|limited stage small cell lung cancer|limited stage small cell lung cancer
5804776|NCT00090909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804777|NCT00090896|recurrent melanoma|recurrent melanoma
5804778|NCT00090896|stage III melanoma|stage iii melanoma
5804779|NCT00090896|stage IV melanoma|stage iv melanoma
5804780|NCT00090870|stage IV renal cell cancer|stage iv renal cell cancer
5804781|NCT00090857|breast cancer|breast cancer
5804782|NCT00090857|stage I breast cancer|stage i breast cancer
5804783|NCT00090857|stage II breast cancer|stage ii breast cancer
5804784|NCT00090857|stage IIIA breast cancer|stage iiia breast cancer
5804785|NCT00090857|stage IIIB breast cancer|stage iiib breast cancer
5804786|NCT00090857|stage IIIC breast cancer|stage iiic breast cancer
5804787|NCT00090857|stage IV breast cancer|stage iv breast cancer
5804788|NCT00090857|breast cancer in situ|breast cancer in situ
5804789|NCT00090857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5804790|NCT00090844|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5804791|NCT00090844|hormone changes|hormone changes
5804792|NCT00090844|stage I breast cancer|stage i breast cancer
5804793|NCT00090844|stage II breast cancer|stage ii breast cancer
5804794|NCT00090831|Emotional Learning|emotional learning
5804795|NCT00090831|Neurotransmitter|neurotransmitter
5804796|NCT00090831|Neural Systems|neural systems
5804797|NCT00090831|Response Control|response control
5804798|NCT00090831|Orbitofrontal Cortex|orbitofrontal cortex
5804799|NCT00090831|Amygdala|amygdala
5804800|NCT00090831|Serotonin|serotonin
5804801|NCT00090831|Healthy Volunteer|healthy volunteer
5804802|NCT00090831|HV|hv
5804803|NCT00090818|Dental Abnormalities|dental abnormalities
5804804|NCT00090818|Lichen Planus|lichen planus
5804805|NCT00090818|Oral Mucosal Disease|oral mucosal disease
5804806|NCT00090818|Genetic Disease|genetic disease
5816805|NCT00006031|biopsy|biopsy
5804807|NCT00090818|Amelogensis Imperfecta|amelogensis imperfecta
5804808|NCT00090818|Maxillofacial Abnormalities|maxillofacial abnormalities
5804809|NCT00090818|Craniofacial Abnormalities|craniofacial abnormalities
5804810|NCT00090818|Craniofacial Genetic Abnormalities|craniofacial genetic abnormalities
5804811|NCT00090779|Acute Infection|acute infection
5804812|NCT00090779|Treatment Naive|treatment naive
5804813|NCT00090727|diffuse|diffuse
5804814|NCT00090727|follicular|follicular
5804815|NCT00090727|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5804816|NCT00090727|colorectal cancer|colorectal cancer
5804818|NCT00090727|acute myelogenous leukemia|acute myelogenous leukemia
5800430|NCT00106119|Deiodinase|deiodinase
5804820|NCT00090727|breast cancer|breast cancer
5804821|NCT00090727|prostate cancer|prostate cancer
5804822|NCT00090727|ovarian cancer|ovarian cancer
5804823|NCT00090727|bladder cancer|bladder cancer
5804824|NCT00090727|hypoxia|hypoxia
5804825|NCT00090727|refractory|refractory
5804826|NCT00090727|metastatic|metastatic
5804827|NCT00090714|DNA|dna
5804828|NCT00090714|Circular|circular
5859642|NCT00006175|P.C.R.|p.c.r.
5804829|NCT00090714|Gene Therapy|gene therapy
5804830|NCT00003217|childhood Burkitt lymphoma|childhood burkitt lymphoma
5804831|NCT00003217|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5804832|NCT00003217|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5804833|NCT00003217|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5804834|NCT00003217|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5804835|NCT00003172|stage III gastric cancer|stage iii gastric cancer
5804836|NCT00003172|stage IV gastric cancer|stage iv gastric cancer
5804837|NCT00003172|recurrent gastric cancer|recurrent gastric cancer
5804838|NCT00003139|oral complications|oral complications
5804839|NCT00003139|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5804840|NCT00003139|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5804841|NCT00003134|recurrent adult brain tumor|recurrent adult brain tumor
5804842|NCT00003134|adult brain stem glioma|adult brain stem glioma
5804843|NCT00003134|adult oligodendroglioma|adult oligodendroglioma
5804844|NCT00003134|adult mixed glioma|adult mixed glioma
5804845|NCT00003134|adult diffuse astrocytoma|adult diffuse astrocytoma
5804846|NCT00003100|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804847|NCT00003088|stage II breast cancer|stage ii breast cancer
5804848|NCT00003088|stage IIIA breast cancer|stage iiia breast cancer
5804849|NCT00003072|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5804850|NCT00003072|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5804851|NCT00003072|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5804852|NCT00003072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5804853|NCT00003072|neurotoxicity|neurotoxicity
5804854|NCT00003048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5804855|NCT00003048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5804856|NCT00003048|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5804857|NCT00003048|Amifostine|amifostine
5804858|NCT00003048|Ethyol|ethyol
5804859|NCT00003048|Ethiofos|ethiofos
5804860|NCT00003048|Gammaphos|gammaphos
5804861|NCT00003039|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804862|NCT00003039|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804863|NCT00003039|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5862632|NCT00001560|Multidisciplinary|multidisciplinary
5681268|NCT00574054|Senile Paranoid Dementia|senile paranoid dementia
5681269|NCT00574041|Multiple Sclerosis|multiple sclerosis
5681270|NCT00574041|Avonex|avonex
5681271|NCT00574041|side effects|side effects
5804864|NCT00003039|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804865|NCT00003039|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804866|NCT00003039|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804867|NCT00003039|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804868|NCT00003039|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804869|NCT00090688|diarrhea|diarrhea
5804870|NCT00003005|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5804871|NCT00003005|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5804872|NCT00003005|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5804873|NCT00002993|stage III uterine sarcoma|stage iii uterine sarcoma
5804874|NCT00002993|stage IV uterine sarcoma|stage iv uterine sarcoma
5804875|NCT00002993|recurrent uterine sarcoma|recurrent uterine sarcoma
5804876|NCT00002980|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804877|NCT00002980|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5804878|NCT00002980|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804879|NCT00002980|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5804880|NCT00002980|extramedullary plasmacytoma|extramedullary plasmacytoma
5804881|NCT00002980|refractory multiple myeloma|refractory multiple myeloma
5804882|NCT00002980|Waldenström macroglobulinemia|waldenström macroglobulinemia
5804883|NCT00002980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5804884|NCT00002980|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5804885|NCT00002980|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5804886|NCT00002980|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5804887|NCT00002980|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5804888|NCT00002980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804889|NCT00002980|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5804890|NCT00002980|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5804891|NCT00002980|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5804892|NCT00002980|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5804893|NCT00002980|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5804894|NCT00002980|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5804895|NCT00002980|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5804897|NCT00002980|primary myelofibrosis|primary myelofibrosis
5804898|NCT00002980|essential thrombocythemia|essential thrombocythemia
5804899|NCT00002980|untreated hairy cell leukemia|untreated hairy cell leukemia
5859854|NCT00005934|Thalassemia|thalassemia
5804900|NCT00002980|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5805517|NCT00003260|adenocarcinoma of the colon|adenocarcinoma of the colon
5804901|NCT00002980|refractory hairy cell leukemia|refractory hairy cell leukemia
5804902|NCT00002980|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5804903|NCT00002980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5804904|NCT00002980|acute undifferentiated leukemia|acute undifferentiated leukemia
5804905|NCT00002980|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804906|NCT00002980|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804907|NCT00002980|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804908|NCT00002980|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804909|NCT00002980|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5804910|NCT00002980|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804911|NCT00002980|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804912|NCT00002980|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804913|NCT00002980|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804914|NCT00002980|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804915|NCT00002980|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804916|NCT00002980|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804917|NCT00002980|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804918|NCT00002980|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804919|NCT00002980|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804920|NCT00002980|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804921|NCT00002980|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804922|NCT00002980|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804923|NCT00002980|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804924|NCT00002980|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804925|NCT00002980|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5804926|NCT00002980|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5804927|NCT00002980|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5804928|NCT00002980|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5804930|NCT00002980|primary systemic amyloidosis|primary systemic amyloidosis
5804931|NCT00002980|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5804932|NCT00002980|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5804933|NCT00002980|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5804934|NCT00002980|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5804935|NCT00002980|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5804936|NCT00002980|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5804937|NCT00002980|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5804938|NCT00002980|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5804939|NCT00002980|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5804940|NCT00002980|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5804941|NCT00002980|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5804942|NCT00002967|stage I breast cancer|stage i breast cancer
5804943|NCT00002967|stage II breast cancer|stage ii breast cancer
5804944|NCT00002967|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5804945|NCT00002946|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5804946|NCT00002946|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5804947|NCT00002946|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5804948|NCT00002946|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5804949|NCT00002946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5804950|NCT00002946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5804951|NCT00002946|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5804952|NCT00002946|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5804953|NCT00002946|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5804954|NCT00002946|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5804955|NCT00002946|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5804956|NCT00002946|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5804957|NCT00002946|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5804958|NCT00002946|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5804959|NCT00002946|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5804960|NCT00002946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5804961|NCT00002946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5804962|NCT00002946|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5804963|NCT00002946|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5804964|NCT00002946|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5804965|NCT00002946|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5804966|NCT00002946|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5804967|NCT00002946|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5804968|NCT00002946|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5804969|NCT00002946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5804970|NCT00002946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5804971|NCT00002946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5804972|NCT00002946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5804973|NCT00002946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5804974|NCT00002946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5804975|NCT00002946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5804976|NCT00002946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5804977|NCT00002946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5804978|NCT00002946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5804979|NCT00002946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5804980|NCT00002946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5804981|NCT00002946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5804982|NCT00002946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5804983|NCT00002946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5804984|NCT00002946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5804985|NCT00002946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5804986|NCT00002946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5804987|NCT00002946|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5804988|NCT00002946|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5862633|NCT00001560|Leukemia|leukemia
5804989|NCT00002946|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5804990|NCT00002946|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5804991|NCT00002946|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5804992|NCT00002946|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5804993|NCT00002946|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5804994|NCT00002946|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5804995|NCT00002946|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5804996|NCT00002946|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5804997|NCT00002946|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5804998|NCT00002946|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5804999|NCT00002946|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5805000|NCT00002946|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5805001|NCT00002946|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5805002|NCT00002946|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5805003|NCT00002946|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5805004|NCT00002946|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5805005|NCT00002946|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5805006|NCT00002946|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5805007|NCT00002946|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5859641|NCT00006175|Prostanoids|prostanoids
5805008|NCT00002946|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5805009|NCT00002946|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5805010|NCT00002946|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5805011|NCT00002946|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5805012|NCT00002946|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5805013|NCT00002946|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5805014|NCT00002946|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5805015|NCT00002946|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5805016|NCT00002946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5805017|NCT00002946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805018|NCT00002946|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5805019|NCT00002946|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5805020|NCT00002946|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5805021|NCT00002946|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5805022|NCT00002946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805023|NCT00002946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805024|NCT00002946|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5817592|NCT00080067|HV|hv
5805025|NCT00002946|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5805026|NCT00002946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5807018|NCT00088686|Orofacial|orofacial
5805027|NCT00002946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5805028|NCT00002946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5805029|NCT00002946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5805030|NCT00002946|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5805031|NCT00002946|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5805032|NCT00002946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805033|NCT00002946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805034|NCT00002946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805035|NCT00002942|stage II breast cancer|stage ii breast cancer
5805036|NCT00002942|stage IV breast cancer|stage iv breast cancer
5805037|NCT00002942|stage IIIA breast cancer|stage iiia breast cancer
5805038|NCT00002942|stage IIIB breast cancer|stage iiib breast cancer
5805039|NCT00002937|recurrent breast cancer|recurrent breast cancer
5805040|NCT00002932|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5805041|NCT00002932|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5805042|NCT00002932|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5805043|NCT00002932|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5805044|NCT00002904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805045|NCT00002897|stage II esophageal cancer|stage ii esophageal cancer
5805046|NCT00002897|stage III esophageal cancer|stage iii esophageal cancer
5862634|NCT00001560|Lymphoma|lymphoma
5805053|NCT00002873|stage I breast cancer|stage i breast cancer
5805054|NCT00002873|stage II breast cancer|stage ii breast cancer
5805055|NCT00002873|medullary ductal breast carcinoma with lymphocytic infiltrate|medullary ductal breast carcinoma with lymphocytic infiltrate
5805056|NCT00002873|mucinous ductal breast carcinoma|mucinous ductal breast carcinoma
5805057|NCT00002873|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5805058|NCT00002873|papillary ductal breast carcinoma|papillary ductal breast carcinoma
5805059|NCT00002873|tubular ductal breast carcinoma|tubular ductal breast carcinoma
5805060|NCT00002872|malignant pleural effusion|malignant pleural effusion
5805061|NCT00002811|actinic keratosis|actinic keratosis
5805062|NCT00002805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5805063|NCT00002805|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5805064|NCT00002805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5805065|NCT00002793|stage IV colon cancer|stage iv colon cancer
5805066|NCT00002793|stage IV rectal cancer|stage iv rectal cancer
5805067|NCT00002793|recurrent colon cancer|recurrent colon cancer
5805068|NCT00002793|recurrent rectal cancer|recurrent rectal cancer
5805069|NCT00002793|liver metastases|liver metastases
5805070|NCT00002791|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5805071|NCT00002791|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5805072|NCT00002791|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5805073|NCT00002790|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5805074|NCT00002790|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5805075|NCT00002790|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5805076|NCT00002790|adult acute myeloid leukemia|adult acute myeloid leukemia
5805077|NCT00002790|chronic myelogenous leukemia|chronic myelogenous leukemia
5686588|NCT00551460|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5686589|NCT00551460|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5686590|NCT00551460|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5805078|NCT00002790|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5805079|NCT00002790|myelodysplastic syndromes|myelodysplastic syndromes
5805080|NCT00002790|graft versus host disease|graft versus host disease
5805081|NCT00002790|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5805082|NCT00002781|stage III melanoma|stage iii melanoma
5805083|NCT00002781|recurrent melanoma|recurrent melanoma
5805084|NCT00002775|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805085|NCT00002775|stage IV prostate cancer|stage iv prostate cancer
5805086|NCT00002775|recurrent prostate cancer|recurrent prostate cancer
5805088|NCT00002767|recurrent melanoma|recurrent melanoma
5805089|NCT00090623|Subfoveal neovascular|subfoveal neovascular
5805090|NCT00090623|Age-related macular degeneration|age-related macular degeneration
5805092|NCT00090623|Wet AMD|wet amd
5805093|NCT00002744|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5805094|NCT00002744|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5805095|NCT00002744|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5805096|NCT00002735|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5805097|NCT00002735|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5805098|NCT00002735|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5805099|NCT00002735|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5805101|NCT00002703|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805102|NCT00002703|stage I prostate cancer|stage i prostate cancer
5805103|NCT00002703|stage IIB prostate cancer|stage iib prostate cancer
5805104|NCT00002703|stage IIA prostate cancer|stage iia prostate cancer
5805105|NCT00090610|Relapsed ovarian cancer|relapsed ovarian cancer
5805106|NCT00090584|Urge urinary incontinence (UUI)|urge urinary incontinence (uui)
5805107|NCT00090584|Drug/Behavior treatment|drug/behavior treatment
5805108|NCT00090493|Myeloma|myeloma
5805109|NCT00090493|Mage-A3|mage-a3
5805110|NCT00090493|Transplant|transplant
5805111|NCT00090493|Peptide|peptide
5805112|NCT00090493|DTPACE|dtpace
5805113|NCT00090493|vaccines|vaccines
5805114|NCT00090493|Immunotherapy|immunotherapy
5805115|NCT00090493|NY-ESO-1|ny-eso-1
5805116|NCT00090480|Cancer|cancer
5805117|NCT00002659|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5805118|NCT00002659|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5805119|NCT00002659|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5805120|NCT00002659|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5805121|NCT00002659|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5805122|NCT00002659|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5805123|NCT00002631|stage I esophageal cancer|stage i esophageal cancer
5805125|NCT00002631|stage III esophageal cancer|stage iii esophageal cancer
5805126|NCT00002631|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5805127|NCT00002631|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5805128|NCT00002628|stage IV breast cancer|stage iv breast cancer
5805129|NCT00002628|recurrent breast cancer|recurrent breast cancer
5805130|NCT00002622|malignant pleural effusion|malignant pleural effusion
5805131|NCT00002616|stage IV breast cancer|stage iv breast cancer
5805132|NCT00002616|recurrent breast cancer|recurrent breast cancer
5805133|NCT00002616|stage IIIB breast cancer|stage iiib breast cancer
5805134|NCT00002616|inflammatory breast cancer|inflammatory breast cancer
5805135|NCT00002593|stage II colon cancer|stage ii colon cancer
5805136|NCT00002593|stage III colon cancer|stage iii colon cancer
5805137|NCT00002570|stage III colon cancer|stage iii colon cancer
5805138|NCT00002570|stage IV colon cancer|stage iv colon cancer
5805139|NCT00002570|stage III rectal cancer|stage iii rectal cancer
5805140|NCT00002570|stage IV rectal cancer|stage iv rectal cancer
5805141|NCT00002570|recurrent colon cancer|recurrent colon cancer
5805142|NCT00002570|recurrent rectal cancer|recurrent rectal cancer
5805143|NCT00002554|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805144|NCT00002554|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5805145|NCT00002527|colon cancer|colon cancer
5805146|NCT00002527|rectal cancer|rectal cancer
5805147|NCT00002509|stage II breast cancer|stage ii breast cancer
5805148|NCT00002509|stage IV breast cancer|stage iv breast cancer
5805149|NCT00002509|stage IIIA breast cancer|stage iiia breast cancer
5805150|NCT00002509|recurrent breast cancer|recurrent breast cancer
5805151|NCT00002509|stage IIIB breast cancer|stage iiib breast cancer
5686592|NCT00551395|laser|laser
5686593|NCT00551395|trabeculoplasty|trabeculoplasty
5686594|NCT00551382|Montelukast|montelukast
5686595|NCT00551382|Upper respiratory tract infection|upper respiratory tract infection
5686596|NCT00551382|leukotriene|leukotriene
5686597|NCT00551382|Children|children
5805152|NCT00090571|JRA ASPs|jra asps
5805153|NCT00090571|Genomics|genomics
5805154|NCT00090376|Erectile Dysfunction|erectile dysfunction
5805155|NCT00090376|Impotence|impotence
5805156|NCT00090376|Prostate Cancer|prostate cancer
5805157|NCT00090376|Prostatectomy|prostatectomy
5805158|NCT00090363|rising PSA|rising psa
5805159|NCT00090363|bone metastases|bone metastases
5805160|NCT00090363|Clinical study|clinical study
5805161|NCT00090363|pain-free or mildly symptomatic|pain-free or mildly symptomatic
5805162|NCT00090324|Schizophrenia|schizophrenia
5805163|NCT00090311|Bipolar I Mania|bipolar i mania
5805164|NCT00004915|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5805165|NCT00004201|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5805166|NCT00004201|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5805167|NCT00004201|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5805168|NCT00004090|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805169|NCT00004029|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805171|NCT00004029|recurrent prostate cancer|recurrent prostate cancer
5805172|NCT00002489|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5805173|NCT00002489|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5805174|NCT00002489|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5805175|NCT00002489|ovarian teratoma|ovarian teratoma
5805176|NCT00002489|extragonadal germ cell tumor|extragonadal germ cell tumor
5805177|NCT00002488|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805178|NCT00002488|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5846875|NCT00042536|Healthy Volunteer|healthy volunteer
5805179|NCT00002488|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805180|NCT00002488|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805181|NCT00002488|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805182|NCT00002488|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805183|NCT00002488|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805184|NCT00002487|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5805185|NCT00002471|childhood Burkitt lymphoma|childhood burkitt lymphoma
5805186|NCT00002471|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5805187|NCT00002471|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5805188|NCT00002471|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5805189|NCT00002471|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5805190|NCT00002471|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5805191|NCT00002471|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5805192|NCT00002471|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5805193|NCT00002471|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5805194|NCT00002471|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5805195|NCT00002471|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5805196|NCT00002471|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5805197|NCT00002471|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5805198|NCT00002471|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805199|NCT00002471|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805200|NCT00002471|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5862635|NCT00001560|Kaposi's Sarcoma|kaposi's sarcoma
5805202|NCT00002471|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5805203|NCT00002471|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5805204|NCT00002471|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5805205|NCT00002471|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5805206|NCT00002471|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5805207|NCT00002458|disseminated neuroblastoma|disseminated neuroblastoma
5805208|NCT00002458|recurrent neuroblastoma|recurrent neuroblastoma
5805209|NCT00090558|Atherosclerosis|atherosclerosis
5805210|NCT00090558|Bone Marrow|bone marrow
5805211|NCT00090558|Exercise|exercise
5805212|NCT00090558|Endothelium|endothelium
5805213|NCT00090558|Nitroglycerin|nitroglycerin
5805214|NCT00090558|Coronary Artery Disease|coronary artery disease
5805216|NCT00090545|Hormone-Refractory|hormone-refractory
5805217|NCT00090545|Proteomics|proteomics
5805218|NCT00090545|Angiogenesis|angiogenesis
5805219|NCT00090545|VEGFR|vegfr
5805220|NCT00090545|Prostate Cancer|prostate cancer
5805221|NCT00090545|Metastatic Prostate Cancer|metastatic prostate cancer
5805222|NCT00090506|Yoga|yoga
5805223|NCT00090506|Meditation|meditation
5805225|NCT00090428|Applied Behavioral Analysis|applied behavioral analysis
5805226|NCT00090428|Gluten|gluten
5805227|NCT00090428|Casein|casein
5805228|NCT00090415|Autism|autism
5805229|NCT00090415|Developmental Delay Disorders|developmental delay disorders
5805230|NCT00090285|anogenital warts|anogenital warts
5805231|NCT00090181|Arcoxia|arcoxia
5805232|NCT00004026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805233|NCT00004026|stage IV prostate cancer|stage iv prostate cancer
5805234|NCT00004026|recurrent prostate cancer|recurrent prostate cancer
5805235|NCT00004009|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805236|NCT00004009|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805237|NCT00004009|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5805238|NCT00004009|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5805239|NCT00004009|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5805240|NCT00004009|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5805241|NCT00004009|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5805243|NCT00003989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5805244|NCT00003989|stage III melanoma|stage iii melanoma
5805245|NCT00003989|stage IV melanoma|stage iv melanoma
5805246|NCT00003989|recurrent melanoma|recurrent melanoma
5805247|NCT00003989|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5805248|NCT00003989|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5805249|NCT00003989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5805250|NCT00003962|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5805251|NCT00003962|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5805252|NCT00003962|refractory multiple myeloma|refractory multiple myeloma
5805253|NCT00003962|stage I multiple myeloma|stage i multiple myeloma
5805254|NCT00003962|stage II multiple myeloma|stage ii multiple myeloma
5805255|NCT00003962|stage III multiple myeloma|stage iii multiple myeloma
5805256|NCT00003962|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5805257|NCT00003962|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5805586|NCT00002742|myelodysplastic syndromes|myelodysplastic syndromes
5805258|NCT00003962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805259|NCT00003962|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805260|NCT00003962|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5805261|NCT00003962|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5805262|NCT00003962|acute undifferentiated leukemia|acute undifferentiated leukemia
5805263|NCT00003962|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805264|NCT00003962|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805265|NCT00003962|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805266|NCT00003962|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5805267|NCT00003962|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805268|NCT00003962|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805269|NCT00003962|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805270|NCT00003962|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805271|NCT00003962|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5805272|NCT00003962|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5796764|NCT00117858|FTP|ftp
5805273|NCT00003962|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5805274|NCT00003962|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5805275|NCT00003962|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5805276|NCT00003962|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805277|NCT00003962|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805278|NCT00003962|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805279|NCT00003962|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805280|NCT00003962|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805281|NCT00003962|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805282|NCT00003778|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5805283|NCT00003778|stage IV uterine sarcoma|stage iv uterine sarcoma
5805284|NCT00003778|recurrent uterine sarcoma|recurrent uterine sarcoma
5805286|NCT00003778|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5805287|NCT00090402|Fish Oils|fish oils
5805288|NCT00090402|Thioctic Acid|thioctic acid
5805289|NCT00090402|Antioxidants|antioxidants
5805290|NCT00090402|Dietary Supplements|dietary supplements
5805291|NCT00090389|Acupuncture|acupuncture
5805292|NCT00090389|Medicine, Chinese Traditional|medicine, chinese traditional
5805294|NCT00090337|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5805295|NCT00090337|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5805296|NCT00090337|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5805297|NCT00090337|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5805298|NCT00090337|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5805299|NCT00090337|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5805300|NCT00090337|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5805301|NCT00090337|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5805302|NCT00090337|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5805303|NCT00090337|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5805304|NCT00090337|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5805305|NCT00090337|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5805306|NCT00090337|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5805307|NCT00090337|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5805308|NCT00090337|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5805309|NCT00090337|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5805310|NCT00090337|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5805311|NCT00090337|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5805312|NCT00090337|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5805313|NCT00090337|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5805314|NCT00090337|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5805315|NCT00090337|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5805316|NCT00090337|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5805317|NCT00090337|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5805318|NCT00090337|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5805319|NCT00090337|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5805320|NCT00090337|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5805587|NCT00002742|childhood Hodgkin lymphoma|childhood hodgkin lymphoma
5805321|NCT00090337|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5805322|NCT00090337|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5805323|NCT00090337|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5805324|NCT00090337|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5805325|NCT00090337|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5805326|NCT00090337|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5805327|NCT00090337|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5805328|NCT00090337|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5805329|NCT00090337|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5805330|NCT00090337|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5805331|NCT00090337|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5805332|NCT00090337|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5805333|NCT00090337|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5805334|NCT00090337|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5862636|NCT00001552|Spasmodic Dysphonia|spasmodic dysphonia
5862637|NCT00001552|Pedigree|pedigree
5825611|NCT00066911|HV|hv
5805335|NCT00090337|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5805336|NCT00090337|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5805337|NCT00090337|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5805338|NCT00090337|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5805339|NCT00090337|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5805340|NCT00090337|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5805341|NCT00090337|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5805342|NCT00090337|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5805343|NCT00090337|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5805344|NCT00090337|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5805345|NCT00090337|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5805346|NCT00090337|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5805347|NCT00090337|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5805348|NCT00090337|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5805349|NCT00090337|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5805350|NCT00090337|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5805351|NCT00090337|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5805352|NCT00090337|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5805353|NCT00090337|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5805354|NCT00090337|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5805355|NCT00090337|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5805356|NCT00090337|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5805357|NCT00090337|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5805358|NCT00090337|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5805359|NCT00090337|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5805360|NCT00090337|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5805361|NCT00090337|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5805362|NCT00090337|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5805363|NCT00090337|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5805364|NCT00090337|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5805365|NCT00090337|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5805366|NCT00090337|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5846483|NCT00044291|Locally advanced breast cancer|locally advanced breast cancer
5805367|NCT00090337|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5805368|NCT00090337|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5805369|NCT00090337|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5805370|NCT00090337|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5805371|NCT00090337|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5805372|NCT00090337|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5805373|NCT00090337|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5805374|NCT00090337|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5805375|NCT00090337|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5805376|NCT00090337|recurrent salivary gland cancer|recurrent salivary gland cancer
5805377|NCT00090337|stage I salivary gland cancer|stage i salivary gland cancer
5805378|NCT00090337|stage II salivary gland cancer|stage ii salivary gland cancer
5805379|NCT00090337|stage III salivary gland cancer|stage iii salivary gland cancer
5805380|NCT00090337|stage IV salivary gland cancer|stage iv salivary gland cancer
5805382|NCT00090194|Transplantation, Homologous|transplantation, homologous
5805383|NCT00090194|HLA Antigens|hla antigens
5805384|NCT00090194|Autoantibodies|autoantibodies
5805385|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5805387|NCT00090194|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5805388|NCT00090129|Psoriatic Arthritis|psoriatic arthritis
5805389|NCT00090129|Moderate plaque psoriasis|moderate plaque psoriasis
5805390|NCT00090129|severe plaque psoriasis|severe plaque psoriasis
5805391|NCT00090129|Onercept|onercept
5805393|NCT00090116|Neramexane|neramexane
5805394|NCT00090116|NMDA receptor antagonist|nmda receptor antagonist
5805395|NCT00090116|Memory Loss|memory loss
5805396|NCT00090116|Alzheimer Disease|alzheimer disease
5805397|NCT00090103|Combination Therapy|combination therapy
5805398|NCT00090103|dutasteride|dutasteride
5805400|NCT00090077|GW695634G|gw695634g
5805401|NCT00090077|GW695634X|gw695634x
5805402|NCT00090077|GW678248X|gw678248x
5805403|NCT00090077|pharmacokinetics|pharmacokinetics
5805404|NCT00090077|NNRTI|nnrti
5805405|NCT00090077|HIV|hiv
5805406|NCT00003654|stage I breast cancer|stage i breast cancer
5805407|NCT00003654|stage II breast cancer|stage ii breast cancer
5805408|NCT00003601|melanoma|melanoma
5805409|NCT00003588|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5805410|NCT00003588|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5805411|NCT00003519|stage II breast cancer|stage ii breast cancer
5686598|NCT00551369|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5686599|NCT00551369|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5686600|NCT00551369|adenocarcinoma of the lung|adenocarcinoma of the lung
5805412|NCT00003519|stage IIIA breast cancer|stage iiia breast cancer
5805413|NCT00003519|stage IIIB breast cancer|stage iiib breast cancer
5805414|NCT00003406|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5805415|NCT00003406|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5805416|NCT00003406|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5805417|NCT00003406|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5805418|NCT00003406|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5805419|NCT00003406|extramedullary plasmacytoma|extramedullary plasmacytoma
5805420|NCT00003406|refractory multiple myeloma|refractory multiple myeloma
5805421|NCT00003406|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5805422|NCT00003406|stage III multiple myeloma|stage iii multiple myeloma
5801258|NCT00102947|daptomycin|daptomycin
5805423|NCT00003406|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5805424|NCT00003406|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5805425|NCT00003406|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805426|NCT00003406|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805427|NCT00003406|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5805428|NCT00003406|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5805429|NCT00003406|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805430|NCT00003406|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5805431|NCT00003406|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5805432|NCT00003406|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5805433|NCT00003406|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5805434|NCT00003406|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5805435|NCT00003406|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5805436|NCT00003406|polycythemia vera|polycythemia vera
5805437|NCT00003406|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5805438|NCT00003406|essential thrombocythemia|essential thrombocythemia
5859855|NCT00005934|Hemoglobin|hemoglobin
5805439|NCT00003406|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5805440|NCT00003406|refractory hairy cell leukemia|refractory hairy cell leukemia
5805441|NCT00003406|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5805442|NCT00003406|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5805443|NCT00003406|acute undifferentiated leukemia|acute undifferentiated leukemia
5805444|NCT00003406|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5805445|NCT00003406|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5805446|NCT00003406|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5805447|NCT00003406|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5805448|NCT00003406|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5805449|NCT00003406|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5805450|NCT00003406|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5805451|NCT00003406|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5805452|NCT00003406|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5805453|NCT00003406|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5805454|NCT00003406|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5805455|NCT00003406|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5805456|NCT00003406|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5805457|NCT00003406|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5805458|NCT00003406|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5805459|NCT00003406|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5805460|NCT00003406|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5805461|NCT00003406|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5805462|NCT00003406|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805463|NCT00003406|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805464|NCT00003406|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805465|NCT00003406|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5805466|NCT00003406|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805467|NCT00003406|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805468|NCT00003406|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805469|NCT00003406|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805470|NCT00003406|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805471|NCT00003406|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5805472|NCT00003406|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5805473|NCT00003406|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5805474|NCT00003406|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5805475|NCT00003406|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5805476|NCT00003406|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5805477|NCT00003406|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5805478|NCT00003406|prolymphocytic leukemia|prolymphocytic leukemia
5805479|NCT00003406|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5805480|NCT00003406|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5805481|NCT00003406|primary systemic amyloidosis|primary systemic amyloidosis
5805482|NCT00003406|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5805483|NCT00003406|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5805484|NCT00003406|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5805485|NCT00003406|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805486|NCT00003406|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5805488|NCT00003406|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805489|NCT00003406|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805490|NCT00003406|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5805491|NCT00003406|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5805492|NCT00003406|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5805493|NCT00003406|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5805494|NCT00003406|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805495|NCT00003406|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805496|NCT00003406|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805497|NCT00003406|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5805498|NCT00003390|stage IV renal cell cancer|stage iv renal cell cancer
5805499|NCT00003390|recurrent renal cell cancer|recurrent renal cell cancer
5805500|NCT00003378|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5805501|NCT00003378|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5805502|NCT00003378|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5805503|NCT00003362|stage III melanoma|stage iii melanoma
5805504|NCT00003362|stage IV melanoma|stage iv melanoma
5805505|NCT00003362|recurrent melanoma|recurrent melanoma
5805506|NCT00003315|infection|infection
5805507|NCT00003304|adult oligodendroglioma|adult oligodendroglioma
5805508|NCT00090064|MDMA|mdma
5805509|NCT00090064|Methylenedioxymethamphetamine|methylenedioxymethamphetamine
5805510|NCT00090064|PTSD|ptsd
5805511|NCT00090064|psychotherapy|psychotherapy
5805512|NCT00003279|limited stage small cell lung cancer|limited stage small cell lung cancer
5805513|NCT00003260|stage IV colon cancer|stage iv colon cancer
5805514|NCT00003260|stage IV rectal cancer|stage iv rectal cancer
5805515|NCT00003260|recurrent colon cancer|recurrent colon cancer
5805518|NCT00003260|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5805519|NCT00003237|stage II gastric cancer|stage ii gastric cancer
5805520|NCT00003237|stage III gastric cancer|stage iii gastric cancer
5805521|NCT00003237|stage II esophageal cancer|stage ii esophageal cancer
5805522|NCT00003237|stage III esophageal cancer|stage iii esophageal cancer
5805523|NCT00003237|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5805524|NCT00003237|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5805525|NCT00003229|stage IV melanoma|stage iv melanoma
5805526|NCT00003229|recurrent melanoma|recurrent melanoma
5805527|NCT00003224|stage II melanoma|stage ii melanoma
5805528|NCT00003224|stage III melanoma|stage iii melanoma
5805529|NCT00003224|stage IV melanoma|stage iv melanoma
5805530|NCT00003224|recurrent melanoma|recurrent melanoma
5805531|NCT00003151|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5805532|NCT00003151|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5805533|NCT00003151|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5805534|NCT00003151|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5805535|NCT00003151|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805536|NCT00003147|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5805537|NCT00003147|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5805538|NCT00003136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5805539|NCT00003136|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5805540|NCT00003131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805541|NCT00002969|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5805542|NCT00002969|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5805543|NCT00002969|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5805544|NCT00002960|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5805545|NCT00002960|malignant ascites|malignant ascites
5805546|NCT00002960|fallopian tube cancer|fallopian tube cancer
5825139|NCT00067743|CC-5013|cc-5013
5805547|NCT00002960|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5805548|NCT00002888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5805549|NCT00002888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5805550|NCT00002888|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5805551|NCT00002888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5805552|NCT00002888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5805553|NCT00002888|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5805554|NCT00002888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5805555|NCT00002888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5805556|NCT00002888|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5801466|NCT00102271|Oxypurinol|oxypurinol
5805558|NCT00002888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5805559|NCT00002888|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5805560|NCT00002888|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5805561|NCT00002888|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5805562|NCT00002888|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5805563|NCT00002881|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805564|NCT00002881|stage IV prostate cancer|stage iv prostate cancer
5805565|NCT00002881|recurrent prostate cancer|recurrent prostate cancer
5805566|NCT00002879|mantle cell lymphoma|mantle cell lymphoma
5805567|NCT00002879|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5805568|NCT00002879|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5805569|NCT00002879|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5805570|NCT00002879|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5805571|NCT00002879|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5805572|NCT00002879|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805573|NCT00002845|stage IV melanoma|stage iv melanoma
5805574|NCT00002845|recurrent melanoma|recurrent melanoma
5805575|NCT00002783|stage II gastric cancer|stage ii gastric cancer
5859856|NCT00005934|Anemia|anemia
5805576|NCT00002783|stage III gastric cancer|stage iii gastric cancer
5805577|NCT00002783|stage IV gastric cancer|stage iv gastric cancer
5805578|NCT00002783|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5805579|NCT00002755|stage II breast cancer|stage ii breast cancer
5805580|NCT00002755|stage IIIA breast cancer|stage iiia breast cancer
5805581|NCT00002742|adult Hodgkin lymphoma|adult hodgkin lymphoma
5805582|NCT00002742|adult non-Hodgkin lymphoma|adult non-hodgkin lymphoma
5805583|NCT00002742|leukemia|leukemia
5805584|NCT00002742|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5805585|NCT00002742|chronic myeloproliferative disorders|chronic myeloproliferative disorders
5805746|NCT00089843|Osteopenia|osteopenia
5805588|NCT00002742|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5805589|NCT00002742|infection|infection
5805590|NCT00002742|multiple myeloma and other plasma cell neoplasms|multiple myeloma and other plasma cell neoplasms
5805591|NCT00002742|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5805592|NCT00002711|stage I esophageal cancer|stage i esophageal cancer
5805593|NCT00002711|stage II esophageal cancer|stage ii esophageal cancer
5805594|NCT00002711|stage III esophageal cancer|stage iii esophageal cancer
5805595|NCT00002711|recurrent esophageal cancer|recurrent esophageal cancer
5805596|NCT00002711|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5805597|NCT00002711|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5805598|NCT00090025|Advanced Biliary Cancer|advanced biliary cancer
5805599|NCT00090025|Cholangiocarcinoma|cholangiocarcinoma
5805600|NCT00090025|Gall bladder tumor|gall bladder tumor
5805601|NCT00090025|Gall bladder cancer|gall bladder cancer
5805603|NCT00090025|Tumor of biliary tree|tumor of biliary tree
5805604|NCT00089999|lapatinib|lapatinib
5812769|NCT00082615|HV|hv
5805605|NCT00089999|advanced|advanced
5805606|NCT00089999|metastatic breast cancer|metastatic breast cancer
5805607|NCT00089999|GW572016|gw572016
5805608|NCT00089999|ErbB2|erbb2
5805609|NCT00089986|severe sepsis|severe sepsis
5805610|NCT00089986|septic shock|septic shock
5805611|NCT00089986|Gram-negative infection|gram-negative infection
5805612|NCT00089986|phospholipid emulsion|phospholipid emulsion
5805613|NCT00005024|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805614|NCT00004906|stage IV breast cancer|stage iv breast cancer
5805615|NCT00004906|recurrent breast cancer|recurrent breast cancer
5805616|NCT00002674|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5805617|NCT00002674|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5805618|NCT00002674|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5805047|NCT00002897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5805091|NCT00090623|AMD|amd
5805619|NCT00002674|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5805620|NCT00002634|localized resectable neuroblastoma|localized resectable neuroblastoma
5805621|NCT00002634|regional neuroblastoma|regional neuroblastoma
5805622|NCT00002634|disseminated neuroblastoma|disseminated neuroblastoma
5805623|NCT00002634|recurrent neuroblastoma|recurrent neuroblastoma
5805624|NCT00002634|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5805625|NCT00002579|stage I breast cancer|stage i breast cancer
5805626|NCT00002579|stage II breast cancer|stage ii breast cancer
5805627|NCT00002579|stage IIIA breast cancer|stage iiia breast cancer
5805628|NCT00002510|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5805629|NCT00002510|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805630|NCT00002510|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805631|NCT00002510|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805633|NCT00002499|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5805634|NCT00002498|stage IV breast cancer|stage iv breast cancer
5805635|NCT00002498|recurrent breast cancer|recurrent breast cancer
5805636|NCT00002493|stage III endometrial carcinoma|stage iii endometrial carcinoma
5805637|NCT00002493|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5805638|NCT00002493|endometrial adenocarcinoma|endometrial adenocarcinoma
5805639|NCT00002493|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5805640|NCT00002493|endometrial adenoacanthoma|endometrial adenoacanthoma
5805641|NCT00002493|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5805642|NCT00002493|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5805643|NCT00002493|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5805644|NCT00002479|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5805645|NCT00002479|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5805646|NCT00002479|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5805647|NCT00002479|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5805648|NCT00089973|breast cancer|breast cancer
5805649|NCT00089960|GIST|gist
5805650|NCT00089947|Anti-T cell antibodies|anti-t cell antibodies
5805651|NCT00089947|Living Donor Renal Transplantation|living donor renal transplantation
5805652|NCT00089947|Acute Renal Allograft Rejection|acute renal allograft rejection
5805653|NCT00089947|Induction Therapy with Reduction of Calcineurin inhibitors|induction therapy with reduction of calcineurin inhibitors
5805654|NCT00089921|Rheumatoid Arthritis|rheumatoid arthritis
5805655|NCT00089921|DMARDs|dmards
5805656|NCT00089921|Methotrexate|methotrexate
5805657|NCT00089921|p38 kinase|p38 kinase
5805658|NCT00004900|stage IV breast cancer|stage iv breast cancer
5805659|NCT00004900|recurrent breast cancer|recurrent breast cancer
5805660|NCT00004900|stage IIIB breast cancer|stage iiib breast cancer
5805661|NCT00004182|stage IV breast cancer|stage iv breast cancer
5805662|NCT00004182|recurrent breast cancer|recurrent breast cancer
5805663|NCT00004136|stage III childhood liver cancer|stage iii childhood liver cancer
5805664|NCT00004136|stage IV childhood liver cancer|stage iv childhood liver cancer
5805665|NCT00004136|recurrent childhood liver cancer|recurrent childhood liver cancer
5805666|NCT00004136|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5805667|NCT00004136|advanced adult primary liver cancer|advanced adult primary liver cancer
5805668|NCT00004136|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5805669|NCT00004136|liver metastases|liver metastases
5805670|NCT00004042|stage III colon cancer|stage iii colon cancer
5805671|NCT00004042|stage IV colon cancer|stage iv colon cancer
5805672|NCT00004042|stage III rectal cancer|stage iii rectal cancer
5805673|NCT00004042|stage IV rectal cancer|stage iv rectal cancer
5805674|NCT00004042|recurrent colon cancer|recurrent colon cancer
5805675|NCT00004042|recurrent rectal cancer|recurrent rectal cancer
5805676|NCT00003974|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5805677|NCT00003974|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5805678|NCT00003974|localized malignant mesothelioma|localized malignant mesothelioma
5805679|NCT00003974|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5805680|NCT00089908|Dengue Vaccine|dengue vaccine
5805681|NCT00089908|Dengue Virus|dengue virus
5805682|NCT00089908|Dengue Hemorrhagic Fever|dengue hemorrhagic fever
5805683|NCT00089908|Dengue Shock Syndrome|dengue shock syndrome
5805684|NCT00089895|myocardial infarction|myocardial infarction
5805685|NCT00089895|acute coronary syndrome|acute coronary syndrome
5805686|NCT00089895|non-ST-segment elevation|non-st-segment elevation
5805687|NCT00089895|eptifibatide|eptifibatide
5805688|NCT00089895|Integrilin|integrilin
5805689|NCT00089895|glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)|glycoprotein iib/iiia inhibitor (gp iib/iiia)
5805690|NCT00089895|percutaneous coronary intervention (PCI)|percutaneous coronary intervention (pci)
5805691|NCT00089895|coronary artery bypass graph surgery (CABG)|coronary artery bypass graph surgery (cabg)
5805692|NCT00089895|catheterization|catheterization
5805693|NCT00089895|angina|angina
5805694|NCT00089895|ischemia|ischemia
5805695|NCT00089895|cardiac ischemia|cardiac ischemia
5805696|NCT00089895|cardiovascular disease|cardiovascular disease
5805697|NCT00089882|Alzheimer disease|alzheimer disease
5805698|NCT00089882|Apolipoproteins E (APOE)|apolipoproteins e (apoe)
5805699|NCT00089882|Genetic susceptibility testing|genetic susceptibility testing
5805700|NCT00089856|Prostate|prostate
5805701|NCT00089856|Cancer|cancer
5805702|NCT00089856|Metastatic|metastatic
5805703|NCT00089856|Hormone-refractory|hormone-refractory
5805704|NCT00089856|GVAX|gvax
5805705|NCT00089856|Chemotherapy|chemotherapy
5805706|NCT00089856|Taxotere|taxotere
5805707|NCT00089856|Docetaxel|docetaxel
5805708|NCT00089856|Prednisone|prednisone
5805709|NCT00089856|Vaccine|vaccine
5805710|NCT00089856|Allogeneic cells|allogeneic cells
5805711|NCT00089856|Advanced Prostate Cancer|advanced prostate cancer
5805712|NCT00003951|recurrent pancreatic cancer|recurrent pancreatic cancer
5805713|NCT00003951|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5805714|NCT00003951|stage IV pancreatic cancer|stage iv pancreatic cancer
5805715|NCT00003897|stage IV melanoma|stage iv melanoma
5805716|NCT00003897|recurrent melanoma|recurrent melanoma
5805717|NCT00003885|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5805718|NCT00003885|stage I multiple myeloma|stage i multiple myeloma
5805719|NCT00003885|stage II multiple myeloma|stage ii multiple myeloma
5805720|NCT00003885|stage III multiple myeloma|stage iii multiple myeloma
5805721|NCT00003885|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805722|NCT00003885|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805723|NCT00003885|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5805724|NCT00003885|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805725|NCT00003885|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805726|NCT00003885|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805727|NCT00003885|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5805728|NCT00003885|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805729|NCT00003885|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805730|NCT00003885|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805731|NCT00003885|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805732|NCT00003885|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805733|NCT00003885|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5805734|NCT00003885|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5827447|NCT00062738|paroxetine|paroxetine
5805735|NCT00003885|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805736|NCT00003885|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805737|NCT00003885|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805738|NCT00003885|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805739|NCT00003885|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805740|NCT00003885|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805741|NCT00003776|metastatic osteosarcoma|metastatic osteosarcoma
5805742|NCT00003751|adult glioblastoma|adult glioblastoma
5805743|NCT00003751|adult giant cell glioblastoma|adult giant cell glioblastoma
5805744|NCT00003751|adult gliosarcoma|adult gliosarcoma
5805747|NCT00089830|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5805748|NCT00089830|Squalamine Lactate|squalamine lactate
5805749|NCT00089804|Lupus|lupus
5805750|NCT00089804|Nephritis|nephritis
5805751|NCT00089804|Kidney|kidney
5805753|NCT00089804|Systemic Lupus Erythematosus|systemic lupus erythematosus
5805754|NCT00089804|Nephritis, Lupus|nephritis, lupus
5805755|NCT00003709|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805756|NCT00003686|oral complications|oral complications
5805757|NCT00003686|quality of life|quality of life
5805758|NCT00003684|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805759|NCT00003684|pulmonary complications|pulmonary complications
5805760|NCT00003684|quality of life|quality of life
5805761|NCT00003626|stage IV prostate cancer|stage iv prostate cancer
5805762|NCT00003626|recurrent prostate cancer|recurrent prostate cancer
5805763|NCT00003556|stage IV melanoma|stage iv melanoma
5805764|NCT00003556|recurrent melanoma|recurrent melanoma
5805765|NCT00089791|Postmenopausal Osteoporosis|postmenopausal osteoporosis
5805766|NCT00003555|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805767|NCT00003543|stage IV colon cancer|stage iv colon cancer
5805768|NCT00003543|stage IV rectal cancer|stage iv rectal cancer
5805769|NCT00003543|recurrent colon cancer|recurrent colon cancer
5805770|NCT00003543|recurrent rectal cancer|recurrent rectal cancer
5805771|NCT00003400|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5805772|NCT00003400|stage IV prostate cancer|stage iv prostate cancer
5805773|NCT00003400|recurrent prostate cancer|recurrent prostate cancer
5805215|NCT00090558|CAD|cad
5805774|NCT00003395|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5805775|NCT00003395|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5805776|NCT00003395|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5805777|NCT00003395|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5805778|NCT00003395|refractory multiple myeloma|refractory multiple myeloma
5805779|NCT00003395|Waldenström macroglobulinemia|waldenström macroglobulinemia
5805780|NCT00003395|stage III multiple myeloma|stage iii multiple myeloma
5805781|NCT00003395|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5805782|NCT00003395|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805783|NCT00003395|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805784|NCT00003395|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5805785|NCT00003395|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5805786|NCT00003395|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5805787|NCT00003395|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5805788|NCT00003395|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5805789|NCT00003395|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5805790|NCT00003395|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5805791|NCT00003395|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5805792|NCT00003395|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5805793|NCT00003395|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5805794|NCT00003395|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5805795|NCT00003395|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5805796|NCT00003395|adult acute basophilic leukemia|adult acute basophilic leukemia
5805797|NCT00003395|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5805798|NCT00003395|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5805799|NCT00003395|refractory hairy cell leukemia|refractory hairy cell leukemia
5805800|NCT00003395|acute undifferentiated leukemia|acute undifferentiated leukemia
5805801|NCT00003395|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5805802|NCT00003395|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5805803|NCT00003395|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5805804|NCT00003395|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5805805|NCT00003395|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5805806|NCT00003395|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5805807|NCT00003395|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5805808|NCT00003395|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5805809|NCT00003395|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5805810|NCT00003395|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805811|NCT00003395|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805812|NCT00003395|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805813|NCT00003395|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5805814|NCT00003395|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805815|NCT00003395|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805816|NCT00003395|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805817|NCT00003395|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805818|NCT00003395|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805819|NCT00003395|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5805820|NCT00003395|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5805821|NCT00003395|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5805822|NCT00003395|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5805823|NCT00003395|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5805824|NCT00003395|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5805825|NCT00003395|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5805826|NCT00003395|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5805827|NCT00003395|intraocular lymphoma|intraocular lymphoma
5805828|NCT00003395|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5805829|NCT00003395|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805830|NCT00003395|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5805831|NCT00003395|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5805832|NCT00003395|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5805833|NCT00003395|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5805834|NCT00003395|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805835|NCT00003395|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805836|NCT00003395|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812342|NCT00083317|PFC|pfc
5805837|NCT00003395|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5805838|NCT00003395|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805839|NCT00003395|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805840|NCT00003395|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805841|NCT00003380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5805842|NCT00003380|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5805843|NCT00003380|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5805844|NCT00003380|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5805845|NCT00003380|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5805846|NCT00003380|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5805847|NCT00003380|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5805848|NCT00003380|fallopian tube cancer|fallopian tube cancer
5805849|NCT00003380|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5805851|NCT00003360|stage IV colon cancer|stage iv colon cancer
5805852|NCT00003360|stage IV rectal cancer|stage iv rectal cancer
5805853|NCT00003360|recurrent colon cancer|recurrent colon cancer
5805854|NCT00003360|recurrent rectal cancer|recurrent rectal cancer
5805855|NCT00003357|stage I breast cancer|stage i breast cancer
5805856|NCT00003357|stage II breast cancer|stage ii breast cancer
5805857|NCT00003357|stage III breast cancer|stage iii breast cancer
5805858|NCT00003348|recurrent adult brain tumor|recurrent adult brain tumor
5805859|NCT00003348|adult glioblastoma|adult glioblastoma
5805860|NCT00003348|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5805861|NCT00003348|adult giant cell glioblastoma|adult giant cell glioblastoma
5805862|NCT00003348|adult gliosarcoma|adult gliosarcoma
5805863|NCT00003340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805864|NCT00003312|stage I prostate cancer|stage i prostate cancer
5805865|NCT00003312|stage IIB prostate cancer|stage iib prostate cancer
5805866|NCT00003312|stage IIA prostate cancer|stage iia prostate cancer
5805867|NCT00089778|Clinical Response|clinical response
5805868|NCT00089778|Toxicity|toxicity
5805869|NCT00089778|Immunologic Response|immunologic response
5805870|NCT00089778|Adjuvant|adjuvant
5805871|NCT00089778|IL-2|il-2
5805872|NCT00089778|Renal Cancer|renal cancer
5805873|NCT00089765|Retinal Angioma|retinal angioma
5805874|NCT00089765|Tumor|tumor
5805875|NCT00089765|Anti-VEGF|anti-vegf
5805876|NCT00089765|Monoclonal Antibody|monoclonal antibody
5805877|NCT00089765|Macular Edema|macular edema
5805878|NCT00089765|Von Hippel-Lindau Disease|von hippel-lindau disease
5805879|NCT00089765|VEGF|vegf
5805880|NCT00089765|Ranibizumab|ranibizumab
5805882|NCT00003294|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5805883|NCT00003294|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5805884|NCT00003294|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5846877|NCT00042536|Normal Control|normal control
5805885|NCT00003294|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5805886|NCT00003294|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5805887|NCT00003294|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805888|NCT00003294|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5805889|NCT00003294|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5805890|NCT00003294|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5805891|NCT00003294|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5805892|NCT00003294|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5805893|NCT00003294|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5805894|NCT00003294|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5805895|NCT00003294|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5805896|NCT00003294|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5805897|NCT00003294|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5805898|NCT00003294|untreated hairy cell leukemia|untreated hairy cell leukemia
5805899|NCT00003294|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5805900|NCT00003294|refractory hairy cell leukemia|refractory hairy cell leukemia
5805901|NCT00003294|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5805902|NCT00003294|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5681272|NCT00574041|flu like symptoms|flu like symptoms
5681273|NCT00574028|IBD Study|ibd study
5681274|NCT00574015|toothache|toothache
5681275|NCT00574015|regional anesthesia|regional anesthesia
5681276|NCT00574015|emergency department|emergency department
5826135|NCT00065741|mycophenolate mofetil|mycophenolate mofetil
5805903|NCT00003294|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5805904|NCT00003294|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5805905|NCT00003294|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5805906|NCT00003294|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5805907|NCT00003294|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5686601|NCT00551369|large cell lung cancer|large cell lung cancer
5805908|NCT00003294|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5805909|NCT00003294|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5805910|NCT00003294|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5805911|NCT00003294|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5805912|NCT00003294|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5805913|NCT00003294|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805914|NCT00003294|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5805915|NCT00003294|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5805916|NCT00003294|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5805917|NCT00003294|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5805918|NCT00003294|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5805919|NCT00003294|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805920|NCT00003294|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5805922|NCT00003294|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5805923|NCT00003294|prolymphocytic leukemia|prolymphocytic leukemia
5805924|NCT00003294|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5805925|NCT00003294|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5805926|NCT00003294|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5805927|NCT00003294|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5805928|NCT00003294|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5805929|NCT00003294|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5805930|NCT00003294|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5805931|NCT00003294|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5805932|NCT00003294|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5805933|NCT00003294|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5805934|NCT00003294|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5805935|NCT00003294|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5805936|NCT00003294|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5805937|NCT00003284|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5805938|NCT00003284|limited stage small cell lung cancer|limited stage small cell lung cancer
5805939|NCT00003284|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5805940|NCT00003284|recurrent small cell lung cancer|recurrent small cell lung cancer
5805941|NCT00003284|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5805942|NCT00003284|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5805943|NCT00003284|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5805944|NCT00003251|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5805945|NCT00003251|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5805946|NCT00003251|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5805947|NCT00003251|stage III salivary gland cancer|stage iii salivary gland cancer
5805948|NCT00003251|stage IV salivary gland cancer|stage iv salivary gland cancer
5805949|NCT00003251|recurrent salivary gland cancer|recurrent salivary gland cancer
5806223|NCT00002562|recurrent vaginal cancer|recurrent vaginal cancer
5805950|NCT00003251|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5805951|NCT00003251|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5805952|NCT00003251|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5805953|NCT00003251|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5805954|NCT00003251|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5805955|NCT00003251|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5805956|NCT00003251|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5805957|NCT00003251|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5805958|NCT00003251|stage III laryngeal cancer|stage iii laryngeal cancer
5805959|NCT00003251|stage IV laryngeal cancer|stage iv laryngeal cancer
5805960|NCT00003251|recurrent laryngeal cancer|recurrent laryngeal cancer
5805961|NCT00003251|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5805962|NCT00003251|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5805963|NCT00003251|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5805964|NCT00003251|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5805965|NCT00003251|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5805966|NCT00003251|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5805967|NCT00003251|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5805968|NCT00003251|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5805969|NCT00003251|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5805970|NCT00003251|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5805386|NCT00090194|Living Donors|living donors
5805971|NCT00003251|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5805972|NCT00003251|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5805973|NCT00003251|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5805974|NCT00003251|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5805975|NCT00003251|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5805976|NCT00003251|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5805977|NCT00003251|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5805978|NCT00003251|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5805979|NCT00003251|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5805980|NCT00003251|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5805981|NCT00003251|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5805982|NCT00003251|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5805983|NCT00003251|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5805984|NCT00003251|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5805985|NCT00003251|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5805986|NCT00003251|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5805987|NCT00003251|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5805988|NCT00003251|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5805989|NCT00003251|radiation toxicity|radiation toxicity
5805990|NCT00003220|stage IV colon cancer|stage iv colon cancer
5805991|NCT00003220|stage IV rectal cancer|stage iv rectal cancer
5805992|NCT00003220|recurrent colon cancer|recurrent colon cancer
5805993|NCT00003220|recurrent rectal cancer|recurrent rectal cancer
5805994|NCT00003220|adenocarcinoma of the colon|adenocarcinoma of the colon
5805995|NCT00003220|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5805996|NCT00003200|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5805997|NCT00003200|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5805998|NCT00003200|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5805999|NCT00003200|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5806000|NCT00003200|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5806001|NCT00003200|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5806002|NCT00003200|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5806003|NCT00003200|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5806004|NCT00003200|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5806005|NCT00003200|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5806006|NCT00003200|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5806007|NCT00003200|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5806008|NCT00003200|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5806009|NCT00003200|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5806010|NCT00003200|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5806112|NCT00002909|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806011|NCT00003200|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5806013|NCT00089739|Suppressor of Cytokine Secretion|suppressor of cytokine secretion
5806014|NCT00089739|GITR|gitr
5806015|NCT00089739|Immunosuppression|immunosuppression
5806016|NCT00089739|GITR Ligand|gitr ligand
5806018|NCT00089726|cancer vaccine|cancer vaccine
5806019|NCT00089726|NSCLC|nsclc
5806020|NCT00089726|immunotherapy|immunotherapy
5806021|NCT00089713|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5806022|NCT00089713|hypertension/drug therapy|hypertension/drug therapy
5806023|NCT00089713|blood pressure|blood pressure
5806024|NCT00089700|HIV|hiv
5806025|NCT00089700|AIDS|aids
5806026|NCT00089700|Treatment Experienced|treatment experienced
5806027|NCT00089700|Optimized Background Therapy|optimized background therapy
5806028|NCT00089700|HIV-1|hiv-1
5806029|NCT00003197|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5806030|NCT00003123|refractory anemia|refractory anemia
5806031|NCT00003123|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5806032|NCT00003123|refractory anemia with excess blasts|refractory anemia with excess blasts
5806033|NCT00003123|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5823391|NCT00071383|Trastuzumab|trastuzumab
5806034|NCT00003115|prostate cancer|prostate cancer
5806035|NCT00003115|pain|pain
5806036|NCT00003102|stage IV renal cell cancer|stage iv renal cell cancer
5806037|NCT00003102|recurrent renal cell cancer|recurrent renal cell cancer
5806038|NCT00003058|adult liposarcoma|adult liposarcoma
5806039|NCT00003058|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5806040|NCT00003044|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5806041|NCT00003025|stage I pancreatic cancer|stage i pancreatic cancer
5806042|NCT00003025|stage II pancreatic cancer|stage ii pancreatic cancer
5806043|NCT00003025|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806044|NCT00003003|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5806045|NCT00003003|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5806046|NCT00002955|stage IV pancreatic cancer|stage iv pancreatic cancer
5806047|NCT00002933|stage IV colon cancer|stage iv colon cancer
5806048|NCT00002933|stage IV rectal cancer|stage iv rectal cancer
5806049|NCT00002933|recurrent colon cancer|recurrent colon cancer
5806050|NCT00002933|recurrent rectal cancer|recurrent rectal cancer
5806051|NCT00002933|adenocarcinoma of the colon|adenocarcinoma of the colon
5806052|NCT00002933|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5806053|NCT00089674|Prostate Cancer|prostate cancer
5806054|NCT00089674|Bone Loss with Prostate Cancer|bone loss with prostate cancer
5806055|NCT00089674|Treatment of bone loss in patients undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer (PC).|treatment of bone loss in patients undergoing androgen deprivation therapy (adt) for non-metastatic prostate cancer (pc).
5806056|NCT00089661|Breast Cancer|breast cancer
5806057|NCT00089661|Bone loss associated with Aromatase Inhibitor therapy (AIT) for non-metastatic BC|bone loss associated with aromatase inhibitor therapy (ait) for non-metastatic bc
5806058|NCT00089661|osteopenia|osteopenia
5806059|NCT00089661|Low bone density|low bone density
5806060|NCT00089635|Colon, Rectal Cancer|colon, rectal cancer
5806061|NCT00089635|ABX-EGF, Panitumumab, EGFr|abx-egf, panitumumab, egfr
5806062|NCT00089635|Immunex, Abgenix, Amgen|immunex, abgenix, amgen
5806063|NCT00089635|Metastatic Colorectal Cancer|metastatic colorectal cancer
5806064|NCT00089635|Vectibix|vectibix
5806065|NCT00002914|recurrent bladder cancer|recurrent bladder cancer
5806066|NCT00002914|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5806067|NCT00002914|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5806068|NCT00002914|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5806069|NCT00002914|recurrent urethral cancer|recurrent urethral cancer
5806070|NCT00002914|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5806071|NCT00002909|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5806072|NCT00002909|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5806073|NCT00002909|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5806074|NCT00002909|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5806075|NCT00002909|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806076|NCT00002909|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806077|NCT00002909|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806078|NCT00002909|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806079|NCT00002909|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5806080|NCT00002909|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5806081|NCT00002909|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5806290|NCT00089557|HIV Infections|hiv infections
5806082|NCT00002909|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5806083|NCT00002909|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5806084|NCT00002909|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806085|NCT00002909|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806086|NCT00002909|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806087|NCT00002909|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806088|NCT00002909|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5806089|NCT00002909|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5806090|NCT00002909|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5862638|NCT00001552|Vocal Fold Paralysis|vocal fold paralysis
5806091|NCT00002909|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5806092|NCT00002909|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5806093|NCT00002909|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806094|NCT00002909|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806095|NCT00002909|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806096|NCT00002909|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5806097|NCT00002909|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5806098|NCT00002909|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5806099|NCT00002909|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5806100|NCT00002909|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5806101|NCT00002909|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5806102|NCT00002909|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5806103|NCT00002909|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5806104|NCT00002909|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806105|NCT00002909|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806106|NCT00002909|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5806107|NCT00002909|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5806108|NCT00002909|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5806109|NCT00002909|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806110|NCT00002909|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806111|NCT00002909|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806113|NCT00002909|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806114|NCT00002909|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806115|NCT00002909|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806116|NCT00002909|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806117|NCT00002909|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806118|NCT00002890|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5806119|NCT00002890|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5806120|NCT00002890|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5806121|NCT00002890|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5806122|NCT00002890|refractory anemia with excess blasts|refractory anemia with excess blasts
5806123|NCT00002890|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5806124|NCT00002890|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5806125|NCT00002890|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806126|NCT00002890|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806127|NCT00002890|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5806128|NCT00002865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5806129|NCT00002749|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5806131|NCT00002749|adult brain stem glioma|adult brain stem glioma
5806132|NCT00002749|childhood oligodendroglioma|childhood oligodendroglioma
5806133|NCT00002749|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5806134|NCT00002749|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5806135|NCT00002749|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5806136|NCT00002749|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5806137|NCT00002749|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5806138|NCT00002749|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5806139|NCT00002749|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5806140|NCT00002749|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5806141|NCT00002749|adult oligodendroglioma|adult oligodendroglioma
5806142|NCT00002655|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5806143|NCT00002655|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5806144|NCT00002655|liver metastases|liver metastases
5806145|NCT00002635|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5806146|NCT00002635|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5806147|NCT00002635|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5806148|NCT00002635|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5806149|NCT00002619|adult brain stem glioma|adult brain stem glioma
5806150|NCT00002619|adult glioblastoma|adult glioblastoma
5806151|NCT00002619|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5806152|NCT00002619|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5806153|NCT00002619|adult giant cell glioblastoma|adult giant cell glioblastoma
5806154|NCT00002619|adult gliosarcoma|adult gliosarcoma
5806155|NCT00002609|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5806156|NCT00002609|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5681277|NCT00573989|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5681278|NCT00573989|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5806157|NCT00002609|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5806158|NCT00002609|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5806159|NCT00002585|stage IV breast cancer|stage iv breast cancer
5806160|NCT00002585|recurrent breast cancer|recurrent breast cancer
5806161|NCT00089596|umbilical cord blood|umbilical cord blood
5806162|NCT00089596|transplant|transplant
5806165|NCT00089596|MDS|mds
5806166|NCT00089596|NHL|nhl
5806167|NCT00089596|CML|cml
5806168|NCT00089583|antiretroviral therapy|antiretroviral therapy
5806169|NCT00089583|pediatrics|pediatrics
5806170|NCT00089583|AGENERASE|agenerase
5806171|NCT00089583|amprenavir|amprenavir
5686602|NCT00551369|squamous cell lung cancer|squamous cell lung cancer
5806172|NCT00089583|fosamprenavir|fosamprenavir
5806173|NCT00089583|HIV Infection|hiv infection
5806174|NCT00089583|ritonavir|ritonavir
5806175|NCT00089583|protease inhibitor|protease inhibitor
5806176|NCT00089583|LEXIVA|lexiva
5806177|NCT00005626|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5806178|NCT00005626|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5806179|NCT00005626|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5806180|NCT00005626|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5806181|NCT00005626|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5806182|NCT00005626|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806183|NCT00005626|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806184|NCT00005626|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806185|NCT00005626|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806186|NCT00005626|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806188|NCT00005626|prolymphocytic leukemia|prolymphocytic leukemia
5806189|NCT00005626|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5806190|NCT00005626|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5806191|NCT00005626|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5806192|NCT00005626|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5806193|NCT00005626|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5806194|NCT00005626|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5806195|NCT00005626|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5806196|NCT00005626|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806197|NCT00005626|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806198|NCT00005626|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5806199|NCT00005626|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5806200|NCT00005626|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5806201|NCT00005626|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806202|NCT00005626|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806203|NCT00005626|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5806204|NCT00005626|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5806205|NCT00005626|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806206|NCT00005626|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806207|NCT00005626|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806208|NCT00005626|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806209|NCT00005626|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5806210|NCT00005626|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5806211|NCT00005626|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806212|NCT00005626|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806213|NCT00005626|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806214|NCT00005607|stage IV gastric cancer|stage iv gastric cancer
5806215|NCT00005607|recurrent gastric cancer|recurrent gastric cancer
5806216|NCT00005607|stage IV esophageal cancer|stage iv esophageal cancer
5806217|NCT00005607|recurrent esophageal cancer|recurrent esophageal cancer
5806218|NCT00005607|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5806219|NCT00005607|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5806220|NCT00002574|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5806221|NCT00002574|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5806222|NCT00002562|recurrent cervical cancer|recurrent cervical cancer
5827597|NCT00062452|Esophageal|esophageal
5806224|NCT00002562|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5806225|NCT00002562|cervical adenocarcinoma|cervical adenocarcinoma
5806226|NCT00002507|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5806227|NCT00002507|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5806228|NCT00002507|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5806229|NCT00002507|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5806230|NCT00002507|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5806231|NCT00002507|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5806232|NCT00002507|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5806233|NCT00002507|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5806234|NCT00002507|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5806235|NCT00002507|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5806236|NCT00002507|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5805752|NCT00089804|SLE|sle
5806237|NCT00002507|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5806238|NCT00002507|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5806239|NCT00002507|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5806240|NCT00002507|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5806241|NCT00002507|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5806242|NCT00002507|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5806243|NCT00002507|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5806244|NCT00002507|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5806245|NCT00002507|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5806246|NCT00002507|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5806248|NCT00002507|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5806249|NCT00002507|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5806250|NCT00002507|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5806251|NCT00002507|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5806252|NCT00002507|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5806253|NCT00002507|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5806254|NCT00002507|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5806255|NCT00002507|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5806256|NCT00002507|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5806257|NCT00002507|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5806258|NCT00002507|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5806259|NCT00002507|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5806260|NCT00002507|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5806261|NCT00002507|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5806262|NCT00002507|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5806263|NCT00002507|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5806264|NCT00002507|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5806265|NCT00002507|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5806266|NCT00002507|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5806267|NCT00002507|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5806268|NCT00089622|Parkinson's Disease|parkinson's disease
5806269|NCT00089622|Motor Fluctuations|motor fluctuations
5806270|NCT00089622|Intravenous Levodopa|intravenous levodopa
5806271|NCT00089622|Antiparkinsonian Response|antiparkinsonian response
5806273|NCT00089622|Parkinson Disease|parkinson disease
5806274|NCT00089622|PD|pd
5806275|NCT00089609|Hormones|hormones
5806276|NCT00089609|Angiogenesis|angiogenesis
5806277|NCT00089609|Markers|markers
5806278|NCT00089609|Tumor|tumor
5806279|NCT00089609|Prostate Cancer|prostate cancer
5806280|NCT00089570|hepatorenal syndrome|hepatorenal syndrome
5806281|NCT00089570|terlipressin|terlipressin
5806282|NCT00089557|Dermal assessment|dermal assessment
5806283|NCT00089557|Pain assessment|pain assessment
5806284|NCT00089557|Diary|diary
5806285|NCT00089557|Analgesics|analgesics
5806286|NCT00089557|Capsaicin|capsaicin
5818798|NCT00079053|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5818799|NCT00079053|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5813411|NCT00082147|MRI|mri
5818801|NCT00079053|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5806287|NCT00089557|Herpes zoster|herpes zoster
5806288|NCT00089557|Neuralgia|neuralgia
5806289|NCT00089557|Pain|pain
5806291|NCT00089557|Peripheral Nervous System Diseases|peripheral nervous system diseases
5806292|NCT00089557|Diabetic Neuropathies|diabetic neuropathies
5806293|NCT00089557|Diabetes Mellitus|diabetes mellitus
5806294|NCT00089557|Polyneuropathies|polyneuropathies
5806295|NCT00089557|Complementary Therapies|complementary therapies
5806296|NCT00005591|stage III pancreatic cancer|stage iii pancreatic cancer
5806297|NCT00005591|recurrent pancreatic cancer|recurrent pancreatic cancer
5806298|NCT00005591|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806299|NCT00005591|stage IV pancreatic cancer|stage iv pancreatic cancer
5806300|NCT00005076|stage III colon cancer|stage iii colon cancer
5806301|NCT00005076|stage IV colon cancer|stage iv colon cancer
5806302|NCT00005076|stage III rectal cancer|stage iii rectal cancer
5806303|NCT00005076|stage IV rectal cancer|stage iv rectal cancer
5806304|NCT00005076|recurrent colon cancer|recurrent colon cancer
5806305|NCT00005076|recurrent rectal cancer|recurrent rectal cancer
5806306|NCT00005070|recurrent cervical cancer|recurrent cervical cancer
5806307|NCT00005070|stage IVB cervical cancer|stage ivb cervical cancer
5806308|NCT00005070|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5806309|NCT00005070|cervical adenocarcinoma|cervical adenocarcinoma
5806310|NCT00005070|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5806311|NCT00005057|stage IV melanoma|stage iv melanoma
5806312|NCT00005057|recurrent melanoma|recurrent melanoma
5806429|NCT00089245|metastatic osteosarcoma|metastatic osteosarcoma
5806313|NCT00005057|lentigo maligna malignant melanoma|lentigo maligna malignant melanoma
5806314|NCT00005057|superficial spreading malignant melanoma|superficial spreading malignant melanoma
5806315|NCT00005057|acral lentiginous malignant melanoma|acral lentiginous malignant melanoma
5806316|NCT00005057|nodular malignant melanoma|nodular malignant melanoma
5806317|NCT00005056|stage I renal cell cancer|stage i renal cell cancer
5806318|NCT00005056|stage II renal cell cancer|stage ii renal cell cancer
5806319|NCT00005056|stage III renal cell cancer|stage iii renal cell cancer
5806320|NCT00005056|stage IV renal cell cancer|stage iv renal cell cancer
5806321|NCT00005056|recurrent renal cell cancer|recurrent renal cell cancer
5806322|NCT00004937|recurrent adult brain tumor|recurrent adult brain tumor
5806323|NCT00004937|adult glioblastoma|adult glioblastoma
5806324|NCT00004937|adult giant cell glioblastoma|adult giant cell glioblastoma
5806325|NCT00004937|adult gliosarcoma|adult gliosarcoma
5806326|NCT00004219|nausea and vomiting|nausea and vomiting
5806327|NCT00004219|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5806328|NCT00004219|testicular seminoma|testicular seminoma
5806329|NCT00004215|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5806330|NCT00004215|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5806331|NCT00004215|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5806332|NCT00004215|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5806333|NCT00004215|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5806334|NCT00004215|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5806335|NCT00004215|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5806336|NCT00004215|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5806338|NCT00004215|neutropenia|neutropenia
5806339|NCT00004215|thrombocytopenia|thrombocytopenia
5806340|NCT00004215|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5806341|NCT00004207|stage IV breast cancer|stage iv breast cancer
5806342|NCT00004207|recurrent breast cancer|recurrent breast cancer
5806343|NCT00089531|Healthy|healthy
5806344|NCT00089531|Virus|virus
5806345|NCT00089531|T-Cells|t-cells
5806346|NCT00089531|HIV-Negative|hiv-negative
5806347|NCT00089531|Immunity|immunity
5806348|NCT00089531|Healthy Volunteer|healthy volunteer
5806349|NCT00089531|HV|hv
5806350|NCT00089531|HIV Preventive Vaccine|hiv preventive vaccine
5806351|NCT00089531|HIV Seronegativity|hiv seronegativity
5806352|NCT00089518|Treatment Experienced|treatment experienced
5806353|NCT00089505|Treatment Experienced|treatment experienced
5806354|NCT00089505|Treatment Naive|treatment naive
5806355|NCT00089505|MTCT|mtct
5806356|NCT00089505|HIV Seronegativity|hiv seronegativity
5806357|NCT00089466|Entry Inhibitors|entry inhibitors
5806358|NCT00089466|CXCR4 Entry Inhibitors|cxcr4 entry inhibitors
5806359|NCT00089466|Treatment Experienced|treatment experienced
5806360|NCT00089466|Treatment Naive|treatment naive
5806361|NCT00089453|Myeloma|myeloma
5806362|NCT00089453|Transplant|transplant
5806363|NCT00089453|Relapsed|relapsed
5806364|NCT00089453|Donor|donor
5806365|NCT00089453|Stem Cell|stem cell
5806366|NCT00089453|Thalidomide|thalidomide
5806367|NCT00089453|Dexamethasone|dexamethasone
5806368|NCT00089453|Cisplatin|cisplatin
5806369|NCT00089453|Adriamycin|adriamycin
5806370|NCT00089453|Cyclophosphamide|cyclophosphamide
5806371|NCT00089453|Etoposide|etoposide
5806372|NCT00089453|Melphalan|melphalan
5806373|NCT00089427|brain tumor|brain tumor
5806374|NCT00089427|malignant glioma|malignant glioma
5806375|NCT00089427|brain neoplasm|brain neoplasm
5806376|NCT00089427|central nervous system|central nervous system
5806378|NCT00089427|resection|resection
5806380|NCT00089427|infusion|infusion
5806381|NCT00089427|glioblastoma multiforme|glioblastoma multiforme
5806382|NCT00089427|anaplastic astrocytoma|anaplastic astrocytoma
5806383|NCT00089427|oligoastrocytoma|oligoastrocytoma
5806384|NCT00089427|Temodar|temodar
5806385|NCT00089427|radiation|radiation
5806386|NCT00089427|convection-enhanced delivery|convection-enhanced delivery
5806387|NCT00089427|GBM|gbm
5806388|NCT00089414|Depression|depression
5806389|NCT00089414|Menstrual Cycle|menstrual cycle
5806390|NCT00089414|Gonadal Steroids|gonadal steroids
5806391|NCT00089414|Ethinyl Estradiol|ethinyl estradiol
5806392|NCT00089414|Drospirenone|drospirenone
5807326|NCT00088387|T231|t231
5806393|NCT00089414|Menstrually Related Mood Disorder|menstrually related mood disorder
5806395|NCT00089401|recurrent colon cancer|recurrent colon cancer
5806396|NCT00089401|stage IV colon cancer|stage iv colon cancer
5806397|NCT00089401|recurrent rectal cancer|recurrent rectal cancer
5806398|NCT00089401|stage IV rectal cancer|stage iv rectal cancer
5806399|NCT00089401|liver metastases|liver metastases
5806400|NCT00089323|stage IA breast cancer|stage ia breast cancer
5806401|NCT00089323|stage II breast cancer|stage ii breast cancer
5806402|NCT00089323|stage IIIA breast cancer|stage iiia breast cancer
5806403|NCT00089323|male breast cancer|male breast cancer
5806404|NCT00089323|stage IB breast cancer|stage ib breast cancer
5806405|NCT00089310|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5806406|NCT00089297|Stage III head and neck cancer|stage iii head and neck cancer
5806407|NCT00089297|Stage IV head and neck cancer|stage iv head and neck cancer
5806408|NCT00089297|Cetuximab|cetuximab
5806409|NCT00089297|Paclitaxel|paclitaxel
5806410|NCT00089297|Carboplatin|carboplatin
5806411|NCT00089258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5806412|NCT00089258|disseminated neuroblastoma|disseminated neuroblastoma
5806413|NCT00089258|regional neuroblastoma|regional neuroblastoma
5806414|NCT00089258|stage 4S neuroblastoma|stage 4s neuroblastoma
5806415|NCT00089258|recurrent neuroblastoma|recurrent neuroblastoma
5806416|NCT00089245|leptomeningeal metastases|leptomeningeal metastases
5806417|NCT00089245|recurrent neuroblastoma|recurrent neuroblastoma
5806418|NCT00089245|disseminated neuroblastoma|disseminated neuroblastoma
5806419|NCT00089245|recurrent adult brain tumor|recurrent adult brain tumor
5806420|NCT00089245|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5806421|NCT00089245|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5806422|NCT00089245|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5806423|NCT00089245|recurrent osteosarcoma|recurrent osteosarcoma
5806424|NCT00089245|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5806425|NCT00089245|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5806426|NCT00089245|adult medulloblastoma|adult medulloblastoma
5806427|NCT00089245|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5806428|NCT00089245|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5806430|NCT00089245|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5806431|NCT00089245|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5806432|NCT00089245|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5806433|NCT00089245|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5806434|NCT00089245|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5806435|NCT00089219|stage III melanoma|stage iii melanoma
5806436|NCT00089219|stage IV melanoma|stage iv melanoma
5806437|NCT00089219|recurrent melanoma|recurrent melanoma
5806438|NCT00089219|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5806439|NCT00089219|extraocular extension melanoma|extraocular extension melanoma
5806441|NCT00089219|recurrent intraocular melanoma|recurrent intraocular melanoma
5806442|NCT00089206|stage III melanoma|stage iii melanoma
5806443|NCT00089206|stage IV melanoma|stage iv melanoma
5806444|NCT00089206|recurrent melanoma|recurrent melanoma
5806445|NCT00089206|recurrent intraocular melanoma|recurrent intraocular melanoma
5806446|NCT00089206|iris melanoma|iris melanoma
5806447|NCT00089206|extraocular extension melanoma|extraocular extension melanoma
5806448|NCT00089206|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5806449|NCT00089193|stage II melanoma|stage ii melanoma
5806450|NCT00089193|stage III melanoma|stage iii melanoma
5860587|NCT00004729|seizure|seizure
5806451|NCT00089193|stage IV melanoma|stage iv melanoma
5806452|NCT00089193|recurrent melanoma|recurrent melanoma
5806453|NCT00089167|primary systemic amyloidosis|primary systemic amyloidosis
5806454|NCT00089141|graft versus host disease|graft versus host disease
5806455|NCT00089141|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5806456|NCT00089141|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5806457|NCT00089141|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5806458|NCT00089141|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5806459|NCT00089141|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5806460|NCT00089141|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5806461|NCT00089141|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5806462|NCT00089141|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5806463|NCT00089141|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5806464|NCT00089141|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5806465|NCT00089141|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5806466|NCT00089141|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5806467|NCT00089141|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5806468|NCT00089141|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806469|NCT00089141|disseminated neuroblastoma|disseminated neuroblastoma
5806470|NCT00089141|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806471|NCT00089141|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5806472|NCT00089141|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5686603|NCT00551369|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5686604|NCT00551356|Diabetes|diabetes
5686605|NCT00551356|Diabetic|diabetic
5686606|NCT00551356|Insulin|insulin
5686607|NCT00551356|Humalog|humalog
5686608|NCT00551356|Lantus|lantus
5686609|NCT00551356|Glargine|glargine
5806473|NCT00089141|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806474|NCT00089141|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5806475|NCT00089141|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5806476|NCT00089141|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5806477|NCT00089141|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5806478|NCT00089141|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5806479|NCT00089141|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5806480|NCT00089141|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5806481|NCT00089141|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5806482|NCT00089141|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5806483|NCT00089141|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5806484|NCT00089141|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5806485|NCT00089141|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5806486|NCT00089141|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5806487|NCT00089141|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5806488|NCT00089141|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806489|NCT00089141|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5806490|NCT00089141|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5806491|NCT00089141|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806492|NCT00089141|stage I multiple myeloma|stage i multiple myeloma
5806493|NCT00089141|stage II multiple myeloma|stage ii multiple myeloma
5806494|NCT00089141|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5806495|NCT00089141|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5806496|NCT00089141|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5806497|NCT00089141|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5806498|NCT00089141|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806499|NCT00089141|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5806500|NCT00089141|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5806501|NCT00089141|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5806502|NCT00089141|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806503|NCT00089141|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806504|NCT00089141|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806505|NCT00089141|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806506|NCT00089141|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806507|NCT00089141|stage III multiple myeloma|stage iii multiple myeloma
5806508|NCT00089141|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5806509|NCT00089141|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806510|NCT00089141|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5806511|NCT00089141|stage IIIA breast cancer|stage iiia breast cancer
5806512|NCT00089141|stage IIIB breast cancer|stage iiib breast cancer
5806513|NCT00089141|stage IIIC breast cancer|stage iiic breast cancer
5806514|NCT00089141|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5806515|NCT00089141|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5806516|NCT00089141|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5806517|NCT00089141|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806518|NCT00089141|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813690|NCT00082030|MDD|mdd
5806519|NCT00089141|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5806520|NCT00089141|stage IV breast cancer|stage iv breast cancer
5806521|NCT00089141|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5806522|NCT00089141|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806523|NCT00089141|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806524|NCT00089141|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806526|NCT00089141|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806527|NCT00089141|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5806528|NCT00089141|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806529|NCT00089141|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5806530|NCT00089128|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5806531|NCT00089128|recurrent bladder cancer|recurrent bladder cancer
5806532|NCT00089128|stage III bladder cancer|stage iii bladder cancer
5806533|NCT00089128|stage IV bladder cancer|stage iv bladder cancer
5806534|NCT00089115|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5806535|NCT00089115|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5806536|NCT00089115|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5806537|NCT00089115|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5806538|NCT00089115|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5806539|NCT00089115|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5806540|NCT00089115|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5806541|NCT00089115|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5802708|NCT00097695|HAE|hae
5806542|NCT00089115|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5806543|NCT00089115|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806544|NCT00089115|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806545|NCT00089115|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806546|NCT00089115|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806547|NCT00089115|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806548|NCT00089115|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806549|NCT00089115|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806550|NCT00089115|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806551|NCT00089115|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806552|NCT00089102|recurrent renal cell cancer|recurrent renal cell cancer
5806553|NCT00089102|stage III renal cell cancer|stage iii renal cell cancer
5806554|NCT00089102|stage IV renal cell cancer|stage iv renal cell cancer
5806555|NCT00089050|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5806556|NCT00089050|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5806557|NCT00089050|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5806558|NCT00089050|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5806559|NCT00089050|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5806560|NCT00089050|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5806561|NCT00089050|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5806562|NCT00089050|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5806563|NCT00089050|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5806564|NCT00089050|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5806565|NCT00089050|adult acute basophilic leukemia|adult acute basophilic leukemia
5806566|NCT00089050|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5806567|NCT00089050|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5806568|NCT00089050|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5806569|NCT00089050|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5806570|NCT00089050|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5806571|NCT00089037|graft versus host disease|graft versus host disease
5806572|NCT00089037|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5806573|NCT00089037|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5806574|NCT00089037|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5806575|NCT00089037|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5806576|NCT00089037|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5806577|NCT00089037|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5806578|NCT00089037|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5806579|NCT00089037|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5806580|NCT00089037|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806581|NCT00089037|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5806582|NCT00089037|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813691|NCT00082030|Healthy Volunteer|healthy volunteer
5806583|NCT00089037|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806584|NCT00089037|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806585|NCT00089037|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5806586|NCT00089037|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5806587|NCT00089037|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5806588|NCT00089037|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5806589|NCT00089037|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5806590|NCT00089037|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5806591|NCT00089037|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5806592|NCT00089037|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5806593|NCT00089037|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5806594|NCT00089037|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5806656|NCT00089037|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5806595|NCT00089037|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5806596|NCT00089037|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5806597|NCT00089037|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806598|NCT00089037|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806599|NCT00089037|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806600|NCT00089037|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5802807|NCT00097318|Brain|brain
5806601|NCT00089037|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5806602|NCT00089037|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806603|NCT00089037|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5806604|NCT00089037|refractory hairy cell leukemia|refractory hairy cell leukemia
5806606|NCT00089037|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5806607|NCT00089037|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5806608|NCT00089037|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5806609|NCT00089037|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5806610|NCT00089037|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5806611|NCT00089037|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5806612|NCT00089037|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5806613|NCT00089037|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5806614|NCT00089037|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5806615|NCT00089037|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5806616|NCT00089037|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5806617|NCT00089037|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5806618|NCT00089037|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5806619|NCT00089037|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5806620|NCT00089037|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5806621|NCT00089037|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5806622|NCT00089037|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5806623|NCT00089037|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5806624|NCT00089037|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5806625|NCT00089037|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806626|NCT00089037|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5806627|NCT00089037|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5806628|NCT00089037|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806629|NCT00089037|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5806630|NCT00089037|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5806631|NCT00089037|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806632|NCT00089037|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806633|NCT00089037|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806634|NCT00089037|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806635|NCT00089037|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806636|NCT00089037|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806637|NCT00089037|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806638|NCT00089037|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806639|NCT00089037|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806640|NCT00089037|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806641|NCT00089037|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5813838|NCT00081887|CLL|cll
5806642|NCT00089037|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806643|NCT00089037|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5806644|NCT00089037|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5806645|NCT00089037|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5806646|NCT00089037|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5806647|NCT00089037|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5806648|NCT00089037|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5806649|NCT00089037|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5806650|NCT00089037|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5806651|NCT00089037|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5806652|NCT00089037|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5806653|NCT00089037|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806654|NCT00089037|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5806655|NCT00089037|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5806657|NCT00089037|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5806658|NCT00089037|stage I multiple myeloma|stage i multiple myeloma
5806659|NCT00089037|stage II multiple myeloma|stage ii multiple myeloma
5806660|NCT00089037|stage III multiple myeloma|stage iii multiple myeloma
5806661|NCT00089037|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5806663|NCT00089037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806664|NCT00089024|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806665|NCT00089024|stage II pancreatic cancer|stage ii pancreatic cancer
5806666|NCT00089024|stage III pancreatic cancer|stage iii pancreatic cancer
5806667|NCT00088998|male breast cancer|male breast cancer
5806668|NCT00088998|recurrent breast cancer|recurrent breast cancer
5806669|NCT00088998|stage IV breast cancer|stage iv breast cancer
5806670|NCT00088985|recurrent breast cancer|recurrent breast cancer
5806671|NCT00088985|stage IIIB breast cancer|stage iiib breast cancer
5806672|NCT00088985|stage IIIC breast cancer|stage iiic breast cancer
5806673|NCT00088985|stage IV breast cancer|stage iv breast cancer
5806674|NCT00088972|breast cancer|breast cancer
5806675|NCT00088972|breast cancer in situ|breast cancer in situ
5806676|NCT00088972|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5806677|NCT00088972|ductal breast carcinoma|ductal breast carcinoma
5806678|NCT00088946|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5806679|NCT00088946|stage 0 bladder cancer|stage 0 bladder cancer
5806680|NCT00088946|stage I bladder cancer|stage i bladder cancer
5806681|NCT00088907|docetaxel|docetaxel
5806682|NCT00088907|gefitinib|gefitinib
5806683|NCT00088907|head and neck cancer|head and neck cancer
5806684|NCT00088868|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5806685|NCT00088868|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5806686|NCT00088868|intraocular lymphoma|intraocular lymphoma
5806687|NCT00088868|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806688|NCT00088868|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806689|NCT00088868|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806690|NCT00088868|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5806691|NCT00088868|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806692|NCT00088868|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806693|NCT00088868|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5806694|NCT00088868|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5806695|NCT00088868|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5806696|NCT00088868|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806697|NCT00088868|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5806698|NCT00088868|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5806699|NCT00088868|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5806700|NCT00088868|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806701|NCT00088868|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806702|NCT00088868|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806703|NCT00088868|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806704|NCT00088868|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806705|NCT00088868|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806706|NCT00088868|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5806707|NCT00088868|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5806708|NCT00088868|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5806709|NCT00088868|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806710|NCT00088868|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5813852|NCT00081874|RAD001|rad001
5806711|NCT00088868|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5806712|NCT00088868|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5806713|NCT00088868|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806714|NCT00088868|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806715|NCT00088868|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806716|NCT00088868|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806717|NCT00088868|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806718|NCT00088868|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806719|NCT00088868|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5806720|NCT00088868|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5686610|NCT00551356|Lispro|lispro
5686611|NCT00551330|Treatment Experienced|treatment experienced
5686612|NCT00551317|SB480848,|sb480848,
5686613|NCT00551317|Japanese healthy volunteers|japanese healthy volunteers
5686614|NCT00551317|darapladib,|darapladib,
5826465|NCT00065104|immune system|immune system
5806721|NCT00088868|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5806722|NCT00088868|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5806723|NCT00088868|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5806724|NCT00088868|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5806725|NCT00088868|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5806726|NCT00088868|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807014|NCT00088686|Preemptive Analgesia|preemptive analgesia
5806727|NCT00088868|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5806728|NCT00088868|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5806729|NCT00088868|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5806730|NCT00088868|small intestine lymphoma|small intestine lymphoma
5806731|NCT00088868|Waldenström macroglobulinemia|waldenström macroglobulinemia
5806732|NCT00088868|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5806733|NCT00088868|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5806734|NCT00088868|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5806735|NCT00088868|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5806736|NCT00088868|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5806737|NCT00088868|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5806738|NCT00088868|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806739|NCT00088868|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806740|NCT00088868|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806741|NCT00088829|stage II breast cancer|stage ii breast cancer
5806742|NCT00088829|stage IIIA breast cancer|stage iiia breast cancer
5806743|NCT00088829|stage IIIB breast cancer|stage iiib breast cancer
5806744|NCT00088829|stage IIIC breast cancer|stage iiic breast cancer
5806745|NCT00088829|stage IV breast cancer|stage iv breast cancer
5806746|NCT00088829|stage IA breast cancer|stage ia breast cancer
5806747|NCT00088829|stage IB breast cancer|stage ib breast cancer
5806748|NCT00088829|HER2-negative breast cancer|her2-negative breast cancer
5806749|NCT00088829|HER2-positive breast cancer|her2-positive breast cancer
5806750|NCT00088816|stage IV gastric cancer|stage iv gastric cancer
5806751|NCT00088816|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5806752|NCT00088803|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5806753|NCT00088803|stage I Wilms tumor|stage i wilms tumor
5806754|NCT00088803|stage II Wilms tumor|stage ii wilms tumor
5806755|NCT00088803|stage III Wilms tumor|stage iii wilms tumor
5806756|NCT00088803|stage IV Wilms tumor|stage iv wilms tumor
5806757|NCT00088803|stage V Wilms tumor|stage v wilms tumor
5806758|NCT00088790|advanced, solid, malignancies|advanced, solid, malignancies
5806760|NCT00088764|Coping|coping
5806761|NCT00088764|Expressive Writing|expressive writing
5806762|NCT00088764|Self-Efficacy|self-efficacy
5806763|NCT00088764|Disclosure|disclosure
5806764|NCT00004193|stage IV colon cancer|stage iv colon cancer
5806765|NCT00004193|stage IV rectal cancer|stage iv rectal cancer
5806766|NCT00004193|recurrent colon cancer|recurrent colon cancer
5806767|NCT00004193|recurrent rectal cancer|recurrent rectal cancer
5806768|NCT00004193|adenocarcinoma of the colon|adenocarcinoma of the colon
5806769|NCT00004193|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5806770|NCT00004187|stage III colon cancer|stage iii colon cancer
5806771|NCT00004187|stage IV colon cancer|stage iv colon cancer
5806772|NCT00004187|stage III rectal cancer|stage iii rectal cancer
5806773|NCT00004187|stage IV rectal cancer|stage iv rectal cancer
5806774|NCT00004187|recurrent colon cancer|recurrent colon cancer
5806775|NCT00004187|recurrent rectal cancer|recurrent rectal cancer
5806776|NCT00004186|limited stage small cell lung cancer|limited stage small cell lung cancer
5806777|NCT00004186|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5806778|NCT00004186|recurrent small cell lung cancer|recurrent small cell lung cancer
5806779|NCT00004162|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5806780|NCT00004162|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5806781|NCT00004162|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5806782|NCT00004162|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5806783|NCT00004162|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5806784|NCT00004162|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5806785|NCT00004096|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5806786|NCT00004096|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5806787|NCT00004080|recurrent adult brain tumor|recurrent adult brain tumor
5806788|NCT00004080|adult glioblastoma|adult glioblastoma
5806789|NCT00004080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5806790|NCT00004080|adult mixed glioma|adult mixed glioma
5806791|NCT00004080|adult giant cell glioblastoma|adult giant cell glioblastoma
5806792|NCT00004080|adult gliosarcoma|adult gliosarcoma
5807001|NCT00088712|Selective Attention|selective attention
5806793|NCT00004064|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5806794|NCT00004064|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5806795|NCT00004064|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5806796|NCT00004064|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5806797|NCT00004064|fallopian tube cancer|fallopian tube cancer
5806798|NCT00004064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5806799|NCT00004040|stage I multiple myeloma|stage i multiple myeloma
5806800|NCT00004040|stage II multiple myeloma|stage ii multiple myeloma
5806801|NCT00004040|stage III multiple myeloma|stage iii multiple myeloma
5806802|NCT00004040|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5806803|NCT00004040|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5806804|NCT00004040|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5806805|NCT00004040|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5806807|NCT00004039|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5806808|NCT00004039|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5806809|NCT00004039|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5806810|NCT00004039|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5806811|NCT00004039|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5806812|NCT00004039|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5806813|NCT00004039|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5806814|NCT00004039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806815|NCT00004039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806816|NCT00004039|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806817|NCT00004039|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806818|NCT00004039|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5806819|NCT00004039|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5806820|NCT00004039|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5806821|NCT00004039|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5806822|NCT00004039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806823|NCT00004039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806824|NCT00004039|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806825|NCT00004039|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806826|NCT00004039|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5806827|NCT00004039|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5806828|NCT00004039|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5806829|NCT00004039|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5806830|NCT00004039|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5806831|NCT00004039|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806832|NCT00003957|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806833|NCT00003957|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5806834|NCT00003957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5806835|NCT00003957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5806836|NCT00003892|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5806837|NCT00003892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5806838|NCT00003828|stage IV melanoma|stage iv melanoma
5806839|NCT00003828|recurrent melanoma|recurrent melanoma
5806840|NCT00003821|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5806841|NCT00003810|stage III pancreatic cancer|stage iii pancreatic cancer
5806842|NCT00003810|stage IV pancreatic cancer|stage iv pancreatic cancer
5806843|NCT00003810|recurrent pancreatic cancer|recurrent pancreatic cancer
5806844|NCT00003810|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806845|NCT00003798|stage II pancreatic cancer|stage ii pancreatic cancer
5806846|NCT00003798|stage III pancreatic cancer|stage iii pancreatic cancer
5806847|NCT00003798|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806848|NCT00003786|stage IV colon cancer|stage iv colon cancer
5806849|NCT00003786|stage IV rectal cancer|stage iv rectal cancer
5806850|NCT00003786|recurrent colon cancer|recurrent colon cancer
5806851|NCT00003786|recurrent rectal cancer|recurrent rectal cancer
5806852|NCT00003786|adenocarcinoma of the colon|adenocarcinoma of the colon
5806854|NCT00003784|Waldenström macroglobulinemia|waldenström macroglobulinemia
5806855|NCT00003784|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5686615|NCT00551278|sentinel lymph node|sentinel lymph node
5806856|NCT00003784|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806857|NCT00003784|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806858|NCT00003784|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806859|NCT00003784|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806860|NCT00003784|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806861|NCT00003784|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5806862|NCT00003784|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5806863|NCT00003784|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5806864|NCT00003784|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5806865|NCT00003784|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5806866|NCT00003784|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5806867|NCT00003760|stage III pancreatic cancer|stage iii pancreatic cancer
5806868|NCT00003760|stage IV pancreatic cancer|stage iv pancreatic cancer
5806869|NCT00003760|recurrent pancreatic cancer|recurrent pancreatic cancer
5806870|NCT00003760|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5806871|NCT00003708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5806873|NCT00003681|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5806874|NCT00003681|refractory anemia with excess blasts|refractory anemia with excess blasts
5806875|NCT00003681|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806876|NCT00003681|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806877|NCT00003681|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5806879|NCT00003663|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5806880|NCT00003663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806881|NCT00003663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806882|NCT00003663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806883|NCT00003663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806884|NCT00003663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806885|NCT00003663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806886|NCT00003663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806887|NCT00003663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806888|NCT00003663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806889|NCT00003663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806890|NCT00003663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806891|NCT00003663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806892|NCT00003663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806893|NCT00003663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806894|NCT00003663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806895|NCT00003663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806896|NCT00003663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806897|NCT00003663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806898|NCT00003662|noninvasive thymoma and thymic carcinoma|noninvasive thymoma and thymic carcinoma
5806899|NCT00003662|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5806900|NCT00003662|refractory anemia|refractory anemia
5806901|NCT00003662|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5806902|NCT00003662|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806903|NCT00003662|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806904|NCT00003662|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5806905|NCT00003662|graft versus host disease|graft versus host disease
5806906|NCT00003662|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5806907|NCT00003661|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5806908|NCT00003661|stage 4S neuroblastoma|stage 4s neuroblastoma
5806909|NCT00003661|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5806910|NCT00003661|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5806911|NCT00003661|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5806912|NCT00003661|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5806913|NCT00003661|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5806914|NCT00003661|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5806915|NCT00003661|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5846878|NCT00042523|Autoantibody|autoantibody
5862639|NCT00001552|Voice Disorder|voice disorder
5806916|NCT00003661|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5806917|NCT00003661|refractory anemia with excess blasts|refractory anemia with excess blasts
5806918|NCT00003661|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5806377|NCT00089427|surgery|surgery
5806919|NCT00003661|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5806920|NCT00003661|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5806921|NCT00003661|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806922|NCT00003661|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5806923|NCT00003661|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5806924|NCT00003661|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5806925|NCT00003661|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5806926|NCT00003661|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5806927|NCT00003661|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5806928|NCT00003661|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5806929|NCT00003661|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806930|NCT00003661|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806931|NCT00003661|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5806932|NCT00003661|graft versus host disease|graft versus host disease
5803230|NCT00096083|recurrent rectal cancer|recurrent rectal cancer
5806933|NCT00003661|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5806934|NCT00003661|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5806935|NCT00003661|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5806936|NCT00003661|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5806937|NCT00003661|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5806938|NCT00003661|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5806939|NCT00003661|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5806940|NCT00003661|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806941|NCT00003661|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806942|NCT00003661|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806943|NCT00003661|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5806944|NCT00003605|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5806945|NCT00003605|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5806946|NCT00003605|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5806947|NCT00003605|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5806948|NCT00003605|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806949|NCT00003605|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5806950|NCT00003605|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5806951|NCT00003605|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5806952|NCT00003605|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5806953|NCT00003605|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5806954|NCT00003605|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5806955|NCT00003605|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5806956|NCT00003605|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5806957|NCT00003605|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5806958|NCT00003605|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5806959|NCT00003605|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5806960|NCT00003542|stage III renal cell cancer|stage iii renal cell cancer
5806961|NCT00003542|stage IV renal cell cancer|stage iv renal cell cancer
5806962|NCT00003539|stage IV breast cancer|stage iv breast cancer
5806963|NCT00003539|recurrent breast cancer|recurrent breast cancer
5806964|NCT00003431|stage IV colon cancer|stage iv colon cancer
5806965|NCT00003431|lung metastases|lung metastases
5806966|NCT00003431|liver metastases|liver metastases
5806967|NCT00003424|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5806968|NCT00003424|advanced adult primary liver cancer|advanced adult primary liver cancer
5806969|NCT00003424|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5806970|NCT00088673|Alzheimer Disease|alzheimer disease
5806971|NCT00003416|Waldenström macroglobulinemia|waldenström macroglobulinemia
5806972|NCT00003415|refractory anemia with excess blasts|refractory anemia with excess blasts
5806973|NCT00003415|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5806974|NCT00003415|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5806975|NCT00003415|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5806976|NCT00003415|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5806977|NCT00003413|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5806978|NCT00003413|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5806979|NCT00003413|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5806980|NCT00088751|Frontotemporal Dementia|frontotemporal dementia
5861139|NCT00004553|Macro-EMG|macro-emg
5806981|NCT00088751|Alzheimer's Disease|alzheimer's disease
5806983|NCT00088751|Stimulant|stimulant
5806984|NCT00088751|Apathy|apathy
5806985|NCT00088751|Disinhibition|disinhibition
5806986|NCT00088751|Antipsychotic|antipsychotic
5806987|NCT00088751|Biomarkers|biomarkers
5806988|NCT00088751|Dementia|dementia
5806990|NCT00088738|Tachykinin|tachykinin
5806991|NCT00088738|Anxiety|anxiety
5806992|NCT00088738|Neuroreceptor|neuroreceptor
5806993|NCT00088738|Internalization|internalization
5806994|NCT00088738|Carbon Dioxide|carbon dioxide
5806995|NCT00088738|Healthy Volunteer|healthy volunteer
5806996|NCT00088738|HV|hv
5806997|NCT00088738|Panic Disorder|panic disorder
5806998|NCT00088712|Behavior and Neurocognition|behavior and neurocognition
5806999|NCT00088712|Functional Brian Activity|functional brian activity
5807000|NCT00088712|Visual Perception|visual perception
5807002|NCT00088712|Information Processing|information processing
5807003|NCT00088712|Age Differences|age differences
5807004|NCT00088712|Childhood Growth and Development|childhood growth and development
5807005|NCT00088712|Cognitive Development|cognitive development
5807006|NCT00088712|Brain Connectivity|brain connectivity
5807007|NCT00088712|Healthy Volunteer|healthy volunteer
5807008|NCT00088712|HV|hv
5807009|NCT00088699|Depression|depression
5807010|NCT00088699|NMDA Antagonist|nmda antagonist
5807011|NCT00088699|Treatment Resistant|treatment resistant
5807013|NCT00088699|Major Depression|major depression
5807016|NCT00088686|Capsaicin|capsaicin
5807020|NCT00088686|Visual Analog Scale (VAS)|visual analog scale (vas)
5807021|NCT00088686|Wisdom Teeth|wisdom teeth
5807022|NCT00088686|Third Molar Extraction|third molar extraction
5807023|NCT00088660|Metastatic|metastatic
5807024|NCT00088647|advanced malignant solid tumors|advanced malignant solid tumors
5807025|NCT00088647|breast cancer|breast cancer
5807026|NCT00088634|Schizophrenia|schizophrenia
5807027|NCT00088634|Latuda|latuda
5807028|NCT00088634|Lurasidone|lurasidone
5807029|NCT00088621|Schizophrenia|schizophrenia
5807030|NCT00088621|Latuda|latuda
5807031|NCT00088621|Lurasidone|lurasidone
5807032|NCT00088595|SOM230|som230
5807033|NCT00088595|Sandostatin|sandostatin
5807034|NCT00088595|Carcinoid syndrome|carcinoid syndrome
5807035|NCT00088582|Acromegaly|acromegaly
5807036|NCT00088582|SOM230|som230
5807037|NCT00088582|Sandostatin|sandostatin
5807038|NCT00003358|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5807039|NCT00003358|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5807040|NCT00003358|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5807041|NCT00003358|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5807042|NCT00003358|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5807043|NCT00003358|fallopian tube cancer|fallopian tube cancer
5807044|NCT00003358|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5807045|NCT00003305|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5807046|NCT00003305|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5807047|NCT00003305|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807048|NCT00003305|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807049|NCT00003259|stage IV prostate cancer|stage iv prostate cancer
5807050|NCT00003256|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5807051|NCT00003256|stage IV prostate cancer|stage iv prostate cancer
5807052|NCT00003214|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5807053|NCT00003214|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5807054|NCT00003213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807055|NCT00003213|nausea and vomiting|nausea and vomiting
5807056|NCT00003182|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5807057|NCT00003182|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5807058|NCT00003182|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5807059|NCT00003182|stage III salivary gland cancer|stage iii salivary gland cancer
5807060|NCT00003182|stage IV salivary gland cancer|stage iv salivary gland cancer
5807061|NCT00003182|recurrent salivary gland cancer|recurrent salivary gland cancer
5807062|NCT00003182|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5807063|NCT00003182|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5807064|NCT00003182|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5807065|NCT00003182|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5807066|NCT00003182|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5807067|NCT00003182|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5807068|NCT00003182|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5807069|NCT00003182|stage III laryngeal cancer|stage iii laryngeal cancer
5807070|NCT00003182|stage IV laryngeal cancer|stage iv laryngeal cancer
5807071|NCT00003182|recurrent laryngeal cancer|recurrent laryngeal cancer
5807072|NCT00003182|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5807073|NCT00003182|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5807074|NCT00003182|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5807075|NCT00003182|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5807076|NCT00003182|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5807077|NCT00003182|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5686616|NCT00551278|metastasis|metastasis
5807078|NCT00003182|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5807079|NCT00003182|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5807080|NCT00003182|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5807081|NCT00003182|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5807082|NCT00003182|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5807083|NCT00003182|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5807084|NCT00003182|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5807085|NCT00003182|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5807086|NCT00003182|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5807087|NCT00003182|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5807088|NCT00003182|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5807089|NCT00003182|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5807090|NCT00003182|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5807091|NCT00003182|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5807092|NCT00003182|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5807093|NCT00003182|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5807094|NCT00003182|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5807095|NCT00003182|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5807096|NCT00003158|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5807097|NCT00003158|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5807098|NCT00003152|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5807099|NCT00003152|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5807100|NCT00003152|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5807101|NCT00003152|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5807102|NCT00003152|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5807103|NCT00003152|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5807104|NCT00003097|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5807105|NCT00003097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5807106|NCT00003090|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807107|NCT00003087|stage II esophageal cancer|stage ii esophageal cancer
5807108|NCT00003087|stage III esophageal cancer|stage iii esophageal cancer
5807109|NCT00003087|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5807110|NCT00003087|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5807111|NCT00003068|stage IV breast cancer|stage iv breast cancer
5807112|NCT00003068|stage IIIA breast cancer|stage iiia breast cancer
5807113|NCT00003068|recurrent breast cancer|recurrent breast cancer
5807114|NCT00003068|stage IIIB breast cancer|stage iiib breast cancer
5807115|NCT00003068|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5807117|NCT00088569|Working Memory|working memory
5807118|NCT00088569|Treatment|treatment
5807119|NCT00088569|Transcranial|transcranial
5807120|NCT00088569|Electrical|electrical
5807121|NCT00088569|Healthy Volunteer|healthy volunteer
5807123|NCT00088556|Non-small cell lung cancer|non-small cell lung cancer
5807124|NCT00088543|Acute myelogenous leukemia (AML)|acute myelogenous leukemia (aml)
5807125|NCT00088543|Acute lymphocytic leukemia (ALL)|acute lymphocytic leukemia (all)
5807126|NCT00088543|Anti-T cell antibodies|anti-t cell antibodies
5807127|NCT00088543|Allogenic stem cell transplant|allogenic stem cell transplant
5807128|NCT00088543|Graft vs. Host Disease (GvHD)|graft vs. host disease (gvhd)
5807129|NCT00003055|stage III gastric cancer|stage iii gastric cancer
5807130|NCT00003055|stage IV gastric cancer|stage iv gastric cancer
5807131|NCT00003055|recurrent gastric cancer|recurrent gastric cancer
5807132|NCT00003055|stage III esophageal cancer|stage iii esophageal cancer
5807133|NCT00003055|stage IV esophageal cancer|stage iv esophageal cancer
5807134|NCT00003055|recurrent esophageal cancer|recurrent esophageal cancer
5807135|NCT00003055|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5807136|NCT00003050|stage II breast cancer|stage ii breast cancer
5807137|NCT00003050|stage IIIA breast cancer|stage iiia breast cancer
5807138|NCT00003050|stage IIIB breast cancer|stage iiib breast cancer
5807139|NCT00003002|stage III breast cancer|stage iii breast cancer
5807140|NCT00003002|stage IV breast cancer|stage iv breast cancer
5807141|NCT00003002|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5807142|NCT00003002|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5807143|NCT00003002|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5807144|NCT00003002|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5807145|NCT00003002|adenocarcinoma of the lung|adenocarcinoma of the lung
5686617|NCT00551278|molecular pathology|molecular pathology
5807146|NCT00003000|pain|pain
5807147|NCT00002984|stage II esophageal cancer|stage ii esophageal cancer
5807148|NCT00002984|stage III esophageal cancer|stage iii esophageal cancer
5807149|NCT00002984|stage IV esophageal cancer|stage iv esophageal cancer
5807150|NCT00002984|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5807151|NCT00002984|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5807152|NCT00002921|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5807153|NCT00002921|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5807154|NCT00002833|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807155|NCT00002833|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807324|NCT00088387|Tau|tau
5807156|NCT00002833|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5807157|NCT00002833|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5807158|NCT00002833|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807159|NCT00002833|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5807160|NCT00002833|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5807161|NCT00002833|refractory anemia with excess blasts|refractory anemia with excess blasts
5807162|NCT00002833|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5807163|NCT00002833|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5807164|NCT00002833|graft versus host disease|graft versus host disease
5807166|NCT00088530|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5807168|NCT00002832|Dacogen|dacogen
5807169|NCT00002832|Filgrastim|filgrastim
5807170|NCT00002832|G-CSF|g-csf
5807171|NCT00002832|Neupogen|neupogen
5807172|NCT00002832|Cyclosporine|cyclosporine
5807173|NCT00002832|Sandimmune|sandimmune
5807174|NCT00002832|CYA|cya
5807175|NCT00002832|Cyclosporin A|cyclosporin a
5807176|NCT00002832|Peripheral blood stem cells|peripheral blood stem cells
5807177|NCT00002832|PBSC|pbsc
5807178|NCT00002832|Allogeneic bone marrow transplantation|allogeneic bone marrow transplantation
5807179|NCT00002832|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5807180|NCT00002832|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5807181|NCT00002832|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807182|NCT00002832|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807183|NCT00002832|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5807184|NCT00002832|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807185|NCT00002832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807186|NCT00002832|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5807187|NCT00002831|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807188|NCT00002831|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5807189|NCT00002831|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807190|NCT00002824|recurrent adult brain tumor|recurrent adult brain tumor
5807191|NCT00002824|adult glioblastoma|adult glioblastoma
5807192|NCT00002824|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5807193|NCT00002824|adult giant cell glioblastoma|adult giant cell glioblastoma
5807194|NCT00002824|adult gliosarcoma|adult gliosarcoma
5807195|NCT00002784|stage II breast cancer|stage ii breast cancer
5807196|NCT00002784|stage IIIA breast cancer|stage iiia breast cancer
5807197|NCT00002779|Waldenström macroglobulinemia|waldenström macroglobulinemia
5807198|NCT00002779|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807199|NCT00002779|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5807200|NCT00002779|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5807201|NCT00002779|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5807202|NCT00002779|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807203|NCT00002779|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807204|NCT00002779|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807205|NCT00002754|recurrent adult brain tumor|recurrent adult brain tumor
5807206|NCT00002754|adult glioblastoma|adult glioblastoma
5807207|NCT00002754|stage IV melanoma|stage iv melanoma
5807208|NCT00002754|tumors metastatic to brain|tumors metastatic to brain
5807209|NCT00002754|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5807210|NCT00002754|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5807211|NCT00002754|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5807212|NCT00002754|adult mixed glioma|adult mixed glioma
5807213|NCT00002754|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5807214|NCT00002754|adult giant cell glioblastoma|adult giant cell glioblastoma
5807215|NCT00002754|adult gliosarcoma|adult gliosarcoma
5807216|NCT00002753|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5807217|NCT00002753|recurrent childhood brain tumor|recurrent childhood brain tumor
5807218|NCT00002753|recurrent adult brain tumor|recurrent adult brain tumor
5807219|NCT00002753|adult glioblastoma|adult glioblastoma
5686618|NCT00551239|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5807220|NCT00002753|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5807221|NCT00002753|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5807222|NCT00002753|adult anaplastic ependymoma|adult anaplastic ependymoma
5807223|NCT00002753|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5807224|NCT00002753|adult mixed glioma|adult mixed glioma
5807225|NCT00002753|adult ependymoblastoma|adult ependymoblastoma
5807226|NCT00002753|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5807227|NCT00002753|recurrent childhood ependymoma|recurrent childhood ependymoma
5807228|NCT00002753|adult giant cell glioblastoma|adult giant cell glioblastoma
5807229|NCT00002753|adult gliosarcoma|adult gliosarcoma
5807230|NCT00002688|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807231|NCT00002675|intraocular retinoblastoma|intraocular retinoblastoma
5807232|NCT00002665|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5807233|NCT00002665|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5807234|NCT00002665|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5807235|NCT00002665|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5807237|NCT00002665|thrombocytopenia|thrombocytopenia
5807238|NCT00002630|refractory multiple myeloma|refractory multiple myeloma
5807239|NCT00002630|stage II multiple myeloma|stage ii multiple myeloma
5807244|NCT00002627|inflammatory breast cancer|inflammatory breast cancer
5807245|NCT00002618|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5807246|NCT00002618|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5807247|NCT00002618|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5807248|NCT00002618|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5807249|NCT00002618|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5807250|NCT00002618|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5807251|NCT00002618|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5807252|NCT00002618|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5807253|NCT00002604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807254|NCT00002588|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807255|NCT00002588|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807256|NCT00002588|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807257|NCT00002588|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807258|NCT00002588|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5807259|NCT00002588|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5807260|NCT00002588|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5807261|NCT00002588|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5807262|NCT00002588|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5807263|NCT00002588|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5807264|NCT00002588|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5807265|NCT00002588|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5807266|NCT00002588|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5807267|NCT00002588|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5807268|NCT00002588|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5807269|NCT00002588|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5807270|NCT00002572|recurrent adult brain tumor|recurrent adult brain tumor
5807271|NCT00002572|adult glioblastoma|adult glioblastoma
5807272|NCT00002572|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5807273|NCT00002572|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5807274|NCT00002572|adult mixed glioma|adult mixed glioma
5807275|NCT00002572|adult giant cell glioblastoma|adult giant cell glioblastoma
5807276|NCT00002572|adult gliosarcoma|adult gliosarcoma
5807277|NCT00002542|stage I breast cancer|stage i breast cancer
5807278|NCT00002542|stage II breast cancer|stage ii breast cancer
5807279|NCT00002542|stage IIIA breast cancer|stage iiia breast cancer
5807280|NCT00002535|stage III melanoma|stage iii melanoma
5807281|NCT00002535|stage IV melanoma|stage iv melanoma
5807282|NCT00002535|recurrent melanoma|recurrent melanoma
5807283|NCT00002529|stage II breast cancer|stage ii breast cancer
5807284|NCT00002529|stage IIIA breast cancer|stage iiia breast cancer
5807285|NCT00088517|Biodistribution|biodistribution
5807286|NCT00088517|MIRD|mird
5807287|NCT00088517|Radiation Absorbed Dose|radiation absorbed dose
5807288|NCT00088517|Healthy|healthy
5807289|NCT00088517|Prefrontal Cortex|prefrontal cortex
5807290|NCT00088517|Radiation Exposure|radiation exposure
5807291|NCT00088517|PET|pet
5807292|NCT00088517|Dopamine D1 Receptor|dopamine d1 receptor
5807293|NCT00088517|(11C)NNC-112|(11c)nnc-112
5807294|NCT00088517|Healthy Volunteer|healthy volunteer
5807295|NCT00088517|HV|hv
5807296|NCT00088504|Hepatitis|hepatitis
5807297|NCT00088452|childhood absence epilepsy|childhood absence epilepsy
5807298|NCT00088452|CAE|cae
5686619|NCT00551239|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5807299|NCT00088452|petit mal epilepsy|petit mal epilepsy
5807301|NCT00088452|seizures|seizures
5807302|NCT00088452|ethosuximide|ethosuximide
5807303|NCT00088452|lamotrigine|lamotrigine
5807304|NCT00088452|valproic acid|valproic acid
5807310|NCT00088413|CEA|cea
5807311|NCT00088413|Vaccine|vaccine
5807312|NCT00088413|Immunotherapy|immunotherapy
5807313|NCT00088413|MUC-1|muc-1
5807314|NCT00088413|Cancer|cancer
5807315|NCT00088413|Adenocarcinoma|adenocarcinoma
5807316|NCT00088413|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5807317|NCT00088400|Transferrin|transferrin
5807318|NCT00088400|Brain Tumor|brain tumor
5807319|NCT00088400|Convection|convection
5807320|NCT00088400|Immunotherapy|immunotherapy
5807321|NCT00088400|Targeted Protein Toxin|targeted protein toxin
5807322|NCT00088400|Glioblastoma Multiforme|glioblastoma multiforme
5807323|NCT00088400|GBM|gbm
5807327|NCT00088387|Amyloid Beta|amyloid beta
5807328|NCT00088387|Beta-Catenin|beta-catenin
5807329|NCT00088387|Alzheimer Disease|alzheimer disease
5807331|NCT00088374|Kidney Cancer|kidney cancer
5807333|NCT00088374|17 AAG|17 aag
5807334|NCT00088374|Chemotherapy|chemotherapy
5807335|NCT00088374|Von Hippel Lindau Disease|von hippel lindau disease
5807336|NCT00088374|Renal Tumor|renal tumor
5807337|NCT00088361|Reconstruction|reconstruction
5807338|NCT00088361|PET Artifacts|pet artifacts
5807339|NCT00088361|PET/CT Motion Artifacts|pet/ct motion artifacts
5807340|NCT00088361|Liver|liver
5807341|NCT00088361|Heart|heart
5807342|NCT00088361|Respiratory Motion|respiratory motion
5807343|NCT00088348|Cornea|cornea
5807344|NCT00088348|Conjunctiva|conjunctiva
5807345|NCT00088348|Keratitis|keratitis
5807346|NCT00088348|Ocular Surface|ocular surface
5807347|NCT00088348|Inflammation|inflammation
5807348|NCT00088348|Evaluation|evaluation
5807349|NCT00088348|Screening|screening
5807350|NCT00088348|Ocular Surface Disease|ocular surface disease
5807351|NCT00088348|Eye|eye
5807352|NCT00088348|Ocular Disease|ocular disease
5807353|NCT00088348|Anterior Segment Disease|anterior segment disease
5807354|NCT00088335|Parkinsonism|parkinsonism
5807355|NCT00088335|Biomarker|biomarker
5807356|NCT00088335|Proteomics|proteomics
5807357|NCT00088335|Parkinson's Disease|parkinson's disease
5807358|NCT00088335|Neurodegenerative Disorders|neurodegenerative disorders
5807359|NCT00088335|Parkinson Disease|parkinson disease
5807360|NCT00088335|PD|pd
5807361|NCT00088309|Drug Resistance|drug resistance
5807362|NCT00088309|HAART|haart
5807363|NCT00088309|Pamidronate|pamidronate
5807364|NCT00088309|Osteopenia|osteopenia
5807365|NCT00088309|Pediatric|pediatric
5807366|NCT00088309|HIV|hiv
5807367|NCT00088309|Pediatrics|pediatrics
5807368|NCT00088309|Treatment Experienced|treatment experienced
5807369|NCT00088296|Osteoarthritis|osteoarthritis
5807370|NCT00088296|MS Contin|ms contin
5807371|NCT00088296|Placebo|placebo
5807372|NCT00088296|Cortisol|cortisol
5807373|NCT00088296|Testosterone|testosterone
5807374|NCT00088296|Degenerative Joint Disease|degenerative joint disease
5807375|NCT00088296|OA|oa
5807376|NCT00088296|Arthritis|arthritis
5807377|NCT00088296|Joint Pain|joint pain
5807378|NCT00088296|Arthritic Pain|arthritic pain
5807379|NCT00088296|Opioid|opioid
5807380|NCT00088283|CRVO|crvo
5807381|NCT00088283|Central Retinal Vein Occlusion|central retinal vein occlusion
5807382|NCT00088283|RVO|rvo
5807383|NCT00088283|Retinal Vein Occlusion|retinal vein occlusion
5807384|NCT00005884|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5807385|NCT00005884|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5807386|NCT00005852|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5807387|NCT00005852|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807388|NCT00005852|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5807389|NCT00005852|refractory multiple myeloma|refractory multiple myeloma
5807390|NCT00005852|stage I multiple myeloma|stage i multiple myeloma
5807391|NCT00005852|stage II multiple myeloma|stage ii multiple myeloma
5807392|NCT00005852|stage III multiple myeloma|stage iii multiple myeloma
5807393|NCT00005852|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5807394|NCT00005852|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5807395|NCT00005852|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807396|NCT00005852|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807397|NCT00005852|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807398|NCT00005852|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5807399|NCT00005852|primary myelofibrosis|primary myelofibrosis
5807400|NCT00005852|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5807401|NCT00005852|refractory hairy cell leukemia|refractory hairy cell leukemia
5807402|NCT00005852|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5807403|NCT00005852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5807404|NCT00005852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5846879|NCT00042523|Anti-DNA Antibody|anti-dna antibody
5807405|NCT00005852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5807406|NCT00005852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5807407|NCT00005852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5807408|NCT00005852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5807409|NCT00005852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5807410|NCT00005852|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5807411|NCT00005852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5807412|NCT00005852|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807413|NCT00005852|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5807414|NCT00005852|graft versus host disease|graft versus host disease
5807415|NCT00005852|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808024|NCT00088023|Solid tumors|solid tumors
5807416|NCT00005852|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5807418|NCT00005852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807419|NCT00005852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807420|NCT00005852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807421|NCT00005852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807422|NCT00005852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5807423|NCT00005852|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5807424|NCT00005805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5807425|NCT00005805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5807426|NCT00005805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5807427|NCT00005805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5807428|NCT00005805|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5807429|NCT00005805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807430|NCT00005805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5807431|NCT00005805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5807432|NCT00005805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5807433|NCT00005805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5807434|NCT00005805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5807435|NCT00005805|childhood Burkitt lymphoma|childhood burkitt lymphoma
5807436|NCT00005805|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5807437|NCT00005805|extramedullary plasmacytoma|extramedullary plasmacytoma
5807438|NCT00005805|refractory multiple myeloma|refractory multiple myeloma
5807439|NCT00005805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5807440|NCT00005805|Waldenström macroglobulinemia|waldenström macroglobulinemia
5807441|NCT00005805|stage I multiple myeloma|stage i multiple myeloma
5807442|NCT00005805|stage II multiple myeloma|stage ii multiple myeloma
5807443|NCT00005805|stage III multiple myeloma|stage iii multiple myeloma
5807444|NCT00005805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5807445|NCT00005805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5807446|NCT00005805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5807447|NCT00005805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5807448|NCT00005805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5807449|NCT00005805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807450|NCT00005805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807451|NCT00005805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807452|NCT00005805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5807453|NCT00005805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807454|NCT00005805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5807455|NCT00005805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5807456|NCT00005805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807457|NCT00005805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5807458|NCT00005805|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5807459|NCT00005805|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5807460|NCT00005805|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5807461|NCT00005805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5807462|NCT00005805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5807463|NCT00005805|polycythemia vera|polycythemia vera
5807464|NCT00005805|primary myelofibrosis|primary myelofibrosis
5807465|NCT00005805|essential thrombocythemia|essential thrombocythemia
5807466|NCT00005805|untreated hairy cell leukemia|untreated hairy cell leukemia
5807467|NCT00005805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5862640|NCT00001551|Stuttering|stuttering
5806878|NCT00003681|anemia|anemia
5807468|NCT00005805|refractory hairy cell leukemia|refractory hairy cell leukemia
5861140|NCT00004553|Myasthenia|myasthenia
5807469|NCT00005805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5807470|NCT00005805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5807471|NCT00005805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5807472|NCT00005805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5807473|NCT00005805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5807474|NCT00005805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5807475|NCT00005805|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5807476|NCT00005805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5807477|NCT00005805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5807478|NCT00005805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5807479|NCT00005805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5807480|NCT00005805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5807481|NCT00005805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5807482|NCT00005805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5807483|NCT00005805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5807484|NCT00005805|stage I adult non-Hodgkin lymphoma|stage i adult non-hodgkin lymphoma
5807485|NCT00005805|stage II adult non-Hodgkin lymphoma|stage ii adult non-hodgkin lymphoma
5807486|NCT00005805|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5807487|NCT00005805|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5807488|NCT00005805|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5807489|NCT00005805|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5807490|NCT00005805|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5807491|NCT00005805|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5807492|NCT00005805|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5807493|NCT00005805|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5807494|NCT00005805|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5807495|NCT00005805|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5807496|NCT00005805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5807497|NCT00005805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5807498|NCT00005805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5807499|NCT00005805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5807500|NCT00005805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5807501|NCT00005805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5807502|NCT00005805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5807503|NCT00005805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5807504|NCT00005805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5807505|NCT00005805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5807506|NCT00005805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5807507|NCT00005805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5807508|NCT00005805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5807509|NCT00005805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5807510|NCT00005805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5807511|NCT00005805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5807512|NCT00005805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5807513|NCT00005805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5807514|NCT00005805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5807515|NCT00005805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5807516|NCT00005805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807517|NCT00005805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5807518|NCT00005805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5807519|NCT00005805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5807520|NCT00005805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5807521|NCT00005805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5807522|NCT00005805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5807523|NCT00005805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5807524|NCT00005805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5807525|NCT00005805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5807526|NCT00005805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5807527|NCT00005805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5807528|NCT00005805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5807529|NCT00005805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5807530|NCT00005805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5807531|NCT00005805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5807532|NCT00005805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807533|NCT00005805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5807534|NCT00005805|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5807536|NCT00005805|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5807537|NCT00005805|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5807538|NCT00005805|primary systemic amyloidosis|primary systemic amyloidosis
5807539|NCT00005805|intraocular lymphoma|intraocular lymphoma
5807540|NCT00005805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5807541|NCT00005805|contiguous stage II adult non-Hodgkin lymphoma|contiguous stage ii adult non-hodgkin lymphoma
5807542|NCT00005805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5807543|NCT00005805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5807544|NCT00005805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5807670|NCT00004875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5807545|NCT00005805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5807546|NCT00005805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5807547|NCT00005805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5807548|NCT00005805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5807549|NCT00005805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5807550|NCT00005805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5807551|NCT00005805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5807552|NCT00005805|noncontiguous stage II adult non-Hodgkin lymphoma|noncontiguous stage ii adult non-hodgkin lymphoma
5807553|NCT00005805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5807554|NCT00005805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5807555|NCT00005805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5807556|NCT00005805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5807557|NCT00005805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5807558|NCT00005805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5807559|NCT00005805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5807560|NCT00005805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5807561|NCT00005805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5807562|NCT00005805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5807564|NCT00005805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5807565|NCT00005805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5807566|NCT00005805|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5807567|NCT00005805|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5807568|NCT00005805|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5807570|NCT00005805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5807571|NCT00005805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5807572|NCT00005805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807573|NCT00005805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5807574|NCT00005805|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5807575|NCT00005805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5807576|NCT00005805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5807577|NCT00005805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5807578|NCT00005805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5807579|NCT00005805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807580|NCT00005805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807581|NCT00005805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5807582|NCT00005633|stage III melanoma|stage iii melanoma
5807583|NCT00005633|stage IV melanoma|stage iv melanoma
5807584|NCT00005633|recurrent melanoma|recurrent melanoma
5807585|NCT00005624|refractory multiple myeloma|refractory multiple myeloma
5807586|NCT00005624|stage II multiple myeloma|stage ii multiple myeloma
5807587|NCT00005624|stage III multiple myeloma|stage iii multiple myeloma
5807588|NCT00005624|plasma cell neoplasm|plasma cell neoplasm
5807589|NCT00005614|stage IV breast cancer|stage iv breast cancer
5807590|NCT00005614|recurrent breast cancer|recurrent breast cancer
5807591|NCT00005611|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807592|NCT00004902|refractory multiple myeloma|refractory multiple myeloma
5807593|NCT00004902|stage I multiple myeloma|stage i multiple myeloma
5807594|NCT00004902|stage II multiple myeloma|stage ii multiple myeloma
5807595|NCT00004902|stage III multiple myeloma|stage iii multiple myeloma
5807596|NCT00004901|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5807597|NCT00004901|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5807598|NCT00004901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5807599|NCT00004901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5807600|NCT00004901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5807601|NCT00004901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5807602|NCT00004901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5807603|NCT00004901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5807605|NCT00004901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5807606|NCT00004901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5807607|NCT00004901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5807608|NCT00004901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5807609|NCT00004901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5807610|NCT00004901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5807611|NCT00004901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5807612|NCT00004901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5807613|NCT00004901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5807614|NCT00004901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5807615|NCT00004901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5807616|NCT00004901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5807617|NCT00004901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5807618|NCT00004901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5807619|NCT00004901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5807620|NCT00004897|stage I esophageal cancer|stage i esophageal cancer
5807621|NCT00004897|stage II esophageal cancer|stage ii esophageal cancer
5807622|NCT00004897|stage III esophageal cancer|stage iii esophageal cancer
5807623|NCT00004897|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5807624|NCT00004897|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5807625|NCT00004875|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5807626|NCT00004875|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5807627|NCT00004875|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5807628|NCT00004875|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5807629|NCT00004875|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807630|NCT00004875|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807631|NCT00004875|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5807632|NCT00004875|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5807633|NCT00004875|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5807634|NCT00004875|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5807635|NCT00004875|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5807636|NCT00004875|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5807637|NCT00004875|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5807638|NCT00004875|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5807639|NCT00004875|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5807640|NCT00004875|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5807641|NCT00004875|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5807642|NCT00004875|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5807643|NCT00004875|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5807644|NCT00004875|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5807645|NCT00004875|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5807646|NCT00004875|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5807647|NCT00004875|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5807648|NCT00004875|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5807649|NCT00004875|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5807650|NCT00004875|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5807651|NCT00004875|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5807652|NCT00004875|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5807653|NCT00004875|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5807654|NCT00004875|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5807655|NCT00004875|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5862641|NCT00001551|Linkage|linkage
5807656|NCT00004875|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5861260|NCT00001969|Volunteer|volunteer
5807657|NCT00004875|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5807658|NCT00004875|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5807659|NCT00004875|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5807660|NCT00004875|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5807661|NCT00004875|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5807662|NCT00004875|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5807663|NCT00004875|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5807664|NCT00004875|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5807665|NCT00004875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5807666|NCT00004875|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5807667|NCT00004875|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5807668|NCT00004875|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5807669|NCT00004875|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5807671|NCT00004875|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5807672|NCT00004875|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5807673|NCT00004875|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5807674|NCT00004875|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5807675|NCT00004875|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5807676|NCT00004875|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5807677|NCT00004875|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5807678|NCT00004875|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5807679|NCT00004875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5807680|NCT00004875|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5807681|NCT00004875|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5807682|NCT00004875|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5807683|NCT00004875|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5807684|NCT00004875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5807685|NCT00004875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5807686|NCT00004875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5807687|NCT00004875|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5807688|NCT00004875|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5807689|NCT00004875|thromboembolism|thromboembolism
5807690|NCT00004875|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5807691|NCT00004875|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5807692|NCT00004875|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807693|NCT00004875|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807694|NCT00004875|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5807695|NCT00004875|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5807696|NCT00004875|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5807697|NCT00004875|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5807698|NCT00004875|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5807699|NCT00004875|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5807700|NCT00004875|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5807701|NCT00004875|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5807702|NCT00004875|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807703|NCT00004875|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807704|NCT00004875|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5807705|NCT00004265|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807706|NCT00004264|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807707|NCT00004264|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5807708|NCT00004264|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5807709|NCT00004263|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807710|NCT00004263|refractory anemia with excess blasts|refractory anemia with excess blasts
5807711|NCT00004263|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5807712|NCT00004263|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807714|NCT00004263|Ara-C|ara-c
5807715|NCT00004263|Cytosar|cytosar
5807716|NCT00004263|DepoCyt|depocyt
5807717|NCT00004263|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5807718|NCT00004263|cytarabine|cytarabine
5807719|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine
5807720|NCT00004263|UCN-01|ucn-01
5807721|NCT00004258|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5807722|NCT00004258|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5807723|NCT00004258|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5807724|NCT00004258|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807725|NCT00004258|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5807726|NCT00004258|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5804207|NCT00091624|CC-5013|cc-5013
5807727|NCT00004258|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5807728|NCT00004258|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5807729|NCT00004258|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5807730|NCT00004258|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5807731|NCT00004258|extramedullary plasmacytoma|extramedullary plasmacytoma
5807732|NCT00004258|refractory multiple myeloma|refractory multiple myeloma
5807733|NCT00004258|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5807734|NCT00004258|stage III multiple myeloma|stage iii multiple myeloma
5807735|NCT00004258|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5807736|NCT00004258|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5807737|NCT00004258|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807738|NCT00004258|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807739|NCT00004258|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807740|NCT00004258|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5807741|NCT00004258|small intestine lymphoma|small intestine lymphoma
5807742|NCT00004258|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807743|NCT00004258|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5807744|NCT00004258|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807745|NCT00004258|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5807746|NCT00004258|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5807747|NCT00004258|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5807748|NCT00004258|polycythemia vera|polycythemia vera
5807749|NCT00004258|essential thrombocythemia|essential thrombocythemia
5807750|NCT00004258|untreated hairy cell leukemia|untreated hairy cell leukemia
5807751|NCT00004258|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5807752|NCT00004258|refractory hairy cell leukemia|refractory hairy cell leukemia
5807753|NCT00004258|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5807754|NCT00004258|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5807755|NCT00004258|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5807756|NCT00004258|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5807757|NCT00004258|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5807758|NCT00004258|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5807759|NCT00004258|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5807760|NCT00004258|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5807761|NCT00004258|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5807762|NCT00004258|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5807763|NCT00004258|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5807764|NCT00004258|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5807765|NCT00004258|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5807766|NCT00004258|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5807767|NCT00004258|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5807768|NCT00004258|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5807769|NCT00004258|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5807770|NCT00004258|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5807771|NCT00004258|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5807772|NCT00004258|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5807773|NCT00004258|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5807774|NCT00004258|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5807775|NCT00004258|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5807776|NCT00004258|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5807777|NCT00004258|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5807778|NCT00004258|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5807779|NCT00004258|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5807780|NCT00004258|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5807781|NCT00004258|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5807782|NCT00004258|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5807783|NCT00004258|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5818126|NCT00079651|Aged|aged
5807784|NCT00004258|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5807785|NCT00004258|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5846880|NCT00042523|Cross-Reactivity|cross-reactivity
5807786|NCT00004258|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5807787|NCT00004258|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807788|NCT00004258|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5807789|NCT00004258|prolymphocytic leukemia|prolymphocytic leukemia
5807790|NCT00004258|primary systemic amyloidosis|primary systemic amyloidosis
5807791|NCT00004258|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5807792|NCT00004258|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5807793|NCT00004258|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5807794|NCT00004258|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5807795|NCT00004258|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5807796|NCT00004258|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807797|NCT00004258|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807798|NCT00004258|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5807799|NCT00004258|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5807800|NCT00004258|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5807801|NCT00004258|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808023|NCT00003225|recurrent rectal cancer|recurrent rectal cancer
5807802|NCT00004258|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807803|NCT00004258|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807804|NCT00004258|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5807805|NCT00004169|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807806|NCT00004169|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5807807|NCT00004159|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807808|NCT00004159|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5807809|NCT00003942|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5807810|NCT00003942|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5807811|NCT00003942|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5807812|NCT00003942|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5807813|NCT00003942|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5807814|NCT00003942|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5807815|NCT00003942|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5807816|NCT00003936|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807817|NCT00003929|primary central nervous system lymphoma|primary central nervous system lymphoma
5807818|NCT00003929|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5807819|NCT00002506|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807820|NCT00002506|recurrent esophageal cancer|recurrent esophageal cancer
5807821|NCT00002506|recurrent cervical cancer|recurrent cervical cancer
5807822|NCT00002506|squamous cell lung cancer|squamous cell lung cancer
5807823|NCT00002506|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5807824|NCT00002506|recurrent penile cancer|recurrent penile cancer
5807825|NCT00002506|recurrent skin cancer|recurrent skin cancer
5807826|NCT00002506|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5807827|NCT00002506|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5807828|NCT00002506|penile squamous cell carcinoma|penile squamous cell carcinoma
5807829|NCT00002506|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5807830|NCT00002506|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5807831|NCT00002506|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5807832|NCT00002506|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5807833|NCT00002506|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5807834|NCT00002506|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5807835|NCT00002504|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5807836|NCT00002504|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5807837|NCT00002504|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5807838|NCT00002504|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5807839|NCT00002504|extramedullary plasmacytoma|extramedullary plasmacytoma
5807840|NCT00002504|refractory multiple myeloma|refractory multiple myeloma
5807841|NCT00002504|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5807842|NCT00002504|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5807844|NCT00002504|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5807845|NCT00002504|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5807846|NCT00002504|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5862642|NCT00001551|Pedigree|pedigree
5807847|NCT00002504|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807848|NCT00002504|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5814391|NCT00005842|glucagonoma|glucagonoma
5807849|NCT00002504|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5846881|NCT00042523|Neuron Loss|neuron loss
5807850|NCT00002504|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5807851|NCT00002504|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5807852|NCT00002504|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5807853|NCT00002504|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5807854|NCT00002504|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5807855|NCT00002504|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5807856|NCT00002504|polycythemia vera|polycythemia vera
5807857|NCT00002504|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5807858|NCT00002504|essential thrombocythemia|essential thrombocythemia
5807859|NCT00002504|untreated hairy cell leukemia|untreated hairy cell leukemia
5807860|NCT00002504|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5807861|NCT00002504|refractory hairy cell leukemia|refractory hairy cell leukemia
5807862|NCT00002504|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5807863|NCT00002504|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5807864|NCT00002504|acute undifferentiated leukemia|acute undifferentiated leukemia
5807865|NCT00002504|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5807866|NCT00002504|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5807867|NCT00002504|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5807868|NCT00002504|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5807869|NCT00002504|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5807870|NCT00002504|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5807871|NCT00002504|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5807872|NCT00002504|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5807873|NCT00002504|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5807874|NCT00002504|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5807875|NCT00002504|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5807876|NCT00002504|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5807877|NCT00002504|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5807878|NCT00002504|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5807879|NCT00002504|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5807880|NCT00002504|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5807881|NCT00002504|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5807882|NCT00002504|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5807883|NCT00002504|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5807884|NCT00002504|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5807885|NCT00002504|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5807886|NCT00002504|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5807887|NCT00002504|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5807888|NCT00002504|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5807889|NCT00002504|prolymphocytic leukemia|prolymphocytic leukemia
5807890|NCT00002504|primary systemic amyloidosis|primary systemic amyloidosis
5807891|NCT00002504|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5807892|NCT00002504|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5807893|NCT00002504|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5807894|NCT00002504|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5807895|NCT00002504|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5807896|NCT00002504|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5807897|NCT00002504|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5807898|NCT00002504|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5807899|NCT00002504|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5807900|NCT00002504|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5807901|NCT00002504|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5807902|NCT00002462|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5807903|NCT00002462|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5807904|NCT00088231|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5807905|NCT00088231|Agnogenic Myeloid Metaplasia (AMM)|agnogenic myeloid metaplasia (amm)
5807906|NCT00088231|Chronic Myelogenous Leukemia-Blastic Phase (CML-BP)|chronic myelogenous leukemia-blastic phase (cml-bp)
5807907|NCT00088218|Acute Myeloid Leukemia|acute myeloid leukemia
5807908|NCT00088218|AML|aml
5807909|NCT00088218|High-Risk Myelodysplastic Syndrome|high-risk myelodysplastic syndrome
5807910|NCT00088218|MDS|mds
5807911|NCT00088218|Clofarabine|clofarabine
5807912|NCT00088218|Cytarabine|cytarabine
5807913|NCT00088218|ara-C|ara-c
5807915|NCT00088179|CPB|cpb
5807916|NCT00087997|sarcoma|sarcoma
5807917|NCT00088192|AMD|amd
5816876|NCT00080431|Activation|activation
5807918|NCT00088192|Age-Related Macular Degeneration|age-related macular degeneration
5807919|NCT00088192|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
5807920|NCT00088166|peritumoral brain edema|peritumoral brain edema
5820423|NCT00077922|Hematological Disease|hematological disease
5820424|NCT00077922|Monoclonal Antibody|monoclonal antibody
5820425|NCT00077922|Neutralizing Antibodies|neutralizing antibodies
5820435|NCT00077896|Transcranial Stimulation|transcranial stimulation
5820436|NCT00077896|Frontal Lobe|frontal lobe
5807921|NCT00088166|edema|edema
5807922|NCT00088166|malignant brain tumor|malignant brain tumor
5807923|NCT00088166|astrocytoma|astrocytoma
5807924|NCT00088166|brain tumor|brain tumor
5807925|NCT00088166|dexamethasone|dexamethasone
5807926|NCT00088166|Decadron|decadron
5807927|NCT00003884|hypercalcemia of malignancy|hypercalcemia of malignancy
5807928|NCT00003884|pain|pain
5807929|NCT00003884|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5807930|NCT00003884|recurrent small cell lung cancer|recurrent small cell lung cancer
5807931|NCT00003884|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5807932|NCT00003884|bone metastases|bone metastases
5807933|NCT00003812|limited stage small cell lung cancer|limited stage small cell lung cancer
5807934|NCT00003808|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5807935|NCT00003808|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5807936|NCT00003808|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5807937|NCT00003808|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5807938|NCT00003781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5807939|NCT00003781|stage IV prostate cancer|stage iv prostate cancer
5807940|NCT00003781|recurrent prostate cancer|recurrent prostate cancer
5807941|NCT00003781|pain|pain
5807942|NCT00003763|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5807943|NCT00003763|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5807944|NCT00003763|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5807945|NCT00003763|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5807946|NCT00003763|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5807947|NCT00003763|ovarian stromal cancer|ovarian stromal cancer
5807948|NCT00003763|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5807949|NCT00003763|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5807950|NCT00003763|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5807951|NCT00003763|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5807952|NCT00003763|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5807953|NCT00003763|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5807954|NCT00003763|ovarian sarcoma|ovarian sarcoma
5807955|NCT00003748|stage I gastric cancer|stage i gastric cancer
5807956|NCT00003748|stage II gastric cancer|stage ii gastric cancer
5807957|NCT00003748|stage III gastric cancer|stage iii gastric cancer
5807958|NCT00003748|stage IV gastric cancer|stage iv gastric cancer
5807959|NCT00003748|recurrent gastric cancer|recurrent gastric cancer
5807960|NCT00003748|stage I esophageal cancer|stage i esophageal cancer
5807961|NCT00003748|stage II esophageal cancer|stage ii esophageal cancer
5807962|NCT00003748|stage III esophageal cancer|stage iii esophageal cancer
5807963|NCT00003748|stage IV esophageal cancer|stage iv esophageal cancer
5807964|NCT00003748|recurrent esophageal cancer|recurrent esophageal cancer
5807965|NCT00003748|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5807966|NCT00003748|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5807967|NCT00003725|stage 0 bladder cancer|stage 0 bladder cancer
5807968|NCT00003725|stage I bladder cancer|stage i bladder cancer
5807969|NCT00003725|recurrent bladder cancer|recurrent bladder cancer
5807970|NCT00003725|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5807971|NCT00003677|recurrent pancreatic cancer|recurrent pancreatic cancer
5807972|NCT00003677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5807973|NCT00003677|stage IV pancreatic cancer|stage iv pancreatic cancer
5807974|NCT00003675|refractory anemia|refractory anemia
5807975|NCT00003675|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5807976|NCT00003675|refractory anemia with excess blasts|refractory anemia with excess blasts
5807977|NCT00003675|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5807978|NCT00003675|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5807979|NCT00003675|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5807980|NCT00003675|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5807981|NCT00003675|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5807983|NCT00003585|stage IV renal cell cancer|stage iv renal cell cancer
5807984|NCT00003585|recurrent renal cell cancer|recurrent renal cell cancer
5807985|NCT00003557|advanced adult primary liver cancer|advanced adult primary liver cancer
5807986|NCT00003557|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5807987|NCT00003557|unresectable gallbladder cancer|unresectable gallbladder cancer
5807988|NCT00003557|recurrent gallbladder cancer|recurrent gallbladder cancer
5844016|NCT00051155|OHT|oht
5807989|NCT00003557|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5807990|NCT00003557|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5807991|NCT00003557|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5807992|NCT00003557|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5807993|NCT00003392|stage IV breast cancer|stage iv breast cancer
5807994|NCT00003392|recurrent breast cancer|recurrent breast cancer
5807995|NCT00003391|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5807997|NCT00003391|recurrent prostate cancer|recurrent prostate cancer
5807998|NCT00003267|stage I cervical cancer|stage i cervical cancer
5807999|NCT00003267|stage II cervical cancer|stage ii cervical cancer
5808000|NCT00003267|stage I vaginal cancer|stage i vaginal cancer
5808001|NCT00003267|stage II vaginal cancer|stage ii vaginal cancer
5808002|NCT00003267|stage I endometrial carcinoma|stage i endometrial carcinoma
5808003|NCT00003267|stage II endometrial carcinoma|stage ii endometrial carcinoma
5808004|NCT00003267|infection|infection
5808005|NCT00003267|perioperative/postoperative complications|perioperative/postoperative complications
5808006|NCT00088153|Anorexia Nervosa|anorexia nervosa
5808007|NCT00088153|Amenorrhea|amenorrhea
5808008|NCT00088153|Bone Mass|bone mass
5808009|NCT00088153|Growth hormone|growth hormone
5808010|NCT00088101|Hematological Malignancies|hematological malignancies
5808011|NCT00088101|Leukemia|leukemia
5808012|NCT00088101|Lymphoma|lymphoma
5808013|NCT00088101|Metastatic|metastatic
5808014|NCT00088101|Unresectable solid tumors|unresectable solid tumors
5808015|NCT00088075|Schizophrenia|schizophrenia
5808016|NCT00088075|Risperidone|risperidone
5808017|NCT00088075|Adolescents|adolescents
5808018|NCT00088062|Crohn's Disease|crohn's disease
5808019|NCT00003238|recurrent prostate cancer|recurrent prostate cancer
5808020|NCT00003225|stage IV colon cancer|stage iv colon cancer
5808026|NCT00087984|Renal cancer|renal cancer
5808027|NCT00087958|Metastatic breast cancer|metastatic breast cancer
5808028|NCT00087945|Treatment Experienced|treatment experienced
5808029|NCT00087880|smoking cessation|smoking cessation
5808030|NCT00087867|Multiple Myeloma|multiple myeloma
5808031|NCT00087867|SCIO-469|scio-469
5808032|NCT00087867|p38 MAP kinase|p38 map kinase
5808034|NCT00087867|bone marrow|bone marrow
5808035|NCT00005996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808036|NCT00005806|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5808037|NCT00005806|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5808038|NCT00005806|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5808039|NCT00005806|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5808040|NCT00005632|recurrent prostate cancer|recurrent prostate cancer
5808041|NCT00005619|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5808042|NCT00005619|refractory hairy cell leukemia|refractory hairy cell leukemia
5808043|NCT00005042|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5808044|NCT00005042|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5808045|NCT00005029|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5808046|NCT00005029|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5808047|NCT00004199|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5808048|NCT00004199|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5808049|NCT00004164|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5808050|NCT00004164|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5808051|NCT00004164|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5808052|NCT00004160|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5808053|NCT00004160|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5808054|NCT00004158|refractory multiple myeloma|refractory multiple myeloma
5808055|NCT00004158|stage I multiple myeloma|stage i multiple myeloma
5808056|NCT00004158|stage II multiple myeloma|stage ii multiple myeloma
5808057|NCT00004158|stage III multiple myeloma|stage iii multiple myeloma
5808058|NCT00004104|stage III melanoma|stage iii melanoma
5808059|NCT00004060|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5808060|NCT00004060|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5808061|NCT00004060|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5808062|NCT00004060|fallopian tube cancer|fallopian tube cancer
5808063|NCT00004060|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5808064|NCT00004047|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5808065|NCT00004047|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5808066|NCT00004047|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5808067|NCT00004047|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808068|NCT00004047|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5808069|NCT00004047|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808070|NCT00004047|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5808071|NCT00004047|refractory anemia with excess blasts|refractory anemia with excess blasts
5846883|NCT00042523|Lupus|lupus
5808072|NCT00004047|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5808073|NCT00004047|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5808074|NCT00004047|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5808075|NCT00004041|recurrent adult brain tumor|recurrent adult brain tumor
5808076|NCT00004041|adult glioblastoma|adult glioblastoma
5808077|NCT00004041|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5808078|NCT00004041|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5808079|NCT00004041|adult mixed glioma|adult mixed glioma
5808080|NCT00004041|adult giant cell glioblastoma|adult giant cell glioblastoma
5808081|NCT00004041|adult gliosarcoma|adult gliosarcoma
5808082|NCT00003881|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5808083|NCT00003881|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5808084|NCT00003881|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5808085|NCT00003219|stage IV breast cancer|stage iv breast cancer
5808086|NCT00003219|recurrent breast cancer|recurrent breast cancer
5808087|NCT00003171|refractory anemia|refractory anemia
5808088|NCT00003171|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5808089|NCT00003171|refractory anemia with excess blasts|refractory anemia with excess blasts
5808090|NCT00003171|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5808091|NCT00003171|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5808092|NCT00003171|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5808093|NCT00003171|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5808094|NCT00003171|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5808095|NCT00003082|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5808096|NCT00003082|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5808097|NCT00003082|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5808098|NCT00003082|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5808099|NCT00003082|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5808100|NCT00003082|extramedullary plasmacytoma|extramedullary plasmacytoma
5808101|NCT00003082|refractory multiple myeloma|refractory multiple myeloma
5808102|NCT00003082|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5808103|NCT00003082|stage III multiple myeloma|stage iii multiple myeloma
5808104|NCT00003082|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5808105|NCT00003082|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5808106|NCT00003082|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5808107|NCT00003082|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808108|NCT00003082|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5808109|NCT00003082|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808110|NCT00003082|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808111|NCT00003082|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5808112|NCT00003082|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5808113|NCT00003082|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5808114|NCT00003082|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5808115|NCT00003082|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5808116|NCT00003082|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5808117|NCT00003082|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5808118|NCT00003082|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5808119|NCT00003082|polycythemia vera|polycythemia vera
5808120|NCT00003082|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5808121|NCT00003082|essential thrombocythemia|essential thrombocythemia
5808122|NCT00003082|untreated hairy cell leukemia|untreated hairy cell leukemia
5808123|NCT00003082|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5808124|NCT00003082|refractory hairy cell leukemia|refractory hairy cell leukemia
5808125|NCT00003082|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5808126|NCT00003082|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5808127|NCT00003082|acute undifferentiated leukemia|acute undifferentiated leukemia
5808128|NCT00003082|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808129|NCT00003082|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5808130|NCT00003082|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5808131|NCT00003082|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5808132|NCT00003082|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5808133|NCT00003082|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5808134|NCT00003082|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5808135|NCT00003082|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5808136|NCT00003082|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5808137|NCT00003082|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5808138|NCT00003082|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808139|NCT00003082|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5862643|NCT00001551|Speech Articulation|speech articulation
5808140|NCT00003082|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5808141|NCT00003082|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5808142|NCT00003082|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5808143|NCT00003082|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5808144|NCT00003082|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5808145|NCT00003082|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5808146|NCT00003082|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808147|NCT00003082|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808148|NCT00003082|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808149|NCT00003082|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808150|NCT00003082|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808151|NCT00003082|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808152|NCT00003082|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808153|NCT00003082|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808154|NCT00003082|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808155|NCT00003082|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5808156|NCT00003082|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5808157|NCT00003082|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5808158|NCT00003082|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5808159|NCT00003082|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5808160|NCT00003082|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5808161|NCT00003082|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5808162|NCT00003082|prolymphocytic leukemia|prolymphocytic leukemia
5808163|NCT00003082|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5808164|NCT00003082|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5808165|NCT00003082|primary systemic amyloidosis|primary systemic amyloidosis
5808166|NCT00003082|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5808167|NCT00003082|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5808168|NCT00003082|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808169|NCT00003082|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5808170|NCT00003082|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5808171|NCT00003082|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808172|NCT00003082|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808173|NCT00003082|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5808174|NCT00003082|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5808175|NCT00003082|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5808176|NCT00003082|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808177|NCT00003082|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808178|NCT00003082|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808179|NCT00003082|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808180|NCT00003057|colon cancer|colon cancer
5808181|NCT00003057|rectal cancer|rectal cancer
5808183|NCT00002998|stage IV breast cancer|stage iv breast cancer
5808184|NCT00002998|recurrent breast cancer|recurrent breast cancer
5808185|NCT00002994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808186|NCT00002956|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5808187|NCT00002956|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5808188|NCT00002956|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5808189|NCT00002956|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5808190|NCT00002956|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5808191|NCT00002956|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5808192|NCT00002956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808193|NCT00002956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808194|NCT00002956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808195|NCT00002956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808196|NCT00002956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808197|NCT00002956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808198|NCT00002956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808199|NCT00002956|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808200|NCT00002956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808201|NCT00002956|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808202|NCT00002956|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5808203|NCT00002956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808204|NCT00002956|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808205|NCT00002956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5681279|NCT00573989|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5681280|NCT00573989|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5681281|NCT00573989|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5808206|NCT00002956|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808208|NCT00002956|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808209|NCT00002925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5808210|NCT00002925|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5808211|NCT00002925|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5808212|NCT00002925|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5808213|NCT00002925|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5808214|NCT00002925|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5808215|NCT00002925|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5808216|NCT00002925|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5808217|NCT00002925|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5808218|NCT00002908|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808219|NCT00002908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808220|NCT00002908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808221|NCT00002908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808222|NCT00002908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808223|NCT00002908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808224|NCT00002908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808225|NCT00002908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808679|NCT00087659|ADT, BMD, US63, H014|adt, bmd, us63, h014
5808226|NCT00002908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808227|NCT00002908|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808228|NCT00002908|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808229|NCT00002908|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808230|NCT00002908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808231|NCT00002908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808232|NCT00002908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808233|NCT00002908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808234|NCT00002907|refractory multiple myeloma|refractory multiple myeloma
5808235|NCT00002862|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5808236|NCT00002862|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5808237|NCT00002862|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808238|NCT00002862|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5808239|NCT00002862|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808240|NCT00002862|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5808241|NCT00002862|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5808242|NCT00002862|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5808243|NCT00002862|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5808244|NCT00002862|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5808245|NCT00002862|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5808246|NCT00002862|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5808247|NCT00002862|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808248|NCT00002862|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808249|NCT00002862|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808250|NCT00002862|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808251|NCT00002862|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808252|NCT00002862|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808253|NCT00002862|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808254|NCT00002862|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808255|NCT00002862|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808256|NCT00002862|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5808257|NCT00002862|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5808258|NCT00002862|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5808259|NCT00002862|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808260|NCT00002862|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5808261|NCT00002862|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5808262|NCT00002862|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808263|NCT00002862|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808264|NCT00002862|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5814807|NCT00081783|NHL|nhl
5808265|NCT00002862|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5814799|NCT00081835|Vaccinia|vaccinia
5808266|NCT00002862|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808267|NCT00002862|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808268|NCT00002862|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808270|NCT00002763|recurrent melanoma|recurrent melanoma
5808271|NCT00002760|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5808272|NCT00002760|recurrent prostate cancer|recurrent prostate cancer
5808273|NCT00002667|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5808274|NCT00002620|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5808275|NCT00002563|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5808276|NCT00002563|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5808277|NCT00002563|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5808278|NCT00002557|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5808279|NCT00002557|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5808280|NCT00002557|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5808281|NCT00002549|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5808282|NCT00002549|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5808283|NCT00002549|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5808284|NCT00002549|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5808285|NCT00002549|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5808286|NCT00002549|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5808287|NCT00002549|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5808288|NCT00002549|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5808289|NCT00002549|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5808290|NCT00002545|adult glioblastoma|adult glioblastoma
5808291|NCT00002545|adult giant cell glioblastoma|adult giant cell glioblastoma
5808292|NCT00002545|adult gliosarcoma|adult gliosarcoma
5808293|NCT00002502|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5808294|NCT00002502|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5808295|NCT00002502|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5808296|NCT00002502|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5808297|NCT00002502|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5808298|NCT00002502|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5808299|NCT00002502|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5808300|NCT00002502|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5808301|NCT00002502|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5808302|NCT00002502|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5808303|NCT00002502|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5808304|NCT00002502|childhood Burkitt lymphoma|childhood burkitt lymphoma
5808305|NCT00002502|refractory multiple myeloma|refractory multiple myeloma
5808306|NCT00002502|Waldenström macroglobulinemia|waldenström macroglobulinemia
5808307|NCT00002502|stage I multiple myeloma|stage i multiple myeloma
5808308|NCT00002502|stage II multiple myeloma|stage ii multiple myeloma
5808309|NCT00002502|stage III multiple myeloma|stage iii multiple myeloma
5808310|NCT00002502|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5808311|NCT00002502|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5808312|NCT00002502|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5808313|NCT00002502|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5808314|NCT00002502|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5808315|NCT00002502|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5808316|NCT00002502|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5808317|NCT00002502|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808318|NCT00002502|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5808319|NCT00002502|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5808320|NCT00002502|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5808321|NCT00002502|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5808322|NCT00002502|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5808323|NCT00002502|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5808324|NCT00002502|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5808325|NCT00002502|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5808326|NCT00002502|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5808327|NCT00002502|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5808328|NCT00002502|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5808329|NCT00002502|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5686620|NCT00551239|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808330|NCT00002502|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5808331|NCT00002502|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5808332|NCT00002502|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5808333|NCT00002502|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5808334|NCT00002502|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5808335|NCT00002502|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5808336|NCT00002502|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5808337|NCT00002502|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5808338|NCT00002502|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5808339|NCT00002502|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5808340|NCT00002502|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5808341|NCT00002502|refractory anemia|refractory anemia
5808342|NCT00002502|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5808343|NCT00002502|refractory anemia with excess blasts|refractory anemia with excess blasts
5808344|NCT00002502|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5808345|NCT00002502|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808346|NCT00002502|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5808347|NCT00002502|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5808348|NCT00002502|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5808349|NCT00002502|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5808350|NCT00002502|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5808351|NCT00002502|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5808352|NCT00002502|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5808353|NCT00002502|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5808354|NCT00002502|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5808355|NCT00002502|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808356|NCT00002502|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5808357|NCT00002502|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5808682|NCT00087542|Hallucinosis/Psychosis|hallucinosis/psychosis
5808358|NCT00002502|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5808359|NCT00002502|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5808360|NCT00002502|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5808361|NCT00002502|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5808362|NCT00002502|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5808363|NCT00002502|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808364|NCT00002502|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808365|NCT00002502|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808366|NCT00002502|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808367|NCT00002502|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808368|NCT00002502|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808369|NCT00002502|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808370|NCT00002502|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808371|NCT00002502|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808372|NCT00002502|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5808373|NCT00002502|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5808374|NCT00002502|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5808375|NCT00002502|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5808376|NCT00002502|intraocular lymphoma|intraocular lymphoma
5808377|NCT00002502|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5808378|NCT00002502|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5808379|NCT00002502|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5808380|NCT00002502|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5808381|NCT00002502|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5808382|NCT00002502|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5808383|NCT00002502|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5808384|NCT00002502|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5808385|NCT00002502|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808386|NCT00002502|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5808387|NCT00002502|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5808388|NCT00002502|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5808389|NCT00002502|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5808390|NCT00002502|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5808391|NCT00002502|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5808392|NCT00002502|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5808393|NCT00002502|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5808394|NCT00002502|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5808395|NCT00002502|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5808396|NCT00002502|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5808397|NCT00002502|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5808398|NCT00002502|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5808399|NCT00002502|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5808400|NCT00002502|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5808401|NCT00002502|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5808402|NCT00002502|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5808403|NCT00002502|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5808404|NCT00002502|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5808405|NCT00002502|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5808406|NCT00002502|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5808407|NCT00002502|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5808408|NCT00002502|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5808409|NCT00002502|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5808410|NCT00002502|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808411|NCT00002502|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5808412|NCT00002502|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5808413|NCT00002502|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5808414|NCT00002502|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5808415|NCT00002502|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808416|NCT00002502|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808417|NCT00002502|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5828307|NCT00061165|adolescents|adolescents
5808418|NCT00002502|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5808419|NCT00002502|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5808420|NCT00002502|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5808421|NCT00002502|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5808422|NCT00002502|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808423|NCT00002502|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5808424|NCT00002502|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5808425|NCT00002502|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808426|NCT00002502|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808427|NCT00002502|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808428|NCT00002502|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5808429|NCT00002495|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5808430|NCT00002495|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5808431|NCT00002465|stage IV breast cancer|stage iv breast cancer
5808432|NCT00002465|recurrent breast cancer|recurrent breast cancer
5808433|NCT00002465|advanced malignant mesothelioma|advanced malignant mesothelioma
5808434|NCT00002465|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5808435|NCT00002465|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5808436|NCT00002465|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5808437|NCT00087932|Complementary Therapies|complementary therapies
5808438|NCT00087841|Hypnosis|hypnosis
5808439|NCT00087841|Analgesia|analgesia
5808440|NCT00087841|Embolization, Therapeutic|embolization, therapeutic
5808441|NCT00087841|Chemoembolization, Therapeutic|chemoembolization, therapeutic
5808442|NCT00087828|Vaccinium macrocarpon|vaccinium macrocarpon
5808443|NCT00087815|cognitive/functional effects|cognitive/functional effects
5808444|NCT00087815|radiation toxicity|radiation toxicity
5808445|NCT00087815|adult brain tumor|adult brain tumor
5808446|NCT00087815|childhood brain tumor|childhood brain tumor
5808447|NCT00087789|Alzheimer's Disease|alzheimer's disease
5808448|NCT00087789|Gene Transfer|gene transfer
5808450|NCT00087763|Age Related Macular Degeneration|age related macular degeneration
5808451|NCT00087763|Exudative Subfoveal Age Related Macular Degeneration with Subfoveal Choroidal Neovascularization|exudative subfoveal age related macular degeneration with subfoveal choroidal neovascularization
5808452|NCT00082511|Lupus|lupus
5808453|NCT00082511|Systemic Lupus Erythematosus|systemic lupus erythematosus
5808455|NCT00082511|Bone Loss|bone loss
5808456|NCT00082511|DHEA|dhea
5808457|NCT00003877|stage IV breast cancer|stage iv breast cancer
5808458|NCT00003877|recurrent breast cancer|recurrent breast cancer
5808459|NCT00003874|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5861583|NCT00001898|Melanoma|melanoma
5808461|NCT00003874|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5808462|NCT00003874|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808463|NCT00003874|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808464|NCT00003874|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5808465|NCT00003874|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5808466|NCT00003874|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5808467|NCT00003874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808468|NCT00003874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808469|NCT00003874|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808470|NCT00003874|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808471|NCT00003874|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808472|NCT00003874|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808473|NCT00003874|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808474|NCT00003874|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808475|NCT00003874|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808476|NCT00003874|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808477|NCT00003874|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5808478|NCT00003874|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808479|NCT00003874|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808480|NCT00003874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808481|NCT00003874|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808482|NCT00003874|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808483|NCT00003874|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808484|NCT00003853|primary systemic amyloidosis|primary systemic amyloidosis
5808485|NCT00003805|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5808486|NCT00003805|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5808487|NCT00003805|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5808488|NCT00003805|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5808684|NCT00087529|Primary progressive MS|primary progressive ms
5808489|NCT00003805|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5808490|NCT00003805|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5808491|NCT00003805|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5808492|NCT00003805|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5808493|NCT00003805|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5808494|NCT00003805|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5808495|NCT00003805|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5808496|NCT00003805|Burkitt lymphoma|burkitt lymphoma
5808497|NCT00003805|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5808498|NCT00003805|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5808499|NCT00003805|stage I multiple myeloma|stage i multiple myeloma
5808500|NCT00003805|stage II multiple myeloma|stage ii multiple myeloma
5808501|NCT00003805|stage III multiple myeloma|stage iii multiple myeloma
5808502|NCT00003805|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5808503|NCT00003805|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5808504|NCT00003805|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5808505|NCT00003805|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5808506|NCT00003805|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5808507|NCT00003805|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5808508|NCT00003805|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5808509|NCT00003805|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5808510|NCT00003805|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5808511|NCT00003805|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5808512|NCT00003805|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5808513|NCT00003805|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808514|NCT00003805|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5808515|NCT00003805|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808516|NCT00003805|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5808517|NCT00003805|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5863161|NCT00001366|Partial Epilepsy|partial epilepsy
5681282|NCT00573989|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5681283|NCT00573989|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5808518|NCT00003805|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5808519|NCT00003805|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808520|NCT00003805|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5808521|NCT00003805|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5808522|NCT00003805|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5808523|NCT00003805|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5808524|NCT00003805|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5808525|NCT00003805|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5808526|NCT00003805|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5808527|NCT00003805|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5808528|NCT00003805|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5808529|NCT00003805|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5808530|NCT00003805|refractory hairy cell leukemia|refractory hairy cell leukemia
5808531|NCT00003805|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5808532|NCT00003805|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5808533|NCT00003805|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5808534|NCT00003805|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5808535|NCT00003805|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5808536|NCT00003805|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5808537|NCT00003805|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5808538|NCT00003805|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5808539|NCT00003805|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5808540|NCT00003805|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5808541|NCT00003805|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5808542|NCT00003805|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5808543|NCT00003805|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5808544|NCT00003805|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808545|NCT00003805|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5808546|NCT00003805|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5808547|NCT00003805|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5808548|NCT00003805|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5808549|NCT00003805|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5808550|NCT00003805|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5808680|NCT00087555|Fibromyalgia|fibromyalgia
5808551|NCT00003805|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5808552|NCT00003805|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5808553|NCT00003805|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5808554|NCT00003805|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808555|NCT00003805|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5808556|NCT00003805|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5808557|NCT00003805|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5808558|NCT00003805|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5808559|NCT00003805|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5808560|NCT00003805|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5808561|NCT00003805|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5808562|NCT00003805|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808563|NCT00003805|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808564|NCT00003805|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5808565|NCT00003805|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808566|NCT00003805|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5808567|NCT00003805|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5808568|NCT00003805|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5808569|NCT00003805|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5808570|NCT00003805|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5808571|NCT00003805|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5808572|NCT00003805|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5808573|NCT00003805|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5808574|NCT00003805|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5808575|NCT00003805|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5808577|NCT00003805|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5808578|NCT00003805|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5808580|NCT00003805|bone marrow suppression|bone marrow suppression
5808581|NCT00003805|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5808582|NCT00003805|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5808583|NCT00003805|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5808584|NCT00003805|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5846485|NCT00044291|stage IV breast cancer|stage iv breast cancer
5808585|NCT00003805|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5808586|NCT00003805|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5808587|NCT00003805|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5808588|NCT00003805|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5808589|NCT00003805|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808590|NCT00003805|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5808591|NCT00003805|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5808592|NCT00003805|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5808593|NCT00003805|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5808594|NCT00003805|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5808595|NCT00003805|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5808596|NCT00003805|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5808597|NCT00003805|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5808598|NCT00003805|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5808599|NCT00003805|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5808600|NCT00003805|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5808601|NCT00003805|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5808602|NCT00003805|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5808603|NCT00003805|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5808604|NCT00003805|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5808605|NCT00003805|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5808606|NCT00003805|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5808607|NCT00003805|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5808608|NCT00003805|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5808609|NCT00003805|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5808610|NCT00003805|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5808685|NCT00087529|Primary progressive multiple sclerosis|primary progressive multiple sclerosis
5808611|NCT00003805|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5808612|NCT00003805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5808613|NCT00003805|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5808614|NCT00003805|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808615|NCT00003805|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5808616|NCT00003805|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5808617|NCT00003805|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5808618|NCT00003805|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5808619|NCT00003805|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808620|NCT00003805|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808621|NCT00003805|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5808622|NCT00003805|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5808623|NCT00003805|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5808624|NCT00003805|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5808625|NCT00003805|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5808626|NCT00003805|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808627|NCT00003805|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808628|NCT00003805|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808629|NCT00003805|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808630|NCT00003805|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5808631|NCT00003804|stage I Wilms tumor|stage i wilms tumor
5808632|NCT00003792|stage IV melanoma|stage iv melanoma
5808633|NCT00003792|recurrent melanoma|recurrent melanoma
5808634|NCT00003743|disseminated neuroblastoma|disseminated neuroblastoma
5808635|NCT00003664|stage IV renal cell cancer|stage iv renal cell cancer
5808637|NCT00003639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808638|NCT00003639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5808639|NCT00003639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5808640|NCT00003639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808641|NCT00003639|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5808642|NCT00003639|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5808643|NCT00003639|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5808644|NCT00003639|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5808645|NCT00003639|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5808646|NCT00003639|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5808647|NCT00003639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5808649|NCT00003639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5808650|NCT00003639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808651|NCT00003639|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5808652|NCT00003639|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5808653|NCT00003639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5808654|NCT00003639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5808655|NCT00003639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5808656|NCT00003604|stage III renal cell cancer|stage iii renal cell cancer
5808657|NCT00003604|stage IV renal cell cancer|stage iv renal cell cancer
5808658|NCT00003359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808659|NCT00003343|stage IV prostate cancer|stage iv prostate cancer
5808660|NCT00003328|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5808661|NCT00003328|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5808662|NCT00003328|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5808663|NCT00003328|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5808664|NCT00003328|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5808665|NCT00003328|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5808666|NCT00003328|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5808667|NCT00003328|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5808668|NCT00087685|Recurrent Endometrial Cancer|recurrent endometrial cancer
5808670|NCT00087685|Endometrioid|endometrioid
5808672|NCT00087685|Uterine Cancer|uterine cancer
5808673|NCT00087672|Myelofibrosis|myelofibrosis
5808674|NCT00087672|Philadelphia negative myeloproliferative disorder|philadelphia negative myeloproliferative disorder
5808675|NCT00087672|CC-5013|cc-5013
5808676|NCT00087672|Lenalidomide|lenalidomide
5808677|NCT00087672|Revlimid|revlimid
5808678|NCT00087672|Antiangiogenesis|antiangiogenesis
5808688|NCT00087477|Malignant Melanoma, Pivanex, Histone deacetylases inhibitor|malignant melanoma, pivanex, histone deacetylases inhibitor
5808689|NCT00087464|Acute Infection|acute infection
5808690|NCT00087464|Treatment Naive|treatment naive
5808691|NCT00087464|Treatment Interruption|treatment interruption
5808692|NCT00087451|Progressive or recurrent malignant glioma|progressive or recurrent malignant glioma
5808693|NCT00086645|Autism|autism
5808694|NCT00086645|Asperger Syndrome|asperger syndrome
5808695|NCT00086645|Pervasive Developmental Disorder|pervasive developmental disorder
5808696|NCT00086645|PDD|pdd
5808697|NCT00086645|Rituals|rituals
5808698|NCT00086645|Compulsions|compulsions
5808699|NCT00086645|Stereotypy|stereotypy
5808700|NCT00086645|Routines|routines
5808701|NCT00086645|Repetitive behavior|repetitive behavior
5808702|NCT00086645|SSRI|ssri
5808703|NCT00086645|Serotonin|serotonin
5808704|NCT00003589|recurrent small cell lung cancer|recurrent small cell lung cancer
5808705|NCT00003589|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5808706|NCT00003589|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5808707|NCT00087438|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5808708|NCT00087438|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5808709|NCT00087438|squamous cell lung cancer|squamous cell lung cancer
5808710|NCT00087438|large cell lung cancer|large cell lung cancer
5808711|NCT00087438|adenocarcinoma of the lung|adenocarcinoma of the lung
5808712|NCT00087438|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5808713|NCT00087425|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5808714|NCT00087425|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5808715|NCT00087425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5808716|NCT00087425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5808717|NCT00087425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5808719|NCT00087425|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5808720|NCT00087425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5808721|NCT00087425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5808722|NCT00087425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5846486|NCT00044291|ductal breast carcinoma|ductal breast carcinoma
5808723|NCT00087425|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5686621|NCT00551239|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5686622|NCT00551239|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5686623|NCT00551239|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5846884|NCT00042523|SLE|sle
5808724|NCT00087425|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5808725|NCT00087425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5808726|NCT00087425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5808727|NCT00087425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5808728|NCT00087425|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5808729|NCT00087425|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5808730|NCT00087425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5808731|NCT00087425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5808732|NCT00087425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5808733|NCT00087425|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808734|NCT00087425|Waldenström macroglobulinemia|waldenström macroglobulinemia
5808735|NCT00087425|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5808736|NCT00087425|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5808737|NCT00087425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5808738|NCT00087425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5808739|NCT00087425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5808740|NCT00087399|breast cancer|breast cancer
5808741|NCT00087399|hot flashes|hot flashes
5808742|NCT00087360|colon cancer|colon cancer
5808743|NCT00087360|rectal cancer|rectal cancer
5808744|NCT00087347|recurrent prostate cancer|recurrent prostate cancer
5808745|NCT00087347|stage I prostate cancer|stage i prostate cancer
5808746|NCT00087347|stage IIB prostate cancer|stage iib prostate cancer
5808747|NCT00087347|stage IIA prostate cancer|stage iia prostate cancer
5808748|NCT00087347|stage III prostate cancer|stage iii prostate cancer
5808749|NCT00087347|stage IV prostate cancer|stage iv prostate cancer
5808750|NCT00087347|stage I breast cancer|stage i breast cancer
5808751|NCT00087347|stage II breast cancer|stage ii breast cancer
5808752|NCT00087347|stage IIIA breast cancer|stage iiia breast cancer
5808753|NCT00087347|stage IIIB breast cancer|stage iiib breast cancer
5808754|NCT00087347|stage IIIC breast cancer|stage iiic breast cancer
5808755|NCT00087347|stage IV breast cancer|stage iv breast cancer
5808756|NCT00087347|recurrent breast cancer|recurrent breast cancer
5808757|NCT00087334|recurrent colon cancer|recurrent colon cancer
5808758|NCT00087334|stage IV colon cancer|stage iv colon cancer
5808759|NCT00087334|recurrent rectal cancer|recurrent rectal cancer
5808760|NCT00087334|stage IV rectal cancer|stage iv rectal cancer
5808761|NCT00087295|recurrent bladder cancer|recurrent bladder cancer
5808762|NCT00087295|stage IV bladder cancer|stage iv bladder cancer
5809080|NCT00086242|stage IIB cervical cancer|stage iib cervical cancer
5808763|NCT00087295|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5808764|NCT00087295|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5808765|NCT00087295|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5808766|NCT00087295|anterior urethral cancer|anterior urethral cancer
5808767|NCT00087295|posterior urethral cancer|posterior urethral cancer
5808768|NCT00087295|recurrent urethral cancer|recurrent urethral cancer
5808769|NCT00087295|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5808770|NCT00087282|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5808771|NCT00087282|advanced adult primary liver cancer|advanced adult primary liver cancer
5808772|NCT00087282|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5808773|NCT00087256|stage I colon cancer|stage i colon cancer
5808774|NCT00087256|adenocarcinoma of the colon|adenocarcinoma of the colon
5808775|NCT00087178|stage I breast cancer|stage i breast cancer
5808776|NCT00087178|stage II breast cancer|stage ii breast cancer
5808777|NCT00087165|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5808778|NCT00087165|recurrent prostate cancer|recurrent prostate cancer
5808779|NCT00087152|stage IV breast cancer|stage iv breast cancer
5808780|NCT00087152|recurrent breast cancer|recurrent breast cancer
5808781|NCT00087126|recurrent cervical cancer|recurrent cervical cancer
5808782|NCT00087126|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5808783|NCT00087113|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5808784|NCT00087113|recurrent cervical cancer|recurrent cervical cancer
5808786|NCT00087113|stage IVA cervical cancer|stage iva cervical cancer
5808787|NCT00087113|stage IVB cervical cancer|stage ivb cervical cancer
5808788|NCT00087100|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5808789|NCT00087100|endometrial adenocarcinoma|endometrial adenocarcinoma
5808790|NCT00087100|stage III endometrial carcinoma|stage iii endometrial carcinoma
5808791|NCT00087100|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5808792|NCT00087087|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5808793|NCT00087087|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5808901|NCT00086541|Pegylated|pegylated
5808794|NCT00087061|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5808795|NCT00087061|recurrent adult brain tumor|recurrent adult brain tumor
5808796|NCT00087061|adult glioblastoma|adult glioblastoma
5808797|NCT00087061|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5808798|NCT00087061|adult giant cell glioblastoma|adult giant cell glioblastoma
5808799|NCT00087061|adult gliosarcoma|adult gliosarcoma
5808800|NCT00087048|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5808801|NCT00087048|recurrent small cell lung cancer|recurrent small cell lung cancer
5808802|NCT00087035|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5808803|NCT00087035|recurrent prostate cancer|recurrent prostate cancer
5808804|NCT00087022|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5808805|NCT00087022|stage I renal cell cancer|stage i renal cell cancer
5808806|NCT00087022|stage II renal cell cancer|stage ii renal cell cancer
5808807|NCT00087022|stage III renal cell cancer|stage iii renal cell cancer
5808808|NCT00087022|stage IV renal cell cancer|stage iv renal cell cancer
5808809|NCT00087009|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5808810|NCT00087009|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5808811|NCT00087009|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5808812|NCT00087009|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5808813|NCT00087009|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5808814|NCT00087009|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5808815|NCT00087009|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5808816|NCT00087009|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5808817|NCT00086996|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5808818|NCT00086996|stage II esophageal cancer|stage ii esophageal cancer
5808819|NCT00086996|stage III esophageal cancer|stage iii esophageal cancer
5808820|NCT00086957|stage IV breast cancer|stage iv breast cancer
5808821|NCT00086957|male breast cancer|male breast cancer
5808822|NCT00086957|recurrent breast cancer|recurrent breast cancer
5808823|NCT00086931|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5808824|NCT00086931|stage III rectal cancer|stage iii rectal cancer
5808825|NCT00086931|stage II rectal cancer|stage ii rectal cancer
5808826|NCT00086892|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5808827|NCT00086892|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5808828|NCT00086879|adult glioblastoma|adult glioblastoma
5808829|NCT00086879|recurrent adult brain tumor|recurrent adult brain tumor
5808830|NCT00086879|adult giant cell glioblastoma|adult giant cell glioblastoma
5808831|NCT00086879|adult gliosarcoma|adult gliosarcoma
5808832|NCT00086866|stage III melanoma|stage iii melanoma
5808833|NCT00086866|stage IV melanoma|stage iv melanoma
5808834|NCT00086866|recurrent melanoma|recurrent melanoma
5808835|NCT00086801|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5808836|NCT00086801|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5808837|NCT00086775|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5808838|NCT00086775|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5808839|NCT00086762|nausea and vomiting|nausea and vomiting
5808840|NCT00086762|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808841|NCT00086762|mindfulness relaxation|mindfulness relaxation
5808842|NCT00086749|breast cancer|breast cancer
5808843|NCT00086749|stage I breast cancer|stage i breast cancer
5808844|NCT00086749|stage II breast cancer|stage ii breast cancer
5808845|NCT00086749|stage IIIA breast cancer|stage iiia breast cancer
5808846|NCT00086749|stage IIIB breast cancer|stage iiib breast cancer
5808847|NCT00086749|stage IIIC breast cancer|stage iiic breast cancer
5808848|NCT00086736|stage I prostate cancer|stage i prostate cancer
5808849|NCT00086736|stage IIB prostate cancer|stage iib prostate cancer
5808850|NCT00086736|stage IIA prostate cancer|stage iia prostate cancer
5808851|NCT00086736|stage III prostate cancer|stage iii prostate cancer
5808852|NCT00086723|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808853|NCT00086684|Interstitial Cystitis|interstitial cystitis
5808854|NCT00086684|Urinary Bladder Pain|urinary bladder pain
5808855|NCT00086658|Hypereosinophilic Syndrome Hypereosinophilia|hypereosinophilic syndrome hypereosinophilia
5808856|NCT00086658|mepolizumab|mepolizumab
5808857|NCT00086658|anti IL-5|anti il-5
5808858|NCT00086632|oregovomab|oregovomab
5808860|NCT00086632|ovarian cancer|ovarian cancer
5808862|NCT00086632|ovarian carcinoma|ovarian carcinoma
5808865|NCT00086619|Osteoporosis|osteoporosis
5808866|NCT00086619|Parathyroid hormone|parathyroid hormone
5808867|NCT00086619|Teriparatide|teriparatide
5808868|NCT00086619|Bone formation|bone formation
5808869|NCT00086619|Bone resorption|bone resorption
5808870|NCT00086593|adjunctive|adjunctive
5808871|NCT00086593|atypical antipsychotics|atypical antipsychotics
5808872|NCT00086593|add-on|add-on
5808873|NCT00086593|Schizophrenia|schizophrenia
5808874|NCT00086593|psychosis|psychosis
5808875|NCT00003297|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5808876|NCT00003297|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5808877|NCT00003297|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5808878|NCT00003296|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5861962|NCT00001766|Abacavir|abacavir
5808879|NCT00003296|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5808880|NCT00003296|advanced adult primary liver cancer|advanced adult primary liver cancer
5808881|NCT00003296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5808882|NCT00003296|localized gallbladder cancer|localized gallbladder cancer
5808883|NCT00003296|unresectable gallbladder cancer|unresectable gallbladder cancer
5808884|NCT00003296|recurrent gallbladder cancer|recurrent gallbladder cancer
5808885|NCT00003296|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5808886|NCT00003296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5808887|NCT00003296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5808888|NCT00003296|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5808889|NCT00003296|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5808890|NCT00003296|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5808891|NCT00003296|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5808892|NCT00003230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5808893|NCT00003230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5808894|NCT00003230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5808895|NCT00003230|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5808896|NCT00003230|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5808897|NCT00003198|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808898|NCT00003109|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5808899|NCT00086541|Chronic Hepatitis C|chronic hepatitis c
5808900|NCT00086541|Liver|liver
5808902|NCT00086541|Interferon|interferon
5808903|NCT00086541|Alpha|alpha
5808904|NCT00086541|Ribavirin|ribavirin
5808905|NCT00086541|Combination|combination
5808906|NCT00086541|Nonresponder|nonresponder
5808907|NCT00086541|HCV|hcv
5808908|NCT00086541|Infergen|infergen
5808909|NCT00086541|SVR|svr
5808910|NCT00086528|Solid Tumors|solid tumors
5808911|NCT00086411|light smokers, smoking cessation treatment programs|light smokers, smoking cessation treatment programs
5808912|NCT00086385|Smoking cessation|smoking cessation
5808913|NCT00086385|Tobacco|tobacco
5808914|NCT00003091|stage IV renal cell cancer|stage iv renal cell cancer
5808915|NCT00003091|recurrent renal cell cancer|recurrent renal cell cancer
5808916|NCT00003091|stage IV melanoma|stage iv melanoma
5808921|NCT00002922|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5808922|NCT00002922|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5808923|NCT00002922|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5808924|NCT00002922|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5808925|NCT00002922|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5808926|NCT00002922|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5808927|NCT00002922|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5808928|NCT00002922|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5808929|NCT00002922|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5808930|NCT00002922|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5808931|NCT00002863|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5808932|NCT00002863|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5808933|NCT00002863|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5808934|NCT00002863|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5808935|NCT00002863|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5808936|NCT00002863|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5808937|NCT00002863|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5862644|NCT00001551|Phonological Processing Disorders|phonological processing disorders
5808938|NCT00002863|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5801609|NCT00101946|CD|cd
5808950|NCT00086554|Blood Sample|blood sample
5808951|NCT00086515|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5808952|NCT00086489|metastatic melanoma|metastatic melanoma
5808953|NCT00086489|multiple dose|multiple dose
5808954|NCT00086463|STEP|step
5808955|NCT00086463|PAH|pah
5808956|NCT00086463|iloprost|iloprost
5808957|NCT00086463|inhalation|inhalation
5808958|NCT00086463|prostacyclin|prostacyclin
5808959|NCT00002999|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5808960|NCT00002999|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5808454|NCT00082511|SLE|sle
5808961|NCT00086476|Gray Platelet Syndrome|gray platelet syndrome
5808962|NCT00086476|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5808963|NCT00086476|Storage Pool Deficiency|storage pool deficiency
5808964|NCT00086476|Organelle Formation|organelle formation
5808965|NCT00086476|Megakaryocyte Development|megakaryocyte development
5808966|NCT00086476|Megakaryocytes|megakaryocytes
5808967|NCT00086476|Platelets|platelets
5808968|NCT00086476|Dense Granules|dense granules
5808969|NCT00086476|Alpha Granules|alpha granules
5808970|NCT00086476|Lysosome-related Organelles|lysosome-related organelles
5808971|NCT00086476|GPS|gps
5808972|NCT00086476|HPS|hps
5808973|NCT00086476|Griscelli Disease|griscelli disease
5808974|NCT00086476|Chediak Higashi Syndrome|chediak higashi syndrome
5808975|NCT00086476|Wiskott Aldrich Syndrome|wiskott aldrich syndrome
5808976|NCT00086476|Platelet|platelet
5808977|NCT00086476|Congenital Bleeding Disorders|congenital bleeding disorders
5808978|NCT00086476|SAC|sac
5808979|NCT00086476|Vesicle|vesicle
5808980|NCT00086346|Liver|liver
5808981|NCT00086346|Transplant|transplant
5808982|NCT00086333|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5808983|NCT00086333|Taxotere|taxotere
5808984|NCT00086333|docetaxel|docetaxel
5808985|NCT00086333|taxanes|taxanes
5808986|NCT00086372|Acute Infection|acute infection
5808987|NCT00086372|Treatment Experienced|treatment experienced
5808988|NCT00086372|Treatment Naive|treatment naive
5808989|NCT00086359|Treatment Naive|treatment naive
5808990|NCT00086359|Perinatal Transmission|perinatal transmission
5808991|NCT00086359|Mother-to-Child Transmission|mother-to-child transmission
5808992|NCT00086359|MTCT|mtct
5808993|NCT00086359|Treatment Experienced|treatment experienced
5808994|NCT00086320|Schizophrenia|schizophrenia
5808995|NCT00086320|paliperidone|paliperidone
5808996|NCT00086320|Risperidone|risperidone
5808997|NCT00086281|Sleep-disordered breathing|sleep-disordered breathing
5808998|NCT00086281|Obstructive sleep apnea syndrome|obstructive sleep apnea syndrome
5808999|NCT00086268|lung cancer|lung cancer
5809000|NCT00086268|ZPACT|zpact
5809001|NCT00086268|US75|us75
5809002|NCT00086268|Bone Metastases|bone metastases
5809003|NCT00002837|stage IV breast cancer|stage iv breast cancer
5809004|NCT00002837|recurrent breast cancer|recurrent breast cancer
5809005|NCT00002804|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5809006|NCT00002804|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5809007|NCT00002751|leptomeningeal metastases|leptomeningeal metastases
5809008|NCT00002733|stage IV renal cell cancer|stage iv renal cell cancer
5809009|NCT00002733|stage IV melanoma|stage iv melanoma
5809010|NCT00002733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809011|NCT00002705|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5809012|NCT00002705|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5809013|NCT00002705|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5809014|NCT00002704|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5809312|NCT00086021|Headache|headache
5809081|NCT00086242|stage III cervical cancer|stage iii cervical cancer
5809015|NCT00002704|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5809016|NCT00002704|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5809017|NCT00002704|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5809018|NCT00002691|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5809019|NCT00002691|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5809020|NCT00002691|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5809021|NCT00002691|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5809022|NCT00002691|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5809023|NCT00002654|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5809024|NCT00002654|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5809025|NCT00002654|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5809026|NCT00002654|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5809027|NCT00002654|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5809028|NCT00002654|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5681284|NCT00573989|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5681285|NCT00573976|SCIM|scim
5681286|NCT00573976|SCIM III|scim iii
5681287|NCT00573976|Multi-Center|multi-center
5681288|NCT00573976|United States|united states
5681289|NCT00573963|Cesarean section|cesarean section
5681290|NCT00573950|cilostazol|cilostazol
5809029|NCT00002654|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5809030|NCT00002654|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5809031|NCT00086307|Pramipexole|pramipexole
5809032|NCT00086307|Escitalopran|escitalopran
5809033|NCT00086307|Antidepressant|antidepressant
5815580|NCT00014391|infection|infection
5809034|NCT00086307|Dopaminergic Receptor Agonist|dopaminergic receptor agonist
5809035|NCT00086307|Depression|depression
5809036|NCT00086307|Major Depression|major depression
5809037|NCT00086294|Non-Dopaminergic|non-dopaminergic
5809038|NCT00086294|Dyskinesias|dyskinesias
5809039|NCT00086294|Fluctuations|fluctuations
5809040|NCT00086294|Inverse Agonist|inverse agonist
5809041|NCT00086294|ACP-103|acp-103
5809042|NCT00086294|Parkinson Disease|parkinson disease
5809043|NCT00086294|PD|pd
5809044|NCT00086255|cocaine dependence|cocaine dependence
5809045|NCT00086216|Multiple myeloma|multiple myeloma
5809046|NCT00002642|squamous cell lung cancer|squamous cell lung cancer
5809047|NCT00002642|large cell lung cancer|large cell lung cancer
5861963|NCT00001766|Salvage|salvage
5809048|NCT00002642|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5809049|NCT00002642|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809050|NCT00002642|adenocarcinoma of the lung|adenocarcinoma of the lung
5809051|NCT00002642|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5809052|NCT00002565|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5809053|NCT00002565|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5809054|NCT00002565|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5809055|NCT00002565|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5809056|NCT00002565|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5809057|NCT00002565|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5809058|NCT00002565|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5809059|NCT00002565|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5809060|NCT00002565|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5809061|NCT00002565|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5809062|NCT00002565|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5809063|NCT00002565|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5809064|NCT00002565|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5809065|NCT00002565|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5809066|NCT00002565|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5809067|NCT00002565|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5809068|NCT00002565|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5809069|NCT00002565|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5809204|NCT00004192|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809070|NCT00002565|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5809071|NCT00002565|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5809072|NCT00002565|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5809073|NCT00002565|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5809074|NCT00002565|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5809075|NCT00002565|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5809076|NCT00086242|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5809077|NCT00086242|stage IA cervical cancer|stage ia cervical cancer
5809078|NCT00086242|stage IB cervical cancer|stage ib cervical cancer
5809079|NCT00086242|stage IIA cervical cancer|stage iia cervical cancer
5828714|NCT00060736|Depression|depression
5809082|NCT00086229|Complementary Therapies|complementary therapies
5809083|NCT00086190|Parkinson disease|parkinson disease
5809085|NCT00086190|Parkinson's disease|parkinson's disease
5809086|NCT00086190|paroxetine|paroxetine
5809087|NCT00086190|venlafaxine|venlafaxine
5809088|NCT00086190|antidepressant|antidepressant
5809089|NCT00086177|Pregnancy,|pregnancy,
5809090|NCT00086177|prevention of preterm birth,|prevention of preterm birth,
5809091|NCT00086177|prevention of preterm labor,|prevention of preterm labor,
5809092|NCT00086164|edifoligide|edifoligide
5809093|NCT00086164|E2F Decoy|e2f decoy
5809094|NCT00086164|Chronic Renal failure|chronic renal failure
5809095|NCT00086164|hemodialysis|hemodialysis
5809096|NCT00086164|AV Graft|av graft
5809097|NCT00086164|neointimal hyperplasia|neointimal hyperplasia
5809098|NCT00086138|Alzheimer's disease|alzheimer's disease
5809100|NCT00086125|Relapsed or refractory hematologic malignancies|relapsed or refractory hematologic malignancies
5809102|NCT00086112|antipsychotic|antipsychotic
5809103|NCT00006041|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5809104|NCT00006041|fallopian tube cancer|fallopian tube cancer
5809105|NCT00006041|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5809106|NCT00005975|stage I breast cancer|stage i breast cancer
5809107|NCT00005975|stage II breast cancer|stage ii breast cancer
5809108|NCT00005975|hot flashes|hot flashes
5809109|NCT00005854|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5809110|NCT00005854|refractory multiple myeloma|refractory multiple myeloma
5686624|NCT00551239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5686625|NCT00551239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5686626|NCT00551239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5863162|NCT00001366|Epilepsy|epilepsy
5809111|NCT00005854|stage I multiple myeloma|stage i multiple myeloma
5809112|NCT00005854|stage II multiple myeloma|stage ii multiple myeloma
5809113|NCT00005854|stage III multiple myeloma|stage iii multiple myeloma
5809114|NCT00005854|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5809115|NCT00005854|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5809116|NCT00005854|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5809117|NCT00005854|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5809118|NCT00005854|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5809119|NCT00005854|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5862319|NCT00001645|Parasite|parasite
5809120|NCT00005854|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5809121|NCT00005854|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5809122|NCT00005854|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5809123|NCT00005854|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5809124|NCT00005854|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5809125|NCT00005854|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5809126|NCT00005854|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5809127|NCT00005854|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5809128|NCT00005854|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5809129|NCT00005854|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809130|NCT00005854|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809131|NCT00005854|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809132|NCT00005854|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809133|NCT00005854|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809134|NCT00005854|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809135|NCT00005854|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809136|NCT00005854|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809137|NCT00005854|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809138|NCT00005854|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5809139|NCT00005854|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5809140|NCT00005854|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5809141|NCT00005854|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5809142|NCT00005854|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5809143|NCT00005854|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5809144|NCT00005854|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809145|NCT00005854|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809146|NCT00005854|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809147|NCT00005854|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809148|NCT00005854|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809149|NCT00005854|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809150|NCT00005854|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5809151|NCT00002505|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809152|NCT00002482|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809153|NCT00005613|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5809154|NCT00005613|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5829082|NCT00060463|Gonorrhea|gonorrhea
5809155|NCT00005613|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5809156|NCT00005613|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809157|NCT00005613|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809158|NCT00005613|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5862645|NCT00001551|Speech Disorder|speech disorder
5681291|NCT00573950|Type 2 Diabetes mellitus|type 2 diabetes mellitus
5809159|NCT00005613|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809160|NCT00005613|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809161|NCT00005613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809162|NCT00005613|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809163|NCT00005613|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815713|NCT00010283|prolymphocytic leukemia|prolymphocytic leukemia
5808579|NCT00003805|infection|infection
5809164|NCT00005613|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809165|NCT00005613|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809166|NCT00005613|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809167|NCT00005613|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809168|NCT00005613|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809169|NCT00005613|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809170|NCT00004202|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5809171|NCT00004202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5809172|NCT00004202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809173|NCT00004197|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5809174|NCT00004197|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5809175|NCT00004197|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5809176|NCT00004197|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5809177|NCT00004197|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5809178|NCT00004197|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5809179|NCT00004197|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5809180|NCT00004197|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5809181|NCT00004197|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5809182|NCT00004197|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5809183|NCT00004197|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5809184|NCT00004197|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5809185|NCT00004197|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5809186|NCT00004197|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5809187|NCT00004197|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5809188|NCT00004197|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5809189|NCT00004197|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5809190|NCT00004197|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5809191|NCT00004197|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5809192|NCT00004197|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5809193|NCT00004197|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5809194|NCT00004197|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5809195|NCT00004197|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5809196|NCT00004197|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5809197|NCT00004197|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5809199|NCT00004192|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5809200|NCT00004192|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809201|NCT00004192|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809202|NCT00004192|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809203|NCT00004192|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809205|NCT00004192|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809206|NCT00004192|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809207|NCT00004192|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809208|NCT00004192|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809209|NCT00004192|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809210|NCT00004192|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809211|NCT00004192|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809212|NCT00004192|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809213|NCT00004192|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809214|NCT00004192|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809215|NCT00003995|stage IV colon cancer|stage iv colon cancer
5809216|NCT00003995|stage IV rectal cancer|stage iv rectal cancer
5809217|NCT00003995|recurrent colon cancer|recurrent colon cancer
5809218|NCT00003995|recurrent rectal cancer|recurrent rectal cancer
5809219|NCT00003946|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809220|NCT00003946|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5809221|NCT00086086|Symptomatic Congestive Heart Failure|symptomatic congestive heart failure
5809224|NCT00086086|Anemia|anemia
5809225|NCT00086073|Parkinson disease|parkinson disease
5809226|NCT00086073|Parkinson's disease|parkinson's disease
5809227|NCT00086073|PD|pd
5809228|NCT00086073|genetics|genetics
5809229|NCT00086073|genes|genes
5809230|NCT00086073|siblings|siblings
5809231|NCT00086073|family|family
5815761|NCT00005875|stage IV melanoma|stage iv melanoma
5808669|NCT00087685|Endometrial|endometrial
5809232|NCT00003762|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5809233|NCT00003762|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809234|NCT00003762|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5809235|NCT00003723|advanced malignant mesothelioma|advanced malignant mesothelioma
5809236|NCT00003723|epithelial mesothelioma|epithelial mesothelioma
5801946|NCT00100542|Child|child
5809237|NCT00003723|sarcomatous mesothelioma|sarcomatous mesothelioma
5809238|NCT00003691|stage III endometrial carcinoma|stage iii endometrial carcinoma
5809239|NCT00003691|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809240|NCT00003691|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5809241|NCT00003667|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5809242|NCT00003667|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5809243|NCT00003667|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5809244|NCT00003667|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5809245|NCT00003667|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5809246|NCT00003630|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5809247|NCT00003630|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809248|NCT00003549|stage II neuroendocrine carcinoma of the skin|stage ii neuroendocrine carcinoma of the skin
5809249|NCT00003549|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5846487|NCT00044291|lobular breast carcinoma|lobular breast carcinoma
5809250|NCT00003549|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5809251|NCT00003369|stage IV cervical cancer|stage iv cervical cancer
5809252|NCT00003369|recurrent cervical cancer|recurrent cervical cancer
5809253|NCT00003369|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5809254|NCT00003369|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5809255|NCT00003317|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5809256|NCT00003127|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809257|NCT00003127|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5809258|NCT00003127|endometrial adenocarcinoma|endometrial adenocarcinoma
5809259|NCT00003127|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5809260|NCT00003127|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5809261|NCT00086060|Internal-External Control|internal-external control
5809262|NCT00086060|Magnetic Resonance Imaging|magnetic resonance imaging
5809263|NCT00086060|fMRI|fmri
5809264|NCT00086060|Exercise|exercise
5809265|NCT00086060|Relaxation|relaxation
5809266|NCT00086047|Juvenile Fibromyalgia Syndrome|juvenile fibromyalgia syndrome
5809267|NCT00086047|JPFS|jpfs
5809268|NCT00086047|Fibromyalgia|fibromyalgia
5809269|NCT00086047|Chronic Pain|chronic pain
5809270|NCT00086047|Pediatric Pain|pediatric pain
5809271|NCT00086047|Juvenile Fibromyalgia|juvenile fibromyalgia
5809272|NCT00086034|Lymphoma|lymphoma
5809273|NCT00086034|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5809274|NCT00086034|Indolent lymphoma|indolent lymphoma
5809275|NCT00086034|Relapsed lymphoma|relapsed lymphoma
5809276|NCT00086034|Refractory lymphoma|refractory lymphoma
5809277|NCT00086034|Motexafin gadolinium|motexafin gadolinium
5809278|NCT00003078|stage III cervical cancer|stage iii cervical cancer
5809279|NCT00003078|stage IIB cervical cancer|stage iib cervical cancer
5809280|NCT00003078|stage IVA cervical cancer|stage iva cervical cancer
5809281|NCT00003078|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5809282|NCT00003078|cervical adenocarcinoma|cervical adenocarcinoma
5809283|NCT00003078|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5809284|NCT00002844|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5809285|NCT00002844|Cyclophosphamide|cyclophosphamide
5809286|NCT00002844|Cytoxan|cytoxan
5809287|NCT00002844|Neosar|neosar
5809288|NCT00002844|Bone Marrow Transplantation|bone marrow transplantation
5809289|NCT00002844|total body irradiation|total body irradiation
5809290|NCT00002844|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5809291|NCT00002844|allogeneic|allogeneic
5809292|NCT00002844|autologous|autologous
5809293|NCT00002816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5809294|NCT00002747|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5809295|NCT00002747|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5809296|NCT00002747|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5809297|NCT00002725|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809298|NCT00002725|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809299|NCT00002725|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809300|NCT00002725|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809301|NCT00002725|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809302|NCT00002725|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809303|NCT00002725|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809304|NCT00002725|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809306|NCT00002725|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809307|NCT00002725|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809308|NCT00002725|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809309|NCT00002725|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809310|NCT00002725|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809311|NCT00002725|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809314|NCT00085969|diabetes|diabetes
5809315|NCT00085969|exenatide|exenatide
5809317|NCT00085969|Lilly|lilly
5809318|NCT00006241|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809319|NCT00006241|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809320|NCT00006241|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809321|NCT00006241|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809322|NCT00006241|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809323|NCT00006241|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809324|NCT00006241|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809325|NCT00006241|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5846488|NCT00044291|stage IIIA breast cancer|stage iiia breast cancer
5809326|NCT00006241|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809327|NCT00006241|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809328|NCT00006241|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809329|NCT00006241|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809330|NCT00006235|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5809331|NCT00006235|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5809332|NCT00006235|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5809333|NCT00006235|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5809334|NCT00006235|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5809335|NCT00006235|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5809336|NCT00006235|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5809337|NCT00006235|fallopian tube cancer|fallopian tube cancer
5809338|NCT00006235|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5809339|NCT00006235|Brenner tumor|brenner tumor
5809340|NCT00006214|prostate cancer|prostate cancer
5809341|NCT00006117|stage III pancreatic cancer|stage iii pancreatic cancer
5809342|NCT00006117|stage IV pancreatic cancer|stage iv pancreatic cancer
5809343|NCT00006117|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5809344|NCT00006116|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5809345|NCT00006116|squamous cell lung cancer|squamous cell lung cancer
5809346|NCT00006116|large cell lung cancer|large cell lung cancer
5809347|NCT00006116|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809348|NCT00006116|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5809349|NCT00006116|adenocarcinoma of the lung|adenocarcinoma of the lung
5809350|NCT00006088|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809351|NCT00002717|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5809352|NCT00002717|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5809353|NCT00002717|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5809354|NCT00002717|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5809355|NCT00002717|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5809356|NCT00002717|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5809357|NCT00002717|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5809358|NCT00002717|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5809359|NCT00002717|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5809360|NCT00002717|Brenner tumor|brenner tumor
5809361|NCT00002657|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5809362|NCT00002657|extramedullary plasmacytoma|extramedullary plasmacytoma
5809363|NCT00002657|refractory multiple myeloma|refractory multiple myeloma
5809364|NCT00002657|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5809365|NCT00002657|stage I multiple myeloma|stage i multiple myeloma
5809366|NCT00002657|stage II multiple myeloma|stage ii multiple myeloma
5809367|NCT00002657|stage III multiple myeloma|stage iii multiple myeloma
5809368|NCT00002657|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5809369|NCT00002657|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5809370|NCT00002657|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5809371|NCT00002657|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5809372|NCT00002657|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5809373|NCT00002657|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5809374|NCT00002657|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5809375|NCT00002657|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5809376|NCT00002657|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5809377|NCT00002657|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5809379|NCT00002657|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5809380|NCT00002657|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5809381|NCT00002657|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5809382|NCT00002657|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5809383|NCT00002657|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5809384|NCT00002657|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5809385|NCT00002657|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5809386|NCT00002657|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5809387|NCT00002657|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5809388|NCT00002657|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5809389|NCT00002657|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5809390|NCT00002657|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5809391|NCT00002657|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5809392|NCT00002657|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5809393|NCT00002657|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5809394|NCT00002657|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5809395|NCT00002657|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5809396|NCT00002657|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5809397|NCT00002657|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5809398|NCT00002657|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5809399|NCT00002657|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5809400|NCT00002657|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5809401|NCT00002657|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5809402|NCT00002657|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5809403|NCT00002657|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5809404|NCT00002657|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809405|NCT00002657|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809406|NCT00002657|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809407|NCT00002657|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809408|NCT00002657|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809409|NCT00002657|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809410|NCT00002657|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809411|NCT00002657|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809412|NCT00002657|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809413|NCT00002657|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5809414|NCT00002657|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5809415|NCT00002657|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5809416|NCT00002657|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5809417|NCT00002657|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5809483|NCT00005993|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5809420|NCT00002657|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5809421|NCT00002657|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5809422|NCT00002657|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5809423|NCT00002657|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5809424|NCT00002657|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5809425|NCT00002657|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5809426|NCT00002657|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5809427|NCT00002657|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5809428|NCT00002657|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5809429|NCT00002657|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5809430|NCT00002657|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5809431|NCT00002657|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809432|NCT00002657|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5809433|NCT00002657|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5809434|NCT00002657|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5809435|NCT00002657|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5809436|NCT00002657|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5809437|NCT00002657|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809439|NCT00002657|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809441|NCT00085995|Ankylosing Spondylitis|ankylosing spondylitis
5809443|NCT00085995|Spondyloarthropathy|spondyloarthropathy
5809444|NCT00085995|Spondyloarthritis|spondyloarthritis
5809448|NCT00085943|ritonavir|ritonavir
5809449|NCT00085943|abacavir|abacavir
5809450|NCT00085943|HIV|hiv
5809451|NCT00085943|lopinavir|lopinavir
5809452|NCT00085943|lamivudine|lamivudine
5809453|NCT00085943|fosamprenavir|fosamprenavir
5809454|NCT00085943|Epzicom|epzicom
5809456|NCT00006035|stage III melanoma|stage iii melanoma
5809457|NCT00006035|stage IV melanoma|stage iv melanoma
5809458|NCT00006035|recurrent melanoma|recurrent melanoma
5809459|NCT00006033|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5809460|NCT00006033|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5809461|NCT00006033|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5809462|NCT00006033|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5809463|NCT00006033|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5862665|NCT00001548|Genetic|genetic
5809464|NCT00006033|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5809465|NCT00006033|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5809466|NCT00006033|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5809467|NCT00006033|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5809468|NCT00006033|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5809469|NCT00006033|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5809470|NCT00006033|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5809471|NCT00006033|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5809472|NCT00006033|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5809473|NCT00006033|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5809474|NCT00006033|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5809475|NCT00006033|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5809476|NCT00006033|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5809477|NCT00006033|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5809478|NCT00005993|stage IV breast cancer|stage iv breast cancer
5809479|NCT00005993|stage IIIA breast cancer|stage iiia breast cancer
5809480|NCT00005993|recurrent breast cancer|recurrent breast cancer
5809481|NCT00005993|stage IIIB breast cancer|stage iiib breast cancer
5809482|NCT00005993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5809484|NCT00005993|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5809485|NCT00005993|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5809486|NCT00005993|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5809487|NCT00005993|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5809488|NCT00005993|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5809489|NCT00005993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5809490|NCT00005993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5809491|NCT00005993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5809492|NCT00005993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5809493|NCT00005993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5809494|NCT00005993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5809495|NCT00005993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809496|NCT00005993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809497|NCT00005993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809498|NCT00005993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809499|NCT00005993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809500|NCT00005993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809501|NCT00005993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809502|NCT00005993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809503|NCT00005993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809504|NCT00005993|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5809505|NCT00005993|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5809506|NCT00005993|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5809507|NCT00005993|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5809508|NCT00005993|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5809509|NCT00005993|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5809510|NCT00005993|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5809512|NCT00005993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5809513|NCT00005993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809514|NCT00005993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809515|NCT00005993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809516|NCT00005993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809517|NCT00005993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809518|NCT00005993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809520|NCT00085904|Advanced cancer|advanced cancer
5809522|NCT00085904|repeat dosing|repeat dosing
5809523|NCT00085904|Phase 1|phase 1
5809524|NCT00085904|pharmacokinetics|pharmacokinetics
5809525|NCT00085904|oncology|oncology
5809526|NCT00085891|Schizophrenia|schizophrenia
5809527|NCT00085891|Schizophrenic disorder|schizophrenic disorder
5809528|NCT00085878|IL-18|il-18
5809529|NCT00085878|subcutaneous|subcutaneous
5809530|NCT00085878|pharmacokinetics|pharmacokinetics
5809531|NCT00085878|Phase 1|phase 1
5809532|NCT00005829|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5809533|NCT00005829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5809534|NCT00005826|adult glioblastoma|adult glioblastoma
5809535|NCT00005826|adult giant cell glioblastoma|adult giant cell glioblastoma
5809536|NCT00005826|adult gliosarcoma|adult gliosarcoma
5809537|NCT00005616|stage I colon cancer|stage i colon cancer
5809538|NCT00005616|stage II colon cancer|stage ii colon cancer
5809539|NCT00005616|stage III colon cancer|stage iii colon cancer
5809540|NCT00005616|stage IV colon cancer|stage iv colon cancer
5809541|NCT00005616|stage I rectal cancer|stage i rectal cancer
5809542|NCT00005616|stage II rectal cancer|stage ii rectal cancer
5809543|NCT00005616|stage III rectal cancer|stage iii rectal cancer
5809544|NCT00005616|stage IV rectal cancer|stage iv rectal cancer
5809545|NCT00005616|recurrent colon cancer|recurrent colon cancer
5809546|NCT00005616|recurrent rectal cancer|recurrent rectal cancer
5809547|NCT00005616|liver metastases|liver metastases
5809548|NCT00005093|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5809549|NCT00005093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5809550|NCT00005093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809551|NCT00005093|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5809552|NCT00005073|stage I prostate cancer|stage i prostate cancer
5809553|NCT00005073|stage IIB prostate cancer|stage iib prostate cancer
5809554|NCT00005073|stage IIA prostate cancer|stage iia prostate cancer
5809555|NCT00005073|stage III prostate cancer|stage iii prostate cancer
5809556|NCT00005073|recurrent prostate cancer|recurrent prostate cancer
5809557|NCT00005048|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5809558|NCT00005048|recurrent prostate cancer|recurrent prostate cancer
5809559|NCT00005041|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5809560|NCT00005041|recurrent small cell lung cancer|recurrent small cell lung cancer
5809561|NCT00004929|recurrent prostate cancer|recurrent prostate cancer
5809562|NCT00004861|stage II pancreatic cancer|stage ii pancreatic cancer
5809563|NCT00004861|stage III pancreatic cancer|stage iii pancreatic cancer
5809564|NCT00004861|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5809565|NCT00004861|stage IV pancreatic cancer|stage iv pancreatic cancer
5809566|NCT00004260|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5809567|NCT00004260|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5809568|NCT00004260|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5809569|NCT00004260|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5809570|NCT00004260|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5809571|NCT00004260|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5809572|NCT00004260|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5809573|NCT00004260|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5809574|NCT00004260|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5809575|NCT00004260|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5809576|NCT00004260|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5809577|NCT00004260|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5809578|NCT00004260|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5806017|NCT00089739|Intraocular Inflammation|intraocular inflammation
5809579|NCT00004260|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5809580|NCT00004260|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5809581|NCT00004260|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5809582|NCT00004260|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5686627|NCT00551239|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5686628|NCT00551239|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5686629|NCT00551239|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5686630|NCT00551239|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5809583|NCT00004260|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5809584|NCT00004260|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5809585|NCT00004260|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5809586|NCT00004260|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5809587|NCT00004260|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5809588|NCT00004260|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5809589|NCT00004260|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5809590|NCT00004260|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5809591|NCT00004260|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5809593|NCT00004260|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809594|NCT00004260|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809595|NCT00004260|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809596|NCT00004260|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809597|NCT00004260|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809598|NCT00004260|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809599|NCT00004260|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822348|NCT00003777|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5822349|NCT00003777|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5822350|NCT00003777|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5822353|NCT00003761|stage IV breast cancer|stage iv breast cancer
5809600|NCT00004260|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809601|NCT00004260|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809602|NCT00004260|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5809603|NCT00004260|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5809604|NCT00004260|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5809605|NCT00004260|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5809606|NCT00004260|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5809607|NCT00004260|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5809608|NCT00004260|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5809609|NCT00004260|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5809610|NCT00004260|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5809611|NCT00004260|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5809612|NCT00004260|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5809613|NCT00004260|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5809614|NCT00004260|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5809615|NCT00004260|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5809616|NCT00004260|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5809617|NCT00004260|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5809618|NCT00004260|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5809619|NCT00004260|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5809620|NCT00004260|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5809621|NCT00004260|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5809622|NCT00004260|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5809623|NCT00004260|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5809624|NCT00004260|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5809625|NCT00004260|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809626|NCT00004260|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5809627|NCT00004260|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5809628|NCT00004260|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5862646|NCT00001550|Immunotherapy|immunotherapy
5809629|NCT00004260|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809630|NCT00004260|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5809631|NCT00004260|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5809632|NCT00004260|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5859857|NCT00005934|Blood|blood
5809633|NCT00004260|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5809634|NCT00004260|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5809635|NCT00004260|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5809636|NCT00004260|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5809637|NCT00004260|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5809638|NCT00004260|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809639|NCT00004260|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809640|NCT00004260|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809641|NCT00004217|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5809642|NCT00004217|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5809643|NCT00004217|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5809644|NCT00004217|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5809645|NCT00004217|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5809646|NCT00004217|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5809647|NCT00004217|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5809648|NCT00004217|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5809649|NCT00004217|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5809651|NCT00085917|Ribavirin|ribavirin
5809652|NCT00085917|Early Virological Response|early virological response
5809653|NCT00085917|Hepatitis C|hepatitis c
5809655|NCT00085852|emphysema|emphysema
5809656|NCT00085852|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5809657|NCT00085852|lung volume reduction|lung volume reduction
5809658|NCT00085852|bronchoscopic|bronchoscopic
5809659|NCT00085852|bronchoscopy|bronchoscopy
5809660|NCT00085852|bronchoscope|bronchoscope
5809661|NCT00085839|Tarceva|tarceva
5809662|NCT00085839|NSCLC|nsclc
5809663|NCT00085839|EGFR|egfr
5809664|NCT00085839|ECOG Performance Status 2|ecog performance status 2
5809665|NCT00085839|erlotinib|erlotinib
5809666|NCT00085839|Non-Small Cell Lung Cancer|non-small cell lung cancer
5809667|NCT00085839|OSI-774|osi-774
5809668|NCT00085826|Lung Cancer|lung cancer
5809669|NCT00085826|NSCLC|nsclc
5809670|NCT00085826|Non-small Cell Lung Cancer|non-small cell lung cancer
5809671|NCT00085813|Platinum-Refractory|platinum-refractory
5809672|NCT00085813|Platinum-Relapsed|platinum-relapsed
5809673|NCT00085813|Non-Small Cell Lung Cancer|non-small cell lung cancer
5809674|NCT00085774|albuterol|albuterol
5809675|NCT00085774|aerosol inhaler|aerosol inhaler
5809676|NCT00085774|metered-dose inhaler|metered-dose inhaler
5809677|NCT00085774|breath-actuated inhaler|breath-actuated inhaler
5809678|NCT00085774|exercise-induced bronchospasm|exercise-induced bronchospasm
5809679|NCT00085761|Dermal assessment|dermal assessment
5809680|NCT00085761|Pain measurement|pain measurement
5809681|NCT00085761|Diary|diary
5809682|NCT00085761|Neuropathy|neuropathy
5809683|NCT00085761|Analgesics/*therapeutic use|analgesics/*therapeutic use
5809684|NCT00085761|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5809685|NCT00085761|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
5809686|NCT00085761|Pain|pain
5809687|NCT00085761|Complementary Therapies|complementary therapies
5809688|NCT00004251|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809689|NCT00004251|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5809690|NCT00004251|endometrial adenocarcinoma|endometrial adenocarcinoma
5809691|NCT00004251|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5809692|NCT00004076|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809693|NCT00004043|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5809694|NCT00004043|recurrent prostate cancer|recurrent prostate cancer
5809695|NCT00003996|adult glioblastoma|adult glioblastoma
5809696|NCT00003996|adult giant cell glioblastoma|adult giant cell glioblastoma
5809697|NCT00003996|adult gliosarcoma|adult gliosarcoma
5809698|NCT00003920|stage IV breast cancer|stage iv breast cancer
5809699|NCT00003920|recurrent breast cancer|recurrent breast cancer
5809700|NCT00003898|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5809701|NCT00003898|oral complications|oral complications
5809702|NCT00003894|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5809703|NCT00003894|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809704|NCT00003894|graft versus host disease|graft versus host disease
5809705|NCT00003891|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809706|NCT00085865|5 HT|5 ht
5809707|NCT00085865|Neuroreceptors|neuroreceptors
5809708|NCT00085865|Radiotracer|radiotracer
5809709|NCT00085865|Neuroimaging|neuroimaging
5816915|NCT00003967|Brenner tumor|brenner tumor
5686631|NCT00551239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809710|NCT00085865|Serotonin Transporter|serotonin transporter
5809711|NCT00085865|Alcoholism|alcoholism
5809713|NCT00085865|Healthy Volunteer|healthy volunteer
5809714|NCT00085865|HV|hv
5809715|NCT00085748|schizophrenia|schizophrenia
5809716|NCT00085748|geriatric|geriatric
5809717|NCT00085748|elderly|elderly
5809718|NCT00085722|Injection Therapy|injection therapy
5809719|NCT00085709|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5809720|NCT00085709|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5809721|NCT00085709|adult acute basophilic leukemia|adult acute basophilic leukemia
5809722|NCT00085709|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5809723|NCT00085709|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5809724|NCT00085709|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5809725|NCT00085709|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5809726|NCT00085709|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5809727|NCT00085709|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5809728|NCT00085709|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5809729|NCT00085709|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5809730|NCT00085709|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5809731|NCT00085709|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5809732|NCT00085709|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5809733|NCT00085709|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5809734|NCT00003871|stage IV prostate cancer|stage iv prostate cancer
5809735|NCT00003871|recurrent prostate cancer|recurrent prostate cancer
5809736|NCT00003860|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5809737|NCT00003847|recurrent small cell lung cancer|recurrent small cell lung cancer
5809738|NCT00003847|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5809739|NCT00003829|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5809740|NCT00003829|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5809741|NCT00003829|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5809742|NCT00003829|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5809743|NCT00003829|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5809744|NCT00003720|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5809745|NCT00003720|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5809746|NCT00003624|stage I cervical cancer|stage i cervical cancer
5809747|NCT00003624|stage II cervical cancer|stage ii cervical cancer
5809748|NCT00003624|stage III cervical cancer|stage iii cervical cancer
5809749|NCT00003624|stage IV cervical cancer|stage iv cervical cancer
5809750|NCT00003624|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5809751|NCT00003624|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5809752|NCT00003624|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5809753|NCT00003624|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5809754|NCT00003624|stage I endometrial carcinoma|stage i endometrial carcinoma
5809755|NCT00003624|stage II endometrial carcinoma|stage ii endometrial carcinoma
5809756|NCT00003624|stage III endometrial carcinoma|stage iii endometrial carcinoma
5809757|NCT00003624|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809758|NCT00003624|endometrial adenocarcinoma|endometrial adenocarcinoma
5809759|NCT00003624|fallopian tube cancer|fallopian tube cancer
5809760|NCT00003624|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5809761|NCT00003624|stage I uterine sarcoma|stage i uterine sarcoma
5809762|NCT00003624|stage II uterine sarcoma|stage ii uterine sarcoma
5809763|NCT00003624|stage III uterine sarcoma|stage iii uterine sarcoma
5809764|NCT00003624|stage IV uterine sarcoma|stage iv uterine sarcoma
5809765|NCT00003624|neurotoxicity|neurotoxicity
5809766|NCT00003592|stage IV salivary gland cancer|stage iv salivary gland cancer
5809767|NCT00003592|recurrent salivary gland cancer|recurrent salivary gland cancer
5809768|NCT00003592|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5809769|NCT00003592|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5809841|NCT00002864|stage I breast cancer|stage i breast cancer
5809770|NCT00003592|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5809771|NCT00003592|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5809772|NCT00003592|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5809773|NCT00003592|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5809774|NCT00003592|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5809775|NCT00003592|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5809776|NCT00003592|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5809223|NCT00086086|Anaemia|anaemia
5809777|NCT00003592|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5809778|NCT00003592|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5809779|NCT00003592|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5809780|NCT00003592|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5809781|NCT00003574|recurrent adult brain tumor|recurrent adult brain tumor
5809782|NCT00003574|adult glioblastoma|adult glioblastoma
5809783|NCT00003574|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5809784|NCT00003574|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5809785|NCT00003574|adult giant cell glioblastoma|adult giant cell glioblastoma
5809786|NCT00003574|adult gliosarcoma|adult gliosarcoma
5809787|NCT00003254|stage IV colon cancer|stage iv colon cancer
5809788|NCT00003254|stage IV rectal cancer|stage iv rectal cancer
5809789|NCT00003254|recurrent colon cancer|recurrent colon cancer
5809790|NCT00003254|recurrent rectal cancer|recurrent rectal cancer
5809791|NCT00003242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809792|NCT00003206|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5809793|NCT00003206|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5809794|NCT00003143|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5809795|NCT00003143|Waldenström macroglobulinemia|waldenström macroglobulinemia
5809796|NCT00003143|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809797|NCT00003143|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809798|NCT00003143|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809799|NCT00003143|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809800|NCT00003143|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809801|NCT00003143|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809802|NCT00003143|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809803|NCT00003143|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809804|NCT00003143|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809805|NCT00003143|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809806|NCT00003143|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809807|NCT00003143|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809808|NCT00003143|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5809809|NCT00003143|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809810|NCT00003143|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5809811|NCT00003099|breast cancer|breast cancer
5809812|NCT00003099|Tamoxifen|tamoxifen
5809813|NCT00003099|Fenretinide|fenretinide
5809814|NCT00003099|Chemoprevention Therapy|chemoprevention therapy
5809815|NCT00003099|N-(4-hydroxyphenyl) Retinamide|n-(4-hydroxyphenyl) retinamide
5809816|NCT00003099|4-HPR|4-hpr
5809817|NCT00003099|Breast Neoplasia|breast neoplasia
5809818|NCT00003099|Diagnostic Core Biopsy|diagnostic core biopsy
5809819|NCT00003099|Surgery|surgery
5809820|NCT00003085|stage I pancreatic cancer|stage i pancreatic cancer
5809821|NCT00003085|stage II pancreatic cancer|stage ii pancreatic cancer
5809822|NCT00003028|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809823|NCT00003009|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809824|NCT00002973|stage III melanoma|stage iii melanoma
5809825|NCT00002973|stage IV melanoma|stage iv melanoma
5809826|NCT00002973|recurrent melanoma|recurrent melanoma
5809827|NCT00002949|stage II cervical cancer|stage ii cervical cancer
5809828|NCT00002949|stage III cervical cancer|stage iii cervical cancer
5809829|NCT00002949|stage IV cervical cancer|stage iv cervical cancer
5809830|NCT00002949|stage II vaginal cancer|stage ii vaginal cancer
5809831|NCT00002949|stage III vaginal cancer|stage iii vaginal cancer
5809832|NCT00002949|stage IVA vaginal cancer|stage iva vaginal cancer
5809833|NCT00002949|stage IVB vaginal cancer|stage ivb vaginal cancer
5809834|NCT00002949|stage II endometrial carcinoma|stage ii endometrial carcinoma
5809835|NCT00002949|stage III endometrial carcinoma|stage iii endometrial carcinoma
5809836|NCT00002949|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809837|NCT00002949|stage II bladder cancer|stage ii bladder cancer
5809838|NCT00002949|stage III bladder cancer|stage iii bladder cancer
5809839|NCT00002949|stage IV bladder cancer|stage iv bladder cancer
5809840|NCT00002915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5809847|NCT00002785|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5809848|NCT00002740|disseminated neuroblastoma|disseminated neuroblastoma
5809849|NCT00085696|Lymphoma|lymphoma
5809850|NCT00085696|Non-Hodgkin's|non-hodgkin's
5809852|NCT00085696|B-Cell|b-cell
5809853|NCT00085696|Indolent|indolent
5809854|NCT00085683|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5809855|NCT00085683|Lumbar Puncture|lumbar puncture
5809856|NCT00085683|Healthy Control Subjects|healthy control subjects
5809857|NCT00085683|Mesial Temporal Sclerosis|mesial temporal sclerosis
5809313|NCT00086021|Acupuncture|acupuncture
5809858|NCT00085683|Neuroexcitotoxicity|neuroexcitotoxicity
5809859|NCT00085683|Seizure Disorder|seizure disorder
5809860|NCT00085683|Epilepsy|epilepsy
5809861|NCT00085683|Healthy Volunteer|healthy volunteer
5809862|NCT00085683|HV|hv
5809868|NCT00085657|Direct Current Stimulation|direct current stimulation
5809870|NCT00085657|Rehabilitation|rehabilitation
5809871|NCT00085657|Acute Stroke|acute stroke
5809872|NCT00085657|Stroke|stroke
5809873|NCT00085631|stage IA cervical cancer|stage ia cervical cancer
5809874|NCT00085631|stage IB cervical cancer|stage ib cervical cancer
5809875|NCT00085631|stage IIA cervical cancer|stage iia cervical cancer
5809876|NCT00085631|stage IIB cervical cancer|stage iib cervical cancer
5809877|NCT00085631|stage III cervical cancer|stage iii cervical cancer
5809878|NCT00085631|stage IVA cervical cancer|stage iva cervical cancer
5809879|NCT00085631|cervical adenocarcinoma|cervical adenocarcinoma
5829983|NCT00059228|Postpartum|postpartum
5809880|NCT00085631|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5809881|NCT00085631|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5809882|NCT00085579|stage III melanoma|stage iii melanoma
5809883|NCT00085579|stage IV melanoma|stage iv melanoma
5809884|NCT00085566|adult glioblastoma|adult glioblastoma
5809885|NCT00085566|recurrent prostate cancer|recurrent prostate cancer
5809886|NCT00085566|recurrent adult brain tumor|recurrent adult brain tumor
5809887|NCT00085566|stage IV prostate cancer|stage iv prostate cancer
5809888|NCT00085566|adult giant cell glioblastoma|adult giant cell glioblastoma
5809889|NCT00085566|adult gliosarcoma|adult gliosarcoma
5809890|NCT00085527|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5809891|NCT00085527|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5809892|NCT00085527|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5809893|NCT00085501|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5809894|NCT00085501|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5809895|NCT00085501|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5809896|NCT00085501|adenocarcinoma of the lung|adenocarcinoma of the lung
5822643|NCT00025532|recurrent gastric cancer|recurrent gastric cancer
5822644|NCT00025532|stage III pancreatic cancer|stage iii pancreatic cancer
5822645|NCT00025532|recurrent pancreatic cancer|recurrent pancreatic cancer
5822646|NCT00025532|stage III rectal cancer|stage iii rectal cancer
5822668|NCT00073398|Hyperacute Lung|hyperacute lung
5809897|NCT00085501|squamous cell lung cancer|squamous cell lung cancer
5809898|NCT00085501|large cell lung cancer|large cell lung cancer
5809899|NCT00085488|recurrent melanoma|recurrent melanoma
5809900|NCT00085488|stage III melanoma|stage iii melanoma
5809901|NCT00085488|stage IV melanoma|stage iv melanoma
5809902|NCT00085475|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5809903|NCT00085475|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5809904|NCT00085475|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5809905|NCT00085475|adult fibrosarcoma|adult fibrosarcoma
5809906|NCT00085475|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5809907|NCT00085462|recurrent melanoma|recurrent melanoma
5809908|NCT00085462|stage IV melanoma|stage iv melanoma
5809909|NCT00085449|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5809910|NCT00085449|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5809911|NCT00085449|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5809912|NCT00085449|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5809913|NCT00085449|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5809914|NCT00085449|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5809915|NCT00085449|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5809916|NCT00085449|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5809917|NCT00085449|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5809918|NCT00085449|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5809919|NCT00085449|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5809920|NCT00085449|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5809990|NCT00085020|recurrent breast cancer|recurrent breast cancer
5809921|NCT00085449|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5809922|NCT00085449|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5809923|NCT00085449|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5809924|NCT00085449|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5809925|NCT00085449|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5809926|NCT00085449|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809927|NCT00085449|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5809928|NCT00085449|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5809929|NCT00085449|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5809930|NCT00085449|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5809931|NCT00085449|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5829083|NCT00060463|Trichomonas|trichomonas
5809932|NCT00085449|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5809933|NCT00085449|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5809934|NCT00085449|refractory multiple myeloma|refractory multiple myeloma
5806379|NCT00089427|temozolomide|temozolomide
5809935|NCT00085449|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5809936|NCT00085449|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5809937|NCT00085449|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5809938|NCT00085449|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5809939|NCT00085449|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5809940|NCT00085449|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5809941|NCT00085449|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5809942|NCT00085436|recurrent renal cell cancer|recurrent renal cell cancer
5809943|NCT00085436|stage IV renal cell cancer|stage iv renal cell cancer
5809945|NCT00085423|stage IV melanoma|stage iv melanoma
5809946|NCT00085397|recurrent melanoma|recurrent melanoma
5809947|NCT00085397|stage III melanoma|stage iii melanoma
5809948|NCT00085397|stage IV melanoma|stage iv melanoma
5809949|NCT00085384|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5809950|NCT00085384|peritoneal cavity cancer|peritoneal cavity cancer
5809951|NCT00085384|fallopian tube cancer|fallopian tube cancer
5809952|NCT00085332|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5809953|NCT00085332|stage III endometrial carcinoma|stage iii endometrial carcinoma
5809954|NCT00085332|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5809955|NCT00085306|recurrent melanoma|recurrent melanoma
5809956|NCT00085306|stage IV melanoma|stage iv melanoma
5863756|NCT00001195|Growth|growth
5809957|NCT00085306|iris melanoma|iris melanoma
5809958|NCT00085306|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5809959|NCT00085306|extraocular extension melanoma|extraocular extension melanoma
5809960|NCT00085306|recurrent intraocular melanoma|recurrent intraocular melanoma
5809961|NCT00085228|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5809962|NCT00085228|recurrent prostate cancer|recurrent prostate cancer
5809963|NCT00085228|stage IV prostate cancer|stage iv prostate cancer
5809964|NCT00085202|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5809965|NCT00085202|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5809966|NCT00085202|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5809967|NCT00085202|untreated childhood pineoblastoma|untreated childhood pineoblastoma
5809968|NCT00085176|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5809969|NCT00085176|neurotoxicity|neurotoxicity
5809970|NCT00085176|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5809971|NCT00085176|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5809972|NCT00085163|adenocarcinoma of the colon|adenocarcinoma of the colon
5809973|NCT00085163|stage III colon cancer|stage iii colon cancer
5809974|NCT00085150|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5809975|NCT00085150|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5809976|NCT00085150|childhood Burkitt lymphoma|childhood burkitt lymphoma
5809977|NCT00085150|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5809978|NCT00085150|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5809979|NCT00085150|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5809980|NCT00085150|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5809981|NCT00085150|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5809982|NCT00085150|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5809983|NCT00085150|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5809984|NCT00085150|acute undifferentiated leukemia|acute undifferentiated leukemia
5809985|NCT00085098|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5809986|NCT00085059|stage IV melanoma|stage iv melanoma
5809987|NCT00085059|recurrent melanoma|recurrent melanoma
5809988|NCT00085020|stage IV breast cancer|stage iv breast cancer
5809989|NCT00085020|male breast cancer|male breast cancer
5809991|NCT00084942|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5809992|NCT00084942|recurrent gallbladder cancer|recurrent gallbladder cancer
5809993|NCT00084942|unresectable gallbladder cancer|unresectable gallbladder cancer
5809994|NCT00084942|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5809995|NCT00084942|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5809996|NCT00084942|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5809997|NCT00084929|colon cancer|colon cancer
5809998|NCT00084929|rectal cancer|rectal cancer
5809999|NCT00084903|cervical cancer|cervical cancer
5810000|NCT00084903|cervical intraepithelial neoplasia|cervical intraepithelial neoplasia
5810001|NCT00084890|stage IVB cervical cancer|stage ivb cervical cancer
5816529|NCT00080470|Refractory|refractory
5809442|NCT00085995|AS|as
5810002|NCT00084890|recurrent cervical cancer|recurrent cervical cancer
5810003|NCT00084890|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5810004|NCT00084864|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5817134|NCT00003412|recurrent breast cancer|recurrent breast cancer
5810005|NCT00084864|stage II prostate cancer|stage ii prostate cancer
5810006|NCT00084864|stage III prostate cancer|stage iii prostate cancer
5810008|NCT00084825|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5810009|NCT00084825|recurrent prostate cancer|recurrent prostate cancer
5810010|NCT00084825|stage IV prostate cancer|stage iv prostate cancer
5810012|NCT00084812|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810013|NCT00084799|recurrent small cell lung cancer|recurrent small cell lung cancer
5810014|NCT00084786|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810015|NCT00084773|recurrent rectal cancer|recurrent rectal cancer
5810016|NCT00084773|stage II rectal cancer|stage ii rectal cancer
5810017|NCT00084773|stage III rectal cancer|stage iii rectal cancer
5810018|NCT00084773|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5810019|NCT00084747|stage II multiple myeloma|stage ii multiple myeloma
5810020|NCT00084747|stage III multiple myeloma|stage iii multiple myeloma
5810021|NCT00084734|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810022|NCT00084721|diarrhea|diarrhea
5810023|NCT00084721|recurrent colon cancer|recurrent colon cancer
5810024|NCT00084721|stage IV colon cancer|stage iv colon cancer
5810025|NCT00084721|recurrent rectal cancer|recurrent rectal cancer
5810026|NCT00084721|stage IV rectal cancer|stage iv rectal cancer
5810027|NCT00084721|stage III colon cancer|stage iii colon cancer
5810028|NCT00084721|stage III rectal cancer|stage iii rectal cancer
5810029|NCT00084708|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810030|NCT00084695|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5810031|NCT00084695|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5810032|NCT00084695|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5810033|NCT00084695|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5810034|NCT00084695|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5810035|NCT00084695|disseminated neuroblastoma|disseminated neuroblastoma
5810036|NCT00084695|regional neuroblastoma|regional neuroblastoma
5810037|NCT00084695|recurrent neuroblastoma|recurrent neuroblastoma
5810038|NCT00084695|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5810039|NCT00084695|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5810040|NCT00084695|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5810041|NCT00084695|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5810042|NCT00084695|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5810043|NCT00084695|childhood Burkitt lymphoma|childhood burkitt lymphoma
5810044|NCT00084695|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5810045|NCT00084695|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5810046|NCT00084695|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5810047|NCT00084695|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5810048|NCT00084695|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5810049|NCT00084695|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5810050|NCT00084695|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5810051|NCT00084695|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5810052|NCT00084695|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5810053|NCT00084695|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5810054|NCT00084695|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5810055|NCT00084695|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5810056|NCT00084695|Fanconi anemia|fanconi anemia
5810057|NCT00084695|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5810058|NCT00084695|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5810059|NCT00084695|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5810060|NCT00084695|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5810061|NCT00084695|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5810062|NCT00084695|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5810063|NCT00084695|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5810064|NCT00084695|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5810065|NCT00084669|hot flashes|hot flashes
5810066|NCT00084669|sleep disorders|sleep disorders
5810067|NCT00084669|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5810068|NCT00084669|breast cancer in situ|breast cancer in situ
5810069|NCT00084669|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5810070|NCT00084669|lobular breast carcinoma|lobular breast carcinoma
5681292|NCT00573950|Metabolic Syndrome|metabolic syndrome
5810071|NCT00084669|recurrent breast cancer|recurrent breast cancer
5810072|NCT00084669|stage I breast cancer|stage i breast cancer
5810073|NCT00084669|stage II breast cancer|stage ii breast cancer
5810074|NCT00084669|stage IIIA breast cancer|stage iiia breast cancer
5810075|NCT00084669|stage IIIB breast cancer|stage iiib breast cancer
5810077|NCT00084669|stage IV breast cancer|stage iv breast cancer
5810078|NCT00084656|stage III melanoma|stage iii melanoma
5810079|NCT00084656|stage IV melanoma|stage iv melanoma
5810080|NCT00084656|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5810081|NCT00084656|extraocular extension melanoma|extraocular extension melanoma
5810082|NCT00084656|iris melanoma|iris melanoma
5810083|NCT00084656|recurrent melanoma|recurrent melanoma
5810084|NCT00084656|recurrent intraocular melanoma|recurrent intraocular melanoma
5810085|NCT00084656|metastatic intraocular melanoma|metastatic intraocular melanoma
5810086|NCT00084591|stage II rectal cancer|stage ii rectal cancer
5810087|NCT00084591|stage III rectal cancer|stage iii rectal cancer
5810088|NCT00084591|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5810089|NCT00084578|stage 0 bladder cancer|stage 0 bladder cancer
5810090|NCT00084578|stage I bladder cancer|stage i bladder cancer
5810091|NCT00084578|stage II bladder cancer|stage ii bladder cancer
5810092|NCT00084578|stage III bladder cancer|stage iii bladder cancer
5810093|NCT00084578|stage IV bladder cancer|stage iv bladder cancer
5810094|NCT00084578|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5810095|NCT00084565|stage IV prostate cancer|stage iv prostate cancer
5810096|NCT00084565|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5810097|NCT00084552|sexual dysfunction|sexual dysfunction
5810098|NCT00084552|sexuality and reproductive issues|sexuality and reproductive issues
5810099|NCT00084552|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5810100|NCT00084552|stage IIB prostate cancer|stage iib prostate cancer
5810101|NCT00084552|stage IIA prostate cancer|stage iia prostate cancer
5810102|NCT00084539|stage I breast cancer|stage i breast cancer
5810103|NCT00084539|stage II breast cancer|stage ii breast cancer
5810104|NCT00084539|breast cancer in situ|breast cancer in situ
5810105|NCT00084526|recurrent prostate cancer|recurrent prostate cancer
5810106|NCT00084526|stage I prostate cancer|stage i prostate cancer
5810107|NCT00084526|stage II prostate cancer|stage ii prostate cancer
5810108|NCT00084526|stage III prostate cancer|stage iii prostate cancer
5810109|NCT00084526|stage IV prostate cancer|stage iv prostate cancer
5810110|NCT00084513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810111|NCT00084448|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5810112|NCT00084448|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5810113|NCT00084435|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5810114|NCT00084435|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810115|NCT00084435|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5810116|NCT00084435|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5810117|NCT00084435|stage III salivary gland cancer|stage iii salivary gland cancer
5810118|NCT00084435|stage IV salivary gland cancer|stage iv salivary gland cancer
5810119|NCT00084435|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5810120|NCT00084435|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810121|NCT00084435|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810122|NCT00084435|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810123|NCT00084435|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5810124|NCT00084435|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810125|NCT00084435|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5810126|NCT00084422|recurrent neuroblastoma|recurrent neuroblastoma
5810127|NCT00084409|non-small cell lung cancer|non-small cell lung cancer
5810128|NCT00084409|squamous lung dysplasia|squamous lung dysplasia
5810129|NCT00084396|stage II breast cancer|stage ii breast cancer
5810130|NCT00084396|stage IIIA breast cancer|stage iiia breast cancer
5810131|NCT00084396|stage IIIB breast cancer|stage iiib breast cancer
5810132|NCT00084383|stage I pancreatic cancer|stage i pancreatic cancer
5810133|NCT00084383|stage II pancreatic cancer|stage ii pancreatic cancer
5810134|NCT00084383|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5810135|NCT00084370|ovarian epithelial cancer|ovarian epithelial cancer
5810136|NCT00084370|BRCA1 mutation carrier|brca1 mutation carrier
5810137|NCT00084370|BRCA2 mutation carrier|brca2 mutation carrier
5810138|NCT00084344|breast cancer|breast cancer
5810139|NCT00084318|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5810140|NCT00084318|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810141|NCT00084318|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5810142|NCT00084318|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5816741|NCT00006368|adult brain stem glioma|adult brain stem glioma
5810143|NCT00084318|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810144|NCT00084318|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5806605|NCT00089037|refractory multiple myeloma|refractory multiple myeloma
5810145|NCT00084318|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5810146|NCT00084318|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5810147|NCT00084279|Chronic Hepatitis C|chronic hepatitis c
5810148|NCT00084279|Liver|liver
5810149|NCT00084279|Pegylated|pegylated
5810150|NCT00084279|Interferon|interferon
5810151|NCT00084279|Alpha|alpha
5810152|NCT00084279|Gamma|gamma
5810153|NCT00084279|Ribavirin|ribavirin
5810154|NCT00084279|Combination|combination
5810155|NCT00084279|Nonresponder|nonresponder
5810156|NCT00084279|Pegasys|pegasys
5810157|NCT00084279|PegIntron|pegintron
5810158|NCT00084266|Staphylococcal pneumonia|staphylococcal pneumonia
5810159|NCT00084266|Methicillin-resistant staphylococcal pneumonia|methicillin-resistant staphylococcal pneumonia
5810160|NCT00084266|healthcare-associated pneumonia|healthcare-associated pneumonia
5810162|NCT00084253|Treatment Naive|treatment naive
5810163|NCT00084305|Bronchoscopy|bronchoscopy
5810164|NCT00084305|Pulmonary Fibrosis|pulmonary fibrosis
5810165|NCT00084305|Lung Biopsy (Clinically-Indicated)|lung biopsy (clinically-indicated)
5810166|NCT00084292|Ischemia|ischemia
5810167|NCT00084292|Pediatric|pediatric
5810168|NCT00084292|Etiology|etiology
5810169|NCT00084292|Treatment|treatment
5810170|NCT00084292|Outcome|outcome
5810171|NCT00084292|Childhood Stroke|childhood stroke
5810172|NCT00084292|Pediatric Stroke|pediatric stroke
5810173|NCT00084292|Ischemic Stroke|ischemic stroke
5810174|NCT00084292|Spastic Hemiplegia|spastic hemiplegia
5810175|NCT00084292|Hemiplegic cerebral palsy|hemiplegic cerebral palsy
5810176|NCT00084214|metastatic|metastatic
5810177|NCT00084214|increased antitumor effect|increased antitumor effect
5810178|NCT00002682|Antibiotic Treatment|antibiotic treatment
5810179|NCT00002682|Gastric Malt Lymphoma|gastric malt lymphoma
5810180|NCT00002682|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5810181|NCT00002682|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5810182|NCT00002676|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5810183|NCT00002670|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5810184|NCT00002670|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5810185|NCT00002670|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810186|NCT00002670|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5810187|NCT00002670|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5810188|NCT00002670|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810189|NCT00002670|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5810190|NCT00002670|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5810191|NCT00002670|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810192|NCT00002670|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5810193|NCT00002670|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810194|NCT00002670|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810195|NCT00002656|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5810196|NCT00002656|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5810197|NCT00002656|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5810198|NCT00002646|stage II breast cancer|stage ii breast cancer
5810199|NCT00002646|stage IIIA breast cancer|stage iiia breast cancer
5810200|NCT00002637|recurrent prostate cancer|recurrent prostate cancer
5810201|NCT00002632|stage IV salivary gland cancer|stage iv salivary gland cancer
5810202|NCT00002632|recurrent salivary gland cancer|recurrent salivary gland cancer
5810203|NCT00002632|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5810204|NCT00002632|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5810205|NCT00002625|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5810206|NCT00002625|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5810207|NCT00002625|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5810208|NCT00002625|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5810209|NCT00002625|recurrent esophageal cancer|recurrent esophageal cancer
5810885|NCT00083460|Bortezomid|bortezomid
5810210|NCT00002625|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5810211|NCT00002625|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5810212|NCT00002625|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5810213|NCT00002625|recurrent small cell lung cancer|recurrent small cell lung cancer
5810214|NCT00002625|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5810215|NCT00002625|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5681293|NCT00573950|adipocytokines|adipocytokines
5681294|NCT00573950|arterial stiffness|arterial stiffness
5681295|NCT00573950|Pulse wave velocity|pulse wave velocity
5810216|NCT00002625|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5810217|NCT00002625|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5810218|NCT00002625|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5810219|NCT00002625|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5810220|NCT00002625|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5810221|NCT00002625|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5810222|NCT00002625|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5810223|NCT00002625|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5810224|NCT00002625|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5810225|NCT00002625|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5810226|NCT00002625|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5810227|NCT00002625|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5810228|NCT00002625|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5810229|NCT00002625|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5810230|NCT00002625|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5810231|NCT00002625|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5810232|NCT00002625|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5810233|NCT00002625|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5810234|NCT00002625|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5810235|NCT00002625|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5810236|NCT00002625|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5863757|NCT00001195|Metabolism|metabolism
5823062|NCT00072553|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823063|NCT00072553|recurrent rectal cancer|recurrent rectal cancer
5810237|NCT00002625|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5810238|NCT00002625|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5810239|NCT00002625|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5810240|NCT00002625|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5810241|NCT00002625|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5810242|NCT00002625|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5810243|NCT00002625|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5810244|NCT00002625|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5810245|NCT00002625|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5810246|NCT00002625|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5810247|NCT00002625|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5810248|NCT00002625|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5810249|NCT00002625|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5810250|NCT00002625|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5810251|NCT00002625|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5810252|NCT00002625|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5810253|NCT00002625|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5810254|NCT00002625|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5810255|NCT00002625|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5810256|NCT00002551|stage II rectal cancer|stage ii rectal cancer
5810257|NCT00002551|stage III rectal cancer|stage iii rectal cancer
5810258|NCT00002551|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5810259|NCT00002538|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5810260|NCT00002538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5810261|NCT00002538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5810262|NCT00002538|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5810263|NCT00002538|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5810264|NCT00002538|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5810265|NCT00002538|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5810266|NCT00002538|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5810267|NCT00002538|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5810268|NCT00002538|fallopian tube cancer|fallopian tube cancer
5810269|NCT00002538|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5810270|NCT00084201|Vaccinium macrocarpon|vaccinium macrocarpon
5810271|NCT00084188|behavioral intervention|behavioral intervention
5810272|NCT00084175|behavioral intervention|behavioral intervention
5810273|NCT00006451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5862647|NCT00001550|Muscle Stiffness|muscle stiffness
5810274|NCT00006451|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5810275|NCT00006451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5686632|NCT00551239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5810276|NCT00006451|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810277|NCT00006451|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810278|NCT00006451|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5810279|NCT00006451|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5810280|NCT00006451|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5810281|NCT00006451|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5810282|NCT00006451|acute undifferentiated leukemia|acute undifferentiated leukemia
5810283|NCT00006451|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5810284|NCT00006451|graft versus host disease|graft versus host disease
5810285|NCT00006387|stage IV colon cancer|stage iv colon cancer
5810286|NCT00006387|recurrent pancreatic cancer|recurrent pancreatic cancer
5810287|NCT00006387|stage IV rectal cancer|stage iv rectal cancer
5810288|NCT00006387|recurrent colon cancer|recurrent colon cancer
5810289|NCT00006387|recurrent rectal cancer|recurrent rectal cancer
5810290|NCT00006387|adenocarcinoma of the colon|adenocarcinoma of the colon
5810291|NCT00006387|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5810292|NCT00006387|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5810293|NCT00006387|stage IV pancreatic cancer|stage iv pancreatic cancer
5810294|NCT00006382|non-small cell lung cancer|non-small cell lung cancer
5810295|NCT00006382|small cell lung cancer|small cell lung cancer
5810296|NCT00006380|stage III prostate cancer|stage iii prostate cancer
5810297|NCT00006380|stage IV prostate cancer|stage iv prostate cancer
5810298|NCT00006380|recurrent prostate cancer|recurrent prostate cancer
5810299|NCT00006378|squamous cell lung cancer|squamous cell lung cancer
5810300|NCT00006378|large cell lung cancer|large cell lung cancer
5810301|NCT00006378|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5810302|NCT00006378|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5810303|NCT00006378|adenocarcinoma of the lung|adenocarcinoma of the lung
5823144|NCT00071760|amprenavir|amprenavir
5823145|NCT00071760|AGENERASE|agenerase
5823146|NCT00071760|HIV|hiv
5823147|NCT00071760|Lexiva|lexiva
5823148|NCT00071760|protease inhibitors|protease inhibitors
5823149|NCT00071760|HIV Infection|hiv infection
5810304|NCT00006378|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5810305|NCT00006378|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5810306|NCT00006374|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5810307|NCT00006374|recurrent small cell lung cancer|recurrent small cell lung cancer
5810308|NCT00005994|nausea and vomiting|nausea and vomiting
5810309|NCT00005994|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810310|NCT00005790|adult brain stem glioma|adult brain stem glioma
5810311|NCT00005790|adult ependymoma|adult ependymoma
5810312|NCT00005790|adult craniopharyngioma|adult craniopharyngioma
5810313|NCT00005790|adult medulloblastoma|adult medulloblastoma
5810314|NCT00005790|adult meningioma|adult meningioma
5810315|NCT00005790|adult glioblastoma|adult glioblastoma
5810316|NCT00005790|adult oligodendroglioma|adult oligodendroglioma
5810317|NCT00005790|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5810318|NCT00005790|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5810319|NCT00005790|adult anaplastic ependymoma|adult anaplastic ependymoma
5810320|NCT00005790|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5810321|NCT00005790|adult mixed glioma|adult mixed glioma
5810322|NCT00005790|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5810323|NCT00005790|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5810324|NCT00005790|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5810325|NCT00005790|adult subependymoma|adult subependymoma
5810326|NCT00005790|adult diffuse astrocytoma|adult diffuse astrocytoma
5810327|NCT00005790|adult ependymoblastoma|adult ependymoblastoma
5810328|NCT00005790|adult pineocytoma|adult pineocytoma
5810329|NCT00005790|adult pineoblastoma|adult pineoblastoma
5810330|NCT00005790|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5810331|NCT00005790|adult choroid plexus tumor|adult choroid plexus tumor
5810332|NCT00005790|adult grade III meningioma|adult grade iii meningioma
5810333|NCT00005790|adult giant cell glioblastoma|adult giant cell glioblastoma
5810334|NCT00005790|adult gliosarcoma|adult gliosarcoma
5810335|NCT00005084|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5810336|NCT00005084|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5810337|NCT00005084|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5810338|NCT00005045|stage III renal cell cancer|stage iii renal cell cancer
5810339|NCT00005045|stage IV renal cell cancer|stage iv renal cell cancer
5810340|NCT00005045|recurrent renal cell cancer|recurrent renal cell cancer
5810341|NCT00004236|stage III gastric cancer|stage iii gastric cancer
5810342|NCT00004236|stage IV gastric cancer|stage iv gastric cancer
5810343|NCT00004236|recurrent gastric cancer|recurrent gastric cancer
5810344|NCT00004236|stage III esophageal cancer|stage iii esophageal cancer
5810345|NCT00004236|stage IV esophageal cancer|stage iv esophageal cancer
5810346|NCT00004236|recurrent esophageal cancer|recurrent esophageal cancer
5810347|NCT00004236|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5810348|NCT00004236|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5810349|NCT00003992|stage II breast cancer|stage ii breast cancer
5810351|NCT00003859|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5810886|NCT00083447|brain tumor|brain tumor
5810352|NCT00003859|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5810353|NCT00003733|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5810354|NCT00003733|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5810355|NCT00003733|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5810356|NCT00003584|stage IV renal cell cancer|stage iv renal cell cancer
5810357|NCT00003584|recurrent renal cell cancer|recurrent renal cell cancer
5810358|NCT00003435|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810359|NCT00003435|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5810360|NCT00003435|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5810361|NCT00003435|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5810362|NCT00003410|adult glioblastoma|adult glioblastoma
5810363|NCT00003410|adult giant cell glioblastoma|adult giant cell glioblastoma
5810364|NCT00003410|adult gliosarcoma|adult gliosarcoma
5810365|NCT00003372|recurrent adult brain tumor|recurrent adult brain tumor
5810366|NCT00003372|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5810367|NCT00003372|adult mixed glioma|adult mixed glioma
5810368|NCT00003236|recurrent breast cancer|recurrent breast cancer
5810369|NCT00002905|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5810370|NCT00002496|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810371|NCT00002496|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810372|NCT00002478|recurrent cervical cancer|recurrent cervical cancer
5810373|NCT00002478|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5810374|NCT00002476|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5810375|NCT00002476|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5810376|NCT00002476|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5810377|NCT00002476|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5810378|NCT00002476|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810453|NCT00005641|essential thrombocythemia|essential thrombocythemia
5810379|NCT00002476|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5810380|NCT00002476|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5810381|NCT00002476|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5810382|NCT00002476|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810383|NCT00002476|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5810384|NCT00002476|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5810385|NCT00002476|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5810386|NCT00002476|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5810387|NCT00002476|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5810388|NCT00002476|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810389|NCT00002476|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5810390|NCT00002476|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5810391|NCT00002476|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810392|NCT00002476|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5810393|NCT00002476|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810394|NCT00002476|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5810395|NCT00002476|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5810396|NCT00002476|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5810397|NCT00002476|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5810398|NCT00002460|stage I breast cancer|stage i breast cancer
5810399|NCT00002460|stage II breast cancer|stage ii breast cancer
5810400|NCT00002460|stage IIIA breast cancer|stage iiia breast cancer
5810401|NCT00084162|PET|pet
5810402|NCT00084162|Heart Rate Variability|heart rate variability
5810403|NCT00084162|N-Back Task|n-back task
5810404|NCT00084162|Isometric Handgrip|isometric handgrip
5810405|NCT00084162|MRI|mri
5810406|NCT00084162|Depression|depression
5810407|NCT00084162|MDD|mdd
5810408|NCT00084162|Heart|heart
5810409|NCT00084149|Acute Infection|acute infection
5810410|NCT00084149|Treatment Naive|treatment naive
5681296|NCT00573937|Neoplasms|neoplasms
5681298|NCT00573937|Methadone|methadone
5681299|NCT00573937|Morphine|morphine
5681300|NCT00573911|Barrett's esophagus|barrett's esophagus
5817041|NCT00003657|metastatic osteosarcoma|metastatic osteosarcoma
5681303|NCT00573885|non-small cell lung cancer|non-small cell lung cancer
5681304|NCT00573885|small cell lung cancer|small cell lung cancer
5681305|NCT00573885|tobacco use disorder|tobacco use disorder
5681306|NCT00573872|Radiosurgery|radiosurgery
5810411|NCT00084136|Treatment Naive|treatment naive
5810412|NCT00084136|Adherence|adherence
5810413|NCT00084136|Drug Resistance|drug resistance
5810414|NCT00084136|Treatment Failure|treatment failure
5810415|NCT00084123|Relaxation Techniques|relaxation techniques
5810416|NCT00084123|Radiation|radiation
5810417|NCT00084123|Drug Therapy|drug therapy
5810418|NCT00084123|Healing Touch|healing touch
5810419|NCT00084110|Aged|aged
5810420|NCT00084110|Mexican Americans|mexican americans
5810421|NCT00084110|Complementary Therapies|complementary therapies
5810422|NCT00083993|Breast Cancer|breast cancer
5810887|NCT00083447|GBM|gbm
5810423|NCT00005960|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5810424|NCT00005960|stage I prostate cancer|stage i prostate cancer
5810425|NCT00005960|stage IIB prostate cancer|stage iib prostate cancer
5810426|NCT00005960|stage IIA prostate cancer|stage iia prostate cancer
5810427|NCT00005960|stage III prostate cancer|stage iii prostate cancer
5810428|NCT00005960|stage IV prostate cancer|stage iv prostate cancer
5810429|NCT00005960|recurrent prostate cancer|recurrent prostate cancer
5810430|NCT00005960|pain|pain
5810431|NCT00005641|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5810432|NCT00005641|refractory multiple myeloma|refractory multiple myeloma
5810433|NCT00005641|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5810434|NCT00005641|stage I multiple myeloma|stage i multiple myeloma
5810435|NCT00005641|stage II multiple myeloma|stage ii multiple myeloma
5810436|NCT00005641|stage III multiple myeloma|stage iii multiple myeloma
5810437|NCT00005641|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5863900|NCT00001162|Giardia|giardia
5810438|NCT00005641|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5810439|NCT00005641|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5810440|NCT00005641|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5810441|NCT00005641|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5810442|NCT00005641|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810443|NCT00005641|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810444|NCT00005641|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5810445|NCT00005641|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5810446|NCT00005641|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5810447|NCT00005641|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5810448|NCT00005641|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5810449|NCT00005641|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5810450|NCT00005641|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5810451|NCT00005641|polycythemia vera|polycythemia vera
5810454|NCT00005641|refractory anemia|refractory anemia
5810455|NCT00005641|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5810456|NCT00005641|refractory anemia with excess blasts|refractory anemia with excess blasts
5810457|NCT00005641|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5810458|NCT00005641|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5810459|NCT00005641|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5810460|NCT00005641|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5810461|NCT00005641|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5810462|NCT00005641|graft versus host disease|graft versus host disease
5810463|NCT00005641|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5810464|NCT00005641|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5810465|NCT00005091|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5810466|NCT00005091|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5810467|NCT00005091|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5810468|NCT00005054|stage IV breast cancer|stage iv breast cancer
5810469|NCT00005054|stage IIIA breast cancer|stage iiia breast cancer
5810470|NCT00005054|recurrent breast cancer|recurrent breast cancer
5810471|NCT00005054|stage IIIB breast cancer|stage iiib breast cancer
5681308|NCT00573872|Cancer|cancer
5681309|NCT00573872|Spinal|spinal
5681311|NCT00573859|Smoking|smoking
5681312|NCT00573859|ADHD|adhd
5681313|NCT00573859|Stimulant medication|stimulant medication
5681314|NCT00573846|IBD|ibd
5682164|NCT00570167|Resurfacing|resurfacing
5681315|NCT00573833|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5681316|NCT00573833|stage IIB prostate cancer|stage iib prostate cancer
5681317|NCT00573833|stage IIA prostate cancer|stage iia prostate cancer
5681318|NCT00573820|Tumors or cancer of the prostate|tumors or cancer of the prostate
5681319|NCT00573820|Cancer of Prostate|cancer of prostate
5681320|NCT00573820|Cancer of the Prostate|cancer of the prostate
5681321|NCT00573820|Neoplasms, Prostate|neoplasms, prostate
5681322|NCT00573820|Neoplasms, Prostatic|neoplasms, prostatic
5681323|NCT00573820|Prostate Cancer|prostate cancer
5681325|NCT00573820|Prostatic Cancer|prostatic cancer
5681326|NCT00573807|Neuralgia, Sciatic|neuralgia, sciatic
5810472|NCT00005050|stage III colon cancer|stage iii colon cancer
5810473|NCT00005050|stage IV colon cancer|stage iv colon cancer
5810474|NCT00005050|stage III rectal cancer|stage iii rectal cancer
5810475|NCT00005050|stage IV rectal cancer|stage iv rectal cancer
5810476|NCT00005050|recurrent colon cancer|recurrent colon cancer
5810477|NCT00005050|recurrent rectal cancer|recurrent rectal cancer
5810478|NCT00084097|Allergy|allergy
5810480|NCT00084097|Eosinophil|eosinophil
5810481|NCT00084097|Monoclonal Antibody|monoclonal antibody
5810482|NCT00084097|Eosinophilic Gastroenteritis|eosinophilic gastroenteritis
5810483|NCT00084097|EG|eg
5810484|NCT00084084|Lysosomes|lysosomes
5810485|NCT00084084|Storage|storage
5810486|NCT00084084|Glycolipid|glycolipid
5810487|NCT00084084|Fabry disease|fabry disease
5810488|NCT00084084|Stroke|stroke
5810489|NCT00084084|Children|children
5810490|NCT00084084|Pediatrics|pediatrics
5810491|NCT00084058|Dose Intensification|dose intensification
5810492|NCT00084058|Pharmacokinetic Sampling|pharmacokinetic sampling
5810493|NCT00084058|Treatment Experienced|treatment experienced
5810494|NCT00084058|Child|child
5810495|NCT00084045|HIV Seronegativity|hiv seronegativity
5810496|NCT00084045|Treatment Naive|treatment naive
5810497|NCT00084045|Pediatric HIV|pediatric hiv
5810498|NCT00084045|Perinatal Transmission|perinatal transmission
5810499|NCT00084032|Acute Infection|acute infection
5810500|NCT00084032|Treatment Interruption|treatment interruption
5810501|NCT00084032|Treatment Naive|treatment naive
5810502|NCT00084032|Primary HIV Infection|primary hiv infection
5810503|NCT00084032|PHI|phi
5810504|NCT00084019|Treatment Experienced|treatment experienced
5810505|NCT00083980|Kava|kava
5810506|NCT00083980|Complementary Therapies|complementary therapies
5810507|NCT00083980|Medicine, Herbal|medicine, herbal
5810508|NCT00083967|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment
5810509|NCT00083967|detached retina|detached retina
5810510|NCT00083967|retinal tear|retinal tear
5810511|NCT00083967|retinal break|retinal break
5810512|NCT00083954|Bipolar I Disorder|bipolar i disorder
5810513|NCT00083941|Renal Cell Cancer|renal cell cancer
5810515|NCT00083941|Stage IV Renal Cell Cancer|stage iv renal cell cancer
5810516|NCT00083928|Asymptomatic|asymptomatic
5810517|NCT00083928|subcutaneous|subcutaneous
5810518|NCT00083928|CA125 Progression|ca125 progression
5810519|NCT00083928|Angstrom|angstrom
5810520|NCT00083928|Ångstrom|ångstrom
5810521|NCT00083928|ovarian cancer|ovarian cancer
5810522|NCT00083915|Multiple Myeloma|multiple myeloma
5810523|NCT00083915|DTPACE|dtpace
5810524|NCT00083915|Tandem Transplant|tandem transplant
5810525|NCT00083915|Cisplatin|cisplatin
5810526|NCT00083915|Cyclophosphamide|cyclophosphamide
5810527|NCT00083915|Dexamethasone|dexamethasone
5810528|NCT00083915|Doxorubicin|doxorubicin
5810529|NCT00083915|Etoposide|etoposide
5810530|NCT00083915|Sargramostim|sargramostim
5810531|NCT00083915|Thalidomide|thalidomide
5810532|NCT00083915|Melphalan|melphalan
5810533|NCT00083902|Myeloma|myeloma
5810534|NCT00083902|Thalidomide|thalidomide
5810535|NCT00083902|Dexamethasone|dexamethasone
5810536|NCT00083876|Multiple Myeloma|multiple myeloma
5810537|NCT00083876|D.T. PACE|d.t. pace
5810538|NCT00083876|Melphalan|melphalan
5810539|NCT00083876|Transplant|transplant
5810540|NCT00083876|Thalidomide|thalidomide
5810541|NCT00083876|Dexamethasone|dexamethasone
5810542|NCT00083876|Cisplatin|cisplatin
5810543|NCT00083876|Cyclophosphamide|cyclophosphamide
5810544|NCT00083876|Doxorubicin|doxorubicin
5810545|NCT00083876|Etoposide|etoposide
5810546|NCT00083876|Filgrastim|filgrastim
5810547|NCT00083876|Interferon-alpha 2b|interferon-alpha 2b
5810548|NCT00083876|Sargramostim|sargramostim
5810549|NCT00005032|recurrent small cell lung cancer|recurrent small cell lung cancer
5829984|NCT00059228|Estradiol|estradiol
5810550|NCT00005030|stage IV colon cancer|stage iv colon cancer
5810551|NCT00005030|stage IV rectal cancer|stage iv rectal cancer
5810552|NCT00005030|recurrent colon cancer|recurrent colon cancer
5810553|NCT00005030|recurrent rectal cancer|recurrent rectal cancer
5810554|NCT00005030|liver metastases|liver metastases
5810555|NCT00004979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810556|NCT00004927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810557|NCT00004877|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810558|NCT00004161|lip and oral cavity cancer|lip and oral cavity cancer
5810559|NCT00004071|stage IV prostate cancer|stage iv prostate cancer
5810560|NCT00004071|recurrent prostate cancer|recurrent prostate cancer
5810561|NCT00004070|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5810562|NCT00004070|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5810563|NCT00004070|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5806982|NCT00088751|Atypical Antipsychotic|atypical antipsychotic
5686633|NCT00551239|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5810565|NCT00004070|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5810566|NCT00004070|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5810567|NCT00004070|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810568|NCT00004070|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5810569|NCT00004070|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5810570|NCT00004070|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5810571|NCT00004070|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5810572|NCT00004070|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5810573|NCT00004070|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810574|NCT00004070|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5810575|NCT00004070|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5810576|NCT00004070|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810577|NCT00004070|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5810578|NCT00004070|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5810579|NCT00004070|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5810580|NCT00004070|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5810581|NCT00004062|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5810582|NCT00004062|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5810583|NCT00004062|recurrent thyroid cancer|recurrent thyroid cancer
5810584|NCT00083772|Heart failure|heart failure
5810585|NCT00083772|Diastolic heart failure|diastolic heart failure
5810586|NCT00083772|Congestive heart failure|congestive heart failure
5810587|NCT00083772|Nesiritide|nesiritide
5810588|NCT00083772|Natrecor|natrecor
5810589|NCT00083772|Left ventricular (LV) diastolic function|left ventricular (lv) diastolic function
5810590|NCT00083772|Fatigue|fatigue
5810591|NCT00083772|Shortness of breath|shortness of breath
5810592|NCT00083772|Edema|edema
5810593|NCT00083772|Heart disease|heart disease
5810594|NCT00004055|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5810595|NCT00003998|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5810596|NCT00003998|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5810597|NCT00003998|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5810598|NCT00003998|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5810599|NCT00003998|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5810600|NCT00003997|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810601|NCT00003997|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810602|NCT00003997|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5810603|NCT00003997|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5862648|NCT00001550|Rigidity|rigidity
5810604|NCT00003997|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5810605|NCT00003991|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5810606|NCT00003939|adult angiosarcoma|adult angiosarcoma
5810607|NCT00003939|adult fibrosarcoma|adult fibrosarcoma
5810608|NCT00003939|adult leiomyosarcoma|adult leiomyosarcoma
5810609|NCT00003939|adult liposarcoma|adult liposarcoma
5810610|NCT00003939|adult neurofibrosarcoma|adult neurofibrosarcoma
5810611|NCT00003939|adult synovial sarcoma|adult synovial sarcoma
5810612|NCT00003939|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5810613|NCT00003939|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5810614|NCT00003939|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5810615|NCT00003939|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5810616|NCT00003939|adult epithelioid sarcoma|adult epithelioid sarcoma
5810617|NCT00003939|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5810618|NCT00003939|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5810619|NCT00003939|adult malignant mesenchymoma|adult malignant mesenchymoma
5810620|NCT00003939|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5810621|NCT00003939|stage IV uterine sarcoma|stage iv uterine sarcoma
5810622|NCT00003939|recurrent uterine sarcoma|recurrent uterine sarcoma
5810623|NCT00003939|uterine carcinosarcoma|uterine carcinosarcoma
5810624|NCT00003939|uterine leiomyosarcoma|uterine leiomyosarcoma
5810625|NCT00003939|endometrial stromal sarcoma|endometrial stromal sarcoma
5810626|NCT00003939|ovarian sarcoma|ovarian sarcoma
5810627|NCT00003939|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5810628|NCT00003939|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5810629|NCT00003856|recurrent salivary gland cancer|recurrent salivary gland cancer
5817234|NCT00002947|gastrinoma|gastrinoma
5810630|NCT00003856|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5810631|NCT00003856|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5810632|NCT00003856|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5810633|NCT00003856|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5810634|NCT00003856|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5810635|NCT00003856|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5810636|NCT00003856|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5810637|NCT00003850|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5810638|NCT00003850|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5810639|NCT00003850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810640|NCT00003850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5810641|NCT00003850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810642|NCT00003850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5810643|NCT00003850|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5810644|NCT00003850|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5810645|NCT00003850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810646|NCT00003850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5810647|NCT00003850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810648|NCT00003850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5810649|NCT00003850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5810650|NCT00003850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5810651|NCT00003787|stage I breast cancer|stage i breast cancer
5810652|NCT00003787|stage II breast cancer|stage ii breast cancer
5810653|NCT00003787|stage IIIA breast cancer|stage iiia breast cancer
5810654|NCT00003787|recurrent breast cancer|recurrent breast cancer
5810655|NCT00003773|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5810656|NCT00003758|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5810657|NCT00003758|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810658|NCT00003758|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5810659|NCT00003758|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5810660|NCT00003758|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5846489|NCT00044291|stage IIIB breast cancer|stage iiib breast cancer
5810661|NCT00003758|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5810662|NCT00003758|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5810663|NCT00003758|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5810664|NCT00003758|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5810665|NCT00003758|adult acute basophilic leukemia|adult acute basophilic leukemia
5821286|NCT00076310|HNSCC|hnscc
5810666|NCT00003758|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5810667|NCT00003758|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5810668|NCT00003758|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5810669|NCT00003758|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5810670|NCT00003758|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5810671|NCT00003758|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5810672|NCT00003758|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5810673|NCT00003758|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5810674|NCT00003758|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5810675|NCT00003758|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5810676|NCT00003755|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810677|NCT00003740|stage IV prostate cancer|stage iv prostate cancer
5810678|NCT00003740|recurrent prostate cancer|recurrent prostate cancer
5810679|NCT00003443|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810680|NCT00003443|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5810681|NCT00003443|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5810161|NCT00084253|HIV|hiv
5810682|NCT00003443|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5810683|NCT00003443|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5810684|NCT00003443|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5810685|NCT00003443|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5810686|NCT00003443|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5810687|NCT00003443|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5810688|NCT00003443|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5810689|NCT00003443|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5810690|NCT00003443|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5810691|NCT00003401|refractory multiple myeloma|refractory multiple myeloma
5810692|NCT00003401|stage I multiple myeloma|stage i multiple myeloma
5810693|NCT00003401|stage II multiple myeloma|stage ii multiple myeloma
5810694|NCT00003401|stage III multiple myeloma|stage iii multiple myeloma
5810695|NCT00003399|refractory multiple myeloma|refractory multiple myeloma
5810696|NCT00003399|stage I multiple myeloma|stage i multiple myeloma
5810697|NCT00003399|stage II multiple myeloma|stage ii multiple myeloma
5810698|NCT00003399|stage III multiple myeloma|stage iii multiple myeloma
5810699|NCT00003396|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5810700|NCT00003396|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5810701|NCT00003396|refractory multiple myeloma|refractory multiple myeloma
5810702|NCT00003396|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5810703|NCT00003396|stage I multiple myeloma|stage i multiple myeloma
5810704|NCT00003396|stage II multiple myeloma|stage ii multiple myeloma
5810705|NCT00003396|stage III multiple myeloma|stage iii multiple myeloma
5810706|NCT00003396|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5810707|NCT00003396|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5810708|NCT00003396|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810709|NCT00003396|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810710|NCT00003396|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5810711|NCT00003396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5810712|NCT00003396|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5810713|NCT00003396|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5810714|NCT00003396|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5810715|NCT00003396|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5810716|NCT00003396|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5810717|NCT00003396|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5810718|NCT00003396|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5810719|NCT00003396|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5810720|NCT00003396|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5810721|NCT00003396|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5810722|NCT00003396|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5810723|NCT00003396|adult acute basophilic leukemia|adult acute basophilic leukemia
5810724|NCT00003396|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5810725|NCT00003396|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5810726|NCT00003396|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5810727|NCT00003396|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5810728|NCT00003396|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5810729|NCT00003396|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5810730|NCT00003396|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5810731|NCT00003396|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5810732|NCT00003396|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5810733|NCT00003396|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5810734|NCT00003396|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5810735|NCT00003396|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5810736|NCT00003396|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5810737|NCT00003396|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5810738|NCT00003396|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5810739|NCT00003396|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5810740|NCT00003396|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5810741|NCT00003396|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5686634|NCT00551239|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5686635|NCT00551239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5810742|NCT00003396|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5810743|NCT00003396|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5810744|NCT00003396|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5810745|NCT00003396|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5810746|NCT00003396|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5810747|NCT00003396|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5810748|NCT00003396|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5810749|NCT00003396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5810750|NCT00003396|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5810751|NCT00003396|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5810752|NCT00003396|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5810753|NCT00003396|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5810754|NCT00003293|recurrent adult brain tumor|recurrent adult brain tumor
5810755|NCT00003293|adult glioblastoma|adult glioblastoma
5810756|NCT00003293|adult giant cell glioblastoma|adult giant cell glioblastoma
5810757|NCT00003293|adult gliosarcoma|adult gliosarcoma
5810758|NCT00003249|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810759|NCT00003231|squamous cell lung cancer|squamous cell lung cancer
5810760|NCT00003231|large cell lung cancer|large cell lung cancer
5810761|NCT00003231|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5810762|NCT00003231|adenocarcinoma of the lung|adenocarcinoma of the lung
5810763|NCT00083720|EGFR-undetectable|egfr-undetectable
5810764|NCT00083720|Metastatic Colorectal Cancer|metastatic colorectal cancer
5810765|NCT00083733|Gene Expression|gene expression
5810766|NCT00083733|Microarray|microarray
5810767|NCT00083733|Stem Cell|stem cell
5810768|NCT00083733|Proteomics|proteomics
5810769|NCT00083733|Metastases|metastases
5810770|NCT00083733|Breast Tissue|breast tissue
5810771|NCT00083733|Normal Breast Tissue|normal breast tissue
5810772|NCT00083733|Breast Cancer|breast cancer
5810773|NCT00083707|Macroglobulinemia|macroglobulinemia
5810774|NCT00083707|Waldenstrom|waldenstrom
5810775|NCT00083707|Thalidomide|thalidomide
5810776|NCT00083694|Leukemia|leukemia
5810777|NCT00083694|Thalidomide|thalidomide
5810778|NCT00083694|relapsed|relapsed
5810779|NCT00083681|Multiple Myeloma|multiple myeloma
5810780|NCT00083681|Thalidomide|thalidomide
5810782|NCT00083681|Cisplatin|cisplatin
5810783|NCT00083681|Etoposide|etoposide
5810784|NCT00083681|Dexamethasone|dexamethasone
5810785|NCT00083681|Cytoxan|cytoxan
5810786|NCT00083681|DCEP|dcep
5810787|NCT00083681|Relapse|relapse
5810788|NCT00083668|Schizophrenia|schizophrenia
5810789|NCT00083668|Paliperidone|paliperidone
5810790|NCT00083668|Olanzapine|olanzapine
5810792|NCT00083668|Extended release|extended release
5810793|NCT00083668|Atypical neuroleptic|atypical neuroleptic
5810794|NCT00083616|EGFr|egfr
5810795|NCT00083616|Clinical Trial|clinical trial
5810796|NCT00083616|Panitumumab|panitumumab
5810797|NCT00083616|ABX-EGF|abx-egf
5810798|NCT00083616|Immunex|immunex
5810799|NCT00083616|Metastatic Cancer|metastatic cancer
5810800|NCT00083616|Vectibix|vectibix
5810801|NCT00083616|Abgenix|abgenix
5810802|NCT00083616|Amgen|amgen
5810803|NCT00083564|Multiple myeloma|multiple myeloma
5810804|NCT00083564|Primary refractory multiple myeloma|primary refractory multiple myeloma
5810805|NCT00083564|STR|str
5810806|NCT00083564|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
5810807|NCT00083564|Holmium-166|holmium-166
5810808|NCT00083564|166-Ho-DOTMP|166-ho-dotmp
5810809|NCT00083642|Brain Plasticity|brain plasticity
5810810|NCT00083642|Functional MRI|functional mri
5810811|NCT00083642|Finger Movement|finger movement
5810812|NCT00083642|Rehabilitation|rehabilitation
5810813|NCT00083642|Improvement|improvement
5810814|NCT00083642|Stroke|stroke
5810815|NCT00083642|Motor Recovery|motor recovery
5810816|NCT00083642|Observation|observation
5810817|NCT00083642|fMRI|fmri
5810818|NCT00083642|Healthy Volunteer|healthy volunteer
5810819|NCT00083642|HV|hv
5810820|NCT00083629|[18F]FECNT|[18f]fecnt
5810821|NCT00083629|Biodistribution|biodistribution
5810822|NCT00083629|Dosimetry|dosimetry
5810823|NCT00083629|Dopamine Transporter|dopamine transporter
5810824|NCT00083629|MIRD|mird
5810825|NCT00083629|Kinetic Analysis|kinetic analysis
5810826|NCT00083629|Compartment Analysis|compartment analysis
5810827|NCT00083629|Healthy Volunteer|healthy volunteer
5810828|NCT00083629|HV|hv
5810829|NCT00083603|HIV Seronegativity|hiv seronegativity
5810830|NCT00083603|HIV Preventive Vaccine|hiv preventive vaccine
5844004|NCT00051194|OHT|oht
5810831|NCT00083603|Vaccinia vector|vaccinia vector
5810832|NCT00083603|Pox vector|pox vector
5810833|NCT00083590|Alzheimer disease|alzheimer disease
5810834|NCT00083590|Cholinesterase inhibitor|cholinesterase inhibitor
5810835|NCT00083577|Multiple Myeloma|multiple myeloma
5810836|NCT00083577|Thalidomide|thalidomide
5810837|NCT00083577|Anti-Angiogenesis|anti-angiogenesis
5810838|NCT00083551|Multiple Myeloma|multiple myeloma
5810839|NCT00083551|Cancer|cancer
5810840|NCT00083551|Therapy|therapy
5810841|NCT00083551|Thalidomide|thalidomide
5810842|NCT00083551|DTPACE|dtpace
5810843|NCT00083551|Transplant|transplant
5810844|NCT00083551|VAD|vad
5810845|NCT00083551|DCEP|dcep
5810846|NCT00083551|CAD|cad
5810847|NCT00083551|Consolidation|consolidation
5810848|NCT00083551|Melphalan|melphalan
5810850|NCT00083538|DTPACE|dtpace
5810851|NCT00083538|Dexamethasone|dexamethasone
5810852|NCT00083538|Thalidomide|thalidomide
5810853|NCT00083538|Cisplatin|cisplatin
5810854|NCT00083538|Cytoxan|cytoxan
5810855|NCT00083538|Doxorubicin|doxorubicin
5810856|NCT00083538|Etoposide|etoposide
5810857|NCT00083538|Dendritic Cell Vaccination|dendritic cell vaccination
5810858|NCT00083538|Leukapheresis|leukapheresis
5810859|NCT00003160|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5810860|NCT00003160|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5810861|NCT00003160|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5810862|NCT00003160|fallopian tube cancer|fallopian tube cancer
5810863|NCT00003160|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5810864|NCT00003079|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810865|NCT00003079|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810866|NCT00003079|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5810867|NCT00003079|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5810868|NCT00003075|cervical cancer|cervical cancer
5810869|NCT00003075|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5810870|NCT00003075|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5810871|NCT00003031|infection|infection
5810872|NCT00003031|pulmonary complications|pulmonary complications
5810873|NCT00003015|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5810874|NCT00003015|childhood oligodendroglioma|childhood oligodendroglioma
5810875|NCT00003015|untreated childhood visual pathway glioma|untreated childhood visual pathway glioma
5810876|NCT00003015|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5810877|NCT00083473|Leukemia Lymphocytic Chronic,|leukemia lymphocytic chronic,
5810878|NCT00083473|Pivanex,|pivanex,
5810879|NCT00083473|Histone deacetylase inhibitor|histone deacetylase inhibitor
5810880|NCT00083460|Multiple Myeloma|multiple myeloma
5810881|NCT00083460|Thalidomide|thalidomide
5810882|NCT00083460|Velcade|velcade
5810883|NCT00083460|PS-341|ps-341
5810884|NCT00083460|Refractory|refractory
5810888|NCT00083447|glioblastoma|glioblastoma
5810889|NCT00083447|glioblastoma multiforme|glioblastoma multiforme
5810890|NCT00083447|brain cancer|brain cancer
5810892|NCT00083434|Anemia|anemia
5810893|NCT00083434|Cancer|cancer
5810894|NCT00006877|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5810895|NCT00006877|squamous cell lung cancer|squamous cell lung cancer
5810896|NCT00006877|large cell lung cancer|large cell lung cancer
5810897|NCT00006877|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5810898|NCT00006877|adenocarcinoma of the lung|adenocarcinoma of the lung
5810899|NCT00006358|recurrent adult brain tumor|recurrent adult brain tumor
5810900|NCT00006358|adult glioblastoma|adult glioblastoma
5810901|NCT00006358|adult giant cell glioblastoma|adult giant cell glioblastoma
5810902|NCT00006358|adult gliosarcoma|adult gliosarcoma
5810903|NCT00006343|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5810904|NCT00006343|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5810905|NCT00006222|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5810906|NCT00006222|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5810907|NCT00006212|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5810908|NCT00006212|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5810909|NCT00006212|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5810910|NCT00006083|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5810911|NCT00006083|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5810912|NCT00006083|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5810913|NCT00006083|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5810914|NCT00006083|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5810915|NCT00006083|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5810916|NCT00006083|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5810917|NCT00006083|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5810918|NCT00006083|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5810919|NCT00006083|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5810920|NCT00006083|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5810921|NCT00006083|stage IB cervical cancer|stage ib cervical cancer
5844019|NCT00051142|OAG|oag
5810922|NCT00006083|Burkitt lymphoma|burkitt lymphoma
5810923|NCT00006083|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5810924|NCT00006083|extramedullary plasmacytoma|extramedullary plasmacytoma
5810925|NCT00006083|refractory multiple myeloma|refractory multiple myeloma
5810926|NCT00006083|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5810927|NCT00006083|stage I multiple myeloma|stage i multiple myeloma
5810928|NCT00006083|stage II multiple myeloma|stage ii multiple myeloma
5810929|NCT00006083|stage III multiple myeloma|stage iii multiple myeloma
5810930|NCT00006083|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5810931|NCT00006083|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5810932|NCT00006083|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5810933|NCT00006083|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5810934|NCT00006083|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5810935|NCT00006083|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5810936|NCT00006083|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5810937|NCT00006083|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5810938|NCT00006083|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5810939|NCT00006083|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5810940|NCT00006083|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5810941|NCT00006083|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5810942|NCT00006083|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5810943|NCT00006083|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5810944|NCT00006083|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5810945|NCT00006083|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5810946|NCT00006083|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5810947|NCT00006083|essential thrombocythemia|essential thrombocythemia
5810948|NCT00006083|untreated hairy cell leukemia|untreated hairy cell leukemia
5810949|NCT00006083|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5810950|NCT00006083|refractory hairy cell leukemia|refractory hairy cell leukemia
5810951|NCT00006083|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5810952|NCT00006083|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5810953|NCT00006083|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5810954|NCT00006083|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5810955|NCT00006083|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5810956|NCT00006083|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5810957|NCT00006083|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5804108|NCT00091936|DOT|dot
5810958|NCT00006083|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5810960|NCT00006083|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5810961|NCT00006083|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5810962|NCT00006083|acute undifferentiated leukemia|acute undifferentiated leukemia
5810963|NCT00006083|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5810964|NCT00006083|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5810965|NCT00006083|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5810966|NCT00006083|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5810967|NCT00006083|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5846490|NCT00044291|recurrent breast cancer|recurrent breast cancer
5810968|NCT00006083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5810969|NCT00006083|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5810970|NCT00006083|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5810971|NCT00006083|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5810972|NCT00006083|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5810973|NCT00006083|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5810974|NCT00006083|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5810975|NCT00006083|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5810976|NCT00006083|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5810977|NCT00006083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5810978|NCT00006083|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5810979|NCT00006083|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5810980|NCT00006083|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5810981|NCT00006083|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5810982|NCT00006083|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5810983|NCT00006083|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5810984|NCT00006083|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5810985|NCT00006083|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5686636|NCT00551239|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5686637|NCT00551239|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5686638|NCT00551239|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5686639|NCT00551239|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5686640|NCT00551239|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5686641|NCT00551239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5681297|NCT00573937|Pain|pain
5810986|NCT00006083|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5810987|NCT00006083|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5810988|NCT00006083|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5810989|NCT00006083|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5810990|NCT00006083|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5810991|NCT00006083|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5810993|NCT00006083|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5810994|NCT00006083|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5810995|NCT00006083|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5810996|NCT00006083|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5810997|NCT00006083|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5810998|NCT00006083|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5810999|NCT00006083|primary central nervous system lymphoma|primary central nervous system lymphoma
5811000|NCT00006083|prolymphocytic leukemia|prolymphocytic leukemia
5811001|NCT00006083|primary systemic amyloidosis|primary systemic amyloidosis
5811002|NCT00006083|veno-occlusive disease|veno-occlusive disease
5811003|NCT00006083|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5811004|NCT00006083|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5811005|NCT00006083|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5811006|NCT00006083|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5811007|NCT00006083|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5811008|NCT00006083|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5811009|NCT00006083|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5811010|NCT00006083|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5811011|NCT00006083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5811012|NCT00006083|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5811013|NCT00006083|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5811014|NCT00006083|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5811015|NCT00006083|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5811016|NCT00006083|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5811017|NCT00006083|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5804175|NCT00091676|vaccine|vaccine
5811018|NCT00006083|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5811019|NCT00006083|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5811020|NCT00006083|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5811021|NCT00006083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5811022|NCT00006083|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5811023|NCT00006083|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5811024|NCT00006083|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811025|NCT00006083|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5811026|NCT00006083|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811027|NCT00006083|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5811028|NCT00006083|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5846491|NCT00044304|Treatment|treatment
5811029|NCT00006083|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5811030|NCT00006083|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5862649|NCT00001550|Anti-GAD Antibodies|anti-gad antibodies
5844238|NCT00011063|Metabolism|metabolism
5811031|NCT00006083|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5686642|NCT00551239|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5687392|NCT00547534|Mantle Cell|mantle cell
5686643|NCT00551239|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5687001|NCT00549575|L-Arginine|l-arginine
5686644|NCT00551239|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5686645|NCT00551239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5686646|NCT00551239|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5686647|NCT00551239|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5686648|NCT00551239|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5686649|NCT00551239|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5686651|NCT00551226|Patients with tuberculosis|patients with tuberculosis
5686652|NCT00551213|anti-IGF-1R|anti-igf-1r
5686653|NCT00551200|Buphenyl|buphenyl
5686654|NCT00551200|Sodium Phenylbutyrate|sodium phenylbutyrate
5686655|NCT00551200|Urea Cycle Disorder|urea cycle disorder
5686656|NCT00551200|UCD|ucd
5681310|NCT00573872|AVM|avm
5811032|NCT00006083|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811033|NCT00006083|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5811034|NCT00006083|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5811035|NCT00006083|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811036|NCT00006083|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811037|NCT00006083|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811038|NCT00006083|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811039|NCT00006083|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5811040|NCT00006083|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5811041|NCT00006083|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811042|NCT00006083|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811043|NCT00006083|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811044|NCT00006079|cervical cancer|cervical cancer
5811045|NCT00006079|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5811046|NCT00006079|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5811047|NCT00006079|Eflornithine|eflornithine
5811048|NCT00006001|stage III colon cancer|stage iii colon cancer
5811049|NCT00006001|stage IV colon cancer|stage iv colon cancer
5811050|NCT00006001|stage III rectal cancer|stage iii rectal cancer
5811051|NCT00006001|stage IV rectal cancer|stage iv rectal cancer
5811052|NCT00006001|recurrent colon cancer|recurrent colon cancer
5811053|NCT00006001|recurrent rectal cancer|recurrent rectal cancer
5811054|NCT00006001|adenocarcinoma of the colon|adenocarcinoma of the colon
5811055|NCT00006001|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5811056|NCT00005939|stage I prostate cancer|stage i prostate cancer
5811057|NCT00005939|stage IIB prostate cancer|stage iib prostate cancer
5811058|NCT00005939|stage IIA prostate cancer|stage iia prostate cancer
5811059|NCT00005939|stage III prostate cancer|stage iii prostate cancer
5811060|NCT00005939|recurrent prostate cancer|recurrent prostate cancer
5811061|NCT00005841|iris melanoma|iris melanoma
5811062|NCT00005841|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5811063|NCT00005841|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5811064|NCT00005841|extraocular extension melanoma|extraocular extension melanoma
5811065|NCT00005841|recurrent intraocular melanoma|recurrent intraocular melanoma
5811066|NCT00005841|stage III melanoma|stage iii melanoma
5811067|NCT00005841|stage IV melanoma|stage iv melanoma
5811068|NCT00005841|recurrent melanoma|recurrent melanoma
5811069|NCT00005645|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811070|NCT00005645|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811071|NCT00005645|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811072|NCT00005645|liver metastases|liver metastases
5811073|NCT00005645|malignant pericardial effusion|malignant pericardial effusion
5811074|NCT00005645|malignant pleural effusion|malignant pleural effusion
5811075|NCT00005645|malignant ascites|malignant ascites
5811076|NCT00005645|fallopian tube cancer|fallopian tube cancer
5811077|NCT00005645|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811078|NCT00005640|stage I colon cancer|stage i colon cancer
5811079|NCT00005640|stage II colon cancer|stage ii colon cancer
5811080|NCT00005640|stage III colon cancer|stage iii colon cancer
5811081|NCT00005640|stage I rectal cancer|stage i rectal cancer
5811082|NCT00005640|stage II rectal cancer|stage ii rectal cancer
5811083|NCT00005640|stage III rectal cancer|stage iii rectal cancer
5811084|NCT00005636|localized malignant mesothelioma|localized malignant mesothelioma
5811085|NCT00005636|advanced malignant mesothelioma|advanced malignant mesothelioma
5811086|NCT00005636|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5811087|NCT00005578|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5811088|NCT00005578|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5811089|NCT00005578|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5811090|NCT00005578|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5811092|NCT00005088|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5811095|NCT00005088|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5811096|NCT00005088|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5811097|NCT00005088|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5811098|NCT00005088|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5811099|NCT00005088|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5811100|NCT00005069|stage IV renal cell cancer|stage iv renal cell cancer
5811101|NCT00005069|recurrent renal cell cancer|recurrent renal cell cancer
5811102|NCT00005059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5811103|NCT00005059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811104|NCT00002923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811105|NCT00002917|stage 0 bladder cancer|stage 0 bladder cancer
5811106|NCT00002917|stage I bladder cancer|stage i bladder cancer
5811107|NCT00002917|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5811108|NCT00002911|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5811109|NCT00002911|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5811110|NCT00002829|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5811111|NCT00002829|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811112|NCT00002829|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811113|NCT00002829|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811114|NCT00002829|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811115|NCT00002829|extranodal marginal zone B-cell lymphoma|extranodal marginal zone b-cell lymphoma
5811116|NCT00002829|mucosa-associated lymphoid tissue|mucosa-associated lymphoid tissue
5811117|NCT00002829|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811118|NCT00002829|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811119|NCT00002827|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5811120|NCT00002827|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5811121|NCT00002827|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5811122|NCT00002827|cardiac toxicity|cardiac toxicity
5811123|NCT00002819|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811124|NCT00002819|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811125|NCT00002819|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5811126|NCT00002819|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5811127|NCT00002819|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5811128|NCT00002819|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5811129|NCT00002819|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5811130|NCT00002819|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5811131|NCT00002819|Brenner tumor|brenner tumor
5811132|NCT00002806|adult diffuse astrocytoma|adult diffuse astrocytoma
5811133|NCT00002721|recurrent prostate cancer|recurrent prostate cancer
5811134|NCT00002639|recurrent adult brain tumor|recurrent adult brain tumor
5811135|NCT00002639|adult glioblastoma|adult glioblastoma
5811136|NCT00002639|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5811137|NCT00002639|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5811138|NCT00002639|adult mixed glioma|adult mixed glioma
5811139|NCT00002639|adult giant cell glioblastoma|adult giant cell glioblastoma
5811140|NCT00002639|adult gliosarcoma|adult gliosarcoma
5811141|NCT00002602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5811142|NCT00002602|stage IIB prostate cancer|stage iib prostate cancer
5811143|NCT00002602|stage IIA prostate cancer|stage iia prostate cancer
5811144|NCT00002602|stage III prostate cancer|stage iii prostate cancer
5811145|NCT00002555|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5811146|NCT00002555|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5811147|NCT00002555|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5811148|NCT00002555|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5811149|NCT00002555|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5811150|NCT00002555|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5811151|NCT00002555|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5811152|NCT00002555|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5811153|NCT00002477|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5811154|NCT00002477|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5811160|NCT00083499|Nonmuscle myosin IIB|nonmuscle myosin iib
5811161|NCT00083499|Nonmuscle myosin IIA|nonmuscle myosin iia
5811162|NCT00083499|Pentology of Cantrell|pentology of cantrell
5811163|NCT00083499|thoracoabdominal syndrdome|thoracoabdominal syndrdome
5811164|NCT00083499|Nonmuscle Myosin IIC|nonmuscle myosin iic
5811165|NCT00083499|Pentalogy of Cantrell|pentalogy of cantrell
5811166|NCT00083499|Non-muscle Myosin Heavy Chain Genes|non-muscle myosin heavy chain genes
5811167|NCT00083408|Multiple Myeloma|multiple myeloma
5811168|NCT00083408|Pamidronate|pamidronate
5811169|NCT00083408|Thalidomide|thalidomide
5811170|NCT00083408|refractory myeloma|refractory myeloma
5811171|NCT00083408|bisphosphonates|bisphosphonates
5811172|NCT00083408|Aredia|aredia
5811173|NCT00004881|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811174|NCT00004200|adult glioblastoma|adult glioblastoma
5811175|NCT00004200|adult giant cell glioblastoma|adult giant cell glioblastoma
5811176|NCT00004200|adult gliosarcoma|adult gliosarcoma
5811177|NCT00004190|stage III pancreatic cancer|stage iii pancreatic cancer
5811178|NCT00004190|recurrent pancreatic cancer|recurrent pancreatic cancer
5811179|NCT00004190|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5811180|NCT00004190|stage IV pancreatic cancer|stage iv pancreatic cancer
5811181|NCT00004176|limited stage small cell lung cancer|limited stage small cell lung cancer
5811182|NCT00004176|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5811183|NCT00004176|radiation toxicity|radiation toxicity
5811184|NCT00004139|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5811185|NCT00004139|squamous cell lung cancer|squamous cell lung cancer
5811186|NCT00004139|large cell lung cancer|large cell lung cancer
5811187|NCT00004139|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5811188|NCT00004139|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811189|NCT00004139|adenocarcinoma of the lung|adenocarcinoma of the lung
5811190|NCT00004139|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5811191|NCT00004112|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5811192|NCT00004112|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5811193|NCT00004112|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5811194|NCT00004112|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5811195|NCT00004112|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811196|NCT00004112|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811197|NCT00004112|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811198|NCT00004112|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811199|NCT00004112|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811200|NCT00004112|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811201|NCT00004112|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5811202|NCT00004112|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5811204|NCT00004112|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5811206|NCT00004112|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811207|NCT00004112|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811208|NCT00004112|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811209|NCT00004112|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811210|NCT00004112|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811211|NCT00004112|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811212|NCT00004112|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811213|NCT00004105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5811214|NCT00004105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5811215|NCT00004105|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811216|NCT00004105|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5811217|NCT00004105|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5811218|NCT00004105|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811219|NCT00004105|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811220|NCT00004105|childhood fibrosarcoma|childhood fibrosarcoma
5811221|NCT00004105|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811222|NCT00004105|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811223|NCT00004105|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5811224|NCT00004105|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5686657|NCT00551161|Alzheimer disease|alzheimer disease
5811225|NCT00004105|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811226|NCT00004105|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811227|NCT00004105|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5811228|NCT00004105|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5811229|NCT00004105|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5811230|NCT00004105|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811231|NCT00004105|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811232|NCT00004105|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5811233|NCT00004105|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811234|NCT00004105|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811235|NCT00004105|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811236|NCT00004105|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5811237|NCT00004105|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811238|NCT00004105|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5811239|NCT00004105|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811240|NCT00004105|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811241|NCT00004105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811242|NCT00004105|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811243|NCT00004105|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811244|NCT00004105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811245|NCT00004105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811246|NCT00004105|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811247|NCT00004105|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5811248|NCT00004105|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5811249|NCT00004105|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5811250|NCT00004105|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5811251|NCT00004105|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811252|NCT00004105|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5811253|NCT00004105|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811254|NCT00004105|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811255|NCT00004105|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811256|NCT00004105|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811257|NCT00004105|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811258|NCT00004105|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811259|NCT00004105|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811260|NCT00004105|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811261|NCT00004105|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811262|NCT00004105|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811263|NCT00004061|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5811264|NCT00004061|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5811265|NCT00004061|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5811266|NCT00004061|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5811267|NCT00004061|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811268|NCT00004061|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5811269|NCT00004061|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5811270|NCT00004061|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5811271|NCT00004061|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5811272|NCT00004061|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5811273|NCT00004061|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811274|NCT00004061|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5811275|NCT00004061|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5811276|NCT00004061|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5811277|NCT00004061|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5811278|NCT00004061|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5811279|NCT00004061|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5811280|NCT00004061|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5811281|NCT00004061|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5811282|NCT00004061|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5811283|NCT00004061|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811284|NCT00004061|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5811286|NCT00004061|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5811287|NCT00004061|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5811288|NCT00004061|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5811289|NCT00004061|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5811290|NCT00004061|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5811291|NCT00004061|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5811292|NCT00004061|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5811293|NCT00004061|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5811294|NCT00004061|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5811295|NCT00004061|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811296|NCT00004061|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811297|NCT00004061|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5811298|NCT00004061|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5811299|NCT00004061|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811300|NCT00004061|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811301|NCT00004061|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5811302|NCT00004061|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5811303|NCT00004061|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5811304|NCT00004061|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811305|NCT00004061|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811306|NCT00004061|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5811307|NCT00004061|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811308|NCT00004061|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5846492|NCT00044304|Eosinophil|eosinophil
5811309|NCT00004061|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811310|NCT00004061|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5811311|NCT00004061|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811312|NCT00004061|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5811313|NCT00004061|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811314|NCT00004061|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811315|NCT00004061|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811316|NCT00004061|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811317|NCT00004061|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811318|NCT00004061|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811319|NCT00004061|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811320|NCT00004061|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811321|NCT00004061|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5811322|NCT00004061|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5811323|NCT00004061|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5811324|NCT00004061|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5811325|NCT00004061|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5811326|NCT00004061|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5811327|NCT00004061|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5811329|NCT00004061|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5811330|NCT00004061|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5811331|NCT00004061|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5811332|NCT00004061|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5811333|NCT00004061|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5811334|NCT00004061|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5811335|NCT00004061|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5811336|NCT00004061|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5811337|NCT00004061|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5811338|NCT00004061|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5811339|NCT00004061|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5811340|NCT00004061|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5811341|NCT00004061|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5811342|NCT00004061|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5811343|NCT00004061|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5811344|NCT00004061|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811345|NCT00004061|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5811346|NCT00004061|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811347|NCT00004061|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5686658|NCT00551161|memantine|memantine
5811348|NCT00004061|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5811349|NCT00004061|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811350|NCT00004061|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811351|NCT00004061|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5811352|NCT00004061|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5811353|NCT00004061|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811354|NCT00004061|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811355|NCT00004061|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811356|NCT00004061|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811357|NCT00004061|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5811358|NCT00004061|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5811359|NCT00004061|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811360|NCT00004061|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811361|NCT00004061|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811362|NCT00004030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811363|NCT00004012|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811364|NCT00004012|fallopian tube cancer|fallopian tube cancer
5811365|NCT00004012|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811366|NCT00003985|non-small cell lung cancer|non-small cell lung cancer
5811367|NCT00003985|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5846493|NCT00044304|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5811368|NCT00003984|refractory anemia with excess blasts|refractory anemia with excess blasts
5811369|NCT00003984|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5811370|NCT00003984|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5811371|NCT00003984|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5811372|NCT00003984|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5811373|NCT00003982|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811374|NCT00003982|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5811375|NCT00003980|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811376|NCT00003944|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811377|NCT00003944|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811378|NCT00003944|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5811379|NCT00003944|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5811380|NCT00003944|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5811381|NCT00003944|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5811382|NCT00003944|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5811383|NCT00003944|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5811384|NCT00003944|fallopian tube cancer|fallopian tube cancer
5811385|NCT00003944|peritoneal cavity cancer|peritoneal cavity cancer
5811386|NCT00003846|regional neuroblastoma|regional neuroblastoma
5811387|NCT00003846|disseminated neuroblastoma|disseminated neuroblastoma
5811389|NCT00003846|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5844005|NCT00051181|Glaucoma|glaucoma
5811390|NCT00003846|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5811391|NCT00003846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5811392|NCT00003752|stage IV breast cancer|stage iv breast cancer
5811393|NCT00003752|recurrent breast cancer|recurrent breast cancer
5811394|NCT00003669|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5811395|NCT00003669|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5811396|NCT00003580|oral complications|oral complications
5811397|NCT00003580|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5811398|NCT00003580|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5811399|NCT00003580|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5811400|NCT00003580|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5811401|NCT00003580|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5811402|NCT00003580|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5811403|NCT00003580|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5811404|NCT00003580|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5811405|NCT00003580|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5811406|NCT00003580|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5811407|NCT00003580|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5811408|NCT00003580|radiation toxicity|radiation toxicity
5811409|NCT00083395|ARVC/ARVD|arvc/arvd
5811410|NCT00083395|Genetics|genetics
5811411|NCT00083395|Sudden Death|sudden death
5819015|NCT00078689|Sirolimus|sirolimus
5811412|NCT00083395|Heart|heart
5811414|NCT00083395|Cardiomyopathy|cardiomyopathy
5811415|NCT00083395|Arrhythmogenic Right Ventricular|arrhythmogenic right ventricular
5811416|NCT00083395|ARVC|arvc
5811417|NCT00083395|Healthy Volunteer|healthy volunteer
5811418|NCT00083395|HV|hv
5811419|NCT00083382|Myeloma|myeloma
5811420|NCT00083382|Thalidomide|thalidomide
5811421|NCT00083382|Pamidronate|pamidronate
5811422|NCT00083382|Aredia|aredia
5811425|NCT00083382|Smoldering/Indolent Myeloma|smoldering/indolent myeloma
5811426|NCT00083382|Zometa|zometa
5811427|NCT00008229|stage I multiple myeloma|stage i multiple myeloma
5811428|NCT00008229|stage II multiple myeloma|stage ii multiple myeloma
5811429|NCT00008229|stage III multiple myeloma|stage iii multiple myeloma
5811430|NCT00008073|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811432|NCT00006344|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5811433|NCT00006269|stage IV colon cancer|stage iv colon cancer
5811434|NCT00006269|stage IV rectal cancer|stage iv rectal cancer
5811435|NCT00006269|recurrent colon cancer|recurrent colon cancer
5811436|NCT00006269|recurrent rectal cancer|recurrent rectal cancer
5811438|NCT00003614|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5811439|NCT00003614|stage IV prostate cancer|stage iv prostate cancer
5811440|NCT00003614|recurrent prostate cancer|recurrent prostate cancer
5811441|NCT00003523|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811442|NCT00003523|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811443|NCT00003518|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5811444|NCT00003518|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5811445|NCT00003518|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5811446|NCT00003518|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5811447|NCT00003444|stage III melanoma|stage iii melanoma
5811448|NCT00003444|stage IV melanoma|stage iv melanoma
5811449|NCT00003444|recurrent melanoma|recurrent melanoma
5811450|NCT00003405|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5811451|NCT00003405|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5811452|NCT00003405|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5811453|NCT00003405|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5811454|NCT00003405|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5811455|NCT00003405|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5811456|NCT00003405|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5811457|NCT00003405|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5811458|NCT00003405|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5811459|NCT00003405|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5811460|NCT00003405|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5811461|NCT00003405|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5811462|NCT00003405|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5811463|NCT00003405|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5811464|NCT00003405|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5811465|NCT00003405|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5811466|NCT00003403|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811468|NCT00003269|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5811469|NCT00003269|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5811470|NCT00003269|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5811471|NCT00003269|stage I breast cancer|stage i breast cancer
5811472|NCT00003269|stage II breast cancer|stage ii breast cancer
5811473|NCT00003269|stage IV breast cancer|stage iv breast cancer
5811474|NCT00003269|stage IIIA breast cancer|stage iiia breast cancer
5811475|NCT00003269|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5811476|NCT00003269|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5811477|NCT00003269|stage IIIB breast cancer|stage iiib breast cancer
5811478|NCT00003269|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5811479|NCT00003269|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5811480|NCT00003269|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5811481|NCT00003269|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5811482|NCT00003269|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5811483|NCT00003269|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5811484|NCT00003269|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811485|NCT00003269|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811486|NCT00003269|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5811487|NCT00003269|limited stage small cell lung cancer|limited stage small cell lung cancer
5811488|NCT00003269|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5811489|NCT00003269|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5811490|NCT00003269|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5811491|NCT00003269|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811492|NCT00003269|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811493|NCT00003269|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5811494|NCT00003269|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5811495|NCT00003269|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5811496|NCT00003269|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5811497|NCT00003269|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5811498|NCT00003269|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5811499|NCT00003269|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5811500|NCT00003269|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5811501|NCT00003269|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5811502|NCT00003269|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811503|NCT00003269|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811504|NCT00003269|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5811505|NCT00003269|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5811506|NCT00003269|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811507|NCT00003269|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811508|NCT00003269|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5811509|NCT00003269|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5811510|NCT00003269|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5811511|NCT00003269|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811512|NCT00003269|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811513|NCT00003269|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5811514|NCT00003269|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811515|NCT00003269|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811516|NCT00003269|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811517|NCT00003269|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5811518|NCT00003269|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811519|NCT00003269|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5811520|NCT00003269|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5811521|NCT00003269|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5811522|NCT00003269|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5811523|NCT00003269|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5811524|NCT00003269|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5811525|NCT00003269|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5811526|NCT00003269|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5811527|NCT00003269|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5811528|NCT00003269|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5811529|NCT00003269|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5811530|NCT00003269|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5811531|NCT00003269|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5811532|NCT00003269|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5811533|NCT00003269|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5811534|NCT00003269|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5811535|NCT00003269|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5811536|NCT00003269|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5811537|NCT00003269|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5811538|NCT00003269|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5811539|NCT00003269|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5811540|NCT00003269|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5811541|NCT00003269|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5811542|NCT00003269|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5811543|NCT00003269|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5811544|NCT00003269|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5811545|NCT00003269|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5811546|NCT00003269|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811547|NCT00003269|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5686659|NCT00551161|cholinesterase inhibitors|cholinesterase inhibitors
5811548|NCT00003269|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5811549|NCT00003269|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5811550|NCT00003269|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5811551|NCT00003269|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5811552|NCT00003269|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811553|NCT00003269|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811554|NCT00003269|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811555|NCT00003269|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811556|NCT00003269|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5811557|NCT00003269|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5811558|NCT00003269|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811560|NCT00003269|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811562|NCT00003195|stage II multiple myeloma|stage ii multiple myeloma
5811563|NCT00003195|stage III multiple myeloma|stage iii multiple myeloma
5811564|NCT00003187|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5811565|NCT00003187|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5811566|NCT00003187|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5811567|NCT00003187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811568|NCT00003187|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5811569|NCT00003187|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5811570|NCT00003187|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5811571|NCT00003187|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5811572|NCT00003187|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5811573|NCT00003187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5811574|NCT00003187|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5811575|NCT00003187|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5811576|NCT00003187|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811577|NCT00003187|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5811578|NCT00003187|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5811579|NCT00003187|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5811580|NCT00003187|refractory anemia|refractory anemia
5811581|NCT00003187|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5811582|NCT00003187|refractory anemia with excess blasts|refractory anemia with excess blasts
5811583|NCT00003187|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5846882|NCT00042523|Imaging|imaging
5811584|NCT00003187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5811585|NCT00003187|acute undifferentiated leukemia|acute undifferentiated leukemia
5811586|NCT00003187|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811587|NCT00003187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5811588|NCT00003187|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5811589|NCT00003187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5811590|NCT00003187|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5811591|NCT00003098|breast cancer|breast cancer
5811592|NCT00003084|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5811593|NCT00003084|stage I prostate cancer|stage i prostate cancer
5811594|NCT00003084|stage II prostate cancer|stage ii prostate cancer
5811595|NCT00003084|stage III prostate cancer|stage iii prostate cancer
5811596|NCT00003084|stage IV prostate cancer|stage iv prostate cancer
5811597|NCT00003084|recurrent prostate cancer|recurrent prostate cancer
5811598|NCT00003084|Chemotherapy|chemotherapy
5811599|NCT00003084|Ketoconazole|ketoconazole
5811600|NCT00003084|Estramustine|estramustine
5811601|NCT00003084|Etoposide|etoposide
5811602|NCT00003084|Paclitaxel|paclitaxel
5811603|NCT00003084|Doxorubicin|doxorubicin
5811604|NCT00003084|Vinblastine|vinblastine
5811605|NCT00003056|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811606|NCT00003056|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811607|NCT00003056|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811608|NCT00003056|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5811609|NCT00003056|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5811610|NCT00003056|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811611|NCT00003056|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811612|NCT00003056|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811613|NCT00003056|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5811614|NCT00003056|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811615|NCT00003056|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811616|NCT00003056|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811617|NCT00003056|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5811618|NCT00003056|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811619|NCT00003056|graft versus host disease|graft versus host disease
5811620|NCT00003056|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811621|NCT00003056|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811622|NCT00003056|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811623|NCT00003056|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811624|NCT00003056|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811626|NCT00003056|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811627|NCT00003056|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5811628|NCT00003004|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811629|NCT00002924|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5811630|NCT00002924|recurrent prostate cancer|recurrent prostate cancer
5811631|NCT00002902|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811632|NCT00002875|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5811633|NCT00002780|stage IV breast cancer|stage iv breast cancer
5811634|NCT00002780|recurrent breast cancer|recurrent breast cancer
5811635|NCT00002780|stage IIIB breast cancer|stage iiib breast cancer
5811636|NCT00002750|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5824622|NCT00068328|stage IA breast cancer|stage ia breast cancer
5824623|NCT00068328|stage IB breast cancer|stage ib breast cancer
5824624|NCT00068328|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5824643|NCT00068237|xerostomia|xerostomia
5811637|NCT00002750|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811638|NCT00002750|Waldenström macroglobulinemia|waldenström macroglobulinemia
5811639|NCT00002750|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5811640|NCT00002750|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5811641|NCT00002750|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5811642|NCT00002750|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811643|NCT00002750|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5811644|NCT00002750|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5811645|NCT00002750|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5811646|NCT00002750|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5811647|NCT00002750|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811648|NCT00002750|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811649|NCT00002750|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811650|NCT00002750|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811651|NCT00002750|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811652|NCT00002750|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811653|NCT00002750|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811654|NCT00002750|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811655|NCT00002750|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5811656|NCT00002750|extragonadal germ cell tumor|extragonadal germ cell tumor
5811657|NCT00002750|leptomeningeal metastases|leptomeningeal metastases
5811658|NCT00002750|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5811659|NCT00002750|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5811660|NCT00002750|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811661|NCT00002750|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811662|NCT00002750|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811663|NCT00002750|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811664|NCT00002750|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811665|NCT00002750|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811666|NCT00002734|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811667|NCT00002734|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811668|NCT00002671|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811669|NCT00002671|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811670|NCT00002671|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811671|NCT00002664|recurrent colon cancer|recurrent colon cancer
5811672|NCT00002664|recurrent rectal cancer|recurrent rectal cancer
5811673|NCT00002576|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5811674|NCT00002576|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5811675|NCT00002576|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5811676|NCT00002576|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5811677|NCT00002576|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5812463|NCT00082823|ovarian sarcoma|ovarian sarcoma
5811678|NCT00002576|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5811679|NCT00002576|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5811680|NCT00002576|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5811681|NCT00002576|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5811682|NCT00002576|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5811683|NCT00002576|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811684|NCT00002576|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811685|NCT00002576|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5811686|NCT00002576|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5811687|NCT00002576|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5811688|NCT00002576|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811689|NCT00002576|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811690|NCT00002576|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5811691|NCT00002576|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811692|NCT00002576|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5811693|NCT00002576|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5824699|NCT00068081|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5824700|NCT00068081|Pain|pain
5824701|NCT00068081|Peripheral nervous system diseases/*complications|peripheral nervous system diseases/*complications
5811694|NCT00002576|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5811695|NCT00002576|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5811696|NCT00002576|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5811697|NCT00002576|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5811698|NCT00002576|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5811699|NCT00002576|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5811700|NCT00002576|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5811701|NCT00002576|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5811702|NCT00002576|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5811703|NCT00002571|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5811704|NCT00002571|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5811705|NCT00002571|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5811706|NCT00002571|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5811707|NCT00002571|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5811708|NCT00002571|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5811709|NCT00002567|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811710|NCT00002567|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5811712|NCT00002567|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5811713|NCT00002567|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5811714|NCT00002567|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5811715|NCT00002567|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5811716|NCT00002567|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5811717|NCT00002567|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5811718|NCT00002567|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5811720|NCT00002567|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5811721|NCT00002552|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811722|NCT00002552|refractory multiple myeloma|refractory multiple myeloma
5844006|NCT00051181|POAG|poag
5811723|NCT00002552|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811724|NCT00002552|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811725|NCT00002552|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811726|NCT00002552|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811727|NCT00002552|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811728|NCT00002552|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811729|NCT00002552|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811730|NCT00002552|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811731|NCT00002552|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811732|NCT00002552|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5811733|NCT00002552|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811734|NCT00002552|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811735|NCT00002552|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811736|NCT00002552|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811737|NCT00002552|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811738|NCT00002552|adult unfavorable prognosis Hodgkin lymphoma|adult unfavorable prognosis hodgkin lymphoma
5811739|NCT00002552|childhood unfavorable prognosis Hodgkin lymphoma|childhood unfavorable prognosis hodgkin lymphoma
5811740|NCT00002547|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5811741|NCT00002547|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811742|NCT00002547|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5811743|NCT00002547|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5811744|NCT00002547|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811745|NCT00002547|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5811746|NCT00002547|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5811747|NCT00002547|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5811748|NCT00002547|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5811749|NCT00002547|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5811750|NCT00002547|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5811751|NCT00002547|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5811752|NCT00002547|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5811753|NCT00002547|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5811754|NCT00002547|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5811755|NCT00002547|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5811756|NCT00002547|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5811757|NCT00002547|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5811758|NCT00002547|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5811759|NCT00002547|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5811760|NCT00002547|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5811761|NCT00002547|refractory anemia with excess blasts|refractory anemia with excess blasts
5811762|NCT00002547|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5811764|NCT00002547|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5811765|NCT00002547|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5811766|NCT00002547|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5811767|NCT00002547|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5811769|NCT00083356|Kinins|kinins
5811770|NCT00083356|Inflammation|inflammation
5811771|NCT00083356|Gene Expression|gene expression
5811772|NCT00083356|Oral Surgey|oral surgey
5811773|NCT00083356|Bradykinin B1 Receptors|bradykinin b1 receptors
5811774|NCT00083356|Acute Peripheral Inflammation|acute peripheral inflammation
5811775|NCT00083356|Inflammatory Gene Expression|inflammatory gene expression
5811776|NCT00083356|Wisdom Teeth|wisdom teeth
5811777|NCT00083356|Third Molar Extraction|third molar extraction
5811778|NCT00005648|Stage II pancreatic cancer|stage ii pancreatic cancer
5811779|NCT00005648|Stage III pancreatic cancer|stage iii pancreatic cancer
5811780|NCT00005648|Recurrent pancreatic cancer|recurrent pancreatic cancer
5811781|NCT00005648|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5811782|NCT00005648|Stage IV pancreatic cancer|stage iv pancreatic cancer
5811783|NCT00004198|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811784|NCT00004198|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811785|NCT00004198|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811786|NCT00004198|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811787|NCT00004126|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5811788|NCT00004126|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5813209|NCT00004892|recurrent adult brain tumor|recurrent adult brain tumor
5811789|NCT00004126|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811790|NCT00004122|stage I bladder cancer|stage i bladder cancer
5811791|NCT00004122|recurrent bladder cancer|recurrent bladder cancer
5811792|NCT00004122|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5811793|NCT00004113|recurrent adult brain tumor|recurrent adult brain tumor
5811794|NCT00004113|adult glioblastoma|adult glioblastoma
5811795|NCT00004113|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5811796|NCT00004113|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5811797|NCT00004113|adult mixed glioma|adult mixed glioma
5811798|NCT00004113|adult giant cell glioblastoma|adult giant cell glioblastoma
5811799|NCT00004113|adult gliosarcoma|adult gliosarcoma
5811800|NCT00003976|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812670|NCT00083265|Adenosine Receptor|adenosine receptor
5811801|NCT00003908|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5811424|NCT00083382|Anti-Angiogenesis|anti-angiogenesis
5811802|NCT00003908|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5811803|NCT00003908|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5811804|NCT00003908|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5811805|NCT00003908|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5811806|NCT00003908|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5811807|NCT00003908|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5811808|NCT00003908|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5811809|NCT00003908|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5811810|NCT00003908|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5811811|NCT00003908|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5811812|NCT00003908|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5811813|NCT00003908|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5811814|NCT00003908|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5811815|NCT00003822|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811816|NCT00003747|stage IV melanoma|stage iv melanoma
5811817|NCT00003747|recurrent melanoma|recurrent melanoma
5811819|NCT00003670|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811820|NCT00003670|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811821|NCT00003670|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811822|NCT00003606|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5811823|NCT00003562|squamous cell lung cancer|squamous cell lung cancer
5811824|NCT00003562|large cell lung cancer|large cell lung cancer
5811825|NCT00003562|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5811826|NCT00003562|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811827|NCT00003562|adenocarcinoma of the lung|adenocarcinoma of the lung
5811828|NCT00003490|refractory multiple myeloma|refractory multiple myeloma
5811829|NCT00003490|stage I multiple myeloma|stage i multiple myeloma
5811830|NCT00003490|stage II multiple myeloma|stage ii multiple myeloma
5811831|NCT00003490|stage III multiple myeloma|stage iii multiple myeloma
5811832|NCT00003447|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5811833|NCT00003447|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5811834|NCT00003365|colon cancer|colon cancer
5811835|NCT00003322|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811836|NCT00003322|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811837|NCT00003322|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5811838|NCT00003322|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5811839|NCT00003322|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5811840|NCT00003322|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5811841|NCT00003322|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5811842|NCT00003322|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5811843|NCT00003322|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5811845|NCT00003289|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5811846|NCT00003289|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5811847|NCT00003289|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5811848|NCT00003289|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5811849|NCT00003289|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811850|NCT00003289|refractory hairy cell leukemia|refractory hairy cell leukemia
5811851|NCT00003289|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811852|NCT00003289|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811853|NCT00003289|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5811854|NCT00003289|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813210|NCT00004892|adult brain stem glioma|adult brain stem glioma
5811855|NCT00003289|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811856|NCT00003289|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811857|NCT00003289|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811858|NCT00003289|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811859|NCT00003289|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811860|NCT00003289|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811861|NCT00003289|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811862|NCT00003289|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811863|NCT00003289|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811864|NCT00003289|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811865|NCT00003289|prolymphocytic leukemia|prolymphocytic leukemia
5811866|NCT00003289|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5811867|NCT00003289|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5811868|NCT00003289|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5811869|NCT00003289|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5811870|NCT00003289|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811871|NCT00003289|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5811872|NCT00003289|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5811873|NCT00003289|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5811874|NCT00003289|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5811875|NCT00003289|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5811876|NCT00003289|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811877|NCT00003289|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5811878|NCT00003250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5811879|NCT00003101|adult oligodendroglioma|adult oligodendroglioma
5811880|NCT00003101|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5811881|NCT00002880|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5811882|NCT00002880|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5811883|NCT00002880|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811884|NCT00002880|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811885|NCT00002880|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811886|NCT00002880|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811887|NCT00002880|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811888|NCT00002880|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811889|NCT00002880|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811890|NCT00002876|recurrent adult brain tumor|recurrent adult brain tumor
5811891|NCT00002876|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5811892|NCT00002876|adult anaplastic ependymoma|adult anaplastic ependymoma
5811893|NCT00002813|recurrent cervical cancer|recurrent cervical cancer
5811894|NCT00002813|stage IVB cervical cancer|stage ivb cervical cancer
5811895|NCT00002813|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5811896|NCT00002707|stage I breast cancer|stage i breast cancer
5811897|NCT00002707|stage II breast cancer|stage ii breast cancer
5811898|NCT00002707|stage IIIA breast cancer|stage iiia breast cancer
5811899|NCT00002692|stage IV colon cancer|stage iv colon cancer
5811900|NCT00002692|stage IV rectal cancer|stage iv rectal cancer
5811901|NCT00002692|recurrent colon cancer|recurrent colon cancer
5811902|NCT00002692|recurrent rectal cancer|recurrent rectal cancer
5811903|NCT00002692|adenocarcinoma of the colon|adenocarcinoma of the colon
5811904|NCT00002692|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5811905|NCT00002692|liver metastases|liver metastases
5811906|NCT00002673|stage IV breast cancer|stage iv breast cancer
5811907|NCT00002673|stage IIIA breast cancer|stage iiia breast cancer
5811908|NCT00002673|stage IIIB breast cancer|stage iiib breast cancer
5811909|NCT00002673|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5811910|NCT00002673|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5811911|NCT00002673|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5811912|NCT00002673|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5811913|NCT00002673|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5811914|NCT00002673|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5811915|NCT00002673|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5811916|NCT00002673|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5811917|NCT00002673|disseminated neuroblastoma|disseminated neuroblastoma
5811918|NCT00002673|recurrent neuroblastoma|recurrent neuroblastoma
5811919|NCT00002673|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5811920|NCT00002673|stage I multiple myeloma|stage i multiple myeloma
5811921|NCT00002673|stage II multiple myeloma|stage ii multiple myeloma
5811922|NCT00002673|stage III multiple myeloma|stage iii multiple myeloma
5811923|NCT00002673|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5811924|NCT00002673|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5811925|NCT00002673|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5811926|NCT00002673|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5811927|NCT00002673|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5811928|NCT00002673|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5811929|NCT00002673|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5811930|NCT00002673|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5811931|NCT00002673|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5811932|NCT00002673|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5811933|NCT00002673|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5811934|NCT00002673|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5811935|NCT00002673|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5811936|NCT00002673|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5811937|NCT00002673|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5811938|NCT00002673|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5811939|NCT00002673|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5811940|NCT00002673|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5811941|NCT00002673|testicular embryonal carcinoma|testicular embryonal carcinoma
5811942|NCT00002673|testicular choriocarcinoma|testicular choriocarcinoma
5811944|NCT00002673|testicular yolk sac tumor|testicular yolk sac tumor
5811945|NCT00002673|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5811946|NCT00002673|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5811947|NCT00002673|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5811948|NCT00002673|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5846496|NCT00044304|Chemotherapy|chemotherapy
5824981|NCT00006223|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5824982|NCT00006223|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5811949|NCT00002673|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5811950|NCT00002673|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5811951|NCT00002673|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5811952|NCT00002673|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5811953|NCT00002673|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5811954|NCT00002673|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5811955|NCT00002673|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5811956|NCT00002673|refractory hairy cell leukemia|refractory hairy cell leukemia
5862650|NCT00001550|Episodic Spasms|episodic spasms
5811957|NCT00002673|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5811958|NCT00002673|ovarian germ cell tumor|ovarian germ cell tumor
5811959|NCT00002673|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5811960|NCT00002673|ovarian yolk sac tumor|ovarian yolk sac tumor
5811961|NCT00002673|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5811962|NCT00002673|ovarian polyembryoma|ovarian polyembryoma
5811963|NCT00002673|ovarian choriocarcinoma|ovarian choriocarcinoma
5811965|NCT00002673|ovarian immature teratoma|ovarian immature teratoma
5811966|NCT00002673|ovarian mature teratoma|ovarian mature teratoma
5811967|NCT00002673|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5811968|NCT00002673|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5811969|NCT00002673|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5811970|NCT00002673|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5811971|NCT00002673|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5811972|NCT00002673|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5811973|NCT00002673|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5811974|NCT00002673|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5811975|NCT00002673|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5811976|NCT00002673|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5811977|NCT00002673|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5811978|NCT00002673|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5811979|NCT00002673|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5811980|NCT00002673|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5811981|NCT00002673|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5811982|NCT00002673|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5811983|NCT00002673|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5811984|NCT00002673|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5811985|NCT00002673|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5811986|NCT00002673|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5811987|NCT00002673|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5811988|NCT00002673|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5811989|NCT00002673|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5811990|NCT00002673|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5811991|NCT00002673|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5811992|NCT00002673|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5811993|NCT00002673|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5811994|NCT00002673|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5811995|NCT00002673|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5811996|NCT00002673|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818630|NCT00079248|osteoporosis|osteoporosis
5811997|NCT00002673|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5811998|NCT00002673|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5811999|NCT00002673|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5812000|NCT00002673|infection|infection
5812001|NCT00002673|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5812002|NCT00002673|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5812003|NCT00002673|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5812004|NCT00002673|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5812005|NCT00002673|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5812006|NCT00002673|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5812007|NCT00002673|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5812008|NCT00002673|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5812009|NCT00002673|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5812010|NCT00002673|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5812011|NCT00002673|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5812012|NCT00002673|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5812014|NCT00002673|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812015|NCT00002673|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5812016|NCT00002673|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5812276|NCT00003685|adenocarcinoma of the lung|adenocarcinoma of the lung
5812017|NCT00002673|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5812018|NCT00002673|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812019|NCT00002673|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812020|NCT00002673|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5812021|NCT00002673|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5812022|NCT00002673|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812023|NCT00002673|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5812024|NCT00002673|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812025|NCT00002673|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5812026|NCT00002673|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812027|NCT00002673|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5812028|NCT00002599|stage I multiple myeloma|stage i multiple myeloma
5812029|NCT00002599|stage II multiple myeloma|stage ii multiple myeloma
5812030|NCT00002599|stage III multiple myeloma|stage iii multiple myeloma
5812032|NCT00083330|T Cells|t cells
5812033|NCT00083330|Immunity|immunity
5812034|NCT00083330|Healthy Volunteer|healthy volunteer
5812035|NCT00083330|HV|hv
5812036|NCT00083278|Breast Cancer|breast cancer
5812037|NCT00083278|Stage IV adenocarcinoma of the breast|stage iv adenocarcinoma of the breast
5812038|NCT00012350|refractory multiple myeloma|refractory multiple myeloma
5812039|NCT00012350|stage II multiple myeloma|stage ii multiple myeloma
5812040|NCT00012350|stage III multiple myeloma|stage iii multiple myeloma
5812041|NCT00012350|plasma cell neoplasm|plasma cell neoplasm
5812042|NCT00010088|stage II pancreatic cancer|stage ii pancreatic cancer
5812043|NCT00010088|stage III pancreatic cancer|stage iii pancreatic cancer
5812044|NCT00010088|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5812045|NCT00010088|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5812046|NCT00010088|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5812047|NCT00010088|stage IV pancreatic cancer|stage iv pancreatic cancer
5812048|NCT00006220|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5812049|NCT00006220|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5812050|NCT00006220|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5812051|NCT00006220|refractory multiple myeloma|refractory multiple myeloma
5812052|NCT00006220|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5812053|NCT00006220|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5812054|NCT00006220|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5812055|NCT00006220|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5844007|NCT00051181|OAG|oag
5812056|NCT00006220|refractory anemia with excess blasts|refractory anemia with excess blasts
5812057|NCT00006220|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5812058|NCT00006220|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5812059|NCT00006220|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5812060|NCT00006220|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5812061|NCT00006220|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5812062|NCT00006220|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5812063|NCT00006220|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5812064|NCT00006220|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5812065|NCT00006220|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5812066|NCT00006220|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5812067|NCT00006220|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5812068|NCT00006220|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5812069|NCT00006220|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5812070|NCT00006220|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5812071|NCT00006220|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5812072|NCT00006220|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812073|NCT00006220|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812074|NCT00006220|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812075|NCT00006220|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812076|NCT00006220|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812077|NCT00006220|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812078|NCT00006220|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812079|NCT00006220|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5812080|NCT00006220|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5812081|NCT00006220|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812082|NCT00006220|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812083|NCT00006220|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5812084|NCT00005814|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5812354|NCT00083304|Brain metastases|brain metastases
5812085|NCT00005814|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5812086|NCT00005814|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5812087|NCT00005814|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5812088|NCT00005814|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5812089|NCT00005814|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5812090|NCT00005814|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5812091|NCT00005814|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5812092|NCT00005814|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5812093|NCT00005814|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5812094|NCT00005814|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5812095|NCT00005814|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5812096|NCT00005814|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5812097|NCT00005814|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5812098|NCT00005814|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5812100|NCT00005581|stage IIIA breast cancer|stage iiia breast cancer
5812101|NCT00005581|stage IIIB breast cancer|stage iiib breast cancer
5812102|NCT00004880|stage IV renal cell cancer|stage iv renal cell cancer
5812103|NCT00004880|recurrent renal cell cancer|recurrent renal cell cancer
5812104|NCT00004211|stage IV prostate cancer|stage iv prostate cancer
5812105|NCT00004211|recurrent prostate cancer|recurrent prostate cancer
5812107|NCT00004156|stage II breast cancer|stage ii breast cancer
5812108|NCT00004156|stage IV breast cancer|stage iv breast cancer
5812109|NCT00004156|stage IIIA breast cancer|stage iiia breast cancer
5812110|NCT00004156|recurrent breast cancer|recurrent breast cancer
5812111|NCT00004156|stage IIIB breast cancer|stage iiib breast cancer
5812112|NCT00004132|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5812113|NCT00004132|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5812114|NCT00004132|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5812115|NCT00004132|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5812116|NCT00004132|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5812117|NCT00004132|childhood Burkitt lymphoma|childhood burkitt lymphoma
5812118|NCT00004132|refractory multiple myeloma|refractory multiple myeloma
5812119|NCT00004132|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5812120|NCT00004132|stage I multiple myeloma|stage i multiple myeloma
5812121|NCT00004132|stage II multiple myeloma|stage ii multiple myeloma
5812122|NCT00004132|stage III multiple myeloma|stage iii multiple myeloma
5812123|NCT00004132|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5812124|NCT00004132|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5812125|NCT00004132|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5812126|NCT00004132|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5686660|NCT00551161|magnetic resonance spectroscopy|magnetic resonance spectroscopy
5812127|NCT00004132|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5812128|NCT00004132|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5812129|NCT00004132|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5812130|NCT00004132|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5812131|NCT00004132|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5812132|NCT00004132|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5812133|NCT00004132|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5812134|NCT00004132|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5864028|NCT00000425|Knee|knee
5812135|NCT00004132|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5812136|NCT00004132|oral complications|oral complications
5812137|NCT00004132|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5812138|NCT00004132|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5812139|NCT00004132|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5812140|NCT00004132|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5812141|NCT00004132|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5812142|NCT00004132|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5812143|NCT00004132|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5812144|NCT00004132|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5812145|NCT00004132|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5812146|NCT00004132|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5812147|NCT00004132|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5812148|NCT00004132|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5812149|NCT00004132|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5812150|NCT00004132|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5812151|NCT00004132|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5812152|NCT00004132|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5812153|NCT00004132|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5812154|NCT00004132|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5812155|NCT00004132|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5812156|NCT00004132|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5812157|NCT00004132|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5812158|NCT00004132|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5812159|NCT00004132|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5812160|NCT00004132|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5812161|NCT00004132|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5812162|NCT00004132|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5812163|NCT00004132|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5812164|NCT00004132|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5812165|NCT00004132|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5812166|NCT00004132|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5812167|NCT00004132|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812168|NCT00004132|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812169|NCT00004132|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812170|NCT00004132|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812171|NCT00004132|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812172|NCT00004132|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812173|NCT00004132|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812174|NCT00004132|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5812175|NCT00004132|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5812177|NCT00004132|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5812178|NCT00004132|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5812179|NCT00004132|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5812180|NCT00004132|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5812181|NCT00004132|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5812182|NCT00004132|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5812183|NCT00004132|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5812184|NCT00004132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5812185|NCT00004132|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5812186|NCT00004132|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5686661|NCT00551161|N-acetylaspartate|n-acetylaspartate
5832578|NCT00049465|fatigue|fatigue
5812187|NCT00004132|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5812188|NCT00004132|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5812189|NCT00004132|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5812190|NCT00004132|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5812191|NCT00004132|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5812192|NCT00004132|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5812193|NCT00004132|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5812194|NCT00004132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5846499|NCT00044304|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5812195|NCT00004132|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5812196|NCT00004132|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5812197|NCT00004132|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5812198|NCT00004132|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5812199|NCT00004132|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5812200|NCT00004132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5812201|NCT00004132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812202|NCT00004132|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812203|NCT00004132|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5812204|NCT00004132|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5812205|NCT00004132|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5812206|NCT00004132|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812207|NCT00004132|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812208|NCT00004132|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5812209|NCT00004132|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5812210|NCT00004132|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5812211|NCT00004132|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5812212|NCT00004132|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812213|NCT00004132|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5812214|NCT00004132|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5812215|NCT00004132|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5812216|NCT00004132|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812217|NCT00004132|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5812218|NCT00004132|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812219|NCT00004073|adult glioblastoma|adult glioblastoma
5812220|NCT00004073|adult giant cell glioblastoma|adult giant cell glioblastoma
5812221|NCT00004073|adult gliosarcoma|adult gliosarcoma
5812222|NCT00004056|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5812223|NCT00004056|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5812224|NCT00004056|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5812225|NCT00004056|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5812226|NCT00004056|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5812227|NCT00004056|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5812228|NCT00004056|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5812229|NCT00004056|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5812230|NCT00004051|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812231|NCT00004038|stage I breast cancer|stage i breast cancer
5812232|NCT00004038|stage II breast cancer|stage ii breast cancer
5812233|NCT00004038|stage IV breast cancer|stage iv breast cancer
5812234|NCT00004038|stage IIIA breast cancer|stage iiia breast cancer
5812235|NCT00004038|recurrent breast cancer|recurrent breast cancer
5812236|NCT00004038|stage IIIB breast cancer|stage iiib breast cancer
5812237|NCT00003924|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5812238|NCT00003924|Waldenström macroglobulinemia|waldenström macroglobulinemia
5812239|NCT00003924|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5812240|NCT00003924|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5812241|NCT00003924|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812242|NCT00003924|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812243|NCT00003924|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812244|NCT00003924|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5686662|NCT00551161|inositol|inositol
5812245|NCT00003924|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812246|NCT00003924|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812247|NCT00003924|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812248|NCT00003924|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812249|NCT00003924|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812250|NCT00003924|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812251|NCT00003924|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812252|NCT00003924|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5812253|NCT00003924|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812254|NCT00003876|recurrent adult brain tumor|recurrent adult brain tumor
5812255|NCT00003876|adult brain stem glioma|adult brain stem glioma
5812256|NCT00003876|adult glioblastoma|adult glioblastoma
5812257|NCT00003876|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5812258|NCT00003876|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5812259|NCT00003876|adult mixed glioma|adult mixed glioma
5812260|NCT00003876|adult giant cell glioblastoma|adult giant cell glioblastoma
5812261|NCT00003876|adult gliosarcoma|adult gliosarcoma
5812262|NCT00003801|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5812263|NCT00003801|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5812264|NCT00003731|adult oligodendroglioma|adult oligodendroglioma
5812265|NCT00003731|adult mixed glioma|adult mixed glioma
5812266|NCT00003700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5812267|NCT00003700|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5812268|NCT00003700|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5812269|NCT00003698|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812270|NCT00003697|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812271|NCT00003685|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5812272|NCT00003685|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5812273|NCT00003685|squamous cell lung cancer|squamous cell lung cancer
5812274|NCT00003685|large cell lung cancer|large cell lung cancer
5863167|NCT00001364|Spinal Arteriography|spinal arteriography
5681327|NCT00573807|Sciatic Neuralgia|sciatic neuralgia
5681328|NCT00573807|Sciatica, Bilateral|sciatica, bilateral
5681329|NCT00573807|Lower back pain|lower back pain
5681330|NCT00573794|Ulcerative Colitis|ulcerative colitis
5681331|NCT00573781|Systems biology|systems biology
5681332|NCT00573781|Nutrigenomics|nutrigenomics
5812275|NCT00003685|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5812277|NCT00003685|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5812278|NCT00003685|fatigue|fatigue
5812279|NCT00003685|nausea and vomiting|nausea and vomiting
5812280|NCT00003685|pain|pain
5812281|NCT00003685|pulmonary complications|pulmonary complications
5812283|NCT00003640|stage II bladder cancer|stage ii bladder cancer
5812284|NCT00003640|stage III bladder cancer|stage iii bladder cancer
5812285|NCT00003640|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5812286|NCT00003575|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5812287|NCT00003575|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5812288|NCT00003575|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5812289|NCT00003575|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5812290|NCT00003439|stage IV colon cancer|stage iv colon cancer
5812291|NCT00003439|stage IV gastric cancer|stage iv gastric cancer
5812292|NCT00003439|recurrent gastric cancer|recurrent gastric cancer
5812293|NCT00003439|recurrent pancreatic cancer|recurrent pancreatic cancer
5812294|NCT00003439|stage IV rectal cancer|stage iv rectal cancer
5812295|NCT00003439|recurrent colon cancer|recurrent colon cancer
5812296|NCT00003439|recurrent rectal cancer|recurrent rectal cancer
5812297|NCT00003439|stage IV anal cancer|stage iv anal cancer
5812298|NCT00003439|recurrent anal cancer|recurrent anal cancer
5812299|NCT00003439|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5812300|NCT00003439|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5812301|NCT00003439|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5812302|NCT00003439|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5812303|NCT00003439|advanced adult primary liver cancer|advanced adult primary liver cancer
5812304|NCT00003439|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5812305|NCT00003439|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5812306|NCT00003439|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5812307|NCT00003439|small intestine adenocarcinoma|small intestine adenocarcinoma
5812308|NCT00003439|unresectable gallbladder cancer|unresectable gallbladder cancer
5812309|NCT00003439|recurrent gallbladder cancer|recurrent gallbladder cancer
5812310|NCT00003439|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5812311|NCT00003439|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5812312|NCT00003439|recurrent small intestine cancer|recurrent small intestine cancer
5812313|NCT00003439|stage IV prostate cancer|stage iv prostate cancer
5812314|NCT00003439|recurrent prostate cancer|recurrent prostate cancer
5812315|NCT00003439|fallopian tube cancer|fallopian tube cancer
5812316|NCT00003439|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5812317|NCT00003439|stage IV pancreatic cancer|stage iv pancreatic cancer
5812318|NCT00003423|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5812319|NCT00003423|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5812320|NCT00003423|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5812321|NCT00003423|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5812322|NCT00003423|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5812323|NCT00003423|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5812324|NCT00003423|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5812325|NCT00003423|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5812326|NCT00003330|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812327|NCT00003326|stage IV esophageal cancer|stage iv esophageal cancer
5812328|NCT00003326|recurrent esophageal cancer|recurrent esophageal cancer
5812329|NCT00003326|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5812330|NCT00003326|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5812331|NCT00003255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5812332|NCT00003255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5812333|NCT00002578|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5812334|NCT00002578|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5812335|NCT00002578|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5812336|NCT00002578|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5812337|NCT00002578|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5812338|NCT00002578|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5812339|NCT00002578|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5812340|NCT00002503|recurrent prostate cancer|recurrent prostate cancer
5812341|NCT00002503|bone metastases|bone metastases
5812343|NCT00083317|Competition|competition
5812344|NCT00083317|Bargaining Games|bargaining games
5812345|NCT00083317|Hyper-Brain Scanning|hyper-brain scanning
5812346|NCT00083317|fMRI|fmri
5812347|NCT00083317|Healthy Volunteer|healthy volunteer
5812348|NCT00083317|HV|hv
5812349|NCT00083304|Breast|breast
5812350|NCT00083304|Brain|brain
5812351|NCT00083304|RSR13|rsr13
5812352|NCT00083304|efaproxiral|efaproxiral
5812353|NCT00083304|Whole Brain Radiation Therapy|whole brain radiation therapy
5812355|NCT00083304|Metastatic breast cancer|metastatic breast cancer
5812356|NCT00083213|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5812357|NCT00083213|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5812358|NCT00083213|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5812359|NCT00083213|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5812360|NCT00083213|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812361|NCT00083213|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5812362|NCT00083213|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812363|NCT00083213|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5812364|NCT00083213|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812365|NCT00083213|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5812366|NCT00083213|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5812367|NCT00083213|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812368|NCT00083213|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812369|NCT00083213|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5812370|NCT00083213|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812372|NCT00083213|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812373|NCT00083213|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812374|NCT00083213|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812375|NCT00083213|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5812376|NCT00083213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812377|NCT00083213|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5812378|NCT00083213|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5812379|NCT00083213|advanced adult primary liver cancer|advanced adult primary liver cancer
5812380|NCT00083213|recurrent cervical cancer|recurrent cervical cancer
5812381|NCT00083213|stage IVA cervical cancer|stage iva cervical cancer
5812382|NCT00083213|stage IVB cervical cancer|stage ivb cervical cancer
5812383|NCT00083213|fallopian tube cancer|fallopian tube cancer
5812384|NCT00083213|ovarian sarcoma|ovarian sarcoma
5812385|NCT00083213|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5812386|NCT00083213|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5812387|NCT00083213|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5812388|NCT00083213|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5812389|NCT00083213|recurrent uterine sarcoma|recurrent uterine sarcoma
5812390|NCT00083213|stage IV uterine sarcoma|stage iv uterine sarcoma
5844009|NCT00051168|Glaucoma|glaucoma
5812391|NCT00083213|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5812392|NCT00083213|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5812393|NCT00083213|ovarian stromal cancer|ovarian stromal cancer
5812394|NCT00083213|recurrent vaginal cancer|recurrent vaginal cancer
5812395|NCT00083213|stage IVA vaginal cancer|stage iva vaginal cancer
5812396|NCT00083213|stage IVB vaginal cancer|stage ivb vaginal cancer
5812397|NCT00083213|recurrent prostate cancer|recurrent prostate cancer
5812398|NCT00083213|stage IV prostate cancer|stage iv prostate cancer
5812399|NCT00083213|recurrent penile cancer|recurrent penile cancer
5812400|NCT00083213|stage IV penile cancer|stage iv penile cancer
5812401|NCT00083213|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5812402|NCT00083213|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5812403|NCT00083213|recurrent bladder cancer|recurrent bladder cancer
5812404|NCT00083213|stage IV bladder cancer|stage iv bladder cancer
5812405|NCT00083213|recurrent vulvar cancer|recurrent vulvar cancer
5812406|NCT00083213|stage IVB vulvar cancer|stage ivb vulvar cancer
5812407|NCT00083213|distal urethral cancer|distal urethral cancer
5812408|NCT00083213|proximal urethral cancer|proximal urethral cancer
5812409|NCT00083213|recurrent urethral cancer|recurrent urethral cancer
5812410|NCT00083213|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5812411|NCT00083213|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5812412|NCT00083213|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812413|NCT00083213|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812414|NCT00083213|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812415|NCT00083213|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5812416|NCT00083213|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812417|NCT00083213|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5812418|NCT00083213|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812419|NCT00083213|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5812420|NCT00082940|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5812421|NCT00082940|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5812422|NCT00082927|stage IV prostate cancer|stage iv prostate cancer
5812425|NCT00082927|recurrent prostate cancer|recurrent prostate cancer
5812426|NCT00082914|recurrent renal cell cancer|recurrent renal cell cancer
5812427|NCT00082914|stage IV renal cell cancer|stage iv renal cell cancer
5812428|NCT00082914|recurrent melanoma|recurrent melanoma
5812429|NCT00082914|stage IV melanoma|stage iv melanoma
5812430|NCT00082862|stage II pancreatic cancer|stage ii pancreatic cancer
5812431|NCT00082862|stage III pancreatic cancer|stage iii pancreatic cancer
5812432|NCT00082862|recurrent pancreatic cancer|recurrent pancreatic cancer
5812433|NCT00082862|stage IV pancreatic cancer|stage iv pancreatic cancer
5812434|NCT00082836|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5812435|NCT00082823|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5812436|NCT00082823|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5812437|NCT00082823|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5812438|NCT00082823|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5812439|NCT00082823|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812440|NCT00082823|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5812441|NCT00082823|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812442|NCT00082823|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5812443|NCT00082823|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812444|NCT00082823|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5812445|NCT00082823|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812446|NCT00082823|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5812447|NCT00082823|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812448|NCT00082823|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5812449|NCT00082823|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812450|NCT00082823|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5812451|NCT00082823|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812452|NCT00082823|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812453|NCT00082823|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812454|NCT00082823|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5812455|NCT00082823|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812456|NCT00082823|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5812457|NCT00082823|advanced adult primary liver cancer|advanced adult primary liver cancer
5812458|NCT00082823|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5812459|NCT00082823|recurrent cervical cancer|recurrent cervical cancer
5811964|NCT00002673|ovarian teratoma|ovarian teratoma
5812460|NCT00082823|stage IVA cervical cancer|stage iva cervical cancer
5812461|NCT00082823|stage IVB cervical cancer|stage ivb cervical cancer
5812462|NCT00082823|fallopian tube cancer|fallopian tube cancer
5812464|NCT00082823|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5812465|NCT00082823|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5812466|NCT00082823|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5812467|NCT00082823|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5812468|NCT00082823|recurrent uterine sarcoma|recurrent uterine sarcoma
5812469|NCT00082823|stage IV uterine sarcoma|stage iv uterine sarcoma
5812470|NCT00082823|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5812471|NCT00082823|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5812472|NCT00082823|ovarian stromal cancer|ovarian stromal cancer
5812473|NCT00082823|recurrent vaginal cancer|recurrent vaginal cancer
5812474|NCT00082823|stage IVA vaginal cancer|stage iva vaginal cancer
5812475|NCT00082823|stage IVB vaginal cancer|stage ivb vaginal cancer
5812476|NCT00082823|recurrent prostate cancer|recurrent prostate cancer
5812477|NCT00082823|stage IV prostate cancer|stage iv prostate cancer
5812478|NCT00082823|recurrent penile cancer|recurrent penile cancer
5812479|NCT00082823|stage IV penile cancer|stage iv penile cancer
5812480|NCT00082823|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5812481|NCT00082823|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5812482|NCT00082823|recurrent bladder cancer|recurrent bladder cancer
5812483|NCT00082823|stage IV bladder cancer|stage iv bladder cancer
5812484|NCT00082823|recurrent vulvar cancer|recurrent vulvar cancer
5812485|NCT00082823|stage IVB vulvar cancer|stage ivb vulvar cancer
5812486|NCT00082823|distal urethral cancer|distal urethral cancer
5812487|NCT00082823|proximal urethral cancer|proximal urethral cancer
5812488|NCT00082823|recurrent urethral cancer|recurrent urethral cancer
5812489|NCT00082823|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5812490|NCT00082823|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5812491|NCT00082823|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812492|NCT00082823|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812493|NCT00082823|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812494|NCT00082823|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5812495|NCT00082823|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812496|NCT00082823|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5812497|NCT00082823|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812506|NCT00082719|stage II bladder cancer|stage ii bladder cancer
5812507|NCT00082719|stage III bladder cancer|stage iii bladder cancer
5812508|NCT00082719|stage IV bladder cancer|stage iv bladder cancer
5812509|NCT00082719|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5812510|NCT00082719|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5812511|NCT00082719|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5812512|NCT00082719|anterior urethral cancer|anterior urethral cancer
5812513|NCT00082719|posterior urethral cancer|posterior urethral cancer
5812514|NCT00082719|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5812523|NCT00082667|breast cancer in situ|breast cancer in situ
5812524|NCT00082667|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5812525|NCT00082654|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5812526|NCT00082654|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5812527|NCT00082654|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5812528|NCT00082654|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5812529|NCT00082654|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5812530|NCT00082654|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5812531|NCT00082654|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5812532|NCT00082654|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5812533|NCT00082654|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5812534|NCT00082654|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5812535|NCT00082654|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5812536|NCT00082654|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5812537|NCT00082654|disseminated neuroblastoma|disseminated neuroblastoma
5812538|NCT00082654|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5812539|NCT00082654|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5812540|NCT00082654|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5812541|NCT00082654|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5812542|NCT00082654|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5812543|NCT00082654|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5812544|NCT00082654|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5812545|NCT00082654|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5812757|NCT00082628|Human Adipose Redistribution Syndrome|human adipose redistribution syndrome
5812546|NCT00082654|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5812547|NCT00082654|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5812548|NCT00082654|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5812549|NCT00082654|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5812550|NCT00082654|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5812551|NCT00082654|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5812552|NCT00082654|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5812553|NCT00082654|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5812554|NCT00082654|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812555|NCT00082654|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5846502|NCT00044278|pediatric|pediatric
5812556|NCT00082654|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812557|NCT00082654|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5812558|NCT00082654|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5812559|NCT00082654|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5812560|NCT00082654|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5812561|NCT00082654|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5812562|NCT00082654|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5812563|NCT00082654|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812564|NCT00082654|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5812565|NCT00082654|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5812566|NCT00082654|recurrent neuroblastoma|recurrent neuroblastoma
5812567|NCT00082654|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5812568|NCT00082654|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5812569|NCT00082654|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5812570|NCT00082654|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5812571|NCT00082654|refractory hairy cell leukemia|refractory hairy cell leukemia
5812572|NCT00082654|refractory multiple myeloma|refractory multiple myeloma
5812573|NCT00082654|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5812574|NCT00082654|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5812576|NCT00082654|stage I multiple myeloma|stage i multiple myeloma
5812577|NCT00082654|stage II multiple myeloma|stage ii multiple myeloma
5812578|NCT00082654|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5812579|NCT00082654|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5812580|NCT00082654|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5812581|NCT00082654|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5812582|NCT00082654|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5812583|NCT00082654|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5812584|NCT00082654|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5812585|NCT00082654|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5812586|NCT00082654|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5812587|NCT00082654|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5812588|NCT00082654|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5812589|NCT00082654|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5812590|NCT00082654|stage III multiple myeloma|stage iii multiple myeloma
5812591|NCT00082654|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5812592|NCT00082654|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5812593|NCT00082654|stage IIIA breast cancer|stage iiia breast cancer
5812594|NCT00082654|stage IIIB breast cancer|stage iiib breast cancer
5812595|NCT00082654|stage IIIC breast cancer|stage iiic breast cancer
5812596|NCT00082654|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5812597|NCT00082654|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5812598|NCT00082654|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5812599|NCT00082654|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5812600|NCT00082654|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5812601|NCT00082654|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5812602|NCT00082654|stage IV breast cancer|stage iv breast cancer
5812603|NCT00082654|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5812604|NCT00082654|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5812605|NCT00082654|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5812606|NCT00082654|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5812099|NCT00005581|stage II breast cancer|stage ii breast cancer
5812607|NCT00082654|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5812608|NCT00082654|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5812609|NCT00082654|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5812610|NCT00082654|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5813207|NCT00004893|stage IV breast cancer|stage iv breast cancer
5812611|NCT00082654|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5812612|NCT00082654|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5812613|NCT00082654|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812614|NCT00082654|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5812615|NCT00082654|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5812616|NCT00082654|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5812617|NCT00082654|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5812618|NCT00082654|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5812619|NCT00082654|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5812620|NCT00082654|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5864327|NCT00000385|Child|child
5812621|NCT00082654|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5812622|NCT00082654|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5812623|NCT00082654|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5812624|NCT00082654|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5812625|NCT00082654|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5812626|NCT00082654|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5812627|NCT00082641|stage IIIA breast cancer|stage iiia breast cancer
5812628|NCT00082641|stage IIIB breast cancer|stage iiib breast cancer
5812629|NCT00003186|stage I colon cancer|stage i colon cancer
5812630|NCT00003186|stage II colon cancer|stage ii colon cancer
5812631|NCT00003186|stage III colon cancer|stage iii colon cancer
5812632|NCT00003186|stage IV colon cancer|stage iv colon cancer
5812633|NCT00003186|stage I rectal cancer|stage i rectal cancer
5812634|NCT00003186|stage II rectal cancer|stage ii rectal cancer
5812635|NCT00003186|stage III rectal cancer|stage iii rectal cancer
5812636|NCT00003186|stage IV rectal cancer|stage iv rectal cancer
5812637|NCT00003186|adenocarcinoma of the colon|adenocarcinoma of the colon
5812638|NCT00003186|liver metastases|liver metastases
5812639|NCT00003183|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5812640|NCT00003183|stage IV prostate cancer|stage iv prostate cancer
5812641|NCT00003183|recurrent prostate cancer|recurrent prostate cancer
5812642|NCT00003154|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5812643|NCT00003154|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5812644|NCT00003118|stage I esophageal cancer|stage i esophageal cancer
5812645|NCT00003118|stage II esophageal cancer|stage ii esophageal cancer
5812646|NCT00003118|stage III esophageal cancer|stage iii esophageal cancer
5812647|NCT00003118|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5812648|NCT00003118|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5812649|NCT00003117|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5812650|NCT00003117|squamous cell lung cancer|squamous cell lung cancer
5812651|NCT00003117|large cell lung cancer|large cell lung cancer
5812652|NCT00003117|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5812653|NCT00003117|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5812654|NCT00003117|adenocarcinoma of the lung|adenocarcinoma of the lung
5812655|NCT00003117|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5812656|NCT00003095|stage II breast cancer|stage ii breast cancer
5812657|NCT00003095|stage III breast cancer|stage iii breast cancer
5812658|NCT00003020|leptomeningeal metastases|leptomeningeal metastases
5812659|NCT00002988|recurrent adult brain tumor|recurrent adult brain tumor
5812660|NCT00002985|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5812661|NCT00002961|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5812662|NCT00002961|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5812663|NCT00083291|Dry Eyes|dry eyes
5812664|NCT00083291|Conjunctiva|conjunctiva
5812665|NCT00083291|Infection|infection
5812666|NCT00083291|Antibodies|antibodies
5812667|NCT00083291|Inflammation|inflammation
5812668|NCT00083291|Ocular Surface Disease|ocular surface disease
5812669|NCT00083291|Helicobacter Pylori|helicobacter pylori
5812671|NCT00083265|Panic Disorder|panic disorder
5812672|NCT00083265|Polymorphism|polymorphism
5812673|NCT00083265|Challenge Study|challenge study
5812674|NCT00083265|Caffeine|caffeine
5812675|NCT00083265|Healthy Volunteer|healthy volunteer
5812677|NCT00083226|doxorubicin|doxorubicin
5812678|NCT00083226|doxorubicin hydrochloride|doxorubicin hydrochloride
5812679|NCT00083226|bortezomib|bortezomib
5812680|NCT00083226|hepatocellular carcinoma|hepatocellular carcinoma
5812681|NCT00083187|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5812682|NCT00083187|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5812683|NCT00083187|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5812684|NCT00083187|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5812685|NCT00083187|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5812686|NCT00083187|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5812687|NCT00083187|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5812688|NCT00083187|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5812689|NCT00083187|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5812690|NCT00083187|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5812691|NCT00083187|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5812692|NCT00083187|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5812693|NCT00083174|breast cancer|breast cancer
5812694|NCT00083161|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5812695|NCT00083161|recurrent small cell lung cancer|recurrent small cell lung cancer
5812696|NCT00083148|recurrent breast cancer|recurrent breast cancer
5812697|NCT00083148|stage IV breast cancer|stage iv breast cancer
5812698|NCT00083135|recurrent neuroblastoma|recurrent neuroblastoma
5812699|NCT00083096|recurrent adult brain tumor|recurrent adult brain tumor
5812700|NCT00083096|adult mixed glioma|adult mixed glioma
5812701|NCT00083096|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5812702|NCT00083096|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5812703|NCT00083096|adult glioblastoma|adult glioblastoma
5812704|NCT00083096|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5812705|NCT00083096|adult anaplastic ependymoma|adult anaplastic ependymoma
5812706|NCT00083096|adult subependymoma|adult subependymoma
5812707|NCT00083096|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5813509|NCT00003239|DepotCyt|depotcyt
5812708|NCT00083096|adult oligodendroglioma|adult oligodendroglioma
5812709|NCT00083096|adult giant cell glioblastoma|adult giant cell glioblastoma
5812710|NCT00083096|adult gliosarcoma|adult gliosarcoma
5812711|NCT00083096|adult diffuse astrocytoma|adult diffuse astrocytoma
5812712|NCT00083096|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5812713|NCT00083096|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5812714|NCT00083083|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5812715|NCT00083083|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5812716|NCT00083083|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5812717|NCT00083070|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5812718|NCT00083070|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5812719|NCT00083070|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5812720|NCT00083070|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5812721|NCT00083070|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5812722|NCT00083057|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5812723|NCT00083057|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5812724|NCT00083057|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5812725|NCT00083057|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5812726|NCT00083057|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5812727|NCT00083057|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5812728|NCT00083057|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5812729|NCT00083057|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5812730|NCT00083057|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5812731|NCT00083057|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5812732|NCT00083057|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5812733|NCT00083057|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5812734|NCT00083057|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5812735|NCT00083057|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5812736|NCT00083057|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5812737|NCT00083057|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5812739|NCT00083044|breast cancer in situ|breast cancer in situ
5812740|NCT00083044|stage I breast cancer|stage i breast cancer
5812741|NCT00083044|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5812742|NCT00083044|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5812743|NCT00083031|recurrent breast cancer|recurrent breast cancer
5812744|NCT00083031|stage IV breast cancer|stage iv breast cancer
5812745|NCT00083018|stage II breast cancer|stage ii breast cancer
5812746|NCT00083018|stage IIIA breast cancer|stage iiia breast cancer
5812747|NCT00083018|stage IIIB breast cancer|stage iiib breast cancer
5819430|NCT00021996|pain|pain
5812748|NCT00083018|stage IIIC breast cancer|stage iiic breast cancer
5812749|NCT00083018|stage IA breast cancer|stage ia breast cancer
5812750|NCT00083018|stage IB breast cancer|stage ib breast cancer
5812751|NCT00083005|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5812752|NCT00083005|recurrent prostate cancer|recurrent prostate cancer
5812753|NCT00083005|stage IV prostate cancer|stage iv prostate cancer
5812754|NCT00082979|breast cancer|breast cancer
5812755|NCT00082628|Growth hormone|growth hormone
5812758|NCT00082628|Human Immunodeficiency Virus lipodystrophy|human immunodeficiency virus lipodystrophy
5812759|NCT00082602|galantamine|galantamine
5812760|NCT00082602|Alzheimer's disease|alzheimer's disease
5812761|NCT00082615|Movement Disorders|movement disorders
5812762|NCT00082615|Recovery Cycle|recovery cycle
5812763|NCT00082615|Blink Reflex|blink reflex
5812764|NCT00082615|Cervical Dystonia|cervical dystonia
5812765|NCT00082615|Blepharospasm|blepharospasm
5812766|NCT00082615|Dystonia|dystonia
5812767|NCT00082615|Craniofacial Dystonia|craniofacial dystonia
5812768|NCT00082615|Healthy Volunteer|healthy volunteer
5812770|NCT00002936|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5812771|NCT00002936|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5812772|NCT00002936|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5812897|NCT00082329|T Cell Polarization|t cell polarization
5812773|NCT00002903|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5812774|NCT00002903|testicular seminoma|testicular seminoma
5812775|NCT00002903|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5812776|NCT00002903|extragonadal germ cell tumor|extragonadal germ cell tumor
5812777|NCT00002896|stage II rectal cancer|stage ii rectal cancer
5812778|NCT00002896|stage III rectal cancer|stage iii rectal cancer
5812779|NCT00002896|recurrent rectal cancer|recurrent rectal cancer
5812780|NCT00002896|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5812781|NCT00002896|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5812782|NCT00002893|stage III colon cancer|stage iii colon cancer
5812783|NCT00002893|stage IV colon cancer|stage iv colon cancer
5812784|NCT00002893|stage III rectal cancer|stage iii rectal cancer
5812785|NCT00002893|stage IV rectal cancer|stage iv rectal cancer
5812786|NCT00002893|recurrent colon cancer|recurrent colon cancer
5812787|NCT00002893|recurrent rectal cancer|recurrent rectal cancer
5812788|NCT00002893|adenocarcinoma of the colon|adenocarcinoma of the colon
5812789|NCT00002893|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5809316|NCT00085969|Amylin|amylin
5812792|NCT00002892|recurrent melanoma|recurrent melanoma
5812793|NCT00082550|Genetics|genetics
5812794|NCT00082550|Serotonin Transporter|serotonin transporter
5812795|NCT00082550|Brain Imaging|brain imaging
5812796|NCT00082550|Neurotransmitter|neurotransmitter
5812797|NCT00082550|OCD|ocd
5812798|NCT00082550|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5812799|NCT00082550|PET|pet
5812800|NCT00082550|Obsessive Compulsive Disorder|obsessive compulsive disorder
5812801|NCT00082550|Healthy Volunteer|healthy volunteer
5812802|NCT00082550|HV|hv
5812803|NCT00082498|SCH-D|sch-d
5812804|NCT00082498|Schering D|schering d
5812805|NCT00082498|Treatment Experienced|treatment experienced
5812806|NCT00082498|Entry Inhibitors|entry inhibitors
5812807|NCT00082498|Fusion Inhibitors|fusion inhibitors
5812808|NCT00082498|Vicriviroc|vicriviroc
5812809|NCT00082485|Cocaine Dependence|cocaine dependence
5812810|NCT00082472|NSCLC|nsclc
5812811|NCT00082472|Metastatic|metastatic
5812812|NCT00082472|Unresectable|unresectable
5812813|NCT00082472|No Prior Chemotherapy|no prior chemotherapy
5812814|NCT00082459|Kidney Cancer|kidney cancer
5812815|NCT00082459|Renal|renal
5812816|NCT00082459|Tumor|tumor
5812817|NCT00082459|Immunotherapy|immunotherapy
5812818|NCT00082420|Vitamin A malnutrition|vitamin a malnutrition
5812819|NCT00082420|low vitamin A status|low vitamin a status
5812820|NCT00002870|stage IV breast cancer|stage iv breast cancer
5812821|NCT00002870|recurrent breast cancer|recurrent breast cancer
5812822|NCT00002826|stage IV breast cancer|stage iv breast cancer
5812823|NCT00002826|recurrent breast cancer|recurrent breast cancer
5812824|NCT00002803|localized resectable neuroblastoma|localized resectable neuroblastoma
5812825|NCT00002803|regional neuroblastoma|regional neuroblastoma
5812826|NCT00002803|stage 4S neuroblastoma|stage 4s neuroblastoma
5812827|NCT00002803|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5812828|NCT00002802|localized resectable neuroblastoma|localized resectable neuroblastoma
5812829|NCT00002802|regional neuroblastoma|regional neuroblastoma
5812830|NCT00002802|disseminated neuroblastoma|disseminated neuroblastoma
5812831|NCT00002802|stage 4S neuroblastoma|stage 4s neuroblastoma
5812832|NCT00002802|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5812833|NCT00082446|Smallpox, vaccine|smallpox, vaccine
5812834|NCT00082381|Diabetes|diabetes
5812835|NCT00082381|Insulin glargine|insulin glargine
5812836|NCT00082381|comparator|comparator
5812837|NCT00082381|Amylin|amylin
5812838|NCT00082381|Lilly|lilly
5812839|NCT00002788|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5812840|NCT00002788|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5686663|NCT00551161|cerebrospinal fluid|cerebrospinal fluid
5686664|NCT00551161|tau proteins|tau proteins
5686665|NCT00551161|amyloid beta-protein|amyloid beta-protein
5686666|NCT00551135|postoperative pain chronic pain|postoperative pain chronic pain
5686667|NCT00551122|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5812841|NCT00002788|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5812842|NCT00002788|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5812843|NCT00002737|stage IV renal cell cancer|stage iv renal cell cancer
5812844|NCT00002737|recurrent renal cell cancer|recurrent renal cell cancer
5812845|NCT00002677|stage IV prostate cancer|stage iv prostate cancer
5812846|NCT00002677|recurrent prostate cancer|recurrent prostate cancer
5813208|NCT00004893|recurrent breast cancer|recurrent breast cancer
5812847|NCT00002677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812848|NCT00002644|breast cancer|breast cancer
5812849|NCT00002644|tamoxifen|tamoxifen
5812850|NCT00002644|prevention|prevention
5812851|NCT00002644|IBIS|ibis
5812852|NCT00002587|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812853|NCT00082407|diabetes|diabetes
5812854|NCT00082407|exendin|exendin
5812855|NCT00082407|Amylin|amylin
5812856|NCT00082407|Lilly|lilly
5812857|NCT00082407|insulin aspart|insulin aspart
5812858|NCT00082394|safety|safety
5812859|NCT00082394|drug efficacy|drug efficacy
5812860|NCT00082394|TRIZIVIR|trizivir
5812861|NCT00082394|tolerability|tolerability
5812862|NCT00082394|COMBIVIR|combivir
5812863|NCT00082394|HIV|hiv
5812864|NCT00082394|atazanavir|atazanavir
5812865|NCT00082316|Dermal assessment|dermal assessment
5812866|NCT00082316|Pain assessment|pain assessment
5812867|NCT00082316|Diary|diary
5812868|NCT00082316|Analgesics|analgesics
5812869|NCT00082316|Capsaicin|capsaicin
5812870|NCT00082316|Herpes zoster|herpes zoster
5812871|NCT00082316|Neuralgia|neuralgia
5812872|NCT00082316|HIV Infections|hiv infections
5812873|NCT00082316|Peripheral Nervous System Diseases|peripheral nervous system diseases
5812874|NCT00082316|Diabetic Neuropathies|diabetic neuropathies
5812875|NCT00082316|Diabetes Mellitus|diabetes mellitus
5812876|NCT00082316|Polyneuropathies|polyneuropathies
5812877|NCT00082316|Complementary Therapies|complementary therapies
5812878|NCT00082368|Tariquidar|tariquidar
5812879|NCT00082368|PET|pet
5812881|NCT00082368|Cancer|cancer
5812882|NCT00082355|r-tPA|r-tpa
5812883|NCT00082355|Thrombolysis|thrombolysis
5812884|NCT00082355|Clot|clot
5812885|NCT00082355|Anticoagulation|anticoagulation
5812886|NCT00082355|Fibrinolysis|fibrinolysis
5812889|NCT00082342|Human Brain|human brain
5812890|NCT00082342|Electrical Stimulation|electrical stimulation
5812891|NCT00082342|Parkinson Disease|parkinson disease
5812892|NCT00082342|PD|pd
5812893|NCT00082329|Hematopoietic Stem Cells|hematopoietic stem cells
5812894|NCT00082329|PBSC's|pbsc's
5812895|NCT00082329|Mobilization|mobilization
5812896|NCT00082329|Alloreactivity|alloreactivity
5812898|NCT00082329|Dendritic Cells|dendritic cells
5812900|NCT00082329|Plerixafor|plerixafor
5812901|NCT00082329|Healthy Volunteer (HV)|healthy volunteer (hv)
5812902|NCT00082303|Music Therapy|music therapy
5812903|NCT00082303|Anxiety|anxiety
5812904|NCT00082303|Depression|depression
5812905|NCT00082290|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812906|NCT00082290|pain|pain
5812907|NCT00082277|hormone-receptor positive, breast cancer|hormone-receptor positive, breast cancer
5812908|NCT00082277|Osteopenia|osteopenia
5812909|NCT00082277|Osteoporosis|osteoporosis
5812910|NCT00082277|risk of fracture|risk of fracture
5812911|NCT00082277|bone loss|bone loss
5812912|NCT00082251|Dyslipidemia|dyslipidemia
5812913|NCT00082251|High Blood Cholesterol|high blood cholesterol
5812914|NCT00082251|Coronary Heart Disease|coronary heart disease
5812915|NCT00082251|Hypertension|hypertension
5812916|NCT00082251|National Cholesterol Education Program|national cholesterol education program
5812917|NCT00082251|Adult Treatment Panel III|adult treatment panel iii
5812918|NCT00082251|Niacin|niacin
5812919|NCT00082251|Simvastatin|simvastatin
5812920|NCT00082251|Diabetes|diabetes
5812921|NCT00082251|Peripheral Vascular Disease|peripheral vascular disease
5812922|NCT00082251|Cerebrovascular disease|cerebrovascular disease
5812923|NCT00082251|Stroke|stroke
5812924|NCT00082251|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5812925|NCT00082251|Hydroxymethyl Glutaryl Coenzyme A|hydroxymethyl glutaryl coenzyme a
5812926|NCT00082251|High-Sensitivity C-Reactive Protein|high-sensitivity c-reactive protein
5812927|NCT00082251|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5812928|NCT00082251|Lipoprotein (a)|lipoprotein (a)
5812929|NCT00082251|Lipoprotein A-I|lipoprotein a-i
5812930|NCT00082251|Total Cholesterol|total cholesterol
5812931|NCT00082251|Triglycerides|triglycerides
5812932|NCT00082225|Hodgkins|hodgkins
5812933|NCT00082225|Non-Hodgkins|non-hodgkins
5812934|NCT00082225|Lymphoma|lymphoma
5812935|NCT00082212|ovarian|ovarian
5812936|NCT00082212|primary peritoneal cancer|primary peritoneal cancer
5812937|NCT00082212|Persistent or Recurrent Ovarian Cancer|persistent or recurrent ovarian cancer
5812938|NCT00082212|Primary Peritoneal Carcinoma|primary peritoneal carcinoma
5812939|NCT00014651|perioperative/postoperative complications|perioperative/postoperative complications
5812940|NCT00014651|stage I pancreatic cancer|stage i pancreatic cancer
5812941|NCT00010322|stage IV breast cancer|stage iv breast cancer
5812942|NCT00010322|recurrent breast cancer|recurrent breast cancer
5812943|NCT00008255|non-small cell lung cancer|non-small cell lung cancer
5812944|NCT00008255|small cell lung cancer|small cell lung cancer
5812945|NCT00002568|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5812946|NCT00002568|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5844010|NCT00051168|POAG|poag
5812947|NCT00002568|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5812948|NCT00002568|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5812949|NCT00002568|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5812950|NCT00002568|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5812951|NCT00002568|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5812952|NCT00002568|Brenner tumor|brenner tumor
5812953|NCT00002516|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5812954|NCT00002516|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5812955|NCT00082160|Meditation|meditation
5812956|NCT00082160|Relaxation|relaxation
5812957|NCT00082134|Prostate cancer|prostate cancer
5812958|NCT00082134|Hormone-refractory prostate cancer|hormone-refractory prostate cancer
5812959|NCT00082134|HRPC|hrpc
5812960|NCT00082134|Prostate|prostate
5812961|NCT00082134|Docetaxel|docetaxel
5812962|NCT00082134|PSA progression|psa progression
5812963|NCT00082134|PSA progressed|psa progressed
5812964|NCT00082121|cardiac bypass|cardiac bypass
5812965|NCT00082121|CABG|cabg
5812966|NCT00082121|complement activation|complement activation
5812967|NCT00011934|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5812968|NCT00011934|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813034|NCT00006039|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5812969|NCT00011934|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5812970|NCT00011934|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5812971|NCT00008242|stage II multiple myeloma|stage ii multiple myeloma
5812972|NCT00008242|stage III multiple myeloma|stage iii multiple myeloma
5812973|NCT00008125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5812975|NCT00008099|stage II pancreatic cancer|stage ii pancreatic cancer
5812976|NCT00008099|stage III pancreatic cancer|stage iii pancreatic cancer
5812977|NCT00008099|stage IV pancreatic cancer|stage iv pancreatic cancer
5812978|NCT00006682|stage IV breast cancer|stage iv breast cancer
5812979|NCT00006682|recurrent breast cancer|recurrent breast cancer
5812980|NCT00006669|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5812981|NCT00006669|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5812982|NCT00006669|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5812983|NCT00006669|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5812984|NCT00006342|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5812985|NCT00006342|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5812986|NCT00006342|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5812987|NCT00006342|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5812988|NCT00006342|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5812989|NCT00006342|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5812990|NCT00006342|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5812991|NCT00006342|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5812992|NCT00006342|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5812993|NCT00006342|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5812994|NCT00006342|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5812995|NCT00006342|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5812996|NCT00006342|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5812997|NCT00006342|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5812998|NCT00006342|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5812999|NCT00006342|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5813000|NCT00006342|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5813001|NCT00006342|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5813002|NCT00006342|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5813003|NCT00006342|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5813004|NCT00006342|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5813005|NCT00006342|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5813006|NCT00006342|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5813007|NCT00006342|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5813008|NCT00006342|recurrent childhood ependymoma|recurrent childhood ependymoma
5813009|NCT00006112|stage IV colon cancer|stage iv colon cancer
5813010|NCT00006112|stage IV rectal cancer|stage iv rectal cancer
5813011|NCT00006112|adenocarcinoma of the colon|adenocarcinoma of the colon
5813012|NCT00006112|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5813013|NCT00006112|carcinoma of the appendix|carcinoma of the appendix
5813014|NCT00006112|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5813015|NCT00006097|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5813016|NCT00006097|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5844011|NCT00051168|OAG|oag
5813017|NCT00006053|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5813018|NCT00006053|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813019|NCT00006053|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5813020|NCT00006053|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5813021|NCT00006039|small intestine lymphoma|small intestine lymphoma
5813022|NCT00006039|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5813023|NCT00006039|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5813024|NCT00006039|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5813025|NCT00006039|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5826136|NCT00065741|HIV|hiv
5826137|NCT00065741|pharmacokinetics|pharmacokinetics
5826138|NCT00065741|interaction|interaction
5826139|NCT00065741|glucuronidation|glucuronidation
5826140|NCT00065741|Healthy|healthy
5826142|NCT00065728|AMD|amd
5813026|NCT00006039|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813027|NCT00006039|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813028|NCT00006039|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5813029|NCT00006039|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5813030|NCT00006039|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5813031|NCT00006039|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5863168|NCT00001362|Magnetic Resonance Imaging|magnetic resonance imaging
5813032|NCT00006039|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5809511|NCT00005993|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5813033|NCT00006039|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5813035|NCT00006039|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813036|NCT00006039|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5813037|NCT00006039|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5813038|NCT00006039|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5813039|NCT00006039|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5813040|NCT00006039|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5813041|NCT00006039|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5813042|NCT00006039|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813043|NCT00006039|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5813044|NCT00006039|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813045|NCT00005988|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5813046|NCT00005988|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813047|NCT00005988|refractory multiple myeloma|refractory multiple myeloma
5813048|NCT00005988|stage I multiple myeloma|stage i multiple myeloma
5813049|NCT00005988|stage II multiple myeloma|stage ii multiple myeloma
5813050|NCT00005988|stage III multiple myeloma|stage iii multiple myeloma
5813051|NCT00005988|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5813052|NCT00005988|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5813053|NCT00005988|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5813054|NCT00005988|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5813055|NCT00005988|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5813056|NCT00005988|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5813057|NCT00005988|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5813058|NCT00005988|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5813059|NCT00005988|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5813060|NCT00005988|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5813061|NCT00005988|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5813062|NCT00005988|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5813063|NCT00005988|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5813064|NCT00005988|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5813065|NCT00005988|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5813066|NCT00005988|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5813067|NCT00005988|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5813068|NCT00005988|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5813069|NCT00005988|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5813070|NCT00005988|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5813071|NCT00005988|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5813072|NCT00005988|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5813073|NCT00005988|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5813074|NCT00005988|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5813075|NCT00005988|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813076|NCT00005988|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5813077|NCT00005988|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5813078|NCT00005988|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5813079|NCT00005988|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5813081|NCT00005988|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5813082|NCT00005988|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5813083|NCT00005988|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5813084|NCT00005988|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813085|NCT00005988|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5813086|NCT00005988|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5813087|NCT00005988|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813088|NCT00005988|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813089|NCT00005988|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813090|NCT00005988|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813091|NCT00005988|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813092|NCT00005988|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813093|NCT00005988|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813094|NCT00005988|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5813095|NCT00005988|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5813096|NCT00005988|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5813097|NCT00005988|graft versus host disease|graft versus host disease
5813442|NCT00003554|stage III multiple myeloma|stage iii multiple myeloma
5813098|NCT00005988|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5813099|NCT00005988|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5813100|NCT00005988|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5813101|NCT00005988|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5813102|NCT00005988|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5813103|NCT00005988|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5813104|NCT00005988|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5813105|NCT00005988|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5813106|NCT00005988|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5813107|NCT00005988|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5813108|NCT00005988|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5813109|NCT00005988|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5813110|NCT00005988|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5813111|NCT00005988|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5813112|NCT00005988|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5813113|NCT00005988|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5813114|NCT00005988|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5813115|NCT00005988|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5813116|NCT00005988|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5813117|NCT00005988|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5813118|NCT00005988|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5813119|NCT00005988|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5813120|NCT00005988|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5813121|NCT00005988|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5813122|NCT00005988|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5813123|NCT00005988|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5813124|NCT00005974|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5813125|NCT00005974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5813126|NCT00005871|recurrent pancreatic cancer|recurrent pancreatic cancer
5813127|NCT00005871|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5813128|NCT00005612|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5813129|NCT00005612|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5813130|NCT00005612|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5813131|NCT00005594|stage III pancreatic cancer|stage iii pancreatic cancer
5813132|NCT00005594|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5813133|NCT00005594|stage IV pancreatic cancer|stage iv pancreatic cancer
5813134|NCT00005081|recurrent adult brain tumor|recurrent adult brain tumor
5813136|NCT00005081|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5813138|NCT00005081|adult giant cell glioblastoma|adult giant cell glioblastoma
5813139|NCT00005081|adult gliosarcoma|adult gliosarcoma
5813140|NCT00005055|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5813141|NCT00005055|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5813142|NCT00005055|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5813143|NCT00005055|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5813144|NCT00005053|stage III pancreatic cancer|stage iii pancreatic cancer
5813145|NCT00005053|recurrent pancreatic cancer|recurrent pancreatic cancer
5813146|NCT00005053|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5813147|NCT00005053|stage IV pancreatic cancer|stage iv pancreatic cancer
5813148|NCT00005021|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5813149|NCT00005021|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5813150|NCT00005021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813151|NCT00005021|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5813152|NCT00005021|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5813153|NCT00005021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5813154|NCT00005021|small intestine lymphoma|small intestine lymphoma
5813155|NCT00005021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813156|NCT00005021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5813157|NCT00005021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5829746|NCT00059579|Anhedonia|anhedonia
5813158|NCT00005021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5813159|NCT00005021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813160|NCT00005021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5813161|NCT00005021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5813162|NCT00005021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5813163|NCT00005021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5813164|NCT00005021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5813165|NCT00005021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5813166|NCT00005021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5813167|NCT00005021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5813168|NCT00005021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5813169|NCT00005021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5813170|NCT00005021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5813171|NCT00005021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813172|NCT00005021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5813173|NCT00005021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5813174|NCT00005021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813175|NCT00005021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813176|NCT00005021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813177|NCT00005021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813178|NCT00005021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813179|NCT00005021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813180|NCT00005021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813181|NCT00005021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813182|NCT00005021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813183|NCT00005021|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5813184|NCT00005021|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5813185|NCT00005021|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5813186|NCT00005021|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5813187|NCT00005021|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5813188|NCT00005021|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5813189|NCT00005021|intraocular lymphoma|intraocular lymphoma
5813190|NCT00005021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5813191|NCT00005021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5813192|NCT00005021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5813193|NCT00005021|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5813194|NCT00005021|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5813195|NCT00005021|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5813196|NCT00005021|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5813197|NCT00005021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5813198|NCT00005021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5813199|NCT00005021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813200|NCT00005021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5813201|NCT00005021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5813202|NCT00005021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5813203|NCT00005021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5813204|NCT00005021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813206|NCT00005021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813211|NCT00004892|adult ependymoma|adult ependymoma
5813212|NCT00004892|adult glioblastoma|adult glioblastoma
5813213|NCT00004892|adult oligodendroglioma|adult oligodendroglioma
5813214|NCT00004892|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5813215|NCT00004892|adult mixed glioma|adult mixed glioma
5813216|NCT00004892|adult giant cell glioblastoma|adult giant cell glioblastoma
5813217|NCT00004892|adult gliosarcoma|adult gliosarcoma
5813218|NCT00004884|stage III pancreatic cancer|stage iii pancreatic cancer
5813219|NCT00004884|recurrent pancreatic cancer|recurrent pancreatic cancer
5813220|NCT00004884|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5813221|NCT00004884|stage IV pancreatic cancer|stage iv pancreatic cancer
5813222|NCT00004246|Radiation Therapy|radiation therapy
5813223|NCT00004246|RT|rt
5813224|NCT00004246|Radiotherapy|radiotherapy
5813225|NCT00004246|Fludarabine|fludarabine
5813226|NCT00004246|Fludara|fludara
5813227|NCT00004246|Fludarabine Phosphate|fludarabine phosphate
5813228|NCT00004246|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5813229|NCT00004246|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5813230|NCT00004246|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5813231|NCT00004246|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5813232|NCT00004246|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5813233|NCT00004246|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5813234|NCT00004246|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5813235|NCT00004246|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5813236|NCT00004246|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5813237|NCT00004246|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5813238|NCT00004230|pulmonary complications|pulmonary complications
5813239|NCT00004230|stage IV breast cancer|stage iv breast cancer
5813240|NCT00004230|stage IIIA breast cancer|stage iiia breast cancer
5813241|NCT00004230|stage IIIB breast cancer|stage iiib breast cancer
5813242|NCT00004230|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5813243|NCT00004230|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813244|NCT00004230|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5813245|NCT00004230|refractory multiple myeloma|refractory multiple myeloma
5813246|NCT00004230|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5813247|NCT00004230|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5813248|NCT00004230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5813249|NCT00004230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5813250|NCT00004230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5813251|NCT00004230|disseminated neuroblastoma|disseminated neuroblastoma
5813252|NCT00004230|recurrent neuroblastoma|recurrent neuroblastoma
5813253|NCT00004230|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5813254|NCT00004230|stage I multiple myeloma|stage i multiple myeloma
5813255|NCT00004230|stage II multiple myeloma|stage ii multiple myeloma
5813256|NCT00004230|stage III multiple myeloma|stage iii multiple myeloma
5813257|NCT00004230|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5813258|NCT00004230|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5813259|NCT00004230|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5813260|NCT00004230|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5813261|NCT00004230|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5813262|NCT00004230|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5813263|NCT00004230|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5813264|NCT00004230|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5813265|NCT00004230|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5813266|NCT00004230|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5813267|NCT00004230|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813268|NCT00004230|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5813269|NCT00004230|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5813270|NCT00004230|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5813271|NCT00004230|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5813272|NCT00004230|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5813273|NCT00004230|testicular embryonal carcinoma|testicular embryonal carcinoma
5813274|NCT00004230|testicular choriocarcinoma|testicular choriocarcinoma
5813275|NCT00004230|testicular teratoma|testicular teratoma
5813276|NCT00004230|testicular yolk sac tumor|testicular yolk sac tumor
5813277|NCT00004230|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5813278|NCT00004230|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5826466|NCT00065104|hormones|hormones
5826467|NCT00065104|body composition|body composition
5826468|NCT00065104|quality of life|quality of life
5826469|NCT00065078|Home-visits|home-visits
5813279|NCT00004230|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5813413|NCT00082147|Fiducial Marker|fiducial marker
5813280|NCT00004230|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5813281|NCT00004230|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5813282|NCT00004230|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5813283|NCT00004230|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5813284|NCT00004230|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5813285|NCT00004230|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5813286|NCT00004230|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5813287|NCT00004230|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5813288|NCT00004230|refractory hairy cell leukemia|refractory hairy cell leukemia
5813289|NCT00004230|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5813290|NCT00004230|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5813292|NCT00004230|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5813293|NCT00004230|ovarian polyembryoma|ovarian polyembryoma
5813294|NCT00004230|ovarian choriocarcinoma|ovarian choriocarcinoma
5813295|NCT00004230|ovarian immature teratoma|ovarian immature teratoma
5813296|NCT00004230|ovarian mature teratoma|ovarian mature teratoma
5813297|NCT00004230|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5813298|NCT00004230|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5813299|NCT00004230|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5813300|NCT00004230|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5813301|NCT00004230|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5813302|NCT00004230|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813303|NCT00004230|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5813304|NCT00004230|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5813305|NCT00004230|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5813306|NCT00004230|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5813307|NCT00004230|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5813308|NCT00004230|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5813309|NCT00004230|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5813310|NCT00004230|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5813311|NCT00004230|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5813312|NCT00004230|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5813313|NCT00004230|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5813314|NCT00004230|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813315|NCT00004230|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5813316|NCT00004230|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5813317|NCT00004230|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813318|NCT00004230|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813319|NCT00004230|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813320|NCT00004230|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813321|NCT00004230|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813322|NCT00004230|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813323|NCT00004230|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813324|NCT00004230|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813325|NCT00004230|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813326|NCT00004230|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5813327|NCT00004230|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5813328|NCT00004230|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5813329|NCT00004230|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5813330|NCT00004230|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5813331|NCT00004230|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5813332|NCT00004230|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5813333|NCT00004230|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5846503|NCT00044278|partial seizures|partial seizures
5813334|NCT00004230|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5813335|NCT00004230|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5813336|NCT00004230|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5813337|NCT00004230|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5813338|NCT00004230|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5813339|NCT00004230|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5813340|NCT00004230|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5813341|NCT00004230|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5813342|NCT00004230|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5813343|NCT00004230|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5813344|NCT00004230|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5813345|NCT00004230|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5813346|NCT00004230|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5813347|NCT00004230|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5813348|NCT00004230|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5813349|NCT00004230|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5813350|NCT00004230|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5813351|NCT00004230|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813352|NCT00004230|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5813353|NCT00004230|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5813354|NCT00004230|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5813355|NCT00004230|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5813356|NCT00004230|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813357|NCT00004230|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5813358|NCT00004230|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813359|NCT00004230|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5813360|NCT00004213|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813361|NCT00004101|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813362|NCT00004101|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813363|NCT00004101|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813364|NCT00004101|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813365|NCT00004101|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813366|NCT00004101|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813367|NCT00004101|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813368|NCT00004101|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813369|NCT00004101|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813370|NCT00004101|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5813371|NCT00004101|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5813372|NCT00004101|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813373|NCT00004101|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813374|NCT00004101|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5813375|NCT00004101|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813376|NCT00004049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813377|NCT00003972|stage II breast cancer|stage ii breast cancer
5813378|NCT00003972|stage IIIA breast cancer|stage iiia breast cancer
5813379|NCT00003968|stage IV renal cell cancer|stage iv renal cell cancer
5813380|NCT00003968|recurrent renal cell cancer|recurrent renal cell cancer
5813381|NCT00003943|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5813382|NCT00003943|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5813383|NCT00003900|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5813384|NCT00003900|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5813385|NCT00003849|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813386|NCT00003849|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5812880|NCT00082368|Sestamibi|sestamibi
5813387|NCT00003849|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5813388|NCT00003825|radiation enteritis|radiation enteritis
5813389|NCT00003825|diarrhea|diarrhea
5813390|NCT00003768|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813391|NCT00003726|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5813392|NCT00003726|recurrent small cell lung cancer|recurrent small cell lung cancer
5813393|NCT00003713|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813394|NCT00003680|stage III breast cancer|stage iii breast cancer
5813395|NCT00003680|inflammatory breast cancer|inflammatory breast cancer
5813396|NCT00003646|adult solid tumor|adult solid tumor
5813397|NCT00003646|body system/site cancer|body system/site cancer
5813399|NCT00003646|melanoma|melanoma
5813400|NCT00003646|recurrent melanoma|recurrent melanoma
5813401|NCT00003646|skin tumor|skin tumor
5813402|NCT00003646|solid tumor|solid tumor
5813403|NCT00003646|stage III melanoma|stage iii melanoma
5813404|NCT00003646|stage IV melanoma|stage iv melanoma
5813405|NCT00003646|stage, melanoma|stage, melanoma
5813406|NCT00003638|stage IV breast cancer|stage iv breast cancer
5813407|NCT00003638|recurrent breast cancer|recurrent breast cancer
5813408|NCT00003622|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5813409|NCT00003622|stage IV prostate cancer|stage iv prostate cancer
5813410|NCT00003622|recurrent prostate cancer|recurrent prostate cancer
5813412|NCT00082147|Biopsy|biopsy
5813414|NCT00082147|Prostate Cancer|prostate cancer
5813415|NCT00082108|Registry|registry
5813416|NCT00082108|FSHD|fshd
5813417|NCT00082108|DM|dm
5813418|NCT00082108|Muscular Dystrophy|muscular dystrophy
5813419|NCT00082108|Facioscapulohumeral Myotonic Dystrophy|facioscapulohumeral myotonic dystrophy
5813420|NCT00082108|Myotonic Dystrophy|myotonic dystrophy
5813421|NCT00082108|DM1|dm1
5813422|NCT00082108|DM2|dm2
5813423|NCT00082108|FSH|fsh
5813424|NCT00082108|MMD|mmd
5813425|NCT00082095|Metastatic breast cancer|metastatic breast cancer
5813426|NCT00082095|Breast Cancer|breast cancer
5809944|NCT00085423|recurrent melanoma|recurrent melanoma
5813427|NCT00082095|Pegylated Liposomal Doxorubicin|pegylated liposomal doxorubicin
5813429|NCT00082095|DOXIL|doxil
5813430|NCT00082095|Xeloda|xeloda
5813431|NCT00082069|Shigella|shigella
5813432|NCT00082069|diarrhea|diarrhea
5813433|NCT00081978|HIV infection|hiv infection
5813434|NCT00081978|TMC125|tmc125
5813435|NCT00081978|Non-nucleoside reverse transcriptase inhibitor, TMC125-C223|non-nucleoside reverse transcriptase inhibitor, tmc125-c223
5845298|NCT00001341|Toxicity|toxicity
5813436|NCT00003583|limited stage small cell lung cancer|limited stage small cell lung cancer
5813437|NCT00003583|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5813438|NCT00003583|radiation toxicity|radiation toxicity
5813439|NCT00003563|tumors metastatic to brain|tumors metastatic to brain
5813440|NCT00003554|stage I multiple myeloma|stage i multiple myeloma
5813443|NCT00003397|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5813444|NCT00003397|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5813445|NCT00003397|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5813446|NCT00003397|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5813447|NCT00003397|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5813448|NCT00003397|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5813449|NCT00003397|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5813450|NCT00003397|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5813451|NCT00003397|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813452|NCT00003397|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5813453|NCT00003397|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5813454|NCT00003397|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5813455|NCT00003397|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5813456|NCT00003397|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5813457|NCT00003397|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5813458|NCT00003397|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5813459|NCT00003397|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5813460|NCT00003397|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5813461|NCT00003397|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813462|NCT00003397|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5813463|NCT00003397|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5813464|NCT00003397|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813465|NCT00003397|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813466|NCT00003397|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813467|NCT00003397|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813468|NCT00003397|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813469|NCT00003397|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813470|NCT00003397|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813471|NCT00003397|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5813472|NCT00003397|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5813473|NCT00003397|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5813474|NCT00003397|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5813475|NCT00003397|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5813476|NCT00003397|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5813477|NCT00003397|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5813478|NCT00003397|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5813479|NCT00003397|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5813480|NCT00003397|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5813481|NCT00003397|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5813482|NCT00003397|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5813483|NCT00003397|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5813484|NCT00003397|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5813564|NCT00006106|oropharyngeal cancer|oropharyngeal cancer
5813485|NCT00003397|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5813486|NCT00003397|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5813487|NCT00003397|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5813488|NCT00003397|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5813489|NCT00003397|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5813490|NCT00003397|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5810011|NCT00084825|bone metastases|bone metastases
5813491|NCT00003394|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5813492|NCT00003394|stage I prostate cancer|stage i prostate cancer
5813493|NCT00003394|stage IIB prostate cancer|stage iib prostate cancer
5813494|NCT00003394|stage IIA prostate cancer|stage iia prostate cancer
5813495|NCT00003394|stage III prostate cancer|stage iii prostate cancer
5813496|NCT00003394|stage IV prostate cancer|stage iv prostate cancer
5813497|NCT00003394|recurrent prostate cancer|recurrent prostate cancer
5813498|NCT00003276|unresectable gallbladder cancer|unresectable gallbladder cancer
5813499|NCT00003276|recurrent gallbladder cancer|recurrent gallbladder cancer
5813500|NCT00003239|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813501|NCT00003239|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5813502|NCT00003239|Homoharringtonine|homoharringtonine
5813504|NCT00003239|cephalotaxus alkaloid|cephalotaxus alkaloid
5813505|NCT00003239|cytarabine|cytarabine
5813506|NCT00003239|Interferon Alpha 2-A|interferon alpha 2-a
5813510|NCT00003239|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5813511|NCT00003181|stage IV renal cell cancer|stage iv renal cell cancer
5813512|NCT00003181|recurrent renal cell cancer|recurrent renal cell cancer
5813513|NCT00003175|recurrent bladder cancer|recurrent bladder cancer
5813514|NCT00003175|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5813515|NCT00003175|recurrent urethral cancer|recurrent urethral cancer
5813516|NCT00003175|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5813517|NCT00003165|stage IV breast cancer|stage iv breast cancer
5813518|NCT00003165|recurrent breast cancer|recurrent breast cancer
5813519|NCT00003133|stage III bladder cancer|stage iii bladder cancer
5813520|NCT00003133|stage IV bladder cancer|stage iv bladder cancer
5813521|NCT00003133|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5813522|NCT00003133|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5813523|NCT00003133|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5813524|NCT00003038|stage IV colon cancer|stage iv colon cancer
5813525|NCT00003038|stage IV breast cancer|stage iv breast cancer
5813526|NCT00003038|recurrent breast cancer|recurrent breast cancer
5813527|NCT00003038|recurrent colon cancer|recurrent colon cancer
5813528|NCT00003038|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5813529|NCT00003038|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5813530|NCT00003038|stage IV prostate cancer|stage iv prostate cancer
5813531|NCT00003038|recurrent prostate cancer|recurrent prostate cancer
5813532|NCT00003038|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813533|NCT00003019|desmoid tumor|desmoid tumor
5813535|NCT00081926|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5813536|NCT00081926|RIGHT Trial|right trial
5813537|NCT00081926|US177|us177
5813538|NCT00081926|CSTI571|csti571
5813539|NCT00014365|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813540|NCT00006483|stage IV renal cell cancer|stage iv renal cell cancer
5864513|NCT00000372|Glycine|glycine
5813541|NCT00006483|recurrent renal cell cancer|recurrent renal cell cancer
5813542|NCT00006483|lung metastases|lung metastases
5813543|NCT00006261|stage IV breast cancer|stage iv breast cancer
5813544|NCT00006261|recurrent breast cancer|recurrent breast cancer
5813545|NCT00006106|adult solid tumor|adult solid tumor
5813546|NCT00006106|body system/site cancer|body system/site cancer
5813547|NCT00006106|cancer|cancer
5813548|NCT00006106|cellular diagnosis, hypopharyngeal cancer|cellular diagnosis, hypopharyngeal cancer
5813549|NCT00006106|cellular diagnosis, laryngeal cancer|cellular diagnosis, laryngeal cancer
5813550|NCT00006106|cellular diagnosis, lip and oral cavity cancer|cellular diagnosis, lip and oral cavity cancer
5813551|NCT00006106|cellular diagnosis, nasopharyngeal cancer|cellular diagnosis, nasopharyngeal cancer
5813552|NCT00006106|cellular diagnosis, oropharyngeal cancer|cellular diagnosis, oropharyngeal cancer
5864515|NCT00000372|Male|male
5813553|NCT00006106|cellular diagnosis, paranasal sinus and nasal cavity cancer|cellular diagnosis, paranasal sinus and nasal cavity cancer
5813554|NCT00006106|head and neck cancer|head and neck cancer
5813555|NCT00006106|hypopharyngeal cancer|hypopharyngeal cancer
5813556|NCT00006106|hypopharyngeal squamous cell carcinoma|hypopharyngeal squamous cell carcinoma
5813557|NCT00006106|laryngeal cancer|laryngeal cancer
5813558|NCT00006106|laryngeal squamous cell carcinoma|laryngeal squamous cell carcinoma
5813559|NCT00006106|lip and oral cavity cancer|lip and oral cavity cancer
5813560|NCT00006106|lip and oral cavity squamous cell carcinoma|lip and oral cavity squamous cell carcinoma
5813561|NCT00006106|metastatic squamous neck cancer with occult primary|metastatic squamous neck cancer with occult primary
5813562|NCT00006106|nasopharyngeal cancer|nasopharyngeal cancer
5813563|NCT00006106|nasopharyngeal squamous cell carcinoma|nasopharyngeal squamous cell carcinoma
5813565|NCT00006106|oropharyngeal squamous cell carcinoma|oropharyngeal squamous cell carcinoma
5813566|NCT00006106|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5813567|NCT00006106|paranasal sinus and nasal cavity squamous cell carcinoma|paranasal sinus and nasal cavity squamous cell carcinoma
5813568|NCT00006106|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5813569|NCT00006106|recurrent laryngeal cancer|recurrent laryngeal cancer
5813570|NCT00006106|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5813571|NCT00006106|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5813572|NCT00006106|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5813573|NCT00006106|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5813574|NCT00006106|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5813575|NCT00006106|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5862651|NCT00001550|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5813576|NCT00006106|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5813577|NCT00006106|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5813578|NCT00006106|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5813579|NCT00006106|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5813645|NCT00002719|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5813580|NCT00006106|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5813582|NCT00006106|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5813583|NCT00006106|stage III laryngeal cancer|stage iii laryngeal cancer
5813584|NCT00006106|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5813585|NCT00006106|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5813586|NCT00006106|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5813587|NCT00006106|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5813588|NCT00006106|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5813589|NCT00006106|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5813590|NCT00006106|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5813591|NCT00006106|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5813592|NCT00006106|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5813593|NCT00006106|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5813594|NCT00006106|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5813595|NCT00006106|stage IV laryngeal cancer|stage iv laryngeal cancer
5813596|NCT00006106|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5813597|NCT00006106|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5813598|NCT00006106|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5813599|NCT00006106|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5813600|NCT00006106|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5813601|NCT00006106|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5813602|NCT00006106|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5813135|NCT00005081|adult glioblastoma|adult glioblastoma
5813603|NCT00006106|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5813604|NCT00006106|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5813605|NCT00006106|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5813606|NCT00006106|stage, hypopharyngeal cancer|stage, hypopharyngeal cancer
5813607|NCT00006106|stage, laryngeal cancer|stage, laryngeal cancer
5813608|NCT00006106|stage, lip and oral cavity cancer|stage, lip and oral cavity cancer
5813609|NCT00006106|stage, metastatic squamous neck cancer with occult primary|stage, metastatic squamous neck cancer with occult primary
5813610|NCT00006106|stage, nasopharyngeal cancer|stage, nasopharyngeal cancer
5813611|NCT00006106|stage, oropharyngeal cancer|stage, oropharyngeal cancer
5813612|NCT00006106|stage, paranasal sinus and nasal cavity cancer|stage, paranasal sinus and nasal cavity cancer
5813613|NCT00003001|stage IV colon cancer|stage iv colon cancer
5813614|NCT00003001|stage IV rectal cancer|stage iv rectal cancer
5813615|NCT00003001|recurrent colon cancer|recurrent colon cancer
5813616|NCT00003001|recurrent rectal cancer|recurrent rectal cancer
5813617|NCT00002977|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5813618|NCT00002977|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5813619|NCT00002977|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5813620|NCT00002977|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5813621|NCT00002977|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5813622|NCT00002977|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5813623|NCT00002977|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5813624|NCT00002977|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5813625|NCT00002977|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5813861|NCT00081861|Rituxan|rituxan
5813627|NCT00002939|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813628|NCT00002912|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5813629|NCT00002912|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5813630|NCT00002912|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5813631|NCT00002884|stage I esophageal cancer|stage i esophageal cancer
5813632|NCT00002884|stage II esophageal cancer|stage ii esophageal cancer
5813633|NCT00002884|stage III esophageal cancer|stage iii esophageal cancer
5813634|NCT00002884|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5813635|NCT00002884|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5813636|NCT00002773|stage II pancreatic cancer|stage ii pancreatic cancer
5813637|NCT00002773|stage III pancreatic cancer|stage iii pancreatic cancer
5813638|NCT00002773|recurrent pancreatic cancer|recurrent pancreatic cancer
5813639|NCT00002773|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5813640|NCT00002773|stage IV pancreatic cancer|stage iv pancreatic cancer
5813641|NCT00002719|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5813642|NCT00002719|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5813643|NCT00002719|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5813644|NCT00002719|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5813732|NCT00005796|recurrent adult brain tumor|recurrent adult brain tumor
5813646|NCT00002719|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5813647|NCT00002719|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5813648|NCT00002719|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5813649|NCT00002719|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5813650|NCT00002719|neutropenia|neutropenia
5813651|NCT00002719|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5813652|NCT00002680|stage IV breast cancer|stage iv breast cancer
5813653|NCT00002680|recurrent breast cancer|recurrent breast cancer
5813654|NCT00002590|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5813655|NCT00002590|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5813656|NCT00002564|recurrent breast cancer|recurrent breast cancer
5813657|NCT00002481|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813658|NCT00002481|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813659|NCT00002481|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813660|NCT00002481|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813661|NCT00002481|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813662|NCT00002481|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813663|NCT00002481|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813664|NCT00002481|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813665|NCT00002481|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813666|NCT00002481|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5813667|NCT00002481|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5813668|NCT00002481|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813669|NCT00002481|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813670|NCT00002481|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5813671|NCT00002481|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813672|NCT00082043|Neurosteroids|neurosteroids
5813673|NCT00082043|5 Alpha-Reductase Inhibitor|5 alpha-reductase inhibitor
5813674|NCT00082043|Depression|depression
5813675|NCT00082043|Menstrual Cycle|menstrual cycle
5813676|NCT00082043|Gonadal Steroids|gonadal steroids
5813677|NCT00082043|Menstrual Cycle Related Mood Disorder|menstrual cycle related mood disorder
5813678|NCT00082043|MRMD|mrmd
5813679|NCT00082043|Healthy Volunteer|healthy volunteer
5813682|NCT00082030|fMRI|fmri
5813683|NCT00082030|Dopamine|dopamine
5813684|NCT00082030|Norepinephrine Depletion|norepinephrine depletion
5813685|NCT00082030|Emotional Stimuli|emotional stimuli
5813686|NCT00082030|Anhedonia|anhedonia
5813687|NCT00082030|Norepinephrine|norepinephrine
5813688|NCT00082030|Dopamine Depletion|dopamine depletion
5813689|NCT00082030|Major Depressive Disorder|major depressive disorder
5813692|NCT00082030|HV|hv
5813693|NCT00082017|Protein Kinase Inhibition|protein kinase inhibition
5813694|NCT00082017|Soluble Tac|soluble tac
5813695|NCT00082017|Gene Expression Profiling|gene expression profiling
5813696|NCT00082017|ALK Expression|alk expression
5813697|NCT00082017|Apoptosis|apoptosis
5813698|NCT00082017|Lymphoma|lymphoma
5806989|NCT00088751|FTD|ftd
5813699|NCT00082017|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5813700|NCT00082017|ALCL|alcl
5813701|NCT00082017|T-Cell Lymphoma|t-cell lymphoma
5813702|NCT00081991|Cataract|cataract
5813703|NCT00081991|Blindness|blindness
5813704|NCT00081991|Clinical|clinical
5813705|NCT00081991|Human Aging|human aging
5813706|NCT00081991|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5813707|NCT00081991|Aging-Related Lens Changes|aging-related lens changes
5813708|NCT00081991|Early Cataract|early cataract
5813709|NCT00081991|Lens|lens
5813710|NCT00081991|AREDS Grading|areds grading
5813711|NCT00081991|In Vivo|in vivo
5813712|NCT00081991|Healthy Volunteer|healthy volunteer
5813713|NCT00081965|breast cancer in situ|breast cancer in situ
5813714|NCT00081965|stage I breast cancer|stage i breast cancer
5813715|NCT00081965|stage II breast cancer|stage ii breast cancer
5813716|NCT00081965|stage IIIA breast cancer|stage iiia breast cancer
5813717|NCT00081965|stage IIIB breast cancer|stage iiib breast cancer
5813719|NCT00081965|recurrent breast cancer|recurrent breast cancer
5813720|NCT00081965|stage IIIC breast cancer|stage iiic breast cancer
5813721|NCT00081965|hot flashes|hot flashes
5813722|NCT00081952|Postmenopause|postmenopause
5813723|NCT00081913|Apheresis|apheresis
5813724|NCT00081913|Cell Transfer|cell transfer
5813725|NCT00081913|Chest Pain|chest pain
5813726|NCT00081913|Adult Stem Cell Therapy|adult stem cell therapy
5813727|NCT00081900|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5813728|NCT00005969|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813729|NCT00005969|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5813730|NCT00005883|non-small cell lung cancer|non-small cell lung cancer
5813731|NCT00005883|small cell lung cancer|small cell lung cancer
5816154|NCT00080782|Celebrex|celebrex
5813733|NCT00005796|adult brain stem glioma|adult brain stem glioma
5813734|NCT00005796|adult ependymoma|adult ependymoma
5813735|NCT00005796|adult medulloblastoma|adult medulloblastoma
5813736|NCT00005796|adult glioblastoma|adult glioblastoma
5813737|NCT00005796|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5813738|NCT00005796|childhood oligodendroglioma|childhood oligodendroglioma
5813739|NCT00005796|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5813740|NCT00005796|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5813741|NCT00005796|adult mixed glioma|adult mixed glioma
5813742|NCT00005796|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5813743|NCT00005796|bone marrow suppression|bone marrow suppression
5813744|NCT00005796|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5813745|NCT00005796|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5813746|NCT00005796|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5813747|NCT00005796|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5813748|NCT00005796|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5813749|NCT00005796|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5813750|NCT00005796|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5813751|NCT00005796|recurrent childhood ependymoma|recurrent childhood ependymoma
5813752|NCT00005796|adult giant cell glioblastoma|adult giant cell glioblastoma
5813753|NCT00005796|adult gliosarcoma|adult gliosarcoma
5813754|NCT00005649|stage IV breast cancer|stage iv breast cancer
5813755|NCT00005649|recurrent breast cancer|recurrent breast cancer
5813756|NCT00004933|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5813757|NCT00004933|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813758|NCT00004933|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5813759|NCT00004923|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813760|NCT00004903|refractory multiple myeloma|refractory multiple myeloma
5813761|NCT00004903|stage I multiple myeloma|stage i multiple myeloma
5813762|NCT00004903|stage II multiple myeloma|stage ii multiple myeloma
5813763|NCT00004903|stage III multiple myeloma|stage iii multiple myeloma
5813764|NCT00004878|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813765|NCT00004878|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5813766|NCT00004878|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5813767|NCT00004878|graft versus host disease|graft versus host disease
5813768|NCT00004872|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5813769|NCT00004858|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5813770|NCT00004858|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5813771|NCT00004858|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5813772|NCT00004858|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813773|NCT00004858|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813774|NCT00004858|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813775|NCT00004858|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813776|NCT00004858|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813777|NCT00004858|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813778|NCT00004858|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813779|NCT00004858|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813780|NCT00004858|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813781|NCT00004858|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5813782|NCT00004858|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5813783|NCT00004858|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813784|NCT00004604|stage IV colon cancer|stage iv colon cancer
5813785|NCT00004604|stage IV breast cancer|stage iv breast cancer
5813786|NCT00004604|recurrent breast cancer|recurrent breast cancer
5813787|NCT00004604|stage IV gastric cancer|stage iv gastric cancer
5813788|NCT00004604|recurrent gastric cancer|recurrent gastric cancer
5813789|NCT00004604|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5813790|NCT00004604|recurrent pancreatic cancer|recurrent pancreatic cancer
5813791|NCT00004604|stage IV rectal cancer|stage iv rectal cancer
5813792|NCT00004604|recurrent colon cancer|recurrent colon cancer
5813793|NCT00004604|recurrent rectal cancer|recurrent rectal cancer
5813794|NCT00004604|inflammatory breast cancer|inflammatory breast cancer
5813795|NCT00004604|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5813796|NCT00004604|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5813797|NCT00004604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5813798|NCT00004604|recurrent small cell lung cancer|recurrent small cell lung cancer
5813799|NCT00004604|unresectable gallbladder cancer|unresectable gallbladder cancer
5813800|NCT00004604|recurrent gallbladder cancer|recurrent gallbladder cancer
5813801|NCT00004604|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5813802|NCT00004604|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5813803|NCT00004604|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5813804|NCT00004604|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5813805|NCT00004604|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5813806|NCT00004604|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5813807|NCT00004604|stage IV salivary gland cancer|stage iv salivary gland cancer
5813808|NCT00004604|recurrent salivary gland cancer|recurrent salivary gland cancer
5813809|NCT00004604|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5813810|NCT00004604|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5813811|NCT00004604|testicular yolk sac tumor|testicular yolk sac tumor
5813812|NCT00004604|lung metastases|lung metastases
5813813|NCT00004604|liver metastases|liver metastases
5813814|NCT00004604|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5813815|NCT00004604|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5813816|NCT00004604|male breast cancer|male breast cancer
5813817|NCT00004604|stage IV pancreatic cancer|stage iv pancreatic cancer
5813818|NCT00004249|limited stage small cell lung cancer|limited stage small cell lung cancer
5813819|NCT00004174|stage IV breast cancer|stage iv breast cancer
5813820|NCT00004174|stage IIIA breast cancer|stage iiia breast cancer
5813821|NCT00004174|recurrent breast cancer|recurrent breast cancer
5813822|NCT00004174|stage IIIB breast cancer|stage iiib breast cancer
5813823|NCT00003960|refractory multiple myeloma|refractory multiple myeloma
5813824|NCT00003960|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813825|NCT00003960|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5813826|NCT00003960|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5813827|NCT00003960|refractory anemia with excess blasts|refractory anemia with excess blasts
5813828|NCT00003960|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5813829|NCT00003960|acute undifferentiated leukemia|acute undifferentiated leukemia
5813830|NCT00003960|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5813831|NCT00003960|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5813832|NCT00003960|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5813833|NCT00003960|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5813834|NCT00003953|stage II breast cancer|stage ii breast cancer
5813835|NCT00003953|stage IIIA breast cancer|stage iiia breast cancer
5813836|NCT00003953|stage IIIB breast cancer|stage iiib breast cancer
5813837|NCT00081887|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5813839|NCT00081887|Leukemia|leukemia
5813840|NCT00081887|Clofarabine|clofarabine
5813841|NCT00081887|Clofarex|clofarex
5813842|NCT00081887|Clolar|clolar
5813843|NCT00081874|Leukemia|leukemia
5813844|NCT00081874|Mantle cell lymphoma|mantle cell lymphoma
5813845|NCT00081874|Myelofibrosis|myelofibrosis
5813846|NCT00081874|Relapsed or Refractory Acute Myeloid Leukemia|relapsed or refractory acute myeloid leukemia
5813847|NCT00081874|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5813848|NCT00081874|Chronic Myeloid Leukemia in Blastic-Phase|chronic myeloid leukemia in blastic-phase
5813849|NCT00081874|Agnogenic Myeloid Metaplasia|agnogenic myeloid metaplasia
5813850|NCT00081874|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5813851|NCT00081874|T-Cell Leukemia|t-cell leukemia
5813853|NCT00081874|Everolimus|everolimus
5813854|NCT00081874|Afinitor|afinitor
5813855|NCT00081861|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5813856|NCT00081861|B-Cell Lymphoma|b-cell lymphoma
5813857|NCT00081861|Lymphoma|lymphoma
5813858|NCT00081861|Avastin|avastin
5813859|NCT00081861|Bevacizumab|bevacizumab
5813860|NCT00081861|Rituximab|rituximab
5813862|NCT00003950|stage IV colon cancer|stage iv colon cancer
5813863|NCT00003950|stage IV rectal cancer|stage iv rectal cancer
5813864|NCT00003950|recurrent colon cancer|recurrent colon cancer
5813865|NCT00003950|recurrent rectal cancer|recurrent rectal cancer
5813866|NCT00003950|adenocarcinoma of the colon|adenocarcinoma of the colon
5813867|NCT00003950|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5813868|NCT00003914|stage IV renal cell cancer|stage iv renal cell cancer
5813869|NCT00003914|recurrent renal cell cancer|recurrent renal cell cancer
5813870|NCT00003887|stage IV breast cancer|stage iv breast cancer
5813871|NCT00003887|stage IIIA breast cancer|stage iiia breast cancer
5813872|NCT00003887|stage IIIB breast cancer|stage iiib breast cancer
5813873|NCT00003887|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5813874|NCT00003887|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5813875|NCT00003887|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5813876|NCT00003887|refractory multiple myeloma|refractory multiple myeloma
5813877|NCT00003887|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5813878|NCT00003887|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5813879|NCT00003887|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5813880|NCT00003887|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5813881|NCT00003887|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816155|NCT00080782|Doxorubicin|doxorubicin
5813882|NCT00003887|disseminated neuroblastoma|disseminated neuroblastoma
5813883|NCT00003887|recurrent neuroblastoma|recurrent neuroblastoma
5813884|NCT00003887|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5813885|NCT00003887|stage I multiple myeloma|stage i multiple myeloma
5813886|NCT00003887|stage II multiple myeloma|stage ii multiple myeloma
5813887|NCT00003887|stage III multiple myeloma|stage iii multiple myeloma
5813888|NCT00003887|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5813889|NCT00003887|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5813890|NCT00003887|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5813891|NCT00003887|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5813892|NCT00003887|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5813893|NCT00003887|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5813894|NCT00003887|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5813895|NCT00003887|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5813896|NCT00003887|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5813897|NCT00003887|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5813898|NCT00003887|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5813899|NCT00003887|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5813900|NCT00003887|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5813901|NCT00003887|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5813902|NCT00003887|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5813903|NCT00003887|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5813904|NCT00003887|testicular embryonal carcinoma|testicular embryonal carcinoma
5813905|NCT00003887|testicular choriocarcinoma|testicular choriocarcinoma
5813906|NCT00003887|testicular teratoma|testicular teratoma
5813907|NCT00003887|testicular yolk sac tumor|testicular yolk sac tumor
5813908|NCT00003887|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5813909|NCT00003887|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5813910|NCT00003887|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5813911|NCT00003887|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5813912|NCT00003887|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5813913|NCT00003887|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5813914|NCT00003887|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5813915|NCT00003887|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5813916|NCT00003887|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5813917|NCT00003887|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5813918|NCT00003887|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5813919|NCT00003887|refractory hairy cell leukemia|refractory hairy cell leukemia
5813920|NCT00003887|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5813921|NCT00003887|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5813922|NCT00003887|ovarian yolk sac tumor|ovarian yolk sac tumor
5813923|NCT00003887|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5813924|NCT00003887|ovarian polyembryoma|ovarian polyembryoma
5813926|NCT00003887|ovarian immature teratoma|ovarian immature teratoma
5813927|NCT00003887|ovarian mature teratoma|ovarian mature teratoma
5813928|NCT00003887|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5813929|NCT00003887|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5844013|NCT00051155|Glaucoma|glaucoma
5813930|NCT00003887|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5813931|NCT00003887|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5813932|NCT00003887|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5813933|NCT00003887|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5813934|NCT00003887|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5813936|NCT00003887|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5813937|NCT00003887|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5813938|NCT00003887|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5813939|NCT00003887|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5813940|NCT00003887|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5813941|NCT00003887|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5813942|NCT00003887|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5813943|NCT00003887|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5813944|NCT00003887|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5813945|NCT00003887|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5813946|NCT00003887|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5813947|NCT00003887|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5813948|NCT00003887|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5813949|NCT00003887|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5813950|NCT00003887|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5813951|NCT00003887|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5813952|NCT00003887|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5813953|NCT00003887|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5813954|NCT00003887|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5813955|NCT00003887|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5813956|NCT00003887|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5813957|NCT00003887|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5813958|NCT00003887|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5813959|NCT00003887|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5813960|NCT00003887|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5813961|NCT00003887|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5813962|NCT00003887|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5813963|NCT00003887|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5813964|NCT00003887|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5813965|NCT00003887|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5813966|NCT00003887|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5813967|NCT00003887|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5813968|NCT00003887|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5813969|NCT00003887|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5686668|NCT00551122|testicular seminoma|testicular seminoma
5813970|NCT00003887|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5813971|NCT00003887|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5813972|NCT00003887|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5813973|NCT00003887|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5813974|NCT00003887|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5813975|NCT00003887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5813976|NCT00003887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5813977|NCT00003887|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5846504|NCT00044265|ACE inhibitor|ace inhibitor
5813978|NCT00003887|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5813979|NCT00003887|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5813980|NCT00003887|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5813981|NCT00003887|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5813982|NCT00003887|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5813983|NCT00003887|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5813984|NCT00003887|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5813985|NCT00003887|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5813986|NCT00003887|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5813988|NCT00003887|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5813989|NCT00003887|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814322|NCT00005842|stage IV rectal cancer|stage iv rectal cancer
5813990|NCT00003887|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5813991|NCT00003887|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5813992|NCT00003819|stage I prostate cancer|stage i prostate cancer
5813993|NCT00003819|stage IIB prostate cancer|stage iib prostate cancer
5813994|NCT00003819|stage IIA prostate cancer|stage iia prostate cancer
5813995|NCT00003819|stage III prostate cancer|stage iii prostate cancer
5813996|NCT00003819|recurrent prostate cancer|recurrent prostate cancer
5813997|NCT00003783|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5813998|NCT00003783|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5813999|NCT00003783|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5814000|NCT00003783|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5814001|NCT00003765|childhood craniopharyngioma|childhood craniopharyngioma
5814002|NCT00003765|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5814003|NCT00003765|childhood oligodendroglioma|childhood oligodendroglioma
5814004|NCT00003765|childhood choroid plexus tumor|childhood choroid plexus tumor
5814005|NCT00003765|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5814006|NCT00003765|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5814007|NCT00003765|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5814008|NCT00003765|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5814009|NCT00003765|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5814010|NCT00003765|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5814011|NCT00003765|recurrent childhood ependymoma|recurrent childhood ependymoma
5814012|NCT00003619|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814013|NCT00003619|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814014|NCT00003619|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814015|NCT00003619|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814016|NCT00003619|polycythemia vera|polycythemia vera
5814017|NCT00003619|primary myelofibrosis|primary myelofibrosis
5814018|NCT00003619|refractory anemia|refractory anemia
5814019|NCT00003619|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5814020|NCT00003619|refractory anemia with excess blasts|refractory anemia with excess blasts
5814021|NCT00003619|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5814022|NCT00003619|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5814023|NCT00003619|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5814024|NCT00003619|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814025|NCT00003619|thrombocytopenia|thrombocytopenia
5814026|NCT00003544|stage IV colon cancer|stage iv colon cancer
5814027|NCT00003544|stage IV rectal cancer|stage iv rectal cancer
5814028|NCT00003544|recurrent colon cancer|recurrent colon cancer
5814029|NCT00003544|recurrent rectal cancer|recurrent rectal cancer
5814030|NCT00003434|stage I pancreatic cancer|stage i pancreatic cancer
5814031|NCT00003434|stage II pancreatic cancer|stage ii pancreatic cancer
5814032|NCT00003434|stage III pancreatic cancer|stage iii pancreatic cancer
5814033|NCT00003434|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5814034|NCT00003427|stage IV colon cancer|stage iv colon cancer
5814035|NCT00003427|stage IV gastric cancer|stage iv gastric cancer
5814036|NCT00003427|recurrent gastric cancer|recurrent gastric cancer
5814037|NCT00003427|recurrent pancreatic cancer|recurrent pancreatic cancer
5814038|NCT00003427|stage IV rectal cancer|stage iv rectal cancer
5814039|NCT00003427|recurrent colon cancer|recurrent colon cancer
5814040|NCT00003427|recurrent rectal cancer|recurrent rectal cancer
5814041|NCT00003427|stage IV anal cancer|stage iv anal cancer
5814042|NCT00003427|recurrent anal cancer|recurrent anal cancer
5814043|NCT00003427|stage IV esophageal cancer|stage iv esophageal cancer
5814044|NCT00003427|recurrent esophageal cancer|recurrent esophageal cancer
5814045|NCT00003427|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5814046|NCT00003427|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5814047|NCT00003427|advanced adult primary liver cancer|advanced adult primary liver cancer
5814048|NCT00003427|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5814049|NCT00003427|unresectable gallbladder cancer|unresectable gallbladder cancer
5814050|NCT00003427|recurrent gallbladder cancer|recurrent gallbladder cancer
5814051|NCT00003427|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5814052|NCT00003427|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5814053|NCT00003427|recurrent small intestine cancer|recurrent small intestine cancer
5814054|NCT00003427|stage IV pancreatic cancer|stage iv pancreatic cancer
5814055|NCT00003407|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814056|NCT00003407|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814057|NCT00003407|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5814058|NCT00003407|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5814059|NCT00003407|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5814060|NCT00003407|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5814061|NCT00003407|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814062|NCT00003407|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5814063|NCT00003407|neutropenia|neutropenia
5814064|NCT00003398|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5814065|NCT00003398|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5814066|NCT00003398|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814067|NCT00003398|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814068|NCT00003398|Burkitt lymphoma|burkitt lymphoma
5814069|NCT00003398|refractory multiple myeloma|refractory multiple myeloma
5814070|NCT00003398|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5814071|NCT00003398|stage I multiple myeloma|stage i multiple myeloma
5814072|NCT00003398|stage II multiple myeloma|stage ii multiple myeloma
5814073|NCT00003398|stage III multiple myeloma|stage iii multiple myeloma
5862652|NCT00001550|Stiff-man Syndrome|stiff-man syndrome
5814074|NCT00003398|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5814075|NCT00003398|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5814076|NCT00003398|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5814077|NCT00003398|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5814078|NCT00003398|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814079|NCT00003398|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5814080|NCT00003398|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5814081|NCT00003398|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5814082|NCT00003398|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5814083|NCT00003398|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814084|NCT00003398|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814085|NCT00003398|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814086|NCT00003398|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5814087|NCT00003398|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5814088|NCT00003398|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5814089|NCT00003398|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5814090|NCT00003398|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5814091|NCT00003398|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814092|NCT00003398|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5814093|NCT00003398|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5814094|NCT00003398|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5814095|NCT00003398|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5814096|NCT00003398|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5814097|NCT00003398|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5814098|NCT00003398|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5814099|NCT00003398|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5814100|NCT00003398|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5814101|NCT00003398|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5814102|NCT00003398|adult acute basophilic leukemia|adult acute basophilic leukemia
5813581|NCT00006106|solid tumor|solid tumor
5814103|NCT00003398|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5814104|NCT00003398|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5814105|NCT00003398|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5814106|NCT00003398|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5814107|NCT00003398|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5814108|NCT00003398|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5814109|NCT00003398|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5814110|NCT00003398|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5814111|NCT00003398|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5814112|NCT00003398|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5814113|NCT00003398|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5814114|NCT00003398|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5814115|NCT00003398|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5814116|NCT00003398|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5814117|NCT00003398|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5814118|NCT00003398|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5814119|NCT00003398|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5814120|NCT00003398|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5814121|NCT00003398|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5814122|NCT00003398|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5814123|NCT00003398|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5814124|NCT00003398|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5814246|NCT00003270|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814125|NCT00003398|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5814126|NCT00003398|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5814127|NCT00003398|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5814128|NCT00003398|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5814129|NCT00003398|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5814130|NCT00003398|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5814131|NCT00003398|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5814132|NCT00003398|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5814133|NCT00003398|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5862653|NCT00001549|Movement Disorders|movement disorders
5814134|NCT00003398|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5814135|NCT00003398|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5814136|NCT00003398|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5814137|NCT00003398|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5814138|NCT00003398|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5814139|NCT00003398|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5814140|NCT00003398|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814141|NCT00003398|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5814142|NCT00003398|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814143|NCT00003398|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814144|NCT00003398|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814145|NCT00003398|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5814146|NCT00003398|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5814147|NCT00003398|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5814148|NCT00003398|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814150|NCT00003398|graft versus host disease|graft versus host disease
5814151|NCT00003398|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5814152|NCT00003398|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5814153|NCT00003398|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5814154|NCT00003398|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5814155|NCT00003398|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5814156|NCT00003398|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5814157|NCT00003398|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5814158|NCT00003398|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5814159|NCT00003398|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5814160|NCT00003398|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5814161|NCT00003398|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5814162|NCT00003398|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5814163|NCT00003398|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5814164|NCT00003398|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5814165|NCT00003398|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5814166|NCT00003398|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5814167|NCT00003398|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5814168|NCT00003398|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5814169|NCT00003398|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5814170|NCT00003398|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5814171|NCT00003398|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5814172|NCT00003398|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5814173|NCT00003398|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5814174|NCT00003398|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5814175|NCT00003398|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5815060|NCT00005608|recurrent breast cancer|recurrent breast cancer
5814176|NCT00003398|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5814177|NCT00003398|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5814178|NCT00003398|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5814179|NCT00003398|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5814180|NCT00003398|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5814181|NCT00003398|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5814182|NCT00003398|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5814321|NCT00005842|stage III rectal cancer|stage iii rectal cancer
5814183|NCT00003398|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5814184|NCT00003398|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5814185|NCT00003398|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5814186|NCT00003398|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814187|NCT00003398|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5814188|NCT00003398|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5814189|NCT00003398|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5814190|NCT00003398|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814191|NCT00003398|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5814192|NCT00003398|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5814193|NCT00003398|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5814194|NCT00003398|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5814195|NCT00003398|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5814196|NCT00003398|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5814197|NCT00003398|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5814198|NCT00003398|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5814199|NCT00003398|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5814200|NCT00003398|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814201|NCT00003398|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5814202|NCT00003398|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5814347|NCT00005842|stage IVB vaginal cancer|stage ivb vaginal cancer
5814203|NCT00003270|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814204|NCT00003270|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814206|NCT00003270|refractory multiple myeloma|refractory multiple myeloma
5814207|NCT00003270|stage I multiple myeloma|stage i multiple myeloma
5814208|NCT00003270|stage II multiple myeloma|stage ii multiple myeloma
5814209|NCT00003270|stage III multiple myeloma|stage iii multiple myeloma
5814210|NCT00003270|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814211|NCT00003270|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814212|NCT00003270|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814213|NCT00003270|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814214|NCT00003270|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814215|NCT00003270|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5814216|NCT00003270|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5814217|NCT00003270|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5814218|NCT00003270|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5814219|NCT00003270|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814220|NCT00003270|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5814221|NCT00003270|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5814222|NCT00003270|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5814223|NCT00003270|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5814224|NCT00003270|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5814225|NCT00003270|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5814226|NCT00003270|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814227|NCT00003270|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814228|NCT00003270|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5814229|NCT00003270|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814230|NCT00003270|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5814231|NCT00003270|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814232|NCT00003270|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814233|NCT00003270|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814234|NCT00003270|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5814235|NCT00003270|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5814236|NCT00003270|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5814237|NCT00003270|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5814238|NCT00003270|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814239|NCT00003270|graft versus host disease|graft versus host disease
5814240|NCT00003270|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5814241|NCT00003270|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5814242|NCT00003270|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814243|NCT00003270|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5814244|NCT00003270|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814245|NCT00003270|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5814247|NCT00003270|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5814249|NCT00003144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814250|NCT00003144|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5814251|NCT00003094|cervical cancer|cervical cancer
5814252|NCT00003081|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5814253|NCT00003081|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5814254|NCT00003081|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5814255|NCT00003081|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5814256|NCT00002964|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5814257|NCT00002964|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5814258|NCT00002964|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5814259|NCT00002964|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5814260|NCT00002964|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5814261|NCT00002964|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5814262|NCT00002964|stage I laryngeal cancer|stage i laryngeal cancer
5814263|NCT00002964|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5814264|NCT00002866|stage IV breast cancer|stage iv breast cancer
5814265|NCT00002866|recurrent breast cancer|recurrent breast cancer
5814266|NCT00002866|neutropenia|neutropenia
5814267|NCT00006475|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814268|NCT00006475|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814348|NCT00005842|recurrent vaginal cancer|recurrent vaginal cancer
5814269|NCT00006475|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5814270|NCT00006475|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5814271|NCT00006463|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5814272|NCT00006357|adult angiosarcoma|adult angiosarcoma
5814273|NCT00006357|adult fibrosarcoma|adult fibrosarcoma
5814274|NCT00006357|adult leiomyosarcoma|adult leiomyosarcoma
5814275|NCT00006357|adult liposarcoma|adult liposarcoma
5814276|NCT00006357|adult neurofibrosarcoma|adult neurofibrosarcoma
5814277|NCT00006357|adult synovial sarcoma|adult synovial sarcoma
5814278|NCT00006357|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5814279|NCT00006357|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5814280|NCT00006357|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5814281|NCT00006357|adult epithelioid sarcoma|adult epithelioid sarcoma
5814282|NCT00006357|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5814283|NCT00006357|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5814284|NCT00006357|adult malignant mesenchymoma|adult malignant mesenchymoma
5814285|NCT00006357|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5814286|NCT00006357|ovarian stromal cancer|ovarian stromal cancer
5814287|NCT00006357|recurrent uterine sarcoma|recurrent uterine sarcoma
5814288|NCT00006357|uterine carcinosarcoma|uterine carcinosarcoma
5814289|NCT00006357|uterine leiomyosarcoma|uterine leiomyosarcoma
5814290|NCT00006357|endometrial stromal sarcoma|endometrial stromal sarcoma
5814291|NCT00006357|ovarian sarcoma|ovarian sarcoma
5814292|NCT00006357|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5814293|NCT00006216|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5814294|NCT00006216|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5814295|NCT00006216|stage II malignant mesothelioma|stage ii malignant mesothelioma
5814296|NCT00006216|stage III malignant mesothelioma|stage iii malignant mesothelioma
5814297|NCT00006049|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5814298|NCT00006049|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5814299|NCT00006049|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5814300|NCT00006048|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5814301|NCT00006048|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5814302|NCT00006048|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5814303|NCT00005870|recurrent pancreatic cancer|recurrent pancreatic cancer
5814304|NCT00005870|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5814305|NCT00005849|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5814306|NCT00005849|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5814307|NCT00005849|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5814308|NCT00005842|stage III colon cancer|stage iii colon cancer
5814310|NCT00005842|stage IV breast cancer|stage iv breast cancer
5814311|NCT00005842|stage IIIA breast cancer|stage iiia breast cancer
5814312|NCT00005842|recurrent breast cancer|recurrent breast cancer
5814313|NCT00005842|stage III gastric cancer|stage iii gastric cancer
5814314|NCT00005842|stage IV gastric cancer|stage iv gastric cancer
5814315|NCT00005842|recurrent gastric cancer|recurrent gastric cancer
5814316|NCT00005842|occult non-small cell lung cancer|occult non-small cell lung cancer
5814317|NCT00005842|stage IIIB breast cancer|stage iiib breast cancer
5814318|NCT00005842|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5814319|NCT00005842|stage III pancreatic cancer|stage iii pancreatic cancer
5814320|NCT00005842|recurrent pancreatic cancer|recurrent pancreatic cancer
5814324|NCT00005842|recurrent rectal cancer|recurrent rectal cancer
5814325|NCT00005842|stage IV anal cancer|stage iv anal cancer
5814326|NCT00005842|recurrent anal cancer|recurrent anal cancer
5814327|NCT00005842|stage III esophageal cancer|stage iii esophageal cancer
5814328|NCT00005842|stage IV esophageal cancer|stage iv esophageal cancer
5814329|NCT00005842|stage IIIA anal cancer|stage iiia anal cancer
5814330|NCT00005842|stage IIIB anal cancer|stage iiib anal cancer
5814331|NCT00005842|recurrent esophageal cancer|recurrent esophageal cancer
5814332|NCT00005842|stage III cervical cancer|stage iii cervical cancer
5814333|NCT00005842|recurrent cervical cancer|recurrent cervical cancer
5814334|NCT00005842|stage IVB cervical cancer|stage ivb cervical cancer
5814335|NCT00005842|stage IVA cervical cancer|stage iva cervical cancer
5814336|NCT00005842|inflammatory breast cancer|inflammatory breast cancer
5814337|NCT00005842|stage III renal cell cancer|stage iii renal cell cancer
5814338|NCT00005842|stage IV renal cell cancer|stage iv renal cell cancer
5814339|NCT00005842|recurrent renal cell cancer|recurrent renal cell cancer
5814340|NCT00005842|metastatic parathyroid cancer|metastatic parathyroid cancer
5814341|NCT00005842|recurrent parathyroid cancer|recurrent parathyroid cancer
5814342|NCT00005842|stage III vulvar cancer|stage iii vulvar cancer
5814343|NCT00005842|stage IVB vulvar cancer|stage ivb vulvar cancer
5814344|NCT00005842|recurrent vulvar cancer|recurrent vulvar cancer
5814345|NCT00005842|stage III vaginal cancer|stage iii vaginal cancer
5814346|NCT00005842|stage IVA vaginal cancer|stage iva vaginal cancer
5814349|NCT00005842|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5814350|NCT00005842|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5814351|NCT00005842|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5814352|NCT00005842|advanced adult primary liver cancer|advanced adult primary liver cancer
5814353|NCT00005842|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5814354|NCT00005842|gastrinoma|gastrinoma
5814355|NCT00005842|stage III endometrial carcinoma|stage iii endometrial carcinoma
5814356|NCT00005842|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5814357|NCT00005842|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5814358|NCT00005842|small intestine adenocarcinoma|small intestine adenocarcinoma
5814359|NCT00005842|unresectable gallbladder cancer|unresectable gallbladder cancer
5814360|NCT00005842|recurrent gallbladder cancer|recurrent gallbladder cancer
5814361|NCT00005842|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5814362|NCT00005842|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5814363|NCT00005842|recurrent small intestine cancer|recurrent small intestine cancer
5814364|NCT00005842|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5814365|NCT00005842|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5814366|NCT00005842|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5814367|NCT00005842|stage III bladder cancer|stage iii bladder cancer
5814368|NCT00005842|recurrent bladder cancer|recurrent bladder cancer
5814369|NCT00005842|stage IV bladder cancer|stage iv bladder cancer
5814370|NCT00005842|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5814371|NCT00005842|stage III prostate cancer|stage iii prostate cancer
5814372|NCT00005842|stage IV prostate cancer|stage iv prostate cancer
5814373|NCT00005842|recurrent prostate cancer|recurrent prostate cancer
5814374|NCT00005842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5814375|NCT00005842|insulinoma|insulinoma
5814376|NCT00005842|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5814377|NCT00005842|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5814378|NCT00005842|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5814379|NCT00005842|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5814380|NCT00005842|anaplastic thyroid cancer|anaplastic thyroid cancer
5814381|NCT00005842|recurrent thyroid cancer|recurrent thyroid cancer
5814382|NCT00005842|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5814383|NCT00005842|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5814384|NCT00005842|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5814385|NCT00005842|stage III salivary gland cancer|stage iii salivary gland cancer
5814386|NCT00005842|stage IV salivary gland cancer|stage iv salivary gland cancer
5814387|NCT00005842|recurrent salivary gland cancer|recurrent salivary gland cancer
5814388|NCT00005842|WDHA syndrome|wdha syndrome
5814389|NCT00005842|somatostatinoma|somatostatinoma
5814390|NCT00005842|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5814392|NCT00005842|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5814393|NCT00005842|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5814394|NCT00005842|recurrent urethral cancer|recurrent urethral cancer
5814395|NCT00005842|distal urethral cancer|distal urethral cancer
5814396|NCT00005842|proximal urethral cancer|proximal urethral cancer
5814397|NCT00005842|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5814398|NCT00005842|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5814399|NCT00005842|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5810959|NCT00006083|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5814400|NCT00005842|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5814401|NCT00005842|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5814402|NCT00005842|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5814403|NCT00005842|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5814404|NCT00005842|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5862654|NCT00001549|Parkinson's|parkinson's
5814405|NCT00005842|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5814406|NCT00005842|tumors metastatic to brain|tumors metastatic to brain
5814408|NCT00005842|liver metastases|liver metastases
5814409|NCT00005842|bone metastases|bone metastases
5814410|NCT00005842|skin metastases|skin metastases
5814411|NCT00005842|leptomeningeal metastases|leptomeningeal metastases
5814412|NCT00005842|malignant pericardial effusion|malignant pericardial effusion
5814413|NCT00005842|malignant pleural effusion|malignant pleural effusion
5814414|NCT00005842|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5814415|NCT00005842|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5814416|NCT00005842|carcinoma of the appendix|carcinoma of the appendix
5814417|NCT00005842|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5814418|NCT00005842|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5814419|NCT00005842|male breast cancer|male breast cancer
5814420|NCT00005842|stage IV pancreatic cancer|stage iv pancreatic cancer
5814421|NCT00005832|stage II pancreatic cancer|stage ii pancreatic cancer
5814422|NCT00005832|stage III pancreatic cancer|stage iii pancreatic cancer
5814423|NCT00005832|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5814424|NCT00005832|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5814425|NCT00005832|stage IV pancreatic cancer|stage iv pancreatic cancer
5814426|NCT00002794|intraocular retinoblastoma|intraocular retinoblastoma
5814427|NCT00002553|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5814428|NCT00002553|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814429|NCT00002553|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814430|NCT00002553|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5814431|NCT00002553|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5814432|NCT00002553|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814433|NCT00002553|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814434|NCT00002553|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814435|NCT00002553|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814436|NCT00002553|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814437|NCT00002553|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5814438|NCT00002553|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5814439|NCT00002553|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814440|NCT00002553|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5814441|NCT00002553|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5816156|NCT00080782|Rubex|rubex
5814442|NCT00002553|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5814443|NCT00002553|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5814444|NCT00002553|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5814445|NCT00002553|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5814446|NCT00002553|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5814447|NCT00002553|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5814448|NCT00002553|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5814449|NCT00002553|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5814450|NCT00002553|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5814451|NCT00002553|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814452|NCT00002553|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814453|NCT00002553|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5814454|NCT00002553|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814455|NCT00002553|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5814456|NCT00002553|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814457|NCT00002553|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814458|NCT00002553|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814459|NCT00002553|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5814460|NCT00002553|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5814461|NCT00002553|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5814462|NCT00002553|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5814463|NCT00002553|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5814465|NCT00002553|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5814466|NCT00002553|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814467|NCT00002553|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5814468|NCT00002553|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814470|NCT00002485|localized osteosarcoma|localized osteosarcoma
5814471|NCT00002485|metastatic osteosarcoma|metastatic osteosarcoma
5814472|NCT00002485|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814473|NCT00002485|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5814474|NCT00002485|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5814475|NCT00002485|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5814476|NCT00002485|childhood craniopharyngioma|childhood craniopharyngioma
5814477|NCT00002485|localized resectable neuroblastoma|localized resectable neuroblastoma
5814478|NCT00002485|regional neuroblastoma|regional neuroblastoma
5814479|NCT00002485|disseminated neuroblastoma|disseminated neuroblastoma
5814480|NCT00002485|stage 4S neuroblastoma|stage 4s neuroblastoma
5814481|NCT00002485|recurrent neuroblastoma|recurrent neuroblastoma
5814482|NCT00002485|stage I childhood liver cancer|stage i childhood liver cancer
5814483|NCT00002485|stage II childhood liver cancer|stage ii childhood liver cancer
5814484|NCT00002485|stage III childhood liver cancer|stage iii childhood liver cancer
5814485|NCT00002485|stage IV childhood liver cancer|stage iv childhood liver cancer
5814486|NCT00002485|recurrent childhood liver cancer|recurrent childhood liver cancer
5814487|NCT00002485|childhood hepatoblastoma|childhood hepatoblastoma
5814488|NCT00002485|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5814489|NCT00002485|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5814490|NCT00002485|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5814491|NCT00002485|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5814492|NCT00002485|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814493|NCT00002485|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5814494|NCT00002485|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814495|NCT00002485|recurrent osteosarcoma|recurrent osteosarcoma
5814496|NCT00002485|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5814497|NCT00002485|childhood germ cell tumor|childhood germ cell tumor
5814498|NCT00002485|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5814499|NCT00002485|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5814500|NCT00002485|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5814501|NCT00002485|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5814502|NCT00002485|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5814503|NCT00002485|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5814504|NCT00002485|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5814505|NCT00002485|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5814506|NCT00002485|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5814507|NCT00002485|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5814508|NCT00002485|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5814509|NCT00002485|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5814510|NCT00002485|extragonadal germ cell tumor|extragonadal germ cell tumor
5814511|NCT00002485|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5814512|NCT00002485|childhood oligodendroglioma|childhood oligodendroglioma
5814513|NCT00002485|childhood choroid plexus tumor|childhood choroid plexus tumor
5814514|NCT00002485|childhood meningioma|childhood meningioma
5814515|NCT00002485|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5814516|NCT00002485|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5814517|NCT00002485|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5814518|NCT00002485|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5814519|NCT00002485|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5814520|NCT00002485|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5814521|NCT00002485|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5814522|NCT00002485|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5814523|NCT00002485|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5814524|NCT00002485|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5814525|NCT00002485|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5814526|NCT00002485|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5814527|NCT00002485|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5814528|NCT00002485|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5811091|NCT00005578|cardiac toxicity|cardiac toxicity
5814529|NCT00002485|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5814530|NCT00002485|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5814531|NCT00002485|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5814532|NCT00002485|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5814533|NCT00002485|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5814535|NCT00002485|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5814536|NCT00002485|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5814537|NCT00002485|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5814538|NCT00002485|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5814539|NCT00002485|recurrent childhood ependymoma|recurrent childhood ependymoma
5814540|NCT00002485|childhood teratoma|childhood teratoma
5814541|NCT00002485|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5814542|NCT00002485|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5814543|NCT00002485|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5814544|NCT00002485|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5814545|NCT00002485|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5814546|NCT00002466|localized osteosarcoma|localized osteosarcoma
5814547|NCT00002466|metastatic osteosarcoma|metastatic osteosarcoma
5814548|NCT00002466|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5814549|NCT00002466|stage III Wilms tumor|stage iii wilms tumor
5814550|NCT00002466|stage IV Wilms tumor|stage iv wilms tumor
5814551|NCT00002466|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5814552|NCT00002466|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5814553|NCT00002466|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5814554|NCT00002466|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5814555|NCT00002466|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5814556|NCT00002466|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5814557|NCT00002466|Askin tumor|askin tumor
5814558|NCT00002466|peripheral primitive neuroectodermal tumor|peripheral primitive neuroectodermal tumor
5814559|NCT00002456|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814560|NCT00002456|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5814561|NCT00002456|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814562|NCT00002456|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814563|NCT00002456|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814564|NCT00002456|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814565|NCT00002456|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814566|NCT00002456|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5814567|NCT00002456|recurrent adult non-Hodgkin lymphoma|recurrent adult non-hodgkin lymphoma
5814568|NCT00002456|graft versus host disease|graft versus host disease
5814570|NCT00081822|clofarabine|clofarabine
5814571|NCT00081822|cytosine arabinoside|cytosine arabinoside
5814572|NCT00081822|acute myeloid leukemia|acute myeloid leukemia
5814573|NCT00081809|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5814574|NCT00081809|Brill-Symmers Disease|brill-symmers disease
5814575|NCT00081809|Follicular Lymphoma|follicular lymphoma
5814576|NCT00081809|Lymphoma, Giant Follicular|lymphoma, giant follicular
5814577|NCT00081809|Lymphoma, Nodular|lymphoma, nodular
5814578|NCT00081809|Follicular Lymphoma, Giant|follicular lymphoma, giant
5814579|NCT00081809|Giant Follicular Lymphoma|giant follicular lymphoma
5814580|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well-Differentiated|lymphocytic lymphoma, diffuse, well-differentiated
5814581|NCT00081809|Lymphocytic Lymphoma, Well-Differentiated|lymphocytic lymphoma, well-differentiated
5814582|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well-Differentiated|lymphoma, lymphocytic, diffuse, well-differentiated
5814583|NCT00081809|Lymphoma, Lymphocytic, Well-Differentiated|lymphoma, lymphocytic, well-differentiated
5814584|NCT00081809|Lymphoma, Lymphoplasmacytoid, CLL|lymphoma, lymphoplasmacytoid, cll
5814585|NCT00081809|Lymphoma, Small Lymphocytic, Plasmacytoid|lymphoma, small lymphocytic, plasmacytoid
5814586|NCT00081809|Lymphoplasmacytoid Lymphoma, CLL|lymphoplasmacytoid lymphoma, cll
5814587|NCT00081809|Diffuse Well-Differentiated Lymphocytic Lymphoma|diffuse well-differentiated lymphocytic lymphoma
5814588|NCT00081809|Lymphocytic Lymphoma, Diffuse, Well Differentiated|lymphocytic lymphoma, diffuse, well differentiated
5814590|NCT00081809|Lymphoma, Lymphocytic, Diffuse, Well Differentiated|lymphoma, lymphocytic, diffuse, well differentiated
5814591|NCT00081809|Lymphoma, Lymphocytic, Well Differentiated|lymphoma, lymphocytic, well differentiated
5814592|NCT00081809|Lymphoma, Mucosa-Associated Lymphoid Tissue|lymphoma, mucosa-associated lymphoid tissue
5814593|NCT00081809|MALT Lymphoma|malt lymphoma
5814594|NCT00081809|Lymphoma of Mucosa-Associated Lymphoid Tissue|lymphoma of mucosa-associated lymphoid tissue
5814595|NCT00081809|Mucosa-Associated Lymphoid Tissue Lymphoma|mucosa-associated lymphoid tissue lymphoma
5814596|NCT00081809|Monocytoid B-cell lymphoma|monocytoid b-cell lymphoma
5814597|NCT00081809|Waldenstrom's macroglobulinemia|waldenstrom's macroglobulinemia
5814598|NCT00081809|Marginal zone lymphoma|marginal zone lymphoma
5814599|NCT00005092|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5814600|NCT00005092|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5814601|NCT00005092|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814602|NCT00005092|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814603|NCT00005092|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5814604|NCT00005092|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5814605|NCT00005092|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5814606|NCT00005092|refractory multiple myeloma|refractory multiple myeloma
5814607|NCT00005092|stage III multiple myeloma|stage iii multiple myeloma
5814608|NCT00005092|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5814609|NCT00005092|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5814610|NCT00005092|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5814611|NCT00005092|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5814612|NCT00005092|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5814613|NCT00005092|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814614|NCT00005092|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814615|NCT00005092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814616|NCT00005092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814617|NCT00005092|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5814618|NCT00005092|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5814619|NCT00005092|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5814620|NCT00005092|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5814621|NCT00005092|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5814622|NCT00005092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814623|NCT00005092|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5814624|NCT00005092|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5814625|NCT00005092|childhood acute monoblastic leukemia and acute monocytic leukemia (M5)|childhood acute monoblastic leukemia and acute monocytic leukemia (m5)
5814626|NCT00005092|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5814627|NCT00005092|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5814628|NCT00005092|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5814629|NCT00005092|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5814630|NCT00005092|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5814631|NCT00005092|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5814632|NCT00005092|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5814633|NCT00005092|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5681333|NCT00573781|Metabolomics|metabolomics
5814634|NCT00005092|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5814635|NCT00005092|non-T, non-B childhood acute lymphoblastic leukemia|non-t, non-b childhood acute lymphoblastic leukemia
5814636|NCT00005092|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5814637|NCT00005092|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5814638|NCT00005092|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5814639|NCT00005092|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5814640|NCT00005092|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5814641|NCT00005092|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5814642|NCT00005092|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5814643|NCT00005092|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5814644|NCT00005092|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5814645|NCT00005092|non-T, non-B, cALLa positive adult acute lymphoblastic leukemia|non-t, non-b, calla positive adult acute lymphoblastic leukemia
5814646|NCT00005092|non-T, non-B, cALLa positive, pre-B adult acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b adult acute lymphoblastic leukemia
5814647|NCT00005092|non-T, non-B, cALLa negative adult acute lymphoblastic leukemia|non-t, non-b, calla negative adult acute lymphoblastic leukemia
5814648|NCT00005092|TdT positive adult acute lymphoblastic leukemia|tdt positive adult acute lymphoblastic leukemia
5814649|NCT00005092|TdT negative adult acute lymphoblastic leukemia|tdt negative adult acute lymphoblastic leukemia
5814650|NCT00005092|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
5814651|NCT00005092|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5814652|NCT00005092|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5814653|NCT00005092|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5814654|NCT00005092|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5814655|NCT00005092|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5814797|NCT00081835|Immune Response, Vaccine|immune response, vaccine
5814656|NCT00005092|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5814657|NCT00005092|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5814658|NCT00005092|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5814659|NCT00005092|adult acute basophilic leukemia|adult acute basophilic leukemia
5814660|NCT00005092|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5814661|NCT00005092|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5814662|NCT00005092|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5814663|NCT00005092|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5814664|NCT00005092|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5814665|NCT00005092|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5814666|NCT00005092|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5814667|NCT00005092|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5814668|NCT00005092|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5814669|NCT00005092|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5814670|NCT00005092|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5814671|NCT00005092|untreated hairy cell leukemia|untreated hairy cell leukemia
5814672|NCT00005092|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5814673|NCT00005092|acute undifferentiated leukemia|acute undifferentiated leukemia
5814674|NCT00005092|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5814675|NCT00005092|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5814676|NCT00005092|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5814677|NCT00005092|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5814678|NCT00005092|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5814679|NCT00005092|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5814680|NCT00005092|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5814681|NCT00005092|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5814682|NCT00005092|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5814683|NCT00005092|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5814684|NCT00005092|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5814685|NCT00005092|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5814686|NCT00005092|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5814687|NCT00005092|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5814688|NCT00005092|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5814689|NCT00005092|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814690|NCT00005092|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5821473|NCT00075842|fatigue|fatigue
5844015|NCT00051155|OAG|oag
5814691|NCT00005092|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814692|NCT00005092|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5814693|NCT00005092|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814694|NCT00005092|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814695|NCT00005092|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814696|NCT00005092|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5814697|NCT00005092|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5814698|NCT00005092|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5814699|NCT00005092|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5814700|NCT00005092|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5846505|NCT00044265|high blood pressure|high blood pressure
5814701|NCT00005092|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5814702|NCT00005092|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5814703|NCT00005092|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814704|NCT00005092|prolymphocytic leukemia|prolymphocytic leukemia
5814705|NCT00005092|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5814706|NCT00005092|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5814707|NCT00005092|intraocular lymphoma|intraocular lymphoma
5814708|NCT00005092|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5814709|NCT00005092|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5814710|NCT00005092|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5814711|NCT00005092|childhood large cell lymphoma|childhood large cell lymphoma
5814712|NCT00005092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5814713|NCT00005092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5814714|NCT00005092|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814715|NCT00005092|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5814716|NCT00005092|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5814717|NCT00005092|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5814718|NCT00005092|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5814719|NCT00005092|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5814720|NCT00005092|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5814721|NCT00005082|adult medulloblastoma|adult medulloblastoma
5814722|NCT00005082|adult glioblastoma|adult glioblastoma
5814723|NCT00005082|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5814724|NCT00005082|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5814725|NCT00005082|adult anaplastic ependymoma|adult anaplastic ependymoma
5814726|NCT00005082|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5814727|NCT00005082|adult mixed glioma|adult mixed glioma
5814728|NCT00005082|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5814729|NCT00005082|adult subependymoma|adult subependymoma
5814730|NCT00005082|adult ependymoblastoma|adult ependymoblastoma
5814731|NCT00005082|adult oligodendroglioma|adult oligodendroglioma
5814732|NCT00005082|adult giant cell glioblastoma|adult giant cell glioblastoma
5814733|NCT00005082|adult gliosarcoma|adult gliosarcoma
5814734|NCT00005023|stage IV breast cancer|stage iv breast cancer
5814735|NCT00005023|stage IIIA breast cancer|stage iiia breast cancer
5814736|NCT00005023|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5814737|NCT00005023|stage IIIB breast cancer|stage iiib breast cancer
5814738|NCT00005023|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5814739|NCT00005023|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5814740|NCT00005023|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5814741|NCT00005023|adenocarcinoma of the lung|adenocarcinoma of the lung
5814742|NCT00004870|stage IV colon cancer|stage iv colon cancer
5814743|NCT00004870|stage IV rectal cancer|stage iv rectal cancer
5814744|NCT00004870|recurrent colon cancer|recurrent colon cancer
5814745|NCT00004870|recurrent rectal cancer|recurrent rectal cancer
5814746|NCT00004870|adenocarcinoma of the colon|adenocarcinoma of the colon
5814747|NCT00004870|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5814748|NCT00004254|localized malignant mesothelioma|localized malignant mesothelioma
5814749|NCT00004254|advanced malignant mesothelioma|advanced malignant mesothelioma
5814750|NCT00004254|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5814751|NCT00004013|stage IV breast cancer|stage iv breast cancer
5814752|NCT00004013|recurrent breast cancer|recurrent breast cancer
5816747|NCT00006368|recurrent melanoma|recurrent melanoma
5814753|NCT00003899|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814754|NCT00003880|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5814755|NCT00003880|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5814756|NCT00003880|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5814757|NCT00003880|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5814758|NCT00003880|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5821570|NCT00075335|Mozobil|mozobil
5814759|NCT00003880|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5814760|NCT00003880|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5814761|NCT00003790|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814762|NCT00003790|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5814763|NCT00003790|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5814764|NCT00003790|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5814765|NCT00003790|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5814766|NCT00003735|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814767|NCT00003735|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814768|NCT00003735|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814769|NCT00003715|stage III melanoma|stage iii melanoma
5814770|NCT00003701|stage III bladder cancer|stage iii bladder cancer
5814771|NCT00003701|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5814772|NCT00003701|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5814773|NCT00003621|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5814774|NCT00003445|stage III cervical cancer|stage iii cervical cancer
5814775|NCT00003445|stage IIB cervical cancer|stage iib cervical cancer
5814776|NCT00003445|stage IVA cervical cancer|stage iva cervical cancer
5814777|NCT00003445|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5814778|NCT00003386|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5814779|NCT00003386|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5814780|NCT00003148|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814781|NCT00003146|stage I multiple myeloma|stage i multiple myeloma
5814782|NCT00003146|stage II multiple myeloma|stage ii multiple myeloma
5814783|NCT00003146|stage III multiple myeloma|stage iii multiple myeloma
5814784|NCT00003076|esophageal cancer|esophageal cancer
5814785|NCT00003041|recurrent breast cancer|recurrent breast cancer
5814786|NCT00081848|Colon Cancer|colon cancer
5814787|NCT00081848|Gastrointestinal Cancer|gastrointestinal cancer
5814788|NCT00081848|Cytokines|cytokines
5814789|NCT00081848|Immunotherapy|immunotherapy
5814790|NCT00081848|Cancer|cancer
5814791|NCT00081848|Solid Tumor|solid tumor
5814795|NCT00081835|Corneal Ulcer|corneal ulcer
5814796|NCT00081835|Keratitis|keratitis
5814800|NCT00081835|Vaccinia Immune Globulin (VIG)|vaccinia immune globulin (vig)
5814801|NCT00081835|Conjunctivitis|conjunctivitis
5814802|NCT00081835|Vaccinia Vaccination|vaccinia vaccination
5814803|NCT00081835|Smallpox Vaccination|smallpox vaccination
5814804|NCT00081796|Metastatic Breast Cancer|metastatic breast cancer
5814805|NCT00081783|T Cells|t cells
5814806|NCT00081783|Immunotherapy|immunotherapy
5814808|NCT00081783|Xcellerated T Cells|xcellerated t cells
5814809|NCT00081757|Advanced|advanced
5814810|NCT00081757|Refractory|refractory
5814811|NCT00081757|Plasmacytoma|plasmacytoma
5814812|NCT00081757|Myeloma Proteins|myeloma proteins
5814813|NCT00021346|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814814|NCT00019357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814815|NCT00003018|stage II pancreatic cancer|stage ii pancreatic cancer
5814816|NCT00003018|stage III pancreatic cancer|stage iii pancreatic cancer
5814817|NCT00003018|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5814818|NCT00003017|stage IV cervical cancer|stage iv cervical cancer
5814819|NCT00003017|recurrent cervical cancer|recurrent cervical cancer
5814820|NCT00003017|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5814821|NCT00003017|cervical adenocarcinoma|cervical adenocarcinoma
5814822|NCT00003017|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5814823|NCT00002952|stage IV melanoma|stage iv melanoma
5814824|NCT00002952|recurrent melanoma|recurrent melanoma
5814825|NCT00002889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5814826|NCT00002889|stage I prostate cancer|stage i prostate cancer
5814827|NCT00002889|stage II prostate cancer|stage ii prostate cancer
5814828|NCT00002889|stage III prostate cancer|stage iii prostate cancer
5814829|NCT00002889|stage IV prostate cancer|stage iv prostate cancer
5814830|NCT00002818|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814831|NCT00002818|refractory multiple myeloma|refractory multiple myeloma
5814832|NCT00002818|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814833|NCT00002818|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814834|NCT00002818|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5814835|NCT00002818|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814836|NCT00002818|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814837|NCT00002818|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814838|NCT00002818|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5814839|NCT00002818|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814840|NCT00002818|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5821661|NCT00075205|Craving|craving
5814841|NCT00002818|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814842|NCT00002818|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814843|NCT00002818|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814844|NCT00002818|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5814845|NCT00002818|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5814846|NCT00002818|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814847|NCT00002818|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5814848|NCT00002818|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814849|NCT00002818|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5814850|NCT00002818|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814851|NCT00002818|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5814852|NCT00002800|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5814853|NCT00002800|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814854|NCT00002800|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5814855|NCT00002800|refractory anemia with excess blasts|refractory anemia with excess blasts
5814856|NCT00002800|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5814857|NCT00002800|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5814858|NCT00002800|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5814859|NCT00002800|neutropenia|neutropenia
5814860|NCT00002772|stage II breast cancer|stage ii breast cancer
5814861|NCT00002772|stage IIIA breast cancer|stage iiia breast cancer
5814862|NCT00002768|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5814863|NCT00002768|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5814864|NCT00002768|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5814865|NCT00002768|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5814866|NCT00002768|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5814867|NCT00002768|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5814868|NCT00002768|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5814869|NCT00002768|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5814870|NCT00002768|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5862656|NCT00001549|Screening|screening
5822329|NCT00073814|levalbuterol|levalbuterol
5814871|NCT00002768|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5814872|NCT00002764|adult angiosarcoma|adult angiosarcoma
5814873|NCT00002764|adult fibrosarcoma|adult fibrosarcoma
5814874|NCT00002764|adult leiomyosarcoma|adult leiomyosarcoma
5814875|NCT00002764|adult liposarcoma|adult liposarcoma
5814876|NCT00002764|adult neurofibrosarcoma|adult neurofibrosarcoma
5814877|NCT00002764|adult synovial sarcoma|adult synovial sarcoma
5814878|NCT00002764|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5814879|NCT00002764|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5814880|NCT00002764|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5814881|NCT00002764|adult malignant mesenchymoma|adult malignant mesenchymoma
5814882|NCT00002764|localized benign pheochromocytoma|localized benign pheochromocytoma
5814883|NCT00002764|regional pheochromocytoma|regional pheochromocytoma
5814884|NCT00002764|lung metastases|lung metastases
5814885|NCT00002764|stage IV uterine sarcoma|stage iv uterine sarcoma
5814886|NCT00002764|recurrent uterine sarcoma|recurrent uterine sarcoma
5814887|NCT00002764|uterine leiomyosarcoma|uterine leiomyosarcoma
5814888|NCT00002764|endometrial stromal sarcoma|endometrial stromal sarcoma
5814889|NCT00002764|ovarian sarcoma|ovarian sarcoma
5814890|NCT00002764|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5814891|NCT00002764|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5814892|NCT00002745|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5814893|NCT00002745|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814894|NCT00002745|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814895|NCT00002745|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814896|NCT00002722|stage III gastric cancer|stage iii gastric cancer
5814897|NCT00002722|stage IV gastric cancer|stage iv gastric cancer
5814898|NCT00002595|desmoid tumor|desmoid tumor
5814899|NCT00002583|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5814900|NCT00002583|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5814901|NCT00002534|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5814902|NCT00002534|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5814903|NCT00002534|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5814904|NCT00002534|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5814905|NCT00002534|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5814906|NCT00002534|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5822677|NCT00073242|leptin|leptin
5814907|NCT00002534|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5814908|NCT00002534|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5814909|NCT00002534|acute undifferentiated leukemia|acute undifferentiated leukemia
5814910|NCT00002519|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5814911|NCT00002519|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5814912|NCT00002501|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5814913|NCT00002501|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5814914|NCT00002501|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814915|NCT00002501|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814916|NCT00002492|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5814917|NCT00002492|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5814918|NCT00002492|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5814919|NCT00002463|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5814920|NCT00002463|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5814921|NCT00002463|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5814922|NCT00002463|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5814923|NCT00002463|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5814924|NCT00002463|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5814925|NCT00002463|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5814926|NCT00002463|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5814927|NCT00002463|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5814928|NCT00002463|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5814929|NCT00081744|Bacterial Infections|bacterial infections
5814930|NCT00019344|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5814931|NCT00019344|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5814932|NCT00019344|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5814933|NCT00019344|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5863901|NCT00001162|Helminth|helminth
5814936|NCT00019344|recurrent prostate cancer|recurrent prostate cancer
5814937|NCT00019344|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814938|NCT00019344|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5814939|NCT00019344|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5815379|NCT00003718|recurrent uterine sarcoma|recurrent uterine sarcoma
5814940|NCT00019344|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5814941|NCT00019344|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5814942|NCT00019344|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5814943|NCT00019344|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5814944|NCT00019344|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5814945|NCT00019344|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5814946|NCT00019344|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5814947|NCT00019344|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5814948|NCT00019344|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5814949|NCT00019344|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5814950|NCT00019344|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814951|NCT00019344|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5814952|NCT00019344|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5814953|NCT00019344|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5814954|NCT00019344|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5814955|NCT00019344|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5814956|NCT00019344|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5814957|NCT00019344|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5814958|NCT00019344|intraocular lymphoma|intraocular lymphoma
5814959|NCT00019344|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5814960|NCT00019344|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814961|NCT00019344|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5814962|NCT00019344|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5814963|NCT00019344|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5814964|NCT00019344|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5814965|NCT00019344|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5814966|NCT00019344|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5814967|NCT00019344|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5814968|NCT00019344|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5814969|NCT00019344|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5814970|NCT00019344|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5814971|NCT00019344|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5814972|NCT00019240|classic Kaposi sarcoma|classic kaposi sarcoma
5814973|NCT00019240|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5814974|NCT00019240|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5814975|NCT00016900|stage III esophageal cancer|stage iii esophageal cancer
5814976|NCT00016900|stage IV esophageal cancer|stage iv esophageal cancer
5814977|NCT00016900|recurrent esophageal cancer|recurrent esophageal cancer
5814978|NCT00016900|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5814979|NCT00016900|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5814980|NCT00010010|stage IV breast cancer|stage iv breast cancer
5814981|NCT00010010|recurrent breast cancer|recurrent breast cancer
5814982|NCT00009828|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5814983|NCT00081614|Metastatic renal cell carcinoma|metastatic renal cell carcinoma
5814984|NCT00081549|Pancreatic Cancer|pancreatic cancer
5814985|NCT00081549|Neoplasms Pancreatic|neoplasms pancreatic
5814986|NCT00081549|Pancreas Cancer|pancreas cancer
5814987|NCT00081549|Pancreas Neoplasms|pancreas neoplasms
5814988|NCT00081549|Pancreatic Tumor|pancreatic tumor
5814989|NCT00081549|Pancreas Tumor|pancreas tumor
5814990|NCT00081549|Unresectable|unresectable
5814992|NCT00081549|Refractory|refractory
5814993|NCT00081536|Colorectal Neoplasms|colorectal neoplasms
5814994|NCT00081536|Colorectal Cancer|colorectal cancer
5814995|NCT00081536|Colorectal Carcinoma|colorectal carcinoma
5814996|NCT00081536|Colorectal Tumor|colorectal tumor
5814997|NCT00081536|Neoplasms, Colorectal|neoplasms, colorectal
5814998|NCT00081536|Unresectable|unresectable
5815000|NCT00081536|Refractory|refractory
5815001|NCT00012129|stage IV breast cancer|stage iv breast cancer
5815002|NCT00012129|stage IIIA breast cancer|stage iiia breast cancer
5815003|NCT00012129|recurrent breast cancer|recurrent breast cancer
5815004|NCT00012129|stage IIIB breast cancer|stage iiib breast cancer
5815005|NCT00012129|male breast cancer|male breast cancer
5815006|NCT00009815|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815008|NCT00005989|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815009|NCT00005958|stage III bladder cancer|stage iii bladder cancer
5815010|NCT00005958|recurrent bladder cancer|recurrent bladder cancer
5815012|NCT00005958|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5815013|NCT00005958|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5815014|NCT00005958|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5815015|NCT00005958|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5815016|NCT00005938|localized gallbladder cancer|localized gallbladder cancer
5815017|NCT00005938|unresectable gallbladder cancer|unresectable gallbladder cancer
5815018|NCT00005938|recurrent gallbladder cancer|recurrent gallbladder cancer
5815019|NCT00005938|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5815020|NCT00005938|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5815021|NCT00005938|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5815022|NCT00005938|liver and intrahepatic biliary tract cancer|liver and intrahepatic biliary tract cancer
5815023|NCT00005938|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5815024|NCT00005938|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5815025|NCT00005938|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5815026|NCT00005828|stage IV prostate cancer|stage iv prostate cancer
5815027|NCT00005828|recurrent prostate cancer|recurrent prostate cancer
5815028|NCT00005827|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815029|NCT00005827|stage II prostate cancer|stage ii prostate cancer
5815030|NCT00005827|stage III prostate cancer|stage iii prostate cancer
5815031|NCT00005827|stage IV prostate cancer|stage iv prostate cancer
5815032|NCT00005827|recurrent prostate cancer|recurrent prostate cancer
5816877|NCT00080431|Latency|latency
5815033|NCT00081640|HIV Seronegativity|hiv seronegativity
5815034|NCT00081640|Vaginal Microbicide|vaginal microbicide
5815035|NCT00081601|prostate cancer|prostate cancer
5815036|NCT00081601|prostate specific antigen|prostate specific antigen
5815037|NCT00081601|PSA|psa
5815038|NCT00081588|TMC114-C215|tmc114-c215
5815039|NCT00081588|Ritonavir|ritonavir
5815040|NCT00081588|HIV infections|hiv infections
5815041|NCT00081588|TMC114-C202|tmc114-c202
5815042|NCT00081588|TMC114-C213|tmc114-c213
5815043|NCT00081575|Bacterial Pneumonia|bacterial pneumonia
5815044|NCT00081380|Bipolar I Disorder|bipolar i disorder
5815045|NCT00081380|Manic Depressive Disorder|manic depressive disorder
5815046|NCT00081380|Manic Depression, Mixed|manic depression, mixed
5815047|NCT00005810|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815048|NCT00005810|stage IV prostate cancer|stage iv prostate cancer
5815049|NCT00005810|recurrent prostate cancer|recurrent prostate cancer
5815050|NCT00005809|colon cancer|colon cancer
5815051|NCT00005809|rectal cancer|rectal cancer
5815052|NCT00005643|stage IV uterine sarcoma|stage iv uterine sarcoma
5815053|NCT00005643|recurrent uterine sarcoma|recurrent uterine sarcoma
5815054|NCT00005643|uterine carcinosarcoma|uterine carcinosarcoma
5815055|NCT00005643|uterine leiomyosarcoma|uterine leiomyosarcoma
5815056|NCT00005643|endometrial stromal sarcoma|endometrial stromal sarcoma
5815057|NCT00005625|metastatic osteosarcoma|metastatic osteosarcoma
5815058|NCT00005625|recurrent osteosarcoma|recurrent osteosarcoma
5815059|NCT00005608|stage IV breast cancer|stage iv breast cancer
5815061|NCT00005071|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5815062|NCT00005071|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5815063|NCT00005071|limited stage small cell lung cancer|limited stage small cell lung cancer
5815064|NCT00004252|stage IV colon cancer|stage iv colon cancer
5815065|NCT00004252|stage IV rectal cancer|stage iv rectal cancer
5815066|NCT00004252|recurrent colon cancer|recurrent colon cancer
5815067|NCT00004252|recurrent rectal cancer|recurrent rectal cancer
5815068|NCT00004252|adenocarcinoma of the colon|adenocarcinoma of the colon
5846506|NCT00044265|pediatric|pediatric
5815069|NCT00004229|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815070|NCT00004178|stage III colon cancer|stage iii colon cancer
5815071|NCT00004178|stage IV colon cancer|stage iv colon cancer
5815072|NCT00004178|stage III gastric cancer|stage iii gastric cancer
5815073|NCT00004178|stage IV gastric cancer|stage iv gastric cancer
5815074|NCT00004178|recurrent gastric cancer|recurrent gastric cancer
5815075|NCT00004178|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815076|NCT00004178|stage II pancreatic cancer|stage ii pancreatic cancer
5815077|NCT00004178|stage III pancreatic cancer|stage iii pancreatic cancer
5815078|NCT00004178|recurrent pancreatic cancer|recurrent pancreatic cancer
5815079|NCT00004178|stage III rectal cancer|stage iii rectal cancer
5815080|NCT00004178|stage IV rectal cancer|stage iv rectal cancer
5815081|NCT00004178|recurrent colon cancer|recurrent colon cancer
5815082|NCT00004178|recurrent rectal cancer|recurrent rectal cancer
5815083|NCT00004178|stage II esophageal cancer|stage ii esophageal cancer
5815085|NCT00004178|stage IV esophageal cancer|stage iv esophageal cancer
5815086|NCT00004178|recurrent esophageal cancer|recurrent esophageal cancer
5815087|NCT00004178|stage III cervical cancer|stage iii cervical cancer
5815088|NCT00004178|recurrent cervical cancer|recurrent cervical cancer
5815089|NCT00004178|stage IVB cervical cancer|stage ivb cervical cancer
5815090|NCT00004178|stage IVA cervical cancer|stage iva cervical cancer
5815091|NCT00004178|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815092|NCT00004178|stage III renal cell cancer|stage iii renal cell cancer
5815093|NCT00004178|stage IV renal cell cancer|stage iv renal cell cancer
5815094|NCT00004178|recurrent renal cell cancer|recurrent renal cell cancer
5815095|NCT00004178|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815096|NCT00004178|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815097|NCT00004178|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815098|NCT00004178|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5815099|NCT00004178|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5815100|NCT00004178|recurrent small cell lung cancer|recurrent small cell lung cancer
5815101|NCT00004178|stage III vaginal cancer|stage iii vaginal cancer
5815102|NCT00004178|stage IVA vaginal cancer|stage iva vaginal cancer
5815103|NCT00004178|stage IVB vaginal cancer|stage ivb vaginal cancer
5815104|NCT00004178|recurrent vaginal cancer|recurrent vaginal cancer
5815105|NCT00004178|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5815106|NCT00004178|advanced adult primary liver cancer|advanced adult primary liver cancer
5815107|NCT00004178|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5815108|NCT00004178|stage III endometrial carcinoma|stage iii endometrial carcinoma
5815109|NCT00004178|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5815110|NCT00004178|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5815111|NCT00004178|small intestine adenocarcinoma|small intestine adenocarcinoma
5815112|NCT00004178|unresectable gallbladder cancer|unresectable gallbladder cancer
5815113|NCT00004178|recurrent gallbladder cancer|recurrent gallbladder cancer
5815114|NCT00004178|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5815115|NCT00004178|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5815116|NCT00004178|recurrent small intestine cancer|recurrent small intestine cancer
5815117|NCT00004178|stage III bladder cancer|stage iii bladder cancer
5815118|NCT00004178|recurrent bladder cancer|recurrent bladder cancer
5815119|NCT00004178|stage IV bladder cancer|stage iv bladder cancer
5815120|NCT00004178|stage III prostate cancer|stage iii prostate cancer
5815121|NCT00004178|stage IV prostate cancer|stage iv prostate cancer
5815122|NCT00004178|recurrent prostate cancer|recurrent prostate cancer
5815123|NCT00004178|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815124|NCT00004178|stage III salivary gland cancer|stage iii salivary gland cancer
5815125|NCT00004178|stage IV salivary gland cancer|stage iv salivary gland cancer
5815126|NCT00004178|recurrent salivary gland cancer|recurrent salivary gland cancer
5815127|NCT00004178|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5815128|NCT00004178|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5815129|NCT00004178|adenocarcinoma of the lung|adenocarcinoma of the lung
5815130|NCT00004178|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5815131|NCT00004178|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5822025|NCT00074438|RA|ra
5815132|NCT00004178|adenocarcinoma of the colon|adenocarcinoma of the colon
5815133|NCT00004178|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5815134|NCT00004178|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5815135|NCT00004178|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5815136|NCT00004178|signet ring adenocarcinoma of the colon|signet ring adenocarcinoma of the colon
5815137|NCT00004178|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815138|NCT00004178|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5815139|NCT00004178|mucinous adenocarcinoma of the rectum|mucinous adenocarcinoma of the rectum
5815140|NCT00004178|signet ring adenocarcinoma of the rectum|signet ring adenocarcinoma of the rectum
5815141|NCT00004178|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5815142|NCT00004178|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5815143|NCT00004178|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5815144|NCT00004178|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5815145|NCT00004178|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5815146|NCT00004178|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5815147|NCT00004178|vaginal adenocarcinoma|vaginal adenocarcinoma
5815148|NCT00004178|vaginal clear cell adenocarcinoma|vaginal clear cell adenocarcinoma
5815149|NCT00004178|endometrial adenocarcinoma|endometrial adenocarcinoma
5815150|NCT00004178|cervical adenocarcinoma|cervical adenocarcinoma
5815151|NCT00004178|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5815152|NCT00004178|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5815153|NCT00004178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5815154|NCT00004178|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5815155|NCT00004178|stage IV pancreatic cancer|stage iv pancreatic cancer
5815158|NCT00081497|r-haGAL|r-hagal
5815159|NCT00081497|Fabry|fabry
5815160|NCT00081497|GL-3|gl-3
5815161|NCT00081497|Fabrazyme|fabrazyme
5815162|NCT00004177|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815163|NCT00004108|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5822681|NCT00073229|Acute Infection|acute infection
5815164|NCT00004108|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5818127|NCT00079651|Nursing Homes|nursing homes
5815165|NCT00004108|advanced adult primary liver cancer|advanced adult primary liver cancer
5815166|NCT00004108|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5815167|NCT00004108|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5815168|NCT00004107|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5815169|NCT00004107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815170|NCT00004107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815171|NCT00004107|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5815172|NCT00004107|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5815173|NCT00004107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815174|NCT00004107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815175|NCT00004107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815176|NCT00004107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815177|NCT00004107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815178|NCT00004107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815179|NCT00004107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815180|NCT00004107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815181|NCT00004107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815182|NCT00004107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815183|NCT00004107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5815184|NCT00004107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815185|NCT00004107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815195|NCT00004087|recurrent rectal cancer|recurrent rectal cancer
5815207|NCT00004086|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5815208|NCT00004086|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815209|NCT00004086|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5815210|NCT00004086|refractory hairy cell leukemia|refractory hairy cell leukemia
5815211|NCT00004086|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815212|NCT00004086|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815213|NCT00004086|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815214|NCT00004086|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815215|NCT00004086|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815216|NCT00004086|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815217|NCT00004086|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815218|NCT00004086|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5822071|NCT00074243|adult glioblastoma|adult glioblastoma
5815219|NCT00004086|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815220|NCT00004086|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815221|NCT00004086|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5815222|NCT00004086|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815223|NCT00004086|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815224|NCT00004086|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815225|NCT00004086|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815226|NCT00004085|stage IV breast cancer|stage iv breast cancer
5815227|NCT00004085|recurrent breast cancer|recurrent breast cancer
5815228|NCT00004084|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5815229|NCT00004084|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5815230|NCT00004084|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5815231|NCT00004084|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5815232|NCT00004084|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815233|NCT00004084|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5815234|NCT00004084|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5815235|NCT00004084|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5815236|NCT00004084|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5815237|NCT00004084|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5815238|NCT00004084|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5815239|NCT00004084|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5815241|NCT00004084|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5815242|NCT00004084|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5815243|NCT00004084|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5815244|NCT00004084|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5815245|NCT00004084|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5815246|NCT00004084|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5815247|NCT00004084|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5815248|NCT00004084|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5815249|NCT00004084|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5815250|NCT00004084|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5815251|NCT00004084|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5815380|NCT00003718|uterine carcinosarcoma|uterine carcinosarcoma
5815252|NCT00004084|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5815253|NCT00004084|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5815254|NCT00004084|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5815255|NCT00004084|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5815256|NCT00004084|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5815257|NCT00004084|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5815258|NCT00004084|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5815259|NCT00004084|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815260|NCT00004084|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815261|NCT00004084|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819008|NCT00078715|Depression|depression
5815262|NCT00004084|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815263|NCT00004084|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815264|NCT00004084|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815265|NCT00004084|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815266|NCT00004084|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815267|NCT00004084|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815268|NCT00004084|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5815269|NCT00004084|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5815270|NCT00004084|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5815271|NCT00004084|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5815272|NCT00004084|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5815273|NCT00004084|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5815274|NCT00004084|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5815275|NCT00004084|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5815276|NCT00004084|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5815277|NCT00004084|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5815278|NCT00004084|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5815279|NCT00004084|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5815280|NCT00004084|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5815281|NCT00004084|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5815282|NCT00004084|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5815283|NCT00004084|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5815284|NCT00004084|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5815285|NCT00004084|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5815286|NCT00004084|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5815287|NCT00004084|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5815288|NCT00004084|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5828680|NCT00004911|small intestine adenocarcinoma|small intestine adenocarcinoma
5828681|NCT00004911|small intestine lymphoma|small intestine lymphoma
5828682|NCT00004911|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5828685|NCT00004911|quality of life|quality of life
5815289|NCT00004084|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5815290|NCT00004084|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815291|NCT00004084|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5815292|NCT00004084|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5815293|NCT00004084|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5815294|NCT00004084|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5815296|NCT00004084|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815297|NCT00004084|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5815298|NCT00004084|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5815299|NCT00004084|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5815300|NCT00004084|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5815301|NCT00004084|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5815302|NCT00004084|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5815303|NCT00004084|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815304|NCT00004084|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815305|NCT00004084|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815306|NCT00004048|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5815307|NCT00004046|stage IV breast cancer|stage iv breast cancer
5815308|NCT00004046|recurrent breast cancer|recurrent breast cancer
5815309|NCT00004045|stage IV prostate cancer|stage iv prostate cancer
5815310|NCT00004045|recurrent prostate cancer|recurrent prostate cancer
5815311|NCT00004033|localized malignant mesothelioma|localized malignant mesothelioma
5815312|NCT00004033|advanced malignant mesothelioma|advanced malignant mesothelioma
5815313|NCT00004033|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5815314|NCT00004016|stage III melanoma|stage iii melanoma
5815315|NCT00004016|stage IV melanoma|stage iv melanoma
5815316|NCT00004016|recurrent melanoma|recurrent melanoma
5815317|NCT00004016|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815318|NCT00004010|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5815319|NCT00004010|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5815320|NCT00004010|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5815321|NCT00004010|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5815322|NCT00004010|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5815323|NCT00004010|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5815324|NCT00004010|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5815325|NCT00081458|Short Bowel Syndrome|short bowel syndrome
5815326|NCT00081458|Parenteral Nutrition|parenteral nutrition
5815328|NCT00003917|limited stage small cell lung cancer|limited stage small cell lung cancer
5815329|NCT00003917|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5815330|NCT00003917|recurrent small cell lung cancer|recurrent small cell lung cancer
5815331|NCT00003870|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5815332|NCT00003870|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815333|NCT00003870|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5815334|NCT00003870|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5815335|NCT00003834|stage IV colon cancer|stage iv colon cancer
5815336|NCT00003834|stage IV rectal cancer|stage iv rectal cancer
5815337|NCT00003834|recurrent colon cancer|recurrent colon cancer
5815338|NCT00003834|recurrent rectal cancer|recurrent rectal cancer
5815339|NCT00003834|adenocarcinoma of the colon|adenocarcinoma of the colon
5815340|NCT00003834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815341|NCT00003834|liver metastases|liver metastases
5815342|NCT00003824|stage 0 bladder cancer|stage 0 bladder cancer
5815343|NCT00003824|recurrent bladder cancer|recurrent bladder cancer
5822218|NCT00073905|pain|pain
5815344|NCT00003824|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5815345|NCT00003809|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5815346|NCT00003809|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5815347|NCT00003809|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5815348|NCT00003809|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5846507|NCT00044252|Neurosteroids|neurosteroids
5815349|NCT00003809|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5815350|NCT00003809|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5815351|NCT00003809|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5815352|NCT00003809|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5815353|NCT00003809|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5815354|NCT00003809|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5815355|NCT00003809|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5815356|NCT00003809|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5815357|NCT00003809|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5815358|NCT00003809|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5815359|NCT00003809|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5815360|NCT00003809|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5815361|NCT00003809|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5815362|NCT00003719|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5815363|NCT00003719|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5815364|NCT00003718|adult angiosarcoma|adult angiosarcoma
5815365|NCT00003718|adult fibrosarcoma|adult fibrosarcoma
5815366|NCT00003718|adult leiomyosarcoma|adult leiomyosarcoma
5815367|NCT00003718|adult liposarcoma|adult liposarcoma
5815368|NCT00003718|adult neurofibrosarcoma|adult neurofibrosarcoma
5815369|NCT00003718|adult synovial sarcoma|adult synovial sarcoma
5815370|NCT00003718|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5815371|NCT00003718|adult extraskeletal chondrosarcoma|adult extraskeletal chondrosarcoma
5815372|NCT00003718|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5815373|NCT00003718|adult epithelioid sarcoma|adult epithelioid sarcoma
5815374|NCT00003718|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5815375|NCT00003718|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5815376|NCT00003718|adult malignant mesenchymoma|adult malignant mesenchymoma
5815377|NCT00003718|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5815378|NCT00003718|stage IV uterine sarcoma|stage iv uterine sarcoma
5815381|NCT00003718|uterine leiomyosarcoma|uterine leiomyosarcoma
5815382|NCT00003718|endometrial stromal sarcoma|endometrial stromal sarcoma
5816013|NCT00081042|stage III melanoma|stage iii melanoma
5815384|NCT00003718|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5815385|NCT00003717|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815386|NCT00003717|stage IV prostate cancer|stage iv prostate cancer
5815387|NCT00003717|recurrent prostate cancer|recurrent prostate cancer
5815388|NCT00003674|stage IV colon cancer|stage iv colon cancer
5815389|NCT00003674|stage IV breast cancer|stage iv breast cancer
5815390|NCT00003674|recurrent breast cancer|recurrent breast cancer
5815391|NCT00003674|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815392|NCT00003674|stage IV rectal cancer|stage iv rectal cancer
5815393|NCT00003674|recurrent colon cancer|recurrent colon cancer
5815394|NCT00003674|recurrent rectal cancer|recurrent rectal cancer
5815395|NCT00003674|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5815396|NCT00003674|recurrent small cell lung cancer|recurrent small cell lung cancer
5815397|NCT00003674|stage IV prostate cancer|stage iv prostate cancer
5815398|NCT00003674|recurrent prostate cancer|recurrent prostate cancer
5815399|NCT00003674|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815400|NCT00003674|veno-occlusive disease|veno-occlusive disease
5815401|NCT00003493|refractory multiple myeloma|refractory multiple myeloma
5815402|NCT00003493|stage I multiple myeloma|stage i multiple myeloma
5815403|NCT00003493|stage II multiple myeloma|stage ii multiple myeloma
5815404|NCT00003493|stage III multiple myeloma|stage iii multiple myeloma
5815405|NCT00003307|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815406|NCT00003307|stage I prostate cancer|stage i prostate cancer
5815407|NCT00003307|stage II prostate cancer|stage ii prostate cancer
5815408|NCT00003307|stage III prostate cancer|stage iii prostate cancer
5815409|NCT00003307|radiation toxicity|radiation toxicity
5815410|NCT00003283|invasive thymoma and thymic carcinoma|invasive thymoma and thymic carcinoma
5815411|NCT00003283|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5815412|NCT00003235|squamous cell lung cancer|squamous cell lung cancer
5686669|NCT00551122|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5815413|NCT00003235|large cell lung cancer|large cell lung cancer
5815414|NCT00003235|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5815415|NCT00003235|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815416|NCT00003235|adenocarcinoma of the lung|adenocarcinoma of the lung
5815417|NCT00003209|stage IB cervical cancer|stage ib cervical cancer
5815418|NCT00003209|stage IIA cervical cancer|stage iia cervical cancer
5815419|NCT00003209|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5815420|NCT00003209|cervical adenocarcinoma|cervical adenocarcinoma
5815421|NCT00003209|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5815422|NCT00003125|stage IV breast cancer|stage iv breast cancer
5815423|NCT00003125|stage IIIA breast cancer|stage iiia breast cancer
5815424|NCT00003125|stage III gastric cancer|stage iii gastric cancer
5815425|NCT00003125|stage IV gastric cancer|stage iv gastric cancer
5815426|NCT00003125|stage IIIB breast cancer|stage iiib breast cancer
5815427|NCT00003125|stage II pancreatic cancer|stage ii pancreatic cancer
5815428|NCT00003125|stage III pancreatic cancer|stage iii pancreatic cancer
5815429|NCT00003125|stage II esophageal cancer|stage ii esophageal cancer
5815430|NCT00003125|stage III esophageal cancer|stage iii esophageal cancer
5815431|NCT00003125|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5815432|NCT00003125|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815433|NCT00003125|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815434|NCT00003125|stage IV pancreatic cancer|stage iv pancreatic cancer
5815435|NCT00003080|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815436|NCT00003080|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815437|NCT00003080|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815438|NCT00003061|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5815439|NCT00003032|stage IV breast cancer|stage iv breast cancer
5815440|NCT00003032|recurrent breast cancer|recurrent breast cancer
5811943|NCT00002673|testicular teratoma|testicular teratoma
5815443|NCT00021398|stage III rectal cancer|stage iii rectal cancer
5815444|NCT00021398|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815445|NCT00021281|stage IV colon cancer|stage iv colon cancer
5815446|NCT00021281|stage IV rectal cancer|stage iv rectal cancer
5815447|NCT00021281|recurrent colon cancer|recurrent colon cancer
5815448|NCT00021281|recurrent rectal cancer|recurrent rectal cancer
5815449|NCT00021281|adenocarcinoma of the colon|adenocarcinoma of the colon
5815450|NCT00021281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815451|NCT00021151|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815452|NCT00021151|prolymphocytic leukemia|prolymphocytic leukemia
5815453|NCT00021008|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815454|NCT00021008|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815455|NCT00021008|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815456|NCT00020774|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5815457|NCT00020774|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5815458|NCT00020774|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5815459|NCT00020774|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5816153|NCT00080782|Celecoxib|celecoxib
5815460|NCT00019552|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815461|NCT00019552|fallopian tube cancer|fallopian tube cancer
5815462|NCT00019552|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5815463|NCT00019474|stage III gastric cancer|stage iii gastric cancer
5815464|NCT00019474|stage IV gastric cancer|stage iv gastric cancer
5815465|NCT00019474|recurrent gastric cancer|recurrent gastric cancer
5815466|NCT00019474|stage II pancreatic cancer|stage ii pancreatic cancer
5815467|NCT00019474|stage III pancreatic cancer|stage iii pancreatic cancer
5815468|NCT00019474|recurrent pancreatic cancer|recurrent pancreatic cancer
5815469|NCT00019474|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5815470|NCT00019474|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5815471|NCT00019474|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5815472|NCT00019474|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5815473|NCT00019474|advanced adult primary liver cancer|advanced adult primary liver cancer
5815474|NCT00019474|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5815475|NCT00019474|small intestine adenocarcinoma|small intestine adenocarcinoma
5815476|NCT00019474|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5815477|NCT00019474|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5815478|NCT00019474|recurrent small intestine cancer|recurrent small intestine cancer
5815479|NCT00019474|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5815480|NCT00019474|stage IV pancreatic cancer|stage iv pancreatic cancer
5815481|NCT00019318|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5815482|NCT00019318|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5815483|NCT00019318|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5822420|NCT00073606|HV|hv
5814991|NCT00081549|Metastatic|metastatic
5815484|NCT00019318|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5815485|NCT00019318|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5815486|NCT00019318|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5815487|NCT00019123|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5815488|NCT00014391|stage IV breast cancer|stage iv breast cancer
5815489|NCT00014391|stage IIIA breast cancer|stage iiia breast cancer
5815490|NCT00014391|stage IIIB breast cancer|stage iiib breast cancer
5815491|NCT00014391|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5815492|NCT00014391|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5846508|NCT00044252|Complex Partial Seizure|complex partial seizure
5815493|NCT00014391|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5815494|NCT00014391|refractory multiple myeloma|refractory multiple myeloma
5815495|NCT00014391|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5815496|NCT00014391|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5815497|NCT00014391|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815498|NCT00014391|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815499|NCT00014391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815500|NCT00014391|disseminated neuroblastoma|disseminated neuroblastoma
5815501|NCT00014391|recurrent neuroblastoma|recurrent neuroblastoma
5815502|NCT00014391|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5815503|NCT00014391|stage I multiple myeloma|stage i multiple myeloma
5815504|NCT00014391|stage II multiple myeloma|stage ii multiple myeloma
5815505|NCT00014391|stage III multiple myeloma|stage iii multiple myeloma
5815506|NCT00014391|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5815507|NCT00014391|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5815508|NCT00014391|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5815509|NCT00014391|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5815510|NCT00014391|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5815511|NCT00014391|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815512|NCT00014391|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5815513|NCT00014391|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815514|NCT00014391|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5815515|NCT00014391|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5815516|NCT00014391|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5815517|NCT00014391|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5815518|NCT00014391|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5815519|NCT00014391|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5815520|NCT00014391|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5815521|NCT00014391|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5815523|NCT00014391|testicular choriocarcinoma|testicular choriocarcinoma
5815524|NCT00014391|testicular teratoma|testicular teratoma
5815525|NCT00014391|testicular yolk sac tumor|testicular yolk sac tumor
5815526|NCT00014391|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5815527|NCT00014391|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5815528|NCT00014391|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5815529|NCT00014391|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5815530|NCT00014391|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5815531|NCT00014391|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5815532|NCT00014391|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5815533|NCT00014391|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5815534|NCT00014391|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5815535|NCT00014391|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5815536|NCT00014391|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5815537|NCT00014391|refractory hairy cell leukemia|refractory hairy cell leukemia
5815538|NCT00014391|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5815539|NCT00014391|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5815540|NCT00014391|ovarian yolk sac tumor|ovarian yolk sac tumor
5815541|NCT00014391|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5815542|NCT00014391|ovarian polyembryoma|ovarian polyembryoma
5815543|NCT00014391|ovarian choriocarcinoma|ovarian choriocarcinoma
5815544|NCT00014391|ovarian immature teratoma|ovarian immature teratoma
5815545|NCT00014391|ovarian mature teratoma|ovarian mature teratoma
5815546|NCT00014391|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5815547|NCT00014391|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5815548|NCT00014391|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5822461|NCT00073580|HIT|hit
5815549|NCT00014391|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5815550|NCT00014391|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5815551|NCT00014391|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5815552|NCT00014391|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5815553|NCT00014391|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5815554|NCT00014391|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5815555|NCT00014391|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5815556|NCT00014391|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5815557|NCT00014391|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5815558|NCT00014391|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5815559|NCT00014391|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5815560|NCT00014391|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5815561|NCT00014391|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5815562|NCT00014391|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5815563|NCT00014391|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5815564|NCT00014391|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5815565|NCT00014391|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5815566|NCT00014391|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815567|NCT00014391|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815568|NCT00014391|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815569|NCT00014391|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815570|NCT00014391|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815571|NCT00014391|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5846497|NCT00044304|Gleevec|gleevec
5815573|NCT00014391|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815574|NCT00014391|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815575|NCT00014391|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5815576|NCT00014391|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5815577|NCT00014391|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5815578|NCT00014391|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5815579|NCT00014391|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5815581|NCT00014391|pulmonary complications|pulmonary complications
5815582|NCT00014391|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5815583|NCT00014391|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5815584|NCT00014391|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5815585|NCT00014391|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5815586|NCT00014391|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5815587|NCT00014391|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5815588|NCT00014391|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5815589|NCT00014391|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5815590|NCT00014391|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5815591|NCT00014391|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5815592|NCT00014391|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5815593|NCT00014391|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5815594|NCT00014391|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5815595|NCT00014391|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5815596|NCT00014391|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815597|NCT00014391|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5815598|NCT00014391|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5815599|NCT00014391|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5815600|NCT00014391|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5815601|NCT00014391|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815602|NCT00014391|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5815603|NCT00014391|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5815604|NCT00014391|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5815605|NCT00014391|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5815606|NCT00014391|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815607|NCT00014391|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815608|NCT00014391|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815609|NCT00014391|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5815610|NCT00012311|stage IV breast cancer|stage iv breast cancer
5815157|NCT00081497|a-GAL|a-gal
5815611|NCT00012311|recurrent breast cancer|recurrent breast cancer
5815612|NCT00010283|stage III breast cancer|stage iii breast cancer
5815613|NCT00010283|stage IV breast cancer|stage iv breast cancer
5815614|NCT00010283|stage IIIA breast cancer|stage iiia breast cancer
5815615|NCT00010283|stage IIIB breast cancer|stage iiib breast cancer
5815616|NCT00010283|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5815617|NCT00010283|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5815618|NCT00010283|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5815619|NCT00010283|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5815620|NCT00010283|Burkitt lymphoma|burkitt lymphoma
5815621|NCT00010283|extramedullary plasmacytoma|extramedullary plasmacytoma
5829050|NCT00004094|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5829051|NCT00004094|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5815622|NCT00010283|refractory multiple myeloma|refractory multiple myeloma
5815623|NCT00010283|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5815624|NCT00010283|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815625|NCT00010283|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815626|NCT00010283|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5815627|NCT00010283|disseminated neuroblastoma|disseminated neuroblastoma
5815628|NCT00010283|recurrent neuroblastoma|recurrent neuroblastoma
5815629|NCT00010283|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5815630|NCT00010283|stage I multiple myeloma|stage i multiple myeloma
5815631|NCT00010283|stage II multiple myeloma|stage ii multiple myeloma
5815632|NCT00010283|stage III multiple myeloma|stage iii multiple myeloma
5815633|NCT00010283|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5815634|NCT00010283|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5815635|NCT00010283|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5815636|NCT00010283|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5815637|NCT00010283|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5815638|NCT00010283|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815639|NCT00010283|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5815640|NCT00010283|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5815641|NCT00010283|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5815642|NCT00010283|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5815643|NCT00010283|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5815644|NCT00010283|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5815645|NCT00010283|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5815646|NCT00010283|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5815647|NCT00010283|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5815648|NCT00010283|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5815649|NCT00010283|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5815650|NCT00010283|essential thrombocythemia|essential thrombocythemia
5815651|NCT00010283|testicular embryonal carcinoma|testicular embryonal carcinoma
5815652|NCT00010283|testicular choriocarcinoma|testicular choriocarcinoma
5815653|NCT00010283|testicular teratoma|testicular teratoma
5815654|NCT00010283|testicular yolk sac tumor|testicular yolk sac tumor
5815865|NCT00004082|fallopian tube cancer|fallopian tube cancer
5815655|NCT00010283|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5815656|NCT00010283|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5815721|NCT00010283|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5815657|NCT00010283|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5815658|NCT00010283|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5815659|NCT00010283|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5815660|NCT00010283|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5815661|NCT00010283|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5815662|NCT00010283|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5815663|NCT00010283|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5815664|NCT00010283|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5815665|NCT00010283|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5815666|NCT00010283|refractory hairy cell leukemia|refractory hairy cell leukemia
5815667|NCT00010283|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5815668|NCT00010283|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5815669|NCT00010283|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5815670|NCT00010283|ovarian yolk sac tumor|ovarian yolk sac tumor
5815671|NCT00010283|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5815672|NCT00010283|ovarian polyembryoma|ovarian polyembryoma
5686670|NCT00551122|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5815673|NCT00010283|ovarian choriocarcinoma|ovarian choriocarcinoma
5815674|NCT00010283|ovarian immature teratoma|ovarian immature teratoma
5815675|NCT00010283|ovarian mature teratoma|ovarian mature teratoma
5815676|NCT00010283|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5815677|NCT00010283|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5815678|NCT00010283|acute undifferentiated leukemia|acute undifferentiated leukemia
5815679|NCT00010283|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5815680|NCT00010283|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5815681|NCT00010283|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5815682|NCT00010283|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5815683|NCT00010283|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5815684|NCT00010283|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5815685|NCT00010283|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5815686|NCT00010283|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5815687|NCT00010283|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5815688|NCT00010283|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5815689|NCT00010283|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5815690|NCT00010283|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5815691|NCT00010283|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5815692|NCT00010283|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5815693|NCT00010283|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5815694|NCT00010283|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5815695|NCT00010283|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5815696|NCT00010283|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5815697|NCT00010283|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815698|NCT00010283|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815699|NCT00010283|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815700|NCT00010283|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815701|NCT00010283|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815702|NCT00010283|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815703|NCT00010283|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815704|NCT00010283|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815705|NCT00010283|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815706|NCT00010283|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5815707|NCT00010283|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5815708|NCT00010283|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5815709|NCT00010283|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5815710|NCT00010283|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5815711|NCT00010283|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5815712|NCT00010283|graft versus host disease|graft versus host disease
5815714|NCT00010283|primary systemic amyloidosis|primary systemic amyloidosis
5815715|NCT00010283|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5815716|NCT00010283|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5815717|NCT00010283|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5815718|NCT00010283|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5815719|NCT00010283|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5815720|NCT00010283|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5815722|NCT00010283|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5815723|NCT00010283|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5815724|NCT00010283|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5815725|NCT00010283|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5815726|NCT00010283|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5815727|NCT00010283|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5815728|NCT00010283|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5815729|NCT00010283|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815730|NCT00010283|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5815731|NCT00010283|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5815732|NCT00010283|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5815733|NCT00010283|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5815734|NCT00010283|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5815735|NCT00010283|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5815736|NCT00010283|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815737|NCT00010283|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5815738|NCT00010283|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5815739|NCT00010283|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5815740|NCT00010283|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5815741|NCT00010283|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815742|NCT00010283|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815743|NCT00010283|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815744|NCT00010283|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5815745|NCT00007943|stage III colon cancer|stage iii colon cancer
5815746|NCT00007943|stage IV colon cancer|stage iv colon cancer
5815747|NCT00007943|stage III rectal cancer|stage iii rectal cancer
5815748|NCT00007943|stage IV rectal cancer|stage iv rectal cancer
5815749|NCT00007943|recurrent colon cancer|recurrent colon cancer
5815750|NCT00007943|recurrent rectal cancer|recurrent rectal cancer
5815751|NCT00006045|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5815752|NCT00006045|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5815753|NCT00006045|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5815754|NCT00006045|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5815755|NCT00006045|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5815756|NCT00006045|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5815757|NCT00006045|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5815758|NCT00006045|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5815759|NCT00006045|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5815760|NCT00006045|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5815762|NCT00005875|recurrent melanoma|recurrent melanoma
5815763|NCT00005874|adult leiomyosarcoma|adult leiomyosarcoma
5815764|NCT00005874|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5815765|NCT00005874|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5815766|NCT00005874|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5815767|NCT00005874|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5815768|NCT00005874|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5815769|NCT00005874|childhood leiomyosarcoma|childhood leiomyosarcoma
5815770|NCT00005874|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5815771|NCT00005874|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5815772|NCT00005873|stage IV breast cancer|stage iv breast cancer
5815773|NCT00005873|recurrent breast cancer|recurrent breast cancer
5815774|NCT00002708|tumors metastatic to brain|tumors metastatic to brain
5815777|NCT00081432|Memory|memory
5815778|NCT00081432|Brain|brain
5815779|NCT00081432|Imaging|imaging
5815780|NCT00081432|Epilepsy|epilepsy
5815781|NCT00081432|Temporal Lobe Epilepsy|temporal lobe epilepsy
5815782|NCT00081419|Bereitschaftspotential|bereitschaftspotential
5815783|NCT00081419|Timing of Volition|timing of volition
5815784|NCT00081419|Urge|urge
5815785|NCT00081419|Conscious Will|conscious will
5815786|NCT00081419|Libet's Clock|libet's clock
5815787|NCT00081419|Tourette Syndrome|tourette syndrome
5815788|NCT00081419|Tic Disorder|tic disorder
5815789|NCT00081419|Healthy Volunteer|healthy volunteer
5815791|NCT00081367|Minority Groups|minority groups
5816160|NCT00080756|BRCA2 mutation carrier|brca2 mutation carrier
5815792|NCT00005872|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815793|NCT00005833|stage IV colon cancer|stage iv colon cancer
5815794|NCT00005833|stage IV rectal cancer|stage iv rectal cancer
5815795|NCT00005833|recurrent colon cancer|recurrent colon cancer
5815796|NCT00005833|recurrent rectal cancer|recurrent rectal cancer
5815797|NCT00005833|adenocarcinoma of the colon|adenocarcinoma of the colon
5815798|NCT00005833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815799|NCT00005820|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815800|NCT00005820|stage IV prostate cancer|stage iv prostate cancer
5815801|NCT00005820|recurrent prostate cancer|recurrent prostate cancer
5815802|NCT00005801|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5815803|NCT00005801|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5815804|NCT00005801|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5815805|NCT00005801|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5815806|NCT00005801|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5815807|NCT00005801|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5815808|NCT00005801|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5815809|NCT00005801|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5815810|NCT00005077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815811|NCT00005066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5822777|NCT00072722|Celgene|celgene
5815812|NCT00005066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5815813|NCT00005061|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815814|NCT00005058|stage I breast cancer|stage i breast cancer
5815815|NCT00005058|stage II breast cancer|stage ii breast cancer
5815816|NCT00005058|stage IIIA breast cancer|stage iiia breast cancer
5815817|NCT00005058|stage IIIB breast cancer|stage iiib breast cancer
5815818|NCT00005058|inflammatory breast cancer|inflammatory breast cancer
5815819|NCT00005040|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5815820|NCT00005040|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815821|NCT00005040|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5815822|NCT00005040|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815823|NCT00005040|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815824|NCT00005040|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815825|NCT00005040|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815826|NCT00005040|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815827|NCT00005040|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5815828|NCT00005040|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815829|NCT00005040|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5815830|NCT00005040|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5815831|NCT00004885|stage IV colon cancer|stage iv colon cancer
5815832|NCT00004885|stage IV rectal cancer|stage iv rectal cancer
5815833|NCT00004885|recurrent colon cancer|recurrent colon cancer
5815834|NCT00004885|recurrent rectal cancer|recurrent rectal cancer
5815835|NCT00004885|adenocarcinoma of the colon|adenocarcinoma of the colon
5815836|NCT00004885|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815837|NCT00004860|stage III colon cancer|stage iii colon cancer
5815838|NCT00004860|stage IV colon cancer|stage iv colon cancer
5815839|NCT00004860|stage III rectal cancer|stage iii rectal cancer
5846501|NCT00044278|epilepsy|epilepsy
5815841|NCT00004860|recurrent colon cancer|recurrent colon cancer
5815842|NCT00004860|recurrent rectal cancer|recurrent rectal cancer
5815843|NCT00004860|adenocarcinoma of the colon|adenocarcinoma of the colon
5815844|NCT00004860|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815845|NCT00004238|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815846|NCT00004238|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815847|NCT00004238|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815848|NCT00004166|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5815849|NCT00004166|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5815850|NCT00004166|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815851|NCT00004166|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815852|NCT00004166|quality of life|quality of life
5815853|NCT00004137|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5815854|NCT00004102|stage IV colon cancer|stage iv colon cancer
5815855|NCT00004102|stage IV rectal cancer|stage iv rectal cancer
5815856|NCT00004102|recurrent colon cancer|recurrent colon cancer
5815857|NCT00004102|recurrent rectal cancer|recurrent rectal cancer
5815858|NCT00004102|adenocarcinoma of the colon|adenocarcinoma of the colon
5815859|NCT00004102|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815860|NCT00004082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5815861|NCT00004082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5815862|NCT00004082|stage III endometrial carcinoma|stage iii endometrial carcinoma
5815863|NCT00004082|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5815864|NCT00004082|endometrial adenocarcinoma|endometrial adenocarcinoma
5815866|NCT00004082|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5815867|NCT00004002|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5815868|NCT00004002|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5815869|NCT00004002|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5815873|NCT00004002|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5815874|NCT00004002|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5815875|NCT00004002|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5815876|NCT00004002|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5815877|NCT00004002|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5815878|NCT00004002|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5815879|NCT00004002|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5815880|NCT00004002|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5815881|NCT00004002|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5815882|NCT00004002|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815883|NCT00004002|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5815884|NCT00004002|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5815885|NCT00004002|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5822901|NCT00072475|refractory anemia|refractory anemia
5815886|NCT00004002|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5815887|NCT00004002|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5815888|NCT00004002|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5815889|NCT00004002|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5815890|NCT00004002|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5815891|NCT00004002|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5815892|NCT00004002|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5815893|NCT00004002|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5815894|NCT00004002|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5815895|NCT00004002|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5815896|NCT00004002|intraocular lymphoma|intraocular lymphoma
5815897|NCT00004002|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5815898|NCT00004002|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5815899|NCT00004002|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5815900|NCT00004002|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5815901|NCT00004002|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5815902|NCT00004002|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5815903|NCT00004002|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5815904|NCT00004002|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5815905|NCT00004002|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5815906|NCT00004002|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5815907|NCT00004002|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5815908|NCT00004002|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5815909|NCT00004002|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5815910|NCT00003911|stage IV melanoma|stage iv melanoma
5815911|NCT00003911|recurrent melanoma|recurrent melanoma
5815912|NCT00003911|tumors metastatic to brain|tumors metastatic to brain
5815921|NCT00081315|- Non-Small cell lung cancer|- non-small cell lung cancer
5815923|NCT00005943|recurrent melanoma|recurrent melanoma
5815924|NCT00003754|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5815925|NCT00003710|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815926|NCT00003692|occult non-small cell lung cancer|occult non-small cell lung cancer
5815927|NCT00003692|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5815928|NCT00003692|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5815929|NCT00003642|stage II bladder cancer|stage ii bladder cancer
5815930|NCT00003642|stage III bladder cancer|stage iii bladder cancer
5815931|NCT00003642|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5815932|NCT00003446|stage IV colon cancer|stage iv colon cancer
5815933|NCT00003446|stage IV rectal cancer|stage iv rectal cancer
5815934|NCT00003446|recurrent colon cancer|recurrent colon cancer
5815935|NCT00003446|recurrent rectal cancer|recurrent rectal cancer
5815936|NCT00003376|stage III bladder cancer|stage iii bladder cancer
5815937|NCT00003376|stage IV bladder cancer|stage iv bladder cancer
5815938|NCT00003376|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5815939|NCT00003376|anterior urethral cancer|anterior urethral cancer
5815940|NCT00003376|posterior urethral cancer|posterior urethral cancer
5815941|NCT00003376|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5815942|NCT00003376|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5815943|NCT00003376|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5815944|NCT00003316|recurrent uterine sarcoma|recurrent uterine sarcoma
5815945|NCT00003316|uterine leiomyosarcoma|uterine leiomyosarcoma
5815946|NCT00003301|recurrent adult brain tumor|recurrent adult brain tumor
5815947|NCT00003301|adult glioblastoma|adult glioblastoma
5815948|NCT00003301|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5815949|NCT00003301|adult giant cell glioblastoma|adult giant cell glioblastoma
5815950|NCT00003301|adult gliosarcoma|adult gliosarcoma
5815951|NCT00003232|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815952|NCT00003232|recurrent prostate cancer|recurrent prostate cancer
5815955|NCT00081302|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5815956|NCT00081302|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815957|NCT00081302|squamous cell lung cancer|squamous cell lung cancer
5815958|NCT00081302|large cell lung cancer|large cell lung cancer
5815959|NCT00081302|adenocarcinoma of the lung|adenocarcinoma of the lung
5815960|NCT00081302|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5815964|NCT00081250|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5815965|NCT00081250|cachexia|cachexia
5815966|NCT00081250|anorexia|anorexia
5815967|NCT00081250|weight changes|weight changes
5815968|NCT00081237|recurrent colon cancer|recurrent colon cancer
5815969|NCT00081237|stage III colon cancer|stage iii colon cancer
5823296|NCT00071370|Epilepsy|epilepsy
5815970|NCT00081237|stage IV colon cancer|stage iv colon cancer
5815971|NCT00081237|recurrent rectal cancer|recurrent rectal cancer
5815972|NCT00081237|stage III rectal cancer|stage iii rectal cancer
5815973|NCT00081237|stage IV rectal cancer|stage iv rectal cancer
5815974|NCT00081224|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5815975|NCT00081224|stage II rectal cancer|stage ii rectal cancer
5815976|NCT00081224|stage III rectal cancer|stage iii rectal cancer
5815977|NCT00081172|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5815978|NCT00081172|recurrent prostate cancer|recurrent prostate cancer
5815979|NCT00081172|stage IV prostate cancer|stage iv prostate cancer
5815980|NCT00081159|recurrent prostate cancer|recurrent prostate cancer
5815981|NCT00081159|stage IV prostate cancer|stage iv prostate cancer
5815982|NCT00081159|bone metastases|bone metastases
5815983|NCT00081133|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5815984|NCT00081133|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5815985|NCT00081133|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815986|NCT00081133|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5815987|NCT00081107|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815988|NCT00081107|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5815989|NCT00081107|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5815990|NCT00081094|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5815991|NCT00081094|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5815992|NCT00081094|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5815993|NCT00081068|Waldenström macroglobulinemia|waldenström macroglobulinemia
5815994|NCT00081055|graft versus host disease|graft versus host disease
5815995|NCT00081055|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5815996|NCT00081055|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5815997|NCT00081055|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5815998|NCT00081055|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5805881|NCT00089765|VHL|vhl
5815999|NCT00081055|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816000|NCT00081055|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816001|NCT00081055|refractory anemia|refractory anemia
5816002|NCT00081055|refractory anemia with excess blasts|refractory anemia with excess blasts
5816003|NCT00081055|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5816004|NCT00081055|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5816005|NCT00081055|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5816006|NCT00081055|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5816007|NCT00081055|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5816008|NCT00081055|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5816009|NCT00081055|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5816010|NCT00081055|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5816011|NCT00081055|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5816012|NCT00081042|recurrent melanoma|recurrent melanoma
5816014|NCT00081042|stage IV melanoma|stage iv melanoma
5816015|NCT00081029|xerostomia|xerostomia
5816016|NCT00081029|radiation toxicity|radiation toxicity
5816161|NCT00080743|recurrent breast cancer|recurrent breast cancer
5816017|NCT00081029|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5816018|NCT00081029|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5816019|NCT00081029|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5816020|NCT00081029|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5816021|NCT00081029|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5816022|NCT00081029|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5816023|NCT00081029|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5816024|NCT00081029|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5816025|NCT00081003|breast cancer|breast cancer
5816026|NCT00080977|recurrent renal cell cancer|recurrent renal cell cancer
5816027|NCT00080977|stage IV renal cell cancer|stage iv renal cell cancer
5816028|NCT00080951|stage IV colon cancer|stage iv colon cancer
5816029|NCT00080951|stage IV rectal cancer|stage iv rectal cancer
5816030|NCT00080951|adenocarcinoma of the colon|adenocarcinoma of the colon
5816031|NCT00080951|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5816032|NCT00080938|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5816033|NCT00080938|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5816034|NCT00080938|squamous cell lung cancer|squamous cell lung cancer
5816035|NCT00080938|adenocarcinoma of the lung|adenocarcinoma of the lung
5816036|NCT00080938|large cell lung cancer|large cell lung cancer
5816037|NCT00080938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5823390|NCT00071383|Herceptin|herceptin
5816038|NCT00080938|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5816039|NCT00080938|tumors metastatic to brain|tumors metastatic to brain
5816040|NCT00080925|prolymphocytic leukemia|prolymphocytic leukemia
5816041|NCT00080925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816042|NCT00080925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816043|NCT00080925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5816044|NCT00080925|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5816045|NCT00080925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5816046|NCT00080925|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5816047|NCT00080925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5816048|NCT00080925|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5816049|NCT00080925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5816050|NCT00080925|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5816051|NCT00080925|refractory anemia with excess blasts|refractory anemia with excess blasts
5816052|NCT00080925|refractory multiple myeloma|refractory multiple myeloma
5816053|NCT00080925|primary myelofibrosis|primary myelofibrosis
5816054|NCT00080925|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816055|NCT00080925|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816056|NCT00080925|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816057|NCT00080925|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816058|NCT00080925|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816059|NCT00080925|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816060|NCT00080925|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816061|NCT00080925|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816062|NCT00080925|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816063|NCT00080925|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816064|NCT00080925|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5816065|NCT00080925|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5816066|NCT00080925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5816067|NCT00080925|polycythemia vera|polycythemia vera
5816068|NCT00080925|essential thrombocythemia|essential thrombocythemia
5816069|NCT00080925|stage II multiple myeloma|stage ii multiple myeloma
5816070|NCT00080925|stage III multiple myeloma|stage iii multiple myeloma
5816071|NCT00080925|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5816072|NCT00080925|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5816073|NCT00080925|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5816074|NCT00080925|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5816075|NCT00080925|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5816076|NCT00080925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5816077|NCT00080925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5816078|NCT00080925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5816079|NCT00080925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5816080|NCT00080925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5816081|NCT00080912|bone metastases|bone metastases
5816082|NCT00080912|pain|pain
5816083|NCT00080886|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816084|NCT00080886|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816085|NCT00080886|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816086|NCT00080886|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816087|NCT00080886|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816088|NCT00080886|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816089|NCT00080886|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816090|NCT00080886|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816091|NCT00080886|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816092|NCT00080886|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816093|NCT00080886|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5816094|NCT00080886|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5816095|NCT00080886|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5816096|NCT00080886|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5816097|NCT00080886|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5816098|NCT00080873|oral complications|oral complications
5816099|NCT00080873|disseminated neuroblastoma|disseminated neuroblastoma
5816100|NCT00080873|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5816101|NCT00080873|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5816102|NCT00080873|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5816103|NCT00080873|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5816104|NCT00080873|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5816105|NCT00080873|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5816106|NCT00080873|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5846509|NCT00044252|Menstrual Cycle|menstrual cycle
5829531|NCT00004095|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5829532|NCT00004095|stage IV pancreatic cancer|stage iv pancreatic cancer
5829541|NCT00019435|stage IV colon cancer|stage iv colon cancer
5829542|NCT00019435|stage IV breast cancer|stage iv breast cancer
5829543|NCT00019435|recurrent breast cancer|recurrent breast cancer
5829544|NCT00019435|stage IV gastric cancer|stage iv gastric cancer
5816107|NCT00080873|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5816108|NCT00080873|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5816109|NCT00080873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5816110|NCT00080873|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5816111|NCT00080873|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5816112|NCT00080873|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5816113|NCT00080873|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5816114|NCT00080873|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5816115|NCT00080873|recurrent neuroblastoma|recurrent neuroblastoma
5816116|NCT00080860|stage II breast cancer|stage ii breast cancer
5816117|NCT00080860|stage IIIA breast cancer|stage iiia breast cancer
5816118|NCT00080860|stage IIIB breast cancer|stage iiib breast cancer
5816119|NCT00080860|stage IIIC breast cancer|stage iiic breast cancer
5816120|NCT00080860|stage IV breast cancer|stage iv breast cancer
5816121|NCT00080834|adenocarcinoma of the colon|adenocarcinoma of the colon
5816122|NCT00080834|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5816123|NCT00080834|recurrent colon cancer|recurrent colon cancer
5816124|NCT00080834|recurrent rectal cancer|recurrent rectal cancer
5816125|NCT00080834|stage III colon cancer|stage iii colon cancer
5816126|NCT00080834|stage IV colon cancer|stage iv colon cancer
5816127|NCT00080834|stage III rectal cancer|stage iii rectal cancer
5816128|NCT00080834|stage IV rectal cancer|stage iv rectal cancer
5816129|NCT00080808|perioperative/postoperative complications|perioperative/postoperative complications
5816130|NCT00080808|sexual dysfunction and infertility|sexual dysfunction and infertility
5816131|NCT00080808|sexuality and reproductive issues|sexuality and reproductive issues
5816132|NCT00080808|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5816133|NCT00080808|stage I prostate cancer|stage i prostate cancer
5816134|NCT00080808|stage II prostate cancer|stage ii prostate cancer
5816135|NCT00080808|prostaglandin E1|prostaglandin e1
5816136|NCT00080808|papaverine|papaverine
5816137|NCT00080808|phentolamine|phentolamine
5816138|NCT00080808|Nerve-sparing radical prostatectomy|nerve-sparing radical prostatectomy
5816139|NCT00080808|nerve grafting|nerve grafting
5816140|NCT00080795|stage III bladder cancer|stage iii bladder cancer
5816141|NCT00080795|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5816142|NCT00080795|anterior urethral cancer|anterior urethral cancer
5816143|NCT00080795|posterior urethral cancer|posterior urethral cancer
5816144|NCT00080795|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5816145|NCT00080782|recurrent prostate cancer|recurrent prostate cancer
5816146|NCT00080782|stage IV prostate cancer|stage iv prostate cancer
5816147|NCT00080782|bone metastases|bone metastases
5816148|NCT00080782|Progressive Androgen-Independent Prostate Cancer|progressive androgen-independent prostate cancer
5816149|NCT00080782|Metastron|metastron
5816151|NCT00080782|Strontium-89|strontium-89
5816152|NCT00080782|strontium chloride Sr 89|strontium chloride sr 89
5816158|NCT00080756|breast cancer|breast cancer
5816159|NCT00080756|BRCA1 mutation carrier|brca1 mutation carrier
5817215|NCT00080275|Lipoprotein|lipoprotein
5816162|NCT00080743|stage IV breast cancer|stage iv breast cancer
5816163|NCT00080678|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5816164|NCT00080678|recurrent prostate cancer|recurrent prostate cancer
5816165|NCT00080678|stage IV prostate cancer|stage iv prostate cancer
5816166|NCT00080678|bone metastases|bone metastases
5816167|NCT00080665|male breast cancer|male breast cancer
5816168|NCT00080665|stage IIIB breast cancer|stage iiib breast cancer
5816169|NCT00080665|stage IIIC breast cancer|stage iiic breast cancer
5816170|NCT00080665|stage IV breast cancer|stage iv breast cancer
5816171|NCT00080665|recurrent breast cancer|recurrent breast cancer
5816172|NCT00080639|ovarian epithelial cancer|ovarian epithelial cancer
5816173|NCT00080626|stage I breast cancer|stage i breast cancer
5816174|NCT00080626|stage II breast cancer|stage ii breast cancer
5816175|NCT00080626|stage IIIA breast cancer|stage iiia breast cancer
5816176|NCT00080626|stage IIIB breast cancer|stage iiib breast cancer
5816177|NCT00080626|stage IIIC breast cancer|stage iiic breast cancer
5816178|NCT00080626|stage IV breast cancer|stage iv breast cancer
5816179|NCT00080600|Post Polio Syndrome|post polio syndrome
5816180|NCT00080600|Magnetic Stimulation|magnetic stimulation
5816181|NCT00080600|Fatigue|fatigue
5816182|NCT00080600|Exercise|exercise
5816183|NCT00080600|Weakness|weakness
5816184|NCT00080600|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5816185|NCT00080600|Post-Exercise Fatigue|post-exercise fatigue
5816186|NCT00080600|Motor Neuron Disease|motor neuron disease
5816187|NCT00080600|Cortical Reorganization|cortical reorganization
5816188|NCT00080600|Intracortical Facilitation|intracortical facilitation
5816189|NCT00080600|Polio|polio
5816190|NCT00080600|Healthy Volunteer|healthy volunteer
5816191|NCT00080600|HV|hv
5816192|NCT00080587|Intravascular Ultrasound|intravascular ultrasound
5816193|NCT00080587|Magnetic Resonance Imaging|magnetic resonance imaging
5816194|NCT00080587|Hyperlipidemia|hyperlipidemia
5816195|NCT00080587|Cholesterol|cholesterol
5816196|NCT00080587|Coronary Artery Disease|coronary artery disease
5816197|NCT00080574|Pharmacokinetics|pharmacokinetics
5816198|NCT00080574|Drug Metabolism|drug metabolism
5816199|NCT00080574|Levothyroxine|levothyroxine
5816200|NCT00080574|Hypothyroidism|hypothyroidism
5816201|NCT00080574|Hyperthyroidism|hyperthyroidism
5816202|NCT00080574|Drug Interactions|drug interactions
5816203|NCT00080574|Cytochrome P450|cytochrome p450
5816204|NCT00080574|P-Glycoprotein|p-glycoprotein
5816205|NCT00080574|Drug Transport Proteins|drug transport proteins
5816206|NCT00080574|Thyroid Hormone|thyroid hormone
5816207|NCT00080574|Thyroid Cancer|thyroid cancer
5816208|NCT00080548|Bereitschafts Potential|bereitschafts potential
5816209|NCT00080548|Timing of Volition|timing of volition
5816210|NCT00080548|Somatic Passivity Phenomenon|somatic passivity phenomenon
5816211|NCT00080548|Conscious Will|conscious will
5816212|NCT00080548|Libet's Clock|libet's clock
5816213|NCT00080548|Schizophrenia|schizophrenia
5816214|NCT00080548|Healthy Volunteer|healthy volunteer
5816215|NCT00080548|HV|hv
5816216|NCT00080535|LMB-2|lmb-2
5816217|NCT00080535|Cutaneous T Cell Lymphoma|cutaneous t cell lymphoma
5816219|NCT00080535|Immunotoxin|immunotoxin
5816220|NCT00080535|Oncology|oncology
5816221|NCT00080522|Treatment Naive|treatment naive
5816222|NCT00080522|Resource Poor Setting|resource poor setting
5816223|NCT00080522|Drug Delivery|drug delivery
5816224|NCT00080522|Household|household
5816225|NCT00080522|South Africa|south africa
5816226|NCT00080496|Pneumonia|pneumonia
5816227|NCT00003176|recurrent adult brain tumor|recurrent adult brain tumor
5816228|NCT00003176|adult glioblastoma|adult glioblastoma
5816229|NCT00003176|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5816230|NCT00003176|adult mixed glioma|adult mixed glioma
5816231|NCT00003176|adult giant cell glioblastoma|adult giant cell glioblastoma
5816232|NCT00003176|adult gliosarcoma|adult gliosarcoma
5816233|NCT00003156|recurrent uterine sarcoma|recurrent uterine sarcoma
5816234|NCT00003156|uterine carcinosarcoma|uterine carcinosarcoma
5816235|NCT00003132|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5816236|NCT00003110|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5816237|NCT00003110|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816238|NCT00003110|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816239|NCT00003110|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816240|NCT00003110|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816241|NCT00003110|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816242|NCT00003110|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816243|NCT00003110|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816244|NCT00003110|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5816245|NCT00003110|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5816246|NCT00003110|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5816247|NCT00003110|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5816248|NCT00003110|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5817216|NCT00080275|Lipid|lipid
5816249|NCT00003110|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5816250|NCT00003110|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5816251|NCT00003110|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5816252|NCT00003110|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5816253|NCT00003110|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816254|NCT00002997|stage IV colon cancer|stage iv colon cancer
5816255|NCT00002997|stage IV rectal cancer|stage iv rectal cancer
5816256|NCT00002997|recurrent colon cancer|recurrent colon cancer
5816257|NCT00002997|recurrent rectal cancer|recurrent rectal cancer
5816258|NCT00002997|adenocarcinoma of the colon|adenocarcinoma of the colon
5816259|NCT00002997|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5816260|NCT00002997|liver metastases|liver metastases
5816261|NCT00024063|stage III colon cancer|stage iii colon cancer
5816262|NCT00024063|stage IV colon cancer|stage iv colon cancer
5816263|NCT00024063|stage IV breast cancer|stage iv breast cancer
5816264|NCT00024063|stage IIIA breast cancer|stage iiia breast cancer
5816265|NCT00024063|recurrent breast cancer|recurrent breast cancer
5829749|NCT00059579|MDD|mdd
5816266|NCT00024063|stage III gastric cancer|stage iii gastric cancer
5816267|NCT00024063|stage IV gastric cancer|stage iv gastric cancer
5816268|NCT00024063|recurrent gastric cancer|recurrent gastric cancer
5816269|NCT00024063|stage IIIB breast cancer|stage iiib breast cancer
5816270|NCT00024063|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5816271|NCT00024063|stage II pancreatic cancer|stage ii pancreatic cancer
5816272|NCT00024063|stage III pancreatic cancer|stage iii pancreatic cancer
5816273|NCT00024063|recurrent pancreatic cancer|recurrent pancreatic cancer
5816274|NCT00024063|stage III rectal cancer|stage iii rectal cancer
5816275|NCT00024063|stage IV rectal cancer|stage iv rectal cancer
5816276|NCT00024063|recurrent colon cancer|recurrent colon cancer
5816277|NCT00024063|recurrent rectal cancer|recurrent rectal cancer
5816278|NCT00024063|refractory multiple myeloma|refractory multiple myeloma
5816279|NCT00024063|stage III renal cell cancer|stage iii renal cell cancer
5816280|NCT00024063|stage IV renal cell cancer|stage iv renal cell cancer
5816281|NCT00024063|recurrent renal cell cancer|recurrent renal cell cancer
5816282|NCT00024063|stage III multiple myeloma|stage iii multiple myeloma
5816283|NCT00024063|stage III prostate cancer|stage iii prostate cancer
5816284|NCT00024063|stage IV prostate cancer|stage iv prostate cancer
5816285|NCT00024063|recurrent prostate cancer|recurrent prostate cancer
5816286|NCT00024063|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5816287|NCT00024063|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5816288|NCT00024063|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5816289|NCT00024063|male breast cancer|male breast cancer
5816290|NCT00024063|stage IV pancreatic cancer|stage iv pancreatic cancer
5816291|NCT00003107|stage IV breast cancer|stage iv breast cancer
5816292|NCT00003107|stage IIIA breast cancer|stage iiia breast cancer
5816293|NCT00003107|stage IIIB breast cancer|stage iiib breast cancer
5816294|NCT00003107|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5816295|NCT00003107|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5816296|NCT00003107|refractory multiple myeloma|refractory multiple myeloma
5816297|NCT00003107|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5816298|NCT00003107|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5816299|NCT00003107|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5816300|NCT00003107|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816301|NCT00003107|disseminated neuroblastoma|disseminated neuroblastoma
5816302|NCT00003107|recurrent neuroblastoma|recurrent neuroblastoma
5816303|NCT00003107|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5816304|NCT00003107|stage I multiple myeloma|stage i multiple myeloma
5816305|NCT00003107|stage II multiple myeloma|stage ii multiple myeloma
5816306|NCT00003107|stage III multiple myeloma|stage iii multiple myeloma
5816307|NCT00003107|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5816308|NCT00003107|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5816309|NCT00003107|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5816310|NCT00003107|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5816311|NCT00003107|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5816312|NCT00003107|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5816313|NCT00003107|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5816314|NCT00003107|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5816315|NCT00003107|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816316|NCT00003107|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816317|NCT00003107|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5816318|NCT00003107|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5816319|NCT00003107|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5816320|NCT00003107|testicular embryonal carcinoma|testicular embryonal carcinoma
5816321|NCT00003107|testicular choriocarcinoma|testicular choriocarcinoma
5816322|NCT00003107|testicular teratoma|testicular teratoma
5816323|NCT00003107|testicular yolk sac tumor|testicular yolk sac tumor
5816324|NCT00003107|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5816325|NCT00003107|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5816326|NCT00003107|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5816327|NCT00003107|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5816328|NCT00003107|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5816329|NCT00003107|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5816330|NCT00003107|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5816331|NCT00003107|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5816332|NCT00003107|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5816333|NCT00003107|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5823393|NCT00071383|Proteomics|proteomics
5815775|NCT00081432|Seizures|seizures
5816334|NCT00003107|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5816335|NCT00003107|refractory hairy cell leukemia|refractory hairy cell leukemia
5816336|NCT00003107|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5816337|NCT00003107|ovarian yolk sac tumor|ovarian yolk sac tumor
5816338|NCT00003107|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5816339|NCT00003107|ovarian polyembryoma|ovarian polyembryoma
5816340|NCT00003107|ovarian choriocarcinoma|ovarian choriocarcinoma
5816341|NCT00003107|ovarian immature teratoma|ovarian immature teratoma
5816342|NCT00003107|ovarian mature teratoma|ovarian mature teratoma
5816343|NCT00003107|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5816344|NCT00003107|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5816345|NCT00003107|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5816346|NCT00003107|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5816347|NCT00003107|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5816348|NCT00003107|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5816349|NCT00003107|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5816350|NCT00003107|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5816351|NCT00003107|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5816352|NCT00003107|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5816353|NCT00003107|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5816354|NCT00003107|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5816355|NCT00003107|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5816356|NCT00003107|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5816357|NCT00003107|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5816358|NCT00003107|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5816359|NCT00003107|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5816360|NCT00003107|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5816361|NCT00003107|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5816362|NCT00003107|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5816363|NCT00003107|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816364|NCT00003107|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816365|NCT00003107|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816366|NCT00003107|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816367|NCT00003107|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816368|NCT00003107|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816369|NCT00003107|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816370|NCT00003107|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816371|NCT00003107|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816372|NCT00003107|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5816373|NCT00003107|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5816374|NCT00003107|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5816375|NCT00003107|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5816376|NCT00003107|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5816377|NCT00003107|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5816378|NCT00003107|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5816379|NCT00003107|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5816380|NCT00003107|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5816381|NCT00003107|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5816382|NCT00003107|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5816383|NCT00003107|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5816384|NCT00003107|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5816385|NCT00003107|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5816386|NCT00003107|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5816387|NCT00003107|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5816388|NCT00003107|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5816389|NCT00003107|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816390|NCT00003107|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5816391|NCT00003107|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5816392|NCT00003107|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5816393|NCT00003107|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5816394|NCT00003107|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5816395|NCT00003107|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5816396|NCT00003107|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5816397|NCT00003107|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5816398|NCT00003107|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5816399|NCT00003107|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5816400|NCT00003107|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5816401|NCT00003107|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5816403|NCT00003103|stage IV colon cancer|stage iv colon cancer
5816404|NCT00003103|stage IV breast cancer|stage iv breast cancer
5816405|NCT00003103|stage IIIA breast cancer|stage iiia breast cancer
5816406|NCT00003103|recurrent breast cancer|recurrent breast cancer
5816407|NCT00003103|stage IIIB breast cancer|stage iiib breast cancer
5816408|NCT00003103|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5816409|NCT00003103|stage III rectal cancer|stage iii rectal cancer
5816410|NCT00003103|stage IV rectal cancer|stage iv rectal cancer
5816411|NCT00003103|recurrent colon cancer|recurrent colon cancer
5816412|NCT00003103|recurrent rectal cancer|recurrent rectal cancer
5816413|NCT00003103|stage II esophageal cancer|stage ii esophageal cancer
5816414|NCT00003103|stage III esophageal cancer|stage iii esophageal cancer
5816415|NCT00003103|stage IV esophageal cancer|stage iv esophageal cancer
5816416|NCT00003103|recurrent esophageal cancer|recurrent esophageal cancer
5816417|NCT00003103|stage III renal cell cancer|stage iii renal cell cancer
5816418|NCT00003103|stage IV renal cell cancer|stage iv renal cell cancer
5816419|NCT00003103|recurrent renal cell cancer|recurrent renal cell cancer
5816420|NCT00003103|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5816421|NCT00003103|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5816422|NCT00003103|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816423|NCT00003103|stage III Wilms tumor|stage iii wilms tumor
5816425|NCT00003103|stage V Wilms tumor|stage v wilms tumor
5816426|NCT00003103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5816427|NCT00003103|stage III bladder cancer|stage iii bladder cancer
5816428|NCT00003103|recurrent bladder cancer|recurrent bladder cancer
5816429|NCT00003103|stage IV bladder cancer|stage iv bladder cancer
5816430|NCT00003103|stage III prostate cancer|stage iii prostate cancer
5816431|NCT00003103|stage IV prostate cancer|stage iv prostate cancer
5816433|NCT00003103|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5816434|NCT00003103|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5816435|NCT00003103|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5816436|NCT00003103|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5816437|NCT00003103|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5816438|NCT00003103|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5816439|NCT00003103|ovarian stromal cancer|ovarian stromal cancer
5816440|NCT00003103|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5816441|NCT00003103|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5816442|NCT00003103|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5816443|NCT00003103|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5816444|NCT00003103|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5816445|NCT00003103|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5816446|NCT00003103|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5816447|NCT00003103|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5816448|NCT00003103|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5816449|NCT00003103|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5816450|NCT00003103|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5816451|NCT00003103|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5816452|NCT00003103|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5816453|NCT00003103|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5816454|NCT00003103|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5816455|NCT00003103|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5816456|NCT00003103|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5816457|NCT00003103|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5816458|NCT00003103|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5816459|NCT00003103|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5816460|NCT00003103|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5816461|NCT00003103|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5815913|NCT00003840|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5815914|NCT00003840|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5815922|NCT00005943|stage IV melanoma|stage iv melanoma
5816462|NCT00003103|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5846510|NCT00044252|Allopregnanolone|allopregnanolone
5816463|NCT00003103|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5816464|NCT00003103|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5816465|NCT00003103|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5816466|NCT00003103|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5816467|NCT00003103|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5816468|NCT00003103|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5816469|NCT00003103|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5816470|NCT00003103|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5816471|NCT00003103|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5816472|NCT00003103|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5816473|NCT00003103|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5816474|NCT00003103|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5816475|NCT00003103|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5816476|NCT00003103|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5816477|NCT00003103|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5816478|NCT00003103|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5816479|NCT00003103|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5816480|NCT00003103|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5816481|NCT00003103|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5816482|NCT00003103|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5816483|NCT00003103|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5816484|NCT00003103|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5816486|NCT00003103|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5816487|NCT00003103|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5816488|NCT00003103|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5816489|NCT00003103|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5816490|NCT00003103|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5816491|NCT00003103|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5816492|NCT00003103|ovarian sarcoma|ovarian sarcoma
5816493|NCT00003103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5816494|NCT00003103|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5816495|NCT00003012|stage II breast cancer|stage ii breast cancer
5816496|NCT00003012|stage IIIA breast cancer|stage iiia breast cancer
5816497|NCT00002987|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5816498|NCT00002987|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5816499|NCT00002814|recurrent adult brain tumor|recurrent adult brain tumor
5816500|NCT00002814|adult glioblastoma|adult glioblastoma
5816501|NCT00002814|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5816502|NCT00002814|adult giant cell glioblastoma|adult giant cell glioblastoma
5816503|NCT00002814|adult gliosarcoma|adult gliosarcoma
5816504|NCT00002774|stage III|stage iii
5816505|NCT00002774|stage IV|stage iv
5816506|NCT00002774|recurrent|recurrent
5816507|NCT00002714|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5816508|NCT00002714|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5816509|NCT00002600|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816510|NCT00002600|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5816511|NCT00002600|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5816512|NCT00002600|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5816513|NCT00002600|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5816514|NCT00002600|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5816515|NCT00002600|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5816516|NCT00002600|fallopian tube cancer|fallopian tube cancer
5816517|NCT00002600|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5816518|NCT00002525|stage II colon cancer|stage ii colon cancer
5816519|NCT00002525|stage III colon cancer|stage iii colon cancer
5816520|NCT00002494|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5816521|NCT00002494|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5816522|NCT00002494|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5816523|NCT00002494|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5816524|NCT00002494|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5816525|NCT00002494|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5816526|NCT00002494|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5816527|NCT00002494|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5816528|NCT00080470|Incontinence|incontinence
5816531|NCT00080470|Urge|urge
5816532|NCT00080470|Stimulation|stimulation
5816533|NCT00080470|Nerve|nerve
5816534|NCT00080470|Microstimulator|microstimulator
5816535|NCT00080470|Neuromodulation|neuromodulation
5816536|NCT00080457|Primary or secondary pulmonary arterial hypertension|primary or secondary pulmonary arterial hypertension
5816537|NCT00080457|Scleroderma|scleroderma
5816538|NCT00080457|Connective tissue disease|connective tissue disease
5816539|NCT00080457|Congenital heart defects|congenital heart defects
5816540|NCT00080457|Lupus|lupus
5816541|NCT00080457|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5816542|NCT00023816|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5816543|NCT00023816|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5816544|NCT00023816|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5816545|NCT00023816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5816546|NCT00023816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5816547|NCT00023816|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5816548|NCT00023816|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5816549|NCT00023816|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5816550|NCT00023816|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5816551|NCT00023816|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5816552|NCT00023816|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5862657|NCT00001549|Diagnostic Puzzles|diagnostic puzzles
5816553|NCT00023816|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5816554|NCT00023816|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5816555|NCT00023816|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5816556|NCT00023816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816557|NCT00023816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816558|NCT00023816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816559|NCT00023816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816560|NCT00023816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816561|NCT00023816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816562|NCT00023816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816563|NCT00023816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816564|NCT00023816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816565|NCT00023816|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5816566|NCT00023816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5816567|NCT00023816|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5816568|NCT00023816|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5816569|NCT00023816|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5816570|NCT00023816|intraocular lymphoma|intraocular lymphoma
5816571|NCT00023816|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5816572|NCT00023816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816573|NCT00023816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5816574|NCT00023816|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5816575|NCT00023816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5816576|NCT00023816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5816577|NCT00023816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5816578|NCT00023816|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5816579|NCT00023816|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5816658|NCT00009841|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5816580|NCT00023816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5816581|NCT00023816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5816582|NCT00023816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5816583|NCT00022386|stage I breast cancer|stage i breast cancer
5816584|NCT00022386|stage II breast cancer|stage ii breast cancer
5816585|NCT00022386|stage IIIA breast cancer|stage iiia breast cancer
5816586|NCT00022386|stage IIIB breast cancer|stage iiib breast cancer
5816588|NCT00022386|fatigue|fatigue
5816589|NCT00022256|adult glioblastoma|adult glioblastoma
5816590|NCT00022256|adult giant cell glioblastoma|adult giant cell glioblastoma
5816591|NCT00022256|adult gliosarcoma|adult gliosarcoma
5816592|NCT00020605|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5816593|NCT00020605|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5816594|NCT00020540|stage IV renal cell cancer|stage iv renal cell cancer
5816595|NCT00020540|recurrent renal cell cancer|recurrent renal cell cancer
5816596|NCT00020540|stage IV melanoma|stage iv melanoma
5816597|NCT00020540|recurrent melanoma|recurrent melanoma
5816598|NCT00019071|adult glioblastoma|adult glioblastoma
5816599|NCT00019071|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5816600|NCT00019071|adult giant cell glioblastoma|adult giant cell glioblastoma
5816601|NCT00019071|adult gliosarcoma|adult gliosarcoma
5816602|NCT00019058|adult glioblastoma|adult glioblastoma
5816603|NCT00019058|adult giant cell glioblastoma|adult giant cell glioblastoma
5816604|NCT00019058|adult gliosarcoma|adult gliosarcoma
5816605|NCT00016042|stage IV colon cancer|stage iv colon cancer
5816606|NCT00016042|stage IV rectal cancer|stage iv rectal cancer
5816607|NCT00016042|recurrent colon cancer|recurrent colon cancer
5816608|NCT00016042|recurrent rectal cancer|recurrent rectal cancer
5816609|NCT00016042|stage IV renal cell cancer|stage iv renal cell cancer
5816610|NCT00016042|recurrent renal cell cancer|recurrent renal cell cancer
5816611|NCT00014573|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5816612|NCT00014573|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5816613|NCT00014573|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5816614|NCT00014573|recurrent adult brain tumor|recurrent adult brain tumor
5816615|NCT00014573|adult brain stem glioma|adult brain stem glioma
5816616|NCT00014573|adult medulloblastoma|adult medulloblastoma
5816617|NCT00014573|adult glioblastoma|adult glioblastoma
5816618|NCT00014573|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5816619|NCT00014573|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5816620|NCT00014573|childhood choroid plexus tumor|childhood choroid plexus tumor
5816621|NCT00014573|childhood grade III meningioma|childhood grade iii meningioma
5816622|NCT00014573|adult anaplastic ependymoma|adult anaplastic ependymoma
5816623|NCT00014573|adult mixed glioma|adult mixed glioma
5816624|NCT00014573|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5816625|NCT00014573|adult ependymoblastoma|adult ependymoblastoma
5816626|NCT00014573|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5844012|NCT00051168|OHT|oht
5816628|NCT00014573|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5816629|NCT00014573|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5816630|NCT00014573|adult choroid plexus tumor|adult choroid plexus tumor
5816631|NCT00014573|recurrent childhood ependymoma|recurrent childhood ependymoma
5816632|NCT00014573|adult grade III meningioma|adult grade iii meningioma
5816633|NCT00014573|adult giant cell glioblastoma|adult giant cell glioblastoma
5816634|NCT00014573|adult gliosarcoma|adult gliosarcoma
5816636|NCT00080418|cancer|cancer
5816637|NCT00080418|NeoPharm|neopharm
5816638|NCT00080418|liposomes|liposomes
5816639|NCT00080418|Taxol|taxol
5816640|NCT00080418|paclitaxel|paclitaxel
5816641|NCT00080418|anti-cancer|anti-cancer
5816642|NCT00080418|advanced neoplasm|advanced neoplasm
5816643|NCT00080418|advanced cancer|advanced cancer
5816644|NCT00080418|chemotherapy|chemotherapy
5816645|NCT00080418|refractory cancer|refractory cancer
5816646|NCT00080418|metastatic cancer|metastatic cancer
5816647|NCT00080405|Relapsed|relapsed
5816648|NCT00080405|Multiple Myeloma|multiple myeloma
5816649|NCT00080405|Pharmacokinetic|pharmacokinetic
5816650|NCT00080405|Pharmacodynamic|pharmacodynamic
5816651|NCT00009841|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5816652|NCT00009841|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5816653|NCT00009841|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5816654|NCT00009841|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5816655|NCT00009841|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5816656|NCT00009841|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5816657|NCT00009841|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5816723|NCT00006368|stage IV breast cancer|stage iv breast cancer
5816724|NCT00006368|recurrent breast cancer|recurrent breast cancer
5816725|NCT00006368|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5816726|NCT00006368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5816727|NCT00006368|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5816728|NCT00006368|recurrent small cell lung cancer|recurrent small cell lung cancer
5816729|NCT00006368|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5816730|NCT00006368|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5816731|NCT00006368|gastrinoma|gastrinoma
5816732|NCT00006368|recurrent adult brain tumor|recurrent adult brain tumor
5816733|NCT00006368|insulinoma|insulinoma
5816734|NCT00006368|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5816735|NCT00006368|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5816736|NCT00006368|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5816737|NCT00006368|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5816738|NCT00006368|recurrent pituitary tumor|recurrent pituitary tumor
5816739|NCT00006368|TSH producing pituitary tumor|tsh producing pituitary tumor
5816740|NCT00006368|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5816742|NCT00006368|adult craniopharyngioma|adult craniopharyngioma
5816743|NCT00006368|adult medulloblastoma|adult medulloblastoma
5816744|NCT00006368|adult meningioma|adult meningioma
5816745|NCT00006368|adult glioblastoma|adult glioblastoma
5816746|NCT00006368|stage IV melanoma|stage iv melanoma
5816748|NCT00006368|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5816749|NCT00006368|WDHA syndrome|wdha syndrome
5816750|NCT00006368|somatostatinoma|somatostatinoma
5816751|NCT00006368|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5816752|NCT00006368|glucagonoma|glucagonoma
5816753|NCT00006368|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5816754|NCT00006368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5816755|NCT00006368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5816756|NCT00006368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5816757|NCT00006368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5816758|NCT00006368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5816759|NCT00006368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5816760|NCT00006368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5816761|NCT00006368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5816762|NCT00006368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5816763|NCT00006368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816764|NCT00006368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816765|NCT00006368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816766|NCT00006368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816767|NCT00006368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816768|NCT00006368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5816769|NCT00006368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5816770|NCT00006368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5816771|NCT00006368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5816772|NCT00006368|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5816773|NCT00006368|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5816774|NCT00006368|adult anaplastic ependymoma|adult anaplastic ependymoma
5816775|NCT00006368|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5816776|NCT00006368|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5816777|NCT00006368|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5816778|NCT00006368|adult subependymoma|adult subependymoma
5816779|NCT00006368|adult ependymoblastoma|adult ependymoblastoma
5816780|NCT00006368|adult pineocytoma|adult pineocytoma
5816781|NCT00006368|adult pineoblastoma|adult pineoblastoma
5816782|NCT00006368|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5816783|NCT00006368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5816784|NCT00006368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5816785|NCT00006368|adult choroid plexus tumor|adult choroid plexus tumor
5816786|NCT00006368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5816787|NCT00006368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5816788|NCT00006368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5816789|NCT00006368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5816790|NCT00006368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5816791|NCT00006368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5816792|NCT00006368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5816793|NCT00006368|adult grade III meningioma|adult grade iii meningioma
5816794|NCT00006368|adult giant cell glioblastoma|adult giant cell glioblastoma
5816795|NCT00006368|adult gliosarcoma|adult gliosarcoma
5816796|NCT00006052|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816797|NCT00006052|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5816798|NCT00006052|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5816799|NCT00006043|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5816800|NCT00006043|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5816801|NCT00006043|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5816802|NCT00006043|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5816803|NCT00006032|stage IV breast cancer|stage iv breast cancer
5816804|NCT00006032|recurrent breast cancer|recurrent breast cancer
5816806|NCT00006031|radioactive seed|radioactive seed
5816807|NCT00006031|nonpalpable lesions|nonpalpable lesions
5816808|NCT00005948|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5816218|NCT00080535|CTCL|ctcl
5816809|NCT00005948|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816810|NCT00005948|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816811|NCT00005860|stage IV colon cancer|stage iv colon cancer
5816812|NCT00005860|stage IV gastric cancer|stage iv gastric cancer
5816813|NCT00005860|recurrent gastric cancer|recurrent gastric cancer
5816814|NCT00005860|recurrent pancreatic cancer|recurrent pancreatic cancer
5816815|NCT00005860|recurrent colon cancer|recurrent colon cancer
5816816|NCT00005860|regional neuroblastoma|regional neuroblastoma
5816817|NCT00005860|stage 4S neuroblastoma|stage 4s neuroblastoma
5816818|NCT00005860|recurrent neuroblastoma|recurrent neuroblastoma
5816819|NCT00005860|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5816820|NCT00005860|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5816821|NCT00005860|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5816822|NCT00005860|advanced adult primary liver cancer|advanced adult primary liver cancer
5816823|NCT00005860|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5816824|NCT00005860|gastrinoma|gastrinoma
5816825|NCT00005860|small intestine adenocarcinoma|small intestine adenocarcinoma
5816826|NCT00005860|small intestine lymphoma|small intestine lymphoma
5816827|NCT00005860|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5816828|NCT00005860|unresectable gallbladder cancer|unresectable gallbladder cancer
5816829|NCT00005860|recurrent gallbladder cancer|recurrent gallbladder cancer
5816830|NCT00005860|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5816831|NCT00005860|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5816832|NCT00005860|recurrent small intestine cancer|recurrent small intestine cancer
5816833|NCT00005860|insulinoma|insulinoma
5816834|NCT00005860|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5816835|NCT00005860|WDHA syndrome|wdha syndrome
5816836|NCT00005860|somatostatinoma|somatostatinoma
5816837|NCT00005860|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5816838|NCT00005860|glucagonoma|glucagonoma
5816839|NCT00005860|regional pheochromocytoma|regional pheochromocytoma
5816840|NCT00005860|metastatic pheochromocytoma|metastatic pheochromocytoma
5816841|NCT00005860|recurrent pheochromocytoma|recurrent pheochromocytoma
5816842|NCT00005860|extragonadal germ cell tumor|extragonadal germ cell tumor
5816844|NCT00005860|malignant ascites|malignant ascites
5816845|NCT00005860|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5816846|NCT00005860|carcinoma of the appendix|carcinoma of the appendix
5816847|NCT00005860|pseudomyxoma peritonei|pseudomyxoma peritonei
5816848|NCT00005860|fallopian tube cancer|fallopian tube cancer
5816849|NCT00005860|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5816850|NCT00005860|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5816851|NCT00005860|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5816852|NCT00005860|stage IV pancreatic cancer|stage iv pancreatic cancer
5816853|NCT00005798|stage II breast cancer|stage ii breast cancer
5816854|NCT00005798|stage IV breast cancer|stage iv breast cancer
5816855|NCT00005798|stage IIIA breast cancer|stage iiia breast cancer
5816856|NCT00005798|recurrent breast cancer|recurrent breast cancer
5816857|NCT00005798|stage IIIB breast cancer|stage iiib breast cancer
5816858|NCT00005798|inflammatory breast cancer|inflammatory breast cancer
5816859|NCT00005628|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5816860|NCT00005628|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5816861|NCT00005618|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5816862|NCT00005618|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816863|NCT00005618|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816864|NCT00005618|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5816865|NCT00005615|stage III melanoma|stage iii melanoma
5816866|NCT00005615|recurrent melanoma|recurrent melanoma
5816867|NCT00005577|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5816868|NCT00005097|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5816869|NCT00005068|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5816870|NCT00003864|stage III esophageal cancer|stage iii esophageal cancer
5816871|NCT00003864|stage IV esophageal cancer|stage iv esophageal cancer
5816872|NCT00003864|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5816873|NCT00080431|Reservoir|reservoir
5816874|NCT00080431|Viral Load|viral load
5816875|NCT00080431|Immunosuppression|immunosuppression
5816879|NCT00080431|HAART|haart
5816880|NCT00080431|Immunosuppressive Drug|immunosuppressive drug
5816881|NCT00080431|Viral Reservoirs|viral reservoirs
5816882|NCT00005031|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5816883|NCT00004248|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5816884|NCT00004248|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5816885|NCT00004248|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5816886|NCT00004097|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5816887|NCT00004097|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5816888|NCT00004097|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5816889|NCT00004097|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5816890|NCT00004097|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5816891|NCT00004097|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5816892|NCT00004097|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5816893|NCT00004097|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5816894|NCT00004097|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5816895|NCT00004097|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5816896|NCT00004097|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5816897|NCT00004097|stage III laryngeal cancer|stage iii laryngeal cancer
5816898|NCT00004097|stage IV laryngeal cancer|stage iv laryngeal cancer
5816899|NCT00004097|recurrent laryngeal cancer|recurrent laryngeal cancer
5816900|NCT00004097|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5816901|NCT00004097|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5816902|NCT00004097|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5816903|NCT00004097|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5816904|NCT00004097|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5816905|NCT00004097|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5816906|NCT00003967|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816907|NCT00003967|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5816908|NCT00003967|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5816909|NCT00003967|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5816910|NCT00003967|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5816911|NCT00003967|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5816912|NCT00003967|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5816913|NCT00003967|fallopian tube cancer|fallopian tube cancer
5816914|NCT00003967|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5816916|NCT00003883|stage IV breast cancer|stage iv breast cancer
5816918|NCT00003883|stage IIIB breast cancer|stage iiib breast cancer
5816919|NCT00003883|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5816920|NCT00003883|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5816921|NCT00003883|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5816922|NCT00003883|refractory multiple myeloma|refractory multiple myeloma
5816923|NCT00003883|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5816924|NCT00003883|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5816925|NCT00003883|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5816926|NCT00003883|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5816927|NCT00003883|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5816928|NCT00003883|disseminated neuroblastoma|disseminated neuroblastoma
5816929|NCT00003883|recurrent neuroblastoma|recurrent neuroblastoma
5816930|NCT00003883|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5816931|NCT00003883|stage I multiple myeloma|stage i multiple myeloma
5816932|NCT00003883|stage II multiple myeloma|stage ii multiple myeloma
5816933|NCT00003883|stage III multiple myeloma|stage iii multiple myeloma
5816934|NCT00003883|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5816935|NCT00003883|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5816936|NCT00003883|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5816937|NCT00003883|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5816938|NCT00003883|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5816939|NCT00003883|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5816940|NCT00003883|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5816941|NCT00003883|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5816942|NCT00003883|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5816943|NCT00003883|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5816944|NCT00003883|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5816945|NCT00003883|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5816946|NCT00003883|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5817210|NCT00080275|Atherosclerosis|atherosclerosis
5816947|NCT00003883|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5817217|NCT00080275|Niacin ER/simvastatin|niacin er/simvastatin
5816948|NCT00003883|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5816949|NCT00003883|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5816950|NCT00003883|testicular embryonal carcinoma|testicular embryonal carcinoma
5819010|NCT00078715|Fast|fast
5816951|NCT00003883|testicular choriocarcinoma|testicular choriocarcinoma
5816952|NCT00003883|testicular teratoma|testicular teratoma
5816953|NCT00003883|testicular yolk sac tumor|testicular yolk sac tumor
5816954|NCT00003883|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5823978|NCT00069927|depression|depression
5816955|NCT00003883|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5816956|NCT00003883|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5816957|NCT00003883|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5816958|NCT00003883|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5816959|NCT00003883|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5816960|NCT00003883|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5816961|NCT00003883|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5816962|NCT00003883|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5816963|NCT00003883|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5816964|NCT00003883|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5816965|NCT00003883|refractory hairy cell leukemia|refractory hairy cell leukemia
5816966|NCT00003883|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5816967|NCT00003883|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5816968|NCT00003883|ovarian yolk sac tumor|ovarian yolk sac tumor
5816969|NCT00003883|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5816970|NCT00003883|ovarian polyembryoma|ovarian polyembryoma
5816971|NCT00003883|ovarian choriocarcinoma|ovarian choriocarcinoma
5816972|NCT00003883|ovarian immature teratoma|ovarian immature teratoma
5816973|NCT00003883|ovarian mature teratoma|ovarian mature teratoma
5816974|NCT00003883|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5816975|NCT00003883|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5816976|NCT00003883|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5816977|NCT00003883|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5816978|NCT00003883|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5816979|NCT00003883|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5816980|NCT00003883|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5816981|NCT00003883|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5816982|NCT00003883|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5816983|NCT00003883|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5816984|NCT00003883|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5816985|NCT00003883|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5816986|NCT00003883|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5816987|NCT00003883|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5816988|NCT00003883|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5816989|NCT00003883|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5816990|NCT00003883|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5816991|NCT00003883|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5816992|NCT00003883|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5816993|NCT00003883|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5816994|NCT00003883|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5816995|NCT00003883|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5816996|NCT00003883|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5816997|NCT00003883|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5816998|NCT00003883|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5816999|NCT00003883|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817000|NCT00003883|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817001|NCT00003883|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5817002|NCT00003883|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817003|NCT00003883|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5817004|NCT00003883|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5817005|NCT00003883|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5817006|NCT00003883|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5817007|NCT00003883|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5817009|NCT00003883|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5817010|NCT00003883|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5817011|NCT00003883|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5817012|NCT00003883|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5817013|NCT00003883|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5817014|NCT00003883|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5817015|NCT00003883|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5817016|NCT00003883|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5817017|NCT00003883|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5817018|NCT00003883|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5817019|NCT00003883|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5817020|NCT00003883|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5817021|NCT00003883|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5817022|NCT00003883|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817023|NCT00003883|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817024|NCT00003883|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5817025|NCT00003883|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5817026|NCT00003883|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5817027|NCT00003883|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5817028|NCT00003883|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5817029|NCT00003883|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817030|NCT00003883|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5817031|NCT00003883|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5817032|NCT00003883|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5817033|NCT00003883|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5817034|NCT00003883|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817035|NCT00003883|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817036|NCT00003883|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817037|NCT00003883|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5817038|NCT00003769|stage II pancreatic cancer|stage ii pancreatic cancer
5817039|NCT00003769|stage III pancreatic cancer|stage iii pancreatic cancer
5817040|NCT00003769|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5817042|NCT00003657|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5817043|NCT00003657|chondrosarcoma|chondrosarcoma
5817044|NCT00003657|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5817045|NCT00003657|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5817046|NCT00003657|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5813680|NCT00082030|Depression|depression
5817048|NCT00003657|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817049|NCT00003657|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5817050|NCT00003657|recurrent small cell lung cancer|recurrent small cell lung cancer
5817051|NCT00003657|recurrent osteosarcoma|recurrent osteosarcoma
5817052|NCT00003657|stage III bladder cancer|stage iii bladder cancer
5817053|NCT00003657|recurrent bladder cancer|recurrent bladder cancer
5817054|NCT00003657|stage IV bladder cancer|stage iv bladder cancer
5817055|NCT00003657|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5817056|NCT00003657|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5817057|NCT00003657|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5817058|NCT00003657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817059|NCT00003657|classic Kaposi sarcoma|classic kaposi sarcoma
5817060|NCT00003657|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5817061|NCT00003657|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5817062|NCT00003657|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5817063|NCT00003657|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5817064|NCT00003657|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5817065|NCT00003657|ovarian stromal cancer|ovarian stromal cancer
5817066|NCT00003657|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5817067|NCT00003657|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5817068|NCT00003657|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5817069|NCT00003657|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5817070|NCT00003657|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5817071|NCT00003657|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5817072|NCT00003657|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5817073|NCT00003657|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5817211|NCT00080275|Hypercholesterolemia|hypercholesterolemia
5817074|NCT00003657|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5817075|NCT00003657|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5817076|NCT00003657|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5817077|NCT00003657|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5817078|NCT00003657|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5816530|NCT00080470|Urinary|urinary
5817079|NCT00003657|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5817080|NCT00003657|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5817081|NCT00003657|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5817082|NCT00003657|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5817083|NCT00003657|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5817084|NCT00003657|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5817085|NCT00003657|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5817086|NCT00003657|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5817087|NCT00003657|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5817088|NCT00003657|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5817089|NCT00003657|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5817090|NCT00003657|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5817091|NCT00003657|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5817092|NCT00003657|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5817093|NCT00003657|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5817094|NCT00003657|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5817095|NCT00003657|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5817096|NCT00003657|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5817097|NCT00003657|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5817098|NCT00003657|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5817099|NCT00003657|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5817100|NCT00003657|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5817101|NCT00003657|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5817102|NCT00003657|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5817103|NCT00003657|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5817104|NCT00003657|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5817105|NCT00003657|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5817106|NCT00003657|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5817107|NCT00003657|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5817108|NCT00003657|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817109|NCT00003657|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5817110|NCT00003657|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5817111|NCT00003657|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5817112|NCT00003657|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817113|NCT00003657|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5817114|NCT00003657|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5817115|NCT00003657|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5817116|NCT00003657|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817117|NCT00003657|extragonadal germ cell tumor|extragonadal germ cell tumor
5817118|NCT00003657|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5817119|NCT00003657|stage III uterine sarcoma|stage iii uterine sarcoma
5817120|NCT00003657|stage IV uterine sarcoma|stage iv uterine sarcoma
5817121|NCT00003657|recurrent uterine sarcoma|recurrent uterine sarcoma
5817122|NCT00003657|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5817123|NCT00003657|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5817125|NCT00003657|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5817126|NCT00003657|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5817127|NCT00003657|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5817218|NCT00080275|Total Cholesterol|total cholesterol
5817128|NCT00003657|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5817129|NCT00003657|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5817130|NCT00003635|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817131|NCT00003635|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5817132|NCT00003635|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5817133|NCT00003412|stage IV breast cancer|stage iv breast cancer
5817135|NCT00003402|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5817136|NCT00003402|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5817137|NCT00003402|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5817138|NCT00003402|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817139|NCT00003402|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5817140|NCT00003402|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5817141|NCT00003402|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5817142|NCT00003402|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5817143|NCT00003402|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817144|NCT00003402|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817145|NCT00003402|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5817146|NCT00003402|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817147|NCT00003402|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817148|NCT00080392|Gene Transfer|gene transfer
5817149|NCT00080392|Therapeutic Angiogenesis|therapeutic angiogenesis
5817150|NCT00080392|Peripheral Arterial Disease|peripheral arterial disease
5817151|NCT00080392|Perfusion|perfusion
5817152|NCT00080392|Magnetic Resonance Imaging|magnetic resonance imaging
5817153|NCT00080392|Peripheral Vascular Disease|peripheral vascular disease
5817154|NCT00080392|Claudication|claudication
5817156|NCT00080392|Leg Claudication|leg claudication
5817157|NCT00080392|Intermittent Claudication|intermittent claudication
5817158|NCT00080314|Bipolar 1 Disorder, depressed|bipolar 1 disorder, depressed
5817159|NCT00080301|Metastatic Breast Cancer|metastatic breast cancer
5817160|NCT00003345|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5817161|NCT00003345|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5817162|NCT00003345|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5817163|NCT00003345|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5817164|NCT00003345|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817165|NCT00003345|fallopian tube cancer|fallopian tube cancer
5817166|NCT00003345|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5817167|NCT00003192|stage III gastric cancer|stage iii gastric cancer
5817169|NCT00003192|recurrent gastric cancer|recurrent gastric cancer
5817170|NCT00003192|stage III esophageal cancer|stage iii esophageal cancer
5817171|NCT00003192|stage IV esophageal cancer|stage iv esophageal cancer
5817172|NCT00003192|recurrent esophageal cancer|recurrent esophageal cancer
5817173|NCT00003192|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5817174|NCT00003157|stage IV gastric cancer|stage iv gastric cancer
5817175|NCT00003157|recurrent gastric cancer|recurrent gastric cancer
5817176|NCT00003157|recurrent pancreatic cancer|recurrent pancreatic cancer
5817177|NCT00003157|stage IV pancreatic cancer|stage iv pancreatic cancer
5817178|NCT00003149|stage I multiple myeloma|stage i multiple myeloma
5817179|NCT00003149|stage II multiple myeloma|stage ii multiple myeloma
5817180|NCT00003149|stage III multiple myeloma|stage iii multiple myeloma
5817181|NCT00002974|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5817182|NCT00002974|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5817183|NCT00080366|Essential Tremor|essential tremor
5817184|NCT00080366|Cross over Design|cross over design
5817185|NCT00080366|Accelerometry|accelerometry
5817186|NCT00080366|Placebo|placebo
5817187|NCT00080366|Alcohol Responsive|alcohol responsive
5817188|NCT00080366|Double Blind|double blind
5817189|NCT00080366|1-Octanol|1-octanol
5817190|NCT00080353|Complete Tumor Regression|complete tumor regression
5817191|NCT00080353|Cell Survival|cell survival
5817192|NCT00080353|Chemotherapy Preparative Regimen|chemotherapy preparative regimen
5817193|NCT00080353|IL-2|il-2
5817194|NCT00080353|Toxicity|toxicity
5817195|NCT00080353|Metastatic Melanoma|metastatic melanoma
5817196|NCT00080288|Excessive Sleepiness|excessive sleepiness
5817197|NCT00080288|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
5817198|NCT00080288|Chronic SWSD|chronic swsd
5817199|NCT00080288|Circadian Rhythm Disorder|circadian rhythm disorder
5817200|NCT00080288|Shift Worker|shift worker
5817201|NCT00080288|Cephalon|cephalon
5817202|NCT00080288|Cephalon, Inc|cephalon, inc
5817203|NCT00080288|Nuvigil|nuvigil
5817204|NCT00080275|Niacin|niacin
5817205|NCT00080275|Statin|statin
5817206|NCT00080275|Zocor|zocor
5817207|NCT00080275|Simvastatin|simvastatin
5817208|NCT00080275|Coronary Heart Disease|coronary heart disease
5817209|NCT00080275|Dyslipidemia|dyslipidemia
5817213|NCT00080275|High-Density Lipoprotein Cholesterol|high-density lipoprotein cholesterol
5817214|NCT00080275|Low-Density Lipoprotein Cholesterol|low-density lipoprotein cholesterol
5817219|NCT00080275|Triglycerides|triglycerides
5817220|NCT00080262|Metastatic Breast Cancer|metastatic breast cancer
5817221|NCT00080236|Liver Transplantation|liver transplantation
5817222|NCT00080223|pulmonary fibrosis|pulmonary fibrosis
5817223|NCT00080223|respiratory diseases|respiratory diseases
5817224|NCT00080158|Dysthymic Disorder|dysthymic disorder
5816635|NCT00080418|neoplasm|neoplasm
5817225|NCT00080158|Adolescent|adolescent
5817226|NCT00012142|stage IV prostate cancer|stage iv prostate cancer
5817227|NCT00002950|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817228|NCT00002947|stage IV renal cell cancer|stage iv renal cell cancer
5817229|NCT00002947|recurrent renal cell cancer|recurrent renal cell cancer
5817230|NCT00002947|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5817231|NCT00002947|recurrent small cell lung cancer|recurrent small cell lung cancer
5817232|NCT00002947|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5817233|NCT00002947|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5817235|NCT00002947|insulinoma|insulinoma
5817236|NCT00002947|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5817237|NCT00002947|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5817238|NCT00002947|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5817239|NCT00002947|iris melanoma|iris melanoma
5817240|NCT00002947|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5817241|NCT00002947|extraocular extension melanoma|extraocular extension melanoma
5817242|NCT00002947|recurrent intraocular melanoma|recurrent intraocular melanoma
5817243|NCT00002947|stage IV melanoma|stage iv melanoma
5817244|NCT00002947|recurrent melanoma|recurrent melanoma
5817245|NCT00002947|WDHA syndrome|wdha syndrome
5817246|NCT00002947|somatostatinoma|somatostatinoma
5817247|NCT00002947|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5817248|NCT00002947|glucagonoma|glucagonoma
5817249|NCT00002947|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5817250|NCT00002947|metastatic pheochromocytoma|metastatic pheochromocytoma
5817251|NCT00002947|recurrent pheochromocytoma|recurrent pheochromocytoma
5817252|NCT00002947|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5817253|NCT00002947|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817254|NCT00002947|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817255|NCT00002947|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5817256|NCT00002947|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5817257|NCT00002887|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5817258|NCT00002759|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5817259|NCT00002759|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5817260|NCT00002759|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5817261|NCT00002759|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5817262|NCT00002759|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5817263|NCT00002759|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5817264|NCT00002759|small intestine lymphoma|small intestine lymphoma
5817265|NCT00002759|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817266|NCT00002759|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5817267|NCT00002759|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5817268|NCT00002759|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5817269|NCT00002759|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5817270|NCT00002759|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5817271|NCT00002759|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5817272|NCT00002759|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5817273|NCT00002759|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5817274|NCT00002759|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5817275|NCT00002759|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5817276|NCT00002759|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5817277|NCT00002759|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5817278|NCT00002759|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5817279|NCT00002759|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5817280|NCT00002759|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5817281|NCT00002759|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5817282|NCT00002759|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5817283|NCT00002759|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5817284|NCT00002759|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817285|NCT00002759|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817286|NCT00002759|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5817287|NCT00002759|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5817288|NCT00002759|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5817289|NCT00002759|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817290|NCT00002759|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817291|NCT00002759|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5817292|NCT00002759|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817293|NCT00002759|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5817294|NCT00002759|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5817295|NCT00002759|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5817296|NCT00002759|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5817297|NCT00002759|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5817298|NCT00002759|neutropenia|neutropenia
5817299|NCT00002759|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5817300|NCT00002759|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5817301|NCT00002759|intraocular lymphoma|intraocular lymphoma
5817302|NCT00002759|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5817303|NCT00002759|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817304|NCT00002759|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817305|NCT00002759|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5817306|NCT00002759|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5817307|NCT00002759|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5817308|NCT00002759|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5817309|NCT00002759|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5817310|NCT00002759|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5817311|NCT00002759|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817312|NCT00002759|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5817313|NCT00002759|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5817314|NCT00002759|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5817315|NCT00002759|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5817316|NCT00002759|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817317|NCT00002759|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817318|NCT00002759|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817319|NCT00002592|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817320|NCT00002592|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817321|NCT00002592|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5817322|NCT00002536|stage IB cervical cancer|stage ib cervical cancer
5817323|NCT00002461|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5817324|NCT00002461|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5817325|NCT00002461|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5817326|NCT00002461|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5817327|NCT00002461|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5817328|NCT00002461|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817329|NCT00002461|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817330|NCT00002461|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5817331|NCT00002461|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5817332|NCT00002461|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5817333|NCT00002461|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817334|NCT00002461|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817335|NCT00002461|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819011|NCT00078715|Affective Disorder|affective disorder
5817336|NCT00002461|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817337|NCT00002461|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817338|NCT00002461|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817339|NCT00080210|elevated uric acid|elevated uric acid
5817340|NCT00080210|Elevated serum uric acid level|elevated serum uric acid level
5817341|NCT00080210|Symptomatic gout|symptomatic gout
5817342|NCT00080197|Breast Cancer|breast cancer
5817343|NCT00080197|Cancer of the Breast|cancer of the breast
5817344|NCT00080184|Fibromyalgia|fibromyalgia
5817345|NCT00080184|Electroencephalograph (EEG) biofeedback|electroencephalograph (eeg) biofeedback
5817346|NCT00080184|Electromagnetic stimulation|electromagnetic stimulation
5817347|NCT00080184|Neurofeedback|neurofeedback
5817348|NCT00080184|Neurotherapy|neurotherapy
5817349|NCT00080184|Complementary and Alternative Medicine|complementary and alternative medicine
5817350|NCT00080171|Osteoarthritis|osteoarthritis
5817351|NCT00080171|Knee Pain|knee pain
5817353|NCT00080145|Autistic Disorder|autistic disorder
5817354|NCT00080145|Asperger Syndrome|asperger syndrome
5817355|NCT00080132|HTG|htg
5817356|NCT00080132|Hypertriglyceridemia, Fredrickson Type I|hypertriglyceridemia, fredrickson type i
5817357|NCT00080132|Hypertriglyceridemia, Fredrickson Type V|hypertriglyceridemia, fredrickson type v
5817358|NCT00080119|Treatment Naive|treatment naive
5817359|NCT00080119|INH Prophylaxis|inh prophylaxis
5817360|NCT00080119|HIV Seronegativity|hiv seronegativity
5817361|NCT00080106|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5830918|NCT00056407|Prostate cancer prevention|prostate cancer prevention
5830919|NCT00056407|prostate|prostate
5830920|NCT00056407|BPH|bph
5817362|NCT00080106|Treatment Experienced|treatment experienced
5817363|NCT00080106|Treatment Interruption|treatment interruption
5817364|NCT00080106|Adenovirus Vector|adenovirus vector
5817365|NCT00008320|stage IV breast cancer|stage iv breast cancer
5817366|NCT00008320|recurrent breast cancer|recurrent breast cancer
5817367|NCT00008151|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5817368|NCT00008151|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817369|NCT00008151|refractory anemia with excess blasts|refractory anemia with excess blasts
5817370|NCT00008151|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5817371|NCT00008151|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5817372|NCT00008151|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5817373|NCT00008151|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5817374|NCT00008151|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5817375|NCT00006348|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5817376|NCT00006348|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5817377|NCT00006348|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5817378|NCT00006348|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5817379|NCT00006348|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5817380|NCT00006348|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5817381|NCT00006348|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5817382|NCT00006348|extramedullary plasmacytoma|extramedullary plasmacytoma
5817383|NCT00006348|refractory multiple myeloma|refractory multiple myeloma
5817384|NCT00006348|Waldenström macroglobulinemia|waldenström macroglobulinemia
5817385|NCT00006348|stage III multiple myeloma|stage iii multiple myeloma
5817386|NCT00006348|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5817387|NCT00006348|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5817388|NCT00006348|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5817389|NCT00006348|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5817390|NCT00006348|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817391|NCT00006348|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5817392|NCT00006348|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817393|NCT00006348|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817394|NCT00006348|small intestine lymphoma|small intestine lymphoma
5817395|NCT00006348|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5817396|NCT00006348|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817397|NCT00006348|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817398|NCT00006348|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5817399|NCT00006348|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5817400|NCT00006348|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5817401|NCT00006348|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5817402|NCT00006348|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5817403|NCT00006348|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5817404|NCT00006348|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5817406|NCT00006348|primary myelofibrosis|primary myelofibrosis
5817407|NCT00006348|essential thrombocythemia|essential thrombocythemia
5817408|NCT00006348|untreated hairy cell leukemia|untreated hairy cell leukemia
5817409|NCT00006348|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5817410|NCT00006348|refractory hairy cell leukemia|refractory hairy cell leukemia
5817411|NCT00006348|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5817412|NCT00006348|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5817413|NCT00006348|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5817414|NCT00006348|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5817415|NCT00006348|acute undifferentiated leukemia|acute undifferentiated leukemia
5817416|NCT00006348|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5817417|NCT00006348|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5817418|NCT00006348|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5817419|NCT00006348|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5817420|NCT00006348|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5821188|NCT00076453|Knee Pain|knee pain
5817421|NCT00006348|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5846511|NCT00044252|Catamenial Epilepsy|catamenial epilepsy
5817422|NCT00006348|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5817423|NCT00006348|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5817424|NCT00006348|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818115|NCT00079768|Anti-CD 52|anti-cd 52
5817425|NCT00006348|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817426|NCT00006348|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817427|NCT00006348|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5817428|NCT00006348|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5817429|NCT00006348|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5817430|NCT00006348|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817431|NCT00006348|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817432|NCT00006348|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5817433|NCT00006348|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817434|NCT00006348|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5819012|NCT00078715|Rapid Onset|rapid onset
5817435|NCT00006348|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5817436|NCT00006348|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5817437|NCT00006348|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5817438|NCT00006348|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5817439|NCT00006348|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5817440|NCT00006348|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5817441|NCT00006348|nausea and vomiting|nausea and vomiting
5817442|NCT00006348|prolymphocytic leukemia|prolymphocytic leukemia
5817443|NCT00006348|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5817444|NCT00006348|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5817445|NCT00006348|primary systemic amyloidosis|primary systemic amyloidosis
5817446|NCT00006348|intraocular lymphoma|intraocular lymphoma
5817447|NCT00006348|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5817448|NCT00006348|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5817449|NCT00006348|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5817450|NCT00006348|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5817451|NCT00006348|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817452|NCT00006348|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817453|NCT00006348|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5817454|NCT00006348|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5817455|NCT00006348|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5862658|NCT00001549|Alzheimer Disease|alzheimer disease
5817456|NCT00006348|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5817458|NCT00006348|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817459|NCT00006348|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5817460|NCT00006348|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5817461|NCT00006348|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817462|NCT00006348|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817463|NCT00006348|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817464|NCT00006348|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5817465|NCT00006345|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5817466|NCT00006345|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5817467|NCT00006345|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5817468|NCT00006262|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5817469|NCT00006262|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5817470|NCT00006262|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817471|NCT00006090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817472|NCT00006090|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5817473|NCT00006084|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817474|NCT00006084|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5817475|NCT00006084|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5817476|NCT00006084|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5817477|NCT00006084|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5817478|NCT00006084|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5817479|NCT00006084|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5817480|NCT00006084|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5817481|NCT00006084|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5817482|NCT00006084|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5817483|NCT00006051|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5817614|NCT00080028|Pyriform Sinus Cancer|pyriform sinus cancer
5846512|NCT00044252|Seizures|seizures
5817484|NCT00006051|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5817485|NCT00006051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5817008|NCT00003883|infection|infection
5817486|NCT00006051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5817487|NCT00006051|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5817488|NCT00006051|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5817489|NCT00006051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5817490|NCT00006051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5817491|NCT00006051|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5817492|NCT00006051|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5817493|NCT00006051|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5817494|NCT00006051|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5817495|NCT00006051|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5817496|NCT00006051|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5817497|NCT00006051|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5817498|NCT00006051|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5817499|NCT00006036|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5817500|NCT00006036|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5817501|NCT00006036|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5817502|NCT00006036|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817503|NCT00006036|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5817504|NCT00006036|recurrent small cell lung cancer|recurrent small cell lung cancer
5817505|NCT00006036|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5817506|NCT00006036|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5817507|NCT00006036|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5817508|NCT00006036|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5817509|NCT00006036|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817510|NCT00006036|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5817511|NCT00006036|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5817512|NCT00006036|ovarian stromal cancer|ovarian stromal cancer
5817514|NCT00006036|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5817515|NCT00006036|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5817516|NCT00006036|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5817517|NCT00006036|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5817518|NCT00006036|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5817519|NCT00006036|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5817520|NCT00006036|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5817521|NCT00006036|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5817522|NCT00006036|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5817523|NCT00006036|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5817524|NCT00006036|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5817525|NCT00006036|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5817526|NCT00006036|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5817527|NCT00006036|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5817528|NCT00006036|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5817529|NCT00006036|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5817530|NCT00006036|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5817531|NCT00006036|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5817532|NCT00006036|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5817533|NCT00006036|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5817534|NCT00006036|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5817535|NCT00006036|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5817536|NCT00006036|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5817537|NCT00006036|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5817538|NCT00006036|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5817539|NCT00006036|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5831152|NCT00022139|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5831153|NCT00022139|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5831154|NCT00022139|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5831155|NCT00005028|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5824663|NCT00068224|ARPKD|arpkd
5831156|NCT00005028|stage IV prostate cancer|stage iv prostate cancer
5831157|NCT00005028|recurrent prostate cancer|recurrent prostate cancer
5831158|NCT00055588|Spinal Reflexes|spinal reflexes
5817540|NCT00006036|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5817541|NCT00006036|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5817542|NCT00006036|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5817543|NCT00006036|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5817544|NCT00006036|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5817545|NCT00006036|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5817546|NCT00006036|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5817547|NCT00006036|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5817548|NCT00006036|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5817549|NCT00006036|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5817550|NCT00006036|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5817551|NCT00006036|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5817552|NCT00006036|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5817553|NCT00006036|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5817554|NCT00006036|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5817555|NCT00006036|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817556|NCT00006036|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5817557|NCT00006036|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5817558|NCT00006036|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5817559|NCT00006036|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817560|NCT00006036|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5862659|NCT00001549|Progressive Supranuclear Palsy|progressive supranuclear palsy
5862660|NCT00001549|PSP|psp
5844014|NCT00051155|POAG|poag
5817562|NCT00006036|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5817563|NCT00006036|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5817564|NCT00006036|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5817568|NCT00080093|HIV Seronegativity|hiv seronegativity
5817569|NCT00080093|HIV Prevention|hiv prevention
5817570|NCT00080093|Behavioral Intervention|behavioral intervention
5817571|NCT00006023|stage IV prostate cancer|stage iv prostate cancer
5817572|NCT00006023|recurrent prostate cancer|recurrent prostate cancer
5817573|NCT00005992|stage IV prostate cancer|stage iv prostate cancer
5817574|NCT00005992|recurrent prostate cancer|recurrent prostate cancer
5817575|NCT00005972|recurrent small cell lung cancer|recurrent small cell lung cancer
5817576|NCT00005944|recurrent colon cancer|recurrent colon cancer
5817577|NCT00005944|recurrent rectal cancer|recurrent rectal cancer
5817578|NCT00005944|adenocarcinoma of the colon|adenocarcinoma of the colon
5817579|NCT00005944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5817580|NCT00005944|liver metastases|liver metastases
5817581|NCT00005944|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5817582|NCT00005865|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5817583|NCT00005865|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5817584|NCT00080067|Movement|movement
5817585|NCT00080067|Anticipation|anticipation
5817586|NCT00080067|Stimulation|stimulation
5817588|NCT00080067|Execution|execution
5817589|NCT00080067|Perception|perception
5817590|NCT00080067|Rhythm|rhythm
5817591|NCT00080067|Healthy Volunteer|healthy volunteer
5831253|NCT00055198|Gram positive bacterial infections|gram positive bacterial infections
5831254|NCT00055198|expanded access program|expanded access program
5831255|NCT00055198|resistant infections|resistant infections
5831256|NCT00055198|bacteremia|bacteremia
5831257|NCT00055198|Bacterial and fungal infections|bacterial and fungal infections
5831258|NCT00055198|bacterial infections|bacterial infections
5831259|NCT00055185|Treatment Experienced|treatment experienced
5831260|NCT00055133|rheumatoid arthritis|rheumatoid arthritis
5831261|NCT00055133|Paxceed|paxceed
5831262|NCT00055133|Micellar Paclitaxel|micellar paclitaxel
5831266|NCT00055159|RT PA|rt pa
5831267|NCT00055159|Blood Clots|blood clots
5831268|NCT00055159|Catheter Directed Thrombolytic Therapy|catheter directed thrombolytic therapy
5831269|NCT00055159|Alteplase|alteplase
5831270|NCT00055159|Deep Vein Thrombosis|deep vein thrombosis
5831271|NCT00055159|DVT|dvt
5817593|NCT00080054|Malignant Glioma|malignant glioma
5817594|NCT00080054|Glioblastoma multiforme|glioblastoma multiforme
5817595|NCT00080054|GBM|gbm
5817596|NCT00080054|Anaplastic astrocytoma|anaplastic astrocytoma
5817597|NCT00080054|AA|aa
5817598|NCT00080054|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5817599|NCT00080054|Anaplastic mixed glioma|anaplastic mixed glioma
5817600|NCT00080054|Brain tumor|brain tumor
5817601|NCT00080054|Brain neoplasm|brain neoplasm
5817602|NCT00080054|Glioma|glioma
5817603|NCT00080041|Antineoplastic Combined Chemotherapy Protocols|antineoplastic combined chemotherapy protocols
5817604|NCT00080028|Head and Neck Cancer|head and neck cancer
5817605|NCT00080028|SCCHN|scchn
5817606|NCT00080028|Oropharynx Cancer|oropharynx cancer
5817607|NCT00080028|Hypopharynx Cancer|hypopharynx cancer
5817608|NCT00080028|Larynx Cancer|larynx cancer
5817609|NCT00080028|Soft palate Cancer|soft palate cancer
5817610|NCT00080028|Tonsil Cancer|tonsil cancer
5817611|NCT00080028|Base of tongue Cancer|base of tongue cancer
5817612|NCT00080028|Supraglottic Cancer|supraglottic cancer
5817613|NCT00080028|Glottic Cancer|glottic cancer
5817615|NCT00080028|Pharyngeal wall Cancer|pharyngeal wall cancer
5817616|NCT00080028|Throat cancer|throat cancer
5817617|NCT00080002|cancer|cancer
5817618|NCT00080002|gastric|gastric
5817619|NCT00080002|gastroesophageal junction|gastroesophageal junction
5817620|NCT00080002|neoplasms|neoplasms
5817621|NCT00080002|gastric cancer|gastric cancer
5817622|NCT00080002|gastric neoplasms|gastric neoplasms
5817623|NCT00079989|Bacterial Infections|bacterial infections
5817624|NCT00005816|stage III renal cell cancer|stage iii renal cell cancer
5817625|NCT00005816|stage IV renal cell cancer|stage iv renal cell cancer
5817626|NCT00004123|adult leiomyosarcoma|adult leiomyosarcoma
5817627|NCT00004123|adult liposarcoma|adult liposarcoma
5817628|NCT00004123|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5817629|NCT00004123|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5817630|NCT00004123|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5817631|NCT00003817|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817632|NCT00003817|nausea and vomiting|nausea and vomiting
5817633|NCT00003693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817634|NCT00003693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5817635|NCT00003693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817636|NCT00003693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5814149|NCT00003398|anemia|anemia
5817637|NCT00003693|refractory anemia with excess blasts|refractory anemia with excess blasts
5817638|NCT00003693|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5817640|NCT00003693|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5817641|NCT00003693|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5817642|NCT00003647|adult solid tumor|adult solid tumor
5817643|NCT00003647|body system/site cancer|body system/site cancer
5817645|NCT00003647|melanoma|melanoma
5817646|NCT00003647|recurrent melanoma|recurrent melanoma
5817647|NCT00003647|skin tumor|skin tumor
5817648|NCT00003647|solid tumor|solid tumor
5817649|NCT00003647|stage III melanoma|stage iii melanoma
5817650|NCT00003647|stage IV melanoma|stage iv melanoma
5817651|NCT00003647|stage, melanoma|stage, melanoma
5817652|NCT00079976|Staphylococcus aureus|staphylococcus aureus
5817653|NCT00079976|Bacterial Infections|bacterial infections
5817655|NCT00079950|sarcoma|sarcoma
5817656|NCT00079950|metastatic|metastatic
5817657|NCT00079937|allergic|allergic
5817658|NCT00079937|asthma|asthma
5817659|NCT00079937|atopic|atopic
5817660|NCT00079937|omalizumab|omalizumab
5817661|NCT00079937|immunoglobulin E|immunoglobulin e
5817662|NCT00079937|IgE|ige
5817663|NCT00079937|anti-IgE|anti-ige
5817664|NCT00003561|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817665|NCT00003561|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5817666|NCT00003561|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5817667|NCT00003356|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5817668|NCT00003356|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5817669|NCT00003356|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5817670|NCT00003356|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5817671|NCT00003356|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5817672|NCT00003356|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5817673|NCT00003356|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817674|NCT00003356|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817675|NCT00003356|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5817676|NCT00003356|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5817677|NCT00003356|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5817678|NCT00003356|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5817679|NCT00003356|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5845620|NCT00050245|Neuropathy|neuropathy
5817680|NCT00003356|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5817681|NCT00003356|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5817682|NCT00003356|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5817683|NCT00003356|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817684|NCT00003356|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817685|NCT00003356|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5817686|NCT00003356|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5817687|NCT00003356|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5817688|NCT00003356|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817689|NCT00003356|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5817690|NCT00003356|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5817691|NCT00003356|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5817692|NCT00003356|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5817693|NCT00003356|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5817694|NCT00003356|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5817695|NCT00003356|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5817696|NCT00003356|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5817697|NCT00003356|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817698|NCT00003356|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817699|NCT00003356|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817700|NCT00003327|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5817701|NCT00003327|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5817702|NCT00003327|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5817703|NCT00003327|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5817704|NCT00003327|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5817705|NCT00003327|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5817706|NCT00003327|stage IV laryngeal cancer|stage iv laryngeal cancer
5817707|NCT00003327|recurrent laryngeal cancer|recurrent laryngeal cancer
5817708|NCT00003327|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5817709|NCT00003327|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5817710|NCT00003327|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5817711|NCT00003327|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5817712|NCT00003321|stage I esophageal cancer|stage i esophageal cancer
5817713|NCT00003321|stage II esophageal cancer|stage ii esophageal cancer
5817714|NCT00003321|stage III esophageal cancer|stage iii esophageal cancer
5817715|NCT00003321|stage IV esophageal cancer|stage iv esophageal cancer
5817716|NCT00003321|recurrent esophageal cancer|recurrent esophageal cancer
5817719|NCT00079911|Genital Herpes|genital herpes
5817722|NCT00079885|Bacterial Pneumonia|bacterial pneumonia
5817723|NCT00022360|recurrent adult brain tumor|recurrent adult brain tumor
5817724|NCT00022360|adult glioblastoma|adult glioblastoma
5817725|NCT00022360|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5817726|NCT00022360|adult giant cell glioblastoma|adult giant cell glioblastoma
5817727|NCT00022360|adult gliosarcoma|adult gliosarcoma
5817728|NCT00022165|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819013|NCT00078715|Major Depression|major depression
5817729|NCT00021138|non-small cell lung cancer|non-small cell lung cancer
5817730|NCT00021138|small cell lung cancer|small cell lung cancer
5817731|NCT00021138|esophageal cancer|esophageal cancer
5817732|NCT00021138|hypopharyngeal cancer|hypopharyngeal cancer
5817733|NCT00021138|laryngeal cancer|laryngeal cancer
5817734|NCT00021138|nasopharyngeal cancer|nasopharyngeal cancer
5817735|NCT00021138|oropharyngeal cancer|oropharyngeal cancer
5817736|NCT00021138|lip and oral cavity cancer|lip and oral cavity cancer
5817737|NCT00021138|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5817738|NCT00021138|tongue cancer|tongue cancer
5817739|NCT00002789|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817740|NCT00002789|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5817741|NCT00002789|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5817742|NCT00079859|Heterozygous Familial Hypercholesterolemia (HeFH)|heterozygous familial hypercholesterolemia (hefh)
5817743|NCT00079846|Homozygous Familial Hypercholesterolemia (HoFH)|homozygous familial hypercholesterolemia (hofh)
5817744|NCT00079833|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions
5817745|NCT00079833|Idiopathic Hypersecretion|idiopathic hypersecretion
5817746|NCT00079833|Excessive Gastric Acid secretion|excessive gastric acid secretion
5817747|NCT00079820|Smallpox|smallpox
5817748|NCT00079820|Smallpox Vaccine|smallpox vaccine
5817749|NCT00079820|Variola virus|variola virus
5817750|NCT00079820|Smallpox Virus|smallpox virus
5817751|NCT00079820|MODIFIED VACCINIA ANKARA|modified vaccinia ankara
5817752|NCT00079820|MVA|mva
5817753|NCT00079820|Dryvax|dryvax
5817754|NCT00079820|Dryvax vaccine|dryvax vaccine
5817755|NCT00079820|Protection against smallpox|protection against smallpox
5817756|NCT00020930|stage IV colon cancer|stage iv colon cancer
5817757|NCT00020930|stage IV rectal cancer|stage iv rectal cancer
5817758|NCT00020930|recurrent colon cancer|recurrent colon cancer
5817759|NCT00020930|recurrent rectal cancer|recurrent rectal cancer
5817760|NCT00020865|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5817761|NCT00020865|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5817762|NCT00020865|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5817763|NCT00020865|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5817764|NCT00020865|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5817765|NCT00020865|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5817766|NCT00020865|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5817767|NCT00020865|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5817768|NCT00020865|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5817769|NCT00020865|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5817770|NCT00020865|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5817771|NCT00020865|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5817772|NCT00020865|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5844020|NCT00051142|OHT|oht
5817773|NCT00020865|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5817774|NCT00020865|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5817775|NCT00020865|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817776|NCT00020865|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5817777|NCT00020865|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817778|NCT00020865|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817779|NCT00020865|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817780|NCT00020865|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817781|NCT00020865|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5817782|NCT00020865|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5817783|NCT00020865|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5817784|NCT00020865|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5817785|NCT00020865|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5817786|NCT00020865|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5817788|NCT00020865|refractory hairy cell leukemia|refractory hairy cell leukemia
5817789|NCT00020865|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5817790|NCT00020865|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5817791|NCT00020865|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5846514|NCT00044252|Healthy Volunteer|healthy volunteer
5817792|NCT00020865|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5817793|NCT00020865|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5817794|NCT00020865|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5817795|NCT00020865|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5817796|NCT00020865|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5817797|NCT00020865|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5817798|NCT00020865|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5817799|NCT00020865|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5817800|NCT00020865|acute undifferentiated leukemia|acute undifferentiated leukemia
5817801|NCT00020865|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5817802|NCT00020865|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5817803|NCT00020865|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5817804|NCT00020865|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5817805|NCT00020865|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5817806|NCT00020865|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5817807|NCT00020865|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5817808|NCT00020865|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5817809|NCT00020865|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5817810|NCT00020865|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5817811|NCT00020865|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5817812|NCT00020865|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5817813|NCT00020865|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5817814|NCT00020865|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5817815|NCT00020865|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5817816|NCT00020865|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5817817|NCT00020865|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5817818|NCT00020865|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5817819|NCT00020865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817820|NCT00020865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817821|NCT00020865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5817822|NCT00020865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5817823|NCT00020865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5817824|NCT00020865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817825|NCT00020865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817826|NCT00020865|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5817827|NCT00020865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817828|NCT00020865|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5817829|NCT00020865|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5817830|NCT00020865|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5817831|NCT00020865|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5817832|NCT00020865|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5817833|NCT00020865|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5817834|NCT00020865|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5817835|NCT00020865|neutropenia|neutropenia
5817836|NCT00020865|infection|infection
5817837|NCT00020865|prolymphocytic leukemia|prolymphocytic leukemia
5817838|NCT00020865|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5817839|NCT00020865|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5817840|NCT00020865|intraocular lymphoma|intraocular lymphoma
5817841|NCT00020865|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5817842|NCT00020865|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5817843|NCT00020865|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5817844|NCT00020865|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5817845|NCT00020865|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5817846|NCT00020865|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5817847|NCT00020865|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5817848|NCT00020865|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5817849|NCT00020865|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5817850|NCT00020865|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5817851|NCT00020865|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5817852|NCT00020865|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5817853|NCT00020865|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5817854|NCT00020865|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5817855|NCT00020865|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5817856|NCT00020865|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5817857|NCT00020865|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5817858|NCT00020865|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5817859|NCT00020865|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5817860|NCT00020865|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5817861|NCT00020865|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5817862|NCT00020865|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5817863|NCT00020865|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5817864|NCT00020865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817865|NCT00020865|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5817866|NCT00020865|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5817867|NCT00020865|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5817868|NCT00020865|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5817869|NCT00020865|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5817870|NCT00020865|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5817871|NCT00020865|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5817872|NCT00020865|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5817873|NCT00020865|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5817874|NCT00020865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5817875|NCT00020865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817876|NCT00020865|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5817877|NCT00020865|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5817878|NCT00020865|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5817879|NCT00020865|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5817880|NCT00020865|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5817881|NCT00020865|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5817882|NCT00020865|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5817883|NCT00020865|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5817884|NCT00020865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817885|NCT00020865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817886|NCT00020865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817887|NCT00014300|recurrent adult brain tumor|recurrent adult brain tumor
5817889|NCT00014300|adult giant cell glioblastoma|adult giant cell glioblastoma
5817891|NCT00012337|stage IV renal cell cancer|stage iv renal cell cancer
5817892|NCT00012337|recurrent renal cell cancer|recurrent renal cell cancer
5817893|NCT00006812|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817894|NCT00006812|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5817895|NCT00006708|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817896|NCT00006708|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817897|NCT00006218|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817898|NCT00006215|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5817899|NCT00006215|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5817900|NCT00006098|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5817901|NCT00006098|refractory multiple myeloma|refractory multiple myeloma
5817902|NCT00006098|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5817903|NCT00006098|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5817904|NCT00006098|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817905|NCT00006098|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5817906|NCT00006098|refractory anemia with excess blasts|refractory anemia with excess blasts
5817907|NCT00006098|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5817908|NCT00006098|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5817909|NCT00006098|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5817910|NCT00006098|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5817911|NCT00006098|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5814407|NCT00005842|lung metastases|lung metastases
5817913|NCT00006098|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5817914|NCT00006098|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5817915|NCT00006098|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5817916|NCT00006098|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5817917|NCT00006098|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5817918|NCT00006098|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5817919|NCT00006098|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5817920|NCT00006098|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5817921|NCT00006098|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5817922|NCT00006098|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5817923|NCT00006098|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5817925|NCT00079807|Peripheral neuropathy|peripheral neuropathy
5817926|NCT00079807|Alpha-Lipoic Acid|alpha-lipoic acid
5817927|NCT00079807|ALA|ala
5817928|NCT00079807|Complementary Therapies|complementary therapies
5817929|NCT00079794|lung cancer|lung cancer
5817930|NCT00079794|herbal medicine|herbal medicine
5817931|NCT00079794|non-small cell cancer|non-small cell cancer
5817932|NCT00079794|Iscar|iscar
5817933|NCT00079794|mistletoe|mistletoe
5817934|NCT00079781|Responsive Stimulation|responsive stimulation
5817935|NCT00079781|Brain Stimulator|brain stimulator
5817936|NCT00079781|Epilepsy|epilepsy
5817937|NCT00079781|Seizures|seizures
5817938|NCT00079755|Anaplastic Large-Cell Lymphoma|anaplastic large-cell lymphoma
5817939|NCT00079755|Lymphoma|lymphoma
5817940|NCT00079755|antigens, CD30|antigens, cd30
5817941|NCT00079755|Monoclonal Antibody|monoclonal antibody
5817942|NCT00079742|Growth restriction in children with cystic fibrosis|growth restriction in children with cystic fibrosis
5817943|NCT00079716|Antigens, CD40|antigens, cd40
5817944|NCT00079716|Antibody, Monoclonal|antibody, monoclonal
5817945|NCT00079716|Blood Coagulation Disorders|blood coagulation disorders
5817946|NCT00079716|Hematologic Diseases|hematologic diseases
5817947|NCT00079716|Hemorrhagic Disorders|hemorrhagic disorders
5817948|NCT00079716|Hemostatic Disorders|hemostatic disorders
5817949|NCT00079716|Immunoproliferative Disorders|immunoproliferative disorders
5817950|NCT00079716|Lymphoproliferative Disorders|lymphoproliferative disorders
5817951|NCT00079716|Paraproteinemias|paraproteinemias
5817952|NCT00079716|Vascular Diseases|vascular diseases
5817953|NCT00079716|Antibody-Dependent Cell Cytotoxicity|antibody-dependent cell cytotoxicity
5817954|NCT00006091|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5817955|NCT00006091|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5817956|NCT00006091|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5817957|NCT00006085|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817958|NCT00006026|recurrent bladder cancer|recurrent bladder cancer
5817959|NCT00006026|stage IV bladder cancer|stage iv bladder cancer
5817960|NCT00006026|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5817961|NCT00006026|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5817962|NCT00006026|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5817963|NCT00006026|recurrent urethral cancer|recurrent urethral cancer
5817964|NCT00006026|anterior urethral cancer|anterior urethral cancer
5817965|NCT00006026|posterior urethral cancer|posterior urethral cancer
5817966|NCT00006026|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5817967|NCT00006026|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5817968|NCT00006026|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5817969|NCT00006026|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5817970|NCT00005866|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5817971|NCT00005866|refractory anemia with excess blasts|refractory anemia with excess blasts
5844021|NCT00051129|AMD|amd
5817972|NCT00005866|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5817973|NCT00005866|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5817974|NCT00005866|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5817975|NCT00005866|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5817976|NCT00005866|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5817977|NCT00005866|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5817978|NCT00005848|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5817979|NCT00005848|stage IV prostate cancer|stage iv prostate cancer
5817980|NCT00005848|recurrent prostate cancer|recurrent prostate cancer
5817981|NCT00005834|refractory multiple myeloma|refractory multiple myeloma
5817982|NCT00005834|stage I multiple myeloma|stage i multiple myeloma
5817983|NCT00005834|stage II multiple myeloma|stage ii multiple myeloma
5817984|NCT00005834|stage III multiple myeloma|stage iii multiple myeloma
5817986|NCT00005635|recurrent breast cancer|recurrent breast cancer
5817988|NCT00005085|stage IV rectal cancer|stage iv rectal cancer
5817989|NCT00005085|recurrent colon cancer|recurrent colon cancer
5817990|NCT00005085|recurrent rectal cancer|recurrent rectal cancer
5817991|NCT00005085|adenocarcinoma of the colon|adenocarcinoma of the colon
5817992|NCT00005085|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5817993|NCT00005037|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5817994|NCT00005037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5817995|NCT00005037|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5817996|NCT00004926|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817997|NCT00004913|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5817998|NCT00004909|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5817999|NCT00004909|peritoneal cavity cancer|peritoneal cavity cancer
5818001|NCT00004865|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5818002|NCT00004865|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5818003|NCT00004865|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5818004|NCT00004865|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5818005|NCT00004865|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5818006|NCT00004865|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5818007|NCT00004865|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5818008|NCT00004865|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5818009|NCT00004865|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5818010|NCT00004865|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5818011|NCT00004865|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5818012|NCT00004865|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5818013|NCT00004865|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5818014|NCT00004865|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5818015|NCT00004864|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818016|NCT00004863|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818017|NCT00004163|stage III salivary gland cancer|stage iii salivary gland cancer
5818018|NCT00004163|stage IV salivary gland cancer|stage iv salivary gland cancer
5818019|NCT00004163|recurrent salivary gland cancer|recurrent salivary gland cancer
5818020|NCT00004163|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5818021|NCT00004163|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5818022|NCT00004163|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5818023|NCT00004163|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5818024|NCT00004163|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5818025|NCT00004163|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5818026|NCT00004163|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5818027|NCT00004163|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5818028|NCT00004151|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5818029|NCT00004151|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5818030|NCT00004151|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818031|NCT00004151|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821386|NCT00075998|InterMune|intermune
5818032|NCT00004142|stage IV colon cancer|stage iv colon cancer
5818033|NCT00004142|stage IV rectal cancer|stage iv rectal cancer
5818034|NCT00004142|recurrent colon cancer|recurrent colon cancer
5818035|NCT00004142|recurrent rectal cancer|recurrent rectal cancer
5844129|NCT00050804|Emotion|emotion
5818036|NCT00004142|liver metastases|liver metastases
5818037|NCT00004109|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5818038|NCT00004109|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5818039|NCT00004109|Doxorubicin|doxorubicin
5818040|NCT00004109|External-Beam RT|external-beam rt
5818041|NCT00004109|XRT|xrt
5818042|NCT00004109|cancer|cancer
5818043|NCT00004109|PREOPERATIVE CONCURRENT CHEMORADIATION|preoperative concurrent chemoradiation
5818044|NCT00004109|EXTREMITY SOFT TISSUE SARCOMAS|extremity soft tissue sarcomas
5818045|NCT00004109|TRUNK SOFT TISSUE SARCOMAS|trunk soft tissue sarcomas
5818046|NCT00004109|Concurrent Chemoradiation|concurrent chemoradiation
5818047|NCT00004109|Surgical Resection|surgical resection
5862661|NCT00001549|Restless Leg Syndrome|restless leg syndrome
5818048|NCT00004109|Localized Extremity Soft Tissue Sarcomas|localized extremity soft tissue sarcomas
5818049|NCT00004109|Body Wall Soft Tissue Sarcomas|body wall soft tissue sarcomas
5818050|NCT00003959|refractory anemia|refractory anemia
5818052|NCT00003959|refractory anemia with excess blasts|refractory anemia with excess blasts
5818053|NCT00003959|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5818054|NCT00003959|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5818055|NCT00003959|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5818056|NCT00003959|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5818057|NCT00003779|stage 0 bladder cancer|stage 0 bladder cancer
5818058|NCT00003779|stage I bladder cancer|stage i bladder cancer
5818059|NCT00003772|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5818060|NCT00003772|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5818061|NCT00003772|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818062|NCT00003772|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5818063|NCT00003772|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818064|NCT00003742|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818065|NCT00003706|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818066|NCT00003705|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818067|NCT00003704|stage III colon cancer|stage iii colon cancer
5818068|NCT00003704|stage III rectal cancer|stage iii rectal cancer
5818069|NCT00003704|recurrent colon cancer|recurrent colon cancer
5818070|NCT00003704|recurrent rectal cancer|recurrent rectal cancer
5818071|NCT00003704|recurrent anal cancer|recurrent anal cancer
5818072|NCT00003704|stage IIIA anal cancer|stage iiia anal cancer
5818073|NCT00003704|stage IIIB anal cancer|stage iiib anal cancer
5818074|NCT00003704|stage III cervical cancer|stage iii cervical cancer
5818075|NCT00003704|recurrent cervical cancer|recurrent cervical cancer
5818076|NCT00003704|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818077|NCT00003704|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818078|NCT00003704|stage III vulvar cancer|stage iii vulvar cancer
5818079|NCT00003704|recurrent vulvar cancer|recurrent vulvar cancer
5818080|NCT00003704|stage III vaginal cancer|stage iii vaginal cancer
5818081|NCT00003704|recurrent vaginal cancer|recurrent vaginal cancer
5818082|NCT00003704|stage III penile cancer|stage iii penile cancer
5818083|NCT00003704|recurrent penile cancer|recurrent penile cancer
5818084|NCT00003704|stage III endometrial carcinoma|stage iii endometrial carcinoma
5818085|NCT00003704|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5818086|NCT00003704|stage III bladder cancer|stage iii bladder cancer
5818087|NCT00003704|recurrent bladder cancer|recurrent bladder cancer
5818088|NCT00003704|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5818089|NCT00003704|stage III prostate cancer|stage iii prostate cancer
5818090|NCT00003704|recurrent prostate cancer|recurrent prostate cancer
5818091|NCT00003704|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5818092|NCT00003704|ovarian stromal cancer|ovarian stromal cancer
5818093|NCT00003704|recurrent urethral cancer|recurrent urethral cancer
5818094|NCT00003704|distal urethral cancer|distal urethral cancer
5818095|NCT00003704|proximal urethral cancer|proximal urethral cancer
5818096|NCT00003704|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5818097|NCT00003704|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5818098|NCT00003704|fallopian tube cancer|fallopian tube cancer
5817561|NCT00006036|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5817565|NCT00006036|ovarian sarcoma|ovarian sarcoma
5817587|NCT00080067|Timing|timing
5818099|NCT00003704|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5818100|NCT00003704|stage III uterine sarcoma|stage iii uterine sarcoma
5818101|NCT00003704|recurrent uterine sarcoma|recurrent uterine sarcoma
5818102|NCT00003704|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5818103|NCT00003704|ovarian sarcoma|ovarian sarcoma
5818104|NCT00003703|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818105|NCT00003695|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5818106|NCT00003695|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818107|NCT00079768|Inflammation|inflammation
5818108|NCT00079768|Myositis|myositis
5818109|NCT00079768|Humanized Monoclonal Antibody|humanized monoclonal antibody
5818110|NCT00079768|Cytotoxic T Cells|cytotoxic t cells
5818111|NCT00079768|Endomysial T Cells|endomysial t cells
5818112|NCT00079768|Alemtuzumab|alemtuzumab
5818113|NCT00079768|Monoclonal Antibodies|monoclonal antibodies
5818114|NCT00079768|IBM|ibm
5818116|NCT00079768|Inclusion Body Myositis|inclusion body myositis
5818117|NCT00079729|Treatment Experienced|treatment experienced
5818118|NCT00079677|Excessive Sleepiness|excessive sleepiness
5818119|NCT00079677|Obstructive Sleep Apnea|obstructive sleep apnea
5818120|NCT00079677|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5818121|NCT00079677|nCPAP|ncpap
5818122|NCT00079677|Cephalon|cephalon
5818123|NCT00079677|Cephalon, Inc|cephalon, inc
5818124|NCT00079677|Nuvigil|nuvigil
5818125|NCT00079664|Tai Ji|tai ji
5818128|NCT00079651|Assisted Living Facilities|assisted living facilities
5818130|NCT00079638|Niacin|niacin
5818131|NCT00079638|Statin|statin
5818132|NCT00079638|Cholesterol|cholesterol
5818133|NCT00079638|Triglycerides|triglycerides
5818134|NCT00079638|Lipid-Modifying Therapies|lipid-modifying therapies
5818136|NCT00079638|Coronary Heart Disease|coronary heart disease
5818137|NCT00079638|Atherosclerosis|atherosclerosis
5818138|NCT00079638|Stroke|stroke
5818139|NCT00079638|VA-HIT|va-hit
5818140|NCT00079638|Niacin Statin Combination Threrapy|niacin statin combination threrapy
5818141|NCT00079638|High Density Lipoprotein|high density lipoprotein
5818142|NCT00079638|Low Density Lipoprotein|low density lipoprotein
5818143|NCT00079638|Hypertension|hypertension
5818144|NCT00079638|Diabetes|diabetes
5818145|NCT00079638|Adult Treatment Panel III|adult treatment panel iii
5818146|NCT00078039|Schizophrenia, paliperidone|schizophrenia, paliperidone
5818147|NCT00003617|stage I gastric cancer|stage i gastric cancer
5818148|NCT00003465|recurrent adult brain tumor|recurrent adult brain tumor
5818149|NCT00003465|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5818150|NCT00003421|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5818151|NCT00003421|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5818152|NCT00003421|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5818153|NCT00003421|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5818154|NCT00003368|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5818155|NCT00003368|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5818156|NCT00003368|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5818157|NCT00003368|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5818158|NCT00003368|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5818159|NCT00003368|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5818160|NCT00003368|small intestine lymphoma|small intestine lymphoma
5818161|NCT00003368|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818162|NCT00003368|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5818163|NCT00003368|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5818164|NCT00003368|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5818165|NCT00003368|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5818166|NCT00003368|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5818167|NCT00003368|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818168|NCT00003368|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5818169|NCT00003368|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5818170|NCT00003368|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5818171|NCT00003368|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5818172|NCT00003368|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5818173|NCT00003368|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818174|NCT00003368|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5818175|NCT00003368|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5818176|NCT00003368|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5818177|NCT00003368|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5818178|NCT00003368|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5818179|NCT00003368|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818180|NCT00003368|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5818181|NCT00003368|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5818182|NCT00003368|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5818183|NCT00003368|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5818184|NCT00003368|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5818185|NCT00003368|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5818186|NCT00003368|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5818187|NCT00003368|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5818188|NCT00003368|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818376|NCT00003212|adult neurofibrosarcoma|adult neurofibrosarcoma
5818189|NCT00003368|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5818190|NCT00003368|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5818191|NCT00003368|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5818192|NCT00003368|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5818193|NCT00003368|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5818194|NCT00003368|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5818195|NCT00003368|intraocular lymphoma|intraocular lymphoma
5818196|NCT00003368|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5818197|NCT00003368|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5818198|NCT00003368|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5818199|NCT00003368|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5818200|NCT00003368|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5862662|NCT00001549|RLS|rls
5681336|NCT00573781|Peripheral mononuclear cells|peripheral mononuclear cells
5681338|NCT00573781|Gene expression profiles|gene expression profiles
5681339|NCT00573781|Personal diets|personal diets
5681340|NCT00573781|Metabolic syndrome|metabolic syndrome
5818201|NCT00003368|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5818202|NCT00003368|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5818203|NCT00003368|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5818204|NCT00003368|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818205|NCT00003368|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5818206|NCT00003368|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5818207|NCT00003368|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5818208|NCT00003368|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5818209|NCT00003368|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5818210|NCT00003368|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818211|NCT00003368|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5818212|NCT00003368|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5818213|NCT00003361|refractory anemia|refractory anemia
5818214|NCT00003361|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5818215|NCT00003361|refractory anemia with excess blasts|refractory anemia with excess blasts
5818216|NCT00003361|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5818217|NCT00003361|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5818218|NCT00003361|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5818219|NCT00003361|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5818220|NCT00003361|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5818221|NCT00003361|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5818222|NCT00003338|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5818223|NCT00003338|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5818224|NCT00003338|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5818225|NCT00003338|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5818226|NCT00003338|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5818227|NCT00003338|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5818228|NCT00003338|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5818229|NCT00003338|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5818230|NCT00003338|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5818231|NCT00003338|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5818232|NCT00003338|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5818233|NCT00003338|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5818234|NCT00003338|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5818235|NCT00003338|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5681334|NCT00573781|Gene expression|gene expression
5817718|NCT00079911|Herpes|herpes
5818236|NCT00003338|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818237|NCT00003338|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5818238|NCT00003338|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5818239|NCT00003338|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5818240|NCT00003338|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5818241|NCT00003338|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5818242|NCT00003338|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818243|NCT00003338|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5818244|NCT00003338|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5818245|NCT00003338|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5818246|NCT00003338|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5818247|NCT00003338|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5818248|NCT00003338|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818249|NCT00003338|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5818250|NCT00003338|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5818251|NCT00003338|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5818252|NCT00003338|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5818253|NCT00003338|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5818254|NCT00003338|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5818255|NCT00003338|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5818596|NCT00079391|Non-Hodgkin Lymphoma|non-hodgkin lymphoma
5862663|NCT00001549|Parkinsonism|parkinsonism
5818256|NCT00003338|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5818257|NCT00003338|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818258|NCT00003338|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5818259|NCT00003338|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5818260|NCT00003338|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5818261|NCT00003338|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5818262|NCT00003338|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5818263|NCT00003338|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5818264|NCT00003338|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5818265|NCT00003338|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5818266|NCT00003338|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5818267|NCT00003338|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5818268|NCT00003338|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5818269|NCT00003338|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5818270|NCT00003338|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5818271|NCT00003338|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5818272|NCT00003338|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5818273|NCT00003338|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5818274|NCT00003338|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5818275|NCT00003338|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5818276|NCT00003338|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5818277|NCT00003338|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5818278|NCT00003338|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5818279|NCT00003338|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5818280|NCT00003338|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5818281|NCT00003338|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5818282|NCT00003338|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5818283|NCT00003338|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5818284|NCT00003338|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818285|NCT00003338|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5818286|NCT00003338|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5818287|NCT00003338|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5818288|NCT00003338|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5818289|NCT00003338|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5818290|NCT00003338|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5818291|NCT00003338|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5818292|NCT00003338|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5818293|NCT00003338|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5818294|NCT00003338|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818295|NCT00003338|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5818296|NCT00003338|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5818297|NCT00003337|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5818298|NCT00003337|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5818299|NCT00003337|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5818300|NCT00003337|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5818301|NCT00003337|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5818302|NCT00003337|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5818303|NCT00003337|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5818304|NCT00003337|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5818305|NCT00003337|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5818306|NCT00003337|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5818307|NCT00003337|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5818308|NCT00003337|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5818309|NCT00003337|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5818310|NCT00003337|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5818311|NCT00003337|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818312|NCT00003337|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5818313|NCT00003337|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5818314|NCT00003337|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5818315|NCT00003337|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5818316|NCT00003337|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5818317|NCT00003337|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818318|NCT00003337|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5818319|NCT00003337|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5818320|NCT00003337|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5818321|NCT00003337|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5818322|NCT00003337|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5818323|NCT00003337|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818324|NCT00003337|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5818325|NCT00003337|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5818326|NCT00003337|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5818327|NCT00003337|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5818328|NCT00003337|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5818329|NCT00003337|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5818330|NCT00003337|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5818331|NCT00003337|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5818332|NCT00003337|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818333|NCT00003337|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5818334|NCT00003337|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5818335|NCT00003337|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5818336|NCT00003337|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5818337|NCT00003337|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5818338|NCT00003337|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5818339|NCT00003337|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5818340|NCT00003337|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5818341|NCT00003337|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5818342|NCT00003337|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5818343|NCT00003337|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5818344|NCT00003337|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5818345|NCT00003337|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5818346|NCT00003337|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5818347|NCT00003337|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5818348|NCT00003337|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5818349|NCT00003337|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5818350|NCT00003337|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5818351|NCT00003337|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5817888|NCT00014300|adult glioblastoma|adult glioblastoma
5818352|NCT00003337|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5818353|NCT00003337|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5818354|NCT00003337|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5818355|NCT00003337|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5818356|NCT00003337|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5818357|NCT00003337|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5818358|NCT00003337|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5818359|NCT00003337|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818360|NCT00003337|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5818361|NCT00003337|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5818362|NCT00003337|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5818363|NCT00003337|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5818364|NCT00003337|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5818365|NCT00003337|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5818366|NCT00003337|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5818367|NCT00003337|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5818368|NCT00003337|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5818369|NCT00003337|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818370|NCT00003337|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5818371|NCT00003337|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5818372|NCT00003212|adult angiosarcoma|adult angiosarcoma
5818373|NCT00003212|adult fibrosarcoma|adult fibrosarcoma
5818374|NCT00003212|adult leiomyosarcoma|adult leiomyosarcoma
5818375|NCT00003212|adult liposarcoma|adult liposarcoma
5818377|NCT00003212|adult synovial sarcoma|adult synovial sarcoma
5818378|NCT00003212|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5818379|NCT00003212|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5818380|NCT00003212|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5818381|NCT00003212|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5818382|NCT00003212|stage IV uterine sarcoma|stage iv uterine sarcoma
5818383|NCT00003212|recurrent uterine sarcoma|recurrent uterine sarcoma
5818384|NCT00003212|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5818385|NCT00003021|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818386|NCT00003014|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5818388|NCT00002930|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5818389|NCT00002930|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5818390|NCT00002930|stage I esophageal cancer|stage i esophageal cancer
5818391|NCT00002930|stage II esophageal cancer|stage ii esophageal cancer
5818392|NCT00002930|stage III esophageal cancer|stage iii esophageal cancer
5818393|NCT00002930|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5818394|NCT00002930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818395|NCT00002928|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818396|NCT00002919|stage II bladder cancer|stage ii bladder cancer
5846516|NCT00044252|Normal Control|normal control
5818397|NCT00002919|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5818398|NCT00002901|stage IV breast cancer|stage iv breast cancer
5818399|NCT00002901|stage IIIA breast cancer|stage iiia breast cancer
5818400|NCT00002901|recurrent breast cancer|recurrent breast cancer
5818401|NCT00002901|stage IIIB breast cancer|stage iiib breast cancer
5818402|NCT00002901|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5818403|NCT00002901|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818404|NCT00002901|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5818405|NCT00002901|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818406|NCT00002901|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5818407|NCT00002901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5818408|NCT00002901|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818409|NCT00002901|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5818410|NCT00002901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818411|NCT00002901|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5818412|NCT00002901|ovarian stromal cancer|ovarian stromal cancer
5818413|NCT00002901|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5818414|NCT00002901|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5818415|NCT00002901|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5818416|NCT00002901|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5818417|NCT00002901|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5818418|NCT00002901|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5818419|NCT00002901|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5817924|NCT00079807|HIV|hiv
5818420|NCT00002901|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5818421|NCT00002901|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5818422|NCT00002901|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5818423|NCT00002901|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5818424|NCT00002901|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5818425|NCT00002901|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5818426|NCT00002901|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5818427|NCT00002901|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5818428|NCT00002901|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5818429|NCT00002901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5818430|NCT00002901|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5818431|NCT00002901|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5818432|NCT00002901|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5818433|NCT00002901|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5818434|NCT00002901|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5818435|NCT00002901|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5818436|NCT00002901|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5818437|NCT00002901|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5818438|NCT00002901|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5862664|NCT00001549|PD|pd
5818439|NCT00002901|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5818440|NCT00002901|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5818441|NCT00002901|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5818442|NCT00002901|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5818443|NCT00002901|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5818444|NCT00002901|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5818445|NCT00002901|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5818446|NCT00002901|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5818447|NCT00002901|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5818448|NCT00002901|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5818449|NCT00002901|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5818450|NCT00002901|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5818451|NCT00002901|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5818452|NCT00002901|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5818453|NCT00002901|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5818454|NCT00002901|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5818455|NCT00002901|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5818456|NCT00002901|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5818457|NCT00002901|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5818458|NCT00002901|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5818459|NCT00002901|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5818460|NCT00002901|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5818461|NCT00002901|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5818462|NCT00002901|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5818463|NCT00002901|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5818464|NCT00002901|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5818466|NCT00002858|limited stage small cell lung cancer|limited stage small cell lung cancer
5818467|NCT00079612|Renal Cell Cancer|renal cell cancer
5818470|NCT00079508|Heparin-induced Thrombocytopenia|heparin-induced thrombocytopenia
5818471|NCT00079508|Heparin-induced Thrombocytopenia/Thrombosis Syndrome|heparin-induced thrombocytopenia/thrombosis syndrome
5818473|NCT00079508|Heparin anti-body positive|heparin anti-body positive
5818474|NCT00021359|stage I multiple myeloma|stage i multiple myeloma
5818475|NCT00021359|stage II multiple myeloma|stage ii multiple myeloma
5818476|NCT00021359|stage III multiple myeloma|stage iii multiple myeloma
5818477|NCT00017030|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5818478|NCT00017030|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5818479|NCT00017030|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5818480|NCT00016978|stage IV colon cancer|stage iv colon cancer
5818481|NCT00016978|stage IV rectal cancer|stage iv rectal cancer
5818482|NCT00016978|recurrent colon cancer|recurrent colon cancer
5818483|NCT00016978|recurrent rectal cancer|recurrent rectal cancer
5818484|NCT00016978|adenocarcinoma of the colon|adenocarcinoma of the colon
5818485|NCT00016978|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5818486|NCT00014547|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5818487|NCT00014547|recurrent small cell lung cancer|recurrent small cell lung cancer
5818488|NCT00007969|stage III melanoma|stage iii melanoma
5818489|NCT00007969|stage IV melanoma|stage iv melanoma
5818490|NCT00007969|recurrent melanoma|recurrent melanoma
5818491|NCT00002823|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5818492|NCT00002823|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5818493|NCT00002823|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5818494|NCT00002823|squamous cell lung cancer|squamous cell lung cancer
5818495|NCT00002823|large cell lung cancer|large cell lung cancer
5818496|NCT00002823|adenocarcinoma of the lung|adenocarcinoma of the lung
5818497|NCT00002823|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5818498|NCT00002650|colon cancer|colon cancer
5818499|NCT00002650|rectal cancer|rectal cancer
5818500|NCT00002601|metastatic osteosarcoma|metastatic osteosarcoma
5818501|NCT00002601|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5818502|NCT00002601|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5818503|NCT00002601|recurrent osteosarcoma|recurrent osteosarcoma
5818504|NCT00002601|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5818505|NCT00002601|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5821717|NCT00075023|TNF-alpha|tnf-alpha
5818506|NCT00002601|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5818507|NCT00002601|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5818508|NCT00002601|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5818509|NCT00002601|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5818510|NCT00002601|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5818511|NCT00002581|stage I breast cancer|stage i breast cancer
5818512|NCT00002581|stage II breast cancer|stage ii breast cancer
5818513|NCT00002581|stage IIIA breast cancer|stage iiia breast cancer
5818514|NCT00002580|stage I breast cancer|stage i breast cancer
5818515|NCT00002580|stage II breast cancer|stage ii breast cancer
5818516|NCT00002580|stage IIIA breast cancer|stage iiia breast cancer
5818517|NCT00002537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5818518|NCT00002537|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5818519|NCT00002537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818520|NCT00002537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5818521|NCT00002526|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5818522|NCT00002526|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5818523|NCT00002526|stage III uterine sarcoma|stage iii uterine sarcoma
5818524|NCT00002526|stage IV uterine sarcoma|stage iv uterine sarcoma
5818525|NCT00002526|recurrent uterine sarcoma|recurrent uterine sarcoma
5818526|NCT00002526|ovarian sarcoma|ovarian sarcoma
5818527|NCT00002526|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5818528|NCT00002508|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5818529|NCT00002508|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5818530|NCT00002508|extragonadal germ cell tumor|extragonadal germ cell tumor
5818531|NCT00002480|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5818532|NCT00002480|stage IIB prostate cancer|stage iib prostate cancer
5818533|NCT00002480|stage IIA prostate cancer|stage iia prostate cancer
5818534|NCT00002480|stage III prostate cancer|stage iii prostate cancer
5818535|NCT00002459|stage I uterine sarcoma|stage i uterine sarcoma
5818536|NCT00002459|stage II uterine sarcoma|stage ii uterine sarcoma
5818537|NCT00002459|uterine carcinosarcoma|uterine carcinosarcoma
5818538|NCT00002459|uterine leiomyosarcoma|uterine leiomyosarcoma
5818539|NCT00002459|endometrial stromal sarcoma|endometrial stromal sarcoma
5818540|NCT00079625|Engraftment|engraftment
5818541|NCT00079625|Graft-Versus-Host Disease|graft-versus-host disease
5818542|NCT00079625|Metastatic Breast Cancer|metastatic breast cancer
5818544|NCT00079599|Carnitine Deficiency|carnitine deficiency
5818545|NCT00079599|Fatigue|fatigue
5818546|NCT00079599|Complementary Therapies|complementary therapies
5818547|NCT00079573|Weight Loss|weight loss
5818548|NCT00079573|Obesity|obesity
5818549|NCT00079573|Overweight|overweight
5818550|NCT00079573|Premenopausal women|premenopausal women
5818551|NCT00079573|Diet|diet
5818553|NCT00079560|Marijuana|marijuana
5818554|NCT00079560|Marinol|marinol
5818555|NCT00079560|Oral THC|oral thc
5818556|NCT00079560|Appetite|appetite
5818557|NCT00079560|Complementary Therapies|complementary therapies
5681335|NCT00573781|Fat tissue|fat tissue
5818558|NCT00079547|Weight Loss|weight loss
5818559|NCT00079534|AIDS|aids
5818560|NCT00079534|HIV|hiv
5818561|NCT00079534|Prayer|prayer
5818562|NCT00079534|Healing|healing
5818563|NCT00079534|Complementary Therapies|complementary therapies
5818564|NCT00079521|Bone Metabolism|bone metabolism
5818565|NCT00079521|Therapeutic Touch|therapeutic touch
5818566|NCT00079495|MS|ms
5818567|NCT00079495|Autoimmune disease|autoimmune disease
5818568|NCT00079495|relapsing|relapsing
5818569|NCT00079495|progressive|progressive
5818570|NCT00079495|Myelin|myelin
5818571|NCT00079495|Myelin Basic Protein|myelin basic protein
5818572|NCT00079495|MBP|mbp
5818573|NCT00079495|acute fulminating|acute fulminating
5818574|NCT00079495|chronic progressive|chronic progressive
5818575|NCT00079495|Altered Peptide Ligand|altered peptide ligand
5818576|NCT00079495|APL|apl
5818577|NCT00079495|Neurocrine|neurocrine
5818578|NCT00079495|NBI-5788|nbi-5788
5818579|NCT00079495|Relapse|relapse
5818580|NCT00079482|AML|aml
5818581|NCT00079469|cancer survivor|cancer survivor
5818582|NCT00079469|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818583|NCT00079391|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5818584|NCT00079391|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5818585|NCT00079391|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5818586|NCT00079391|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5818587|NCT00079391|Myelodysplastic Syndromes (MDS)|myelodysplastic syndromes (mds)
5818588|NCT00079391|Peripheral Blood Stem Cells|peripheral blood stem cells
5818589|NCT00079391|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5818590|NCT00079391|Graft-Versus-Host Disease (GVHD)|graft-versus-host disease (gvhd)
5818591|NCT00079391|Cyclosporine|cyclosporine
5818592|NCT00079391|Fludarabine|fludarabine
5818593|NCT00079391|Leukemia|leukemia
5818594|NCT00079391|Myelodysplastic Syndrome|myelodysplastic syndrome
5822052|NCT00074360|Blood Flow|blood flow
5818595|NCT00079391|Myeloproliferative Syndrome|myeloproliferative syndrome
5818597|NCT00079365|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5818598|NCT00079365|stage II pancreatic cancer|stage ii pancreatic cancer
5818599|NCT00079365|stage III pancreatic cancer|stage iii pancreatic cancer
5818600|NCT00079365|stage IV pancreatic cancer|stage iv pancreatic cancer
5818602|NCT00079313|CML|cml
5818603|NCT00079313|Gleevec|gleevec
5818605|NCT00079313|STI-571|sti-571
5818606|NCT00079313|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5818607|NCT00079313|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5818608|NCT00079313|Atypical Chronic Myelogenous Leukemia|atypical chronic myelogenous leukemia
5818609|NCT00079313|Chronic Myelomoncytic Leukemia|chronic myelomoncytic leukemia
5818610|NCT00079313|Leukemia|leukemia
5818611|NCT00079300|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5818612|NCT00079287|adenocarcinoma of the lung|adenocarcinoma of the lung
5818613|NCT00079287|large cell lung cancer|large cell lung cancer
5818614|NCT00079287|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5818615|NCT00079287|squamous cell lung cancer|squamous cell lung cancer
5818616|NCT00079287|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818617|NCT00079287|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5818618|NCT00079261|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5818619|NCT00079261|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5818620|NCT00079261|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5818621|NCT00079261|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818622|NCT00079261|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5818623|NCT00079261|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5818624|NCT00079261|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818625|NCT00079261|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5818626|NCT00079261|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5818627|NCT00079261|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5818628|NCT00079261|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5818629|NCT00079261|small intestine lymphoma|small intestine lymphoma
5818631|NCT00079248|stage I breast cancer|stage i breast cancer
5818632|NCT00079248|stage II breast cancer|stage ii breast cancer
5818633|NCT00079248|menopausal symptoms|menopausal symptoms
5818634|NCT00079248|hot flashes|hot flashes
5818635|NCT00079222|infection|infection
5818636|NCT00079222|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5818637|NCT00079222|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5818638|NCT00079222|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5818639|NCT00079222|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5818640|NCT00079222|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5818641|NCT00079222|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5818642|NCT00079222|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5818643|NCT00079222|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5818644|NCT00079222|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5818645|NCT00079222|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5818646|NCT00079222|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5818647|NCT00079222|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5818648|NCT00079222|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5818649|NCT00079222|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5818650|NCT00079222|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5818651|NCT00079222|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5818652|NCT00079222|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5818653|NCT00079222|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5818654|NCT00079222|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5818655|NCT00079222|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5818656|NCT00079222|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5818657|NCT00079222|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5818658|NCT00079222|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5818659|NCT00079222|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5818660|NCT00079222|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5818661|NCT00079222|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5818662|NCT00079222|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5818663|NCT00079222|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5818664|NCT00079222|primary myelofibrosis|primary myelofibrosis
5818665|NCT00079222|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5818666|NCT00079222|stage I multiple myeloma|stage i multiple myeloma
5818667|NCT00079222|stage II multiple myeloma|stage ii multiple myeloma
5818668|NCT00079222|stage III multiple myeloma|stage iii multiple myeloma
5818669|NCT00079222|refractory hairy cell leukemia|refractory hairy cell leukemia
5818670|NCT00079222|refractory multiple myeloma|refractory multiple myeloma
5818671|NCT00079222|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818672|NCT00079222|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5818674|NCT00079222|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5818675|NCT00079222|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5818676|NCT00079222|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5818677|NCT00079222|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5818678|NCT00079222|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5818679|NCT00079222|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5818680|NCT00079222|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5818681|NCT00079222|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5818682|NCT00079222|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5818683|NCT00079222|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5818684|NCT00079222|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5818685|NCT00079222|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5818686|NCT00079222|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5818687|NCT00079222|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5818688|NCT00079222|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5818689|NCT00079222|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5818690|NCT00079222|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5818691|NCT00079222|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5818692|NCT00079222|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5818693|NCT00079222|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5818694|NCT00079222|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5818695|NCT00079222|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5818696|NCT00079222|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5818697|NCT00079222|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5818698|NCT00079222|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818699|NCT00079222|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5818700|NCT00079222|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5818701|NCT00079222|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5818702|NCT00079222|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5818703|NCT00079222|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5818704|NCT00079222|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5818705|NCT00079222|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5686671|NCT00551122|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5686672|NCT00551122|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5686673|NCT00551122|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5681337|NCT00573781|Gene clusters|gene clusters
5818706|NCT00079222|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5818707|NCT00079222|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818708|NCT00079222|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819016|NCT00078689|Daclizumab|daclizumab
5818709|NCT00079222|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5818710|NCT00079222|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5818711|NCT00079222|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5818712|NCT00079222|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5818713|NCT00079222|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5818714|NCT00079222|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5818715|NCT00079222|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818716|NCT00079222|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5818717|NCT00079222|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5818718|NCT00079222|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5818719|NCT00079222|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5818720|NCT00079222|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818721|NCT00079222|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5818722|NCT00079222|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818723|NCT00079222|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5862666|NCT00001548|Psychiatric Disorder|psychiatric disorder
5818724|NCT00079222|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5818725|NCT00079222|disseminated neuroblastoma|disseminated neuroblastoma
5818727|NCT00079222|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5823425|NCT00071123|Emotion|emotion
5818728|NCT00079222|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5844347|NCT00004557|Cognition|cognition
5818729|NCT00079222|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5818730|NCT00079222|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5818731|NCT00079222|stage IIIA breast cancer|stage iiia breast cancer
5818733|NCT00079222|stage IIIC breast cancer|stage iiic breast cancer
5818734|NCT00079222|stage IV breast cancer|stage iv breast cancer
5818735|NCT00079222|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5818736|NCT00079222|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5818737|NCT00079222|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5818738|NCT00079222|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818739|NCT00079222|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5818740|NCT00079222|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5818741|NCT00079222|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5818742|NCT00079222|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5818744|NCT00079222|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818745|NCT00079222|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5818746|NCT00079222|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5818747|NCT00079222|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5818748|NCT00079222|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5818749|NCT00079222|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5818750|NCT00079222|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5818751|NCT00079222|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5818752|NCT00079222|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5818753|NCT00079170|male breast cancer|male breast cancer
5818754|NCT00079170|recurrent breast cancer|recurrent breast cancer
5818755|NCT00079170|stage IIIA breast cancer|stage iiia breast cancer
5818756|NCT00079170|stage IIIB breast cancer|stage iiib breast cancer
5818757|NCT00079170|stage IIIC breast cancer|stage iiic breast cancer
5818758|NCT00079170|stage IV breast cancer|stage iv breast cancer
5818759|NCT00079157|recurrent breast cancer|recurrent breast cancer
5818760|NCT00079157|stage IV breast cancer|stage iv breast cancer
5818761|NCT00079144|recurrent melanoma|recurrent melanoma
5818762|NCT00079144|stage IV melanoma|stage iv melanoma
5818763|NCT00079118|stage IV breast cancer|stage iv breast cancer
5818764|NCT00079118|recurrent breast cancer|recurrent breast cancer
5818765|NCT00079118|male breast cancer|male breast cancer
5818766|NCT00079105|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5818767|NCT00079105|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5818768|NCT00079105|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5818769|NCT00079105|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5818770|NCT00079092|recurrent adult brain tumor|recurrent adult brain tumor
5818771|NCT00079092|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5818772|NCT00079092|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5818773|NCT00079092|adult glioblastoma|adult glioblastoma
5818774|NCT00079092|adult mixed glioma|adult mixed glioma
5818775|NCT00079092|adult giant cell glioblastoma|adult giant cell glioblastoma
5818776|NCT00079092|adult gliosarcoma|adult gliosarcoma
5818777|NCT00079079|stage II salivary gland cancer|stage ii salivary gland cancer
5818778|NCT00079079|stage III salivary gland cancer|stage iii salivary gland cancer
5818779|NCT00079079|stage IV salivary gland cancer|stage iv salivary gland cancer
5818780|NCT00079079|recurrent salivary gland cancer|recurrent salivary gland cancer
5818781|NCT00079079|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5818782|NCT00079079|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5818783|NCT00079079|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5818784|NCT00079079|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5818785|NCT00079079|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5818786|NCT00079079|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5818787|NCT00079079|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5818788|NCT00079079|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5818789|NCT00079079|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5818790|NCT00079066|quality of life|quality of life
5818791|NCT00079066|stage IV colon cancer|stage iv colon cancer
5818792|NCT00079066|recurrent colon cancer|recurrent colon cancer
5818793|NCT00079066|recurrent rectal cancer|recurrent rectal cancer
5818794|NCT00079066|stage IV rectal cancer|stage iv rectal cancer
5818795|NCT00079053|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5818796|NCT00079053|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5818797|NCT00079053|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5819159|NCT00004904|polycythemia vera|polycythemia vera
5818883|NCT00078611|Inflammatory Bowel Disease|inflammatory bowel disease
5818800|NCT00079053|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5818802|NCT00079053|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5815295|NCT00004084|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818803|NCT00079053|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5818804|NCT00079053|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5818805|NCT00079053|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5818806|NCT00079053|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5818807|NCT00079053|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5818808|NCT00079053|stage III salivary gland cancer|stage iii salivary gland cancer
5818809|NCT00079053|stage IV salivary gland cancer|stage iv salivary gland cancer
5818810|NCT00079027|advanced adult primary liver cancer|advanced adult primary liver cancer
5818811|NCT00079027|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5818812|NCT00079001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5818813|NCT00079001|recurrent prostate cancer|recurrent prostate cancer
5818814|NCT00079001|stage IV prostate cancer|stage iv prostate cancer
5818815|NCT00079001|bone metastases|bone metastases
5818816|NCT00078988|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5818817|NCT00078988|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5818818|NCT00078988|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5818819|NCT00078975|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5818820|NCT00078975|recurrent pancreatic cancer|recurrent pancreatic cancer
5818821|NCT00078975|stage II pancreatic cancer|stage ii pancreatic cancer
5818822|NCT00078975|stage III pancreatic cancer|stage iii pancreatic cancer
5818823|NCT00078975|stage IV pancreatic cancer|stage iv pancreatic cancer
5818828|NCT00078923|stage I prostate cancer|stage i prostate cancer
5818829|NCT00078923|stage II prostate cancer|stage ii prostate cancer
5818830|NCT00078923|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5818831|NCT00078910|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5818832|NCT00078910|stage IIB prostate cancer|stage iib prostate cancer
5818833|NCT00078910|stage IIA prostate cancer|stage iia prostate cancer
5818834|NCT00078910|stage III prostate cancer|stage iii prostate cancer
5818835|NCT00078897|colon cancer|colon cancer
5818836|NCT00078897|rectal cancer|rectal cancer
5818837|NCT00078897|colorectal cancer|colorectal cancer
5818838|NCT00078897|adenomatous polyp|adenomatous polyp
5818839|NCT00078845|neurotoxicity|neurotoxicity
5818840|NCT00078845|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5818841|NCT00078845|recurrent prostate cancer|recurrent prostate cancer
5818842|NCT00078845|stage I prostate cancer|stage i prostate cancer
5818843|NCT00078845|stage IIB prostate cancer|stage iib prostate cancer
5818844|NCT00078845|stage IIA prostate cancer|stage iia prostate cancer
5818845|NCT00078845|stage III prostate cancer|stage iii prostate cancer
5818846|NCT00078845|stage IV prostate cancer|stage iv prostate cancer
5818847|NCT00078845|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5818848|NCT00078845|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5818849|NCT00078845|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5818850|NCT00078845|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5818851|NCT00078845|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5818852|NCT00078845|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5818853|NCT00078845|limited stage small cell lung cancer|limited stage small cell lung cancer
5818854|NCT00078845|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5818855|NCT00078845|recurrent small cell lung cancer|recurrent small cell lung cancer
5818856|NCT00078845|recurrent breast cancer|recurrent breast cancer
5818857|NCT00078845|stage I breast cancer|stage i breast cancer
5818858|NCT00078845|stage II breast cancer|stage ii breast cancer
5818859|NCT00078845|stage IIIA breast cancer|stage iiia breast cancer
5818860|NCT00078845|stage IIIB breast cancer|stage iiib breast cancer
5818861|NCT00078845|stage IIIC breast cancer|stage iiic breast cancer
5818862|NCT00078845|stage IV breast cancer|stage iv breast cancer
5818863|NCT00078845|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5818864|NCT00078845|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5818865|NCT00078845|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5818866|NCT00078845|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5818867|NCT00078845|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5818868|NCT00078832|breast cancer, chemoprevention|breast cancer, chemoprevention
5818869|NCT00078819|Pediatric Psoriasis|pediatric psoriasis
5818870|NCT00078806|Systemic Onset Juvenile Rheumatoid Arthritis|systemic onset juvenile rheumatoid arthritis
5818871|NCT00078806|SOJRA|sojra
5818872|NCT00078806|Fever|fever
5818873|NCT00078806|Rash|rash
5818874|NCT00078806|Joint Pain|joint pain
5818876|NCT00078793|Registry|registry
5818877|NCT00078767|PTSD|ptsd
5818878|NCT00078767|Depression|depression
5818879|NCT00078767|Anxiety|anxiety
5818880|NCT00078741|Psychotic Disorders|psychotic disorders
5818881|NCT00078728|Anxiety|anxiety
5818882|NCT00078611|Crohn's disease|crohn's disease
5818885|NCT00078611|Gastroenterology|gastroenterology
5818886|NCT00078611|Regional Enteritis|regional enteritis
5818887|NCT00078611|Colitis|colitis
5818888|NCT00007007|tumors metastatic to brain|tumors metastatic to brain
5818889|NCT00007007|radiation toxicity|radiation toxicity
5818890|NCT00007007|cognitive/functional effects|cognitive/functional effects
5818891|NCT00006890|refractory multiple myeloma|refractory multiple myeloma
5818892|NCT00006890|stage I multiple myeloma|stage i multiple myeloma
5818893|NCT00006890|stage II multiple myeloma|stage ii multiple myeloma
5818894|NCT00006890|stage III multiple myeloma|stage iii multiple myeloma
5818895|NCT00006467|stage III pancreatic cancer|stage iii pancreatic cancer
5818896|NCT00006467|recurrent pancreatic cancer|recurrent pancreatic cancer
5818897|NCT00006467|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5818898|NCT00006467|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5818899|NCT00006467|stage IV pancreatic cancer|stage iv pancreatic cancer
5818901|NCT00006452|adult giant cell glioblastoma|adult giant cell glioblastoma
5818902|NCT00006452|adult gliosarcoma|adult gliosarcoma
5818903|NCT00006350|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5818904|NCT00006350|refractory multiple myeloma|refractory multiple myeloma
5818905|NCT00006350|stage I multiple myeloma|stage i multiple myeloma
5818906|NCT00006350|stage II multiple myeloma|stage ii multiple myeloma
5818907|NCT00006350|stage III multiple myeloma|stage iii multiple myeloma
5818908|NCT00006350|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5818909|NCT00006350|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5818910|NCT00006350|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5818911|NCT00006350|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5818912|NCT00006350|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5818913|NCT00006350|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5818914|NCT00006350|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5818915|NCT00006350|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5818916|NCT00006350|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5818917|NCT00006350|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5818918|NCT00006350|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5818919|NCT00006350|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5818920|NCT00006350|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5818921|NCT00006350|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5818922|NCT00006350|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5826207|NCT00014248|cachexia|cachexia
5818923|NCT00006350|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5818924|NCT00006350|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5818925|NCT00006350|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5818926|NCT00006350|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5818927|NCT00006350|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5818928|NCT00006350|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5818929|NCT00006350|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5818930|NCT00006350|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5818931|NCT00006350|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5818932|NCT00006350|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5818933|NCT00006350|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5818934|NCT00006350|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5818935|NCT00006350|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5818936|NCT00006350|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5818937|NCT00006350|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5818938|NCT00006350|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5818939|NCT00006350|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5818940|NCT00006350|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5818941|NCT00006350|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5818942|NCT00006350|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5818943|NCT00006350|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5818944|NCT00006350|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5818945|NCT00006350|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5818946|NCT00006350|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5818947|NCT00006350|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5818948|NCT00006350|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5818949|NCT00006350|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5818950|NCT00006350|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5818951|NCT00006350|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5818952|NCT00006350|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5818953|NCT00006350|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5818954|NCT00006350|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5818955|NCT00006350|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5818956|NCT00006350|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5818957|NCT00006350|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5818958|NCT00006350|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5818959|NCT00006350|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5818960|NCT00006350|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5818961|NCT00006350|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5818962|NCT00006350|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5818963|NCT00006350|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5818964|NCT00006350|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5818965|NCT00006350|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5818966|NCT00006350|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5818967|NCT00006350|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5818968|NCT00006350|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5818969|NCT00006350|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5818970|NCT00006350|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5818971|NCT00006350|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5818972|NCT00006350|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5818973|NCT00006350|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5818974|NCT00006350|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5818975|NCT00006350|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5818976|NCT00006350|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5818977|NCT00006350|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5818978|NCT00006350|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818979|NCT00006350|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5818980|NCT00006350|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5818981|NCT00006259|tumors metastatic to brain|tumors metastatic to brain
5818982|NCT00006253|symptom management|symptom management
5818983|NCT00006253|cancer|cancer
5818984|NCT00006253|chemotherapy treatment|chemotherapy treatment
5818985|NCT00006253|Behavioral Research|behavioral research
5818986|NCT00006253|Physiological Effects of Drugs|physiological effects of drugs
5818987|NCT00006253|Clinical Trial, Phase II|clinical trial, phase ii
5818988|NCT00006126|stage IV breast cancer|stage iv breast cancer
5818989|NCT00006126|recurrent breast cancer|recurrent breast cancer
5818990|NCT00006126|stage IV renal cell cancer|stage iv renal cell cancer
5818991|NCT00006126|recurrent renal cell cancer|recurrent renal cell cancer
5818992|NCT00006126|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5818993|NCT00006126|recurrent small cell lung cancer|recurrent small cell lung cancer
5818994|NCT00006126|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5818995|NCT00006126|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5818996|NCT00006126|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5818997|NCT00006126|stage IV melanoma|stage iv melanoma
5818998|NCT00006126|recurrent melanoma|recurrent melanoma
5818999|NCT00006115|stage IV colon cancer|stage iv colon cancer
5819000|NCT00006115|stage IV rectal cancer|stage iv rectal cancer
5819001|NCT00006115|recurrent colon cancer|recurrent colon cancer
5819002|NCT00006115|recurrent rectal cancer|recurrent rectal cancer
5819003|NCT00006115|adenocarcinoma of the colon|adenocarcinoma of the colon
5819004|NCT00006115|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5819005|NCT00006018|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819006|NCT00078715|Yohimbine|yohimbine
5819007|NCT00078715|Sleep Deprivation|sleep deprivation
5819017|NCT00078689|Inflammation|inflammation
5819018|NCT00078689|Induce Tolerance|induce tolerance
5819019|NCT00078689|Uveitis|uveitis
5819020|NCT00078689|Immune Tolerance|immune tolerance
5819021|NCT00078689|T Cell|t cell
5819022|NCT00006000|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819023|NCT00005965|stage III cervical cancer|stage iii cervical cancer
5819024|NCT00005965|recurrent cervical cancer|recurrent cervical cancer
5819025|NCT00005965|stage IVB cervical cancer|stage ivb cervical cancer
5819026|NCT00005965|stage IVA cervical cancer|stage iva cervical cancer
5819027|NCT00005965|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5819028|NCT00005965|cervical adenocarcinoma|cervical adenocarcinoma
5819029|NCT00005965|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5819030|NCT00005947|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5819031|NCT00005947|stage IV prostate cancer|stage iv prostate cancer
5819032|NCT00005947|recurrent prostate cancer|recurrent prostate cancer
5819033|NCT00005946|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5819034|NCT00005946|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819036|NCT00005946|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5819037|NCT00005946|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5819038|NCT00005946|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5819039|NCT00005946|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5819040|NCT00005946|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5819041|NCT00005946|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5819042|NCT00005946|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5819043|NCT00005946|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5819044|NCT00005946|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5819045|NCT00005946|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5819046|NCT00005946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819047|NCT00005946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819048|NCT00005946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819049|NCT00005946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819050|NCT00005946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819051|NCT00005946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819052|NCT00005946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819053|NCT00005946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819054|NCT00005946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5819055|NCT00005946|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5819056|NCT00005946|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5819057|NCT00005946|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5819058|NCT00005946|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5819059|NCT00005946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5819060|NCT00005946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819061|NCT00005946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819062|NCT00005946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5818543|NCT00079625|MBC|mbc
5819063|NCT00005946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819064|NCT00005946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819065|NCT00005946|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5819066|NCT00005843|recurrent pancreatic cancer|recurrent pancreatic cancer
5819067|NCT00005843|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5819068|NCT00005843|stage IV pancreatic cancer|stage iv pancreatic cancer
5819070|NCT00078663|ICU|icu
5819071|NCT00078663|Pneumonia|pneumonia
5819072|NCT00078663|Pathogens|pathogens
5819073|NCT00078663|Intubation|intubation
5819074|NCT00078663|Intubated|intubated
5819075|NCT00078663|Oral Hygiene|oral hygiene
5819076|NCT00078663|Intensive Care|intensive care
5819077|NCT00078624|Osteoarthritis|osteoarthritis
5819078|NCT00078624|Knee Joint|knee joint
5819079|NCT00078624|Joint Stability|joint stability
5819080|NCT00078624|Motor Control|motor control
5819081|NCT00078624|Exercise Therapy|exercise therapy
5819082|NCT00005595|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819083|NCT00005096|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5819084|NCT00005096|stage II prostate cancer|stage ii prostate cancer
5819085|NCT00005096|stage III prostate cancer|stage iii prostate cancer
5819086|NCT00005035|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5819087|NCT00005035|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5819088|NCT00005035|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5819089|NCT00005035|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5819090|NCT00005035|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5819091|NCT00005035|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5819092|NCT00005035|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5819093|NCT00005035|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5819094|NCT00005035|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5819095|NCT00005035|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5819096|NCT00005035|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5819097|NCT00005035|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5819098|NCT00005035|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5819650|NCT00078364|SNP's|snp's
5819099|NCT00005035|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5819100|NCT00005035|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5819101|NCT00005035|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5819102|NCT00005035|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5819103|NCT00005035|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5819104|NCT00005035|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5819105|NCT00004914|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819106|NCT00004914|anemia|anemia
5819107|NCT00004914|fatigue|fatigue
5819108|NCT00078598|Relapsed|relapsed
5819109|NCT00078598|Follicular|follicular
5819110|NCT00078572|XELODA|xeloda
5819111|NCT00078572|Metastatic|metastatic
5819112|NCT00078572|Breast Cancer|breast cancer
5819113|NCT00078572|Advanced|advanced
5819114|NCT00078572|HERCEPTIN|herceptin
5819115|NCT00078507|Outcome and Process Assessment (Health Care)|outcome and process assessment (health care)
5819116|NCT00078507|Behavior Control|behavior control
5819117|NCT00078507|Sensation|sensation
5819118|NCT00078507|Randomized Controlled Trials|randomized controlled trials
5819119|NCT00078507|Adolescent|adolescent
5819120|NCT00078507|Adult|adult
5819121|NCT00004912|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819122|NCT00004912|fatigue|fatigue
5819123|NCT00004912|cachexia|cachexia
5819124|NCT00004908|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819125|NCT00004908|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5819126|NCT00004908|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819127|NCT00004908|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819128|NCT00004908|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819129|NCT00004908|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819130|NCT00004908|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819131|NCT00004908|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819132|NCT00004908|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819133|NCT00004908|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5818601|NCT00079313|CMML|cmml
5819134|NCT00004908|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819135|NCT00004908|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819136|NCT00004908|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819137|NCT00004908|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819138|NCT00004908|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819139|NCT00004904|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5819140|NCT00004904|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5819141|NCT00004904|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5819142|NCT00004904|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5819143|NCT00004904|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5819144|NCT00004904|extramedullary plasmacytoma|extramedullary plasmacytoma
5819145|NCT00004904|refractory multiple myeloma|refractory multiple myeloma
5819146|NCT00004904|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5819147|NCT00004904|stage III multiple myeloma|stage iii multiple myeloma
5819148|NCT00004904|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5819149|NCT00004904|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5819150|NCT00004904|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5819151|NCT00004904|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5819152|NCT00004904|small intestine lymphoma|small intestine lymphoma
5819153|NCT00004904|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5819154|NCT00004904|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5819155|NCT00004904|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5819156|NCT00004904|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5819157|NCT00004904|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5819158|NCT00004904|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5819160|NCT00004904|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5819161|NCT00004904|essential thrombocythemia|essential thrombocythemia
5819162|NCT00004904|refractory hairy cell leukemia|refractory hairy cell leukemia
5819163|NCT00004904|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5819164|NCT00004904|acute undifferentiated leukemia|acute undifferentiated leukemia
5819165|NCT00004904|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5819166|NCT00004904|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5819167|NCT00004904|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5819168|NCT00004904|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5819169|NCT00004904|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5819170|NCT00004904|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5819171|NCT00004904|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5819172|NCT00004904|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5819173|NCT00004904|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5819174|NCT00004904|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5819175|NCT00004904|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5819176|NCT00004904|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5819177|NCT00004904|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5819178|NCT00004904|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5819179|NCT00004904|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819180|NCT00004904|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5819181|NCT00004904|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5819183|NCT00004904|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819184|NCT00004904|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819185|NCT00004904|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819186|NCT00004904|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819187|NCT00004904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819188|NCT00004904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819189|NCT00004904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819190|NCT00004904|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819191|NCT00004904|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5819192|NCT00004904|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5819193|NCT00004904|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5819194|NCT00004904|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5819195|NCT00004904|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5819196|NCT00004904|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5819197|NCT00004904|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5819198|NCT00004904|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5819199|NCT00004904|graft versus host disease|graft versus host disease
5819200|NCT00004904|primary systemic amyloidosis|primary systemic amyloidosis
5819201|NCT00004904|intraocular lymphoma|intraocular lymphoma
5819202|NCT00004904|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5819203|NCT00004904|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5819204|NCT00004904|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5819205|NCT00004904|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5819206|NCT00004904|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5819207|NCT00004904|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5819208|NCT00004904|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5819209|NCT00004904|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5819210|NCT00004904|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819720|NCT00004148|recurrent melanoma|recurrent melanoma
5819211|NCT00004904|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819212|NCT00004904|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5819213|NCT00004904|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5819214|NCT00004904|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5819215|NCT00004904|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5819216|NCT00004904|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819217|NCT00004904|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819218|NCT00004904|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819219|NCT00004904|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5819220|NCT00004898|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5819221|NCT00004898|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5819222|NCT00004898|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5819223|NCT00004898|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5819224|NCT00004898|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5819225|NCT00004898|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5819226|NCT00004898|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5819227|NCT00004898|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5819228|NCT00004898|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5819229|NCT00004898|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5819230|NCT00004898|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5819231|NCT00004898|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5819651|NCT00078364|Acute Pain|acute pain
5819232|NCT00004898|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5819234|NCT00004898|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5819235|NCT00004898|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5819236|NCT00004898|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5819237|NCT00004898|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5819238|NCT00004898|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5819239|NCT00004898|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5819240|NCT00004898|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5819241|NCT00004898|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819242|NCT00004898|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819243|NCT00004898|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5819244|NCT00004898|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5819245|NCT00004898|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5819246|NCT00004898|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5819247|NCT00004898|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5819248|NCT00004898|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5819249|NCT00004898|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5819250|NCT00004898|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5819251|NCT00004898|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5819252|NCT00004898|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5819253|NCT00004898|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5819255|NCT00004235|recurrent gastric cancer|recurrent gastric cancer
5819256|NCT00004235|stage II esophageal cancer|stage ii esophageal cancer
5819257|NCT00004235|stage III esophageal cancer|stage iii esophageal cancer
5819258|NCT00004235|stage IV esophageal cancer|stage iv esophageal cancer
5819259|NCT00004235|recurrent esophageal cancer|recurrent esophageal cancer
5819260|NCT00004235|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5819261|NCT00004235|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5818726|NCT00079222|recurrent neuroblastoma|recurrent neuroblastoma
5819262|NCT00004175|stage IIIA breast cancer|stage iiia breast cancer
5819263|NCT00004175|stage IIIB breast cancer|stage iiib breast cancer
5819264|NCT00078559|Immunosuppression|immunosuppression
5819265|NCT00078559|Renal Failure|renal failure
5819266|NCT00078546|EBV|ebv
5819267|NCT00078546|NASOPHARYNGEAL|nasopharyngeal
5819268|NCT00078546|CARCINOMA|carcinoma
5819269|NCT00078546|EBV POSITIVE NASOPHARYNGEAL CARCINOMA|ebv positive nasopharyngeal carcinoma
5819270|NCT00078533|Allogeneic|allogeneic
5819271|NCT00078533|Transplant|transplant
5819272|NCT00078533|CMV|cmv
5819273|NCT00078533|Stem Cell|stem cell
5819274|NCT00078533|Donor|donor
5819275|NCT00078533|Allogeneic stem cell recipients at risk for CMV reactivation|allogeneic stem cell recipients at risk for cmv reactivation
5819276|NCT00078520|Leukemia|leukemia
5819277|NCT00078494|Immunization|immunization
5819278|NCT00078494|Vaccine|vaccine
5819279|NCT00078494|Nasopharyngeal Cancer|nasopharyngeal cancer
5819280|NCT00078494|Immunotherapy|immunotherapy
5819281|NCT00078494|Cancer|cancer
5819282|NCT00078494|NPC|npc
5819283|NCT00078481|Neurodegeneration|neurodegeneration
5819284|NCT00078481|Anti-Oxidant|anti-oxidant
5819285|NCT00078481|Neuropathy|neuropathy
5819286|NCT00078481|Hereditary|hereditary
5819287|NCT00078481|Spinocerebellar|spinocerebellar
5819288|NCT00078481|Friedreich Ataxia|friedreich ataxia
5819289|NCT00078481|FRDA|frda
5819290|NCT00078455|NSCLC|nsclc
5819291|NCT00078455|Non-small Cell Lung Cancer|non-small cell lung cancer
5819292|NCT00078455|Non-small Cell Lung Carcinoma|non-small cell lung carcinoma
5819293|NCT00078455|Locally Advanced NSCLC|locally advanced nsclc
5819294|NCT00078455|Metastatic NSCLC|metastatic nsclc
5819295|NCT00078221|Dry AMD|dry amd
5819296|NCT00078221|Age-related Macular Degeneration|age-related macular degeneration
5819297|NCT00078221|Rheopheresis|rheopheresis
5819298|NCT00004171|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819299|NCT00004171|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5819300|NCT00004171|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5819301|NCT00004171|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819302|NCT00004171|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819303|NCT00004171|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819304|NCT00004171|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819305|NCT00004171|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819306|NCT00004091|cervical cancer|cervical cancer
5819307|NCT00003351|stage IV breast cancer|stage iv breast cancer
5819308|NCT00003302|breast cancer|breast cancer
5819309|NCT00003264|stage IV salivary gland cancer|stage iv salivary gland cancer
5819310|NCT00003264|recurrent salivary gland cancer|recurrent salivary gland cancer
5844348|NCT00004557|Dementia|dementia
5819311|NCT00003264|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5819312|NCT00003264|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5819313|NCT00003264|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5819314|NCT00003264|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5819315|NCT00003264|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5819316|NCT00003264|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5819317|NCT00003264|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5819318|NCT00003264|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5819319|NCT00003264|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5846519|NCT00044239|Immunology|immunology
5819320|NCT00003264|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5819321|NCT00003264|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5819322|NCT00003264|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5819323|NCT00003264|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5819324|NCT00003264|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5819325|NCT00003264|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5819326|NCT00003070|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5819327|NCT00003070|cardiac toxicity|cardiac toxicity
5819328|NCT00003040|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5819329|NCT00003040|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5819330|NCT00003040|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5819331|NCT00002825|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5819332|NCT00002825|recurrent neuroblastoma|recurrent neuroblastoma
5819333|NCT00002825|recurrent osteosarcoma|recurrent osteosarcoma
5819334|NCT00002825|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5819335|NCT00002825|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5819336|NCT00002825|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5819337|NCT00002825|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5819338|NCT00002825|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5819339|NCT00002825|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5819340|NCT00002825|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5819341|NCT00002825|recurrent childhood ependymoma|recurrent childhood ependymoma
5819342|NCT00002652|refractory multiple myeloma|refractory multiple myeloma
5819343|NCT00026429|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5819344|NCT00026429|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5819345|NCT00026429|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5819346|NCT00026429|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5819347|NCT00026429|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5819348|NCT00026429|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5819349|NCT00026429|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5819350|NCT00026429|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5819351|NCT00026429|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5819352|NCT00026429|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5819353|NCT00026429|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5819354|NCT00026429|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5819355|NCT00026429|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5819356|NCT00026429|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5819357|NCT00026429|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5819358|NCT00026429|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5819359|NCT00026429|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5819360|NCT00026429|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5819361|NCT00026429|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5819362|NCT00026429|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5819363|NCT00026429|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5819364|NCT00026429|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5819365|NCT00026429|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5819366|NCT00026429|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819367|NCT00026429|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819368|NCT00026429|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819369|NCT00026429|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819370|NCT00026429|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819371|NCT00026429|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819372|NCT00026429|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819374|NCT00026429|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5819375|NCT00026429|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5819376|NCT00026429|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5819377|NCT00026429|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5819378|NCT00026429|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5819379|NCT00026429|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5819380|NCT00026429|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5819381|NCT00026429|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5819382|NCT00026429|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5819383|NCT00026429|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5819384|NCT00026429|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5819385|NCT00026429|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5819386|NCT00026429|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5819387|NCT00026429|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5819388|NCT00026429|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5819389|NCT00026429|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5819390|NCT00026429|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5819391|NCT00026429|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5819392|NCT00026429|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5819393|NCT00026429|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819394|NCT00026429|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819395|NCT00026429|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5819396|NCT00026429|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5819397|NCT00026429|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5819398|NCT00026429|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5819399|NCT00026429|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5819400|NCT00026429|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5819401|NCT00026429|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5819402|NCT00026429|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5819403|NCT00026429|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819404|NCT00025012|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5819405|NCT00025012|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5819407|NCT00024037|oral complications|oral complications
5819408|NCT00022308|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5819409|NCT00022308|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5819410|NCT00022308|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5819411|NCT00022308|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5819412|NCT00022217|recurrent salivary gland cancer|recurrent salivary gland cancer
5819413|NCT00022217|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5819414|NCT00022217|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5819415|NCT00022217|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5819416|NCT00022217|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5819417|NCT00022217|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5819418|NCT00022217|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5819419|NCT00022217|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5819420|NCT00022217|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5819421|NCT00022217|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5819422|NCT00022217|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5819423|NCT00022217|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5819424|NCT00022217|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5819425|NCT00022178|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5819426|NCT00022178|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5819427|NCT00022178|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5819428|NCT00022178|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5819429|NCT00021996|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819431|NCT00021372|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5815953|NCT00003232|pain|pain
5819432|NCT00021372|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819433|NCT00021372|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819434|NCT00021372|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819435|NCT00021372|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819436|NCT00021372|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819437|NCT00021372|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819438|NCT00021372|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819439|NCT00021372|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5819440|NCT00021372|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5819441|NCT00021372|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819442|NCT00021372|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833142|NCT00047164|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5833143|NCT00047164|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5833144|NCT00047164|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5833150|NCT00047138|mixed cell type Wilms tumor|mixed cell type wilms tumor
5819443|NCT00021372|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819444|NCT00021372|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819445|NCT00021372|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819446|NCT00020618|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819448|NCT00020098|breast cancer|breast cancer
5819449|NCT00019409|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5819450|NCT00019409|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5819451|NCT00019409|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5819452|NCT00019409|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5819453|NCT00017303|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5819454|NCT00017303|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5826906|NCT00063778|HIV-1|hiv-1
5819455|NCT00017303|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5819456|NCT00017303|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5819457|NCT00017303|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5819458|NCT00017303|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5819459|NCT00017303|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5819460|NCT00017303|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5819461|NCT00017303|Brenner tumor|brenner tumor
5819462|NCT00016367|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5819463|NCT00016367|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5819464|NCT00015964|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5819465|NCT00015964|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5819466|NCT00015964|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5819467|NCT00015964|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5819468|NCT00015964|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5819469|NCT00015964|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5819470|NCT00015964|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5819471|NCT00015964|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5819472|NCT00015964|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5819473|NCT00015964|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5819474|NCT00015964|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5819475|NCT00015964|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5819476|NCT00015964|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5819477|NCT00015964|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5819478|NCT00002597|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5819479|NCT00002597|stage I prostate cancer|stage i prostate cancer
5819480|NCT00002597|stage IIB prostate cancer|stage iib prostate cancer
5819481|NCT00002597|stage IIA prostate cancer|stage iia prostate cancer
5819482|NCT00002577|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5819483|NCT00002577|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5819484|NCT00002577|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5819485|NCT00002577|squamous cell lung cancer|squamous cell lung cancer
5819486|NCT00002577|large cell lung cancer|large cell lung cancer
5819487|NCT00002577|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5819488|NCT00002577|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5819489|NCT00002577|adenocarcinoma of the lung|adenocarcinoma of the lung
5819490|NCT00002454|lung papilloma|lung papilloma
5819491|NCT00078442|Treatment Experienced|treatment experienced
5819492|NCT00078442|Treatment Interruption|treatment interruption
5819495|NCT00078390|Lung carcinoma|lung carcinoma
5819496|NCT00078390|Non small cell lung cancer|non small cell lung cancer
5844349|NCT00004557|Memory|memory
5819497|NCT00078390|Stage IIIA non small cell lung cancer|stage iiia non small cell lung cancer
5819498|NCT00078390|Stage IIIB non small cell lung cancer|stage iiib non small cell lung cancer
5819499|NCT00078390|NSCLC|nsclc
5819500|NCT00078390|Stage III|stage iii
5819501|NCT00078390|chemotherapy|chemotherapy
5819502|NCT00078390|radiation|radiation
5819503|NCT00078390|chemoradiation|chemoradiation
5819504|NCT00078390|matrix metalloproteinases|matrix metalloproteinases
5819505|NCT00078390|neovascularization|neovascularization
5819506|NCT00078390|antiangiogenesis|antiangiogenesis
5819507|NCT00078390|type IV collagenases|type iv collagenases
5819508|NCT00078390|Unresectable locally advanced non-small cell lung cancer|unresectable locally advanced non-small cell lung cancer
5819509|NCT00078377|Narcolepsy|narcolepsy
5819510|NCT00078377|Excessive Sleepiness|excessive sleepiness
5819511|NCT00078377|Cataplexy|cataplexy
5819512|NCT00078377|Sleep Attacks|sleep attacks
5819513|NCT00078377|Excessive Sleepiness associated with Narcolepsy|excessive sleepiness associated with narcolepsy
5819514|NCT00078377|Cephalon|cephalon
5819515|NCT00078377|Cephalon, Inc|cephalon, inc
5819516|NCT00078377|Nuvigil|nuvigil
5819517|NCT00014690|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5819518|NCT00014690|fallopian tube cancer|fallopian tube cancer
5819519|NCT00014690|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5819520|NCT00014339|stage II multiple myeloma|stage ii multiple myeloma
5819521|NCT00014339|stage III multiple myeloma|stage iii multiple myeloma
5819522|NCT00012259|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5819523|NCT00012259|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5819524|NCT00012259|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5819525|NCT00010179|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5819526|NCT00010179|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5819069|NCT00078663|Oral Care|oral care
5819527|NCT00010179|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5819528|NCT00010179|fallopian tube cancer|fallopian tube cancer
5819529|NCT00010179|peritoneal cavity cancer|peritoneal cavity cancer
5819530|NCT00006472|stage I esophageal cancer|stage i esophageal cancer
5819531|NCT00006472|stage II esophageal cancer|stage ii esophageal cancer
5819532|NCT00006472|stage III esophageal cancer|stage iii esophageal cancer
5819533|NCT00006472|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5819534|NCT00006472|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5819535|NCT00006365|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5819536|NCT00006365|stage I prostate cancer|stage i prostate cancer
5819537|NCT00006365|stage IIB prostate cancer|stage iib prostate cancer
5819538|NCT00006365|stage IIA prostate cancer|stage iia prostate cancer
5819539|NCT00006108|stage IV breast cancer|stage iv breast cancer
5819540|NCT00006108|recurrent breast cancer|recurrent breast cancer
5819541|NCT00006037|stage IV colon cancer|stage iv colon cancer
5819542|NCT00006037|stage IV rectal cancer|stage iv rectal cancer
5819543|NCT00006037|recurrent colon cancer|recurrent colon cancer
5819544|NCT00006037|recurrent rectal cancer|recurrent rectal cancer
5819545|NCT00006037|adenocarcinoma of the colon|adenocarcinoma of the colon
5819546|NCT00006037|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5819547|NCT00006014|advanced malignant mesothelioma|advanced malignant mesothelioma
5819548|NCT00006014|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5819549|NCT00006014|epithelial mesothelioma|epithelial mesothelioma
5819550|NCT00006014|sarcomatous mesothelioma|sarcomatous mesothelioma
5819551|NCT00078403|Treatment Experienced|treatment experienced
5819552|NCT00078325|Excessive Sleepiness|excessive sleepiness
5819553|NCT00078325|Obstructive Sleep Apnea|obstructive sleep apnea
5819554|NCT00078325|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5819555|NCT00078325|nCPAP|ncpap
5819556|NCT00078325|Cephalon|cephalon
5819557|NCT00078325|Cephalon, Inc|cephalon, inc
5819558|NCT00078325|NUVIGIL|nuvigil
5819559|NCT00078312|Excessive Sleepiness|excessive sleepiness
5819560|NCT00078312|Narcolepsy|narcolepsy
5819561|NCT00078312|Cataplexy|cataplexy
5819562|NCT00078312|Sleep Attacks|sleep attacks
5819563|NCT00078312|Obstructive Sleep Apnea|obstructive sleep apnea
5819564|NCT00078312|Obstructive Sleep Hypopnea|obstructive sleep hypopnea
5819565|NCT00078312|nCPAP|ncpap
5819566|NCT00078312|Chronic Shift Work Sleep Disorder|chronic shift work sleep disorder
5819567|NCT00078312|Chronic SWSD|chronic swsd
5819568|NCT00078312|Circadian Rhythm Disorder|circadian rhythm disorder
5819569|NCT00078312|Shift Worker|shift worker
5819570|NCT00078312|Cepahlon|cepahlon
5819571|NCT00078312|Cephalon, Inc|cephalon, inc
5819572|NCT00078312|Nuvigil|nuvigil
5819573|NCT00005991|stage IV breast cancer|stage iv breast cancer
5819574|NCT00005991|recurrent breast cancer|recurrent breast cancer
5819575|NCT00005880|non-small cell lung cancer|non-small cell lung cancer
5819576|NCT00005880|small cell lung cancer|small cell lung cancer
5819577|NCT00005869|stage II pancreatic cancer|stage ii pancreatic cancer
5819578|NCT00005869|stage III pancreatic cancer|stage iii pancreatic cancer
5819579|NCT00005869|recurrent pancreatic cancer|recurrent pancreatic cancer
5819580|NCT00005869|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5819581|NCT00005869|stage IV pancreatic cancer|stage iv pancreatic cancer
5819582|NCT00005864|stage IV colon cancer|stage iv colon cancer
5844668|NCT00001740|Ultrasound|ultrasound
5819583|NCT00005864|stage IV rectal cancer|stage iv rectal cancer
5819584|NCT00005864|recurrent colon cancer|recurrent colon cancer
5819585|NCT00005864|recurrent rectal cancer|recurrent rectal cancer
5846520|NCT00044239|Magnetic Resonance Imaging|magnetic resonance imaging
5819586|NCT00005593|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5819587|NCT00005593|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5819588|NCT00005593|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5819589|NCT00005593|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5819590|NCT00005593|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5819591|NCT00005593|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5819592|NCT00005593|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5819593|NCT00005593|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5819594|NCT00005593|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5819595|NCT00005593|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5819596|NCT00005593|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5819597|NCT00005593|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5819598|NCT00005593|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5819599|NCT00005593|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5819600|NCT00005593|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5819601|NCT00005593|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5819602|NCT00005593|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5819603|NCT00005593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5819604|NCT00005593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5819605|NCT00005593|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5819606|NCT00005593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5819607|NCT00005593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5819608|NCT00005593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5819609|NCT00005593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5819610|NCT00005593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5819611|NCT00005593|refractory anemia with excess blasts|refractory anemia with excess blasts
5819612|NCT00005593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5819613|NCT00005593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5819614|NCT00005593|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5819615|NCT00005593|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5819616|NCT00005593|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5819617|NCT00005593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5819618|NCT00005593|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5819619|NCT00005593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5819620|NCT00005593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5819621|NCT00005075|stage I prostate cancer|stage i prostate cancer
5819622|NCT00005075|stage II prostate cancer|stage ii prostate cancer
5819623|NCT00005075|recurrent prostate cancer|recurrent prostate cancer
5819624|NCT00005026|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5819625|NCT00005026|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5819626|NCT00005026|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5819627|NCT00005026|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5819628|NCT00005026|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5819629|NCT00005026|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5819630|NCT00005026|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5819631|NCT00005026|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5819632|NCT00005026|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5819633|NCT00005026|Brenner tumor|brenner tumor
5819634|NCT00004223|stage III bladder cancer|stage iii bladder cancer
5819635|NCT00004223|recurrent bladder cancer|recurrent bladder cancer
5819636|NCT00004223|stage IV bladder cancer|stage iv bladder cancer
5819637|NCT00004223|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5819638|NCT00004223|posterior urethral cancer|posterior urethral cancer
5819639|NCT00004223|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5819640|NCT00004223|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5819641|NCT00004216|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819642|NCT00004183|localized malignant mesothelioma|localized malignant mesothelioma
5819643|NCT00004183|advanced malignant mesothelioma|advanced malignant mesothelioma
5819644|NCT00004183|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5819645|NCT00004183|epithelial mesothelioma|epithelial mesothelioma
5819646|NCT00004183|sarcomatous mesothelioma|sarcomatous mesothelioma
5819648|NCT00078364|NSAID Analgesia|nsaid analgesia
5819649|NCT00078364|Pain Mechanisms|pain mechanisms
5819652|NCT00078364|Wisdom Teeth|wisdom teeth
5819653|NCT00078364|Third Molar Extraction|third molar extraction
5819654|NCT00078364|Third Molar Impaction|third molar impaction
5819655|NCT00078351|Chronic Pain|chronic pain
5819656|NCT00078351|Synvisc|synvisc
5819657|NCT00078351|Temporomandibular Joint|temporomandibular joint
5819658|NCT00078351|Osteoarthritis|osteoarthritis
5819659|NCT00078351|TMD|tmd
5819660|NCT00078351|Temporomandibular Joint Osteoarthritis|temporomandibular joint osteoarthritis
5819661|NCT00078351|TMJ OA|tmj oa
5819662|NCT00078351|Temporomandibular Joint Disease|temporomandibular joint disease
5819663|NCT00078351|TMJ|tmj
5819664|NCT00078286|Antidepressive Agents|antidepressive agents
5819665|NCT00078273|Gambling|gambling
5819666|NCT00078273|Pathological Gambling|pathological gambling
5819667|NCT00078273|Problem Gambling|problem gambling
5819668|NCT00078273|College Students|college students
5819669|NCT00078273|Prevention|prevention
5819670|NCT00078299|Cortical|cortical
5819671|NCT00078299|Nuclear Sclerosis|nuclear sclerosis
5819672|NCT00078299|Posterior Subcapsular|posterior subcapsular
5819673|NCT00078299|Photographic Methods|photographic methods
5819674|NCT00078299|Reproducibility (intra and interobserver)|reproducibility (intra and interobserver)
5819675|NCT00078299|Cataract|cataract
5819676|NCT00078299|Agreement|agreement
5819677|NCT00078299|Grading System|grading system
5819678|NCT00078247|Antiretroviral Therapy|antiretroviral therapy
5819679|NCT00078247|Africa|africa
5819680|NCT00078234|CLL|cll
5819681|NCT00078234|Leukemia|leukemia
5819682|NCT00078234|Chronic|chronic
5819683|NCT00078234|Cancer|cancer
5827067|NCT00063765|RP|rp
5819684|NCT00078234|Adult|adult
5819685|NCT00078234|Lymphocytic|lymphocytic
5819686|NCT00078234|Genasense|genasense
5819687|NCT00078234|G3139|g3139
5819688|NCT00078234|Genta|genta
5819689|NCT00078234|Bcl-2|bcl-2
5819690|NCT00078234|Antisense|antisense
5819691|NCT00078234|Oligonucleotide|oligonucleotide
5819692|NCT00078234|oblimersen|oblimersen
5819693|NCT00078169|behavioral intervention|behavioral intervention
5819694|NCT00078156|behavioral intervention|behavioral intervention
5819695|NCT00078143|behavioral intervention|behavioral intervention
5819696|NCT00078208|Pediatric|pediatric
5819697|NCT00078208|Non-Invasive|non-invasive
5819698|NCT00078208|Anti-Inflammatory|anti-inflammatory
5819699|NCT00078208|pH|ph
5819700|NCT00078208|Mediators|mediators
5819701|NCT00078208|Asthma|asthma
5819702|NCT00078208|Childhood Asthma|childhood asthma
5819703|NCT00078208|Healthy Volunteer|healthy volunteer
5819704|NCT00078208|HV|hv
5819705|NCT00078195|Ragweed|ragweed
5819706|NCT00078195|Immunotherapy|immunotherapy
5819707|NCT00078195|Rush Immunotherapy|rush immunotherapy
5819708|NCT00078195|RIT|rit
5819709|NCT00078195|Hayfever|hayfever
5819710|NCT00078195|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5819711|NCT00078182|HIV Prevention|hiv prevention
5819712|NCT00078130|opioid dependence|opioid dependence
5819713|NCT00078130|behavioral intervention|behavioral intervention
5819714|NCT00078117|opiate dependence|opiate dependence
5819715|NCT00078065|multiple myeloma|multiple myeloma
5819716|NCT00078065|fludarabine|fludarabine
5819717|NCT00078065|Xcellerated T Cells|xcellerated t cells
5819718|NCT00004148|stage III melanoma|stage iii melanoma
5819719|NCT00004148|stage IV melanoma|stage iv melanoma
5819721|NCT00003935|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5819722|NCT00003814|stage 0 bladder cancer|stage 0 bladder cancer
5819723|NCT00003814|stage I bladder cancer|stage i bladder cancer
5819724|NCT00003814|recurrent bladder cancer|recurrent bladder cancer
5819725|NCT00003814|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5819726|NCT00003766|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819727|NCT00003623|recurrent bladder cancer|recurrent bladder cancer
5819728|NCT00003615|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5819729|NCT00003615|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5819730|NCT00003615|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5819731|NCT00003615|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5819732|NCT00003615|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5819733|NCT00003615|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5819734|NCT00003615|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5819735|NCT00003615|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5819736|NCT00003615|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5819737|NCT00003615|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5819738|NCT00003615|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5819739|NCT00003615|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5819740|NCT00003615|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819741|NCT00003615|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819742|NCT00003615|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819743|NCT00003615|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819744|NCT00003615|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5819745|NCT00003615|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5819746|NCT00003615|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5819747|NCT00003615|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5819748|NCT00003615|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5819749|NCT00003615|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5819750|NCT00003615|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5819751|NCT00003615|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5819752|NCT00003615|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5819753|NCT00003615|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5819754|NCT00003615|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5819755|NCT00003615|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5819756|NCT00003615|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5819757|NCT00003615|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819758|NCT00003615|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819759|NCT00003615|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5819760|NCT00003615|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5819761|NCT00003615|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5819762|NCT00003615|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5819763|NCT00003615|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819764|NCT00003615|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819765|NCT00003615|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819766|NCT00003573|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5819767|NCT00003572|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5819768|NCT00003572|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5819769|NCT00003572|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5819770|NCT00003572|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5819771|NCT00003572|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819772|NCT00003572|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5819773|NCT00003572|stage I multiple myeloma|stage i multiple myeloma
5819774|NCT00003572|stage II multiple myeloma|stage ii multiple myeloma
5819775|NCT00003572|stage III multiple myeloma|stage iii multiple myeloma
5819776|NCT00003572|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5819777|NCT00003572|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5819778|NCT00003572|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5819779|NCT00003572|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5819780|NCT00003572|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5819781|NCT00003572|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5819782|NCT00003572|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5819783|NCT00003572|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5819784|NCT00003572|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5819785|NCT00003572|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5819786|NCT00003572|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5819787|NCT00003572|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5819788|NCT00003572|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5819789|NCT00003572|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5819790|NCT00003572|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5819791|NCT00003572|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5819792|NCT00003572|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5819793|NCT00003572|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5819794|NCT00003572|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5819795|NCT00003572|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5819796|NCT00003572|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5819797|NCT00003572|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5819798|NCT00003572|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5820009|NCT00003089|large cell lung cancer|large cell lung cancer
5819799|NCT00003572|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5819800|NCT00003572|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5819801|NCT00003572|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5819802|NCT00003572|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5819803|NCT00003572|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5819804|NCT00003572|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819805|NCT00003572|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5819806|NCT00003572|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5819807|NCT00003572|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5819808|NCT00003572|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5819809|NCT00003572|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5819810|NCT00003572|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5819811|NCT00003572|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5819812|NCT00003572|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5819813|NCT00003572|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5820510|NCT00077337|stage III rectal cancer|stage iii rectal cancer
5819814|NCT00003572|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5819815|NCT00003572|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5819816|NCT00003572|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5819817|NCT00003572|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5819818|NCT00003572|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5819819|NCT00003572|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5819820|NCT00003572|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5819821|NCT00003572|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5819822|NCT00003572|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5819823|NCT00003572|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5819824|NCT00003572|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5819825|NCT00003572|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5819826|NCT00003572|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5819827|NCT00003572|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5819828|NCT00003572|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5819829|NCT00003572|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5819830|NCT00003572|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5819831|NCT00003572|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5819832|NCT00003572|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5819833|NCT00003572|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5819834|NCT00003572|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5819835|NCT00003572|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5819836|NCT00003572|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5819837|NCT00003572|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5819838|NCT00003572|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5819839|NCT00003572|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5819840|NCT00003572|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5819841|NCT00003572|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5819842|NCT00003572|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5819843|NCT00003572|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5819844|NCT00003572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819845|NCT00003572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819846|NCT00003572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819847|NCT00003548|stage IV colon cancer|stage iv colon cancer
5819848|NCT00003548|stage IV breast cancer|stage iv breast cancer
5819849|NCT00003548|recurrent breast cancer|recurrent breast cancer
5819850|NCT00003548|stage IV gastric cancer|stage iv gastric cancer
5819851|NCT00003548|recurrent gastric cancer|recurrent gastric cancer
5819852|NCT00003548|recurrent pancreatic cancer|recurrent pancreatic cancer
5819853|NCT00003548|stage IV rectal cancer|stage iv rectal cancer
5819854|NCT00003548|recurrent colon cancer|recurrent colon cancer
5819855|NCT00003548|recurrent rectal cancer|recurrent rectal cancer
5819856|NCT00003548|stage IV anal cancer|stage iv anal cancer
5819857|NCT00003548|recurrent anal cancer|recurrent anal cancer
5819858|NCT00003548|stage IV esophageal cancer|stage iv esophageal cancer
5819859|NCT00003548|recurrent esophageal cancer|recurrent esophageal cancer
5819860|NCT00003548|stage IV cervical cancer|stage iv cervical cancer
5819862|NCT00003548|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5819863|NCT00003548|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5819864|NCT00003548|stage IV vulvar cancer|stage iv vulvar cancer
5819865|NCT00003548|recurrent vulvar cancer|recurrent vulvar cancer
5819867|NCT00003548|stage IVB vaginal cancer|stage ivb vaginal cancer
5819868|NCT00003548|recurrent vaginal cancer|recurrent vaginal cancer
5819869|NCT00003548|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5819870|NCT00003548|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5819871|NCT00003548|advanced adult primary liver cancer|advanced adult primary liver cancer
5844881|NCT00001584|Resistance|resistance
5819872|NCT00003548|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5819873|NCT00003548|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5819874|NCT00003548|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5819875|NCT00003548|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5819876|NCT00003548|unresectable gallbladder cancer|unresectable gallbladder cancer
5819877|NCT00003548|recurrent gallbladder cancer|recurrent gallbladder cancer
5819878|NCT00003548|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5819879|NCT00003548|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5819880|NCT00003548|recurrent small intestine cancer|recurrent small intestine cancer
5819881|NCT00003548|carcinoma of the appendix|carcinoma of the appendix
5819882|NCT00003548|fallopian tube cancer|fallopian tube cancer
5819883|NCT00003548|stage IV uterine sarcoma|stage iv uterine sarcoma
5819884|NCT00003548|recurrent uterine sarcoma|recurrent uterine sarcoma
5819885|NCT00003548|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5819886|NCT00003548|stage IV pancreatic cancer|stage iv pancreatic cancer
5819887|NCT00003425|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5819888|NCT00003425|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5819889|NCT00003425|stage IV breast cancer|stage iv breast cancer
5819890|NCT00003425|stage IIIA breast cancer|stage iiia breast cancer
5819891|NCT00003425|recurrent breast cancer|recurrent breast cancer
5819892|NCT00003425|stage IIIB breast cancer|stage iiib breast cancer
5819893|NCT00003425|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5819894|NCT00003425|refractory multiple myeloma|refractory multiple myeloma
5827320|NCT00063011|Osteopenia|osteopenia
5819895|NCT00003425|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5819896|NCT00003425|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5819897|NCT00003425|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5819898|NCT00003425|regional neuroblastoma|regional neuroblastoma
5819899|NCT00003425|disseminated neuroblastoma|disseminated neuroblastoma
5819900|NCT00003425|stage 4S neuroblastoma|stage 4s neuroblastoma
5819901|NCT00003425|recurrent neuroblastoma|recurrent neuroblastoma
5819902|NCT00003425|stage III multiple myeloma|stage iii multiple myeloma
5819903|NCT00003425|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5819904|NCT00003425|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5819905|NCT00003425|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5819906|NCT00003425|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5819907|NCT00003425|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5819908|NCT00003425|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5819909|NCT00003425|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5819910|NCT00003425|ovarian stromal cancer|ovarian stromal cancer
5820511|NCT00077337|stage IV rectal cancer|stage iv rectal cancer
5819911|NCT00003425|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5819912|NCT00003425|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5819913|NCT00003425|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5819914|NCT00003425|acute undifferentiated leukemia|acute undifferentiated leukemia
5819915|NCT00003425|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5819916|NCT00003425|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5819917|NCT00003425|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5819918|NCT00003425|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5819919|NCT00003425|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5819920|NCT00003425|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5819921|NCT00003425|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5819922|NCT00003425|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5819923|NCT00003425|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5819924|NCT00003425|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5819925|NCT00003425|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5819926|NCT00003425|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5819927|NCT00003425|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5819928|NCT00003425|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5819929|NCT00003425|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5819930|NCT00003425|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5819931|NCT00003425|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5819932|NCT00003425|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5819933|NCT00003425|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5819934|NCT00003425|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5819935|NCT00003425|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5819936|NCT00003425|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5819937|NCT00003425|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5819938|NCT00003425|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820020|NCT00003046|gastrointestinal carcinoid tumor|gastrointestinal carcinoid tumor
5819939|NCT00003425|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819940|NCT00003425|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5819941|NCT00003425|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5819942|NCT00003425|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5819943|NCT00003425|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5819945|NCT00003425|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5819946|NCT00003425|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5819947|NCT00003425|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5819948|NCT00003425|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5819949|NCT00003425|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5819950|NCT00003425|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5819951|NCT00003425|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5819952|NCT00003425|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5819953|NCT00003425|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5819954|NCT00003425|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5819955|NCT00003425|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5819956|NCT00003425|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827488|NCT00062556|PAD|pad
5819957|NCT00003425|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5819958|NCT00003425|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5819959|NCT00003425|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5819960|NCT00003411|stage II pancreatic cancer|stage ii pancreatic cancer
5819961|NCT00003411|stage III pancreatic cancer|stage iii pancreatic cancer
5819962|NCT00003411|unresectable gallbladder cancer|unresectable gallbladder cancer
5819963|NCT00003411|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5819964|NCT00003411|stage IV pancreatic cancer|stage iv pancreatic cancer
5819965|NCT00003299|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5819966|NCT00003240|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5819967|NCT00003240|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5819968|NCT00003240|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5819969|NCT00003240|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5819970|NCT00003240|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5819971|NCT00003120|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5819972|NCT00003120|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5819973|NCT00003120|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5819974|NCT00003120|fallopian tube cancer|fallopian tube cancer
5819975|NCT00003120|peritoneal cavity cancer|peritoneal cavity cancer
5819976|NCT00078104|Prostanoid|prostanoid
5819977|NCT00078104|Cyclooxygenase (COX)|cyclooxygenase (cox)
5819978|NCT00078104|Selective Cox Inhibitor|selective cox inhibitor
5819979|NCT00078104|Acute Peripheral Inflammation|acute peripheral inflammation
5819980|NCT00078104|Neuronal Expression of COX|neuronal expression of cox
5819981|NCT00078104|Pain|pain
5819982|NCT00078104|Coxibs|coxibs
5819983|NCT00078104|Wisdom Teeth|wisdom teeth
5819984|NCT00078104|Third Molar Extraction|third molar extraction
5819985|NCT00078104|Third Molar Impaction|third molar impaction
5819986|NCT00078091|Obesity|obesity
5819987|NCT00078091|Retinopathy|retinopathy
5819988|NCT00078091|Dyslipidemia|dyslipidemia
5819989|NCT00078091|Insulin Resistance|insulin resistance
5819990|NCT00078091|Hypogonadism|hypogonadism
5819991|NCT00078091|Polydactyly|polydactyly
5819992|NCT00078091|Bardet-Biedl Syndrome|bardet-biedl syndrome
5819994|NCT00078078|Organic Acidemias|organic acidemias
5819995|NCT00078078|Cobalamin|cobalamin
5819996|NCT00078078|Vitamin B12|vitamin b12
5819997|NCT00078078|Methylmalonic Acidemia|methylmalonic acidemia
5819998|NCT00078078|Hyperhomocysteinemia|hyperhomocysteinemia
5819999|NCT00078078|MMA|mma
5820000|NCT00078078|Metabolic Disease|metabolic disease
5820001|NCT00078026|Apomine|apomine
5820002|NCT00078026|Osteoporosis|osteoporosis
5820003|NCT00078026|Bone Mass|bone mass
5820004|NCT00078026|Postmenopausal|postmenopausal
5820006|NCT00030602|recurrent prostate cancer|recurrent prostate cancer
5820007|NCT00003089|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5820008|NCT00003089|squamous cell lung cancer|squamous cell lung cancer
5820010|NCT00003089|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5820011|NCT00003089|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820012|NCT00003089|adenocarcinoma of the lung|adenocarcinoma of the lung
5820013|NCT00003089|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5820014|NCT00003046|anal cancer|anal cancer
5820015|NCT00003046|carcinoma of the appendix|carcinoma of the appendix
5820016|NCT00003046|colorectal cancer|colorectal cancer
5820017|NCT00003046|extrahepatic bile duct cancer|extrahepatic bile duct cancer
5820018|NCT00003046|gallbladder cancer|gallbladder cancer
5820019|NCT00003046|gastric cancer|gastric cancer
5820021|NCT00003046|malignant mesothelioma|malignant mesothelioma
5820022|NCT00003046|pancreatic cancer|pancreatic cancer
5820023|NCT00003046|small intestine cancer|small intestine cancer
5820024|NCT00003046|stage IV colon cancer|stage iv colon cancer
5820025|NCT00003046|stage IV gastric cancer|stage iv gastric cancer
5820026|NCT00003046|recurrent gastric cancer|recurrent gastric cancer
5820027|NCT00003046|recurrent pancreatic cancer|recurrent pancreatic cancer
5820028|NCT00003046|stage IV rectal cancer|stage iv rectal cancer
5820029|NCT00003046|recurrent colon cancer|recurrent colon cancer
5820030|NCT00003046|recurrent rectal cancer|recurrent rectal cancer
5820031|NCT00003046|stage IV anal cancer|stage iv anal cancer
5820032|NCT00003046|recurrent anal cancer|recurrent anal cancer
5820033|NCT00003046|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5820034|NCT00003046|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5820035|NCT00003046|advanced malignant mesothelioma|advanced malignant mesothelioma
5820036|NCT00003046|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5820037|NCT00003046|small intestine adenocarcinoma|small intestine adenocarcinoma
5820038|NCT00003046|unresectable gallbladder cancer|unresectable gallbladder cancer
5820039|NCT00003046|recurrent gallbladder cancer|recurrent gallbladder cancer
5820040|NCT00003046|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5820041|NCT00003046|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5820042|NCT00003046|recurrent small intestine cancer|recurrent small intestine cancer
5820043|NCT00003046|stage IV pancreatic cancer|stage iv pancreatic cancer
5820044|NCT00003035|stage IIIA breast cancer|stage iiia breast cancer
5820045|NCT00003035|stage IIIB breast cancer|stage iiib breast cancer
5820046|NCT00078013|AMI|ami
5820047|NCT00078013|STEMI|stemi
5820048|NCT00078013|Infarct|infarct
5820049|NCT00078013|acute myocardial infarction with ST segment elevation|acute myocardial infarction with st segment elevation
5820050|NCT00077961|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5820051|NCT00077961|NHL|nhl
5820052|NCT00077961|CAMPATH|campath
5820053|NCT00077961|alemtuzumab|alemtuzumab
5820054|NCT00077948|positive inotrope|positive inotrope
5820055|NCT00077948|enoximone|enoximone
5820056|NCT00077948|beta-blocker|beta-blocker
5820057|NCT00077948|intolerant|intolerant
5820058|NCT00077870|Moderate to severe rheumatoid arthritis|moderate to severe rheumatoid arthritis
5820059|NCT00077792|Receiving fibrinolytic therapy|receiving fibrinolytic therapy
5820060|NCT00077727|Schizophrenia|schizophrenia
5820061|NCT00077727|cognitive impairment|cognitive impairment
5820062|NCT00077727|galantamine|galantamine
5820063|NCT00077727|acetylcholinesterase inhibitors|acetylcholinesterase inhibitors
5820064|NCT00077727|antipsychotic drugs|antipsychotic drugs
5820065|NCT00077727|BACS|bacs
5820066|NCT00077714|Schizophrenia|schizophrenia
5820067|NCT00077714|Paliperidone|paliperidone
5820068|NCT00076973|RSV Bronchiolitis|rsv bronchiolitis
5820069|NCT00027924|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5820070|NCT00027924|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5820071|NCT00027924|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5820072|NCT00027924|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5820073|NCT00027924|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5820074|NCT00027924|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5820075|NCT00027924|refractory anemia|refractory anemia
5820076|NCT00027924|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5820077|NCT00027924|refractory anemia with excess blasts|refractory anemia with excess blasts
5820078|NCT00027924|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5820079|NCT00027924|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5820080|NCT00027924|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5820081|NCT00027924|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5820082|NCT00027924|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5820083|NCT00027924|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5820084|NCT00027924|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5820085|NCT00023647|stage IV melanoma|stage iv melanoma
5820086|NCT00023647|recurrent melanoma|recurrent melanoma
5820087|NCT00021294|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5820088|NCT00021294|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5820089|NCT00021294|actinic keratosis|actinic keratosis
5820361|NCT00003867|carcinoma of the appendix|carcinoma of the appendix
5820090|NCT00021034|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5820091|NCT00021034|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5820092|NCT00021034|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5820093|NCT00021034|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5820094|NCT00021034|fallopian tube cancer|fallopian tube cancer
5820095|NCT00021034|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5820096|NCT00021021|stage IV renal cell cancer|stage iv renal cell cancer
5820097|NCT00021021|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5820098|NCT00020917|stage IV colon cancer|stage iv colon cancer
5820099|NCT00020917|stage IV rectal cancer|stage iv rectal cancer
5820100|NCT00020553|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5820101|NCT00017459|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820102|NCT00017459|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820103|NCT00017459|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820104|NCT00017199|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5820107|NCT00017199|somatostatinoma|somatostatinoma
5820108|NCT00017199|glucagonoma|glucagonoma
5820109|NCT00017056|stage IV gastric cancer|stage iv gastric cancer
5820110|NCT00017056|recurrent gastric cancer|recurrent gastric cancer
5820111|NCT00017056|stage IV esophageal cancer|stage iv esophageal cancer
5820112|NCT00017056|recurrent esophageal cancer|recurrent esophageal cancer
5820113|NCT00017056|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5820114|NCT00017056|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5820115|NCT00016172|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5820116|NCT00016172|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5820117|NCT00016172|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5820118|NCT00016172|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5820119|NCT00016172|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5820120|NCT00016172|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5820121|NCT00016172|small intestine lymphoma|small intestine lymphoma
5827569|NCT00062582|Roflumilast|roflumilast
5820122|NCT00016172|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820123|NCT00016172|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5820124|NCT00016172|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5820125|NCT00016172|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5820126|NCT00016172|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5820127|NCT00016172|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5820128|NCT00016172|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5820129|NCT00016172|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5820130|NCT00016172|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5820131|NCT00016172|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5820132|NCT00016172|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5820133|NCT00016172|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5820134|NCT00016172|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5820135|NCT00016172|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5820136|NCT00016172|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5820137|NCT00016172|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5820138|NCT00016172|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5820139|NCT00016172|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5820140|NCT00016172|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5820141|NCT00016172|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5820142|NCT00016172|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5820143|NCT00016172|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5820144|NCT00016172|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820145|NCT00016172|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5820146|NCT00016172|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820147|NCT00016172|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820148|NCT00016172|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5820149|NCT00016172|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820150|NCT00016172|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5820151|NCT00016172|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5820152|NCT00016172|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5820153|NCT00016172|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5820154|NCT00016172|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5820155|NCT00016172|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5820156|NCT00016172|intraocular lymphoma|intraocular lymphoma
5820157|NCT00016172|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5827076|NCT00063648|PTLD|ptld
5820158|NCT00016172|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5820159|NCT00016172|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820160|NCT00016172|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5820161|NCT00016172|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5820162|NCT00016172|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5820163|NCT00016172|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5820164|NCT00016172|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5820165|NCT00016172|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5820166|NCT00016172|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5820167|NCT00016172|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5820168|NCT00016172|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5820169|NCT00016172|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5820170|NCT00016172|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5820171|NCT00016172|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5820172|NCT00016172|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5820173|NCT00016172|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5820174|NCT00014625|stage IV melanoma|stage iv melanoma
5820175|NCT00014625|recurrent melanoma|recurrent melanoma
5820176|NCT00014430|stage IV breast cancer|stage iv breast cancer
5820177|NCT00014430|stage IIIA breast cancer|stage iiia breast cancer
5820178|NCT00014430|recurrent breast cancer|recurrent breast cancer
5820179|NCT00014430|stage IIIB breast cancer|stage iiib breast cancer
5820180|NCT00008281|stage IV colon cancer|stage iv colon cancer
5820181|NCT00008281|stage IV rectal cancer|stage iv rectal cancer
5820182|NCT00008281|recurrent colon cancer|recurrent colon cancer
5820183|NCT00008281|recurrent rectal cancer|recurrent rectal cancer
5820184|NCT00008281|adenocarcinoma of the colon|adenocarcinoma of the colon
5820185|NCT00008281|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5820186|NCT00006122|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5820187|NCT00006122|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5820188|NCT00006122|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5820189|NCT00006122|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5820190|NCT00006122|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5820191|NCT00006122|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5820192|NCT00006122|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5820193|NCT00006122|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5820194|NCT00006122|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5820195|NCT00006122|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5820196|NCT00005795|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5820197|NCT00005795|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5820198|NCT00005795|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5820199|NCT00005795|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5820200|NCT00005795|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5820201|NCT00005795|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5820202|NCT00005795|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5820203|NCT00005795|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5820204|NCT00005795|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5820205|NCT00005795|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5820206|NCT00005795|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5820207|NCT00005791|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820208|NCT00005631|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820209|NCT00005631|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820210|NCT00005631|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5820211|NCT00005609|Waldenström macroglobulinemia|waldenström macroglobulinemia
5820212|NCT00005089|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5820213|NCT00005089|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5820214|NCT00005089|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5820215|NCT00005089|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5820216|NCT00005089|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5862667|NCT00001548|Affected Sib Pairs|affected sib pairs
5820217|NCT00005089|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5820218|NCT00005089|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5820219|NCT00005089|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5820220|NCT00005089|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5820221|NCT00004152|stage III melanoma|stage iii melanoma
5820222|NCT00004152|stage IV melanoma|stage iv melanoma
5820223|NCT00004152|recurrent melanoma|recurrent melanoma
5820224|NCT00004145|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5820225|NCT00004145|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5820226|NCT00004145|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5820227|NCT00004145|refractory multiple myeloma|refractory multiple myeloma
5820229|NCT00004145|stage II multiple myeloma|stage ii multiple myeloma
5820230|NCT00004145|stage III multiple myeloma|stage iii multiple myeloma
5820231|NCT00004145|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5820232|NCT00004145|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5820233|NCT00004145|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5820521|NCT00077311|adenocarcinoma of the lung|adenocarcinoma of the lung
5820234|NCT00004145|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5820235|NCT00004145|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5820236|NCT00004145|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5820237|NCT00004145|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5820238|NCT00004145|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5820239|NCT00004145|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5820240|NCT00004145|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5820241|NCT00004145|refractory anemia|refractory anemia
5820242|NCT00004145|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5820243|NCT00004145|refractory anemia with excess blasts|refractory anemia with excess blasts
5820244|NCT00004145|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5820245|NCT00004145|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5820246|NCT00004145|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5820247|NCT00004145|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5820248|NCT00004145|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5824092|NCT00069654|Ischemia|ischemia
5820249|NCT00004145|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5820250|NCT00004145|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5820251|NCT00004145|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5820252|NCT00004145|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5820253|NCT00004145|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5820254|NCT00004145|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5820255|NCT00004145|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5820256|NCT00004145|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5820257|NCT00004145|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5820258|NCT00004145|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5820259|NCT00004145|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5820260|NCT00004145|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5820261|NCT00004145|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5820262|NCT00004145|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5820263|NCT00004145|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5820264|NCT00004145|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5820265|NCT00004145|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5820266|NCT00004145|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5820267|NCT00004145|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820268|NCT00004145|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5820269|NCT00004145|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820270|NCT00004145|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820271|NCT00004145|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5820272|NCT00004145|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820273|NCT00004145|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5820274|NCT00004145|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5820275|NCT00004145|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5820276|NCT00004145|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5820277|NCT00004145|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5820278|NCT00004145|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5820279|NCT00004145|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820280|NCT00004145|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5862668|NCT00001548|Obsessions|obsessions
5820281|NCT00004145|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5820282|NCT00004145|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5820283|NCT00004145|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5820284|NCT00004145|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5820285|NCT00004145|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5820286|NCT00004145|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5820287|NCT00004145|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5820288|NCT00004145|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5820289|NCT00004114|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5827077|NCT00063648|CTL Therapy|ctl therapy
5820290|NCT00004114|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5820292|NCT00004114|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5820293|NCT00004114|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5820294|NCT00004114|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5820295|NCT00004114|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5820296|NCT00004114|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5820595|NCT00004157|recurrent neuroblastoma|recurrent neuroblastoma
5820297|NCT00004114|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5820298|NCT00004114|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5820299|NCT00004114|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820300|NCT00004114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5820301|NCT00004114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820302|NCT00004114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820303|NCT00004114|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5820304|NCT00004114|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820305|NCT00004114|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5820306|NCT00004114|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5820307|NCT00004114|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5820308|NCT00004114|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820309|NCT00004114|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5820310|NCT00004114|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5820311|NCT00004114|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5820312|NCT00004114|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5820313|NCT00004114|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5820314|NCT00004114|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5820315|NCT00004114|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5820316|NCT00004114|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5820317|NCT00003916|adult glioblastoma|adult glioblastoma
5820318|NCT00003916|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5820319|NCT00003916|adult giant cell glioblastoma|adult giant cell glioblastoma
5820320|NCT00003916|adult gliosarcoma|adult gliosarcoma
5820321|NCT00003867|stage III colon cancer|stage iii colon cancer
5820322|NCT00003867|stage IV colon cancer|stage iv colon cancer
5820323|NCT00003867|stage IV breast cancer|stage iv breast cancer
5820324|NCT00003867|stage IIIA breast cancer|stage iiia breast cancer
5820325|NCT00003867|recurrent breast cancer|recurrent breast cancer
5820326|NCT00003867|stage III gastric cancer|stage iii gastric cancer
5820327|NCT00003867|stage IV gastric cancer|stage iv gastric cancer
5820328|NCT00003867|recurrent gastric cancer|recurrent gastric cancer
5820329|NCT00003867|stage IIIB breast cancer|stage iiib breast cancer
5820330|NCT00003867|stage II pancreatic cancer|stage ii pancreatic cancer
5820331|NCT00003867|stage III pancreatic cancer|stage iii pancreatic cancer
5820332|NCT00003867|recurrent pancreatic cancer|recurrent pancreatic cancer
5820333|NCT00003867|stage III rectal cancer|stage iii rectal cancer
5820334|NCT00003867|stage IV rectal cancer|stage iv rectal cancer
5820335|NCT00003867|recurrent colon cancer|recurrent colon cancer
5820336|NCT00003867|recurrent rectal cancer|recurrent rectal cancer
5820337|NCT00003867|stage IV anal cancer|stage iv anal cancer
5820338|NCT00003867|recurrent anal cancer|recurrent anal cancer
5820339|NCT00003867|stage II esophageal cancer|stage ii esophageal cancer
5820340|NCT00003867|stage III esophageal cancer|stage iii esophageal cancer
5820341|NCT00003867|stage IV esophageal cancer|stage iv esophageal cancer
5820342|NCT00003867|stage IIIA anal cancer|stage iiia anal cancer
5820343|NCT00003867|stage IIIB anal cancer|stage iiib anal cancer
5820344|NCT00003867|recurrent esophageal cancer|recurrent esophageal cancer
5820345|NCT00003867|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5820346|NCT00003867|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5820347|NCT00003867|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5820348|NCT00003867|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5862669|NCT00001548|Compulsions|compulsions
5820349|NCT00003867|advanced adult primary liver cancer|advanced adult primary liver cancer
5820350|NCT00003867|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5820351|NCT00003867|small intestine adenocarcinoma|small intestine adenocarcinoma
5820352|NCT00003867|small intestine lymphoma|small intestine lymphoma
5820353|NCT00003867|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5820354|NCT00003867|unresectable gallbladder cancer|unresectable gallbladder cancer
5820355|NCT00003867|recurrent gallbladder cancer|recurrent gallbladder cancer
5820356|NCT00003867|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5820357|NCT00003867|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5820358|NCT00003867|recurrent small intestine cancer|recurrent small intestine cancer
5820359|NCT00003867|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820360|NCT00003867|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5820362|NCT00003867|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5820363|NCT00003867|stage IV pancreatic cancer|stage iv pancreatic cancer
5820364|NCT00003632|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5820365|NCT00003582|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5820366|NCT00003582|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5820367|NCT00003582|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5820368|NCT00003582|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5820369|NCT00003582|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5820370|NCT00003582|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5820371|NCT00003582|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5820372|NCT00003582|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5820373|NCT00003582|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5820374|NCT00003582|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5820375|NCT00003582|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5820376|NCT00003582|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5820377|NCT00003582|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5820378|NCT00003545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5820379|NCT00003545|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5820380|NCT00003545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5820381|NCT00003545|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5820382|NCT00003545|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5820383|NCT00003545|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5820384|NCT00003545|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5820385|NCT00003207|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820386|NCT00003207|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5820387|NCT00003207|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5820388|NCT00003150|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5820389|NCT00003150|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5820390|NCT00003150|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5820391|NCT00003150|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5820392|NCT00003150|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5820393|NCT00003150|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5820394|NCT00003150|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5820395|NCT00003150|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5820396|NCT00003150|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5820397|NCT00003150|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5820398|NCT00003150|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5820399|NCT00003150|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5820400|NCT00003150|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5820401|NCT00003150|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5820402|NCT00003150|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5820403|NCT00003066|stage IV breast cancer|stage iv breast cancer
5820404|NCT00003066|recurrent breast cancer|recurrent breast cancer
5820405|NCT00003062|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820406|NCT00003062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820407|NCT00003011|recurrent small cell lung cancer|recurrent small cell lung cancer
5820408|NCT00002869|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5862670|NCT00001548|Family Study|family study
5820409|NCT00002869|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5820410|NCT00002869|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5820411|NCT00002868|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5820412|NCT00002532|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5820413|NCT00002531|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5820414|NCT00002531|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5820415|NCT00002531|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5820416|NCT00002531|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5820418|NCT00077922|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5820419|NCT00077922|CLL|cll
5820420|NCT00077922|Immunotoxin|immunotoxin
5820421|NCT00077922|Oncology|oncology
5820422|NCT00077922|Lymphocytes|lymphocytes
5820437|NCT00077896|Pick's Disease|pick's disease
5820438|NCT00077896|Cognitive Impairment|cognitive impairment
5820439|NCT00077896|Dementia|dementia
5820440|NCT00077896|Frontotemporal Dementia|frontotemporal dementia
5820441|NCT00077896|FTD|ftd
5820442|NCT00077675|Abscess|abscess
5820443|NCT00077675|Burns|burns
5820444|NCT00077675|Cellulitis|cellulitis
5820445|NCT00077675|Ulcer|ulcer
5820446|NCT00077675|Wound infections|wound infections
5820447|NCT00077662|Pompe Disease|pompe disease
5845195|NCT00001415|Depression|depression
5820448|NCT00077662|Glycogen Storage Disease Type II|glycogen storage disease type ii
5820449|NCT00077662|GSD-II|gsd-ii
5820450|NCT00077662|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5820451|NCT00077662|Glycogenosis 2|glycogenosis 2
5820452|NCT00077558|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5820453|NCT00077558|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5820454|NCT00077558|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5820455|NCT00077558|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5820456|NCT00077558|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5820457|NCT00077558|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5820458|NCT00077558|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5820459|NCT00077558|prolymphocytic leukemia|prolymphocytic leukemia
5820460|NCT00077558|refractory anemia with excess blasts|refractory anemia with excess blasts
5820461|NCT00077558|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5820462|NCT00077558|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5820463|NCT00077558|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5820464|NCT00077558|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5820465|NCT00077558|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5820466|NCT00077558|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5820467|NCT00077558|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5820468|NCT00077558|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5820469|NCT00077558|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5820470|NCT00077558|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5820471|NCT00077558|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5820472|NCT00077558|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5820473|NCT00077558|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5820474|NCT00077558|adult acute basophilic leukemia|adult acute basophilic leukemia
5820475|NCT00077558|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5820476|NCT00077558|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5820477|NCT00077558|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5820478|NCT00077558|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5820479|NCT00077558|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5820480|NCT00077558|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5820481|NCT00077558|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5820482|NCT00077532|stage IV melanoma|stage iv melanoma
5820483|NCT00077532|recurrent melanoma|recurrent melanoma
5820484|NCT00077519|stage II pancreatic cancer|stage ii pancreatic cancer
5820485|NCT00077519|stage III pancreatic cancer|stage iii pancreatic cancer
5820486|NCT00077519|recurrent pancreatic cancer|recurrent pancreatic cancer
5820487|NCT00077493|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5820488|NCT00077493|Burkitt lymphoma|burkitt lymphoma
5820489|NCT00077493|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5820490|NCT00077493|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5820491|NCT00077493|childhood non-Hodgkin lymphoma|childhood non-hodgkin lymphoma
5820492|NCT00077415|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820493|NCT00077415|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5862671|NCT00001548|OCD Spectrum Disorders|ocd spectrum disorders
5820494|NCT00077415|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820495|NCT00077415|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820496|NCT00077415|adenocarcinoma of the lung|adenocarcinoma of the lung
5820497|NCT00077415|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5820498|NCT00077415|large cell lung cancer|large cell lung cancer
5820499|NCT00077415|squamous cell lung cancer|squamous cell lung cancer
5820500|NCT00077402|recurrent prostate cancer|recurrent prostate cancer
5820501|NCT00077402|stage III prostate cancer|stage iii prostate cancer
5820502|NCT00077402|stage IV prostate cancer|stage iv prostate cancer
5820503|NCT00077402|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5820504|NCT00077389|childhood hepatoblastoma|childhood hepatoblastoma
5820505|NCT00077389|stage IV childhood liver cancer|stage iv childhood liver cancer
5820506|NCT00077337|recurrent colon cancer|recurrent colon cancer
5820507|NCT00077337|stage III colon cancer|stage iii colon cancer
5820508|NCT00077337|stage IV colon cancer|stage iv colon cancer
5820509|NCT00077337|recurrent rectal cancer|recurrent rectal cancer
5820512|NCT00077324|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5820513|NCT00077311|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5820515|NCT00077311|neutropenia|neutropenia
5820516|NCT00077311|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820517|NCT00077311|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820518|NCT00077311|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820519|NCT00077311|squamous cell lung cancer|squamous cell lung cancer
5820520|NCT00077311|large cell lung cancer|large cell lung cancer
5820522|NCT00077311|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5820523|NCT00077311|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5820524|NCT00007852|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5820525|NCT00007852|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5820526|NCT00007852|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5820527|NCT00007852|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820528|NCT00007852|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5820529|NCT00007852|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820530|NCT00007852|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820531|NCT00007852|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820532|NCT00007852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820533|NCT00007852|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5820534|NCT00007852|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5820535|NCT00007852|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5820536|NCT00007852|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5820537|NCT00007852|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5820538|NCT00006786|stage IV colon cancer|stage iv colon cancer
5820539|NCT00006786|stage IV rectal cancer|stage iv rectal cancer
5820540|NCT00006786|recurrent colon cancer|recurrent colon cancer
5820541|NCT00006786|recurrent rectal cancer|recurrent rectal cancer
5820542|NCT00006786|adenocarcinoma of the colon|adenocarcinoma of the colon
5820543|NCT00006786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5820544|NCT00006459|stage IV breast cancer|stage iv breast cancer
5820545|NCT00006459|stage IIIA breast cancer|stage iiia breast cancer
5820546|NCT00006459|recurrent breast cancer|recurrent breast cancer
5820547|NCT00006459|stage IIIB breast cancer|stage iiib breast cancer
5820548|NCT00006388|adult glioblastoma|adult glioblastoma
5820549|NCT00006388|adult giant cell glioblastoma|adult giant cell glioblastoma
5820550|NCT00006388|adult gliosarcoma|adult gliosarcoma
5820551|NCT00006375|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820552|NCT00006123|stage IV breast cancer|stage iv breast cancer
5820553|NCT00006047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820554|NCT00006038|stage II gastric cancer|stage ii gastric cancer
5820555|NCT00006038|stage III gastric cancer|stage iii gastric cancer
5820556|NCT00006038|stage IV gastric cancer|stage iv gastric cancer
5820557|NCT00006038|stage II esophageal cancer|stage ii esophageal cancer
5820558|NCT00006038|stage III esophageal cancer|stage iii esophageal cancer
5820559|NCT00006038|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5820560|NCT00006038|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5820561|NCT00005995|stage IV renal cell cancer|stage iv renal cell cancer
5820562|NCT00005995|recurrent renal cell cancer|recurrent renal cell cancer
5820563|NCT00005986|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5820564|NCT00005986|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5820565|NCT00005986|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5820566|NCT00005877|stage III colon cancer|stage iii colon cancer
5820567|NCT00005877|stage IV colon cancer|stage iv colon cancer
5820568|NCT00005877|stage III rectal cancer|stage iii rectal cancer
5820569|NCT00005877|stage IV rectal cancer|stage iv rectal cancer
5820570|NCT00005877|recurrent colon cancer|recurrent colon cancer
5820571|NCT00005877|recurrent rectal cancer|recurrent rectal cancer
5820572|NCT00005862|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5820573|NCT00005862|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5820574|NCT00005862|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5820575|NCT00005862|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5820577|NCT00005610|recurrent melanoma|recurrent melanoma
5820578|NCT00005610|lung metastases|lung metastases
5820579|NCT00004889|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5820580|NCT00004203|recurrent bladder cancer|recurrent bladder cancer
5820581|NCT00004203|stage IV bladder cancer|stage iv bladder cancer
5820582|NCT00004203|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5820583|NCT00004203|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5820584|NCT00004203|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5820586|NCT00004157|stage IIIA breast cancer|stage iiia breast cancer
5820587|NCT00004157|stage IIIB breast cancer|stage iiib breast cancer
5820588|NCT00004157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5820589|NCT00004157|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5820590|NCT00004157|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5820591|NCT00004157|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5820592|NCT00004157|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5820593|NCT00004157|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5820594|NCT00004157|disseminated neuroblastoma|disseminated neuroblastoma
5820596|NCT00004157|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5820597|NCT00004157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5820598|NCT00004157|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5820599|NCT00004157|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5820600|NCT00004157|testicular embryonal carcinoma|testicular embryonal carcinoma
5820601|NCT00004157|testicular choriocarcinoma|testicular choriocarcinoma
5820602|NCT00004157|testicular teratoma|testicular teratoma
5820603|NCT00004157|testicular yolk sac tumor|testicular yolk sac tumor
5820604|NCT00004157|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5820605|NCT00004157|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5820606|NCT00004157|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5820607|NCT00004157|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5820608|NCT00004157|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5820609|NCT00004157|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5820610|NCT00004157|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5820611|NCT00004157|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5820612|NCT00004157|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5820613|NCT00004157|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5820614|NCT00004157|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5820615|NCT00004157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5820616|NCT00004157|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5820617|NCT00004157|ovarian yolk sac tumor|ovarian yolk sac tumor
5820618|NCT00004157|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5820619|NCT00004157|ovarian polyembryoma|ovarian polyembryoma
5820620|NCT00004157|ovarian choriocarcinoma|ovarian choriocarcinoma
5820621|NCT00004157|ovarian immature teratoma|ovarian immature teratoma
5820622|NCT00004157|ovarian mature teratoma|ovarian mature teratoma
5820623|NCT00004157|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5820624|NCT00004157|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5820625|NCT00004157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5820626|NCT00004157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5820627|NCT00004157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5820628|NCT00004157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5820629|NCT00004157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5820630|NCT00004157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5820631|NCT00004157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5820632|NCT00004157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5820633|NCT00004157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5820634|NCT00004157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5820635|NCT00004157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5820636|NCT00004157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5820637|NCT00004157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5820638|NCT00004157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5820639|NCT00004157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5820640|NCT00004157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5820641|NCT00004157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5820642|NCT00004157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5820643|NCT00004157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5820644|NCT00004157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5820645|NCT00004157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5820646|NCT00004157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820647|NCT00004157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5820648|NCT00004157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820649|NCT00004157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5820650|NCT00004157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5820651|NCT00004157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820652|NCT00004157|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5820653|NCT00004157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5820654|NCT00004157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5820655|NCT00004157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5820656|NCT00004157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5820657|NCT00004157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5820727|NCT00077168|breast cancer in situ|breast cancer in situ
5820658|NCT00004157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5820659|NCT00004157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5820660|NCT00004157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5820661|NCT00004157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5820662|NCT00004157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5820663|NCT00004157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5820664|NCT00004157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5820665|NCT00004157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5820666|NCT00004157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5820667|NCT00004157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820668|NCT00004157|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5820669|NCT00004157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5820670|NCT00004157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5820671|NCT00004157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5820672|NCT00004157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5820673|NCT00004157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5820674|NCT00004157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5820675|NCT00004157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5820676|NCT00004157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5820677|NCT00004157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5820678|NCT00004157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5820679|NCT00004157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5820680|NCT00004003|stage III pancreatic cancer|stage iii pancreatic cancer
5820681|NCT00004003|recurrent pancreatic cancer|recurrent pancreatic cancer
5820682|NCT00004003|stage IV pancreatic cancer|stage iv pancreatic cancer
5820684|NCT00077584|Finger Ulcers|finger ulcers
5820685|NCT00077584|Digital Ulcers|digital ulcers
5820686|NCT00077584|Systemic Sclerosis|systemic sclerosis
5820687|NCT00077285|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5820688|NCT00077285|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5820689|NCT00077285|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5820690|NCT00077285|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5820691|NCT00077285|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5820692|NCT00077285|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5820693|NCT00077285|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5820694|NCT00077285|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5820695|NCT00077285|adult malignant mesenchymoma|adult malignant mesenchymoma
5820696|NCT00077285|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5820697|NCT00077285|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5820698|NCT00077285|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5820699|NCT00077259|recurrent colon cancer|recurrent colon cancer
5820700|NCT00077259|recurrent rectal cancer|recurrent rectal cancer
5820701|NCT00077259|stage III colon cancer|stage iii colon cancer
5820702|NCT00077259|stage III rectal cancer|stage iii rectal cancer
5820703|NCT00077259|stage IV colon cancer|stage iv colon cancer
5820704|NCT00077259|stage IV rectal cancer|stage iv rectal cancer
5820705|NCT00077259|adenocarcinoma of the colon|adenocarcinoma of the colon
5820706|NCT00077259|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821134|NCT00076596|Spastic Hemiplegia|spastic hemiplegia
5820707|NCT00077246|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820708|NCT00077246|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820709|NCT00077233|adenocarcinoma of the colon|adenocarcinoma of the colon
5820710|NCT00077233|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5820711|NCT00077233|recurrent colon cancer|recurrent colon cancer
5817352|NCT00080171|Knee Health|knee health
5820712|NCT00077233|recurrent rectal cancer|recurrent rectal cancer
5820713|NCT00077233|stage IV colon cancer|stage iv colon cancer
5820714|NCT00077233|stage IV rectal cancer|stage iv rectal cancer
5820715|NCT00077220|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5820716|NCT00077220|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5820717|NCT00077220|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820718|NCT00077207|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5820719|NCT00077207|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5820720|NCT00077207|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5820721|NCT00077207|childhood oligodendroglioma|childhood oligodendroglioma
5820722|NCT00077207|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5820723|NCT00077194|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5820724|NCT00077194|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5820725|NCT00077194|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5820726|NCT00077168|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5820728|NCT00077142|advanced adult primary liver cancer|advanced adult primary liver cancer
5820729|NCT00077142|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5820730|NCT00077142|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5820731|NCT00077142|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5820732|NCT00077142|Oral TAC-101|oral tac-101
5820733|NCT00077129|stage III renal cell cancer|stage iii renal cell cancer
5820734|NCT00077129|stage IV renal cell cancer|stage iv renal cell cancer
5820735|NCT00077129|recurrent renal cell cancer|recurrent renal cell cancer
5820736|NCT00077116|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5820737|NCT00077116|refractory anemia with excess blasts|refractory anemia with excess blasts
5820738|NCT00077116|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5820739|NCT00077116|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5820740|NCT00077116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5820741|NCT00077116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5820742|NCT00077116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5820743|NCT00077116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5820744|NCT00077116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5820745|NCT00077116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5820746|NCT00077116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5820747|NCT00077116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5820748|NCT00077103|anaplastic thyroid cancer|anaplastic thyroid cancer
5820749|NCT00077090|lymphedema|lymphedema
5820750|NCT00077090|radiation fibrosis|radiation fibrosis
5820751|NCT00077090|perioperative/postoperative complications|perioperative/postoperative complications
5820752|NCT00077090|stage I breast cancer|stage i breast cancer
5820753|NCT00077090|stage II breast cancer|stage ii breast cancer
5820754|NCT00077090|stage IIIA breast cancer|stage iiia breast cancer
5820755|NCT00077077|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820756|NCT00077064|radiation fibrosis|radiation fibrosis
5820757|NCT00077064|pulmonary complications|pulmonary complications
5820758|NCT00077064|limited stage small cell lung cancer|limited stage small cell lung cancer
5820759|NCT00077064|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5820760|NCT00077064|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5820761|NCT00077064|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820762|NCT00077064|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5820763|NCT00077051|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5820764|NCT00077051|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5820765|NCT00077051|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5820766|NCT00077051|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5820767|NCT00077025|metastatic breast cancer|metastatic breast cancer
5820769|NCT00077038|Visual Feedback|visual feedback
5820770|NCT00077038|Cortical Connectivity|cortical connectivity
5820771|NCT00077038|Magnetoencephalography|magnetoencephalography
5820772|NCT00077038|Eye Tracking|eye tracking
5820773|NCT00077038|Healthy Volunteer|healthy volunteer
5820774|NCT00077038|HV|hv
5820775|NCT00076986|brain tumor|brain tumor
5820776|NCT00076986|recurrent malignant glioma|recurrent malignant glioma
5820777|NCT00076986|brain neoplasm|brain neoplasm
5820778|NCT00076986|central nervous system|central nervous system
5820779|NCT00076986|surgery|surgery
5820780|NCT00076986|resection|resection
5820781|NCT00076986|GLIADEL|gliadel
5820782|NCT00076986|infusion|infusion
5820783|NCT00076986|glioblastoma multiforme|glioblastoma multiforme
5828109|NCT00061737|Bowel|bowel
5820784|NCT00076986|convection-enhanced delivery|convection-enhanced delivery
5820785|NCT00076986|first recurrence|first recurrence
5820786|NCT00076986|recurrent GBM|recurrent gbm
5820788|NCT00076986|supratentorial GBM|supratentorial gbm
5820789|NCT00076960|hyperbilirubinemia|hyperbilirubinemia
5820790|NCT00076960|jaundice|jaundice
5820791|NCT00076960|tin-mesoporphyrin|tin-mesoporphyrin
5820792|NCT00076960|stannsoporfin|stannsoporfin
5820793|NCT00076960|exchange transfusion|exchange transfusion
5820794|NCT00076960|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia
5820795|NCT00076947|HIV Preventive Vaccine|hiv preventive vaccine
5820796|NCT00076947|HIV Seronegativity|hiv seronegativity
5820797|NCT00076947|Protein|protein
5820798|NCT00076934|Ataxia|ataxia
5820799|NCT00076934|MRI|mri
5820800|NCT00076934|MS|ms
5820801|NCT00076934|CTLA4-IgG4m|ctla4-igg4m
5820802|NCT00076934|Costimulatory Signals|costimulatory signals
5820803|NCT00076934|Autoimmune Disorders|autoimmune disorders
5820804|NCT00003937|localized osteosarcoma|localized osteosarcoma
5820805|NCT00003937|cardiac toxicity|cardiac toxicity
5820806|NCT00003923|stage I pancreatic cancer|stage i pancreatic cancer
5820807|NCT00003923|stage II pancreatic cancer|stage ii pancreatic cancer
5820808|NCT00003923|stage III pancreatic cancer|stage iii pancreatic cancer
5822377|NCT00073723|Taxol|taxol
5820809|NCT00003923|stage IV pancreatic cancer|stage iv pancreatic cancer
5820810|NCT00003923|recurrent pancreatic cancer|recurrent pancreatic cancer
5820811|NCT00003923|unresectable gallbladder cancer|unresectable gallbladder cancer
5820812|NCT00003923|recurrent gallbladder cancer|recurrent gallbladder cancer
5820813|NCT00003923|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5821135|NCT00076596|Spastic Diplegia|spastic diplegia
5820814|NCT00003923|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5820815|NCT00003923|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5820816|NCT00003923|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5820817|NCT00003923|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5820818|NCT00003721|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820819|NCT00003665|stage IV melanoma|stage iv melanoma
5820820|NCT00003665|recurrent melanoma|recurrent melanoma
5820821|NCT00003616|recurrent adult brain tumor|recurrent adult brain tumor
5820822|NCT00003616|adult brain stem glioma|adult brain stem glioma
5820823|NCT00003616|adult oligodendroglioma|adult oligodendroglioma
5820824|NCT00003616|adult mixed glioma|adult mixed glioma
5820825|NCT00003616|adult diffuse astrocytoma|adult diffuse astrocytoma
5820826|NCT00003370|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5820827|NCT00003367|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5820828|NCT00003367|stage I prostate cancer|stage i prostate cancer
5820829|NCT00003367|stage IIB prostate cancer|stage iib prostate cancer
5820830|NCT00003367|stage IIA prostate cancer|stage iia prostate cancer
5820831|NCT00003367|stage III prostate cancer|stage iii prostate cancer
5820832|NCT00003367|stage IV prostate cancer|stage iv prostate cancer
5820833|NCT00003367|recurrent prostate cancer|recurrent prostate cancer
5820834|NCT00003334|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5820835|NCT00003334|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5820836|NCT00003334|fallopian tube cancer|fallopian tube cancer
5820837|NCT00003334|stage IV uterine sarcoma|stage iv uterine sarcoma
5820838|NCT00003334|recurrent uterine sarcoma|recurrent uterine sarcoma
5820839|NCT00003334|uterine carcinosarcoma|uterine carcinosarcoma
5820840|NCT00003334|uterine leiomyosarcoma|uterine leiomyosarcoma
5820841|NCT00003334|endometrial stromal sarcoma|endometrial stromal sarcoma
5820842|NCT00003334|ovarian sarcoma|ovarian sarcoma
5820843|NCT00003334|ovarian carcinosarcoma|ovarian carcinosarcoma
5820844|NCT00003222|stage III melanoma|stage iii melanoma
5820845|NCT00003222|stage IV melanoma|stage iv melanoma
5820846|NCT00003222|recurrent melanoma|recurrent melanoma
5820847|NCT00003185|adult glioblastoma|adult glioblastoma
5820848|NCT00003185|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5820849|NCT00003185|adult giant cell glioblastoma|adult giant cell glioblastoma
5820850|NCT00003185|adult gliosarcoma|adult gliosarcoma
5820851|NCT00003108|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5820852|NCT00003086|stage IV breast cancer|stage iv breast cancer
5820853|NCT00076869|Definite or probable Invasive Aspergillosis either refractory or intolerant to prior antifungal treatment.|definite or probable invasive aspergillosis either refractory or intolerant to prior antifungal treatment.
5820854|NCT00076817|HIV Preventive Vaccine|hiv preventive vaccine
5820855|NCT00076817|ALVAC Vaccine|alvac vaccine
5820857|NCT00076817|Deltoid|deltoid
5820858|NCT00076817|Groin|groin
5820859|NCT00076817|Targeted Inguinal Lymph Node|targeted inguinal lymph node
5820860|NCT00076817|TILN|tiln
5820861|NCT00076804|Directly Observed Therapy|directly observed therapy
5820863|NCT00076791|HIV Seronegativity|hiv seronegativity
5820864|NCT00033592|non-small cell lung cancer|non-small cell lung cancer
5820865|NCT00033592|small cell lung cancer|small cell lung cancer
5820866|NCT00026377|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5820867|NCT00026377|stage IIB prostate cancer|stage iib prostate cancer
5820868|NCT00026377|stage IIA prostate cancer|stage iia prostate cancer
5820869|NCT00026377|stage III prostate cancer|stage iii prostate cancer
5820870|NCT00026377|stage IV prostate cancer|stage iv prostate cancer
5820871|NCT00024362|stage III pancreatic cancer|stage iii pancreatic cancer
5820873|NCT00024362|stage IV pancreatic cancer|stage iv pancreatic cancer
5820874|NCT00003320|tumors metastatic to brain|tumors metastatic to brain
5820875|NCT00003073|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5820876|NCT00003073|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5820877|NCT00003073|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5820878|NCT00003073|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5820879|NCT00003073|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5820880|NCT00003073|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5820881|NCT00003073|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5820882|NCT00003073|leptomeningeal metastases|leptomeningeal metastases
5820883|NCT00003073|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5820884|NCT00003073|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5820886|NCT00002801|stage III colon cancer|stage iii colon cancer
5820887|NCT00002801|stage I rectal cancer|stage i rectal cancer
5820888|NCT00002801|stage II rectal cancer|stage ii rectal cancer
5820889|NCT00002801|stage III rectal cancer|stage iii rectal cancer
5820890|NCT00002679|stage II breast cancer|stage ii breast cancer
5820891|NCT00002679|stage IIIA breast cancer|stage iiia breast cancer
5820892|NCT00002679|male breast cancer|male breast cancer
5820893|NCT00076843|Interleukin-15|interleukin-15
5820894|NCT00076843|CD8+ T-cells|cd8+ t-cells
5820895|NCT00076843|HAM/TSP|ham/tsp
5820896|NCT00076843|HTLV-1|htlv-1
5820897|NCT00076843|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
5820898|NCT00076843|Tropical Spastic Paraparesis|tropical spastic paraparesis
5820899|NCT00076830|Bone|bone
5820900|NCT00076830|Growth|growth
5820901|NCT00076830|Skin|skin
5820902|NCT00076830|Connective Tissue Disorders|connective tissue disorders
5820903|NCT00076726|Giant Cell Arteritis|giant cell arteritis
5820904|NCT00076726|infliximab|infliximab
5820905|NCT00076544|Intrathecal|intrathecal
5820906|NCT00076518|Treatment Experienced|treatment experienced
5820907|NCT00022373|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5820908|NCT00022373|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5820909|NCT00022373|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5820910|NCT00022373|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5820911|NCT00022373|stage I salivary gland cancer|stage i salivary gland cancer
5820912|NCT00022373|stage II salivary gland cancer|stage ii salivary gland cancer
5820913|NCT00022373|stage III salivary gland cancer|stage iii salivary gland cancer
5820914|NCT00022373|stage IV salivary gland cancer|stage iv salivary gland cancer
5820915|NCT00022373|recurrent salivary gland cancer|recurrent salivary gland cancer
5820916|NCT00022373|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5820917|NCT00022373|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5820918|NCT00022373|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5820919|NCT00022373|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5820920|NCT00022373|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5820921|NCT00022373|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5820922|NCT00022373|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5820923|NCT00022373|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5820924|NCT00022373|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5820925|NCT00022373|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5820926|NCT00022373|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5820927|NCT00022373|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5820928|NCT00022373|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5820929|NCT00022373|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5820930|NCT00022373|radiation toxicity|radiation toxicity
5820931|NCT00022373|oral complications of radiation therapy|oral complications of radiation therapy
5820932|NCT00022243|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820933|NCT00022243|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5820934|NCT00022243|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820935|NCT00022243|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820936|NCT00022204|stage I breast cancer|stage i breast cancer
5820937|NCT00022204|stage II breast cancer|stage ii breast cancer
5820938|NCT00022204|stage IIIA breast cancer|stage iiia breast cancer
5820939|NCT00022204|lymphedema|lymphedema
5820940|NCT00022204|male breast cancer|male breast cancer
5820941|NCT00021385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5820942|NCT00021385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5820943|NCT00021385|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5820944|NCT00021385|ovarian stromal cancer|ovarian stromal cancer
5828110|NCT00061724|Esophageal|esophageal
5820945|NCT00021385|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5820946|NCT00021385|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5820947|NCT00021385|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5820950|NCT00020696|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5820951|NCT00020696|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5820952|NCT00017407|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820953|NCT00017407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820954|NCT00017407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820955|NCT00014105|recurrent adult brain tumor|recurrent adult brain tumor
5820956|NCT00014105|adult glioblastoma|adult glioblastoma
5820957|NCT00014105|adult giant cell glioblastoma|adult giant cell glioblastoma
5820958|NCT00014105|adult gliosarcoma|adult gliosarcoma
5820959|NCT00014066|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5820960|NCT00014066|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5820961|NCT00014066|limited stage small cell lung cancer|limited stage small cell lung cancer
5820962|NCT00014066|recurrent small cell lung cancer|recurrent small cell lung cancer
5820963|NCT00014066|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5820964|NCT00010244|stage IIB prostate cancer|stage iib prostate cancer
5820965|NCT00010244|stage IIA prostate cancer|stage iia prostate cancer
5820966|NCT00010244|stage III prostate cancer|stage iii prostate cancer
5820967|NCT00076752|Refractory SLE|refractory sle
5820968|NCT00076752|Immunoablation|immunoablation
5820969|NCT00076752|Immunological Recovery|immunological recovery
5820970|NCT00076752|Efficacy|efficacy
5820971|NCT00076752|Mechanism of Disease|mechanism of disease
5820972|NCT00076752|Lupus|lupus
5820973|NCT00076752|Systemic Lupus Erythematosus|systemic lupus erythematosus
5820975|NCT00076739|Prefrontal Cortex|prefrontal cortex
5820976|NCT00076739|Semantic Memory|semantic memory
5820977|NCT00076739|Semantic Relations|semantic relations
5820978|NCT00076739|Priming Paradigm|priming paradigm
5820979|NCT00076739|fMRI|fmri
5820980|NCT00076739|Healthy Volunteer|healthy volunteer
5820982|NCT00076713|Antiphospholipid|antiphospholipid
5820983|NCT00009997|stage II breast cancer|stage ii breast cancer
5820984|NCT00009997|stage IIIA breast cancer|stage iiia breast cancer
5820985|NCT00009997|stage IIIB breast cancer|stage iiib breast cancer
5820986|NCT00008333|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5820987|NCT00008333|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5820988|NCT00008034|stage II breast cancer|stage ii breast cancer
5820989|NCT00008034|stage IIIA breast cancer|stage iiia breast cancer
5820990|NCT00008034|stage IIIB breast cancer|stage iiib breast cancer
5820991|NCT00008034|inflammatory breast cancer|inflammatory breast cancer
5820992|NCT00006460|adult glioblastoma|adult glioblastoma
5820993|NCT00006460|adult giant cell glioblastoma|adult giant cell glioblastoma
5820994|NCT00006460|adult gliosarcoma|adult gliosarcoma
5820995|NCT00006454|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5820996|NCT00006454|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5820997|NCT00006454|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5820998|NCT00006454|fallopian tube cancer|fallopian tube cancer
5820999|NCT00006111|stage II bladder cancer|stage ii bladder cancer
5821000|NCT00006111|stage III bladder cancer|stage iii bladder cancer
5821001|NCT00006111|stage IV bladder cancer|stage iv bladder cancer
5821002|NCT00006111|anterior urethral cancer|anterior urethral cancer
5821003|NCT00006111|posterior urethral cancer|posterior urethral cancer
5821004|NCT00006111|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5821005|NCT00006111|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5821006|NCT00006111|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5821007|NCT00076700|Cross-Modal Plasticity|cross-modal plasticity
5821008|NCT00076700|Functional MRI|functional mri
5821009|NCT00076700|Behavior|behavior
5821010|NCT00076700|Memory|memory
5821011|NCT00076700|Blind|blind
5821012|NCT00076700|Blindness|blindness
5821013|NCT00076700|Healthy Volunteer|healthy volunteer
5821014|NCT00076700|HV|hv
5821015|NCT00006050|stage IV colon cancer|stage iv colon cancer
5821016|NCT00006050|stage IV rectal cancer|stage iv rectal cancer
5821017|NCT00006050|liver metastases|liver metastases
5862672|NCT00001548|Trichotillomania|trichotillomania
5821018|NCT00005881|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5821019|NCT00005881|childhood Burkitt lymphoma|childhood burkitt lymphoma
5821020|NCT00005881|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5821021|NCT00005881|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5821022|NCT00005881|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5821023|NCT00005881|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5821024|NCT00005881|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5821025|NCT00005881|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5821026|NCT00005881|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5821027|NCT00005881|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5821028|NCT00005881|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5821029|NCT00005881|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5821030|NCT00005881|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5821031|NCT00005881|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5821032|NCT00005881|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5821033|NCT00005881|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5821034|NCT00005881|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5821035|NCT00005881|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5821036|NCT00005881|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5821037|NCT00005881|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5821038|NCT00005881|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5821039|NCT00005881|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5821040|NCT00005881|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5846522|NCT00044239|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5821041|NCT00005881|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5821042|NCT00005881|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5821043|NCT00005881|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5821044|NCT00005881|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5821045|NCT00005792|refractory multiple myeloma|refractory multiple myeloma
5821046|NCT00005792|stage I multiple myeloma|stage i multiple myeloma
5821047|NCT00005792|stage II multiple myeloma|stage ii multiple myeloma
5821048|NCT00005792|stage III multiple myeloma|stage iii multiple myeloma
5821050|NCT00076635|Pulmonary|pulmonary
5821051|NCT00076635|Fibrosis|fibrosis
5821052|NCT00076635|IPF|ipf
5821053|NCT00076635|Lung|lung
5821054|NCT00076635|Actimmune|actimmune
5821055|NCT00076635|Interferon|interferon
5821056|NCT00076635|Gamma|gamma
5821057|NCT00076635|InterMune|intermune
5821058|NCT00076674|Parkinson's Disease|parkinson's disease
5821059|NCT00076674|Keppra|keppra
5821060|NCT00076674|Motor Fluctuations|motor fluctuations
5821061|NCT00076674|Intravenous Levodopa|intravenous levodopa
5821062|NCT00076674|Antiparkinsonian Response|antiparkinsonian response
5821063|NCT00076674|Parkinson Disease|parkinson disease
5821064|NCT00076674|PD|pd
5821065|NCT00076622|Antidepressant drugs|antidepressant drugs
5821066|NCT00076622|Nursing Homes|nursing homes
5821067|NCT00005022|limited stage small cell lung cancer|limited stage small cell lung cancer
5821068|NCT00004862|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5821069|NCT00004862|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5821070|NCT00004239|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5821071|NCT00004239|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5821072|NCT00004239|refractory multiple myeloma|refractory multiple myeloma
5821073|NCT00004239|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5821074|NCT00004239|stage III multiple myeloma|stage iii multiple myeloma
5821075|NCT00004239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5821076|NCT00004239|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5821077|NCT00004239|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5821078|NCT00004239|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5821079|NCT00004239|polycythemia vera|polycythemia vera
5821080|NCT00004239|primary myelofibrosis|primary myelofibrosis
5821081|NCT00004239|essential thrombocythemia|essential thrombocythemia
5821082|NCT00004239|refractory hairy cell leukemia|refractory hairy cell leukemia
5821083|NCT00004239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5821084|NCT00004239|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5821085|NCT00004239|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5821086|NCT00004239|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5821087|NCT00004239|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5821088|NCT00004239|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5821089|NCT00004239|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5821090|NCT00004239|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5821091|NCT00004239|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5821092|NCT00004239|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5821093|NCT00004239|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5821094|NCT00004239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5821095|NCT00004239|prolymphocytic leukemia|prolymphocytic leukemia
5821096|NCT00004239|primary systemic amyloidosis|primary systemic amyloidosis
5821097|NCT00004239|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5821098|NCT00004239|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5821099|NCT00004239|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5821100|NCT00004239|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5821101|NCT00004239|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5821102|NCT00004239|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5821103|NCT00004239|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5821104|NCT00004239|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5821105|NCT00003888|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5821106|NCT00003888|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5821107|NCT00003888|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5821108|NCT00003888|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5821109|NCT00003888|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5821110|NCT00003888|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5821111|NCT00003888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5846523|NCT00044239|Children|children
5846524|NCT00044239|Adolescents|adolescents
5821112|NCT00003888|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5821113|NCT00076609|hepatocellular carcinoma|hepatocellular carcinoma
5821114|NCT00076609|advanced|advanced
5821115|NCT00076609|unresectable|unresectable
5821116|NCT00076609|liver cancer|liver cancer
5821117|NCT00076609|systemic chemotherapy|systemic chemotherapy
5821118|NCT00076609|botanical|botanical
5821119|NCT00076609|herbal|herbal
5821120|NCT00076609|alternative and complementary medicine|alternative and complementary medicine
5821121|NCT00076609|capecitabine|capecitabine
5821122|NCT00076609|PHY906|phy906
5821123|NCT00076609|oral|oral
5821125|NCT00076609|traditional chinese medicine|traditional chinese medicine
5821127|NCT00076609|QOL|qol
5821128|NCT00076609|quality of life|quality of life
5821129|NCT00076557|Hemophilia B|hemophilia b
5821130|NCT00076557|Factor IX|factor ix
5821131|NCT00076557|Gene Transfer|gene transfer
5821132|NCT00076557|Adeno-Associated Virus (AAV)|adeno-associated virus (aav)
5821133|NCT00076596|Corticospinal Tracts|corticospinal tracts
5821136|NCT00076596|Cortical Re-Organization|cortical re-organization
5821137|NCT00076596|Functional Outcome|functional outcome
5821138|NCT00076596|Cerebral Palsy|cerebral palsy
5821139|NCT00076583|Motor Learning|motor learning
5821140|NCT00076583|Co-contraction|co-contraction
5828627|NCT00060866|SAI|sai
5820576|NCT00005610|stage IV melanoma|stage iv melanoma
5821141|NCT00076583|Reciprocal Inhibition|reciprocal inhibition
5821142|NCT00076583|Spinal Plasticity|spinal plasticity
5821143|NCT00076583|Rhythmic Movement|rhythmic movement
5821144|NCT00076583|Healthy Volunteer|healthy volunteer
5821145|NCT00076583|HV|hv
5821146|NCT00076570|Tolerance|tolerance
5821147|NCT00076570|Kidney|kidney
5821148|NCT00076570|Transplant|transplant
5821149|NCT00076570|Polyclonal|polyclonal
5821150|NCT00076570|Antibody|antibody
5821151|NCT00076570|Kidney Transplant|kidney transplant
5821152|NCT00076531|Prostate|prostate
5821153|NCT00076531|Cancer|cancer
5821154|NCT00076531|PSA|psa
5821155|NCT00076531|Leuprolide|leuprolide
5821156|NCT00076492|Parkinson's disease|parkinson's disease
5821157|NCT00076492|Parkinson disease|parkinson disease
5821158|NCT00076492|CoQ10|coq10
5821159|NCT00076492|GPI 1485|gpi 1485
5821160|NCT00003882|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821161|NCT00003852|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5821162|NCT00003852|childhood germ cell tumor|childhood germ cell tumor
5821163|NCT00003852|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5821164|NCT00003852|extragonadal germ cell tumor|extragonadal germ cell tumor
5821165|NCT00003683|stage IV renal cell cancer|stage iv renal cell cancer
5821166|NCT00003682|stage IV prostate cancer|stage iv prostate cancer
5821167|NCT00003682|recurrent prostate cancer|recurrent prostate cancer
5821168|NCT00003578|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5821169|NCT00003578|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5821170|NCT00003578|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5821171|NCT00003578|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5821172|NCT00003578|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5821173|NCT00003578|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5821174|NCT00003578|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5821175|NCT00003578|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5821176|NCT00076505|Mitochondria|mitochondria
5821177|NCT00076505|Proteasome|proteasome
5821178|NCT00076505|Lipid|lipid
5821179|NCT00076505|Polymorphism|polymorphism
5821180|NCT00076505|Genetic|genetic
5821181|NCT00076505|Parkinson's Disease|parkinson's disease
5821182|NCT00076505|Parkinson Disease|parkinson disease
5821183|NCT00076505|PD|pd
5821185|NCT00076505|Parkinson Disease At Risk|parkinson disease at risk
5821189|NCT00076453|Degenerative Arthritis|degenerative arthritis
5821190|NCT00076453|Cartilage Disease|cartilage disease
5821191|NCT00076453|Non-drug Therapy|non-drug therapy
5821192|NCT00076440|Alzheimer disease|alzheimer disease
5821194|NCT00076401|chronic lymphocytic leukemia|chronic lymphocytic leukemia
5821195|NCT00076401|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia
5821196|NCT00076401|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5821197|NCT00076401|Leukemia|leukemia
5821198|NCT00076401|Motexafin gadolinium|motexafin gadolinium
5821199|NCT00076401|Chronic leukemia|chronic leukemia
5821200|NCT00076401|Lymphocytic leukemia, chronic|lymphocytic leukemia, chronic
5821201|NCT00076479|Aphasia|aphasia
5821202|NCT00076479|Rehabilitation|rehabilitation
5821203|NCT00076479|Neuroplasticity|neuroplasticity
5821204|NCT00076479|Picture Naming|picture naming
5821205|NCT00076479|Transcranial Magnetic|transcranial magnetic
5821206|NCT00076479|Stroke|stroke
5821207|NCT00076479|Healthy Volunteer|healthy volunteer
5821208|NCT00076479|HV|hv
5821209|NCT00076466|Brain Excitability|brain excitability
5821210|NCT00076466|Reaction Time|reaction time
5821211|NCT00076466|Plasticity|plasticity
5846643|NCT00043875|pediatric|pediatric
5821212|NCT00076466|Motor Evoked Potential|motor evoked potential
5821213|NCT00076466|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5821214|NCT00076466|Healthy Volunteer|healthy volunteer
5821215|NCT00076466|HV|hv
5821216|NCT00076388|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5821217|NCT00076375|Atopic Dermatitis|atopic dermatitis
5821218|NCT00076375|Eczema|eczema
5821219|NCT00003541|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5821220|NCT00003541|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5821221|NCT00003418|stage I breast cancer|stage i breast cancer
5821222|NCT00003418|stage II breast cancer|stage ii breast cancer
5821223|NCT00003418|stage III breast cancer|stage iii breast cancer
5821224|NCT00003364|limited stage small cell lung cancer|limited stage small cell lung cancer
5821225|NCT00003298|stage II gastric cancer|stage ii gastric cancer
5821226|NCT00003298|stage III gastric cancer|stage iii gastric cancer
5821227|NCT00003298|stage IV gastric cancer|stage iv gastric cancer
5821228|NCT00003298|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5821229|NCT00003287|stage IV colon cancer|stage iv colon cancer
5821230|NCT00003287|stage IV rectal cancer|stage iv rectal cancer
5821231|NCT00003287|recurrent colon cancer|recurrent colon cancer
5821232|NCT00003287|recurrent rectal cancer|recurrent rectal cancer
5846521|NCT00044239|Basal Ganglia|basal ganglia
5821233|NCT00003287|adenocarcinoma of the colon|adenocarcinoma of the colon
5821234|NCT00003287|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821235|NCT00076427|Immunity|immunity
5821236|NCT00076427|Liver|liver
5821237|NCT00076427|Apheresis|apheresis
5821238|NCT00076427|Cytokine|cytokine
5821239|NCT00076427|Virology|virology
5821240|NCT00076427|Hepatitis C|hepatitis c
5821241|NCT00076427|HCV|hcv
5821242|NCT00076427|Hepatitis C co-infection|hepatitis c co-infection
5821243|NCT00076414|Endothelial Function|endothelial function
5821244|NCT00076414|Lopinavir/Ritonavir|lopinavir/ritonavir
5821245|NCT00076414|HIV|hiv
5821246|NCT00076414|Blood Flow Studies|blood flow studies
5821247|NCT00076414|Flow-Mediated Vasodilatation|flow-mediated vasodilatation
5821248|NCT00076414|Healthy Volunteer|healthy volunteer
5821249|NCT00076414|HV|hv
5821250|NCT00076349|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5821251|NCT00076349|NHL|nhl
5821252|NCT00076349|Rituxan|rituxan
5821253|NCT00076349|Mantle Cell|mantle cell
5821254|NCT00076349|mabs|mabs
5821255|NCT00003137|stage IV gastric cancer|stage iv gastric cancer
5821256|NCT00003137|stage IV esophageal cancer|stage iv esophageal cancer
5821257|NCT00003137|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5821258|NCT00003137|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5821259|NCT00003137|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5821260|NCT00003137|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5821261|NCT00003007|refractory multiple myeloma|refractory multiple myeloma
5821262|NCT00003007|stage III multiple myeloma|stage iii multiple myeloma
5821263|NCT00002840|recurrent adult brain tumor|recurrent adult brain tumor
5821264|NCT00002840|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5821265|NCT00002840|adult mixed glioma|adult mixed glioma
5821266|NCT00002817|stage III melanoma|stage iii melanoma
5821267|NCT00002817|stage IV melanoma|stage iv melanoma
5821268|NCT00002817|recurrent melanoma|recurrent melanoma
5821269|NCT00002748|recurrent neuroblastoma|recurrent neuroblastoma
5821270|NCT00076323|G6PD|g6pd
5821271|NCT00076323|Favism|favism
5821272|NCT00076323|G6PD Deficiency|g6pd deficiency
5821273|NCT00076323|hemolysis|hemolysis
5821274|NCT00076323|drug reaction|drug reaction
5821275|NCT00076323|drug-induced hemolysis|drug-induced hemolysis
5821276|NCT00076310|Head and Neck Cancer|head and neck cancer
5821277|NCT00076310|Squamous Cell Cancer|squamous cell cancer
5821278|NCT00076310|OSI-774|osi-774
5821279|NCT00076310|Cisplatin|cisplatin
5821280|NCT00076310|Platinol®-AQ|platinol®-aq
5821281|NCT00076310|Platinol®|platinol®
5821283|NCT00076310|Docetaxel|docetaxel
5821284|NCT00076310|Taxotere|taxotere
5821287|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride
5821288|NCT00076284|CCR5 Antagonist|ccr5 antagonist
5821289|NCT00076284|Coreceptor Inhibitor|coreceptor inhibitor
5821290|NCT00076284|Fusion Inhibitor|fusion inhibitor
5821291|NCT00076284|Entry Inhibitor|entry inhibitor
5821292|NCT00076284|Antiretroviral|antiretroviral
5821293|NCT00076284|HIV|hiv
5821294|NCT00076271|Strabismus|strabismus
5821295|NCT00076271|Cataract, Pediatric|cataract, pediatric
5821296|NCT00076271|Optic Nerve Anomaly|optic nerve anomaly
5821297|NCT00076271|Coloboma|coloboma
5821298|NCT00076271|Evaluation and Treatment|evaluation and treatment
5821299|NCT00076271|Pediatric Ophthalmology|pediatric ophthalmology
5821300|NCT00076271|Genetic Eye Disease|genetic eye disease
5821301|NCT00076271|Nystagmus|nystagmus
5821302|NCT00076271|Pediatric Eye Disease|pediatric eye disease
5821303|NCT00076271|Developmental Eye Condition|developmental eye condition
5821304|NCT00076271|Cataract|cataract
5821305|NCT00076271|Juvenile Glaucoma|juvenile glaucoma
5821306|NCT00076271|Eye Movement Disorder|eye movement disorder
5821307|NCT00076258|Exercise therapy|exercise therapy
5821308|NCT00076258|Complementary Therapies|complementary therapies
5821309|NCT00076245|Phototherapy|phototherapy
5846644|NCT00043875|epilepsy|epilepsy
5821310|NCT00076219|Acute Renal Failure|acute renal failure
5821311|NCT00076219|Renal Replacement Therapy|renal replacement therapy
5822676|NCT00073268|adolescent|adolescent
5821312|NCT00076219|multi-site randomization trial|multi-site randomization trial
5821313|NCT00076219|Hemodialysis|hemodialysis
5821314|NCT00076219|Hemofiltration|hemofiltration
5821315|NCT00076219|Critical Illness|critical illness
5821316|NCT00076219|Hemodiafiltration|hemodiafiltration
5821317|NCT00076232|HIV Seronegativity|hiv seronegativity
5821318|NCT00076154|ALS|als
5821319|NCT00076141|relatively healthy male|relatively healthy male
5821320|NCT00076115|Bipolar|bipolar
5821321|NCT00076115|Mania|mania
5821322|NCT00076115|Manic|manic
5821323|NCT00076115|Depressive|depressive
5821324|NCT00076115|Manic Depressive|manic depressive
5821325|NCT00076115|Bipolar mania|bipolar mania
5821326|NCT00076115|risperidone|risperidone
5821327|NCT00076115|adolescents|adolescents
5821328|NCT00076115|children|children
5821329|NCT00076180|cytotoxic activity against T-LGL cells|cytotoxic activity against t-lgl cells
5821330|NCT00076180|chronic lymphoproliferative disorder|chronic lymphoproliferative disorder
5821331|NCT00076180|T-LGL Leukemia|t-lgl leukemia
5821332|NCT00076180|Natural Killer Cells|natural killer cells
5821333|NCT00076180|Leukemia|leukemia
5821334|NCT00076180|Lymphocytic Leukemia|lymphocytic leukemia
5821335|NCT00076180|T-LGL|t-lgl
5821336|NCT00076089|Roflumilast|roflumilast
5821337|NCT00076089|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5821338|NCT00076089|COPD|copd
5821339|NCT00076076|Roflumilast|roflumilast
5821340|NCT00076076|Asthma|asthma
5821341|NCT00033735|recurrent pancreatic cancer|recurrent pancreatic cancer
5821342|NCT00033735|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5821343|NCT00027508|advanced malignant mesothelioma|advanced malignant mesothelioma
5821344|NCT00027508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5821345|NCT00024401|stage IV colon cancer|stage iv colon cancer
5821346|NCT00024401|stage IV rectal cancer|stage iv rectal cancer
5821347|NCT00024401|recurrent colon cancer|recurrent colon cancer
5821348|NCT00024401|recurrent rectal cancer|recurrent rectal cancer
5821349|NCT00002566|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5821350|NCT00002566|extragonadal germ cell tumor|extragonadal germ cell tumor
5821351|NCT00076102|Side Effect|side effect
5821352|NCT00076102|Oral Administration|oral administration
5821353|NCT00076102|Nerve Sheath Tumor|nerve sheath tumor
5821354|NCT00076102|Antifibrotic Agent|antifibrotic agent
5821355|NCT00076102|Volumetric Tumor Measurement|volumetric tumor measurement
5821356|NCT00076102|Plexiform Neurofibroma|plexiform neurofibroma
5821357|NCT00076102|Neurofibromatosis Type 1|neurofibromatosis type 1
5821358|NCT00076102|Volumetric MRI Analysis|volumetric mri analysis
5821359|NCT00076102|Time to Progression|time to progression
5821360|NCT00076102|NF1|nf1
5821361|NCT00076063|HIV Seronegativity|hiv seronegativity
5821362|NCT00076063|ALVAC-HIV vCP1452|alvac-hiv vcp1452
5821363|NCT00076063|ALVAC Vaccine|alvac vaccine
5821364|NCT00076063|HIV-1|hiv-1
5821365|NCT00076063|Normal Values|normal values
5821366|NCT00076063|HIV Preventive Vaccine|hiv preventive vaccine
5821367|NCT00076037|HIV Preventive Vaccine|hiv preventive vaccine
5821368|NCT00076037|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5821369|NCT00076037|AIDS Vaccines|aids vaccines
5821370|NCT00076037|HIV-1|hiv-1
5821371|NCT00076037|HIV Seronegativity|hiv seronegativity
5821372|NCT00076037|Injections, Intramuscular|injections, intramuscular
5821373|NCT00076037|RC529|rc529
5821374|NCT00076037|Epitopes|epitopes
5821375|NCT00076037|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5821376|NCT00076024|metastatic breast cancer|metastatic breast cancer
5821377|NCT00075998|Idiopathic|idiopathic
5821378|NCT00075998|Pulmonary|pulmonary
5821379|NCT00075998|Fibrosis|fibrosis
5821381|NCT00075998|Lung|lung
5821382|NCT00075998|Interferon|interferon
5821383|NCT00075998|Gamma|gamma
5821384|NCT00075998|Actimmune|actimmune
5821385|NCT00075998|INSPIRE|inspire
5821388|NCT00075959|cerebral vascular accident|cerebral vascular accident
5821390|NCT00075959|Hemorrhage|hemorrhage
5821391|NCT00075959|Intracerebral Hemorrhage (ICH)|intracerebral hemorrhage (ich)
5821392|NCT00075959|Brain Attack|brain attack
5821393|NCT00075959|Cataplexy|cataplexy
5821394|NCT00075946|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5821395|NCT00075946|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5821396|NCT00075946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5821397|NCT00075946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5821398|NCT00075946|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5821399|NCT00075946|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5821400|NCT00075946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5821401|NCT00075946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5821402|NCT00075946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5821403|NCT00075946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5846645|NCT00043862|Hycamtin|hycamtin
5834935|NCT00030108|childhood teratoma|childhood teratoma
5821404|NCT00075946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5821405|NCT00024388|stage III renal cell cancer|stage iii renal cell cancer
5821406|NCT00024388|stage IV renal cell cancer|stage iv renal cell cancer
5821407|NCT00024388|recurrent renal cell cancer|recurrent renal cell cancer
5821408|NCT00022347|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5821409|NCT00022347|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5821410|NCT00022347|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5821411|NCT00022347|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5821412|NCT00022347|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5821413|NCT00022347|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5821414|NCT00022347|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5821415|NCT00022347|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5821416|NCT00022347|fallopian tube cancer|fallopian tube cancer
5821417|NCT00022347|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5821418|NCT00022321|refractory anemia|refractory anemia
5821419|NCT00022321|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5821420|NCT00022321|refractory anemia with excess blasts|refractory anemia with excess blasts
5821421|NCT00022321|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5821422|NCT00022321|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5821423|NCT00021333|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5821424|NCT00021333|recurrent small cell lung cancer|recurrent small cell lung cancer
5821425|NCT00021333|recurrent thyroid cancer|recurrent thyroid cancer
5821426|NCT00021333|recurrent salivary gland cancer|recurrent salivary gland cancer
5821427|NCT00021333|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5821428|NCT00021333|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5821429|NCT00021333|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5821430|NCT00021333|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5821431|NCT00021333|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5821432|NCT00021333|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5821433|NCT00021333|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5821434|NCT00021333|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5821435|NCT00021333|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5821436|NCT00021333|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5821437|NCT00021333|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5821438|NCT00021333|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5821439|NCT00021333|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5821440|NCT00021333|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5862673|NCT00001548|Tourette's Syndrome|tourette's syndrome
5862674|NCT00001547|Drug|drug
5821441|NCT00021333|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5821442|NCT00021333|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5821443|NCT00021307|recurrent adult brain tumor|recurrent adult brain tumor
5821444|NCT00021307|adult glioblastoma|adult glioblastoma
5821445|NCT00021307|adult giant cell glioblastoma|adult giant cell glioblastoma
5821446|NCT00021307|adult gliosarcoma|adult gliosarcoma
5821448|NCT00075907|Treatment Experienced|treatment experienced
5821449|NCT00075907|Treatment Naive|treatment naive
5821450|NCT00075894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5821451|NCT00075894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5821452|NCT00075894|adult glioblastoma|adult glioblastoma
5821453|NCT00075894|recurrent adult brain tumor|recurrent adult brain tumor
5821454|NCT00075894|adult giant cell glioblastoma|adult giant cell glioblastoma
5821455|NCT00075894|adult gliosarcoma|adult gliosarcoma
5821456|NCT00075868|radiation enteritis|radiation enteritis
5821457|NCT00075868|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5821458|NCT00075868|stage I rectal cancer|stage i rectal cancer
5821459|NCT00075868|stage II rectal cancer|stage ii rectal cancer
5821460|NCT00075868|stage III rectal cancer|stage iii rectal cancer
5821461|NCT00075868|stage IIIA anal cancer|stage iiia anal cancer
5821462|NCT00075868|stage IIIB anal cancer|stage iiib anal cancer
5821463|NCT00075868|recurrent anal cancer|recurrent anal cancer
5821464|NCT00075868|stage I anal cancer|stage i anal cancer
5821465|NCT00075868|stage II anal cancer|stage ii anal cancer
5821466|NCT00075868|recurrent rectal cancer|recurrent rectal cancer
5821467|NCT00075855|sexual dysfunction|sexual dysfunction
5821468|NCT00075855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821469|NCT00075855|sexuality and reproductive issues|sexuality and reproductive issues
5821470|NCT00075855|cancer survivor|cancer survivor
5821471|NCT00075842|sleep disorders|sleep disorders
5821472|NCT00075842|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821474|NCT00075829|Stage II Multiple Myeloma|stage ii multiple myeloma
5821475|NCT00075829|Stage III Multiple Myeloma|stage iii multiple myeloma
5821476|NCT00075829|Refractory Plasma Cell Neoplasm|refractory plasma cell neoplasm
5821477|NCT00075803|Myelodysplastic and Myeloproliferative Diseases|myelodysplastic and myeloproliferative diseases
5821478|NCT00075777|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5821479|NCT00075777|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5821480|NCT00075764|stage IV breast cancer|stage iv breast cancer
5821481|NCT00075764|recurrent breast cancer|recurrent breast cancer
5821482|NCT00075738|stage IV esophageal cancer|stage iv esophageal cancer
5821483|NCT00075738|recurrent esophageal cancer|recurrent esophageal cancer
5821484|NCT00075725|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5821485|NCT00075725|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5821486|NCT00075725|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5821487|NCT00075725|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5821488|NCT00075712|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5820856|NCT00076817|Immunization Site|immunization site
5821489|NCT00075712|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5821490|NCT00075712|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5821491|NCT00075712|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5821492|NCT00075712|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5821493|NCT00075712|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5821494|NCT00075712|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5821495|NCT00075712|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5821496|NCT00075712|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5821497|NCT00075712|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5821498|NCT00075712|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5821499|NCT00075712|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5821500|NCT00075699|epithelial mesothelioma|epithelial mesothelioma
5821501|NCT00075699|localized malignant mesothelioma|localized malignant mesothelioma
5821502|NCT00075699|advanced malignant mesothelioma|advanced malignant mesothelioma
5821503|NCT00075686|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5821504|NCT00075686|stage III pancreatic cancer|stage iii pancreatic cancer
5821505|NCT00075686|stage IV pancreatic cancer|stage iv pancreatic cancer
5821506|NCT00075920|Heart|heart
5821507|NCT00075920|Function|function
5821508|NCT00075920|Ultrasound|ultrasound
5821509|NCT00075920|MRI|mri
5821510|NCT00075920|Left Ventricle|left ventricle
5821511|NCT00075920|Healthy Volunteer|healthy volunteer
5821512|NCT00075920|HV|hv
5821513|NCT00075920|Heart Disease|heart disease
5821514|NCT00075673|recurrent breast cancer|recurrent breast cancer
5821515|NCT00075673|stage IV breast cancer|stage iv breast cancer
5821516|NCT00075660|recurrent renal cell cancer|recurrent renal cell cancer
5821517|NCT00075660|stage III renal cell cancer|stage iii renal cell cancer
5821518|NCT00075660|stage IV renal cell cancer|stage iv renal cell cancer
5821519|NCT00075621|primary systemic amyloidosis|primary systemic amyloidosis
5862675|NCT00001547|Imaging|imaging
5821520|NCT00075608|primary systemic amyloidosis|primary systemic amyloidosis
5821521|NCT00075595|stage IV colon cancer|stage iv colon cancer
5821522|NCT00075595|stage IV rectal cancer|stage iv rectal cancer
5821523|NCT00075595|recurrent colon cancer|recurrent colon cancer
5821524|NCT00075595|recurrent rectal cancer|recurrent rectal cancer
5821525|NCT00075595|adenocarcinoma of the colon|adenocarcinoma of the colon
5821526|NCT00075595|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821528|NCT00075569|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5821529|NCT00075556|stage III colon cancer|stage iii colon cancer
5821530|NCT00075556|stage IV colon cancer|stage iv colon cancer
5821531|NCT00075556|stage III rectal cancer|stage iii rectal cancer
5821532|NCT00075556|stage IV rectal cancer|stage iv rectal cancer
5821533|NCT00075556|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821534|NCT00075556|adenocarcinoma of the colon|adenocarcinoma of the colon
5821535|NCT00075543|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5821536|NCT00075543|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5821537|NCT00075543|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5821538|NCT00075517|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5821539|NCT00075517|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821540|NCT00075517|adenocarcinoma of the lung|adenocarcinoma of the lung
5821541|NCT00075517|large cell lung cancer|large cell lung cancer
5821542|NCT00075517|squamous cell lung cancer|squamous cell lung cancer
5821543|NCT00075465|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5821544|NCT00075465|stage III gastric cancer|stage iii gastric cancer
5821545|NCT00075465|stage IV gastric cancer|stage iv gastric cancer
5821546|NCT00075452|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5821547|NCT00075452|stage II pancreatic cancer|stage ii pancreatic cancer
5821548|NCT00075452|stage III pancreatic cancer|stage iii pancreatic cancer
5821549|NCT00075452|stage IV pancreatic cancer|stage iv pancreatic cancer
5821550|NCT00075426|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5821551|NCT00075426|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5821552|NCT00075426|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821553|NCT00075426|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5821554|NCT00075413|stage IIIB breast cancer|stage iiib breast cancer
5821555|NCT00075413|stage IIIC breast cancer|stage iiic breast cancer
5821556|NCT00075413|stage IV breast cancer|stage iv breast cancer
5821557|NCT00075413|recurrent breast cancer|recurrent breast cancer
5821558|NCT00075413|stage IIIA breast cancer|stage iiia breast cancer
5821559|NCT00075374|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5821560|NCT00075374|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821561|NCT00075374|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5821562|NCT00075348|renal cell carcinoma|renal cell carcinoma
5821563|NCT00075348|von Hippel-Lindau syndrome|von hippel-lindau syndrome
5821564|NCT00075335|Hematopoietic Stem Cells|hematopoietic stem cells
5821565|NCT00075335|Mobilization|mobilization
5821566|NCT00075335|Alloreactivity|alloreactivity
5820981|NCT00076739|HV|hv
5821567|NCT00075335|T Cell Polarization|t cell polarization
5821568|NCT00075335|Dendritic Cells|dendritic cells
5821569|NCT00075335|Plerixafor|plerixafor
5821571|NCT00075335|Healthy Volunteer (HV)|healthy volunteer (hv)
5821572|NCT00075296|Major Depressive Disorder|major depressive disorder
5821573|NCT00075296|Bipolar Disorder|bipolar disorder
5821574|NCT00075296|Negative Feedback|negative feedback
5821575|NCT00075296|Cognitive Performance|cognitive performance
5821576|NCT00075296|Negative Affect|negative affect
5821577|NCT00075296|Depression|depression
5821578|NCT00075296|Major Depression|major depression
5821579|NCT00075296|MDD|mdd
5821580|NCT00075296|Healthy Volunteer|healthy volunteer
5821581|NCT00075296|HV|hv
5821582|NCT00075283|Physical Therapy|physical therapy
5821583|NCT00075283|Locomotion therapy|locomotion therapy
5821584|NCT00075283|Gait training|gait training
5821585|NCT00075283|Stroke|stroke
5821586|NCT00075283|Robotics|robotics
5821587|NCT00075283|Rehabilitation|rehabilitation
5821588|NCT00075283|Treadmill|treadmill
5821589|NCT00075283|Hemiparetic stroke|hemiparetic stroke
5821590|NCT00075283|Unilateral brain lesion|unilateral brain lesion
5821591|NCT00075270|metastatic breast cancer|metastatic breast cancer
5821592|NCT00075270|ErbB1|erbb1
5821593|NCT00075270|kinase inhibitor|kinase inhibitor
5821594|NCT00075270|ErbB2|erbb2
5821595|NCT00075270|EGFR|egfr
5821596|NCT00075270|lapatinib|lapatinib
5821597|NCT00075270|Her2-neu|her2-neu
5821598|NCT00075231|Treatment Naive|treatment naive
5821599|NCT00075153|ADOLESCENCE|adolescence
5821600|NCT00075153|HIV INFECTION|hiv infection
5821601|NCT00075153|PEDIATRIC AIDS|pediatric aids
5821602|NCT00075153|QUALITY OF LIFE|quality of life
5821603|NCT00075153|HIV|hiv
5821604|NCT00020787|stage IV gastric cancer|stage iv gastric cancer
5821605|NCT00020787|recurrent gastric cancer|recurrent gastric cancer
5821606|NCT00020787|stage IV esophageal cancer|stage iv esophageal cancer
5821607|NCT00020787|recurrent esophageal cancer|recurrent esophageal cancer
5821608|NCT00020787|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5821609|NCT00020787|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5821610|NCT00017576|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5821611|NCT00017576|stage IV prostate cancer|stage iv prostate cancer
5821612|NCT00017576|recurrent prostate cancer|recurrent prostate cancer
5821613|NCT00017537|stage IV breast cancer|stage iv breast cancer
5821614|NCT00017537|recurrent breast cancer|recurrent breast cancer
5821615|NCT00017537|stage IV gastric cancer|stage iv gastric cancer
5821616|NCT00017537|recurrent gastric cancer|recurrent gastric cancer
5821617|NCT00017537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5821618|NCT00017537|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5821619|NCT00017537|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5821620|NCT00017537|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5821621|NCT00017537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821622|NCT00017537|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821623|NCT00017433|refractory multiple myeloma|refractory multiple myeloma
5821624|NCT00017433|stage II multiple myeloma|stage ii multiple myeloma
5821625|NCT00017433|stage III multiple myeloma|stage iii multiple myeloma
5821626|NCT00075244|Lysosomes|lysosomes
5821627|NCT00075244|Storage|storage
5821628|NCT00075244|Glycolipid|glycolipid
5821629|NCT00075244|Fabry Disease|fabry disease
5821630|NCT00075244|Stroke|stroke
5821631|NCT00017082|stage IV colon cancer|stage iv colon cancer
5821632|NCT00017082|stage IV rectal cancer|stage iv rectal cancer
5821633|NCT00017082|recurrent colon cancer|recurrent colon cancer
5821634|NCT00017082|recurrent rectal cancer|recurrent rectal cancer
5821635|NCT00017082|adenocarcinoma of the colon|adenocarcinoma of the colon
5821636|NCT00017082|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821637|NCT00016237|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5821638|NCT00016237|squamous cell lung cancer|squamous cell lung cancer
5821639|NCT00016237|stage IV renal cell cancer|stage iv renal cell cancer
5821640|NCT00016237|recurrent renal cell cancer|recurrent renal cell cancer
5821641|NCT00016237|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5821642|NCT00016237|recurrent small cell lung cancer|recurrent small cell lung cancer
5821643|NCT00016237|recurrent bladder cancer|recurrent bladder cancer
5821644|NCT00016237|stage IV bladder cancer|stage iv bladder cancer
5821645|NCT00016237|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5821646|NCT00016237|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5821647|NCT00016237|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5821648|NCT00016198|stage IV colon cancer|stage iv colon cancer
5821649|NCT00016198|stage IV rectal cancer|stage iv rectal cancer
5821650|NCT00016198|recurrent colon cancer|recurrent colon cancer
5821651|NCT00016198|recurrent rectal cancer|recurrent rectal cancer
5821652|NCT00016198|adenocarcinoma of the colon|adenocarcinoma of the colon
5821653|NCT00016198|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5821654|NCT00014404|lip and oral cavity cancer|lip and oral cavity cancer
5821655|NCT00014287|stage 0 bladder cancer|stage 0 bladder cancer
5821656|NCT00014287|stage I bladder cancer|stage i bladder cancer
5821657|NCT00014287|recurrent bladder cancer|recurrent bladder cancer
5821658|NCT00075205|Alcohol Consumption|alcohol consumption
5821659|NCT00075205|Alcohol Treatment|alcohol treatment
5821660|NCT00075205|Medication Trial|medication trial
5821662|NCT00075205|Cannabinoids|cannabinoids
5821663|NCT00075205|CB 1 Receptor Antagonist|cb 1 receptor antagonist
5821664|NCT00075205|SR141716|sr141716
5821665|NCT00075205|Alcoholism|alcoholism
5821666|NCT00075179|Pulmonary hypertension|pulmonary hypertension
5821667|NCT00075179|cancer|cancer
5821668|NCT00075179|lung cancer|lung cancer
5821669|NCT00075179|lung disease|lung disease
5821670|NCT00075179|cardiothoracic surgery|cardiothoracic surgery
5821671|NCT00075179|Nesiritide|nesiritide
5821672|NCT00075179|Natrecor|natrecor
5821673|NCT00075179|CV Surgery|cv surgery
5821674|NCT00075179|Lung Tumor|lung tumor
5821675|NCT00075166|Stereotactic|stereotactic
5821676|NCT00075166|Carcinoma|carcinoma
5821677|NCT00075166|Melanoma|melanoma
5821678|NCT00075166|Surgical Resection|surgical resection
5821679|NCT00075166|Metastases|metastases
5821680|NCT00075166|Metastatic Brain Tumor|metastatic brain tumor
5821681|NCT00075166|Surgery|surgery
5821682|NCT00075166|Radiosurgery|radiosurgery
5821683|NCT00075166|Treatment|treatment
5821684|NCT00075140|Patient Care Management|patient care management
5821685|NCT00075140|Family|family
5821686|NCT00075140|Huntington's Disease|huntington's disease
5821687|NCT00075114|Self Care|self care
5821688|NCT00075114|Behavior Modification|behavior modification
5821689|NCT00075101|Drug Adverse Effect|drug adverse effect
5821690|NCT00075101|Pediatric Cancer|pediatric cancer
5821691|NCT00075088|Telemedicine|telemedicine
5821692|NCT00075088|Emergency Care|emergency care
5821693|NCT00075088|Cardiac|cardiac
5821694|NCT00075075|Infliximab|infliximab
5821695|NCT00075075|Scleritis|scleritis
5821696|NCT00075075|Intraocular Inflammatory Disease|intraocular inflammatory disease
5821697|NCT00075075|Corticosteroids|corticosteroids
5821698|NCT00075075|Immunosuppressives|immunosuppressives
5821699|NCT00075049|malaria|malaria
5821700|NCT00014183|stage IV renal cell cancer|stage iv renal cell cancer
5821701|NCT00014183|recurrent renal cell cancer|recurrent renal cell cancer
5821702|NCT00012116|tumors metastatic to brain|tumors metastatic to brain
5821703|NCT00009893|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5821704|NCT00009893|advanced adult primary liver cancer|advanced adult primary liver cancer
5821705|NCT00009893|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5821706|NCT00009893|unresectable gallbladder cancer|unresectable gallbladder cancer
5821707|NCT00009893|recurrent gallbladder cancer|recurrent gallbladder cancer
5821708|NCT00009893|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5821709|NCT00009893|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5821710|NCT00075036|Health Disparities|health disparities
5821712|NCT00075036|Trust|trust
5821713|NCT00075036|Interview|interview
5821714|NCT00075036|Ethnic Bias|ethnic bias
5821715|NCT00075023|Stomatitis|stomatitis
5821716|NCT00075023|Oropharyngeal pain|oropharyngeal pain
5821718|NCT00075023|Allogeneic hematopoietic stem cell transplant|allogeneic hematopoietic stem cell transplant
5821719|NCT00075023|Inflammation|inflammation
5821720|NCT00075023|Thalidomide|thalidomide
5821721|NCT00075023|Oral chronic graft-versus-host disease|oral chronic graft-versus-host disease
5821722|NCT00075010|Relapsed/Refractory Leukemia|relapsed/refractory leukemia
5821723|NCT00075010|Myelodysplastic Syndromes|myelodysplastic syndromes
5821724|NCT00074997|Gene Therapy|gene therapy
5821725|NCT00074997|Anti-HIV-1 Ribozyme|anti-hiv-1 ribozyme
5821727|NCT00074997|HIV-1 Infections|hiv-1 infections
5821728|NCT00009698|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5821729|NCT00009698|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5821730|NCT00009698|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5821731|NCT00009698|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5821732|NCT00006481|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5821733|NCT00006481|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5821734|NCT00006481|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5821735|NCT00006481|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5821736|NCT00006481|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5821737|NCT00006481|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5821738|NCT00006481|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5821739|NCT00006481|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5821740|NCT00006481|skin reactions secondary to radiation therapy|skin reactions secondary to radiation therapy
5821741|NCT00006480|disseminated neuroblastoma|disseminated neuroblastoma
5821742|NCT00006480|recurrent neuroblastoma|recurrent neuroblastoma
5821743|NCT00074984|a-Galactosidase A|a-galactosidase a
5821744|NCT00074984|aGAL|agal
5821745|NCT00074984|r-haGAL|r-hagal
5821746|NCT00074984|Fabry|fabry
5821747|NCT00074984|GL-3|gl-3
5821748|NCT00074984|Fabrazyme|fabrazyme
5821749|NCT00074971|a-Galactosidase A|a-galactosidase a
5821750|NCT00074971|aGAL|agal
5821751|NCT00074971|r-haGAL|r-hagal
5821752|NCT00074971|Fabry|fabry
5821753|NCT00074971|GL-3|gl-3
5821754|NCT00074971|Fabrazyme|fabrazyme
5821755|NCT00074958|a-Galactosidase A|a-galactosidase a
5821756|NCT00074958|aGal|agal
5821757|NCT00074958|r-haGAL|r-hagal
5821758|NCT00074958|Fabry|fabry
5821759|NCT00074958|GL-3|gl-3
5821760|NCT00074958|Fabrazyme|fabrazyme
5821761|NCT00074932|Glycogen Storage Disease Type II|glycogen storage disease type ii
5821762|NCT00074932|GSD-II|gsd-ii
5821763|NCT00074932|Pompe Disease|pompe disease
5821764|NCT00074932|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5821765|NCT00074919|Glycogen Storage Disease Type II|glycogen storage disease type ii
5821766|NCT00074919|GSD-II|gsd-ii
5821767|NCT00074919|Pompe Disease|pompe disease
5821768|NCT00074919|Acid Maltase Deficiency Disease|acid maltase deficiency disease
5821769|NCT00074906|Aspiration of gastric contents|aspiration of gastric contents
5821770|NCT00074945|Obesity|obesity
5821771|NCT00074945|Resting Energy Expenditure|resting energy expenditure
5821772|NCT00074945|Metabolic Rate|metabolic rate
5821773|NCT00074945|Visceral Fat|visceral fat
5821774|NCT00074945|Body Fat Distribution|body fat distribution
5821775|NCT00074893|Repetitive Strain Injuries|repetitive strain injuries
5821776|NCT00074893|Vibration Damping|vibration damping
5821777|NCT00074893|Protective Brace|protective brace
5821778|NCT00074893|Piezoelectric|piezoelectric
5821779|NCT00074893|SmartWear|smartwear
5821780|NCT00074841|MALARIA|malaria
5821781|NCT00074841|INDIA|india
5821782|NCT00074841|CHLOROQUINE|chloroquine
5821783|NCT00074841|PLASMODIUM FALCIPARUM|plasmodium falciparum
5821784|NCT00074841|SULFADOXINE-PYRIMETHAMINE|sulfadoxine-pyrimethamine
5821785|NCT00006384|stage IV renal cell cancer|stage iv renal cell cancer
5821786|NCT00006384|recurrent renal cell cancer|recurrent renal cell cancer
5821787|NCT00006353|adult glioblastoma|adult glioblastoma
5821788|NCT00006353|adult giant cell glioblastoma|adult giant cell glioblastoma
5821789|NCT00006353|adult gliosarcoma|adult gliosarcoma
5821790|NCT00006247|childhood craniopharyngioma|childhood craniopharyngioma
5821791|NCT00006247|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5821792|NCT00006247|childhood oligodendroglioma|childhood oligodendroglioma
5821793|NCT00006247|childhood choroid plexus tumor|childhood choroid plexus tumor
5821794|NCT00006247|childhood grade I meningioma|childhood grade i meningioma
5821795|NCT00006247|childhood grade II meningioma|childhood grade ii meningioma
5821796|NCT00006247|childhood grade III meningioma|childhood grade iii meningioma
5821797|NCT00006247|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5821798|NCT00006247|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5821799|NCT00006247|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5821800|NCT00006247|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5822053|NCT00074360|Conditioning|conditioning
5821801|NCT00006247|recurrent childhood ependymoma|recurrent childhood ependymoma
5821802|NCT00006104|stage IV breast cancer|stage iv breast cancer
5821803|NCT00006104|recurrent breast cancer|recurrent breast cancer
5821804|NCT00074880|Cardiac Hypertrophy|cardiac hypertrophy
5821805|NCT00074880|Diastolic Dysfunction|diastolic dysfunction
5821806|NCT00074880|Cardiac Glycosides|cardiac glycosides
5821807|NCT00074880|Cardiac Fibrosis|cardiac fibrosis
5821808|NCT00074880|Atrial Systole|atrial systole
5821809|NCT00074828|elective|elective
5821810|NCT00074828|primary unilateral|primary unilateral
5821811|NCT00074763|Leukemia|leukemia
5821812|NCT00074763|Lymphoma|lymphoma
5821813|NCT00074763|ALL|all
5821814|NCT00074763|CLL|cll
5821815|NCT00074763|AML|aml
5821816|NCT00074763|CML|cml
5821817|NCT00074763|MDS|mds
5821818|NCT00074763|Remission|remission
5821819|NCT00074763|Hematologic Disorder|hematologic disorder
5821820|NCT00074763|Transfusion|transfusion
5821821|NCT00074763|Thrombosol|thrombosol
5821822|NCT00074763|Autologous Platelet Transfusion|autologous platelet transfusion
5821823|NCT00074763|Platelet Transfusion|platelet transfusion
5821824|NCT00074763|Single donor platelet apheresis|single donor platelet apheresis
5821825|NCT00074763|Cryopreservation|cryopreservation
5822678|NCT00073242|obesity|obesity
5821826|NCT00074763|Thrombocytopenia|thrombocytopenia
5821827|NCT00074750|AML|aml
5821828|NCT00074750|CMML|cmml
5822255|NCT00004261|stage IV breast cancer|stage iv breast cancer
5821829|NCT00074737|Refractory or Relapsed Acute Myelogenous Leukemia (AML)|refractory or relapsed acute myelogenous leukemia (aml)
5821830|NCT00074737|Antisense|antisense
5821831|NCT00006099|ovarian epithelial cancer|ovarian epithelial cancer
5821832|NCT00006087|non-small cell lung cancer|non-small cell lung cancer
5821833|NCT00006087|small cell lung cancer|small cell lung cancer
5821834|NCT00006080|recurrent adult brain tumor|recurrent adult brain tumor
5821835|NCT00006080|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5821836|NCT00006080|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5821837|NCT00006080|adult mixed glioma|adult mixed glioma
5821838|NCT00005978|localized resectable neuroblastoma|localized resectable neuroblastoma
5821839|NCT00005978|regional neuroblastoma|regional neuroblastoma
5821840|NCT00005978|disseminated neuroblastoma|disseminated neuroblastoma
5821841|NCT00005978|stage 4S neuroblastoma|stage 4s neuroblastoma
5821842|NCT00005978|recurrent neuroblastoma|recurrent neuroblastoma
5821843|NCT00005978|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5821844|NCT00005963|stage IV breast cancer|stage iv breast cancer
5821845|NCT00005963|recurrent breast cancer|recurrent breast cancer
5821846|NCT00074815|Child|child
5821847|NCT00074815|Adolescent|adolescent
5821848|NCT00074802|Social Phobia|social phobia
5821849|NCT00074789|Early Head Start Program|early head start program
5821850|NCT00074776|Bipolar Depression|bipolar depression
5821851|NCT00074711|Bone Mineral Density|bone mineral density
5821852|NCT00074711|Calcium|calcium
5821853|NCT00074698|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5821854|NCT00074698|IPF|ipf
5821855|NCT00074698|Pulmonary fibrosis|pulmonary fibrosis
5821856|NCT00074698|Respiratory disease|respiratory disease
5821857|NCT00074685|Congenital|congenital
5821858|NCT00074685|Epidermal nevus|epidermal nevus
5821859|NCT00074685|Erythroderma|erythroderma
5821860|NCT00074685|Darier|darier
5821861|NCT00074685|Hailey-Hailey|hailey-hailey
5821862|NCT00074685|Harlequin|harlequin
5821863|NCT00074685|Ichthyosiform|ichthyosiform
5821864|NCT00074685|Ichthyosiform erythroderma|ichthyosiform erythroderma
5821865|NCT00074685|Keratoderma|keratoderma
5821866|NCT00074685|Keratosis|keratosis
5821867|NCT00074685|Pachyonychia|pachyonychia
5821868|NCT00074685|Sjogren-Larsson|sjogren-larsson
5821869|NCT00074646|CC-8490|cc-8490
5821870|NCT00074646|CC8490|cc8490
5821871|NCT00074646|Glio|glio
5821872|NCT00074646|Glioblastoma|glioblastoma
5821873|NCT00074646|Malignant Gliomas|malignant gliomas
5821874|NCT00074633|Type 2 Diabetes|type 2 diabetes
5821875|NCT00074633|Self-Esteem|self-esteem
5821876|NCT00074620|Haemodialysis|haemodialysis
5821877|NCT00074620|PEG-Hirudin|peg-hirudin
5821878|NCT00074620|Vascular graft occlusion|vascular graft occlusion
5821879|NCT00074620|Renal replacement therapy|renal replacement therapy
5821880|NCT00074620|Hemodialysis|hemodialysis
5821881|NCT00074672|Prepulse Inhibition|prepulse inhibition
5821882|NCT00074672|PPI|ppi
5821883|NCT00074672|Dopamine|dopamine
5821884|NCT00074672|Sensorimotor Integration|sensorimotor integration
5821885|NCT00074672|Dopaminergic|dopaminergic
5821886|NCT00074607|Neoplastic meningitis|neoplastic meningitis
5821887|NCT00074581|HIV Infections|hiv infections
5821888|NCT00074581|HIV Seronegativity|hiv seronegativity
5821890|NCT00074568|Transmission Dysequilibrium Testing|transmission dysequilibrium testing
5821891|NCT00074568|Genome Wide Scan|genome wide scan
5821892|NCT00074568|Family Study|family study
5821893|NCT00074555|African American, Rheumatoid Arthritis|african american, rheumatoid arthritis
5821894|NCT00005959|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5821895|NCT00005959|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5821896|NCT00005959|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5821897|NCT00005959|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5821898|NCT00005959|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5821899|NCT00005959|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5821900|NCT00005959|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5821901|NCT00005959|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5821902|NCT00005959|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5821903|NCT00005959|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5821904|NCT00005959|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5821905|NCT00005959|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5821906|NCT00005959|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5821907|NCT00005959|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5821908|NCT00005959|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5821909|NCT00005959|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5821910|NCT00005959|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5821911|NCT00005959|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5821912|NCT00005959|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5821913|NCT00005959|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5821914|NCT00005959|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5821915|NCT00005959|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5821916|NCT00005959|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5821917|NCT00005959|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5821918|NCT00005876|stage III gastric cancer|stage iii gastric cancer
5821919|NCT00005876|stage IV gastric cancer|stage iv gastric cancer
5821920|NCT00005876|recurrent gastric cancer|recurrent gastric cancer
5821921|NCT00005876|stage III esophageal cancer|stage iii esophageal cancer
5821922|NCT00005876|stage IV esophageal cancer|stage iv esophageal cancer
5821923|NCT00005876|recurrent esophageal cancer|recurrent esophageal cancer
5821924|NCT00005876|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5821925|NCT00005876|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5821926|NCT00005646|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5821927|NCT00005642|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821928|NCT00005634|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5821929|NCT00005634|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5821930|NCT00005634|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5821931|NCT00005634|extramedullary plasmacytoma|extramedullary plasmacytoma
5821932|NCT00005634|refractory multiple myeloma|refractory multiple myeloma
5821933|NCT00005634|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5821934|NCT00005634|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5821935|NCT00005634|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5821936|NCT00005634|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5821937|NCT00005634|small intestine lymphoma|small intestine lymphoma
5821938|NCT00005634|recurrent prostate cancer|recurrent prostate cancer
5821939|NCT00005634|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5821940|NCT00005634|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5821941|NCT00005634|refractory hairy cell leukemia|refractory hairy cell leukemia
5821942|NCT00005634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5821943|NCT00005634|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5821944|NCT00005634|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5821945|NCT00005634|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5821946|NCT00005634|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5821947|NCT00005634|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5821948|NCT00005634|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5821949|NCT00005634|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5821950|NCT00005634|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5821951|NCT00005634|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5821387|NCT00075959|Stroke|stroke
5821952|NCT00005634|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5821953|NCT00005634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5821954|NCT00005634|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5821955|NCT00005634|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5821956|NCT00005634|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5821957|NCT00005634|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5821958|NCT00005634|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5821959|NCT00005634|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5821960|NCT00005634|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5821962|NCT00074542|colon|colon
5821963|NCT00074542|small bowel|small bowel
5821964|NCT00074542|inflammation|inflammation
5821965|NCT00074542|steroid therapy|steroid therapy
5821966|NCT00074542|free fatty acids|free fatty acids
5821967|NCT00005598|refractory anemia|refractory anemia
5821968|NCT00005598|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5821969|NCT00005598|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5821970|NCT00005598|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5821971|NCT00005592|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5821972|NCT00005592|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5821973|NCT00005592|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5821974|NCT00005592|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5821975|NCT00005592|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5821976|NCT00005592|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5821977|NCT00005592|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5821978|NCT00005592|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5821979|NCT00005592|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5821980|NCT00005083|adult glioblastoma|adult glioblastoma
5821981|NCT00005083|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5821982|NCT00005083|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5821983|NCT00005083|adult anaplastic ependymoma|adult anaplastic ependymoma
5821984|NCT00005083|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5821985|NCT00005083|adult mixed glioma|adult mixed glioma
5821986|NCT00005083|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5821987|NCT00005083|adult subependymoma|adult subependymoma
5821988|NCT00005083|adult ependymoblastoma|adult ependymoblastoma
5821989|NCT00005083|adult oligodendroglioma|adult oligodendroglioma
5821990|NCT00005083|adult giant cell glioblastoma|adult giant cell glioblastoma
5821991|NCT00005083|adult gliosarcoma|adult gliosarcoma
5821992|NCT00004890|stage I renal cell cancer|stage i renal cell cancer
5821993|NCT00004890|stage II renal cell cancer|stage ii renal cell cancer
5821994|NCT00004890|stage III renal cell cancer|stage iii renal cell cancer
5821995|NCT00004890|stage IV renal cell cancer|stage iv renal cell cancer
5821996|NCT00004890|recurrent renal cell cancer|recurrent renal cell cancer
5821997|NCT00004890|drug extravasation|drug extravasation
5821998|NCT00004874|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5821999|NCT00004874|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5822000|NCT00004874|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5822001|NCT00074516|Immunosuppression|immunosuppression
5822003|NCT00074516|Cysteamine|cysteamine
5822004|NCT00074516|Steroid-Free|steroid-free
5822005|NCT00074516|Outcomes|outcomes
5822006|NCT00074503|Positron Emission Tomography|positron emission tomography
5822007|NCT00074503|Phospholipids|phospholipids
5822008|NCT00074503|Alcoholism|alcoholism
5822009|NCT00074503|[11C]Docosahexaenoate|[11c]docosahexaenoate
5822010|NCT00074503|[150]Water|[150]water
5822011|NCT00074503|Brain|brain
5822012|NCT00074503|Fatty Acids|fatty acids
5822013|NCT00074503|Blood Flow|blood flow
5822014|NCT00074503|Healthy|healthy
5822015|NCT00074490|Leukemia|leukemia
5822016|NCT00074490|Lymphoma|lymphoma
5822017|NCT00074490|Multiple Myeloma|multiple myeloma
5822018|NCT00074490|Bone Marrow Transplantation|bone marrow transplantation
5822019|NCT00074490|Immune Therapy|immune therapy
5822020|NCT00074477|Schizophrenia|schizophrenia
5822021|NCT00074477|Paliperidone palmitate|paliperidone palmitate
5822022|NCT00074477|R092670|r092670
5822023|NCT00074477|antipsychotic|antipsychotic
5822024|NCT00074438|Rituxan|rituxan
5822026|NCT00074425|HIV Seronegativity|hiv seronegativity
5822027|NCT00074425|Anti-Infective Agents, Local|anti-infective agents, local
5822028|NCT00074425|BufferGel|buffergel
5822029|NCT00074425|PRO 2000|pro 2000
5822030|NCT00074425|Vagina|vagina
5822031|NCT00074425|Risk Factors|risk factors
5822032|NCT00074412|HIV Seronegativity|hiv seronegativity
5822033|NCT00074412|Treatment Experienced|treatment experienced
5862676|NCT00001547|Brain|brain
5822034|NCT00074412|Treatment Naive|treatment naive
5822035|NCT00074399|Maternal/Infant Transmisson|maternal/infant transmisson
5822036|NCT00074399|Vertical Transmission|vertical transmission
5822037|NCT00074399|Pregnancy|pregnancy
5822038|NCT00074399|HIV Seronegativity|hiv seronegativity
5822041|NCT00074386|Liver|liver
5822042|NCT00074386|Kidney|kidney
5822043|NCT00074386|Organ|organ
5822044|NCT00074386|Treatment Experienced|treatment experienced
5822045|NCT00074386|Kidney Transplant|kidney transplant
5822046|NCT00074386|Liver Transplant|liver transplant
5822047|NCT00074373|Anti-SSA/Ro Antibodies|anti-ssa/ro antibodies
5822048|NCT00074373|Anti-SSB/La Antibodies|anti-ssb/la antibodies
5822049|NCT00021983|refractory hairy cell leukemia|refractory hairy cell leukemia
5822050|NCT00074360|Ethanol|ethanol
5822051|NCT00074360|fMRI|fmri
5822054|NCT00074360|Reinforcement|reinforcement
5822055|NCT00074334|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5822056|NCT00074334|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5822057|NCT00074334|childhood oligodendroglioma|childhood oligodendroglioma
5822058|NCT00074334|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5822059|NCT00074334|recurrent childhood ependymoma|recurrent childhood ependymoma
5822060|NCT00074334|recurrent childhood brain tumor|recurrent childhood brain tumor
5822061|NCT00074295|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5822062|NCT00074295|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822063|NCT00074295|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822064|NCT00074295|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822065|NCT00074282|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5822066|NCT00074282|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5822067|NCT00074269|recurrent breast cancer|recurrent breast cancer
5822068|NCT00074269|stage IV breast cancer|stage iv breast cancer
5822069|NCT00074243|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5822070|NCT00074243|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5822072|NCT00074243|adult mixed glioma|adult mixed glioma
5822073|NCT00074243|adult brain stem glioma|adult brain stem glioma
5822074|NCT00074243|recurrent adult brain tumor|recurrent adult brain tumor
5822075|NCT00074243|adult giant cell glioblastoma|adult giant cell glioblastoma
5822076|NCT00074243|adult gliosarcoma|adult gliosarcoma
5822077|NCT00074230|stage IV melanoma|stage iv melanoma
5822078|NCT00074230|recurrent melanoma|recurrent melanoma
5822079|NCT00074204|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822080|NCT00074204|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822081|NCT00074204|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822082|NCT00074191|intraocular lymphoma|intraocular lymphoma
5822083|NCT00074191|primary central nervous system lymphoma|primary central nervous system lymphoma
5822084|NCT00074178|primary central nervous system lymphoma|primary central nervous system lymphoma
5822085|NCT00074178|intraocular lymphoma|intraocular lymphoma
5822086|NCT00074165|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5822087|NCT00074165|thrombocytopenia|thrombocytopenia
5822088|NCT00074165|intraocular lymphoma|intraocular lymphoma
5822089|NCT00074165|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5822090|NCT00074165|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5822091|NCT00074152|recurrent breast cancer|recurrent breast cancer
5822092|NCT00074152|stage I breast cancer|stage i breast cancer
5822093|NCT00074152|stage II breast cancer|stage ii breast cancer
5822094|NCT00074152|stage IIIA breast cancer|stage iiia breast cancer
5822095|NCT00074152|stage IIIB breast cancer|stage iiib breast cancer
5822096|NCT00074152|stage IIIC breast cancer|stage iiic breast cancer
5822097|NCT00074139|stage IIIA breast cancer|stage iiia breast cancer
5822098|NCT00074139|recurrent breast cancer|recurrent breast cancer
5822099|NCT00074139|stage IIIB breast cancer|stage iiib breast cancer
5822100|NCT00074139|stage IIIC breast cancer|stage iiic breast cancer
5822101|NCT00074139|stage IV breast cancer|stage iv breast cancer
5822102|NCT00074100|stage IV breast cancer|stage iv breast cancer
5822103|NCT00074100|recurrent breast cancer|recurrent breast cancer
5822104|NCT00074087|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5822105|NCT00074087|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5822106|NCT00074087|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5822107|NCT00074087|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5822108|NCT00074087|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5822109|NCT00074087|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5822110|NCT00074074|refractory anemia with excess blasts|refractory anemia with excess blasts
5822111|NCT00074074|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5822112|NCT00074074|refractory anemia|refractory anemia
5822113|NCT00074074|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5822114|NCT00074074|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5822115|NCT00074074|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5822116|NCT00074048|refractory hairy cell leukemia|refractory hairy cell leukemia
5822117|NCT00074009|recurrent gastric cancer|recurrent gastric cancer
5822118|NCT00074009|stage III gastric cancer|stage iii gastric cancer
5822119|NCT00074009|stage IV gastric cancer|stage iv gastric cancer
5822121|NCT00073983|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5822122|NCT00073983|chondrosarcoma|chondrosarcoma
5822123|NCT00073983|recurrent osteosarcoma|recurrent osteosarcoma
5822124|NCT00073970|recurrent prostate cancer|recurrent prostate cancer
5822125|NCT00073970|stage I prostate cancer|stage i prostate cancer
5822126|NCT00073970|stage II prostate cancer|stage ii prostate cancer
5822127|NCT00073970|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5822128|NCT00073957|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5822129|NCT00073957|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822130|NCT00073957|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5822131|NCT00073944|acute undifferentiated leukemia|acute undifferentiated leukemia
5822132|NCT00073944|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5822133|NCT00073944|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5822134|NCT00073944|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5822135|NCT00073944|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5822136|NCT00073944|primary myelofibrosis|primary myelofibrosis
5822137|NCT00073944|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5822138|NCT00073944|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5822139|NCT00073944|essential thrombocythemia|essential thrombocythemia
5822140|NCT00073944|intraocular lymphoma|intraocular lymphoma
5822141|NCT00073944|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5822142|NCT00073944|polycythemia vera|polycythemia vera
5822143|NCT00073944|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5822144|NCT00073944|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5822145|NCT00073944|prolymphocytic leukemia|prolymphocytic leukemia
5822146|NCT00073944|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5822147|NCT00073944|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5822148|NCT00073944|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5822149|NCT00073944|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5822150|NCT00073944|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5822151|NCT00073944|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5822152|NCT00073944|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5822153|NCT00073944|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5822154|NCT00073944|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822155|NCT00073944|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5822156|NCT00073944|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5822157|NCT00073944|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5822158|NCT00073944|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5822159|NCT00073944|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5822160|NCT00073944|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5822161|NCT00073944|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5822162|NCT00073944|refractory hairy cell leukemia|refractory hairy cell leukemia
5822163|NCT00073944|refractory multiple myeloma|refractory multiple myeloma
5822164|NCT00073944|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5822165|NCT00073944|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5822166|NCT00073944|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5822167|NCT00073944|Waldenström macroglobulinemia|waldenström macroglobulinemia
5822168|NCT00073944|adenocarcinoma of the colon|adenocarcinoma of the colon
5822169|NCT00073944|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5822170|NCT00073944|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5822171|NCT00073944|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5822172|NCT00073944|recurrent adult brain tumor|recurrent adult brain tumor
5822173|NCT00073944|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5822174|NCT00073944|recurrent colon cancer|recurrent colon cancer
5822175|NCT00073944|recurrent esophageal cancer|recurrent esophageal cancer
5822176|NCT00073944|recurrent gastric cancer|recurrent gastric cancer
5822177|NCT00073944|recurrent melanoma|recurrent melanoma
5822178|NCT00073944|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822179|NCT00073944|recurrent pancreatic cancer|recurrent pancreatic cancer
5822180|NCT00073944|recurrent rectal cancer|recurrent rectal cancer
5822181|NCT00073944|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5822182|NCT00073944|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5822183|NCT00073944|adult glioblastoma|adult glioblastoma
5822184|NCT00073944|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5822185|NCT00073944|adult subependymoma|adult subependymoma
5822186|NCT00073944|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5822187|NCT00073944|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5862677|NCT00001547|Metabolism|metabolism
5822188|NCT00073944|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5818465|NCT00002901|ovarian sarcoma|ovarian sarcoma
5822189|NCT00073944|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5822190|NCT00073944|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5822191|NCT00073944|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5822192|NCT00073944|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5822193|NCT00073944|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5822194|NCT00073944|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5822195|NCT00073944|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5822196|NCT00073944|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5822197|NCT00073944|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5822198|NCT00073944|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5822199|NCT00073944|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5822200|NCT00073944|adult diffuse astrocytoma|adult diffuse astrocytoma
5822201|NCT00073944|adult giant cell glioblastoma|adult giant cell glioblastoma
5822203|NCT00073944|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5822204|NCT00073931|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5822205|NCT00073931|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5822206|NCT00073931|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5822207|NCT00073931|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5822208|NCT00073931|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822209|NCT00073931|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5822210|NCT00073931|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5822211|NCT00073931|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5822212|NCT00073931|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5822213|NCT00073931|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5822214|NCT00073905|unresectable gallbladder cancer|unresectable gallbladder cancer
5822215|NCT00073905|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5822216|NCT00073905|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5822217|NCT00073905|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5822219|NCT00073905|recurrent gallbladder cancer|recurrent gallbladder cancer
5822220|NCT00073905|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5822221|NCT00073905|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5822222|NCT00073905|advanced adult primary liver cancer|advanced adult primary liver cancer
5822223|NCT00073905|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5822224|NCT00073892|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5822225|NCT00073892|stage IV melanoma|stage iv melanoma
5822226|NCT00073892|recurrent melanoma|recurrent melanoma
5822227|NCT00073879|stage IV renal cell cancer|stage iv renal cell cancer
5822228|NCT00073879|recurrent renal cell cancer|recurrent renal cell cancer
5822229|NCT00073866|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822230|NCT00073866|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822231|NCT00073866|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822232|NCT00073853|paraplegia|paraplegia
5822233|NCT00073853|quadraplegia|quadraplegia
5822234|NCT00073853|tetraplegia|tetraplegia
5822235|NCT00073853|paralysis|paralysis
5822236|NCT00073853|nerve regeneration|nerve regeneration
5822237|NCT00073853|Acute, Complete SCI|acute, complete sci
5822238|NCT00073840|levalbuterol|levalbuterol
5822240|NCT00073840|bronchoconstriction|bronchoconstriction
5822241|NCT00073840|adolescent|adolescent
5822242|NCT00073840|adult|adult
5822243|NCT00073827|adolescent|adolescent
5822244|NCT00073827|adult|adult
5822245|NCT00073827|asthma|asthma
5822246|NCT00073827|levalbuterol|levalbuterol
5822247|NCT00073827|bronchoconstriction|bronchoconstriction
5822248|NCT00004857|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5822249|NCT00004857|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5822250|NCT00004857|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5822251|NCT00004857|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5822252|NCT00004857|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5822253|NCT00004261|stage I breast cancer|stage i breast cancer
5822254|NCT00004261|stage II breast cancer|stage ii breast cancer
5822256|NCT00004261|stage IIIA breast cancer|stage iiia breast cancer
5822257|NCT00004261|breast cancer in situ|breast cancer in situ
5822258|NCT00004261|recurrent breast cancer|recurrent breast cancer
5822259|NCT00004261|stage IIIB breast cancer|stage iiib breast cancer
5822260|NCT00004261|stage 0 cervical cancer|stage 0 cervical cancer
5822261|NCT00004261|stage III cervical cancer|stage iii cervical cancer
5822262|NCT00004261|recurrent cervical cancer|recurrent cervical cancer
5822263|NCT00004261|stage IB cervical cancer|stage ib cervical cancer
5822264|NCT00004261|stage IIB cervical cancer|stage iib cervical cancer
5822265|NCT00004261|stage IVB cervical cancer|stage ivb cervical cancer
5822266|NCT00004261|stage IA cervical cancer|stage ia cervical cancer
5822267|NCT00004261|stage IIA cervical cancer|stage iia cervical cancer
5822268|NCT00004261|stage IVA cervical cancer|stage iva cervical cancer
5822269|NCT00004261|inflammatory breast cancer|inflammatory breast cancer
5822270|NCT00004261|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5822271|NCT00004261|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5822273|NCT00004261|stage IIB prostate cancer|stage iib prostate cancer
5822274|NCT00004261|stage IIA prostate cancer|stage iia prostate cancer
5822275|NCT00004261|stage III prostate cancer|stage iii prostate cancer
5822276|NCT00004261|stage IV prostate cancer|stage iv prostate cancer
5822277|NCT00004261|recurrent prostate cancer|recurrent prostate cancer
5822278|NCT00004261|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5822279|NCT00004261|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5822280|NCT00004261|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5822281|NCT00004261|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5822282|NCT00004261|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5822283|NCT00004261|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5822284|NCT00004261|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5822285|NCT00004261|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5822286|NCT00004261|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5822287|NCT00004261|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5822288|NCT00004261|stage I salivary gland cancer|stage i salivary gland cancer
5822289|NCT00004261|stage II salivary gland cancer|stage ii salivary gland cancer
5822290|NCT00004261|stage III salivary gland cancer|stage iii salivary gland cancer
5822291|NCT00004261|stage IV salivary gland cancer|stage iv salivary gland cancer
5822292|NCT00004261|recurrent salivary gland cancer|recurrent salivary gland cancer
5822293|NCT00004261|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5822294|NCT00004261|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5822295|NCT00004261|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5822296|NCT00004261|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5822297|NCT00004261|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5822298|NCT00004261|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5822299|NCT00004261|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5822300|NCT00004261|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5822301|NCT00004261|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5822302|NCT00004261|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5822303|NCT00004261|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5822304|NCT00004261|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5822305|NCT00004261|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5822306|NCT00004261|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5822307|NCT00004261|stage I laryngeal cancer|stage i laryngeal cancer
5822308|NCT00004261|stage II laryngeal cancer|stage ii laryngeal cancer
5822309|NCT00004261|stage III laryngeal cancer|stage iii laryngeal cancer
5822310|NCT00004261|stage IV laryngeal cancer|stage iv laryngeal cancer
5822311|NCT00004261|recurrent laryngeal cancer|recurrent laryngeal cancer
5822312|NCT00004261|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5822313|NCT00004261|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5822314|NCT00004261|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5822315|NCT00004261|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5822316|NCT00004261|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5822317|NCT00004261|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5822318|NCT00004261|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5822319|NCT00004261|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5822320|NCT00004261|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5822321|NCT00004261|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5822322|NCT00004261|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5822323|NCT00004261|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5822324|NCT00004242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5822325|NCT00003927|stage II breast cancer|stage ii breast cancer
5822326|NCT00003927|stage IV breast cancer|stage iv breast cancer
5822327|NCT00003927|stage IIIA breast cancer|stage iiia breast cancer
5822328|NCT00003927|stage IIIB breast cancer|stage iiib breast cancer
5822330|NCT00073814|pediatric|pediatric
5822331|NCT00073814|asthma|asthma
5822332|NCT00003811|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5822333|NCT00003811|childhood teratoma|childhood teratoma
5822334|NCT00003811|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5822335|NCT00003811|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5822336|NCT00003811|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5822337|NCT00003811|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5822338|NCT00003777|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5822339|NCT00003777|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5822340|NCT00003777|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5822341|NCT00003777|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5822342|NCT00003777|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5822343|NCT00003777|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5822344|NCT00003777|stage III laryngeal cancer|stage iii laryngeal cancer
5822345|NCT00003777|stage IV laryngeal cancer|stage iv laryngeal cancer
5822346|NCT00003777|recurrent laryngeal cancer|recurrent laryngeal cancer
5822347|NCT00003777|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5822642|NCT00025532|stage IV gastric cancer|stage iv gastric cancer
5822351|NCT00003777|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5822352|NCT00003777|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5822354|NCT00003761|recurrent breast cancer|recurrent breast cancer
5822355|NCT00003729|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5822356|NCT00003729|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5822357|NCT00003729|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5822363|NCT00003734|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5822364|NCT00003734|stage I prostate cancer|stage i prostate cancer
5822365|NCT00003734|stage IIB prostate cancer|stage iib prostate cancer
5822366|NCT00003734|stage IIA prostate cancer|stage iia prostate cancer
5822367|NCT00003734|stage III prostate cancer|stage iii prostate cancer
5822368|NCT00003734|stage IV prostate cancer|stage iv prostate cancer
5822370|NCT00073749|Non-Hodgkin's|non-hodgkin's
5822371|NCT00073749|Lymphoma|lymphoma
5822372|NCT00073736|Hepatocellular|hepatocellular
5822373|NCT00073736|Carcinoma|carcinoma
5822374|NCT00073736|Liver|liver
5822375|NCT00073736|Cancer|cancer
5822376|NCT00073723|Non-Small Cell Lung Cancer|non-small cell lung cancer
5822378|NCT00073723|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5822379|NCT00003716|childhood Burkitt lymphoma|childhood burkitt lymphoma
5822380|NCT00003716|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5822381|NCT00003716|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5822382|NCT00003716|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5822383|NCT00003716|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822384|NCT00003716|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5822385|NCT00003716|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5822386|NCT00003716|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5822387|NCT00003716|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5822388|NCT00003716|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5822389|NCT00003679|stage IIIA breast cancer|stage iiia breast cancer
5822390|NCT00003679|stage IIIB breast cancer|stage iiib breast cancer
5822391|NCT00003679|inflammatory breast cancer|inflammatory breast cancer
5822392|NCT00003598|cervical cancer|cervical cancer
5822393|NCT00003598|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5822394|NCT00003598|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5822395|NCT00003450|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5822396|NCT00003450|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822397|NCT00003450|peritoneal cavity cancer|peritoneal cavity cancer
5822398|NCT00073710|secondary hyperparathyroidism|secondary hyperparathyroidism
5822399|NCT00073697|Psychotherapy|psychotherapy
5822400|NCT00073697|Depressive disorder|depressive disorder
5822401|NCT00073697|Antidepressive agents|antidepressive agents
5822402|NCT00073697|Citalopram|citalopram
5822403|NCT00073684|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5822404|NCT00073684|Depression|depression
5822405|NCT00073684|Anxiety|anxiety
5822406|NCT00073671|Adolescent|adolescent
5822407|NCT00073658|Alzheimer disease|alzheimer disease
5822408|NCT00073658|Aggression|aggression
5822409|NCT00073658|Delusions|delusions
5822410|NCT00073658|Paranoid behavior|paranoid behavior
5822411|NCT00073619|Violence|violence
5822412|NCT00073619|School based|school based
5822413|NCT00073619|Urban Youth|urban youth
5822414|NCT00073619|Prevention|prevention
5822415|NCT00073619|Community|community
5822416|NCT00073606|Spinal Reflexes|spinal reflexes
5822417|NCT00073606|Locomotion|locomotion
5822418|NCT00073606|Motor Practice|motor practice
5822419|NCT00073606|Healthy Volunteer|healthy volunteer
5822421|NCT00003426|stage II pancreatic cancer|stage ii pancreatic cancer
5822422|NCT00003426|stage III pancreatic cancer|stage iii pancreatic cancer
5822423|NCT00003426|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5822424|NCT00003414|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5822425|NCT00003414|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5822426|NCT00003414|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5822427|NCT00003414|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5830316|NCT00002658|neutropenia|neutropenia
5822428|NCT00003414|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5822429|NCT00003414|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5822430|NCT00003414|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5822431|NCT00003414|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5822432|NCT00003414|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5822433|NCT00003414|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822434|NCT00003414|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5822437|NCT00003414|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5822438|NCT00003414|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5822439|NCT00003414|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5822440|NCT00003414|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5822441|NCT00003414|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5822442|NCT00003414|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5822443|NCT00003414|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5822444|NCT00003414|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5822445|NCT00003409|adult glioblastoma|adult glioblastoma
5822446|NCT00003409|adult giant cell glioblastoma|adult giant cell glioblastoma
5822447|NCT00003409|adult gliosarcoma|adult gliosarcoma
5822448|NCT00003388|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5822449|NCT00003388|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5822450|NCT00003388|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5822451|NCT00003388|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5822452|NCT00003388|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5822453|NCT00003388|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5822454|NCT00003388|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5822455|NCT00003388|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5822456|NCT00073593|Off-Pump Coronary Artery Bypass Graft Surgery|off-pump coronary artery bypass graft surgery
5822457|NCT00073593|CABG|cabg
5822458|NCT00073593|OPCAB|opcab
5822459|NCT00073593|Heparin|heparin
5822460|NCT00073593|Patients requiring off-pump CABG|patients requiring off-pump cabg
5822462|NCT00073580|HITTS|hitts
5822463|NCT00073580|Heparin-antibodies|heparin-antibodies
5822464|NCT00073580|Coronary artery bypass surgery|coronary artery bypass surgery
5822465|NCT00073580|CABG|cabg
5822466|NCT00073580|Heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5822467|NCT00073580|Heparin-induced thrombocytopenia and thrombosis syndrome|heparin-induced thrombocytopenia and thrombosis syndrome
5822468|NCT00073541|EGFR; HER-1; monoclonal antibody; targeted therapy|egfr; her-1; monoclonal antibody; targeted therapy
5822469|NCT00073528|metastatic|metastatic
5822470|NCT00073528|advanced breast cancer|advanced breast cancer
5822471|NCT00073528|breast cancer|breast cancer
5822472|NCT00003387|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5822473|NCT00003387|squamous cell lung cancer|squamous cell lung cancer
5822474|NCT00003387|large cell lung cancer|large cell lung cancer
5822475|NCT00003387|adenocarcinoma of the lung|adenocarcinoma of the lung
5822476|NCT00003313|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5822477|NCT00003313|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5822478|NCT00003313|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822479|NCT00003313|oral complications|oral complications
5822480|NCT00003313|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5822481|NCT00003313|radiation toxicity|radiation toxicity
5822482|NCT00003253|stage IV breast cancer|stage iv breast cancer
5822483|NCT00003253|recurrent breast cancer|recurrent breast cancer
5822484|NCT00003253|male breast cancer|male breast cancer
5822485|NCT00003202|squamous cell lung cancer|squamous cell lung cancer
5822486|NCT00003202|large cell lung cancer|large cell lung cancer
5822487|NCT00003202|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5822488|NCT00003202|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822489|NCT00003202|adenocarcinoma of the lung|adenocarcinoma of the lung
5822490|NCT00003202|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5822491|NCT00003191|recurrent neuroblastoma|recurrent neuroblastoma
5822492|NCT00003191|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5822493|NCT00073515|central venous access device|central venous access device
5822494|NCT00073515|thrombosis|thrombosis
5822495|NCT00073515|central venous catheter|central venous catheter
5822496|NCT00073515|thrombolysis|thrombolysis
5822497|NCT00073515|fibrinolysis|fibrinolysis
5822498|NCT00073489|chronic leukemia|chronic leukemia
5822499|NCT00073489|leukemia|leukemia
5822500|NCT00073489|CLL|cll
5822501|NCT00073463|Gene Transfer|gene transfer
5822502|NCT00073463|Pulmonary function|pulmonary function
5822503|NCT00003130|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5822504|NCT00003060|recurrent melanoma|recurrent melanoma
5822505|NCT00003037|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5822506|NCT00003037|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822507|NCT00002989|stage I multiple myeloma|stage i multiple myeloma
5822508|NCT00002989|stage II multiple myeloma|stage ii multiple myeloma
5822509|NCT00002989|stage III multiple myeloma|stage iii multiple myeloma
5822510|NCT00002989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5822511|NCT00002989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5822512|NCT00002989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5822513|NCT00002989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5822514|NCT00002989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5822515|NCT00002989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5822516|NCT00002989|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5822517|NCT00002989|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5822518|NCT00002989|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5822519|NCT00002989|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5822520|NCT00002989|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5822521|NCT00002989|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5822522|NCT00002989|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5822523|NCT00002989|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5822524|NCT00002989|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5822525|NCT00002989|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5822526|NCT00002989|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5822527|NCT00002989|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5822528|NCT00002989|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5822529|NCT00002989|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5822530|NCT00002989|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5822531|NCT00002989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5822532|NCT00002989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5822533|NCT00002989|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5822534|NCT00002989|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5822535|NCT00002989|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5822536|NCT00002989|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5822537|NCT00002989|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5822538|NCT00002989|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5822539|NCT00002989|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5822540|NCT00002989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5822541|NCT00002989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5822542|NCT00002989|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5822543|NCT00002989|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5822544|NCT00002989|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5822545|NCT00002989|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5822546|NCT00002989|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5822547|NCT00002989|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5822548|NCT00002989|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5822549|NCT00002989|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5822550|NCT00002989|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5822551|NCT00002989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5822552|NCT00002989|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5822553|NCT00002989|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5822554|NCT00002989|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5822555|NCT00002989|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5822556|NCT00002989|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5822557|NCT00002989|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5822558|NCT00002989|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5822559|NCT00002989|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5822560|NCT00002989|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5822561|NCT00002989|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5822562|NCT00002989|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5822563|NCT00002989|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5822564|NCT00002989|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5862678|NCT00001547|Organic Mental Syndrome|organic mental syndrome
5822565|NCT00002989|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5822566|NCT00002989|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5822567|NCT00002989|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5822568|NCT00002989|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5822569|NCT00002989|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5822570|NCT00002989|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5822571|NCT00002989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5822572|NCT00002989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5822573|NCT00002989|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5822574|NCT00002989|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5822575|NCT00002989|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5822576|NCT00002989|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5822577|NCT00002989|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5822578|NCT00002989|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5822579|NCT00002989|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5822580|NCT00002989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5822581|NCT00002989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5822582|NCT00002989|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5822583|NCT00002989|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5822584|NCT00002989|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5822585|NCT00002989|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5822586|NCT00002989|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5822587|NCT00002989|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5822680|NCT00073229|Vertical Transmission|vertical transmission
5822588|NCT00002989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5822589|NCT00002989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5822590|NCT00002989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5822591|NCT00002989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5822592|NCT00073450|Squamous Cell Carcinoma of the Head & Neck|squamous cell carcinoma of the head & neck
5822593|NCT00073437|Sarcoidosis|sarcoidosis
5822594|NCT00073437|Infliximab|infliximab
5822595|NCT00073437|Pulmonary involvement|pulmonary involvement
5822596|NCT00073437|Remicade|remicade
5822597|NCT00002940|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5822598|NCT00002836|recurrent breast cancer|recurrent breast cancer
5822599|NCT00002828|stage III colon cancer|stage iii colon cancer
5822600|NCT00002828|stage IV colon cancer|stage iv colon cancer
5822601|NCT00002828|stage III rectal cancer|stage iii rectal cancer
5822602|NCT00002828|stage IV rectal cancer|stage iv rectal cancer
5822603|NCT00002828|recurrent colon cancer|recurrent colon cancer
5822604|NCT00002828|recurrent rectal cancer|recurrent rectal cancer
5822605|NCT00002812|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5822606|NCT00002812|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5822607|NCT00002812|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5822608|NCT00002761|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5822609|NCT00002761|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5822610|NCT00002761|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5822611|NCT00073424|Treatment Experienced|treatment experienced
5822612|NCT00073385|Lung cancer, Docetaxel, Histone deacetylase inhibitor|lung cancer, docetaxel, histone deacetylase inhibitor
5822613|NCT00073372|Acute ischemic stroke|acute ischemic stroke
5822614|NCT00073372|abciximab|abciximab
5822615|NCT00073372|ReoPro|reopro
5822616|NCT00073372|drug safety|drug safety
5822617|NCT00073372|drug efficacy|drug efficacy
5822618|NCT00073372|intracranial hemorrhage|intracranial hemorrhage
5822619|NCT00073372|stroke|stroke
5822620|NCT00073359|Adolescent|adolescent
5822621|NCT00073346|Hoarding Disorder|hoarding disorder
5822622|NCT00073333|Phobic Disorders|phobic disorders
5822623|NCT00073320|Schizophrenia|schizophrenia
5822624|NCT00073320|Paliperidone palmitate|paliperidone palmitate
5822625|NCT00073320|R092670|r092670
5822626|NCT00073320|antipsychotic|antipsychotic
5822627|NCT00073307|Renal Cell Cancer (RCC)|renal cell cancer (rcc)
5822628|NCT00073307|Cancer|cancer
5822629|NCT00036920|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822630|NCT00036920|squamous cell lung cancer|squamous cell lung cancer
5822631|NCT00036920|large cell lung cancer|large cell lung cancer
5822632|NCT00036920|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822633|NCT00036920|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822634|NCT00036920|adenocarcinoma of the lung|adenocarcinoma of the lung
5822635|NCT00036920|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5822636|NCT00036920|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5822637|NCT00027521|stage III pancreatic cancer|stage iii pancreatic cancer
5822639|NCT00025532|stage III colon cancer|stage iii colon cancer
5822640|NCT00025532|stage IV colon cancer|stage iv colon cancer
5822641|NCT00025532|stage III gastric cancer|stage iii gastric cancer
5822647|NCT00025532|stage IV rectal cancer|stage iv rectal cancer
5822648|NCT00025532|recurrent colon cancer|recurrent colon cancer
5822649|NCT00025532|recurrent rectal cancer|recurrent rectal cancer
5822650|NCT00025532|stage III esophageal cancer|stage iii esophageal cancer
5822651|NCT00025532|stage IV esophageal cancer|stage iv esophageal cancer
5822652|NCT00025532|recurrent esophageal cancer|recurrent esophageal cancer
5822653|NCT00025532|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5822654|NCT00025532|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5822655|NCT00025532|adenocarcinoma of the colon|adenocarcinoma of the colon
5822656|NCT00025532|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5822657|NCT00025532|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5822658|NCT00025532|stage IV pancreatic cancer|stage iv pancreatic cancer
5822659|NCT00002561|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5822660|NCT00002561|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5822661|NCT00002561|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5822662|NCT00002561|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5822663|NCT00002561|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5822664|NCT00002561|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5822665|NCT00073398|Anti-tumor Vaccination|anti-tumor vaccination
5822666|NCT00073398|Alpha (1,3) Galactosyltransferase|alpha (1,3) galactosyltransferase
5822667|NCT00073398|Allogeneic Tumor Cells|allogeneic tumor cells
5822669|NCT00073398|NSCLC|nsclc
5822670|NCT00073398|Lung Cancer|lung cancer
5822671|NCT00073398|Non-Small Cell Lung Cancer|non-small cell lung cancer
5822672|NCT00073294|diabetes|diabetes
5822673|NCT00073281|diabetes|diabetes
5822674|NCT00073281|autoimmunity|autoimmunity
5822682|NCT00073216|HIV Seronegativity|hiv seronegativity
5822683|NCT00073216|HIV Preventive Vaccine|hiv preventive vaccine
5822684|NCT00073190|Patient Education|patient education
5822685|NCT00073190|Physician Education|physician education
5822686|NCT00073125|Advanced histologically documented renal cell carcinoma|advanced histologically documented renal cell carcinoma
5822687|NCT00073047|Ulcerative Colitis|ulcerative colitis
5822688|NCT00073047|Inflammatory Bowel Disease|inflammatory bowel disease
5822689|NCT00073047|Gastrointestinal|gastrointestinal
5822690|NCT00073047|Humanized Monoclonal antibody|humanized monoclonal antibody
5822691|NCT00073034|Neuropathic Pain|neuropathic pain
5822692|NCT00073034|Diabetic Neuropathy|diabetic neuropathy
5822693|NCT00073099|Dry Eye|dry eye
5822694|NCT00073099|Lissamine Green|lissamine green
5822695|NCT00073099|Fluorescein|fluorescein
5822696|NCT00073099|Conjunctiva|conjunctiva
5822697|NCT00073099|Cornea|cornea
5822698|NCT00073099|Digital Photography|digital photography
5822699|NCT00073099|Corneal and Conjunctival Staining|corneal and conjunctival staining
5822700|NCT00073086|Coronavirus|coronavirus
5822701|NCT00073086|Pneumonia|pneumonia
5822702|NCT00073086|Asia|asia
5822703|NCT00073086|China|china
5822704|NCT00073086|Severe Acut Respiratory Syndrome|severe acut respiratory syndrome
5822705|NCT00073086|SARS|sars
5822706|NCT00073086|Suspected SARS|suspected sars
5822707|NCT00073073|Chemoprevention|chemoprevention
5822708|NCT00073073|Mammographic Density|mammographic density
5822709|NCT00073073|Bone Mineral Density|bone mineral density
5822710|NCT00073073|Biomarkers|biomarkers
5822711|NCT00073073|Safety|safety
5822712|NCT00073073|Breast Cancer|breast cancer
5822713|NCT00073073|Postmenopausal|postmenopausal
5822721|NCT00073008|EGFR|egfr
5822722|NCT00073008|ErbB1|erbb1
5822723|NCT00073008|ErbB2|erbb2
5822724|NCT00073008|metastatic|metastatic
5822725|NCT00073008|lapatinib|lapatinib
5822726|NCT00073008|Her-2/neu|her-2/neu
5822727|NCT00073008|protein kinase inhibitor|protein kinase inhibitor
5822728|NCT00073008|BAC|bac
5822729|NCT00073008|GW572016|gw572016
5822730|NCT00073008|Advanced|advanced
5822731|NCT00073008|NSCLC|nsclc
5822732|NCT00072982|Fish oil|fish oil
5822733|NCT00072982|Borage oil|borage oil
5822734|NCT00072943|Crohn's Disease|crohn's disease
5822735|NCT00072943|Colitis|colitis
5822736|NCT00072943|Monoclonal antibody therapy|monoclonal antibody therapy
5822737|NCT00072943|anti-interferon gamma|anti-interferon gamma
5822738|NCT00072917|obesity|obesity
5822739|NCT00072917|thinness|thinness
5822740|NCT00072917|weight gain|weight gain
5822741|NCT00072917|physical activity|physical activity
5822743|NCT00072917|fat oxidation|fat oxidation
5822744|NCT00072917|hunger|hunger
5822745|NCT00072917|feeding behavior|feeding behavior
5822746|NCT00072917|overfeeding|overfeeding
5822747|NCT00072904|Cystic Fibrosis Related Diabetes|cystic fibrosis related diabetes
5822748|NCT00072904|Diabetes without Fasting Hyperglycemia|diabetes without fasting hyperglycemia
5822749|NCT00072891|Diabetes|diabetes
5822750|NCT00072969|Immunosuppression|immunosuppression
5822751|NCT00072969|Myelodysplastic Syndrome|myelodysplastic syndrome
5822752|NCT00072969|MDS|mds
5822753|NCT00072956|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5822755|NCT00072956|Cervical Dystonia|cervical dystonia
5822756|NCT00072956|Surround Inhibition|surround inhibition
5822757|NCT00072956|Sensory Tricks|sensory tricks
5822758|NCT00072787|gastric cancer|gastric cancer
5822759|NCT00072787|phase 2 clinical trial|phase 2 clinical trial
5822760|NCT00072774|Depressive Disorder, Major|depressive disorder, major
5822761|NCT00072774|Melancholia, Involutional|melancholia, involutional
5822762|NCT00072774|Depression, Involutional|depression, involutional
5822763|NCT00072761|silent cerebral infarct|silent cerebral infarct
5822764|NCT00072761|silent stroke|silent stroke
5822765|NCT00072761|sickle cell anemia|sickle cell anemia
5822766|NCT00072761|stroke|stroke
5822767|NCT00072761|transfusion therapy|transfusion therapy
5822768|NCT00072748|Advanced Colorectal Cancer|advanced colorectal cancer
5822769|NCT00072748|Colorectal Carcinoma|colorectal carcinoma
5822770|NCT00072748|Colorectal Tumors|colorectal tumors
5822771|NCT00072748|Neoplasms, Colorectal|neoplasms, colorectal
5822772|NCT00072722|Prostate Cancer|prostate cancer
5822773|NCT00072722|Metastatic Hormone Refractory Prostate Cancer|metastatic hormone refractory prostate cancer
5822774|NCT00072722|CC4047|cc4047
5822775|NCT00072722|CC-4047|cc-4047
5822776|NCT00072722|Prostate Carcinoma|prostate carcinoma
5822778|NCT00017017|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822779|NCT00017017|fallopian tube cancer|fallopian tube cancer
5822780|NCT00017017|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5822781|NCT00014677|recurrent adult brain tumor|recurrent adult brain tumor
5822782|NCT00014677|adult glioblastoma|adult glioblastoma
5822783|NCT00014677|adult giant cell glioblastoma|adult giant cell glioblastoma
5822784|NCT00014677|adult gliosarcoma|adult gliosarcoma
5822785|NCT00014638|stage IV breast cancer|stage iv breast cancer
5822786|NCT00014638|recurrent breast cancer|recurrent breast cancer
5822787|NCT00014352|stage III prostate cancer|stage iii prostate cancer
5822788|NCT00014352|stage IV prostate cancer|stage iv prostate cancer
5822789|NCT00014352|recurrent prostate cancer|recurrent prostate cancer
5822790|NCT00014352|thromboembolism|thromboembolism
5822791|NCT00072826|3-hydroxy-3-methlglutaryl (HMG)|3-hydroxy-3-methlglutaryl (hmg)
5822792|NCT00072826|Inhibitors|inhibitors
5822793|NCT00072826|Endothelial Function|endothelial function
5822794|NCT00072826|Leukocyte Gene Expression|leukocyte gene expression
5822795|NCT00072826|Statins|statins
5822796|NCT00072826|Atorvastatin|atorvastatin
5822797|NCT00072826|Sickle Cell Disease|sickle cell disease
5822798|NCT00072813|Genetics|genetics
5822799|NCT00072813|Seizures|seizures
5822800|NCT00072813|Brain Imaging|brain imaging
5822801|NCT00072813|Diffusion|diffusion
5822802|NCT00072813|Temporal Lobe|temporal lobe
5822803|NCT00072800|Reliability|reliability
5822804|NCT00072800|Muscle Tone Abnormality|muscle tone abnormality
5822805|NCT00072800|Spasticity|spasticity
5822806|NCT00072800|Dystonia|dystonia
5822807|NCT00072800|Rigidity|rigidity
5822808|NCT00072800|Cerebral Palsy|cerebral palsy
5822809|NCT00072800|CP|cp
5822810|NCT00072800|Children|children
5822811|NCT00072709|ALS|als
5822812|NCT00072709|Lou Gehrig's disease|lou gehrig's disease
5822813|NCT00072683|Sodium|sodium
5822814|NCT00072683|SIADH|siadh
5822239|NCT00073840|asthma|asthma
5822815|NCT00072683|Vasopressin|vasopressin
5822816|NCT00072683|CHF|chf
5822817|NCT00072683|Cirrhosis|cirrhosis
5822818|NCT00072683|salt|salt
5822819|NCT00072683|water|water
5822820|NCT00072683|electrolyte|electrolyte
5822821|NCT00072670|Prostate cancer|prostate cancer
5822822|NCT00072670|Advanced prostate cancer|advanced prostate cancer
5822823|NCT00072670|Metastatic prostate cancer|metastatic prostate cancer
5822824|NCT00072670|Trabectedin|trabectedin
5822825|NCT00072670|Yondelis|yondelis
5822826|NCT00072670|ET-743|et-743
5822827|NCT00012090|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822828|NCT00012090|fallopian tube cancer|fallopian tube cancer
5822829|NCT00012090|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5822830|NCT00010309|stage II melanoma|stage ii melanoma
5822831|NCT00010309|stage III melanoma|stage iii melanoma
5822832|NCT00010309|stage IV melanoma|stage iv melanoma
5822833|NCT00008372|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5822834|NCT00008372|recurrent small cell lung cancer|recurrent small cell lung cancer
5822835|NCT00006367|polycythemia vera|polycythemia vera
5822836|NCT00006367|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5822837|NCT00006367|essential thrombocythemia|essential thrombocythemia
5822838|NCT00006224|recurrent cervical cancer|recurrent cervical cancer
5822839|NCT00006224|cervical adenocarcinoma|cervical adenocarcinoma
5822840|NCT00006224|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5822841|NCT00072735|Use Dependent Plasticity|use dependent plasticity
5822842|NCT00072735|Cortical Reorganization|cortical reorganization
5822843|NCT00072735|Rehabilitation|rehabilitation
5822844|NCT00072735|Somatosensory Nerve|somatosensory nerve
5822845|NCT00072735|Amphetamine|amphetamine
5822846|NCT00072735|Stroke|stroke
5822847|NCT00072735|Healthy Volunteer|healthy volunteer
5822849|NCT00072657|Arthritis|arthritis
5822850|NCT00072657|Pain|pain
5822851|NCT00072657|Meditation|meditation
5822853|NCT00072657|Chronic Illness|chronic illness
5822854|NCT00072657|Depression|depression
5822855|NCT00072644|HIV|hiv
5822856|NCT00072644|Osteonecrosis|osteonecrosis
5822857|NCT00072644|Drug Interaction|drug interaction
5822858|NCT00072644|P-Glycoprotein|p-glycoprotein
5822859|NCT00072644|Cytochrome P 450|cytochrome p 450
5822860|NCT00072644|Healthy Volunteer|healthy volunteer
5822861|NCT00072644|HV|hv
5822862|NCT00072631|Tarceva|tarceva
5822863|NCT00072631|erlotinib|erlotinib
5822864|NCT00072631|NSCLC|nsclc
5822865|NCT00072631|Non-Small Cell Lung Cancer|non-small cell lung cancer
5822866|NCT00072631|EGFR|egfr
5822867|NCT00072631|OSI-774|osi-774
5822868|NCT00072501|breast cancer|breast cancer
5822869|NCT00072488|disseminated neuroblastoma|disseminated neuroblastoma
5822870|NCT00072488|localized resectable neuroblastoma|localized resectable neuroblastoma
5822871|NCT00072488|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5822872|NCT00072488|regional neuroblastoma|regional neuroblastoma
5822873|NCT00072488|stage 4S neuroblastoma|stage 4s neuroblastoma
5822874|NCT00072488|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5822875|NCT00072488|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5822876|NCT00072488|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5822877|NCT00072488|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5822878|NCT00072488|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5822879|NCT00072488|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5822880|NCT00072488|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5822881|NCT00072488|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5822882|NCT00072488|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5822883|NCT00072488|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5822884|NCT00072488|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5822885|NCT00072488|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5822886|NCT00072488|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5822887|NCT00072488|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5822888|NCT00072488|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5822889|NCT00072488|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5822890|NCT00072488|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5822891|NCT00072488|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5822892|NCT00072488|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5822893|NCT00072488|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5822894|NCT00072475|refractory anemia with excess blasts|refractory anemia with excess blasts
5822895|NCT00072475|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5822896|NCT00072475|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5822897|NCT00072475|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5822272|NCT00004261|stage I prostate cancer|stage i prostate cancer
5822898|NCT00072475|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5822899|NCT00072475|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5822900|NCT00072475|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5822902|NCT00072475|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5822903|NCT00072462|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5822904|NCT00072462|breast cancer in situ|breast cancer in situ
5822905|NCT00072449|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5822906|NCT00072410|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822907|NCT00072410|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5822908|NCT00072358|disseminated neuroblastoma|disseminated neuroblastoma
5822909|NCT00072358|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5822910|NCT00072358|recurrent neuroblastoma|recurrent neuroblastoma
5822911|NCT00072358|regional neuroblastoma|regional neuroblastoma
5822912|NCT00072358|stage 4S neuroblastoma|stage 4s neuroblastoma
5822913|NCT00072345|stage III melanoma|stage iii melanoma
5822914|NCT00072345|stage IV melanoma|stage iv melanoma
5822915|NCT00072345|recurrent melanoma|recurrent melanoma
5822916|NCT00072345|iris melanoma|iris melanoma
5822917|NCT00072345|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5822918|NCT00072345|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5822919|NCT00072345|extraocular extension melanoma|extraocular extension melanoma
5822920|NCT00072345|recurrent intraocular melanoma|recurrent intraocular melanoma
5822921|NCT00072332|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5822922|NCT00072332|stage IV esophageal cancer|stage iv esophageal cancer
5822923|NCT00072332|stage IV gastric cancer|stage iv gastric cancer
5822924|NCT00072319|stage I breast cancer|stage i breast cancer
5822925|NCT00072319|stage II breast cancer|stage ii breast cancer
5822926|NCT00072319|stage IIIA breast cancer|stage iiia breast cancer
5822928|NCT00072319|stage IIIC breast cancer|stage iiic breast cancer
5822929|NCT00072319|inflammatory breast cancer|inflammatory breast cancer
5822931|NCT00072293|stage IB breast cancer|stage ib breast cancer
5822932|NCT00072293|stage II breast cancer|stage ii breast cancer
5822933|NCT00072293|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5822934|NCT00072293|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5822935|NCT00072293|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5822936|NCT00072293|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5822937|NCT00072280|childhood fibrosarcoma|childhood fibrosarcoma
5822938|NCT00072280|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5822939|NCT00072267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5822940|NCT00072267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5822941|NCT00072267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5822942|NCT00072267|fallopian tube cancer|fallopian tube cancer
5822943|NCT00072267|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5822944|NCT00072215|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5822945|NCT00072215|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5822946|NCT00072215|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5822947|NCT00072215|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5822948|NCT00072215|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5822949|NCT00072215|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5822950|NCT00072215|testicular choriocarcinoma|testicular choriocarcinoma
5822951|NCT00072215|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5822952|NCT00072215|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5822953|NCT00072215|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5822954|NCT00072215|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5822955|NCT00072215|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5822956|NCT00072215|testicular embryonal carcinoma|testicular embryonal carcinoma
5822958|NCT00072215|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5822959|NCT00072215|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5822960|NCT00072215|testicular yolk sac tumor|testicular yolk sac tumor
5822961|NCT00072215|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5822962|NCT00072215|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5822963|NCT00072215|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5822964|NCT00072215|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5822965|NCT00072215|testicular immature teratoma|testicular immature teratoma
5822966|NCT00072215|testicular mature teratoma|testicular mature teratoma
5822967|NCT00072215|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5822968|NCT00072124|stage IV melanoma|stage iv melanoma
5822969|NCT00072124|recurrent melanoma|recurrent melanoma
5822970|NCT00072111|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5822971|NCT00072098|stage IV colon cancer|stage iv colon cancer
5822972|NCT00072098|stage IV rectal cancer|stage iv rectal cancer
5822973|NCT00072098|liver metastases|liver metastases
5822974|NCT00072098|recurrent rectal cancer|recurrent rectal cancer
5822975|NCT00072098|recurrent colon cancer|recurrent colon cancer
5822976|NCT00072085|stage IV melanoma|stage iv melanoma
5822977|NCT00072085|recurrent melanoma|recurrent melanoma
5822978|NCT00072072|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822979|NCT00072072|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822980|NCT00072072|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822981|NCT00072059|anemia|anemia
5822982|NCT00072059|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5822983|NCT00072059|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5822984|NCT00072059|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5822985|NCT00072046|stage IV renal cell cancer|stage iv renal cell cancer
5822986|NCT00072046|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5822987|NCT00072046|recurrent renal cell cancer|recurrent renal cell cancer
5822988|NCT00072033|stage II esophageal cancer|stage ii esophageal cancer
5822989|NCT00072033|stage III esophageal cancer|stage iii esophageal cancer
5822990|NCT00072033|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5822991|NCT00072033|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5822992|NCT00072020|bone metastases|bone metastases
5822993|NCT00072020|stage II breast cancer|stage ii breast cancer
5822994|NCT00072020|stage IIIA breast cancer|stage iiia breast cancer
5822995|NCT00072020|stage IIIB breast cancer|stage iiib breast cancer
5822996|NCT00072020|stage IIIC breast cancer|stage iiic breast cancer
5822997|NCT00072007|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5822999|NCT00072007|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5823000|NCT00072007|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5823001|NCT00072007|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5823002|NCT00072007|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5823003|NCT00071981|stage IV melanoma|stage iv melanoma
5823004|NCT00071981|recurrent melanoma|recurrent melanoma
5823005|NCT00071968|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5823006|NCT00071968|stage IIB prostate cancer|stage iib prostate cancer
5823007|NCT00071968|stage IIA prostate cancer|stage iia prostate cancer
5823008|NCT00071968|stage I prostate cancer|stage i prostate cancer
5823009|NCT00071955|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5823112|NCT00071877|Neuropathy|neuropathy
5823010|NCT00071955|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5823011|NCT00071955|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5823012|NCT00071955|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5823013|NCT00071955|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5823014|NCT00071955|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5823015|NCT00071955|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5823016|NCT00071955|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5823017|NCT00071955|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5823018|NCT00071929|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5823019|NCT00003141|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5823020|NCT00003141|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5823021|NCT00003141|disseminated neuroblastoma|disseminated neuroblastoma
5823022|NCT00003141|stage 4S neuroblastoma|stage 4s neuroblastoma
5823023|NCT00003141|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5823024|NCT00003141|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5823025|NCT00003141|childhood choroid plexus tumor|childhood choroid plexus tumor
5823026|NCT00003141|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5823027|NCT00003141|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5823028|NCT00003141|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5823029|NCT00003141|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5823030|NCT00003141|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5823031|NCT00003141|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5823032|NCT00003141|localized resectable neuroblastoma|localized resectable neuroblastoma
5823033|NCT00003141|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5823034|NCT00003141|regional neuroblastoma|regional neuroblastoma
5823035|NCT00003141|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5823036|NCT00003141|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5823037|NCT00003141|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5823038|NCT00003141|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5823039|NCT00003141|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5823040|NCT00003141|childhood central nervous system germinoma|childhood central nervous system germinoma
5822679|NCT00073229|AIDS|aids
5823041|NCT00003141|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5823042|NCT00003141|childhood central nervous system teratoma|childhood central nervous system teratoma
5823043|NCT00003141|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5823044|NCT00072605|Healthy|healthy
5823045|NCT00072605|T Cells|t cells
5823046|NCT00072605|Immunity|immunity
5823047|NCT00072605|Hemorrhagic Fever|hemorrhagic fever
5823048|NCT00072605|Healthy Volunteer|healthy volunteer
5823050|NCT00072592|ANCA|anca
5823051|NCT00072592|B Lymphocyte|b lymphocyte
5823052|NCT00072592|Vasculitis|vasculitis
5823053|NCT00072592|Treatment|treatment
5823054|NCT00072592|Remission|remission
5823055|NCT00072592|Wegener Granulomatosis|wegener granulomatosis
5823056|NCT00072592|WG|wg
5823057|NCT00072579|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5823058|NCT00072579|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5823059|NCT00072553|stage IV rectal cancer|stage iv rectal cancer
5823060|NCT00072553|stage IV colon cancer|stage iv colon cancer
5823061|NCT00072553|adenocarcinoma of the colon|adenocarcinoma of the colon
5823064|NCT00072553|recurrent colon cancer|recurrent colon cancer
5823065|NCT00072527|limited stage small cell lung cancer|limited stage small cell lung cancer
5823066|NCT00071916|Hepatitis C, African Americans, ribavirin|hepatitis c, african americans, ribavirin
5823067|NCT00071851|HIV Seronegativity|hiv seronegativity
5823068|NCT00071851|HIV Preventive Vaccine|hiv preventive vaccine
5823069|NCT00071812|RA|ra
5823070|NCT00006008|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5823071|NCT00006008|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5823072|NCT00006008|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5823073|NCT00006008|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5823074|NCT00005964|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5823075|NCT00005964|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5823076|NCT00005964|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5823077|NCT00005964|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5823078|NCT00005964|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5823079|NCT00005964|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5823080|NCT00005964|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5823081|NCT00005964|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5823082|NCT00005964|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5823083|NCT00005964|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5823084|NCT00005964|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5823085|NCT00005964|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5823086|NCT00005962|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5823087|NCT00005962|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5823088|NCT00005962|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5823089|NCT00005962|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5823090|NCT00005962|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5823091|NCT00005962|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5823092|NCT00005962|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5823093|NCT00005962|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5823094|NCT00005962|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5823095|NCT00005962|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5823096|NCT00071903|Thrombophilia|thrombophilia
5823097|NCT00071903|Idiopathic Intracranial Hypertension|idiopathic intracranial hypertension
5823098|NCT00071903|Kidney Involvement|kidney involvement
5823099|NCT00071903|Lysosomal Storage Disorder|lysosomal storage disorder
5823101|NCT00071903|Pseudotumor Cerebri|pseudotumor cerebri
5823102|NCT00071903|Susceptibility to Thrombosis|susceptibility to thrombosis
5823103|NCT00071903|Nephropathic Cystinosis|nephropathic cystinosis
5823104|NCT00071903|PTC|ptc
5823105|NCT00071903|Intracranial Hypertension|intracranial hypertension
5823106|NCT00071890|Interleukin 2|interleukin 2
5823107|NCT00071890|Treatment Interruption|treatment interruption
5823108|NCT00071890|HIV|hiv
5823109|NCT00071877|Lysosomal Disease|lysosomal disease
5823110|NCT00071877|Hypohidrosis|hypohidrosis
5823111|NCT00071877|Pain|pain
5823113|NCT00071877|X-Linked|x-linked
5823114|NCT00071877|Fabry Disease|fabry disease
5823115|NCT00071877|Children|children
5823116|NCT00005072|stage I prostate cancer|stage i prostate cancer
5823117|NCT00005072|stage IIB prostate cancer|stage iib prostate cancer
5823118|NCT00005072|stage IIA prostate cancer|stage iia prostate cancer
5823119|NCT00005072|recurrent prostate cancer|recurrent prostate cancer
5823120|NCT00005046|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5823121|NCT00005046|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5823122|NCT00004206|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5823123|NCT00004093|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5823124|NCT00004093|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5823125|NCT00071838|Neuroimmunology|neuroimmunology
5823126|NCT00071838|Therapy|therapy
5823127|NCT00071838|Demyelinating Disease|demyelinating disease
5823128|NCT00071838|Immunological Mechanism|immunological mechanism
5823129|NCT00071838|MRI|mri
5823130|NCT00071838|Multiple Sclerosis|multiple sclerosis
5823131|NCT00071838|MS|ms
5823132|NCT00071773|diabetic macular edema|diabetic macular edema
5823133|NCT00071773|laser photocoagulation|laser photocoagulation
5823134|NCT00071773|etdrs|etdrs
5823135|NCT00071773|macular grid photocoagulation|macular grid photocoagulation
5823136|NCT00071773|DME|dme
5823422|NCT00071123|Habituation|habituation
5823150|NCT00071760|fosamprenavir|fosamprenavir
5823151|NCT00071747|schizophrenia|schizophrenia
5823152|NCT00071747|lamotrigine|lamotrigine
5823153|NCT00071721|Alzheimer disease|alzheimer disease
5823154|NCT00071721|Agitation|agitation
5823155|NCT00071721|Psychosis|psychosis
5823156|NCT00071682|herbal medicine|herbal medicine
5823157|NCT00071682|alternative medicines|alternative medicines
5823158|NCT00071682|anticoagulation|anticoagulation
5823159|NCT00071682|side effects|side effects
5823160|NCT00071682|bleeding|bleeding
5823161|NCT00071682|clotting|clotting
5823162|NCT00071669|Mood Disorder|mood disorder
5823163|NCT00071669|Acupuncture|acupuncture
5823164|NCT00071643|Stroke|stroke
5823165|NCT00071630|Adolescent|adolescent
5823166|NCT00071617|Suicide|suicide
5823167|NCT00071617|Adolescence|adolescence
5823168|NCT00071578|Psychotherapy|psychotherapy
5823169|NCT00071578|Treatment|treatment
5823171|NCT00071734|Auditory Feedback|auditory feedback
5823172|NCT00071734|Motor Control|motor control
5823173|NCT00071734|Adult|adult
5823174|NCT00071734|BOLD|bold
5823175|NCT00071734|Healthy Volunteer|healthy volunteer
5823177|NCT00071565|familial intracranial aneurysm|familial intracranial aneurysm
5823178|NCT00071565|intracranial aneurysm|intracranial aneurysm
5823179|NCT00071565|brain aneurysm|brain aneurysm
5823180|NCT00071565|aneurysm|aneurysm
5823181|NCT00071565|subarachnoid hemorrhage|subarachnoid hemorrhage
5823182|NCT00071565|stroke|stroke
5823183|NCT00071552|Poorly Controlled Asthma|poorly controlled asthma
5823184|NCT00071539|gross total resection|gross total resection
5823185|NCT00004050|stage IIB prostate cancer|stage iib prostate cancer
5823186|NCT00004050|stage IIA prostate cancer|stage iia prostate cancer
5823187|NCT00004050|stage III prostate cancer|stage iii prostate cancer
5823188|NCT00004025|stage III melanoma|stage iii melanoma
5823189|NCT00004025|stage IV melanoma|stage iv melanoma
5823190|NCT00004025|recurrent melanoma|recurrent melanoma
5823191|NCT00003794|stage I ovarian germ cell tumor|stage i ovarian germ cell tumor
5823192|NCT00003794|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5823193|NCT00003794|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5823194|NCT00003794|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5823195|NCT00003794|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5823196|NCT00003648|stage I colon cancer|stage i colon cancer
5823197|NCT00003648|stage II colon cancer|stage ii colon cancer
5823198|NCT00003648|stage III colon cancer|stage iii colon cancer
5823199|NCT00003648|stage IV colon cancer|stage iv colon cancer
5823200|NCT00003648|stage I rectal cancer|stage i rectal cancer
5823201|NCT00003648|stage II rectal cancer|stage ii rectal cancer
5823202|NCT00003648|stage III rectal cancer|stage iii rectal cancer
5823203|NCT00003648|stage IV rectal cancer|stage iv rectal cancer
5823204|NCT00003648|recurrent colon cancer|recurrent colon cancer
5823205|NCT00003648|recurrent rectal cancer|recurrent rectal cancer
5823211|NCT00071513|Adolescent|adolescent
5823212|NCT00071513|Substance Abuse|substance abuse
5823214|NCT00071500|Compliance|compliance
5823215|NCT00071500|Adherence|adherence
5823216|NCT00071500|Computerized|computerized
5823217|NCT00071500|Electronic Pillbox|electronic pillbox
5823218|NCT00071500|Treatment Experienced|treatment experienced
5823219|NCT00071487|SLE|sle
5823220|NCT00003595|childhood Burkitt lymphoma|childhood burkitt lymphoma
5823221|NCT00003595|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5823222|NCT00003595|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5823223|NCT00003595|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5823224|NCT00003595|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5823225|NCT00003266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823226|NCT00003266|fatigue|fatigue
5823227|NCT00003234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5823228|NCT00003234|recurrent neuroblastoma|recurrent neuroblastoma
5823229|NCT00003234|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5823230|NCT00003234|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5823231|NCT00003234|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5823232|NCT00003234|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5823354|NCT00071097|TMC114|tmc114
5823423|NCT00071123|Extinction|extinction
5823233|NCT00003234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5823234|NCT00003234|recurrent childhood ependymoma|recurrent childhood ependymoma
5823235|NCT00003126|renal cell cancer|renal cell cancer
5823236|NCT00003126|renal cell carcinoma|renal cell carcinoma
5823237|NCT00003126|interleukin-2|interleukin-2
5823238|NCT00071474|temporomandibular disroders|temporomandibular disroders
5823239|NCT00071474|shamanism|shamanism
5823240|NCT00071474|chronic pain|chronic pain
5823241|NCT00071461|Idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5823242|NCT00071461|Interstitial lung disease|interstitial lung disease
5823243|NCT00071461|Bosentan|bosentan
5823244|NCT00071461|BUILD|build
5823246|NCT00071435|Voluntary Movement|voluntary movement
5823247|NCT00071435|Motor Cortex|motor cortex
5823248|NCT00071435|Reaction Time|reaction time
5823249|NCT00071435|Corticospinal|corticospinal
5823250|NCT00071435|Primary Lateral Sclerosis|primary lateral sclerosis
5823251|NCT00071435|PLS|pls
5823252|NCT00071435|Healthy Volunteer|healthy volunteer
5823253|NCT00071435|HV|hv
5823254|NCT00071422|Type 2 diabetes|type 2 diabetes
5823255|NCT00071409|Type 1 diabetes|type 1 diabetes
5823256|NCT00071396|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5823257|NCT00071396|CD-52 and CD-20 Positive|cd-52 and cd-20 positive
5823258|NCT00071396|Refractory|refractory
5823259|NCT00071396|Relapsed|relapsed
5823260|NCT00033527|non-small cell lung cancer|non-small cell lung cancer
5823261|NCT00033527|small cell lung cancer|small cell lung cancer
5823262|NCT00025350|stage IV colon cancer|stage iv colon cancer
5823264|NCT00025350|recurrent colon cancer|recurrent colon cancer
5823265|NCT00025350|recurrent rectal cancer|recurrent rectal cancer
5823266|NCT00025350|adenocarcinoma of the colon|adenocarcinoma of the colon
5823267|NCT00025350|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823268|NCT00002935|stage 0 esophageal cancer|stage 0 esophageal cancer
5823269|NCT00002723|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5823270|NCT00002723|stage III prostate cancer|stage iii prostate cancer
5823271|NCT00002723|stage IV prostate cancer|stage iv prostate cancer
5823272|NCT00002723|recurrent prostate cancer|recurrent prostate cancer
5823273|NCT00071331|chronic heart failure|chronic heart failure
5823274|NCT00071331|heart failure|heart failure
5823275|NCT00071292|rheumatoid arthritis|rheumatoid arthritis
5823276|NCT00071292|stress reduction|stress reduction
5823278|NCT00071292|mindfulness|mindfulness
5823279|NCT00071292|MBSR|mbsr
5823280|NCT00071292|mindfulness-based stress reduction|mindfulness-based stress reduction
5823281|NCT00071292|mind-body skills|mind-body skills
5823282|NCT00030420|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5823283|NCT00030420|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5823284|NCT00030420|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5823285|NCT00030420|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5823286|NCT00026260|recurrent cervical cancer|recurrent cervical cancer
5823287|NCT00026260|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5823288|NCT00024128|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5823289|NCT00024128|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5823290|NCT00023738|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5823291|NCT00023738|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5823292|NCT00023738|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5823293|NCT00071370|Magnetoencephalography|magnetoencephalography
5823294|NCT00071370|Electroencephalogram (EEG)|electroencephalogram (eeg)
5823295|NCT00071370|Interictal Epileptiform Discharges|interictal epileptiform discharges
5823297|NCT00071370|Sleep Deprivation|sleep deprivation
5823299|NCT00071305|Magnetoencephalography|magnetoencephalography
5823300|NCT00071305|Electroencephalography|electroencephalography
5823301|NCT00071305|Epilepsy|epilepsy
5823302|NCT00071305|Dipole Modeling|dipole modeling
5823303|NCT00071305|Surgery|surgery
5823304|NCT00071266|Intermittent Claudication|intermittent claudication
5823305|NCT00071266|Peripheral Arterial Disease|peripheral arterial disease
5823306|NCT00071266|Atherosclerosis|atherosclerosis
5823307|NCT00071266|Niacin|niacin
5823308|NCT00071266|Lovastatin|lovastatin
5823309|NCT00071266|PAD|pad
5823310|NCT00071266|IC|ic
5823311|NCT00071253|Bipolar Disorder - Mania|bipolar disorder - mania
5823312|NCT00071240|Growth Hormone|growth hormone
5823313|NCT00071240|HIV|hiv
5823314|NCT00071240|AIDS|aids
5823315|NCT00071240|Thymus|thymus
5823316|NCT00071240|CD4 Cell|cd4 cell
5823317|NCT00071240|Immune System|immune system
5823318|NCT00071240|Treatment Experienced|treatment experienced
5823319|NCT00071214|Staphylococcal infection|staphylococcal infection
5823320|NCT00071214|Gram positive bacteria|gram positive bacteria
5823321|NCT00071214|Staphylococcus|staphylococcus
5823322|NCT00071214|Staphylococcus aureus|staphylococcus aureus
5823323|NCT00071214|Staphylococcus aureus infection|staphylococcus aureus infection
5823424|NCT00071123|Amygdala|amygdala
5823324|NCT00064428|ST-segment elevation myocardial infarction|st-segment elevation myocardial infarction
5823421|NCT00071123|fMRI|fmri
5823325|NCT00064428|fondaparinux|fondaparinux
5823326|NCT00064428|Acute Myocardial Infarction|acute myocardial infarction
5823327|NCT00064428|acute coronary syndrome|acute coronary syndrome
5823328|NCT00071227|Age Related Macular Degeneration|age related macular degeneration
5823329|NCT00071227|Macular Edema|macular edema
5823330|NCT00071227|Inflammation|inflammation
5823331|NCT00071227|Choroidal Neovascularization|choroidal neovascularization
5823332|NCT00071227|CRVO|crvo
5823333|NCT00071227|Diabetic Retinopathy|diabetic retinopathy
5823334|NCT00071227|Age Related Macular Edema|age related macular edema
5823335|NCT00071227|AMD|amd
5823336|NCT00071188|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5823337|NCT00071175|Lupus|lupus
5823338|NCT00071175|Genetics|genetics
5823339|NCT00071162|Pain|pain
5823340|NCT00071162|Fatigue|fatigue
5823341|NCT00071162|Sleep|sleep
5823342|NCT00071162|Depression|depression
5823343|NCT00071162|Irritable Bowel Syndrome|irritable bowel syndrome
5823344|NCT00071162|Chronic Fatigue Syndrome|chronic fatigue syndrome
5823345|NCT00071149|Rheumatoid Arthritis|rheumatoid arthritis
5823346|NCT00071149|TCM|tcm
5823347|NCT00071149|Diagnosis|diagnosis
5823348|NCT00071149|Traditional Chinese Medicine|traditional chinese medicine
5823349|NCT00071149|Complementary Therapies|complementary therapies
5823350|NCT00071110|Acupuncture|acupuncture
5823351|NCT00071110|Electroacupuncture|electroacupuncture
5823352|NCT00071110|Alternative therapy|alternative therapy
5823353|NCT00071097|HIV|hiv
5823355|NCT00071097|Ritonavir|ritonavir
5823357|NCT00071097|Safety and efficacy|safety and efficacy
5823359|NCT00071084|Skin cancer|skin cancer
5823360|NCT00071084|Lymphoma|lymphoma
5823361|NCT00071084|Mycosis fungoides|mycosis fungoides
5823362|NCT00071084|Sezary syndrome|sezary syndrome
5823363|NCT00071071|Skin cancer|skin cancer
5823364|NCT00071071|Lymphoma|lymphoma
5823365|NCT00071071|Mycosis fungoides|mycosis fungoides
5823366|NCT00071071|Sezary syndrome|sezary syndrome
5823367|NCT00023725|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5823368|NCT00023699|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5823369|NCT00023699|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5823370|NCT00022282|refractory multiple myeloma|refractory multiple myeloma
5823371|NCT00016250|stage IV colon cancer|stage iv colon cancer
5823372|NCT00016250|stage IV rectal cancer|stage iv rectal cancer
5823373|NCT00016250|recurrent colon cancer|recurrent colon cancer
5823374|NCT00016250|recurrent rectal cancer|recurrent rectal cancer
5823375|NCT00016250|adenocarcinoma of the colon|adenocarcinoma of the colon
5823376|NCT00016250|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823377|NCT00015886|stage IV breast cancer|stage iv breast cancer
5823378|NCT00015886|recurrent breast cancer|recurrent breast cancer
5823379|NCT00015886|stage IIIB breast cancer|stage iiib breast cancer
5823380|NCT00014144|recurrent bladder cancer|recurrent bladder cancer
5823381|NCT00014144|stage IV bladder cancer|stage iv bladder cancer
5823382|NCT00014144|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5823383|NCT00014144|recurrent urethral cancer|recurrent urethral cancer
5823384|NCT00014144|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5823385|NCT00014144|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5823386|NCT00014144|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5823387|NCT00014144|anterior urethral cancer|anterior urethral cancer
5823388|NCT00014144|posterior urethral cancer|posterior urethral cancer
5823389|NCT00007917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823392|NCT00071383|Microdissection|microdissection
5823394|NCT00071383|Microarrays|microarrays
5823395|NCT00071383|Metastatic Brain Tumor|metastatic brain tumor
5823396|NCT00071383|Breast Cancer|breast cancer
5823398|NCT00071383|Carcinoma|carcinoma
5823399|NCT00071383|Genomics|genomics
5823400|NCT00071383|Metastatic Breast Cancer|metastatic breast cancer
5823401|NCT00071383|Metastatic Breast Tumor|metastatic breast tumor
5823402|NCT00071357|Microarray|microarray
5823403|NCT00071357|Herceptin|herceptin
5823404|NCT00071357|Trastuzumab|trastuzumab
5823405|NCT00071357|Carcinoma|carcinoma
5823406|NCT00071357|Proteomics|proteomics
5823407|NCT00071357|Breast Cancer|breast cancer
5823408|NCT00071357|Metastatic Breast Cancer|metastatic breast cancer
5823409|NCT00071357|Metastatic Breast Tumor|metastatic breast tumor
5823410|NCT00071344|Microarray|microarray
5823411|NCT00071344|Genomics|genomics
5823412|NCT00071344|Trastuzumab|trastuzumab
5823413|NCT00071344|Carcinoma|carcinoma
5823414|NCT00071344|Non-Small Cell Lung Cancer|non-small cell lung cancer
5823415|NCT00071344|Metastatic Brain Tumor|metastatic brain tumor
5823417|NCT00071344|Microarrays|microarrays
5823418|NCT00071344|Microdissection|microdissection
5823426|NCT00071123|Major Depressive Disorder|major depressive disorder
5823427|NCT00071123|Medial Prefrontal Cortex|medial prefrontal cortex
5823428|NCT00071123|Backward Masking|backward masking
5823429|NCT00071123|Depression|depression
5823430|NCT00071123|MDD|mdd
5823431|NCT00071123|Healthy Volunteer|healthy volunteer
5823432|NCT00071123|HV|hv
5823433|NCT00071032|Blood Disease|blood disease
5823434|NCT00071032|blood transfusion|blood transfusion
5823435|NCT00070993|ALS|als
5823436|NCT00070993|Creatine|creatine
5823437|NCT00070980|Complementary Therapies|complementary therapies
5823438|NCT00070967|Acupuncture|acupuncture
5823439|NCT00070967|Quality of Life|quality of life
5823440|NCT00070967|Complementary Therapies|complementary therapies
5823441|NCT00070967|TCM|tcm
5823442|NCT00070967|Traditional Chinese Medicine|traditional chinese medicine
5823443|NCT00070954|ECT|ect
5823444|NCT00070954|Memory|memory
5823445|NCT00070954|Ginkgo biloba|ginkgo biloba
5823446|NCT00070941|Parkinsons Disease|parkinsons disease
5823447|NCT00070941|Depression|depression
5823448|NCT00070941|SAM-e|sam-e
5823449|NCT00070928|Sleep|sleep
5823450|NCT00070902|Spinal Manipulation|spinal manipulation
5823451|NCT00070902|Chiropractic|chiropractic
5823452|NCT00070902|Zygapophysial Joints|zygapophysial joints
5823453|NCT00070889|Complementary Therapies|complementary therapies
5823454|NCT00070850|Screening|screening
5823455|NCT00070850|Prenatal|prenatal
5823456|NCT00070850|Amniocentesis|amniocentesis
5823457|NCT00070824|Acupuncture|acupuncture
5823458|NCT00070824|SPECT|spect
5823459|NCT00070824|f-MRI|f-mri
5823460|NCT00070824|Functional brain imaging|functional brain imaging
5823461|NCT00070824|RCT|rct
5823462|NCT00070811|Facial form|facial form
5823463|NCT00070811|Facial animation|facial animation
5823464|NCT00070811|Lip muscle reconstruction|lip muscle reconstruction
5823465|NCT00070811|Lip form|lip form
5823466|NCT00070811|Lip function|lip function
5823468|NCT00070720|Change in practitioner behavior|change in practitioner behavior
5823469|NCT00070720|Episiotomy|episiotomy
5823470|NCT00070720|Active management of third stage of labor|active management of third stage of labor
5823471|NCT00070720|Global Network|global network
5823472|NCT00070720|Latin America|latin america
5823473|NCT00070720|Uruguay|uruguay
5823474|NCT00070720|Argentina|argentina
5823475|NCT00070720|Maternal and child health|maternal and child health
5823476|NCT00070720|International|international
5823477|NCT00070720|Women's health|women's health
5823478|NCT00071058|P-glycoprotein Inhibition|p-glycoprotein inhibition
5823479|NCT00071058|Drug Resistance Reversal|drug resistance reversal
5823480|NCT00071058|Pharmacodynamics|pharmacodynamics
5823481|NCT00071058|Molecular Target|molecular target
5823482|NCT00071058|Endocrine Cancer|endocrine cancer
5823483|NCT00071058|Adrenocortical Cancer|adrenocortical cancer
5823485|NCT00071058|Adrenocortical Tumor|adrenocortical tumor
5823486|NCT00071045|Tissue Procurement|tissue procurement
5823487|NCT00071045|Sample Collection|sample collection
5823488|NCT00071045|Laboratory Research Specimens|laboratory research specimens
5823489|NCT00070746|Perinatal mortality [PNM]|perinatal mortality [pnm]
5823490|NCT00070746|Neonatal mortality|neonatal mortality
5823491|NCT00070746|Low birth weight [LBW]|low birth weight [lbw]
5823492|NCT00070746|Spontaneous preterm delivery [SPTD]|spontaneous preterm delivery [sptd]
5823493|NCT00070746|Premature rupture of membranes [PROM]|premature rupture of membranes [prom]
5823494|NCT00070746|Histological chorioamnionitis|histological chorioamnionitis
5823495|NCT00070746|Global Network|global network
5823496|NCT00070746|Pakistan|pakistan
5823497|NCT00070746|Maternal and child health|maternal and child health
5823498|NCT00070746|International|international
5823499|NCT00070746|Women's health|women's health
5823500|NCT00070733|Testosterone|testosterone
5823501|NCT00070733|5-alpha Reductase|5-alpha reductase
5823502|NCT00070733|Muscle Strength|muscle strength
5823503|NCT00070733|Libido|libido
5823504|NCT00070733|Sexual Function|sexual function
5823505|NCT00070733|Muscle Mass|muscle mass
5823506|NCT00070733|Testosterone 5-alpha-Reductase|testosterone 5-alpha-reductase
5823507|NCT00070707|Seasonal Allergic Rhinitis|seasonal allergic rhinitis
5823508|NCT00070707|Asthma|asthma
5823509|NCT00070876|Child|child
5823510|NCT00070876|Adolescent|adolescent
5823511|NCT00069433|Psychotic Disorders|psychotic disorders
5823512|NCT00017368|regional neuroblastoma|regional neuroblastoma
5823513|NCT00017368|disseminated neuroblastoma|disseminated neuroblastoma
5823514|NCT00017368|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5823515|NCT00017368|stage 4S neuroblastoma|stage 4s neuroblastoma
5823516|NCT00003907|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5823517|NCT00003907|advanced adult primary liver cancer|advanced adult primary liver cancer
5823518|NCT00003907|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5823519|NCT00003907|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5823520|NCT00003907|liver metastases|liver metastases
5823521|NCT00070785|Nasopharyngeal Cancer|nasopharyngeal cancer
5823522|NCT00070785|EBV Virus|ebv virus
5823523|NCT00070785|Epitope Mapping|epitope mapping
5823524|NCT00070785|Epstein-Barr Virus|epstein-barr virus
5823525|NCT00070785|Latent Protein-2|latent protein-2
5823526|NCT00070785|Healthy Volunteer|healthy volunteer
5823527|NCT00070785|HV|hv
5823528|NCT00070759|Daclizumab|daclizumab
5823529|NCT00070759|Uveitis|uveitis
5823530|NCT00070759|Active|active
5823531|NCT00070759|Acute|acute
5823532|NCT00070642|Immunotherapy, skin cancer|immunotherapy, skin cancer
5830738|NCT00056901|PPD|ppd
5823533|NCT00070629|Immunotherapy|immunotherapy
5823534|NCT00070629|lung cancer|lung cancer
5823535|NCT00070616|mucositis|mucositis
5823536|NCT00070616|chemotherapy|chemotherapy
5823537|NCT00070616|radiation therapy|radiation therapy
5823538|NCT00070590|Scleroderma|scleroderma
5823539|NCT00070590|Fibrosing alveolitis|fibrosing alveolitis
5823540|NCT00070590|Build|build
5823541|NCT00070590|bosentan|bosentan
5823542|NCT00007839|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5823543|NCT00007839|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5823544|NCT00007839|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5823545|NCT00007839|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5823546|NCT00007839|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5823547|NCT00007839|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5823548|NCT00007839|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5823549|NCT00007839|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5823550|NCT00007839|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5823551|NCT00007839|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5862679|NCT00001547|Magnetic Resonance Imaging|magnetic resonance imaging
5823552|NCT00007839|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5823553|NCT00007839|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5823554|NCT00007839|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5823555|NCT00007839|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5823556|NCT00007839|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5823557|NCT00007839|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5823558|NCT00007839|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5823559|NCT00007839|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5823560|NCT00007839|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5823561|NCT00007839|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5823562|NCT00007839|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5823563|NCT00007839|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5823564|NCT00007839|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5823565|NCT00007839|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5823566|NCT00007839|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5823567|NCT00007839|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5823568|NCT00007839|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5823569|NCT00007839|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5823570|NCT00007839|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5823571|NCT00007839|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5823572|NCT00007839|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5823573|NCT00007839|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5823574|NCT00007839|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5823575|NCT00006482|recurrent cervical cancer|recurrent cervical cancer
5823576|NCT00006482|stage IVB cervical cancer|stage ivb cervical cancer
5823577|NCT00006482|stage IVA cervical cancer|stage iva cervical cancer
5823578|NCT00006482|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5823579|NCT00006466|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5823580|NCT00006466|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5823581|NCT00006466|extramedullary plasmacytoma|extramedullary plasmacytoma
5823582|NCT00006466|refractory multiple myeloma|refractory multiple myeloma
5823583|NCT00006466|stage I multiple myeloma|stage i multiple myeloma
5823584|NCT00006466|stage II multiple myeloma|stage ii multiple myeloma
5823585|NCT00006466|stage III multiple myeloma|stage iii multiple myeloma
5823586|NCT00006257|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823588|NCT00006121|stage IV breast cancer|stage iv breast cancer
5823589|NCT00006121|recurrent breast cancer|recurrent breast cancer
5823590|NCT00006012|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5823592|NCT00006012|limited stage small cell lung cancer|limited stage small cell lung cancer
5823593|NCT00006009|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5823594|NCT00006009|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5823595|NCT00006009|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5823922|NCT00069992|polycythemia vera|polycythemia vera
5823596|NCT00006009|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5823597|NCT00006009|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5823598|NCT00006009|small intestine lymphoma|small intestine lymphoma
5830825|NCT00056719|AS|as
5822957|NCT00072215|testicular seminoma|testicular seminoma
5823599|NCT00006009|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5823600|NCT00006009|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5823601|NCT00006009|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5823602|NCT00006009|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5823603|NCT00006009|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5823604|NCT00006009|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5823605|NCT00006009|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5823606|NCT00006009|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5823607|NCT00006009|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5823608|NCT00006009|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5823609|NCT00005998|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5823610|NCT00005998|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5823611|NCT00005998|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5823612|NCT00005998|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5823613|NCT00005998|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5823614|NCT00005998|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5823615|NCT00005998|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5862680|NCT00001547|Spectroscopy|spectroscopy
5823616|NCT00005998|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5823617|NCT00005998|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5823618|NCT00005998|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5823619|NCT00005998|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5823620|NCT00005998|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5823621|NCT00005998|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5823622|NCT00005998|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5823623|NCT00005998|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5823624|NCT00005998|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5823625|NCT00005800|stage IIIA breast cancer|stage iiia breast cancer
5823626|NCT00005800|stage IIIB breast cancer|stage iiib breast cancer
5823627|NCT00005800|inflammatory breast cancer|inflammatory breast cancer
5823628|NCT00005794|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823629|NCT00070694|Affective Disorders|affective disorders
5823631|NCT00070694|Augmentation|augmentation
5823632|NCT00070694|Polysomogram|polysomogram
5823633|NCT00070694|Combination Therapy|combination therapy
5823634|NCT00070694|Affective Disorder|affective disorder
5823635|NCT00070694|Depression|depression
5823636|NCT00070694|Major Depression|major depression
5823637|NCT00070564|stage II breast cancer|stage ii breast cancer
5823638|NCT00070564|stage IA breast cancer|stage ia breast cancer
5823639|NCT00070564|stage IB breast cancer|stage ib breast cancer
5823640|NCT00070564|stage IIIC breast cancer|stage iiic breast cancer
5823641|NCT00070564|male breast cancer|male breast cancer
5823642|NCT00070564|HER2-positive breast cancer|her2-positive breast cancer
5823643|NCT00070564|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5823644|NCT00070564|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5823645|NCT00070564|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5823646|NCT00070564|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5823647|NCT00070538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5823711|NCT00070382|stage I multiple myeloma|stage i multiple myeloma
5823648|NCT00070538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5823649|NCT00070538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5823650|NCT00070538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5823651|NCT00070538|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5823652|NCT00070538|refractory anemia with excess blasts|refractory anemia with excess blasts
5823653|NCT00070538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5823654|NCT00070538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5823655|NCT00070538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5823656|NCT00070538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5823657|NCT00070538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5823658|NCT00070538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5823659|NCT00070538|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5823660|NCT00070538|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5823661|NCT00070538|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5823662|NCT00070538|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5823923|NCT00069992|essential thrombocythemia|essential thrombocythemia
5823663|NCT00070538|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5823664|NCT00070486|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5823665|NCT00070486|adenocarcinoma of the lung|adenocarcinoma of the lung
5823666|NCT00070486|squamous cell lung cancer|squamous cell lung cancer
5823667|NCT00070486|large cell lung cancer|large cell lung cancer
5823668|NCT00070486|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5823669|NCT00070473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5823670|NCT00070447|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5823671|NCT00070447|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5823672|NCT00070447|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5823673|NCT00070447|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5823674|NCT00070434|stage II rectal cancer|stage ii rectal cancer
5823675|NCT00070434|stage III rectal cancer|stage iii rectal cancer
5823676|NCT00070434|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823677|NCT00070421|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5823678|NCT00070421|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5823679|NCT00070421|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5823680|NCT00070421|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5823681|NCT00070421|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5823682|NCT00070421|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5824081|NCT00069693|HV|hv
5823683|NCT00070421|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5823684|NCT00070421|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5823685|NCT00070421|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5823686|NCT00070421|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5823687|NCT00070421|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5823688|NCT00070421|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5823689|NCT00070421|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5823690|NCT00070421|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5823691|NCT00070421|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5823692|NCT00070421|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5823693|NCT00070421|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5823694|NCT00070421|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5823695|NCT00070421|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5823696|NCT00070421|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5823697|NCT00070421|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5823699|NCT00070421|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5823700|NCT00070421|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5823701|NCT00070421|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5823702|NCT00070421|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5823704|NCT00070382|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823705|NCT00070382|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5823706|NCT00070382|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5823707|NCT00070382|extramedullary plasmacytoma|extramedullary plasmacytoma
5823708|NCT00070382|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5823709|NCT00070382|refractory multiple myeloma|refractory multiple myeloma
5823710|NCT00070382|primary systemic amyloidosis|primary systemic amyloidosis
5823712|NCT00070382|stage II multiple myeloma|stage ii multiple myeloma
5823713|NCT00070382|stage III multiple myeloma|stage iii multiple myeloma
5823714|NCT00070382|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5823715|NCT00070382|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5823716|NCT00070382|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5823717|NCT00070382|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5823718|NCT00070382|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5823719|NCT00070382|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5823720|NCT00070382|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5823721|NCT00070382|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5823722|NCT00070382|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5823723|NCT00070382|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5823724|NCT00070382|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5823725|NCT00070382|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5823726|NCT00070382|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5823996|NCT00070577|Age|age
5823997|NCT00070577|Sex|sex
5823727|NCT00070382|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5823728|NCT00070382|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5823729|NCT00070382|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5823730|NCT00070382|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5823731|NCT00070382|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5823732|NCT00070382|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5823733|NCT00070382|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5823734|NCT00070382|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5823735|NCT00070382|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5823736|NCT00070382|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5823737|NCT00070382|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5823738|NCT00070382|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5823739|NCT00070382|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5823740|NCT00070382|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5823741|NCT00070382|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5823742|NCT00070382|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5823743|NCT00070382|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5823744|NCT00070382|prolymphocytic leukemia|prolymphocytic leukemia
5823745|NCT00070382|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5823746|NCT00070382|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5823747|NCT00070382|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5823748|NCT00070382|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5823749|NCT00070382|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5823751|NCT00070382|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5823752|NCT00070382|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5823753|NCT00070382|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5823754|NCT00070382|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5823755|NCT00070382|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5823756|NCT00070382|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5823757|NCT00070382|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5823758|NCT00070382|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5823759|NCT00070382|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5823760|NCT00070382|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5823761|NCT00070382|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5823762|NCT00070382|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5846647|NCT00043862|Radiation Sensitization|radiation sensitization
5823763|NCT00070382|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5823764|NCT00070382|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5823765|NCT00070382|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5823766|NCT00070382|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5823767|NCT00070382|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5823768|NCT00070382|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5823769|NCT00070382|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5823770|NCT00070382|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5823771|NCT00070382|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5823772|NCT00070382|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5823773|NCT00070382|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5823774|NCT00070382|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5823775|NCT00070382|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5823776|NCT00070382|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5823777|NCT00070382|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5823778|NCT00070382|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5823779|NCT00070382|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5823780|NCT00070382|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5823781|NCT00070382|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5823782|NCT00070382|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5823783|NCT00070382|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5823784|NCT00070382|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5823785|NCT00070382|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5823786|NCT00070382|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5823787|NCT00070382|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5823788|NCT00070382|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5823789|NCT00070382|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5823790|NCT00070382|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5823791|NCT00070382|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5823792|NCT00070382|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5823794|NCT00070343|stage III melanoma|stage iii melanoma
5823795|NCT00070304|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5823796|NCT00070304|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5823797|NCT00070304|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5823798|NCT00070304|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5823799|NCT00070304|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5823800|NCT00070291|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5823801|NCT00070278|stage II breast cancer|stage ii breast cancer
5823802|NCT00070278|stage IIIA breast cancer|stage iiia breast cancer
5823803|NCT00070278|stage IIIB breast cancer|stage iiib breast cancer
5823804|NCT00070278|stage IIIC breast cancer|stage iiic breast cancer
5823805|NCT00070213|adenocarcinoma of the colon|adenocarcinoma of the colon
5823806|NCT00070213|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823807|NCT00070213|stage IV rectal cancer|stage iv rectal cancer
5823808|NCT00070213|stage IV colon cancer|stage iv colon cancer
5823809|NCT00070213|recurrent rectal cancer|recurrent rectal cancer
5823811|NCT00070200|recurrent neuroblastoma|recurrent neuroblastoma
5823813|NCT00070200|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5823814|NCT00070200|localized resectable neuroblastoma|localized resectable neuroblastoma
5823815|NCT00070200|regional neuroblastoma|regional neuroblastoma
5823816|NCT00070200|disseminated neuroblastoma|disseminated neuroblastoma
5823817|NCT00070187|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5823818|NCT00070187|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5816878|NCT00080431|HIV|hiv
5823819|NCT00070174|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5823820|NCT00070174|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5823821|NCT00070174|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5823822|NCT00070174|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5823823|NCT00070174|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5823824|NCT00070174|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5846648|NCT00043862|Small Cell Lung Cancer|small cell lung cancer
5823825|NCT00070174|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5823826|NCT00070174|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5823827|NCT00070174|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5823828|NCT00070161|radiation toxicity|radiation toxicity
5823829|NCT00070161|adult mixed glioma|adult mixed glioma
5823830|NCT00070161|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5823831|NCT00070161|adult brain stem glioma|adult brain stem glioma
5823832|NCT00070161|adult craniopharyngioma|adult craniopharyngioma
5823833|NCT00070161|adult medulloblastoma|adult medulloblastoma
5823834|NCT00070161|adult meningioma|adult meningioma
5823835|NCT00070161|adult choroid plexus tumor|adult choroid plexus tumor
5823836|NCT00070161|adult tumors metastatic to brain|adult tumors metastatic to brain
5823837|NCT00070161|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5823838|NCT00070161|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5823839|NCT00070161|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5823840|NCT00070161|adult subependymoma|adult subependymoma
5823841|NCT00070161|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5823842|NCT00070161|adult ependymoblastoma|adult ependymoblastoma
5823843|NCT00070161|adult anaplastic ependymoma|adult anaplastic ependymoma
5823844|NCT00070161|adult pineoblastoma|adult pineoblastoma
5823845|NCT00070161|adult pineocytoma|adult pineocytoma
5823846|NCT00070161|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5823847|NCT00070161|adult glioblastoma|adult glioblastoma
5823848|NCT00070161|adult grade III meningioma|adult grade iii meningioma
5823849|NCT00070161|adult oligodendroglioma|adult oligodendroglioma
5823850|NCT00070161|adult giant cell glioblastoma|adult giant cell glioblastoma
5823851|NCT00070161|adult gliosarcoma|adult gliosarcoma
5823852|NCT00070161|adult ependymoma|adult ependymoma
5823853|NCT00070148|weight changes|weight changes
5823854|NCT00070148|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5823855|NCT00070135|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5823856|NCT00070135|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5823857|NCT00070135|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5823858|NCT00070135|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5823277|NCT00071292|meditation|meditation
5823859|NCT00070135|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5823860|NCT00070135|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5823861|NCT00070135|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5823862|NCT00070135|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5823863|NCT00070135|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5823864|NCT00070135|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5823865|NCT00070135|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5823866|NCT00070135|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5823867|NCT00070135|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5823868|NCT00070135|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5823869|NCT00070096|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5823870|NCT00070096|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5824082|NCT00069680|Gene Identification|gene identification
5823871|NCT00070096|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5823872|NCT00070096|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5823873|NCT00070096|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5823874|NCT00070096|testicular seminoma|testicular seminoma
5823875|NCT00070096|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5823876|NCT00070096|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5823878|NCT00070096|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5823879|NCT00070096|testicular choriocarcinoma|testicular choriocarcinoma
5823880|NCT00070096|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5823881|NCT00070096|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5823882|NCT00070096|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5823883|NCT00070096|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5823884|NCT00070096|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5823885|NCT00070096|testicular embryonal carcinoma|testicular embryonal carcinoma
5823886|NCT00070096|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5823887|NCT00070096|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5823888|NCT00070096|testicular yolk sac tumor|testicular yolk sac tumor
5823889|NCT00070096|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5823890|NCT00070096|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5823891|NCT00070096|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5823892|NCT00070096|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5823893|NCT00070096|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5823894|NCT00070096|testicular immature teratoma|testicular immature teratoma
5823895|NCT00070096|testicular mature teratoma|testicular mature teratoma
5823896|NCT00070083|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5823897|NCT00070083|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5823898|NCT00070083|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5823899|NCT00070083|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5823900|NCT00070070|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5823901|NCT00070070|stage I bladder cancer|stage i bladder cancer
5823902|NCT00070031|recurrent breast cancer|recurrent breast cancer
5823903|NCT00070031|stage IIIA breast cancer|stage iiia breast cancer
5823904|NCT00070031|stage IIIB breast cancer|stage iiib breast cancer
5823905|NCT00070031|stage IIIC breast cancer|stage iiic breast cancer
5823906|NCT00070031|stage IV breast cancer|stage iv breast cancer
5823907|NCT00070018|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5823908|NCT00070018|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5823909|NCT00070018|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5823910|NCT00070018|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5823911|NCT00070018|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5823912|NCT00070018|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5823913|NCT00070018|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5823914|NCT00070018|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5823915|NCT00070018|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5823916|NCT00070018|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5823917|NCT00070005|perioperative/postoperative complications|perioperative/postoperative complications
5823918|NCT00070005|stage I rectal cancer|stage i rectal cancer
5823919|NCT00070005|stage II rectal cancer|stage ii rectal cancer
5823356|NCT00071097|Tolerability|tolerability
5823358|NCT00071097|TMC114-C211|tmc114-c211
5823920|NCT00070005|stage III rectal cancer|stage iii rectal cancer
5823921|NCT00070005|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5823924|NCT00069992|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5823925|NCT00069992|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5823926|NCT00069992|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5823927|NCT00069992|primary myelofibrosis|primary myelofibrosis
5823928|NCT00069992|chronic myelogenous leukemia|chronic myelogenous leukemia
5823929|NCT00069992|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5823930|NCT00069992|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5823931|NCT00069992|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5823932|NCT00069992|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5823933|NCT00069992|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5823934|NCT00069992|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5823935|NCT00069966|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5823936|NCT00069966|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5823937|NCT00069966|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5823938|NCT00069966|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5823939|NCT00069966|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5823940|NCT00069966|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5823941|NCT00069953|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5823942|NCT00069953|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5823944|NCT00069953|stage III esophageal cancer|stage iii esophageal cancer
5823945|NCT00069940|adult glioblastoma|adult glioblastoma
5823946|NCT00069940|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5823947|NCT00069940|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5823948|NCT00069940|adult synovial sarcoma|adult synovial sarcoma
5823949|NCT00069940|childhood synovial sarcoma|childhood synovial sarcoma
5823950|NCT00069940|childhood leiomyosarcoma|childhood leiomyosarcoma
5823951|NCT00069940|adult leiomyosarcoma|adult leiomyosarcoma
5823952|NCT00069940|adult liposarcoma|adult liposarcoma
5823953|NCT00069940|childhood liposarcoma|childhood liposarcoma
5823954|NCT00069940|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5823955|NCT00069940|recurrent childhood brain tumor|recurrent childhood brain tumor
5823956|NCT00069940|recurrent adult brain tumor|recurrent adult brain tumor
5823957|NCT00069940|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5823958|NCT00069940|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5823959|NCT00069940|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5823960|NCT00069940|adult giant cell glioblastoma|adult giant cell glioblastoma
5823961|NCT00069940|adult gliosarcoma|adult gliosarcoma
5823962|NCT00069940|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5823963|NCT00069940|adult oligodendroglioma|adult oligodendroglioma
5823964|NCT00069940|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5823965|NCT00069940|adult diffuse astrocytoma|adult diffuse astrocytoma
5823966|NCT00069940|adult mixed glioma|adult mixed glioma
5823967|NCT00069940|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5823968|NCT00069940|adult anaplastic ependymoma|adult anaplastic ependymoma
5823969|NCT00069940|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5823970|NCT00069940|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5823971|NCT00069940|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5823972|NCT00069940|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5823973|NCT00069940|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5823974|NCT00069940|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5823975|NCT00069940|recurrent childhood ependymoma|recurrent childhood ependymoma
5823976|NCT00069940|childhood oligodendroglioma|childhood oligodendroglioma
5823977|NCT00069927|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5823979|NCT00069927|neurotoxicity|neurotoxicity
5823980|NCT00006034|stage 0 bladder cancer|stage 0 bladder cancer
5823981|NCT00006034|recurrent bladder cancer|recurrent bladder cancer
5823982|NCT00003868|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5823983|NCT00003868|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5823984|NCT00003868|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5823985|NCT00003868|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5823986|NCT00003868|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5823987|NCT00003868|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5823988|NCT00003868|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5823989|NCT00003868|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5823990|NCT00070577|Alcohol Clamp|alcohol clamp
5823991|NCT00070577|Pharmacokinetics|pharmacokinetics
5823992|NCT00070577|Pharmacodynamics|pharmacodynamics
5823993|NCT00070577|Alcohol|alcohol
5823994|NCT00070577|Metabolism|metabolism
5823995|NCT00070577|Response|response
5824000|NCT00069901|ovarian cancer|ovarian cancer
5824001|NCT00069901|paclitaxel|paclitaxel
5824002|NCT00069901|carboplatin|carboplatin
5824003|NCT00069784|Impaired Fasting Glucose (IFG)|impaired fasting glucose (ifg)
5824004|NCT00069784|Impaired Glucose Tolerance (IGT)|impaired glucose tolerance (igt)
5824005|NCT00069745|Prostatic Neoplasms|prostatic neoplasms
5824006|NCT00069745|Cancer Treatment Protocols|cancer treatment protocols
5824007|NCT00069745|Antineoplastic protocols|antineoplastic protocols
5824008|NCT00069745|One Prior Cytotoxic Chemotherapy Regimen|one prior cytotoxic chemotherapy regimen
5824009|NCT00069719|open-angle|open-angle
5824010|NCT00069719|glaucoma|glaucoma
5824011|NCT00069719|ocular|ocular
5824012|NCT00069719|hypertension|hypertension
5824013|NCT00069719|POAG|poag
5824014|NCT00069706|open-angle|open-angle
5824015|NCT00069706|glaucoma|glaucoma
5824016|NCT00069706|ocular|ocular
5824017|NCT00069706|hypertension|hypertension
5824018|NCT00069706|POAG|poag
5824019|NCT00069914|Immunization|immunization
5824020|NCT00069914|Immune Activation|immune activation
5824022|NCT00069914|Antibodies|antibodies
5824023|NCT00069914|Titers|titers
5824024|NCT00069914|HIV|hiv
5824025|NCT00069914|Healthy Volunteer|healthy volunteer
5824026|NCT00069914|HV|hv
5824027|NCT00069862|Beta Thalassemia|beta thalassemia
5824028|NCT00069836|AVANDAMET insulin type 2 diabetes|avandamet insulin type 2 diabetes
5824030|NCT00069732|Weight loss maintenance|weight loss maintenance
5824031|NCT00069732|CAM therapy|cam therapy
5824033|NCT00069732|Acupressure|acupressure
5824034|NCT00069732|Traditional Chinese Medicine|traditional chinese medicine
5824035|NCT00069758|NHL, indolent NHL, non-Hodgkin's lymphoma, lymphoma|nhl, indolent nhl, non-hodgkin's lymphoma, lymphoma
5824036|NCT00069641|Mucopolysaccharidosis II|mucopolysaccharidosis ii
5824037|NCT00069641|MPS II|mps ii
5824038|NCT00069641|Hunter Syndrome|hunter syndrome
5824039|NCT00069641|iduronate-2-sulfatase|iduronate-2-sulfatase
5824040|NCT00069641|I2S|i2s
5824041|NCT00069641|Iduronate-2-sulfatase deficiency|iduronate-2-sulfatase deficiency
5824042|NCT00069524|Highly active antiretroviral therapy (HAART)|highly active antiretroviral therapy (haart)
5824043|NCT00069524|Ritonavir|ritonavir
5824044|NCT00069524|Oyster mushrooms|oyster mushrooms
5824045|NCT00069524|Non-HDL cholesterol|non-hdl cholesterol
5824046|NCT00069524|Complementary Therapies|complementary therapies
5824047|NCT00069524|Treatment Experienced|treatment experienced
5824048|NCT00005630|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5824049|NCT00005630|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5824050|NCT00005630|large cell lung cancer|large cell lung cancer
5824051|NCT00005630|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5824052|NCT00005630|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5824053|NCT00005630|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5824054|NCT00005630|adenocarcinoma of the lung|adenocarcinoma of the lung
5824055|NCT00005630|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5824056|NCT00005629|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5824057|NCT00005629|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5824058|NCT00005629|advanced adult primary liver cancer|advanced adult primary liver cancer
5824059|NCT00005629|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5824060|NCT00005629|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5824061|NCT00004922|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5824062|NCT00004922|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5824063|NCT00004922|stage III neuroendocrine carcinoma of the skin|stage iii neuroendocrine carcinoma of the skin
5824064|NCT00004922|recurrent neuroendocrine carcinoma of the skin|recurrent neuroendocrine carcinoma of the skin
5824065|NCT00004922|neuroendocrine carcinoma|neuroendocrine carcinoma
5824066|NCT00004886|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824067|NCT00069693|Dysautonomia|dysautonomia
5824068|NCT00069693|Sympathetic Nervous System|sympathetic nervous system
5824069|NCT00069693|Autonomic Nervous System|autonomic nervous system
5824070|NCT00069693|Syncope|syncope
5824071|NCT00069693|Post Tachycardia Syndrome|post tachycardia syndrome
5824072|NCT00069693|POTS|pots
5824073|NCT00069693|Neurocardiogenic Syncope|neurocardiogenic syncope
5824074|NCT00069693|Baroreflex|baroreflex
5824075|NCT00069693|Norepinephrine|norepinephrine
5824076|NCT00069693|Epinephrine|epinephrine
5824077|NCT00069693|Neurocardiology|neurocardiology
5824078|NCT00069693|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5824079|NCT00069693|COI|coi
5824080|NCT00069693|Healthy Volunteer|healthy volunteer
5824083|NCT00069680|Linkage Analysis|linkage analysis
5824084|NCT00069680|Homozygosity Mapping|homozygosity mapping
5824085|NCT00069680|Gray Platelet Syndrome|gray platelet syndrome
5824086|NCT00069680|GPS|gps
5824087|NCT00069680|Platelet Function Defect|platelet function defect
5824088|NCT00069680|Bleeding Disorder|bleeding disorder
5824089|NCT00069654|Endothelium|endothelium
5824090|NCT00069654|Atherosclerosis|atherosclerosis
5824091|NCT00069654|Vasodilation|vasodilation
5824094|NCT00069654|Coronary Artery Disease|coronary artery disease
5824095|NCT00069654|CAD|cad
5824096|NCT00069628|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5824097|NCT00069628|Type 1 Diabetes|type 1 diabetes
5824098|NCT00069628|Diabetes in Children|diabetes in children
5824099|NCT00069628|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5824100|NCT00069615|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5824101|NCT00069615|Type 1 Diabetes|type 1 diabetes
5824102|NCT00069615|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5824103|NCT00069615|Electronic Data Collection|electronic data collection
5824104|NCT00069602|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5824105|NCT00069602|Blood glucose profiles in normal children|blood glucose profiles in normal children
5824106|NCT00069602|Blood glucose profiles in non-diabetic children|blood glucose profiles in non-diabetic children
5824107|NCT00069589|Baldness|baldness
5824108|NCT00069589|Autoimmunity|autoimmunity
5824109|NCT00069589|Hair|hair
5824110|NCT00069589|Alopecia Areata|alopecia areata
5824111|NCT00069589|Alopecia Partialis|alopecia partialis
5824112|NCT00069589|Alopecia Totalis|alopecia totalis
5824113|NCT00069589|Alopecia Universalis|alopecia universalis
5824114|NCT00069589|Autoimmune Hair Loss|autoimmune hair loss
5824115|NCT00069576|Mild gestational diabetes mellitus|mild gestational diabetes mellitus
5681342|NCT00573781|Atherosclerosis|atherosclerosis
5681343|NCT00573768|Ankle, sprain, diclofenac diethylamine|ankle, sprain, diclofenac diethylamine
5844098|NCT00050882|Bloating|bloating
5824116|NCT00069576|Maternal Fetal Medicine Units Network|maternal fetal medicine units network
5824117|NCT00069563|Internalizing psychopathology|internalizing psychopathology
5824118|NCT00069563|Externalizing psychopathology|externalizing psychopathology
5824119|NCT00069550|Glutamate/NMDA receptors|glutamate/nmda receptors
5824120|NCT00069550|Cholinergic upregulation|cholinergic upregulation
5824121|NCT00069550|Dextromethorphan|dextromethorphan
5824122|NCT00069550|Donepezil hydrochloride|donepezil hydrochloride
5824123|NCT00069550|Aricept|aricept
5824124|NCT00069537|Diabetes Mellitus, Insulin-Dependent|diabetes mellitus, insulin-dependent
5824125|NCT00069537|Type 1 Diabetes|type 1 diabetes
5824126|NCT00069537|Diabetes in Children|diabetes in children
5824127|NCT00069537|Continuous Glucose Monitoring Devices|continuous glucose monitoring devices
5824128|NCT00069511|Hepatitis C|hepatitis c
5824129|NCT00069498|Mucosa|mucosa
5824130|NCT00069498|Inflammation|inflammation
5824131|NCT00069498|Tissue Viral Load|tissue viral load
5824132|NCT00069498|Anti-inflammatory|anti-inflammatory
5824133|NCT00069498|HIV-related diarrhea|hiv-related diarrhea
5824134|NCT00069498|Mucosal Inflammation|mucosal inflammation
5824135|NCT00069498|Treatment Experienced|treatment experienced
5824136|NCT00069485|HIV Seronegativity|hiv seronegativity
5824137|NCT00003930|stage II bladder cancer|stage ii bladder cancer
5824138|NCT00003930|stage III bladder cancer|stage iii bladder cancer
5824140|NCT00069459|Winter depression, winter blues, depression, seasonal depression, seasonal affective disorder|winter depression, winter blues, depression, seasonal depression, seasonal affective disorder
5824141|NCT00069446|Diabetes|diabetes
5824142|NCT00069446|Diabetic|diabetic
5824143|NCT00069446|Diabetic Foot Ulcer|diabetic foot ulcer
5824144|NCT00069368|Healthy|healthy
5824145|NCT00069407|Bipolar Disorder|bipolar disorder
5824146|NCT00003827|refractory anemia with excess blasts|refractory anemia with excess blasts
5824147|NCT00003827|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5824148|NCT00003827|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5824149|NCT00003827|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5824150|NCT00003827|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5824151|NCT00003594|stage III colon cancer|stage iii colon cancer
5824152|NCT00003594|stage IV colon cancer|stage iv colon cancer
5824153|NCT00003594|stage III rectal cancer|stage iii rectal cancer
5824154|NCT00003594|stage IV rectal cancer|stage iv rectal cancer
5824155|NCT00003594|recurrent colon cancer|recurrent colon cancer
5824156|NCT00003594|recurrent rectal cancer|recurrent rectal cancer
5845504|NCT00001189|Surgery|surgery
5824157|NCT00003594|adenocarcinoma of the colon|adenocarcinoma of the colon
5824158|NCT00003594|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5824159|NCT00003540|stage IV breast cancer|stage iv breast cancer
5824160|NCT00003540|recurrent breast cancer|recurrent breast cancer
5824161|NCT00003463|recurrent adult brain tumor|recurrent adult brain tumor
5824162|NCT00003463|adult brain stem glioma|adult brain stem glioma
5824163|NCT00003463|adult glioblastoma|adult glioblastoma
5824164|NCT00003463|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5824165|NCT00003463|adult mixed glioma|adult mixed glioma
5824166|NCT00003463|adult giant cell glioblastoma|adult giant cell glioblastoma
5824167|NCT00003463|adult gliosarcoma|adult gliosarcoma
5824168|NCT00069355|PTSD|ptsd
5824169|NCT00069355|Catecholamines|catecholamines
5824170|NCT00069355|Conditioning|conditioning
5824171|NCT00069355|Memory|memory
5824172|NCT00069355|Psychophysiology|psychophysiology
5824173|NCT00069355|Acute Stress Disorder|acute stress disorder
5824174|NCT00069355|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5824175|NCT00069342|Chronic Pain|chronic pain
5824176|NCT00069342|Pain|pain
5824177|NCT00069342|Rheumatoid Arthritis|rheumatoid arthritis
5824178|NCT00069342|Depression|depression
5824179|NCT00069342|Function|function
5824180|NCT00069342|Rheumatic Disease|rheumatic disease
5824181|NCT00069277|Cancer, tumors|cancer, tumors
5824182|NCT00069264|Metastatic Tumors|metastatic tumors
5824183|NCT00069264|Advanced Solid Tumors|advanced solid tumors
5824184|NCT00069264|Stage IV Tumors|stage iv tumors
5824185|NCT00069264|Solid Tumors|solid tumors
5824186|NCT00069264|Recurrent Solid Tumors|recurrent solid tumors
5824187|NCT00069251|amphetamine dependence|amphetamine dependence
5824188|NCT00003449|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5824189|NCT00003281|recurrent small cell lung cancer|recurrent small cell lung cancer
5824190|NCT00003280|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5824191|NCT00003280|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5824192|NCT00003280|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5824193|NCT00003280|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5824194|NCT00003280|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5824195|NCT00003280|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5824196|NCT00003245|Waldenström macroglobulinemia|waldenström macroglobulinemia
5824197|NCT00003245|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5824198|NCT00003245|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5824199|NCT00003245|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5824200|NCT00003245|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5824201|NCT00003245|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5824202|NCT00003245|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5824203|NCT00003245|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5824204|NCT00003245|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5824205|NCT00003245|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5824206|NCT00003245|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5824207|NCT00003245|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5824208|NCT00003245|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5824209|NCT00003245|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5824210|NCT00003245|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5824211|NCT00003113|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5824212|NCT00003113|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5824213|NCT00003113|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5824214|NCT00003113|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5824215|NCT00003113|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5824216|NCT00003113|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5824217|NCT00003113|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5824218|NCT00003113|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5824219|NCT00003113|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5824220|NCT00003113|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5824221|NCT00003113|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5824222|NCT00003113|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5824223|NCT00003113|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5824224|NCT00003113|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5824225|NCT00003113|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5824226|NCT00003113|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5824227|NCT00003113|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5824228|NCT00003113|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5824229|NCT00003113|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5824230|NCT00003113|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5824231|NCT00003113|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5824232|NCT00003113|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5824233|NCT00003113|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5824234|NCT00003113|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5824235|NCT00003113|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5824236|NCT00003113|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5824237|NCT00003113|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5824238|NCT00003113|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5824239|NCT00003113|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5824240|NCT00003113|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5824241|NCT00003113|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5824242|NCT00003113|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5824243|NCT00003113|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5824244|NCT00003113|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5824245|NCT00003113|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5824246|NCT00003113|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5824247|NCT00003113|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5824248|NCT00003113|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5824249|NCT00003113|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5824250|NCT00003113|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5824251|NCT00003113|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5824252|NCT00069329|Central Nervous System|central nervous system
5824253|NCT00069329|Abnormalities|abnormalities
5824255|NCT00069329|Urticaria|urticaria
5824256|NCT00069329|Papilledema|papilledema
5824257|NCT00069329|Auto-Inflammation|auto-inflammation
5824258|NCT00069329|Inflammatory Disease|inflammatory disease
5824259|NCT00069329|Neonatal Onset Multisystem Inflammatory Disease|neonatal onset multisystem inflammatory disease
5824261|NCT00069329|CINCA Syndrome|cinca syndrome
5824262|NCT00069316|West Nile Virus|west nile virus
5824263|NCT00069316|Encephalitis|encephalitis
5824264|NCT00069316|Virus|virus
5824265|NCT00069316|Mosquito|mosquito
5824266|NCT00069316|Fever|fever
5824267|NCT00069316|WNV|wnv
5824268|NCT00069316|Myelitis|myelitis
5824269|NCT00069303|West Nile Virus|west nile virus
5824270|NCT00069303|Encephalitis|encephalitis
5824271|NCT00069303|Virus|virus
5824272|NCT00069303|Mosquito|mosquito
5824273|NCT00069303|Fever|fever
5824274|NCT00069303|WNV|wnv
5824275|NCT00069303|Myelitis|myelitis
5824276|NCT00069186|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5824277|NCT00069186|ALS|als
5824278|NCT00069186|Creatine|creatine
5824279|NCT00069186|Creatine Monohydrate|creatine monohydrate
5824280|NCT00069186|Muscle Strength|muscle strength
5824281|NCT00069238|Lymphoma|lymphoma
5824282|NCT00069238|T-Cell Lymphoma|t-cell lymphoma
5824283|NCT00069238|NK -Cell Lymphoma|nk -cell lymphoma
5824284|NCT00069225|fMRI|fmri
5824285|NCT00069225|Prolonged Exposure|prolonged exposure
5824287|NCT00069225|Conditioning|conditioning
5824288|NCT00069225|Paroxetine|paroxetine
5824289|NCT00069225|PTSD|ptsd
5824290|NCT00069225|Differential Fear Conditioning|differential fear conditioning
5824291|NCT00069225|Masked Faces|masked faces
5824292|NCT00069225|Amygdala|amygdala
5824293|NCT00069225|Hippocampus|hippocampus
5824294|NCT00069225|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5824295|NCT00069212|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5824296|NCT00069212|Neural Circuits|neural circuits
5824297|NCT00069212|Fear|fear
5824298|NCT00069212|Emotional Regulation|emotional regulation
5824299|NCT00069212|Reward|reward
5824300|NCT00069212|PTSD|ptsd
5824301|NCT00069199|Reproducibility|reproducibility
5824302|NCT00069199|Macular Edema|macular edema
5824303|NCT00069199|OCT2|oct2
5824304|NCT00069199|OCT3|oct3
5824305|NCT00069199|Retina|retina
5824306|NCT00002638|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5824307|NCT00002559|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5824308|NCT00002559|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5824309|NCT00002533|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5824310|NCT00002533|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5824311|NCT00002533|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5824312|NCT00002533|oral complications|oral complications
5824368|NCT00002533|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5824313|NCT00002533|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5824314|NCT00002533|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5824315|NCT00002533|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5824316|NCT00002533|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5824317|NCT00002533|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5824318|NCT00002533|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5824319|NCT00002533|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5824320|NCT00002533|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5824321|NCT00002533|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5824322|NCT00002533|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5823793|NCT00070343|stage IV melanoma|stage iv melanoma
5824323|NCT00002533|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5824324|NCT00002533|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5824325|NCT00002533|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5824326|NCT00002533|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5828111|NCT00061724|Reflux|reflux
5824327|NCT00002533|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5824328|NCT00002533|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5824329|NCT00002533|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5824330|NCT00002533|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5824331|NCT00002533|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5824332|NCT00002533|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5824333|NCT00002533|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5824334|NCT00002533|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5824335|NCT00002533|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5824336|NCT00002533|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5824337|NCT00002533|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5824338|NCT00002533|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5824339|NCT00002533|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5824340|NCT00002533|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5824341|NCT00002533|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5824342|NCT00002533|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5824343|NCT00002533|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5824344|NCT00002533|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5824345|NCT00002533|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5824346|NCT00002533|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5824347|NCT00002533|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5824348|NCT00002533|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5824349|NCT00002533|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5824350|NCT00002533|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5824351|NCT00002533|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5824352|NCT00002533|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5824353|NCT00002533|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5824354|NCT00002533|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5824355|NCT00002533|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5846650|NCT00043862|limited stage|limited stage
5846651|NCT00043862|topotecan|topotecan
5824356|NCT00002533|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5824357|NCT00002533|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5824358|NCT00002533|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5824359|NCT00002533|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5824360|NCT00002533|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5824361|NCT00002533|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5824362|NCT00002533|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5824363|NCT00002533|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5824364|NCT00002533|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5824365|NCT00002533|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5824366|NCT00002533|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5824367|NCT00002533|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5824369|NCT00002533|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5824370|NCT00002533|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5824371|NCT00002533|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5824372|NCT00002533|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5824373|NCT00002533|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5824374|NCT00002533|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5824375|NCT00002533|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5823810|NCT00070213|recurrent colon cancer|recurrent colon cancer
5824376|NCT00002533|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5824377|NCT00002533|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5824378|NCT00002533|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5824379|NCT00002533|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5824463|NCT00068887|type 2 diabetes|type 2 diabetes
5828272|NCT00061334|fMRI|fmri
5824380|NCT00002533|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5824381|NCT00002533|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5824382|NCT00002533|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5862681|NCT00001547|Neuropsychiatric Disorders|neuropsychiatric disorders
5824383|NCT00002533|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5824384|NCT00002533|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5824385|NCT00002533|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5824386|NCT00002533|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5824387|NCT00002533|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5824388|NCT00002533|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5824389|NCT00002533|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5824390|NCT00002533|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5824391|NCT00002533|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5824392|NCT00002533|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5824393|NCT00002533|infection|infection
5824394|NCT00069173|Females|females
5824395|NCT00069173|Sedentary|sedentary
5824396|NCT00069173|School-based|school-based
5824397|NCT00069134|glutathione kinetics|glutathione kinetics
5824398|NCT00069134|oxidant damage|oxidant damage
5824399|NCT00069134|anti-oxidant capacity|anti-oxidant capacity
5824400|NCT00069134|oxidative stress|oxidative stress
5824401|NCT00069134|cysteine kinetics|cysteine kinetics
5824402|NCT00069134|severe childhood malnutrition|severe childhood malnutrition
5824403|NCT00026286|stage I breast cancer|stage i breast cancer
5824404|NCT00026286|stage II breast cancer|stage ii breast cancer
5824405|NCT00026286|breast cancer in situ|breast cancer in situ
5824406|NCT00026286|ductal breast carcinoma|ductal breast carcinoma
5824408|NCT00026286|menopausal symptoms|menopausal symptoms
5824409|NCT00025116|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5824410|NCT00025116|recurrent prostate cancer|recurrent prostate cancer
5824411|NCT00069160|Pharmacokinetics|pharmacokinetics
5824412|NCT00069160|Pharmacodynamics|pharmacodynamics
5824413|NCT00069160|Multidrug Resistance Reversal|multidrug resistance reversal
5824414|NCT00069160|Molecular Target|molecular target
5824415|NCT00069160|P-Glycoprotein Inhibition|p-glycoprotein inhibition
5824416|NCT00069160|Lung Cancer|lung cancer
5824417|NCT00069160|Ovarian Cancer|ovarian cancer
5824418|NCT00069160|Cervical Cancer|cervical cancer
5824419|NCT00069160|Renal Cancer|renal cancer
5824420|NCT00069082|Headache|headache
5824421|NCT00069082|Cluster|cluster
5824423|NCT00069082|Episodic Cluster|episodic cluster
5824424|NCT00069030|HIV Seronegativity|hiv seronegativity
5824425|NCT00069030|HIV Preventive Vaccine|hiv preventive vaccine
5824426|NCT00069030|HIV-1|hiv-1
5824427|NCT00069030|AIDS Vaccines|aids vaccines
5824428|NCT00069030|Vaccines, DNA|vaccines, dna
5824429|NCT00069030|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5824430|NCT00069030|Cytokines|cytokines
5824431|NCT00069030|Plasmids|plasmids
5824432|NCT00069030|Adjuvants, Immunologic|adjuvants, immunologic
5824433|NCT00069030|Drug Administration Schedule|drug administration schedule
5824434|NCT00069030|Interleukin|interleukin
5824435|NCT00069030|IL2|il2
5824436|NCT00069030|Ig|ig
5824437|NCT00069030|IL@/Ig|il@/ig
5824438|NCT00069004|HIV-Associated Lipodystrophy Syndrome|hiv-associated lipodystrophy syndrome
5824439|NCT00069004|HIV Lipodystrophy Syndrome|hiv lipodystrophy syndrome
5824440|NCT00069004|Treatment Experienced|treatment experienced
5824441|NCT00069004|Lipodystrophy|lipodystrophy
5824442|NCT00069004|Dyslipidemia|dyslipidemia
5824443|NCT00069004|Osteoporosis|osteoporosis
5824444|NCT00069004|Osteopenia|osteopenia
5824445|NCT00068991|Behavioral Intervention Study|behavioral intervention study
5824446|NCT00068991|Randomized Prevention Trial|randomized prevention trial
5824447|NCT00068991|China|china
5824448|NCT00068991|Condom Use|condom use
5824449|NCT00068991|STDs|stds
5824450|NCT00068991|Sexual Partners|sexual partners
5824451|NCT00068991|HIV Seronegativity|hiv seronegativity
5824452|NCT00068978|HIV Seronegativity|hiv seronegativity
5824453|NCT00068978|HIV Preventive Vaccine|hiv preventive vaccine
5824454|NCT00068978|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5824455|NCT00069069|Stroke|stroke
5824456|NCT00069069|TIA|tia
5824457|NCT00069056|Grid Laser|grid laser
5824458|NCT00069056|Focal Laser|focal laser
5824459|NCT00069056|Glycemic Control|glycemic control
5824460|NCT00069056|Diabetes|diabetes
5824461|NCT00069056|Diabetic Macular Edema|diabetic macular edema
5824462|NCT00069056|Macular Edema|macular edema
5824464|NCT00068887|some studies - family history of type 2 diabetes|some studies - family history of type 2 diabetes
5824465|NCT00068926|Biodefense|biodefense
5824466|NCT00068926|Prevention|prevention
5824467|NCT00068926|Emergent|emergent
5824468|NCT00068926|Virus|virus
5824469|NCT00068926|Immune Response|immune response
5824470|NCT00068926|Healthy Volunteer|healthy volunteer
5824471|NCT00068926|HV|hv
5824472|NCT00068913|Lactic Acidosis|lactic acidosis
5824473|NCT00068913|Mitochondrial Disorder|mitochondrial disorder
5824474|NCT00068913|Stroke|stroke
5824475|NCT00068913|Seizure|seizure
5824476|NCT00068874|African American|african american
5824477|NCT00068874|Adolescent|adolescent
5824478|NCT00068874|Coping|coping
5824479|NCT00068874|Adjustment|adjustment
5824480|NCT00068874|Quality of Life|quality of life
5824481|NCT00068848|Oral Contraceptives|oral contraceptives
5824482|NCT00068848|Initiation|initiation
5824483|NCT00068848|Continuation|continuation
5824484|NCT00068835|Reading|reading
5824485|NCT00068835|Brain imaging|brain imaging
5824486|NCT00068822|Vertebroplasty|vertebroplasty
5824487|NCT00068822|Crushed Vertebrae|crushed vertebrae
5824488|NCT00068822|Back Pain|back pain
5824489|NCT00068822|Structurally Unstable Vertebrae|structurally unstable vertebrae
5824490|NCT00068822|polymethylmethacrylate|polymethylmethacrylate
5824491|NCT00068822|INVEST|invest
5824492|NCT00068822|PMMA|pmma
5824493|NCT00068822|RDQ|rdq
5824494|NCT00068809|Treatment experienced|treatment experienced
5824495|NCT00068809|Treatment interruption|treatment interruption
5824496|NCT00068770|adult glioblastoma|adult glioblastoma
5824497|NCT00068770|adult giant cell glioblastoma|adult giant cell glioblastoma
5824498|NCT00068770|adult gliosarcoma|adult gliosarcoma
5824499|NCT00068757|recurrent breast cancer|recurrent breast cancer
5824500|NCT00068757|stage IIIB breast cancer|stage iiib breast cancer
5824501|NCT00068757|stage IIIC breast cancer|stage iiic breast cancer
5824502|NCT00068757|stage IV breast cancer|stage iv breast cancer
5824503|NCT00068757|male breast cancer|male breast cancer
5824504|NCT00068757|HER2-positive breast cancer|her2-positive breast cancer
5824505|NCT00068744|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5824506|NCT00068744|stage II anal cancer|stage ii anal cancer
5824507|NCT00068744|stage IIIA anal cancer|stage iiia anal cancer
5824508|NCT00068744|stage IIIB anal cancer|stage iiib anal cancer
5824509|NCT00068731|stage IV prostate cancer|stage iv prostate cancer
5824510|NCT00068731|recurrent prostate cancer|recurrent prostate cancer
5824511|NCT00068692|rectal cancer|rectal cancer
5824512|NCT00068692|chemotherapy|chemotherapy
5824513|NCT00068692|irinotecan|irinotecan
5824514|NCT00068692|oxaliplatin|oxaliplatin
5824515|NCT00068666|stage IV melanoma|stage iv melanoma
5824516|NCT00068666|recurrent melanoma|recurrent melanoma
5824517|NCT00068666|tumors metastatic to brain|tumors metastatic to brain
5824518|NCT00068653|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5824519|NCT00068614|stage IV breast cancer|stage iv breast cancer
5824520|NCT00068614|stage II breast cancer|stage ii breast cancer
5824521|NCT00068614|stage IIIA breast cancer|stage iiia breast cancer
5824522|NCT00068614|stage IIIB breast cancer|stage iiib breast cancer
5824523|NCT00068614|stage IIIC breast cancer|stage iiic breast cancer
5824524|NCT00068601|infertility|infertility
5824525|NCT00068601|menopausal symptoms|menopausal symptoms
5824526|NCT00068601|stage II breast cancer|stage ii breast cancer
5824527|NCT00068601|stage IIIA breast cancer|stage iiia breast cancer
5824528|NCT00068601|stage IA breast cancer|stage ia breast cancer
5824529|NCT00068601|stage IB breast cancer|stage ib breast cancer
5824530|NCT00068601|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5824531|NCT00068601|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5824532|NCT00068575|stage I pancreatic cancer|stage i pancreatic cancer
5824533|NCT00068575|stage II pancreatic cancer|stage ii pancreatic cancer
5824534|NCT00068575|stage III pancreatic cancer|stage iii pancreatic cancer
5824535|NCT00068575|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5824536|NCT00068523|refractory multiple myeloma|refractory multiple myeloma
5824537|NCT00068523|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5824538|NCT00068523|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5824539|NCT00068523|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5824540|NCT00068523|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5824541|NCT00068523|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5847562|NCT00038818|HD|hd
5824542|NCT00068523|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5824543|NCT00068523|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5824544|NCT00068523|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5824545|NCT00068523|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5824546|NCT00068523|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5824547|NCT00068523|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5824548|NCT00068523|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5824549|NCT00068523|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5824550|NCT00068523|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5824551|NCT00068523|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5824552|NCT00068523|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5824553|NCT00068523|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5824554|NCT00068523|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5824555|NCT00068523|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5824556|NCT00068523|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5824557|NCT00068523|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5824558|NCT00068523|refractory anemia with excess blasts|refractory anemia with excess blasts
5824559|NCT00068523|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5824560|NCT00068523|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5824561|NCT00068523|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5824562|NCT00068523|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5824563|NCT00068523|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5824564|NCT00068523|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5824565|NCT00068523|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5824566|NCT00068523|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5824567|NCT00068523|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5824568|NCT00068523|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5824569|NCT00068523|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5824570|NCT00068523|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5824571|NCT00068523|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5824572|NCT00068523|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5824573|NCT00068523|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5824574|NCT00068523|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5824575|NCT00068523|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5824576|NCT00068523|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5824577|NCT00068523|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5824578|NCT00068523|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5824579|NCT00068523|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5824580|NCT00068523|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5824581|NCT00068523|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5824582|NCT00068523|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5824583|NCT00068523|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5824584|NCT00068510|adult glioblastoma|adult glioblastoma
5824585|NCT00068510|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5824586|NCT00068510|adult brain tumor|adult brain tumor
5824587|NCT00068510|adult giant cell glioblastoma|adult giant cell glioblastoma
5824588|NCT00068510|adult gliosarcoma|adult gliosarcoma
5824589|NCT00068510|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5824590|NCT00068471|infection|infection
5824591|NCT00068471|neutropenia|neutropenia
5824592|NCT00068471|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5824593|NCT00068458|weight changes|weight changes
5824594|NCT00068458|depression|depression
5824595|NCT00068458|stage I breast cancer|stage i breast cancer
5824596|NCT00068458|stage II breast cancer|stage ii breast cancer
5824597|NCT00068458|stage IIIA breast cancer|stage iiia breast cancer
5824598|NCT00068445|neurotoxicity|neurotoxicity
5824599|NCT00068445|pain|pain
5824600|NCT00068445|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824601|NCT00068432|recurrent pancreatic cancer|recurrent pancreatic cancer
5824602|NCT00068432|stage IV pancreatic cancer|stage iv pancreatic cancer
5824603|NCT00068393|Sarcomatoid|sarcomatoid
5824604|NCT00068393|Gemcitabine|gemcitabine
5824605|NCT00068393|Doxorubicin|doxorubicin
5824606|NCT00068393|Renal cell cancer|renal cell cancer
5824607|NCT00068393|Kidney cancer|kidney cancer
5824608|NCT00068367|adult neurofibrosarcoma|adult neurofibrosarcoma
5824029|NCT00069732|Overweight|overweight
5824609|NCT00068367|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5824715|NCT00068107|Lysosomal Storage|lysosomal storage
5824610|NCT00068367|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5824611|NCT00068367|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5824612|NCT00068367|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5824613|NCT00068341|stage IIIA breast cancer|stage iiia breast cancer
5824614|NCT00068341|stage IIIB breast cancer|stage iiib breast cancer
5824615|NCT00068341|stage IIIC breast cancer|stage iiic breast cancer
5824616|NCT00068341|stage II breast cancer|stage ii breast cancer
5824617|NCT00068328|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5824618|NCT00068328|stage II breast cancer|stage ii breast cancer
5824619|NCT00068328|stage IIIA breast cancer|stage iiia breast cancer
5824620|NCT00068328|stage IIIB breast cancer|stage iiib breast cancer
5824621|NCT00068328|stage IIIC breast cancer|stage iiic breast cancer
5824625|NCT00068328|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5862682|NCT00001547|Drug Effects|drug effects
5824626|NCT00068302|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5824627|NCT00068302|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5824628|NCT00068302|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5824629|NCT00068302|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5824630|NCT00068302|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5824631|NCT00068289|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5824632|NCT00068289|recurrent small cell lung cancer|recurrent small cell lung cancer
5824633|NCT00068276|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5824634|NCT00068276|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5824635|NCT00068276|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5824636|NCT00068276|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5824637|NCT00068276|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5824638|NCT00068276|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5824639|NCT00068263|stage I breast cancer|stage i breast cancer
5824640|NCT00068263|stage II breast cancer|stage ii breast cancer
5824641|NCT00068250|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5824642|NCT00068250|primary central nervous system Hodgkin lymphoma|primary central nervous system hodgkin lymphoma
5824644|NCT00068237|radiation toxicity|radiation toxicity
5824645|NCT00068237|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5824646|NCT00068237|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5824647|NCT00068237|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5824648|NCT00068237|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5824649|NCT00068237|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5824650|NCT00068237|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5824651|NCT00068237|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5824652|NCT00068237|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5824653|NCT00068237|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5824654|NCT00068237|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5824656|NCT00068211|Melanoma|melanoma
5824657|NCT00068211|Inoperable Locally Advanced Melanoma|inoperable locally advanced melanoma
5824658|NCT00068224|Caroli's Syndrome|caroli's syndrome
5824659|NCT00068224|Congenital Hepatic Fibrosis|congenital hepatic fibrosis
5824660|NCT00068224|Ductal Plate Malformation|ductal plate malformation
5824661|NCT00068224|Polycystic Kidney|polycystic kidney
5824662|NCT00068224|Autosomal Recessive Polycystic Kidney Disease|autosomal recessive polycystic kidney disease
5824665|NCT00068224|Liver|liver
5824666|NCT00068185|Black cohosh|black cohosh
5824667|NCT00068185|Pharmacokinetics|pharmacokinetics
5824668|NCT00068185|Alternative therapies|alternative therapies
5824669|NCT00068185|Natural product|natural product
5824670|NCT00021268|stage IV colon cancer|stage iv colon cancer
5824671|NCT00021268|stage IV rectal cancer|stage iv rectal cancer
5824672|NCT00021268|recurrent colon cancer|recurrent colon cancer
5824673|NCT00021268|recurrent rectal cancer|recurrent rectal cancer
5824674|NCT00020904|stage IV breast cancer|stage iv breast cancer
5824675|NCT00020904|recurrent breast cancer|recurrent breast cancer
5824681|NCT00068146|Adenopathy|adenopathy
5824682|NCT00068146|Genetic Disorder|genetic disorder
5824683|NCT00068146|Apoptosis|apoptosis
5824684|NCT00068146|Diagnostic Imaging|diagnostic imaging
5824685|NCT00068146|Hodgkins|hodgkins
5824686|NCT00068146|Autoimmune Lymphoproliferative|autoimmune lymphoproliferative
5824687|NCT00068146|Syndrome|syndrome
5824688|NCT00068146|ALPS|alps
5824689|NCT00068146|ALPS-Associated Lymphoma|alps-associated lymphoma
5686674|NCT00551122|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5686675|NCT00551122|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5681341|NCT00573781|Type 2 Diabetes|type 2 diabetes
5824690|NCT00068120|Urinary tract infection|urinary tract infection
5824691|NCT00068094|Probiotics|probiotics
5824692|NCT00068094|Bacteria|bacteria
5824693|NCT00068081|Dermal assessment|dermal assessment
5824694|NCT00068081|Pain measurement|pain measurement
5824695|NCT00068081|Diary|diary
5824696|NCT00068081|Analgesics/*therapeutic use|analgesics/*therapeutic use
5824697|NCT00068081|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5824698|NCT00068081|Herpes zoster/*complication/drug therapy|herpes zoster/*complication/drug therapy
5826128|NCT00065754|Expectation|expectation
5824702|NCT00017043|stage IV gastric cancer|stage iv gastric cancer
5824703|NCT00017043|recurrent gastric cancer|recurrent gastric cancer
5824704|NCT00017043|stage IV esophageal cancer|stage iv esophageal cancer
5824705|NCT00017043|recurrent esophageal cancer|recurrent esophageal cancer
5824706|NCT00017043|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5824707|NCT00017043|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5824708|NCT00016939|stage III renal cell cancer|stage iii renal cell cancer
5824709|NCT00016939|stage IV renal cell cancer|stage iv renal cell cancer
5824710|NCT00016939|recurrent renal cell cancer|recurrent renal cell cancer
5824711|NCT00016874|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824712|NCT00016341|stage III endometrial carcinoma|stage iii endometrial carcinoma
5824713|NCT00016341|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5824714|NCT00016341|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5824716|NCT00068107|Renal Insufficiency|renal insufficiency
5824717|NCT00068107|Stroke|stroke
5824718|NCT00068107|Hypohidrosis|hypohidrosis
5824719|NCT00068107|Peripheral Neuropathy|peripheral neuropathy
5824720|NCT00068107|Fabry Disease|fabry disease
5824721|NCT00068068|Photodynamic therapy|photodynamic therapy
5824722|NCT00068068|Liver metastases|liver metastases
5824723|NCT00068068|Colorectal cancer|colorectal cancer
5824724|NCT00068068|Litx™|litx™
5824725|NCT00068068|Light Infusion Technology™|light infusion technology™
5824726|NCT00068068|Talaporfin sodium|talaporfin sodium
5824727|NCT00068068|LS11|ls11
5824728|NCT00068068|Liver mets|liver mets
5824729|NCT00068068|Metastatic colorectal cancer|metastatic colorectal cancer
5824730|NCT00068068|Light emittting diodes (LED)|light emittting diodes (led)
5824732|NCT00068068|Combination therapy|combination therapy
5824733|NCT00068055|West Nile Virus, encephalitis, myelitis, immunoglobulin G|west nile virus, encephalitis, myelitis, immunoglobulin g
5824734|NCT00067899|cigarette smoking|cigarette smoking
5824735|NCT00067899|tocopherol|tocopherol
5824736|NCT00067899|bioavailability|bioavailability
5824737|NCT00067899|metabolism|metabolism
5824738|NCT00067899|oxidative stress|oxidative stress
5824739|NCT00067990|chronic allograft nephropathy|chronic allograft nephropathy
5824740|NCT00067990|post transplant proteinuria|post transplant proteinuria
5824741|NCT00067951|Hyperglycemia|hyperglycemia
5824742|NCT00067951|HbA1c|hba1c
5824743|NCT00067951|Hemoglobin A1c|hemoglobin a1c
5824744|NCT00067951|Type 2 diabetes mellitus|type 2 diabetes mellitus
5824745|NCT00067938|bipolar disorder|bipolar disorder
5824746|NCT00067938|lamotrigine|lamotrigine
5824752|NCT00067925|Weight-bearing physical activity|weight-bearing physical activity
5824753|NCT00067925|Calcium intake|calcium intake
5824754|NCT00067925|School-based health education|school-based health education
5824755|NCT00067925|Adolescent girls|adolescent girls
5824756|NCT00067925|Child nutrition|child nutrition
5824757|NCT00067925|Diet|diet
5824758|NCT00010036|adult glioblastoma|adult glioblastoma
5824759|NCT00010036|adult giant cell glioblastoma|adult giant cell glioblastoma
5824760|NCT00010036|adult gliosarcoma|adult gliosarcoma
5824761|NCT00008359|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5824762|NCT00008359|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5824763|NCT00008359|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5824764|NCT00008359|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5824765|NCT00008359|stage IV breast cancer|stage iv breast cancer
5824766|NCT00008359|stage IIIA breast cancer|stage iiia breast cancer
5824767|NCT00008359|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5824768|NCT00008359|stage IIIB breast cancer|stage iiib breast cancer
5824769|NCT00008359|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5824770|NCT00008359|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5824771|NCT00008359|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5824772|NCT00008359|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5824773|NCT00008359|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5824774|NCT00008359|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5824775|NCT00008359|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5824776|NCT00008359|extramedullary plasmacytoma|extramedullary plasmacytoma
5824777|NCT00008359|refractory multiple myeloma|refractory multiple myeloma
5824778|NCT00008359|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5824779|NCT00008359|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5824780|NCT00008359|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5824781|NCT00008359|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5824782|NCT00008359|disseminated neuroblastoma|disseminated neuroblastoma
5824783|NCT00008359|recurrent neuroblastoma|recurrent neuroblastoma
5824784|NCT00008359|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5824785|NCT00008359|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5824786|NCT00008359|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5824787|NCT00008359|stage I multiple myeloma|stage i multiple myeloma
5824788|NCT00008359|stage II multiple myeloma|stage ii multiple myeloma
5824789|NCT00008359|stage III multiple myeloma|stage iii multiple myeloma
5824790|NCT00008359|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5824791|NCT00008359|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5824792|NCT00008359|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5824793|NCT00008359|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5824794|NCT00008359|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5824795|NCT00008359|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5824796|NCT00008359|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5824797|NCT00008359|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5824798|NCT00008359|small intestine lymphoma|small intestine lymphoma
5824799|NCT00008359|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5824800|NCT00008359|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5824801|NCT00008359|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824802|NCT00008359|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5824803|NCT00008359|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5824804|NCT00008359|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5824805|NCT00008359|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5824806|NCT00008359|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5824807|NCT00008359|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5824808|NCT00008359|polycythemia vera|polycythemia vera
5824809|NCT00008359|primary myelofibrosis|primary myelofibrosis
5824811|NCT00008359|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5824812|NCT00008359|testicular embryonal carcinoma|testicular embryonal carcinoma
5824813|NCT00008359|testicular choriocarcinoma|testicular choriocarcinoma
5824814|NCT00008359|testicular teratoma|testicular teratoma
5824815|NCT00008359|testicular yolk sac tumor|testicular yolk sac tumor
5824816|NCT00008359|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5824817|NCT00008359|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5824818|NCT00008359|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5824819|NCT00008359|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5824820|NCT00008359|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5824821|NCT00008359|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5825359|NCT00067067|Glioma|glioma
5824822|NCT00008359|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5824823|NCT00008359|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5824824|NCT00008359|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5824825|NCT00008359|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5824826|NCT00008359|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5824827|NCT00008359|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5824828|NCT00008359|refractory hairy cell leukemia|refractory hairy cell leukemia
5824829|NCT00008359|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5824830|NCT00008359|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5824831|NCT00008359|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5824832|NCT00008359|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5824833|NCT00008359|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5824834|NCT00008359|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5824835|NCT00008359|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5824836|NCT00008359|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5824837|NCT00008359|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5824838|NCT00008359|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5824254|NCT00069329|Arthropathy|arthropathy
5824839|NCT00008359|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5824840|NCT00008359|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5824841|NCT00008359|ovarian yolk sac tumor|ovarian yolk sac tumor
5824842|NCT00008359|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5824843|NCT00008359|ovarian polyembryoma|ovarian polyembryoma
5824844|NCT00008359|ovarian choriocarcinoma|ovarian choriocarcinoma
5824845|NCT00008359|ovarian immature teratoma|ovarian immature teratoma
5824846|NCT00008359|ovarian mature teratoma|ovarian mature teratoma
5824847|NCT00008359|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5824848|NCT00008359|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5824849|NCT00008359|acute undifferentiated leukemia|acute undifferentiated leukemia
5828273|NCT00061334|Development|development
5824850|NCT00008359|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5824851|NCT00008359|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5824852|NCT00008359|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5824853|NCT00008359|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5824854|NCT00008359|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5824855|NCT00008359|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5824856|NCT00008359|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5824857|NCT00008359|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5862683|NCT00001547|Interferon-alpha|interferon-alpha
5824858|NCT00008359|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5824859|NCT00008359|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5824860|NCT00008359|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5824861|NCT00008359|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5824862|NCT00008359|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5824863|NCT00008359|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5824864|NCT00008359|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5824865|NCT00008359|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5824866|NCT00008359|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5824867|NCT00008359|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5824868|NCT00008359|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5824869|NCT00008359|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5824870|NCT00008359|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5824871|NCT00008359|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5820885|NCT00002801|stage II colon cancer|stage ii colon cancer
5824872|NCT00008359|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5824873|NCT00008359|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5824874|NCT00008359|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5824875|NCT00008359|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5824876|NCT00008359|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5824877|NCT00008359|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5824878|NCT00008359|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5824879|NCT00008359|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5824880|NCT00008359|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5824881|NCT00008359|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5824882|NCT00008359|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5824883|NCT00008359|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5824884|NCT00008359|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5824885|NCT00008359|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5824886|NCT00008359|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5824887|NCT00008359|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5824890|NCT00008359|prolymphocytic leukemia|prolymphocytic leukemia
5824891|NCT00008359|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5824892|NCT00008359|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5824893|NCT00008359|primary systemic amyloidosis|primary systemic amyloidosis
5824894|NCT00008359|intraocular lymphoma|intraocular lymphoma
5824895|NCT00008359|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5824896|NCT00008359|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5824897|NCT00008359|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5824898|NCT00008359|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5824899|NCT00008359|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5824900|NCT00008359|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5824901|NCT00008359|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5824902|NCT00008359|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5824903|NCT00008359|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5824904|NCT00008359|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5824905|NCT00008359|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5824906|NCT00008359|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5824907|NCT00008359|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5824908|NCT00008359|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5824909|NCT00008359|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5824910|NCT00008359|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5824911|NCT00008359|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5824912|NCT00008359|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5824913|NCT00008359|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5824914|NCT00008359|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5824915|NCT00008359|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5824916|NCT00008359|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5824917|NCT00008359|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5824918|NCT00008359|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5824919|NCT00008359|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5824920|NCT00008359|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5824921|NCT00008359|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5824922|NCT00008359|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5824923|NCT00008359|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5824924|NCT00008359|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5824925|NCT00008359|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5824926|NCT00008359|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5824927|NCT00008359|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5824928|NCT00008359|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5824929|NCT00008359|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5824930|NCT00008359|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5824931|NCT00008359|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5824932|NCT00008359|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5824933|NCT00008359|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5824934|NCT00008359|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5824935|NCT00008359|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5824936|NCT00008359|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5824937|NCT00008359|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5824938|NCT00008359|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5824939|NCT00008359|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5824940|NCT00008359|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5824941|NCT00008359|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5824942|NCT00008086|recurrent adult brain tumor|recurrent adult brain tumor
5824943|NCT00008086|adult brain stem glioma|adult brain stem glioma
5824944|NCT00008086|adult craniopharyngioma|adult craniopharyngioma
5824945|NCT00008086|adult medulloblastoma|adult medulloblastoma
5824946|NCT00008086|adult meningioma|adult meningioma
5824947|NCT00008086|adult glioblastoma|adult glioblastoma
5824948|NCT00008086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824949|NCT00008086|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5824950|NCT00008086|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5824951|NCT00008086|adult anaplastic ependymoma|adult anaplastic ependymoma
5824952|NCT00008086|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5824953|NCT00008086|adult mixed glioma|adult mixed glioma
5824954|NCT00008086|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5824955|NCT00008086|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5824956|NCT00008086|adult subependymoma|adult subependymoma
5824957|NCT00008086|adult ependymoblastoma|adult ependymoblastoma
5824958|NCT00008086|adult pineocytoma|adult pineocytoma
5824959|NCT00008086|adult pineoblastoma|adult pineoblastoma
5824960|NCT00008086|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5824961|NCT00008086|adult choroid plexus tumor|adult choroid plexus tumor
5824962|NCT00008086|adult grade III meningioma|adult grade iii meningioma
5824963|NCT00008086|adult oligodendroglioma|adult oligodendroglioma
5824964|NCT00008086|adult giant cell glioblastoma|adult giant cell glioblastoma
5824965|NCT00008086|adult gliosarcoma|adult gliosarcoma
5844534|NCT00001814|MET|met
5824966|NCT00006346|stage II breast cancer|stage ii breast cancer
5824967|NCT00006346|stage IV breast cancer|stage iv breast cancer
5824968|NCT00006346|stage IIIA breast cancer|stage iiia breast cancer
5824969|NCT00006346|stage IIIB breast cancer|stage iiib breast cancer
5824970|NCT00006346|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5824971|NCT00006265|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5824972|NCT00006254|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5824973|NCT00006223|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5824974|NCT00006223|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5824975|NCT00006223|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5824976|NCT00006223|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5824977|NCT00006223|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5824978|NCT00006223|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5824979|NCT00006223|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5824980|NCT00006223|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5824983|NCT00006103|stage III colon cancer|stage iii colon cancer
5824984|NCT00006103|stage IV colon cancer|stage iv colon cancer
5824985|NCT00006103|stage III rectal cancer|stage iii rectal cancer
5824986|NCT00006103|stage IV rectal cancer|stage iv rectal cancer
5824987|NCT00006103|recurrent colon cancer|recurrent colon cancer
5824988|NCT00006103|recurrent rectal cancer|recurrent rectal cancer
5824989|NCT00006103|adenocarcinoma of the colon|adenocarcinoma of the colon
5824990|NCT00006103|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5824991|NCT00006096|stage I vulvar cancer|stage i vulvar cancer
5824992|NCT00006096|stage II vulvar cancer|stage ii vulvar cancer
5824993|NCT00006096|stage III vulvar cancer|stage iii vulvar cancer
5824994|NCT00006096|stage IVB vulvar cancer|stage ivb vulvar cancer
5824995|NCT00006096|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5824996|NCT00067847|obesity|obesity
5824997|NCT00067847|food policy|food policy
5824998|NCT00067847|physical fitness (Respiratory Burst)|physical fitness (respiratory burst)
5824999|NCT00067847|academic achievement|academic achievement
5825000|NCT00067834|Electromagnetic Fields|electromagnetic fields
5825001|NCT00067834|Bone|bone
5825002|NCT00067834|Forelimb|forelimb
5825003|NCT00067834|Radius|radius
5825004|NCT00006019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5825005|NCT00006019|refractory multiple myeloma|refractory multiple myeloma
5825006|NCT00006019|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5825007|NCT00006019|recurrent prostate cancer|recurrent prostate cancer
5825008|NCT00006019|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5825009|NCT00006019|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5822675|NCT00073268|diabetes|diabetes
5825010|NCT00006019|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5825011|NCT00006019|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5825012|NCT00006019|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5825013|NCT00006019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5825014|NCT00006019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5825360|NCT00067067|Brain Tumor|brain tumor
5825015|NCT00006019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5825016|NCT00006019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5825017|NCT00006019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5825018|NCT00006019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5825019|NCT00006019|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5825020|NCT00006019|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5825021|NCT00006019|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5825022|NCT00006019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5825023|NCT00006019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5825024|NCT00006019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5825025|NCT00006019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5825026|NCT00006019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5825027|NCT00006002|stage IV prostate cancer|stage iv prostate cancer
5825028|NCT00006002|recurrent prostate cancer|recurrent prostate cancer
5825029|NCT00005887|tumors metastatic to brain|tumors metastatic to brain
5825030|NCT00005886|stage I breast cancer|stage i breast cancer
5825031|NCT00005886|stage II breast cancer|stage ii breast cancer
5825032|NCT00005886|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5825033|NCT00005886|breast cancer in situ|breast cancer in situ
5825034|NCT00005857|stage IV prostate cancer|stage iv prostate cancer
5825035|NCT00005857|recurrent prostate cancer|recurrent prostate cancer
5825041|NCT00067808|Myelodysplastic Syndrome|myelodysplastic syndrome
5825042|NCT00067808|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5825044|NCT00067808|Decitabine|decitabine
5825045|NCT00067808|Dacogen|dacogen
5825046|NCT00067808|Methylation|methylation
5825047|NCT00067795|Treatment Experienced|treatment experienced
5825048|NCT00067795|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5825049|NCT00067795|HIV Antigens|hiv antigens
5825050|NCT00067795|Cohort Studies|cohort studies
5825051|NCT00067795|Immunity, Cellular|immunity, cellular
5825052|NCT00067795|T-Lymphocytes|t-lymphocytes
5825053|NCT00067782|HIV|hiv
5825054|NCT00067782|Treatment Experienced|treatment experienced
5825055|NCT00067769|Encopresis|encopresis
5825056|NCT00067769|Internet|internet
5825057|NCT00067769|Web|web
5825058|NCT00067769|Treatment|treatment
5825059|NCT00067769|Intervention|intervention
5825060|NCT00005804|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5845622|NCT00050245|Anti-MAG|anti-mag
5825061|NCT00005804|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5825062|NCT00005804|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5825063|NCT00005804|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5825064|NCT00005804|Burkitt lymphoma|burkitt lymphoma
5825065|NCT00005804|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5825066|NCT00005804|extramedullary plasmacytoma|extramedullary plasmacytoma
5825067|NCT00005804|refractory multiple myeloma|refractory multiple myeloma
5825068|NCT00005804|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5825069|NCT00005804|stage III multiple myeloma|stage iii multiple myeloma
5825070|NCT00005804|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5825071|NCT00005804|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5825072|NCT00005804|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5825073|NCT00005804|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5825074|NCT00005804|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5825075|NCT00005804|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5825076|NCT00005804|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5825077|NCT00005804|small intestine lymphoma|small intestine lymphoma
5825078|NCT00005804|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5825079|NCT00005804|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5825080|NCT00005804|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5825081|NCT00005804|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5825082|NCT00005804|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5825083|NCT00005804|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5825084|NCT00005804|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5825085|NCT00005804|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5821126|NCT00076609|tcm|tcm
5825086|NCT00005804|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5825087|NCT00005804|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5825088|NCT00005804|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5825089|NCT00005804|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5825090|NCT00005804|polycythemia vera|polycythemia vera
5825091|NCT00005804|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5825092|NCT00005804|essential thrombocythemia|essential thrombocythemia
5825093|NCT00005804|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5825094|NCT00005804|refractory hairy cell leukemia|refractory hairy cell leukemia
5825095|NCT00005804|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5825096|NCT00005804|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5825097|NCT00005804|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5825098|NCT00005804|acute undifferentiated leukemia|acute undifferentiated leukemia
5825099|NCT00005804|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5825100|NCT00005804|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5825101|NCT00005804|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5825102|NCT00005804|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5825103|NCT00005804|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5825104|NCT00005804|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5825105|NCT00005804|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5825106|NCT00005804|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5825107|NCT00005804|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5825108|NCT00005804|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5825109|NCT00005804|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5825110|NCT00005804|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5825111|NCT00005804|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5825112|NCT00005804|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5825113|NCT00005804|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5825114|NCT00005804|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5825115|NCT00005804|prolymphocytic leukemia|prolymphocytic leukemia
5825116|NCT00005804|primary systemic amyloidosis|primary systemic amyloidosis
5825117|NCT00005804|intraocular lymphoma|intraocular lymphoma
5825118|NCT00005804|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5825119|NCT00005804|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5825120|NCT00005804|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5825121|NCT00005804|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5825122|NCT00005804|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5825123|NCT00005804|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5825124|NCT00005804|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5825125|NCT00005804|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5825126|NCT00005804|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5825127|NCT00005804|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5825128|NCT00005804|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5825129|NCT00005804|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5825130|NCT00005804|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5825131|NCT00005804|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5681347|NCT00573729|vascular malformation|vascular malformation
5681348|NCT00573716|bone mineral content|bone mineral content
5825132|NCT00005090|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5825133|NCT00005090|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5825134|NCT00067756|Pulmonary Disease|pulmonary disease
5825135|NCT00067756|Liver Disease|liver disease
5825137|NCT00067743|Pain syndrome|pain syndrome
5825138|NCT00067743|Reflex sympathetic dystrophy|reflex sympathetic dystrophy
5825140|NCT00067743|CC5013|cc5013
5825141|NCT00067743|Revlimid|revlimid
5825142|NCT00067743|Celgene|celgene
5825143|NCT00067743|CRPS|crps
5825144|NCT00067717|breast reconstruction surgery|breast reconstruction surgery
5825145|NCT00067717|prayer|prayer
5825146|NCT00067717|distance healing|distance healing
5825147|NCT00067717|wound healing|wound healing
5825148|NCT00067704|Complementary Therapies|complementary therapies
5825149|NCT00067691|Lung cancer|lung cancer
5825150|NCT00067691|Breast cancer|breast cancer
5825151|NCT00067691|Shortness of breath|shortness of breath
5825152|NCT00067691|Dyspnea|dyspnea
5825153|NCT00067691|Metastasis|metastasis
5825154|NCT00067691|Breathlessness|breathlessness
5825155|NCT00067691|Acupuncture|acupuncture
5825156|NCT00067678|diabetic nephropathy|diabetic nephropathy
5825157|NCT00067678|nephropathy|nephropathy
5825158|NCT00067678|diabetes|diabetes
5825159|NCT00067678|diabetes mellitus|diabetes mellitus
5825160|NCT00067678|type I diabetes|type i diabetes
5825161|NCT00067678|soy protein|soy protein
5825162|NCT00067665|hemodialysis|hemodialysis
5825163|NCT00067639|Multiple Myeloma|multiple myeloma
5825164|NCT00067639|PBSC mobilization|pbsc mobilization
5825165|NCT00067639|Pegfilgrastim|pegfilgrastim
5825166|NCT00067639|Neulasta|neulasta
5825167|NCT00067639|PEG-G-CSF|peg-g-csf
5825168|NCT00067626|glucose tolerance test|glucose tolerance test
5825169|NCT00067626|minerals|minerals
5825170|NCT00067626|chromium|chromium
5825171|NCT00067626|complementary and alternative medicine|complementary and alternative medicine
5825172|NCT00067613|NICHD Neonatal Research Network|nichd neonatal research network
5825173|NCT00067613|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5825174|NCT00067613|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5825175|NCT00067613|Prematurity|prematurity
5825176|NCT00067613|Mechanical ventilation|mechanical ventilation
5825177|NCT00067613|Benchmarking|benchmarking
5825178|NCT00067613|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5825179|NCT00067587|Treatment experienced|treatment experienced
5825180|NCT00067587|Treatment naive|treatment naive
5825181|NCT00067574|Structured treatment interruption|structured treatment interruption
5825182|NCT00067574|Treatment experienced|treatment experienced
5825183|NCT00067561|Dose-ranging|dose-ranging
5825184|NCT00067561|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5825185|NCT00067561|d-IBS|d-ibs
5825186|NCT00067561|IBS|ibs
5825187|NCT00067561|Irritable Bowel Syndrome|irritable bowel syndrome
5825188|NCT00067548|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5825189|NCT00067535|cocaine dependence|cocaine dependence
5825190|NCT00067522|Family Planning|family planning
5825191|NCT00067522|Sexually Transmitted Diseases|sexually transmitted diseases
5825192|NCT00067522|HIV|hiv
5825193|NCT00067522|Africa|africa
5825194|NCT00067522|Zambia|zambia
5825195|NCT00067522|AIDS|aids
5825196|NCT00067522|Contraception|contraception
5825197|NCT00067522|HIV Prevention|hiv prevention
5825198|NCT00067509|Female|female
5825199|NCT00004256|stage I laryngeal cancer|stage i laryngeal cancer
5681344|NCT00573755|stage IV breast cancer|stage iv breast cancer
5825200|NCT00004256|stage II laryngeal cancer|stage ii laryngeal cancer
5825201|NCT00004256|recurrent laryngeal cancer|recurrent laryngeal cancer
5825202|NCT00004256|oral complications|oral complications
5825203|NCT00004256|radiation toxicity|radiation toxicity
5825204|NCT00004233|stage III gastric cancer|stage iii gastric cancer
5825205|NCT00004233|stage IV gastric cancer|stage iv gastric cancer
5825206|NCT00004233|recurrent gastric cancer|recurrent gastric cancer
5825207|NCT00004233|stage III esophageal cancer|stage iii esophageal cancer
5825208|NCT00004233|stage IV esophageal cancer|stage iv esophageal cancer
5825209|NCT00004233|recurrent esophageal cancer|recurrent esophageal cancer
5825210|NCT00004233|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5825211|NCT00004233|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5825212|NCT00004125|stage II breast cancer|stage ii breast cancer
5825213|NCT00004125|stage IIIA breast cancer|stage iiia breast cancer
5825214|NCT00067496|Pain|pain
5825215|NCT00067496|Weakness|weakness
5825216|NCT00067496|Depression|depression
5825217|NCT00067496|Poliomyelitis|poliomyelitis
5825218|NCT00067496|Sleep Apnea|sleep apnea
5825219|NCT00067496|Post-Polio Syndrome|post-polio syndrome
5825220|NCT00067496|PPS|pps
5825221|NCT00067483|Cataract|cataract
5825222|NCT00067483|Pre-Senile|pre-senile
5825223|NCT00067483|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5825224|NCT00067483|Light Scattering|light scattering
5681349|NCT00573716|aripiprazole monotherapy|aripiprazole monotherapy
5681350|NCT00573716|risperidone monotherapy|risperidone monotherapy
5681351|NCT00573703|Laparoscopic Burch colposuspension|laparoscopic burch colposuspension
5681352|NCT00573703|Stress incontinence|stress incontinence
5681355|NCT00573703|Treatment|treatment
5845683|NCT00050089|ART|art
5825225|NCT00067483|Lens|lens
5825226|NCT00067483|Cataracts|cataracts
5825227|NCT00067457|PRN|prn
5825228|NCT00067457|Diarrhea-Predominant Irritable Bowel Syndrome|diarrhea-predominant irritable bowel syndrome
5825229|NCT00067457|Irritable Bowel Syndrome (IBS)|irritable bowel syndrome (ibs)
5825230|NCT00067444|Elderly|elderly
5825231|NCT00067444|Major Depressive Disorder|major depressive disorder
5825232|NCT00067444|MDD|mdd
5825233|NCT00067431|Partial Seizures|partial seizures
5825234|NCT00067405|Fibromyalgia|fibromyalgia
5825235|NCT00067405|Intravenous micronutrient therapy|intravenous micronutrient therapy
5825236|NCT00067405|IVMT|ivmt
5825237|NCT00067405|alternative medicine|alternative medicine
5825238|NCT00067405|complementary medicine|complementary medicine
5825239|NCT00067405|vitamins|vitamins
5825240|NCT00067405|vitamin supplements|vitamin supplements
5825241|NCT00067392|Partial edentulism|partial edentulism
5825242|NCT00067392|Bone atrophy|bone atrophy
5825243|NCT00067392|Bone healing|bone healing
5825244|NCT00004004|recurrent adult brain tumor|recurrent adult brain tumor
5825245|NCT00004004|adult glioblastoma|adult glioblastoma
5825246|NCT00004004|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5825247|NCT00004004|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5825248|NCT00004004|adult giant cell glioblastoma|adult giant cell glioblastoma
5825249|NCT00004004|adult gliosarcoma|adult gliosarcoma
5825250|NCT00003931|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5825251|NCT00003931|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5825252|NCT00003890|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5825253|NCT00003736|breast cancer|breast cancer
5825254|NCT00003464|adult glioblastoma|adult glioblastoma
5825255|NCT00003464|adult giant cell glioblastoma|adult giant cell glioblastoma
5825256|NCT00003464|adult gliosarcoma|adult gliosarcoma
5825257|NCT00067418|Glioma|glioma
5825258|NCT00067418|Brain Tumor|brain tumor
5825259|NCT00067418|Spectroscopy|spectroscopy
5825260|NCT00067353|Early Childhood Caries|early childhood caries
5825261|NCT00067327|Relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis
5825262|NCT00067327|Multiple sclerosis|multiple sclerosis
5825263|NCT00067327|Peroxynitrite|peroxynitrite
5825264|NCT00067327|Uric acid|uric acid
5825265|NCT00067327|Inosine|inosine
5825266|NCT00067301|depression|depression
5825267|NCT00067301|citalopram|citalopram
5825268|NCT00067301|Celexa|celexa
5825269|NCT00067301|Polyunsaturated Fatty Acids|polyunsaturated fatty acids
5825270|NCT00067301|omega-3|omega-3
5825271|NCT00067301|EPA|epa
5825272|NCT00067301|antidepressants|antidepressants
5825273|NCT00067288|Stage 3 cancer;|stage 3 cancer;
5825274|NCT00067288|Stage 4 cancer;|stage 4 cancer;
5825275|NCT00067288|solid tumor cancer;|solid tumor cancer;
5825276|NCT00067288|Non-Hodgkin's Lymphoma;|non-hodgkin's lymphoma;
5825277|NCT00067288|solid tumors;|solid tumors;
5825278|NCT00067288|end-stage cancer;|end-stage cancer;
5825279|NCT00067288|group psychotherapy;|group psychotherapy;
5825280|NCT00067288|psychotherapy;|psychotherapy;
5825281|NCT00067288|emotional support;|emotional support;
5825282|NCT00067288|support groups|support groups
5825283|NCT00067262|Bipolar Disorder Type 1 (manic or mixed type)|bipolar disorder type 1 (manic or mixed type)
5825284|NCT00067249|Race|race
5825285|NCT00067249|Ethnicity|ethnicity
5825286|NCT00067249|Complementary and Alternative Medicine|complementary and alternative medicine
5825287|NCT00067249|Women's health|women's health
5825288|NCT00067249|Social determinants of Health|social determinants of health
5825289|NCT00067275|Stroke|stroke
5825290|NCT00067275|Motor Training|motor training
5825291|NCT00067275|Positron Emission Tomograhy|positron emission tomograhy
5825292|NCT00067275|Plasticity|plasticity
5846653|NCT00043849|Agitation, Psychomotor|agitation, psychomotor
5825293|NCT00067275|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5825294|NCT00067275|Healthy Volunteer|healthy volunteer
5825296|NCT00067223|Transcranial Magnetic Stimulation (TMS)|transcranial magnetic stimulation (tms)
5825297|NCT00067223|Unilateral Finger Movement|unilateral finger movement
5825298|NCT00067223|Interhemispheric Inhibition|interhemispheric inhibition
5825299|NCT00067223|Motor Training|motor training
5825300|NCT00067223|Plasticity|plasticity
5825301|NCT00067223|Healthy Volunteer|healthy volunteer
5825302|NCT00067223|HV|hv
5825303|NCT00067210|Brain|brain
5825304|NCT00067210|Epilepsy|epilepsy
5825305|NCT00067210|Core|core
5825306|NCT00067210|Temperature|temperature
5825307|NCT00067197|Transcranial Direct Current Stimulation (tDCS)|transcranial direct current stimulation (tdcs)
5825308|NCT00067197|Cortical Reorganization|cortical reorganization
5825309|NCT00067197|Rehabilitation|rehabilitation
5825310|NCT00067197|Motor Learning|motor learning
5825311|NCT00067197|Activity of Daily Living (ADL)|activity of daily living (adl)
5825312|NCT00067197|Stroke|stroke
5825313|NCT00067197|Healthy Volunteer|healthy volunteer
5825314|NCT00067197|HV|hv
5825315|NCT00067184|methadone|methadone
5825316|NCT00067184|fetus|fetus
5825317|NCT00067171|behavioral intervention|behavioral intervention
5825318|NCT00067158|nicotine dependence|nicotine dependence
5825319|NCT00067119|Graft Failure|graft failure
5825320|NCT00067119|Access Blood Flow Monitoring|access blood flow monitoring
5825321|NCT00067119|Clinical Trial Vascular Access|clinical trial vascular access
5825322|NCT00067119|Fistula Failure|fistula failure
5825323|NCT00067119|Hemodialysis|hemodialysis
5825324|NCT00067119|Vascular Access|vascular access
5825325|NCT00067106|HIV|hiv
5825326|NCT00067106|Women|women
5825327|NCT00067106|Genital tract|genital tract
5825328|NCT00067106|Treatment experienced|treatment experienced
5825329|NCT00067106|Drug resistance|drug resistance
5825330|NCT00067080|Sickle cell disease|sickle cell disease
5825331|NCT00067080|iron overload|iron overload
5825332|NCT00067080|deferoxamine|deferoxamine
5825333|NCT00067080|hemosiderosis|hemosiderosis
5825334|NCT00067041|Critical Limb Ischemia|critical limb ischemia
5825335|NCT00067041|Autogenous Bypass Graft|autogenous bypass graft
5825336|NCT00067041|CLI|cli
5825337|NCT00067028|Chronic Myeloid Leukemia|chronic myeloid leukemia
5825338|NCT00067028|CML Myeloid Blast Phase|cml myeloid blast phase
5825339|NCT00067028|Acute Myeloid Leukemia|acute myeloid leukemia
5825340|NCT00067028|Myelodysplastic Syndrome|myelodysplastic syndrome
5825341|NCT00067028|Clofarabine|clofarabine
5825342|NCT00067028|Clofarex|clofarex
5825343|NCT00067028|Clolar|clolar
5825344|NCT00067028|Ara-C|ara-c
5825345|NCT00067028|Cytarabine|cytarabine
5825346|NCT00067028|Cytosar|cytosar
5825347|NCT00067028|DepoCyt|depocyt
5825348|NCT00067028|Cytosine arabinosine hydrochloride|cytosine arabinosine hydrochloride
5825350|NCT00067028|Idamycin|idamycin
5825351|NCT00003433|stage IV colon cancer|stage iv colon cancer
5825352|NCT00003433|liver metastases|liver metastases
5825353|NCT00003323|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5825354|NCT00003323|recurrent prostate cancer|recurrent prostate cancer
5825355|NCT00003323|sexual dysfunction and infertility|sexual dysfunction and infertility
5825356|NCT00003114|AIDS-related lymphoma|aids-related lymphoma
5825357|NCT00003114|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5825358|NCT00003006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5825361|NCT00067067|Endothelial Progenitor Cells|endothelial progenitor cells
5825362|NCT00067054|Volunteer|volunteer
5825363|NCT00067054|Plasmapheresis|plasmapheresis
5825364|NCT00067054|Leukapheresis|leukapheresis
5825365|NCT00067054|Immunology|immunology
5825366|NCT00067054|Leukocyte|leukocyte
5825367|NCT00067054|Healthy Volunteer|healthy volunteer
5825369|NCT00067015|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5825370|NCT00067015|stage III prostate cancer|stage iii prostate cancer
5825371|NCT00067002|ALL|all
5825372|NCT00067002|Leukemia, Lymphocytic, Acute|leukemia, lymphocytic, acute
5825373|NCT00067002|AML|aml
5825374|NCT00067002|Leukemia, Myelocytic, Acute|leukemia, myelocytic, acute
5825375|NCT00067002|CML|cml
5825376|NCT00067002|Leukemia, Myeloid, Chronic|leukemia, myeloid, chronic
5825377|NCT00067002|NHL|nhl
5825378|NCT00067002|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5825379|NCT00067002|double cord blood transplant|double cord blood transplant
5825380|NCT00067002|expanded cord blood transplant|expanded cord blood transplant
5825381|NCT00067002|Rituxan|rituxan
5825383|NCT00067002|Melphalan|melphalan
5825385|NCT00067002|Thiotepa|thiotepa
5825386|NCT00067002|Fludarabine|fludarabine
5825387|NCT00067002|Fludarabine phosphate|fludarabine phosphate
5825388|NCT00067002|Fludara|fludara
5825389|NCT00067002|Cyclophosphamide|cyclophosphamide
5825390|NCT00067002|Cytoxan|cytoxan
5825391|NCT00067002|Neosar|neosar
5825392|NCT00067002|Mesna|mesna
5825393|NCT00067002|Mesnex|mesnex
5825394|NCT00066989|Staphylococcal infection|staphylococcal infection
5825395|NCT00066989|Gram positive bacteria|gram positive bacteria
5825396|NCT00066989|Staphylococcus|staphylococcus
5825397|NCT00066989|Staphylococcus aureus|staphylococcus aureus
5825398|NCT00046878|adult glioblastoma|adult glioblastoma
5825399|NCT00046878|adult giant cell glioblastoma|adult giant cell glioblastoma
5825400|NCT00046878|adult gliosarcoma|adult gliosarcoma
5825401|NCT00002621|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5825402|NCT00002621|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5825403|NCT00002621|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5825404|NCT00002621|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5825405|NCT00002621|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5825406|NCT00002621|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5681356|NCT00573703|Predominant or genuine stress urinary incontinence|predominant or genuine stress urinary incontinence
5681357|NCT00573690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5681358|NCT00573664|Cesarean section|cesarean section
5681360|NCT00573651|JIA|jia
5681361|NCT00573651|SEA syndrome|sea syndrome
5681362|NCT00573651|AS|as
5845895|NCT00048477|HV|hv
5825407|NCT00002621|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5825408|NCT00002621|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5825409|NCT00002621|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5825410|NCT00002621|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5825411|NCT00002621|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5825412|NCT00002621|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5826129|NCT00065741|Milk thistle|milk thistle
5825413|NCT00002621|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5825414|NCT00002621|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5825415|NCT00002621|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5825416|NCT00002621|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5825417|NCT00002621|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5825418|NCT00002621|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5825419|NCT00002621|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5825420|NCT00002621|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5825421|NCT00002621|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5825422|NCT00002621|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5825423|NCT00002621|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5825424|NCT00002621|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5825425|NCT00002548|stage I multiple myeloma|stage i multiple myeloma
5846646|NCT00043862|oral|oral
5825426|NCT00002548|stage II multiple myeloma|stage ii multiple myeloma
5825427|NCT00002548|stage III multiple myeloma|stage iii multiple myeloma
5825428|NCT00002520|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5825429|NCT00002520|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5825430|NCT00002520|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5825431|NCT00002520|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5825432|NCT00002520|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5825433|NCT00002520|stage I colon cancer|stage i colon cancer
5825434|NCT00002520|stage II colon cancer|stage ii colon cancer
5825435|NCT00002520|stage I breast cancer|stage i breast cancer
5825436|NCT00002520|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5825437|NCT00002520|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5825438|NCT00002520|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5825439|NCT00002520|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5825440|NCT00002520|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5825441|NCT00002520|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5825442|NCT00002520|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5825443|NCT00002520|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5825444|NCT00002520|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5825445|NCT00002520|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5825446|NCT00002520|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5825447|NCT00002520|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5825448|NCT00002520|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5825449|NCT00002520|intraocular lymphoma|intraocular lymphoma
5824888|NCT00008359|neutropenia|neutropenia
5825450|NCT00002520|limited stage small cell lung cancer|limited stage small cell lung cancer
5825451|NCT00002520|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5825452|NCT00002520|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5825453|NCT00002520|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5825455|NCT00002520|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5862684|NCT00001545|Affective Disorders|affective disorders
5681363|NCT00573651|psoriatic arthritis|psoriatic arthritis
5681364|NCT00573651|HPV vaccine|hpv vaccine
5681365|NCT00573638|glaucoma|glaucoma
5681366|NCT00573638|compliance|compliance
5681367|NCT00573638|eye drops|eye drops
5681368|NCT00573638|deliver aid|deliver aid
5845999|NCT00047905|Simulated Clients|simulated clients
5825456|NCT00002520|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5825457|NCT00002520|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5838350|NCT00006994|pain|pain
5825458|NCT00002520|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5825459|NCT00002520|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5825460|NCT00002520|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5825461|NCT00002520|primary central nervous system lymphoma|primary central nervous system lymphoma
5825462|NCT00002520|tobacco use disorder|tobacco use disorder
5825463|NCT00002520|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5825464|NCT00002520|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5825465|NCT00002520|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5825466|NCT00002520|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5825467|NCT00002520|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5825468|NCT00002520|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5825469|NCT00002520|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5825470|NCT00002520|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5825471|NCT00002520|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5825472|NCT00002520|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5825473|NCT00002520|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5826130|NCT00065741|silymarin|silymarin
5825474|NCT00002520|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5825475|NCT00002520|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5825476|NCT00002520|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5825477|NCT00002520|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5825478|NCT00002520|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5825479|NCT00002520|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5825480|NCT00002520|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5825481|NCT00002520|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5825482|NCT00002520|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5825483|NCT00002520|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5825485|NCT00002520|stage I prostate cancer|stage i prostate cancer
5825486|NCT00002520|stage I rectal cancer|stage i rectal cancer
5825487|NCT00002520|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5825488|NCT00002520|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5825489|NCT00002520|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5825490|NCT00002520|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5825491|NCT00002520|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5825492|NCT00002520|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5825493|NCT00002520|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5825494|NCT00002520|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5825495|NCT00002520|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5825496|NCT00002520|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5825497|NCT00002520|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5825498|NCT00002520|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5825499|NCT00002520|stage II bladder cancer|stage ii bladder cancer
5825500|NCT00002520|stage II breast cancer|stage ii breast cancer
5825501|NCT00002520|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5825502|NCT00002520|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5825503|NCT00002520|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5825504|NCT00002520|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5835103|NCT00027963|pain|pain
5825505|NCT00002520|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5825506|NCT00002520|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5825507|NCT00002520|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5825508|NCT00002520|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5825509|NCT00002520|stage I bladder cancer|stage i bladder cancer
5825510|NCT00002520|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5825511|NCT00002520|stage II prostate cancer|stage ii prostate cancer
5825512|NCT00002520|stage II rectal cancer|stage ii rectal cancer
5825513|NCT00002520|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5825514|NCT00002520|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5825515|NCT00002520|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5825516|NCT00002520|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5825517|NCT00002520|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5825518|NCT00002520|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5825519|NCT00002520|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5825520|NCT00002520|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5825521|NCT00002520|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5825522|NCT00002520|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5825523|NCT00002520|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5825524|NCT00002520|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5825525|NCT00002520|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5825526|NCT00002520|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5825527|NCT00002520|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5825528|NCT00002520|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5825529|NCT00002520|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5825530|NCT00002520|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5825531|NCT00002520|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5825532|NCT00002520|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5826131|NCT00065741|piperine|piperine
5825533|NCT00002520|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5825534|NCT00002520|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5825535|NCT00002520|stage III prostate cancer|stage iii prostate cancer
5825536|NCT00002520|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5825537|NCT00002520|stage IIIA breast cancer|stage iiia breast cancer
5825538|NCT00002520|stage IIIB breast cancer|stage iiib breast cancer
5825539|NCT00002520|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5825540|NCT00002520|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5825541|NCT00002520|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5825542|NCT00002520|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5825544|NCT00002520|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5825545|NCT00002520|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5825546|NCT00002520|stage IV breast cancer|stage iv breast cancer
5825547|NCT00002520|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5825548|NCT00002520|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5825549|NCT00002520|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5825550|NCT00002520|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5825551|NCT00002520|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5825552|NCT00002520|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5825553|NCT00002520|stage IV prostate cancer|stage iv prostate cancer
5825554|NCT00002520|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5825555|NCT00002520|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5825556|NCT00002520|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5825557|NCT00002520|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5825558|NCT00002520|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5825559|NCT00002520|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5825560|NCT00002520|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5825561|NCT00002520|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5825562|NCT00002520|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5825563|NCT00002520|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5681345|NCT00573755|recurrent breast cancer|recurrent breast cancer
5825564|NCT00002520|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5681369|NCT00573638|Patients could range anywhere from 40 to 80 years old|patients could range anywhere from 40 to 80 years old
5681370|NCT00573638|Patients must have diagnosis requiring treatment with Xalatan.|patients must have diagnosis requiring treatment with xalatan.
5681371|NCT00573638|Patients will be male or female and from any racial/ethnic background.|patients will be male or female and from any racial/ethnic background.
5681372|NCT00573612|Fibromyalgia|fibromyalgia
5681373|NCT00573612|Fibromyalgia patients|fibromyalgia patients
5681374|NCT00573599|Migraine|migraine
5681375|NCT00573599|Emergency|emergency
5681376|NCT00573599|imitrex|imitrex
5681377|NCT00573599|prochlorperazine|prochlorperazine
5681378|NCT00573599|Acute Migraine Headache in the Emergency Department|acute migraine headache in the emergency department
5681379|NCT00573573|PRIMARY HYPERPARATHYROIDISM|primary hyperparathyroidism
5681380|NCT00573573|PARATHYROID NEOPLASMS|parathyroid neoplasms
5681381|NCT00573573|SECONDARY HYPERPARATHYROIDISM|secondary hyperparathyroidism
5681382|NCT00573573|HYPOCALCEMIA|hypocalcemia
5681383|NCT00573560|Heart failure|heart failure
5681384|NCT00573560|percutaneous|percutaneous
5681385|NCT00573560|interventional cardiology|interventional cardiology
5846221|NCT00046293|MRI|mri
5825565|NCT00002520|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5825566|NCT00002520|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5825567|NCT00002520|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5825568|NCT00066976|Prenatal|prenatal
5825569|NCT00066976|Respiration|respiration
5825570|NCT00066976|Ultrasound|ultrasound
5825572|NCT00066976|Diagnoses|diagnoses
5825573|NCT00066976|Fetal Breathing-Movement|fetal breathing-movement
5825574|NCT00066976|Doppler Sonography|doppler sonography
5825575|NCT00066976|Amniotic Fluid|amniotic fluid
5825576|NCT00066976|Oligohydraminos|oligohydraminos
5825577|NCT00066976|Polyhydraminos|polyhydraminos
5825578|NCT00066976|Pregnancy|pregnancy
5825579|NCT00066963|Early Childhood Caries|early childhood caries
5825580|NCT00066950|Early childhood caries|early childhood caries
5825581|NCT00066924|spirituality|spirituality
5825582|NCT00066924|religiosity|religiosity
5825583|NCT00066924|immune functioning|immune functioning
5825584|NCT00066924|psychoneuroimmunology|psychoneuroimmunology
5825585|NCT00066924|cytokines|cytokines
5825586|NCT00066924|cancer|cancer
5825587|NCT00066924|death|death
5825588|NCT00066924|depression|depression
5825589|NCT00066898|succinobucol|succinobucol
5825590|NCT00066898|AGI-1067|agi-1067
5825591|NCT00066898|coronary artery disease|coronary artery disease
5825592|NCT00066885|DN101|dn101
5825593|NCT00066885|Calcitriol|calcitriol
5825594|NCT00066885|Lung Cancer|lung cancer
5825595|NCT00066885|NSCLC|nsclc
5825596|NCT00066885|Taxotere|taxotere
5825597|NCT00011973|stage III renal cell cancer|stage iii renal cell cancer
5825598|NCT00011973|stage IV renal cell cancer|stage iv renal cell cancer
5825599|NCT00011973|recurrent renal cell cancer|recurrent renal cell cancer
5825600|NCT00005027|stage III renal cell cancer|stage iii renal cell cancer
5825601|NCT00005027|stage IV renal cell cancer|stage iv renal cell cancer
5825602|NCT00005027|recurrent renal cell cancer|recurrent renal cell cancer
5825603|NCT00066911|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5825604|NCT00066911|Vocalization|vocalization
5825605|NCT00066911|Spasmodic Dysphonia|spasmodic dysphonia
5825606|NCT00066911|Muscular Tension Dysphonia|muscular tension dysphonia
5825607|NCT00066911|Topical Lidocaine|topical lidocaine
5825608|NCT00066911|Voice Disorders|voice disorders
5825609|NCT00066911|Vocal Tremor|vocal tremor
5825610|NCT00066911|Healthy Volunteer|healthy volunteer
5825612|NCT00066872|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5826132|NCT00065741|glucarate|glucarate
5826141|NCT00065741|Complementary Therapies|complementary therapies
5825614|NCT00066859|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5825615|NCT00066846|adenocarcinoma of the colon|adenocarcinoma of the colon
5825616|NCT00066846|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5825617|NCT00066846|stage IV rectal cancer|stage iv rectal cancer
5825618|NCT00066846|recurrent rectal cancer|recurrent rectal cancer
5825619|NCT00066846|stage IV colon cancer|stage iv colon cancer
5825620|NCT00066846|recurrent colon cancer|recurrent colon cancer
5825621|NCT00066807|stage IIIA breast cancer|stage iiia breast cancer
5825622|NCT00066807|stage I breast cancer|stage i breast cancer
5825623|NCT00066807|stage II breast cancer|stage ii breast cancer
5825624|NCT00066794|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5825625|NCT00066794|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5825626|NCT00066794|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5825627|NCT00066794|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5825628|NCT00066794|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5825629|NCT00066794|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5825630|NCT00066794|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5825631|NCT00066794|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5825632|NCT00066794|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5825633|NCT00066794|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5825634|NCT00066794|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5825635|NCT00066794|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5825636|NCT00066794|adult pure erythroid leukemia (M6b)|adult pure erythroid leukemia (m6b)
5825637|NCT00066794|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5825638|NCT00066781|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5825639|NCT00066781|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5825640|NCT00066781|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5825641|NCT00066781|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5825642|NCT00066729|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5825643|NCT00066729|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5825644|NCT00066729|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5825645|NCT00066729|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5825646|NCT00066729|fallopian tube cancer|fallopian tube cancer
5825647|NCT00066716|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5825648|NCT00066716|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5825649|NCT00066716|stage I esophageal cancer|stage i esophageal cancer
5825650|NCT00066716|stage II esophageal cancer|stage ii esophageal cancer
5825651|NCT00066716|stage III esophageal cancer|stage iii esophageal cancer
5825652|NCT00066716|stage IV esophageal cancer (lymph node metastasis only)|stage iv esophageal cancer (lymph node metastasis only)
5825653|NCT00066703|stage II breast cancer|stage ii breast cancer
5825654|NCT00066703|stage IIIA breast cancer|stage iiia breast cancer
5825655|NCT00066703|estrogen receptor-positive breast cancer|estrogen receptor-positive breast cancer
5825656|NCT00066703|progesterone receptor-positive breast cancer|progesterone receptor-positive breast cancer
5825657|NCT00066703|stage IA breast cancer|stage ia breast cancer
5825658|NCT00066703|stage IB breast cancer|stage ib breast cancer
5825659|NCT00066690|tamoxifen|tamoxifen
5825660|NCT00066690|ovarian function suppression + tamoxifen|ovarian function suppression + tamoxifen
5846654|NCT00043836|ejection fraction|ejection fraction
5825661|NCT00066690|ovarian function suppression + exemestane|ovarian function suppression + exemestane
5825662|NCT00066677|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5825663|NCT00066677|recurrent pancreatic cancer|recurrent pancreatic cancer
5825664|NCT00066677|stage IV pancreatic cancer|stage iv pancreatic cancer
5825665|NCT00066664|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5825666|NCT00066664|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5825667|NCT00066664|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5825668|NCT00066664|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5825669|NCT00066664|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5825670|NCT00066664|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5825671|NCT00066664|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5825672|NCT00066664|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5825673|NCT00066664|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5825674|NCT00066664|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5825675|NCT00066651|ovarian carcinosarcoma|ovarian carcinosarcoma
5825676|NCT00066651|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5825677|NCT00066651|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5825678|NCT00066651|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5825679|NCT00066651|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5825680|NCT00066651|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5825681|NCT00066651|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5825682|NCT00066651|Brenner tumor|brenner tumor
5825683|NCT00066651|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5825684|NCT00066651|fallopian tube cancer|fallopian tube cancer
5825685|NCT00066651|epithelial mesothelioma|epithelial mesothelioma
5825686|NCT00066651|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5825687|NCT00066651|recurrent pancreatic cancer|recurrent pancreatic cancer
5825688|NCT00066651|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5825689|NCT00066651|recurrent cervical cancer|recurrent cervical cancer
5825690|NCT00066651|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5825691|NCT00066651|squamous cell lung cancer|squamous cell lung cancer
5825692|NCT00066651|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5825693|NCT00066651|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5825694|NCT00066651|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5686676|NCT00551122|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5681346|NCT00573742|hypertension|hypertension
5825695|NCT00066651|recurrent salivary gland cancer|recurrent salivary gland cancer
5825696|NCT00066651|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5825697|NCT00066651|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5825698|NCT00066651|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5825699|NCT00066651|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5825700|NCT00066651|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5825701|NCT00066612|recurrent bladder cancer|recurrent bladder cancer
5825702|NCT00066612|stage IV bladder cancer|stage iv bladder cancer
5825703|NCT00066612|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5825704|NCT00066612|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5825705|NCT00066612|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5825706|NCT00066612|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5825707|NCT00066612|anterior urethral cancer|anterior urethral cancer
5825708|NCT00066612|posterior urethral cancer|posterior urethral cancer
5825709|NCT00066612|recurrent urethral cancer|recurrent urethral cancer
5825710|NCT00066612|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5825711|NCT00066599|neutropenia|neutropenia
5825712|NCT00066599|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5825713|NCT00066599|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5825714|NCT00066599|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5825715|NCT00066599|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5825716|NCT00066599|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5825717|NCT00066599|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5825718|NCT00066599|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5825719|NCT00066599|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5825720|NCT00066599|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5825721|NCT00066599|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5825722|NCT00066599|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5825723|NCT00066599|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5825724|NCT00066599|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5825725|NCT00066599|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5825726|NCT00066599|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5825727|NCT00066599|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5825728|NCT00066599|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5825729|NCT00066599|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5825730|NCT00066599|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5825731|NCT00066599|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5825732|NCT00066599|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5825733|NCT00066599|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5825734|NCT00066599|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5825735|NCT00066599|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5825736|NCT00066599|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5825737|NCT00066599|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5825738|NCT00066599|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5825739|NCT00066599|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5825740|NCT00066599|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5681387|NCT00573560|LV dilatation|lv dilatation
5681388|NCT00573560|akinesis|akinesis
5825741|NCT00066599|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5825742|NCT00066599|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5826134|NCT00065741|abacavir|abacavir
5825743|NCT00066599|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5825744|NCT00066599|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5825745|NCT00066599|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5825746|NCT00066599|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5825747|NCT00066599|intraocular lymphoma|intraocular lymphoma
5825748|NCT00066599|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5825749|NCT00066599|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5686677|NCT00551122|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5686678|NCT00551122|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5686679|NCT00551122|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5686680|NCT00551122|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5681354|NCT00573703|TOT|tot
5825750|NCT00066599|acute undifferentiated leukemia|acute undifferentiated leukemia
5825850|NCT00066391|stage IV penile cancer|stage iv penile cancer
5825751|NCT00066599|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5825752|NCT00066599|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5825753|NCT00066599|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5825754|NCT00066599|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5825755|NCT00066599|disseminated neuroblastoma|disseminated neuroblastoma
5825756|NCT00066599|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5825757|NCT00066599|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5825758|NCT00066599|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5825759|NCT00066599|stage I multiple myeloma|stage i multiple myeloma
5825760|NCT00066599|stage II multiple myeloma|stage ii multiple myeloma
5825761|NCT00066599|stage III multiple myeloma|stage iii multiple myeloma
5825762|NCT00066599|refractory multiple myeloma|refractory multiple myeloma
5825763|NCT00066599|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5825764|NCT00066599|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5825765|NCT00066599|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5825766|NCT00066599|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5825767|NCT00066599|recurrent neuroblastoma|recurrent neuroblastoma
5825768|NCT00066599|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5825769|NCT00066599|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5825770|NCT00066586|breast cancer|breast cancer
5825771|NCT00066573|stage IIIA breast cancer|stage iiia breast cancer
5825772|NCT00066573|stage I breast cancer|stage i breast cancer
5825773|NCT00066573|stage II breast cancer|stage ii breast cancer
5825774|NCT00066547|recurrent breast cancer|recurrent breast cancer
5825775|NCT00066547|stage IIIA breast cancer|stage iiia breast cancer
5825776|NCT00066547|stage IIIB breast cancer|stage iiib breast cancer
5825777|NCT00066547|stage IIIC breast cancer|stage iiic breast cancer
5825778|NCT00066547|stage IV breast cancer|stage iv breast cancer
5825779|NCT00066508|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5825780|NCT00066482|childhood teratoma|childhood teratoma
5825781|NCT00066482|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5825782|NCT00066469|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5825783|NCT00066443|stage IIIA breast cancer|stage iiia breast cancer
5825784|NCT00066443|stage IIIB breast cancer|stage iiib breast cancer
5825785|NCT00066443|stage IIIC breast cancer|stage iiic breast cancer
5825786|NCT00066443|inflammatory breast cancer|inflammatory breast cancer
5825787|NCT00066430|anal cancer|anal cancer
5825788|NCT00066430|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5825789|NCT00066417|essential thrombocythemia|essential thrombocythemia
5825790|NCT00066417|polycythemia vera|polycythemia vera
5825791|NCT00066417|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5825792|NCT00066417|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5825793|NCT00066417|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5825794|NCT00066417|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5825795|NCT00066417|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5825796|NCT00066417|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5822039|NCT00074386|HIV|hiv
5825797|NCT00066417|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5825798|NCT00066417|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5825799|NCT00066417|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5825800|NCT00066417|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5825801|NCT00066417|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5825802|NCT00066417|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5825803|NCT00066417|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5825804|NCT00066417|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5825805|NCT00066417|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5825806|NCT00066417|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5825807|NCT00066417|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5825808|NCT00066417|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5825809|NCT00066417|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5828274|NCT00061334|Stereotypes|stereotypes
5825810|NCT00066417|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5825811|NCT00066417|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5825812|NCT00066417|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5825813|NCT00066404|advanced malignant mesothelioma|advanced malignant mesothelioma
5825814|NCT00066404|male breast cancer|male breast cancer
5825815|NCT00066404|localized malignant mesothelioma|localized malignant mesothelioma
5825816|NCT00066404|recurrent bladder cancer|recurrent bladder cancer
5825817|NCT00066404|recurrent renal cell cancer|recurrent renal cell cancer
5825818|NCT00066404|recurrent urethral cancer|recurrent urethral cancer
5825819|NCT00066404|recurrent breast cancer|recurrent breast cancer
5825820|NCT00066404|recurrent penile cancer|recurrent penile cancer
5825821|NCT00066404|recurrent prostate cancer|recurrent prostate cancer
5825822|NCT00066404|recurrent anal cancer|recurrent anal cancer
5825823|NCT00066404|recurrent colon cancer|recurrent colon cancer
5825824|NCT00066404|recurrent esophageal cancer|recurrent esophageal cancer
5825825|NCT00066404|recurrent gastric cancer|recurrent gastric cancer
5825826|NCT00066404|recurrent pancreatic cancer|recurrent pancreatic cancer
5825827|NCT00066404|recurrent rectal cancer|recurrent rectal cancer
5825828|NCT00066404|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5825829|NCT00066404|recurrent small intestine cancer|recurrent small intestine cancer
5825830|NCT00066404|recurrent gallbladder cancer|recurrent gallbladder cancer
5825831|NCT00066404|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5825832|NCT00066404|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5825833|NCT00066404|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5825834|NCT00066404|recurrent small cell lung cancer|recurrent small cell lung cancer
5825835|NCT00066404|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5825836|NCT00066404|recurrent melanoma|recurrent melanoma
5825837|NCT00066404|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5825838|NCT00066404|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5825839|NCT00066404|recurrent cervical cancer|recurrent cervical cancer
5825840|NCT00066404|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5825841|NCT00066404|fallopian tube cancer|fallopian tube cancer
5825842|NCT00066404|recurrent vulvar cancer|recurrent vulvar cancer
5825843|NCT00066404|recurrent vaginal cancer|recurrent vaginal cancer
5825844|NCT00066404|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5825845|NCT00066404|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5825846|NCT00066404|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5825847|NCT00066404|malignant pleural effusion|malignant pleural effusion
5825848|NCT00066391|penile squamous cell carcinoma|penile squamous cell carcinoma
5825849|NCT00066391|stage III penile cancer|stage iii penile cancer
5825851|NCT00066378|recurrent breast cancer|recurrent breast cancer
5825852|NCT00066378|stage IIIA breast cancer|stage iiia breast cancer
5825853|NCT00066378|stage IIIB breast cancer|stage iiib breast cancer
5825854|NCT00066378|stage IIIC breast cancer|stage iiic breast cancer
5825855|NCT00066378|stage IV breast cancer|stage iv breast cancer
5825856|NCT00066365|metastatic osteosarcoma|metastatic osteosarcoma
5825857|NCT00066365|recurrent osteosarcoma|recurrent osteosarcoma
5825858|NCT00066365|lung metastases|lung metastases
5825859|NCT00066352|recurrent bladder cancer|recurrent bladder cancer
5825860|NCT00066352|stage IV bladder cancer|stage iv bladder cancer
5825861|NCT00066352|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5825862|NCT00066352|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5825863|NCT00066352|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5825864|NCT00066352|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5825865|NCT00066339|stage IV breast cancer|stage iv breast cancer
5825866|NCT00066339|recurrent breast cancer|recurrent breast cancer
5825867|NCT00066326|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5825868|NCT00066326|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5825869|NCT00066326|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5825870|NCT00066326|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5825871|NCT00066326|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5863169|NCT00001362|Contrast Enhancement|contrast enhancement
5681390|NCT00573547|depression|depression
5681391|NCT00573547|chronic renal failures|chronic renal failures
5681392|NCT00573547|end stage renal disease|end stage renal disease
5846762|NCT00043459|NHL|nhl
5825872|NCT00066313|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5686681|NCT00551122|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5686682|NCT00551122|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5686683|NCT00551122|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5686685|NCT00551096|Biliary or Pancreatic Malignancies|biliary or pancreatic malignancies
5686686|NCT00551044|prostatic neoplasms|prostatic neoplasms
5686687|NCT00551044|bicalutamide|bicalutamide
5681359|NCT00573664|Gabapentin|gabapentin
5825873|NCT00066313|limited stage small cell lung cancer|limited stage small cell lung cancer
5825874|NCT00066274|stage IV colon cancer|stage iv colon cancer
5825875|NCT00066274|stage IV rectal cancer|stage iv rectal cancer
5825876|NCT00066248|cachexia|cachexia
5825877|NCT00066248|unspecified childhood solid tumor|unspecified childhood solid tumor
5825878|NCT00066248|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5825879|NCT00066248|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5825880|NCT00066248|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5825881|NCT00066248|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5825882|NCT00066248|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5825883|NCT00066248|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5825884|NCT00066248|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5825885|NCT00066248|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5825886|NCT00066248|childhood oligodendroglioma|childhood oligodendroglioma
5825887|NCT00066248|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5825888|NCT00066248|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5825889|NCT00066248|hypothalamic glioma|hypothalamic glioma
5825890|NCT00066248|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5825891|NCT00066248|untreated childhood visual pathway|untreated childhood visual pathway
5825892|NCT00066248|childhood supratentorial primitive neuroectodermal tumor|childhood supratentorial primitive neuroectodermal tumor
5825893|NCT00066248|childhood craniopharyngioma|childhood craniopharyngioma
5825894|NCT00066248|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5825895|NCT00066248|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5825896|NCT00066248|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5825897|NCT00066248|recurrent childhood ependymoma|recurrent childhood ependymoma
5825898|NCT00066248|childhood choroid plexus tumor|childhood choroid plexus tumor
5825899|NCT00066248|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5825900|NCT00066248|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5825901|NCT00066248|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5825902|NCT00066248|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5825903|NCT00066248|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5825904|NCT00066248|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5825905|NCT00066248|untreated childhood acute myeloid leukemia|untreated childhood acute myeloid leukemia
5825906|NCT00066248|other myeloid malignancies|other myeloid malignancies
5825907|NCT00066248|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5825908|NCT00066248|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5825909|NCT00066248|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5825910|NCT00066248|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5825911|NCT00066248|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5825912|NCT00066248|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5825913|NCT00066248|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5825914|NCT00066248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5825915|NCT00066248|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5825916|NCT00066248|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5825917|NCT00066248|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5825918|NCT00066248|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5825919|NCT00066248|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5825920|NCT00066248|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5825921|NCT00066248|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5825922|NCT00066248|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5825923|NCT00066248|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5825924|NCT00066248|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5825925|NCT00066248|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5686688|NCT00551044|quality of life|quality of life
5686689|NCT00551044|osteoporosis|osteoporosis
5686690|NCT00551031|Influenza|influenza
5686691|NCT00551031|Orthomyxoviruses|orthomyxoviruses
5686692|NCT00551031|Myxovirus Infection|myxovirus infection
5686693|NCT00551031|Inactivated Split-virion influenza vaccine|inactivated split-virion influenza vaccine
5686694|NCT00551031|Elderly|elderly
5825926|NCT00066248|refractory hairy cell leukemia|refractory hairy cell leukemia
5838788|NCT00006340|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5838789|NCT00006340|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5815327|NCT00081458|SBS|sbs
5838790|NCT00006340|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5825927|NCT00066248|untreated hairy cell leukemia|untreated hairy cell leukemia
5833685|NCT00044980|malnutrition|malnutrition
5825928|NCT00066248|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5825929|NCT00066248|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5825930|NCT00066248|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5825931|NCT00066248|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5825932|NCT00066248|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5825933|NCT00066248|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5825934|NCT00066248|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5825935|NCT00066248|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5825936|NCT00066248|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5825937|NCT00066248|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5825938|NCT00066248|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5825939|NCT00066248|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5825940|NCT00066248|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5825941|NCT00066248|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5825942|NCT00066248|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5825943|NCT00066248|recurrent childhood brain tumor|recurrent childhood brain tumor
5825944|NCT00066248|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5825945|NCT00066248|myelodysplastic/myeloproliferative disease|myelodysplastic/myeloproliferative disease
5825946|NCT00066248|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5825947|NCT00066248|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5825948|NCT00066248|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5825949|NCT00066248|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5825950|NCT00066248|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5825951|NCT00066222|limited stage small cell lung cancer|limited stage small cell lung cancer
5825952|NCT00020462|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5825953|NCT00020462|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5825954|NCT00020462|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5825955|NCT00020462|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5825956|NCT00020462|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5825957|NCT00020462|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5825958|NCT00020462|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5825959|NCT00020462|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5825960|NCT00020462|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5825961|NCT00019721|stage IV melanoma|stage iv melanoma
5825962|NCT00019721|recurrent melanoma|recurrent melanoma
5825963|NCT00019383|recurrent melanoma|recurrent melanoma
5825964|NCT00066209|Inflammation|inflammation
5825965|NCT00066209|Coronavirus|coronavirus
5825966|NCT00066209|Immunity|immunity
5825967|NCT00066209|Interferon|interferon
5825968|NCT00066209|Cytokine|cytokine
5825969|NCT00066209|Severe Acute Respiratory Syndrome|severe acute respiratory syndrome
5825971|NCT00066209|Healthy Volunteer|healthy volunteer
5825972|NCT00066209|HV|hv
5825973|NCT00066170|Narcolepsy|narcolepsy
5825974|NCT00066170|Daytime Sleepiness|daytime sleepiness
5825975|NCT00066170|Daytime sleepiness in narcolepsy|daytime sleepiness in narcolepsy
5825976|NCT00033722|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5825977|NCT00033722|squamous cell lung cancer|squamous cell lung cancer
5825978|NCT00033722|large cell lung cancer|large cell lung cancer
5825979|NCT00033722|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5825980|NCT00033722|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5825981|NCT00033722|adenocarcinoma of the lung|adenocarcinoma of the lung
5825982|NCT00033722|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5686695|NCT00551018|Treatment Naive|treatment naive
5825983|NCT00033306|stage IV colon cancer|stage iv colon cancer
5825984|NCT00033306|stage IV rectal cancer|stage iv rectal cancer
5825985|NCT00033306|recurrent colon cancer|recurrent colon cancer
5825986|NCT00033306|recurrent rectal cancer|recurrent rectal cancer
5825987|NCT00033306|adenocarcinoma of the colon|adenocarcinoma of the colon
5825988|NCT00033306|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5825989|NCT00031811|stage I breast cancer|stage i breast cancer
5825990|NCT00031811|stage II breast cancer|stage ii breast cancer
5825991|NCT00031811|stage IIIA breast cancer|stage iiia breast cancer
5825992|NCT00031811|stage IIIB breast cancer|stage iiib breast cancer
5825993|NCT00031811|osteoporosis|osteoporosis
5825994|NCT00031811|menopausal symptoms|menopausal symptoms
5825995|NCT00031785|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5825996|NCT00031785|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5825997|NCT00031785|limited stage small cell lung cancer|limited stage small cell lung cancer
5825998|NCT00031785|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5825999|NCT00031785|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826000|NCT00031785|anorexia|anorexia
5826001|NCT00031785|cachexia|cachexia
5826002|NCT00066183|Fibroblast Growth Factor 23|fibroblast growth factor 23
5826003|NCT00066183|FGF-23|fgf-23
5826004|NCT00066183|Hypophosphatemia|hypophosphatemia
5826005|NCT00066183|Phosphaturia|phosphaturia
5826006|NCT00066183|Phosphorus|phosphorus
5826007|NCT00066183|Phosphorus Metabolism|phosphorus metabolism
5826008|NCT00066157|Alzheimer disease|alzheimer disease
5826009|NCT00066157|Hormone replacement therapy|hormone replacement therapy
5826010|NCT00066157|Postmenopausal women|postmenopausal women
5826011|NCT00066144|menopause|menopause
5826012|NCT00066144|hot flashes|hot flashes
5826013|NCT00066144|red clover|red clover
5826014|NCT00066144|black cohosh|black cohosh
5826015|NCT00066144|sexual dysfunction|sexual dysfunction
5826016|NCT00066118|neurologic|neurologic
5826017|NCT00066118|nerve conduction|nerve conduction
5826018|NCT00066118|neurobehavioral|neurobehavioral
5826019|NCT00066118|renal disease|renal disease
5826020|NCT00066092|PBPC transplant|pbpc transplant
5826021|NCT00066092|Hodgkin's Disease|hodgkin's disease
5826022|NCT00066092|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5826023|NCT00066092|NHL|nhl
5826024|NCT00066092|mobilization|mobilization
5826025|NCT00066079|Sickle Cell Pain|sickle cell pain
5826026|NCT00066079|Sickle Cell Disease|sickle cell disease
5826027|NCT00066079|Chronic Pain|chronic pain
5826028|NCT00066079|Alternative Medicine/Therapy|alternative medicine/therapy
5826029|NCT00066079|Complementary Medicine|complementary medicine
5826030|NCT00066079|Massage Therapy|massage therapy
5826031|NCT00066079|Relaxation Technique|relaxation technique
5826032|NCT00066079|Home-based Therapy|home-based therapy
5826033|NCT00066053|Heart attacks|heart attacks
5826034|NCT00066053|Stroke|stroke
5826035|NCT00066053|Angina|angina
5826036|NCT00066040|mutans streptococci infections|mutans streptococci infections
5826037|NCT00066027|periodontitis, metabolic bone diseases, doxycycline|periodontitis, metabolic bone diseases, doxycycline
5826038|NCT00066014|Dental Implantation-Osseointegrated|dental implantation-osseointegrated
5826039|NCT00066014|Dentures|dentures
5826040|NCT00066014|Dental Prostheses|dental prostheses
5826041|NCT00066014|Denture, Implant-Supported|denture, implant-supported
5826042|NCT00065975|chronic low back pain|chronic low back pain
5826043|NCT00065975|acupuncture|acupuncture
5826044|NCT00065975|chiropractic|chiropractic
5826045|NCT00065975|massage therapy|massage therapy
5826046|NCT00065975|CAM therapies|cam therapies
5826047|NCT00065962|Pervasive Developmental Disorders|pervasive developmental disorders
5826048|NCT00065962|Secretin, synthetic porcine|secretin, synthetic porcine
5826049|NCT00065962|Secretin, biological porcine|secretin, biological porcine
5826050|NCT00065962|Autism Diagnostic Observation Schedule - Generic (ADOS-G)|autism diagnostic observation schedule - generic (ados-g)
5826051|NCT00065962|Rimland Questionnaire|rimland questionnaire
5826052|NCT00065962|Expressive Vocabulary Test|expressive vocabulary test
5826053|NCT00065962|MacArthur Communication Inventory|macarthur communication inventory
5826054|NCT00065962|Aberrant Behavior Checklist|aberrant behavior checklist
5826055|NCT00065949|Low birthweight infants|low birthweight infants
5826056|NCT00065949|Magnesium supplementation|magnesium supplementation
5826057|NCT00065949|Intracranial hemorrhage|intracranial hemorrhage
5826058|NCT00065949|Cystic periventricular leukomalacia|cystic periventricular leukomalacia
5826059|NCT00065949|Mental retardation|mental retardation
5826060|NCT00065936|Intractable self-injurious behavior|intractable self-injurious behavior
5826061|NCT00065936|Naltrexone|naltrexone
5826062|NCT00065936|Transcutaneous electrical nerve stimulation|transcutaneous electrical nerve stimulation
5826063|NCT00065936|Substance P|substance p
5826064|NCT00065936|Met-enkephalin|met-enkephalin
5826065|NCT00065936|Cortisol|cortisol
5826066|NCT00065923|Prader-Willi Syndrome|prader-willi syndrome
5826067|NCT00065923|Self-Injurious Behavior|self-injurious behavior
5826068|NCT00065910|Joint attention|joint attention
5826069|NCT00065910|Developmental delay|developmental delay
5826070|NCT00065910|Caregiver interaction|caregiver interaction
5686696|NCT00551005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5686697|NCT00550992|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5686698|NCT00550992|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5686699|NCT00550992|acute undifferentiated leukemia|acute undifferentiated leukemia
5686700|NCT00550979|gestational diabetes mellitus|gestational diabetes mellitus
5686701|NCT00550979|cardiovascular disease risk|cardiovascular disease risk
5686702|NCT00550979|heart disease risk|heart disease risk
5686703|NCT00550966|Fibromyalgia|fibromyalgia
5686704|NCT00550966|Quality of life|quality of life
5686705|NCT00550966|Primary Care|primary care
5686706|NCT00550966|Non-pharmacological treatment|non-pharmacological treatment
5686707|NCT00550966|Cost / Cost-efficacy|cost / cost-efficacy
5686708|NCT00550940|epilepsy|epilepsy
5686709|NCT00550940|attention|attention
5686710|NCT00550940|emotion|emotion
5686711|NCT00550940|behavior problems|behavior problems
5686712|NCT00550940|child|child
5686713|NCT00550940|adolescent|adolescent
5686714|NCT00550927|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826071|NCT00065897|Amniocentesis|amniocentesis
5826072|NCT00065897|Transabdominal chorionic villus sampling|transabdominal chorionic villus sampling
5826073|NCT00065897|Fluorescence in situ hybridization|fluorescence in situ hybridization
5826074|NCT00065897|Alpha fetoprotein|alpha fetoprotein
5826075|NCT00065897|Acetylcholinesterase|acetylcholinesterase
5826077|NCT00065897|Prenatal diagnosis|prenatal diagnosis
5826078|NCT00065884|Adolescents|adolescents
5826079|NCT00065871|Pharmacist prescribers|pharmacist prescribers
5826080|NCT00065871|Increased access|increased access
5826081|NCT00065871|Hormonal contraception|hormonal contraception
5826082|NCT00065871|Birth control pills|birth control pills
5826083|NCT00065871|Birth control patch|birth control patch
5826084|NCT00065871|Vaginal contraceptive ring|vaginal contraceptive ring
5826085|NCT00065858|Contraception|contraception
5826086|NCT00065858|Nonoxynol 9|nonoxynol 9
5826087|NCT00065858|Microbicide|microbicide
5826088|NCT00065858|Spermicide|spermicide
5826089|NCT00065845|Urinary incontinence|urinary incontinence
5826090|NCT00065845|Pelvic organ prolapse|pelvic organ prolapse
5826091|NCT00065845|Stress incontinence|stress incontinence
5826092|NCT00065845|Sacrocolpopexy|sacrocolpopexy
5826093|NCT00065845|Burch urethropexy|burch urethropexy
5826094|NCT00065845|Surgical Trials|surgical trials
5826096|NCT00031707|cachexia|cachexia
5826097|NCT00026273|stage III colon cancer|stage iii colon cancer
5826098|NCT00026273|stage III rectal cancer|stage iii rectal cancer
5826099|NCT00026273|adenocarcinoma of the colon|adenocarcinoma of the colon
5826100|NCT00026273|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5826101|NCT00025688|stage IV breast cancer|stage iv breast cancer
5826102|NCT00025688|recurrent breast cancer|recurrent breast cancer
5826103|NCT00024024|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5826104|NCT00024024|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5826105|NCT00022477|stage IV colon cancer|stage iv colon cancer
5826106|NCT00022477|stage IV rectal cancer|stage iv rectal cancer
5826107|NCT00022477|recurrent colon cancer|recurrent colon cancer
5826108|NCT00022477|recurrent rectal cancer|recurrent rectal cancer
5826109|NCT00022477|adenocarcinoma of the colon|adenocarcinoma of the colon
5826110|NCT00022477|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5826111|NCT00065832|Reading disabilities|reading disabilities
5826112|NCT00065832|Inner-city|inner-city
5826113|NCT00065832|Urban|urban
5826114|NCT00065819|HIV|hiv
5826115|NCT00065819|African American|african american
5826116|NCT00065819|Symptom Management|symptom management
5826117|NCT00065806|Pediatric lupus|pediatric lupus
5826118|NCT00065806|Atherosclerosis|atherosclerosis
5826119|NCT00065806|SLE|sle
5826120|NCT00065806|HMG CoA reductase inhibitor|hmg coa reductase inhibitor
5826121|NCT00065767|Alzheimer disease|alzheimer disease
5826122|NCT00065767|Postmenopausal women|postmenopausal women
5826123|NCT00065767|Hormone therapy|hormone therapy
5826124|NCT00065754|Placebo|placebo
5826125|NCT00065754|Analgesia|analgesia
5826126|NCT00065754|Pain|pain
5826127|NCT00065754|Brain mechanism|brain mechanism
5826143|NCT00065728|age-related macular degeneration|age-related macular degeneration
5826144|NCT00065728|Anecortave|anecortave
5826145|NCT00065728|Acetate|acetate
5826146|NCT00065728|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
5826147|NCT00065728|CNV|cnv
5826148|NCT00065728|Anecortave Acetate|anecortave acetate
5826149|NCT00065715|head cold|head cold
5826150|NCT00065715|common cold|common cold
5826151|NCT00065715|echinacea|echinacea
5826152|NCT00065715|placebo|placebo
5826153|NCT00065702|fibromyalgia|fibromyalgia
5826154|NCT00065702|homeopathy|homeopathy
5826155|NCT00065702|EEG|eeg
5826156|NCT00065702|EKG|ekg
5826157|NCT00065702|chronic pain|chronic pain
5826158|NCT00065689|Alzheimer's disease|alzheimer's disease
5826159|NCT00065689|light therapy|light therapy
5826160|NCT00065689|long-term care|long-term care
5826161|NCT00065689|depression|depression
5826162|NCT00065689|sleep|sleep
5826163|NCT00065689|agitation|agitation
5826171|NCT00065663|gene transfer|gene transfer
5826172|NCT00065663|adenovirus|adenovirus
5826173|NCT00065663|platelet-derived growth factor-B|platelet-derived growth factor-b
5826174|NCT00065663|collagen|collagen
5826175|NCT00065663|diabetic ulcer|diabetic ulcer
5826176|NCT00065663|foot|foot
5826177|NCT00065663|wounds|wounds
5826178|NCT00065663|diabetic|diabetic
5826179|NCT00065663|ulcers|ulcers
5826180|NCT00065650|Diabetes Mellitus Type 2|diabetes mellitus type 2
5826181|NCT00065650|Vedic medicine|vedic medicine
5826182|NCT00065650|Ayurveda|ayurveda
5826183|NCT00065650|Transcendental Meditation|transcendental meditation
5826184|NCT00065624|Lipoic acid|lipoic acid
5826185|NCT00065624|F2-isoprostanes|f2-isoprostanes
5826186|NCT00065624|endothelial dysfunction|endothelial dysfunction
5826187|NCT00065624|natural product|natural product
5826188|NCT00065585|low back pain|low back pain
5826189|NCT00065585|acupuncture|acupuncture
5826190|NCT00065572|Kidney Cancer|kidney cancer
5826191|NCT00065572|Metastatic|metastatic
5826192|NCT00065572|Newly diagnosed renal cell carcinoma|newly diagnosed renal cell carcinoma
5826193|NCT00014560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5826194|NCT00014560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5826195|NCT00014560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5826196|NCT00014560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5826197|NCT00014560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5826198|NCT00014560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5826199|NCT00014560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5826200|NCT00014560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5826202|NCT00014560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5826203|NCT00014560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5826204|NCT00014560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5826205|NCT00014261|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826206|NCT00014248|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826208|NCT00014209|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5826209|NCT00014209|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5863170|NCT00001362|Neuroanatomic Morphometry|neuroanatomic morphometry
5826210|NCT00014209|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5826211|NCT00014209|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5826213|NCT00010127|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5826214|NCT00010127|stage IV prostate cancer|stage iv prostate cancer
5826216|NCT00065611|Osteoporosis|osteoporosis
5826217|NCT00065611|Proteinuria|proteinuria
5826218|NCT00065611|Minimal Change Disease|minimal change disease
5826219|NCT00065611|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5826220|NCT00065611|FSGS|fsgs
5826221|NCT00065611|MCD|mcd
5826222|NCT00065611|Kidney Disease|kidney disease
5826223|NCT00065507|hepatic decompensation|hepatic decompensation
5826224|NCT00006799|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5826225|NCT00006799|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5826226|NCT00006799|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5826227|NCT00006799|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5826228|NCT00006799|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5826229|NCT00006799|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5826230|NCT00006799|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5826231|NCT00006799|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5826232|NCT00006799|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5846421|NCT00044538|NSCLC|nsclc
5826375|NCT00065377|Diabetes|diabetes
5826233|NCT00006799|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5826234|NCT00006799|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5826235|NCT00006799|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5826236|NCT00006799|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5826237|NCT00006799|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5826238|NCT00006799|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5826239|NCT00006799|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5826240|NCT00006799|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5826241|NCT00006799|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5826242|NCT00006799|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5826243|NCT00006799|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5826244|NCT00006799|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5826245|NCT00006799|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5826246|NCT00006799|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5826247|NCT00006799|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5826248|NCT00006799|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5826249|NCT00006799|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5826250|NCT00006799|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5826251|NCT00006799|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5826252|NCT00006799|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5826253|NCT00006799|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5826254|NCT00006799|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5826255|NCT00006799|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5826256|NCT00006799|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5826257|NCT00006799|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5826258|NCT00006799|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5826259|NCT00006799|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5826260|NCT00006799|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5826261|NCT00006799|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5826262|NCT00006799|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5826263|NCT00006799|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5826264|NCT00006799|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5826265|NCT00006799|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5826266|NCT00006799|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5826267|NCT00006799|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5826268|NCT00006799|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5826269|NCT00006799|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5826270|NCT00006799|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5826271|NCT00006799|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5826272|NCT00006799|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5826273|NCT00006799|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5826274|NCT00006799|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5826275|NCT00006799|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5826276|NCT00006799|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5826277|NCT00006799|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5826278|NCT00006799|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5826279|NCT00006799|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5826280|NCT00006799|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5826281|NCT00006799|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5826282|NCT00006799|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5686715|NCT00550914|Papilloma, Papillomatosis, Laser, Laser Surgery|papilloma, papillomatosis, laser, laser surgery
5686716|NCT00550901|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826283|NCT00006799|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5826284|NCT00006799|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5826285|NCT00006799|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5826286|NCT00006799|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5826287|NCT00006799|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5826288|NCT00006799|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5826289|NCT00006799|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5826290|NCT00006799|anorexia|anorexia
5826291|NCT00006799|cachexia|cachexia
5826292|NCT00006799|quality of life|quality of life
5826293|NCT00006453|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5826294|NCT00006352|limited stage small cell lung cancer|limited stage small cell lung cancer
5826295|NCT00006240|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5826296|NCT00065468|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5826297|NCT00065468|Kidney Cancer|kidney cancer
5826298|NCT00006229|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826299|NCT00006229|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5826300|NCT00006081|stage III gastric cancer|stage iii gastric cancer
5826301|NCT00006081|stage IV gastric cancer|stage iv gastric cancer
5826302|NCT00006081|stage III esophageal cancer|stage iii esophageal cancer
5826303|NCT00006081|stage IV esophageal cancer|stage iv esophageal cancer
5826304|NCT00006081|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5826305|NCT00006081|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5826306|NCT00065455|Retinitis Pigmentosa|retinitis pigmentosa
5826307|NCT00065455|Vitamin A|vitamin a
5826310|NCT00065442|prostate cancer|prostate cancer
5826311|NCT00065442|prostate|prostate
5826313|NCT00065442|androgen-independent|androgen-independent
5826314|NCT00065442|androgen independent|androgen independent
5826315|NCT00065442|hormone insensitive|hormone insensitive
5826316|NCT00065442|hormone-insensitive|hormone-insensitive
5826317|NCT00065442|PSA|psa
5826318|NCT00065442|prostatic adenocarcinoma|prostatic adenocarcinoma
5826319|NCT00065442|hormone-refractory|hormone-refractory
5826320|NCT00065442|hormone refractory|hormone refractory
5826321|NCT00065442|HRPC|hrpc
5826322|NCT00065442|LHRH|lhrh
5826323|NCT00065442|immune therapy|immune therapy
5826324|NCT00065442|immunotherapy|immunotherapy
5826325|NCT00065442|vaccine|vaccine
5826326|NCT00065442|dendritic cells|dendritic cells
5826327|NCT00065442|antigen-presenting cells|antigen-presenting cells
5826328|NCT00065442|antigen presenting cells|antigen presenting cells
5826329|NCT00065442|cancer vaccine|cancer vaccine
5826330|NCT00065442|therapeutic vaccine|therapeutic vaccine
5826331|NCT00065442|therapeutic cancer vaccine|therapeutic cancer vaccine
5826332|NCT00065442|recombinant|recombinant
5826333|NCT00065442|biological|biological
5826334|NCT00065442|biopharmaceutical|biopharmaceutical
5826335|NCT00065442|biotechnology|biotechnology
5826336|NCT00065442|biotech|biotech
5826337|NCT00004887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5681393|NCT00573534|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5681394|NCT00573534|ADHD|adhd
5681395|NCT00573534|ADD|add
5681396|NCT00573534|Prevention|prevention
5681397|NCT00573534|Substance use|substance use
5681399|NCT00573521|ESBL positive cultures|esbl positive cultures
5681400|NCT00573508|Overactive Bladder|overactive bladder
5681401|NCT00573495|Advanced breast cancer|advanced breast cancer
5681402|NCT00573482|weight gain prevention|weight gain prevention
5681403|NCT00573482|obesity|obesity
5681404|NCT00573482|overweight|overweight
5826338|NCT00004887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826339|NCT00004887|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5826340|NCT00065416|neck pain|neck pain
5826341|NCT00065416|cervicalgia|cervicalgia
5826342|NCT00065416|massage|massage
5826343|NCT00065403|Irritable Bowel Syndrome|irritable bowel syndrome
5826344|NCT00065403|Acupuncture|acupuncture
5826345|NCT00065364|Preterm infant|preterm infant
5826346|NCT00065364|Premature infant|premature infant
5826347|NCT00065364|Developmental care|developmental care
5826348|NCT00065364|MRI|mri
5826349|NCT00065364|qEEG|qeeg
5826350|NCT00065364|Neurodevelopment|neurodevelopment
5826351|NCT00065364|Behavior|behavior
5826352|NCT00065364|Infants|infants
5826353|NCT00065364|NICU|nicu
5826354|NCT00065351|Multiple Myeloma|multiple myeloma
5826355|NCT00065351|CC-5013|cc-5013
5826356|NCT00065351|Revlimid|revlimid
5826357|NCT00065351|MM|mm
5826358|NCT00065351|CC5013|cc5013
5826359|NCT00065351|relapsed and refractory multiple myeloma|relapsed and refractory multiple myeloma
5826360|NCT00065338|Physical activity|physical activity
5826361|NCT00065325|Locally advanced breast cancer|locally advanced breast cancer
5826362|NCT00065325|metastatic breast cancer|metastatic breast cancer
5826363|NCT00065325|Breast Cancer|breast cancer
5826364|NCT00065325|Cancer of Breast|cancer of breast
5828275|NCT00061334|Memory|memory
5826365|NCT00065325|Cancer of the Breast|cancer of the breast
5826366|NCT00004253|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5826367|NCT00004253|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5826368|NCT00004253|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826369|NCT00065390|ALPS|alps
5826370|NCT00065390|Pyrimethamine|pyrimethamine
5826371|NCT00065390|Folinic Acid|folinic acid
5826372|NCT00065390|Lymphadenopathy|lymphadenopathy
5826373|NCT00065390|Splenomegaly|splenomegaly
5826374|NCT00065390|Autoimmune Lymphoproliferative Syndrome|autoimmune lymphoproliferative syndrome
5826377|NCT00065377|Capillary Blood Flow|capillary blood flow
5826378|NCT00065377|Osteoarthritis|osteoarthritis
5826379|NCT00065377|Endothelial Dysfunction|endothelial dysfunction
5826380|NCT00065377|Obesity|obesity
5826381|NCT00065377|Healthy Volunteer|healthy volunteer
5826382|NCT00065377|HV|hv
5826383|NCT00065312|Type 2 diabetes|type 2 diabetes
5826384|NCT00065299|Hyperphenylalaninemia|hyperphenylalaninemia
5826385|NCT00065299|PKU|pku
5826386|NCT00065299|Maternal PKU|maternal pku
5826387|NCT00065299|Pregnancy outcome|pregnancy outcome
5826388|NCT00065299|Phenylalanine restricted diet|phenylalanine restricted diet
5826389|NCT00065299|Tyrosine supplementation|tyrosine supplementation
5826390|NCT00065299|Maternal hyperphenylalanemia during pregnancy|maternal hyperphenylalanemia during pregnancy
5826391|NCT00065286|Akathisia|akathisia
5826392|NCT00065286|Mental retardation|mental retardation
5826393|NCT00065286|Schizophrenia|schizophrenia
5826394|NCT00065286|Neuroleptic medication|neuroleptic medication
5826395|NCT00065286|Tardive dyskinesia|tardive dyskinesia
5826396|NCT00065286|Brief Psychiatric Rating Scale|brief psychiatric rating scale
5826397|NCT00065286|Barnes test|barnes test
5826398|NCT00065286|Stereotypy Checklist Test|stereotypy checklist test
5826399|NCT00065286|DISCUS Tardive Dyskinesia test|discus tardive dyskinesia test
5826400|NCT00065273|Severe aberrant behavior|severe aberrant behavior
5826401|NCT00065273|Risperidone|risperidone
5826402|NCT00065273|Clozapine|clozapine
5826403|NCT00065273|Haloperidol|haloperidol
5826404|NCT00065273|Laboratory operant tasks|laboratory operant tasks
5826405|NCT00065273|Simple acquisition procedures|simple acquisition procedures
5826406|NCT00065273|Matching to sample task|matching to sample task
5826407|NCT00065273|Lag sequential analysis|lag sequential analysis
5826408|NCT00065247|Bone|bone
5826409|NCT00065247|Children|children
5826410|NCT00065247|After-school program|after-school program
5826411|NCT00065247|Osteoporosis|osteoporosis
5826412|NCT00065247|Calcium|calcium
5826413|NCT00065247|Physical activity|physical activity
5826414|NCT00065234|Colostomy|colostomy
5826415|NCT00065234|Ileostomy|ileostomy
5826416|NCT00065221|Ginger|ginger
5826417|NCT00065221|Plant preparation|plant preparation
5826418|NCT00065221|Herbal medicine|herbal medicine
5826419|NCT00065221|Chemotherapy|chemotherapy
5826420|NCT00065221|Nausea|nausea
5826421|NCT00065208|Prostate cancer|prostate cancer
5826422|NCT00065208|Reiki|reiki
5826423|NCT00065208|Energy Healing|energy healing
5826424|NCT00065260|Alemtuzumab (Campath-1H)|alemtuzumab (campath-1h)
5826425|NCT00065260|Rabbit ATG|rabbit atg
5826426|NCT00065260|Severe Aplastic Anemia|severe aplastic anemia
5826427|NCT00065260|Cyclosporine|cyclosporine
5826428|NCT00065260|Thrombocytopenia|thrombocytopenia
5826429|NCT00065260|Leukopenia|leukopenia
5826430|NCT00065260|Neutropenia|neutropenia
5826431|NCT00065260|Autoimmunity|autoimmunity
5826432|NCT00065260|Relapse|relapse
5826433|NCT00065260|Anemia|anemia
5826434|NCT00065195|Massage|massage
5826435|NCT00065195|Palliative Care|palliative care
5826436|NCT00065195|Hospices|hospices
5826437|NCT00065195|Cancer|cancer
5826438|NCT00065182|HYCAMTIN|hycamtin
5826439|NCT00065182|TAXOTERE|taxotere
5826440|NCT00065182|non-small cell lung cancer|non-small cell lung cancer
5826441|NCT00065182|NSCLC|nsclc
5826442|NCT00065182|docetaxel|docetaxel
5826443|NCT00065182|topotecan|topotecan
5826444|NCT00065182|Stage IIIB/IV|stage iiib/iv
5826445|NCT00065182|Advanced|advanced
5826447|NCT00065156|CC-5013|cc-5013
5826448|NCT00065156|Revlimid|revlimid
5826449|NCT00065156|Celgene|celgene
5826450|NCT00065143|Newly diagnosed and previously untreated acute myeloid leukemia (AML)|newly diagnosed and previously untreated acute myeloid leukemia (aml)
5826451|NCT00065143|High-risk myelodysplastic syndrome (MDS) (>/= 10% bone marrow blasts)|high-risk myelodysplastic syndrome (mds) (>/= 10% bone marrow blasts)
5826452|NCT00065143|Acute Myeloid Leukemia (AML)|acute myeloid leukemia (aml)
5826453|NCT00065143|Myelodysplastic Syndrome (MDS)|myelodysplastic syndrome (mds)
5826454|NCT00065117|metastatic|metastatic
5686717|NCT00550888|uterus|uterus
5686718|NCT00550888|abdominal delivery|abdominal delivery
5686719|NCT00550888|suture techniques|suture techniques
5686720|NCT00550875|Allergic rhinoconjunctivitis,|allergic rhinoconjunctivitis,
5686721|NCT00550875|Immunotherapy|immunotherapy
5826455|NCT00065117|colorectal|colorectal
5826456|NCT00065117|first-line|first-line
5826457|NCT00065117|adjuvant|adjuvant
5826458|NCT00065117|cancer|cancer
5826459|NCT00065117|Colorectal Cancer|colorectal cancer
5826460|NCT00065117|Colorectal Carcinoma|colorectal carcinoma
5826461|NCT00065117|Colorectal Tumors|colorectal tumors
5826462|NCT00065117|Neoplasms, Colorectal|neoplasms, colorectal
5826463|NCT00065104|HIV|hiv
5826464|NCT00065104|DHEA|dhea
5826470|NCT00065078|Community nurse|community nurse
5826471|NCT00065078|Unintended pregnancy|unintended pregnancy
5826472|NCT00065065|Rosiglitazone|rosiglitazone
5826473|NCT00065065|Ulcerative|ulcerative
5826474|NCT00065065|Colitis|colitis
5826475|NCT00065052|physical activity|physical activity
5826476|NCT00065052|television|television
5826477|NCT00065052|child obesity|child obesity
5826478|NCT00065052|Reduce TV|reduce tv
5826479|NCT00065052|Usual control|usual control
5826480|NCT00065013|obesity|obesity
5826481|NCT00065013|gastric bypass|gastric bypass
5826482|NCT00065013|obesity surgery|obesity surgery
5826483|NCT00065013|bariatric surgery|bariatric surgery
5826484|NCT00065013|exercise|exercise
5826485|NCT00004204|recurrent adult brain tumor|recurrent adult brain tumor
5826486|NCT00004204|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5826487|NCT00004204|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5826488|NCT00004006|intraocular retinoblastoma|intraocular retinoblastoma
5826489|NCT00004006|extraocular retinoblastoma|extraocular retinoblastoma
5826490|NCT00004006|recurrent retinoblastoma|recurrent retinoblastoma
5826491|NCT00003795|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5826492|NCT00003795|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5826493|NCT00003795|stage I endometrial carcinoma|stage i endometrial carcinoma
5826494|NCT00003795|stage II endometrial carcinoma|stage ii endometrial carcinoma
5826495|NCT00003759|stage 0 bladder cancer|stage 0 bladder cancer
5826496|NCT00003759|stage I bladder cancer|stage i bladder cancer
5826497|NCT00003759|recurrent bladder cancer|recurrent bladder cancer
5826498|NCT00064987|Male reproduction hormones|male reproduction hormones
5826499|NCT00064987|Hypogonadotropic hypogonadism|hypogonadotropic hypogonadism
5826500|NCT00064987|FSH|fsh
5826501|NCT00064987|LH|lh
5826502|NCT00064987|GnRH|gnrh
5826503|NCT00064974|MDS|mds
5826504|NCT00064974|CC-5013|cc-5013
5826505|NCT00064974|Revlimid|revlimid
5826506|NCT00064974|Celgene|celgene
5826507|NCT00064961|Smoking Cessation|smoking cessation
5826508|NCT00064935|Endometrium|endometrium
5826509|NCT00064935|Luteal phase|luteal phase
5826510|NCT00064935|Endometrial biopsy|endometrial biopsy
5826511|NCT00064922|nicotine dependence|nicotine dependence
5826512|NCT00064870|Alzheimer disease|alzheimer disease
5826513|NCT00064870|Late Onset Alzheimer disease risk factor genes|late onset alzheimer disease risk factor genes
5826514|NCT00064870|Genetics|genetics
5826515|NCT00064870|Initiative|initiative
5826516|NCT00064870|Dementia|dementia
5826517|NCT00064857|lymphedema|lymphedema
5826518|NCT00064857|breast|breast
5826519|NCT00064857|cancer|cancer
5826520|NCT00064857|plant preparation|plant preparation
5826521|NCT00064857|herbal preparation|herbal preparation
5826522|NCT00064857|pine bark extract|pine bark extract
5826523|NCT00064909|Multiple Sclerosis|multiple sclerosis
5826524|NCT00064909|MRI|mri
5826525|NCT00064909|Perfusion|perfusion
5826526|NCT00064909|Imaging|imaging
5826527|NCT00064909|Cerebral Blood Flow|cerebral blood flow
5826528|NCT00064909|Cerebral Blood Volume|cerebral blood volume
5826529|NCT00064909|CO2 Inhalation|co2 inhalation
5826530|NCT00064909|Contrast Agent|contrast agent
5826531|NCT00064909|Healthy Volunteer|healthy volunteer
5826533|NCT00064896|Blood Flow|blood flow
5826534|NCT00064896|Revascularization|revascularization
5826535|NCT00064896|Image Fusion|image fusion
5826536|NCT00064896|Fluoroscopy|fluoroscopy
5826537|NCT00064896|MRI|mri
5826538|NCT00064896|Chronic Total Occlusion of Arteries|chronic total occlusion of arteries
5826539|NCT00064896|Claudication|claudication
5826540|NCT00064896|Safety|safety
5826541|NCT00064896|Atherosclerosis|atherosclerosis
5826542|NCT00064896|Cardiovascular Disease|cardiovascular disease
5826549|NCT00064844|Smoking|smoking
5826550|NCT00064844|Alcoholism|alcoholism
5826551|NCT00064831|estrogen stimulation|estrogen stimulation
5826552|NCT00064831|relief of hot flashes|relief of hot flashes
5826553|NCT00064831|nipple aspirate fluid|nipple aspirate fluid
5826554|NCT00064831|body fluid levels of black cohosh|body fluid levels of black cohosh
5826555|NCT00064818|connective tissue|connective tissue
5826556|NCT00064818|ultrasound|ultrasound
5826557|NCT00064818|acupuncture|acupuncture
5826558|NCT00064805|Cognitive therapy|cognitive therapy
5686809|NCT00550511|emergency department|emergency department
5826559|NCT00064805|Aphasia therapy|aphasia therapy
5826560|NCT00064805|Alexia|alexia
5826561|NCT00064805|Acquired dyslexia|acquired dyslexia
5826562|NCT00064805|Phonological deficits|phonological deficits
5826563|NCT00064805|Orthographic deficits|orthographic deficits
5826564|NCT00064805|Brain disorders|brain disorders
5826565|NCT00064805|Brain injury|brain injury
5826566|NCT00064805|Stroke|stroke
5826567|NCT00064779|CNS neoplasms|cns neoplasms
5826568|NCT00064779|Brain neoplasms|brain neoplasms
5826569|NCT00064779|neurosurgery|neurosurgery
5826570|NCT00064779|intralesional infusion|intralesional infusion
5826571|NCT00064779|recombinant proteins|recombinant proteins
5826572|NCT00064779|immunotoxins|immunotoxins
5826573|NCT00064766|Norplant|norplant
5826574|NCT00064766|Periodontal disease|periodontal disease
5826575|NCT00064766|Endometrial bleeding|endometrial bleeding
5826576|NCT00064766|Progestin-induced endometrial bleeding|progestin-induced endometrial bleeding
5826577|NCT00064753|homocysteine|homocysteine
5826578|NCT00064753|multi-vitamin|multi-vitamin
5826579|NCT00064753|cardiovascular disease|cardiovascular disease
5826580|NCT00064753|renal transplant recipients|renal transplant recipients
5826581|NCT00003712|recurrent adult brain tumor|recurrent adult brain tumor
5826582|NCT00003712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826583|NCT00003712|tumors metastatic to brain|tumors metastatic to brain
5826584|NCT00003707|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826585|NCT00003645|stage I prostate cancer|stage i prostate cancer
5826586|NCT00003645|stage II prostate cancer|stage ii prostate cancer
5826587|NCT00003571|stage III colon cancer|stage iii colon cancer
5826588|NCT00003571|adenocarcinoma of the colon|adenocarcinoma of the colon
5826589|NCT00003382|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5826590|NCT00003382|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5826591|NCT00003382|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5826592|NCT00003382|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5826593|NCT00003382|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5826594|NCT00003382|fallopian tube cancer|fallopian tube cancer
5826595|NCT00003382|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5826596|NCT00064792|Cholesterol|cholesterol
5826598|NCT00064792|HMG-COA Reductase Inhibitor|hmg-coa reductase inhibitor
5826599|NCT00064792|Malformation Syndrome|malformation syndrome
5826600|NCT00064792|Mental Retardation|mental retardation
5826601|NCT00064792|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5826602|NCT00064740|Human Immunodeficiency Viruses|human immunodeficiency viruses
5826603|NCT00064740|Relaxation|relaxation
5826604|NCT00064740|Acupuncture|acupuncture
5826605|NCT00064740|Complementary therapies|complementary therapies
5826606|NCT00064701|De Novo Kidney Transplant|de novo kidney transplant
5826607|NCT00064701|cyclosporine|cyclosporine
5826608|NCT00064701|Prograf®|prograf®
5826609|NCT00064701|mycophenolate mofetil|mycophenolate mofetil
5826610|NCT00064701|tacrolimus|tacrolimus
5826611|NCT00006073|Evaluation|evaluation
5826612|NCT00006073|Endocrinology|endocrinology
5826613|NCT00006073|Hormones|hormones
5826614|NCT00006073|Metabolism|metabolism
5826615|NCT00006073|Teaching|teaching
5826616|NCT00006073|Endocrine Disorder|endocrine disorder
5826617|NCT00064727|Ventricular Contractile Function|ventricular contractile function
5826618|NCT00064727|Diastolic Dysfunction|diastolic dysfunction
5826619|NCT00064727|PPAR gamma|ppar gamma
5826620|NCT00064727|Gene Expression Patterns|gene expression patterns
5826621|NCT00064727|Insulin Sensitization|insulin sensitization
5826622|NCT00064727|Glucose Intolerance|glucose intolerance
5826623|NCT00064727|Intolerance|intolerance
5826624|NCT00064714|Type 1 Diabetes Mellitus (T1DM)|type 1 diabetes mellitus (t1dm)
5826625|NCT00064714|Beta-Cell|beta-cell
5826626|NCT00064714|C-Peptide|c-peptide
5826627|NCT00064714|Immunosuppression|immunosuppression
5826628|NCT00064714|Insulin|insulin
5826629|NCT00064714|Islet|islet
5826630|NCT00064714|Function|function
5826631|NCT00064714|AC2993 (Synthetic Exendin-4)|ac2993 (synthetic exendin-4)
5826633|NCT00064714|Type I Diabetes Mellitus|type i diabetes mellitus
5826634|NCT00064714|T1DM|t1dm
5826635|NCT00064662|Stress urinary incontinence|stress urinary incontinence
5826636|NCT00064662|Surgery|surgery
5826637|NCT00064649|prostate|prostate
5826638|NCT00064649|benign disease|benign disease
5826639|NCT00064649|TUNA|tuna
5826640|NCT00064649|TUMT|tumt
5826641|NCT00064649|medical therapy|medical therapy
5826642|NCT00064623|Dermal assessment|dermal assessment
5826643|NCT00064623|Pain measurement|pain measurement
5826645|NCT00064623|Analgesics/*therapeutic use|analgesics/*therapeutic use
5826646|NCT00064623|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5826647|NCT00064623|HIV Infections/*complications/*drug therapy|hiv infections/*complications/*drug therapy
5826648|NCT00064623|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
5826649|NCT00064623|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
5826650|NCT00064610|Advanced androgen-independent prostate cancer|advanced androgen-independent prostate cancer
5826651|NCT00064597|Fetal cells|fetal cells
5826652|NCT00064597|Prenatal diagnosis|prenatal diagnosis
5826653|NCT00064597|Cytogenetic disorders|cytogenetic disorders
5826654|NCT00064597|Chromosomal disorders|chromosomal disorders
5826655|NCT00064597|Single gene mutation detection|single gene mutation detection
5826656|NCT00064597|Abnormal serum marker profile|abnormal serum marker profile
5826657|NCT00064597|Fluorescence activated cell sorting (FACS)|fluorescence activated cell sorting (facs)
5826658|NCT00064597|Magnetic activated cell sorting (MACS)|magnetic activated cell sorting (macs)
5826659|NCT00064597|Fluorescence in situ hybridization (FISH)|fluorescence in situ hybridization (fish)
5826660|NCT00064597|Chromosomal disorders of the fetus|chromosomal disorders of the fetus
5826661|NCT00064597|Single gene defects of the fetus|single gene defects of the fetus
5826662|NCT00063726|Relapsed Multiple Myeloma|relapsed multiple myeloma
5826663|NCT00063726|Refractory Multiple Myeloma|refractory multiple myeloma
5826664|NCT00003184|stage IV breast cancer|stage iv breast cancer
5826665|NCT00003184|recurrent breast cancer|recurrent breast cancer
5826666|NCT00003045|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5826667|NCT00003045|stage II prostate cancer|stage ii prostate cancer
5826668|NCT00003045|stage III prostate cancer|stage iii prostate cancer
5826669|NCT00003008|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5826670|NCT00003008|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5826671|NCT00002965|recurrent adult brain tumor|recurrent adult brain tumor
5826672|NCT00064571|unilateral vocal fold paralysis|unilateral vocal fold paralysis
5826673|NCT00064467|lethargic|lethargic
5826674|NCT00064467|decreased interest|decreased interest
5826675|NCT00064467|decreased motivation|decreased motivation
5826676|NCT00064467|depression|depression
5826677|NCT00064454|Ulcerative Colitis|ulcerative colitis
5826678|NCT00064441|Ulcerative Colitis|ulcerative colitis
5826679|NCT00064376|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5826680|NCT00064376|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5826681|NCT00064376|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5826682|NCT00064376|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5826683|NCT00064376|refractory anemia with excess blasts|refractory anemia with excess blasts
5826684|NCT00064376|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5826685|NCT00064376|refractory anemia|refractory anemia
5826686|NCT00064376|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5826687|NCT00064363|recurrent adult brain tumor|recurrent adult brain tumor
5826688|NCT00064363|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5826689|NCT00064363|adult glioblastoma|adult glioblastoma
5826690|NCT00064363|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5826691|NCT00064363|adult mixed glioma|adult mixed glioma
5826692|NCT00064363|adult giant cell glioblastoma|adult giant cell glioblastoma
5826693|NCT00064363|adult gliosarcoma|adult gliosarcoma
5826694|NCT00064363|adult brain stem glioma|adult brain stem glioma
5826695|NCT00064350|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5826696|NCT00064350|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826697|NCT00064350|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5826698|NCT00064350|sorafenib|sorafenib
5826699|NCT00064337|primary systemic amyloidosis|primary systemic amyloidosis
5826700|NCT00064337|stage II multiple myeloma|stage ii multiple myeloma
5826701|NCT00064337|stage III multiple myeloma|stage iii multiple myeloma
5826702|NCT00064311|infection|infection
5826703|NCT00064311|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5826704|NCT00064311|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5826705|NCT00064311|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5826706|NCT00064311|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5826707|NCT00064311|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5826708|NCT00064311|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5826709|NCT00064311|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5826710|NCT00064311|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5826711|NCT00064311|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5826712|NCT00064311|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5826713|NCT00064311|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5826714|NCT00064311|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5826715|NCT00064311|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5846655|NCT00043836|exercise tolerance|exercise tolerance
5826716|NCT00064311|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5826717|NCT00064311|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5826718|NCT00064311|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5826719|NCT00064311|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5826720|NCT00064311|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5826721|NCT00064311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5826722|NCT00064311|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5826723|NCT00064311|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5826724|NCT00064311|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5826725|NCT00064311|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5826726|NCT00064311|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5826727|NCT00064311|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5826728|NCT00064311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5826729|NCT00064311|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5826730|NCT00064311|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5826731|NCT00064311|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5826732|NCT00064311|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5826733|NCT00064311|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5826734|NCT00064311|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5826735|NCT00064311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5826736|NCT00064311|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5826737|NCT00064311|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5826738|NCT00064311|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5826739|NCT00064311|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5826740|NCT00064311|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5826741|NCT00064311|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5826742|NCT00064311|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5826743|NCT00064311|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5826744|NCT00064311|refractory hairy cell leukemia|refractory hairy cell leukemia
5826745|NCT00064311|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5826746|NCT00064311|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5826747|NCT00064311|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5826748|NCT00064311|stage I multiple myeloma|stage i multiple myeloma
5826749|NCT00064311|stage II multiple myeloma|stage ii multiple myeloma
5826750|NCT00064311|stage III multiple myeloma|stage iii multiple myeloma
5826751|NCT00064311|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5826752|NCT00064311|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5826753|NCT00064311|disseminated neuroblastoma|disseminated neuroblastoma
5826754|NCT00064311|recurrent neuroblastoma|recurrent neuroblastoma
5826755|NCT00064311|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5826756|NCT00064311|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5826757|NCT00064311|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5826758|NCT00064311|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5826759|NCT00064311|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5826760|NCT00064311|stage IIIA breast cancer|stage iiia breast cancer
5826761|NCT00064311|stage IIIB breast cancer|stage iiib breast cancer
5826762|NCT00064311|stage IV breast cancer|stage iv breast cancer
5826763|NCT00064311|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5826764|NCT00064311|primary myelofibrosis|primary myelofibrosis
5826765|NCT00064311|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5826766|NCT00064311|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5826767|NCT00064311|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5826768|NCT00064311|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5826769|NCT00064311|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5826770|NCT00064311|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5826771|NCT00064311|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5826772|NCT00064311|stage IIIC breast cancer|stage iiic breast cancer
5826773|NCT00064311|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5826774|NCT00064311|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5826775|NCT00064311|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5826776|NCT00064311|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5826777|NCT00064311|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5826778|NCT00064311|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5826779|NCT00064311|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5826780|NCT00064311|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5826781|NCT00064311|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5826215|NCT00065611|Steroids|steroids
5826782|NCT00064311|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5826783|NCT00064298|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5826784|NCT00064298|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5826785|NCT00064298|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5826786|NCT00064298|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5826787|NCT00064298|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5826788|NCT00064298|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5826789|NCT00064298|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5826790|NCT00064298|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5826791|NCT00064298|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5826792|NCT00064298|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5826793|NCT00064298|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5826794|NCT00064298|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5826795|NCT00064298|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5826796|NCT00064298|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5826797|NCT00064298|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5826798|NCT00064298|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5826799|NCT00064285|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5826800|NCT00064285|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5826801|NCT00064285|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5826802|NCT00064285|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5826803|NCT00064285|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5826804|NCT00064285|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5826805|NCT00064285|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5826806|NCT00064285|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5826807|NCT00064285|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5826808|NCT00064285|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5826809|NCT00064285|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5826810|NCT00064285|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5826811|NCT00064285|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5826812|NCT00064285|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5826813|NCT00064285|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5826814|NCT00064272|nausea and vomiting|nausea and vomiting
5826815|NCT00064272|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826816|NCT00064233|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5826817|NCT00064233|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5826818|NCT00064233|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5826819|NCT00064220|adult leiomyosarcoma|adult leiomyosarcoma
5826820|NCT00064220|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5826821|NCT00064220|adult liposarcoma|adult liposarcoma
5826822|NCT00064220|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5826823|NCT00064220|adult synovial sarcoma|adult synovial sarcoma
5826824|NCT00064220|adult fibrosarcoma|adult fibrosarcoma
5826825|NCT00064220|adult angiosarcoma|adult angiosarcoma
5826826|NCT00064220|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5826827|NCT00064220|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5826828|NCT00064220|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5826829|NCT00064207|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5826830|NCT00064207|stage I pancreatic cancer|stage i pancreatic cancer
5826831|NCT00064207|stage II pancreatic cancer|stage ii pancreatic cancer
5826832|NCT00064207|stage III pancreatic cancer|stage iii pancreatic cancer
5826833|NCT00064194|prostate cancer|prostate cancer
5826834|NCT00064194|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5826835|NCT00064181|adenocarcinoma of the colon|adenocarcinoma of the colon
5826836|NCT00064181|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5826837|NCT00064181|stage IV colon cancer|stage iv colon cancer
5826838|NCT00064181|stage IV rectal cancer|stage iv rectal cancer
5826839|NCT00064116|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5826840|NCT00064116|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5826841|NCT00064116|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5826376|NCT00065377|Insulin Resistance|insulin resistance
5826842|NCT00064116|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5826843|NCT00064116|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5826844|NCT00064090|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5826845|NCT00064090|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5826846|NCT00064090|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5826847|NCT00064090|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5826848|NCT00064090|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5826849|NCT00064090|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5826850|NCT00064090|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5826851|NCT00064090|refractory anemia with excess blasts|refractory anemia with excess blasts
5826852|NCT00064090|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5826853|NCT00064090|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5826930|NCT00042900|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5826854|NCT00064090|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5826855|NCT00064090|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5826856|NCT00064090|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5826857|NCT00064090|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5826858|NCT00064090|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5826859|NCT00064090|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5826860|NCT00064064|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5826861|NCT00064064|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5826862|NCT00064051|stage II pancreatic cancer|stage ii pancreatic cancer
5826863|NCT00064051|stage III pancreatic cancer|stage iii pancreatic cancer
5826864|NCT00064051|recurrent pancreatic cancer|recurrent pancreatic cancer
5826865|NCT00064051|stage IV pancreatic cancer|stage iv pancreatic cancer
5826866|NCT00064038|stage I multiple myeloma|stage i multiple myeloma
5826867|NCT00064038|stage II multiple myeloma|stage ii multiple myeloma
5826868|NCT00064038|stage III multiple myeloma|stage iii multiple myeloma
5826869|NCT00064012|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5826870|NCT00064012|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5826871|NCT00064012|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5826872|NCT00063986|esophageal cancer|esophageal cancer
5826873|NCT00063986|minimally invasive esophagectomy (MIE)|minimally invasive esophagectomy (mie)
5826874|NCT00063960|stage IV colon cancer|stage iv colon cancer
5826875|NCT00063960|adenocarcinoma of the colon|adenocarcinoma of the colon
5826876|NCT00063960|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5826877|NCT00063960|stage IV rectal cancer|stage iv rectal cancer
5826878|NCT00063960|liver metastases|liver metastases
5826879|NCT00063882|stage IIB prostate cancer|stage iib prostate cancer
5826880|NCT00063882|stage IIA prostate cancer|stage iia prostate cancer
5826881|NCT00063882|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5826882|NCT00063869|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5826883|NCT00063869|Fibrosis, Pulmonary|fibrosis, pulmonary
5826884|NCT00063869|Pulmonary Fibroses|pulmonary fibroses
5826885|NCT00063869|Fibroses, Pulmonary|fibroses, pulmonary
5826886|NCT00023907|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5826887|NCT00023907|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5826888|NCT00003211|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5826889|NCT00003211|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5826890|NCT00002878|refractory multiple myeloma|refractory multiple myeloma
5826891|NCT00063856|Smallpox, wetvax|smallpox, wetvax
5826892|NCT00063843|Bacillus anthracis (anthrax)|bacillus anthracis (anthrax)
5826893|NCT00063830|Ulcerative Colitis|ulcerative colitis
5826894|NCT00063817|End-stage renal disease|end-stage renal disease
5826895|NCT00063817|Renal Transplant|renal transplant
5826896|NCT00063817|Bone Marrow Transplant|bone marrow transplant
5826897|NCT00063817|nonmyeloablative conditioning regimen|nonmyeloablative conditioning regimen
5826898|NCT00063804|HIV Seronegativity|hiv seronegativity
5826901|NCT00063791|Relapsed or Refractory|relapsed or refractory
5826902|NCT00063778|HIV Seronegativity|hiv seronegativity
5826903|NCT00063778|HIV Preventive Vaccine|hiv preventive vaccine
5826904|NCT00063778|AIDS Vaccines|aids vaccines
5826907|NCT00063778|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5826908|NCT00063778|Injections, Subcutaneous|injections, subcutaneous
5826909|NCT00045357|recurrent melanoma|recurrent melanoma
5826910|NCT00045357|stage IV melanoma|stage iv melanoma
5826911|NCT00042900|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5826912|NCT00042900|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5826913|NCT00042900|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5686722|NCT00550862|PBC, Primary Biliary Cirrhosis, Liver,|pbc, primary biliary cirrhosis, liver,
5686723|NCT00550836|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5686724|NCT00550836|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5686725|NCT00550836|stage IV pancreatic cancer|stage iv pancreatic cancer
5686726|NCT00550810|Sutent|sutent
5686727|NCT00550797|Steroid-naive, non-smokers|steroid-naive, non-smokers
5686728|NCT00550797|Mild to moderate allergic asthmatic adults|mild to moderate allergic asthmatic adults
5686729|NCT00550784|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5826914|NCT00042900|Waldenström macroglobulinemia|waldenström macroglobulinemia
5826915|NCT00042900|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5826916|NCT00042900|acute undifferentiated leukemia|acute undifferentiated leukemia
5826917|NCT00042900|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5826918|NCT00042900|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5826920|NCT00042900|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5826921|NCT00042900|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5826922|NCT00042900|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5826923|NCT00042900|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5826924|NCT00042900|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5826925|NCT00042900|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5826926|NCT00042900|essential thrombocythemia|essential thrombocythemia
5826927|NCT00042900|extramedullary plasmacytoma|extramedullary plasmacytoma
5826928|NCT00042900|intraocular lymphoma|intraocular lymphoma
5826929|NCT00042900|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5826931|NCT00042900|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5826932|NCT00042900|polycythemia vera|polycythemia vera
5826933|NCT00042900|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5826934|NCT00042900|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5826935|NCT00042900|primary systemic amyloidosis|primary systemic amyloidosis
5826936|NCT00042900|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5826937|NCT00042900|prolymphocytic leukemia|prolymphocytic leukemia
5826938|NCT00042900|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5826939|NCT00042900|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5826940|NCT00042900|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5826941|NCT00042900|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5826942|NCT00042900|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5826943|NCT00042900|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5826944|NCT00042900|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5826945|NCT00042900|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5826946|NCT00042900|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5826947|NCT00042900|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5826948|NCT00042900|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5826949|NCT00042900|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5826950|NCT00042900|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5826951|NCT00042900|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5826952|NCT00042900|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5826953|NCT00042900|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5826954|NCT00042900|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5826955|NCT00042900|refractory hairy cell leukemia|refractory hairy cell leukemia
5826956|NCT00042900|refractory multiple myeloma|refractory multiple myeloma
5826957|NCT00042900|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5826958|NCT00042900|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5826959|NCT00042900|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5826960|NCT00042900|small intestine lymphoma|small intestine lymphoma
5826961|NCT00042900|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5826962|NCT00042900|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5826963|NCT00042900|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5826964|NCT00042900|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5826965|NCT00042900|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5847478|NCT00039663|Hyperlipidemia|hyperlipidemia
5826446|NCT00065156|MDS|mds
5826966|NCT00042900|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5826967|NCT00042900|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5826968|NCT00042900|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5826969|NCT00042900|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5826970|NCT00042900|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5826971|NCT00042900|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5826972|NCT00042900|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5826973|NCT00042900|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5826974|NCT00042900|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5826975|NCT00042900|stage III multiple myeloma|stage iii multiple myeloma
5826976|NCT00042900|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5826977|NCT00042900|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5826978|NCT00042900|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5826979|NCT00042900|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5826980|NCT00042900|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5846656|NCT00043836|heart failure, congestive|heart failure, congestive
5826981|NCT00042900|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5826982|NCT00042900|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5826983|NCT00042900|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5826984|NCT00042900|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5826985|NCT00042900|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5826986|NCT00042900|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5826987|NCT00042900|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5826988|NCT00042900|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5826989|NCT00042900|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5826990|NCT00042900|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5826991|NCT00042900|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5826992|NCT00042900|untreated hairy cell leukemia|untreated hairy cell leukemia
5826993|NCT00042900|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5826994|NCT00042900|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5826995|NCT00042900|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5826996|NCT00042900|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5826997|NCT00042900|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5826998|NCT00042900|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5826999|NCT00042900|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5827000|NCT00042900|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5827001|NCT00042900|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827002|NCT00042900|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827003|NCT00042900|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5827004|NCT00042900|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5827006|NCT00040820|stage IV colon cancer|stage iv colon cancer
5827007|NCT00040820|stage III rectal cancer|stage iii rectal cancer
5827008|NCT00040820|stage IV rectal cancer|stage iv rectal cancer
5827009|NCT00040820|recurrent colon cancer|recurrent colon cancer
5827010|NCT00040820|recurrent rectal cancer|recurrent rectal cancer
5827011|NCT00040820|adenocarcinoma of the colon|adenocarcinoma of the colon
5827012|NCT00040820|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5827013|NCT00039169|stage III renal cell cancer|stage iii renal cell cancer
5827014|NCT00039169|stage IV renal cell cancer|stage iv renal cell cancer
5827015|NCT00039169|recurrent renal cell cancer|recurrent renal cell cancer
5827016|NCT00036660|recurrent adult brain tumor|recurrent adult brain tumor
5827017|NCT00036660|adult glioblastoma|adult glioblastoma
5827018|NCT00036660|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5827019|NCT00036660|adult giant cell glioblastoma|adult giant cell glioblastoma
5827020|NCT00036660|adult gliosarcoma|adult gliosarcoma
5827021|NCT00033384|stage III colon cancer|stage iii colon cancer
5827022|NCT00033384|stage IV colon cancer|stage iv colon cancer
5827023|NCT00033384|stage IV breast cancer|stage iv breast cancer
5827024|NCT00033384|stage IIIA breast cancer|stage iiia breast cancer
5827025|NCT00033384|recurrent breast cancer|recurrent breast cancer
5827026|NCT00033384|stage IIIB breast cancer|stage iiib breast cancer
5827027|NCT00033384|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5827028|NCT00033384|stage II pancreatic cancer|stage ii pancreatic cancer
5827029|NCT00033384|stage III pancreatic cancer|stage iii pancreatic cancer
5827030|NCT00033384|recurrent pancreatic cancer|recurrent pancreatic cancer
5827031|NCT00033384|recurrent colon cancer|recurrent colon cancer
5827032|NCT00033384|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827033|NCT00033384|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827034|NCT00033384|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5827035|NCT00033384|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5827036|NCT00033384|stage IV pancreatic cancer|stage iv pancreatic cancer
5827037|NCT00002752|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5827038|NCT00002752|recurrent childhood brain tumor|recurrent childhood brain tumor
5827039|NCT00002752|recurrent adult brain tumor|recurrent adult brain tumor
5827040|NCT00002752|adult medulloblastoma|adult medulloblastoma
5827041|NCT00002752|adult glioblastoma|adult glioblastoma
5827042|NCT00002752|tumors metastatic to brain|tumors metastatic to brain
5827043|NCT00002752|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5827044|NCT00002752|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5827045|NCT00002752|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5827046|NCT00002752|adult anaplastic ependymoma|adult anaplastic ependymoma
5827047|NCT00002752|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5827048|NCT00002752|adult mixed glioma|adult mixed glioma
5827049|NCT00002752|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5827050|NCT00002752|adult subependymoma|adult subependymoma
5827051|NCT00002752|adult ependymoblastoma|adult ependymoblastoma
5827052|NCT00002752|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5827053|NCT00002752|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5827054|NCT00002752|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5827055|NCT00002752|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5827056|NCT00002752|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5827057|NCT00002752|recurrent childhood ependymoma|recurrent childhood ependymoma
5827058|NCT00002752|adult oligodendroglioma|adult oligodendroglioma
5827059|NCT00002752|adult giant cell glioblastoma|adult giant cell glioblastoma
5827060|NCT00002752|adult gliosarcoma|adult gliosarcoma
5827061|NCT00002582|stage I breast cancer|stage i breast cancer
5827062|NCT00002582|stage II breast cancer|stage ii breast cancer
5827063|NCT00002582|stage IIIA breast cancer|stage iiia breast cancer
5827065|NCT00063765|CNTF|cntf
5827066|NCT00063765|Retinitis Pigmentosa|retinitis pigmentosa
5827068|NCT00063700|obesity in school aged children|obesity in school aged children
5827069|NCT00063674|exercise|exercise
5827070|NCT00063674|eating|eating
5827071|NCT00063674|dance|dance
5827072|NCT00063674|health education|health education
5827073|NCT00063674|obesity prevention|obesity prevention
5827074|NCT00063674|diabetes prevention|diabetes prevention
5827075|NCT00063674|children|children
5827078|NCT00063648|Post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5827079|NCT00063635|Non alcoholic fatty liver disease|non alcoholic fatty liver disease
5827080|NCT00063622|Non alcoholic steatohepatitis|non alcoholic steatohepatitis
5827081|NCT00063622|Steatohepatitis|steatohepatitis
5827082|NCT00063609|Prostate Cancer|prostate cancer
5827083|NCT00063609|Bone Loss|bone loss
5827084|NCT00063609|Osteoporosis|osteoporosis
5827085|NCT00063609|Bone Mineral Density|bone mineral density
5827086|NCT00063609|Androgen Deprivation Therapy|androgen deprivation therapy
5827087|NCT00063661|fMRI|fmri
5827088|NCT00063661|Brain Activity|brain activity
5827089|NCT00063661|Overlearned|overlearned
5827090|NCT00063661|Dual-Task|dual-task
5827091|NCT00063661|Mechanism|mechanism
5827092|NCT00063661|Parkinson Disease|parkinson disease
5827093|NCT00063661|PD|pd
5827094|NCT00063596|Vitamin A|vitamin a
5827095|NCT00063596|Hepatitis B vaccine|hepatitis b vaccine
5827096|NCT00063596|Immune responses|immune responses
5827097|NCT00063596|T-cell subsets|t-cell subsets
5827098|NCT00063596|Chronic lung disease|chronic lung disease
5827099|NCT00063596|Cytokines, intracytoplasmic|cytokines, intracytoplasmic
5827190|NCT00063193|neuroprotection|neuroprotection
5827100|NCT00063596|Antibodies, hepatitis B and tetanus toxoid|antibodies, hepatitis b and tetanus toxoid
5827101|NCT00063583|Kidney disease|kidney disease
5827102|NCT00063570|Cancer of Breast|cancer of breast
5827103|NCT00063570|Cancer of the Breast|cancer of the breast
5827104|NCT00063323|Maintenance treatment|maintenance treatment
5827105|NCT00063323|Smoking relapse|smoking relapse
5827106|NCT00063323|Bupropion|bupropion
5827107|NCT00063323|Nicotine replacement|nicotine replacement
5827108|NCT00033319|colon cancer|colon cancer
5827109|NCT00033319|rectal cancer|rectal cancer
5827110|NCT00031954|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5827111|NCT00031954|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5827112|NCT00031954|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5827113|NCT00031954|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5827114|NCT00031954|fallopian tube cancer|fallopian tube cancer
5827115|NCT00031954|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5827116|NCT00031889|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5827117|NCT00031889|stage IV prostate cancer|stage iv prostate cancer
5827118|NCT00031889|recurrent prostate cancer|recurrent prostate cancer
5827119|NCT00031668|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5834167|NCT00037024|depression|depression
5827120|NCT00031668|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5848444|NCT00034723|DTI|dti
5827121|NCT00031668|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5827122|NCT00031668|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5827123|NCT00031668|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5827124|NCT00028938|squamous cell lung cancer|squamous cell lung cancer
5827125|NCT00028938|large cell lung cancer|large cell lung cancer
5827126|NCT00028938|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827127|NCT00028938|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827128|NCT00028938|adenocarcinoma of the lung|adenocarcinoma of the lung
5827129|NCT00028938|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5827130|NCT00063479|Osteogenesis Imperfecta|osteogenesis imperfecta
5827131|NCT00063479|OI|oi
5827132|NCT00063479|bone markers|bone markers
5827133|NCT00063479|fracture|fracture
5827134|NCT00063479|bone loss|bone loss
5827135|NCT00063479|pediatric|pediatric
5827136|NCT00063479|bisphosphonate|bisphosphonate
5827137|NCT00063479|brittle bone disease|brittle bone disease
5827138|NCT00063479|pamidronate|pamidronate
5827139|NCT00028925|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5827140|NCT00028613|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5823397|NCT00071383|Brain|brain
5827142|NCT00063427|Colorectal Carcinoma|colorectal carcinoma
5827143|NCT00063427|Colorectal Tumors|colorectal tumors
5827144|NCT00063427|Neoplasms, Colorectal|neoplasms, colorectal
5827145|NCT00063427|Colorectal Neoplasms|colorectal neoplasms
5827146|NCT00063401|ovarian|ovarian
5827147|NCT00063401|primary peritoneal cancer|primary peritoneal cancer
5827148|NCT00063401|fallopian tube cancer|fallopian tube cancer
5827150|NCT00063388|Small|small
5827151|NCT00063388|Cell|cell
5827152|NCT00063388|Lung|lung
5827153|NCT00063388|Cancer|cancer
5827154|NCT00063362|Depression|depression
5827155|NCT00030446|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5827156|NCT00030446|fallopian tube cancer|fallopian tube cancer
5827157|NCT00030446|peritoneal cavity cancer|peritoneal cavity cancer
5827158|NCT00028483|stage IV breast cancer|stage iv breast cancer
5827159|NCT00028483|recurrent breast cancer|recurrent breast cancer
5827160|NCT00006968|stage III renal cell cancer|stage iii renal cell cancer
5827161|NCT00006968|stage IV renal cell cancer|stage iv renal cell cancer
5827162|NCT00006968|recurrent renal cell cancer|recurrent renal cell cancer
5827163|NCT00003352|stage IV breast cancer|stage iv breast cancer
5827164|NCT00003352|recurrent breast cancer|recurrent breast cancer
5827165|NCT00003352|stage IIIB breast cancer|stage iiib breast cancer
5827166|NCT00063310|Alzheimer disease|alzheimer disease
5827167|NCT00063310|Aging Women|aging women
5827168|NCT00063310|Hormone therapy|hormone therapy
5827169|NCT00063297|schizophrenia with negative symptoms|schizophrenia with negative symptoms
5827170|NCT00040729|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827171|NCT00063284|Electrical Stimulation|electrical stimulation
5827172|NCT00063284|Human Brain|human brain
5827173|NCT00063284|Parkinson Disease|parkinson disease
5827174|NCT00063284|PD|pd
5827175|NCT00063258|Non-Small Cell Lung Cancer|non-small cell lung cancer
5827176|NCT00063258|Lung Cancer|lung cancer
5827177|NCT00063258|OSI-774|osi-774
5827178|NCT00063258|Tarceva|tarceva
5827179|NCT00063258|Carboplatin|carboplatin
5827180|NCT00063258|Paclitaxel|paclitaxel
5827181|NCT00063258|NSCLC|nsclc
5827182|NCT00063219|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5827183|NCT00063219|Lung Cancer|lung cancer
5827184|NCT00063219|Cancer of Lung|cancer of lung
5827185|NCT00063206|Depressive Disorder, Major|depressive disorder, major
5827186|NCT00063206|Depression, Involutional|depression, involutional
5827187|NCT00063193|Parkinson's disease|parkinson's disease
5827188|NCT00063193|minocycline|minocycline
5827189|NCT00063193|creatine|creatine
5827191|NCT00063154|Lung cancer|lung cancer
5827192|NCT00030797|stage III colon cancer|stage iii colon cancer
5827193|NCT00030797|stage IV colon cancer|stage iv colon cancer
5827194|NCT00030797|stage III rectal cancer|stage iii rectal cancer
5827195|NCT00030797|stage IV rectal cancer|stage iv rectal cancer
5827196|NCT00026520|stage IV melanoma|stage iv melanoma
5827197|NCT00026520|recurrent melanoma|recurrent melanoma
5827198|NCT00026364|stage IV colon cancer|stage iv colon cancer
5827199|NCT00026364|stage IV rectal cancer|stage iv rectal cancer
5827200|NCT00026364|recurrent colon cancer|recurrent colon cancer
5827201|NCT00026364|recurrent rectal cancer|recurrent rectal cancer
5827202|NCT00026364|adenocarcinoma of the colon|adenocarcinoma of the colon
5827203|NCT00026364|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5827204|NCT00026351|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5827205|NCT00026351|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5827206|NCT00026351|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5827207|NCT00026351|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5827208|NCT00026351|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5827209|NCT00026351|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5827210|NCT00026351|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5827211|NCT00026351|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5827212|NCT00026351|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5827213|NCT00026351|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5827214|NCT00026351|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5827215|NCT00026351|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5827216|NCT00026351|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5827217|NCT00026351|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5827218|NCT00026351|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5827219|NCT00026351|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5827220|NCT00026351|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5827221|NCT00026351|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5827222|NCT00026351|prolymphocytic leukemia|prolymphocytic leukemia
5827223|NCT00026351|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5827224|NCT00026351|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5827225|NCT00026351|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5827226|NCT00026351|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5827227|NCT00026351|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5827228|NCT00026351|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5827229|NCT00026351|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5827230|NCT00026351|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5827232|NCT00026351|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5827233|NCT00026351|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5827234|NCT00026351|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5827235|NCT00026351|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5827236|NCT00026351|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5827237|NCT00026351|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5827238|NCT00026351|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827239|NCT00026351|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5827240|NCT00026351|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5827241|NCT00026351|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827242|NCT00025571|squamous cell lung cancer|squamous cell lung cancer
5827243|NCT00025571|large cell lung cancer|large cell lung cancer
5827244|NCT00025571|adenocarcinoma of the lung|adenocarcinoma of the lung
5827245|NCT00025571|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5827246|NCT00025571|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5827247|NCT00006013|refractory multiple myeloma|refractory multiple myeloma
5827248|NCT00004037|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5827249|NCT00004037|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5827250|NCT00004037|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5827251|NCT00003054|recurrent uterine sarcoma|recurrent uterine sarcoma
5827252|NCT00003054|uterine leiomyosarcoma|uterine leiomyosarcoma
5827253|NCT00063245|Motor Cortex|motor cortex
5827254|NCT00063245|Mood|mood
5827255|NCT00063245|Reward|reward
5827256|NCT00063245|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5827257|NCT00063245|Magnetic Coil|magnetic coil
5827258|NCT00063245|Healthy Volunteer|healthy volunteer
5827259|NCT00063245|HV|hv
5827260|NCT00063232|Insulin|insulin
5827261|NCT00063232|Obesity|obesity
5827262|NCT00063232|Fatty Liver|fatty liver
5827263|NCT00063232|Diabetes|diabetes
5827264|NCT00063232|Cirrhosis|cirrhosis
5827265|NCT00063232|Metformin|metformin
5827359|NCT00062946|HV|hv
5827266|NCT00063232|Insulin Resistance|insulin resistance
5827267|NCT00063232|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5827268|NCT00063232|Hepatitis|hepatitis
5827269|NCT00063232|NASH|nash
5827270|NCT00063180|Diaschisis|diaschisis
5827271|NCT00063180|Glucose|glucose
5827272|NCT00063180|GABA|gaba
5827273|NCT00063180|N-Acetylaspartate|n-acetylaspartate
5827274|NCT00063180|Glutamate|glutamate
5827275|NCT00063180|Stroke|stroke
5827276|NCT00063180|Healthy Volunteer|healthy volunteer
5827277|NCT00063180|HV|hv
5827278|NCT00063115|Praxis Movements|praxis movements
5827279|NCT00063115|Pantomime|pantomime
5827280|NCT00063115|Statistical Parametric Mapping|statistical parametric mapping
5827281|NCT00063115|Functional Connectivity|functional connectivity
5827282|NCT00063115|Path Analysis|path analysis
5827283|NCT00063115|Ideomotor Apraxia|ideomotor apraxia
5827284|NCT00063115|Healthy Volunteer|healthy volunteer
5827285|NCT00063115|HV|hv
5827286|NCT00063089|Staphylococcal infection|staphylococcal infection
5827287|NCT00063089|Gram positive bacteria|gram positive bacteria
5827288|NCT00063089|Staphylococcus|staphylococcus
5827289|NCT00063089|Staphylococcus aureus|staphylococcus aureus
5827290|NCT00063076|Alopecia Areata|alopecia areata
5827291|NCT00063076|Alopecia Totalis|alopecia totalis
5827292|NCT00063076|Alopecia Universalis|alopecia universalis
5827293|NCT00063076|Targretin Gel|targretin gel
5827294|NCT00063063|NICHD Neonatal Research Network|nichd neonatal research network
5827295|NCT00063063|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5827296|NCT00063063|Prematurity|prematurity
5827297|NCT00063050|Bone density|bone density
5827298|NCT00063050|Children|children
5827299|NCT00063050|Adolescents|adolescents
5827300|NCT00063050|Behavior|behavior
5827301|NCT00063050|Health education|health education
5827302|NCT00063050|Health promotion|health promotion
5827303|NCT00063050|Physical fitness|physical fitness
5827304|NCT00063050|Diet|diet
5827305|NCT00063050|Parent training|parent training
5827306|NCT00063050|Injury control|injury control
5827307|NCT00063037|Bone mass|bone mass
5827308|NCT00063037|Calcium intake|calcium intake
5827309|NCT00063037|Prevention of osteoporosis|prevention of osteoporosis
5827310|NCT00063037|Optimizing peak bone mass|optimizing peak bone mass
5827311|NCT00063037|Bone mineral density|bone mineral density
5827312|NCT00063024|Bone health|bone health
5827313|NCT00063024|Weight-bearing physical activity|weight-bearing physical activity
5827314|NCT00063024|Calcium|calcium
5827316|NCT00063011|Calcium-rich diet|calcium-rich diet
5827317|NCT00063011|Adolescents|adolescents
5827318|NCT00063011|Females|females
5827319|NCT00063011|Bone mass|bone mass
5827321|NCT00025545|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5827322|NCT00025545|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5827323|NCT00025545|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5827324|NCT00025545|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5827325|NCT00025545|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5827326|NCT00025545|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5827327|NCT00025545|acute undifferentiated leukemia|acute undifferentiated leukemia
5827328|NCT00025545|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5827329|NCT00024323|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827330|NCT00024310|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827331|NCT00024310|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5827332|NCT00024141|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827333|NCT00062985|obesity treatment|obesity treatment
5827334|NCT00062985|weight management|weight management
5827335|NCT00062985|managed care|managed care
5831352|NCT00054977|cancer|cancer
5827336|NCT00062972|Multiple Sclerosis|multiple sclerosis
5827337|NCT00062972|Cognitive Dysfunction|cognitive dysfunction
5827338|NCT00062972|Treatment Interventions|treatment interventions
5827339|NCT00062972|Verbal memory deficits|verbal memory deficits
5827340|NCT00062959|Adolescence|adolescence
5827341|NCT00062959|Parenting|parenting
5827342|NCT00062959|School|school
5827343|NCT00062959|Primary Prevention|primary prevention
5827344|NCT00062959|School-based intervention|school-based intervention
5827345|NCT00062894|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5827346|NCT00062894|BEXXAR|bexxar
5827347|NCT00062894|non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5827348|NCT00062946|Thalamus|thalamus
5827349|NCT00062946|Cerebral Cortices|cerebral cortices
5827350|NCT00062946|Quantification|quantification
5827351|NCT00062946|Reproducibility|reproducibility
5827352|NCT00062946|Dopamine Release|dopamine release
5827353|NCT00062946|(18F) Fallypride|(18f) fallypride
5827354|NCT00062946|D-Amphetamine|d-amphetamine
5827355|NCT00062946|Alpha-Methyl-Para-Tyrosine (AMPT)|alpha-methyl-para-tyrosine (ampt)
5827356|NCT00062946|PET|pet
5827357|NCT00062946|Dopamine D2 Receptor|dopamine d2 receptor
5827358|NCT00062946|Healthy Volunteer|healthy volunteer
5827360|NCT00062933|Clinical Response|clinical response
5827361|NCT00062933|Duration of Response|duration of response
5827362|NCT00062933|Quality of Life|quality of life
5827363|NCT00062933|Hyperthermia|hyperthermia
5827364|NCT00062933|Survival|survival
5827365|NCT00062933|Melanoma|melanoma
5827366|NCT00062933|Ocular Melanoma|ocular melanoma
5827367|NCT00062933|Eye Cancer|eye cancer
5827368|NCT00062881|Cancer|cancer
5827369|NCT00062881|Leukemia|leukemia
5827370|NCT00062881|Lymphoma|lymphoma
5827371|NCT00062881|Solid Tumor|solid tumor
5827372|NCT00062868|Lymphoma|lymphoma
5827373|NCT00062868|EBV-T/NK lymphoproliferative disease|ebv-t/nk lymphoproliferative disease
5827374|NCT00062868|Severe Chronic EBV|severe chronic ebv
5827375|NCT00062868|LMP1/2|lmp1/2
5827376|NCT00062868|CTL|ctl
5827377|NCT00062868|EBV|ebv
5827378|NCT00062868|Relapse|relapse
5827379|NCT00062868|LMP2A|lmp2a
5827380|NCT00062855|GENE MODIFIED AUTOLOGOUS NEUROBLASTOMA CELLS|gene modified autologous neuroblastoma cells
5827381|NCT00062855|Gene Therapy|gene therapy
5827382|NCT00062829|Teen driving|teen driving
5681406|NCT00573482|The intervention group received the education in REDE techniques|the intervention group received the education in rede techniques
5827383|NCT00062829|Adolescent risk behavior|adolescent risk behavior
5827384|NCT00062829|Parenting|parenting
5827385|NCT00062829|Checkpoints Program|checkpoints program
5827386|NCT00062829|Health Education|health education
5827387|NCT00062816|Hepatitis|hepatitis
5827388|NCT00062816|Chronic|chronic
5827389|NCT00002643|neutropenia|neutropenia
5827390|NCT00002643|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5827391|NCT00062790|Testosterone|testosterone
5827392|NCT00062790|DHT|dht
5827393|NCT00062790|TURP|turp
5827394|NCT00027612|adult glioblastoma|adult glioblastoma
5827395|NCT00027612|adult giant cell glioblastoma|adult giant cell glioblastoma
5827396|NCT00027612|adult gliosarcoma|adult gliosarcoma
5827397|NCT00025376|stage IV renal cell cancer|stage iv renal cell cancer
5827398|NCT00025376|recurrent renal cell cancer|recurrent renal cell cancer
5827399|NCT00023868|stage IV colon cancer|stage iv colon cancer
5827400|NCT00023868|stage IV rectal cancer|stage iv rectal cancer
5827401|NCT00023868|recurrent colon cancer|recurrent colon cancer
5827402|NCT00023868|recurrent rectal cancer|recurrent rectal cancer
5827403|NCT00023868|adenocarcinoma of the colon|adenocarcinoma of the colon
5827404|NCT00023868|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5827406|NCT00022594|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5827407|NCT00022594|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5846657|NCT00043836|quality of life|quality of life
5827408|NCT00022594|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5827409|NCT00022594|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5827410|NCT00022594|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5827411|NCT00022594|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5827412|NCT00022594|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5827413|NCT00022594|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5827414|NCT00022594|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5827415|NCT00022594|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5827416|NCT00022594|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5827417|NCT00022594|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5827418|NCT00022594|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5827419|NCT00022594|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5827420|NCT00062777|Genetics|genetics
5827421|NCT00062777|Populations|populations
5827422|NCT00062777|CVD Risk|cvd risk
5831353|NCT00054977|tumor|tumor
5827423|NCT00062777|Gene Mapping|gene mapping
5827424|NCT00062777|Epidemiology|epidemiology
5827425|NCT00062777|Framingham Study|framingham study
5827426|NCT00062777|Vascular Diseases|vascular diseases
5827427|NCT00062764|Insulin Resistance|insulin resistance
5827428|NCT00062764|Obesity|obesity
5827429|NCT00062764|Fatty Liver|fatty liver
5827430|NCT00062764|Cirrhosis|cirrhosis
5827431|NCT00062764|Diabetes|diabetes
5827432|NCT00062764|Pioglitazone|pioglitazone
5827433|NCT00062764|Thiazolidinediones|thiazolidinediones
5827434|NCT00062764|Peroxisome Proliferator-Advanced Receptor Gamma|peroxisome proliferator-advanced receptor gamma
5827435|NCT00062764|PPAR Gama|ppar gama
5827436|NCT00062764|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5827437|NCT00062764|Hepatitis|hepatitis
5827438|NCT00062764|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5827439|NCT00062764|NASH|nash
5827440|NCT00062751|breast|breast
5827441|NCT00062751|neoplasms|neoplasms
5827442|NCT00062738|Parkinson's disease|parkinson's disease
5827443|NCT00062738|Parkinson disease|parkinson disease
5827444|NCT00062738|depression|depression
5827445|NCT00062738|antidepressants|antidepressants
5827446|NCT00062738|nortriptyline|nortriptyline
5827448|NCT00062712|Immunosuppression|immunosuppression
5827449|NCT00062712|Transplant|transplant
5827450|NCT00062712|Kidney Transplant|kidney transplant
5827451|NCT00062686|Lapatinib|lapatinib
5827452|NCT00062686|Metastatic Breast Cancer|metastatic breast cancer
5827453|NCT00062686|HERCEPTIN refractory|herceptin refractory
5827454|NCT00062634|Female condom use|female condom use
5827455|NCT00062634|Male condom use|male condom use
5827456|NCT00062634|AIDS education|aids education
5827457|NCT00062634|AIDS prevention|aids prevention
5827458|NCT00062634|HIV Seronegativity|hiv seronegativity
5827459|NCT00062621|Immune tolerance|immune tolerance
5827460|NCT00062621|Graft vs host disease|graft vs host disease
5681599|NCT00572624|Gastric bypass surgery|gastric bypass surgery
5681407|NCT00573482|The control group received no intervention at all.|the control group received no intervention at all.
5681408|NCT00573482|Both groups were exposed to the food labels and the new lower ED foods.|both groups were exposed to the food labels and the new lower ed foods.
5827461|NCT00062621|Kidney Failure|kidney failure
5827462|NCT00062621|Kidney diseases|kidney diseases
5827463|NCT00062621|End Stage Renal Disease|end stage renal disease
5827464|NCT00062621|Multiple Myeloma|multiple myeloma
5827465|NCT00062621|Bone Marrow Transplant|bone marrow transplant
5827466|NCT00062621|Kidney Transplant|kidney transplant
5827467|NCT00062621|Renal Transplant|renal transplant
5827468|NCT00062621|Tolerance|tolerance
5827469|NCT00062621|Chimerism|chimerism
5827470|NCT00062621|ESRD|esrd
5827471|NCT00062608|Abdominal|abdominal
5827472|NCT00062595|Menopause|menopause
5827473|NCT00062595|Vitamin K|vitamin k
5827474|NCT00062595|Bone turnover|bone turnover
5827475|NCT00062595|Bone Density|bone density
5827476|NCT00062569|Alzheimer disease|alzheimer disease
5827477|NCT00062569|Resistiveness to baths|resistiveness to baths
5827478|NCT00062569|Caregiver stress|caregiver stress
5827479|NCT00062569|Bathing support intervention|bathing support intervention
5827480|NCT00062569|Reminiscence|reminiscence
5827481|NCT00062569|Agitated behavior|agitated behavior
5827482|NCT00062569|Resistiveness to care|resistiveness to care
5827483|NCT00062556|Intermittent Claudication|intermittent claudication
5827484|NCT00062556|Peripheral Arterial Disease|peripheral arterial disease
5827486|NCT00062556|Niacin|niacin
5827487|NCT00062556|Lovastatin|lovastatin
5827490|NCT00062543|Severe hepatic dysfunction post stem cell transplantation|severe hepatic dysfunction post stem cell transplantation
5827491|NCT00062543|Stem Cell Transplantation|stem cell transplantation
5827492|NCT00062543|Hepatic Artery Infusion|hepatic artery infusion
5827493|NCT00062543|Liver Diseases|liver diseases
5827494|NCT00062543|CD34+ Cells|cd34+ cells
5827495|NCT00062543|SCT|sct
5827496|NCT00062530|AIDS|aids
5827497|NCT00062530|HIV seronegativity|hiv seronegativity
5827498|NCT00062530|HIV preventive vaccine|hiv preventive vaccine
5827499|NCT00022009|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827500|NCT00022009|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827501|NCT00022009|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5827502|NCT00018954|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5827503|NCT00018954|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5827504|NCT00018954|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5827505|NCT00018954|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5827506|NCT00018954|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5827507|NCT00018954|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5827508|NCT00018954|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5827509|NCT00018954|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5827510|NCT00018954|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5827511|NCT00018954|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5827512|NCT00018954|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5827513|NCT00018954|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5828276|NCT00061334|Healthy Volunteer|healthy volunteer
5827514|NCT00018954|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5827515|NCT00018954|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5827516|NCT00018954|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5827517|NCT00018954|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5827518|NCT00018954|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5827519|NCT00018954|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5827520|NCT00018954|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5827521|NCT00018954|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5827522|NCT00018954|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5827523|NCT00018954|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5827524|NCT00018954|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5827525|NCT00018954|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5827526|NCT00018954|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5827527|NCT00018954|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5827599|NCT00062439|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5681409|NCT00573482|Only the intervention group received the education sessions and only they were eligible for the price reductions.|only the intervention group received the education sessions and only they were eligible for the price reductions.
5827528|NCT00018954|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5827529|NCT00018954|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5827530|NCT00018954|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5827531|NCT00018954|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5827532|NCT00018954|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5827533|NCT00018954|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5827534|NCT00018954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5827535|NCT00018954|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5827536|NCT00018954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5827537|NCT00018954|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5827538|NCT00018954|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5827539|NCT00018954|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5827540|NCT00018954|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5827541|NCT00018954|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5827542|NCT00018954|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5827543|NCT00018954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5827544|NCT00018954|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5827545|NCT00018954|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5827546|NCT00018954|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5827547|NCT00018954|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5827548|NCT00018954|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5827549|NCT00018954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5827550|NCT00018954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5827551|NCT00018954|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5827552|NCT00018954|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5827553|NCT00018954|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5827554|NCT00018954|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5827555|NCT00018954|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5827556|NCT00018954|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5827557|NCT00018954|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5827558|NCT00018954|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827559|NCT00018954|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5827560|NCT00018954|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5827561|NCT00018954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827562|NCT00018954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5827563|NCT00018954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5827564|NCT00017446|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5827565|NCT00017446|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5827566|NCT00017446|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5827568|NCT00017316|recurrent melanoma|recurrent melanoma
5827570|NCT00062582|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5827571|NCT00062582|COPD|copd
5827572|NCT00014664|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5827573|NCT00014664|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5827574|NCT00014664|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5827575|NCT00014664|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5828277|NCT00061334|HV|hv
5827576|NCT00014664|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5827577|NCT00014664|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827578|NCT00014534|stage III bladder cancer|stage iii bladder cancer
5827579|NCT00014534|stage IV bladder cancer|stage iv bladder cancer
5827580|NCT00014534|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5827581|NCT00062517|Amygdala|amygdala
5827582|NCT00062517|Generalized Anxiety Disorder|generalized anxiety disorder
5827583|NCT00062517|Anxiety Disorder|anxiety disorder
5827584|NCT00062517|GAD|gad
5827585|NCT00062517|Social Anxiety Disorder|social anxiety disorder
5827586|NCT00062517|SAD|sad
5827587|NCT00012155|stage IV colon cancer|stage iv colon cancer
5681411|NCT00573469|GI|gi
5681412|NCT00573469|Crohn's disease|crohn's disease
5681413|NCT00573469|Japan|japan
5681414|NCT00573469|Japanese|japanese
5681415|NCT00573456|Thye 1 Diabetes|thye 1 diabetes
5681416|NCT00573456|Type 2 Diabetes|type 2 diabetes
5849041|NCT00031408|Informed Consent|informed consent
5849044|NCT00031395|ADHD|adhd
5827588|NCT00012155|recurrent colon cancer|recurrent colon cancer
5827589|NCT00012155|adenocarcinoma of the colon|adenocarcinoma of the colon
5827590|NCT00012155|liver metastases|liver metastases
5827591|NCT00062465|DMARD|dmard
5827592|NCT00062465|Clinical Trial|clinical trial
5827593|NCT00062465|Thunder God Vine|thunder god vine
5827594|NCT00062465|Chinese Herb|chinese herb
5827595|NCT00062465|Rheumatoid Arthritis|rheumatoid arthritis
5827600|NCT00062439|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827601|NCT00062439|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827602|NCT00062426|adenocarcinoma of the colon|adenocarcinoma of the colon
5827603|NCT00062426|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5827604|NCT00062426|recurrent colon cancer|recurrent colon cancer
5827605|NCT00062426|stage IV colon cancer|stage iv colon cancer
5827606|NCT00062426|recurrent rectal cancer|recurrent rectal cancer
5827607|NCT00062426|stage IV rectal cancer|stage iv rectal cancer
5827608|NCT00062400|sexual dysfunction and infertility|sexual dysfunction and infertility
5827609|NCT00062400|sexuality and reproductive issues|sexuality and reproductive issues
5827610|NCT00062400|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5827611|NCT00062400|stage II breast cancer|stage ii breast cancer
5827612|NCT00062400|stage IA breast cancer|stage ia breast cancer
5827613|NCT00062400|stage IB breast cancer|stage ib breast cancer
5827614|NCT00062387|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5827615|NCT00062387|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5827616|NCT00062387|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5827617|NCT00062387|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5827618|NCT00062387|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5827619|NCT00062387|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5827620|NCT00062387|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5827622|NCT00062387|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5827623|NCT00062387|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5827624|NCT00062387|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5827625|NCT00062387|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5827626|NCT00062387|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5827627|NCT00062387|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5827628|NCT00062387|recurrent salivary gland cancer|recurrent salivary gland cancer
5827629|NCT00062387|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5827630|NCT00062387|stage IV salivary gland cancer|stage iv salivary gland cancer
5827631|NCT00062348|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5827632|NCT00062348|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5827633|NCT00062348|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5827634|NCT00062348|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5827635|NCT00062348|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5827636|NCT00062348|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5827637|NCT00062348|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5827638|NCT00062348|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5827639|NCT00062348|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5827640|NCT00062348|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5827641|NCT00062348|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5827706|NCT00062296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5828278|NCT00061282|Pouchitis|pouchitis
5827642|NCT00062348|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5827643|NCT00062348|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5827644|NCT00062348|recurrent thyroid cancer|recurrent thyroid cancer
5827645|NCT00062348|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5827646|NCT00062348|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5827647|NCT00062348|stage IVA colon cancer|stage iva colon cancer
5827648|NCT00062348|stage IVB colon cancer|stage ivb colon cancer
5827649|NCT00062348|recurrent colon cancer|recurrent colon cancer
5827650|NCT00062348|adenocarcinoma of the colon|adenocarcinoma of the colon
5827651|NCT00062348|recurrent rectal cancer|recurrent rectal cancer
5827652|NCT00062348|stage IVA rectal cancer|stage iva rectal cancer
5827653|NCT00062348|stage IVB rectal cancer|stage ivb rectal cancer
5827654|NCT00062348|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5827655|NCT00062348|anaplastic thyroid cancer|anaplastic thyroid cancer
5827656|NCT00062348|insular thyroid cancer|insular thyroid cancer
5827657|NCT00062348|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5827658|NCT00062348|liver metastases|liver metastases
5827659|NCT00062348|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5827660|NCT00062348|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5827661|NCT00062348|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5686730|NCT00550784|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5681405|NCT00573482|food environment|food environment
5827662|NCT00062348|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5827663|NCT00062348|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5827664|NCT00062348|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5827665|NCT00062348|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5827666|NCT00062348|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5827667|NCT00062348|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5827668|NCT00062348|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5827669|NCT00062348|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5827670|NCT00062348|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5827671|NCT00062348|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5827672|NCT00062348|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5827673|NCT00062348|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5827674|NCT00062348|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5827675|NCT00062348|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5827676|NCT00062348|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5827677|NCT00062348|stage I papillary thyroid cancer|stage i papillary thyroid cancer
5827678|NCT00062348|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5827679|NCT00062348|stage III papillary thyroid cancer|stage iii papillary thyroid cancer
5827680|NCT00062348|stage I follicular thyroid cancer|stage i follicular thyroid cancer
5827681|NCT00062348|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5827682|NCT00062348|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5827683|NCT00062348|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5827684|NCT00062348|recurrent salivary gland cancer|recurrent salivary gland cancer
5827685|NCT00062348|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5827686|NCT00062348|stage I salivary gland cancer|stage i salivary gland cancer
5827687|NCT00062348|stage II salivary gland cancer|stage ii salivary gland cancer
5827688|NCT00062348|stage III salivary gland cancer|stage iii salivary gland cancer
5827689|NCT00062348|stage IV salivary gland cancer|stage iv salivary gland cancer
5827690|NCT00062348|tongue cancer|tongue cancer
5827691|NCT00062335|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5827692|NCT00062335|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5827693|NCT00062335|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827694|NCT00062322|limited stage small cell lung cancer|limited stage small cell lung cancer
5827695|NCT00062309|stage II prostate cancer|stage ii prostate cancer
5827696|NCT00062309|stage III prostate cancer|stage iii prostate cancer
5827697|NCT00062309|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5827698|NCT00062296|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5827699|NCT00062296|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5827700|NCT00062296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5827701|NCT00062296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5827702|NCT00062296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5827703|NCT00062296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5863171|NCT00001362|Neurobehavioral Deficits|neurobehavioral deficits
5681417|NCT00573443|Amyotrophic Lateral Sclerosis (Lou Gehrig's disease, ALS)|amyotrophic lateral sclerosis (lou gehrig's disease, als)
5681419|NCT00573430|Candesartan Cilexetil|candesartan cilexetil
5681420|NCT00573430|Non-diabetic Nephropathy|non-diabetic nephropathy
5681421|NCT00573430|hypertension|hypertension
5681422|NCT00573430|urine protein creatinine ratio|urine protein creatinine ratio
5681423|NCT00573417|Schizophrenia|schizophrenia
5681424|NCT00573417|Clozapine|clozapine
5827704|NCT00062296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5827705|NCT00062296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5827707|NCT00062296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5827708|NCT00062296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5827709|NCT00062296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5827710|NCT00062296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5827711|NCT00062296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5827712|NCT00062296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827713|NCT00062296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5827714|NCT00062296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5827715|NCT00062283|advanced malignant mesothelioma|advanced malignant mesothelioma
5827716|NCT00062283|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5827717|NCT00062283|metastatic osteosarcoma|metastatic osteosarcoma
5827718|NCT00062283|recurrent osteosarcoma|recurrent osteosarcoma
5827719|NCT00062283|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5827720|NCT00062283|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5827721|NCT00062283|chondrosarcoma|chondrosarcoma
5827722|NCT00062283|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5827723|NCT00062283|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827724|NCT00062283|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5845851|NCT00048698|Cognition|cognition
5827725|NCT00062283|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5827726|NCT00062283|recurrent pancreatic cancer|recurrent pancreatic cancer
5827727|NCT00062283|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5827728|NCT00062283|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5827729|NCT00062283|stage IV pancreatic cancer|stage iv pancreatic cancer
5827730|NCT00062270|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827731|NCT00062270|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827732|NCT00062257|recurrent gastric cancer|recurrent gastric cancer
5827733|NCT00062257|stage IV gastric cancer|stage iv gastric cancer
5827734|NCT00062257|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5827735|NCT00062231|infection|infection
5827737|NCT00062231|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5827738|NCT00062231|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827739|NCT00062231|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5827740|NCT00062231|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5827741|NCT00062231|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5827742|NCT00062231|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5827743|NCT00062231|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5827744|NCT00062231|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5827745|NCT00062231|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5827746|NCT00062231|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5827747|NCT00062231|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5827748|NCT00062231|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5827749|NCT00062231|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5827750|NCT00062231|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5827751|NCT00062231|extramedullary plasmacytoma|extramedullary plasmacytoma
5827752|NCT00062231|refractory multiple myeloma|refractory multiple myeloma
5827753|NCT00062231|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5827754|NCT00062231|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5827755|NCT00062231|stage I multiple myeloma|stage i multiple myeloma
5827756|NCT00062231|stage II multiple myeloma|stage ii multiple myeloma
5827757|NCT00062231|stage III multiple myeloma|stage iii multiple myeloma
5827758|NCT00062231|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5846658|NCT00043823|Non-Small Cell Lung Cancer|non-small cell lung cancer
5827759|NCT00062231|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5827760|NCT00062231|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5827761|NCT00062231|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5827762|NCT00062231|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5827763|NCT00062231|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5827764|NCT00062231|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5827765|NCT00062231|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5827766|NCT00062231|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5827767|NCT00062231|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5827768|NCT00062231|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5827769|NCT00062231|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5827770|NCT00062231|polycythemia vera|polycythemia vera
5827771|NCT00062231|primary myelofibrosis|primary myelofibrosis
5827772|NCT00062231|essential thrombocythemia|essential thrombocythemia
5827773|NCT00062231|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5827774|NCT00062231|refractory hairy cell leukemia|refractory hairy cell leukemia
5827775|NCT00062231|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5828030|NCT00009789|large cell lung cancer|large cell lung cancer
5827776|NCT00062231|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5827777|NCT00062231|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5827778|NCT00062231|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5827779|NCT00062231|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5827780|NCT00062231|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5827781|NCT00062231|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5827782|NCT00062231|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5827783|NCT00062231|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5827784|NCT00062231|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5827785|NCT00062231|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5827786|NCT00062231|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5827787|NCT00062231|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5827788|NCT00062231|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5827789|NCT00062231|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5827790|NCT00062231|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5827791|NCT00062231|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5845977|NCT00047931|Healthy|healthy
5827792|NCT00062231|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5827793|NCT00062231|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5827794|NCT00062231|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5827795|NCT00062231|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5827796|NCT00062231|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5827797|NCT00062231|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5827798|NCT00062231|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5827799|NCT00062231|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5827800|NCT00062231|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5827801|NCT00062231|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5827802|NCT00062231|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5827803|NCT00062231|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5827804|NCT00062231|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5827805|NCT00062231|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5827806|NCT00062231|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5827807|NCT00062231|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5827808|NCT00062231|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5827809|NCT00062231|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5827810|NCT00062231|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5827811|NCT00062231|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5827812|NCT00062231|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5827813|NCT00062231|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5827814|NCT00062231|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5827815|NCT00062231|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5827816|NCT00062231|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5681427|NCT00573417|Negative Symptoms|negative symptoms
5827817|NCT00062231|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5827818|NCT00062231|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5827819|NCT00062231|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5827820|NCT00062231|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5827821|NCT00062231|acute undifferentiated leukemia|acute undifferentiated leukemia
5827822|NCT00062231|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5827823|NCT00062231|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5827824|NCT00062231|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5827825|NCT00062231|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5827826|NCT00062231|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5827827|NCT00062231|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5827828|NCT00062231|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5827829|NCT00062231|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5827830|NCT00062231|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5827831|NCT00062231|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5827832|NCT00062231|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5827833|NCT00062231|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5827834|NCT00062231|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5827835|NCT00062231|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5827836|NCT00062231|prolymphocytic leukemia|prolymphocytic leukemia
5827837|NCT00062231|primary systemic amyloidosis|primary systemic amyloidosis
5827838|NCT00062231|intraocular lymphoma|intraocular lymphoma
5827839|NCT00062231|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5827840|NCT00062231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5686731|NCT00550784|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5686732|NCT00550784|fallopian tube cancer|fallopian tube cancer
5848737|NCT00033969|HV|hv
5827841|NCT00062231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5827842|NCT00062231|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5827843|NCT00062231|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5827844|NCT00062231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5827845|NCT00062231|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5827846|NCT00062231|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5827847|NCT00062231|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5827848|NCT00062231|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5827849|NCT00062231|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5827850|NCT00062231|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5827851|NCT00062231|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5827852|NCT00062231|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5827853|NCT00062231|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5827977|NCT00061997|small cell lung cancer|small cell lung cancer
5827854|NCT00062231|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5827855|NCT00062231|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5827856|NCT00062231|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5827857|NCT00062231|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5824139|NCT00069472|Genetics|genetics
5827858|NCT00062231|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5827859|NCT00062231|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5827860|NCT00062231|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5827861|NCT00062231|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5827862|NCT00062231|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5827863|NCT00062231|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5827864|NCT00062231|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5827865|NCT00062231|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5827866|NCT00062231|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827867|NCT00062231|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5827868|NCT00062231|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5827869|NCT00062231|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5827870|NCT00062231|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5827871|NCT00062231|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5827872|NCT00062231|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5827873|NCT00062231|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5827874|NCT00062231|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5863172|NCT00001362|Neurological Disorders|neurological disorders
5827875|NCT00062231|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5827876|NCT00062231|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827877|NCT00062231|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5827878|NCT00062231|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5827879|NCT00062231|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5827880|NCT00062231|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5827881|NCT00062231|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5827882|NCT00062205|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5827883|NCT00062179|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5827885|NCT00062166|Rate of Tumor Growth|rate of tumor growth
5827886|NCT00062166|Familial Cancer Syndrome|familial cancer syndrome
5827887|NCT00062166|Surgical Resection|surgical resection
5827888|NCT00062140|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5827889|NCT00062140|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5827890|NCT00062140|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5827891|NCT00062140|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5827892|NCT00062140|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5827893|NCT00062140|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5827894|NCT00062140|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5827895|NCT00062140|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5686733|NCT00550784|peritoneal cavity cancer|peritoneal cavity cancer
5686734|NCT00550758|Methacholine challenge; Spirometry, Early childhood|methacholine challenge; spirometry, early childhood
5686735|NCT00550732|Triazoles|triazoles
5686736|NCT00550706|Prescription point prevalence|prescription point prevalence
5686737|NCT00550706|Drug utilization|drug utilization
5827896|NCT00062140|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5827897|NCT00062140|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5827898|NCT00062140|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5827899|NCT00062140|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5828280|NCT00061282|Ileitis|ileitis
5827900|NCT00062140|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5827901|NCT00062140|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5827902|NCT00062140|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5827903|NCT00062140|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5827904|NCT00062140|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5827905|NCT00062140|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5827906|NCT00062140|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5827907|NCT00062140|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5827908|NCT00062140|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5827909|NCT00062140|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5827910|NCT00062140|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5827911|NCT00062140|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5827912|NCT00062140|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5827913|NCT00062140|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5827978|NCT00061997|precancerous condition|precancerous condition
5827914|NCT00062140|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5827915|NCT00062140|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5846649|NCT00043862|newly diagnosed|newly diagnosed
5827916|NCT00062140|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5827917|NCT00062140|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5827918|NCT00062140|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5827919|NCT00062140|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5827920|NCT00062140|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5827921|NCT00062140|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5827922|NCT00062140|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5827923|NCT00062140|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5827924|NCT00062140|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5827925|NCT00062140|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5827926|NCT00062140|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5827927|NCT00062140|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5827928|NCT00062140|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5827929|NCT00062140|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5827930|NCT00062140|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5827931|NCT00062140|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5827932|NCT00062140|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5827933|NCT00062140|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5827934|NCT00062140|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5827935|NCT00062140|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5827936|NCT00062140|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5827937|NCT00062140|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5827938|NCT00062140|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5827939|NCT00062140|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5827940|NCT00062140|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5827941|NCT00062140|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5827942|NCT00062140|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5827943|NCT00062140|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5827944|NCT00062140|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5827945|NCT00062140|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5686738|NCT00550706|Define Daily Dose|define daily dose
5686739|NCT00550693|bloodstream infections|bloodstream infections
5686740|NCT00550693|hemodialysis catheter|hemodialysis catheter
5848952|NCT00032487|DM|dm
5827946|NCT00062140|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5827947|NCT00062140|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5827948|NCT00062140|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5827949|NCT00062140|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5827950|NCT00062140|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5827951|NCT00062140|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5827952|NCT00062140|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5827953|NCT00062140|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5827954|NCT00062140|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5827955|NCT00062140|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5827956|NCT00062140|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5827957|NCT00062140|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5827958|NCT00062140|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5827959|NCT00062140|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5828031|NCT00009789|adenocarcinoma of the lung|adenocarcinoma of the lung
5827960|NCT00062140|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5827961|NCT00062140|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5827962|NCT00062114|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5827963|NCT00062114|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5827964|NCT00062114|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5827965|NCT00062062|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5827966|NCT00062062|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5827967|NCT00062049|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5827968|NCT00062036|stage IV melanoma|stage iv melanoma
5827969|NCT00062036|recurrent melanoma|recurrent melanoma
5827970|NCT00062023|colorectal cancer|colorectal cancer
5827971|NCT00062023|stage I colon cancer|stage i colon cancer
5827972|NCT00062023|stage II colon cancer|stage ii colon cancer
5827973|NCT00062023|stage III colon cancer|stage iii colon cancer
5827974|NCT00062023|stage IV colon cancer|stage iv colon cancer
5827975|NCT00062010|recurrent small cell lung cancer|recurrent small cell lung cancer
5827976|NCT00061997|non-small cell lung cancer|non-small cell lung cancer
5827979|NCT00061984|adult angiosarcoma|adult angiosarcoma
5827980|NCT00061984|adult epithelioid sarcoma|adult epithelioid sarcoma
5827981|NCT00061984|adult fibrosarcoma|adult fibrosarcoma
5827982|NCT00061984|adult leiomyosarcoma|adult leiomyosarcoma
5827983|NCT00061984|adult liposarcoma|adult liposarcoma
5827984|NCT00061984|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5827985|NCT00061984|adult synovial sarcoma|adult synovial sarcoma
5827986|NCT00061984|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5827987|NCT00061984|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5827988|NCT00061984|adult neurofibrosarcoma|adult neurofibrosarcoma
5827989|NCT00061984|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5827990|NCT00061984|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5827991|NCT00061919|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5827992|NCT00061919|limited stage small cell lung cancer|limited stage small cell lung cancer
5827993|NCT00061906|insular thyroid cancer|insular thyroid cancer
5827994|NCT00061906|recurrent thyroid cancer|recurrent thyroid cancer
5827995|NCT00061906|stage II follicular thyroid cancer|stage ii follicular thyroid cancer
5827996|NCT00061906|stage II papillary thyroid cancer|stage ii papillary thyroid cancer
5827997|NCT00061906|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5827998|NCT00061906|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5827999|NCT00061893|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5828000|NCT00061880|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5681428|NCT00573417|Wakefulness|wakefulness
5681429|NCT00573417|Fatigue|fatigue
5681430|NCT00573404|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5681431|NCT00573378|CML|cml
5681432|NCT00573365|dermatitis|dermatitis
5681433|NCT00573365|skin|skin
5681434|NCT00573365|radiation|radiation
5681435|NCT00573365|light|light
5681436|NCT00573365|LED photomodulation|led photomodulation
5681437|NCT00573365|Gentlewaves|gentlewaves
5828001|NCT00061880|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5828002|NCT00061880|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5686741|NCT00550667|Attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder
5686742|NCT00550667|adult|adult
5686743|NCT00550667|diagnostic validity|diagnostic validity
5681141|NCT00574561|CT angiography (CTA)|ct angiography (cta)
5686744|NCT00550667|neuropsychological functions|neuropsychological functions
5686745|NCT00550667|social functioning|social functioning
5681410|NCT00573469|gastrointestinal|gastrointestinal
5828003|NCT00061880|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5828004|NCT00061880|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5828005|NCT00061880|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5828006|NCT00061880|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5828007|NCT00061880|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5828008|NCT00061880|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5828009|NCT00061880|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5828010|NCT00061867|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5828011|NCT00061867|stage III prostate cancer|stage iii prostate cancer
5828012|NCT00061867|stage IV prostate cancer|stage iv prostate cancer
5828013|NCT00061854|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5828014|NCT00061854|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5828015|NCT00061854|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5828016|NCT00061854|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5828017|NCT00010231|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5828018|NCT00010231|stage III prostate cancer|stage iii prostate cancer
5828019|NCT00010231|stage IV prostate cancer|stage iv prostate cancer
5828020|NCT00010231|recurrent prostate cancer|recurrent prostate cancer
5828021|NCT00010114|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5828022|NCT00010114|childhood choroid plexus tumor|childhood choroid plexus tumor
5828023|NCT00010114|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5828024|NCT00010114|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5828025|NCT00010114|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5828026|NCT00009932|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5828027|NCT00009802|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5828028|NCT00009789|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5828029|NCT00009789|squamous cell lung cancer|squamous cell lung cancer
5828032|NCT00009789|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5828033|NCT00009789|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5828034|NCT00008424|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5828035|NCT00008398|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5828036|NCT00008398|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5828037|NCT00008398|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5828038|NCT00008398|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5828039|NCT00008398|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5828040|NCT00008398|stage 0 paranasal sinus and nasal cavity cancer|stage 0 paranasal sinus and nasal cavity cancer
5828041|NCT00008398|stage 0 nasopharyngeal cancer|stage 0 nasopharyngeal cancer
5828042|NCT00008398|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5828043|NCT00008398|stage 0 laryngeal cancer|stage 0 laryngeal cancer
5828044|NCT00008398|stage 0 hypopharyngeal cancer|stage 0 hypopharyngeal cancer
5828045|NCT00008398|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5828046|NCT00008398|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5828047|NCT00008398|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5828048|NCT00008398|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5828049|NCT00008398|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5828050|NCT00008398|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5828051|NCT00008398|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5828052|NCT00008398|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5828053|NCT00008398|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5828054|NCT00008398|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5828055|NCT00008398|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5828056|NCT00008398|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5681438|NCT00573352|Arthritis, Degenerative|arthritis, degenerative
5681440|NCT00573352|Osteoarthrosis Deformans|osteoarthrosis deformans
5681441|NCT00573339|Cardiac|cardiac
5828057|NCT00008398|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5828058|NCT00008398|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5828059|NCT00008398|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5828060|NCT00008398|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5828061|NCT00008398|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5828062|NCT00008398|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5828063|NCT00008398|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5828064|NCT00008398|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5828065|NCT00008398|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5828066|NCT00008398|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5828067|NCT00008398|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5828068|NCT00008398|oral complications|oral complications
5828069|NCT00008398|radiation toxicity|radiation toxicity
5828070|NCT00008203|stage II breast cancer|stage ii breast cancer
5828071|NCT00008203|stage IIIA breast cancer|stage iiia breast cancer
5828072|NCT00008203|stage IIIB breast cancer|stage iiib breast cancer
5828073|NCT00008112|stage III cervical cancer|stage iii cervical cancer
5828074|NCT00008112|stage IIB cervical cancer|stage iib cervical cancer
5828075|NCT00008112|stage IVA cervical cancer|stage iva cervical cancer
5828076|NCT00008112|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5828077|NCT00008112|cervical adenocarcinoma|cervical adenocarcinoma
5828078|NCT00008112|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5828079|NCT00061789|Schizophrenia|schizophrenia
5828081|NCT00061789|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5828082|NCT00061789|Cigarette Smoking|cigarette smoking
5828083|NCT00061789|Cognitive Dysfunction|cognitive dysfunction
5828084|NCT00061789|Reproducibility|reproducibility
5828085|NCT00061789|Quantification|quantification
5828086|NCT00061789|Healthy Volunteer|healthy volunteer
5828088|NCT00061776|Dermal assessment|dermal assessment
5828089|NCT00061776|Pain measurement|pain measurement
5828090|NCT00061776|Diary|diary
5828091|NCT00061776|Shingles|shingles
5828092|NCT00061776|Neuropathy|neuropathy
5828093|NCT00061776|Analgesics/*therapeutic use|analgesics/*therapeutic use
5828094|NCT00061776|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5828095|NCT00061776|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
5828096|NCT00061776|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5828097|NCT00061776|Pain|pain
5828098|NCT00061776|Peripheral Nervous System Diseases/*complications|peripheral nervous system diseases/*complications
5828099|NCT00061763|beta-thalassemia|beta-thalassemia
5828100|NCT00061763|iron overload|iron overload
5828101|NCT00061763|deferoxamine|deferoxamine
5828102|NCT00061763|Myelodysplastic Syndromes|myelodysplastic syndromes
5828103|NCT00061763|Fanconi Syndrome|fanconi syndrome
5828104|NCT00061763|Anemia, Diamond-Blackfan|anemia, diamond-blackfan
5828105|NCT00061763|Anemia, Aplastic|anemia, aplastic
5828106|NCT00061750|Thalassemia, iron overload, deferoxamine, hemosiderosis|thalassemia, iron overload, deferoxamine, hemosiderosis
5828107|NCT00061737|Pediatric IBD|pediatric ibd
5828108|NCT00061737|Inflammatory|inflammatory
5828112|NCT00061672|Non-Hodgkin's Lymphoma (NHL)|non-hodgkin's lymphoma (nhl)
5828113|NCT00061672|Hodgkin's Lymphoma (HL)|hodgkin's lymphoma (hl)
5828114|NCT00061659|high grade locally advanced/metastatic soft tissue sarcoma|high grade locally advanced/metastatic soft tissue sarcoma
5828115|NCT00061646|Stage IIIb with pleural effusion or IV NSCLC|stage iiib with pleural effusion or iv nsclc
5828116|NCT00051714|Social Behavior Disorders|social behavior disorders
5828117|NCT00061620|Investigational|investigational
5828118|NCT00061620|Chemotherapy|chemotherapy
5828119|NCT00061620|Hematologic Malignancies|hematologic malignancies
5828120|NCT00061620|Nucleoside analogue|nucleoside analogue
5824407|NCT00026286|hot flashes|hot flashes
5828121|NCT00059462|Treatment experienced|treatment experienced
5828122|NCT00008021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5828123|NCT00008021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5828124|NCT00008021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5828125|NCT00008021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5828126|NCT00008021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5828127|NCT00008021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5828128|NCT00008021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5828129|NCT00008021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5828130|NCT00008021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5681443|NCT00573339|normal controls|normal controls
5681444|NCT00573313|Alcoholic Liver Disease (ALD)|alcoholic liver disease (ald)
5681445|NCT00573313|S-adenosylmethionine|s-adenosylmethionine
5681446|NCT00573313|SAMe|same
5681447|NCT00573300|Schizophrenia|schizophrenia
5681448|NCT00573300|Immune System|immune system
5681449|NCT00573300|Kynurenate|kynurenate
5681450|NCT00573300|tryptophan metabolism|tryptophan metabolism
5681451|NCT00573300|NMDA receptor|nmda receptor
5686746|NCT00550654|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5686747|NCT00550654|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5686748|NCT00550654|recurrent melanoma|recurrent melanoma
5686749|NCT00550654|recurrent osteosarcoma|recurrent osteosarcoma
5686750|NCT00550654|recurrent renal cell cancer|recurrent renal cell cancer
5686751|NCT00550654|recurrent uterine sarcoma|recurrent uterine sarcoma
5687002|NCT00549575|Nitric Oxide Donor|nitric oxide donor
5681418|NCT00573443|Multiple Sclerosis (MS)|multiple sclerosis (ms)
5681452|NCT00573300|indolamine 2,3-deoxygenase (IDO)|indolamine 2,3-deoxygenase (ido)
5681453|NCT00573287|Clozapine, risperidone, first episode,|clozapine, risperidone, first episode,
5681454|NCT00573274|Cesarean section|cesarean section
5681455|NCT00573274|Cardiac Output|cardiac output
5681456|NCT00573274|Physioflow|physioflow
5681457|NCT00573274|Cardiography, Impedance|cardiography, impedance
5828131|NCT00008021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5828132|NCT00008021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5828133|NCT00008021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5828134|NCT00008021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5828135|NCT00008021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5828136|NCT00008021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5828137|NCT00006864|stage IV renal cell cancer|stage iv renal cell cancer
5828138|NCT00006864|recurrent renal cell cancer|recurrent renal cell cancer
5828139|NCT00006864|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5828140|NCT00006484|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5828141|NCT00006484|squamous cell lung cancer|squamous cell lung cancer
5828142|NCT00006484|large cell lung cancer|large cell lung cancer
5828143|NCT00006484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5828144|NCT00006484|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5828145|NCT00006484|adenocarcinoma of the lung|adenocarcinoma of the lung
5828146|NCT00061607|Motor Neuron Disease|motor neuron disease
5828147|NCT00061607|Neuromuscular Disease|neuromuscular disease
5828148|NCT00061607|Histone Deacytelase Inhibitors|histone deacytelase inhibitors
5828149|NCT00061607|Spinal Muscular Atrophy|spinal muscular atrophy
5828151|NCT00061594|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5820862|NCT00076804|DOT|dot
5828152|NCT00061542|Glaucoma|glaucoma
5828153|NCT00061542|Ocular Hypertension|ocular hypertension
5828154|NCT00061529|Open-Angle Glaucoma|open-angle glaucoma
5828155|NCT00061529|Ocular Hypertension|ocular hypertension
5828156|NCT00061516|Glaucoma|glaucoma
5828157|NCT00061516|Ocular Hypertension|ocular hypertension
5828158|NCT00061503|Glaucoma|glaucoma
5828159|NCT00061503|Ocular Hypertension|ocular hypertension
5828160|NCT00006464|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5828161|NCT00006457|non-small cell lung cancer|non-small cell lung cancer
5828162|NCT00006457|small cell lung cancer|small cell lung cancer
5828163|NCT00006383|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5846660|NCT00043823|Lung Cancer|lung cancer
5828164|NCT00006383|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5828165|NCT00006383|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5828166|NCT00006383|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5828167|NCT00006377|stage III endometrial carcinoma|stage iii endometrial carcinoma
5828168|NCT00006377|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5828169|NCT00006377|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5828170|NCT00006361|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5828171|NCT00006361|recurrent skin cancer|recurrent skin cancer
5828172|NCT00006361|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5828173|NCT00006361|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5828174|NCT00006361|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5828175|NCT00006361|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5828176|NCT00006361|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5681458|NCT00573261|Diabetic neuropathy|diabetic neuropathy
5681459|NCT00573261|Pregabalin|pregabalin
5681460|NCT00573261|Lyrica|lyrica
5681461|NCT00573248|Nicotine|nicotine
5681462|NCT00573248|ADHD|adhd
5681463|NCT00573248|Gender|gender
5681464|NCT00573235|isolates|isolates
5681465|NCT00573235|infection|infection
5681466|NCT00573235|E coli isolates|e coli isolates
5681425|NCT00573417|Cognition|cognition
5681467|NCT00573222|Asthma|asthma
5681468|NCT00573209|Impotence|impotence
5681469|NCT00573209|Male Impotence|male impotence
5681470|NCT00573209|Male Sexual Impotence|male sexual impotence
5681471|NCT00573196|Affective Psychosis, Bipolar|affective psychosis, bipolar
5681472|NCT00573196|Depression, Bipolar|depression, bipolar
5828177|NCT00006361|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5828178|NCT00006361|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5828179|NCT00006361|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5828180|NCT00006361|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5828181|NCT00006361|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5831354|NCT00054951|Hepatoma|hepatoma
5828182|NCT00006361|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5828183|NCT00006361|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5828184|NCT00006361|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5828185|NCT00006361|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5828186|NCT00006361|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5828187|NCT00006361|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5828188|NCT00006361|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5828189|NCT00061581|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5828190|NCT00061581|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5828191|NCT00061581|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5828192|NCT00061581|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5828193|NCT00061581|Myelodysplastic Syndrome|myelodysplastic syndrome
5828194|NCT00061581|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5828195|NCT00061581|Graft-Versus Leukemia/Myeloma|graft-versus leukemia/myeloma
5828196|NCT00061581|Graft-Versus-Host Disease|graft-versus-host disease
5828197|NCT00061581|Cyclosporine|cyclosporine
5828198|NCT00061581|Fludarabine|fludarabine
5828199|NCT00061581|Myelodysplasia Syndrome|myelodysplasia syndrome
5828200|NCT00061568|Stem Cell Transplant|stem cell transplant
5828201|NCT00061568|Low Dose Radiation|low dose radiation
5828202|NCT00061568|Alemtuzumab (Campath)|alemtuzumab (campath)
5828203|NCT00061568|Sirolimus (Rapamune)|sirolimus (rapamune)
5828204|NCT00061568|Donor Apheresis|donor apheresis
5828205|NCT00061568|Sickle Cell Anemia|sickle cell anemia
5828207|NCT00061568|Thalassemia|thalassemia
5828208|NCT00061568|Diamond-Blackfan Anemia|diamond-blackfan anemia
5828210|NCT00061490|Osteoarthritis|osteoarthritis
5828211|NCT00061490|Arthritis|arthritis
5828212|NCT00061490|Weight Loss|weight loss
5828213|NCT00006349|depression|depression
5828214|NCT00006349|delirium|delirium
5828215|NCT00006349|cognitive/functional effects|cognitive/functional effects
5828216|NCT00006349|radiation toxicity|radiation toxicity
5828217|NCT00006349|limited stage small cell lung cancer|limited stage small cell lung cancer
5828218|NCT00006349|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5828219|NCT00006349|recurrent small cell lung cancer|recurrent small cell lung cancer
5828220|NCT00006341|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5828221|NCT00006341|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5828222|NCT00006341|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5828223|NCT00061438|non-infected necrotizing pancreatitis|non-infected necrotizing pancreatitis
5828224|NCT00061438|pancreatic infection|pancreatic infection
5828225|NCT00061438|peripancreatic infection|peripancreatic infection
5828226|NCT00061425|NHL|nhl
5828227|NCT00061425|recurrent B-cell lymphoma|recurrent b-cell lymphoma
5828228|NCT00061412|Low reading and writing achievement|low reading and writing achievement
5828229|NCT00061412|At-risk students|at-risk students
5828230|NCT00061412|Reading Disability|reading disability
5828231|NCT00061412|Writing Disability|writing disability
5681473|NCT00573196|Mania|mania
5681474|NCT00573196|Manic Disorder|manic disorder
5681475|NCT00573196|Manic State|manic state
5681476|NCT00573196|Manic-Depressive Psychosis|manic-depressive psychosis
5681477|NCT00573196|Psychoses, Manic-Depressive|psychoses, manic-depressive
5681478|NCT00573196|Psychosis, Manic-Depressive|psychosis, manic-depressive
5681479|NCT00573183|Cocaine, methamphetamine, amphetamine, other stimulant drugs|cocaine, methamphetamine, amphetamine, other stimulant drugs
5681480|NCT00573170|Migraine, acute|migraine, acute
5681481|NCT00573170|Migraine|migraine
5850197|NCT00025987|Control|control
5828232|NCT00061399|TBI|tbi
5828233|NCT00061399|Prospective memory|prospective memory
5828234|NCT00061386|Postpartum|postpartum
5828235|NCT00061386|Low income|low income
5828236|NCT00061386|Diet|diet
5828237|NCT00061386|Physical activity|physical activity
5828238|NCT00061321|Nevirapine|nevirapine
5828239|NCT00061321|Pregnancy|pregnancy
5828240|NCT00061321|Maternal to Infant transmission|maternal to infant transmission
5828241|NCT00061321|Infant|infant
5686752|NCT00550654|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5828279|NCT00061282|Colitis|colitis
5828243|NCT00061321|HIV Seronegativity|hiv seronegativity
5828244|NCT00061308|Ovarian cancer|ovarian cancer
5828245|NCT00061308|peritoneal cancer|peritoneal cancer
5828246|NCT00061308|cancer|cancer
5828247|NCT00061308|Fallopian cancer|fallopian cancer
5828248|NCT00061295|Locomotion|locomotion
5828249|NCT00061295|Spinal Cord Injury|spinal cord injury
5828250|NCT00061295|Body Weight Supported Walking|body weight supported walking
5828251|NCT00045149|recurrent melanoma|recurrent melanoma
5828252|NCT00045149|stage IV melanoma|stage iv melanoma
5828253|NCT00019734|stage IV melanoma|stage iv melanoma
5828254|NCT00019734|recurrent melanoma|recurrent melanoma
5828255|NCT00061373|Alteplase|alteplase
5828256|NCT00061373|Recombinant tissue plasminogen activator|recombinant tissue plasminogen activator
5828257|NCT00061373|Reperfusion therapy|reperfusion therapy
5828258|NCT00061373|Magnetic Resonance Imaging|magnetic resonance imaging
5828259|NCT00061373|Clinical Trial|clinical trial
5828260|NCT00061373|Tinzaparin|tinzaparin
5828261|NCT00061373|Eptifibatide|eptifibatide
5828262|NCT00061373|Ischemic Stroke|ischemic stroke
5828263|NCT00061360|Bone Marrow Failure|bone marrow failure
5828264|NCT00061360|Cyclosporine|cyclosporine
5828265|NCT00061360|Anti Thymocyte Globulin|anti thymocyte globulin
5828266|NCT00061360|Severe Aplastic Anemia|severe aplastic anemia
5828267|NCT00061347|Fiducial Marker|fiducial marker
5828268|NCT00061347|MRI|mri
5828269|NCT00061347|Prostate Cancer|prostate cancer
5828270|NCT00061347|Radiation|radiation
5828271|NCT00061334|Attitudes|attitudes
5828281|NCT00041353|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5828282|NCT00041353|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5828283|NCT00019175|stage IV melanoma|stage iv melanoma
5828284|NCT00019175|recurrent melanoma|recurrent melanoma
5828285|NCT00002786|stage IV melanoma|stage iv melanoma
5828286|NCT00002786|recurrent melanoma|recurrent melanoma
5828287|NCT00061269|Infected pancreatic necrosis|infected pancreatic necrosis
5828288|NCT00061256|Bone Mineral Density|bone mineral density
5828289|NCT00061256|Lumbar Vertebrae|lumbar vertebrae
5828290|NCT00061256|Treatment Experienced|treatment experienced
5828292|NCT00061243|Vaccine|vaccine
5828293|NCT00061243|DNA prime|dna prime
5828294|NCT00061243|Protein boost|protein boost
5828295|NCT00061243|HIV Seronegativity|hiv seronegativity
5828296|NCT00061243|HIV preventive vaccine|hiv preventive vaccine
5828297|NCT00061230|Relaxation training|relaxation training
5828298|NCT00061217|Transtibial amputees|transtibial amputees
5828299|NCT00061217|Rectified sockets|rectified sockets
5828300|NCT00061217|Unrectified sockets|unrectified sockets
5828301|NCT00061217|Gait|gait
5828302|NCT00061217|Energy expenditure|energy expenditure
5828303|NCT00061217|Prosthetic evaluation questionnaire|prosthetic evaluation questionnaire
5828304|NCT00061165|obesity|obesity
5828305|NCT00061165|overweight|overweight
5828308|NCT00061165|African American|african american
5828309|NCT00061165|diet|diet
5828310|NCT00061165|nutrition|nutrition
5828311|NCT00061165|physical activity|physical activity
5828312|NCT00061165|Chicago|chicago
5828313|NCT00019084|stage IV colon cancer|stage iv colon cancer
5828314|NCT00019084|stage IV breast cancer|stage iv breast cancer
5828315|NCT00019084|recurrent breast cancer|recurrent breast cancer
5828316|NCT00019084|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5828317|NCT00019084|stage II pancreatic cancer|stage ii pancreatic cancer
5828318|NCT00019084|stage III pancreatic cancer|stage iii pancreatic cancer
5828319|NCT00019084|recurrent pancreatic cancer|recurrent pancreatic cancer
5828320|NCT00019084|recurrent colon cancer|recurrent colon cancer
5828321|NCT00019084|recurrent cervical cancer|recurrent cervical cancer
5828322|NCT00019084|stage IVB cervical cancer|stage ivb cervical cancer
5828323|NCT00019084|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5828324|NCT00019084|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5828325|NCT00019084|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5828326|NCT00019084|recurrent small cell lung cancer|recurrent small cell lung cancer
5828327|NCT00019084|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5828328|NCT00019084|stage IV pancreatic cancer|stage iv pancreatic cancer
5828329|NCT00004868|recurrent adult brain tumor|recurrent adult brain tumor
5828330|NCT00004868|adult meningioma|adult meningioma
5828331|NCT00004868|adult glioblastoma|adult glioblastoma
5828332|NCT00004868|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5828333|NCT00004868|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5828334|NCT00004868|adult mixed glioma|adult mixed glioma
5828335|NCT00004868|adult grade III meningioma|adult grade iii meningioma
5828336|NCT00004868|adult giant cell glioblastoma|adult giant cell glioblastoma
5828337|NCT00004868|adult gliosarcoma|adult gliosarcoma
5828338|NCT00003408|stage IV breast cancer|stage iv breast cancer
5828339|NCT00003408|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5828340|NCT00003408|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5828341|NCT00003408|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5828342|NCT00003408|refractory multiple myeloma|refractory multiple myeloma
5824655|NCT00068211|Metastatic Melanoma|metastatic melanoma
5828343|NCT00003408|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5828344|NCT00003408|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5828345|NCT00003408|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5828346|NCT00003408|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5828347|NCT00003408|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5828348|NCT00003408|disseminated neuroblastoma|disseminated neuroblastoma
5828349|NCT00003408|recurrent neuroblastoma|recurrent neuroblastoma
5828350|NCT00003408|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5828351|NCT00003408|stage I multiple myeloma|stage i multiple myeloma
5828352|NCT00003408|stage II multiple myeloma|stage ii multiple myeloma
5828353|NCT00003408|stage III multiple myeloma|stage iii multiple myeloma
5828354|NCT00003408|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5828355|NCT00003408|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5828356|NCT00003408|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5828357|NCT00003408|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5828358|NCT00003408|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5828359|NCT00003408|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5828360|NCT00003408|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5828361|NCT00003408|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5828362|NCT00003408|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5831454|NCT00050531|Gleevec|gleevec
5828363|NCT00003408|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5828364|NCT00003408|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5828365|NCT00003408|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5828366|NCT00003408|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5828367|NCT00003408|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5828368|NCT00003408|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5828369|NCT00003408|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5828370|NCT00003408|testicular embryonal carcinoma|testicular embryonal carcinoma
5828371|NCT00003408|testicular choriocarcinoma|testicular choriocarcinoma
5828372|NCT00003408|testicular teratoma|testicular teratoma
5828373|NCT00003408|testicular yolk sac tumor|testicular yolk sac tumor
5828374|NCT00003408|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5828375|NCT00003408|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5828376|NCT00003408|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5828377|NCT00003408|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5828378|NCT00003408|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5828379|NCT00003408|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5828380|NCT00003408|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5828381|NCT00003408|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5828382|NCT00003408|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5828383|NCT00003408|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5828384|NCT00003408|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5828385|NCT00003408|refractory hairy cell leukemia|refractory hairy cell leukemia
5863175|NCT00001362|Normal Volunteer|normal volunteer
5681482|NCT00573170|Butalbital-containing Combination Medication (BCM)|butalbital-containing combination medication (bcm)
5681483|NCT00573170|Naproxen sodium|naproxen sodium
5681484|NCT00573170|Sumatriptan succinate|sumatriptan succinate
5681485|NCT00573170|TREXIMET®|treximet®
5681486|NCT00573157|nephritis|nephritis
5681487|NCT00573157|atacicept|atacicept
5681488|NCT00573131|Esophageal cancer|esophageal cancer
5681489|NCT00573131|Localized esophageal cancer|localized esophageal cancer
5828386|NCT00003408|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5828387|NCT00003408|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5828388|NCT00003408|ovarian yolk sac tumor|ovarian yolk sac tumor
5828389|NCT00003408|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5828390|NCT00003408|ovarian polyembryoma|ovarian polyembryoma
5828391|NCT00003408|ovarian choriocarcinoma|ovarian choriocarcinoma
5828392|NCT00003408|ovarian immature teratoma|ovarian immature teratoma
5828393|NCT00003408|ovarian mature teratoma|ovarian mature teratoma
5828394|NCT00003408|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5828395|NCT00003408|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5828396|NCT00003408|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5828397|NCT00003408|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5828398|NCT00003408|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5828399|NCT00003408|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5828400|NCT00003408|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5828401|NCT00003408|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5828402|NCT00003408|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5828403|NCT00003408|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5828404|NCT00003408|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5828405|NCT00003408|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5828406|NCT00003408|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5828407|NCT00003408|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5828408|NCT00003408|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5846661|NCT00043823|Avastin|avastin
5828409|NCT00003408|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5828410|NCT00003408|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5828411|NCT00003408|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5828412|NCT00003408|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5828413|NCT00003408|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5828414|NCT00003408|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5828415|NCT00003408|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5828416|NCT00003408|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5828417|NCT00003408|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5828418|NCT00003408|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5828419|NCT00003408|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5828420|NCT00003408|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5828421|NCT00003408|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5828422|NCT00003408|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5828423|NCT00003408|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5828424|NCT00003408|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5828425|NCT00003408|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5828426|NCT00003408|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5828427|NCT00003408|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5828428|NCT00003408|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5828429|NCT00003408|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5828430|NCT00003408|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5828431|NCT00003408|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5828432|NCT00003408|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5828433|NCT00003408|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5828434|NCT00003408|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5828435|NCT00003408|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5828436|NCT00003408|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5828437|NCT00003408|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5828438|NCT00003408|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5828439|NCT00003408|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5828440|NCT00003408|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5828441|NCT00003408|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5846351|NCT00045812|Absorption|absorption
5828442|NCT00003408|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5828443|NCT00003408|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5828444|NCT00003408|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5828445|NCT00003408|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5828446|NCT00003408|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5828447|NCT00003408|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5828448|NCT00003408|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5828449|NCT00003408|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5828450|NCT00003408|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5828451|NCT00003408|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5828452|NCT00003408|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5828453|NCT00003408|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5828454|NCT00003408|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5828455|NCT00003408|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5828456|NCT00003408|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5828457|NCT00061204|fMRI|fmri
5686753|NCT00550654|stage IV melanoma|stage iv melanoma
5686754|NCT00550654|stage IV uterine sarcoma|stage iv uterine sarcoma
5686755|NCT00550654|ovarian sarcoma|ovarian sarcoma
5686756|NCT00550654|chondrosarcoma|chondrosarcoma
5686757|NCT00550654|metastatic osteosarcoma|metastatic osteosarcoma
5686758|NCT00550654|stage IV renal cell cancer|stage iv renal cell cancer
5686759|NCT00550654|lung metastases|lung metastases
5686760|NCT00550654|liver metastases|liver metastases
5828458|NCT00061204|Susceptibility Artifacts|susceptibility artifacts
5828459|NCT00061204|Prefrontal Cortex|prefrontal cortex
5828460|NCT00061204|Temporal Lobes|temporal lobes
5828462|NCT00061204|Healthy Volunteer|healthy volunteer
5828463|NCT00061204|HV|hv
5828464|NCT00061152|Pain Measurement|pain measurement
5828465|NCT00061152|Diary|diary
5828466|NCT00061152|Painful HIV Neuropathy|painful hiv neuropathy
5828467|NCT00061152|HIV Neuropathy|hiv neuropathy
5828469|NCT00061152|Analgesics/*therapeutic use|analgesics/*therapeutic use
5828470|NCT00061152|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5828471|NCT00061152|Peripheral Nervous System Diseases/*complications/diagnosis/*therapy|peripheral nervous system diseases/*complications/diagnosis/*therapy
5828472|NCT00061152|Peripheral Nervous System Diseases/drug therapy/*etiology/physiopathology|peripheral nervous system diseases/drug therapy/*etiology/physiopathology
5828473|NCT00061152|Pain|pain
5828474|NCT00061139|Cerebral palsy|cerebral palsy
5828475|NCT00061139|Hemiparesis|hemiparesis
5828476|NCT00061139|Pediatric CI therapy|pediatric ci therapy
5828477|NCT00061139|Upper extremity|upper extremity
5828478|NCT00061139|Training|training
5828479|NCT00061139|Limb restraint|limb restraint
5828480|NCT00061126|Prostate Cancer|prostate cancer
5828481|NCT00061126|PSA|psa
5828482|NCT00061126|Hormone refractory|hormone refractory
5828483|NCT00061126|Rising PSA|rising psa
5828484|NCT00061113|alcohol dependence|alcohol dependence
5828485|NCT00061113|marijuana dependence|marijuana dependence
5828486|NCT00061100|HIV|hiv
5828487|NCT00061100|methadone maintenance|methadone maintenance
5828488|NCT00061087|ADHD|adhd
5828489|NCT00061087|Cocaine|cocaine
5828490|NCT00061087|Treatment|treatment
5828491|NCT00061087|Methadone|methadone
5828492|NCT00061074|Smoking|smoking
5828493|NCT00061061|Tobacco Cessation|tobacco cessation
5828494|NCT00061061|Postmenopausal Women|postmenopausal women
5828495|NCT00061035|Prostate Cancer; Immunotherapy|prostate cancer; immunotherapy
5828496|NCT00006095|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5828497|NCT00006086|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5828498|NCT00006082|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5828499|NCT00006082|recurrent small cell lung cancer|recurrent small cell lung cancer
5828500|NCT00061048|Monoclonal Antibody|monoclonal antibody
5828501|NCT00061048|HTLV-1|htlv-1
5828502|NCT00061048|CD52|cd52
5828503|NCT00061048|Flow Cytometry|flow cytometry
5828504|NCT00061048|Antibody Saturation|antibody saturation
5828505|NCT00061048|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
5828506|NCT00061048|ATL|atl
5828507|NCT00061022|Stroke|stroke
5828508|NCT00061022|cerebral vascular accident|cerebral vascular accident
5828509|NCT00061022|CVA|cva
5828510|NCT00061022|Ischemia|ischemia
5828511|NCT00061022|Hemorrhage|hemorrhage
5828512|NCT00061022|TIA|tia
5828513|NCT00061022|Transient Ischemic Attack|transient ischemic attack
5828514|NCT00061022|Brain Attack|brain attack
5828515|NCT00061022|Cataplexy|cataplexy
5828516|NCT00006046|stage IV colon cancer|stage iv colon cancer
5828517|NCT00006046|stage IV rectal cancer|stage iv rectal cancer
5828518|NCT00006046|recurrent colon cancer|recurrent colon cancer
5828519|NCT00006046|recurrent rectal cancer|recurrent rectal cancer
5828520|NCT00005999|recurrent cervical cancer|recurrent cervical cancer
5828521|NCT00005999|stage IVB cervical cancer|stage ivb cervical cancer
5828522|NCT00005999|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5828523|NCT00005999|cervical adenocarcinoma|cervical adenocarcinoma
5828524|NCT00005977|childhood Burkitt lymphoma|childhood burkitt lymphoma
5828525|NCT00005977|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5828526|NCT00005977|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5828527|NCT00005977|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5828528|NCT00005977|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5828529|NCT00005977|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5828530|NCT00005977|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5828531|NCT00005977|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5828532|NCT00005977|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5686761|NCT00550654|bone metastases|bone metastases
5686762|NCT00550641|fibromyalgia|fibromyalgia
5686763|NCT00550641|pool-based exercise|pool-based exercise
5686764|NCT00550628|neoplasm of uncertain malignant potential|neoplasm of uncertain malignant potential
5828087|NCT00061789|HV|hv
5828533|NCT00005971|stage IV melanoma|stage iv melanoma
5828534|NCT00005956|stage II breast cancer|stage ii breast cancer
5828535|NCT00005956|stage IV breast cancer|stage iv breast cancer
5828536|NCT00005956|stage IIIA breast cancer|stage iiia breast cancer
5828537|NCT00005956|stage II gastric cancer|stage ii gastric cancer
5828538|NCT00005956|stage III gastric cancer|stage iii gastric cancer
5828539|NCT00005956|stage IV gastric cancer|stage iv gastric cancer
5828540|NCT00005956|stage IIIB breast cancer|stage iiib breast cancer
5828541|NCT00005956|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5828542|NCT00005956|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5828543|NCT00005868|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5828544|NCT00061009|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5828545|NCT00061009|Dysautonomia|dysautonomia
5828546|NCT00061009|Postural Tachycardia Syndrome|postural tachycardia syndrome
5828547|NCT00061009|Neurocardiogenic|neurocardiogenic
5828549|NCT00061009|Neurocardiogenic Syncope|neurocardiogenic syncope
5828550|NCT00061009|COI|coi
5828551|NCT00061009|POTS|pots
5828552|NCT00061009|Neurocardogenic Syncope|neurocardogenic syncope
5828553|NCT00061009|NCS|ncs
5828554|NCT00061009|Healthy Volunteer|healthy volunteer
5828555|NCT00061009|HV|hv
5828556|NCT00060996|Critical Limb Ischemia|critical limb ischemia
5828557|NCT00060996|Peripheral Vascular Disease|peripheral vascular disease
5828558|NCT00060996|UT-15|ut-15
5828559|NCT00060996|Remodulin|remodulin
5828560|NCT00060996|treprostinil|treprostinil
5828561|NCT00005813|adult glioblastoma|adult glioblastoma
5828562|NCT00005813|adult giant cell glioblastoma|adult giant cell glioblastoma
5828563|NCT00005813|adult gliosarcoma|adult gliosarcoma
5828564|NCT00060983|Locomotion|locomotion
5828565|NCT00060983|Spinal Cord Injury, ASIA C|spinal cord injury, asia c
5828566|NCT00060983|Body weight support (BWS)|body weight support (bws)
5828567|NCT00060983|Functional electrical stimulation (FES)|functional electrical stimulation (fes)
5828568|NCT00060983|Gait|gait
5828569|NCT00060983|Treadmill training|treadmill training
5828570|NCT00060983|Physical Therapy|physical therapy
5828571|NCT00060970|Disuse atrophy|disuse atrophy
5828572|NCT00060970|Ankle fracture|ankle fracture
5828573|NCT00060970|Exercise, therapy|exercise, therapy
5828574|NCT00060970|Cast immobilization|cast immobilization
5828575|NCT00060970|Deconditioning|deconditioning
5828576|NCT00060970|Sarcopenia|sarcopenia
5828577|NCT00060957|Cerebral Palsy|cerebral palsy
5828578|NCT00060957|Spasticity|spasticity
5828579|NCT00060957|Botulinum toxin|botulinum toxin
5828580|NCT00060957|BOTOX|botox
5828581|NCT00060944|Trabectedin|trabectedin
5828582|NCT00060944|Yondelis|yondelis
5828583|NCT00060944|ET-743|et-743
5828584|NCT00060944|Ecteinascidin|ecteinascidin
5828585|NCT00060944|Anthracycline|anthracycline
5828586|NCT00060944|Ifosfamide|ifosfamide
5828587|NCT00060944|Dexamethasone|dexamethasone
5828588|NCT00060944|Intravenous|intravenous
5828589|NCT00060944|Cancer|cancer
5828590|NCT00060944|Malignant|malignant
5828591|NCT00060944|Metastatic|metastatic
5828592|NCT00005861|stage III endometrial carcinoma|stage iii endometrial carcinoma
5828593|NCT00005861|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5828594|NCT00005861|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5828595|NCT00005588|stage I breast cancer|stage i breast cancer
5828596|NCT00005588|stage II breast cancer|stage ii breast cancer
5828597|NCT00005588|stage IIIA breast cancer|stage iiia breast cancer
5828598|NCT00005587|stage I breast cancer|stage i breast cancer
5828599|NCT00005587|stage II breast cancer|stage ii breast cancer
5828600|NCT00005587|stage IIIA breast cancer|stage iiia breast cancer
5828601|NCT00003203|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5828602|NCT00003203|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5828603|NCT00003203|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5828604|NCT00003203|regional neuroblastoma|regional neuroblastoma
5828605|NCT00003203|stage 4S neuroblastoma|stage 4s neuroblastoma
5828606|NCT00060931|hypertension|hypertension
5828607|NCT00060931|beta-blockers|beta-blockers
5828608|NCT00060931|Type 2 diabetes|type 2 diabetes
5828609|NCT00060918|Type 2 diabetes|type 2 diabetes
5828610|NCT00060918|hypertension|hypertension
5828611|NCT00060918|beta-blockers|beta-blockers
5828612|NCT00060905|Bipolar Disorder (manic or mixed type)|bipolar disorder (manic or mixed type)
5828613|NCT00060892|Critical Limb Ischemia|critical limb ischemia
5828614|NCT00005086|stage IV bladder cancer|stage iv bladder cancer
5828615|NCT00005086|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5686765|NCT00550628|colon cancer|colon cancer
5686766|NCT00550615|Non-Hodgkins Lymphoma|non-hodgkins lymphoma
5686767|NCT00550615|Relapsed Non Hodgkins Lymphoma|relapsed non hodgkins lymphoma
5686768|NCT00550615|Refractory Non Hodgkins Lymphoma|refractory non hodgkins lymphoma
5686770|NCT00550602|Tracheomalacia|tracheomalacia
5686771|NCT00550602|Tracheobronchomalacia|tracheobronchomalacia
5686772|NCT00550602|Airway Stabilization|airway stabilization
5686773|NCT00550602|Bronchoscopy|bronchoscopy
5686774|NCT00550602|Stent Placement|stent placement
5686775|NCT00550602|Tracheobronchoplasty|tracheobronchoplasty
5686776|NCT00550602|COPD|copd
5686777|NCT00550589|high-grade squamous intraepithelial lesion|high-grade squamous intraepithelial lesion
5686778|NCT00550589|stage 0 anal cancer|stage 0 anal cancer
5686779|NCT00550576|Digoxin Antibodies|digoxin antibodies
5686780|NCT00550576|Bipolar Disorder|bipolar disorder
5681442|NCT00573339|MRI|mri
5828616|NCT00005078|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5828617|NCT00060866|Beta-Adrenoceptors|beta-adrenoceptors
5828618|NCT00060866|Beta-Adrenoceptor Blocker|beta-adrenoceptor blocker
5828619|NCT00060866|Neurocardiogenic Syncope|neurocardiogenic syncope
5828620|NCT00060866|Chronic Orthostatic Intolerance|chronic orthostatic intolerance
5828621|NCT00060866|Neurocardiogenic|neurocardiogenic
5828622|NCT00060866|Dysautonomia|dysautonomia
5828623|NCT00060866|Autonomic Nervous System|autonomic nervous system
5828624|NCT00060866|Nurocardiogenic Syncope|nurocardiogenic syncope
5828626|NCT00060866|Sympathoadrenal Imbalance|sympathoadrenal imbalance
5828628|NCT00060866|Orthostatic Intolerance|orthostatic intolerance
5828629|NCT00060840|Left Ventricular Assist Device Implantation|left ventricular assist device implantation
5828630|NCT00060840|Progressive Left Ventricular Failure|progressive left ventricular failure
5828631|NCT00060827|Mild traumatic brain injury|mild traumatic brain injury
5828632|NCT00060853|Amygdala|amygdala
5828633|NCT00060853|Orbitofrontal Cortex|orbitofrontal cortex
5828634|NCT00060853|Emotion|emotion
5828635|NCT00060853|Cognition|cognition
5828636|NCT00060853|Theory of Mind|theory of mind
5828637|NCT00060853|Healthy Volunteer|healthy volunteer
5828638|NCT00060853|HV|hv
5828639|NCT00060801|Cystic Fibrosis|cystic fibrosis
5828640|NCT00060801|BIIL 284|biil 284
5828641|NCT00060801|Boehringer Ingelheim|boehringer ingelheim
5828642|NCT00060788|Antisocial behavior|antisocial behavior
5828643|NCT00060788|Mauritius Child Health Project|mauritius child health project
5828644|NCT00060788|Intergenerational transmission|intergenerational transmission
5828645|NCT00004928|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5828646|NCT00004928|stage I prostate cancer|stage i prostate cancer
5828647|NCT00004928|stage IIB prostate cancer|stage iib prostate cancer
5828648|NCT00004928|stage IIA prostate cancer|stage iia prostate cancer
5828649|NCT00004928|stage III prostate cancer|stage iii prostate cancer
5828650|NCT00004928|stage IV prostate cancer|stage iv prostate cancer
5828651|NCT00004928|recurrent prostate cancer|recurrent prostate cancer
5828652|NCT00004925|stage IV breast cancer|stage iv breast cancer
5828653|NCT00004925|recurrent breast cancer|recurrent breast cancer
5828654|NCT00004925|stage IIIB breast cancer|stage iiib breast cancer
5828655|NCT00004925|inflammatory breast cancer|inflammatory breast cancer
5828656|NCT00004916|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5828657|NCT00004916|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5828658|NCT00004916|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5828659|NCT00004916|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5828660|NCT00004916|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5828661|NCT00004911|stage I colon cancer|stage i colon cancer
5828662|NCT00004911|stage II colon cancer|stage ii colon cancer
5828663|NCT00004911|stage III colon cancer|stage iii colon cancer
5828664|NCT00004911|stage IV colon cancer|stage iv colon cancer
5828665|NCT00004911|stage I gastric cancer|stage i gastric cancer
5828666|NCT00004911|stage II gastric cancer|stage ii gastric cancer
5828667|NCT00004911|stage III gastric cancer|stage iii gastric cancer
5828668|NCT00004911|stage IV gastric cancer|stage iv gastric cancer
5828669|NCT00004911|recurrent gastric cancer|recurrent gastric cancer
5828670|NCT00004911|stage I rectal cancer|stage i rectal cancer
5686781|NCT00550563|recurrent colon cancer|recurrent colon cancer
5686782|NCT00550563|stage I colon cancer|stage i colon cancer
5686783|NCT00550563|stage II colon cancer|stage ii colon cancer
5686784|NCT00550563|stage III colon cancer|stage iii colon cancer
5686785|NCT00550563|stage IV colon cancer|stage iv colon cancer
5686786|NCT00550563|recurrent rectal cancer|recurrent rectal cancer
5686787|NCT00550563|stage I rectal cancer|stage i rectal cancer
5686788|NCT00550563|stage II rectal cancer|stage ii rectal cancer
5686789|NCT00550563|stage III rectal cancer|stage iii rectal cancer
5686790|NCT00550563|stage IV rectal cancer|stage iv rectal cancer
5686791|NCT00550550|rhinoconjunctivitis|rhinoconjunctivitis
5686792|NCT00550550|rhinitis|rhinitis
5828671|NCT00004911|stage II rectal cancer|stage ii rectal cancer
5828672|NCT00004911|stage III rectal cancer|stage iii rectal cancer
5828673|NCT00004911|stage IV rectal cancer|stage iv rectal cancer
5828674|NCT00004911|recurrent colon cancer|recurrent colon cancer
5828675|NCT00004911|recurrent rectal cancer|recurrent rectal cancer
5828676|NCT00004911|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5828677|NCT00004911|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5828678|NCT00004911|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5828679|NCT00004911|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5845567|NCT00050388|Lesion|lesion
5828683|NCT00004911|recurrent small intestine cancer|recurrent small intestine cancer
5828684|NCT00004911|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5828686|NCT00004911|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5828692|NCT00060762|Weight Loss|weight loss
5828693|NCT00060723|Polysomnography|polysomnography
5828694|NCT00060723|Sleep-disordered breathing|sleep-disordered breathing
5828695|NCT00060723|Sleep apnea, obstructive|sleep apnea, obstructive
5828696|NCT00060723|Hyperactivity|hyperactivity
5828697|NCT00060723|Sleep|sleep
5828698|NCT00060723|Child|child
5828699|NCT00060710|melanoma|melanoma
5828700|NCT00060749|Stargardt|stargardt
5828701|NCT00060749|Macular Dystrophy|macular dystrophy
5828702|NCT00060749|ELOVL4|elovl4
5828703|NCT00060749|DHA|dha
5828704|NCT00060749|Stargardt's Disease|stargardt's disease
5828705|NCT00060749|Autosomal Dominant Macular Dystrophy|autosomal dominant macular dystrophy
5828706|NCT00060749|Autosomal Recessive Macular Dystrophy|autosomal recessive macular dystrophy
5828707|NCT00060736|Hormone Replacement|hormone replacement
5828708|NCT00060736|Gonadal Steroids|gonadal steroids
5828709|NCT00060736|Estrogen|estrogen
5828710|NCT00060736|Major Depression|major depression
5828711|NCT00060736|Minor Depression|minor depression
5828712|NCT00060736|Perimenopause|perimenopause
5828713|NCT00060736|Estradiol|estradiol
5828715|NCT00060736|Perimenopausal Depression|perimenopausal depression
5828716|NCT00060697|Sexual risk taking|sexual risk taking
5828717|NCT00060697|Mother-child communication|mother-child communication
5828718|NCT00060697|Problem behaviors|problem behaviors
5828719|NCT00060684|Pixantrone|pixantrone
5828720|NCT00060684|BBR 2778|bbr 2778
5828721|NCT00060684|chemotherapy|chemotherapy
5828722|NCT00060684|DNA Intercalator|dna intercalator
5828723|NCT00060684|mitoxantrone|mitoxantrone
5828724|NCT00060684|fludarabine|fludarabine
5828725|NCT00060684|dexamethasone|dexamethasone
5828726|NCT00060684|Rituximab|rituximab
5828728|NCT00060684|Mabthera|mabthera
5828729|NCT00060684|monoclonal antibody|monoclonal antibody
5828730|NCT00060684|antibody|antibody
5828731|NCT00060684|NHL|nhl
5828732|NCT00060684|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5828733|NCT00060684|indolent|indolent
5828734|NCT00060684|low grade|low grade
5828735|NCT00060684|Novuspharma|novuspharma
5828736|NCT00060671|Pixantrone|pixantrone
5828737|NCT00060671|BBR 2778|bbr 2778
5828738|NCT00060671|chemotherapy|chemotherapy
5828739|NCT00060671|DNA Intercalator|dna intercalator
5828740|NCT00060671|Anthracycline|anthracycline
5828741|NCT00060671|Rituximab|rituximab
5828742|NCT00060671|Rituxan|rituxan
5828743|NCT00060671|Mabthera|mabthera
5828744|NCT00060671|monoclonal antibody|monoclonal antibody
5828745|NCT00060671|antibody|antibody
5828746|NCT00060671|NHL|nhl
5828747|NCT00060671|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5828749|NCT00060671|low grade|low grade
5828750|NCT00060671|Novuspharma|novuspharma
5828751|NCT00060645|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
5686793|NCT00550550|conjunctivitis|conjunctivitis
5686794|NCT00550550|allergy|allergy
5686795|NCT00550550|allergen|allergen
5686796|NCT00550550|immunotherapy|immunotherapy
5686797|NCT00550537|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5848031|NCT00036582|Structural MRI|structural mri
5686798|NCT00550537|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5686799|NCT00550537|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5686800|NCT00550537|squamous cell lung cancer|squamous cell lung cancer
5686801|NCT00550537|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5828752|NCT00060632|Advanced, refractory or recurrent solid tumors|advanced, refractory or recurrent solid tumors
5828754|NCT00060619|Functional abdominal pain|functional abdominal pain
5828755|NCT00060619|Biofeedback|biofeedback
5828756|NCT00060619|Psychological assessment|psychological assessment
5828757|NCT00060658|Prefrontal Cortex|prefrontal cortex
5828758|NCT00060658|Calculation|calculation
5828759|NCT00060658|Mathematician|mathematician
5828760|NCT00060658|Cognition|cognition
5828761|NCT00060658|Brain Mapping|brain mapping
5828762|NCT00060658|Healthy Volunteer|healthy volunteer
5828763|NCT00060658|HV|hv
5828764|NCT00060606|Maternal fetal surgery|maternal fetal surgery
5828765|NCT00060606|Fetal diagnosis|fetal diagnosis
5828766|NCT00060606|Myelomeningocele|myelomeningocele
5828767|NCT00060606|Meningomyelocele|meningomyelocele
5828768|NCT00060606|Open neural tube defect|open neural tube defect
5828769|NCT00060606|ONTD|ontd
5828770|NCT00060606|Spina bifida|spina bifida
5828771|NCT00060567|E7070|e7070
5828772|NCT00060567|Irinotecan|irinotecan
5828773|NCT00060567|hydrochloride|hydrochloride
5828774|NCT00060567|gastrointestinal|gastrointestinal
5828775|NCT00060567|cancer|cancer
5828776|NCT00004910|stage I colon cancer|stage i colon cancer
5828777|NCT00004910|stage II colon cancer|stage ii colon cancer
5828778|NCT00004910|stage III colon cancer|stage iii colon cancer
5828779|NCT00004910|stage IV colon cancer|stage iv colon cancer
5828780|NCT00004910|stage I gastric cancer|stage i gastric cancer
5828781|NCT00004910|stage II gastric cancer|stage ii gastric cancer
5828782|NCT00004910|stage III gastric cancer|stage iii gastric cancer
5828783|NCT00004910|stage IV gastric cancer|stage iv gastric cancer
5828784|NCT00004910|recurrent gastric cancer|recurrent gastric cancer
5828785|NCT00004910|stage I pancreatic cancer|stage i pancreatic cancer
5828786|NCT00004910|stage II pancreatic cancer|stage ii pancreatic cancer
5828787|NCT00004910|stage III pancreatic cancer|stage iii pancreatic cancer
5828788|NCT00004910|recurrent pancreatic cancer|recurrent pancreatic cancer
5828789|NCT00004910|recurrent colon cancer|recurrent colon cancer
5828790|NCT00004910|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5828791|NCT00004910|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5828792|NCT00004910|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5828793|NCT00004910|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5828794|NCT00004910|small intestine adenocarcinoma|small intestine adenocarcinoma
5828795|NCT00004910|small intestine lymphoma|small intestine lymphoma
5828796|NCT00004910|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5828797|NCT00004910|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5828798|NCT00004910|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5828799|NCT00004910|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5828800|NCT00004910|recurrent small intestine cancer|recurrent small intestine cancer
5828801|NCT00004910|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5828802|NCT00004910|quality of life|quality of life
5828803|NCT00004910|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5828804|NCT00004910|stage IV pancreatic cancer|stage iv pancreatic cancer
5828805|NCT00004895|stage I colon cancer|stage i colon cancer
5828806|NCT00004895|stage II colon cancer|stage ii colon cancer
5828807|NCT00004895|stage III colon cancer|stage iii colon cancer
5828808|NCT00004895|stage IV colon cancer|stage iv colon cancer
5846459|NCT00044356|Neoplasm|neoplasm
5828809|NCT00004895|stage I gastric cancer|stage i gastric cancer
5828810|NCT00004895|stage II gastric cancer|stage ii gastric cancer
5828811|NCT00004895|stage III gastric cancer|stage iii gastric cancer
5828812|NCT00004895|stage IV gastric cancer|stage iv gastric cancer
5828813|NCT00004895|recurrent gastric cancer|recurrent gastric cancer
5828814|NCT00004895|stage I pancreatic cancer|stage i pancreatic cancer
5828815|NCT00004895|stage II pancreatic cancer|stage ii pancreatic cancer
5828816|NCT00004895|stage III pancreatic cancer|stage iii pancreatic cancer
5828817|NCT00004895|stage IV pancreatic cancer|stage iv pancreatic cancer
5828818|NCT00004895|recurrent pancreatic cancer|recurrent pancreatic cancer
5828819|NCT00004895|stage I rectal cancer|stage i rectal cancer
5828820|NCT00004895|stage II rectal cancer|stage ii rectal cancer
5828821|NCT00004895|stage III rectal cancer|stage iii rectal cancer
5828822|NCT00004895|stage IV rectal cancer|stage iv rectal cancer
5828823|NCT00004895|recurrent colon cancer|recurrent colon cancer
5828824|NCT00004895|recurrent rectal cancer|recurrent rectal cancer
5828825|NCT00004895|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5828826|NCT00004895|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5828827|NCT00004895|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5828828|NCT00004895|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5828829|NCT00004895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5828830|NCT00004895|small intestine adenocarcinoma|small intestine adenocarcinoma
5828831|NCT00004895|small intestine lymphoma|small intestine lymphoma
5828832|NCT00004895|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5828833|NCT00004895|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5828834|NCT00004895|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5828835|NCT00004895|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5828836|NCT00004895|recurrent small intestine cancer|recurrent small intestine cancer
5828837|NCT00004895|constipation, impaction, and bowel obstruction|constipation, impaction, and bowel obstruction
5828838|NCT00004895|peritoneal cavity cancer|peritoneal cavity cancer
5828840|NCT00004895|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5828841|NCT00004255|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5828842|NCT00004255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5828843|NCT00004255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5828844|NCT00004255|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5828845|NCT00004255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5828846|NCT00004255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5828847|NCT00004255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5828848|NCT00004255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5828849|NCT00004255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5828850|NCT00004255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5828851|NCT00004255|refractory anemia with excess blasts|refractory anemia with excess blasts
5828852|NCT00004255|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5828853|NCT00004255|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5828854|NCT00004255|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5828855|NCT00004255|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5828856|NCT00004255|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5828857|NCT00004255|graft versus host disease|graft versus host disease
5828858|NCT00004255|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5828859|NCT00004232|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5828860|NCT00004232|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5828861|NCT00004232|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5828862|NCT00004232|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5828863|NCT00004232|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5828864|NCT00004232|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5828865|NCT00004232|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5828866|NCT00004232|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5828867|NCT00004232|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5828868|NCT00004232|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5828869|NCT00004232|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5837119|NCT00017121|lung metastases|lung metastases
5828870|NCT00004232|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5828871|NCT00004232|Burkitt lymphoma|burkitt lymphoma
5828872|NCT00004232|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5828873|NCT00004232|extramedullary plasmacytoma|extramedullary plasmacytoma
5828874|NCT00004232|refractory multiple myeloma|refractory multiple myeloma
5828875|NCT00004232|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5828876|NCT00004232|stage I multiple myeloma|stage i multiple myeloma
5828877|NCT00004232|stage II multiple myeloma|stage ii multiple myeloma
5828878|NCT00004232|stage III multiple myeloma|stage iii multiple myeloma
5828879|NCT00004232|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5828880|NCT00004232|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5828881|NCT00004232|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5828882|NCT00004232|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5828883|NCT00004232|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5686802|NCT00550537|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5686803|NCT00550537|large cell lung cancer|large cell lung cancer
5686804|NCT00550537|adenocarcinoma of the lung|adenocarcinoma of the lung
5686805|NCT00550524|Knee osteoarthritis|knee osteoarthritis
5686806|NCT00550511|Abdominal pain|abdominal pain
5686810|NCT00550511|diagnostic accuracy|diagnostic accuracy
5686811|NCT00550498|Retinal Vasculitis|retinal vasculitis
5686812|NCT00550498|Retinal Edema|retinal edema
5686813|NCT00550498|Behcet's Disease|behcet's disease
5828884|NCT00004232|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5828885|NCT00004232|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5828886|NCT00004232|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5828887|NCT00004232|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5828888|NCT00004232|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5828889|NCT00004232|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5828890|NCT00004232|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5828891|NCT00004232|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5828892|NCT00004232|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5828893|NCT00004232|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5828894|NCT00004232|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5828895|NCT00004232|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5828896|NCT00004232|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5828897|NCT00004232|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5828898|NCT00004232|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5828899|NCT00004232|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5828900|NCT00004232|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5828901|NCT00004232|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5828902|NCT00004232|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5828903|NCT00004232|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5828904|NCT00004232|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5828905|NCT00004232|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5828906|NCT00004232|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5828907|NCT00004232|essential thrombocythemia|essential thrombocythemia
5828908|NCT00004232|untreated hairy cell leukemia|untreated hairy cell leukemia
5828909|NCT00004232|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5828910|NCT00004232|refractory hairy cell leukemia|refractory hairy cell leukemia
5828911|NCT00004232|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5828912|NCT00004232|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5828913|NCT00004232|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5828914|NCT00004232|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5828915|NCT00004232|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5828916|NCT00004232|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5828917|NCT00004232|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5828918|NCT00004232|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5828919|NCT00004232|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5828920|NCT00004232|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5828921|NCT00004232|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5828922|NCT00004232|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5828923|NCT00004232|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5828924|NCT00004232|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5828925|NCT00004232|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5828926|NCT00004232|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5828927|NCT00004232|acute undifferentiated leukemia|acute undifferentiated leukemia
5829613|NCT00002971|adult glioblastoma|adult glioblastoma
5828928|NCT00004232|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5828929|NCT00004232|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5828930|NCT00004232|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5828931|NCT00004232|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5681490|NCT00573131|Operable esophageal cancer|operable esophageal cancer
5828932|NCT00004232|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5828933|NCT00004232|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5828934|NCT00004232|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5828935|NCT00004232|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5828936|NCT00004232|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5828937|NCT00004232|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5828938|NCT00004232|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5828939|NCT00004232|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5828940|NCT00004232|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5846461|NCT00044356|Metastasis|metastasis
5828941|NCT00004232|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5828942|NCT00004232|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5828943|NCT00004232|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5828944|NCT00004232|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5828945|NCT00004232|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5828946|NCT00004232|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5828947|NCT00004232|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5828948|NCT00004232|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5828949|NCT00004232|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5828950|NCT00004232|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5828951|NCT00004232|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5828952|NCT00004232|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5828953|NCT00004232|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5828954|NCT00004232|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5828955|NCT00004232|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5828956|NCT00004232|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5828957|NCT00004232|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5828958|NCT00004232|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5828960|NCT00004232|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5828961|NCT00004232|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5828962|NCT00004232|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5828963|NCT00004232|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5828965|NCT00004232|prolymphocytic leukemia|prolymphocytic leukemia
5828966|NCT00004232|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5828967|NCT00004232|primary systemic amyloidosis|primary systemic amyloidosis
5828968|NCT00004232|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5828969|NCT00004232|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5828970|NCT00004232|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5828971|NCT00004232|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5828972|NCT00004232|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5828973|NCT00004232|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5828974|NCT00004232|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5828975|NCT00004232|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5828976|NCT00004232|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5828977|NCT00004232|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5828978|NCT00004232|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5828979|NCT00004232|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5828980|NCT00004232|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5828981|NCT00004232|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5829126|NCT00060268|stage I esophageal cancer|stage i esophageal cancer
5828982|NCT00004232|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5828983|NCT00004232|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5828984|NCT00004232|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5828985|NCT00004232|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5828986|NCT00004232|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5828987|NCT00004232|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5828988|NCT00004232|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5828989|NCT00004232|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5863176|NCT00001361|Movement Disorders|movement disorders
5828990|NCT00004232|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5828991|NCT00004232|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5828992|NCT00004232|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5828993|NCT00004232|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5828994|NCT00004232|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5828995|NCT00004232|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5828996|NCT00004232|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5828997|NCT00004232|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5828998|NCT00004232|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5828999|NCT00004232|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5846572|NCT00044109|Low Back|low back
5829000|NCT00004232|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5829001|NCT00004232|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829002|NCT00004232|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5829003|NCT00004232|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5829004|NCT00004232|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5829005|NCT00004232|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5829006|NCT00004232|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5829007|NCT00004232|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5829008|NCT00004232|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5829009|NCT00004232|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5829010|NCT00004232|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5829011|NCT00004232|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829012|NCT00004232|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829013|NCT00004232|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5829014|NCT00004232|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5829015|NCT00004232|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5829016|NCT00004232|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5825382|NCT00067002|Rituximab|rituximab
5829020|NCT00004232|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5829021|NCT00004232|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829022|NCT00004232|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829023|NCT00004232|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829024|NCT00004232|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5829025|NCT00004180|adult liposarcoma|adult liposarcoma
5829026|NCT00004180|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5829027|NCT00060593|Balance|balance
5829028|NCT00060593|Functional Connectivity|functional connectivity
5829029|NCT00060593|Healthy Volunteer|healthy volunteer
5829030|NCT00060593|HV|hv
5829031|NCT00060580|Retinal Measurements|retinal measurements
5829032|NCT00060580|Lutein in Vivo|lutein in vivo
5829033|NCT00060580|Raman Spectroscopy|raman spectroscopy
5829034|NCT00060580|Retinal Measurements of Lutein in Vivo in the Human Eye|retinal measurements of lutein in vivo in the human eye
5829035|NCT00060580|Healthy Volunteer|healthy volunteer
5829036|NCT00060580|HV|hv
5829037|NCT00060554|Elective PCI|elective pci
5829038|NCT00060554|Heart catherization|heart catherization
5829039|NCT00060554|Acute coronary syndromes|acute coronary syndromes
5829040|NCT00060502|cachexia|cachexia
5829041|NCT00060502|pancreatic cancer|pancreatic cancer
5829042|NCT00060502|infliximab|infliximab
5829043|NCT00060502|anorexia|anorexia
5829044|NCT00060502|anemia|anemia
5829045|NCT00060502|Remicade.|remicade.
5829046|NCT00060489|Bipolar Depression|bipolar depression
5829047|NCT00004094|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5829048|NCT00004094|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5829049|NCT00004094|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5829052|NCT00004094|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5829053|NCT00004094|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5829054|NCT00004094|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5829055|NCT00004094|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5829056|NCT00004068|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5829057|NCT00004068|childhood high-grade cerebellar astrocytoma|childhood high-grade cerebellar astrocytoma
5829058|NCT00004068|childhood oligodendroglioma|childhood oligodendroglioma
5829059|NCT00004068|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5863177|NCT00001361|Sensory Processing|sensory processing
5829060|NCT00004068|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5829061|NCT00004059|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829062|NCT00004052|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5686814|NCT00550472|probiotics|probiotics
5829063|NCT00004052|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5829064|NCT00004008|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5829065|NCT00004008|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5829066|NCT00004008|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5829067|NCT00004008|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5829068|NCT00004008|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5829075|NCT00060528|Cytokines|cytokines
5829076|NCT00060528|Immune Assays|immune assays
5829077|NCT00060528|Prostate Cancer|prostate cancer
5829078|NCT00060463|Emergency contraceptive pills|emergency contraceptive pills
5829079|NCT00060463|Pregnancy|pregnancy
5829080|NCT00060463|Sexually transmitted infection|sexually transmitted infection
5829081|NCT00060463|Chlamydia|chlamydia
5829084|NCT00060463|Contraception|contraception
5829085|NCT00060450|Ischemia-reperfusion lung injury|ischemia-reperfusion lung injury
5829086|NCT00060450|IRLI|irli
5829087|NCT00060437|stage IV prostate cancer|stage iv prostate cancer
5829088|NCT00060437|recurrent prostate cancer|recurrent prostate cancer
5829089|NCT00060437|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5829090|NCT00060398|recurrent prostate cancer|recurrent prostate cancer
5829091|NCT00060398|anemia|anemia
5829092|NCT00060398|fatigue|fatigue
5829093|NCT00060385|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5829094|NCT00060385|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5829095|NCT00060385|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5829096|NCT00060385|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5829097|NCT00060385|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5829098|NCT00060385|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5829099|NCT00060385|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5829100|NCT00060385|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5829102|NCT00060385|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5829103|NCT00060385|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5829104|NCT00060385|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5829105|NCT00060385|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5829106|NCT00060385|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5829107|NCT00060385|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5829108|NCT00060385|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5829109|NCT00060385|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5829110|NCT00060346|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5829112|NCT00060346|CHOP|chop
5829113|NCT00060333|recurrent melanoma|recurrent melanoma
5829114|NCT00060333|stage I melanoma|stage i melanoma
5829115|NCT00060333|stage II melanoma|stage ii melanoma
5829116|NCT00060333|stage III melanoma|stage iii melanoma
5829117|NCT00060320|stage IV breast cancer|stage iv breast cancer
5829118|NCT00060320|stage I breast cancer|stage i breast cancer
5829119|NCT00060320|stage II breast cancer|stage ii breast cancer
5829120|NCT00060320|stage IIIA breast cancer|stage iiia breast cancer
5829121|NCT00060320|stage IIIB breast cancer|stage iiib breast cancer
5829122|NCT00060320|stage IIIC breast cancer|stage iiic breast cancer
5829123|NCT00060320|hot flashes|hot flashes
5829124|NCT00060294|Waldenström macroglobulinemia|waldenström macroglobulinemia
5829125|NCT00060268|recurrent esophageal cancer|recurrent esophageal cancer
5829127|NCT00060268|stage II esophageal cancer|stage ii esophageal cancer
5829128|NCT00060268|stage III esophageal cancer|stage iii esophageal cancer
5829129|NCT00060268|stage IV esophageal cancer|stage iv esophageal cancer
5829130|NCT00060255|stage IV breast cancer|stage iv breast cancer
5829131|NCT00060255|male breast cancer|male breast cancer
5829132|NCT00060255|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5829133|NCT00060255|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5829134|NCT00060255|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5829135|NCT00060255|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5829136|NCT00060255|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5829137|NCT00060255|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5829138|NCT00060255|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5829139|NCT00060255|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5829140|NCT00060255|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5829141|NCT00060255|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5863178|NCT00001361|Stroke|stroke
5836481|NCT00020007|lung metastases|lung metastases
5829142|NCT00060255|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5829143|NCT00060255|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5829144|NCT00060255|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829145|NCT00060255|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829146|NCT00060255|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5829147|NCT00060255|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5829148|NCT00060255|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829149|NCT00060255|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829150|NCT00060255|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5829151|NCT00060255|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5829152|NCT00060255|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5829153|NCT00060255|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5829154|NCT00060255|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5829155|NCT00060255|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5829156|NCT00060255|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829157|NCT00060255|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5829158|NCT00060255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829159|NCT00060255|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5829160|NCT00060255|stage IIIA breast cancer|stage iiia breast cancer
5829161|NCT00060255|stage IIIB breast cancer|stage iiib breast cancer
5829162|NCT00060255|stage IIIC breast cancer|stage iiic breast cancer
5829163|NCT00060255|recurrent breast cancer|recurrent breast cancer
5829164|NCT00060255|primary systemic amyloidosis|primary systemic amyloidosis
5829165|NCT00060255|refractory multiple myeloma|refractory multiple myeloma
5829166|NCT00060255|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5829167|NCT00060255|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5829168|NCT00060255|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829169|NCT00060255|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829170|NCT00060255|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829171|NCT00060255|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829172|NCT00060255|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829173|NCT00060255|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5829174|NCT00060255|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5829175|NCT00060255|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5829176|NCT00060255|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5829177|NCT00060255|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5829178|NCT00060242|anaplastic thyroid cancer|anaplastic thyroid cancer
5829179|NCT00060242|recurrent thyroid cancer|recurrent thyroid cancer
5829180|NCT00060203|stage III multiple myeloma|stage iii multiple myeloma
5829181|NCT00060203|refractory multiple myeloma|refractory multiple myeloma
5829182|NCT00060151|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829183|NCT00060138|hypercalcemia of malignancy|hypercalcemia of malignancy
5829185|NCT00060138|recurrent breast cancer|recurrent breast cancer
5829186|NCT00060138|bone metastases|bone metastases
5829188|NCT00060099|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5829189|NCT00060099|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5829190|NCT00060099|human papilloma virus infection|human papilloma virus infection
5829191|NCT00060086|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5829192|NCT00060086|recurrent prostate cancer|recurrent prostate cancer
5829193|NCT00060021|oral complications|oral complications
5829194|NCT00060021|pain|pain
5829195|NCT00060021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5829196|NCT00060021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5829197|NCT00060021|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5829198|NCT00060021|primary myelofibrosis|primary myelofibrosis
5829199|NCT00060021|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5829200|NCT00060021|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5829201|NCT00060021|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5829202|NCT00060021|disseminated neuroblastoma|disseminated neuroblastoma
5829203|NCT00060021|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5829204|NCT00060021|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5829205|NCT00060021|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5829206|NCT00060021|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5829207|NCT00060021|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5829208|NCT00060021|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5829209|NCT00060021|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5829210|NCT00060021|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5829211|NCT00060021|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5829212|NCT00060021|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5829213|NCT00060021|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5829214|NCT00060021|ovarian choriocarcinoma|ovarian choriocarcinoma
5829215|NCT00060021|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5829216|NCT00060021|ovarian yolk sac tumor|ovarian yolk sac tumor
5829217|NCT00060021|ovarian immature teratoma|ovarian immature teratoma
5829218|NCT00060021|ovarian mature teratoma|ovarian mature teratoma
5830147|NCT00058994|anecortave acetate|anecortave acetate
5829219|NCT00060021|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5829220|NCT00060021|ovarian polyembryoma|ovarian polyembryoma
5829221|NCT00060021|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5829222|NCT00060021|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5829223|NCT00060021|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5829224|NCT00060021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5829225|NCT00060021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829226|NCT00060021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829227|NCT00060021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5829228|NCT00060021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5829229|NCT00060021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829230|NCT00060021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829231|NCT00060021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5829232|NCT00060021|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5829233|NCT00060021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5825571|NCT00066976|Prematurity|prematurity
5829234|NCT00060021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5829235|NCT00060021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5829237|NCT00060021|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5829238|NCT00060021|recurrent neuroblastoma|recurrent neuroblastoma
5829239|NCT00060021|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5829240|NCT00060021|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5829241|NCT00060021|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5829242|NCT00060021|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5829243|NCT00060021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5829244|NCT00060021|refractory hairy cell leukemia|refractory hairy cell leukemia
5829245|NCT00060021|refractory multiple myeloma|refractory multiple myeloma
5829246|NCT00060021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5829247|NCT00060021|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5829248|NCT00060021|stage I multiple myeloma|stage i multiple myeloma
5829249|NCT00060021|stage II multiple myeloma|stage ii multiple myeloma
5829250|NCT00060021|stage III multiple myeloma|stage iii multiple myeloma
5829251|NCT00060021|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5829252|NCT00060021|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5829253|NCT00060021|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5829254|NCT00060021|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5829255|NCT00060021|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5829256|NCT00060021|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5829257|NCT00060021|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5829258|NCT00060021|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5829259|NCT00060021|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5829260|NCT00060021|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5829261|NCT00060021|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5829262|NCT00060021|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5829263|NCT00060021|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5829264|NCT00060021|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5829265|NCT00060021|stage IIIA breast cancer|stage iiia breast cancer
5829266|NCT00060021|stage IIIB breast cancer|stage iiib breast cancer
5829267|NCT00060021|stage IIIC breast cancer|stage iiic breast cancer
5829268|NCT00060021|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5829269|NCT00060021|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5829270|NCT00060021|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5836654|NCT00019513|recurrent colon cancer|recurrent colon cancer
5829271|NCT00060021|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5829272|NCT00060021|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5829273|NCT00060021|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5686815|NCT00550472|atopic dermatitis|atopic dermatitis
5829274|NCT00060021|stage IV breast cancer|stage iv breast cancer
5829275|NCT00060021|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5829276|NCT00060021|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5829277|NCT00060021|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5829278|NCT00060021|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5829279|NCT00060021|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5829280|NCT00060021|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5829281|NCT00060021|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5829282|NCT00060021|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5829283|NCT00060021|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5829284|NCT00060021|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5829285|NCT00060021|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5829286|NCT00060021|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5829287|NCT00060021|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5829288|NCT00060021|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5829289|NCT00060021|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5829290|NCT00060021|testicular embryonal carcinoma|testicular embryonal carcinoma
5829291|NCT00060021|testicular teratoma|testicular teratoma
5829292|NCT00060021|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5829293|NCT00060021|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5829294|NCT00060021|testicular yolk sac tumor|testicular yolk sac tumor
5829295|NCT00060021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5829296|NCT00060021|testicular choriocarcinoma|testicular choriocarcinoma
5829297|NCT00060021|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5829298|NCT00060021|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5829299|NCT00060021|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5829300|NCT00060021|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5829301|NCT00060021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829302|NCT00060021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829303|NCT00060021|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5829304|NCT00060021|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5829305|NCT00060021|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5829306|NCT00060021|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5829307|NCT00060021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829308|NCT00060021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829309|NCT00060021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829311|NCT00060008|plexiform neurofibroma|plexiform neurofibroma
5829312|NCT00059995|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829313|NCT00059995|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5829314|NCT00059995|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5829315|NCT00059995|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829316|NCT00059995|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5829317|NCT00059995|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5829318|NCT00059982|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5829319|NCT00059982|stage II pancreatic cancer|stage ii pancreatic cancer
5829320|NCT00059982|stage III pancreatic cancer|stage iii pancreatic cancer
5829321|NCT00059982|stage IV pancreatic cancer|stage iv pancreatic cancer
5829322|NCT00059943|stage IV breast cancer|stage iv breast cancer
5829323|NCT00059943|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5829324|NCT00059943|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5829325|NCT00059943|recurrent breast cancer|recurrent breast cancer
5829326|NCT00059943|stage IV prostate cancer|stage iv prostate cancer
5829327|NCT00059943|recurrent prostate cancer|recurrent prostate cancer
5829328|NCT00059930|liver metastases|liver metastases
5829329|NCT00059930|stage IV colon cancer|stage iv colon cancer
5829330|NCT00059930|stage IV rectal cancer|stage iv rectal cancer
5829331|NCT00059930|adenocarcinoma of the colon|adenocarcinoma of the colon
5829332|NCT00059930|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5829333|NCT00059930|recurrent colon cancer|recurrent colon cancer
5829334|NCT00059930|recurrent rectal cancer|recurrent rectal cancer
5829335|NCT00059917|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829336|NCT00059904|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829337|NCT00059904|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829338|NCT00059904|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829339|NCT00059891|perioperative/postoperative complications|perioperative/postoperative complications
5686816|NCT00550472|immune system|immune system
5829340|NCT00059891|stage II anal cancer|stage ii anal cancer
5829341|NCT00059891|stage I anal cancer|stage i anal cancer
5829342|NCT00059891|stage III anal cancer|stage iii anal cancer
5829343|NCT00059891|stage I rectal cancer|stage i rectal cancer
5829344|NCT00059891|stage II rectal cancer|stage ii rectal cancer
5829345|NCT00059891|stage III rectal cancer|stage iii rectal cancer
5829347|NCT00059878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829348|NCT00059865|advanced adult primary liver cancer|advanced adult primary liver cancer
5829349|NCT00059865|unresectable gallbladder cancer|unresectable gallbladder cancer
5829350|NCT00059865|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5829351|NCT00059865|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5829352|NCT00059852|male breast cancer|male breast cancer
5829353|NCT00059852|recurrent breast cancer|recurrent breast cancer
5829354|NCT00059852|stage IV breast cancer|stage iv breast cancer
5829355|NCT00059839|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5829356|NCT00059826|stage I pancreatic cancer|stage i pancreatic cancer
5829357|NCT00059826|stage II pancreatic cancer|stage ii pancreatic cancer
5829358|NCT00059826|stage III pancreatic cancer|stage iii pancreatic cancer
5829359|NCT00059826|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5829360|NCT00059800|recurrent melanoma|recurrent melanoma
5829361|NCT00059800|stage 0 melanoma|stage 0 melanoma
5829362|NCT00059800|stage I melanoma|stage i melanoma
5829363|NCT00059800|stage II melanoma|stage ii melanoma
5829364|NCT00059800|stage III melanoma|stage iii melanoma
5829365|NCT00059800|stage IV melanoma|stage iv melanoma
5829366|NCT00059761|limited stage small cell lung cancer|limited stage small cell lung cancer
5829367|NCT00059735|kidney cancer|kidney cancer
5829368|NCT00059735|kidney neoplasms|kidney neoplasms
5829369|NCT00059735|renal cell cancer|renal cell cancer
5829370|NCT00043108|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5829371|NCT00043108|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5829372|NCT00043108|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5829373|NCT00030524|stage III colon cancer|stage iii colon cancer
5829374|NCT00030524|stage IV colon cancer|stage iv colon cancer
5829375|NCT00030524|stage III rectal cancer|stage iii rectal cancer
5829376|NCT00030524|stage IV rectal cancer|stage iv rectal cancer
5829377|NCT00030524|recurrent colon cancer|recurrent colon cancer
5829378|NCT00030524|recurrent rectal cancer|recurrent rectal cancer
5829379|NCT00030524|adenocarcinoma of the colon|adenocarcinoma of the colon
5829380|NCT00030524|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5829381|NCT00027599|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5829382|NCT00027599|stage I prostate cancer|stage i prostate cancer
5829383|NCT00027599|stage IIB prostate cancer|stage iib prostate cancer
5829384|NCT00027599|stage IIA prostate cancer|stage iia prostate cancer
5829385|NCT00027599|stage III prostate cancer|stage iii prostate cancer
5829386|NCT00027599|stage IV prostate cancer|stage iv prostate cancer
5829387|NCT00027599|recurrent prostate cancer|recurrent prostate cancer
5829388|NCT00017134|ovarian epithelial cancer|ovarian epithelial cancer
5829389|NCT00016315|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5829390|NCT00016315|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5829391|NCT00006225|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5829392|NCT00006225|stage IV breast cancer|stage iv breast cancer
5829393|NCT00006225|stage IIIA breast cancer|stage iiia breast cancer
5829394|NCT00006225|recurrent breast cancer|recurrent breast cancer
5829395|NCT00006225|stage IIIB breast cancer|stage iiib breast cancer
5829396|NCT00006225|stage IIIC breast cancer|stage iiic breast cancer
5829397|NCT00006225|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829398|NCT00006225|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5829399|NCT00006225|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5829400|NCT00006225|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5829401|NCT00006225|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5829402|NCT00006225|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5830305|NCT00058656|Xcellerated|xcellerated
5829403|NCT00006225|extramedullary plasmacytoma|extramedullary plasmacytoma
5829404|NCT00006225|refractory multiple myeloma|refractory multiple myeloma
5829405|NCT00006225|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5829406|NCT00006225|stage I multiple myeloma|stage i multiple myeloma
5829407|NCT00006225|stage II multiple myeloma|stage ii multiple myeloma
5829408|NCT00006225|stage III multiple myeloma|stage iii multiple myeloma
5829409|NCT00006225|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5829410|NCT00006225|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5829411|NCT00006225|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5829412|NCT00006225|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5829413|NCT00006225|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5829414|NCT00006225|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5829415|NCT00006225|acute undifferentiated leukemia|acute undifferentiated leukemia
5829416|NCT00006225|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5829417|NCT00006225|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5829418|NCT00006225|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5829419|NCT00006225|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5829420|NCT00006225|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5829421|NCT00006225|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5829422|NCT00006225|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5829423|NCT00006225|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5829424|NCT00006225|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5829425|NCT00006225|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5829426|NCT00006225|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5829427|NCT00006225|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5829428|NCT00006225|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5829429|NCT00006225|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5829430|NCT00006225|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5829659|NCT00003926|cerebral astrocytoma|cerebral astrocytoma
5829431|NCT00006225|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5829432|NCT00006225|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5829433|NCT00006225|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5829434|NCT00006225|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5829435|NCT00006225|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5829436|NCT00006225|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5829437|NCT00006225|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5829438|NCT00006225|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829439|NCT00006225|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829440|NCT00006225|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829441|NCT00006225|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5829442|NCT00006225|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5829443|NCT00006225|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5829444|NCT00006225|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5829445|NCT00006225|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5829446|NCT00006225|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5829447|NCT00006225|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5829448|NCT00006225|primary central nervous system lymphoma|primary central nervous system lymphoma
5829450|NCT00006225|intraocular lymphoma|intraocular lymphoma
5829451|NCT00006225|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5829452|NCT00006225|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5829453|NCT00006225|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5829454|NCT00006225|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5829455|NCT00006225|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5829456|NCT00006225|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5829457|NCT00006225|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5829458|NCT00006225|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5829459|NCT00006225|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5829460|NCT00006225|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5829461|NCT00006225|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5829462|NCT00006225|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5829463|NCT00006225|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5829464|NCT00006225|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5829465|NCT00006225|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5829466|NCT00006225|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5829467|NCT00006225|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5829468|NCT00006225|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5829469|NCT00006225|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5829470|NCT00006225|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5829471|NCT00006225|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5829472|NCT00006225|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5829473|NCT00006225|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5686817|NCT00550472|human|human
5829474|NCT00006225|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829475|NCT00006225|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5829476|NCT00006225|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5829477|NCT00006225|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5829478|NCT00006225|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5829479|NCT00006225|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5829480|NCT00006225|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5829481|NCT00006225|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5829482|NCT00006225|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5829483|NCT00006225|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5829484|NCT00006225|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5829485|NCT00006225|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5829486|NCT00006225|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5829487|NCT00006225|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829488|NCT00006225|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829489|NCT00006225|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5829490|NCT00006225|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5829491|NCT00006225|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5829660|NCT00003926|ependymoma|ependymoma
5829492|NCT00006225|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5829493|NCT00006225|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5829494|NCT00006225|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5829495|NCT00006225|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829496|NCT00006225|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829497|NCT00006225|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829498|NCT00005793|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5829499|NCT00005793|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5829500|NCT00005793|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5829501|NCT00005793|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5829502|NCT00005793|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5829503|NCT00005793|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5829504|NCT00005793|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5829505|NCT00005793|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5829506|NCT00005793|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5829507|NCT00005793|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5829508|NCT00005793|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5829509|NCT00005793|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5829510|NCT00005793|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5829511|NCT00004127|stage IV gastric cancer|stage iv gastric cancer
5829512|NCT00004127|recurrent gastric cancer|recurrent gastric cancer
5829513|NCT00004127|stage IV esophageal cancer|stage iv esophageal cancer
5829514|NCT00004127|recurrent esophageal cancer|recurrent esophageal cancer
5829515|NCT00004127|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5829516|NCT00004127|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5829517|NCT00004095|stage IV colon cancer|stage iv colon cancer
5829518|NCT00004095|stage IV breast cancer|stage iv breast cancer
5829519|NCT00004095|recurrent breast cancer|recurrent breast cancer
5829520|NCT00004095|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5829521|NCT00004095|recurrent pancreatic cancer|recurrent pancreatic cancer
5829522|NCT00004095|stage IV rectal cancer|stage iv rectal cancer
5829523|NCT00004095|recurrent colon cancer|recurrent colon cancer
5829524|NCT00004095|recurrent rectal cancer|recurrent rectal cancer
5829525|NCT00004095|stage IV renal cell cancer|stage iv renal cell cancer
5829526|NCT00004095|recurrent renal cell cancer|recurrent renal cell cancer
5829527|NCT00004095|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5829528|NCT00004095|recurrent small cell lung cancer|recurrent small cell lung cancer
5829529|NCT00004095|recurrent bladder cancer|recurrent bladder cancer
5829530|NCT00004095|stage IV bladder cancer|stage iv bladder cancer
5829545|NCT00019435|recurrent gastric cancer|recurrent gastric cancer
5829546|NCT00019435|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5829547|NCT00019435|recurrent pancreatic cancer|recurrent pancreatic cancer
5829548|NCT00019435|recurrent colon cancer|recurrent colon cancer
5829549|NCT00019435|stage IV esophageal cancer|stage iv esophageal cancer
5829550|NCT00019435|recurrent esophageal cancer|recurrent esophageal cancer
5829551|NCT00019435|recurrent bladder cancer|recurrent bladder cancer
5829552|NCT00019435|stage IV bladder cancer|stage iv bladder cancer
5829553|NCT00019435|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5686818|NCT00550472|Lactobacillus|lactobacillus
5829554|NCT00019435|stage IV pancreatic cancer|stage iv pancreatic cancer
5829555|NCT00002765|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829556|NCT00002765|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5829557|NCT00002765|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5829558|NCT00002765|Waldenström macroglobulinemia|waldenström macroglobulinemia
5829559|NCT00002765|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5829560|NCT00002765|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5829561|NCT00002765|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5829562|NCT00002765|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5829563|NCT00002765|refractory hairy cell leukemia|refractory hairy cell leukemia
5829564|NCT00002765|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829565|NCT00002765|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5829566|NCT00002765|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5829567|NCT00002765|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5829568|NCT00002765|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5829569|NCT00002765|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829570|NCT00002765|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829571|NCT00002765|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829572|NCT00002765|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5829745|NCT00059579|Dopaminergic Mechanisms|dopaminergic mechanisms
5829573|NCT00002765|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5829574|NCT00002765|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5829575|NCT00002765|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5829576|NCT00002765|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5829577|NCT00002765|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5829578|NCT00002765|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5829579|NCT00002765|prolymphocytic leukemia|prolymphocytic leukemia
5829580|NCT00002765|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829581|NCT00002765|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5829582|NCT00002765|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5829583|NCT00002765|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829584|NCT00002765|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829585|NCT00002765|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829586|NCT00002765|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829587|NCT00059722|NSCLC|nsclc
5829588|NCT00059722|locally advanced or metastatic|locally advanced or metastatic
5829589|NCT00059722|second-line|second-line
5829590|NCT00059709|Conflict Resolution training|conflict resolution training
5829591|NCT00059709|Children|children
5829592|NCT00059696|Constraint-Induced Movement Therapy|constraint-induced movement therapy
5829593|NCT00059696|CI therapy|ci therapy
5829594|NCT00059696|Rehabilitation|rehabilitation
5829595|NCT00059696|Cerebrovascular accident|cerebrovascular accident
5829596|NCT00059696|Upper extremity|upper extremity
5829597|NCT00059696|Concentrated, extended practice|concentrated, extended practice
5829598|NCT00059696|Limb restraint|limb restraint
5829599|NCT00059696|Motor Deficits|motor deficits
5829600|NCT00059683|Preterm Birth|preterm birth
5829601|NCT00059683|Premature Birth|premature birth
5829602|NCT00059683|Cervical cerclage|cervical cerclage
5829603|NCT00059683|Vaginal ultrasound|vaginal ultrasound
5829604|NCT00059683|Cervical length|cervical length
5829605|NCT00018941|stage IV renal cell cancer|stage iv renal cell cancer
5846663|NCT00043823|rhuMAb VEGF|rhumab vegf
5829606|NCT00018941|recurrent renal cell cancer|recurrent renal cell cancer
5829607|NCT00005837|recurrent cervical cancer|recurrent cervical cancer
5830510|NCT00057837|Etoposide|etoposide
5829608|NCT00005837|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5829609|NCT00005025|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5829610|NCT00005025|fallopian tube cancer|fallopian tube cancer
5829611|NCT00005025|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5829612|NCT00002971|recurrent adult brain tumor|recurrent adult brain tumor
5829614|NCT00002971|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5829615|NCT00002971|adult giant cell glioblastoma|adult giant cell glioblastoma
5829616|NCT00002971|adult gliosarcoma|adult gliosarcoma
5829618|NCT00059670|Dysphagia|dysphagia
5829619|NCT00059657|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
5829621|NCT00059657|peripheral, vascular|peripheral, vascular
5829622|NCT00059657|amputation|amputation
5829623|NCT00059657|Angioplasty|angioplasty
5829624|NCT00059657|by-pass|by-pass
5829625|NCT00059657|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
5829626|NCT00059644|Ecraprost in lipid emulsion|ecraprost in lipid emulsion
5829627|NCT00059644|CLI|cli
5829628|NCT00059644|peripheral|peripheral
5829629|NCT00059644|vascular|vascular
5836944|NCT00019019|adult gliosarcoma|adult gliosarcoma
5829630|NCT00059644|amputation|amputation
5829631|NCT00059644|Critical Limb Ischemia due to peripheral arterial disease|critical limb ischemia due to peripheral arterial disease
5829632|NCT00003933|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5829633|NCT00003926|soft tissue sarcoma|soft tissue sarcoma
5829634|NCT00003926|regional neuroblastoma|regional neuroblastoma
5829635|NCT00003926|disseminated neuroblastoma|disseminated neuroblastoma
5829636|NCT00003926|recurrent Wilms tumor|recurrent wilms tumor
5829637|NCT00003926|recurrent retinoblastoma|recurrent retinoblastoma
5829638|NCT00003926|recurrent adult brain tumor|recurrent adult brain tumor
5829639|NCT00003926|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5829640|NCT00003926|ovarian germ cell tumor|ovarian germ cell tumor
5829641|NCT00003926|chordoma|chordoma
5829642|NCT00003926|ovarian sarcoma|ovarian sarcoma
5829643|NCT00003926|unresectable neuroblastoma|unresectable neuroblastoma
5829644|NCT00003926|desmoplastic small round cell tumor|desmoplastic small round cell tumor
5829645|NCT00003926|rhabdomyosarcoma|rhabdomyosarcoma
5829646|NCT00003926|Ewing sarcoma|ewing sarcoma
5829647|NCT00003926|neuroectodermal tumor|neuroectodermal tumor
5829648|NCT00003926|teratoma|teratoma
5829649|NCT00003926|malignant testicular germ cell tumor|malignant testicular germ cell tumor
5829650|NCT00003926|malignant ovarian germ cell tumor|malignant ovarian germ cell tumor
5829651|NCT00003926|extragonadal germ cell tumor|extragonadal germ cell tumor
5829652|NCT00003926|malignant germ cell tumor|malignant germ cell tumor
5829653|NCT00003926|hepatoblastoma|hepatoblastoma
5829654|NCT00003926|liver cancer|liver cancer
5829655|NCT00003926|medulloblastoma|medulloblastoma
5829656|NCT00003926|cerebellar astrocytoma|cerebellar astrocytoma
5829657|NCT00003926|brain stem glioma|brain stem glioma
5829658|NCT00003926|glioma|glioma
5829661|NCT00003925|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829662|NCT00003802|iris melanoma|iris melanoma
5829663|NCT00003802|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5829664|NCT00003802|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5829665|NCT00003802|extraocular extension melanoma|extraocular extension melanoma
5829666|NCT00003802|recurrent intraocular melanoma|recurrent intraocular melanoma
5829667|NCT00003802|stage IV melanoma|stage iv melanoma
5829668|NCT00003802|recurrent melanoma|recurrent melanoma
5829669|NCT00003797|recurrent pancreatic cancer|recurrent pancreatic cancer
5829670|NCT00003797|stage IV pancreatic cancer|stage iv pancreatic cancer
5829672|NCT00059631|Advanced Androgen-Independent Prostate Cancer|advanced androgen-independent prostate cancer
5829673|NCT00059631|AI-PCa|ai-pca
5829674|NCT00059631|Advanced Prostate Cancer|advanced prostate cancer
5829675|NCT00059631|Novantrone|novantrone
5829676|NCT00059631|Mitoxantrone|mitoxantrone
5829677|NCT00059631|PS-341|ps-341
5829678|NCT00059631|Bortezomib|bortezomib
5829679|NCT00059631|Velcade|velcade
5829680|NCT00059631|LDP-341|ldp-341
5829681|NCT00059631|MLN341|mln341
5829682|NCT00059631|20S proteasome|20s proteasome
5829683|NCT00059618|Platinum Resistant|platinum resistant
5829684|NCT00059618|Taxane Resistant|taxane resistant
5829685|NCT00059618|Ovarian Cancer|ovarian cancer
5829686|NCT00059618|Primary Peritoneal Cancer|primary peritoneal cancer
5829687|NCT00059618|Fallopian Tube Cancer|fallopian tube cancer
5829688|NCT00059618|Bortezomib|bortezomib
5829689|NCT00059618|PS-341|ps-341
5829690|NCT00059618|Velcade|velcade
5829691|NCT00059618|LDP-341|ldp-341
5829692|NCT00059618|MLN341|mln341
5829693|NCT00059618|Carboplatin|carboplatin
5829694|NCT00059618|Paraplatin|paraplatin
5829695|NCT00059605|Non-Small Cell Lung Cancer|non-small cell lung cancer
5829696|NCT00059605|Small Cell Lung Cancer|small cell lung cancer
5829697|NCT00059605|Lung Cancer|lung cancer
5829698|NCT00059605|NSCLC|nsclc
5829699|NCT00059605|SCLC|sclc
5829700|NCT00059605|DOTAP:Chol-fus1|dotap:chol-fus1
5829701|NCT00059605|gene|gene
5829702|NCT00059605|gene transfer|gene transfer
5829703|NCT00003757|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5829704|NCT00003757|refractory hairy cell leukemia|refractory hairy cell leukemia
5829705|NCT00003649|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5829706|NCT00003649|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5829707|NCT00003649|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5829708|NCT00003649|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5829709|NCT00003627|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5829710|NCT00003627|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5829711|NCT00003627|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5829712|NCT00003627|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5829713|NCT00003484|localized resectable neuroblastoma|localized resectable neuroblastoma
5829714|NCT00003484|recurrent adult brain tumor|recurrent adult brain tumor
5829715|NCT00003484|adult craniopharyngioma|adult craniopharyngioma
5829716|NCT00003484|adult medulloblastoma|adult medulloblastoma
5829717|NCT00003484|adult meningioma|adult meningioma
5686819|NCT00550472|Bifidobacterium|bifidobacterium
5829718|NCT00003484|adult glioblastoma|adult glioblastoma
5829719|NCT00003484|adult oligodendroglioma|adult oligodendroglioma
5829720|NCT00003484|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5829721|NCT00003484|adult mixed glioma|adult mixed glioma
5829722|NCT00003484|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5829723|NCT00003484|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5829724|NCT00003484|adult grade III meningioma|adult grade iii meningioma
5829725|NCT00003484|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5829726|NCT00003484|adult giant cell glioblastoma|adult giant cell glioblastoma
5829727|NCT00003484|adult gliosarcoma|adult gliosarcoma
5829728|NCT00003436|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5829729|NCT00003436|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5829730|NCT00003436|refractory anemia with excess blasts|refractory anemia with excess blasts
5829731|NCT00003436|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5829732|NCT00003436|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5829733|NCT00003436|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5829734|NCT00003436|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5829735|NCT00003436|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5829736|NCT00059579|Reward|reward
5829737|NCT00059579|Cortex|cortex
5829738|NCT00059579|Dopamine|dopamine
5829739|NCT00059579|Neuroimaging|neuroimaging
5829740|NCT00059579|Strirtum|strirtum
5829741|NCT00059579|Major Depressive Disorder (MDD)|major depressive disorder (mdd)
5829742|NCT00059579|Melancholic Features|melancholic features
5829743|NCT00059579|Brain Imaging|brain imaging
5829744|NCT00059579|Functional Magnetic Resonance Imaging (fMRI)|functional magnetic resonance imaging (fmri)
5829748|NCT00059579|Major Depressive Disorder|major depressive disorder
5829750|NCT00059579|Healthy Volunteer|healthy volunteer
5829751|NCT00059579|HV|hv
5829752|NCT00059553|spinal cord injury|spinal cord injury
5829753|NCT00059553|walking|walking
5829754|NCT00059553|training|training
5829755|NCT00059553|treadmill|treadmill
5829756|NCT00059553|incomplete spinal cord injury|incomplete spinal cord injury
5829757|NCT00059540|NICHD Neonatal Research Network|nichd neonatal research network
5829758|NCT00059540|Maternal Lifestyle Study|maternal lifestyle study
5829760|NCT00059540|Cocaine dependence|cocaine dependence
5829761|NCT00059540|Opiate abuse|opiate abuse
5829764|NCT00059540|Neurodevelopmental outcome|neurodevelopmental outcome
5829765|NCT00059540|Substance-related disorders|substance-related disorders
5829767|NCT00059527|Nutrition|nutrition
5829768|NCT00059527|Self Efficacy|self efficacy
5829769|NCT00059527|Middle School|middle school
5829770|NCT00059527|Intervention|intervention
5829771|NCT00059514|Youth|youth
5829772|NCT00059514|Adolescents|adolescents
5829773|NCT00059514|Smoking cessation|smoking cessation
5829774|NCT00059514|Smoking prevention|smoking prevention
5829775|NCT00059514|Risk factors|risk factors
5829776|NCT00059514|Arab Americans|arab americans
5829777|NCT00059449|Enterocolitis|enterocolitis
5829778|NCT00005836|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5829779|NCT00005836|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5829780|NCT00059501|Postural Stability|postural stability
5829781|NCT00059501|EEG|eeg
5829782|NCT00059501|Aging|aging
5829783|NCT00059501|Falls|falls
5829784|NCT00059501|Healthy Volunteer|healthy volunteer
5829785|NCT00059501|HV|hv
5829786|NCT00059475|Adjuvant Therapy|adjuvant therapy
5829787|NCT00059475|MART-1 Peptides|mart-1 peptides
5829788|NCT00059475|GP100 Peptide|gp100 peptide
5829789|NCT00059475|Immunologic Response|immunologic response
5829790|NCT00059475|Melanoma|melanoma
5829791|NCT00059436|Muscle strengthening|muscle strengthening
5829792|NCT00059436|Skeletal muscle Contractions|skeletal muscle contractions
5829793|NCT00059436|Rehabilitative exercise|rehabilitative exercise
5829794|NCT00059410|Alzheimer disease|alzheimer disease
5829795|NCT00059410|Caregivers|caregivers
5829796|NCT00059410|African Americans|african americans
5829797|NCT00059410|Perceptions|perceptions
5829798|NCT00059410|Cultural Competency|cultural competency
5829799|NCT00059423|Leukapheresis|leukapheresis
5829800|NCT00059423|G-CSF|g-csf
5829801|NCT00059423|Dexamethasone|dexamethasone
5829802|NCT00059423|mRNA|mrna
5829803|NCT00059423|Benign Ethnic Neutropenia|benign ethnic neutropenia
5829804|NCT00059423|BEN|ben
5829805|NCT00059423|Healthy Volunteer|healthy volunteer
5829806|NCT00059423|HV|hv
5829807|NCT00059397|Hepatitis C|hepatitis c
5829808|NCT00003432|stage IV breast cancer|stage iv breast cancer
5829809|NCT00003346|stage III melanoma|stage iii melanoma
5829810|NCT00003346|stage IV melanoma|stage iv melanoma
5829811|NCT00003346|recurrent melanoma|recurrent melanoma
5829812|NCT00003341|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5829813|NCT00003341|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5848117|NCT00036426|GM-CSF|gm-csf
5829814|NCT00003341|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5829815|NCT00003341|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5829816|NCT00003341|refractory multiple myeloma|refractory multiple myeloma
5829817|NCT00003341|Waldenström macroglobulinemia|waldenström macroglobulinemia
5829818|NCT00003341|stage II multiple myeloma|stage ii multiple myeloma
5829819|NCT00003341|stage III multiple myeloma|stage iii multiple myeloma
5829820|NCT00003341|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5829821|NCT00003341|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5829822|NCT00003341|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5829823|NCT00003341|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5829824|NCT00003341|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5829825|NCT00003341|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5829826|NCT00003341|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5829827|NCT00003341|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5829828|NCT00003341|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5829829|NCT00003341|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5829830|NCT00003341|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5829831|NCT00003341|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5829832|NCT00003341|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5829833|NCT00003341|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5829834|NCT00003341|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5829835|NCT00003341|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5829836|NCT00003341|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5829907|NCT00059319|aorta clamping|aorta clamping
5829837|NCT00003341|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5829838|NCT00003341|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5829839|NCT00003341|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5829840|NCT00003341|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5829841|NCT00003341|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5829842|NCT00003341|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5829843|NCT00003341|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5829844|NCT00003341|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5829845|NCT00003341|anemia|anemia
5829846|NCT00003341|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5829847|NCT00003341|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5829848|NCT00003341|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5829849|NCT00003341|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5829850|NCT00003341|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5829851|NCT00003341|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5829852|NCT00003341|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5829853|NCT00003341|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5829854|NCT00003341|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5829855|NCT00003341|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5829856|NCT00003341|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5829857|NCT00003341|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5829858|NCT00003341|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5829859|NCT00003341|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5846988|NCT00042016|Chronic phase|chronic phase
5829860|NCT00003341|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5829861|NCT00003341|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5829862|NCT00003341|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5829863|NCT00003341|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5829864|NCT00003341|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829865|NCT00003341|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5829866|NCT00003341|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5829867|NCT00003341|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5829868|NCT00003341|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5829869|NCT00003341|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5829870|NCT00003341|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5829871|NCT00003341|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5829872|NCT00003341|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5829873|NCT00003341|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5829874|NCT00003341|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5829875|NCT00003341|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5829876|NCT00003341|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5829877|NCT00003341|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5829878|NCT00003324|tumors metastatic to brain|tumors metastatic to brain
5829879|NCT00003311|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5829880|NCT00003311|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5829881|NCT00003311|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5829882|NCT00003311|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5829883|NCT00003311|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5829884|NCT00059384|Treatment experienced|treatment experienced
5829885|NCT00059384|Therapeutic Drug Monitoring|therapeutic drug monitoring
5829886|NCT00059371|Male circumcision|male circumcision
5829887|NCT00059371|HIV acquisition|hiv acquisition
5829888|NCT00059371|Sexually transmitted infection|sexually transmitted infection
5829889|NCT00059371|HIV Seronegativity|hiv seronegativity
5829891|NCT00059358|HCV|hcv
5829892|NCT00059358|Ribavirin|ribavirin
5829893|NCT00059358|Interferon|interferon
5829894|NCT00059358|Co-infection|co-infection
5829895|NCT00059358|Treatment experienced|treatment experienced
5829896|NCT00059345|Acupuncture|acupuncture
5829897|NCT00059345|Arthritis|arthritis
5829898|NCT00059332|stroke|stroke
5829899|NCT00059332|brain attack|brain attack
5829900|NCT00059332|magnesium sulfate|magnesium sulfate
5829901|NCT00059332|neuroprotection|neuroprotection
5829902|NCT00059332|prehospital care|prehospital care
5829903|NCT00059332|emergency medical services|emergency medical services
5829904|NCT00059319|coronary artery bypass graft surgery|coronary artery bypass graft surgery
5829905|NCT00059319|CABG surgery|cabg surgery
5829906|NCT00059319|neurobehavioral impairment|neurobehavioral impairment
5829908|NCT00059319|aorta manipulation|aorta manipulation
5829909|NCT00059319|microemboli|microemboli
5829910|NCT00059306|stroke|stroke
5829911|NCT00059306|hypertension|hypertension
5829912|NCT00059306|high blood pressure|high blood pressure
5829913|NCT00059306|lacunar stroke|lacunar stroke
5829914|NCT00059306|subcortical stroke|subcortical stroke
5829915|NCT00059306|aspirin|aspirin
5829916|NCT00059306|clopidogrel|clopidogrel
5829918|NCT00058981|LADA|lada
5829919|NCT00058981|latent autoimmune diabetes in adults|latent autoimmune diabetes in adults
5829920|NCT00059280|Pompe disease|pompe disease
5829921|NCT00059280|Glycogen storage disease type II|glycogen storage disease type ii
5829922|NCT00059280|GSD-II|gsd-ii
5829923|NCT00059280|Acid maltase deficiency disease|acid maltase deficiency disease
5829924|NCT00059280|Glycogenosis 2|glycogenosis 2
5829925|NCT00059254|fatty acids|fatty acids
5829926|NCT00059254|oleic acid|oleic acid
5829927|NCT00059254|palmitic acid|palmitic acid
5829928|NCT00059254|fat oxidation|fat oxidation
5829929|NCT00059254|energy expenditure|energy expenditure
5829930|NCT00059254|body composition|body composition
5829931|NCT00059254|monounsaturated fat|monounsaturated fat
5829932|NCT00059254|human|human
5829933|NCT00059241|Early sexual initiation|early sexual initiation
5829934|NCT00059241|Prevention of early sexual activity|prevention of early sexual activity
5829935|NCT00059241|Middle childhood|middle childhood
5829936|NCT00003290|stage IIB prostate cancer|stage iib prostate cancer
5829937|NCT00003290|stage IIA prostate cancer|stage iia prostate cancer
5829938|NCT00003290|stage III prostate cancer|stage iii prostate cancer
5829939|NCT00003262|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5829940|NCT00003262|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5829941|NCT00003262|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5829942|NCT00003262|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5829943|NCT00003262|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5830511|NCT00057837|Cisplatin|cisplatin
5846989|NCT00042016|Decitabine|decitabine
5829944|NCT00003262|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5829945|NCT00003205|stage IV breast cancer|stage iv breast cancer
5829946|NCT00003205|recurrent breast cancer|recurrent breast cancer
5829947|NCT00003193|oral complications|oral complications
5829948|NCT00003193|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5830257|NCT00058695|AMD|amd
5829949|NCT00003193|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5829950|NCT00003193|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5829951|NCT00003193|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5829952|NCT00003193|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5829953|NCT00003193|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5829954|NCT00003193|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5863179|NCT00001361|Spinal Cord Injury|spinal cord injury
5837238|NCT00016081|infection|infection
5829955|NCT00003193|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5829956|NCT00003193|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5829957|NCT00003193|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5829958|NCT00003193|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5829959|NCT00003193|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5829960|NCT00003173|intraocular retinoblastoma|intraocular retinoblastoma
5829961|NCT00003173|recurrent retinoblastoma|recurrent retinoblastoma
5829962|NCT00003173|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5829963|NCT00003173|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5829964|NCT00003173|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5829965|NCT00003173|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5829966|NCT00003173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829967|NCT00003173|childhood germ cell tumor|childhood germ cell tumor
5829968|NCT00003173|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5829969|NCT00003173|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5829970|NCT00003173|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5829971|NCT00003173|extragonadal germ cell tumor|extragonadal germ cell tumor
5829972|NCT00003173|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5829973|NCT00003173|childhood teratoma|childhood teratoma
5829974|NCT00003173|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5829975|NCT00003173|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5829976|NCT00003173|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5829977|NCT00003173|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5829978|NCT00059228|Pregnancy|pregnancy
5829979|NCT00059228|Gonadal Steroids|gonadal steroids
5829980|NCT00059228|Antidepressants|antidepressants
5829981|NCT00059228|Puerperium|puerperium
5829982|NCT00059228|Depression|depression
5829985|NCT00059228|Estrogen Response Element|estrogen response element
5829986|NCT00059228|Postpartum Depression|postpartum depression
5829987|NCT00059202|Urso|urso
5829988|NCT00059202|PSC|psc
5829990|NCT00059189|Prefrontal Cortex|prefrontal cortex
5829991|NCT00059189|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5829992|NCT00059189|Inhibition|inhibition
5829993|NCT00059189|Cortical Excitability|cortical excitability
5829994|NCT00059189|Blindness|blindness
5829995|NCT00059189|Healthy Volunteer|healthy volunteer
5829996|NCT00059189|HV|hv
5829997|NCT00005839|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829998|NCT00004220|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5829999|NCT00059137|Gating|gating
5830000|NCT00059137|Respiratory Misregistration|respiratory misregistration
5830001|NCT00059137|Abdominal Belt|abdominal belt
5830002|NCT00059137|Percutaneous|percutaneous
5830003|NCT00059137|CT Guided Biopsy|ct guided biopsy
5830004|NCT00059137|Respiratory Cycle|respiratory cycle
5830005|NCT00059137|Needle Biopsy|needle biopsy
5830006|NCT00004257|stage I esophageal cancer|stage i esophageal cancer
5830007|NCT00004257|stage II esophageal cancer|stage ii esophageal cancer
5830008|NCT00004257|stage III esophageal cancer|stage iii esophageal cancer
5830009|NCT00004257|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5830010|NCT00004257|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5830011|NCT00004243|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5830012|NCT00003597|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5830013|NCT00003597|recurrent renal cell cancer|recurrent renal cell cancer
5830014|NCT00003597|recurrent neuroblastoma|recurrent neuroblastoma
5830015|NCT00003597|recurrent childhood liver cancer|recurrent childhood liver cancer
5830016|NCT00003597|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5830017|NCT00003597|recurrent retinoblastoma|recurrent retinoblastoma
5830018|NCT00003597|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5830019|NCT00003597|recurrent osteosarcoma|recurrent osteosarcoma
5830020|NCT00003597|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5830021|NCT00003597|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5830022|NCT00003597|recurrent intraocular melanoma|recurrent intraocular melanoma
5830023|NCT00003597|recurrent melanoma|recurrent melanoma
5830024|NCT00003597|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5830025|NCT00003597|childhood germ cell tumor|childhood germ cell tumor
5830026|NCT00003597|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5830027|NCT00003597|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5830028|NCT00003597|extragonadal germ cell tumor|extragonadal germ cell tumor
5837256|NCT00015938|stage IV breast cancer|stage iv breast cancer
5830029|NCT00003597|recurrent uterine sarcoma|recurrent uterine sarcoma
5830030|NCT00003597|neutropenia|neutropenia
5830031|NCT00003597|thrombocytopenia|thrombocytopenia
5830032|NCT00003597|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5830033|NCT00003597|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5830034|NCT00003597|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5830035|NCT00003597|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5830036|NCT00003597|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5830037|NCT00003597|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5830038|NCT00003597|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5830039|NCT00003163|refractory multiple myeloma|refractory multiple myeloma
5830040|NCT00003163|Waldenström macroglobulinemia|waldenström macroglobulinemia
5830041|NCT00003163|stage I multiple myeloma|stage i multiple myeloma
5830042|NCT00003163|stage II multiple myeloma|stage ii multiple myeloma
5830043|NCT00003163|stage III multiple myeloma|stage iii multiple myeloma
5830044|NCT00003163|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5830045|NCT00003163|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5830046|NCT00003163|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5830047|NCT00003163|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5830048|NCT00003163|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5830049|NCT00003163|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5830050|NCT00003163|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5830051|NCT00003163|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5830052|NCT00003163|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5830053|NCT00003163|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5830054|NCT00003163|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5830055|NCT00003163|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5830056|NCT00003163|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5830057|NCT00003163|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5830565|NCT00057707|Schizoaffective Disorder|schizoaffective disorder
5830058|NCT00003163|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5830059|NCT00003163|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5830060|NCT00003163|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5830061|NCT00003163|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5830062|NCT00003163|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5830063|NCT00003163|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5830064|NCT00003163|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5830065|NCT00003163|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5830066|NCT00003163|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5830067|NCT00003163|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5830068|NCT00003163|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5830069|NCT00003163|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5830070|NCT00003163|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5830071|NCT00003163|primary systemic amyloidosis|primary systemic amyloidosis
5830072|NCT00003163|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5830073|NCT00003163|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5830074|NCT00003163|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5830075|NCT00003163|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5830076|NCT00003163|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5830077|NCT00003163|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5830078|NCT00003163|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5830079|NCT00003163|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5830080|NCT00003163|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5830081|NCT00003163|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5830082|NCT00003163|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5830083|NCT00003163|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5830084|NCT00003163|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5830085|NCT00003163|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5830086|NCT00003163|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5830087|NCT00003163|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5830088|NCT00003163|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5830089|NCT00003163|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5686820|NCT00550472|healthy subjects|healthy subjects
5686821|NCT00550459|Hyponatremia|hyponatremia
5830090|NCT00003163|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5830091|NCT00003163|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5830092|NCT00003163|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5830093|NCT00003163|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5830094|NCT00003163|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5830095|NCT00003163|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5830096|NCT00003163|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5830097|NCT00003163|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5830098|NCT00003163|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5830099|NCT00003163|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5830100|NCT00003163|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5830101|NCT00003163|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5830102|NCT00003163|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5830103|NCT00003163|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5830104|NCT00003163|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5830105|NCT00003163|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5830106|NCT00003163|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5830107|NCT00003163|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5830108|NCT00003162|stage IV breast cancer|stage iv breast cancer
5830109|NCT00003162|recurrent breast cancer|recurrent breast cancer
5830110|NCT00003162|stage IV prostate cancer|stage iv prostate cancer
5830111|NCT00003162|recurrent prostate cancer|recurrent prostate cancer
5830112|NCT00003162|bone metastases|bone metastases
5830114|NCT00003129|stage 0 bladder cancer|stage 0 bladder cancer
5830115|NCT00003129|stage I bladder cancer|stage i bladder cancer
5830116|NCT00003129|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5830117|NCT00003124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5830118|NCT00003124|stage I prostate cancer|stage i prostate cancer
5830119|NCT00003124|stage IIB prostate cancer|stage iib prostate cancer
5830121|NCT00003124|stage III prostate cancer|stage iii prostate cancer
5830122|NCT00003064|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5830123|NCT00003064|fallopian tube cancer|fallopian tube cancer
5830124|NCT00003064|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5830125|NCT00002972|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5830126|NCT00002972|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5830127|NCT00002972|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5830128|NCT00002972|adenocarcinoma of the lung|adenocarcinoma of the lung
5830130|NCT00059046|PET Measurements|pet measurements
5830131|NCT00059046|Kinetic Analysis|kinetic analysis
5830132|NCT00059046|Test/Retest|test/retest
5830133|NCT00059046|Healthy Volunteer|healthy volunteer
5830135|NCT00059033|6-[18F]Fluorodopamine|6-[18f]fluorodopamine
5830136|NCT00059033|Autonomic Failure|autonomic failure
5830137|NCT00059033|Parkinson's Disease|parkinson's disease
5830138|NCT00059033|Multiple System Atrophy|multiple system atrophy
5830139|NCT00059033|Pure Autonomic Failure|pure autonomic failure
5830140|NCT00059033|Primary Chronic Autonomic Failure|primary chronic autonomic failure
5830142|NCT00059020|Glioma|glioma
5830143|NCT00059020|Brain Tumor|brain tumor
5830144|NCT00059020|Epidermal Growth Factor|epidermal growth factor
5830145|NCT00059020|Polymorphisms|polymorphisms
5830146|NCT00058994|AMD|amd
5830149|NCT00058994|age-related macular degeneration|age-related macular degeneration
5830150|NCT00058994|Macular Degeneration|macular degeneration
5830151|NCT00058994|Maculopathy, Age-Related|maculopathy, age-related
5830152|NCT00058994|Age-Related Maculopathies|age-related maculopathies
5830153|NCT00058994|Age-Related Maculopathy|age-related maculopathy
5830154|NCT00058994|Maculopathies, Age-Related|maculopathies, age-related
5830155|NCT00058968|neuropathy|neuropathy
5830156|NCT00058968|pain|pain
5830157|NCT00058968|diabetes|diabetes
5830158|NCT00058968|chronic pain|chronic pain
5830159|NCT00058968|persistent pain|persistent pain
5830160|NCT00058968|leg pain|leg pain
5830161|NCT00058968|peripheral neuropathy|peripheral neuropathy
5830162|NCT00058968|foot pain|foot pain
5830163|NCT00058968|painful neuropathy|painful neuropathy
5830164|NCT00058968|diabetic neuropathy|diabetic neuropathy
5830165|NCT00058955|ghb|ghb
5830166|NCT00058955|Xyrem|xyrem
5830167|NCT00058955|triazolam|triazolam
5830168|NCT00058955|pentobarbital|pentobarbital
5830169|NCT00058955|sedative|sedative
5830170|NCT00058955|abuse|abuse
5830171|NCT00058942|Drinking Water|drinking water
5830172|NCT00058903|Cholestatic|cholestatic
5830173|NCT00058903|Pruritus|pruritus
5830174|NCT00058903|Sertraline|sertraline
5863180|NCT00001361|Blood Flow|blood flow
5830175|NCT00058903|primary biliary cirrhosis|primary biliary cirrhosis
5830176|NCT00058903|hepatitis C|hepatitis c
5830177|NCT00058890|itching|itching
5830178|NCT00058890|pruritus|pruritus
5830179|NCT00058890|cholestasis|cholestasis
5830180|NCT00058890|liver disease|liver disease
5830181|NCT00058890|hepatitis|hepatitis
5830182|NCT00058890|cirrhosis|cirrhosis
5830183|NCT00002945|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5830184|NCT00002945|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5830185|NCT00002945|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5830186|NCT00002945|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5830187|NCT00002945|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5830188|NCT00002945|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5830189|NCT00002945|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5830190|NCT00002945|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5830191|NCT00002945|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5830192|NCT00002934|breast cancer in situ|breast cancer in situ
5830193|NCT00002934|ductal breast carcinoma|ductal breast carcinoma
5830194|NCT00002835|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5830195|NCT00002835|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5830196|NCT00002835|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5830197|NCT00002835|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5830198|NCT00002835|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5830199|NCT00002835|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5830200|NCT00002835|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5830201|NCT00002835|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5830202|NCT00002835|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5830203|NCT00002835|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5830204|NCT00002835|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5830205|NCT00002835|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5830206|NCT00002835|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5830207|NCT00002835|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5830208|NCT00002835|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5830209|NCT00002835|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5830210|NCT00002835|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5830211|NCT00002835|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5830212|NCT00002835|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5830213|NCT00002835|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5830214|NCT00002835|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5830215|NCT00002835|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5830216|NCT00002835|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5830217|NCT00002835|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5830218|NCT00002835|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5830219|NCT00002822|limited stage small cell lung cancer|limited stage small cell lung cancer
5830220|NCT00002822|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5830221|NCT00058851|Manual lymph drainage|manual lymph drainage
5830222|NCT00058851|Combined physiotherapy|combined physiotherapy
5830224|NCT00058825|stem cell transplant|stem cell transplant
5830225|NCT00058812|Cytotoxic T Lymphocytes|cytotoxic t lymphocytes
5830226|NCT00058812|bone marrow transplant|bone marrow transplant
5830227|NCT00058812|EBV+ lymphoproliferative disease|ebv+ lymphoproliferative disease
5830228|NCT00058773|Hodgkin disease|hodgkin disease
5830229|NCT00058773|non-Hodgkins Lymphoma|non-hodgkins lymphoma
5830230|NCT00058773|bone marrow transplant|bone marrow transplant
5830231|NCT00058760|Prevention of early sexual behavior|prevention of early sexual behavior
5830512|NCT00057837|Irinotecan|irinotecan
5830232|NCT00058760|NIA intervention|nia intervention
5830233|NCT00058747|Granulocytic Leukemia, Chronic|granulocytic leukemia, chronic
5830234|NCT00058747|Leukemia, Granulocytic, Chronic|leukemia, granulocytic, chronic
5830235|NCT00058747|Leukemia, Myelocytic, Chronic|leukemia, myelocytic, chronic
5830236|NCT00058747|Leukemia, Myelogenous, Chronic|leukemia, myelogenous, chronic
5830237|NCT00058747|Myelocytic Leukemia, Chronic|myelocytic leukemia, chronic
5830238|NCT00058747|Myelogenous Leukemia, Chronic|myelogenous leukemia, chronic
5830239|NCT00058747|Myeloid Leukemia, Chronic|myeloid leukemia, chronic
5830240|NCT00058734|Dendritic Cell|dendritic cell
5830241|NCT00058734|Immunotherapy|immunotherapy
5830242|NCT00058734|Acute HIV|acute hiv
5830243|NCT00058734|Human Immunodeficiency Virus|human immunodeficiency virus
5830244|NCT00058734|AIDS|aids
5686822|NCT00550459|Cognitive|cognitive
5830245|NCT00058734|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5830246|NCT00058734|Treatment Experienced|treatment experienced
5830247|NCT00058734|Treatment Interruption|treatment interruption
5830248|NCT00058721|Dementia|dementia
5830249|NCT00058721|Feasibility|feasibility
5830250|NCT00058721|Dopamine|dopamine
5830251|NCT00058721|Lewy Body|lewy body
5830252|NCT00058721|Parkinson Disease|parkinson disease
5830253|NCT00058721|PD|pd
5830254|NCT00058721|Healthy Volunteer|healthy volunteer
5830255|NCT00058721|HV|hv
5830256|NCT00058695|Macualar Degeneration|macualar degeneration
5830258|NCT00058695|Healthy Volunteer|healthy volunteer
5830259|NCT00058695|HV|hv
5830260|NCT00058682|Fungal Infection|fungal infection
5830261|NCT00058682|Mycoses|mycoses
5830262|NCT00058682|Candida Species|candida species
5830263|NCT00058682|Candidiasis|candidiasis
5830264|NCT00002777|stage IV breast cancer|stage iv breast cancer
5830265|NCT00002777|recurrent breast cancer|recurrent breast cancer
5830266|NCT00002701|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5830267|NCT00002701|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5830268|NCT00002695|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5830269|NCT00002695|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5830270|NCT00002695|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5830271|NCT00002695|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5830272|NCT00002695|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5830273|NCT00002695|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5830274|NCT00002695|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5830275|NCT00002695|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5830276|NCT00002695|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5830277|NCT00002695|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5830278|NCT00002695|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5830279|NCT00002695|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5830280|NCT00002695|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5830281|NCT00002695|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5830282|NCT00002695|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5830283|NCT00002695|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5830284|NCT00002695|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5830285|NCT00002695|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5830286|NCT00002695|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5830287|NCT00002695|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5830288|NCT00002695|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5830289|NCT00002695|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5830290|NCT00002695|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5830291|NCT00002695|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5830292|NCT00002695|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5830293|NCT00002693|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5830294|NCT00002693|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5830295|NCT00002693|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5830296|NCT00002693|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5830297|NCT00002693|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5830299|NCT00002669|stage IV melanoma|stage iv melanoma
5830300|NCT00002669|recurrent melanoma|recurrent melanoma
5830301|NCT00058656|Immunotherapy|immunotherapy
5830302|NCT00058656|T Cell Therapy|t cell therapy
5830303|NCT00058656|Adoptive immunotherapy|adoptive immunotherapy
5830306|NCT00002658|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5830307|NCT00002658|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5830308|NCT00002658|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5830309|NCT00002658|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5830310|NCT00002658|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5830311|NCT00002658|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5830312|NCT00002658|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5830313|NCT00002658|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5830314|NCT00002658|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5830315|NCT00002658|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5830317|NCT00002658|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5830318|NCT00002653|stage I multiple myeloma|stage i multiple myeloma
5830319|NCT00002653|stage II multiple myeloma|stage ii multiple myeloma
5830320|NCT00002653|stage III multiple myeloma|stage iii multiple myeloma
5830321|NCT00002575|stage I colon cancer|stage i colon cancer
5830322|NCT00002575|stage II colon cancer|stage ii colon cancer
5830323|NCT00002575|stage III colon cancer|stage iii colon cancer
5830324|NCT00002575|adenocarcinoma of the colon|adenocarcinoma of the colon
5830325|NCT00002550|squamous cell lung cancer|squamous cell lung cancer
5830326|NCT00002550|large cell lung cancer|large cell lung cancer
5830327|NCT00002550|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5830328|NCT00002550|adenocarcinoma of the lung|adenocarcinoma of the lung
5830329|NCT00002550|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5830330|NCT00002539|localized osteosarcoma|localized osteosarcoma
5830331|NCT00058617|EBV Positive Hodgkin's Lymphoma|ebv positive hodgkin's lymphoma
5830332|NCT00058617|EBV Positive Non-Hodgkin's Lymphoma|ebv positive non-hodgkin's lymphoma
5830333|NCT00058617|EBV Specific Cytotoxic T-Lymphocytes|ebv specific cytotoxic t-lymphocytes
5830334|NCT00058552|Advanced, refractory, or recurrent ovarian cancer|advanced, refractory, or recurrent ovarian cancer
5830335|NCT00058526|dHER2-AS15 ASCI|dher2-as15 asci
5830336|NCT00058526|Immunotherapeutic|immunotherapeutic
5830337|NCT00058526|Dose escalation|dose escalation
5830338|NCT00058526|Breast cancer|breast cancer
5830339|NCT00058487|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5830340|NCT00058487|advanced adult primary liver cancer|advanced adult primary liver cancer
5830341|NCT00058487|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5830342|NCT00058487|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5830343|NCT00058474|stage II rectal cancer|stage ii rectal cancer
5830344|NCT00058474|stage III rectal cancer|stage iii rectal cancer
5830345|NCT00058474|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5830346|NCT00058448|stage II penile cancer|stage ii penile cancer
5830347|NCT00058448|stage III penile cancer|stage iii penile cancer
5830348|NCT00058448|stage IV penile cancer|stage iv penile cancer
5830349|NCT00058435|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5830350|NCT00058435|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5830351|NCT00058435|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5830352|NCT00058435|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5830354|NCT00058435|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5830355|NCT00058422|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5830356|NCT00058422|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5830357|NCT00058422|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5830358|NCT00058396|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5830359|NCT00058396|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5830360|NCT00058396|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5830361|NCT00058396|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5830362|NCT00058396|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5830363|NCT00058396|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5830364|NCT00058396|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5830365|NCT00058396|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5830366|NCT00058396|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5830367|NCT00058396|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5830368|NCT00058396|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5830369|NCT00058370|adult medulloblastoma|adult medulloblastoma
5830370|NCT00058370|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5830371|NCT00058357|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5830372|NCT00058357|pain|pain
5830373|NCT00058318|stage IV renal cell cancer|stage iv renal cell cancer
5830374|NCT00058318|stage III renal cell cancer|stage iii renal cell cancer
5830375|NCT00058292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5830376|NCT00058292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5830377|NCT00058292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5830378|NCT00058292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5830379|NCT00058292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5830380|NCT00058292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5830381|NCT00058292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5830382|NCT00058292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5830383|NCT00058292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5830384|NCT00058292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5830385|NCT00058292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5686823|NCT00550459|Neurological Function|neurological function
5830386|NCT00058292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5830387|NCT00058292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5830388|NCT00058292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5830389|NCT00058292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5830390|NCT00058279|stage IV melanoma|stage iv melanoma
5830391|NCT00058279|extraocular extension melanoma|extraocular extension melanoma
5830392|NCT00058279|recurrent melanoma|recurrent melanoma
5830393|NCT00058279|iris melanoma|iris melanoma
5830394|NCT00058279|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5830395|NCT00058279|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5830396|NCT00058279|recurrent intraocular melanoma|recurrent intraocular melanoma
5830397|NCT00058266|stage I prostate cancer|stage i prostate cancer
5830398|NCT00058266|stage II prostate cancer|stage ii prostate cancer
5830399|NCT00058201|acinar cell adenocarcinoma of the pancreas|acinar cell adenocarcinoma of the pancreas
5830400|NCT00058201|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5830401|NCT00058201|stage I pancreatic cancer|stage i pancreatic cancer
5830402|NCT00058201|stage II pancreatic cancer|stage ii pancreatic cancer
5830403|NCT00058201|stage III pancreatic cancer|stage iii pancreatic cancer
5830404|NCT00058201|stage IV pancreatic cancer|stage iv pancreatic cancer
5830405|NCT00058188|osteoporosis|osteoporosis
5830406|NCT00058188|stage III prostate cancer|stage iii prostate cancer
5830407|NCT00058188|stage IV prostate cancer|stage iv prostate cancer
5830408|NCT00058149|stage II pancreatic cancer|stage ii pancreatic cancer
5830409|NCT00058149|stage III pancreatic cancer|stage iii pancreatic cancer
5830410|NCT00058149|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5830411|NCT00058149|stage IV pancreatic cancer|stage iv pancreatic cancer
5830412|NCT00058123|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5830413|NCT00058123|adult mixed glioma|adult mixed glioma
5830414|NCT00058123|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5830415|NCT00058123|recurrent adult brain tumor|recurrent adult brain tumor
5830416|NCT00058123|adult anaplastic ependymoma|adult anaplastic ependymoma
5830417|NCT00058071|peripheral neuropathy|peripheral neuropathy
5830418|NCT00058071|neurotoxicity|neurotoxicity
5830419|NCT00058071|hydatidiform mole|hydatidiform mole
5830420|NCT00058071|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5830421|NCT00058058|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5830422|NCT00058058|invasive ductal breast carcinoma|invasive ductal breast carcinoma
5830423|NCT00058058|invasive lobular breast carcinoma|invasive lobular breast carcinoma
5830424|NCT00058058|breast cancer in situ|breast cancer in situ
5830425|NCT00058058|stage I breast cancer|stage i breast cancer
5830426|NCT00058058|stage II breast cancer|stage ii breast cancer
5830427|NCT00058058|stage IIIA breast cancer|stage iiia breast cancer
5830428|NCT00058058|stage IIIB breast cancer|stage iiib breast cancer
5830429|NCT00058058|stage IIIC breast cancer|stage iiic breast cancer
5830430|NCT00058058|stage IV breast cancer|stage iv breast cancer
5830431|NCT00058058|Magnetic resonance imaging|magnetic resonance imaging
5830433|NCT00058045|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5830434|NCT00058032|ovarian epithelial cancer|ovarian epithelial cancer
5830435|NCT00058006|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5830436|NCT00058006|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5830437|NCT00058006|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5830438|NCT00058006|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5830439|NCT00058006|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5830440|NCT00058006|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5830441|NCT00058006|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5830442|NCT00058006|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5830443|NCT00058006|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5830444|NCT00058006|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5830445|NCT00058006|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5830446|NCT00058006|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5830706|NCT00056940|Media use|media use
5830447|NCT00058006|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5830448|NCT00058006|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5830449|NCT00058006|stage I salivary gland cancer|stage i salivary gland cancer
5830450|NCT00058006|stage II salivary gland cancer|stage ii salivary gland cancer
5830451|NCT00057993|stage IV breast cancer|stage iv breast cancer
5830452|NCT00057993|stage IIIA breast cancer|stage iiia breast cancer
5830453|NCT00057993|stage IIIB breast cancer|stage iiib breast cancer
5830454|NCT00057993|stage IIIC breast cancer|stage iiic breast cancer
5686824|NCT00550459|Elderly|elderly
5830455|NCT00057980|advanced adult primary liver cancer|advanced adult primary liver cancer
5830456|NCT00057980|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5830457|NCT00057980|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5830458|NCT00057967|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5830459|NCT00057967|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5830460|NCT00057967|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5830461|NCT00057967|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5830462|NCT00057967|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5830463|NCT00057967|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5830464|NCT00057967|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5830465|NCT00057967|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5830466|NCT00057967|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5830467|NCT00057967|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5830468|NCT00057954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5830469|NCT00057954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5830470|NCT00057954|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5830471|NCT00057954|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5830472|NCT00057954|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5830473|NCT00057954|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5830474|NCT00057954|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5830475|NCT00057954|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5830476|NCT00057954|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5830477|NCT00057954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5830478|NCT00057954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5830479|NCT00057954|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5830480|NCT00057954|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5830481|NCT00057954|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5830482|NCT00057954|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5830483|NCT00057954|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5830484|NCT00057954|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5830485|NCT00057954|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5830486|NCT00057954|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5830487|NCT00057928|recurrent cervical cancer|recurrent cervical cancer
5830488|NCT00057928|stage IVB cervical cancer|stage ivb cervical cancer
5830489|NCT00057915|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5830490|NCT00057889|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5830491|NCT00057889|stage IV renal cell cancer|stage iv renal cell cancer
5830492|NCT00057889|recurrent renal cell cancer|recurrent renal cell cancer
5830493|NCT00057876|stage III pancreatic cancer|stage iii pancreatic cancer
5830494|NCT00057876|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5830495|NCT00057850|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5830496|NCT00057850|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5830497|NCT00057850|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5830498|NCT00057850|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5830499|NCT00057850|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5830500|NCT00057850|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5830501|NCT00057850|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5830502|NCT00057850|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5830503|NCT00057850|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5830504|NCT00057850|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5830505|NCT00057850|recurrent salivary gland cancer|recurrent salivary gland cancer
5830506|NCT00057850|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5846990|NCT00042016|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5830507|NCT00057850|stage IV salivary gland cancer|stage iv salivary gland cancer
5830508|NCT00057837|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5830513|NCT00057798|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5830514|NCT00057798|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5830515|NCT00057798|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5830516|NCT00057798|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5830517|NCT00057785|oral complications of radiation therapy|oral complications of radiation therapy
5830518|NCT00057785|radiation toxicity|radiation toxicity
5830519|NCT00057785|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5830520|NCT00057785|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5830521|NCT00057785|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5830522|NCT00057785|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5830523|NCT00057759|sexual dysfunction|sexual dysfunction
5830524|NCT00057759|sexuality and reproductive issues|sexuality and reproductive issues
5830525|NCT00057759|radiation toxicity|radiation toxicity
5830526|NCT00057759|stage IIB prostate cancer|stage iib prostate cancer
5830527|NCT00057759|stage IIA prostate cancer|stage iia prostate cancer
5830528|NCT00057759|stage III prostate cancer|stage iii prostate cancer
5830529|NCT00057759|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5830530|NCT00057746|limited stage small cell lung cancer|limited stage small cell lung cancer
5830531|NCT00057733|anxiety disorder|anxiety disorder
5830532|NCT00057733|depression|depression
5830533|NCT00057733|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5830534|NCT00023673|squamous cell lung cancer|squamous cell lung cancer
5830535|NCT00023673|large cell lung cancer|large cell lung cancer
5830536|NCT00023673|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5830537|NCT00023673|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5830538|NCT00023673|adenocarcinoma of the lung|adenocarcinoma of the lung
5830539|NCT00023673|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5830540|NCT00057720|ovary|ovary
5830541|NCT00057681|Mania|mania
5830542|NCT00057655|Social Welfare|social welfare
5830543|NCT00057655|Mentally Ill Persons|mentally ill persons
5830544|NCT00057655|Mental Health Services|mental health services
5830545|NCT00057642|Hispanic Americans|hispanic americans
5830546|NCT00057629|Rape|rape
5830547|NCT00057629|Sex Offenses|sex offenses
5830548|NCT00057616|Metastatic Melanoma|metastatic melanoma
5830549|NCT00057616|Melanoma|melanoma
5830550|NCT00057616|Revimid|revimid
5830552|NCT00057564|Newly Diagnosed Multiple Myeloma|newly diagnosed multiple myeloma
5830553|NCT00057564|Multiple Myeloma|multiple myeloma
5830554|NCT00057707|Catecholamines|catecholamines
5830555|NCT00057707|Dopamine|dopamine
5830556|NCT00057707|fMRI|fmri
5830557|NCT00057707|Working Memory|working memory
5830558|NCT00057707|Clinical Trial|clinical trial
5830559|NCT00057707|Stabilization|stabilization
5830560|NCT00057707|Inpatients|inpatients
5830561|NCT00057707|Placebo|placebo
5830562|NCT00057707|Modafinil|modafinil
5830563|NCT00057707|Normal Volunteers|normal volunteers
5830564|NCT00057707|Schizophrenia|schizophrenia
5830566|NCT00057707|Healthy Volunteer|healthy volunteer
5830567|NCT00057707|HV|hv
5830568|NCT00057694|Qualitative|qualitative
5830569|NCT00057694|Telephone Interviews|telephone interviews
5830570|NCT00057694|Genetic Counseling|genetic counseling
5830571|NCT00057694|Family History|family history
5830572|NCT00057694|Health Information|health information
5830573|NCT00057694|Adult Adoptees|adult adoptees
5830574|NCT00057694|Adult Adoptee|adult adoptee
5830575|NCT00057694|Interview|interview
5830576|NCT00057538|HIV|hiv
5830577|NCT00057538|Randomized Trial|randomized trial
5830578|NCT00057538|Stress|stress
5830579|NCT00057538|Spirituality|spirituality
5830580|NCT00057538|Quality of Life|quality of life
5830581|NCT00057538|Complementary Therapies|complementary therapies
5830582|NCT00057525|Anthrax|anthrax
5830583|NCT00057499|Juvenile diabetes|juvenile diabetes
5830584|NCT00057499|Diabetes|diabetes
5830585|NCT00057499|Insulin|insulin
5830586|NCT00057499|Vaccine|vaccine
5830587|NCT00057499|Type 1 Diabetes|type 1 diabetes
5830588|NCT00057499|Diabetes Mellitus|diabetes mellitus
5830589|NCT00057486|Chronic Diarrhea|chronic diarrhea
5830590|NCT00057486|Interleukin 12|interleukin 12
5830591|NCT00057473|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5830592|NCT00057447|lymphoma|lymphoma
5830593|NCT00057434|Vitamin A|vitamin a
5830594|NCT00057421|Tuberculosis|tuberculosis
5830595|NCT00057421|HIV infection|hiv infection
5830596|NCT00057421|Prednisolone|prednisolone
5830597|NCT00057421|Safety|safety
5830598|NCT00057421|Immune activation|immune activation
5830599|NCT00057460|Antiepileptic Drug|antiepileptic drug
5830600|NCT00057460|Neuroprotection|neuroprotection
5830601|NCT00057460|Seizure Disorder|seizure disorder
5830602|NCT00057460|TMS Stimulation|tms stimulation
5830603|NCT00057460|EEG|eeg
5830604|NCT00057460|AMPA Antagonist|ampa antagonist
5830605|NCT00057460|Dosing|dosing
5830606|NCT00057460|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5830607|NCT00057460|Healthy Volunteer|healthy volunteer
5830608|NCT00057460|HV|hv
5830609|NCT00057408|Autism|autism
5830610|NCT00057408|Pervasive Developmental Disorder|pervasive developmental disorder
5830611|NCT00057408|Treatment|treatment
5830612|NCT00057408|Olanzapine|olanzapine
5830613|NCT00057408|Antipsychotic|antipsychotic
5830614|NCT00057395|Esophageal Neoplasms|esophageal neoplasms
5830615|NCT00057395|Esophagus Neoplasm|esophagus neoplasm
5830616|NCT00057395|Esophagus Cancer|esophagus cancer
5830617|NCT00057395|Esophageal Cancer|esophageal cancer
5830618|NCT00057395|Esophageal Tumors|esophageal tumors
5830619|NCT00057395|Esophagus Tumors|esophagus tumors
5830620|NCT00057395|Neoplasms, Esophageal|neoplasms, esophageal
5830621|NCT00057395|Hepatocellular Carcinoma|hepatocellular carcinoma
5830622|NCT00057395|Carcinoma, Hepatocellular|carcinoma, hepatocellular
5830623|NCT00057395|Hepatoma|hepatoma
5830624|NCT00057395|Colorectal Neoplasms|colorectal neoplasms
5830625|NCT00057395|Colorectal Cancer|colorectal cancer
5830626|NCT00057395|Colorectal Carcinoma|colorectal carcinoma
5830627|NCT00057395|Colorectal Tumor|colorectal tumor
5830628|NCT00057395|Neoplasms, Colorectal|neoplasms, colorectal
5830629|NCT00057395|Ovarian Neoplasms|ovarian neoplasms
5830630|NCT00057395|Ovary Neoplasms|ovary neoplasms
5830631|NCT00057395|Ovary Cancer|ovary cancer
5830632|NCT00057395|Ovary Carcinoma|ovary carcinoma
5830633|NCT00057395|Ovarian Cancer|ovarian cancer
5830634|NCT00057395|Ovarian Carcinoma|ovarian carcinoma
5830635|NCT00057395|Neoplasms, Ovarian|neoplasms, ovarian
5830636|NCT00057395|Pancreatic Neoplasms|pancreatic neoplasms
5830637|NCT00057395|Pancreatic Cancer|pancreatic cancer
5830638|NCT00057395|Pancreas Neoplasms|pancreas neoplasms
5830639|NCT00057395|Pancreas Cancer|pancreas cancer
5830640|NCT00057395|Neoplasms, Pancreatic|neoplasms, pancreatic
5830641|NCT00057395|Neoplasms, Pancreas|neoplasms, pancreas
5830642|NCT00057395|and other solid tumors|and other solid tumors
5830643|NCT00057382|liver cancer|liver cancer
5830644|NCT00057356|Chronic Heart Failure|chronic heart failure
5830645|NCT00057356|YM078|ym078
5830646|NCT00057291|Orphanage|orphanage
5830647|NCT00057291|Caregiving|caregiving
5830648|NCT00057291|Training|training
5830649|NCT00057291|Child development|child development
5830650|NCT00057031|myelodysplastic syndrome|myelodysplastic syndrome
5830652|NCT00057278|Gabapentin|gabapentin
5830653|NCT00057200|Home Care|home care
5830654|NCT00057252|Diagnostic Radiology|diagnostic radiology
5830655|NCT00057252|Imaging|imaging
5830656|NCT00057252|Algorithms|algorithms
5830657|NCT00057252|Healthy Volunteer|healthy volunteer
5830658|NCT00057252|HV|hv
5830659|NCT00057239|GW353162|gw353162
5830660|NCT00057239|Major Depressive Disorder|major depressive disorder
5830661|NCT00057239|MDD|mdd
5830662|NCT00057226|GW353162,|gw353162,
5830663|NCT00057226|Major depressive disorder,|major depressive disorder,
5830664|NCT00057226|flexible|flexible
5830665|NCT00057213|Major Depressive Disorder (MDD),|major depressive disorder (mdd),
5830666|NCT00057213|Flexible|flexible
5830667|NCT00057213|GW353162,|gw353162,
5830668|NCT00057174|Proton pump inhibitor|proton pump inhibitor
5847005|NCT00042003|Gleevec|gleevec
5830669|NCT00057148|massage therapy|massage therapy
5830670|NCT00057148|pain management|pain management
5830671|NCT00057148|post-surgical|post-surgical
5830672|NCT00057148|complementary therapy|complementary therapy
5830673|NCT00057135|Schizophrenia|schizophrenia
5830674|NCT00057135|Treatment Refusal|treatment refusal
5830675|NCT00057135|Drug Packaging|drug packaging
5830676|NCT00057135|Reminder Systems|reminder systems
5830677|NCT00057135|Antipsychotic Agents|antipsychotic agents
5830678|NCT00057122|Preventive therapy|preventive therapy
5830679|NCT00057083|Telemedicine|telemedicine
5830680|NCT00057083|Remote consultation|remote consultation
5830681|NCT00057083|Patient Satisfaction|patient satisfaction
5830682|NCT00057083|Physician patient relations|physician patient relations
5830683|NCT00057083|Provider satisfaction|provider satisfaction
5830684|NCT00057083|Doctor-patient relations|doctor-patient relations
5830685|NCT00057018|stroke|stroke
5830686|NCT00057018|cerebrovascular accident|cerebrovascular accident
5830687|NCT00057018|upper extremity|upper extremity
5830688|NCT00057018|physical therapy|physical therapy
5830689|NCT00057018|constraint-induced therapy|constraint-induced therapy
5830690|NCT00057005|LEUKEMIA|leukemia
5830691|NCT00056979|Metabolic diseases|metabolic diseases
5830692|NCT00056966|Acute myeloid leukemia|acute myeloid leukemia
5830693|NCT00056966|Acute lymphoblastic leukemia|acute lymphoblastic leukemia
5830694|NCT00056966|Chronic myeloid leukemia|chronic myeloid leukemia
5830695|NCT00056966|Non-Hodgkin's lymphoma|non-hodgkin's lymphoma
5830696|NCT00056966|Hodgkin's disease|hodgkin's disease
5830697|NCT00056966|Myelodysplastic syndrome|myelodysplastic syndrome
5830698|NCT00056966|Myeloproliferative disorders|myeloproliferative disorders
5830699|NCT00056966|Multiple myeloma|multiple myeloma
5830700|NCT00056966|Severe aplastic anemia|severe aplastic anemia
5830701|NCT00056953|health behavior|health behavior
5830702|NCT00056953|adolescent behavior|adolescent behavior
5830703|NCT00056953|peer mentoring|peer mentoring
5830704|NCT00056940|Prevention|prevention
5830705|NCT00056940|Parenting strategies|parenting strategies
5830708|NCT00056940|Firearm storage|firearm storage
5830709|NCT00056927|Smoking|smoking
5830710|NCT00056927|Primary Prevention|primary prevention
5853515|NCT00002128|Adenine|adenine
5830711|NCT00056927|Health Education|health education
5830712|NCT00056927|Child|child
5830713|NCT00056927|Parents|parents
5830714|NCT00056927|Parenting Education|parenting education
5830715|NCT00056927|Communication|communication
5830716|NCT00056875|graft versus host disease|graft versus host disease
5830717|NCT00056875|bone marrow transplant|bone marrow transplant
5830718|NCT00056875|alternative donor|alternative donor
5830719|NCT00056914|Magnetic Resonance Imaging|magnetic resonance imaging
5830720|NCT00056914|Functional Imaging|functional imaging
5830721|NCT00056914|Cerebral Blood Flow|cerebral blood flow
5830722|NCT00056914|Parallel Imaging|parallel imaging
5830723|NCT00056914|BOLD Effect|bold effect
5830724|NCT00056914|Spectroscopic Imaging|spectroscopic imaging
5830725|NCT00056914|Healthy Volunteer|healthy volunteer
5830727|NCT00056901|Puerperium|puerperium
5830728|NCT00056901|Pregnancy|pregnancy
5830729|NCT00056901|Mood Disorders|mood disorders
5830730|NCT00056901|Estradiol|estradiol
5830731|NCT00056901|Progesterone|progesterone
5830732|NCT00056901|Mood|mood
5830733|NCT00056901|Behavior|behavior
5830734|NCT00056901|Cognition|cognition
5830735|NCT00056901|Perimenopause|perimenopause
5830736|NCT00056901|Menopause|menopause
5830737|NCT00056901|Post Partum Depression|post partum depression
5830739|NCT00056901|Healthy Volunteer|healthy volunteer
5830741|NCT00056888|Electroencephalogram|electroencephalogram
5830742|NCT00056888|Functional (BOLD) MRI|functional (bold) mri
5830743|NCT00056888|Startle Reflex|startle reflex
5830744|NCT00056888|Electromyogram|electromyogram
5830745|NCT00056888|Psychogenic|psychogenic
5830746|NCT00056888|Paroxysmal|paroxysmal
5830747|NCT00056888|Dyskinesia|dyskinesia
5830748|NCT00056888|Kinesiogenic|kinesiogenic
5830750|NCT00056888|Movement-Related Potential|movement-related potential
5830751|NCT00056888|Movement Disorder|movement disorder
5830752|NCT00056888|Paroxysmal Hyperkinetic Movement|paroxysmal hyperkinetic movement
5830753|NCT00056888|Disorder|disorder
5830754|NCT00056888|Paroxysmal Dyskinesia|paroxysmal dyskinesia
5830755|NCT00056836|AMD|amd
5830756|NCT00056836|Neovascular age-related macular degeneration|neovascular age-related macular degeneration
5830757|NCT00056823|AMD|amd
5830758|NCT00056862|Hepatitis C Virus|hepatitis c virus
5830759|NCT00056862|Antiviral Agents|antiviral agents
5830760|NCT00056862|Hemolysis|hemolysis
5830761|NCT00056862|Neutropenia|neutropenia
5830762|NCT00056862|Cirrhosis|cirrhosis
5830763|NCT00056862|Hemolytic Anemia|hemolytic anemia
5830764|NCT00056862|Viral Hepatitis|viral hepatitis
5827149|NCT00063388|Non|non
5830766|NCT00056862|Alfa Interferon|alfa interferon
5830767|NCT00056862|Pegylated Interferon|pegylated interferon
5830768|NCT00056862|Hepatitis C|hepatitis c
5830769|NCT00056862|HCV|hcv
5830770|NCT00056849|Arthritis|arthritis
5830771|NCT00056849|Spondyloarthropathy|spondyloarthropathy
5830772|NCT00056849|Spine|spine
5830773|NCT00056849|Hereditary|hereditary
5830775|NCT00056849|Ankylosing Spondylitis|ankylosing spondylitis
5830777|NCT00056849|Spondyloarthritis|spondyloarthritis
5830778|NCT00056810|Guillain Barre Syndrome|guillain barre syndrome
5830779|NCT00056810|4-aminopyridine|4-aminopyridine
5830780|NCT00056797|HIV Therapeutic vaccine|hiv therapeutic vaccine
5830781|NCT00056797|IL-2|il-2
5830782|NCT00056797|Structured Treatment Interruption|structured treatment interruption
5830783|NCT00056797|Treatment Experienced|treatment experienced
5830784|NCT00056784|TGF-Beta|tgf-beta
5830785|NCT00056784|Kidney|kidney
5830786|NCT00056784|Transplantation|transplantation
5830787|NCT00056784|Rejection|rejection
5830788|NCT00056784|Immunosuppression|immunosuppression
5830789|NCT00056784|Kidney Transplant|kidney transplant
5830790|NCT00056784|Chronic Allograft Nephropathy|chronic allograft nephropathy
5830791|NCT00056784|CAN|can
5830792|NCT00056771|Cataract|cataract
5830793|NCT00056771|Congenital Cataracts|congenital cataracts
5830794|NCT00056771|Hereditary Cataracts|hereditary cataracts
5830795|NCT00056758|HIV-1|hiv-1
5830796|NCT00056758|HAART|haart
5830797|NCT00056758|Therapeutic immunization|therapeutic immunization
5830798|NCT00056758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5830799|NCT00056758|Treatment Experienced|treatment experienced
5830800|NCT00056745|HIV seronegativity|hiv seronegativity
5830801|NCT00056745|HIV preventive vaccine|hiv preventive vaccine
5830802|NCT00056693|Neuroendocrine tumor, advanced disease, sunitinib, Phase 2|neuroendocrine tumor, advanced disease, sunitinib, phase 2
5830803|NCT00056680|Prematurity|prematurity
5830804|NCT00056680|low birthweight|low birthweight
5830805|NCT00056680|parenting|parenting
5830806|NCT00056680|intervention|intervention
5830807|NCT00056667|Treatment|treatment
5830808|NCT00056667|Pain|pain
5830809|NCT00056667|Relaxation Response|relaxation response
5830810|NCT00056667|Cognitive Behavioral Therapy|cognitive behavioral therapy
5830811|NCT00056654|Leuprolide|leuprolide
5830812|NCT00056654|Prostatic Neoplasms|prostatic neoplasms
5830813|NCT00056654|Testosterone|testosterone
5830814|NCT00056654|Prostate-specific Antigen|prostate-specific antigen
5830815|NCT00056654|Pharmacokinetics|pharmacokinetics
5830816|NCT00056654|luprolide acetate|luprolide acetate
5830817|NCT00056719|Arthritis|arthritis
5830818|NCT00056719|Spondylarthropathy|spondylarthropathy
5830820|NCT00056719|Hereditary|hereditary
5830821|NCT00056719|Disability|disability
5830822|NCT00056719|Ankylosing Spondylitis|ankylosing spondylitis
5830823|NCT00056719|Spondyloarthropathy|spondyloarthropathy
5830824|NCT00056719|Spondyloarthritis|spondyloarthritis
5830826|NCT00056706|Motor Deficit|motor deficit
5837564|NCT00014079|colon cancer|colon cancer
5846684|NCT00043745|soy|soy
5830827|NCT00056706|Somatosensory Deficit|somatosensory deficit
5830828|NCT00056706|Cortical Reorganization|cortical reorganization
5830829|NCT00056706|Disinhibition|disinhibition
5830830|NCT00056706|Rehabilitation|rehabilitation
5830831|NCT00056706|Plasticity|plasticity
5830832|NCT00056706|Stroke|stroke
5830833|NCT00056628|Alzheimer disease|alzheimer disease
5830834|NCT00056628|Dementia|dementia
5830835|NCT00056628|Ventriculoperitoneal shunt|ventriculoperitoneal shunt
5830836|NCT00056628|Tau|tau
5830837|NCT00056628|ABeta|abeta
5830838|NCT00056602|Utility|utility
5830839|NCT00056602|Health Status|health status
5830840|NCT00056602|Preferences|preferences
5830841|NCT00056602|Response Criteria|response criteria
5830842|NCT00056602|Treatment|treatment
5830843|NCT00056602|Rheumatoid Arthritis|rheumatoid arthritis
5830844|NCT00056602|RA|ra
5830845|NCT00056576|Monotherapy|monotherapy
5830846|NCT00056576|Complex Partial Seizures|complex partial seizures
5830847|NCT00056576|Epilepsy|epilepsy
5830848|NCT00056576|anti-epilepsy drug|anti-epilepsy drug
5830849|NCT00056576|AED|aed
5830850|NCT00056563|Parkinson's disease|parkinson's disease
5830851|NCT00056563|levo-dopa|levo-dopa
5830852|NCT00056563|tremor|tremor
5830853|NCT00056563|dyskinesia|dyskinesia
5830854|NCT00056563|subthalamic nucleus|subthalamic nucleus
5830855|NCT00056563|globus pallidus|globus pallidus
5830856|NCT00056550|Antithrombin Deficiency, Congenital|antithrombin deficiency, congenital
5830857|NCT00056550|Antithrombin III Deficiency|antithrombin iii deficiency
5830858|NCT00056524|ALS|als
5830859|NCT00056524|MS|ms
5830860|NCT00056524|CNS|cns
5830861|NCT00056524|AD|ad
5830862|NCT00056524|TBI|tbi
5830863|NCT00056524|Dextromethorphan|dextromethorphan
5830864|NCT00056524|IEED|ieed
5830865|NCT00056524|Emotional|emotional
5830866|NCT00056511|Garlic|garlic
5830867|NCT00056511|Supplements|supplements
5830868|NCT00056511|Adults|adults
5830869|NCT00056511|Hypercholesterolemics|hypercholesterolemics
5830870|NCT00056511|Randomized Clinical Trial|randomized clinical trial
5830871|NCT00056485|Nursing homes|nursing homes
5830872|NCT00056485|Aging|aging
5831351|NCT00054990|HV|hv
5830873|NCT00056472|Major depressive disorder with psychotic features|major depressive disorder with psychotic features
5830874|NCT00056472|Delusional Depression|delusional depression
5830875|NCT00056472|Randomized Trial|randomized trial
5830876|NCT00056472|Combination Treatment|combination treatment
5830878|NCT00056472|Atypical Antipsychotic|atypical antipsychotic
5830879|NCT00012454|Transforming Growth Factor-Beta|transforming growth factor-beta
5830880|NCT00012454|Stroke|stroke
5830881|NCT00012454|Prevention|prevention
5830882|NCT00012454|Mucosal Tolerance|mucosal tolerance
5830883|NCT00012454|E-selectin|e-selectin
5830884|NCT00056459|Colorectal Cancer|colorectal cancer
5830885|NCT00056459|PTK787|ptk787
5830886|NCT00056459|Vatalanib|vatalanib
5830887|NCT00056459|VEGF inhibitor|vegf inhibitor
5830888|NCT00056459|Oxaliplatin|oxaliplatin
5830889|NCT00056459|Angiogenesis|angiogenesis
5830890|NCT00056459|Rectal Cancer|rectal cancer
5830891|NCT00056459|Colon Cancer|colon cancer
5830892|NCT00056459|Colorectal Carcinoma|colorectal carcinoma
5830893|NCT00056459|Colorectal Tumor|colorectal tumor
5830894|NCT00056446|Colorectal Cancer|colorectal cancer
5830895|NCT00056446|Oxaliplatin|oxaliplatin
5830896|NCT00056446|VEGF inhibitor|vegf inhibitor
5830897|NCT00056446|Vatalanib|vatalanib
5830898|NCT00056446|PTK787|ptk787
5830899|NCT00056446|Colon Cancer|colon cancer
5830900|NCT00056446|Colorectal Carcinoma|colorectal carcinoma
5830901|NCT00056446|Rectal Cancer|rectal cancer
5830902|NCT00056446|Colorectal Tumor|colorectal tumor
5830903|NCT00056433|Fetal Hemoglobin Induction|fetal hemoglobin induction
5830904|NCT00056433|L-Arginine|l-arginine
5830905|NCT00056433|Nitric Oxide Therapy|nitric oxide therapy
5830906|NCT00056433|Sickle Cell Disease|sickle cell disease
5830907|NCT00056433|Sildenafil (Viagra)|sildenafil (viagra)
5830908|NCT00056433|Sickle Cell Anemia|sickle cell anemia
5830909|NCT00056420|Tourette's Syndrome|tourette's syndrome
5830910|NCT00056420|Tic Disorder|tic disorder
5830911|NCT00056420|(EEG) Electroencephalography|(eeg) electroencephalography
5830912|NCT00056420|Event-Related Desynchronization/Synchronization|event-related desynchronization/synchronization
5830913|NCT00056420|Coherence|coherence
5830914|NCT00056420|Tourette's|tourette's
5830915|NCT00056420|Tourette Syndrome|tourette syndrome
5830916|NCT00056420|Healthy Volunteer|healthy volunteer
5830917|NCT00056420|HV|hv
5845677|NCT00050128|Frequency|frequency
5830921|NCT00056407|enlarged prostate|enlarged prostate
5830922|NCT00056407|PSA|psa
5830923|NCT00056407|prostate cancer|prostate cancer
5830924|NCT00056394|Early Rheumatoid Arthritis|early rheumatoid arthritis
5830925|NCT00056394|Coping Skills Training|coping skills training
5830926|NCT00056394|Pain|pain
5830927|NCT00056394|Physical Disability|physical disability
5830928|NCT00056394|Psychological Disability|psychological disability
5830929|NCT00056394|Daily Diary Measures|daily diary measures
5830930|NCT00056381|neutropenia|neutropenia
5830931|NCT00056381|fever|fever
5830932|NCT00056381|febrile neutropenia|febrile neutropenia
5830933|NCT00056368|Candida blood stream infections|candida blood stream infections
5830934|NCT00056368|Candida infections|candida infections
5830935|NCT00056368|Candidemia|candidemia
5830936|NCT00056368|Invasive Candidiasis|invasive candidiasis
5830937|NCT00056329|Aging Persons|aging persons
5830938|NCT00056329|Down Syndrome|down syndrome
5830939|NCT00056329|Vitamin E|vitamin e
5830940|NCT00056329|Alzheimer disease|alzheimer disease
5830941|NCT00056355|Pheresis|pheresis
5830942|NCT00056355|Cytokine|cytokine
5830943|NCT00056355|Lymphocyte|lymphocyte
5830944|NCT00056355|Remission|remission
5830945|NCT00056355|Ultraviolet A Light|ultraviolet a light
5830946|NCT00056355|Crohn's Disease|crohn's disease
5830947|NCT00056355|Crohn Disease|crohn disease
5830948|NCT00056316|Caregiving|caregiving
5830949|NCT00056316|Dementia|dementia
5830950|NCT00056316|Alzheimer's|alzheimer's
5830951|NCT00056316|Depression|depression
5830952|NCT00056316|Technology|technology
5830953|NCT00056316|Treatment|treatment
5830954|NCT00056303|Attachment|attachment
5830955|NCT00056303|Intervention|intervention
5830956|NCT00056303|Prevention|prevention
5830957|NCT00056290|Diabetes Mellitus|diabetes mellitus
5830958|NCT00056290|Neuropathy|neuropathy
5830959|NCT00056290|Peripheral Artery Disease|peripheral artery disease
5830960|NCT00056264|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5830961|NCT00056264|COPD|copd
5830962|NCT00056264|Infliximab|infliximab
5830963|NCT00056264|Remicade|remicade
5830964|NCT00056251|Interstitial Cystitis|interstitial cystitis
5830965|NCT00056251|Bladder|bladder
5830966|NCT00056238|Neurologic Diseases (General)|neurologic diseases (general)
5830967|NCT00056238|Hemorrhagic Stroke|hemorrhagic stroke
5830968|NCT00056238|Cerebral Amyloid Angiopathy|cerebral amyloid angiopathy
5830969|NCT00056238|Cerebrovascular Accident|cerebrovascular accident
5830970|NCT00056225|homocysteine|homocysteine
5830971|NCT00056173|Metastatic Renal Cell Carcinoma|metastatic renal cell carcinoma
5830972|NCT00056199|Vision Loss|vision loss
5830973|NCT00056199|Optic Nerve Tumors|optic nerve tumors
5830974|NCT00056199|Macular Edema|macular edema
5830975|NCT00056199|Von Hippel-Lindau Disease|von hippel-lindau disease
5830976|NCT00056199|VEGF|vegf
5830977|NCT00056199|EYE001|eye001
5830979|NCT00056186|Adaptation|adaptation
5830980|NCT00056186|Neurodegenerative|neurodegenerative
5830981|NCT00056186|Health Care Provider|health care provider
5830983|NCT00056186|Chronic Illness/Disability|chronic illness/disability
5830984|NCT00056186|Friedreich's Ataxia|friedreich's ataxia
5830985|NCT00056186|Friedreich Ataxia|friedreich ataxia
5830986|NCT00056186|FA|fa
5830987|NCT00056160|Multiple Myeloma|multiple myeloma
5830988|NCT00056160|Refractory and Relapsed|refractory and relapsed
5830989|NCT00056160|Revlimid|revlimid
5830990|NCT00056160|CC5013|cc5013
5830991|NCT00056147|cystic fibrosis|cystic fibrosis
5830992|NCT00056134|recurrent melanoma|recurrent melanoma
5830993|NCT00056134|stage IV melanoma|stage iv melanoma
5830994|NCT00056134|stage IIIA melanoma|stage iiia melanoma
5830995|NCT00056134|stage IIIB melanoma|stage iiib melanoma
5830996|NCT00056134|stage IIIC melanoma|stage iiic melanoma
5830999|NCT00056082|breast cancer|breast cancer
5831000|NCT00056069|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5831001|NCT00056069|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5831002|NCT00056056|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5831003|NCT00056056|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5831004|NCT00056056|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5831005|NCT00056030|liver metastases|liver metastases
5831006|NCT00056030|stage IV colon cancer|stage iv colon cancer
5831007|NCT00056030|stage IV rectal cancer|stage iv rectal cancer
5831008|NCT00056030|adenocarcinoma of the colon|adenocarcinoma of the colon
5831009|NCT00056030|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5831010|NCT00056004|non-small cell lung cancer|non-small cell lung cancer
5831011|NCT00056004|small cell lung cancer|small cell lung cancer
5831012|NCT00056004|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5831013|NCT00056004|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5845678|NCT00050128|Inhibition|inhibition
5831014|NCT00056004|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5846991|NCT00042016|Methylation|methylation
5831015|NCT00056004|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5831016|NCT00056004|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5831017|NCT00056004|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5831018|NCT00056004|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5831019|NCT00056004|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5831020|NCT00056004|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5831021|NCT00056004|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5853145|NCT00002193|VX 478|vx 478
5831022|NCT00056004|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5831023|NCT00055991|breast cancer|breast cancer
5831024|NCT00055978|non-small cell lung cancer|non-small cell lung cancer
5831025|NCT00055978|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5831026|NCT00055965|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5831027|NCT00055965|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831028|NCT00055965|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5831029|NCT00055952|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5831030|NCT00055952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5831031|NCT00055952|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5831032|NCT00055952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5831033|NCT00055952|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5831034|NCT00055952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5831035|NCT00055952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5831036|NCT00055939|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5831037|NCT00055939|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5831038|NCT00055926|recurrent breast cancer|recurrent breast cancer
5831039|NCT00055926|stage IV breast cancer|stage iv breast cancer
5831040|NCT00055926|male breast cancer|male breast cancer
5831041|NCT00055887|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831042|NCT00055887|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5831043|NCT00055887|adenocarcinoma of the lung|adenocarcinoma of the lung
5831044|NCT00055887|squamous cell lung cancer|squamous cell lung cancer
5831045|NCT00055887|large cell lung cancer|large cell lung cancer
5831046|NCT00055874|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831047|NCT00055874|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5831048|NCT00055874|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5831049|NCT00055848|adenocarcinoma of the colon|adenocarcinoma of the colon
5831050|NCT00055848|stage I colon cancer|stage i colon cancer
5831051|NCT00055848|stage II colon cancer|stage ii colon cancer
5831053|NCT00055848|stage IV colon cancer|stage iv colon cancer
5823999|NCT00070577|HV|hv
5831054|NCT00055835|recurrent bladder cancer|recurrent bladder cancer
5831055|NCT00055835|stage III bladder cancer|stage iii bladder cancer
5831056|NCT00055835|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5831057|NCT00055835|stage II bladder cancer|stage ii bladder cancer
5831058|NCT00055835|recurrent urethral cancer|recurrent urethral cancer
5831059|NCT00055835|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5831060|NCT00055835|distal urethral cancer|distal urethral cancer
5831061|NCT00055835|proximal urethral cancer|proximal urethral cancer
5831062|NCT00055835|stage IV bladder cancer|stage iv bladder cancer
5831063|NCT00055835|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5831064|NCT00055822|adenocarcinoma of the colon|adenocarcinoma of the colon
5831065|NCT00055822|recurrent colon cancer|recurrent colon cancer
5831066|NCT00055822|stage III colon cancer|stage iii colon cancer
5831067|NCT00055822|stage IV colon cancer|stage iv colon cancer
5831068|NCT00055822|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5831069|NCT00055822|recurrent rectal cancer|recurrent rectal cancer
5831070|NCT00055822|stage III rectal cancer|stage iii rectal cancer
5831071|NCT00055822|stage IV rectal cancer|stage iv rectal cancer
5831072|NCT00055783|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5831073|NCT00055731|stage III prostate cancer|stage iii prostate cancer
5831074|NCT00055731|stage IIB prostate cancer|stage iib prostate cancer
5831075|NCT00055731|stage IIA prostate cancer|stage iia prostate cancer
5831076|NCT00055718|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5831077|NCT00055718|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5831078|NCT00055705|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5831079|NCT00055705|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5831080|NCT00055705|fallopian tube cancer|fallopian tube cancer
5831081|NCT00055705|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5831082|NCT00055705|recurrent colon cancer|recurrent colon cancer
5831083|NCT00055705|stage IV colon cancer|stage iv colon cancer
5831084|NCT00055705|ovarian sarcoma|ovarian sarcoma
5831085|NCT00055705|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5831086|NCT00055705|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5831087|NCT00055705|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5831088|NCT00055705|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5831089|NCT00055705|recurrent uterine sarcoma|recurrent uterine sarcoma
5831090|NCT00055705|stage IV uterine sarcoma|stage iv uterine sarcoma
5831091|NCT00055705|ovarian stromal cancer|ovarian stromal cancer
5831092|NCT00055705|recurrent rectal cancer|recurrent rectal cancer
5831093|NCT00055705|stage IV rectal cancer|stage iv rectal cancer
5831094|NCT00055705|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5831095|NCT00055705|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5831096|NCT00055705|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5831097|NCT00055705|advanced malignant mesothelioma|advanced malignant mesothelioma
5831098|NCT00055705|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5831099|NCT00055705|recurrent gastric cancer|recurrent gastric cancer
5831100|NCT00055705|stage IV gastric cancer|stage iv gastric cancer
5831101|NCT00055705|carcinoma of the appendix|carcinoma of the appendix
5831102|NCT00055705|small intestine adenocarcinoma|small intestine adenocarcinoma
5831103|NCT00055705|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5831104|NCT00055705|small intestine lymphoma|small intestine lymphoma
5831105|NCT00055705|recurrent small intestine cancer|recurrent small intestine cancer
5831106|NCT00055705|recurrent gallbladder cancer|recurrent gallbladder cancer
5831107|NCT00055705|unresectable gallbladder cancer|unresectable gallbladder cancer
5831108|NCT00055705|advanced adult primary liver cancer|advanced adult primary liver cancer
5831109|NCT00055705|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5831110|NCT00055705|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5831111|NCT00055679|stage I breast cancer|stage i breast cancer
5831112|NCT00055666|graft versus host disease|graft versus host disease
5831113|NCT00055653|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5831114|NCT00055653|refractory anemia with excess blasts|refractory anemia with excess blasts
5831115|NCT00055653|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5831116|NCT00055653|refractory anemia|refractory anemia
5831117|NCT00055653|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5831118|NCT00055653|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5831119|NCT00055653|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831120|NCT00055653|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5831121|NCT00055653|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5831122|NCT00055653|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5831123|NCT00055653|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5831124|NCT00055653|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5831125|NCT00055653|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831127|NCT00055653|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5831128|NCT00055653|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5831129|NCT00055653|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5831130|NCT00055653|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5831131|NCT00055653|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5831132|NCT00055653|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5831133|NCT00055653|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831134|NCT00055653|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831135|NCT00055653|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831136|NCT00055653|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5831137|NCT00055653|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831138|NCT00055640|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5831139|NCT00055640|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5831140|NCT00055640|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5831141|NCT00055640|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5831142|NCT00055640|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5831143|NCT00055614|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5831144|NCT00055614|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5831145|NCT00055614|fallopian tube cancer|fallopian tube cancer
5831146|NCT00055614|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5831147|NCT00055601|stage II bladder cancer|stage ii bladder cancer
5831148|NCT00055601|stage III bladder cancer|stage iii bladder cancer
5831149|NCT00022139|stage III gastric cancer|stage iii gastric cancer
5831150|NCT00022139|stage II esophageal cancer|stage ii esophageal cancer
5831151|NCT00022139|stage III esophageal cancer|stage iii esophageal cancer
5831160|NCT00055588|Spinal Cord Injury|spinal cord injury
5831161|NCT00055588|Locomotion|locomotion
5831162|NCT00055588|Healthy Volunteer|healthy volunteer
5831163|NCT00055588|HV|hv
5831164|NCT00055575|Scopolamine|scopolamine
5831165|NCT00055575|Depression|depression
5831166|NCT00055575|fMRI|fmri
5831167|NCT00055575|Cognition|cognition
5831168|NCT00055575|Emotion|emotion
5831170|NCT00055575|Bipolar Disorder|bipolar disorder
5831171|NCT00055575|Major Depressive Disorder|major depressive disorder
5831172|NCT00055575|MDD|mdd
5831173|NCT00055575|Healthy Volunteer|healthy volunteer
5831174|NCT00055575|HV|hv
5830651|NCT00057031|MDS|mds
5831175|NCT00055562|Metastatic Melanoma|metastatic melanoma
5831176|NCT00055562|Metastatic Malignant Melanoma|metastatic malignant melanoma
5831177|NCT00055562|Revimid|revimid
5831178|NCT00055562|CC5013|cc5013
5831179|NCT00055549|Dextromethorphan|dextromethorphan
5831180|NCT00055549|Sensorimotor Modulation|sensorimotor modulation
5831181|NCT00055549|Spasmodic Dysphonia|spasmodic dysphonia
5831182|NCT00055549|Muscular Tension Dysphonia|muscular tension dysphonia
5831183|NCT00055549|Voice Tremor|voice tremor
5831184|NCT00055549|Lorazepam|lorazepam
5831185|NCT00055549|Dysphonia|dysphonia
5831186|NCT00055549|Macular Tension Dysphonia|macular tension dysphonia
5831187|NCT00055510|BO-653|bo-653
5831188|NCT00055510|Coronary restenosis|coronary restenosis
5831189|NCT00055510|Stent restenosis|stent restenosis
5831190|NCT00055510|LDL oxidative inhibitor|ldl oxidative inhibitor
5831191|NCT00055510|Antioxidant|antioxidant
5831192|NCT00055484|Migraine Headache|migraine headache
5831193|NCT00055484|prophylaxis|prophylaxis
5831194|NCT00055484|AED|aed
5831195|NCT00055484|migraine prophylaxis|migraine prophylaxis
5831196|NCT00055471|prostate cancer|prostate cancer
5831197|NCT00055471|Metastatic prostate cancer|metastatic prostate cancer
5831198|NCT00055471|bone metastases|bone metastases
5831199|NCT00055445|Complementary Therapies|complementary therapies
5831200|NCT00055445|IdB 1016|idb 1016
5831201|NCT00055445|Silybin|silybin
5831202|NCT00055445|Antioxidant|antioxidant
5831203|NCT00055445|Hepatitis C Virus|hepatitis c virus
5831204|NCT00055445|Phosphatidylcholine|phosphatidylcholine
5831205|NCT00055432|recurrent ovarian cancer|recurrent ovarian cancer
5831206|NCT00055432|platinum-resistant|platinum-resistant
5831207|NCT00055432|platinum-sensitive|platinum-sensitive
5831208|NCT00055432|folate receptor antagonist|folate receptor antagonist
5831209|NCT00055419|Stage IV colorectal cancer|stage iv colorectal cancer
5831210|NCT00055380|Molecular Targets|molecular targets
5831211|NCT00055380|Keratinocytes|keratinocytes
5831212|NCT00055380|Cell Cycle|cell cycle
5831213|NCT00055380|Small Molecule|small molecule
5831214|NCT00055380|Gene Expression|gene expression
5831215|NCT00055380|Pharmacodynamics|pharmacodynamics
5831216|NCT00055380|Surrogate Markers|surrogate markers
5831217|NCT00055380|Targeted Therapy|targeted therapy
5831218|NCT00055380|Buccal Mucosa|buccal mucosa
5831219|NCT00055380|Pharmacogenomics|pharmacogenomics
5831220|NCT00055380|Oral Mucosa|oral mucosa
5831221|NCT00055354|Acupuncture|acupuncture
5831222|NCT00055354|Medicine, Chinese Traditional|medicine, chinese traditional
5831223|NCT00055302|vaginal bleeding|vaginal bleeding
5831224|NCT00055302|advanced bone age|advanced bone age
5831225|NCT00055302|fibrous dysplasia|fibrous dysplasia
5831226|NCT00055302|MAS|mas
5847559|NCT00038818|CML|cml
5831227|NCT00055302|McCune-Albright Syndrome|mccune-albright syndrome
5831228|NCT00055263|advanced solid tumor malignancies|advanced solid tumor malignancies
5831229|NCT00055289|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5831230|NCT00055289|Counting|counting
5831231|NCT00055289|Sensorimotor Integration|sensorimotor integration
5831232|NCT00055289|Superior Temporal Cortex|superior temporal cortex
5831233|NCT00055289|Dorsal Premotor Cortex|dorsal premotor cortex
5831234|NCT00055289|Healthy Volunteer|healthy volunteer
5831235|NCT00055289|HV|hv
5831236|NCT00055237|Angiogenesis|angiogenesis
5831237|NCT00055237|Cancer|cancer
5831238|NCT00055237|HHV-8|hhv-8
5831239|NCT00055237|KSHV|kshv
5831240|NCT00055237|Skin|skin
5831241|NCT00055237|Kaposi Sarcoma|kaposi sarcoma
5831242|NCT00055237|KS|ks
5845679|NCT00050128|Pinch|pinch
5831272|NCT00055120|Anti-HIV Agents|anti-hiv agents
5831273|NCT00055120|Disease Progression|disease progression
5831274|NCT00055120|Drug Administration Schedule|drug administration schedule
5831275|NCT00055120|Viral Load|viral load
5831276|NCT00055120|HIV-1|hiv-1
5831277|NCT00055120|Treatment Outcome|treatment outcome
5831278|NCT00055120|Survival Analysis|survival analysis
5831279|NCT00055120|Treatment Naive|treatment naive
5831280|NCT00055107|Nitazoxanide|nitazoxanide
5831281|NCT00055107|Antiprotozoal Agents|antiprotozoal agents
5831282|NCT00055107|Cryptosporidiosis|cryptosporidiosis
5831283|NCT00055107|Cryptosporidium parvum|cryptosporidium parvum
5831284|NCT00055107|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5831285|NCT00055107|Pharmacokinetics|pharmacokinetics
5831286|NCT00055107|Drug Adminstration Schedule|drug adminstration schedule
5831287|NCT00055094|Immune system|immune system
5831288|NCT00055094|Helper T-Cells|helper t-cells
5831289|NCT00055094|Acute Infection|acute infection
5831290|NCT00055094|Treatment naive|treatment naive
5831291|NCT00055081|Homeless Persons|homeless persons
5831312|NCT00055042|Types 1 and 2 Diabetes|types 1 and 2 diabetes
5831313|NCT00055042|Diode Laser Photocoagulation|diode laser photocoagulation
5831314|NCT00055042|Vitamin E|vitamin e
5831315|NCT00055042|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5831331|NCT00055016|Natural History|natural history
5831332|NCT00055016|Fabry Disease|fabry disease
5831333|NCT00055003|Amygdala|amygdala
5831334|NCT00055003|Medial Prefrontal Cortex|medial prefrontal cortex
5686825|NCT00550446|Janus Kinase 3 Clinical Trial|janus kinase 3 clinical trial
5831335|NCT00055003|Orbitofrontal Cortex|orbitofrontal cortex
5831336|NCT00055003|Cortisol|cortisol
5831337|NCT00055003|Memory|memory
5831338|NCT00055003|Glucocorticoid|glucocorticoid
5831339|NCT00055003|Hydrocortisone|hydrocortisone
5831340|NCT00055003|Stress|stress
5831341|NCT00055003|Perception|perception
5831342|NCT00055003|Affect|affect
5831343|NCT00055003|Healthy Volunteer|healthy volunteer
5831344|NCT00055003|HV|hv
5831345|NCT00054990|Antiepileptic Drugs|antiepileptic drugs
5831346|NCT00054990|Cortical Excitability|cortical excitability
5831347|NCT00054990|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5831348|NCT00054990|Epilepsy|epilepsy
5831349|NCT00054990|TMS|tms
5831350|NCT00054990|Healthy Volunteer|healthy volunteer
5831355|NCT00054951|Liver Cancer|liver cancer
5831356|NCT00054938|SLE|sle
5831357|NCT00054938|Accelerated Atherosclerosis|accelerated atherosclerosis
5831358|NCT00054938|Cholesterol|cholesterol
5831359|NCT00054912|vaccine|vaccine
5831360|NCT00054912|colon|colon
5831361|NCT00054912|cancer|cancer
5831362|NCT00054912|colorectal|colorectal
5831363|NCT00054912|neoplasm|neoplasm
5831364|NCT00054912|Colonic Cancer|colonic cancer
5831365|NCT00054912|Colon Cancer|colon cancer
5831366|NCT00054912|Cancer of the Colon|cancer of the colon
5831367|NCT00054899|vaccine|vaccine
5831368|NCT00054899|lung|lung
5831369|NCT00054899|cancer|cancer
5831370|NCT00054899|Carcinoma, Large Cell|carcinoma, large cell
5831371|NCT00054899|Non-Small-Cell Lung Carcinoma|non-small-cell lung carcinoma
5831372|NCT00054873|Adenocarcinoma of the esophagus or stomach|adenocarcinoma of the esophagus or stomach
5831373|NCT00054860|HIV Preventive Vaccine|hiv preventive vaccine
5831374|NCT00054860|HIV Seronegativity|hiv seronegativity
5831375|NCT00054860|HIV-1|hiv-1
5831376|NCT00054860|AIDS Vaccines|aids vaccines
5831377|NCT00054860|Vaccines, DNA|vaccines, dna
5831378|NCT00054860|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5831379|NCT00054860|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5831380|NCT00054860|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5831381|NCT00054860|Epitopes|epitopes
5831383|NCT00054847|cardiovascular|cardiovascular
5831384|NCT00054847|chronic diseases|chronic diseases
5831385|NCT00054847|clinical trial|clinical trial
5831387|NCT00054847|multi-site trial|multi-site trial
5831388|NCT00054847|prospective|prospective
5831389|NCT00054821|Osteoarthritis, Ankle|osteoarthritis, ankle
5831391|NCT00054808|Gallium Nitrate|gallium nitrate
5831392|NCT00054808|Ganite|ganite
5831393|NCT00054808|NHL|nhl
5831394|NCT00054808|Relapsed|relapsed
5831395|NCT00054795|Brain Neoplasms/radiotherapy|brain neoplasms/radiotherapy
5831396|NCT00054795|Neoplasms/complications/prevention & control,|neoplasms/complications/prevention & control,
5831397|NCT00054795|Neuropsychological Tests,|neuropsychological tests,
5831398|NCT00054795|Metalloporphyrins/therapeutic use,|metalloporphyrins/therapeutic use,
5831399|NCT00054795|Combined Modality Therapy,|combined modality therapy,
5831400|NCT00054795|Drug therapy,|drug therapy,
5831401|NCT00054795|Quality of Life,|quality of life,
5831402|NCT00054795|Cranial Irradiation,|cranial irradiation,
5831403|NCT00054795|Radiotherapy/Targeted,|radiotherapy/targeted,
5831404|NCT00054795|Prospective Studies,|prospective studies,
5831405|NCT00054795|Neoplasm Recurrence/Local,|neoplasm recurrence/local,
5831406|NCT00054795|Treatment Outcome|treatment outcome
5831407|NCT00054795|Brain metastases|brain metastases
5831408|NCT00054795|Brain Neoplasms/secondary|brain neoplasms/secondary
5831409|NCT00054795|Non-small cell lung cancer|non-small cell lung cancer
5831410|NCT00054769|Pediatrics|pediatrics
5831411|NCT00054769|Polymerase Chain Reaction|polymerase chain reaction
5831412|NCT00054730|Fragile X Syndrome|fragile x syndrome
5831413|NCT00054730|Autism|autism
5831414|NCT00054756|Hypothalamic Releasing Factor|hypothalamic releasing factor
5831415|NCT00054756|Neuropeptide|neuropeptide
5831416|NCT00054756|Diagnostic Testing|diagnostic testing
5831417|NCT00054756|Pituitary Tumors|pituitary tumors
5831418|NCT00054756|Central Hypothyroidism|central hypothyroidism
5831419|NCT00054756|Pituitary Disorder|pituitary disorder
5831420|NCT00054756|Thyroid Disorder|thyroid disorder
5831421|NCT00054756|Healthy Volunteer|healthy volunteer
5831422|NCT00054743|Race|race
5848218|NCT00035620|Sarcoma|sarcoma
5831423|NCT00054743|Ethnicity|ethnicity
5831424|NCT00054743|Pharmacogenetics|pharmacogenetics
5831425|NCT00054743|Cytochrome P450|cytochrome p450
5831426|NCT00054743|Population Pharmacokinetics|population pharmacokinetics
5831427|NCT00054743|HIV|hiv
5831428|NCT00054704|Riluzole|riluzole
5831429|NCT00054704|Neuroprotective|neuroprotective
5831430|NCT00054704|Open-Label Study|open-label study
5831431|NCT00054704|Glutamate Dysfunction|glutamate dysfunction
5831432|NCT00054704|Bipolar Mood Disorder|bipolar mood disorder
5831433|NCT00054704|Bipolar Disorder|bipolar disorder
5831434|NCT00054704|Mood Disorder|mood disorder
5831435|NCT00054691|Skin Cancer|skin cancer
5831436|NCT00054691|Squamous Cell Carcinoma of the Skin|squamous cell carcinoma of the skin
5831437|NCT00054691|Gefitinib|gefitinib
5831438|NCT00054691|ZD1839|zd1839
5830819|NCT00056719|Spine|spine
5831439|NCT00054691|Iressa|iressa
5831440|NCT00054691|Epidermal Growth Factor Receptor|epidermal growth factor receptor
5831441|NCT00054691|EGFR|egfr
5831442|NCT00054678|Myocardial infarction|myocardial infarction
5831443|NCT00054678|Heart disease|heart disease
5831444|NCT00054678|Endoventricular|endoventricular
5831445|NCT00054678|Cardiovascular|cardiovascular
5831446|NCT00054678|Interventional|interventional
5831447|NCT00054678|ICD|icd
5831448|NCT00054678|Heart failure|heart failure
5831449|NCT00054678|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5831450|NCT00050531|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5831451|NCT00050531|CML|cml
5831452|NCT00050531|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
5831453|NCT00050531|Imatinib Mesylate|imatinib mesylate
5831455|NCT00050531|Peg-Alpha Interferon|peg-alpha interferon
5831456|NCT00050531|Peg-Intron|peg-intron
5831457|NCT00050531|Sargramostim|sargramostim
5831458|NCT00050531|GM-CSF|gm-csf
5831459|NCT00054665|BCL-2|bcl-2
5831460|NCT00054665|NFK-B|nfk-b
5831461|NCT00054665|Drug Resistance|drug resistance
5831462|NCT00054665|Translational|translational
5831463|NCT00054665|Lymphoma|lymphoma
5831464|NCT00054665|Large B-Cell Lymphoma|large b-cell lymphoma
5831465|NCT00054652|Geste Antagoniste|geste antagoniste
5831466|NCT00054652|TMS|tms
5831467|NCT00054652|Sensorimotor Integration|sensorimotor integration
5831468|NCT00054652|Writer's Cramp|writer's cramp
5831469|NCT00054652|Sensory Input|sensory input
5831470|NCT00054652|Focal Dystonia|focal dystonia
5831471|NCT00054626|stage II bladder cancer|stage ii bladder cancer
5831472|NCT00054626|stage III bladder cancer|stage iii bladder cancer
5831473|NCT00054626|stage IV bladder cancer|stage iv bladder cancer
5831474|NCT00054626|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5831475|NCT00054613|Graft-versus-Host Disease|graft-versus-host disease
5831476|NCT00054613|Extracorporeal Photopheresis|extracorporeal photopheresis
5831477|NCT00054600|Extracorporeal Photopheresis|extracorporeal photopheresis
5831478|NCT00054600|Graft-versus-Host Disease|graft-versus-host disease
5831479|NCT00054587|stage II breast cancer|stage ii breast cancer
5831480|NCT00054587|stage IIIA breast cancer|stage iiia breast cancer
5831481|NCT00054574|recurrent prostate cancer|recurrent prostate cancer
5831482|NCT00054574|stage I prostate cancer|stage i prostate cancer
5831483|NCT00054574|stage II prostate cancer|stage ii prostate cancer
5831484|NCT00054574|stage III prostate cancer|stage iii prostate cancer
5831485|NCT00054561|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5831486|NCT00054561|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5831487|NCT00054561|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5831488|NCT00054561|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5831489|NCT00054561|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5831490|NCT00054561|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5831491|NCT00054561|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5831492|NCT00054561|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5831493|NCT00054535|stage IV melanoma|stage iv melanoma
5831494|NCT00054535|recurrent melanoma|recurrent melanoma
5831495|NCT00054522|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5831496|NCT00054522|recurrent prostate cancer|recurrent prostate cancer
5831497|NCT00054496|adult glioblastoma|adult glioblastoma
5831498|NCT00054496|recurrent adult brain tumor|recurrent adult brain tumor
5831499|NCT00054496|adult giant cell glioblastoma|adult giant cell glioblastoma
5831500|NCT00054496|adult gliosarcoma|adult gliosarcoma
5831501|NCT00054470|stage IV breast cancer|stage iv breast cancer
5831502|NCT00054470|recurrent breast cancer|recurrent breast cancer
5831503|NCT00054470|male breast cancer|male breast cancer
5831504|NCT00054457|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5831505|NCT00054457|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5831506|NCT00054457|stage IV gastric cancer|stage iv gastric cancer
5831507|NCT00054457|recurrent gastric cancer|recurrent gastric cancer
5831508|NCT00054457|stage IV esophageal cancer|stage iv esophageal cancer
5831509|NCT00054457|recurrent esophageal cancer|recurrent esophageal cancer
5831510|NCT00054418|osteoporosis|osteoporosis
5831511|NCT00054418|stage I breast cancer|stage i breast cancer
5831512|NCT00054418|stage II breast cancer|stage ii breast cancer
5831513|NCT00054418|stage IIIA breast cancer|stage iiia breast cancer
5831514|NCT00054418|stage IIIB breast cancer|stage iiib breast cancer
5831515|NCT00054392|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5831516|NCT00054392|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5831517|NCT00054392|large cell lung cancer|large cell lung cancer
5831518|NCT00054392|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5831519|NCT00054392|squamous cell lung cancer|squamous cell lung cancer
5831520|NCT00054392|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831521|NCT00054392|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5831522|NCT00054392|adenocarcinoma of the lung|adenocarcinoma of the lung
5831523|NCT00054340|graft versus host disease|graft versus host disease
5831524|NCT00054340|polycythemia vera|polycythemia vera
5831525|NCT00054340|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5831526|NCT00054340|essential thrombocythemia|essential thrombocythemia
5831527|NCT00054340|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5831528|NCT00054340|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831529|NCT00054340|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831530|NCT00054340|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5831531|NCT00054340|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831532|NCT00054340|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831533|NCT00054340|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831534|NCT00054340|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5831535|NCT00054340|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5831536|NCT00054340|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831537|NCT00054340|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831538|NCT00054340|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831539|NCT00054340|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831540|NCT00054340|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831541|NCT00054340|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831542|NCT00054340|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5831543|NCT00054327|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5831544|NCT00054327|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5831545|NCT00054327|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831546|NCT00054327|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831547|NCT00054327|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5831548|NCT00054327|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5831549|NCT00054327|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5831550|NCT00054327|refractory anemia with excess blasts|refractory anemia with excess blasts
5831551|NCT00054327|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5831552|NCT00054327|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5831553|NCT00054327|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5831554|NCT00054327|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5831555|NCT00054327|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5831556|NCT00054327|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5831557|NCT00054327|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5831558|NCT00054327|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5831559|NCT00054327|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5831560|NCT00054327|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5831561|NCT00054327|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831562|NCT00054327|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5831563|NCT00054327|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5831564|NCT00054327|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5831565|NCT00054327|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5831566|NCT00054327|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5831567|NCT00054327|refractory anemia|refractory anemia
5831568|NCT00054327|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5831569|NCT00054327|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5831570|NCT00054327|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831571|NCT00054327|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831572|NCT00054327|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831573|NCT00054327|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5838400|NCT00006981|fallopian tube cancer|fallopian tube cancer
5831574|NCT00054327|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5831575|NCT00054327|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5831576|NCT00054327|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831577|NCT00054327|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5831578|NCT00054327|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831579|NCT00054327|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831580|NCT00054327|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831581|NCT00054327|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831582|NCT00054327|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831583|NCT00054327|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5831584|NCT00054314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5831585|NCT00054301|stage I breast cancer|stage i breast cancer
5831586|NCT00054301|stage II breast cancer|stage ii breast cancer
5831587|NCT00054301|stage IIIA breast cancer|stage iiia breast cancer
5831588|NCT00054301|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5831589|NCT00054301|breast cancer in situ|breast cancer in situ
5831590|NCT00054288|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5831591|NCT00054275|recurrent breast cancer|recurrent breast cancer
5831592|NCT00054275|stage IV breast cancer|stage iv breast cancer
5831593|NCT00054275|male breast cancer|male breast cancer
5831594|NCT00054262|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5831595|NCT00054262|advanced adult primary liver cancer|advanced adult primary liver cancer
5831596|NCT00054262|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5831597|NCT00054249|recurrent gastric cancer|recurrent gastric cancer
5831598|NCT00054236|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5831599|NCT00054236|refractory anemia with excess blasts|refractory anemia with excess blasts
5831600|NCT00054236|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5831601|NCT00054236|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5831602|NCT00054236|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831603|NCT00054236|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831604|NCT00054236|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5831605|NCT00054236|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5831606|NCT00054236|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5831607|NCT00054236|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5831608|NCT00054236|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5831609|NCT00054236|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5831610|NCT00054236|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5831611|NCT00054236|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5831612|NCT00054236|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5831613|NCT00054236|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5831614|NCT00054236|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5831615|NCT00054236|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831616|NCT00054236|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831617|NCT00054236|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5831618|NCT00054236|stage I multiple myeloma|stage i multiple myeloma
5831619|NCT00054236|stage II multiple myeloma|stage ii multiple myeloma
5831620|NCT00054236|stage III multiple myeloma|stage iii multiple myeloma
5831621|NCT00054236|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5831623|NCT00054236|primary myelofibrosis|primary myelofibrosis
5831624|NCT00054236|essential thrombocythemia|essential thrombocythemia
5831625|NCT00054236|refractory multiple myeloma|refractory multiple myeloma
5831626|NCT00054236|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5831627|NCT00054236|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5831628|NCT00054236|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5831629|NCT00054236|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5831630|NCT00054236|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5831631|NCT00054236|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5831632|NCT00054236|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5846664|NCT00043823|Anti-VEGF monoclonal antibody|anti-vegf monoclonal antibody
5831633|NCT00054236|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5831634|NCT00054236|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5831635|NCT00054236|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5831636|NCT00054236|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5831637|NCT00054236|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5831638|NCT00054236|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5831639|NCT00054236|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5831640|NCT00054236|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5831641|NCT00054236|Burkitt lymphoma|burkitt lymphoma
5831642|NCT00054236|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5831643|NCT00054236|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5831644|NCT00054236|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5831645|NCT00054236|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5831646|NCT00054236|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5831647|NCT00054236|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831648|NCT00054236|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5831649|NCT00054236|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5831650|NCT00054236|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5831651|NCT00054236|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5831652|NCT00054236|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5831653|NCT00054236|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5831654|NCT00054236|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831655|NCT00054236|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831656|NCT00054236|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831657|NCT00054236|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831658|NCT00054236|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831659|NCT00054236|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5845681|NCT00050089|AIDS|aids
5831660|NCT00054223|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5831661|NCT00054223|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5831662|NCT00054210|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5831663|NCT00054210|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831664|NCT00054210|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5831665|NCT00054197|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5831666|NCT00054197|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831667|NCT00054197|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5831668|NCT00054184|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5831669|NCT00054184|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5831670|NCT00054184|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5831671|NCT00054171|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5831672|NCT00054171|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5831673|NCT00054171|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5831674|NCT00054171|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5831675|NCT00054171|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5831676|NCT00054158|stage I multiple myeloma|stage i multiple myeloma
5831677|NCT00054158|stage II multiple myeloma|stage ii multiple myeloma
5846659|NCT00043823|NSCLC|nsclc
5831678|NCT00054158|stage III multiple myeloma|stage iii multiple myeloma
5831679|NCT00054145|male breast cancer|male breast cancer
5831680|NCT00054145|recurrent breast cancer|recurrent breast cancer
5831681|NCT00054145|stage IV breast cancer|stage iv breast cancer
5831682|NCT00054145|stage IIIA breast cancer|stage iiia breast cancer
5831683|NCT00054145|stage IIIB breast cancer|stage iiib breast cancer
5831684|NCT00054145|stage IIIC breast cancer|stage iiic breast cancer
5831685|NCT00054106|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5831686|NCT00054106|stage III prostate cancer|stage iii prostate cancer
5831687|NCT00054106|stage II prostate cancer|stage ii prostate cancer
5831688|NCT00054067|cervical adenocarcinoma|cervical adenocarcinoma
5831689|NCT00054067|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5831690|NCT00054067|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5831691|NCT00054067|stage IB cervical cancer|stage ib cervical cancer
5831692|NCT00054054|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5831693|NCT00054054|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5831694|NCT00054054|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5831695|NCT00054054|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5831696|NCT00054054|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5831697|NCT00054054|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5831698|NCT00054015|recurrent prostate cancer|recurrent prostate cancer
5831699|NCT00054015|stage IV prostate cancer|stage iv prostate cancer
5831700|NCT00054002|localized malignant mesothelioma|localized malignant mesothelioma
5831801|NCT00053781|recurrent melanoma|recurrent melanoma
5831701|NCT00054002|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5831702|NCT00054002|epithelial mesothelioma|epithelial mesothelioma
5831703|NCT00054002|sarcomatous mesothelioma|sarcomatous mesothelioma
5831704|NCT00053989|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5831705|NCT00053989|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5831706|NCT00053989|primary myelofibrosis|primary myelofibrosis
5831707|NCT00053989|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831708|NCT00053989|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831709|NCT00053989|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5831169|NCT00055575|Brain|brain
5831710|NCT00053989|refractory anemia with excess blasts|refractory anemia with excess blasts
5831711|NCT00053989|stage I multiple myeloma|stage i multiple myeloma
5831712|NCT00053989|stage II multiple myeloma|stage ii multiple myeloma
5831713|NCT00053989|stage III multiple myeloma|stage iii multiple myeloma
5831714|NCT00053989|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5831715|NCT00053989|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5831716|NCT00053989|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5831717|NCT00053989|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5831718|NCT00053989|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5831719|NCT00053989|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5831720|NCT00053989|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5831721|NCT00053989|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5831722|NCT00053989|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5831723|NCT00053989|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5831724|NCT00053989|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831725|NCT00053989|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5831726|NCT00053989|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5831727|NCT00053989|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5831728|NCT00053989|refractory multiple myeloma|refractory multiple myeloma
5831729|NCT00053989|refractory anemia|refractory anemia
5831730|NCT00053989|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5831731|NCT00053989|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831732|NCT00053989|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831733|NCT00053989|grade 1 follicular lymphoma|grade 1 follicular lymphoma
5831734|NCT00053989|grade 2 follicular lymphoma|grade 2 follicular lymphoma
5831735|NCT00053989|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5831736|NCT00053989|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5831737|NCT00053989|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831738|NCT00053989|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5831740|NCT00053989|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5831741|NCT00053989|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831742|NCT00053989|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5847561|NCT00038818|NHL|nhl
5831743|NCT00053989|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5831744|NCT00053989|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5831745|NCT00053989|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5831746|NCT00053989|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5831747|NCT00053989|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831748|NCT00053989|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831749|NCT00053989|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831750|NCT00053989|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831751|NCT00053989|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831752|NCT00053989|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5831753|NCT00053976|graft versus host disease|graft versus host disease
5831754|NCT00053937|plexiform neurofibroma|plexiform neurofibroma
5831755|NCT00053937|neurofibromatosis type 1|neurofibromatosis type 1
5831756|NCT00053924|recurrent pancreatic cancer|recurrent pancreatic cancer
5831757|NCT00053924|stage II pancreatic cancer|stage ii pancreatic cancer
5831758|NCT00053924|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5831759|NCT00053924|stage III pancreatic cancer|stage iii pancreatic cancer
5831760|NCT00053924|stage IV pancreatic cancer|stage iv pancreatic cancer
5831761|NCT00053911|recurrent breast cancer|recurrent breast cancer
5831762|NCT00053911|stage I breast cancer|stage i breast cancer
5831763|NCT00053911|stage II breast cancer|stage ii breast cancer
5831764|NCT00053911|stage IIIA breast cancer|stage iiia breast cancer
5831765|NCT00053898|breast cancer in situ|breast cancer in situ
5831766|NCT00053898|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5831767|NCT00053885|advanced malignant mesothelioma|advanced malignant mesothelioma
5831768|NCT00053885|epithelial mesothelioma|epithelial mesothelioma
5831769|NCT00053885|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5831770|NCT00053885|sarcomatous mesothelioma|sarcomatous mesothelioma
5831771|NCT00053872|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5831773|NCT00053846|pulmonary complications|pulmonary complications
5831774|NCT00053846|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5831775|NCT00053833|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5831776|NCT00053833|fallopian tube cancer|fallopian tube cancer
5831777|NCT00053833|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5831316|NCT00055042|Diabetes Type I|diabetes type i
5831317|NCT00055042|Diabetes Type II|diabetes type ii
5831318|NCT00055042|Diabetic Macular Edema|diabetic macular edema
5831327|NCT00055016|Lysosomal Disease|lysosomal disease
5831328|NCT00055016|Renal Function|renal function
5831329|NCT00055016|Stroke|stroke
5831330|NCT00055016|Cardiac Disease|cardiac disease
5831778|NCT00053833|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5831779|NCT00053833|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5831780|NCT00053820|stage IV renal cell cancer|stage iv renal cell cancer
5831781|NCT00053807|stage III renal cell cancer|stage iii renal cell cancer
5831782|NCT00053807|stage IV renal cell cancer|stage iv renal cell cancer
5831783|NCT00053794|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5831784|NCT00053794|adult angiosarcoma|adult angiosarcoma
5831785|NCT00053794|adult fibrosarcoma|adult fibrosarcoma
5831786|NCT00053794|adult leiomyosarcoma|adult leiomyosarcoma
5831787|NCT00053794|adult liposarcoma|adult liposarcoma
5831788|NCT00053794|adult synovial sarcoma|adult synovial sarcoma
5831789|NCT00053794|endometrial stromal sarcoma|endometrial stromal sarcoma
5831790|NCT00053794|uterine leiomyosarcoma|uterine leiomyosarcoma
5831791|NCT00053794|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5831792|NCT00053794|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5831793|NCT00053794|stage III uterine sarcoma|stage iii uterine sarcoma
5831794|NCT00053794|stage IV uterine sarcoma|stage iv uterine sarcoma
5831795|NCT00053794|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5831796|NCT00053794|recurrent uterine sarcoma|recurrent uterine sarcoma
5831797|NCT00053794|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5831798|NCT00053794|adult neurofibrosarcoma|adult neurofibrosarcoma
5831799|NCT00053794|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5831800|NCT00053794|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5831802|NCT00053781|stage IV melanoma|stage iv melanoma
5831803|NCT00053768|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5831804|NCT00053768|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5831805|NCT00053768|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5831806|NCT00053768|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5831807|NCT00053768|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5831808|NCT00053768|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5831809|NCT00053768|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5831810|NCT00053768|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5831811|NCT00053768|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5831812|NCT00053768|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5831813|NCT00053768|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5831814|NCT00053768|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5831896|NCT00053456|Nitric Oxide|nitric oxide
5831815|NCT00053768|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5831816|NCT00053768|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5828306|NCT00061165|children|children
5831817|NCT00053768|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5831818|NCT00053768|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5831819|NCT00053768|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5831820|NCT00053768|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5831821|NCT00053768|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5831822|NCT00053768|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5831823|NCT00053768|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5831824|NCT00053768|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5831825|NCT00053768|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5831826|NCT00053768|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5831827|NCT00053768|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5831828|NCT00053768|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5831829|NCT00053768|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5831830|NCT00053768|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5831831|NCT00053768|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5831832|NCT00053768|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5831833|NCT00053768|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5686826|NCT00550420|open-label extension|open-label extension
5831834|NCT00053768|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5831835|NCT00053768|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5831836|NCT00053768|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5831837|NCT00053768|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5831838|NCT00053716|Angioplasty & PGE1 Treatment of Peripheral Vascular Disease|angioplasty & pge1 treatment of peripheral vascular disease
5831839|NCT00045123|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5831840|NCT00045123|recurrent prostate cancer|recurrent prostate cancer
5831841|NCT00028678|adult glioblastoma|adult glioblastoma
5831842|NCT00028678|adult giant cell glioblastoma|adult giant cell glioblastoma
5831843|NCT00028678|adult gliosarcoma|adult gliosarcoma
5831844|NCT00017342|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831845|NCT00017342|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831846|NCT00017342|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831847|NCT00017342|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831848|NCT00017342|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831849|NCT00017342|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831851|NCT00053742|Vaccine|vaccine
5831852|NCT00053742|Vaccination|vaccination
5831853|NCT00053742|Variola|variola
5831854|NCT00053742|Adults|adults
5831855|NCT00053742|Healthy Volunteer|healthy volunteer
5831857|NCT00053742|Smallpox Vaccine|smallpox vaccine
5831858|NCT00053703|Psychotic Disorders|psychotic disorders
5831859|NCT00053703|Schizophreniform Disorder|schizophreniform disorder
5831860|NCT00053690|Comorbidity|comorbidity
5831861|NCT00053690|Schizophrenia|schizophrenia
5831862|NCT00053690|Bipolar Disorder|bipolar disorder
5831863|NCT00053690|Depression|depression
5831864|NCT00053677|Impulse Control Disorders|impulse control disorders
5831865|NCT00053638|HIV-1 Efavirenz Tenofovir|hiv-1 efavirenz tenofovir
5831866|NCT00053625|Parkinson's disease|parkinson's disease
5831867|NCT00053625|PD|pd
5831868|NCT00053625|deep brain stimulation|deep brain stimulation
5831869|NCT00053625|DBS|dbs
5831870|NCT00053612|HIV-1|hiv-1
5831871|NCT00053612|Women|women
5831872|NCT00053612|Vitamin A|vitamin a
5831873|NCT00053612|Shedding|shedding
5845888|NCT00048490|Epilepsy|epilepsy
5831874|NCT00053599|Cholesterol-lowering drug|cholesterol-lowering drug
5831875|NCT00053599|Mild to Moderate Alzheimer disease|mild to moderate alzheimer disease
5831876|NCT00053573|Glycogen Storage Disease Type II|glycogen storage disease type ii
5831877|NCT00053573|GSD-II|gsd-ii
5831878|NCT00053573|Pompe Disease|pompe disease
5831879|NCT00053560|lupus|lupus
5831880|NCT00053560|systemic lupus erythematosus|systemic lupus erythematosus
5831881|NCT00053560|SLE|sle
5831882|NCT00053560|bone loss|bone loss
5831883|NCT00053560|DHEA|dhea
5831884|NCT00053495|Smallpox|smallpox
5831885|NCT00053482|Smallpox vaccines|smallpox vaccines
5831886|NCT00053482|Dryvax®|dryvax®
5831887|NCT00053482|Orthopoxvirus|orthopoxvirus
5831888|NCT00053482|Vaccinia virus|vaccinia virus
5831889|NCT00053482|ACAM2000|acam2000
5831890|NCT00053469|Cognitive Development|cognitive development
5831891|NCT00053469|Motor Planning|motor planning
5831892|NCT00053469|Categorization|categorization
5831893|NCT00053469|Perception|perception
5831894|NCT00053469|Adaptation|adaptation
5831895|NCT00053456|Endothelium|endothelium
5831897|NCT00053456|Myocardial Ischemia|myocardial ischemia
5831898|NCT00053456|Exercise|exercise
5831899|NCT00053456|Endothelial Progenitor Cells|endothelial progenitor cells
5831900|NCT00053443|Adherence|adherence
5831902|NCT00053430|Immune Modulation|immune modulation
5831903|NCT00053430|Thalidomide|thalidomide
5831904|NCT00053430|Immune reconstitution|immune reconstitution
5831905|NCT00053430|Treatment Experienced|treatment experienced
5831906|NCT00053417|Walking Ability|walking ability
5831907|NCT00053417|Muscle strength|muscle strength
5831908|NCT00053417|Spasticity|spasticity
5831909|NCT00053404|Treatment Experienced|treatment experienced
5831910|NCT00053404|Drug Resistance|drug resistance
5831911|NCT00053391|stage III melanoma|stage iii melanoma
5831912|NCT00053391|stage IV melanoma|stage iv melanoma
5831913|NCT00053391|recurrent melanoma|recurrent melanoma
5831914|NCT00053378|hypocalcemia, ionized calcium, intensive care|hypocalcemia, ionized calcium, intensive care
5831915|NCT00053300|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5831916|NCT00053287|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5831917|NCT00053287|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5831918|NCT00053287|refractory anemia with excess blasts|refractory anemia with excess blasts
5831919|NCT00053287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831920|NCT00053287|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831921|NCT00053287|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5831922|NCT00053287|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5831923|NCT00053287|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5831924|NCT00053287|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5831925|NCT00053287|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831926|NCT00053287|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831927|NCT00053287|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5831928|NCT00053287|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5831929|NCT00053287|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5831930|NCT00053287|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831931|NCT00053287|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831932|NCT00053287|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831933|NCT00053287|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831934|NCT00053261|sexuality and reproductive issues|sexuality and reproductive issues
5831935|NCT00053261|stage IB cervical cancer|stage ib cervical cancer
5831936|NCT00053248|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831937|NCT00053248|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5831938|NCT00053222|recurrent pancreatic cancer|recurrent pancreatic cancer
5831939|NCT00053222|stage II pancreatic cancer|stage ii pancreatic cancer
5831940|NCT00053222|stage III pancreatic cancer|stage iii pancreatic cancer
5831941|NCT00053222|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5831942|NCT00053222|stage IV pancreatic cancer|stage iv pancreatic cancer
5831943|NCT00053209|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5831944|NCT00053209|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5831945|NCT00053209|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5831946|NCT00053209|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5831947|NCT00053209|recurrent bladder cancer|recurrent bladder cancer
5831948|NCT00053209|stage III bladder cancer|stage iii bladder cancer
5831949|NCT00053209|stage IV bladder cancer|stage iv bladder cancer
5831950|NCT00053209|anterior urethral cancer|anterior urethral cancer
5831951|NCT00053209|posterior urethral cancer|posterior urethral cancer
5831952|NCT00053209|recurrent urethral cancer|recurrent urethral cancer
5831953|NCT00053209|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5831954|NCT00053196|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5831955|NCT00053196|prolymphocytic leukemia|prolymphocytic leukemia
5831956|NCT00053196|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5831957|NCT00053196|stage I multiple myeloma|stage i multiple myeloma
5831958|NCT00053196|stage II multiple myeloma|stage ii multiple myeloma
5831959|NCT00053196|stage III multiple myeloma|stage iii multiple myeloma
5831960|NCT00053196|refractory multiple myeloma|refractory multiple myeloma
5831961|NCT00053196|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5831962|NCT00053196|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5831963|NCT00053196|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5831964|NCT00053196|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5831965|NCT00053196|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5831966|NCT00053196|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5831967|NCT00053196|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5831968|NCT00053196|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5831969|NCT00053196|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5831970|NCT00053196|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5831971|NCT00053196|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5831972|NCT00053196|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5831973|NCT00053196|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5831974|NCT00053196|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5831975|NCT00053196|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5831976|NCT00053196|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5831977|NCT00053196|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5831978|NCT00053196|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5831979|NCT00053196|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5831980|NCT00053196|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5831981|NCT00053196|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5831982|NCT00053196|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5831983|NCT00053196|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5831984|NCT00053196|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5846666|NCT00043823|OSI-774|osi-774
5831985|NCT00053196|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5686827|NCT00550420|tolerability|tolerability
5845680|NCT00050128|Stroke|stroke
5831986|NCT00053196|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5831987|NCT00053196|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5831988|NCT00053196|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5831989|NCT00053196|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5831990|NCT00053196|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5831991|NCT00053183|adult glioblastoma|adult glioblastoma
5831992|NCT00053183|adult giant cell glioblastoma|adult giant cell glioblastoma
5831993|NCT00053183|adult gliosarcoma|adult gliosarcoma
5831994|NCT00053157|graft versus host disease|graft versus host disease
5831995|NCT00053157|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5831996|NCT00053157|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5831997|NCT00053157|primary myelofibrosis|primary myelofibrosis
5831998|NCT00053157|childhood acute myeloid leukemia/other myeloid malignancies|childhood acute myeloid leukemia/other myeloid malignancies
5831999|NCT00053157|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5832000|NCT00053157|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5832001|NCT00053157|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5832002|NCT00053157|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5832284|NCT00052611|oropharyngeal cancer|oropharyngeal cancer
5832003|NCT00053157|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5832004|NCT00053157|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5832005|NCT00053157|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5832006|NCT00053157|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5832007|NCT00053157|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832008|NCT00053157|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832009|NCT00053157|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5832010|NCT00053157|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5832011|NCT00053157|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5832012|NCT00053157|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5832013|NCT00053157|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5832201|NCT00003830|stage I breast cancer|stage i breast cancer
5832014|NCT00053157|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5832015|NCT00053157|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5832016|NCT00053157|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5832017|NCT00053157|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5832018|NCT00053157|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5832019|NCT00053157|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5832020|NCT00053157|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832021|NCT00053157|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832022|NCT00053157|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832024|NCT00053157|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832025|NCT00053157|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832026|NCT00053157|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5832028|NCT00053157|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832029|NCT00053157|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832030|NCT00053157|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832031|NCT00053157|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832032|NCT00053157|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832033|NCT00053157|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832034|NCT00053157|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5832035|NCT00053157|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832036|NCT00053157|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5832037|NCT00053157|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5832038|NCT00053157|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5832039|NCT00053157|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5832040|NCT00053157|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5832041|NCT00053157|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5832042|NCT00053157|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5844097|NCT00050882|Diabetic gastroparesis|diabetic gastroparesis
5844099|NCT00050882|Delayed gastric emptying|delayed gastric emptying
5844100|NCT00050882|Mitemcinal|mitemcinal
5832043|NCT00053157|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832044|NCT00053157|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832045|NCT00053157|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5832046|NCT00053157|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832047|NCT00053157|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5832048|NCT00053157|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832049|NCT00053157|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832050|NCT00053157|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832051|NCT00053157|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832052|NCT00053157|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832053|NCT00053157|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832054|NCT00053157|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832055|NCT00053157|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832056|NCT00053157|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832057|NCT00053157|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832058|NCT00053157|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5832059|NCT00053157|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5832060|NCT00053157|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5832061|NCT00053157|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5832062|NCT00053157|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5832063|NCT00053157|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5832064|NCT00053157|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5832065|NCT00053157|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5832066|NCT00053157|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5832067|NCT00053157|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5832068|NCT00053157|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5832069|NCT00053157|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5832070|NCT00053157|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832071|NCT00053157|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832072|NCT00053157|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832073|NCT00053157|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832074|NCT00053157|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832075|NCT00053157|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832076|NCT00053157|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832077|NCT00053157|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832078|NCT00053157|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832079|NCT00053157|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5832080|NCT00053157|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5832081|NCT00053157|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5832082|NCT00053157|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5832083|NCT00053157|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5832084|NCT00053157|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5832085|NCT00053144|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5832086|NCT00053144|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5832087|NCT00053144|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832088|NCT00053144|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5832089|NCT00053144|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5832090|NCT00053144|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5832091|NCT00053144|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5832285|NCT00052611|nasopharyngeal cancer|nasopharyngeal cancer
5832092|NCT00053144|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5832093|NCT00053144|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5832094|NCT00053144|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5832095|NCT00053144|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5832096|NCT00053144|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5832097|NCT00053144|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5832098|NCT00053144|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5832099|NCT00053131|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5832100|NCT00053131|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5832101|NCT00053131|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5832102|NCT00053131|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5832103|NCT00053118|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5832104|NCT00053118|childhood choroid plexus tumor|childhood choroid plexus tumor
5832105|NCT00053118|childhood craniopharyngioma|childhood craniopharyngioma
5832106|NCT00053118|childhood grade I meningioma|childhood grade i meningioma
5832107|NCT00053118|childhood grade II meningioma|childhood grade ii meningioma
5832108|NCT00053118|childhood grade III meningioma|childhood grade iii meningioma
5832109|NCT00053118|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5832110|NCT00053118|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5832111|NCT00053118|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5832112|NCT00053118|recurrent childhood ependymoma|recurrent childhood ependymoma
5832113|NCT00053118|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5832114|NCT00053118|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5832115|NCT00053118|recurrent neuroblastoma|recurrent neuroblastoma
5832116|NCT00053118|recurrent retinoblastoma|recurrent retinoblastoma
5832117|NCT00053118|childhood visual pathway and hypothalamic glioma|childhood visual pathway and hypothalamic glioma
5832118|NCT00053118|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5832119|NCT00053118|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5832120|NCT00053105|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832121|NCT00053105|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832122|NCT00053105|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832123|NCT00053105|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832124|NCT00053092|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5832125|NCT00053092|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5832126|NCT00053092|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5832127|NCT00053092|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832128|NCT00053092|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832129|NCT00053053|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832130|NCT00053053|cachexia|cachexia
5832131|NCT00053053|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832132|NCT00053053|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832133|NCT00053053|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832134|NCT00053053|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832135|NCT00053053|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832136|NCT00053053|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5845889|NCT00048477|Endothelium|endothelium
5832137|NCT00053053|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832138|NCT00053053|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832139|NCT00053053|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832140|NCT00053053|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832141|NCT00053053|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832142|NCT00053053|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5832143|NCT00053053|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5832144|NCT00053053|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5832145|NCT00053053|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5832146|NCT00053053|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5832147|NCT00053053|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5832148|NCT00053053|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5832149|NCT00053053|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5832150|NCT00053053|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832151|NCT00053053|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832152|NCT00053053|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5832153|NCT00053053|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832154|NCT00053053|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832155|NCT00053053|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832156|NCT00053053|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832157|NCT00053053|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832158|NCT00053053|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5832159|NCT00053053|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832160|NCT00053053|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832161|NCT00053053|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5832162|NCT00053053|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832163|NCT00053053|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832164|NCT00053053|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832165|NCT00053053|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832166|NCT00053053|intraocular lymphoma|intraocular lymphoma
5832167|NCT00053053|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5832168|NCT00053053|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832169|NCT00053053|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5832170|NCT00053053|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5832171|NCT00053053|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832172|NCT00053053|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832173|NCT00053053|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832174|NCT00053053|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832175|NCT00053053|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832176|NCT00053053|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832177|NCT00053053|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832178|NCT00053053|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832179|NCT00053053|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832180|NCT00053040|recurrent childhood brain tumor|recurrent childhood brain tumor
5832181|NCT00053027|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5832182|NCT00053027|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5832183|NCT00053027|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5832184|NCT00053027|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832185|NCT00053027|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832186|NCT00053014|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5832187|NCT00053014|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5832188|NCT00053014|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5832189|NCT00053014|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5832190|NCT00053014|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5832191|NCT00053001|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5832192|NCT00053001|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832193|NCT00053001|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832195|NCT00053001|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5832196|NCT00053001|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5832197|NCT00053001|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5832198|NCT00041275|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5832199|NCT00041275|advanced adult primary liver cancer|advanced adult primary liver cancer
5832200|NCT00041275|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5846112|NCT00047463|sleep apnea|sleep apnea
5832202|NCT00003830|stage II breast cancer|stage ii breast cancer
5832203|NCT00052962|Appendiceal Cancer|appendiceal cancer
5832204|NCT00052962|Regional Therapy|regional therapy
5832205|NCT00052962|Carcinomatosis|carcinomatosis
5832206|NCT00052962|Hyperthermia|hyperthermia
5832207|NCT00052936|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5832208|NCT00052936|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5832209|NCT00052936|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832210|NCT00052936|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5832211|NCT00052936|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832212|NCT00052936|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5832213|NCT00052936|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5832214|NCT00052936|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5832215|NCT00052936|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5832216|NCT00052936|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5832217|NCT00052936|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5832218|NCT00052936|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5832219|NCT00052936|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5832220|NCT00052936|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832221|NCT00052936|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5832222|NCT00052936|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5846669|NCT00043810|MDS|mds
5832223|NCT00052936|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5832224|NCT00052936|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5832225|NCT00052936|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832226|NCT00052936|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5832227|NCT00052936|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5832228|NCT00052936|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5832229|NCT00052936|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832230|NCT00052936|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832231|NCT00052936|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5832232|NCT00052936|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5832233|NCT00052936|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5832234|NCT00052936|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5832235|NCT00052936|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832236|NCT00052936|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5832237|NCT00052936|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5832238|NCT00052936|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832239|NCT00052936|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832240|NCT00052936|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832241|NCT00052936|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5832242|NCT00052936|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832243|NCT00052936|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832244|NCT00052923|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832245|NCT00052910|stage I gastric cancer|stage i gastric cancer
5832246|NCT00052910|stage II gastric cancer|stage ii gastric cancer
5832247|NCT00052910|stage III gastric cancer|stage iii gastric cancer
5832248|NCT00052910|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5832249|NCT00052910|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5832250|NCT00052910|stage I esophageal cancer|stage i esophageal cancer
5832251|NCT00052910|stage II esophageal cancer|stage ii esophageal cancer
5832252|NCT00052910|stage III esophageal cancer|stage iii esophageal cancer
5832253|NCT00052897|anal cancer|anal cancer
5832254|NCT00052884|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5832255|NCT00052884|primary systemic amyloidosis|primary systemic amyloidosis
5832256|NCT00052845|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5832257|NCT00052845|recurrent prostate cancer|recurrent prostate cancer
5832258|NCT00052845|stage IV prostate cancer|stage iv prostate cancer
5832259|NCT00052832|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5832260|NCT00052832|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832261|NCT00052832|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832262|NCT00052832|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5832263|NCT00052832|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5832264|NCT00052832|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5832265|NCT00052754|adult synovial sarcoma|adult synovial sarcoma
5832266|NCT00052754|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5832267|NCT00052754|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5832268|NCT00052754|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5832269|NCT00052728|stage IV breast cancer|stage iv breast cancer
5832270|NCT00052728|recurrent breast cancer|recurrent breast cancer
5832271|NCT00052715|adult glioblastoma|adult glioblastoma
5832272|NCT00052715|adult giant cell glioblastoma|adult giant cell glioblastoma
5832274|NCT00052676|stage I breast cancer|stage i breast cancer
5832275|NCT00052676|stage II breast cancer|stage ii breast cancer
5832276|NCT00052637|bladder cancer|bladder cancer
5832277|NCT00052637|recurrent bladder cancer|recurrent bladder cancer
5832278|NCT00052637|stage 0 bladder cancer|stage 0 bladder cancer
5832279|NCT00052624|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5832280|NCT00052611|lip and oral cavity cancer|lip and oral cavity cancer
5832281|NCT00052611|paranasal sinus and nasal cavity cancer|paranasal sinus and nasal cavity cancer
5832283|NCT00052611|laryngeal cancer|laryngeal cancer
5832286|NCT00052611|salivary gland cancer|salivary gland cancer
5832287|NCT00052572|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5832288|NCT00052572|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5832289|NCT00052572|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5847563|NCT00038818|CLL|cll
5832290|NCT00052572|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832291|NCT00052572|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832292|NCT00052572|Waldenström macroglobulinemia|waldenström macroglobulinemia
5832293|NCT00052572|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832294|NCT00052572|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832295|NCT00052572|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832296|NCT00052572|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832297|NCT00052572|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832298|NCT00052572|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832299|NCT00052507|stage IV colon cancer|stage iv colon cancer
5832300|NCT00052507|stage IV rectal cancer|stage iv rectal cancer
5832301|NCT00052507|adenocarcinoma of the colon|adenocarcinoma of the colon
5832302|NCT00052507|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5832303|NCT00052507|recurrent colon cancer|recurrent colon cancer
5832304|NCT00052507|recurrent rectal cancer|recurrent rectal cancer
5832305|NCT00052494|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5832306|NCT00052494|recurrent small cell lung cancer|recurrent small cell lung cancer
5839111|NCT00006093|adult gliosarcoma|adult gliosarcoma
5832307|NCT00052481|stage IIB prostate cancer|stage iib prostate cancer
5832308|NCT00052481|stage IIA prostate cancer|stage iia prostate cancer
5832309|NCT00052481|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5832310|NCT00052468|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5832311|NCT00052468|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5832312|NCT00052468|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5832313|NCT00052468|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5832314|NCT00052468|fallopian tube cancer|fallopian tube cancer
5832315|NCT00052455|adult glioblastoma|adult glioblastoma
5832316|NCT00052455|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5832317|NCT00052455|recurrent adult brain tumor|recurrent adult brain tumor
5832318|NCT00052455|adult giant cell glioblastoma|adult giant cell glioblastoma
5832319|NCT00052455|adult gliosarcoma|adult gliosarcoma
5832320|NCT00052442|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832321|NCT00052442|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832322|NCT00052442|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832323|NCT00052442|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832324|NCT00052442|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832325|NCT00052442|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832326|NCT00052442|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832327|NCT00052442|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832328|NCT00052429|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5832329|NCT00052429|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5832330|NCT00052429|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5832331|NCT00052429|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5832332|NCT00052429|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5832333|NCT00052429|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5832334|NCT00052416|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5832335|NCT00052416|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5832336|NCT00052416|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5832337|NCT00052416|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5832338|NCT00052416|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5832339|NCT00052416|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5832340|NCT00052416|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5832341|NCT00052416|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832342|NCT00052416|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832343|NCT00052416|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5832547|NCT00049608|recurrent pancreatic cancer|recurrent pancreatic cancer
5832344|NCT00052416|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5832345|NCT00052416|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5832346|NCT00052416|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5832347|NCT00052416|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5832348|NCT00052416|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832349|NCT00052416|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832350|NCT00052416|Waldenström macroglobulinemia|waldenström macroglobulinemia
5832351|NCT00052416|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5832352|NCT00052416|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5832353|NCT00052416|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5832354|NCT00052416|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5832355|NCT00052416|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5832356|NCT00052416|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5832357|NCT00052416|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832358|NCT00052416|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832359|NCT00052416|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832360|NCT00052416|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832361|NCT00052416|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832362|NCT00052416|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832363|NCT00052416|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832364|NCT00052390|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5832365|NCT00052390|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5832366|NCT00052390|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5832367|NCT00052351|stage II breast cancer|stage ii breast cancer
5832368|NCT00052351|stage IIIA breast cancer|stage iiia breast cancer
5832369|NCT00052351|stage IIIB breast cancer|stage iiib breast cancer
5832370|NCT00052325|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5832371|NCT00052325|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5832372|NCT00052312|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5832373|NCT00052312|stage III endometrial carcinoma|stage iii endometrial carcinoma
5832374|NCT00052312|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5832375|NCT00052312|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5832376|NCT00052299|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5832377|NCT00052299|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5832378|NCT00052299|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5832379|NCT00052299|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5832380|NCT00052299|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5832381|NCT00052299|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5834600|NCT00031980|thrombocytopenia|thrombocytopenia
5832382|NCT00052299|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5832383|NCT00052299|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5832384|NCT00052299|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5832385|NCT00052299|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832386|NCT00052299|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5832387|NCT00052299|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5832388|NCT00052299|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5832389|NCT00052299|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5832390|NCT00052286|adult brain tumor|adult brain tumor
5832392|NCT00052286|cognitive/functional effects|cognitive/functional effects
5832393|NCT00052273|unspecified adult solid tumor|unspecified adult solid tumor
5832394|NCT00052273|protocol specific|protocol specific
5832395|NCT00052221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832396|NCT00052221|fatigue|fatigue
5832397|NCT00052195|Mycobacterium vaccae|mycobacterium vaccae
5832398|NCT00052195|BCG|bcg
5832399|NCT00052195|Disseminated tuberculosis|disseminated tuberculosis
5832400|NCT00052195|SRL-172|srl-172
5832401|NCT00052195|DAR-901|dar-901
5832402|NCT00052182|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5832403|NCT00052182|CTL Epitope|ctl epitope
5832404|NCT00052182|Treatment Experienced|treatment experienced
5832405|NCT00052169|metastatic breast cancer|metastatic breast cancer
5832406|NCT00052169|docetaxel|docetaxel
5832407|NCT00052169|Taxotere|taxotere
5832408|NCT00052169|ZD 1839|zd 1839
5832409|NCT00052169|gefitinib|gefitinib
5832410|NCT00052169|NSABP|nsabp
5832411|NCT00052169|advanced breast cancer|advanced breast cancer
5832412|NCT00052169|AstraZeneca|astrazeneca
5832413|NCT00049712|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5832414|NCT00049712|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5832415|NCT00049712|intraocular lymphoma|intraocular lymphoma
5832416|NCT00049712|primary central nervous system lymphoma|primary central nervous system lymphoma
5832417|NCT00049712|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832418|NCT00049712|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5828748|NCT00060671|indolent|indolent
5832419|NCT00049712|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832421|NCT00049712|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832422|NCT00049712|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832423|NCT00049712|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832424|NCT00049712|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5832425|NCT00049712|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832426|NCT00049712|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832427|NCT00049712|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832428|NCT00049712|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832429|NCT00049712|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832430|NCT00049712|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5832431|NCT00049712|small intestine lymphoma|small intestine lymphoma
5832432|NCT00049712|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832433|NCT00049712|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832434|NCT00049712|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832435|NCT00049712|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832436|NCT00049712|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5832437|NCT00049712|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832438|NCT00049712|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5832439|NCT00049712|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5832440|NCT00049712|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832441|NCT00049712|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832442|NCT00049712|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832443|NCT00049712|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832444|NCT00049712|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5832445|NCT00049712|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832446|NCT00049712|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832447|NCT00049712|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5832448|NCT00049712|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5832449|NCT00049712|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5832450|NCT00049712|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5832451|NCT00049712|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5832452|NCT00049712|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5832453|NCT00049712|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5832454|NCT00049712|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5832455|NCT00049712|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832456|NCT00049712|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832457|NCT00049712|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5832458|NCT00049712|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832459|NCT00049712|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5832460|NCT00049712|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5832461|NCT00049712|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832462|NCT00049712|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832463|NCT00049712|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832464|NCT00049712|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832465|NCT00049712|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832466|NCT00049712|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832467|NCT00049712|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832468|NCT00049712|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832469|NCT00049712|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832470|NCT00049699|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5832471|NCT00049699|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5832472|NCT00049699|intraocular lymphoma|intraocular lymphoma
5832473|NCT00049699|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5832474|NCT00049699|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832475|NCT00049699|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832476|NCT00049699|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832477|NCT00049699|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832478|NCT00049699|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832479|NCT00049699|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832480|NCT00049699|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5846460|NCT00044356|Lesion|lesion
5832481|NCT00049699|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5832482|NCT00049699|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832483|NCT00049699|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832484|NCT00049699|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832485|NCT00049699|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832486|NCT00049699|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832487|NCT00049699|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5832489|NCT00049699|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832490|NCT00049699|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832491|NCT00049699|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5846672|NCT00043810|Transplant|transplant
5832492|NCT00049699|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832493|NCT00049699|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5832494|NCT00049699|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832495|NCT00049699|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832496|NCT00049699|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5832497|NCT00049699|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5832498|NCT00049699|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832499|NCT00049699|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832500|NCT00049699|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832501|NCT00049699|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832502|NCT00049699|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5832503|NCT00049699|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832504|NCT00049699|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832505|NCT00049699|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832506|NCT00049699|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832507|NCT00049699|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832508|NCT00049699|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832509|NCT00049699|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832510|NCT00049699|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832511|NCT00049686|acute undifferentiated leukemia|acute undifferentiated leukemia
5832512|NCT00049686|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5832513|NCT00049686|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832514|NCT00049686|prolymphocytic leukemia|prolymphocytic leukemia
5832515|NCT00049686|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5832516|NCT00049686|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5832517|NCT00049686|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5832518|NCT00049686|refractory anemia with excess blasts|refractory anemia with excess blasts
5832519|NCT00049686|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5832520|NCT00049686|refractory hairy cell leukemia|refractory hairy cell leukemia
5832521|NCT00049686|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5832522|NCT00049686|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832523|NCT00049686|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832524|NCT00049686|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5832525|NCT00049686|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5832526|NCT00049673|stage I multiple myeloma|stage i multiple myeloma
5832527|NCT00049673|stage II multiple myeloma|stage ii multiple myeloma
5832528|NCT00049673|stage III multiple myeloma|stage iii multiple myeloma
5832529|NCT00049660|stage IV breast cancer|stage iv breast cancer
5832530|NCT00049634|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5832531|NCT00049634|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5832532|NCT00049634|essential thrombocythemia|essential thrombocythemia
5832533|NCT00049634|polycythemia vera|polycythemia vera
5832534|NCT00049634|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832535|NCT00049634|refractory anemia with excess blasts|refractory anemia with excess blasts
5832536|NCT00049634|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5832537|NCT00049634|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832538|NCT00049634|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832539|NCT00049634|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5832540|NCT00049634|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5832541|NCT00049634|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5832542|NCT00049634|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5832543|NCT00049608|male breast cancer|male breast cancer
5832544|NCT00049608|recurrent breast cancer|recurrent breast cancer
5832545|NCT00049608|recurrent colon cancer|recurrent colon cancer
5832548|NCT00049608|recurrent rectal cancer|recurrent rectal cancer
5832549|NCT00049608|stage III colon cancer|stage iii colon cancer
5832550|NCT00049608|stage III pancreatic cancer|stage iii pancreatic cancer
5832551|NCT00049608|stage III rectal cancer|stage iii rectal cancer
5832552|NCT00049608|stage IIIA breast cancer|stage iiia breast cancer
5832553|NCT00049608|stage IIIB breast cancer|stage iiib breast cancer
5832554|NCT00049608|stage IIIC breast cancer|stage iiic breast cancer
5832555|NCT00049608|stage IV breast cancer|stage iv breast cancer
5832556|NCT00049608|stage IV colon cancer|stage iv colon cancer
5832557|NCT00049608|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5832558|NCT00049608|stage IV rectal cancer|stage iv rectal cancer
5832559|NCT00049608|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5832560|NCT00049608|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5832561|NCT00049608|stage IV pancreatic cancer|stage iv pancreatic cancer
5832759|NCT00049335|recurrent rectal cancer|recurrent rectal cancer
5832562|NCT00049595|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5832563|NCT00049595|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5832564|NCT00049595|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5832565|NCT00049595|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5832566|NCT00049595|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5832567|NCT00049556|fallopian tube cancer|fallopian tube cancer
5832568|NCT00049556|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5832569|NCT00049556|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5832570|NCT00049556|recurrent cervical cancer|recurrent cervical cancer
5832571|NCT00049556|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5832572|NCT00049530|recurrent melanoma|recurrent melanoma
5832573|NCT00049530|stage IV melanoma|stage iv melanoma
5832574|NCT00049517|acute myeloid leukemia|acute myeloid leukemia
5832575|NCT00049517|autologous transplantation|autologous transplantation
5832576|NCT00049517|gemtuzumab ozogamicin|gemtuzumab ozogamicin
5832577|NCT00049465|depression|depression
5832579|NCT00049465|menopausal symptoms|menopausal symptoms
5832580|NCT00049465|transitional care planning|transitional care planning
5832581|NCT00049465|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5832582|NCT00049465|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5832583|NCT00049465|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5832584|NCT00049465|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5832585|NCT00049465|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5832586|NCT00049465|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5832587|NCT00049465|disseminated neuroblastoma|disseminated neuroblastoma
5832588|NCT00049465|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5832589|NCT00049465|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5832590|NCT00049465|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5832591|NCT00049465|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5832592|NCT00049465|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5832593|NCT00049465|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5832594|NCT00049465|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5832595|NCT00049465|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5832596|NCT00049465|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5832597|NCT00049465|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5832598|NCT00049465|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5832599|NCT00049465|ovarian choriocarcinoma|ovarian choriocarcinoma
5832600|NCT00049465|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5832601|NCT00049465|ovarian yolk sac tumor|ovarian yolk sac tumor
5832602|NCT00049465|ovarian immature teratoma|ovarian immature teratoma
5832603|NCT00049465|ovarian mature teratoma|ovarian mature teratoma
5832604|NCT00049465|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5832605|NCT00049465|ovarian polyembryoma|ovarian polyembryoma
5832606|NCT00049465|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5832607|NCT00049465|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5832608|NCT00049465|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5832609|NCT00049465|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5832610|NCT00049465|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5832611|NCT00049465|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832612|NCT00049465|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832613|NCT00049465|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832615|NCT00049465|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832616|NCT00049465|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832617|NCT00049465|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832618|NCT00049465|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832619|NCT00049465|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832620|NCT00049465|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832621|NCT00049465|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832622|NCT00049465|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832623|NCT00049465|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5832624|NCT00049465|recurrent neuroblastoma|recurrent neuroblastoma
5846673|NCT00043810|Peripheral Stem Cell|peripheral stem cell
5832625|NCT00049465|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5832626|NCT00049465|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5832627|NCT00049465|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5832628|NCT00049465|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5832629|NCT00049465|refractory hairy cell leukemia|refractory hairy cell leukemia
5832630|NCT00049465|refractory multiple myeloma|refractory multiple myeloma
5832631|NCT00049465|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5832632|NCT00049465|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832633|NCT00049465|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5832634|NCT00049465|stage I multiple myeloma|stage i multiple myeloma
5832635|NCT00049465|stage II multiple myeloma|stage ii multiple myeloma
5832636|NCT00049465|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5863181|NCT00001361|Blood Volume|blood volume
5832637|NCT00049465|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5832638|NCT00049465|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5832639|NCT00049465|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5832640|NCT00049465|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5832641|NCT00049465|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5832642|NCT00049465|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5832643|NCT00049465|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5832644|NCT00049465|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5832645|NCT00049465|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5832646|NCT00049465|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5832647|NCT00049465|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5832648|NCT00049465|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5832649|NCT00049465|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5832650|NCT00049465|stage IIIA breast cancer|stage iiia breast cancer
5832651|NCT00049465|stage IIIB breast cancer|stage iiib breast cancer
5832652|NCT00049465|stage IIIC breast cancer|stage iiic breast cancer
5832653|NCT00049465|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832654|NCT00049465|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832655|NCT00049465|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832656|NCT00049465|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832657|NCT00049465|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832658|NCT00049465|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832659|NCT00049465|stage IV breast cancer|stage iv breast cancer
5832660|NCT00049465|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5832661|NCT00049465|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832662|NCT00049465|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832663|NCT00049465|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832664|NCT00049465|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832665|NCT00049465|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5832666|NCT00049465|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5832667|NCT00049465|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5832668|NCT00049465|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5832669|NCT00049465|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5832670|NCT00049465|testicular choriocarcinoma|testicular choriocarcinoma
5832671|NCT00049465|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5832672|NCT00049465|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5832673|NCT00049465|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5832674|NCT00049465|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5832675|NCT00049465|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5832676|NCT00049465|testicular embryonal carcinoma|testicular embryonal carcinoma
5832678|NCT00049465|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5832679|NCT00049465|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5832680|NCT00049465|testicular yolk sac tumor|testicular yolk sac tumor
5832681|NCT00049465|stage III multiple myeloma|stage iii multiple myeloma
5832682|NCT00049465|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5832683|NCT00049465|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5832684|NCT00049465|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5832685|NCT00049465|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5832686|NCT00049465|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5832687|NCT00049465|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5832688|NCT00049465|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832689|NCT00049465|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832690|NCT00049465|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832691|NCT00049465|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5832692|NCT00049465|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832693|NCT00049465|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832760|NCT00049335|stage IV rectal cancer|stage iv rectal cancer
5832694|NCT00049465|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832695|NCT00049465|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832696|NCT00049465|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832697|NCT00049452|osteoporosis|osteoporosis
5832698|NCT00049452|stage I breast cancer|stage i breast cancer
5832699|NCT00049452|stage II breast cancer|stage ii breast cancer
5832700|NCT00049439|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5832701|NCT00049439|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5832702|NCT00049439|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5686828|NCT00550420|Alzheimer's disease|alzheimer's disease
5832703|NCT00049439|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5832704|NCT00049439|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5832705|NCT00049439|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5832706|NCT00049413|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5832707|NCT00049413|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5832708|NCT00049413|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5832709|NCT00049413|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5832710|NCT00049413|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5832711|NCT00049413|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5832712|NCT00049413|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5832713|NCT00049413|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5832714|NCT00049413|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832715|NCT00049413|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5832716|NCT00049413|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5832717|NCT00049413|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832718|NCT00049400|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832719|NCT00049400|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5832720|NCT00049400|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5832721|NCT00049400|intraocular lymphoma|intraocular lymphoma
5832722|NCT00049400|primary central nervous system lymphoma|primary central nervous system lymphoma
5832723|NCT00049400|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832724|NCT00049400|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5832725|NCT00049400|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832726|NCT00049400|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5832727|NCT00049400|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5832728|NCT00049400|recurrent grade 1, 2, or 3 follicular lymphoma|recurrent grade 1, 2, or 3 follicular lymphoma
5832729|NCT00049400|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832730|NCT00049400|small intestine lymphoma|small intestine lymphoma
5832731|NCT00049400|stage IV adult diffuse large cell or mixed cell lymphoma|stage iv adult diffuse large cell or mixed cell lymphoma
5832732|NCT00049400|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832733|NCT00049400|stage IV adult Burkitt lymphoma or Hodgkin lymphoma|stage iv adult burkitt lymphoma or hodgkin lymphoma
5832734|NCT00049400|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5832735|NCT00049400|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832736|NCT00049400|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5832737|NCT00049400|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5832738|NCT00049400|stage IV grade 1, 2, or 3 follicular lymphoma|stage iv grade 1, 2, or 3 follicular lymphoma
5832739|NCT00049400|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832740|NCT00049400|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832741|NCT00049400|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832742|NCT00049400|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832743|NCT00049400|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832744|NCT00049400|extranodal marginal zone B-cell lymphoma of MALT|extranodal marginal zone b-cell lymphoma of malt
5832745|NCT00049400|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832746|NCT00049400|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832747|NCT00049400|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832748|NCT00049400|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832749|NCT00049400|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832750|NCT00049400|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832751|NCT00049374|refractory multiple myeloma|refractory multiple myeloma
5832752|NCT00049361|adult tumors metastatic to brain|adult tumors metastatic to brain
5832753|NCT00049361|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832754|NCT00049348|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5832755|NCT00049348|stage II pancreatic cancer|stage ii pancreatic cancer
5832756|NCT00049348|stage III pancreatic cancer|stage iii pancreatic cancer
5832757|NCT00049335|recurrent colon cancer|recurrent colon cancer
5832758|NCT00049335|stage IV colon cancer|stage iv colon cancer
5832761|NCT00049322|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5832762|NCT00049322|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5832763|NCT00049322|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5832764|NCT00049309|stage I prostate cancer|stage i prostate cancer
5832765|NCT00049309|stage IIB prostate cancer|stage iib prostate cancer
5832766|NCT00049309|stage IIA prostate cancer|stage iia prostate cancer
5832767|NCT00049309|stage III prostate cancer|stage iii prostate cancer
5832768|NCT00049296|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5832769|NCT00049296|male breast cancer|male breast cancer
5832770|NCT00049296|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5832771|NCT00049296|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5832772|NCT00049296|adult brain stem glioma|adult brain stem glioma
5832773|NCT00049296|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5832774|NCT00049296|adult choroid plexus tumor|adult choroid plexus tumor
5832775|NCT00049296|adult craniopharyngioma|adult craniopharyngioma
5832776|NCT00049296|adult ependymoblastoma|adult ependymoblastoma
5832777|NCT00049296|adult glioblastoma|adult glioblastoma
5832778|NCT00049296|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5832779|NCT00049296|adult anaplastic ependymoma|adult anaplastic ependymoma
5832780|NCT00049296|adult medulloblastoma|adult medulloblastoma
5832781|NCT00049296|adult meningioma|adult meningioma
5832782|NCT00049296|adult pineoblastoma|adult pineoblastoma
5832783|NCT00049296|adult pineocytoma|adult pineocytoma
5832784|NCT00049296|adult subependymoma|adult subependymoma
5832785|NCT00049296|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5832786|NCT00049296|advanced adult primary liver cancer|advanced adult primary liver cancer
5832787|NCT00049296|anterior urethral cancer|anterior urethral cancer
5832788|NCT00049296|carcinoma of the appendix|carcinoma of the appendix
5832789|NCT00049296|chondrosarcoma|chondrosarcoma
5832790|NCT00049296|classic Kaposi sarcoma|classic kaposi sarcoma
5832791|NCT00049296|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5832792|NCT00049296|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5832793|NCT00049296|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5832794|NCT00049296|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5832795|NCT00049296|disseminated neuroblastoma|disseminated neuroblastoma
5832796|NCT00049296|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5832797|NCT00049296|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5832798|NCT00049296|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5832799|NCT00049296|metastatic osteosarcoma|metastatic osteosarcoma
5832800|NCT00049296|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5832801|NCT00049296|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5832802|NCT00049296|adult mixed glioma|adult mixed glioma
5832803|NCT00049296|ovarian sarcoma|ovarian sarcoma
5832804|NCT00049296|posterior urethral cancer|posterior urethral cancer
5832805|NCT00049296|primary central nervous system lymphoma|primary central nervous system lymphoma
5832806|NCT00049296|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5832807|NCT00049296|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5832808|NCT00049296|recurrent adult brain tumor|recurrent adult brain tumor
5832809|NCT00049296|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5832810|NCT00049296|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5832811|NCT00049296|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5832812|NCT00049296|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832813|NCT00049296|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5832814|NCT00049296|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5832815|NCT00049296|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5832816|NCT00049296|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5832818|NCT00049296|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5832819|NCT00049296|recurrent bladder cancer|recurrent bladder cancer
5832820|NCT00049296|recurrent breast cancer|recurrent breast cancer
5832822|NCT00049296|recurrent esophageal cancer|recurrent esophageal cancer
5832823|NCT00049296|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5832824|NCT00049296|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5832825|NCT00049296|recurrent gallbladder cancer|recurrent gallbladder cancer
5845372|NCT00001296|TNF|tnf
5832826|NCT00049296|recurrent gastric cancer|recurrent gastric cancer
5832827|NCT00049296|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5832828|NCT00049296|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5832829|NCT00049296|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5832830|NCT00049296|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5832831|NCT00049296|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5832832|NCT00049296|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5834807|NCT00030758|stage II breast cancer|stage ii breast cancer
5832833|NCT00049296|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5832834|NCT00049296|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5832835|NCT00049296|recurrent melanoma|recurrent melanoma
5832836|NCT00049296|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5832837|NCT00049296|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5844846|NCT00001617|Aging|aging
5832838|NCT00049296|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5832839|NCT00049296|recurrent neuroblastoma|recurrent neuroblastoma
5832840|NCT00049296|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5832841|NCT00049296|recurrent osteosarcoma|recurrent osteosarcoma
5832842|NCT00049296|recurrent pancreatic cancer|recurrent pancreatic cancer
5832843|NCT00049296|recurrent rectal cancer|recurrent rectal cancer
5832844|NCT00049296|recurrent renal cell cancer|recurrent renal cell cancer
5832845|NCT00049296|recurrent small cell lung cancer|recurrent small cell lung cancer
5832846|NCT00049296|recurrent small intestine cancer|recurrent small intestine cancer
5832847|NCT00049296|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5832848|NCT00049296|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5832849|NCT00049296|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5832850|NCT00049296|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5832851|NCT00049296|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5832852|NCT00049296|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5832853|NCT00049296|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5832854|NCT00049296|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5832855|NCT00049296|recurrent urethral cancer|recurrent urethral cancer
5832856|NCT00049296|recurrent uterine sarcoma|recurrent uterine sarcoma
5832857|NCT00049296|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5832858|NCT00049296|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5832859|NCT00049296|refractory multiple myeloma|refractory multiple myeloma
5832860|NCT00049296|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5832861|NCT00049296|small intestine adenocarcinoma|small intestine adenocarcinoma
5832862|NCT00049296|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5832863|NCT00049296|small intestine lymphoma|small intestine lymphoma
5832864|NCT00049296|stage II esophageal cancer|stage ii esophageal cancer
5832865|NCT00049296|stage II pancreatic cancer|stage ii pancreatic cancer
5832866|NCT00049296|stage III esophageal cancer|stage iii esophageal cancer
5834806|NCT00030758|stage I breast cancer|stage i breast cancer
5832867|NCT00049296|stage III multiple myeloma|stage iii multiple myeloma
5832868|NCT00049296|stage III pancreatic cancer|stage iii pancreatic cancer
5832869|NCT00049296|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5832870|NCT00049296|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5832871|NCT00049296|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5832872|NCT00049296|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5832873|NCT00049296|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5832874|NCT00049296|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5830304|NCT00058656|Xcellerate|xcellerate
5832877|NCT00049296|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5832878|NCT00049296|stage IV bladder cancer|stage iv bladder cancer
5832879|NCT00049296|stage IV breast cancer|stage iv breast cancer
5832880|NCT00049296|stage IV colon cancer|stage iv colon cancer
5832881|NCT00049296|stage IV esophageal cancer|stage iv esophageal cancer
5832882|NCT00049296|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5832883|NCT00049296|stage IV gastric cancer|stage iv gastric cancer
5832884|NCT00049296|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5832885|NCT00049296|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5832886|NCT00049296|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5832887|NCT00049296|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5832888|NCT00049296|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5832889|NCT00049296|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5832890|NCT00049296|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5832891|NCT00049296|stage IV melanoma|stage iv melanoma
5832892|NCT00049296|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5832893|NCT00049296|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5832894|NCT00049296|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5832895|NCT00049296|stage IV rectal cancer|stage iv rectal cancer
5832896|NCT00049296|stage IV renal cell cancer|stage iv renal cell cancer
5832897|NCT00049296|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5832898|NCT00049296|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5832899|NCT00049296|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5832900|NCT00049296|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5832901|NCT00049296|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5832902|NCT00049296|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5832903|NCT00049296|stage IV uterine sarcoma|stage iv uterine sarcoma
5832904|NCT00049296|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5832905|NCT00049296|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5832906|NCT00049296|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5832907|NCT00049296|unresectable gallbladder cancer|unresectable gallbladder cancer
5832908|NCT00049296|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832909|NCT00049296|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5832910|NCT00049296|recurrent salivary gland cancer|recurrent salivary gland cancer
5832911|NCT00049296|stage IV salivary gland cancer|stage iv salivary gland cancer
5832912|NCT00049296|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5832913|NCT00049296|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5832914|NCT00049296|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5832915|NCT00049296|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5832916|NCT00049296|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5832917|NCT00049296|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5832918|NCT00049296|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5832919|NCT00049296|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5832920|NCT00049296|adult grade III meningioma|adult grade iii meningioma
5832921|NCT00049296|adult oligodendroglioma|adult oligodendroglioma
5832922|NCT00049296|adult giant cell glioblastoma|adult giant cell glioblastoma
5832923|NCT00049296|adult gliosarcoma|adult gliosarcoma
5832924|NCT00049296|stage IV pancreatic cancer|stage iv pancreatic cancer
5832925|NCT00049257|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5832926|NCT00049257|recurrent prostate cancer|recurrent prostate cancer
5832927|NCT00049257|stage IV prostate cancer|stage iv prostate cancer
5832928|NCT00049244|recurrent breast cancer|recurrent breast cancer
5832929|NCT00049244|stage IV breast cancer|stage iv breast cancer
5832930|NCT00049231|cervical adenocarcinoma|cervical adenocarcinoma
5832931|NCT00049231|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5832932|NCT00049231|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5832933|NCT00049231|stage IIB cervical cancer|stage iib cervical cancer
5832934|NCT00049231|stage III cervical cancer|stage iii cervical cancer
5832935|NCT00049231|stage IVA cervical cancer|stage iva cervical cancer
5832936|NCT00049218|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5832937|NCT00049179|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5832938|NCT00049179|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5832939|NCT00049179|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5832940|NCT00049179|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5832941|NCT00049179|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5832942|NCT00049179|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5832943|NCT00049179|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5832944|NCT00049179|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5832945|NCT00049179|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5832946|NCT00049179|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5832947|NCT00049179|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5832948|NCT00049179|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5832949|NCT00049179|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5845569|NCT00050388|Clinical trial|clinical trial
5845570|NCT00050388|Allovectin-7®|allovectin-7®
5845578|NCT00050375|OvaRex|ovarex
5833280|NCT00046826|recurrent prostate cancer|recurrent prostate cancer
5832950|NCT00049140|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5832951|NCT00049140|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5832952|NCT00049140|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5832953|NCT00049140|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5832954|NCT00049140|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5832955|NCT00049140|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5832956|NCT00049140|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5832957|NCT00049140|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5832958|NCT00049140|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5847785|NCT00038142|Dexrazoxane|dexrazoxane
5832959|NCT00049140|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5832960|NCT00049140|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5832961|NCT00049140|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5832962|NCT00049140|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5832963|NCT00049140|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5832964|NCT00049140|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5832965|NCT00049140|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5832966|NCT00049140|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5832967|NCT00049140|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5832968|NCT00049140|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5832969|NCT00049140|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5832970|NCT00049140|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5832971|NCT00049140|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5832972|NCT00049140|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5832973|NCT00049140|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5832974|NCT00049140|stage I salivary gland cancer|stage i salivary gland cancer
5832975|NCT00049140|stage II salivary gland cancer|stage ii salivary gland cancer
5832976|NCT00049140|stage III salivary gland cancer|stage iii salivary gland cancer
5832977|NCT00049140|stage IV salivary gland cancer|stage iv salivary gland cancer
5832978|NCT00049140|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5832979|NCT00049101|recurrent colon cancer|recurrent colon cancer
5832980|NCT00049101|stage IV colon cancer|stage iv colon cancer
5832981|NCT00049101|recurrent rectal cancer|recurrent rectal cancer
5832982|NCT00049101|stage IV rectal cancer|stage iv rectal cancer
5832983|NCT00049075|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5832984|NCT00049075|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5832985|NCT00049075|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5832986|NCT00049075|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5832987|NCT00049075|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5832988|NCT00049062|recurrent breast cancer|recurrent breast cancer
5832989|NCT00049062|stage IIIB breast cancer|stage iiib breast cancer
5832990|NCT00049062|stage IIIC breast cancer|stage iiic breast cancer
5832991|NCT00049062|stage IV breast cancer|stage iv breast cancer
5832992|NCT00049023|childhood grade III meningioma|childhood grade iii meningioma
5832993|NCT00049023|disseminated neuroblastoma|disseminated neuroblastoma
5832994|NCT00049023|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5832995|NCT00049023|metastatic pheochromocytoma|metastatic pheochromocytoma
5832996|NCT00049023|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5832997|NCT00049023|recurrent childhood brain tumor|recurrent childhood brain tumor
5832999|NCT00049023|recurrent neuroblastoma|recurrent neuroblastoma
5833000|NCT00049023|recurrent pheochromocytoma|recurrent pheochromocytoma
5833001|NCT00049023|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5833002|NCT00049023|regional neuroblastoma|regional neuroblastoma
5833003|NCT00049023|regional pheochromocytoma|regional pheochromocytoma
5846675|NCT00043797|Diabetic polyneuropathy|diabetic polyneuropathy
5845682|NCT00050089|antiretrovirals|antiretrovirals
5845684|NCT00050089|drug-free period|drug-free period
5845685|NCT00050089|HAART|haart
5845686|NCT00050089|HIV|hiv
5845687|NCT00050089|human immunodeficiency virus|human immunodeficiency virus
5845688|NCT00050089|randomized|randomized
5833004|NCT00049023|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5833005|NCT00049023|recurrent childhood ependymoma|recurrent childhood ependymoma
5833006|NCT00049023|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5833007|NCT00049023|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5833008|NCT00049023|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5833009|NCT00049023|gastrinoma|gastrinoma
5833010|NCT00049023|insulinoma|insulinoma
5833011|NCT00049023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5847151|NCT00041535|Lysosomal|lysosomal
5833012|NCT00049023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5833013|NCT00049023|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5833014|NCT00049010|stage I melanoma|stage i melanoma
5681491|NCT00573131|Loco-regional esophageal cancer|loco-regional esophageal cancer
5833015|NCT00049010|stage II melanoma|stage ii melanoma
5833016|NCT00048997|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5833017|NCT00048997|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5833018|NCT00048971|adenocarcinoma of the colon|adenocarcinoma of the colon
5833019|NCT00048971|stage III colon cancer|stage iii colon cancer
5833020|NCT00048971|diarrhea|diarrhea
5833021|NCT00048971|neutropenia|neutropenia
5839436|NCT00005961|stage III melanoma|stage iii melanoma
5833022|NCT00047385|small cell lung cancer|small cell lung cancer
5833023|NCT00047385|non-small cell lung cancer|non-small cell lung cancer
5833024|NCT00047320|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5833025|NCT00047320|childhood teratoma|childhood teratoma
5847786|NCT00038142|Zinecard|zinecard
5833026|NCT00047320|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5833027|NCT00047320|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5833028|NCT00047320|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5833029|NCT00047320|childhood central nervous system germinoma|childhood central nervous system germinoma
5833030|NCT00047320|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5833031|NCT00047320|childhood central nervous system teratoma|childhood central nervous system teratoma
5833032|NCT00047320|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5833033|NCT00047320|recurrent childhood central nervous system embryonal tumor|recurrent childhood central nervous system embryonal tumor
5833034|NCT00047294|adult mixed glioma|adult mixed glioma
5833035|NCT00047294|adult glioblastoma|adult glioblastoma
5833036|NCT00047294|adult giant cell glioblastoma|adult giant cell glioblastoma
5833037|NCT00047294|adult gliosarcoma|adult gliosarcoma
5833038|NCT00047281|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5833039|NCT00047281|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5833040|NCT00047281|adult glioblastoma|adult glioblastoma
5833041|NCT00047281|adult mixed glioma|adult mixed glioma
5833042|NCT00047281|recurrent adult brain tumor|recurrent adult brain tumor
5833043|NCT00047281|adult giant cell glioblastoma|adult giant cell glioblastoma
5833044|NCT00047281|adult gliosarcoma|adult gliosarcoma
5833045|NCT00047268|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5833046|NCT00047268|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5833047|NCT00047268|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5833048|NCT00047268|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5833049|NCT00047268|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5833050|NCT00047255|stage IIIB breast cancer|stage iiib breast cancer
5833051|NCT00047255|stage IIIC breast cancer|stage iiic breast cancer
5833052|NCT00047255|stage IV breast cancer|stage iv breast cancer
5833053|NCT00047255|recurrent breast cancer|recurrent breast cancer
5833054|NCT00047242|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833055|NCT00047229|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5833056|NCT00047229|advanced adult primary liver cancer|advanced adult primary liver cancer
5833057|NCT00047229|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5833058|NCT00047229|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5833059|NCT00047216|recurrent bladder cancer|recurrent bladder cancer
5833060|NCT00047216|stage 0 bladder cancer|stage 0 bladder cancer
5833061|NCT00047216|stage I bladder cancer|stage i bladder cancer
5829449|NCT00006225|male breast cancer|male breast cancer
5833062|NCT00047216|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5833064|NCT00047177|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5833065|NCT00047177|recurrent childhood ependymoma|recurrent childhood ependymoma
5833066|NCT00047177|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5833067|NCT00047164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833068|NCT00047164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833069|NCT00047164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5833070|NCT00047164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5833071|NCT00047164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5833072|NCT00047164|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5833073|NCT00047164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5833074|NCT00047164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5833075|NCT00047164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5833076|NCT00047164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833077|NCT00047164|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5833078|NCT00047164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5833079|NCT00047164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5833080|NCT00047164|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5833081|NCT00047164|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5833082|NCT00047164|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5833083|NCT00047164|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5833084|NCT00047164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5833085|NCT00047164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839505|NCT00005951|adult glioblastoma|adult glioblastoma
5833086|NCT00047164|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5833087|NCT00047164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5833088|NCT00047164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5833089|NCT00047164|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5833090|NCT00047164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5833091|NCT00047164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833092|NCT00047164|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5833093|NCT00047164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5833094|NCT00047164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5833095|NCT00047164|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5833096|NCT00047164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5833097|NCT00047164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833098|NCT00047164|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5833099|NCT00047164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5833100|NCT00047164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5833101|NCT00047164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5833102|NCT00047164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5833103|NCT00047164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5833104|NCT00047164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5833105|NCT00047164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5833106|NCT00047164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5833107|NCT00047164|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5833108|NCT00047164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5833109|NCT00047164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833110|NCT00047164|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5833111|NCT00047164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5833112|NCT00047164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5833113|NCT00047164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833114|NCT00047164|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5833115|NCT00047164|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5833116|NCT00047164|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5833117|NCT00047164|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5833118|NCT00047164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833119|NCT00047164|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5833120|NCT00047164|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5833121|NCT00047164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5830148|NCT00058994|wet AMD|wet amd
5833122|NCT00047164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5833123|NCT00047164|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5845892|NCT00048477|Hemoglobin|hemoglobin
5845893|NCT00048477|Blood Flow|blood flow
5845894|NCT00048477|Healthy Volunteer|healthy volunteer
5845896|NCT00048373|LANGERHANS|langerhans
5845897|NCT00048373|HISTIOCYTOSIS|histiocytosis
5845898|NCT00048360|ADD|add
5833124|NCT00047164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833125|NCT00047164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833126|NCT00047164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5833127|NCT00047164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833128|NCT00047164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833129|NCT00047164|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5833130|NCT00047164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5833131|NCT00047164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5833132|NCT00047164|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5833133|NCT00047164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5833134|NCT00047164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833135|NCT00047164|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5833136|NCT00047164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5833137|NCT00047164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5833138|NCT00047164|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5833139|NCT00047164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5833140|NCT00047164|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5833141|NCT00047164|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5846674|NCT00043797|ARI|ari
5834064|NCT00039572|tumors metastatic to brain|tumors metastatic to brain
5833145|NCT00047164|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5833146|NCT00047164|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5833147|NCT00047164|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5833148|NCT00047138|blastema predominant Wilms tumor|blastema predominant wilms tumor
5833149|NCT00047138|epithelial predominant Wilms tumor|epithelial predominant wilms tumor
5833151|NCT00047138|stage I Wilms tumor|stage i wilms tumor
5833152|NCT00047138|stage II Wilms tumor|stage ii wilms tumor
5833153|NCT00047138|stage III Wilms tumor|stage iii wilms tumor
5833154|NCT00047138|stage IV Wilms tumor|stage iv wilms tumor
5833155|NCT00047138|stage V Wilms tumor|stage v wilms tumor
5833156|NCT00047138|stromal predominant Wilms tumor|stromal predominant wilms tumor
5833157|NCT00047125|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5833300|NCT00045591|recurrent breast cancer|recurrent breast cancer
5833158|NCT00047125|squamous cell carcinoma of unknown primary|squamous cell carcinoma of unknown primary
5833159|NCT00047112|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5833160|NCT00047112|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5833161|NCT00047112|stage I esophageal cancer|stage i esophageal cancer
5833162|NCT00047112|stage II esophageal cancer|stage ii esophageal cancer
5833163|NCT00047099|stage II breast cancer|stage ii breast cancer
5833164|NCT00047099|stage IIIA breast cancer|stage iiia breast cancer
5833165|NCT00047099|stage IIIB breast cancer|stage iiib breast cancer
5833166|NCT00047073|recurrent adult brain tumor|recurrent adult brain tumor
5833167|NCT00047073|adult glioblastoma|adult glioblastoma
5833168|NCT00047073|adult giant cell glioblastoma|adult giant cell glioblastoma
5833169|NCT00047073|adult gliosarcoma|adult gliosarcoma
5833176|NCT00047021|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5833177|NCT00047021|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5833178|NCT00047021|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5833179|NCT00047021|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5833180|NCT00047021|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833181|NCT00047021|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833182|NCT00047021|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833183|NCT00047021|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5833184|NCT00047021|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833185|NCT00047021|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833186|NCT00047021|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5833187|NCT00047021|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5846000|NCT00047905|Prenatal Genetic Counseling|prenatal genetic counseling
5846001|NCT00047879|Brain Tumors|brain tumors
5846002|NCT00047879|Experimental|experimental
5846003|NCT00047879|Toxicities|toxicities
5846004|NCT00047879|Efficacy|efficacy
5833188|NCT00047021|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5829620|NCT00059657|CLI|cli
5833190|NCT00047021|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5833191|NCT00047021|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5833192|NCT00047021|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833193|NCT00047021|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833194|NCT00047021|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833195|NCT00047021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833196|NCT00047021|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5833197|NCT00047021|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5833198|NCT00047021|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5833199|NCT00047021|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5833200|NCT00047021|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5833201|NCT00047021|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833202|NCT00047021|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833203|NCT00047021|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833204|NCT00047021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833205|NCT00047021|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833206|NCT00047021|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5833207|NCT00047021|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5833208|NCT00047021|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5863163|NCT00001364|Spinal Arteriovenous Malformations|spinal arteriovenous malformations
5833209|NCT00047021|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5847152|NCT00041535|Myoclonus|myoclonus
5833210|NCT00047021|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5833211|NCT00047008|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5833212|NCT00047008|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5833213|NCT00047008|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5833214|NCT00047008|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5833215|NCT00047008|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5833216|NCT00047008|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5833217|NCT00047008|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5833218|NCT00047008|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5833219|NCT00046995|adenocarcinoma of the colon|adenocarcinoma of the colon
5833220|NCT00046995|stage IIB colon cancer|stage iib colon cancer
5833221|NCT00046995|stage IIIA colon cancer|stage iiia colon cancer
5833222|NCT00046995|stage IIIB colon cancer|stage iiib colon cancer
5833223|NCT00046995|stage IIIC colon cancer|stage iiic colon cancer
5833224|NCT00046969|anemia|anemia
5833225|NCT00046969|stage IIB cervical cancer|stage iib cervical cancer
5833226|NCT00046969|stage III cervical cancer|stage iii cervical cancer
5833227|NCT00046969|stage IVA cervical cancer|stage iva cervical cancer
5833228|NCT00046969|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5833229|NCT00046969|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5833230|NCT00046969|cervical adenocarcinoma|cervical adenocarcinoma
5833231|NCT00046943|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5833232|NCT00046943|recurrent prostate cancer|recurrent prostate cancer
5833233|NCT00046943|stage IIB prostate cancer|stage iib prostate cancer
5833234|NCT00046943|stage IIA prostate cancer|stage iia prostate cancer
5833235|NCT00046943|stage III prostate cancer|stage iii prostate cancer
5833236|NCT00046943|stage IV prostate cancer|stage iv prostate cancer
5833237|NCT00046930|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5833238|NCT00046930|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5833239|NCT00046930|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5833240|NCT00046930|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5833241|NCT00046930|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5833242|NCT00046930|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5833243|NCT00046930|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5833244|NCT00046930|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5833245|NCT00046930|refractory anemia with excess blasts|refractory anemia with excess blasts
5833246|NCT00046930|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5833247|NCT00046930|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5833248|NCT00046930|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833249|NCT00046930|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5833250|NCT00046930|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5833251|NCT00046930|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5833252|NCT00046930|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5833253|NCT00046930|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5833254|NCT00046904|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833256|NCT00046904|cachexia|cachexia
5833257|NCT00046891|neurotoxicity|neurotoxicity
5833258|NCT00046891|stage I breast cancer|stage i breast cancer
5833259|NCT00046891|stage II breast cancer|stage ii breast cancer
5833260|NCT00046891|stage IIIA breast cancer|stage iiia breast cancer
5833261|NCT00046891|stage IIIB breast cancer|stage iiib breast cancer
5833262|NCT00046891|stage IIIC breast cancer|stage iiic breast cancer
5833263|NCT00046865|nausea and vomiting|nausea and vomiting
5833264|NCT00046865|stage I breast cancer|stage i breast cancer
5833265|NCT00046865|stage II breast cancer|stage ii breast cancer
5833266|NCT00046865|stage IIIA breast cancer|stage iiia breast cancer
5833267|NCT00046865|stage IIIB breast cancer|stage iiib breast cancer
5833268|NCT00046865|stage IIIC breast cancer|stage iiic breast cancer
5833269|NCT00046865|stage IV breast cancer|stage iv breast cancer
5833270|NCT00046852|infection|infection
5833271|NCT00046852|refractory multiple myeloma|refractory multiple myeloma
5833272|NCT00046852|stage I multiple myeloma|stage i multiple myeloma
5833273|NCT00046852|stage II multiple myeloma|stage ii multiple myeloma
5833274|NCT00046852|stage III multiple myeloma|stage iii multiple myeloma
5833275|NCT00046839|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5833276|NCT00046839|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5833277|NCT00046839|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5833278|NCT00046826|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5833279|NCT00046826|stage IV prostate cancer|stage iv prostate cancer
5847363|NCT00039845|Imaging|imaging
5833281|NCT00045747|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5839706|NCT00005807|ovarian sarcoma|ovarian sarcoma
5833282|NCT00045747|recurrent pancreatic cancer|recurrent pancreatic cancer
5833283|NCT00045747|stage IV pancreatic cancer|stage iv pancreatic cancer
5833284|NCT00045721|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5833285|NCT00045695|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5833286|NCT00045669|recurrent salivary gland cancer|recurrent salivary gland cancer
5833287|NCT00045669|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5833288|NCT00045669|stage III salivary gland cancer|stage iii salivary gland cancer
5833289|NCT00045669|stage IV salivary gland cancer|stage iv salivary gland cancer
5833290|NCT00045630|anterior urethral cancer|anterior urethral cancer
5833291|NCT00045630|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5833292|NCT00045630|posterior urethral cancer|posterior urethral cancer
5833293|NCT00045630|stage II bladder cancer|stage ii bladder cancer
5833294|NCT00045630|stage III bladder cancer|stage iii bladder cancer
5833295|NCT00045630|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5833296|NCT00045630|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5833297|NCT00045630|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5833298|NCT00045617|limited stage small cell lung cancer|limited stage small cell lung cancer
5833299|NCT00045604|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5833301|NCT00045591|stage IV breast cancer|stage iv breast cancer
5833302|NCT00045539|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5833303|NCT00045513|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5833304|NCT00045513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833305|NCT00045500|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5833306|NCT00045500|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5833307|NCT00045500|intraocular lymphoma|intraocular lymphoma
5833308|NCT00045500|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5833309|NCT00045500|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833310|NCT00045500|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5833311|NCT00045500|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833312|NCT00045500|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5846216|NCT00046358|Nonsteroidal Antiinflammatory|nonsteroidal antiinflammatory
5846217|NCT00046358|Healthy Volunteer|healthy volunteer
5846218|NCT00046293|Stroke|stroke
5846219|NCT00046293|Abciximab|abciximab
5846220|NCT00046293|Retavase|retavase
5846222|NCT00046293|Cerebral Blood Flow|cerebral blood flow
5846223|NCT00046267|Delayed-Action Preparations|delayed-action preparations
5846224|NCT00046267|Blood Glucose|blood glucose
5846225|NCT00046267|Insulin|insulin
5846226|NCT00046267|Alanine Transaminase|alanine transaminase
5846227|NCT00046267|Aspartate Aminotransferases|aspartate aminotransferases
5846228|NCT00046267|Fructosamine|fructosamine
5846229|NCT00046267|Glucose Tolerance Test|glucose tolerance test
5846230|NCT00046267|Treatment Experienced|treatment experienced
5846231|NCT00046254|hip fracture|hip fracture
5846232|NCT00046254|recurrent fracture|recurrent fracture
5846233|NCT00046254|fracture|fracture
5846234|NCT00046254|bone loss|bone loss
5846236|NCT00046254|bone mineral density|bone mineral density
5846237|NCT00046254|osteoporosis|osteoporosis
5833313|NCT00045500|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833314|NCT00045500|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833315|NCT00045500|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5833316|NCT00045500|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5833317|NCT00045500|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833318|NCT00045500|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833319|NCT00045500|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833320|NCT00045500|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833321|NCT00045500|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5833322|NCT00045500|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833323|NCT00045500|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833324|NCT00045500|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833325|NCT00045500|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833326|NCT00045500|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833327|NCT00045500|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833328|NCT00045487|recurrent renal cell cancer|recurrent renal cell cancer
5833329|NCT00045487|stage III renal cell cancer|stage iii renal cell cancer
5833330|NCT00045487|stage IV renal cell cancer|stage iv renal cell cancer
5833331|NCT00045474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5848332|NCT00035126|tumour|tumour
5833332|NCT00045474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5833333|NCT00045474|adult glioblastoma|adult glioblastoma
5851305|NCT00006207|Irritants|irritants
5833334|NCT00045474|recurrent adult brain tumor|recurrent adult brain tumor
5833335|NCT00045474|adult giant cell glioblastoma|adult giant cell glioblastoma
5833336|NCT00045474|adult gliosarcoma|adult gliosarcoma
5833337|NCT00045461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5833338|NCT00045461|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5833339|NCT00045461|stage IIIA fallopian tube cancer|stage iiia fallopian tube cancer
5833340|NCT00045461|stage IIIB fallopian tube cancer|stage iiib fallopian tube cancer
5833341|NCT00045461|stage IIIC fallopian tube cancer|stage iiic fallopian tube cancer
5833342|NCT00045461|stage IV fallopian tube cancer|stage iv fallopian tube cancer
5833343|NCT00045461|recurrent primary peritoneal cavity cancer|recurrent primary peritoneal cavity cancer
5833344|NCT00045461|stage IIIA primary peritoneal cavity cancer|stage iiia primary peritoneal cavity cancer
5833345|NCT00045461|stage IIIB primary peritoneal cavity cancer|stage iiib primary peritoneal cavity cancer
5833346|NCT00045461|stage IIIC primary peritoneal cavity cancer|stage iiic primary peritoneal cavity cancer
5833347|NCT00045461|stage IV primary peritoneal cavity cancer|stage iv primary peritoneal cavity cancer
5834283|NCT00036790|small intestine lymphoma|small intestine lymphoma
5833348|NCT00045461|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5833349|NCT00045461|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5833350|NCT00045461|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5833351|NCT00045461|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5833352|NCT00045448|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833353|NCT00045422|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5833354|NCT00045422|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5833355|NCT00045422|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5833356|NCT00045370|recurrent renal cell cancer|recurrent renal cell cancer
5833357|NCT00045370|stage III renal cell cancer|stage iii renal cell cancer
5833358|NCT00045370|stage IV renal cell cancer|stage iv renal cell cancer
5833359|NCT00045331|recurrent prostate cancer|recurrent prostate cancer
5833360|NCT00045331|stage I prostate cancer|stage i prostate cancer
5833361|NCT00045331|stage IIB prostate cancer|stage iib prostate cancer
5833362|NCT00045331|stage IIA prostate cancer|stage iia prostate cancer
5833363|NCT00045331|stage III prostate cancer|stage iii prostate cancer
5833364|NCT00045331|stage IV prostate cancer|stage iv prostate cancer
5833365|NCT00045318|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833366|NCT00045305|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5833367|NCT00045305|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833368|NCT00045305|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5833369|NCT00045305|refractory anemia|refractory anemia
5833370|NCT00045305|refractory anemia with excess blasts|refractory anemia with excess blasts
5833371|NCT00045305|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5833372|NCT00045305|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833373|NCT00045305|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5833374|NCT00045305|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5833375|NCT00045292|infection|infection
5833376|NCT00045292|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5833377|NCT00045292|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5833378|NCT00045292|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5833379|NCT00045292|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5833380|NCT00045292|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5833381|NCT00045292|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5833382|NCT00045292|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5833383|NCT00045292|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5833384|NCT00045292|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5833385|NCT00045292|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5833386|NCT00045292|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5833387|NCT00045292|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5833388|NCT00045292|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5833389|NCT00045292|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5833390|NCT00045292|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5833391|NCT00045292|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5833392|NCT00045292|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5833393|NCT00045292|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5833394|NCT00045292|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5833395|NCT00045292|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5833396|NCT00045292|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5833397|NCT00045292|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5686829|NCT00550420|Rosiglitazone extended-release (XR)|rosiglitazone extended-release (xr)
5833398|NCT00045292|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5833399|NCT00045292|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5833400|NCT00045292|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833401|NCT00045292|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5833402|NCT00045292|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5833403|NCT00045292|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833405|NCT00045292|recurrent neuroblastoma|recurrent neuroblastoma
5833406|NCT00045292|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5833407|NCT00045292|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833408|NCT00045292|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5833409|NCT00045292|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5833410|NCT00045292|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5833411|NCT00045292|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5846677|NCT00043784|Acute coronary syndromes|acute coronary syndromes
5833412|NCT00045292|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5833413|NCT00045292|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5833414|NCT00045292|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5833415|NCT00045292|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833416|NCT00045292|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5833417|NCT00045292|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5833418|NCT00045292|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5833419|NCT00045292|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833420|NCT00045292|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5833421|NCT00045292|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5833422|NCT00045292|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5833423|NCT00045292|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833424|NCT00045292|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5833425|NCT00045292|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5833426|NCT00045292|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5833427|NCT00045292|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5833679|NCT00045006|male breast cancer|male breast cancer
5833428|NCT00045292|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5833429|NCT00045292|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5833430|NCT00045292|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5833431|NCT00045292|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5833432|NCT00045292|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5833433|NCT00045292|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5833434|NCT00045292|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833435|NCT00045292|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833436|NCT00045292|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833437|NCT00045292|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5833438|NCT00045292|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5833439|NCT00045292|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5833440|NCT00045292|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5833441|NCT00045292|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5833442|NCT00045292|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5833443|NCT00045292|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5833444|NCT00045292|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833445|NCT00045292|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5833446|NCT00045292|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5833447|NCT00045292|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5833448|NCT00045292|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5833449|NCT00045292|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5833450|NCT00045292|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833451|NCT00045292|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5833452|NCT00045292|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5833453|NCT00045292|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5833454|NCT00045292|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5863182|NCT00001361|Cognitive Function|cognitive function
5833455|NCT00045292|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5833456|NCT00045292|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5833457|NCT00045292|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5833458|NCT00045292|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5833459|NCT00045292|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5833460|NCT00045292|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5833461|NCT00045292|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5833462|NCT00045292|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5833463|NCT00045292|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5833464|NCT00045292|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5833465|NCT00045292|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5833466|NCT00045292|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5833467|NCT00045292|refractory hairy cell leukemia|refractory hairy cell leukemia
5833468|NCT00045292|refractory multiple myeloma|refractory multiple myeloma
5833469|NCT00045292|stage I multiple myeloma|stage i multiple myeloma
5833470|NCT00045292|stage II multiple myeloma|stage ii multiple myeloma
5846525|NCT00044239|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5846527|NCT00044239|Obsessive Compulsive Disorder|obsessive compulsive disorder
5833471|NCT00045292|stage III multiple myeloma|stage iii multiple myeloma
5833472|NCT00045292|stage IIIA breast cancer|stage iiia breast cancer
5833473|NCT00045292|stage IIIB breast cancer|stage iiib breast cancer
5833474|NCT00045292|stage IIIC breast cancer|stage iiic breast cancer
5833475|NCT00045292|stage IV breast cancer|stage iv breast cancer
5833476|NCT00045292|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5833477|NCT00045292|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5833478|NCT00045292|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833479|NCT00045292|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833480|NCT00045292|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5833481|NCT00045292|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5833482|NCT00045292|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5833483|NCT00045292|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5833484|NCT00045292|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833485|NCT00045292|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833486|NCT00045292|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833487|NCT00045292|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5833488|NCT00045279|stage IV renal cell cancer|stage iv renal cell cancer
5833489|NCT00045266|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833490|NCT00045266|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833491|NCT00045266|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833492|NCT00045266|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5833493|NCT00045266|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833494|NCT00045266|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5826597|NCT00064792|SLOS|slos
5833495|NCT00045266|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833496|NCT00045266|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833497|NCT00045266|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833499|NCT00045266|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5833500|NCT00045266|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5833501|NCT00045266|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5833502|NCT00045266|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5833503|NCT00045266|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5833504|NCT00045266|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5833505|NCT00045266|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5833506|NCT00045266|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5833507|NCT00045266|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5833508|NCT00045266|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5833509|NCT00045266|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833510|NCT00045266|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833511|NCT00045266|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833512|NCT00045266|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5833513|NCT00045266|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5833514|NCT00045266|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833515|NCT00045266|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833516|NCT00045266|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833517|NCT00045227|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5833518|NCT00045227|recurrent prostate cancer|recurrent prostate cancer
5833519|NCT00045227|stage IV prostate cancer|stage iv prostate cancer
5833520|NCT00045175|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5833521|NCT00045175|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5833522|NCT00045175|fallopian tube cancer|fallopian tube cancer
5833523|NCT00045162|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5833524|NCT00045136|refractory multiple myeloma|refractory multiple myeloma
5833525|NCT00045136|stage I multiple myeloma|stage i multiple myeloma
5833526|NCT00045136|stage II multiple myeloma|stage ii multiple myeloma
5833527|NCT00045136|stage III multiple myeloma|stage iii multiple myeloma
5833528|NCT00045097|male breast cancer|male breast cancer
5833529|NCT00045097|recurrent breast cancer|recurrent breast cancer
5833530|NCT00045097|stage IIIB breast cancer|stage iiib breast cancer
5833531|NCT00045097|stage IIIC breast cancer|stage iiic breast cancer
5833532|NCT00045097|stage IV breast cancer|stage iv breast cancer
5833533|NCT00045045|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5833534|NCT00045045|testicular choriocarcinoma|testicular choriocarcinoma
5833535|NCT00045045|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5833536|NCT00045045|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5833537|NCT00045045|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5833538|NCT00045045|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5833539|NCT00045045|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5833540|NCT00045045|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5833541|NCT00045045|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5834350|NCT00036790|stage III colon cancer|stage iii colon cancer
5833542|NCT00045045|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5833543|NCT00045045|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5833544|NCT00045045|testicular embryonal carcinoma|testicular embryonal carcinoma
5833545|NCT00045045|testicular teratoma|testicular teratoma
5833546|NCT00045045|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5833547|NCT00045045|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5833548|NCT00045045|testicular yolk sac tumor|testicular yolk sac tumor
5833549|NCT00045019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833550|NCT00045006|acute undifferentiated leukemia|acute undifferentiated leukemia
5833551|NCT00045006|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833552|NCT00045006|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5833553|NCT00045006|ovarian sarcoma|ovarian sarcoma
5833554|NCT00045006|ovarian stromal cancer|ovarian stromal cancer
5833555|NCT00045006|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5833556|NCT00045006|prolymphocytic leukemia|prolymphocytic leukemia
5833557|NCT00045006|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833558|NCT00045006|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5833680|NCT00044993|male breast cancer|male breast cancer
5833559|NCT00045006|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5833560|NCT00045006|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5833561|NCT00045006|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833562|NCT00045006|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833563|NCT00045006|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833564|NCT00045006|recurrent bladder cancer|recurrent bladder cancer
5833566|NCT00045006|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5833567|NCT00045006|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833568|NCT00045006|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833569|NCT00045006|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833570|NCT00045006|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5833571|NCT00045006|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5833572|NCT00045006|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5833573|NCT00045006|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5833574|NCT00045006|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5833575|NCT00045006|recurrent prostate cancer|recurrent prostate cancer
5833576|NCT00045006|recurrent renal cell cancer|recurrent renal cell cancer
5833577|NCT00045006|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5833578|NCT00045006|refractory hairy cell leukemia|refractory hairy cell leukemia
5833579|NCT00045006|refractory multiple myeloma|refractory multiple myeloma
5833580|NCT00045006|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5833581|NCT00045006|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5833582|NCT00045006|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833583|NCT00045006|stage III multiple myeloma|stage iii multiple myeloma
5833584|NCT00045006|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5833585|NCT00045006|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5833586|NCT00045006|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5833587|NCT00045006|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5833588|NCT00045006|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833589|NCT00045006|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5833590|NCT00045006|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5833591|NCT00045006|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5833592|NCT00045006|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5833593|NCT00045006|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5833594|NCT00045006|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5833595|NCT00045006|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5833596|NCT00045006|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5846744|NCT00043615|Drug Resistance|drug resistance
5846745|NCT00043615|Signal Transduction|signal transduction
5846746|NCT00043615|EGFR|egfr
5833597|NCT00045006|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5833598|NCT00045006|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5833599|NCT00045006|stage III bladder cancer|stage iii bladder cancer
5833600|NCT00045006|stage IV bladder cancer|stage iv bladder cancer
5833601|NCT00045006|stage IIIA breast cancer|stage iiia breast cancer
5833602|NCT00045006|stage IIIB breast cancer|stage iiib breast cancer
5833603|NCT00045006|stage IIIC breast cancer|stage iiic breast cancer
5833604|NCT00045006|stage IV breast cancer|stage iv breast cancer
5833605|NCT00045006|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5833606|NCT00045006|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5833607|NCT00045006|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5833608|NCT00045006|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5833609|NCT00045006|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5833610|NCT00045006|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5833611|NCT00045006|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5833612|NCT00045006|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5833613|NCT00045006|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5833614|NCT00045006|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5833615|NCT00045006|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5833616|NCT00045006|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5833617|NCT00045006|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5833618|NCT00045006|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5833619|NCT00045006|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5833620|NCT00045006|stage III prostate cancer|stage iii prostate cancer
5833621|NCT00045006|stage IV prostate cancer|stage iv prostate cancer
5833622|NCT00045006|stage III renal cell cancer|stage iii renal cell cancer
5833623|NCT00045006|stage IV renal cell cancer|stage iv renal cell cancer
5833624|NCT00045006|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5833625|NCT00045006|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5833626|NCT00045006|recurrent salivary gland cancer|recurrent salivary gland cancer
5833627|NCT00045006|stage IV salivary gland cancer|stage iv salivary gland cancer
5833628|NCT00045006|stage III salivary gland cancer|stage iii salivary gland cancer
5833629|NCT00045006|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5833630|NCT00045006|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5833631|NCT00045006|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5833632|NCT00045006|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5833634|NCT00045006|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5833635|NCT00045006|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5833636|NCT00045006|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5833637|NCT00045006|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5833638|NCT00045006|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5833639|NCT00045006|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5833640|NCT00045006|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5833641|NCT00045006|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5833642|NCT00045006|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5833643|NCT00045006|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5833644|NCT00045006|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5833645|NCT00045006|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5833646|NCT00045006|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5833647|NCT00045006|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5686830|NCT00550420|safety|safety
5833648|NCT00045006|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5833649|NCT00045006|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5833650|NCT00045006|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5833651|NCT00045006|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5833652|NCT00045006|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5846678|NCT00043784|non-ST-segment elevation|non-st-segment elevation
5833653|NCT00045006|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833654|NCT00045006|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5833655|NCT00045006|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5833656|NCT00045006|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5833657|NCT00045006|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833658|NCT00045006|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5833659|NCT00045006|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5833660|NCT00045006|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5833661|NCT00045006|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833662|NCT00045006|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5833663|NCT00045006|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5833664|NCT00045006|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5833665|NCT00045006|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5833666|NCT00045006|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5833667|NCT00045006|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5833668|NCT00045006|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5833669|NCT00045006|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5833670|NCT00045006|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5833671|NCT00045006|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5833672|NCT00045006|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5833673|NCT00045006|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5833674|NCT00045006|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5833675|NCT00045006|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5833676|NCT00045006|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5833677|NCT00045006|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5833678|NCT00045006|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5833683|NCT00044993|stage IIIC breast cancer|stage iiic breast cancer
5833684|NCT00044993|stage IV breast cancer|stage iv breast cancer
5833686|NCT00044980|stage I prostate cancer|stage i prostate cancer
5833687|NCT00044980|stage II B prostate cancer|stage ii b prostate cancer
5833688|NCT00044980|stage II A prostate cancer|stage ii a prostate cancer
5833689|NCT00044967|stage I colon cancer|stage i colon cancer
5833690|NCT00044967|stage II colon cancer|stage ii colon cancer
5833691|NCT00044967|stage III colon cancer|stage iii colon cancer
5833692|NCT00044967|stage I rectal cancer|stage i rectal cancer
5833693|NCT00044967|stage II rectal cancer|stage ii rectal cancer
5833694|NCT00044967|stage III rectal cancer|stage iii rectal cancer
5833695|NCT00044967|adenocarcinoma of the colon|adenocarcinoma of the colon
5833696|NCT00044967|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5833697|NCT00044954|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5833698|NCT00044954|stage I multiple myeloma|stage i multiple myeloma
5833699|NCT00044954|stage II multiple myeloma|stage ii multiple myeloma
5833700|NCT00044954|stage III multiple myeloma|stage iii multiple myeloma
5833701|NCT00044954|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5833702|NCT00044954|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5833703|NCT00044954|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5833704|NCT00044954|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5863183|NCT00001361|Neurobehavioral Deficits|neurobehavioral deficits
5833705|NCT00044954|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833706|NCT00044954|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833707|NCT00044954|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5686831|NCT00550420|cognition|cognition
5833708|NCT00044954|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833709|NCT00044954|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833710|NCT00044954|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5833711|NCT00044954|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5833712|NCT00044954|refractory multiple myeloma|refractory multiple myeloma
5833713|NCT00044954|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5833714|NCT00044954|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5833715|NCT00044954|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5833716|NCT00044954|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5833717|NCT00044954|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5833718|NCT00044954|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5833719|NCT00044954|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5833720|NCT00044954|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5833721|NCT00044954|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5833722|NCT00044954|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5833723|NCT00044954|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5833724|NCT00043147|graft versus host disease|graft versus host disease
5833725|NCT00043134|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5833726|NCT00043134|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5833727|NCT00043134|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5833728|NCT00043134|refractory anemia|refractory anemia
5833729|NCT00043134|refractory anemia with excess blasts|refractory anemia with excess blasts
5833730|NCT00043134|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5833731|NCT00043134|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5833732|NCT00043134|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5833733|NCT00043134|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833734|NCT00043134|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5833735|NCT00043134|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5833736|NCT00043095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833737|NCT00043082|peritoneal cavity cancer|peritoneal cavity cancer
5833738|NCT00043082|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5833739|NCT00043082|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5833740|NCT00043082|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5833741|NCT00043069|osteoporosis|osteoporosis
5833742|NCT00043069|stage I prostate cancer|stage i prostate cancer
5833743|NCT00043069|stage IIB prostate cancer|stage iib prostate cancer
5833744|NCT00043069|stage IIA prostate cancer|stage iia prostate cancer
5833745|NCT00043069|stage III prostate cancer|stage iii prostate cancer
5833746|NCT00043043|colorectal cancer|colorectal cancer
5833747|NCT00043030|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5833748|NCT00043030|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833750|NCT00043017|stage IIIB breast cancer|stage iiib breast cancer
5833751|NCT00043017|stage IIIC breast cancer|stage iiic breast cancer
5833752|NCT00043004|liver metastases|liver metastases
5833753|NCT00043004|stage IV colon cancer|stage iv colon cancer
5833754|NCT00043004|stage IV rectal cancer|stage iv rectal cancer
5833755|NCT00042965|recurrent renal cell cancer|recurrent renal cell cancer
5833756|NCT00042965|stage IV renal cell cancer|stage iv renal cell cancer
5833757|NCT00042939|pancreatic cancer|pancreatic cancer
5833758|NCT00042939|metastatic pancreatic cancer|metastatic pancreatic cancer
5833760|NCT00042939|irinotecan|irinotecan
5833761|NCT00042939|docetaxel|docetaxel
5833762|NCT00042939|cetuximab|cetuximab
5833763|NCT00042926|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5833764|NCT00042926|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5833765|NCT00042913|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833766|NCT00042887|stage 0 bladder cancer|stage 0 bladder cancer
5833767|NCT00042887|stage I bladder cancer|stage i bladder cancer
5833768|NCT00042887|recurrent bladder cancer|recurrent bladder cancer
5833769|NCT00042887|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5833770|NCT00042861|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833772|NCT00042848|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833773|NCT00042822|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5681493|NCT00573131|Phase 2|phase 2
5681494|NCT00573131|Paclitaxel|paclitaxel
5681495|NCT00573131|Tumor|tumor
5681496|NCT00573131|Local|local
5681497|NCT00573131|Chemotherapy|chemotherapy
5681498|NCT00573131|radiation therapy|radiation therapy
5681499|NCT00573131|surgery|surgery
5681500|NCT00573131|OncoGel|oncogel
5681501|NCT00573131|Squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5681600|NCT00572624|Diet and exercise|diet and exercise
5681502|NCT00573118|Pregnancy complications: preeclampsia , severe IUGR , IUFD or placental abruption (n = 5).|pregnancy complications: preeclampsia , severe iugr , iufd or placental abruption (n = 5).
5681503|NCT00573092|Cardiovascular Epidemiology|cardiovascular epidemiology
5681504|NCT00573092|Genomics|genomics
5833774|NCT00042822|refractory anemia with excess blasts|refractory anemia with excess blasts
5833775|NCT00042822|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5833776|NCT00042822|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5833777|NCT00042822|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833778|NCT00042822|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5833779|NCT00042822|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5833780|NCT00042822|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5833781|NCT00042822|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833782|NCT00042822|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833783|NCT00042822|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833784|NCT00042822|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833785|NCT00042822|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833786|NCT00042822|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5833787|NCT00042822|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5833788|NCT00042822|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5833789|NCT00042822|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5833790|NCT00042822|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5833791|NCT00042822|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5833792|NCT00042822|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5833793|NCT00042783|stage IV melanoma|stage iv melanoma
5833794|NCT00042783|recurrent melanoma|recurrent melanoma
5833795|NCT00042770|malignant pleural effusion|malignant pleural effusion
5833796|NCT00042770|pulmonary complications|pulmonary complications
5833797|NCT00042731|stage I prostate cancer|stage i prostate cancer
5833798|NCT00042731|stage IIB prostate cancer|stage iib prostate cancer
5833799|NCT00042731|stage IIA prostate cancer|stage iia prostate cancer
5833800|NCT00041379|Waldenström macroglobulinemia|waldenström macroglobulinemia
5833801|NCT00041327|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5833802|NCT00041327|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5833803|NCT00041327|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5833804|NCT00041327|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5833805|NCT00041314|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5833806|NCT00041314|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5833807|NCT00041314|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5833808|NCT00041301|stage I prostate cancer|stage i prostate cancer
5833809|NCT00041301|stage IIB prostate cancer|stage iib prostate cancer
5833810|NCT00041301|stage IIA prostate cancer|stage iia prostate cancer
5833811|NCT00041301|stage III prostate cancer|stage iii prostate cancer
5833812|NCT00041301|stage IV prostate cancer|stage iv prostate cancer
5833813|NCT00041288|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5833814|NCT00041288|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5833815|NCT00041288|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833816|NCT00041288|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833817|NCT00041288|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833818|NCT00041288|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5848441|NCT00034736|Ceftriaxone|ceftriaxone
5833819|NCT00041262|stage IIB esophageal cancer|stage iib esophageal cancer
5833820|NCT00041262|stage IIIA esophageal cancer|stage iiia esophageal cancer
5847788|NCT00038142|ImmTher|immther
5833821|NCT00041262|stage IIIB esophageal cancer|stage iiib esophageal cancer
5833822|NCT00041262|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5833823|NCT00041249|adult angiosarcoma|adult angiosarcoma
5833824|NCT00041249|adult fibrosarcoma|adult fibrosarcoma
5833825|NCT00041249|adult leiomyosarcoma|adult leiomyosarcoma
5833826|NCT00041249|adult liposarcoma|adult liposarcoma
5833827|NCT00041249|adult neurofibrosarcoma|adult neurofibrosarcoma
5833828|NCT00041249|adult synovial sarcoma|adult synovial sarcoma
5833829|NCT00041249|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5833830|NCT00041249|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5833831|NCT00041249|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5833832|NCT00041249|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5833833|NCT00041249|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5833834|NCT00041249|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5833835|NCT00041249|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5833836|NCT00041236|adult angiosarcoma|adult angiosarcoma
5833837|NCT00041236|adult fibrosarcoma|adult fibrosarcoma
5833838|NCT00041236|adult leiomyosarcoma|adult leiomyosarcoma
5833839|NCT00041236|adult liposarcoma|adult liposarcoma
5833840|NCT00041236|adult neurofibrosarcoma|adult neurofibrosarcoma
5833841|NCT00041236|adult synovial sarcoma|adult synovial sarcoma
5833842|NCT00041236|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5833843|NCT00041236|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5833844|NCT00041236|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5833845|NCT00041236|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5833846|NCT00041236|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5833847|NCT00041236|stage IV uterine sarcoma|stage iv uterine sarcoma
5833848|NCT00041236|recurrent uterine sarcoma|recurrent uterine sarcoma
5833849|NCT00041236|uterine leiomyosarcoma|uterine leiomyosarcoma
5833850|NCT00041223|radiation fibrosis|radiation fibrosis
5833851|NCT00041223|stage I breast cancer|stage i breast cancer
5833852|NCT00041223|stage II breast cancer|stage ii breast cancer
5833853|NCT00041223|stage IIIA breast cancer|stage iiia breast cancer
5833854|NCT00041210|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5833855|NCT00041210|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5833856|NCT00041210|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5833857|NCT00041210|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5833858|NCT00041210|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5833859|NCT00041210|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5833860|NCT00041210|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5833861|NCT00041210|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5833862|NCT00041171|stage IV breast cancer|stage iv breast cancer
5833863|NCT00041171|stage IIIA breast cancer|stage iiia breast cancer
5833864|NCT00041171|recurrent breast cancer|recurrent breast cancer
5833865|NCT00041171|stage IIIB breast cancer|stage iiib breast cancer
5833866|NCT00041171|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5833867|NCT00041171|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5833868|NCT00041171|recurrent small cell lung cancer|recurrent small cell lung cancer
5833869|NCT00041171|stage III bladder cancer|stage iii bladder cancer
5833870|NCT00041171|recurrent bladder cancer|recurrent bladder cancer
5833871|NCT00041171|stage IV bladder cancer|stage iv bladder cancer
5833872|NCT00041171|stage III prostate cancer|stage iii prostate cancer
5833873|NCT00041171|stage IV prostate cancer|stage iv prostate cancer
5833874|NCT00041171|recurrent prostate cancer|recurrent prostate cancer
5833875|NCT00041171|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5833876|NCT00041171|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5833877|NCT00041171|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5833878|NCT00041171|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5833879|NCT00041171|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5833880|NCT00041171|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5833881|NCT00041171|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5833882|NCT00041171|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5833883|NCT00041171|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5833884|NCT00041171|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5833885|NCT00041171|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5833886|NCT00041171|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5833887|NCT00041171|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5833888|NCT00041171|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5833889|NCT00041171|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5833890|NCT00041171|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5833891|NCT00041171|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5833892|NCT00041171|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5833893|NCT00041171|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5833894|NCT00041171|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5833895|NCT00041171|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5833896|NCT00041171|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5833897|NCT00041171|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5833898|NCT00041171|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5833899|NCT00041171|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5833900|NCT00041171|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5833901|NCT00041171|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5833902|NCT00041171|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5833903|NCT00041171|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5833904|NCT00041171|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5833905|NCT00041171|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5833906|NCT00041171|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5833907|NCT00041171|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5833908|NCT00041171|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5833909|NCT00041171|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5833910|NCT00041171|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5833911|NCT00041171|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5833912|NCT00041171|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5833913|NCT00041171|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5833914|NCT00041171|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5833915|NCT00041171|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5833916|NCT00041171|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5833917|NCT00041171|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5833918|NCT00041171|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5833919|NCT00041171|stage III inverting papilloma of the paranasal sinus and nasal cavity|stage iii inverting papilloma of the paranasal sinus and nasal cavity
5833920|NCT00041171|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5833921|NCT00041171|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833922|NCT00041171|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5833923|NCT00041171|stage IV inverting papilloma of the paranasal sinus and nasal cavity|stage iv inverting papilloma of the paranasal sinus and nasal cavity
5833924|NCT00041171|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5833925|NCT00041171|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833926|NCT00041171|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5833927|NCT00041171|recurrent inverting papilloma of the paranasal sinus and nasal cavity|recurrent inverting papilloma of the paranasal sinus and nasal cavity
5833993|NCT00040911|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5833928|NCT00041171|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5833929|NCT00041171|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5833930|NCT00041171|recurrent salivary gland cancer|recurrent salivary gland cancer
5833931|NCT00041171|stage III salivary gland cancer|stage iii salivary gland cancer
5833932|NCT00041171|stage IV salivary gland cancer|stage iv salivary gland cancer
5833933|NCT00041132|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5833934|NCT00041132|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5833935|NCT00041132|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5833936|NCT00041132|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5833937|NCT00041119|stage IB breast cancer|stage ib breast cancer
5833938|NCT00041119|stage II breast cancer|stage ii breast cancer
5833939|NCT00041067|stage IV breast cancer|stage iv breast cancer
5833940|NCT00041067|recurrent breast cancer|recurrent breast cancer
5833941|NCT00041054|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5833942|NCT00041028|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5833943|NCT00041028|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5833944|NCT00041028|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5833945|NCT00041028|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5847999|NCT00037102|autoimmune|autoimmune
5833946|NCT00041015|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5833947|NCT00041015|recurrent small cell lung cancer|recurrent small cell lung cancer
5833948|NCT00040950|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833949|NCT00040950|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5833950|NCT00040950|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5833951|NCT00040950|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5833952|NCT00040950|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5833953|NCT00040950|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5833954|NCT00040950|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5833955|NCT00040950|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5833956|NCT00040950|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5686832|NCT00550420|BRL-049653|brl-049653
5857160|NCT00000663|IgG|igg
5833957|NCT00040950|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5833958|NCT00040950|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5833959|NCT00040950|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5833960|NCT00040950|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5833961|NCT00040950|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5833962|NCT00040950|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5833963|NCT00040937|stage I multiple myeloma|stage i multiple myeloma
5833964|NCT00040937|stage II multiple myeloma|stage ii multiple myeloma
5833965|NCT00040937|stage III multiple myeloma|stage iii multiple myeloma
5833966|NCT00040911|nausea and vomiting|nausea and vomiting
5833967|NCT00040911|localized osteosarcoma|localized osteosarcoma
5833968|NCT00040911|metastatic osteosarcoma|metastatic osteosarcoma
5833969|NCT00040911|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5847370|NCT00039845|Healthy Volunteer|healthy volunteer
5847371|NCT00039845|HV|hv
5847372|NCT00039845|Normal Control|normal control
5847373|NCT00039832|Stroke|stroke
5847374|NCT00039832|Abciximab|abciximab
5847375|NCT00039832|Reteplase|reteplase
5847376|NCT00039832|MRI|mri
5847377|NCT00039832|Cerebral Blood Flow|cerebral blood flow
5847378|NCT00039793|Cancer-related fatigue|cancer-related fatigue
5847379|NCT00039793|alternative medicine|alternative medicine
5847380|NCT00039793|cancer rehabilitation /care|cancer rehabilitation /care
5847381|NCT00039793|fatigue|fatigue
5833970|NCT00040911|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5833971|NCT00040911|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5833972|NCT00040911|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5833973|NCT00040911|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5833974|NCT00040911|childhood teratoma|childhood teratoma
5833975|NCT00040911|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5833976|NCT00040911|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5833977|NCT00040911|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5833978|NCT00040911|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5833979|NCT00040911|localized resectable neuroblastoma|localized resectable neuroblastoma
5833980|NCT00040911|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5833981|NCT00040911|disseminated neuroblastoma|disseminated neuroblastoma
5833982|NCT00040911|regional neuroblastoma|regional neuroblastoma
5833983|NCT00040911|stage 4S neuroblastoma|stage 4s neuroblastoma
5833984|NCT00040911|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5833985|NCT00040911|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5833986|NCT00040911|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5833987|NCT00040911|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5833988|NCT00040911|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5833989|NCT00040911|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5833990|NCT00040911|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5833991|NCT00040911|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5833992|NCT00040911|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5833994|NCT00040911|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5833995|NCT00040911|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5833996|NCT00040911|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5840843|NCT00004065|ovarian stromal cancer|ovarian stromal cancer
5833997|NCT00040911|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5833998|NCT00040911|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5833999|NCT00040911|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5834000|NCT00040898|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5834001|NCT00040898|advanced adult primary liver cancer|advanced adult primary liver cancer
5834002|NCT00040898|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5834003|NCT00040898|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5834004|NCT00040885|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5834005|NCT00040885|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834006|NCT00040885|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834007|NCT00040885|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5834008|NCT00040885|fatigue|fatigue
5834009|NCT00040885|anorexia|anorexia
5834010|NCT00040885|cachexia|cachexia
5834011|NCT00040872|regional neuroblastoma|regional neuroblastoma
5834012|NCT00040872|disseminated neuroblastoma|disseminated neuroblastoma
5848206|NCT00035815|Myotrophin|myotrophin
5834013|NCT00040872|recurrent neuroblastoma|recurrent neuroblastoma
5834014|NCT00040872|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5834015|NCT00040859|stage IV gastric cancer|stage iv gastric cancer
5834016|NCT00040859|recurrent gastric cancer|recurrent gastric cancer
5834017|NCT00040859|stage III esophageal cancer|stage iii esophageal cancer
5834018|NCT00040859|stage IV esophageal cancer|stage iv esophageal cancer
5834019|NCT00040859|recurrent esophageal cancer|recurrent esophageal cancer
5834020|NCT00040859|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5834021|NCT00040859|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5834022|NCT00040833|stage III pancreatic cancer|stage iii pancreatic cancer
5834023|NCT00040833|recurrent pancreatic cancer|recurrent pancreatic cancer
5834024|NCT00040833|pain|pain
5834025|NCT00040833|stage IV pancreatic cancer|stage iv pancreatic cancer
5834026|NCT00040807|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5834027|NCT00040807|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5834028|NCT00040807|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5834029|NCT00040807|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5834030|NCT00040807|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5834031|NCT00040807|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5834032|NCT00040807|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5834033|NCT00040807|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5834034|NCT00040807|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5834035|NCT00040807|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5834036|NCT00040807|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5834037|NCT00040807|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5834038|NCT00040807|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5834039|NCT00040807|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5834040|NCT00040807|recurrent salivary gland cancer|recurrent salivary gland cancer
5834041|NCT00040807|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5834042|NCT00040807|stage IV salivary gland cancer|stage iv salivary gland cancer
5834043|NCT00040742|nausea|nausea
5834044|NCT00040742|vomiting|vomiting
5834045|NCT00040690|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5834046|NCT00040690|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5834047|NCT00040690|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5834048|NCT00040690|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5834049|NCT00040690|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5834050|NCT00040690|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5834051|NCT00040690|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5834052|NCT00039611|stage III colon cancer|stage iii colon cancer
5834053|NCT00039611|stage IV colon cancer|stage iv colon cancer
5834054|NCT00039611|stage III rectal cancer|stage iii rectal cancer
5834055|NCT00039611|stage IV rectal cancer|stage iv rectal cancer
5834056|NCT00039611|recurrent colon cancer|recurrent colon cancer
5834057|NCT00039611|recurrent rectal cancer|recurrent rectal cancer
5834058|NCT00039585|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5834059|NCT00039585|fallopian tube cancer|fallopian tube cancer
5834060|NCT00039585|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5834061|NCT00039585|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5834062|NCT00039572|adult glioblastoma|adult glioblastoma
5681505|NCT00573092|Genome-Wide Association Study|genome-wide association study
5681507|NCT00573079|Infants|infants
5681508|NCT00573066|Postoperative from cardiac surgery|postoperative from cardiac surgery
5681509|NCT00573066|Dexmedetomidine|dexmedetomidine
5681510|NCT00573053|hypercapneic response|hypercapneic response
5857949|NCT00017927|Acromegaly|acromegaly
5834063|NCT00039572|stage IV melanoma|stage iv melanoma
5834065|NCT00039572|adult giant cell glioblastoma|adult giant cell glioblastoma
5834066|NCT00039572|adult gliosarcoma|adult gliosarcoma
5834067|NCT00039559|ovarian epithelial cancer|ovarian epithelial cancer
5834068|NCT00039546|stage I breast cancer|stage i breast cancer
5834069|NCT00039546|stage II breast cancer|stage ii breast cancer
5834070|NCT00039520|stage IV breast cancer|stage iv breast cancer
5834071|NCT00039520|recurrent breast cancer|recurrent breast cancer
5834072|NCT00039507|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5834073|NCT00039507|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5834074|NCT00039468|adult glioblastoma|adult glioblastoma
5834075|NCT00039468|recurrent adult brain tumor|recurrent adult brain tumor
5834076|NCT00039468|adult giant cell glioblastoma|adult giant cell glioblastoma
5834077|NCT00039468|adult gliosarcoma|adult gliosarcoma
5834078|NCT00039429|stage IV renal cell cancer|stage iv renal cell cancer
5834079|NCT00039429|recurrent renal cell cancer|recurrent renal cell cancer
5686833|NCT00550407|Lamotrigine|lamotrigine
5834080|NCT00039364|recurrent adult brain tumor|recurrent adult brain tumor
5834081|NCT00039364|adult glioblastoma|adult glioblastoma
5834082|NCT00039364|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5834083|NCT00039364|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5834084|NCT00039364|adult mixed glioma|adult mixed glioma
5834085|NCT00039364|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5834086|NCT00039364|adult subependymoma|adult subependymoma
5834087|NCT00039364|adult giant cell glioblastoma|adult giant cell glioblastoma
5834088|NCT00039364|adult gliosarcoma|adult gliosarcoma
5834089|NCT00039364|adult diffuse astrocytoma|adult diffuse astrocytoma
5834090|NCT00039351|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5834091|NCT00039351|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5834092|NCT00039351|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834093|NCT00039351|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5834094|NCT00039351|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5834095|NCT00039351|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5834096|NCT00039338|stage IB cervical cancer|stage ib cervical cancer
5834097|NCT00039338|stage IIB cervical cancer|stage iib cervical cancer
5834098|NCT00039338|stage IIA cervical cancer|stage iia cervical cancer
5834099|NCT00039338|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5834100|NCT00039338|cervical adenocarcinoma|cervical adenocarcinoma
5834101|NCT00039338|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5834102|NCT00039325|stage IV melanoma|stage iv melanoma
5834103|NCT00039325|recurrent melanoma|recurrent melanoma
5834104|NCT00039312|cervical cancer|cervical cancer
5834105|NCT00039299|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5834106|NCT00039299|recurrent prostate cancer|recurrent prostate cancer
5834107|NCT00039286|stage II breast cancer|stage ii breast cancer
5834108|NCT00039286|stage IIIA breast cancer|stage iiia breast cancer
5834109|NCT00039286|recurrent breast cancer|recurrent breast cancer
5834110|NCT00039273|stage IV colon cancer|stage iv colon cancer
5834111|NCT00039273|stage IV rectal cancer|stage iv rectal cancer
5834112|NCT00039273|recurrent colon cancer|recurrent colon cancer
5834113|NCT00039273|recurrent rectal cancer|recurrent rectal cancer
5834114|NCT00039234|stage IV melanoma|stage iv melanoma
5834115|NCT00039234|recurrent melanoma|recurrent melanoma
5834116|NCT00039234|liver metastases|liver metastases
5834117|NCT00039208|stage III colon cancer|stage iii colon cancer
5834118|NCT00039208|stage IV colon cancer|stage iv colon cancer
5834119|NCT00039208|stage III rectal cancer|stage iii rectal cancer
5834120|NCT00039208|stage IV rectal cancer|stage iv rectal cancer
5834121|NCT00039208|recurrent colon cancer|recurrent colon cancer
5834122|NCT00039208|recurrent rectal cancer|recurrent rectal cancer
5834123|NCT00039195|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5834124|NCT00039195|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5834125|NCT00039195|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834126|NCT00039195|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5834127|NCT00039195|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5834128|NCT00039156|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834129|NCT00039156|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5834130|NCT00039156|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5834131|NCT00039156|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5834132|NCT00039156|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5834133|NCT00039156|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5834134|NCT00039156|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834135|NCT00039130|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5834136|NCT00039130|L3 adult acute lymphoblastic leukemia|l3 adult acute lymphoblastic leukemia
5834137|NCT00039130|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5834138|NCT00039130|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5834139|NCT00039130|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5834140|NCT00039130|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5834141|NCT00039130|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5834142|NCT00039078|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5834143|NCT00039078|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5834144|NCT00039078|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5834146|NCT00039052|recurrent breast cancer|recurrent breast cancer
5834147|NCT00039052|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5834148|NCT00039052|stage IV renal cell cancer|stage iv renal cell cancer
5834149|NCT00039052|recurrent renal cell cancer|recurrent renal cell cancer
5834150|NCT00039052|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5834151|NCT00039052|male breast cancer|male breast cancer
5863033|NCT00001412|GnRH Agonist|gnrh agonist
5686834|NCT00550407|Prevention of relapse or recurrence of a mood episode|prevention of relapse or recurrence of a mood episode
5686835|NCT00550407|Bipolar I disorder|bipolar i disorder
5686836|NCT00550394|Adolescents|adolescents
5686837|NCT00550381|healthy subjects|healthy subjects
5686838|NCT00550342|Focal segmental glomerulosclerosis|focal segmental glomerulosclerosis
5686840|NCT00550342|Proteinuria|proteinuria
5686841|NCT00550342|rituximab|rituximab
5686842|NCT00550342|B cell|b cell
5686843|NCT00550342|autoimmune|autoimmune
5686844|NCT00550342|CD20|cd20
5686845|NCT00550342|treatment|treatment
5686846|NCT00550342|children|children
5686847|NCT00550290|vulvectomy|vulvectomy
5686848|NCT00550290|wound infection|wound infection
5681492|NCT00573131|Esophagectomy|esophagectomy
5834152|NCT00039039|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5834153|NCT00039039|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834154|NCT00039039|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834155|NCT00037037|stage III melanoma|stage iii melanoma
5834156|NCT00037037|stage IV melanoma|stage iv melanoma
5834157|NCT00037037|recurrent melanoma|recurrent melanoma
5834158|NCT00037024|stage I breast cancer|stage i breast cancer
5834159|NCT00037024|stage II breast cancer|stage ii breast cancer
5834160|NCT00037024|stage I prostate cancer|stage i prostate cancer
5834161|NCT00037024|stage II B prostate cancer|stage ii b prostate cancer
5834162|NCT00037024|stage II A prostate cancer|stage ii a prostate cancer
5834163|NCT00037024|male breast cancer|male breast cancer
5834164|NCT00037024|fatigue|fatigue
5834165|NCT00037024|malnutrition|malnutrition
5834166|NCT00037024|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5834168|NCT00037011|disseminated neuroblastoma|disseminated neuroblastoma
5834169|NCT00037011|recurrent neuroblastoma|recurrent neuroblastoma
5834170|NCT00036998|stage I breast cancer|stage i breast cancer
5834171|NCT00036998|stage II breast cancer|stage ii breast cancer
5834172|NCT00036985|stage IIIA breast cancer|stage iiia breast cancer
5834173|NCT00036972|recurrent adult brain tumor|recurrent adult brain tumor
5834174|NCT00036972|adult glioblastoma|adult glioblastoma
5834175|NCT00036972|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5834176|NCT00036972|adult mixed glioma|adult mixed glioma
5834177|NCT00036972|adult giant cell glioblastoma|adult giant cell glioblastoma
5834178|NCT00036972|adult gliosarcoma|adult gliosarcoma
5834179|NCT00036959|metastatic osteosarcoma|metastatic osteosarcoma
5834180|NCT00036959|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5834181|NCT00036959|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5834182|NCT00036959|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5834183|NCT00036959|childhood craniopharyngioma|childhood craniopharyngioma
5834184|NCT00036959|disseminated neuroblastoma|disseminated neuroblastoma
5834185|NCT00036959|recurrent neuroblastoma|recurrent neuroblastoma
5834186|NCT00036959|recurrent childhood liver cancer|recurrent childhood liver cancer
5834187|NCT00036959|stage IV childhood liver cancer|stage iv childhood liver cancer
5834188|NCT00036959|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5834189|NCT00036959|stage IV Wilms tumor|stage iv wilms tumor
5834190|NCT00036959|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5834191|NCT00036959|recurrent osteosarcoma|recurrent osteosarcoma
5834192|NCT00036959|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5834193|NCT00036959|childhood germ cell tumor|childhood germ cell tumor
5834194|NCT00036959|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5834195|NCT00036959|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5834196|NCT00036959|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5834197|NCT00036959|childhood oligodendroglioma|childhood oligodendroglioma
5834198|NCT00036959|childhood choroid plexus tumor|childhood choroid plexus tumor
5834199|NCT00036959|childhood grade I meningioma|childhood grade i meningioma
5834200|NCT00036959|childhood grade II meningioma|childhood grade ii meningioma
5830877|NCT00056472|SSRI|ssri
5834201|NCT00036959|childhood grade III meningioma|childhood grade iii meningioma
5834202|NCT00036959|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5834203|NCT00036959|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5686849|NCT00550290|wound complication|wound complication
5834204|NCT00036959|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5834205|NCT00036959|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5834206|NCT00036959|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5834207|NCT00036959|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5834208|NCT00036959|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5834209|NCT00036959|recurrent childhood ependymoma|recurrent childhood ependymoma
5834210|NCT00036959|childhood teratoma|childhood teratoma
5834211|NCT00036959|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5834212|NCT00036959|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5834213|NCT00036959|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5834214|NCT00036959|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5834215|NCT00036946|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834216|NCT00036946|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5834217|NCT00036946|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5834218|NCT00036946|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5834219|NCT00036946|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5834220|NCT00036946|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5834221|NCT00036946|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834222|NCT00036946|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5834223|NCT00036946|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5834224|NCT00036946|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5834225|NCT00036946|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5834226|NCT00036946|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5834227|NCT00036946|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834228|NCT00036946|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5834367|NCT00036790|stage IV laryngeal cancer|stage iv laryngeal cancer
5834229|NCT00036946|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5834230|NCT00036946|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5834231|NCT00036946|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5834232|NCT00036946|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5834233|NCT00036946|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5834234|NCT00036946|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5834235|NCT00036946|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834236|NCT00036946|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5834237|NCT00036946|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5834238|NCT00036946|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5834239|NCT00036946|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5834240|NCT00036946|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5834241|NCT00036946|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5834242|NCT00036946|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5834243|NCT00036933|stage III prostate cancer|stage iii prostate cancer
5834244|NCT00036933|recurrent prostate cancer|recurrent prostate cancer
5834245|NCT00036894|recurrent adult brain tumor|recurrent adult brain tumor
5834246|NCT00036894|adult glioblastoma|adult glioblastoma
5834247|NCT00036894|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5834248|NCT00036894|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5834249|NCT00036894|adult mixed glioma|adult mixed glioma
5834250|NCT00036894|adult ependymoblastoma|adult ependymoblastoma
5834251|NCT00036894|adult anaplastic ependymoma|adult anaplastic ependymoma
5834252|NCT00036894|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5834253|NCT00036894|adult meningioma|adult meningioma
5834254|NCT00036894|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5834255|NCT00036894|adult brain stem glioma|adult brain stem glioma
5834256|NCT00036894|adult grade III meningioma|adult grade iii meningioma
5834257|NCT00036894|adult giant cell glioblastoma|adult giant cell glioblastoma
5834258|NCT00036894|adult gliosarcoma|adult gliosarcoma
5834259|NCT00036868|stage IV breast cancer|stage iv breast cancer
5834260|NCT00036868|recurrent breast cancer|recurrent breast cancer
5834261|NCT00036842|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5834262|NCT00036842|extragonadal germ cell tumor|extragonadal germ cell tumor
5834263|NCT00036829|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834265|NCT00036816|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5834266|NCT00036790|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5834267|NCT00036790|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5834268|NCT00036790|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5863184|NCT00001361|Neurological Disorders|neurological disorders
5834269|NCT00036790|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5834270|NCT00036790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5834271|NCT00036790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5834272|NCT00036790|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5834273|NCT00036790|extramedullary plasmacytoma|extramedullary plasmacytoma
5834274|NCT00036790|refractory multiple myeloma|refractory multiple myeloma
5834275|NCT00036790|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5834276|NCT00036790|stage III multiple myeloma|stage iii multiple myeloma
5834277|NCT00036790|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5834278|NCT00036790|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5834279|NCT00036790|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5834280|NCT00036790|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5834281|NCT00036790|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5834282|NCT00036790|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5834284|NCT00036790|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834285|NCT00036790|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5834286|NCT00036790|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5834287|NCT00036790|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5834288|NCT00036790|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5834289|NCT00036790|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5834290|NCT00036790|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5834291|NCT00036790|refractory hairy cell leukemia|refractory hairy cell leukemia
5834292|NCT00036790|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5834293|NCT00036790|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5834294|NCT00036790|acute undifferentiated leukemia|acute undifferentiated leukemia
5834295|NCT00036790|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5834296|NCT00036790|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5834297|NCT00036790|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5834298|NCT00036790|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5834299|NCT00036790|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5834300|NCT00036790|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5834301|NCT00036790|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5834302|NCT00036790|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5834303|NCT00036790|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5834304|NCT00036790|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5834305|NCT00036790|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5834306|NCT00036790|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5834307|NCT00036790|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5834308|NCT00036790|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5834309|NCT00036790|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834310|NCT00036790|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5834311|NCT00036790|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5834312|NCT00036790|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5834313|NCT00036790|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5834314|NCT00036790|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5834315|NCT00036790|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834316|NCT00036790|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5834317|NCT00036790|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5834318|NCT00036790|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5834319|NCT00036790|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5834320|NCT00036790|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5834321|NCT00036790|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5834322|NCT00036790|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5834323|NCT00036790|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5834324|NCT00036790|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5834325|NCT00036790|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5834326|NCT00036790|prolymphocytic leukemia|prolymphocytic leukemia
5834327|NCT00036790|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5834328|NCT00036790|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5834329|NCT00036790|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834330|NCT00036790|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5834331|NCT00036790|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5857742|NCT00021502|Shock|shock
5834332|NCT00036790|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5834333|NCT00036790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5834334|NCT00036790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5834336|NCT00036790|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5834337|NCT00036790|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5834338|NCT00036790|recurrent small cell lung cancer|recurrent small cell lung cancer
5834339|NCT00036790|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834340|NCT00036790|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834341|NCT00036790|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5834342|NCT00036790|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5834343|NCT00036790|limited stage small cell lung cancer|limited stage small cell lung cancer
5834345|NCT00036790|stage IIIA breast cancer|stage iiia breast cancer
5834346|NCT00036790|stage IIIB breast cancer|stage iiib breast cancer
5834347|NCT00036790|stage IIIC breast cancer|stage iiic breast cancer
5834348|NCT00036790|stage IV breast cancer|stage iv breast cancer
5834349|NCT00036790|recurrent colon cancer|recurrent colon cancer
5847368|NCT00039845|Children|children
5834351|NCT00036790|stage IV colon cancer|stage iv colon cancer
5834352|NCT00036790|recurrent prostate cancer|recurrent prostate cancer
5834353|NCT00036790|stage III prostate cancer|stage iii prostate cancer
5834354|NCT00036790|stage IV prostate cancer|stage iv prostate cancer
5834355|NCT00036790|recurrent lip and oral cavity cancer|recurrent lip and oral cavity cancer
5834356|NCT00036790|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5834357|NCT00036790|stage IV lip and oral cavity cancer|stage iv lip and oral cavity cancer
5834358|NCT00036790|recurrent paranasal sinus and nasal cavity cancer|recurrent paranasal sinus and nasal cavity cancer
5834359|NCT00036790|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5834360|NCT00036790|stage IV paranasal sinus and nasal cavity cancer|stage iv paranasal sinus and nasal cavity cancer
5834361|NCT00036790|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5834362|NCT00036790|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5834363|NCT00036790|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5834364|NCT00036790|stage IV hypopharyngeal cancer|stage iv hypopharyngeal cancer
5834365|NCT00036790|recurrent laryngeal cancer|recurrent laryngeal cancer
5834366|NCT00036790|stage III laryngeal cancer|stage iii laryngeal cancer
5834368|NCT00036790|recurrent oropharyngeal cancer|recurrent oropharyngeal cancer
5834369|NCT00036790|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5834370|NCT00036790|stage IV oropharyngeal cancer|stage iv oropharyngeal cancer
5834371|NCT00036790|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5834372|NCT00036790|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5834373|NCT00036790|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5834374|NCT00036790|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5834375|NCT00036790|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5834376|NCT00036790|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5834377|NCT00036790|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5834378|NCT00036790|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5834379|NCT00036790|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5834380|NCT00036790|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5834381|NCT00036790|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5834382|NCT00036790|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5834383|NCT00036790|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5834384|NCT00036790|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5834385|NCT00036790|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5834386|NCT00036790|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5834387|NCT00036790|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5834388|NCT00036790|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5834389|NCT00036790|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5834390|NCT00036712|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5834391|NCT00036712|refractory multiple myeloma|refractory multiple myeloma
5834392|NCT00036712|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5834393|NCT00036712|disseminated neuroblastoma|disseminated neuroblastoma
5834394|NCT00036712|recurrent neuroblastoma|recurrent neuroblastoma
5834395|NCT00036712|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5834396|NCT00036712|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5834397|NCT00036712|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5834398|NCT00036712|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5834399|NCT00036712|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5686850|NCT00550290|prophylactic antibiotic|prophylactic antibiotic
5681511|NCT00573053|hyperoxic response|hyperoxic response
5681512|NCT00573053|breathing pattern|breathing pattern
5681513|NCT00573053|periodic breathing|periodic breathing
5681515|NCT00573040|Radiotherapy|radiotherapy
5681516|NCT00573040|NSCLC|nsclc
5681517|NCT00573040|Stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5681518|NCT00573027|microvascular dysfunction|microvascular dysfunction
5681519|NCT00573027|Microvascular|microvascular
5681520|NCT00573014|Obtunded blunt trauma patients|obtunded blunt trauma patients
5834400|NCT00036712|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5834401|NCT00036712|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5834402|NCT00036712|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5834403|NCT00036712|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5834404|NCT00036712|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5834405|NCT00036712|primary myelofibrosis|primary myelofibrosis
5834406|NCT00036712|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5834407|NCT00036712|refractory hairy cell leukemia|refractory hairy cell leukemia
5834408|NCT00036712|oral complications|oral complications
5834409|NCT00036712|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5834410|NCT00036712|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5834411|NCT00036712|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5834412|NCT00036712|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5834414|NCT00036712|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5834415|NCT00036712|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5834416|NCT00036712|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5834417|NCT00036712|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5834418|NCT00036712|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5834419|NCT00036712|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5834420|NCT00036712|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5834421|NCT00036712|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5834422|NCT00036686|stage I breast cancer|stage i breast cancer
5834423|NCT00036686|stage II breast cancer|stage ii breast cancer
5834424|NCT00036686|stage IIIA breast cancer|stage iiia breast cancer
5834425|NCT00036686|stage IIIB breast cancer|stage iiib breast cancer
5834426|NCT00036686|stage IIIC breast cancer|stage iiic breast cancer
5834427|NCT00036686|recurrent breast cancer|recurrent breast cancer
5834428|NCT00036686|stage IV breast cancer|stage iv breast cancer
5834429|NCT00033748|stage IV colon cancer|stage iv colon cancer
5834430|NCT00033748|stage IV rectal cancer|stage iv rectal cancer
5834431|NCT00033748|recurrent colon cancer|recurrent colon cancer
5834432|NCT00033748|recurrent rectal cancer|recurrent rectal cancer
5834433|NCT00033748|liver metastases|liver metastases
5834434|NCT00033709|adult leiomyosarcoma|adult leiomyosarcoma
5834435|NCT00033709|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5834653|NCT00031915|childhood synovial sarcoma|childhood synovial sarcoma
5834436|NCT00033709|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5834437|NCT00033709|stage III uterine sarcoma|stage iii uterine sarcoma
5834438|NCT00033709|stage IV uterine sarcoma|stage iv uterine sarcoma
5834439|NCT00033709|recurrent uterine sarcoma|recurrent uterine sarcoma
5834440|NCT00033709|uterine leiomyosarcoma|uterine leiomyosarcoma
5834441|NCT00033709|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5834442|NCT00033696|limited stage small cell lung cancer|limited stage small cell lung cancer
5834443|NCT00033683|stage I breast cancer|stage i breast cancer
5834444|NCT00033683|stage II breast cancer|stage ii breast cancer
5834445|NCT00033657|stage I gastric cancer|stage i gastric cancer
5834446|NCT00033657|stage II gastric cancer|stage ii gastric cancer
5834447|NCT00033657|stage III gastric cancer|stage iii gastric cancer
5834448|NCT00033657|stage IV gastric cancer|stage iv gastric cancer
5834449|NCT00033657|stage I esophageal cancer|stage i esophageal cancer
5834450|NCT00033657|stage II esophageal cancer|stage ii esophageal cancer
5834451|NCT00033657|stage III esophageal cancer|stage iii esophageal cancer
5834452|NCT00033657|stage IV esophageal cancer|stage iv esophageal cancer
5834453|NCT00033657|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5834454|NCT00033657|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5834455|NCT00033644|stage IV uterine sarcoma|stage iv uterine sarcoma
5834456|NCT00033644|recurrent uterine sarcoma|recurrent uterine sarcoma
5834457|NCT00033644|uterine leiomyosarcoma|uterine leiomyosarcoma
5834458|NCT00033631|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5834459|NCT00033631|stage IIB prostate cancer|stage iib prostate cancer
5834460|NCT00033631|stage IIA prostate cancer|stage iia prostate cancer
5834461|NCT00033566|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834462|NCT00033553|squamous cell lung cancer|squamous cell lung cancer
5834464|NCT00033553|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5686851|NCT00550290|Post-operative wound complications following vulvectomy|post-operative wound complications following vulvectomy
5686852|NCT00550277|Renal Cell Carcinoma|renal cell carcinoma
5686853|NCT00550277|Refractory|refractory
5686854|NCT00550277|LBH589|lbh589
5686855|NCT00550264|Hospital Readmission|hospital readmission
5686856|NCT00550264|Continuity of Care|continuity of care
5681506|NCT00573079|Kidney|kidney
5834465|NCT00033553|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834466|NCT00033553|adenocarcinoma of the lung|adenocarcinoma of the lung
5834467|NCT00033553|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5834468|NCT00033540|unresectable gallbladder cancer|unresectable gallbladder cancer
5834469|NCT00033540|recurrent gallbladder cancer|recurrent gallbladder cancer
5834470|NCT00033540|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5834471|NCT00033540|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5834472|NCT00033540|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5834473|NCT00033540|adenocarcinoma with squamous metaplasia of the gallbladder|adenocarcinoma with squamous metaplasia of the gallbladder
5834474|NCT00033540|squamous cell carcinoma of the gallbladder|squamous cell carcinoma of the gallbladder
5834475|NCT00033540|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5834476|NCT00033540|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5834477|NCT00033540|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5834478|NCT00033514|stage IV breast cancer|stage iv breast cancer
5834479|NCT00033514|recurrent breast cancer|recurrent breast cancer
5834480|NCT00033488|ovarian epithelial cancer|ovarian epithelial cancer
5834481|NCT00033475|post-transplant lymphoproliferative disorder|post-transplant lymphoproliferative disorder
5834482|NCT00033436|stage I bladder cancer|stage i bladder cancer
5834483|NCT00033436|stage II bladder cancer|stage ii bladder cancer
5834484|NCT00033436|stage III bladder cancer|stage iii bladder cancer
5834485|NCT00033436|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5834486|NCT00033423|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5834487|NCT00033423|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5834488|NCT00033423|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834489|NCT00033423|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5834490|NCT00033423|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5834491|NCT00033423|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5834492|NCT00033423|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5834493|NCT00033423|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5834494|NCT00033410|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5834495|NCT00033410|squamous cell lung cancer|squamous cell lung cancer
5834496|NCT00033410|large cell lung cancer|large cell lung cancer
5834497|NCT00033410|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834498|NCT00033410|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834499|NCT00033410|adenocarcinoma of the lung|adenocarcinoma of the lung
5834500|NCT00033397|stage II breast cancer|stage ii breast cancer
5834501|NCT00033397|stage IV breast cancer|stage iv breast cancer
5834502|NCT00033397|stage IIIA breast cancer|stage iiia breast cancer
5834503|NCT00033397|stage IIIB breast cancer|stage iiib breast cancer
5834504|NCT00033397|stage IIIC breast cancer|stage iiic breast cancer
5834505|NCT00033397|inflammatory breast cancer|inflammatory breast cancer
5834507|NCT00033332|stage I multiple myeloma|stage i multiple myeloma
5834508|NCT00033332|stage II multiple myeloma|stage ii multiple myeloma
5834509|NCT00033332|stage III multiple myeloma|stage iii multiple myeloma
5834510|NCT00033280|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5834511|NCT00033280|adult mixed glioma|adult mixed glioma
5834512|NCT00033241|stage II pancreatic cancer|stage ii pancreatic cancer
5834513|NCT00033241|stage III pancreatic cancer|stage iii pancreatic cancer
5834514|NCT00033241|recurrent pancreatic cancer|recurrent pancreatic cancer
5834515|NCT00033241|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834516|NCT00033241|stage IV pancreatic cancer|stage iv pancreatic cancer
5834517|NCT00033228|stage IV melanoma|stage iv melanoma
5834518|NCT00033228|recurrent melanoma|recurrent melanoma
5834519|NCT00032175|stage III pancreatic cancer|stage iii pancreatic cancer
5834520|NCT00032175|duct cell adenocarcinoma of the pancreas|duct cell adenocarcinoma of the pancreas
5834521|NCT00032175|stage IV pancreatic cancer|stage iv pancreatic cancer
5834522|NCT00032162|stage III cervical cancer|stage iii cervical cancer
5834523|NCT00032162|recurrent cervical cancer|recurrent cervical cancer
5834524|NCT00032162|stage IB cervical cancer|stage ib cervical cancer
5834525|NCT00032162|stage IIB cervical cancer|stage iib cervical cancer
5834526|NCT00032162|stage IVB cervical cancer|stage ivb cervical cancer
5834527|NCT00032162|stage IA cervical cancer|stage ia cervical cancer
5834528|NCT00032162|stage IIA cervical cancer|stage iia cervical cancer
5834529|NCT00032162|stage IVA cervical cancer|stage iva cervical cancer
5681521|NCT00573001|naive|naive
5681522|NCT00573001|HIV-1|hiv-1
5681523|NCT00573001|simplified treatment|simplified treatment
5681524|NCT00573001|Treatment Experienced|treatment experienced
5681525|NCT00572988|symptom management|symptom management
5834530|NCT00032162|stage I endometrial carcinoma|stage i endometrial carcinoma
5834531|NCT00032162|stage II endometrial carcinoma|stage ii endometrial carcinoma
5834532|NCT00032162|stage III endometrial carcinoma|stage iii endometrial carcinoma
5834533|NCT00032162|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5834534|NCT00032162|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5834536|NCT00032162|stage I uterine sarcoma|stage i uterine sarcoma
5834537|NCT00032162|stage II uterine sarcoma|stage ii uterine sarcoma
5834538|NCT00032162|stage III uterine sarcoma|stage iii uterine sarcoma
5834539|NCT00032162|stage IV uterine sarcoma|stage iv uterine sarcoma
5834540|NCT00032162|recurrent uterine sarcoma|recurrent uterine sarcoma
5834541|NCT00032162|ovarian sarcoma|ovarian sarcoma
5834542|NCT00032162|ovarian carcinosarcoma|ovarian carcinosarcoma
5834543|NCT00032149|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5834544|NCT00032149|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5834545|NCT00032149|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5834546|NCT00032149|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5834547|NCT00032149|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5834548|NCT00032149|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5834549|NCT00032149|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5834550|NCT00032149|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5834551|NCT00032136|stage I breast cancer|stage i breast cancer
5834552|NCT00032136|stage II breast cancer|stage ii breast cancer
5834553|NCT00032123|stage IV gastric cancer|stage iv gastric cancer
5834554|NCT00032123|stage IV esophageal cancer|stage iv esophageal cancer
5834555|NCT00032123|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5834556|NCT00032123|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5834557|NCT00032123|recurrent esophageal cancer|recurrent esophageal cancer
5834558|NCT00032123|recurrent gastric cancer|recurrent gastric cancer
5834559|NCT00032097|adult glioblastoma|adult glioblastoma
5834560|NCT00032097|adult giant cell glioblastoma|adult giant cell glioblastoma
5834561|NCT00032097|adult gliosarcoma|adult gliosarcoma
5834562|NCT00032084|non-small cell lung cancer|non-small cell lung cancer
5834563|NCT00032084|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5834564|NCT00032084|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5834565|NCT00032058|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5834566|NCT00032058|stage I prostate cancer|stage i prostate cancer
5834567|NCT00032058|stage IIB prostate cancer|stage iib prostate cancer
5834568|NCT00032058|stage IIA prostate cancer|stage iia prostate cancer
5834569|NCT00032045|iris melanoma|iris melanoma
5834570|NCT00032045|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5834571|NCT00032045|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5834572|NCT00032045|extraocular extension melanoma|extraocular extension melanoma
5834573|NCT00032045|recurrent intraocular melanoma|recurrent intraocular melanoma
5834574|NCT00032045|stage IV melanoma|stage iv melanoma
5834575|NCT00032045|recurrent melanoma|recurrent melanoma
5834576|NCT00032032|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5834577|NCT00032032|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5834578|NCT00032032|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834579|NCT00032032|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834580|NCT00032019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5834581|NCT00032019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5834582|NCT00032019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834583|NCT00032019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5834584|NCT00032019|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5834585|NCT00032019|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5834586|NCT00032019|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5834587|NCT00032019|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5834588|NCT00032006|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5834589|NCT00032006|stage I prostate cancer|stage i prostate cancer
5834590|NCT00032006|stage IIB prostate cancer|stage iib prostate cancer
5834591|NCT00032006|stage IIA prostate cancer|stage iia prostate cancer
5834592|NCT00032006|recurrent prostate cancer|recurrent prostate cancer
5834593|NCT00031980|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5834594|NCT00031980|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5834595|NCT00031980|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5834596|NCT00031980|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5834597|NCT00031980|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5834598|NCT00031980|anemia|anemia
5834599|NCT00031980|neutropenia|neutropenia
5834601|NCT00031967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834602|NCT00031967|tumors metastatic to brain|tumors metastatic to brain
5834603|NCT00031967|radiation toxicity|radiation toxicity
5834604|NCT00031941|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5834605|NCT00031941|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5834606|NCT00031941|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5834607|NCT00031941|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5834608|NCT00031941|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834609|NCT00031941|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5834610|NCT00031941|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5834611|NCT00031941|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5834612|NCT00031941|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5834613|NCT00031941|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5834614|NCT00031941|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5834615|NCT00031941|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5834616|NCT00031941|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5834617|NCT00031941|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5834618|NCT00031941|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5834619|NCT00031941|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5834620|NCT00031941|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834621|NCT00031941|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5834622|NCT00031941|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5834623|NCT00031941|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5834624|NCT00031941|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5834625|NCT00031941|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5834626|NCT00031941|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5834627|NCT00031941|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5834628|NCT00031941|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5834629|NCT00031941|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5834630|NCT00031941|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834631|NCT00031941|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5834632|NCT00031941|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5834633|NCT00031941|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5834634|NCT00031941|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5834635|NCT00031941|small intestine lymphoma|small intestine lymphoma
5834636|NCT00031941|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5834638|NCT00031941|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5834639|NCT00031941|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5834640|NCT00031941|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5834641|NCT00031941|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5834642|NCT00031941|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5834643|NCT00031928|leptomeningeal metastases|leptomeningeal metastases
5834644|NCT00031915|metastatic osteosarcoma|metastatic osteosarcoma
5834645|NCT00031915|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5834646|NCT00031915|recurrent osteosarcoma|recurrent osteosarcoma
5834647|NCT00031915|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5834648|NCT00031915|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5834649|NCT00031915|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5834650|NCT00031915|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5834651|NCT00031915|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5834652|NCT00031915|childhood fibrosarcoma|childhood fibrosarcoma
5834654|NCT00031915|childhood liposarcoma|childhood liposarcoma
5834655|NCT00031915|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5834656|NCT00031915|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5834657|NCT00031915|childhood angiosarcoma|childhood angiosarcoma
5834658|NCT00031915|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
5834659|NCT00031915|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5834660|NCT00031915|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5681527|NCT00572988|physical activity|physical activity
5681528|NCT00572988|health care utilization|health care utilization
5681529|NCT00572975|New diagnostic test for Cystic Fibrosis.|new diagnostic test for cystic fibrosis.
5848207|NCT00035802|Bipolar|bipolar
5681530|NCT00572949|heart disease|heart disease
5681531|NCT00572949|chest pain|chest pain
5834661|NCT00031915|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5834662|NCT00031915|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5834663|NCT00031902|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5834664|NCT00031902|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5834665|NCT00031902|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5834666|NCT00031902|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5834667|NCT00031902|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5834668|NCT00031902|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5834669|NCT00031902|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5834670|NCT00031876|stage IV breast cancer|stage iv breast cancer
5834671|NCT00031876|recurrent breast cancer|recurrent breast cancer
5834672|NCT00031863|stage II colon cancer|stage ii colon cancer
5834673|NCT00031863|stage III colon cancer|stage iii colon cancer
5834674|NCT00031863|stage II rectal cancer|stage ii rectal cancer
5834675|NCT00031863|stage III rectal cancer|stage iii rectal cancer
5834677|NCT00031837|thromboembolism|thromboembolism
5834678|NCT00031837|stage III pancreatic cancer|stage iii pancreatic cancer
5834679|NCT00031837|recurrent pancreatic cancer|recurrent pancreatic cancer
5834680|NCT00031837|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5834681|NCT00031837|stage IV pancreatic cancer|stage iv pancreatic cancer
5834682|NCT00031824|graft versus host disease|graft versus host disease
5834683|NCT00031798|fatigue|fatigue
5834684|NCT00031798|depression|depression
5834685|NCT00031798|quality of life|quality of life
5834686|NCT00031798|cognitive/functional effects|cognitive/functional effects
5834687|NCT00031798|recurrent adult brain tumor|recurrent adult brain tumor
5834688|NCT00031798|adult brain stem glioma|adult brain stem glioma
5834689|NCT00031798|adult glioblastoma|adult glioblastoma
5834690|NCT00031798|adult tumors metastatic to brain|adult tumors metastatic to brain
5834691|NCT00031798|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5834692|NCT00031798|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5834693|NCT00031798|adult mixed glioma|adult mixed glioma
5834694|NCT00031798|adult meningioma|adult meningioma
5834695|NCT00031798|adult anaplastic ependymoma|adult anaplastic ependymoma
5834696|NCT00031798|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5834697|NCT00031798|adult ependymoblastoma|adult ependymoblastoma
5834698|NCT00031798|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5834699|NCT00031798|adult subependymoma|adult subependymoma
5834700|NCT00031798|adult grade III meningioma|adult grade iii meningioma
5834701|NCT00031798|adult giant cell glioblastoma|adult giant cell glioblastoma
5834702|NCT00031798|adult gliosarcoma|adult gliosarcoma
5834703|NCT00031798|adult grade II meningioma|adult grade ii meningioma
5834704|NCT00031772|recurrent breast cancer|recurrent breast cancer
5834705|NCT00031772|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5834706|NCT00031759|cervical cancer|cervical cancer
5834707|NCT00031759|cervical intraepithelial neoplasia grade 1|cervical intraepithelial neoplasia grade 1
5834708|NCT00031759|cervical intraepithelial neoplasia grade 2|cervical intraepithelial neoplasia grade 2
5834709|NCT00031759|cervical intraepithelial neoplasia grade 3|cervical intraepithelial neoplasia grade 3
5834710|NCT00031746|prostate cancer|prostate cancer
5834711|NCT00031733|iris melanoma|iris melanoma
5834712|NCT00031733|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5834713|NCT00031733|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5834715|NCT00031733|recurrent intraocular melanoma|recurrent intraocular melanoma
5834716|NCT00031733|stage II melanoma|stage ii melanoma
5834717|NCT00031733|stage III melanoma|stage iii melanoma
5834718|NCT00031733|stage IV melanoma|stage iv melanoma
5834719|NCT00031733|recurrent melanoma|recurrent melanoma
5834720|NCT00031720|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5834721|NCT00031720|stage I breast cancer|stage i breast cancer
5834722|NCT00031720|stage II breast cancer|stage ii breast cancer
5834723|NCT00031720|stage IIIA breast cancer|stage iiia breast cancer
5834724|NCT00031720|recurrent breast cancer|recurrent breast cancer
5834725|NCT00031720|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5834726|NCT00031720|hot flashes|hot flashes
5834727|NCT00031642|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5834728|NCT00031642|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5834729|NCT00031642|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5834804|NCT00030771|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5834730|NCT00031642|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5834731|NCT00031642|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5834732|NCT00031642|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5834733|NCT00031642|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5834734|NCT00031642|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5834344|NCT00036790|recurrent breast cancer|recurrent breast cancer
5834735|NCT00031642|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834736|NCT00031642|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5834737|NCT00031642|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5834738|NCT00031642|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5834739|NCT00031642|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5834740|NCT00031642|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5834741|NCT00031616|stage IV colon cancer|stage iv colon cancer
5834742|NCT00031616|stage IV rectal cancer|stage iv rectal cancer
5834743|NCT00031616|recurrent colon cancer|recurrent colon cancer
5834744|NCT00031616|recurrent rectal cancer|recurrent rectal cancer
5834745|NCT00031616|adenocarcinoma of the colon|adenocarcinoma of the colon
5834746|NCT00031616|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5834747|NCT00031590|average risk medulloblastoma|average risk medulloblastoma
5834748|NCT00031590|craniospinal radiotherapy|craniospinal radiotherapy
5834750|NCT00031577|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5834752|NCT00031564|renal cell carcinoma|renal cell carcinoma
5834753|NCT00030914|hot flashes|hot flashes
5834754|NCT00030901|prostate cancer|prostate cancer
5834755|NCT00030901|high grade prostatic intraepithelial neoplasia|high grade prostatic intraepithelial neoplasia
5834756|NCT00030888|stage III renal cell cancer|stage iii renal cell cancer
5834757|NCT00030888|stage IV renal cell cancer|stage iv renal cell cancer
5834758|NCT00030888|recurrent renal cell cancer|recurrent renal cell cancer
5834759|NCT00030875|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5834760|NCT00030875|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5834761|NCT00030875|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5834762|NCT00030875|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5834763|NCT00030875|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5834764|NCT00030875|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5834765|NCT00030862|stage II esophageal cancer|stage ii esophageal cancer
5834766|NCT00030862|stage III esophageal cancer|stage iii esophageal cancer
5834767|NCT00030862|stage IV esophageal cancer|stage iv esophageal cancer
5834768|NCT00030862|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5834769|NCT00030862|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5834770|NCT00030849|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5834771|NCT00030849|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5834772|NCT00030849|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5834773|NCT00030849|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5834774|NCT00030849|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5834775|NCT00030823|stage I breast cancer|stage i breast cancer
5834776|NCT00030823|stage II breast cancer|stage ii breast cancer
5834777|NCT00030823|stage IV breast cancer|stage iv breast cancer
5834778|NCT00030823|stage IIIA breast cancer|stage iiia breast cancer
5834779|NCT00030823|recurrent breast cancer|recurrent breast cancer
5834780|NCT00030823|stage IIIB breast cancer|stage iiib breast cancer
5834781|NCT00030823|stage IIIC breast cancer|stage iiic breast cancer
5834782|NCT00030823|male breast cancer|male breast cancer
5834783|NCT00030810|squamous cell lung cancer|squamous cell lung cancer
5834784|NCT00030810|large cell lung cancer|large cell lung cancer
5834785|NCT00030810|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5847369|NCT00039845|Language|language
5834786|NCT00030810|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5834787|NCT00030784|adult angiosarcoma|adult angiosarcoma
5834788|NCT00030784|adult fibrosarcoma|adult fibrosarcoma
5834789|NCT00030784|adult leiomyosarcoma|adult leiomyosarcoma
5834790|NCT00030784|adult liposarcoma|adult liposarcoma
5834791|NCT00030784|adult neurofibrosarcoma|adult neurofibrosarcoma
5834792|NCT00030784|adult synovial sarcoma|adult synovial sarcoma
5834793|NCT00030784|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5834794|NCT00030784|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5834795|NCT00030784|adult epithelioid sarcoma|adult epithelioid sarcoma
5834796|NCT00030784|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5834797|NCT00030784|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5834798|NCT00030784|adult malignant mesenchymoma|adult malignant mesenchymoma
5834799|NCT00030784|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5834800|NCT00030784|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5834801|NCT00030771|squamous cell lung cancer|squamous cell lung cancer
5834802|NCT00030771|large cell lung cancer|large cell lung cancer
5681532|NCT00572949|coronary artery disease|coronary artery disease
5681533|NCT00572949|atherosclerosis|atherosclerosis
5681534|NCT00572936|Glaucoma|glaucoma
5681535|NCT00572936|Ocular Hypertension|ocular hypertension
5681536|NCT00572936|Timolol®, Latanoprost® and Dorzolamide®|timolol®, latanoprost® and dorzolamide®
5681537|NCT00572923|radiotherapy|radiotherapy
5681538|NCT00572923|LD-SCLC|ld-sclc
5681539|NCT00572923|stage I-III small cell lung cancer|stage i-iii small cell lung cancer
5686857|NCT00550264|Quality of Health Care|quality of health care
5686858|NCT00550251|Nausea|nausea
5686859|NCT00550251|Vomiting|vomiting
5686860|NCT00550251|Emesis|emesis
5686861|NCT00550251|Palliative|palliative
5686862|NCT00550251|Terminal|terminal
5686863|NCT00550251|Cancer|cancer
5686864|NCT00550238|Parkinson's Disease Psychosis|parkinson's disease psychosis
5686865|NCT00550225|succinate|succinate
5686866|NCT00550225|anti-muscarinic|anti-muscarinic
5686867|NCT00550225|b-agonist|b-agonist
5686868|NCT00550212|healthy subjects|healthy subjects
5859059|NCT00007631|NMSC|nmsc
5834803|NCT00030771|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5834805|NCT00030758|neutropenia|neutropenia
5834808|NCT00030745|stage IA malignant mesothelioma|stage ia malignant mesothelioma
5834809|NCT00030745|stage IB malignant mesothelioma|stage ib malignant mesothelioma
5834810|NCT00030745|stage II malignant mesothelioma|stage ii malignant mesothelioma
5834811|NCT00030745|stage III malignant mesothelioma|stage iii malignant mesothelioma
5834812|NCT00030732|stage III pancreatic cancer|stage iii pancreatic cancer
5834813|NCT00030732|recurrent pancreatic cancer|recurrent pancreatic cancer
5834814|NCT00030732|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5834815|NCT00030732|stage IV pancreatic cancer|stage iv pancreatic cancer
5834816|NCT00030719|regional neuroblastoma|regional neuroblastoma
5834817|NCT00030719|disseminated neuroblastoma|disseminated neuroblastoma
5834818|NCT00030719|stage 4S neuroblastoma|stage 4s neuroblastoma
5834819|NCT00030719|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5846665|NCT00043823|Tarceva|tarceva
5834821|NCT00030706|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5834822|NCT00030706|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5834823|NCT00030706|peritoneal cavity cancer|peritoneal cavity cancer
5834825|NCT00030654|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5834826|NCT00030654|stage IIB prostate cancer|stage iib prostate cancer
5834827|NCT00030654|stage IIA prostate cancer|stage iia prostate cancer
5834828|NCT00030654|stage III prostate cancer|stage iii prostate cancer
5834829|NCT00030654|stage IV prostate cancer|stage iv prostate cancer
5834830|NCT00030654|recurrent prostate cancer|recurrent prostate cancer
5834831|NCT00030641|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5834832|NCT00030641|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834833|NCT00030641|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5834834|NCT00030628|tumors metastatic to brain|tumors metastatic to brain
5834835|NCT00030589|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5834836|NCT00030589|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5834837|NCT00030589|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5834838|NCT00030589|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5834839|NCT00030589|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5834840|NCT00030589|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5834841|NCT00030576|recurrent metastatic squamous neck cancer occult primary|recurrent metastatic squamous neck cancer occult primary
5834842|NCT00030576|neck cancer with occult primary squamous carcinoma|neck cancer with occult primary squamous carcinoma
5834843|NCT00030576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5834844|NCT00030576|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5834845|NCT00030576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5834846|NCT00030576|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5834847|NCT00030576|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5834848|NCT00030576|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5834849|NCT00030576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5834850|NCT00030576|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5834851|NCT00030576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5834852|NCT00030576|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5834853|NCT00030576|squamous cell carcinoma of paranasal sinus and nasal cavity|squamous cell carcinoma of paranasal sinus and nasal cavity
5834854|NCT00030576|recurrent squamous cell carcinoma of sinus and nasal cavity|recurrent squamous cell carcinoma of sinus and nasal cavity
5834855|NCT00030563|liver metastases|liver metastases
5834856|NCT00030563|stage IV colon cancer|stage iv colon cancer
5834857|NCT00030563|stage IV rectal cancer|stage iv rectal cancer
5834463|NCT00033553|large cell lung cancer|large cell lung cancer
5834858|NCT00030563|adenocarcinoma of the colon|adenocarcinoma of the colon
5863185|NCT00001361|Magnetic Resonance Imaging|magnetic resonance imaging
5681540|NCT00572897|Myelofibrosis|myelofibrosis
5681541|NCT00572897|Myeloproliferative disease|myeloproliferative disease
5681542|NCT00572897|Stem Cell Transplant|stem cell transplant
5681543|NCT00572897|Allogeneic Transplant|allogeneic transplant
5681544|NCT00572897|Conditioning Regimen|conditioning regimen
5859147|NCT00007215|Age-Related Changes|age-related changes
5834859|NCT00030563|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5834860|NCT00030563|recurrent colon cancer|recurrent colon cancer
5834861|NCT00030563|recurrent rectal cancer|recurrent rectal cancer
5834862|NCT00030550|refractory anemia|refractory anemia
5834863|NCT00030550|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5834864|NCT00030550|refractory anemia with excess blasts|refractory anemia with excess blasts
5834865|NCT00030550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5834866|NCT00030550|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5848736|NCT00033969|Healthy Volunteer|healthy volunteer
5848738|NCT00033956|Metastatic Melanoma|metastatic melanoma
5834867|NCT00030550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5834868|NCT00030550|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5834869|NCT00030550|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5834870|NCT00030537|stage IV breast cancer|stage iv breast cancer
5834871|NCT00030537|recurrent breast cancer|recurrent breast cancer
5834872|NCT00030537|stage IIIB breast cancer|stage iiib breast cancer
5834873|NCT00030537|male breast cancer|male breast cancer
5834874|NCT00030511|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5834875|NCT00030511|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5834876|NCT00030511|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5834877|NCT00030511|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5834878|NCT00030485|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5834879|NCT00030485|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5834880|NCT00030485|endometrial adenocarcinoma|endometrial adenocarcinoma
5834881|NCT00030485|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5834882|NCT00030472|recurrent cervical cancer|recurrent cervical cancer
5834883|NCT00030472|stage IVB cervical cancer|stage ivb cervical cancer
5834884|NCT00030472|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5834885|NCT00030459|localized malignant mesothelioma|localized malignant mesothelioma
5834886|NCT00030459|advanced malignant mesothelioma|advanced malignant mesothelioma
5834887|NCT00030459|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5834888|NCT00030433|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5834889|NCT00030407|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5834890|NCT00030407|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5834891|NCT00030355|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5834892|NCT00030355|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5834893|NCT00030355|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5834894|NCT00030355|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5834895|NCT00030355|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5834896|NCT00030342|stage IV colon cancer|stage iv colon cancer
5834897|NCT00030342|stage IV rectal cancer|stage iv rectal cancer
5834898|NCT00030342|recurrent colon cancer|recurrent colon cancer
5834899|NCT00030342|recurrent rectal cancer|recurrent rectal cancer
5834900|NCT00030342|stage IV renal cell cancer|stage iv renal cell cancer
5834901|NCT00030342|recurrent renal cell cancer|recurrent renal cell cancer
5834902|NCT00030303|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5834903|NCT00030303|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5834904|NCT00030290|stage I prostate cancer|stage i prostate cancer
5834905|NCT00030290|stage IIB prostate cancer|stage iib prostate cancer
5834906|NCT00030290|stage IIA prostate cancer|stage iia prostate cancer
5834907|NCT00030277|stage I prostate cancer|stage i prostate cancer
5834908|NCT00030277|stage IIB prostate cancer|stage iib prostate cancer
5834909|NCT00030277|stage IIA prostate cancer|stage iia prostate cancer
5834910|NCT00030277|recurrent prostate cancer|recurrent prostate cancer
5834911|NCT00030264|plexiform neurofibroma|plexiform neurofibroma
5834912|NCT00030264|neurofibromatosis type 1|neurofibromatosis type 1
5834913|NCT00030108|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5834914|NCT00030108|childhood craniopharyngioma|childhood craniopharyngioma
5834915|NCT00030108|recurrent neuroblastoma|recurrent neuroblastoma
5834916|NCT00030108|recurrent childhood liver cancer|recurrent childhood liver cancer
5834917|NCT00030108|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5834918|NCT00030108|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5697781|NCT00508612|Ambulatory Blood Pressure Monitoring|ambulatory blood pressure monitoring
5686869|NCT00550199|Solid Tumors|solid tumors
5686870|NCT00550199|Phase I|phase i
5686871|NCT00550199|LBH589|lbh589
5686872|NCT00550199|Gemcitabine|gemcitabine
5686873|NCT00550186|spinal anesthesia|spinal anesthesia
5686874|NCT00550186|preload|preload
5697783|NCT00508612|Meditation|meditation
5697784|NCT00508612|Coping Skills|coping skills
5834919|NCT00030108|recurrent osteosarcoma|recurrent osteosarcoma
5834920|NCT00030108|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5834921|NCT00030108|childhood germ cell tumor|childhood germ cell tumor
5834922|NCT00030108|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5834923|NCT00030108|childhood oligodendroglioma|childhood oligodendroglioma
5834924|NCT00030108|childhood choroid plexus tumor|childhood choroid plexus tumor
5834925|NCT00030108|childhood grade I meningioma|childhood grade i meningioma
5834926|NCT00030108|childhood grade II meningioma|childhood grade ii meningioma
5834927|NCT00030108|childhood grade III meningioma|childhood grade iii meningioma
5834928|NCT00030108|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5834929|NCT00030108|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5834930|NCT00030108|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5834931|NCT00030108|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5848844|NCT00032942|opiate dependence|opiate dependence
5848845|NCT00032929|Cocaine Dependence|cocaine dependence
5848846|NCT00032903|Malignant Glioma, Camptothecin, Pharmacokinetics|malignant glioma, camptothecin, pharmacokinetics
5848847|NCT00032890|osteoarthritis|osteoarthritis
5834932|NCT00030108|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5834933|NCT00030108|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5834934|NCT00030108|recurrent childhood ependymoma|recurrent childhood ependymoma
5834936|NCT00030108|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5834937|NCT00030108|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5834938|NCT00030108|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5834939|NCT00030108|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5834940|NCT00030108|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5834941|NCT00030108|childhood acute basophilic leukemia|childhood acute basophilic leukemia
5834942|NCT00030108|childhood acute eosinophilic leukemia|childhood acute eosinophilic leukemia
5834943|NCT00030108|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5834944|NCT00030108|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5834945|NCT00030108|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5834946|NCT00030108|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5834947|NCT00030108|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5834948|NCT00030108|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5834949|NCT00030108|non-T, non-B, cALLa negative childhood acute lymphoblastic leukemia|non-t, non-b, calla negative childhood acute lymphoblastic leukemia
5834950|NCT00030108|non-T, non-B, cALLa positive childhood acute lymphoblastic leukemia|non-t, non-b, calla positive childhood acute lymphoblastic leukemia
5834951|NCT00030108|non-T, non-B, cALLa positive, pre-B childhood acute lymphoblastic leukemia|non-t, non-b, calla positive, pre-b childhood acute lymphoblastic leukemia
5834952|NCT00030108|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5834953|NCT00030108|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5834954|NCT00030108|TdT negative childhood acute lymphoblastic leukemia|tdt negative childhood acute lymphoblastic leukemia
5834955|NCT00030108|TdT positive childhood acute lymphoblastic leukemia|tdt positive childhood acute lymphoblastic leukemia
5834956|NCT00030108|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5834957|NCT00030108|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5834958|NCT00030095|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5834959|NCT00030082|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5834960|NCT00030082|advanced adult primary liver cancer|advanced adult primary liver cancer
5834961|NCT00030082|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5834962|NCT00030082|liver metastases|liver metastases
5834963|NCT00029029|bone metastases|bone metastases
5834965|NCT00028990|stage IV breast cancer|stage iv breast cancer
5834966|NCT00028990|recurrent breast cancer|recurrent breast cancer
5834967|NCT00028990|male breast cancer|male breast cancer
5834968|NCT00028977|stage IV breast cancer|stage iv breast cancer
5834969|NCT00028977|recurrent breast cancer|recurrent breast cancer
5834970|NCT00028964|stage I breast cancer|stage i breast cancer
5834971|NCT00028964|stage II breast cancer|stage ii breast cancer
5834972|NCT00028964|stage IIIA breast cancer|stage iiia breast cancer
5834973|NCT00028964|recurrent breast cancer|recurrent breast cancer
5686875|NCT00550186|diuresis|diuresis
5681526|NCT00572988|function status|function status
5834974|NCT00028964|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5834975|NCT00028951|lymphedema|lymphedema
5863186|NCT00001361|Plasticity|plasticity
5697786|NCT00508599|type 2 diabetes|type 2 diabetes
5697787|NCT00508599|bed rest|bed rest
5697788|NCT00508599|insulin resistance|insulin resistance
5697789|NCT00508599|insulin|insulin
5697790|NCT00508599|glucose|glucose
5697793|NCT00508586|PTC299|ptc299
5681545|NCT00572897|Reduced Intensity Regimen|reduced intensity regimen
5681546|NCT00572897|Fludarabine|fludarabine
5681547|NCT00572897|Melphalan|melphalan
5834976|NCT00028951|perioperative/postoperative complications|perioperative/postoperative complications
5834977|NCT00028951|stage I vulvar cancer|stage i vulvar cancer
5834978|NCT00028951|stage II vulvar cancer|stage ii vulvar cancer
5834979|NCT00028951|stage III vulvar cancer|stage iii vulvar cancer
5834980|NCT00028951|stage IVB vulvar cancer|stage ivb vulvar cancer
5834981|NCT00028912|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5834982|NCT00028912|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5834983|NCT00028912|fallopian tube cancer|fallopian tube cancer
5834984|NCT00028899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5834985|NCT00028899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5834986|NCT00028899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5834987|NCT00028886|stage II multiple myeloma|stage ii multiple myeloma
5834988|NCT00028886|stage III multiple myeloma|stage iii multiple myeloma
5834989|NCT00028873|stage IV breast cancer|stage iv breast cancer
5834990|NCT00028873|recurrent breast cancer|recurrent breast cancer
5828209|NCT00061568|DBA|dba
5834991|NCT00028860|stage III bladder cancer|stage iii bladder cancer
5834992|NCT00028860|stage IV bladder cancer|stage iv bladder cancer
5848950|NCT00032500|common cold|common cold
5848951|NCT00032500|Echinacea|echinacea
5848953|NCT00032487|glycemic control|glycemic control
5848954|NCT00032487|insulin|insulin
5834993|NCT00028860|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5834994|NCT00028860|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5834995|NCT00028860|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5834996|NCT00028847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5834997|NCT00028847|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5834998|NCT00028795|childhood brain stem glioma|childhood brain stem glioma
5834999|NCT00028795|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5835000|NCT00028795|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5835001|NCT00028795|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5835002|NCT00028769|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835003|NCT00028769|stage IV prostate cancer|stage iv prostate cancer
5835004|NCT00028769|recurrent prostate cancer|recurrent prostate cancer
5835005|NCT00028743|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5835006|NCT00028743|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5835007|NCT00028743|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5835008|NCT00028743|fallopian tube cancer|fallopian tube cancer
5835009|NCT00028743|peritoneal cavity cancer|peritoneal cavity cancer
5835010|NCT00028730|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5835011|NCT00028730|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5835012|NCT00028730|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5835013|NCT00028730|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5835014|NCT00028730|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5835015|NCT00028730|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5835016|NCT00028730|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5835017|NCT00028730|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5835018|NCT00028730|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5835019|NCT00028730|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5835020|NCT00028730|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5835021|NCT00028717|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5835022|NCT00028717|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5835023|NCT00028717|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5835024|NCT00028717|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5835025|NCT00028717|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5835026|NCT00028717|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5835027|NCT00028717|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5835028|NCT00028717|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5835029|NCT00028717|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5686877|NCT00550147|ADHD-Combined TypeDisruptive behavior Disorder|adhd-combined typedisruptive behavior disorder
5686878|NCT00550134|Breast Cancer|breast cancer
5686879|NCT00550134|Quality of life|quality of life
5686880|NCT00550108|pancreatic cyst|pancreatic cyst
5686881|NCT00550108|ethanol injection|ethanol injection
5835030|NCT00028717|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5835031|NCT00028717|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5835032|NCT00028717|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5835033|NCT00028717|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5835034|NCT00028717|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5835035|NCT00028717|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5835036|NCT00028704|stage II breast cancer|stage ii breast cancer
5835037|NCT00028704|stage IIIA breast cancer|stage iiia breast cancer
5835038|NCT00028704|stage IIIB breast cancer|stage iiib breast cancer
5835039|NCT00028704|inflammatory breast cancer|inflammatory breast cancer
5835040|NCT00028691|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5835041|NCT00028691|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5835042|NCT00028691|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5835043|NCT00028691|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5835044|NCT00028691|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5835045|NCT00028691|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5835046|NCT00028665|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5835047|NCT00028665|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5835048|NCT00028665|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5835049|NCT00028665|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5835050|NCT00028665|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5849042|NCT00031408|Genetic Screening|genetic screening
5849043|NCT00031395|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5849045|NCT00031395|clonidine|clonidine
5849048|NCT00031382|Functional MRI|functional mri
5835051|NCT00028665|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5835052|NCT00028665|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5835053|NCT00028665|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5835054|NCT00028665|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5835055|NCT00028665|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5835056|NCT00028665|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5835057|NCT00028665|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5835058|NCT00028665|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5835059|NCT00028665|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5835060|NCT00028665|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5835061|NCT00028665|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5835062|NCT00028665|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5835064|NCT00028665|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5835065|NCT00028665|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5835066|NCT00028665|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5835067|NCT00028665|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5835068|NCT00028665|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5835069|NCT00028665|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5835070|NCT00028665|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5835071|NCT00028665|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5835072|NCT00028652|skin metastases|skin metastases
5835073|NCT00028639|stage IV breast cancer|stage iv breast cancer
5835074|NCT00028639|recurrent breast cancer|recurrent breast cancer
5835075|NCT00028626|liver metastases|liver metastases
5835076|NCT00028626|adenocarcinoma of the colon|adenocarcinoma of the colon
5835077|NCT00028626|recurrent colon cancer|recurrent colon cancer
5835078|NCT00028626|stage IV colon cancer|stage iv colon cancer
5835079|NCT00028626|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835080|NCT00028626|recurrent rectal cancer|recurrent rectal cancer
5848209|NCT00035802|Pediatric|pediatric
5835081|NCT00028626|stage IV rectal cancer|stage iv rectal cancer
5835082|NCT00028600|refractory multiple myeloma|refractory multiple myeloma
5835083|NCT00028600|stage I multiple myeloma|stage i multiple myeloma
5835084|NCT00028600|stage II multiple myeloma|stage ii multiple myeloma
5835085|NCT00028600|stage III multiple myeloma|stage iii multiple myeloma
5835086|NCT00028574|stage I prostate cancer|stage i prostate cancer
5835087|NCT00028574|stage IIB prostate cancer|stage iib prostate cancer
5834749|NCT00031590|newly diagnosed|newly diagnosed
5835088|NCT00028574|stage IIA prostate cancer|stage iia prostate cancer
5835089|NCT00028574|stage III prostate cancer|stage iii prostate cancer
5835090|NCT00028574|stage IV prostate cancer|stage iv prostate cancer
5681550|NCT00572884|pyrethroid|pyrethroid
5681551|NCT00572884|pharmacokinetics|pharmacokinetics
5681552|NCT00572884|metabolism|metabolism
5681553|NCT00572884|accelerator mass spectrometry|accelerator mass spectrometry
5681554|NCT00572884|human exposure|human exposure
5835091|NCT00028574|recurrent prostate cancer|recurrent prostate cancer
5835092|NCT00028574|hot flashes|hot flashes
5835093|NCT00028548|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835094|NCT00028509|neurotoxicity|neurotoxicity
5835095|NCT00028509|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5835096|NCT00028015|stage IV colon cancer|stage iv colon cancer
5835097|NCT00028015|stage IV rectal cancer|stage iv rectal cancer
5835098|NCT00028015|recurrent colon cancer|recurrent colon cancer
5835099|NCT00028015|recurrent rectal cancer|recurrent rectal cancer
5835100|NCT00027989|stage IV breast cancer|stage iv breast cancer
5835101|NCT00027976|actinic keratosis|actinic keratosis
5835102|NCT00027963|neurotoxicity|neurotoxicity
5835104|NCT00027937|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5835105|NCT00027937|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5835106|NCT00027937|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5835107|NCT00027937|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5835108|NCT00027937|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5835109|NCT00027937|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5835110|NCT00027937|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835111|NCT00027937|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5835112|NCT00027937|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5835113|NCT00027937|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5835114|NCT00027937|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5835115|NCT00027937|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5835116|NCT00027937|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5835117|NCT00027937|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5835118|NCT00027937|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5835119|NCT00027937|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5835120|NCT00027937|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5835121|NCT00027937|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5835122|NCT00027937|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5835123|NCT00027937|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5835124|NCT00027937|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5835125|NCT00027937|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5835126|NCT00027937|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5835127|NCT00027937|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5835128|NCT00027937|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5835129|NCT00027937|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5835130|NCT00027937|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5835131|NCT00027937|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5835132|NCT00027937|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5835133|NCT00027937|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5835134|NCT00027937|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5835135|NCT00027937|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5835136|NCT00027937|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5835137|NCT00027937|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5835138|NCT00027937|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5835139|NCT00027937|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5835140|NCT00027937|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5835141|NCT00027937|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5835142|NCT00027937|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5835143|NCT00027937|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5835144|NCT00027937|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5835145|NCT00027937|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5835146|NCT00027937|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5835147|NCT00027937|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5835148|NCT00027937|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5835149|NCT00027937|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5835150|NCT00027937|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5686882|NCT00550095|Microalbuminuria/proteinuria|microalbuminuria/proteinuria
5686883|NCT00550095|hypertensive patients with type 2 diabetes|hypertensive patients with type 2 diabetes
5686884|NCT00550095|Valsartan|valsartan
5686885|NCT00550095|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes|microalbuminuria/proteinuria in hypertensive patients with type 2 diabetes
5686886|NCT00550082|Anticoagulation|anticoagulation
5686887|NCT00550082|High-Risk|high-risk
5686888|NCT00550082|Deep Vein Thrombosis|deep vein thrombosis
5835151|NCT00027937|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5835152|NCT00027937|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5835153|NCT00027937|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5835154|NCT00027937|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5835155|NCT00027937|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5835156|NCT00027937|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5835157|NCT00027937|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5835158|NCT00027937|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5835159|NCT00027937|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5835160|NCT00027937|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5835161|NCT00027937|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5835162|NCT00027937|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5835163|NCT00027937|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5835164|NCT00027937|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5835165|NCT00027937|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5835166|NCT00027937|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5835167|NCT00027937|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5835168|NCT00027937|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5835169|NCT00027937|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5835170|NCT00027937|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5835171|NCT00027937|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5849256|NCT00030199|Blink Reflex|blink reflex
5849257|NCT00030199|Motor Cortex|motor cortex
5849258|NCT00030199|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5849259|NCT00030199|Healthy Volunteer|healthy volunteer
5849260|NCT00030199|HV|hv
5849261|NCT00030199|Normal Control|normal control
5849262|NCT00030186|AML|aml
5849263|NCT00030186|FLT-3 mutation|flt-3 mutation
5849266|NCT00030160|Obesity|obesity
5835172|NCT00027937|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5835173|NCT00027937|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5835174|NCT00027937|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5835175|NCT00027937|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5835176|NCT00027937|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5835177|NCT00027937|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5835178|NCT00027937|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5835179|NCT00027937|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5835180|NCT00027937|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5835181|NCT00027937|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5835182|NCT00027937|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5835183|NCT00027937|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5835184|NCT00027937|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5835185|NCT00027937|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5835186|NCT00027937|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5835187|NCT00027937|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5835188|NCT00027937|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5835189|NCT00027937|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5835190|NCT00027937|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5835191|NCT00027937|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5835192|NCT00027937|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5686889|NCT00550082|Pulmonary Embolism|pulmonary embolism
5686890|NCT00550082|Surgery|surgery
5686891|NCT00550069|late preterm infants|late preterm infants
5686892|NCT00550069|near term infants|near term infants
5686893|NCT00550069|outcome|outcome
5686894|NCT00550056|PTSD, Posttraumatic Stress Disorder, refugees, war|ptsd, posttraumatic stress disorder, refugees, war
5835193|NCT00027937|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5835194|NCT00027937|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5835195|NCT00027937|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5835196|NCT00027937|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5835197|NCT00027937|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5835198|NCT00027937|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5835199|NCT00027937|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5835200|NCT00027937|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5835202|NCT00027911|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5835203|NCT00027911|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5835204|NCT00027911|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5681556|NCT00572845|Basal Energy Expenditure|basal energy expenditure
5681557|NCT00572845|Spasticity|spasticity
5681558|NCT00572845|Modified Ashworth Scale|modified ashworth scale
5681559|NCT00572845|Penn Spasm Frequency Score|penn spasm frequency score
5835205|NCT00027911|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5835206|NCT00027885|stage IV breast cancer|stage iv breast cancer
5835207|NCT00027885|stage IIIA breast cancer|stage iiia breast cancer
5835208|NCT00027885|stage IIIB breast cancer|stage iiib breast cancer
5835209|NCT00027885|stage IIIC breast cancer|stage iiic breast cancer
5835210|NCT00027885|male breast cancer|male breast cancer
5835211|NCT00027859|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835212|NCT00027859|stage III prostate cancer|stage iii prostate cancer
5848210|NCT00035802|Children|children
5835213|NCT00027846|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5835214|NCT00027846|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5835215|NCT00027846|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5835216|NCT00027833|stage IV colon cancer|stage iv colon cancer
5835217|NCT00027833|stage IV rectal cancer|stage iv rectal cancer
5835218|NCT00027833|adenocarcinoma of the colon|adenocarcinoma of the colon
5835219|NCT00027833|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835220|NCT00027807|stage IV breast cancer|stage iv breast cancer
5835221|NCT00027807|recurrent breast cancer|recurrent breast cancer
5835222|NCT00027807|ductal breast carcinoma|ductal breast carcinoma
5835223|NCT00027794|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835224|NCT00027794|stage III prostate cancer|stage iii prostate cancer
5835225|NCT00027781|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835226|NCT00027781|recurrent prostate cancer|recurrent prostate cancer
5835227|NCT00027768|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5835228|NCT00027768|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5835229|NCT00027742|iris melanoma|iris melanoma
5835230|NCT00027742|extraocular extension melanoma|extraocular extension melanoma
5835231|NCT00027742|recurrent intraocular melanoma|recurrent intraocular melanoma
5835232|NCT00027742|stage III melanoma|stage iii melanoma
5835233|NCT00027742|stage IV melanoma|stage iv melanoma
5835234|NCT00027742|recurrent melanoma|recurrent melanoma
5835235|NCT00027729|recurrent colon cancer|recurrent colon cancer
5835236|NCT00027729|recurrent rectal cancer|recurrent rectal cancer
5835237|NCT00027716|metastatic osteosarcoma|metastatic osteosarcoma
5835238|NCT00027716|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5835239|NCT00027716|recurrent osteosarcoma|recurrent osteosarcoma
5835240|NCT00027716|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5835241|NCT00027716|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5835242|NCT00027716|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5835243|NCT00027716|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5835244|NCT00027677|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835245|NCT00027664|stage IV renal cell cancer|stage iv renal cell cancer
5835246|NCT00027638|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5835247|NCT00027638|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5835248|NCT00027638|gastrinoma|gastrinoma
5835249|NCT00027638|insulinoma|insulinoma
5835250|NCT00027638|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5835251|NCT00027638|WDHA syndrome|wdha syndrome
5835252|NCT00027638|somatostatinoma|somatostatinoma
5835253|NCT00027638|pancreatic polypeptide tumor|pancreatic polypeptide tumor
5835254|NCT00027638|glucagonoma|glucagonoma
5686895|NCT00550043|Rheumatoid arthritis|rheumatoid arthritis
5686896|NCT00550030|Psoriasis|psoriasis
5686897|NCT00550030|UVB radiation|uvb radiation
5686898|NCT00550030|Biologics|biologics
5834964|NCT00029029|pain|pain
5835255|NCT00027638|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5835256|NCT00027625|recurrent adult brain tumor|recurrent adult brain tumor
5835257|NCT00027625|adult glioblastoma|adult glioblastoma
5835258|NCT00027625|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5835259|NCT00027625|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5835260|NCT00027625|adult mixed glioma|adult mixed glioma
5835261|NCT00027625|adult giant cell glioblastoma|adult giant cell glioblastoma
5835262|NCT00027625|adult gliosarcoma|adult gliosarcoma
5835263|NCT00027586|stage IV melanoma|stage iv melanoma
5835264|NCT00027586|recurrent melanoma|recurrent melanoma
5835265|NCT00027586|Imatinib Mesylate|imatinib mesylate
5835266|NCT00027586|Gleevec|gleevec
5835267|NCT00027586|protein tyrosine kinases|protein tyrosine kinases
5835268|NCT00027586|PTK|ptk
5835269|NCT00027586|Gleevec targets|gleevec targets
5835270|NCT00027586|metastatic melanoma|metastatic melanoma
5835271|NCT00027573|stage IV renal cell cancer|stage iv renal cell cancer
5835272|NCT00027573|recurrent renal cell cancer|recurrent renal cell cancer
5835273|NCT00027573|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5835274|NCT00027573|papillary renal cell carcinoma|papillary renal cell carcinoma
5835275|NCT00027560|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5835276|NCT00027560|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5835277|NCT00027560|refractory multiple myeloma|refractory multiple myeloma
5835278|NCT00027560|stage II multiple myeloma|stage ii multiple myeloma
5835279|NCT00027560|stage III multiple myeloma|stage iii multiple myeloma
5835280|NCT00027560|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5835281|NCT00027560|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5835282|NCT00027560|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5835283|NCT00027560|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5835284|NCT00027560|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5835285|NCT00027560|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5835286|NCT00027560|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5835287|NCT00027560|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5835288|NCT00027560|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5835289|NCT00027560|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5835444|NCT00025649|regional neuroblastoma|regional neuroblastoma
5835290|NCT00027560|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5835291|NCT00027560|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5835292|NCT00027560|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5835293|NCT00027560|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5835294|NCT00027560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5835295|NCT00027560|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5835296|NCT00027560|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5835401|NCT00026117|stage IV breast cancer|stage iv breast cancer
5849469|NCT00029341|Drug Therapy, Combination|drug therapy, combination
5849470|NCT00029341|Drug Administration Schedule|drug administration schedule
5835297|NCT00027560|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5835298|NCT00027560|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5835299|NCT00027560|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5835300|NCT00027560|Waldenström macroglobulinemia|waldenström macroglobulinemia
5835301|NCT00027560|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5835302|NCT00027560|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5835303|NCT00027560|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5835304|NCT00027560|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5835305|NCT00027560|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5835306|NCT00027560|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5835307|NCT00027560|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5835308|NCT00027560|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5835309|NCT00027560|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5835310|NCT00027560|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5835311|NCT00027547|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5835312|NCT00027547|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5835313|NCT00027534|recurrent colon cancer|recurrent colon cancer
5686899|NCT00550030|Etanercept|etanercept
5686900|NCT00550030|PASI|pasi
5686901|NCT00550004|Unresectable|unresectable
5686902|NCT00550004|locally advanced|locally advanced
5686903|NCT00550004|metastatic pancreatic adenocarcinoma|metastatic pancreatic adenocarcinoma
5686904|NCT00550004|Stage III|stage iii
5686905|NCT00550004|Stage IV|stage iv
5686906|NCT00549991|High Blood Pressure|high blood pressure
5697785|NCT00508612|Adolescents|adolescents
5835314|NCT00027534|stage III colon cancer|stage iii colon cancer
5835315|NCT00027534|stage IV colon cancer|stage iv colon cancer
5835316|NCT00027534|recurrent breast cancer|recurrent breast cancer
5835317|NCT00027534|stage IIIA breast cancer|stage iiia breast cancer
5835318|NCT00027534|stage IIIB breast cancer|stage iiib breast cancer
5835319|NCT00027534|stage IIIC breast cancer|stage iiic breast cancer
5835320|NCT00027534|stage IV breast cancer|stage iv breast cancer
5835321|NCT00027534|recurrent gastric cancer|recurrent gastric cancer
5835322|NCT00027534|stage III gastric cancer|stage iii gastric cancer
5835323|NCT00027534|stage IV gastric cancer|stage iv gastric cancer
5835324|NCT00027534|recurrent pancreatic cancer|recurrent pancreatic cancer
5835325|NCT00027534|stage II pancreatic cancer|stage ii pancreatic cancer
5835326|NCT00027534|stage III pancreatic cancer|stage iii pancreatic cancer
5835327|NCT00027534|recurrent rectal cancer|recurrent rectal cancer
5835328|NCT00027534|stage III rectal cancer|stage iii rectal cancer
5835329|NCT00027534|stage IV rectal cancer|stage iv rectal cancer
5835330|NCT00027534|advanced adult primary liver cancer|advanced adult primary liver cancer
5835331|NCT00027534|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5835332|NCT00027534|recurrent gallbladder cancer|recurrent gallbladder cancer
5835333|NCT00027534|unresectable gallbladder cancer|unresectable gallbladder cancer
5835334|NCT00027534|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5835335|NCT00027534|recurrent salivary gland cancer|recurrent salivary gland cancer
5835336|NCT00027534|stage III salivary gland cancer|stage iii salivary gland cancer
5835337|NCT00027534|stage IV salivary gland cancer|stage iv salivary gland cancer
5835338|NCT00027534|Paget disease of the breast with intraductal carcinoma|paget disease of the breast with intraductal carcinoma
5835339|NCT00027534|Paget disease of the breast with invasive ductal carcinoma|paget disease of the breast with invasive ductal carcinoma
5681560|NCT00572832|Human Papillomavirus Vaccine|human papillomavirus vaccine
5681562|NCT00572819|Misoprostol|misoprostol
5681563|NCT00572819|Postmenopausal women|postmenopausal women
5681564|NCT00572819|Cervical ripening|cervical ripening
5681565|NCT00572819|Dilatation|dilatation
5681566|NCT00572819|Sequential trial|sequential trial
5681567|NCT00572819|Estradiol|estradiol
5681568|NCT00572780|Crohn's Disease|crohn's disease
5681569|NCT00572780|CT Enteroclysis|ct enteroclysis
5681570|NCT00572767|randomised-controlled trial|randomised-controlled trial
5835340|NCT00027534|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5835341|NCT00027534|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5835342|NCT00027534|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5835343|NCT00027534|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5835344|NCT00027534|adenocarcinoma of the colon|adenocarcinoma of the colon
5835345|NCT00027534|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5835346|NCT00027534|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835347|NCT00027534|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5835348|NCT00027534|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5835349|NCT00027534|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5835350|NCT00027534|male breast cancer|male breast cancer
5835351|NCT00027534|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5835352|NCT00027534|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5835353|NCT00027534|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5835354|NCT00027534|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5835355|NCT00027534|stage IV pancreatic cancer|stage iv pancreatic cancer
5835356|NCT00027495|colon cancer|colon cancer
5835357|NCT00026533|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5835358|NCT00026533|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5835359|NCT00026533|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5835360|NCT00026533|recurrent thyroid cancer|recurrent thyroid cancer
5835361|NCT00026533|insular thyroid cancer|insular thyroid cancer
5835362|NCT00026494|tumors metastatic to brain|tumors metastatic to brain
5835363|NCT00026468|colon cancer|colon cancer
5835364|NCT00026468|rectal cancer|rectal cancer
5835365|NCT00026468|small intestine cancer|small intestine cancer
5835366|NCT00026442|stage IV breast cancer|stage iv breast cancer
5835367|NCT00026442|stage IIIA breast cancer|stage iiia breast cancer
5681548|NCT00572897|ATG|atg
5849047|NCT00031395|MPH|mph
5835368|NCT00026442|stage IIIB breast cancer|stage iiib breast cancer
5835369|NCT00026442|stage IIIC breast cancer|stage iiic breast cancer
5835370|NCT00026416|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5835371|NCT00026416|localized osteosarcoma|localized osteosarcoma
5835372|NCT00026416|metastatic osteosarcoma|metastatic osteosarcoma
5835373|NCT00026416|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5835374|NCT00026416|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5835375|NCT00026403|stage III pancreatic cancer|stage iii pancreatic cancer
5835376|NCT00026403|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5835377|NCT00026403|stage IV pancreatic cancer|stage iv pancreatic cancer
5835378|NCT00026338|stage III pancreatic cancer|stage iii pancreatic cancer
5835379|NCT00026338|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5835380|NCT00026338|stage IV pancreatic cancer|stage iv pancreatic cancer
5835381|NCT00026299|stage IV colon cancer|stage iv colon cancer
5835382|NCT00026299|stage IV rectal cancer|stage iv rectal cancer
5835383|NCT00026299|recurrent colon cancer|recurrent colon cancer
5835384|NCT00026299|recurrent rectal cancer|recurrent rectal cancer
5835385|NCT00026299|adenocarcinoma of the colon|adenocarcinoma of the colon
5835386|NCT00026299|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835387|NCT00026247|bone metastases|bone metastases
5835388|NCT00026247|pain|pain
5835389|NCT00026247|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5832273|NCT00052715|adult gliosarcoma|adult gliosarcoma
5835390|NCT00026195|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835392|NCT00026156|squamous cell lung cancer|squamous cell lung cancer
5835393|NCT00026156|large cell lung cancer|large cell lung cancer
5835394|NCT00026156|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5835395|NCT00026156|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5835396|NCT00026156|adenocarcinoma of the lung|adenocarcinoma of the lung
5835397|NCT00026130|stage II pancreatic cancer|stage ii pancreatic cancer
5681571|NCT00572767|ischemic stroke|ischemic stroke
5681572|NCT00572767|motor recovery|motor recovery
5681573|NCT00572767|amphetamine|amphetamine
5860035|NCT00005906|Somatostatin|somatostatin
5835398|NCT00026130|stage III pancreatic cancer|stage iii pancreatic cancer
5835399|NCT00026130|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5835402|NCT00026117|recurrent breast cancer|recurrent breast cancer
5835403|NCT00026117|stage IV rectal cancer|stage iv rectal cancer
5835404|NCT00026117|recurrent colon cancer|recurrent colon cancer
5835405|NCT00026117|recurrent rectal cancer|recurrent rectal cancer
5835406|NCT00026117|male breast cancer|male breast cancer
5835407|NCT00026078|stage IV breast cancer|stage iv breast cancer
5835408|NCT00026078|recurrent breast cancer|recurrent breast cancer
5835409|NCT00025675|recurrent adult brain tumor|recurrent adult brain tumor
5835410|NCT00025675|adult meningioma|adult meningioma
5835411|NCT00025675|adult glioblastoma|adult glioblastoma
5835412|NCT00025675|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5835413|NCT00025675|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5835414|NCT00025675|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5835415|NCT00025675|adult subependymoma|adult subependymoma
5835416|NCT00025675|adult mixed glioma|adult mixed glioma
5835417|NCT00025675|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5835418|NCT00025675|adult grade III meningioma|adult grade iii meningioma
5835419|NCT00025675|adult giant cell glioblastoma|adult giant cell glioblastoma
5835420|NCT00025675|adult gliosarcoma|adult gliosarcoma
5835421|NCT00025675|adult grade I meningioma|adult grade i meningioma
5835422|NCT00025675|adult grade II meningioma|adult grade ii meningioma
5835423|NCT00025662|Peripheral Blood Stem Cell|peripheral blood stem cell
5835424|NCT00025662|Melphalan|melphalan
5835425|NCT00025662|Fludarabine|fludarabine
5835426|NCT00025662|Donor Apheresis|donor apheresis
5835427|NCT00025662|Non-Myeloablative|non-myeloablative
5835429|NCT00025662|Chronic Myeloid Leukemia|chronic myeloid leukemia
5835430|NCT00025662|CML|cml
5835431|NCT00025662|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5835432|NCT00025662|CLL|cll
5835433|NCT00025662|Lymphoma|lymphoma
5835434|NCT00025662|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5835435|NCT00025662|Hodgkin's Disease|hodgkin's disease
5835436|NCT00025662|Mantle Cell Lymphoma|mantle cell lymphoma
5835437|NCT00025662|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5835438|NCT00025662|Chronic Myeloid Leukemia (CML)|chronic myeloid leukemia (cml)
5835439|NCT00025662|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5835440|NCT00025662|Myelodysplasia (MDS)|myelodysplasia (mds)
5835441|NCT00025662|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5835442|NCT00025662|Bone Marrow Transplant|bone marrow transplant
5835443|NCT00025649|localized resectable neuroblastoma|localized resectable neuroblastoma
5835445|NCT00025649|disseminated neuroblastoma|disseminated neuroblastoma
5835446|NCT00025649|stage 4S neuroblastoma|stage 4s neuroblastoma
5835447|NCT00025649|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5835448|NCT00025636|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5686907|NCT00549978|Safety and Pharmacokinetics in healthy subjects|safety and pharmacokinetics in healthy subjects
5686908|NCT00549939|child|child
5686909|NCT00549939|bladder|bladder
5686910|NCT00549939|neuropathic|neuropathic
5686911|NCT00549939|alpha blockers|alpha blockers
5681549|NCT00572884|permethrin|permethrin
5835449|NCT00025623|disseminated neuroblastoma|disseminated neuroblastoma
5835450|NCT00025610|disseminated neuroblastoma|disseminated neuroblastoma
5835451|NCT00025610|stage 4S neuroblastoma|stage 4s neuroblastoma
5835452|NCT00025597|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5835453|NCT00025558|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5835454|NCT00025558|recurrent adult brain tumor|recurrent adult brain tumor
5835455|NCT00025558|adult medulloblastoma|adult medulloblastoma
5835456|NCT00025558|adult glioblastoma|adult glioblastoma
5835457|NCT00025558|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5835458|NCT00025558|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5835459|NCT00025558|adult mixed glioma|adult mixed glioma
5835460|NCT00025558|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5835461|NCT00025558|adult pineoblastoma|adult pineoblastoma
5835462|NCT00025558|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5835463|NCT00025558|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5835464|NCT00025558|recurrent childhood ependymoma|recurrent childhood ependymoma
5835465|NCT00025558|adult giant cell glioblastoma|adult giant cell glioblastoma
5835466|NCT00025558|adult gliosarcoma|adult gliosarcoma
5835467|NCT00025558|adult anaplastic ependymoma|adult anaplastic ependymoma
5835468|NCT00025558|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5835469|NCT00025519|stage IV renal cell cancer|stage iv renal cell cancer
5835470|NCT00025519|recurrent renal cell cancer|recurrent renal cell cancer
5835471|NCT00025519|clear cell renal cell carcinoma|clear cell renal cell carcinoma
5835472|NCT00025493|stage IV breast cancer|stage iv breast cancer
5835473|NCT00025493|recurrent breast cancer|recurrent breast cancer
5835474|NCT00025480|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5835475|NCT00025480|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5863187|NCT00001361|Normal Volunteer|normal volunteer
5681574|NCT00572767|motor recovery of patients after a first-ever ischemic stroke|motor recovery of patients after a first-ever ischemic stroke
5681576|NCT00572741|vitamin B 12|vitamin b 12
5681577|NCT00572741|glutathione|glutathione
5681578|NCT00572715|kidney|kidney
5681579|NCT00572715|neonates|neonates
5835476|NCT00025454|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835477|NCT00025441|chondrosarcoma|chondrosarcoma
5835478|NCT00025441|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5835479|NCT00025441|fibrosarcomatous osteosarcoma|fibrosarcomatous osteosarcoma
5835480|NCT00025441|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5835481|NCT00025441|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5835482|NCT00025441|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5835483|NCT00025441|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5835484|NCT00025441|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5835485|NCT00025441|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5835486|NCT00025441|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5835487|NCT00025441|childhood fibrosarcoma|childhood fibrosarcoma
5835488|NCT00025441|childhood synovial sarcoma|childhood synovial sarcoma
5835489|NCT00025441|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5835490|NCT00025441|childhood liposarcoma|childhood liposarcoma
5835491|NCT00025441|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5835492|NCT00025441|childhood leiomyosarcoma|childhood leiomyosarcoma
5835493|NCT00025441|childhood angiosarcoma|childhood angiosarcoma
5835494|NCT00025441|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5835495|NCT00025441|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5835496|NCT00025441|stage IV uterine sarcoma|stage iv uterine sarcoma
5835497|NCT00025441|uterine leiomyosarcoma|uterine leiomyosarcoma
5835498|NCT00025441|ovarian sarcoma|ovarian sarcoma
5835764|NCT00023829|stage IIB prostate cancer|stage iib prostate cancer
5835499|NCT00025441|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5835500|NCT00025441|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5835501|NCT00025428|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5835502|NCT00025402|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5835503|NCT00025402|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5835504|NCT00025402|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5835505|NCT00025402|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5835506|NCT00025402|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5835507|NCT00025389|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5835508|NCT00025389|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5835509|NCT00025389|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5835510|NCT00025324|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5835511|NCT00025324|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5835512|NCT00025311|leptomeningeal metastases|leptomeningeal metastases
5835513|NCT00025298|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5848211|NCT00035802|Adolescent|adolescent
5835514|NCT00025298|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5835515|NCT00025298|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5835516|NCT00025298|oral complications|oral complications
5849771|NCT00028106|Fluorodopamine|fluorodopamine
5849772|NCT00028106|PET|pet
5849773|NCT00028106|Methylprednisolone|methylprednisolone
5849774|NCT00028106|Catecholamines|catecholamines
5849775|NCT00028106|Metanephrines|metanephrines
5849776|NCT00028106|Alpha-Methyl-Para-Tyrosine|alpha-methyl-para-tyrosine
5849777|NCT00028106|Retinoic Acid|retinoic acid
5849778|NCT00028106|Carbidopa|carbidopa
5849779|NCT00028093|Chronic Hepatitis|chronic hepatitis
5835517|NCT00025298|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5835518|NCT00025298|radiation toxicity|radiation toxicity
5835519|NCT00025285|squamous cell lung cancer|squamous cell lung cancer
5835520|NCT00025285|large cell lung cancer|large cell lung cancer
5835521|NCT00025285|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5835522|NCT00025285|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5835523|NCT00025285|adenocarcinoma of the lung|adenocarcinoma of the lung
5835524|NCT00025285|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5835525|NCT00025285|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5835526|NCT00025272|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5835528|NCT00025194|stage IV prostate cancer|stage iv prostate cancer
5863374|NCT00001310|Uveitis|uveitis
5835529|NCT00025194|recurrent prostate cancer|recurrent prostate cancer
5835530|NCT00025181|iris melanoma|iris melanoma
5835531|NCT00025181|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5835532|NCT00025181|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5835533|NCT00025181|extraocular extension melanoma|extraocular extension melanoma
5835535|NCT00025181|stage III melanoma|stage iii melanoma
5835536|NCT00025181|stage IV melanoma|stage iv melanoma
5835537|NCT00025181|recurrent melanoma|recurrent melanoma
5835538|NCT00025168|stage III pancreatic cancer|stage iii pancreatic cancer
5835539|NCT00025142|stage IV colon cancer|stage iv colon cancer
5835540|NCT00025142|stage IV rectal cancer|stage iv rectal cancer
5835541|NCT00025142|recurrent colon cancer|recurrent colon cancer
5835542|NCT00025142|recurrent rectal cancer|recurrent rectal cancer
5835543|NCT00025142|adenocarcinoma of the colon|adenocarcinoma of the colon
5835544|NCT00025142|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835545|NCT00025129|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5835546|NCT00025129|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5835547|NCT00025129|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5835548|NCT00025129|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5835549|NCT00025129|small intestine lymphoma|small intestine lymphoma
5835550|NCT00025129|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835551|NCT00025129|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5835552|NCT00025129|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5835553|NCT00025129|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5835554|NCT00025129|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5835555|NCT00025129|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5835556|NCT00025129|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5835557|NCT00025129|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5835558|NCT00025129|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5835559|NCT00025129|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5835560|NCT00025129|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5835561|NCT00025129|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5835562|NCT00025129|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5835563|NCT00025129|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5835564|NCT00025129|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5835565|NCT00025129|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5835566|NCT00025129|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5835567|NCT00025129|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5835568|NCT00025129|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5686912|NCT00549913|adjacent vertebral levels between L1 and S1|adjacent vertebral levels between l1 and s1
5686913|NCT00549900|HPV vaccine,|hpv vaccine,
5686914|NCT00549900|Cervical cancer|cervical cancer
5686915|NCT00549900|Human papillomavirus infection,|human papillomavirus infection,
5681555|NCT00572858|Hypo E|hypo e
5835569|NCT00025129|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5835570|NCT00025129|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5835571|NCT00025129|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5835572|NCT00025129|intraocular lymphoma|intraocular lymphoma
5835573|NCT00025129|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5849874|NCT00027287|Diode Laser Photocoagulation|diode laser photocoagulation
5849875|NCT00027287|Vitamin E|vitamin e
5849876|NCT00027287|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5835574|NCT00025129|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5835575|NCT00025129|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5835576|NCT00025129|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5835577|NCT00025129|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5835578|NCT00025129|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5835579|NCT00025129|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5835580|NCT00025129|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5835581|NCT00025129|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5835582|NCT00025129|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5835583|NCT00025129|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5835584|NCT00025129|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5835585|NCT00025129|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5835586|NCT00025103|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5835587|NCT00025103|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5835588|NCT00025090|stage I anal cancer|stage i anal cancer
5835589|NCT00025090|stage II anal cancer|stage ii anal cancer
5835590|NCT00025090|stage IIIA anal cancer|stage iiia anal cancer
5835591|NCT00025090|stage IIIB anal cancer|stage iiib anal cancer
5835592|NCT00025090|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5835593|NCT00025090|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5835594|NCT00025090|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5835595|NCT00025077|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5835596|NCT00025077|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5835597|NCT00025064|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5835598|NCT00025064|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5835599|NCT00025064|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5835600|NCT00025064|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5835601|NCT00025064|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5835602|NCT00025051|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5835603|NCT00025051|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5835604|NCT00025025|colon cancer|colon cancer
5835605|NCT00025025|rectal cancer|rectal cancer
5835606|NCT00024466|stage I multiple myeloma|stage i multiple myeloma
5835607|NCT00024466|stage II multiple myeloma|stage ii multiple myeloma
5835608|NCT00024466|stage III multiple myeloma|stage iii multiple myeloma
5835609|NCT00024453|infection|infection
5835610|NCT00024440|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5835611|NCT00024440|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5835612|NCT00024427|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5835613|NCT00024427|stage II pancreatic cancer|stage ii pancreatic cancer
5835614|NCT00024427|stage III pancreatic cancer|stage iii pancreatic cancer
5835615|NCT00024427|recurrent pancreatic cancer|recurrent pancreatic cancer
5835616|NCT00024427|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5835617|NCT00024427|stage IV pancreatic cancer|stage iv pancreatic cancer
5835618|NCT00024414|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835619|NCT00024414|stage IV prostate cancer|stage iv prostate cancer
5835620|NCT00024414|recurrent prostate cancer|recurrent prostate cancer
5835621|NCT00024375|recurrent pancreatic cancer|recurrent pancreatic cancer
5835622|NCT00024375|stage IV pancreatic cancer|stage iv pancreatic cancer
5835623|NCT00024349|stage II bladder cancer|stage ii bladder cancer
5835624|NCT00024349|stage III bladder cancer|stage iii bladder cancer
5835625|NCT00024349|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5835626|NCT00024349|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5835627|NCT00024349|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5835628|NCT00024336|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5835629|NCT00024297|thromboembolism|thromboembolism
5835630|NCT00024284|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5835631|NCT00024271|localized malignant mesothelioma|localized malignant mesothelioma
5835632|NCT00024271|advanced malignant mesothelioma|advanced malignant mesothelioma
5835633|NCT00024271|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5835634|NCT00024258|metastatic osteosarcoma|metastatic osteosarcoma
5835635|NCT00024258|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5835636|NCT00024258|regional neuroblastoma|regional neuroblastoma
5835637|NCT00024258|disseminated neuroblastoma|disseminated neuroblastoma
5835638|NCT00024258|stage 4S neuroblastoma|stage 4s neuroblastoma
5835639|NCT00024258|recurrent neuroblastoma|recurrent neuroblastoma
5849975|NCT00026975|Laryngectomy|laryngectomy
5849976|NCT00026975|Tissue Oxygenation|tissue oxygenation
5849977|NCT00026975|Irradiated Tissue|irradiated tissue
5849978|NCT00026975|Hyperbaric Oxygen|hyperbaric oxygen
5849979|NCT00026975|Angiogenesis|angiogenesis
5849980|NCT00026975|EF5|ef5
5849981|NCT00026962|Breast|breast
5849982|NCT00026962|Hormones|hormones
5849983|NCT00026962|Prevention|prevention
5849984|NCT00026962|Saliva|saliva
5849985|NCT00026962|Serum|serum
5849986|NCT00026949|Etoposide|etoposide
5849987|NCT00026949|Breast Cancer|breast cancer
5849988|NCT00026949|Pharmacokinetics|pharmacokinetics
5849989|NCT00026936|External Beam Radiotherapy|external beam radiotherapy
5849990|NCT00026936|TCP|tcp
5849991|NCT00026936|DVH|dvh
5849992|NCT00026936|NTCP|ntcp
5849993|NCT00026936|3-D Programming|3-d programming
5835765|NCT00023829|stage IIA prostate cancer|stage iia prostate cancer
5835640|NCT00024258|stage III childhood liver cancer|stage iii childhood liver cancer
5835641|NCT00024258|stage IV childhood liver cancer|stage iv childhood liver cancer
5835642|NCT00024258|recurrent childhood liver cancer|recurrent childhood liver cancer
5835643|NCT00024258|childhood hepatoblastoma|childhood hepatoblastoma
5835644|NCT00024258|stage III Wilms tumor|stage iii wilms tumor
5835645|NCT00024258|stage IV Wilms tumor|stage iv wilms tumor
5835646|NCT00024258|stage V Wilms tumor|stage v wilms tumor
5835647|NCT00024258|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5835648|NCT00024258|intraocular retinoblastoma|intraocular retinoblastoma
5835649|NCT00024258|extraocular retinoblastoma|extraocular retinoblastoma
5835650|NCT00024258|recurrent retinoblastoma|recurrent retinoblastoma
5835651|NCT00024258|recurrent osteosarcoma|recurrent osteosarcoma
5835652|NCT00024258|childhood germ cell tumor|childhood germ cell tumor
5835653|NCT00024258|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5835654|NCT00024258|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5681580|NCT00572702|Biocompatible Materials|biocompatible materials
5835655|NCT00024258|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5835656|NCT00024258|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5835715|NCT00024102|stage I breast cancer|stage i breast cancer
5835657|NCT00024258|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5835658|NCT00024258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5835659|NCT00024258|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5835661|NCT00024258|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5835662|NCT00024258|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5835663|NCT00024258|childhood teratoma|childhood teratoma
5835664|NCT00024258|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5835665|NCT00024258|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5835666|NCT00024258|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5835667|NCT00024258|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5835668|NCT00024245|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835669|NCT00024232|stage IV prostate cancer|stage iv prostate cancer
5835670|NCT00024232|recurrent prostate cancer|recurrent prostate cancer
5835671|NCT00024193|stage 4S neuroblastoma|stage 4s neuroblastoma
5835672|NCT00024180|Waldenström macroglobulinemia|waldenström macroglobulinemia
5835673|NCT00024180|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5835674|NCT00024180|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5835675|NCT00024180|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5835676|NCT00024180|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5835677|NCT00024180|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5835678|NCT00024180|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5835679|NCT00024167|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835680|NCT00024167|stage IV prostate cancer|stage iv prostate cancer
5835681|NCT00024167|recurrent prostate cancer|recurrent prostate cancer
5835682|NCT00024167|Strontium-89|strontium-89
5850086|NCT00026728|Epidemiology|epidemiology
5850087|NCT00026728|Population-Based Study|population-based study
5850088|NCT00026728|Kaposi's Sarcoma Herpes Virus|kaposi's sarcoma herpes virus
5850089|NCT00026715|Renal Function|renal function
5850091|NCT00026702|Acute Kidney Injury|acute kidney injury
5686916|NCT00549874|insulin resistance|insulin resistance
5686917|NCT00549874|type 2 diabetes|type 2 diabetes
5686918|NCT00549874|myocardial perfusion|myocardial perfusion
5686919|NCT00549874|nitrosative stress|nitrosative stress
5686920|NCT00549874|thiazolidinediones|thiazolidinediones
5686921|NCT00549861|Cardiac Magnetic Resonance Imaging|cardiac magnetic resonance imaging
5686922|NCT00549861|Contrast agents|contrast agents
5686923|NCT00549861|Gadobutrol|gadobutrol
5686924|NCT00549861|Fibrosis|fibrosis
5686925|NCT00549861|Prognosis|prognosis
5686926|NCT00549861|Magnetic Resonance|magnetic resonance
5686927|NCT00549861|Gadolinium|gadolinium
5850092|NCT00026689|Evaluation|evaluation
5850093|NCT00026689|Screening|screening
5850094|NCT00026689|Cancer|cancer
5850095|NCT00026689|Radiation|radiation
5850096|NCT00026689|Eligibility|eligibility
5850097|NCT00026676|Surrogate Markers|surrogate markers
5850098|NCT00026676|Genotypic Resistance|genotypic resistance
5850100|NCT00026676|Selenium|selenium
5835683|NCT00024167|Induction Chemotherapy|induction chemotherapy
5835684|NCT00024167|Androgen-Independent Prostate Cancer|androgen-independent prostate cancer
5835685|NCT00024115|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5835686|NCT00024115|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5835687|NCT00024115|stage III grade I follicular small cleaved cell lymphoma|stage iii grade i follicular small cleaved cell lymphoma
5835688|NCT00024115|stage III grade II follicular mixed cell lymphoma|stage iii grade ii follicular mixed cell lymphoma
5835689|NCT00024115|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5835690|NCT00024115|stage IV grade I follicular small cleaved cell lymphoma|stage iv grade i follicular small cleaved cell lymphoma
5835691|NCT00024115|stage IV grade II follicular mixed cell lymphoma|stage iv grade ii follicular mixed cell lymphoma
5835692|NCT00024115|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5835693|NCT00024115|recurrent grade I follicular small cleaved cell lymphoma|recurrent grade i follicular small cleaved cell lymphoma
5835694|NCT00024115|recurrent grade II follicular mixed cell lymphoma|recurrent grade ii follicular mixed cell lymphoma
5835695|NCT00024115|recurrent grade III follicular large cell lymphoma|recurrent grade iii follicular large cell lymphoma
5835696|NCT00024115|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5835697|NCT00024115|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5835698|NCT00024115|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5835699|NCT00024115|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5835700|NCT00024115|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5835701|NCT00024115|recurrent adult diffuse small noncleaved cell/Burkitt's lymphoma|recurrent adult diffuse small noncleaved cell/burkitt's lymphoma
5835702|NCT00024115|prolymphocytic leukemia|prolymphocytic leukemia
5835703|NCT00024115|contiguous stage II grade I follicular small cleaved cell lymphoma|contiguous stage ii grade i follicular small cleaved cell lymphoma
5835766|NCT00023790|stage IV breast cancer|stage iv breast cancer
5835704|NCT00024115|contiguous stage II grade II follicular mixed cell lymphoma|contiguous stage ii grade ii follicular mixed cell lymphoma
5863164|NCT00001364|Spinal Dural Arteriovenous Fistulas|spinal dural arteriovenous fistulas
5681581|NCT00572702|Female|female
5681582|NCT00572702|Humans|humans
5681584|NCT00572702|Polypropylenes|polypropylenes
5681585|NCT00572702|Prostheses and Implants|prostheses and implants
5681586|NCT00572702|Surgical Mesh|surgical mesh
5681587|NCT00572702|Uterine Prolapse/*therapy|uterine prolapse/*therapy
5681588|NCT00572689|Exenatide|exenatide
5681589|NCT00572689|TCF7L2 polymorphism|tcf7l2 polymorphism
5681590|NCT00572689|Pharmacodynamics|pharmacodynamics
5681591|NCT00572689|Pharmacokinetics|pharmacokinetics
5681592|NCT00572663|Proteinuria|proteinuria
5681593|NCT00572663|Antioxidant|antioxidant
5835705|NCT00024115|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5835706|NCT00024115|noncontiguous stage II grade I follicular small cleaved cell lymphoma|noncontiguous stage ii grade i follicular small cleaved cell lymphoma
5835707|NCT00024115|noncontiguous stage II grade II follicular mixed cell lymphoma|noncontiguous stage ii grade ii follicular mixed cell lymphoma
5835708|NCT00024115|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5835709|NCT00024115|stage III diffuse small lymphocytic/marginal zone lymphoma|stage iii diffuse small lymphocytic/marginal zone lymphoma
5835710|NCT00024115|contiguous stage II diffuse small lymphocytic/marginal zone lymphoma|contiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
5686928|NCT00549848|Leukemia|leukemia
5686929|NCT00549835|mucositis pain|mucositis pain
5686930|NCT00549835|cancer|cancer
5686931|NCT00549835|pain|pain
5686932|NCT00549835|acupuncture|acupuncture
5835711|NCT00024115|noncontiguous stage II diffuse small lymphocytic/marginal zone lymphoma|noncontiguous stage ii diffuse small lymphocytic/marginal zone lymphoma
5835712|NCT00024115|stage IV diffuse small lymphocytic/marginal zone lymphoma|stage iv diffuse small lymphocytic/marginal zone lymphoma
5835713|NCT00024115|recurrent diffuse small lymphocytic/marginal zone lymphoma|recurrent diffuse small lymphocytic/marginal zone lymphoma
5835714|NCT00024115|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5835716|NCT00024102|stage II breast cancer|stage ii breast cancer
5835717|NCT00024102|stage IIIA breast cancer|stage iiia breast cancer
5835718|NCT00024102|stage IIIB breast cancer|stage iiib breast cancer
5835719|NCT00024102|stage IIIC breast cancer|stage iiic breast cancer
5835720|NCT00024089|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5835721|NCT00024089|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5846680|NCT00043693|Schizoaffective Disorder|schizoaffective disorder
5850196|NCT00025987|Cooling of the Head and Neck|cooling of the head and neck
5850198|NCT00025987|Epilepsy|epilepsy
5850199|NCT00025987|Healthy Volunteer|healthy volunteer
5850200|NCT00025987|HV|hv
5850201|NCT00025974|PET|pet
5850202|NCT00025974|5-HT1A Receptors|5-ht1a receptors
5850203|NCT00025974|Benzodiazepine Receptors|benzodiazepine receptors
5850204|NCT00025974|Panic Disorder|panic disorder
5850205|NCT00025974|PTSD|ptsd
5850206|NCT00025974|Serotonin Type 1A Receptors|serotonin type 1a receptors
5850212|NCT00025974|HV|hv
5835722|NCT00024089|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5835723|NCT00024089|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5835724|NCT00024089|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5835725|NCT00024089|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5835726|NCT00024089|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5835727|NCT00024089|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5835728|NCT00024089|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5835729|NCT00024089|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5835730|NCT00024089|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5835731|NCT00024089|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5835732|NCT00024089|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5835733|NCT00024089|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5835734|NCT00024089|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5835735|NCT00024076|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5835736|NCT00024076|recurrent small cell lung cancer|recurrent small cell lung cancer
5835737|NCT00024076|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5835738|NCT00024076|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5863165|NCT00001364|Surgery|surgery
5835739|NCT00024076|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5835740|NCT00024076|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5835741|NCT00024076|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5835742|NCT00024076|lung metastases|lung metastases
5835743|NCT00024050|refractory anemia|refractory anemia
5835744|NCT00024050|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5835745|NCT00024050|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5835746|NCT00024050|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5835747|NCT00024050|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5835748|NCT00024050|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5835749|NCT00023985|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5835750|NCT00023985|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5835751|NCT00023985|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5835752|NCT00023972|stage III pancreatic cancer|stage iii pancreatic cancer
5835753|NCT00023972|stage IV pancreatic cancer|stage iv pancreatic cancer
5835754|NCT00023894|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5835755|NCT00023881|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5835756|NCT00023881|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5835757|NCT00023881|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5835758|NCT00023881|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5835759|NCT00023855|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5686933|NCT00549835|mucositis|mucositis
5680488|NCT00577798|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5681142|NCT00574561|Magnetocardiography (MCG)|magnetocardiography (mcg)
5686934|NCT00549835|cancer pain|cancer pain
5686935|NCT00549822|aromatase inhibitor|aromatase inhibitor
5835760|NCT00023842|stage 0 bladder cancer|stage 0 bladder cancer
5835761|NCT00023842|recurrent bladder cancer|recurrent bladder cancer
5835762|NCT00023842|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5835763|NCT00023829|stage III prostate cancer|stage iii prostate cancer
5835767|NCT00023790|recurrent breast cancer|recurrent breast cancer
5835768|NCT00023790|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5835769|NCT00023790|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5835770|NCT00023790|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5835771|NCT00023790|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5846681|NCT00043693|Substance Abuse|substance abuse
5835772|NCT00023790|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5835773|NCT00023790|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5835774|NCT00023790|recurrent skin cancer|recurrent skin cancer
5835775|NCT00023790|classic Kaposi sarcoma|classic kaposi sarcoma
5835776|NCT00023790|immunosuppressive treatment related Kaposi sarcoma|immunosuppressive treatment related kaposi sarcoma
5835777|NCT00023790|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5835778|NCT00023790|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5835779|NCT00023790|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5835780|NCT00023790|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5835781|NCT00023790|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5835840|NCT00023660|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5835782|NCT00023790|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5835783|NCT00023790|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5835784|NCT00023790|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5835785|NCT00023790|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5835786|NCT00023790|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5835787|NCT00023790|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5835788|NCT00023790|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5835789|NCT00023790|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5835790|NCT00023790|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5835791|NCT00023790|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5835792|NCT00023790|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5836942|NCT00019019|adult oligodendroglioma|adult oligodendroglioma
5835793|NCT00023790|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5835794|NCT00023790|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5835795|NCT00023790|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5835796|NCT00023790|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5835797|NCT00023790|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5835798|NCT00023790|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5835799|NCT00023790|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5835800|NCT00023790|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5835801|NCT00023790|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5863586|NCT00001245|Nematode|nematode
5835802|NCT00023790|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5835803|NCT00023790|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5835804|NCT00023790|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5835805|NCT00023790|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5835806|NCT00023790|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5835807|NCT00023790|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5835808|NCT00023790|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5835809|NCT00023790|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5686936|NCT00549822|CA 15-3|ca 15-3
5860248|NCT00005673|HIV|hiv
5835810|NCT00023790|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5835812|NCT00023790|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5835813|NCT00023790|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5835814|NCT00023790|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5835815|NCT00023790|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5835816|NCT00023790|male breast cancer|male breast cancer
5835817|NCT00023777|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5835818|NCT00023777|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5835819|NCT00023777|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5835820|NCT00023777|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5835821|NCT00023777|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5835822|NCT00023777|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5835898|NCT00022516|stage IIIB breast cancer|stage iiib breast cancer
5835823|NCT00023777|adult acute eosinophilic leukemia|adult acute eosinophilic leukemia
5835824|NCT00023777|adult acute basophilic leukemia|adult acute basophilic leukemia
5846682|NCT00043771|CHF|chf
5846683|NCT00043758|CHF|chf
5850412|NCT00024791|Healthy Volunteer|healthy volunteer
5850413|NCT00024791|HV|hv
5850414|NCT00024791|Normal Control|normal control
5850415|NCT00024687|SS1(dsFv)-PE38 Anti-Mesothelin Immunotoxin|ss1(dsfv)-pe38 anti-mesothelin immunotoxin
5850416|NCT00024687|advanced malignancy|advanced malignancy
5850417|NCT00024674|SS1(dsFv)-PE38|ss1(dsfv)-pe38
5850418|NCT00024674|SS1P|ss1p
5850419|NCT00024674|anti-mesothelin immunotoxin|anti-mesothelin immunotoxin
5850426|NCT00024648|LErafAON|lerafaon
5835825|NCT00023777|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5835826|NCT00023777|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5835827|NCT00023777|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5835828|NCT00023751|stage I rectal cancer|stage i rectal cancer
5835829|NCT00023751|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835830|NCT00023686|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835831|NCT00023686|stage IIB prostate cancer|stage iib prostate cancer
5835832|NCT00023686|stage IIA prostate cancer|stage iia prostate cancer
5835833|NCT00023660|stage III cervical cancer|stage iii cervical cancer
5835834|NCT00023660|stage IB cervical cancer|stage ib cervical cancer
5835835|NCT00023660|stage IIB cervical cancer|stage iib cervical cancer
5835836|NCT00023660|stage IIA cervical cancer|stage iia cervical cancer
5835837|NCT00023660|stage IVA cervical cancer|stage iva cervical cancer
5835838|NCT00023660|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5835839|NCT00023660|cervical adenocarcinoma|cervical adenocarcinoma
5835841|NCT00023634|stage II gastric cancer|stage ii gastric cancer
5835842|NCT00023634|stage III gastric cancer|stage iii gastric cancer
5835843|NCT00023634|stage IV gastric cancer|stage iv gastric cancer
5835844|NCT00023634|recurrent gastric cancer|recurrent gastric cancer
5835845|NCT00023634|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835846|NCT00023634|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5835847|NCT00023634|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5835848|NCT00023634|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5835849|NCT00023634|recurrent adult brain tumor|recurrent adult brain tumor
5835850|NCT00023634|stage IV prostate cancer|stage iv prostate cancer
5835851|NCT00023634|recurrent prostate cancer|recurrent prostate cancer
5835852|NCT00023634|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5835853|NCT00023621|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5835854|NCT00022724|recurrent adult brain tumor|recurrent adult brain tumor
5835855|NCT00022724|adult glioblastoma|adult glioblastoma
5835856|NCT00022724|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5835857|NCT00022724|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5835858|NCT00022724|adult mixed glioma|adult mixed glioma
5835859|NCT00022724|adult giant cell glioblastoma|adult giant cell glioblastoma
5835860|NCT00022724|adult gliosarcoma|adult gliosarcoma
5864396|NCT00000379|Human|human
5835861|NCT00022711|recurrent small cell lung cancer|recurrent small cell lung cancer
5835862|NCT00022711|intermediate type small cell lung cancer|intermediate type small cell lung cancer
5835863|NCT00022698|stage III colon cancer|stage iii colon cancer
5835864|NCT00022698|stage IV colon cancer|stage iv colon cancer
5835865|NCT00022698|stage III rectal cancer|stage iii rectal cancer
5835866|NCT00022698|stage IV rectal cancer|stage iv rectal cancer
5835867|NCT00022698|recurrent colon cancer|recurrent colon cancer
5835868|NCT00022698|recurrent rectal cancer|recurrent rectal cancer
5835869|NCT00022698|adenocarcinoma of the colon|adenocarcinoma of the colon
5835870|NCT00022698|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5835871|NCT00022685|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5835872|NCT00022685|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5835874|NCT00022646|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5835875|NCT00022633|recurrent bladder cancer|recurrent bladder cancer
5835876|NCT00022633|stage IV bladder cancer|stage iv bladder cancer
5835877|NCT00022633|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5835878|NCT00022633|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5835879|NCT00022633|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5835880|NCT00022633|recurrent urethral cancer|recurrent urethral cancer
5835881|NCT00022633|anterior urethral cancer|anterior urethral cancer
5835882|NCT00022633|posterior urethral cancer|posterior urethral cancer
5835883|NCT00022633|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5835884|NCT00022633|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5835885|NCT00022633|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5835886|NCT00022633|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5835887|NCT00022620|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5835888|NCT00022620|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5835889|NCT00022607|refractory multiple myeloma|refractory multiple myeloma
5835890|NCT00022607|stage I multiple myeloma|stage i multiple myeloma
5835891|NCT00022607|stage II multiple myeloma|stage ii multiple myeloma
5835892|NCT00022607|stage III multiple myeloma|stage iii multiple myeloma
5835893|NCT00022568|stage IV melanoma|stage iv melanoma
5835894|NCT00022568|recurrent melanoma|recurrent melanoma
5835895|NCT00022516|stage IA breast cancer|stage ia breast cancer
5835896|NCT00022516|stage II breast cancer|stage ii breast cancer
5835897|NCT00022516|stage IIIA breast cancer|stage iiia breast cancer
5835899|NCT00022516|stage IB breast cancer|stage ib breast cancer
5835900|NCT00022516|estrogen receptor-negative breast cancer|estrogen receptor-negative breast cancer
5835901|NCT00022516|progesterone receptor-negative breast cancer|progesterone receptor-negative breast cancer
5835902|NCT00022516|triple-negative breast cancer|triple-negative breast cancer
5835903|NCT00022516|low-dose maintenance chemotherapy|low-dose maintenance chemotherapy
5835904|NCT00022516|stroma|stroma
5835905|NCT00022516|angiogenesis|angiogenesis
5835906|NCT00022490|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5835907|NCT00022490|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5835908|NCT00022464|stage IV melanoma|stage iv melanoma
5835909|NCT00022464|recurrent melanoma|recurrent melanoma
5835910|NCT00022451|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5835911|NCT00022451|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5835912|NCT00022451|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5835913|NCT00022451|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5835914|NCT00022451|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5836107|NCT00020852|stage I breast cancer|stage i breast cancer
5835915|NCT00022451|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5835916|NCT00022451|acute undifferentiated leukemia|acute undifferentiated leukemia
5835917|NCT00022451|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5835918|NCT00022451|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5835919|NCT00022438|stage IV melanoma|stage iv melanoma
5835920|NCT00022438|recurrent melanoma|recurrent melanoma
5835921|NCT00022425|recurrent breast cancer|recurrent breast cancer
5835922|NCT00022412|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835923|NCT00022412|stage I prostate cancer|stage i prostate cancer
5835924|NCT00022412|stage II prostate cancer|stage ii prostate cancer
5835925|NCT00022399|stage I prostate cancer|stage i prostate cancer
5835926|NCT00022399|stage IIB prostate cancer|stage iib prostate cancer
5835927|NCT00022399|stage IIA prostate cancer|stage iia prostate cancer
5835928|NCT00022399|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5835929|NCT00022334|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5835930|NCT00022334|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5835931|NCT00022334|advanced adult primary liver cancer|advanced adult primary liver cancer
5835932|NCT00022334|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5835933|NCT00022334|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5835934|NCT00022295|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5835935|NCT00022230|stage II breast cancer|stage ii breast cancer
5835936|NCT00022230|stage IIIA breast cancer|stage iiia breast cancer
5835937|NCT00022230|stage IIIB breast cancer|stage iiib breast cancer
5835938|NCT00022230|stage IIIC breast cancer|stage iiic breast cancer
5835939|NCT00022191|stage IV bladder cancer|stage iv bladder cancer
5835940|NCT00022191|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5835941|NCT00022191|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5835942|NCT00022191|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5686937|NCT00549822|Hormone receptor positive|hormone receptor positive
5835943|NCT00022191|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5835945|NCT00022152|recurrent breast cancer|recurrent breast cancer
5835946|NCT00022126|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5835947|NCT00022126|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5835948|NCT00022126|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5835949|NCT00022126|acute undifferentiated leukemia|acute undifferentiated leukemia
5835950|NCT00022087|osteoporosis|osteoporosis
5835951|NCT00022087|stage I breast cancer|stage i breast cancer
5835952|NCT00022087|stage II breast cancer|stage ii breast cancer
5835953|NCT00022087|stage IV breast cancer|stage iv breast cancer
5835954|NCT00022087|stage IIIA breast cancer|stage iiia breast cancer
5835955|NCT00022087|stage IIIB breast cancer|stage iiib breast cancer
5835956|NCT00022087|stage IIIC breast cancer|stage iiic breast cancer
5835957|NCT00022074|stage I breast cancer|stage i breast cancer
5835958|NCT00022074|stage II breast cancer|stage ii breast cancer
5835959|NCT00022074|stage IV breast cancer|stage iv breast cancer
5835960|NCT00022074|stage IIIA breast cancer|stage iiia breast cancer
5835961|NCT00022074|recurrent breast cancer|recurrent breast cancer
5835962|NCT00022074|stage IIIB breast cancer|stage iiib breast cancer
5835963|NCT00022074|stage IIIC breast cancer|stage iiic breast cancer
5835965|NCT00022074|depression|depression
5835966|NCT00022074|hot flashes|hot flashes
5835967|NCT00022048|refractory anemia|refractory anemia
5835968|NCT00022048|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5835969|NCT00022048|refractory anemia with excess blasts|refractory anemia with excess blasts
5835970|NCT00022048|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5835971|NCT00022048|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5835972|NCT00022048|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5835973|NCT00022048|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5835974|NCT00022048|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5835975|NCT00022048|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5835976|NCT00022035|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5835977|NCT00022035|infection|infection
5835978|NCT00022022|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5835979|NCT00022022|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5835980|NCT00022022|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5835981|NCT00021450|stage IIB prostate cancer|stage iib prostate cancer
5835982|NCT00021450|stage IIA prostate cancer|stage iia prostate cancer
5835983|NCT00021424|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5835984|NCT00021424|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5835985|NCT00021424|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5835986|NCT00021424|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5835987|NCT00021424|skin metastases|skin metastases
5835988|NCT00021320|stage 0 esophageal cancer|stage 0 esophageal cancer
5835989|NCT00021320|stage I esophageal cancer|stage i esophageal cancer
5835990|NCT00021320|stage II esophageal cancer|stage ii esophageal cancer
5835991|NCT00021320|stage III esophageal cancer|stage iii esophageal cancer
5835992|NCT00021320|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5835993|NCT00021320|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5835994|NCT00021242|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5835995|NCT00021242|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5835996|NCT00021242|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5835997|NCT00021229|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5835998|NCT00021229|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5835999|NCT00021229|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5836000|NCT00021229|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5836001|NCT00021229|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5836002|NCT00021164|stage IV melanoma|stage iv melanoma
5864397|NCT00000379|Male|male
5861040|NCT00004647|pain|pain
5836003|NCT00021164|recurrent melanoma|recurrent melanoma
5836004|NCT00021164|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836005|NCT00021125|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5836006|NCT00021125|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5836007|NCT00021125|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5836008|NCT00021125|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5836009|NCT00021125|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5686938|NCT00549809|mechanical ventilation; respiratory failure|mechanical ventilation; respiratory failure
5686939|NCT00549796|coronary artery disease|coronary artery disease
5686940|NCT00549796|angioplasty|angioplasty
5686942|NCT00549796|percutaneous coronary intervention|percutaneous coronary intervention
5686943|NCT00549796|on-site cardiac surgery|on-site cardiac surgery
5686944|NCT00549796|randomized trial|randomized trial
5686945|NCT00549770|Hypertension, valsartan, LCZ696|hypertension, valsartan, lcz696
5686946|NCT00549757|Type 2 diabetes mellitus|type 2 diabetes mellitus
5686947|NCT00549757|renal morbidity and mortality|renal morbidity and mortality
5686948|NCT00549757|cardiovascular disease|cardiovascular disease
5845568|NCT00050388|Cancer treatment|cancer treatment
5836010|NCT00021125|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5836011|NCT00021125|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5836012|NCT00021125|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5836013|NCT00021125|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5836014|NCT00021125|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5836015|NCT00021125|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5836016|NCT00021125|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5836017|NCT00021125|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5836018|NCT00021125|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5836019|NCT00021125|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5836020|NCT00021125|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5836021|NCT00021125|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5836022|NCT00021125|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5836023|NCT00021125|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5836024|NCT00021125|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5836025|NCT00021125|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836026|NCT00021125|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5836027|NCT00021125|stage I salivary gland cancer|stage i salivary gland cancer
5836028|NCT00021125|stage II salivary gland cancer|stage ii salivary gland cancer
5836029|NCT00021125|stage III salivary gland cancer|stage iii salivary gland cancer
5836030|NCT00021125|stage IV salivary gland cancer|stage iv salivary gland cancer
5836031|NCT00021112|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836033|NCT00021047|recurrent gastric cancer|recurrent gastric cancer
5836034|NCT00021047|stage II esophageal cancer|stage ii esophageal cancer
5836035|NCT00021047|stage III esophageal cancer|stage iii esophageal cancer
5836036|NCT00021047|stage IV esophageal cancer|stage iv esophageal cancer
5836037|NCT00021047|recurrent esophageal cancer|recurrent esophageal cancer
5836038|NCT00021047|advanced adult primary liver cancer|advanced adult primary liver cancer
5836039|NCT00021047|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5836040|NCT00021047|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5836041|NCT00021047|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5836042|NCT00021047|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836043|NCT00021047|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5836044|NCT00021047|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836045|NCT00021047|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836046|NCT00021047|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5836047|NCT00021047|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5836048|NCT00021047|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5836049|NCT00021047|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5836050|NCT00021047|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836051|NCT00021047|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5836052|NCT00021047|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5836053|NCT00021047|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5836054|NCT00021047|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5836055|NCT00021047|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5836056|NCT00021047|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5836057|NCT00021047|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5836058|NCT00021047|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5681594|NCT00572663|N-acetylcysteine|n-acetylcysteine
5681595|NCT00572650|Type-2 diabetes, DPP-4 inhibitor, vildagliptin|type-2 diabetes, dpp-4 inhibitor, vildagliptin
5681596|NCT00572624|Heart Metabolism|heart metabolism
5681597|NCT00572624|Obesity|obesity
5681598|NCT00572624|Weight loss|weight loss
5681601|NCT00572611|Mass Balance|mass balance
5681602|NCT00572611|Metabolism|metabolism
5681603|NCT00572611|Absorption|absorption
5681604|NCT00572611|Excretion|excretion
5681605|NCT00572611|Pharmacokinetics|pharmacokinetics
5836059|NCT00021047|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5836060|NCT00021047|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5836061|NCT00021047|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5836063|NCT00021047|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5836064|NCT00021047|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5836065|NCT00021047|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5836066|NCT00021047|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5836067|NCT00021047|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5836068|NCT00021047|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5836069|NCT00021047|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836070|NCT00021047|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5836071|NCT00021047|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5836072|NCT00021047|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836073|NCT00021047|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5836074|NCT00021047|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5836075|NCT00021047|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5836076|NCT00021047|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836077|NCT00021047|recurrent salivary gland cancer|recurrent salivary gland cancer
5836078|NCT00021047|stage IV salivary gland cancer|stage iv salivary gland cancer
5836079|NCT00020995|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5836080|NCT00020995|stage I prostate cancer|stage i prostate cancer
5836081|NCT00020995|stage IIB prostate cancer|stage iib prostate cancer
5836082|NCT00020995|stage IIA prostate cancer|stage iia prostate cancer
5836083|NCT00020995|stage III prostate cancer|stage iii prostate cancer
5836084|NCT00020995|stage IV prostate cancer|stage iv prostate cancer
5836085|NCT00020969|refractory anemia|refractory anemia
5836086|NCT00020969|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5836087|NCT00020969|refractory anemia with excess blasts|refractory anemia with excess blasts
5836088|NCT00020969|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5836089|NCT00020969|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5836090|NCT00020969|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5836091|NCT00020969|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5836092|NCT00020969|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5836093|NCT00020969|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5836094|NCT00020969|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5836095|NCT00020943|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5836096|NCT00020943|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5836097|NCT00020943|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5836098|NCT00020943|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5836099|NCT00020943|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5836100|NCT00020891|stage I prostate cancer|stage i prostate cancer
5836101|NCT00020891|stage IIB prostate cancer|stage iib prostate cancer
5836102|NCT00020891|stage IIA prostate cancer|stage iia prostate cancer
5836103|NCT00020891|stage III prostate cancer|stage iii prostate cancer
5836104|NCT00020891|stage IV prostate cancer|stage iv prostate cancer
5836105|NCT00020891|recurrent prostate cancer|recurrent prostate cancer
5836106|NCT00020878|non-small cell lung cancer|non-small cell lung cancer
5864398|NCT00000379|Placebos|placebos
5681606|NCT00572598|PET|pet
5681607|NCT00572598|multidrug resistance|multidrug resistance
5681608|NCT00572598|fluoropaclitaxel|fluoropaclitaxel
5681609|NCT00572598|paclitaxel|paclitaxel
5681610|NCT00572598|breast cancer|breast cancer
5681611|NCT00572598|dosimetry|dosimetry
5681612|NCT00572598|imaging feasibility|imaging feasibility
5681613|NCT00572585|Ulcerative colitis|ulcerative colitis
5836108|NCT00020852|stage II breast cancer|stage ii breast cancer
5836109|NCT00020839|stage IV melanoma|stage iv melanoma
5836110|NCT00020839|recurrent melanoma|recurrent melanoma
5836111|NCT00020839|tumors metastatic to brain|tumors metastatic to brain
5836112|NCT00020826|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5836113|NCT00020800|Waldenström macroglobulinemia|waldenström macroglobulinemia
5836114|NCT00020761|stage IV gastric cancer|stage iv gastric cancer
5836115|NCT00020761|recurrent gastric cancer|recurrent gastric cancer
5836116|NCT00020761|stage IV esophageal cancer|stage iv esophageal cancer
5836117|NCT00020761|recurrent esophageal cancer|recurrent esophageal cancer
5836118|NCT00020761|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5836119|NCT00020761|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5836120|NCT00020748|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836121|NCT00020735|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5836123|NCT00020735|stage II prostate cancer|stage ii prostate cancer
5836124|NCT00020722|stage IV breast cancer|stage iv breast cancer
5836125|NCT00020722|recurrent breast cancer|recurrent breast cancer
5836126|NCT00020670|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5836127|NCT00020670|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5836128|NCT00020670|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5836129|NCT00020670|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5836130|NCT00020657|nausea and vomiting|nausea and vomiting
5836131|NCT00020657|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836132|NCT00020644|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836133|NCT00020631|radiation fibrosis|radiation fibrosis
5836134|NCT00020579|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5836135|NCT00020579|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5836136|NCT00020579|small intestine lymphoma|small intestine lymphoma
5836137|NCT00020579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5836138|NCT00020579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5836139|NCT00020579|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5836140|NCT00020579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5836141|NCT00020579|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5836142|NCT00020579|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5836143|NCT00020579|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5836144|NCT00020579|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5836145|NCT00020579|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5836146|NCT00020579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5836147|NCT00020579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5836148|NCT00020579|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5836149|NCT00020579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5836150|NCT00020579|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5836151|NCT00020579|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5836152|NCT00020579|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5836153|NCT00020579|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5836154|NCT00020579|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5836155|NCT00020579|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5836156|NCT00020579|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5836157|NCT00020579|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5836158|NCT00020579|intraocular lymphoma|intraocular lymphoma
5836159|NCT00020579|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5836160|NCT00020579|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5836161|NCT00020579|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5836162|NCT00020579|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5836163|NCT00020579|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5836164|NCT00020579|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5836165|NCT00020579|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5836166|NCT00020579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5836167|NCT00020579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5836168|NCT00020579|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5836169|NCT00020579|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5836170|NCT00020579|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5836171|NCT00020579|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5836172|NCT00020579|male breast cancer|male breast cancer
5836173|NCT00020579|stage IIIA breast cancer|stage iiia breast cancer
5836174|NCT00020579|stage IIIB breast cancer|stage iiib breast cancer
5836175|NCT00020579|stage IIIC breast cancer|stage iiic breast cancer
5836176|NCT00020579|stage IV breast cancer|stage iv breast cancer
5836177|NCT00020579|recurrent pancreatic cancer|recurrent pancreatic cancer
5836178|NCT00020579|stage III pancreatic cancer|stage iii pancreatic cancer
5836179|NCT00020579|recurrent colon cancer|recurrent colon cancer
5836180|NCT00020579|stage III colon cancer|stage iii colon cancer
5836181|NCT00020579|stage IV colon cancer|stage iv colon cancer
5836182|NCT00020579|recurrent rectal cancer|recurrent rectal cancer
5836183|NCT00020579|stage III rectal cancer|stage iii rectal cancer
5836184|NCT00020579|stage IV rectal cancer|stage iv rectal cancer
5836185|NCT00020579|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5836186|NCT00020579|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5845890|NCT00048477|Vasodilation|vasodilation
5836188|NCT00020579|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5836189|NCT00020579|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5836190|NCT00020579|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5836191|NCT00020579|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5836192|NCT00020579|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5836193|NCT00020579|recurrent cervical cancer|recurrent cervical cancer
5836194|NCT00020579|stage III cervical cancer|stage iii cervical cancer
5836195|NCT00020579|stage IVA cervical cancer|stage iva cervical cancer
5836196|NCT00020579|stage IVB cervical cancer|stage ivb cervical cancer
5836197|NCT00020579|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5836198|NCT00020579|stage III endometrial carcinoma|stage iii endometrial carcinoma
5836199|NCT00020579|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5836200|NCT00020579|fallopian tube cancer|fallopian tube cancer
5836201|NCT00020579|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5836202|NCT00020579|recurrent uterine sarcoma|recurrent uterine sarcoma
5836203|NCT00020579|stage III uterine sarcoma|stage iii uterine sarcoma
5836204|NCT00020579|stage IV uterine sarcoma|stage iv uterine sarcoma
5836205|NCT00020579|recurrent vaginal cancer|recurrent vaginal cancer
5836206|NCT00020579|stage III vaginal cancer|stage iii vaginal cancer
5836207|NCT00020579|stage IVA vaginal cancer|stage iva vaginal cancer
5836208|NCT00020579|stage IVB vaginal cancer|stage ivb vaginal cancer
5836209|NCT00020579|recurrent vulvar cancer|recurrent vulvar cancer
5836210|NCT00020579|stage III vulvar cancer|stage iii vulvar cancer
5836211|NCT00020579|stage IV vulvar cancer|stage iv vulvar cancer
5836212|NCT00020579|recurrent anal cancer|recurrent anal cancer
5836213|NCT00020579|stage IIIA anal cancer|stage iiia anal cancer
5836214|NCT00020579|stage IIIB anal cancer|stage iiib anal cancer
5836215|NCT00020579|stage IV anal cancer|stage iv anal cancer
5836216|NCT00020579|recurrent esophageal cancer|recurrent esophageal cancer
5836217|NCT00020579|stage III esophageal cancer|stage iii esophageal cancer
5836218|NCT00020579|stage IV esophageal cancer|stage iv esophageal cancer
5836219|NCT00020579|recurrent gastric cancer|recurrent gastric cancer
5836220|NCT00020579|stage III gastric cancer|stage iii gastric cancer
5836221|NCT00020579|stage IV gastric cancer|stage iv gastric cancer
5836222|NCT00020579|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5836223|NCT00020579|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5836224|NCT00020579|advanced adult primary liver cancer|advanced adult primary liver cancer
5836225|NCT00020579|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5836226|NCT00020579|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5836227|NCT00020579|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5836228|NCT00020579|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5836229|NCT00020579|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5836230|NCT00020579|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5836231|NCT00020579|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5836232|NCT00020579|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5836233|NCT00020579|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5836234|NCT00020579|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836235|NCT00020579|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5862685|NCT00001545|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5836236|NCT00020579|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5836237|NCT00020579|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5836238|NCT00020579|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836239|NCT00020579|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5836240|NCT00020579|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5836241|NCT00020579|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5836242|NCT00020579|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5836243|NCT00020579|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5836244|NCT00020579|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5836245|NCT00020579|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5836246|NCT00020579|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5836247|NCT00020579|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5836248|NCT00020579|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5836249|NCT00020579|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5836250|NCT00020579|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5833189|NCT00047021|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5836251|NCT00020579|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836252|NCT00020579|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5836253|NCT00020579|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5836254|NCT00020579|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5836255|NCT00020579|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836256|NCT00020579|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5836257|NCT00020579|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5836258|NCT00020579|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5836259|NCT00020579|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836260|NCT00020579|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5836261|NCT00020579|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5836262|NCT00020579|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836264|NCT00020579|recurrent parathyroid cancer|recurrent parathyroid cancer
5836265|NCT00020579|recurrent salivary gland cancer|recurrent salivary gland cancer
5836266|NCT00020579|stage III salivary gland cancer|stage iii salivary gland cancer
5836267|NCT00020579|stage IV salivary gland cancer|stage iv salivary gland cancer
5836268|NCT00020579|recurrent bladder cancer|recurrent bladder cancer
5836269|NCT00020579|recurrent gallbladder cancer|recurrent gallbladder cancer
5836270|NCT00020579|stage III bladder cancer|stage iii bladder cancer
5836271|NCT00020579|stage IV bladder cancer|stage iv bladder cancer
5836272|NCT00020579|unresectable gallbladder cancer|unresectable gallbladder cancer
5836273|NCT00020579|recurrent renal cell cancer|recurrent renal cell cancer
5851125|NCT00006442|HIV-1|hiv-1
5836274|NCT00020579|stage III renal cell cancer|stage iii renal cell cancer
5836275|NCT00020579|stage IV renal cell cancer|stage iv renal cell cancer
5836276|NCT00020579|stage III Wilms tumor|stage iii wilms tumor
5836277|NCT00020579|stage IV Wilms tumor|stage iv wilms tumor
5836278|NCT00020579|stage V Wilms tumor|stage v wilms tumor
5836279|NCT00020579|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5836280|NCT00020579|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5836281|NCT00020579|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5836283|NCT00020579|posterior urethral cancer|posterior urethral cancer
5836284|NCT00020579|recurrent urethral cancer|recurrent urethral cancer
5836285|NCT00020579|recurrent penile cancer|recurrent penile cancer
5836286|NCT00020579|stage III penile cancer|stage iii penile cancer
5836287|NCT00020579|stage IV penile cancer|stage iv penile cancer
5836288|NCT00020579|recurrent prostate cancer|recurrent prostate cancer
5836289|NCT00020579|stage III prostate cancer|stage iii prostate cancer
5836290|NCT00020579|stage IV prostate cancer|stage iv prostate cancer
5836291|NCT00020579|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5836292|NCT00020579|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5836293|NCT00020579|metastatic osteosarcoma|metastatic osteosarcoma
5836294|NCT00020579|recurrent osteosarcoma|recurrent osteosarcoma
5836295|NCT00020579|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5836296|NCT00020579|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5836297|NCT00020579|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5836298|NCT00020579|classic Kaposi sarcoma|classic kaposi sarcoma
5836299|NCT00020579|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5836300|NCT00020579|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5686949|NCT00549757|micro-albuminuria|micro-albuminuria
5836301|NCT00020579|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5836302|NCT00020579|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5836303|NCT00020579|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5836304|NCT00020579|extraocular extension melanoma|extraocular extension melanoma
5836305|NCT00020579|iris melanoma|iris melanoma
5836306|NCT00020579|recurrent intraocular melanoma|recurrent intraocular melanoma
5836307|NCT00020579|recurrent melanoma|recurrent melanoma
5836308|NCT00020579|stage III melanoma|stage iii melanoma
5836309|NCT00020579|stage IV melanoma|stage iv melanoma
5836310|NCT00020579|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836311|NCT00020579|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836312|NCT00020579|recurrent small cell lung cancer|recurrent small cell lung cancer
5836313|NCT00020579|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5836314|NCT00020579|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836316|NCT00020579|recurrent thymoma and thymic carcinoma|recurrent thymoma and thymic carcinoma
5836317|NCT00020579|advanced malignant mesothelioma|advanced malignant mesothelioma
5836318|NCT00020579|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5836319|NCT00020579|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5836320|NCT00020579|stage III adrenocortical carcinoma|stage iii adrenocortical carcinoma
5836321|NCT00020579|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5836322|NCT00020579|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5836323|NCT00020579|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5836324|NCT00020579|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5836325|NCT00020579|desmoid tumor|desmoid tumor
5836326|NCT00020579|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5836327|NCT00020579|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5836328|NCT00020579|undifferentiated carcinoma of unknown primary|undifferentiated carcinoma of unknown primary
5836329|NCT00020579|carcinoma of the appendix|carcinoma of the appendix
5836330|NCT00020579|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836331|NCT00020579|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5836332|NCT00020579|recurrent pituitary tumor|recurrent pituitary tumor
5836333|NCT00020579|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5836334|NCT00020579|adult astrocytic tumors|adult astrocytic tumors
5836335|NCT00020579|adult diffuse astrocytoma|adult diffuse astrocytoma
5836336|NCT00020579|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5836337|NCT00020579|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5836338|NCT00020579|adult brain stem glioma|adult brain stem glioma
5836339|NCT00020579|adult oligodendroglioma|adult oligodendroglioma
5836340|NCT00020579|adult mixed glioma|adult mixed glioma
5836341|NCT00020579|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5836342|NCT00020579|adult choroid plexus tumor|adult choroid plexus tumor
5836343|NCT00020579|adult craniopharyngioma|adult craniopharyngioma
5836344|NCT00020579|adult anaplastic ependymoma|adult anaplastic ependymoma
5836345|NCT00020579|adult subependymoma|adult subependymoma
5836346|NCT00020579|adult medulloblastoma|adult medulloblastoma
5836347|NCT00020579|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5836348|NCT00020579|adult ependymoblastoma|adult ependymoblastoma
5836349|NCT00020579|adult ependymoma|adult ependymoma
5836350|NCT00020579|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5836351|NCT00020579|adult anaplastic meningioma|adult anaplastic meningioma
5836352|NCT00020579|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5836353|NCT00020579|adult meningioma|adult meningioma
5836354|NCT00020579|adult papillary meningioma|adult papillary meningioma
5836355|NCT00020579|adult grade I meningioma|adult grade i meningioma
5836356|NCT00020579|adult grade II meningioma|adult grade ii meningioma
5836357|NCT00020579|adult grade III meningioma|adult grade iii meningioma
5836358|NCT00020579|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5836359|NCT00020579|recurrent adult brain tumor|recurrent adult brain tumor
5836360|NCT00020579|stage IV pancreatic cancer|stage iv pancreatic cancer
5836361|NCT00020579|stage III thymoma|stage iii thymoma
5836362|NCT00020579|stage IVA thymoma|stage iva thymoma
5836363|NCT00020579|stage IVB thymoma|stage ivb thymoma
5836364|NCT00020566|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5836365|NCT00020566|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5681614|NCT00572585|immunosuppressive therapy|immunosuppressive therapy
5681615|NCT00572585|AEB071|aeb071
5681616|NCT00572585|Modified Baron score|modified baron score
5681617|NCT00572585|Partial Mayo score|partial mayo score
5681618|NCT00572533|End-Stage Renal Disease|end-stage renal disease
5681619|NCT00572533|Chronic Hemodialysis|chronic hemodialysis
5681620|NCT00572520|Depressive Disorder|depressive disorder
5681621|NCT00572520|Weight Loss|weight loss
5681622|NCT00572520|Behavioral Treatment|behavioral treatment
5686950|NCT00549757|macro-albuminuria|macro-albuminuria
5686951|NCT00549757|RAAS|raas
5686952|NCT00549757|renin inhibitor|renin inhibitor
5686953|NCT00549757|Reduced estimated glomerular filtration rate|reduced estimated glomerular filtration rate
5686954|NCT00549744|ASTHMA|asthma
5686955|NCT00549744|CLINICAL ENDPOINT,|clinical endpoint,
5686956|NCT00549731|autism|autism
5686957|NCT00549731|autistic|autistic
5686958|NCT00549731|language|language
5686959|NCT00549731|development|development
5681623|NCT00572520|Behavior Therapy|behavior therapy
5681624|NCT00572520|Randomized Clinical Trial|randomized clinical trial
5861555|NCT00001911|Mycobacterial Infection|mycobacterial infection
5836366|NCT00020527|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5836367|NCT00020527|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5836368|NCT00020527|disseminated neuroblastoma|disseminated neuroblastoma
5836369|NCT00020527|recurrent neuroblastoma|recurrent neuroblastoma
5836370|NCT00020527|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5836371|NCT00020527|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5836372|NCT00020527|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5836373|NCT00020527|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5836374|NCT00020527|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5847787|NCT00038142|VACdxr|vacdxr
5836376|NCT00020527|neutropenia|neutropenia
5836377|NCT00020527|infection|infection
5836378|NCT00020527|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5836379|NCT00020527|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5836784|NCT00019110|stage III cervical cancer|stage iii cervical cancer
5836380|NCT00020527|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5836381|NCT00020501|stage IV colon cancer|stage iv colon cancer
5836382|NCT00020501|stage IV rectal cancer|stage iv rectal cancer
5836383|NCT00020501|recurrent colon cancer|recurrent colon cancer
5836384|NCT00020501|recurrent rectal cancer|recurrent rectal cancer
5836385|NCT00020501|liver metastases|liver metastases
5836386|NCT00020488|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836387|NCT00020449|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5836388|NCT00020449|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5836389|NCT00020410|stage IV breast cancer|stage iv breast cancer
5836390|NCT00020410|recurrent breast cancer|recurrent breast cancer
5836391|NCT00020410|male breast cancer|male breast cancer
5836392|NCT00020397|recurrent melanoma|recurrent melanoma
5836393|NCT00020397|stage IV melanoma|stage iv melanoma
5836394|NCT00020358|stage I melanoma|stage i melanoma
5836395|NCT00020358|stage II melanoma|stage ii melanoma
5836396|NCT00020358|stage III melanoma|stage iii melanoma
5836397|NCT00020358|stage IV melanoma|stage iv melanoma
5836398|NCT00020358|recurrent melanoma|recurrent melanoma
5836399|NCT00020332|stage IV breast cancer|stage iv breast cancer
5836400|NCT00020332|stage IIIA breast cancer|stage iiia breast cancer
5836401|NCT00020332|recurrent breast cancer|recurrent breast cancer
5836402|NCT00020332|stage IIIB breast cancer|stage iiib breast cancer
5836403|NCT00020332|male breast cancer|male breast cancer
5836404|NCT00020254|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5836405|NCT00020254|recurrent prostate cancer|recurrent prostate cancer
5836406|NCT00020189|thromboembolism|thromboembolism
5836407|NCT00020189|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5836408|NCT00020189|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836409|NCT00020189|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5836410|NCT00020189|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836411|NCT00020189|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836412|NCT00020189|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5836413|NCT00020189|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5836414|NCT00020189|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5836415|NCT00020189|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5836416|NCT00020189|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5681625|NCT00572507|Absorbable Monofilament Suture Material|absorbable monofilament suture material
5836417|NCT00020189|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5686960|NCT00549731|developmental|developmental
5686961|NCT00549731|assessment|assessment
5686962|NCT00549718|Schizophrenia|schizophrenia
5686963|NCT00549718|SM-13496|sm-13496
5686964|NCT00549718|Latuda|latuda
5686965|NCT00549718|Lurasidone|lurasidone
5686966|NCT00549705|Anticoagulation|anticoagulation
5686967|NCT00549705|Thrombosis|thrombosis
5686968|NCT00549705|Bleeding|bleeding
5836418|NCT00020189|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836419|NCT00020189|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5836420|NCT00020189|recurrent salivary gland cancer|recurrent salivary gland cancer
5836421|NCT00020189|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5836422|NCT00020189|stage IV salivary gland cancer|stage iv salivary gland cancer
5836423|NCT00020176|stage IV breast cancer|stage iv breast cancer
5836424|NCT00020176|recurrent breast cancer|recurrent breast cancer
5836425|NCT00020176|male breast cancer|male breast cancer
5836426|NCT00020150|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5836427|NCT00020150|childhood craniopharyngioma|childhood craniopharyngioma
5836428|NCT00020150|recurrent childhood brain tumor|recurrent childhood brain tumor
5836429|NCT00020150|recurrent neuroblastoma|recurrent neuroblastoma
5836430|NCT00020150|recurrent childhood liver cancer|recurrent childhood liver cancer
5836431|NCT00020150|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5836432|NCT00020150|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5836433|NCT00020150|recurrent osteosarcoma|recurrent osteosarcoma
5836434|NCT00020150|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5836435|NCT00020150|childhood germ cell tumor|childhood germ cell tumor
5836436|NCT00020150|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5836437|NCT00020150|childhood oligodendroglioma|childhood oligodendroglioma
5836438|NCT00020150|childhood choroid plexus tumor|childhood choroid plexus tumor
5836439|NCT00020150|childhood grade I meningioma|childhood grade i meningioma
5836440|NCT00020150|childhood grade II meningioma|childhood grade ii meningioma
5836441|NCT00020150|childhood grade III meningioma|childhood grade iii meningioma
5836442|NCT00020150|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5836443|NCT00020150|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5836444|NCT00020150|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5836445|NCT00020150|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5836446|NCT00020150|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5836447|NCT00020150|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5836785|NCT00019110|stage IV cervical cancer|stage iv cervical cancer
5836448|NCT00020150|recurrent childhood ependymoma|recurrent childhood ependymoma
5836449|NCT00020150|childhood teratoma|childhood teratoma
5836450|NCT00020150|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5836451|NCT00020150|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5836452|NCT00020150|childhood malignant ovarian germ cell tumor|childhood malignant ovarian germ cell tumor
5836453|NCT00020150|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5836454|NCT00020124|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836455|NCT00020124|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836456|NCT00020124|recurrent small cell lung cancer|recurrent small cell lung cancer
5836457|NCT00020124|advanced malignant mesothelioma|advanced malignant mesothelioma
5836458|NCT00020124|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5836459|NCT00020124|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836460|NCT00020124|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836461|NCT00020124|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5836462|NCT00020124|lung metastases|lung metastases
5836463|NCT00020111|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5836464|NCT00020111|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5836465|NCT00020111|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5836466|NCT00020111|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5836467|NCT00020111|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5836468|NCT00020111|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5836469|NCT00020111|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5836470|NCT00020111|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5836471|NCT00020111|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5836472|NCT00020072|cutaneous T-cell non-Hodgkin lymphoma|cutaneous t-cell non-hodgkin lymphoma
5836473|NCT00020072|mycosis fungoides/Sezary syndrome|mycosis fungoides/sezary syndrome
5836474|NCT00020007|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836475|NCT00020007|limited stage small cell lung cancer|limited stage small cell lung cancer
5836476|NCT00020007|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836477|NCT00020007|recurrent small cell lung cancer|recurrent small cell lung cancer
5681628|NCT00572507|Laparotomy|laparotomy
5681629|NCT00572494|Tibial arteries|tibial arteries
5681630|NCT00572494|Absorbable implants|absorbable implants
5681632|NCT00572494|Limb salvage|limb salvage
5681633|NCT00572481|Sentinel Lymph Node Biopsy|sentinel lymph node biopsy
5681634|NCT00572481|Axillary Node Dissection|axillary node dissection
5681635|NCT00572481|Prevention of lymphedema|prevention of lymphedema
5681636|NCT00572481|Prevention of neuroma|prevention of neuroma
5681637|NCT00572481|Prevention of seroma|prevention of seroma
5681638|NCT00572468|cancer|cancer
5681639|NCT00572468|pre-operative surgery|pre-operative surgery
5681640|NCT00572468|prostate|prostate
5836478|NCT00020007|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5836479|NCT00020007|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836480|NCT00020007|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836482|NCT00020007|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5836483|NCT00020007|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5836484|NCT00019994|stage IV melanoma|stage iv melanoma
5836485|NCT00019994|recurrent melanoma|recurrent melanoma
5836486|NCT00019955|stage I renal cell cancer|stage i renal cell cancer
5836487|NCT00019955|stage II renal cell cancer|stage ii renal cell cancer
5836488|NCT00019929|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5836489|NCT00019929|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836490|NCT00019916|stage IV breast cancer|stage iv breast cancer
5836491|NCT00019916|recurrent breast cancer|recurrent breast cancer
5836492|NCT00019916|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5836493|NCT00019916|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5836494|NCT00019864|cardiac toxicity|cardiac toxicity
5836495|NCT00019864|localized osteosarcoma|localized osteosarcoma
5836496|NCT00019864|metastatic osteosarcoma|metastatic osteosarcoma
5836497|NCT00019864|recurrent osteosarcoma|recurrent osteosarcoma
5836498|NCT00019838|Waldenström macroglobulinemia|waldenström macroglobulinemia
5836499|NCT00019838|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5836500|NCT00019838|refractory hairy cell leukemia|refractory hairy cell leukemia
5836501|NCT00019838|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5836502|NCT00019838|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5836503|NCT00019838|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5836504|NCT00019838|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5836505|NCT00019838|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5836506|NCT00019838|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5836507|NCT00019838|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5836508|NCT00019838|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5836509|NCT00019825|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836510|NCT00019825|stage II esophageal cancer|stage ii esophageal cancer
5836511|NCT00019825|stage III esophageal cancer|stage iii esophageal cancer
5836512|NCT00019825|stage IV esophageal cancer|stage iv esophageal cancer
5836513|NCT00019825|recurrent esophageal cancer|recurrent esophageal cancer
5836514|NCT00019825|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836515|NCT00019825|recurrent small cell lung cancer|recurrent small cell lung cancer
5836516|NCT00019825|advanced malignant mesothelioma|advanced malignant mesothelioma
5836517|NCT00019825|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5836518|NCT00019825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836519|NCT00019825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836520|NCT00019825|malignant pleural effusion|malignant pleural effusion
5836521|NCT00019812|stage IV breast cancer|stage iv breast cancer
5836522|NCT00019812|male breast cancer|male breast cancer
5836523|NCT00019786|stage IV colon cancer|stage iv colon cancer
5836524|NCT00019786|stage IV rectal cancer|stage iv rectal cancer
5836525|NCT00019786|recurrent colon cancer|recurrent colon cancer
5836526|NCT00019786|recurrent rectal cancer|recurrent rectal cancer
5836527|NCT00019786|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5836528|NCT00019786|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5681641|NCT00572468|prostatectomy|prostatectomy
5681642|NCT00572468|radiation|radiation
5681643|NCT00572455|Open-Angle Glaucoma|open-angle glaucoma
5681644|NCT00572455|Ocular Hypertension|ocular hypertension
5681645|NCT00572442|Non-invasive heart scan|non-invasive heart scan
5681646|NCT00572442|MCG|mcg
5681647|NCT00572442|Cardiac Risk Factors|cardiac risk factors
5681648|NCT00572442|healthy volunteers|healthy volunteers
5681649|NCT00572429|HIV/AIDS|hiv/aids
5836529|NCT00019786|recurrent islet cell carcinoma|recurrent islet cell carcinoma
5836530|NCT00019786|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5836531|NCT00019786|adenocarcinoma of the colon|adenocarcinoma of the colon
5836532|NCT00019786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5836533|NCT00019786|liver metastases|liver metastases
5836534|NCT00019786|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5836535|NCT00019786|advanced adult primary liver cancer|advanced adult primary liver cancer
5836536|NCT00019786|recurrent childhood liver cancer|recurrent childhood liver cancer
5836537|NCT00019786|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5836538|NCT00019786|stage III childhood liver cancer|stage iii childhood liver cancer
5836539|NCT00019786|stage IV childhood liver cancer|stage iv childhood liver cancer
5836540|NCT00019786|neuroendocrine carcinoma|neuroendocrine carcinoma
5836541|NCT00019773|stage I colon cancer|stage i colon cancer
5836542|NCT00019773|stage II colon cancer|stage ii colon cancer
5836543|NCT00019773|stage III colon cancer|stage iii colon cancer
5836544|NCT00019773|stage IV colon cancer|stage iv colon cancer
5836545|NCT00019773|stage 0 colon cancer|stage 0 colon cancer
5836546|NCT00019773|stage 0 rectal cancer|stage 0 rectal cancer
5836547|NCT00019773|stage I rectal cancer|stage i rectal cancer
5836548|NCT00019773|stage II rectal cancer|stage ii rectal cancer
5836549|NCT00019773|stage III rectal cancer|stage iii rectal cancer
5836550|NCT00019773|stage IV rectal cancer|stage iv rectal cancer
5836551|NCT00019773|recurrent colon cancer|recurrent colon cancer
5836552|NCT00019773|recurrent rectal cancer|recurrent rectal cancer
5836553|NCT00019773|small intestine adenocarcinoma|small intestine adenocarcinoma
5836554|NCT00019773|small intestine lymphoma|small intestine lymphoma
5836555|NCT00019773|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5836556|NCT00019773|recurrent small intestine cancer|recurrent small intestine cancer
5836557|NCT00019773|carcinoma of the appendix|carcinoma of the appendix
5836558|NCT00019747|stage IV colon cancer|stage iv colon cancer
5836559|NCT00019747|stage IV rectal cancer|stage iv rectal cancer
5836560|NCT00019747|recurrent colon cancer|recurrent colon cancer
5836561|NCT00019747|recurrent rectal cancer|recurrent rectal cancer
5836562|NCT00019669|stage IV melanoma|stage iv melanoma
5836563|NCT00019669|recurrent melanoma|recurrent melanoma
5836564|NCT00019656|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5836565|NCT00019656|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5836566|NCT00019656|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836567|NCT00019656|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5836568|NCT00019656|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5836569|NCT00019656|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5836570|NCT00019656|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5836571|NCT00019656|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5836572|NCT00019656|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5836573|NCT00019656|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5836574|NCT00019656|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5836575|NCT00019656|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5836576|NCT00019656|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5836577|NCT00019656|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5836578|NCT00019656|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5836580|NCT00019656|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5836581|NCT00019656|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5836582|NCT00019656|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5836583|NCT00019656|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5836584|NCT00019656|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5836585|NCT00019656|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5836586|NCT00019656|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5836587|NCT00019656|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5681650|NCT00572429|HAART|haart
5681651|NCT00572429|high cholesterol|high cholesterol
5681652|NCT00572429|exercise|exercise
5681653|NCT00572429|L-carnitine|l-carnitine
5681654|NCT00572429|Complimentary therapies|complimentary therapies
5681655|NCT00572416|fatigue|fatigue
5836588|NCT00019656|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5836589|NCT00019656|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5836590|NCT00019656|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5848324|NCT00035165|malignant|malignant
5836591|NCT00019656|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5836592|NCT00019656|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5836593|NCT00019656|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5836594|NCT00019656|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5836595|NCT00019656|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5861471|NCT00001926|PET|pet
5836596|NCT00019656|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5836597|NCT00019656|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5836598|NCT00019656|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5836599|NCT00019656|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5836600|NCT00019656|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5836601|NCT00019656|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5836602|NCT00019604|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5836603|NCT00019604|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5836604|NCT00019604|liver metastases|liver metastases
5836605|NCT00019604|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836606|NCT00019591|stage III colon cancer|stage iii colon cancer
5836607|NCT00019591|stage IV colon cancer|stage iv colon cancer
5836608|NCT00019591|stage III rectal cancer|stage iii rectal cancer
5836609|NCT00019591|stage IV rectal cancer|stage iv rectal cancer
5836610|NCT00019591|recurrent colon cancer|recurrent colon cancer
5836611|NCT00019591|recurrent rectal cancer|recurrent rectal cancer
5836612|NCT00019565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836613|NCT00019513|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5836614|NCT00019513|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5836615|NCT00019513|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5836616|NCT00019513|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5836617|NCT00019513|small intestine lymphoma|small intestine lymphoma
5836618|NCT00019513|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836619|NCT00019513|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5836620|NCT00019513|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5836621|NCT00019513|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5836622|NCT00019513|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5836623|NCT00019513|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5836624|NCT00019513|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5836625|NCT00019513|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5836626|NCT00019513|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5836627|NCT00019513|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5836628|NCT00019513|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5833565|NCT00045006|recurrent breast cancer|recurrent breast cancer
5836629|NCT00019513|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5836630|NCT00019513|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5836631|NCT00019513|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5836632|NCT00019513|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5836633|NCT00019513|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5836634|NCT00019513|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5836635|NCT00019513|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5836636|NCT00019513|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5836637|NCT00019513|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5836638|NCT00019513|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5836639|NCT00019513|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5836640|NCT00019513|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5836641|NCT00019513|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5836642|NCT00019513|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5836643|NCT00019513|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5836644|NCT00019513|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5681657|NCT00572416|sleep-wake|sleep-wake
5681658|NCT00572416|psychological distress|psychological distress
5681659|NCT00572416|symptom management|symptom management
5681660|NCT00572403|microalbuminuria|microalbuminuria
5681661|NCT00572403|risk factors|risk factors
5681662|NCT00572377|Sexual|sexual
5681663|NCT00572377|Arousal|arousal
5681664|NCT00572377|Female|female
5681665|NCT00572364|Cancer|cancer
5862077|NCT00001726|Plaque|plaque
5836645|NCT00019513|advanced adult primary liver cancer|advanced adult primary liver cancer
5836646|NCT00019513|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5836647|NCT00019513|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836648|NCT00019513|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836649|NCT00019513|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836650|NCT00019513|recurrent small cell lung cancer|recurrent small cell lung cancer
5836651|NCT00019513|recurrent pancreatic cancer|recurrent pancreatic cancer
5836652|NCT00019513|stage IV esophageal cancer|stage iv esophageal cancer
5836653|NCT00019513|recurrent esophageal cancer|recurrent esophageal cancer
5686969|NCT00549705|Clotting|clotting
5686970|NCT00549705|Pulmonary Embolism|pulmonary embolism
5686971|NCT00549705|Deep Vein Thrombosis|deep vein thrombosis
5686972|NCT00549679|Chronic Obstructive Pulmonary Disease (COPD)|chronic obstructive pulmonary disease (copd)
5686973|NCT00549679|COPD|copd
5686974|NCT00549679|Repeat Dose|repeat dose
5686975|NCT00549679|GSK256066|gsk256066
5686976|NCT00549666|OC DDI|oc ddi
5686977|NCT00549666|lurasidone|lurasidone
5686978|NCT00549666|Latuda|latuda
5686979|NCT00549666|schizophenia|schizophenia
5686980|NCT00549653|GW856553,|gw856553,
5686981|NCT00549653|drug-drug interactions,|drug-drug interactions,
5836655|NCT00019513|stage IV colon cancer|stage iv colon cancer
5836656|NCT00019513|recurrent gallbladder cancer|recurrent gallbladder cancer
5836657|NCT00019513|unresectable gallbladder cancer|unresectable gallbladder cancer
5836658|NCT00019513|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5836659|NCT00019513|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5836660|NCT00019513|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5836661|NCT00019513|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5836662|NCT00019513|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5836663|NCT00019513|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5837225|NCT00016263|recurrent melanoma|recurrent melanoma
5836664|NCT00019513|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5836665|NCT00019513|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5836666|NCT00019513|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5836667|NCT00019513|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5836668|NCT00019513|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5836669|NCT00019513|stage IV pancreatic cancer|stage iv pancreatic cancer
5836670|NCT00019487|stage IV melanoma|stage iv melanoma
5836671|NCT00019487|recurrent melanoma|recurrent melanoma
5836672|NCT00019461|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5836673|NCT00019461|fallopian tube cancer|fallopian tube cancer
5836674|NCT00019461|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5836675|NCT00019422|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5836676|NCT00019422|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5836677|NCT00019422|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5836678|NCT00019422|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5836679|NCT00019422|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5836680|NCT00019422|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5836681|NCT00019422|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5836682|NCT00019422|recurrent childhood ependymoma|recurrent childhood ependymoma
5836683|NCT00019331|stage IV colon cancer|stage iv colon cancer
5836684|NCT00019331|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836685|NCT00019331|stage II pancreatic cancer|stage ii pancreatic cancer
5836686|NCT00019331|stage III pancreatic cancer|stage iii pancreatic cancer
5836687|NCT00019331|recurrent pancreatic cancer|recurrent pancreatic cancer
5836688|NCT00019331|recurrent colon cancer|recurrent colon cancer
5836689|NCT00019331|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5836691|NCT00019331|advanced adult primary liver cancer|advanced adult primary liver cancer
5836692|NCT00019331|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5836693|NCT00019331|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5836694|NCT00019331|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5830223|NCT00058825|Campath|campath
5836695|NCT00019331|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5836696|NCT00019331|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5836697|NCT00019331|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5836698|NCT00019331|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5836699|NCT00019331|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5836700|NCT00019331|anaplastic thyroid cancer|anaplastic thyroid cancer
5836701|NCT00019331|recurrent thyroid cancer|recurrent thyroid cancer
5836702|NCT00019331|stage IV melanoma|stage iv melanoma
5836703|NCT00019331|recurrent melanoma|recurrent melanoma
5836704|NCT00019331|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5686982|NCT00549653|rosuvastatin|rosuvastatin
5686983|NCT00549640|nicotine dependence|nicotine dependence
5836705|NCT00019331|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836706|NCT00019331|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5836707|NCT00019331|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836708|NCT00019331|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5836710|NCT00019331|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836711|NCT00019331|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5836712|NCT00019331|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5836713|NCT00019331|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5836714|NCT00019331|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5836715|NCT00019331|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836716|NCT00019331|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5836717|NCT00019331|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5836718|NCT00019331|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5836719|NCT00019331|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5836720|NCT00019331|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5848325|NCT00035165|metastatic|metastatic
5836721|NCT00019331|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5836722|NCT00019331|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5836723|NCT00019331|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5836724|NCT00019331|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5836725|NCT00019331|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5836726|NCT00019331|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5836727|NCT00019331|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5836728|NCT00019331|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5836729|NCT00019331|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5836730|NCT00019331|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5836731|NCT00019331|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5836732|NCT00019331|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5836733|NCT00019331|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5836734|NCT00019331|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836735|NCT00019331|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5836736|NCT00019331|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5836737|NCT00019331|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836738|NCT00019331|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5846686|NCT00043745|alternative hormone therapy|alternative hormone therapy
5836739|NCT00019331|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5836740|NCT00019331|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5836741|NCT00019331|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836742|NCT00019331|insular thyroid cancer|insular thyroid cancer
5836743|NCT00019331|recurrent salivary gland cancer|recurrent salivary gland cancer
5836744|NCT00019331|stage IV salivary gland cancer|stage iv salivary gland cancer
5836745|NCT00019331|stage IV pancreatic cancer|stage iv pancreatic cancer
5836746|NCT00019227|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5836747|NCT00019227|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5836748|NCT00019227|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5836749|NCT00019227|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5836750|NCT00019227|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5836751|NCT00019227|radiation toxicity|radiation toxicity
5836752|NCT00019214|recurrent melanoma|recurrent melanoma
5836753|NCT00019201|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5836754|NCT00019201|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5681666|NCT00572364|Advanced solid malignancies|advanced solid malignancies
5836755|NCT00019201|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5836756|NCT00019201|limited stage small cell lung cancer|limited stage small cell lung cancer
5686984|NCT00549640|tobacco dependence|tobacco dependence
5686985|NCT00549614|heart failure|heart failure
5686986|NCT00549601|Alzheimer's|alzheimer's
5686987|NCT00549601|rivastigmine|rivastigmine
5686988|NCT00549601|transdermal|transdermal
5686989|NCT00549601|safety|safety
5686990|NCT00549601|randomized|randomized
5686991|NCT00549601|switch|switch
5686992|NCT00549601|patch|patch
5686993|NCT00549588|Polymorphic light eruption|polymorphic light eruption
5686994|NCT00549588|UV radiation|uv radiation
5686995|NCT00549588|photoprotection|photoprotection
5686996|NCT00549588|sunscreen|sunscreen
5686997|NCT00549588|DNA repair enzymes|dna repair enzymes
5686998|NCT00549588|after-sun-lotion|after-sun-lotion
5681626|NCT00572507|Safety and Efficacy|safety and efficacy
5681627|NCT00572507|Abdominal Wall/ Fascia|abdominal wall/ fascia
5836757|NCT00019201|stage I nasopharyngeal cancer|stage i nasopharyngeal cancer
5836758|NCT00019201|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5836759|NCT00019201|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5836760|NCT00019201|stage I lip and oral cavity cancer|stage i lip and oral cavity cancer
5836761|NCT00019201|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5836762|NCT00019201|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5836763|NCT00019201|stage I hypopharyngeal cancer|stage i hypopharyngeal cancer
5836764|NCT00019201|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5836765|NCT00019201|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5836766|NCT00019201|stage I laryngeal cancer|stage i laryngeal cancer
5836767|NCT00019201|stage II laryngeal cancer|stage ii laryngeal cancer
5836768|NCT00019201|stage III laryngeal cancer|stage iii laryngeal cancer
5837146|NCT00016926|stage III cervical cancer|stage iii cervical cancer
5836769|NCT00019201|stage I paranasal sinus and nasal cavity cancer|stage i paranasal sinus and nasal cavity cancer
5836770|NCT00019201|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5836771|NCT00019201|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5836772|NCT00019201|stage I oropharyngeal cancer|stage i oropharyngeal cancer
5836773|NCT00019201|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5836774|NCT00019201|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5836775|NCT00019136|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5836776|NCT00019110|stage IV anal cancer|stage iv anal cancer
5836777|NCT00019110|recurrent anal cancer|recurrent anal cancer
5836778|NCT00019110|stage II esophageal cancer|stage ii esophageal cancer
5836779|NCT00019110|stage III esophageal cancer|stage iii esophageal cancer
5836780|NCT00019110|stage IV esophageal cancer|stage iv esophageal cancer
5836781|NCT00019110|stage IIIA anal cancer|stage iiia anal cancer
5836782|NCT00019110|stage IIIB anal cancer|stage iiib anal cancer
5836783|NCT00019110|recurrent esophageal cancer|recurrent esophageal cancer
5836786|NCT00019110|recurrent cervical cancer|recurrent cervical cancer
5836787|NCT00019110|stage III vulvar cancer|stage iii vulvar cancer
5836788|NCT00019110|stage IVB vulvar cancer|stage ivb vulvar cancer
5836789|NCT00019110|recurrent vulvar cancer|recurrent vulvar cancer
5836790|NCT00019110|stage III penile cancer|stage iii penile cancer
5836791|NCT00019110|stage IV penile cancer|stage iv penile cancer
5836792|NCT00019110|recurrent penile cancer|recurrent penile cancer
5836793|NCT00019110|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836794|NCT00019110|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5836795|NCT00019110|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5836796|NCT00019110|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5836797|NCT00019110|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5836798|NCT00019110|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5836799|NCT00019110|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5836800|NCT00019110|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836801|NCT00019110|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5836802|NCT00019110|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5836803|NCT00019110|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5686999|NCT00549575|Severe Intra uterine growth retardation below the third centile with abnormal uterine doppler|severe intra uterine growth retardation below the third centile with abnormal uterine doppler
5848032|NCT00036582|Genetics|genetics
5687000|NCT00549575|Severe growth retardation with pathologic uterine Doppler|severe growth retardation with pathologic uterine doppler
5687003|NCT00549562|Autistic Disorder|autistic disorder
5687004|NCT00549536|calcium supplementation|calcium supplementation
5687005|NCT00549536|intracellular ions|intracellular ions
5836804|NCT00019110|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836805|NCT00019110|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5836806|NCT00019110|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5836807|NCT00019110|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5836808|NCT00019110|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5836809|NCT00019110|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5836810|NCT00019110|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5836811|NCT00019110|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5836812|NCT00019110|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5836813|NCT00019110|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5836814|NCT00019110|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5836815|NCT00019110|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5836816|NCT00019110|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5836817|NCT00019110|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5681667|NCT00572351|Wine|wine
5681668|NCT00572325|radiotherapy|radiotherapy
5681669|NCT00572325|NSCLC|nsclc
5681670|NCT00572325|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5681671|NCT00572312|Proteinuria,|proteinuria,
5681672|NCT00572312|atorvastatin|atorvastatin
5681673|NCT00572299|glucocorticoids, prednisone, alendronate,osteoclasts|glucocorticoids, prednisone, alendronate,osteoclasts
5681674|NCT00572286|heart transplant|heart transplant
5681675|NCT00572286|advanced heart failure|advanced heart failure
5681676|NCT00572286|orthotropic heart transplantation|orthotropic heart transplantation
5836818|NCT00019110|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5836819|NCT00019110|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5836820|NCT00019110|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5836821|NCT00019110|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5836822|NCT00019110|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5836823|NCT00019110|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5836824|NCT00019110|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5836825|NCT00019110|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5836826|NCT00019110|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5836827|NCT00019110|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5836828|NCT00019110|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5836829|NCT00019110|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5836893|NCT00019019|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5836830|NCT00019110|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5836831|NCT00019110|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5836832|NCT00019110|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5836833|NCT00019110|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836834|NCT00019110|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5836835|NCT00019110|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5836836|NCT00019110|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5836837|NCT00019110|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5687006|NCT00549536|sodium/hydrogen exchange activity|sodium/hydrogen exchange activity
5687008|NCT00549523|Alternative Medicine|alternative medicine
5687009|NCT00549523|Complementary Medicine|complementary medicine
5687010|NCT00549510|COREG CR,|coreg cr,
5687011|NCT00549510|lisinopril,|lisinopril,
5836838|NCT00019110|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5836907|NCT00019019|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5836839|NCT00019110|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5836840|NCT00019110|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5836841|NCT00019110|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5836842|NCT00019110|recurrent salivary gland cancer|recurrent salivary gland cancer
5836843|NCT00019110|stage IV salivary gland cancer|stage iv salivary gland cancer
5836844|NCT00019110|stage III salivary gland cancer|stage iii salivary gland cancer
5836845|NCT00019032|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5836846|NCT00019032|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5836847|NCT00019019|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5836848|NCT00019019|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5836849|NCT00019019|stage IV breast cancer|stage iv breast cancer
5836850|NCT00019019|stage IIIA breast cancer|stage iiia breast cancer
5836851|NCT00019019|recurrent breast cancer|recurrent breast cancer
5836852|NCT00019019|stage IIIB breast cancer|stage iiib breast cancer
5836853|NCT00019019|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5836854|NCT00019019|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5836855|NCT00019019|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5836856|NCT00019019|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5836857|NCT00019019|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5681677|NCT00572286|(MCG) magnetocardiograph|(mcg) magnetocardiograph
5681679|NCT00572260|MRSA|mrsa
5862488|NCT00001603|Cytokines|cytokines
5836858|NCT00019019|stage III renal cell cancer|stage iii renal cell cancer
5836859|NCT00019019|stage IV renal cell cancer|stage iv renal cell cancer
5836860|NCT00019019|recurrent renal cell cancer|recurrent renal cell cancer
5836861|NCT00019019|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5836862|NCT00019019|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5836863|NCT00019019|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5836864|NCT00019019|recurrent adult brain tumor|recurrent adult brain tumor
5836865|NCT00019019|small intestine lymphoma|small intestine lymphoma
5836866|NCT00019019|adult brain stem glioma|adult brain stem glioma
5836867|NCT00019019|adult craniopharyngioma|adult craniopharyngioma
5836868|NCT00019019|adult medulloblastoma|adult medulloblastoma
5836869|NCT00019019|adult meningioma|adult meningioma
5836870|NCT00019019|adult glioblastoma|adult glioblastoma
5836871|NCT00019019|stage III melanoma|stage iii melanoma
5836872|NCT00019019|stage IV melanoma|stage iv melanoma
5836873|NCT00019019|recurrent melanoma|recurrent melanoma
5836874|NCT00019019|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5836875|NCT00019019|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5836876|NCT00019019|stage IIIC breast cancer|stage iiic breast cancer
5836877|NCT00019019|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836878|NCT00019019|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836879|NCT00019019|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5836880|NCT00019019|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5836881|NCT00019019|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5836882|NCT00019019|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5836883|NCT00019019|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5836884|NCT00019019|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5836885|NCT00019019|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5836886|NCT00019019|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5836887|NCT00019019|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5836888|NCT00019019|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5836889|NCT00019019|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5836890|NCT00019019|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5836891|NCT00019019|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5836892|NCT00019019|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5836894|NCT00019019|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5687292|NCT00548054|West Bengal|west bengal
5687012|NCT00549510|hypertension,|hypertension,
5687013|NCT00549510|dose proportionality,|dose proportionality,
5687014|NCT00549510|fixed dose combination (FDC)|fixed dose combination (fdc)
5687015|NCT00549497|GW870086X, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin|gw870086x, inhaled, asthma, cortisol, pharmacokinetics, osteocalcin
5687016|NCT00549484|Thrombocytopenia|thrombocytopenia
5687017|NCT00549484|Thrombopoietin|thrombopoietin
5687018|NCT00549484|Platelet Transfusion|platelet transfusion
5836895|NCT00019019|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5836896|NCT00019019|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5836897|NCT00019019|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5836898|NCT00019019|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5836899|NCT00019019|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5836900|NCT00019019|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5836901|NCT00019019|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5836902|NCT00019019|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5836903|NCT00019019|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5836904|NCT00019019|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5836905|NCT00019019|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5836906|NCT00019019|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5837239|NCT00016068|infection|infection
5836908|NCT00019019|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5836909|NCT00019019|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5836910|NCT00019019|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5836911|NCT00019019|adult anaplastic ependymoma|adult anaplastic ependymoma
5836912|NCT00019019|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5836913|NCT00019019|adult mixed glioma|adult mixed glioma
5836914|NCT00019019|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5836915|NCT00019019|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5836916|NCT00019019|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5836917|NCT00019019|adult subependymoma|adult subependymoma
5836918|NCT00019019|adult ependymoblastoma|adult ependymoblastoma
5836919|NCT00019019|adult pineocytoma|adult pineocytoma
5836920|NCT00019019|adult pineoblastoma|adult pineoblastoma
5836921|NCT00019019|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5836922|NCT00019019|intraocular lymphoma|intraocular lymphoma
5862686|NCT00001545|Mania|mania
5681680|NCT00572260|Increased risk for infection|increased risk for infection
5681681|NCT00572234|Methamphetamine|methamphetamine
5681682|NCT00572234|Bupropion SR (Sustained Release)|bupropion sr (sustained release)
5681683|NCT00572221|CQI|cqi
5681684|NCT00572221|QA|qa
5862587|NCT00001575|Anti -Tac|anti -tac
5836923|NCT00019019|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5836924|NCT00019019|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5836925|NCT00019019|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5836926|NCT00019019|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5836927|NCT00019019|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5836928|NCT00019019|adult choroid plexus tumor|adult choroid plexus tumor
5836929|NCT00019019|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5836930|NCT00019019|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5836931|NCT00019019|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5836932|NCT00019019|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5836933|NCT00019019|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5836934|NCT00019019|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5836935|NCT00019019|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5836936|NCT00019019|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5836937|NCT00019019|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5836938|NCT00019019|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5836939|NCT00019019|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5836940|NCT00019019|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5836941|NCT00019019|adult grade III meningioma|adult grade iii meningioma
5836943|NCT00019019|adult giant cell glioblastoma|adult giant cell glioblastoma
5836945|NCT00018967|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5836946|NCT00018967|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5847586|NCT00038779|AA|aa
5836947|NCT00018967|neurotoxicity|neurotoxicity
5836949|NCT00017602|stage I multiple myeloma|stage i multiple myeloma
5836950|NCT00017602|stage II multiple myeloma|stage ii multiple myeloma
5836951|NCT00017602|stage III multiple myeloma|stage iii multiple myeloma
5836952|NCT00017589|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5836953|NCT00017563|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5836954|NCT00017563|stage II prostate cancer|stage ii prostate cancer
5836955|NCT00017563|stage III prostate cancer|stage iii prostate cancer
5836956|NCT00017550|refractory anemia|refractory anemia
5836957|NCT00017550|refractory anemia with excess blasts|refractory anemia with excess blasts
5836958|NCT00017550|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5836959|NCT00017550|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5836960|NCT00017524|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5836961|NCT00017511|stage I salivary gland cancer|stage i salivary gland cancer
5836962|NCT00017511|stage II salivary gland cancer|stage ii salivary gland cancer
5836963|NCT00017511|stage III salivary gland cancer|stage iii salivary gland cancer
5836964|NCT00017511|stage IV salivary gland cancer|stage iv salivary gland cancer
5836965|NCT00017511|recurrent salivary gland cancer|recurrent salivary gland cancer
5836966|NCT00017511|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5836967|NCT00017511|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5836968|NCT00017511|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5836969|NCT00017511|oral complications|oral complications
5836970|NCT00017511|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5836971|NCT00017511|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5836972|NCT00017511|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5836973|NCT00017511|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5836974|NCT00017511|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5836975|NCT00017511|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5836976|NCT00017511|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5837240|NCT00016055|stage IV melanoma|stage iv melanoma
5836977|NCT00017511|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5836978|NCT00017511|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5836979|NCT00017511|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5836980|NCT00017511|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5864487|NCT00000373|Adolescence|adolescence
5681685|NCT00572221|Best Practice|best practice
5681686|NCT00572221|Quality Improvement|quality improvement
5681687|NCT00572221|Nursing Facilities|nursing facilities
5681688|NCT00572221|Nursing Homes|nursing homes
5681689|NCT00572221|Care|care
5681690|NCT00572195|Epilepsy|epilepsy
5682892|NCT00567125|endostatin|endostatin
5681691|NCT00572195|Responsive neurostimulation|responsive neurostimulation
5681692|NCT00572195|RNS System|rns system
5836981|NCT00017511|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5836982|NCT00017511|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5836983|NCT00017511|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5836984|NCT00017511|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5836985|NCT00017511|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5836986|NCT00017511|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5836987|NCT00017511|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5836988|NCT00017511|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5836989|NCT00017511|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5836990|NCT00017511|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5836991|NCT00017511|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5836992|NCT00017511|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5836993|NCT00017511|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5836994|NCT00017511|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5836995|NCT00017511|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5836996|NCT00017511|stage I lymphoepithelioma of the oropharynx|stage i lymphoepithelioma of the oropharynx
5836997|NCT00017511|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5836998|NCT00017511|stage II lymphoepithelioma of the oropharynx|stage ii lymphoepithelioma of the oropharynx
5836999|NCT00017511|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5687019|NCT00549484|Platelet Factor 4|platelet factor 4
5837000|NCT00017511|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5837001|NCT00017511|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837002|NCT00017511|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5837003|NCT00017511|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5837004|NCT00017511|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5837005|NCT00017511|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5837006|NCT00017511|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5837007|NCT00017511|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5837008|NCT00017511|stage II lymphoepithelioma of the nasopharynx|stage ii lymphoepithelioma of the nasopharynx
5837009|NCT00017511|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5837010|NCT00017511|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5837011|NCT00017511|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5837012|NCT00017511|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5837013|NCT00017511|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5837014|NCT00017511|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5837015|NCT00017511|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5837016|NCT00017511|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5837017|NCT00017511|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5837018|NCT00017511|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837019|NCT00017511|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5837020|NCT00017511|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5837021|NCT00017511|stage I verrucous carcinoma of the larynx|stage i verrucous carcinoma of the larynx
5837022|NCT00017511|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5837023|NCT00017511|stage II verrucous carcinoma of the larynx|stage ii verrucous carcinoma of the larynx
5837024|NCT00017511|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837025|NCT00017511|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5681694|NCT00572195|Brain stimulation|brain stimulation
5681695|NCT00572195|Seizures|seizures
5681696|NCT00572182|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5681697|NCT00572182|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5681698|NCT00572182|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5681882|NCT00571376|Health care costs|health care costs
5681699|NCT00572182|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5681700|NCT00572182|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5681701|NCT00572182|childhood choroid plexus tumor|childhood choroid plexus tumor
5681702|NCT00572182|childhood craniopharyngioma|childhood craniopharyngioma
5681703|NCT00572182|recurrent childhood ependymoma|recurrent childhood ependymoma
5681704|NCT00572182|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5681705|NCT00572182|childhood oligodendroglioma|childhood oligodendroglioma
5681706|NCT00572182|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5681707|NCT00572182|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5837026|NCT00017511|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837027|NCT00017511|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5837028|NCT00017511|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5837029|NCT00017511|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5837030|NCT00017511|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5837031|NCT00017511|stage I inverted papilloma of the paranasal sinus and nasal cavity|stage i inverted papilloma of the paranasal sinus and nasal cavity
5837032|NCT00017511|stage I midline lethal granuloma of the paranasal sinus and nasal cavity|stage i midline lethal granuloma of the paranasal sinus and nasal cavity
5837033|NCT00017511|stage I esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837034|NCT00017511|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5837035|NCT00017511|stage II inverted papilloma of the paranasal sinus and nasal cavity|stage ii inverted papilloma of the paranasal sinus and nasal cavity
5837036|NCT00017511|stage II midline lethal granuloma of the paranasal sinus and nasal cavity|stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
5837037|NCT00017511|stage II esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837038|NCT00017511|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5687020|NCT00549471|children with cerebral palsy ages eight to eleven.|children with cerebral palsy ages eight to eleven.
5687021|NCT00549458|Week pelvic floor muscle in females|week pelvic floor muscle in females
5687022|NCT00549445|Chronic Obstructive Pulmonary Disease|chronic obstructive pulmonary disease
5687023|NCT00549445|COPD|copd
5687024|NCT00549445|Exacerbation|exacerbation
5712601|NCT00455143|PD|pd
5687025|NCT00549445|Macrolide|macrolide
5687026|NCT00549406|Vision|vision
5687027|NCT00549406|Visual attention|visual attention
5687028|NCT00549406|Postural balance|postural balance
5837039|NCT00017511|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5837040|NCT00017511|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5837041|NCT00017511|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837042|NCT00017511|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5837043|NCT00017511|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5837044|NCT00017511|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5837045|NCT00017511|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837046|NCT00017511|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5837047|NCT00017511|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5837048|NCT00017511|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5864488|NCT00000373|Adult|adult
5681708|NCT00572182|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5681709|NCT00572182|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5681710|NCT00572182|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5681711|NCT00572182|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5681712|NCT00572182|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5681713|NCT00572182|childhood grade III meningioma|childhood grade iii meningioma
5681714|NCT00572156|IGF-1 Deficiency|igf-1 deficiency
5681715|NCT00572156|growth|growth
5681716|NCT00572156|ISS|iss
5681717|NCT00572156|Constitutional growth delay|constitutional growth delay
5681718|NCT00572156|Primary IGFD|primary igfd
5681719|NCT00572156|Primary IGF Deficiency|primary igf deficiency
5681720|NCT00572143|Colonic Neoplasms/surgery*|colonic neoplasms/surgery*
5681721|NCT00572143|Continuity of Patient Care*|continuity of patient care*
5681722|NCT00572143|Follow-Up Studies|follow-up studies
5681723|NCT00572143|Quality of Life|quality of life
5681724|NCT00572143|Patient Satisfaction|patient satisfaction
5681725|NCT00572130|Tumor-targeted gene medicine|tumor-targeted gene medicine
5862903|NCT00001464|Oxygen|oxygen
5837049|NCT00017511|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837050|NCT00017511|radiation toxicity|radiation toxicity
5837051|NCT00017498|stage IV salivary gland cancer|stage iv salivary gland cancer
5837052|NCT00017498|recurrent salivary gland cancer|recurrent salivary gland cancer
5837053|NCT00017498|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5837054|NCT00017498|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5837055|NCT00017498|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5837056|NCT00017485|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5837057|NCT00017485|recurrent skin cancer|recurrent skin cancer
5837058|NCT00017355|stage IV melanoma|stage iv melanoma
5837059|NCT00017355|recurrent melanoma|recurrent melanoma
5837060|NCT00017329|stage IV renal cell cancer|stage iv renal cell cancer
5837061|NCT00017290|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5837062|NCT00017290|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5837063|NCT00017290|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5837064|NCT00017290|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5837065|NCT00017290|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5837066|NCT00017290|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5837067|NCT00017277|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5687029|NCT00549406|Geriatrics|geriatrics
5687030|NCT00549393|intensive care unit|intensive care unit
5687031|NCT00549393|Healthcare associated infections (HAI)|healthcare associated infections (hai)
5687032|NCT00549393|pediatric|pediatric
5837068|NCT00017277|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5837069|NCT00017277|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5837070|NCT00017277|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837071|NCT00017277|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5837072|NCT00017277|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5837073|NCT00017277|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837074|NCT00017277|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837075|NCT00017277|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5837076|NCT00017277|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5837077|NCT00017277|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5837078|NCT00017277|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837079|NCT00017277|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5862687|NCT00001545|Bipolar Disorder|bipolar disorder
5681726|NCT00572130|Cyclin G1 gene|cyclin g1 gene
5681727|NCT00572130|Osteosarcoma|osteosarcoma
5681728|NCT00572117|Bipolar Disorder|bipolar disorder
5681729|NCT00572117|Manic Disorder|manic disorder
5681730|NCT00572117|Alcoholism|alcoholism
5681731|NCT00572117|Alcohol Abuse|alcohol abuse
5681732|NCT00572117|Alcohol Dependence|alcohol dependence
5681733|NCT00572117|Clinical Trial|clinical trial
5681734|NCT00572117|Evaluation Trial|evaluation trial
5681735|NCT00572117|Intervention Trial|intervention trial
5681736|NCT00572117|Validation Studies|validation studies
5681737|NCT00572091|Heart Failure|heart failure
5681738|NCT00572091|Mitral Regurgitation|mitral regurgitation
5681739|NCT00572078|solid tumor|solid tumor
5862996|NCT00001418|Dysautonomias|dysautonomias
5837080|NCT00017277|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5837081|NCT00017277|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837082|NCT00017277|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837083|NCT00017264|recurrent adult brain tumor|recurrent adult brain tumor
5837084|NCT00017264|adult glioblastoma|adult glioblastoma
5837085|NCT00017264|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837086|NCT00017264|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5837087|NCT00017264|adult giant cell glioblastoma|adult giant cell glioblastoma
5837088|NCT00017264|adult gliosarcoma|adult gliosarcoma
5837089|NCT00017225|localized resectable neuroblastoma|localized resectable neuroblastoma
5837090|NCT00017225|regional neuroblastoma|regional neuroblastoma
5837091|NCT00017225|disseminated neuroblastoma|disseminated neuroblastoma
5837092|NCT00017225|stage 4S neuroblastoma|stage 4s neuroblastoma
5837093|NCT00017225|recurrent neuroblastoma|recurrent neuroblastoma
5837094|NCT00017225|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5837095|NCT00017212|stage III gastric cancer|stage iii gastric cancer
5837096|NCT00017212|stage IV gastric cancer|stage iv gastric cancer
5837097|NCT00017212|recurrent gastric cancer|recurrent gastric cancer
5837098|NCT00017212|stage III esophageal cancer|stage iii esophageal cancer
5837099|NCT00017212|stage IV esophageal cancer|stage iv esophageal cancer
5837100|NCT00017212|recurrent esophageal cancer|recurrent esophageal cancer
5837101|NCT00017212|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837102|NCT00017212|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5837103|NCT00017186|localized malignant mesothelioma|localized malignant mesothelioma
5837104|NCT00017186|advanced malignant mesothelioma|advanced malignant mesothelioma
5837105|NCT00017186|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5837106|NCT00017173|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5837107|NCT00017173|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837108|NCT00017173|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837109|NCT00017173|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837110|NCT00017173|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5837111|NCT00017173|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837112|NCT00017173|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837113|NCT00017173|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5837114|NCT00017147|adult glioblastoma|adult glioblastoma
5837115|NCT00017147|adult giant cell glioblastoma|adult giant cell glioblastoma
5687033|NCT00549380|Aneurysmal Disease in Thorax, Abdominal or Extremity|aneurysmal disease in thorax, abdominal or extremity
5687034|NCT00549367|Nutritional status|nutritional status
5687036|NCT00549367|Nutrition assessment|nutrition assessment
5687038|NCT00549367|Alternative Medicine|alternative medicine
5837116|NCT00017147|adult gliosarcoma|adult gliosarcoma
5837117|NCT00017121|stage IV melanoma|stage iv melanoma
5837118|NCT00017121|recurrent melanoma|recurrent melanoma
5837120|NCT00017108|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5837121|NCT00017108|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5837122|NCT00017108|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5837123|NCT00017095|stage II breast cancer|stage ii breast cancer
5837124|NCT00017095|stage IIIA breast cancer|stage iiia breast cancer
5837125|NCT00017095|stage IIIB breast cancer|stage iiib breast cancer
5837126|NCT00017095|stage IIIC breast cancer|stage iiic breast cancer
5837127|NCT00017095|inflammatory breast cancer|inflammatory breast cancer
5837128|NCT00017069|refractory multiple myeloma|refractory multiple myeloma
5837129|NCT00017069|stage II multiple myeloma|stage ii multiple myeloma
5837130|NCT00017069|stage III multiple myeloma|stage iii multiple myeloma
5865498|NCT00000217|drug abuse|drug abuse
5681740|NCT00572039|Age-Related Macular Degeneration|age-related macular degeneration
5681742|NCT00572039|Vision Function|vision function
5681743|NCT00572039|Problem Solving Treatment|problem solving treatment
5681744|NCT00572039|PST|pst
5681745|NCT00572026|Attention deficit|attention deficit
5681746|NCT00572026|Hyperactivity|hyperactivity
5681747|NCT00572026|Attention deficit hyperactivity disorder|attention deficit hyperactivity disorder
5681748|NCT00571987|Breast cancer|breast cancer
5681749|NCT00571987|Lumpectomy|lumpectomy
5681750|NCT00571987|Radiofrequency Ablation|radiofrequency ablation
5681751|NCT00571987|Negative margins|negative margins
5681752|NCT00571987|Breast Conserving Surgery|breast conserving surgery
5681753|NCT00571961|HIV|hiv
5681754|NCT00571961|Pharmacokinetics|pharmacokinetics
5681755|NCT00571961|Buprenorphine|buprenorphine
5681756|NCT00571961|Kaletra|kaletra
5681757|NCT00571961|HIV Seronegativity|hiv seronegativity
5681758|NCT00571948|infant, complementary food, iron, meat, LC-PUFA, omega-3,|infant, complementary food, iron, meat, lc-pufa, omega-3,
5681759|NCT00571948|rapeseed oil, diet|rapeseed oil, diet
5681760|NCT00571922|methamphetamine, crystal, treatment|methamphetamine, crystal, treatment
5681761|NCT00571909|Polycystic Kidney Disease|polycystic kidney disease
5681762|NCT00571909|Chronic Kidney Pain|chronic kidney pain
5681763|NCT00571909|Autosomal Dominant Polycystic Kidney|autosomal dominant polycystic kidney
5681764|NCT00571909|Kidney Cyst|kidney cyst
5681765|NCT00571909|VSPL|vspl
5681766|NCT00571909|video thoracoscopic splanchnicectomy|video thoracoscopic splanchnicectomy
5681767|NCT00571896|constipation|constipation
5837131|NCT00016991|recurrent adult brain tumor|recurrent adult brain tumor
5837132|NCT00016991|adult glioblastoma|adult glioblastoma
5837133|NCT00016991|adult giant cell glioblastoma|adult giant cell glioblastoma
5837134|NCT00016991|adult gliosarcoma|adult gliosarcoma
5837135|NCT00016965|stage II pancreatic cancer|stage ii pancreatic cancer
5837136|NCT00016965|stage III pancreatic cancer|stage iii pancreatic cancer
5837137|NCT00016965|recurrent pancreatic cancer|recurrent pancreatic cancer
5837138|NCT00016965|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837139|NCT00016965|stage IV pancreatic cancer|stage iv pancreatic cancer
5837140|NCT00016952|stage IV colon cancer|stage iv colon cancer
5837141|NCT00016952|stage IV rectal cancer|stage iv rectal cancer
5837142|NCT00016952|recurrent colon cancer|recurrent colon cancer
5837143|NCT00016952|recurrent rectal cancer|recurrent rectal cancer
5837144|NCT00016952|adenocarcinoma of the colon|adenocarcinoma of the colon
5837145|NCT00016952|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5837147|NCT00016926|recurrent cervical cancer|recurrent cervical cancer
5837148|NCT00016926|stage IVB cervical cancer|stage ivb cervical cancer
5837149|NCT00016926|stage IVA cervical cancer|stage iva cervical cancer
5837150|NCT00016926|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5837151|NCT00016913|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5837152|NCT00016913|stage III prostate cancer|stage iii prostate cancer
5837153|NCT00016887|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5837154|NCT00016887|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5837155|NCT00016861|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5837156|NCT00016432|stage I breast cancer|stage i breast cancer
5837157|NCT00016432|stage II breast cancer|stage ii breast cancer
5837158|NCT00016432|stage IIIA breast cancer|stage iiia breast cancer
5837159|NCT00016419|refractory anemia|refractory anemia
5837160|NCT00016419|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5681768|NCT00571896|SennaS|sennas
5681769|NCT00571883|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5687039|NCT00549367|Complementary Medicine|complementary medicine
5687040|NCT00549354|Abdominal Infrarenal Aortic|abdominal infrarenal aortic
5687041|NCT00549354|Aorto-Iliac Aneurysms|aorto-iliac aneurysms
5687042|NCT00549341|Torticollis|torticollis
5687043|NCT00549341|Cervical Dystonia|cervical dystonia
5687044|NCT00549328|anti-angiogenesis|anti-angiogenesis
5687045|NCT00549328|Non-small cell lung cancer,|non-small cell lung cancer,
5687046|NCT00549328|pazopanib (GW786034)|pazopanib (gw786034)
5681770|NCT00571883|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5681771|NCT00571883|tongue cancer|tongue cancer
5681772|NCT00571844|High Blood Pressure|high blood pressure
5681773|NCT00571844|Exercise|exercise
5681774|NCT00571844|Diet|diet
5681775|NCT00571844|Biomarkers|biomarkers
5681776|NCT00571831|macula edema|macula edema
5681777|NCT00571831|intraocular lens|intraocular lens
5681778|NCT00571831|prospective randomized parallel clinical design|prospective randomized parallel clinical design
5681779|NCT00571818|euglycemic|euglycemic
5681780|NCT00571818|transplant|transplant
5681781|NCT00571818|pancreas|pancreas
5681782|NCT00571818|hyperglycemic|hyperglycemic
5681784|NCT00571805|cigarette|cigarette
5681785|NCT00571805|craving|craving
5681786|NCT00571805|reward|reward
5681787|NCT00571792|COPD|copd
5681883|NCT00571350|Cystocele|cystocele
5863197|NCT00001359|Children|children
5863198|NCT00001359|Tic Disorders|tic disorders
5837161|NCT00016419|refractory anemia with excess blasts|refractory anemia with excess blasts
5837162|NCT00016419|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5837163|NCT00016419|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5837164|NCT00016419|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5837165|NCT00016406|stage II breast cancer|stage ii breast cancer
5837166|NCT00016406|stage IIIA breast cancer|stage iiia breast cancer
5837167|NCT00016406|stage IIIB breast cancer|stage iiib breast cancer
5837168|NCT00016406|stage IIIC breast cancer|stage iiic breast cancer
5837169|NCT00016406|inflammatory breast cancer|inflammatory breast cancer
5837170|NCT00016393|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5837171|NCT00016393|stage IV prostate cancer|stage iv prostate cancer
5837172|NCT00016393|recurrent prostate cancer|recurrent prostate cancer
5837173|NCT00016380|nausea and vomiting|nausea and vomiting
5837174|NCT00016380|stage I colon cancer|stage i colon cancer
5837175|NCT00016380|stage II colon cancer|stage ii colon cancer
5837176|NCT00016380|stage III colon cancer|stage iii colon cancer
5837177|NCT00016380|stage IV colon cancer|stage iv colon cancer
5837178|NCT00016380|stage I gastric cancer|stage i gastric cancer
5837179|NCT00016380|stage II gastric cancer|stage ii gastric cancer
5837180|NCT00016380|stage III gastric cancer|stage iii gastric cancer
5837181|NCT00016380|stage IV gastric cancer|stage iv gastric cancer
5837182|NCT00016380|recurrent gastric cancer|recurrent gastric cancer
5837183|NCT00016380|stage I pancreatic cancer|stage i pancreatic cancer
5837184|NCT00016380|stage II pancreatic cancer|stage ii pancreatic cancer
5837185|NCT00016380|stage III pancreatic cancer|stage iii pancreatic cancer
5837186|NCT00016380|recurrent pancreatic cancer|recurrent pancreatic cancer
5837187|NCT00016380|recurrent colon cancer|recurrent colon cancer
5837188|NCT00016380|recurrent cervical cancer|recurrent cervical cancer
5837189|NCT00016380|stage IB cervical cancer|stage ib cervical cancer
5837190|NCT00016380|stage IIB cervical cancer|stage iib cervical cancer
5837191|NCT00016380|stage IVB cervical cancer|stage ivb cervical cancer
5837192|NCT00016380|stage IA cervical cancer|stage ia cervical cancer
5837193|NCT00016380|stage IIA cervical cancer|stage iia cervical cancer
5837194|NCT00016380|stage IVA cervical cancer|stage iva cervical cancer
5837195|NCT00016380|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5837196|NCT00016380|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5837197|NCT00016380|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5837198|NCT00016380|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5837199|NCT00016380|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5837200|NCT00016380|localized gastrointestinal carcinoid tumor|localized gastrointestinal carcinoid tumor
5837201|NCT00016380|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5837202|NCT00016380|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5681788|NCT00571792|The cohort will be comprised of normal non-smoking individuals, those individuals|the cohort will be comprised of normal non-smoking individuals, those individuals
5681789|NCT00571792|who smoke who do not exhibit symptoms of COPD and individuals who smoke who do demonstrate|who smoke who do not exhibit symptoms of copd and individuals who smoke who do demonstrate
5681790|NCT00571792|symptoms of COPD|symptoms of copd
5681791|NCT00571766|chronic hypertension in pregnancy|chronic hypertension in pregnancy
5687047|NCT00549263|Safety|safety
5687048|NCT00549263|Pharmacokinetics|pharmacokinetics
5687049|NCT00549263|Bioequivalence|bioequivalence
5687050|NCT00549250|Human papillomavirus 6/11|human papillomavirus 6/11
5687051|NCT00549250|Neonates|neonates
5687052|NCT00549250|Human papillomavirus 6 or 11 infection|human papillomavirus 6 or 11 infection
5687053|NCT00549237|RYGBP|rygbp
5687054|NCT00549237|Early nutrition|early nutrition
5687055|NCT00549237|Lean body mass|lean body mass
5687056|NCT00549237|Length of stay|length of stay
5687057|NCT00549237|Body Composition|body composition
5687350|NCT00547833|reading|reading
5687058|NCT00549211|Healthy Subjects,|healthy subjects,
5687059|NCT00549211|Safety,|safety,
5687060|NCT00549211|Tolerability,|tolerability,
5687061|NCT00549211|Pharmacokinetics|pharmacokinetics
5687062|NCT00549198|tenofovir|tenofovir
5687063|NCT00549198|HIV|hiv
5687064|NCT00549198|efavirenz|efavirenz
5687065|NCT00549198|naive|naive
5687066|NCT00549198|lamivudine|lamivudine
5687067|NCT00549198|abacavir|abacavir
5687068|NCT00549198|emtricitabine|emtricitabine
5687069|NCT00549198|renal|renal
5687070|NCT00549172|Osteoarthritis, Knee|osteoarthritis, knee
5681792|NCT00571766|chronic Hypertension|chronic hypertension
5681793|NCT00571753|pulmonary tuberculosis|pulmonary tuberculosis
5681795|NCT00571753|hepatotoxicity of isoniazid|hepatotoxicity of isoniazid
5681796|NCT00571740|stage IV colon cancer|stage iv colon cancer
5681797|NCT00571740|stage IV rectal cancer|stage iv rectal cancer
5681798|NCT00571740|recurrent colon cancer|recurrent colon cancer
5681799|NCT00571740|recurrent rectal cancer|recurrent rectal cancer
5837203|NCT00016380|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5837204|NCT00016380|localized resectable adult primary liver cancer|localized resectable adult primary liver cancer
5837205|NCT00016380|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5837206|NCT00016380|advanced adult primary liver cancer|advanced adult primary liver cancer
5837207|NCT00016380|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5837208|NCT00016380|small intestine adenocarcinoma|small intestine adenocarcinoma
5837209|NCT00016380|small intestine lymphoma|small intestine lymphoma
5837210|NCT00016380|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5837211|NCT00016380|localized gallbladder cancer|localized gallbladder cancer
5837212|NCT00016380|unresectable gallbladder cancer|unresectable gallbladder cancer
5837213|NCT00016380|recurrent gallbladder cancer|recurrent gallbladder cancer
5837214|NCT00016380|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5837215|NCT00016380|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5837216|NCT00016380|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5837217|NCT00016380|recurrent small intestine cancer|recurrent small intestine cancer
5837218|NCT00016380|testicular seminoma|testicular seminoma
5837219|NCT00016380|carcinoma of the appendix|carcinoma of the appendix
5837220|NCT00016380|quality of life|quality of life
5837221|NCT00016380|stage IV pancreatic cancer|stage iv pancreatic cancer
5837222|NCT00016354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5837224|NCT00016263|stage IV melanoma|stage iv melanoma
5837226|NCT00016224|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5837227|NCT00016211|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5837228|NCT00016185|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5837229|NCT00016159|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5837230|NCT00016159|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5837231|NCT00016159|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5837232|NCT00016159|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5837233|NCT00016159|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5837234|NCT00016146|recurrent prostate cancer|recurrent prostate cancer
5687071|NCT00549172|Arthroscopic Surgery|arthroscopic surgery
5687072|NCT00549172|Menisci, Medial|menisci, medial
5687073|NCT00549172|Placebo Effect|placebo effect
5687074|NCT00549172|Treatment Efficacy|treatment efficacy
5687075|NCT00549159|menorrhagia|menorrhagia
5687076|NCT00549159|dysfunctional uterine bleeding|dysfunctional uterine bleeding
5687077|NCT00549159|endometrial ablation|endometrial ablation
5687078|NCT00549146|reversibility|reversibility
5687079|NCT00549146|COPD|copd
5687080|NCT00549146|lung function|lung function
5687081|NCT00549133|Microalbuminaria in hypertensive patients with type II diabetes mellitus|microalbuminaria in hypertensive patients with type ii diabetes mellitus
5687082|NCT00549120|Healthy Subjects|healthy subjects
5687083|NCT00549120|muscarinic receptor antagonist|muscarinic receptor antagonist
5687084|NCT00549120|propranolol|propranolol
5687085|NCT00549120|beta-blocker|beta-blocker
5687086|NCT00549120|beta-agonist|beta-agonist
5687087|NCT00549107|low cardiac output syndrome|low cardiac output syndrome
5687088|NCT00549107|open heart surgery|open heart surgery
5687089|NCT00549107|infants|infants
5687090|NCT00549107|Low cardiac output syndrome in infants undergoing corrective open heart surgery|low cardiac output syndrome in infants undergoing corrective open heart surgery
5837235|NCT00016133|stage II colon cancer|stage ii colon cancer
5837236|NCT00016133|stage III colon cancer|stage iii colon cancer
5837237|NCT00016133|adenocarcinoma of the colon|adenocarcinoma of the colon
5837241|NCT00016055|recurrent melanoma|recurrent melanoma
5837242|NCT00016029|colon cancer|colon cancer
5837243|NCT00016029|rectal cancer|rectal cancer
5837244|NCT00015977|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5837245|NCT00015977|stage IV prostate cancer|stage iv prostate cancer
5837246|NCT00015977|recurrent prostate cancer|recurrent prostate cancer
5837247|NCT00015951|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837248|NCT00015951|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5837249|NCT00015951|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5837250|NCT00015951|refractory anemia with excess blasts|refractory anemia with excess blasts
5837251|NCT00015951|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5862696|NCT00001544|Bipolar Affective Disorders|bipolar affective disorders
5681800|NCT00571727|growth|growth
5681801|NCT00571727|insulin like growth factor|insulin like growth factor
5681802|NCT00571727|Larons syndrome|larons syndrome
5681803|NCT00571714|Chronic hepatitis C|chronic hepatitis c
5681804|NCT00571714|Pilot Comparison|pilot comparison
5681805|NCT00571714|Peginterferon alph-2a|peginterferon alph-2a
5681806|NCT00571714|Ribavirin|ribavirin
5681807|NCT00571714|Betaine|betaine
5681808|NCT00571714|Genotype 1|genotype 1
5681809|NCT00571714|Treatment naive|treatment naive
5681810|NCT00571701|HPV|hpv
5681811|NCT00571701|RRP|rrp
5681812|NCT00571688|Bipolar Disorder|bipolar disorder
5681813|NCT00571688|Depression, Bipolar|depression, bipolar
5681814|NCT00571688|Mania|mania
5837252|NCT00015951|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5837253|NCT00015951|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5837254|NCT00015951|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837255|NCT00015951|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5837257|NCT00015938|recurrent breast cancer|recurrent breast cancer
5837258|NCT00015925|refractory multiple myeloma|refractory multiple myeloma
5837259|NCT00015925|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837260|NCT00015925|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5837261|NCT00015925|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5837262|NCT00015925|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5837263|NCT00015925|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5837264|NCT00015925|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5687091|NCT00549081|DHEA|dhea
5687092|NCT00549081|IVF|ivf
5687093|NCT00549081|low ovarian response|low ovarian response
5687094|NCT00549055|Macugen Age-related macular degeneration (AMD) Observational study|macugen age-related macular degeneration (amd) observational study
5687095|NCT00549042|Back Pain|back pain
5687096|NCT00549042|Chronic Low Back Pain|chronic low back pain
5687097|NCT00549042|Chronic Back Pain|chronic back pain
5687098|NCT00549042|Pain|pain
5687099|NCT00549042|Chronic Pain|chronic pain
5687100|NCT00549029|muscle disorder|muscle disorder
5687101|NCT00549029|statins|statins
5687102|NCT00549029|creatine kinase|creatine kinase
5687103|NCT00549016|Aneurysm Exclusion|aneurysm exclusion
5687104|NCT00548977|spermatogenesis defect|spermatogenesis defect
5837265|NCT00015925|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5837266|NCT00015925|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5837267|NCT00015925|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5837268|NCT00015925|refractory anemia with excess blasts|refractory anemia with excess blasts
5837269|NCT00015925|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5837270|NCT00015925|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5837271|NCT00015925|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5837272|NCT00015925|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5837273|NCT00015925|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837274|NCT00015925|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5837275|NCT00015925|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5837276|NCT00015925|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5837277|NCT00015925|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5837278|NCT00015925|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5837279|NCT00015925|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5837280|NCT00015925|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5837282|NCT00015899|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5837283|NCT00015899|childhood oligodendroglioma|childhood oligodendroglioma
5837284|NCT00015899|childhood choroid plexus tumor|childhood choroid plexus tumor
5837285|NCT00015899|childhood grade I meningioma|childhood grade i meningioma
5837286|NCT00015899|childhood grade II meningioma|childhood grade ii meningioma
5837287|NCT00015899|childhood grade III meningioma|childhood grade iii meningioma
5837288|NCT00015899|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5837289|NCT00015899|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5837290|NCT00015899|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5837291|NCT00015899|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5837292|NCT00015899|recurrent childhood ependymoma|recurrent childhood ependymoma
5837293|NCT00015899|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5837294|NCT00015899|childhood spinal cord neoplasm|childhood spinal cord neoplasm
5837295|NCT00015873|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5837296|NCT00015860|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5837297|NCT00015860|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5837298|NCT00015860|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5681815|NCT00571675|Prostate Cancer|prostate cancer
5681816|NCT00571675|Hormone Refractory Prostate Cancer|hormone refractory prostate cancer
5681817|NCT00571675|HRPC|hrpc
5681818|NCT00571675|Docetaxel|docetaxel
5681819|NCT00571675|Taxotere|taxotere
5681820|NCT00571675|Prednisone|prednisone
5681821|NCT00571675|Metastatic (Stage IV) Disease|metastatic (stage iv) disease
5681822|NCT00571675|Chemotherapy-naïve metastatic Hormone Refractory Prostate Cancer (HRPC)|chemotherapy-naïve metastatic hormone refractory prostate cancer (hrpc)
5681823|NCT00571649|Acute medical illnesses with increased risk for VTE.|acute medical illnesses with increased risk for vte.
5681824|NCT00571649|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5681825|NCT00571649|Pulmonary embolism (PE),|pulmonary embolism (pe),
5681826|NCT00571649|Venous Thromboembolic disease (VTE),|venous thromboembolic disease (vte),
5681827|NCT00571649|Medical illness|medical illness
5681828|NCT00571636|Opioids infusion|opioids infusion
5687105|NCT00548977|male infertility|male infertility
5687106|NCT00548977|azoospermia|azoospermia
5687107|NCT00548977|oligozoospermia|oligozoospermia
5687108|NCT00548977|Y chromosome markers|y chromosome markers
5687109|NCT00548977|estrogen gene|estrogen gene
5687110|NCT00548964|Ketamine|ketamine
5687111|NCT00548964|glutamate|glutamate
5687112|NCT00548964|N-methyl-D-aspartate|n-methyl-d-aspartate
5687113|NCT00548964|treatment resistant|treatment resistant
5687114|NCT00548964|major depressive disorder|major depressive disorder
5687115|NCT00548964|lithium|lithium
5687116|NCT00548951|Dementia|dementia
5687117|NCT00548938|Brain Tumor|brain tumor
5687118|NCT00548938|GBM|gbm
5687119|NCT00548938|Glioblastoma Multiforme|glioblastoma multiforme
5687120|NCT00548938|Giladel|giladel
5687121|NCT00548938|Temozolomide|temozolomide
5687122|NCT00548912|Kidney Failure, Chronic|kidney failure, chronic
5681143|NCT00574561|heart disease|heart disease
5687123|NCT00548912|Hemodialysis|hemodialysis
5687124|NCT00548912|Spironolactone|spironolactone
5687125|NCT00548899|Neoadjuvant chemotherapy|neoadjuvant chemotherapy
5687126|NCT00548899|Targeted therapy|targeted therapy
5687127|NCT00548886|QT Prolongation|qt prolongation
5687128|NCT00548886|QT Interval|qt interval
5687129|NCT00548886|Epinephrine|epinephrine
5687130|NCT00548886|Stress test|stress test
5687131|NCT00548847|Leukemia|leukemia
5687132|NCT00548834|CDP870|cdp870
5687133|NCT00548834|Certolizumab Pegol|certolizumab pegol
5687134|NCT00548795|Acute Respiratory Distress Syndrome|acute respiratory distress syndrome
5687135|NCT00548795|ARDS|ards
5687136|NCT00548795|Neutrophil|neutrophil
5681829|NCT00571636|mechanical ventilation|mechanical ventilation
5681830|NCT00571623|Brain Injury|brain injury
5681831|NCT00571623|Intracranial hypertension|intracranial hypertension
5681832|NCT00571623|Human subjects|human subjects
5681833|NCT00571623|Nursing care|nursing care
5681834|NCT00571610|Heart Failure|heart failure
5681835|NCT00571610|Mitral Regurgitation|mitral regurgitation
5681836|NCT00571597|surgery|surgery
5681837|NCT00571597|ablation|ablation
5681838|NCT00571597|radiofrequency|radiofrequency
5681839|NCT00571597|minimaze|minimaze
5681840|NCT00571597|transtelephonic monitoring|transtelephonic monitoring
5681841|NCT00571571|Identity difussion|identity difussion
5681842|NCT00571571|Adolescent psychotherapy|adolescent psychotherapy
5681843|NCT00571571|Transference Focused Psychotherapy for Adolescents|transference focused psychotherapy for adolescents
5681844|NCT00571571|Identity|identity
5681845|NCT00571571|Identity crisis|identity crisis
5681846|NCT00571571|Identity pathology|identity pathology
5681847|NCT00571545|Traumatic brain injury|traumatic brain injury
5681848|NCT00571545|Depression|depression
5681849|NCT00571545|Exercise|exercise
5837299|NCT00015847|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5837300|NCT00015847|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5837301|NCT00015847|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5837302|NCT00014612|stage IA breast cancer|stage ia breast cancer
5837303|NCT00014612|stage IB breast cancer|stage ib breast cancer
5837304|NCT00014612|stage II breast cancer|stage ii breast cancer
5837305|NCT00014599|stage III vulvar cancer|stage iii vulvar cancer
5837306|NCT00014599|stage IV vulvar cancer|stage iv vulvar cancer
5837307|NCT00014599|recurrent vulvar cancer|recurrent vulvar cancer
5837308|NCT00014599|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5837309|NCT00014586|stage I prostate cancer|stage i prostate cancer
5687137|NCT00548769|PK,|pk,
5687138|NCT00548769|SB-683699,|sb-683699,
5687139|NCT00548769|multiple sclerosis|multiple sclerosis
5687140|NCT00548769|firategrast,|firategrast,
5687141|NCT00548769|surface area,|surface area,
5687142|NCT00548756|Brain Cancer|brain cancer
5687143|NCT00548756|Whole Brain Radiation Therapy|whole brain radiation therapy
5687144|NCT00548756|Quality of Life|quality of life
5687145|NCT00548756|QOL|qol
5687146|NCT00548756|Questionnaire|questionnaire
5687147|NCT00548756|Survey|survey
5687148|NCT00548756|WBRT|wbrt
5687149|NCT00548743|Depression|depression
5687150|NCT00548743|Postpartum|postpartum
5687151|NCT00548743|Dyad satisfaction|dyad satisfaction
5687152|NCT00548743|Parenting comfort|parenting comfort
5687153|NCT00548743|Screening|screening
5687154|NCT00548743|Management|management
5687155|NCT00548743|Follow up|follow up
5687156|NCT00548743|Primary care|primary care
5687157|NCT00548743|Practice based research|practice based research
5687158|NCT00548730|Bronchoscopy|bronchoscopy
5687159|NCT00548730|Endoscopy|endoscopy
5687160|NCT00548730|Image Enhancement|image enhancement
5687161|NCT00548730|Autofluorescence|autofluorescence
5837310|NCT00014586|stage IIB prostate cancer|stage iib prostate cancer
5837311|NCT00014586|stage IIA prostate cancer|stage iia prostate cancer
5837312|NCT00014586|stage III prostate cancer|stage iii prostate cancer
5837313|NCT00014521|recurrent adult brain tumor|recurrent adult brain tumor
5681850|NCT00571506|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5681851|NCT00571506|Vascular Diseases|vascular diseases
5681852|NCT00571506|Thiazolidinediones|thiazolidinediones
5681853|NCT00571506|Platelet Aggregation|platelet aggregation
5681854|NCT00571493|non-hodgkin's lymphoma|non-hodgkin's lymphoma
5681855|NCT00571493|mantle cell lymphoma|mantle cell lymphoma
5681856|NCT00571493|BEAM|beam
5681857|NCT00571493|Velcade|velcade
5681858|NCT00571480|auricular acupuncture|auricular acupuncture
5681859|NCT00571480|pregnancy related low back pain|pregnancy related low back pain
5681860|NCT00571480|acupuncture|acupuncture
5681861|NCT00571467|Autoimmune Diseases|autoimmune diseases
5681862|NCT00571467|Bleeding Disorders|bleeding disorders
5681863|NCT00571467|Blood and Blood Disorders|blood and blood disorders
5681864|NCT00571454|depression|depression
5681865|NCT00571454|primary care|primary care
5681866|NCT00571454|Latino|latino
5681867|NCT00571454|telephone|telephone
5681868|NCT00571454|care management|care management
5681870|NCT00571441|Brain injury|brain injury
5681871|NCT00571441|nursing|nursing
5681872|NCT00571441|Critical care|critical care
5681873|NCT00571428|COPD|copd
5681874|NCT00571428|Chronic Bronchitis|chronic bronchitis
5681875|NCT00571428|Emphysema|emphysema
5681876|NCT00571415|Image guided adaptive radiotherapy|image guided adaptive radiotherapy
5681877|NCT00571402|Family Treatment|family treatment
5681878|NCT00571402|Pharmacotherapy|pharmacotherapy
5681879|NCT00571389|Stage IV|stage iv
5863607|NCT00001240|Stomach|stomach
5837314|NCT00014521|adult glioblastoma|adult glioblastoma
5837315|NCT00014521|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837316|NCT00014521|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5837317|NCT00014521|adult giant cell glioblastoma|adult giant cell glioblastoma
5837318|NCT00014521|adult gliosarcoma|adult gliosarcoma
5837319|NCT00014508|refractory multiple myeloma|refractory multiple myeloma
5837320|NCT00014508|stage I multiple myeloma|stage i multiple myeloma
5837321|NCT00014508|stage II multiple myeloma|stage ii multiple myeloma
5837322|NCT00014508|stage III multiple myeloma|stage iii multiple myeloma
5837323|NCT00014495|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5837708|NCT00010153|stage II breast cancer|stage ii breast cancer
5837324|NCT00014495|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837325|NCT00014495|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5837326|NCT00014495|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5687162|NCT00548730|Narrow Band Image|narrow band image
5687163|NCT00548717|GVHD|gvhd
5687164|NCT00548717|Stem cell transplantation|stem cell transplantation
5687165|NCT00548717|Sirolimus|sirolimus
5687166|NCT00548704|Extravasation|extravasation
5687167|NCT00548704|Anthracyclines|anthracyclines
5687168|NCT00548678|diclofenac, platelet aggregation, ketorolac, aspirin|diclofenac, platelet aggregation, ketorolac, aspirin
5687169|NCT00548665|Atherosclerosis|atherosclerosis
5687170|NCT00548665|Smoking cessation|smoking cessation
5687171|NCT00548665|Diagnostic techniques, cardiovascular|diagnostic techniques, cardiovascular
5687172|NCT00548665|Ultrasonography|ultrasonography
5687173|NCT00548665|Health behavior|health behavior
5687174|NCT00548652|apathy|apathy
5687175|NCT00548652|obesity|obesity
5687176|NCT00548652|methylphenidate|methylphenidate
5687177|NCT00548652|MOVE|move
5681794|NCT00571753|NAT2 genotyping|nat2 genotyping
5837327|NCT00014495|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5837328|NCT00014495|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5837329|NCT00014495|refractory anemia with excess blasts|refractory anemia with excess blasts
5837330|NCT00014495|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5837331|NCT00014495|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5837332|NCT00014495|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837333|NCT00014495|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5837334|NCT00014495|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5837335|NCT00014495|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5837336|NCT00014495|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5837337|NCT00014495|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5681880|NCT00571389|Advanced Stage III|advanced stage iii
5681881|NCT00571376|Quality of health care|quality of health care
5681893|NCT00571311|Informed Consent|informed consent
5681894|NCT00571298|Extrapleural pneumonectomy|extrapleural pneumonectomy
5681895|NCT00571298|Pleurectomy Decortication|pleurectomy decortication
5681897|NCT00571298|cisplatin|cisplatin
5681898|NCT00571298|gemcitabine|gemcitabine
5681899|NCT00571298|amifostine|amifostine
5681900|NCT00571298|sodium thiosulfate|sodium thiosulfate
5681901|NCT00571285|Parkinson's disease|parkinson's disease
5681902|NCT00571285|Nutrition|nutrition
5681903|NCT00571285|Vitamin supplement|vitamin supplement
5837338|NCT00014495|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5837339|NCT00014495|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5837340|NCT00014495|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5837341|NCT00014495|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5837342|NCT00014495|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5837343|NCT00014482|anxiety disorder|anxiety disorder
5837344|NCT00014482|depression|depression
5837345|NCT00014482|pain|pain
5837346|NCT00014482|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5837347|NCT00014482|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5837348|NCT00014482|refractory multiple myeloma|refractory multiple myeloma
5837349|NCT00014482|stage I multiple myeloma|stage i multiple myeloma
5837350|NCT00014482|stage II multiple myeloma|stage ii multiple myeloma
5837351|NCT00014482|stage III multiple myeloma|stage iii multiple myeloma
5837352|NCT00014482|primary myelofibrosis|primary myelofibrosis
5837353|NCT00014482|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5837354|NCT00014482|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5837355|NCT00014482|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5837356|NCT00014482|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5837357|NCT00014482|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5837358|NCT00014482|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5837620|NCT00012207|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5687178|NCT00548652|medical crisis counselling|medical crisis counselling
5687179|NCT00548626|Pancreatic Cancer|pancreatic cancer
5687180|NCT00548626|Endoscopic Ultrasonography|endoscopic ultrasonography
5687181|NCT00548626|Fine-Needle Aspiration|fine-needle aspiration
5687182|NCT00548626|Cytopathology|cytopathology
5687183|NCT00548613|Myocardial Infarction|myocardial infarction
5687184|NCT00548613|Heart Attack|heart attack
5687185|NCT00548613|Coronary Artery Bypass Grafting|coronary artery bypass grafting
5687186|NCT00548600|Prostate Cancer|prostate cancer
5687187|NCT00548600|Iridium|iridium
5687188|NCT00548600|Implant|implant
5687189|NCT00548600|Radiotherapy|radiotherapy
5687190|NCT00548587|Acute Coronary Syndrome|acute coronary syndrome
5837359|NCT00014482|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5837360|NCT00014482|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5837361|NCT00014482|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5837362|NCT00014482|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5837363|NCT00014482|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5837364|NCT00014482|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5837365|NCT00014482|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5837366|NCT00014482|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5837367|NCT00014482|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5837368|NCT00014482|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5837369|NCT00014482|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5837371|NCT00014482|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5837372|NCT00014482|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5848327|NCT00035165|epothilone|epothilone
5837373|NCT00014482|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5837374|NCT00014482|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5837375|NCT00014482|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5837376|NCT00014482|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5837377|NCT00014482|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5837378|NCT00014482|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5837379|NCT00014482|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5837380|NCT00014482|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5837381|NCT00014482|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837382|NCT00014482|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5837383|NCT00014482|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5862697|NCT00001544|Schizophrenia|schizophrenia
5681905|NCT00571285|Non-motor function|non-motor function
5681912|NCT00571259|Sodium citrate|sodium citrate
5681913|NCT00571259|Gentamicin|gentamicin
5681914|NCT00571259|Prophylaxis|prophylaxis
5681915|NCT00571259|Hemodialysis|hemodialysis
5681916|NCT00571259|Central venous catheter|central venous catheter
5681917|NCT00571246|treatment|treatment
5681918|NCT00571246|Lamotrigine|lamotrigine
5681919|NCT00571246|Topiramate|topiramate
5681920|NCT00571246|alcohol dependence|alcohol dependence
5681921|NCT00571246|post traumatic stress disorder|post traumatic stress disorder
5681922|NCT00571233|Single Ventricle|single ventricle
5681923|NCT00571233|Congenital Heart Disease|congenital heart disease
5681924|NCT00571233|Children|children
5681925|NCT00571233|Fontan|fontan
5681926|NCT00571233|Tricuspid Atresia|tricuspid atresia
5681927|NCT00571233|Hypoplastic Left Heart Syndrome|hypoplastic left heart syndrome
5837384|NCT00014482|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5837385|NCT00014482|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5837386|NCT00014482|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5837387|NCT00014482|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5837388|NCT00014482|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5837389|NCT00014482|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5837390|NCT00014482|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5687191|NCT00548561|extravasation|extravasation
5687192|NCT00548561|anthracyclines|anthracyclines
5687193|NCT00548548|Avastin|avastin
5687194|NCT00548548|Metastatic Adenocarcinoma|metastatic adenocarcinoma
5687195|NCT00548548|AVAGAST|avagast
5703743|NCT00488306|cIAI|ciai
5687196|NCT00548522|Type 1 Diabetes|type 1 diabetes
5687197|NCT00548522|Pregnancy|pregnancy
5687198|NCT00548522|Islet Mass|islet mass
5687199|NCT00548522|C-peptide|c-peptide
5687200|NCT00548496|fractured wrist|fractured wrist
5687201|NCT00548496|Distal radial fracture,|distal radial fracture,
5687202|NCT00548483|Endotracheal intubation|endotracheal intubation
5687203|NCT00548483|Laryngeal edema|laryngeal edema
5687204|NCT00548483|Cuff-leak test|cuff-leak test
5687205|NCT00548483|Corticosteroids|corticosteroids
5687293|NCT00548054|India|india
5687294|NCT00548054|immunogenicity|immunogenicity
5687295|NCT00548054|safety|safety
5687296|NCT00548054|infants|infants
5687393|NCT00547534|Indolent|indolent
5687206|NCT00548483|This study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.|this study was to ascertain whether administration of dexamethasone to critically intubated patients prevent postextubation airway obstruction.
5687207|NCT00548483|This study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients|this study was to compare high dose and low dose dexamethasone in preventing noninvasive ventilation or reintubation among critically ill intubated patients
5687208|NCT00548470|schizophrenia|schizophrenia
5687209|NCT00548470|varenicline|varenicline
5687210|NCT00548470|cognition|cognition
5687211|NCT00548470|cigarette smoking|cigarette smoking
5863034|NCT00001412|Testosterone|testosterone
5695724|NCT00515385|Double-Blind|double-blind
5687212|NCT00548457|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries|the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries
5687213|NCT00548444|Tuberculosis|tuberculosis
5687214|NCT00548444|Lymphocyte kinetics|lymphocyte kinetics
5687215|NCT00548444|MVA85A|mva85a
5837391|NCT00014482|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5837392|NCT00014482|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5837393|NCT00014482|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5837394|NCT00014482|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5837395|NCT00014482|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5837396|NCT00014482|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5837397|NCT00014482|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5837398|NCT00014482|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5837399|NCT00014482|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5837400|NCT00014482|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5837401|NCT00014482|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5837402|NCT00014482|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5687216|NCT00548444|Deuterium|deuterium
5687217|NCT00548431|Leukemia, Lymphocytic, Acute [C04.557.337.428.511]|leukemia, lymphocytic, acute [c04.557.337.428.511]
5687218|NCT00548431|6-mercaptopurine|6-mercaptopurine
5687219|NCT00548431|methotrexate|methotrexate
5687220|NCT00548431|asparaginase|asparaginase
5687221|NCT00548405|Multiple Sclerosis|multiple sclerosis
5687222|NCT00548392|breast|breast
5687224|NCT00548392|ultrasound|ultrasound
5687225|NCT00548392|high risk|high risk
5687226|NCT00548392|marker clip|marker clip
5687227|NCT00548379|vitamin D|vitamin d
5687228|NCT00548379|pneumonia|pneumonia
5687229|NCT00548366|cirrhosis|cirrhosis
5687230|NCT00548366|portal hypertension|portal hypertension
5687231|NCT00548366|ascites|ascites
5687232|NCT00548366|sodium restriction|sodium restriction
5687233|NCT00548327|Genes|genes
5687234|NCT00548327|Dorsolateral Prefrontal Cortex|dorsolateral prefrontal cortex
5687235|NCT00548327|Dopamine|dopamine
5687236|NCT00548327|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5687237|NCT00548327|Neuropsychological Testing|neuropsychological testing
5687238|NCT00548327|Schizophrenia|schizophrenia
5687239|NCT00548327|Atomoxetine|atomoxetine
5687240|NCT00548327|Cognitive Study|cognitive study
5687241|NCT00548327|Pharmacogenetics|pharmacogenetics
5687242|NCT00548327|Normal Volunteers|normal volunteers
5687243|NCT00548327|Catechol-O-Methyltransferase|catechol-o-methyltransferase
5687244|NCT00548327|Healthy Volunteer|healthy volunteer
5687245|NCT00548314|Matriderm|matriderm
5687246|NCT00548314|Dermal matrix|dermal matrix
5687247|NCT00548314|VAC therapy|vac therapy
5837403|NCT00014482|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5837404|NCT00014482|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5837405|NCT00014482|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5837406|NCT00014482|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5837407|NCT00014482|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5837408|NCT00014469|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5837409|NCT00014469|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5837410|NCT00014469|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837411|NCT00014469|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5837413|NCT00014469|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5837414|NCT00014469|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5837415|NCT00014469|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5837416|NCT00014469|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5837417|NCT00014469|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5837418|NCT00014469|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5837419|NCT00014469|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5837420|NCT00014469|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5681929|NCT00571233|Biomarkers|biomarkers
5681930|NCT00571233|Single ventricle physiology such as:|single ventricle physiology such as:
5681931|NCT00571233|unbalanced AV canal|unbalanced av canal
5681932|NCT00571233|Interested in patients both before and after Fontan Surgery|interested in patients both before and after fontan surgery
5681933|NCT00571220|gastric bypass|gastric bypass
5681934|NCT00571220|diabetes|diabetes
5681936|NCT00571220|diet-induced weight loss|diet-induced weight loss
5687248|NCT00548314|Split skin graft|split skin graft
5687249|NCT00548314|Burns|burns
5687250|NCT00548314|Scar quality|scar quality
5687251|NCT00548275|Buprenorphine|buprenorphine
5687252|NCT00548275|Drug counseling|drug counseling
5687253|NCT00548275|HIV risk reduction counseling|hiv risk reduction counseling
5687254|NCT00548275|HIV Seronegativity|hiv seronegativity
5687255|NCT00548275|HIV risk behaviors|hiv risk behaviors
5687256|NCT00548262|Open-label|open-label
5687257|NCT00548262|non-comparative study to evaluate short course of IV anidulafungin|non-comparative study to evaluate short course of iv anidulafungin
5687258|NCT00548262|followed by oral voriconazole|followed by oral voriconazole
5681937|NCT00571220|incretin levels (GLP-1,GIP)|incretin levels (glp-1,gip)
5863999|NCT00001145|KLH|klh
5837421|NCT00014469|refractory anemia with excess blasts|refractory anemia with excess blasts
5837422|NCT00014469|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5837423|NCT00014469|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5837424|NCT00014469|acute undifferentiated leukemia|acute undifferentiated leukemia
5837425|NCT00014469|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5837426|NCT00014469|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5837427|NCT00014469|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837428|NCT00014469|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5837429|NCT00014469|graft versus host disease|graft versus host disease
5837430|NCT00014469|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5837431|NCT00014469|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5837432|NCT00014469|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5837433|NCT00014469|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5848439|NCT00034736|Quinolones|quinolones
5837434|NCT00014469|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5837435|NCT00014469|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5837436|NCT00014469|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5837437|NCT00014469|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5837438|NCT00014469|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5837439|NCT00014469|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5837440|NCT00014456|stage IV breast cancer|stage iv breast cancer
5837441|NCT00014456|recurrent breast cancer|recurrent breast cancer
5837442|NCT00014456|stage IV gastric cancer|stage iv gastric cancer
5837443|NCT00014456|recurrent gastric cancer|recurrent gastric cancer
5837444|NCT00014456|metastatic osteosarcoma|metastatic osteosarcoma
5837445|NCT00014456|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5837446|NCT00014456|stage II pancreatic cancer|stage ii pancreatic cancer
5837447|NCT00014456|stage III pancreatic cancer|stage iii pancreatic cancer
5837448|NCT00014456|recurrent pancreatic cancer|recurrent pancreatic cancer
5837449|NCT00014456|stage II esophageal cancer|stage ii esophageal cancer
5837450|NCT00014456|stage III esophageal cancer|stage iii esophageal cancer
5837451|NCT00014456|stage IV esophageal cancer|stage iv esophageal cancer
5837452|NCT00014456|recurrent esophageal cancer|recurrent esophageal cancer
5837453|NCT00014456|chondrosarcoma|chondrosarcoma
5837454|NCT00014456|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5837455|NCT00014456|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5837456|NCT00014456|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5837457|NCT00014456|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5837458|NCT00014456|recurrent small cell lung cancer|recurrent small cell lung cancer
5837459|NCT00014456|recurrent osteosarcoma|recurrent osteosarcoma
5837460|NCT00014456|recurrent bladder cancer|recurrent bladder cancer
5837461|NCT00014456|stage IV bladder cancer|stage iv bladder cancer
5837462|NCT00014456|stage IV prostate cancer|stage iv prostate cancer
5837463|NCT00014456|recurrent prostate cancer|recurrent prostate cancer
5837465|NCT00014456|recurrent melanoma|recurrent melanoma
5837466|NCT00014456|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5837467|NCT00014456|stage IV salivary gland cancer|stage iv salivary gland cancer
5837468|NCT00014456|recurrent salivary gland cancer|recurrent salivary gland cancer
5837469|NCT00014456|classic Kaposi sarcoma|classic kaposi sarcoma
5837470|NCT00014456|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5837471|NCT00014456|recurrent Kaposi sarcoma|recurrent kaposi sarcoma
5687259|NCT00548262|for tx of candidemia/invasive candidiasis.|for tx of candidemia/invasive candidiasis.
5687260|NCT00548249|Subjects with ESRD receiving chronic Hemodialysis|subjects with esrd receiving chronic hemodialysis
5687261|NCT00548236|exercise intervention|exercise intervention
5687262|NCT00548236|AACT|aact
5687263|NCT00548223|recurrence of stroke|recurrence of stroke
5687264|NCT00548223|Dengzhan Shengmai Capsule|dengzhan shengmai capsule
5687265|NCT00548223|Traditional Chinese Medicine|traditional chinese medicine
5687266|NCT00548210|Hypertrophy|hypertrophy
5687267|NCT00548210|scarring|scarring
5687268|NCT00548210|scar treatment|scar treatment
5687269|NCT00548210|silicone|silicone
5687270|NCT00548197|Intravitreal Bevacizumab injection|intravitreal bevacizumab injection
5687271|NCT00548197|Pars plana vitrectomy|pars plana vitrectomy
5687272|NCT00548197|tractional retinal detachment|tractional retinal detachment
5687273|NCT00548197|Diabetic retinopathy|diabetic retinopathy
5681904|NCT00571285|Motor function|motor function
5837472|NCT00014456|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5837474|NCT00014456|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5837475|NCT00014456|stage IV uterine sarcoma|stage iv uterine sarcoma
5837476|NCT00014456|recurrent uterine sarcoma|recurrent uterine sarcoma
5837477|NCT00014456|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5837478|NCT00014456|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5837480|NCT00014456|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5837481|NCT00014456|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5837482|NCT00014456|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5837483|NCT00014456|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837484|NCT00014456|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5837485|NCT00014456|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5837486|NCT00014456|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837487|NCT00014456|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5848119|NCT00036400|Anemia|anemia
5837488|NCT00014456|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5837489|NCT00014456|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837490|NCT00014456|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5837491|NCT00014456|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5837492|NCT00014456|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5837493|NCT00014456|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5837494|NCT00014456|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5837495|NCT00014456|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5837496|NCT00014456|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5837497|NCT00014456|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837498|NCT00014456|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837711|NCT00010140|stage IIIB breast cancer|stage iiib breast cancer
5837499|NCT00014456|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5837500|NCT00014456|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5837501|NCT00014456|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5837502|NCT00014456|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837503|NCT00014456|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5837504|NCT00014456|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5687274|NCT00548184|primary breast cancers|primary breast cancers
5687275|NCT00548184|Locally advanced breast cancers|locally advanced breast cancers
5687276|NCT00548158|diabetes|diabetes
5687277|NCT00548145|Pitavastatin|pitavastatin
5687278|NCT00548145|Statins|statins
5687279|NCT00548145|Donepezil|donepezil
5687280|NCT00548145|Alzheimer's Disease|alzheimer's disease
5687281|NCT00548145|Hypercholesterolemia|hypercholesterolemia
5687282|NCT00548145|ADAS-Jcog|adas-jcog
5687283|NCT00548145|Alzheimer Disease (MMSE 15-23 and CDR1 or 2)|alzheimer disease (mmse 15-23 and cdr1 or 2)
5681928|NCT00571233|Heart Failure|heart failure
5681935|NCT00571220|obesity|obesity
5837505|NCT00014456|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5837506|NCT00014456|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5837507|NCT00014456|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5837508|NCT00014456|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5837509|NCT00014456|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5837510|NCT00014456|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5837511|NCT00014456|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5837512|NCT00014456|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5837513|NCT00014456|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5837514|NCT00014456|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5837515|NCT00014456|stage IV pancreatic cancer|stage iv pancreatic cancer
5837516|NCT00014443|recurrent adult brain tumor|recurrent adult brain tumor
5837517|NCT00014443|adult glioblastoma|adult glioblastoma
5837518|NCT00014443|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837519|NCT00014443|adult giant cell glioblastoma|adult giant cell glioblastoma
5837521|NCT00014378|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5837522|NCT00014326|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5837523|NCT00014326|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5837524|NCT00014326|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5837525|NCT00014326|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5837526|NCT00014326|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5837527|NCT00014326|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5837528|NCT00014326|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5837529|NCT00014326|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5837530|NCT00014326|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5837531|NCT00014326|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5837532|NCT00014326|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5837533|NCT00014326|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5837534|NCT00014326|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5837535|NCT00014326|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5837536|NCT00014326|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5837537|NCT00014326|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5837538|NCT00014313|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5837539|NCT00014274|stage III bladder cancer|stage iii bladder cancer
5837541|NCT00014274|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5837542|NCT00014274|anterior urethral cancer|anterior urethral cancer
5837543|NCT00014274|posterior urethral cancer|posterior urethral cancer
5837544|NCT00014274|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5837621|NCT00012207|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5837545|NCT00014274|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5837546|NCT00014274|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5837547|NCT00014222|stage I breast cancer|stage i breast cancer
5837548|NCT00014222|stage II breast cancer|stage ii breast cancer
5837549|NCT00014222|stage IIIA breast cancer|stage iiia breast cancer
5837550|NCT00014222|stage IIIB breast cancer|stage iiib breast cancer
5837551|NCT00014196|squamous cell lung cancer|squamous cell lung cancer
5837479|NCT00014456|ovarian sarcoma|ovarian sarcoma
5837552|NCT00014196|large cell lung cancer|large cell lung cancer
5837553|NCT00014196|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5837554|NCT00014196|adenocarcinoma of the lung|adenocarcinoma of the lung
5837555|NCT00014131|stage III renal cell cancer|stage iii renal cell cancer
5837556|NCT00014131|stage IV renal cell cancer|stage iv renal cell cancer
5837557|NCT00014131|recurrent renal cell cancer|recurrent renal cell cancer
5837558|NCT00014118|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837712|NCT00010140|stage IIIC breast cancer|stage iiic breast cancer
5837559|NCT00014118|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837560|NCT00014118|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837561|NCT00014118|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837563|NCT00014092|recurrent melanoma|recurrent melanoma
5837565|NCT00014079|rectal cancer|rectal cancer
5837566|NCT00012389|stage IV colon cancer|stage iv colon cancer
5837567|NCT00012389|stage IV rectal cancer|stage iv rectal cancer
5837568|NCT00012389|recurrent colon cancer|recurrent colon cancer
5837569|NCT00012389|recurrent rectal cancer|recurrent rectal cancer
5837570|NCT00012363|stage IV gastric cancer|stage iv gastric cancer
5837571|NCT00012363|recurrent gastric cancer|recurrent gastric cancer
5837572|NCT00012363|stage IV esophageal cancer|stage iv esophageal cancer
5837573|NCT00012363|recurrent esophageal cancer|recurrent esophageal cancer
5837574|NCT00012363|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837575|NCT00012363|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5837576|NCT00012363|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5837577|NCT00012324|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5837578|NCT00012324|advanced adult primary liver cancer|advanced adult primary liver cancer
5837579|NCT00012324|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5837580|NCT00012324|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5837581|NCT00012246|stage II colon cancer|stage ii colon cancer
5837582|NCT00012246|stage III colon cancer|stage iii colon cancer
5837583|NCT00012246|stage IV colon cancer|stage iv colon cancer
5837584|NCT00012246|stage II gastric cancer|stage ii gastric cancer
5837585|NCT00012246|stage III gastric cancer|stage iii gastric cancer
5837586|NCT00012246|stage IV gastric cancer|stage iv gastric cancer
5837587|NCT00012246|recurrent gastric cancer|recurrent gastric cancer
5837588|NCT00012246|stage II pancreatic cancer|stage ii pancreatic cancer
5837589|NCT00012246|stage III pancreatic cancer|stage iii pancreatic cancer
5837590|NCT00012246|recurrent pancreatic cancer|recurrent pancreatic cancer
5837591|NCT00012246|stage II rectal cancer|stage ii rectal cancer
5837592|NCT00012246|stage III rectal cancer|stage iii rectal cancer
5837593|NCT00012246|stage IV rectal cancer|stage iv rectal cancer
5837594|NCT00012246|recurrent colon cancer|recurrent colon cancer
5837595|NCT00012246|recurrent rectal cancer|recurrent rectal cancer
5837596|NCT00012246|stage II esophageal cancer|stage ii esophageal cancer
5837597|NCT00012246|stage III esophageal cancer|stage iii esophageal cancer
5837598|NCT00012246|stage IV esophageal cancer|stage iv esophageal cancer
5837599|NCT00012246|recurrent esophageal cancer|recurrent esophageal cancer
5837600|NCT00012246|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837601|NCT00012246|small intestine adenocarcinoma|small intestine adenocarcinoma
5837602|NCT00012246|localized gallbladder cancer|localized gallbladder cancer
5837603|NCT00012246|unresectable gallbladder cancer|unresectable gallbladder cancer
5837604|NCT00012246|recurrent gallbladder cancer|recurrent gallbladder cancer
5837605|NCT00012246|localized extrahepatic bile duct cancer|localized extrahepatic bile duct cancer
5837606|NCT00012246|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5837607|NCT00012246|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5837608|NCT00012246|recurrent small intestine cancer|recurrent small intestine cancer
5837609|NCT00012246|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5837610|NCT00012246|adenocarcinoma of the colon|adenocarcinoma of the colon
5837611|NCT00012246|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5837612|NCT00012246|adenocarcinoma of the gallbladder|adenocarcinoma of the gallbladder
5837613|NCT00012246|adenocarcinoma of the extrahepatic bile duct|adenocarcinoma of the extrahepatic bile duct
5837614|NCT00012246|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837615|NCT00012246|stage IV pancreatic cancer|stage iv pancreatic cancer
5837616|NCT00012220|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837617|NCT00012220|stage IV pancreatic cancer|stage iv pancreatic cancer
5837618|NCT00012207|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5837619|NCT00012207|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5837693|NCT00010270|stage III colon cancer|stage iii colon cancer
5837622|NCT00012207|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5837623|NCT00012207|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5837624|NCT00012207|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5837625|NCT00012168|stage 0 oropharyngeal cancer|stage 0 oropharyngeal cancer
5837626|NCT00012168|stage 0 lip and oral cavity cancer|stage 0 lip and oral cavity cancer
5844729|NCT00001685|Cancer|cancer
5837562|NCT00014092|stage IV melanoma|stage iv melanoma
5837627|NCT00012168|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5837628|NCT00012168|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5837629|NCT00012168|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5837630|NCT00012168|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837631|NCT00012168|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5837632|NCT00012168|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5848972|NCT00032422|Acupuncture|acupuncture
5837633|NCT00012168|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837634|NCT00012168|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837635|NCT00012103|non-small cell lung cancer|non-small cell lung cancer
5837636|NCT00012103|small cell lung cancer|small cell lung cancer
5837637|NCT00012064|stage IV melanoma|stage iv melanoma
5837638|NCT00012064|recurrent melanoma|recurrent melanoma
5837639|NCT00012051|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5837640|NCT00012051|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5837641|NCT00012038|recurrent adult brain tumor|recurrent adult brain tumor
5837642|NCT00012038|adult glioblastoma|adult glioblastoma
5837643|NCT00012038|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837644|NCT00012038|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5837645|NCT00012038|adult giant cell glioblastoma|adult giant cell glioblastoma
5837646|NCT00012038|adult gliosarcoma|adult gliosarcoma
5837647|NCT00012025|stage IV breast cancer|stage iv breast cancer
5837648|NCT00012025|recurrent breast cancer|recurrent breast cancer
5837649|NCT00012025|stage IIIB breast cancer|stage iiib breast cancer
5837650|NCT00012025|stage IIIC breast cancer|stage iiic breast cancer
5837651|NCT00012012|radiation toxicity|radiation toxicity
5837652|NCT00012012|stage III cervical cancer|stage iii cervical cancer
5837653|NCT00012012|stage IVA cervical cancer|stage iva cervical cancer
5837654|NCT00012012|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5837655|NCT00012012|cervical adenocarcinoma|cervical adenocarcinoma
5837656|NCT00012012|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5837657|NCT00011999|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5837658|NCT00011999|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837659|NCT00011999|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837660|NCT00011999|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837661|NCT00011999|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5837662|NCT00011999|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837663|NCT00011999|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837664|NCT00011999|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837665|NCT00011960|stage I gastric cancer|stage i gastric cancer
5837666|NCT00011960|stage II gastric cancer|stage ii gastric cancer
5837667|NCT00011960|stage III gastric cancer|stage iii gastric cancer
5837668|NCT00011960|stage I esophageal cancer|stage i esophageal cancer
5837670|NCT00011960|stage III esophageal cancer|stage iii esophageal cancer
5837671|NCT00011960|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837672|NCT00011960|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5837673|NCT00011921|limited stage small cell lung cancer|limited stage small cell lung cancer
5837674|NCT00011921|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5837675|NCT00010270|stage IV colon cancer|stage iv colon cancer
5837676|NCT00010270|stage IV rectal cancer|stage iv rectal cancer
5837677|NCT00010270|recurrent colon cancer|recurrent colon cancer
5837678|NCT00010270|recurrent rectal cancer|recurrent rectal cancer
5837679|NCT00010270|adenocarcinoma of the colon|adenocarcinoma of the colon
5837680|NCT00010270|stage III pancreatic cancer|stage iii pancreatic cancer
5837681|NCT00010270|stage II pancreatic cancer|stage ii pancreatic cancer
5837682|NCT00010270|recurrent pancreatic cancer|recurrent pancreatic cancer
5837683|NCT00010270|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837684|NCT00010270|stage IV gastric cancer|stage iv gastric cancer
5837685|NCT00010270|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837686|NCT00010270|recurrent gastric cancer|recurrent gastric cancer
5837687|NCT00010270|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5837688|NCT00010270|stage IV esophageal cancer|stage iv esophageal cancer
5837689|NCT00010270|stage III esophageal cancer|stage iii esophageal cancer
5837690|NCT00010270|recurrent esophageal cancer|recurrent esophageal cancer
5837691|NCT00010270|stage II esophageal cancer|stage ii esophageal cancer
5837692|NCT00010270|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5837694|NCT00010270|stage III rectal cancer|stage iii rectal cancer
5837695|NCT00010270|stage III gastric cancer|stage iii gastric cancer
5837696|NCT00010270|stage IV pancreatic cancer|stage iv pancreatic cancer
5837698|NCT00010257|thymic carcinoma|thymic carcinoma
5837699|NCT00010218|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5837700|NCT00010218|squamous cell lung cancer|squamous cell lung cancer
5837701|NCT00010218|large cell lung cancer|large cell lung cancer
5837702|NCT00010218|adenocarcinoma of the lung|adenocarcinoma of the lung
5837703|NCT00010218|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5837704|NCT00010218|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5837705|NCT00010166|stage I pancreatic cancer|stage i pancreatic cancer
5837706|NCT00010166|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837707|NCT00010153|stage I breast cancer|stage i breast cancer
5837709|NCT00010140|stage II breast cancer|stage ii breast cancer
5837710|NCT00010140|stage IIIA breast cancer|stage iiia breast cancer
5837713|NCT00010101|childhood choroid plexus tumor|childhood choroid plexus tumor
5837714|NCT00010101|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5846688|NCT00043732|Rheumatoid arthritis|rheumatoid arthritis
5837715|NCT00010101|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5837716|NCT00010101|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5837717|NCT00010075|stage IV breast cancer|stage iv breast cancer
5837718|NCT00010075|recurrent breast cancer|recurrent breast cancer
5837719|NCT00010062|stage I pancreatic cancer|stage i pancreatic cancer
5837720|NCT00010062|stage II pancreatic cancer|stage ii pancreatic cancer
5837721|NCT00010062|stage III pancreatic cancer|stage iii pancreatic cancer
5837722|NCT00010062|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5837723|NCT00010062|stage IV pancreatic cancer|stage iv pancreatic cancer
5837724|NCT00010049|recurrent adult brain tumor|recurrent adult brain tumor
5837725|NCT00010049|adult meningioma|adult meningioma
5837726|NCT00010049|adult glioblastoma|adult glioblastoma
5837727|NCT00010049|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837728|NCT00010049|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5837729|NCT00010049|adult mixed glioma|adult mixed glioma
5837730|NCT00010049|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5837731|NCT00010049|adult subependymoma|adult subependymoma
5837732|NCT00010049|adult grade III meningioma|adult grade iii meningioma
5837733|NCT00010049|adult giant cell glioblastoma|adult giant cell glioblastoma
5837734|NCT00010049|adult gliosarcoma|adult gliosarcoma
5837735|NCT00010023|stage IV breast cancer|stage iv breast cancer
5837736|NCT00010023|stage IIIA breast cancer|stage iiia breast cancer
5837737|NCT00010023|recurrent breast cancer|recurrent breast cancer
5837738|NCT00010023|stage III gastric cancer|stage iii gastric cancer
5837739|NCT00010023|stage IV gastric cancer|stage iv gastric cancer
5837740|NCT00010023|recurrent gastric cancer|recurrent gastric cancer
5837741|NCT00010023|stage IIIB breast cancer|stage iiib breast cancer
5837742|NCT00010023|stage IIIC breast cancer|stage iiic breast cancer
5837743|NCT00010023|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5837744|NCT00010023|stage III pancreatic cancer|stage iii pancreatic cancer
5837745|NCT00010023|recurrent pancreatic cancer|recurrent pancreatic cancer
5837746|NCT00010023|stage III esophageal cancer|stage iii esophageal cancer
5837747|NCT00010023|stage IV esophageal cancer|stage iv esophageal cancer
5837748|NCT00010023|recurrent esophageal cancer|recurrent esophageal cancer
5837749|NCT00010023|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5837750|NCT00010023|recurrent small cell lung cancer|recurrent small cell lung cancer
5837751|NCT00010023|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5837752|NCT00010023|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5837753|NCT00010023|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5837754|NCT00010023|advanced adult primary liver cancer|advanced adult primary liver cancer
5837755|NCT00010023|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5837756|NCT00010023|small intestine adenocarcinoma|small intestine adenocarcinoma
5837757|NCT00010023|unresectable gallbladder cancer|unresectable gallbladder cancer
5837758|NCT00010023|recurrent gallbladder cancer|recurrent gallbladder cancer
5837759|NCT00010023|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5837760|NCT00010023|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5837761|NCT00010023|recurrent small intestine cancer|recurrent small intestine cancer
5837762|NCT00010023|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5837763|NCT00010023|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5837764|NCT00010023|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5837765|NCT00010023|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5837766|NCT00010023|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5837767|NCT00010023|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5837768|NCT00010023|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5837821|NCT00010023|stage IV salivary gland cancer|stage iv salivary gland cancer
5837769|NCT00010023|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5837770|NCT00010023|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5837771|NCT00010023|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5837772|NCT00010023|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5837773|NCT00010023|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5837774|NCT00010023|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5837775|NCT00010023|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5837776|NCT00010023|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5837777|NCT00010023|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5837778|NCT00010023|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5837779|NCT00010023|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5837838|NCT00009854|tumors metastatic to brain|tumors metastatic to brain
5837780|NCT00010023|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5837781|NCT00010023|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5837782|NCT00010023|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5837783|NCT00010023|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5837784|NCT00010023|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5837785|NCT00010023|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5837786|NCT00010023|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5837787|NCT00010023|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5837788|NCT00010023|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5837789|NCT00010023|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5837790|NCT00010023|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5837791|NCT00010023|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5837792|NCT00010023|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5837793|NCT00010023|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5837794|NCT00010023|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5837795|NCT00010023|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5837796|NCT00010023|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5837797|NCT00010023|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5837798|NCT00010023|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5837799|NCT00010023|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5837800|NCT00010023|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5837801|NCT00010023|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5837802|NCT00010023|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5843925|NCT00051701|Non-Hodgkins lymphoma|non-hodgkins lymphoma
5837803|NCT00010023|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5837804|NCT00010023|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5837805|NCT00010023|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5837806|NCT00010023|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837807|NCT00010023|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5837808|NCT00010023|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5837809|NCT00010023|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5837810|NCT00010023|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837811|NCT00010023|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5837812|NCT00010023|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5837813|NCT00010023|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5837814|NCT00010023|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5837815|NCT00010023|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5837816|NCT00010023|carcinoma of the appendix|carcinoma of the appendix
5837817|NCT00010023|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5837818|NCT00010023|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5837819|NCT00010023|recurrent salivary gland cancer|recurrent salivary gland cancer
5837820|NCT00010023|stage III salivary gland cancer|stage iii salivary gland cancer
5837822|NCT00010023|stage IV pancreatic cancer|stage iv pancreatic cancer
5837823|NCT00009971|limited stage small cell lung cancer|limited stage small cell lung cancer
5837824|NCT00009971|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5837825|NCT00009971|recurrent small cell lung cancer|recurrent small cell lung cancer
5837826|NCT00009945|stage I breast cancer|stage i breast cancer
5837827|NCT00009945|stage II breast cancer|stage ii breast cancer
5837828|NCT00009880|stage I gastric cancer|stage i gastric cancer
5837829|NCT00009880|stage II gastric cancer|stage ii gastric cancer
5837830|NCT00009880|stage III gastric cancer|stage iii gastric cancer
5837831|NCT00009880|stage I esophageal cancer|stage i esophageal cancer
5837832|NCT00009880|stage II esophageal cancer|stage ii esophageal cancer
5837833|NCT00009880|stage III esophageal cancer|stage iii esophageal cancer
5837834|NCT00009880|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5837835|NCT00009880|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5837836|NCT00009880|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5849531|NCT00029172|depression|depression
5837839|NCT00009854|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5837840|NCT00009854|adult anaplastic ependymoma|adult anaplastic ependymoma
5837841|NCT00009854|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5837842|NCT00009854|adult giant cell glioblastoma|adult giant cell glioblastoma
5837843|NCT00009854|adult gliosarcoma|adult gliosarcoma
5837844|NCT00009776|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5837845|NCT00009776|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5837846|NCT00009776|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5837847|NCT00009776|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5837848|NCT00009776|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5837849|NCT00009776|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5837850|NCT00009776|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5837851|NCT00009776|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5837852|NCT00009776|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5837853|NCT00009776|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5837854|NCT00009776|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5837855|NCT00009776|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5837856|NCT00009776|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5837857|NCT00009776|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5837858|NCT00009776|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5837859|NCT00009763|stage IV breast cancer|stage iv breast cancer
5837860|NCT00009763|recurrent breast cancer|recurrent breast cancer
5837861|NCT00009750|stage IV prostate cancer|stage iv prostate cancer
5837862|NCT00009750|recurrent prostate cancer|recurrent prostate cancer
5837863|NCT00009711|long-term effects secondary to cancer therapy in children|long-term effects secondary to cancer therapy in children
5837864|NCT00009711|pulmonary complications|pulmonary complications
5837865|NCT00008697|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5837866|NCT00008697|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837867|NCT00008697|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5837868|NCT00008697|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5837869|NCT00008437|stage I breast cancer|stage i breast cancer
5837870|NCT00008437|stage II breast cancer|stage ii breast cancer
5837871|NCT00008437|stage IIIA breast cancer|stage iiia breast cancer
5837872|NCT00008411|stage IV breast cancer|stage iv breast cancer
5837873|NCT00008411|recurrent breast cancer|recurrent breast cancer
5837874|NCT00008385|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5837876|NCT00008307|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5837877|NCT00008307|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5837878|NCT00008307|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5837879|NCT00008307|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5837880|NCT00008307|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5837881|NCT00008307|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5837882|NCT00008307|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5837883|NCT00008307|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5837884|NCT00008307|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5837885|NCT00008307|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5837886|NCT00008307|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5837887|NCT00008307|refractory multiple myeloma|refractory multiple myeloma
5837888|NCT00008307|stage I multiple myeloma|stage i multiple myeloma
5837889|NCT00008307|stage II multiple myeloma|stage ii multiple myeloma
5837890|NCT00008307|stage III multiple myeloma|stage iii multiple myeloma
5837891|NCT00008307|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5837892|NCT00008307|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5837893|NCT00008307|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5837894|NCT00008307|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5837895|NCT00008307|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5837896|NCT00008307|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5837897|NCT00008307|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5837898|NCT00008307|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5837899|NCT00008307|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5837900|NCT00008307|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5837901|NCT00008307|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5837902|NCT00008307|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5837903|NCT00008307|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5837904|NCT00008307|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5837905|NCT00008307|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5838029|NCT00008268|stage I multiple myeloma|stage i multiple myeloma
5837906|NCT00008307|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5837907|NCT00008307|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5837908|NCT00008307|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5837909|NCT00008307|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5837910|NCT00008307|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5837911|NCT00008307|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5837912|NCT00008307|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5837913|NCT00008307|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5837914|NCT00008307|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5837915|NCT00008307|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5837916|NCT00008307|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5837917|NCT00008307|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5837918|NCT00008307|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5837919|NCT00008307|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5837920|NCT00008307|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5837921|NCT00008307|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5837922|NCT00008307|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5837923|NCT00008307|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5837924|NCT00008307|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5837925|NCT00008307|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5837926|NCT00008307|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5837927|NCT00008307|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5837928|NCT00008307|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5837929|NCT00008307|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5837930|NCT00008307|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5837931|NCT00008307|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5849255|NCT00030199|Facial Muscles|facial muscles
5837932|NCT00008307|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5837933|NCT00008307|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5837934|NCT00008307|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5837935|NCT00008307|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5837937|NCT00008307|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5837938|NCT00008307|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5837939|NCT00008307|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5837940|NCT00008307|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5837941|NCT00008307|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5837942|NCT00008307|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5837943|NCT00008307|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5837944|NCT00008307|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5837945|NCT00008307|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5837946|NCT00008307|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5837947|NCT00008307|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5837948|NCT00008307|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5837949|NCT00008307|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5837950|NCT00008307|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5837951|NCT00008307|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5837952|NCT00008307|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5837953|NCT00008307|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5837954|NCT00008307|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5837955|NCT00008307|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5837956|NCT00008307|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5837957|NCT00008307|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5837958|NCT00008307|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5837959|NCT00008307|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5837960|NCT00008307|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5837961|NCT00008307|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5837962|NCT00008307|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5837963|NCT00008307|intraocular lymphoma|intraocular lymphoma
5837964|NCT00008307|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5837965|NCT00008307|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5837966|NCT00008307|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5837967|NCT00008307|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5838030|NCT00008268|stage II multiple myeloma|stage ii multiple myeloma
5837968|NCT00008307|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5837969|NCT00008307|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5837970|NCT00008307|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5837971|NCT00008307|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5837972|NCT00008307|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5837973|NCT00008307|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5837974|NCT00008307|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5837975|NCT00008307|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5837976|NCT00008307|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5837977|NCT00008307|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5837978|NCT00008307|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5837979|NCT00008307|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5837980|NCT00008307|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5837981|NCT00008307|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5837982|NCT00008307|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5837983|NCT00008307|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5837984|NCT00008307|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5837985|NCT00008307|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5838078|NCT00008216|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5837986|NCT00008307|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5837987|NCT00008307|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5837988|NCT00008307|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5837989|NCT00008307|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5837990|NCT00008307|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5837991|NCT00008307|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5837992|NCT00008307|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5837993|NCT00008307|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5837994|NCT00008307|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5837995|NCT00008307|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5837996|NCT00008307|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5837997|NCT00008307|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5837998|NCT00008307|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5837999|NCT00008307|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5838000|NCT00008307|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5838001|NCT00008307|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5838002|NCT00008307|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5838003|NCT00008307|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5838004|NCT00008307|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5838005|NCT00008307|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838006|NCT00008307|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838007|NCT00008307|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838008|NCT00008307|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5845427|NCT00001267|HIV|hiv
5838009|NCT00008307|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838010|NCT00008307|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5838011|NCT00008307|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5838012|NCT00008307|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5838013|NCT00008307|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5838014|NCT00008307|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838015|NCT00008307|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838016|NCT00008307|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5838017|NCT00008307|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838018|NCT00008307|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5838019|NCT00008307|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5838020|NCT00008307|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5838021|NCT00008307|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5838023|NCT00008294|stage IV rectal cancer|stage iv rectal cancer
5838024|NCT00008294|adenocarcinoma of the colon|adenocarcinoma of the colon
5838025|NCT00008294|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5838026|NCT00008294|liver metastases|liver metastases
5838027|NCT00008294|recurrent colon cancer|recurrent colon cancer
5838028|NCT00008294|recurrent rectal cancer|recurrent rectal cancer
5838031|NCT00008268|stage III multiple myeloma|stage iii multiple myeloma
5838032|NCT00008216|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5838033|NCT00008216|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838034|NCT00008216|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838035|NCT00008216|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5838036|NCT00008216|refractory multiple myeloma|refractory multiple myeloma
5838037|NCT00008216|stage I multiple myeloma|stage i multiple myeloma
5838038|NCT00008216|stage II multiple myeloma|stage ii multiple myeloma
5838039|NCT00008216|stage III multiple myeloma|stage iii multiple myeloma
5838040|NCT00008216|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5838041|NCT00008216|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5838042|NCT00008216|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5838043|NCT00008216|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5838044|NCT00008216|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5838045|NCT00008216|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5838046|NCT00008216|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5838047|NCT00008216|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5838048|NCT00008216|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5838049|NCT00008216|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5838050|NCT00008216|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5838051|NCT00008216|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5838053|NCT00008216|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5838054|NCT00008216|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5838055|NCT00008216|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5838057|NCT00008216|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5838058|NCT00008216|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5838059|NCT00008216|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5838060|NCT00008216|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5838061|NCT00008216|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5838062|NCT00008216|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5838063|NCT00008216|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5838064|NCT00008216|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838065|NCT00008216|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838066|NCT00008216|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838067|NCT00008216|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5838068|NCT00008216|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5838069|NCT00008216|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5838070|NCT00008216|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5838071|NCT00008216|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5838072|NCT00008216|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5838073|NCT00008216|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5838074|NCT00008216|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838075|NCT00008216|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838076|NCT00008216|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838077|NCT00008216|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838079|NCT00008216|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5838465|NCT00006476|stage I bladder cancer|stage i bladder cancer
5838080|NCT00008216|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5838081|NCT00008216|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5838082|NCT00008216|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5838083|NCT00008216|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838084|NCT00008216|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838085|NCT00008216|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838086|NCT00008216|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838087|NCT00008216|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838088|NCT00008216|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838089|NCT00008216|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838090|NCT00008216|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838091|NCT00008216|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838092|NCT00008216|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5850385|NCT00024908|Cognition|cognition
5838093|NCT00008216|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5838094|NCT00008216|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5838095|NCT00008216|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5838096|NCT00008216|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5838097|NCT00008216|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5838098|NCT00008216|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5838099|NCT00008216|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5838100|NCT00008216|intraocular lymphoma|intraocular lymphoma
5838101|NCT00008216|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5838102|NCT00008216|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5838103|NCT00008216|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5838104|NCT00008216|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5838105|NCT00008216|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5838106|NCT00008216|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5838107|NCT00008216|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5838108|NCT00008216|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5838109|NCT00008216|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5838110|NCT00008216|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5838111|NCT00008216|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5838112|NCT00008216|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5838113|NCT00008216|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5838114|NCT00008216|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5838115|NCT00008216|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5838116|NCT00008216|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5838117|NCT00008216|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5838118|NCT00008216|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5838119|NCT00008216|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5838120|NCT00008216|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5838121|NCT00008216|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5838122|NCT00008216|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5838123|NCT00008216|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5838124|NCT00008216|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5838125|NCT00008216|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5838126|NCT00008216|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5838127|NCT00008216|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5838128|NCT00008216|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5838129|NCT00008216|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5838130|NCT00008216|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838131|NCT00008216|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838132|NCT00008216|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5838133|NCT00008216|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5843926|NCT00051701|NHL|nhl
5838134|NCT00008216|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5838135|NCT00008216|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5838136|NCT00008216|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5838137|NCT00008216|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5838138|NCT00008216|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5838139|NCT00008216|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5838140|NCT00008216|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5838141|NCT00008216|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5838142|NCT00008216|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5838143|NCT00008216|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5838144|NCT00008216|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838145|NCT00008216|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838146|NCT00008216|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838147|NCT00008216|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838148|NCT00008216|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838149|NCT00008216|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5838150|NCT00008216|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5838151|NCT00008216|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838152|NCT00008216|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838153|NCT00008216|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5838154|NCT00008216|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838155|NCT00008216|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5838156|NCT00008216|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5838157|NCT00008216|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5838158|NCT00008216|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5838159|NCT00008216|adult Langerhans cell histiocytosis|adult langerhans cell histiocytosis
5838160|NCT00008190|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838161|NCT00008190|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5838162|NCT00008190|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5838163|NCT00008190|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5838164|NCT00008190|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5838165|NCT00008190|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5838166|NCT00008190|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5838167|NCT00008190|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5838168|NCT00008190|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5862699|NCT00001544|Neuropsychiatric Disorders|neuropsychiatric disorders
5838169|NCT00008164|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838170|NCT00008164|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838171|NCT00008164|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5838172|NCT00008164|refractory multiple myeloma|refractory multiple myeloma
5838174|NCT00008164|stage II multiple myeloma|stage ii multiple myeloma
5838175|NCT00008164|stage III multiple myeloma|stage iii multiple myeloma
5838176|NCT00008164|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5838177|NCT00008164|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5838178|NCT00008164|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5838179|NCT00008164|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5838180|NCT00008164|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5838181|NCT00008164|childhood Langerhans cell histiocytosis|childhood langerhans cell histiocytosis
5838182|NCT00008164|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5838183|NCT00008164|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5838184|NCT00008164|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5838185|NCT00008164|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5838186|NCT00008164|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5838187|NCT00008164|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5838188|NCT00008164|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5838189|NCT00008164|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5838190|NCT00008164|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838191|NCT00008164|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5838192|NCT00008164|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838193|NCT00008164|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838194|NCT00008164|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5838195|NCT00008164|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5838196|NCT00008164|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5838197|NCT00008164|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5838198|NCT00008164|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5838199|NCT00008164|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5838200|NCT00008164|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5838201|NCT00008164|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838202|NCT00008164|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838203|NCT00008164|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838204|NCT00008164|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838205|NCT00008164|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5838206|NCT00008164|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5838207|NCT00008164|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5838208|NCT00008164|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5838209|NCT00008164|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5838210|NCT00008164|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838211|NCT00008164|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838212|NCT00008164|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838213|NCT00008164|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838214|NCT00008164|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838215|NCT00008164|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838216|NCT00008164|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838217|NCT00008164|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838218|NCT00008164|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838219|NCT00008164|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5838220|NCT00008164|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5838221|NCT00008164|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5838222|NCT00008164|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5838223|NCT00008164|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5838224|NCT00008164|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5838225|NCT00008164|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5838226|NCT00008164|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5838227|NCT00008164|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5838228|NCT00008164|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5838229|NCT00008164|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5838230|NCT00008164|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5838231|NCT00008164|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5838232|NCT00008164|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5838233|NCT00008164|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5838234|NCT00008164|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5838235|NCT00008164|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5838237|NCT00008164|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838238|NCT00008164|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838239|NCT00008164|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5838240|NCT00008164|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5838241|NCT00008164|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5838242|NCT00008164|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5838243|NCT00008164|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5838244|NCT00008164|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5838245|NCT00008164|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838246|NCT00008164|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838247|NCT00008164|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5838248|NCT00008164|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5838249|NCT00008164|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838250|NCT00008164|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838251|NCT00008164|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838252|NCT00008164|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5845817|NCT00048789|UVA|uva
5838253|NCT00008164|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838254|NCT00008164|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5838255|NCT00008164|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838256|NCT00008164|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5838357|NCT00006994|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5838257|NCT00008164|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5838258|NCT00008164|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5838259|NCT00008164|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5838260|NCT00008138|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5838261|NCT00008138|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5838262|NCT00008138|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5838263|NCT00008138|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5838264|NCT00008138|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5838265|NCT00008138|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5838266|NCT00008138|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5838267|NCT00008138|fallopian tube cancer|fallopian tube cancer
5838268|NCT00008138|peritoneal cavity cancer|peritoneal cavity cancer
5838269|NCT00008060|stage IV colon cancer|stage iv colon cancer
5838270|NCT00008060|stage IV rectal cancer|stage iv rectal cancer
5838271|NCT00008060|recurrent colon cancer|recurrent colon cancer
5838272|NCT00008060|recurrent rectal cancer|recurrent rectal cancer
5838273|NCT00008060|adenocarcinoma of the colon|adenocarcinoma of the colon
5838274|NCT00008060|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5838275|NCT00008047|stage II esophageal cancer|stage ii esophageal cancer
5838276|NCT00008047|stage III esophageal cancer|stage iii esophageal cancer
5838277|NCT00008008|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5838278|NCT00008008|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5838279|NCT00008008|recurrent adult brain tumor|recurrent adult brain tumor
5838280|NCT00008008|adult medulloblastoma|adult medulloblastoma
5838282|NCT00008008|adult oligodendroglioma|adult oligodendroglioma
5838283|NCT00008008|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5838284|NCT00008008|childhood oligodendroglioma|childhood oligodendroglioma
5838285|NCT00008008|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5838286|NCT00008008|adult anaplastic ependymoma|adult anaplastic ependymoma
5838287|NCT00008008|adult mixed glioma|adult mixed glioma
5838288|NCT00008008|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5838289|NCT00008008|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5838290|NCT00008008|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5838291|NCT00008008|recurrent childhood ependymoma|recurrent childhood ependymoma
5838292|NCT00008008|adult giant cell glioblastoma|adult giant cell glioblastoma
5838293|NCT00008008|adult gliosarcoma|adult gliosarcoma
5838294|NCT00008008|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5838295|NCT00007995|refractory multiple myeloma|refractory multiple myeloma
5838296|NCT00007995|stage I multiple myeloma|stage i multiple myeloma
5838297|NCT00007995|stage II multiple myeloma|stage ii multiple myeloma
5838298|NCT00007995|stage III multiple myeloma|stage iii multiple myeloma
5838299|NCT00007995|primary systemic amyloidosis|primary systemic amyloidosis
5838300|NCT00007982|recurrent adult brain tumor|recurrent adult brain tumor
5838301|NCT00007982|adult medulloblastoma|adult medulloblastoma
5838302|NCT00007982|adult oligodendroglioma|adult oligodendroglioma
5838303|NCT00007982|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5838304|NCT00007982|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5838305|NCT00007982|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5838306|NCT00007982|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5838307|NCT00007982|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5838308|NCT00007956|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838309|NCT00007956|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838310|NCT00007956|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838311|NCT00007956|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838312|NCT00007956|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838313|NCT00007956|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838314|NCT00007956|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838315|NCT00007956|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838316|NCT00007956|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838317|NCT00007956|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838318|NCT00007930|stage I rectal cancer|stage i rectal cancer
5838319|NCT00007930|stage II rectal cancer|stage ii rectal cancer
5838320|NCT00007930|stage III rectal cancer|stage iii rectal cancer
5838321|NCT00007904|stage II breast cancer|stage ii breast cancer
5838322|NCT00007904|stage IIIA breast cancer|stage iiia breast cancer
5838323|NCT00007904|male breast cancer|male breast cancer
5838324|NCT00007891|stage IV breast cancer|stage iv breast cancer
5838325|NCT00007891|recurrent breast cancer|recurrent breast cancer
5838326|NCT00007891|male breast cancer|male breast cancer
5838327|NCT00007865|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838328|NCT00007865|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838329|NCT00007865|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838330|NCT00007865|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838331|NCT00007865|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838332|NCT00007865|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838333|NCT00007865|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838334|NCT00007865|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838335|NCT00007865|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838336|NCT00007865|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838337|NCT00007865|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838338|NCT00007865|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838339|NCT00007865|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838340|NCT00007865|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838341|NCT00007826|stage II colon cancer|stage ii colon cancer
5838342|NCT00007826|stage III colon cancer|stage iii colon cancer
5838343|NCT00007826|stage IV colon cancer|stage iv colon cancer
5838344|NCT00007826|stage II rectal cancer|stage ii rectal cancer
5838345|NCT00007826|stage III rectal cancer|stage iii rectal cancer
5838346|NCT00007826|stage IV rectal cancer|stage iv rectal cancer
5838347|NCT00007826|adenocarcinoma of the colon|adenocarcinoma of the colon
5838348|NCT00007826|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5838349|NCT00006994|oral complications of radiation therapy|oral complications of radiation therapy
5838351|NCT00006994|radiation toxicity|radiation toxicity
5838352|NCT00006994|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5838353|NCT00006994|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5838354|NCT00006994|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5838355|NCT00006994|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5838356|NCT00006994|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5838358|NCT00006994|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5838359|NCT00006994|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5838360|NCT00006981|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5838361|NCT00006981|stage III cervical cancer|stage iii cervical cancer
5838362|NCT00006981|recurrent cervical cancer|recurrent cervical cancer
5838363|NCT00006981|stage IVB cervical cancer|stage ivb cervical cancer
5838364|NCT00006981|stage IVA cervical cancer|stage iva cervical cancer
5838365|NCT00006981|squamous cell lung cancer|squamous cell lung cancer
5838366|NCT00006981|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5838367|NCT00006981|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5838368|NCT00006981|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5838369|NCT00006981|advanced malignant mesothelioma|advanced malignant mesothelioma
5838371|NCT00006981|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5838372|NCT00006981|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5838373|NCT00006981|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5838374|NCT00006981|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5838375|NCT00006981|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5838376|NCT00006981|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5838377|NCT00006981|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5838378|NCT00006981|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5838379|NCT00006981|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5838380|NCT00006981|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5838381|NCT00006981|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5838382|NCT00006981|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5838383|NCT00006981|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5838384|NCT00006981|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5838385|NCT00006981|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5838386|NCT00006981|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5838387|NCT00006981|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5838388|NCT00006981|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5838389|NCT00006981|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5838390|NCT00006981|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5838391|NCT00006981|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5838392|NCT00006981|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5838393|NCT00006981|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5838394|NCT00006981|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5838395|NCT00006981|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5838396|NCT00006981|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5838397|NCT00006981|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5838398|NCT00006981|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5838399|NCT00006981|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5838401|NCT00006981|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5838404|NCT00006981|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5838405|NCT00006981|recurrent salivary gland cancer|recurrent salivary gland cancer
5838406|NCT00006981|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5838407|NCT00006981|stage III salivary gland cancer|stage iii salivary gland cancer
5838408|NCT00006981|stage IV salivary gland cancer|stage iv salivary gland cancer
5838409|NCT00006981|recurrent pancreatic cancer|recurrent pancreatic cancer
5838410|NCT00006981|stage II pancreatic cancer|stage ii pancreatic cancer
5838411|NCT00006981|stage III pancreatic cancer|stage iii pancreatic cancer
5838412|NCT00006981|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5838413|NCT00006981|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5838414|NCT00006981|ovarian sarcoma|ovarian sarcoma
5838415|NCT00006981|ovarian stromal cancer|ovarian stromal cancer
5838416|NCT00006981|stage IV pancreatic cancer|stage iv pancreatic cancer
5838417|NCT00006916|adult glioblastoma|adult glioblastoma
5838418|NCT00006916|adult giant cell glioblastoma|adult giant cell glioblastoma
5838419|NCT00006916|adult gliosarcoma|adult gliosarcoma
5838420|NCT00006825|stage IV breast cancer|stage iv breast cancer
5838421|NCT00006825|recurrent breast cancer|recurrent breast cancer
5838422|NCT00006760|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838423|NCT00006760|childhood lymphocyte predominant Hodgkin lymphoma|childhood lymphocyte predominant hodgkin lymphoma
5838424|NCT00006760|childhood lymphocyte depletion Hodgkin lymphoma|childhood lymphocyte depletion hodgkin lymphoma
5838425|NCT00006760|childhood nodular sclerosis Hodgkin lymphoma|childhood nodular sclerosis hodgkin lymphoma
5838426|NCT00006760|childhood mixed cellularity Hodgkin lymphoma|childhood mixed cellularity hodgkin lymphoma
5838427|NCT00006747|graft versus host disease|graft versus host disease
5838428|NCT00006747|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5838429|NCT00006747|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5838430|NCT00006747|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5838431|NCT00006747|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5838432|NCT00006747|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838433|NCT00006747|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838434|NCT00006734|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5838435|NCT00006721|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838436|NCT00006721|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838437|NCT00006721|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5838438|NCT00006721|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838439|NCT00006721|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838440|NCT00006721|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838441|NCT00006721|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5838442|NCT00006721|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5838443|NCT00006721|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5838444|NCT00006721|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5838445|NCT00006721|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5838446|NCT00006721|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5838447|NCT00006695|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838448|NCT00006695|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838449|NCT00006695|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838450|NCT00006656|recurrent adult brain tumor|recurrent adult brain tumor
5838452|NCT00006656|adult giant cell glioblastoma|adult giant cell glioblastoma
5838453|NCT00006656|adult gliosarcoma|adult gliosarcoma
5838454|NCT00006485|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838455|NCT00006479|stage IV colon cancer|stage iv colon cancer
5838456|NCT00006479|stage IV rectal cancer|stage iv rectal cancer
5838457|NCT00006479|recurrent colon cancer|recurrent colon cancer
5838458|NCT00006479|recurrent rectal cancer|recurrent rectal cancer
5838459|NCT00006479|liver metastases|liver metastases
5838460|NCT00006478|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838461|NCT00006478|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838462|NCT00006478|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838463|NCT00006477|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838464|NCT00006476|stage 0 bladder cancer|stage 0 bladder cancer
5838466|NCT00006476|recurrent bladder cancer|recurrent bladder cancer
5838467|NCT00006474|recurrent adult brain tumor|recurrent adult brain tumor
5838468|NCT00006474|adult glioblastoma|adult glioblastoma
5838469|NCT00006474|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5838470|NCT00006474|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5838471|NCT00006474|adult mixed glioma|adult mixed glioma
5838472|NCT00006474|adult oligodendroglioma|adult oligodendroglioma
5838473|NCT00006474|adult giant cell glioblastoma|adult giant cell glioblastoma
5838474|NCT00006474|adult gliosarcoma|adult gliosarcoma
5838475|NCT00006471|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5838476|NCT00006471|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5838477|NCT00006471|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5838478|NCT00006471|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5838479|NCT00006471|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5838480|NCT00006471|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5838481|NCT00006471|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5838482|NCT00006471|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5838483|NCT00006471|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5838484|NCT00006471|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5838485|NCT00006471|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5838486|NCT00006471|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5838487|NCT00006471|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5862700|NCT00001543|Major Depression|major depression
5681938|NCT00571220|incretin effect|incretin effect
5681939|NCT00571207|driving under the influence of drugs|driving under the influence of drugs
5681940|NCT00571207|on-site oral fluid screening devices|on-site oral fluid screening devices
5681941|NCT00571207|checklist|checklist
5681942|NCT00571194|pravastatin, peritoneal dialysis, pediatric patients|pravastatin, peritoneal dialysis, pediatric patients
5681943|NCT00571181|Algorithms|algorithms
5681944|NCT00571181|Anesthesia, General/*methods|anesthesia, general/*methods
5681945|NCT00571181|Anesthetics, Intravenous/*administration & dosage|anesthetics, intravenous/*administration & dosage
5681946|NCT00571181|Drug Delivery Systems/*methods/statistics & numerical data|drug delivery systems/*methods/statistics & numerical data
5681947|NCT00571181|Electroencephalography/drug effects/*methods/|electroencephalography/drug effects/*methods/
5681948|NCT00571181|Feasibility Studies|feasibility studies
5681949|NCT00571181|Propofol/*administration & dosage|propofol/*administration & dosage
5681950|NCT00571181|Remifentanil/*administration & dosage|remifentanil/*administration & dosage
5681951|NCT00571181|Bronchoscopy/*methods|bronchoscopy/*methods
5681952|NCT00571181|Prospective Studies|prospective studies
5681953|NCT00571181|Software|software
5681954|NCT00571168|chemotherapy induced nausea and vomiting|chemotherapy induced nausea and vomiting
5681955|NCT00571168|autologous peripheral blood stemcell transplantation|autologous peripheral blood stemcell transplantation
5681956|NCT00571168|high dose chemotherapy|high dose chemotherapy
5681957|NCT00571142|edema|edema
5681958|NCT00571142|retinal thickness|retinal thickness
5681959|NCT00571142|diabetic retinopathy|diabetic retinopathy
5681961|NCT00571116|Metastatic Melanoma|metastatic melanoma
5681962|NCT00571116|Disulfiram|disulfiram
5681963|NCT00571116|Arsenic Trioxide|arsenic trioxide
5681964|NCT00571116|Metastatic Melanoma and at Least One Prior Systemic Therapy|metastatic melanoma and at least one prior systemic therapy
5681965|NCT00571103|acamprosate, impulse-control disorders|acamprosate, impulse-control disorders
5681966|NCT00571090|Thyroid nodule|thyroid nodule
5681967|NCT00571090|Biopsy, Fine-Needle|biopsy, fine-needle
5681968|NCT00571077|Thyroid neoplasms|thyroid neoplasms
5681969|NCT00571077|thyroid nodules|thyroid nodules
5681970|NCT00571077|electrical impedance scanning|electrical impedance scanning
5681971|NCT00571051|MEG, mindfulness, tactile perception|meg, mindfulness, tactile perception
5698699|NCT00505479|pregnancy|pregnancy
5846309|NCT00045981|aged|aged
5838451|NCT00006656|adult glioblastoma|adult glioblastoma
5682882|NCT00567190|HER2-positive|her2-positive
5682979|NCT00566800|esophageal cancer|esophageal cancer
5683079|NCT00566423|BNP|bnp
5683376|NCT00565071|Malaria|malaria
5683466|NCT00564655|Anesthesia|anesthesia
5683659|NCT00563745|Telemedicine|telemedicine
5683742|NCT00563316|colorectal cancer|colorectal cancer
5684672|NCT00559338|CHF|chf
5684859|NCT00558623|calcium|calcium
5685175|NCT00557362|Natamycin|natamycin
5685265|NCT00556868|Breakfast|breakfast
5685750|NCT00555022|FTIH,|ftih,
5686123|NCT00553449|rabeprazole|rabeprazole
5686212|NCT00553046|mechanical ventilation|mechanical ventilation
5686218|NCT00552994|Diabetics|diabetics
5686306|NCT00552630|lead poisoning|lead poisoning
5686941|NCT00549796|stent|stent
5687223|NCT00548392|cancer|cancer
5687419|NCT00547300|Hypertension|hypertension
5687674|NCT00546013|glaucoma|glaucoma
5688406|NCT00543504|Erlotinib|erlotinib
5688407|NCT00543504|OSI-774|osi-774
5688238|NCT00544128|HIV|hiv
5688300|NCT00544115|Burkitt lymphoma|burkitt lymphoma
5688473|NCT00543114|Revlimid|revlimid
5688577|NCT00542724|Juvenile diabetes|juvenile diabetes
5689427|NCT00538850|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5689657|NCT00538850|adult craniopharyngioma|adult craniopharyngioma
5690878|NCT00534534|alcoholism|alcoholism
5690439|NCT00536393|toxicity|toxicity
5690744|NCT00535145|Invega|invega
5690933|NCT00534417|Hormone|hormone
5691084|NCT00533975|colonoscopy|colonoscopy
5691269|NCT00533130|AO|ao
5691575|NCT00531622|Depression|depression
5692414|NCT00528164|children|children
5692999|NCT00526045|ER+|er+
5693099|NCT00525759|Synergy|synergy
5693497|NCT00524355|PPI|ppi
5693748|NCT00523510|HIV|hiv
5693906|NCT00522873|Vaginal dryness|vaginal dryness
5694008|NCT00522457|Her-2/neu expressing breast cancer|her-2/neu expressing breast cancer
5694107|NCT00522171|Obesity|obesity
5694203|NCT00521807|Chronic widespread pain,|chronic widespread pain,
5694455|NCT00521079|Obesity|obesity
5694542|NCT00520715|commensal flora|commensal flora
5694645|NCT00520234|Intensive care unit (ICU)|intensive care unit (icu)
5694740|NCT00519662|Solid|solid
5694938|NCT00518908|Organ protection|organ protection
5695050|NCT00518388|HPV|hpv
5695236|NCT00517569|HIV-1|hiv-1
5695911|NCT00514774|tauroursodeoxycholic acid|tauroursodeoxycholic acid
5696111|NCT00513994|Pharmacokinetics|pharmacokinetics
5696198|NCT00513682|Pancreatic insufficiency|pancreatic insufficiency
5696333|NCT00513422|Glucosamine|glucosamine
5696370|NCT00513279|Safety,|safety,
5696769|NCT00511901|anemia|anemia
5696864|NCT00511550|filgrastim-mobilized|filgrastim-mobilized
5696965|NCT00511134|smoking|smoking
5697166|NCT00510393|Drug Eluting Stent|drug eluting stent
5697266|NCT00510016|opioid withdrawal|opioid withdrawal
5848043|NCT00036569|Brainstem Glioma|brainstem glioma
5698215|NCT00507260|BMT|bmt
5698494|NCT00506168|Secondary|secondary
5698711|NCT00505427|alpha lipoic acid|alpha lipoic acid
5698848|NCT00504907|RSV|rsv
5699038|NCT00504335|BIO 300|bio 300
5699112|NCT00504205|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5699189|NCT00503997|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5699418|NCT00503256|CLL|cll
5699449|NCT00503061|GPRD|gprd
5700309|NCT00500188|NSC-716051|nsc-716051
5700489|NCT00499733|stage IV breast cancer|stage iv breast cancer
5700649|NCT00499642|Healthy Subjects|healthy subjects
5700738|NCT00499382|RNV|rnv
5700870|NCT00499187|Fanconi|fanconi
5701171|NCT00498147|CHF|chf
5701477|NCT00496873|Follicular lymphoma|follicular lymphoma
5701678|NCT00496236|neck|neck
5701901|NCT00495352|NRT|nrt
5701998|NCT00495079|malignancy|malignancy
5702335|NCT00493766|LBH589|lbh589
5702566|NCT00492882|FSH|fsh
5702642|NCT00492622|heartburn|heartburn
5703072|NCT00490789|sirolimus|sirolimus
5703171|NCT00490347|Cardiomyopathy|cardiomyopathy
5703172|NCT00490334|Carcinomas|carcinomas
5703762|NCT00488254|Romano Ward|romano ward
5704471|NCT00485485|Gleevec|gleevec
5704569|NCT00485030|stent|stent
5705169|NCT00482846|mucositis|mucositis
5705370|NCT00482066|ANCA|anca
5705446|NCT00481858|CD19|cd19
5705542|NCT00481403|Sperm, male fertility, microarrays|sperm, male fertility, microarrays
5705642|NCT00481039|Sickle cell disease|sickle cell disease
5705747|NCT00480584|pancreatic|pancreatic
5705850|NCT00480233|Hebrew|hebrew
5706100|NCT00479154|RLS|rls
5706671|NCT00477113|MS|ms
5706852|NCT00476567|complications|complications
5707061|NCT00475800|Osteoarthritis|osteoarthritis
5707222|NCT00475189|PMS|pms
5707278|NCT00475046|smoking|smoking
5707350|NCT00474942|Hypokalemia|hypokalemia
5707531|NCT00474162|Cesarean section|cesarean section
5708778|NCT00469664|Cognition|cognition
5708779|NCT00469664|Memory|memory
5709068|NCT00468468|computer|computer
5709275|NCT00467805|women|women
5709550|NCT00466622|pregnancy|pregnancy
5709557|NCT00466609|placebo|placebo
5709663|NCT00466128|PPROM|pprom
5687284|NCT00548106|infant formula, milk allergy, hydrolized whey|infant formula, milk allergy, hydrolized whey
5687285|NCT00548093|non-small cell lung cancer|non-small cell lung cancer
5687286|NCT00548093|advanced|advanced
5687287|NCT00548093|previously treated|previously treated
5687288|NCT00548067|High blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine|high blood pressure, hypertension, drug interaction, steady state, valsartan, hydrochlorothiazide, amlodipine
5687289|NCT00548054|cholera|cholera
5687290|NCT00548054|vaccine|vaccine
5687291|NCT00548054|Kolkata|kolkata
5687297|NCT00548054|expanded programme on immunization|expanded programme on immunization
5687299|NCT00548041|Emergency Department|emergency department
5687300|NCT00548041|HIV Seronegativity|hiv seronegativity
5687301|NCT00548002|Staphylococcus aureus|staphylococcus aureus
5687302|NCT00548002|bacteremia|bacteremia
5687303|NCT00548002|endocarditis|endocarditis
5687305|NCT00548002|fluoroquinolone|fluoroquinolone
5687306|NCT00548002|rifampin|rifampin
5687307|NCT00548002|levofloxacin|levofloxacin
5687308|NCT00548002|trovafloxacin|trovafloxacin
5687309|NCT00547989|ASA class I and II|asa class i and ii
5687310|NCT00547976|Inflammation|inflammation
5687311|NCT00547976|Unstable Plaque|unstable plaque
5687312|NCT00547976|Macrophage|macrophage
5687313|NCT00547976|Thrombosis|thrombosis
5687314|NCT00547976|Autoradiography|autoradiography
5687315|NCT00547976|Atherosclerosis|atherosclerosis
5687316|NCT00547976|Vasculitis|vasculitis
5687317|NCT00547963|Alcohol Drinking|alcohol drinking
5687318|NCT00547963|Marijuana Smoking|marijuana smoking
5687319|NCT00547963|Substance Use|substance use
5687320|NCT00547963|Emergency Department (ED)|emergency department (ed)
5687321|NCT00547937|Sleep Apnea|sleep apnea
5687322|NCT00547937|Oxidative Stress|oxidative stress
5687323|NCT00547937|Nitric oxide|nitric oxide
5687324|NCT00547937|Cardiovascular disease|cardiovascular disease
5687326|NCT00547911|Carbidopa|carbidopa
5687327|NCT00547911|Locus Ceruleus/Norepinephrine-Autonomic System|locus ceruleus/norepinephrine-autonomic system
5687328|NCT00547911|Norepinephrine|norepinephrine
5687329|NCT00547911|Adrenergic Nervous System|adrenergic nervous system
5687330|NCT00547898|HIV|hiv
5687331|NCT00547898|AIDS|aids
5687332|NCT00547898|Diarrhea|diarrhea
5687347|NCT00547833|language disorders|language disorders
5687516|NCT00546949|x-stop|x-stop
5687593|NCT00546351|Lacosamide|lacosamide
5687695|NCT00545961|sinusitis|sinusitis
5687798|NCT00545493|Hemiparesis|hemiparesis
5687980|NCT00544453|SPECT|spect
5677910|NCT00589225|PH|ph
5709743|NCT00465842|HCC|hcc
5688142|NCT00544336|stage II salivary gland cancer|stage ii salivary gland cancer
5688221|NCT00544193|stage III gastric cancer|stage iii gastric cancer
5709938|NCT00465062|Lipids|lipids
5688312|NCT00544115|aplastic anemia|aplastic anemia
5688487|NCT00543075|Genasense|genasense
5688590|NCT00542659|Maze procedure|maze procedure
5690580|NCT00535912|CLL|cll
5688799|NCT00541710|menopause|menopause
5688887|NCT00541138|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5688955|NCT00540969|stage IV melanoma|stage iv melanoma
5689041|NCT00540449|AIDS|aids
5689141|NCT00539994|SB-275833|sb-275833
5689257|NCT00539422|cancer|cancer
5689343|NCT00539136|GSK561679,|gsk561679,
5689815|NCT00538850|chondrosarcoma|chondrosarcoma
5689487|NCT00538850|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5848036|NCT00036582|Placebo|placebo
5691412|NCT00532402|Propofol|propofol
5689796|NCT00538850|lung papilloma|lung papilloma
5689876|NCT00538850|stage I thymoma|stage i thymoma
5690059|NCT00537992|vitrectomy,|vitrectomy,
5690160|NCT00537524|toddlers|toddlers
5690256|NCT00537108|Pregnancy in adolescence|pregnancy in adolescence
5690455|NCT00536328|PPU|ppu
5690542|NCT00536016|AMD|amd
5690635|NCT00535600|Insulin Action|insulin action
5690750|NCT00535106|AED|aed
5690833|NCT00534729|Taxol|taxol
5681118|NCT00574626|BMT|bmt
5691064|NCT00534001|non-small cell lung cancer|non-small cell lung cancer
5691146|NCT00533806|Relaxation Therapy|relaxation therapy
5691147|NCT00533806|Young Children|young children
5691236|NCT00533234|Elbow dislocation|elbow dislocation
5691351|NCT00532701|Genotype 2|genotype 2
5691645|NCT00531284|lymphoma|lymphoma
5691736|NCT00530855|Epilepsy|epilepsy
5691820|NCT00530400|Neurosurgery|neurosurgery
5691921|NCT00530049|07-098|07-098
5692001|NCT00529802|metastatic|metastatic
5692182|NCT00529022|Azacitidine|azacitidine
5692274|NCT00528671|phenprocoumon|phenprocoumon
5692365|NCT00528385|Proteinuria|proteinuria
5692662|NCT00527176|q Space Imaging|q space imaging
5692788|NCT00526630|gait|gait
5692860|NCT00526370|self test|self test
5692954|NCT00526149|ovarian sarcoma|ovarian sarcoma
5693038|NCT00525915|5-FU|5-fu
5693241|NCT00525239|triglycerides|triglycerides
5693336|NCT00524875|Bevacizumab|bevacizumab
5693433|NCT00524550|Appetite regulation|appetite regulation
5693637|NCT00523848|stage II multiple myeloma|stage ii multiple myeloma
5693744|NCT00523510|infant feeding|infant feeding
5693747|NCT00523510|pmtct|pmtct
5693873|NCT00522951|MRI|mri
5693956|NCT00522652|lymphoma|lymphoma
5694240|NCT00521677|Oral care|oral care
5694385|NCT00521274|Docetaxel|docetaxel
5694438|NCT00521196|tms|tms
5694582|NCT00520533|Pharmacokinetics|pharmacokinetics
5694601|NCT00520468|MDS|mds
5694680|NCT00520026|lithium|lithium
5694883|NCT00519090|leukemia cells|leukemia cells
5694884|NCT00519090|bone marrow disease|bone marrow disease
5694974|NCT00518752|Ventilator Acquired Pneumonia|ventilator acquired pneumonia
5695384|NCT00516802|dacarbazine|dacarbazine
5695446|NCT00516490|GnRH agonist|gnrh agonist
5695447|NCT00516490|IVF/ICSI outcome|ivf/icsi outcome
5695538|NCT00516191|Velcade|velcade
5695637|NCT00515736|outcome|outcome
5695744|NCT00515359|Sedative agent|sedative agent
5695839|NCT00515099|New-onset Type 1 Diabetes|new-onset type 1 diabetes
5696137|NCT00513890|Infant|infant
5696229|NCT00513604|Cytokines|cytokines
5696334|NCT00513422|Chondroitin|chondroitin
5696395|NCT00513214|Type 2|type 2
5696396|NCT00513214|Mellitus|mellitus
5696496|NCT00512889|CTL|ctl
5696596|NCT00512564|Iron overload|iron overload
5696608|NCT00512512|liver|liver
5696765|NCT00511927|igf|igf
5696893|NCT00511459|Randomized|randomized
5696998|NCT00511017|Calcium|calcium
5697101|NCT00510653|Ovarian Cancer|ovarian cancer
5697300|NCT00509769|Trastuzumab emtansine|trastuzumab emtansine
5697446|NCT00509678|Rituxan|rituxan
5697794|NCT00508586|VEGF|vegf
5698007|NCT00507975|pregnancy|pregnancy
5698113|NCT00507650|Nursing home|nursing home
5698415|NCT00506467|Lung Cancer|lung cancer
5698512|NCT00506129|PBPC|pbpc
5698669|NCT00505570|PFO|pfo
5698725|NCT00505388|Symbicort|symbicort
5698939|NCT00504582|Tisseel|tisseel
5699047|NCT00504309|DHA|dha
5699049|NCT00504309|fish|fish
5699136|NCT00504179|cardiovascular disease|cardiovascular disease
5699199|NCT00503984|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5699300|NCT00503763|Smoldering multiple myeloma|smoldering multiple myeloma
5699360|NCT00503594|Cytarabine|cytarabine
5699364|NCT00503555|Primary Health Care|primary health care
5699469|NCT00502983|Acute Myelogenous Leukemia|acute myelogenous leukemia
5699581|NCT00502606|prosthesis|prosthesis
5699882|NCT00501553|Vitamin D status,|vitamin d status,
5699989|NCT00501228|RhG-CSF|rhg-csf
5699991|NCT00501215|PHPT|phpt
5700121|NCT00500773|aerobic and exertional exercise|aerobic and exertional exercise
5700123|NCT00500760|panitumumab|panitumumab
5700226|NCT00500435|Cervical Cancer|cervical cancer
5700330|NCT00500110|Zoladex|zoladex
5700432|NCT00499798|adult papillary meningioma|adult papillary meningioma
5701411|NCT00497107|UFT/LV|uft/lv
5700587|NCT00499707|HbA1c|hba1c
5700632|NCT00499668|grade 3 follicular lymphoma|grade 3 follicular lymphoma
5700721|NCT00499421|EBRT|ebrt
5701289|NCT00497575|L-thyroxine|l-thyroxine
5701291|NCT00497562|Fibromyalgia|fibromyalgia
5701498|NCT00496860|fusion protein|fusion protein
5701499|NCT00496860|antitumor|antitumor
5701590|NCT00496574|efficacy|efficacy
5701595|NCT00496574|PC20M|pc20m
5701693|NCT00496184|Vestibulitis|vestibulitis
5701786|NCT00495794|organization of care|organization of care
5702015|NCT00495014|Single Dose,|single dose,
5702024|NCT00494949|Hemospan|hemospan
5702210|NCT00494221|Metastatic Cancer|metastatic cancer
5702340|NCT00493727|Oxidative stress|oxidative stress
5702449|NCT00493337|Compliance|compliance
5702568|NCT00492869|rejection|rejection
5702660|NCT00492544|Human Papillomavirus (HPV) vaccine|human papillomavirus (hpv) vaccine
5702767|NCT00492128|combination therapy|combination therapy
5702894|NCT00491634|treosulfan|treosulfan
5703090|NCT00490737|dialysis|dialysis
5703195|NCT00490282|ART|art
5703284|NCT00489931|Avian Influenza|avian influenza
5703528|NCT00489034|HIV|hiv
5703785|NCT00488137|PAC-SYM|pac-sym
5704035|NCT00487344|OSU|osu
5703983|NCT00487383|Cerebellum|cerebellum
5704093|NCT00487149|Respiratory Muscle Strength|respiratory muscle strength
5704285|NCT00486330|HIV|hiv
5704286|NCT00486330|Pharmacokinetics|pharmacokinetics
5704381|NCT00485953|Osteoporosis|osteoporosis
5704484|NCT00485394|AMD|amd
5704578|NCT00484991|Phenylketonurias|phenylketonurias
5704626|NCT00484861|HV|hv
5704669|NCT00484705|Muscle sympathetic nerve activity|muscle sympathetic nerve activity
5704672|NCT00484692|smoking cessation|smoking cessation
5704768|NCT00484276|malignant pleural mesothelioma|malignant pleural mesothelioma
5704864|NCT00483834|Bevacizumab|bevacizumab
5704938|NCT00483769|Glucose intolerance|glucose intolerance
5705020|NCT00483392|insulin|insulin
5705174|NCT00482833|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5705332|NCT00482274|stage I prostate cancer|stage i prostate cancer
5705531|NCT00481442|Sepsis|sepsis
5705735|NCT00480623|Prostate Cancer|prostate cancer
5705843|NCT00480259|nutrition|nutrition
5705939|NCT00479908|Organic nitrate|organic nitrate
5706044|NCT00479479|methylmalonic acid|methylmalonic acid
5706144|NCT00479011|fluid management|fluid management
5706246|NCT00478686|Xeloda|xeloda
5706440|NCT00477919|ovarian stromal cancer|ovarian stromal cancer
5706631|NCT00477217|knee|knee
5706731|NCT00476905|Spectral Diagnosis|spectral diagnosis
5707036|NCT00475891|linezolid|linezolid
5707251|NCT00475111|Emotion Regulation|emotion regulation
5707332|NCT00474994|adult malignant mesenchymoma|adult malignant mesenchymoma
5707415|NCT00474539|Vaccine|vaccine
5707503|NCT00474240|cholesterol|cholesterol
5707504|NCT00474227|obesity|obesity
5707707|NCT00473460|AECB|aecb
5707818|NCT00473057|stem cells|stem cells
5707944|NCT00472446|Surgery|surgery
5708023|NCT00472056|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5708122|NCT00471679|regional neuroblastoma|regional neuroblastoma
5708325|NCT00471055|knee|knee
5708429|NCT00470574|recurrent breast cancer|recurrent breast cancer
5708510|NCT00470392|Erythema|erythema
5708566|NCT00470366|stage IIIB ovarian germ cell tumor|stage iiib ovarian germ cell tumor
5708654|NCT00470080|Premature infant|premature infant
5708810|NCT00469560|MDS|mds
5708946|NCT00469014|AML|aml
5709122|NCT00468260|EPO906|epo906
5709334|NCT00467428|ADHD|adhd
5709418|NCT00467090|PD|pd
5709699|NCT00465985|children|children
5709799|NCT00465634|abruption|abruption
5709900|NCT00465205|Women|women
5710227|NCT00464139|pain|pain
5710275|NCT00463931|Soiltransmitted helminthiasis|soiltransmitted helminthiasis
5710442|NCT00463333|EEG|eeg
5710471|NCT00463229|interdisciplinary|interdisciplinary
5710564|NCT00462943|Omacetaxine|omacetaxine
5710566|NCT00462917|family genetics|family genetics
5710681|NCT00462644|etomidate|etomidate
5710748|NCT00462371|quality of life|quality of life
5710848|NCT00461968|Statin|statin
5710955|NCT00461552|Lipodystrophy|lipodystrophy
5710956|NCT00461552|HIV|hiv
5711055|NCT00461188|PAP|pap
5711153|NCT00460707|GW679769|gw679769
5711256|NCT00460343|professional roles|professional roles
5711455|NCT00459654|HRPC|hrpc
5711557|NCT00459303|cataract|cataract
5711563|NCT00459277|Pain|pain
5711658|NCT00458796|pain|pain
5711722|NCT00458666|D-dimer|d-dimer
5711805|NCT00458380|Embryos|embryos
5712015|NCT00457652|Ischemia|ischemia
5737272|NCT00368095|HT|ht
5712183|NCT00456911|prevention|prevention
5712390|NCT00456027|Autoimmunity|autoimmunity
5712498|NCT00455650|cognition|cognition
5712599|NCT00455156|Vaginal Ring|vaginal ring
5712690|NCT00454779|Recurrent|recurrent
5712781|NCT00454441|Sleep Quality|sleep quality
5712865|NCT00454168|adult erythroleukemia (M6a)|adult erythroleukemia (m6a)
5712973|NCT00453791|MDI|mdi
5729220|NCT00397462|Osteoporosis|osteoporosis
5713326|NCT00453180|acetylcysteine|acetylcysteine
5713695|NCT00451711|Liposomal Amphotericin B|liposomal amphotericin b
5713713|NCT00451594|ITP|itp
5713795|NCT00451204|estriol|estriol
5713970|NCT00450580|naive,|naive,
5714154|NCT00449917|lutein|lutein
5714244|NCT00449514|tamoxifen|tamoxifen
5714332|NCT00449098|anti scarring|anti scarring
5714438|NCT00448617|FluMist|flumist
5714597|NCT00448344|veterans|veterans
5714624|NCT00448214|Atrial fibrillation|atrial fibrillation
5714726|NCT00448188|thrombocytes|thrombocytes
5714749|NCT00448084|Healthy Volunteer|healthy volunteer
5714853|NCT00447694|Chelator|chelator
5714950|NCT00447239|hospital stay|hospital stay
5715146|NCT00446459|Hypertension|hypertension
5715259|NCT00446082|Refractory or resistant carcinoid disease and acromegaly|refractory or resistant carcinoid disease and acromegaly
5715260|NCT00446043|Acne Vulgaris|acne vulgaris
5710317|NCT00463788|cancer|cancer
5715554|NCT00445913|type 1 diabetes|type 1 diabetes
5705646|NCT00481013|Adult|adult
5715660|NCT00445731|refractory hairy cell leukemia|refractory hairy cell leukemia
5798815|NCT00110929|Sensipar®|sensipar®
5741533|NCT00352586|HV|hv
5716054|NCT00444717|inflammation|inflammation
5711505|NCT00459498|NIS|nis
5716327|NCT00443820|Dermatophytes|dermatophytes
5716432|NCT00443391|ADHD|adhd
5716536|NCT00019643|cancer|cancer
5716614|NCT00443066|neuromuscular disease|neuromuscular disease
5716711|NCT00019890|cancer|cancer
5716874|NCT00003552|cancer|cancer
5716971|NCT00442442|mosquito control|mosquito control
5717065|NCT00442247|Anterior vaginal wall prolapse|anterior vaginal wall prolapse
5717283|NCT00441311|primary care physicians|primary care physicians
5717390|NCT00440947|REYATAZ|reyataz
5717513|NCT00440479|hematological neoplasms|hematological neoplasms
5717515|NCT00440479|efficacy|efficacy
5717832|NCT00439296|Relapsed ALL|relapsed all
5717934|NCT00438958|refractory anemia|refractory anemia
5717988|NCT00438958|Waldenström macroglobulinemia|waldenström macroglobulinemia
5718082|NCT00438646|Epidemiology|epidemiology
5718083|NCT00438633|proximal humerus fracture|proximal humerus fracture
5680692|NCT00576888|Thrombocytopenia|thrombocytopenia
5718413|NCT00437177|spect|spect
5718498|NCT00436774|childhood teratoma|childhood teratoma
5718569|NCT00436618|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5680801|NCT00576251|Ocular inflammation|ocular inflammation
5718729|NCT00436189|Pelvic|pelvic
5718730|NCT00436189|Mass|mass
5718880|NCT00435461|once daily|once daily
5718973|NCT00435097|Colon Cancer Stage III|colon cancer stage iii
5719061|NCT00434733|Influenza H5N1, pandemic|influenza h5n1, pandemic
5719163|NCT00434421|Asthma|asthma
5719275|NCT00434096|Obesity disease|obesity disease
5719377|NCT00433784|CYP3A|cyp3a
5719464|NCT00433602|ovarian sarcoma|ovarian sarcoma
5719613|NCT00433108|ALT|alt
5719926|NCT00432003|HIV|hiv
5720038|NCT00431561|Antisense|antisense
5720131|NCT00431210|NPC|npc
5720224|NCT00430846|Disease, Hodgkin|disease, hodgkin
5720256|NCT00430768|AAT|aat
5720418|NCT00430105|Renal vasculitis|renal vasculitis
5720503|NCT00429715|No response to leishmanin|no response to leishmanin
5720598|NCT00429416|Hematopoietic stem cell transplantation|hematopoietic stem cell transplantation
5720694|NCT00429156|COPD|copd
5720883|NCT00428441|D-dimer|d-dimer
5721200|NCT00427336|ATG|atg
5721358|NCT00426842|Midodrine|midodrine
5721553|NCT00426205|MDS|mds
5721554|NCT00426205|AML|aml
5721644|NCT00425802|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5721711|NCT00425633|Potassium|potassium
5721797|NCT00425334|Blood loss|blood loss
5722353|NCT00423605|Pain|pain
5721972|NCT00424242|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5722125|NCT00424060|adult glioblastoma|adult glioblastoma
5722112|NCT00424125|Asthma|asthma
5722186|NCT00423839|Antigen 85A|antigen 85a
5722269|NCT00423813|Fibro|fibro
5722339|NCT00423618|adult synovial sarcoma|adult synovial sarcoma
5722419|NCT00423475|recurrent prostate cancer|recurrent prostate cancer
5722530|NCT00422981|Memory|memory
5722637|NCT00422591|AML|aml
5722718|NCT00422240|Adapalene|adapalene
5722815|NCT00421720|sufentanil|sufentanil
5722830|NCT00421668|HIV|hiv
5722906|NCT00421369|Augmentation|augmentation
5723329|NCT00419497|Waist|waist
5723426|NCT00419146|Models, Statistical|models, statistical
5723621|NCT00418223|Ultrasound|ultrasound
5723641|NCT00418132|SSc|ssc
5723719|NCT00417716|Anti-VEGF drugs|anti-vegf drugs
5723820|NCT00417365|Lactobacilli|lactobacilli
5723914|NCT00417027|Labor analgesia|labor analgesia
5723981|NCT00416897|stage I multiple myeloma|stage i multiple myeloma
5724052|NCT00416663|Progenitor cells|progenitor cells
5725107|NCT00413452|Amgen|amgen
5724119|NCT00416624|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5724192|NCT00416611|Treatment|treatment
5724251|NCT00416364|inguinal|inguinal
5725207|NCT00413322|PXD101|pxd101
5724571|NCT00415493|non-allergic rhinitis|non-allergic rhinitis
5724650|NCT00415220|Chiropractic|chiropractic
5724795|NCT00414765|Metastatic Melanoma|metastatic melanoma
5724990|NCT00413920|de novo renal transplantation|de novo renal transplantation
5724996|NCT00413855|Laparoscopy|laparoscopy
5725083|NCT00413504|Fondaparinux|fondaparinux
5725179|NCT00413322|Facial Neoplasms|facial neoplasms
5725279|NCT00413153|Body Composition|body composition
5725486|NCT00412399|Physical activity|physical activity
5725680|NCT00411632|OSI-774|osi-774
5725856|NCT00410982|Alkeran|alkeran
5726005|NCT00410644|pain|pain
5742952|NCT00346749|FEV1|fev1
5726090|NCT00410436|Type 1 Diabetes|type 1 diabetes
5726199|NCT00409942|Chronic heart failure|chronic heart failure
5726201|NCT00409942|Myocardial fibrosis|myocardial fibrosis
5726287|NCT00409487|obstructive sleep apnea|obstructive sleep apnea
5726492|NCT00408772|adenocarcinoma of the colon|adenocarcinoma of the colon
5726493|NCT00408772|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5726587|NCT00408395|influenza disease|influenza disease
5726780|NCT00407394|Pneumonia|pneumonia
5726784|NCT00407394|India|india
5726885|NCT00406809|Navitoclax|navitoclax
5726988|NCT00406211|Varicella|varicella
5727075|NCT00405821|HIV|hiv
5727135|NCT00405665|Cystic Fibrosis|cystic fibrosis
5727309|NCT00404963|Dose Escalation,|dose escalation,
5744679|NCT00340847|IHC|ihc
5744680|NCT00340847|Lung Cancer|lung cancer
5727459|NCT00404339|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5727514|NCT00404248|adult gliosarcoma|adult gliosarcoma
5727590|NCT00403767|Blood Clot|blood clot
5727663|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide
5728018|NCT00402428|CHC|chc
5728219|NCT00401635|first-line|first-line
5728326|NCT00401102|depression|depression
5728406|NCT00400881|mechanical ventilation|mechanical ventilation
5728506|NCT00400543|atherosclerosis|atherosclerosis
5728710|NCT00399620|Saliva|saliva
5728813|NCT00399191|iron deficiency|iron deficiency
5729005|NCT00398333|Nutritional Status|nutritional status
5848050|NCT00036569|Pediatric Brain Tumor|pediatric brain tumor
5729276|NCT00397163|Troponin-T|troponin-t
5729377|NCT00396760|cardiac surgery|cardiac surgery
5729391|NCT00396734|PET|pet
5729480|NCT00396487|chemotherapy|chemotherapy
5729675|NCT00395681|Obesity|obesity
5729676|NCT00395681|Propofol|propofol
5729781|NCT00395317|multiple sclerosis|multiple sclerosis
5729891|NCT00394875|Nurses|nurses
5729981|NCT00394446|Refractory|refractory
5730479|NCT00392769|Serous Tumor|serous tumor
5730576|NCT00392483|Dementia|dementia
5730678|NCT00391911|CRRT|crrt
5730859|NCT00391170|Mouth Pain|mouth pain
5730861|NCT00391157|Transplant|transplant
5730978|NCT00390702|VSD|vsd
5731057|NCT00390416|06-096|06-096
5731150|NCT00390117|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5731233|NCT00389766|recurrent neuroblastoma|recurrent neuroblastoma
5731532|NCT00388648|Mortality|mortality
5731646|NCT00388167|Invader fungal infection (IFI)|invader fungal infection (ifi)
5731755|NCT00387946|smoking|smoking
5731851|NCT00387595|CAC|cac
5731899|NCT00387413|Duloxetine|duloxetine
5731980|NCT00387205|malignant tumor|malignant tumor
5732187|NCT00386516|intra-hepatic|intra-hepatic
5732294|NCT00386100|Drug-naive|drug-naive
5732395|NCT00385684|Agitation|agitation
5732501|NCT00385190|SAD|sad
5732596|NCT00384696|Questionnaire|questionnaire
5732703|NCT00384202|Tacrolimus|tacrolimus
5732807|NCT00383682|stump pain|stump pain
5733180|NCT00382291|OCD|ocd
5733194|NCT00382265|kidney stones|kidney stones
5733296|NCT00381888|ovarian sarcoma|ovarian sarcoma
5733395|NCT00381576|Strength training|strength training
5733549|NCT00381004|FCR|fcr
5733703|NCT00380094|ACS|acs
5733807|NCT00379587|Rituximab|rituximab
5734008|NCT00378820|Casein|casein
5734068|NCT00378781|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5734140|NCT00378781|prolymphocytic leukemia|prolymphocytic leukemia
5734200|NCT00378781|intraocular lymphoma|intraocular lymphoma
5734686|NCT00376987|oropharyngeal cancer|oropharyngeal cancer
5789087|NCT00149968|GI problems|gi problems
5735265|NCT00375583|Nematode|nematode
5735360|NCT00375245|breast cancer|breast cancer
5735455|NCT00374933|Acute Myelogenous Leukemia|acute myelogenous leukemia
5735547|NCT00374556|eszopiclone|eszopiclone
5735856|NCT00373412|cytomegalovirus|cytomegalovirus
5735952|NCT00373087|Entacapone|entacapone
5735953|NCT00373087|pharmacogenetic|pharmacogenetic
5736046|NCT00372723|toxic epidermal necrlysis|toxic epidermal necrlysis
5736307|NCT00371878|Vaccine|vaccine
5736312|NCT00371878|HIV|hiv
5736405|NCT00371436|Triage|triage
5736597|NCT00370708|Oral|oral
5680955|NCT00575484|Congestive Heart Failure|congestive heart failure
5736784|NCT00369863|Macular thickness|macular thickness
5732033|NCT00387023|Eye|eye
5736938|NCT00369486|macular|macular
5737042|NCT00369057|Robotic|robotic
5737150|NCT00368537|skin infection|skin infection
5737600|NCT00366548|Infant|infant
5737701|NCT00366145|acute GVHD|acute gvhd
5737708|NCT00366132|TRT|trt
5737795|NCT00365768|stage I Wilms tumor|stage i wilms tumor
5737881|NCT00365508|small cell lung cancer|small cell lung cancer
5737906|NCT00365443|HPV|hpv
5737968|NCT00365287|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5738044|NCT00365274|mAb|mab
5738116|NCT00365105|recurrent breast cancer|recurrent breast cancer
5738300|NCT00364390|CAD|cad
5738427|NCT00363779|Gene Expression|gene expression
5738515|NCT00363428|tobacco use disorder|tobacco use disorder
5738609|NCT00363051|RADIANT-1|radiant-1
5738648|NCT00362908|Obesity|obesity
5738708|NCT00362440|HIV lipodystrophy|hiv lipodystrophy
5738809|NCT00362089|pregnancy|pregnancy
5738810|NCT00362089|lactation|lactation
5738911|NCT00361660|Stroke|stroke
5739013|NCT00361270|Pain coping strategies|pain coping strategies
5680974|NCT00575354|Sevoflurane|sevoflurane
5739239|NCT00360802|anxiety|anxiety
5739343|NCT00360373|adolescent|adolescent
5739456|NCT00359957|Weight|weight
5739608|NCT00359372|CRT|crt
5739669|NCT00359112|overweight|overweight
5739670|NCT00359112|AVANDAMET|avandamet
5739758|NCT00358787|ulnar nerve injury|ulnar nerve injury
5739890|NCT00358345|AMD|amd
5739958|NCT00358072|Minimal residual disease|minimal residual disease
5740146|NCT00357344|Gray Matter|gray matter
5740472|NCT00356317|Family|family
5740694|NCT00355511|patient care team|patient care team
5740789|NCT00355160|Headache|headache
5740893|NCT00354861|IMP321|imp321
5740982|NCT00354549|large cell lung cancer|large cell lung cancer
5740995|NCT00354523|Gleevec|gleevec
5741172|NCT00353873|SERETIDE|seretide
5741199|NCT00353795|MRI|mri
5741396|NCT00353054|Diet|diet
5741527|NCT00352586|Anxiety|anxiety
5741616|NCT00352430|Sickle Cell|sickle cell
5741787|NCT00351949|IMP321|imp321
5741788|NCT00351949|Monotherapy|monotherapy
5741887|NCT00351572|colon cancer|colon cancer
5742094|NCT00350766|Stem cells|stem cells
5742291|NCT00349869|yoga|yoga
5742386|NCT00349323|treatment coverage,|treatment coverage,
5742528|NCT00348829|CHF|chf
5742546|NCT00348777|Womac indice|womac indice
5742645|NCT00348114|autologous|autologous
5742693|NCT00347880|BNP|bnp
5742747|NCT00347659|BLVR|blvr
5742843|NCT00347191|Corneal thickness|corneal thickness
5742953|NCT00346749|Sputum|sputum
5743048|NCT00346398|food allergy|food allergy
5743216|NCT00345878|Cervical neoplasia|cervical neoplasia
5743315|NCT00345579|Infants|infants
5743417|NCT00345163|Brain Cancer|brain cancer
5743513|NCT00344721|Blepharitis|blepharitis
5743611|NCT00344318|Immunogenicity|immunogenicity
5743895|NCT00343187|EGFR-1 Rash|egfr-1 rash
5744248|NCT00342030|Fruit|fruit
5744413|NCT00341536|Environmental|environmental
5745063|NCT00339664|Pharmacodynamics|pharmacodynamics
5745348|NCT00338702|Foot|foot
5745438|NCT00338377|Cytoxan|cytoxan
5745549|NCT00338000|Chronic renal failure|chronic renal failure
5745553|NCT00337974|memory|memory
5745645|NCT00337441|Chronic Anemia|chronic anemia
5745904|NCT00336388|Malaria|malaria
5745802|NCT00336830|coronary angioplasty|coronary angioplasty
5745926|NCT00336284|ICD|icd
5746083|NCT00335517|Pain relief|pain relief
5746329|NCT00334516|PLS|pls
5746365|NCT00334321|IMRT|imrt
5746592|NCT00333554|DHA|dha
5746642|NCT00333242|Pain|pain
5746939|NCT00331760|cervical adenocarcinoma|cervical adenocarcinoma
5747342|NCT00330174|Alcoholism|alcoholism
5747445|NCT00329706|PET|pet
5747548|NCT00329251|Viral load|viral load
5747656|NCT00328835|Optic Nerve|optic nerve
5747738|NCT00328536|omega-3 fatty acids|omega-3 fatty acids
5747841|NCT00328146|cardiac|cardiac
5747946|NCT00327756|Mitochondrial Enhancer|mitochondrial enhancer
5748046|NCT00327301|POAG|poag
5862870|NCT00001475|Thalidomide|thalidomide
5748340|NCT00326170|MDS|mds
5681005|NCT00575224|Hepatitis C|hepatitis c
5748641|NCT00324922|Vancomycin|vancomycin
5748788|NCT00324545|Diets|diets
5765167|NCT00263237|Colonoscopy|colonoscopy
5748929|NCT00324324|stage IIIC breast cancer|stage iiic breast cancer
5749018|NCT00323960|prednisone|prednisone
5749119|NCT00323557|Prevnar|prevnar
5749212|NCT00323245|physiotherapy|physiotherapy
5749305|NCT00322699|Bladder Cancer|bladder cancer
5749810|NCT00320697|nicotine|nicotine
5750255|NCT00318773|PMS|pms
5750413|NCT00318123|HIV|hiv
5750568|NCT00317772|Hycamtin|hycamtin
5750569|NCT00317772|Gefitinib|gefitinib
5750980|NCT00316160|MDD|mdd
5751138|NCT00315705|AML|aml
5751177|NCT00315562|timing|timing
5751287|NCT00315081|Risperidone|risperidone
5751379|NCT00314795|CKD|ckd
5751492|NCT00314379|Diabetes|diabetes
5751590|NCT00314028|Condoms|condoms
5751715|NCT00313573|pain|pain
5751772|NCT00313339|bone marrow|bone marrow
5751984|NCT00312429|Lymphoma|lymphoma
5752188|NCT00311571|bedrest|bedrest
5752332|NCT00310973|HIV|hiv
5752510|NCT00310284|Sleep|sleep
5752576|NCT00310128|recurrent adult Burkitt's lymphoma|recurrent adult burkitt's lymphoma
5752647|NCT00309985|docetaxel|docetaxel
5752713|NCT00309751|pitavastatin|pitavastatin
5753221|NCT00307398|CNV|cnv
5753434|NCT00306605|stress|stress
5753625|NCT00305851|primary myelofibrosis|primary myelofibrosis
5753674|NCT00305851|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5753789|NCT00305643|Xeloda|xeloda
5753838|NCT00305448|oncology|oncology
5753936|NCT00305110|Severe|severe
5754135|NCT00304330|gram negative infection|gram negative infection
5754227|NCT00303992|stage IV breast cancer|stage iv breast cancer
5754281|NCT00303914|stage III colon cancer|stage iii colon cancer
5754305|NCT00303901|lung metastases|lung metastases
5754359|NCT00303784|hot flashes|hot flashes
5754557|NCT00303082|Probiotics|probiotics
5754753|NCT00302211|PAH|pah
5754760|NCT00302172|Cancer|cancer
5754900|NCT00301912|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5755046|NCT00301587|folate|folate
5755028|NCT00301652|vasculitis|vasculitis
5755127|NCT00301171|Wheezing|wheezing
5755222|NCT00300716|Memantine|memantine
5755322|NCT00300248|ARDS, Human|ards, human
5755418|NCT00299897|HIV|hiv
5755631|NCT00299312|MECP2 mutation|mecp2 mutation
5755741|NCT00298896|Lung|lung
5755822|NCT00298493|Sedation strategies|sedation strategies
5755931|NCT00298025|Antagon|antagon
5756140|NCT00297193|HSCT|hsct
5756348|NCT00296413|lamotrigine|lamotrigine
5756349|NCT00296413|oral contraceptive|oral contraceptive
5756441|NCT00296036|stage IIIC breast cancer|stage iiic breast cancer
5848273|NCT00035373|Radiation Therapy|radiation therapy
5848274|NCT00035373|CNS Tumor|cns tumor
5756714|NCT00295854|frequency|frequency
5756878|NCT00295308|Clonidine|clonidine
5756975|NCT00294814|CABG|cabg
5757104|NCT00294424|Health services|health services
5757105|NCT00294424|Social services|social services
5757310|NCT00293618|PONV|ponv
5757606|NCT00292994|Obesity|obesity
5862888|NCT00001469|Genotyping|genotyping
5757568|NCT00293228|ELISPOT|elispot
5757740|NCT00292266|Avonex®|avonex®
5757741|NCT00292266|interferon-beta-1a|interferon-beta-1a
5757841|NCT00291746|GERD|gerd
5758046|NCT00291018|Degenerative disc disease|degenerative disc disease
5758242|NCT00290641|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5710123|NCT00464373|Drug therapy|drug therapy
5758364|NCT00290550|NSCLC|nsclc
5758483|NCT00290225|yoga|yoga
5758584|NCT00289861|risperidone|risperidone
5758782|NCT00288860|mental health|mental health
5759253|NCT00286910|AQP-2|aqp-2
5759678|NCT00284869|TNF|tnf
5759845|NCT00284024|randomized controlled trial|randomized controlled trial
5760157|NCT00282815|stroke|stroke
5760256|NCT00282295|diptheria|diptheria
5776764|NCT00213083|HIV|hiv
5798871|NCT00110708|diarrhea|diarrhea
5798872|NCT00110708|constipation|constipation
5756111|NCT00297284|attention|attention
5751647|NCT00313716|anemia|anemia
5760726|NCT00281619|CellCept|cellcept
5760826|NCT00281034|SF-36|sf-36
5760923|NCT00280657|Acne papulopustulosa|acne papulopustulosa
5761131|NCT00279682|elderly|elderly
5761112|NCT00279708|Pulmonary Function|pulmonary function
5761115|NCT00279708|Biomarkers|biomarkers
5761207|NCT00279318|Environment|environment
5761304|NCT00278915|McCune-Albright Syndrome|mccune-albright syndrome
5863975|NCT00001148|Glioblastoma Multiforme|glioblastoma multiforme
5761487|NCT00278265|neutropenia|neutropenia
5763688|NCT00269490|Yoga Nidra|yoga nidra
5761632|NCT00277875|Aging|aging
5761716|NCT00277433|Genetics|genetics
5761754|NCT00277238|HCV|hcv
5761888|NCT00276718|childhood teratoma|childhood teratoma
5761950|NCT00276497|Impaired glucose tolerance|impaired glucose tolerance
5762115|NCT00275301|BPD|bpd
5762155|NCT00275158|Inulin clearance|inulin clearance
5779168|NCT00201474|organic brain disorders|organic brain disorders
5762403|NCT00274729|Obesity|obesity
5762458|NCT00274352|sarcoidosis|sarcoidosis
5762566|NCT00273702|Gambler|gambler
5762656|NCT00273325|Pneumococcal polysaccharide, 4|pneumococcal polysaccharide, 4
5762855|NCT00272454|cilostazol|cilostazol
5762954|NCT00271921|body fat distribution|body fat distribution
5763179|NCT00271076|CEA|cea
5763180|NCT00271076|CAS|cas
5763181|NCT00271076|IVUS|ivus
5763484|NCT00270075|epogen|epogen
5763590|NCT00269828|female|female
5763803|NCT00268853|lymphoma|lymphoma
5763895|NCT00268359|adult glioblastoma|adult glioblastoma
5764083|NCT00267813|FDG|fdg
5764178|NCT00267293|children|children
5764276|NCT00266877|Neratinib|neratinib
5764380|NCT00266396|THA|tha
5764470|NCT00266058|PK|pk
5764471|NCT00266058|HIV|hiv
5773750|NCT00228124|Bone loss|bone loss
5681028|NCT00575042|PBC|pbc
5764685|NCT00265525|Exercise Intervention|exercise intervention
5765083|NCT00263549|Allergy|allergy
5765183|NCT00263133|synaptic plasticity|synaptic plasticity
5782369|NCT00182845|Aricept|aricept
5765370|NCT00262093|preeclampsia|preeclampsia
5765475|NCT00261573|galantamine|galantamine
5765601|NCT00261001|HIV|hiv
5765775|NCT00260442|elderly|elderly
5765870|NCT00260130|energy balance|energy balance
5766076|NCT00259025|Renal failure, chronic|renal failure, chronic
5766177|NCT00258765|PSA|psa
5792853|NCT00132535|IPT|ipt
5766517|NCT00257478|Safety|safety
5766716|NCT00256620|Neurologic morbidity|neurologic morbidity
5766887|NCT00255749|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5766947|NCT00255749|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5769196|NCT00247728|PI-88|pi-88
5681044|NCT00574990|Quality Assurance, Health Care|quality assurance, health care
5767123|NCT00255671|radiation toxicity|radiation toxicity
5767198|NCT00255411|NES|nes
5767200|NCT00255411|HV|hv
5767301|NCT00254930|risperidone|risperidone
5767502|NCT00254033|Apathy|apathy
5762984|NCT00271804|MDS|mds
5767757|NCT00253396|warfarin|warfarin
5767793|NCT00253383|stage IV bladder cancer|stage iv bladder cancer
5767919|NCT00253045|HIV|hiv
5768089|NCT00252096|Rectum|rectum
5768188|NCT00251563|Cancer,Risk factors|cancer,risk factors
5768396|NCT00250679|COPD|copd
5768801|NCT00248911|Cognitive-affective behavioral learning|cognitive-affective behavioral learning
5768999|NCT00248469|Sexual behavior|sexual behavior
5769006|NCT00248469|HIV Seronegativity|hiv seronegativity
5769099|NCT00248144|Herpes labialis|herpes labialis
5769101|NCT00248118|Randomized|randomized
5769189|NCT00247754|Anxiety|anxiety
5769287|NCT00247507|Anemia|anemia
5769394|NCT00247130|Omeprazole|omeprazole
5769504|NCT00246792|Learning disabilities|learning disabilities
5769803|NCT00245336|surgery|surgery
5765282|NCT00262652|asthma|asthma
5770074|NCT00244842|Treatment Outcome|treatment outcome
5770069|NCT00244842|Female|female
5770167|NCT00244491|chronic illness|chronic illness
5770271|NCT00243932|CoQ10|coq10
5770363|NCT00243568|HIV Infections|hiv infections
5770368|NCT00243568|vicriviroc|vicriviroc
5770648|NCT00242424|infants|infants
5770538|NCT00242866|without aura|without aura
5770685|NCT00242242|HV|hv
5770757|NCT00241605|Metformin|metformin
5770861|NCT00241111|cancer|cancer
5771061|NCT00240071|Bevacizumab|bevacizumab
5771170|NCT00239317|male|male
5771254|NCT00238875|radiotherapy|radiotherapy
5771941|NCT00236691|seizures|seizures
5771808|NCT00237055|Colonoscopy|colonoscopy
5771948|NCT00236665|Obesity|obesity
5772014|NCT00236509|Classic Migraine|classic migraine
5772113|NCT00236249|Adult|adult
5772311|NCT00235183|bleeding|bleeding
5772627|NCT00233506|CLL|cll
5772721|NCT00233038|Pancreatic cancer|pancreatic cancer
5772816|NCT00232427|Fluid balance|fluid balance
5772910|NCT00231868|UPSC|upsc
5773117|NCT00231049|Vaccine|vaccine
5773220|NCT00230607|aGAL|agal
5773221|NCT00230607|rh aGAL|rh agal
5773382|NCT00229814|MRI|mri
5773541|NCT00229125|Rebound Effect|rebound effect
5773738|NCT00228189|Immunotherapy|immunotherapy
5774258|NCT00225537|hcv|hcv
5773913|NCT00227383|Diabetes|diabetes
5800874|NCT00104585|PD|pd
5774215|NCT00225680|coronary artery|coronary artery
5774216|NCT00225680|stent|stent
5774318|NCT00225316|addiction|addiction
5774517|NCT00224367|fracture|fracture
5774522|NCT00224354|B-CLL|b-cll
5774608|NCT00224003|Anemia|anemia
5775770|NCT00218673|HIV|hiv
5774705|NCT00223652|Clinical Trial|clinical trial
5774800|NCT00223171|Gleason Score > 7|gleason score > 7
5775002|NCT00222352|Troponin I|troponin i
5775296|NCT00221143|Pain|pain
5775391|NCT00220714|relapse|relapse
5775598|NCT00219531|brain-gut axis|brain-gut axis
5775599|NCT00219518|Defecography|defecography
5775675|NCT00219102|diabetes,|diabetes,
5775771|NCT00218673|injection drug use|injection drug use
5775946|NCT00217386|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5776198|NCT00216034|PSK|psk
5776247|NCT00215787|Nasal polyps|nasal polyps
5776769|NCT00213083|HSV|hsv
5776907|NCT00212329|T1D|t1d
5776935|NCT00212238|physical activity|physical activity
5777041|NCT00211835|TBI|tbi
5777236|NCT00211055|Hemoglobin|hemoglobin
5777331|NCT00210769|schizophrenia|schizophrenia
5777429|NCT00210522|Anticonvulsants|anticonvulsants
5777582|NCT00209729|S-1|s-1
5777620|NCT00209443|Aorto-iliac Stenosis|aorto-iliac stenosis
5777716|NCT00209209|Lymphoma, Mantle-Cell|lymphoma, mantle-cell
5777918|NCT00208156|PMD|pmd
5778015|NCT00207740|Asthma|asthma
5778113|NCT00207259|Cognitive Restructuring|cognitive restructuring
5778218|NCT00206570|PANSS|panss
5778219|NCT00206557|Schizophrenia|schizophrenia
5778324|NCT00206011|Condylar neck|condylar neck
5778425|NCT00205621|FDDNP|fddnp
5778640|NCT00204100|cycling|cycling
5778727|NCT00203736|Efficacy|efficacy
5778829|NCT00202904|atorvastatin|atorvastatin
5778926|NCT00202423|Spasticity|spasticity
5779034|NCT00202072|pulmonary exacerbation|pulmonary exacerbation
5779145|NCT00201591|Intensity|intensity
5779365|NCT00200434|Beta-Blocker|beta-blocker
5779373|NCT00200369|HIV|hiv
5779468|NCT00199901|Phase II|phase ii
5779492|NCT00199849|DNA|dna
5779566|NCT00199576|Intubation-extubation|intubation-extubation
5779663|NCT00199069|ALL|all
5779965|NCT00197704|Tanzania|tanzania
5780159|NCT00196664|Paroxetine|paroxetine
5780369|NCT00195637|HIBM|hibm
5780567|NCT00194493|Cancer|cancer
5780667|NCT00193921|High dose|high dose
5780864|NCT00192634|fixed dose combination|fixed dose combination
5780959|NCT00190476|weekly|weekly
5781160|NCT00189605|Leg Pain|leg pain
5781258|NCT00189150|Mycophenolate Mofetil|mycophenolate mofetil
5781491|NCT00187941|MMF|mmf
5781648|NCT00187239|Patient is medically stable.|patient is medically stable.
5781845|NCT00185250|Adenovirus|adenovirus
5782043|NCT00184145|EMDR|emdr
5782128|NCT00183612|Mental Health|mental health
5782235|NCT00183248|renal transplant|renal transplant
5782427|NCT00182624|Prostate Cancer|prostate cancer
5782529|NCT00182247|DVT|dvt
5782609|NCT00181987|bipolar disorder|bipolar disorder
5782718|NCT00181610|Lactation|lactation
5783150|NCT00179309|CEA|cea
5783435|NCT00177671|Depression|depression
5800591|NCT00105417|HIV|hiv
5783703|NCT00176436|Weight loss|weight loss
5783721|NCT00176345|exercise training|exercise training
5783825|NCT00175942|inflammation|inflammation
5783917|NCT00175552|IPT|ipt
5783929|NCT00175513|valtrex|valtrex
5784033|NCT00175045|reflux|reflux
5681100|NCT00574691|Angioplasty|angioplasty
5784601|NCT00171730|IGF-1|igf-1
5784694|NCT00171301|Deferasirox|deferasirox
5784864|NCT00170482|Fluzone|fluzone
5784949|NCT00169910|Calcineurin Inhibitor|calcineurin inhibitor
5785154|NCT00169117|Bednets|bednets
5785171|NCT00169052|older|older
5785402|NCT00167947|Kidney|kidney
5785557|NCT00167479|Double-Blind|double-blind
5785755|NCT00166647|Cancer|cancer
5785884|NCT00165919|HIV|hiv
5785959|NCT00165477|IMiD|imid
5786473|NCT00162916|Citalopram|citalopram
5786663|NCT00161369|homocysteine|homocysteine
5786737|NCT00161187|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5786805|NCT00161187|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5782008|NCT00184288|Lipid|lipid
5786946|NCT00161135|MRI|mri
5787042|NCT00160680|ICAM-1|icam-1
5787227|NCT00159588|randomized|randomized
5787624|NCT00157729|Hypertension|hypertension
5787828|NCT00156637|intervention studies|intervention studies
5788302|NCT00154388|SCLC|sclc
5788383|NCT00154050|stent angioplasty|stent angioplasty
5788486|NCT00153634|Biofilms|biofilms
5788487|NCT00153621|Pediatrics|pediatrics
5788588|NCT00152945|triglycerides|triglycerides
5788594|NCT00152893|HIV|hiv
5788676|NCT00152360|Obesity|obesity
5788764|NCT00151814|Olmesartan PK in children|olmesartan pk in children
5788986|NCT00150722|HDL|hdl
5789217|NCT00149383|malaria|malaria
5789305|NCT00149058|primary angioplasty|primary angioplasty
5789404|NCT00148629|Anemia|anemia
5789619|NCT00147771|morphea|morphea
5789712|NCT00147290|ATP|atp
5790030|NCT00146094|Treatment Naive|treatment naive
5790136|NCT00145600|Lymphoma|lymphoma
5790331|NCT00144703|GVHD|gvhd
5790683|NCT00142350|S-1|s-1
5790823|NCT00141804|renal transplantation|renal transplantation
5791016|NCT00140556|radiotherapy|radiotherapy
5791119|NCT00140218|pramipexole|pramipexole
5791215|NCT00139451|Puberty|puberty
5791313|NCT00138983|rheumatic diseases|rheumatic diseases
5791407|NCT00138437|leprosy|leprosy
5791413|NCT00138372|malaria|malaria
5791499|NCT00138008|RCT|rct
5791572|NCT00137696|polio|polio
5791677|NCT00137345|Kidney transplantation|kidney transplantation
5791769|NCT00136864|Radiation Planning|radiation planning
5792077|NCT00135629|Hayfever|hayfever
5792269|NCT00134667|verteporfin|verteporfin
5792363|NCT00134186|Kidney cancer|kidney cancer
5792366|NCT00134160|Aged|aged
5792428|NCT00134017|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5846712|NCT00043667|IL-2 Receptor|il-2 receptor
5792637|NCT00133744|iron|iron
5792721|NCT00133224|Docetaxel|docetaxel
5787911|NCT00156221|MRI|mri
5792926|NCT00132327|Healthy Volunteer|healthy volunteer
5793016|NCT00132015|mantle cell lymphoma|mantle cell lymphoma
5793310|NCT00130910|HIV|hiv
5793316|NCT00130884|chronic heart failure|chronic heart failure
5793411|NCT00130429|Hopkins verbal learning test|hopkins verbal learning test
5793518|NCT00130091|hernia|hernia
5793619|NCT00129610|Agoraphobia|agoraphobia
5793634|NCT00129545|AF|af
5793823|NCT00129129|Safety|safety
5794029|NCT00128375|Smoking|smoking
5794127|NCT00127959|tenofovir|tenofovir
5794222|NCT00127517|Oncology|oncology
5794321|NCT00127231|HIV|hiv
5794406|NCT00126802|high risk prostate cancer|high risk prostate cancer
5681226|NCT00574249|Psoriasis|psoriasis
5795022|NCT00124514|Menopause|menopause
5795206|NCT00123708|Muscle Weakness|muscle weakness
5795398|NCT00122785|bronchiolitis|bronchiolitis
5795793|NCT00121446|fibrinolytic therapy|fibrinolytic therapy
5795873|NCT00121173|cervical cancer|cervical cancer
5796063|NCT00120575|Pediatrics|pediatrics
5796206|NCT00119977|RSA|rsa
5796270|NCT00119678|SLE|sle
5796371|NCT00119210|Zyban|zyban
5796470|NCT00118846|Women|women
5796658|NCT00118300|stage III vaginal cancer|stage iii vaginal cancer
5796737|NCT00117936|growth factor|growth factor
5796826|NCT00117663|health care setting|health care setting
5796922|NCT00117299|ZK 222584|zk 222584
5797122|NCT00116649|actinic keratosis|actinic keratosis
5797123|NCT00116636|HIV|hiv
5797222|NCT00116337|cervical spinal cord injury|cervical spinal cord injury
5797224|NCT00116324|Asthma|asthma
5797420|NCT00115648|HIV Seronegativity|hiv seronegativity
5797514|NCT00115284|Practice improvement|practice improvement
5797617|NCT00114959|ChemGenex Pharmaceuticals, Ltd|chemgenex pharmaceuticals, ltd
5797716|NCT00114699|HIV|hiv
5797806|NCT00114478|albuterol|albuterol
5797977|NCT00113932|Myeloma|myeloma
5798082|NCT00113477|Q10|q10
5798603|NCT00111657|Gout|gout
5798604|NCT00111657|Tophi|tophi
5798909|NCT00110604|Hearing|hearing
5799071|NCT00110045|primary myelofibrosis|primary myelofibrosis
5862620|NCT00001564|Tumor Vaccine|tumor vaccine
5799191|NCT00110045|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5799488|NCT00109512|endometriosis|endometriosis
5799588|NCT00109265|Cancer|cancer
5799717|NCT00108667|PD|pd
5799816|NCT00108316|DNA|dna
5799909|NCT00108056|Malignant|malignant
5800003|NCT00107705|allergoid|allergoid
5800086|NCT00107458|childhood grade II meningioma|childhood grade ii meningioma
5800156|NCT00107120|Depression|depression
5800292|NCT00106691|premalignant|premalignant
5800293|NCT00106691|precancerous|precancerous
5800394|NCT00106223|CBT|cbt
5800585|NCT00105430|Pediatric|pediatric
5800685|NCT00105040|Partial onset seizures|partial onset seizures
5800922|NCT00104455|rFVIIa|rfviia
5801131|NCT00103545|immune response|immune response
5801156|NCT00103415|Job|job
5801322|NCT00102700|solid tumor|solid tumor
5801434|NCT00102401|Pulmonary Disease, chronic obstructive|pulmonary disease, chronic obstructive
5801537|NCT00102011|colon cancer|colon cancer
5801721|NCT00101426|Diabetic Neuropathy|diabetic neuropathy
5801860|NCT00100789|lip|lip
5801872|NCT00100724|Anthrax|anthrax
5802069|NCT00100139|Taxol|taxol
5802070|NCT00100139|Paclitaxel|paclitaxel
5802169|NCT00099710|Curcumin|curcumin
5802484|NCT00098566|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5802600|NCT00098072|PPH|pph
5802670|NCT00097786|Prevention|prevention
5802770|NCT00097396|vaccine|vaccine
5802870|NCT00097149|Latin America|latin america
5802994|NCT00096707|cancer|cancer
5803068|NCT00096382|stage IV melanoma|stage iv melanoma
5803330|NCT00095706|Bevacizumab|bevacizumab
5803726|NCT00093951|memory|memory
5803727|NCT00093951|cognition|cognition
5803735|NCT00093873|Cancer|cancer
5803807|NCT00093678|intraocular lymphoma|intraocular lymphoma
5804109|NCT00091936|TB|tb
5804153|NCT00091741|HIV|hiv
5804209|NCT00091624|Revlimid|revlimid
5804293|NCT00091442|DOXIL|doxil
5804339|NCT00004036|polycythemia vera|polycythemia vera
5799975|NCT00107809|CPAP|cpap
5804473|NCT00003451|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5804534|NCT00003441|MGI-114|mgi-114
5804644|NCT00091533|Bimodal Neurons|bimodal neurons
5846874|NCT00042536|ED|ed
5804819|NCT00090727|head and neck cancer|head and neck cancer
5804896|NCT00002980|polycythemia vera|polycythemia vera
5805224|NCT00090428|Autism|autism
5805087|NCT00002767|stage IV melanoma|stage iv melanoma
5805170|NCT00004029|stage IV prostate cancer|stage iv prostate cancer
5805242|NCT00004009|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5846876|NCT00042536|HV|hv
5796778|NCT00117806|Adult|adult
5805381|NCT00090194|Kidney Transplantation|kidney transplantation
5805487|NCT00003406|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5805557|NCT00002888|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5805632|NCT00002510|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5805850|NCT00003380|Brenner tumor|brenner tumor
5805921|NCT00003294|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5806130|NCT00002749|recurrent adult brain tumor|recurrent adult brain tumor
5806187|NCT00005626|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5806247|NCT00002507|stage I lymphoepithelioma of the nasopharynx|stage i lymphoepithelioma of the nasopharynx
5806272|NCT00089622|Lisuride Patch|lisuride patch
5806337|NCT00004215|anemia|anemia
5806440|NCT00089219|iris melanoma|iris melanoma
5860588|NCT00004729|ketogenic|ketogenic
5798468|NCT00112229|CpG|cpg
5860589|NCT00004729|diet|diet
5806662|NCT00089037|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5806806|NCT00004040|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5806872|NCT00003681|refractory anemia|refractory anemia
5807012|NCT00088699|Glutamatergic System|glutamatergic system
5807116|NCT00088569|Frontal Lobe|frontal lobe
5807167|NCT00002832|Decitabine|decitabine
5807236|NCT00002665|neutropenia|neutropenia
5807332|NCT00088374|VHL|vhl
5807417|NCT00005852|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5808025|NCT00087984|Kidney cancer|kidney cancer
5807563|NCT00005805|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5807604|NCT00004901|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5808021|NCT00003225|stage IV rectal cancer|stage iv rectal cancer
5800013|NCT00107679|HIV|hiv
5820434|NCT00077896|Treatment|treatment
5807996|NCT00003391|stage IV prostate cancer|stage iv prostate cancer
5808182|NCT00003057|diarrhea|diarrhea
5808207|NCT00002956|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5846484|NCT00044291|Locally recurrent breast cancer|locally recurrent breast cancer
5808460|NCT00003874|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5829074|NCT00060528|Immunotherapy|immunotherapy
5808576|NCT00003805|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5808636|NCT00003664|recurrent renal cell cancer|recurrent renal cell cancer
5808648|NCT00003639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5808718|NCT00087425|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5808785|NCT00087113|stage III cervical cancer|stage iii cervical cancer
5808864|NCT00086606|Peanut|peanut
5808939|NCT00002863|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5809099|NCT00086138|Depression|depression
5809101|NCT00086112|Anxiety|anxiety
5809305|NCT00002725|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5809440|NCT00085995|Syndesmophyte|syndesmophyte
5809519|NCT00005968|stage IV melanoma|stage iv melanoma
5863755|NCT00001195|Hormones|hormones
5809650|NCT00085917|Pegasys|pegasys
5829747|NCT00059579|Depression|depression
5809869|NCT00085657|Cortical Reorganization|cortical reorganization
5810007|NCT00084838|childhood atypical teratoid/rhabdoid tumor|childhood atypical teratoid/rhabdoid tumor
5810076|NCT00084669|stage IIIC breast cancer|stage iiic breast cancer
5810452|NCT00005641|primary myelofibrosis|primary myelofibrosis
5823143|NCT00071760|ritonavir|ritonavir
5810350|NCT00003992|stage IIIA breast cancer|stage iiia breast cancer
5681307|NCT00573872|Phase II|phase ii
5681324|NCT00573820|Prostate Neoplasms|prostate neoplasms
5810564|NCT00004070|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5810781|NCT00083681|G-CSF|g-csf
5810849|NCT00083538|Multiple Myeloma|multiple myeloma
5811423|NCT00083382|Bisphosphonate|bisphosphonate
5810992|NCT00006083|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5811203|NCT00004112|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5811205|NCT00004112|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5811285|NCT00004061|oral complications|oral complications
5811328|NCT00004061|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5811388|NCT00003846|stage 4S neuroblastoma|stage 4s neuroblastoma
5811467|NCT00003269|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5811561|NCT00003195|refractory multiple myeloma|refractory multiple myeloma
5818884|NCT00078611|IBD|ibd
5811711|NCT00002567|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5846495|NCT00044304|Biologicals|biologicals
5811844|NCT00003322|Brenner tumor|brenner tumor
5808449|NCT00087763|AMD|amd
5812031|NCT00083330|Healthy|healthy
5812106|NCT00004156|stage I breast cancer|stage i breast cancer
5846500|NCT00044304|HES|hes
5812282|NCT00003685|quality of life|quality of life
5812371|NCT00083213|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5812575|NCT00082654|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5812676|NCT00083265|HV|hv
5812738|NCT00083044|breast cancer|breast cancer
5812790|NCT00002892|stage II melanoma|stage ii melanoma
5812791|NCT00002892|stage III melanoma|stage iii melanoma
5812887|NCT00082355|Deep Vein Thrombosis|deep vein thrombosis
5812888|NCT00082355|DVT|dvt
5812974|NCT00008099|stage I pancreatic cancer|stage i pancreatic cancer
5813441|NCT00003554|stage II multiple myeloma|stage ii multiple myeloma
5813137|NCT00005081|adult mixed glioma|adult mixed glioma
5864514|NCT00000372|Human|human
5813291|NCT00004230|ovarian yolk sac tumor|ovarian yolk sac tumor
5813507|NCT00003239|Roferon-A|roferon-a
5813428|NCT00082095|Capecitabine|capecitabine
5813718|NCT00081965|stage IV breast cancer|stage iv breast cancer
5813935|NCT00003887|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5816157|NCT00080782|Adriamycin|adriamycin
5814248|NCT00003270|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5814323|NCT00005842|recurrent colon cancer|recurrent colon cancer
5814469|NCT00002553|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5862655|NCT00001549|Alzheimer's|alzheimer's
5814792|NCT00081848|Liver Metastasis|liver metastasis
5814793|NCT00081835|Smallpox|smallpox
5814794|NCT00081835|Cowpox|cowpox
5844017|NCT00051142|Glaucoma|glaucoma
5814934|NCT00019344|small intestine lymphoma|small intestine lymphoma
5814935|NCT00019344|stage IV prostate cancer|stage iv prostate cancer
5815007|NCT00005989|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5815011|NCT00005958|stage IV bladder cancer|stage iv bladder cancer
5815084|NCT00004178|stage III esophageal cancer|stage iii esophageal cancer
5815156|NCT00081497|alpha-galactosidase A|alpha-galactosidase a
5815383|NCT00003718|ovarian sarcoma|ovarian sarcoma
5815441|NCT00003010|recurrent breast cancer|recurrent breast cancer
5815442|NCT00021398|stage II rectal cancer|stage ii rectal cancer
5815522|NCT00014391|testicular embryonal carcinoma|testicular embryonal carcinoma
5815572|NCT00014391|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5819009|NCT00078715|Mood Disorder|mood disorder
5815776|NCT00081432|Language|language
5815840|NCT00004860|stage IV rectal cancer|stage iv rectal cancer
5815954|NCT00003232|quality of life|quality of life
5816150|NCT00080782|Sr-89|sr-89
5816402|NCT00003103|stage III colon cancer|stage iii colon cancer
5816432|NCT00003103|recurrent prostate cancer|recurrent prostate cancer
5816485|NCT00003103|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5830134|NCT00059046|HV|hv
5816627|NCT00014573|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5816843|NCT00005860|liver metastases|liver metastases
5821187|NCT00076505|HV|hv
5817047|NCT00003657|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5817124|NCT00003657|ovarian sarcoma|ovarian sarcoma
5817405|NCT00006348|polycythemia vera|polycythemia vera
5817457|NCT00006348|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5846513|NCT00044252|Epilepsy|epilepsy
5817566|NCT00006030|stage I breast cancer|stage i breast cancer
5817639|NCT00003693|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5817721|NCT00079911|HSV|hsv
5817787|NCT00020865|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5817890|NCT00014300|adult gliosarcoma|adult gliosarcoma
5817912|NCT00006098|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5817987|NCT00005085|stage IV colon cancer|stage iv colon cancer
5818000|NCT00004909|quality of life|quality of life
5818051|NCT00003959|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5818135|NCT00079638|Dyslipidemia|dyslipidemia
5844346|NCT00004557|Attention|attention
5818387|NCT00003014|testicular seminoma|testicular seminoma
5818472|NCT00079508|HIT/HITTS|hit/hitts
5818552|NCT00079560|HIV|hiv
5818604|NCT00079313|Glivec|glivec
5818673|NCT00079222|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5818732|NCT00079222|stage IIIB breast cancer|stage iiib breast cancer
5818900|NCT00006452|adult glioblastoma|adult glioblastoma
5819035|NCT00005946|refractory multiple myeloma|refractory multiple myeloma
5819254|NCT00004235|stage IV gastric cancer|stage iv gastric cancer
5819406|NCT00025012|melanoma|melanoma
5819493|NCT00078442|Treatment Naive|treatment naive
5824093|NCT00069654|Exercise|exercise
5819866|NCT00003548|stage IVA vaginal cancer|stage iva vaginal cancer
5820106|NCT00017199|insulinoma|insulinoma
5820228|NCT00004145|stage I multiple myeloma|stage i multiple myeloma
5820291|NCT00004114|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5820417|NCT00077922|LMB-2|lmb-2
5820585|NCT00004157|stage IV breast cancer|stage iv breast cancer
5820683|NCT00077584|Scleroderma|scleroderma
5820768|NCT00077012|BPH|bph
5820872|NCT00024362|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5820948|NCT00021385|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5820949|NCT00021385|ovarian sarcoma|ovarian sarcoma
5821049|NCT00076635|Idiopathic|idiopathic
5821186|NCT00076505|Healthy Volunteer|healthy volunteer
5821184|NCT00076505|Heredity|heredity
5821193|NCT00076401|CLL|cll
5821282|NCT00076310|CDDP|cddp
5821389|NCT00075959|CVA|cva
5821447|NCT00075907|Acute Infection|acute infection
5821527|NCT00075569|cervical cancer|cervical cancer
5821726|NCT00074997|OZ1|oz1
5821889|NCT00074568|Genetic Study|genetic study
5821961|NCT00074542|Crohn's|crohn's
5822040|NCT00074386|Transplant|transplant
5822120|NCT00074009|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5822202|NCT00073944|adult gliosarcoma|adult gliosarcoma
5822369|NCT00073749|B-Cell|b-cell
5822436|NCT00003414|graft versus host disease|graft versus host disease
5823419|NCT00071344|Lung Cancer|lung cancer
5818875|NCT00078793|JRA|jra
5822638|NCT00027521|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5822754|NCT00072956|Torticollis|torticollis
5822852|NCT00072657|Tai Chi|tai chi
5822927|NCT00072319|stage IIIB breast cancer|stage iiib breast cancer
5822930|NCT00072293|stage IA breast cancer|stage ia breast cancer
5822998|NCT00072007|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5823170|NCT00071734|fMRI|fmri
5823176|NCT00071734|HV|hv
5823263|NCT00025350|stage IV rectal cancer|stage iv rectal cancer
5823416|NCT00071344|Brain|brain
5823467|NCT00070720|Behavior change|behavior change
5823484|NCT00071058|ACC|acc
5823587|NCT00006121|stage III breast cancer|stage iii breast cancer
5823703|NCT00070382|anemia|anemia
5823750|NCT00070382|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5823812|NCT00070200|stage 4S neuroblastoma|stage 4s neuroblastoma
5823877|NCT00070096|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5710213|NCT00464178|myeloma protein WIE|myeloma protein wie
5823943|NCT00069953|stage II esophageal cancer|stage ii esophageal cancer
5824032|NCT00069732|Qigong|qigong
5824260|NCT00069329|NOMID|nomid
5824422|NCT00069082|EC|ec
5846652|NCT00043849|Psychosis|psychosis
5824664|NCT00068224|Kidney|kidney
5824731|NCT00068068|Tumor ablation|tumor ablation
5824810|NCT00008359|essential thrombocythemia|essential thrombocythemia
5824889|NCT00008359|infection|infection
5845621|NCT00050245|B Cells|b cells
5825043|NCT00067808|MDS|mds
5825349|NCT00067028|Idarubicin|idarubicin
5825484|NCT00002520|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5825543|NCT00002520|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5825613|NCT00066859|depression|depression
5826133|NCT00065741|zidovudine|zidovudine
5681386|NCT00573560|apical remodeling|apical remodeling
5681389|NCT00573560|dyskinesis|dyskinesis
5826095|NCT00031707|anorexia|anorexia
5826212|NCT00014209|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5826312|NCT00065442|AIPC|aipc
5826644|NCT00064623|Diary|diary
5830707|NCT00056940|Discipline|discipline
5826900|NCT00063804|AMD11070|amd11070
5826919|NCT00042900|primary myelofibrosis|primary myelofibrosis
5827064|NCT00063765|NT-501|nt-501
5827141|NCT00063427|Colorectal Cancer|colorectal cancer
5827231|NCT00026351|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5827315|NCT00063011|Weight-bearing exercise|weight-bearing exercise
5827405|NCT00023868|liver metastases|liver metastases
5848865|NCT00032838|HV|hv
5827485|NCT00062556|Atherosclerosis|atherosclerosis
5827489|NCT00062556|IC|ic
5827621|NCT00062387|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5827736|NCT00062231|neutropenia|neutropenia
5681426|NCT00573417|Metabolic Syndrome|metabolic syndrome
5827884|NCT00062166|Imaging Studies|imaging studies
5863173|NCT00001362|Blood Flow|blood flow
5863174|NCT00001362|Blood Volume|blood volume
5681439|NCT00573352|Osteoarthrosis|osteoarthrosis
5828150|NCT00061607|SMA|sma
5828242|NCT00061321|Breastfeeding|breastfeeding
5828468|NCT00061152|Capsaicin|capsaicin
5828753|NCT00060619|Migraine|migraine
5828839|NCT00004895|nausea and vomiting|nausea and vomiting
5828959|NCT00004232|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5829017|NCT00004232|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5829019|NCT00004232|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5829101|NCT00060385|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5829184|NCT00060138|stage IV breast cancer|stage iv breast cancer
5829236|NCT00060021|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5829346|NCT00059878|infection|infection
5846662|NCT00043823|Bevacizumab|bevacizumab
5829671|NCT00059631|Prostate Cancer|prostate cancer
5829762|NCT00059540|Opiate dependence|opiate dependence
5829763|NCT00059540|Follow-up|follow-up
5829766|NCT00059527|Physical Activity|physical activity
5829890|NCT00059358|HIV|hiv
5829917|NCT00058981|Diabetes|diabetes
5829989|NCT00059189|Occipital Cortex|occipital cortex
5830113|NCT00003162|pain|pain
5830120|NCT00003124|stage IIA prostate cancer|stage iia prostate cancer
5830141|NCT00059033|CAF|caf
5830774|NCT00056849|Disability|disability
5830551|NCT00057616|CC5013|cc5013
5846685|NCT00043745|isoflavones|isoflavones
5830432|NCT00058058|MRI|mri
5830509|NCT00057837|Topotecan|topotecan
5830749|NCT00056888|EEG|eeg
5830765|NCT00056862|Ribavirin|ribavirin
5830978|NCT00056199|VHL|vhl
5831052|NCT00055848|stage III colon cancer|stage iii colon cancer
5831126|NCT00055653|acute undifferentiated leukemia|acute undifferentiated leukemia
5831390|NCT00054821|Ankle Distraction|ankle distraction
5846992|NCT00042016|STI 571|sti 571
5831622|NCT00054236|polycythemia vera|polycythemia vera
5831772|NCT00053846|dyspnea|dyspnea
5831850|NCT00053742|Smallpox|smallpox
5831901|NCT00053443|Treatment Experienced|treatment experienced
5832027|NCT00053157|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5846667|NCT00043823|Erlotinib Hydrocholoride|erlotinib hydrocholoride
5846668|NCT00043810|AML|aml
5832282|NCT00052611|hypopharyngeal cancer|hypopharyngeal cancer
5846670|NCT00043810|Gelonin|gelonin
5832420|NCT00049712|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832488|NCT00049699|small intestine lymphoma|small intestine lymphoma
5832546|NCT00049608|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5832614|NCT00049465|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5847675|NCT00038558|Velban|velban
5846419|NCT00044538|Taxane|taxane
5832821|NCT00049296|recurrent colon cancer|recurrent colon cancer
5832817|NCT00049296|recurrent anal cancer|recurrent anal cancer
5832875|NCT00049296|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5832998|NCT00049023|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5846676|NCT00043797|Diabetic complications|diabetic complications
5845891|NCT00048477|Exercise|exercise
5833255|NCT00046904|anorexia|anorexia
5847364|NCT00039845|Pediatrics|pediatrics
5833498|NCT00045266|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5846743|NCT00043615|Angiogenesis|angiogenesis
5833633|NCT00045006|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5833682|NCT00044993|stage IIIB breast cancer|stage iiib breast cancer
5833749|NCT00043017|stage IIIA breast cancer|stage iiia breast cancer
5833771|NCT00042848|fatigue|fatigue
5847366|NCT00039845|Development|development
5834145|NCT00039052|stage IV breast cancer|stage iv breast cancer
5847367|NCT00039845|fMRI|fmri
5834335|NCT00036790|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5681514|NCT00573053|sighs|sighs
5834506|NCT00033345|breast cancer|breast cancer
5834535|NCT00032162|fallopian tube cancer|fallopian tube cancer
5834676|NCT00031850|breast cancer|breast cancer
5834751|NCT00031564|stage IV|stage iv
5834820|NCT00030706|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5834824|NCT00030680|desmoid tumor|desmoid tumor
5697782|NCT00508612|Relaxation|relaxation
5848208|NCT00035802|Mania|mania
5835063|NCT00028665|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5681561|NCT00572819|Hysteroscopy|hysteroscopy
5835391|NCT00026156|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5681575|NCT00572741|Autism|autism
5835527|NCT00025194|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5850090|NCT00026715|Iothalamate|iothalamate
5681583|NCT00572702|Pelvic Floor|pelvic floor
5835811|NCT00023790|skin metastases|skin metastases
5835873|NCT00022646|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5835944|NCT00022152|stage IV breast cancer|stage iv breast cancer
5836032|NCT00021047|stage IV gastric cancer|stage iv gastric cancer
5836062|NCT00021047|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5836122|NCT00020735|stage I prostate cancer|stage i prostate cancer
5836187|NCT00020579|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5847584|NCT00038779|ALL|all
5836315|NCT00020579|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5836375|NCT00020527|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5847585|NCT00038779|MDS|mds
5681631|NCT00572494|Stents|stents
5836579|NCT00019656|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5681656|NCT00572416|activity-rest|activity-rest
5836690|NCT00019331|recurrent small cell lung cancer|recurrent small cell lung cancer
5846687|NCT00043745|bone loss|bone loss
5681678|NCT00572286|echocardiogram|echocardiogram
5681693|NCT00572195|NeuroPace|neuropace
5681741|NCT00572039|AMD|amd
5837223|NCT00016263|stage III melanoma|stage iii melanoma
5681869|NCT00571441|stroke|stroke
5837370|NCT00014482|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5837412|NCT00014469|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5862698|NCT00001544|Mental Retardation|mental retardation
5837473|NCT00014456|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5837540|NCT00014274|stage IV bladder cancer|stage iv bladder cancer
5837669|NCT00011960|stage II esophageal cancer|stage ii esophageal cancer
5837837|NCT00009854|adult glioblastoma|adult glioblastoma
5837875|NCT00008346|breast cancer|breast cancer
5837936|NCT00008307|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5838022|NCT00008294|stage IV colon cancer|stage iv colon cancer
5838056|NCT00008216|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5838173|NCT00008164|stage I multiple myeloma|stage i multiple myeloma
5838236|NCT00008164|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5838370|NCT00006981|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5838403|NCT00006981|Brenner tumor|brenner tumor
5761272|NCT00279071|acupuncture|acupuncture
5799665|NCT00108901|obesity|obesity
5839014|NCT00006120|stage IV breast cancer|stage iv breast cancer
5710214|NCT00464178|myeloma-associated membrane antigen KMA|myeloma-associated membrane antigen kma
5710791|NCT00462189|HA22|ha22
5711713|NCT00458718|abstinence|abstinence
5711963|NCT00457834|RVapex|rvapex
5712206|NCT00456833|RAD|rad
5712261|NCT00456547|Coagulation|coagulation
5712365|NCT00456105|Type 2 diabetes|type 2 diabetes
5712583|NCT00455221|CML|cml
5836709|NCT00019331|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5836948|NCT00017602|refractory multiple myeloma|refractory multiple myeloma
5848326|NCT00035165|intravenous|intravenous
5830776|NCT00056849|AS|as
5712767|NCT00454480|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5848118|NCT00036413|(ALS)|(als)
5713133|NCT00453336|oral leukoplakia|oral leukoplakia
5837281|NCT00015899|childhood craniopharyngioma|childhood craniopharyngioma
5839693|NCT00005807|stage IV breast cancer|stage iv breast cancer
5713193|NCT00453232|testicular embryonal carcinoma|testicular embryonal carcinoma
5713249|NCT00453206|refractory multiple myeloma|refractory multiple myeloma
5713470|NCT00452621|TBE|tbe
5713878|NCT00450866|male breast cancer|male breast cancer
5713954|NCT00450593|recurrent melanoma|recurrent melanoma
5837697|NCT00010257|thymoma|thymoma
5714136|NCT00449982|Genital warts|genital warts
5714329|NCT00449098|ologen|ologen
5848333|NCT00035126|intravenous|intravenous
5714407|NCT00448734|platinum drug|platinum drug
5714487|NCT00448513|catechin|catechin
5714615|NCT00448266|Breast cancer|breast cancer
5715159|NCT00446381|VEGF|vegf
5715253|NCT00446082|acromegaly|acromegaly
5715337|NCT00445965|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5715551|NCT00445952|infection|infection
5838402|NCT00006981|ovarian carcinosarcoma|ovarian carcinosarcoma
5840802|NCT00004066|ovarian sarcoma|ovarian sarcoma
5715613|NCT00445731|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5716464|NCT00020345|solid tumor|solid tumor
5716551|NCT00443326|Psoriasis|psoriasis
5716899|NCT00442780|early Parkinson's Disease|early parkinson's disease
5717103|NCT00442091|Compositae|compositae
5717322|NCT00441207|Cancer|cancer
5717554|NCT00440349|Corticosteroids|corticosteroids
5717761|NCT00439569|SMA|sma
5717860|NCT00439218|SMA|sma
5798819|NCT00110929|calcimimetic|calcimimetic
5718047|NCT00438724|therapy|therapy
5718420|NCT00437164|D2O|d2o
5846700|NCT00043680|Classic|classic
5718697|NCT00436358|Epidemiology|epidemiology
5718797|NCT00435903|smoking|smoking
5719095|NCT00434616|Gangrene|gangrene
5839633|NCT00005850|fatigue|fatigue
5846995|NCT00042016|BCR/ABL|bcr/abl
5720165|NCT00431054|Ovarian Cancer|ovarian cancer
5856333|NCT00000798|HIV-1|hiv-1
5862233|NCT00001666|TMS|tms
5720358|NCT00430365|Maintenance therapy|maintenance therapy
5720363|NCT00430313|ES|es
5720451|NCT00429962|Visudyne®|visudyne®
5720547|NCT00429572|Fludarabine|fludarabine
5720639|NCT00429312|Melanoma|melanoma
5720826|NCT00428675|fatigue|fatigue
5721498|NCT00426374|heart failure|heart failure
5840326|NCT00004917|anemia|anemia
5842695|NCT00003140|stage I breast cancer|stage i breast cancer
5721590|NCT00425984|Sexually transmitted infections|sexually transmitted infections
5721672|NCT00425789|post-deep peel|post-deep peel
5721830|NCT00425126|Delayed Graft Function|delayed graft function
5847813|NCT00038025|Lymphoma|lymphoma
5721831|NCT00425126|Kidney Transplantation|kidney transplantation
5721928|NCT00424515|Imatinib|imatinib
5722063|NCT00424203|depression|depression
5798822|NCT00110916|Osteoarthritis|osteoarthritis
5861654|NCT00001874|Imaging|imaging
5861866|NCT00001826|HIV|hiv
5844307|NCT00005570|Bleeding|bleeding
5842702|NCT00003138|filgrastim|filgrastim
5843922|NCT00051753|levofloxacin|levofloxacin
5862395|NCT00001625|Obesity|obesity
5843923|NCT00051753|amoxicillin|amoxicillin
5841542|NCT00003816|aplastic anemia|aplastic anemia
5843903|NCT00051857|MRI|mri
5859246|NCT00006494|HIV|hiv
5846702|NCT00043680|Neovascular|neovascular
5844143|NCT00050726|HIV|hiv
5722229|NCT00423826|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5844516|NCT00001840|MRI|mri
5722384|NCT00423540|cramp diary|cramp diary
5722568|NCT00422825|bioavailability|bioavailability
5844716|NCT00001705|Cancer|cancer
5853882|NCT00002052|Amoxicillin|amoxicillin
5722764|NCT00421993|Benzoyl Peroxide|benzoyl peroxide
5845244|NCT00001377|Linkage|linkage
5850193|NCT00025987|Lower|lower
5845447|NCT00001232|Depression|depression
5722765|NCT00421967|Postoperative pain|postoperative pain
5845546|NCT00001142|MRI|mri
5845703|NCT00050050|ADD|add
5739422|NCT00360009|globus pallidus interna|globus pallidus interna
5739627|NCT00359294|PharmaMar|pharmamar
5846056|NCT00047723|ALS|als
5724191|NCT00416611|Awareness|awareness
5846304|NCT00045994|aged|aged
5741115|NCT00354042|GW597901X|gw597901x
5861780|NCT00001849|PET|pet
5724433|NCT00415974|Adolescent|adolescent
5846865|NCT00042614|HV|hv
5848816|NCT00033176|dithiol|dithiol
5724785|NCT00414830|health technology assessment|health technology assessment
5849625|NCT00029042|Joints|joints
5847657|NCT00038610|Mesnex|mesnex
5847780|NCT00038142|Vincristine|vincristine
5843995|NCT00051259|MDD|mdd
5848135|NCT00036335|pain|pain
5848370|NCT00035061|Metastatic|metastatic
5848484|NCT00034606|Lung cancer|lung cancer
5844394|NCT00001944|Pgp|pgp
5848697|NCT00034021|placebo|placebo
5844570|NCT00001782|Language|language
5724846|NCT00414544|Dermal filler|dermal filler
5725141|NCT00413374|Prophylaxis|prophylaxis
5849282|NCT00030134|X-Linked|x-linked
5725738|NCT00411359|Symptomology|symptomology
5845217|NCT00001385|FDG|fdg
5850020|NCT00026832|PET|pet
5845864|NCT00048672|Gleevec|gleevec
5850360|NCT00024999|HV|hv
5726000|NCT00410657|stage IV breast cancer|stage iv breast cancer
5726101|NCT00410384|SLE|sle
5726357|NCT00409214|Glioblastoma multiforme|glioblastoma multiforme
5848331|NCT00035126|tumor|tumor
5726661|NCT00408031|NMDA receptor|nmda receptor
5726870|NCT00406861|ENL|enl
5727040|NCT00406003|safety|safety
5727152|NCT00405574|PSA|psa
5847306|NCT00040209|PD|pd
5727456|NCT00404352|Multiple Sclerosis|multiple sclerosis
5851694|NCT00004583|ABT 378|abt 378
5744776|NCT00340574|HV|hv
5728202|NCT00401700|influenza|influenza
5852093|NCT00002391|HIV-1|hiv-1
5728309|NCT00401167|memantine|memantine
5728592|NCT00400114|esophagus|esophagus
5728991|NCT00398385|large cell lung cancer|large cell lung cancer
5729165|NCT00397657|atherosclerosis|atherosclerosis
5730477|NCT00392769|EGFR|egfr
5730672|NCT00391924|Fatigue|fatigue
5730957|NCT00390780|HIV patients|hiv patients
5852999|NCT00002216|VX 478|vx 478
5853204|NCT00002184|Zidovudine|zidovudine
5853307|NCT00002169|Placebos|placebos
5849718|NCT00028210|Amputee|amputee
5731056|NCT00390416|Metastatic Gastroesophageal Adenocarcinoma|metastatic gastroesophageal adenocarcinoma
5731645|NCT00388180|fat|fat
5850490|NCT00023439|TB|tb
5731804|NCT00387738|Seasonal|seasonal
5850692|NCT00016718|Efavirenz|efavirenz
5854297|NCT00001118|Viral Load|viral load
5854394|NCT00001096|Adjuvants, Immunologic|adjuvants, immunologic
5731895|NCT00387439|Anal incontinence|anal incontinence
5732083|NCT00386802|Neutropenia|neutropenia
5732699|NCT00384241|Stress|stress
5732961|NCT00383071|HV|hv
5855621|NCT00000904|Risk-Taking|risk-taking
5855827|NCT00000882|HIV-1|hiv-1
5732990|NCT00382928|Medical Devices|medical devices
5733308|NCT00381849|Cystone|cystone
5733704|NCT00380094|NSTEMI|nstemi
5733909|NCT00379210|ERP|erp
5734006|NCT00378820|Children|children
5734007|NCT00378820|Whey|whey
5734301|NCT00378534|AML|aml
5734528|NCT00377689|ADL|adl
5734593|NCT00377390|Immunoglobulin|immunoglobulin
5844135|NCT00050765|ICD|icd
5734757|NCT00376922|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5734858|NCT00376909|breast cancer|breast cancer
5735560|NCT00374491|ACL|acl
5735795|NCT00373607|Adult|adult
5736055|NCT00372684|Plasmodium falciparum|plasmodium falciparum
5736210|NCT00372320|Dry mouth|dry mouth
5736799|NCT00369798|MDD|mdd
5736800|NCT00369798|Healthy Volunteer|healthy volunteer
5736895|NCT00369603|fMRI|fmri
5737414|NCT00367588|infection prevention|infection prevention
5857975|NCT00017823|Nausea|nausea
5737626|NCT00366444|Bunionectomy|bunionectomy
5737730|NCT00366028|Evidence-based Medicine|evidence-based medicine
5737910|NCT00365430|Prevention|prevention
5738042|NCT00365274|NHL|nhl
5854839|NCT00001028|Dapsone|dapsone
5858490|NCT00013546|Turners|turners
5846107|NCT00047476|fatigue|fatigue
5738047|NCT00365274|Cyclophosphamide|cyclophosphamide
5738245|NCT00364559|statins|statins
5738457|NCT00363636|relapsed|relapsed
5738548|NCT00363246|Elderly|elderly
5739421|NCT00360009|STN|stn
5739195|NCT00360932|facial lipoatrophy|facial lipoatrophy
5859723|NCT00006161|Varices|varices
5856036|NCT00000853|HIV-1|hiv-1
5847570|NCT00038805|ALL|all
5739607|NCT00359372|Heart Function|heart function
5848040|NCT00036582|HV|hv
5860548|NCT00004734|folic acid|folic acid
5740007|NCT00357890|beta cell preservation|beta cell preservation
5740646|NCT00355693|Reaction|reaction
5741040|NCT00354328|HCM|hcm
5741126|NCT00354016|vaccine|vaccine
5741853|NCT00351663|Factor Xa|factor xa
5742254|NCT00350025|advanced|advanced
5742330|NCT00349622|ALS|als
5861472|NCT00001926|Blind|blind
5742360|NCT00349466|KCS|kcs
5742438|NCT00349037|tolerability|tolerability
5857954|NCT00017927|MAS|mas
5858266|NCT00014963|benzene|benzene
5742724|NCT00347763|trachoma|trachoma
5863261|NCT00001343|TS|ts
5743289|NCT00345683|Humans|humans
5858823|NCT00010725|CVD|cvd
5859006|NCT00008476|Capsaicin|capsaicin
5864197|NCT00000405|Diet|diet
5743584|NCT00344422|Dexamethasone|dexamethasone
5744682|NCT00340834|FTY720|fty720
5745698|NCT00337233|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5746042|NCT00335725|FSH|fsh
5746149|NCT00335179|AK|ak
5746326|NCT00334516|MRI|mri
5746522|NCT00333840|CML|cml
5746792|NCT00332592|Infants|infants
5859989|NCT00005914|Genes|genes
5747306|NCT00330304|HIV|hiv
5865137|NCT00004332|acromegaly|acromegaly
5747602|NCT00329043|Sunitinib Malate|sunitinib malate
5747801|NCT00328250|CBT|cbt
5748765|NCT00324597|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5749276|NCT00322894|Risk factors|risk factors
5749374|NCT00322322|L-carnitine supplementation|l-carnitine supplementation
5749496|NCT00321867|graft|graft
5749698|NCT00321061|HV|hv
5749825|NCT00320632|MDD|mdd
5750084|NCT00319553|acellular pertussis|acellular pertussis
5750179|NCT00319189|Glucose|glucose
5750378|NCT00318253|vaginosis|vaginosis
5750480|NCT00317876|Fanconi anemia|fanconi anemia
5750836|NCT00316810|Campath 1H|campath 1h
5750936|NCT00316355|Anxiety|anxiety
5751030|NCT00316056|Learning|learning
5751548|NCT00314132|Japanese Encephalitis|japanese encephalitis
5751650|NCT00313716|rhEpo|rhepo
5751876|NCT00312832|HIV|hiv
5752043|NCT00312273|Humans|humans
5752249|NCT00311285|Ergonomics|ergonomics
5752459|NCT00310427|Anxiety|anxiety
5752466|NCT00310414|FHD|fhd
5752604|NCT00310115|gastric cancer|gastric cancer
5753179|NCT00307593|Infliximab/rituximab|infliximab/rituximab
5753182|NCT00307580|CVADS|cvads
5753482|NCT00306423|exercise|exercise
5753713|NCT00305851|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5754720|NCT00302302|Triglyceride|triglyceride
5755190|NCT00300807|Hepatitis C|hepatitis c
5755903|NCT00298207|high blood pressure|high blood pressure
5756224|NCT00296972|ribavirin|ribavirin
5756321|NCT00296517|depression|depression
5756921|NCT00295113|Cardiac output|cardiac output
5756617|NCT00295945|recurrent fallopian tube cancer|recurrent fallopian tube cancer
5757285|NCT00293748|Vascular Disease Risk|vascular disease risk
5757548|NCT00293319|recurrent neuroblastoma|recurrent neuroblastoma
5758021|NCT00291083|Ki-67|ki-67
5758488|NCT00290212|Menopause|menopause
5758356|NCT00290602|cytokines|cytokines
5758563|NCT00289952|Histone deacetylase Inhibitor|histone deacetylase inhibitor
5758564|NCT00289952|HIV Reservoirs|hiv reservoirs
5758853|NCT00288431|cancer|cancer
5758950|NCT00288002|stage II breast cancer|stage ii breast cancer
5759129|NCT00287482|Quality of Life|quality of life
5759619|NCT00285155|Persons|persons
5759550|NCT00285441|HIV|hiv
5759713|NCT00284622|Arthroscopy|arthroscopy
5759914|NCT00283829|Immunotherapy|immunotherapy
5760128|NCT00283010|memory|memory
5762047|NCT00275834|weight loss|weight loss
5760508|NCT00281827|adenocarcinoma of the lung|adenocarcinoma of the lung
5760689|NCT00281749|FRAILTY|frailty
5760812|NCT00281099|ICD|icd
5761083|NCT00279968|ICD|icd
5761486|NCT00278265|anemia|anemia
5761683|NCT00277615|Children|children
5762125|NCT00275275|Parkinson's|parkinson's
5762395|NCT00274742|anti-CD19|anti-cd19
5762427|NCT00274664|Dose-response|dose-response
5762732|NCT00272896|VIP|vip
5763142|NCT00271219|addiction|addiction
5763559|NCT00269945|Zidovudine|zidovudine
5764150|NCT00267436|adaptation|adaptation
5764456|NCT00266084|Cervix|cervix
5764532|NCT00265837|graft versus host disease|graft versus host disease
5765003|NCT00264095|Transfusion|transfusion
5764861|NCT00264654|Social|social
5765558|NCT00261248|Vaccine|vaccine
5766026|NCT00259389|DOT|dot
5766171|NCT00258791|ECT|ect
5766253|NCT00258453|weight changes|weight changes
5766369|NCT00258193|IBS|ibs
5766651|NCT00256919|CRP|crp
5767486|NCT00254111|hand|hand
5767416|NCT00254397|Lupron|lupron
5768016|NCT00252486|Bipolar|bipolar
5768111|NCT00252018|Flow mediated dilation|flow mediated dilation
5768420|NCT00250588|Asthma|asthma
5768630|NCT00249496|HIV|hiv
5768834|NCT00248781|Aging|aging
5769232|NCT00247611|HIV|hiv
5769411|NCT00247091|measles vaccine|measles vaccine
5769412|NCT00247091|children|children
5769518|NCT00246740|Doxycycline|doxycycline
5769709|NCT00245869|vascularization|vascularization
5769809|NCT00245310|liver cirrhosis|liver cirrhosis
5769939|NCT00245037|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5848603|NCT00034216|Cancer|cancer
5770269|NCT00243932|ALS|als
5770879|NCT00241020|Octreotide|octreotide
5771362|NCT00238407|stage III esophageal cancer|stage iii esophageal cancer
5772343|NCT00234975|HIV|hiv
5772357|NCT00234923|Kaletra|kaletra
5772456|NCT00234377|Schizophrenia|schizophrenia
5772746|NCT00232882|Hypertension|hypertension
5772940|NCT00231712|solid tumor|solid tumor
5773145|NCT00230984|Survival|survival
5773247|NCT00230490|Hepatitis B, Chronic|hepatitis b, chronic
5773352|NCT00229892|cardiac|cardiac
5773458|NCT00229476|EEG|eeg
5773765|NCT00228046|CD|cd
5773849|NCT00227682|refractory multiple myeloma|refractory multiple myeloma
5774089|NCT00226304|EBV|ebv
5774188|NCT00225862|RLS|rls
5774345|NCT00225251|Wellbutrin XL|wellbutrin xl
5774446|NCT00224653|Obesity.|obesity.
5775136|NCT00221767|open Study|open study
5775533|NCT00219908|MRI|mri
5775809|NCT00218309|opiate dependence|opiate dependence
5776574|NCT00213876|allelotyping|allelotyping
5777173|NCT00211211|Spine|spine
5777575|NCT00209768|sepsis|sepsis
5778689|NCT00203853|HAART|haart
5778786|NCT00203476|ezetimibe|ezetimibe
5778882|NCT00202683|Altitude|altitude
5778984|NCT00202228|HIV|hiv
5779201|NCT00201357|thalidomide|thalidomide
5779745|NCT00198718|HIV|hiv
5780027|NCT00197353|Sympathectomy|sympathectomy
5780221|NCT00196378|dyspareunia|dyspareunia
5781909|NCT00184847|acetylcholine|acetylcholine
5782833|NCT00180700|HIV|hiv
5783506|NCT00177294|Elderly|elderly
5783603|NCT00176826|T-cell depletion|t-cell depletion
5783698|NCT00176449|Nicotine Dependence|nicotine dependence
5783871|NCT00175760|pediatric|pediatric
5784464|NCT00172120|Osteoporosis|osteoporosis
5784567|NCT00171834|EPO|epo
5785423|NCT00167856|Effexor|effexor
5785928|NCT00165581|Stage I breast cancer|stage i breast cancer
5786131|NCT00164606|child maltreatment|child maltreatment
5786513|NCT00162734|HCV|hcv
5787006|NCT00160927|neuropathy|neuropathy
5786855|NCT00161187|stage I pancreatic cancer|stage i pancreatic cancer
5787115|NCT00160407|lipase|lipase
5787802|NCT00156715|Quetiapine|quetiapine
5788182|NCT00154960|multiplex PCR|multiplex pcr
5788559|NCT00153283|Antiepileptic drug|antiepileptic drug
5788738|NCT00152100|Transplantation|transplantation
5789230|NCT00149370|QALY|qaly
5790449|NCT00143793|atrial fibrillation|atrial fibrillation
5790634|NCT00142493|Amnesia|amnesia
5791212|NCT00139451|GH|gh
5791694|NCT00137280|Guidelines|guidelines
5791896|NCT00136409|myelofibrosis|myelofibrosis
5792090|NCT00135603|treatment.|treatment.
5792376|NCT00134134|Raptiva|raptiva
5792385|NCT00134056|bone metastases|bone metastases
5792474|NCT00134017|refractory multiple myeloma|refractory multiple myeloma
5792650|NCT00133692|INVEST|invest
5793456|NCT00130286|HIV|hiv
5793880|NCT00128908|salvage therapy|salvage therapy
5794307|NCT00127270|OAB|oab
5795094|NCT00124176|Asthma|asthma
5795279|NCT00123344|symptomatic bradycardia|symptomatic bradycardia
5795476|NCT00122512|DCF data collection forms|dcf data collection forms
5795498|NCT00122499|Tadalafil|tadalafil
5795879|NCT00121147|glaucoma|glaucoma
5796160|NCT00120198|NHL|nhl
5796337|NCT00119483|body composition|body composition
5796646|NCT00118313|stage II melanoma|stage ii melanoma
5796736|NCT00117936|FGF-1|fgf-1
5797094|NCT00116727|DMARD|dmard
5797543|NCT00115193|NHL|nhl
5797789|NCT00114517|hormone therapy|hormone therapy
5797941|NCT00114023|AK|ak
5798060|NCT00113620|pain|pain
5798158|NCT00113334|ABT-510|abt-510
5798329|NCT00112619|childhood grade I meningioma|childhood grade i meningioma
5799178|NCT00110045|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5799564|NCT00109304|VEE|vee
5799873|NCT00108134|sBCC|sbcc
5800069|NCT00107484|male breast cancer|male breast cancer
5800784|NCT00104871|papillary|papillary
5801362|NCT00102583|Dry Eye|dry eye
5801567|NCT00101972|vaginal adenocarcinoma|vaginal adenocarcinoma
5801654|NCT00101764|Macular Edema|macular edema
5801838|NCT00100919|HV|hv
5802003|NCT00100334|Alzheimer's Disease|alzheimer's disease
5802312|NCT00099242|Alzheimer's Disease|alzheimer's disease
5815188|NCT00004100|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5802443|NCT00098761|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5802603|NCT00098059|herpes simplex|herpes simplex
5803016|NCT00096629|stage IV renal cell cancer|stage iv renal cell cancer
5804047|NCT00092950|Biomarkers|biomarkers
5803475|NCT00094978|NSCLC|nsclc
5803669|NCT00094146|Obesity|obesity
5804064|NCT00092326|molar removal|molar removal
5804084|NCT00092235|cGVHD|cgvhd
5804642|NCT00091533|fMRI|fmri
5804929|NCT00002980|prolymphocytic leukemia|prolymphocytic leukemia
5805124|NCT00002631|stage II esophageal cancer|stage ii esophageal cancer
5805201|NCT00002471|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5805285|NCT00003778|ovarian sarcoma|ovarian sarcoma
5805745|NCT00089843|Eating Disorders|eating disorders
5805392|NCT00090129|Placebo|placebo
5805602|NCT00090025|Bile duct tumor|bile duct tumor
5827596|NCT00062465|RA|ra
5806164|NCT00089596|AML|aml
5806525|NCT00089141|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5806853|NCT00003786|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5807015|NCT00088686|Vanilloid|vanilloid
5807300|NCT00088452|epilepsy|epilepsy
5807569|NCT00005805|multiple myeloma|multiple myeloma
5807713|NCT00004263|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5807843|NCT00002504|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5807982|NCT00003675|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5808269|NCT00002763|stage III melanoma|stage iii melanoma
5808671|NCT00087685|RAD001|rad001
5808863|NCT00086632|front-line|front-line
5808949|NCT00086554|Intestinal Resection|intestinal resection
5809198|NCT00004192|neutropenia|neutropenia
5809378|NCT00002657|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5809438|NCT00002657|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5809592|NCT00004260|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5810514|NCT00083941|Requiring IL-2 treatment|requiring il-2 treatment
5810791|NCT00083668|PANSS|panss
5810891|NCT00083447|treatment|treatment
5812756|NCT00082628|Serostim®|serostim®
5811431|NCT00006344|limited stage small cell lung cancer|limited stage small cell lung cancer
5811559|NCT00003269|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5811625|NCT00003056|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5846494|NCT00044304|Hypereosinophilia|hypereosinophilia
5811763|NCT00002547|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5812013|NCT00002673|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5846498|NCT00044304|Eosinophils|eosinophils
5844008|NCT00051181|OHT|oht
5812423|NCT00082927|bone metastases|bone metastases
5864512|NCT00000372|Female|female
5813080|NCT00005988|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5813205|NCT00005021|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5813626|NCT00002977|Brenner tumor|brenner tumor
5813925|NCT00003887|ovarian choriocarcinoma|ovarian choriocarcinoma
5813987|NCT00003887|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5814205|NCT00003270|Burkitt lymphoma|burkitt lymphoma
5814309|NCT00005842|stage IV colon cancer|stage iv colon cancer
5814464|NCT00002553|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5814534|NCT00002485|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5814589|NCT00081809|Lymphocytic Lymphoma, Well Differentiated|lymphocytic lymphoma, well differentiated
5808033|NCT00087867|myeloma|myeloma
5814999|NCT00081536|Metastatic|metastatic
5815240|NCT00004084|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5844018|NCT00051142|POAG|poag
5816424|NCT00003103|stage IV Wilms tumor|stage iv wilms tumor
5816917|NCT00003883|stage IIIA breast cancer|stage iiia breast cancer
5817168|NCT00003192|stage IV gastric cancer|stage iv gastric cancer
5817513|NCT00006036|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5817654|NCT00079950|soft|soft
5817717|NCT00003274|stage II melanoma|stage ii melanoma
5846515|NCT00044252|HV|hv
5819014|NCT00078715|MDD|mdd
5817985|NCT00005635|stage IV breast cancer|stage iv breast cancer
5818129|NCT00079638|Niaspan|niaspan
5818743|NCT00079222|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5846517|NCT00044239|Tic Disorders|tic disorders
5846518|NCT00044239|Neurophyschological|neurophyschological
5819182|NCT00004904|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5819233|NCT00004898|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5819373|NCT00026429|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5819447|NCT00020618|pain|pain
5819494|NCT00078390|Lung cancer|lung cancer
5819861|NCT00003548|recurrent cervical cancer|recurrent cervical cancer
5819944|NCT00003425|ovarian sarcoma|ovarian sarcoma
5847583|NCT00038779|AML|aml
5820005|NCT00030602|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5820105|NCT00017199|gastrinoma|gastrinoma
5821711|NCT00075036|Transplantation|transplantation
5822435|NCT00003414|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5823420|NCT00071344|NSCLC|nsclc
5823100|NCT00071903|Cystine|cystine
5823213|NCT00071513|At-risk|at-risk
5823591|NCT00006012|radiation toxicity|radiation toxicity
5823630|NCT00070694|Refractory|refractory
5823698|NCT00070421|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5823998|NCT00070577|Healthy Volunteer|healthy volunteer
5824286|NCT00069225|Brain Activation|brain activation
5825295|NCT00067275|HV|hv
5825384|NCT00067002|Alkeran|alkeran
5825454|NCT00002520|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5826076|NCT00065897|Prenatal testing|prenatal testing
5826201|NCT00014560|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5826309|NCT00065455|RP|rp
5826532|NCT00064909|HV|hv
5826632|NCT00064714|Diabetes Mellitus|diabetes mellitus
5826905|NCT00063778|Gene Products, gag|gene products, gag
5827005|NCT00040820|stage III colon cancer|stage iii colon cancer
5827567|NCT00017316|stage IV melanoma|stage iv melanoma
5828080|NCT00061789|SPECT|spect
5828461|NCT00061204|Methodology|methodology
5828964|NCT00004232|graft versus host disease|graft versus host disease
5829018|NCT00004232|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5829111|NCT00060346|Rituximab|rituximab
5829187|NCT00060138|pain|pain
5829310|NCT00060008|neurofibromatosis type 1|neurofibromatosis type 1
5829759|NCT00059540|Cocaine abuse|cocaine abuse
5830129|NCT00059046|Neuroreceptors|neuroreceptors
5830298|NCT00002693|neutropenia|neutropenia
5830353|NCT00058435|fallopian tube cancer|fallopian tube cancer
5830740|NCT00056901|HV|hv
5830982|NCT00056186|Psychosocial|psychosocial
5847006|NCT00042003|BCR/ABL|bcr/abl
5831159|NCT00055588|Motor Practice|motor practice
5831386|NCT00054847|heart|heart
5847560|NCT00038818|MM|mm
5831739|NCT00053989|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5832023|NCT00053157|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5832194|NCT00053001|anemia|anemia
5847673|NCT00038558|DTIC-Dome|dtic-dome
5846671|NCT00043810|Purging|purging
5847674|NCT00038558|Vinblastine|vinblastine
5832677|NCT00049465|testicular teratoma|testicular teratoma
5832876|NCT00049296|stage IV anal cancer|stage iv anal cancer
5833063|NCT00047177|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5846235|NCT00046254|bisphosphonate|bisphosphonate
5833404|NCT00045292|disseminated neuroblastoma|disseminated neuroblastoma
5847365|NCT00039845|Mapping|mapping
5833681|NCT00044993|stage IIIA breast cancer|stage iiia breast cancer
5833759|NCT00042939|EGF-r|egf-r
5835400|NCT00026117|stage IV colon cancer|stage iv colon cancer
5834264|NCT00036829|pain|pain
5834637|NCT00031941|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5834714|NCT00031733|extraocular extension melanoma|extraocular extension melanoma
5846679|NCT00043693|Psychotic Disorders|psychotic disorders
5849046|NCT00031395|methylphenidate|methylphenidate
5835201|NCT00027911|adult synovial sarcoma|adult synovial sarcoma
5835428|NCT00025662|MDS|mds
5835534|NCT00025181|recurrent intraocular melanoma|recurrent intraocular melanoma
5835660|NCT00024258|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5835964|NCT00022074|anxiety disorder|anxiety disorder
5838503|NCT00006456|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838504|NCT00006456|lung metastases|lung metastases
5838505|NCT00006456|liver metastases|liver metastases
5838506|NCT00006455|stage I childhood anaplastic large cell lymphoma|stage i childhood anaplastic large cell lymphoma
5838507|NCT00006455|stage II childhood anaplastic large cell lymphoma|stage ii childhood anaplastic large cell lymphoma
5838508|NCT00006455|stage III childhood anaplastic large cell lymphoma|stage iii childhood anaplastic large cell lymphoma
5838509|NCT00006455|stage IV childhood anaplastic large cell lymphoma|stage iv childhood anaplastic large cell lymphoma
5838510|NCT00006455|recurrent childhood anaplastic large cell lymphoma|recurrent childhood anaplastic large cell lymphoma
5838511|NCT00006392|prostate cancer|prostate cancer
5838512|NCT00006391|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5838513|NCT00006391|fallopian tube cancer|fallopian tube cancer
5838514|NCT00006391|peritoneal cavity cancer|peritoneal cavity cancer
5838515|NCT00006390|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5838516|NCT00006390|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5838517|NCT00006390|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5838518|NCT00006390|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5838519|NCT00006390|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5838520|NCT00006386|adult glioblastoma|adult glioblastoma
5838521|NCT00006386|adult giant cell glioblastoma|adult giant cell glioblastoma
5838522|NCT00006386|adult gliosarcoma|adult gliosarcoma
5838523|NCT00006385|stage IV melanoma|stage iv melanoma
5838524|NCT00006385|recurrent melanoma|recurrent melanoma
5838525|NCT00006381|stage IV breast cancer|stage iv breast cancer
5838526|NCT00006381|recurrent breast cancer|recurrent breast cancer
5838527|NCT00006379|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5838528|NCT00006379|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838529|NCT00006379|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838530|NCT00006379|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5838531|NCT00006379|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5838532|NCT00006379|extramedullary plasmacytoma|extramedullary plasmacytoma
5838533|NCT00006379|refractory multiple myeloma|refractory multiple myeloma
5838534|NCT00006379|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5838535|NCT00006379|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5838536|NCT00006379|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5838537|NCT00006379|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5838538|NCT00006379|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5838539|NCT00006379|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5838540|NCT00006379|small intestine lymphoma|small intestine lymphoma
5838541|NCT00006379|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5838542|NCT00006379|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5838543|NCT00006379|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5838544|NCT00006379|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5838545|NCT00006379|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5838546|NCT00006379|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5838547|NCT00006379|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5838548|NCT00006379|polycythemia vera|polycythemia vera
5838549|NCT00006379|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5838550|NCT00006379|essential thrombocythemia|essential thrombocythemia
5838551|NCT00006379|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5838552|NCT00006379|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5838553|NCT00006379|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5838554|NCT00006379|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5838555|NCT00006379|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838556|NCT00006379|refractory anemia with excess blasts|refractory anemia with excess blasts
5838557|NCT00006379|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5838558|NCT00006379|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5838559|NCT00006379|acute undifferentiated leukemia|acute undifferentiated leukemia
5838560|NCT00006379|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838561|NCT00006379|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838562|NCT00006379|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838563|NCT00006379|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838564|NCT00006379|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838565|NCT00006379|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838566|NCT00006379|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838567|NCT00006379|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838568|NCT00006379|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838569|NCT00006379|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5838570|NCT00006379|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5838571|NCT00006379|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5838572|NCT00006379|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5838573|NCT00006379|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5838574|NCT00006379|prolymphocytic leukemia|prolymphocytic leukemia
5838575|NCT00006379|primary systemic amyloidosis|primary systemic amyloidosis
5838576|NCT00006379|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5838577|NCT00006379|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5838578|NCT00006379|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5838579|NCT00006379|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5838580|NCT00006379|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838581|NCT00006379|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5838582|NCT00006379|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5838583|NCT00006379|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5838584|NCT00006379|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5838585|NCT00006379|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5838586|NCT00006379|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5838587|NCT00006379|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5838588|NCT00006379|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5838589|NCT00006379|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5838590|NCT00006379|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5836263|NCT00020579|metastatic parathyroid cancer|metastatic parathyroid cancer
5838591|NCT00006379|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838592|NCT00006379|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838593|NCT00006379|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838594|NCT00006379|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838725|NCT00006340|stage II grade 1 follicular lymphoma|stage ii grade 1 follicular lymphoma
5838595|NCT00006379|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5838596|NCT00006379|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838597|NCT00006379|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5838598|NCT00006379|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5838599|NCT00006379|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5838600|NCT00006379|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5838601|NCT00006373|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5838602|NCT00006373|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5838603|NCT00006373|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838604|NCT00006373|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838605|NCT00006373|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838606|NCT00006373|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838607|NCT00006373|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838608|NCT00006373|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838609|NCT00006373|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838610|NCT00006373|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838611|NCT00006373|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838612|NCT00006373|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838613|NCT00006373|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838614|NCT00006373|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838615|NCT00006373|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838616|NCT00006373|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838617|NCT00006373|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838618|NCT00006372|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838619|NCT00006366|stage II rectal cancer|stage ii rectal cancer
5838620|NCT00006366|stage III rectal cancer|stage iii rectal cancer
5838621|NCT00006366|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5838622|NCT00006362|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5838623|NCT00006362|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5838624|NCT00006362|extramedullary plasmacytoma|extramedullary plasmacytoma
5838625|NCT00006362|refractory multiple myeloma|refractory multiple myeloma
5838626|NCT00006362|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5838627|NCT00006362|stage III multiple myeloma|stage iii multiple myeloma
5838628|NCT00006362|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5838629|NCT00006362|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5838630|NCT00006362|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838631|NCT00006362|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5838632|NCT00006362|untreated hairy cell leukemia|untreated hairy cell leukemia
5838633|NCT00006362|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5838634|NCT00006362|refractory hairy cell leukemia|refractory hairy cell leukemia
5838635|NCT00006362|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838636|NCT00006362|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838637|NCT00006362|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838638|NCT00006362|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838639|NCT00006362|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5838640|NCT00006362|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5838641|NCT00006362|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5838642|NCT00006362|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5838643|NCT00006362|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5838644|NCT00006362|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838645|NCT00006362|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838646|NCT00006362|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838647|NCT00006362|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838648|NCT00006362|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838649|NCT00006362|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838650|NCT00006362|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5836282|NCT00020579|anterior urethral cancer|anterior urethral cancer
5838651|NCT00006362|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838652|NCT00006362|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838653|NCT00006362|primary systemic amyloidosis|primary systemic amyloidosis
5838654|NCT00006362|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838655|NCT00006362|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838656|NCT00006362|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838657|NCT00006362|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838658|NCT00006362|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838659|NCT00006362|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838660|NCT00006362|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838661|NCT00006362|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838662|NCT00006362|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838663|NCT00006360|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5838664|NCT00006360|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5838665|NCT00006360|radiation toxicity|radiation toxicity
5838666|NCT00006359|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5838667|NCT00006359|stage I prostate cancer|stage i prostate cancer
5838668|NCT00006359|stage II prostate cancer|stage ii prostate cancer
5838669|NCT00006359|stage III prostate cancer|stage iii prostate cancer
5838670|NCT00006356|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5838671|NCT00006355|adult glioblastoma|adult glioblastoma
5838672|NCT00006355|adult giant cell glioblastoma|adult giant cell glioblastoma
5838673|NCT00006355|adult gliosarcoma|adult gliosarcoma
5838674|NCT00006354|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838675|NCT00006351|recurrent bladder cancer|recurrent bladder cancer
5838676|NCT00006351|stage IV bladder cancer|stage iv bladder cancer
5838677|NCT00006351|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5838678|NCT00006351|recurrent urethral cancer|recurrent urethral cancer
5838679|NCT00006351|anterior urethral cancer|anterior urethral cancer
5838680|NCT00006351|posterior urethral cancer|posterior urethral cancer
5838681|NCT00006351|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5838682|NCT00006351|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5838683|NCT00006351|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5838684|NCT00006347|recurrent small cell lung cancer|recurrent small cell lung cancer
5838685|NCT00006340|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5838686|NCT00006340|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5838687|NCT00006340|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5838688|NCT00006340|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5838689|NCT00006340|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838690|NCT00006340|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5838691|NCT00006340|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5838692|NCT00006340|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5838693|NCT00006340|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5838694|NCT00006340|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5838695|NCT00006340|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5838696|NCT00006340|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5838697|NCT00006340|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5838698|NCT00006340|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5838699|NCT00006340|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5838700|NCT00006340|small intestine lymphoma|small intestine lymphoma
5838701|NCT00006340|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5838702|NCT00006340|grade I lymphomatoid granulomatosis|grade i lymphomatoid granulomatosis
5838703|NCT00006340|grade II lymphomatoid granulomatosis|grade ii lymphomatoid granulomatosis
5838704|NCT00006340|adult grade III lymphomatoid granulomatosis|adult grade iii lymphomatoid granulomatosis
5838705|NCT00006340|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5838706|NCT00006340|childhood grade III lymphomatoid granulomatosis|childhood grade iii lymphomatoid granulomatosis
5838707|NCT00006340|recurrent childhood grade III lymphomatoid granulomatosis|recurrent childhood grade iii lymphomatoid granulomatosis
5838708|NCT00006340|recurrent grade I lymphomatoid granulomatosis|recurrent grade i lymphomatoid granulomatosis
5838709|NCT00006340|recurrent grade II lymphomatoid granulomatosis|recurrent grade ii lymphomatoid granulomatosis
5838710|NCT00006340|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5838711|NCT00006340|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5838712|NCT00006340|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5838713|NCT00006340|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5838714|NCT00006340|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838715|NCT00006340|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5838716|NCT00006340|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5838717|NCT00006340|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5838718|NCT00006340|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5838719|NCT00006340|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5838720|NCT00006340|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5838721|NCT00006340|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5838722|NCT00006340|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5838723|NCT00006340|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5838724|NCT00006340|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5838726|NCT00006340|stage II grade 2 follicular lymphoma|stage ii grade 2 follicular lymphoma
5838727|NCT00006340|stage II grade 3 follicular lymphoma|stage ii grade 3 follicular lymphoma
5838728|NCT00006340|stage II adult diffuse small cleaved cell lymphoma|stage ii adult diffuse small cleaved cell lymphoma
5838729|NCT00006340|stage II adult diffuse mixed cell lymphoma|stage ii adult diffuse mixed cell lymphoma
5838730|NCT00006340|stage II adult diffuse large cell lymphoma|stage ii adult diffuse large cell lymphoma
5838731|NCT00006340|stage II adult immunoblastic large cell lymphoma|stage ii adult immunoblastic large cell lymphoma
5839582|NCT00005858|stage IV breast cancer|stage iv breast cancer
5838732|NCT00006340|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5838733|NCT00006340|stage II adult Burkitt lymphoma|stage ii adult burkitt lymphoma
5838734|NCT00006340|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838735|NCT00006340|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838736|NCT00006340|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5838737|NCT00006340|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5839928|NCT00005617|recurrent melanoma|recurrent melanoma
5838738|NCT00006340|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5838739|NCT00006340|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5838740|NCT00006340|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5838741|NCT00006340|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5838742|NCT00006340|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5838743|NCT00006340|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838744|NCT00006340|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838745|NCT00006340|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838746|NCT00006340|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838747|NCT00006340|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5838748|NCT00006340|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5838749|NCT00006340|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5838750|NCT00006340|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5838751|NCT00006340|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5838752|NCT00006340|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838753|NCT00006340|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838754|NCT00006340|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5838755|NCT00006340|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838756|NCT00006340|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5862701|NCT00001543|Metabolic Clearance Rate|metabolic clearance rate
5838757|NCT00006340|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838758|NCT00006340|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838759|NCT00006340|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838760|NCT00006340|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838761|NCT00006340|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5838762|NCT00006340|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5838763|NCT00006340|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5838764|NCT00006340|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5838765|NCT00006340|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5838766|NCT00006340|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5838767|NCT00006340|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5838768|NCT00006340|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5838769|NCT00006340|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5838770|NCT00006340|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5838771|NCT00006340|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5838772|NCT00006340|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5838773|NCT00006340|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5838774|NCT00006340|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5838775|NCT00006340|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5838776|NCT00006340|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5838777|NCT00006340|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5838778|NCT00006340|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5838779|NCT00006340|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5838780|NCT00006340|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838781|NCT00006340|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838782|NCT00006340|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5838783|NCT00006340|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5838784|NCT00006340|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5838785|NCT00006340|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5838786|NCT00006340|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5838787|NCT00006340|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5839447|NCT00005955|disseminated neuroblastoma|disseminated neuroblastoma
5838791|NCT00006340|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838792|NCT00006340|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5838793|NCT00006340|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5838794|NCT00006340|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5838795|NCT00006340|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5838796|NCT00006340|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5838797|NCT00006340|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5838798|NCT00006340|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838799|NCT00006340|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838800|NCT00006340|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838801|NCT00006340|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838802|NCT00006340|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5838803|NCT00006268|recurrent adult brain tumor|recurrent adult brain tumor
5838804|NCT00006268|adult glioblastoma|adult glioblastoma
5838805|NCT00006268|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5838806|NCT00006268|adult mixed glioma|adult mixed glioma
5838807|NCT00006268|adult giant cell glioblastoma|adult giant cell glioblastoma
5838808|NCT00006268|adult gliosarcoma|adult gliosarcoma
5838809|NCT00006267|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5838810|NCT00006267|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5838811|NCT00006267|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5838812|NCT00006264|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5838813|NCT00006263|adult brain stem glioma|adult brain stem glioma
5838814|NCT00006263|adult glioblastoma|adult glioblastoma
5838815|NCT00006263|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5838816|NCT00006263|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5838817|NCT00006263|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5838818|NCT00006263|adult giant cell glioblastoma|adult giant cell glioblastoma
5838819|NCT00006263|adult gliosarcoma|adult gliosarcoma
5838820|NCT00006260|stage IV breast cancer|stage iv breast cancer
5838821|NCT00006260|recurrent breast cancer|recurrent breast cancer
5838822|NCT00006258|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5838824|NCT00006258|adult medulloblastoma|adult medulloblastoma
5838825|NCT00006258|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5838826|NCT00006258|adult anaplastic ependymoma|adult anaplastic ependymoma
5838827|NCT00006258|adult ependymoblastoma|adult ependymoblastoma
5839866|NCT00005638|stage II gastric cancer|stage ii gastric cancer
5838828|NCT00006258|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5838829|NCT00006258|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5838830|NCT00006258|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5838831|NCT00006258|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5838836|NCT00006255|stage III renal cell cancer|stage iii renal cell cancer
5838837|NCT00006255|stage IV renal cell cancer|stage iv renal cell cancer
5838838|NCT00006255|recurrent renal cell cancer|recurrent renal cell cancer
5838839|NCT00006255|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838840|NCT00006255|liver metastases|liver metastases
5838841|NCT00006252|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5838842|NCT00006252|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5838843|NCT00006252|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5838844|NCT00006252|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5838845|NCT00006252|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838846|NCT00006252|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838847|NCT00006252|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5838848|NCT00006252|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838849|NCT00006252|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838850|NCT00006252|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838851|NCT00006252|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5848212|NCT00035802|Topiramate|topiramate
5838852|NCT00006252|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5838853|NCT00006252|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838854|NCT00006252|prolymphocytic leukemia|prolymphocytic leukemia
5838855|NCT00006252|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5838856|NCT00006252|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5839448|NCT00005955|stage 4S neuroblastoma|stage 4s neuroblastoma
5838857|NCT00006252|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5838858|NCT00006252|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5838859|NCT00006252|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5838860|NCT00006252|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5838861|NCT00006252|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5838862|NCT00006252|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5861500|NCT00001921|Schizophrenia|schizophrenia
5838863|NCT00006252|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5838864|NCT00006252|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5838865|NCT00006252|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838866|NCT00006252|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838867|NCT00006252|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5838868|NCT00006252|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5838869|NCT00006252|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5838870|NCT00006252|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5838871|NCT00006252|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5838872|NCT00006252|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5838873|NCT00006252|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5850504|NCT00023374|treatment|treatment
5838874|NCT00006252|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5838875|NCT00006252|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5838876|NCT00006252|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5838877|NCT00006252|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5838878|NCT00006252|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5838879|NCT00006252|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5838880|NCT00006252|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5838881|NCT00006252|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5838882|NCT00006250|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5838883|NCT00006250|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5838884|NCT00006250|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5838885|NCT00006250|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838886|NCT00006250|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838887|NCT00006250|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838888|NCT00006249|stage III melanoma|stage iii melanoma
5838889|NCT00006248|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5838890|NCT00006248|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5838891|NCT00006248|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5838892|NCT00006248|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5838893|NCT00006248|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5838894|NCT00006248|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5838895|NCT00006248|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5838896|NCT00006248|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5838897|NCT00006248|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5838898|NCT00006248|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5838899|NCT00006248|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5838900|NCT00006248|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5838901|NCT00006246|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838902|NCT00006246|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5838903|NCT00006246|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5838904|NCT00006246|recurrent childhood brain tumor|recurrent childhood brain tumor
5838905|NCT00006246|recurrent retinoblastoma|recurrent retinoblastoma
5838906|NCT00006246|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5838907|NCT00006246|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5838908|NCT00006246|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5838909|NCT00006246|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5838910|NCT00006246|leptomeningeal metastases|leptomeningeal metastases
5838911|NCT00006246|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5838912|NCT00006246|childhood oligodendroglioma|childhood oligodendroglioma
5838913|NCT00006246|childhood choroid plexus tumor|childhood choroid plexus tumor
5838914|NCT00006246|childhood grade I meningioma|childhood grade i meningioma
5838915|NCT00006246|childhood grade II meningioma|childhood grade ii meningioma
5838916|NCT00006246|childhood grade III meningioma|childhood grade iii meningioma
5838917|NCT00006246|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5839718|NCT00005797|stage II multiple myeloma|stage ii multiple myeloma
5838918|NCT00006246|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5838919|NCT00006246|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5838920|NCT00006246|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5838921|NCT00006246|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5853190|NCT00002186|Gels|gels
5838922|NCT00006246|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5838923|NCT00006246|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5838924|NCT00006246|recurrent childhood ependymoma|recurrent childhood ependymoma
5838925|NCT00006246|recurrent childhood malignant germ cell tumor|recurrent childhood malignant germ cell tumor
5838926|NCT00006245|stage III esophageal cancer|stage iii esophageal cancer
5838927|NCT00006245|stage IV esophageal cancer|stage iv esophageal cancer
5838928|NCT00006245|recurrent esophageal cancer|recurrent esophageal cancer
5838929|NCT00006245|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5838930|NCT00006245|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5838931|NCT00006239|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5838932|NCT00006239|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5838933|NCT00006239|refractory anemia|refractory anemia
5838934|NCT00006239|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5838935|NCT00006239|refractory anemia with excess blasts|refractory anemia with excess blasts
5839000|NCT00006221|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5838936|NCT00006239|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5838937|NCT00006239|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5838938|NCT00006239|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5838939|NCT00006239|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5838940|NCT00006239|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5838941|NCT00006239|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5838942|NCT00006239|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838943|NCT00006239|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5838944|NCT00006239|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5838945|NCT00006239|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5838946|NCT00006237|stage III melanoma|stage iii melanoma
5838947|NCT00006237|recurrent melanoma|recurrent melanoma
5838948|NCT00006234|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5838949|NCT00006234|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5838950|NCT00006234|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5838952|NCT00006234|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5838953|NCT00006234|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5838954|NCT00006234|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5838955|NCT00006234|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5838956|NCT00006233|stage IV melanoma|stage iv melanoma
5838957|NCT00006233|recurrent melanoma|recurrent melanoma
5838958|NCT00006232|stage II multiple myeloma|stage ii multiple myeloma
5838959|NCT00006232|stage III multiple myeloma|stage iii multiple myeloma
5838960|NCT00006231|localized malignant mesothelioma|localized malignant mesothelioma
5838961|NCT00006231|advanced malignant mesothelioma|advanced malignant mesothelioma
5838962|NCT00006231|perioperative/postoperative complications|perioperative/postoperative complications
5838963|NCT00006230|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5838964|NCT00006230|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5838965|NCT00006230|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5838966|NCT00006221|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5838967|NCT00006221|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5838968|NCT00006221|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5838969|NCT00006221|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5838970|NCT00006221|small intestine lymphoma|small intestine lymphoma
5838971|NCT00006221|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838972|NCT00006221|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5838973|NCT00006221|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5838974|NCT00006221|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5838975|NCT00006221|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5838976|NCT00006221|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5838977|NCT00006221|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5838978|NCT00006221|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5838979|NCT00006221|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5846690|NCT00043719|Human Female|human female
5838980|NCT00006221|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5838981|NCT00006221|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5838982|NCT00006221|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5848219|NCT00035620|Neutropenia|neutropenia
5838983|NCT00006221|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5861728|NCT00001861|Orthoptics|orthoptics
5838984|NCT00006221|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5838985|NCT00006221|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5838986|NCT00006221|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5838987|NCT00006221|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5838988|NCT00006221|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5838989|NCT00006221|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5838990|NCT00006221|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5838991|NCT00006221|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5838992|NCT00006221|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5838993|NCT00006221|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5838994|NCT00006221|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5838995|NCT00006221|intraocular lymphoma|intraocular lymphoma
5838996|NCT00006221|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5838997|NCT00006221|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5838998|NCT00006221|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5838999|NCT00006221|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5839267|NCT00006004|adenocarcinoma of the lung|adenocarcinoma of the lung
5839001|NCT00006221|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5839002|NCT00006221|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839003|NCT00006221|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839004|NCT00006221|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839005|NCT00006221|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5839006|NCT00006221|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839007|NCT00006221|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839008|NCT00006221|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839009|NCT00006219|multiple myeloma|multiple myeloma
5839010|NCT00006125|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839011|NCT00006125|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839012|NCT00006125|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839013|NCT00006125|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5839015|NCT00006120|stage IIIA breast cancer|stage iiia breast cancer
5839016|NCT00006120|recurrent breast cancer|recurrent breast cancer
5839017|NCT00006120|stage IIIB breast cancer|stage iiib breast cancer
5839018|NCT00006119|recurrent adult brain tumor|recurrent adult brain tumor
5839019|NCT00006119|adult grade III meningioma|adult grade iii meningioma
5839020|NCT00006119|adult grade I meningioma|adult grade i meningioma
5839021|NCT00006119|adult grade II meningioma|adult grade ii meningioma
5839022|NCT00006118|stage III bladder cancer|stage iii bladder cancer
5839023|NCT00006118|stage IV bladder cancer|stage iv bladder cancer
5839024|NCT00006118|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5839025|NCT00006114|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5839026|NCT00006114|stage IV prostate cancer|stage iv prostate cancer
5839027|NCT00006114|recurrent prostate cancer|recurrent prostate cancer
5839028|NCT00006113|stage III melanoma|stage iii melanoma
5839029|NCT00006113|stage IV melanoma|stage iv melanoma
5839030|NCT00006113|recurrent melanoma|recurrent melanoma
5839031|NCT00006110|stage II breast cancer|stage ii breast cancer
5839032|NCT00006110|stage IV breast cancer|stage iv breast cancer
5839033|NCT00006110|stage IIIA breast cancer|stage iiia breast cancer
5839034|NCT00006110|stage IIIB breast cancer|stage iiib breast cancer
5839035|NCT00006110|stage IIIC breast cancer|stage iiic breast cancer
5839036|NCT00006110|inflammatory breast cancer|inflammatory breast cancer
5839037|NCT00006107|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5839038|NCT00006107|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5839039|NCT00006107|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5839040|NCT00006107|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5839041|NCT00006107|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5839042|NCT00006107|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5839043|NCT00006107|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5839044|NCT00006107|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5839045|NCT00006107|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5839046|NCT00006107|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5839047|NCT00006107|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5839048|NCT00006107|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5839049|NCT00006107|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5839050|NCT00006107|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5839051|NCT00006107|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5839052|NCT00006107|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5839053|NCT00006107|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5839054|NCT00006107|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5839055|NCT00006107|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5839056|NCT00006107|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5839057|NCT00006107|recurrent salivary gland cancer|recurrent salivary gland cancer
5839058|NCT00006107|stage III salivary gland cancer|stage iii salivary gland cancer
5839059|NCT00006107|stage IV salivary gland cancer|stage iv salivary gland cancer
5839060|NCT00006107|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5839061|NCT00006107|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5839062|NCT00006107|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5839063|NCT00006107|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5839064|NCT00006107|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5839595|NCT00005858|recurrent bladder cancer|recurrent bladder cancer
5839065|NCT00006107|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5839066|NCT00006107|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5839067|NCT00006105|stage II bladder cancer|stage ii bladder cancer
5839068|NCT00006105|stage III bladder cancer|stage iii bladder cancer
5839069|NCT00006105|stage IV bladder cancer|stage iv bladder cancer
5839070|NCT00006105|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5839071|NCT00006102|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5839072|NCT00006102|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5839073|NCT00006102|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5839074|NCT00006102|childhood craniopharyngioma|childhood craniopharyngioma
5839075|NCT00006102|disseminated neuroblastoma|disseminated neuroblastoma
5839076|NCT00006102|recurrent neuroblastoma|recurrent neuroblastoma
5839077|NCT00006102|intraocular retinoblastoma|intraocular retinoblastoma
5839078|NCT00006102|extraocular retinoblastoma|extraocular retinoblastoma
5839079|NCT00006102|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5839080|NCT00006102|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5839081|NCT00006102|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5839082|NCT00006102|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5839083|NCT00006102|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5839084|NCT00006102|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5839085|NCT00006102|childhood oligodendroglioma|childhood oligodendroglioma
5839086|NCT00006102|childhood choroid plexus tumor|childhood choroid plexus tumor
5839087|NCT00006102|childhood grade I meningioma|childhood grade i meningioma
5839088|NCT00006102|childhood grade II meningioma|childhood grade ii meningioma
5839089|NCT00006102|childhood grade III meningioma|childhood grade iii meningioma
5839090|NCT00006102|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5839091|NCT00006102|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5839092|NCT00006102|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5839093|NCT00006102|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5839094|NCT00006102|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5839095|NCT00006102|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5839096|NCT00006102|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5839097|NCT00006102|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5839098|NCT00006102|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5839099|NCT00006102|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5839100|NCT00006102|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5839101|NCT00006102|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5839102|NCT00006102|recurrent childhood ependymoma|recurrent childhood ependymoma
5839103|NCT00006102|recurrent retinoblastoma|recurrent retinoblastoma
5839104|NCT00006101|stage I prostate cancer|stage i prostate cancer
5839105|NCT00006100|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839106|NCT00006093|recurrent adult brain tumor|recurrent adult brain tumor
5846691|NCT00043719|Osteoporosis|osteoporosis
5839108|NCT00006093|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839109|NCT00006093|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839110|NCT00006093|adult giant cell glioblastoma|adult giant cell glioblastoma
5839112|NCT00006092|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839113|NCT00006092|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5839114|NCT00006092|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5839115|NCT00006092|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5839116|NCT00006092|lymphoid leukemia|lymphoid leukemia
5839117|NCT00006092|myeloid and monocytic leukemia|myeloid and monocytic leukemia
5839118|NCT00006078|prostate cancer|prostate cancer
5839119|NCT00006044|stage IV prostate cancer|stage iv prostate cancer
5839120|NCT00006044|recurrent prostate cancer|recurrent prostate cancer
5839121|NCT00006042|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839122|NCT00006042|Burkitt lymphoma|burkitt lymphoma
5839123|NCT00006042|refractory multiple myeloma|refractory multiple myeloma
5839124|NCT00006042|stage II multiple myeloma|stage ii multiple myeloma
5839125|NCT00006042|stage III multiple myeloma|stage iii multiple myeloma
5839126|NCT00006042|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5839127|NCT00006042|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5839128|NCT00006042|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5839129|NCT00006042|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5839130|NCT00006042|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5839131|NCT00006042|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5839132|NCT00006042|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5839133|NCT00006042|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5839134|NCT00006042|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5839135|NCT00006042|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5839136|NCT00006042|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5839137|NCT00006042|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5839138|NCT00006042|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5839139|NCT00006042|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5839140|NCT00006042|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5839141|NCT00006042|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5839142|NCT00006042|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5839143|NCT00006042|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5839144|NCT00006042|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5839145|NCT00006042|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5839146|NCT00006042|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5839147|NCT00006042|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5839148|NCT00006042|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5839149|NCT00006042|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5839150|NCT00006042|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5839151|NCT00006042|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5839152|NCT00006042|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5839153|NCT00006042|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839154|NCT00006042|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839155|NCT00006042|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5839156|NCT00006042|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839157|NCT00006042|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839158|NCT00006042|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5839159|NCT00006042|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5839160|NCT00006042|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839161|NCT00006042|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5839162|NCT00006042|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839163|NCT00006042|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839164|NCT00006042|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5839165|NCT00006042|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5839166|NCT00006042|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5839167|NCT00006042|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5839168|NCT00006042|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5839169|NCT00006042|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5839170|NCT00006042|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5839171|NCT00006042|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5839172|NCT00006042|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5839173|NCT00006042|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5839174|NCT00006042|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5862126|NCT00001719|Liver|liver
5839175|NCT00006042|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5839176|NCT00006042|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5839177|NCT00006042|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5839178|NCT00006042|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5848330|NCT00035126|cancer|cancer
5839179|NCT00006042|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839180|NCT00006042|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839181|NCT00006042|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5839182|NCT00006042|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5839183|NCT00006042|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839184|NCT00006042|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5839185|NCT00006042|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839186|NCT00006042|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839187|NCT00006042|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839188|NCT00006042|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839189|NCT00006042|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839190|NCT00006042|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839191|NCT00006042|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839192|NCT00006042|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5839193|NCT00006042|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5839194|NCT00006040|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839195|NCT00006040|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839196|NCT00006040|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5839197|NCT00006040|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5839198|NCT00006040|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5839199|NCT00006040|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839200|NCT00006040|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5840243|NCT00005052|stage II melanoma|stage ii melanoma
5839201|NCT00006040|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5839202|NCT00006029|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839203|NCT00006029|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5839204|NCT00006028|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5839205|NCT00006028|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5839206|NCT00006027|stage I endometrial carcinoma|stage i endometrial carcinoma
5839207|NCT00006027|stage II endometrial carcinoma|stage ii endometrial carcinoma
5839208|NCT00006027|endometrial adenocarcinoma|endometrial adenocarcinoma
5839209|NCT00006027|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5839210|NCT00006027|endometrial adenoacanthoma|endometrial adenoacanthoma
5839211|NCT00006027|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5839212|NCT00006027|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5839213|NCT00006025|recurrent adult brain tumor|recurrent adult brain tumor
5839215|NCT00006025|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839216|NCT00006025|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839217|NCT00006025|adult mixed glioma|adult mixed glioma
5839218|NCT00006025|adult giant cell glioblastoma|adult giant cell glioblastoma
5839219|NCT00006025|adult gliosarcoma|adult gliosarcoma
5839220|NCT00006024|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5839221|NCT00006022|stage III renal cell cancer|stage iii renal cell cancer
5839222|NCT00006022|stage IV renal cell cancer|stage iv renal cell cancer
5839223|NCT00006022|recurrent renal cell cancer|recurrent renal cell cancer
5839224|NCT00006022|stage III melanoma|stage iii melanoma
5839225|NCT00006022|stage IV melanoma|stage iv melanoma
5839226|NCT00006022|recurrent melanoma|recurrent melanoma
5839227|NCT00006021|refractory multiple myeloma|refractory multiple myeloma
5839228|NCT00006021|stage II multiple myeloma|stage ii multiple myeloma
5839229|NCT00006021|stage III multiple myeloma|stage iii multiple myeloma
5839230|NCT00006020|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839231|NCT00006020|L1 adult acute lymphoblastic leukemia|l1 adult acute lymphoblastic leukemia
5839232|NCT00006020|L2 adult acute lymphoblastic leukemia|l2 adult acute lymphoblastic leukemia
5839233|NCT00006020|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5839234|NCT00006020|non-T, non-B adult acute lymphoblastic leukemia|non-t, non-b adult acute lymphoblastic leukemia
5839235|NCT00006017|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5839236|NCT00006017|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5839237|NCT00006017|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5839238|NCT00006015|stage IV colon cancer|stage iv colon cancer
5839239|NCT00006015|stage IV rectal cancer|stage iv rectal cancer
5839240|NCT00006015|recurrent colon cancer|recurrent colon cancer
5839241|NCT00006015|recurrent rectal cancer|recurrent rectal cancer
5839242|NCT00006015|adenocarcinoma of the colon|adenocarcinoma of the colon
5839243|NCT00006015|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5839244|NCT00006010|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5839245|NCT00006010|advanced adult primary liver cancer|advanced adult primary liver cancer
5839246|NCT00006010|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5839247|NCT00006010|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5839248|NCT00006007|stage IV breast cancer|stage iv breast cancer
5839249|NCT00006007|recurrent breast cancer|recurrent breast cancer
5839250|NCT00006006|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5839251|NCT00006006|advanced adult primary liver cancer|advanced adult primary liver cancer
5839252|NCT00006006|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5839253|NCT00006006|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5839254|NCT00006005|stage I uterine sarcoma|stage i uterine sarcoma
5839255|NCT00006005|stage II uterine sarcoma|stage ii uterine sarcoma
5839256|NCT00006005|stage III uterine sarcoma|stage iii uterine sarcoma
5839257|NCT00006005|stage IV uterine sarcoma|stage iv uterine sarcoma
5839258|NCT00006005|recurrent uterine sarcoma|recurrent uterine sarcoma
5839259|NCT00006005|uterine carcinosarcoma|uterine carcinosarcoma
5839260|NCT00006005|uterine leiomyosarcoma|uterine leiomyosarcoma
5839261|NCT00006005|endometrial stromal sarcoma|endometrial stromal sarcoma
5839262|NCT00006004|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5839263|NCT00006004|squamous cell lung cancer|squamous cell lung cancer
5839264|NCT00006004|large cell lung cancer|large cell lung cancer
5839265|NCT00006004|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5839266|NCT00006004|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5839268|NCT00006004|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5839269|NCT00006004|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5839270|NCT00005997|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5839271|NCT00005997|advanced adult primary liver cancer|advanced adult primary liver cancer
5839272|NCT00005997|unresectable gallbladder cancer|unresectable gallbladder cancer
5839273|NCT00005997|unresectable extrahepatic bile duct cancer|unresectable extrahepatic bile duct cancer
5839274|NCT00005997|adult primary hepatocellular carcinoma|adult primary hepatocellular carcinoma
5839275|NCT00005997|cholangiocarcinoma of the gallbladder|cholangiocarcinoma of the gallbladder
5839276|NCT00005997|cholangiocarcinoma of the extrahepatic bile duct|cholangiocarcinoma of the extrahepatic bile duct
5839277|NCT00005997|adult primary cholangiocellular carcinoma|adult primary cholangiocellular carcinoma
5839278|NCT00005990|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5839280|NCT00005987|stage II multiple myeloma|stage ii multiple myeloma
5839281|NCT00005987|stage III multiple myeloma|stage iii multiple myeloma
5839282|NCT00005985|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5839283|NCT00005985|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5839284|NCT00005985|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5839285|NCT00005985|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5839286|NCT00005985|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839287|NCT00005985|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5839288|NCT00005985|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5839289|NCT00005985|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5839290|NCT00005985|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5839291|NCT00005985|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5839292|NCT00005985|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5839293|NCT00005985|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5839294|NCT00005985|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5839295|NCT00005985|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5839296|NCT00005985|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5839297|NCT00005985|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5839298|NCT00005985|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5839299|NCT00005985|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5839300|NCT00005985|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5839301|NCT00005985|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5839302|NCT00005985|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5839303|NCT00005985|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5839304|NCT00005985|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5846692|NCT00043719|Postmenopausal|postmenopausal
5839305|NCT00005985|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5839306|NCT00005985|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5839307|NCT00005985|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5839308|NCT00005985|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5839309|NCT00005985|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5839310|NCT00005985|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5839311|NCT00005985|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5839312|NCT00005985|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5839313|NCT00005985|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5839314|NCT00005985|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5839315|NCT00005985|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839316|NCT00005985|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839317|NCT00005985|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5839318|NCT00005985|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839319|NCT00005985|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839320|NCT00005985|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5839321|NCT00005985|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5839322|NCT00005985|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839323|NCT00005985|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5839324|NCT00005985|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5839325|NCT00005985|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5839326|NCT00005985|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5839327|NCT00005985|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5839328|NCT00005985|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5839329|NCT00005985|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5839330|NCT00005985|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5839331|NCT00005985|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5839332|NCT00005985|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5839333|NCT00005985|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5839334|NCT00005985|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5839335|NCT00005985|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5839336|NCT00005985|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5839337|NCT00005985|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5839338|NCT00005985|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5839339|NCT00005985|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5862703|NCT00001543|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5839340|NCT00005985|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5839341|NCT00005985|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5839342|NCT00005985|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5839343|NCT00005985|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5839344|NCT00005985|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5839345|NCT00005985|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5839346|NCT00005985|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5839347|NCT00005985|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5839348|NCT00005985|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839349|NCT00005985|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5839350|NCT00005985|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5839351|NCT00005985|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839352|NCT00005984|chronic phase myelogenous leukemia|chronic phase myelogenous leukemia
5839353|NCT00005984|accelerated phase myelogenous leukemia|accelerated phase myelogenous leukemia
5839354|NCT00005983|stage II breast cancer|stage ii breast cancer
5839355|NCT00005981|stage IV colon cancer|stage iv colon cancer
5839356|NCT00005981|stage IV rectal cancer|stage iv rectal cancer
5839357|NCT00005981|recurrent colon cancer|recurrent colon cancer
5839358|NCT00005981|recurrent rectal cancer|recurrent rectal cancer
5839359|NCT00005980|stage IV breast cancer|stage iv breast cancer
5839360|NCT00005980|recurrent breast cancer|recurrent breast cancer
5839361|NCT00005979|stage III colon cancer|stage iii colon cancer
5839362|NCT00005979|adenocarcinoma of the colon|adenocarcinoma of the colon
5839363|NCT00005976|recurrent adult brain tumor|recurrent adult brain tumor
5839364|NCT00005976|adult glioblastoma|adult glioblastoma
5839365|NCT00005976|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839366|NCT00005976|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839367|NCT00005976|adult mixed glioma|adult mixed glioma
5839368|NCT00005976|adult oligodendroglioma|adult oligodendroglioma
5839369|NCT00005976|adult giant cell glioblastoma|adult giant cell glioblastoma
5839370|NCT00005976|adult gliosarcoma|adult gliosarcoma
5839371|NCT00005967|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5839372|NCT00005967|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5839373|NCT00005967|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839374|NCT00005967|refractory multiple myeloma|refractory multiple myeloma
5839375|NCT00005967|stage III multiple myeloma|stage iii multiple myeloma
5839376|NCT00005967|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5839377|NCT00005967|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5839378|NCT00005967|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839379|NCT00005967|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839380|NCT00005967|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5839381|NCT00005967|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5839382|NCT00005967|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5839383|NCT00005967|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5839384|NCT00005967|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5839385|NCT00005967|refractory anemia with excess blasts|refractory anemia with excess blasts
5839386|NCT00005967|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5839387|NCT00005967|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5839388|NCT00005967|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5839389|NCT00005967|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5839390|NCT00005967|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5839391|NCT00005967|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5839392|NCT00005967|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5839393|NCT00005967|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5841000|NCT00004017|adult glioblastoma|adult glioblastoma
5839394|NCT00005967|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5839395|NCT00005967|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5839396|NCT00005967|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5839397|NCT00005967|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5839398|NCT00005967|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5839399|NCT00005967|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5839400|NCT00005967|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5839401|NCT00005967|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5839402|NCT00005967|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5839403|NCT00005967|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5839404|NCT00005967|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5839405|NCT00005967|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5839407|NCT00005967|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839408|NCT00005967|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839409|NCT00005967|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5839410|NCT00005967|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839411|NCT00005967|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839412|NCT00005967|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5839413|NCT00005967|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5839414|NCT00005967|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839415|NCT00005967|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839416|NCT00005967|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839417|NCT00005967|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5839418|NCT00005967|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5839419|NCT00005967|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5839420|NCT00005967|polycythemia vera|polycythemia vera
5839421|NCT00005967|primary myelofibrosis|primary myelofibrosis
5839422|NCT00005967|essential thrombocythemia|essential thrombocythemia
5839423|NCT00005967|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5839424|NCT00005967|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5839425|NCT00005967|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839426|NCT00005967|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839427|NCT00005967|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5839428|NCT00005967|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5839429|NCT00005967|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839430|NCT00005967|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5839431|NCT00005967|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839432|NCT00005967|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839433|NCT00005967|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839434|NCT00005966|stage III renal cell cancer|stage iii renal cell cancer
5839435|NCT00005966|stage IV renal cell cancer|stage iv renal cell cancer
5839437|NCT00005961|stage IV melanoma|stage iv melanoma
5839438|NCT00005961|recurrent melanoma|recurrent melanoma
5839439|NCT00005957|stage I breast cancer|stage i breast cancer
5839440|NCT00005957|stage II breast cancer|stage ii breast cancer
5839441|NCT00005955|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5839442|NCT00005955|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5839443|NCT00005955|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5839444|NCT00005955|childhood craniopharyngioma|childhood craniopharyngioma
5839445|NCT00005955|localized resectable neuroblastoma|localized resectable neuroblastoma
5839446|NCT00005955|regional neuroblastoma|regional neuroblastoma
5839449|NCT00005955|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5839450|NCT00005955|childhood oligodendroglioma|childhood oligodendroglioma
5839451|NCT00005955|childhood choroid plexus tumor|childhood choroid plexus tumor
5839452|NCT00005955|childhood grade I meningioma|childhood grade i meningioma
5839453|NCT00005955|childhood grade II meningioma|childhood grade ii meningioma
5839454|NCT00005955|childhood grade III meningioma|childhood grade iii meningioma
5839455|NCT00005955|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5839456|NCT00005955|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5839457|NCT00005955|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5839458|NCT00005955|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5839459|NCT00005955|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5839460|NCT00005955|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5839461|NCT00005955|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5839462|NCT00005955|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5839463|NCT00005955|childhood central nervous system teratoma|childhood central nervous system teratoma
5839464|NCT00005955|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5839465|NCT00005954|adult tumors metastatic to brain|adult tumors metastatic to brain
5839596|NCT00005858|stage IV bladder cancer|stage iv bladder cancer
5839466|NCT00005952|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5839467|NCT00005952|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5839468|NCT00005952|childhood craniopharyngioma|childhood craniopharyngioma
5839469|NCT00005952|disseminated neuroblastoma|disseminated neuroblastoma
5839470|NCT00005952|stage 4S neuroblastoma|stage 4s neuroblastoma
5839471|NCT00005952|recurrent neuroblastoma|recurrent neuroblastoma
5839472|NCT00005952|stage IV Wilms tumor|stage iv wilms tumor
5839473|NCT00005952|stage V Wilms tumor|stage v wilms tumor
5839474|NCT00005952|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5839475|NCT00005952|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5839476|NCT00005952|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5839477|NCT00005952|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5839478|NCT00005952|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5839479|NCT00005952|recurrent nasopharyngeal cancer|recurrent nasopharyngeal cancer
5839480|NCT00005952|childhood germ cell tumor|childhood germ cell tumor
5839481|NCT00005952|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5839482|NCT00005952|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5839483|NCT00005952|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5839484|NCT00005952|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5839485|NCT00005952|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5839486|NCT00005952|childhood oligodendroglioma|childhood oligodendroglioma
5839487|NCT00005952|childhood choroid plexus tumor|childhood choroid plexus tumor
5839488|NCT00005952|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5839489|NCT00005952|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5839490|NCT00005952|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5839491|NCT00005952|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5839492|NCT00005952|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5839493|NCT00005952|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5839494|NCT00005952|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5839495|NCT00005952|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5839496|NCT00005952|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5839497|NCT00005952|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5839498|NCT00005952|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5839499|NCT00005952|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5839500|NCT00005952|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5839501|NCT00005952|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5839502|NCT00005952|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5839503|NCT00005952|recurrent childhood ependymoma|recurrent childhood ependymoma
5839504|NCT00005951|recurrent adult brain tumor|recurrent adult brain tumor
5839506|NCT00005951|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839507|NCT00005951|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839508|NCT00005951|adult mixed glioma|adult mixed glioma
5839509|NCT00005951|adult giant cell glioblastoma|adult giant cell glioblastoma
5839510|NCT00005951|adult gliosarcoma|adult gliosarcoma
5839511|NCT00005945|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5839512|NCT00005945|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5839513|NCT00005945|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5839514|NCT00005945|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5839515|NCT00005941|stage III cervical cancer|stage iii cervical cancer
5839516|NCT00005941|recurrent cervical cancer|recurrent cervical cancer
5839517|NCT00005941|stage IVB cervical cancer|stage ivb cervical cancer
5839518|NCT00005941|stage IVA cervical cancer|stage iva cervical cancer
5839519|NCT00005941|stage III vaginal cancer|stage iii vaginal cancer
5839520|NCT00005941|stage IVA vaginal cancer|stage iva vaginal cancer
5839521|NCT00005941|stage IVB vaginal cancer|stage ivb vaginal cancer
5839522|NCT00005941|recurrent vaginal cancer|recurrent vaginal cancer
5839523|NCT00005879|breast cancer|breast cancer
5839524|NCT00005878|esophageal cancer|esophageal cancer
5839525|NCT00005867|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5839526|NCT00005867|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5839527|NCT00005867|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5839528|NCT00005867|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5839529|NCT00005867|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5839530|NCT00005867|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5839531|NCT00005867|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5839532|NCT00005867|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5850506|NCT00023374|toxicity|toxicity
5839533|NCT00005867|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5839534|NCT00005867|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5839535|NCT00005867|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5839536|NCT00005867|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5839537|NCT00005867|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5839538|NCT00005867|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5863166|NCT00001364|Embolization|embolization
5839539|NCT00005867|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5839540|NCT00005867|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5839541|NCT00005867|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5839542|NCT00005867|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5839543|NCT00005867|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5839544|NCT00005867|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5839545|NCT00005863|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5839546|NCT00005863|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839547|NCT00005863|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5839548|NCT00005863|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5839549|NCT00005863|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5839550|NCT00005863|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5839551|NCT00005863|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5839552|NCT00005863|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5839553|NCT00005863|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5839554|NCT00005863|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5839555|NCT00005863|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5839556|NCT00005863|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5839557|NCT00005863|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5839558|NCT00005863|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5839559|NCT00005863|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5839560|NCT00005863|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5839561|NCT00005863|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5839562|NCT00005863|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5839563|NCT00005863|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5839564|NCT00005863|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5839565|NCT00005863|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839566|NCT00005863|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839567|NCT00005863|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5839568|NCT00005863|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5839569|NCT00005863|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5839570|NCT00005863|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5839571|NCT00005863|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839572|NCT00005863|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839573|NCT00005863|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839649|NCT00005824|AIDS-related small noncleaved cell lymphoma|aids-related small noncleaved cell lymphoma
5839574|NCT00005863|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839575|NCT00005863|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5839576|NCT00005859|recurrent adult brain tumor|recurrent adult brain tumor
5839578|NCT00005859|adult giant cell glioblastoma|adult giant cell glioblastoma
5839579|NCT00005859|adult gliosarcoma|adult gliosarcoma
5839580|NCT00005858|stage III colon cancer|stage iii colon cancer
5839581|NCT00005858|stage IV colon cancer|stage iv colon cancer
5839583|NCT00005858|stage IIIA breast cancer|stage iiia breast cancer
5839584|NCT00005858|recurrent breast cancer|recurrent breast cancer
5839585|NCT00005858|stage IIIB breast cancer|stage iiib breast cancer
5839586|NCT00005858|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5839587|NCT00005858|stage II pancreatic cancer|stage ii pancreatic cancer
5839588|NCT00005858|stage III pancreatic cancer|stage iii pancreatic cancer
5839589|NCT00005858|recurrent pancreatic cancer|recurrent pancreatic cancer
5839590|NCT00005858|recurrent colon cancer|recurrent colon cancer
5839591|NCT00005858|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5839592|NCT00005858|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5839593|NCT00005858|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5839594|NCT00005858|stage III bladder cancer|stage iii bladder cancer
5850703|NCT00016601|Nelfinavir|nelfinavir
5839597|NCT00005858|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5839598|NCT00005858|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5839599|NCT00005858|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5839600|NCT00005858|ovarian stromal cancer|ovarian stromal cancer
5839601|NCT00005858|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5839602|NCT00005858|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5839603|NCT00005858|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5839604|NCT00005858|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5839606|NCT00005858|male breast cancer|male breast cancer
5839607|NCT00005858|stage IV pancreatic cancer|stage iv pancreatic cancer
5839608|NCT00005855|adult glioblastoma|adult glioblastoma
5839609|NCT00005855|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839610|NCT00005855|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839611|NCT00005855|recurrent adult brain tumor|recurrent adult brain tumor
5839612|NCT00005855|adult giant cell glioblastoma|adult giant cell glioblastoma
5839613|NCT00005855|adult gliosarcoma|adult gliosarcoma
5839614|NCT00005853|refractory anemia|refractory anemia
5839615|NCT00005853|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5839616|NCT00005853|refractory anemia with excess blasts|refractory anemia with excess blasts
5839617|NCT00005853|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5839618|NCT00005853|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5839619|NCT00005853|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839620|NCT00005853|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839621|NCT00005853|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5839622|NCT00005853|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5839623|NCT00005850|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5839624|NCT00005850|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5839625|NCT00005850|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5839626|NCT00005850|squamous cell lung cancer|squamous cell lung cancer
5839627|NCT00005850|large cell lung cancer|large cell lung cancer
5839628|NCT00005850|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5839629|NCT00005850|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5839630|NCT00005850|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5839631|NCT00005850|adenocarcinoma of the lung|adenocarcinoma of the lung
5839632|NCT00005850|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5839634|NCT00005850|anxiety disorder|anxiety disorder
5839635|NCT00005850|depression|depression
5839636|NCT00005847|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5839637|NCT00005847|stage IV prostate cancer|stage iv prostate cancer
5839638|NCT00005847|recurrent prostate cancer|recurrent prostate cancer
5839639|NCT00005844|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5839640|NCT00005835|regional neuroblastoma|regional neuroblastoma
5839641|NCT00005835|disseminated neuroblastoma|disseminated neuroblastoma
5839642|NCT00005835|recurrent neuroblastoma|recurrent neuroblastoma
5839643|NCT00005835|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5839644|NCT00005825|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5839645|NCT00005825|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5839646|NCT00005824|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5839647|NCT00005824|AIDS-related diffuse large cell lymphoma|aids-related diffuse large cell lymphoma
5839648|NCT00005824|AIDS-related immunoblastic large cell lymphoma|aids-related immunoblastic large cell lymphoma
5839717|NCT00005797|refractory multiple myeloma|refractory multiple myeloma
5839650|NCT00005824|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5839651|NCT00005824|AIDS-related diffuse mixed cell lymphoma|aids-related diffuse mixed cell lymphoma
5839652|NCT00005824|AIDS-related diffuse small cleaved cell lymphoma|aids-related diffuse small cleaved cell lymphoma
5839653|NCT00005824|AIDS-related lymphoblastic lymphoma|aids-related lymphoblastic lymphoma
5839654|NCT00005823|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5839655|NCT00005823|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5839656|NCT00005823|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5839657|NCT00005823|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5839658|NCT00005823|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5839659|NCT00005823|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5839660|NCT00005823|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5839661|NCT00005823|refractory anemia with excess blasts|refractory anemia with excess blasts
5839662|NCT00005823|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5839663|NCT00005823|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5839664|NCT00005823|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5839665|NCT00005823|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5839666|NCT00005823|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5850907|NCT00011037|Peru|peru
5839667|NCT00005823|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839668|NCT00005823|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5839669|NCT00005823|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5839670|NCT00005823|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5839671|NCT00005823|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839672|NCT00005823|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839673|NCT00005823|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839674|NCT00005823|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839675|NCT00005822|stage IV breast cancer|stage iv breast cancer
5839676|NCT00005822|recurrent breast cancer|recurrent breast cancer
5839677|NCT00005822|stage IIIB breast cancer|stage iiib breast cancer
5839678|NCT00005822|inflammatory breast cancer|inflammatory breast cancer
5839679|NCT00005822|male breast cancer|male breast cancer
5839680|NCT00005821|stage I breast cancer|stage i breast cancer
5839681|NCT00005821|stage II breast cancer|stage ii breast cancer
5839682|NCT00005819|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5839683|NCT00005815|iris melanoma|iris melanoma
5839684|NCT00005815|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5839685|NCT00005815|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5839686|NCT00005815|extraocular extension melanoma|extraocular extension melanoma
5839687|NCT00005815|recurrent intraocular melanoma|recurrent intraocular melanoma
5839688|NCT00005815|stage III melanoma|stage iii melanoma
5839689|NCT00005815|stage IV melanoma|stage iv melanoma
5839690|NCT00005815|recurrent melanoma|recurrent melanoma
5839691|NCT00005812|leptomeningeal metastases|leptomeningeal metastases
5839692|NCT00005812|temozolomide|temozolomide
5839694|NCT00005807|stage IIIA breast cancer|stage iiia breast cancer
5839695|NCT00005807|recurrent breast cancer|recurrent breast cancer
5839696|NCT00005807|stage IIIB breast cancer|stage iiib breast cancer
5839697|NCT00005807|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5839698|NCT00005807|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5839699|NCT00005807|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5839700|NCT00005807|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5839701|NCT00005807|ovarian stromal cancer|ovarian stromal cancer
5839702|NCT00005807|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5839703|NCT00005807|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5839704|NCT00005807|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5839705|NCT00005807|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5839707|NCT00005807|male breast cancer|male breast cancer
5839708|NCT00005802|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5839709|NCT00005802|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5839710|NCT00005802|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839711|NCT00005802|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839712|NCT00005802|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839713|NCT00005802|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839714|NCT00005802|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839715|NCT00005802|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839716|NCT00005802|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5839719|NCT00005797|stage III multiple myeloma|stage iii multiple myeloma
5839720|NCT00005797|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5839721|NCT00005797|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5839722|NCT00005797|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839723|NCT00005797|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839724|NCT00005797|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5839725|NCT00005797|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5839726|NCT00005797|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5839727|NCT00005797|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5839728|NCT00005797|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5839729|NCT00005797|polycythemia vera|polycythemia vera
5839730|NCT00005797|primary myelofibrosis|primary myelofibrosis
5839731|NCT00005797|essential thrombocythemia|essential thrombocythemia
5839732|NCT00005797|refractory anemia|refractory anemia
5839733|NCT00005797|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5839734|NCT00005797|refractory anemia with excess blasts|refractory anemia with excess blasts
5839735|NCT00005797|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5839736|NCT00005797|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5839737|NCT00005797|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839738|NCT00005797|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5839739|NCT00005797|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5839740|NCT00005797|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5839741|NCT00005797|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5839742|NCT00005797|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5839743|NCT00005797|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839744|NCT00005797|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839745|NCT00005797|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839746|NCT00005797|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839747|NCT00005797|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5839748|NCT00005797|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5839749|NCT00005788|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5839750|NCT00005788|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5839751|NCT00005788|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5839752|NCT00005788|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5839753|NCT00005788|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5839754|NCT00005788|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5839755|NCT00005788|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5839756|NCT00005788|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5839757|NCT00005788|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5839758|NCT00005788|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5839760|NCT00005787|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5839761|NCT00005787|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839762|NCT00005787|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839763|NCT00005787|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5839764|NCT00005787|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839765|NCT00005787|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839766|NCT00005787|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5839767|NCT00005787|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5839768|NCT00005787|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839769|NCT00005787|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5839770|NCT00005787|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839771|NCT00005787|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839772|NCT00005787|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839773|NCT00005787|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839774|NCT00005787|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839775|NCT00005647|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5839776|NCT00005647|anaplastic thyroid cancer|anaplastic thyroid cancer
5839777|NCT00005647|recurrent thyroid cancer|recurrent thyroid cancer
5839778|NCT00005647|recurrent salivary gland cancer|recurrent salivary gland cancer
5839779|NCT00005647|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5839780|NCT00005647|stage III follicular thyroid cancer|stage iii follicular thyroid cancer
5839781|NCT00005647|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5839782|NCT00005647|recurrent hypopharyngeal cancer|recurrent hypopharyngeal cancer
5839783|NCT00005647|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5839784|NCT00005647|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5839785|NCT00005647|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5839786|NCT00005647|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5839787|NCT00005647|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5839788|NCT00005647|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5839789|NCT00005647|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5839790|NCT00005647|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5839791|NCT00005647|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5839792|NCT00005647|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5839793|NCT00005647|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5839794|NCT00005647|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5839795|NCT00005647|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5839796|NCT00005647|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5863060|NCT00001407|Multiple Drug Resistant Tuberculosis|multiple drug resistant tuberculosis
5839797|NCT00005647|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5839798|NCT00005644|stage III bladder cancer|stage iii bladder cancer
5839799|NCT00005644|recurrent bladder cancer|recurrent bladder cancer
5839800|NCT00005644|stage IV bladder cancer|stage iv bladder cancer
5839801|NCT00005644|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5839802|NCT00005644|recurrent urethral cancer|recurrent urethral cancer
5839803|NCT00005644|distal urethral cancer|distal urethral cancer
5839804|NCT00005644|proximal urethral cancer|proximal urethral cancer
5839805|NCT00005644|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5839806|NCT00005644|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5839807|NCT00005644|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5839808|NCT00005644|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5839809|NCT00005639|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5839810|NCT00005639|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5839811|NCT00005639|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839812|NCT00005639|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5839813|NCT00005639|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5839814|NCT00005639|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5839815|NCT00005639|small intestine lymphoma|small intestine lymphoma
5837464|NCT00014456|stage IV melanoma|stage iv melanoma
5839816|NCT00005639|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5839817|NCT00005639|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5839818|NCT00005639|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5839819|NCT00005639|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5839820|NCT00005639|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5839821|NCT00005639|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5839822|NCT00005639|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5839823|NCT00005639|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5839824|NCT00005639|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5839825|NCT00005639|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5863738|NCT00001201|EMG|emg
5839826|NCT00005639|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5839827|NCT00005639|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5839828|NCT00005639|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5839829|NCT00005639|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5839830|NCT00005639|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5839831|NCT00005639|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5839832|NCT00005639|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5839833|NCT00005639|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5839834|NCT00005639|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5839835|NCT00005639|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5839836|NCT00005639|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839837|NCT00005639|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5839838|NCT00005639|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5839839|NCT00005639|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5839840|NCT00005639|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5839841|NCT00005639|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5839842|NCT00005639|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5839843|NCT00005639|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5839844|NCT00005639|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5839845|NCT00005639|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5839846|NCT00005639|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5839847|NCT00005639|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5839848|NCT00005639|intraocular lymphoma|intraocular lymphoma
5839849|NCT00005639|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5839850|NCT00005639|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5839851|NCT00005639|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5839852|NCT00005639|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5839853|NCT00005639|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5839854|NCT00005639|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5839855|NCT00005639|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5839856|NCT00005639|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5839857|NCT00005639|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839858|NCT00005639|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5863072|NCT00001404|Abnormalities, Multiple|abnormalities, multiple
5839859|NCT00005639|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5839860|NCT00005639|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5839861|NCT00005639|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839862|NCT00005639|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5839863|NCT00005639|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839864|NCT00005639|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839865|NCT00005639|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839867|NCT00005638|stage III gastric cancer|stage iii gastric cancer
5839868|NCT00005638|stage II esophageal cancer|stage ii esophageal cancer
5839869|NCT00005638|stage III esophageal cancer|stage iii esophageal cancer
5839870|NCT00005638|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5839871|NCT00005638|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5839872|NCT00005638|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5839873|NCT00005637|adult glioblastoma|adult glioblastoma
5839874|NCT00005637|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5839875|NCT00005637|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5839876|NCT00005637|adult mixed glioma|adult mixed glioma
5839877|NCT00005637|adult giant cell glioblastoma|adult giant cell glioblastoma
5839878|NCT00005637|adult gliosarcoma|adult gliosarcoma
5839879|NCT00005637|adult anaplastic ependymoma|adult anaplastic ependymoma
5837520|NCT00014443|adult gliosarcoma|adult gliosarcoma
5839880|NCT00005627|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5839881|NCT00005627|recurrent prostate cancer|recurrent prostate cancer
5839882|NCT00005623|stage IV prostate cancer|stage iv prostate cancer
5839883|NCT00005623|recurrent prostate cancer|recurrent prostate cancer
5839884|NCT00005623|hot flashes|hot flashes
5839885|NCT00005622|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5839886|NCT00005622|refractory multiple myeloma|refractory multiple myeloma
5839887|NCT00005622|stage I multiple myeloma|stage i multiple myeloma
5839888|NCT00005622|stage II multiple myeloma|stage ii multiple myeloma
5839889|NCT00005622|stage III multiple myeloma|stage iii multiple myeloma
5839890|NCT00005622|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5839891|NCT00005622|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5839892|NCT00005622|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5839893|NCT00005622|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5839894|NCT00005622|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5839895|NCT00005622|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5839896|NCT00005622|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839897|NCT00005622|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5839898|NCT00005622|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5839899|NCT00005622|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5839900|NCT00005622|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5839901|NCT00005622|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5839902|NCT00005622|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5839903|NCT00005622|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5839904|NCT00005622|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5839905|NCT00005622|polycythemia vera|polycythemia vera
5839906|NCT00005622|primary myelofibrosis|primary myelofibrosis
5839907|NCT00005622|essential thrombocythemia|essential thrombocythemia
5839908|NCT00005622|refractory anemia|refractory anemia
5839909|NCT00005622|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5839910|NCT00005622|refractory anemia with excess blasts|refractory anemia with excess blasts
5839911|NCT00005622|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5839912|NCT00005622|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5839913|NCT00005622|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5839914|NCT00005622|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5839915|NCT00005622|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5839916|NCT00005622|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5839917|NCT00005622|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5839918|NCT00005622|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5839919|NCT00005622|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5839920|NCT00005622|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5839921|NCT00005622|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5839922|NCT00005622|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5839923|NCT00005622|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5839924|NCT00005622|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5839925|NCT00005622|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5863073|NCT00001404|Hypothalamic Hamartoma|hypothalamic hamartoma
5839926|NCT00005622|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5839927|NCT00005617|stage IV melanoma|stage iv melanoma
5839929|NCT00005606|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5839930|NCT00005606|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5839931|NCT00005606|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5839932|NCT00005606|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5839933|NCT00005606|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5839934|NCT00005606|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5839935|NCT00005606|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5839936|NCT00005606|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5839937|NCT00005606|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5839938|NCT00005606|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5839939|NCT00005606|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5839940|NCT00005606|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5839941|NCT00005606|extramedullary plasmacytoma|extramedullary plasmacytoma
5839942|NCT00005606|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5839943|NCT00005606|stage I multiple myeloma|stage i multiple myeloma
5839944|NCT00005606|stage II multiple myeloma|stage ii multiple myeloma
5839945|NCT00005606|stage III multiple myeloma|stage iii multiple myeloma
5839946|NCT00005606|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5839947|NCT00005606|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5839948|NCT00005606|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5839949|NCT00005606|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5839950|NCT00005606|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5839951|NCT00005606|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5839952|NCT00005606|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5839953|NCT00005606|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5839954|NCT00005606|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5839955|NCT00005606|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5839956|NCT00005606|untreated hairy cell leukemia|untreated hairy cell leukemia
5839957|NCT00005606|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5839958|NCT00005606|refractory hairy cell leukemia|refractory hairy cell leukemia
5839959|NCT00005606|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5839960|NCT00005606|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5839961|NCT00005606|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5839962|NCT00005606|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5841478|NCT00003831|large cell lung cancer|large cell lung cancer
5839963|NCT00005606|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5839964|NCT00005606|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5839965|NCT00005606|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5839966|NCT00005606|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5839967|NCT00005606|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5839968|NCT00005606|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5839969|NCT00005606|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5839970|NCT00005606|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5839971|NCT00005606|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5839972|NCT00005606|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5839973|NCT00005606|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5839974|NCT00005606|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5839975|NCT00005606|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5839976|NCT00005606|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5839977|NCT00005606|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5839978|NCT00005606|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5839979|NCT00005606|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5839980|NCT00005606|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5839981|NCT00005606|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5839982|NCT00005606|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5839983|NCT00005606|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5839984|NCT00005606|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5839985|NCT00005606|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5839986|NCT00005606|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5839987|NCT00005606|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5839988|NCT00005606|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5839989|NCT00005606|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5839990|NCT00005606|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5839991|NCT00005605|osteoporosis|osteoporosis
5839992|NCT00005605|stage I breast cancer|stage i breast cancer
5839993|NCT00005605|stage II breast cancer|stage ii breast cancer
5839994|NCT00005603|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5839995|NCT00005603|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5839996|NCT00005602|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5839997|NCT00005601|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5839998|NCT00005601|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5839999|NCT00005601|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840000|NCT00005601|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840001|NCT00005601|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840002|NCT00005601|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5840003|NCT00005601|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840004|NCT00005601|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5840005|NCT00005601|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5840007|NCT00005601|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5840008|NCT00005601|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840009|NCT00005601|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840010|NCT00005601|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5840011|NCT00005601|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840012|NCT00005600|stage I breast cancer|stage i breast cancer
5840013|NCT00005600|stage II breast cancer|stage ii breast cancer
5840014|NCT00005600|lymphedema|lymphedema
5840015|NCT00005600|perioperative/postoperative complications|perioperative/postoperative complications
5840016|NCT00005599|stage III gastric cancer|stage iii gastric cancer
5840017|NCT00005599|stage IV gastric cancer|stage iv gastric cancer
5840018|NCT00005599|recurrent gastric cancer|recurrent gastric cancer
5840019|NCT00005599|stage III esophageal cancer|stage iii esophageal cancer
5840020|NCT00005599|stage IV esophageal cancer|stage iv esophageal cancer
5840021|NCT00005599|recurrent esophageal cancer|recurrent esophageal cancer
5840022|NCT00005599|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5840023|NCT00005599|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5840024|NCT00005597|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5840025|NCT00005596|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5840026|NCT00005590|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5840027|NCT00005590|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5840028|NCT00005590|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5840029|NCT00005590|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5840030|NCT00005590|recurrent breast cancer|recurrent breast cancer
5840031|NCT00005590|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5840032|NCT00005590|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5840033|NCT00005590|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5840034|NCT00005590|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5840035|NCT00005590|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5840036|NCT00005590|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840037|NCT00005590|limited stage small cell lung cancer|limited stage small cell lung cancer
5840038|NCT00005590|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5840039|NCT00005590|recurrent small cell lung cancer|recurrent small cell lung cancer
5840040|NCT00005590|small intestine lymphoma|small intestine lymphoma
5840041|NCT00005590|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5840042|NCT00005590|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5840697|NCT00004135|stage IV melanoma|stage iv melanoma
5840043|NCT00005590|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840044|NCT00005590|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5840045|NCT00005590|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5840046|NCT00005590|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5840047|NCT00005590|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5840048|NCT00005590|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5840049|NCT00005590|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5840050|NCT00005590|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5840051|NCT00005590|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5840052|NCT00005590|stage II ovarian germ cell tumor|stage ii ovarian germ cell tumor
5840053|NCT00005590|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5840054|NCT00005590|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5840055|NCT00005590|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5863074|NCT00001404|Polysyndactyly|polysyndactyly
5840056|NCT00005590|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5840057|NCT00005590|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5840248|NCT00005049|stage II colon cancer|stage ii colon cancer
5840058|NCT00005590|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5840059|NCT00005590|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5840060|NCT00005590|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5840061|NCT00005590|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5840062|NCT00005590|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5840063|NCT00005590|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5840064|NCT00005590|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5840065|NCT00005590|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5840066|NCT00005590|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5840067|NCT00005590|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5840068|NCT00005590|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5840069|NCT00005590|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5840070|NCT00005590|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5840071|NCT00005590|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5840072|NCT00005590|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5840073|NCT00005590|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840074|NCT00005590|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840075|NCT00005590|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840076|NCT00005590|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840077|NCT00005590|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840078|NCT00005590|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5846693|NCT00043719|Nitric Oxide|nitric oxide
5840079|NCT00005590|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840080|NCT00005590|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5840081|NCT00005590|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5840082|NCT00005590|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5840083|NCT00005590|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5840084|NCT00005590|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5840085|NCT00005590|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5840086|NCT00005590|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5840087|NCT00005590|extragonadal germ cell tumor|extragonadal germ cell tumor
5840088|NCT00005590|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5840089|NCT00005590|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5840090|NCT00005590|infection|infection
5840091|NCT00005590|intraocular lymphoma|intraocular lymphoma
5840092|NCT00005590|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5840093|NCT00005590|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5840094|NCT00005590|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5840095|NCT00005590|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5840096|NCT00005590|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5840097|NCT00005590|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5840098|NCT00005590|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5840099|NCT00005590|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5840100|NCT00005590|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5840101|NCT00005590|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5840102|NCT00005590|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5840103|NCT00005590|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5840104|NCT00005590|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5840105|NCT00005590|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5840106|NCT00005590|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5840107|NCT00005590|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5840108|NCT00005590|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5840109|NCT00005590|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5840110|NCT00005590|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5840111|NCT00005590|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5840112|NCT00005590|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5840113|NCT00005590|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5840114|NCT00005590|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5840115|NCT00005590|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840116|NCT00005590|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5840117|NCT00005590|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5840118|NCT00005590|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5840119|NCT00005590|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5840120|NCT00005590|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5840121|NCT00005590|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5840122|NCT00005590|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840123|NCT00005590|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5840124|NCT00005590|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5840125|NCT00005590|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5840126|NCT00005590|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5840128|NCT00005590|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840129|NCT00005590|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5840130|NCT00005590|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5840131|NCT00005590|stage II small lymphocytic lymphoma|stage ii small lymphocytic lymphoma
5840132|NCT00005590|stage II marginal zone lymphoma|stage ii marginal zone lymphoma
5840133|NCT00005590|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5840134|NCT00005590|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5840135|NCT00005590|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5840136|NCT00005590|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5840137|NCT00005590|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840138|NCT00005590|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5840139|NCT00005590|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840140|NCT00005589|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840141|NCT00005589|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840142|NCT00005589|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840143|NCT00005586|stage II colon cancer|stage ii colon cancer
5840144|NCT00005586|stage III colon cancer|stage iii colon cancer
5840145|NCT00005586|stage II rectal cancer|stage ii rectal cancer
5840146|NCT00005586|stage III rectal cancer|stage iii rectal cancer
5840147|NCT00005585|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5840148|NCT00005585|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5841765|NCT00003687|prolymphocytic leukemia|prolymphocytic leukemia
5840149|NCT00005584|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5840150|NCT00005584|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5840151|NCT00005584|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5840152|NCT00005583|stage I endometrial carcinoma|stage i endometrial carcinoma
5840153|NCT00005583|stage II endometrial carcinoma|stage ii endometrial carcinoma
5840154|NCT00005583|endometrial adenocarcinoma|endometrial adenocarcinoma
5840155|NCT00005583|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5840156|NCT00005583|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5840157|NCT00005580|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840158|NCT00005580|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5840159|NCT00005580|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5840160|NCT00005580|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5840161|NCT00005580|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5840162|NCT00005580|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5840163|NCT00005580|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5840164|NCT00005580|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5840165|NCT00005580|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5840166|NCT00005580|refractory hairy cell leukemia|refractory hairy cell leukemia
5840167|NCT00005580|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840168|NCT00005580|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840169|NCT00005580|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840170|NCT00005580|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5840171|NCT00005580|prolymphocytic leukemia|prolymphocytic leukemia
5840172|NCT00005580|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840173|NCT00005580|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840174|NCT00005580|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5840175|NCT00005580|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840176|NCT00005580|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840177|NCT00005580|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5863075|NCT00001404|Autosomal Dominant|autosomal dominant
5840178|NCT00005580|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840179|NCT00005579|Waldenström macroglobulinemia|waldenström macroglobulinemia
5840180|NCT00005579|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5840181|NCT00005579|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5840182|NCT00005579|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5840183|NCT00005579|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5840184|NCT00005579|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5840185|NCT00005579|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5840186|NCT00005579|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5840187|NCT00005579|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5840188|NCT00005579|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5840189|NCT00005579|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5840190|NCT00005579|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5840191|NCT00005579|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840192|NCT00005579|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840193|NCT00005579|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840194|NCT00005579|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840195|NCT00005579|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5840196|NCT00005579|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5840197|NCT00005095|ovarian epithelial cancer|ovarian epithelial cancer
5831856|NCT00053742|HV|hv
5840198|NCT00005095|hereditary breast/ovarian cancer (BRCA1, BRCA2)|hereditary breast/ovarian cancer (brca1, brca2)
5840199|NCT00005095|fallopian tube cancer|fallopian tube cancer
5840200|NCT00005095|ovarian germ cell tumor|ovarian germ cell tumor
5840201|NCT00005095|ovarian sarcoma|ovarian sarcoma
5840202|NCT00005095|ovarian stromal cancer|ovarian stromal cancer
5840203|NCT00005095|endometrial cancer|endometrial cancer
5840204|NCT00005095|uterine sarcoma|uterine sarcoma
5840205|NCT00005095|vaginal cancer|vaginal cancer
5840206|NCT00005095|cervical cancer|cervical cancer
5840207|NCT00005095|vulvar cancer|vulvar cancer
5840208|NCT00005095|uterine leiomyomata|uterine leiomyomata
5840209|NCT00005087|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5840210|NCT00005087|metastatic squamous neck cancer with occult primary squamous cell carcinoma|metastatic squamous neck cancer with occult primary squamous cell carcinoma
5840211|NCT00005087|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5840212|NCT00005087|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5840213|NCT00005087|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5840214|NCT00005087|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5840215|NCT00005087|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5840216|NCT00005087|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5840217|NCT00005087|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5840218|NCT00005087|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5840219|NCT00005087|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5840220|NCT00005087|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5840221|NCT00005087|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5840222|NCT00005087|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5840223|NCT00005087|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5840224|NCT00005087|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5840225|NCT00005087|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5840226|NCT00005087|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5840227|NCT00005087|stage I squamous cell carcinoma of the paranasal sinus and nasal cavity|stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
5840228|NCT00005087|stage II squamous cell carcinoma of the paranasal sinus and nasal cavity|stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
5840229|NCT00005087|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5840306|NCT00004921|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840230|NCT00005087|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5840231|NCT00005079|stage I breast cancer|stage i breast cancer
5840232|NCT00005079|stage II breast cancer|stage ii breast cancer
5840233|NCT00005079|stage IIIA breast cancer|stage iiia breast cancer
5840234|NCT00005079|stage IIIB breast cancer|stage iiib breast cancer
5840235|NCT00005074|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5840236|NCT00005074|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5840237|NCT00005074|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5840238|NCT00005074|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5863076|NCT00001404|Mutation|mutation
5840239|NCT00005074|stage II mantle cell lymphoma|stage ii mantle cell lymphoma
5840240|NCT00005062|limited stage small cell lung cancer|limited stage small cell lung cancer
5840241|NCT00005060|stage II gastric cancer|stage ii gastric cancer
5840242|NCT00005060|stage III gastric cancer|stage iii gastric cancer
5840244|NCT00005051|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5840245|NCT00005051|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5840246|NCT00005051|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840247|NCT00005051|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840249|NCT00005049|stage III colon cancer|stage iii colon cancer
5840250|NCT00005049|stage II gastric cancer|stage ii gastric cancer
5840251|NCT00005049|stage III gastric cancer|stage iii gastric cancer
5840252|NCT00005049|recurrent gastric cancer|recurrent gastric cancer
5840253|NCT00005049|stage II rectal cancer|stage ii rectal cancer
5840254|NCT00005049|stage III rectal cancer|stage iii rectal cancer
5840255|NCT00005049|recurrent colon cancer|recurrent colon cancer
5840256|NCT00005049|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840257|NCT00005049|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5840258|NCT00005049|regional gastrointestinal carcinoid tumor|regional gastrointestinal carcinoid tumor
5840259|NCT00005049|small intestine adenocarcinoma|small intestine adenocarcinoma
5840260|NCT00005049|small intestine lymphoma|small intestine lymphoma
5840261|NCT00005049|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5840262|NCT00005049|recurrent small intestine cancer|recurrent small intestine cancer
5840263|NCT00005049|peritoneal cavity cancer|peritoneal cavity cancer
5840264|NCT00005049|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5840265|NCT00005047|stage I bladder cancer|stage i bladder cancer
5840266|NCT00005047|stage II bladder cancer|stage ii bladder cancer
5840267|NCT00005047|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5840268|NCT00005044|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5840269|NCT00005044|stage IIB prostate cancer|stage iib prostate cancer
5840270|NCT00005044|stage IIA prostate cancer|stage iia prostate cancer
5840271|NCT00005044|stage III prostate cancer|stage iii prostate cancer
5840272|NCT00005038|stage IV renal cell cancer|stage iv renal cell cancer
5840273|NCT00005038|recurrent renal cell cancer|recurrent renal cell cancer
5840274|NCT00005033|recurrent osteosarcoma|recurrent osteosarcoma
5840275|NCT00004936|stage III cervical cancer|stage iii cervical cancer
5840276|NCT00004936|stage IB cervical cancer|stage ib cervical cancer
5840277|NCT00004936|stage IIB cervical cancer|stage iib cervical cancer
5840278|NCT00004936|stage IVB cervical cancer|stage ivb cervical cancer
5840279|NCT00004936|stage IIA cervical cancer|stage iia cervical cancer
5840280|NCT00004936|stage IVA cervical cancer|stage iva cervical cancer
5840281|NCT00004936|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5840282|NCT00004936|cervical adenocarcinoma|cervical adenocarcinoma
5840283|NCT00004936|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5840284|NCT00004935|stage IV breast cancer|stage iv breast cancer
5840285|NCT00004935|recurrent breast cancer|recurrent breast cancer
5840286|NCT00004934|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5840287|NCT00004934|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840288|NCT00004934|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840289|NCT00004934|fallopian tube cancer|fallopian tube cancer
5840290|NCT00004934|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5840291|NCT00004932|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5840292|NCT00004932|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5840293|NCT00004932|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5840294|NCT00004932|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5840295|NCT00004932|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5840296|NCT00004930|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5840297|NCT00004930|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5840298|NCT00004930|recurrent small cell lung cancer|recurrent small cell lung cancer
5840299|NCT00004930|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5840300|NCT00004930|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5840301|NCT00004930|lung metastases|lung metastases
5840302|NCT00004930|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5840303|NCT00004924|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5840304|NCT00004924|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5840305|NCT00004921|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840307|NCT00004920|localized malignant mesothelioma|localized malignant mesothelioma
5840308|NCT00004920|advanced malignant mesothelioma|advanced malignant mesothelioma
5840309|NCT00004920|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5840310|NCT00004917|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5840311|NCT00004917|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5840312|NCT00004917|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5863077|NCT00001404|Gelastic|gelastic
5863078|NCT00001404|Gelastic Seizure|gelastic seizure
5840313|NCT00004917|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5840314|NCT00004917|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5840315|NCT00004917|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5840316|NCT00004917|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5840317|NCT00004917|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5840318|NCT00004917|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5840319|NCT00004917|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5840449|NCT00004250|stage IV melanoma|stage iv melanoma
5840320|NCT00004917|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5840321|NCT00004917|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5840322|NCT00004917|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5840323|NCT00004917|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5840324|NCT00004917|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5840325|NCT00004917|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5840327|NCT00004907|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5840328|NCT00004907|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840329|NCT00004907|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840330|NCT00004907|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840331|NCT00004907|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840332|NCT00004907|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840333|NCT00004907|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840334|NCT00004907|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5840335|NCT00004907|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840336|NCT00004907|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840337|NCT00004907|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5840338|NCT00004907|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840339|NCT00004907|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840340|NCT00004907|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5840341|NCT00004907|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840342|NCT00004899|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5840343|NCT00004899|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5840344|NCT00004899|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5840345|NCT00004899|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5840346|NCT00004899|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5840347|NCT00004899|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5840348|NCT00004899|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5840349|NCT00004899|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5840350|NCT00004899|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5840351|NCT00004899|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5840352|NCT00004899|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5840353|NCT00004899|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5840354|NCT00004899|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5840355|NCT00004899|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5840356|NCT00004899|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5840357|NCT00004899|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5840358|NCT00004899|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5840359|NCT00004899|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5840360|NCT00004899|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5840361|NCT00004899|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840362|NCT00004899|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5840363|NCT00004899|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5840364|NCT00004899|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5840365|NCT00004899|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5840366|NCT00004899|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5840367|NCT00004899|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5840368|NCT00004899|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5840369|NCT00004899|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5840370|NCT00004896|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5840371|NCT00004896|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5840372|NCT00004896|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5840373|NCT00004896|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5840374|NCT00004896|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5840375|NCT00004896|adult acute promyelocytic leukemia (M3)|adult acute promyelocytic leukemia (m3)
5840376|NCT00004896|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5840377|NCT00004896|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5840378|NCT00004896|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5840379|NCT00004896|refractory anemia|refractory anemia
5840380|NCT00004896|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5840381|NCT00004896|refractory anemia with excess blasts|refractory anemia with excess blasts
5840382|NCT00004896|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5840383|NCT00004896|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5840384|NCT00004896|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5840385|NCT00004896|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840386|NCT00004896|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5840387|NCT00004896|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5840388|NCT00004896|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5840389|NCT00004896|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5838052|NCT00008216|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5840390|NCT00004896|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5840391|NCT00004896|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5840392|NCT00004896|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5840393|NCT00004896|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5840394|NCT00004891|stage II rectal cancer|stage ii rectal cancer
5840395|NCT00004891|stage III rectal cancer|stage iii rectal cancer
5840396|NCT00004891|stage IV rectal cancer|stage iv rectal cancer
5840397|NCT00004879|recurrent renal cell cancer|recurrent renal cell cancer
5840398|NCT00004879|recurrent prostate cancer|recurrent prostate cancer
5840399|NCT00004879|recurrent colon cancer|recurrent colon cancer
5840400|NCT00004879|recurrent rectal cancer|recurrent rectal cancer
5840401|NCT00004879|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5840402|NCT00004879|recurrent pancreatic cancer|recurrent pancreatic cancer
5840403|NCT00004879|recurrent esophageal cancer|recurrent esophageal cancer
5840404|NCT00004876|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840405|NCT00004876|stage IC ovarian epithelial cancer|stage ic ovarian epithelial cancer
5840406|NCT00004876|stage IIA ovarian epithelial cancer|stage iia ovarian epithelial cancer
5840407|NCT00004876|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5840408|NCT00004876|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5840409|NCT00004876|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5840410|NCT00004876|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5840411|NCT00004876|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5840412|NCT00004873|stage III gastric cancer|stage iii gastric cancer
5840413|NCT00004873|stage IV gastric cancer|stage iv gastric cancer
5840414|NCT00004873|recurrent gastric cancer|recurrent gastric cancer
5840415|NCT00004871|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5840416|NCT00004871|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5840417|NCT00004871|refractory anemia|refractory anemia
5840418|NCT00004871|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5840419|NCT00004871|refractory anemia with excess blasts|refractory anemia with excess blasts
5840420|NCT00004871|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5840421|NCT00004871|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5840422|NCT00004871|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5840423|NCT00004871|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840424|NCT00004871|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5840425|NCT00004871|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5840426|NCT00004871|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5840427|NCT00004867|stage I esophageal cancer|stage i esophageal cancer
5840428|NCT00004867|stage II esophageal cancer|stage ii esophageal cancer
5840429|NCT00004867|stage III esophageal cancer|stage iii esophageal cancer
5840430|NCT00004867|stage IV esophageal cancer|stage iv esophageal cancer
5840431|NCT00004867|squamous cell carcinoma of the esophagus|squamous cell carcinoma of the esophagus
5840695|NCT00004135|stage IV renal cell cancer|stage iv renal cell cancer
5840432|NCT00004867|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5840433|NCT00004866|stage III cervical cancer|stage iii cervical cancer
5840434|NCT00004866|stage IV cervical cancer|stage iv cervical cancer
5840435|NCT00004866|recurrent cervical cancer|recurrent cervical cancer
5840436|NCT00004866|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5840437|NCT00004859|squamous cell lung cancer|squamous cell lung cancer
5840438|NCT00004859|large cell lung cancer|large cell lung cancer
5840439|NCT00004859|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5840440|NCT00004859|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5840441|NCT00004859|adenocarcinoma of the lung|adenocarcinoma of the lung
5840442|NCT00004859|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5840443|NCT00004859|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5840444|NCT00004259|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5840445|NCT00004259|adult mixed glioma|adult mixed glioma
5840446|NCT00004250|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5840447|NCT00004250|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5840448|NCT00004250|stage III melanoma|stage iii melanoma
5851306|NCT00006207|PRO 2000|pro 2000
5840450|NCT00004250|recurrent melanoma|recurrent melanoma
5840451|NCT00004250|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5840452|NCT00004245|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5840453|NCT00004245|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5840454|NCT00004245|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5840455|NCT00004245|refractory anemia with excess blasts|refractory anemia with excess blasts
5840456|NCT00004245|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5840458|NCT00004245|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840459|NCT00004245|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5840460|NCT00004245|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5840461|NCT00004245|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5840462|NCT00004245|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5840463|NCT00004245|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5846694|NCT00043719|Nitroglycerin|nitroglycerin
5846695|NCT00043719|Calcium|calcium
5840464|NCT00004245|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5840465|NCT00004245|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5840466|NCT00004244|stage IV renal cell cancer|stage iv renal cell cancer
5840467|NCT00004244|recurrent renal cell cancer|recurrent renal cell cancer
5840468|NCT00004244|stage IV melanoma|stage iv melanoma
5840469|NCT00004244|recurrent melanoma|recurrent melanoma
5840470|NCT00004237|stage I breast cancer|stage i breast cancer
5840471|NCT00004237|stage II breast cancer|stage ii breast cancer
5840472|NCT00004234|oral complications|oral complications
5840473|NCT00004234|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5840474|NCT00004234|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5840475|NCT00004234|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5840476|NCT00004234|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5840477|NCT00004234|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5840478|NCT00004234|stage I squamous cell carcinoma of the oropharynx|stage i squamous cell carcinoma of the oropharynx
5840479|NCT00004234|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5840480|NCT00004234|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5840481|NCT00004234|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5840482|NCT00004234|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5840483|NCT00004234|stage I squamous cell carcinoma of the nasopharynx|stage i squamous cell carcinoma of the nasopharynx
5840484|NCT00004234|stage II squamous cell carcinoma of the nasopharynx|stage ii squamous cell carcinoma of the nasopharynx
5840485|NCT00004234|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5840486|NCT00004234|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5840487|NCT00004234|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5840488|NCT00004234|stage I squamous cell carcinoma of the hypopharynx|stage i squamous cell carcinoma of the hypopharynx
5840489|NCT00004234|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5840490|NCT00004234|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5840491|NCT00004234|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5840492|NCT00004234|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5840493|NCT00004234|stage I squamous cell carcinoma of the larynx|stage i squamous cell carcinoma of the larynx
5840494|NCT00004234|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5840696|NCT00004135|recurrent renal cell cancer|recurrent renal cell cancer
5840495|NCT00004234|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5863079|NCT00001404|Hypothalamic|hypothalamic
5840496|NCT00004234|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5840497|NCT00004234|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5840498|NCT00004231|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5840499|NCT00004231|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5840500|NCT00004231|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840501|NCT00004228|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5840502|NCT00004228|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5840503|NCT00004227|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5840504|NCT00004227|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5840505|NCT00004227|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5840506|NCT00004227|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5840507|NCT00004227|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5840570|NCT00004205|stage IIIA breast cancer|stage iiia breast cancer
5840508|NCT00004227|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5840509|NCT00004227|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5840510|NCT00004227|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5840511|NCT00004227|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5840512|NCT00004226|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5846689|NCT00043732|Scio-469|scio-469
5840513|NCT00004226|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5840514|NCT00004226|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5840515|NCT00004226|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5840516|NCT00004226|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5840517|NCT00004226|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5840518|NCT00004225|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5840519|NCT00004224|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5840520|NCT00004224|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5840521|NCT00004224|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5840522|NCT00004218|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5840523|NCT00004218|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5840524|NCT00004218|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5840525|NCT00004218|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5840526|NCT00004218|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5840527|NCT00004212|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5840528|NCT00004212|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5840529|NCT00004212|childhood craniopharyngioma|childhood craniopharyngioma
5840530|NCT00004212|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5840531|NCT00004212|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5840532|NCT00004212|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5840533|NCT00004212|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5840534|NCT00004212|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5840535|NCT00004212|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5840536|NCT00004212|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5840537|NCT00004212|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5840538|NCT00004212|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5840539|NCT00004212|childhood oligodendroglioma|childhood oligodendroglioma
5840540|NCT00004212|childhood choroid plexus tumor|childhood choroid plexus tumor
5840541|NCT00004212|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5840542|NCT00004212|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5840543|NCT00004212|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5840544|NCT00004212|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5840545|NCT00004212|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5840546|NCT00004212|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5840547|NCT00004212|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5840548|NCT00004212|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5840549|NCT00004212|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5840550|NCT00004212|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5840551|NCT00004212|untreated childhood cerebellar astrocytoma|untreated childhood cerebellar astrocytoma
5840552|NCT00004212|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5840553|NCT00004212|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5840554|NCT00004212|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5848334|NCT00035126|epothilone|epothilone
5840555|NCT00004212|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5840556|NCT00004212|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5840557|NCT00004212|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5840558|NCT00004212|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5840559|NCT00004212|recurrent childhood ependymoma|recurrent childhood ependymoma
5840560|NCT00004210|colon cancer|colon cancer
5840561|NCT00004210|rectal cancer|rectal cancer
5840562|NCT00004208|refractory anemia|refractory anemia
5840563|NCT00004208|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5840564|NCT00004208|refractory anemia with excess blasts|refractory anemia with excess blasts
5840565|NCT00004208|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5840566|NCT00004208|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840567|NCT00004208|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5840568|NCT00004205|stage I breast cancer|stage i breast cancer
5840569|NCT00004205|stage II breast cancer|stage ii breast cancer
5840571|NCT00004205|breast cancer in situ|breast cancer in situ
5840572|NCT00004205|recurrent breast cancer|recurrent breast cancer
5840573|NCT00004205|ductal breast carcinoma|ductal breast carcinoma
5840574|NCT00004205|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5840575|NCT00004196|stage I melanoma|stage i melanoma
5840576|NCT00004196|stage II melanoma|stage ii melanoma
5840577|NCT00004196|stage III melanoma|stage iii melanoma
5838281|NCT00008008|adult glioblastoma|adult glioblastoma
5840578|NCT00004189|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5840579|NCT00004189|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5840580|NCT00004189|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5840581|NCT00004189|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5840582|NCT00004189|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5840583|NCT00004189|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840584|NCT00004189|small intestine lymphoma|small intestine lymphoma
5857428|NCT00023101|endocrine dysfunction|endocrine dysfunction
5857429|NCT00023088|Rehabilitation|rehabilitation
5857430|NCT00023088|Functional Level|functional level
5857431|NCT00023088|Activity of Daily Living|activity of daily living
5857432|NCT00023088|Mobility|mobility
5857433|NCT00023088|Normal Volunteer|normal volunteer
5857434|NCT00023075|MRI|mri
5857435|NCT00023075|Neuromuscular Disease|neuromuscular disease
5857436|NCT00023075|N-Acetyl Aspartate|n-acetyl aspartate
5857437|NCT00023075|Choline|choline
5857438|NCT00023075|Creatine|creatine
5857439|NCT00023075|Spasms|spasms
5857440|NCT00023075|Spasticity|spasticity
5857441|NCT00023075|Primary Lateral Sclerosis|primary lateral sclerosis
5857442|NCT00023075|Hereditary Spastic Paraplegia|hereditary spastic paraplegia
5840585|NCT00004189|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840586|NCT00004189|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5840587|NCT00004189|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5840588|NCT00004189|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5840589|NCT00004189|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5840590|NCT00004189|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5840591|NCT00004189|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5840592|NCT00004189|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5840593|NCT00004189|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5840594|NCT00004189|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5840595|NCT00004189|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5840596|NCT00004189|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5840597|NCT00004189|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5840598|NCT00004189|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5840599|NCT00004189|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5840600|NCT00004189|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5840601|NCT00004189|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5840602|NCT00004189|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5840603|NCT00004189|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5840604|NCT00004189|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840605|NCT00004189|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840606|NCT00004189|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840607|NCT00004189|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840608|NCT00004189|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840609|NCT00004189|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5859545|NCT00006202|Safety|safety
5840610|NCT00004189|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840611|NCT00004189|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5840612|NCT00004189|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5840613|NCT00004189|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5840614|NCT00004189|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5840615|NCT00004189|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5840616|NCT00004189|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5840617|NCT00004189|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5840618|NCT00004189|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5840619|NCT00004189|intraocular lymphoma|intraocular lymphoma
5840620|NCT00004189|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5840621|NCT00004189|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5840622|NCT00004189|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840623|NCT00004189|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5840624|NCT00004189|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5840625|NCT00004189|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5840626|NCT00004189|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5840627|NCT00004189|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840628|NCT00004189|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5840629|NCT00004189|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840630|NCT00004189|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5840631|NCT00004189|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5840632|NCT00004189|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5840633|NCT00004189|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5840634|NCT00004189|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840635|NCT00004189|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841235|NCT00003938|ovarian mature teratoma|ovarian mature teratoma
5840636|NCT00004189|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840637|NCT00004188|localized resectable neuroblastoma|localized resectable neuroblastoma
5840638|NCT00004188|regional neuroblastoma|regional neuroblastoma
5840639|NCT00004188|disseminated neuroblastoma|disseminated neuroblastoma
5840640|NCT00004188|stage 4S neuroblastoma|stage 4s neuroblastoma
5840641|NCT00004188|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5840642|NCT00004181|refractory multiple myeloma|refractory multiple myeloma
5840643|NCT00004181|stage I multiple myeloma|stage i multiple myeloma
5840644|NCT00004181|stage II multiple myeloma|stage ii multiple myeloma
5840645|NCT00004181|stage III multiple myeloma|stage iii multiple myeloma
5840646|NCT00004181|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5840647|NCT00004181|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5840648|NCT00004181|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5840649|NCT00004179|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5840650|NCT00004179|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5840651|NCT00004179|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5840652|NCT00004179|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5840653|NCT00004179|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5840654|NCT00004179|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5840655|NCT00004179|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840656|NCT00004179|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840657|NCT00004179|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840658|NCT00004173|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840659|NCT00004165|refractory multiple myeloma|refractory multiple myeloma
5840660|NCT00004165|stage I multiple myeloma|stage i multiple myeloma
5840661|NCT00004165|stage II multiple myeloma|stage ii multiple myeloma
5840662|NCT00004165|stage III multiple myeloma|stage iii multiple myeloma
5840663|NCT00004165|primary systemic amyloidosis|primary systemic amyloidosis
5840664|NCT00004154|stage 0 bladder cancer|stage 0 bladder cancer
5840665|NCT00004154|stage I bladder cancer|stage i bladder cancer
5840666|NCT00004154|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5840667|NCT00004153|stage I melanoma|stage i melanoma
5840668|NCT00004153|stage II melanoma|stage ii melanoma
5840669|NCT00004153|stage III melanoma|stage iii melanoma
5840670|NCT00004153|stage IV melanoma|stage iv melanoma
5840671|NCT00004150|stage III colon cancer|stage iii colon cancer
5840672|NCT00004150|adenocarcinoma of the colon|adenocarcinoma of the colon
5840673|NCT00004150|mucinous adenocarcinoma of the colon|mucinous adenocarcinoma of the colon
5840674|NCT00004149|stage IV prostate cancer|stage iv prostate cancer
5840675|NCT00004149|recurrent prostate cancer|recurrent prostate cancer
5840676|NCT00004147|recurrent adult brain tumor|recurrent adult brain tumor
5840677|NCT00004147|adult glioblastoma|adult glioblastoma
5840678|NCT00004147|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5840679|NCT00004147|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5840680|NCT00004147|adult giant cell glioblastoma|adult giant cell glioblastoma
5840681|NCT00004147|adult gliosarcoma|adult gliosarcoma
5840682|NCT00004144|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840683|NCT00004143|sickle cell anemia|sickle cell anemia
5840684|NCT00004143|severe aplastic anemia|severe aplastic anemia
5840685|NCT00004141|stage III melanoma|stage iii melanoma
5840686|NCT00004141|stage IV melanoma|stage iv melanoma
5840687|NCT00004141|recurrent melanoma|recurrent melanoma
5840688|NCT00004138|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5840689|NCT00004138|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5840690|NCT00004138|squamous cell lung cancer|squamous cell lung cancer
5840691|NCT00004138|large cell lung cancer|large cell lung cancer
5840692|NCT00004138|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5840693|NCT00004138|adenocarcinoma of the lung|adenocarcinoma of the lung
5840694|NCT00004138|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5840698|NCT00004135|recurrent melanoma|recurrent melanoma
5840699|NCT00004129|recurrent adult brain tumor|recurrent adult brain tumor
5840700|NCT00004129|adult glioblastoma|adult glioblastoma
5840701|NCT00004129|adult giant cell glioblastoma|adult giant cell glioblastoma
5840702|NCT00004129|adult gliosarcoma|adult gliosarcoma
5840703|NCT00004128|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5840704|NCT00004128|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5840705|NCT00004128|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5840706|NCT00004128|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5840707|NCT00004128|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5840708|NCT00004128|adult acute monoblastic leukemia (M5a)|adult acute monoblastic leukemia (m5a)
5840709|NCT00004128|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5840710|NCT00004128|adult acute monocytic leukemia (M5b)|adult acute monocytic leukemia (m5b)
5840711|NCT00004128|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5840712|NCT00004128|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5840713|NCT00004128|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5840714|NCT00004128|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5840715|NCT00004128|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5840716|NCT00004124|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5840717|NCT00004124|stage I prostate cancer|stage i prostate cancer
5840718|NCT00004124|stage II prostate cancer|stage ii prostate cancer
5840719|NCT00004124|stage III prostate cancer|stage iii prostate cancer
5840720|NCT00004115|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5840721|NCT00004115|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5840722|NCT00004115|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840723|NCT00004115|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840724|NCT00004115|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5840725|NCT00004110|regional neuroblastoma|regional neuroblastoma
5840726|NCT00004110|disseminated neuroblastoma|disseminated neuroblastoma
5840727|NCT00004110|recurrent neuroblastoma|recurrent neuroblastoma
5840728|NCT00004110|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5840729|NCT00004106|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5840730|NCT00004106|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5840731|NCT00004106|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5840732|NCT00004106|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5840733|NCT00004106|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840734|NCT00004106|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5840735|NCT00004106|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5840736|NCT00004106|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5840737|NCT00004106|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5840738|NCT00004106|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840739|NCT00004103|stage I gastric cancer|stage i gastric cancer
5840740|NCT00004103|stage II gastric cancer|stage ii gastric cancer
5840741|NCT00004103|stage III gastric cancer|stage iii gastric cancer
5840742|NCT00004103|stage IV gastric cancer|stage iv gastric cancer
5840743|NCT00004099|stage II gastric cancer|stage ii gastric cancer
5840744|NCT00004099|stage III gastric cancer|stage iii gastric cancer
5840745|NCT00004099|stage IV gastric cancer|stage iv gastric cancer
5840746|NCT00004099|intestinal adenocarcinoma of the stomach|intestinal adenocarcinoma of the stomach
5840747|NCT00004099|diffuse adenocarcinoma of the stomach|diffuse adenocarcinoma of the stomach
5840748|NCT00004099|mixed adenocarcinoma of the stomach|mixed adenocarcinoma of the stomach
5840749|NCT00004092|stage II breast cancer|stage ii breast cancer
5840750|NCT00004092|stage IIIA breast cancer|stage iiia breast cancer
5840751|NCT00004092|stage IIIB breast cancer|stage iiib breast cancer
5840752|NCT00004088|stage I multiple myeloma|stage i multiple myeloma
5840753|NCT00004088|stage II multiple myeloma|stage ii multiple myeloma
5840754|NCT00004088|stage III multiple myeloma|stage iii multiple myeloma
5840755|NCT00004081|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5840756|NCT00004081|peritoneal cavity cancer|peritoneal cavity cancer
5840757|NCT00004077|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5840758|NCT00004077|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5840759|NCT00004077|testicular embryonal carcinoma|testicular embryonal carcinoma
5840760|NCT00004077|testicular choriocarcinoma|testicular choriocarcinoma
5840761|NCT00004077|testicular teratoma|testicular teratoma
5840762|NCT00004077|testicular yolk sac tumor|testicular yolk sac tumor
5840763|NCT00004077|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5840764|NCT00004077|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5840765|NCT00004077|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5840766|NCT00004077|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5840767|NCT00004077|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5840768|NCT00004077|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5840769|NCT00004075|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840770|NCT00004075|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5840771|NCT00004075|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5840772|NCT00004075|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840773|NCT00004075|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840774|NCT00004075|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5840775|NCT00004075|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840776|NCT00004075|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5840777|NCT00004075|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840778|NCT00004075|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840779|NCT00004075|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840780|NCT00004075|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840781|NCT00004075|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5840782|NCT00004075|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5840783|NCT00004075|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840784|NCT00004075|recurrent adult grade III lymphomatoid granulomatosis|recurrent adult grade iii lymphomatoid granulomatosis
5840785|NCT00004075|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5840786|NCT00004075|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5840787|NCT00004075|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5840788|NCT00004075|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5840789|NCT00004075|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5840790|NCT00004072|refractory multiple myeloma|refractory multiple myeloma
5840791|NCT00004072|stage I multiple myeloma|stage i multiple myeloma
5840792|NCT00004072|stage II multiple myeloma|stage ii multiple myeloma
5840793|NCT00004072|stage III multiple myeloma|stage iii multiple myeloma
5840795|NCT00004067|stage IIIA breast cancer|stage iiia breast cancer
5840796|NCT00004066|adult leiomyosarcoma|adult leiomyosarcoma
5840797|NCT00004066|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5840798|NCT00004066|small intestine leiomyosarcoma|small intestine leiomyosarcoma
5840799|NCT00004066|stage IV uterine sarcoma|stage iv uterine sarcoma
5840800|NCT00004066|recurrent uterine sarcoma|recurrent uterine sarcoma
5840801|NCT00004066|uterine leiomyosarcoma|uterine leiomyosarcoma
5840803|NCT00004066|recurrent small intestine cancer|recurrent small intestine cancer
5840804|NCT00004066|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5840805|NCT00004065|stage III colon cancer|stage iii colon cancer
5840806|NCT00004065|stage IV colon cancer|stage iv colon cancer
5840807|NCT00004065|stage IV breast cancer|stage iv breast cancer
5840808|NCT00004065|stage IIIA breast cancer|stage iiia breast cancer
5840809|NCT00004065|recurrent breast cancer|recurrent breast cancer
5840810|NCT00004065|stage III gastric cancer|stage iii gastric cancer
5840811|NCT00004065|stage IV gastric cancer|stage iv gastric cancer
5840812|NCT00004065|recurrent gastric cancer|recurrent gastric cancer
5840813|NCT00004065|stage IIIB breast cancer|stage iiib breast cancer
5840814|NCT00004065|stage IIIC breast cancer|stage iiic breast cancer
5840815|NCT00004065|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5840816|NCT00004065|recurrent colon cancer|recurrent colon cancer
5840817|NCT00004065|stage III renal cell cancer|stage iii renal cell cancer
5840818|NCT00004065|stage IV renal cell cancer|stage iv renal cell cancer
5840819|NCT00004065|recurrent renal cell cancer|recurrent renal cell cancer
5840820|NCT00004065|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5840821|NCT00004065|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5840822|NCT00004065|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5840823|NCT00004065|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5840824|NCT00004065|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5840825|NCT00004065|stage III bladder cancer|stage iii bladder cancer
5840826|NCT00004065|recurrent bladder cancer|recurrent bladder cancer
5840827|NCT00004065|stage IV bladder cancer|stage iv bladder cancer
5840828|NCT00004065|stage III prostate cancer|stage iii prostate cancer
5840829|NCT00004065|stage IV prostate cancer|stage iv prostate cancer
5840830|NCT00004065|recurrent prostate cancer|recurrent prostate cancer
5840831|NCT00004065|stage III melanoma|stage iii melanoma
5840832|NCT00004065|stage IV melanoma|stage iv melanoma
5840833|NCT00004065|recurrent melanoma|recurrent melanoma
5840834|NCT00004065|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5840835|NCT00004065|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5840836|NCT00004065|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5840837|NCT00004065|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840838|NCT00004065|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5840839|NCT00004065|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5840840|NCT00004065|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5840841|NCT00004065|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5840842|NCT00004065|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5840845|NCT00004065|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5840846|NCT00004065|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5838495|NCT00006468|stage IV rectal cancer|stage iv rectal cancer
5840847|NCT00004065|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5840848|NCT00004065|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5840849|NCT00004065|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5865290|NCT00000170|Amblyopia|amblyopia
5840850|NCT00004065|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5851405|NCT00005918|RNA, Viral|rna, viral
5840851|NCT00004065|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5840852|NCT00004065|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5840853|NCT00004065|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5840854|NCT00004065|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5840855|NCT00004065|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5840856|NCT00004065|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5840857|NCT00004065|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5840858|NCT00004065|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5840859|NCT00004065|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5840860|NCT00004065|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5840861|NCT00004065|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5840862|NCT00004065|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5840863|NCT00004065|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5840864|NCT00004065|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5840865|NCT00004065|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5840866|NCT00004065|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5840867|NCT00004065|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5840868|NCT00004065|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5840869|NCT00004065|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5840870|NCT00004065|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5840871|NCT00004065|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5840872|NCT00004065|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5840873|NCT00004065|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5840874|NCT00004065|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5840875|NCT00004065|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5840876|NCT00004065|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5840877|NCT00004065|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5840878|NCT00004065|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5840879|NCT00004065|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5840880|NCT00004065|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5840881|NCT00004065|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5840882|NCT00004065|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5840883|NCT00004065|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5840884|NCT00004065|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5840885|NCT00004065|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5840886|NCT00004065|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5840887|NCT00004065|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5840888|NCT00004065|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5840889|NCT00004065|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5846698|NCT00043576|Prostate Cancer|prostate cancer
5857946|NCT00017953|Physical Fitness/Physical Activity|physical fitness/physical activity
5857947|NCT00017953|Psychosocial outcomes (e.g., depression, eating disorders)|psychosocial outcomes (e.g., depression, eating disorders)
5857948|NCT00017953|Bone Density|bone density
5857951|NCT00017927|IGF-1|igf-1
5840890|NCT00004065|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5840891|NCT00004065|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5840892|NCT00004065|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5840893|NCT00004065|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5840894|NCT00004065|borderline ovarian surface epithelial-stromal tumor|borderline ovarian surface epithelial-stromal tumor
5840895|NCT00004065|ovarian sarcoma|ovarian sarcoma
5840896|NCT00004065|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5840897|NCT00004065|recurrent salivary gland cancer|recurrent salivary gland cancer
5840898|NCT00004065|stage IV salivary gland cancer|stage iv salivary gland cancer
5840899|NCT00004065|stage III salivary gland cancer|stage iii salivary gland cancer
5840900|NCT00004063|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5840901|NCT00004058|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5840902|NCT00004058|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5840903|NCT00004058|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5851999|NCT00002406|Indinavir|indinavir
5840904|NCT00004058|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5841863|NCT00003641|stage III melanoma|stage iii melanoma
5840905|NCT00004058|extramedullary plasmacytoma|extramedullary plasmacytoma
5840906|NCT00004058|refractory multiple myeloma|refractory multiple myeloma
5840907|NCT00004058|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5840908|NCT00004058|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5840909|NCT00004058|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5840910|NCT00004058|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5840911|NCT00004058|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5840912|NCT00004058|polycythemia vera|polycythemia vera
5840913|NCT00004058|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5840914|NCT00004058|essential thrombocythemia|essential thrombocythemia
5840915|NCT00004058|refractory hairy cell leukemia|refractory hairy cell leukemia
5840916|NCT00004058|refractory anemia|refractory anemia
5840917|NCT00004058|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5840918|NCT00004058|refractory anemia with excess blasts|refractory anemia with excess blasts
5840919|NCT00004058|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5840920|NCT00004058|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5840921|NCT00004058|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5840922|NCT00004058|acute undifferentiated leukemia|acute undifferentiated leukemia
5840923|NCT00004058|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5840924|NCT00004058|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5840925|NCT00004058|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5840926|NCT00004058|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5840927|NCT00004058|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5840928|NCT00004058|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5840929|NCT00004058|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5840930|NCT00004058|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5840931|NCT00004058|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5840932|NCT00004058|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5840933|NCT00004058|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5840934|NCT00004058|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840935|NCT00004058|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5840936|NCT00004058|primary central nervous system lymphoma|primary central nervous system lymphoma
5840937|NCT00004058|prolymphocytic leukemia|prolymphocytic leukemia
5840938|NCT00004058|primary systemic amyloidosis|primary systemic amyloidosis
5840939|NCT00004058|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5840940|NCT00004058|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5840941|NCT00004058|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5840942|NCT00004058|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5840943|NCT00004058|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5840944|NCT00004058|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5840945|NCT00004058|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5840946|NCT00004058|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5838489|NCT00006471|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5840947|NCT00004058|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5840948|NCT00004058|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5840949|NCT00004058|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5840950|NCT00004058|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5840951|NCT00004058|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5840952|NCT00004058|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5840953|NCT00004054|stage IIB prostate cancer|stage iib prostate cancer
5840954|NCT00004054|stage IIA prostate cancer|stage iia prostate cancer
5840955|NCT00004054|stage III prostate cancer|stage iii prostate cancer
5840956|NCT00004054|stage IV prostate cancer|stage iv prostate cancer
5840957|NCT00004031|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5840958|NCT00004031|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5840959|NCT00004031|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5840960|NCT00004031|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5840961|NCT00004031|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5840962|NCT00004031|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5840963|NCT00004031|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5840964|NCT00004031|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5840965|NCT00004031|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5840966|NCT00004031|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5840967|NCT00004031|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5840968|NCT00004031|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5840969|NCT00004031|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5840970|NCT00004031|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5840971|NCT00004031|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5840972|NCT00004031|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5840973|NCT00004031|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5840974|NCT00004031|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5840975|NCT00004031|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5840976|NCT00004031|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5840977|NCT00004031|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5840978|NCT00004031|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5840979|NCT00004031|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5840980|NCT00004031|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5840981|NCT00004028|recurrent adult brain tumor|recurrent adult brain tumor
5840982|NCT00004028|adult glioblastoma|adult glioblastoma
5840983|NCT00004028|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5840984|NCT00004028|adult anaplastic ependymoma|adult anaplastic ependymoma
5840985|NCT00004028|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5840986|NCT00004028|adult mixed glioma|adult mixed glioma
5840987|NCT00004028|adult ependymoblastoma|adult ependymoblastoma
5840988|NCT00004028|adult giant cell glioblastoma|adult giant cell glioblastoma
5840989|NCT00004028|adult gliosarcoma|adult gliosarcoma
5840990|NCT00004024|recurrent adult brain tumor|recurrent adult brain tumor
5840991|NCT00004024|adult glioblastoma|adult glioblastoma
5840992|NCT00004024|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5840993|NCT00004024|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5840994|NCT00004024|adult subependymoma|adult subependymoma
5840995|NCT00004024|adult oligodendroglioma|adult oligodendroglioma
5840996|NCT00004024|adult giant cell glioblastoma|adult giant cell glioblastoma
5840997|NCT00004024|adult gliosarcoma|adult gliosarcoma
5840998|NCT00004024|adult diffuse astrocytoma|adult diffuse astrocytoma
5840999|NCT00004017|recurrent adult brain tumor|recurrent adult brain tumor
5841001|NCT00004017|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5841002|NCT00004017|adult giant cell glioblastoma|adult giant cell glioblastoma
5841003|NCT00004017|adult gliosarcoma|adult gliosarcoma
5841004|NCT00004015|adult glioblastoma|adult glioblastoma
5841005|NCT00004015|adult giant cell glioblastoma|adult giant cell glioblastoma
5841006|NCT00004015|adult gliosarcoma|adult gliosarcoma
5841007|NCT00004011|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5841008|NCT00004011|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5841009|NCT00004011|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5841010|NCT00004005|stage III colon cancer|stage iii colon cancer
5841011|NCT00004005|stage IV colon cancer|stage iv colon cancer
5841012|NCT00004005|stage III rectal cancer|stage iii rectal cancer
5841013|NCT00004005|stage IV rectal cancer|stage iv rectal cancer
5841014|NCT00004005|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5841015|NCT00004005|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841016|NCT00004005|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5841017|NCT00004005|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5841018|NCT00004005|recurrent carcinoma of unknown primary|recurrent carcinoma of unknown primary
5841019|NCT00004001|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5841020|NCT00004001|stage IV prostate cancer|stage iv prostate cancer
5841021|NCT00004001|recurrent prostate cancer|recurrent prostate cancer
5841022|NCT00003993|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5841023|NCT00003993|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5841024|NCT00003993|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5841025|NCT00003993|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5841026|NCT00003993|small intestine lymphoma|small intestine lymphoma
5841027|NCT00003993|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841028|NCT00003993|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5841029|NCT00003993|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5841030|NCT00003993|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5841031|NCT00003993|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5841032|NCT00003993|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841033|NCT00003993|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841034|NCT00003993|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841035|NCT00003993|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5841036|NCT00003993|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5841037|NCT00003993|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5852000|NCT00002406|RNA, Viral|rna, viral
5841038|NCT00003993|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841039|NCT00003993|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841040|NCT00003993|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841041|NCT00003993|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841042|NCT00003993|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841043|NCT00003993|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841044|NCT00003993|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841045|NCT00003993|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841046|NCT00003993|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5841047|NCT00003993|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5841048|NCT00003993|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5841049|NCT00003993|intraocular lymphoma|intraocular lymphoma
5841050|NCT00003993|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5841051|NCT00003993|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841052|NCT00003993|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5841053|NCT00003993|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5841054|NCT00003993|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5841055|NCT00003993|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5841056|NCT00003993|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841057|NCT00003993|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841058|NCT00003993|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5841059|NCT00003993|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5841060|NCT00003993|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5841061|NCT00003993|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841062|NCT00003993|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5841063|NCT00003981|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841064|NCT00003979|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841065|NCT00003977|stage III cervical cancer|stage iii cervical cancer
5841066|NCT00003977|recurrent cervical cancer|recurrent cervical cancer
5841067|NCT00003977|stage IB cervical cancer|stage ib cervical cancer
5841068|NCT00003977|stage IIB cervical cancer|stage iib cervical cancer
5841069|NCT00003977|stage IVB cervical cancer|stage ivb cervical cancer
5841070|NCT00003977|stage IA cervical cancer|stage ia cervical cancer
5841071|NCT00003977|stage IIA cervical cancer|stage iia cervical cancer
5841072|NCT00003977|stage IVA cervical cancer|stage iva cervical cancer
5841073|NCT00003969|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841074|NCT00003966|veno-occlusive disease|veno-occlusive disease
5841075|NCT00003963|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5841076|NCT00003963|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841077|NCT00003963|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841078|NCT00003963|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841079|NCT00003963|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841080|NCT00003963|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841081|NCT00003963|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841082|NCT00003963|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841083|NCT00003963|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841084|NCT00003963|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841085|NCT00003963|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841086|NCT00003963|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841087|NCT00003963|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841088|NCT00003963|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5841089|NCT00003963|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841090|NCT00003963|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5841621|NCT00003750|metastatic osteosarcoma|metastatic osteosarcoma
5841091|NCT00003961|refractory anemia with excess blasts|refractory anemia with excess blasts
5841092|NCT00003961|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5841093|NCT00003961|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841094|NCT00003961|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841095|NCT00003961|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5841096|NCT00003961|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841097|NCT00003961|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5841098|NCT00003961|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5841099|NCT00003961|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5841100|NCT00003955|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5841101|NCT00003955|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5842701|NCT00003138|erythropoietin|erythropoietin
5841102|NCT00003955|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5841103|NCT00003955|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5841104|NCT00003955|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5841105|NCT00003955|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5841106|NCT00003955|adult malignant mesenchymoma|adult malignant mesenchymoma
5841107|NCT00003955|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5841108|NCT00003945|recurrent cervical cancer|recurrent cervical cancer
5841109|NCT00003945|stage IVB cervical cancer|stage ivb cervical cancer
5841110|NCT00003945|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5841111|NCT00003945|cervical adenocarcinoma|cervical adenocarcinoma
5841112|NCT00003945|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5841113|NCT00003941|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5841114|NCT00003941|mediastinal cancer|mediastinal cancer
5841115|NCT00003941|testicular embryonal carcinoma|testicular embryonal carcinoma
5841116|NCT00003941|testicular choriocarcinoma|testicular choriocarcinoma
5841117|NCT00003941|testicular teratoma|testicular teratoma
5841118|NCT00003941|testicular yolk sac tumor|testicular yolk sac tumor
5841119|NCT00003941|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5841120|NCT00003941|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5841121|NCT00003941|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5841122|NCT00003941|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5841123|NCT00003941|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5841124|NCT00003941|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5841125|NCT00003941|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5841126|NCT00003941|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5841127|NCT00003941|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5841128|NCT00003941|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5841129|NCT00003941|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5841130|NCT00003941|tumors metastatic to brain|tumors metastatic to brain
5841131|NCT00003941|liver metastases|liver metastases
5841132|NCT00003941|bone metastases|bone metastases
5841133|NCT00003938|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5841134|NCT00003938|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5841135|NCT00003938|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5841136|NCT00003938|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5841137|NCT00003938|stage IV breast cancer|stage iv breast cancer
5841138|NCT00003938|stage IIIA breast cancer|stage iiia breast cancer
5841139|NCT00003938|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5841140|NCT00003938|stage IIIB breast cancer|stage iiib breast cancer
5841141|NCT00003938|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5841142|NCT00003938|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5841143|NCT00003938|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5841144|NCT00003938|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5841145|NCT00003938|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5841146|NCT00003938|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5841147|NCT00003938|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5841148|NCT00003938|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5841149|NCT00003938|extramedullary plasmacytoma|extramedullary plasmacytoma
5841150|NCT00003938|refractory multiple myeloma|refractory multiple myeloma
5841151|NCT00003938|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5841152|NCT00003938|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5841153|NCT00003938|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5841154|NCT00003938|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5841155|NCT00003938|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5841156|NCT00003938|disseminated neuroblastoma|disseminated neuroblastoma
5841157|NCT00003938|recurrent neuroblastoma|recurrent neuroblastoma
5838823|NCT00006258|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5841222|NCT00003938|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5841158|NCT00003938|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5841159|NCT00003938|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5841160|NCT00003938|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5841161|NCT00003938|stage I multiple myeloma|stage i multiple myeloma
5841162|NCT00003938|stage II multiple myeloma|stage ii multiple myeloma
5841163|NCT00003938|stage III multiple myeloma|stage iii multiple myeloma
5841164|NCT00003938|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5841165|NCT00003938|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5841166|NCT00003938|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5841167|NCT00003938|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5841168|NCT00003938|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5841169|NCT00003938|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5841170|NCT00003938|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5841171|NCT00003938|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841172|NCT00003938|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841173|NCT00003938|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5841174|NCT00003938|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5841175|NCT00003938|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5841176|NCT00003938|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5841177|NCT00003938|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5841178|NCT00003938|small intestine lymphoma|small intestine lymphoma
5841179|NCT00003938|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5841180|NCT00003938|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5841181|NCT00003938|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5841182|NCT00003938|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841183|NCT00003938|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5841184|NCT00003938|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5841185|NCT00003938|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5841186|NCT00003938|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5841187|NCT00003938|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5841188|NCT00003938|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5841189|NCT00003938|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5841190|NCT00003938|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5841191|NCT00003938|polycythemia vera|polycythemia vera
5841192|NCT00003938|primary myelofibrosis|primary myelofibrosis
5841193|NCT00003938|essential thrombocythemia|essential thrombocythemia
5841194|NCT00003938|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5841195|NCT00003938|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5841196|NCT00003938|testicular embryonal carcinoma|testicular embryonal carcinoma
5841197|NCT00003938|testicular choriocarcinoma|testicular choriocarcinoma
5841198|NCT00003938|testicular teratoma|testicular teratoma
5841199|NCT00003938|testicular yolk sac tumor|testicular yolk sac tumor
5841200|NCT00003938|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5841201|NCT00003938|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5841202|NCT00003938|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5858456|NCT00013624|Parkinson's Disease|parkinson's disease
5858457|NCT00013611|HIV|hiv
5858458|NCT00013611|Proleukin|proleukin
5858459|NCT00013611|IL-2|il-2
5858460|NCT00013611|Adult|adult
5858461|NCT00013611|HAART|haart
5858462|NCT00013611|Treatment Experienced|treatment experienced
5858463|NCT00013598|Insulin Resistance|insulin resistance
5858464|NCT00013598|Obesity|obesity
5858465|NCT00013598|Diabetes|diabetes
5858466|NCT00013598|Fatty Liver|fatty liver
5858467|NCT00013598|Cirrhosis|cirrhosis
5841203|NCT00003938|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5841204|NCT00003938|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5841205|NCT00003938|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5841206|NCT00003938|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5841207|NCT00003938|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5841208|NCT00003938|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5841209|NCT00003938|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5841210|NCT00003938|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5841211|NCT00003938|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5841212|NCT00003938|refractory hairy cell leukemia|refractory hairy cell leukemia
5841213|NCT00003938|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5841214|NCT00003938|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5841215|NCT00003938|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5841216|NCT00003938|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5841217|NCT00003938|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5841218|NCT00003938|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5841219|NCT00003938|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5841220|NCT00003938|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5841221|NCT00003938|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5849040|NCT00031408|Blood|blood
5841223|NCT00003938|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5841224|NCT00003938|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5841225|NCT00003938|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5841226|NCT00003938|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5841227|NCT00003938|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5841228|NCT00003938|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841229|NCT00003938|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5841230|NCT00003938|ovarian yolk sac tumor|ovarian yolk sac tumor
5841231|NCT00003938|ovarian embryonal carcinoma|ovarian embryonal carcinoma
5841232|NCT00003938|ovarian polyembryoma|ovarian polyembryoma
5841233|NCT00003938|ovarian choriocarcinoma|ovarian choriocarcinoma
5841234|NCT00003938|ovarian immature teratoma|ovarian immature teratoma
5841236|NCT00003938|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5841237|NCT00003938|ovarian mixed germ cell tumor|ovarian mixed germ cell tumor
5841238|NCT00003938|acute undifferentiated leukemia|acute undifferentiated leukemia
5841239|NCT00003938|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5841240|NCT00003938|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5841241|NCT00003938|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5841242|NCT00003938|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5841243|NCT00003938|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5841244|NCT00003938|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5841245|NCT00003938|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5841246|NCT00003938|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5841247|NCT00003938|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5841248|NCT00003938|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5841249|NCT00003938|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5841250|NCT00003938|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5841251|NCT00003938|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5841252|NCT00003938|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841253|NCT00003938|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841254|NCT00003938|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841255|NCT00003938|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5841256|NCT00003938|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5841257|NCT00003938|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841258|NCT00003938|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841259|NCT00003938|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841260|NCT00003938|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841261|NCT00003938|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841262|NCT00003938|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5862702|NCT00001543|Pulsatility|pulsatility
5841263|NCT00003938|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841264|NCT00003938|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841265|NCT00003938|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841266|NCT00003938|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5841267|NCT00003938|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5841268|NCT00003938|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5841269|NCT00003938|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5841270|NCT00003938|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5841271|NCT00003938|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841272|NCT00003938|high risk metastatic gestational trophoblastic tumor|high risk metastatic gestational trophoblastic tumor
5841273|NCT00003938|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5841274|NCT00003938|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841275|NCT00003938|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5841276|NCT00003938|neutropenia|neutropenia
5841277|NCT00003938|infection|infection
5841278|NCT00003938|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5841279|NCT00003938|prolymphocytic leukemia|prolymphocytic leukemia
5838951|NCT00006234|bone metastases|bone metastases
5841280|NCT00003938|primary systemic amyloidosis|primary systemic amyloidosis
5841281|NCT00003938|intraocular lymphoma|intraocular lymphoma
5841282|NCT00003938|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5841283|NCT00003938|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5841284|NCT00003938|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5841285|NCT00003938|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5841286|NCT00003938|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5842826|NCT00003023|metastatic osteosarcoma|metastatic osteosarcoma
5841287|NCT00003938|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5849146|NCT00031109|Macaca|macaca
5841288|NCT00003938|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5841289|NCT00003938|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5841290|NCT00003938|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5841291|NCT00003938|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5841292|NCT00003938|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5841293|NCT00003938|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5841294|NCT00003938|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5841295|NCT00003938|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5841296|NCT00003938|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5841297|NCT00003938|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5853042|NCT00002209|Indinavir|indinavir
5841298|NCT00003938|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5841299|NCT00003938|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5841300|NCT00003938|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5841301|NCT00003938|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5841302|NCT00003938|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5841303|NCT00003938|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5841304|NCT00003938|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5841305|NCT00003938|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5841306|NCT00003938|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5841307|NCT00003938|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5841308|NCT00003938|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5841309|NCT00003938|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5841310|NCT00003938|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5841311|NCT00003938|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5841312|NCT00003938|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5858651|NCT00011674|Children|children
5858652|NCT00011674|Psychology|psychology
5858653|NCT00011674|Toxicology|toxicology
5858654|NCT00011674|Teratology|teratology
5858655|NCT00011661|Lead poisoning|lead poisoning
5841313|NCT00003938|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5841314|NCT00003938|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5841315|NCT00003938|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841316|NCT00003938|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5841317|NCT00003938|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5841318|NCT00003938|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5841319|NCT00003938|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5841320|NCT00003938|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5841321|NCT00003938|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5841322|NCT00003938|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5841323|NCT00003938|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5841324|NCT00003938|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5841325|NCT00003938|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5841326|NCT00003938|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5841327|NCT00003938|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5841328|NCT00003938|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5841329|NCT00003938|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5841330|NCT00003938|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5841331|NCT00003938|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841332|NCT00003938|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841333|NCT00003938|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5841334|NCT00003938|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5848329|NCT00035126|breast|breast
5841335|NCT00003938|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5841336|NCT00003938|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5841337|NCT00003938|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5841338|NCT00003938|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5841339|NCT00003938|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5841340|NCT00003938|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841341|NCT00003938|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5841342|NCT00003938|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5841343|NCT00003928|stage IV renal cell cancer|stage iv renal cell cancer
5841344|NCT00003928|recurrent renal cell cancer|recurrent renal cell cancer
5841345|NCT00003913|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5841346|NCT00003913|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5841347|NCT00003913|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5841348|NCT00003913|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5841349|NCT00003913|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5841350|NCT00003913|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5841351|NCT00003913|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5841352|NCT00003913|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5841353|NCT00003913|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5841354|NCT00003913|refractory anemia|refractory anemia
5841355|NCT00003913|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5841356|NCT00003913|refractory anemia with excess blasts|refractory anemia with excess blasts
5841357|NCT00003913|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5841358|NCT00003913|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841359|NCT00003913|acute undifferentiated leukemia|acute undifferentiated leukemia
5841360|NCT00003913|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5841361|NCT00003913|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841362|NCT00003913|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5841363|NCT00003913|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841364|NCT00003913|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5841365|NCT00003913|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5841366|NCT00003913|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5841367|NCT00003913|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5841368|NCT00003913|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5841369|NCT00003913|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5846993|NCT00042016|Imatinib mesylate|imatinib mesylate
5858750|NCT00011258|stroke|stroke
5841370|NCT00003913|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5841371|NCT00003912|stage I childhood liver cancer|stage i childhood liver cancer
5841372|NCT00003912|stage II childhood liver cancer|stage ii childhood liver cancer
5841373|NCT00003912|stage III childhood liver cancer|stage iii childhood liver cancer
5841374|NCT00003912|stage IV childhood liver cancer|stage iv childhood liver cancer
5841375|NCT00003912|recurrent childhood liver cancer|recurrent childhood liver cancer
5841376|NCT00003912|childhood hepatoblastoma|childhood hepatoblastoma
5841377|NCT00003912|childhood hepatocellular carcinoma|childhood hepatocellular carcinoma
5841378|NCT00003910|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5841379|NCT00003910|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5841380|NCT00003910|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841381|NCT00003910|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841382|NCT00003910|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5841384|NCT00003906|breast cancer|breast cancer
5841385|NCT00003903|stage I prostate cancer|stage i prostate cancer
5841386|NCT00003903|stage IIB prostate cancer|stage iib prostate cancer
5841387|NCT00003903|stage IIA prostate cancer|stage iia prostate cancer
5841388|NCT00003903|stage III prostate cancer|stage iii prostate cancer
5841389|NCT00003903|stage IV prostate cancer|stage iv prostate cancer
5841390|NCT00003903|osteoporosis|osteoporosis
5841391|NCT00003902|stage IV breast cancer|stage iv breast cancer
5841392|NCT00003901|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5841393|NCT00003901|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5841394|NCT00003901|squamous cell lung cancer|squamous cell lung cancer
5841395|NCT00003901|large cell lung cancer|large cell lung cancer
5841396|NCT00003901|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5841397|NCT00003901|adenocarcinoma of the lung|adenocarcinoma of the lung
5841398|NCT00003896|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5841399|NCT00003896|peritoneal cavity cancer|peritoneal cavity cancer
5841400|NCT00003896|fallopian tube cancer|fallopian tube cancer
5841401|NCT00003893|stage I breast cancer|stage i breast cancer
5841402|NCT00003878|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5839107|NCT00006093|adult glioblastoma|adult glioblastoma
5841403|NCT00003878|tumors metastatic to brain|tumors metastatic to brain
5841404|NCT00003865|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5841405|NCT00003865|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5841406|NCT00003863|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5841407|NCT00003863|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5841408|NCT00003863|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5841409|NCT00003863|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5841410|NCT00003863|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5841411|NCT00003863|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5841412|NCT00003863|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5841413|NCT00003863|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5841414|NCT00003863|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5841415|NCT00003863|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5841416|NCT00003863|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5841619|NCT00003753|recurrent colon cancer|recurrent colon cancer
5841417|NCT00003863|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841418|NCT00003863|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841419|NCT00003863|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841420|NCT00003863|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5841421|NCT00003863|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841422|NCT00003863|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841423|NCT00003863|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841424|NCT00003863|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841425|NCT00003863|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841426|NCT00003863|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5841632|NCT00003746|untreated hairy cell leukemia|untreated hairy cell leukemia
5841427|NCT00003863|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5841428|NCT00003863|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5841429|NCT00003863|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5841430|NCT00003863|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5841431|NCT00003863|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5841432|NCT00003863|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5846994|NCT00042016|Gleevec|gleevec
5858854|NCT00009659|Menopause|menopause
5858855|NCT00009659|Progesterone|progesterone
5858856|NCT00009659|Postmenopausal Women|postmenopausal women
5858857|NCT00009659|Hormone Replacement|hormone replacement
5858858|NCT00009646|Chronic lung disease|chronic lung disease
5858859|NCT00009646|Indocin|indocin
5841433|NCT00003863|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5841437|NCT00003863|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5841438|NCT00003863|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5841439|NCT00003863|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5841440|NCT00003863|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5841441|NCT00003863|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841442|NCT00003862|stage I gastric cancer|stage i gastric cancer
5856901|NCT00000707|Lung|lung
5841443|NCT00003862|stage II gastric cancer|stage ii gastric cancer
5841444|NCT00003862|stage III gastric cancer|stage iii gastric cancer
5841445|NCT00003862|stage IV gastric cancer|stage iv gastric cancer
5841446|NCT00003862|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5841447|NCT00003857|breast cancer in situ|breast cancer in situ
5841448|NCT00003857|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5841449|NCT00003855|stage IA breast cancer|stage ia breast cancer
5841450|NCT00003855|stage IB breast cancer|stage ib breast cancer
5841451|NCT00003855|stage II breast cancer|stage ii breast cancer
5841452|NCT00003854|stage IA breast cancer|stage ia breast cancer
5841453|NCT00003854|stage IB breast cancer|stage ib breast cancer
5841454|NCT00003854|stage II breast cancer|stage ii breast cancer
5841455|NCT00003851|malnutrition|malnutrition
5841456|NCT00003851|stage II pancreatic cancer|stage ii pancreatic cancer
5841457|NCT00003851|stage III pancreatic cancer|stage iii pancreatic cancer
5841458|NCT00003851|stage IV pancreatic cancer|stage iv pancreatic cancer
5841459|NCT00003851|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5841460|NCT00003843|stage IV colon cancer|stage iv colon cancer
5841461|NCT00003843|stage IV rectal cancer|stage iv rectal cancer
5841462|NCT00003843|recurrent colon cancer|recurrent colon cancer
5841463|NCT00003843|recurrent rectal cancer|recurrent rectal cancer
5841469|NCT00003837|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5841470|NCT00003837|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5841471|NCT00003837|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841472|NCT00003833|stage II colon cancer|stage ii colon cancer
5841473|NCT00003833|stage III colon cancer|stage iii colon cancer
5841474|NCT00003833|adenocarcinoma of the colon|adenocarcinoma of the colon
5841475|NCT00003831|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5841476|NCT00003831|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5841477|NCT00003831|squamous cell lung cancer|squamous cell lung cancer
5841479|NCT00003831|adenocarcinoma of the lung|adenocarcinoma of the lung
5841480|NCT00003816|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5841481|NCT00003816|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5841482|NCT00003816|Burkitt lymphoma|burkitt lymphoma
5841483|NCT00003816|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5841484|NCT00003816|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5841485|NCT00003816|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5841486|NCT00003816|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5841620|NCT00003753|recurrent rectal cancer|recurrent rectal cancer
5841487|NCT00003816|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5841488|NCT00003816|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5841489|NCT00003816|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5841490|NCT00003816|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5841491|NCT00003816|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5841492|NCT00003816|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5841493|NCT00003816|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5841494|NCT00003816|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5841495|NCT00003816|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5842703|NCT00003135|stage IV breast cancer|stage iv breast cancer
5841496|NCT00003816|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5841497|NCT00003816|polycythemia vera|polycythemia vera
5841498|NCT00003816|essential thrombocythemia|essential thrombocythemia
5841499|NCT00003816|refractory anemia|refractory anemia
5841500|NCT00003816|refractory anemia with excess blasts|refractory anemia with excess blasts
5841501|NCT00003816|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5841502|NCT00003816|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841503|NCT00003816|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5841504|NCT00003816|acute undifferentiated leukemia|acute undifferentiated leukemia
5841505|NCT00003816|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841506|NCT00003816|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841507|NCT00003816|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841508|NCT00003816|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841509|NCT00003816|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841510|NCT00003816|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841511|NCT00003816|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841512|NCT00003816|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841513|NCT00003816|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841514|NCT00003816|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5841515|NCT00003816|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5841516|NCT00003816|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841517|NCT00003816|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5841518|NCT00003816|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841519|NCT00003816|prolymphocytic leukemia|prolymphocytic leukemia
5841520|NCT00003816|intraocular lymphoma|intraocular lymphoma
5841521|NCT00003816|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5841522|NCT00003816|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5841523|NCT00003816|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841524|NCT00003816|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5841525|NCT00003816|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5841526|NCT00003816|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5841527|NCT00003816|primary myelofibrosis|primary myelofibrosis
5841528|NCT00003816|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5841529|NCT00003816|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5841530|NCT00003816|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5841531|NCT00003816|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841532|NCT00003816|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841533|NCT00003816|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5841534|NCT00003816|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841535|NCT00003816|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5841536|NCT00003816|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5841537|NCT00003816|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5841538|NCT00003816|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5841539|NCT00003816|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5841540|NCT00003816|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5841541|NCT00003816|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5841543|NCT00003816|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841544|NCT00003816|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5841545|NCT00003815|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5841546|NCT00003815|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5841547|NCT00003815|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5841548|NCT00003815|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5841549|NCT00003815|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5841550|NCT00003815|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5841551|NCT00003815|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5841552|NCT00003815|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5841553|NCT00003815|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841554|NCT00003815|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841555|NCT00003815|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841556|NCT00003815|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5846699|NCT00043576|Androgen Independent Prostate Cancer|androgen independent prostate cancer
5859047|NCT00007683|Left ventricular ejection fraction less than or eq|left ventricular ejection fraction less than or eq
5859048|NCT00007683|NYHA Class II, III or IV CHF|nyha class ii, iii or iv chf
5859049|NCT00007683|symptomatic CHF|symptomatic chf
5859050|NCT00007683|warfarin|warfarin
5859060|NCT00007631|nonmelanoma skin cancer|nonmelanoma skin cancer
5859061|NCT00007631|topical tretinoin cream|topical tretinoin cream
5841557|NCT00003815|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5841558|NCT00003815|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5853241|NCT00002179|Lamivudine|lamivudine
5841559|NCT00003815|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5841560|NCT00003815|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5841561|NCT00003815|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5841562|NCT00003815|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5841563|NCT00003815|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5841564|NCT00003815|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5841565|NCT00003803|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5841566|NCT00003803|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5841567|NCT00003803|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5841568|NCT00003800|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5841569|NCT00003800|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5841570|NCT00003800|testicular embryonal carcinoma|testicular embryonal carcinoma
5841571|NCT00003800|testicular choriocarcinoma|testicular choriocarcinoma
5841572|NCT00003800|testicular teratoma|testicular teratoma
5841573|NCT00003800|testicular yolk sac tumor|testicular yolk sac tumor
5841574|NCT00003800|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5841575|NCT00003800|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5841576|NCT00003800|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5841577|NCT00003800|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5841578|NCT00003800|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5841579|NCT00003800|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5841580|NCT00003796|stage IV breast cancer|stage iv breast cancer
5841581|NCT00003796|recurrent breast cancer|recurrent breast cancer
5841582|NCT00003796|male breast cancer|male breast cancer
5841583|NCT00003793|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5841584|NCT00003793|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841585|NCT00003793|localized osteosarcoma|localized osteosarcoma
5841586|NCT00003793|metastatic osteosarcoma|metastatic osteosarcoma
5841587|NCT00003793|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5841588|NCT00003793|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5841589|NCT00003793|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5841590|NCT00003793|childhood fibrosarcoma|childhood fibrosarcoma
5841591|NCT00003793|childhood synovial sarcoma|childhood synovial sarcoma
5841592|NCT00003793|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5841593|NCT00003793|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5839279|NCT00005987|stage I multiple myeloma|stage i multiple myeloma
5841594|NCT00003793|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5841595|NCT00003793|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5841596|NCT00003788|recurrent adult brain tumor|recurrent adult brain tumor
5841597|NCT00003788|adult glioblastoma|adult glioblastoma
5841598|NCT00003788|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5841599|NCT00003788|adult giant cell glioblastoma|adult giant cell glioblastoma
5841600|NCT00003788|adult gliosarcoma|adult gliosarcoma
5841601|NCT00003782|stage I breast cancer|stage i breast cancer
5841602|NCT00003782|stage II breast cancer|stage ii breast cancer
5841603|NCT00003782|stage IIIA breast cancer|stage iiia breast cancer
5841604|NCT00003771|menopausal symptoms|menopausal symptoms
5841605|NCT00003771|stage I breast cancer|stage i breast cancer
5841606|NCT00003771|stage II breast cancer|stage ii breast cancer
5841607|NCT00003771|breast cancer in situ|breast cancer in situ
5841608|NCT00003764|stage 0 chronic lymphocytic leukemia|stage 0 chronic lymphocytic leukemia
5841609|NCT00003764|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5841610|NCT00003764|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5859146|NCT00007215|Dynamic Laser Scattering (DLS)|dynamic laser scattering (dls)
5859148|NCT00007215|Test Re-test Reproducibility|test re-test reproducibility
5859149|NCT00007215|Normal Volunteers|normal volunteers
5859151|NCT00007215|Healthy Volunteer|healthy volunteer
5841611|NCT00003764|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841612|NCT00003764|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841613|NCT00003764|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5841614|NCT00003753|stage IV colon cancer|stage iv colon cancer
5841615|NCT00003753|stage IV rectal cancer|stage iv rectal cancer
5841616|NCT00003753|adenocarcinoma of the colon|adenocarcinoma of the colon
5841617|NCT00003753|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5841618|NCT00003753|liver metastases|liver metastases
5841622|NCT00003750|recurrent neuroblastoma|recurrent neuroblastoma
5841623|NCT00003750|recurrent osteosarcoma|recurrent osteosarcoma
5841624|NCT00003750|recurrent melanoma|recurrent melanoma
5841625|NCT00003750|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5841626|NCT00003750|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5841627|NCT00003750|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5841628|NCT00003749|stage I endometrial carcinoma|stage i endometrial carcinoma
5841629|NCT00003749|stage II endometrial carcinoma|stage ii endometrial carcinoma
5841630|NCT00003749|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5841631|NCT00003749|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5841633|NCT00003746|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5841634|NCT00003746|prolymphocytic leukemia|prolymphocytic leukemia
5841635|NCT00003745|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5841636|NCT00003745|recurrent osteosarcoma|recurrent osteosarcoma
5841637|NCT00003745|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5841638|NCT00003745|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5841639|NCT00003745|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5841640|NCT00003745|extraosseous Ewing sarcoma/peripheral primitive neuroectodermal tumor|extraosseous ewing sarcoma/peripheral primitive neuroectodermal tumor
5841641|NCT00003745|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5841642|NCT00003744|stage III salivary gland cancer|stage iii salivary gland cancer
5841643|NCT00003744|stage IV salivary gland cancer|stage iv salivary gland cancer
5841644|NCT00003744|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5841645|NCT00003744|salivary gland acinic cell tumor|salivary gland acinic cell tumor
5841646|NCT00003744|low-grade salivary gland mucoepidermoid carcinoma|low-grade salivary gland mucoepidermoid carcinoma
5841647|NCT00003744|high-grade salivary gland mucoepidermoid carcinoma|high-grade salivary gland mucoepidermoid carcinoma
5841648|NCT00003744|salivary gland adenocarcinoma|salivary gland adenocarcinoma
5841649|NCT00003744|salivary gland poorly differentiated carcinoma|salivary gland poorly differentiated carcinoma
5841650|NCT00003744|salivary gland anaplastic carcinoma|salivary gland anaplastic carcinoma
5841651|NCT00003744|salivary gland malignant mixed cell type tumor|salivary gland malignant mixed cell type tumor
5841652|NCT00003744|salivary gland adenoid cystic carcinoma|salivary gland adenoid cystic carcinoma
5841653|NCT00003741|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5841654|NCT00003741|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5841655|NCT00003739|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5841656|NCT00003739|fever, sweats, and hot flashes|fever, sweats, and hot flashes
5841658|NCT00003737|recurrent neuroblastoma|recurrent neuroblastoma
5841659|NCT00003732|stage IIB ovarian epithelial cancer|stage iib ovarian epithelial cancer
5841660|NCT00003732|stage IIC ovarian epithelial cancer|stage iic ovarian epithelial cancer
5841661|NCT00003732|stage IIIA ovarian epithelial cancer|stage iiia ovarian epithelial cancer
5841662|NCT00003732|stage IIIB ovarian epithelial cancer|stage iiib ovarian epithelial cancer
5841663|NCT00003732|stage IIIC ovarian epithelial cancer|stage iiic ovarian epithelial cancer
5841664|NCT00003732|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5841665|NCT00003730|stage IV breast cancer|stage iv breast cancer
5841666|NCT00003730|recurrent breast cancer|recurrent breast cancer
5841667|NCT00003728|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5841668|NCT00003728|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5841669|NCT00003728|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5843917|NCT00051766|intervention|intervention
5841670|NCT00003728|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5841671|NCT00003728|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5846701|NCT00043680|Occult|occult
5859245|NCT00006494|Phenotype|phenotype
5859247|NCT00006494|Genotype|genotype
5859248|NCT00006494|Treatment Experienced|treatment experienced
5859293|NCT00006439|HIV|hiv
5841672|NCT00003728|L1 childhood acute lymphoblastic leukemia|l1 childhood acute lymphoblastic leukemia
5841673|NCT00003728|L2 childhood acute lymphoblastic leukemia|l2 childhood acute lymphoblastic leukemia
5841674|NCT00003728|T-cell childhood acute lymphoblastic leukemia|t-cell childhood acute lymphoblastic leukemia
5841675|NCT00003728|B-cell childhood acute lymphoblastic leukemia|b-cell childhood acute lymphoblastic leukemia
5841676|NCT00003728|acute undifferentiated leukemia|acute undifferentiated leukemia
5841677|NCT00003727|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5841678|NCT00003727|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5841679|NCT00003727|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5841680|NCT00003727|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5841681|NCT00003727|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5841682|NCT00003696|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5841683|NCT00003690|stage IV breast cancer|stage iv breast cancer
5841684|NCT00003690|recurrent breast cancer|recurrent breast cancer
5841685|NCT00003690|stage IV prostate cancer|stage iv prostate cancer
5841686|NCT00003690|recurrent prostate cancer|recurrent prostate cancer
5841687|NCT00003690|stage IV melanoma|stage iv melanoma
5841688|NCT00003690|recurrent melanoma|recurrent melanoma
5841689|NCT00003690|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841690|NCT00003688|recurrent gestational trophoblastic tumor|recurrent gestational trophoblastic tumor
5841691|NCT00003688|nonmetastatic gestational trophoblastic tumor|nonmetastatic gestational trophoblastic tumor
5841692|NCT00003688|low risk metastatic gestational trophoblastic tumor|low risk metastatic gestational trophoblastic tumor
5841693|NCT00003687|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5841694|NCT00003687|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5841695|NCT00003687|monoclonal gammopathy of undetermined significance|monoclonal gammopathy of undetermined significance
5841696|NCT00003687|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5841697|NCT00003687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5841698|NCT00003687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5841699|NCT00003687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5841700|NCT00003687|isolated plasmacytoma of bone|isolated plasmacytoma of bone
5841701|NCT00003687|extramedullary plasmacytoma|extramedullary plasmacytoma
5841702|NCT00003687|refractory multiple myeloma|refractory multiple myeloma
5841703|NCT00003687|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5841704|NCT00003687|stage III multiple myeloma|stage iii multiple myeloma
5839214|NCT00006025|adult glioblastoma|adult glioblastoma
5841705|NCT00003687|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841706|NCT00003687|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841707|NCT00003687|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5841708|NCT00003687|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5841709|NCT00003687|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5841710|NCT00003687|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5841711|NCT00003687|small intestine lymphoma|small intestine lymphoma
5841712|NCT00003687|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841713|NCT00003687|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5841714|NCT00003687|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5841715|NCT00003687|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5841716|NCT00003687|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5841717|NCT00003687|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5841718|NCT00003687|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5841719|NCT00003687|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5841720|NCT00003687|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5841721|NCT00003687|polycythemia vera|polycythemia vera
5841722|NCT00003687|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5841723|NCT00003687|essential thrombocythemia|essential thrombocythemia
5841724|NCT00003687|untreated hairy cell leukemia|untreated hairy cell leukemia
5839406|NCT00005967|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841725|NCT00003687|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5841726|NCT00003687|refractory hairy cell leukemia|refractory hairy cell leukemia
5841727|NCT00003687|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841728|NCT00003687|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5841729|NCT00003687|acute undifferentiated leukemia|acute undifferentiated leukemia
5841730|NCT00003687|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5859348|NCT00006422|Eye Movements|eye movements
5859349|NCT00006422|Child Vision|child vision
5859354|NCT00006418|Schizophrenia|schizophrenia
5859355|NCT00006418|Genetics|genetics
5859356|NCT00006417|Fludarabine|fludarabine
5859357|NCT00006417|Non-Myeloablative BMT|non-myeloablative bmt
5859358|NCT00006417|Immunodeficiency|immunodeficiency
5859359|NCT00006417|Neutrophils|neutrophils
5859428|NCT00006334|TS|ts
5841731|NCT00003687|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5841732|NCT00003687|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5841733|NCT00003687|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5841734|NCT00003687|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5841735|NCT00003687|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5841736|NCT00003687|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5841737|NCT00003687|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5841738|NCT00003687|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5841739|NCT00003687|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5841740|NCT00003687|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5841741|NCT00003687|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5841742|NCT00003687|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5841743|NCT00003687|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841744|NCT00003687|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841745|NCT00003687|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841746|NCT00003687|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5841747|NCT00003687|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5841748|NCT00003687|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841749|NCT00003687|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841750|NCT00003687|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841751|NCT00003687|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841752|NCT00003687|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842019|NCT00003565|stage IV bladder cancer|stage iv bladder cancer
5841753|NCT00003687|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841754|NCT00003687|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841755|NCT00003687|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841756|NCT00003687|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841757|NCT00003687|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5841758|NCT00003687|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5841759|NCT00003687|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5841760|NCT00003687|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5841761|NCT00003687|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5853242|NCT00002179|Indinavir|indinavir
5841762|NCT00003687|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5841763|NCT00003687|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841766|NCT00003687|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5841767|NCT00003687|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5841768|NCT00003687|primary systemic amyloidosis|primary systemic amyloidosis
5841769|NCT00003687|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5841770|NCT00003687|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5841771|NCT00003687|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5841772|NCT00003687|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841773|NCT00003687|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5841774|NCT00003687|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5841775|NCT00003687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5841776|NCT00003687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5841777|NCT00003687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5841778|NCT00003687|chronic eosinophilic leukemia|chronic eosinophilic leukemia
5841779|NCT00003687|chronic neutrophilic leukemia|chronic neutrophilic leukemia
5841780|NCT00003687|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841781|NCT00003687|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841782|NCT00003687|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5841783|NCT00003687|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5859455|NCT00006318|Imaging|imaging
5841784|NCT00003687|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5841785|NCT00003687|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5841786|NCT00003687|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5841787|NCT00003687|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5841788|NCT00003687|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5841789|NCT00003687|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5841790|NCT00003678|stage I breast cancer|stage i breast cancer
5841791|NCT00003678|stage II breast cancer|stage ii breast cancer
5841792|NCT00003659|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5841793|NCT00003659|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841794|NCT00003659|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841795|NCT00003658|Waldenström macroglobulinemia|waldenström macroglobulinemia
5841796|NCT00003658|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5841797|NCT00003658|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5841798|NCT00003658|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5841799|NCT00003658|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5841800|NCT00003658|B-cell chronic lymphocytic leukemia|b-cell chronic lymphocytic leukemia
5841801|NCT00003658|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5841802|NCT00003658|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5841803|NCT00003658|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5841804|NCT00003658|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5841805|NCT00003658|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5841806|NCT00003658|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5841807|NCT00003658|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841808|NCT00003658|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841809|NCT00003658|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5841810|NCT00003658|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5841811|NCT00003658|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5863080|NCT00001404|Malformations|malformations
5841812|NCT00003658|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5841813|NCT00003658|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5841814|NCT00003658|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5841815|NCT00003658|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841816|NCT00003658|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5841817|NCT00003658|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5841818|NCT00003658|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5841819|NCT00003656|stage IV renal cell cancer|stage iv renal cell cancer
5841820|NCT00003656|recurrent renal cell cancer|recurrent renal cell cancer
5842419|NCT00003458|Neurocytoma|neurocytoma
5841821|NCT00003653|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5841822|NCT00003653|recurrent prostate cancer|recurrent prostate cancer
5841823|NCT00003652|stage II anal cancer|stage ii anal cancer
5841824|NCT00003652|stage III anal cancer|stage iii anal cancer
5841825|NCT00003652|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5841826|NCT00003652|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5841827|NCT00003652|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5841828|NCT00003650|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5841829|NCT00003650|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5841830|NCT00003650|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5841831|NCT00003650|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5841832|NCT00003644|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5841833|NCT00003644|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5841834|NCT00003644|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5841835|NCT00003644|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5841836|NCT00003644|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5841837|NCT00003644|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5841838|NCT00003644|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5841839|NCT00003644|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5841840|NCT00003644|Brenner tumor|brenner tumor
5841841|NCT00003643|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5841842|NCT00003643|testicular seminoma|testicular seminoma
5841843|NCT00003643|testicular embryonal carcinoma|testicular embryonal carcinoma
5841844|NCT00003643|testicular choriocarcinoma|testicular choriocarcinoma
5841845|NCT00003643|testicular yolk sac tumor|testicular yolk sac tumor
5841846|NCT00003643|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5841847|NCT00003643|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5841848|NCT00003643|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5859550|NCT00006190|Lipoproteins|lipoproteins
5859551|NCT00006190|Insulin resistance|insulin resistance
5859552|NCT00006190|Adipose tissue|adipose tissue
5859553|NCT00006188|Behcet's Disease|behcet's disease
5859554|NCT00006188|Sarcoidosis|sarcoidosis
5859555|NCT00006188|Iritis|iritis
5841849|NCT00003643|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5841850|NCT00003643|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5841851|NCT00003643|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5841852|NCT00003643|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5841853|NCT00003643|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5841854|NCT00003643|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5841855|NCT00003643|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5841856|NCT00003643|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5841857|NCT00003643|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5841858|NCT00003643|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5841859|NCT00003643|testicular immature teratoma|testicular immature teratoma
5841860|NCT00003643|testicular mature teratoma|testicular mature teratoma
5841861|NCT00003643|adult teratoma|adult teratoma
5841862|NCT00003641|stage II melanoma|stage ii melanoma
5841864|NCT00003637|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5841865|NCT00003637|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5841866|NCT00003637|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5841867|NCT00003637|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5841868|NCT00003636|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5841869|NCT00003636|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5841870|NCT00003636|fallopian tube cancer|fallopian tube cancer
5841871|NCT00003636|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5841872|NCT00003633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5841873|NCT00003633|stage IV prostate cancer|stage iv prostate cancer
5841874|NCT00003633|recurrent prostate cancer|recurrent prostate cancer
5863081|NCT00001404|Polydactyly|polydactyly
5841875|NCT00003631|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5841876|NCT00003631|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5841878|NCT00003612|recurrent breast cancer|recurrent breast cancer
5841879|NCT00003611|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5841880|NCT00003611|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5841881|NCT00003607|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5841882|NCT00003607|stage I prostate cancer|stage i prostate cancer
5841883|NCT00003607|stage IIB prostate cancer|stage iib prostate cancer
5841884|NCT00003607|stage IIA prostate cancer|stage iia prostate cancer
5841885|NCT00003607|stage III prostate cancer|stage iii prostate cancer
5841886|NCT00003603|refractory multiple myeloma|refractory multiple myeloma
5841887|NCT00003603|stage I multiple myeloma|stage i multiple myeloma
5841888|NCT00003603|stage II multiple myeloma|stage ii multiple myeloma
5841889|NCT00003603|stage III multiple myeloma|stage iii multiple myeloma
5841890|NCT00003602|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5862704|NCT00001543|Cortisol|cortisol
5841891|NCT00003602|refractory anemia with excess blasts|refractory anemia with excess blasts
5841892|NCT00003602|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5841893|NCT00003602|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5841894|NCT00003602|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841895|NCT00003602|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841896|NCT00003596|stage II anal cancer|stage ii anal cancer
5841897|NCT00003596|stage III anal cancer|stage iii anal cancer
5841898|NCT00003596|squamous cell carcinoma of the anus|squamous cell carcinoma of the anus
5841899|NCT00003596|cloacogenic carcinoma of the anus|cloacogenic carcinoma of the anus
5841900|NCT00003596|basaloid carcinoma of the anus|basaloid carcinoma of the anus
5842704|NCT00003135|recurrent breast cancer|recurrent breast cancer
5841901|NCT00003593|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5841902|NCT00003593|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5841903|NCT00003593|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5841904|NCT00003593|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5841905|NCT00003593|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5841906|NCT00003593|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5841907|NCT00003593|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5841908|NCT00003593|refractory anemia|refractory anemia
5841909|NCT00003593|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5841910|NCT00003593|refractory anemia with excess blasts|refractory anemia with excess blasts
5841911|NCT00003593|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5841912|NCT00003593|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5841913|NCT00003593|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5841914|NCT00003593|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5841915|NCT00003593|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5841916|NCT00003593|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5841917|NCT00003593|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5841918|NCT00003593|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5841919|NCT00003593|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5841920|NCT00003590|recurrent adult brain tumor|recurrent adult brain tumor
5841921|NCT00003590|adult grade I meningioma|adult grade i meningioma
5841922|NCT00003577|stage I breast cancer|stage i breast cancer
5841923|NCT00003577|stage II breast cancer|stage ii breast cancer
5841924|NCT00003576|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5841925|NCT00003576|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5841926|NCT00003576|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5841927|NCT00003576|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5841928|NCT00003576|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5841929|NCT00003576|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5841930|NCT00003576|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5841931|NCT00003576|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5841932|NCT00003576|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5841933|NCT00003576|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5841934|NCT00003569|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5841935|NCT00003569|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5841936|NCT00003569|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5841937|NCT00003569|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5841938|NCT00003569|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5841939|NCT00003569|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5841940|NCT00003569|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5841941|NCT00003569|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5841942|NCT00003569|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5841943|NCT00003569|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5841944|NCT00003569|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5841945|NCT00003569|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5841946|NCT00003569|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5841947|NCT00003569|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5841948|NCT00003569|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5841949|NCT00003569|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5841950|NCT00003569|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5842420|NCT00003458|Oligodendroglioma|oligodendroglioma
5841951|NCT00003569|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5841952|NCT00003569|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5841953|NCT00003569|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5841954|NCT00003569|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5843918|NCT00051766|treatment experienced|treatment experienced
5841955|NCT00003569|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5841956|NCT00003569|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5841957|NCT00003569|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5841958|NCT00003569|neurotoxicity|neurotoxicity
5841959|NCT00003569|recurrent salivary gland cancer|recurrent salivary gland cancer
5841960|NCT00003569|stage IV salivary gland cancer|stage iv salivary gland cancer
5841961|NCT00003569|salivary gland squamous cell carcinoma|salivary gland squamous cell carcinoma
5841962|NCT00003569|stage III salivary gland cancer|stage iii salivary gland cancer
5841963|NCT00003568|stage IV melanoma|stage iv melanoma
5846703|NCT00043680|Celecoxib|celecoxib
5859762|NCT00006148|Granulocyte Colony - Stimulation Factor|granulocyte colony - stimulation factor
5859764|NCT00006148|Splenomegaly|splenomegaly
5859765|NCT00006077|Clinical Trial|clinical trial
5859766|NCT00006077|Dyskinesias|dyskinesias
5841964|NCT00003568|recurrent melanoma|recurrent melanoma
5841965|NCT00003567|recurrent adult brain tumor|recurrent adult brain tumor
5841966|NCT00003567|adult brain stem glioma|adult brain stem glioma
5841967|NCT00003567|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5841968|NCT00003567|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5841969|NCT00003567|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5841970|NCT00003567|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5841971|NCT00003567|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5841972|NCT00003567|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5841973|NCT00003567|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5841974|NCT00003567|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5841975|NCT00003567|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5841976|NCT00003567|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5841977|NCT00003567|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5841978|NCT00003567|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5841979|NCT00003567|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5841980|NCT00003567|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5841981|NCT00003567|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5841982|NCT00003567|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5841983|NCT00003567|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5841984|NCT00003567|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5841985|NCT00003567|adult mixed glioma|adult mixed glioma
5841986|NCT00003567|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5841987|NCT00003567|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5841988|NCT00003567|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5841989|NCT00003567|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5841990|NCT00003567|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5841991|NCT00003567|adult glioblastoma|adult glioblastoma
5841992|NCT00003567|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5841993|NCT00003567|adult subependymoma|adult subependymoma
5841994|NCT00003567|adult anaplastic ependymoma|adult anaplastic ependymoma
5841995|NCT00003567|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5841996|NCT00003567|adult ependymoblastoma|adult ependymoblastoma
5841997|NCT00003567|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5841998|NCT00003567|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5841999|NCT00003567|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5842000|NCT00003567|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5842001|NCT00003567|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5842002|NCT00003567|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5842003|NCT00003567|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5842004|NCT00003567|adult oligodendroglioma|adult oligodendroglioma
5842005|NCT00003567|adult giant cell glioblastoma|adult giant cell glioblastoma
5842006|NCT00003567|adult gliosarcoma|adult gliosarcoma
5842007|NCT00003567|adult diffuse astrocytoma|adult diffuse astrocytoma
5842008|NCT00003566|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5842009|NCT00003565|stage IV breast cancer|stage iv breast cancer
5842010|NCT00003565|stage IIIA breast cancer|stage iiia breast cancer
5842011|NCT00003565|recurrent breast cancer|recurrent breast cancer
5842012|NCT00003565|stage IIIB breast cancer|stage iiib breast cancer
5842013|NCT00003565|stage IIIC breast cancer|stage iiic breast cancer
5842014|NCT00003565|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5842015|NCT00003565|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5842016|NCT00003565|recurrent small cell lung cancer|recurrent small cell lung cancer
5842017|NCT00003565|stage III bladder cancer|stage iii bladder cancer
5842018|NCT00003565|recurrent bladder cancer|recurrent bladder cancer
5842020|NCT00003565|stage IV nasopharyngeal cancer|stage iv nasopharyngeal cancer
5842021|NCT00003565|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5842022|NCT00003565|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5842023|NCT00003565|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5842024|NCT00003565|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5842025|NCT00003565|untreated metastatic squamous neck cancer with occult primary|untreated metastatic squamous neck cancer with occult primary
5842026|NCT00003565|recurrent metastatic squamous neck cancer with occult primary|recurrent metastatic squamous neck cancer with occult primary
5842027|NCT00003565|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5842028|NCT00003565|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5842029|NCT00003565|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5842030|NCT00003565|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5842031|NCT00003565|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5842032|NCT00003565|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5842033|NCT00003565|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5839759|NCT00005787|neutropenia|neutropenia
5842034|NCT00003565|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5842035|NCT00003565|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5842036|NCT00003565|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5842037|NCT00003565|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5842038|NCT00003565|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5842039|NCT00003565|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5842040|NCT00003565|recurrent verrucous carcinoma of the oral cavity|recurrent verrucous carcinoma of the oral cavity
5842041|NCT00003565|recurrent mucoepidermoid carcinoma of the oral cavity|recurrent mucoepidermoid carcinoma of the oral cavity
5842042|NCT00003565|recurrent adenoid cystic carcinoma of the oral cavity|recurrent adenoid cystic carcinoma of the oral cavity
5842043|NCT00003565|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5842044|NCT00003565|stage III lymphoepithelioma of the oropharynx|stage iii lymphoepithelioma of the oropharynx
5842045|NCT00003565|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5842046|NCT00003565|stage IV lymphoepithelioma of the oropharynx|stage iv lymphoepithelioma of the oropharynx
5842047|NCT00003565|recurrent squamous cell carcinoma of the oropharynx|recurrent squamous cell carcinoma of the oropharynx
5842048|NCT00003565|recurrent lymphoepithelioma of the oropharynx|recurrent lymphoepithelioma of the oropharynx
5842049|NCT00003565|stage III squamous cell carcinoma of the nasopharynx|stage iii squamous cell carcinoma of the nasopharynx
5842050|NCT00003565|stage III lymphoepithelioma of the nasopharynx|stage iii lymphoepithelioma of the nasopharynx
5842051|NCT00003565|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5842052|NCT00003565|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5842053|NCT00003565|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5842054|NCT00003565|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5863082|NCT00001404|Pallister-Hall Syndrome|pallister-hall syndrome
5842055|NCT00003565|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5842056|NCT00003565|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5842057|NCT00003565|recurrent squamous cell carcinoma of the hypopharynx|recurrent squamous cell carcinoma of the hypopharynx
5842058|NCT00003565|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5842059|NCT00003565|stage III verrucous carcinoma of the larynx|stage iii verrucous carcinoma of the larynx
5842060|NCT00003565|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5842061|NCT00003565|stage IV verrucous carcinoma of the larynx|stage iv verrucous carcinoma of the larynx
5842062|NCT00003565|recurrent squamous cell carcinoma of the larynx|recurrent squamous cell carcinoma of the larynx
5842063|NCT00003565|recurrent verrucous carcinoma of the larynx|recurrent verrucous carcinoma of the larynx
5842064|NCT00003565|stage III squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
5839605|NCT00005858|ovarian sarcoma|ovarian sarcoma
5842065|NCT00003565|stage III inverted papilloma of the paranasal sinus and nasal cavity|stage iii inverted papilloma of the paranasal sinus and nasal cavity
5842066|NCT00003565|stage III midline lethal granuloma of the paranasal sinus and nasal cavity|stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
5842067|NCT00003565|stage III esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
5842068|NCT00003565|stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity|stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
5842069|NCT00003565|stage IV inverted papilloma of the paranasal sinus and nasal cavity|stage iv inverted papilloma of the paranasal sinus and nasal cavity
5842070|NCT00003565|stage IV midline lethal granuloma of the paranasal sinus and nasal cavity|stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
5842071|NCT00003565|stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity|stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
5842072|NCT00003565|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5842073|NCT00003565|recurrent inverted papilloma of the paranasal sinus and nasal cavity|recurrent inverted papilloma of the paranasal sinus and nasal cavity
5842074|NCT00003565|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity|recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
5842075|NCT00003565|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity|recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
5842076|NCT00003565|recurrent salivary gland cancer|recurrent salivary gland cancer
5859931|NCT00006054|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
5859932|NCT00006054|primary immunodeficiency disease|primary immunodeficiency disease
5859933|NCT00006054|rare disease|rare disease
5859934|NCT00006054|severe combined immunodeficiency|severe combined immunodeficiency
5859935|NCT00006054|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
5859936|NCT00005933|Chronic Disease|chronic disease
5859937|NCT00005933|Pediatric|pediatric
5859938|NCT00005933|Pulmonary|pulmonary
5859939|NCT00005933|Intelligence|intelligence
5842077|NCT00003565|stage III salivary gland cancer|stage iii salivary gland cancer
5842078|NCT00003565|stage IV salivary gland cancer|stage iv salivary gland cancer
5842079|NCT00003560|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5853243|NCT00002179|RNA, Viral|rna, viral
5842080|NCT00003560|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5842081|NCT00003560|stage III endometrial carcinoma|stage iii endometrial carcinoma
5842082|NCT00003560|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5842083|NCT00003560|endometrial papillary serous carcinoma|endometrial papillary serous carcinoma
5842084|NCT00003560|fallopian tube cancer|fallopian tube cancer
5842085|NCT00003560|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5842086|NCT00003558|adenocarcinoma of unknown primary|adenocarcinoma of unknown primary
5842087|NCT00003558|newly diagnosed carcinoma of unknown primary|newly diagnosed carcinoma of unknown primary
5842088|NCT00003553|stage IV renal cell cancer|stage iv renal cell cancer
5842089|NCT00003553|recurrent renal cell cancer|recurrent renal cell cancer
5842090|NCT00003538|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5842091|NCT00003538|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5842092|NCT00003538|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5842093|NCT00003538|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5842094|NCT00003538|stage IV breast cancer|stage iv breast cancer
5842095|NCT00003538|stage IIIA breast cancer|stage iiia breast cancer
5842096|NCT00003538|stage IIIB breast cancer|stage iiib breast cancer
5842097|NCT00003538|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5842098|NCT00003538|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5842099|NCT00003538|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5842100|NCT00003538|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5842101|NCT00003538|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5842102|NCT00003538|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5842103|NCT00003538|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5842104|NCT00003538|disseminated neuroblastoma|disseminated neuroblastoma
5842105|NCT00003538|recurrent neuroblastoma|recurrent neuroblastoma
5842106|NCT00003538|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5842107|NCT00003538|Waldenstrom macroglobulinemia|waldenstrom macroglobulinemia
5842108|NCT00003538|stage I multiple myeloma|stage i multiple myeloma
5842109|NCT00003538|stage II multiple myeloma|stage ii multiple myeloma
5842110|NCT00003538|stage III multiple myeloma|stage iii multiple myeloma
5842111|NCT00003538|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5842112|NCT00003538|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5842113|NCT00003538|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5842114|NCT00003538|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5842115|NCT00003538|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5842116|NCT00003538|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5842117|NCT00003538|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5842118|NCT00003538|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5842119|NCT00003538|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5842120|NCT00003538|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5842121|NCT00003538|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5842122|NCT00003538|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5842123|NCT00003538|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5842124|NCT00003538|meningeal chronic myelogenous leukemia|meningeal chronic myelogenous leukemia
5842125|NCT00003538|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5842126|NCT00003538|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5842127|NCT00003538|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5842128|NCT00003538|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5860036|NCT00005906|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5860037|NCT00005905|Adipocyte - Development|adipocyte - development
5842129|NCT00003538|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5842130|NCT00003538|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5842131|NCT00003538|myelodysplastic syndromes|myelodysplastic syndromes
5842132|NCT00003538|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5842133|NCT00003538|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5842134|NCT00003538|untreated hairy cell leukemia|untreated hairy cell leukemia
5842135|NCT00003538|progressive hairy cell leukemia, initial treatment|progressive hairy cell leukemia, initial treatment
5842136|NCT00003538|refractory hairy cell leukemia|refractory hairy cell leukemia
5842137|NCT00003538|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5850192|NCT00025987|Temperature|temperature
5842138|NCT00003538|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5842140|NCT00003538|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5842141|NCT00003538|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5842142|NCT00003538|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5842143|NCT00003538|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5842144|NCT00003538|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5842145|NCT00003538|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5842146|NCT00003538|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5842147|NCT00003538|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5842148|NCT00003538|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5842149|NCT00003538|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5842150|NCT00003538|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5842151|NCT00003538|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5842152|NCT00003538|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5842153|NCT00003538|acute undifferentiated leukemia|acute undifferentiated leukemia
5842154|NCT00003538|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5842155|NCT00003538|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5842156|NCT00003538|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5842157|NCT00003538|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5842158|NCT00003538|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5842159|NCT00003538|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5842160|NCT00003538|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5842161|NCT00003538|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5842162|NCT00003538|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5842163|NCT00003538|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5842164|NCT00003538|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5842165|NCT00003538|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5842166|NCT00003538|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5842167|NCT00003538|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5842168|NCT00003538|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5842169|NCT00003538|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5842170|NCT00003538|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5842171|NCT00003538|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5842172|NCT00003538|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5842173|NCT00003538|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5842174|NCT00003538|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5842175|NCT00003538|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5842176|NCT00003538|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5842177|NCT00003538|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842178|NCT00003538|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5842179|NCT00003538|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5842180|NCT00003538|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5842181|NCT00003538|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5842182|NCT00003538|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5842183|NCT00003538|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5842184|NCT00003538|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5842185|NCT00003538|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5860123|NCT00005889|low birth weight|low birth weight
5860124|NCT00005889|neonatal disorders|neonatal disorders
5860125|NCT00005889|rare disease|rare disease
5860126|NCT00005888|gastrointestinal disorders|gastrointestinal disorders
5860127|NCT00005888|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5842186|NCT00003538|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5842187|NCT00003538|poor prognosis metastatic gestational trophoblastic tumor|poor prognosis metastatic gestational trophoblastic tumor
5842188|NCT00003538|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5842189|NCT00003538|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5842190|NCT00003538|anemia|anemia
5842191|NCT00003538|graft versus host disease|graft versus host disease
5842192|NCT00003538|prolymphocytic leukemia|prolymphocytic leukemia
5842193|NCT00003538|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5842194|NCT00003538|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5842195|NCT00003538|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5842196|NCT00003538|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5842197|NCT00003538|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5842198|NCT00003538|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5842199|NCT00003538|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5842200|NCT00003538|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5842201|NCT00003538|non-Hodgkin lymphoma during pregnancy|non-hodgkin lymphoma during pregnancy
5842202|NCT00003538|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5842203|NCT00003538|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5842204|NCT00003538|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5842205|NCT00003538|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5842206|NCT00003538|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5842207|NCT00003538|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5842208|NCT00003538|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5842273|NCT00003514|TSH producing pituitary tumor|tsh producing pituitary tumor
5842209|NCT00003538|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5842210|NCT00003538|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5842211|NCT00003538|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5842212|NCT00003538|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5842213|NCT00003538|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5842214|NCT00003538|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5842215|NCT00003538|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5842216|NCT00003538|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5842217|NCT00003538|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5842218|NCT00003538|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5842219|NCT00003538|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5842220|NCT00003538|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5842221|NCT00003538|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5842222|NCT00003538|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5842223|NCT00003538|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5842224|NCT00003538|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5842225|NCT00003538|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5842226|NCT00003538|angioimmunoblastic T-cell lymphoma|angioimmunoblastic t-cell lymphoma
5842227|NCT00003538|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5842228|NCT00003538|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5842229|NCT00003538|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5842230|NCT00003538|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5842231|NCT00003538|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5842232|NCT00003538|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5842233|NCT00003538|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5842234|NCT00003538|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5842235|NCT00003538|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5842236|NCT00003538|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5842237|NCT00003538|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5846869|NCT00042536|Sexual Function|sexual function
5842238|NCT00003538|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5842239|NCT00003538|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5842240|NCT00003538|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5842241|NCT00003538|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5842242|NCT00003538|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5842243|NCT00003538|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5842244|NCT00003537|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842245|NCT00003535|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
5842246|NCT00003535|childhood glioblastoma multiforme|childhood glioblastoma multiforme
5842247|NCT00003534|Refractory stage IV prostate cancer|refractory stage iv prostate cancer
5842248|NCT00003533|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5842249|NCT00003532|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5842250|NCT00003532|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5842251|NCT00003532|Stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5842252|NCT00003532|Stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5842253|NCT00003531|Adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5842254|NCT00003530|Childhood primary liver cancer|childhood primary liver cancer
5842255|NCT00003530|Adult primary liver cancer|adult primary liver cancer
5842256|NCT00003525|recurrent cervical cancer|recurrent cervical cancer
5842257|NCT00003525|recurrent vulvar cancer|recurrent vulvar cancer
5842258|NCT00003524|Stage III and IV Stomach (Gastric) Cancer|stage iii and iv stomach (gastric) cancer
5842259|NCT00003524|Recurrent Stomach (Gastric) Cancer|recurrent stomach (gastric) cancer
5842260|NCT00003522|recurrent small intestine cancer|recurrent small intestine cancer
5842261|NCT00003521|Stage III and IV Soft Tissue Sarcoma|stage iii and iv soft tissue sarcoma
5842262|NCT00003521|Recurrent Soft Tissue Sarcoma|recurrent soft tissue sarcoma
5842263|NCT00003520|stage IV renal cell cancer|stage iv renal cell cancer
5840006|NCT00005601|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5842264|NCT00003516|Stage III or Stage IV Prostate Cancer Stage III|stage iii or stage iv prostate cancer stage iii
5842265|NCT00003516|Stage III or Stage IV Prostate Cancer Stage IV|stage iii or stage iv prostate cancer stage iv
5842266|NCT00003515|Metastatic Primitive Neuroectodermal Tumor|metastatic primitive neuroectodermal tumor
5842267|NCT00003515|Recurrent Primitive Neuroectodermal Tumor|recurrent primitive neuroectodermal tumor
5842268|NCT00003515|Refractory Primitive Neuroectodermal Tumor|refractory primitive neuroectodermal tumor
5842269|NCT00003514|ACTH-producing pituitary tumor|acth-producing pituitary tumor
5842270|NCT00003514|prolactin-producing pituitary tumor|prolactin-producing pituitary tumor
5842271|NCT00003514|growth hormone-producing pituitary tumor|growth hormone-producing pituitary tumor
5842272|NCT00003514|recurrent pituitary tumor|recurrent pituitary tumor
5842274|NCT00003514|nonfunctioning pituitary tumor|nonfunctioning pituitary tumor
5842275|NCT00003514|somatostatinoma|somatostatinoma
5842276|NCT00003514|stage III Merkel cell carcinoma|stage iii merkel cell carcinoma
5842277|NCT00003514|recurrent Merkel cell carcinoma|recurrent merkel cell carcinoma
5842278|NCT00003514|neuroendocrine carcinoma|neuroendocrine carcinoma
5842279|NCT00003513|Metastatic Neuroblastoma|metastatic neuroblastoma
5842280|NCT00003513|Recurrent Neuroblastoma|recurrent neuroblastoma
5842281|NCT00003513|Refractory Neuroblastoma|refractory neuroblastoma
5842282|NCT00003512|Waldenstrom Macroglobulinemia Recurrent|waldenstrom macroglobulinemia recurrent
5842283|NCT00003512|Waldenstrom Macroglobulinemia Refractory|waldenstrom macroglobulinemia refractory
5842284|NCT00003511|Stage I multiple myeloma|stage i multiple myeloma
5842285|NCT00003511|Stage II multiple myeloma|stage ii multiple myeloma
5842286|NCT00003511|Stage III multiple myeloma|stage iii multiple myeloma
5842287|NCT00003509|Stage IV melanoma of the skin|stage iv melanoma of the skin
5842288|NCT00003508|advanced malignant mesothelioma|advanced malignant mesothelioma
5842289|NCT00003508|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5842290|NCT00003501|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5842291|NCT00003501|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
5842292|NCT00003501|High-Grade Stage II - IV Non-Hodgkin's Lymphoma|high-grade stage ii - iv non-hodgkin's lymphoma
5842293|NCT00003500|Refractory Non-Hodgkin's Lymphoma|refractory non-hodgkin's lymphoma
5842294|NCT00003500|Recurrent Non-Hodgkin's Lymphoma|recurrent non-hodgkin's lymphoma
5842295|NCT00003500|Intermediate-Grade Stage II - IV Non-Hodgkin's Lymphoma|intermediate-grade stage ii - iv non-hodgkin's lymphoma
5842296|NCT00003499|Low-grade non-Hodgkin's lymphoma|low-grade non-hodgkin's lymphoma
5842297|NCT00003498|Non Hodgkin Lymphoma Recurrent|non hodgkin lymphoma recurrent
5842298|NCT00003498|Non Hodgkin Lymphoma Refractory|non hodgkin lymphoma refractory
5842299|NCT00003497|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5842300|NCT00003496|recurrent small cell lung cancer|recurrent small cell lung cancer
5842301|NCT00003495|recurrent lung cancer|recurrent lung cancer
5842302|NCT00003494|Bronchial Alveolar Cancer Recurrent|bronchial alveolar cancer recurrent
5842303|NCT00003494|Bronchial Alveolar Cancer Stage IV|bronchial alveolar cancer stage iv
5842304|NCT00003492|Stage IV large cell lung cancer|stage iv large cell lung cancer
5842305|NCT00003492|Stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5842306|NCT00003491|non-small cell adenocarcinoma of the lung|non-small cell adenocarcinoma of the lung
5842307|NCT00003489|Advanced Head and Neck Cancer|advanced head and neck cancer
5842308|NCT00003489|Recurrent Head and Neck Cancer|recurrent head and neck cancer
5842309|NCT00003489|Oral Cavity Cancer|oral cavity cancer
5842310|NCT00003489|Nasopharyngeal Cancer|nasopharyngeal cancer
5842311|NCT00003489|Hypopharyngeal Cancer|hypopharyngeal cancer
5842312|NCT00003489|Laryngeal Cancer|laryngeal cancer
5842313|NCT00003489|Nasal Cavity Cancer|nasal cavity cancer
5842314|NCT00003489|Paranasal Sinus Cancer|paranasal sinus cancer
5842315|NCT00003489|Oropharyngeal Cancer|oropharyngeal cancer
5842316|NCT00003489|Salivary Gland Cancer|salivary gland cancer
5842317|NCT00003489|Stage IV Head and Neck Cancer|stage iv head and neck cancer
5842318|NCT00003487|stage IV esophageal cancer|stage iv esophageal cancer
5842319|NCT00003487|recurrent esophageal cancer|recurrent esophageal cancer
5842320|NCT00003487|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5842321|NCT00003485|stage IV colon cancer|stage iv colon cancer
5842322|NCT00003485|unresectable colon cancer|unresectable colon cancer
5842323|NCT00003483|adult meningioma|adult meningioma
5842324|NCT00003483|recurrent adult meningioma|recurrent adult meningioma
5842325|NCT00003479|Ependymoma|ependymoma
5842326|NCT00003479|Anaplastic Ependymoma|anaplastic ependymoma
5842327|NCT00003478|recurrent adult brain tumor|recurrent adult brain tumor
5842328|NCT00003478|adult brain stem glioma|adult brain stem glioma
5842329|NCT00003478|adult medulloblastoma|adult medulloblastoma
5842330|NCT00003478|adult glioblastoma|adult glioblastoma
5842331|NCT00003478|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842332|NCT00003478|adult anaplastic ependymoma|adult anaplastic ependymoma
5842333|NCT00003478|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5842334|NCT00003478|adult mixed glioma|adult mixed glioma
5842335|NCT00003478|adult ependymoblastoma|adult ependymoblastoma
5842336|NCT00003478|adult giant cell glioblastoma|adult giant cell glioblastoma
5842337|NCT00003478|adult gliosarcoma|adult gliosarcoma
5842338|NCT00003477|visual pathway glioma not amenable to standard therapy|visual pathway glioma not amenable to standard therapy
5842339|NCT00003477|visual pathway glioma not responding to standard therapy|visual pathway glioma not responding to standard therapy
5842340|NCT00003476|childhood anaplastic astrocytoma|childhood anaplastic astrocytoma
5842341|NCT00003476|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5842342|NCT00003476|childhood glioblastoma multiforme|childhood glioblastoma multiforme
5842343|NCT00003476|recurrent childhood glioblastoma multiforme|recurrent childhood glioblastoma multiforme
5842344|NCT00003476|childhood brainstem glioma|childhood brainstem glioma
5842345|NCT00003476|recurrent childhood brainstem glioma|recurrent childhood brainstem glioma
5842346|NCT00003476|childhood primitive neuroectodermal tumor|childhood primitive neuroectodermal tumor
5842347|NCT00003476|recurrent childhood primitive neuroectodermal tumor|recurrent childhood primitive neuroectodermal tumor
5842348|NCT00003475|adult glioblastoma multiforme|adult glioblastoma multiforme
5842349|NCT00003475|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842350|NCT00003475|adult anaplastic astrocytoma/Mixed|adult anaplastic astrocytoma/mixed
5842351|NCT00003474|adult glioblastoma|adult glioblastoma
5842352|NCT00003474|recurrent glioblastoma|recurrent glioblastoma
5842353|NCT00003473|recurrent adult mixed glioma|recurrent adult mixed glioma
5842354|NCT00003473|refractoy adult mixed glioma|refractoy adult mixed glioma
5842355|NCT00003472|Recurrent/progressive adult oligodendroglioma|recurrent/progressive adult oligodendroglioma
5842356|NCT00003472|Recurrent/progressive adult anaplastic oligodendroglioma|recurrent/progressive adult anaplastic oligodendroglioma
5842357|NCT00003471|Recurrent/progressive adult low grade astrocytoma|recurrent/progressive adult low grade astrocytoma
5842358|NCT00003470|persistent anaplastic astrocytoma|persistent anaplastic astrocytoma
5842359|NCT00003470|recurrent anaplastic astrocytoma|recurrent anaplastic astrocytoma
5842360|NCT00003470|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842361|NCT00003469|childhood rhabdoid tumor|childhood rhabdoid tumor
5842362|NCT00003468|childhood low-grade astrocytoma|childhood low-grade astrocytoma
5842363|NCT00003468|recurrent childhood astrocytoma|recurrent childhood astrocytoma
5842364|NCT00003468|persistent childhood astrocytoma|persistent childhood astrocytoma
5842365|NCT00003467|recurrent adult brain tumor|recurrent adult brain tumor
5842366|NCT00003467|adult brain stem glioma|adult brain stem glioma
5842367|NCT00003467|adult mixed glioma|adult mixed glioma
5842368|NCT00003467|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842369|NCT00003467|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5842370|NCT00003467|adult oligodendroglioma|adult oligodendroglioma
5842371|NCT00003466|recurrent adult brain tumor|recurrent adult brain tumor
5842372|NCT00003466|adult mixed glioma|adult mixed glioma
5842373|NCT00003466|childhood mixed glioma|childhood mixed glioma
5842374|NCT00003466|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5842375|NCT00003466|adult subependymoma|adult subependymoma
5842376|NCT00003466|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5842377|NCT00003466|adult brain stem glioma|adult brain stem glioma
5842378|NCT00003466|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5842379|NCT00003466|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5842380|NCT00003466|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5842381|NCT00003466|untreated childhood visual pathway and hypothalamic glioma|untreated childhood visual pathway and hypothalamic glioma
5860425|NCT00005003|Linkage|linkage
5842382|NCT00003466|adult oligodendroglioma|adult oligodendroglioma
5842383|NCT00003466|adult diffuse astrocytoma|adult diffuse astrocytoma
5842384|NCT00003462|leptomeningeal metastases|leptomeningeal metastases
5842385|NCT00003461|localized resectable neuroblastoma|localized resectable neuroblastoma
5842386|NCT00003461|recurrent neuroblastoma|recurrent neuroblastoma
5842387|NCT00003461|recurrent adult brain tumor|recurrent adult brain tumor
5842388|NCT00003461|adult craniopharyngioma|adult craniopharyngioma
5842389|NCT00003461|adult medulloblastoma|adult medulloblastoma
5842390|NCT00003461|adult meningioma|adult meningioma
5842391|NCT00003461|adult glioblastoma|adult glioblastoma
5842392|NCT00003461|adult oligodendroglioma|adult oligodendroglioma
5842393|NCT00003461|tumors metastatic to brain|tumors metastatic to brain
5842394|NCT00003461|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842395|NCT00003461|adult mixed glioma|adult mixed glioma
5842396|NCT00003461|adult pineal parenchymal tumor|adult pineal parenchymal tumor
5842397|NCT00003461|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5842398|NCT00003461|adult grade III meningioma|adult grade iii meningioma
5842399|NCT00003461|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5842400|NCT00003461|adult giant cell glioblastoma|adult giant cell glioblastoma
5842401|NCT00003461|adult gliosarcoma|adult gliosarcoma
5842402|NCT00003461|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5842403|NCT00003460|Recurrent primitive neuroectodermal tumor|recurrent primitive neuroectodermal tumor
5842404|NCT00003459|recurrent adult brain stem glioma|recurrent adult brain stem glioma
5842405|NCT00003459|untreated adult brain stem glioma|untreated adult brain stem glioma
5842406|NCT00003459|untreated childhood brain stem glioma|untreated childhood brain stem glioma
5842407|NCT00003459|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5842408|NCT00003458|Anaplastic astrocytoma|anaplastic astrocytoma
5842409|NCT00003458|Anaplastic glioma|anaplastic glioma
5842410|NCT00003458|Anaplastic oligodendroglioma|anaplastic oligodendroglioma
5842411|NCT00003458|Astrocytoma|astrocytoma
5842412|NCT00003458|Astrocytoma pilocytic|astrocytoma pilocytic
5840127|NCT00005590|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5842413|NCT00003458|Brain stem glioma|brain stem glioma
5842414|NCT00003458|Craniopharyngioma|craniopharyngioma
5842415|NCT00003458|Ganglioglioma|ganglioglioma
5842416|NCT00003458|Glioblastoma multiforme|glioblastoma multiforme
5842417|NCT00003458|Gliosarcoma|gliosarcoma
5842418|NCT00003458|Medulloepithelioma|medulloepithelioma
5842421|NCT00003458|Oligodendroglioma-brainstem|oligodendroglioma-brainstem
5842422|NCT00003458|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
5842423|NCT00003457|Anaplastic astrocytoma|anaplastic astrocytoma
5842424|NCT00003457|Anaplastic astrocytoma/Mixed|anaplastic astrocytoma/mixed
5842425|NCT00003457|Astrocytoma|astrocytoma
5842426|NCT00003457|Astrocytoma/Pilocytic|astrocytoma/pilocytic
5842427|NCT00003457|Brainstem glioma|brainstem glioma
5842428|NCT00003457|Glioblastoma multiforme|glioblastoma multiforme
5842429|NCT00003457|Glioma|glioma
5842430|NCT00003457|Neurocytoma|neurocytoma
5842566|NCT00003332|stage III pancreatic cancer|stage iii pancreatic cancer
5842431|NCT00003457|Primitive neuroectodermal tumor|primitive neuroectodermal tumor
5842432|NCT00003457|Tectal glioma|tectal glioma
5842433|NCT00003456|adult glioblastoma|adult glioblastoma
5842434|NCT00003454|recurrent breast cancer|recurrent breast cancer
5842435|NCT00003453|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5842436|NCT00003452|recurrent bladder cancer|recurrent bladder cancer
5843919|NCT00051753|Otitis Media|otitis media
5842437|NCT00003437|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5842438|NCT00003437|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5842439|NCT00003429|stage I cervical cancer|stage i cervical cancer
5842440|NCT00003429|stage II cervical cancer|stage ii cervical cancer
5842441|NCT00003429|recurrent cervical cancer|recurrent cervical cancer
5842442|NCT00003422|stage I rectal cancer|stage i rectal cancer
5842443|NCT00003422|stage II rectal cancer|stage ii rectal cancer
5842444|NCT00003422|stage III rectal cancer|stage iii rectal cancer
5842445|NCT00003422|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5842446|NCT00003420|stage I malignant testicular germ cell tumor|stage i malignant testicular germ cell tumor
5842447|NCT00003420|testicular teratoma|testicular teratoma
5842448|NCT00003419|AIDS-related Kaposi sarcoma|aids-related kaposi sarcoma
5842449|NCT00003417|adult glioblastoma|adult glioblastoma
5842450|NCT00003417|adult giant cell glioblastoma|adult giant cell glioblastoma
5842451|NCT00003417|adult gliosarcoma|adult gliosarcoma
5842452|NCT00003404|recurrent breast cancer|recurrent breast cancer
5842453|NCT00003404|phyllodes tumor|phyllodes tumor
5842454|NCT00003389|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5842455|NCT00003389|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5842456|NCT00003389|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5842457|NCT00003389|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5842458|NCT00003389|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5842459|NCT00003389|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5842460|NCT00003389|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5842461|NCT00003385|stage I ovarian epithelial cancer|stage i ovarian epithelial cancer
5860506|NCT00004982|iron poisoning|iron poisoning
5860507|NCT00004982|thalassemia|thalassemia
5860508|NCT00004982|chelating agent|chelating agent
5860509|NCT00004982|deferoxamine|deferoxamine
5860510|NCT00004982|drug screening /evaluation|drug screening /evaluation
5860511|NCT00004982|therapy evaluation|therapy evaluation
5860512|NCT00004980|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860513|NCT00004980|rare disease|rare disease
5860514|NCT00004980|schizophrenia|schizophrenia
5860515|NCT00004854|moderate heart failure|moderate heart failure
5860516|NCT00004853|AMGEN|amgen
5860517|NCT00004853|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5842462|NCT00003385|stage II ovarian epithelial cancer|stage ii ovarian epithelial cancer
5842463|NCT00003385|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5842464|NCT00003385|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5842465|NCT00003385|ovarian undifferentiated adenocarcinoma|ovarian undifferentiated adenocarcinoma
5842466|NCT00003385|ovarian mixed epithelial carcinoma|ovarian mixed epithelial carcinoma
5842467|NCT00003385|ovarian serous cystadenocarcinoma|ovarian serous cystadenocarcinoma
5842468|NCT00003385|ovarian mucinous cystadenocarcinoma|ovarian mucinous cystadenocarcinoma
5842469|NCT00003385|ovarian endometrioid adenocarcinoma|ovarian endometrioid adenocarcinoma
5842470|NCT00003385|ovarian clear cell cystadenocarcinoma|ovarian clear cell cystadenocarcinoma
5842471|NCT00003385|fallopian tube cancer|fallopian tube cancer
5842472|NCT00003385|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5842473|NCT00003385|Brenner tumor|brenner tumor
5842474|NCT00003379|stage III cervical cancer|stage iii cervical cancer
5842475|NCT00003379|stage IB cervical cancer|stage ib cervical cancer
5842476|NCT00003379|stage IIB cervical cancer|stage iib cervical cancer
5842477|NCT00003379|stage IIA cervical cancer|stage iia cervical cancer
5842478|NCT00003379|stage IVA cervical cancer|stage iva cervical cancer
5842479|NCT00003379|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5842480|NCT00003379|cervical adenocarcinoma|cervical adenocarcinoma
5842481|NCT00003379|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5842482|NCT00003379|cervical small cell carcinoma|cervical small cell carcinoma
5842483|NCT00003377|stage III cervical cancer|stage iii cervical cancer
5842484|NCT00003377|stage IVA cervical cancer|stage iva cervical cancer
5842485|NCT00003377|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5842486|NCT00003377|cervical adenocarcinoma|cervical adenocarcinoma
5842487|NCT00003377|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5842488|NCT00003375|adult oligodendroglioma|adult oligodendroglioma
5842489|NCT00003375|adult diffuse astrocytoma|adult diffuse astrocytoma
5842490|NCT00003375|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5842491|NCT00003354|stage I colon cancer|stage i colon cancer
5842492|NCT00003354|stage II colon cancer|stage ii colon cancer
5842493|NCT00003354|stage III colon cancer|stage iii colon cancer
5842494|NCT00003354|stage IV colon cancer|stage iv colon cancer
5842495|NCT00003354|stage 0 colon cancer|stage 0 colon cancer
5842496|NCT00003354|stage 0 rectal cancer|stage 0 rectal cancer
5842497|NCT00003354|stage I rectal cancer|stage i rectal cancer
5842498|NCT00003354|stage II rectal cancer|stage ii rectal cancer
5842499|NCT00003354|stage III rectal cancer|stage iii rectal cancer
5842500|NCT00003354|stage IV rectal cancer|stage iv rectal cancer
5842501|NCT00003342|stage III bladder cancer|stage iii bladder cancer
5842502|NCT00003342|stage IV bladder cancer|stage iv bladder cancer
5842503|NCT00003342|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5842504|NCT00003342|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5842505|NCT00003342|localized transitional cell cancer of the renal pelvis and ureter|localized transitional cell cancer of the renal pelvis and ureter
5842700|NCT00003138|myelodysplastic syndromes|myelodysplastic syndromes
5842506|NCT00003342|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5842507|NCT00003336|refractory anemia|refractory anemia
5842508|NCT00003336|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5842509|NCT00003336|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5842510|NCT00003336|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5842511|NCT00003336|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5842512|NCT00003336|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5842513|NCT00003336|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5847205|NCT00040508|Proteinuria|proteinuria
5842514|NCT00003336|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5842515|NCT00003335|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5842516|NCT00003335|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5842517|NCT00003335|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5842518|NCT00003335|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5842519|NCT00003335|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5842520|NCT00003335|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5842521|NCT00003335|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5842522|NCT00003335|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5842523|NCT00003335|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5842524|NCT00003335|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5842525|NCT00003335|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5842526|NCT00003335|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5842527|NCT00003335|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5842528|NCT00003335|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5842529|NCT00003335|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5842530|NCT00003335|refractory anemia with excess blasts|refractory anemia with excess blasts
5842531|NCT00003335|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5842532|NCT00003335|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5842533|NCT00003335|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5842534|NCT00003335|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5842535|NCT00003335|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5843920|NCT00051753|Acute Otitis Media|acute otitis media
5842536|NCT00003335|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842537|NCT00003335|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5842538|NCT00003335|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5842539|NCT00003335|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5842540|NCT00003335|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5842541|NCT00003335|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5842542|NCT00003335|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5842543|NCT00003335|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5842544|NCT00003335|graft versus host disease|graft versus host disease
5842545|NCT00003335|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5842546|NCT00003335|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5842547|NCT00003335|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5842548|NCT00003335|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5842549|NCT00003335|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5842550|NCT00003335|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5842551|NCT00003335|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5842552|NCT00003335|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5842553|NCT00003335|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5842554|NCT00003335|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5842555|NCT00003335|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5842556|NCT00003335|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5842557|NCT00003335|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5842558|NCT00003335|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5842559|NCT00003335|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5842560|NCT00003335|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5842561|NCT00003335|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5842562|NCT00003335|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5842563|NCT00003335|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5842564|NCT00003332|stage I pancreatic cancer|stage i pancreatic cancer
5842565|NCT00003332|stage II pancreatic cancer|stage ii pancreatic cancer
5842567|NCT00003332|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5842568|NCT00003329|stage I colon cancer|stage i colon cancer
5842569|NCT00003329|stage II colon cancer|stage ii colon cancer
5842570|NCT00003329|stage III colon cancer|stage iii colon cancer
5842571|NCT00003329|stage IV colon cancer|stage iv colon cancer
5842572|NCT00003329|stage I breast cancer|stage i breast cancer
5842573|NCT00003329|stage II breast cancer|stage ii breast cancer
5842574|NCT00003329|stage IIIA breast cancer|stage iiia breast cancer
5842575|NCT00003329|stage IIIB breast cancer|stage iiib breast cancer
5842576|NCT00003329|stage IIIC breast cancer|stage iiic breast cancer
5842577|NCT00003329|stage IV breast cancer|stage iv breast cancer
5842578|NCT00003329|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5842579|NCT00003329|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5842580|NCT00003329|stage III non-small cell lung cancer|stage iii non-small cell lung cancer
5842581|NCT00003329|limited stage small cell lung cancer|limited stage small cell lung cancer
5842582|NCT00003329|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5842583|NCT00003329|stage I prostate cancer|stage i prostate cancer
5842584|NCT00003329|stage II prostate cancer|stage ii prostate cancer
5842585|NCT00003329|stage III prostate cancer|stage iii prostate cancer
5842586|NCT00003329|stage IV prostate cancer|stage iv prostate cancer
5842587|NCT00003329|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5842588|NCT00003325|stage I vulvar cancer|stage i vulvar cancer
5842589|NCT00003325|stage II vulvar cancer|stage ii vulvar cancer
5842590|NCT00003325|squamous cell carcinoma of the vulva|squamous cell carcinoma of the vulva
5842591|NCT00003309|adult medulloblastoma|adult medulloblastoma
5842592|NCT00003309|adult anaplastic ependymoma|adult anaplastic ependymoma
5842593|NCT00003309|adult ependymoma|adult ependymoma
5842594|NCT00003309|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5842595|NCT00003308|metastatic osteosarcoma|metastatic osteosarcoma
5842596|NCT00003308|chondrosarcoma|chondrosarcoma
5842597|NCT00003308|stage IV renal cell cancer|stage iv renal cell cancer
5842598|NCT00003308|stage IV melanoma|stage iv melanoma
5842599|NCT00003308|tumors metastatic to brain|tumors metastatic to brain
5842600|NCT00003308|stage IV uterine sarcoma|stage iv uterine sarcoma
5842601|NCT00003308|ovarian sarcoma|ovarian sarcoma
5842602|NCT00003308|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5842603|NCT00003308|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5842604|NCT00003291|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5842605|NCT00003278|primary central nervous system non-Hodgkin lymphoma|primary central nervous system non-hodgkin lymphoma
5842606|NCT00003278|intraocular lymphoma|intraocular lymphoma
5842607|NCT00003273|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5842608|NCT00003273|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5842609|NCT00003273|localized resectable neuroblastoma|localized resectable neuroblastoma
5842610|NCT00003273|regional neuroblastoma|regional neuroblastoma
5842611|NCT00003273|disseminated neuroblastoma|disseminated neuroblastoma
5842612|NCT00003273|stage 4S neuroblastoma|stage 4s neuroblastoma
5842613|NCT00003273|extraocular retinoblastoma|extraocular retinoblastoma
5842614|NCT00003273|childhood choroid plexus tumor|childhood choroid plexus tumor
5842615|NCT00003273|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5842616|NCT00003273|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5842617|NCT00003273|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5842618|NCT00003273|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5842619|NCT00003273|newly diagnosed childhood ependymoma|newly diagnosed childhood ependymoma
5842620|NCT00003268|untreated adult acute myeloid leukemia|untreated adult acute myeloid leukemia
5842621|NCT00003268|adult acute monoblastic leukemia and acute monocytic leukemia (M5)|adult acute monoblastic leukemia and acute monocytic leukemia (m5)
5842622|NCT00003268|adult acute erythroid leukemia (M6)|adult acute erythroid leukemia (m6)
5842623|NCT00003268|adult acute myeloblastic leukemia without maturation (M1)|adult acute myeloblastic leukemia without maturation (m1)
5842624|NCT00003268|adult acute myeloblastic leukemia with maturation (M2)|adult acute myeloblastic leukemia with maturation (m2)
5842625|NCT00003268|adult acute myelomonocytic leukemia (M4)|adult acute myelomonocytic leukemia (m4)
5842626|NCT00003268|adult acute megakaryoblastic leukemia (M7)|adult acute megakaryoblastic leukemia (m7)
5842627|NCT00003268|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5842628|NCT00003268|adult acute minimally differentiated myeloid leukemia (M0)|adult acute minimally differentiated myeloid leukemia (m0)
5842629|NCT00003261|AIDS-related primary CNS lymphoma|aids-related primary cns lymphoma
5842691|NCT00003159|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5842630|NCT00003243|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5842631|NCT00003243|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5842632|NCT00003243|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5842633|NCT00003243|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5842634|NCT00003243|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5863088|NCT00001400|Heart Disease|heart disease
5842635|NCT00003243|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5853883|NCT00002052|Ceftriaxone|ceftriaxone
5842636|NCT00003243|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5842637|NCT00003243|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5842638|NCT00003243|acute undifferentiated leukemia|acute undifferentiated leukemia
5842639|NCT00003243|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842640|NCT00003243|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5842641|NCT00003243|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5842642|NCT00003243|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5842643|NCT00003243|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5842644|NCT00003243|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5842645|NCT00003243|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5842646|NCT00003243|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5842647|NCT00003243|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5842648|NCT00003243|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5842649|NCT00003243|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5842650|NCT00003243|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5842651|NCT00003216|stage I pancreatic cancer|stage i pancreatic cancer
5842652|NCT00003216|stage II pancreatic cancer|stage ii pancreatic cancer
5842653|NCT00003216|stage III pancreatic cancer|stage iii pancreatic cancer
5842654|NCT00003216|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5842655|NCT00003216|stage IV pancreatic cancer|stage iv pancreatic cancer
5842656|NCT00003215|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5842657|NCT00003215|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5842658|NCT00003215|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5842659|NCT00003215|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5842660|NCT00003215|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5842661|NCT00003215|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5842662|NCT00003215|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5842663|NCT00003215|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5842664|NCT00003215|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5842665|NCT00003215|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5842666|NCT00003215|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5842667|NCT00003215|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5842668|NCT00003215|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5842669|NCT00003215|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5842670|NCT00003215|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5842671|NCT00003215|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5842672|NCT00003194|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5842673|NCT00003179|endometrial cancer|endometrial cancer
5842674|NCT00003178|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5842675|NCT00003178|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5842676|NCT00003178|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5842677|NCT00003178|childhood acute promyelocytic leukemia (M3)|childhood acute promyelocytic leukemia (m3)
5842678|NCT00003178|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5842679|NCT00003178|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5842680|NCT00003178|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5842681|NCT00003178|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5842682|NCT00003178|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5842683|NCT00003178|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5842684|NCT00003174|stage I chronic lymphocytic leukemia|stage i chronic lymphocytic leukemia
5842685|NCT00003174|stage II chronic lymphocytic leukemia|stage ii chronic lymphocytic leukemia
5842686|NCT00003174|stage III chronic lymphocytic leukemia|stage iii chronic lymphocytic leukemia
5842687|NCT00003174|stage IV chronic lymphocytic leukemia|stage iv chronic lymphocytic leukemia
5842688|NCT00003174|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5842689|NCT00003159|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5842690|NCT00003159|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5842692|NCT00003159|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5842693|NCT00003159|stage 0 non-small cell lung cancer|stage 0 non-small cell lung cancer
5842694|NCT00003153|refractory multiple myeloma|refractory multiple myeloma
5842696|NCT00003140|stage II breast cancer|stage ii breast cancer
5842697|NCT00003140|stage IIIA breast cancer|stage iiia breast cancer
5842698|NCT00003138|anemia|anemia
5842699|NCT00003138|refractory anemia|refractory anemia
5842705|NCT00003135|recurrent cervical cancer|recurrent cervical cancer
5842706|NCT00003135|stage IVB cervical cancer|stage ivb cervical cancer
5842707|NCT00003135|stage IVA cervical cancer|stage iva cervical cancer
5842708|NCT00003135|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5842709|NCT00003135|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5842710|NCT00003135|stage IV endometrial carcinoma|stage iv endometrial carcinoma
5842711|NCT00003135|recurrent endometrial carcinoma|recurrent endometrial carcinoma
5847577|NCT00038805|CMA-676|cma-676
5842712|NCT00003135|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5842713|NCT00003135|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5842714|NCT00003135|male breast cancer|male breast cancer
5842715|NCT00003128|stage III uterine sarcoma|stage iii uterine sarcoma
5842716|NCT00003128|stage IV uterine sarcoma|stage iv uterine sarcoma
5842717|NCT00003128|recurrent uterine sarcoma|recurrent uterine sarcoma
5842718|NCT00003128|uterine carcinosarcoma|uterine carcinosarcoma
5842719|NCT00003122|localized resectable neuroblastoma|localized resectable neuroblastoma
5842720|NCT00003122|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5842721|NCT00003119|localized resectable neuroblastoma|localized resectable neuroblastoma
5842722|NCT00003119|stage 4S neuroblastoma|stage 4s neuroblastoma
5842723|NCT00003116|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5842724|NCT00003116|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5842725|NCT00003116|refractory multiple myeloma|refractory multiple myeloma
5842726|NCT00003116|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5842727|NCT00003116|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5842728|NCT00003116|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5842729|NCT00003116|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5842730|NCT00003116|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5842731|NCT00003116|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5842732|NCT00003116|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5842733|NCT00003116|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5842734|NCT00003116|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5842735|NCT00003116|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5842736|NCT00003116|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5842737|NCT00003116|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5842738|NCT00003116|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5842739|NCT00003116|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842740|NCT00003116|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5842741|NCT00003116|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5842742|NCT00003116|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5842743|NCT00003116|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5842744|NCT00003116|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5842745|NCT00003116|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5840457|NCT00004245|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5842746|NCT00003116|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5842747|NCT00003116|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5842748|NCT00003116|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5842749|NCT00003116|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5842750|NCT00003116|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5842751|NCT00003116|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5842752|NCT00003116|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5842753|NCT00003116|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5842754|NCT00003116|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5842755|NCT00003116|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5842756|NCT00003116|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5842757|NCT00003116|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5842758|NCT00003116|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5842759|NCT00003116|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5842835|NCT00003022|metastatic osteosarcoma|metastatic osteosarcoma
5850195|NCT00025987|Rectal|rectal
5842760|NCT00003116|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5842761|NCT00003116|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5842762|NCT00003116|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5842763|NCT00003111|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5842764|NCT00003105|stage III bladder cancer|stage iii bladder cancer
5842765|NCT00003105|recurrent bladder cancer|recurrent bladder cancer
5842766|NCT00003105|stage IV bladder cancer|stage iv bladder cancer
5842767|NCT00003105|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5842768|NCT00003105|metastatic transitional cell cancer of the renal pelvis and ureter|metastatic transitional cell cancer of the renal pelvis and ureter
5842769|NCT00003105|regional transitional cell cancer of the renal pelvis and ureter|regional transitional cell cancer of the renal pelvis and ureter
5842770|NCT00003105|recurrent transitional cell cancer of the renal pelvis and ureter|recurrent transitional cell cancer of the renal pelvis and ureter
5842771|NCT00003104|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5842772|NCT00003104|stage IIB prostate cancer|stage iib prostate cancer
5842773|NCT00003104|stage IIA prostate cancer|stage iia prostate cancer
5842774|NCT00003096|untreated childhood supratentorial primitive neuroectodermal tumor|untreated childhood supratentorial primitive neuroectodermal tumor
5842775|NCT00003096|untreated childhood medulloblastoma|untreated childhood medulloblastoma
5842776|NCT00003093|regional neuroblastoma|regional neuroblastoma
5842777|NCT00003093|disseminated neuroblastoma|disseminated neuroblastoma
5842778|NCT00003093|stage 4S neuroblastoma|stage 4s neuroblastoma
5842779|NCT00003093|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5842780|NCT00003092|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5842781|NCT00003067|recurrent adult brain tumor|recurrent adult brain tumor
5842782|NCT00003067|adult glioblastoma|adult glioblastoma
5842783|NCT00003067|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842784|NCT00003067|adult mixed glioma|adult mixed glioma
5842785|NCT00003067|adult giant cell glioblastoma|adult giant cell glioblastoma
5842786|NCT00003067|adult gliosarcoma|adult gliosarcoma
5842787|NCT00003065|recurrent cervical cancer|recurrent cervical cancer
5842788|NCT00003065|stage IVB cervical cancer|stage ivb cervical cancer
5842789|NCT00003065|stage IVA cervical cancer|stage iva cervical cancer
5842790|NCT00003065|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5842791|NCT00003065|cervical adenocarcinoma|cervical adenocarcinoma
5842792|NCT00003063|stage II colon cancer|stage ii colon cancer
5842793|NCT00003063|stage III colon cancer|stage iii colon cancer
5842794|NCT00003063|stage II rectal cancer|stage ii rectal cancer
5842795|NCT00003063|stage III rectal cancer|stage iii rectal cancer
5842796|NCT00003053|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5842797|NCT00003053|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5842798|NCT00003053|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5842799|NCT00003052|adult angiosarcoma|adult angiosarcoma
5842800|NCT00003052|adult fibrosarcoma|adult fibrosarcoma
5842801|NCT00003052|adult leiomyosarcoma|adult leiomyosarcoma
5842802|NCT00003052|adult liposarcoma|adult liposarcoma
5842803|NCT00003052|adult neurofibrosarcoma|adult neurofibrosarcoma
5842804|NCT00003052|adult synovial sarcoma|adult synovial sarcoma
5842805|NCT00003052|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5842806|NCT00003052|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5842807|NCT00003052|adult extraskeletal osteosarcoma|adult extraskeletal osteosarcoma
5842808|NCT00003052|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5842809|NCT00003052|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5842810|NCT00003052|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5842811|NCT00003052|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5846696|NCT00043719|Vitamin D|vitamin d
5842812|NCT00003049|stage I pancreatic cancer|stage i pancreatic cancer
5842813|NCT00003049|stage II pancreatic cancer|stage ii pancreatic cancer
5842814|NCT00003049|stage III pancreatic cancer|stage iii pancreatic cancer
5842815|NCT00003049|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5842816|NCT00003042|stage IIIB breast cancer|stage iiib breast cancer
5842817|NCT00003042|inflammatory breast cancer|inflammatory breast cancer
5842818|NCT00003034|localized malignant mesothelioma|localized malignant mesothelioma
5842819|NCT00003034|advanced malignant mesothelioma|advanced malignant mesothelioma
5842820|NCT00003034|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5842821|NCT00003029|stage III pancreatic cancer|stage iii pancreatic cancer
5842822|NCT00003029|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5842823|NCT00003029|stage IV pancreatic cancer|stage iv pancreatic cancer
5842824|NCT00003027|stage IV melanoma|stage iv melanoma
5842825|NCT00003026|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5842827|NCT00003023|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5842828|NCT00003023|disseminated neuroblastoma|disseminated neuroblastoma
5842829|NCT00003023|stage 4S neuroblastoma|stage 4s neuroblastoma
5842830|NCT00003023|recurrent neuroblastoma|recurrent neuroblastoma
5842831|NCT00003023|recurrent osteosarcoma|recurrent osteosarcoma
5842832|NCT00003023|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5842833|NCT00003023|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5842834|NCT00003023|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5842836|NCT00003022|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5842837|NCT00003022|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5842838|NCT00003022|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5842839|NCT00003022|regional neuroblastoma|regional neuroblastoma
5842840|NCT00003022|disseminated neuroblastoma|disseminated neuroblastoma
5842841|NCT00003022|stage 4S neuroblastoma|stage 4s neuroblastoma
5863089|NCT00001400|Screening|screening
5842842|NCT00003022|recurrent neuroblastoma|recurrent neuroblastoma
5842844|NCT00003022|intraocular retinoblastoma|intraocular retinoblastoma
5842845|NCT00003022|extraocular retinoblastoma|extraocular retinoblastoma
5842846|NCT00003022|recurrent retinoblastoma|recurrent retinoblastoma
5842984|NCT00002931|ovarian mature teratoma|ovarian mature teratoma
5842847|NCT00003022|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5842848|NCT00003022|recurrent small cell lung cancer|recurrent small cell lung cancer
5842849|NCT00003022|recurrent osteosarcoma|recurrent osteosarcoma
5842850|NCT00003022|recurrent adult brain tumor|recurrent adult brain tumor
5842851|NCT00003022|iris melanoma|iris melanoma
5861046|NCT00004646|rare disease|rare disease
5861047|NCT00004645|Balo's concentric sclerosis|balo's concentric sclerosis
5861048|NCT00004645|Devic's syndrome|devic's syndrome
5861049|NCT00004645|Marburg's variant of multiple sclerosis|marburg's variant of multiple sclerosis
5861050|NCT00004645|acute disseminated encephalomyelitis|acute disseminated encephalomyelitis
5861051|NCT00004645|acute transverse myelitis|acute transverse myelitis
5861052|NCT00004645|multiple sclerosis|multiple sclerosis
5861054|NCT00004645|rare disease|rare disease
5842852|NCT00003022|ciliary body and choroid melanoma, small size|ciliary body and choroid melanoma, small size
5842853|NCT00003022|ciliary body and choroid melanoma, medium/large size|ciliary body and choroid melanoma, medium/large size
5842854|NCT00003022|extraocular extension melanoma|extraocular extension melanoma
5842855|NCT00003022|recurrent intraocular melanoma|recurrent intraocular melanoma
5842856|NCT00003022|adult brain stem glioma|adult brain stem glioma
5842857|NCT00003022|adult medulloblastoma|adult medulloblastoma
5842858|NCT00003022|stage IV melanoma|stage iv melanoma
5842859|NCT00003022|recurrent melanoma|recurrent melanoma
5842860|NCT00003022|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5842861|NCT00003022|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5842862|NCT00003022|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5842863|NCT00003022|adult anaplastic ependymoma|adult anaplastic ependymoma
5842864|NCT00003022|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5842865|NCT00003022|adult mixed glioma|adult mixed glioma
5842866|NCT00003022|localized unresectable neuroblastoma|localized unresectable neuroblastoma
5842867|NCT00003022|adult ependymoblastoma|adult ependymoblastoma
5842868|NCT00003022|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5842869|NCT00003022|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5842870|NCT00003022|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5842871|NCT00003022|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5842872|NCT00003022|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5842873|NCT00003022|previously treated childhood rhabdomyosarcoma|previously treated childhood rhabdomyosarcoma
5842874|NCT00003022|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5842875|NCT00003022|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5842876|NCT00003022|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5842877|NCT00003022|recurrent childhood ependymoma|recurrent childhood ependymoma
5842878|NCT00003022|adult oligodendroglioma|adult oligodendroglioma
5842879|NCT00003022|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5842880|NCT00003022|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5842881|NCT00003022|adult diffuse astrocytoma|adult diffuse astrocytoma
5842882|NCT00003022|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5842883|NCT00003022|adult giant cell glioblastoma|adult giant cell glioblastoma
5842885|NCT00003022|adult gliosarcoma|adult gliosarcoma
5842886|NCT00003016|stage I breast cancer|stage i breast cancer
5842887|NCT00003016|stage II breast cancer|stage ii breast cancer
5842888|NCT00003016|stage IIIA breast cancer|stage iiia breast cancer
5842889|NCT00003016|stage IIIB breast cancer|stage iiib breast cancer
5842890|NCT00003016|stage IIIC breast cancer|stage iiic breast cancer
5842891|NCT00003013|stage II breast cancer|stage ii breast cancer
5842892|NCT00003013|stage IIIA breast cancer|stage iiia breast cancer
5842893|NCT00002996|pain|pain
5842894|NCT00002995|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5842895|NCT00002995|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5842896|NCT00002995|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5842897|NCT00002995|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5842898|NCT00002995|adult malignant mesenchymoma|adult malignant mesenchymoma
5842899|NCT00002995|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5842900|NCT00002995|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5842901|NCT00002995|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5842902|NCT00002995|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5842903|NCT00002995|stage I adult soft tissue sarcoma|stage i adult soft tissue sarcoma
5842904|NCT00002990|stage 0 bladder cancer|stage 0 bladder cancer
5842905|NCT00002990|stage I bladder cancer|stage i bladder cancer
5842906|NCT00002990|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5842907|NCT00002986|recurrent adult brain tumor|recurrent adult brain tumor
5861142|NCT00004553|Neuromuscular Transmission|neuromuscular transmission
5861143|NCT00004553|Motor Dysfunction|motor dysfunction
5861144|NCT00004553|Neuromuscular Disorder|neuromuscular disorder
5861145|NCT00004550|Screening|screening
5861146|NCT00004550|Longitudinal|longitudinal
5861147|NCT00004550|Transition|transition
5861148|NCT00004550|Treatment|treatment
5861149|NCT00004550|Comorbidity|comorbidity
5843045|NCT00002883|stage I esophageal cancer|stage i esophageal cancer
5842908|NCT00002982|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5842909|NCT00002982|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5842910|NCT00002982|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5842911|NCT00002982|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5842912|NCT00002982|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5842913|NCT00002982|anaplastic large cell lymphoma|anaplastic large cell lymphoma
5842914|NCT00002981|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5842915|NCT00002981|stage IV prostate cancer|stage iv prostate cancer
5842916|NCT00002981|recurrent prostate cancer|recurrent prostate cancer
5842917|NCT00002976|stage I endometrial carcinoma|stage i endometrial carcinoma
5842918|NCT00002976|stage II endometrial carcinoma|stage ii endometrial carcinoma
5842919|NCT00002976|endometrial adenocarcinoma|endometrial adenocarcinoma
5842920|NCT00002975|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5842921|NCT00002975|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5842922|NCT00002975|actinic keratosis|actinic keratosis
5842923|NCT00002963|basal cell carcinoma of the skin|basal cell carcinoma of the skin
5842924|NCT00002963|squamous cell carcinoma of the skin|squamous cell carcinoma of the skin
5842925|NCT00002951|stage II esophageal cancer|stage ii esophageal cancer
5842926|NCT00002951|stage III esophageal cancer|stage iii esophageal cancer
5842927|NCT00002951|stage II nasopharyngeal cancer|stage ii nasopharyngeal cancer
5842928|NCT00002951|stage III nasopharyngeal cancer|stage iii nasopharyngeal cancer
5842929|NCT00002951|stage II lip and oral cavity cancer|stage ii lip and oral cavity cancer
5842930|NCT00002951|stage III lip and oral cavity cancer|stage iii lip and oral cavity cancer
5842931|NCT00002951|stage II hypopharyngeal cancer|stage ii hypopharyngeal cancer
5842932|NCT00002951|stage III hypopharyngeal cancer|stage iii hypopharyngeal cancer
5842933|NCT00002951|stage II laryngeal cancer|stage ii laryngeal cancer
5842934|NCT00002951|stage III laryngeal cancer|stage iii laryngeal cancer
5842935|NCT00002951|stage II paranasal sinus and nasal cavity cancer|stage ii paranasal sinus and nasal cavity cancer
5842936|NCT00002951|stage III paranasal sinus and nasal cavity cancer|stage iii paranasal sinus and nasal cavity cancer
5842937|NCT00002951|stage II oropharyngeal cancer|stage ii oropharyngeal cancer
5842938|NCT00002951|stage III oropharyngeal cancer|stage iii oropharyngeal cancer
5842939|NCT00002948|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5842940|NCT00002944|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5842941|NCT00002944|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5842942|NCT00002944|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5842943|NCT00002944|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5842944|NCT00002944|childhood low-grade cerebellar astrocytoma|childhood low-grade cerebellar astrocytoma
5842945|NCT00002944|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5842946|NCT00002943|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5842947|NCT00002943|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5842948|NCT00002943|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5842949|NCT00002943|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5842950|NCT00002943|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5842951|NCT00002943|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5842952|NCT00002943|extragonadal germ cell tumor|extragonadal germ cell tumor
5842953|NCT00002941|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5842954|NCT00002941|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5842955|NCT00002941|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5842956|NCT00002941|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5842957|NCT00002941|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5842958|NCT00002941|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5842959|NCT00002938|recurrent prostate cancer|recurrent prostate cancer
5842960|NCT00002931|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5842961|NCT00002931|testicular seminoma|testicular seminoma
5842962|NCT00002931|testicular embryonal carcinoma|testicular embryonal carcinoma
5842963|NCT00002931|testicular choriocarcinoma|testicular choriocarcinoma
5842964|NCT00002931|testicular yolk sac tumor|testicular yolk sac tumor
5842965|NCT00002931|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5842966|NCT00002931|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5842967|NCT00002931|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5842968|NCT00002931|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5842969|NCT00002931|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5842970|NCT00002931|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5842971|NCT00002931|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5842972|NCT00002931|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5842973|NCT00002931|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5842974|NCT00002931|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5842975|NCT00002931|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5842976|NCT00002931|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5842977|NCT00002931|recurrent extragonadal non-seminomatous germ cell tumor|recurrent extragonadal non-seminomatous germ cell tumor
5842978|NCT00002931|recurrent extragonadal seminoma|recurrent extragonadal seminoma
5842979|NCT00002931|recurrent extragonadal germ cell tumor|recurrent extragonadal germ cell tumor
5842980|NCT00002931|adult teratoma|adult teratoma
5842981|NCT00002931|testicular immature teratoma|testicular immature teratoma
5842982|NCT00002931|testicular mature teratoma|testicular mature teratoma
5842983|NCT00002931|ovarian immature teratoma|ovarian immature teratoma
5842985|NCT00002931|ovarian monodermal and highly specialized teratoma|ovarian monodermal and highly specialized teratoma
5842986|NCT00002931|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5842987|NCT00002931|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5842988|NCT00002931|stage IV extragonadal non-seminomatous germ cell tumor|stage iv extragonadal non-seminomatous germ cell tumor
5842989|NCT00002931|stage IV extragonadal seminoma|stage iv extragonadal seminoma
5842990|NCT00002931|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5842991|NCT00002926|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5842992|NCT00002926|refractory anemia|refractory anemia
5842993|NCT00002926|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5842994|NCT00002926|refractory anemia with excess blasts|refractory anemia with excess blasts
5842995|NCT00002926|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5842996|NCT00002926|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5842997|NCT00002926|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5842998|NCT00002926|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5842999|NCT00002926|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5843000|NCT00002926|refractory cytopenia with multilineage dysplasia|refractory cytopenia with multilineage dysplasia
5843001|NCT00002926|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5843002|NCT00002920|endometrial cancer|endometrial cancer
5843003|NCT00002920|stage I breast cancer|stage i breast cancer
5843004|NCT00002920|stage II breast cancer|stage ii breast cancer
5843005|NCT00002920|ductal breast carcinoma in situ|ductal breast carcinoma in situ
5843006|NCT00002920|lobular breast carcinoma in situ|lobular breast carcinoma in situ
5843007|NCT00002920|Paget disease of the breast|paget disease of the breast
5843008|NCT00002916|stage IB cervical cancer|stage ib cervical cancer
5843009|NCT00002916|stage IIA cervical cancer|stage iia cervical cancer
5843010|NCT00002916|cervical squamous cell carcinoma|cervical squamous cell carcinoma
5843011|NCT00002916|cervical adenocarcinoma|cervical adenocarcinoma
5843012|NCT00002916|cervical adenosquamous cell carcinoma|cervical adenosquamous cell carcinoma
5843013|NCT00002900|stage I breast cancer|stage i breast cancer
5843014|NCT00002900|stage II breast cancer|stage ii breast cancer
5843015|NCT00002900|ductal breast carcinoma|ductal breast carcinoma
5843016|NCT00002900|cardiac toxicity|cardiac toxicity
5843017|NCT00002899|tumors metastatic to brain|tumors metastatic to brain
5843018|NCT00002898|embryonal childhood rhabdomyosarcoma|embryonal childhood rhabdomyosarcoma
5843019|NCT00002898|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5843020|NCT00002898|pleomorphic childhood rhabdomyosarcoma|pleomorphic childhood rhabdomyosarcoma
5843021|NCT00002898|mixed childhood rhabdomyosarcoma|mixed childhood rhabdomyosarcoma
5843022|NCT00002898|embryonal-botryoid childhood rhabdomyosarcoma|embryonal-botryoid childhood rhabdomyosarcoma
5843023|NCT00002898|nonmetastatic childhood soft tissue sarcoma|nonmetastatic childhood soft tissue sarcoma
5843024|NCT00002898|childhood fibrosarcoma|childhood fibrosarcoma
5843025|NCT00002898|childhood synovial sarcoma|childhood synovial sarcoma
5843026|NCT00002898|childhood malignant hemangiopericytoma|childhood malignant hemangiopericytoma
5843027|NCT00002898|childhood liposarcoma|childhood liposarcoma
5843028|NCT00002898|childhood alveolar soft-part sarcoma|childhood alveolar soft-part sarcoma
5843029|NCT00002898|childhood leiomyosarcoma|childhood leiomyosarcoma
5843030|NCT00002898|childhood neurofibrosarcoma|childhood neurofibrosarcoma
5843031|NCT00002898|childhood angiosarcoma|childhood angiosarcoma
5843032|NCT00002898|childhood epithelioid sarcoma|childhood epithelioid sarcoma
5843033|NCT00002898|childhood malignant fibrous histiocytoma of bone|childhood malignant fibrous histiocytoma of bone
5843034|NCT00002898|childhood malignant mesenchymoma|childhood malignant mesenchymoma
5843035|NCT00002898|previously untreated childhood rhabdomyosarcoma|previously untreated childhood rhabdomyosarcoma
5863090|NCT00001400|Follow-Up|follow-up
5843036|NCT00002898|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5843037|NCT00002898|localized Ewing sarcoma/peripheral primitive neuroectodermal tumor|localized ewing sarcoma/peripheral primitive neuroectodermal tumor
5843038|NCT00002895|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5843039|NCT00002895|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5843040|NCT00002895|fallopian tube cancer|fallopian tube cancer
5843041|NCT00002894|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5843042|NCT00002894|primary peritoneal cavity cancer|primary peritoneal cavity cancer
5846697|NCT00043589|Memory|memory
5843043|NCT00002883|stage I gastric cancer|stage i gastric cancer
5843044|NCT00002883|stage II gastric cancer|stage ii gastric cancer
5843046|NCT00002883|stage II esophageal cancer|stage ii esophageal cancer
5843047|NCT00002883|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5843048|NCT00002883|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5843049|NCT00002882|stage III melanoma|stage iii melanoma
5843050|NCT00002874|stage IIB prostate cancer|stage iib prostate cancer
5843051|NCT00002874|stage IIA prostate cancer|stage iia prostate cancer
5843052|NCT00002874|stage III prostate cancer|stage iii prostate cancer
5843053|NCT00002874|recurrent prostate cancer|recurrent prostate cancer
5843054|NCT00002860|stage IV melanoma|stage iv melanoma
5843055|NCT00002860|recurrent melanoma|recurrent melanoma
5843056|NCT00002855|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5843057|NCT00002855|stage III prostate cancer|stage iii prostate cancer
5843924|NCT00051753|clavulanate|clavulanate
5843058|NCT00002855|stage IV prostate cancer|stage iv prostate cancer
5843059|NCT00002855|recurrent prostate cancer|recurrent prostate cancer
5843060|NCT00002854|stage IV colon cancer|stage iv colon cancer
5843061|NCT00002854|stage II breast cancer|stage ii breast cancer
5843062|NCT00002854|stage IV breast cancer|stage iv breast cancer
5843063|NCT00002854|stage IIIA breast cancer|stage iiia breast cancer
5843064|NCT00002854|recurrent breast cancer|recurrent breast cancer
5843065|NCT00002854|stage IV gastric cancer|stage iv gastric cancer
5843066|NCT00002854|recurrent gastric cancer|recurrent gastric cancer
5843067|NCT00002854|localized osteosarcoma|localized osteosarcoma
5843068|NCT00002854|metastatic osteosarcoma|metastatic osteosarcoma
5843069|NCT00002854|stage IIIB breast cancer|stage iiib breast cancer
5843070|NCT00002854|recurrent pancreatic cancer|recurrent pancreatic cancer
5843071|NCT00002854|stage IV rectal cancer|stage iv rectal cancer
5843072|NCT00002854|recurrent colon cancer|recurrent colon cancer
5843073|NCT00002854|recurrent rectal cancer|recurrent rectal cancer
5843074|NCT00002854|stage IV anal cancer|stage iv anal cancer
5843075|NCT00002854|recurrent anal cancer|recurrent anal cancer
5843076|NCT00002854|stage IV esophageal cancer|stage iv esophageal cancer
5843077|NCT00002854|recurrent esophageal cancer|recurrent esophageal cancer
5843078|NCT00002854|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5843079|NCT00002854|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5843080|NCT00002854|stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5843081|NCT00002854|stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5843082|NCT00002854|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5843083|NCT00002854|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5843084|NCT00002854|advanced adult primary liver cancer|advanced adult primary liver cancer
5843085|NCT00002854|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5840794|NCT00004067|stage II breast cancer|stage ii breast cancer
5843086|NCT00002854|recurrent osteosarcoma|recurrent osteosarcoma
5843087|NCT00002854|recurrent gallbladder cancer|recurrent gallbladder cancer
5843088|NCT00002854|recurrent extrahepatic bile duct cancer|recurrent extrahepatic bile duct cancer
5843089|NCT00002854|recurrent small intestine cancer|recurrent small intestine cancer
5843090|NCT00002854|stage II melanoma|stage ii melanoma
5843091|NCT00002854|stage III melanoma|stage iii melanoma
5843092|NCT00002854|stage IV melanoma|stage iv melanoma
5843093|NCT00002854|recurrent melanoma|recurrent melanoma
5843094|NCT00002854|metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor|metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
5843095|NCT00002854|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5843096|NCT00002854|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5843097|NCT00002854|stage IV pancreatic cancer|stage iv pancreatic cancer
5843098|NCT00002851|stage I breast cancer|stage i breast cancer
5843099|NCT00002851|stage II breast cancer|stage ii breast cancer
5843100|NCT00002851|stage IIIA breast cancer|stage iiia breast cancer
5843101|NCT00002850|stage I multiple myeloma|stage i multiple myeloma
5843102|NCT00002850|stage II multiple myeloma|stage ii multiple myeloma
5843103|NCT00002850|stage III multiple myeloma|stage iii multiple myeloma
5843105|NCT00002849|primary systemic amyloidosis|primary systemic amyloidosis
5843106|NCT00002848|stage I prostate cancer|stage i prostate cancer
5843107|NCT00002848|stage IIB prostate cancer|stage iib prostate cancer
5848396|NCT00034970|support|support
5843108|NCT00002848|stage IIA prostate cancer|stage iia prostate cancer
5843109|NCT00002848|psychosocial effects of cancer and its treatment|psychosocial effects of cancer and its treatment
5843110|NCT00002847|stage IV renal cell cancer|stage iv renal cell cancer
5843111|NCT00002847|recurrent renal cell cancer|recurrent renal cell cancer
5843112|NCT00002846|stage IV renal cell cancer|stage iv renal cell cancer
5843113|NCT00002846|recurrent renal cell cancer|recurrent renal cell cancer
5843114|NCT00002842|stage IV colon cancer|stage iv colon cancer
5843115|NCT00002842|stage IV rectal cancer|stage iv rectal cancer
5843116|NCT00002842|recurrent colon cancer|recurrent colon cancer
5843117|NCT00002842|recurrent rectal cancer|recurrent rectal cancer
5843118|NCT00002842|liver metastases|liver metastases
5843119|NCT00002839|stage II squamous cell carcinoma of the hypopharynx|stage ii squamous cell carcinoma of the hypopharynx
5848335|NCT00035126|taxane|taxane
5843120|NCT00002839|stage III squamous cell carcinoma of the hypopharynx|stage iii squamous cell carcinoma of the hypopharynx
5843121|NCT00002839|stage IV squamous cell carcinoma of the hypopharynx|stage iv squamous cell carcinoma of the hypopharynx
5843122|NCT00002839|stage III squamous cell carcinoma of the larynx|stage iii squamous cell carcinoma of the larynx
5843440|NCT00002662|recurrent breast cancer|recurrent breast cancer
5843123|NCT00002839|stage IV squamous cell carcinoma of the larynx|stage iv squamous cell carcinoma of the larynx
5843124|NCT00002810|refractory multiple myeloma|refractory multiple myeloma
5843125|NCT00002810|stage I multiple myeloma|stage i multiple myeloma
5843126|NCT00002810|stage II multiple myeloma|stage ii multiple myeloma
5843127|NCT00002810|stage III multiple myeloma|stage iii multiple myeloma
5843128|NCT00002810|primary systemic amyloidosis|primary systemic amyloidosis
5843129|NCT00002809|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5843921|NCT00051753|ear infection|ear infection
5843130|NCT00002809|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5843131|NCT00002809|refractory chronic lymphocytic leukemia|refractory chronic lymphocytic leukemia
5853884|NCT00002051|Thymopentin|thymopentin
5843132|NCT00002809|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5843133|NCT00002809|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5843134|NCT00002809|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5843135|NCT00002809|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5843136|NCT00002809|refractory anemia|refractory anemia
5843137|NCT00002809|refractory anemia with excess blasts|refractory anemia with excess blasts
5843138|NCT00002809|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5843139|NCT00002809|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5843140|NCT00002809|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5843141|NCT00002809|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5843142|NCT00002809|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5843143|NCT00002809|adult acute myeloid leukemia with t(8;21)(q22;q22)|adult acute myeloid leukemia with t(8;21)(q22;q22)
5843144|NCT00002809|adult acute myeloid leukemia with t(16;16)(p13;q22)|adult acute myeloid leukemia with t(16;16)(p13;q22)
5843145|NCT00002809|adult acute myeloid leukemia with inv(16)(p13;q22)|adult acute myeloid leukemia with inv(16)(p13;q22)
5843146|NCT00002809|adult acute myeloid leukemia with 11q23 (MLL) abnormalities|adult acute myeloid leukemia with 11q23 (mll) abnormalities
5843147|NCT00002809|adult acute myeloid leukemia with t(15;17)(q22;q12)|adult acute myeloid leukemia with t(15;17)(q22;q12)
5843148|NCT00002807|stage I endometrial carcinoma|stage i endometrial carcinoma
5843149|NCT00002807|stage II endometrial carcinoma|stage ii endometrial carcinoma
5843150|NCT00002807|endometrial adenocarcinoma|endometrial adenocarcinoma
5843151|NCT00002807|endometrial adenosquamous cell carcinoma|endometrial adenosquamous cell carcinoma
5840844|NCT00004065|stage III ovarian germ cell tumor|stage iii ovarian germ cell tumor
5843152|NCT00002807|endometrial papillary carcinoma|endometrial papillary carcinoma
5843153|NCT00002807|endometrial clear cell carcinoma|endometrial clear cell carcinoma
5843154|NCT00002792|polycythemia vera|polycythemia vera
5843155|NCT00002792|chronic idiopathic myelofibrosis|chronic idiopathic myelofibrosis
5843156|NCT00002792|essential thrombocythemia|essential thrombocythemia
5843157|NCT00002792|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5843158|NCT00002792|myelodysplastic/myeloproliferative disease, unclassifiable|myelodysplastic/myeloproliferative disease, unclassifiable
5843159|NCT00002778|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5843160|NCT00002778|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5843161|NCT00002778|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5843162|NCT00002778|Philadelphia chromosome positive chronic myelogenous leukemia|philadelphia chromosome positive chronic myelogenous leukemia
5843163|NCT00002778|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5843164|NCT00002778|atypical chronic myeloid leukemia|atypical chronic myeloid leukemia
5843165|NCT00002771|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5843166|NCT00002771|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5843167|NCT00002771|Philadelphia chromosome negative chronic myelogenous leukemia|philadelphia chromosome negative chronic myelogenous leukemia
5843168|NCT00002771|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5848497|NCT00034554|DNA vaccine|dna vaccine
5861556|NCT00001911|Nontuberculosis Mycobacterial Infection|nontuberculosis mycobacterial infection
5861557|NCT00001911|Pulmonary Nontuberculous Mycobacterial Infection|pulmonary nontuberculous mycobacterial infection
5861558|NCT00001910|T Cells|t cells
5861559|NCT00001910|Allergy|allergy
5861560|NCT00001910|Asthma|asthma
5861561|NCT00001910|Cytokine|cytokine
5861562|NCT00001910|Vaccine|vaccine
5861563|NCT00001905|Neutrophil|neutrophil
5861564|NCT00001905|Immunodeficiency|immunodeficiency
5861565|NCT00001905|Cytokine|cytokine
5861566|NCT00001905|Treatment|treatment
5861567|NCT00001905|Trafficking|trafficking
5843169|NCT00002766|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5843170|NCT00002766|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5843171|NCT00002766|chronic myelogenous leukemia, BCR-ABL1 positive|chronic myelogenous leukemia, bcr-abl1 positive
5843172|NCT00002766|T-cell adult acute lymphoblastic leukemia|t-cell adult acute lymphoblastic leukemia
5843173|NCT00002766|B-cell adult acute lymphoblastic leukemia|b-cell adult acute lymphoblastic leukemia
5843174|NCT00002766|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5843175|NCT00002766|stage II adult lymphoblastic lymphoma|stage ii adult lymphoblastic lymphoma
5843176|NCT00002766|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5843177|NCT00002766|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5843178|NCT00002766|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5843179|NCT00002766|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5843180|NCT00002762|stage I breast cancer|stage i breast cancer
5843181|NCT00002762|stage II breast cancer|stage ii breast cancer
5843182|NCT00002762|perioperative/postoperative complications|perioperative/postoperative complications
5843183|NCT00002757|childhood Burkitt lymphoma|childhood burkitt lymphoma
5843184|NCT00002757|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5843185|NCT00002757|L3 childhood acute lymphoblastic leukemia|l3 childhood acute lymphoblastic leukemia
5843186|NCT00002757|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5843187|NCT00002757|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5843188|NCT00002757|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5843189|NCT00002757|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5843190|NCT00002757|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5843191|NCT00002757|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5843192|NCT00002757|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5843193|NCT00002757|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5843194|NCT00002756|untreated childhood acute lymphoblastic leukemia|untreated childhood acute lymphoblastic leukemia
5843195|NCT00002756|acute undifferentiated leukemia|acute undifferentiated leukemia
5843196|NCT00002746|refractory anemia|refractory anemia
5843197|NCT00002746|refractory anemia with ringed sideroblasts|refractory anemia with ringed sideroblasts
5843198|NCT00002746|refractory anemia with excess blasts|refractory anemia with excess blasts
5843199|NCT00002746|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5843200|NCT00002746|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5843201|NCT00002746|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5843202|NCT00002746|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5843203|NCT00002746|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5843204|NCT00002746|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5843205|NCT00002746|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5843206|NCT00002738|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5843207|NCT00002738|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5843208|NCT00002738|recurrent osteosarcoma|recurrent osteosarcoma
5843209|NCT00002738|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5843210|NCT00002738|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5843211|NCT00002727|stage II squamous cell carcinoma of the larynx|stage ii squamous cell carcinoma of the larynx
5843212|NCT00002720|stage I breast cancer|stage i breast cancer
5843213|NCT00002718|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5843214|NCT00002718|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5861655|NCT00001874|Spectroscopy|spectroscopy
5843215|NCT00002718|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5843216|NCT00002718|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5843217|NCT00002718|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5843218|NCT00002718|recurrent adult acute lymphoblastic leukemia|recurrent adult acute lymphoblastic leukemia
5843219|NCT00002718|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5843220|NCT00002718|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5843221|NCT00002718|accelerated phase chronic myelogenous leukemia|accelerated phase chronic myelogenous leukemia
5843222|NCT00002718|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5843223|NCT00002718|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5843224|NCT00002718|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5843225|NCT00002718|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5843226|NCT00002718|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5863091|NCT00001399|Gene Therapy|gene therapy
5843227|NCT00002718|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5843228|NCT00002718|secondary acute myeloid leukemia|secondary acute myeloid leukemia
5843229|NCT00002718|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5843230|NCT00002718|previously treated myelodysplastic syndromes|previously treated myelodysplastic syndromes
5843231|NCT00002718|secondary myelodysplastic syndromes|secondary myelodysplastic syndromes
5843232|NCT00002718|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia
5843233|NCT00002718|childhood chronic myelogenous leukemia|childhood chronic myelogenous leukemia
5843234|NCT00002718|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5843235|NCT00002718|myelodysplastic/myeloproliferative neoplasm, unclassifiable|myelodysplastic/myeloproliferative neoplasm, unclassifiable
5843236|NCT00002718|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5843237|NCT00002718|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5843238|NCT00002716|stage IV colon cancer|stage iv colon cancer
5843239|NCT00002716|stage IV rectal cancer|stage iv rectal cancer
5843240|NCT00002716|recurrent colon cancer|recurrent colon cancer
5843241|NCT00002716|recurrent rectal cancer|recurrent rectal cancer
5843242|NCT00002716|adenocarcinoma of the colon|adenocarcinoma of the colon
5843243|NCT00002716|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5843244|NCT00002716|liver metastases|liver metastases
5843245|NCT00002715|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5843246|NCT00002715|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5843247|NCT00002715|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5843248|NCT00002715|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5843249|NCT00002715|adult lymphocyte predominant Hodgkin lymphoma|adult lymphocyte predominant hodgkin lymphoma
5843250|NCT00002715|adult lymphocyte depletion Hodgkin lymphoma|adult lymphocyte depletion hodgkin lymphoma
5843251|NCT00002715|adult nodular sclerosis Hodgkin lymphoma|adult nodular sclerosis hodgkin lymphoma
5843252|NCT00002715|adult mixed cellularity Hodgkin lymphoma|adult mixed cellularity hodgkin lymphoma
5843253|NCT00002702|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5843254|NCT00002702|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5843255|NCT00002702|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5843256|NCT00002702|stage II squamous cell carcinoma of the oropharynx|stage ii squamous cell carcinoma of the oropharynx
5843257|NCT00002702|stage III squamous cell carcinoma of the oropharynx|stage iii squamous cell carcinoma of the oropharynx
5843258|NCT00002702|stage IV squamous cell carcinoma of the oropharynx|stage iv squamous cell carcinoma of the oropharynx
5843259|NCT00002702|tongue cancer|tongue cancer
5843260|NCT00002700|untreated adult acute lymphoblastic leukemia|untreated adult acute lymphoblastic leukemia
5843261|NCT00002700|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5843262|NCT00002700|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5843263|NCT00002700|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5843264|NCT00002700|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5843265|NCT00002700|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5843266|NCT00002697|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5843267|NCT00002697|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5843268|NCT00002697|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5843269|NCT00002697|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5843270|NCT00002697|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5843271|NCT00002697|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5843272|NCT00002697|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5843273|NCT00002697|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5843274|NCT00002697|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5861757|NCT00001854|Hemolytic Anemia|hemolytic anemia
5861758|NCT00001854|Hemolysis|hemolysis
5861763|NCT00001852|Xerostomia|xerostomia
5861764|NCT00001852|Oral Dryness|oral dryness
5861765|NCT00001852|Salivary Function|salivary function
5861766|NCT00001851|Marrow|marrow
5861767|NCT00001851|Grafting|grafting
5861768|NCT00001851|Imaging|imaging
5861769|NCT00001851|Injection|injection
5861770|NCT00001851|Aspiration|aspiration
5861771|NCT00001851|Bone Marrow Stromal Cells|bone marrow stromal cells
5861772|NCT00001851|Bone Grafting|bone grafting
5861773|NCT00001851|Bone Graft Substitutes|bone graft substitutes
5861774|NCT00001851|Bio and Pharmacological Regulators of Bone Turnover|bio and pharmacological regulators of bone turnover
5861802|NCT00001845|MRI|mri
5843275|NCT00002697|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5843276|NCT00002697|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5843277|NCT00002697|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5843278|NCT00002696|stage IIIA breast cancer|stage iiia breast cancer
5843279|NCT00002696|stage IIIB breast cancer|stage iiib breast cancer
5843280|NCT00002696|stage IIIC breast cancer|stage iiic breast cancer
5843281|NCT00002689|stage I pancreatic cancer|stage i pancreatic cancer
5843282|NCT00002689|stage II pancreatic cancer|stage ii pancreatic cancer
5843283|NCT00002689|stage III pancreatic cancer|stage iii pancreatic cancer
5843284|NCT00002689|adenocarcinoma of the pancreas|adenocarcinoma of the pancreas
5843285|NCT00002687|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5843286|NCT00002687|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5843287|NCT00002687|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5843288|NCT00002687|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5843289|NCT00002687|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5843290|NCT00002687|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5843291|NCT00002687|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5843292|NCT00002687|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5843293|NCT00002684|stage III bladder cancer|stage iii bladder cancer
5843294|NCT00002684|recurrent bladder cancer|recurrent bladder cancer
5843295|NCT00002684|stage IV bladder cancer|stage iv bladder cancer
5843296|NCT00002684|squamous cell carcinoma of the bladder|squamous cell carcinoma of the bladder
5843297|NCT00002684|adenocarcinoma of the bladder|adenocarcinoma of the bladder
5843298|NCT00002684|recurrent urethral cancer|recurrent urethral cancer
5843299|NCT00002684|distal urethral cancer|distal urethral cancer
5843300|NCT00002684|proximal urethral cancer|proximal urethral cancer
5843301|NCT00002684|urethral cancer associated with invasive bladder cancer|urethral cancer associated with invasive bladder cancer
5843302|NCT00002681|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5843303|NCT00002681|recurrent adult acute myeloid leukemia|recurrent adult acute myeloid leukemia
5843304|NCT00002681|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5843305|NCT00002681|chronic phase chronic myelogenous leukemia|chronic phase chronic myelogenous leukemia
5843306|NCT00002681|atypical chronic myeloid leukemia, BCR-ABL negative|atypical chronic myeloid leukemia, bcr-abl negative
5843307|NCT00002678|stage I multiple myeloma|stage i multiple myeloma
5843308|NCT00002678|stage II multiple myeloma|stage ii multiple myeloma
5843309|NCT00002678|stage III multiple myeloma|stage iii multiple myeloma
5843310|NCT00002668|stage IV breast cancer|stage iv breast cancer
5843311|NCT00002668|recurrent breast cancer|recurrent breast cancer
5843312|NCT00002668|stage IV prostate cancer|stage iv prostate cancer
5843313|NCT00002668|recurrent prostate cancer|recurrent prostate cancer
5843314|NCT00002668|pain|pain
5843315|NCT00002663|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5843316|NCT00002663|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5843441|NCT00002662|stage IIIB breast cancer|stage iiib breast cancer
5843317|NCT00002663|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5843318|NCT00002663|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5843319|NCT00002663|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5843320|NCT00002663|stage I cutaneous T-cell non-Hodgkin lymphoma|stage i cutaneous t-cell non-hodgkin lymphoma
5843321|NCT00002663|stage II cutaneous T-cell non-Hodgkin lymphoma|stage ii cutaneous t-cell non-hodgkin lymphoma
5861861|NCT00001826|CD-4-Naive T Cells|cd-4-naive t cells
5861862|NCT00001826|CD-4-Memory T Cells|cd-4-memory t cells
5861863|NCT00001826|Antiviral Activity|antiviral activity
5861864|NCT00001826|VB Repertoire|vb repertoire
5861865|NCT00001826|Immunizations|immunizations
5861867|NCT00001826|Treatment Experienced|treatment experienced
5861878|NCT00001807|CNS directed therapy|cns directed therapy
5861879|NCT00001807|Neurotoxicity|neurotoxicity
5843322|NCT00002663|stage III cutaneous T-cell non-Hodgkin lymphoma|stage iii cutaneous t-cell non-hodgkin lymphoma
5843323|NCT00002663|stage IV cutaneous T-cell non-Hodgkin lymphoma|stage iv cutaneous t-cell non-hodgkin lymphoma
5843324|NCT00002663|recurrent cutaneous T-cell non-Hodgkin lymphoma|recurrent cutaneous t-cell non-hodgkin lymphoma
5843325|NCT00002663|childhood Burkitt lymphoma|childhood burkitt lymphoma
5843326|NCT00002663|stage I childhood lymphoblastic lymphoma|stage i childhood lymphoblastic lymphoma
5843327|NCT00002663|stage II childhood lymphoblastic lymphoma|stage ii childhood lymphoblastic lymphoma
5843328|NCT00002663|stage III childhood lymphoblastic lymphoma|stage iii childhood lymphoblastic lymphoma
5843329|NCT00002663|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5843330|NCT00002663|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5843331|NCT00002663|childhood diffuse large cell lymphoma|childhood diffuse large cell lymphoma
5843332|NCT00002663|childhood immunoblastic large cell lymphoma|childhood immunoblastic large cell lymphoma
5843334|NCT00002663|stage I childhood Hodgkin lymphoma|stage i childhood hodgkin lymphoma
5843335|NCT00002663|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5843336|NCT00002663|stage IV childhood Hodgkin lymphoma|stage iv childhood hodgkin lymphoma
5843337|NCT00002663|recurrent/refractory childhood Hodgkin lymphoma|recurrent/refractory childhood hodgkin lymphoma
5843338|NCT00002663|stage I grade 1 follicular lymphoma|stage i grade 1 follicular lymphoma
5843339|NCT00002663|stage I grade 2 follicular lymphoma|stage i grade 2 follicular lymphoma
5843340|NCT00002663|stage I grade 3 follicular lymphoma|stage i grade 3 follicular lymphoma
5843341|NCT00002663|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5843342|NCT00002663|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5863092|NCT00001399|Stem Cell Rescue|stem cell rescue
5843343|NCT00002663|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5843344|NCT00002663|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5843345|NCT00002663|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5843346|NCT00002663|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5843347|NCT00002663|T-cell large granular lymphocyte leukemia|t-cell large granular lymphocyte leukemia
5843348|NCT00002663|stage III grade 1 follicular lymphoma|stage iii grade 1 follicular lymphoma
5843349|NCT00002663|stage III grade 2 follicular lymphoma|stage iii grade 2 follicular lymphoma
5843350|NCT00002663|stage III grade 3 follicular lymphoma|stage iii grade 3 follicular lymphoma
5843351|NCT00002663|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5843352|NCT00002663|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5843353|NCT00002663|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5843354|NCT00002663|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5843355|NCT00002663|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5843356|NCT00002663|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5843357|NCT00002663|stage IV grade 1 follicular lymphoma|stage iv grade 1 follicular lymphoma
5843358|NCT00002663|stage IV grade 2 follicular lymphoma|stage iv grade 2 follicular lymphoma
5843359|NCT00002663|stage IV grade 3 follicular lymphoma|stage iv grade 3 follicular lymphoma
5843360|NCT00002663|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5843361|NCT00002663|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5843362|NCT00002663|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5843363|NCT00002663|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5843364|NCT00002663|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5843365|NCT00002663|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5843366|NCT00002663|recurrent grade 1 follicular lymphoma|recurrent grade 1 follicular lymphoma
5843367|NCT00002663|recurrent grade 2 follicular lymphoma|recurrent grade 2 follicular lymphoma
5843368|NCT00002663|recurrent grade 3 follicular lymphoma|recurrent grade 3 follicular lymphoma
5843369|NCT00002663|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5843370|NCT00002663|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5843371|NCT00002663|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5846870|NCT00042536|Erectile Dysfunction|erectile dysfunction
5861969|NCT00001765|Minitransplant|minitransplant
5861970|NCT00001765|Fludarabine|fludarabine
5861971|NCT00001765|Neutrophil|neutrophil
5861972|NCT00001765|Allogenic|allogenic
5861973|NCT00001765|Donor Apheresis|donor apheresis
5843372|NCT00002663|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5843373|NCT00002663|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5843374|NCT00002663|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5843375|NCT00002663|stage I adult T-cell leukemia/lymphoma|stage i adult t-cell leukemia/lymphoma
5843376|NCT00002663|stage II adult T-cell leukemia/lymphoma|stage ii adult t-cell leukemia/lymphoma
5843377|NCT00002663|stage III adult T-cell leukemia/lymphoma|stage iii adult t-cell leukemia/lymphoma
5843378|NCT00002663|stage IV adult T-cell leukemia/lymphoma|stage iv adult t-cell leukemia/lymphoma
5843379|NCT00002663|recurrent adult T-cell leukemia/lymphoma|recurrent adult t-cell leukemia/lymphoma
5843380|NCT00002663|AIDS-related peripheral/systemic lymphoma|aids-related peripheral/systemic lymphoma
5843381|NCT00002663|HIV-associated Hodgkin lymphoma|hiv-associated hodgkin lymphoma
5843382|NCT00002663|stage I childhood small noncleaved cell lymphoma|stage i childhood small noncleaved cell lymphoma
5843383|NCT00002663|stage I childhood large cell lymphoma|stage i childhood large cell lymphoma
5843384|NCT00002663|stage II childhood small noncleaved cell lymphoma|stage ii childhood small noncleaved cell lymphoma
5843385|NCT00002663|stage II childhood large cell lymphoma|stage ii childhood large cell lymphoma
5843386|NCT00002663|stage III childhood small noncleaved cell lymphoma|stage iii childhood small noncleaved cell lymphoma
5843387|NCT00002663|stage III childhood large cell lymphoma|stage iii childhood large cell lymphoma
5843388|NCT00002663|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5843389|NCT00002663|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5843390|NCT00002663|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5843391|NCT00002663|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5843392|NCT00002663|stage I mantle cell lymphoma|stage i mantle cell lymphoma
5843393|NCT00002663|contiguous stage II grade 1 follicular lymphoma|contiguous stage ii grade 1 follicular lymphoma
5843394|NCT00002663|contiguous stage II grade 2 follicular lymphoma|contiguous stage ii grade 2 follicular lymphoma
5843395|NCT00002663|contiguous stage II grade 3 follicular lymphoma|contiguous stage ii grade 3 follicular lymphoma
5843396|NCT00002663|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5843397|NCT00002663|contiguous stage II mantle cell lymphoma|contiguous stage ii mantle cell lymphoma
5843398|NCT00002663|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5863093|NCT00001399|Bone Marrow Failure|bone marrow failure
5843399|NCT00002663|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5843400|NCT00002663|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5843401|NCT00002663|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5843402|NCT00002663|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5843403|NCT00002663|noncontiguous stage II grade 1 follicular lymphoma|noncontiguous stage ii grade 1 follicular lymphoma
5843404|NCT00002663|noncontiguous stage II grade 2 follicular lymphoma|noncontiguous stage ii grade 2 follicular lymphoma
5843405|NCT00002663|noncontiguous stage II grade 3 follicular lymphoma|noncontiguous stage ii grade 3 follicular lymphoma
5843406|NCT00002663|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5843407|NCT00002663|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5843408|NCT00002663|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5843409|NCT00002663|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5843410|NCT00002663|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5843411|NCT00002663|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5843412|NCT00002663|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5843413|NCT00002663|stage III mantle cell lymphoma|stage iii mantle cell lymphoma
5843414|NCT00002663|stage IV mantle cell lymphoma|stage iv mantle cell lymphoma
5843415|NCT00002663|recurrent mantle cell lymphoma|recurrent mantle cell lymphoma
5843416|NCT00002663|stage I mycosis fungoides/Sezary syndrome|stage i mycosis fungoides/sezary syndrome
5843417|NCT00002663|stage II mycosis fungoides/Sezary syndrome|stage ii mycosis fungoides/sezary syndrome
5843418|NCT00002663|stage III mycosis fungoides/Sezary syndrome|stage iii mycosis fungoides/sezary syndrome
5843419|NCT00002663|stage IV mycosis fungoides/Sezary syndrome|stage iv mycosis fungoides/sezary syndrome
5843420|NCT00002663|recurrent mycosis fungoides/Sezary syndrome|recurrent mycosis fungoides/sezary syndrome
5843421|NCT00002663|contiguous stage II small lymphocytic lymphoma|contiguous stage ii small lymphocytic lymphoma
5843422|NCT00002663|contiguous stage II marginal zone lymphoma|contiguous stage ii marginal zone lymphoma
5862071|NCT00001728|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5862072|NCT00001728|McCune-Albright Syndrome|mccune-albright syndrome
5862073|NCT00001727|Fibrous Dysplasia (FD)|fibrous dysplasia (fd)
5862074|NCT00001727|McCune-Albright Syndrome|mccune-albright syndrome
5862075|NCT00001727|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5862076|NCT00001726|Bacterial Colonization|bacterial colonization
5862079|NCT00001726|Saliva|saliva
5843423|NCT00002663|noncontiguous stage II small lymphocytic lymphoma|noncontiguous stage ii small lymphocytic lymphoma
5843424|NCT00002663|noncontiguous stage II marginal zone lymphoma|noncontiguous stage ii marginal zone lymphoma
5843425|NCT00002663|extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
5843426|NCT00002663|nodal marginal zone B-cell lymphoma|nodal marginal zone b-cell lymphoma
5843427|NCT00002663|splenic marginal zone lymphoma|splenic marginal zone lymphoma
5843428|NCT00002663|recurrent marginal zone lymphoma|recurrent marginal zone lymphoma
5843429|NCT00002663|recurrent small lymphocytic lymphoma|recurrent small lymphocytic lymphoma
5843430|NCT00002663|stage I marginal zone lymphoma|stage i marginal zone lymphoma
5843431|NCT00002663|stage I small lymphocytic lymphoma|stage i small lymphocytic lymphoma
5843432|NCT00002663|stage III small lymphocytic lymphoma|stage iii small lymphocytic lymphoma
5843433|NCT00002663|stage III marginal zone lymphoma|stage iii marginal zone lymphoma
5843434|NCT00002663|stage IV small lymphocytic lymphoma|stage iv small lymphocytic lymphoma
5843435|NCT00002663|stage IV marginal zone lymphoma|stage iv marginal zone lymphoma
5843436|NCT00002663|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5843437|NCT00002663|unspecified childhood solid tumor, protocol specific|unspecified childhood solid tumor, protocol specific
5843438|NCT00002662|stage IV breast cancer|stage iv breast cancer
5843439|NCT00002662|stage IIIA breast cancer|stage iiia breast cancer
5843442|NCT00002662|stage IIIC breast cancer|stage iiic breast cancer
5843443|NCT00002651|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5843444|NCT00002651|stage IV prostate cancer|stage iv prostate cancer
5843445|NCT00002651|recurrent prostate cancer|recurrent prostate cancer
5843446|NCT00002647|recurrent adult brain tumor|recurrent adult brain tumor
5843447|NCT00002647|tumors metastatic to brain|tumors metastatic to brain
5843448|NCT00002647|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5843449|NCT00002647|recurrent childhood anaplastic astrocytoma|recurrent childhood anaplastic astrocytoma
5843450|NCT00002647|recurrent childhood anaplastic oligoastrocytoma|recurrent childhood anaplastic oligoastrocytoma
5854342|NCT00001110|HIV-1|hiv-1
5843451|NCT00002647|recurrent childhood anaplastic oligodendroglioma|recurrent childhood anaplastic oligodendroglioma
5843452|NCT00002647|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5843453|NCT00002647|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5843454|NCT00002647|recurrent childhood diffuse astrocytoma|recurrent childhood diffuse astrocytoma
5843455|NCT00002647|recurrent childhood fibrillary astrocytoma|recurrent childhood fibrillary astrocytoma
5843456|NCT00002647|recurrent childhood gemistocytic astrocytoma|recurrent childhood gemistocytic astrocytoma
5843457|NCT00002647|recurrent childhood giant cell glioblastoma|recurrent childhood giant cell glioblastoma
5843458|NCT00002647|recurrent childhood glioblastoma|recurrent childhood glioblastoma
5843459|NCT00002647|recurrent childhood gliomatosis cerebri|recurrent childhood gliomatosis cerebri
5843460|NCT00002647|recurrent childhood gliosarcoma|recurrent childhood gliosarcoma
5843461|NCT00002647|recurrent childhood oligodendroglioma|recurrent childhood oligodendroglioma
5843462|NCT00002647|recurrent childhood pilocytic astrocytoma|recurrent childhood pilocytic astrocytoma
5843463|NCT00002647|recurrent childhood pilomyxoid astrocytoma|recurrent childhood pilomyxoid astrocytoma
5843464|NCT00002647|recurrent childhood pleomorphic xanthoastrocytoma|recurrent childhood pleomorphic xanthoastrocytoma
5843465|NCT00002647|recurrent childhood protoplasmic astrocytoma|recurrent childhood protoplasmic astrocytoma
5843466|NCT00002647|recurrent childhood subependymal giant cell astrocytoma|recurrent childhood subependymal giant cell astrocytoma
5843467|NCT00002647|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5843468|NCT00002647|recurrent childhood visual pathway glioma|recurrent childhood visual pathway glioma
5843469|NCT00002647|recurrent childhood pineoblastoma|recurrent childhood pineoblastoma
5843470|NCT00002647|recurrent childhood supratentorial primitive neuroectodermal tumor|recurrent childhood supratentorial primitive neuroectodermal tumor
5843471|NCT00002647|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5843472|NCT00002647|recurrent childhood ependymoma|recurrent childhood ependymoma
5843473|NCT00002647|recurrent childhood brain tumor|recurrent childhood brain tumor
5843474|NCT00002647|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5849295|NCT00030043|Brainstem|brainstem
5843475|NCT00002647|adult anaplastic ependymoma|adult anaplastic ependymoma
5843476|NCT00002647|adult anaplastic meningioma|adult anaplastic meningioma
5843477|NCT00002647|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5843478|NCT00002647|adult brain stem glioma|adult brain stem glioma
5843479|NCT00002647|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5843480|NCT00002647|adult choroid plexus tumor|adult choroid plexus tumor
5843481|NCT00002647|adult craniopharyngioma|adult craniopharyngioma
5843482|NCT00002647|adult diffuse astrocytoma|adult diffuse astrocytoma
5843483|NCT00002647|adult ependymoblastoma|adult ependymoblastoma
5843484|NCT00002647|adult ependymoma|adult ependymoma
5843485|NCT00002647|adult giant cell glioblastoma|adult giant cell glioblastoma
5843486|NCT00002647|adult glioblastoma|adult glioblastoma
5843487|NCT00002647|adult gliosarcoma|adult gliosarcoma
5843488|NCT00002647|adult medulloblastoma|adult medulloblastoma
5843489|NCT00002647|meningeal melanocytoma|meningeal melanocytoma
5843490|NCT00002647|adult meningeal hemangiopericytoma|adult meningeal hemangiopericytoma
5843491|NCT00002647|adult oligodendroglioma|adult oligodendroglioma
5843492|NCT00002647|adult papillary meningioma|adult papillary meningioma
5843493|NCT00002647|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5843494|NCT00002647|adult pineal gland astrocytoma|adult pineal gland astrocytoma
5843495|NCT00002647|adult pineoblastoma|adult pineoblastoma
5843496|NCT00002647|adult pineocytoma|adult pineocytoma
5843497|NCT00002647|adult subependymal giant cell astrocytoma|adult subependymal giant cell astrocytoma
5843498|NCT00002647|adult subependymoma|adult subependymoma
5843499|NCT00002647|adult supratentorial primitive neuroectodermal tumor (PNET)|adult supratentorial primitive neuroectodermal tumor (pnet)
5843500|NCT00002647|childhood grade I meningioma|childhood grade i meningioma
5843501|NCT00002647|childhood grade II meningioma|childhood grade ii meningioma
5843502|NCT00002647|childhood grade III meningioma|childhood grade iii meningioma
5843503|NCT00002647|adult grade III meningioma|adult grade iii meningioma
5843504|NCT00002647|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5843505|NCT00002647|childhood choroid plexus tumor|childhood choroid plexus tumor
5843506|NCT00002647|childhood craniopharyngioma|childhood craniopharyngioma
5843507|NCT00002647|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5843508|NCT00002647|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5843509|NCT00002647|childhood low-grade cerebral astrocytoma|childhood low-grade cerebral astrocytoma
5843510|NCT00002647|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5843512|NCT00002641|adult fibrosarcoma|adult fibrosarcoma
5843513|NCT00002641|adult leiomyosarcoma|adult leiomyosarcoma
5843514|NCT00002641|adult liposarcoma|adult liposarcoma
5843515|NCT00002641|adult neurofibrosarcoma|adult neurofibrosarcoma
5843516|NCT00002641|adult synovial sarcoma|adult synovial sarcoma
5843517|NCT00002641|stage III adult soft tissue sarcoma|stage iii adult soft tissue sarcoma
5843518|NCT00002641|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5843519|NCT00002641|adult alveolar soft-part sarcoma|adult alveolar soft-part sarcoma
5843520|NCT00002641|adult epithelioid sarcoma|adult epithelioid sarcoma
5843521|NCT00002641|adult malignant fibrous histiocytoma|adult malignant fibrous histiocytoma
5843522|NCT00002641|adult malignant hemangiopericytoma|adult malignant hemangiopericytoma
5843523|NCT00002641|adult malignant mesenchymoma|adult malignant mesenchymoma
5843524|NCT00002641|adult rhabdomyosarcoma|adult rhabdomyosarcoma
5843525|NCT00002641|localized benign pheochromocytoma|localized benign pheochromocytoma
5843526|NCT00002641|regional pheochromocytoma|regional pheochromocytoma
5843527|NCT00002641|recurrent pheochromocytoma|recurrent pheochromocytoma
5843528|NCT00002641|stage II uterine sarcoma|stage ii uterine sarcoma
5843529|NCT00002641|stage III uterine sarcoma|stage iii uterine sarcoma
5843530|NCT00002641|recurrent uterine sarcoma|recurrent uterine sarcoma
5843531|NCT00002641|uterine carcinosarcoma|uterine carcinosarcoma
5843532|NCT00002641|uterine leiomyosarcoma|uterine leiomyosarcoma
5843533|NCT00002641|endometrial stromal sarcoma|endometrial stromal sarcoma
5843534|NCT00002641|ovarian sarcoma|ovarian sarcoma
5843535|NCT00002641|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5843536|NCT00002641|stage II adult soft tissue sarcoma|stage ii adult soft tissue sarcoma
5843537|NCT00002633|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5843538|NCT00002633|stage II prostate cancer|stage ii prostate cancer
5843539|NCT00002633|stage III prostate cancer|stage iii prostate cancer
5843540|NCT00002633|stage IV prostate cancer|stage iv prostate cancer
5843541|NCT00002624|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5843542|NCT00002624|squamous cell lung cancer|squamous cell lung cancer
5843543|NCT00002624|large cell lung cancer|large cell lung cancer
5843544|NCT00002624|adenocarcinoma of the lung|adenocarcinoma of the lung
5843545|NCT00002624|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5843546|NCT00002623|squamous cell lung cancer|squamous cell lung cancer
5843547|NCT00002623|large cell lung cancer|large cell lung cancer
5843548|NCT00002623|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5843549|NCT00002623|adenocarcinoma of the lung|adenocarcinoma of the lung
5843550|NCT00002623|adenosquamous cell lung cancer|adenosquamous cell lung cancer
5849296|NCT00030043|Electrodes|electrodes
5862281|NCT00001654|Socialization|socialization
5862282|NCT00001654|Gender|gender
5843551|NCT00002623|bronchoalveolar cell lung cancer|bronchoalveolar cell lung cancer
5843552|NCT00002615|stage II gastric cancer|stage ii gastric cancer
5843553|NCT00002615|stage III gastric cancer|stage iii gastric cancer
5843554|NCT00002615|adenocarcinoma of the stomach|adenocarcinoma of the stomach
5843555|NCT00002611|stage I Wilms tumor|stage i wilms tumor
5843556|NCT00002611|stage II Wilms tumor|stage ii wilms tumor
5843557|NCT00002611|stage III Wilms tumor|stage iii wilms tumor
5843558|NCT00002611|stage IV Wilms tumor|stage iv wilms tumor
5843559|NCT00002611|stage V Wilms tumor|stage v wilms tumor
5843560|NCT00002611|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5843561|NCT00002610|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5843562|NCT00002610|clear cell sarcoma of the kidney|clear cell sarcoma of the kidney
5843563|NCT00002610|rhabdoid tumor of the kidney|rhabdoid tumor of the kidney
5843564|NCT00002608|childhood brain tumor|childhood brain tumor
5843565|NCT00002608|childhood infratentorial ependymoma|childhood infratentorial ependymoma
5843566|NCT00002608|childhood supratentorial ependymoma|childhood supratentorial ependymoma
5843567|NCT00002608|recurrent adult soft tissue sarcoma|recurrent adult soft tissue sarcoma
5843568|NCT00002608|recurrent childhood brain tumor|recurrent childhood brain tumor
5843569|NCT00002608|childhood liver cancer|childhood liver cancer
5843570|NCT00002608|stage IV childhood liver cancer|stage iv childhood liver cancer
5843571|NCT00002608|recurrent childhood liver cancer|recurrent childhood liver cancer
5843572|NCT00002608|advanced malignant mesothelioma|advanced malignant mesothelioma
5843573|NCT00002608|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5843574|NCT00002608|localized unresectable adult primary liver cancer|localized unresectable adult primary liver cancer
5843575|NCT00002608|advanced adult primary liver cancer|advanced adult primary liver cancer
5843576|NCT00002608|recurrent adult primary liver cancer|recurrent adult primary liver cancer
5843577|NCT00002608|recurrent adult brain tumor|recurrent adult brain tumor
5843578|NCT00002608|stage IV adrenocortical carcinoma|stage iv adrenocortical carcinoma
5843579|NCT00002608|recurrent adrenocortical carcinoma|recurrent adrenocortical carcinoma
5843580|NCT00002608|stage IV papillary thyroid cancer|stage iv papillary thyroid cancer
5843581|NCT00002608|stage IV follicular thyroid cancer|stage iv follicular thyroid cancer
5843582|NCT00002608|thyroid gland medullary carcinoma|thyroid gland medullary carcinoma
5843583|NCT00002608|anaplastic thyroid cancer|anaplastic thyroid cancer
5843584|NCT00002608|recurrent thyroid cancer|recurrent thyroid cancer
5843585|NCT00002608|adult brain stem glioma|adult brain stem glioma
5843586|NCT00002608|adult medulloblastoma|adult medulloblastoma
5843587|NCT00002608|adult glioblastoma|adult glioblastoma
5843588|NCT00002608|metastatic pheochromocytoma|metastatic pheochromocytoma
5844308|NCT00005570|Cytokines|cytokines
5843589|NCT00002608|recurrent pheochromocytoma|recurrent pheochromocytoma
5843590|NCT00002608|childhood soft tissue sarcoma|childhood soft tissue sarcoma
5843591|NCT00002608|metastatic childhood soft tissue sarcoma|metastatic childhood soft tissue sarcoma
5843592|NCT00002608|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5843593|NCT00002608|childhood high-grade cerebral astrocytoma|childhood high-grade cerebral astrocytoma
5843594|NCT00002608|childhood oligodendroglioma|childhood oligodendroglioma
5843595|NCT00002608|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5843596|NCT00002608|adult myxopapillary ependymoma|adult myxopapillary ependymoma
5843597|NCT00002608|adult anaplastic ependymoma|adult anaplastic ependymoma
5843598|NCT00002608|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5843599|NCT00002608|adult mixed glioma|adult mixed glioma
5843600|NCT00002608|adult pilocytic astrocytoma|adult pilocytic astrocytoma
5843601|NCT00002608|adult subependymoma|adult subependymoma
5843602|NCT00002608|recurrent childhood brain stem glioma|recurrent childhood brain stem glioma
5843603|NCT00002608|recurrent childhood cerebellar astrocytoma|recurrent childhood cerebellar astrocytoma
5843604|NCT00002608|recurrent childhood cerebral astrocytoma|recurrent childhood cerebral astrocytoma
5843605|NCT00002608|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5843606|NCT00002608|recurrent childhood visual pathway and hypothalamic glioma|recurrent childhood visual pathway and hypothalamic glioma
5843607|NCT00002608|recurrent childhood ependymoma|recurrent childhood ependymoma
5843608|NCT00002608|stage IV adult soft tissue sarcoma|stage iv adult soft tissue sarcoma
5843609|NCT00002608|adult oligodendroglioma|adult oligodendroglioma
5843610|NCT00002608|adult giant cell glioblastoma|adult giant cell glioblastoma
5843611|NCT00002608|adult gliosarcoma|adult gliosarcoma
5843612|NCT00002608|adult diffuse astrocytoma|adult diffuse astrocytoma
5843613|NCT00002598|relapsing chronic myelogenous leukemia|relapsing chronic myelogenous leukemia
5843614|NCT00002598|blastic phase chronic myelogenous leukemia|blastic phase chronic myelogenous leukemia
5843615|NCT00002598|atypical chronic myeloid leukemia, BCR-ABL1 negative|atypical chronic myeloid leukemia, bcr-abl1 negative
5843616|NCT00002596|stage II malignant testicular germ cell tumor|stage ii malignant testicular germ cell tumor
5843617|NCT00002596|stage III malignant testicular germ cell tumor|stage iii malignant testicular germ cell tumor
5843618|NCT00002596|testicular seminoma|testicular seminoma
5843619|NCT00002596|testicular embryonal carcinoma|testicular embryonal carcinoma
5862382|NCT00001630|Thrombocytopenia|thrombocytopenia
5862383|NCT00001630|Autoimmune Disease|autoimmune disease
5862385|NCT00001630|Autoimmune Hemolytic Anemia|autoimmune hemolytic anemia
5862386|NCT00001630|Episodic Bleeding|episodic bleeding
5862392|NCT00001626|Severe Aplastic Anemia|severe aplastic anemia
5862393|NCT00001626|Immunosuppression|immunosuppression
5862394|NCT00001625|Insulin Resistance|insulin resistance
5862396|NCT00001625|Hypertension|hypertension
5862397|NCT00001625|Diabetes|diabetes
5843620|NCT00002596|testicular choriocarcinoma|testicular choriocarcinoma
5843621|NCT00002596|testicular teratoma|testicular teratoma
5843622|NCT00002596|testicular yolk sac tumor|testicular yolk sac tumor
5843623|NCT00002596|testicular embryonal carcinoma and teratoma|testicular embryonal carcinoma and teratoma
5843624|NCT00002596|testicular embryonal carcinoma and teratoma with seminoma|testicular embryonal carcinoma and teratoma with seminoma
5843625|NCT00002596|testicular embryonal carcinoma and yolk sac tumor|testicular embryonal carcinoma and yolk sac tumor
5843626|NCT00002596|testicular embryonal carcinoma and yolk sac tumor with seminoma|testicular embryonal carcinoma and yolk sac tumor with seminoma
5843627|NCT00002596|testicular embryonal carcinoma and seminoma|testicular embryonal carcinoma and seminoma
5843628|NCT00002596|testicular yolk sac tumor and teratoma|testicular yolk sac tumor and teratoma
5843629|NCT00002596|testicular yolk sac tumor and teratoma with seminoma|testicular yolk sac tumor and teratoma with seminoma
5843630|NCT00002596|testicular choriocarcinoma and yolk sac tumor|testicular choriocarcinoma and yolk sac tumor
5843631|NCT00002596|testicular choriocarcinoma and embryonal carcinoma|testicular choriocarcinoma and embryonal carcinoma
5843632|NCT00002596|testicular choriocarcinoma and teratoma|testicular choriocarcinoma and teratoma
5843633|NCT00002596|testicular choriocarcinoma and seminoma|testicular choriocarcinoma and seminoma
5843634|NCT00002596|extragonadal germ cell tumor|extragonadal germ cell tumor
5843635|NCT00002596|childhood teratoma|childhood teratoma
5843636|NCT00002596|childhood malignant testicular germ cell tumor|childhood malignant testicular germ cell tumor
5843637|NCT00002596|childhood extragonadal germ cell tumor|childhood extragonadal germ cell tumor
5843638|NCT00002594|recurrent childhood brain tumor|recurrent childhood brain tumor
5843639|NCT00002594|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5843640|NCT00002594|recurrent childhood medulloblastoma|recurrent childhood medulloblastoma
5843641|NCT00002589|stage III renal cell cancer|stage iii renal cell cancer
5843642|NCT00002589|stage IV renal cell cancer|stage iv renal cell cancer
5843643|NCT00002589|recurrent renal cell cancer|recurrent renal cell cancer
5843644|NCT00002586|non-small cell lung cancer|non-small cell lung cancer
5843645|NCT00002586|small cell lung cancer|small cell lung cancer
5843646|NCT00002586|drug/agent toxicity by tissue/organ|drug/agent toxicity by tissue/organ
5843647|NCT00002569|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5843648|NCT00002569|adult mixed glioma|adult mixed glioma
5843649|NCT00002560|recurrent neuroblastoma|recurrent neuroblastoma
5843650|NCT00002558|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5843651|NCT00002558|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5843652|NCT00002558|extragonadal germ cell tumor|extragonadal germ cell tumor
5843653|NCT00002546|stage I uterine sarcoma|stage i uterine sarcoma
5843654|NCT00002546|stage II uterine sarcoma|stage ii uterine sarcoma
5843655|NCT00002546|stage III uterine sarcoma|stage iii uterine sarcoma
5843656|NCT00002546|stage IV uterine sarcoma|stage iv uterine sarcoma
5843657|NCT00002546|uterine carcinosarcoma|uterine carcinosarcoma
5843658|NCT00002544|stage IV breast cancer|stage iv breast cancer
5843659|NCT00002544|recurrent breast cancer|recurrent breast cancer
5843660|NCT00002528|stage I breast cancer|stage i breast cancer
5843661|NCT00002528|stage II breast cancer|stage ii breast cancer
5843662|NCT00002523|stage II rectal cancer|stage ii rectal cancer
5843663|NCT00002523|stage III rectal cancer|stage iii rectal cancer
5843664|NCT00002523|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5843665|NCT00002522|stage I adult Hodgkin lymphoma|stage i adult hodgkin lymphoma
5843666|NCT00002522|stage II adult Hodgkin lymphoma|stage ii adult hodgkin lymphoma
5843667|NCT00002522|stage III adult Hodgkin lymphoma|stage iii adult hodgkin lymphoma
5843668|NCT00002522|stage IV adult Hodgkin lymphoma|stage iv adult hodgkin lymphoma
5843886|NCT00051831|Anti-HIV Agents|anti-hiv agents
5843669|NCT00002522|recurrent adult Hodgkin lymphoma|recurrent adult hodgkin lymphoma
5843670|NCT00002521|stage I adult diffuse small cleaved cell lymphoma|stage i adult diffuse small cleaved cell lymphoma
5843671|NCT00002521|stage I adult diffuse mixed cell lymphoma|stage i adult diffuse mixed cell lymphoma
5846871|NCT00042536|Alpha-2 Adrenoreceptor|alpha-2 adrenoreceptor
5862489|NCT00001603|Squamous Cell Carcinoma|squamous cell carcinoma
5862490|NCT00001603|Papilloma|papilloma
5862492|NCT00001603|Immunity|immunity
5843672|NCT00002521|stage I adult diffuse large cell lymphoma|stage i adult diffuse large cell lymphoma
5843673|NCT00002521|stage I adult immunoblastic large cell lymphoma|stage i adult immunoblastic large cell lymphoma
5843674|NCT00002521|stage I adult lymphoblastic lymphoma|stage i adult lymphoblastic lymphoma
5843675|NCT00002521|stage I adult Burkitt lymphoma|stage i adult burkitt lymphoma
5843676|NCT00002521|stage III adult diffuse small cleaved cell lymphoma|stage iii adult diffuse small cleaved cell lymphoma
5843677|NCT00002521|stage III adult diffuse mixed cell lymphoma|stage iii adult diffuse mixed cell lymphoma
5843678|NCT00002521|stage III adult diffuse large cell lymphoma|stage iii adult diffuse large cell lymphoma
5843679|NCT00002521|stage III adult immunoblastic large cell lymphoma|stage iii adult immunoblastic large cell lymphoma
5843680|NCT00002521|stage III adult lymphoblastic lymphoma|stage iii adult lymphoblastic lymphoma
5843681|NCT00002521|stage III adult Burkitt lymphoma|stage iii adult burkitt lymphoma
5843682|NCT00002521|stage IV adult diffuse small cleaved cell lymphoma|stage iv adult diffuse small cleaved cell lymphoma
5843683|NCT00002521|stage IV adult diffuse mixed cell lymphoma|stage iv adult diffuse mixed cell lymphoma
5843684|NCT00002521|stage IV adult diffuse large cell lymphoma|stage iv adult diffuse large cell lymphoma
5843685|NCT00002521|stage IV adult immunoblastic large cell lymphoma|stage iv adult immunoblastic large cell lymphoma
5843686|NCT00002521|stage IV adult lymphoblastic lymphoma|stage iv adult lymphoblastic lymphoma
5843687|NCT00002521|stage IV adult Burkitt lymphoma|stage iv adult burkitt lymphoma
5843688|NCT00002521|recurrent adult diffuse small cleaved cell lymphoma|recurrent adult diffuse small cleaved cell lymphoma
5843689|NCT00002521|recurrent adult diffuse mixed cell lymphoma|recurrent adult diffuse mixed cell lymphoma
5843690|NCT00002521|recurrent adult diffuse large cell lymphoma|recurrent adult diffuse large cell lymphoma
5843691|NCT00002521|recurrent adult immunoblastic large cell lymphoma|recurrent adult immunoblastic large cell lymphoma
5843692|NCT00002521|recurrent adult lymphoblastic lymphoma|recurrent adult lymphoblastic lymphoma
5843693|NCT00002521|recurrent adult Burkitt lymphoma|recurrent adult burkitt lymphoma
5843694|NCT00002521|contiguous stage II adult diffuse small cleaved cell lymphoma|contiguous stage ii adult diffuse small cleaved cell lymphoma
5843695|NCT00002521|contiguous stage II adult diffuse mixed cell lymphoma|contiguous stage ii adult diffuse mixed cell lymphoma
5843696|NCT00002521|contiguous stage II adult immunoblastic large cell lymphoma|contiguous stage ii adult immunoblastic large cell lymphoma
5843697|NCT00002521|contiguous stage II adult diffuse large cell lymphoma|contiguous stage ii adult diffuse large cell lymphoma
5843698|NCT00002521|contiguous stage II adult Burkitt lymphoma|contiguous stage ii adult burkitt lymphoma
5843699|NCT00002521|contiguous stage II adult lymphoblastic lymphoma|contiguous stage ii adult lymphoblastic lymphoma
5843700|NCT00002521|noncontiguous stage II adult diffuse small cleaved cell lymphoma|noncontiguous stage ii adult diffuse small cleaved cell lymphoma
5843701|NCT00002521|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5843702|NCT00002521|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5843703|NCT00002521|noncontiguous stage II adult diffuse large cell lymphoma|noncontiguous stage ii adult diffuse large cell lymphoma
5843704|NCT00002521|noncontiguous stage II adult Burkitt lymphoma|noncontiguous stage ii adult burkitt lymphoma
5843705|NCT00002521|noncontiguous stage II adult lymphoblastic lymphoma|noncontiguous stage ii adult lymphoblastic lymphoma
5843706|NCT00002517|childhood myelodysplastic syndromes|childhood myelodysplastic syndromes
5843707|NCT00002517|untreated childhood acute myeloid leukemia and other myeloid malignancies|untreated childhood acute myeloid leukemia and other myeloid malignancies
5843708|NCT00002517|childhood acute myeloblastic leukemia without maturation (M1)|childhood acute myeloblastic leukemia without maturation (m1)
5843709|NCT00002517|childhood acute myeloblastic leukemia with maturation (M2)|childhood acute myeloblastic leukemia with maturation (m2)
5843710|NCT00002517|childhood acute myelomonocytic leukemia (M4)|childhood acute myelomonocytic leukemia (m4)
5843711|NCT00002517|childhood acute monoblastic leukemia (M5a)|childhood acute monoblastic leukemia (m5a)
5843712|NCT00002517|childhood acute monocytic leukemia (M5b)|childhood acute monocytic leukemia (m5b)
5843713|NCT00002517|childhood acute erythroleukemia (M6)|childhood acute erythroleukemia (m6)
5843714|NCT00002517|childhood acute megakaryocytic leukemia (M7)|childhood acute megakaryocytic leukemia (m7)
5843715|NCT00002517|refractory anemia with excess blasts|refractory anemia with excess blasts
5843716|NCT00002517|refractory anemia with excess blasts in transformation|refractory anemia with excess blasts in transformation
5843717|NCT00002517|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5843718|NCT00002517|de novo myelodysplastic syndromes|de novo myelodysplastic syndromes
5843719|NCT00002517|childhood acute minimally differentiated myeloid leukemia (M0)|childhood acute minimally differentiated myeloid leukemia (m0)
5843720|NCT00002515|chondrosarcoma|chondrosarcoma
5843721|NCT00002515|recurrent childhood rhabdomyosarcoma|recurrent childhood rhabdomyosarcoma
5843722|NCT00002515|stage IV childhood liver cancer|stage iv childhood liver cancer
5843723|NCT00002515|recurrent neuroblastoma|recurrent neuroblastoma
5843724|NCT00002515|recurrent childhood liver cancer|recurrent childhood liver cancer
5862588|NCT00001575|Calcium DTPA|calcium dtpa
5862589|NCT00001574|Metabolites|metabolites
5862590|NCT00001574|Proton Nuclear Magnetic Resonance Spectroscopic Imaging|proton nuclear magnetic resonance spectroscopic imaging
5862591|NCT00001574|Scans|scans
5843725|NCT00002515|recurrent Wilms tumor and other childhood kidney tumors|recurrent wilms tumor and other childhood kidney tumors
5843726|NCT00002515|stage IV Wilms tumor|stage iv wilms tumor
5843727|NCT00002515|recurrent retinoblastoma|recurrent retinoblastoma
5843728|NCT00002515|stage IV childhood lymphoblastic lymphoma|stage iv childhood lymphoblastic lymphoma
5843729|NCT00002515|recurrent childhood lymphoblastic lymphoma|recurrent childhood lymphoblastic lymphoma
5843730|NCT00002515|recurrent osteosarcoma|recurrent osteosarcoma
5843731|NCT00002515|stage IV ovarian germ cell tumor|stage iv ovarian germ cell tumor
5843732|NCT00002515|recurrent malignant testicular germ cell tumor|recurrent malignant testicular germ cell tumor
5843733|NCT00002515|childhood germ cell tumor|childhood germ cell tumor
5843734|NCT00002515|alveolar childhood rhabdomyosarcoma|alveolar childhood rhabdomyosarcoma
5843735|NCT00002515|recurrent childhood soft tissue sarcoma|recurrent childhood soft tissue sarcoma
5843736|NCT00002515|recurrent ovarian germ cell tumor|recurrent ovarian germ cell tumor
5843737|NCT00002515|childhood fibrosarcoma|childhood fibrosarcoma
5843738|NCT00002515|extragonadal germ cell tumor|extragonadal germ cell tumor
5843739|NCT00002515|childhood desmoplastic small round cell tumor|childhood desmoplastic small round cell tumor
5843740|NCT00002515|recurrent childhood small noncleaved cell lymphoma|recurrent childhood small noncleaved cell lymphoma
5843741|NCT00002515|stage IV childhood small noncleaved cell lymphoma|stage iv childhood small noncleaved cell lymphoma
5843742|NCT00002515|recurrent childhood large cell lymphoma|recurrent childhood large cell lymphoma
5843743|NCT00002515|stage IV childhood large cell lymphoma|stage iv childhood large cell lymphoma
5843744|NCT00002515|recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor|recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
5843745|NCT00002515|stage IV lymphoepithelioma of the nasopharynx|stage iv lymphoepithelioma of the nasopharynx
5843746|NCT00002515|stage IV squamous cell carcinoma of the nasopharynx|stage iv squamous cell carcinoma of the nasopharynx
5843747|NCT00002515|recurrent squamous cell carcinoma of the nasopharynx|recurrent squamous cell carcinoma of the nasopharynx
5843748|NCT00002515|recurrent lymphoepithelioma of the nasopharynx|recurrent lymphoepithelioma of the nasopharynx
5843749|NCT00002514|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5843750|NCT00002511|adenocarcinoma of the prostate|adenocarcinoma of the prostate
5843751|NCT00002511|stage I prostate cancer|stage i prostate cancer
5843752|NCT00002511|stage IIB prostate cancer|stage iib prostate cancer
5843753|NCT00002511|stage IIA prostate cancer|stage iia prostate cancer
5843754|NCT00002511|stage III prostate cancer|stage iii prostate cancer
5843755|NCT00002490|stage I bladder cancer|stage i bladder cancer
5843756|NCT00002490|transitional cell carcinoma of the bladder|transitional cell carcinoma of the bladder
5843757|NCT00002484|stage I non-small cell lung cancer|stage i non-small cell lung cancer
5843758|NCT00002484|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5843759|NCT00002484|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5843760|NCT00002484|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5843761|NCT00002475|stage III colon cancer|stage iii colon cancer
5843762|NCT00002475|stage IV colon cancer|stage iv colon cancer
5843763|NCT00002475|stage IV breast cancer|stage iv breast cancer
5843764|NCT00002475|stage IIIA breast cancer|stage iiia breast cancer
5843765|NCT00002475|recurrent breast cancer|recurrent breast cancer
5843766|NCT00002475|stage IIIB breast cancer|stage iiib breast cancer
5843767|NCT00002475|recurrent non-small cell lung cancer|recurrent non-small cell lung cancer
5843768|NCT00002475|stage II pancreatic cancer|stage ii pancreatic cancer
5843769|NCT00002475|stage III pancreatic cancer|stage iii pancreatic cancer
5843770|NCT00002475|recurrent pancreatic cancer|recurrent pancreatic cancer
5843771|NCT00002475|recurrent colon cancer|recurrent colon cancer
5843772|NCT00002475|stage III renal cell cancer|stage iii renal cell cancer
5843773|NCT00002475|stage IV renal cell cancer|stage iv renal cell cancer
5843774|NCT00002475|recurrent renal cell cancer|recurrent renal cell cancer
5843775|NCT00002475|extensive stage small cell lung cancer|extensive stage small cell lung cancer
5843776|NCT00002475|recurrent small cell lung cancer|recurrent small cell lung cancer
5843777|NCT00002475|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5843778|NCT00002475|stage IIIB non-small cell lung cancer|stage iiib non-small cell lung cancer
5843779|NCT00002475|stage IIIC breast cancer|stage iiic breast cancer
5843780|NCT00002475|stage IV non-small cell lung cancer|stage iv non-small cell lung cancer
5843781|NCT00002475|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5843782|NCT00002475|recurrent malignant mesothelioma|recurrent malignant mesothelioma
5843783|NCT00002475|stage IV pancreatic cancer|stage iv pancreatic cancer
5843784|NCT00002474|recurrent ovarian epithelial cancer|recurrent ovarian epithelial cancer
5843785|NCT00002473|stage I renal cell cancer|stage i renal cell cancer
5843786|NCT00002473|stage II renal cell cancer|stage ii renal cell cancer
5862688|NCT00001545|Depression|depression
5862689|NCT00001545|Unipolar Disorder|unipolar disorder
5862690|NCT00001545|Unipolar Depression|unipolar depression
5862691|NCT00001544|DNA Probes|dna probes
5862692|NCT00001544|Trinucleotide Repeats|trinucleotide repeats
5862693|NCT00001544|Family Studies|family studies
5862694|NCT00001544|Lymphoblast Cell Lines|lymphoblast cell lines
5862695|NCT00001544|Genotyping|genotyping
5862739|NCT00001532|Asthma|asthma
5843787|NCT00002472|childhood central nervous system germ cell tumor|childhood central nervous system germ cell tumor
5843788|NCT00002472|extragonadal germ cell tumor|extragonadal germ cell tumor
5843789|NCT00002472|adult central nervous system germ cell tumor|adult central nervous system germ cell tumor
5843790|NCT00002472|childhood teratoma|childhood teratoma
5843791|NCT00002472|childhood central nervous system choriocarcinoma|childhood central nervous system choriocarcinoma
5843792|NCT00002472|childhood central nervous system embryonal tumor|childhood central nervous system embryonal tumor
5843793|NCT00002472|childhood central nervous system germinoma|childhood central nervous system germinoma
5843794|NCT00002472|childhood central nervous system mixed germ cell tumor|childhood central nervous system mixed germ cell tumor
5843795|NCT00002472|childhood central nervous system teratoma|childhood central nervous system teratoma
5843796|NCT00002472|childhood central nervous system yolk sac tumor|childhood central nervous system yolk sac tumor
5843797|NCT00002470|metastatic gastrointestinal carcinoid tumor|metastatic gastrointestinal carcinoid tumor
5843798|NCT00002470|recurrent gastrointestinal carcinoid tumor|recurrent gastrointestinal carcinoid tumor
5843799|NCT00002470|pulmonary carcinoid tumor|pulmonary carcinoid tumor
5843800|NCT00002455|stage I colon cancer|stage i colon cancer
5843801|NCT00002455|stage II colon cancer|stage ii colon cancer
5843802|NCT00002455|stage III colon cancer|stage iii colon cancer
5843803|NCT00002455|stage I breast cancer|stage i breast cancer
5843804|NCT00002455|stage II breast cancer|stage ii breast cancer
5843805|NCT00002455|stage IIIA breast cancer|stage iiia breast cancer
5843806|NCT00002455|recurrent breast cancer|recurrent breast cancer
5843807|NCT00002455|recurrent colon cancer|recurrent colon cancer
5843808|NCT00002455|stage I melanoma|stage i melanoma
5843809|NCT00002455|stage II melanoma|stage ii melanoma
5843810|NCT00002455|stage III melanoma|stage iii melanoma
5843811|NCT00002455|recurrent melanoma|recurrent melanoma
5843812|NCT00052143|Huntington's disease|huntington's disease
5843813|NCT00052143|HD|hd
5843814|NCT00052143|Huntington disease|huntington disease
5843815|NCT00051818|chronic HIV infection|chronic hiv infection
5843816|NCT00051818|treatment interruption|treatment interruption
5843817|NCT00051818|HIV-specific immune response|hiv-specific immune response
5843818|NCT00051818|immune response|immune response
5843819|NCT00051818|virological response|virological response
5843820|NCT00051818|treatment experienced|treatment experienced
5843821|NCT00052091|Geriatrics|geriatrics
5843822|NCT00052078|Phobic Disorders|phobic disorders
5843823|NCT00052078|Anxiety, Separation|anxiety, separation
5843824|NCT00052052|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5843825|NCT00052052|IPF|ipf
5843826|NCT00052026|Adolescent|adolescent
5843827|NCT00052026|Adrenergic alpha-Antagonists/therapeutic use|adrenergic alpha-antagonists/therapeutic use
5843828|NCT00052026|Adrenergic alpha-Antagonists/pharmacokinetics|adrenergic alpha-antagonists/pharmacokinetics
5843829|NCT00052026|Adrenergic alpha-Antagonists/administration & dosage|adrenergic alpha-antagonists/administration & dosage
5843830|NCT00052026|Adrenergic beta-Antagonists/therapeutic use|adrenergic beta-antagonists/therapeutic use
5843831|NCT00052026|Adrenergic beta-Antagonists/pharmacokinetics|adrenergic beta-antagonists/pharmacokinetics
5843832|NCT00052026|Adrenergic beta-Antagonists/administration & dosage|adrenergic beta-antagonists/administration & dosage
5843833|NCT00052026|Age Factors|age factors
5843834|NCT00052026|Carbazoles/therapeutic use|carbazoles/therapeutic use
5843835|NCT00052026|Carbazoles/administration & dosage|carbazoles/administration & dosage
5843836|NCT00052026|Child|child
5843837|NCT00052026|Child, Preschool|child, preschool
5843838|NCT00052026|Drug Administration Schedule|drug administration schedule
5843839|NCT00052026|Female|female
5843840|NCT00052026|Heart Failure, Congestive/etiology|heart failure, congestive/etiology
5843841|NCT00052026|Heart Failure, Congestive/drug therapy|heart failure, congestive/drug therapy
5843842|NCT00052026|Heart Failure, Congestive/blood|heart failure, congestive/blood
5843843|NCT00052026|Human|human
5843844|NCT00052026|Infant|infant
5843845|NCT00052026|Infant, Newborn|infant, newborn
5843846|NCT00052026|Male|male
5843847|NCT00052026|Natriuretic Peptide, Brain/blood|natriuretic peptide, brain/blood
5843848|NCT00052026|Placebos|placebos
5843849|NCT00052026|Propanolamines/therapeutic use|propanolamines/therapeutic use
5843850|NCT00052026|Propanolamines/administration & dosage|propanolamines/administration & dosage
5843851|NCT00052026|Prospective Studies|prospective studies
5843852|NCT00052026|Support, Non-U.S. Gov't|support, non-u.s. gov't
5862787|NCT00001507|CD34+ Selection|cd34+ selection
5862788|NCT00001507|T-Cell Depletion|t-cell depletion
5862789|NCT00001507|Apheresis|apheresis
5862790|NCT00001507|Mobilization|mobilization
5862801|NCT00001504|Retinoids|retinoids
5862802|NCT00001504|Biomarkers|biomarkers
5862803|NCT00001503|Cancer|cancer
5862804|NCT00001503|Late Effects|late effects
5862805|NCT00001503|Survival|survival
5862806|NCT00001503|Follow-Up|follow-up
5862807|NCT00001500|Smoking|smoking
5862808|NCT00001500|Alcohol|alcohol
5862809|NCT00001500|HIV|hiv
5862810|NCT00001500|AIDS|aids
5862811|NCT00001500|DNA Markers|dna markers
5862812|NCT00001500|Personality|personality
5862813|NCT00001500|Healthy Volunteers|healthy volunteers
5862814|NCT00001500|Normal Volunteer|normal volunteer
5862815|NCT00001496|BRCA-1|brca-1
5862816|NCT00001496|Familial Breast Cancer|familial breast cancer
5862817|NCT00001496|Breast Cell Culture|breast cell culture
5862818|NCT00001496|High Risk|high risk
5862819|NCT00001491|Ceramidetrihexosidase Deficiency|ceramidetrihexosidase deficiency
5862820|NCT00001491|Sural Nerve Biopsy|sural nerve biopsy
5862825|NCT00001491|Fabrys|fabrys
5843853|NCT00052026|Treatment Outcome|treatment outcome
5843854|NCT00052026|Ventricular Dysfunction/drug therapy|ventricular dysfunction/drug therapy
5843855|NCT00052026|Ventricular Dysfunction/complications|ventricular dysfunction/complications
5843856|NCT00052026|Ventricular Dysfunction/blood|ventricular dysfunction/blood
5843857|NCT00052026|Ventricular Function/drug effects|ventricular function/drug effects
5843858|NCT00052026|Ventricular Remodeling/drug effects|ventricular remodeling/drug effects
5843859|NCT00052039|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis
5843860|NCT00052013|von Hippel-Lindau disease,|von hippel-lindau disease,
5843861|NCT00052013|CNS,|cns,
5843862|NCT00052013|hemangioblastoma,|hemangioblastoma,
5843863|NCT00052013|retinal|retinal
5843864|NCT00051935|Glycogen Storage Disease Type II|glycogen storage disease type ii
5843865|NCT00051935|GSD-II|gsd-ii
5843866|NCT00051935|Pompe Disease|pompe disease
5843867|NCT00051922|HIV Preventive Vaccine|hiv preventive vaccine
5843868|NCT00051922|HIV Seronegativity|hiv seronegativity
5843869|NCT00051961|Dopamine|dopamine
5843870|NCT00051961|Spinal Physiology|spinal physiology
5843871|NCT00051961|Flexor Reflex|flexor reflex
5843872|NCT00051961|Ropinirole|ropinirole
5843873|NCT00051961|Motor Control|motor control
5843874|NCT00051961|Dopaminergic|dopaminergic
5843875|NCT00051961|Restless Legs|restless legs
5843876|NCT00051909|Alzheimer's Disease|alzheimer's disease
5843877|NCT00051844|HIV|hiv
5843878|NCT00051844|NNRTI Failure|nnrti failure
5843879|NCT00051844|HIV Infections|hiv infections
5843880|NCT00051831|Treatment Naive|treatment naive
5843881|NCT00051831|HIV-1|hiv-1
5843882|NCT00051831|Virus Replication|virus replication
5843883|NCT00051831|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5843884|NCT00051831|Immunologic Memory|immunologic memory
5843885|NCT00051831|Pentafuside|pentafuside
5843887|NCT00051831|Drug Therapy, Combination|drug therapy, combination
5843888|NCT00051831|Saquinavir|saquinavir
5843889|NCT00051831|Ritonavir|ritonavir
5843890|NCT00051831|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5843891|NCT00051831|RNA, Viral|rna, viral
5843892|NCT00051831|Viral Load|viral load
5843893|NCT00051831|Fusion Inhibitors|fusion inhibitors
5843894|NCT00051831|Entry Inhibitors|entry inhibitors
5843895|NCT00051870|Verbal Memory|verbal memory
5843896|NCT00051870|Inhibition|inhibition
5843897|NCT00051870|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5843898|NCT00051870|Cortical Excitability|cortical excitability
5843899|NCT00051870|Nonverbal Memory|nonverbal memory
5843900|NCT00051857|Patello-Femoral|patello-femoral
5843901|NCT00051857|Knee|knee
5843902|NCT00051857|Motion|motion
5843904|NCT00051857|Kinematics|kinematics
5843905|NCT00051805|Patient Compliance|patient compliance
5843906|NCT00051805|Adherence|adherence
5849725|NCT00028210|HV|hv
5862904|NCT00001464|Bronchoalveolar Lavage|bronchoalveolar lavage
5862905|NCT00001464|DNA Repair|dna repair
5862906|NCT00001464|Carbonyl Groups|carbonyl groups
5862907|NCT00001464|Serum|serum
5862908|NCT00001464|Human Volunteers|human volunteers
5862909|NCT00001460|Training Protocol|training protocol
5862910|NCT00001460|Cardiac Diagnosis|cardiac diagnosis
5862911|NCT00001460|Congenital Heart Disease|congenital heart disease
5862912|NCT00001460|Acquired Heart Disease|acquired heart disease
5862913|NCT00001460|Arrhythmias|arrhythmias
5862925|NCT00001457|Nucleoside Analogues|nucleoside analogues
5862926|NCT00001457|Delta Hepatitis|delta hepatitis
5862927|NCT00001457|Glomerulonephritis|glomerulonephritis
5862928|NCT00001457|Polyarteritis Nodosa|polyarteritis nodosa
5862929|NCT00001457|Hepatitis Mutants|hepatitis mutants
5862930|NCT00001457|3TC|3tc
5862931|NCT00001457|Chronic Hepatitis B|chronic hepatitis b
5862932|NCT00001457|Chronic Hepatitis D|chronic hepatitis d
5862933|NCT00001457|Cirrhosis|cirrhosis
5862934|NCT00001457|Lamivudine|lamivudine
5862939|NCT00001454|Estrogen|estrogen
5862940|NCT00001454|Progesterone|progesterone
5862941|NCT00001454|Menses|menses
5843907|NCT00051805|Treatment Experienced|treatment experienced
5843908|NCT00051779|CAL|cal
5843909|NCT00051779|Parathyroid hormone-related protein (PTHrP)|parathyroid hormone-related protein (pthrp)
5843910|NCT00051779|Breast Cancer|breast cancer
5843911|NCT00051779|Bone Metastasis|bone metastasis
5843912|NCT00051779|Hypercalcemia|hypercalcemia
5843913|NCT00051766|compliance|compliance
5843914|NCT00051766|medication|medication
5843915|NCT00051766|antiretroviral|antiretroviral
5843916|NCT00051766|adherence|adherence
5862997|NCT00001418|Postural Tachycardia Syndrome|postural tachycardia syndrome
5862998|NCT00001418|Neurocardiogenic Syncope|neurocardiogenic syncope
5862999|NCT00001418|Hypernoradrenergic Hypertension|hypernoradrenergic hypertension
5863000|NCT00001418|Sympathectomy|sympathectomy
5863001|NCT00001418|Fluorodopamine|fluorodopamine
5863002|NCT00001418|Positron Emission Tomography|positron emission tomography
5863003|NCT00001418|Norepinephrine|norepinephrine
5863004|NCT00001418|Dopamine|dopamine
5863005|NCT00001418|Neurocardiologic Disorder|neurocardiologic disorder
5863006|NCT00001417|Needle Biopsy|needle biopsy
5863007|NCT00001417|Computed Tomography|computed tomography
5863008|NCT00001417|Magnetic Resonance Imaging|magnetic resonance imaging
5843974|NCT00051337|Paroxysmal Dyskinesia|paroxysmal dyskinesia
5843975|NCT00051337|Psychogenic Movement Disorders|psychogenic movement disorders
5843976|NCT00051337|Single Photon Emission|single photon emission
5843977|NCT00051337|Computed Tomography (SPECT)|computed tomography (spect)
5843978|NCT00051324|Huntington's disease|huntington's disease
5843979|NCT00051324|Huntington disease|huntington disease
5843981|NCT00051285|CHF|chf
5843982|NCT00051285|heart|heart
5843983|NCT00051285|failure|failure
5843984|NCT00051285|congestive|congestive
5843985|NCT00051285|enoximone|enoximone
5843986|NCT00051285|phosphodiesterase|phosphodiesterase
5843987|NCT00051285|inhibitor|inhibitor
5843988|NCT00051311|Lymphoma|lymphoma
5843989|NCT00051311|Leukemia|leukemia
5843990|NCT00051311|Hodgkin's Disease|hodgkin's disease
5843991|NCT00051311|Multiple Myeloma|multiple myeloma
5843992|NCT00051311|Immunotherapy|immunotherapy
5843993|NCT00051272|depression, sexual dysfunction, orgasm disorder, MDD|depression, sexual dysfunction, orgasm disorder, mdd
5843994|NCT00051259|depression|depression
5843996|NCT00051259|sexual dysfunction|sexual dysfunction
5843997|NCT00051259|orgasm disorder|orgasm disorder
5843998|NCT00051207|Mood Disorders|mood disorders
5843999|NCT00051207|Psychotherapy|psychotherapy
5844000|NCT00051207|Comorbidity|comorbidity
5844001|NCT00051194|Glaucoma|glaucoma
5844002|NCT00051194|POAG|poag
5844003|NCT00051194|OAG|oag
5844022|NCT00051129|anecortave acetate|anecortave acetate
5844023|NCT00051129|wet AMD|wet amd
5844024|NCT00051129|age-related macular degeneration|age-related macular degeneration
5844025|NCT00051129|Macular Degeneration|macular degeneration
5844026|NCT00051129|Maculopathy, Age-Related|maculopathy, age-related
5844027|NCT00051129|Age-Related Maculopathies|age-related maculopathies
5844028|NCT00051129|Age-Related Maculopathy|age-related maculopathy
5844029|NCT00051129|Maculopathies, Age-Related|maculopathies, age-related
5844030|NCT00051116|Multiple Myeloma|multiple myeloma
5844031|NCT00051116|Revimid|revimid
5844032|NCT00051116|CC5013|cc5013
5844033|NCT00051116|CC-5013|cc-5013
5844034|NCT00051103|Refractory|refractory
5844035|NCT00051090|Hepatitis B|hepatitis b
5844036|NCT00051090|Antiretroviral Therapy, Highly-Active|antiretroviral therapy, highly-active
5844037|NCT00051090|HIV Infections|hiv infections
5844038|NCT00051090|Lamivudine|lamivudine
5844039|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5844040|NCT00051090|Antiviral Agents|antiviral agents
5844041|NCT00051090|Drug Therapy, Combination|drug therapy, combination
5844042|NCT00051090|Treatment Naive|treatment naive
5844043|NCT00051077|HIV Infections|hiv infections
5844044|NCT00051077|Hepatitis B|hepatitis b
5844045|NCT00051077|Hepatitis C|hepatitis c
5844046|NCT00051077|Interferon Alfa-2a|interferon alfa-2a
5844047|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil
5844048|NCT00051077|Ribavirin|ribavirin
5844049|NCT00051077|Antiviral Agents|antiviral agents
5844050|NCT00051077|Drug Resistance, Viral|drug resistance, viral
5844051|NCT00051077|Treatment Experienced|treatment experienced
5844052|NCT00050986|Brain Neoplasms|brain neoplasms
5844053|NCT00050986|CNS Diseases|cns diseases
5844054|NCT00050986|Glioblastoma Multiforme|glioblastoma multiforme
5844055|NCT00050986|Temozolomide|temozolomide
5844056|NCT00050986|Temodar|temodar
5844057|NCT00050986|R115777|r115777
5844058|NCT00050986|Zarnestra|zarnestra
5844059|NCT00050973|NSCLC|nsclc
5844060|NCT00050973|Targretin|targretin
5844061|NCT00050973|Retinoid|retinoid
5844062|NCT00050973|Bexarotene|bexarotene
5844063|NCT00050960|NSCLC|nsclc
5844064|NCT00050960|Targretin|targretin
5844065|NCT00050960|Retinoid|retinoid
5863096|NCT00001398|Stem Cell Cycling|stem cell cycling
5863097|NCT00001398|Bone Marrow Failure|bone marrow failure
5863098|NCT00001398|Acquired Aplastic Anemia|acquired aplastic anemia
5863105|NCT00001396|Pacemaker|pacemaker
5863106|NCT00001396|Pediatric|pediatric
5863107|NCT00001396|Obstructive HCM|obstructive hcm
5863108|NCT00001394|Hyperparathyroidism|hyperparathyroidism
5863109|NCT00001394|Arterial Stimulation|arterial stimulation
5863110|NCT00001394|Venous Sampling|venous sampling
5863111|NCT00001394|Parathyroid Adenoma|parathyroid adenoma
5863112|NCT00001394|Parathyroid Hyperplasia|parathyroid hyperplasia
5863120|NCT00001391|Augmentation|augmentation
5863121|NCT00001391|Osteogenesis|osteogenesis
5863122|NCT00001391|Stem Cells|stem cells
5863123|NCT00001391|Bone Formation|bone formation
5863124|NCT00001391|Bone Induction|bone induction
5863125|NCT00001390|Saliva|saliva
5863126|NCT00001390|Parotid|parotid
5863127|NCT00001390|Lip Biopsy|lip biopsy
5863128|NCT00001390|Health|health
5863129|NCT00001390|Exocrine|exocrine
5863130|NCT00001390|Normal Volunteer|normal volunteer
5863131|NCT00001386|AIDS|aids
5863132|NCT00001386|Retrovirus|retrovirus
5863133|NCT00001386|Therapeutic Vaccine|therapeutic vaccine
5863134|NCT00001386|Vaccine|vaccine
5863135|NCT00001386|Helper T Cells|helper t cells
5863151|NCT00001368|Cerebral Ischemia|cerebral ischemia
5863152|NCT00001368|Hypertension|hypertension
5863153|NCT00001368|Immune Response|immune response
5863154|NCT00001368|Carotid Stenosis|carotid stenosis
5863155|NCT00001368|Atherosclerosis|atherosclerosis
5863159|NCT00001366|Seizures|seizures
5844066|NCT00050960|Bexarotene|bexarotene
5844067|NCT00050947|partial seizures|partial seizures
5844068|NCT00050934|partial seizures|partial seizures
5844069|NCT00050921|HIV Infections|hiv infections
5844070|NCT00050921|CD4 Lymphocyte Count|cd4 lymphocyte count
5844071|NCT00050921|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5844072|NCT00050921|Growth Hormone|growth hormone
5844073|NCT00050921|Cell Division|cell division
5844074|NCT00050921|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5844075|NCT00050921|Treatment Experienced|treatment experienced
5844076|NCT00050908|Brachial Artery|brachial artery
5844077|NCT00050908|Endothelium, Vascular|endothelium, vascular
5844078|NCT00050908|Vasodilation|vasodilation
5844079|NCT00050908|Nitroglycerin|nitroglycerin
5844080|NCT00050908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5844081|NCT00050908|HIV Protease Inhibitors|hiv protease inhibitors
5844082|NCT00050908|Drug Therapy, Combination|drug therapy, combination
5844083|NCT00050908|Ritonavir|ritonavir
5844084|NCT00050908|efavirenz|efavirenz
5844085|NCT00050908|lopinavir|lopinavir
5844086|NCT00050908|stavudine|stavudine
5844087|NCT00050908|lamivudine|lamivudine
5844088|NCT00050908|zidovudine|zidovudine
5844089|NCT00050908|Treatment Naive|treatment naive
5844090|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5844091|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors
5844092|NCT00050895|Drug Therapy, Combination|drug therapy, combination
5844093|NCT00050895|Delayed Action Preparations|delayed action preparations
5844094|NCT00050895|Treatment Naive|treatment naive
5844095|NCT00050895|HIV-1|hiv-1
5844096|NCT00050882|GM-611|gm-611
5845152|NCT00001435|Depression|depression
5844101|NCT00050869|Mirror Neurons|mirror neurons
5844102|NCT00050869|Performance|performance
5844103|NCT00050869|Use-Dependent Plasticity|use-dependent plasticity
5844104|NCT00050869|Attention|attention
5844105|NCT00050869|Premotor Cortex|premotor cortex
5863199|NCT00001359|Streptococcal Infections|streptococcal infections
5863200|NCT00001359|Childhood Onset Neuropsychiatric Disorder|childhood onset neuropsychiatric disorder
5863201|NCT00001357|Cytokines|cytokines
5863202|NCT00001357|Immunoregulation|immunoregulation
5863203|NCT00001357|CD4 Cells|cd4 cells
5863204|NCT00001356|IL-3|il-3
5863205|NCT00001356|Stem Cell Factor|stem cell factor
5863206|NCT00001356|Cytokines|cytokines
5863207|NCT00001356|Cell Differentiation|cell differentiation
5863208|NCT00001356|Receptors|receptors
5863209|NCT00001356|Bone Marrow|bone marrow
5863210|NCT00001356|Mastocytosis|mastocytosis
5863216|NCT00001354|AIDS|aids
5863217|NCT00001354|Immunotherapy|immunotherapy
5863218|NCT00001354|CD4 Cells|cd4 cells
5863219|NCT00001354|Immunomodulator|immunomodulator
5863220|NCT00001354|Cytokines|cytokines
5863221|NCT00001353|AIDS|aids
5863222|NCT00001353|Immune Based Therapy|immune based therapy
5863223|NCT00001353|Adoptive Immunotherapy|adoptive immunotherapy
5863224|NCT00001353|Lymphapheresis|lymphapheresis
5844106|NCT00050856|Antiretrovial Therapy|antiretrovial therapy
5844107|NCT00050856|Salvage|salvage
5844108|NCT00050856|CD4+Lymphocyte Count|cd4+lymphocyte count
5844109|NCT00050856|HIV-1 RNA Level|hiv-1 rna level
5844110|NCT00050856|Subcutaneous Injection|subcutaneous injection
5844111|NCT00050817|Embolism|embolism
5844112|NCT00050791|Obesity|obesity
5844113|NCT00050791|Weightloss|weightloss
5844114|NCT00050791|Leptin|leptin
5844115|NCT00050791|Diet|diet
5844116|NCT00050791|Reducing|reducing
5844117|NCT00050791|Overweight|overweight
5844119|NCT00050778|Multiple Sclerosis|multiple sclerosis
5844120|NCT00050778|Active Relapsing-Remitting Multiple Sclerosis|active relapsing-remitting multiple sclerosis
5844121|NCT00050804|Acute Stress Disorder|acute stress disorder
5844122|NCT00050804|PTSD|ptsd
5844123|NCT00050804|Treatment|treatment
5844124|NCT00050804|SSRI|ssri
5844125|NCT00050804|Startle|startle
5844126|NCT00050804|Psychophysiology|psychophysiology
5844127|NCT00050804|Trauma|trauma
5844128|NCT00050804|Anxiety|anxiety
5844130|NCT00050765|Myocardial Infarction|myocardial infarction
5844131|NCT00050765|Heart disease|heart disease
5844132|NCT00050765|Coronary bypass graft (CABG) surgery|coronary bypass graft (cabg) surgery
5844133|NCT00050765|Implantable Cardioverter Defibrillator (ICD)|implantable cardioverter defibrillator (icd)
5844134|NCT00050765|CABG|cabg
5844136|NCT00050765|Heart failure|heart failure
5844141|NCT00050726|Interleukin-2|interleukin-2
5844142|NCT00050726|Immunotherapy|immunotherapy
5844144|NCT00050726|IL-2|il-2
5844145|NCT00050713|Kidney Disease|kidney disease
5844146|NCT00050713|Glomerulonephritis|glomerulonephritis
5844147|NCT00050713|Lupus Nephritis|lupus nephritis
5844148|NCT00050713|Nephrotic Syndrome|nephrotic syndrome
5844149|NCT00050713|Hyperlipidemia|hyperlipidemia
5844150|NCT00050700|PET|pet
5844151|NCT00050700|[18F]FP-TZTP|[18f]fp-tztp
5844152|NCT00050700|Bipolar Disorder|bipolar disorder
5844153|NCT00050700|Major Depressive Disorder|major depressive disorder
5844154|NCT00050700|Muscarinic 2 Receptors|muscarinic 2 receptors
5844155|NCT00050674|lung cancer, oncology, neutropenia, chemotherapy, filgrastim|lung cancer, oncology, neutropenia, chemotherapy, filgrastim
5844156|NCT00050661|psoriasis|psoriasis
5844157|NCT00050661|Cyclosporine|cyclosporine
5844158|NCT00050661|Daclizamub|daclizamub
5844159|NCT00050661|anti-TAC|anti-tac
5844160|NCT00050661|dermatology|dermatology
5844161|NCT00050661|skin|skin
5844162|NCT00050661|lesions|lesions
5844163|NCT00050648|psoriasis|psoriasis
5844164|NCT00050648|Daclizumab|daclizumab
5844165|NCT00050648|Cyclosporin|cyclosporin
5844166|NCT00050648|anti-TAC|anti-tac
5844167|NCT00050648|dermatology|dermatology
5844168|NCT00050648|skin|skin
5844169|NCT00050635|chemotherapy induced diarrhea|chemotherapy induced diarrhea
5844170|NCT00050635|diarrhea|diarrhea
5863298|NCT00001328|Recurrent Tumors|recurrent tumors
5863299|NCT00001328|Primary Tumors|primary tumors
5863300|NCT00001328|Metastases|metastases
5863301|NCT00001328|Anti-Viral Drugs|anti-viral drugs
5863302|NCT00001328|Chemosensitization|chemosensitization
5863303|NCT00001328|Brain Tumors|brain tumors
5863304|NCT00001328|Gene Therapy|gene therapy
5863305|NCT00001328|Ganciclovir|ganciclovir
5863306|NCT00001327|Syringomyelia|syringomyelia
5863307|NCT00001327|Chiari Malformation|chiari malformation
5863308|NCT00001327|Magnetic Resonance Imaging|magnetic resonance imaging
5863309|NCT00001327|Intraoperative Ultrasonography|intraoperative ultrasonography
5863310|NCT00001327|Hydrocephalus|hydrocephalus
5863311|NCT00001327|Spinal Cord|spinal cord
5863312|NCT00001327|Ventriculostomy|ventriculostomy
5863313|NCT00001327|Lumbar Puncture|lumbar puncture
5863314|NCT00001327|Pressure Measurement|pressure measurement
5844171|NCT00050635|CTID|ctid
5844172|NCT00050635|colorectal cancer|colorectal cancer
5844173|NCT00050635|Sandostatin LAR Depot|sandostatin lar depot
5844174|NCT00050635|Sandostatin|sandostatin
5844175|NCT00050635|adverse events|adverse events
5844176|NCT00050635|side effects|side effects
5844177|NCT00050427|Trabectedin|trabectedin
5844178|NCT00050427|Yondelis|yondelis
5844179|NCT00050427|ET743|et743
5844180|NCT00050427|Advanced breast cancer|advanced breast cancer
5844181|NCT00050427|Breast|breast
5844182|NCT00050427|Cancer|cancer
5844183|NCT00050427|Antineoplastic Agents, Alkylating Agents|antineoplastic agents, alkylating agents
5844184|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5844185|NCT00050518|Smallpox|smallpox
5844186|NCT00050518|Aventis Pasteur|aventis pasteur
5844187|NCT00050518|Vaccine|vaccine
5844188|NCT00050505|smallpox, Dryvax, vaccine, dilution|smallpox, dryvax, vaccine, dilution
5844190|NCT00050492|Cytokine|cytokine
5844191|NCT00050492|Chemokine|chemokine
5844192|NCT00050492|Viruses|viruses
5844193|NCT00050492|Autoantibody|autoantibody
5844194|NCT00050492|Retina|retina
5844195|NCT00050492|Vasculitis|vasculitis
5844196|NCT00050492|Adhesion Molecules|adhesion molecules
5844197|NCT00050479|Types 1 and 2 diabetes|types 1 and 2 diabetes
5844198|NCT00050479|Diode Laser Photocoagulation|diode laser photocoagulation
5844199|NCT00050479|Elevated Low-Density Lipoprotein (LDL-C) Cholesterol|elevated low-density lipoprotein (ldl-c) cholesterol
5844200|NCT00050466|Normal Volunteers|normal volunteers
5844201|NCT00050466|Dynamic Light Scattering (DLS)|dynamic light scattering (dls)
5844202|NCT00050466|Corneal Opacities|corneal opacities
5844203|NCT00050466|Cornea|cornea
5844204|NCT00050466|Transparency|transparency
5844205|NCT00050466|Vision|vision
5844206|NCT00050440|Endometrial|endometrial
5844207|NCT00050440|Cancer|cancer
5844208|NCT00050440|Carcinoma|carcinoma
5844209|NCT00050440|Trabectedin|trabectedin
5844210|NCT00050440|Ecteinascidin 743|ecteinascidin 743
5844211|NCT00050440|ET743|et743
5844212|NCT00050440|Antineoplastic Agents|antineoplastic agents
5844213|NCT00050440|Alkylating Agents|alkylating agents
5844214|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action
5844215|NCT00050414|Ovarian cancer|ovarian cancer
5844216|NCT00050414|Ovary|ovary
5844217|NCT00050414|Cancer|cancer
5844218|NCT00050414|Trabectedin|trabectedin
5844219|NCT00050414|Yondelis|yondelis
5844220|NCT00050414|ET743|et743
5844221|NCT00050414|Ecteinascidin 743|ecteinascidin 743
5844222|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5844223|NCT00050414|Alkylating Agents|alkylating agents
5844224|NCT00050401|ventilator-associated|ventilator-associated
5844225|NCT00050401|nosocomial|nosocomial
5844226|NCT00011635|Caffeine|caffeine
5844227|NCT00011635|Cytochrome P 450|cytochrome p 450
5844228|NCT00011635|Dextromethorphan|dextromethorphan
5844229|NCT00011635|Drug Interaction|drug interaction
5844230|NCT00011635|Metabolism|metabolism
5844231|NCT00011635|Drug Metabolism|drug metabolism
5844232|NCT00011635|Healthy Volunteer|healthy volunteer
5844233|NCT00011635|Milk Thistle|milk thistle
5844234|NCT00011063|Anti-Epileptic|anti-epileptic
5844235|NCT00011063|CYP2C9|cyp2c9
5844236|NCT00011063|Herbal|herbal
5844237|NCT00011063|Interaction|interaction
5844239|NCT00011063|Drug Interaction|drug interaction
5863401|NCT00001306|Ovulation|ovulation
5863402|NCT00001306|Autoimmune|autoimmune
5863403|NCT00001306|Follicle|follicle
5863404|NCT00001306|Menopause|menopause
5863405|NCT00001306|Biopsy|biopsy
5863406|NCT00001306|Glucocorticoids|glucocorticoids
5863407|NCT00001306|Premature Ovarian Failure|premature ovarian failure
5863408|NCT00001306|Amenorrhea|amenorrhea
5863409|NCT00001306|Ovarian Failure|ovarian failure
5863410|NCT00001306|POF|pof
5863411|NCT00001305|Osteogenesis Imperfecta|osteogenesis imperfecta
5863412|NCT00001304|Hypoparathyroidism|hypoparathyroidism
5863413|NCT00001304|Parathyroid Hormone|parathyroid hormone
5863414|NCT00001304|Vitamin D|vitamin d
5863417|NCT00001304|Bone|bone
5844240|NCT00011063|Drug Metabolism|drug metabolism
5844241|NCT00011063|Ginko Biloba|ginko biloba
5844242|NCT00011063|Healthy Volunteer|healthy volunteer
5844243|NCT00009542|Caffeine|caffeine
5844244|NCT00009542|Cytochrome P 450|cytochrome p 450
5844245|NCT00009542|Dextromethorphan|dextromethorphan
5844246|NCT00009542|Herbal|herbal
5844247|NCT00009542|Interactions|interactions
5844248|NCT00009542|Alternative Therapy|alternative therapy
5844249|NCT00009542|Healthy Volunteer|healthy volunteer
5844250|NCT00009542|Kava|kava
5844251|NCT00006395|Antiepileptic|antiepileptic
5844252|NCT00006395|CYP3A4|cyp3a4
5844253|NCT00006395|Herbal|herbal
5844254|NCT00006395|Induction|induction
5844255|NCT00006395|Interaction|interaction
5844256|NCT00006191|Antiepileptic Drugs|antiepileptic drugs
5844257|NCT00006191|Motor Cortex|motor cortex
5844258|NCT00006191|Myoclonus|myoclonus
5844259|NCT00006191|Healthy Volunteer|healthy volunteer
5844260|NCT00006155|DNA Damage|dna damage
5844261|NCT00006155|DNA Repair|dna repair
5844262|NCT00006155|FLK-1|flk-1
5844263|NCT00006155|Pharmacokinetics|pharmacokinetics
5844264|NCT00006155|VEGF|vegf
5844265|NCT00006155|Fallopian Tube Cancer|fallopian tube cancer
5844266|NCT00006155|Ovarian Cancer|ovarian cancer
5844267|NCT00006155|Platinum-Refractory Disease|platinum-refractory disease
5844268|NCT00006071|Brachial Reactivity|brachial reactivity
5844269|NCT00006071|Endothelial Function|endothelial function
5844270|NCT00006071|Endothelial Markers|endothelial markers
5844271|NCT00006071|Forearm Flow|forearm flow
5844272|NCT00006071|Insulin Resistance|insulin resistance
5844273|NCT00006071|Elevated Cholesterol|elevated cholesterol
5844274|NCT00006071|Hypertension|hypertension
5844275|NCT00006062|Liver Impairment|liver impairment
5844276|NCT00006062|Pharmacokinetics|pharmacokinetics
5844277|NCT00006062|Platinum Analogues|platinum analogues
5844278|NCT00005926|Cancer|cancer
5844279|NCT00005926|Gemzar|gemzar
5844280|NCT00005926|Her-2/Neu|her-2/neu
5844281|NCT00005926|Pancreatic|pancreatic
5844282|NCT00005926|Radiotherapy|radiotherapy
5844283|NCT00005926|Pancreatic Cancer|pancreatic cancer
5844284|NCT00005912|Aspergillosis|aspergillosis
5844285|NCT00005912|Candidiasis|candidiasis
5844286|NCT00005912|Fungal Infections|fungal infections
5844287|NCT00005912|Fungemia|fungemia
5844288|NCT00005912|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
5844289|NCT00005912|Pediatric Fungal Infection|pediatric fungal infection
5844290|NCT00005783|Fetal Hemoglobin|fetal hemoglobin
5844291|NCT00005783|Hematopoietic Growth Factor|hematopoietic growth factor
5844292|NCT00005783|Peripheral Blood CD34 Cells|peripheral blood cd34 cells
5844293|NCT00005783|Vasoocclusive Crisis|vasoocclusive crisis
5844294|NCT00005783|Sickle Cell Anemia|sickle cell anemia
5844295|NCT00005783|Sickle Cell Disease|sickle cell disease
5844296|NCT00005783|Sickle Cell Disorder|sickle cell disorder
5844297|NCT00005781|Epidemiology|epidemiology
5844298|NCT00005781|NHANES|nhanes
5844299|NCT00005781|Photography|photography
5844300|NCT00005781|Prevalence|prevalence
5844301|NCT00005781|Skin Disease|skin disease
5844302|NCT00005781|Healthy Volunteer|healthy volunteer
5844303|NCT00005574|Becker Muscular Dystrophy|becker muscular dystrophy
5844304|NCT00005574|Duchenne Muscular Dystrophy|duchenne muscular dystrophy
5844305|NCT00005574|Muscle Disease|muscle disease
5844306|NCT00005574|Myopathy|myopathy
5844309|NCT00005570|Immune Response|immune response
5844310|NCT00005570|Pharmacogenomic|pharmacogenomic
5844311|NCT00005570|Serum Antibodies|serum antibodies
5844312|NCT00005570|ITP|itp
5844313|NCT00005570|Immune Thrombocytopenia Purpura|immune thrombocytopenia purpura
5844314|NCT00005111|Blood Flow|blood flow
5844315|NCT00005111|Glucose|glucose
5844316|NCT00005111|Lysosomal Disease|lysosomal disease
5863504|NCT00001260|Suicide|suicide
5863505|NCT00001260|Dementia|dementia
5863506|NCT00001260|Neuropsychiatric Disorders|neuropsychiatric disorders
5863507|NCT00001260|Tourette's Syndrome|tourette's syndrome
5863508|NCT00001260|Normal Controls|normal controls
5863515|NCT00001258|Neuropsychology|neuropsychology
5863516|NCT00001258|Cerebral Blood Flow|cerebral blood flow
5863517|NCT00001258|Cognitive Disorders|cognitive disorders
5863518|NCT00001258|Prefrontal Cortex|prefrontal cortex
5863519|NCT00001258|Hormones|hormones
5863520|NCT00001258|Psychosis|psychosis
5863521|NCT00001258|Neuroimaging|neuroimaging
5863522|NCT00001258|Brain Scan|brain scan
5863523|NCT00001258|Healthy Volunteers|healthy volunteers
5863524|NCT00001258|Schizophrenia|schizophrenia
5863525|NCT00001257|Lymphokines|lymphokines
5863531|NCT00001256|Cytotoxic Therapy|cytotoxic therapy
5863532|NCT00001256|Inflammation|inflammation
5863533|NCT00001256|Glomerulonephritis|glomerulonephritis
5863534|NCT00001256|Inflammatory Sinusitis|inflammatory sinusitis
5863535|NCT00001255|Retroviral Vector|retroviral vector
5863536|NCT00001255|Gene Therapy|gene therapy
5863537|NCT00001255|PEG-ADA|peg-ada
5863538|NCT00001255|Severe Combined Immunodeficiency (SCID)|severe combined immunodeficiency (scid)
5863539|NCT00001255|Adenosine Deaminase Deficiency (ADA)|adenosine deaminase deficiency (ada)
5863667|NCT00001220|Swallowing Disorders|swallowing disorders
5863541|NCT00001253|Turner's Syndrome|turner's syndrome
5863542|NCT00001253|Estrogen|estrogen
5863543|NCT00001253|Ethinyl estradiol|ethinyl estradiol
5863544|NCT00001253|Learning|learning
5863545|NCT00001253|Ovarian dysgenesis|ovarian dysgenesis
5863549|NCT00001251|Meningeal Malignancy|meningeal malignancy
5863550|NCT00001251|Pediatric|pediatric
5863551|NCT00001251|Alkylating Agents|alkylating agents
5844317|NCT00005111|Metabolic|metabolic
5844318|NCT00005111|Uptake|uptake
5844319|NCT00005111|Fabry Disease|fabry disease
5844320|NCT00005016|Fetal Anomaly|fetal anomaly
5844321|NCT00005016|Genetic Counseling|genetic counseling
5844322|NCT00005016|Prenatal Diagnosis|prenatal diagnosis
5844323|NCT00005016|Psychosocial Issues|psychosocial issues
5844324|NCT00005016|Qualitative|qualitative
5844325|NCT00005016|HPE|hpe
5844326|NCT00005016|Holoprosencephaly|holoprosencephaly
5844327|NCT00004851|HCV Antibody Library|hcv antibody library
5844328|NCT00004848|AIDS|aids
5844329|NCT00004848|Autologous Blood|autologous blood
5844330|NCT00004848|Cardiac Surgery|cardiac surgery
5844331|NCT00004848|HIV|hiv
5844332|NCT00004848|Hepatocellular Inflammation|hepatocellular inflammation
5844333|NCT00004848|Liver Biopsy|liver biopsy
5844334|NCT00004848|Long Term Sera Storage|long term sera storage
5844335|NCT00004848|Non-A Hepatitis|non-a hepatitis
5844336|NCT00004848|Non-B Hepatitis|non-b hepatitis
5844337|NCT00004576|Dyskinesias|dyskinesias
5844338|NCT00004576|Glutamate|glutamate
5863608|NCT00001240|Hypersecretion|hypersecretion
5863609|NCT00001240|Hyposecretion|hyposecretion
5863610|NCT00001240|Gastrinoma|gastrinoma
5863611|NCT00001240|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5863616|NCT00001235|Primary Neuronal Degeneration|primary neuronal degeneration
5863617|NCT00001235|Genetics|genetics
5863618|NCT00001235|Neurotransmitters|neurotransmitters
5863619|NCT00001235|DNA|dna
5863620|NCT00001235|Lymphoblasts|lymphoblasts
5863621|NCT00001235|Skin Fibroblast|skin fibroblast
5863622|NCT00001235|Alzheimer's Disease|alzheimer's disease
5863623|NCT00001234|Bone Marrow|bone marrow
5863624|NCT00001234|Retroviral-Mediated Gene Transfer|retroviral-mediated gene transfer
5863625|NCT00001234|Hematopoietic Progenitor Cell|hematopoietic progenitor cell
5863638|NCT00001228|Interferon|interferon
5863639|NCT00001228|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5863640|NCT00001226|Nonradioactive Isotopes|nonradioactive isotopes
5863641|NCT00001226|Lipoprotein Kinetics|lipoprotein kinetics
5863642|NCT00001226|Apolipoproteins|apolipoproteins
5863643|NCT00001226|Dyslipoproteinemia|dyslipoproteinemia
5863644|NCT00001226|Healthy Volunteers|healthy volunteers
5863645|NCT00001225|DNA Polymorphisms|dna polymorphisms
5863646|NCT00001225|Echocardiography|echocardiography
5844339|NCT00004576|Levodopa|levodopa
5844340|NCT00004576|Parkinson's Disease|parkinson's disease
5844341|NCT00004574|Abetalipoproteinemia|abetalipoproteinemia
5844342|NCT00004574|Ataxia|ataxia
5844343|NCT00004574|Retinitis Pigmentosa|retinitis pigmentosa
5844344|NCT00004574|Vitamin A|vitamin a
5844345|NCT00004574|Vitamin E|vitamin e
5844350|NCT00004557|Object Recognition|object recognition
5844351|NCT00004557|Spatial Processes|spatial processes
5844353|NCT00001986|Octanol|octanol
5844354|NCT00001986|Treatment|treatment
5844355|NCT00001986|Tremor|tremor
5844356|NCT00001982|Aminotransferases|aminotransferases
5844357|NCT00001982|Anti-HCV|anti-hcv
5844358|NCT00001982|Blood Donors|blood donors
5844359|NCT00001982|HCV RNA|hcv rna
5844360|NCT00001982|Hepatitis C|hepatitis c
5844361|NCT00001982|Liver Biopsy|liver biopsy
5844362|NCT00001982|Serum Aminotransferases|serum aminotransferases
5844363|NCT00001982|Transfusion|transfusion
5844364|NCT00001977|Alzheimer's Disease|alzheimer's disease
5844365|NCT00001977|Attention|attention
5844366|NCT00001977|Brain|brain
5844367|NCT00001977|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5844368|NCT00001977|Physostigmine|physostigmine
5844369|NCT00001977|Positron Emission Tomography|positron emission tomography
5844370|NCT00001977|Working Memory|working memory
5844371|NCT00001968|AIDS|aids
5844372|NCT00001968|Anti-Retroviral Therapy|anti-retroviral therapy
5844373|NCT00001968|Drug Interactions|drug interactions
5844375|NCT00001968|Protease Inhibitor|protease inhibitor
5844376|NCT00001966|Adjustment|adjustment
5844377|NCT00001966|Alternative|alternative
5844378|NCT00001966|Anxiety|anxiety
5844379|NCT00001966|Guided-Imagery|guided-imagery
5844380|NCT00001966|Meditation|meditation
5844381|NCT00001966|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5844382|NCT00001965|Calcineurin|calcineurin
5844383|NCT00001965|Cardiac Hypertrophy|cardiac hypertrophy
5844384|NCT00001965|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5844385|NCT00001963|Blood Flow|blood flow
5863709|NCT00001206|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5863710|NCT00001206|Disruptive Behavior Disorders|disruptive behavior disorders
5863711|NCT00001206|Cerebrospinal Fluid|cerebrospinal fluid
5863712|NCT00001206|Lumbar Puncture|lumbar puncture
5863713|NCT00001206|CSF|csf
5863714|NCT00001206|Longitudinal Prospective Follow-Up|longitudinal prospective follow-up
5863715|NCT00001206|Psychosocial Functioning|psychosocial functioning
5863716|NCT00001206|Risk Factors|risk factors
5863717|NCT00001206|Genetics|genetics
5863718|NCT00001205|Taenia Solium|taenia solium
5863719|NCT00001205|Neurocysticercosis|neurocysticercosis
5844386|NCT00001963|Exercise|exercise
5844387|NCT00001963|Microcirculation|microcirculation
5844388|NCT00001963|S-nitrosohemoglobin|s-nitrosohemoglobin
5844389|NCT00001963|Vasodilation|vasodilation
5844390|NCT00001963|Healthy Volunteer|healthy volunteer
5844391|NCT00001944|Drug Resistance|drug resistance
5844392|NCT00001944|MDR-1|mdr-1
5844393|NCT00001944|P-Glycoprotein Blocker|p-glycoprotein blocker
5844395|NCT00001944|Resistance Reversal|resistance reversal
5844396|NCT00001940|Antifungal Agent|antifungal agent
5844397|NCT00001940|Aspergillosis|aspergillosis
5844398|NCT00001940|Candidemia|candidemia
5844399|NCT00001940|Fungemia|fungemia
5844400|NCT00001937|Aspergillosis|aspergillosis
5844401|NCT00001937|Candidiasis|candidiasis
5844402|NCT00001937|Fungal Infections|fungal infections
5844403|NCT00001937|Fungemia|fungemia
5844404|NCT00001937|Prophylactic Antifungal Therapy|prophylactic antifungal therapy
5844405|NCT00001931|Continuous Stimulation|continuous stimulation
5844406|NCT00001931|Dose Finding|dose finding
5844407|NCT00001931|Skin Patch|skin patch
5844408|NCT00001930|Amantadine|amantadine
5844409|NCT00001930|Chorea|chorea
5844410|NCT00001930|Glutamate Antagonist|glutamate antagonist
5844411|NCT00001929|Dyskinesias|dyskinesias
5844412|NCT00001929|Glutamate Antagonist|glutamate antagonist
5844413|NCT00001929|Levodopa|levodopa
5844414|NCT00001928|Diagnosis|diagnosis
5844415|NCT00001928|Infusion|infusion
5844416|NCT00001928|Parkinsonism|parkinsonism
5844417|NCT00001918|Cognitive Function|cognitive function
5844418|NCT00001918|Depression|depression
5844419|NCT00001918|EMG|emg
5844420|NCT00001918|Eosinophilia Myalgia Syndrome|eosinophilia myalgia syndrome
5844421|NCT00001918|Impurities|impurities
5844422|NCT00001918|L-5-HTP|l-5-htp
5844423|NCT00001918|Memory Impairment|memory impairment
5844424|NCT00001918|Nerve-Muscle Biopsy|nerve-muscle biopsy
5844425|NCT00001918|Sleep Disorders|sleep disorders
5844426|NCT00001916|Bone Remodeling|bone remodeling
5844427|NCT00001916|Corticosteroids|corticosteroids
5859763|NCT00006148|Peripheral Blood Stem Cells|peripheral blood stem cells
5844428|NCT00001916|Cytokine|cytokine
5844429|NCT00001916|Depression|depression
5844430|NCT00001916|Glucocorticoids|glucocorticoids
5844431|NCT00001916|Osteopenia|osteopenia
5844432|NCT00001916|Osteoporosis|osteoporosis
5844433|NCT00001916|Primary Affective Disorder|primary affective disorder
5844434|NCT00001909|Allergy|allergy
5844435|NCT00001909|Immunomodulator|immunomodulator
5844436|NCT00001909|Inflammation|inflammation
5844437|NCT00001909|Interleukin|interleukin
5844438|NCT00001909|Th2|th2
5844439|NCT00001909|Asthma|asthma
5844440|NCT00001906|Alum|alum
5844441|NCT00001906|Antigen|antigen
5844442|NCT00001906|Cytokine|cytokine
5844443|NCT00001906|Parasitic Infection|parasitic infection
5844444|NCT00001906|Phase I|phase i
5844445|NCT00001906|Cutaneous Leishmaniasis|cutaneous leishmaniasis
5844446|NCT00001904|Atherosclerosis|atherosclerosis
5844447|NCT00001904|Cardiovascular Disease|cardiovascular disease
5844448|NCT00001904|Computerized Edge Reader|computerized edge reader
5844449|NCT00001904|Myocardial Infarction|myocardial infarction
5844450|NCT00001904|Risk Factor|risk factor
5844451|NCT00001903|Immunization|immunization
5844452|NCT00001903|Immunocompromised|immunocompromised
5844453|NCT00001903|Immunoglobulin|immunoglobulin
5844454|NCT00001903|Prophylaxis|prophylaxis
5844455|NCT00001903|Respiratory Virus|respiratory virus
5844456|NCT00001903|Bone Marrow Transplantation|bone marrow transplantation
5844457|NCT00001903|Mini-Transplantation|mini-transplantation
5844458|NCT00001903|Peripheral Stem Cell Transplantation|peripheral stem cell transplantation
5844459|NCT00001891|CABG|cabg
5844460|NCT00001891|Hibernation|hibernation
5844461|NCT00001891|LV Function|lv function
5844462|NCT00001891|Microbubbles|microbubbles
5844463|NCT00001891|Revascularization|revascularization
5844464|NCT00001891|Coronary Artery Disease|coronary artery disease
5844465|NCT00001890|Cellular Immunity|cellular immunity
5863807|NCT00001180|Cushing Syndrome|cushing syndrome
5863808|NCT00001180|Psychiatric Hypercortisolism|psychiatric hypercortisolism
5863809|NCT00001180|Adrenal Insufficiency|adrenal insufficiency
5863810|NCT00001180|Normal Volunteer|normal volunteer
5863811|NCT00001178|Alzheimer's Disease|alzheimer's disease
5863812|NCT00001178|Cerebral Metabolism|cerebral metabolism
5863813|NCT00001178|Cerebrospinal Fluid|cerebrospinal fluid
5863814|NCT00001178|Dementia of the Alzheimer Type|dementia of the alzheimer type
5863815|NCT00001178|18-F-Fluoro-2-Deoxy-D-Glucose (FDG)|18-f-fluoro-2-deoxy-d-glucose (fdg)
5863816|NCT00001178|Magnetic Resonance Imaging|magnetic resonance imaging
5863817|NCT00001178|Positron Emission Tomography|positron emission tomography
5863818|NCT00001178|X-Ray Computed Tomography (CT)|x-ray computed tomography (ct)
5863819|NCT00001178|Senile Dementia|senile dementia
5863820|NCT00001178|Down Syndrome|down syndrome
5863821|NCT00001178|Trisomy 21|trisomy 21
5863822|NCT00001177|Mood|mood
5844466|NCT00001890|Cytokines|cytokines
5844467|NCT00001890|Estrogen|estrogen
5844468|NCT00001890|Humoral Immunity|humoral immunity
5844469|NCT00001890|Progesterone|progesterone
5844470|NCT00001890|Chlamydia Pneumoniae|chlamydia pneumoniae
5844471|NCT00001890|Human Cytomegalovirus|human cytomegalovirus
5844472|NCT00001890|Postmenopause|postmenopause
5844473|NCT00001889|Microbubbles|microbubbles
5844474|NCT00001889|Myocardial Blood Flow|myocardial blood flow
5844475|NCT00001889|Myocardial Ischemia|myocardial ischemia
5844476|NCT00001889|Second Harmonics|second harmonics
5844477|NCT00001889|Ultrasound|ultrasound
5844478|NCT00001889|Coronary Artery Disease|coronary artery disease
5844479|NCT00001887|Airway Inflammation|airway inflammation
5844480|NCT00001887|Allergen Challenge|allergen challenge
5844481|NCT00001887|Bronchoscopy|bronchoscopy
5844482|NCT00001887|Cytokines|cytokines
5844483|NCT00001887|Receptors|receptors
5844484|NCT00001887|Asthma|asthma
5844485|NCT00001887|Normal Volunteer|normal volunteer
5844486|NCT00001886|Coronary Artery Disease|coronary artery disease
5844487|NCT00001886|Ischemia|ischemia
5844488|NCT00001886|Ultrasound|ultrasound
5844489|NCT00001886|Ventricular Function|ventricular function
5844490|NCT00001886|Wall Motion|wall motion
5844491|NCT00001881|Cardiac Hypertrophy|cardiac hypertrophy
5844492|NCT00001881|Genetics|genetics
5844493|NCT00001881|Phenotypes|phenotypes
5844494|NCT00001881|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5844495|NCT00001879|Liver Disease|liver disease
5844496|NCT00001879|Novel Agents|novel agents
5844497|NCT00001879|Serum|serum
5844498|NCT00001879|Viruses|viruses
5844499|NCT00001879|non-A,G Hepatitis|non-a,g hepatitis
5844500|NCT00001879|Seronegative Acute Hepatitis|seronegative acute hepatitis
5844501|NCT00001871|Genetic Mutations|genetic mutations
5844502|NCT00001871|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5844503|NCT00001871|Oculopharyngeal Muscular Dystrophy|oculopharyngeal muscular dystrophy
5844504|NCT00001867|Cytokine|cytokine
5844505|NCT00001867|Gestation|gestation
5844506|NCT00001867|Postpartum|postpartum
5844507|NCT00001867|Pregnancy|pregnancy
5844508|NCT00001867|Th 1 Lymphocyte|th 1 lymphocyte
5844509|NCT00001867|Th 2 Lymphocyte|th 2 lymphocyte
5844510|NCT00001867|Uveitis|uveitis
5844511|NCT00001857|Costimulation|costimulation
5844512|NCT00001857|Immunosuppression|immunosuppression
5844513|NCT00001857|Tolerance|tolerance
5844514|NCT00001840|Infarct|infarct
5844515|NCT00001840|Ischemia|ischemia
5844517|NCT00001840|Natural History|natural history
5844518|NCT00001840|Stroke|stroke
5844519|NCT00001840|Treatment|treatment
5844520|NCT00001840|Brain Stroke|brain stroke
5844521|NCT00001839|Anemia|anemia
5844522|NCT00001839|Immunosuppressive|immunosuppressive
5844523|NCT00001839|Phase II Trial|phase ii trial
5844524|NCT00001839|Pre-Leukemia|pre-leukemia
5844525|NCT00001839|Therapy|therapy
5844526|NCT00001839|Myelodysplastic Syndrome|myelodysplastic syndrome
5844527|NCT00001816|Anger|anger
5844528|NCT00001816|Loneliness|loneliness
5844529|NCT00001816|Mood|mood
5844530|NCT00001816|Psychosocial|psychosocial
5844531|NCT00001816|Virtual Network|virtual network
5844532|NCT00001814|Hereditary|hereditary
5844533|NCT00001814|Kidney|kidney
5844535|NCT00001814|Oncocytoma|oncocytoma
5863905|NCT00001162|Strongyloides|strongyloides
5863906|NCT00001162|Protozoa|protozoa
5863907|NCT00001162|Small Bowel Biopsy|small bowel biopsy
5863908|NCT00001162|E. Histolytica|e. histolytica
5863909|NCT00001162|Duodenal Aspiration|duodenal aspiration
5863910|NCT00001162|Coccidiosis|coccidiosis
5863911|NCT00001162|Clonorchis|clonorchis
5863912|NCT00001162|Amebiasis|amebiasis
5863913|NCT00001162|Parasitic Disease|parasitic disease
5863914|NCT00001162|Tapeworm|tapeworm
5863915|NCT00001162|Trichinosis|trichinosis
5863916|NCT00001162|Gastrointestinal Trematodes|gastrointestinal trematodes
5844536|NCT00001814|VHL|vhl
5844537|NCT00001812|Mucositis|mucositis
5844538|NCT00001812|Oral Candidiasis|oral candidiasis
5844539|NCT00001812|Prophylaxis|prophylaxis
5844540|NCT00001812|Stomatitis|stomatitis
5844541|NCT00001812|Swish and Swallow|swish and swallow
5844542|NCT00001810|Antifungal Agent|antifungal agent
5844543|NCT00001810|Aspergillosis|aspergillosis
5844544|NCT00001810|Candidiasis|candidiasis
5844545|NCT00001810|Fungemia|fungemia
5844546|NCT00001805|Breast Cancer|breast cancer
5844547|NCT00001805|Colon Cancer|colon cancer
5844548|NCT00001805|Gastric Cancer|gastric cancer
5844549|NCT00001805|Lung Cancer|lung cancer
5844550|NCT00001805|Pancreatic Cancer|pancreatic cancer
5844551|NCT00001797|Cytokines|cytokines
5844552|NCT00001797|Immunomodulation|immunomodulation
5844553|NCT00001797|Inflammation|inflammation
5844554|NCT00001797|Skin|skin
5844555|NCT00001797|Therapy|therapy
5844556|NCT00001790|Aspergillosis|aspergillosis
5844557|NCT00001790|Candidiasis|candidiasis
5844558|NCT00001790|Empiric Therapy|empiric therapy
5844559|NCT00001790|Fungal Infection|fungal infection
5844560|NCT00001790|Fungemia|fungemia
5844561|NCT00001789|Autoantibody|autoantibody
5844562|NCT00001789|Autoimmunity|autoimmunity
5844563|NCT00001789|Inflammation|inflammation
5844564|NCT00001789|Kidney|kidney
5844565|NCT00001789|Lymphocyte|lymphocyte
5844566|NCT00001789|Proliferative Lupus Glomerulonephritis|proliferative lupus glomerulonephritis
5844567|NCT00001789|SLE-GN|sle-gn
5844568|NCT00001782|Deafness|deafness
5844569|NCT00001782|Hemisphere Dominance|hemisphere dominance
5844571|NCT00001782|Plasticity|plasticity
5844572|NCT00001782|Speech|speech
5844573|NCT00001782|rTMS|rtms
5844574|NCT00001777|Frontal Lobe Dementia|frontal lobe dementia
5844575|NCT00001777|Serotonergic Transmission|serotonergic transmission
5844576|NCT00001774|Acetylcholine|acetylcholine
5844577|NCT00001774|Blood Flow|blood flow
5844578|NCT00001774|Blood vessel|blood vessel
5844579|NCT00001774|Resistance|resistance
5844580|NCT00001774|Sodium Nitroprusside|sodium nitroprusside
5844581|NCT00001774|Fabry Disease|fabry disease
5844582|NCT00001774|Normal Volunteer|normal volunteer
5844583|NCT00001772|Bipolar Disorder|bipolar disorder
5844584|NCT00001772|Rapid Cycling|rapid cycling
5844585|NCT00001772|Screening|screening
5844586|NCT00001768|Autoimmunity|autoimmunity
5844587|NCT00001768|Childhood Onset Schizophrenia|childhood onset schizophrenia
5844588|NCT00001768|Intravenous Gammaglobulin|intravenous gammaglobulin
5844589|NCT00001763|AIDS|aids
5844590|NCT00001763|Cell Mediated Immunity|cell mediated immunity
5844591|NCT00001763|Cytokine|cytokine
5844593|NCT00001763|Thl Response|thl response
5844594|NCT00001761|Autoimmunity|autoimmunity
5844595|NCT00001761|Cytokine|cytokine
5844596|NCT00001761|Inflammation|inflammation
5844597|NCT00001761|Interleukin|interleukin
5844598|NCT00001761|Vasculitis|vasculitis
5844599|NCT00001761|Wegener's Granulomatosis|wegener's granulomatosis
5844600|NCT00001759|Allergy|allergy
5844601|NCT00001759|Fluorodeoxyglucose|fluorodeoxyglucose
5844602|NCT00001759|Imaging|imaging
5844603|NCT00001759|PET|pet
5844604|NCT00001759|Wegener's Granulomatosis|wegener's granulomatosis
5844605|NCT00001759|Asthma|asthma
5844606|NCT00001757|Azole|azole
5844607|NCT00001757|Immunocompromised|immunocompromised
5844608|NCT00001757|Mycosis|mycosis
5844609|NCT00001757|Invasive Fungal Infection|invasive fungal infection
5844610|NCT00001757|Systemic Fungal Infection|systemic fungal infection
5844611|NCT00001754|Dwarfism|dwarfism
5844612|NCT00001754|Gene Mapping|gene mapping
5844613|NCT00001754|Linkage|linkage
5844614|NCT00001754|Mutation Analysis|mutation analysis
5844615|NCT00001754|Skeletal Biology|skeletal biology
5844616|NCT00001754|Brachydactyly Types C & E|brachydactyly types c & e
5844617|NCT00001754|Cartilage-Hair Hypoplasia|cartilage-hair hypoplasia
5844618|NCT00001754|Ellis Van Crevald|ellis van crevald
5844619|NCT00001754|FgFR-3|fgfr-3
5844620|NCT00001754|Proximal Symphalangism|proximal symphalangism
5844621|NCT00001754|Pyknodysotosis|pyknodysotosis
5844622|NCT00001754|Schmid Metaphyseal|schmid metaphyseal
5844623|NCT00001754|Short Stature|short stature
5844624|NCT00001754|Skeletal Dysplasia|skeletal dysplasia
5844625|NCT00001754|Type II Collagen Disorder|type ii collagen disorder
5844626|NCT00001753|Exercise|exercise
5844627|NCT00001753|MRI|mri
5844628|NCT00001753|MRS|mrs
5844629|NCT00001753|Normal Volunteer|normal volunteer
5844630|NCT00001753|Tibialix Anterior|tibialix anterior
5844631|NCT00001752|Adhesion Molecules|adhesion molecules
5844632|NCT00001752|Endothelial Function|endothelial function
5844633|NCT00001752|Inflammation|inflammation
5844634|NCT00001752|Lipoproteins|lipoproteins
5844635|NCT00001752|Nitric Oxide|nitric oxide
5844636|NCT00001752|Hormone Therapy|hormone therapy
5844637|NCT00001752|Postmenopausal Women|postmenopausal women
5844638|NCT00001748|Cyclophosphamide|cyclophosphamide
5844639|NCT00001748|Donor Apheresis|donor apheresis
5844640|NCT00001748|Graft vs. Host Disease|graft vs. host disease
5844641|NCT00001748|Graft-Versus-Leukemia|graft-versus-leukemia
5844642|NCT00001748|Leukemic Relapse|leukemic relapse
5844643|NCT00001748|Myeloma|myeloma
5844644|NCT00001748|Peripheral Blood Stem Cells|peripheral blood stem cells
5844645|NCT00001748|Whole Body Irradiation|whole body irradiation
5844646|NCT00001748|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5844647|NCT00001748|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5844648|NCT00001748|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5844649|NCT00001748|Hematological Malignancies|hematological malignancies
5844650|NCT00001748|Myelodysplastic Syndrome|myelodysplastic syndrome
5844651|NCT00001748|Myeloproliferative Disorders|myeloproliferative disorders
5844652|NCT00001747|Brachial Artery|brachial artery
5844653|NCT00001747|Doppler|doppler
5844654|NCT00001747|Endothelium|endothelium
5844655|NCT00001747|Nitric Oxide|nitric oxide
5844656|NCT00001747|Nitroglycerin|nitroglycerin
5844657|NCT00001747|Normal Volunteer|normal volunteer
5844658|NCT00001742|Acetylcholine|acetylcholine
5844659|NCT00001742|Aspirin|aspirin
5844660|NCT00001742|Nitric Oxide|nitric oxide
5844661|NCT00001742|Sodium Nitroprusside|sodium nitroprusside
5844662|NCT00001742|Hypercholesterolemia|hypercholesterolemia
5844663|NCT00001742|Hypertension|hypertension
5844664|NCT00001740|Cardiac|cardiac
5844665|NCT00001740|Function|function
5844666|NCT00001740|MRI|mri
5844667|NCT00001740|Reconstruction|reconstruction
5844669|NCT00001740|Heart Disease (Cardiovascular Disease)|heart disease (cardiovascular disease)
5844670|NCT00001738|Intermediate Uveitis|intermediate uveitis
5844671|NCT00001738|Pars Planitis|pars planitis
5844672|NCT00001738|Retinal Vasculature|retinal vasculature
5844673|NCT00001738|Uveitis|uveitis
5844674|NCT00001738|Vascular Permeability|vascular permeability
5844675|NCT00001738|Vitreous|vitreous
5844676|NCT00001736|Corneal Crystals|corneal crystals
5844677|NCT00001736|Cysteamine|cysteamine
5844678|NCT00001736|Cystinosis|cystinosis
5844679|NCT00001736|Eye|eye
5844680|NCT00001735|Gene Therapy|gene therapy
5844681|NCT00001735|Graft|graft
5844682|NCT00001735|Ornithine|ornithine
5844683|NCT00001735|Retina|retina
5844684|NCT00001735|Retinovirus|retinovirus
5844685|NCT00001735|Retrovirus|retrovirus
5844686|NCT00001735|Skin|skin
5844687|NCT00001735|Gyrate Atrophy|gyrate atrophy
5844688|NCT00001731|Conjunctiva|conjunctiva
5844689|NCT00001731|Dry Eyes|dry eyes
5844690|NCT00001731|Inflammation|inflammation
5844691|NCT00001731|Lacrimal Gland|lacrimal gland
5844692|NCT00001731|T Lymphocyte|t lymphocyte
5844693|NCT00001731|Keratoconjunctivitis Sicca|keratoconjunctivitis sicca
5844694|NCT00001730|Ablation|ablation
5844695|NCT00001730|Activity-Time Curves|activity-time curves
5844696|NCT00001730|Iodine Biokinetics|iodine biokinetics
5844697|NCT00001730|Thyroid Carcinoma|thyroid carcinoma
5844698|NCT00001730|Thyroid Remnant|thyroid remnant
5844699|NCT00001718|Biofeedback|biofeedback
5844700|NCT00001718|Swallowing|swallowing
5844701|NCT00001718|Swallowing Therapy|swallowing therapy
5844702|NCT00001718|Tongue/Palate|tongue/palate
5844703|NCT00001718|Ultrasound|ultrasound
5844704|NCT00001718|Dysphagia|dysphagia
5844705|NCT00001717|Compensation|compensation
5844706|NCT00001717|Motivations|motivations
5844707|NCT00001717|Volunteers|volunteers
5844708|NCT00001717|HIV|hiv
5844709|NCT00001714|MRI|mri
5844710|NCT00001714|Macromolecules|macromolecules
5844711|NCT00001714|Magnetization Transfer|magnetization transfer
5844712|NCT00001714|Metabolites|metabolites
5844713|NCT00001714|Tissue Characterization|tissue characterization
5844714|NCT00001714|Normal Volunteer|normal volunteer
5844715|NCT00001705|Antigen|antigen
5842139|NCT00003538|stage III childhood Hodgkin lymphoma|stage iii childhood hodgkin lymphoma
5844717|NCT00001705|Immunotherapy|immunotherapy
5844718|NCT00001699|AIDS|aids
5844719|NCT00001699|Compliance|compliance
5844720|NCT00001699|HIV|hiv
5844721|NCT00001699|Medication|medication
5844722|NCT00001699|Perceived Threat|perceived threat
5844723|NCT00001699|Teenagers|teenagers
5850267|NCT00025857|Emotion|emotion
5844724|NCT00001696|Anti-metastatic|anti-metastatic
5844725|NCT00001696|Chemoprevention|chemoprevention
5844726|NCT00001696|Isoflavinoid|isoflavinoid
5844727|NCT00001696|Prostate Cancer|prostate cancer
5844728|NCT00001696|Signal Transduction|signal transduction
5844730|NCT00001685|IL-12|il-12
5844731|NCT00001685|IL-2|il-2
5844732|NCT00001685|Immunotherapy|immunotherapy
5844733|NCT00001685|Vaccine|vaccine
5844734|NCT00001681|Cytokines|cytokines
5844735|NCT00001681|Gene Regulation|gene regulation
5844736|NCT00001681|Immunization|immunization
5844737|NCT00001681|Influenza|influenza
5844738|NCT00001681|Pathogenesis|pathogenesis
5844739|NCT00001680|Double-masked|double-masked
5844740|NCT00001680|Neuropathy|neuropathy
5844741|NCT00001680|Occlusive Dressing|occlusive dressing
5844742|NCT00001680|Pilot|pilot
5844743|NCT00001680|Placebo|placebo
5844744|NCT00001679|Immunogenetics|immunogenetics
5844745|NCT00001679|Joint Damage|joint damage
5844746|NCT00001679|Reactive Arthritis|reactive arthritis
5844747|NCT00001679|Rheumatoid Arthritis|rheumatoid arthritis
5844748|NCT00001679|Synovium|synovium
5844749|NCT00001679|Synovitis|synovitis
5844750|NCT00001677|Immunosuppression|immunosuppression
5844751|NCT00001677|Lymphocytes|lymphocytes
5844752|NCT00001677|Magnetic Resonance|magnetic resonance
5844753|NCT00001677|Synovial Biopsy|synovial biopsy
5844754|NCT00001677|Synovitis|synovitis
5844755|NCT00001677|Rheumatoid Arthritis|rheumatoid arthritis
5844756|NCT00001672|Brain Mapping|brain mapping
5844757|NCT00001672|Cognition|cognition
5844758|NCT00001672|Noninvasive|noninvasive
5844759|NCT00001672|Temporal Lobe|temporal lobe
5844760|NCT00001672|Visual Naming|visual naming
5844762|NCT00001669|EDSS|edss
5844763|NCT00001669|MRI|mri
5844764|NCT00001669|SNRS|snrs
5844765|NCT00001669|Multiple Sclerosis|multiple sclerosis
5844766|NCT00001668|Deafness|deafness
5844767|NCT00001668|Hemangioblastoma|hemangioblastoma
5844768|NCT00001668|Papillary Carcinoma|papillary carcinoma
5844769|NCT00001668|VHL Gene|vhl gene
5844770|NCT00001668|Vestibular Function|vestibular function
5844771|NCT00001668|von Hippel-Lindau Disease|von hippel-lindau disease
5844772|NCT00001667|Family Studies|family studies
5844773|NCT00001667|Genetic|genetic
5844774|NCT00001667|Myoclonus|myoclonus
5844775|NCT00001667|Tics|tics
5844776|NCT00001667|Tremor|tremor
5844777|NCT00001667|Movement Disorders|movement disorders
5844778|NCT00001667|Neurological Disease|neurological disease
5844779|NCT00001665|Magnetic Stimulation|magnetic stimulation
5844780|NCT00001665|Motor Skills|motor skills
5844781|NCT00001665|Parkinson's Disease|parkinson's disease
5844782|NCT00001665|rTMS|rtms
5844783|NCT00001658|Amoxicillin|amoxicillin
5844784|NCT00001658|Antibiotics|antibiotics
5844785|NCT00001658|Cytokines|cytokines
5844786|NCT00001658|Group A beta-Hemolytic Strep Infections|group a beta-hemolytic strep infections
5844787|NCT00001658|Obsessive Compulsive Disorder|obsessive compulsive disorder
5844788|NCT00001658|Streptococcal Infection|streptococcal infection
5844789|NCT00001658|Tic Disorders|tic disorders
5844790|NCT00001657|15 O PET Scanning|15 o pet scanning
5844791|NCT00001657|Anxiety|anxiety
5844792|NCT00001657|Cerebral Blood Flow|cerebral blood flow
5844793|NCT00001657|Depression|depression
5844794|NCT00001657|Domestic Abuse|domestic abuse
5844795|NCT00001657|Neuroendocrine|neuroendocrine
5844796|NCT00001657|PET Scanning|pet scanning
5844797|NCT00001657|Police Officers|police officers
5844798|NCT00001657|Post Traumatic Stress Disorder|post traumatic stress disorder
5844799|NCT00001657|Repetitive Transcranial Magnetic Stimulation|repetitive transcranial magnetic stimulation
5844800|NCT00001646|Aspergillus|aspergillus
5844801|NCT00001646|Azole|azole
5844802|NCT00001646|Immunocompromise|immunocompromise
5844803|NCT00001642|Chromosomal Deletion|chromosomal deletion
5844804|NCT00001642|Mutations|mutations
5844805|NCT00001642|Paucity of Bile Ducts|paucity of bile ducts
5844806|NCT00001642|Physical Map|physical map
5844807|NCT00001642|Transcript Identification|transcript identification
5844808|NCT00001642|Alagille Syndrome|alagille syndrome
5844809|NCT00001642|Syndromic Bile Duct Paucity|syndromic bile duct paucity
5844810|NCT00001639|Gene Dosage|gene dosage
5844811|NCT00001639|Haploinsufficiency|haploinsufficiency
5844812|NCT00001639|Karyotype|karyotype
5844813|NCT00001639|Malformations|malformations
5844814|NCT00001639|Mental Retardation|mental retardation
5844815|NCT00001633|Contrast Media|contrast media
5844816|NCT00001633|Coronary Artery Disease|coronary artery disease
5844817|NCT00001633|Coronary Vessels|coronary vessels
5844818|NCT00001633|Magnetic Resonance Angiography|magnetic resonance angiography
5844819|NCT00001633|Magnetic Resonance Imaging|magnetic resonance imaging
5844820|NCT00001629|Angiotensin AT-1 Receptor|angiotensin at-1 receptor
5844821|NCT00001629|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
5844822|NCT00001629|Atherosclerosis|atherosclerosis
5844823|NCT00001629|Blood Flow|blood flow
5844824|NCT00001629|Cold Pressor Test|cold pressor test
5844825|NCT00001629|Endothelium|endothelium
5844826|NCT00001629|Exercise|exercise
5844827|NCT00001629|Coronary Artery Disease|coronary artery disease
5844828|NCT00001629|Heart Failure|heart failure
5844829|NCT00001628|Angiotensin Receptor Antagonist|angiotensin receptor antagonist
5844830|NCT00001628|Atherosclerosis|atherosclerosis
5844831|NCT00001628|Blood Flow|blood flow
5844832|NCT00001628|Endothelium|endothelium
5844833|NCT00001628|Endothelial Dysfunction|endothelial dysfunction
5844834|NCT00001624|BQ-123|bq-123
5844835|NCT00001624|Endothelin|endothelin
5844836|NCT00001624|Insulin|insulin
5844837|NCT00001624|Plethysmography|plethysmography
5844838|NCT00001624|Vasoconstriction|vasoconstriction
5844839|NCT00001624|Healthy Volunteer|healthy volunteer
5844840|NCT00001622|Endothelium|endothelium
5845258|NCT00001375|Synovitis|synovitis
5844841|NCT00001622|Hypercholesterolemia|hypercholesterolemia
5844842|NCT00001622|Hypertension|hypertension
5844843|NCT00001622|Microvessels|microvessels
5844844|NCT00001622|Vasodilation|vasodilation
5844845|NCT00001622|Normal Volunteer|normal volunteer
5844847|NCT00001617|Cataract|cataract
5844848|NCT00001617|Eye|eye
5844849|NCT00001617|Human Lens|human lens
5844850|NCT00001617|Normal Volunteer|normal volunteer
5844851|NCT00001615|Age-Related Macular Degeneration|age-related macular degeneration
5844852|NCT00001615|Choroidal Neovascularization|choroidal neovascularization
5844853|NCT00001615|Disciform|disciform
5844854|NCT00001615|Drusen|drusen
5844855|NCT00001615|Natural History|natural history
5844856|NCT00001615|Periocular|periocular
5844857|NCT00001615|Quality of Life|quality of life
5844858|NCT00001615|Steroids|steroids
5844859|NCT00001615|Corticosteroid|corticosteroid
5844860|NCT00001614|Eye|eye
5844861|NCT00001614|Immunosuppression|immunosuppression
5844862|NCT00001614|Inflammation|inflammation
5847709|NCT00038415|CLL|cll
5844864|NCT00001614|Joint|joint
5844865|NCT00001614|Oral Tolerance|oral tolerance
5844866|NCT00001614|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5844867|NCT00001614|Uveitis|uveitis
5844868|NCT00001612|Diabetic Retinopathy|diabetic retinopathy
5844869|NCT00001612|Long-Term Visual Outcome|long-term visual outcome
5844870|NCT00001612|Photocoagulation|photocoagulation
5844871|NCT00001612|J. H. Wilmer Eye Institute|j. h. wilmer eye institute
5844872|NCT00001605|Conjugate Vaccine|conjugate vaccine
5844873|NCT00001605|Detoxified Lipooligosaccharide|detoxified lipooligosaccharide
5844874|NCT00001605|Tetanus Toxoid|tetanus toxoid
5844875|NCT00001605|Normal Volunteers|normal volunteers
5844876|NCT00001587|Hyperthermia|hyperthermia
5844877|NCT00001587|Metastases|metastases
5844878|NCT00001587|Organ Perfusion|organ perfusion
5844879|NCT00001587|Regional Therapy|regional therapy
5844880|NCT00001584|Pathogenesis|pathogenesis
5844882|NCT00001584|Sanctuary Sites|sanctuary sites
5844883|NCT00001584|Semen|semen
5844884|NCT00001584|Sexual Transmission|sexual transmission
5844885|NCT00001579|Biochemical Modulation|biochemical modulation
5844886|NCT00001579|Dihydropyrimidine Dehydrogenase|dihydropyrimidine dehydrogenase
5844887|NCT00001579|Oral Administration|oral administration
5844888|NCT00001579|Pharmacokinetics|pharmacokinetics
5844889|NCT00001577|Chemotherapy|chemotherapy
5844890|NCT00001577|Hyperthermia|hyperthermia
5844891|NCT00001577|Isolation perfusion|isolation perfusion
5844892|NCT00001577|Regional Therapy|regional therapy
5844893|NCT00001573|Glioma|glioma
5844894|NCT00001573|PDGF|pdgf
5844895|NCT00001573|Pharmacokinetics|pharmacokinetics
5844896|NCT00001573|Sarcoma|sarcoma
5844897|NCT00001573|Toxicity|toxicity
5844898|NCT00001571|Cancer|cancer
5844899|NCT00001571|DDT, PCB|ddt, pcb
5844900|NCT00001571|Epidemiology|epidemiology
5844901|NCT00001571|Pesticides|pesticides
5844902|NCT00001571|Serum|serum
5844903|NCT00001570|Cytochrome P 450|cytochrome p 450
5844904|NCT00001570|Multi-Drug Resistance|multi-drug resistance
5844905|NCT00001570|P-Glycoprotein|p-glycoprotein
5844906|NCT00001570|Pharmacokinetics|pharmacokinetics
5844907|NCT00001565|Brain Tumors|brain tumors
5844908|NCT00001565|Differentiation|differentiation
5844909|NCT00001565|Maximally Tolerated Dose|maximally tolerated dose
5844910|NCT00001565|Neuroblastoma|neuroblastoma
5844911|NCT00001565|Phenylacetate|phenylacetate
5844912|NCT00001554|Cortical Localization|cortical localization
5844913|NCT00001554|Optical Imaging|optical imaging
5844914|NCT00001554|Thermal Imaging|thermal imaging
5844915|NCT00001553|Plasticity|plasticity
5844916|NCT00001553|Recovery|recovery
5844917|NCT00001553|Stroke|stroke
5844918|NCT00001553|Use|use
5844919|NCT00001553|Cortico-subcortical Stroke|cortico-subcortical stroke
5844920|NCT00001546|Biochemical Screening|biochemical screening
5844921|NCT00001546|Body Temperature|body temperature
5844922|NCT00001546|Consent Form|consent form
5844923|NCT00001546|EEG|eeg
5844924|NCT00001546|EKG|ekg
5844925|NCT00001546|Melatonin|melatonin
5844926|NCT00001546|Mood|mood
5844927|NCT00001546|Physical Examination|physical examination
5844928|NCT00001546|Psychiatric Examination|psychiatric examination
5844929|NCT00001546|Sleep Duration|sleep duration
5844930|NCT00001546|Sleep Disorders|sleep disorders
5844931|NCT00001540|Diagnostic|diagnostic
5844932|NCT00001540|Immune Function|immune function
5844933|NCT00001540|Immunization|immunization
5844934|NCT00001540|Immunodeficiency|immunodeficiency
5844935|NCT00001540|Quantitative|quantitative
5844936|NCT00001538|AIDS|aids
5844937|NCT00001538|DNA Vaccine|dna vaccine
5844938|NCT00001538|Naked DNA|naked dna
5844939|NCT00001538|Plasmid|plasmid
5844940|NCT00001538|gp 160|gp 160
5844941|NCT00001536|Disability|disability
5844942|NCT00001536|Dwarfism|dwarfism
5844943|NCT00001536|Ethics in Genetic Counseling|ethics in genetic counseling
5844944|NCT00001536|Quality of Life|quality of life
5844945|NCT00001536|Reproductive Issues|reproductive issues
5844946|NCT00001536|Support Groups|support groups
5844947|NCT00001536|Achondroplasia|achondroplasia
5844948|NCT00001533|Anemia|anemia
5844949|NCT00001533|Chronic T Cell Lymphocytosis with Neutropenia|chronic t cell lymphocytosis with neutropenia
5844950|NCT00001533|Immunosuppression|immunosuppression
5844951|NCT00001533|Neutropenia|neutropenia
5844952|NCT00001533|T-LGL Leukemia|t-lgl leukemia
5844953|NCT00001531|Atherogenesis|atherogenesis
5844954|NCT00001531|Cell Mediated Immunity|cell mediated immunity
5844955|NCT00001531|Coronary Artery Disease|coronary artery disease
5844956|NCT00001530|Cardiac Hypertrophy|cardiac hypertrophy
5844957|NCT00001530|Drug-Refractory|drug-refractory
5844958|NCT00001530|Hemodynamic Benefits|hemodynamic benefits
5844959|NCT00001530|Obstruction|obstruction
5844960|NCT00001530|Pacemaker Therapy|pacemaker therapy
5844961|NCT00001530|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5844962|NCT00001528|Coronary Artery Disease|coronary artery disease
5844963|NCT00001528|Gated Blood Pool Tomography|gated blood pool tomography
5844964|NCT00001528|Myocardial Blood Flow|myocardial blood flow
5844965|NCT00001528|Myocardial Stunning|myocardial stunning
5847837|NCT00037960|CVA|cva
5844966|NCT00001528|Positron Emission Tomography|positron emission tomography
5844968|NCT00001527|BQ-788|bq-788
5844969|NCT00001527|Endothelin|endothelin
5844970|NCT00001527|Endothelium|endothelium
5844971|NCT00001527|Plethysmography|plethysmography
5844972|NCT00001527|Essential Hypertension|essential hypertension
5844973|NCT00001523|Cytology|cytology
5844974|NCT00001523|Diagnostic Imaging|diagnostic imaging
5844975|NCT00001523|Radiation Damage|radiation damage
5844976|NCT00001523|Saliva|saliva
5844977|NCT00001523|Serostomia|serostomia
5844978|NCT00001523|Xerostomia|xerostomia
5844979|NCT00001523|Head Cancer|head cancer
5844980|NCT00001523|Neck Cancer|neck cancer
5844981|NCT00001520|Endotracheal Intubation|endotracheal intubation
5844982|NCT00001520|Neuromuscular Blockade|neuromuscular blockade
5844983|NCT00001520|Neuromuscular Blocking Agents|neuromuscular blocking agents
5844984|NCT00001520|Paralysis|paralysis
5844985|NCT00001520|Reversal Agents|reversal agents
5844986|NCT00001519|Exercise|exercise
5844987|NCT00001519|Exercise Intensity|exercise intensity
5844988|NCT00001519|Non-Linear Regression|non-linear regression
5844989|NCT00001519|Oxygen Uptake|oxygen uptake
5844990|NCT00001519|Recovery|recovery
5844991|NCT00001519|Subject Comparison|subject comparison
5844992|NCT00001519|Time Constant|time constant
5844994|NCT00001518|Groshong Catheter|groshong catheter
5844995|NCT00001518|Heparinized Flush Solution|heparinized flush solution
5844996|NCT00001518|Intraluminal Clot|intraluminal clot
5844997|NCT00001518|Urokinase|urokinase
5844998|NCT00001518|Venous Access Device|venous access device
5844999|NCT00001518|Withdrawal Occlusion|withdrawal occlusion
5845000|NCT00001509|Differentiation|differentiation
5845001|NCT00001509|N-myc Expression|n-myc expression
5845002|NCT00001509|Retinoid|retinoid
5845003|NCT00001509|Solid Tumor|solid tumor
5845004|NCT00001509|Trk Expression|trk expression
5845005|NCT00001502|Blood-Brain Barrier|blood-brain barrier
5845006|NCT00001502|Bradykinin|bradykinin
5845007|NCT00001502|Children|children
5845008|NCT00001502|Glioma|glioma
5845009|NCT00001502|Medulloblastoma|medulloblastoma
5845010|NCT00001499|Carcinoma|carcinoma
5845011|NCT00001499|Combination Chemotherapy|combination chemotherapy
5845012|NCT00001499|Combined Modality Therapy|combined modality therapy
5845013|NCT00001499|Infusion|infusion
5845014|NCT00001499|Intravenous|intravenous
5845015|NCT00001499|Lung Neoplasm|lung neoplasm
5845016|NCT00001499|Non-Small Cell Lung Cancer|non-small cell lung cancer
5845017|NCT00001498|5-Fluorouracil|5-fluorouracil
5845018|NCT00001498|Cyclophosphamide|cyclophosphamide
5845019|NCT00001498|Methotrexate|methotrexate
5845020|NCT00001498|Thiotepa|thiotepa
5845021|NCT00001497|Brain Imaging|brain imaging
5845022|NCT00001497|Encephalopathy|encephalopathy
5845023|NCT00001497|Hyperactivity|hyperactivity
5845024|NCT00001497|Neuroimmunology|neuroimmunology
5845025|NCT00001497|Reaction Time Tasks|reaction time tasks
5845026|NCT00001495|Camptothecin|camptothecin
5845027|NCT00001495|Cancer|cancer
5845028|NCT00001495|Chemotherapy|chemotherapy
5845029|NCT00001495|Natural Products|natural products
5845030|NCT00001495|Neoplasms|neoplasms
5845031|NCT00001493|Dose Intensity|dose intensity
5845032|NCT00001493|Gene Therapy|gene therapy
5845033|NCT00001493|Multidrug Resistance|multidrug resistance
5845034|NCT00001489|Cerebral Metabolism|cerebral metabolism
5845035|NCT00001489|Complex Partial Seizures|complex partial seizures
5845036|NCT00001489|Epilepsy|epilepsy
5845037|NCT00001485|Chemical Mediators|chemical mediators
5845038|NCT00001485|Circadian Rhythms|circadian rhythms
5845039|NCT00001485|Gender Differences|gender differences
5845040|NCT00001485|Melatonin|melatonin
5845041|NCT00001485|Photoperiodism|photoperiodism
5845042|NCT00001485|Seasonal Changes|seasonal changes
5845043|NCT00001482|Anticonvulsants|anticonvulsants
5845044|NCT00001482|Bipolar Disorder|bipolar disorder
5845045|NCT00001482|Depression|depression
5845046|NCT00001482|Gabapentin|gabapentin
5845047|NCT00001482|Lamotrigine|lamotrigine
5845048|NCT00001482|Mania|mania
5845049|NCT00001482|Mood Disorders|mood disorders
5845050|NCT00001479|ACTH|acth
5845051|NCT00001479|Adrenocorticotropic Hormone|adrenocorticotropic hormone
5845052|NCT00001479|Antidepressant Treatment|antidepressant treatment
5845053|NCT00001479|Chaos Theory|chaos theory
5845054|NCT00001479|Chronic Fatigue Syndrome|chronic fatigue syndrome
5845055|NCT00001479|Major Depression|major depression
5845056|NCT00001479|Normal Volunteer|normal volunteer
5845057|NCT00001479|Primary Affective Disorder|primary affective disorder
5845058|NCT00001478|Bupropion|bupropion
5845059|NCT00001478|Carbamazepine|carbamazepine
5845060|NCT00001478|Cerebral Blood Flow|cerebral blood flow
5845061|NCT00001478|Gabapentin|gabapentin
5845062|NCT00001478|Lamotrigine|lamotrigine
5845063|NCT00001478|Mood Disorders|mood disorders
5845064|NCT00001478|Nimodipine|nimodipine
5845065|NCT00001478|Oxygen-15|oxygen-15
5845066|NCT00001478|Positron Emission Tomography|positron emission tomography
5845067|NCT00001478|Venlafaxine|venlafaxine
5845068|NCT00001477|Communicable Infection|communicable infection
5845069|NCT00001477|Monitoring|monitoring
5845070|NCT00001477|Non-Invasive Tests|non-invasive tests
5845071|NCT00001477|Opportunistic Infection|opportunistic infection
5845072|NCT00001468|Behavioral and Attitudinal Changes|behavioral and attitudinal changes
5845073|NCT00001468|Breast Cancer|breast cancer
5845074|NCT00001468|High Risk Families|high risk families
5845075|NCT00001468|Inherited Susceptibility|inherited susceptibility
5845076|NCT00001468|Psychological Responses to Risk|psychological responses to risk
5845077|NCT00001466|Clinical Genetics|clinical genetics
5845078|NCT00001466|Etiology|etiology
5845079|NCT00001466|Medical Screening|medical screening
5845080|NCT00001466|Prognosis|prognosis
5845081|NCT00001466|Genetic Disorders|genetic disorders
5845082|NCT00001462|Alpha 1-Antitrypsin Deficiency|alpha 1-antitrypsin deficiency
5845083|NCT00001462|Emphysema|emphysema
5845084|NCT00001462|Genetic Diseases|genetic diseases
5845085|NCT00001462|Inflammation|inflammation
5845086|NCT00001462|Nitric Oxide|nitric oxide
5845087|NCT00001462|Protease|protease
5845088|NCT00001461|Angiotensin Converting Enzyme|angiotensin converting enzyme
5854343|NCT00001110|Viremia|viremia
5845089|NCT00001461|Angiotensin Converting Enzyme Inhibitors|angiotensin converting enzyme inhibitors
5845090|NCT00001461|Bradykinin|bradykinin
5845091|NCT00001461|Endothelial Function|endothelial function
5845093|NCT00001461|Coronary Artery Disease|coronary artery disease
5845094|NCT00001459|Gated Blood Pool|gated blood pool
5845095|NCT00001459|SPECT Scan|spect scan
5845096|NCT00001459|Coronary Artery Disease|coronary artery disease
5845097|NCT00001459|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5845098|NCT00001459|Microvascular Angina|microvascular angina
5845099|NCT00001455|Genetics|genetics
5845100|NCT00001455|Hemochromatosis|hemochromatosis
5845101|NCT00001455|Iron Metabolism|iron metabolism
5845102|NCT00001455|Iron Storage Disorder|iron storage disorder
5845103|NCT00001455|Pedigree|pedigree
5845104|NCT00001455|Iron Overload|iron overload
5845105|NCT00001450|Chemotherapy|chemotherapy
5845106|NCT00001450|In Vitro Testing|in vitro testing
5845107|NCT00001450|Infusional|infusional
5845108|NCT00001450|Lung Neoplasm|lung neoplasm
5845109|NCT00001450|Pharmacokinetics|pharmacokinetics
5845110|NCT00001449|Anti-Cancer Agents|anti-cancer agents
5845111|NCT00001449|Antimetabolite|antimetabolite
5845112|NCT00001449|Palliation|palliation
5845113|NCT00001449|Pharmacodynamics|pharmacodynamics
5845114|NCT00001449|Pharmacokinetics|pharmacokinetics
5845115|NCT00001448|Antifungal Therapy|antifungal therapy
5845116|NCT00001448|Articulation|articulation
5845117|NCT00001448|Behavior|behavior
5845118|NCT00001448|Expressive Language|expressive language
5845119|NCT00001448|Thrush|thrush
5845120|NCT00001446|Angiogenesis|angiogenesis
5845121|NCT00001446|Malignancy|malignancy
5845122|NCT00001446|Neuropathy|neuropathy
5845123|NCT00001446|Pharmacokinetics|pharmacokinetics
5845124|NCT00001446|Sedation|sedation
5845125|NCT00001445|Adjuvant-Controlled Study|adjuvant-controlled study
5845126|NCT00001445|Double Blind Randomization|double blind randomization
5845127|NCT00001445|Env-Deleted Inactivated HIV-1|env-deleted inactivated hiv-1
5845128|NCT00001445|Therapeutic HIV Vaccine|therapeutic hiv vaccine
5845129|NCT00001443|AIDS|aids
5845130|NCT00001443|Bioavailability|bioavailability
5845131|NCT00001443|Immunologic Evaluations|immunologic evaluations
5845132|NCT00001443|Pharmacokinetics|pharmacokinetics
5845133|NCT00001443|Toxicity|toxicity
5845134|NCT00001439|Cancer|cancer
5845135|NCT00001439|Immunotherapy|immunotherapy
5845136|NCT00001438|HIV Infection|hiv infection
5845137|NCT00001438|Immune Response|immune response
5845138|NCT00001438|Pediatric|pediatric
5845139|NCT00001438|Pharmacokinetics|pharmacokinetics
5845140|NCT00001438|Toxicity|toxicity
5845141|NCT00001437|Cytokines|cytokines
5845142|NCT00001437|Fibrosis Intensity|fibrosis intensity
5845143|NCT00001437|Post-Radiation Fibrosis|post-radiation fibrosis
5845144|NCT00001437|Radiation Injury|radiation injury
5845145|NCT00001437|Trental|trental
5845146|NCT00001436|Hormone Interactions|hormone interactions
5845147|NCT00001436|IGF-I|igf-i
5845148|NCT00001436|Metastatic|metastatic
5845149|NCT00001436|Pediatric|pediatric
5845150|NCT00001436|Recurrent|recurrent
5845151|NCT00001435|Anxiety|anxiety
5845153|NCT00001435|Family Functioning|family functioning
5845154|NCT00001435|Psychosocial Adjustment|psychosocial adjustment
5845155|NCT00001435|Social Support|social support
5845156|NCT00001431|Combined Modality|combined modality
5845157|NCT00001431|GI Cancer|gi cancer
5845158|NCT00001431|Pancreatic Cancer|pancreatic cancer
5845159|NCT00001431|Radiotherapy|radiotherapy
5845160|NCT00001428|Chemotherapy|chemotherapy
5845161|NCT00001428|Cytokine|cytokine
5845162|NCT00001428|Efficacy|efficacy
5845163|NCT00001428|Palliation|palliation
5845164|NCT00001428|Solid Tumor|solid tumor
5845165|NCT00001427|Pharmacodynamic Studies|pharmacodynamic studies
5845166|NCT00001427|Pharmacokinetics|pharmacokinetics
5845167|NCT00001424|AIDS|aids
5845168|NCT00001424|Children|children
5845169|NCT00001424|Human Immunodeficiency Virus|human immunodeficiency virus
5845170|NCT00001422|Adenine Analogue|adenine analogue
5845171|NCT00001422|Apoptosis|apoptosis
5845172|NCT00001422|Cytokines|cytokines
5845174|NCT00001422|Synovium|synovium
5845175|NCT00001422|Psoriatic Arthritis|psoriatic arthritis
5845176|NCT00001421|Cytotoxicity|cytotoxicity
5845177|NCT00001421|HLA Class I|hla class i
5845178|NCT00001421|Lymphocytes|lymphocytes
5845179|NCT00001421|Muscle|muscle
5845180|NCT00001421|Myositis|myositis
5845181|NCT00001421|Thionamides|thionamides
5845182|NCT00001421|Dermatomyositis|dermatomyositis
5845183|NCT00001421|Polymyositis|polymyositis
5845184|NCT00001416|Bone Disease|bone disease
5845185|NCT00001416|Calcitriol|calcitriol
5845186|NCT00001416|Enzyme Replacement Therapy|enzyme replacement therapy
5845187|NCT00001416|Gaucher's Disease|gaucher's disease
5845188|NCT00001416|Vitamin D|vitamin d
5845189|NCT00001415|IL-1|il-1
5845190|NCT00001415|IL-6|il-6
5845191|NCT00001415|Immune Response|immune response
5845192|NCT00001415|Inflammation|inflammation
5845193|NCT00001415|Steroids|steroids
5845194|NCT00001415|Chronic Fatigue Syndrome|chronic fatigue syndrome
5845196|NCT00001415|Fibromyalgia|fibromyalgia
5845197|NCT00001415|Normal Volunteer|normal volunteer
5845198|NCT00001402|Dilated Cardiomyopathy|dilated cardiomyopathy
5845199|NCT00001402|Hibernating Myocardium|hibernating myocardium
5845200|NCT00001402|Ischemic Cardiomyopathy|ischemic cardiomyopathy
5845201|NCT00001402|Metoprolol|metoprolol
5845202|NCT00001402|Stress Thallium Scintigraphy|stress thallium scintigraphy
5845203|NCT00001402|Congestive Cardiomyopathy|congestive cardiomyopathy
5845204|NCT00001402|Congestive Heart Failure|congestive heart failure
5845205|NCT00001402|Heart Failure|heart failure
5845206|NCT00001395|Cataracts|cataracts
5845207|NCT00001395|Complications|complications
5845208|NCT00001395|Rates of Progression|rates of progression
5845209|NCT00001395|Diabetic Retinopathy|diabetic retinopathy
5845210|NCT00001387|Paclitaxel|paclitaxel
5845211|NCT00001387|Pediatric|pediatric
5845212|NCT00001387|Pharmacokinetics|pharmacokinetics
5845214|NCT00001387|Toxicity|toxicity
5845215|NCT00001385|Cancer Diagnosis|cancer diagnosis
5845216|NCT00001385|Cancer Metabolism|cancer metabolism
5845218|NCT00001385|FDG Breast Imaging|fdg breast imaging
5845219|NCT00001385|PET|pet
5845220|NCT00001385|Positron Emission Mammography|positron emission mammography
5845221|NCT00001385|Radiopharmaceutical|radiopharmaceutical
5845222|NCT00001385|Scintimammography|scintimammography
5845223|NCT00001384|14-Day Cycle|14-day cycle
5845224|NCT00001384|Dose Intensity|dose intensity
5845225|NCT00001384|Filgrastim|filgrastim
5845226|NCT00001384|Lymph Node Positive|lymph node positive
5845227|NCT00001384|Non-Cross Resistant|non-cross resistant
5845228|NCT00001383|Cyclosporine Analogue|cyclosporine analogue
5845229|NCT00001383|Multidrug Resistance|multidrug resistance
5845230|NCT00001383|Pgp Blocker|pgp blocker
5845231|NCT00001383|Pump Blocker|pump blocker
5845232|NCT00001383|Taxol Over 90 Hours|taxol over 90 hours
5845233|NCT00001382|Immunotherapy|immunotherapy
5845234|NCT00001382|Vaccine|vaccine
5845235|NCT00001381|Adult|adult
5845236|NCT00001381|Intravesical Chemotherapy|intravesical chemotherapy
5845237|NCT00001378|4-Quadrant Fine Needle Aspiration|4-quadrant fine needle aspiration
5845238|NCT00001378|Biomarkers|biomarkers
5845239|NCT00001378|Chemoprevention|chemoprevention
5845240|NCT00001378|Nipple Suction Aspirates|nipple suction aspirates
5845241|NCT00001378|TGF Beta|tgf beta
5845242|NCT00001377|Familial|familial
5845243|NCT00001377|Inherited Prostate Cancer|inherited prostate cancer
5845245|NCT00001377|Prostate Cancer|prostate cancer
5845246|NCT00001376|Androgens|androgens
5845247|NCT00001376|Female|female
5845248|NCT00001376|Immunology|immunology
5845249|NCT00001376|Neuroendocrine Axis|neuroendocrine axis
5845250|NCT00001376|Rheumatoid Arthritis|rheumatoid arthritis
5845251|NCT00001376|Postpartum|postpartum
5845252|NCT00001376|Pregnancy|pregnancy
5845253|NCT00001375|Infection|infection
5845254|NCT00001375|Reactive Arthritis|reactive arthritis
5845255|NCT00001375|Rheumatoid Arthritis|rheumatoid arthritis
5845256|NCT00001375|Synovial Biopsy|synovial biopsy
5845257|NCT00001375|Synovial Fluid|synovial fluid
5845259|NCT00001371|Inflammation|inflammation
5845260|NCT00001371|Lipocortin|lipocortin
5845261|NCT00001371|Phospholipase A-2|phospholipase a-2
5845262|NCT00001371|Skin|skin
5845263|NCT00001371|Uteroglobin|uteroglobin
5845264|NCT00001371|Psoriasis|psoriasis
5845265|NCT00001365|Dextromethorphan|dextromethorphan
5845266|NCT00001365|Dextrorphan|dextrorphan
5845267|NCT00001365|Glutamate Antagonist|glutamate antagonist
5845268|NCT00001365|Parkinson's Disease|parkinson's disease
5845269|NCT00001363|Blood Flow|blood flow
5845270|NCT00001363|Chess Play|chess play
5845271|NCT00001363|Frontal Lobe|frontal lobe
5845272|NCT00001363|Neurobehavioral Deficits|neurobehavioral deficits
5845273|NCT00001363|Neuropsychology|neuropsychology
5845274|NCT00001363|Positron Emission Tomography|positron emission tomography
5845275|NCT00001363|Prefrontal Cortex|prefrontal cortex
5845276|NCT00001346|Diabetic Macular Edema|diabetic macular edema
5845277|NCT00001346|Diabetic Retinopathy|diabetic retinopathy
5845278|NCT00001346|Macular Edema|macular edema
5848161|NCT00036036|renal|renal
5845279|NCT00001346|Photocoagulation|photocoagulation
5845280|NCT00001346|Psychophysical Testing|psychophysical testing
5845281|NCT00001346|Stiles-Crawford Effect|stiles-crawford effect
5845282|NCT00001344|Diabetes Mellitus|diabetes mellitus
5845283|NCT00001344|Diabetic Neuropathy|diabetic neuropathy
5845284|NCT00001344|Memantine|memantine
5845285|NCT00001344|NMDA Receptor Antagonists|nmda receptor antagonists
5845286|NCT00001344|Neuropathic Pain|neuropathic pain
5845287|NCT00001344|Neuropathy|neuropathy
5845288|NCT00001344|Post-Herpetic Neuralgia|post-herpetic neuralgia
5845289|NCT00001344|Shingles|shingles
5845290|NCT00001342|Electrooculography|electrooculography
5845291|NCT00001342|Electroretinogram|electroretinogram
5845292|NCT00001342|Fluorescein Angiogram|fluorescein angiogram
5845293|NCT00001342|Glycogen Storage Disease|glycogen storage disease
5845294|NCT00001341|Antifolate|antifolate
5845295|NCT00001341|Inhibitor|inhibitor
5845296|NCT00001341|Pharmacokinetics|pharmacokinetics
5845297|NCT00001341|Thymidylate Synthetase|thymidylate synthetase
5845299|NCT00001338|Fusion Protein|fusion protein
5845300|NCT00001333|Intraventricular|intraventricular
5845301|NCT00001333|Meningeal Malignancy|meningeal malignancy
5845302|NCT00001333|NSC 609699|nsc 609699
5845303|NCT00001333|SKF 104864|skf 104864
5845304|NCT00001333|Topoisomerase 1|topoisomerase 1
5845305|NCT00001332|Cancer Treatment|cancer treatment
5845306|NCT00001332|Chemotherapy|chemotherapy
5845307|NCT00001332|Regional Therapy|regional therapy
5845309|NCT00001330|Autoimmune Diseases|autoimmune diseases
5845310|NCT00001330|Connective Tissue Disease|connective tissue disease
5845311|NCT00001330|Scleroderma|scleroderma
5845312|NCT00001330|Silicone Device Implants|silicone device implants
5845313|NCT00001330|Silicone Injection|silicone injection
5845314|NCT00001330|Idiopathic Scleroderma|idiopathic scleroderma
5845315|NCT00001330|Myositis|myositis
5845316|NCT00001330|Systemic Sclerosis|systemic sclerosis
5845317|NCT00001324|Ataxia|ataxia
5845318|NCT00001324|Brain|brain
5845319|NCT00001324|Motor Learning|motor learning
5845320|NCT00001324|Parkinson's Disease|parkinson's disease
5845321|NCT00001324|Physiology|physiology
5845322|NCT00001324|Positron Emission Tomography|positron emission tomography
5845323|NCT00001324|Stroke|stroke
5845324|NCT00001324|Tremor|tremor
5845325|NCT00001324|Voluntary and Involuntary Movement Physiology|voluntary and involuntary movement physiology
5845326|NCT00001324|Movement Disorders|movement disorders
5845327|NCT00001324|Normal Volunteer|normal volunteer
5845328|NCT00001318|Immune Adjuvant|immune adjuvant
5845329|NCT00001318|Phagocytes|phagocytes
5845330|NCT00001318|Non-tuberculous Mycobacterial Infection|non-tuberculous mycobacterial infection
5845331|NCT00001317|Children|children
5845332|NCT00001317|Gamma Interferon|gamma interferon
5845333|NCT00001317|Hospitalizations|hospitalizations
5845334|NCT00001317|Infection|infection
5845335|NCT00001317|Chronic Granulomatous Disease|chronic granulomatous disease
5845336|NCT00001314|Aortic Regurgitation|aortic regurgitation
5845337|NCT00001314|Dobutamine Stress|dobutamine stress
5845338|NCT00001314|Left Ventricular Function|left ventricular function
5845339|NCT00001314|Mitral Regurgitation|mitral regurgitation
5845340|NCT00001314|Myocardial Contractile Reserve|myocardial contractile reserve
5845341|NCT00001314|Transesophageal Echocardiography|transesophageal echocardiography
5845342|NCT00001311|Cell/Flare Meter|cell/flare meter
5845343|NCT00001311|Heparin Coating|heparin coating
5845344|NCT00001311|Inflammation|inflammation
5845345|NCT00001311|Laser Cell Flare Photometry|laser cell flare photometry
5845346|NCT00001311|Multicentric|multicentric
5845347|NCT00001311|Polymethylmetacrylate|polymethylmetacrylate
5845348|NCT00001311|Specular Micrography|specular micrography
5845349|NCT00001311|Specular Microscopy|specular microscopy
5845350|NCT00001301|Adverse Effects|adverse effects
5845351|NCT00001301|Burkitt's Lymphoma|burkitt's lymphoma
5845352|NCT00001301|Diffuse Large Cell Lymphoma|diffuse large cell lymphoma
5845353|NCT00001301|Extended Remission|extended remission
5845354|NCT00001301|Health Status|health status
5845355|NCT00001301|Lymphoblastic Lymphoma|lymphoblastic lymphoma
5845356|NCT00001301|Molecular Studies|molecular studies
5845357|NCT00001300|Adjuvant Chemotherapy|adjuvant chemotherapy
5845358|NCT00001300|Ifosfamide|ifosfamide
5845359|NCT00001300|Randomized Study|randomized study
5845360|NCT00001300|Soft Tissue Sarcoma|soft tissue sarcoma
5845361|NCT00001298|Antibody|antibody
5845362|NCT00001298|DAMPA|dampa
5845363|NCT00001298|Enzyme|enzyme
5845364|NCT00001298|Kidney|kidney
5845365|NCT00001298|Pharmacokinetics|pharmacokinetics
5845366|NCT00001298|Thymidine|thymidine
5845367|NCT00001298|Toxicity|toxicity
5845368|NCT00001296|Interferon-Gamma|interferon-gamma
5845369|NCT00001296|Isolated Limb Perfusion|isolated limb perfusion
5845370|NCT00001296|Melanoma|melanoma
5845371|NCT00001296|Melphalan|melphalan
5845373|NCT00001292|DNA Markers|dna markers
5845374|NCT00001292|Family Studies|family studies
5845375|NCT00001292|Gene Mapping|gene mapping
5845376|NCT00001292|Ichthyosis|ichthyosis
5845377|NCT00001292|Keratin|keratin
5845378|NCT00001292|Linkage Analysis|linkage analysis
5845379|NCT00001292|Scaling Disorders|scaling disorders
5845380|NCT00001292|Skin|skin
5845381|NCT00001291|Osteoarthritis|osteoarthritis
5845382|NCT00001291|Psoriatic Arthritis|psoriatic arthritis
5845383|NCT00001291|Rheumatoid Arthritis|rheumatoid arthritis
5845384|NCT00001291|Synovial Biopsy|synovial biopsy
5845385|NCT00001291|Synovitis|synovitis
5845386|NCT00001291|Synovium|synovium
5845387|NCT00001287|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5845388|NCT00001287|Monoclonal Gammopathies|monoclonal gammopathies
5845389|NCT00001287|Peripheral Nerve Demyelination|peripheral nerve demyelination
5845390|NCT00001287|CIDP|cidp
5845391|NCT00001287|Chronic Inflammatory Demyelinating Polyneuropathy|chronic inflammatory demyelinating polyneuropathy
5845392|NCT00001285|Circadian Rhythms|circadian rhythms
5845393|NCT00001285|Environmental Light|environmental light
5845394|NCT00001285|Estrogen|estrogen
5845395|NCT00001285|Melatonin|melatonin
5845396|NCT00001285|Progesterone|progesterone
5845397|NCT00001285|Rapid Cycling Bipolar Disorder|rapid cycling bipolar disorder
5845398|NCT00001285|Sleep|sleep
5845399|NCT00001285|Testosterone|testosterone
5845400|NCT00001285|Depression|depression
5845401|NCT00001285|Hypomania|hypomania
5845402|NCT00001285|Mania|mania
5845403|NCT00001280|Aspergillosis|aspergillosis
5845404|NCT00001280|Phagocyte Defect|phagocyte defect
5845405|NCT00001280|Torulopsis|torulopsis
5845406|NCT00001280|Chronic Granulomatous Disease|chronic granulomatous disease
5845407|NCT00001278|Conjunctival Biopsy|conjunctival biopsy
5845408|NCT00001278|Lacrimal Gland Biopsy|lacrimal gland biopsy
5845409|NCT00001278|Sarcoid Uveitis|sarcoid uveitis
5845410|NCT00001278|Sarcoidosis|sarcoidosis
5845411|NCT00001278|Conjunctiva|conjunctiva
5845412|NCT00001278|Inflammatory Eye Disease|inflammatory eye disease
5845413|NCT00001272|Adult|adult
5845414|NCT00001272|Cytotoxic Chemotherapy|cytotoxic chemotherapy
5845415|NCT00001272|Hematopoietic Growth Factor|hematopoietic growth factor
5845416|NCT00001271|Antigen Modulation|antigen modulation
5845417|NCT00001271|Pharmacokinetics|pharmacokinetics
5845418|NCT00001271|Ricin A Chain|ricin a chain
5845419|NCT00001270|Chemotherapy|chemotherapy
5845420|NCT00001270|High Dose|high dose
5845421|NCT00001270|Protection|protection
5845422|NCT00001269|Dose-Intensive Chemotherapy|dose-intensive chemotherapy
5845423|NCT00001269|Hematopoietic Growth Factor|hematopoietic growth factor
5845424|NCT00001269|Peripheral Blood Progenitor Cell|peripheral blood progenitor cell
5845425|NCT00001267|Anti-Viral|anti-viral
5845426|NCT00001267|Dideoxynucleosides|dideoxynucleosides
5845428|NCT00001267|Retrovirus|retrovirus
5845429|NCT00001249|Interleukin-2 Receptor|interleukin-2 receptor
5845430|NCT00001239|5-Fluorouracil|5-fluorouracil
5845431|NCT00001239|Adriamycin|adriamycin
5845432|NCT00001239|Breast Carcinoma|breast carcinoma
5845433|NCT00001239|Leucovorin|leucovorin
5845434|NCT00001239|Phase II|phase ii
5845435|NCT00001237|Burkitt's Lymphoma|burkitt's lymphoma
5845436|NCT00001237|GM-CSF|gm-csf
5845437|NCT00001237|High-Grade|high-grade
5845438|NCT00001233|Adolescence|adolescence
5845439|NCT00001233|Aggressivity|aggressivity
5845440|NCT00001233|Anger|anger
5845441|NCT00001233|Developmental Psychopathology|developmental psychopathology
5845442|NCT00001233|Disruptive Behavior Disorders|disruptive behavior disorders
5845443|NCT00001233|Early Onset Aggression|early onset aggression
5845444|NCT00001233|Emotion Regulation|emotion regulation
5845445|NCT00001233|Family Violence|family violence
5845446|NCT00001233|Preschool Conduct Problems|preschool conduct problems
5845448|NCT00001232|FSH|fsh
5845449|NCT00001232|GnRH|gnrh
5845450|NCT00001232|LH|lh
5845451|NCT00001232|Menopause|menopause
5845452|NCT00001232|Menstrual Cycle|menstrual cycle
5845453|NCT00001229|Calcium-Pentagastrin|calcium-pentagastrin
5845454|NCT00001229|Clonidine|clonidine
5845455|NCT00001229|Glucagon|glucagon
5845456|NCT00001229|Pheochromocytoma|pheochromocytoma
5845457|NCT00001218|Baseline Data|baseline data
5845458|NCT00001218|Curve Averaging|curve averaging
5845459|NCT00001218|Curve Fitting|curve fitting
5845460|NCT00001218|Movement Patterns|movement patterns
5845461|NCT00001218|Normative Data|normative data
5845462|NCT00001218|Polar Distribution|polar distribution
5845463|NCT00001218|Tongue|tongue
5845464|NCT00001218|Tongue Shape|tongue shape
5845465|NCT00001218|Ultrasound|ultrasound
5845466|NCT00001217|Non-Metastatic Osteosarcoma|non-metastatic osteosarcoma
5845467|NCT00001217|Presurgical Chemotherapy|presurgical chemotherapy
5845468|NCT00001216|Amputations|amputations
5845469|NCT00001216|Brainstem Stimulation|brainstem stimulation
5845470|NCT00001216|Cerebellar Stimulation|cerebellar stimulation
5845471|NCT00001216|Cortical Motor Physiology|cortical motor physiology
5845472|NCT00001216|Electrical Stimulation|electrical stimulation
5845473|NCT00001216|Motor Cortex|motor cortex
5845474|NCT00001216|Plasticity|plasticity
5845475|NCT00001216|Spinal Cord Injury|spinal cord injury
5845476|NCT00001216|Stroke|stroke
5845477|NCT00001211|Ectodermal Dysplasia|ectodermal dysplasia
5845478|NCT00001211|Edentulous|edentulous
5845479|NCT00001211|Endosseous|endosseous
5845480|NCT00001211|Implants|implants
5845481|NCT00001211|Mandibular Atrophy|mandibular atrophy
5845482|NCT00001211|Oral|oral
5845483|NCT00001211|Titanium|titanium
5845484|NCT00001210|Blood Donors|blood donors
5845485|NCT00001210|Epitopes|epitopes
5845486|NCT00001210|HIV|hiv
5845487|NCT00001209|Combined Chemotherapy|combined chemotherapy
5845488|NCT00001209|Irradiation|irradiation
5845489|NCT00001209|Unresectable|unresectable
5845490|NCT00001194|Helium Cryogen|helium cryogen
5845491|NCT00001194|Magnetic Field|magnetic field
5845492|NCT00001194|Multi-Institute|multi-institute
5845493|NCT00001194|Nitrogen Cryogen|nitrogen cryogen
5845494|NCT00001194|Radiofrequency|radiofrequency
5845495|NCT00001193|Autologous|autologous
5845496|NCT00001193|Melphalan|melphalan
5845497|NCT00001193|Stage III|stage iii
5845498|NCT00001193|Transplantation|transplantation
5845499|NCT00001189|Adjuvant Radiotherapy|adjuvant radiotherapy
5845500|NCT00001189|Low-Grade Sarcoma|low-grade sarcoma
5845501|NCT00001189|Radiotherapy|radiotherapy
5845502|NCT00001189|Randomized Study|randomized study
5845503|NCT00001189|Sarcoma|sarcoma
5845505|NCT00001188|Chemotherapy|chemotherapy
5845506|NCT00001188|Radiation Therapy|radiation therapy
5845507|NCT00001188|Sarcoma|sarcoma
5845508|NCT00001188|Surgery|surgery
5845509|NCT00001173|B Cells|b cells
5845510|NCT00001173|Humoral Immunity|humoral immunity
5845511|NCT00001173|Lymphocytes|lymphocytes
5845512|NCT00001173|Tetanus Toxoid|tetanus toxoid
5845513|NCT00001169|Chemotherapy|chemotherapy
5845514|NCT00001169|Cytokines|cytokines
5845515|NCT00001169|Immunology|immunology
5845516|NCT00001169|Kala-Azar|kala-azar
5845517|NCT00001169|Leishmaniasis|leishmaniasis
5845518|NCT00001164|Genetic Evaluation|genetic evaluation
5845519|NCT00001164|Immunologic Evaluations|immunologic evaluations
5845520|NCT00001164|Inflammatory Skin Disease|inflammatory skin disease
5845521|NCT00001164|Muscular Dystrophies|muscular dystrophies
5845522|NCT00001164|Neoplastic Skin Diseases|neoplastic skin diseases
5845523|NCT00001164|Neuronal Degenerations|neuronal degenerations
5845524|NCT00001164|Retinal Degenerations|retinal degenerations
5845525|NCT00001164|Viral Diseases|viral diseases
5845526|NCT00001158|Cellular Immunity|cellular immunity
5845527|NCT00001158|Humoral Immunity|humoral immunity
5845528|NCT00001158|Immunodeficiency Disease|immunodeficiency disease
5845529|NCT00001153|Albinism|albinism
5845530|NCT00001153|Ocular Albinism|ocular albinism
5845531|NCT00001153|Oculocutaneous Albinism|oculocutaneous albinism
5845532|NCT00001153|Tyrosinase Negative|tyrosinase negative
5845533|NCT00001153|Tyrosinase Positive|tyrosinase positive
5845534|NCT00001152|Aqueous Humor Dynamics|aqueous humor dynamics
5845535|NCT00001152|Glaucoma|glaucoma
5845536|NCT00001152|Ocular Hypertension|ocular hypertension
5845537|NCT00001152|Pigment Dispersion Syndrome|pigment dispersion syndrome
5845538|NCT00001152|Primary Open Angle Glaucoma|primary open angle glaucoma
5845539|NCT00001152|Pseudo-Exfoliation of the Lens Capsule|pseudo-exfoliation of the lens capsule
5845540|NCT00001142|Body Fat|body fat
5845541|NCT00001142|DXA|dxa
5845542|NCT00001142|HAART|haart
5845543|NCT00001142|Hyperlipidemia|hyperlipidemia
5845544|NCT00001142|Insulin Resistance|insulin resistance
5850194|NCT00025987|Tympanic|tympanic
5845545|NCT00001142|Lipodystrophy|lipodystrophy
5845547|NCT00001142|Protease Inhibitor|protease inhibitor
5845548|NCT00001142|Side-Effects|side-effects
5845549|NCT00001142|Visceral Fat|visceral fat
5845550|NCT00001142|Chronic Infection|chronic infection
5845551|NCT00001142|HIV|hiv
5845552|NCT00001142|Healthy Volunteer|healthy volunteer
5845553|NCT00050388|Cancer|cancer
5845554|NCT00050388|Carcinoma|carcinoma
5845555|NCT00050388|Neoplasm|neoplasm
5845556|NCT00050388|Head cancer|head cancer
5845557|NCT00050388|Neck cancer|neck cancer
5845558|NCT00050388|Tongue cancer|tongue cancer
5845559|NCT00050388|Lip cancer|lip cancer
5845560|NCT00050388|Oral Cavity|oral cavity
5845561|NCT00050388|Oropharynx|oropharynx
5845562|NCT00050388|Pharynx|pharynx
5845563|NCT00050388|Larynx|larynx
5845564|NCT00050388|Squamous Cell|squamous cell
5845565|NCT00050388|Salivary Glands|salivary glands
5845566|NCT00050388|Tumor|tumor
5845571|NCT00050388|Otorhinolaryngologic Neoplasm|otorhinolaryngologic neoplasm
5845572|NCT00050388|Otolaryngologic Cancer|otolaryngologic cancer
5845573|NCT00050388|Gene therapy|gene therapy
5845574|NCT00050388|Immunotherapy|immunotherapy
5845575|NCT00050388|Cancer research|cancer research
5845576|NCT00050388|Cancer vaccine|cancer vaccine
5845577|NCT00050388|Cancer cells|cancer cells
5845579|NCT00050375|ovarian|ovarian
5845580|NCT00050375|CA125|ca125
5845581|NCT00050375|murine|murine
5845582|NCT00050375|antibody|antibody
5845583|NCT00050375|immunotherapy|immunotherapy
5845584|NCT00050362|Pain|pain
5845585|NCT00050362|NSAID|nsaid
5845586|NCT00050362|Oral Surgery|oral surgery
5845587|NCT00050362|Hyperalgesia|hyperalgesia
5845588|NCT00050362|Preemptive Analgesia|preemptive analgesia
5845589|NCT00050349|cancer|cancer
5845590|NCT00050349|tumor|tumor
5845591|NCT00050349|tumour|tumour
5845592|NCT00050349|neoplasm|neoplasm
5845593|NCT00050349|carcinoma|carcinoma
5845594|NCT00050349|carcinoid|carcinoid
5845595|NCT00050349|neuroendocrine|neuroendocrine
5845596|NCT00050349|Islet cell|islet cell
5845597|NCT00050349|Gastrinoma|gastrinoma
5845598|NCT00050349|VIPoma|vipoma
5845599|NCT00050349|metastatic|metastatic
5845600|NCT00050349|intravenous|intravenous
5845601|NCT00050349|epothilone|epothilone
5845602|NCT00050336|Stage 3b or 4 (metastatic) non-small cell lung cancer|stage 3b or 4 (metastatic) non-small cell lung cancer
5845603|NCT00050323|Stage IV Renal Cell Carcinoma|stage iv renal cell carcinoma
5845604|NCT00050323|Kidney Cancer|kidney cancer
5845605|NCT00050323|Cancer (General)|cancer (general)
5845609|NCT00050284|Treatment Experienced|treatment experienced
5845610|NCT00050284|Disease Progression|disease progression
5845611|NCT00050284|Anti-HIV Agents|anti-hiv agents
5845612|NCT00050284|Treatment Interruption|treatment interruption
5845613|NCT00050271|Acetylcarnitine|acetylcarnitine
5845614|NCT00050271|Dideoxynucleosides|dideoxynucleosides
5845615|NCT00050271|Epidermis|epidermis
5845617|NCT00050271|Immunohistochemistry|immunohistochemistry
5845618|NCT00050271|Nerve Fibers|nerve fibers
5845619|NCT00050271|Treatment Experienced|treatment experienced
5845623|NCT00050245|Demyelination|demyelination
5845625|NCT00050245|RITUXAN|rituxan
5845626|NCT00050245|Monoclonal Antibodies|monoclonal antibodies
5845627|NCT00050245|Retuximab|retuximab
5845628|NCT00050245|Demyelinating Neuropathy|demyelinating neuropathy
5845629|NCT00050232|Pseudobulbar Affect|pseudobulbar affect
5845630|NCT00050232|Uncontrolled|uncontrolled
5845631|NCT00050232|Laughing|laughing
5845632|NCT00050232|Crying|crying
5845633|NCT00050219|Raclopride|raclopride
5845634|NCT00050219|D2 Receptors|d2 receptors
5845635|NCT00050219|Striatum|striatum
5845636|NCT00050219|Low-Response|low-response
5845637|NCT00050219|Alcoholism|alcoholism
5845638|NCT00050219|Alcohol|alcohol
5845639|NCT00050219|Dopamine|dopamine
5845640|NCT00050219|Response|response
5845641|NCT00050141|Breast cancer|breast cancer
5845642|NCT00050141|ZARNESTRA|zarnestra
5845643|NCT00050141|tipifarnib|tipifarnib
5845644|NCT00050141|R115777|r115777
5845645|NCT00050141|Estrogen receptor positive|estrogen receptor positive
5845646|NCT00050141|Progesterone receptor positive|progesterone receptor positive
5845647|NCT00050141|Anti-estrogen therapy|anti-estrogen therapy
5845648|NCT00050167|Breast Cancer|breast cancer
5845649|NCT00050167|Capecitabine|capecitabine
5845650|NCT00050167|Docetaxel|docetaxel
5845651|NCT00050167|Paclitaxel|paclitaxel
5845652|NCT00050167|Taxotere|taxotere
5845653|NCT00050167|Taxol|taxol
5845654|NCT00050167|Xeloda|xeloda
5845655|NCT00050167|Taxanes|taxanes
5845656|NCT00050167|Operable Breast Cancer|operable breast cancer
5845657|NCT00050193|Children|children
5845658|NCT00050193|Mast Cells|mast cells
5845659|NCT00050193|Urticaria Pigmentosa|urticaria pigmentosa
5845660|NCT00050193|Bone Marrow|bone marrow
5845661|NCT00050193|Severe|severe
5845662|NCT00050193|Mastocytosis|mastocytosis
5845663|NCT00050193|Pediatric Mastocytosis|pediatric mastocytosis
5845664|NCT00050180|P-Glycoprotein|p-glycoprotein
5845665|NCT00050180|Protease Inhibitor|protease inhibitor
5845666|NCT00050180|Antiretrovirals|antiretrovirals
5845667|NCT00050180|Cytochrome P450|cytochrome p450
5845668|NCT00050180|Drug Transporters|drug transporters
5845669|NCT00050180|Healthy Volunteer|healthy volunteer
5845671|NCT00050154|R115777|r115777
5845672|NCT00050154|Myelodysplastic syndromes|myelodysplastic syndromes
5845673|NCT00050154|Tipifarnib|tipifarnib
5845674|NCT00050154|Zarnestra|zarnestra
5845675|NCT00050128|Rehabilitation|rehabilitation
5845676|NCT00050128|Plasticity|plasticity
5845689|NCT00050089|structured treatment interruptions|structured treatment interruptions
5845690|NCT00050076|Congestive Heart Failure|congestive heart failure
5845691|NCT00050076|Cardiac Failure|cardiac failure
5845692|NCT00050076|Heart Decompensation|heart decompensation
5845693|NCT00050076|Drug Therapy|drug therapy
5845694|NCT00050063|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5845695|NCT00050063|Treatment Experienced|treatment experienced
5845696|NCT00050063|AIDS Vaccines|aids vaccines
5845697|NCT00050063|Treatment Interruption|treatment interruption
5845698|NCT00050063|Viral Load|viral load
5845699|NCT00050063|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5845700|NCT00050063|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5845701|NCT00050050|Adult|adult
5845702|NCT00050050|ADHD|adhd
5845710|NCT00050024|TMS|tms
5845711|NCT00050024|Afferent Stimulation|afferent stimulation
5845712|NCT00050024|Motor Cortex|motor cortex
5845713|NCT00050024|Writer's Cramp|writer's cramp
5845714|NCT00050024|Surround Inhibition|surround inhibition
5845715|NCT00050024|Heterotopic Inhibition|heterotopic inhibition
5845716|NCT00050024|Focal Dystonia|focal dystonia
5845717|NCT00050024|Writer Cramp|writer cramp
5845718|NCT00050011|cancer-treatment related bone loss|cancer-treatment related bone loss
5845719|NCT00050011|postmenopausal women|postmenopausal women
5845720|NCT00050011|breast cancer|breast cancer
5845721|NCT00050011|hormone receptor positive breast cancer|hormone receptor positive breast cancer
5845722|NCT00050011|adjuvant therapy|adjuvant therapy
5845723|NCT00050011|hormonal therapy|hormonal therapy
5845724|NCT00050011|bone loss|bone loss
5845725|NCT00050011|bisphosphonates|bisphosphonates
5845726|NCT00050011|ZFAST|zfast
5845728|NCT00050011|Zoledronic Acid|zoledronic acid
5845729|NCT00050011|US32|us32
5845730|NCT00049998|Nonsmall Cell Lung cancer|nonsmall cell lung cancer
5845731|NCT00049998|advanced|advanced
5845732|NCT00049998|Second-line|second-line
5845733|NCT00049998|topotecan|topotecan
5845734|NCT00049998|Hycamtin|hycamtin
5845735|NCT00049998|oral|oral
5845736|NCT00049998|docetaxel|docetaxel
5845737|NCT00049972|Major Depressive Disorder Open-label discontinued|major depressive disorder open-label discontinued
5845738|NCT00049959|Verteporfin PDT|verteporfin pdt
5845739|NCT00049959|multiple basal cell carcinoma|multiple basal cell carcinoma
5845740|NCT00049959|nevoid basal cell carcinoma syndrome|nevoid basal cell carcinoma syndrome
5845741|NCT00049946|Talnetant|talnetant
5845742|NCT00049946|schizophrenia|schizophrenia
5845743|NCT00049946|NK3 receptor antagonist|nk3 receptor antagonist
5845744|NCT00049946|psychosis|psychosis
5845745|NCT00049829|Bisphosphonate,BMD,Height loss, Hip protectors,HRT,|bisphosphonate,bmd,height loss, hip protectors,hrt,
5845746|NCT00049829|Osteoporosis|osteoporosis
5845747|NCT00049816|knee|knee
5845748|NCT00049816|aerobic exercise|aerobic exercise
5845749|NCT00049816|walking|walking
5845750|NCT00049816|cycling|cycling
5845751|NCT00049816|gait|gait
5845753|NCT00049803|Narcolepsy|narcolepsy
5845754|NCT00049803|Sodium Oxybate|sodium oxybate
5845755|NCT00049803|Cataplexy|cataplexy
5845756|NCT00049803|Excessive Daytime Sleepiness|excessive daytime sleepiness
5845757|NCT00049803|GHB|ghb
5845758|NCT00049803|Gamma Hydroxybutyric Acid|gamma hydroxybutyric acid
5845759|NCT00049803|Orphan Medical|orphan medical
5845760|NCT00049803|Orphan Drug|orphan drug
5845761|NCT00049790|Advanced non-small cell lung cancer|advanced non-small cell lung cancer
5845762|NCT00049738|Psychosis|psychosis
5845763|NCT00049738|Childhood Onset Schizophrenia|childhood onset schizophrenia
5845764|NCT00049738|Schizophrenia|schizophrenia
5845765|NCT00049738|Schizoaffective|schizoaffective
5845766|NCT00049738|Psychotic Disorder|psychotic disorder
5845767|NCT00049738|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
5845768|NCT00049725|Autoimmune Disease|autoimmune disease
5845769|NCT00049725|Monoclonal Antibody Therapy|monoclonal antibody therapy
5845770|NCT00049725|Anti-IL2 Receptor|anti-il2 receptor
5845771|NCT00049725|Platelets|platelets
5845772|NCT00049725|Monoclonal Antibody|monoclonal antibody
5845773|NCT00049725|Immune Thrombocytopenia|immune thrombocytopenia
5845774|NCT00049725|ITP|itp
5845775|NCT00048841|Male|male
5845776|NCT00048841|Osteoporosis|osteoporosis
5845777|NCT00048841|Prostate cancer|prostate cancer
5845778|NCT00048841|Hypogonadism|hypogonadism
5845779|NCT00048841|Bisphosphonates|bisphosphonates
5845780|NCT00048841|Bone mineral density|bone mineral density
5845781|NCT00048815|Minor Depression|minor depression
5845782|NCT00048815|St. John's Wart|st. john's wart
5845783|NCT00048802|Adolescence|adolescence
5845784|NCT00048906|Pharmacokinetics|pharmacokinetics
5845785|NCT00048906|Enzyme|enzyme
5842843|NCT00003022|retinoblastoma|retinoblastoma
5845786|NCT00048906|Lysosomal|lysosomal
5845787|NCT00048906|Kidney|kidney
5845788|NCT00048906|Stroke|stroke
5845789|NCT00048906|Fabry Disease|fabry disease
5845790|NCT00048906|Fabrys|fabrys
5845791|NCT00048906|Fabry's|fabry's
5845792|NCT00048893|CEA vaccine|cea vaccine
5845793|NCT00048893|Metastatic Breast Cancer|metastatic breast cancer
5845794|NCT00048893|T- Cell Repertoire|t- cell repertoire
5845795|NCT00048893|High-dose Chemotherapy|high-dose chemotherapy
5845796|NCT00048893|Breast Cancer|breast cancer
5845797|NCT00048880|Anaplastic Large Cell Lymphoma|anaplastic large cell lymphoma
5845798|NCT00048880|Monoclonal Antibody|monoclonal antibody
5845799|NCT00048880|CD30|cd30
5850375|NCT00024960|Stuttering|stuttering
5845800|NCT00048880|Antibody Saturation|antibody saturation
5845801|NCT00048880|Apoptosis|apoptosis
5845802|NCT00048880|Flow Cytometry|flow cytometry
5845803|NCT00048880|Cancer|cancer
5845804|NCT00048776|Secondary Raynaud's|secondary raynaud's
5845805|NCT00048776|circulatory|circulatory
5845806|NCT00048776|vascular|vascular
5845807|NCT00048776|scleroderma|scleroderma
5845808|NCT00048776|lupus|lupus
5845809|NCT00048776|mixed connective tissue disease|mixed connective tissue disease
5845810|NCT00048763|circulatory|circulatory
5845811|NCT00048763|vascular|vascular
5845812|NCT00048763|idiopathic|idiopathic
5845813|NCT00048789|Psoralen|psoralen
5845814|NCT00048789|Refractory|refractory
5845815|NCT00048789|Transplantation|transplantation
5845816|NCT00048789|Stem Cell|stem cell
5845818|NCT00048789|Graft-versus-host Disease|graft-versus-host disease
5845819|NCT00048789|GVHD|gvhd
5845820|NCT00048750|Anti-Fungal Therapy|anti-fungal therapy
5845821|NCT00048750|Preemptive Anti-Fungal Therapy|preemptive anti-fungal therapy
5845822|NCT00048750|Invasive Fungal Infection|invasive fungal infection
5845823|NCT00048750|Micafungin|micafungin
5845824|NCT00048750|ICU|icu
5845825|NCT00048737|Leukemia|leukemia
5845826|NCT00048737|Lymphoma|lymphoma
5845827|NCT00048737|Lymphoid Malignancy|lymphoid malignancy
5845828|NCT00048737|Cyclophosphamide|cyclophosphamide
5845829|NCT00048737|Cytoxan|cytoxan
5845830|NCT00048737|Neosar|neosar
5845831|NCT00048737|Fludarabine|fludarabine
5845832|NCT00048737|Fludarabine Phosphate|fludarabine phosphate
5845833|NCT00048737|Fludara|fludara
5845834|NCT00048737|Rituximab|rituximab
5845835|NCT00048737|Rituxan|rituxan
5845836|NCT00048737|Zevalin|zevalin
5845837|NCT00048737|Indium Zevalin|indium zevalin
5845838|NCT00048737|90Y Zevalin|90y zevalin
5845839|NCT00048737|CD-20-positive|cd-20-positive
5845840|NCT00048737|B-cell Lymphoma|b-cell lymphoma
5845841|NCT00048737|CD-20-positive B-cell Lymphoma|cd-20-positive b-cell lymphoma
5845842|NCT00048737|NHL|nhl
5845843|NCT00048737|CLL|cll
5845844|NCT00048737|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5845845|NCT00048737|Allogeneic Stem Cell Transplantation|allogeneic stem cell transplantation
5845846|NCT00048737|ASCT|asct
5845847|NCT00048724|Hepatitis C; Cirrhosis|hepatitis c; cirrhosis
5845848|NCT00048698|Frontal Lobe|frontal lobe
5845849|NCT00048698|Motor Cortex|motor cortex
5845850|NCT00048698|Dementia|dementia
5845852|NCT00048698|Healthy Volunteer|healthy volunteer
5845853|NCT00048698|HV|hv
5845854|NCT00048685|Caries|caries
5845855|NCT00048685|Bacteria|bacteria
5845856|NCT00048685|Saliva|saliva
5845857|NCT00048685|Teeth|teeth
5845858|NCT00048685|Autoimmune|autoimmune
5845859|NCT00048685|Dry Mouth|dry mouth
5845860|NCT00048685|Salivary Gland Dysfunction|salivary gland dysfunction
5845861|NCT00048685|Sjogren's Syndrome|sjogren's syndrome
5845862|NCT00048672|Early Chronic Phase Chronic Myelogenous Leukemia|early chronic phase chronic myelogenous leukemia
5845863|NCT00048672|Leukemia|leukemia
5845865|NCT00048672|STI571|sti571
5845866|NCT00048672|Imatinib mesylate|imatinib mesylate
5845867|NCT00048659|Androgen-independent prostate cancer|androgen-independent prostate cancer
5845868|NCT00048646|TBI|tbi
5845869|NCT00048646|ProTECT|protect
5845870|NCT00048633|Chemotherapy resistance advanced breast cancer|chemotherapy resistance advanced breast cancer
5845871|NCT00048542|Polyarticular Juvenile Idiopathic Arthritis|polyarticular juvenile idiopathic arthritis
5845872|NCT00048529|adenocarcinoma of the esophagus|adenocarcinoma of the esophagus
5845873|NCT00048503|Zarnestra|zarnestra
5845874|NCT00048503|Acute myeloid leukemia|acute myeloid leukemia
5845875|NCT00048503|Tipifarnib|tipifarnib
5845876|NCT00048464|Immunotherapy|immunotherapy
5845877|NCT00048464|T Cell Therapy|t cell therapy
5845878|NCT00048464|Peripheral Blood Stem Cell Transplant|peripheral blood stem cell transplant
5845879|NCT00048464|Bone marrow transplant|bone marrow transplant
5845880|NCT00048464|Adoptive immunotherapy|adoptive immunotherapy
5845881|NCT00048464|Xcellerate|xcellerate
5845882|NCT00048425|Decompensated chronic heart failure|decompensated chronic heart failure
5845883|NCT00048490|Seizures|seizures
5845884|NCT00048490|Magnetism|magnetism
5845885|NCT00048490|Brain|brain
5845886|NCT00048490|Stimulation|stimulation
5845887|NCT00048490|Therapy|therapy
5845899|NCT00048360|ADHD|adhd
5845900|NCT00048360|attention deficit|attention deficit
5845901|NCT00048360|hyperactivity|hyperactivity
5842884|NCT00003022|adult glioblastoma|adult glioblastoma
5845902|NCT00048308|CABG|cabg
5845903|NCT00048347|Lymphocyte|lymphocyte
5845904|NCT00048347|Monocyte|monocyte
5845905|NCT00048347|Inflammation|inflammation
5845906|NCT00048347|Th2|th2
5845907|NCT00048347|Colonoscopy|colonoscopy
5845908|NCT00048347|Ulcerative Colitis|ulcerative colitis
5845909|NCT00048334|Histone Acetylation|histone acetylation
5845910|NCT00048334|Cancer|cancer
5845911|NCT00048282|Incidence|incidence
5845912|NCT00048282|HIV Seroprevalence|hiv seroprevalence
5845913|NCT00048282|Vagina|vagina
5845914|NCT00048282|Anti-Infective Agents|anti-infective agents
5845915|NCT00048282|Administration, Topical|administration, topical
5845916|NCT00048282|Gels|gels
5845917|NCT00048282|HIV Seronegativity|hiv seronegativity
5845918|NCT00048230|Relapsed Multiple Myeloma|relapsed multiple myeloma
5845919|NCT00048230|Refractory Multiple Myeloma|refractory multiple myeloma
5845920|NCT00048217|Treatment Experienced|treatment experienced
5845921|NCT00048204|Depression|depression
5845922|NCT00048204|Psychiatry|psychiatry
5845923|NCT00048204|Major Depressive Disorder|major depressive disorder
5845924|NCT00048256|Cancer|cancer
5845925|NCT00048256|Personality Assessment|personality assessment
5845926|NCT00048256|Coping Styles|coping styles
5845927|NCT00048256|Psychological Distress|psychological distress
5845928|NCT00048256|Bone Marrow Transplants|bone marrow transplants
5845929|NCT00048256|Bone Marrow Transplant|bone marrow transplant
5845930|NCT00048113|Crohn's|crohn's
5845931|NCT00048100|Dendritic cells|dendritic cells
5845932|NCT00048100|Lymphocytes|lymphocytes
5845933|NCT00048100|AML|aml
5845934|NCT00048087|Non-small cell lung cancer|non-small cell lung cancer
5845935|NCT00047983|Kidney Transplantation|kidney transplantation
5845936|NCT00047983|Fatty Acids, Omega-3|fatty acids, omega-3
5845937|NCT00047983|Erythrocyte Membrane|erythrocyte membrane
5845938|NCT00047983|Graft Survival|graft survival
5845939|NCT00047970|Breast Cancer|breast cancer
5845940|NCT00047970|Sisters|sisters
5845941|NCT00047827|Aspergillus|aspergillus
5845942|NCT00047827|Aspergillosis|aspergillosis
5845943|NCT00047827|Anti-Fungal|anti-fungal
5845944|NCT00047827|AmBisome|ambisome
5845945|NCT00047827|Micafungin|micafungin
5845946|NCT00047814|HCV|hcv
5845956|NCT00047957|Transcranial|transcranial
5848889|NCT00032812|PD|pd
5845958|NCT00047957|Stimulation|stimulation
5845959|NCT00047957|Motor|motor
5845960|NCT00047957|Cortex|cortex
5845961|NCT00047957|Motor Cortex|motor cortex
5845962|NCT00047957|Afferent Stimulation|afferent stimulation
5845963|NCT00047957|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5845964|NCT00047957|Healthy Volunteer|healthy volunteer
5845965|NCT00047957|HV|hv
5845966|NCT00047944|Attention|attention
5845967|NCT00047944|Emotion|emotion
5845968|NCT00047944|Amygdala|amygdala
5845969|NCT00047944|Prefrontal Cortex|prefrontal cortex
5845970|NCT00047944|Facial Expression|facial expression
5845971|NCT00047944|Magnetic Resonance Imaging|magnetic resonance imaging
5845972|NCT00047944|fMRI|fmri
5845973|NCT00047944|Depression|depression
5845974|NCT00047944|Anxiety|anxiety
5845975|NCT00047944|Adolescence|adolescence
5845976|NCT00047944|Children|children
5845978|NCT00047931|HIV-Negative|hiv-negative
5845979|NCT00047931|Placebo-Controlled|placebo-controlled
5845980|NCT00047931|Volunteer|volunteer
5845981|NCT00047931|Dose-Escalation|dose-escalation
5845982|NCT00047931|HIV Seronegativity|hiv seronegativity
5845983|NCT00047931|Healthy Volunteer|healthy volunteer
5845984|NCT00047931|HV|hv
5845985|NCT00047918|Mast Cells|mast cells
5845986|NCT00047918|Bone Marrow|bone marrow
5845987|NCT00047918|Flushing|flushing
5845988|NCT00047918|Mutations|mutations
5845989|NCT00047918|Mastocytosis|mastocytosis
5845990|NCT00047918|Anaphylaxis|anaphylaxis
5845991|NCT00047905|Qualitative|qualitative
5845992|NCT00047905|Communication Analysis|communication analysis
5845993|NCT00047905|RIAS|rias
5845994|NCT00047905|Counseling Models|counseling models
5845995|NCT00047905|Videotaping|videotaping
5845996|NCT00047905|Prenatal Genetic Counselors|prenatal genetic counselors
5845997|NCT00047905|Counseling Process|counseling process
5845998|NCT00047905|Video Tape Study|video tape study
5850613|NCT00021463|Nevirapine|nevirapine
5846005|NCT00047879|Progression-Free|progression-free
5846006|NCT00047879|Brain Tumor|brain tumor
5846007|NCT00047879|Glioma|glioma
5846008|NCT00047866|Limbic System|limbic system
5846009|NCT00047866|Amphetamine|amphetamine
5846010|NCT00047866|Dopamine|dopamine
5846011|NCT00047866|Brain Imaging|brain imaging
5846012|NCT00047866|Cerebral Blood Flow|cerebral blood flow
5846013|NCT00047866|Cerebral Blood Volume|cerebral blood volume
5846014|NCT00047866|Alcoholism|alcoholism
5846015|NCT00047866|Tyrosine Depletion|tyrosine depletion
5846016|NCT00047866|Amino Acids|amino acids
5846017|NCT00047866|Affect|affect
5846018|NCT00047866|Healthy Volunteer|healthy volunteer
5846019|NCT00047866|HV|hv
5846027|NCT00047788|Relapsed Multiple Myeloma|relapsed multiple myeloma
5846028|NCT00047554|open-angle|open-angle
5846029|NCT00047554|glaucoma|glaucoma
5846030|NCT00047554|ocular|ocular
5846031|NCT00047554|hypertension|hypertension
5846032|NCT00047554|primary open-angle glaucoma|primary open-angle glaucoma
5846033|NCT00047554|iris|iris
5846034|NCT00047554|pigmentation|pigmentation
5846035|NCT00047541|open-angle|open-angle
5846036|NCT00047541|glaucoma|glaucoma
5846037|NCT00047541|ocular|ocular
5846038|NCT00047541|hypertension|hypertension
5846039|NCT00047541|POAG|poag
5846040|NCT00047528|open-angle|open-angle
5846041|NCT00047528|glaucoma|glaucoma
5846042|NCT00047528|ocular|ocular
5846043|NCT00047528|hypertension|hypertension
5846044|NCT00047528|POAG|poag
5846045|NCT00047515|open-angle|open-angle
5846046|NCT00047515|glaucoma|glaucoma
5846047|NCT00047515|ocular|ocular
5846048|NCT00047515|hypertension|hypertension
5846049|NCT00047515|POAG|poag
5846050|NCT00047749|pain|pain
5846051|NCT00047749|ziconotide|ziconotide
5846052|NCT00047749|Prialt|prialt
5846053|NCT00047749|intrathecal|intrathecal
5846054|NCT00047749|Synchromed|synchromed
5846055|NCT00047736|Non-small cell lung cancer|non-small cell lung cancer
5846057|NCT00047723|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5846058|NCT00047723|minocycline|minocycline
5846059|NCT00047710|pancreatic cancer|pancreatic cancer
5846060|NCT00047710|pancreas cancer|pancreas cancer
5846061|NCT00047710|pancreas|pancreas
5846062|NCT00047684|Child Abuse, Sexual|child abuse, sexual
5846063|NCT00047671|Depressive Disorder|depressive disorder
5846064|NCT00047645|lung|lung
5846065|NCT00047645|IPF|ipf
5846066|NCT00047632|ovarian|ovarian
5846067|NCT00047632|carcinoma|carcinoma
5846068|NCT00047632|peritoneal|peritoneal
5846069|NCT00047632|cancer|cancer
5846070|NCT00047632|ovary|ovary
5846071|NCT00047632|interferon gamma|interferon gamma
5846072|NCT00047606|open-angle|open-angle
5846073|NCT00047606|glaucoma|glaucoma
5846074|NCT00047606|ocular|ocular
5846075|NCT00047606|hypertension|hypertension
5846076|NCT00047606|POAG|poag
5846077|NCT00047606|Iris|iris
5846078|NCT00047606|Pigmentation|pigmentation
5846079|NCT00047606|Japanese|japanese
5846080|NCT00047593|open-angle|open-angle
5846081|NCT00047593|glaucoma|glaucoma
5846082|NCT00047593|ocular|ocular
5846083|NCT00047593|hypertension|hypertension
5846085|NCT00047593|Iris|iris
5846086|NCT00047593|Pigmentation|pigmentation
5846087|NCT00047593|Japanese|japanese
5846088|NCT00047619|Decubitus Ulcers|decubitus ulcers
5846089|NCT00047619|Pulsatile Lavage|pulsatile lavage
5846090|NCT00047619|SCI|sci
5846091|NCT00047619|Spinal Cord Injury|spinal cord injury
5846092|NCT00047619|Wound healing|wound healing
5846093|NCT00047619|pressure ulcer|pressure ulcer
5846094|NCT00047580|Spasticity|spasticity
5846095|NCT00047580|spasticity secondary to Multiple Sclerosis|spasticity secondary to multiple sclerosis
5846096|NCT00047580|Spinal Cord Injury|spinal cord injury
5846097|NCT00047580|Stroke|stroke
5846098|NCT00047567|ZONISAMIDE|zonisamide
5846099|NCT00047567|BIPOLAR|bipolar
5846100|NCT00046371|Cancer Vaccines|cancer vaccines
5846101|NCT00046371|Aromatase|aromatase
5846102|NCT00046371|Receptors, Estrogen|receptors, estrogen
5846103|NCT00046371|Receptors, Progesterone|receptors, progesterone
5846104|NCT00047476|neurobehavioral function|neurobehavioral function
5846105|NCT00047476|chemobrain|chemobrain
5846106|NCT00047476|chemo brain|chemo brain
5846108|NCT00047476|memory loss|memory loss
5846109|NCT00047476|exhausted|exhausted
5846110|NCT00047476|trouble concentrating|trouble concentrating
5846111|NCT00047463|epilepsy|epilepsy
5846113|NCT00047463|obstructive sleep apnea|obstructive sleep apnea
5846114|NCT00047463|continuous positive airway pressure|continuous positive airway pressure
5846115|NCT00047463|CPAP|cpap
5846116|NCT00047450|Psychotic Disorders|psychotic disorders
5846117|NCT00047411|CPR, AED|cpr, aed
5846118|NCT00046800|Ovarian Cancer|ovarian cancer
5846119|NCT00046787|Small Cell Lung Cancer|small cell lung cancer
5846120|NCT00046761|Acute Ischemic Stroke|acute ischemic stroke
5846121|NCT00046774|Safety|safety
5846122|NCT00046774|Nephritis|nephritis
5846123|NCT00046774|Biologic Therapy|biologic therapy
5846124|NCT00046774|Lymphocytes|lymphocytes
5846125|NCT00046774|Response|response
5846126|NCT00046774|Lupus|lupus
5846127|NCT00046774|Systemic Lupus Erythematosus|systemic lupus erythematosus
5846128|NCT00046774|SLE|sle
5846129|NCT00046735|solid tumors|solid tumors
5846130|NCT00046735|Revimid|revimid
5846131|NCT00046735|CC5013|cc5013
5846132|NCT00046735|CC-5013|cc-5013
5846133|NCT00046722|treatment experienced|treatment experienced
5846134|NCT00046722|complementary therapies|complementary therapies
5846135|NCT00046722|Neuropathy|neuropathy
5846136|NCT00046722|Peripheral Neuropathy|peripheral neuropathy
5846137|NCT00046722|HIV-Related Peripheral Neuropathy|hiv-related peripheral neuropathy
5846138|NCT00046722|HIV|hiv
5846139|NCT00046527|Metastatic breast cancer|metastatic breast cancer
5846140|NCT00046527|Taxol|taxol
5846141|NCT00046527|Taxane|taxane
5846142|NCT00046514|Metastatic Breast Cancer|metastatic breast cancer
5846143|NCT00046514|Taxol|taxol
5846144|NCT00046423|Cancer|cancer
5846145|NCT00046423|solid tumor|solid tumor
5846146|NCT00046423|Advanced malignancy|advanced malignancy
5846147|NCT00046423|Taxane therapy|taxane therapy
5846148|NCT00046423|Biopsy-proven diagnosis of advanced malignancy|biopsy-proven diagnosis of advanced malignancy
5846149|NCT00046423|Various solid tumors which are refractory|various solid tumors which are refractory
5846150|NCT00046709|Cancer pain|cancer pain
5846151|NCT00046709|All types of cancer except lung cancer|all types of cancer except lung cancer
5846152|NCT00046696|Cancer|cancer
5846153|NCT00046696|Cancer Alternative Therapies|cancer alternative therapies
5846154|NCT00046696|Living with Cancer|living with cancer
5846155|NCT00046683|Adult acute leukemia|adult acute leukemia
5846156|NCT00046683|Adult chronic leukemia|adult chronic leukemia
5846157|NCT00046683|Childhood leukemia|childhood leukemia
5846158|NCT00046683|Campath|campath
5846159|NCT00046683|Alemtuzumab|alemtuzumab
5846160|NCT00046540|Liposome-Encapsulated SN38|liposome-encapsulated sn38
5846161|NCT00046540|Irinotecan|irinotecan
5846162|NCT00046540|CPT-11|cpt-11
5846163|NCT00046540|Malignant Tumors|malignant tumors
5846164|NCT00046488|Chronic Lymphoblastic Leukemia|chronic lymphoblastic leukemia
5846165|NCT00046488|Leukemia, Lymphoblastic, Chronic|leukemia, lymphoblastic, chronic
5846166|NCT00046488|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5846167|NCT00046488|CLL|cll
5846168|NCT00046631|built environment|built environment
5846169|NCT00046631|parks|parks
5846170|NCT00046631|retail outlets|retail outlets
5846171|NCT00046631|adolescent girls|adolescent girls
5846172|NCT00046631|physical activity|physical activity
5846173|NCT00046553|Cortisol|cortisol
5846174|NCT00046553|CRH|crh
5846175|NCT00046553|HPA Axis|hpa axis
5846176|NCT00046553|Hypothalamus|hypothalamus
5846177|NCT00046553|Hippocampus|hippocampus
5846178|NCT00046553|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5846179|NCT00046553|PTSD|ptsd
5846180|NCT00046553|Healthy Volunteer|healthy volunteer
5846181|NCT00046436|AIDS Serodiagnosis|aids serodiagnosis
5846182|NCT00046436|Pregnancy Complications, Infectious|pregnancy complications, infectious
5846183|NCT00046436|Anti-HIV Agents|anti-hiv agents
5846184|NCT00046436|Disease Transmission, Vertical|disease transmission, vertical
5846185|NCT00046410|MRI|mri
5846186|NCT00046410|Diffusion|diffusion
5846188|NCT00046410|Stroke|stroke
5846189|NCT00046410|Heart|heart
5846190|NCT00046410|Coronary Artery Disease|coronary artery disease
5846191|NCT00046410|Heart Disease|heart disease
5846192|NCT00046397|Smallpox|smallpox
5846193|NCT00046397|Vaccine|vaccine
5846194|NCT00046397|Vaccination|vaccination
5846195|NCT00046397|Variola|variola
5846196|NCT00046397|Adults|adults
5846197|NCT00046397|Smallpox Vaccine|smallpox vaccine
5846198|NCT00046397|Healthy Volunteer|healthy volunteer
5846199|NCT00046397|Small Pox|small pox
5846200|NCT00046345|treatment experienced|treatment experienced
5846201|NCT00046332|Integrase inhibitors|integrase inhibitors
5846202|NCT00046332|Monotherapy|monotherapy
5846203|NCT00046332|HIV-1 infection|hiv-1 infection
5846204|NCT00046319|Pulmonary Arterial Hypertension|pulmonary arterial hypertension
5846205|NCT00046319|Primary Pulmonary Hypertension|primary pulmonary hypertension
5846206|NCT00046306|Oxidative Stress|oxidative stress
5846207|NCT00046306|Cardiovascular Disease|cardiovascular disease
5846208|NCT00046306|Cancer|cancer
5846209|NCT00046358|Cerebrospinal Fluid|cerebrospinal fluid
5846210|NCT00046358|Cholesterol|cholesterol
5846211|NCT00046358|Statin|statin
5846212|NCT00046358|NSAID|nsaid
5846213|NCT00046358|Antiinflammatory|antiinflammatory
5846214|NCT00046358|Dementia|dementia
5846215|NCT00046358|Alzheimer's Disease|alzheimer's disease
5846238|NCT00046254|zoledronic acid|zoledronic acid
5846239|NCT00046254|geriatrics|geriatrics
5846240|NCT00046254|rehabilitation|rehabilitation
5846241|NCT00046254|elderly|elderly
5846242|NCT00046254|nursing home|nursing home
5846243|NCT00046254|orthopedic|orthopedic
5846244|NCT00046241|seasonal depression winter blues winter depression|seasonal depression winter blues winter depression
5846245|NCT00046228|Myocardial infarction|myocardial infarction
5846246|NCT00046228|percutaneous coronary intervention|percutaneous coronary intervention
5846247|NCT00046228|abciximab|abciximab
5846248|NCT00046228|reteplase|reteplase
5846249|NCT00046228|safety and efficacy|safety and efficacy
5846250|NCT00046215|Virtual Lesion Study|virtual lesion study
5846251|NCT00046215|Motor Imagery|motor imagery
5846252|NCT00046215|Primary Motor Cortex|primary motor cortex
5846253|NCT00046215|Motor Inhibition|motor inhibition
5846254|NCT00046215|Motor Execution|motor execution
5846255|NCT00046215|Healthy Volunteer|healthy volunteer
5846272|NCT00046176|HIV-1 Abacavir Lamivudine Antiretroviral-experienced|hiv-1 abacavir lamivudine antiretroviral-experienced
5846273|NCT00046163|Neurology|neurology
5846274|NCT00046163|Cardiology|cardiology
5846275|NCT00046111|oral|oral
5846276|NCT00046111|Bioequivalence|bioequivalence
5846277|NCT00046111|Hycamtin|hycamtin
5846278|NCT00046111|Topotecan|topotecan
5846279|NCT00046085|Schizophrenia|schizophrenia
5846280|NCT00046085|Family|family
5846281|NCT00046085|Psychoeducation|psychoeducation
5846282|NCT00046085|Internet|internet
5846283|NCT00046072|Sepsis|sepsis
5846284|NCT00046072|Shock|shock
5846285|NCT00046072|Septic|septic
5843104|NCT00002850|infection|infection
5846286|NCT00046072|Sepsis Syndrome|sepsis syndrome
5846287|NCT00046072|Septicemia|septicemia
5846288|NCT00046072|Endotoxins|endotoxins
5846289|NCT00046072|Endotoxemia|endotoxemia
5846290|NCT00046072|Infection|infection
5846296|NCT00046033|Dose-Relationship, Drug|dose-relationship, drug
5846297|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors
5846298|NCT00046033|Salvage Therapy|salvage therapy
5846299|NCT00046033|Viral Load|viral load
5846300|NCT00046033|RNA, Viral|rna, viral
5846301|NCT00046033|Drug Therapy, Combination|drug therapy, combination
5846302|NCT00046020|Depression|depression
5846303|NCT00045994|cardiovascular|cardiovascular
5846305|NCT00045994|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5846306|NCT00045994|hypertension/*drug therapy|hypertension/*drug therapy
5846307|NCT00045994|blood pressure|blood pressure
5846308|NCT00045981|cardiovascular|cardiovascular
5846310|NCT00045981|antihypertensive agents/therapeutic use|antihypertensive agents/therapeutic use
5846311|NCT00045981|hypertension/*drug therapy|hypertension/*drug therapy
5846312|NCT00045981|blood pressure|blood pressure
5846313|NCT00045968|oncology|oncology
5846314|NCT00045968|neurology|neurology
5846315|NCT00045968|glioma|glioma
5846316|NCT00045968|brain tumor|brain tumor
5846317|NCT00045968|brain cancer|brain cancer
5846318|NCT00045968|glioblastoma multiforme|glioblastoma multiforme
5846319|NCT00045968|glioblastoma|glioblastoma
5846320|NCT00045968|newly diagnosed glioblastoma|newly diagnosed glioblastoma
5846321|NCT00045968|immunotherapy|immunotherapy
5846322|NCT00045968|dendritic cells|dendritic cells
5846323|NCT00045968|immune therapy|immune therapy
5846324|NCT00045968|GBM|gbm
5846325|NCT00045968|Brain cancer, primary|brain cancer, primary
5846326|NCT00045968|tumor vaccine|tumor vaccine
5846327|NCT00045968|grade IV astrocytoma|grade iv astrocytoma
5846328|NCT00045968|DCVax|dcvax
5846329|NCT00045968|Grade IV brain cancer|grade iv brain cancer
5846330|NCT00045942|AML|aml
5846331|NCT00045942|MDS|mds
5846332|NCT00045942|high risk myelodysplastic syndrome|high risk myelodysplastic syndrome
5846333|NCT00045916|Electroconvulsive therapy|electroconvulsive therapy
5846334|NCT00045916|Antidepressive Agents|antidepressive agents
5846335|NCT00045903|Cognitive Behavioral Therapy|cognitive behavioral therapy
5846336|NCT00045877|Low-Grade or Follicular Non-Hodgkin's Lymphoma|low-grade or follicular non-hodgkin's lymphoma
5846337|NCT00045864|Intermediate and High-Grade Non-Hodgkin's Lymphoma|intermediate and high-grade non-hodgkin's lymphoma
5846338|NCT00045838|Healthy|healthy
5846339|NCT00045838|HIV-Negative|hiv-negative
5846340|NCT00045838|Placebo Controlled|placebo controlled
5846341|NCT00045838|Volunteer|volunteer
5846342|NCT00045838|Dose-Escalation|dose-escalation
5846343|NCT00045838|Healthy Volunteers|healthy volunteers
5846344|NCT00045838|HV|hv
5846345|NCT00045838|HIV Seronegativity|hiv seronegativity
5846346|NCT00045838|HIV Preventive Vaccine|hiv preventive vaccine
5846347|NCT00045812|Cholesterol|cholesterol
5846348|NCT00045812|Sitosterol|sitosterol
5846349|NCT00045812|Atherosclerosis|atherosclerosis
5846350|NCT00045812|Intestine|intestine
5846352|NCT00045812|Homozygous Sitosterolemia|homozygous sitosterolemia
5846353|NCT00045812|Sterol Metabolism|sterol metabolism
5846354|NCT00045786|myelodysplastic syndrome|myelodysplastic syndrome
5846355|NCT00044928|Abdominal Infections|abdominal infections
5846356|NCT00044915|Acute Ischemic Stroke Without Hemorrhage|acute ischemic stroke without hemorrhage
5846357|NCT00044889|CLO221|clo221
5846358|NCT00044889|clolar|clolar
5846359|NCT00044863|EGFr|egfr
5846360|NCT00044863|Metastatic Colorectal Carcinoma|metastatic colorectal carcinoma
5846361|NCT00044837|Lopinavir|lopinavir
5846362|NCT00044837|HIV-1|hiv-1
5846363|NCT00044837|HIV Protease Inhibitors|hiv protease inhibitors
5846364|NCT00044837|Ritonavir|ritonavir
5846365|NCT00044837|Postmenopause|postmenopause
5846366|NCT00044837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5846367|NCT00044837|Pharmacokinetics|pharmacokinetics
5846368|NCT00044837|Area Under Curve|area under curve
5846369|NCT00044837|Hormone Replacement Therapy|hormone replacement therapy
5846370|NCT00044837|efavirenz|efavirenz
5846371|NCT00044837|estradiol|estradiol
5846372|NCT00044876|Endometrium|endometrium
5846373|NCT00044876|Progesterone|progesterone
5846374|NCT00044876|Estrogen|estrogen
5846375|NCT00044876|Leiomyoma|leiomyoma
5846376|NCT00044876|Uterine Leiomyoma|uterine leiomyoma
5846377|NCT00044876|Uterine Fibroids|uterine fibroids
5846378|NCT00044876|Fibroids|fibroids
5846379|NCT00044798|Aged|aged
5846380|NCT00044785|colorectal cancer|colorectal cancer
5846381|NCT00044785|gastric cancer|gastric cancer
5846382|NCT00044785|breast cancer|breast cancer
5846383|NCT00044772|Panic|panic
5846384|NCT00044772|Disorder|disorder
5846385|NCT00044759|Hematologic|hematologic
5846386|NCT00044759|Neoplasms|neoplasms
5846387|NCT00044746|Diabetes|diabetes
5846388|NCT00044733|Leukemia|leukemia
5846389|NCT00044733|Stem Cell Transplant|stem cell transplant
5846390|NCT00044720|Kidney Transplant|kidney transplant
5846391|NCT00044707|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5846392|NCT00044694|Diabetes Mellitus, Type 2|diabetes mellitus, type 2
5846393|NCT00044681|Risperidone|risperidone
5846394|NCT00044681|depression|depression
5846395|NCT00044681|melancholia|melancholia
5846396|NCT00044681|depressive disorder|depressive disorder
5846397|NCT00044681|antipsychotic agents|antipsychotic agents
5846398|NCT00044668|exenatide|exenatide
5846399|NCT00044668|exendin-4|exendin-4
5846400|NCT00044668|diabetes|diabetes
5846401|NCT00044668|Amylin|amylin
5846402|NCT00044668|Lilly|lilly
5846403|NCT00044642|Anxiety|anxiety
5846404|NCT00044629|Sleep Deprivation|sleep deprivation
5846405|NCT00044629|Insomnia|insomnia
5846406|NCT00044629|Sleep Disorders|sleep disorders
5846407|NCT00044603|Pregnancy|pregnancy
5846408|NCT00044590|Parkinson's disease|parkinson's disease
5671246|NCT00616590|stage I adenoid cystic carcinoma of the oral cavity|stage i adenoid cystic carcinoma of the oral cavity
5671247|NCT00616590|stage I mucoepidermoid carcinoma of the oral cavity|stage i mucoepidermoid carcinoma of the oral cavity
5671248|NCT00616590|stage I verrucous carcinoma of the oral cavity|stage i verrucous carcinoma of the oral cavity
5671388|NCT00616239|Dark spots on the face|dark spots on the face
5671249|NCT00616590|stage II adenoid cystic carcinoma of the oral cavity|stage ii adenoid cystic carcinoma of the oral cavity
5671250|NCT00616590|stage II mucoepidermoid carcinoma of the oral cavity|stage ii mucoepidermoid carcinoma of the oral cavity
5671251|NCT00616590|stage II verrucous carcinoma of the oral cavity|stage ii verrucous carcinoma of the oral cavity
5671252|NCT00616590|stage III adenoid cystic carcinoma of the oral cavity|stage iii adenoid cystic carcinoma of the oral cavity
5671253|NCT00616590|stage III mucoepidermoid carcinoma of the oral cavity|stage iii mucoepidermoid carcinoma of the oral cavity
5671254|NCT00616590|stage III verrucous carcinoma of the oral cavity|stage iii verrucous carcinoma of the oral cavity
5671255|NCT00616590|stage IV adenoid cystic carcinoma of the oral cavity|stage iv adenoid cystic carcinoma of the oral cavity
5671256|NCT00616590|stage IV mucoepidermoid carcinoma of the oral cavity|stage iv mucoepidermoid carcinoma of the oral cavity
5671257|NCT00616590|stage IV verrucous carcinoma of the oral cavity|stage iv verrucous carcinoma of the oral cavity
5671258|NCT00616590|stage I squamous cell carcinoma of the lip and oral cavity|stage i squamous cell carcinoma of the lip and oral cavity
5671259|NCT00616590|stage II squamous cell carcinoma of the lip and oral cavity|stage ii squamous cell carcinoma of the lip and oral cavity
5671260|NCT00616590|stage III squamous cell carcinoma of the lip and oral cavity|stage iii squamous cell carcinoma of the lip and oral cavity
5671261|NCT00616590|stage IV squamous cell carcinoma of the lip and oral cavity|stage iv squamous cell carcinoma of the lip and oral cavity
5671262|NCT00616590|recurrent basal cell carcinoma of the lip|recurrent basal cell carcinoma of the lip
5671263|NCT00616590|recurrent squamous cell carcinoma of the lip and oral cavity|recurrent squamous cell carcinoma of the lip and oral cavity
5671264|NCT00616590|stage I basal cell carcinoma of the lip|stage i basal cell carcinoma of the lip
5671265|NCT00616590|stage II basal cell carcinoma of the lip|stage ii basal cell carcinoma of the lip
5671266|NCT00616590|stage III basal cell carcinoma of the lip|stage iii basal cell carcinoma of the lip
5671267|NCT00616590|stage IV basal cell carcinoma of the lip|stage iv basal cell carcinoma of the lip
5671490|NCT00615810|LDL|ldl
5672433|NCT00611936|Stress|stress
5673106|NCT00609401|RCC|rcc
5673552|NCT00607815|CPT|cpt
5674515|NCT00603304|BPH|bph
5676314|NCT00595504|rozerem|rozerem
5677420|NCT00590499|outcome|outcome
5678113|NCT00588263|Cancer|cancer
5678444|NCT00586807|UC|uc
5678620|NCT00586053|Colon|colon
5679838|NCT00580294|Opana|opana
5680202|NCT00578708|VSD|vsd
5681783|NCT00571818|kidney|kidney
5683855|NCT00562913|Cancer|cancer
5684896|NCT00558363|PSA|psa
5685406|NCT00556218|QOL|qol
5687037|NCT00549367|HIV|hiv
5687304|NCT00548002|sepsis|sepsis
5687676|NCT00545987|HIV|hiv
5688709|NCT00542152|IBD|ibd
5690461|NCT00536302|CAM|cam
5691694|NCT00531050|COPD|copd
5692654|NCT00527228|MM|mm
5694499|NCT00520884|frailty|frailty
5695189|NCT00517764|MDD|mdd
5695300|NCT00517153|Zavesca|zavesca
5695398|NCT00516685|EGF|egf
5695497|NCT00516308|CLI|cli
5695688|NCT00515541|DHA|dha
5697255|NCT00510068|NET|net
5699753|NCT00501982|RDS|rds
5700318|NCT00500123|AAT|aat
5701294|NCT00497562|FIQ|fiq
5701471|NCT00496873|NHL|nhl
5701566|NCT00496639|stents|stents
5701983|NCT00495079|acute|acute
5703290|NCT00489931|HV|hv
5703553|NCT00488943|AAA|aaa
5703768|NCT00488215|MTD|mtd
5706069|NCT00479271|RCT|rct
5706820|NCT00476606|ARV|arv
5707711|NCT00473447|Arm|arm
5708063|NCT00471913|Femur|femur
5712517|NCT00455572|ASCI|asci
5715557|NCT00445913|safety|safety
5715930|NCT00445237|TMS|tms
5716350|NCT00443651|RA|ra
5716663|NCT00020202|cancer|cancer
5717766|NCT00439569|SMN|smn
5717874|NCT00439205|MDM|mdm
5719216|NCT00434278|CF|cf
5721036|NCT00427843|hip|hip
5722471|NCT00423189|LUV|luv
5722268|NCT00423813|FMS|fms
5722474|NCT00423189|PDT|pdt
5723061|NCT00420719|ALS|als
5723144|NCT00420316|Finland|finland
5723274|NCT00419692|RLS|rls
5723367|NCT00419263|flu|flu
5723604|NCT00418288|PET|pet
5724022|NCT00416741|Obesity|obesity
5725126|NCT00413400|TNF|tnf
5725597|NCT00412009|control|control
5726021|NCT00410592|GERD|gerd
5726502|NCT00408746|maxilla|maxilla
5726739|NCT00407602|RP|rp
5727110|NCT00405717|statin|statin
5727255|NCT00405184|PID|pid
5729224|NCT00397462|DEXA|dexa
5729516|NCT00396292|Anemia|anemia
5730522|NCT00392678|Obesity|obesity
5733397|NCT00381576|CNS|cns
5736580|NCT00370760|PVR|pvr
5738851|NCT00361855|MI|mi
5739591|NCT00359385|DXA|dxa
5739852|NCT00358423|CME|cme
5740134|NCT00357435|Linkage|linkage
5740629|NCT00355732|ICU|icu
5740689|NCT00355524|HIV-1|hiv-1
5741296|NCT00353366|safety|safety
5741997|NCT00351169|MDD|mdd
5746463|NCT00334074|AML|aml
5748801|NCT00324467|PET|pet
5748991|NCT00324103|HIV|hiv
5749991|NCT00319930|CLL|cll
5750619|NCT00317616|ALS|als
5750734|NCT00317239|Anemia|anemia
5750854|NCT00316732|BPH|bph
5752153|NCT00311779|Ova|ova
5755188|NCT00300820|BP|bp
5755456|NCT00299819|Lupus|lupus
5755685|NCT00299156|MDS|mds
5755757|NCT00298857|Healthy|healthy
5755849|NCT00298402|MMP|mmp
5756024|NCT00297570|CML|cml
5756772|NCT00295698|HIV|hiv
5758707|NCT00289237|CHD|chd
5759829|NCT00284115|Stroke|stroke
5760024|NCT00283439|CIT|cit
5760739|NCT00281554|RSD1235|rsd1235
5760684|NCT00281762|AQP-2|aqp-2
5762578|NCT00273650|B12|b12
5762957|NCT00271908|HIV|hiv
5764296|NCT00266773|CBT|cbt
5764944|NCT00264381|STP|stp
5765404|NCT00261846|Myeloid|myeloid
5767315|NCT00254852|DBM|dbm
5771741|NCT00237341|opioid|opioid
5772130|NCT00236145|BTP|btp
5773075|NCT00231205|CAD|cad
5774156|NCT00226005|cancer|cancer
5774760|NCT00223457|hope|hope
5776226|NCT00215852|HIV|hiv
5776444|NCT00214903|HRT|hrt
5777123|NCT00211523|lesions|lesions
5777750|NCT00209040|PTSD|ptsd
5778951|NCT00202345|Iron|iron
5779060|NCT00201994|CHF|chf
5780988|NCT00190398|Open|open
5782653|NCT00181831|ADHD|adhd
5785446|NCT00167830|BMI|bmi
5785532|NCT00167531|Stroke|stroke
5785824|NCT00166179|CAD|cad
5786003|NCT00165347|Myeloma|myeloma
5787016|NCT00160875|CPT11|cpt11
5787797|NCT00156780|safety|safety
5788506|NCT00153504|HIV|hiv
5790530|NCT00143039|NIH|nih
5792107|NCT00135551|PROBE|probe
5792784|NCT00132847|Child|child
5793079|NCT00131716|severe|severe
5793505|NCT00130156|SBP|sbp
5793586|NCT00129792|Insulin|insulin
5793904|NCT00128830|TMC125|tmc125
5794050|NCT00128284|GI|gi
5796965|NCT00117143|ITP|itp
5797478|NCT00115414|TAC|tac
5798039|NCT00113750|Allergy|allergy
5799688|NCT00108810|OA|oa
5802145|NCT00099788|Angina|angina
5807122|NCT00088569|HV|hv
5808861|NCT00086632|ovary|ovary
5813398|NCT00003646|cancer|cancer
5813681|NCT00082030|PET|pet
5821285|NCT00076310|Tarceva|tarceva
5817644|NCT00003647|cancer|cancer
5818469|NCT00079612|Cancer|cancer
5819993|NCT00078091|BBS|bbs
5822002|NCT00074516|Kidney|kidney
5823298|NCT00071370|Seizure|seizure
5828548|NCT00061009|Syncope|syncope
5831382|NCT00054847|CABG|cabg
5832391|NCT00052286|fatigue|fatigue
5846457|NCT00044356|Immunotherapy|immunotherapy
5846462|NCT00044356|Cancerous mole|cancerous mole
5846463|NCT00044356|Melanoma vaccine|melanoma vaccine
5846464|NCT00044356|Cancer research|cancer research
5846465|NCT00044356|Cancer cells|cancer cells
5846466|NCT00044356|Allovectin-7®|allovectin-7®
5846467|NCT00044343|colorectal cancer|colorectal cancer
5846468|NCT00044343|EGFR inhibitor|egfr inhibitor
5846469|NCT00044343|lapatinib|lapatinib
5846470|NCT00044343|metastatic|metastatic
5846472|NCT00044317|Smoking|smoking
5846473|NCT00044317|antioxidents|antioxidents
5846474|NCT00044317|lung growth|lung growth
5846475|NCT00044291|Atamestane|atamestane
5846526|NCT00044239|PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated d|pandas (pediatric autoimmune neuropsychiatric disorders associated d
5846529|NCT00044239|Healthy Volunteers|healthy volunteers
5846530|NCT00044239|HV|hv
5846531|NCT00044226|BPH|bph
5846532|NCT00044226|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5846533|NCT00044226|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5846534|NCT00044226|Enlarged Prostate|enlarged prostate
5846535|NCT00044187|schizoaffective disorder|schizoaffective disorder
5846536|NCT00044187|schizophreniform disorder|schizophreniform disorder
5846537|NCT00044187|bipolar I disorder|bipolar i disorder
5846538|NCT00044200|Phospholipase A2|phospholipase a2
5846539|NCT00044200|Arachidonic Acid|arachidonic acid
5846540|NCT00044200|Blood Flow|blood flow
5846541|NCT00044200|Coupling|coupling
5846542|NCT00044200|Neurotransmission|neurotransmission
5846543|NCT00044200|PET|pet
5846544|NCT00044200|Signal Transduction|signal transduction
5846545|NCT00044200|Activation|activation
5846546|NCT00044200|Brain|brain
5846547|NCT00044200|[15O]H20|[15o]h20
5846550|NCT00044148|Persistent Albuminuria|persistent albuminuria
5846551|NCT00044135|clevudine|clevudine
5846552|NCT00044135|hepatitis B|hepatitis b
5846553|NCT00044070|ARTIST|artist
5846554|NCT00044070|Acute ischemic stroke|acute ischemic stroke
5846555|NCT00044057|ARTIST|artist
5848498|NCT00034541|cetuximab|cetuximab
5846556|NCT00044044|Schizophrenia|schizophrenia
5846557|NCT00044044|Latuda|latuda
5846558|NCT00044044|Lurasidone|lurasidone
5846559|NCT00044031|pancreatic cancer|pancreatic cancer
5846560|NCT00044031|G17DT|g17dt
5846561|NCT00044031|gemcitabine|gemcitabine
5846562|NCT00044018|Revimid|revimid
5846563|NCT00044018|CC5013|cc5013
5846564|NCT00044005|Schizophrenia|schizophrenia
5846565|NCT00044005|Latuda|latuda
5846566|NCT00044005|Lurasidone|lurasidone
5846567|NCT00043329|Registry|registry
5846568|NCT00043329|Actimmune|actimmune
5846569|NCT00043329|osteopetrosis|osteopetrosis
5846571|NCT00044109|Pain|pain
5846573|NCT00044109|Radiculopathy|radiculopathy
5846574|NCT00044109|Electromagnetic Treatment|electromagnetic treatment
5846575|NCT00044109|Back Device|back device
5846576|NCT00044109|Sciatica|sciatica
5846577|NCT00044109|Low Back Pain|low back pain
5846578|NCT00044096|SSRI|ssri
5846579|NCT00044096|Anxiety|anxiety
5846580|NCT00044096|Stress|stress
5846581|NCT00044096|Citalopram|citalopram
5846582|NCT00044096|Benadryl|benadryl
5846583|NCT00044096|Diphenhydramine|diphenhydramine
5846584|NCT00044096|Startle|startle
5846585|NCT00044096|Fear-Potentiated Startle|fear-potentiated startle
5846586|NCT00044096|Fear|fear
5846587|NCT00044096|Normal Volunteers|normal volunteers
5846588|NCT00044096|Healthy Volunteers|healthy volunteers
5846589|NCT00044096|HV|hv
5846590|NCT00044083|Catecholamines|catecholamines
5846591|NCT00044083|Dopamine|dopamine
5846592|NCT00044083|Clinical Trial|clinical trial
5846593|NCT00044083|fMRI|fmri
5846594|NCT00044083|PFC|pfc
5846595|NCT00044083|Vitamin B2|vitamin b2
5846596|NCT00044083|Riboflavin|riboflavin
5846597|NCT00044083|Tolcapone|tolcapone
5846598|NCT00044083|Placebo|placebo
5846599|NCT00044083|Normal Volunteers|normal volunteers
5846600|NCT00044083|Schizophrenia|schizophrenia
5846601|NCT00044083|Healthy Volunteers|healthy volunteers
5846602|NCT00044083|HV|hv
5846603|NCT00043992|Asthma|asthma
5846604|NCT00043992|Allergens|allergens
5846605|NCT00043966|treatment naive|treatment naive
5846606|NCT00043953|treatment naive|treatment naive
5846617|NCT00043979|Rhabdomyosarcoma|rhabdomyosarcoma
5846618|NCT00043979|Desmoplastic Small Round Cell Tumor|desmoplastic small round cell tumor
5846620|NCT00043979|Ewing Sarcoma|ewing sarcoma
5846621|NCT00043940|thrombosis|thrombosis
5846622|NCT00043940|bivalirudin|bivalirudin
5846623|NCT00043940|direct thrombin inhibitor|direct thrombin inhibitor
5846624|NCT00043940|HIT|hit
5846625|NCT00043940|HITTS|hitts
5846626|NCT00043940|HIT/HITTS|hit/hitts
5846627|NCT00043927|Chemotherapy-naive|chemotherapy-naive
5846628|NCT00043927|Small Cell Lung Cancer|small cell lung cancer
5846629|NCT00043927|SCLC|sclc
5846630|NCT00043927|Extensive disease|extensive disease
5846631|NCT00043927|ED|ed
5846632|NCT00043927|topotecan|topotecan
5846633|NCT00043927|Hycamtin|hycamtin
5846634|NCT00043927|oral|oral
5846635|NCT00043914|epilepsy|epilepsy
5846636|NCT00043914|monotherapy conversion|monotherapy conversion
5846637|NCT00043901|PGTC|pgtc
5846638|NCT00043901|Lamotrigine|lamotrigine
5846639|NCT00043901|epilepsy|epilepsy
5846640|NCT00043901|seizures|seizures
5846641|NCT00043901|primary generalized tonic-clonic|primary generalized tonic-clonic
5846642|NCT00043875|partial seizures|partial seizures
5846765|NCT00043407|Renal Cell Carcinoma, Phase I, Phase II, Immunotherapy|renal cell carcinoma, phase i, phase ii, immunotherapy
5846766|NCT00043394|CpG 7909 subcutaneous injection combination with Herceptin® metastatic breast cancer.|cpg 7909 subcutaneous injection combination with herceptin® metastatic breast cancer.
5846767|NCT00043381|myelodysplastic syndrome|myelodysplastic syndrome
5846768|NCT00043381|MDS|mds
5846769|NCT00043381|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia
5846770|NCT00043381|CMML|cmml
5846771|NCT00043381|decitabine|decitabine
5846772|NCT00043381|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5846773|NCT00043368|CPG 7909 continuation study|cpg 7909 continuation study
5846774|NCT00043355|pulmonary|pulmonary
5846775|NCT00043355|mycobacterium avium complex infection|mycobacterium avium complex infection
5846776|NCT00043355|MAC|mac
5846777|NCT00043355|nontuberculous|nontuberculous
5846778|NCT00043355|mycobacteria|mycobacteria
5846779|NCT00043355|lung|lung
5846780|NCT00043342|cystic fibrosis|cystic fibrosis
5846781|NCT00043342|pulmonary impairment|pulmonary impairment
5846787|NCT00043316|cystic fibrosis|cystic fibrosis
5846788|NCT00043316|pulmonary impairment|pulmonary impairment
5846789|NCT00043303|hepatitis C|hepatitis c
5846790|NCT00043303|liver fibrosis|liver fibrosis
5846791|NCT00043303|liver cirrhosis|liver cirrhosis
5846792|NCT00043277|neonates|neonates
5846793|NCT00043277|thrombosis|thrombosis
5846794|NCT00043277|bivalirudin|bivalirudin
5846795|NCT00043277|direct thrombin inhibitor|direct thrombin inhibitor
5846796|NCT00043238|PCBs|pcbs
5846797|NCT00043238|Thyroid|thyroid
5846798|NCT00043238|Hyperactivity|hyperactivity
5846799|NCT00043238|School Performance|school performance
5846800|NCT00043238|Mohawk Tribe|mohawk tribe
5843333|NCT00002663|stage II childhood Hodgkin lymphoma|stage ii childhood hodgkin lymphoma
5846801|NCT00043212|prostate cancer|prostate cancer
5846802|NCT00043212|oncology|oncology
5846803|NCT00043212|urology|urology
5846804|NCT00043212|hormone refractory prostate cancer|hormone refractory prostate cancer
5846805|NCT00043199|Colorectal Neoplasms|colorectal neoplasms
5846806|NCT00043199|Colorectal Cancer|colorectal cancer
5846807|NCT00043199|Colorectal Carcinoma|colorectal carcinoma
5846808|NCT00043199|Colorectal Tumor|colorectal tumor
5846809|NCT00043199|Neoplasms, Colorectal|neoplasms, colorectal
5846810|NCT00043199|Unresectable|unresectable
5846811|NCT00043199|Metastatic|metastatic
5846812|NCT00043199|Refractory|refractory
5846821|NCT00043186|bone loss|bone loss
5846822|NCT00043186|osteoporosis|osteoporosis
5846823|NCT00042718|Chronic Bronchitis|chronic bronchitis
5846824|NCT00042718|Acute Bacterial Exacerbation of Chronic Bronchitis|acute bacterial exacerbation of chronic bronchitis
5846825|NCT00042705|asthma|asthma
5846826|NCT00042705|indoor allergens|indoor allergens
5846827|NCT00042692|catechol thioethers|catechol thioethers
5846828|NCT00042692|Parkinson's disease|parkinson's disease
5846829|NCT00042692|neurodegenerative disease|neurodegenerative disease
5846830|NCT00042679|Non-Small-Cell Lung Cancer|non-small-cell lung cancer
5846831|NCT00042679|Adenocarcinoma|adenocarcinoma
5846832|NCT00042679|Carcinoma Squamous|carcinoma squamous
5846833|NCT00042679|Adult Lung Cancer|adult lung cancer
5846834|NCT00042588|Safety and Efficacy|safety and efficacy
5846835|NCT00042588|Community-Acquired Pneumonia, Sepsis|community-acquired pneumonia, sepsis
5846836|NCT00042575|Sad, blue, lack of energy, depressed, hopelessness, guilt|sad, blue, lack of energy, depressed, hopelessness, guilt
5846837|NCT00042562|Depressed|depressed
5846838|NCT00042562|blues|blues
5846839|NCT00042562|sadness|sadness
5846840|NCT00042562|feelings of guilt|feelings of guilt
5846841|NCT00042562|hopelessness|hopelessness
5846842|NCT00042562|lack of energy|lack of energy
5846843|NCT00042549|Gallstones|gallstones
5846844|NCT00042549|Gallstone|gallstone
5846845|NCT00042549|Biliary stones|biliary stones
5846846|NCT00042549|Gallbladder stones|gallbladder stones
5846847|NCT00042549|Gallbladder|gallbladder
5846848|NCT00042549|Lithotripsy|lithotripsy
5846849|NCT00042549|Cholelithiasis|cholelithiasis
5846850|NCT00042549|ESWL|eswl
5846851|NCT00042549|Shock wave|shock wave
5846852|NCT00042549|Shock waves|shock waves
5846853|NCT00042549|shockwaves|shockwaves
5846854|NCT00042549|shockwave|shockwave
5846855|NCT00042627|Cataracts|cataracts
5846856|NCT00042627|Granulocytapheresis|granulocytapheresis
5846857|NCT00042627|Granulocyte Donors|granulocyte donors
5846858|NCT00042614|Genes|genes
5846859|NCT00042614|Heart|heart
5846860|NCT00042614|Lymphocytes|lymphocytes
5846861|NCT00042614|Proteomics|proteomics
5846863|NCT00042614|Heart Transplant|heart transplant
5846864|NCT00042614|Healthy Volunteer|healthy volunteer
5846866|NCT00042614|Normal Control|normal control
5846867|NCT00042536|Yohimbine|yohimbine
5846868|NCT00042536|Naltrexone|naltrexone
5846885|NCT00042523|Systemic Lupus Erythematosus|systemic lupus erythematosus
5846886|NCT00042510|Gastroesophageal cancer|gastroesophageal cancer
5846887|NCT00042510|Gastric cancer|gastric cancer
5846888|NCT00042484|Asthma|asthma
5846889|NCT00042484|Children's Health|children's health
5846890|NCT00042484|Community Based Research|community based research
5846891|NCT00042445|Neoplasm|neoplasm
5846892|NCT00042445|Petrochemical|petrochemical
5846893|NCT00042445|Leukemia|leukemia
5846894|NCT00042445|Taiwan|taiwan
5846895|NCT00042419|Industrial Injuries|industrial injuries
5846896|NCT00042419|Tendonitis|tendonitis
5846897|NCT00042419|Assembly Line|assembly line
5846898|NCT00042393|Hepatitis B, Chronic|hepatitis b, chronic
5846899|NCT00042354|CLO222|clo222
5846900|NCT00042354|clolar|clolar
5846901|NCT00042354|Pediatric Acute Myelogenous Leukemia|pediatric acute myelogenous leukemia
5846902|NCT00042341|CLO212|clo212
5846903|NCT00042341|clolar|clolar
5846904|NCT00042341|pediatric ALL|pediatric all
5846905|NCT00042341|Leukemia, Lymphoblastic, Acute - pediatric|leukemia, lymphoblastic, acute - pediatric
5846906|NCT00042328|Cancer|cancer
5846907|NCT00042289|Pregnancy|pregnancy
5846908|NCT00042289|Pharmacokinetics|pharmacokinetics
5846909|NCT00042289|Treatment Experienced|treatment experienced
5846910|NCT00041483|AMD|amd
5846911|NCT00041483|age-related macular degeneration|age-related macular degeneration
5846912|NCT00041483|Anecortave|anecortave
5846913|NCT00041483|Acetate|acetate
5846914|NCT00041483|Wet form of age-related macular degeneration|wet form of age-related macular degeneration
5846915|NCT00042380|Antidepressant|antidepressant
5846916|NCT00042380|Anxiety|anxiety
5846917|NCT00042380|Dopamine|dopamine
5846918|NCT00042380|Tyrosine Kinase Inhibitor|tyrosine kinase inhibitor
5846919|NCT00042380|Affective Disorder|affective disorder
5846920|NCT00042380|Phytoestrogen|phytoestrogen
5846921|NCT00042380|Genistein|genistein
5846922|NCT00042380|Major Depression|major depression
5846923|NCT00042380|Depression|depression
5846924|NCT00042276|Pressure Pain Threshold|pressure pain threshold
5846925|NCT00042276|MTrP|mtrp
5846926|NCT00042276|Musculoskeletal Pain|musculoskeletal pain
5846927|NCT00042276|Soft Tissue Pain|soft tissue pain
5846928|NCT00042276|Pathophysiology|pathophysiology
5846929|NCT00042276|Myofascial Pain|myofascial pain
5846930|NCT00042276|Microdialysis|microdialysis
5846931|NCT00042276|Myofascial Trigger Points|myofascial trigger points
5846932|NCT00042276|Rehabilitation|rehabilitation
5846933|NCT00042276|Muscle Pain|muscle pain
5846934|NCT00042276|Neck Pain|neck pain
5846935|NCT00042276|Healthy Volunteer|healthy volunteer
5846936|NCT00042276|HV|hv
5846937|NCT00042276|Normal Control|normal control
5846938|NCT00042263|health disparities|health disparities
5846939|NCT00042263|social environment|social environment
5846940|NCT00042263|physical environment|physical environment
5846941|NCT00042263|racial health disparities|racial health disparities
5846942|NCT00042250|Cell Cycle Interphase|cell cycle interphase
5846943|NCT00042250|G0|g0
5846944|NCT00042250|G1|g1
5846945|NCT00042250|G2|g2
5846946|NCT00042250|S Phase|s phase
5846947|NCT00042237|Child Abuse, Sexual|child abuse, sexual
5846948|NCT00042224|Electroconvulsive Therapy|electroconvulsive therapy
5846949|NCT00042211|Depressive Disorder|depressive disorder
5846950|NCT00042211|Blindness|blindness
5846951|NCT00042211|Aged|aged
5846952|NCT00042198|Cognitive therapy|cognitive therapy
5846953|NCT00042198|Relaxation techniques|relaxation techniques
5846954|NCT00042185|Adolescence|adolescence
5846955|NCT00042185|Prevention and Control|prevention and control
5846957|NCT00042172|Cognition|cognition
5846958|NCT00042172|Memory|memory
5846959|NCT00042159|Auditory hallucinations (voices)|auditory hallucinations (voices)
5846960|NCT00042146|Insomnia|insomnia
5846961|NCT00042146|Sleep Disorders|sleep disorders
5846962|NCT00042146|Sleep Deprivation|sleep deprivation
5846963|NCT00042133|aging|aging
5846964|NCT00042133|disability|disability
5846965|NCT00042133|longitudinal studies|longitudinal studies
5846966|NCT00042133|neighborhood factors|neighborhood factors
5846967|NCT00042133|socio-economic status|socio-economic status
5846968|NCT00042133|race|race
5846969|NCT00042120|Parkinson's disease|parkinson's disease
5846970|NCT00042120|Movement Disorders|movement disorders
5846971|NCT00042120|Epidemiological Study|epidemiological study
5846972|NCT00042107|Parkinson Disease|parkinson disease
5846973|NCT00042107|Neurodegenerative|neurodegenerative
5846974|NCT00042094|Smallpox|smallpox
5846975|NCT00042094|Smallpox Vaccine|smallpox vaccine
5846976|NCT00042094|Vaccinia|vaccinia
5846977|NCT00042081|CABG|cabg
5846978|NCT00042081|coronary artery bypass surgery|coronary artery bypass surgery
5846979|NCT00042081|coronary artery disease|coronary artery disease
5846980|NCT00042081|coronary arteriosclerosis|coronary arteriosclerosis
5846981|NCT00042081|coronary stenosis|coronary stenosis
5846982|NCT00042081|coronary occlusion|coronary occlusion
5846983|NCT00042055|Crohn's Disease|crohn's disease
5846984|NCT00042055|Inflammatory Bowel Disease|inflammatory bowel disease
5846985|NCT00042016|Chronic myelogenous leukemia|chronic myelogenous leukemia
5846986|NCT00042016|CML|cml
5846987|NCT00042016|CML-CP|cml-cp
5846996|NCT00042003|Chronic myelogenous leukemia|chronic myelogenous leukemia
5846997|NCT00042003|CML|cml
5846998|NCT00042003|CML-BP|cml-bp
5846999|NCT00042003|Blast phase|blast phase
5847000|NCT00042003|Decitabine|decitabine
5847001|NCT00042003|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5847002|NCT00042003|Methylation|methylation
5847003|NCT00042003|STI 571|sti 571
5847004|NCT00042003|Imatinib mesylate|imatinib mesylate
5847007|NCT00041990|Chronic myelogenous leukemia|chronic myelogenous leukemia
5847008|NCT00041990|CML|cml
5847009|NCT00041990|CML-AP|cml-ap
5847010|NCT00041990|Accelerated phase|accelerated phase
5847011|NCT00041990|Decitabine|decitabine
5847012|NCT00041990|5-aza-2'deoxycytidine|5-aza-2'deoxycytidine
5847013|NCT00041990|Methylation|methylation
5847014|NCT00041990|STI 571|sti 571
5847015|NCT00041990|Imatinib mesylate|imatinib mesylate
5847016|NCT00041990|Gleevec|gleevec
5847017|NCT00041990|BCR/ABL|bcr/abl
5847018|NCT00041977|Rosacea|rosacea
5847019|NCT00041964|Lopinavir|lopinavir
5847020|NCT00041964|Pregnancy Trimester, Third|pregnancy trimester, third
5847021|NCT00041964|Pregnancy Complications, Infectious|pregnancy complications, infectious
5847022|NCT00041964|HIV Protease Inhibitors|hiv protease inhibitors
5847023|NCT00041964|Ritonavir|ritonavir
5847024|NCT00041964|Nelfinavir|nelfinavir
5847025|NCT00041964|Viral Load|viral load
5847026|NCT00041964|puerperium|puerperium
5847027|NCT00041951|Childhood Absence Epilepsy|childhood absence epilepsy
5847028|NCT00041951|CAE|cae
5847029|NCT00041951|Petit Mal|petit mal
5847030|NCT00041951|Epilepsy|epilepsy
5847031|NCT00041951|Seizures|seizures
5847032|NCT00041951|Genes|genes
5847033|NCT00041951|Inheritance|inheritance
5847034|NCT00041951|Genetics|genetics
5847035|NCT00041951|Genetic Linkage|genetic linkage
5847036|NCT00041938|heart disease|heart disease
5847037|NCT00041938|stroke|stroke
5847038|NCT00041938|ischemic heart disease|ischemic heart disease
5847039|NCT00041938|myocardial infarction|myocardial infarction
5847040|NCT00041938|atrial fibrillation|atrial fibrillation
5847041|NCT00041938|low ejection fraction|low ejection fraction
5847042|NCT00041938|cardiac failure|cardiac failure
5847044|NCT00041938|Warfarin|warfarin
5847045|NCT00041938|anticoagulant|anticoagulant
5847046|NCT00041925|atherosclerotic vascular disease|atherosclerotic vascular disease
5847047|NCT00041925|chronic critical limb ischemia|chronic critical limb ischemia
5847048|NCT00041925|neointimal hyperplasia|neointimal hyperplasia
5847049|NCT00041925|peripheral vein bypass|peripheral vein bypass
5847050|NCT00041925|infra-inguinal bypass grafting surgery|infra-inguinal bypass grafting surgery
5847051|NCT00041925|graft stenosis|graft stenosis
5847052|NCT00041925|occluded grafts|occluded grafts
5847053|NCT00041860|Benzene|benzene
5847054|NCT00041860|Air pollution|air pollution
5847055|NCT00041847|gene|gene
5847056|NCT00041847|environment|environment
5847057|NCT00041847|occupation|occupation
5847058|NCT00041847|diet|diet
5847059|NCT00041847|interaction|interaction
5847060|NCT00041834|childhood asthma|childhood asthma
5847061|NCT00041834|traffic|traffic
5847062|NCT00041821|rhinitis|rhinitis
5847063|NCT00041821|irritation|irritation
5847064|NCT00041821|trigeminal|trigeminal
5847065|NCT00041899|Progesterone|progesterone
5847066|NCT00041899|Cortisol|cortisol
5847067|NCT00041899|Menstrual Cycle|menstrual cycle
5847068|NCT00041899|Formulation|formulation
5847069|NCT00041899|Endometrium|endometrium
5847070|NCT00041899|Estrogen|estrogen
5847071|NCT00041886|Minimally Invasive Surgery|minimally invasive surgery
5847072|NCT00041886|Percutaneous|percutaneous
5847073|NCT00041886|Radiofrequency Ablation|radiofrequency ablation
5847074|NCT00041886|Soft Tissue Metastases|soft tissue metastases
5847075|NCT00041886|Thermal Ablation|thermal ablation
5847076|NCT00041886|Soft Tissue Neoplasm|soft tissue neoplasm
5847077|NCT00041886|Tumor|tumor
5847078|NCT00041808|Metastatic liver cancer|metastatic liver cancer
5847079|NCT00041808|Cholangiocarcinoma|cholangiocarcinoma
5847080|NCT00041808|colorectal cancer|colorectal cancer
5847081|NCT00041808|esophageal cancer|esophageal cancer
5847082|NCT00041808|gastric cancer|gastric cancer
5847083|NCT00041808|pancreatic cancer|pancreatic cancer
5847084|NCT00041808|breast cancer|breast cancer
5847085|NCT00041808|malignant melanoma|malignant melanoma
5847086|NCT00041808|sarcoma|sarcoma
5847087|NCT00041808|GIST|gist
5847088|NCT00041808|gastrointestinal stromal tumor|gastrointestinal stromal tumor
5847089|NCT00041808|lung cancer|lung cancer
5847090|NCT00041808|liver cancer|liver cancer
5847091|NCT00041782|Deep Vein Thrombosis|deep vein thrombosis
5847092|NCT00041769|Drug Therapy, Combination|drug therapy, combination
5847093|NCT00041769|HIV Protease Inhibitors|hiv protease inhibitors
5847094|NCT00041769|Salvage Therapy|salvage therapy
5847095|NCT00041769|Viral Load|viral load
5847096|NCT00041769|Treatment Experienced|treatment experienced
5847097|NCT00041756|Primary Disease: Knee Primary Osteoarthritis|primary disease: knee primary osteoarthritis
5847099|NCT00041730|vaccine|vaccine
5847100|NCT00041730|idiotype|idiotype
5847101|NCT00041730|KLH|klh
5847102|NCT00041730|GM-CSF|gm-csf
5847103|NCT00041730|FavId|favid
5847104|NCT00041717|spinal cord injury|spinal cord injury
5847106|NCT00041704|Azole-Refractory Mucosal Candidiasis|azole-refractory mucosal candidiasis
5847107|NCT00041704|Mucosal Candidiasis|mucosal candidiasis
5847108|NCT00041691|Colorectal Cancer|colorectal cancer
5847109|NCT00041691|Colon Cancer|colon cancer
5847110|NCT00041691|Rectal Cancer|rectal cancer
5847111|NCT00041691|Colorectal Neoplasms|colorectal neoplasms
5847112|NCT00041691|Colorectal Carcinoma|colorectal carcinoma
5847113|NCT00041691|Colorectal Tumor|colorectal tumor
5847114|NCT00041678|Psychosis Associated with Dementia of the Alzheimer's Type|psychosis associated with dementia of the alzheimer's type
5847115|NCT00041652|Colorectal Cancer|colorectal cancer
5847116|NCT00041652|Colon Cancer|colon cancer
5847117|NCT00041652|Rectal Cancer|rectal cancer
5847118|NCT00041652|Colorectal Neoplasms|colorectal neoplasms
5847119|NCT00041652|Colorectal Carcinoma|colorectal carcinoma
5847120|NCT00041652|Breast Cancer|breast cancer
5847121|NCT00041652|Breast Neoplasms|breast neoplasms
5847122|NCT00041639|Pancreatic Cancer|pancreatic cancer
5847123|NCT00041639|Pancreatic Carcinoma|pancreatic carcinoma
5847124|NCT00041639|Pancreatic Neoplasms|pancreatic neoplasms
5847125|NCT00041639|Pancreas Cancer|pancreas cancer
5847126|NCT00041639|Pancreatic Tumor|pancreatic tumor
5847127|NCT00041626|Recurrent Squamous Cell Carcinoma of the Head and Neck|recurrent squamous cell carcinoma of the head and neck
5847128|NCT00041613|Refractory Squamous Cell Carcinoma of the Head and Neck|refractory squamous cell carcinoma of the head and neck
5847129|NCT00041600|epilepsy|epilepsy
5847130|NCT00041600|seizures|seizures
5847131|NCT00041600|disorders of human cognition|disorders of human cognition
5847132|NCT00041600|neuronal migration|neuronal migration
5847133|NCT00041600|neuronal migration disorders|neuronal migration disorders
5847134|NCT00041600|lissencephaly|lissencephaly
5847135|NCT00041600|schizencephaly|schizencephaly
5847136|NCT00041600|polymicrogyria|polymicrogyria
5847137|NCT00041600|agenesis of the corpus callosum|agenesis of the corpus callosum
5847138|NCT00041600|heterotopia|heterotopia
5847139|NCT00041587|Cancer|cancer
5847140|NCT00041587|Recurrent resectable supratentorial malignant glioma|recurrent resectable supratentorial malignant glioma
5843511|NCT00002641|adult angiosarcoma|adult angiosarcoma
5847141|NCT00041509|venous thromboembolism|venous thromboembolism
5847142|NCT00041509|thromboembolism|thromboembolism
5847143|NCT00041509|pulmonary embolism|pulmonary embolism
5847144|NCT00041509|deep vein thrombosis|deep vein thrombosis
5847145|NCT00041496|symptomatic atrial fibrillation|symptomatic atrial fibrillation
5847146|NCT00041496|persistent atrial fibrillation|persistent atrial fibrillation
5847147|NCT00041561|Acute hypoxemic respiratory failure|acute hypoxemic respiratory failure
5847148|NCT00041535|Eye Movements|eye movements
5847149|NCT00041535|Saccades|saccades
5847150|NCT00041535|Metabolic|metabolic
5847153|NCT00041535|Gaucher Disease|gaucher disease
5847154|NCT00041535|Neuronopathic Gaucher Disease|neuronopathic gaucher disease
5847155|NCT00040677|sickle cell anemia|sickle cell anemia
5847156|NCT00040677|sickle cell disease|sickle cell disease
5847157|NCT00040677|anemia|anemia
5847158|NCT00040677|ICA-17043|ica-17043
5847159|NCT00040677|senicapoc|senicapoc
5847160|NCT00040664|pediatrics|pediatrics
5847161|NCT00040664|HIV|hiv
5847162|NCT00040664|protease inhibitors|protease inhibitors
5847163|NCT00040664|ritonavir|ritonavir
5847164|NCT00040664|fosamprenavir|fosamprenavir
5847165|NCT00040664|LEXIVA|lexiva
5847166|NCT00040664|AGENERASE|agenerase
5847167|NCT00040664|amprenavir|amprenavir
5847168|NCT00040651|Systemic Sclerosis|systemic sclerosis
5847169|NCT00040651|Chemotherapy|chemotherapy
5847170|NCT00040651|Cyclophosphamide|cyclophosphamide
5847171|NCT00040651|Fludarabine|fludarabine
5847179|NCT00040027|hepatitis C, chronic|hepatitis c, chronic
5847180|NCT00040599|Colon Cancer|colon cancer
5847181|NCT00040599|Rectal Cancer|rectal cancer
5847182|NCT00040599|Colorectal Neoplasms|colorectal neoplasms
5847183|NCT00040599|Colorectal Carcinoma|colorectal carcinoma
5847184|NCT00040599|Colorectal Tumor|colorectal tumor
5847185|NCT00040586|hormone-refractory|hormone-refractory
5847186|NCT00040573|Brain neoplasm|brain neoplasm
5847187|NCT00040573|Clinical trial, phase I/II|clinical trial, phase i/ii
5847188|NCT00040560|Lung Cancer|lung cancer
5847189|NCT00040560|Metastatic Brain Cancer|metastatic brain cancer
5847190|NCT00040547|Cancer-Advanced Solid Tumors|cancer-advanced solid tumors
5847191|NCT00040534|Advanced Cancer|advanced cancer
5847192|NCT00040521|Crohn's Disease|crohn's disease
5847193|NCT00040521|Active Crohns Disease|active crohns disease
5847194|NCT00040495|Peptic|peptic
5847195|NCT00040495|Ulcer|ulcer
5847196|NCT00040495|Hemorrhage|hemorrhage
5847197|NCT00040456|Hemoglobin SC disease|hemoglobin sc disease
5847198|NCT00040456|sickle cell-hemoglobin|sickle cell-hemoglobin
5847199|NCT00040443|Mild Cognitive Impairment|mild cognitive impairment
5847200|NCT00040443|Memory Loss|memory loss
5847201|NCT00040443|Alzheimer's Disease|alzheimer's disease
5847202|NCT00040443|Brain Aging|brain aging
5847203|NCT00040443|Ampalex®|ampalex®
5847204|NCT00040443|CX516|cx516
5847210|NCT00040508|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5847211|NCT00040508|FSGS|fsgs
5847212|NCT00040404|Parkinson's disease|parkinson's disease
5847213|NCT00040404|Idiopathic Parkinson's disease|idiopathic parkinson's disease
5847214|NCT00040404|Idiopathic Parkinson disease|idiopathic parkinson disease
5847215|NCT00040404|Parkinson's disease, idiopathic|parkinson's disease, idiopathic
5847216|NCT00040391|Pharmacia|pharmacia
5847217|NCT00040378|Alzheimer Disease|alzheimer disease
5847218|NCT00040378|Vitamin E|vitamin e
5847219|NCT00040378|Selenium|selenium
5847220|NCT00040365|Prostate Cancer|prostate cancer
5847221|NCT00040365|Radiation Therapy|radiation therapy
5847222|NCT00040365|Rectal Toxicity|rectal toxicity
5847223|NCT00040365|Amifostine|amifostine
5847224|NCT00040365|Radioprotector|radioprotector
5847231|NCT00040339|brain injury|brain injury
5847232|NCT00040339|hypothermia|hypothermia
5847233|NCT00040339|body cooling|body cooling
5847234|NCT00040339|body temperature|body temperature
5847235|NCT00040326|epilepsy|epilepsy
5847236|NCT00040326|mesial temporal lobe epilepsy|mesial temporal lobe epilepsy
5847237|NCT00040326|temporal lobe epilepsy|temporal lobe epilepsy
5847238|NCT00040326|MTLE|mtle
5847239|NCT00040326|seizures|seizures
5847240|NCT00040326|anteromesial temporal resection|anteromesial temporal resection
5847241|NCT00040326|surgery|surgery
5847242|NCT00040326|antiepileptic drugs|antiepileptic drugs
5847243|NCT00040326|hippocampal sclerosis|hippocampal sclerosis
5847244|NCT00040300|treatment experienced|treatment experienced
5847245|NCT00040300|HIV|hiv
5847246|NCT00040300|Phase I|phase i
5847247|NCT00040300|Combination Therapy|combination therapy
5847248|NCT00040287|smoking|smoking
5847249|NCT00040287|obesity|obesity
5847250|NCT00040287|weight loss|weight loss
5847251|NCT00040287|smoking cessation|smoking cessation
5847252|NCT00040287|weight control|weight control
5847253|NCT00040274|HIV|hiv
5847254|NCT00040274|Phase I|phase i
5847255|NCT00040183|Tarceva, EGFR, erlotinib, OSI-774|tarceva, egfr, erlotinib, osi-774
5847256|NCT00040170|Adenocarcinoma of the prostate|adenocarcinoma of the prostate
5847257|NCT00040157|treatment experienced,|treatment experienced,
5847258|NCT00040157|Stable triple anti-retroviral combination therapy in HIV-infected,|stable triple anti-retroviral combination therapy in hiv-infected,
5847259|NCT00040157|Achillion|achillion
5847260|NCT00040144|E-Antigen positive,|e-antigen positive,
5847261|NCT00040144|Lamivudine-Resistant Chronic Hepatitis B,|lamivudine-resistant chronic hepatitis b,
5847262|NCT00040144|Achillion|achillion
5847263|NCT00040261|Antiglutamatergic|antiglutamatergic
5847264|NCT00040261|Neuroprotective|neuroprotective
5847265|NCT00040261|Unipolar Depression|unipolar depression
5847266|NCT00040261|Treatment|treatment
5847267|NCT00040261|Antidepressant|antidepressant
5847268|NCT00040261|Depression|depression
5847269|NCT00040261|Glutamate|glutamate
5847270|NCT00040261|Memantine|memantine
5847271|NCT00040261|Pathophysiology|pathophysiology
5847272|NCT00040261|Positron Emission Tomography|positron emission tomography
5847273|NCT00040261|Major Depression|major depression
5847274|NCT00040248|Relapse|relapse
5847275|NCT00040248|Monoclonal Antibody|monoclonal antibody
5847276|NCT00040248|Biologic Agent|biologic agent
5847277|NCT00040248|Anti-CD25|anti-cd25
5847288|NCT00040235|HV|hv
5847289|NCT00040235|Normal Control|normal control
5847300|NCT00040209|JP 1730|jp 1730
5847301|NCT00040209|Dyskinesias|dyskinesias
5847302|NCT00040209|Levodopa Infusion|levodopa infusion
5847303|NCT00040209|Apomorphine Infusion|apomorphine infusion
5847304|NCT00040209|Clinical Trial|clinical trial
5847305|NCT00040209|Parkinson Disease|parkinson disease
5847307|NCT00040196|Parkinson's Disease|parkinson's disease
5847308|NCT00040196|Levodopa|levodopa
5847309|NCT00040196|Perfusion fMRI|perfusion fmri
5847310|NCT00040196|Aging|aging
5847311|NCT00040196|Motor Control|motor control
5847312|NCT00040196|PD|pd
5847316|NCT00040105|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
5847317|NCT00040105|R115777|r115777
5847318|NCT00040105|Zarnestra|zarnestra
5847319|NCT00040105|Tipifarnib|tipifarnib
5847320|NCT00040105|Imatinib Mesylate|imatinib mesylate
5847321|NCT00040105|Gleevec|gleevec
5847322|NCT00040105|Imatinib|imatinib
5847323|NCT00040105|STI571|sti571
5847324|NCT00040105|NSC-716051|nsc-716051
5847325|NCT00040092|Virulizin|virulizin
5847326|NCT00040092|Immunotherapy|immunotherapy
5847327|NCT00040092|Pancreas|pancreas
5847328|NCT00040092|Pancreatic Cancer|pancreatic cancer
5847329|NCT00040092|clinical trial|clinical trial
5847330|NCT00039988|Treatment Outcome|treatment outcome
5847331|NCT00039988|Multiple Sclerosis|multiple sclerosis
5847332|NCT00039988|Albuterol|albuterol
5847333|NCT00039988|Copolymer 1|copolymer 1
5847334|NCT00039975|Drug Interactions|drug interactions
5847335|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors
5847336|NCT00039975|Ritonavir|ritonavir
5847337|NCT00039975|Indinavir|indinavir
5847338|NCT00039975|Calcium Channel Blockers|calcium channel blockers
5847339|NCT00039975|Pharmacokinetics|pharmacokinetics
5847340|NCT00039975|Diltiazem|diltiazem
5847341|NCT00039975|Amlodipine|amlodipine
5847342|NCT00039962|hepatitis C|hepatitis c
5847343|NCT00039962|hepatitis C, chronic|hepatitis c, chronic
5847344|NCT00039962|cirrhosis, liver|cirrhosis, liver
5847345|NCT00039936|Binge Eating|binge eating
5847346|NCT00039936|Obesity|obesity
5847347|NCT00039936|Cognitive|cognitive
5847348|NCT00039936|Behavior|behavior
5847349|NCT00040053|amphetamine dependence|amphetamine dependence
5847350|NCT00039923|Hemolysis|hemolysis
5847351|NCT00039923|CD55|cd55
5847352|NCT00039923|CD59|cd59
5847353|NCT00039923|Transfusion|transfusion
5847354|NCT00039923|Paroxysmal Nocturnal Hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5847355|NCT00039923|PNH|pnh
5847356|NCT00039884|Cervical cancer|cervical cancer
5847357|NCT00039858|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia
5847358|NCT00039858|heparin-induced thrombocytopenia and thrombosis|heparin-induced thrombocytopenia and thrombosis
5847359|NCT00039858|HIT|hit
5847360|NCT00039858|HITTS|hitts
5847361|NCT00039858|anticoagulation|anticoagulation
5847362|NCT00039845|Brain|brain
5847382|NCT00039793|human therapy evaluation|human therapy evaluation
5847383|NCT00039793|physical therapy|physical therapy
5847384|NCT00039793|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
5847385|NCT00039793|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
5847386|NCT00039780|Breast|breast
5847387|NCT00039780|Cancer|cancer
5847388|NCT00039780|Metastatic|metastatic
5847389|NCT00039780|Paclitaxel|paclitaxel
5847390|NCT00039780|Peripheral|peripheral
5847391|NCT00039780|Taxol|taxol
5847392|NCT00039780|Neuropathy|neuropathy
5847393|NCT00039780|Neurotoxicity|neurotoxicity
5847394|NCT00039780|Paresthesias|paresthesias
5847395|NCT00039780|Weekly|weekly
5847396|NCT00039780|BNP7787|bnp7787
5847397|NCT00039780|7787|7787
5847398|NCT00039780|Tavocept|tavocept
5847399|NCT00039780|Prevention|prevention
5847400|NCT00039819|Spinal Cord|spinal cord
5847401|NCT00039819|Sensory Stimulation|sensory stimulation
5847402|NCT00039819|Locomotion|locomotion
5847403|NCT00039819|Magnetic Stimulation|magnetic stimulation
5847404|NCT00039819|Reflexes|reflexes
5847405|NCT00039819|Healthy Volunteer|healthy volunteer
5847406|NCT00039819|HV|hv
5847407|NCT00039819|Normal Control|normal control
5847408|NCT00039754|Multiple myeloma|multiple myeloma
5847409|NCT00039754|Transplant|transplant
5847410|NCT00039754|Skeletal Targeted Radiotherapy|skeletal targeted radiotherapy
5847411|NCT00039754|Holmium|holmium
5847412|NCT00039741|Drug Therapy, Combination|drug therapy, combination
5847413|NCT00039741|HIV Protease Inhibitors|hiv protease inhibitors
5847414|NCT00039741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5847415|NCT00039741|Viral Load|viral load
5847416|NCT00039741|Treatment Naive|treatment naive
5847417|NCT00039767|Fibrin Sleeves|fibrin sleeves
5847418|NCT00039767|Anticoagulants|anticoagulants
5847419|NCT00039767|Catheters|catheters
5847420|NCT00039767|Thrombosis|thrombosis
5847421|NCT00039767|Hirudin|hirudin
5847422|NCT00039767|Lepirudin|lepirudin
5847423|NCT00039026|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
5847424|NCT00039000|Immunotherapy, Cancer, Melanoma, Skin Cancer, tumor|immunotherapy, cancer, melanoma, skin cancer, tumor
5847425|NCT00038987|Smallpox|smallpox
5847426|NCT00038987|APSV|apsv
5847427|NCT00038987|Aventis Pasteur Smallpox Vaccine|aventis pasteur smallpox vaccine
5847428|NCT00038987|vaccinia-naive|vaccinia-naive
5847429|NCT00038974|Hepatitis C|hepatitis c
5847430|NCT00038974|Interferon|interferon
5847431|NCT00038974|Ribavirin|ribavirin
5847433|NCT00038974|Viral load|viral load
5847434|NCT00038974|Genetics|genetics
5847435|NCT00038974|Cytokines|cytokines
5847436|NCT00038974|Immunology|immunology
5847437|NCT00038961|fondaparinux sodium|fondaparinux sodium
5847438|NCT00038961|DVT Prevention|dvt prevention
5847439|NCT00038961|abdominal surgery|abdominal surgery
5847440|NCT00038961|VTE prevention|vte prevention
5847453|NCT00039715|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5847454|NCT00039715|Healthy Volunteer|healthy volunteer
5847455|NCT00039715|HV|hv
5847456|NCT00039715|Normal Control|normal control
5847457|NCT00039702|Nicotinic Acetylcholine Receptors|nicotinic acetylcholine receptors
5847458|NCT00039702|Alzheimer's Disease|alzheimer's disease
5847459|NCT00039702|SPECT|spect
5847460|NCT00039702|AD|ad
5847461|NCT00039702|Healthy Volunteer|healthy volunteer
5847462|NCT00039702|HV|hv
5847463|NCT00039702|Normal Control|normal control
5847479|NCT00039663|Insulin Resistance|insulin resistance
5847480|NCT00039663|Coronary Artery Disease|coronary artery disease
5847481|NCT00039663|Lipodystrophy|lipodystrophy
5847482|NCT00039663|Antiretroviral Therapy|antiretroviral therapy
5847483|NCT00039663|HIV Infection|hiv infection
5847484|NCT00039663|Treatment Experienced|treatment experienced
5847485|NCT00039650|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5847486|NCT00039650|T Cells|t cells
5847487|NCT00039650|Peripheral Blood Stem Cells|peripheral blood stem cells
5847488|NCT00039650|Apheresis|apheresis
5847489|NCT00039650|Hematopoietic Progenitor Cell Transplantation|hematopoietic progenitor cell transplantation
5847490|NCT00039650|Healthy Volunteer|healthy volunteer
5847491|NCT00039650|HV|hv
5847492|NCT00039650|Normal Control|normal control
5847493|NCT00039624|Radiation Therapy|radiation therapy
5847494|NCT00039624|Prostate|prostate
5847495|NCT00039624|MRI|mri
5847496|NCT00039624|Brachytherapy|brachytherapy
5847497|NCT00039624|Phase II|phase ii
5847498|NCT00039624|Prostate Cancer|prostate cancer
5847499|NCT00038948|Renal|renal
5847500|NCT00038948|Allograft|allograft
5847501|NCT00038948|Recipients|recipients
5847502|NCT00038935|Hemophilia|hemophilia
5847503|NCT00038922|Left-Sided|left-sided
5847504|NCT00038922|Ulcerative|ulcerative
5847505|NCT00038922|Colitis|colitis
5847506|NCT00038896|Panic|panic
5847507|NCT00038896|Disorder|disorder
5847508|NCT00038883|Lymphoid Malignancies|lymphoid malignancies
5847509|NCT00038883|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5847510|NCT00038883|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5847511|NCT00038883|Low grade Lymphoma|low grade lymphoma
5847512|NCT00038883|B and T cell Lymphoma of the intermediate and high grade|b and t cell lymphoma of the intermediate and high grade
5847513|NCT00038870|AML|aml
5847514|NCT00038870|CML|cml
5847515|NCT00038870|Dendritic Cells|dendritic cells
5847516|NCT00038857|Acute Myelogenous Leukemia|acute myelogenous leukemia
5847517|NCT00038857|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5847518|NCT00038857|Myelodysplastic Syndrome|myelodysplastic syndrome
5847519|NCT00038857|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5847520|NCT00038857|Leukemia|leukemia
5847521|NCT00038857|Lymphoma|lymphoma
5847522|NCT00038857|Non Hodgkin's Lymphoma|non hodgkin's lymphoma
5847523|NCT00038857|T cell depletion|t cell depletion
5847524|NCT00038857|CD34 selected progenitors cell|cd34 selected progenitors cell
5847525|NCT00038857|GVHD|gvhd
5847526|NCT00038844|Lymphoma|lymphoma
5847527|NCT00038844|Leukemia|leukemia
5847528|NCT00038844|Campath-1 H|campath-1 h
5847529|NCT00038844|Campath|campath
5847530|NCT00038844|Alemtuzumab|alemtuzumab
5847531|NCT00038844|Fludarabine|fludarabine
5847532|NCT00038844|Fludarabine Phosphate|fludarabine phosphate
5847533|NCT00038844|Fludara|fludara
5847534|NCT00038844|Cyclophosphamide|cyclophosphamide
5847535|NCT00038844|Cytoxan|cytoxan
5847536|NCT00038844|Neosar|neosar
5847537|NCT00038844|Rituxan|rituxan
5847538|NCT00038844|Rituximab|rituximab
5847539|NCT00038831|Acute Myelogenous leukemia|acute myelogenous leukemia
5847541|NCT00038831|Myelodysplastic Syndrome|myelodysplastic syndrome
5847542|NCT00038831|MDS|mds
5847543|NCT00038831|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5847544|NCT00038831|CML|cml
5847545|NCT00038831|Mylotarg|mylotarg
5847546|NCT00038831|Gemtuzumab|gemtuzumab
5847547|NCT00038831|Gemtuzumab ozogamicin|gemtuzumab ozogamicin
5847548|NCT00038831|Melphalan|melphalan
5847549|NCT00038831|Alkeran|alkeran
5847550|NCT00038831|Fludarabine Phosphate|fludarabine phosphate
5847551|NCT00038831|Fludarabine|fludarabine
5847552|NCT00038831|Fludara|fludara
5847553|NCT00038831|Anti-thymocyte globulin|anti-thymocyte globulin
5847554|NCT00038831|ATG|atg
5847555|NCT00038831|Allogeneic Bone Marrow|allogeneic bone marrow
5847556|NCT00038831|Peripheral Blood Stem Cell Transplantation|peripheral blood stem cell transplantation
5847557|NCT00038831|Allo PBSCT|allo pbsct
5847558|NCT00038831|Allogeneic transplantation|allogeneic transplantation
5847564|NCT00038818|CD8 Depleted|cd8 depleted
5847565|NCT00038818|Donor Lymphocyte|donor lymphocyte
5847566|NCT00038805|High Risk Acute Myeloid Leukemia|high risk acute myeloid leukemia
5847567|NCT00038805|Acute Lymphocytic Leukemia|acute lymphocytic leukemia
5847568|NCT00038805|Chronic Myeloid Leukemia|chronic myeloid leukemia
5847569|NCT00038805|Myelodysplastic Syndrome|myelodysplastic syndrome
5847571|NCT00038805|AML|aml
5847572|NCT00038805|MDS|mds
5847573|NCT00038805|CML|cml
5847574|NCT00038805|CMML|cmml
5847575|NCT00038805|Nonmyeloablative Preparative Regimen|nonmyeloablative preparative regimen
5847576|NCT00038805|Mylotarg|mylotarg
5847578|NCT00038792|Acute Graft Versus Host Disease|acute graft versus host disease
5847579|NCT00038792|Refractory|refractory
5847580|NCT00038779|Lymphoma|lymphoma
5847581|NCT00038779|CML|cml
5847587|NCT00038766|Inflammatory Bowel Disease|inflammatory bowel disease
5847588|NCT00038753|vision screening|vision screening
5847589|NCT00038727|DPP|dpp
5847590|NCT00038727|IGT|igt
5847591|NCT00038727|Prediabetes|prediabetes
5847592|NCT00038727|Type 2 diabetes|type 2 diabetes
5847593|NCT00038727|Macrovascular disease|macrovascular disease
5847594|NCT00038727|Microvascular disease|microvascular disease
5847595|NCT00038727|Lifestyle|lifestyle
5847596|NCT00038727|Metformin|metformin
5847597|NCT00038727|Obesity|obesity
5847598|NCT00038714|HPV|hpv
5847599|NCT00038714|Papilloma|papilloma
5847600|NCT00038701|Metastatic Pancreas Cancer|metastatic pancreas cancer
5847601|NCT00038688|Health Education|health education
5847602|NCT00038688|Substance Abuse, Intravenous|substance abuse, intravenous
5847603|NCT00038688|Program Evaluation|program evaluation
5847604|NCT00038688|Peer Group|peer group
5847605|NCT00038688|Risk-Taking|risk-taking
5847606|NCT00038688|HIV Seronegativity|hiv seronegativity
5847607|NCT00038688|Substance-related Disorders|substance-related disorders
5847608|NCT00038675|Leukemia|leukemia
5847609|NCT00038675|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5847610|NCT00038675|Chronic Myeloid Leukemia|chronic myeloid leukemia
5847611|NCT00038675|Polycythemia Vera|polycythemia vera
5847612|NCT00038675|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5847613|NCT00038675|Mastocytosis|mastocytosis
5847614|NCT00038675|Imatinib Mesylate|imatinib mesylate
5847615|NCT00038675|Gleevec|gleevec
5847616|NCT00038649|Philadelphia chromosome positive|philadelphia chromosome positive
5847617|NCT00038649|early chronic phase (diagnosis < 12 months)|early chronic phase (diagnosis < 12 months)
5847618|NCT00038649|Chronic Myelogenous Leukemia, Chronic Phase|chronic myelogenous leukemia, chronic phase
5847619|NCT00038649|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5847620|NCT00038649|CML|cml
5847621|NCT00038649|Gleevec|gleevec
5847622|NCT00038649|STI571|sti571
5847623|NCT00038636|HIV|hiv
5847624|NCT00038623|Relapsed/Refractory Mantle Cell Lymphoma|relapsed/refractory mantle cell lymphoma
5847625|NCT00038623|Yttrium-Ibritumomab|yttrium-ibritumomab
5847626|NCT00038623|Zevalin|zevalin
5847627|NCT00038610|Leukemia|leukemia
5847628|NCT00038610|Lymphoblastic|lymphoblastic
5847629|NCT00038610|Acute|acute
5847630|NCT00038610|Philadelphia-Positive|philadelphia-positive
5847631|NCT00038610|Imatinib Mesylate|imatinib mesylate
5847632|NCT00038610|Gleevec|gleevec
5847633|NCT00038610|Glivec|glivec
5847634|NCT00038610|Imatinib|imatinib
5847635|NCT00038610|STI571|sti571
5847636|NCT00038610|STI-571|sti-571
5847637|NCT00038610|CGP-57148B|cgp-57148b
5847638|NCT00038610|NSC-716051|nsc-716051
5847639|NCT00038610|Cyclophosphamide|cyclophosphamide
5847640|NCT00038610|Cytoxan®,|cytoxan®,
5847641|NCT00038610|Neosar®|neosar®
5847642|NCT00038610|Doxorubicin|doxorubicin
5847643|NCT00038610|Adriamycin ®|adriamycin ®
5847644|NCT00038610|Rubex ®|rubex ®
5847645|NCT00038610|Adriamycin PFS|adriamycin pfs
5847646|NCT00038610|Adriamycin RDF|adriamycin rdf
5847647|NCT00038610|Vincristine|vincristine
5847648|NCT00038610|Dexamethasone|dexamethasone
5847649|NCT00038610|Decadron|decadron
5847650|NCT00038610|Methotrexate|methotrexate
5847651|NCT00038610|Cytarabine|cytarabine
5847652|NCT00038610|Ara-C|ara-c
5847653|NCT00038610|Cytosar|cytosar
5847654|NCT00038610|DepoCyt|depocyt
5847655|NCT00038610|Cytosine Arabinosine Hydrochloride|cytosine arabinosine hydrochloride
5847658|NCT00038610|G-CSF|g-csf
5847659|NCT00038610|Filgrastim|filgrastim
5847660|NCT00038610|Neupogen|neupogen
5847661|NCT00038597|Philadelphia chromosome positive CML|philadelphia chromosome positive cml
5847662|NCT00038597|Myelogenous Leukemia, Chronic, Chronic Phase|myelogenous leukemia, chronic, chronic phase
5847663|NCT00038597|Myelogenous Leukemia, Chronic, Accelerated Phase|myelogenous leukemia, chronic, accelerated phase
5847664|NCT00038571|Cancer|cancer
5847665|NCT00038571|Relapsed|relapsed
5847666|NCT00038571|Refractory|refractory
5847667|NCT00038571|B cell lymphoma|b cell lymphoma
5847668|NCT00038571|Proteasome Inhibitor|proteasome inhibitor
5847669|NCT00038571|PS-341|ps-341
5847670|NCT00038558|Hodgkin's lymphoma|hodgkin's lymphoma
5847671|NCT00038558|Dacarbazine|dacarbazine
5847672|NCT00038558|DTIC|dtic
5847676|NCT00038558|Bleomycin sulfate|bleomycin sulfate
5847677|NCT00038558|Blenoxane|blenoxane
5847678|NCT00038558|BLM|blm
5847679|NCT00038558|Doxorubicin Hydrochloride|doxorubicin hydrochloride
5847680|NCT00038558|Adriamycin|adriamycin
5847681|NCT00038558|Filgrastim|filgrastim
5847683|NCT00038558|Neupogen|neupogen
5847684|NCT00038558|Pegfilgrastim|pegfilgrastim
5847685|NCT00038558|granulocyte colony-stimulating factor|granulocyte colony-stimulating factor
5847686|NCT00038545|LYMPHOMA|lymphoma
5847687|NCT00038545|NON-HODGKINS|non-hodgkins
5847688|NCT00038545|AGGRESSIVE|aggressive
5847689|NCT00038545|RELAPSED AND REFRACTORY|relapsed and refractory
5850495|NCT00023426|dose|dose
5847703|NCT00038480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5847704|NCT00038454|Oxygen Therapeutics|oxygen therapeutics
5847705|NCT00038454|CABG|cabg
5847706|NCT00038454|Transfusion|transfusion
5847707|NCT00038441|Malignant Glioma|malignant glioma
5847708|NCT00038415|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5847710|NCT00038415|Binet Stage A|binet stage a
5847711|NCT00038415|Vaccination|vaccination
5847712|NCT00038415|Idiotypic|idiotypic
5847713|NCT00038415|Genetic|genetic
5847714|NCT00038415|Deoxyribonucleic acid|deoxyribonucleic acid
5847715|NCT00038415|DNA|dna
5847716|NCT00038402|Breast Cancer|breast cancer
5847717|NCT00038402|Non-Inflammatory Breast Cancer|non-inflammatory breast cancer
5847718|NCT00038402|Operable Breast Cancer|operable breast cancer
5847719|NCT00038402|Herceptin|herceptin
5847720|NCT00038402|Taxol|taxol
5847721|NCT00038402|FEC|fec
5847722|NCT00038402|Fluorouracil|fluorouracil
5847723|NCT00038402|Cyclophosphamide|cyclophosphamide
5847724|NCT00038402|Epirubicin|epirubicin
5847725|NCT00038402|Trastuzumab|trastuzumab
5847726|NCT00038402|Paclitaxel|paclitaxel
5847727|NCT00038402|Neosar|neosar
5847728|NCT00038389|Brain Stem Tumor|brain stem tumor
5847729|NCT00038376|T-cell lymphoma|t-cell lymphoma
5847730|NCT00038376|accutane|accutane
5847731|NCT00038376|isotretinoin|isotretinoin
5847732|NCT00038376|mycosis fungoides|mycosis fungoides
5847733|NCT00038376|T-cell malignancies|t-cell malignancies
5847734|NCT00038363|Frail|frail
5847735|NCT00038363|Disable|disable
5847736|NCT00038363|Disabled Persons|disabled persons
5847737|NCT00038363|Physically disabled|physically disabled
5847738|NCT00038363|Elderly|elderly
5847739|NCT00038363|Rehabilitation|rehabilitation
5847740|NCT00038363|Subacute care|subacute care
5847741|NCT00038350|Age|age
5847742|NCT00038350|Dysphagia|dysphagia
5847743|NCT00038350|Swallowing|swallowing
5847744|NCT00038337|Health Literacy|health literacy
5847745|NCT00038337|Visual|visual
5847746|NCT00038337|Cognitive|cognitive
5847747|NCT00038285|Amputation|amputation
5847748|NCT00038285|Cardiovascular Disease|cardiovascular disease
5847749|NCT00038285|PVD|pvd
5847750|NCT00038272|Placebos|placebos
5847751|NCT00038272|Drug Therapy, Combination|drug therapy, combination
5847752|NCT00038272|Anti-HIV Agents|anti-hiv agents
5847753|NCT00038272|Mycophenolate Mofetil|mycophenolate mofetil
5847754|NCT00038272|2,6-diaminopurine dioxolane|2,6-diaminopurine dioxolane
5847755|NCT00038272|Treatment Experienced|treatment experienced
5847756|NCT00038272|DAPD|dapd
5847757|NCT00038272|MMF|mmf
5847758|NCT00038259|Interleukin-2|interleukin-2
5847759|NCT00038259|Drug Administration Schedule|drug administration schedule
5847760|NCT00038259|CD4 Lymphocyte Count|cd4 lymphocyte count
5847761|NCT00038259|Anti-HIV Agents|anti-hiv agents
5847762|NCT00038259|Viral Load|viral load
5847763|NCT00038259|Treatment Interruption|treatment interruption
5847764|NCT00038259|Treatment Experienced|treatment experienced
5847765|NCT00038259|STI|sti
5847766|NCT00038246|Prostate Cancer|prostate cancer
5847767|NCT00038233|myeloma|myeloma
5847768|NCT00038220|HIV|hiv
5847769|NCT00038207|soft tissue sarcoma|soft tissue sarcoma
5847770|NCT00038207|Bone sarcomas|bone sarcomas
5847771|NCT00038194|Prostate Cancer|prostate cancer
5847772|NCT00038194|bone metastasis|bone metastasis
5847773|NCT00038181|Prostate Cancer|prostate cancer
5847774|NCT00038168|Prostate Cancer|prostate cancer
5847775|NCT00038155|Ambulation|ambulation
5847776|NCT00038155|Difficulties in ambulation|difficulties in ambulation
5847777|NCT00038155|Geriatric|geriatric
5847778|NCT00038155|Rehabilitation|rehabilitation
5847779|NCT00038142|Ewing's Sarcoma|ewing's sarcoma
5847781|NCT00038142|Doxorubicin|doxorubicin
5847782|NCT00038142|Adriamycin|adriamycin
5847783|NCT00038142|Rubex|rubex
5847784|NCT00038142|Cyclophosphamide|cyclophosphamide
5847789|NCT00038116|Parkinson's disease|parkinson's disease
5847791|NCT00038116|dopamine|dopamine
5847792|NCT00038116|embryonic dopamine cell implant surgery|embryonic dopamine cell implant surgery
5847793|NCT00038116|tissue implants|tissue implants
5847794|NCT00038090|Myeloma|myeloma
5847795|NCT00038090|Thalidomide|thalidomide
5847796|NCT00038090|Thalomid|thalomid
5847797|NCT00038090|Dexamethasone|dexamethasone
5847798|NCT00038090|Decadron|decadron
5847799|NCT00038064|anemia of cancer/chemotherapy|anemia of cancer/chemotherapy
5847800|NCT00038064|non-myeloid malignancies|non-myeloid malignancies
5847801|NCT00038064|Drug Therapy|drug therapy
5847802|NCT00038051|Acute Myeloid Leukemia|acute myeloid leukemia
5847803|NCT00038051|AML|aml
5847804|NCT00038051|Chronic Myelomonocytic Leukemia|chronic myelomonocytic leukemia
5847805|NCT00038051|CMML|cmml
5847806|NCT00038051|Myeloproliferative Disorders|myeloproliferative disorders
5847807|NCT00038051|Refractory Anemia with Excess of Blasts|refractory anemia with excess of blasts
5847808|NCT00038051|RAEB-t|raeb-t
5847809|NCT00038051|RAEB|raeb
5847810|NCT00038051|Hum-195/rGel|hum-195/rgel
5847811|NCT00038038|Squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck
5847812|NCT00038025|Mycosis Fungoides|mycosis fungoides
5847814|NCT00038025|Chronic lymphocytic leukemia|chronic lymphocytic leukemia
5847815|NCT00038025|Deoxycoformycin|deoxycoformycin
5847816|NCT00038025|Pentostatin|pentostatin
5847817|NCT00038025|All other lymphomas|all other lymphomas
5847818|NCT00038025|Nucleoside analogue|nucleoside analogue
5847819|NCT00038025|Adenosine deaminase inhibitor|adenosine deaminase inhibitor
5847820|NCT00038025|T-cells|t-cells
5847821|NCT00038012|Dose-intensified carboplatin|dose-intensified carboplatin
5847822|NCT00038012|autologous cryopreserved platelets|autologous cryopreserved platelets
5847823|NCT00038012|thrombopoietin|thrombopoietin
5847824|NCT00038012|Gynecologic malignancy|gynecologic malignancy
5847825|NCT00037999|Muscle strength|muscle strength
5847826|NCT00037999|Testosterone|testosterone
5847827|NCT00037999|Rehabilitation|rehabilitation
5847828|NCT00037999|Impaired muscle strength|impaired muscle strength
5847829|NCT00037986|Audiology|audiology
5847830|NCT00037986|Hearing|hearing
5847831|NCT00037986|Hearing Aids|hearing aids
5847832|NCT00037986|Quality of Life|quality of life
5847833|NCT00037973|COPD|copd
5847834|NCT00037973|Ventilation|ventilation
5847835|NCT00037960|Constrained Induced|constrained induced
5847836|NCT00037960|CI therapy|ci therapy
5847838|NCT00037960|Strokes|strokes
5847839|NCT00037947|Multiple Sclerosis|multiple sclerosis
5847840|NCT00037947|MS|ms
5847841|NCT00037947|Hearing|hearing
5847842|NCT00037934|Robot|robot
5847843|NCT00037934|Stroke|stroke
5847844|NCT00037934|Upper Extremity|upper extremity
5847845|NCT00037921|SCI|sci
5847846|NCT00037921|UTI|uti
5847847|NCT00037908|Stroke|stroke
5847848|NCT00037908|Hemiparesis|hemiparesis
5847849|NCT00037908|Upper limb function|upper limb function
5847850|NCT00037908|Strength training|strength training
5847851|NCT00037895|Stroke|stroke
5847852|NCT00037895|Ambulation Training|ambulation training
5847853|NCT00037895|Rehabilitation|rehabilitation
5847854|NCT00037895|Treadmill|treadmill
5847855|NCT00037882|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5847856|NCT00037882|Interferon alpha|interferon alpha
5847857|NCT00037882|Roferon|roferon
5847858|NCT00037882|Intron|intron
5847859|NCT00037882|Chronic Myelogenous Leukemia-Philadelphia positive|chronic myelogenous leukemia-philadelphia positive
5847860|NCT00037869|Metastatic neuroendocrine tumors|metastatic neuroendocrine tumors
5847861|NCT00037843|adrenal diseases|adrenal diseases
5847862|NCT00037830|Parkinson's disease|parkinson's disease
5847863|NCT00037830|PD|pd
5847864|NCT00037830|GM1 Ganglioside|gm1 ganglioside
5847865|NCT00037830|Sygen|sygen
5847866|NCT00037817|Toxicity Evaluation|toxicity evaluation
5847867|NCT00037817|Pharmacokinetics|pharmacokinetics
5847868|NCT00037817|Apoptosis|apoptosis
5847869|NCT00037817|Gene Induction|gene induction
5847870|NCT00037817|Gene Expression|gene expression
5847871|NCT00037817|Lung Cancer|lung cancer
5847872|NCT00037817|Small Cell Lung Cancer|small cell lung cancer
5847873|NCT00037817|Non-Small Cell Lung Cancer|non-small cell lung cancer
5847874|NCT00037817|Pleural Mesothelioma|pleural mesothelioma
5847875|NCT00037804|Pharmacia|pharmacia
5847876|NCT00004575|Endothelium|endothelium
5847877|NCT00004575|Vasodilation|vasodilation
5847878|NCT00004575|Vascular Biology|vascular biology
5847879|NCT00004575|Venous Occlusion Plethysmography|venous occlusion plethysmography
5847880|NCT00001908|Allergy|allergy
5847881|NCT00001908|Interleukin|interleukin
5847882|NCT00001908|Immunomodulator|immunomodulator
5847883|NCT00001908|Th2|th2
5847884|NCT00001908|Inflammation|inflammation
5847885|NCT00001908|Asthma|asthma
5847886|NCT00001866|Eye Movements|eye movements
5847887|NCT00001866|Eye Oscillations|eye oscillations
5847888|NCT00001866|Extraocular Muscles|extraocular muscles
5847889|NCT00001866|Eye Development|eye development
5847890|NCT00001866|Pediatric Ophthalmology|pediatric ophthalmology
5847891|NCT00001866|Congenital Nystagmus|congenital nystagmus
5847892|NCT00001864|Lazy Eye|lazy eye
5847893|NCT00001864|Atropine Penalization|atropine penalization
5847894|NCT00001864|Patching|patching
5847895|NCT00001864|Vision Loss|vision loss
5847896|NCT00001864|Amblyopia|amblyopia
5847897|NCT00001818|Antiretrovirals|antiretrovirals
5847898|NCT00001818|Resistant Virus|resistant virus
5847899|NCT00001818|T-cell activation|t-cell activation
5847900|NCT00001818|Immune Suppression|immune suppression
5847901|NCT00001818|Cytotoxic Agent|cytotoxic agent
5847902|NCT00001688|CD4 Cells|cd4 cells
5847903|NCT00001688|Cytokines|cytokines
5847904|NCT00001688|Anti-Retroviral Activity|anti-retroviral activity
5847905|NCT00001688|V Beta Repertoire|v beta repertoire
5847906|NCT00001688|CD-4-Naive T Cells|cd-4-naive t cells
5847907|NCT00001688|CD-4-Memory T Cells|cd-4-memory t cells
5847908|NCT00001542|Candidiasis|candidiasis
5847909|NCT00001542|Azole|azole
5847910|NCT00001542|Resistance|resistance
5847911|NCT00001542|Candida Albicans|candida albicans
5847912|NCT00001542|Oropharynx|oropharynx
5847913|NCT00001190|Growth|growth
5847914|NCT00001190|Adolescence|adolescence
5847915|NCT00001190|Children|children
5847916|NCT00037713|LD Small Cell Lung Cancer|ld small cell lung cancer
5847917|NCT00037713|BEC2, vaccine|bec2, vaccine
5847918|NCT00037713|adjuvant, monoclonal antibody|adjuvant, monoclonal antibody
5847919|NCT00037713|LD Small Cell Lung Cancer (VA Classification, Zelen, 1973)|ld small cell lung cancer (va classification, zelen, 1973)
5847920|NCT00037687|Severe sepsis|severe sepsis
5847921|NCT00037687|Platelet-activating factor acetylhydrolase|platelet-activating factor acetylhydrolase
5847922|NCT00037674|Bipolar Disorder|bipolar disorder
5847923|NCT00037674|Bipolar|bipolar
5847924|NCT00037674|Mania|mania
5847925|NCT00037674|Topiramate|topiramate
5847926|NCT00037674|Lithium|lithium
5847927|NCT00037661|dry eye|dry eye
5847928|NCT00037622|E-antigen positive, treatment naïve chronic HBV infected, lamivudine resistant chronic Hepatitis B, Achillion|e-antigen positive, treatment naïve chronic hbv infected, lamivudine resistant chronic hepatitis b, achillion
5847929|NCT00037609|Metastatic breast cancer|metastatic breast cancer
5847930|NCT00037583|Acute|acute
5847931|NCT00037583|Myeloid|myeloid
5847932|NCT00037583|Leukemia|leukemia
5847933|NCT00037570|Peptic|peptic
5847934|NCT00037570|Ulcer|ulcer
5847935|NCT00037570|Hemorrhage|hemorrhage
5847936|NCT00037557|Hemophilia B|hemophilia b
5847937|NCT00037544|Severe|severe
5847938|NCT00037544|Hemophilia|hemophilia
5847940|NCT00037531|Transplant|transplant
5847942|NCT00037518|Severe primary hyperparathyroidism|severe primary hyperparathyroidism
5847943|NCT00037518|Parathyroid carcinoma|parathyroid carcinoma
5847944|NCT00037492|stroke|stroke
5847945|NCT00037492|recovery|recovery
5847946|NCT00037479|neurologic Lyme disease|neurologic lyme disease
5847947|NCT00037479|Lyme disease|lyme disease
5847948|NCT00037479|ceftriaxone|ceftriaxone
5847949|NCT00037479|Rocephin|rocephin
5847950|NCT00037479|PET scans|pet scans
5847951|NCT00037479|Lyme encephalopathy|lyme encephalopathy
5847952|NCT00037479|neuroborreliosis|neuroborreliosis
5847953|NCT00037479|borreliosis|borreliosis
5847954|NCT00037219|Anidulafungin|anidulafungin
5847955|NCT00037219|Candidemia|candidemia
5847956|NCT00037219|Invasive Candidiasis|invasive candidiasis
5847957|NCT00037206|Invasive Aspergillosis|invasive aspergillosis
5847958|NCT00037167|Fall-Prevention|fall-prevention
5847959|NCT00037167|Balance|balance
5847960|NCT00037167|Musculoskeletal Systems|musculoskeletal systems
5847961|NCT00037167|Protective Devices|protective devices
5847962|NCT00037167|Gait|gait
5847963|NCT00037167|Equilibrium|equilibrium
5847964|NCT00037167|Accidental Falls|accidental falls
5847965|NCT00037167|Frail Elderly|frail elderly
5847966|NCT00037154|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5847967|NCT00037154|Herbal Therapies|herbal therapies
5847968|NCT00037154|Complementary and Alternative Medicine|complementary and alternative medicine
5847969|NCT00037154|Men's Health|men's health
5847970|NCT00037141|Prostate|prostate
5847972|NCT00037141|Prostatitis|prostatitis
5847973|NCT00037128|Lupus|lupus
5847974|NCT00037128|SLE|sle
5847975|NCT00037128|DHEA|dhea
5847976|NCT00037128|GL701|gl701
5847977|NCT00037115|Demyelinating|demyelinating
5847978|NCT00037115|Multiple Sclerosis|multiple sclerosis
5847979|NCT00037115|Myelitis|myelitis
5847980|NCT00037115|Neuritis|neuritis
5847981|NCT00037115|Optic Neuritis|optic neuritis
5847982|NCT00037115|AVONEX|avonex
5847983|NCT00037115|methotrexate|methotrexate
5847984|NCT00037115|methylprednisolone|methylprednisolone
5847985|NCT00037115|interferon beta 1a|interferon beta 1a
5847986|NCT00037115|demyelination|demyelination
5847987|NCT00037115|central nervous system|central nervous system
5847988|NCT00037115|brain|brain
5847989|NCT00037115|nerve|nerve
5847990|NCT00037115|lesions|lesions
5847991|NCT00037115|enhancement|enhancement
5847992|NCT00037115|enhancing|enhancing
5847993|NCT00037102|Multiple Sclerosis|multiple sclerosis
5847994|NCT00037102|Relapsing|relapsing
5847995|NCT00037102|Methotrexate|methotrexate
5847996|NCT00037102|AVONEX|avonex
5847997|NCT00037102|interferon beta 1a|interferon beta 1a
5847998|NCT00037102|demyelinating|demyelinating
5848000|NCT00037076|HIV Seropositivity|hiv seropositivity
5848001|NCT00037076|Hepatitis C|hepatitis c
5848002|NCT00037076|Polymerase Chain Reaction|polymerase chain reaction
5848003|NCT00037076|RNA, Viral|rna, viral
5848004|NCT00037076|Prevalence|prevalence
5848005|NCT00037076|Disease Transmission, Vertical|disease transmission, vertical
5848006|NCT00037076|Hepacivirus|hepacivirus
5848007|NCT00037076|Enzyme Immunoassay|enzyme immunoassay
5848008|NCT00037076|GB virus C|gb virus c
5848009|NCT00037063|Pilot Projects|pilot projects
5848010|NCT00037063|Recurrence|recurrence
5848011|NCT00037063|Antioxidants|antioxidants
5848012|NCT00037063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5848013|NCT00037063|Anti-HIV Agents|anti-hiv agents
5848014|NCT00037063|Ascorbic Acid|ascorbic acid
5848015|NCT00037063|Alpha-Tocopherol|alpha-tocopherol
5848016|NCT00037063|Riboflavin|riboflavin
5848017|NCT00037063|Thiamine|thiamine
5848018|NCT00037063|Lactic Acid|lactic acid
5848019|NCT00036647|Non-Small Cell Lung Cancer|non-small cell lung cancer
5848020|NCT00036647|Tarceva|tarceva
5848021|NCT00036647|EGFR|egfr
5848022|NCT00036647|erlotinib|erlotinib
5848023|NCT00036634|treatment naive|treatment naive
5848024|NCT00036595|Subdural|subdural
5848025|NCT00036595|Epilepsy|epilepsy
5848051|NCT00036556|Hormone-Refractory Prostate Cancer|hormone-refractory prostate cancer
5848052|NCT00036543|Hormone-Refractory, Prostate Cancer|hormone-refractory, prostate cancer
5848053|NCT00036517|Stage III and Stage IV colorectal cancer|stage iii and stage iv colorectal cancer
5848054|NCT00036517|diarrhea|diarrhea
5848055|NCT00036517|reduce|reduce
5848056|NCT00036517|alleviate|alleviate
5848057|NCT00036517|modulate|modulate
5848058|NCT00036517|Saltz regimen|saltz regimen
5848059|NCT00036517|CPT-11|cpt-11
5848060|NCT00036517|irinotecan|irinotecan
5848061|NCT00036517|camptosar|camptosar
5848062|NCT00036517|5-fluorouracil|5-fluorouracil
5848063|NCT00036517|leucovorin|leucovorin
5848064|NCT00036517|5-FU|5-fu
5848065|NCT00036517|LV|lv
5848066|NCT00036517|chemotherapy|chemotherapy
5848067|NCT00036517|side effect|side effect
5848068|NCT00036517|toxicity|toxicity
5848069|NCT00036517|botanical drug|botanical drug
5848070|NCT00036517|herbal medicine|herbal medicine
5848071|NCT00036517|chinese herbal medicine|chinese herbal medicine
5848072|NCT00036517|traditional chinese medicine|traditional chinese medicine
5848073|NCT00036517|TCM|tcm
5848074|NCT00036517|oral dose|oral dose
5848075|NCT00036517|oral administration|oral administration
5848076|NCT00036517|concomitant use|concomitant use
5848077|NCT00036504|Diabetes mellitus, insulin deficiency, hyperglycemia|diabetes mellitus, insulin deficiency, hyperglycemia
5848078|NCT00036491|Systemic Lupus Erythematosus|systemic lupus erythematosus
5848079|NCT00036491|SLE|sle
5848080|NCT00036491|B-Lymphocytes|b-lymphocytes
5848081|NCT00036491|anti-CD20|anti-cd20
5848082|NCT00036491|rituximab|rituximab
5848083|NCT00036478|Pilot Projects|pilot projects
5848084|NCT00036478|Exercise|exercise
5848085|NCT00036478|Phosphorus Isotopes|phosphorus isotopes
5848086|NCT00036478|Mitochondria|mitochondria
5848087|NCT00036478|Lactates|lactates
5848088|NCT00036478|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5848089|NCT00036465|Pilot Projects|pilot projects
5848090|NCT00036465|HIV-1|hiv-1
5848091|NCT00036465|RNA, Viral|rna, viral
5848092|NCT00036465|Genotype|genotype
5848093|NCT00036465|Viral Load|viral load
5848094|NCT00036465|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5848095|NCT00036465|Treatment Experienced|treatment experienced
5848096|NCT00036452|Lopinavir|lopinavir
5848097|NCT00036452|HIV-1|hiv-1
5848098|NCT00036452|Drug Administration Schedule|drug administration schedule
5848099|NCT00036452|Stavudine|stavudine
5848100|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors
5848101|NCT00036452|Ritonavir|ritonavir
5848102|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5848103|NCT00036452|Self Care|self care
5848104|NCT00036452|Viral Load|viral load
5848105|NCT00036452|Emtricitabine|emtricitabine
5848106|NCT00036452|Directly Observed Therapy|directly observed therapy
5848107|NCT00036452|Tenofovir Disoproxil Fumarate|tenofovir disoproxil fumarate
5848108|NCT00036452|Treatment Naive|treatment naive
5848109|NCT00036439|ulcerative colitis|ulcerative colitis
5848110|NCT00036439|infliximab|infliximab
5848111|NCT00036439|Remicade|remicade
5848112|NCT00036439|infusion|infusion
5848113|NCT00036426|lymphoma|lymphoma
5848114|NCT00036426|vaccine|vaccine
5848115|NCT00036426|idiotype|idiotype
5848116|NCT00036426|KLH|klh
5848120|NCT00036400|Gastric Cancer|gastric cancer
5848121|NCT00036400|Rectal Cancer|rectal cancer
5848122|NCT00036400|Epoetin Alfa|epoetin alfa
5848123|NCT00036387|Rheumatoid arthritis|rheumatoid arthritis
5848124|NCT00036387|infliximab|infliximab
5848125|NCT00036387|anti-TNF|anti-tnf
5848126|NCT00036387|methotrexate|methotrexate
5848127|NCT00036387|safety and efficacy|safety and efficacy
5848128|NCT00036387|Remicade|remicade
5848129|NCT00036374|Juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5848130|NCT00036374|Infliximab|infliximab
5848131|NCT00036374|Methotrexate|methotrexate
5848132|NCT00036374|remicade|remicade
5848133|NCT00036348|Bipolar I disorder|bipolar i disorder
5848134|NCT00036335|depression|depression
5848136|NCT00036335|blues|blues
5848137|NCT00036335|sadness|sadness
5848138|NCT00036335|aches|aches
5848139|NCT00036309|Major Depressive Disorder|major depressive disorder
5848140|NCT00036309|Diagnostic and Statistical Manual of Mental Disorders Fourth Edition-defined major depressive disorder without psychotic features|diagnostic and statistical manual of mental disorders fourth edition-defined major depressive disorder without psychotic features
5848141|NCT00036296|Involuntary Movements|involuntary movements
5848142|NCT00036296|Abnormal Movements|abnormal movements
5848143|NCT00036296|Advanced Parkinson's disease|advanced parkinson's disease
5848144|NCT00036296|Levodopa induced dyskinesia|levodopa induced dyskinesia
5848145|NCT00036257|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5848146|NCT00036257|Leukemia|leukemia
5848147|NCT00036257|CLL|cll
5848148|NCT00036179|Candidemia|candidemia
5848149|NCT00036179|Anti-Fungal|anti-fungal
5848150|NCT00036166|Aspergillus|aspergillus
5848151|NCT00036166|Anti-Fungal|anti-fungal
5848152|NCT00036153|Tacrolimus, Prograf®, FK506|tacrolimus, prograf®, fk506
5848153|NCT00036140|Pharmacia|pharmacia
5848154|NCT00036127|agitated schizophrenic patients|agitated schizophrenic patients
5848155|NCT00036114|Psychosis associated with dementia of the Alzheimer's type|psychosis associated with dementia of the alzheimer's type
5848156|NCT00036101|Bipolar I Disorder|bipolar i disorder
5848157|NCT00036075|prostate cancer|prostate cancer
5848158|NCT00036075|prostate|prostate
5848159|NCT00036062|Sivelestat|sivelestat
5848160|NCT00036062|acute lung injury|acute lung injury
5848162|NCT00036036|renal cell cancer|renal cell cancer
5848163|NCT00036036|renal cell carcinoma|renal cell carcinoma
5848164|NCT00036036|kidney cancer|kidney cancer
5848165|NCT00035997|Hormone-sensitive Prostate Cancer|hormone-sensitive prostate cancer
5848166|NCT00035997|Prostate Cancer|prostate cancer
5848167|NCT00035997|Bone Metastasis|bone metastasis
5848168|NCT00035984|Type 2 Diabetes Mellitis|type 2 diabetes mellitis
5848169|NCT00035958|Juvenile Dermatomyositis|juvenile dermatomyositis
5848170|NCT00035958|Pediatric|pediatric
5848171|NCT00035958|Randomized Clinical Trial|randomized clinical trial
5848172|NCT00035958|Pediatric Rheumatology|pediatric rheumatology
5848173|NCT00035919|Colon cancer|colon cancer
5848174|NCT00035919|Targeted Injectable Vector|targeted injectable vector
5848175|NCT00035919|Gene Transfer|gene transfer
5848176|NCT00035919|Gene Therapy|gene therapy
5848177|NCT00035919|Retroviral vector|retroviral vector
5848178|NCT00035906|Diabetes|diabetes
5848179|NCT00035906|Macular Edema|macular edema
5848180|NCT00035906|Diabetic Macular Edema|diabetic macular edema
5848181|NCT00035906|Diabetic Retinopathy|diabetic retinopathy
5848182|NCT00035906|Cystoid Macular Edema|cystoid macular edema
5848184|NCT00035906|Vision|vision
5848185|NCT00035906|Eye|eye
5848186|NCT00035906|Retina|retina
5848187|NCT00035906|Retinal Vein Occlusion|retinal vein occlusion
5848188|NCT00035906|Irvine-Gass Syndrome|irvine-gass syndrome
5848189|NCT00035893|treatment interruption|treatment interruption
5848190|NCT00035893|HIV Infections|hiv infections
5848191|NCT00035880|Acute graft versus host disease|acute graft versus host disease
5848192|NCT00035880|Stem Cell Transplantation|stem cell transplantation
5848193|NCT00035854|Pharmacia|pharmacia
5848194|NCT00035854|Drug Resistance, Microbial|drug resistance, microbial
5848195|NCT00035828|COPD|copd
5848196|NCT00035828|Chronic bronchitis|chronic bronchitis
5848197|NCT00035828|Chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5848198|NCT00035828|Shortness of breath|shortness of breath
5848199|NCT00035828|Dyspnea|dyspnea
5848200|NCT00035828|Bronchitis|bronchitis
5848201|NCT00035815|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5848202|NCT00035815|ALS|als
5848203|NCT00035815|progressive weakness|progressive weakness
5848204|NCT00035815|insulin-like growth factor-1|insulin-like growth factor-1
5848205|NCT00035815|IGF-I|igf-i
5848213|NCT00035802|Anticonvulsants|anticonvulsants
5848214|NCT00035802|Central Nervous System Agents|central nervous system agents
5848215|NCT00035802|Protective Agents|protective agents
5848216|NCT00035802|Neuroprotectiive Agents|neuroprotectiive agents
5848217|NCT00035620|Bone cancer|bone cancer
5848220|NCT00035620|Chemotherapy|chemotherapy
5848221|NCT00035594|Breast cancer|breast cancer
5848222|NCT00035594|Neutropenia|neutropenia
5848223|NCT00035594|Chemotherapy|chemotherapy
5848224|NCT00035581|treatment experienced|treatment experienced
5848225|NCT00035581|HIV Infections|hiv infections
5848226|NCT00035581|HIV|hiv
5848227|NCT00035581|HAART|haart
5848228|NCT00035581|early virologic failure|early virologic failure
5848229|NCT00035568|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5848230|NCT00035555|kidney|kidney
5848231|NCT00035555|transplant|transplant
5848232|NCT00035555|rejection|rejection
5848233|NCT00035542|Diabetes Mellitus, Type II|diabetes mellitus, type ii
5848234|NCT00035529|MS|ms
5863094|NCT00001399|Fanconi Anemia|fanconi anemia
5848235|NCT00035438|obsessive compulsive disorder|obsessive compulsive disorder
5848236|NCT00035438|ocd|ocd
5848237|NCT00035438|Anxiety|anxiety
5848238|NCT00035438|St. John’s Wort|st. john’s wort
5848239|NCT00035438|Wisconsin|wisconsin
5848240|NCT00035438|Psychiatric|psychiatric
5848241|NCT00035438|Mental health|mental health
5848242|NCT00035412|Social phobia|social phobia
5848243|NCT00035412|Social anxiety|social anxiety
5848244|NCT00035412|Anxiety|anxiety
5848245|NCT00035412|St. John’ Wort|st. john’ wort
5848246|NCT00035412|Wisconsin|wisconsin
5848247|NCT00035412|Psychiatric|psychiatric
5848248|NCT00035412|Mental health|mental health
5848249|NCT00035399|acupressure /acupuncture|acupressure /acupuncture
5848250|NCT00035399|alternative medicine|alternative medicine
5848251|NCT00035399|arthritis therapy|arthritis therapy
5848252|NCT00035399|combination therapy|combination therapy
5848253|NCT00035399|human therapy evaluation|human therapy evaluation
5848254|NCT00035399|knee|knee
5848255|NCT00035399|osteoarthritis|osteoarthritis
5848256|NCT00035399|physical therapy|physical therapy
5848257|NCT00035399|chronic pain|chronic pain
5848258|NCT00035399|clinical trial|clinical trial
5848259|NCT00035399|functional ability|functional ability
5848260|NCT00035360|PEG-Intron|peg-intron
5848261|NCT00035360|treatment experienced|treatment experienced
5848262|NCT00035386|Outflow Obstruction|outflow obstruction
5848264|NCT00035386|HCM|hcm
5848275|NCT00035334|Familial Mediterranean Fever|familial mediterranean fever
5848276|NCT00035334|Amyloidosis|amyloidosis
5848277|NCT00035334|Secondary (AA) Amyloidosis|secondary (aa) amyloidosis
5848278|NCT00035334|Nephrotic Syndrome|nephrotic syndrome
5848279|NCT00035308|Immunologic Diseases|immunologic diseases
5848280|NCT00035308|Autoimmune Diseases|autoimmune diseases
5848281|NCT00035308|Systemic Lupus Erythematosus|systemic lupus erythematosus
5848282|NCT00035308|SLE|sle
5848283|NCT00035308|Lupus Nephritis|lupus nephritis
5848284|NCT00035308|Lupus Glomerulonephritis|lupus glomerulonephritis
5848285|NCT00035269|Pharmacia|pharmacia
5848286|NCT00035243|kidney cancer|kidney cancer
5848287|NCT00035243|renal cancer|renal cancer
5848288|NCT00035243|cancer|cancer
5848289|NCT00035243|tumor|tumor
5848290|NCT00035243|tumour|tumour
5848291|NCT00035243|neoplasm|neoplasm
5848292|NCT00035243|carcinoma|carcinoma
5848293|NCT00035243|clear cell|clear cell
5848294|NCT00035243|sarcomatoid|sarcomatoid
5848295|NCT00035243|papillary|papillary
5848296|NCT00035243|medullary|medullary
5848297|NCT00035243|collecting duct|collecting duct
5848298|NCT00035243|chromophobe|chromophobe
5848299|NCT00035243|intravenous|intravenous
5848300|NCT00035243|epothilone|epothilone
5848301|NCT00035230|Bipolar disorders|bipolar disorders
5848302|NCT00035230|Bipolar|bipolar
5848303|NCT00035230|mania|mania
5848304|NCT00035230|Topiramate|topiramate
5848305|NCT00035230|Lithium|lithium
5848306|NCT00035204|Donepezil|donepezil
5848307|NCT00035204|Alzheimer's|alzheimer's
5848308|NCT00035204|Dementia|dementia
5848309|NCT00035204|Cognitive impairment|cognitive impairment
5848310|NCT00035204|Aricept|aricept
5848311|NCT00035204|Alzheimer's disease|alzheimer's disease
5848312|NCT00035204|Razadyne|razadyne
5848313|NCT00035204|Galantamine|galantamine
5848314|NCT00035191|Dementia|dementia
5848315|NCT00035191|vascular dementia|vascular dementia
5848316|NCT00035191|cerebral vascular disease|cerebral vascular disease
5848317|NCT00035178|ESRD|esrd
5848318|NCT00035178|End-stage renal disease|end-stage renal disease
5848319|NCT00035178|Hemodialysis|hemodialysis
5848320|NCT00035165|melanoma|melanoma
5848321|NCT00035165|cancer|cancer
5848322|NCT00035165|tumor|tumor
5848323|NCT00035165|tumour|tumour
5848328|NCT00035139|pediatric traumatic brain injury|pediatric traumatic brain injury
5848336|NCT00035126|anthracycline|anthracycline
5848337|NCT00035113|prostate cancer|prostate cancer
5848338|NCT00035113|prostate|prostate
5848339|NCT00035113|androgen independent|androgen independent
5848341|NCT00035113|tumor|tumor
5848342|NCT00035113|tumour|tumour
5848343|NCT00035113|neoplasm|neoplasm
5848344|NCT00035113|carcinoma|carcinoma
5848345|NCT00035113|intravenous|intravenous
5848346|NCT00035113|epothilone|epothilone
5848347|NCT00035100|ovarian|ovarian
5848348|NCT00035100|ovary|ovary
5848349|NCT00035100|peritoneal cancer|peritoneal cancer
5848350|NCT00035100|fallopian cancer|fallopian cancer
5848351|NCT00035100|cancer|cancer
5848352|NCT00035100|tumor|tumor
5848353|NCT00035100|tumour|tumour
5848354|NCT00035100|neoplasm|neoplasm
5848355|NCT00035100|carcinoma|carcinoma
5848356|NCT00035100|intravenous|intravenous
5848357|NCT00035100|epothilone|epothilone
5848358|NCT00035087|colon|colon
5848359|NCT00035087|rectum|rectum
5848360|NCT00035087|colorectal|colorectal
5848361|NCT00035087|rectal|rectal
5848362|NCT00035087|cancer|cancer
5848363|NCT00035087|tumor|tumor
5848364|NCT00035087|tumour|tumour
5848365|NCT00035087|neoplasm|neoplasm
5848366|NCT00035087|carcinoma|carcinoma
5848367|NCT00035087|intravenous|intravenous
5848368|NCT00035087|epothilone|epothilone
5848369|NCT00035061|Bladder Cancer|bladder cancer
5848371|NCT00035061|Recurrent|recurrent
5848372|NCT00035061|Transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5848373|NCT00035035|Pancreas|pancreas
5848374|NCT00035035|Cancer|cancer
5848375|NCT00035035|Unresectable or Metastatic Cancer of the Pancreas|unresectable or metastatic cancer of the pancreas
5848376|NCT00035035|Alimta|alimta
5848377|NCT00035022|Leukemia, Lymphoma, T-Cell|leukemia, lymphoma, t-cell
5848378|NCT00034970|alternative medicine|alternative medicine
5848379|NCT00034970|art|art
5848380|NCT00034970|cancer|cancer
5848381|NCT00034970|combination cancer therapy|combination cancer therapy
5848382|NCT00034970|creative-expression|creative-expression
5848383|NCT00034970|group therapy|group therapy
5848384|NCT00034970|holistic|holistic
5843980|NCT00051324|HD|hd
5848385|NCT00034970|human therapy evaluation|human therapy evaluation
5848386|NCT00034970|meditation|meditation
5848387|NCT00034970|neoplasm /cancer chemotherapy|neoplasm /cancer chemotherapy
5848388|NCT00034970|coping|coping
5848389|NCT00034970|gender difference|gender difference
5848390|NCT00034970|outcomes research|outcomes research
5848392|NCT00034970|psychological stressor|psychological stressor
5848393|NCT00034970|quality of life|quality of life
5848394|NCT00034970|racial /ethnic difference|racial /ethnic difference
5848395|NCT00034970|stress management|stress management
5848397|NCT00034970|behavioral /social science research|behavioral /social science research
5848398|NCT00034970|patient oriented research|patient oriented research
5848399|NCT00034957|Pharmacia|pharmacia
5848400|NCT00034918|Metastatic breast cancer|metastatic breast cancer
5848401|NCT00034879|Locally advanced and/or metastatic non-operable|locally advanced and/or metastatic non-operable
5848402|NCT00034879|non-small cell lung cancer (stage III or IV)|non-small cell lung cancer (stage iii or iv)
5848403|NCT00034879|patients who have failed standard therapy.|patients who have failed standard therapy.
5848404|NCT00034866|HIV|hiv
5848405|NCT00034866|treatment experienced|treatment experienced
5848406|NCT00034866|Boehringer|boehringer
5848407|NCT00034866|tipranavir|tipranavir
5848408|NCT00034866|ritonavir|ritonavir
5848409|NCT00034840|hypertension|hypertension
5848410|NCT00034840|telmisartan|telmisartan
5848411|NCT00034840|valsartan|valsartan
5848412|NCT00034840|boehringer|boehringer
5848413|NCT00034801|Depression|depression
5848414|NCT00034801|Comorbid Depression|comorbid depression
5848415|NCT00034801|Schizophrenia|schizophrenia
5848416|NCT00034801|Schizoaffective Disorder|schizoaffective disorder
5848417|NCT00034788|Regranex|regranex
5848418|NCT00034788|Foot ulcers|foot ulcers
5848419|NCT00034788|Diabetes|diabetes
5848420|NCT00034788|Diabetes mellitus|diabetes mellitus
5848421|NCT00034788|Diabetic foot|diabetic foot
5848422|NCT00034775|Schizophrenia|schizophrenia
5848423|NCT00034775|intramuscular injection|intramuscular injection
5848424|NCT00034775|antipsychotic agents|antipsychotic agents
5848425|NCT00034775|risperidone|risperidone
5848426|NCT00034762|Alzheimer's disease|alzheimer's disease
5848427|NCT00034762|psychosis|psychosis
5848428|NCT00034762|elderly|elderly
5848429|NCT00034762|dementia|dementia
5848430|NCT00034762|risperidone|risperidone
5848431|NCT00034762|antipsychotic agents|antipsychotic agents
5848432|NCT00034749|Adolescents|adolescents
5848433|NCT00034749|Schizophrenia|schizophrenia
5848434|NCT00034749|risperidone|risperidone
5848435|NCT00034736|Pneumonia|pneumonia
5848436|NCT00034736|Bacterial pneumonia|bacterial pneumonia
5848437|NCT00034736|Community acquired pneumonia|community acquired pneumonia
5848438|NCT00034736|Lung Inflammation|lung inflammation
5848440|NCT00034736|Levofloxacin|levofloxacin
5848442|NCT00034736|Erythromycin|erythromycin
5848443|NCT00034736|Clarithromycin|clarithromycin
5848445|NCT00034723|MRSI|mrsi
5848446|NCT00034723|MTR|mtr
5848447|NCT00034723|NAWN|nawn
5848448|NCT00034723|Fiber-Tract|fiber-tract
5848449|NCT00034723|Normal Control|normal control
5848450|NCT00034723|Healthy Volunteer|healthy volunteer
5848451|NCT00034723|HV|hv
5848452|NCT00034723|HTLV-1 Associated Myelopathy|htlv-1 associated myelopathy
5848453|NCT00034723|Tropical Spastic Paraparesis|tropical spastic paraparesis
5848454|NCT00034723|HAM/TSP|ham/tsp
5848455|NCT00034710|Analgesics/*therapeutic use|analgesics/*therapeutic use
5848456|NCT00034710|Capsaicin/*administration & dosage/adverse effects|capsaicin/*administration & dosage/adverse effects
5848457|NCT00034710|Herpes Zoster/*complications/drug therapy|herpes zoster/*complications/drug therapy
5848458|NCT00034710|Neuralgia/*drug therapy/etiology|neuralgia/*drug therapy/etiology
5848459|NCT00034710|Pain|pain
5848460|NCT00034710|Capsicum|capsicum
5848461|NCT00034710|Pepper|pepper
5848462|NCT00034710|Dermal assessment|dermal assessment
5848463|NCT00034710|Pain measurement|pain measurement
5848464|NCT00034710|Diary|diary
5848465|NCT00034710|PHN|phn
5848466|NCT00034710|Postherpetic Neuralgia|postherpetic neuralgia
5848467|NCT00034710|allodynia|allodynia
5848468|NCT00034710|hyperalgesia|hyperalgesia
5848469|NCT00034710|shingles|shingles
5848470|NCT00034710|varicella|varicella
5848471|NCT00034697|Brain mets|brain mets
5848472|NCT00034697|non-small cell lung cancer|non-small cell lung cancer
5848473|NCT00034684|Leukemia|leukemia
5848474|NCT00034684|Myelodysplastic Syndromes|myelodysplastic syndromes
5848475|NCT00034684|Leukemia, Myeloid|leukemia, myeloid
5848476|NCT00034684|Leukemia, Lymphocytic|leukemia, lymphocytic
5848477|NCT00034671|Aspergillosis, Candidiasis, Mucormycosis, Cryptococcosis|aspergillosis, candidiasis, mucormycosis, cryptococcosis
5848478|NCT00034671|Invasive Fungal Infections|invasive fungal infections
5848479|NCT00034658|Aspergillosis, Candidiasis, Cryptococcosis,|aspergillosis, candidiasis, cryptococcosis,
5848480|NCT00034645|Allogenic Stem cell transplantation|allogenic stem cell transplantation
5848481|NCT00034645|Fungal infections|fungal infections
5848482|NCT00034632|Aspergillosis, Candidiasis, Cryptococcosis, Phaeohyphomycosis|aspergillosis, candidiasis, cryptococcosis, phaeohyphomycosis
5848483|NCT00034632|Invasive Fungal Infections|invasive fungal infections
5848485|NCT00034606|cancer|cancer
5848486|NCT00034606|neoplasm|neoplasm
5848487|NCT00034606|non-small|non-small
5848488|NCT00034606|chemotherapy|chemotherapy
5848489|NCT00034593|Bladder cancer|bladder cancer
5848490|NCT00034593|metastatic|metastatic
5848491|NCT00034593|transitional cell carcinoma of the urothelium|transitional cell carcinoma of the urothelium
5848492|NCT00034580|Bipolar I Disorder|bipolar i disorder
5848493|NCT00034567|Prevention|prevention
5848494|NCT00034554|AJCC stage III or stage IV malignant melanoma|ajcc stage iii or stage iv malignant melanoma
5848495|NCT00034554|melanoma|melanoma
5848499|NCT00034541|epidermal growth factor receptor|epidermal growth factor receptor
5848500|NCT00034541|antibody|antibody
5848501|NCT00034541|non-small cell lung cancer|non-small cell lung cancer
5848502|NCT00034541|carboplatin|carboplatin
5848503|NCT00034541|paclitaxel|paclitaxel
5848504|NCT00034489|metastatic breast cancer|metastatic breast cancer
5848505|NCT00034489|combination therapy|combination therapy
5848506|NCT00034489|Alimta|alimta
5848507|NCT00034476|Sepsis, sPLA2 Inhibitor|sepsis, spla2 inhibitor
5848508|NCT00034463|metastatic cancer|metastatic cancer
5848509|NCT00034463|chemotherapy|chemotherapy
5848510|NCT00034450|Terminal Cancer|terminal cancer
5848511|NCT00034437|Normal Volunteer|normal volunteer
5848512|NCT00034437|Phlebotomy|phlebotomy
5848513|NCT00034437|Cytomegalovirus|cytomegalovirus
5848514|NCT00034437|CMV|cmv
5848515|NCT00034437|CMV Seropositve|cmv seropositve
5848516|NCT00034424|Genetics|genetics
5848517|NCT00034424|Hereditary|hereditary
5848518|NCT00034424|Screening|screening
5848519|NCT00034424|Behavioral|behavioral
5848520|NCT00034424|Familial Testicular Germ Cell Tumor|familial testicular germ cell tumor
5848521|NCT00034424|Testicular Cancer|testicular cancer
5848522|NCT00034398|Basal Ganglia|basal ganglia
5848523|NCT00034398|Neuroimaging|neuroimaging
5848524|NCT00034398|Inhibitory Neurons|inhibitory neurons
5848525|NCT00034398|Disinhibition|disinhibition
5848526|NCT00034398|Tics|tics
5848527|NCT00034398|Tourette's Syndrome|tourette's syndrome
5848528|NCT00034398|Tourette Syndrome|tourette syndrome
5848529|NCT00034398|Healthy Volunteer|healthy volunteer
5848530|NCT00034398|HV|hv
5848531|NCT00034398|Normal Control|normal control
5848532|NCT00034385|Cytomegalovirus|cytomegalovirus
5848533|NCT00034385|Prophylaxis|prophylaxis
5848534|NCT00034385|Renal Transplant|renal transplant
5848535|NCT00034385|Valcyte|valcyte
5848536|NCT00034385|Kidney Transplant|kidney transplant
5848537|NCT00034372|immunotherapy|immunotherapy
5848538|NCT00034372|monoclonal|monoclonal
5848539|NCT00034372|antibody|antibody
5848540|NCT00034372|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5848541|NCT00034372|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5848542|NCT00034359|E-antigen positive|e-antigen positive
5848543|NCT00034359|Treatment Naive Chronic Hepatitis B, Achillion|treatment naive chronic hepatitis b, achillion
5848544|NCT00017862|Eosinophils|eosinophils
5848545|NCT00017862|Monoclonal Antibody|monoclonal antibody
5848546|NCT00017862|Hypereosinophilia|hypereosinophilia
5848547|NCT00017862|Biologicals|biologicals
5848548|NCT00017862|Hypereosinophilic Syndrome|hypereosinophilic syndrome
5848549|NCT00034346|Advanced|advanced
5848550|NCT00034346|Non-Small-Cell|non-small-cell
5848551|NCT00034346|Lung|lung
5848552|NCT00034346|Cancer|cancer
5848553|NCT00034346|NSCLC|nsclc
5848554|NCT00034346|Carcinoma|carcinoma
5848555|NCT00034346|Advanced Non-Small-Cell Lung Cancer (NSCLC)|advanced non-small-cell lung cancer (nsclc)
5848556|NCT00034333|Hepatoma|hepatoma
5848557|NCT00034333|Unresectable adult primary liver cancer|unresectable adult primary liver cancer
5848558|NCT00034333|liver cancer|liver cancer
5848559|NCT00034333|HCC|hcc
5848560|NCT00034333|Hepatocellular Carcinoma|hepatocellular carcinoma
5848561|NCT00034294|C. difficile-associated diarrhea|c. difficile-associated diarrhea
5848562|NCT00034294|CDAD|cdad
5848563|NCT00034294|Clostridium difficile-Associated Diarrhea|clostridium difficile-associated diarrhea
5848564|NCT00034294|Clostridium enterocolitis|clostridium enterocolitis
5848565|NCT00034294|antibiotic-associated diarrhea|antibiotic-associated diarrhea
5848566|NCT00034294|clostridium difficile colitis|clostridium difficile colitis
5848567|NCT00034294|infectious diarrhea|infectious diarrhea
5848568|NCT00034294|chronic diarrhea|chronic diarrhea
5848569|NCT00034294|antibiotic-associated colitis|antibiotic-associated colitis
5848570|NCT00034281|Gene, HER2|gene, her2
5848571|NCT00034281|Clinical Trial, Phase I|clinical trial, phase i
5848572|NCT00034281|Breast neoplasm|breast neoplasm
5848573|NCT00034281|Pancreatic neoplasm|pancreatic neoplasm
5848574|NCT00034281|Ovarian neoplasm|ovarian neoplasm
5848575|NCT00034281|Colorectal neoplasm|colorectal neoplasm
5848576|NCT00034281|Renal neoplasm|renal neoplasm
5848577|NCT00034281|Prostate neoplasm|prostate neoplasm
5848578|NCT00034281|Cancer|cancer
5848579|NCT00034268|non-small cell lung cancer|non-small cell lung cancer
5848835|NCT00033085|cocaine dependence|cocaine dependence
5848580|NCT00034268|Stage IIIB or IV non-small cell lung cancer (NSCLC)|stage iiib or iv non-small cell lung cancer (nsclc)
5848581|NCT00034177|Locally Advanced, Metastatic, or Recurrent Transitional Cell Carcinoma of the Urothelium|locally advanced, metastatic, or recurrent transitional cell carcinoma of the urothelium
5848582|NCT00034242|Ataxia|ataxia
5848583|NCT00034242|Treatment|treatment
5848584|NCT00034242|IVIG|ivig
5848585|NCT00034242|SCA|sca
5848586|NCT00034242|Cerebellar Degeneration|cerebellar degeneration
5848587|NCT00034242|Cerebellar Ataxia|cerebellar ataxia
5848588|NCT00034242|Cerebellum|cerebellum
5848589|NCT00034229|Antidepressant|antidepressant
5848590|NCT00034229|Anti-Glutamatergic|anti-glutamatergic
5848591|NCT00034229|Bipolar Disorder|bipolar disorder
5848592|NCT00034229|Depression|depression
5848593|NCT00034229|Treatment Refractory|treatment refractory
5848594|NCT00034229|Felbamate|felbamate
5848595|NCT00034229|Glutamate|glutamate
5848609|NCT00034138|Stage III ovarian epithelial cancer|stage iii ovarian epithelial cancer
5848610|NCT00034138|Stage IV ovarian epithelial cancer|stage iv ovarian epithelial cancer
5848611|NCT00034125|cancer|cancer
5848612|NCT00034125|metastatic breast cancer|metastatic breast cancer
5848613|NCT00034125|hormonal therapy|hormonal therapy
5848614|NCT00034112|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease
5848615|NCT00034112|combination therapy,|combination therapy,
5848616|NCT00034112|emphysema|emphysema
5848617|NCT00034112|exercise|exercise
5848618|NCT00034112|human therapy evaluation|human therapy evaluation
5848619|NCT00034112|rehabilitation|rehabilitation
5848620|NCT00034112|respiratory disease /disorder therapy|respiratory disease /disorder therapy
5848621|NCT00034112|respiratory function|respiratory function
5848622|NCT00034112|biomechanics|biomechanics
5848623|NCT00034112|body movement|body movement
5848624|NCT00034112|diaphragm|diaphragm
5848625|NCT00034112|dyspnea|dyspnea
5848626|NCT00034112|muscle tension|muscle tension
5848627|NCT00034112|musculoskeletal system|musculoskeletal system
5848628|NCT00034112|outcomes research|outcomes research
5848629|NCT00034112|quality of life|quality of life
5848630|NCT00034112|somatic reflex|somatic reflex
5848631|NCT00034086|Lopinavir|lopinavir
5848632|NCT00034086|OspA Protein|ospa protein
5848633|NCT00034086|HIV-1|hiv-1
5848634|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors
5848635|NCT00034086|CD4 Lymphocyte Count|cd4 lymphocyte count
5848636|NCT00034086|Ritonavir|ritonavir
5848637|NCT00034086|Haemophilus Vaccines|haemophilus vaccines
5848638|NCT00034086|HAART|haart
5848639|NCT00034086|Pneumococcal Vaccines|pneumococcal vaccines
5848640|NCT00034086|tenofovir disoproxil|tenofovir disoproxil
5848641|NCT00034073|Imaging|imaging
5848642|NCT00034073|Pediatrics|pediatrics
5848643|NCT00034073|Brain|brain
5848644|NCT00034073|Mapping|mapping
5848645|NCT00034073|Development|development
5848646|NCT00034073|Healthy Volunteer|healthy volunteer
5848647|NCT00034073|HV|hv
5848648|NCT00034073|Normal Control|normal control
5848649|NCT00034060|Cytokines|cytokines
5848650|NCT00034060|Exanercept|exanercept
5848651|NCT00034060|Cachexia|cachexia
5848652|NCT00034060|Body Composition|body composition
5848653|NCT00034060|Vascular Endothelial System|vascular endothelial system
5848654|NCT00034060|Rheumatoid Arthritis|rheumatoid arthritis
5848655|NCT00034060|RA|ra
5848656|NCT00034060|Women|women
5848657|NCT00034060|Healthy Volunteer|healthy volunteer
5848658|NCT00034060|HV|hv
5848659|NCT00034060|Normal Control|normal control
5848660|NCT00034047|Endometriosis|endometriosis
5848661|NCT00034047|Pelvic pain|pelvic pain
5848662|NCT00034047|Acupuncture|acupuncture
5848663|NCT00034047|Chinese herbs|chinese herbs
5848664|NCT00034047|Hormone therapy|hormone therapy
5848665|NCT00034047|Nafarelin|nafarelin
5848666|NCT00034034|Advanced colorectal cancer|advanced colorectal cancer
5848667|NCT00034034|acupressure /acupuncture|acupressure /acupuncture
5848668|NCT00034034|anxiety|anxiety
5848669|NCT00034034|colorectal neoplasm|colorectal neoplasm
5848670|NCT00034034|human therapy evaluation|human therapy evaluation
5848671|NCT00034034|neoplasm /cancer palliative treatment|neoplasm /cancer palliative treatment
5848672|NCT00034034|quality of life|quality of life
5848673|NCT00034034|terminal patient care|terminal patient care
5848674|NCT00034034|hypothalamic pituitary adrenal axis|hypothalamic pituitary adrenal axis
5848675|NCT00034034|pain|pain
5848676|NCT00034034|psychological aspect of cancer|psychological aspect of cancer
5848677|NCT00034034|stress management|stress management
5848678|NCT00034034|alternative medicine|alternative medicine
5848679|NCT00034034|behavioral /social science research tag|behavioral /social science research tag
5848680|NCT00034034|human subject|human subject
5848681|NCT00034034|patient oriented research|patient oriented research
5848682|NCT00034021|Female Sexual Arousal Disorder|female sexual arousal disorder
5848683|NCT00034021|Female Orgasmic Disorder|female orgasmic disorder
5848684|NCT00034021|ginkgo biloba|ginkgo biloba
5848685|NCT00034021|human therapy evaluation|human therapy evaluation
5848686|NCT00034021|sex behavior|sex behavior
5848687|NCT00034021|antidepressant|antidepressant
5848688|NCT00034021|blood flow|blood flow
5848689|NCT00034021|clinical trial|clinical trial
5848690|NCT00034021|drug adverse effect|drug adverse effect
5848691|NCT00034021|mental disorder chemotherapy|mental disorder chemotherapy
5848692|NCT00034021|relaxation|relaxation
5848693|NCT00034021|smooth muscle|smooth muscle
5848694|NCT00034021|alternative medicine|alternative medicine
5848695|NCT00034021|blood flow measurement|blood flow measurement
5848698|NCT00034021|women's health|women's health
5848699|NCT00034021|Secondary to either to fluoxetine, sertraline, or paroxetine use.|secondary to either to fluoxetine, sertraline, or paroxetine use.
5848700|NCT00034008|Energy Medicine|energy medicine
5848701|NCT00034008|Healing Touch|healing touch
5848702|NCT00034008|CAM Research|cam research
5848703|NCT00034008|Neonates|neonates
5848704|NCT00034008|Stress|stress
5848836|NCT00033033|cocaine dependence|cocaine dependence
5848705|NCT00034008|Conditions resulting from stress|conditions resulting from stress
5851296|NCT00006208|efavirenz|efavirenz
5848707|NCT00034008|Healing of stress and prevention of negative|healing of stress and prevention of negative
5848708|NCT00034008|Developmental outcomes – physical and behavioral|developmental outcomes – physical and behavioral
5848709|NCT00034008|Therapeutic Touch|therapeutic touch
5848710|NCT00034008|Touch therapies|touch therapies
5848711|NCT00034008|Energy therapies|energy therapies
5848712|NCT00034008|Infant touch|infant touch
5848713|NCT00034008|Infant stimulation|infant stimulation
5848714|NCT00033995|Tics|tics
5848715|NCT00033995|Basal Ganglia|basal ganglia
5848716|NCT00033995|Neuroimaging|neuroimaging
5848717|NCT00033995|Sleep|sleep
5848718|NCT00033995|Suppression of Tics|suppression of tics
5848719|NCT00033995|Tourette Syndrome|tourette syndrome
5848720|NCT00033995|Tourette's Syndrome|tourette's syndrome
5848721|NCT00033995|Tic Disorder|tic disorder
5848722|NCT00033995|Healthy Volunteer|healthy volunteer
5848723|NCT00033995|HV|hv
5848724|NCT00033995|Normal Control|normal control
5848725|NCT00033982|Triazole|triazole
5848726|NCT00033982|Refractory|refractory
5848727|NCT00033982|Antifungal|antifungal
5848728|NCT00033982|Fungal Infection|fungal infection
5848729|NCT00033969|CRPS|crps
5848730|NCT00033969|RSD|rsd
5848731|NCT00033969|Causalgia|causalgia
5848732|NCT00033969|Chronic Pain|chronic pain
5848733|NCT00033969|Neuropathic Pain|neuropathic pain
5848734|NCT00033969|Normal Control|normal control
5848735|NCT00033969|Complex Regional Pain Syndrome|complex regional pain syndrome
5848739|NCT00033956|Renal Cell Carcinoma|renal cell carcinoma
5848740|NCT00033956|IL-2|il-2
5848741|NCT00033956|Interleukin-2|interleukin-2
5848742|NCT00033956|Hypotension|hypotension
5848743|NCT00033917|intraventricular hemorrhage (IVH)|intraventricular hemorrhage (ivh)
5848744|NCT00033917|bleeding in the brain|bleeding in the brain
5848745|NCT00033917|indomethacin|indomethacin
5848746|NCT00033917|prematurity|prematurity
5848747|NCT00033917|very low birth weight infants|very low birth weight infants
5848748|NCT00033904|Kidney Cancer, renal, immunotherapy, tumor,|kidney cancer, renal, immunotherapy, tumor,
5848749|NCT00033891|Muscle Weakness|muscle weakness
5848750|NCT00033891|Muscle Biopsy|muscle biopsy
5848751|NCT00033891|Gene Expression Profiling|gene expression profiling
5848752|NCT00033891|MRI|mri
5848753|NCT00033891|Inflammation|inflammation
5848754|NCT00033891|Polymyositis|polymyositis
5848755|NCT00033891|Dermatomyositis|dermatomyositis
5848756|NCT00033878|Advanced Cancer|advanced cancer
5848757|NCT00033865|Insomnia|insomnia
5848758|NCT00033865|Yoga|yoga
5848759|NCT00033865|Meditation|meditation
5848760|NCT00033865|Behavioral treatment|behavioral treatment
5848761|NCT00033852|complementary therapies|complementary therapies
5848762|NCT00033852|Depression|depression
5848763|NCT00033852|HIV|hiv
5848764|NCT00033852|Massage Therapy|massage therapy
5848765|NCT00033852|Alternative Treatments|alternative treatments
5848766|NCT00033839|Headache|headache
5848767|NCT00033839|Cluster|cluster
5848768|NCT00033839|EC|ec
5848769|NCT00033839|Episodic Cluster|episodic cluster
5848770|NCT00033826|Vitamin D|vitamin d
5848771|NCT00033826|Adipose tissue|adipose tissue
5848772|NCT00033826|Metabolism|metabolism
5848773|NCT00033813|Duchenne|duchenne
5848774|NCT00033813|muscular|muscular
5848775|NCT00033813|dystrophy|dystrophy
5848776|NCT00033813|controlled clinical trial|controlled clinical trial
5848777|NCT00033813|CINRG|cinrg
5848778|NCT00033787|Depression|depression
5848779|NCT00033787|Tryptophan Depletion|tryptophan depletion
5848780|NCT00033787|PET|pet
5848781|NCT00033787|Serotonin|serotonin
5848782|NCT00033787|Pathophysiology|pathophysiology
5848783|NCT00033787|Emotional Stimuli|emotional stimuli
5848784|NCT00033787|GABA MRS|gaba mrs
5848785|NCT00033787|MDD|mdd
5848786|NCT00033787|Healthy Volunteer|healthy volunteer
5848787|NCT00033787|HV|hv
5848803|NCT00033202|Pharmacokinetics|pharmacokinetics
5848804|NCT00033189|duchenne|duchenne
5848805|NCT00033189|dystrophy|dystrophy
5848806|NCT00033189|DMD|dmd
5848807|NCT00033189|clinical trial|clinical trial
5848809|NCT00033176|complementary therapies|complementary therapies
5848810|NCT00033176|Immune restoration|immune restoration
5848811|NCT00033176|HIV infection|hiv infection
5848812|NCT00033176|AIDS|aids
5848813|NCT00033176|HAART non-responsiveness|haart non-responsiveness
5848814|NCT00033176|glutathione restoration|glutathione restoration
5848815|NCT00033176|lipoic acid|lipoic acid
5848824|NCT00033163|Tenofovir disoproxil fumarate|tenofovir disoproxil fumarate
5848825|NCT00033163|Treatment Experienced|treatment experienced
5848826|NCT00033150|Specific Language Impairment|specific language impairment
5848827|NCT00033150|Fast ForWord|fast forword
5848828|NCT00033150|Language therapy|language therapy
5848829|NCT00033150|Auditory processing|auditory processing
5848837|NCT00033020|substance use disorders|substance use disorders
5848838|NCT00033007|substance use disorders|substance use disorders
5848839|NCT00032994|substance use disorders|substance use disorders
5848840|NCT00032981|substance use disorder|substance use disorder
5848841|NCT00032968|opiate dependence|opiate dependence
5848842|NCT00032955|opiate addiction|opiate addiction
5848843|NCT00032955|morphine addiction|morphine addiction
5850708|NCT00016601|efavirenz|efavirenz
5848848|NCT00032890|knee pain|knee pain
5848849|NCT00032877|Linkage Study|linkage study
5848850|NCT00032877|Gene Identification Study|gene identification study
5848851|NCT00032877|Diaphragmatic Hernia|diaphragmatic hernia
5848852|NCT00032877|Fraser Syndrome|fraser syndrome
5848853|NCT00032877|Cryptophthalmos|cryptophthalmos
5848854|NCT00032877|Fryns Syndrome|fryns syndrome
5848855|NCT00032877|Hydrolethalus Syndrome|hydrolethalus syndrome
5848856|NCT00032877|Positional Cloning|positional cloning
5848857|NCT00032864|amputations, diabetes,|amputations, diabetes,
5848858|NCT00032838|Hydrocortisone|hydrocortisone
5848859|NCT00032838|Yohimbine|yohimbine
5848860|NCT00032838|Cognition|cognition
5848861|NCT00032838|Norepinephrine|norepinephrine
5848862|NCT00032838|Cortisol|cortisol
5848864|NCT00032838|Healthy Volunteer|healthy volunteer
5848866|NCT00032838|Normal Control|normal control
5848867|NCT00032825|Combination|combination
5848868|NCT00032825|Microtubule|microtubule
5848869|NCT00032825|Hormonal|hormonal
5848870|NCT00032825|Chemotherapy|chemotherapy
5848871|NCT00032825|Pharmacokinetics|pharmacokinetics
5848872|NCT00032825|Prostate Cancer|prostate cancer
5848873|NCT00032825|Prostate|prostate
5848874|NCT00032773|acute graft versus host disease|acute graft versus host disease
5848875|NCT00032773|aGVHD|agvhd
5848876|NCT00032773|allogeneic hematopoietic stem cell transplantation|allogeneic hematopoietic stem cell transplantation
5848877|NCT00032773|peripheral blood stem cell transplantation|peripheral blood stem cell transplantation
5848878|NCT00032773|cord blood transplant|cord blood transplant
5848879|NCT00032773|pentostatin|pentostatin
5848880|NCT00032773|Nipent|nipent
5848881|NCT00032773|deoxycoformycin|deoxycoformycin
5848882|NCT00032812|Motor Learning|motor learning
5848883|NCT00032812|Sequencing|sequencing
5848884|NCT00032812|Functional Imaging|functional imaging
5848885|NCT00032812|Raclopride|raclopride
5848886|NCT00032812|Connectivity|connectivity
5848887|NCT00032812|Parkinson Disease|parkinson disease
5848888|NCT00032812|Parkinson's Disease|parkinson's disease
5848890|NCT00032812|Healthy Volunteer|healthy volunteer
5848891|NCT00032812|HV|hv
5848892|NCT00032812|Normal Control|normal control
5848893|NCT00032760|binge eating disorder|binge eating disorder
5848894|NCT00032760|human therapy evaluation|human therapy evaluation
5848895|NCT00032760|meditation|meditation
5848896|NCT00032760|obesity|obesity
5848897|NCT00032760|nutrition education|nutrition education
5848898|NCT00032760|psychotherapy|psychotherapy
5848899|NCT00032760|racial /ethnic difference|racial /ethnic difference
5848900|NCT00032760|adult human|adult human
5848901|NCT00032760|alternative medicine|alternative medicine
5848902|NCT00032760|patient oriented research|patient oriented research
5848903|NCT00032747|Chronic Heart Failure|chronic heart failure
5848904|NCT00032747|Heart Disease|heart disease
5848905|NCT00032734|Low Blood Sodium (Hyponatremia)|low blood sodium (hyponatremia)
5848906|NCT00032734|SIADH|siadh
5848907|NCT00032734|Inappropriate ADH Syndrome|inappropriate adh syndrome
5848908|NCT00032721|complementary therapies|complementary therapies
5848909|NCT00032721|Alternative medicine|alternative medicine
5848910|NCT00032721|Complementary and alternative medicine|complementary and alternative medicine
5848912|NCT00032721|Reiki|reiki
5848913|NCT00032721|HIV/AIDS|hiv/aids
5848914|NCT00032695|myelopathy|myelopathy
5848915|NCT00032695|AIDS-myelopathy|aids-myelopathy
5848916|NCT00032695|AIDS vacuolar myelopathy|aids vacuolar myelopathy
5848917|NCT00032695|methionine|methionine
5848918|NCT00032682|Bowel Movement|bowel movement
5848919|NCT00032682|Children|children
5848920|NCT00032682|Stool|stool
5848921|NCT00032682|Symptom Management|symptom management
5848922|NCT00032682|Cancer|cancer
5848923|NCT00032682|Constipation|constipation
5848924|NCT00032669|Antiretrovirals|antiretrovirals
5848925|NCT00032669|Adherence|adherence
5848926|NCT00032669|Dose Adjustments|dose adjustments
5848927|NCT00032669|Genotypic Resistance|genotypic resistance
5848928|NCT00032669|Phenotypic Resistance|phenotypic resistance
5848929|NCT00032656|Adolescents|adolescents
5848930|NCT00032656|Alternative and complimentary medication use|alternative and complimentary medication use
5848931|NCT00032656|Health services utilization|health services utilization
5848932|NCT00032656|Communication|communication
5848933|NCT00032656|Quality of care|quality of care
5848934|NCT00032617|PTSD|ptsd
5848938|NCT00032591|Mechanical heart valve (MHV)|mechanical heart valve (mhv)
5848939|NCT00032539|Informed Consent|informed consent
5848955|NCT00032487|type 2 diabetes mellitus|type 2 diabetes mellitus
5848956|NCT00032474|Ginkgo biloba|ginkgo biloba
5848957|NCT00032474|type 2 diabetes|type 2 diabetes
5848958|NCT00032474|platelet function|platelet function
5848959|NCT00032474|antioxidant|antioxidant
5848960|NCT00032461|chronic fatigue syndrome|chronic fatigue syndrome
5848961|NCT00032461|fibromyalgia|fibromyalgia
5848962|NCT00032461|post-traumatic stress disorder|post-traumatic stress disorder
5848963|NCT00032461|neurologic abnormalities|neurologic abnormalities
5848964|NCT00032448|Hernia|hernia
5848965|NCT00032448|laparoscopic herniorrhaphy|laparoscopic herniorrhaphy
5848966|NCT00032448|tension-free herniorrhaphy|tension-free herniorrhaphy
5848967|NCT00032435|folate|folate
5848968|NCT00032435|pyridoxine|pyridoxine
5848969|NCT00032435|vitamin B6|vitamin b6
5848970|NCT00032435|cyanocobalamin|cyanocobalamin
5848971|NCT00032435|homoc|homoc
5848973|NCT00032422|Heart Failure|heart failure
5848974|NCT00032422|Autonomic nervous system|autonomic nervous system
5848975|NCT00032409|Music Therapy|music therapy
5848976|NCT00032409|Relaxation Therapy|relaxation therapy
5848977|NCT00032409|Stress Reduction|stress reduction
5848978|NCT00032409|Bone Marrow Transplantation|bone marrow transplantation
5848979|NCT00032409|Stem Cell Transplantation|stem cell transplantation
5848981|NCT00032396|ARMD|armd
5848982|NCT00032396|Age-Related Macular Degeneration|age-related macular degeneration
5848983|NCT00032396|Subfoveal Choroidal Neovascularization|subfoveal choroidal neovascularization
5848984|NCT00032396|CNV|cnv
5848985|NCT00032383|Rehabilitation|rehabilitation
5848986|NCT00032383|Tai Chi|tai chi
5848987|NCT00032370|myocardial infarction|myocardial infarction
5848988|NCT00032370|Prophylactic coronary artery revascularization|prophylactic coronary artery revascularization
5848989|NCT00032357|Ferritin reduction|ferritin reduction
5848990|NCT00032357|Peripheral Vascular Disease (PVD)|peripheral vascular disease (pvd)
5848991|NCT00032357|phlebotomy|phlebotomy
5848992|NCT00032357|Reduction of Total Body Iron Storage(TBIS)|reduction of total body iron storage(tbis)
5848993|NCT00032357|Total Body Iron Storage(TBIS)|total body iron storage(tbis)
5848994|NCT00032344|large (>1 cm) adenomas|large (>1 cm) adenomas
5848995|NCT00032331|PET imaging, benign and malignant solitary pulmonary nodules|pet imaging, benign and malignant solitary pulmonary nodules
5848996|NCT00032305|Colitis|colitis
5848997|NCT00032305|Gastrointestinal Disease|gastrointestinal disease
5848998|NCT00032305|Digestive System Disease|digestive system disease
5848999|NCT00032305|Intestinal Disease|intestinal disease
5849000|NCT00032305|Colonic Disease|colonic disease
5849001|NCT00032240|Biomechanics|biomechanics
5849002|NCT00032227|Carpal Tunnel Release|carpal tunnel release
5849003|NCT00032227|MR Nerve Imaging|mr nerve imaging
5849004|NCT00032227|Wrist MRI|wrist mri
5849005|NCT00032201|Surgery|surgery
5849006|NCT00032201|Tissue Sample|tissue sample
5849007|NCT00032201|Gene Expression Profiling|gene expression profiling
5849008|NCT00032201|Tissue Array Gene Expression|tissue array gene expression
5849009|NCT00032201|Comparative Genomic Hybridization|comparative genomic hybridization
5849010|NCT00032201|Breast Cancer|breast cancer
5849011|NCT00032201|Breast Cancer Risk|breast cancer risk
5849012|NCT00032201|Breast|breast
5849013|NCT00031551|Stomatitis|stomatitis
5849014|NCT00031551|Oropharyngeal pain|oropharyngeal pain
5849015|NCT00031551|TNF|tnf
5849016|NCT00031551|Etanercept|etanercept
5849017|NCT00031551|Bone marrow transplantation|bone marrow transplantation
5849018|NCT00031551|Chemotherapy|chemotherapy
5849019|NCT00031551|Cancer|cancer
5849020|NCT00031551|Oral cavity|oral cavity
5849021|NCT00031551|Oral mucous membranes|oral mucous membranes
5849022|NCT00031551|Randomized controlled clinical trial|randomized controlled clinical trial
5849023|NCT00031551|Inflammation|inflammation
5849024|NCT00031538|Brain Tumor|brain tumor
5849025|NCT00031538|Surgery|surgery
5849026|NCT00031538|Molecular|molecular
5849027|NCT00031538|Glioma|glioma
5849028|NCT00031538|Intraoperative|intraoperative
5849029|NCT00031538|Gliomas|gliomas
5849030|NCT00031512|enterovirus, enteroviral sepsis, Pleconaril, infants|enterovirus, enteroviral sepsis, pleconaril, infants
5849031|NCT00031499|Azithromycin, Syphilis, Penicillin|azithromycin, syphilis, penicillin
5849032|NCT00031486|encephalitis, herpes simplex, valacyclovir|encephalitis, herpes simplex, valacyclovir
5849033|NCT00031473|Ribavirin|ribavirin
5849035|NCT00031460|acyclovir, central nervous system, Herpes Simplex Virus|acyclovir, central nervous system, herpes simplex virus
5849036|NCT00031447|Herpes Simplex, Acyclovir, Infants|herpes simplex, acyclovir, infants
5849037|NCT00031434|Valganciclovir, congenital cytomegalovirus, ganciclovir|valganciclovir, congenital cytomegalovirus, ganciclovir
5849038|NCT00031421|CMV, cytomegalovirus, children, ganciclovir|cmv, cytomegalovirus, children, ganciclovir
5849049|NCT00031382|Dual Task|dual task
5849050|NCT00031382|Neural Activation|neural activation
5849051|NCT00031382|Basal Ganglia|basal ganglia
5849052|NCT00031382|Cerebellum|cerebellum
5849053|NCT00031382|Healthy Volunteer|healthy volunteer
5849054|NCT00031382|HV|hv
5849055|NCT00031382|Normal Control|normal control
5849056|NCT00031369|MRI|mri
5849066|NCT00031343|Liver Disease|liver disease
5849067|NCT00031343|Virologic Response|virologic response
5849068|NCT00031343|Immune Mechanisms|immune mechanisms
5849069|NCT00031343|Eradication|eradication
5849070|NCT00031343|Antiviral Therapy|antiviral therapy
5849072|NCT00031343|Hepatitis C|hepatitis c
5849073|NCT00031343|HCV|hcv
5849074|NCT00031343|Coinfection|coinfection
5849075|NCT00031317|Depression|depression
5849076|NCT00031317|Treatment|treatment
5849077|NCT00031317|Antidepressant|antidepressant
5854634|NCT00001061|Foscarnet|foscarnet
5849078|NCT00031317|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
5849079|NCT00031317|SSRI (paroxetine)|ssri (paroxetine)
5849080|NCT00031317|Combined Treatment|combined treatment
5849081|NCT00031317|Panic Disorder (PD)|panic disorder (pd)
5849082|NCT00031317|Panic Disorder|panic disorder
5849083|NCT00031317|PD|pd
5849084|NCT00031304|HIV|hiv
5849085|NCT00031304|AIDS|aids
5849086|NCT00031304|Vaccine|vaccine
5849087|NCT00031304|Screening|screening
5849088|NCT00031304|Prevention|prevention
5849089|NCT00031304|HV|hv
5849090|NCT00031304|Healthy Volunteer|healthy volunteer
5849091|NCT00031304|Volunteer|volunteer
5849092|NCT00031304|HIV Seronegativity|hiv seronegativity
5849093|NCT00031304|HIV Preventive Vaccine|hiv preventive vaccine
5849094|NCT00031291|Anthrax|anthrax
5849095|NCT00031291|Immune Globulin|immune globulin
5849096|NCT00031291|Plasmapheresis|plasmapheresis
5849097|NCT00031291|Vaccine|vaccine
5849098|NCT00031278|Metastatic|metastatic
5849099|NCT00031278|Breast|breast
5849100|NCT00031278|Cancer|cancer
5849101|NCT00031278|immunotherapy|immunotherapy
5849102|NCT00031278|CPG 7909|cpg 7909
5849103|NCT00031265|stroke|stroke
5849104|NCT00031265|telephone|telephone
5849105|NCT00031265|intervention|intervention
5849106|NCT00031187|Prostate|prostate
5849107|NCT00031187|Lewis Blood-Group System|lewis blood-group system
5849108|NCT00031187|Antibodies, Monoclonal|antibodies, monoclonal
5849109|NCT00031187|Antigens, Neoplasm|antigens, neoplasm
5849110|NCT00031187|Antineoplastic Agents|antineoplastic agents
5849120|NCT00031161|Tyrosine|tyrosine
5849121|NCT00031161|Diet|diet
5849122|NCT00031161|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione|2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione
5849123|NCT00031161|4-Hydroxyphenylpyruvate Dioxygenase|4-hydroxyphenylpyruvate dioxygenase
5849124|NCT00031161|Enzyme Inhibitors|enzyme inhibitors
5849125|NCT00031148|Keratinocyte growth factor|keratinocyte growth factor
5849126|NCT00031148|Bone Marrow Transplantation|bone marrow transplantation
5849127|NCT00031148|Hematopoietic Stem Cell Transplantation|hematopoietic stem cell transplantation
5849128|NCT00031148|HLA Antigens|hla antigens
5849129|NCT00031148|Transplantation, Homologous|transplantation, homologous
5849130|NCT00031148|Recombinant Proteins|recombinant proteins
5849131|NCT00031135|Parenteral Nutrition, Total|parenteral nutrition, total
5849132|NCT00031135|Lipotropic Agents|lipotropic agents
5849133|NCT00031135|Choline|choline
5849134|NCT00031122|Genetic Predisposition to Disease|genetic predisposition to disease
5849135|NCT00031122|Environmental Exposure|environmental exposure
5849136|NCT00031122|Chromosome Mapping|chromosome mapping
5849137|NCT00031122|Data Collection|data collection
5849138|NCT00031109|HIV Antibodies|hiv antibodies
5849139|NCT00031109|HIV-1|hiv-1
5849140|NCT00031109|HIV Envelope Protein gp160|hiv envelope protein gp160
5849141|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic
5849142|NCT00031109|AIDS Vaccines|aids vaccines
5849143|NCT00031109|CD4 Lymphocyte Count|cd4 lymphocyte count
5849144|NCT00031109|Disease Models, Animal|disease models, animal
5849145|NCT00031109|Antibody Formation|antibody formation
5849147|NCT00031109|Neutralization Tests|neutralization tests
5849148|NCT00031109|Viral Load|viral load
5849149|NCT00031109|aluminum hydroxide|aluminum hydroxide
5849150|NCT00031109|HIV Preventive Vaccine|hiv preventive vaccine
5849151|NCT00031096|Acne Vulgaris|acne vulgaris
5849152|NCT00031096|Propionibacterium acnes|propionibacterium acnes
5849154|NCT00031083|Brain Tumor|brain tumor
5849155|NCT00031083|Adenovirus|adenovirus
5849156|NCT00031083|Gene Therapy|gene therapy
5849157|NCT00031083|Biogen|biogen
5849158|NCT00031070|Zidovudine|zidovudine
5849159|NCT00031070|CD4 Lymphocyte Count|cd4 lymphocyte count
5849160|NCT00031070|Lamivudine|lamivudine
5849161|NCT00031070|Cyclosporine|cyclosporine
5849162|NCT00031070|Hepatitis A Vaccine|hepatitis a vaccine
5849163|NCT00031070|Rabies Vaccine|rabies vaccine
5849164|NCT00031070|abacavir|abacavir
5849165|NCT00031070|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5849166|NCT00031070|efavirenz|efavirenz
5849167|NCT00031070|Treatment Naive|treatment naive
5849168|NCT00031057|Administration, Oral|administration, oral
5849169|NCT00031057|Blood|blood
5849170|NCT00031057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849171|NCT00031057|Riboflavin|riboflavin
5849172|NCT00031057|Thiamine|thiamine
5849173|NCT00031057|Vitamin B Complex|vitamin b complex
5849174|NCT00031057|Lactic Acid|lactic acid
5849175|NCT00031044|HIV-1|hiv-1
5849176|NCT00031044|Drug Therapy, Combination|drug therapy, combination
5849177|NCT00031044|RNA, Viral|rna, viral
5849178|NCT00031044|Salvage Therapy|salvage therapy
5849179|NCT00031044|Anti-HIV Agents|anti-hiv agents
5849180|NCT00031044|Viral Load|viral load
5849181|NCT00031044|Purines|purines
5849182|NCT00031044|T-20 Peptide|t-20 peptide
5849183|NCT00031044|ABT 378|abt 378
5849184|NCT00031044|Treatment Experienced|treatment experienced
5849185|NCT00031031|MTD|mtd
5849186|NCT00031031|Safety|safety
5849187|NCT00031031|Pharmacokinetics|pharmacokinetics
5849188|NCT00031031|Efficacy|efficacy
5849189|NCT00031018|Inflammation|inflammation
5849190|NCT00031018|immunosenescence|immunosenescence
5849191|NCT00031018|autoimmunity|autoimmunity
5849192|NCT00031018|atherosclerosis|atherosclerosis
5849193|NCT00031018|pro-inflammatory cytokines|pro-inflammatory cytokines
5849194|NCT00031018|Hayflick phenomenon|hayflick phenomenon
5849195|NCT00031005|Non-Myeloablative|non-myeloablative
5849196|NCT00031005|Campath 1-H|campath 1-h
5849197|NCT00031005|Fludarabine|fludarabine
5849198|NCT00031005|Immunodeficiency|immunodeficiency
5849199|NCT00031005|Infection|infection
5849200|NCT00031005|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
5849201|NCT00031005|LAD|lad
5849202|NCT00030992|Epothilone B|epothilone b
5849203|NCT00030992|Ixabepilone|ixabepilone
5849204|NCT00030992|Renal Cell Carcinoma|renal cell carcinoma
5849205|NCT00030992|Kidney Cancer|kidney cancer
5849206|NCT00030979|Mild Dementia|mild dementia
5849207|NCT00030979|Acetylcholine|acetylcholine
5849208|NCT00030979|Memory|memory
5849209|NCT00030979|Hallucinations|hallucinations
5849210|NCT00030979|Washout|washout
5849211|NCT00030979|Parkinson Disease|parkinson disease
5849212|NCT00030979|Parkinson's Disease|parkinson's disease
5849213|NCT00030979|PD|pd
5849214|NCT00030979|Dementia|dementia
5849215|NCT00030966|Multiple Sclerosis|multiple sclerosis
5849217|NCT00030953|Tourette's Syndrome|tourette's syndrome
5849218|NCT00030953|GABA|gaba
5849219|NCT00030953|NAA|naa
5849220|NCT00030953|Choline|choline
5849221|NCT00030953|Creatine|creatine
5849222|NCT00030953|Tourette Syndrome|tourette syndrome
5849223|NCT00030953|Healthy Volunteer|healthy volunteer
5849224|NCT00030953|HV|hv
5849225|NCT00030953|Normal Control|normal control
5849226|NCT00030940|Antigenic Epitopes|antigenic epitopes
5849227|NCT00030940|Glutamic Acid Decarboxylase (GAD)|glutamic acid decarboxylase (gad)
5849228|NCT00030940|Auto-antibodies|auto-antibodies
5849229|NCT00030940|Stiffness Index|stiffness index
5849230|NCT00030940|SPS|sps
5849231|NCT00030940|Anti-GAD|anti-gad
5849232|NCT00030940|MR Spectroscopy|mr spectroscopy
5849233|NCT00030940|GAD|gad
5849234|NCT00030940|Stiff Person Syndrome|stiff person syndrome
5849235|NCT00030238|Body Fat|body fat
5849236|NCT00030238|Weight Gain|weight gain
5849237|NCT00030238|Adult|adult
5849238|NCT00030238|Hypertension|hypertension
5849239|NCT00030238|Dietary Supplements|dietary supplements
5849240|NCT00030238|Healthy Volunteer|healthy volunteer
5849241|NCT00030238|HIV|hiv
5849242|NCT00030238|Body Weight|body weight
5849243|NCT00030225|Fulminant Hepatic Failure|fulminant hepatic failure
5849244|NCT00030212|T Cell|t cell
5849245|NCT00030212|IBM|ibm
5849246|NCT00030212|Inflammatory Myopathies|inflammatory myopathies
5849247|NCT00030212|Antigenic Epitopes|antigenic epitopes
5849248|NCT00030212|Endomysial T Lymphocytes|endomysial t lymphocytes
5849249|NCT00030212|Myositis|myositis
5849250|NCT00030212|Inclusion Body Myositis|inclusion body myositis
5849251|NCT00030212|Inflammatory Myopathy|inflammatory myopathy
5849252|NCT00030199|Transcranial Magnetic Stimuli|transcranial magnetic stimuli
5849253|NCT00030199|Eletromyography|eletromyography
5849254|NCT00030199|Needle Electrode|needle electrode
5849264|NCT00030173|Epothilone D|epothilone d
5849265|NCT00030173|tubulin polymerization|tubulin polymerization
5849267|NCT00030160|Prevention|prevention
5849268|NCT00030160|Exercise|exercise
5849269|NCT00030147|Gonadal Steroids|gonadal steroids
5849270|NCT00030147|Estrogen Receptor|estrogen receptor
5849271|NCT00030147|Mood Disorders|mood disorders
5849272|NCT00030147|Perimenopause|perimenopause
5849273|NCT00030147|Estradiol|estradiol
5849274|NCT00030147|Depression|depression
5849275|NCT00030147|Estrogen Response Element|estrogen response element
5849276|NCT00030147|Perimenopausal|perimenopausal
5849277|NCT00030147|Perimenopausal Depression|perimenopausal depression
5849278|NCT00030134|Natural History|natural history
5849279|NCT00030134|Female Carrier|female carrier
5849280|NCT00030134|Alpha-Galactosidase|alpha-galactosidase
5849281|NCT00030134|Lysosomal Disease|lysosomal disease
5849283|NCT00030134|Fabry|fabry
5849284|NCT00030134|Fabry Disease|fabry disease
5849285|NCT00030121|Acute Respiratory Distress|acute respiratory distress
5849286|NCT00030121|Acute Lung Injury|acute lung injury
5849287|NCT00030069|Hematopoiesis|hematopoiesis
5849288|NCT00030069|Apoptosis|apoptosis
5849289|NCT00030069|Cell Differentiation|cell differentiation
5849290|NCT00030069|Bone Marrow Cells|bone marrow cells
5849291|NCT00030056|Sargramostim|sargramostim
5849292|NCT00030056|Injections, Subcutaneous|injections, subcutaneous
5849293|NCT00030043|Electric Stimulation|electric stimulation
5849294|NCT00030043|Implants, Artificial|implants, artificial
5849297|NCT00030043|Speech Perception|speech perception
5849298|NCT00029991|Leg pain|leg pain
5849299|NCT00029991|Peripheral angiopathies|peripheral angiopathies
5849300|NCT00029991|Vascular Diseases, peripheral|vascular diseases, peripheral
5849310|NCT00029952|Cortisol|cortisol
5849311|NCT00029952|Bone Density|bone density
5849312|NCT00029952|Cushing Syndrome|cushing syndrome
5849313|NCT00029952|Postoperative|postoperative
5849314|NCT00029939|Preparation|preparation
5849315|NCT00029939|Subconscious|subconscious
5849316|NCT00029939|Healthy Volunteer|healthy volunteer
5849317|NCT00029939|HV|hv
5849318|NCT00029939|Normal Control|normal control
5849319|NCT00029926|Imaging|imaging
5849320|NCT00029926|Immune System|immune system
5849321|NCT00029926|Autoimmune Disease|autoimmune disease
5849322|NCT00029926|Lymphonodes|lymphonodes
5849323|NCT00029926|Spleen|spleen
5849324|NCT00029926|Systemic Lupus Erythematosus|systemic lupus erythematosus
5849325|NCT00029926|Lupus|lupus
5849326|NCT00029926|SLE|sle
5849327|NCT00029913|Placebos|placebos
5849328|NCT00029913|AIDS Vaccines|aids vaccines
5849329|NCT00029913|CD4 Lymphocyte Count|cd4 lymphocyte count
5849330|NCT00029913|Disease Progression|disease progression
5849331|NCT00029913|Viral Load|viral load
5849332|NCT00029913|HIV Preventive Vaccine|hiv preventive vaccine
5849333|NCT00029900|Dose-Response Relationship, Drug|dose-response relationship, drug
5849334|NCT00029900|Polyethylene Glycol|polyethylene glycol
5849335|NCT00029900|Arginine Deiminase|arginine deiminase
5849336|NCT00029874|Tetracyclines|tetracyclines
5849337|NCT00029874|Dose-Response Relationship, Drug|dose-response relationship, drug
5849338|NCT00029861|Weight Loss|weight loss
5849339|NCT00029861|Obesity|obesity
5849340|NCT00029861|Weight Reduction|weight reduction
5849341|NCT00029861|Overweight|overweight
5849342|NCT00029848|Diabetes|diabetes
5849343|NCT00029848|Obesity|obesity
5849344|NCT00029835|Obesity|obesity
5849345|NCT00029822|Acute Urinary Retention|acute urinary retention
5849347|NCT00029822|Benign Prostatic Hyperplasia|benign prostatic hyperplasia
5849348|NCT00029822|Benign Prostatic Hypertrophy|benign prostatic hypertrophy
5849349|NCT00029822|BPH|bph
5849350|NCT00029822|Enlarged Prostate|enlarged prostate
5849351|NCT00029809|Parkinsons Disease|parkinsons disease
5849352|NCT00029809|Chinese exercise|chinese exercise
5849353|NCT00029783|Glioblastoma|glioblastoma
5849354|NCT00029783|Brain tumor|brain tumor
5849355|NCT00029783|Distant healing|distant healing
5849356|NCT00029783|Distance healing|distance healing
5849357|NCT00029757|Surgical menopause|surgical menopause
5849358|NCT00029744|AIDS Vaccines|aids vaccines
5849359|NCT00029744|Clinical Protocols|clinical protocols
5849360|NCT00029744|HIV Seronegativity|hiv seronegativity
5849361|NCT00029744|Patient Selection|patient selection
5849362|NCT00029744|Patient Acceptance of Health Care|patient acceptance of health care
5849363|NCT00029744|Demography|demography
5849364|NCT00029744|HIV Preventive Vaccine|hiv preventive vaccine
5849365|NCT00029731|Nitric Oxide|nitric oxide
5849366|NCT00029731|Administration, Oral|administration, oral
5849367|NCT00029718|Chronic Stroke|chronic stroke
5849368|NCT00029718|Transcallosal Inhibition|transcallosal inhibition
5849369|NCT00029718|Motor Cortex|motor cortex
5849370|NCT00029718|Motor Control|motor control
5849371|NCT00029718|Motor Recovery|motor recovery
5849372|NCT00029718|Healthy Volunteer|healthy volunteer
5849373|NCT00029718|HV|hv
5849374|NCT00029718|Normal Control|normal control
5849375|NCT00029666|Motor Cortex|motor cortex
5849376|NCT00029666|Sham Stimulation|sham stimulation
5849377|NCT00029666|Prefrontal Cortex|prefrontal cortex
5849378|NCT00029666|Brain Stimulation|brain stimulation
5849379|NCT00029666|Gait|gait
5849380|NCT00029666|Parkinson|parkinson
5849381|NCT00029666|Parkinson's|parkinson's
5849382|NCT00029666|PD|pd
5849383|NCT00029653|Frontal Lobe|frontal lobe
5849384|NCT00029653|Reaction Time|reaction time
5849385|NCT00029653|Movement Preparation|movement preparation
5849386|NCT00029653|Motor Threshold|motor threshold
5849387|NCT00029653|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5849388|NCT00029653|Motor Cortex|motor cortex
5849389|NCT00029653|Healthy Volunteer|healthy volunteer
5849390|NCT00029653|Normal Control|normal control
5849392|NCT00029640|MRI|mri
5849393|NCT00029640|MRS|mrs
5849394|NCT00029640|SSRI|ssri
5849395|NCT00029640|Children|children
5849396|NCT00029640|Depression|depression
5849397|NCT00029640|Augmentation|augmentation
5845092|NCT00001461|Nitric Oxide|nitric oxide
5849398|NCT00029640|Magnetic Resonance Imaging|magnetic resonance imaging
5849399|NCT00029640|Major Depression|major depression
5849400|NCT00029640|MDD|mdd
5849401|NCT00029627|Alpha2-Adrenoreceptors|alpha2-adrenoreceptors
5849402|NCT00029627|Polymorphisms|polymorphisms
5849403|NCT00029627|Challenge Study|challenge study
5849404|NCT00029627|Yohimbine|yohimbine
5849405|NCT00029627|Clonidine|clonidine
5849406|NCT00029627|Subtypes|subtypes
5849407|NCT00029627|Normal Control|normal control
5849408|NCT00029627|HV|hv
5849409|NCT00029627|Healthy Volunteer|healthy volunteer
5849410|NCT00029614|ADHD|adhd
5849411|NCT00029614|Substance Use|substance use
5851700|NCT00004582|ABT 378|abt 378
5849412|NCT00029601|Magnetic Stimulation|magnetic stimulation
5849413|NCT00029601|Intracortical Inhibition|intracortical inhibition
5849414|NCT00029601|Intracortical Facilitation|intracortical facilitation
5844761|NCT00001669|EAE|eae
5849415|NCT00029601|Motor Evoked Potential|motor evoked potential
5849416|NCT00029601|Reaction Time|reaction time
5849417|NCT00029601|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5849418|NCT00029601|Dystonia|dystonia
5849419|NCT00029601|Focal Dystonia|focal dystonia
5849420|NCT00029601|Healthy Volunteer|healthy volunteer
5849421|NCT00029601|HV|hv
5849422|NCT00029601|Normal Control|normal control
5849423|NCT00029588|fMRI|fmri
5849424|NCT00029588|Adolescents and Adults|adolescents and adults
5849425|NCT00029588|Depression|depression
5849426|NCT00029588|Anxiety|anxiety
5849427|NCT00029588|Anxiety Disorder|anxiety disorder
5849428|NCT00029588|GAD|gad
5849429|NCT00029588|Adolescents|adolescents
5849430|NCT00029588|Healthy Volunteer|healthy volunteer
5849431|NCT00029588|HV|hv
5849432|NCT00029588|Normal Control|normal control
5849433|NCT00029575|Atherosclerotic|atherosclerotic
5849434|NCT00029575|Plaque|plaque
5849435|NCT00029575|Resolution|resolution
5849436|NCT00029575|Adventitia|adventitia
5849437|NCT00029575|Ultrasound|ultrasound
5849438|NCT00029575|Cardiac Catheterization|cardiac catheterization
5849439|NCT00029575|Arteriosclerosis|arteriosclerosis
5849440|NCT00029575|Coronary Artery Disease|coronary artery disease
5849441|NCT00029536|Epilepsy|epilepsy
5849442|NCT00029536|Seizure|seizure
5849443|NCT00029536|Hormone|hormone
5849444|NCT00029536|Progesterone|progesterone
5849445|NCT00029536|Catamenial|catamenial
5849446|NCT00029523|neoplastic|neoplastic
5849447|NCT00029523|meningitis|meningitis
5849448|NCT00029523|cerebrospinal fluid|cerebrospinal fluid
5849449|NCT00029523|CSF|csf
5849450|NCT00029523|meningeal|meningeal
5849451|NCT00029523|meninges|meninges
5849452|NCT00029523|CNS|cns
5849453|NCT00029523|Leptomeningeal Neoplasms|leptomeningeal neoplasms
5849454|NCT00029458|Placebo Controlled|placebo controlled
5849455|NCT00029458|Atypical Anti-Psychotic|atypical anti-psychotic
5849456|NCT00029458|Bipolar Mood Disorder|bipolar mood disorder
5849457|NCT00029458|Positron Emission Tomography|positron emission tomography
5849458|NCT00029458|Dopamine Receptor Blockade|dopamine receptor blockade
5849459|NCT00029458|Antimanic|antimanic
5849460|NCT00029458|Mania|mania
5849461|NCT00029458|Pathophysiology|pathophysiology
5849462|NCT00029458|Treatment-Resistant|treatment-resistant
5849463|NCT00029458|Mood Disorder|mood disorder
5849464|NCT00029458|BPD|bpd
5849465|NCT00029458|Bipolar|bipolar
5850709|NCT00016588|HIV-1|hiv-1
5849471|NCT00029341|Drug Resistance, Microbial|drug resistance, microbial
5849472|NCT00029341|Genotype|genotype
5849473|NCT00029341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849474|NCT00029341|Anti-HIV Agents|anti-hiv agents
5849475|NCT00029341|Viral Load|viral load
5849476|NCT00029341|Pharmacokinetics|pharmacokinetics
5849477|NCT00029341|Efavirenz|efavirenz
5849478|NCT00029341|Treatment Interruption|treatment interruption
5849479|NCT00029328|TNFR-Fc fusion protein|tnfr-fc fusion protein
5849480|NCT00029328|Stem Cell Transplantation|stem cell transplantation
5849481|NCT00029328|Transplantation, Homologous|transplantation, homologous
5849482|NCT00029328|Respiratory Function Tests|respiratory function tests
5849483|NCT00029315|Intraventricular hemorrhage|intraventricular hemorrhage
5849484|NCT00029315|Subarachnoid hemorrhage|subarachnoid hemorrhage
5849485|NCT00029315|Intracerebral hemorrhage|intracerebral hemorrhage
5849486|NCT00029315|Pharmacokinetics|pharmacokinetics
5849487|NCT00029315|Recombinant Proteins|recombinant proteins
5849488|NCT00029315|Anticoagulants|anticoagulants
5849489|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator
5849490|NCT00029315|Pharmacology|pharmacology
5849491|NCT00029315|Catheters, Indwelling|catheters, indwelling
5849492|NCT00029315|Cerebral Ventricles|cerebral ventricles
5849493|NCT00029302|fMRI|fmri
5849494|NCT00029302|Voluntary Movement|voluntary movement
5849495|NCT00029302|Healthy Volunteer|healthy volunteer
5849497|NCT00029302|Normal Control|normal control
5849498|NCT00029276|Parkinson's|parkinson's
5849499|NCT00029276|Depression|depression
5849500|NCT00029276|Magnetic Stimulation|magnetic stimulation
5849501|NCT00029250|complementary therapies|complementary therapies
5849502|NCT00029250|garlic|garlic
5849503|NCT00029250|Allium sativum|allium sativum
5849504|NCT00029250|metabolic diseases|metabolic diseases
5849505|NCT00029250|HAART|haart
5849506|NCT00029250|Protease inhibitors|protease inhibitors
5849507|NCT00029237|Behavioral intervention|behavioral intervention
5849508|NCT00029237|Psychoneuroimmunology|psychoneuroimmunology
5849509|NCT00029237|Complementary therapy|complementary therapy
5849510|NCT00029237|Stress and coping|stress and coping
5849511|NCT00029237|complementary therapies|complementary therapies
5849512|NCT00029224|bone lesions|bone lesions
5849513|NCT00029224|breast cancer|breast cancer
5849514|NCT00029224|multiple myeloma|multiple myeloma
5849515|NCT00029224|prostate cancer|prostate cancer
5849516|NCT00029224|bone metastases|bone metastases
5849517|NCT00029224|pain|pain
5849518|NCT00029198|Massage Therapy|massage therapy
5849519|NCT00029198|Preterm Infants|preterm infants
5849520|NCT00029198|Weight Gain|weight gain
5849521|NCT00029198|Vagal Tone|vagal tone
5849522|NCT00029198|IGF-1|igf-1
5849523|NCT00029198|Oxytocin|oxytocin
5849524|NCT00029198|Brazelton|brazelton
5849525|NCT00029185|Corneal Erosion|corneal erosion
5849526|NCT00029185|Dextrans|dextrans
5849527|NCT00029185|Administration, Topical|administration, topical
5849528|NCT00029185|Ophthalmic Solutions|ophthalmic solutions
5849529|NCT00029185|Thimerosal|thimerosal
5849530|NCT00029172|stroke|stroke
5849532|NCT00029159|Turner syndrome|turner syndrome
5849533|NCT00029159|estrogen|estrogen
5849534|NCT00029159|androgen|androgen
5849535|NCT00029159|growth hormone|growth hormone
5849536|NCT00029146|stroke|stroke
5849537|NCT00029146|transient ischemic attack (TIA)|transient ischemic attack (tia)
5849538|NCT00029146|carotid arteries|carotid arteries
5849539|NCT00029146|cerebral infarction|cerebral infarction
5849540|NCT00029133|aneurysm|aneurysm
5849541|NCT00029133|hypothermia|hypothermia
5849542|NCT00029133|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage
5849543|NCT00028431|Stage III melanoma|stage iii melanoma
5849544|NCT00028431|Stage IV melanoma|stage iv melanoma
5849545|NCT00028431|Interleukin-12|interleukin-12
5849546|NCT00028431|Cancer Vaccines|cancer vaccines
5849547|NCT00028431|Antineoplastic Agents, Combined|antineoplastic agents, combined
5849548|NCT00028431|Incomplete Freund's adjuvant|incomplete freund's adjuvant
5849549|NCT00028431|Monophenol Monooxygenase|monophenol monooxygenase
5849550|NCT00028431|Mannitol|mannitol
5849551|NCT00028431|Adjuvants, Immunologic|adjuvants, immunologic
5849552|NCT00028431|Melan-A Protein|melan-a protein
5849553|NCT00028431|Antigens, Neoplasm|antigens, neoplasm
5849554|NCT00028431|Antibodies|antibodies
5849555|NCT00028431|Melanocyte lineage-specific antigen gp100|melanocyte lineage-specific antigen gp100
5849556|NCT00028431|CTLA-4|ctla-4
5849557|NCT00028418|Acute Leukemia|acute leukemia
5849558|NCT00028418|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5849559|NCT00028418|Antineoplastic Agents|antineoplastic agents
5849560|NCT00028418|Nucleosides|nucleosides
5849561|NCT00028418|Dose-Response Relationship, Drug|dose-response relationship, drug
5849562|NCT00028418|Cladribine|cladribine
5849563|NCT00028418|Fludarabine|fludarabine
5849564|NCT00028405|Photodynamic Therapy|photodynamic therapy
5849566|NCT00028405|Refractory Tumor|refractory tumor
5849567|NCT00028405|Head and Neck Cancer|head and neck cancer
5849568|NCT00028405|Breast Cancer|breast cancer
5849569|NCT00028405|Pelvic Tumors|pelvic tumors
5849570|NCT00028405|Liver Metastasis|liver metastasis
5849571|NCT00028405|Colorectal Cancer|colorectal cancer
5849572|NCT00028405|Sarcoma|sarcoma
5849573|NCT00028405|Anal Cancer|anal cancer
5849574|NCT00028405|Oral Cancer|oral cancer
5849575|NCT00028405|Recurrent|recurrent
5849576|NCT00028405|Lymphadenopathy|lymphadenopathy
5849577|NCT00028405|Ovarian Cancer|ovarian cancer
5849578|NCT00028405|Cervical Cancer|cervical cancer
5849579|NCT00029120|Alzheimer's Disease|alzheimer's disease
5849580|NCT00029120|Spectroscopy|spectroscopy
5849581|NCT00029120|Longitudinal|longitudinal
5849582|NCT00029120|Perfusion|perfusion
5849583|NCT00029120|Hippocampus|hippocampus
5849584|NCT00029120|N-acetylaspartic Acid|n-acetylaspartic acid
5849585|NCT00029120|Cerebral Blood Flow|cerebral blood flow
5849586|NCT00029120|Aging|aging
5849587|NCT00029120|Dementia|dementia
5849588|NCT00029120|Alzheimer's|alzheimer's
5849589|NCT00029120|Memory Disorder|memory disorder
5849590|NCT00029120|Memory|memory
5849591|NCT00029120|Healthy Volunteer|healthy volunteer
5849592|NCT00029120|HV|hv
5849593|NCT00029120|Normal Control|normal control
5849594|NCT00029107|Hepatitis|hepatitis
5849595|NCT00029107|Vasculitis|vasculitis
5849596|NCT00029107|Rituximab|rituximab
5849597|NCT00029107|Cryoglobulinemia|cryoglobulinemia
5849598|NCT00029107|Hepatitis C|hepatitis c
5849599|NCT00029107|HcV-cV|hcv-cv
5849600|NCT00029107|Cryoglobulinemic Vasculitis|cryoglobulinemic vasculitis
5849601|NCT00029068|Neurophysiology|neurophysiology
5849602|NCT00029068|Tourette Syndrome|tourette syndrome
5849603|NCT00029068|Anorexia|anorexia
5849604|NCT00029068|SRIs|sris
5849605|NCT00029068|Personality|personality
5849606|NCT00029068|Obsessive-Compulsive Disorder (OCD)|obsessive-compulsive disorder (ocd)
5849607|NCT00029068|Cortical Excitability|cortical excitability
5849608|NCT00029068|Motor Cortex|motor cortex
5849609|NCT00029068|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5849610|NCT00029068|OCD Spectrum Disorders|ocd spectrum disorders
5849611|NCT00029068|Obsessive Compulsive|obsessive compulsive
5849612|NCT00029068|OCD|ocd
5849613|NCT00029068|Healthy Volunteer|healthy volunteer
5849614|NCT00029068|Normal Control|normal control
5849615|NCT00029068|HV|hv
5849616|NCT00029042|MRI|mri
5849617|NCT00029042|Inflammation|inflammation
5849618|NCT00029042|Joint Disability|joint disability
5849619|NCT00029042|Imaging|imaging
5849620|NCT00029042|Biologic Therapy|biologic therapy
5849621|NCT00029042|Rheumatoid Arthritis|rheumatoid arthritis
5849622|NCT00029042|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5849623|NCT00029042|JRA|jra
5849624|NCT00029042|Children|children
5849626|NCT00029042|Joint Inflammation|joint inflammation
5849627|NCT00028379|Plasticity|plasticity
5849628|NCT00028379|Motor Cortex|motor cortex
5849629|NCT00028379|Stroke|stroke
5849630|NCT00028379|Somatosensory|somatosensory
5849631|NCT00028379|Hemiparesis|hemiparesis
5849632|NCT00028366|HIV-1|hiv-1
5849633|NCT00028366|Drug Therapy, Combination|drug therapy, combination
5849634|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors
5849635|NCT00028366|Ritonavir|ritonavir
5849636|NCT00028366|RNA, Viral|rna, viral
5849637|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849638|NCT00028366|Viral Load|viral load
5849639|NCT00028366|ABT 378|abt 378
5849640|NCT00028366|tenofovir disoproxil|tenofovir disoproxil
5849641|NCT00028366|VX-175|vx-175
5849642|NCT00028366|Treatment Experienced|treatment experienced
5849643|NCT00028353|PIN|pin
5849644|NCT00028353|High Grade Prostate Intraepithelial Neoplasia (PIN)|high grade prostate intraepithelial neoplasia (pin)
5849645|NCT00028340|Breast Cancer|breast cancer
5849646|NCT00028327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5849647|NCT00028327|Zidovudine|zidovudine
5849648|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors
5849649|NCT00028327|CD4 Lymphocyte Count|cd4 lymphocyte count
5849650|NCT00028327|Lamivudine|lamivudine
5849651|NCT00028327|Pneumonia|pneumonia
5849652|NCT00028327|Nelfinavir|nelfinavir
5849653|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849654|NCT00028327|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5849655|NCT00028327|Efavirenz|efavirenz
5849656|NCT00028327|Intensive Care Units|intensive care units
5849657|NCT00028327|Sepsis|sepsis
5849658|NCT00028314|HIV-1|hiv-1
5849659|NCT00028314|Abacavir|abacavir
5849660|NCT00028314|Nevirapine|nevirapine
5849661|NCT00028314|Ritonavir|ritonavir
5849662|NCT00028314|RNA, Viral|rna, viral
5849663|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors
5849664|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849665|NCT00028314|Anti-HIV Agents|anti-hiv agents
5849666|NCT00028314|Viral Load|viral load
5849667|NCT00028314|HIV Wasting Syndrome|hiv wasting syndrome
5849668|NCT00028314|ABT 378|abt 378
5849669|NCT00028314|Treatment Experienced|treatment experienced
5850710|NCT00016588|Adenine|adenine
5849670|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors
5849671|NCT00028301|RNA, Viral|rna, viral
5849672|NCT00028301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849673|NCT00028301|Anti-HIV Agents|anti-hiv agents
5849674|NCT00028301|Viral Load|viral load
5849675|NCT00028301|Lipids|lipids
5849676|NCT00028301|ABT 378|abt 378
5849677|NCT00028301|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5849678|NCT00028301|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
5849679|NCT00028288|Asthma|asthma
5849680|NCT00028288|Daclizumab|daclizumab
5849681|NCT00028288|anti-Tac monoclonal antibody|anti-tac monoclonal antibody
5849682|NCT00028288|anti-IL-2|anti-il-2
5849683|NCT00028288|Zenapax|zenapax
5849684|NCT00028275|Hepatitis C Virus|hepatitis c virus
5849685|NCT00028275|Cirrhosis|cirrhosis
5849686|NCT00028275|Antiviral Agents|antiviral agents
5849687|NCT00028275|Viral Resistance|viral resistance
5849688|NCT00028275|Alpha Interferon|alpha interferon
5849689|NCT00028275|Hepatitis C|hepatitis c
5849690|NCT00028275|Hepatitis|hepatitis
5849691|NCT00028262|Palmitoyl-Protein Thioesterase|palmitoyl-protein thioesterase
5849692|NCT00028262|Lysosomes|lysosomes
5849693|NCT00028262|Batten Disease|batten disease
5849694|NCT00028262|Encephalopathy|encephalopathy
5849695|NCT00028262|Progressive Neurodegeneration|progressive neurodegeneration
5849696|NCT00028262|CLN 1|cln 1
5849697|NCT00028262|Infantile Neuronal Ceroid Lipofuscinosis|infantile neuronal ceroid lipofuscinosis
5849698|NCT00028262|Cystagon|cystagon
5849699|NCT00028249|Patient Satisfaction|patient satisfaction
5849700|NCT00028249|Self Efficacy|self efficacy
5849701|NCT00028249|Social Support|social support
5849702|NCT00028249|Symptom Management|symptom management
5849703|NCT00028249|Advanced Malignancies|advanced malignancies
5849704|NCT00028249|Pain Intervention|pain intervention
5849705|NCT00028236|Peripheral Blood Stem Cells|peripheral blood stem cells
5849706|NCT00028236|Common Gamma Chain (GC)|common gamma chain (gc)
5849707|NCT00028236|Immune Reconstitution|immune reconstitution
5849708|NCT00028236|T Lymphocytes|t lymphocytes
5849709|NCT00028236|B Lymphocytes|b lymphocytes
5849710|NCT00028236|X-Linked Severe Combined Immune Deficiency (XSCID)|x-linked severe combined immune deficiency (xscid)
5849711|NCT00028236|Gene Therapy|gene therapy
5849712|NCT00028236|NK Cell|nk cell
5849713|NCT00028236|Bone Marrow Transplantation|bone marrow transplantation
5849714|NCT00028236|Engraftment|engraftment
5849715|NCT00028236|XSCID|xscid
5849716|NCT00028236|Immune Deficiency|immune deficiency
5849717|NCT00028236|Immune System|immune system
5849719|NCT00028210|Plasticity|plasticity
5849720|NCT00028210|Somatosensory|somatosensory
5849721|NCT00028210|Upper Limb Amputation|upper limb amputation
5849722|NCT00028210|Tactile Performance|tactile performance
5849723|NCT00028210|Cortical Reorganization|cortical reorganization
5849724|NCT00028210|Healthy Volunteer|healthy volunteer
5849726|NCT00028210|Normal Control|normal control
5849727|NCT00028197|Voluntary Movement|voluntary movement
5849728|NCT00028197|Functional MRI|functional mri
5849729|NCT00028197|Sensorimotor Integration|sensorimotor integration
5849730|NCT00028197|Superior Parietal Lobe|superior parietal lobe
5849731|NCT00028197|Supplementary Motor Area|supplementary motor area
5849732|NCT00028197|Normal Control|normal control
5849734|NCT00028197|Healthy Volunteer|healthy volunteer
5849735|NCT00028184|Chronic Stroke|chronic stroke
5849736|NCT00028184|Ipsilateral Motor Cortex|ipsilateral motor cortex
5849737|NCT00028184|Motor Control|motor control
5849738|NCT00028184|Motor Recovery|motor recovery
5849739|NCT00028184|Stroke|stroke
5849740|NCT00028184|Healthy Volunteer|healthy volunteer
5849741|NCT00028184|HV|hv
5849742|NCT00028184|Healthy Control|healthy control
5849743|NCT00028158|Antineoplastic agents|antineoplastic agents
5849744|NCT00028158|Herpes virus|herpes virus
5849745|NCT00028158|Brain tumor|brain tumor
5849746|NCT00028158|Oncolytic virs|oncolytic virs
5849747|NCT00028145|Women's Health|women's health
5849748|NCT00028145|Disease Transmission, Vertical|disease transmission, vertical
5849749|NCT00028145|Preventive Medicine|preventive medicine
5849750|NCT00028145|Treatment Experienced|treatment experienced
5849751|NCT00028132|Risk Factors|risk factors
5849752|NCT00028132|Mucous Membrane|mucous membrane
5849753|NCT00028132|Anti-Infective Agents|anti-infective agents
5849754|NCT00028132|Cervix Uteri|cervix uteri
5849755|NCT00028132|Vagina|vagina
5849756|NCT00028132|Anti-HIV Agents|anti-hiv agents
5849757|NCT00028132|Pharmacokinetics|pharmacokinetics
5849758|NCT00028132|Vulva|vulva
5849759|NCT00028132|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5849760|NCT00028132|HIV Seronegativity|hiv seronegativity
5849761|NCT00028119|Clinical Trials|clinical trials
5849762|NCT00028119|Sexual Partners|sexual partners
5849763|NCT00028119|Risk Factors|risk factors
5849764|NCT00028119|Incidence|incidence
5849765|NCT00028119|HIV Seronegativity|hiv seronegativity
5849766|NCT00028119|India|india
5849767|NCT00028119|Patient Compliance|patient compliance
5849768|NCT00028119|Preventive Health Services|preventive health services
5849769|NCT00028106|Cancer|cancer
5849770|NCT00028106|Metastasis|metastasis
5849780|NCT00028093|Cirrhosis|cirrhosis
5849781|NCT00028093|Hepatitis C Virus|hepatitis c virus
5849782|NCT00028093|Hemolysis|hemolysis
5849783|NCT00028093|Ribavirin|ribavirin
5849784|NCT00028093|Alpha Interferon|alpha interferon
5849785|NCT00028093|Peginterferon|peginterferon
5849786|NCT00028093|Antiviral Agents|antiviral agents
5849787|NCT00028093|Viral Hepatitis|viral hepatitis
5849788|NCT00028093|Hemolytic Anemia|hemolytic anemia
5849789|NCT00028093|Renal Failure|renal failure
5849790|NCT00028093|Renal Dialysis|renal dialysis
5849791|NCT00028093|Hepatitis|hepatitis
5849792|NCT00028093|Hepatitis C|hepatitis c
5849798|NCT00028067|Drug Therapy, Combination|drug therapy, combination
5849799|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors
5849800|NCT00028067|RNA, Viral|rna, viral
5849801|NCT00028067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5849802|NCT00028067|Viral Load|viral load
5849803|NCT00028067|BMS 232632|bms 232632
5849804|NCT00027482|T Cell|t cell
5849805|NCT00027482|B Cell|b cell
5849806|NCT00027482|Flow Cytometry|flow cytometry
5849807|NCT00027482|Cell-Mediated Immunity|cell-mediated immunity
5849808|NCT00027482|Thymus|thymus
5849809|NCT00027482|HIV|hiv
5849810|NCT00027482|Immunity|immunity
5849811|NCT00027482|Lymphocytes|lymphocytes
5849812|NCT00027482|Monocytes|monocytes
5849813|NCT00027482|Healthy Volunteer|healthy volunteer
5849814|NCT00027482|HV|hv
5849815|NCT00027482|Normal Control|normal control
5849816|NCT00027469|Atheroembolism|atheroembolism
5849817|NCT00027469|Atherosclerosis|atherosclerosis
5849818|NCT00027469|MRI|mri
5849819|NCT00027469|Renal Artery Stenosis|renal artery stenosis
5849820|NCT00027469|Renovascular Hypertension|renovascular hypertension
5849822|NCT00027469|Renovascular Disease|renovascular disease
5849823|NCT00027469|Renal Artery Stenting|renal artery stenting
5849824|NCT00027469|PTRAS|ptras
5849825|NCT00027456|Insulin Resistance|insulin resistance
5849826|NCT00027456|Diabetes Mellitus|diabetes mellitus
5849827|NCT00027456|Adipocytes|adipocytes
5849828|NCT00027456|Rabson Mendenhall Syndrome|rabson mendenhall syndrome
5849829|NCT00027456|Leprechaunism|leprechaunism
5849830|NCT00027456|Leptin|leptin
5849831|NCT00027443|Giant Cell Myocarditis|giant cell myocarditis
5849832|NCT00027417|Congenital heart defects|congenital heart defects
5849833|NCT00027417|Hypoplastic left heart syndrome|hypoplastic left heart syndrome
5849834|NCT00027417|Complete atrioventricular canal defect|complete atrioventricular canal defect
5849835|NCT00027417|Triostat|triostat
5849836|NCT00027417|Cardiac surgery|cardiac surgery
5849837|NCT00027404|Adult, Autism|adult, autism
5849838|NCT00027391|Muscle Weakness, Muscular Dystrophy|muscle weakness, muscular dystrophy
5849839|NCT00027378|fluoxetine,|fluoxetine,
5849840|NCT00027378|adolescents,|adolescents,
5849841|NCT00027378|alcohol dependence,|alcohol dependence,
5849842|NCT00027378|major depression|major depression
5849844|NCT00027365|HIV Seronegativity|hiv seronegativity
5849845|NCT00027365|HIV Preventive Vaccine|hiv preventive vaccine
5849846|NCT00027365|Injections, Intramuscular|injections, intramuscular
5849847|NCT00027365|HIV Antibodies|hiv antibodies
5849849|NCT00027365|HIV Envelope Protein gp120|hiv envelope protein gp120
5849850|NCT00027365|Gene Products, tat|gene products, tat
5849851|NCT00027365|AIDS Vaccines|aids vaccines
5849852|NCT00027365|Neutralization Tests|neutralization tests
5849853|NCT00027365|Vaccines, Combined|vaccines, combined
5849854|NCT00027365|AIDS Seronegativity|aids seronegativity
5849855|NCT00027365|Gene Products, nef|gene products, nef
5849856|NCT00027352|Physician's Practice Patterns|physician's practice patterns
5849857|NCT00027352|Anti-HIV Agents|anti-hiv agents
5849858|NCT00027339|HIV-1|hiv-1
5849859|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors
5849860|NCT00027339|RNA, Viral|rna, viral
5849861|NCT00027339|Phenotype|phenotype
5849862|NCT00027339|Viral Load|viral load
5849863|NCT00027339|Pharmacokinetics|pharmacokinetics
5849864|NCT00027339|Treatment Experienced|treatment experienced
5849871|NCT00027300|Relapsing Remitting Multiple Sclerosis|relapsing remitting multiple sclerosis
5849872|NCT00027287|Type I Diabetes|type i diabetes
5849873|NCT00027287|Type 2 Diabetes|type 2 diabetes
5849974|NCT00026975|Laryngeal Cancer|laryngeal cancer
5849877|NCT00027287|Diabetic Retinopathy|diabetic retinopathy
5849878|NCT00027287|Macular Edema|macular edema
5849879|NCT00027287|Type II Diabetes|type ii diabetes
5849880|NCT00027274|Franconi Anemia|franconi anemia
5849881|NCT00027274|Diamond Blackfan Anemia|diamond blackfan anemia
5849882|NCT00027274|Dyskeratosis Congenita|dyskeratosis congenita
5849883|NCT00027274|Shwachman-Diamond Syndrome|shwachman-diamond syndrome
5849884|NCT00027274|Hereditary|hereditary
5849885|NCT00027274|Fanconi's Anemia|fanconi's anemia
5849886|NCT00027274|Bone Marrow|bone marrow
5849887|NCT00027274|Inherited Bone Marrow Failure Syndromes|inherited bone marrow failure syndromes
5849888|NCT00027274|IBMFS|ibmfs
5849889|NCT00027274|Familial Cancer|familial cancer
5849890|NCT00027261|Vaccines, Synthetic|vaccines, synthetic
5849891|NCT00027261|HIV-1|hiv-1
5849892|NCT00027261|AIDS Vaccines|aids vaccines
5849893|NCT00027261|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5849894|NCT00027261|HIV Seronegativity|hiv seronegativity
5849895|NCT00027261|Avipoxvirus|avipoxvirus
5849896|NCT00027261|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5849897|NCT00027261|HIV Preventive Vaccine|hiv preventive vaccine
5849898|NCT00027248|central venous catheter|central venous catheter
5849899|NCT00027248|bloodstream infection|bloodstream infection
5849900|NCT00027248|CVC|cvc
5849901|NCT00027248|catheter colonization|catheter colonization
5849902|NCT00027248|local catheter site infection|local catheter site infection
5849903|NCT00027209|seizures|seizures
5849904|NCT00027209|epilepsy|epilepsy
5849905|NCT00027209|menopause|menopause
5849906|NCT00027196|Genetics|genetics
5849907|NCT00027196|Cardiac Diseases|cardiac diseases
5849908|NCT00027196|Cardiac Hypertrophy|cardiac hypertrophy
5849909|NCT00027196|Sudden Death|sudden death
5849910|NCT00027196|Arrhythmias|arrhythmias
5849916|NCT00027170|Myocardial Infarction|myocardial infarction
5849917|NCT00027170|Myocardial Viability|myocardial viability
5849918|NCT00027170|Myocardial Perfusion|myocardial perfusion
5849919|NCT00027170|Myocardial Ischemia|myocardial ischemia
5849920|NCT00027170|Atherosclerosis|atherosclerosis
5849921|NCT00027157|Coronary Spasm|coronary spasm
5849922|NCT00027157|Endothelial-Derived-Relaxation Factor|endothelial-derived-relaxation factor
5849923|NCT00027157|Nitric Oxide Synthase|nitric oxide synthase
5849924|NCT00027157|Susceptibility Genes|susceptibility genes
5849925|NCT00027157|Tetrahydrobiopterin|tetrahydrobiopterin
5849926|NCT00027144|Leukemia|leukemia
5849927|NCT00027144|Vaccine|vaccine
5849928|NCT00027131|vaccine|vaccine
5849929|NCT00027131|immunotherapy|immunotherapy
5849930|NCT00027118|Shoulder|shoulder
5849931|NCT00027118|Breast Cancer|breast cancer
5849932|NCT00027118|Physical Therapy|physical therapy
5849933|NCT00027118|Lymphedema|lymphedema
5849934|NCT00027118|Quality of Life|quality of life
5849935|NCT00027118|Breast Cancer Surgery|breast cancer surgery
5849936|NCT00027118|Healthy Volunteer|healthy volunteer
5849937|NCT00027118|HV|hv
5849938|NCT00027118|Normal Control|normal control
5849939|NCT00027105|Fatigue|fatigue
5849940|NCT00027105|Shoulder function|shoulder function
5849941|NCT00027105|Lymphedema|lymphedema
5849942|NCT00027105|Breast Cancer|breast cancer
5849943|NCT00027105|Breast Cancer Surgery|breast cancer surgery
5849944|NCT00027105|Quality of Life|quality of life
5849945|NCT00027092|Infusions, Intravenous|infusions, intravenous
5849946|NCT00027092|Testosterone|testosterone
5849947|NCT00027092|Insulin Resistance|insulin resistance
5849948|NCT00027092|Hormone Replacement Therapy|hormone replacement therapy
5849949|NCT00027092|Glucose Tolerance Test|glucose tolerance test
5849950|NCT00027066|stroke|stroke
5849951|NCT00027066|aspirin|aspirin
5849952|NCT00027066|warfarin|warfarin
5849953|NCT00027053|alcoholism|alcoholism
5849954|NCT00027053|alcohol dependence|alcohol dependence
5849955|NCT00027053|trazadone|trazadone
5849956|NCT00027053|sleep|sleep
5849957|NCT00027040|AIDS Dementia Complex|aids dementia complex
5849958|NCT00027040|Selegiline|selegiline
5849959|NCT00027040|Oxidative Stress|oxidative stress
5849960|NCT00027040|Cognition|cognition
5849961|NCT00027040|Neuroprotective Agents|neuroprotective agents
5849962|NCT00027040|Brain Injuries|brain injuries
5849963|NCT00027040|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5849964|NCT00027040|Protons|protons
5849965|NCT00027014|opioid|opioid
5849966|NCT00027014|St. John's wort|st. john's wort
5849967|NCT00027014|analgesia|analgesia
5849968|NCT00027014|metabolism|metabolism
5849969|NCT00027014|transporter|transporter
5849970|NCT00027001|Qigong, exercise, circulatory assist devices|qigong, exercise, circulatory assist devices
5849971|NCT00026988|Huntington's disease|huntington's disease
5849972|NCT00026988|creatine|creatine
5849973|NCT00026988|energy depletion|energy depletion
5850085|NCT00026728|NHANES|nhanes
5849994|NCT00026923|Laparoscopy|laparoscopy
5849995|NCT00026923|Telemedicine|telemedicine
5849996|NCT00026923|Surgery|surgery
5849997|NCT00026923|Endoscopy|endoscopy
5849998|NCT00026910|Cell-Cycle|cell-cycle
5849999|NCT00026910|Apoptosis|apoptosis
5850000|NCT00026910|Molecular Prognosis|molecular prognosis
5850001|NCT00026897|Adoptive Immunotherapy|adoptive immunotherapy
5850002|NCT00026897|Cellular Therapy|cellular therapy
5850003|NCT00026897|Lymphocyte Migration|lymphocyte migration
5850004|NCT00026897|Tumor Imaging|tumor imaging
5850010|NCT00026871|Non-Therapeutic|non-therapeutic
5850011|NCT00026871|Radiation Therapy|radiation therapy
5850012|NCT00026871|Dosimetry|dosimetry
5850013|NCT00026871|Dose-Rate|dose-rate
5850014|NCT00026871|Fiberoptic|fiberoptic
5850015|NCT00026858|Bone Marrow Transplantation|bone marrow transplantation
5850016|NCT00026858|Leukemia|leukemia
5850017|NCT00026858|Breast Cancer|breast cancer
5850018|NCT00026858|Multiple Myeloma|multiple myeloma
5850019|NCT00026858|Total Body Irradiation|total body irradiation
5850021|NCT00026832|Major Depression|major depression
5850022|NCT00026832|MRI|mri
5850023|NCT00026832|Cerebral Blood Flow|cerebral blood flow
5850024|NCT00026832|Neuroendocrine|neuroendocrine
5850025|NCT00026832|Bipolar Disorder|bipolar disorder
5850026|NCT00026832|Serotonin1A|serotonin1a
5850027|NCT00026832|Mood Disorder|mood disorder
5850028|NCT00026832|Major Depressive Disorder|major depressive disorder
5850029|NCT00026832|MDD|mdd
5850030|NCT00026832|Depression|depression
5850031|NCT00026832|Healthy Volunteer|healthy volunteer
5850032|NCT00026832|HV|hv
5850033|NCT00026832|Normal Control|normal control
5850034|NCT00026819|NSAID|nsaid
5850035|NCT00026819|Acute Pain Model|acute pain model
5850036|NCT00026819|Hyperalgesia|hyperalgesia
5850037|NCT00026819|Central Sensitization|central sensitization
5850038|NCT00026819|Wisdom Teeth|wisdom teeth
5850039|NCT00026819|Wisdom Teeth Extraction|wisdom teeth extraction
5850040|NCT00026819|Third Molar|third molar
5850041|NCT00026806|HIV Infection|hiv infection
5850042|NCT00026806|Mental Health|mental health
5850043|NCT00026806|Risk Behaviors|risk behaviors
5850044|NCT00026806|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5850045|NCT00026806|Youth|youth
5850046|NCT00026806|HIV|hiv
5850047|NCT00026806|Long Term Survivor|long term survivor
5850056|NCT00026780|CT Scan|ct scan
5850057|NCT00026780|MRI Scan|mri scan
5850058|NCT00026780|Childhood Cancer|childhood cancer
5850059|NCT00026780|Eligibility Screening|eligibility screening
5850060|NCT00026780|Tissue Procurement|tissue procurement
5850061|NCT00026780|Pediatric|pediatric
5850062|NCT00026780|Children|children
5850063|NCT00026780|Screening|screening
5850064|NCT00026767|Risk Factors|risk factors
5850065|NCT00026767|Epidemiology|epidemiology
5850066|NCT00026767|BMT/SCT|bmt/sct
5850067|NCT00026767|Fungal Infection|fungal infection
5850068|NCT00026767|Bone Marrow Stem Cell Transplant|bone marrow stem cell transplant
5850069|NCT00026767|Organ Transplant|organ transplant
5850077|NCT00026741|Cytokine|cytokine
5850078|NCT00026741|Inflammation|inflammation
5850079|NCT00026741|Lymphocyte|lymphocyte
5850080|NCT00026741|T Cell|t cell
5850081|NCT00026741|Migration|migration
5850082|NCT00026741|Healthy Volunteer|healthy volunteer
5850083|NCT00026741|Skin Biopsy|skin biopsy
5850084|NCT00026728|Human Herpesvirus B|human herpesvirus b
5850099|NCT00026676|Phenotypic Resistance|phenotypic resistance
5850109|NCT00026637|depression|depression
5850110|NCT00026637|epilepsy|epilepsy
5850111|NCT00026637|seizures|seizures
5850112|NCT00026624|Virus Replication|virus replication
5850113|NCT00026624|Injections, Subcutaneous|injections, subcutaneous
5850114|NCT00026624|HIV-1|hiv-1
5850115|NCT00026624|AIDS Vaccines|aids vaccines
5850116|NCT00026624|Dendritic Cells|dendritic cells
5850117|NCT00026624|Adoptive Transfer|adoptive transfer
5850118|NCT00026624|Keyhole-Limpet Hemocyanin|keyhole-limpet hemocyanin
5850119|NCT00026624|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5850120|NCT00026611|Vaccine prophylaxis|vaccine prophylaxis
5850121|NCT00026598|Basal Ganglia|basal ganglia
5850122|NCT00026598|Cerebral Cortex|cerebral cortex
5850123|NCT00026598|Functional Neuroanatomy|functional neuroanatomy
5851701|NCT00004582|efavirenz|efavirenz
5850124|NCT00026598|Bradykinesia|bradykinesia
5850125|NCT00026598|Bradyphrenia|bradyphrenia
5850126|NCT00026598|Parkinson's Disease|parkinson's disease
5850127|NCT00026598|Parkinson Disease|parkinson disease
5850129|NCT00026598|Healthy Volunteer|healthy volunteer
5850131|NCT00026598|Normal Control|normal control
5850132|NCT00026585|Bipolar Disorder|bipolar disorder
5850133|NCT00026585|Antimanic|antimanic
5850134|NCT00026585|Placebo Controlled|placebo controlled
5850135|NCT00026585|Randomized|randomized
5850136|NCT00026585|Cytochrome P450|cytochrome p450
5850137|NCT00026585|Mania|mania
5850138|NCT00026585|PKC Inhibitor|pkc inhibitor
5850139|NCT00026585|Tamoxifen|tamoxifen
5850140|NCT00026585|Bipolar|bipolar
5850141|NCT00026585|Manic|manic
5850142|NCT00026585|BPD|bpd
5850150|NCT00026546|Stop Task|stop task
5850151|NCT00026546|Functional (BOLD) MRI|functional (bold) mri
5850152|NCT00026546|Developmental|developmental
5850153|NCT00026546|Inhibitory Control|inhibitory control
5850154|NCT00026546|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5850155|NCT00026546|ADHD|adhd
5850156|NCT00026546|Impulsivity|impulsivity
5850157|NCT00026546|Healthy Volunteer|healthy volunteer
5850158|NCT00026546|Normal Volunteer|normal volunteer
5850159|NCT00026546|HV|hv
5850160|NCT00026065|Hypertension|hypertension
5850161|NCT00026065|BIofeedback|biofeedback
5850162|NCT00026065|Non-pharmacological treatment|non-pharmacological treatment
5850163|NCT00026065|Prediction|prediction
5850164|NCT00026052|Riluzole|riluzole
5850165|NCT00026052|Neuroprotective|neuroprotective
5850166|NCT00026052|Open-Label Study|open-label study
5850167|NCT00026052|Glutamate Dysfunction|glutamate dysfunction
5850168|NCT00026052|Unipolar Depression|unipolar depression
5850169|NCT00026052|Antidepressant|antidepressant
5850170|NCT00026052|Depression|depression
5850171|NCT00026052|Major Depression|major depression
5850172|NCT00026039|stroke|stroke
5850173|NCT00026039|estrogen|estrogen
5850174|NCT00026026|Human tooth agenesis|human tooth agenesis
5850175|NCT00026013|contraception|contraception
5850176|NCT00026013|hormonal contraception|hormonal contraception
5850177|NCT00026013|herbal remedies|herbal remedies
5850178|NCT00026013|hypericum perforatum|hypericum perforatum
5850179|NCT00026013|contraceptive effectiveness|contraceptive effectiveness
5850180|NCT00026000|Voluntary Movement|voluntary movement
5850181|NCT00026000|Basal Ganglia|basal ganglia
5850182|NCT00026000|Frontal Lobe|frontal lobe
5850183|NCT00026000|Motor Cortex|motor cortex
5850184|NCT00026000|Motor Tic Disorder|motor tic disorder
5850185|NCT00026000|Tourette's Syndrome|tourette's syndrome
5850186|NCT00026000|Vocal Tic Disorder|vocal tic disorder
5850187|NCT00026000|Tic|tic
5850188|NCT00026000|Healthy Volunteer|healthy volunteer
5850189|NCT00026000|HV|hv
5850190|NCT00026000|Normal Control|normal control
5850191|NCT00025987|Brain|brain
5850207|NCT00025974|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5850208|NCT00025974|Major Depression|major depression
5850209|NCT00025974|Anxiety|anxiety
5850210|NCT00025974|Depression|depression
5850211|NCT00025974|Healthy Volunteer|healthy volunteer
5850213|NCT00025974|Normal Control|normal control
5850226|NCT00025922|Immunization|immunization
5850227|NCT00025922|Titers|titers
5850228|NCT00025922|Immune Activation|immune activation
5850229|NCT00025922|Antibody|antibody
5850230|NCT00025922|CD4 Cell Count|cd4 cell count
5850231|NCT00025922|HIV|hiv
5850232|NCT00025909|Therapy|therapy
5850233|NCT00025909|Antiretrovirals|antiretrovirals
5850234|NCT00025909|Interruption|interruption
5850235|NCT00025909|CD4+ T Cell|cd4+ t cell
5850236|NCT00025909|Plasma Viremia|plasma viremia
5850237|NCT00025909|HIV|hiv
5850238|NCT00025909|Treatment Experienced|treatment experienced
5850239|NCT00025909|Treatment Interuption|treatment interuption
5850240|NCT00025818|dry eyes|dry eyes
5850241|NCT00025818|rheumatoid arthritis|rheumatoid arthritis
5850242|NCT00025818|Lupus|lupus
5850243|NCT00025818|Sjogren's syndrome|sjogren's syndrome
5850244|NCT00025818|myositis|myositis
5850245|NCT00025818|scleroderma|scleroderma
5850246|NCT00025818|autoimmune disorder|autoimmune disorder
5850247|NCT00025883|Lipoatrophic Diabetes|lipoatrophic diabetes
5850248|NCT00025883|Diabetes Mellitus|diabetes mellitus
5850249|NCT00025883|Hypertriglyceridemia|hypertriglyceridemia
5850250|NCT00025883|NASH|nash
5850251|NCT00025883|Lipodystrophy|lipodystrophy
5850252|NCT00025883|Leptin|leptin
5850253|NCT00025883|Diabetes|diabetes
5850254|NCT00025870|Genetics|genetics
5850255|NCT00025870|Metabolic|metabolic
5850256|NCT00025870|Dysmorphology|dysmorphology
5850257|NCT00025870|Training|training
5850258|NCT00025870|DNA|dna
5850259|NCT00025870|DNA Testing|dna testing
5850260|NCT00025870|Dysmorphic Syndromes|dysmorphic syndromes
5850261|NCT00025870|Developmental Delay|developmental delay
5850262|NCT00025870|Genetic Counseling|genetic counseling
5850263|NCT00025870|Molecular Genetics|molecular genetics
5850264|NCT00025857|fMRI|fmri
5850265|NCT00025857|Depression|depression
5850266|NCT00025857|PTSD|ptsd
5850268|NCT00025857|Magnetic Resonance Imaging|magnetic resonance imaging
5850269|NCT00025857|Anxiety|anxiety
5850270|NCT00025857|Normal Volunteers|normal volunteers
5850271|NCT00025857|Adolescence|adolescence
5850272|NCT00025857|Memory|memory
5850273|NCT00025857|Physical/Sexual Abuse History|physical/sexual abuse history
5850274|NCT00025857|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5850275|NCT00025857|Adolescent|adolescent
5855092|NCT00000991|Dapsone|dapsone
5850276|NCT00025857|Healthy Volunteer|healthy volunteer
5850277|NCT00025857|HV|hv
5850278|NCT00025857|Normal Control|normal control
5850279|NCT00025844|Stress|stress
5850280|NCT00025844|Anxiety|anxiety
5850281|NCT00025844|Adults|adults
5850282|NCT00025844|Fear Conditioning|fear conditioning
5850283|NCT00025844|Normal Volunteers|normal volunteers
5850284|NCT00025844|Associative Learning|associative learning
5850285|NCT00025844|Virtual Reality|virtual reality
5850286|NCT00025844|Context Conditioning|context conditioning
5850287|NCT00025844|Healthy Volunteer|healthy volunteer
5850288|NCT00025844|HV|hv
5850289|NCT00025844|Normal Control|normal control
5850290|NCT00025831|Buccal|buccal
5850291|NCT00025831|DNA|dna
5850292|NCT00025831|Pooling|pooling
5850293|NCT00025831|Genotyping|genotyping
5850294|NCT00025831|Mouthwash|mouthwash
5850295|NCT00025831|Healthy Volunteer|healthy volunteer
5850296|NCT00025831|HV|hv
5850297|NCT00025831|Normal Control|normal control
5850298|NCT00025805|Cytokines|cytokines
5850299|NCT00025805|Th1 Th2 Response|th1 th2 response
5850300|NCT00025805|Inflammatory Bowel Dx|inflammatory bowel dx
5850301|NCT00025805|Lymphocyte|lymphocyte
5850302|NCT00025805|Colonoscopy|colonoscopy
5850303|NCT00025805|Crohn's Disease|crohn's disease
5850304|NCT00025805|Crohn's|crohn's
5850305|NCT00025792|Pramipexole|pramipexole
5850306|NCT00025792|Neuroprotective|neuroprotective
5850307|NCT00025792|Placebo Controlled|placebo controlled
5850308|NCT00025792|Depression|depression
5850309|NCT00025792|Brain Imaging|brain imaging
5850310|NCT00025792|Antidepressant|antidepressant
5850311|NCT00025792|Bipolar Disorder|bipolar disorder
5850312|NCT00025792|Bipolar|bipolar
5850313|NCT00025792|BPD|bpd
5850314|NCT00025792|Bipolar Depression|bipolar depression
5850315|NCT00025779|Hyperactivity|hyperactivity
5850316|NCT00025779|Distractibility|distractibility
5850317|NCT00025779|Impulsiveness|impulsiveness
5850318|NCT00025779|Pervasive Development Disorders|pervasive development disorders
5850319|NCT00025740|SSRI (paroxetine)|ssri (paroxetine)
5850320|NCT00025740|Benzodiazepine (clonazepam)|benzodiazepine (clonazepam)
5850321|NCT00025740|Post-Traumatic Stress Disorder (PTSD)|post-traumatic stress disorder (ptsd)
5850322|NCT00025740|Combined Treatment|combined treatment
5850323|NCT00025740|Rapid Treatment|rapid treatment
5850324|NCT00025740|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5850325|NCT00025740|PTSD|ptsd
5850326|NCT00025727|HIV-1|hiv-1
5850327|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors
5850328|NCT00025727|Ritonavir|ritonavir
5850329|NCT00025727|RNA, Viral|rna, viral
5850330|NCT00025727|Anti-HIV Agents|anti-hiv agents
5850331|NCT00025727|Viral Load|viral load
5850332|NCT00025727|ABT 378|abt 378
5850333|NCT00025727|VX-175|vx-175
5850334|NCT00025714|Serotonin Receptor|serotonin receptor
5850335|NCT00025714|Cell Culture|cell culture
5850336|NCT00025714|Temporal Lobe|temporal lobe
5850337|NCT00025714|Endothelial Cells|endothelial cells
5850338|NCT00025714|Superficial Temporal Artery|superficial temporal artery
5850339|NCT00025714|Epilepsy|epilepsy
5850340|NCT00025714|Intractable Epilepsy|intractable epilepsy
5850341|NCT00025701|Cortex|cortex
5850342|NCT00025701|Inhibition|inhibition
5850343|NCT00025701|Motor Control|motor control
5850344|NCT00025701|Event-Related Synchronization|event-related synchronization
5850345|NCT00025701|Event-Related Desynchronization|event-related desynchronization
5850346|NCT00025701|Focal Hand Dystonia|focal hand dystonia
5850347|NCT00025701|Focal Dystonia|focal dystonia
5850348|NCT00025701|Dystonia|dystonia
5850349|NCT00025701|Hand|hand
5850350|NCT00025701|Healthy Volunteer|healthy volunteer
5850352|NCT00024999|Movement|movement
5850353|NCT00024999|Coordination|coordination
5850354|NCT00024999|Correlation|correlation
5850355|NCT00024999|Coherence|coherence
5850356|NCT00024999|Parietofrontal Circuitry|parietofrontal circuitry
5850357|NCT00024999|Apraxia|apraxia
5850358|NCT00024999|Ideomotor Apraxia|ideomotor apraxia
5850359|NCT00024999|Healthy Volunteer|healthy volunteer
5850361|NCT00024999|Normal Control|normal control
5850362|NCT00024986|HAART|haart
5850363|NCT00024986|Genotypic Resistance|genotypic resistance
5850364|NCT00024986|Phenotypic Resistance|phenotypic resistance
5850365|NCT00024986|Immune Reconstitution|immune reconstitution
5850366|NCT00024986|Bone Density|bone density
5850367|NCT00024986|HIV|hiv
5850368|NCT00024986|Children|children
5850369|NCT00024986|Pediatric HIV Infection|pediatric hiv infection
5850370|NCT00024960|Speech|speech
5850371|NCT00024960|Motor Control|motor control
5850372|NCT00024960|Phenotype|phenotype
5850373|NCT00024960|Dysfluency|dysfluency
5850374|NCT00024960|Fluency|fluency
5850376|NCT00024960|Healthy Volunteer|healthy volunteer
5850377|NCT00024960|HV|hv
5850378|NCT00024960|Normal Control|normal control
5850379|NCT00024934|Immunodeficiency|immunodeficiency
5850380|NCT00024934|Primary|primary
5850381|NCT00024934|Cancer|cancer
5850382|NCT00024934|Genetics|genetics
5850383|NCT00024934|IGA Deficiency|iga deficiency
5850384|NCT00024934|Immune Deficiency|immune deficiency
5850386|NCT00024908|Frontal Lobes|frontal lobes
5850387|NCT00024908|Frontotemporal Dementia|frontotemporal dementia
5850388|NCT00024908|Focal Lesions|focal lesions
5850389|NCT00024908|Executive Functions|executive functions
5850390|NCT00024908|Frontotemporal Lobe Dementia|frontotemporal lobe dementia
5850391|NCT00024908|Frontal Lobe|frontal lobe
5850392|NCT00024908|Frontal Lobe Dementia|frontal lobe dementia
5850393|NCT00024908|Healthy Volunteer|healthy volunteer
5850394|NCT00024908|HV|hv
5850395|NCT00024908|Normal Control|normal control
5850396|NCT00024804|SKELETAL DISEASE|skeletal disease
5850397|NCT00024804|Osteoporosis|osteoporosis
5850398|NCT00024804|Dysplasia|dysplasia
5850399|NCT00024804|Osteomalacia|osteomalacia
5850400|NCT00024804|Bone Diseases|bone diseases
5850401|NCT00024791|Cerebral Palsy|cerebral palsy
5850402|NCT00024791|Pediatric|pediatric
5850403|NCT00024791|Cognition|cognition
5850404|NCT00024791|Motor Learning|motor learning
5850405|NCT00024791|Visuomotor Integration|visuomotor integration
5850406|NCT00024791|Corticospinal Tracts|corticospinal tracts
5850407|NCT00024791|Cortical Re-Organization|cortical re-organization
5850408|NCT00024791|Spastic Hemiplegia|spastic hemiplegia
5850409|NCT00024791|Spastic Diplegia|spastic diplegia
5850410|NCT00024791|Functional Outcome|functional outcome
5850411|NCT00024791|Children|children
5850420|NCT00024674|advanced malignancy|advanced malignancy
5850421|NCT00024661|recurrent solid tumors|recurrent solid tumors
5850422|NCT00024661|liposomes containing AON to c-raf protein (LErafAON)|liposomes containing aon to c-raf protein (lerafaon)
5850423|NCT00024648|advanced malignancy|advanced malignancy
5850424|NCT00024648|liposomes containing AON to c-raf messenger RNA|liposomes containing aon to c-raf messenger rna
5850425|NCT00024648|antisense oligodeoxynucleotide (AON)|antisense oligodeoxynucleotide (aon)
5850437|NCT00024570|neurosurgery, craniotomy|neurosurgery, craniotomy
5850438|NCT00024570|convection-enhanced delivery|convection-enhanced delivery
5850439|NCT00024570|CNS interstitial infusion|cns interstitial infusion
5850440|NCT00024570|recombinant toxins|recombinant toxins
5850441|NCT00024570|malignant glioma, recurrent|malignant glioma, recurrent
5850442|NCT00024570|catheter, stereotaxic|catheter, stereotaxic
5850443|NCT00024570|intratumoral therapy|intratumoral therapy
5850444|NCT00024570|positive pressure microinfusion|positive pressure microinfusion
5850445|NCT00024557|neurosurgery, craniotomy|neurosurgery, craniotomy
5850446|NCT00024557|convection-enhanced delivery|convection-enhanced delivery
5850447|NCT00024557|CNS interstitial infusion|cns interstitial infusion
5850448|NCT00024557|recombinant toxins|recombinant toxins
5850449|NCT00024557|malignant glioma, recurrent|malignant glioma, recurrent
5850450|NCT00024557|intratumoral therapy|intratumoral therapy
5850451|NCT00024557|positive pressure microinfusion|positive pressure microinfusion
5850452|NCT00024544|asthma|asthma
5850453|NCT00024544|anti-IL-4 monoclonal antibody|anti-il-4 monoclonal antibody
5850454|NCT00024544|pascolizumab|pascolizumab
5850455|NCT00024531|Alzheimer disease|alzheimer disease
5850456|NCT00024531|Cholesterol-lowering drugs|cholesterol-lowering drugs
5850457|NCT00024518|Diabetes|diabetes
5850458|NCT00024518|Immunotherapy|immunotherapy
5850459|NCT00024518|Study Drug|study drug
5850460|NCT00024518|Insulin Dependent Diabetes|insulin dependent diabetes
5850461|NCT00024518|Diabetes Mellitus|diabetes mellitus
5850462|NCT00024518|TIBM|tibm
5850463|NCT00024492|Liposome Encapsulated Mitoxantrone (LEM)|liposome encapsulated mitoxantrone (lem)
5850464|NCT00024492|solid tumors|solid tumors
5850465|NCT00024479|Minorities|minorities
5850466|NCT00024479|Rheumatic Disease|rheumatic disease
5850467|NCT00024479|Community Based|community based
5850468|NCT00024479|Ethnicity|ethnicity
5850470|NCT00023582|Syphilis|syphilis
5850471|NCT00023582|Herpes Genitalis|herpes genitalis
5850472|NCT00023582|Risk Factors|risk factors
5850473|NCT00023582|Incidence|incidence
5850474|NCT00023582|Prevalence|prevalence
5850475|NCT00023582|Homosexuality, Male|homosexuality, male
5850476|NCT00023582|Informed Consent|informed consent
5850477|NCT00023582|Peru|peru
5850478|NCT00023582|HIV Seronegativity|hiv seronegativity
5850480|NCT00023569|Conjoint Movement|conjoint movement
5850481|NCT00023569|Chronic Hemiplegia|chronic hemiplegia
5850482|NCT00023569|Brain Plasticity|brain plasticity
5850483|NCT00023569|Electrical Stimulation|electrical stimulation
5850484|NCT00023569|Stroke|stroke
5850485|NCT00023569|CVA|cva
5850488|NCT00023452|Latent TB infection|latent tb infection
5850489|NCT00023439|tuberculosis|tuberculosis
5850491|NCT00023426|tuberculosis|tuberculosis
5850492|NCT00023426|tb|tb
5850493|NCT00023426|rifapentine|rifapentine
5850494|NCT00023426|safety|safety
5850496|NCT00023413|tuberculosis|tuberculosis
5850497|NCT00023413|TB|tb
5850498|NCT00023400|tuberculosis|tuberculosis
5850499|NCT00023400|TB|tb
5850500|NCT00023374|tuberculosis|tuberculosis
5850501|NCT00023374|TB|tb
5850502|NCT00023374|isoniazid resistance|isoniazid resistance
5850503|NCT00023374|isoniazid intolerance|isoniazid intolerance
5850507|NCT00023361|tuberculosis|tuberculosis
5850508|NCT00023361|TB|tb
5850509|NCT00023348|Tuberculosis|tuberculosis
5850510|NCT00023348|TB|tb
5850511|NCT00023491|Sjogren's Syndrome|sjogren's syndrome
5850811|NCT00013585|Selegiline|selegiline
5850512|NCT00023491|Peripheral Blood Stem Cell|peripheral blood stem cell
5850513|NCT00023491|Tissue Regeneration|tissue regeneration
5850514|NCT00023491|Graft-versus-host Disease|graft-versus-host disease
5850515|NCT00023491|Head and Neck Cancer|head and neck cancer
5850516|NCT00023491|Salivary Gland|salivary gland
5850517|NCT00023491|Saliva Gland|saliva gland
5850518|NCT00023491|Salivary Gland Dysfunction|salivary gland dysfunction
5850519|NCT00023322|Cirrhosis|cirrhosis
5850520|NCT00023322|Chronic Hepatitis|chronic hepatitis
5850521|NCT00023322|Alpha Interferon|alpha interferon
5850522|NCT00023322|Hepatitis D Virus|hepatitis d virus
5850523|NCT00023322|Delta Hepatitis|delta hepatitis
5850524|NCT00023322|Viral Hepatitis|viral hepatitis
5850525|NCT00023322|Antiviral Agents|antiviral agents
5850526|NCT00023322|Hepatitis D|hepatitis d
5850527|NCT00023322|HDV|hdv
5850528|NCT00023322|Liver|liver
5850529|NCT00023322|Hepatitis|hepatitis
5850530|NCT00023309|Adefovir Dipivoxil|adefovir dipivoxil
5850531|NCT00023309|Lamivudine|lamivudine
5850532|NCT00023309|Nucleoside/Nucleotide Analogue|nucleoside/nucleotide analogue
5850533|NCT00023309|Chronic Hepatitis B|chronic hepatitis b
5850534|NCT00023309|Hepatitis B Mutants|hepatitis b mutants
5850535|NCT00023309|Liver Biopsy|liver biopsy
5850536|NCT00023309|Hepatitis B|hepatitis b
5850537|NCT00023309|Hepatitis|hepatitis
5850538|NCT00023309|HBV|hbv
5850539|NCT00023309|Liver|liver
5850540|NCT00023296|Acute Chest Syndrome|acute chest syndrome
5850541|NCT00023296|Blood Flow|blood flow
5850542|NCT00023296|Nitric Oxide|nitric oxide
5850543|NCT00023296|NO Therapy|no therapy
5850544|NCT00023296|Vaso-Occlusive Crisis|vaso-occlusive crisis
5850545|NCT00023296|Sickle Cell Anemia|sickle cell anemia
5850546|NCT00023296|Sickle Cell|sickle cell
5850547|NCT00023296|ACS|acs
5850548|NCT00023296|Pulmonary Hypertension|pulmonary hypertension
5850549|NCT00023218|Liver|liver
5850550|NCT00023218|HIV-1|hiv-1
5850551|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors
5850552|NCT00023218|Ritonavir|ritonavir
5850553|NCT00023218|Biopsy|biopsy
5850554|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850555|NCT00023218|Anti-HIV Agents|anti-hiv agents
5850556|NCT00023218|ABT 378|abt 378
5850557|NCT00023218|Acidosis, Lactic|acidosis, lactic
5850558|NCT00023218|efavirenz|efavirenz
5850559|NCT00023218|Alanine Transaminase|alanine transaminase
5850560|NCT00023205|Arthritis|arthritis
5850561|NCT00023205|Health literacy|health literacy
5850562|NCT00023205|Patient education|patient education
5850563|NCT00023205|Self-efficacy|self-efficacy
5850564|NCT00022763|Anti-HIV Agents|anti-hiv agents
5850565|NCT00022763|pentafuside|pentafuside
5850566|NCT00021775|Risk Factors|risk factors
5850567|NCT00021775|Incidence|incidence
5850568|NCT00021775|Patient Selection|patient selection
5850569|NCT00021775|HIV Seronegativity|hiv seronegativity
5850570|NCT00021762|Virus Replication|virus replication
5850571|NCT00021762|HIV-1|hiv-1
5850572|NCT00021762|Drug Administration Schedule|drug administration schedule
5850573|NCT00021762|AIDS Vaccines|aids vaccines
5850574|NCT00021762|RNA, Viral|rna, viral
5850575|NCT00021762|Viral Load|viral load
5850576|NCT00021762|HIV-1 immunogen, incomplete Freund's adjuvant|hiv-1 immunogen, incomplete freund's adjuvant
5850577|NCT00021762|Treatment Interruption|treatment interruption
5850578|NCT00021762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5850579|NCT00021671|Drug Therapy, Combination|drug therapy, combination
5850580|NCT00021671|Ampicillin|ampicillin
5850581|NCT00021671|Nevirapine|nevirapine
5850582|NCT00021671|Disease Transmission, Vertical|disease transmission, vertical
5850583|NCT00021671|Anti-Infective Agents|anti-infective agents
5850584|NCT00021671|Erythromycin|erythromycin
5850585|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850586|NCT00021671|Metronidazole|metronidazole
5850587|NCT00021671|Anti-HIV Agents|anti-hiv agents
5850588|NCT00021671|Chorioamnionitis|chorioamnionitis
5850589|NCT00021671|HIV Seronegativity|hiv seronegativity
5850590|NCT00021632|Ribavirin|ribavirin
5850591|NCT00021632|Drug Interactions|drug interactions
5850592|NCT00021632|Drug Therapy, Combination|drug therapy, combination
5850593|NCT00021632|Zidovudine|zidovudine
5850594|NCT00021632|Stavudine|stavudine
5850595|NCT00021632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850597|NCT00021632|Pharmacokinetics|pharmacokinetics
5850598|NCT00021632|Area Under Curve|area under curve
5850600|NCT00021554|Drug Therapy, Combination|drug therapy, combination
5851798|NCT00002442|Lamivudine|lamivudine
5850601|NCT00021554|HIV Protease Inhibitors|hiv protease inhibitors
5850602|NCT00021554|RNA, Viral|rna, viral
5850603|NCT00021554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850604|NCT00021554|Anti-HIV Agents|anti-hiv agents
5850605|NCT00021554|Viral Load|viral load
5850606|NCT00021554|pentafuside|pentafuside
5850607|NCT00021489|Placebos|placebos
5855468|NCT00000932|Viral Load|viral load
5850608|NCT00021489|Drug Therapy, Combination|drug therapy, combination
5850609|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850610|NCT00021489|Anti-HIV Agents|anti-hiv agents
5850611|NCT00021489|abacavir|abacavir
5850612|NCT00021489|mycophenolate mofetil|mycophenolate mofetil
5850614|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850615|NCT00021463|Anti-HIV Agents|anti-hiv agents
5850616|NCT00021463|Triglycerides|triglycerides
5850617|NCT00021463|abacavir|abacavir
5850618|NCT00021463|efavirenz|efavirenz
5850619|NCT00021463|Lipoproteins, LDL Cholesterol|lipoproteins, ldl cholesterol
5850621|NCT00017992|Drug Administration Schedule|drug administration schedule
5850622|NCT00017992|Stavudine|stavudine
5850623|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors
5850624|NCT00017992|Ritonavir|ritonavir
5850625|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850626|NCT00017992|Anti-HIV Agents|anti-hiv agents
5850627|NCT00017992|Pharmacokinetics|pharmacokinetics
5850628|NCT00017992|ABT 378|abt 378
5850629|NCT00017992|emtricitabine|emtricitabine
5850630|NCT00017797|Pregnancy Complications, Infectious|pregnancy complications, infectious
5850631|NCT00017797|HIV-1|hiv-1
5850632|NCT00017797|HIV Protease Inhibitors|hiv protease inhibitors
5850633|NCT00017797|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850634|NCT00017797|Anti-HIV Agents|anti-hiv agents
5850635|NCT00017797|Glucose Intolerance|glucose intolerance
5850636|NCT00017784|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5850637|NCT00017784|Infusions, Intravenous|infusions, intravenous
5850638|NCT00017784|Antiviral Agents|antiviral agents
5850639|NCT00017784|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5850640|NCT00017784|valganciclovir|valganciclovir
5850641|NCT00017771|HIV-1|hiv-1
5850642|NCT00017771|CD4 Lymphocyte Count|cd4 lymphocyte count
5850643|NCT00017771|Risk Factors|risk factors
5850644|NCT00017771|Hydroxyurea|hydroxyurea
5850645|NCT00017771|Disease Progression|disease progression
5850646|NCT00017771|Alcohol Drinking|alcohol drinking
5850647|NCT00017771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850648|NCT00017771|Anti-HIV Agents|anti-hiv agents
5850649|NCT00017771|Viral Load|viral load
5850650|NCT00017771|Polyneuropathies|polyneuropathies
5850651|NCT00017771|Treatment Experienced|treatment experienced
5850652|NCT00017758|Drug Interactions|drug interactions
5850653|NCT00017758|Nelfinavir|nelfinavir
5850654|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850655|NCT00017758|Anti-HIV Agents|anti-hiv agents
5850656|NCT00017758|Pharmacokinetics|pharmacokinetics
5850657|NCT00017758|Pravastatin|pravastatin
5850658|NCT00017758|efavirenz|efavirenz
5850659|NCT00017758|Simvastatin|simvastatin
5850660|NCT00017758|atorvastatin|atorvastatin
5850661|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors
5850662|NCT00017719|Pregnancy Complications, Infectious|pregnancy complications, infectious
5850663|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors
5850664|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850665|NCT00017719|Anti-HIV Agents|anti-hiv agents
5850666|NCT00017719|Viral Load|viral load
5850667|NCT00017719|Combivir|combivir
5850668|NCT00017719|Treatment Naive|treatment naive
5850669|NCT00017693|Recombinant Proteins|recombinant proteins
5850670|NCT00017693|Aerosols|aerosols
5850671|NCT00017693|Asthma|asthma
5850672|NCT00017693|Receptors, Interleukin-4|receptors, interleukin-4
5850673|NCT00017693|Forced Expiratory Volume|forced expiratory volume
5850674|NCT00016783|Drug Therapy, Combination|drug therapy, combination
5850675|NCT00016783|Drug Administration Schedule|drug administration schedule
5850676|NCT00016783|HIV Protease Inhibitors|hiv protease inhibitors
5850677|NCT00016783|CD4 Lymphocyte Count|cd4 lymphocyte count
5850678|NCT00016783|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5850679|NCT00016783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850680|NCT00016783|Anti-HIV Agents|anti-hiv agents
5850681|NCT00016783|Viral Load|viral load
5850682|NCT00016783|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5850683|NCT00016783|Treatment Experienced|treatment experienced
5850684|NCT00016783|Treatment Interruption|treatment interruption
5850685|NCT00016718|Didanosine|didanosine
5850686|NCT00016718|Drug Therapy, Combination|drug therapy, combination
5850687|NCT00016718|Drug Administration Schedule|drug administration schedule
5850688|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850689|NCT00016718|Anti-HIV Agents|anti-hiv agents
5850690|NCT00016718|Pharmacokinetics|pharmacokinetics
5850691|NCT00016718|Deoxycytidine|deoxycytidine
5850693|NCT00016718|Treatment Naive|treatment naive
5850694|NCT00016692|Drug tolerance|drug tolerance
5850695|NCT00016692|Acute Infection|acute infection
5850696|NCT00016601|Delayed-Action Preparations|delayed-action preparations
5850697|NCT00016601|Drug Interactions|drug interactions
5850698|NCT00016601|Drug Therapy, Combination|drug therapy, combination
5850699|NCT00016601|Nevirapine|nevirapine
5850700|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors
5850701|NCT00016601|Ritonavir|ritonavir
5850702|NCT00016601|Indinavir|indinavir
5845957|NCT00047957|Magnetic|magnetic
5850704|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850705|NCT00016601|Anti-HIV Agents|anti-hiv agents
5850706|NCT00016601|Pharmacokinetics|pharmacokinetics
5850707|NCT00016601|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
5850711|NCT00016588|Anti-HIV Agents|anti-hiv agents
5850712|NCT00016588|Viral Load|viral load
5850713|NCT00016588|Organophosphorus Compounds|organophosphorus compounds
5850714|NCT00016536|Antiviral Agents|antiviral agents
5850715|NCT00016536|Mucous Membrane|mucous membrane
5850716|NCT00016536|Spermatocidal Agents|spermatocidal agents
5850717|NCT00016536|Penis|penis
5850718|NCT00016536|Epithelium|epithelium
5850719|NCT00016536|PRO 2000|pro 2000
5850720|NCT00016536|Urethra|urethra
5850721|NCT00016536|HIV Seronegativity|hiv seronegativity
5850722|NCT00015704|Treatment Experienced|treatment experienced
5850723|NCT00015704|Treatment Interruption|treatment interruption
5850724|NCT00015704|Drug Administration Schedule|drug administration schedule
5850725|NCT00015704|CD4 Lymphocyte Count|cd4 lymphocyte count
5850726|NCT00015704|Anti-HIV Agents|anti-hiv agents
5850727|NCT00015704|Tetanus Toxoid|tetanus toxoid
5850728|NCT00015704|Aldesleukin|aldesleukin
5850729|NCT00015704|Diphtheria Toxoid|diphtheria toxoid
5850730|NCT00015691|Drug Therapy, Combination|drug therapy, combination
5850731|NCT00015691|Adipose Tissue|adipose tissue
5850732|NCT00015691|Area Under Curve|area under curve
5850733|NCT00015691|Hypoglycemic Agents|hypoglycemic agents
5850734|NCT00015691|Anthropometry|anthropometry
5850735|NCT00015691|Hyperinsulinemia|hyperinsulinemia
5850736|NCT00015691|Metformin|metformin
5850737|NCT00015691|BRL 49653|brl 49653
5850738|NCT00015691|Insulin|insulin
5850739|NCT00015691|Glucose Tolerance Test|glucose tolerance test
5850740|NCT00015652|Ribavirin|ribavirin
5850741|NCT00015652|Polyethylene Glycols|polyethylene glycols
5850742|NCT00015652|Interferon Alfa-2b|interferon alfa-2b
5850743|NCT00015652|Dose-Response Relationship, Drug|dose-response relationship, drug
5850744|NCT00015652|Drug Therapy, Combination|drug therapy, combination
5850745|NCT00015652|Antiviral Agents|antiviral agents
5850746|NCT00015652|Hepatitis C|hepatitis c
5850747|NCT00015652|Aldesleukin|aldesleukin
5850748|NCT00015652|Peginterferon|peginterferon
5850749|NCT00014937|HIV-1|hiv-1
5850750|NCT00014937|Didanosine|didanosine
5850751|NCT00014937|Drug Therapy, Combination|drug therapy, combination
5850752|NCT00014937|Zidovudine|zidovudine
5850753|NCT00014937|Nevirapine|nevirapine
5850754|NCT00014937|Stavudine|stavudine
5850755|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors
5850756|NCT00014937|Ritonavir|ritonavir
5850757|NCT00014937|Lamivudine|lamivudine
5850758|NCT00014937|RNA, Viral|rna, viral
5850759|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850760|NCT00014937|Anti-HIV Agents|anti-hiv agents
5850761|NCT00014937|Viral Load|viral load
5850762|NCT00014937|ABT 378|abt 378
5850763|NCT00014937|Combivir|combivir
5850764|NCT00014937|Efavirenz|efavirenz
5850765|NCT00014937|Treatment Experienced|treatment experienced
5850766|NCT00014053|Reference Values|reference values
5850767|NCT00014053|HIV Seropositivity|hiv seropositivity
5850768|NCT00014053|Immune System|immune system
5850769|NCT00014053|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5850770|NCT00014053|HIV Seronegativity|hiv seronegativity
5850771|NCT00014053|Antigens, CD|antigens, cd
5850772|NCT00014014|Zidovudine|zidovudine
5850773|NCT00014014|Phosphorylation|phosphorylation
5850774|NCT00014014|Drug Administration Schedule|drug administration schedule
5850775|NCT00014014|Lamivudine|lamivudine
5850776|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850777|NCT00014014|Anti-HIV Agents|anti-hiv agents
5850778|NCT00014014|Pharmacokinetics|pharmacokinetics
5850779|NCT00014014|Combivir|combivir
5850780|NCT00013897|Placebos|placebos
5850781|NCT00013897|Drug Therapy, Combination|drug therapy, combination
5850782|NCT00013897|Zidovudine|zidovudine
5850783|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors
5850784|NCT00013897|Lamivudine|lamivudine
5850785|NCT00013897|RNA, Viral|rna, viral
5850786|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850787|NCT00013897|Anti-HIV Agents|anti-hiv agents
5850788|NCT00013897|Viral Load|viral load
5850789|NCT00013897|BMS 232632|bms 232632
5850790|NCT00013897|efavirenz|efavirenz
5850791|NCT00013871|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5690953|NCT00534352|HIV|hiv
5850792|NCT00013871|Antibodies, Viral|antibodies, viral
5850793|NCT00013871|Hepatitis B Vaccines|hepatitis b vaccines
5850794|NCT00013871|Immunization, Secondary|immunization, secondary
5850795|NCT00013871|Pneumococcal Vaccines|pneumococcal vaccines
5850796|NCT00013871|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5850797|NCT00013871|Diphtheria-Tetanus-acellular Pertussis Vaccines|diphtheria-tetanus-acellular pertussis vaccines
5850798|NCT00013663|Virus Replication|virus replication
5850799|NCT00013663|HIV-1|hiv-1
5850800|NCT00013663|AIDS Vaccines|aids vaccines
5850801|NCT00013663|RNA, Viral|rna, viral
5850802|NCT00013663|Avipoxvirus|avipoxvirus
5850803|NCT00013663|Genetic Vectors|genetic vectors
5850804|NCT00013663|Viral Load|viral load
5850805|NCT00013663|aldesleukin|aldesleukin
5850906|NCT00011037|Trinidad and Tobago|trinidad and tobago
5850806|NCT00013663|Antiretroviral Therapy, Highly Active|antiretroviral therapy, highly active
5850807|NCT00013663|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5850808|NCT00013663|Treatment Interruption|treatment interruption
5850809|NCT00013585|Cognitive Disorders|cognitive disorders
5850810|NCT00013585|AIDS Dementia Complex|aids dementia complex
5850812|NCT00013585|Administration, Cutaneous|administration, cutaneous
5850813|NCT00013585|Neuroprotective Agents|neuroprotective agents
5850814|NCT00013572|Injections, Intramuscular|injections, intramuscular
5850815|NCT00013572|Injections, Intradermal|injections, intradermal
5850816|NCT00013572|Injections, Subcutaneous|injections, subcutaneous
5850817|NCT00013572|HIV-1|hiv-1
5850818|NCT00013572|AIDS Vaccines|aids vaccines
5850819|NCT00013572|Dendritic Cells|dendritic cells
5850820|NCT00013572|HIV Seronegativity|hiv seronegativity
5850821|NCT00013572|Genes, env|genes, env
5850822|NCT00013572|Genes, pol|genes, pol
5850823|NCT00013572|Genes, gag|genes, gag
5850824|NCT00013572|Transfection|transfection
5850825|NCT00013572|HIV Preventive Vaccine|hiv preventive vaccine
5850826|NCT00013520|HIV-1|hiv-1
5850827|NCT00013520|Didanosine|didanosine
5850828|NCT00013520|Drug Therapy, Combination|drug therapy, combination
5850829|NCT00013520|Zidovudine|zidovudine
5850830|NCT00013520|Nevirapine|nevirapine
5850831|NCT00013520|Stavudine|stavudine
5850832|NCT00013520|Lamivudine|lamivudine
5850833|NCT00013520|RNA, Viral|rna, viral
5850834|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850835|NCT00013520|Anti-HIV Agents|anti-hiv agents
5850836|NCT00013520|Viral Load|viral load
5850837|NCT00013520|Combivir|combivir
5850838|NCT00013520|BMS 232632|bms 232632
5850839|NCT00013520|Efavirenz|efavirenz
5850840|NCT00013520|Treatment Naive|treatment naive
5850841|NCT00012519|Dose-Response Relationship, Drug|dose-response relationship, drug
5850842|NCT00012519|Drug Therapy, Combination|drug therapy, combination
5850843|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors
5850844|NCT00012519|Ritonavir|ritonavir
5850845|NCT00012519|Indinavir|indinavir
5850846|NCT00012519|Anti-HIV Agents|anti-hiv agents
5850847|NCT00012519|Viral Load|viral load
5850848|NCT00012519|Pharmacokinetics|pharmacokinetics
5850849|NCT00012519|Treatment Experienced|treatment experienced
5850850|NCT00012467|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5850851|NCT00012467|Injections, Subcutaneous|injections, subcutaneous
5850852|NCT00012467|Itraconazole|itraconazole
5850853|NCT00012467|Dose-Response Relationship, Drug|dose-response relationship, drug
5850854|NCT00012467|Fluconazole|fluconazole
5850855|NCT00012467|Flucytosine|flucytosine
5850856|NCT00012467|Antifungal Agents|antifungal agents
5850857|NCT00012467|Amphotericin B|amphotericin b
5850858|NCT00012467|Meningitis, Cryptococcal|meningitis, cryptococcal
5850859|NCT00011895|HIV-1|hiv-1
5850860|NCT00011895|Drug Therapy, Combination|drug therapy, combination
5850861|NCT00011895|Zidovudine|zidovudine
5850862|NCT00011895|Lamivudine|lamivudine
5850863|NCT00011895|Drug Combinations|drug combinations
5850864|NCT00011895|RNA, Viral|rna, viral
5850865|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850866|NCT00011895|Anti-HIV Agents|anti-hiv agents
5850867|NCT00011895|Viral Load|viral load
5850868|NCT00011895|abacavir|abacavir
5850869|NCT00011895|efavirenz|efavirenz
5850870|NCT00011479|Administration, Oral|administration, oral
5850871|NCT00011479|Drug Administration Schedule|drug administration schedule
5850872|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850873|NCT00011479|Anti-HIV Agents|anti-hiv agents
5850874|NCT00011479|Pharmacokinetics|pharmacokinetics
5850875|NCT00011479|abacavir|abacavir
5850876|NCT00011128|HIV-1|hiv-1
5850877|NCT00011128|Drug Resistance, Microbial|drug resistance, microbial
5850878|NCT00011128|Microbial Sensitivity Tests|microbial sensitivity tests
5850879|NCT00011128|Salvage Therapy|salvage therapy
5850880|NCT00011128|Anti-HIV Agents|anti-hiv agents
5850881|NCT00011128|Viral Load|viral load
5850882|NCT00011128|Treatment Experienced|treatment experienced
5850883|NCT00011089|HIV-1|hiv-1
5850884|NCT00011089|Disease Progression|disease progression
5850885|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850886|NCT00011089|Anti-HIV Agents|anti-hiv agents
5850887|NCT00011089|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5850888|NCT00011050|Specimen Handling|specimen handling
5850889|NCT00011050|Blood|blood
5850890|NCT00011050|Cryopreservation|cryopreservation
5850891|NCT00011050|Lactic Acid|lactic acid
5850892|NCT00011050|Sodium Fluoride|sodium fluoride
5850893|NCT00011050|Oxalates|oxalates
5850894|NCT00011037|HIV Antibodies|hiv antibodies
5850895|NCT00011037|HIV Antigens|hiv antigens
5850896|NCT00011037|HIV Envelope Protein gp120|hiv envelope protein gp120
5850897|NCT00011037|AIDS Vaccines|aids vaccines
5850898|NCT00011037|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5850899|NCT00011037|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5850900|NCT00011037|Neutralization Tests|neutralization tests
5850901|NCT00011037|Haiti|haiti
5850902|NCT00011037|Brazil|brazil
5850903|NCT00011037|Cytotoxicity, Immunologic|cytotoxicity, immunologic
5850904|NCT00011037|Epitopes|epitopes
5850905|NCT00011037|Viral Proteins|viral proteins
5850908|NCT00011037|HIV Preventive Vaccine|hiv preventive vaccine
5850909|NCT00011037|HIV Seronegativity|hiv seronegativity
5850910|NCT00011011|HIV-1|hiv-1
5850911|NCT00011011|Drug Administration Schedule|drug administration schedule
5850912|NCT00011011|AIDS Vaccines|aids vaccines
5850913|NCT00011011|CD4 Lymphocyte Count|cd4 lymphocyte count
5850914|NCT00011011|RNA, Viral|rna, viral
5850915|NCT00011011|Anti-HIV Agents|anti-hiv agents
5850916|NCT00011011|Viral Load|viral load
5850917|NCT00011011|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5850918|NCT00011011|Treatment Interruption|treatment interruption
5850919|NCT00009555|Testosterone|testosterone
5850920|NCT00009555|Anthropometry|anthropometry
5850921|NCT00009555|Obesity|obesity
5850922|NCT00009555|Abdomen|abdomen
5850923|NCT00009061|HIV-1|hiv-1
5850924|NCT00009061|Drug Therapy, Combination|drug therapy, combination
5850925|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors
5850926|NCT00009061|Ritonavir|ritonavir
5850927|NCT00009061|Lamivudine|lamivudine
5850928|NCT00009061|Nelfinavir|nelfinavir
5850929|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850930|NCT00009061|Anti-HIV Agents|anti-hiv agents
5850931|NCT00009061|abacavir|abacavir
5850932|NCT00008866|HIV-1|hiv-1
5850933|NCT00008866|Didanosine|didanosine
5850934|NCT00008866|Drug Therapy, Combination|drug therapy, combination
5850935|NCT00008866|Drug Administration Schedule|drug administration schedule
5850936|NCT00008866|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5850937|NCT00008866|Hydroxyurea|hydroxyurea
5850938|NCT00008866|RNA, Viral|rna, viral
5850939|NCT00008866|Genotype|genotype
5850940|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850941|NCT00008866|Anti-HIV Agents|anti-hiv agents
5850942|NCT00008866|Viral Load|viral load
5850943|NCT00008853|Clinical Evaluation|clinical evaluation
5850944|NCT00008554|HIV-1|hiv-1
5850945|NCT00008554|Drug Therapy, Combination|drug therapy, combination
5850946|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors
5850947|NCT00008554|Lamivudine|lamivudine
5850948|NCT00008554|Nelfinavir|nelfinavir
5850949|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850950|NCT00008554|Anti-HIV Agents|anti-hiv agents
5850951|NCT00008554|abacavir|abacavir
5850952|NCT00008528|HIV-1|hiv-1
5850953|NCT00008528|Drug Therapy, Combination|drug therapy, combination
5850954|NCT00008528|Drug Resistance, Microbial|drug resistance, microbial
5850955|NCT00008528|RNA, Viral|rna, viral
5850956|NCT00008528|Membrane Fusion|membrane fusion
5850957|NCT00008528|Anti-HIV Agents|anti-hiv agents
5850958|NCT00008528|Viral Load|viral load
5850959|NCT00008489|Didanosine|didanosine
5850960|NCT00008489|Gastrointestinal System|gastrointestinal system
5850961|NCT00008489|Tablets|tablets
5850962|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850963|NCT00008489|Anti-HIV Agents|anti-hiv agents
5850964|NCT00008489|Capsules|capsules
5850965|NCT00008463|Ribavirin|ribavirin
5850966|NCT00008463|Polyethylene Glycols|polyethylene glycols
5850967|NCT00008463|Interferon Alfa-2a|interferon alfa-2a
5850968|NCT00008463|HIV-1|hiv-1
5850969|NCT00008463|Antiviral Agents|antiviral agents
5850970|NCT00008463|Hepatitis C, Chronic|hepatitis c, chronic
5850971|NCT00007488|HIV-1|hiv-1
5850972|NCT00007488|Lymphoid Tissue|lymphoid tissue
5850973|NCT00007488|Viremia|viremia
5850974|NCT00007488|RNA, Viral|rna, viral
5850975|NCT00007488|Saliva|saliva
5850976|NCT00007488|Anti-HIV Agents|anti-hiv agents
5850977|NCT00007488|Viral Load|viral load
5850978|NCT00007488|Genitalia, Female|genitalia, female
5850979|NCT00007488|Genitalia, Male|genitalia, male
5850980|NCT00007449|HIV-1|hiv-1
5850981|NCT00007449|Drug Therapy, Combination|drug therapy, combination
5850982|NCT00007449|RNA, Viral|rna, viral
5850983|NCT00007449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850984|NCT00007449|Anti-HIV Agents|anti-hiv agents
5850985|NCT00007449|Viral Load|viral load
5850986|NCT00007436|HIV-1|hiv-1
5850987|NCT00007436|Drug Therapy, Combination|drug therapy, combination
5850988|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850989|NCT00007436|Anti-HIV Agents|anti-hiv agents
5850990|NCT00007436|9-(2-phosphonylmethoxypropyl)adenine|9-(2-phosphonylmethoxypropyl)adenine
5850991|NCT00007423|HIV Antibodies|hiv antibodies
5850992|NCT00007423|HIV-1|hiv-1
5850993|NCT00007423|AIDS Vaccines|aids vaccines
5850994|NCT00007423|HIV Seronegativity|hiv seronegativity
5850995|NCT00007423|Uganda|uganda
5850996|NCT00007423|Cross Reactions|cross reactions
5850997|NCT00007423|HIV Preventive Vaccine|hiv preventive vaccine
5850998|NCT00007332|Drug Therapy, Combination|drug therapy, combination
5850999|NCT00007332|HIV Envelope Protein gp120|hiv envelope protein gp120
5851000|NCT00007332|AIDS Vaccines|aids vaccines
5851799|NCT00002442|Indinavir|indinavir
5851001|NCT00007332|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5851002|NCT00007332|HIV Seronegativity|hiv seronegativity
5851003|NCT00007332|AIDSVAX|aidsvax
5851004|NCT00007332|HIV Preventive Vaccine|hiv preventive vaccine
5851005|NCT00007319|HIV Protease Inhibitors|hiv protease inhibitors
5851006|NCT00007319|Risk Factors|risk factors
5851007|NCT00007319|HIV Seronegativity|hiv seronegativity
5851008|NCT00007319|Anti-HIV Agents|anti-hiv agents
5851009|NCT00007319|Carotid Artery|carotid artery
5851010|NCT00007319|Tunica Intima|tunica intima
5851011|NCT00007319|Atherosclerosis|atherosclerosis
5851012|NCT00007202|Virus Replication|virus replication
5851013|NCT00007202|HIV-1|hiv-1
5851014|NCT00007202|Didanosine|didanosine
5851015|NCT00007202|Drug Therapy, Combination|drug therapy, combination
5851016|NCT00007202|Stavudine|stavudine
5851017|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors
5851018|NCT00007202|Sensitivity and Specificity|sensitivity and specificity
5851019|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851020|NCT00007202|Anti-HIV Agents|anti-hiv agents
5851021|NCT00007202|Viral Load|viral load
5851022|NCT00007202|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
5851023|NCT00007202|Acute Infection|acute infection
5851024|NCT00006643|Liver|liver
5851025|NCT00006643|Hepatitis C|hepatitis c
5851026|NCT00006643|Biopsy|biopsy
5851027|NCT00006643|Tomography, Emission-Computed, Single-Photon|tomography, emission-computed, single-photon
5851028|NCT00006630|Smallpox Vaccine|smallpox vaccine
5851029|NCT00006630|Injections, Intramuscular|injections, intramuscular
5851030|NCT00006630|Immunoglobulins|immunoglobulins
5851031|NCT00006630|Orthopoxvirus|orthopoxvirus
5851032|NCT00006617|HIV-1|hiv-1
5851033|NCT00006617|Drug Therapy, Combination|drug therapy, combination
5851034|NCT00006617|Zidovudine|zidovudine
5851035|NCT00006617|Lymphoid Tissue|lymphoid tissue
5851036|NCT00006617|Gastrointestinal System|gastrointestinal system
5851037|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors
5851038|NCT00006617|Lamivudine|lamivudine
5851039|NCT00006617|Lymphocyte Subsets|lymphocyte subsets
5851040|NCT00006617|VX 478|vx 478
5851041|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851042|NCT00006617|Anti-HIV Agents|anti-hiv agents
5851043|NCT00006617|Viral Load|viral load
5851044|NCT00006617|Cerebrospinal Fluid|cerebrospinal fluid
5851045|NCT00006617|abacavir|abacavir
5851046|NCT00006604|Dose-Response Relationship, Drug|dose-response relationship, drug
5851047|NCT00006604|Drug Therapy, Combination|drug therapy, combination
5851048|NCT00006604|Drug Administration Schedule|drug administration schedule
5851049|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors
5851050|NCT00006604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851051|NCT00006604|Anti-HIV Agents|anti-hiv agents
5851052|NCT00006604|Pharmacokinetics|pharmacokinetics
5851053|NCT00006604|Treatment Experienced|treatment experienced
5851054|NCT00006604|Treatment Naive|treatment naive
5851055|NCT00006591|Drug Therapy, Combination|drug therapy, combination
5851056|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors
5851057|NCT00006591|Ritonavir|ritonavir
5851058|NCT00006591|VX 478|vx 478
5851059|NCT00006591|Salvage Therapy|salvage therapy
5851060|NCT00006591|Anti-HIV Agents|anti-hiv agents
5851061|NCT00006591|Drug Monitoring|drug monitoring
5851062|NCT00006591|Nelfinavir|nelfinavir
5851063|NCT00006591|Treatment Experienced|treatment experienced
5851064|NCT00006578|Drug Therapy, Combination|drug therapy, combination
5851065|NCT00006578|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5851066|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors
5851067|NCT00006578|Ritonavir|ritonavir
5851068|NCT00006578|Lamivudine|lamivudine
5851069|NCT00006578|Stem Cells|stem cells
5851070|NCT00006578|VX 478|vx 478
5851071|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851072|NCT00006578|Anti-HIV Agents|anti-hiv agents
5851073|NCT00006578|Antigens, CD34|antigens, cd34
5851074|NCT00006578|abacavir|abacavir
5851075|NCT00006578|Treatment Naive|treatment naive
5851076|NCT00006509|Recombinant Proteins|recombinant proteins
5851077|NCT00006509|HIV Envelope Protein gp160|hiv envelope protein gp160
5851078|NCT00006509|AIDS Vaccines|aids vaccines
5851079|NCT00006509|Anti-HIV Agents|anti-hiv agents
5851080|NCT00006509|Treatment Experienced|treatment experienced
5851081|NCT00006509|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851082|NCT00006495|Placebos|placebos
5846862|NCT00042614|Transplant|transplant
5851083|NCT00006495|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5851084|NCT00006495|AIDS Vaccines|aids vaccines
5851085|NCT00006495|RNA, Viral|rna, viral
5851086|NCT00006495|HIV Core Protein p24|hiv core protein p24
5851087|NCT00006495|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5851088|NCT00006495|Anti-HIV Agents|anti-hiv agents
5851089|NCT00006495|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851090|NCT00006490|HIV-1|hiv-1
5851091|NCT00006490|Drug Resistance, Microbial|drug resistance, microbial
5851092|NCT00006490|Sequence Analysis, DNA|sequence analysis, dna
5851093|NCT00006490|Microbial Sensitivity Tests|microbial sensitivity tests
5851094|NCT00006490|Genotype|genotype
5851095|NCT00006490|Phenotype|phenotype
5851096|NCT00006490|Anti-HIV Agents|anti-hiv agents
5851097|NCT00006444|Drug Therapy, Combination|drug therapy, combination
5851098|NCT00006444|Papillomavirus, Human|papillomavirus, human
5851099|NCT00006444|DNA, Viral|dna, viral
5851100|NCT00006444|Anti-HIV Agent|anti-hiv agent
5851101|NCT00006444|Treatment Naive|treatment naive
5851102|NCT00006443|T-Lymphocytes|t-lymphocytes
5851103|NCT00006443|HIV-1|hiv-1
5851104|NCT00006443|Lymphoid Tissue|lymphoid tissue
5851105|NCT00006443|Stavudine|stavudine
5851106|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors
5855470|NCT00000931|Risk-Taking|risk-taking
5851107|NCT00006443|Polymerase Chain Reaction|polymerase chain reaction
5851108|NCT00006443|Biological Markers|biological markers
5851109|NCT00006443|Lamivudine|lamivudine
5851110|NCT00006443|Indinavir|indinavir
5851111|NCT00006443|RNA, Viral|rna, viral
5851112|NCT00006443|Genotype|genotype
5851113|NCT00006443|Phenotype|phenotype
5851114|NCT00006443|Cytokines|cytokines
5851115|NCT00006443|Nelfinavir|nelfinavir
5851116|NCT00006443|Macrophages|macrophages
5851117|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851118|NCT00006443|In Situ Hybridization|in situ hybridization
5851119|NCT00006443|Anti-HIV Agents|anti-hiv agents
5851120|NCT00006443|Viral Load|viral load
5851121|NCT00006443|Cell Membrane|cell membrane
5851122|NCT00006443|Acute Infection|acute infection
5851123|NCT00006443|Treatment Naive|treatment naive
5851124|NCT00006442|Lymphocytes|lymphocytes
5851126|NCT00006442|Lymphoid Tissue|lymphoid tissue
5851127|NCT00006442|Blood|blood
5851128|NCT00006442|Anti-HIV Agents|anti-hiv agents
5851129|NCT00006442|Viral Load|viral load
5851130|NCT00006441|Virus Replication|virus replication
5851131|NCT00006441|HIV-1|hiv-1
5851132|NCT00006441|Interleukin-2|interleukin-2
5851133|NCT00006441|Drug Therapy, Combination|drug therapy, combination
5851134|NCT00006441|Zidovudine|zidovudine
5851135|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors
5851136|NCT00006441|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5851137|NCT00006441|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5851138|NCT00006441|Biological Markers|biological markers
5851139|NCT00006441|Lamivudine|lamivudine
5851140|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851141|NCT00006441|Anti-HIV Agents|anti-hiv agents
5851142|NCT00006441|Nelfinavir|nelfinavir
5851143|NCT00006441|Cytotoxicity, Immunologic|cytotoxicity, immunologic
5851144|NCT00006441|Acute Infection|acute infection
5851145|NCT00006440|Risk Factors|risk factors
5851146|NCT00006440|Behavior Therapy|behavior therapy
5851147|NCT00006440|Substance-Related Disorders|substance-related disorders
5851148|NCT00006440|Feasibility Studies|feasibility studies
5851149|NCT00006415|Virus Replication|virus replication
5851150|NCT00006415|HIV-1|hiv-1
5851151|NCT00006415|Polymerase Chain Reaction|polymerase chain reaction
5851152|NCT00006415|DNA, Viral|dna, viral
5851153|NCT00006415|RNA, Viral|rna, viral
5851154|NCT00006415|Sensitivity and Specificity|sensitivity and specificity
5851155|NCT00006415|Anti-HIV Agents|anti-hiv agents
5851156|NCT00006415|Viral Load|viral load
5851157|NCT00006415|Proviruses|proviruses
5851158|NCT00006415|Acute Infection|acute infection
5851159|NCT00006412|Hyperlipidemia|hyperlipidemia
5851160|NCT00006412|Procetofen|procetofen
5851161|NCT00006412|Pravastatin|pravastatin
5851162|NCT00006412|Antilipemic Agents|antilipemic agents
5851163|NCT00006397|Didanosine|didanosine
5851164|NCT00006397|Drug Therapy, Combination|drug therapy, combination
5851165|NCT00006397|Stavudine|stavudine
5851166|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors
5851167|NCT00006397|Sex Factors|sex factors
5851168|NCT00006397|Ritonavir|ritonavir
5851169|NCT00006397|Indinavir|indinavir
5851170|NCT00006397|Dosage Forms|dosage forms
5851171|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851172|NCT00006397|Anti-HIV Agents|anti-hiv agents
5851173|NCT00006396|Pregnancy Complications, Infectious|pregnancy complications, infectious
5851174|NCT00006396|HIV-1|hiv-1
5851175|NCT00006396|Administration, Oral|administration, oral
5851176|NCT00006396|Zidovudine|zidovudine
5851177|NCT00006396|Nevirapine|nevirapine
5851178|NCT00006396|RNA, Viral|rna, viral
5851179|NCT00006396|Disease Transmission, Vertical|disease transmission, vertical
5851180|NCT00006396|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5851181|NCT00006396|Blotting, Western|blotting, western
5851182|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851183|NCT00006396|Anti-HIV Agents|anti-hiv agents
5851184|NCT00006396|Viral Load|viral load
5851185|NCT00006396|HIV Seronegativity|hiv seronegativity
5851186|NCT00006339|Prospective Studies|prospective studies
5851187|NCT00006339|HIV-1|hiv-1
5851188|NCT00006339|Didanosine|didanosine
5851189|NCT00006339|Drug Therapy, Combination|drug therapy, combination
5851190|NCT00006339|Stavudine|stavudine
5851191|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors
5851193|NCT00006339|Ritonavir|ritonavir
5851194|NCT00006339|Indinavir|indinavir
5851195|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851196|NCT00006339|Anti-HIV Agents|anti-hiv agents
5851197|NCT00006339|Viral Load|viral load
5851198|NCT00006339|Reverse Transcriptase Polymerase Chain Reaction|reverse transcriptase polymerase chain reaction
5851892|NCT00002426|VX 478|vx 478
5790253|NCT00145028|AUC|auc
5851199|NCT00006327|Recombinant Proteins|recombinant proteins
5851200|NCT00006327|HIV-1|hiv-1
5851201|NCT00006327|AIDS Serodiagnosis|aids serodiagnosis
5851202|NCT00006327|Substance Abuse, Intravenous|substance abuse, intravenous
5851203|NCT00006327|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5851204|NCT00006327|Blotting, Western|blotting, western
5851205|NCT00006327|HIV Envelope Protein gp120|hiv envelope protein gp120
5851206|NCT00006327|AIDSVAX|aidsvax
5851207|NCT00006326|Drug Therapy, Combination|drug therapy, combination
5851208|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors
5851209|NCT00006326|Ritonavir|ritonavir
5851210|NCT00006326|Indinavir|indinavir
5851211|NCT00006326|Delavirdine|delavirdine
5851212|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851213|NCT00006326|Salvage Therapy|salvage therapy
5851214|NCT00006326|Anti-HIV Agents|anti-hiv agents
5851215|NCT00006326|Viral Load|viral load
5851216|NCT00006326|Nelfinavir|nelfinavir
5851217|NCT00006325|Polyethylene Glycols|polyethylene glycols
5851218|NCT00006325|Interferon Alfa-2b|interferon alfa-2b
5851220|NCT00006325|Dose-Response Relationship, Drug|dose-response relationship, drug
5851221|NCT00006325|Drug Therapy, Combination|drug therapy, combination
5851222|NCT00006325|Virus Inhibitors|virus inhibitors
5851223|NCT00006325|Anti-HIV Agents|anti-hiv agents
5851224|NCT00006325|Pharmacokinetics|pharmacokinetics
5851225|NCT00006324|HIV Seronegativity|hiv seronegativity
5851226|NCT00006324|Delayed-Action Preparations|delayed-action preparations
5851227|NCT00006324|Risk Factors|risk factors
5851228|NCT00006324|Prevalence|prevalence
5851229|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female
5851230|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined
5851231|NCT00006324|Medroxyprogesterone 17-Acetate|medroxyprogesterone 17-acetate
5851232|NCT00006316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851233|NCT00006316|Histoplasmosis|histoplasmosis
5851234|NCT00006316|Antifungal Agents|antifungal agents
5851235|NCT00006316|Recurrence|recurrence
5851236|NCT00006316|Anti-HIV Agents|anti-hiv agents
5851237|NCT00006304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851238|NCT00006304|AIDS-Related Complex|aids-related complex
5851239|NCT00006298|HIV Antibodies|hiv antibodies
5851240|NCT00006298|HIV-1|hiv-1
5851241|NCT00006298|CD4 Lymphocyte Count|cd4 lymphocyte count
5851242|NCT00006298|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5851243|NCT00006298|Genotype|genotype
5851244|NCT00006298|Species Specificity|species specificity
5851245|NCT00006298|Neutralization Tests|neutralization tests
5851246|NCT00006298|Viral Load|viral load
5851247|NCT00006298|Alleles|alleles
5851248|NCT00006298|HLA Antigens|hla antigens
5851249|NCT00006298|Cross Reactions|cross reactions
5851250|NCT00006298|Immunodominant Epitopes|immunodominant epitopes
5851251|NCT00006298|Haplotypes|haplotypes
5851252|NCT00006291|Virus Replication|virus replication
5851253|NCT00006291|T-Lymphocytes|t-lymphocytes
5851254|NCT00006291|Lymphocyte Transformation|lymphocyte transformation
5851255|NCT00006291|AIDS Vaccines|aids vaccines
5851256|NCT00006291|Anti-HIV Agents|anti-hiv agents
5851257|NCT00006291|Viral Load|viral load
5851258|NCT00006291|Aldesleukin|aldesleukin
5851259|NCT00006291|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851260|NCT00006290|Drug Therapy, Combination|drug therapy, combination
5851261|NCT00006290|Questionnaires|questionnaires
5851262|NCT00006290|Quality of Life|quality of life
5851263|NCT00006290|Patient Compliance|patient compliance
5851264|NCT00006290|Body Composition|body composition
5851265|NCT00006290|Anti-HIV Agents|anti-hiv agents
5851266|NCT00006290|Adipose Tissue|adipose tissue
5851267|NCT00006290|Body Image|body image
5851268|NCT00006279|Pregnancy Complications, Infectious|pregnancy complications, infectious
5851269|NCT00006279|Dose-Response Relationship, Drug|dose-response relationship, drug
5851270|NCT00006279|Drug Administration Schedule|drug administration schedule
5851271|NCT00006279|Nevirapine|nevirapine
5851272|NCT00006279|Disease Transmission, Vertical|disease transmission, vertical
5851273|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851274|NCT00006279|Anti-HIV Agents|anti-hiv agents
5851275|NCT00006279|Breast Feeding|breast feeding
5851276|NCT00006211|Drug Therapy, Combination|drug therapy, combination
5851277|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors
5847098|NCT00041730|lymphoma|lymphoma
5851278|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851279|NCT00006211|Anti-HIV Agents|anti-hiv agents
5851280|NCT00006211|Viral Load|viral load
5851281|NCT00006211|Nelfinavir|nelfinavir
5851282|NCT00006209|HIV-1|hiv-1
5851283|NCT00006209|Immunity, Cellular|immunity, cellular
5851284|NCT00006209|Drug Therapy, Combination|drug therapy, combination
5851285|NCT00006209|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5851286|NCT00006209|Antigens|antigens
5851287|NCT00006209|Anti-HIV Agents|anti-hiv agents
5851288|NCT00006209|Viral Load|viral load
5851289|NCT00006209|tucaresol|tucaresol
5851290|NCT00006208|HIV-1|hiv-1
5851291|NCT00006208|Didanosine|didanosine
5851292|NCT00006208|Drug Therapy, Combination|drug therapy, combination
5851293|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851294|NCT00006208|Anti-HIV Agents|anti-hiv agents
5851295|NCT00006208|Deoxycytidine|deoxycytidine
5851297|NCT00006207|HIV Seropositivity|hiv seropositivity
5851298|NCT00006207|Dose-Response Relationship, Drug|dose-response relationship, drug
5851299|NCT00006207|HIV Seronegativity|hiv seronegativity
5851300|NCT00006207|Mucous Membrane|mucous membrane
5851301|NCT00006207|Ulcer|ulcer
5851302|NCT00006207|Vagina|vagina
5851303|NCT00006207|Anti-HIV Agents|anti-hiv agents
5851304|NCT00006207|Sexual Abstinence|sexual abstinence
5851307|NCT00006154|Interleukin-2|interleukin-2
5851308|NCT00006154|Didanosine|didanosine
5851309|NCT00006154|Drug Therapy, Combination|drug therapy, combination
5851310|NCT00006154|Stavudine|stavudine
5851311|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors
5851312|NCT00006154|Ritonavir|ritonavir
5851313|NCT00006154|Indinavir|indinavir
5851314|NCT00006154|Virus Latency|virus latency
5851315|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851316|NCT00006154|Anti-HIV Agents|anti-hiv agents
5851317|NCT00006154|abacavir|abacavir
5851318|NCT00006154|efavirenz|efavirenz
5851319|NCT00006154|Acute Infection|acute infection
5851320|NCT00006153|HIV Antibodies|hiv antibodies
5851321|NCT00006153|Immunity, Cellular|immunity, cellular
5851322|NCT00006153|Drug Therapy, Combination|drug therapy, combination
5851323|NCT00006153|Anti-HIV Agents|anti-hiv agents
5851324|NCT00006153|remune|remune
5851325|NCT00006153|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851326|NCT00006152|Drug Therapy, Combination|drug therapy, combination
5851327|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors
5851328|NCT00006152|Ritonavir|ritonavir
5851329|NCT00006152|VX 478|vx 478
5851330|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851331|NCT00006152|Anti-HIV Agents|anti-hiv agents
5851332|NCT00006152|Viral Load|viral load
5851333|NCT00006152|abacavir|abacavir
5851334|NCT00006145|Ganciclovir|ganciclovir
5851335|NCT00006145|Cytomegalovirus|cytomegalovirus
5851336|NCT00006145|Cytomegalovirus Infections|cytomegalovirus infections
5851337|NCT00006145|Administration, Oral|administration, oral
5851338|NCT00006145|Antiviral Agents|antiviral agents
5851339|NCT00006145|Polymerase Chain Reaction|polymerase chain reaction
5851340|NCT00006145|Viremia|viremia
5851341|NCT00006145|DNA, Viral|dna, viral
5851342|NCT00006144|Drug Therapy, Combination|drug therapy, combination
5851343|NCT00006144|Stavudine|stavudine
5851344|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors
5851345|NCT00006144|Cohort Studies|cohort studies
5851346|NCT00006144|Ritonavir|ritonavir
5851347|NCT00006144|Disease Progression|disease progression
5851348|NCT00006144|Antigens, CD|antigens, cd
5851349|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851350|NCT00006144|Anti-HIV Agents|anti-hiv agents
5851351|NCT00006144|Immunophenotyping|immunophenotyping
5851352|NCT00006144|Deoxycytidine|deoxycytidine
5851353|NCT00006143|Treatment Outcome|treatment outcome
5851354|NCT00006143|serostim|serostim
5851355|NCT00006143|Developmental Disabilities|developmental disabilities
5851356|NCT00006075|Pregnancy Complications, Infectious|pregnancy complications, infectious
5851357|NCT00006075|Dose-Response Relationship, Drug|dose-response relationship, drug
5851358|NCT00006075|Polymerase Chain Reaction|polymerase chain reaction
5851359|NCT00006075|Disease Transmission, Vertical|disease transmission, vertical
5851360|NCT00006075|Labor|labor
5851361|NCT00006075|Disinfectants|disinfectants
5851362|NCT00006075|Vagina|vagina
5851363|NCT00006075|Chlorhexidine|chlorhexidine
5851364|NCT00006075|Irrigation|irrigation
5851365|NCT00006066|Injections, Subcutaneous|injections, subcutaneous
5851366|NCT00006066|Interleukin-2|interleukin-2
5851367|NCT00006066|Dose-Response Relationship, Drug|dose-response relationship, drug
5851368|NCT00006066|Drug Therapy, Combination|drug therapy, combination
5851369|NCT00006066|Immunocompromised Host|immunocompromised host
5851370|NCT00006066|CD4 Lymphocyte Count|cd4 lymphocyte count
5851371|NCT00006066|Anti-HIV Agents|anti-hiv agents
5851372|NCT00006064|Tumor Necrosis Factor|tumor necrosis factor
5851373|NCT00006064|CD4 Lymphocyte Count|cd4 lymphocyte count
5851374|NCT00006064|Polymerase Chain Reaction|polymerase chain reaction
5851375|NCT00006064|Enzyme-Linked Immunosorbent Assay|enzyme-linked immunosorbent assay
5851376|NCT00006064|RNA, Messenger|rna, messenger
5851377|NCT00006064|Interleukin-1|interleukin-1
5851378|NCT00006064|Body Composition|body composition
5851379|NCT00006064|Anti-HIV Agents|anti-hiv agents
5851380|NCT00006064|Viral Load|viral load
5851381|NCT00006064|Age Factors|age factors
5851382|NCT00006064|Anthropometry|anthropometry
5851383|NCT00005931|Skin Neoplasms|skin neoplasms
5851384|NCT00005931|Sarcoma, Kaposi|sarcoma, kaposi
5851385|NCT00005931|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851386|NCT00005931|Antineoplastic Agents|antineoplastic agents
5851387|NCT00005931|Enzyme Inhibitors|enzyme inhibitors
5851388|NCT00005931|SU 5416|su 5416
5851389|NCT00005931|Protein-Tyrosine Kinase|protein-tyrosine kinase
5851390|NCT00005921|Dose-Response Relationship, Drug|dose-response relationship, drug
5851391|NCT00005921|Antifungal Agents|antifungal agents
5851392|NCT00005921|Candidiasis|candidiasis
5851393|NCT00005921|Esophageal Diseases|esophageal diseases
5851394|NCT00005921|MK 0991|mk 0991
5851395|NCT00005920|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851994|NCT00002408|Diarrhea|diarrhea
5851396|NCT00005920|Dose-Response Relationship, Drug|dose-response relationship, drug
5851397|NCT00005920|Fluconazole|fluconazole
5851398|NCT00005920|Antifungal Agents|antifungal agents
5851399|NCT00005920|Candidiasis, Oral|candidiasis, oral
5851400|NCT00005920|Pharyngeal Diseases|pharyngeal diseases
5851401|NCT00005920|MK 0991|mk 0991
5851402|NCT00005918|Drug Therapy, Combination|drug therapy, combination
5851403|NCT00005918|Stavudine|stavudine
5851406|NCT00005918|Dosage Forms|dosage forms
5851407|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851408|NCT00005918|Anti-HIV Agents|anti-hiv agents
5851409|NCT00005918|Viral Load|viral load
5851410|NCT00005918|efavirenz|efavirenz
5851411|NCT00005915|HIV-1|hiv-1
5851412|NCT00005915|Drug Administration Schedule|drug administration schedule
5851413|NCT00005915|Drug Resistance, Microbial|drug resistance, microbial
5851414|NCT00005915|Disease Progression|disease progression
5851415|NCT00005915|Genotype|genotype
5851416|NCT00005915|Phenotype|phenotype
5851417|NCT00005915|Drug Resistance, Multiple|drug resistance, multiple
5851418|NCT00005915|Anti-HIV Agents|anti-hiv agents
5851419|NCT00005915|Treatment Experienced|treatment experienced
5851420|NCT00005779|Virus Replication|virus replication
5851421|NCT00005779|HIV-1|hiv-1
5851422|NCT00005779|AIDS Vaccines|aids vaccines
5851423|NCT00005779|CD4 Lymphocyte Count|cd4 lymphocyte count
5851424|NCT00005779|Cohort Studies|cohort studies
5851425|NCT00005779|Interleukin-12|interleukin-12
5851426|NCT00005779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851427|NCT00005764|HIV-1|hiv-1
5851428|NCT00005764|Zalcitabine|zalcitabine
5851429|NCT00005764|Didanosine|didanosine
5851430|NCT00005764|Drug Therapy, Combination|drug therapy, combination
5851431|NCT00005764|Zidovudine|zidovudine
5851432|NCT00005764|Stavudine|stavudine
5851433|NCT00005764|Lamivudine|lamivudine
5851434|NCT00005764|Blood|blood
5851435|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851436|NCT00005764|Anti-HIV Agents|anti-hiv agents
5851437|NCT00005764|Lipodystrophy|lipodystrophy
5851438|NCT00005764|Combivir|combivir
5851439|NCT00005764|Lactic Acid|lactic acid
5851440|NCT00005764|abacavir|abacavir
5851441|NCT00005762|Drug Interactions|drug interactions
5851442|NCT00005762|Drug Therapy, Combination|drug therapy, combination
5851443|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors
5851444|NCT00005762|Ritonavir|ritonavir
5851445|NCT00005762|Dosage Forms|dosage forms
5851446|NCT00005762|Saquinavir|saquinavir
5851447|NCT00005762|VX 478|vx 478
5851448|NCT00005762|Anti-HIV Agents|anti-hiv agents
5851449|NCT00005762|Nelfinavir|nelfinavir
5851450|NCT00005762|Pharmacokinetics|pharmacokinetics
5851451|NCT00005762|efavirenz|efavirenz
5851452|NCT00005758|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5851453|NCT00005758|Combined Modality Therapy|combined modality therapy
5851454|NCT00005758|HIV Envelope Protein gp120|hiv envelope protein gp120
5851455|NCT00005758|AIDS Vaccines|aids vaccines
5851456|NCT00005758|RNA, Viral|rna, viral
5851457|NCT00005758|HIV Core Protein p24|hiv core protein p24
5851458|NCT00005758|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5851459|NCT00005758|Anti-HIV Agents|anti-hiv agents
5851460|NCT00005758|Viral Load|viral load
5851461|NCT00005758|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5851462|NCT00005663|Herpes Simplex|herpes simplex
5851463|NCT00005663|Antiviral Agents|antiviral agents
5851464|NCT00005663|Anus Diseases|anus diseases
5851465|NCT00005663|Herpes Genitalis|herpes genitalis
5851466|NCT00005663|Recurrence|recurrence
5851467|NCT00005663|valacyclovir|valacyclovir
5851468|NCT00005572|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851469|NCT00005572|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5851470|NCT00005572|Lymphocytes|lymphocytes
5851471|NCT00005572|Histoplasmosis|histoplasmosis
5851472|NCT00005572|Recurrence|recurrence
5851473|NCT00005572|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5851474|NCT00005572|Cell Division|cell division
5851475|NCT00005572|Immunocompetence|immunocompetence
5851476|NCT00005572|Anti-HIV Agents|anti-hiv agents
5851477|NCT00005120|CD4 Lymphocyte Count|cd4 lymphocyte count
5851478|NCT00005120|Biological Markers|biological markers
5851479|NCT00005120|Anti-HIV Agents|anti-hiv agents
5851480|NCT00005120|Viral Load|viral load
5851481|NCT00005120|Pharmacokinetics|pharmacokinetics
5851482|NCT00005120|calanolide A|calanolide a
5851483|NCT00005118|HIV-1|hiv-1
5851484|NCT00005118|Drug Therapy, Combination|drug therapy, combination
5851485|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors
5851486|NCT00005118|Ritonavir|ritonavir
5851487|NCT00005118|Indinavir|indinavir
5851488|NCT00005118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851489|NCT00005118|Anti-HIV Agents|anti-hiv agents
5851490|NCT00005118|Viral Load|viral load
5851491|NCT00005118|Nelfinavir|nelfinavir
5851492|NCT00005106|Drug Therapy, Combination|drug therapy, combination
5851493|NCT00005106|Zidovudine|zidovudine
5851494|NCT00005106|Stavudine|stavudine
5851495|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors
5851496|NCT00005106|Lamivudine|lamivudine
5851497|NCT00005106|Nelfinavir|nelfinavir
5851498|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851499|NCT00005106|Anti-HIV Agents|anti-hiv agents
5851500|NCT00005106|Adipose Tissue|adipose tissue
5851501|NCT00005106|Lipodystrophy|lipodystrophy
5851502|NCT00005106|abacavir|abacavir
5851503|NCT00005020|CD4 Lymphocyte Count|cd4 lymphocyte count
5851504|NCT00005020|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5851505|NCT00005020|Phenotype|phenotype
5851506|NCT00005020|Viral Load|viral load
5851507|NCT00005020|Acute Infection|acute infection
5851508|NCT00005018|HIV-1|hiv-1
5851509|NCT00005018|Didanosine|didanosine
5851510|NCT00005018|Drug Therapy, Combination|drug therapy, combination
5851511|NCT00005018|Zidovudine|zidovudine
5851512|NCT00005018|Stavudine|stavudine
5851513|NCT00005018|HIV Protease Inhibitors|hiv protease inhibitors
5851514|NCT00005018|Hydroxyurea|hydroxyurea
5851515|NCT00005018|RNA, Viral|rna, viral
5851516|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851517|NCT00005018|Anti-HIV Agents|anti-hiv agents
5851518|NCT00005018|Viral Load|viral load
5851519|NCT00005018|abacavir|abacavir
5851520|NCT00005018|efavirenz|efavirenz
5851521|NCT00005017|HIV-1|hiv-1
5851522|NCT00005017|Drug Therapy, Combination|drug therapy, combination
5851523|NCT00005017|Stavudine|stavudine
5851524|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors
5851525|NCT00005017|Ritonavir|ritonavir
5851526|NCT00005017|Lamivudine|lamivudine
5851527|NCT00005017|VX 478|vx 478
5851528|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851529|NCT00005017|Anti-HIV Agents|anti-hiv agents
5851530|NCT00005017|abacavir|abacavir
5851531|NCT00005017|efavirenz|efavirenz
5851532|NCT00005012|Interferon Alfa-2b|interferon alfa-2b
5851533|NCT00005012|Lymphocyte Transformation|lymphocyte transformation
5851534|NCT00005012|CD4 Lymphocyte Count|cd4 lymphocyte count
5851535|NCT00005012|RNA, Viral|rna, viral
5851536|NCT00005012|Virus Inhibitors|virus inhibitors
5851537|NCT00005012|Anti-HIV Agents|anti-hiv agents
5851538|NCT00005012|Viral Load|viral load
5851539|NCT00005009|pediatric renal transplant recipients|pediatric renal transplant recipients
5851540|NCT00005009|varicella zoster virus (VZV) vaccine|varicella zoster virus (vzv) vaccine
5851541|NCT00005009|herpes zoster vaccine|herpes zoster vaccine
5851542|NCT00005009|VZV susceptible|vzv susceptible
5851543|NCT00005009|safety|safety
5851544|NCT00005009|immunogenicity|immunogenicity
5851545|NCT00005002|HIV-1|hiv-1
5851546|NCT00005002|Drug Therapy, Combination|drug therapy, combination
5851547|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors
5851548|NCT00005002|CD4 Lymphocyte Count|cd4 lymphocyte count
5851549|NCT00005002|Nelfinavir|nelfinavir
5851550|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851551|NCT00005002|Anti-HIV Agents|anti-hiv agents
5851552|NCT00005002|Viral Load|viral load
5851553|NCT00005002|remune|remune
5851554|NCT00005002|Combivir|combivir
5851555|NCT00005001|HIV-1|hiv-1
5851556|NCT00005001|Drug Therapy, Combination|drug therapy, combination
5851557|NCT00005001|RNA, Viral|rna, viral
5851558|NCT00005001|Anti-HIV Agents|anti-hiv agents
5851559|NCT00005001|Viral Load|viral load
5851560|NCT00005001|remune|remune
5851561|NCT00005000|HIV-1|hiv-1
5851562|NCT00005000|Drug Therapy, Combination|drug therapy, combination
5851563|NCT00005000|Lymphoid Tissue|lymphoid tissue
5851564|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors
5851565|NCT00005000|Genotype|genotype
5851566|NCT00005000|Phenotype|phenotype
5851567|NCT00005000|Nelfinavir|nelfinavir
5851568|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851569|NCT00005000|Anti-HIV Agents|anti-hiv agents
5851570|NCT00005000|Viral Load|viral load
5851571|NCT00005000|Adipose Tissue|adipose tissue
5851572|NCT00005000|Glucose|glucose
5851573|NCT00005000|Lipids|lipids
5851574|NCT00005000|Immunophenotyping|immunophenotyping
5851575|NCT00005000|efavirenz|efavirenz
5851576|NCT00004999|Drug Therapy, Combination|drug therapy, combination
5851577|NCT00004999|Zidovudine|zidovudine
5851578|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors
5851579|NCT00004999|Lamivudine|lamivudine
5847432|NCT00038974|Efficacy|efficacy
5851580|NCT00004999|Disease Progression|disease progression
5851581|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851583|NCT00004999|Viral Load|viral load
5851584|NCT00004999|Nelfinavir|nelfinavir
5851585|NCT00004999|Combivir|combivir
5851586|NCT00004998|Drug Therapy, Combination|drug therapy, combination
5851587|NCT00004998|Zidovudine|zidovudine
5851588|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors
5851589|NCT00004998|Lamivudine|lamivudine
5851590|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851591|NCT00004998|Anti-HIV Agents|anti-hiv agents
5851592|NCT00004998|Nelfinavir|nelfinavir
5851593|NCT00004998|Combivir|combivir
5851594|NCT00004987|Anti-HIV Agents|anti-hiv agents
5851595|NCT00004987|Viral Load|viral load
5851596|NCT00004987|dextrin 2-sulfate|dextrin 2-sulfate
5851597|NCT00004987|Infusions, Parenteral|infusions, parenteral
5851598|NCT00004986|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851599|NCT00004986|Cryptosporidiosis|cryptosporidiosis
5851600|NCT00004986|Drug Evaluation|drug evaluation
5852195|NCT00002376|Viral Load|viral load
5851601|NCT00004986|Antiprotozoal Agents|antiprotozoal agents
5851602|NCT00004986|Treatment Failure|treatment failure
5851603|NCT00004986|nitazoxanide|nitazoxanide
5851604|NCT00004985|HIV-1|hiv-1
5851605|NCT00004985|Drug Therapy, Combination|drug therapy, combination
5851606|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors
5851607|NCT00004985|RNA, Viral|rna, viral
5851608|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851609|NCT00004985|Anti-HIV Agents|anti-hiv agents
5851610|NCT00004985|Viral Load|viral load
5851611|NCT00004985|Nelfinavir|nelfinavir
5851612|NCT00004981|Drug Therapy, Combination|drug therapy, combination
5851613|NCT00004981|Zidovudine|zidovudine
5851614|NCT00004981|Drug Administration Schedule|drug administration schedule
5851615|NCT00004981|Lamivudine|lamivudine
5851616|NCT00004981|RNA, Viral|rna, viral
5851617|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851618|NCT00004981|Anti-HIV Agents|anti-hiv agents
5851619|NCT00004981|Viral Load|viral load
5851620|NCT00004981|Combivir|combivir
5851621|NCT00004981|abacavir|abacavir
5851622|NCT00004978|Recombinant Proteins|recombinant proteins
5851623|NCT00004978|Injections, Subcutaneous|injections, subcutaneous
5851624|NCT00004978|HIV-1|hiv-1
5851625|NCT00004978|Interleukin-2|interleukin-2
5851626|NCT00004978|Drug Therapy, Combination|drug therapy, combination
5851627|NCT00004978|CD4 Lymphocyte Count|cd4 lymphocyte count
5851628|NCT00004978|Disease Progression|disease progression
5851629|NCT00004978|Follow-Up Studies|follow-up studies
5851630|NCT00004978|Anti-HIV Agents|anti-hiv agents
5851631|NCT00004855|Drug Therapy, Combination|drug therapy, combination
5851632|NCT00004855|Nevirapine|nevirapine
5851633|NCT00004855|Stavudine|stavudine
5851634|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors
5851635|NCT00004855|Ritonavir|ritonavir
5851636|NCT00004855|Lamivudine|lamivudine
5851637|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851638|NCT00004855|Anti-HIV Agents|anti-hiv agents
5851639|NCT00004855|ABT 378|abt 378
5851640|NCT00004855|abacavir|abacavir
5851641|NCT00004852|HIV-1|hiv-1
5851642|NCT00004852|Drug Therapy, Combination|drug therapy, combination
5851643|NCT00004852|Zidovudine|zidovudine
5851644|NCT00004852|Drug Administration Schedule|drug administration schedule
5851645|NCT00004852|Lamivudine|lamivudine
5851646|NCT00004852|Genotype|genotype
5851647|NCT00004852|Phenotype|phenotype
5851648|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851649|NCT00004852|Anti-HIV Agents|anti-hiv agents
5851650|NCT00004852|Viral Load|viral load
5851651|NCT00004852|efavirenz|efavirenz
5851652|NCT00004736|Tuberculosis|tuberculosis
5851653|NCT00004736|Rifabutin|rifabutin
5851654|NCT00004736|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851655|NCT00004736|Drug Therapy, Combination|drug therapy, combination
5851656|NCT00004736|Antitubercular Agents|antitubercular agents
5851657|NCT00004736|Anti-HIV Agents|anti-hiv agents
5851658|NCT00004735|Viral Vaccines|viral vaccines
5851659|NCT00004735|Drug Therapy, Combination|drug therapy, combination
5851660|NCT00004735|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5851661|NCT00004735|Immunologic Memory|immunologic memory
5851662|NCT00004735|Antibody Formation|antibody formation
5851663|NCT00004735|Anti-HIV Agents|anti-hiv agents
5851664|NCT00004735|Tetanus Toxoid|tetanus toxoid
5851665|NCT00004735|Hepatitis A Virus, Human|hepatitis a virus, human
5851666|NCT00004735|Enfuvirtide|enfuvirtide
5851667|NCT00004735|T-20|t-20
5851668|NCT00004735|Treatment Naive|treatment naive
5851669|NCT00004735|Treatment Experienced|treatment experienced
5851670|NCT00004585|Drug Therapy, Combination|drug therapy, combination
5851671|NCT00004585|Zidovudine|zidovudine
5851672|NCT00004585|Lamivudine|lamivudine
5851673|NCT00004585|RNA, Viral|rna, viral
5851674|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851675|NCT00004585|Anti-HIV Agents|anti-hiv agents
5851676|NCT00004585|Viral Load|viral load
5851677|NCT00004585|abacavir|abacavir
5851678|NCT00004585|efavirenz|efavirenz
5851679|NCT00004584|Dose-Response Relationship, Drug|dose-response relationship, drug
5851680|NCT00004584|Drug Therapy, Combination|drug therapy, combination
5851681|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors
5851682|NCT00004584|Ritonavir|ritonavir
5851683|NCT00004584|Saquinavir|saquinavir
5851684|NCT00004584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851685|NCT00004584|Anti-HIV Agents|anti-hiv agents
5851686|NCT00004583|Drug Therapy, Combination|drug therapy, combination
5851687|NCT00004583|Administration, Oral|administration, oral
5851688|NCT00004583|Stavudine|stavudine
5851689|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors
5851690|NCT00004583|Lamivudine|lamivudine
5851691|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851692|NCT00004583|Anti-HIV Agents|anti-hiv agents
5851693|NCT00004583|Nelfinavir|nelfinavir
5851695|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors
5851696|NCT00004582|Ritonavir|ritonavir
5851697|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851698|NCT00004582|Anti-HIV Agents|anti-hiv agents
5851699|NCT00004582|Viral Load|viral load
5851702|NCT00004581|Drug Therapy, Combination|drug therapy, combination
5851703|NCT00004581|Nevirapine|nevirapine
5851704|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors
5851705|NCT00004581|Ritonavir|ritonavir
5851706|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851707|NCT00004581|Anti-HIV Agents|anti-hiv agents
5851709|NCT00004580|Drug Therapy, Combination|drug therapy, combination
5851710|NCT00004580|Nevirapine|nevirapine
5851711|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors
5851712|NCT00004580|Ritonavir|ritonavir
5851713|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851714|NCT00004579|Vaccines, Synthetic|vaccines, synthetic
5851715|NCT00004579|Viral Vaccines|viral vaccines
5851716|NCT00004579|HIV-1|hiv-1
5851717|NCT00004579|Dose-Response Relationship, Drug|dose-response relationship, drug
5851718|NCT00004579|HIV Envelope Protein gp160|hiv envelope protein gp160
5851719|NCT00004579|AIDS Vaccines|aids vaccines
5851720|NCT00004579|HIV Seronegativity|hiv seronegativity
5851721|NCT00004579|Avipoxvirus|avipoxvirus
5851722|NCT00004579|Immunization|immunization
5851723|NCT00004579|HIV Envelope Protein gp120|hiv envelope protein gp120
5851724|NCT00004579|Recombination, Genetic|recombination, genetic
5851725|NCT00004578|Stavudine|stavudine
5851726|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors
5851727|NCT00004578|Ritonavir|ritonavir
5851728|NCT00004578|Lamivudine|lamivudine
5851729|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851730|NCT00002453|HIV-1|hiv-1
5851731|NCT00002453|Drug Therapy, Combination|drug therapy, combination
5851732|NCT00002453|Disease Progression|disease progression
5851733|NCT00002453|Anti-HIV Agents|anti-hiv agents
5851734|NCT00002452|Drug Therapy, Combination|drug therapy, combination
5851735|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors
5851736|NCT00002452|Indinavir|indinavir
5851737|NCT00002452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851738|NCT00002452|Anti-HIV Agents|anti-hiv agents
5851739|NCT00002452|Viral Load|viral load
5851740|NCT00002451|Drug Therapy, Combination|drug therapy, combination
5851741|NCT00002451|Stavudine|stavudine
5851742|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors
5851743|NCT00002451|CD4 Lymphocyte Count|cd4 lymphocyte count
5851744|NCT00002451|Ritonavir|ritonavir
5851745|NCT00002451|Lamivudine|lamivudine
5851746|NCT00002451|Indinavir|indinavir
5851747|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851748|NCT00002451|Anti-HIV Agents|anti-hiv agents
5851749|NCT00002451|Viral Load|viral load
5851750|NCT00002450|HIV-1|hiv-1
5851751|NCT00002450|Drug Therapy, Combination|drug therapy, combination
5851752|NCT00002450|Drug Administration Schedule|drug administration schedule
5851753|NCT00002450|RNA, Viral|rna, viral
5851754|NCT00002450|Anti-HIV Agents|anti-hiv agents
5851755|NCT00002450|Viral Load|viral load
5851756|NCT00002449|Recombinant Proteins|recombinant proteins
5851757|NCT00002449|Injections, Subcutaneous|injections, subcutaneous
5851758|NCT00002449|Interleukin-2|interleukin-2
5851759|NCT00002449|Dose-Response Relationship, Drug|dose-response relationship, drug
5851760|NCT00002449|CD4 Lymphocyte Count|cd4 lymphocyte count
5851761|NCT00002449|Anti-HIV Agents|anti-hiv agents
5851762|NCT00002449|Viral Load|viral load
5851763|NCT00002449|Pharmacokinetics|pharmacokinetics
5851764|NCT00002448|Drug Therapy, Combination|drug therapy, combination
5851765|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors
5851766|NCT00002448|Ritonavir|ritonavir
5851767|NCT00002448|Dosage Forms|dosage forms
5851768|NCT00002448|Saquinavir|saquinavir
5851769|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851770|NCT00002448|Anti-HIV Agents|anti-hiv agents
5851771|NCT00002448|efavirenz|efavirenz
5851772|NCT00002447|Drug Therapy, Combination|drug therapy, combination
5851773|NCT00002447|Saquinavir|saquinavir
5851774|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors
5851775|NCT00002447|Ritonavir|ritonavir
5847682|NCT00038558|G-CSF|g-csf
5851776|NCT00002447|Dosage Forms|dosage forms
5851777|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851778|NCT00002447|Anti-HIV Agents|anti-hiv agents
5851779|NCT00002447|efavirenz|efavirenz
5851780|NCT00002446|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851781|NCT00002446|Fluconazole|fluconazole
5851782|NCT00002446|Administration, Oral|administration, oral
5851783|NCT00002446|Antifungal Agents|antifungal agents
5851784|NCT00002446|Candidiasis, Oral|candidiasis, oral
5851785|NCT00002446|Pharyngeal Diseases|pharyngeal diseases
5851786|NCT00002446|posaconazole|posaconazole
5851787|NCT00002445|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851788|NCT00002445|Placebos|placebos
5851789|NCT00002445|Sarcoma, Kaposi|sarcoma, kaposi
5851790|NCT00002445|Antineoplastic Agents|antineoplastic agents
5851791|NCT00002445|Treatment Outcome|treatment outcome
5851792|NCT00002445|Quality of Life|quality of life
5851793|NCT00002442|Drug Therapy, Combination|drug therapy, combination
5851794|NCT00002442|Zidovudine|zidovudine
5851795|NCT00002442|Drug Administration Schedule|drug administration schedule
5851796|NCT00002442|Stavudine|stavudine
5851797|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors
5851800|NCT00002442|Dosage Forms|dosage forms
5851801|NCT00002442|Nelfinavir|nelfinavir
5851802|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851803|NCT00002442|Anti-HIV Agents|anti-hiv agents
5851898|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors
5851805|NCT00002441|Dose-Response Relationship, Drug|dose-response relationship, drug
5851806|NCT00002441|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851807|NCT00002441|AIDS Vaccines|aids vaccines
5851808|NCT00002441|Sexually Transmitted Diseases|sexually transmitted diseases
5851809|NCT00002441|Risk Factors|risk factors
5851810|NCT00002441|HIV Seronegativity|hiv seronegativity
5851811|NCT00002441|Antigens, Viral|antigens, viral
5851812|NCT00002441|Alum Compounds|alum compounds
5851813|NCT00002440|HIV-1|hiv-1
5851814|NCT00002440|Drug Therapy, Combination|drug therapy, combination
5851815|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors
5851816|NCT00002440|Mutation|mutation
5851817|NCT00002440|HIV-1 Reverse Transcriptase|hiv-1 reverse transcriptase
5851818|NCT00002440|HIV Protease|hiv protease
5851819|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851820|NCT00002440|Anti-HIV Agents|anti-hiv agents
5851821|NCT00002440|abacavir|abacavir
5851822|NCT00002438|Itraconazole|itraconazole
5851823|NCT00002438|Histoplasmosis|histoplasmosis
5851824|NCT00002438|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851825|NCT00002437|Retinitis|retinitis
5851826|NCT00002437|Probenecid|probenecid
5851827|NCT00002437|Drug Therapy, Combination|drug therapy, combination
5851828|NCT00002437|Cytomegalovirus Infections|cytomegalovirus infections
5851829|NCT00002437|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851830|NCT00002437|Antiviral Agents|antiviral agents
5851831|NCT00002437|cidofovir|cidofovir
5851832|NCT00002436|Zalcitabine|zalcitabine
5851833|NCT00002436|Drug Therapy, Combination|drug therapy, combination
5851834|NCT00002436|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851835|NCT00002436|AIDS-Related Complex|aids-related complex
5851836|NCT00002436|Antiviral Agents|antiviral agents
5851837|NCT00002436|Zidovudine|zidovudine
5851838|NCT00002435|Drug Therapy, Combination|drug therapy, combination
5851839|NCT00002435|Antiviral Agents|antiviral agents
5851840|NCT00002435|Zidovudine|zidovudine
5851841|NCT00002435|thymic humoral factor gamma 2|thymic humoral factor gamma 2
5851842|NCT00002434|Trimetrexate|trimetrexate
5851843|NCT00002434|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5851844|NCT00002434|Leucovorin|leucovorin
5851845|NCT00002434|Drug Therapy, Combination|drug therapy, combination
5851846|NCT00002434|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851847|NCT00002433|Pulmonary Alveoli|pulmonary alveoli
5851848|NCT00002433|Macrophage Activation|macrophage activation
5851849|NCT00002433|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5851850|NCT00002433|Injections, Subcutaneous|injections, subcutaneous
5851851|NCT00002433|Aerosols|aerosols
5851852|NCT00002433|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851853|NCT00002432|Retinitis|retinitis
5851854|NCT00002432|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851855|NCT00002432|Foscarnet|foscarnet
5851856|NCT00002432|Cytomegalovirus Infections|cytomegalovirus infections
5851857|NCT00002432|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851858|NCT00002431|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5851859|NCT00002431|chlorhexidine gluconate|chlorhexidine gluconate
5851860|NCT00002431|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851861|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local
5851862|NCT00002431|AIDS-Related Complex|aids-related complex
5851863|NCT00002431|Candidiasis, Oral|candidiasis, oral
5851864|NCT00002430|Drug Therapy, Combination|drug therapy, combination
5851865|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors
5851866|NCT00002430|Lamivudine|lamivudine
5851867|NCT00002430|Indinavir|indinavir
5851868|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851869|NCT00002430|Anti-HIV Agents|anti-hiv agents
5851870|NCT00002430|Nelfinavir|nelfinavir
5851871|NCT00002429|Didanosine|didanosine
5851872|NCT00002429|Drug Therapy, Combination|drug therapy, combination
5851873|NCT00002429|Stavudine|stavudine
5851874|NCT00002429|RNA, Viral|rna, viral
5851875|NCT00002429|Nelfinavir|nelfinavir
5851876|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851877|NCT00002429|Anti-HIV Agents|anti-hiv agents
5851878|NCT00002428|Vaccines, Synthetic|vaccines, synthetic
5851879|NCT00002428|HIV-1|hiv-1
5851880|NCT00002428|HIV Envelope Protein gp120|hiv envelope protein gp120
5851881|NCT00002428|AIDS Vaccines|aids vaccines
5851882|NCT00002428|HIV Seronegativity|hiv seronegativity
5851883|NCT00002427|Didanosine|didanosine
5851884|NCT00002427|Dose-Response Relationship, Drug|dose-response relationship, drug
5851885|NCT00002427|Drug Therapy, Combination|drug therapy, combination
5851886|NCT00002427|Stavudine|stavudine
5851887|NCT00002427|Hydroxyurea|hydroxyurea
5851888|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851889|NCT00002427|Anti-HIV Agents|anti-hiv agents
5851890|NCT00002426|HIV-1|hiv-1
5851891|NCT00002426|RNA, Viral|rna, viral
5851893|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851894|NCT00002426|Anti-HIV Agents|anti-hiv agents
5851895|NCT00002426|Viral Load|viral load
5851896|NCT00002425|Drug Therapy, Combination|drug therapy, combination
5851897|NCT00002425|Saquinavir|saquinavir
5851899|NCT00002425|Dosage Forms|dosage forms
5851900|NCT00002425|Anti-HIV Agents|anti-hiv agents
5851901|NCT00002424|Drug Therapy, Combination|drug therapy, combination
5851902|NCT00002424|Drug Administration Schedule|drug administration schedule
5851903|NCT00002424|Stavudine|stavudine
5851904|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors
5851905|NCT00002424|Lamivudine|lamivudine
5851906|NCT00002424|Indinavir|indinavir
5851907|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851908|NCT00002424|Anti-HIV Agents|anti-hiv agents
5851909|NCT00002423|Drug Therapy, Combination|drug therapy, combination
5851910|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors
5851911|NCT00002423|Lamivudine|lamivudine
5851912|NCT00002423|Indinavir|indinavir
5851913|NCT00002423|Nelfinavir|nelfinavir
5851915|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851916|NCT00002423|Anti-HIV Agents|anti-hiv agents
5851917|NCT00002423|Viral Load|viral load
5851918|NCT00002423|abacavir|abacavir
5851919|NCT00002422|Injections, Intramuscular|injections, intramuscular
5851920|NCT00002422|Drug Interactions|drug interactions
5851921|NCT00002422|Salvage Therapy|salvage therapy
5851922|NCT00002422|Anti-HIV Agents|anti-hiv agents
5851923|NCT00002420|Drug Therapy, Combination|drug therapy, combination
5851924|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851925|NCT00002420|Anti-HIV Agents|anti-hiv agents
5851926|NCT00002419|Drug Therapy, Combination|drug therapy, combination
5851927|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors
5851928|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851929|NCT00002419|Anti-HIV Agents|anti-hiv agents
5851930|NCT00002418|Drug Therapy, Combination|drug therapy, combination
5851931|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851932|NCT00002418|Anti-HIV Agents|anti-hiv agents
5851933|NCT00002418|Viral Load|viral load
5851934|NCT00002417|Drug Therapy, Combination|drug therapy, combination
5851935|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors
5851936|NCT00002417|VX 478|vx 478
5851937|NCT00002417|Lipodystrophy|lipodystrophy
5851938|NCT00002417|Hyperlipidemia|hyperlipidemia
5851939|NCT00002416|HIV-1|hiv-1
5851940|NCT00002416|Zalcitabine|zalcitabine
5851941|NCT00002416|Zidovudine|zidovudine
5851942|NCT00002416|Stavudine|stavudine
5851943|NCT00002416|HIV Protease Inhibitors|hiv protease inhibitors
5851944|NCT00002416|Lamivudine|lamivudine
5851945|NCT00002416|RNA, Viral|rna, viral
5851946|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851947|NCT00002416|Anti-HIV Agents|anti-hiv agents
5851948|NCT00002415|Drug Therapy, Combination|drug therapy, combination
5851949|NCT00002415|Prodrugs|prodrugs
5851950|NCT00002415|Anti-HIV Agents|anti-hiv agents
5851951|NCT00002414|AIDS Dementia Complex|aids dementia complex
5851952|NCT00002414|Anti-HIV Agents|anti-hiv agents
5851953|NCT00002413|Anti-HIV Agents|anti-hiv agents
5851954|NCT00002413|Viral Load|viral load
5851955|NCT00002413|MKC 442|mkc 442
5851956|NCT00002412|Didanosine|didanosine
5851957|NCT00002412|Drug Therapy, Combination|drug therapy, combination
5851958|NCT00002412|Stavudine|stavudine
5851959|NCT00002412|Hydroxyurea|hydroxyurea
5851960|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851961|NCT00002412|Anti-HIV Agents|anti-hiv agents
5851962|NCT00002412|Viral Load|viral load
5851963|NCT00002412|MKC 442|mkc 442
5851964|NCT00002411|HIV-1|hiv-1
5851965|NCT00002411|Didanosine|didanosine
5851966|NCT00002411|Drug Therapy, Combination|drug therapy, combination
5851967|NCT00002411|Zidovudine|zidovudine
5851968|NCT00002411|Stavudine|stavudine
5847971|NCT00037141|BPH|bph
5851969|NCT00002411|Lamivudine|lamivudine
5851970|NCT00002411|RNA, Viral|rna, viral
5851971|NCT00002411|Nelfinavir|nelfinavir
5851972|NCT00002411|Anti-HIV Agents|anti-hiv agents
5851973|NCT00002411|Viral Load|viral load
5851974|NCT00002410|HIV-1|hiv-1
5851975|NCT00002410|Drug Therapy, Combination|drug therapy, combination
5851976|NCT00002410|Zidovudine|zidovudine
5851977|NCT00002410|Drug Resistance, Microbial|drug resistance, microbial
5851978|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors
5851979|NCT00002410|Lamivudine|lamivudine
5851980|NCT00002410|Indinavir|indinavir
5851981|NCT00002410|Genotype|genotype
5851982|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851983|NCT00002410|efavirenz|efavirenz
5851984|NCT00002409|Drug Therapy, Combination|drug therapy, combination
5851985|NCT00002409|Zidovudine|zidovudine
5851986|NCT00002409|HIV Protease Inhibitors|hiv protease inhibitors
5851987|NCT00002409|Lamivudine|lamivudine
5851988|NCT00002409|Patient Education|patient education
5851989|NCT00002409|Patient Compliance|patient compliance
5851990|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5851991|NCT00002409|Anti-HIV Agents|anti-hiv agents
5851992|NCT00002409|Viral Load|viral load
5851993|NCT00002409|abacavir|abacavir
5851995|NCT00002408|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5851996|NCT00002406|HIV-1|hiv-1
5851997|NCT00002406|Dose-Response Relationship, Drug|dose-response relationship, drug
5851998|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors
5852001|NCT00002406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852002|NCT00002405|Drug Therapy, Combination|drug therapy, combination
5852003|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors
5852005|NCT00002405|Anti-HIV Agents|anti-hiv agents
5852006|NCT00002404|HIV-1|hiv-1
5852007|NCT00002404|Antiviral Agents|antiviral agents
5852008|NCT00002404|Herpes Genitalis|herpes genitalis
5852009|NCT00002404|Recurrence|recurrence
5852010|NCT00002404|DNA, Viral|dna, viral
5852011|NCT00002404|RNA, Viral|rna, viral
5852012|NCT00002404|valacyclovir|valacyclovir
5852013|NCT00002404|Herpesvirus 2, Human|herpesvirus 2, human
5852014|NCT00002403|HIV-1|hiv-1
5852015|NCT00002403|Dose-Response Relationship, Drug|dose-response relationship, drug
5852016|NCT00002403|HIV Integrase Inhibitors|hiv integrase inhibitors
5852017|NCT00002403|HIV Integrase|hiv integrase
5852018|NCT00002402|HIV-1|hiv-1
5852019|NCT00002402|Dose-Response Relationship, Drug|dose-response relationship, drug
5852020|NCT00002402|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852021|NCT00002402|AIDS Vaccines|aids vaccines
5852022|NCT00002402|HIV Seronegativity|hiv seronegativity
5852023|NCT00002402|Antigens, Viral|antigens, viral
5852024|NCT00002402|Alum Compounds|alum compounds
5852025|NCT00002401|HIV-1|hiv-1
5852026|NCT00002401|Zidovudine|zidovudine
5852027|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors
5852028|NCT00002401|Lamivudine|lamivudine
5852029|NCT00002401|Indinavir|indinavir
5852030|NCT00002401|RNA, Viral|rna, viral
5852031|NCT00002401|Delavirdine|delavirdine
5852032|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852033|NCT00002401|Viral Load|viral load
5852034|NCT00002400|HIV-1|hiv-1
5852035|NCT00002400|Drug Therapy, Combination|drug therapy, combination
5852036|NCT00002400|Zidovudine|zidovudine
5852037|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors
5852038|NCT00002400|Lamivudine|lamivudine
5852039|NCT00002400|Indinavir|indinavir
5852040|NCT00002400|RNA, Viral|rna, viral
5852041|NCT00002400|Delavirdine|delavirdine
5852042|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852043|NCT00002399|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852044|NCT00002399|Fluconazole|fluconazole
5852045|NCT00002399|Antifungal Agents|antifungal agents
5852046|NCT00002399|Candidiasis|candidiasis
5852047|NCT00002399|Triazoles|triazoles
5852048|NCT00002398|HIV-1|hiv-1
5852049|NCT00002398|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852050|NCT00002398|Adenine|adenine
5852051|NCT00002398|Anti-HIV Agents|anti-hiv agents
5852052|NCT00002397|Kidney Failure, Chronic|kidney failure, chronic
5852053|NCT00002397|HIV-1|hiv-1
5852054|NCT00002397|Drug Therapy, Combination|drug therapy, combination
5852055|NCT00002397|Stavudine|stavudine
5852056|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors
5852057|NCT00002397|Lamivudine|lamivudine
5852058|NCT00002397|Saquinavir|saquinavir
5852059|NCT00002397|AIDS-Associated Nephropathy|aids-associated nephropathy
5852060|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852061|NCT00002397|Viral Load|viral load
5852062|NCT00002397|Nelfinavir|nelfinavir
5852063|NCT00002396|Dose-Response Relationship, Drug|dose-response relationship, drug
5852064|NCT00002396|Adenine|adenine
5852065|NCT00002396|Anti-HIV Agents|anti-hiv agents
5847656|NCT00038610|Mesna|mesna
5852066|NCT00002395|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852067|NCT00002395|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5852068|NCT00002395|Infusions, Intravenous|infusions, intravenous
5852069|NCT00002395|Drug Administration Schedule|drug administration schedule
5852070|NCT00002395|Topotecan|topotecan
5852071|NCT00002394|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852072|NCT00002394|Dose-Response Relationship, Drug|dose-response relationship, drug
5852073|NCT00002394|Fluconazole|fluconazole
5852074|NCT00002394|Antifungal Agents|antifungal agents
5852075|NCT00002394|Candidiasis, Oral|candidiasis, oral
5852076|NCT00002394|Drug Administration Schedule|drug administration schedule
5852077|NCT00002394|terbinafine|terbinafine
5852078|NCT00002393|Placebos|placebos
5852079|NCT00002393|Drug Therapy, Combination|drug therapy, combination
5852080|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors
5852081|NCT00002393|Indinavir|indinavir
5852082|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852083|NCT00002393|efavirenz|efavirenz
5852084|NCT00002392|Lymphocyte Transformation|lymphocyte transformation
5852085|NCT00002392|Immunity, Cellular|immunity, cellular
5852086|NCT00002392|Drug Therapy, Combination|drug therapy, combination
5852087|NCT00002392|Adjuvants, Immunologic|adjuvants, immunologic
5852088|NCT00002392|Thalidomide|thalidomide
5852089|NCT00002392|Immunologic Memory|immunologic memory
5852090|NCT00002392|Streptococcus pneumoniae|streptococcus pneumoniae
5852091|NCT00002392|Tetanus Toxoid|tetanus toxoid
5852092|NCT00002392|Pneumococcal Vaccines|pneumococcal vaccines
5852094|NCT00002391|Drug Therapy, Combination|drug therapy, combination
5852095|NCT00002391|Zidovudine|zidovudine
5852096|NCT00002391|Lamivudine|lamivudine
5852097|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5856331|NCT00000799|cidofovir|cidofovir
5852098|NCT00002391|Anti-HIV Agents|anti-hiv agents
5852099|NCT00002391|Viral Load|viral load
5852100|NCT00002391|Child Development|child development
5852101|NCT00002391|abacavir|abacavir
5852102|NCT00002389|HIV-1|hiv-1
5852103|NCT00002389|Drug Therapy, Combination|drug therapy, combination
5852104|NCT00002389|Antiviral Agents|antiviral agents
5852105|NCT00002389|Zidovudine|zidovudine
5852106|NCT00002389|CD4 Lymphocyte Count|cd4 lymphocyte count
5852107|NCT00002389|Lamivudine|lamivudine
5852108|NCT00002389|RNA, Viral|rna, viral
5852109|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852110|NCT00002389|Anti-HIV Agents|anti-hiv agents
5852111|NCT00002389|Viral Load|viral load
5852112|NCT00002389|abacavir|abacavir
5852113|NCT00002388|HIV-1|hiv-1
5852114|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852115|NCT00002388|Anti-HIV Agents|anti-hiv agents
5852116|NCT00002387|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852117|NCT00002387|Drug Administration Schedule|drug administration schedule
5852118|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors
5852119|NCT00002387|Indinavir|indinavir
5852120|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852121|NCT00002387|Anti-HIV Agents|anti-hiv agents
5852122|NCT00002387|efavirenz|efavirenz
5852123|NCT00002386|Drug Therapy, Combination|drug therapy, combination
5852124|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors
5852125|NCT00002386|Indinavir|indinavir
5852126|NCT00002386|Factor VIII|factor viii
5852127|NCT00002386|Factor IX|factor ix
5852128|NCT00002386|Half-Life|half-life
5852129|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852130|NCT00002386|Anti-HIV Agents|anti-hiv agents
5852131|NCT00002386|Platelet Aggregation|platelet aggregation
5852132|NCT00002386|Hemophilia A|hemophilia a
5852133|NCT00002386|Hemophilia B|hemophilia b
5852134|NCT00002385|Dose-Response Relationship, Drug|dose-response relationship, drug
5852135|NCT00002385|Cohort Studies|cohort studies
5852136|NCT00002385|Anti-HIV Agents|anti-hiv agents
5852137|NCT00002383|Drug Administration Schedule|drug administration schedule
5852138|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors
5852139|NCT00002383|Dosage Forms|dosage forms
5852140|NCT00002383|Saquinavir|saquinavir
5852141|NCT00002383|Anti-HIV Agents|anti-hiv agents
5852142|NCT00002382|Zalcitabine|zalcitabine
5852143|NCT00002382|Didanosine|didanosine
5852144|NCT00002382|Drug Therapy, Combination|drug therapy, combination
5852145|NCT00002382|Zidovudine|zidovudine
5852146|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors
5852147|NCT00002382|Saquinavir|saquinavir
5852148|NCT00002382|Patient Selection|patient selection
5852149|NCT00002382|Anti-HIV Agents|anti-hiv agents
5852150|NCT00002381|HIV-1|hiv-1
5852151|NCT00002381|Drug Therapy, Combination|drug therapy, combination
5852152|NCT00002381|Nevirapine|nevirapine
5852153|NCT00002381|Stavudine|stavudine
5852154|NCT00002381|RNA, Viral|rna, viral
5852155|NCT00002381|Nelfinavir|nelfinavir
5852156|NCT00002381|Anti-HIV Agents|anti-hiv agents
5852157|NCT00002381|Viral Load|viral load
5852158|NCT00002380|Drug Therapy, Combination|drug therapy, combination
5852159|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors
5852160|NCT00002380|Dosage Forms|dosage forms
5847790|NCT00038116|PD|pd
5852161|NCT00002380|Saquinavir|saquinavir
5852162|NCT00002380|Nelfinavir|nelfinavir
5852163|NCT00002380|Anti-HIV Agents|anti-hiv agents
5852164|NCT00002379|HIV-1|hiv-1
5852165|NCT00002379|Drug Therapy, Combination|drug therapy, combination
5852166|NCT00002379|Administration, Oral|administration, oral
5848183|NCT00035906|Uveitis|uveitis
5852167|NCT00002379|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852168|NCT00002379|Zidovudine|zidovudine
5852169|NCT00002379|Stavudine|stavudine
5852170|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors
5852171|NCT00002379|CD4 Lymphocyte Count|cd4 lymphocyte count
5852172|NCT00002379|Lamivudine|lamivudine
5852173|NCT00002379|Indinavir|indinavir
5852174|NCT00002379|RNA, Viral|rna, viral
5852175|NCT00002379|Adenine|adenine
5852176|NCT00002379|Anti-HIV Agents|anti-hiv agents
5852177|NCT00002379|Viral Load|viral load
5852178|NCT00002378|HIV-1|hiv-1
5852179|NCT00002378|Drug Therapy, Combination|drug therapy, combination
5852180|NCT00002378|Zidovudine|zidovudine
5852181|NCT00002378|Stavudine|stavudine
5852182|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors
5852183|NCT00002378|Lamivudine|lamivudine
5852184|NCT00002378|RNA, Viral|rna, viral
5852185|NCT00002378|Dosage Forms|dosage forms
5852186|NCT00002378|Saquinavir|saquinavir
5852187|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852188|NCT00002378|Anti-HIV Agents|anti-hiv agents
5852189|NCT00002378|Viral Load|viral load
5852190|NCT00002378|Nelfinavir|nelfinavir
5852191|NCT00002376|HIV-1|hiv-1
5852192|NCT00002376|CD4 Lymphocyte Count|cd4 lymphocyte count
5852193|NCT00002376|RNA, Viral|rna, viral
5852194|NCT00002376|Anti-HIV Agents|anti-hiv agents
5852196|NCT00002375|Drug Therapy, Combination|drug therapy, combination
5852197|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors
5852198|NCT00002375|Indinavir|indinavir
5852199|NCT00002375|Nelfinavir|nelfinavir
5852200|NCT00002375|Anti-HIV Agents|anti-hiv agents
5852201|NCT00002374|HIV-1|hiv-1
5852202|NCT00002374|Drug Therapy, Combination|drug therapy, combination
5852203|NCT00002374|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852204|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors
5852205|NCT00002374|RNA, Viral|rna, viral
5852206|NCT00002374|Saquinavir|saquinavir
5852207|NCT00002374|Anti-HIV Agents|anti-hiv agents
5852208|NCT00002374|Viral Load|viral load
5852209|NCT00002373|Cytomegalovirus|cytomegalovirus
5852210|NCT00002373|Cytomegalovirus Infections|cytomegalovirus infections
5852211|NCT00002373|Administration, Oral|administration, oral
5852212|NCT00002373|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852213|NCT00002373|Antiviral Agents|antiviral agents
5852214|NCT00002373|Virus Shedding|virus shedding
5852215|NCT00002373|Viral Load|viral load
5852216|NCT00002372|Drug Therapy, Combination|drug therapy, combination
5852217|NCT00002372|Administration, Oral|administration, oral
5852218|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors
5852219|NCT00002372|Indinavir|indinavir
5852220|NCT00002372|Saquinavir|saquinavir
5852221|NCT00002372|Nelfinavir|nelfinavir
5852222|NCT00002372|VX 478|vx 478
5852223|NCT00002371|HIV-1|hiv-1
5852224|NCT00002371|Drug Therapy, Combination|drug therapy, combination
5852225|NCT00002371|Stavudine|stavudine
5852226|NCT00002371|Lamivudine|lamivudine
5852227|NCT00002371|RNA, Viral|rna, viral
5852228|NCT00002371|Anti-HIV Agents|anti-hiv agents
5852229|NCT00002371|Viral Load|viral load
5852230|NCT00002370|Itraconazole|itraconazole
5852231|NCT00002370|Administration, Oral|administration, oral
5852232|NCT00002370|Antifungal Agents|antifungal agents
5852233|NCT00002370|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852234|NCT00002370|Drug Administration Schedule|drug administration schedule
5852235|NCT00002369|Drug Therapy, Combination|drug therapy, combination
5852236|NCT00002369|Zidovudine|zidovudine
5852237|NCT00002369|Stavudine|stavudine
5852238|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors
5852239|NCT00002369|CD4 Lymphocyte Count|cd4 lymphocyte count
5852240|NCT00002369|Lamivudine|lamivudine
5852241|NCT00002369|Indinavir|indinavir
5852242|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852243|NCT00002369|Anti-HIV Agents|anti-hiv agents
5852244|NCT00002369|Viral Load|viral load
5852245|NCT00002368|Drug Therapy, Combination|drug therapy, combination
5852246|NCT00002368|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852247|NCT00002368|Nevirapine|nevirapine
5852248|NCT00002368|Lamivudine|lamivudine
5852249|NCT00002368|Disease Progression|disease progression
5852250|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852251|NCT00002368|Anti-HIV Agents|anti-hiv agents
5852252|NCT00002367|Drug Therapy, Combination|drug therapy, combination
5852253|NCT00002367|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852254|NCT00002367|Zidovudine|zidovudine
5852255|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors
5852256|NCT00002367|Lamivudine|lamivudine
5852257|NCT00002367|Saquinavir|saquinavir
5852258|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852259|NCT00002367|Anti-HIV Agents|anti-hiv agents
5852260|NCT00002366|Skin Neoplasms|skin neoplasms
5852261|NCT00002366|Sarcoma, Kaposi|sarcoma, kaposi
5852262|NCT00002366|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852263|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors
5852264|NCT00002366|Ritonavir|ritonavir
5852265|NCT00002365|Dose-Response Relationship, Drug|dose-response relationship, drug
5848263|NCT00035386|ICE|ice
5852266|NCT00002365|Administration, Oral|administration, oral
5852267|NCT00002365|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852268|NCT00002365|Anti-HIV Agents|anti-hiv agents
5852269|NCT00002364|Drug Therapy, Combination|drug therapy, combination
5852270|NCT00002364|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852271|NCT00002364|AIDS-Related Complex|aids-related complex
5852272|NCT00002364|Antiviral Agents|antiviral agents
5852273|NCT00002363|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852274|NCT00002363|AIDS-Related Complex|aids-related complex
5852275|NCT00002363|Antiviral Agents|antiviral agents
5852276|NCT00002362|Dideoxynucleosides|dideoxynucleosides
5852277|NCT00002362|Drug Therapy, Combination|drug therapy, combination
5852278|NCT00002362|Stavudine|stavudine
5852279|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852280|NCT00002362|abacavir|abacavir
5852281|NCT00002362|efavirenz|efavirenz
5852282|NCT00002361|Drug Therapy, Combination|drug therapy, combination
5852283|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors
5852284|NCT00002361|Ritonavir|ritonavir
5852285|NCT00002361|Indinavir|indinavir
5852286|NCT00002361|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852287|NCT00002361|Anti-HIV Agents|anti-hiv agents
5852288|NCT00002361|Viral Load|viral load
5852289|NCT00002360|Didanosine|didanosine
5852290|NCT00002360|Tablets|tablets
5852382|NCT00002339|Candidiasis|candidiasis
5852291|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852292|NCT00002360|Anti-HIV Agents|anti-hiv agents
5852293|NCT00002360|Therapeutic Equivalency|therapeutic equivalency
5852941|NCT00002225|Stavudine|stavudine
5856520|NCT00000766|Foscarnet|foscarnet
5852294|NCT00002359|Vaccines, Synthetic|vaccines, synthetic
5852295|NCT00002359|Viral Vaccines|viral vaccines
5852296|NCT00002359|HIV-1|hiv-1
5852297|NCT00002359|AIDS-Related Complex|aids-related complex
5852298|NCT00002359|AIDS Vaccines|aids vaccines
5852299|NCT00002359|Salk HIV Immunogen|salk hiv immunogen
5852300|NCT00002358|Herpes Zoster|herpes zoster
5852301|NCT00002358|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852302|NCT00002358|AIDS-Related Complex|aids-related complex
5852303|NCT00002358|Antiviral Agents|antiviral agents
5852304|NCT00002358|sorivudine|sorivudine
5852305|NCT00002358|Chickenpox|chickenpox
5852306|NCT00002357|Drug Therapy, Combination|drug therapy, combination
5852307|NCT00002357|AIDS-Related Complex|aids-related complex
5852308|NCT00002357|Antiviral Agents|antiviral agents
5852309|NCT00002357|Zidovudine|zidovudine
5852310|NCT00002356|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852311|NCT00002356|Antiviral Agents|antiviral agents
5852312|NCT00002356|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5852313|NCT00002355|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852314|NCT00002355|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852315|NCT00002355|Antiviral Agents|antiviral agents
5852316|NCT00002355|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5852317|NCT00002354|Drug Therapy, Combination|drug therapy, combination
5852318|NCT00002354|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852319|NCT00002354|AIDS-Related Complex|aids-related complex
5852320|NCT00002354|Stavudine|stavudine
5852321|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors
5852322|NCT00002354|Indinavir|indinavir
5852323|NCT00002353|Vaccines, Synthetic|vaccines, synthetic
5852324|NCT00002353|AIDS Vaccines|aids vaccines
5852325|NCT00002352|Cytomegalovirus Infections|cytomegalovirus infections
5852326|NCT00002352|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852327|NCT00002352|Antiviral Agents|antiviral agents
5852328|NCT00002351|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852329|NCT00002351|AIDS-Related Complex|aids-related complex
5852330|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors
5852331|NCT00002351|Indinavir|indinavir
5852332|NCT00002350|Vaccines, Synthetic|vaccines, synthetic
5852333|NCT00002350|AIDS Vaccines|aids vaccines
5852334|NCT00002350|DNA, Viral|dna, viral
5852335|NCT00002349|AIDS-Related Complex|aids-related complex
5852336|NCT00002349|Stavudine|stavudine
5852337|NCT00002348|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5852338|NCT00002348|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852339|NCT00002348|Lymphoma, AIDS-Related|lymphoma, aids-related
5852340|NCT00002348|Mitoguazone|mitoguazone
5852341|NCT00002347|Zalcitabine|zalcitabine
5852342|NCT00002347|Drug Therapy, Combination|drug therapy, combination
5852343|NCT00002347|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852344|NCT00002347|AIDS-Related Complex|aids-related complex
5852345|NCT00002347|Zidovudine|zidovudine
5852346|NCT00002347|Nevirapine|nevirapine
5852347|NCT00002347|Saquinavir|saquinavir
5852348|NCT00002346|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852349|NCT00002346|AIDS-Related Complex|aids-related complex
5852350|NCT00002346|Antiviral Agents|antiviral agents
5852351|NCT00002346|Adenine|adenine
5852352|NCT00002345|Megestrol|megestrol
5852353|NCT00002345|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5848391|NCT00034970|psychological aspect of cancer|psychological aspect of cancer
5852354|NCT00002345|Anorexia|anorexia
5852355|NCT00002345|Cachexia|cachexia
5852356|NCT00002345|Suspensions|suspensions
5852357|NCT00002344|Azithromycin|azithromycin
5852358|NCT00002344|Bacterial Infections|bacterial infections
5852359|NCT00002343|Rifabutin|rifabutin
5852360|NCT00002343|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5852361|NCT00002343|Drug Therapy, Combination|drug therapy, combination
5852362|NCT00002343|Ethambutol|ethambutol
5852363|NCT00002343|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852364|NCT00002342|Neoplasms|neoplasms
5852365|NCT00002342|Sarcoma, Kaposi|sarcoma, kaposi
5852366|NCT00002342|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852367|NCT00002342|Antineoplastic Agents|antineoplastic agents
5852368|NCT00002342|tecogalan|tecogalan
5852369|NCT00002341|Itraconazole|itraconazole
5852370|NCT00002341|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852371|NCT00002341|AIDS-Related Complex|aids-related complex
5852372|NCT00002341|Candidiasis, Oral|candidiasis, oral
5852373|NCT00002340|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852374|NCT00002340|Pentamidine|pentamidine
5852375|NCT00002340|Antifungal Agents|antifungal agents
5852376|NCT00002340|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852377|NCT00002340|AIDS-Related Complex|aids-related complex
5852378|NCT00002340|atovaquone|atovaquone
5852379|NCT00002339|Esophagitis|esophagitis
5852380|NCT00002339|Fluconazole|fluconazole
5852381|NCT00002339|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852383|NCT00002339|Immunocompromised Host|immunocompromised host
5852384|NCT00002338|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852385|NCT00002338|AIDS-Related Complex|aids-related complex
5853040|NCT00002209|Zidovudine|zidovudine
5852386|NCT00002338|Antiviral Agents|antiviral agents
5852387|NCT00002337|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852388|NCT00002337|Antiviral Agents|antiviral agents
5852389|NCT00002337|vesnarinone|vesnarinone
5852390|NCT00002336|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
5852391|NCT00002336|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852392|NCT00002336|Clarithromycin|clarithromycin
5852393|NCT00002335|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852394|NCT00002335|AIDS-Related Complex|aids-related complex
5852395|NCT00002335|Antiviral Agents|antiviral agents
5852396|NCT00002334|Drug Therapy, Combination|drug therapy, combination
5852397|NCT00002334|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852398|NCT00002334|AIDS-Related Complex|aids-related complex
5852399|NCT00002334|Zidovudine|zidovudine
5852400|NCT00002334|Saquinavir|saquinavir
5852401|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors
5852402|NCT00002333|Zalcitabine|zalcitabine
5852403|NCT00002333|Drug Therapy, Combination|drug therapy, combination
5852404|NCT00002333|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852405|NCT00002333|AIDS-Related Complex|aids-related complex
5852406|NCT00002333|Saquinavir|saquinavir
5852407|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors
5852408|NCT00002332|Thymopentin|thymopentin
5852409|NCT00002332|AIDS-Related Complex|aids-related complex
5852410|NCT00002331|Mycobacterium avium-intracellular Infection|mycobacterium avium-intracellular infection
5852411|NCT00002331|Drug Therapy, Combination|drug therapy, combination
5852412|NCT00002331|Ethambutol|ethambutol
5852413|NCT00002331|Clofazimine|clofazimine
5852414|NCT00002331|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852415|NCT00002331|Clarithromycin|clarithromycin
5852416|NCT00002330|Retinitis|retinitis
5852417|NCT00002330|Ganciclovir|ganciclovir
5852418|NCT00002330|Cytomegalovirus Infections|cytomegalovirus infections
5852419|NCT00002330|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852420|NCT00002329|MDL 28574|mdl 28574
5852421|NCT00002328|Antidiarrheals|antidiarrheals
5852422|NCT00002328|Cryptosporidiosis|cryptosporidiosis
5852423|NCT00002328|Diarrhea|diarrhea
5852424|NCT00002328|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852425|NCT00002328|Azithromycin|azithromycin
5852426|NCT00002327|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852427|NCT00002327|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852428|NCT00002327|AIDS-Related Complex|aids-related complex
5852429|NCT00002327|Antiviral Agents|antiviral agents
5852430|NCT00002327|Condylomata Acuminata|condylomata acuminata
5852431|NCT00002327|cidofovir|cidofovir
5852432|NCT00002326|Drug Therapy, Combination|drug therapy, combination
5852433|NCT00002326|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852434|NCT00002326|AIDS-Related Complex|aids-related complex
5852435|NCT00002326|Antiviral Agents|antiviral agents
5852436|NCT00002326|Zidovudine|zidovudine
5852437|NCT00002326|Adenine|adenine
5852438|NCT00002325|Mycoses|mycoses
5852439|NCT00002325|Fluconazole|fluconazole
5852440|NCT00002325|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852441|NCT00002325|AIDS-Related Complex|aids-related complex
5852442|NCT00002325|Coccidioidomycosis|coccidioidomycosis
5848496|NCT00034554|gp75|gp75
5852443|NCT00002324|Drug Therapy, Combination|drug therapy, combination
5852444|NCT00002324|AIDS-Related Complex|aids-related complex
5852445|NCT00002324|Zidovudine|zidovudine
5852446|NCT00002324|Nevirapine|nevirapine
5852447|NCT00002323|Drug Therapy, Combination|drug therapy, combination
5852448|NCT00002323|Zidovudine|zidovudine
5852449|NCT00002323|Nevirapine|nevirapine
5852450|NCT00002322|Drug Therapy, Combination|drug therapy, combination
5852451|NCT00002322|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852452|NCT00002322|AIDS-Related Complex|aids-related complex
5852453|NCT00002322|Antiviral Agents|antiviral agents
5852454|NCT00002321|Retinitis|retinitis
5852455|NCT00002321|Interleukin-2|interleukin-2
5852456|NCT00002321|Ganciclovir|ganciclovir
5852457|NCT00002321|Drug Therapy, Combination|drug therapy, combination
5852458|NCT00002321|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852459|NCT00002321|Antiviral Agents|antiviral agents
5852460|NCT00002320|Drug Therapy, Combination|drug therapy, combination
5852461|NCT00002320|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852462|NCT00002320|AIDS-Related Complex|aids-related complex
5852463|NCT00002320|Antiviral Agents|antiviral agents
5852464|NCT00002320|Zidovudine|zidovudine
5852465|NCT00002319|Sarcoma, Kaposi|sarcoma, kaposi
5852467|NCT00002319|Doxorubicin|doxorubicin
5852468|NCT00002319|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852469|NCT00002319|Drug Carriers|drug carriers
5852470|NCT00002318|Vincristine|vincristine
5852471|NCT00002318|Sarcoma, Kaposi|sarcoma, kaposi
5852472|NCT00002318|Liposomes|liposomes
5852473|NCT00002318|Doxorubicin|doxorubicin
5852655|NCT00002283|Dapsone|dapsone
5852474|NCT00002318|Drug Therapy, Combination|drug therapy, combination
5852475|NCT00002318|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852476|NCT00002318|Bleomycin|bleomycin
5852477|NCT00002318|Drug Carriers|drug carriers
5852478|NCT00002317|Trimetrexate|trimetrexate
5852479|NCT00002317|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852480|NCT00002317|Leucovorin|leucovorin
5852481|NCT00002317|Drug Therapy, Combination|drug therapy, combination
5852482|NCT00002317|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852483|NCT00002316|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852484|NCT00002316|Meningitis|meningitis
5852485|NCT00002316|Drug Therapy, Combination|drug therapy, combination
5852486|NCT00002316|Antifungal Agents|antifungal agents
5852487|NCT00002316|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852488|NCT00002316|Amphotericin B|amphotericin b
5852489|NCT00002315|Herpes Zoster|herpes zoster
5852490|NCT00002315|Acyclovir|acyclovir
5852491|NCT00002315|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852492|NCT00002315|AIDS-Related Complex|aids-related complex
5852493|NCT00002315|Antiviral Agents|antiviral agents
5852494|NCT00002314|Sarcoma, Kaposi|sarcoma, kaposi
5852495|NCT00002314|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852496|NCT00002314|Antineoplastic Agents|antineoplastic agents
5852497|NCT00002314|Gene Products, tat|gene products, tat
5852498|NCT00002313|Nystatin|nystatin
5852499|NCT00002313|Didanosine|didanosine
5852500|NCT00002313|Drug Therapy, Combination|drug therapy, combination
5852501|NCT00002313|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852502|NCT00002313|AIDS-Related Complex|aids-related complex
5852503|NCT00002312|Drug Interactions|drug interactions
5852504|NCT00002312|Antiviral Agents|antiviral agents
5852505|NCT00002312|Zidovudine|zidovudine
5852506|NCT00002311|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852507|NCT00002311|AIDS-Related Complex|aids-related complex
5852508|NCT00002311|Wobenzym|wobenzym
5852509|NCT00002311|Hydrolases|hydrolases
5852510|NCT00002310|Herpes Simplex|herpes simplex
5852511|NCT00002310|HIV-1|hiv-1
5852512|NCT00002310|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852513|NCT00002310|Antiviral Agents|antiviral agents
5852514|NCT00002310|Administration, Topical|administration, topical
5852515|NCT00002309|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5852516|NCT00002309|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852517|NCT00002309|AIDS-Related Complex|aids-related complex
5852518|NCT00002309|Azithromycin|azithromycin
5852519|NCT00002308|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852520|NCT00002308|AIDS-Related Complex|aids-related complex
5852521|NCT00002308|Stavudine|stavudine
5852522|NCT00002307|Zidovudine|zidovudine
5852523|NCT00002307|Stavudine|stavudine
5852524|NCT00002306|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852525|NCT00002306|Meningitis|meningitis
5852526|NCT00002306|Cryptococcosis|cryptococcosis
5852527|NCT00002306|Fluconazole|fluconazole
5852528|NCT00002306|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852529|NCT00002306|Amphotericin B|amphotericin b
5852530|NCT00002305|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852531|NCT00002305|Meningitis|meningitis
5852532|NCT00002305|Cryptococcosis|cryptococcosis
5852533|NCT00002305|Drug Therapy, Combination|drug therapy, combination
5852534|NCT00002305|Fluconazole|fluconazole
5852535|NCT00002305|Flucytosine|flucytosine
5852536|NCT00002305|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852537|NCT00002305|Amphotericin B|amphotericin b
5852538|NCT00002304|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852539|NCT00002304|Immune Tolerance|immune tolerance
5852540|NCT00002304|Ketoconazole|ketoconazole
5852541|NCT00002304|Esophagitis|esophagitis
5852542|NCT00002304|Fluconazole|fluconazole
5852543|NCT00002304|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852544|NCT00002304|Candidiasis, Oral|candidiasis, oral
5852545|NCT00002303|Recombinant Proteins|recombinant proteins
5852546|NCT00002303|Erythropoietin|erythropoietin
5852547|NCT00002303|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852548|NCT00002303|Anemia|anemia
5852549|NCT00002303|AIDS-Related Complex|aids-related complex
5852550|NCT00002303|Zidovudine|zidovudine
5852551|NCT00002302|Recombinant Proteins|recombinant proteins
5852552|NCT00002302|Injections, Subcutaneous|injections, subcutaneous
5852553|NCT00002302|Erythropoietin|erythropoietin
5852554|NCT00002302|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852555|NCT00002302|Anemia|anemia
5852556|NCT00002302|Zidovudine|zidovudine
5852557|NCT00002301|Retinitis|retinitis
5852558|NCT00002301|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852560|NCT00002301|Foscarnet|foscarnet
5852561|NCT00002301|Cytomegalovirus Infections|cytomegalovirus infections
5852562|NCT00002301|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852563|NCT00002301|Antiviral Agents|antiviral agents
5852564|NCT00002300|T-Lymphocytes|t-lymphocytes
5852565|NCT00002300|Megestrol|megestrol
5852566|NCT00002300|Dose-Response Relationship, Drug|dose-response relationship, drug
5852567|NCT00002300|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852568|NCT00002300|Anorexia|anorexia
5852569|NCT00002300|Cachexia|cachexia
5852570|NCT00002299|Retinitis|retinitis
5852571|NCT00002299|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852572|NCT00002299|Ganciclovir|ganciclovir
5852573|NCT00002299|Drug Therapy, Combination|drug therapy, combination
5852574|NCT00002299|Cytomegalovirus Infections|cytomegalovirus infections
5852575|NCT00002299|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852576|NCT00002299|Interferon Type I|interferon type i
5852577|NCT00002298|Ribavirin|ribavirin
5852578|NCT00002298|AIDS-Related Complex|aids-related complex
5852579|NCT00002297|Inosine Pranobex|inosine pranobex
5852580|NCT00002297|AIDS-Related Complex|aids-related complex
5852581|NCT00002296|T-Lymphocytes|t-lymphocytes
5852582|NCT00002296|Immune Tolerance|immune tolerance
5852583|NCT00002296|Inosine Pranobex|inosine pranobex
5852584|NCT00002296|Killer Cells|killer cells
5852585|NCT00002296|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5852586|NCT00002296|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852587|NCT00002296|AIDS-Related Complex|aids-related complex
5852588|NCT00002295|Infusions, Intravenous|infusions, intravenous
5852589|NCT00002295|Drug Evaluation|drug evaluation
5852590|NCT00002295|Administration, Oral|administration, oral
5852591|NCT00002295|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852592|NCT00002295|AIDS-Related Complex|aids-related complex
5852593|NCT00002295|Zidovudine|zidovudine
5852594|NCT00002295|Biological Availability|biological availability
5852595|NCT00002294|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852596|NCT00002294|Meningitis|meningitis
5852597|NCT00002294|Cryptococcosis|cryptococcosis
5852598|NCT00002294|Fluconazole|fluconazole
5852599|NCT00002294|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852600|NCT00002293|Nystatin|nystatin
5852601|NCT00002293|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852602|NCT00002293|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852603|NCT00002293|AIDS-Related Complex|aids-related complex
5852604|NCT00002293|Candidiasis, Oral|candidiasis, oral
5852605|NCT00002292|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852606|NCT00002292|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852607|NCT00002292|Pentamidine|pentamidine
5852608|NCT00002292|Injections, Intravenous|injections, intravenous
5852609|NCT00002292|Administration, Inhalation|administration, inhalation
5852610|NCT00002292|Aerosols|aerosols
5852611|NCT00002292|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852612|NCT00002291|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852613|NCT00002291|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852614|NCT00002291|Pentamidine|pentamidine
5852615|NCT00002291|Dose-Response Relationship, Drug|dose-response relationship, drug
5852616|NCT00002291|Aerosols|aerosols
5852617|NCT00002291|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852618|NCT00002290|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852619|NCT00002290|Drug Therapy, Combination|drug therapy, combination
5852620|NCT00002290|Acyclovir|acyclovir
5852621|NCT00002290|AIDS-Related Complex|aids-related complex
5852622|NCT00002290|Zidovudine|zidovudine
5852623|NCT00002289|Semen|semen
5852624|NCT00002289|Thymopentin|thymopentin
5852625|NCT00002289|Leukocytes, Mononuclear|leukocytes, mononuclear
5852626|NCT00002289|HIV Seropositivity|hiv seropositivity
5852627|NCT00002289|AIDS-Related Complex|aids-related complex
5852628|NCT00002288|Neuropsychological Tests|neuropsychological tests
5852629|NCT00002288|AIDS-Related Complex|aids-related complex
5852630|NCT00002288|Zidovudine|zidovudine
5852631|NCT00002287|Health Manpower|health manpower
5852632|NCT00002287|Accidents, Occupational|accidents, occupational
5852633|NCT00002287|Zidovudine|zidovudine
5852634|NCT00002286|Pilot Projects|pilot projects
5852635|NCT00002286|Psoriasis|psoriasis
5852636|NCT00002286|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852637|NCT00002286|Zidovudine|zidovudine
5852638|NCT00002285|Virus Replication|virus replication
5852639|NCT00002285|Pilot Projects|pilot projects
5852640|NCT00002285|Immune Tolerance|immune tolerance
5852642|NCT00002285|Drug Evaluation|drug evaluation
5852643|NCT00002285|Combined Modality Therapy|combined modality therapy
5852644|NCT00002285|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852645|NCT00002285|Transplantation, Homologous|transplantation, homologous
5852646|NCT00002285|Zidovudine|zidovudine
5852647|NCT00002284|Lymphoma, Large-Cell|lymphoma, large-cell
5852648|NCT00002284|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852649|NCT00002284|AIDS-Related Complex|aids-related complex
5852650|NCT00002284|Zidovudine|zidovudine
5852651|NCT00002284|Bone Marrow Transplantation|bone marrow transplantation
5852652|NCT00002283|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5852653|NCT00002283|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852654|NCT00002283|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852656|NCT00002283|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852657|NCT00002282|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852658|NCT00002282|Fluconazole|fluconazole
5852659|NCT00002282|Clotrimazole|clotrimazole
5852660|NCT00002282|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852661|NCT00002282|Candidiasis, Oral|candidiasis, oral
5852662|NCT00002281|Injections, Subcutaneous|injections, subcutaneous
5852663|NCT00002281|Erythropoietin|erythropoietin
5852664|NCT00002281|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852665|NCT00002281|AIDS-Related Complex|aids-related complex
5852666|NCT00002281|Zidovudine|zidovudine
5852667|NCT00002280|Didanosine|didanosine
5852668|NCT00002280|Drugs, Investigational|drugs, investigational
5852669|NCT00002280|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852670|NCT00002280|Zidovudine|zidovudine
5852671|NCT00002279|Zalcitabine|zalcitabine
5852672|NCT00002279|Didanosine|didanosine
5852673|NCT00002279|Drugs, Investigational|drugs, investigational
5852674|NCT00002279|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852675|NCT00002279|AIDS-Related Complex|aids-related complex
5852676|NCT00002279|Zidovudine|zidovudine
5852677|NCT00002278|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852678|NCT00002278|Cryptosporidiosis|cryptosporidiosis
5852679|NCT00002278|Diarrhea|diarrhea
5852680|NCT00002278|diclazuril|diclazuril
5852681|NCT00002278|Coccidiostats|coccidiostats
5852682|NCT00002278|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852683|NCT00002277|Mycoses|mycoses
5852684|NCT00002277|Neoplasms|neoplasms
5852685|NCT00002277|Neutropenia|neutropenia
5852686|NCT00002277|Fluconazole|fluconazole
5852687|NCT00002277|Amphotericin B|amphotericin b
5852688|NCT00002276|Blood Platelets|blood platelets
5852689|NCT00002276|Ibuprofen|ibuprofen
5852690|NCT00002276|Drug Interactions|drug interactions
5852691|NCT00002276|Zidovudine|zidovudine
5852692|NCT00002276|Hemophilia A|hemophilia a
5852693|NCT00002275|Weight Loss|weight loss
5852694|NCT00002275|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5852695|NCT00002275|Parenteral Nutrition|parenteral nutrition
5852696|NCT00002275|Liposyn|liposyn
5852697|NCT00002275|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852698|NCT00002274|Didanosine|didanosine
5852699|NCT00002274|Drugs, Investigational|drugs, investigational
5852700|NCT00002274|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852701|NCT00002274|Zidovudine|zidovudine
5852702|NCT00002273|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852703|NCT00002273|Ganciclovir|ganciclovir
5852704|NCT00002273|Cytomegalovirus Infections|cytomegalovirus infections
5852705|NCT00002273|Colitis|colitis
5852706|NCT00002273|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852707|NCT00002272|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852708|NCT00002272|Immune Tolerance|immune tolerance
5852709|NCT00002272|Injections, Intravenous|injections, intravenous
5852710|NCT00002272|Herpes Simplex|herpes simplex
5852711|NCT00002272|Immunity, Cellular|immunity, cellular
5852712|NCT00002272|Drug Resistance|drug resistance
5852713|NCT00002272|Foscarnet|foscarnet
5852714|NCT00002272|Acyclovir|acyclovir
5852715|NCT00002272|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852716|NCT00002272|Antiviral Agents|antiviral agents
5852717|NCT00002271|Thymidine|thymidine
5852718|NCT00002271|Nucleosides|nucleosides
5852719|NCT00002271|Antiviral Agents|antiviral agents
5848808|NCT00033189|CINRG|cinrg
5852720|NCT00002270|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5852721|NCT00002270|Interferon Alfa-2b|interferon alfa-2b
5852722|NCT00002270|Drug Evaluation|drug evaluation
5852723|NCT00002270|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852724|NCT00002270|Zidovudine|zidovudine
5852725|NCT00002269|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852726|NCT00002269|ampligen|ampligen
5852727|NCT00002269|AIDS-Related Complex|aids-related complex
5852728|NCT00002269|Zidovudine|zidovudine
5852729|NCT00002268|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852730|NCT00002268|Immunotherapy|immunotherapy
5852731|NCT00002268|Drug Evaluation|drug evaluation
5852732|NCT00002268|Cytomegalovirus Infections|cytomegalovirus infections
5852733|NCT00002268|Antibodies, Monoclonal|antibodies, monoclonal
5852734|NCT00002267|Rifabutin|rifabutin
5852735|NCT00002267|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852736|NCT00002267|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5852737|NCT00002267|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852738|NCT00002267|Antitubercular Agents|antitubercular agents
5852739|NCT00002266|Drug Therapy, Combination|drug therapy, combination
5852740|NCT00002266|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852741|NCT00002266|AIDS-Related Complex|aids-related complex
5852742|NCT00002266|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5852743|NCT00002265|Zalcitabine|zalcitabine
5852744|NCT00002265|Drug Evaluation|drug evaluation
5852745|NCT00002265|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852746|NCT00002265|AIDS-Related Complex|aids-related complex
5852748|NCT00002263|Pilot Projects|pilot projects
5852749|NCT00002263|Neutropenia|neutropenia
5852750|NCT00002263|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5853041|NCT00002209|Lamivudine|lamivudine
5852751|NCT00002263|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852752|NCT00002263|Zidovudine|zidovudine
5852753|NCT00002262|Skin Neoplasms|skin neoplasms
5852754|NCT00002262|Tumor Necrosis Factor|tumor necrosis factor
5852755|NCT00002262|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852756|NCT00002261|Vaccines, Synthetic|vaccines, synthetic
5852757|NCT00002261|Vaccinia Virus|vaccinia virus
5852758|NCT00002261|Viral Vaccines|viral vaccines
5852759|NCT00002261|Smallpox Vaccine|smallpox vaccine
5852760|NCT00002261|HIV-1|hiv-1
5852761|NCT00002261|AIDS Vaccines|aids vaccines
5852762|NCT00002261|HIV Seronegativity|hiv seronegativity
5852763|NCT00002260|Biological Availability|biological availability
5852764|NCT00002260|alovudine|alovudine
5852765|NCT00002260|Food|food
5852766|NCT00002259|Mitoxantrone|mitoxantrone
5852767|NCT00002259|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852768|NCT00002258|Interleukin-3|interleukin-3
5852769|NCT00002258|Recombinant Proteins|recombinant proteins
5852770|NCT00002258|Leukopenia|leukopenia
5852771|NCT00002258|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852772|NCT00002258|AIDS-Related Complex|aids-related complex
5852773|NCT00002258|Thrombocytopenia|thrombocytopenia
5852774|NCT00002257|Retinitis|retinitis
5852775|NCT00002257|Ganciclovir|ganciclovir
5852776|NCT00002257|Cytomegalovirus Infections|cytomegalovirus infections
5852777|NCT00002257|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852778|NCT00002256|Zalcitabine|zalcitabine
5852779|NCT00002256|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852780|NCT00002256|AIDS-Related Complex|aids-related complex
5852781|NCT00002256|Zidovudine|zidovudine
5852782|NCT00002255|Erythropoietin|erythropoietin
5852783|NCT00002255|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5852784|NCT00002255|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852785|NCT00002255|AIDS-Related Complex|aids-related complex
5852786|NCT00002255|Zidovudine|zidovudine
5852787|NCT00002254|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852788|NCT00002253|Octreotide|octreotide
5852789|NCT00002253|Diarrhea|diarrhea
5852790|NCT00002253|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852791|NCT00002253|AIDS-Related Complex|aids-related complex
5852792|NCT00002252|Octreotide|octreotide
5852793|NCT00002252|Diarrhea|diarrhea
5852794|NCT00002252|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852795|NCT00002252|AIDS-Related Complex|aids-related complex
5852796|NCT00002251|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852797|NCT00002251|Ganciclovir|ganciclovir
5852798|NCT00002251|Cytomegalovirus Infections|cytomegalovirus infections
5852799|NCT00002251|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852800|NCT00002251|Biological Availability|biological availability
5852801|NCT00002250|Recombinant Proteins|recombinant proteins
5852803|NCT00002250|Drug Evaluation|drug evaluation
5852804|NCT00002250|Antigens, CD4|antigens, cd4
5852805|NCT00002249|Anti-Infective Agents, Quinolone|anti-infective agents, quinolone
5852806|NCT00002249|Ofloxacin|ofloxacin
5852807|NCT00002249|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5848980|NCT00032396|AMD|amd
5852808|NCT00002248|Antidiarrheals|antidiarrheals
5852809|NCT00002248|Cryptosporidiosis|cryptosporidiosis
5852810|NCT00002248|Diarrhea|diarrhea
5852811|NCT00002248|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852812|NCT00002248|Cryptosporidium|cryptosporidium
5852813|NCT00002248|Immunization, Passive|immunization, passive
5852814|NCT00002247|Retinitis|retinitis
5852815|NCT00002247|Ganciclovir|ganciclovir
5852816|NCT00002247|Cytomegalovirus Infections|cytomegalovirus infections
5852817|NCT00002247|Administration, Oral|administration, oral
5852818|NCT00002247|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852819|NCT00002246|AIDS Dementia Complex|aids dementia complex
5852820|NCT00002246|Zidovudine|zidovudine
5852821|NCT00002246|Stavudine|stavudine
5852822|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852823|NCT00002245|Drug Therapy, Combination|drug therapy, combination
5852824|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors
5852825|NCT00002245|Lamivudine|lamivudine
5852826|NCT00002245|Carbohydrates|carbohydrates
5852827|NCT00002245|VX 478|vx 478
5852828|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852829|NCT00002245|Anti-HIV Agents|anti-hiv agents
5852830|NCT00002245|Lipids|lipids
5852831|NCT00002245|Insulin Resistance|insulin resistance
5852832|NCT00002245|abacavir|abacavir
5852833|NCT00002244|Placebos|placebos
5852834|NCT00002244|Infusions, Intravenous|infusions, intravenous
5852835|NCT00002244|Quality of Life|quality of life
5852836|NCT00002244|Anti-HIV Agents|anti-hiv agents
5852837|NCT00002244|tetrachlorodecaoxide|tetrachlorodecaoxide
5852838|NCT00002243|Anti-HIV Agents|anti-hiv agents
5852839|NCT00002241|Drug Therapy, Combination|drug therapy, combination
5852840|NCT00002241|Stavudine|stavudine
5852841|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors
5852842|NCT00002241|Ritonavir|ritonavir
5852843|NCT00002241|Lamivudine|lamivudine
5852844|NCT00002241|Indinavir|indinavir
5853039|NCT00002209|AIDS Dementia Complex|aids dementia complex
5852845|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852846|NCT00002241|Anti-HIV Agents|anti-hiv agents
5852847|NCT00002241|Viral Load|viral load
5852848|NCT00002240|Didanosine|didanosine
5852849|NCT00002240|Dose-Response Relationship, Drug|dose-response relationship, drug
5852850|NCT00002240|Drug Therapy, Combination|drug therapy, combination
5852851|NCT00002240|Stavudine|stavudine
5852852|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors
5852853|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852854|NCT00002240|Anti-HIV Agents|anti-hiv agents
5852855|NCT00002240|Nelfinavir|nelfinavir
5852856|NCT00002239|HIV-1|hiv-1
5852857|NCT00002239|Dose-Response Relationship, Drug|dose-response relationship, drug
5852858|NCT00002239|Drug Therapy, Combination|drug therapy, combination
5852859|NCT00002239|VX 478|vx 478
5852860|NCT00002239|Anti-HIV Agents|anti-hiv agents
5852861|NCT00002239|pentafuside|pentafuside
5852862|NCT00002239|abacavir|abacavir
5852863|NCT00002239|efavirenz|efavirenz
5852864|NCT00002238|Drug Therapy, Combination|drug therapy, combination
5852865|NCT00002238|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5852866|NCT00002238|AIDS-Related Complex|aids-related complex
5852867|NCT00002238|Zidovudine|zidovudine
5852868|NCT00002238|Interferon Type I|interferon type i
5852869|NCT00002237|Placebos|placebos
5852870|NCT00002237|Administration, Oral|administration, oral
5852871|NCT00002237|Anti-HIV Agents|anti-hiv agents
5852872|NCT00002237|Viral Load|viral load
5852873|NCT00002237|peldesine|peldesine
5852874|NCT00002236|Drug Therapy, Combination|drug therapy, combination
5852875|NCT00002236|Zidovudine|zidovudine
5852876|NCT00002236|Drug Administration Schedule|drug administration schedule
5852877|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors
5852878|NCT00002236|CD4 Lymphocyte Count|cd4 lymphocyte count
5852879|NCT00002236|Indinavir|indinavir
5852880|NCT00002236|Delavirdine|delavirdine
5852881|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852882|NCT00002236|Anti-HIV Agents|anti-hiv agents
5852883|NCT00002236|Viral Load|viral load
5852884|NCT00002235|Drug Therapy, Combination|drug therapy, combination
5852885|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors
5852886|NCT00002235|Indinavir|indinavir
5852887|NCT00002235|Nelfinavir|nelfinavir
5852888|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852889|NCT00002235|Anti-HIV Agents|anti-hiv agents
5852890|NCT00002235|efavirenz|efavirenz
5852891|NCT00002234|Drug Therapy, Combination|drug therapy, combination
5852892|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852893|NCT00002234|Anti-HIV Agents|anti-hiv agents
5852894|NCT00002233|Drug Therapy, Combination|drug therapy, combination
5852895|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors
5852896|NCT00002233|CD4 Lymphocyte Count|cd4 lymphocyte count
5848696|NCT00034021|female|female
5852897|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852898|NCT00002233|Anti-HIV Agents|anti-hiv agents
5852899|NCT00002233|Viral Load|viral load
5852900|NCT00002232|Injections, Intradermal|injections, intradermal
5852901|NCT00002232|Injections, Intramuscular|injections, intramuscular
5849039|NCT00031408|Specimen Handling|specimen handling
5852902|NCT00002232|HIV Antibodies|hiv antibodies
5852903|NCT00002232|Immunity, Cellular|immunity, cellular
5852904|NCT00002232|AIDS Vaccines|aids vaccines
5852905|NCT00002232|HIV Seronegativity|hiv seronegativity
5852906|NCT00002232|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5852907|NCT00002232|Vaccines, DNA|vaccines, dna
5852908|NCT00002232|Immunity, Mucosal|immunity, mucosal
5852909|NCT00002231|Injections, Intramuscular|injections, intramuscular
5852910|NCT00002231|HIV Antibodies|hiv antibodies
5852911|NCT00002231|Immunity, Cellular|immunity, cellular
5852912|NCT00002231|AIDS Vaccines|aids vaccines
5852913|NCT00002231|HIV Seronegativity|hiv seronegativity
5852914|NCT00002231|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5852915|NCT00002231|Vaccines, DNA|vaccines, dna
5852916|NCT00002230|Didanosine|didanosine
5852917|NCT00002230|Drug Therapy, Combination|drug therapy, combination
5852919|NCT00002230|Hydroxyurea|hydroxyurea
5852920|NCT00002230|Anti-HIV Agents|anti-hiv agents
5852921|NCT00002229|Drug Therapy, Combination|drug therapy, combination
5852922|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors
5852923|NCT00002229|Dosage Forms|dosage forms
5852924|NCT00002229|Saquinavir|saquinavir
5852925|NCT00002229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852926|NCT00002229|Anti-HIV Agents|anti-hiv agents
5852927|NCT00002228|Injections, Subcutaneous|injections, subcutaneous
5852928|NCT00002228|HIV-1|hiv-1
5852929|NCT00002228|Anti-HIV Agents|anti-hiv agents
5852930|NCT00002228|peptide T20|peptide t20
5852931|NCT00002227|Drug Therapy, Combination|drug therapy, combination
5852932|NCT00002227|Stavudine|stavudine
5852933|NCT00002227|Lamivudine|lamivudine
5852934|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852935|NCT00002227|efavirenz|efavirenz
5852936|NCT00002226|Skin Neoplasms|skin neoplasms
5852937|NCT00002226|Sarcoma, Kaposi|sarcoma, kaposi
5852938|NCT00002226|Antineoplastic Agents|antineoplastic agents
5852939|NCT00002225|Didanosine|didanosine
5852940|NCT00002225|Drug Therapy, Combination|drug therapy, combination
5852942|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852943|NCT00002225|efavirenz|efavirenz
5852944|NCT00002224|Didanosine|didanosine
5852945|NCT00002224|Drug Therapy, Combination|drug therapy, combination
5852946|NCT00002224|Drug Administration Schedule|drug administration schedule
5852947|NCT00002224|Stavudine|stavudine
5852948|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors
5852949|NCT00002224|Nelfinavir|nelfinavir
5852950|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5852951|NCT00002224|Anti-HIV Agents|anti-hiv agents
5852952|NCT00002224|Viral Load|viral load
5852953|NCT00002223|Drug Therapy, Combination|drug therapy, combination
5852954|NCT00002223|Adolescent Behavior|adolescent behavior
5852955|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors
5852956|NCT00002223|Ritonavir|ritonavir
5852957|NCT00002223|Indinavir|indinavir
5852958|NCT00002222|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5852959|NCT00002222|Ganciclovir|ganciclovir
5852960|NCT00002222|Antiviral Agents|antiviral agents
5852961|NCT00002222|Drug Administration Schedule|drug administration schedule
5853210|NCT00002184|Saquinavir|saquinavir
5852962|NCT00002222|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5852963|NCT00002222|Prodrugs|prodrugs
5852964|NCT00002221|Lymphoma, Non-Hodgkin|lymphoma, non-hodgkin
5852965|NCT00002221|Bone Marrow|bone marrow
5852966|NCT00002221|Lymphocyte Transformation|lymphocyte transformation
5852967|NCT00002221|HIV-1|hiv-1
5852968|NCT00002221|Retroviridae|retroviridae
5852969|NCT00002221|Lymphoma, AIDS-Related|lymphoma, aids-related
5852970|NCT00002221|Genetic Vectors|genetic vectors
5852971|NCT00002221|Transduction, Genetic|transduction, genetic
5852972|NCT00002221|Gene Transfer Techniques|gene transfer techniques
5852973|NCT00002220|Drug Resistance|drug resistance
5852974|NCT00002220|Drug Therapy, Combination|drug therapy, combination
5852975|NCT00002220|Antiviral Agents|antiviral agents
5852976|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors
5852977|NCT00002220|Indinavir|indinavir
5852978|NCT00002220|RNA, Viral|rna, viral
5852979|NCT00002220|Adenine|adenine
5852980|NCT00002220|efavirenz|efavirenz
5852981|NCT00002219|Dose-Response Relationship, Drug|dose-response relationship, drug
5852982|NCT00002219|Antiviral Agents|antiviral agents
5852983|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors
5852984|NCT00002219|Disease Progression|disease progression
5852985|NCT00002219|RNA, Viral|rna, viral
5852986|NCT00002219|Adenine|adenine
5852987|NCT00002219|Viral Load|viral load
5852988|NCT00002219|Age Factors|age factors
5852989|NCT00002219|Nelfinavir|nelfinavir
5852990|NCT00002218|HIV-1|hiv-1
5852991|NCT00002218|Dose-Response Relationship, Drug|dose-response relationship, drug
5852992|NCT00002218|Anti-HIV Agents|anti-hiv agents
5852993|NCT00002217|Drug Therapy, Combination|drug therapy, combination
5852994|NCT00002217|Patient Compliance|patient compliance
5852995|NCT00002217|Anti-HIV Agents|anti-hiv agents
5852996|NCT00002217|abacavir|abacavir
5852997|NCT00002216|Drug Therapy, Combination|drug therapy, combination
5852998|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors
5853000|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853001|NCT00002216|Anti-HIV Agents|anti-hiv agents
5853002|NCT00002216|abacavir|abacavir
5853003|NCT00002215|Drug Therapy, Combination|drug therapy, combination
5853004|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors
5853005|NCT00002215|RNA, Viral|rna, viral
5853006|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853007|NCT00002215|Viral Load|viral load
5853008|NCT00002215|Nelfinavir|nelfinavir
5853009|NCT00002215|Uracil|uracil
5853010|NCT00002214|Dose-Response Relationship, Drug|dose-response relationship, drug
5853011|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853012|NCT00002213|HIV-1|hiv-1
5853013|NCT00002213|Drug Therapy, Combination|drug therapy, combination
5853014|NCT00002213|Antiviral Agents|antiviral agents
5853015|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors
5853016|NCT00002213|RNA, Viral|rna, viral
5853018|NCT00002213|Anti-HIV Agents|anti-hiv agents
5853019|NCT00002213|abacavir|abacavir
5853020|NCT00002213|efavirenz|efavirenz
5853021|NCT00002212|Sarcoma, Kaposi|sarcoma, kaposi
5853022|NCT00002212|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853023|NCT00002212|Anticarcinogenic Agents|anticarcinogenic agents
5853024|NCT00002211|HIV-1|hiv-1
5853026|NCT00002211|Stavudine|stavudine
5853027|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors
5853028|NCT00002211|RNA, Viral|rna, viral
5853029|NCT00002211|Delavirdine|delavirdine
5853030|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853031|NCT00002211|Viral Load|viral load
5853032|NCT00002211|Nelfinavir|nelfinavir
5853033|NCT00002210|HIV-1|hiv-1
5853034|NCT00002210|Drug Therapy, Combination|drug therapy, combination
5853036|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853037|NCT00002209|Dose-Response Relationship, Drug|dose-response relationship, drug
5853038|NCT00002209|Drug Therapy, Combination|drug therapy, combination
5853043|NCT00002209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853044|NCT00002208|HIV-1|hiv-1
5853045|NCT00002208|Drug Therapy, Combination|drug therapy, combination
5853046|NCT00002208|Zidovudine|zidovudine
5853047|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors
5853048|NCT00002208|Lamivudine|lamivudine
5853049|NCT00002208|Indinavir|indinavir
5853050|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853051|NCT00002207|Didanosine|didanosine
5853052|NCT00002207|Drug Therapy, Combination|drug therapy, combination
5853053|NCT00002207|Stavudine|stavudine
5853054|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853055|NCT00002206|HIV-1|hiv-1
5853056|NCT00002206|Adenine|adenine
5853057|NCT00002206|Anti-HIV Agents|anti-hiv agents
5853058|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors
5853059|NCT00002205|VX 478|vx 478
5853060|NCT00002205|Anti-HIV Agents|anti-hiv agents
5853061|NCT00002205|abacavir|abacavir
5853062|NCT00002204|Reference Values|reference values
5853063|NCT00002204|Placebos|placebos
5853064|NCT00002204|AIDS Vaccines|aids vaccines
5853065|NCT00002204|HIV Core Protein p24|hiv core protein p24
5853066|NCT00002204|HIV Seronegativity|hiv seronegativity
5853067|NCT00002204|MF59 oil emulsion|mf59 oil emulsion
5853068|NCT00002203|Drug Therapy, Combination|drug therapy, combination
5853069|NCT00002203|Zidovudine|zidovudine
5853070|NCT00002203|HIV Protease Inhibitors|hiv protease inhibitors
5853071|NCT00002203|CD4 Lymphocyte Count|cd4 lymphocyte count
5853072|NCT00002203|CD4-CD8 Ratio|cd4-cd8 ratio
5853073|NCT00002203|Lamivudine|lamivudine
5853074|NCT00002203|Patient Compliance|patient compliance
5853075|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853076|NCT00002203|Anti-HIV Agents|anti-hiv agents
5853077|NCT00002203|Viral Load|viral load
5853078|NCT00002202|HIV-1|hiv-1
5853079|NCT00002202|Drug Therapy, Combination|drug therapy, combination
5853080|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors
5853081|NCT00002202|Indinavir|indinavir
5853082|NCT00002202|RNA, Viral|rna, viral
5853083|NCT00002202|VX 478|vx 478
5853084|NCT00002202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853085|NCT00002202|Anti-HIV Agents|anti-hiv agents
5853086|NCT00002202|Viral Load|viral load
5853087|NCT00002201|Drug Therapy, Combination|drug therapy, combination
5853088|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors
5853089|NCT00002201|Ritonavir|ritonavir
5853090|NCT00002201|Nelfinavir|nelfinavir
5853091|NCT00002201|Anti-HIV Agents|anti-hiv agents
5853092|NCT00002200|HIV-1|hiv-1
5853093|NCT00002200|Administration, Oral|administration, oral
5853094|NCT00002200|CD4 Lymphocyte Count|cd4 lymphocyte count
5853095|NCT00002200|RNA, Viral|rna, viral
5853096|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853097|NCT00002200|Anti-HIV Agents|anti-hiv agents
5853098|NCT00002200|Viral Load|viral load
5853099|NCT00002200|abacavir|abacavir
5853100|NCT00002199|HIV-1|hiv-1
5853101|NCT00002199|Drug Therapy, Combination|drug therapy, combination
5853102|NCT00002199|Zidovudine|zidovudine
5853103|NCT00002199|Drug Resistance, Microbial|drug resistance, microbial
5853104|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors
5853105|NCT00002199|Lamivudine|lamivudine
5853106|NCT00002199|Indinavir|indinavir
5853107|NCT00002199|Genotype|genotype
5853108|NCT00002199|Phenotype|phenotype
5853109|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853110|NCT00002199|Anti-HIV Agents|anti-hiv agents
5853111|NCT00002199|abacavir|abacavir
5853112|NCT00002198|Drug Interactions|drug interactions
5853113|NCT00002198|Antiviral Agents|antiviral agents
5853114|NCT00002198|Ethanol|ethanol
5853115|NCT00002198|abacavir|abacavir
5853116|NCT00002197|HIV-1|hiv-1
5853117|NCT00002197|CD4 Lymphocyte Count|cd4 lymphocyte count
5853118|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853119|NCT00002197|Anti-HIV Agents|anti-hiv agents
5853120|NCT00002197|Viral Load|viral load
5853121|NCT00002197|abacavir|abacavir
5853122|NCT00002196|Dose-Response Relationship, Drug|dose-response relationship, drug
5853123|NCT00002196|Administration, Oral|administration, oral
5853124|NCT00002196|Drug Administration Schedule|drug administration schedule
5853125|NCT00002196|CD4 Lymphocyte Count|cd4 lymphocyte count
5853126|NCT00002196|Anti-HIV Agents|anti-hiv agents
5853127|NCT00002195|Drug Therapy, Combination|drug therapy, combination
5853128|NCT00002195|Zidovudine|zidovudine
5853130|NCT00002195|Lamivudine|lamivudine
5853131|NCT00002195|VX 478|vx 478
5853132|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853133|NCT00002195|Anti-HIV Agents|anti-hiv agents
5853134|NCT00002195|Viral Load|viral load
5853135|NCT00002194|Antibiotics, Macrolide|antibiotics, macrolide
5853136|NCT00002194|Clarithromycin|clarithromycin
5853137|NCT00002194|Nevirapine|nevirapine
5853138|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853139|NCT00002194|Cytochrome P-450|cytochrome p-450
5853140|NCT00002194|Anti-HIV Agents|anti-hiv agents
5853141|NCT00002193|HIV-1|hiv-1
5853142|NCT00002193|Drug Therapy, Combination|drug therapy, combination
5853143|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors
5853144|NCT00002193|RNA, Viral|rna, viral
5853146|NCT00002193|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853147|NCT00002193|Anti-HIV Agents|anti-hiv agents
5853148|NCT00002193|Viral Load|viral load
5853149|NCT00002192|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853150|NCT00002192|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853151|NCT00002192|Drug Therapy, Combination|drug therapy, combination
5853152|NCT00002192|Antitubercular Agents|antitubercular agents
5853153|NCT00002192|Azithromycin|azithromycin
5853154|NCT00002192|Clarithromycin|clarithromycin
5853155|NCT00002192|Bacteremia|bacteremia
5853156|NCT00002192|rifapentine|rifapentine
5853157|NCT00002191|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853158|NCT00002191|Placebos|placebos
5853159|NCT00002191|Protozoan Infections|protozoan infections
5853160|NCT00002191|Intestinal Diseases|intestinal diseases
5853161|NCT00002191|Albendazole|albendazole
5853162|NCT00002191|Microsporida|microsporida
5853163|NCT00002191|Anthelmintics|anthelmintics
5853164|NCT00002190|Drug Therapy, Combination|drug therapy, combination
5853165|NCT00002190|Zidovudine|zidovudine
5853166|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors
5853167|NCT00002190|Lamivudine|lamivudine
5853168|NCT00002190|Saquinavir|saquinavir
5853169|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853170|NCT00002190|Anti-HIV Agents|anti-hiv agents
5853171|NCT00002189|Sarcoma, Kaposi|sarcoma, kaposi
5853172|NCT00002189|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853173|NCT00002189|Paclitaxel|paclitaxel
5853174|NCT00002189|Treatment Outcome|treatment outcome
5853175|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic
5853176|NCT00002188|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853177|NCT00002188|Sarcoma, Kaposi|sarcoma, kaposi
5853178|NCT00002188|Antineoplastic Agents|antineoplastic agents
5853179|NCT00002187|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853180|NCT00002187|Antiviral Agents|antiviral agents
5853181|NCT00002187|Drug Administration Schedule|drug administration schedule
5853182|NCT00002187|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5853183|NCT00002187|fomivirsen|fomivirsen
5853184|NCT00002187|Vitreous Body|vitreous body
5853185|NCT00002186|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853186|NCT00002186|Herpes Simplex|herpes simplex
5853187|NCT00002186|Drug Therapy, Combination|drug therapy, combination
5849034|NCT00031473|RSV|rsv
5853188|NCT00002186|Acyclovir|acyclovir
5853189|NCT00002186|Antiviral Agents|antiviral agents
5853191|NCT00002186|SP 303|sp 303
5853192|NCT00002185|Skin Neoplasms|skin neoplasms
5853193|NCT00002185|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853194|NCT00002185|Sarcoma, Kaposi|sarcoma, kaposi
5853195|NCT00002185|Drug Therapy, Combination|drug therapy, combination
5853196|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors
5853197|NCT00002185|Mucous Membrane|mucous membrane
5853198|NCT00002185|Nelfinavir|nelfinavir
5853199|NCT00002185|Anti-HIV Agents|anti-hiv agents
5853200|NCT00002184|HIV-1|hiv-1
5853201|NCT00002184|Dose-Response Relationship, Drug|dose-response relationship, drug
5853202|NCT00002184|Drug Therapy, Combination|drug therapy, combination
5853203|NCT00002184|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853205|NCT00002184|Stavudine|stavudine
5853206|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors
5853207|NCT00002184|CD4 Lymphocyte Count|cd4 lymphocyte count
5853208|NCT00002184|Lamivudine|lamivudine
5853209|NCT00002184|RNA, Viral|rna, viral
5853211|NCT00002184|Nelfinavir|nelfinavir
5853212|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853213|NCT00002184|Adenine|adenine
5853214|NCT00002184|Anti-HIV Agents|anti-hiv agents
5853215|NCT00002184|Viral Load|viral load
5853216|NCT00002183|Drug Therapy, Combination|drug therapy, combination
5863095|NCT00001398|Hematopoiesis|hematopoiesis
5853217|NCT00002183|Drug Administration Schedule|drug administration schedule
5853218|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors
5853220|NCT00002183|Anti-HIV Agents|anti-hiv agents
5853221|NCT00002182|Placebos|placebos
5853222|NCT00002182|Appetite Stimulants|appetite stimulants
5853223|NCT00002182|Megestrol Acetate|megestrol acetate
5853224|NCT00002182|Failure to Thrive|failure to thrive
5853225|NCT00002181|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853226|NCT00002181|Herpes Simplex|herpes simplex
5853227|NCT00002181|Acyclovir|acyclovir
5853228|NCT00002181|Antiviral Agents|antiviral agents
5853229|NCT00002181|Gels|gels
5853230|NCT00002181|cidofovir|cidofovir
5853231|NCT00002180|Placebos|placebos
5853232|NCT00002180|Anti-HIV Agents|anti-hiv agents
5853233|NCT00002180|Adenine|adenine
5853234|NCT00002179|Semen|semen
5853235|NCT00002179|Monocytes|monocytes
5853236|NCT00002179|HIV-1|hiv-1
5853237|NCT00002179|Drug Therapy, Combination|drug therapy, combination
5853240|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors
5853244|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853245|NCT00002179|Anti-HIV Agents|anti-hiv agents
5853246|NCT00002179|Viral Load|viral load
5853247|NCT00002178|HIV-1|hiv-1
5853248|NCT00002178|Drug Therapy, Combination|drug therapy, combination
5853249|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors
5853250|NCT00002178|RNA, Viral|rna, viral
5853251|NCT00002178|Dosage Forms|dosage forms
5853252|NCT00002178|Saquinavir|saquinavir
5853253|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853254|NCT00002178|Anti-HIV Agents|anti-hiv agents
5853255|NCT00002178|Viral Load|viral load
5853256|NCT00002177|Pilot Projects|pilot projects
5853257|NCT00002177|HIV-1|hiv-1
5853258|NCT00002177|Didanosine|didanosine
5853259|NCT00002177|Drug Therapy, Combination|drug therapy, combination
5853260|NCT00002177|Stavudine|stavudine
5853261|NCT00002177|Hydroxyurea|hydroxyurea
5853262|NCT00002177|RNA, Viral|rna, viral
5853263|NCT00002177|Nelfinavir|nelfinavir
5853264|NCT00002177|Anti-HIV Agents|anti-hiv agents
5853265|NCT00002177|Viral Load|viral load
5853266|NCT00002176|Pilot Projects|pilot projects
5853267|NCT00002176|Didanosine|didanosine
5853268|NCT00002176|Drug Therapy, Combination|drug therapy, combination
5853269|NCT00002176|Stavudine|stavudine
5853270|NCT00002176|Hydroxyurea|hydroxyurea
5853271|NCT00002176|Nelfinavir|nelfinavir
5853272|NCT00002176|Anti-HIV Agents|anti-hiv agents
5853273|NCT00002176|Viral Load|viral load
5853274|NCT00002175|Cohort Studies|cohort studies
5853275|NCT00002175|RNA, Viral|rna, viral
5853276|NCT00002175|Administration, Cutaneous|administration, cutaneous
5853277|NCT00002175|Anti-HIV Agents|anti-hiv agents
5853278|NCT00002175|Dinitrobenzenes|dinitrobenzenes
5853279|NCT00002174|Adjuvants, Immunologic|adjuvants, immunologic
5853280|NCT00002174|Thalidomide|thalidomide
5853281|NCT00002174|Cytokines|cytokines
5853282|NCT00002174|Viral Load|viral load
5853283|NCT00002173|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853284|NCT00002173|AIDS Vaccines|aids vaccines
5853285|NCT00002173|CD4 Lymphocyte Count|cd4 lymphocyte count
5853286|NCT00002173|Salk HIV Immunogen|salk hiv immunogen
5853287|NCT00002172|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853288|NCT00002172|AIDS Vaccines|aids vaccines
5853289|NCT00002172|CD4 Lymphocyte Count|cd4 lymphocyte count
5853290|NCT00002172|Salk HIV Immunogen|salk hiv immunogen
5853291|NCT00002171|Placebos|placebos
5853292|NCT00002171|Drug Therapy, Combination|drug therapy, combination
5853293|NCT00002171|Stavudine|stavudine
5853294|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors
5853295|NCT00002171|Lamivudine|lamivudine
5853296|NCT00002171|Nelfinavir|nelfinavir
5853297|NCT00002171|Anti-HIV Agents|anti-hiv agents
5853298|NCT00002170|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853299|NCT00002170|Placebos|placebos
5853300|NCT00002170|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853301|NCT00002170|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853302|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors
5853303|NCT00002170|Nelfinavir|nelfinavir
5853304|NCT00002170|Anti-Infective Agents|anti-infective agents
5853305|NCT00002170|Anti-HIV Agents|anti-hiv agents
5853306|NCT00002169|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853308|NCT00002169|Antiviral Agents|antiviral agents
5853309|NCT00002169|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5853310|NCT00002169|Treatment Outcome|treatment outcome
5853311|NCT00002169|Nelfinavir|nelfinavir
5853312|NCT00002168|Didanosine|didanosine
5853313|NCT00002168|Drug Therapy, Combination|drug therapy, combination
5853314|NCT00002168|Zidovudine|zidovudine
5853315|NCT00002168|Stavudine|stavudine
5853316|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors
5853317|NCT00002168|CD4 Lymphocyte Count|cd4 lymphocyte count
5853318|NCT00002168|Lamivudine|lamivudine
5853319|NCT00002168|Indinavir|indinavir
5853320|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853321|NCT00002168|Anti-HIV Agents|anti-hiv agents
5853322|NCT00002168|Viral Load|viral load
5853323|NCT00002167|Skin Neoplasms|skin neoplasms
5853324|NCT00002167|Sarcoma, Kaposi|sarcoma, kaposi
5853325|NCT00002167|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853326|NCT00002167|Photochemotherapy|photochemotherapy
5853327|NCT00002167|tin etiopurpurin|tin etiopurpurin
5853328|NCT00002167|Radiation-Sensitizing Agents|radiation-sensitizing agents
5853329|NCT00002166|Nevirapine|nevirapine
5853330|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853332|NCT00002165|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853333|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors
5853334|NCT00002165|CD4 Lymphocyte Count|cd4 lymphocyte count
5853335|NCT00002165|Nelfinavir|nelfinavir
5853336|NCT00002165|Anti-HIV Agents|anti-hiv agents
5853337|NCT00002164|Biological Availability|biological availability
5853338|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors
5853339|NCT00002164|Dosage Forms|dosage forms
5853340|NCT00002164|Nelfinavir|nelfinavir
5853341|NCT00002163|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853342|NCT00002163|AIDS Dementia Complex|aids dementia complex
5853343|NCT00002163|Antiviral Agents|antiviral agents
5853344|NCT00002163|abacavir|abacavir
5853345|NCT00002162|Drug Therapy, Combination|drug therapy, combination
5853346|NCT00002162|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853347|NCT00002162|AIDS-Related Complex|aids-related complex
5853348|NCT00002162|Antiviral Agents|antiviral agents
5853349|NCT00002162|Saquinavir|saquinavir
5853350|NCT00002161|Drug Therapy, Combination|drug therapy, combination
5853351|NCT00002161|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853352|NCT00002161|AIDS-Related Complex|aids-related complex
5853353|NCT00002161|Antiviral Agents|antiviral agents
5853354|NCT00002161|Adenine|adenine
5853355|NCT00002160|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853356|NCT00002160|AIDS-Related Complex|aids-related complex
5853357|NCT00002160|Pain|pain
5853358|NCT00002160|Palliative Care|palliative care
5853359|NCT00002160|omega-conopeptide MVIIA|omega-conopeptide mviia
5853360|NCT00002160|Calcium Channel Blockers|calcium channel blockers
5853361|NCT00002159|Itraconazole|itraconazole
5853362|NCT00002159|Histoplasmosis|histoplasmosis
5853363|NCT00002159|Antifungal Agents|antifungal agents
5853364|NCT00002159|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853365|NCT00002159|Amphotericin B|amphotericin b
5853366|NCT00002159|AIDS-Related Complex|aids-related complex
5853367|NCT00002159|Blastomycosis|blastomycosis
5853368|NCT00002159|Antibiotics, Antifungal|antibiotics, antifungal
5853369|NCT00002158|Cryptosporidiosis|cryptosporidiosis
5853370|NCT00002158|Diarrhea|diarrhea
5853371|NCT00002158|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853372|NCT00002158|nitazoxanide|nitazoxanide
5853373|NCT00002158|Antiparasitic Agents|antiparasitic agents
5853374|NCT00002157|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853375|NCT00002157|Cachexia|cachexia
5853376|NCT00002157|Thalidomide|thalidomide
5853377|NCT00002156|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853378|NCT00002156|Ganciclovir|ganciclovir
5853379|NCT00002156|Drug Therapy, Combination|drug therapy, combination
5853380|NCT00002156|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853381|NCT00002156|Antiviral Agents|antiviral agents
5853382|NCT00002156|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5853383|NCT00002156|Injections|injections
5853384|NCT00002155|Drug Therapy, Combination|drug therapy, combination
5853385|NCT00002155|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853386|NCT00002155|Antiviral Agents|antiviral agents
5853387|NCT00002155|Zidovudine|zidovudine
5853388|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors
5853389|NCT00002155|Lamivudine|lamivudine
5853390|NCT00002155|Indinavir|indinavir
5853391|NCT00002154|Drug Therapy, Combination|drug therapy, combination
5853392|NCT00002154|Cognition Disorders|cognition disorders
5853393|NCT00002154|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853394|NCT00002154|AIDS-Related Complex|aids-related complex
5853395|NCT00002154|Thioctic Acid|thioctic acid
5853396|NCT00002154|Selegiline|selegiline
5853397|NCT00002153|Skin Neoplasms|skin neoplasms
5853398|NCT00002153|Sarcoma, Kaposi|sarcoma, kaposi
5853399|NCT00002153|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853400|NCT00002153|Antineoplastic Agents|antineoplastic agents
5853401|NCT00002152|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853402|NCT00002152|Antiviral Agents|antiviral agents
5853403|NCT00002151|Drug Therapy, Combination|drug therapy, combination
5853404|NCT00002151|AIDS-Related Complex|aids-related complex
5853405|NCT00002151|Zidovudine|zidovudine
5853406|NCT00002151|MDL 28574|mdl 28574
5853407|NCT00002150|Drug Therapy, Combination|drug therapy, combination
5853408|NCT00002150|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853409|NCT00002150|AIDS-Related Complex|aids-related complex
5853410|NCT00002150|Zidovudine|zidovudine
5853411|NCT00002150|MDL 28574|mdl 28574
5853412|NCT00002149|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853413|NCT00002149|Drug Therapy, Combination|drug therapy, combination
5853414|NCT00002149|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853416|NCT00002149|Sinusitis|sinusitis
5853417|NCT00002149|Ephedrine|ephedrine
5853418|NCT00002149|Acupuncture Therapy|acupuncture therapy
5853419|NCT00002149|Drugs, Chinese Herbal|drugs, chinese herbal
5853420|NCT00002149|Medicine, Chinese Traditional|medicine, chinese traditional
5853421|NCT00002149|Drug Combinations|drug combinations
5853422|NCT00002149|Antibiotics, Combined|antibiotics, combined
5853423|NCT00002149|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination
5853424|NCT00002148|Cognition Disorders|cognition disorders
5853425|NCT00002148|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853426|NCT00002148|AIDS-Related Complex|aids-related complex
5853427|NCT00002148|Free Radical Scavengers|free radical scavengers
5853793|NCT00002068|Flucytosine|flucytosine
5853428|NCT00002148|Antioxidants|antioxidants
5853429|NCT00002148|OPC 14117|opc 14117
5853430|NCT00002147|Sarcoma, Kaposi|sarcoma, kaposi
5853433|NCT00002147|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853434|NCT00002147|Drug Carriers|drug carriers
5853435|NCT00002146|Infusions, Intravenous|infusions, intravenous
5853436|NCT00002146|Foscarnet|foscarnet
5853437|NCT00002146|Cytomegalovirus Infections|cytomegalovirus infections
5853438|NCT00002146|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853439|NCT00002146|Magnesium Sulfate|magnesium sulfate
5853440|NCT00002146|Magnesium Deficiency|magnesium deficiency
5853441|NCT00002146|Hypocalcemia|hypocalcemia
5853442|NCT00002145|Foscarnet|foscarnet
5853443|NCT00002145|Cytomegalovirus Infections|cytomegalovirus infections
5853444|NCT00002145|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853445|NCT00002144|Herpes Simplex|herpes simplex
5853446|NCT00002144|Foscarnet|foscarnet
5853447|NCT00002144|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853448|NCT00002143|Psoriasis|psoriasis
5853449|NCT00002143|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853450|NCT00002143|AIDS-Related Complex|aids-related complex
5853451|NCT00002143|Acitretin|acitretin
5853452|NCT00002142|Retinitis|retinitis
5853453|NCT00002142|Probenecid|probenecid
5853454|NCT00002142|Drug Therapy, Combination|drug therapy, combination
5853455|NCT00002142|Cytomegalovirus Infections|cytomegalovirus infections
5853456|NCT00002142|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853457|NCT00002142|Antiviral Agents|antiviral agents
5853458|NCT00002142|cidofovir|cidofovir
5853459|NCT00002141|Biological Availability|biological availability
5853460|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5853461|NCT00002141|Food-Drug Interactions|food-drug interactions
5853462|NCT00002141|abacavir|abacavir
5853463|NCT00002140|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853464|NCT00002140|Drug Therapy, Combination|drug therapy, combination
5853465|NCT00002140|Ethambutol|ethambutol
5853466|NCT00002140|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853467|NCT00002140|Azithromycin|azithromycin
5853468|NCT00002140|Clarithromycin|clarithromycin
5853469|NCT00002139|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853470|NCT00002139|Azithromycin|azithromycin
5853471|NCT00002139|Bacterial Infections|bacterial infections
5853472|NCT00002138|Neoplasms|neoplasms
5853473|NCT00002138|Sarcoma, Kaposi|sarcoma, kaposi
5853474|NCT00002138|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853475|NCT00002138|Antineoplastic Agents|antineoplastic agents
5853476|NCT00002138|tecogalan|tecogalan
5853477|NCT00002137|Neoplasms|neoplasms
5853478|NCT00002137|Sarcoma, Kaposi|sarcoma, kaposi
5853479|NCT00002137|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5849391|NCT00029653|HV|hv
5853480|NCT00002137|Antineoplastic Agents|antineoplastic agents
5853481|NCT00002137|tecogalan|tecogalan
5853482|NCT00002136|Neoplasms|neoplasms
5853483|NCT00002136|Sarcoma, Kaposi|sarcoma, kaposi
5853484|NCT00002136|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853485|NCT00002136|Antineoplastic Agents|antineoplastic agents
5853486|NCT00002136|tecogalan|tecogalan
5853487|NCT00002135|Retinitis|retinitis
5853488|NCT00002135|Ganciclovir|ganciclovir
5853489|NCT00002135|Administration, Oral|administration, oral
5853490|NCT00002135|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853491|NCT00002134|Retinitis|retinitis
5853492|NCT00002134|Ganciclovir|ganciclovir
5853493|NCT00002134|Administration, Oral|administration, oral
5853494|NCT00002134|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853495|NCT00002133|Itraconazole|itraconazole
5853496|NCT00002133|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853497|NCT00002133|AIDS-Related Complex|aids-related complex
5853498|NCT00002133|Candidiasis, Oral|candidiasis, oral
5853499|NCT00002132|Itraconazole|itraconazole
5853500|NCT00002132|Fluconazole|fluconazole
5853501|NCT00002132|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853502|NCT00002132|Candidiasis|candidiasis
5853503|NCT00002132|Immunocompromised Host|immunocompromised host
5853504|NCT00002131|Sarcoma, Kaposi|sarcoma, kaposi
5863156|NCT00001367|Healthy Volunteer|healthy volunteer
5853505|NCT00002131|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853506|NCT00002131|Antiviral Agents|antiviral agents
5853507|NCT00002131|vesnarinone|vesnarinone
5853508|NCT00002130|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853509|NCT00002130|Antiviral Agents|antiviral agents
5853510|NCT00002130|vesnarinone|vesnarinone
5853512|NCT00002128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853513|NCT00002128|AIDS-Related Complex|aids-related complex
5853514|NCT00002128|Antiviral Agents|antiviral agents
5853516|NCT00002127|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853517|NCT00002127|Cachexia|cachexia
5853518|NCT00002127|Thalidomide|thalidomide
5853519|NCT00002126|Neutropenia|neutropenia
5853520|NCT00002126|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5853521|NCT00002126|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853522|NCT00002125|Retinitis|retinitis
5853523|NCT00002125|Infusions, Intravenous|infusions, intravenous
5853524|NCT00002125|Foscarnet|foscarnet
5853525|NCT00002125|Cytomegalovirus Infections|cytomegalovirus infections
5853526|NCT00002125|Administration, Oral|administration, oral
5853527|NCT00002125|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853528|NCT00002125|Fluid Therapy|fluid therapy
5853529|NCT00002124|Drug Therapy, Combination|drug therapy, combination
5853530|NCT00002124|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853531|NCT00002124|AIDS-Related Complex|aids-related complex
5853532|NCT00002124|Antiviral Agents|antiviral agents
5853533|NCT00002124|Zidovudine|zidovudine
5853534|NCT00002123|Didanosine|didanosine
5853535|NCT00002123|Drug Therapy, Combination|drug therapy, combination
5853536|NCT00002123|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853537|NCT00002123|AIDS-Related Complex|aids-related complex
5853538|NCT00002123|Antiviral Agents|antiviral agents
5853539|NCT00002122|Rifabutin|rifabutin
5853540|NCT00002122|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853541|NCT00002122|Mycoses|mycoses
5853542|NCT00002122|Drug Therapy, Combination|drug therapy, combination
5853543|NCT00002122|Fluconazole|fluconazole
5853544|NCT00002122|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853545|NCT00002122|Azithromycin|azithromycin
5853546|NCT00002121|Antidiarrheals|antidiarrheals
5853547|NCT00002121|Diarrhea|diarrhea
5853548|NCT00002121|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853549|NCT00002121|AIDS-Related Complex|aids-related complex
5853550|NCT00002121|N(1),N(14)-bis(ethyl)homospermine|n(1),n(14)-bis(ethyl)homospermine
5853551|NCT00002120|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5853552|NCT00002120|Trimetrexate|trimetrexate
5853553|NCT00002120|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853554|NCT00002120|Leucovorin|leucovorin
5853555|NCT00002120|Dapsone|dapsone
5853556|NCT00002120|Drug Therapy, Combination|drug therapy, combination
5853557|NCT00002120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853558|NCT00002119|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853559|NCT00002119|AIDS-Related Complex|aids-related complex
5853560|NCT00002119|Antiviral Agents|antiviral agents
5853561|NCT00002118|Zalcitabine|zalcitabine
5853562|NCT00002118|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853563|NCT00002118|AIDS-Related Complex|aids-related complex
5853564|NCT00002117|Zalcitabine|zalcitabine
5853565|NCT00002117|Drug Therapy, Combination|drug therapy, combination
5853566|NCT00002117|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853567|NCT00002117|AIDS-Related Complex|aids-related complex
5853568|NCT00002117|Zidovudine|zidovudine
5853569|NCT00002116|Herpes Simplex|herpes simplex
5849496|NCT00029302|HV|hv
5853570|NCT00002116|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853571|NCT00002116|Antiviral Agents|antiviral agents
5853572|NCT00002116|cidofovir|cidofovir
5853573|NCT00002115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853574|NCT00002115|Antiviral Agents|antiviral agents
5853575|NCT00002115|Adenine|adenine
5853576|NCT00002113|Meningitis|meningitis
5853577|NCT00002113|Cryptococcosis|cryptococcosis
5853578|NCT00002113|Drug Therapy, Combination|drug therapy, combination
5853579|NCT00002113|Fluconazole|fluconazole
5853580|NCT00002113|Flucytosine|flucytosine
5853581|NCT00002113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853582|NCT00002112|Nystatin|nystatin
5853583|NCT00002112|Fluconazole|fluconazole
5853584|NCT00002112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853585|NCT00002112|AIDS-Related Complex|aids-related complex
5853586|NCT00002112|Candidiasis, Oral|candidiasis, oral
5853587|NCT00002111|AIDS-Related Complex|aids-related complex
5853588|NCT00002111|Saquinavir|saquinavir
5853589|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors
5853590|NCT00002110|Drug Therapy, Combination|drug therapy, combination
5853591|NCT00002110|AIDS-Related Complex|aids-related complex
5853592|NCT00002110|Zidovudine|zidovudine
5853593|NCT00002110|Cysteamine|cysteamine
5853594|NCT00002109|Thymopentin|thymopentin
5853595|NCT00002109|Zalcitabine|zalcitabine
5853596|NCT00002109|Didanosine|didanosine
5853597|NCT00002109|Drug Therapy, Combination|drug therapy, combination
5853598|NCT00002109|Zidovudine|zidovudine
5853599|NCT00002109|Stavudine|stavudine
5853600|NCT00002108|Drug Therapy, Combination|drug therapy, combination
5853601|NCT00002108|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853602|NCT00002108|AIDS-Related Complex|aids-related complex
5853603|NCT00002108|Antiviral Agents|antiviral agents
5853604|NCT00002108|Zidovudine|zidovudine
5853605|NCT00002107|Interleukin-2|interleukin-2
5853606|NCT00002107|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853607|NCT00002107|AIDS-Related Complex|aids-related complex
5853608|NCT00002106|Ranitidine|ranitidine
5853609|NCT00002105|Vincristine|vincristine
5853610|NCT00002105|Sarcoma, Kaposi|sarcoma, kaposi
5853611|NCT00002105|Liposomes|liposomes
5853612|NCT00002105|Doxorubicin|doxorubicin
5853613|NCT00002105|Drug Therapy, Combination|drug therapy, combination
5853614|NCT00002105|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853615|NCT00002105|Bleomycin|bleomycin
5853616|NCT00002105|Drug Carriers|drug carriers
5853617|NCT00002104|Mycobacterium tuberculosis|mycobacterium tuberculosis
5856699|NCT00000733|Ribavirin|ribavirin
5853618|NCT00002104|Mycobacterium Infections|mycobacterium infections
5853619|NCT00002104|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853620|NCT00002104|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853621|NCT00002104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853622|NCT00002104|AIDS-Related Complex|aids-related complex
5853623|NCT00002104|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5853624|NCT00002104|Thalidomide|thalidomide
5853625|NCT00002103|Trimetrexate|trimetrexate
5853626|NCT00002103|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853627|NCT00002103|Leucovorin|leucovorin
5853628|NCT00002103|Drug Therapy, Combination|drug therapy, combination
5853629|NCT00002103|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853630|NCT00002102|Trimetrexate|trimetrexate
5853631|NCT00002102|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853632|NCT00002102|Leucovorin|leucovorin
5853633|NCT00002102|Drug Therapy, Combination|drug therapy, combination
5853634|NCT00002102|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853635|NCT00002101|Rifabutin|rifabutin
5853636|NCT00002101|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853637|NCT00002101|Drug Therapy, Combination|drug therapy, combination
5853638|NCT00002101|Ethambutol|ethambutol
5853639|NCT00002101|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853640|NCT00002101|Clarithromycin|clarithromycin
5853641|NCT00002100|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853642|NCT00002100|AIDS-Related Complex|aids-related complex
5853643|NCT00002100|curdlan sulfate|curdlan sulfate
5853644|NCT00002099|Didanosine|didanosine
5853645|NCT00002099|Drug Therapy, Combination|drug therapy, combination
5853646|NCT00002099|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853647|NCT00002099|AIDS-Related Complex|aids-related complex
5853648|NCT00002099|Lentinan|lentinan
5853649|NCT00002098|Didanosine|didanosine
5853650|NCT00002098|Drug Therapy, Combination|drug therapy, combination
5853651|NCT00002098|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853652|NCT00002098|AIDS-Related Complex|aids-related complex
5853653|NCT00002098|Lentinan|lentinan
5853654|NCT00002097|Nystatin|nystatin
5853655|NCT00002097|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853656|NCT00002097|AIDS-Related Complex|aids-related complex
5853657|NCT00002096|Didanosine|didanosine
5853658|NCT00002096|Ganciclovir|ganciclovir
5853659|NCT00002096|Drug Interactions|drug interactions
5853660|NCT00002096|Cytomegalovirus Infections|cytomegalovirus infections
5853661|NCT00002096|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853662|NCT00002096|Zidovudine|zidovudine
5853663|NCT00002095|Ganciclovir|ganciclovir
5853664|NCT00002095|Cytomegalovirus Infections|cytomegalovirus infections
5853665|NCT00002095|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853666|NCT00002094|Virus Replication|virus replication
5853667|NCT00002094|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853668|NCT00002094|Antiviral Agents|antiviral agents
5853669|NCT00002093|Vincristine|vincristine
5853670|NCT00002093|Sarcoma, Kaposi|sarcoma, kaposi
5853671|NCT00002093|Liposomes|liposomes
5853672|NCT00002093|Doxorubicin|doxorubicin
5853673|NCT00002093|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853674|NCT00002093|Bleomycin|bleomycin
5853675|NCT00002093|Daunorubicin|daunorubicin
5853676|NCT00002093|Drug Carriers|drug carriers
5853677|NCT00002092|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853678|NCT00002092|AIDS-Related Complex|aids-related complex
5853679|NCT00002092|Cimetidine|cimetidine
5853680|NCT00002091|Pentoxifylline|pentoxifylline
5853681|NCT00002091|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853682|NCT00002091|AIDS-Related Complex|aids-related complex
5853683|NCT00002090|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853684|NCT00002090|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853685|NCT00002090|Azithromycin|azithromycin
5863157|NCT00001367|Nervous System Disease|nervous system disease
5853686|NCT00002089|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853687|NCT00002089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853688|NCT00002089|Azithromycin|azithromycin
5853690|NCT00002088|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853691|NCT00002088|AIDS-Related Complex|aids-related complex
5853692|NCT00002088|Saccharomyces|saccharomyces
5853693|NCT00002087|Recombinant Proteins|recombinant proteins
5853694|NCT00002087|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853695|NCT00002087|Antigens, CD4|antigens, cd4
5853696|NCT00002087|AIDS-Related Complex|aids-related complex
5853697|NCT00002086|Zalcitabine|zalcitabine
5853698|NCT00002086|Drug Therapy, Combination|drug therapy, combination
5853699|NCT00002086|AIDS-Related Complex|aids-related complex
5853700|NCT00002086|Zidovudine|zidovudine
5853701|NCT00002086|Interferon-alpha|interferon-alpha
5853702|NCT00002085|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853703|NCT00002085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853704|NCT00002085|Azithromycin|azithromycin
5857246|NCT00000646|Cachexia|cachexia
5853705|NCT00002085|Mycobacterium Infections, Atypical|mycobacterium infections, atypical
5853706|NCT00002084|Acyclovir|acyclovir
5853707|NCT00002084|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853708|NCT00002084|AIDS-Related Complex|aids-related complex
5853709|NCT00002084|Antiviral Agents|antiviral agents
5853710|NCT00002084|Anus Diseases|anus diseases
5853711|NCT00002084|Herpes Genitalis|herpes genitalis
5853712|NCT00002083|Peptide T|peptide t
5853713|NCT00002083|HIV-1|hiv-1
5853714|NCT00002083|Administration, Intranasal|administration, intranasal
5853715|NCT00002083|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853716|NCT00002083|Peripheral Nervous System Diseases|peripheral nervous system diseases
5853717|NCT00002082|Cryptosporidiosis|cryptosporidiosis
5853718|NCT00002082|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853719|NCT00002082|Azithromycin|azithromycin
5853720|NCT00002081|Zalcitabine|zalcitabine
5853721|NCT00002081|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853722|NCT00002081|AIDS-Related Complex|aids-related complex
5853723|NCT00002081|Zidovudine|zidovudine
5853724|NCT00002080|Rifabutin|rifabutin
5853725|NCT00002080|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853726|NCT00002080|AIDS-Related Complex|aids-related complex
5853727|NCT00002080|Mycobacterium avium Complex|mycobacterium avium complex
5853728|NCT00002080|Bacteremia|bacteremia
5853729|NCT00002079|Zidovudine|zidovudine
5853730|NCT00002079|1-Deoxynojirimycin|1-deoxynojirimycin
5853731|NCT00002078|Drug Evaluation|drug evaluation
5853732|NCT00002078|Interferon-alpha|interferon-alpha
5853733|NCT00002077|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853734|NCT00002077|Meningitis|meningitis
5853735|NCT00002077|Injections, Intravenous|injections, intravenous
5853736|NCT00002077|Cryptococcosis|cryptococcosis
5853737|NCT00002077|Fluconazole|fluconazole
5853738|NCT00002077|Administration, Oral|administration, oral
5853739|NCT00002077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853740|NCT00002076|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853741|NCT00002076|Meningitis|meningitis
5853742|NCT00002076|Cryptococcosis|cryptococcosis
5853743|NCT00002076|Fluconazole|fluconazole
5853744|NCT00002076|Administration, Oral|administration, oral
5853745|NCT00002076|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853746|NCT00002075|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853747|NCT00002075|Meningitis|meningitis
5849733|NCT00028197|HV|hv
5853748|NCT00002075|Cryptococcosis|cryptococcosis
5853749|NCT00002075|Drug Therapy, Combination|drug therapy, combination
5853750|NCT00002075|Fluconazole|fluconazole
5853751|NCT00002075|Flucytosine|flucytosine
5853752|NCT00002075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853753|NCT00002075|Amphotericin B|amphotericin b
5853754|NCT00002074|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853755|NCT00002074|Meningitis|meningitis
5853756|NCT00002074|Cryptococcosis|cryptococcosis
5853757|NCT00002074|Fluconazole|fluconazole
5853758|NCT00002074|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5850130|NCT00026598|HV|hv
5853759|NCT00002074|Amphotericin B|amphotericin b
5853760|NCT00002073|Recombinant Proteins|recombinant proteins
5853761|NCT00002073|Injections, Subcutaneous|injections, subcutaneous
5853762|NCT00002073|Erythropoietin|erythropoietin
5853763|NCT00002073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853764|NCT00002073|Anemia|anemia
5853765|NCT00002073|Zidovudine|zidovudine
5853766|NCT00002072|Recombinant Proteins|recombinant proteins
5853767|NCT00002072|Erythropoietin|erythropoietin
5853768|NCT00002072|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853769|NCT00002072|Anemia|anemia
5853770|NCT00002072|Zidovudine|zidovudine
5853771|NCT00002071|Recombinant Proteins|recombinant proteins
5853772|NCT00002071|Erythropoietin|erythropoietin
5853773|NCT00002071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853774|NCT00002071|Anemia|anemia
5853775|NCT00002071|Zidovudine|zidovudine
5853776|NCT00002070|Recombinant Proteins|recombinant proteins
5853777|NCT00002070|Retinitis|retinitis
5853778|NCT00002070|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853780|NCT00002070|Ganciclovir|ganciclovir
5853781|NCT00002070|Drug Therapy, Combination|drug therapy, combination
5853782|NCT00002070|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5853783|NCT00002070|Cytomegalovirus Infections|cytomegalovirus infections
5853784|NCT00002070|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853785|NCT00002069|Ditiocarb|ditiocarb
5853786|NCT00002069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853787|NCT00002069|AIDS-Related Complex|aids-related complex
5853788|NCT00002068|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853789|NCT00002068|Meningitis|meningitis
5853790|NCT00002068|Cryptococcosis|cryptococcosis
5853791|NCT00002068|Drug Therapy, Combination|drug therapy, combination
5853792|NCT00002068|Fluconazole|fluconazole
5853794|NCT00002068|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853795|NCT00002068|Amphotericin B|amphotericin b
5853796|NCT00002067|Body Weight|body weight
5853797|NCT00002067|T-Lymphocytes|t-lymphocytes
5853798|NCT00002067|Nutritional Status|nutritional status
5853799|NCT00002067|Megestrol|megestrol
5853800|NCT00002067|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853801|NCT00002067|Anorexia|anorexia
5853802|NCT00002067|Cachexia|cachexia
5853803|NCT00002067|Energy Intake|energy intake
5853804|NCT00002066|Thymopentin|thymopentin
5853805|NCT00002066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853921|NCT00002042|Erythropoietin|erythropoietin
5853806|NCT00002065|Delayed-Action Preparations|delayed-action preparations
5853807|NCT00002065|Disulfiram|disulfiram
5853808|NCT00002065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853809|NCT00002065|AIDS-Related Complex|aids-related complex
5853810|NCT00002064|Sulfonamides|sulfonamides
5853811|NCT00002064|Toxoplasmosis|toxoplasmosis
5853812|NCT00002064|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853813|NCT00002064|Pyrimethamine|pyrimethamine
5853814|NCT00002064|Drug Therapy, Combination|drug therapy, combination
5853815|NCT00002064|Encephalitis|encephalitis
5853816|NCT00002064|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853817|NCT00002064|Clindamycin|clindamycin
5853818|NCT00002063|Immune Tolerance|immune tolerance
5853819|NCT00002063|AIDS-Related Complex|aids-related complex
5853820|NCT00002063|Zidovudine|zidovudine
5853821|NCT00002062|Spiramycin|spiramycin
5853822|NCT00002062|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853823|NCT00002062|Immune Tolerance|immune tolerance
5853824|NCT00002062|Cryptosporidiosis|cryptosporidiosis
5853825|NCT00002062|Diarrhea|diarrhea
5853826|NCT00002062|Drugs, Investigational|drugs, investigational
5853827|NCT00002062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853828|NCT00002061|T-Lymphocytes|t-lymphocytes
5853829|NCT00002061|Immune Tolerance|immune tolerance
5853830|NCT00002061|Inosine Pranobex|inosine pranobex
5853831|NCT00002061|Killer Cells|killer cells
5853832|NCT00002061|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5853833|NCT00002061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853834|NCT00002061|AIDS-Related Complex|aids-related complex
5853835|NCT00002060|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853836|NCT00002060|Inosine Pranobex|inosine pranobex
5853837|NCT00002060|Homosexuality|homosexuality
5853838|NCT00002060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853839|NCT00002060|AIDS-Related Complex|aids-related complex
5853840|NCT00002059|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
5853841|NCT00002059|Neoplasms|neoplasms
5853842|NCT00002059|Inosine Pranobex|inosine pranobex
5853843|NCT00002059|Killer Cells|killer cells
5853844|NCT00002059|T-Lymphocytes, Helper-Inducer|t-lymphocytes, helper-inducer
5853845|NCT00002059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853846|NCT00002059|AIDS-Related Complex|aids-related complex
5853847|NCT00002058|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853848|NCT00002058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853849|NCT00002058|Clofazimine|clofazimine
5853850|NCT00002058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853851|NCT00002057|Nystatin|nystatin
5853852|NCT00002057|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853853|NCT00002057|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853854|NCT00002057|AIDS-Related Complex|aids-related complex
5853855|NCT00002057|Candidiasis, Oral|candidiasis, oral
5853856|NCT00002056|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5853857|NCT00002056|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853858|NCT00002056|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853859|NCT00002056|Pentamidine|pentamidine
5853860|NCT00002056|Injections, Intravenous|injections, intravenous
5853861|NCT00002056|Administration, Oral|administration, oral
5853862|NCT00002056|Aerosols|aerosols
5853863|NCT00002056|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853864|NCT00002055|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853865|NCT00002055|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853867|NCT00002055|Dose-Response Relationship, Drug|dose-response relationship, drug
5853868|NCT00002055|Aerosols|aerosols
5853869|NCT00002055|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853870|NCT00002054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853871|NCT00002054|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853872|NCT00002054|Pentamidine|pentamidine
5853873|NCT00002054|Dose-Response Relationship, Drug|dose-response relationship, drug
5853874|NCT00002054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853875|NCT00002053|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853876|NCT00002053|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853877|NCT00002053|Pentamidine|pentamidine
5853878|NCT00002053|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853879|NCT00002052|Salmonella Infections|salmonella infections
5853880|NCT00002052|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853881|NCT00002052|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853885|NCT00002051|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853886|NCT00002050|Semen|semen
5853887|NCT00002050|Thymopentin|thymopentin
5853888|NCT00002050|Leukocytes, Mononuclear|leukocytes, mononuclear
5853889|NCT00002050|AIDS-Related Complex|aids-related complex
5853890|NCT00002049|Semen|semen
5853891|NCT00002049|Thymopentin|thymopentin
5853892|NCT00002049|Leukocytes, Mononuclear|leukocytes, mononuclear
5853893|NCT00002049|HIV Seropositivity|hiv seropositivity
5853894|NCT00002049|AIDS-Related Complex|aids-related complex
5853895|NCT00002048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853896|NCT00002048|Zidovudine|zidovudine
5853897|NCT00002047|Kidney Failure, Chronic|kidney failure, chronic
5853898|NCT00002047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853899|NCT00002047|AIDS-Related Complex|aids-related complex
5853900|NCT00002047|Zidovudine|zidovudine
5853901|NCT00002047|Renal Dialysis|renal dialysis
5853902|NCT00002046|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853903|NCT00002046|AIDS-Related Complex|aids-related complex
5853904|NCT00002046|Zidovudine|zidovudine
5853905|NCT00002045|Prospective Studies|prospective studies
5853906|NCT00002045|Zidovudine|zidovudine
5853907|NCT00002044|Pilot Projects|pilot projects
5853908|NCT00002044|Neuromuscular Diseases|neuromuscular diseases
5853909|NCT00002044|Drug Evaluation|drug evaluation
5853910|NCT00002044|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853911|NCT00002044|AIDS Dementia Complex|aids dementia complex
5853912|NCT00002044|AIDS-Related Complex|aids-related complex
5853913|NCT00002044|Zidovudine|zidovudine
5853914|NCT00002043|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853915|NCT00002043|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853916|NCT00002043|Leukoplakia, Oral|leukoplakia, oral
5853917|NCT00002043|Dapsone|dapsone
5853918|NCT00002043|AIDS-Related Complex|aids-related complex
5853919|NCT00002043|Candidiasis, Oral|candidiasis, oral
5853920|NCT00002042|Recombinant Proteins|recombinant proteins
5853922|NCT00002042|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853924|NCT00002042|AIDS-Related Complex|aids-related complex
5853925|NCT00002042|Zidovudine|zidovudine
5853926|NCT00002041|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853927|NCT00002041|Esophagitis|esophagitis
5853928|NCT00002041|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853929|NCT00002041|Amphotericin B|amphotericin b
5853930|NCT00002041|Candidiasis, Oral|candidiasis, oral
5853931|NCT00002040|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853932|NCT00002040|Meningitis|meningitis
5853933|NCT00002040|Injections, Intravenous|injections, intravenous
5853934|NCT00002040|Cryptococcosis|cryptococcosis
5853935|NCT00002040|Fluconazole|fluconazole
5853936|NCT00002040|Administration, Oral|administration, oral
5853937|NCT00002040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853938|NCT00002039|Retinitis|retinitis
5853939|NCT00002039|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853940|NCT00002039|Drug Therapy, Combination|drug therapy, combination
5853941|NCT00002039|Foscarnet|foscarnet
5853942|NCT00002039|Cytomegalovirus Infections|cytomegalovirus infections
5853943|NCT00002039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853944|NCT00002039|Antiviral Agents|antiviral agents
5853945|NCT00002039|Zidovudine|zidovudine
5853946|NCT00002038|Mycoses|mycoses
5853947|NCT00002038|Drugs, Investigational|drugs, investigational
5853948|NCT00002038|Fluconazole|fluconazole
5853949|NCT00002037|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853950|NCT00002037|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853951|NCT00002037|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5853952|NCT00002037|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853953|NCT00002036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853954|NCT00002036|AIDS-Related Complex|aids-related complex
5853955|NCT00002036|Immunization, Passive|immunization, passive
5853956|NCT00002035|Didanosine|didanosine
5853957|NCT00002035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853958|NCT00002035|AIDS-Related Complex|aids-related complex
5853960|NCT00002034|Retinitis|retinitis
5853961|NCT00002034|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853962|NCT00002034|Ganciclovir|ganciclovir
5853963|NCT00002034|Drug Interactions|drug interactions
5853964|NCT00002034|Cytomegalovirus Infections|cytomegalovirus infections
5853965|NCT00002034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853966|NCT00002034|Zidovudine|zidovudine
5853967|NCT00002033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853968|NCT00002033|AIDS-Related Complex|aids-related complex
5853969|NCT00002033|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5853970|NCT00002033|Zidovudine|zidovudine
5853971|NCT00002032|Rifabutin|rifabutin
5853972|NCT00002032|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853973|NCT00002032|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5853974|NCT00002032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857457|NCT00023049|Deafness|deafness
5853975|NCT00002032|Antitubercular Agents|antitubercular agents
5853976|NCT00002031|Langerhans Cells|langerhans cells
5853977|NCT00002031|Dinitrochlorobenzene|dinitrochlorobenzene
5853978|NCT00002031|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853979|NCT00002031|AIDS-Related Complex|aids-related complex
5853980|NCT00002030|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853981|NCT00002030|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5853982|NCT00002030|Pentamidine|pentamidine
5853983|NCT00002030|Aerosols|aerosols
5853984|NCT00002030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853985|NCT00002029|Weight Loss|weight loss
5853986|NCT00002029|Parenteral Nutrition, Total|parenteral nutrition, total
5853987|NCT00002029|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853988|NCT00002029|Liposyn|liposyn
5853989|NCT00002029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853990|NCT00002028|Didanosine|didanosine
5853991|NCT00002028|Drugs, Investigational|drugs, investigational
5853992|NCT00002028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5853993|NCT00002028|AIDS-Related Complex|aids-related complex
5853994|NCT00002028|Zidovudine|zidovudine
5853995|NCT00002027|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5853996|NCT00002027|Cryptosporidiosis|cryptosporidiosis
5853997|NCT00002027|Diarrhea|diarrhea
5853998|NCT00002027|diclazuril|diclazuril
5853999|NCT00002027|Coccidiostats|coccidiostats
5854000|NCT00002027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854001|NCT00002026|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854002|NCT00002026|Leukoplakia, Oral|leukoplakia, oral
5854003|NCT00002026|Herpesvirus 4, Human|herpesvirus 4, human
5854004|NCT00002026|Acyclovir|acyclovir
5854005|NCT00002026|AIDS-Related Complex|aids-related complex
5854006|NCT00002025|Retinitis|retinitis
5854007|NCT00002025|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854008|NCT00002025|Immune Tolerance|immune tolerance
5854009|NCT00002025|Injections, Intravenous|injections, intravenous
5854010|NCT00002025|Ganciclovir|ganciclovir
5854011|NCT00002025|Cytomegalovirus Infections|cytomegalovirus infections
5854012|NCT00002025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854013|NCT00002024|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854014|NCT00002024|Immune Tolerance|immune tolerance
5854015|NCT00002024|Ganciclovir|ganciclovir
5854016|NCT00002024|Drugs, Investigational|drugs, investigational
5854017|NCT00002024|Cytomegalovirus Infections|cytomegalovirus infections
5854018|NCT00002024|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854019|NCT00002023|Dose-Response Relationship, Drug|dose-response relationship, drug
5854020|NCT00002023|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854021|NCT00002023|AIDS-Related Complex|aids-related complex
5854022|NCT00002023|Zidovudine|zidovudine
5854023|NCT00002022|Recombinant Proteins|recombinant proteins
5854024|NCT00002022|Drugs, Investigational|drugs, investigational
5854025|NCT00002022|Erythropoietin|erythropoietin
5854026|NCT00002022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854027|NCT00002022|Anemia|anemia
5854028|NCT00002022|Zidovudine|zidovudine
5854029|NCT00002021|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854030|NCT00002021|Immune Tolerance|immune tolerance
5854031|NCT00002021|Injections, Intravenous|injections, intravenous
5854032|NCT00002021|Herpes Simplex|herpes simplex
5854033|NCT00002021|Immunity, Cellular|immunity, cellular
5854034|NCT00002021|Foscarnet|foscarnet
5854035|NCT00002021|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854036|NCT00002021|Antiviral Agents|antiviral agents
5854037|NCT00002020|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854038|NCT00002020|AIDS-Related Complex|aids-related complex
5854039|NCT00002020|Zidovudine|zidovudine
5854040|NCT00002019|Meningitis|meningitis
5854041|NCT00002019|Liposomes|liposomes
5854042|NCT00002019|Cryptococcosis|cryptococcosis
5854043|NCT00002019|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854044|NCT00002019|Amphotericin B|amphotericin b
5854045|NCT00002019|Chemistry, Pharmaceutical|chemistry, pharmaceutical
5854046|NCT00002018|Interferon Type I|interferon type i
5854047|NCT00002017|Polyethylene Glycols|polyethylene glycols
5854048|NCT00002017|Interleukin-2|interleukin-2
5854049|NCT00002016|Retinitis|retinitis
5854050|NCT00002016|Ganciclovir|ganciclovir
5854051|NCT00002016|Cytomegalovirus|cytomegalovirus
5854052|NCT00002016|Cytomegalovirus Infections|cytomegalovirus infections
5854053|NCT00002016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854054|NCT00002016|Antibodies, Monoclonal|antibodies, monoclonal
5854055|NCT00002015|Retinitis|retinitis
5854056|NCT00002015|Ganciclovir|ganciclovir
5854057|NCT00002015|Cytomegalovirus Infections|cytomegalovirus infections
5854058|NCT00002015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854059|NCT00002015|Immunocompromised Host|immunocompromised host
5854060|NCT00002014|Didanosine|didanosine
5854061|NCT00002014|Drug Evaluation|drug evaluation
5854062|NCT00002014|Zidovudine|zidovudine
5854063|NCT00002013|Drug Therapy, Combination|drug therapy, combination
5854064|NCT00002013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854065|NCT00002013|AIDS-Related Complex|aids-related complex
5854066|NCT00002013|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5854067|NCT00002013|Zidovudine|zidovudine
5854068|NCT00002012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854069|NCT00002012|AIDS-Related Complex|aids-related complex
5854070|NCT00002012|Interferon Type I, Recombinant|interferon type i, recombinant
5854071|NCT00002011|PUVA Therapy|puva therapy
5854072|NCT00002011|Methoxsalen|methoxsalen
5854073|NCT00002011|AIDS-Related Complex|aids-related complex
5854074|NCT00002010|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854075|NCT00002010|Meningitis|meningitis
5854076|NCT00002010|Fluconazole|fluconazole
5854077|NCT00002010|Coccidioidin|coccidioidin
5854078|NCT00002010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854079|NCT00002010|Coccidioidomycosis|coccidioidomycosis
5854080|NCT00002009|Leukopenia|leukopenia
5854081|NCT00002009|Drug Evaluation|drug evaluation
5854082|NCT00002009|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5854083|NCT00002008|Leukopenia|leukopenia
5854084|NCT00002008|Drug Evaluation|drug evaluation
5854085|NCT00002008|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5854086|NCT00002007|Leukopenia|leukopenia
5854087|NCT00002007|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5854088|NCT00002007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854089|NCT00002007|Zidovudine|zidovudine
5854090|NCT00002006|Neutropenia|neutropenia
5854091|NCT00002006|Drug Interactions|drug interactions
5854092|NCT00002006|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5854093|NCT00002006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854094|NCT00002006|Zidovudine|zidovudine
5854095|NCT00002005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854096|NCT00002005|Antigens, CD4|antigens, cd4
5854097|NCT00002005|AIDS-Related Complex|aids-related complex
5854098|NCT00002004|Recombinant Proteins|recombinant proteins
5854099|NCT00002004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854100|NCT00002004|Antigens, CD4|antigens, cd4
5854101|NCT00002004|AIDS-Related Complex|aids-related complex
5854102|NCT00002003|Mitoxantrone|mitoxantrone
5854103|NCT00002003|Lymphoma, Large-Cell|lymphoma, large-cell
5854104|NCT00002003|Etoposide|etoposide
5854105|NCT00002003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854106|NCT00002002|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854107|NCT00002002|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854108|NCT00002002|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854109|NCT00002002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854110|NCT00002001|Zalcitabine|zalcitabine
5850596|NCT00021632|Anti-HIV Agents|anti-hiv agents
5854111|NCT00002001|Didanosine|didanosine
5854112|NCT00002001|Drug Therapy, Combination|drug therapy, combination
5854113|NCT00002001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854114|NCT00002001|Zidovudine|zidovudine
5854115|NCT00002000|Acyclovir|acyclovir
5854116|NCT00002000|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854117|NCT00002000|AIDS-Related Complex|aids-related complex
5854118|NCT00002000|Antiviral Agents|antiviral agents
5854119|NCT00002000|Anus Diseases|anus diseases
5854120|NCT00002000|Herpes Genitalis|herpes genitalis
5854121|NCT00001999|Retinitis|retinitis
5854122|NCT00001999|Gamma-Globulins|gamma-globulins
5854123|NCT00001999|Ganciclovir|ganciclovir
5854124|NCT00001999|Drug Therapy, Combination|drug therapy, combination
5854125|NCT00001999|Cytomegalovirus Infections|cytomegalovirus infections
5854126|NCT00001999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854127|NCT00001999|Immunization, Passive|immunization, passive
5854128|NCT00001998|Nystatin|nystatin
5854129|NCT00001998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854130|NCT00001998|AIDS-Related Complex|aids-related complex
5854131|NCT00001997|Recombinant Proteins|recombinant proteins
5854132|NCT00001997|Polyethylene Glycols|polyethylene glycols
5854133|NCT00001997|Interleukin-2|interleukin-2
5854134|NCT00001997|Didanosine|didanosine
5854135|NCT00001997|Zidovudine|zidovudine
5854136|NCT00001996|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854137|NCT00001996|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854138|NCT00001996|Pentamidine|pentamidine
5854139|NCT00001996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854140|NCT00001996|atovaquone|atovaquone
5854141|NCT00001995|Rifabutin|rifabutin
5854142|NCT00001995|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854143|NCT00001995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854144|NCT00001994|Toxoplasmosis|toxoplasmosis
5854145|NCT00001994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854146|NCT00001994|Naphthoquinones|naphthoquinones
5854147|NCT00001994|Encephalitis|encephalitis
5854148|NCT00001994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854149|NCT00001993|Drug Therapy, Combination|drug therapy, combination
5854150|NCT00001993|Zidovudine|zidovudine
5854151|NCT00001992|Vaccines, Synthetic|vaccines, synthetic
5854152|NCT00001992|Drug Evaluation|drug evaluation
5854153|NCT00001992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854154|NCT00001992|AIDS Vaccines|aids vaccines
5854155|NCT00001991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854156|NCT00001991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854157|NCT00001991|Antifungal Agents|antifungal agents
5854158|NCT00001991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854159|NCT00001991|atovaquone|atovaquone
5854160|NCT00001990|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854161|NCT00001990|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854162|NCT00001990|Pentamidine|pentamidine
5854163|NCT00001990|Antifungal Agents|antifungal agents
5854164|NCT00001990|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854165|NCT00001990|atovaquone|atovaquone
5854166|NCT00001989|Trichosanthin|trichosanthin
5854167|NCT00001989|Drug Evaluation|drug evaluation
5854168|NCT00001989|Drug Therapy, Combination|drug therapy, combination
5854169|NCT00001989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854170|NCT00001989|AIDS-Related Complex|aids-related complex
5854171|NCT00001989|Antiviral Agents|antiviral agents
5854172|NCT00001989|Zidovudine|zidovudine
5854173|NCT00001137|Treatment Experienced|treatment experienced
5854174|NCT00001137|Treatment Naive|treatment naive
5854175|NCT00001137|Virus Replication|virus replication
5854176|NCT00001137|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854178|NCT00001137|Risk Factors|risk factors
5854179|NCT00001137|Incidence|incidence
5854180|NCT00001137|RNA, Viral|rna, viral
5854181|NCT00001137|Anti-HIV Agents|anti-hiv agents
5854182|NCT00001137|Viral Load|viral load
5854183|NCT00001137|Lipodystrophy|lipodystrophy
5854184|NCT00001137|Nervous System|nervous system
5854185|NCT00001137|Cardiovascular System|cardiovascular system
5854186|NCT00001137|Neurologic Symptoms|neurologic symptoms
5854187|NCT00001136|Injections, Intramuscular|injections, intramuscular
5854188|NCT00001136|HIV-1|hiv-1
5854189|NCT00001136|AIDS Vaccines|aids vaccines
5854190|NCT00001136|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5854191|NCT00001136|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5854192|NCT00001136|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5854193|NCT00001136|Gene Products, gag|gene products, gag
5854194|NCT00001136|HIV Seronegativity|hiv seronegativity
5854195|NCT00001136|Immunologic Memory|immunologic memory
5854196|NCT00001136|Antibodies, Viral|antibodies, viral
5854197|NCT00001136|Genetic Vectors|genetic vectors
5854198|NCT00001136|Gene Products, env|gene products, env
5854199|NCT00001136|Poxviridae|poxviridae
5854200|NCT00001136|HIV Preventive Vaccine|hiv preventive vaccine
5854201|NCT00001135|Placebos|placebos
5854202|NCT00001135|Pregnancy|pregnancy
5854203|NCT00001135|Pregnancy Complications, Infectious|pregnancy complications, infectious
5854204|NCT00001135|Nevirapine|nevirapine
5854205|NCT00001135|Disease Transmission, Vertical|disease transmission, vertical
5854206|NCT00001135|Labor|labor
5854207|NCT00001135|Anti-HIV Agents|anti-hiv agents
5854208|NCT00001133|Dose-Response Relationship, Drug|dose-response relationship, drug
5854209|NCT00001133|Drug Therapy, Combination|drug therapy, combination
5854210|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors
5854211|NCT00001133|Ritonavir|ritonavir
5854212|NCT00001133|Indinavir|indinavir
5854213|NCT00001133|Anti-HIV Agents|anti-hiv agents
5854214|NCT00001133|Pharmacokinetics|pharmacokinetics
5854215|NCT00001133|Treatment Experienced|treatment experienced
5854216|NCT00001132|Placebos|placebos
5854217|NCT00001132|HIV-1|hiv-1
5854218|NCT00001132|Drug Therapy, Combination|drug therapy, combination
5854219|NCT00001132|RNA, Viral|rna, viral
5854220|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854221|NCT00001132|Anti-HIV Agents|anti-hiv agents
5854223|NCT00001132|abacavir|abacavir
5854224|NCT00001131|Interleukin-2|interleukin-2
5854225|NCT00001131|Drug Therapy, Combination|drug therapy, combination
5854226|NCT00001131|Drug Administration Schedule|drug administration schedule
5854228|NCT00001131|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5854229|NCT00001131|Anti-HIV Agents|anti-hiv agents
5854230|NCT00001131|Treatment Experienced|treatment experienced
5854231|NCT00001130|Questionnaires|questionnaires
5854232|NCT00001130|Antibodies, Viral|antibodies, viral
5854233|NCT00001130|Emergency Service, Hospital|emergency service, hospital
5854234|NCT00001129|Drug Therapy, Combination|drug therapy, combination
5854235|NCT00001129|RNA, Viral|rna, viral
5854236|NCT00001129|Patient Compliance|patient compliance
5854237|NCT00001129|Anti-HIV Agents|anti-hiv agents
5854238|NCT00001129|Viral Load|viral load
5854239|NCT00001129|Reminder Systems|reminder systems
5854240|NCT00001129|Treatment Experienced|treatment experienced
5854241|NCT00001129|Treatment Naive|treatment naive
5854242|NCT00001128|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854243|NCT00001128|Cryptosporidiosis|cryptosporidiosis
5854244|NCT00001128|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854245|NCT00001128|Azithromycin|azithromycin
5854246|NCT00001128|Paromomycin|paromomycin
5854247|NCT00001128|Interleukin-12|interleukin-12
5854248|NCT00001125|Antibodies, Viral|antibodies, viral
5854249|NCT00001125|Chickenpox|chickenpox
5854250|NCT00001125|Chickenpox Vaccine|chickenpox vaccine
5854251|NCT00001122|Didanosine|didanosine
5854252|NCT00001122|Drug Therapy, Combination|drug therapy, combination
5854253|NCT00001122|Stavudine|stavudine
5854254|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors
5854255|NCT00001122|CD4 Lymphocyte Count|cd4 lymphocyte count
5854256|NCT00001122|Nelfinavir|nelfinavir
5854257|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854258|NCT00001122|Self Care|self care
5854259|NCT00001122|Anti-HIV Agents|anti-hiv agents
5854260|NCT00001122|Viral Load|viral load
5854261|NCT00001122|efavirenz|efavirenz
5854262|NCT00001122|Treatment Naive|treatment naive
5854263|NCT00001121|Placebos|placebos
5854264|NCT00001121|AIDS Vaccines|aids vaccines
5854265|NCT00001121|Follow-Up Studies|follow-up studies
5854266|NCT00001121|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5854267|NCT00001120|Prospective Studies|prospective studies
5854268|NCT00001120|Sarcoma, Kaposi|sarcoma, kaposi
5854269|NCT00001120|Herpesvirus 4, Human|herpesvirus 4, human
5854270|NCT00001120|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854271|NCT00001120|Cohort Studies|cohort studies
5854272|NCT00001120|Risk Factors|risk factors
5854273|NCT00001120|Lymphoma, AIDS-Related|lymphoma, aids-related
5854274|NCT00001120|Antibodies, Viral|antibodies, viral
5854275|NCT00001120|Lymphoproliferative Disorders|lymphoproliferative disorders
5854276|NCT00001120|Viral Load|viral load
5854277|NCT00001120|Herpesvirus, Kaposi Sarcoma-Associated|herpesvirus, kaposi sarcoma-associated
5854278|NCT00001120|Translocation (Genetics)|translocation (genetics)
5854279|NCT00001119|Immunity, Cellular|immunity, cellular
5854280|NCT00001119|Drug Therapy, Combination|drug therapy, combination
5854281|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors
5854282|NCT00001119|Antibody Formation|antibody formation
5854283|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854284|NCT00001119|Anti-HIV Agents|anti-hiv agents
5854285|NCT00001119|Viral Load|viral load
5850479|NCT00023569|TMS|tms
5854286|NCT00001119|Tetanus Toxoid|tetanus toxoid
5854287|NCT00001119|Case-Control Studies|case-control studies
5854288|NCT00001119|Hepatitis B Surface Antigens|hepatitis b surface antigens
5854289|NCT00001119|Acute Infection|acute infection
5854290|NCT00001118|Injections, Intravenous|injections, intravenous
5854291|NCT00001118|Injections, Subcutaneous|injections, subcutaneous
5854292|NCT00001118|Drug Therapy, Combination|drug therapy, combination
5854293|NCT00001118|HIV Protease Inhibitors|hiv protease inhibitors
5854294|NCT00001118|Membrane Fusion|membrane fusion
5854295|NCT00001118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854296|NCT00001118|Anti-HIV Agents|anti-hiv agents
5854298|NCT00001118|peptide T20|peptide t20
5854299|NCT00001117|HIV-1|hiv-1
5854300|NCT00001117|Drug Therapy, Combination|drug therapy, combination
5854301|NCT00001117|Hepatitis C|hepatitis c
5854302|NCT00001117|RNA, Viral|rna, viral
5854303|NCT00001117|Anti-HIV Agents|anti-hiv agents
5854304|NCT00001116|Tumor Necrosis Factor|tumor necrosis factor
5854305|NCT00001116|Interleukin-2|interleukin-2
5854306|NCT00001116|Immunity, Cellular|immunity, cellular
5854307|NCT00001116|Antiviral Agents|antiviral agents
5854308|NCT00001116|Interleukin-6|interleukin-6
5854309|NCT00001116|Receptors, Tumor Necrosis Factor|receptors, tumor necrosis factor
5854310|NCT00001115|Herpes Simplex|herpes simplex
5854311|NCT00001115|Acyclovir|acyclovir
5854312|NCT00001115|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854313|NCT00001114|Sarcoma, Kaposi|sarcoma, kaposi
5854314|NCT00001114|Didanosine|didanosine
5854315|NCT00001114|Drug Interactions|drug interactions
5854316|NCT00001114|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854317|NCT00001114|Interferon-alpha|interferon-alpha
5854318|NCT00001113|Interferon Alfa-2a|interferon alfa-2a
5854319|NCT00001113|Sarcoma, Kaposi|sarcoma, kaposi
5854320|NCT00001113|Dose-Response Relationship, Drug|dose-response relationship, drug
5854321|NCT00001113|Drug Evaluation|drug evaluation
5854322|NCT00001113|Drug Therapy, Combination|drug therapy, combination
5854323|NCT00001113|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854325|NCT00001113|Interferon Type I|interferon type i
5854326|NCT00001112|Monocytes|monocytes
5854327|NCT00001112|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5854328|NCT00001112|Injections, Subcutaneous|injections, subcutaneous
5854329|NCT00001112|Immune System|immune system
5854330|NCT00001112|Drug Evaluation|drug evaluation
5854331|NCT00001112|Drug Therapy, Combination|drug therapy, combination
5854332|NCT00001112|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854333|NCT00001112|Zidovudine|zidovudine
5854334|NCT00001112|Blood Bactericidal Activity|blood bactericidal activity
5854335|NCT00001111|Drug Therapy, Combination|drug therapy, combination
5854336|NCT00001111|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854337|NCT00001111|AIDS-Related Complex|aids-related complex
5854338|NCT00001111|Antiviral Agents|antiviral agents
5854339|NCT00001111|Zidovudine|zidovudine
5854340|NCT00001111|Nevirapine|nevirapine
5854341|NCT00001110|Lung|lung
5854344|NCT00001110|Anti-HIV Agents|anti-hiv agents
5854345|NCT00001110|Viral Load|viral load
5854346|NCT00001110|Bronchoalveolar Lavage Fluid|bronchoalveolar lavage fluid
5854347|NCT00001109|Monocytes|monocytes
5854348|NCT00001109|Flow Cytometry|flow cytometry
5854349|NCT00001109|HIV Seronegativity|hiv seronegativity
5854350|NCT00001109|Phenotype|phenotype
5854351|NCT00001109|Lymphocyte Subsets|lymphocyte subsets
5854352|NCT00001108|Dose-Response Relationship, Drug|dose-response relationship, drug
5854353|NCT00001108|Drug Therapy, Combination|drug therapy, combination
5854354|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors
5854355|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854356|NCT00001108|Salvage Therapy|salvage therapy
5854357|NCT00001108|Anti-HIV Agents|anti-hiv agents
5854358|NCT00001106|Pregnancy|pregnancy
5854359|NCT00001106|Pregnancy Complications, Infectious|pregnancy complications, infectious
5854360|NCT00001106|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
5854361|NCT00001106|Drug Evaluation|drug evaluation
5854362|NCT00001106|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854363|NCT00001106|Zidovudine|zidovudine
5854364|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal
5854365|NCT00001105|AIDS-Related Complex|aids-related complex
5854366|NCT00001105|Immunization, Passive|immunization, passive
5854367|NCT00001104|Sex Behavior|sex behavior
5854368|NCT00001104|T-Lymphocytes|t-lymphocytes
5854369|NCT00001104|HIV Antibodies|hiv antibodies
5854370|NCT00001104|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854371|NCT00001104|AIDS-Related Complex|aids-related complex
5854372|NCT00001104|Zidovudine|zidovudine
5854373|NCT00001104|Hemophilia A|hemophilia a
5854374|NCT00001103|Neuropsychological Tests|neuropsychological tests
5854375|NCT00001103|HIV-1|hiv-1
5854376|NCT00001103|RNA, Viral|rna, viral
5854377|NCT00001103|Anti-HIV Agents|anti-hiv agents
5854378|NCT00001103|Viral Load|viral load
5854379|NCT00001102|Drug Therapy, Combination|drug therapy, combination
5854380|NCT00001102|HIV Protease Inhibitors|hiv protease inhibitors
5854381|NCT00001102|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5850599|NCT00021554|HIV-1|hiv-1
5854382|NCT00001102|Body Composition|body composition
5854383|NCT00001102|Anti-HIV Agents|anti-hiv agents
5854384|NCT00001102|Cholesterol|cholesterol
5854385|NCT00001102|Triglycerides|triglycerides
5854386|NCT00001097|Drug Therapy, Combination|drug therapy, combination
5854387|NCT00001097|HIV Protease Inhibitors|hiv protease inhibitors
5854388|NCT00001097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854389|NCT00001097|Anti-HIV Agents|anti-hiv agents
5854390|NCT00001096|Vaccines, Synthetic|vaccines, synthetic
5854391|NCT00001096|HIV Antibodies|hiv antibodies
5854392|NCT00001096|HIV Antigens|hiv antigens
5854393|NCT00001096|HIV-1|hiv-1
5854395|NCT00001096|AIDS Vaccines|aids vaccines
5854396|NCT00001096|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5854397|NCT00001096|HIV Seronegativity|hiv seronegativity
5854398|NCT00001096|HIV Envelope Protein gp120|hiv envelope protein gp120
5854399|NCT00001096|Alum Compounds|alum compounds
5854400|NCT00001096|HIV Preventive Vaccine|hiv preventive vaccine
5854401|NCT00001095|Drug Therapy, Combination|drug therapy, combination
5854402|NCT00001095|Zidovudine|zidovudine
5854403|NCT00001095|Nevirapine|nevirapine
5854404|NCT00001095|Stavudine|stavudine
5854405|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors
5854406|NCT00001095|Lamivudine|lamivudine
5854407|NCT00001095|VX 478|vx 478
5854408|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854409|NCT00001095|Anti-HIV Agents|anti-hiv agents
5854410|NCT00001095|Viral Load|viral load
5854411|NCT00001094|HIV-1|hiv-1
5854412|NCT00001094|Drug Therapy, Combination|drug therapy, combination
5854413|NCT00001094|Zidovudine|zidovudine
5854414|NCT00001094|Lamivudine|lamivudine
5854415|NCT00001094|RNA, Viral|rna, viral
5854416|NCT00001094|Saquinavir|saquinavir
5854417|NCT00001094|Delavirdine|delavirdine
5854418|NCT00001094|Anti-HIV Agents|anti-hiv agents
5854420|NCT00001093|Immunity, Cellular|immunity, cellular
5854421|NCT00001093|Sexual Partners|sexual partners
5854422|NCT00001093|Treatment Outcome|treatment outcome
5854423|NCT00001093|Anti-HIV Agents|anti-hiv agents
5854424|NCT00001093|Viral Load|viral load
5854425|NCT00001093|Acute Infection|acute infection
5854426|NCT00001092|Semen|semen
5854427|NCT00001092|HIV-1|hiv-1
5854428|NCT00001092|Sexual Partners|sexual partners
5854429|NCT00001092|Drug Resistance, Microbial|drug resistance, microbial
5854430|NCT00001092|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5854431|NCT00001092|Saliva|saliva
5854432|NCT00001092|Blood|blood
5854433|NCT00001092|Cervix Uteri|cervix uteri
5854434|NCT00001092|Vagina|vagina
5854435|NCT00001092|Acute Infection|acute infection
5854436|NCT00001091|Drug Therapy, Combination|drug therapy, combination
5854437|NCT00001091|Nevirapine|nevirapine
5854438|NCT00001091|Stavudine|stavudine
5854439|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors
5854440|NCT00001091|Ritonavir|ritonavir
5854441|NCT00001091|Lamivudine|lamivudine
5854442|NCT00001091|Nelfinavir|nelfinavir
5854728|NCT00001046|HIV Preventive Vaccine|hiv preventive vaccine
5854443|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854444|NCT00001090|Reference Values|reference values
5854445|NCT00001090|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5854446|NCT00001090|AIDS Vaccines|aids vaccines
5854447|NCT00001090|HIV Seronegativity|hiv seronegativity
5854448|NCT00001090|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5854449|NCT00001090|HIV Preventive Vaccine|hiv preventive vaccine
5854450|NCT00001089|Prospective Studies|prospective studies
5854451|NCT00001089|HIV-1|hiv-1
5854452|NCT00001089|Cytomegalovirus|cytomegalovirus
5854453|NCT00001089|Cytomegalovirus Infections|cytomegalovirus infections
5854454|NCT00001089|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854455|NCT00001089|Anti-HIV Agents|anti-hiv agents
5854456|NCT00001089|Viral Load|viral load
5854457|NCT00001089|Multiple Organ Failure|multiple organ failure
5854458|NCT00001088|Injections, Intramuscular|injections, intramuscular
5854459|NCT00001088|AIDS Vaccines|aids vaccines
5854460|NCT00001088|HIV Seronegativity|hiv seronegativity
5854461|NCT00001088|Dose-Response Relationship, Immunologic|dose-response relationship, immunologic
5854462|NCT00001088|Fusion Proteins, gag-pol|fusion proteins, gag-pol
5854463|NCT00001088|Vaccines, DNA|vaccines, dna
5854464|NCT00001088|HIV Preventive Vaccine|hiv preventive vaccine
5854465|NCT00001087|Drug Therapy, Combination|drug therapy, combination
5854466|NCT00001087|Antiviral Agents|antiviral agents
5854467|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors
5854468|NCT00001087|Ritonavir|ritonavir
5854469|NCT00001087|Saquinavir|saquinavir
5854470|NCT00001087|Nelfinavir|nelfinavir
5854471|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854472|NCT00001087|Adenine|adenine
5854473|NCT00001087|Anti-HIV Agents|anti-hiv agents
5854474|NCT00001087|efavirenz|efavirenz
5854475|NCT00001086|Placebos|placebos
5854476|NCT00001086|HIV-1|hiv-1
5854477|NCT00001086|Drug Therapy, Combination|drug therapy, combination
5854478|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors
5854479|NCT00001086|Indinavir|indinavir
5854480|NCT00001086|RNA, Viral|rna, viral
5854481|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854482|NCT00001086|Anti-HIV Agents|anti-hiv agents
5854483|NCT00001086|Viral Load|viral load
5854484|NCT00001086|efavirenz|efavirenz
5854485|NCT00001085|HIV-1|hiv-1
5854486|NCT00001085|Drug Therapy, Combination|drug therapy, combination
5854487|NCT00001085|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854488|NCT00001085|Zidovudine|zidovudine
5854489|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors
5854490|NCT00001085|Lamivudine|lamivudine
5854491|NCT00001085|RNA, Viral|rna, viral
5854492|NCT00001085|VX 478|vx 478
5854493|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854494|NCT00001085|Anti-HIV Agents|anti-hiv agents
5854495|NCT00001085|Viral Load|viral load
5854496|NCT00001084|Prospective Studies|prospective studies
5854497|NCT00001084|Drug Therapy, Combination|drug therapy, combination
5854498|NCT00001084|Zidovudine|zidovudine
5854499|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors
5854500|NCT00001084|Lamivudine|lamivudine
5854501|NCT00001084|Indinavir|indinavir
5854502|NCT00001084|RNA, Viral|rna, viral
5854503|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854504|NCT00001084|Anti-HIV Agents|anti-hiv agents
5854505|NCT00001084|Viral Load|viral load
5854506|NCT00001083|HIV-1|hiv-1
5854507|NCT00001083|Drug Therapy, Combination|drug therapy, combination
5854508|NCT00001083|Zidovudine|zidovudine
5854509|NCT00001083|Nevirapine|nevirapine
5854510|NCT00001083|Stavudine|stavudine
5854511|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors
5854512|NCT00001083|Ritonavir|ritonavir
5854513|NCT00001083|Lamivudine|lamivudine
5854514|NCT00001083|Indinavir|indinavir
5854515|NCT00001083|RNA, Viral|rna, viral
5854516|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5854517|NCT00001083|Anti-HIV Agents|anti-hiv agents
5854518|NCT00001082|Cytomegalovirus Infections|cytomegalovirus infections
5854519|NCT00001082|Antiviral Agents|antiviral agents
5854520|NCT00001082|CD4 Lymphocyte Count|cd4 lymphocyte count
5854521|NCT00001082|Prodrugs|prodrugs
5854522|NCT00001082|Survival|survival
5854523|NCT00001082|Adenine|adenine
5854524|NCT00001081|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854525|NCT00001081|Cryptosporidiosis|cryptosporidiosis
5854526|NCT00001081|Antiprotozoal Agents|antiprotozoal agents
5854527|NCT00001081|nitazoxanide|nitazoxanide
5854528|NCT00001080|Lymphocyte Transformation|lymphocyte transformation
5854529|NCT00001080|HIV-1|hiv-1
5854530|NCT00001080|Drug Resistance, Microbial|drug resistance, microbial
5854531|NCT00001080|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5854532|NCT00001080|Lamivudine|lamivudine
5854533|NCT00001080|Influenza Vaccine|influenza vaccine
5854534|NCT00001080|RNA, Viral|rna, viral
5854535|NCT00001080|Bacterial Vaccines|bacterial vaccines
5854536|NCT00001080|Anti-HIV Agents|anti-hiv agents
5854537|NCT00001080|Pneumonia, Pneumococcal|pneumonia, pneumococcal
5854538|NCT00001080|Viral Load|viral load
5854539|NCT00001079|Placebos|placebos
5854540|NCT00001079|Drug Therapy, Combination|drug therapy, combination
5854541|NCT00001079|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854542|NCT00001079|AIDS-Related Complex|aids-related complex
5854543|NCT00001079|HIV Wasting Syndrome|hiv wasting syndrome
5854544|NCT00001079|Megestrol Acetate|megestrol acetate
5854545|NCT00001079|dihydrotestosterone heptanoate|dihydrotestosterone heptanoate
5854546|NCT00001078|Viral Vaccines|viral vaccines
5854547|NCT00001078|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854548|NCT00001078|Anti-HIV Agents|anti-hiv agents
5854549|NCT00001078|Hepatitis A Virus, Human|hepatitis a virus, human
5854550|NCT00001077|Weight Loss|weight loss
5854551|NCT00001077|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854552|NCT00001077|Nutritional Support|nutritional support
5854553|NCT00001076|Vaccines, Synthetic|vaccines, synthetic
5854554|NCT00001076|HIV Envelope Protein gp120|hiv envelope protein gp120
5854555|NCT00001076|AIDS Vaccines|aids vaccines
5854556|NCT00001076|HIV Seronegativity|hiv seronegativity
5854557|NCT00001076|Avipoxvirus|avipoxvirus
5854558|NCT00001076|HIV Preventive Vaccine|hiv preventive vaccine
5854559|NCT00001075|Drug Therapy, Combination|drug therapy, combination
5854560|NCT00001075|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854561|NCT00001075|AIDS-Related Complex|aids-related complex
5854562|NCT00001075|Antiviral Agents|antiviral agents
5854563|NCT00001075|Zidovudine|zidovudine
5854564|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors
5854565|NCT00001075|Ritonavir|ritonavir
5854566|NCT00001075|Lamivudine|lamivudine
5854567|NCT00001074|Didanosine|didanosine
5854568|NCT00001074|Drug Therapy, Combination|drug therapy, combination
5854569|NCT00001074|Antiviral Agents|antiviral agents
5854570|NCT00001074|Hydroxyurea|hydroxyurea
5854571|NCT00001073|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854572|NCT00001073|AIDS-Related Complex|aids-related complex
5854573|NCT00001073|Cervix Dysplasia|cervix dysplasia
5854574|NCT00001073|Cervix Diseases|cervix diseases
5854575|NCT00001073|Isotretinoin|isotretinoin
5854576|NCT00001073|Cervical Intraepithelial Neoplasia|cervical intraepithelial neoplasia
5854577|NCT00001073|Cervix Neoplasms|cervix neoplasms
5854578|NCT00001073|Keratolytic Agents|keratolytic agents
5854579|NCT00001072|Vaccines, Synthetic|vaccines, synthetic
5854580|NCT00001072|HIV Envelope Protein gp120|hiv envelope protein gp120
5854581|NCT00001072|AIDS Vaccines|aids vaccines
5854582|NCT00001072|HIV Seronegativity|hiv seronegativity
5854583|NCT00001072|Avipoxvirus|avipoxvirus
5854584|NCT00001072|HIV Preventive Vaccine|hiv preventive vaccine
5854585|NCT00001071|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5854586|NCT00001071|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854587|NCT00001071|AIDS-Related Complex|aids-related complex
5854588|NCT00001071|Stem Cells|stem cells
5854589|NCT00001069|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854590|NCT00001069|AIDS-Related Complex|aids-related complex
5854591|NCT00001069|Antiviral Agents|antiviral agents
5854592|NCT00001069|Decision Making|decision making
5854593|NCT00001069|Physician's Practice Patterns|physician's practice patterns
5854594|NCT00001068|Zalcitabine|zalcitabine
5854595|NCT00001068|Didanosine|didanosine
5854596|NCT00001068|Drug Therapy, Combination|drug therapy, combination
5854597|NCT00001068|AIDS-Related Complex|aids-related complex
5854598|NCT00001068|Antiviral Agents|antiviral agents
5854599|NCT00001068|Zidovudine|zidovudine
5854600|NCT00001068|Lamivudine|lamivudine
5854601|NCT00001067|Drug Therapy, Combination|drug therapy, combination
5854602|NCT00001067|AIDS-Related Complex|aids-related complex
5854603|NCT00001067|Zidovudine|zidovudine
5854604|NCT00001067|Stavudine|stavudine
5854605|NCT00001067|Lamivudine|lamivudine
5854606|NCT00001066|Didanosine|didanosine
5854607|NCT00001066|Drug Therapy, Combination|drug therapy, combination
5854608|NCT00001066|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854609|NCT00001066|AIDS-Related Complex|aids-related complex
5854610|NCT00001066|Zidovudine|zidovudine
5854611|NCT00001066|Lamivudine|lamivudine
5854612|NCT00001065|Administration, Oral|administration, oral
5854613|NCT00001065|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854614|NCT00001065|Amphotericin B|amphotericin b
5854615|NCT00001065|AIDS-Related Complex|aids-related complex
5854616|NCT00001065|Candidiasis, Oral|candidiasis, oral
5854617|NCT00001065|Suspensions|suspensions
5854618|NCT00001064|HIV Antigens|hiv antigens
5854619|NCT00001064|Immunotherapy, Adoptive|immunotherapy, adoptive
5854620|NCT00001064|Dendritic Cells|dendritic cells
5854621|NCT00001063|Didanosine|didanosine
5854622|NCT00001063|Drug Therapy, Combination|drug therapy, combination
5854623|NCT00001063|AIDS-Related Complex|aids-related complex
5854624|NCT00001063|Zidovudine|zidovudine
5854625|NCT00001063|Stavudine|stavudine
5854626|NCT00001062|Infusions, Intravenous|infusions, intravenous
5854627|NCT00001062|Ganciclovir|ganciclovir
5854628|NCT00001062|Administration, Oral|administration, oral
5854629|NCT00001062|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854630|NCT00001062|Antiviral Agents|antiviral agents
5854631|NCT00001062|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5854632|NCT00001061|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854633|NCT00001061|Ganciclovir|ganciclovir
5854635|NCT00001061|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854636|NCT00001061|Antibodies, Monoclonal|antibodies, monoclonal
5854637|NCT00001061|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5854638|NCT00001060|Vaccines, Synthetic|vaccines, synthetic
5854640|NCT00001060|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854641|NCT00001060|AIDS-Related Complex|aids-related complex
5854642|NCT00001060|AIDS Vaccines|aids vaccines
5854643|NCT00001060|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5854644|NCT00001059|Vincristine|vincristine
5854645|NCT00001059|Sarcoma, Kaposi|sarcoma, kaposi
5854646|NCT00001059|Liposomes|liposomes
5854647|NCT00001059|Doxorubicin|doxorubicin
5854648|NCT00001059|Drug Therapy, Combination|drug therapy, combination
5854649|NCT00001059|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5854650|NCT00001059|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854651|NCT00001059|Bleomycin|bleomycin
5854652|NCT00001059|Drug Carriers|drug carriers
5854653|NCT00001058|Rifabutin|rifabutin
5854654|NCT00001058|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854655|NCT00001058|Drug Therapy, Combination|drug therapy, combination
5854656|NCT00001058|Ethambutol|ethambutol
5854657|NCT00001058|Clofazimine|clofazimine
5854658|NCT00001058|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854659|NCT00001058|Ciprofloxacin|ciprofloxacin
5854660|NCT00001058|Clarithromycin|clarithromycin
5854661|NCT00001057|Didanosine|didanosine
5854662|NCT00001057|Drug Therapy, Combination|drug therapy, combination
5854663|NCT00001057|Zidovudine|zidovudine
5854664|NCT00001056|Vaccines, Synthetic|vaccines, synthetic
5854665|NCT00001056|Vaccinia Virus|vaccinia virus
5854666|NCT00001056|Viral Vaccines|viral vaccines
5854667|NCT00001056|HIV-1|hiv-1
5854668|NCT00001056|HIV Envelope Protein gp160|hiv envelope protein gp160
5854669|NCT00001056|AIDS Vaccines|aids vaccines
5854670|NCT00001056|HIV Seronegativity|hiv seronegativity
5854671|NCT00001056|HIV Preventive Vaccine|hiv preventive vaccine
5854672|NCT00001055|Vaccines, Synthetic|vaccines, synthetic
5854673|NCT00001055|HIV Envelope Protein gp120|hiv envelope protein gp120
5854674|NCT00001055|AIDS Vaccines|aids vaccines
5854675|NCT00001055|HIV Seronegativity|hiv seronegativity
5854676|NCT00001055|Avipoxvirus|avipoxvirus
5854677|NCT00001055|HIV Preventive Vaccine|hiv preventive vaccine
5854678|NCT00001054|Herpes Zoster|herpes zoster
5854679|NCT00001054|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854680|NCT00001054|Herpes Simplex|herpes simplex
5854681|NCT00001054|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854682|NCT00001054|AIDS-Related Complex|aids-related complex
5854683|NCT00001054|valacyclovir|valacyclovir
5851192|NCT00006339|Hydroxyurea|hydroxyurea
5854684|NCT00001054|Chickenpox|chickenpox
5854685|NCT00001053|Vaccines, Synthetic|vaccines, synthetic
5854686|NCT00001053|Recombinant Proteins|recombinant proteins
5854687|NCT00001053|HIV-1|hiv-1
5854688|NCT00001053|AIDS Vaccines|aids vaccines
5854689|NCT00001053|HIV Core Protein p24|hiv core protein p24
5854690|NCT00001053|p24-VLP vaccine|p24-vlp vaccine
5854691|NCT00001053|Gene Products, gag|gene products, gag
5854692|NCT00001053|HIV Seronegativity|hiv seronegativity
5854693|NCT00001053|HIV Preventive Vaccine|hiv preventive vaccine
5854694|NCT00001052|Vaccines, Synthetic|vaccines, synthetic
5854695|NCT00001052|Drug Therapy, Combination|drug therapy, combination
5854696|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic
5854697|NCT00001052|HIV Envelope Protein gp120|hiv envelope protein gp120
5854698|NCT00001052|AIDS Vaccines|aids vaccines
5854699|NCT00001052|HIV Seronegativity|hiv seronegativity
5854700|NCT00001052|HIV Preventive Vaccine|hiv preventive vaccine
5854702|NCT00001049|Drug Therapy, Combination|drug therapy, combination
5854703|NCT00001049|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854704|NCT00001049|AIDS-Related Complex|aids-related complex
5854705|NCT00001049|Zidovudine|zidovudine
5854706|NCT00001048|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5854708|NCT00001048|Cytarabine|cytarabine
5854709|NCT00001048|Zalcitabine|zalcitabine
5854710|NCT00001048|Didanosine|didanosine
5854711|NCT00001048|Drug Therapy, Combination|drug therapy, combination
5854712|NCT00001048|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5854713|NCT00001048|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854714|NCT00001048|Zidovudine|zidovudine
5854715|NCT00001048|Injections, Spinal|injections, spinal
5854716|NCT00001047|Rifabutin|rifabutin
5854717|NCT00001047|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854718|NCT00001047|Drug Therapy, Combination|drug therapy, combination
5854719|NCT00001047|Ethambutol|ethambutol
5854720|NCT00001047|Clofazimine|clofazimine
5854721|NCT00001047|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854722|NCT00001047|Clarithromycin|clarithromycin
5854723|NCT00001046|Vaccines, Synthetic|vaccines, synthetic
5854724|NCT00001046|Pregnancy|pregnancy
5854725|NCT00001046|Pregnancy Complications, Infectious|pregnancy complications, infectious
5854726|NCT00001046|AIDS-Related Complex|aids-related complex
5854727|NCT00001046|HIV Envelope Protein gp120|hiv envelope protein gp120
5854729|NCT00001046|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5854730|NCT00001045|Didanosine|didanosine
5854731|NCT00001045|Drug Therapy, Combination|drug therapy, combination
5854732|NCT00001045|Zidovudine|zidovudine
5854733|NCT00001045|Nevirapine|nevirapine
5854734|NCT00001044|Vaccines, Synthetic|vaccines, synthetic
5854735|NCT00001044|Drug Therapy, Combination|drug therapy, combination
5854736|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic
5854737|NCT00001044|HIV Envelope Protein gp120|hiv envelope protein gp120
5854738|NCT00001044|AIDS Vaccines|aids vaccines
5854739|NCT00001044|HIV Seronegativity|hiv seronegativity
5854740|NCT00001044|HIV Preventive Vaccine|hiv preventive vaccine
5854741|NCT00001043|Vaccines, Synthetic|vaccines, synthetic
5854742|NCT00001043|Vaccinia Virus|vaccinia virus
5854743|NCT00001043|Viral Vaccines|viral vaccines
5854744|NCT00001043|Smallpox Vaccine|smallpox vaccine
5854745|NCT00001043|HIV-1|hiv-1
5854746|NCT00001043|HIV Envelope Protein gp160|hiv envelope protein gp160
5854747|NCT00001043|AIDS Vaccines|aids vaccines
5854748|NCT00001043|HIV Seronegativity|hiv seronegativity
5854749|NCT00001043|HIV Preventive Vaccine|hiv preventive vaccine
5854750|NCT00001042|Vaccines, Synthetic|vaccines, synthetic
5854751|NCT00001042|Drug Therapy, Combination|drug therapy, combination
5854752|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic
5854753|NCT00001042|HIV Envelope Protein gp120|hiv envelope protein gp120
5854754|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine
5854755|NCT00001042|monophosphoryl lipid A|monophosphoryl lipid a
5854756|NCT00001042|AIDS Vaccines|aids vaccines
5854757|NCT00001042|HIV Seronegativity|hiv seronegativity
5854758|NCT00001042|HIV Preventive Vaccine|hiv preventive vaccine
5854759|NCT00001041|Vaccines, Synthetic|vaccines, synthetic
5854760|NCT00001041|Pregnancy|pregnancy
5854761|NCT00001041|Pregnancy Complications, Infectious|pregnancy complications, infectious
5854762|NCT00001041|HIV Envelope Protein gp120|hiv envelope protein gp120
5854763|NCT00001041|AIDS Vaccines|aids vaccines
5854764|NCT00001041|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5854765|NCT00001040|Zalcitabine|zalcitabine
5854766|NCT00001040|Drug Therapy, Combination|drug therapy, combination
5854767|NCT00001040|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854768|NCT00001040|AIDS-Related Complex|aids-related complex
5854769|NCT00001040|Zidovudine|zidovudine
5854770|NCT00001040|Saquinavir|saquinavir
5854771|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors
5854772|NCT00001039|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854773|NCT00001039|Drug Therapy, Combination|drug therapy, combination
5854774|NCT00001039|Ethambutol|ethambutol
5854775|NCT00001039|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854776|NCT00001039|Clarithromycin|clarithromycin
5854777|NCT00001038|Cytomegalovirus Infections|cytomegalovirus infections
5854778|NCT00001038|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854779|NCT00001038|Antiviral Agents|antiviral agents
5854780|NCT00001037|Vaccines, Synthetic|vaccines, synthetic
5854781|NCT00001037|HIV-1|hiv-1
5854782|NCT00001037|HIV Envelope Protein gp160|hiv envelope protein gp160
5854783|NCT00001037|AIDS Vaccines|aids vaccines
5854784|NCT00001037|HIV Seronegativity|hiv seronegativity
5854785|NCT00001037|HIV Preventive Vaccine|hiv preventive vaccine
5854786|NCT00001036|T-Lymphocytes|t-lymphocytes
5854787|NCT00001036|Polyethylene Glycols|polyethylene glycols
5854788|NCT00001036|Interleukin-2|interleukin-2
5854789|NCT00001036|Drug Therapy, Combination|drug therapy, combination
5854790|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic
5854791|NCT00001036|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854792|NCT00001036|Zidovudine|zidovudine
5854793|NCT00001036|thymosin alpha(1)|thymosin alpha(1)
5854794|NCT00001035|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854795|NCT00001035|Interferon Alfa-2b|interferon alfa-2b
5854796|NCT00001035|Zalcitabine|zalcitabine
5854797|NCT00001035|Didanosine|didanosine
5854798|NCT00001035|Drug Therapy, Combination|drug therapy, combination
5854799|NCT00001035|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854800|NCT00001035|Zidovudine|zidovudine
5854801|NCT00001035|Hepatitis C|hepatitis c
5854802|NCT00001034|Retinitis|retinitis
5854803|NCT00001034|Ganciclovir|ganciclovir
5854804|NCT00001034|Cytomegalovirus Infections|cytomegalovirus infections
5854805|NCT00001034|Administration, Oral|administration, oral
5854806|NCT00001034|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854807|NCT00001034|Gastrointestinal System|gastrointestinal system
5854808|NCT00001033|Isoniazid|isoniazid
5854809|NCT00001033|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5854810|NCT00001033|Pyrazinamide|pyrazinamide
5854811|NCT00001033|Pyridoxine|pyridoxine
5854812|NCT00001033|Ofloxacin|ofloxacin
5854813|NCT00001033|Rifampin|rifampin
5854814|NCT00001033|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854815|NCT00001033|Ethambutol|ethambutol
5854816|NCT00001033|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854817|NCT00001032|Zalcitabine|zalcitabine
5854818|NCT00001032|Drug Therapy, Combination|drug therapy, combination
5854819|NCT00001032|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854820|NCT00001032|AIDS-Related Complex|aids-related complex
5854821|NCT00001032|Zidovudine|zidovudine
5854822|NCT00001031|Vaccines, Synthetic|vaccines, synthetic
5854824|NCT00001031|HIV Envelope Protein gp120|hiv envelope protein gp120
5854825|NCT00001031|AIDS Vaccines|aids vaccines
5854826|NCT00001031|HIV Seronegativity|hiv seronegativity
5854827|NCT00001031|HIV Preventive Vaccine|hiv preventive vaccine
5854828|NCT00001030|Rifabutin|rifabutin
5854829|NCT00001030|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854830|NCT00001030|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854831|NCT00001030|Clarithromycin|clarithromycin
5854832|NCT00001029|Zalcitabine|zalcitabine
5854833|NCT00001029|Didanosine|didanosine
5854834|NCT00001029|Drug Therapy, Combination|drug therapy, combination
5854835|NCT00001029|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854836|NCT00001029|Zidovudine|zidovudine
5854837|NCT00001028|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854838|NCT00001028|Pentamidine|pentamidine
5854840|NCT00001028|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854841|NCT00001028|AIDS-Related Complex|aids-related complex
5854842|NCT00001027|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854843|NCT00001027|Pentamidine|pentamidine
5854844|NCT00001027|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854845|NCT00001027|AIDS-Related Complex|aids-related complex
5854846|NCT00001026|Vaccines, Synthetic|vaccines, synthetic
5854847|NCT00001026|Vaccinia Virus|vaccinia virus
5854848|NCT00001026|Viral Vaccines|viral vaccines
5854849|NCT00001026|HIV Envelope Protein gp160|hiv envelope protein gp160
5854850|NCT00001026|HIV Envelope Protein gp120|hiv envelope protein gp120
5854851|NCT00001026|AIDS Vaccines|aids vaccines
5854852|NCT00001026|HIV Seronegativity|hiv seronegativity
5854853|NCT00001026|HIV Preventive Vaccine|hiv preventive vaccine
5854854|NCT00001025|Virus Replication|virus replication
5854855|NCT00001025|Didanosine|didanosine
5854856|NCT00001025|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854857|NCT00001025|AIDS-Related Complex|aids-related complex
5854858|NCT00001025|Zidovudine|zidovudine
5854859|NCT00001024|Didanosine|didanosine
5854860|NCT00001024|AIDS-Related Complex|aids-related complex
5854861|NCT00001024|Zidovudine|zidovudine
5854862|NCT00001024|Lymph Nodes|lymph nodes
5854863|NCT00001024|Lymphoid Tissue|lymphoid tissue
5854864|NCT00001023|Rifabutin|rifabutin
5854865|NCT00001023|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5854866|NCT00001023|Drug Interactions|drug interactions
5854867|NCT00001023|Azithromycin|azithromycin
5854868|NCT00001023|Clarithromycin|clarithromycin
5854869|NCT00001022|Zalcitabine|zalcitabine
5854870|NCT00001022|Didanosine|didanosine
5854871|NCT00001022|Drug Therapy, Combination|drug therapy, combination
5854872|NCT00001022|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854873|NCT00001022|AIDS-Related Complex|aids-related complex
5854874|NCT00001022|Zidovudine|zidovudine
5854875|NCT00001021|Vaccines, Synthetic|vaccines, synthetic
5854876|NCT00001021|HIV-1|hiv-1
5854877|NCT00001021|HIV Envelope Protein gp120|hiv envelope protein gp120
5854878|NCT00001021|AIDS Vaccines|aids vaccines
5854879|NCT00001021|HIV Seronegativity|hiv seronegativity
5854880|NCT00001021|HIV Preventive Vaccine|hiv preventive vaccine
5854881|NCT00001020|Vaccines, Synthetic|vaccines, synthetic
5854882|NCT00001020|Viral Vaccines|viral vaccines
5854883|NCT00001020|HIV-1|hiv-1
5854884|NCT00001020|HIV Envelope Protein gp120|hiv envelope protein gp120
5854885|NCT00001020|AIDS Vaccines|aids vaccines
5854886|NCT00001020|HIV Seronegativity|hiv seronegativity
5854887|NCT00001020|HIV Preventive Vaccine|hiv preventive vaccine
5854888|NCT00001019|Vaccines, Synthetic|vaccines, synthetic
5854889|NCT00001019|Adjuvants, Immunologic|adjuvants, immunologic
5854890|NCT00001019|HIV Envelope Protein gp120|hiv envelope protein gp120
5854891|NCT00001019|AIDS Vaccines|aids vaccines
5854892|NCT00001019|HIV Seronegativity|hiv seronegativity
5854893|NCT00001019|HIV Preventive Vaccine|hiv preventive vaccine
5854894|NCT00001018|Cryptosporidiosis|cryptosporidiosis
5854895|NCT00001018|Diarrhea|diarrhea
5854896|NCT00001018|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854897|NCT00001018|Antiprotozoal Agents|antiprotozoal agents
5854898|NCT00001018|Triazines|triazines
5854899|NCT00001017|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854900|NCT00001017|Meningitis|meningitis
5854901|NCT00001017|Injections, Intravenous|injections, intravenous
5854902|NCT00001017|Cryptococcosis|cryptococcosis
5854903|NCT00001017|Fluconazole|fluconazole
5854904|NCT00001017|Administration, Oral|administration, oral
5854905|NCT00001017|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854906|NCT00001017|Amphotericin B|amphotericin b
5854907|NCT00001016|Trimetrexate|trimetrexate
5854908|NCT00001016|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854909|NCT00001016|Quinazolines|quinazolines
5854910|NCT00001016|Infusions, Intravenous|infusions, intravenous
5854911|NCT00001016|Injections, Intravenous|injections, intravenous
5854912|NCT00001016|Leucovorin|leucovorin
5854913|NCT00001016|Drug Evaluation|drug evaluation
5854914|NCT00001016|Drug Therapy, Combination|drug therapy, combination
5854915|NCT00001016|Administration, Oral|administration, oral
5854916|NCT00001016|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854917|NCT00001016|Antiprotozoal Agents|antiprotozoal agents
5854918|NCT00001016|AIDS-Related Complex|aids-related complex
5854919|NCT00001015|Ribavirin|ribavirin
5854920|NCT00001015|T-Lymphocytes|t-lymphocytes
5854921|NCT00001015|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854922|NCT00001015|AIDS-Related Complex|aids-related complex
5854923|NCT00001014|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854924|NCT00001014|Trimetrexate|trimetrexate
5854925|NCT00001014|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854926|NCT00001014|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854927|NCT00001014|Infusions, Intravenous|infusions, intravenous
5854928|NCT00001014|Leucovorin|leucovorin
5854929|NCT00001014|Drug Therapy, Combination|drug therapy, combination
5854930|NCT00001014|Administration, Oral|administration, oral
5854931|NCT00001014|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854932|NCT00001014|Antiprotozoal Agents|antiprotozoal agents
5854933|NCT00001014|AIDS-Related Complex|aids-related complex
5854934|NCT00001014|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5854935|NCT00001013|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5854936|NCT00001013|Trimetrexate|trimetrexate
5854937|NCT00001013|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5854938|NCT00001013|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5854939|NCT00001013|Pentamidine|pentamidine
5854940|NCT00001013|Infusions, Intravenous|infusions, intravenous
5854941|NCT00001013|Leucovorin|leucovorin
5854942|NCT00001013|Drug Therapy, Combination|drug therapy, combination
5854943|NCT00001013|Folic Acid Antagonists|folic acid antagonists
5854944|NCT00001013|Aerosols|aerosols
5854945|NCT00001013|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854946|NCT00001013|Antiprotozoal Agents|antiprotozoal agents
5854947|NCT00001013|AIDS-Related Complex|aids-related complex
5854948|NCT00001013|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5854949|NCT00001012|Virus Replication|virus replication
5854950|NCT00001012|T-Lymphocytes|t-lymphocytes
5854951|NCT00001012|Dose-Response Relationship, Drug|dose-response relationship, drug
5854952|NCT00001012|Drug Evaluation|drug evaluation
5854953|NCT00001012|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854954|NCT00001012|AL 721|al 721
5854955|NCT00001012|AIDS-Related Complex|aids-related complex
5854956|NCT00001012|Antiviral Agents|antiviral agents
5854957|NCT00001011|Virus Replication|virus replication
5854958|NCT00001011|AIDS-Related Complex|aids-related complex
5854959|NCT00001011|Zidovudine|zidovudine
5854960|NCT00001010|Immune Tolerance|immune tolerance
5854961|NCT00001010|Dose-Response Relationship, Drug|dose-response relationship, drug
5854962|NCT00001010|Drug Evaluation|drug evaluation
5854963|NCT00001010|Drug Therapy, Combination|drug therapy, combination
5854964|NCT00001010|Acyclovir|acyclovir
5854965|NCT00001010|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854966|NCT00001010|AIDS-Related Complex|aids-related complex
5854967|NCT00001010|Zidovudine|zidovudine
5854968|NCT00001009|T-Lymphocytes|t-lymphocytes
5854969|NCT00001009|HIV Antigens|hiv antigens
5854970|NCT00001009|Dextran Sulfate|dextran sulfate
5854971|NCT00001009|Dose-Response Relationship, Drug|dose-response relationship, drug
5854972|NCT00001009|Drug Evaluation|drug evaluation
5854973|NCT00001009|Drug Therapy, Combination|drug therapy, combination
5854974|NCT00001009|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854975|NCT00001009|AIDS-Related Complex|aids-related complex
5854976|NCT00001008|Substance Withdrawal Syndrome|substance withdrawal syndrome
5854977|NCT00001008|Methadone|methadone
5854978|NCT00001008|Opioid-Related Disorders|opioid-related disorders
5854979|NCT00001008|Drug Evaluation|drug evaluation
5854980|NCT00001008|Drug Interactions|drug interactions
5854981|NCT00001008|Drug Therapy, Combination|drug therapy, combination
5854982|NCT00001008|Administration, Oral|administration, oral
5863158|NCT00001366|Neuroimaging|neuroimaging
5854983|NCT00001008|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854984|NCT00001008|AIDS-Related Complex|aids-related complex
5854985|NCT00001008|Zidovudine|zidovudine
5854986|NCT00001007|Pregnancy|pregnancy
5854987|NCT00001007|Pregnancy Complications, Infectious|pregnancy complications, infectious
5854988|NCT00001007|Infant, Newborn, Diseases|infant, newborn, diseases
5854989|NCT00001007|Infusions, Intravenous|infusions, intravenous
5854990|NCT00001007|Drug Evaluation|drug evaluation
5854991|NCT00001007|Administration, Oral|administration, oral
5854992|NCT00001007|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854993|NCT00001007|Zidovudine|zidovudine
5854994|NCT00001006|Infusions, Intravenous|infusions, intravenous
5856231|NCT00000818|Lymph Nodes|lymph nodes
5854995|NCT00001006|Immunologic Surveillance|immunologic surveillance
5854996|NCT00001006|Drug Evaluation|drug evaluation
5854997|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic
5854998|NCT00001006|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5854999|NCT00001006|AIDS-Related Complex|aids-related complex
5855000|NCT00001006|ammonium trichloro(dioxoethylene-O,O'-)tellurute|ammonium trichloro(dioxoethylene-o,o'-)tellurute
5855001|NCT00001005|Recombinant Proteins|recombinant proteins
5855091|NCT00000991|Pentamidine|pentamidine
5855002|NCT00001005|HIV Seropositivity|hiv seropositivity
5855003|NCT00001005|Interleukin-2|interleukin-2
5855004|NCT00001005|Drug Evaluation|drug evaluation
5855005|NCT00001005|Drug Therapy, Combination|drug therapy, combination
5855006|NCT00001005|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855007|NCT00001005|AIDS-Related Complex|aids-related complex
5855008|NCT00001005|Zidovudine|zidovudine
5855009|NCT00001004|Tumor Necrosis Factor|tumor necrosis factor
5855010|NCT00001004|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5855011|NCT00001004|HIV Antigens|hiv antigens
5855012|NCT00001004|Immunologic Surveillance|immunologic surveillance
5855013|NCT00001004|Drug Therapy, Combination|drug therapy, combination
5855014|NCT00001004|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855015|NCT00001004|AIDS-Related Complex|aids-related complex
5855016|NCT00001003|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855017|NCT00001003|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855018|NCT00001003|Pentamidine|pentamidine
5855019|NCT00001003|Nebulizers and Vaporizers|nebulizers and vaporizers
5855020|NCT00001003|Lung|lung
5855021|NCT00001003|Administration, Inhalation|administration, inhalation
5855022|NCT00001003|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855023|NCT00001003|Zidovudine|zidovudine
5855024|NCT00001002|Drug Therapy, Combination|drug therapy, combination
5855025|NCT00001002|Foscarnet|foscarnet
5855026|NCT00001002|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855027|NCT00001002|AIDS-Related Complex|aids-related complex
5855028|NCT00001002|Antiviral Agents|antiviral agents
5855029|NCT00001002|Zidovudine|zidovudine
5855030|NCT00001001|Liver|liver
5855031|NCT00001001|Liver Diseases|liver diseases
5855032|NCT00001001|Liver Function Tests|liver function tests
5855033|NCT00001001|HIV Seropositivity|hiv seropositivity
5855034|NCT00001001|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855035|NCT00001001|Zidovudine|zidovudine
5855036|NCT00001001|Biological Availability|biological availability
5855037|NCT00001000|Macrophage Activation|macrophage activation
5855038|NCT00001000|Lymphocyte Transformation|lymphocyte transformation
5855039|NCT00001000|Immunologic Surveillance|immunologic surveillance
5855040|NCT00001000|ampligen|ampligen
5855041|NCT00001000|Antiviral Agents|antiviral agents
5855042|NCT00000999|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855043|NCT00000999|AIDS-Related Complex|aids-related complex
5855044|NCT00000999|Zidovudine|zidovudine
5855045|NCT00000998|Trimetrexate|trimetrexate
5855046|NCT00000998|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855047|NCT00000998|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855048|NCT00000998|Injections, Intravenous|injections, intravenous
5855049|NCT00000998|Leucovorin|leucovorin
5855050|NCT00000998|Dose-Response Relationship, Drug|dose-response relationship, drug
5855051|NCT00000998|Drug Therapy, Combination|drug therapy, combination
5855052|NCT00000998|Folic Acid Antagonists|folic acid antagonists
5855053|NCT00000998|Administration, Oral|administration, oral
5855054|NCT00000998|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855055|NCT00000998|Antineoplastic Agents|antineoplastic agents
5855056|NCT00000997|Zalcitabine|zalcitabine
5855057|NCT00000997|Drug Evaluation|drug evaluation
5855058|NCT00000997|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855059|NCT00000997|AIDS-Related Complex|aids-related complex
5855060|NCT00000997|Biological Availability|biological availability
5855061|NCT00000996|Doxorubicin|doxorubicin
5855062|NCT00000996|Drug Evaluation|drug evaluation
5855063|NCT00000996|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855064|NCT00000995|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855065|NCT00000995|Ganciclovir|ganciclovir
5855066|NCT00000995|Drug Evaluation|drug evaluation
5855067|NCT00000995|Drug Therapy, Combination|drug therapy, combination
5855068|NCT00000995|Cytomegalovirus Infections|cytomegalovirus infections
5855069|NCT00000995|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855070|NCT00000995|Zidovudine|zidovudine
5855071|NCT00000994|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855072|NCT00000994|Sarcoma, Kaposi|sarcoma, kaposi
5855073|NCT00000994|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855074|NCT00000994|Zidovudine|zidovudine
5855075|NCT00000993|HIV-1|hiv-1
5855076|NCT00000993|Drug Evaluation|drug evaluation
5855077|NCT00000993|Accidents|accidents
5855078|NCT00000993|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855079|NCT00000993|AIDS Serodiagnosis|aids serodiagnosis
5855080|NCT00000993|Zidovudine|zidovudine
5855081|NCT00000992|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855082|NCT00000992|Ketoconazole|ketoconazole
5855083|NCT00000992|Histoplasmosis|histoplasmosis
5855084|NCT00000992|Drug Evaluation|drug evaluation
5855085|NCT00000992|Antifungal Agents|antifungal agents
5855086|NCT00000992|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855087|NCT00000991|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5855088|NCT00000991|Toxoplasmosis|toxoplasmosis
5855089|NCT00000991|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855090|NCT00000991|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855093|NCT00000991|Drug Evaluation|drug evaluation
5855094|NCT00000991|Drug Therapy, Combination|drug therapy, combination
5855095|NCT00000991|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855096|NCT00000991|Zidovudine|zidovudine
5855097|NCT00000991|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5855098|NCT00000990|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855099|NCT00000990|Pulmonary Fibrosis|pulmonary fibrosis
5855100|NCT00000990|Zidovudine|zidovudine
5855101|NCT00000989|Retinitis|retinitis
5855102|NCT00000989|Ganciclovir|ganciclovir
5855103|NCT00000989|Drug Evaluation|drug evaluation
5855104|NCT00000989|Drug Therapy, Combination|drug therapy, combination
5855105|NCT00000989|Cytomegalovirus Infections|cytomegalovirus infections
5855106|NCT00000989|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855107|NCT00000989|Zidovudine|zidovudine
5855108|NCT00000988|Injections, Intravenous|injections, intravenous
5855109|NCT00000988|Drug Evaluation|drug evaluation
5855110|NCT00000988|Administration, Oral|administration, oral
5855111|NCT00000988|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855112|NCT00000988|AIDS-Related Complex|aids-related complex
5855113|NCT00000988|Antiviral Agents|antiviral agents
5855114|NCT00000987|Vincristine|vincristine
5855115|NCT00000987|Doxorubicin|doxorubicin
5855116|NCT00000987|Drug Therapy, Combination|drug therapy, combination
5855117|NCT00000987|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855118|NCT00000987|Zidovudine|zidovudine
5855119|NCT00000987|Bleomycin|bleomycin
5855120|NCT00000986|Recombinant Proteins|recombinant proteins
5855121|NCT00000986|Interleukin-2|interleukin-2
5855122|NCT00000986|Drug Interactions|drug interactions
5855123|NCT00000986|Drug Therapy, Combination|drug therapy, combination
5855124|NCT00000986|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855125|NCT00000986|AIDS-Related Complex|aids-related complex
5855126|NCT00000986|Zidovudine|zidovudine
5855127|NCT00000985|Vidarabine|vidarabine
5855128|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid
5855129|NCT00000985|Herpes Simplex|herpes simplex
5855130|NCT00000985|Foscarnet|foscarnet
5855131|NCT00000985|Acyclovir|acyclovir
5855132|NCT00000985|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855133|NCT00000984|Recombinant Proteins|recombinant proteins
5855134|NCT00000984|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855135|NCT00000984|Antigens, CD4|antigens, cd4
5855136|NCT00000984|Antiviral Agents|antiviral agents
5855137|NCT00000983|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855138|NCT00000983|Zidovudine|zidovudine
5855139|NCT00000982|Central Nervous System Diseases|central nervous system diseases
5855140|NCT00000982|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855141|NCT00000982|Zidovudine|zidovudine
5855142|NCT00000981|Retinitis|retinitis
5855143|NCT00000981|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855144|NCT00000981|Pyrimidine Nucleosides|pyrimidine nucleosides
5855145|NCT00000981|Drug Evaluation|drug evaluation
5855146|NCT00000981|fiacitabine|fiacitabine
5855147|NCT00000981|Cytomegalovirus Infections|cytomegalovirus infections
5855148|NCT00000981|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855149|NCT00000981|Antiviral Agents|antiviral agents
5855150|NCT00000980|Single-Blind Method|single-blind method
5855151|NCT00000980|Spiramycin|spiramycin
5855152|NCT00000980|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855153|NCT00000980|Injections, Intravenous|injections, intravenous
5855154|NCT00000980|Cryptosporidiosis|cryptosporidiosis
5855155|NCT00000980|Diarrhea|diarrhea
5855156|NCT00000980|Drug Evaluation|drug evaluation
5855157|NCT00000980|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855158|NCT00000979|Didanosine|didanosine
5855159|NCT00000979|Zidovudine|zidovudine
5855160|NCT00000978|Zalcitabine|zalcitabine
5855161|NCT00000978|Drug Therapy, Combination|drug therapy, combination
5855162|NCT00000978|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855163|NCT00000978|AIDS-Related Complex|aids-related complex
5855164|NCT00000978|Zidovudine|zidovudine
5855165|NCT00000977|Vaccines, Synthetic|vaccines, synthetic
5855166|NCT00000977|HIV Seropositivity|hiv seropositivity
5855167|NCT00000977|HIV-1|hiv-1
5855168|NCT00000977|Drug Evaluation|drug evaluation
5855169|NCT00000977|AIDS Vaccines|aids vaccines
5855170|NCT00000977|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5855171|NCT00000976|Recombinant Proteins|recombinant proteins
5855172|NCT00000976|Injections, Intravenous|injections, intravenous
5855174|NCT00000976|Drug Evaluation|drug evaluation
5855175|NCT00000976|Administration, Oral|administration, oral
5855176|NCT00000976|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855177|NCT00000976|Antigens, CD4|antigens, cd4
5855178|NCT00000976|Zidovudine|zidovudine
5855179|NCT00000976|Carrier Proteins|carrier proteins
5855180|NCT00000975|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855181|NCT00000975|Histoplasmosis|histoplasmosis
5855182|NCT00000975|Drug Evaluation|drug evaluation
5855183|NCT00000975|Antifungal Agents|antifungal agents
5855184|NCT00000975|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855185|NCT00000974|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855186|NCT00000974|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855188|NCT00000974|Injections, Intravenous|injections, intravenous
5855189|NCT00000974|Drug Evaluation|drug evaluation
5855190|NCT00000974|Aerosols|aerosols
5855191|NCT00000974|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855192|NCT00000973|Toxoplasmosis|toxoplasmosis
5855193|NCT00000973|Toxoplasma|toxoplasma
5855194|NCT00000973|Pyrimethamine|pyrimethamine
5855195|NCT00000973|Leucovorin|leucovorin
5855196|NCT00000973|Drug Evaluation|drug evaluation
5855197|NCT00000973|Encephalitis|encephalitis
5855198|NCT00000973|Zidovudine|zidovudine
5855199|NCT00000972|Vaccines, Synthetic|vaccines, synthetic
5855200|NCT00000972|Drug Evaluation|drug evaluation
5855201|NCT00000972|Adjuvants, Immunologic|adjuvants, immunologic
5855202|NCT00000972|AIDS Vaccines|aids vaccines
5855203|NCT00000972|HIV Preventive Vaccine|hiv preventive vaccine
5855204|NCT00000971|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855205|NCT00000971|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855206|NCT00000971|Didanosine|didanosine
5855207|NCT00000971|Drug Evaluation|drug evaluation
5855208|NCT00000971|Drug Interactions|drug interactions
5855209|NCT00000971|Drug Therapy, Combination|drug therapy, combination
5855210|NCT00000971|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855211|NCT00000971|Zidovudine|zidovudine
5855212|NCT00000970|Retinitis|retinitis
5855213|NCT00000970|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855214|NCT00000970|Ganciclovir|ganciclovir
5855215|NCT00000970|Drug Evaluation|drug evaluation
5855216|NCT00000970|Drug Therapy, Combination|drug therapy, combination
5855217|NCT00000970|Foscarnet|foscarnet
5855218|NCT00000970|Cytomegalovirus Infections|cytomegalovirus infections
5855219|NCT00000970|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855220|NCT00000969|Zalcitabine|zalcitabine
5855221|NCT00000969|Didanosine|didanosine
5855222|NCT00000969|Drug Evaluation|drug evaluation
5855223|NCT00000969|Zidovudine|zidovudine
5855224|NCT00000968|Vaccines, Synthetic|vaccines, synthetic
5855225|NCT00000968|Drug Evaluation|drug evaluation
5855226|NCT00000968|HIV Envelope Protein gp160|hiv envelope protein gp160
5855227|NCT00000968|AIDS Vaccines|aids vaccines
5855228|NCT00000968|HIV Seronegativity|hiv seronegativity
5855229|NCT00000968|HIV Preventive Vaccine|hiv preventive vaccine
5855230|NCT00000967|Drug Therapy, Combination|drug therapy, combination
5855231|NCT00000967|AIDS-Related Complex|aids-related complex
5855232|NCT00000967|Zidovudine|zidovudine
5855233|NCT00000967|Interferon Type I|interferon type i
5851804|NCT00002441|HIV-1|hiv-1
5855234|NCT00000966|Toxoplasmosis|toxoplasmosis
5855235|NCT00000966|Toxoplasma|toxoplasma
5855236|NCT00000966|Pyrimethamine|pyrimethamine
5855237|NCT00000966|Leucovorin|leucovorin
5855238|NCT00000966|Drug Evaluation|drug evaluation
5855239|NCT00000966|Drug Therapy, Combination|drug therapy, combination
5855240|NCT00000966|Encephalitis|encephalitis
5855241|NCT00000966|Administration, Oral|administration, oral
5855242|NCT00000966|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855243|NCT00000966|Azithromycin|azithromycin
5855244|NCT00000965|Leukocytes, Mononuclear|leukocytes, mononuclear
5855245|NCT00000965|Drug Evaluation|drug evaluation
5855246|NCT00000965|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855247|NCT00000965|AIDS-Related Complex|aids-related complex
5855248|NCT00000965|Zidovudine|zidovudine
5855249|NCT00000965|Phosphorylation|phosphorylation
5855250|NCT00000964|Ranitidine|ranitidine
5855251|NCT00000964|Phosphorus Acids|phosphorus acids
5855252|NCT00000964|Drug Evaluation|drug evaluation
5855253|NCT00000964|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855254|NCT00000963|Didanosine|didanosine
5855255|NCT00000963|Drug Evaluation|drug evaluation
5855256|NCT00000963|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855257|NCT00000963|AIDS-Related Complex|aids-related complex
5855258|NCT00000963|Zidovudine|zidovudine
5855259|NCT00000962|Drug Evaluation|drug evaluation
5855260|NCT00000962|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855261|NCT00000962|AIDS-Related Complex|aids-related complex
5855262|NCT00000962|Nevirapine|nevirapine
5855263|NCT00000961|Drug Therapy, Combination|drug therapy, combination
5855264|NCT00000961|Zidovudine|zidovudine
5855265|NCT00000960|Pregnancy|pregnancy
5855266|NCT00000960|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855267|NCT00000960|Prenatal Exposure Delayed Effects|prenatal exposure delayed effects
5855268|NCT00000960|Administration, Oral|administration, oral
5855269|NCT00000960|AIDS-Related Complex|aids-related complex
5855270|NCT00000960|Zidovudine|zidovudine
5857327|NCT00000635|Bacitracin|bacitracin
5855271|NCT00000959|Tuberculosis|tuberculosis
5855272|NCT00000959|Isoniazid|isoniazid
5855273|NCT00000959|Pyridoxine|pyridoxine
5855274|NCT00000959|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855275|NCT00000959|Drug Evaluation|drug evaluation
5855276|NCT00000959|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855277|NCT00000959|Antitubercular Agents|antitubercular agents
5855278|NCT00000958|Vaccines, Synthetic|vaccines, synthetic
5855279|NCT00000958|Recombinant Proteins|recombinant proteins
5855280|NCT00000958|Adjuvants, Immunologic|adjuvants, immunologic
5855281|NCT00000958|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855282|NCT00000958|HIV Envelope Protein gp120|hiv envelope protein gp120
5855283|NCT00000958|AIDS Vaccines|aids vaccines
5855284|NCT00000958|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5855285|NCT00000957|Vaccines, Synthetic|vaccines, synthetic
5855286|NCT00000957|Vaccinia Virus|vaccinia virus
5855287|NCT00000957|Viral Vaccines|viral vaccines
5855288|NCT00000957|HIV-1|hiv-1
5855289|NCT00000957|Drug Evaluation|drug evaluation
5855290|NCT00000957|HIV Envelope Protein gp160|hiv envelope protein gp160
5855291|NCT00000957|Drug Administration Schedule|drug administration schedule
5855292|NCT00000957|AIDS Vaccines|aids vaccines
5855293|NCT00000957|HIV Seronegativity|hiv seronegativity
5855294|NCT00000957|HIV Preventive Vaccine|hiv preventive vaccine
5855295|NCT00000956|Vaccines, Synthetic|vaccines, synthetic
5855296|NCT00000956|Vaccinia Virus|vaccinia virus
5855297|NCT00000956|HIV-1|hiv-1
5855298|NCT00000956|HIV Envelope Protein gp160|hiv envelope protein gp160
5855299|NCT00000956|AIDS Vaccines|aids vaccines
5855300|NCT00000956|HIV Seronegativity|hiv seronegativity
5855301|NCT00000956|HIV Preventive Vaccine|hiv preventive vaccine
5855302|NCT00000955|Tuberculosis|tuberculosis
5855303|NCT00000955|Immunologic Tests|immunologic tests
5855304|NCT00000955|Tuberculin|tuberculin
5855305|NCT00000955|Tuberculin Test|tuberculin test
5855306|NCT00000955|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855307|NCT00000955|Injections, Intradermal|injections, intradermal
5855308|NCT00000955|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855309|NCT00000955|AIDS-Related Complex|aids-related complex
5855310|NCT00000955|Hypersensitivity, Delayed|hypersensitivity, delayed
5855311|NCT00000954|Vincristine|vincristine
5855312|NCT00000954|Sarcoma, Kaposi|sarcoma, kaposi
5855313|NCT00000954|Zalcitabine|zalcitabine
5855314|NCT00000954|Didanosine|didanosine
5855315|NCT00000954|Doxorubicin|doxorubicin
5855316|NCT00000954|Drug Evaluation|drug evaluation
5855317|NCT00000954|Drug Interactions|drug interactions
5855318|NCT00000954|Drug Therapy, Combination|drug therapy, combination
5855319|NCT00000954|Combined Modality Therapy|combined modality therapy
5855320|NCT00000954|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855321|NCT00000954|Antineoplastic Agents|antineoplastic agents
5855322|NCT00000954|Antineoplastic Agents, Combined|antineoplastic agents, combined
5855323|NCT00000954|Antiviral Agents|antiviral agents
5855324|NCT00000954|Bleomycin|bleomycin
5855325|NCT00000953|Herpes Zoster|herpes zoster
5855326|NCT00000953|Acyclovir|acyclovir
5855327|NCT00000953|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855328|NCT00000953|AIDS-Related Complex|aids-related complex
5855329|NCT00000953|Antiviral Agents|antiviral agents
5855330|NCT00000953|sorivudine|sorivudine
5855331|NCT00000952|Dose-Response Relationship, Drug|dose-response relationship, drug
5855332|NCT00000952|Drug Therapy, Combination|drug therapy, combination
5855333|NCT00000952|Zidovudine|zidovudine
5855334|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors
5855335|NCT00000952|Ritonavir|ritonavir
5855336|NCT00000952|Lamivudine|lamivudine
5855337|NCT00000952|Anti-HIV Agents|anti-hiv agents
5855338|NCT00000951|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855339|NCT00000951|Fluconazole|fluconazole
5855340|NCT00000951|Antifungal Agents|antifungal agents
5855341|NCT00000951|Candidiasis, Oral|candidiasis, oral
5855342|NCT00000951|Drug Administration Schedule|drug administration schedule
5855343|NCT00000951|Pharyngeal Diseases|pharyngeal diseases
5855344|NCT00000950|Tuberculosis|tuberculosis
5855345|NCT00000950|Isoniazid|isoniazid
5855346|NCT00000950|Pyrazinamide|pyrazinamide
5855347|NCT00000950|Pyridoxine|pyridoxine
5855348|NCT00000950|Rifampin|rifampin
5855349|NCT00000950|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855350|NCT00000950|Drug Therapy, Combination|drug therapy, combination
5855351|NCT00000950|Ethambutol|ethambutol
5855352|NCT00000950|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855353|NCT00000950|Antitubercular Agents|antitubercular agents
5855354|NCT00000949|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855355|NCT00000949|Interleukin-2|interleukin-2
5855356|NCT00000949|Dose-Response Relationship, Drug|dose-response relationship, drug
5855357|NCT00000949|Adolescent Behavior|adolescent behavior
5855358|NCT00000949|CD4 Lymphocyte Count|cd4 lymphocyte count
5855359|NCT00000949|RNA, Viral|rna, viral
5855360|NCT00000949|Quality of Life|quality of life
5855361|NCT00000949|Anti-HIV Agents|anti-hiv agents
5855362|NCT00000949|Viral Load|viral load
5855363|NCT00000948|Injections, Subcutaneous|injections, subcutaneous
5855364|NCT00000948|Interleukin-2|interleukin-2
5855365|NCT00000948|Dose-Response Relationship, Drug|dose-response relationship, drug
5855366|NCT00000948|Drug Therapy, Combination|drug therapy, combination
5855367|NCT00000948|CD4 Lymphocyte Count|cd4 lymphocyte count
5855368|NCT00000948|Anti-HIV Agents|anti-hiv agents
5855369|NCT00000947|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855370|NCT00000947|Placebos|placebos
5855371|NCT00000947|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855469|NCT00000931|Homosexuality, Male|homosexuality, male
5855372|NCT00000947|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855373|NCT00000947|Antitubercular Agents|antitubercular agents
5855374|NCT00000947|Azithromycin|azithromycin
5855375|NCT00000947|Drug Resistance, Microbial|drug resistance, microbial
5855376|NCT00000947|CD4 Lymphocyte Count|cd4 lymphocyte count
5855377|NCT00000947|Antibiotics|antibiotics
5855378|NCT00000947|Time Factors|time factors
5855379|NCT00000947|Anti-HIV Agents|anti-hiv agents
5855380|NCT00000947|Pneumonia, Bacterial|pneumonia, bacterial
5855381|NCT00000947|Streptococcus pneumoniae|streptococcus pneumoniae
5855382|NCT00000946|Drug Evaluation|drug evaluation
5855383|NCT00000946|Drug Therapy, Combination|drug therapy, combination
5855384|NCT00000946|AIDS Vaccines|aids vaccines
5855385|NCT00000946|HIV Seronegativity|hiv seronegativity
5855386|NCT00000946|HIV Preventive Vaccine|hiv preventive vaccine
5855387|NCT00000945|Leukoencephalopathy, Progressive Multifocal|leukoencephalopathy, progressive multifocal
5855388|NCT00000945|Probenecid|probenecid
5855390|NCT00000945|Central Nervous System Diseases|central nervous system diseases
5855391|NCT00000945|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855392|NCT00000945|DNA, Viral|dna, viral
5855393|NCT00000945|cidofovir|cidofovir
5855394|NCT00000945|Anti-HIV Agents|anti-hiv agents
5855395|NCT00000945|Neurologic Examination|neurologic examination
5855396|NCT00000945|Renal Agents|renal agents
5855397|NCT00000944|Pregnancy|pregnancy
5855398|NCT00000944|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855399|NCT00000944|Drug Therapy, Combination|drug therapy, combination
5855400|NCT00000944|Zidovudine|zidovudine
5855401|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors
5855402|NCT00000944|Lamivudine|lamivudine
5855403|NCT00000944|Indinavir|indinavir
5855404|NCT00000944|Disease Transmission, Vertical|disease transmission, vertical
5855405|NCT00000944|Anti-HIV Agents|anti-hiv agents
5855406|NCT00000943|Lymphocytes|lymphocytes
5855407|NCT00000943|Interleukin-2|interleukin-2
5855408|NCT00000943|Drug Therapy, Combination|drug therapy, combination
5855409|NCT00000943|AIDS Vaccines|aids vaccines
5855410|NCT00000943|CD4 Lymphocyte Count|cd4 lymphocyte count
5855411|NCT00000943|Cell Division|cell division
5855412|NCT00000943|HIV Core Protein p24|hiv core protein p24
5855413|NCT00000943|Anti-HIV Agents|anti-hiv agents
5855414|NCT00000943|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5855415|NCT00000942|Placebos|placebos
5855416|NCT00000942|Pregnancy|pregnancy
5855417|NCT00000942|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855418|NCT00000942|Nevirapine|nevirapine
5855419|NCT00000942|Disease Transmission, Vertical|disease transmission, vertical
5855420|NCT00000942|Labor|labor
5855421|NCT00000942|Anti-HIV Agents|anti-hiv agents
5855422|NCT00000941|Drug Interactions|drug interactions
5855423|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors
5855424|NCT00000941|Ritonavir|ritonavir
5855425|NCT00000941|HIV Seronegativity|hiv seronegativity
5855426|NCT00000941|Saquinavir|saquinavir
5855427|NCT00000941|Nelfinavir|nelfinavir
5855428|NCT00000941|Anticholesteremic Agents|anticholesteremic agents
5855429|NCT00000940|Drug Therapy, Combination|drug therapy, combination
5855430|NCT00000940|Stavudine|stavudine
5855431|NCT00000940|Amprenavir/Ritonavir|amprenavir/ritonavir
5855432|NCT00000940|Protease Inhibitors|protease inhibitors
5855433|NCT00000940|Lamivudine|lamivudine
5855434|NCT00000940|VX 478|vx 478
5855435|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855436|NCT00000940|Anti-HIV Agents|anti-hiv agents
5855437|NCT00000940|Viral Load|viral load
5855438|NCT00000940|Abacavir Sulfate|abacavir sulfate
5855439|NCT00000940|Acute Infection|acute infection
5855440|NCT00000940|Treatment Interruption|treatment interruption
5855441|NCT00000939|Didanosine|didanosine
5855442|NCT00000939|Drug Therapy, Combination|drug therapy, combination
5855443|NCT00000939|Stavudine|stavudine
5855444|NCT00000939|HIV Protease Inhibitors|hiv protease inhibitors
5855445|NCT00000939|Hydroxyurea|hydroxyurea
5855446|NCT00000939|RNA, Viral|rna, viral
5855447|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855448|NCT00000939|Anti-HIV Agents|anti-hiv agents
5855449|NCT00000939|Viral Load|viral load
5855450|NCT00000939|efavirenz|efavirenz
5855451|NCT00000933|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855452|NCT00000933|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855453|NCT00000933|Antibiotics, Macrolide|antibiotics, macrolide
5855454|NCT00000933|Azithromycin|azithromycin
5855455|NCT00000933|Drug Administration Schedule|drug administration schedule
5855456|NCT00000933|Drug Resistance, Microbial|drug resistance, microbial
5855457|NCT00000933|Carrier State|carrier state
5855458|NCT00000933|Streptococcus pneumoniae|streptococcus pneumoniae
5855459|NCT00000932|Prospective Studies|prospective studies
5855460|NCT00000932|HIV-1|hiv-1
5855461|NCT00000932|Drug Therapy, Combination|drug therapy, combination
5855462|NCT00000932|Drug Resistance, Microbial|drug resistance, microbial
5855463|NCT00000932|CD4 Lymphocyte Count|cd4 lymphocyte count
5855464|NCT00000932|Disease Progression|disease progression
5855465|NCT00000932|Treatment Outcome|treatment outcome
5855466|NCT00000932|Genotype|genotype
5855467|NCT00000932|Anti-HIV Agents|anti-hiv agents
5855471|NCT00000931|Behavior Therapy|behavior therapy
5855472|NCT00000931|HIV Seronegativity|hiv seronegativity
5855473|NCT00000930|Sexual Partners|sexual partners
5855474|NCT00000930|Drug Resistance, Microbial|drug resistance, microbial
5855475|NCT00000930|Cohort Studies|cohort studies
5855476|NCT00000930|Risk Factors|risk factors
5855477|NCT00000930|Substance Abuse, Intravenous|substance abuse, intravenous
5855478|NCT00000930|Disease Progression|disease progression
5855479|NCT00000930|Homosexuality, Male|homosexuality, male
5855480|NCT00000930|Genotype|genotype
5855481|NCT00000930|Phenotype|phenotype
5855482|NCT00000929|Sexual Partners|sexual partners
5855483|NCT00000929|Homosexuality, Male|homosexuality, male
5855484|NCT00000929|Anti-Infective Agents|anti-infective agents
5855485|NCT00000929|Patient Compliance|patient compliance
5855486|NCT00000929|Nonoxynol|nonoxynol
5855487|NCT00000929|Rectum|rectum
5855488|NCT00000928|Sexual Partners|sexual partners
5855489|NCT00000928|Condoms|condoms
5855490|NCT00000928|Counseling|counseling
5855491|NCT00000927|Administration, Topical|administration, topical
5855492|NCT00000927|Mucous Membrane|mucous membrane
5855493|NCT00000927|Anti-Infective Agents|anti-infective agents
5855494|NCT00000927|Cervix Uteri|cervix uteri
5855495|NCT00000927|Vagina|vagina
5855496|NCT00000927|Vulva|vulva
5855497|NCT00000927|Buffers|buffers
5855498|NCT00000926|Nonoxynol|nonoxynol
5855499|NCT00000925|Dietary Proteins|dietary proteins
5855500|NCT00000925|HIV Wasting Syndrome|hiv wasting syndrome
5855501|NCT00000924|Drug Therapy, Combination|drug therapy, combination
5855502|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors
5855503|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855504|NCT00000924|Anti-HIV Agents|anti-hiv agents
5855505|NCT00000923|Interleukin-2|interleukin-2
5855506|NCT00000923|Drug Therapy, Combination|drug therapy, combination
5855507|NCT00000923|CD4 Lymphocyte Count|cd4 lymphocyte count
5855508|NCT00000923|Anti-HIV Agents|anti-hiv agents
5855509|NCT00000923|Viral Load|viral load
5855510|NCT00000922|Drug Therapy, Combination|drug therapy, combination
5855511|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors
5855512|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855513|NCT00000922|Anti-HIV Agents|anti-hiv agents
5855514|NCT00000922|Treatment Naive|treatment naive
5855515|NCT00000921|Drug Therapy, Combination|drug therapy, combination
5855516|NCT00000921|Prednisone|prednisone
5855517|NCT00000921|Anti-HIV Agents|anti-hiv agents
5855518|NCT00000920|Pregnancy|pregnancy
5855519|NCT00000920|Drug Therapy, Combination|drug therapy, combination
5855520|NCT00000920|Zidovudine|zidovudine
5855521|NCT00000920|Pregnancy Complications|pregnancy complications
5855522|NCT00000920|Ritonavir|ritonavir
5855523|NCT00000920|Lamivudine|lamivudine
5855524|NCT00000920|Saquinavir|saquinavir
5855525|NCT00000920|Anti-HIV Agents|anti-hiv agents
5855526|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors
5855527|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855528|NCT00000919|Anti-HIV Agents|anti-hiv agents
5855529|NCT00000919|Viral Load|viral load
5855530|NCT00000918|Drug Therapy, Combination|drug therapy, combination
5855531|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors
5855532|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855533|NCT00000918|Salvage Therapy|salvage therapy
5855534|NCT00000918|Anti-HIV Agents|anti-hiv agents
5855535|NCT00000918|Viral Load|viral load
5855536|NCT00000917|Gene Therapy|gene therapy
5855537|NCT00000917|Specimen Handling|specimen handling
5855538|NCT00000917|Blood Banks|blood banks
5855539|NCT00000917|Fetal Blood|fetal blood
5855540|NCT00000916|Drug Therapy, Combination|drug therapy, combination
5855541|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors
5855542|NCT00000916|Hydroxyurea|hydroxyurea
5855543|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855544|NCT00000916|Anti-HIV Agents|anti-hiv agents
5855545|NCT00000916|Viral Load|viral load
5855546|NCT00000915|AIDS Vaccines|aids vaccines
5855547|NCT00000915|Incidence|incidence
5855548|NCT00000915|Knowledge, Attitudes, Practice|knowledge, attitudes, practice
5855549|NCT00000915|Risk-Taking|risk-taking
5855550|NCT00000914|Drug Therapy, Combination|drug therapy, combination
5855551|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors
5855552|NCT00000914|Ritonavir|ritonavir
5855553|NCT00000914|Indinavir|indinavir
5855554|NCT00000914|Saquinavir|saquinavir
5855555|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855556|NCT00000914|Viral Load|viral load
5855557|NCT00000914|Nelfinavir|nelfinavir
5855558|NCT00000913|Saquinavir|saquinavir
5855559|NCT00000913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855560|NCT00000913|Anti-HIV Agents|anti-hiv agents
5855561|NCT00000913|Viral Load|viral load
5855562|NCT00000912|Placebos|placebos
5855563|NCT00000912|Drug Therapy, Combination|drug therapy, combination
5855564|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors
5855565|NCT00000912|VX 478|vx 478
5855566|NCT00000912|Anti-HIV Agents|anti-hiv agents
5855567|NCT00000912|Viral Load|viral load
5855568|NCT00000912|efavirenz|efavirenz
5855569|NCT00000911|Semen|semen
5855570|NCT00000911|HIV-1|hiv-1
5857458|NCT00023049|Genes|genes
5855571|NCT00000911|Immunity, Cellular|immunity, cellular
5855572|NCT00000911|Lymph Nodes|lymph nodes
5855574|NCT00000911|Antibodies, Viral|antibodies, viral
5855575|NCT00000911|Vagina|vagina
5855576|NCT00000911|Viral Load|viral load
5855577|NCT00000911|Acute Infection|acute infection
5855578|NCT00000910|Pregnancy|pregnancy
5855579|NCT00000910|Anti-HIV Agents|anti-hiv agents
5855580|NCT00000909|Interleukin-2|interleukin-2
5855581|NCT00000909|Dose-Response Relationship, Drug|dose-response relationship, drug
5855582|NCT00000909|CD4 Lymphocyte Count|cd4 lymphocyte count
5855583|NCT00000909|RNA, Viral|rna, viral
5855584|NCT00000908|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855585|NCT00000908|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855586|NCT00000908|Antiviral Agents|antiviral agents
5855587|NCT00000908|CD4 Lymphocyte Count|cd4 lymphocyte count
5855588|NCT00000908|RNA, Viral|rna, viral
5855589|NCT00000907|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855590|NCT00000907|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855591|NCT00000907|Immunity, Cellular|immunity, cellular
5855592|NCT00000907|Antibiotics, Macrolide|antibiotics, macrolide
5855593|NCT00000907|Mycobacterium avium Complex|mycobacterium avium complex
5855594|NCT00000907|CD4 Lymphocyte Count|cd4 lymphocyte count
5855595|NCT00000907|Disease Progression|disease progression
5855596|NCT00000907|Anti-HIV Agents|anti-hiv agents
5855597|NCT00000906|Methadone|methadone
5855598|NCT00000906|HIV-1|hiv-1
5855599|NCT00000906|Dose-Response Relationship, Drug|dose-response relationship, drug
5855600|NCT00000906|Drug Interactions|drug interactions
5855601|NCT00000906|Drug Therapy, Combination|drug therapy, combination
5855602|NCT00000906|Saquinavir|saquinavir
5855603|NCT00000906|Adolescent Behavior|adolescent behavior
5855604|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors
5855605|NCT00000906|Ritonavir|ritonavir
5855606|NCT00000906|Narcotics|narcotics
5855607|NCT00000906|Substance-Related Disorders|substance-related disorders
5855608|NCT00000905|Immunity, Cellular|immunity, cellular
5855609|NCT00000905|Disease Progression|disease progression
5855610|NCT00000905|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5855611|NCT00000905|DNA, Viral|dna, viral
5855612|NCT00000905|Prognosis|prognosis
5855613|NCT00000904|Vaccines, Synthetic|vaccines, synthetic
5855614|NCT00000904|Viral Vaccines|viral vaccines
5855615|NCT00000904|HIV Antibodies|hiv antibodies
5855616|NCT00000904|HIV Envelope Protein gp160|hiv envelope protein gp160
5855617|NCT00000904|AIDS Vaccines|aids vaccines
5855618|NCT00000904|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5855619|NCT00000904|HIV Seronegativity|hiv seronegativity
5855620|NCT00000904|Antibody Formation|antibody formation
5855622|NCT00000904|Avipoxvirus|avipoxvirus
5855623|NCT00000904|Genetic Vectors|genetic vectors
5855624|NCT00000904|Immunization|immunization
5855625|NCT00000904|HIV Preventive Vaccine|hiv preventive vaccine
5855626|NCT00000903|Drug Therapy, Combination|drug therapy, combination
5855627|NCT00000903|Zidovudine|zidovudine
5855628|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors
5855629|NCT00000903|Lamivudine|lamivudine
5855630|NCT00000903|Indinavir|indinavir
5855631|NCT00000903|RNA, Viral|rna, viral
5855632|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855633|NCT00000903|Nelfinavir|nelfinavir
5855634|NCT00000903|efavirenz|efavirenz
5855635|NCT00000902|Zalcitabine|zalcitabine
5855636|NCT00000902|Didanosine|didanosine
5855637|NCT00000902|Drug Therapy, Combination|drug therapy, combination
5855638|NCT00000902|Zidovudine|zidovudine
5855639|NCT00000902|Nevirapine|nevirapine
5855640|NCT00000902|Stavudine|stavudine
5855641|NCT00000902|Ritonavir|ritonavir
5855642|NCT00000902|Lamivudine|lamivudine
5855643|NCT00000902|RNA, Viral|rna, viral
5855644|NCT00000902|Anti-HIV Agents|anti-hiv agents
5855645|NCT00000902|Nelfinavir|nelfinavir
5855646|NCT00000901|Dose-Response Relationship, Drug|dose-response relationship, drug
5855647|NCT00000901|Drug Therapy, Combination|drug therapy, combination
5855648|NCT00000901|Stavudine|stavudine
5855649|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors
5855650|NCT00000901|Lamivudine|lamivudine
5855651|NCT00000901|Indinavir|indinavir
5855652|NCT00000901|RNA, Viral|rna, viral
5855653|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855654|NCT00000901|Viral Load|viral load
5855655|NCT00000900|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855656|NCT00000900|HIV-1|hiv-1
5855657|NCT00000900|Antiviral Agents|antiviral agents
5857328|NCT00000635|Polymyxin B|polymyxin b
5855658|NCT00000900|CD4 Lymphocyte Count|cd4 lymphocyte count
5855659|NCT00000900|Polymerase Chain Reaction|polymerase chain reaction
5855660|NCT00000900|RNA, Viral|rna, viral
5855661|NCT00000900|Fever|fever
5855662|NCT00000900|Viral Load|viral load
5855663|NCT00000899|Cyclophosphamide|cyclophosphamide
5855664|NCT00000899|Dose-Response Relationship, Drug|dose-response relationship, drug
5855665|NCT00000899|Drug Therapy, Combination|drug therapy, combination
5855666|NCT00000899|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5855667|NCT00000899|Combined Modality Therapy|combined modality therapy
5855668|NCT00000899|Antineoplastic Agents|antineoplastic agents
5855669|NCT00000899|Lymph Nodes|lymph nodes
5855670|NCT00000899|Stavudine|stavudine
5855671|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors
5855672|NCT00000899|Lamivudine|lamivudine
5855673|NCT00000899|DNA, Viral|dna, viral
5855674|NCT00000899|RNA, Viral|rna, viral
5855675|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855676|NCT00000899|Anti-HIV Agents|anti-hiv agents
5855677|NCT00000899|Nelfinavir|nelfinavir
5855678|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating
5855679|NCT00000898|Drug Interactions|drug interactions
5855680|NCT00000898|Drug Therapy, Combination|drug therapy, combination
5855681|NCT00000898|Saquinavir|saquinavir
5855682|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors
5855683|NCT00000898|Ritonavir|ritonavir
5855684|NCT00000898|Nelfinavir|nelfinavir
5855685|NCT00000897|Drug Interactions|drug interactions
5855686|NCT00000897|Zidovudine|zidovudine
5855687|NCT00000897|Sex Factors|sex factors
5855688|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855689|NCT00000897|Contraceptives, Oral|contraceptives, oral
5855690|NCT00000897|Progestational Hormones, Synthetic|progestational hormones, synthetic
5855691|NCT00000897|Anti-HIV Agents|anti-hiv agents
5855692|NCT00000897|Viral Load|viral load
5855693|NCT00000897|Estrogens|estrogens
5855694|NCT00000896|HIV-1|hiv-1
5855695|NCT00000896|Drug Therapy, Combination|drug therapy, combination
5855696|NCT00000896|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5855697|NCT00000896|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855698|NCT00000896|Zidovudine|zidovudine
5855699|NCT00000896|Nevirapine|nevirapine
5855700|NCT00000896|Stavudine|stavudine
5855701|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors
5855702|NCT00000896|Lamivudine|lamivudine
5855703|NCT00000896|Indinavir|indinavir
5855704|NCT00000896|Interleukin-12|interleukin-12
5855705|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855706|NCT00000895|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855707|NCT00000895|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855708|NCT00000895|HIV-1|hiv-1
5855709|NCT00000895|Drug Therapy, Combination|drug therapy, combination
5855710|NCT00000895|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855711|NCT00000895|Mycobacterium avium Complex|mycobacterium avium complex
5855712|NCT00000895|Bacteremia|bacteremia
5855713|NCT00000895|Nevirapine|nevirapine
5855714|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors
5855715|NCT00000895|Risk Factors|risk factors
5855716|NCT00000895|RNA, Viral|rna, viral
5855717|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855718|NCT00000895|Nelfinavir|nelfinavir
5855719|NCT00000894|Infusions, Intravenous|infusions, intravenous
5855721|NCT00000894|Drug Therapy, Combination|drug therapy, combination
5855722|NCT00000894|Administration, Oral|administration, oral
5855723|NCT00000894|Antiviral Agents|antiviral agents
5855724|NCT00000894|Drug Implants|drug implants
5855725|NCT00000894|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5855726|NCT00000894|Eye|eye
5855727|NCT00000894|cidofovir|cidofovir
5855728|NCT00000893|Dose-Response Relationship, Drug|dose-response relationship, drug
5855729|NCT00000893|Drug Therapy, Combination|drug therapy, combination
5855730|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors
5855731|NCT00000893|Nelfinavir|nelfinavir
5855732|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855733|NCT00000893|Area Under Curve|area under curve
5855734|NCT00000893|efavirenz|efavirenz
5855735|NCT00000892|HIV-1|hiv-1
5855736|NCT00000892|Drug Therapy, Combination|drug therapy, combination
5855737|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors
5855738|NCT00000892|Ritonavir|ritonavir
5855739|NCT00000892|Indinavir|indinavir
5855740|NCT00000892|RNA, Viral|rna, viral
5855741|NCT00000892|Saquinavir|saquinavir
5855742|NCT00000892|Delavirdine|delavirdine
5855743|NCT00000892|Nelfinavir|nelfinavir
5855744|NCT00000892|Adenine|adenine
5855745|NCT00000892|Anti-HIV Agents|anti-hiv agents
5855746|NCT00000892|Viral Load|viral load
5855747|NCT00000891|Drug Therapy, Combination|drug therapy, combination
5855748|NCT00000891|Hypersensitivity, Delayed|hypersensitivity, delayed
5855749|NCT00000891|Follow-Up Studies|follow-up studies
5855750|NCT00000891|Anti-HIV Agents|anti-hiv agents
5855751|NCT00000891|Viral Load|viral load
5855752|NCT00000890|HIV-1|hiv-1
5855753|NCT00000890|Muscles|muscles
5855754|NCT00000890|RNA, Viral|rna, viral
5855755|NCT00000890|Body Composition|body composition
5855756|NCT00000890|Anti-HIV Agents|anti-hiv agents
5855757|NCT00000890|Viral Load|viral load
5855758|NCT00000889|Interleukin-2|interleukin-2
5855759|NCT00000889|CD4 Lymphocyte Count|cd4 lymphocyte count
5855760|NCT00000889|Anti-HIV Agents|anti-hiv agents
5855761|NCT00000888|Pregnancy|pregnancy
5855762|NCT00000888|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855763|NCT00000888|Drug Therapy, Combination|drug therapy, combination
5855764|NCT00000888|Administration, Oral|administration, oral
5855765|NCT00000888|Zidovudine|zidovudine
5855766|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors
5855767|NCT00000888|Ritonavir|ritonavir
5855768|NCT00000888|Disease Transmission, Vertical|disease transmission, vertical
5855769|NCT00000888|Anti-HIV Agents|anti-hiv agents
5855771|NCT00000887|Pregnancy|pregnancy
5855772|NCT00000887|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855773|NCT00000887|Drug Therapy, Combination|drug therapy, combination
5855774|NCT00000887|Zidovudine|zidovudine
5855775|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors
5855776|NCT00000887|Lamivudine|lamivudine
5855777|NCT00000887|Disease Transmission, Vertical|disease transmission, vertical
5855778|NCT00000887|Nelfinavir|nelfinavir
5855779|NCT00000887|Anti-HIV Agents|anti-hiv agents
5855780|NCT00000886|HIV Antibodies|hiv antibodies
5855781|NCT00000886|HIV Envelope Protein gp120|hiv envelope protein gp120
5855782|NCT00000886|Drug Carriers|drug carriers
5855783|NCT00000886|Hypersensitivity, Delayed|hypersensitivity, delayed
5855784|NCT00000886|AIDS Vaccines|aids vaccines
5855785|NCT00000886|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5855786|NCT00000886|CD8-Positive T-Lymphocytes|cd8-positive t-lymphocytes
5855787|NCT00000886|HIV Seronegativity|hiv seronegativity
5855788|NCT00000886|Neutralization Tests|neutralization tests
5855789|NCT00000886|Mineral Oil|mineral oil
5855790|NCT00000886|Oleic Acids|oleic acids
5855791|NCT00000886|Mannose|mannose
5855792|NCT00000886|HLA-B7 Antigen|hla-b7 antigen
5855793|NCT00000886|HLA-A2 Antigen|hla-a2 antigen
5855794|NCT00000886|HIV Preventive Vaccine|hiv preventive vaccine
5855795|NCT00000885|HIV-1|hiv-1
5855796|NCT00000885|Drug Therapy, Combination|drug therapy, combination
5855797|NCT00000885|Zidovudine|zidovudine
5855798|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors
5855799|NCT00000885|Lamivudine|lamivudine
5855800|NCT00000885|Indinavir|indinavir
5855801|NCT00000885|RNA, Viral|rna, viral
5855802|NCT00000885|Treatment Failure|treatment failure
5855803|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855804|NCT00000885|Anti-HIV Agents|anti-hiv agents
5855805|NCT00000885|Viral Load|viral load
5855806|NCT00000884|Vaccines, Synthetic|vaccines, synthetic
5855807|NCT00000884|Injections, Intramuscular|injections, intramuscular
5855808|NCT00000884|HIV-1|hiv-1
5855809|NCT00000884|Immunity, Cellular|immunity, cellular
5855810|NCT00000884|AIDS Vaccines|aids vaccines
5855811|NCT00000884|HIV Seronegativity|hiv seronegativity
5855812|NCT00000884|Mucous Membrane|mucous membrane
5855813|NCT00000884|Antibodies, Viral|antibodies, viral
5855814|NCT00000884|Avipoxvirus|avipoxvirus
5855815|NCT00000884|Genetic Vectors|genetic vectors
5855816|NCT00000884|HIV Envelope Protein gp120|hiv envelope protein gp120
5855817|NCT00000884|Immunity, Mucosal|immunity, mucosal
5855818|NCT00000884|Rabies Vaccines|rabies vaccines
5855819|NCT00000884|HIV Preventive Vaccine|hiv preventive vaccine
5855820|NCT00000883|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855821|NCT00000883|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855822|NCT00000883|Antibiotics, Macrolide|antibiotics, macrolide
5855823|NCT00000883|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5855824|NCT00000883|Azithromycin|azithromycin
5855825|NCT00000883|CD4 Lymphocyte Count|cd4 lymphocyte count
5855826|NCT00000883|Anti-HIV Agents|anti-hiv agents
5855828|NCT00000882|Drug Therapy, Combination|drug therapy, combination
5855829|NCT00000882|Stavudine|stavudine
5855830|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors
5855831|NCT00000882|Lamivudine|lamivudine
5855832|NCT00000882|Indinavir|indinavir
5855833|NCT00000882|RNA, Viral|rna, viral
5855834|NCT00000882|Delavirdine|delavirdine
5855835|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855836|NCT00000882|Anti-HIV Agents|anti-hiv agents
5855837|NCT00000882|Viral Load|viral load
5855838|NCT00000881|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855839|NCT00000881|Cytomegalovirus Infections|cytomegalovirus infections
5855840|NCT00000881|Antiviral Agents|antiviral agents
5855841|NCT00000881|cidofovir|cidofovir
5855842|NCT00000880|T-Lymphocytes|t-lymphocytes
5855843|NCT00000880|Lymphocyte Transformation|lymphocyte transformation
5855844|NCT00000880|HIV-1|hiv-1
5855845|NCT00000880|Drug Therapy, Combination|drug therapy, combination
5855846|NCT00000880|Immunosuppressive Agents|immunosuppressive agents
5855847|NCT00000880|Apoptosis|apoptosis
5855848|NCT00000880|Cyclosporine|cyclosporine
5855849|NCT00000880|Anti-HIV Agents|anti-hiv agents
5855850|NCT00000879|Pregnancy|pregnancy
5855851|NCT00000879|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855852|NCT00000879|AIDS Vaccines|aids vaccines
5855853|NCT00000879|Disease Transmission, Vertical|disease transmission, vertical
5855854|NCT00000879|Avipoxvirus|avipoxvirus
5855855|NCT00000879|HIV Preventive Vaccine|hiv preventive vaccine
5855856|NCT00000879|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5855857|NCT00000878|Pregnancy|pregnancy
5855858|NCT00000878|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855859|NCT00000878|Drug Therapy, Combination|drug therapy, combination
5855860|NCT00000878|Stavudine|stavudine
5855861|NCT00000878|Lamivudine|lamivudine
5857459|NCT00023049|Impairment|impairment
5855862|NCT00000878|Disease Transmission, Vertical|disease transmission, vertical
5855863|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855864|NCT00000878|Anti-HIV Agents|anti-hiv agents
5855865|NCT00000878|Viral Load|viral load
5855866|NCT00000877|Rifabutin|rifabutin
5855867|NCT00000877|Drug Therapy, Combination|drug therapy, combination
5855868|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors
5855869|NCT00000877|Indinavir|indinavir
5855870|NCT00000877|HIV Seronegativity|hiv seronegativity
5855871|NCT00000877|Anti-HIV Agents|anti-hiv agents
5855872|NCT00000876|Antiviral Agents|antiviral agents
5855873|NCT00000876|CD4-IgG(2)|cd4-igg(2)
5855875|NCT00000875|Drug Therapy, Combination|drug therapy, combination
5855876|NCT00000875|Immunotherapy, Adoptive|immunotherapy, adoptive
5855877|NCT00000875|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5855878|NCT00000875|Anti-HIV Agents|anti-hiv agents
5855879|NCT00000875|Viral Load|viral load
5855880|NCT00000874|HIV-1|hiv-1
5855881|NCT00000874|Drug Therapy, Combination|drug therapy, combination
5855882|NCT00000874|Zidovudine|zidovudine
5855883|NCT00000874|Stavudine|stavudine
5855884|NCT00000874|Drug Resistance, Microbial|drug resistance, microbial
5855885|NCT00000874|HIV Protease Inhibitors|hiv protease inhibitors
5855886|NCT00000874|CD4 Lymphocyte Count|cd4 lymphocyte count
5855887|NCT00000874|Ritonavir|ritonavir
5855888|NCT00000874|Lamivudine|lamivudine
5855889|NCT00000874|Indinavir|indinavir
5855890|NCT00000874|RNA, Viral|rna, viral
5855891|NCT00000874|Genotype|genotype
5855892|NCT00000874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855893|NCT00000874|Anti-HIV Agents|anti-hiv agents
5855894|NCT00000874|Viral Load|viral load
5855895|NCT00000873|Nutritional Status|nutritional status
5855896|NCT00000873|HIV Seronegativity|hiv seronegativity
5855897|NCT00000873|Infant Food|infant food
5855898|NCT00000872|Virus Replication|virus replication
5855899|NCT00000872|HIV-1|hiv-1
5855900|NCT00000872|Drug Therapy, Combination|drug therapy, combination
5855901|NCT00000872|Zidovudine|zidovudine
5855902|NCT00000872|Nevirapine|nevirapine
5855903|NCT00000872|Stavudine|stavudine
5855904|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors
5855905|NCT00000872|CD4 Lymphocyte Count|cd4 lymphocyte count
5855906|NCT00000872|Lamivudine|lamivudine
5855907|NCT00000872|RNA, Viral|rna, viral
5855908|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855909|NCT00000872|Anti-HIV Agents|anti-hiv agents
5855910|NCT00000872|Viral Load|viral load
5855911|NCT00000872|Nelfinavir|nelfinavir
5855912|NCT00000871|Vaccines, Synthetic|vaccines, synthetic
5852466|NCT00002319|Liposomes|liposomes
5855913|NCT00000871|AIDS Vaccines|aids vaccines
5855914|NCT00000871|HIV Seronegativity|hiv seronegativity
5855915|NCT00000871|Avipoxvirus|avipoxvirus
5855916|NCT00000871|HIV Preventive Vaccine|hiv preventive vaccine
5855917|NCT00000870|Recombinant Proteins|recombinant proteins
5855918|NCT00000870|Infusions, Intravenous|infusions, intravenous
5855919|NCT00000870|Injections, Intravenous|injections, intravenous
5855920|NCT00000870|Injections, Subcutaneous|injections, subcutaneous
5855921|NCT00000870|Interleukin-2|interleukin-2
5855922|NCT00000870|Drug Administration Schedule|drug administration schedule
5855923|NCT00000870|CD4 Lymphocyte Count|cd4 lymphocyte count
5855924|NCT00000870|Quality of Life|quality of life
5855925|NCT00000870|Anti-HIV Agents|anti-hiv agents
5855926|NCT00000869|Pregnancy Trimester, Third|pregnancy trimester, third
5855927|NCT00000869|Placebos|placebos
5855928|NCT00000869|Pregnancy|pregnancy
5855929|NCT00000869|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855930|NCT00000869|Administration, Oral|administration, oral
5855931|NCT00000869|Nevirapine|nevirapine
5855932|NCT00000869|Disease Transmission, Vertical|disease transmission, vertical
5855933|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855934|NCT00000869|Anti-HIV Agents|anti-hiv agents
5855935|NCT00000868|Vaccines, Synthetic|vaccines, synthetic
5855936|NCT00000868|HIV-1|hiv-1
5855937|NCT00000868|Administration, Oral|administration, oral
5855939|NCT00000868|HIV Seronegativity|hiv seronegativity
5855940|NCT00000868|HIV Envelope Protein gp120|hiv envelope protein gp120
5855941|NCT00000868|Recombination, Genetic|recombination, genetic
5855942|NCT00000868|Salmonella typhi|salmonella typhi
5855943|NCT00000868|HIV Preventive Vaccine|hiv preventive vaccine
5855944|NCT00000867|Drug Therapy, Combination|drug therapy, combination
5855945|NCT00000867|Administration, Oral|administration, oral
5855946|NCT00000867|AIDS Dementia Complex|aids dementia complex
5855947|NCT00000867|Zidovudine|zidovudine
5855948|NCT00000867|Anti-HIV Agents|anti-hiv agents
5855949|NCT00000867|Memantine|memantine
5858044|NCT00016731|MRI|mri
5855950|NCT00000866|Vaccines, Synthetic|vaccines, synthetic
5855951|NCT00000866|Vaccinia Virus|vaccinia virus
5855952|NCT00000866|Placebos|placebos
5855953|NCT00000866|HIV-1|hiv-1
5855954|NCT00000866|AIDS Vaccines|aids vaccines
5855955|NCT00000866|HIV Seronegativity|hiv seronegativity
5855956|NCT00000866|Genes, env|genes, env
5855957|NCT00000866|Genes, pol|genes, pol
5855958|NCT00000866|Genes, gag|genes, gag
5855959|NCT00000866|HIV Preventive Vaccine|hiv preventive vaccine
5855960|NCT00000865|Drug Therapy, Combination|drug therapy, combination
5855961|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855962|NCT00000865|Anti-HIV Agents|anti-hiv agents
5855963|NCT00000864|Pregnancy|pregnancy
5855964|NCT00000864|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855965|NCT00000864|HIV-1|hiv-1
5855966|NCT00000864|Drug Therapy, Combination|drug therapy, combination
5855967|NCT00000864|Zidovudine|zidovudine
5855968|NCT00000864|Drug Administration Schedule|drug administration schedule
5855969|NCT00000864|Disease Transmission, Vertical|disease transmission, vertical
5855970|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5855971|NCT00000864|Anti-HIV Agents|anti-hiv agents
5855972|NCT00000863|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855973|NCT00000863|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5855974|NCT00000863|Administration, Oral|administration, oral
5855975|NCT00000863|WR 6026|wr 6026
5855976|NCT00000862|Pregnancy|pregnancy
5855977|NCT00000862|Pregnancy Complications, Infectious|pregnancy complications, infectious
5855978|NCT00000862|Administration, Oral|administration, oral
5855979|NCT00000862|Zidovudine|zidovudine
5855980|NCT00000862|Delivery|delivery
5855981|NCT00000862|Labor|labor
5855982|NCT00000862|Anti-HIV Agents|anti-hiv agents
5855983|NCT00000861|Drug Administration Schedule|drug administration schedule
5855984|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors
5855985|NCT00000861|CD4 Lymphocyte Count|cd4 lymphocyte count
5855986|NCT00000861|Indinavir|indinavir
5855987|NCT00000861|RNA, Viral|rna, viral
5855988|NCT00000861|Anti-HIV Agents|anti-hiv agents
5855989|NCT00000861|Viral Load|viral load
5855990|NCT00000860|Tumor Necrosis Factor|tumor necrosis factor
5855991|NCT00000860|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5855992|NCT00000860|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5855993|NCT00000860|Drug Therapy, Combination|drug therapy, combination
5855994|NCT00000860|Anti-HIV Agents|anti-hiv agents
5855995|NCT00000859|HIV-1|hiv-1
5855996|NCT00000859|Drug Resistance|drug resistance
5855997|NCT00000859|Drug Therapy, Combination|drug therapy, combination
5855998|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors
5855999|NCT00000859|CD4 Lymphocyte Count|cd4 lymphocyte count
5856000|NCT00000859|Ritonavir|ritonavir
5856001|NCT00000859|Indinavir|indinavir
5856002|NCT00000859|Disease Progression|disease progression
5856003|NCT00000859|RNA, Viral|rna, viral
5856004|NCT00000859|Genotype|genotype
5856005|NCT00000859|Nelfinavir|nelfinavir
5856006|NCT00000859|Anti-HIV Agents|anti-hiv agents
5852559|NCT00002301|Ganciclovir|ganciclovir
5856007|NCT00000859|Viral Load|viral load
5856008|NCT00000858|HIV-1|hiv-1
5856009|NCT00000858|Vagina|vagina
5856010|NCT00000857|Recombinant Proteins|recombinant proteins
5856011|NCT00000857|T-Lymphocytes|t-lymphocytes
5856012|NCT00000857|Dose-Response Relationship, Drug|dose-response relationship, drug
5856013|NCT00000857|Mycobacterium avium Complex|mycobacterium avium complex
5856014|NCT00000857|CD4 Lymphocyte Count|cd4 lymphocyte count
5856015|NCT00000857|Interleukin-12|interleukin-12
5856016|NCT00000857|Killer Cells, Natural|killer cells, natural
5856017|NCT00000857|Th1 Cells|th1 cells
5856018|NCT00000857|Interferon Type II|interferon type ii
5856019|NCT00000856|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856020|NCT00000856|Ganciclovir|ganciclovir
5856021|NCT00000856|Drug Therapy, Combination|drug therapy, combination
5856022|NCT00000856|Encephalitis|encephalitis
5856023|NCT00000856|Foscarnet|foscarnet
5856024|NCT00000856|Cytomegalovirus Infections|cytomegalovirus infections
5856025|NCT00000856|Antiviral Agents|antiviral agents
5856026|NCT00000856|Radiculopathy|radiculopathy
5856027|NCT00000855|Zidovudine|zidovudine
5856028|NCT00000855|Anti-HIV Agents|anti-hiv agents
5856029|NCT00000854|Placebos|placebos
5856030|NCT00000854|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856031|NCT00000854|AIDS-Related Complex|aids-related complex
5856033|NCT00000854|HIV Wasting Syndrome|hiv wasting syndrome
5856034|NCT00000854|nandrolone decanoate|nandrolone decanoate
5856035|NCT00000853|Vaccines, Synthetic|vaccines, synthetic
5856037|NCT00000853|HIV Envelope Protein gp120|hiv envelope protein gp120
5856038|NCT00000853|AIDS Vaccines|aids vaccines
5856039|NCT00000853|HIV Seronegativity|hiv seronegativity
5856040|NCT00000853|HIV Preventive Vaccine|hiv preventive vaccine
5856041|NCT00000852|T-Lymphocytes|t-lymphocytes
5856042|NCT00000852|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856043|NCT00000852|Transplantation, Homologous|transplantation, homologous
5856044|NCT00000852|Immunotherapy, Adoptive|immunotherapy, adoptive
5856045|NCT00000851|Didanosine|didanosine
5856046|NCT00000851|Drug Therapy, Combination|drug therapy, combination
5856047|NCT00000851|Antiviral Agents|antiviral agents
5856048|NCT00000851|Stavudine|stavudine
5856049|NCT00000850|HIV-1|hiv-1
5856050|NCT00000850|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5856051|NCT00000850|RNA, Viral|rna, viral
5856052|NCT00000850|Anti-HIV Agents|anti-hiv agents
5856053|NCT00000850|Viral Load|viral load
5856054|NCT00000850|Receptors, Chemokine|receptors, chemokine
5856055|NCT00000849|Interleukin-2|interleukin-2
5856056|NCT00000849|Immunity, Cellular|immunity, cellular
5856057|NCT00000849|Dose-Response Relationship, Drug|dose-response relationship, drug
5856151|NCT00000833|Antiviral Agents|antiviral agents
5856058|NCT00000849|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856059|NCT00000849|AIDS-Related Complex|aids-related complex
5856060|NCT00000849|Viral Load|viral load
5856061|NCT00000848|Administration, Oral|administration, oral
5856062|NCT00000848|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856063|NCT00000848|AIDS-Related Complex|aids-related complex
5856064|NCT00000848|Antiviral Agents|antiviral agents
5856065|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors
5856066|NCT00000848|Biological Markers|biological markers
5856067|NCT00000848|Indinavir|indinavir
5856068|NCT00000848|Viremia|viremia
5856069|NCT00000848|RNA, Viral|rna, viral
5856070|NCT00000848|Saquinavir|saquinavir
5856071|NCT00000847|Vaccines, Synthetic|vaccines, synthetic
5856072|NCT00000847|HIV Envelope Protein gp120|hiv envelope protein gp120
5856073|NCT00000847|AIDS Vaccines|aids vaccines
5856074|NCT00000847|HIV Seronegativity|hiv seronegativity
5856075|NCT00000847|Avipoxvirus|avipoxvirus
5856076|NCT00000847|HIV Preventive Vaccine|hiv preventive vaccine
5856077|NCT00000846|Vaccines, Synthetic|vaccines, synthetic
5856078|NCT00000846|HIV-1|hiv-1
5856079|NCT00000846|AIDS Vaccines|aids vaccines
5856080|NCT00000846|HIV Seronegativity|hiv seronegativity
5856081|NCT00000846|HIV Preventive Vaccine|hiv preventive vaccine
5856082|NCT00000845|Vaccines, Synthetic|vaccines, synthetic
5856083|NCT00000845|AIDS Vaccines|aids vaccines
5856084|NCT00000845|HIV Seronegativity|hiv seronegativity
5856085|NCT00000845|HIV Preventive Vaccine|hiv preventive vaccine
5856086|NCT00000844|Drug Therapy, Combination|drug therapy, combination
5856087|NCT00000844|Adjuvants, Immunologic|adjuvants, immunologic
5856088|NCT00000844|Administration, Oral|administration, oral
5856089|NCT00000844|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856090|NCT00000844|AIDS-Related Complex|aids-related complex
5856091|NCT00000844|Interferon-alpha|interferon-alpha
5856092|NCT00000843|Antiviral Agents|antiviral agents
5856093|NCT00000843|Adenine|adenine
5856094|NCT00000842|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856095|NCT00000842|AIDS-Related Complex|aids-related complex
5856096|NCT00000842|Peripheral Nervous System Diseases|peripheral nervous system diseases
5856097|NCT00000842|Nerve Growth Factors|nerve growth factors
5856098|NCT00000842|Growth Substances|growth substances
5856099|NCT00000841|Drug Therapy, Combination|drug therapy, combination
5856100|NCT00000841|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856101|NCT00000841|Antiviral Agents|antiviral agents
5856102|NCT00000841|Zidovudine|zidovudine
5856103|NCT00000841|Stavudine|stavudine
5856104|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors
5856105|NCT00000841|Lamivudine|lamivudine
5856106|NCT00000841|Indinavir|indinavir
5856107|NCT00000840|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856108|NCT00000840|AIDS-Related Complex|aids-related complex
5856109|NCT00000840|Antiviral Agents|antiviral agents
5856110|NCT00000840|Zidovudine|zidovudine
5856111|NCT00000840|Biological Markers|biological markers
5856112|NCT00000840|Viremia|viremia
5856113|NCT00000840|RNA, Viral|rna, viral
5856114|NCT00000839|Pregnancy Trimester, Third|pregnancy trimester, third
5856115|NCT00000839|Pregnancy|pregnancy
5856116|NCT00000839|Pregnancy Complications, Infectious|pregnancy complications, infectious
5856117|NCT00000839|Didanosine|didanosine
5856118|NCT00000839|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856119|NCT00000839|AIDS-Related Complex|aids-related complex
5856120|NCT00000838|Didanosine|didanosine
5856121|NCT00000838|Drug Therapy, Combination|drug therapy, combination
5856122|NCT00000838|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856123|NCT00000838|AIDS-Related Complex|aids-related complex
5856124|NCT00000838|Antiviral Agents|antiviral agents
5856125|NCT00000838|Zidovudine|zidovudine
5856126|NCT00000838|Stavudine|stavudine
5856127|NCT00000838|Lamivudine|lamivudine
5856128|NCT00000837|Herpesvirus 3, Human|herpesvirus 3, human
5856129|NCT00000837|Viral Vaccines|viral vaccines
5856130|NCT00000837|AIDS-Related Complex|aids-related complex
5856131|NCT00000837|Vaccines, Attenuated|vaccines, attenuated
5856132|NCT00000837|Chickenpox|chickenpox
5856133|NCT00000837|Chickenpox Vaccine|chickenpox vaccine
5856134|NCT00000836|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856135|NCT00000836|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856136|NCT00000836|Antibodies, Monoclonal|antibodies, monoclonal
5856137|NCT00000836|Cytomegalovirus Retinitis|cytomegalovirus retinitis
5856138|NCT00000834|Methotrexate|methotrexate
5856232|NCT00000818|Lymphoid Tissue|lymphoid tissue
5856139|NCT00000834|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856140|NCT00000834|AIDS-Related Complex|aids-related complex
5856141|NCT00000834|Zidovudine|zidovudine
5856142|NCT00000834|Lamivudine|lamivudine
5856143|NCT00000834|Disease Progression|disease progression
5856144|NCT00000834|Anti-Inflammatory Agents|anti-inflammatory agents
5856145|NCT00000834|Anti-HIV Agents|anti-hiv agents
5856146|NCT00000833|Ribavirin|ribavirin
5856147|NCT00000833|Didanosine|didanosine
5856148|NCT00000833|Drug Therapy, Combination|drug therapy, combination
5856149|NCT00000833|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856150|NCT00000833|AIDS-Related Complex|aids-related complex
5856152|NCT00000832|Vaccines, Synthetic|vaccines, synthetic
5856153|NCT00000832|HIV-1|hiv-1
5856154|NCT00000832|Adjuvants, Immunologic|adjuvants, immunologic
5856155|NCT00000832|HIV Envelope Protein gp120|hiv envelope protein gp120
5856156|NCT00000832|AIDS Vaccines|aids vaccines
5856157|NCT00000832|HIV Seronegativity|hiv seronegativity
5856158|NCT00000832|HIV Preventive Vaccine|hiv preventive vaccine
5856159|NCT00000831|Didanosine|didanosine
5856160|NCT00000831|Drug Therapy, Combination|drug therapy, combination
5856161|NCT00000831|AIDS-Related Complex|aids-related complex
5856162|NCT00000831|Antiviral Agents|antiviral agents
5856163|NCT00000831|Zidovudine|zidovudine
5856164|NCT00000831|Stavudine|stavudine
5856165|NCT00000831|Lamivudine|lamivudine
5856166|NCT00000831|Drug Combinations|drug combinations
5856167|NCT00000829|Vaccines, Synthetic|vaccines, synthetic
5856168|NCT00000829|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856169|NCT00000829|AIDS-Related Complex|aids-related complex
5856170|NCT00000829|Pneumococcal Infections|pneumococcal infections
5856171|NCT00000829|Bacterial Vaccines|bacterial vaccines
5856172|NCT00000828|Pregnancy|pregnancy
5856173|NCT00000828|Pregnancy Complications, Infectious|pregnancy complications, infectious
5856174|NCT00000828|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856175|NCT00000828|AIDS-Related Complex|aids-related complex
5856176|NCT00000828|Zidovudine|zidovudine
5856177|NCT00000828|Drug Resistance, Microbial|drug resistance, microbial
5856178|NCT00000828|Disease Transmission, Vertical|disease transmission, vertical
5856179|NCT00000827|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856180|NCT00000827|AIDS-Related Complex|aids-related complex
5856181|NCT00000827|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5856182|NCT00000827|Immunization, Passive|immunization, passive
5856183|NCT00000826|Rifabutin|rifabutin
5856184|NCT00000826|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856185|NCT00000826|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856186|NCT00000826|Dapsone|dapsone
5856187|NCT00000826|Drug Interactions|drug interactions
5856188|NCT00000826|Fluconazole|fluconazole
5856189|NCT00000826|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856190|NCT00000826|AIDS-Related Complex|aids-related complex
5856191|NCT00000826|Clarithromycin|clarithromycin
5856192|NCT00000826|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856193|NCT00000825|HIV-1|hiv-1
5856194|NCT00000825|Interleukin-2|interleukin-2
5856195|NCT00000825|Dose-Response Relationship, Drug|dose-response relationship, drug
5856196|NCT00000825|Antiviral Agents|antiviral agents
5856197|NCT00000825|CD4 Lymphocyte Count|cd4 lymphocyte count
5856198|NCT00000825|DNA, Viral|dna, viral
5856199|NCT00000824|Immunotherapy, Adoptive|immunotherapy, adoptive
5856200|NCT00000824|T-Lymphocyte Subsets|t-lymphocyte subsets
5856201|NCT00000824|T-Lymphocytes, Cytotoxic|t-lymphocytes, cytotoxic
5856202|NCT00000824|Dendritic Cells|dendritic cells
5856203|NCT00000823|Didanosine|didanosine
5856204|NCT00000823|Drug Therapy, Combination|drug therapy, combination
5856205|NCT00000823|Zidovudine|zidovudine
5856206|NCT00000823|Drug Administration Schedule|drug administration schedule
5856207|NCT00000822|Vaccines, Synthetic|vaccines, synthetic
5856208|NCT00000822|Didanosine|didanosine
5856209|NCT00000822|Drug Therapy, Combination|drug therapy, combination
5856210|NCT00000822|HIV Envelope Protein gp160|hiv envelope protein gp160
5856211|NCT00000822|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856212|NCT00000822|AIDS-Related Complex|aids-related complex
5856213|NCT00000822|Stavudine|stavudine
5856214|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors
5856215|NCT00000822|AIDS Vaccines|aids vaccines
5856217|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors
5856218|NCT00000822|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856219|NCT00000821|Interleukin-2|interleukin-2
5856220|NCT00000821|AIDS-Related Complex|aids-related complex
5856221|NCT00000820|Interleukin-2|interleukin-2
5856222|NCT00000820|Drug Therapy, Combination|drug therapy, combination
5856223|NCT00000820|AIDS-Related Complex|aids-related complex
5856224|NCT00000820|Antiviral Agents|antiviral agents
5856225|NCT00000819|AIDS-Related Complex|aids-related complex
5856226|NCT00000819|Prednisone|prednisone
5856227|NCT00000819|AIDS-Associated Nephropathy|aids-associated nephropathy
5856228|NCT00000818|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856229|NCT00000818|AIDS-Related Complex|aids-related complex
5856230|NCT00000818|Zidovudine|zidovudine
5856233|NCT00000817|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856234|NCT00000817|AIDS-Related Complex|aids-related complex
5856235|NCT00000817|Peripheral Nervous System Diseases|peripheral nervous system diseases
5856236|NCT00000817|Amitriptyline|amitriptyline
5856237|NCT00000817|Pain|pain
5856238|NCT00000817|Acupuncture Therapy|acupuncture therapy
5856239|NCT00000816|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856240|NCT00000816|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5857460|NCT00023049|Auditory|auditory
5856241|NCT00000816|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856242|NCT00000816|AIDS-Related Complex|aids-related complex
5856969|NCT00000696|Zidovudine|zidovudine
5856243|NCT00000816|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856244|NCT00000815|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856245|NCT00000815|AIDS-Related Complex|aids-related complex
5856246|NCT00000815|Measles-Mumps-Rubella Vaccine|measles-mumps-rubella vaccine
5856247|NCT00000815|Vaccines, Attenuated|vaccines, attenuated
5856248|NCT00000815|Measles Vaccine|measles vaccine
5856249|NCT00000815|Immunization Schedule|immunization schedule
5856250|NCT00000815|Measles Virus|measles virus
5856251|NCT00000815|Measles|measles
5856252|NCT00000814|Didanosine|didanosine
5856253|NCT00000814|Drug Therapy, Combination|drug therapy, combination
5856254|NCT00000814|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856255|NCT00000814|AIDS-Related Complex|aids-related complex
5856256|NCT00000814|Zidovudine|zidovudine
5856257|NCT00000814|Nevirapine|nevirapine
5856258|NCT00000813|Vaccines, Synthetic|vaccines, synthetic
5856259|NCT00000813|HIV Envelope Protein gp160|hiv envelope protein gp160
5856260|NCT00000813|HIV Envelope Protein gp120|hiv envelope protein gp120
5856261|NCT00000813|AIDS Vaccines|aids vaccines
5856262|NCT00000813|HIV Seronegativity|hiv seronegativity
5856263|NCT00000813|Avipoxvirus|avipoxvirus
5856264|NCT00000813|HIV Preventive Vaccine|hiv preventive vaccine
5856265|NCT00000812|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856266|NCT00000812|AIDS-Related Complex|aids-related complex
5856267|NCT00000812|Thalidomide|thalidomide
5856268|NCT00000811|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856269|NCT00000811|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856270|NCT00000811|Drug Therapy, Combination|drug therapy, combination
5856271|NCT00000811|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856272|NCT00000811|Antiprotozoal Agents|antiprotozoal agents
5856273|NCT00000811|AIDS-Related Complex|aids-related complex
5856274|NCT00000811|Azithromycin|azithromycin
5856275|NCT00000811|Bacterial Infections|bacterial infections
5856276|NCT00000811|atovaquone|atovaquone
5856277|NCT00000810|Didanosine|didanosine
5856278|NCT00000810|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856279|NCT00000810|AIDS-Related Complex|aids-related complex
5856280|NCT00000810|Antiviral Agents|antiviral agents
5856281|NCT00000810|Zidovudine|zidovudine
5856282|NCT00000809|HIV Preventive Vaccine|hiv preventive vaccine
5856283|NCT00000809|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856284|NCT00000808|Pregnancy|pregnancy
5856285|NCT00000808|Pregnancy Complications, Infectious|pregnancy complications, infectious
5856286|NCT00000808|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856287|NCT00000808|AIDS-Related Complex|aids-related complex
5856289|NCT00000807|Sarcoma, Kaposi|sarcoma, kaposi
5856290|NCT00000807|Etoposide|etoposide
5856291|NCT00000807|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856292|NCT00000806|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856293|NCT00000806|AIDS-Related Complex|aids-related complex
5856294|NCT00000806|HIV Protease Inhibitors|hiv protease inhibitors
5856295|NCT00000805|Ganciclovir|ganciclovir
5856296|NCT00000805|Cytomegalovirus Infections|cytomegalovirus infections
5856297|NCT00000805|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856298|NCT00000803|Didanosine|didanosine
5856299|NCT00000803|Drug Therapy, Combination|drug therapy, combination
5856300|NCT00000803|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856301|NCT00000803|AIDS-Related Complex|aids-related complex
5856302|NCT00000803|Antiviral Agents|antiviral agents
5856303|NCT00000803|Zidovudine|zidovudine
5856304|NCT00000802|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856305|NCT00000802|Dapsone|dapsone
5856306|NCT00000802|Antifungal Agents|antifungal agents
5856307|NCT00000802|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856308|NCT00000802|atovaquone|atovaquone
5856309|NCT00000801|Vincristine|vincristine
5856310|NCT00000801|Cyclophosphamide|cyclophosphamide
5856311|NCT00000801|Cytarabine|cytarabine
5856312|NCT00000801|Dexamethasone|dexamethasone
5856313|NCT00000801|Doxorubicin|doxorubicin
5856314|NCT00000801|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5856315|NCT00000801|Combined Modality Therapy|combined modality therapy
5856316|NCT00000801|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856317|NCT00000801|Antineoplastic Agents, Combined|antineoplastic agents, combined
5856318|NCT00000801|Brain Neoplasms|brain neoplasms
5856319|NCT00000801|Lymphoma, High-Grade|lymphoma, high-grade
5856320|NCT00000801|Lymphoma, Intermediate-Grade|lymphoma, intermediate-grade
5856321|NCT00000800|Methadone|methadone
5856322|NCT00000800|Drug Interactions|drug interactions
5856323|NCT00000800|Drug Therapy, Combination|drug therapy, combination
5856324|NCT00000800|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856325|NCT00000800|AIDS-Related Complex|aids-related complex
5856326|NCT00000800|Zidovudine|zidovudine
5856327|NCT00000799|Retinitis|retinitis
5856328|NCT00000799|Cytomegalovirus Infections|cytomegalovirus infections
5856329|NCT00000799|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856330|NCT00000799|Antiviral Agents|antiviral agents
5856332|NCT00000798|Vaccines, Synthetic|vaccines, synthetic
5856334|NCT00000798|Administration, Oral|administration, oral
5856335|NCT00000798|AIDS Vaccines|aids vaccines
5856336|NCT00000798|HIV Seronegativity|hiv seronegativity
5856337|NCT00000798|HIV Preventive Vaccine|hiv preventive vaccine
5856338|NCT00000796|Isoniazid|isoniazid
5856339|NCT00000796|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5856340|NCT00000796|Pyrazinamide|pyrazinamide
5856341|NCT00000796|Pyridoxine|pyridoxine
5856342|NCT00000796|Ofloxacin|ofloxacin
5856343|NCT00000796|Rifampin|rifampin
5856344|NCT00000796|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856345|NCT00000796|Drug Therapy, Combination|drug therapy, combination
5856346|NCT00000796|Ethambutol|ethambutol
5856347|NCT00000796|Clofazimine|clofazimine
5856348|NCT00000796|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856349|NCT00000796|Amikacin|amikacin
5856350|NCT00000796|Drug Resistance, Microbial|drug resistance, microbial
5856351|NCT00000796|Cycloserine|cycloserine
5856352|NCT00000796|Capreomycin Sulfate|capreomycin sulfate
5856353|NCT00000796|Ethionamide|ethionamide
5856354|NCT00000796|Aminosalicylic Acids|aminosalicylic acids
5856355|NCT00000796|Streptomycin|streptomycin
5856356|NCT00000796|p-Aminosalicylic Acid|p-aminosalicylic acid
5856357|NCT00000795|Vaccines, Synthetic|vaccines, synthetic
5856358|NCT00000795|HIV-1|hiv-1
5856359|NCT00000795|AIDS Vaccines|aids vaccines
5856360|NCT00000795|HIV Seronegativity|hiv seronegativity
5856361|NCT00000795|HIV Preventive Vaccine|hiv preventive vaccine
5856362|NCT00000794|Pyrimethamine|pyrimethamine
5856363|NCT00000794|Leucovorin|leucovorin
5856364|NCT00000794|Drug Therapy, Combination|drug therapy, combination
5856365|NCT00000794|Encephalitis|encephalitis
5856366|NCT00000794|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856367|NCT00000794|Antiprotozoal Agents|antiprotozoal agents
5856368|NCT00000794|Clarithromycin|clarithromycin
5856369|NCT00000794|atovaquone|atovaquone
5856370|NCT00000794|Toxoplasmosis, Cerebral|toxoplasmosis, cerebral
5856371|NCT00000794|Sulfadiazine|sulfadiazine
5856372|NCT00000793|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856373|NCT00000793|AIDS-Related Complex|aids-related complex
5856374|NCT00000793|Peripheral Nervous System Diseases|peripheral nervous system diseases
5856375|NCT00000793|Amitriptyline|amitriptyline
5856376|NCT00000793|Pain|pain
5856377|NCT00000793|Mexiletine|mexiletine
5856378|NCT00000793|benzatropine methanesulfonate|benzatropine methanesulfonate
5856379|NCT00000793|Parasympatholytics|parasympatholytics
5856380|NCT00000792|Administration, Oral|administration, oral
5856381|NCT00000792|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856382|NCT00000792|AIDS-Related Complex|aids-related complex
5856383|NCT00000792|Antiviral Agents|antiviral agents
5856384|NCT00000791|Drug Therapy, Combination|drug therapy, combination
5856385|NCT00000791|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856386|NCT00000791|AIDS-Related Complex|aids-related complex
5856387|NCT00000791|Antiviral Agents|antiviral agents
5856388|NCT00000791|Zidovudine|zidovudine
5856389|NCT00000790|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856390|NCT00000790|AIDS-Related Complex|aids-related complex
5856391|NCT00000790|Thalidomide|thalidomide
5856392|NCT00000790|Stomatitis, Aphthous|stomatitis, aphthous
5856393|NCT00000789|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856394|NCT00000789|AIDS-Related Complex|aids-related complex
5856395|NCT00000789|Zidovudine|zidovudine
5856396|NCT00000789|Stavudine|stavudine
5856397|NCT00000788|Methadone|methadone
5856398|NCT00000788|Drug Interactions|drug interactions
5856399|NCT00000788|Drug Therapy, Combination|drug therapy, combination
5856400|NCT00000788|Fluconazole|fluconazole
5856401|NCT00000788|Antifungal Agents|antifungal agents
5856402|NCT00000788|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856403|NCT00000788|AIDS-Related Complex|aids-related complex
5856404|NCT00000787|Sex Behavior|sex behavior
5856405|NCT00000785|Tuberculosis|tuberculosis
5856406|NCT00000785|Mycobacterium tuberculosis|mycobacterium tuberculosis
5856407|NCT00000785|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856408|NCT00000785|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856409|NCT00000785|Drug Resistance, Microbial|drug resistance, microbial
5856410|NCT00000784|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856411|NCT00000784|AIDS-Related Complex|aids-related complex
5856412|NCT00000783|Sex Behavior|sex behavior
5856413|NCT00000783|Sexual Partners|sexual partners
5856414|NCT00000782|Vaccines, Synthetic|vaccines, synthetic
5856415|NCT00000782|Injections, Intradermal|injections, intradermal
5856416|NCT00000782|HIV Antigens|hiv antigens
5856417|NCT00000782|HIV-1|hiv-1
5856418|NCT00000782|HIV Envelope Protein gp160|hiv envelope protein gp160
5856419|NCT00000782|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856420|NCT00000782|AIDS-Related Complex|aids-related complex
5856421|NCT00000782|Hypersensitivity, Delayed|hypersensitivity, delayed
5856422|NCT00000782|AIDS Vaccines|aids vaccines
5856423|NCT00000782|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856424|NCT00000781|Zalcitabine|zalcitabine
5856425|NCT00000781|Didanosine|didanosine
5857461|NCT00023049|Vestibular|vestibular
5856426|NCT00000781|Drug Therapy, Combination|drug therapy, combination
5857589|NCT00022854|Analgesia|analgesia
5856427|NCT00000781|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856428|NCT00000781|Zidovudine|zidovudine
5856429|NCT00000781|Nevirapine|nevirapine
5856430|NCT00000780|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856431|NCT00000780|AIDS-Related Complex|aids-related complex
5856432|NCT00000780|Adolescent Behavior|adolescent behavior
5856433|NCT00000779|Vaccines, Synthetic|vaccines, synthetic
5856434|NCT00000779|HIV-1|hiv-1
5856435|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic
5856436|NCT00000779|AIDS-Related Complex|aids-related complex
5856437|NCT00000779|HIV Envelope Protein gp120|hiv envelope protein gp120
5856438|NCT00000779|AIDS Vaccines|aids vaccines
5856439|NCT00000779|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856440|NCT00000778|Isoniazid|isoniazid
5856441|NCT00000778|Tuberculosis, Pulmonary|tuberculosis, pulmonary
5856442|NCT00000778|Pyridoxine|pyridoxine
5856443|NCT00000778|Ofloxacin|ofloxacin
5856444|NCT00000778|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856445|NCT00000778|Drug Evaluation|drug evaluation
5856446|NCT00000778|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856447|NCT00000778|Sputum|sputum
5856448|NCT00000778|Colony Count, Microbial|colony count, microbial
5856449|NCT00000777|Vaccines, Synthetic|vaccines, synthetic
5856450|NCT00000777|Pregnancy|pregnancy
5856451|NCT00000777|Pregnancy Complications, Infectious|pregnancy complications, infectious
5856452|NCT00000777|HIV Envelope Protein gp160|hiv envelope protein gp160
5856453|NCT00000777|AIDS Vaccines|aids vaccines
5856454|NCT00000777|HIV Preventive Vaccine|hiv preventive vaccine
5856455|NCT00000777|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856456|NCT00000776|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856457|NCT00000776|Meningitis|meningitis
5856458|NCT00000776|Cryptococcosis|cryptococcosis
5856459|NCT00000776|Dexamethasone|dexamethasone
5856460|NCT00000776|Drug Therapy, Combination|drug therapy, combination
5856461|NCT00000776|Fluconazole|fluconazole
5856462|NCT00000776|Flucytosine|flucytosine
5856463|NCT00000776|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856464|NCT00000776|Amphotericin B|amphotericin b
5856465|NCT00000776|Brain Diseases|brain diseases
5856466|NCT00000775|Vaccines, Synthetic|vaccines, synthetic
5856467|NCT00000775|HIV-1|hiv-1
5856468|NCT00000775|HIV Envelope Protein gp120|hiv envelope protein gp120
5853025|NCT00002211|Didanosine|didanosine
5856469|NCT00000775|AIDS Vaccines|aids vaccines
5856470|NCT00000775|HIV Seronegativity|hiv seronegativity
5856471|NCT00000775|HIV Preventive Vaccine|hiv preventive vaccine
5856472|NCT00000774|Vaccines, Synthetic|vaccines, synthetic
5856473|NCT00000774|Virus Replication|virus replication
5856474|NCT00000774|HIV Envelope Protein gp120|hiv envelope protein gp120
5856475|NCT00000774|AIDS Vaccines|aids vaccines
5856476|NCT00000774|HIV Preventive Vaccine|hiv preventive vaccine
5856477|NCT00000774|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856478|NCT00000773|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856479|NCT00000773|Antifungal Agents|antifungal agents
5856480|NCT00000773|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856481|NCT00000773|AIDS-Related Complex|aids-related complex
5856482|NCT00000773|Biological Availability|biological availability
5856483|NCT00000773|atovaquone|atovaquone
5856484|NCT00000772|Ribavirin|ribavirin
5856485|NCT00000772|Didanosine|didanosine
5856486|NCT00000772|Drug Therapy, Combination|drug therapy, combination
5856487|NCT00000772|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856488|NCT00000772|AIDS-Related Complex|aids-related complex
5856489|NCT00000771|Cryptosporidiosis|cryptosporidiosis
5856490|NCT00000771|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856491|NCT00000771|Paromomycin|paromomycin
5856492|NCT00000770|Didanosine|didanosine
5856493|NCT00000770|Drug Therapy, Combination|drug therapy, combination
5856494|NCT00000770|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856495|NCT00000770|AIDS-Related Complex|aids-related complex
5856496|NCT00000770|Zidovudine|zidovudine
5856497|NCT00000770|Nevirapine|nevirapine
5856498|NCT00000769|Sarcoma, Kaposi|sarcoma, kaposi
5856499|NCT00000769|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856500|NCT00000769|Interleukin-4|interleukin-4
5856501|NCT00000768|Intestinal Absorption|intestinal absorption
5856502|NCT00000768|Ganciclovir|ganciclovir
5856503|NCT00000768|Drug Therapy, Combination|drug therapy, combination
5856504|NCT00000768|Cytomegalovirus Infections|cytomegalovirus infections
5856505|NCT00000768|Colitis|colitis
5856506|NCT00000768|Administration, Oral|administration, oral
5856507|NCT00000768|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856508|NCT00000768|Biological Availability|biological availability
5856509|NCT00000768|Glutamic Acid|glutamic acid
5856510|NCT00000767|Vaccines, Synthetic|vaccines, synthetic
5856511|NCT00000767|Vaccinia Virus|vaccinia virus
5856512|NCT00000767|Viral Vaccines|viral vaccines
5856513|NCT00000767|Smallpox Vaccine|smallpox vaccine
5856514|NCT00000767|HIV-1|hiv-1
5856515|NCT00000767|AIDS Vaccines|aids vaccines
5856516|NCT00000767|HIV Seronegativity|hiv seronegativity
5856517|NCT00000767|HIV Preventive Vaccine|hiv preventive vaccine
5856518|NCT00000766|Retinitis|retinitis
5856519|NCT00000766|Ganciclovir|ganciclovir
5856521|NCT00000766|Cytomegalovirus Infections|cytomegalovirus infections
5856522|NCT00000766|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856523|NCT00000765|Zidovudine|zidovudine
5856524|NCT00000764|Interferon Alfa-2a|interferon alfa-2a
5856525|NCT00000764|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856526|NCT00000764|AIDS-Related Complex|aids-related complex
5856527|NCT00000764|Anus Neoplasms|anus neoplasms
5856528|NCT00000764|Papillomavirus, Human|papillomavirus, human
5856529|NCT00000764|Papovaviridae Infections|papovaviridae infections
5856530|NCT00000764|Tumor Virus Infections|tumor virus infections
5856531|NCT00000764|Isotretinoin|isotretinoin
5856532|NCT00000763|Sarcoma, Kaposi|sarcoma, kaposi
5856533|NCT00000763|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856534|NCT00000763|Antineoplastic Agents|antineoplastic agents
5856535|NCT00000762|Vaccines, Synthetic|vaccines, synthetic
5856536|NCT00000762|HIV Envelope Protein gp160|hiv envelope protein gp160
5856537|NCT00000762|HIV Envelope Protein gp120|hiv envelope protein gp120
5856538|NCT00000762|AIDS Vaccines|aids vaccines
5856539|NCT00000762|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856540|NCT00000761|Interferon-gamma, Recombinant|interferon-gamma, recombinant
5856541|NCT00000761|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856542|NCT00000761|AIDS-Related Complex|aids-related complex
5856543|NCT00000760|Didanosine|didanosine
5856544|NCT00000760|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856545|NCT00000760|AIDS-Related Complex|aids-related complex
5856546|NCT00000760|Antiviral Agents|antiviral agents
5856547|NCT00000760|Zidovudine|zidovudine
5856548|NCT00000760|Gene Products, tat|gene products, tat
5856549|NCT00000759|Central Nervous System Diseases|central nervous system diseases
5856550|NCT00000759|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856551|NCT00000759|AIDS-Related Complex|aids-related complex
5856552|NCT00000759|Peripheral Nervous System Diseases|peripheral nervous system diseases
5856553|NCT00000758|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856554|NCT00000758|AIDS-Related Complex|aids-related complex
5856555|NCT00000758|Fluorouracil|fluorouracil
5856556|NCT00000758|Cervix Dysplasia|cervix dysplasia
5856557|NCT00000758|Cervix Diseases|cervix diseases
5856558|NCT00000757|Vaccines, Synthetic|vaccines, synthetic
5853129|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors
5856559|NCT00000757|Vaccinia Virus|vaccinia virus
5856561|NCT00000757|HIV Envelope Protein gp160|hiv envelope protein gp160
5856562|NCT00000757|AIDS Vaccines|aids vaccines
5856563|NCT00000757|HIV Seronegativity|hiv seronegativity
5856564|NCT00000757|HIV Preventive Vaccine|hiv preventive vaccine
5856565|NCT00000756|T-Lymphocytes|t-lymphocytes
5856915|NCT00000705|Hemophilia A|hemophilia a
5856566|NCT00000756|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856567|NCT00000756|AIDS-Related Complex|aids-related complex
5856568|NCT00000756|Immunotherapy, Adoptive|immunotherapy, adoptive
5856569|NCT00000756|Transplantation, Autologous|transplantation, autologous
5856570|NCT00000755|Vaccines, Synthetic|vaccines, synthetic
5856571|NCT00000755|HIV-1|hiv-1
5856572|NCT00000755|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856573|NCT00000755|AIDS-Related Complex|aids-related complex
5856574|NCT00000755|Zidovudine|zidovudine
5856575|NCT00000755|HIV Envelope Protein gp120|hiv envelope protein gp120
5856576|NCT00000755|AIDS Vaccines|aids vaccines
5856577|NCT00000755|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5856578|NCT00000754|Zalcitabine|zalcitabine
5856579|NCT00000754|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856580|NCT00000754|AIDS-Related Complex|aids-related complex
5856581|NCT00000754|Zidovudine|zidovudine
5856582|NCT00000754|Interferon-alpha|interferon-alpha
5856583|NCT00000753|Zalcitabine|zalcitabine
5856584|NCT00000753|Didanosine|didanosine
5856585|NCT00000753|Drug Therapy, Combination|drug therapy, combination
5856586|NCT00000753|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856587|NCT00000753|AIDS-Related Complex|aids-related complex
5856588|NCT00000753|Antiviral Agents|antiviral agents
5856589|NCT00000753|Zidovudine|zidovudine
5856590|NCT00000752|Drug Therapy, Combination|drug therapy, combination
5856591|NCT00000752|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856592|NCT00000752|AIDS-Related Complex|aids-related complex
5856593|NCT00000752|cefuroxime axetil|cefuroxime axetil
5856594|NCT00000752|Beclomethasone|beclomethasone
5856595|NCT00000752|Guaiacol Glyceryl Ether|guaiacol glyceryl ether
5856596|NCT00000752|Sinusitis|sinusitis
5856597|NCT00000752|Ephedrine|ephedrine
5856598|NCT00000751|Pregnancy|pregnancy
5856863|NCT00000712|Drug Therapy, Combination|drug therapy, combination
5856599|NCT00000751|Pregnancy Complications, Infectious|pregnancy complications, infectious
5856600|NCT00000751|Drug Therapy, Combination|drug therapy, combination
5856601|NCT00000751|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856602|NCT00000751|AIDS-Related Complex|aids-related complex
5856603|NCT00000751|Zidovudine|zidovudine
5856604|NCT00000751|Immunoglobulins, Intravenous|immunoglobulins, intravenous
5856605|NCT00000751|Immunization, Passive|immunization, passive
5856606|NCT00000750|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856607|NCT00000750|AIDS-Related Complex|aids-related complex
5856608|NCT00000750|Zidovudine|zidovudine
5856609|NCT00000749|Vaccines, Synthetic|vaccines, synthetic
5856610|NCT00000749|HIV Envelope Protein gp120|hiv envelope protein gp120
5856611|NCT00000749|AIDS Vaccines|aids vaccines
5856612|NCT00000749|HIV Seronegativity|hiv seronegativity
5856613|NCT00000749|HIV Preventive Vaccine|hiv preventive vaccine
5856614|NCT00000748|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856615|NCT00000748|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856616|NCT00000748|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856617|NCT00000748|AIDS-Related Complex|aids-related complex
5856618|NCT00000748|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856619|NCT00000747|Drug Resistance|drug resistance
5856620|NCT00000747|AIDS-Related Complex|aids-related complex
5856621|NCT00000747|Antiviral Agents|antiviral agents
5856622|NCT00000747|Nevirapine|nevirapine
5856623|NCT00000746|Vaccines, Synthetic|vaccines, synthetic
5856624|NCT00000746|Vaccinia Virus|vaccinia virus
5856625|NCT00000746|Viral Vaccines|viral vaccines
5856627|NCT00000746|HIV Envelope Protein gp160|hiv envelope protein gp160
5856628|NCT00000746|HIV Envelope Protein gp120|hiv envelope protein gp120
5856629|NCT00000746|AIDS Vaccines|aids vaccines
5856630|NCT00000746|HIV Seronegativity|hiv seronegativity
5856631|NCT00000746|HIV Preventive Vaccine|hiv preventive vaccine
5856632|NCT00000745|Vaccines, Synthetic|vaccines, synthetic
5856633|NCT00000745|Vaccinia Virus|vaccinia virus
5856634|NCT00000745|Viral Vaccines|viral vaccines
5856635|NCT00000745|HIV-1|hiv-1
5856636|NCT00000745|HIV Envelope Protein gp160|hiv envelope protein gp160
5856637|NCT00000745|AIDS Vaccines|aids vaccines
5856638|NCT00000745|HIV Seronegativity|hiv seronegativity
5856639|NCT00000745|HIV Preventive Vaccine|hiv preventive vaccine
5856640|NCT00000744|Fluconazole|fluconazole
5856641|NCT00000744|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856642|NCT00000744|AIDS-Related Complex|aids-related complex
5856643|NCT00000744|Candidiasis|candidiasis
5856644|NCT00000743|Recombinant Proteins|recombinant proteins
5856645|NCT00000743|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856646|NCT00000743|Antigens, CD4|antigens, cd4
5856647|NCT00000743|AIDS-Related Complex|aids-related complex
5856648|NCT00000743|Zidovudine|zidovudine
5856649|NCT00000742|Didanosine|didanosine
5856650|NCT00000742|Drug Therapy, Combination|drug therapy, combination
5856651|NCT00000742|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856652|NCT00000742|AIDS-Related Complex|aids-related complex
5856653|NCT00000742|Antiviral Agents|antiviral agents
5856654|NCT00000742|Zidovudine|zidovudine
5856655|NCT00000741|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856656|NCT00000741|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856657|NCT00000741|Methylprednisolone|methylprednisolone
5856658|NCT00000740|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856659|NCT00000740|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856660|NCT00000740|AIDS-Related Complex|aids-related complex
5856661|NCT00000740|WR 6026|wr 6026
5856662|NCT00000739|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856663|NCT00000739|Dapsone|dapsone
5856664|NCT00000739|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856665|NCT00000739|AIDS-Related Complex|aids-related complex
5856666|NCT00000739|Drug Administration Schedule|drug administration schedule
5856667|NCT00000738|Central Nervous System Diseases|central nervous system diseases
5856668|NCT00000738|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856669|NCT00000738|AIDS Dementia Complex|aids dementia complex
5856670|NCT00000738|AIDS-Related Complex|aids-related complex
5856671|NCT00000738|Zidovudine|zidovudine
5856672|NCT00000738|Nimodipine|nimodipine
5856673|NCT00000737|Weight Loss|weight loss
5856675|NCT00000737|Cachexia|cachexia
5856676|NCT00000737|Eating Disorders|eating disorders
5856677|NCT00000737|Tetrahydrocannabinol|tetrahydrocannabinol
5856678|NCT00000737|Appetite|appetite
5856679|NCT00000736|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856680|NCT00000736|AIDS-Related Complex|aids-related complex
5856681|NCT00000736|Zidovudine|zidovudine
5856682|NCT00000735|Virus Replication|virus replication
5856683|NCT00000735|T-Lymphocytes|t-lymphocytes
5856684|NCT00000735|Infusions, Intravenous|infusions, intravenous
5856685|NCT00000735|Immunologic Surveillance|immunologic surveillance
5856686|NCT00000735|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856687|NCT00000735|ampligen|ampligen
5856688|NCT00000735|AIDS-Related Complex|aids-related complex
5856689|NCT00000735|Antiviral Agents|antiviral agents
5856690|NCT00000734|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856691|NCT00000734|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856692|NCT00000734|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856693|NCT00000734|Drug Interactions|drug interactions
5856694|NCT00000734|Drug Therapy, Combination|drug therapy, combination
5856695|NCT00000734|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856696|NCT00000734|AIDS-Related Complex|aids-related complex
5856697|NCT00000734|Zidovudine|zidovudine
5856698|NCT00000734|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856700|NCT00000733|T-Lymphocytes|t-lymphocytes
5856701|NCT00000733|Infusions, Intravenous|infusions, intravenous
5856702|NCT00000733|Immunologic Surveillance|immunologic surveillance
5856703|NCT00000733|Administration, Oral|administration, oral
5856704|NCT00000733|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856705|NCT00000732|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856706|NCT00000732|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856707|NCT00000732|Drug Interactions|drug interactions
5856708|NCT00000732|Drug Therapy, Combination|drug therapy, combination
5856709|NCT00000732|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856710|NCT00000732|AIDS-Related Complex|aids-related complex
5856711|NCT00000732|Zidovudine|zidovudine
5856712|NCT00000732|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856713|NCT00000731|Acetaminophen|acetaminophen
5856714|NCT00000731|Drug Interactions|drug interactions
5856715|NCT00000731|Drug Therapy, Combination|drug therapy, combination
5856716|NCT00000731|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856717|NCT00000731|AIDS-Related Complex|aids-related complex
5856718|NCT00000731|Zidovudine|zidovudine
5856719|NCT00000730|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856720|NCT00000730|Trimetrexate|trimetrexate
5856721|NCT00000730|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856722|NCT00000730|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856723|NCT00000730|Leucovorin|leucovorin
5856724|NCT00000730|Folic Acid Antagonists|folic acid antagonists
5856725|NCT00000730|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856726|NCT00000730|Antiprotozoal Agents|antiprotozoal agents
5856727|NCT00000730|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856728|NCT00000729|Virus Replication|virus replication
5856729|NCT00000729|Infusions, Intravenous|infusions, intravenous
5853017|NCT00002213|VX 478|vx 478
5856730|NCT00000729|Dose-Response Relationship, Drug|dose-response relationship, drug
5856731|NCT00000729|Foscarnet|foscarnet
5856732|NCT00000729|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856733|NCT00000729|AIDS-Related Complex|aids-related complex
5856734|NCT00000729|Antiviral Agents|antiviral agents
5856735|NCT00000729|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5853331|NCT00002166|Anti-HIV Agents|anti-hiv agents
5856736|NCT00000728|Immune Tolerance|immune tolerance
5856737|NCT00000728|Interleukin-2|interleukin-2
5856738|NCT00000728|Drug Therapy, Combination|drug therapy, combination
5856739|NCT00000728|AIDS-Related Complex|aids-related complex
5856740|NCT00000728|Zidovudine|zidovudine
5856741|NCT00000728|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5856742|NCT00000727|Sulfadoxine|sulfadoxine
5856743|NCT00000727|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856744|NCT00000727|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856745|NCT00000727|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856746|NCT00000727|Pentamidine|pentamidine
5856747|NCT00000727|Pyrimethamine|pyrimethamine
5856748|NCT00000727|Drug Evaluation|drug evaluation
5856749|NCT00000727|Administration, Inhalation|administration, inhalation
5856750|NCT00000727|Administration, Oral|administration, oral
5856751|NCT00000727|Aerosols|aerosols
5856752|NCT00000727|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856753|NCT00000727|Zidovudine|zidovudine
5856754|NCT00000726|Retinitis|retinitis
5856755|NCT00000726|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856756|NCT00000726|Foscarnet|foscarnet
5856757|NCT00000726|Cytomegalovirus Infections|cytomegalovirus infections
5856758|NCT00000726|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856759|NCT00000726|Antiviral Agents|antiviral agents
5859301|NCT00006437|MMP|mmp
5856760|NCT00000725|Interferon Alfa-2a|interferon alfa-2a
5856761|NCT00000725|Sarcoma, Kaposi|sarcoma, kaposi
5856762|NCT00000725|Dose-Response Relationship, Drug|dose-response relationship, drug
5856763|NCT00000725|Drug Therapy, Combination|drug therapy, combination
5856764|NCT00000725|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856765|NCT00000725|Zidovudine|zidovudine
5856766|NCT00000725|Interferon Type I|interferon type i
5856767|NCT00000724|Trimetrexate|trimetrexate
5856768|NCT00000724|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856769|NCT00000724|Injections, Intravenous|injections, intravenous
5856770|NCT00000724|Leucovorin|leucovorin
5856771|NCT00000724|Drug Evaluation|drug evaluation
5856772|NCT00000724|Drug Therapy, Combination|drug therapy, combination
5856773|NCT00000724|Folic Acid Antagonists|folic acid antagonists
5856774|NCT00000724|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856775|NCT00000724|Antiprotozoal Agents|antiprotozoal agents
5856776|NCT00000723|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856777|NCT00000723|Lymphoma|lymphoma
5856778|NCT00000723|Methotrexate|methotrexate
5856779|NCT00000723|Leucovorin|leucovorin
5856780|NCT00000723|Dexamethasone|dexamethasone
5856781|NCT00000723|Drug Evaluation|drug evaluation
5856782|NCT00000723|Drug Therapy, Combination|drug therapy, combination
5856783|NCT00000723|Combined Modality Therapy|combined modality therapy
5856784|NCT00000723|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856785|NCT00000723|Zidovudine|zidovudine
5856786|NCT00000723|Brain Neoplasms|brain neoplasms
5857580|NCT00022867|Calcium|calcium
5856787|NCT00000722|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857590|NCT00022854|Pain|pain
5856788|NCT00000722|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856789|NCT00000722|Pentamidine|pentamidine
5856790|NCT00000722|Injections, Intravenous|injections, intravenous
5856792|NCT00000722|Administration, Inhalation|administration, inhalation
5856793|NCT00000722|Aerosols|aerosols
5856794|NCT00000722|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856795|NCT00000721|Recombinant Proteins|recombinant proteins
5856796|NCT00000721|Infusions, Intravenous|infusions, intravenous
5856797|NCT00000721|Injections, Intramuscular|injections, intramuscular
5856798|NCT00000721|Injections, Intravenous|injections, intravenous
5856916|NCT00000704|HIV Antigens|hiv antigens
5856799|NCT00000721|Injections, Subcutaneous|injections, subcutaneous
5856800|NCT00000721|Dose-Response Relationship, Drug|dose-response relationship, drug
5856801|NCT00000721|Drug Evaluation|drug evaluation
5856802|NCT00000721|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856803|NCT00000721|Antigens, CD4|antigens, cd4
5856804|NCT00000721|AIDS-Related Complex|aids-related complex
5856805|NCT00000720|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856806|NCT00000720|Placebos|placebos
5856807|NCT00000720|Infusions, Intravenous|infusions, intravenous
5856808|NCT00000720|Gamma-Globulins|gamma-globulins
5856809|NCT00000720|Combined Modality Therapy|combined modality therapy
5856810|NCT00000720|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856811|NCT00000720|Zidovudine|zidovudine
5856812|NCT00000720|Bacterial Infections|bacterial infections
5856813|NCT00000720|Immunization, Passive|immunization, passive
5856814|NCT00000719|Zalcitabine|zalcitabine
5856815|NCT00000719|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856816|NCT00000719|Zidovudine|zidovudine
5856817|NCT00000718|Zalcitabine|zalcitabine
5856818|NCT00000718|Dose-Response Relationship, Drug|dose-response relationship, drug
5856819|NCT00000718|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856820|NCT00000718|AIDS-Related Complex|aids-related complex
5856821|NCT00000718|Zidovudine|zidovudine
5856822|NCT00000717|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856823|NCT00000717|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856824|NCT00000717|Primaquine|primaquine
5856825|NCT00000717|Infusions, Intravenous|infusions, intravenous
5856826|NCT00000717|Drug Evaluation|drug evaluation
5856827|NCT00000717|Drug Therapy, Combination|drug therapy, combination
5856828|NCT00000717|Administration, Oral|administration, oral
5856829|NCT00000717|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856830|NCT00000717|Clindamycin|clindamycin
5856831|NCT00000716|Drug Evaluation|drug evaluation
5856832|NCT00000716|Administration, Oral|administration, oral
5856833|NCT00000716|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856834|NCT00000716|Zidovudine|zidovudine
5856835|NCT00000715|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5856836|NCT00000715|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856837|NCT00000715|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856838|NCT00000715|Pentamidine|pentamidine
5856839|NCT00000715|Infusions, Intravenous|infusions, intravenous
5856840|NCT00000715|Administration, Inhalation|administration, inhalation
5856841|NCT00000715|Aerosols|aerosols
5856842|NCT00000715|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856843|NCT00000715|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5856844|NCT00000714|Trimetrexate|trimetrexate
5856845|NCT00000714|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856846|NCT00000714|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856847|NCT00000714|Leucovorin|leucovorin
5856848|NCT00000714|Drug Evaluation|drug evaluation
5856849|NCT00000714|Drug Therapy, Combination|drug therapy, combination
5856850|NCT00000714|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856851|NCT00000714|Antiprotozoal Agents|antiprotozoal agents
5856852|NCT00000713|Polyribonucleotides|polyribonucleotides
5856853|NCT00000713|HIV Seropositivity|hiv seropositivity
5856854|NCT00000713|Dose-Response Relationship, Drug|dose-response relationship, drug
5856855|NCT00000713|Drug Evaluation|drug evaluation
5856856|NCT00000713|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856857|NCT00000713|ampligen|ampligen
5856858|NCT00000713|AIDS-Related Complex|aids-related complex
5856859|NCT00000713|Antiviral Agents|antiviral agents
5856860|NCT00000712|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856861|NCT00000712|Herpesviridae Infections|herpesviridae infections
5856862|NCT00000712|Drug Evaluation|drug evaluation
5856864|NCT00000712|Herpesvirus 4, Human|herpesvirus 4, human
5856865|NCT00000712|Cytomegalovirus Infections|cytomegalovirus infections
5856866|NCT00000712|Acyclovir|acyclovir
5856867|NCT00000712|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856868|NCT00000712|Antiviral Agents|antiviral agents
5856869|NCT00000712|Zidovudine|zidovudine
5856870|NCT00000711|Neutropenia|neutropenia
5856871|NCT00000711|Drug Evaluation|drug evaluation
5856872|NCT00000711|Drug Therapy, Combination|drug therapy, combination
5856873|NCT00000711|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5856874|NCT00000711|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856875|NCT00000711|AIDS-Related Complex|aids-related complex
5856876|NCT00000711|Zidovudine|zidovudine
5856877|NCT00000710|Injections, Intravenous|injections, intravenous
5856878|NCT00000710|Didanosine|didanosine
5856879|NCT00000710|Dose-Response Relationship, Drug|dose-response relationship, drug
5856880|NCT00000710|Drug Evaluation|drug evaluation
5856881|NCT00000710|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856882|NCT00000710|AIDS-Related Complex|aids-related complex
5856883|NCT00000709|Neuropsychological Tests|neuropsychological tests
5856884|NCT00000709|AIDS Dementia Complex|aids dementia complex
5856885|NCT00000709|Zidovudine|zidovudine
5856886|NCT00000709|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5856887|NCT00000708|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856888|NCT00000708|Meningitis|meningitis
5856889|NCT00000708|Injections, Intravenous|injections, intravenous
5856890|NCT00000708|Cryptococcus neoformans|cryptococcus neoformans
5856891|NCT00000708|Cryptococcosis|cryptococcosis
5856892|NCT00000708|Drug Therapy, Combination|drug therapy, combination
5856893|NCT00000708|Fluconazole|fluconazole
5856894|NCT00000708|Administration, Oral|administration, oral
5856895|NCT00000708|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856896|NCT00000708|Amphotericin B|amphotericin b
5856897|NCT00000707|Respiratory Function Tests|respiratory function tests
5856898|NCT00000707|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856899|NCT00000707|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856900|NCT00000707|Pentamidine|pentamidine
5856902|NCT00000707|HIV Seropositivity|hiv seropositivity
5856903|NCT00000707|Drug Evaluation|drug evaluation
5856904|NCT00000707|Administration, Inhalation|administration, inhalation
5856905|NCT00000707|Aerosols|aerosols
5856906|NCT00000707|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856907|NCT00000706|Quinine|quinine
5856908|NCT00000706|Probenecid|probenecid
5844352|NCT00001986|Alcohol|alcohol
5853511|NCT00002129|vesnarinone|vesnarinone
5856909|NCT00000706|Drug Therapy, Combination|drug therapy, combination
5856910|NCT00000706|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856911|NCT00000706|AIDS-Related Complex|aids-related complex
5856912|NCT00000706|Zidovudine|zidovudine
5856913|NCT00000705|Drug Evaluation|drug evaluation
5856914|NCT00000705|Zidovudine|zidovudine
5856917|NCT00000704|Immunologic Surveillance|immunologic surveillance
5856918|NCT00000704|Zalcitabine|zalcitabine
5856919|NCT00000704|Dose-Response Relationship, Drug|dose-response relationship, drug
5856920|NCT00000704|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856921|NCT00000704|AIDS-Related Complex|aids-related complex
5856922|NCT00000704|CD4-Positive T-Lymphocytes|cd4-positive t-lymphocytes
5856923|NCT00000703|Vincristine|vincristine
5856924|NCT00000703|Lymphoma|lymphoma
5856925|NCT00000703|Methotrexate|methotrexate
5856926|NCT00000703|Cyclophosphamide|cyclophosphamide
5856927|NCT00000703|Cytarabine|cytarabine
5856928|NCT00000703|Dexamethasone|dexamethasone
5856929|NCT00000703|Doxorubicin|doxorubicin
5856930|NCT00000703|Drug Therapy, Combination|drug therapy, combination
5856931|NCT00000703|Combined Modality Therapy|combined modality therapy
5856932|NCT00000703|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856933|NCT00000703|Antineoplastic Agents, Combined|antineoplastic agents, combined
5856934|NCT00000703|Zidovudine|zidovudine
5856935|NCT00000703|Bleomycin|bleomycin
5856936|NCT00000702|AIDS Dementia Complex|aids dementia complex
5856937|NCT00000702|Zidovudine|zidovudine
5856938|NCT00000701|Drug Evaluation|drug evaluation
5856939|NCT00000701|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856940|NCT00000701|AIDS-Related Complex|aids-related complex
5856941|NCT00000701|Zidovudine|zidovudine
5856942|NCT00000700|United States|united states
5856943|NCT00000700|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856944|NCT00000700|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5856945|NCT00000700|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856946|NCT00000700|Zidovudine|zidovudine
5856947|NCT00000699|Ribavirin|ribavirin
5856948|NCT00000699|Inosine Pranobex|inosine pranobex
5856949|NCT00000699|Dose-Response Relationship, Drug|dose-response relationship, drug
5856950|NCT00000699|Drug Evaluation|drug evaluation
5856951|NCT00000699|Drug Therapy, Combination|drug therapy, combination
5856952|NCT00000699|AIDS-Related Complex|aids-related complex
5856953|NCT00000698|Retinitis|retinitis
5856954|NCT00000698|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856955|NCT00000698|Ganciclovir|ganciclovir
5856956|NCT00000698|Cytomegalovirus Infections|cytomegalovirus infections
5856957|NCT00000698|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856958|NCT00000697|Retinitis|retinitis
5856959|NCT00000697|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856960|NCT00000697|Bone Marrow|bone marrow
5856961|NCT00000697|Ganciclovir|ganciclovir
5856962|NCT00000697|Foscarnet|foscarnet
5856963|NCT00000697|Cytomegalovirus Infections|cytomegalovirus infections
5856964|NCT00000697|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856965|NCT00000697|Antiviral Agents|antiviral agents
5856966|NCT00000696|Interferon Alfa-2a|interferon alfa-2a
5856967|NCT00000696|Drug Therapy, Combination|drug therapy, combination
5856968|NCT00000696|AIDS-Related Complex|aids-related complex
5856970|NCT00000695|Drug Evaluation|drug evaluation
5856971|NCT00000695|Drug Therapy, Combination|drug therapy, combination
5856972|NCT00000695|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856973|NCT00000695|Zidovudine|zidovudine
5856974|NCT00000695|Interferon Type I|interferon type i
5856975|NCT00000694|Interferon Alfa-2b|interferon alfa-2b
5856976|NCT00000694|Immune System|immune system
5856977|NCT00000694|Drug Evaluation|drug evaluation
5856978|NCT00000694|Drug Therapy, Combination|drug therapy, combination
5856979|NCT00000694|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5856980|NCT00000694|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856981|NCT00000694|Zidovudine|zidovudine
5856982|NCT00000693|Retinitis|retinitis
5856983|NCT00000693|Drug Evaluation|drug evaluation
5856984|NCT00000693|Drug Therapy, Combination|drug therapy, combination
5856985|NCT00000693|Cytomegalovirus Infections|cytomegalovirus infections
5856986|NCT00000693|Acyclovir|acyclovir
5856987|NCT00000693|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856988|NCT00000693|Zidovudine|zidovudine
5856989|NCT00000692|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5856990|NCT00000692|AIDS-Related Complex|aids-related complex
5856991|NCT00000692|Antiviral Agents|antiviral agents
5856992|NCT00000692|Biological Availability|biological availability
5856993|NCT00000692|1-Deoxynojirimycin|1-deoxynojirimycin
5856994|NCT00000691|Retinitis|retinitis
5856995|NCT00000691|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5856996|NCT00000691|Ganciclovir|ganciclovir
5856997|NCT00000691|Drug Evaluation|drug evaluation
5856998|NCT00000691|Foscarnet|foscarnet
5856999|NCT00000691|Cytomegalovirus Infections|cytomegalovirus infections
5857000|NCT00000691|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857001|NCT00000691|Antiviral Agents|antiviral agents
5857002|NCT00000690|Reference Values|reference values
5857003|NCT00000690|Infusions, Intravenous|infusions, intravenous
5857004|NCT00000690|Intestinal Absorption|intestinal absorption
5857005|NCT00000690|Dextran Sulfate|dextran sulfate
5857006|NCT00000690|Administration, Oral|administration, oral
5857007|NCT00000690|Blood Coagulation|blood coagulation
5857008|NCT00000689|M-BACOD protocol|m-bacod protocol
5857009|NCT00000689|Nervous System Neoplasms|nervous system neoplasms
5857010|NCT00000689|Infusions, Intravenous|infusions, intravenous
5857011|NCT00000689|Injections, Intravenous|injections, intravenous
5857012|NCT00000689|Leucovorin|leucovorin
5857013|NCT00000689|Cytarabine|cytarabine
5857014|NCT00000689|Drug Evaluation|drug evaluation
5857015|NCT00000689|Drug Therapy, Combination|drug therapy, combination
5857016|NCT00000689|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5857017|NCT00000689|Administration, Oral|administration, oral
5857018|NCT00000689|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857019|NCT00000689|Antineoplastic Agents, Combined|antineoplastic agents, combined
5857020|NCT00000688|Retinitis|retinitis
5857021|NCT00000688|Injections, Intravenous|injections, intravenous
5857022|NCT00000688|Ganciclovir|ganciclovir
5857023|NCT00000688|Cytomegalovirus Infections|cytomegalovirus infections
5857024|NCT00000688|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857025|NCT00000687|Interferon Alfa-2a|interferon alfa-2a
5857026|NCT00000687|Drug Evaluation|drug evaluation
5857027|NCT00000687|Drug Therapy, Combination|drug therapy, combination
5857028|NCT00000687|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857029|NCT00000687|Zidovudine|zidovudine
5857030|NCT00000686|Drug Evaluation|drug evaluation
5857031|NCT00000686|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857032|NCT00000686|AIDS-Related Complex|aids-related complex
5857033|NCT00000686|Antiviral Agents|antiviral agents
5857034|NCT00000686|Zidovudine|zidovudine
5857035|NCT00000685|Kidney Diseases|kidney diseases
5857036|NCT00000685|Drug Evaluation|drug evaluation
5857037|NCT00000685|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857038|NCT00000685|Zidovudine|zidovudine
5857039|NCT00000685|Renal Dialysis|renal dialysis
5857040|NCT00000684|Infusions, Intravenous|infusions, intravenous
5857041|NCT00000684|Dextran Sulfate|dextran sulfate
5857042|NCT00000684|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857043|NCT00000683|Vaccines, Synthetic|vaccines, synthetic
5857044|NCT00000683|Vaccinia Virus|vaccinia virus
5857045|NCT00000683|Viral Envelope Proteins|viral envelope proteins
5857046|NCT00000683|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857047|NCT00000683|AIDS Vaccines|aids vaccines
5857048|NCT00000683|HIV Seronegativity|hiv seronegativity
5857049|NCT00000683|HIV Preventive Vaccine|hiv preventive vaccine
5857050|NCT00000682|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857051|NCT00000682|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5857052|NCT00000682|Zalcitabine|zalcitabine
5857053|NCT00000682|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857054|NCT00000682|Zidovudine|zidovudine
5857055|NCT00000681|Vincristine|vincristine
5857056|NCT00000681|Doxorubicin|doxorubicin
5857057|NCT00000681|Drug Evaluation|drug evaluation
5857058|NCT00000681|Drug Therapy, Combination|drug therapy, combination
5857059|NCT00000681|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5857060|NCT00000681|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857061|NCT00000681|Zidovudine|zidovudine
5857062|NCT00000681|Bleomycin|bleomycin
5857063|NCT00000680|T-Lymphocytes, Suppressor-Effector|t-lymphocytes, suppressor-effector
5857064|NCT00000680|Indium Radioisotopes|indium radioisotopes
5857065|NCT00000680|Leukapheresis|leukapheresis
5857066|NCT00000680|Interleukin-2|interleukin-2
5857067|NCT00000680|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857068|NCT00000680|AIDS-Related Complex|aids-related complex
5857069|NCT00000680|Zidovudine|zidovudine
5857070|NCT00000680|Immunization, Passive|immunization, passive
5857071|NCT00000679|Zalcitabine|zalcitabine
5857072|NCT00000679|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857073|NCT00000679|AIDS-Related Complex|aids-related complex
5857074|NCT00000679|Zidovudine|zidovudine
5857075|NCT00000678|Zalcitabine|zalcitabine
5857076|NCT00000678|Drug Evaluation|drug evaluation
5857077|NCT00000678|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857078|NCT00000678|AIDS-Related Complex|aids-related complex
5857079|NCT00000678|Zidovudine|zidovudine
5857080|NCT00000677|Sch 39304|sch 39304
5857081|NCT00000677|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857082|NCT00000677|Meningitis|meningitis
5857083|NCT00000677|Cryptococcosis|cryptococcosis
5857084|NCT00000677|Drug Evaluation|drug evaluation
5857085|NCT00000677|Antifungal Agents|antifungal agents
5857086|NCT00000677|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857088|NCT00000676|Fluconazole|fluconazole
5857089|NCT00000676|Clotrimazole|clotrimazole
5844592|NCT00001763|MAC|mac
5857090|NCT00000676|Antifungal Agents|antifungal agents
5857091|NCT00000676|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857092|NCT00000676|AIDS-Related Complex|aids-related complex
5857093|NCT00000675|Recombinant Proteins|recombinant proteins
5857094|NCT00000675|IgG|igg
5857095|NCT00000675|Drug Evaluation|drug evaluation
5857096|NCT00000675|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857097|NCT00000675|Antigens, CD4|antigens, cd4
5857098|NCT00000675|AIDS-Related Complex|aids-related complex
5857099|NCT00000675|Carrier Proteins|carrier proteins
5857100|NCT00000674|Toxoplasmosis|toxoplasmosis
5857101|NCT00000674|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857102|NCT00000674|Pyrimethamine|pyrimethamine
5857103|NCT00000674|Leucovorin|leucovorin
5857104|NCT00000674|Drug Evaluation|drug evaluation
5857105|NCT00000674|Drug Therapy, Combination|drug therapy, combination
5857106|NCT00000674|Encephalitis|encephalitis
5857107|NCT00000674|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857108|NCT00000674|Clindamycin|clindamycin
5857109|NCT00000673|Retinitis|retinitis
5857110|NCT00000673|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857111|NCT00000673|Ganciclovir|ganciclovir
5857112|NCT00000673|Cytomegalovirus Infections|cytomegalovirus infections
5857113|NCT00000673|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857114|NCT00000672|Didanosine|didanosine
5857115|NCT00000672|Zidovudine|zidovudine
5857116|NCT00000671|Didanosine|didanosine
5857117|NCT00000671|Zidovudine|zidovudine
5857118|NCT00000670|Probenecid|probenecid
5857119|NCT00000670|Drug Evaluation|drug evaluation
5857120|NCT00000670|Drug Interactions|drug interactions
5857121|NCT00000670|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857122|NCT00000670|Zidovudine|zidovudine
5857123|NCT00000669|Didanosine|didanosine
5857124|NCT00000669|Drug Evaluation|drug evaluation
5857125|NCT00000669|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857126|NCT00000669|AIDS-Related Complex|aids-related complex
5857127|NCT00000668|Retinitis|retinitis
5857128|NCT00000668|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857129|NCT00000668|Ganciclovir|ganciclovir
5857130|NCT00000668|Cytomegalovirus Infections|cytomegalovirus infections
5857131|NCT00000668|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857132|NCT00000667|Vaccines, Synthetic|vaccines, synthetic
5857133|NCT00000667|Injections, Intradermal|injections, intradermal
5857134|NCT00000667|HIV Antigens|hiv antigens
5857135|NCT00000667|HIV Seropositivity|hiv seropositivity
5857136|NCT00000667|HIV-1|hiv-1
5857137|NCT00000667|Drug Evaluation|drug evaluation
5857138|NCT00000667|Hypersensitivity, Delayed|hypersensitivity, delayed
5857139|NCT00000667|AIDS Vaccines|aids vaccines
5857140|NCT00000667|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5857141|NCT00000666|Toxoplasmosis|toxoplasmosis
5857142|NCT00000666|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857143|NCT00000666|Pyrimethamine|pyrimethamine
5857144|NCT00000666|Drug Evaluation|drug evaluation
5857145|NCT00000666|Encephalitis|encephalitis
5857146|NCT00000666|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857147|NCT00000665|Retinitis|retinitis
5857148|NCT00000665|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857149|NCT00000665|Ganciclovir|ganciclovir
5857150|NCT00000665|Foscarnet|foscarnet
5857151|NCT00000665|Cytomegalovirus Infections|cytomegalovirus infections
5857152|NCT00000665|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857153|NCT00000665|Antiviral Agents|antiviral agents
5857154|NCT00000664|Polyethylene Glycols|polyethylene glycols
5857155|NCT00000664|Interleukin-2|interleukin-2
5857156|NCT00000664|Drug Evaluation|drug evaluation
5857157|NCT00000664|Zidovudine|zidovudine
5857158|NCT00000663|Recombinant Proteins|recombinant proteins
5857159|NCT00000663|Injections, Intravenous|injections, intravenous
5857161|NCT00000663|Drug Evaluation|drug evaluation
5857162|NCT00000663|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857163|NCT00000663|Antigens, CD4|antigens, cd4
5857164|NCT00000663|Carrier Proteins|carrier proteins
5857165|NCT00000662|Drugs, Investigational|drugs, investigational
5857166|NCT00000662|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857167|NCT00000662|AIDS-Related Complex|aids-related complex
5857168|NCT00000662|Zidovudine|zidovudine
5857169|NCT00000661|Oxazepam|oxazepam
5857170|NCT00000661|Drug Evaluation|drug evaluation
5857171|NCT00000661|Drug Interactions|drug interactions
5857172|NCT00000661|Zidovudine|zidovudine
5857173|NCT00000660|Sarcoma, Kaposi|sarcoma, kaposi
5857174|NCT00000660|Drug Evaluation|drug evaluation
5857175|NCT00000660|Etoposide|etoposide
5857176|NCT00000660|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857177|NCT00000659|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857178|NCT00000659|Antigens, CD4|antigens, cd4
5857179|NCT00000659|AIDS-Related Complex|aids-related complex
5857180|NCT00000659|Zidovudine|zidovudine
5857181|NCT00000658|M-BACOD protocol|m-bacod protocol
5857182|NCT00000658|Granulocyte-Macrophage Colony-Stimulating Factor|granulocyte-macrophage colony-stimulating factor
5853779|NCT00002070|Neutropenia|neutropenia
5857183|NCT00000658|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857184|NCT00000658|Allopurinol|allopurinol
5857185|NCT00000658|Antineoplastic Agents, Combined|antineoplastic agents, combined
5857186|NCT00000657|Didanosine|didanosine
5857187|NCT00000657|Drug Evaluation|drug evaluation
5857188|NCT00000657|Drugs, Investigational|drugs, investigational
5857189|NCT00000657|AIDS Dementia Complex|aids dementia complex
5857190|NCT00000657|Zidovudine|zidovudine
5857191|NCT00000656|Didanosine|didanosine
5857192|NCT00000656|Drug Therapy, Combination|drug therapy, combination
5857193|NCT00000656|Zidovudine|zidovudine
5857194|NCT00000655|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5857195|NCT00000655|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857196|NCT00000655|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5857197|NCT00000655|Naphthoquinones|naphthoquinones
5857198|NCT00000655|Antifungal Agents|antifungal agents
5857199|NCT00000655|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857200|NCT00000655|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5857201|NCT00000654|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857202|NCT00000654|Pyrimidine Nucleosides|pyrimidine nucleosides
5857203|NCT00000654|Herpesviridae Infections|herpesviridae infections
5857204|NCT00000654|Drug Evaluation|drug evaluation
5857205|NCT00000654|Antiviral Agents|antiviral agents
5857206|NCT00000654|Hepatitis B|hepatitis b
5857207|NCT00000653|Zalcitabine|zalcitabine
5857208|NCT00000653|Drug Evaluation|drug evaluation
5857209|NCT00000653|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857210|NCT00000653|AIDS-Related Complex|aids-related complex
5857211|NCT00000652|Didanosine|didanosine
5857212|NCT00000652|Drug Evaluation|drug evaluation
5857213|NCT00000652|Drug Therapy, Combination|drug therapy, combination
5857214|NCT00000652|Zidovudine|zidovudine
5857215|NCT00000651|Zalcitabine|zalcitabine
5857216|NCT00000651|Antiviral Agents|antiviral agents
5857217|NCT00000651|Zidovudine|zidovudine
5857218|NCT00000650|Drug Evaluation|drug evaluation
5857219|NCT00000650|Ditiocarb|ditiocarb
5857220|NCT00000650|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857221|NCT00000649|Drug Therapy, Combination|drug therapy, combination
5857222|NCT00000649|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857223|NCT00000649|AIDS-Related Complex|aids-related complex
5857224|NCT00000649|Zidovudine|zidovudine
5857225|NCT00000649|Nevirapine|nevirapine
5857226|NCT00000648|Penicillin G|penicillin g
5857227|NCT00000648|Neurosyphilis|neurosyphilis
5857228|NCT00000648|Drug Evaluation|drug evaluation
5857229|NCT00000648|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857230|NCT00000648|AIDS-Related Complex|aids-related complex
5857231|NCT00000648|Ceftriaxone|ceftriaxone
5857232|NCT00000647|Recombinant Proteins|recombinant proteins
5857234|NCT00000647|Drug Evaluation|drug evaluation
5857235|NCT00000647|Drug Therapy, Combination|drug therapy, combination
5857236|NCT00000647|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857237|NCT00000647|Antigens, CD4|antigens, cd4
5857238|NCT00000647|Zidovudine|zidovudine
5857239|NCT00000647|Carrier Proteins|carrier proteins
5857240|NCT00000647|Interferon Type I|interferon type i
5857241|NCT00000646|Pentoxifylline|pentoxifylline
5857242|NCT00000646|Virus Replication|virus replication
5857243|NCT00000646|Tumor Necrosis Factor|tumor necrosis factor
5857244|NCT00000646|Drug Evaluation|drug evaluation
5857245|NCT00000646|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857247|NCT00000646|Drug Synergism|drug synergism
5857248|NCT00000645|Drug Evaluation|drug evaluation
5857907|NCT00018031|Cirrhosis|cirrhosis
5857249|NCT00000645|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857250|NCT00000645|AIDS-Related Complex|aids-related complex
5857251|NCT00000645|Antiviral Agents|antiviral agents
5857252|NCT00000644|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857253|NCT00000644|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5857254|NCT00000644|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857255|NCT00000644|Clarithromycin|clarithromycin
5857256|NCT00000643|Toxoplasmosis|toxoplasmosis
5857257|NCT00000643|Pyrimethamine|pyrimethamine
5857258|NCT00000643|Leucovorin|leucovorin
5857259|NCT00000643|Drug Evaluation|drug evaluation
5857260|NCT00000643|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857261|NCT00000643|AIDS-Related Complex|aids-related complex
5857262|NCT00000643|Brain Diseases|brain diseases
5857263|NCT00000642|Recombinant Proteins|recombinant proteins
5857264|NCT00000642|Pregnancy Trimester, Third|pregnancy trimester, third
5857265|NCT00000642|Pregnancy|pregnancy
5857266|NCT00000642|Pregnancy Complications, Infectious|pregnancy complications, infectious
5857267|NCT00000642|IgG|igg
5857268|NCT00000642|Drug Evaluation|drug evaluation
5857269|NCT00000642|Antigens, CD4|antigens, cd4
5857270|NCT00000642|AIDS-Related Complex|aids-related complex
5857271|NCT00000642|Immunization, Passive|immunization, passive
5857272|NCT00000641|Rifampin|rifampin
5853866|NCT00002055|Pentamidine|pentamidine
5857273|NCT00000641|Mycobacterium avium-intracellulare Infection|mycobacterium avium-intracellulare infection
5857274|NCT00000641|Drug Evaluation|drug evaluation
5857275|NCT00000641|Drug Therapy, Combination|drug therapy, combination
5857276|NCT00000641|Ethambutol|ethambutol
5857277|NCT00000641|Clofazimine|clofazimine
5857278|NCT00000641|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857279|NCT00000641|Amikacin|amikacin
5857280|NCT00000641|Azithromycin|azithromycin
5857281|NCT00000641|Ciprofloxacin|ciprofloxacin
5857282|NCT00000640|Trimethoprim-Sulfamethoxazole Combination|trimethoprim-sulfamethoxazole combination
5857283|NCT00000640|Pneumonia, Pneumocystis carinii|pneumonia, pneumocystis carinii
5857284|NCT00000640|Primaquine|primaquine
5857285|NCT00000640|Dapsone|dapsone
5857286|NCT00000640|Drug Therapy, Combination|drug therapy, combination
5857287|NCT00000640|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857288|NCT00000640|Clindamycin|clindamycin
5857289|NCT00000640|Sulfamethoxazole-Trimethoprim|sulfamethoxazole-trimethoprim
5857290|NCT00000639|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857291|NCT00000639|Meningitis|meningitis
5857292|NCT00000639|Cryptococcosis|cryptococcosis
5857293|NCT00000639|Drug Evaluation|drug evaluation
5857294|NCT00000639|Drug Therapy, Combination|drug therapy, combination
5857295|NCT00000639|Fluconazole|fluconazole
5857296|NCT00000639|Flucytosine|flucytosine
5857297|NCT00000639|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857298|NCT00000639|Amphotericin B|amphotericin b
5857299|NCT00000639|Brain Diseases|brain diseases
5857300|NCT00000638|Tuberculosis|tuberculosis
5857301|NCT00000638|Isoniazid|isoniazid
5857302|NCT00000638|Mycobacterium tuberculosis|mycobacterium tuberculosis
5857303|NCT00000638|Pyrazinamide|pyrazinamide
5857304|NCT00000638|Pyridoxine|pyridoxine
5857305|NCT00000638|Rifampin|rifampin
5857306|NCT00000638|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857307|NCT00000638|Drug Therapy, Combination|drug therapy, combination
5857308|NCT00000638|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857309|NCT00000638|Antitubercular Agents|antitubercular agents
5857310|NCT00000638|AIDS-Related Complex|aids-related complex
5857311|NCT00000637|Didanosine|didanosine
5857312|NCT00000637|Drug Evaluation|drug evaluation
5857313|NCT00000637|Drug Therapy, Combination|drug therapy, combination
5857314|NCT00000637|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857315|NCT00000637|AIDS-Related Complex|aids-related complex
5857316|NCT00000637|Zidovudine|zidovudine
5857317|NCT00000636|Tuberculosis|tuberculosis
5857318|NCT00000636|Isoniazid|isoniazid
5857319|NCT00000636|Pyrazinamide|pyrazinamide
5857320|NCT00000636|Pyridoxine|pyridoxine
5857321|NCT00000636|Rifampin|rifampin
5857322|NCT00000636|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857323|NCT00000636|Drug Therapy, Combination|drug therapy, combination
5857324|NCT00000636|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857325|NCT00000636|Antitubercular Agents|antitubercular agents
5857326|NCT00000636|AIDS-Related Complex|aids-related complex
5857329|NCT00000635|Trifluridine|trifluridine
5857330|NCT00000635|AIDS-Related Opportunistic Infections|aids-related opportunistic infections
5857331|NCT00000635|Herpesviridae Infections|herpesviridae infections
5857332|NCT00000635|Drug Evaluation|drug evaluation
5857333|NCT00000635|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857334|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local
5857335|NCT00000635|Antiviral Agents|antiviral agents
5857336|NCT00000634|Benzodiazepines|benzodiazepines
5857337|NCT00000634|Drug Evaluation|drug evaluation
5857338|NCT00000634|Drugs, Investigational|drugs, investigational
5857339|NCT00000634|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857340|NCT00000634|Antiviral Agents|antiviral agents
5857341|NCT00000633|Vaccines, Synthetic|vaccines, synthetic
5857342|NCT00000633|Vaccinia Virus|vaccinia virus
5857343|NCT00000633|Viral Vaccines|viral vaccines
5857345|NCT00000633|HIV Envelope Protein gp160|hiv envelope protein gp160
5857346|NCT00000633|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857347|NCT00000633|AIDS-Related Complex|aids-related complex
5857348|NCT00000633|AIDS Vaccines|aids vaccines
5857349|NCT00000633|HIV Therapeutic Vaccine|hiv therapeutic vaccine
5857350|NCT00000632|Vaccines, Synthetic|vaccines, synthetic
5857351|NCT00000632|Drug Evaluation|drug evaluation
5857352|NCT00000632|Adjuvants, Immunologic|adjuvants, immunologic
5857353|NCT00000632|AIDS Vaccines|aids vaccines
5857354|NCT00000632|HIV Preventive Vaccine|hiv preventive vaccine
5857355|NCT00000631|Vaccines, Synthetic|vaccines, synthetic
5857356|NCT00000631|Vaccinia Virus|vaccinia virus
5857357|NCT00000631|Viral Envelope Proteins|viral envelope proteins
5857358|NCT00000631|Viral Vaccines|viral vaccines
5857359|NCT00000631|AIDS Vaccines|aids vaccines
5857360|NCT00000631|HIV Seronegativity|hiv seronegativity
5857361|NCT00000631|HIV Preventive Vaccine|hiv preventive vaccine
5857362|NCT00000630|Vaccines, Synthetic|vaccines, synthetic
5857363|NCT00000630|Vaccinia Virus|vaccinia virus
5857364|NCT00000630|Viral Envelope Proteins|viral envelope proteins
5853689|NCT00002088|Diarrhea|diarrhea
5857365|NCT00000630|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857366|NCT00000630|AIDS Vaccines|aids vaccines
5857367|NCT00000630|HIV Seronegativity|hiv seronegativity
5857368|NCT00000630|HIV Preventive Vaccine|hiv preventive vaccine
5857369|NCT00000629|Valproic Acid|valproic acid
5857370|NCT00000629|Zidovudine|zidovudine
5857371|NCT00000628|Drug Evaluation|drug evaluation
5857372|NCT00000628|Drugs, Investigational|drugs, investigational
5857373|NCT00000628|Drug Therapy, Combination|drug therapy, combination
5857374|NCT00000628|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857375|NCT00000628|AIDS-Related Complex|aids-related complex
5857376|NCT00000628|Antiviral Agents|antiviral agents
5857377|NCT00000627|Pilot Projects|pilot projects
5857378|NCT00000627|Histoplasmosis|histoplasmosis
5857379|NCT00000627|Drug Evaluation|drug evaluation
5857380|NCT00000627|Fluconazole|fluconazole
5857381|NCT00000627|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857382|NCT00000627|Recurrence|recurrence
5857383|NCT00000626|Granulocyte Colony-Stimulating Factor|granulocyte colony-stimulating factor
5857384|NCT00000626|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5857385|NCT00000626|Antineoplastic Agents, Combined|antineoplastic agents, combined
5857386|NCT00000626|AIDS-Related Complex|aids-related complex
5857387|NCT00000626|Hodgkin Disease|hodgkin disease
5857388|NCT00000626|ABVD protocol|abvd protocol
5857389|NCT00000625|Zalcitabine|zalcitabine
5857390|NCT00000625|Didanosine|didanosine
5857391|NCT00000625|Drug Therapy, Combination|drug therapy, combination
5857392|NCT00000625|AIDS-Related Complex|aids-related complex
5857393|NCT00000625|Antiviral Agents|antiviral agents
5857394|NCT00000625|Zidovudine|zidovudine
5857395|NCT00023192|Campath 1-H|campath 1-h
5857396|NCT00023192|T-Cell Depletion|t-cell depletion
5857397|NCT00023192|Therapy|therapy
5857398|NCT00023192|Stem Cell Transplantation|stem cell transplantation
5857399|NCT00023192|Chronic Granulomatous Disease|chronic granulomatous disease
5857400|NCT00023192|CGD|cgd
5857401|NCT00023166|Phase I|phase i
5857402|NCT00023166|Open label|open label
5857403|NCT00023166|Safety/efficacy|safety/efficacy
5857404|NCT00023166|Lymphomas|lymphomas
5857405|NCT00023166|Advanced primary and/or metastatic solid tumors|advanced primary and/or metastatic solid tumors
5857406|NCT00023166|Neoplasms|neoplasms
5857407|NCT00023166|Neoplasm metastasis|neoplasm metastasis
5857408|NCT00023153|Drug Resistance|drug resistance
5857409|NCT00023153|Viral Load|viral load
5857410|NCT00023153|Liver|liver
5857411|NCT00023153|Immunology|immunology
5857412|NCT00023153|Liver Histology|liver histology
5857413|NCT00023153|Hepatitis B|hepatitis b
5857414|NCT00023153|HBV|hbv
5857415|NCT00023153|HIV|hiv
5857416|NCT00023140|biomarkers|biomarkers
5857417|NCT00023140|exposure|exposure
5857418|NCT00023140|adducts|adducts
5857419|NCT00023140|metabolites|metabolites
5857420|NCT00023140|butadiene|butadiene
5857421|NCT00023127|Asthma|asthma
5857422|NCT00023127|Allergen|allergen
5857423|NCT00023127|Cockroach|cockroach
5857424|NCT00023114|lung function|lung function
5857425|NCT00023114|smoking|smoking
5857426|NCT00023114|metabolism|metabolism
5857427|NCT00023101|lead|lead
5857443|NCT00023075|Spastic Paraparesis|spastic paraparesis
5857444|NCT00023075|Healthy Volunteer|healthy volunteer
5857445|NCT00023075|HV|hv
5857446|NCT00023075|Normal Control|normal control
5857447|NCT00023062|Natural History|natural history
5857448|NCT00023062|Motor Cortex|motor cortex
5857449|NCT00023062|Behavior|behavior
5857450|NCT00023062|Healthy Volunteers|healthy volunteers
5857451|NCT00023062|Motor Control|motor control
5857452|NCT00023062|Parkinson Disease|parkinson disease
5857453|NCT00023062|Parkinson's|parkinson's
5857454|NCT00023062|Healthy Volunteer|healthy volunteer
5857455|NCT00023062|HV|hv
5857456|NCT00023062|Normal Control|normal control
5857462|NCT00023049|Hereditary Hearing Disorder|hereditary hearing disorder
5857463|NCT00023049|Hearing Impairment|hearing impairment
5857464|NCT00023049|Sensorineural Hearing Loss|sensorineural hearing loss
5857465|NCT00023049|Vestibular Dysfunction|vestibular dysfunction
5857466|NCT00023049|SNHL|snhl
5857483|NCT00023010|CD18|cd18
5857484|NCT00023010|Retrovirus|retrovirus
5857486|NCT00023010|Stem Cell|stem cell
5857487|NCT00023010|Gene Transfer|gene transfer
5857488|NCT00023010|Leukocyte Adhesion Deficiency|leukocyte adhesion deficiency
5857489|NCT00023010|LAD|lad
5857490|NCT00022997|Phenylthiocarbamide|phenylthiocarbamide
5857491|NCT00022997|Phlebotomy|phlebotomy
5857492|NCT00022997|Chemoreceptors|chemoreceptors
5857493|NCT00022997|Population Associations|population associations
5857494|NCT00022997|Non-Tasters|non-tasters
5857495|NCT00022997|Taste|taste
5857496|NCT00022997|Healthy Volunteer|healthy volunteer
5857497|NCT00022997|HV|hv
5857498|NCT00022997|Normal Control|normal control
5857499|NCT00022984|Attitudes Towards Technology|attitudes towards technology
5857500|NCT00022984|Cardiovascular Disease|cardiovascular disease
5857501|NCT00022984|Illness Representation|illness representation
5857502|NCT00022984|Implantable Cardioverter Defibrillator|implantable cardioverter defibrillator
5857503|NCT00022984|Symptom Distress|symptom distress
5857504|NCT00022984|Heart Disease|heart disease
5857505|NCT00022984|ICD|icd
5857506|NCT00022971|Monoclonal Antibody|monoclonal antibody
5857507|NCT00022971|Lymphoma|lymphoma
5857508|NCT00022971|Rituximab|rituximab
5857509|NCT00022971|Hu1D10|hu1d10
5857510|NCT00022971|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5857511|NCT00022971|NHL|nhl
5857512|NCT00022971|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5857513|NCT00022971|CLL|cll
5857514|NCT00022971|Leukemia|leukemia
5857515|NCT00022958|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5857516|NCT00022958|Radioimmunotherapy|radioimmunotherapy
5857517|NCT00022958|Monoclonal Antibody|monoclonal antibody
5857518|NCT00022958|Corixa|corixa
5857519|NCT00022958|Bexxar|bexxar
5857520|NCT00022958|Anti-B1 Antibody|anti-b1 antibody
5857521|NCT00022958|Tositumomab|tositumomab
5857522|NCT00022958|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857523|NCT00022958|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857524|NCT00022945|Mantle Cell Lymphoma|mantle cell lymphoma
5857525|NCT00022945|Radioimmunotherapy|radioimmunotherapy
5857526|NCT00022945|Monoclonal Antibody|monoclonal antibody
5857527|NCT00022945|Corixa|corixa
5857528|NCT00022945|Bexxar|bexxar
5857529|NCT00022945|Anti-B1 Antibody|anti-b1 antibody
5857530|NCT00022945|Tositumomab|tositumomab
5857531|NCT00022945|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857532|NCT00022945|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857533|NCT00022932|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5857534|NCT00022932|Radioimmunotherapy|radioimmunotherapy
5857535|NCT00022932|Monoclonal Antibody|monoclonal antibody
5857536|NCT00022932|Corixa|corixa
5857537|NCT00022932|Bexxar|bexxar
5857538|NCT00022932|Anti-B1 Antibody|anti-b1 antibody
5857539|NCT00022932|Tositumomab|tositumomab
5857540|NCT00022932|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857541|NCT00022932|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857542|NCT00022919|Microdissection|microdissection
5857543|NCT00022919|Chromosome|chromosome
5857544|NCT00022919|Karyotype|karyotype
5857545|NCT00022919|Tumor|tumor
5857546|NCT00022919|Malignancy|malignancy
5857547|NCT00022919|Prostate Adenocarcinoma|prostate adenocarcinoma
5857548|NCT00022919|Prostate Intraepithelial Neoplasia|prostate intraepithelial neoplasia
5857549|NCT00022919|Prostate Cancer|prostate cancer
5857550|NCT00022919|Prostate|prostate
5857551|NCT00022906|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5857552|NCT00022906|Radioimmunotherapy|radioimmunotherapy
5857553|NCT00022906|Monoclonal Antibody|monoclonal antibody
5857554|NCT00022906|Corixa|corixa
5857555|NCT00022906|Bexxar|bexxar
5857556|NCT00022906|Anti-B1 Antibody|anti-b1 antibody
5857557|NCT00022906|Tositumomab|tositumomab
5857558|NCT00022906|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857559|NCT00022906|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857560|NCT00022893|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5857561|NCT00022893|Radioimmunotherapy|radioimmunotherapy
5857562|NCT00022893|Monoclonal Antibody|monoclonal antibody
5857563|NCT00022893|Corixa|corixa
5857564|NCT00022893|Bexxar|bexxar
5857565|NCT00022893|Anti-B1 Antibody|anti-b1 antibody
5857566|NCT00022893|Tositumomab|tositumomab
5857567|NCT00022893|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857568|NCT00022893|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857569|NCT00022880|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5857570|NCT00022880|Dose-Escalation|dose-escalation
5857571|NCT00022880|Radioimmunotherapy|radioimmunotherapy
5857572|NCT00022880|Monoclonal Antibody|monoclonal antibody
5857573|NCT00022880|Corixa|corixa
5857574|NCT00022880|Bexxar|bexxar
5857575|NCT00022880|Anti-B1 Antibody|anti-b1 antibody
5857576|NCT00022880|Tositumomab|tositumomab
5857577|NCT00022880|Iodine -131 Anti-B1 Antibody|iodine -131 anti-b1 antibody
5857578|NCT00022880|Iodine I 131 Tositumomab|iodine i 131 tositumomab
5857579|NCT00022867|Bone growth|bone growth
5857587|NCT00022854|Outcome survey|outcome survey
5857588|NCT00022854|Anesthesia|anesthesia
5857591|NCT00022841|Bone mineral density (BMD)|bone mineral density (bmd)
5857592|NCT00022841|Children|children
5857593|NCT00022841|Glucocorticoids|glucocorticoids
5857594|NCT00022841|Osteoporosis|osteoporosis
5857595|NCT00022841|Pediatric|pediatric
5857596|NCT00022841|Pamidronate|pamidronate
5857597|NCT00022841|Steroids|steroids
5857598|NCT00022828|Laser|laser
5857599|NCT00022828|Cervical|cervical
5857600|NCT00022828|Spinal|spinal
5857601|NCT00022828|Spine|spine
5857602|NCT00022828|Neck|neck
5857603|NCT00022828|Illinois|illinois
5857604|NCT00022815|Compartment syndrome|compartment syndrome
5857605|NCT00022815|Tissue ultrafiltration|tissue ultrafiltration
5857606|NCT00022815|Reperfusion injury|reperfusion injury
5857607|NCT00022815|Ischemia|ischemia
5857608|NCT00022802|Biomedical equipment development|biomedical equipment development
5857609|NCT00022802|Computer assisted patient care|computer assisted patient care
5857610|NCT00022802|Digital imaging|digital imaging
5857611|NCT00022802|Hip surgery|hip surgery
5857612|NCT00022802|Orthopedics|orthopedics
5857613|NCT00022802|Trauma|trauma
5857614|NCT00022802|Radiography|radiography
5857615|NCT00022802|Biomedical imaging|biomedical imaging
5857616|NCT00022776|Human therapy evaluation|human therapy evaluation
5857617|NCT00022776|Orthopedics|orthopedics
5857618|NCT00022776|Physical therapy|physical therapy
5857619|NCT00022776|Nonsurgical treatment|nonsurgical treatment
5857620|NCT00022776|Surgical decompression|surgical decompression
5857621|NCT00022776|Surgery|surgery
5857622|NCT00022776|Lumbar|lumbar
5857623|NCT00022776|Spine disorder|spine disorder
5857624|NCT00022776|Spinal stenosis|spinal stenosis
5857625|NCT00022776|Gender difference|gender difference
5857626|NCT00022776|Medical rehabilitation|medical rehabilitation
5857627|NCT00022789|Sleep-Disordered Breathing|sleep-disordered breathing
5857628|NCT00022750|Type 2 Diabetes Mellitus|type 2 diabetes mellitus
5857629|NCT00022750|Nurse Case Manager|nurse case manager
5857630|NCT00022750|Community Health Worker|community health worker
5857631|NCT00022750|Behavioral Interventions|behavioral interventions
5857632|NCT00022750|Cost-effectiveness|cost-effectiveness
5857634|NCT00021866|epilepsy|epilepsy
5857635|NCT00021866|seizure|seizure
5857636|NCT00021866|pregnancy|pregnancy
5857637|NCT00021866|antiepileptic|antiepileptic
5857638|NCT00021866|AED|aed
5857639|NCT00021866|carbamazepine|carbamazepine
5857640|NCT00021866|phenytoin|phenytoin
5857641|NCT00021866|valproate|valproate
5857642|NCT00021866|lamotrigine|lamotrigine
5857643|NCT00021866|child|child
5857644|NCT00021866|behavior|behavior
5857645|NCT00021853|Individualized|individualized
5857646|NCT00021853|Finger|finger
5857647|NCT00021853|Training|training
5857648|NCT00021853|Splinting|splinting
5857649|NCT00021853|TMS|tms
5857650|NCT00021853|Dystonia|dystonia
5857651|NCT00021853|Focal Dystonia|focal dystonia
5857652|NCT00021853|Movement Disorder|movement disorder
5857653|NCT00021853|Focal Hand Dystonia|focal hand dystonia
5857654|NCT00021853|Writer's Cramp|writer's cramp
5857655|NCT00021827|parathyroid hormone-related protein|parathyroid hormone-related protein
5857656|NCT00021827|parathyroid hormone|parathyroid hormone
5857657|NCT00021827|anabolic skeletal therapy|anabolic skeletal therapy
5857658|NCT00021827|postmenopausal women|postmenopausal women
5857659|NCT00021814|BPH progression|bph progression
5857660|NCT00021814|Medical Therapy|medical therapy
5857661|NCT00021814|Finasteride|finasteride
5857662|NCT00021814|Doxazosin|doxazosin
5857663|NCT00021814|Randomized|randomized
5857664|NCT00021814|Multi-center|multi-center
5857665|NCT00021814|Clinical Trial|clinical trial
5857666|NCT00021814|Proscar|proscar
5857667|NCT00021814|Cardura|cardura
5857668|NCT00021801|Type I Diabetes Mellitus|type i diabetes mellitus
5857669|NCT00021801|Immunosuppression|immunosuppression
5857670|NCT00021801|Islet Cell Transplant|islet cell transplant
5857671|NCT00021801|Percutaneous Transhepatic Portal|percutaneous transhepatic portal
5857672|NCT00021788|Type I Diabetes Mellitus|type i diabetes mellitus
5857673|NCT00021788|Immunosuppression|immunosuppression
5857674|NCT00021788|Islet Cell Transplantation|islet cell transplantation
5857675|NCT00021788|PercutaneousTranshepaticPortalVein Catheterization|percutaneoustranshepaticportalvein catheterization
5857676|NCT00021749|CLL|cll
5857677|NCT00021749|Leukemia|leukemia
5857678|NCT00021749|Chronic|chronic
5857679|NCT00021749|Cancer|cancer
5857680|NCT00021749|Adult|adult
5857681|NCT00021749|Lymphocytic|lymphocytic
5857682|NCT00021749|Genasense|genasense
5857683|NCT00021749|G3139|g3139
5857684|NCT00021749|Genta|genta
5857685|NCT00021749|Bcl-2|bcl-2
5857686|NCT00021749|Antisense|antisense
5857687|NCT00021749|Oligonucleotide|oligonucleotide
5857688|NCT00021749|oblimerson|oblimerson
5857689|NCT00021736|choroidal neovascularization (CNV)|choroidal neovascularization (cnv)
5857690|NCT00021736|subretinal neovascularization|subretinal neovascularization
5857691|NCT00021723|Alzheimer's|alzheimer's
5857692|NCT00021723|AN-1792|an-1792
5857698|NCT00021710|Rehabilitation|rehabilitation
5857699|NCT00021710|Premotor|premotor
5857700|NCT00021710|Normal Control|normal control
5857908|NCT00018031|Eradication|eradication
5857701|NCT00021710|Healthy Volunteer|healthy volunteer
5857702|NCT00021710|HV|hv
5857703|NCT00021710|Motor Learning|motor learning
5857704|NCT00021697|AVP-923|avp-923
5857705|NCT00021697|Dextromethorphan|dextromethorphan
5857706|NCT00021697|Quinidine|quinidine
5857707|NCT00021697|Pseudobulbar Affect|pseudobulbar affect
5857708|NCT00021658|Epidemiology|epidemiology
5857709|NCT00021658|pesticide|pesticide
5857710|NCT00021658|asthma|asthma
5857711|NCT00021658|children|children
5857712|NCT00021658|exposure|exposure
5857713|NCT00021645|Corticosteroids|corticosteroids
5857714|NCT00021645|Immunosuppressives|immunosuppressives
5857715|NCT00021645|Intraocular Inflammatory Disease|intraocular inflammatory disease
5857716|NCT00021645|Uveitis|uveitis
5857717|NCT00021645|Macular Edema|macular edema
5857718|NCT00021567|Pneumonia|pneumonia
5857719|NCT00021567|Cytokine|cytokine
5857720|NCT00021567|Aerosol|aerosol
5857721|NCT00021567|Therapy|therapy
5857722|NCT00021567|Mycobacteria|mycobacteria
5857723|NCT00021567|Mycobacterium Avium Complex|mycobacterium avium complex
5857724|NCT00021567|MAC|mac
5857725|NCT00021567|Pulmonary Infection|pulmonary infection
5857726|NCT00021567|Lung Infection|lung infection
5857727|NCT00021541|Surrogate Markers|surrogate markers
5853959|NCT00002035|Zidovudine|zidovudine
5857728|NCT00021541|3-Dimensional Magnetic Resonance Imaging (MRI)|3-dimensional magnetic resonance imaging (mri)
5845213|NCT00001387|Phase I|phase i
5854222|NCT00001132|Viral Load|viral load
5857729|NCT00021541|Natural History of Neurofibromatosis Type 1 (NF1)|natural history of neurofibromatosis type 1 (nf1)
5857730|NCT00021541|Tumor Tissue Bank|tumor tissue bank
5857731|NCT00021541|Neurofibromatosis|neurofibromatosis
5857732|NCT00021541|NF1|nf1
5857733|NCT00021541|Neurofibromatosis Type 1|neurofibromatosis type 1
5857734|NCT00021541|Plexiform Neurofibroma|plexiform neurofibroma
5857735|NCT00021541|Neurofibroma|neurofibroma
5857736|NCT00021528|Sequential Treatment|sequential treatment
5857737|NCT00021528|Major Depression|major depression
5857738|NCT00021528|Treatment Resistant Depression|treatment resistant depression
5857739|NCT00021502|Pyridoxalated hemoglobin polyoxyethylene conjugate (PHP)|pyridoxalated hemoglobin polyoxyethylene conjugate (php)
5857740|NCT00021502|Systemic Inflammatory Response Syndrome (SIRS)|systemic inflammatory response syndrome (sirs)
5857741|NCT00021502|Nitric oxide (NO)|nitric oxide (no)
5857743|NCT00021476|Whiplash|whiplash
5857744|NCT00021476|Chronic pain|chronic pain
5857745|NCT00021476|Motor vehicle accidents|motor vehicle accidents
5857746|NCT00021437|Bloom syndrome protein|bloom syndrome protein
5857747|NCT00018902|Depressive Disorder|depressive disorder
5857748|NCT00018902|Adolescents|adolescents
5857749|NCT00018902|Teenagers|teenagers
5857750|NCT00018902|Teens|teens
5857751|NCT00018902|Cognitive Behavior Therapy|cognitive behavior therapy
5857752|NCT00018889|Clinical Evaluation|clinical evaluation
5857753|NCT00018889|Genetic Study|genetic study
5857754|NCT00018889|Essential Tremor|essential tremor
5857755|NCT00018889|Familial Myoclonus|familial myoclonus
5857756|NCT00018889|Hereditary Ataxia|hereditary ataxia
5857757|NCT00018889|Movement Disorder|movement disorder
5857758|NCT00018889|Inherited Movement Disorder|inherited movement disorder
5857759|NCT00018876|Epidural fibrosis|epidural fibrosis
5857760|NCT00018876|Failed back surgery syndrome|failed back surgery syndrome
5857761|NCT00018876|Postlaminectomy syndrome|postlaminectomy syndrome
5857762|NCT00018876|Lumbar laminectomy|lumbar laminectomy
5857763|NCT00018876|Radiotherapy|radiotherapy
5857764|NCT00018876|Radiation|radiation
5857765|NCT00018876|Perineural scar formation|perineural scar formation
5857766|NCT00018876|Peridural fibrosis|peridural fibrosis
5857767|NCT00018876|Back surgery|back surgery
5857768|NCT00018863|ADHD|adhd
5857769|NCT00018850|schizophrenia|schizophrenia
5857771|NCT00018850|nicotine|nicotine
5857772|NCT00018850|haloperidol|haloperidol
5857773|NCT00018811|Relaxation Techniques|relaxation techniques
5857774|NCT00018811|Behavior Therapy Feedback|behavior therapy feedback
5857775|NCT00018811|Psychophysiology|psychophysiology
5857776|NCT00018798|Combat-Related PTSD, Vietnam Veterans|combat-related ptsd, vietnam veterans
5857777|NCT00018785|kidney transplantation|kidney transplantation
5857778|NCT00018785|immunosuppression|immunosuppression
5857779|NCT00018785|bone marrow|bone marrow
5857780|NCT00018772|coagulation|coagulation
5857781|NCT00018772|thrombosis genetic markers|thrombosis genetic markers
5857782|NCT00018759|Serotonin, Hypertension, Depression|serotonin, hypertension, depression
5857783|NCT00018733|Depression|depression
5857784|NCT00018720|triglyceride|triglyceride
5857785|NCT00018720|bile acids|bile acids
5857786|NCT00018720|cholelithias|cholelithias
5857787|NCT00018694|bile acid synthesis|bile acid synthesis
5857788|NCT00018694|chenodeoxycholic acid|chenodeoxycholic acid
5857789|NCT00018694|sterol 27-hydroxylase|sterol 27-hydroxylase
5857790|NCT00018668|Antipsychotics|antipsychotics
5857791|NCT00018668|schizophrenia|schizophrenia
5857792|NCT00018668|motor retardation|motor retardation
5857793|NCT00018668|bradykinesia|bradykinesia
5857794|NCT00018655|Mood Disorders|mood disorders
5857795|NCT00018655|Substance-Related Disorders|substance-related disorders
5857796|NCT00018642|quetiapine|quetiapine
5857797|NCT00018642|haloperidol decanoate|haloperidol decanoate
5857798|NCT00018629|Aging|aging
5857799|NCT00018629|Neuropsychology|neuropsychology
5857800|NCT00018629|Psychotherapy|psychotherapy
5857801|NCT00018629|Rehabilitation|rehabilitation
5857802|NCT00018629|Schizophrenia|schizophrenia
5857803|NCT00018616|compliance|compliance
5857804|NCT00018616|MEMS|mems
5857805|NCT00018616|metformin|metformin
5857806|NCT00018603|PTSD|ptsd
5857807|NCT00018590|Vascular Diseases|vascular diseases
5857808|NCT00018538|vitamin D|vitamin d
5857809|NCT00018538|prostatic neoplasms|prostatic neoplasms
5857810|NCT00018538|neoplasm recurrence|neoplasm recurrence
5857811|NCT00018512|dental implant|dental implant
5857812|NCT00018499|Traumatic Brain Injury|traumatic brain injury
5857813|NCT00018473|Risk Factors|risk factors
5857814|NCT00018473|Genes|genes
5857815|NCT00018473|Epidemiology|epidemiology
5857816|NCT00018473|Apolipoproteins E|apolipoproteins e
5857817|NCT00018473|Alzheimer's Disease|alzheimer's disease
5857818|NCT00018460|geriatrics|geriatrics
5857819|NCT00018460|vitamin B complex|vitamin b complex
5857820|NCT00018460|thrombomodulin|thrombomodulin
5857821|NCT00018460|anticoagulants|anticoagulants
5857822|NCT00018447|osteoporosis|osteoporosis
5857823|NCT00018434|Infection|infection
5857824|NCT00018421|Cerebrovascular Disorders|cerebrovascular disorders
5845308|NCT00001332|Surgery|surgery
5854324|NCT00001113|Zidovudine|zidovudine
5857825|NCT00018421|Exercise|exercise
5857826|NCT00018421|Rehabilitation|rehabilitation
5857827|NCT00018408|COPD|copd
5857828|NCT00018408|Smoking|smoking
5857829|NCT00018395|Calcium Metabolism|calcium metabolism
5857830|NCT00018369|Aging|aging
5857831|NCT00018369|Hydrocortisone Corticotropin Feedback|hydrocortisone corticotropin feedback
5857832|NCT00018356|Aging|aging
5857833|NCT00018356|nutrition|nutrition
5857834|NCT00018356|rehabilitation|rehabilitation
5857835|NCT00018330|Behavioral|behavioral
5857836|NCT00018330|Weight Loss|weight loss
5857837|NCT00018330|Genetics|genetics
5857838|NCT00018330|Lipoprotein lipase|lipoprotein lipase
5857839|NCT00018330|Visceral fat|visceral fat
5857840|NCT00018330|Lipoprotein|lipoprotein
5857841|NCT00018317|Diet|diet
5857842|NCT00018317|exercise|exercise
5857843|NCT00018304|blood pressure|blood pressure
5857844|NCT00018304|insulin sensitivity|insulin sensitivity
5857845|NCT00018304|blood flow|blood flow
5857846|NCT00018291|Dementia|dementia
5857847|NCT00018291|Agitated Behavior|agitated behavior
5857848|NCT00018291|Behavioral disturbance|behavioral disturbance
5857849|NCT00018265|Rehabilitation|rehabilitation
5857850|NCT00018265|exercise test|exercise test
5857851|NCT00018265|aging|aging
5857852|NCT00018213|Naltrexone|naltrexone
5857853|NCT00018213|Nicotine patch|nicotine patch
5857854|NCT00018213|Tobacco dependence|tobacco dependence
5857855|NCT00018200|analgesia|analgesia
5857856|NCT00018200|Back pain|back pain
5857857|NCT00018200|sciatica|sciatica
5857858|NCT00018187|smoking cessation|smoking cessation
5857859|NCT00018187|bupropion|bupropion
5857860|NCT00018187|mecamylamine|mecamylamine
5857861|NCT00018187|nicotine|nicotine
5857862|NCT00018174|Depression|depression
5857863|NCT00018174|Fluoxetine|fluoxetine
5857864|NCT00018174|Nicotine dependence|nicotine dependence
5857865|NCT00018161|Nicotine|nicotine
5857866|NCT00018161|addiction|addiction
5857867|NCT00018161|cigarette smoking|cigarette smoking
5857868|NCT00018148|smoking cessation|smoking cessation
5857869|NCT00018135|high iPTH levels|high ipth levels
5857870|NCT00018122|Islet cell transplant|islet cell transplant
5857871|NCT00018096|Genetics|genetics
5857872|NCT00018096|Lipopolysaccharide|lipopolysaccharide
5857873|NCT00018070|Age-Related Macular Degeneration|age-related macular degeneration
5857889|NCT00018057|Healthy Volunteer|healthy volunteer
5857890|NCT00018057|Normal Control|normal control
5857904|NCT00018031|Liver Disease|liver disease
5857905|NCT00018031|Virologic Response|virologic response
5857906|NCT00018031|Immune Mechanisms|immune mechanisms
5857911|NCT00018018|Gene Therapy|gene therapy
5857912|NCT00018018|ADA-SCID|ada-scid
5857913|NCT00018018|Stem Cells|stem cells
5857914|NCT00018018|Retroviruses|retroviruses
5857915|NCT00018018|Immune Deficiency Disease|immune deficiency disease
5857916|NCT00018018|Adenosine Deaminase Deficiency|adenosine deaminase deficiency
5857917|NCT00018018|ADA-Deficiency|ada-deficiency
5857918|NCT00018018|Retroviral Vectors|retroviral vectors
5857919|NCT00018018|Hematopoietic Progenitors|hematopoietic progenitors
5857920|NCT00018018|Severe Combined Immunodeficiency|severe combined immunodeficiency
5857921|NCT00018018|SCID|scid
5857922|NCT00018018|Immune Deficiency|immune deficiency
5857923|NCT00018005|Heart Failure|heart failure
5857924|NCT00018005|Self-Management|self-management
5857925|NCT00018005|Behavioral Clinical Trial|behavioral clinical trial
5857926|NCT00017979|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5857927|NCT00017979|Motor Cortex|motor cortex
5857928|NCT00017979|Motor Imagery|motor imagery
5857929|NCT00017979|Reaction Time|reaction time
5857930|NCT00017979|Cerebral Inhibition|cerebral inhibition
5857931|NCT00017979|Healthy Volunteer|healthy volunteer
5857932|NCT00017979|Normal Control|normal control
5857933|NCT00017966|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5857934|NCT00017966|Motor Cortex|motor cortex
5857935|NCT00017966|Cerebral Inhibition|cerebral inhibition
5857936|NCT00017966|Corpus Callosum|corpus callosum
5857937|NCT00017966|Evoked Potential|evoked potential
5857938|NCT00017966|Healthy Volunteer|healthy volunteer
5857939|NCT00017966|Normal Control|normal control
5857940|NCT00017940|Gene Therapy|gene therapy
5857941|NCT00017953|Diabetes|diabetes
5857942|NCT00017953|Weight loss|weight loss
5857943|NCT00017953|Heart Attack|heart attack
5857944|NCT00017953|Heart disease|heart disease
5857945|NCT00017953|Lifestyle Intervention|lifestyle intervention
5858148|NCT00015756|Apheresis|apheresis
5857950|NCT00017927|McCune-Albright Syndrome|mccune-albright syndrome
5857952|NCT00017927|Adenoma|adenoma
5857953|NCT00017927|Hyperplasia|hyperplasia
5857955|NCT00017927|Polyostotic Fibrous Dysplasia|polyostotic fibrous dysplasia
5857956|NCT00017927|PFD|pfd
5857962|NCT00017875|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5857963|NCT00017875|Intracortical Inhibition|intracortical inhibition
5857964|NCT00017875|Dystonia|dystonia
5857965|NCT00017875|Focal Dystonia|focal dystonia
5857966|NCT00017875|Dystonic Disorder|dystonic disorder
5857967|NCT00017875|DYTI Dystonia|dyti dystonia
5854177|NCT00001137|HIV-1|hiv-1
5857968|NCT00017875|Movement Disorder|movement disorder
5857969|NCT00017875|Generalized Dystonia|generalized dystonia
5857970|NCT00017875|Healthy Control|healthy control
5857971|NCT00017875|Normal Volunteer|normal volunteer
5857972|NCT00017823|complementary therapies|complementary therapies
5857973|NCT00017823|Acupressure|acupressure
5857974|NCT00017823|HIV Infections|hiv infections
5857976|NCT00017823|Vomiting|vomiting
5857977|NCT00017810|complementary therapies|complementary therapies
5857978|NCT00017810|Behavior Therapy|behavior therapy
5857979|NCT00017810|Diarrhea|diarrhea
5857980|NCT00017810|Diet Therapy|diet therapy
5857981|NCT00017810|Food|food
5857982|NCT00017810|HIV Seropositivity|hiv seropositivity
5857983|NCT00017745|DNA|dna
5857984|NCT00017745|Hereditary Myopathies|hereditary myopathies
5857985|NCT00017745|Intermediate Filaments|intermediate filaments
5857986|NCT00017745|Cardiomyopathies|cardiomyopathies
5857987|NCT00017745|Genetic Testing|genetic testing
5857988|NCT00017745|Myopathy|myopathy
5857989|NCT00017745|Inherited Neuromuscular Disorder|inherited neuromuscular disorder
5857990|NCT00017732|Malformations|malformations
5857991|NCT00017732|Ethnicity|ethnicity
5857992|NCT00017732|Mutations|mutations
5857993|NCT00017732|Cholesterol|cholesterol
5857994|NCT00017732|Metabolism|metabolism
5857995|NCT00017732|Smith-Lemli-Opitz Syndrome|smith-lemli-opitz syndrome
5857996|NCT00017732|SLOS|slos
5857997|NCT00017732|Cholesterol Metabolism|cholesterol metabolism
5857998|NCT00017706|physician education|physician education
5857999|NCT00017706|behavioral weight control|behavioral weight control
5858000|NCT00017706|physician intervention|physician intervention
5858001|NCT00017706|obesity counseling|obesity counseling
5858002|NCT00016848|Obesity|obesity
5858003|NCT00016848|Endocrine|endocrine
5858004|NCT00016848|Diet|diet
5858005|NCT00016848|Metabolism|metabolism
5858006|NCT00016848|Macronutrients|macronutrients
5858007|NCT00016835|Type 2 diabetes mellitus|type 2 diabetes mellitus
5858008|NCT00016835|Glycemic control|glycemic control
5858009|NCT00016835|Periodontal therapy|periodontal therapy
5858010|NCT00017680|amyloidosis|amyloidosis
5858011|NCT00017680|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858012|NCT00017680|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5858221|NCT00015457|Calcium Channel Antagonists|calcium channel antagonists
5858013|NCT00017680|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5858014|NCT00017680|oncologic disorders|oncologic disorders
5858015|NCT00017680|plasma cell neoplasm|plasma cell neoplasm
5858016|NCT00017680|primary systemic amyloidosis|primary systemic amyloidosis
5858017|NCT00017680|rare disease|rare disease
5858018|NCT00017654|aplastic anemia|aplastic anemia
5858019|NCT00017654|disease-related problem/condition|disease-related problem/condition
5858020|NCT00017654|graft versus host disease|graft versus host disease
5858021|NCT00017654|hematologic disorders|hematologic disorders
5858022|NCT00017654|rare disease|rare disease
5858023|NCT00017641|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858024|NCT00017641|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5858025|NCT00017641|rare disease|rare disease
5858026|NCT00017641|systemic lupus erythematosus|systemic lupus erythematosus
5858027|NCT00017628|multiple sclerosis|multiple sclerosis
5858028|NCT00017628|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5858029|NCT00017628|rare disease|rare disease
5858030|NCT00016796|Reading|reading
5858031|NCT00016796|Naming|naming
5858032|NCT00016731|Depression|depression
5858033|NCT00016731|Anxiety|anxiety
5858034|NCT00016731|CAH|cah
5858035|NCT00016731|Adults|adults
5858036|NCT00016731|FMPP|fmpp
5858037|NCT00016731|Emotion|emotion
5858038|NCT00016731|Cushing's Syndrome|cushing's syndrome
5858039|NCT00016731|Adolescence|adolescence
5858040|NCT00016731|Magnetic Resonance Imaging|magnetic resonance imaging
5858041|NCT00016731|fMRI|fmri
5858042|NCT00016731|Healthy Volunteer|healthy volunteer
5858043|NCT00016731|HV|hv
5858045|NCT00016679|Pharmacokinetics|pharmacokinetics
5858046|NCT00016679|Metabolism|metabolism
5858047|NCT00016679|Toxicity|toxicity
5858048|NCT00016679|Side Effects|side effects
5858049|NCT00016679|Essential Tremor|essential tremor
5858050|NCT00016679|Tremor|tremor
5858051|NCT00016679|Movement Disorder|movement disorder
5858052|NCT00016666|Season|season
5858053|NCT00016666|Light|light
5858054|NCT00016666|Propranolol|propranolol
5858055|NCT00016666|Photoperiod|photoperiod
5858056|NCT00016666|Pharmacokinetics|pharmacokinetics
5858057|NCT00016666|Circadian Rhythm|circadian rhythm
5858058|NCT00016666|Seasonal Rhythm|seasonal rhythm
5858059|NCT00016666|Seasonal Affective Disorder|seasonal affective disorder
5858060|NCT00016666|Pineal Gland|pineal gland
5858061|NCT00016666|Suprachiasmatic Nucleus|suprachiasmatic nucleus
5858062|NCT00016666|Healthy Volunteer|healthy volunteer
5858063|NCT00016666|HV|hv
5858064|NCT00016666|Winter Depression|winter depression
5858065|NCT00016666|SAD|sad
5858066|NCT00016653|Duchenne|duchenne
5858067|NCT00016653|muscular|muscular
5858068|NCT00016653|dystrophy|dystrophy
5858069|NCT00016653|treatment|treatment
5858070|NCT00016562|Genetic|genetic
5858071|NCT00016562|Degenerative|degenerative
5858072|NCT00016562|Lysosomal|lysosomal
5858073|NCT00016562|Brain|brain
5858074|NCT00016562|Mental Retardation|mental retardation
5858075|NCT00016562|Neurodegenerative Disorder|neurodegenerative disorder
5858076|NCT00016562|Neurometabolic|neurometabolic
5858077|NCT00016562|Metabolic Neurological Disorder|metabolic neurological disorder
5858078|NCT00016562|Abnormal Metabolism|abnormal metabolism
5858079|NCT00016549|Endothelial Proliferation|endothelial proliferation
5858080|NCT00016549|Endothelial Apoptosis|endothelial apoptosis
5858081|NCT00016549|VEGF|vegf
5858082|NCT00016549|Magnetic Resonance Imaging|magnetic resonance imaging
5858083|NCT00016549|Molecular Targets|molecular targets
5858084|NCT00016549|Breast Cancer|breast cancer
5858085|NCT00016549|Inflammatory Breast Cancer|inflammatory breast cancer
5858086|NCT00016549|IBC|ibc
5858087|NCT00016523|NICHD Neonatal Research Network|nichd neonatal research network
5858088|NCT00016523|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5858089|NCT00016523|Very Low Birth Weight (VLBW)|very low birth weight (vlbw)
5858090|NCT00016523|Prematurity|prematurity
5858091|NCT00016523|Inhaled nitric oxide|inhaled nitric oxide
5858092|NCT00016523|Aspiration syndrome|aspiration syndrome
5858093|NCT00016523|Idiopathic pulmonary hypertension|idiopathic pulmonary hypertension
5858094|NCT00016523|Pulmonary hypoplasia|pulmonary hypoplasia
5858095|NCT00016510|Bilingualism|bilingualism
5858096|NCT00016510|Fluency|fluency
5858097|NCT00016510|Age at Acquisition|age at acquisition
5858098|NCT00016510|Words and Sentences|words and sentences
5858099|NCT00016510|Cortical Area|cortical area
5858100|NCT00016510|Healthy Volunteer|healthy volunteer
5858101|NCT00016510|HV|hv
5858102|NCT00016510|Bilingual|bilingual
5858103|NCT00016510|Second Language|second language
5858104|NCT00016497|otitis media with effusion|otitis media with effusion
5858105|NCT00016497|children|children
5858106|NCT00016497|tympanostomy tubes|tympanostomy tubes
5858107|NCT00016497|adenoidectomy|adenoidectomy
5858108|NCT00016458|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858109|NCT00016458|rare disease|rare disease
5858110|NCT00016458|systemic sclerosis|systemic sclerosis
5858111|NCT00016445|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5858112|NCT00016445|cystic fibrosis|cystic fibrosis
5858222|NCT00015457|Torticollis|torticollis
5858113|NCT00016445|disease-related problem/condition|disease-related problem/condition
5858114|NCT00016445|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5858115|NCT00016445|quality of life|quality of life
5858116|NCT00016445|rare disease|rare disease
5858117|NCT00015808|Neurodegeneration|neurodegeneration
5858118|NCT00015808|Anti-Oxidant|anti-oxidant
5858119|NCT00015808|Neuropathy|neuropathy
5858120|NCT00015808|Hereditary|hereditary
5858121|NCT00015808|Spinocerebellar|spinocerebellar
5858122|NCT00015808|Friedreich's Ataxia|friedreich's ataxia
5858123|NCT00015808|Friedreich Ataxia|friedreich ataxia
5858124|NCT00015808|FRDA|frda
5858125|NCT00015795|Pressure|pressure
5858126|NCT00015795|Botulinum Toxin|botulinum toxin
5858127|NCT00015795|Voice|voice
5858128|NCT00015795|Dystonia|dystonia
5858129|NCT00015795|Pathophysiology|pathophysiology
5858130|NCT00015795|Healthy Volunteer|healthy volunteer
5858131|NCT00015795|HV|hv
5858132|NCT00015795|ABSD|absd
5858133|NCT00015795|Spasmodic Dysphonia|spasmodic dysphonia
5858134|NCT00015795|Abductor Spasmodic Dysphonia|abductor spasmodic dysphonia
5858135|NCT00015782|Metabolic|metabolic
5858136|NCT00015782|Genetic|genetic
5858137|NCT00015782|Storage|storage
5858138|NCT00015782|Retinal Disease|retinal disease
5858139|NCT00015782|Degenerative|degenerative
5858140|NCT00015782|Mucolipidosis Type IV|mucolipidosis type iv
5858141|NCT00015782|ML-IV|ml-iv
5858142|NCT00015769|Mania|mania
5858143|NCT00015769|Depression|depression
5858144|NCT00015769|Anticonvulsants|anticonvulsants
5858145|NCT00015769|Mood Stabilizers|mood stabilizers
5858146|NCT00015769|Bipolar|bipolar
5858147|NCT00015769|Mood Stabilizer|mood stabilizer
5858149|NCT00015756|Transplantation|transplantation
5858150|NCT00015756|Type III Secretion Pathway|type iii secretion pathway
5858151|NCT00015756|Exotoxins|exotoxins
5858152|NCT00015756|Pseudomonas Aeruginosa|pseudomonas aeruginosa
5858153|NCT00015756|Cystic Fibrosis|cystic fibrosis
5858154|NCT00015756|CF|cf
5858155|NCT00015717|Imaging|imaging
5858156|NCT00015717|Complications|complications
5858157|NCT00015717|Stenosis|stenosis
5858158|NCT00015717|Treatment|treatment
5858159|NCT00015717|Strokes|strokes
5858160|NCT00015717|Cerebral Ischemia|cerebral ischemia
5858161|NCT00015717|Cranial Cervical Angioplasty|cranial cervical angioplasty
5858162|NCT00015678|Motor Cortex|motor cortex
5858163|NCT00015678|Drug|drug
5858164|NCT00015678|GABA|gaba
5858165|NCT00015678|Cortical Modulation|cortical modulation
5858166|NCT00015678|Magnetic Stimulation|magnetic stimulation
5858167|NCT00015678|Healthy Volunteer|healthy volunteer
5858168|NCT00015665|Fungal|fungal
5858169|NCT00015665|Immunodeficiency|immunodeficiency
5858170|NCT00015665|Infection|infection
5845624|NCT00050245|MAG|mag
5854639|NCT00001060|HIV-1|hiv-1
5858171|NCT00015665|Refractory|refractory
5858172|NCT00015665|Severe|severe
5858173|NCT00015665|Fungal Infections|fungal infections
5858174|NCT00015639|Blood Donors|blood donors
5858175|NCT00015639|Employees|employees
5858176|NCT00015639|Heparin|heparin
5858177|NCT00015639|Histidine-Rich Glycoprotein|histidine-rich glycoprotein
5858178|NCT00015639|Membrane|membrane
5858179|NCT00015639|Healthy Volunteer|healthy volunteer
5858180|NCT00015613|Hispanics|hispanics
5858181|NCT00015613|Acculturation|acculturation
5858182|NCT00015613|Maternal Exposure|maternal exposure
5858183|NCT00015613|Infant, Low Birth Weight|infant, low birth weight
5858184|NCT00015613|Infant, Premature|infant, premature
5858185|NCT00015613|Organophosphates|organophosphates
5858186|NCT00015613|Pesticides|pesticides
5858187|NCT00015613|Stress|stress
5858188|NCT00015613|Nutrition|nutrition
5858189|NCT00015600|Pesticide|pesticide
5858190|NCT00015600|Farmworker|farmworker
5858191|NCT00015600|Occupational health|occupational health
5858192|NCT00015587|Molecular Epidemiology|molecular epidemiology
5858193|NCT00015587|Case Control|case control
5858194|NCT00015574|arrhythmia|arrhythmia
5858195|NCT00015574|cardiac|cardiac
5858196|NCT00015574|air pollution|air pollution
5858197|NCT00015574|time series|time series
5858198|NCT00015561|population studies|population studies
5858199|NCT00015561|laboratory evaluation|laboratory evaluation
5858200|NCT00015561|hormone analysis|hormone analysis
5858201|NCT00015561|semen analysis|semen analysis
5858202|NCT00015561|chromosome studies|chromosome studies
5858203|NCT00015548|antipsychotic treatment|antipsychotic treatment
5858204|NCT00015548|Alzheimer's disease|alzheimer's disease
5858205|NCT00015548|agitation|agitation
5858206|NCT00015548|dementia|dementia
5858207|NCT00015548|psychosis|psychosis
5858208|NCT00015548|behavioral symptoms|behavioral symptoms
5858209|NCT00015548|hallucinations|hallucinations
5858210|NCT00015548|delusions|delusions
5858211|NCT00015483|Hematotoxicity|hematotoxicity
5858212|NCT00015483|Benzene|benzene
5858213|NCT00015483|Bone Marrow|bone marrow
5858214|NCT00015470|Myopathy|myopathy
5858215|NCT00015470|Dystrophy|dystrophy
5858216|NCT00015470|Neuropathy|neuropathy
5858217|NCT00015470|Muscle Weakness|muscle weakness
5858218|NCT00015470|Muscle Cramps and Pains|muscle cramps and pains
5858219|NCT00015470|Neuromuscular Disorders|neuromuscular disorders
5858220|NCT00015457|Writer's Cramp|writer's cramp
5858748|NCT00011284|Hepatocytes|hepatocytes
5858223|NCT00015457|Chemodenervation|chemodenervation
5858224|NCT00015444|Apparently Sporadic Spastic Paraplegia|apparently sporadic spastic paraplegia
5858225|NCT00015444|Spasticity|spasticity
5858226|NCT00015444|Motor Neuron Disease|motor neuron disease
5858227|NCT00015444|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5858228|NCT00015444|Primary Lateral Sclerosis|primary lateral sclerosis
5858229|NCT00015444|Muscle Stiffness|muscle stiffness
5858230|NCT00015444|Involuntary Muscle Contraction|involuntary muscle contraction
5858231|NCT00015444|Isaacs Syndrome|isaacs syndrome
5858232|NCT00015431|Malabsorption|malabsorption
5858233|NCT00015431|Endoscopy|endoscopy
5858234|NCT00015431|Cytokine|cytokine
5858235|NCT00015431|Immunophenotype|immunophenotype
5858236|NCT00015431|Lymphocyte|lymphocyte
5858237|NCT00015431|Common Variable Immunodeficiency|common variable immunodeficiency
5858238|NCT00015431|Gastrointestinal|gastrointestinal
5858239|NCT00015015|Dichloroacetate|dichloroacetate
5858240|NCT00015015|Chlorinated hydrocarbons|chlorinated hydrocarbons
5858241|NCT00015015|Genetic disease|genetic disease
5858242|NCT00015015|Toxicology|toxicology
5858243|NCT00015015|Biotransformation|biotransformation
5858244|NCT00015340|Opioid Dependence|opioid dependence
5858245|NCT00015249|cocaine dependence|cocaine dependence
5858246|NCT00015210|Cocaine Use Disorders Dependence Depression|cocaine use disorders dependence depression
5858247|NCT00015171|opioid dependence|opioid dependence
5858248|NCT00015132|cocaine dependence|cocaine dependence
5858249|NCT00015106|cocaine dependence|cocaine dependence
5858250|NCT00015080|cocaine dependence|cocaine dependence
5858251|NCT00015054|cocaine dependence|cocaine dependence
5858252|NCT00015041|opiate dependence|opiate dependence
5858253|NCT00015028|opioid dependence|opioid dependence
5858254|NCT00015002|Antenatal corticosteroids|antenatal corticosteroids
5858255|NCT00015002|Preterm delivery|preterm delivery
5858256|NCT00014989|Preterm delivery|preterm delivery
5858257|NCT00014989|Cerebral palsy|cerebral palsy
5858258|NCT00014989|Magnesium sulfate|magnesium sulfate
5858259|NCT00014976|Pyramidal Tract|pyramidal tract
5858260|NCT00014976|Primary Lateral Sclerosis|primary lateral sclerosis
5858261|NCT00014976|Spastic Paraparesis|spastic paraparesis
5858262|NCT00014976|EMG|emg
5858263|NCT00014976|Magnetic Stimulation|magnetic stimulation
5858264|NCT00014976|Muscle Spasticity|muscle spasticity
5858265|NCT00014976|Healthy Volunteer|healthy volunteer
5858267|NCT00014963|biomarkers|biomarkers
5858268|NCT00014963|air pollution|air pollution
5858269|NCT00014963|muconic acid|muconic acid
5858270|NCT00014963|phenylmercapturic acid|phenylmercapturic acid
5845752|NCT00049816|MRI|mri
5854701|NCT00001049|Didanosine|didanosine
5858271|NCT00014950|Cystic Fibrosis|cystic fibrosis
5858272|NCT00014950|Immunoreactive trypsinogen|immunoreactive trypsinogen
5858273|NCT00014950|deltaF508- CFTR gene|deltaf508- cftr gene
5858274|NCT00014950|newborn screening|newborn screening
5858275|NCT00014950|Pseudomonas aeruginosa infection|pseudomonas aeruginosa infection
5858276|NCT00014950|nutrition|nutrition
5858277|NCT00014950|pulmonary status|pulmonary status
5858278|NCT00014950|meconium ileus|meconium ileus
5858279|NCT00014950|growth|growth
5858280|NCT00014950|Genetic counseling|genetic counseling
5858281|NCT00014950|risk communication|risk communication
5858282|NCT00014898|Lead exposure|lead exposure
5858283|NCT00014898|Bone lead|bone lead
5858284|NCT00014898|Attention deficit|attention deficit
5858285|NCT00014885|Lead exposure|lead exposure
5858286|NCT00014885|Bone lead|bone lead
5858287|NCT00014885|Cognitive function|cognitive function
5858288|NCT00014885|Academic achievement|academic achievement
5858289|NCT00014885|Neurobehavior|neurobehavior
5858290|NCT00014859|Pulmonary surfactant|pulmonary surfactant
5858291|NCT00014859|Surfactant protein B|surfactant protein b
5858292|NCT00014859|Surfactant protein C|surfactant protein c
5858293|NCT00014859|ABCA3|abca3
5858294|NCT00014859|NKX2-1|nkx2-1
5858295|NCT00014859|Alveolar type 2 cell|alveolar type 2 cell
5858297|NCT00014807|Organophosphate|organophosphate
5858298|NCT00014807|Biomarkers of exposure|biomarkers of exposure
5858299|NCT00014807|Poisoning|poisoning
5858300|NCT00014807|Occupational Health|occupational health
5858301|NCT00014794|Arthritis|arthritis
5858302|NCT00014794|Vascularity|vascularity
5858303|NCT00014794|Angiogenesis|angiogenesis
5858304|NCT00014794|Imaging|imaging
5858305|NCT00014794|MRI|mri
5858306|NCT00014794|Rheumatoid Arthritis|rheumatoid arthritis
5858307|NCT00014794|PET Scan|pet scan
5858308|NCT00014794|Synovitis|synovitis
5858309|NCT00014781|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5858310|NCT00014781|cystic fibrosis|cystic fibrosis
5858311|NCT00014781|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5858312|NCT00014781|rare disease|rare disease
5858313|NCT00014768|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5858314|NCT00014768|cystic fibrosis|cystic fibrosis
5858315|NCT00014768|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5858316|NCT00014768|rare disease|rare disease
5858317|NCT00014755|multiple sclerosis|multiple sclerosis
5858318|NCT00014755|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5858319|NCT00014755|rare disease|rare disease
5858320|NCT00014742|Dupuytren's disease|dupuytren's disease
5858321|NCT00014742|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858322|NCT00014742|rare disease|rare disease
5858323|NCT00014729|dermatologic disorders|dermatologic disorders
5858324|NCT00014729|epidermolysis bullosa|epidermolysis bullosa
5858325|NCT00014729|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5858326|NCT00014729|rare disease|rare disease
5858327|NCT00014040|Angina Pectoris|angina pectoris
5858328|NCT00014040|Endothelium|endothelium
5858329|NCT00014040|Platelets|platelets
5858330|NCT00014040|Inflammation|inflammation
5858331|NCT00014040|Atherosclerosis|atherosclerosis
5858332|NCT00014040|Coronary Artery Disease|coronary artery disease
5858333|NCT00014040|Chest Pain|chest pain
5858334|NCT00014040|Nitrous Oxide Inhalation|nitrous oxide inhalation
5858335|NCT00014040|Treadmill Exercise|treadmill exercise
5858336|NCT00014027|Omega-3 Fatty Acids|omega-3 fatty acids
5858337|NCT00014027|Cerebrospinal Fluid|cerebrospinal fluid
5858338|NCT00014027|Neurotransmitters|neurotransmitters
5858339|NCT00014027|Cardiovascular|cardiovascular
5858340|NCT00014027|Reactivity|reactivity
5858341|NCT00014027|Healthy Volunteer|healthy volunteer
5858342|NCT00014027|Lumbar Puncture|lumbar puncture
5858343|NCT00014027|MRI|mri
5858344|NCT00014001|Antipsychotic Treatment|antipsychotic treatment
5858345|NCT00014001|Effectiveness|effectiveness
5858346|NCT00013975|Framingham Risk Scoring|framingham risk scoring
5858347|NCT00013975|Brachial Artery Reactivity|brachial artery reactivity
5858348|NCT00013975|EPC Colony Assay|epc colony assay
5858349|NCT00013975|Healthy Volunteer|healthy volunteer
5858350|NCT00013975|Atherosclerosis Risk Factors|atherosclerosis risk factors
5858351|NCT00013975|Cholesterol|cholesterol
5858352|NCT00013975|Hypertension|hypertension
5858353|NCT00013975|Smoking|smoking
5858354|NCT00013975|Diabetes|diabetes
5858355|NCT00013975|Postmenopausal|postmenopausal
5858356|NCT00013975|Heart Disease Risk Factors|heart disease risk factors
5858357|NCT00013975|Risk Factors|risk factors
5858358|NCT00013949|Holter monitoring|holter monitoring
5858359|NCT00013949|ECG|ecg
5858360|NCT00013949|Cardiac|cardiac
5858361|NCT00013949|particulate exposure|particulate exposure
5858362|NCT00013936|Instrument Development|instrument development
5858363|NCT00013936|Psychophysical Methods|psychophysical methods
5858364|NCT00013936|ETDRS|etdrs
5858365|NCT00013936|Computer-Based Methods|computer-based methods
5858366|NCT00013936|Validation Study|validation study
5858367|NCT00013936|Visual Acuity|visual acuity
5858368|NCT00013936|Vision Tests/Instrumentation|vision tests/instrumentation
5858369|NCT00013936|Psychophysics|psychophysics
5858370|NCT00013936|Modified Binary Search|modified binary search
5858371|NCT00013936|Visual Acuity Test|visual acuity test
5858372|NCT00013923|Nutritional Supplement|nutritional supplement
5858373|NCT00013910|glucagon-like peptide 1|glucagon-like peptide 1
5858374|NCT00013858|methylmercury|methylmercury
5858375|NCT00013858|PCBs|pcbs
5858376|NCT00013858|lead|lead
5858377|NCT00013858|fish consumption|fish consumption
5858378|NCT00013858|breast-feeding|breast-feeding
5858379|NCT00013884|HIV|hiv
5858380|NCT00013884|T20|t20
5858381|NCT00013884|HAART|haart
5858382|NCT00013884|Interruption|interruption
5858383|NCT00013884|Therapy|therapy
5858384|NCT00013884|Fusion Inhibitor T20|fusion inhibitor t20
5858385|NCT00013884|Treatment Interuption|treatment interuption
5858386|NCT00013845|Seizures|seizures
5858387|NCT00013845|Anti-Epileptic Drugs|anti-epileptic drugs
5858388|NCT00013845|Pharmacotherapy|pharmacotherapy
5858389|NCT00013845|Neuropsychology|neuropsychology
5858390|NCT00013845|Temporal Lobe Epilepsy|temporal lobe epilepsy
5858391|NCT00013845|Frontal Lobe Epilepsy|frontal lobe epilepsy
5858392|NCT00013845|Complex Partial Seizures|complex partial seizures
5858393|NCT00013845|Grand Mal Seizures|grand mal seizures
5858394|NCT00013845|Generalized Seizures|generalized seizures
5858395|NCT00013845|Epilepsy|epilepsy
5858396|NCT00013832|Pressure|pressure
5858397|NCT00013832|Swallowing|swallowing
5858398|NCT00013832|Tongue|tongue
5858399|NCT00013832|Healthy Volunteer|healthy volunteer
5858400|NCT00013832|Dysphagia|dysphagia
5858401|NCT00013819|lead poisoning|lead poisoning
5858402|NCT00013819|central nervous system|central nervous system
5858403|NCT00013819|peripheral nervous system|peripheral nervous system
5858404|NCT00013819|occupational health|occupational health
5858405|NCT00013819|genetic susceptibility|genetic susceptibility
5858406|NCT00013806|Relapsed and refractory neuroblastoma|relapsed and refractory neuroblastoma
5858407|NCT00013780|ozone uptake|ozone uptake
5858408|NCT00013780|inhalation toxicology|inhalation toxicology
5858409|NCT00013780|nasal cavities|nasal cavities
5858410|NCT00013780|antioxidants|antioxidants
5858411|NCT00013767|Pesticide|pesticide
5858412|NCT00013767|Insecticide|insecticide
5858413|NCT00013767|Organophosphate|organophosphate
5858414|NCT00013767|Child Health|child health
5858415|NCT00013767|Exposure Prevention|exposure prevention
5858416|NCT00013754|pesticide|pesticide
5858417|NCT00013754|insecticide|insecticide
5858418|NCT00013754|organophosphate|organophosphate
5858419|NCT00013754|exposure|exposure
5858420|NCT00013754|child health|child health
5858421|NCT00013741|Acute Myocardial Infarction|acute myocardial infarction
5858422|NCT00013741|Diabetes Mellitus|diabetes mellitus
5858423|NCT00013741|Renal Dialysis|renal dialysis
5858424|NCT00013741|Heart Attack|heart attack
5858425|NCT00013741|Coronary Heart Disease|coronary heart disease
5858426|NCT00013728|asthma|asthma
5858427|NCT00013728|particulate matter|particulate matter
5858428|NCT00013715|Asthma|asthma
5858429|NCT00013715|Rhinovirus|rhinovirus
5858430|NCT00013715|Ozone|ozone
5858431|NCT00013702|Immunology|immunology
5858432|NCT00013702|Cirrhosis|cirrhosis
5858433|NCT00013702|Ascites|ascites
5858434|NCT00013702|Open-Label|open-label
5858435|NCT00013702|Chronic|chronic
5858437|NCT00013702|Hepatitis B|hepatitis b
5858438|NCT00013689|Lymphadenopathy|lymphadenopathy
5858439|NCT00013689|Splenomegaly|splenomegaly
5858440|NCT00013689|Children|children
5858441|NCT00013689|Tomography|tomography
5858442|NCT00013689|Autoimmune Lymphoproliferative Syndrome (ALPS)|autoimmune lymphoproliferative syndrome (alps)
5858443|NCT00013650|Alzheimer's Disease|alzheimer's disease
5858444|NCT00013650|Immunomodulatory|immunomodulatory
5858445|NCT00013650|Antiinflammatory|antiinflammatory
5858446|NCT00013650|Cyclophosphamide|cyclophosphamide
5858447|NCT00013650|Non-steroidal|non-steroidal
5858448|NCT00013650|Complement|complement
5858449|NCT00013650|Immune Function|immune function
5858450|NCT00013650|Immunotherapy|immunotherapy
5858451|NCT00013637|Osteoporosis|osteoporosis
5858452|NCT00013637|Lead|lead
5858453|NCT00013624|Riluzole|riluzole
5858454|NCT00013624|Dyskinesias|dyskinesias
5858455|NCT00013624|L-Dopa Infusion|l-dopa infusion
5858468|NCT00013598|Thiazolidinediones|thiazolidinediones
5858469|NCT00013598|Peroxisome Proliferator-Activated Receptor Gamma|peroxisome proliferator-activated receptor gamma
5858470|NCT00013598|PPARgamma|ppargamma
5858471|NCT00013598|Nonalcoholic Steatohepatitis|nonalcoholic steatohepatitis
5858472|NCT00013598|Pioglitazone|pioglitazone
5858473|NCT00013598|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5858474|NCT00013598|Liver Biopsy|liver biopsy
5858475|NCT00013598|Pharmacotherapy|pharmacotherapy
5858483|NCT00013546|Osteoporosis|osteoporosis
5858484|NCT00013546|Body Composition|body composition
5858485|NCT00013546|Estrogen|estrogen
5858487|NCT00013546|Ovarian Failure|ovarian failure
5858488|NCT00013546|Turner's Syndrome|turner's syndrome
5858489|NCT00013546|Hormone Replacement|hormone replacement
5858491|NCT00013546|Turner's|turner's
5858493|NCT00013533|Leukemia|leukemia
5858494|NCT00013533|Myelodysplastic Syndrome|myelodysplastic syndrome
5858495|NCT00013533|Bone Marrow Transplant|bone marrow transplant
5858496|NCT00013533|Pediatric Oncology|pediatric oncology
5858497|NCT00013533|Lymphoma|lymphoma
5858498|NCT00013533|Efficacy|efficacy
5858499|NCT00013533|Safety|safety
5858500|NCT00013533|Childhood Cancer|childhood cancer
5858501|NCT00013507|Frail|frail
5858502|NCT00013507|FIT|fit
5858503|NCT00013507|transfer|transfer
5858504|NCT00013507|continence|continence
5858505|NCT00013507|ambulation|ambulation
5858506|NCT00013507|balance|balance
5858507|NCT00013507|fall risk|fall risk
5858508|NCT00013507|strength,endurance|strength,endurance
5858509|NCT00013494|Hemiplegia|hemiplegia
5858510|NCT00013494|elderly|elderly
5858511|NCT00013494|Video|video
5858512|NCT00013494|F-PAT,Functional Performance|f-pat,functional performance
5858513|NCT00013494|digitized videoclips|digitized videoclips
5858514|NCT00013481|stroke, hemiparesis, CNS, motor coordination|stroke, hemiparesis, cns, motor coordination
5858515|NCT00013468|Hearing loss, ear, steroids, auditory|hearing loss, ear, steroids, auditory
5858516|NCT00013455|Hearing aid, hearing impaired|hearing aid, hearing impaired
5858517|NCT00013442|Aphasia, auditory evoked, aging|aphasia, auditory evoked, aging
5863160|NCT00001366|Cerebral Localization|cerebral localization
5858518|NCT00013429|Vision, Opthalmology, blindness, aging|vision, opthalmology, blindness, aging
5858519|NCT00013416|Hearing loss, hearing aid, amplification|hearing loss, hearing aid, amplification
5858520|NCT00013403|Vision, quality of life|vision, quality of life
5858521|NCT00013390|Auditory, tinnitus|auditory, tinnitus
5858522|NCT00013377|Low vision, Driving rehabilitation|low vision, driving rehabilitation
5858523|NCT00013364|Hearing loss, speech recognition|hearing loss, speech recognition
5858524|NCT00013351|Aging adult, attention, falls, vision|aging adult, attention, falls, vision
5858525|NCT00013338|Spinal cord injury, ambulation, treadmill|spinal cord injury, ambulation, treadmill
5858526|NCT00013325|Spinal cord injury, heart disease, electrocardiography|spinal cord injury, heart disease, electrocardiography
5858527|NCT00013312|Spinal cord injury, gastrointestinal motility, gastrointestinal transit|spinal cord injury, gastrointestinal motility, gastrointestinal transit
5858528|NCT00013299|Foot ulcers, amputation prevention, diabetes, footwear, insoles|foot ulcers, amputation prevention, diabetes, footwear, insoles
5858529|NCT00013286|Diabetes mellitus, foot ulcer, endothelium|diabetes mellitus, foot ulcer, endothelium
5858530|NCT00013273|Venous insufficiency, plethysmography, hypertension|venous insufficiency, plethysmography, hypertension
5858531|NCT00013260|Case management|case management
5858532|NCT00013260|Nurse intervention|nurse intervention
5858533|NCT00013195|Telephone|telephone
5858534|NCT00013026|Congestive Heart Failure|congestive heart failure
5858853|NCT00009659|Antihormone|antihormone
5858535|NCT00012844|Musculoskeletal Disorders|musculoskeletal disorders
5858536|NCT00012844|Patient Lifting|patient lifting
5858537|NCT00012844|Occupational Accidents|occupational accidents
5858538|NCT00012779|Health Care Education|health care education
5858539|NCT00012779|Health Care Cost|health care cost
5858541|NCT00012558|Mood Disorders|mood disorders
5858542|NCT00012558|Manic-Depressive Illness|manic-depressive illness
5858543|NCT00012558|Hypomania|hypomania
5858545|NCT00012558|Mood Stabilizer|mood stabilizer
5858549|NCT00012493|Cardiac event|cardiac event
5858550|NCT00012493|Heart disease|heart disease
5858551|NCT00012493|Particulate Matter|particulate matter
5858552|NCT00012480|Lead|lead
5858553|NCT00012480|Male infertility|male infertility
5858554|NCT00012480|Gene expression|gene expression
5858555|NCT00012480|Economics, Medical|economics, medical
5858556|NCT00012441|Renal Dialysis|renal dialysis
5858557|NCT00012428|Cognitive development|cognitive development
5858558|NCT00012428|Prenatal exposure|prenatal exposure
5858559|NCT00012428|PCBs|pcbs
5858560|NCT00011908|Safety|safety
5858561|NCT00011908|B-Lymphocyte Depletion|b-lymphocyte depletion
5858562|NCT00011908|Anti-CD22|anti-cd22
5858563|NCT00011908|Response|response
5858564|NCT00011908|Efficacy|efficacy
5858565|NCT00011908|Lupus|lupus
5858566|NCT00011908|Immunotherapy|immunotherapy
5858567|NCT00011856|Intracranial Aneurysms|intracranial aneurysms
5858568|NCT00011856|Cerebral|cerebral
5858569|NCT00011856|Loci|loci
5858570|NCT00011856|Susceptibility Genes|susceptibility genes
5858571|NCT00011856|Cerebral Aneurysm|cerebral aneurysm
5858572|NCT00011856|Familial Cerebral Aneurysm|familial cerebral aneurysm
5858573|NCT00011856|Genetics|genetics
5858574|NCT00011843|X-Linked|x-linked
5858575|NCT00011843|Heterogeneous|heterogeneous
5858576|NCT00011843|Embryologic Development|embryologic development
5858577|NCT00011843|Mental Retardation|mental retardation
5858578|NCT00011843|Brain Development|brain development
5858579|NCT00011843|Microphthalmia|microphthalmia
5858580|NCT00011843|Anophthalmia|anophthalmia
5858581|NCT00011843|Malformations|malformations
5858582|NCT00011843|Lenz Dysplasia|lenz dysplasia
5858583|NCT00011843|Microphthalmia/Anophthalmia|microphthalmia/anophthalmia
5858585|NCT00011843|Gene Characterization|gene characterization
5858586|NCT00011830|Stem Cell Cryopreservation|stem cell cryopreservation
5858587|NCT00011830|Leukapheresis|leukapheresis
5858588|NCT00011817|Evaluation and Treatment|evaluation and treatment
5858589|NCT00011817|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
5858590|NCT00011817|Genetic Testing|genetic testing
5858591|NCT00011817|Genetic Eye Diseases|genetic eye diseases
5858592|NCT00011817|Evaluation|evaluation
5858593|NCT00011804|Low Back Pain|low back pain
5858594|NCT00011804|Lumbar Radiculopathy|lumbar radiculopathy
5858595|NCT00011804|Anticonvulsants|anticonvulsants
5858596|NCT00011804|Neuropathic Pain|neuropathic pain
5858597|NCT00011804|Analgesia|analgesia
5858598|NCT00011804|Sciatica|sciatica
5858599|NCT00011791|CAH|cah
5858600|NCT00011791|Catecholamines|catecholamines
5858601|NCT00011791|Adrenal Medulla|adrenal medulla
5858602|NCT00011791|Endocrine|endocrine
5858603|NCT00011791|Congenital Adrenal Hyperplasia|congenital adrenal hyperplasia
5858604|NCT00011791|Exercise|exercise
5858605|NCT00011791|Healthy Volunteer|healthy volunteer
5858606|NCT00011778|Cell Cycle|cell cycle
5858607|NCT00011778|NFKB|nfkb
5858608|NCT00011778|Combined Modality|combined modality
5858609|NCT00011778|Radiosensitizer|radiosensitizer
5858610|NCT00011778|Ubiquitin|ubiquitin
5858611|NCT00011778|Head and Neck Cancer|head and neck cancer
5858612|NCT00011778|Squamous Cell Carcinoma|squamous cell carcinoma
5858613|NCT00011778|Radiation Therapy|radiation therapy
5858614|NCT00011778|Protease Inhibitor|protease inhibitor
5858620|NCT00011765|Domestic Violence|domestic violence
5858621|NCT00011765|Physical Aggression|physical aggression
5858622|NCT00011765|Serotonin Reuptake Inhibitor|serotonin reuptake inhibitor
5858623|NCT00011752|Serotonin Reuptake|serotonin reuptake
5858624|NCT00011752|Large Neutral Amino Acids|large neutral amino acids
5858625|NCT00011752|5-Hydroxyindoleacetic Acid|5-hydroxyindoleacetic acid
5858627|NCT00011752|PET|pet
5858628|NCT00011752|TRP|trp
5858629|NCT00011752|Tryptophan Depletion|tryptophan depletion
5858630|NCT00011752|Healthy Volunteer|healthy volunteer
5858631|NCT00011739|Low back pain, Magnetic resonance imaging (MRI),|low back pain, magnetic resonance imaging (mri),
5858632|NCT00011726|Pregnancy|pregnancy
5858633|NCT00011726|Lead Exposure|lead exposure
5858634|NCT00011726|Lactation|lactation
5858635|NCT00011726|Bone Mineralization|bone mineralization
5858636|NCT00011726|Maternal-Fetal Exchange|maternal-fetal exchange
5858637|NCT00011713|Semen|semen
5858638|NCT00011713|Infertility|infertility
5858959|NCT00009035|Radiation|radiation
5858639|NCT00011713|ART - Assisted Reproduction Technology|art - assisted reproduction technology
5858640|NCT00011713|Phthalates|phthalates
5858641|NCT00011713|Bisphenol A|bisphenol a
5858642|NCT00011700|idiopathic pulmonary hemorrhage in infants,|idiopathic pulmonary hemorrhage in infants,
5858643|NCT00011700|toxigenic mold exposure|toxigenic mold exposure
5858644|NCT00011687|Fertility|fertility
5858645|NCT00011687|Hormones|hormones
5858646|NCT00011687|Semen|semen
5858647|NCT00011687|Reproductive Health|reproductive health
5858648|NCT00011674|Lead|lead
5858649|NCT00011674|Prenatal|prenatal
5858650|NCT00011674|Development|development
5858656|NCT00011661|Native Americans|native americans
5858662|NCT00011609|Robotics; Activities of Daily Living; Spinal Cord Injuries|robotics; activities of daily living; spinal cord injuries
5858663|NCT00011596|Hemiplegia, gait, electric stimulation|hemiplegia, gait, electric stimulation
5858664|NCT00011583|Cerebrovascular|cerebrovascular
5858665|NCT00011583|Hemiplegia|hemiplegia
5858666|NCT00011583|Robotics|robotics
5858667|NCT00011570|defecation|defecation
5858668|NCT00011570|electrical stimulation|electrical stimulation
5858669|NCT00011570|penile erection|penile erection
5858670|NCT00011570|Spinal cord injury|spinal cord injury
5858671|NCT00011570|urology|urology
5858672|NCT00011557|Bladder, electromagnetic fields, Spinal cord injury|bladder, electromagnetic fields, spinal cord injury
5858673|NCT00011544|wheelchair, biomechanics, aging, functional outcome, disability|wheelchair, biomechanics, aging, functional outcome, disability
5858674|NCT00011531|Decubitus Ulcers|decubitus ulcers
5858675|NCT00011531|dehiscence|dehiscence
5858677|NCT00011531|wound healing|wound healing
5858678|NCT00011518|Arsenic|arsenic
5858679|NCT00011518|Bladder Cancer|bladder cancer
5858680|NCT00011518|Drinking Water|drinking water
5858681|NCT00011505|G-CSF|g-csf
5858682|NCT00011505|Leukapheresis|leukapheresis
5858683|NCT00011505|Stem Cell Cryopreservation|stem cell cryopreservation
5858684|NCT00011505|Central Line Placement|central line placement
5858685|NCT00011505|G-CSF Administration|g-csf administration
5858686|NCT00011505|Stem Cell Preservation|stem cell preservation
5858687|NCT00011505|Diamond Blackfan Anemia|diamond blackfan anemia
5858688|NCT00011505|Healthy Volunteer|healthy volunteer
5858694|NCT00011466|ADHD|adhd
5858695|NCT00011466|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5858696|NCT00011466|Carbohydrate Craving|carbohydrate craving
5858697|NCT00011453|NQO1|nqo1
5858698|NCT00011453|DT-diaphorase|dt-diaphorase
5858699|NCT00011453|Benzene|benzene
5858700|NCT00011453|Leukemia|leukemia
5858701|NCT00011453|Aplastic anemia|aplastic anemia
5858702|NCT00011440|Allergy|allergy
5858703|NCT00011440|Air pollution|air pollution
5858704|NCT00011440|Lung function|lung function
5858705|NCT00011440|Inflammation|inflammation
5858706|NCT00011414|Drug Resistance|drug resistance
5858707|NCT00011414|PEDIATRIC SOLID TUMORS|pediatric solid tumors
5858708|NCT00011414|Chemotherapy|chemotherapy
5858709|NCT00011414|p-glycoprotien|p-glycoprotien
5858710|NCT00011414|Brain Tumors|brain tumors
5858711|NCT00011414|Childhood Cancer|childhood cancer
5858712|NCT00011414|Brain Tumor|brain tumor
5858713|NCT00011388|Organochlorine compounds|organochlorine compounds
5858714|NCT00011388|Endocrine disruptors|endocrine disruptors
5858715|NCT00011388|Sex Hormones|sex hormones
5858716|NCT00011388|Reproductive function|reproductive function
5858717|NCT00011388|Menstrual Disturbances|menstrual disturbances
5858718|NCT00011375|Phosphodiesterase Inhibitor|phosphodiesterase inhibitor
5858719|NCT00011375|Immunology|immunology
5858720|NCT00011375|Immunomodulation|immunomodulation
5858721|NCT00011375|Antidepressant|antidepressant
5858722|NCT00011375|Therapy|therapy
5858723|NCT00011375|Multiple Sclerosis|multiple sclerosis
5858724|NCT00011375|Immunotherapy|immunotherapy
5858725|NCT00011362|NICHD Neonatal Research Network|nichd neonatal research network
5858726|NCT00011362|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5858727|NCT00011362|Prematurity|prematurity
5858728|NCT00011362|Dexamethasone|dexamethasone
5858729|NCT00011362|Glucocorticoids|glucocorticoids
5858730|NCT00011362|Respiratory Distress Syndrome|respiratory distress syndrome
5858731|NCT00011362|Respiratory insufficiency|respiratory insufficiency
5858732|NCT00011362|Steroids|steroids
5858733|NCT00011349|Prostate Cancer|prostate cancer
5858735|NCT00011336|chronic respiratory symptoms|chronic respiratory symptoms
5858736|NCT00011336|measures of pulmonary function|measures of pulmonary function
5858737|NCT00011336|respiratory illness|respiratory illness
5858738|NCT00011323|osteoporosis,smoking, alcohol, caffeine|osteoporosis,smoking, alcohol, caffeine
5858739|NCT00011310|Particulates|particulates
5858740|NCT00011310|Air Pollution|air pollution
5858741|NCT00011310|Cardiopulmonary Disease|cardiopulmonary disease
5858742|NCT00011310|Lung|lung
5858743|NCT00011310|Inflammation|inflammation
5858744|NCT00011284|Liver|liver
5858745|NCT00011284|Inflammation|inflammation
5858746|NCT00011284|Endotoxin|endotoxin
5858747|NCT00011284|Neutrophils|neutrophils
5858749|NCT00011258|Atherosclerosis of the carotid arteries|atherosclerosis of the carotid arteries
5858751|NCT00011258|lipoprotein metabolism|lipoprotein metabolism
5858752|NCT00011258|paraoxonase|paraoxonase
5858753|NCT00011245|Arachnoiditis|arachnoiditis
5858755|NCT00011245|Intraoperative Ultrasonography|intraoperative ultrasonography
5858756|NCT00011245|Magnetic Resonance|magnetic resonance
5858757|NCT00011245|CSF Pressure|csf pressure
5858759|NCT00011245|Meningitis|meningitis
5858760|NCT00011245|Paralysis|paralysis
5858761|NCT00011245|Spondylosis|spondylosis
5858762|NCT00011245|Spinal Syringomyelia|spinal syringomyelia
5858763|NCT00011245|Presyringomyelia|presyringomyelia
5858764|NCT00011245|Spinal Cord Edema|spinal cord edema
5858765|NCT00011245|Magnetic Resonance Imaging (MRI)|magnetic resonance imaging (mri)
5858766|NCT00011245|Intraoperative Radiation|intraoperative radiation
5858767|NCT00011245|Ultrasonography|ultrasonography
5858768|NCT00011141|Immune-mediated diabetes mellitus|immune-mediated diabetes mellitus
5858769|NCT00011193|Cardiovascular Diseases|cardiovascular diseases
5858770|NCT00011193|Hypertension|hypertension
5858771|NCT00011193|Postmenopausal|postmenopausal
5858772|NCT00011193|Overweight or Obese|overweight or obese
5858773|NCT00011193|Women|women
5858774|NCT00011193|Sedentary|sedentary
5858775|NCT00011180|Venous thromboembolism (VTE)|venous thromboembolism (vte)
5858776|NCT00011180|Deep vein thrombosis (DVT)|deep vein thrombosis (dvt)
5858777|NCT00011180|Pulmonary embolism (PE)|pulmonary embolism (pe)
5858778|NCT00011076|Deskar|deskar
5858779|NCT00011076|Fibrosis|fibrosis
5858780|NCT00011076|Myocardium|myocardium
5858781|NCT00011076|Scarring|scarring
5858782|NCT00011076|Arrhythmia|arrhythmia
5858783|NCT00011076|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5858784|NCT00011076|Left Ventricular Diastolic Dysfunction|left ventricular diastolic dysfunction
5858785|NCT00011076|Myocardial Fibrosis|myocardial fibrosis
5858786|NCT00011115|overweight|overweight
5858787|NCT00011102|weight gain|weight gain
5858788|NCT00010998|Multiple Sclerosis|multiple sclerosis
5858789|NCT00010998|Yoga|yoga
5858790|NCT00010985|Backpain|backpain
5858791|NCT00010985|Pain|pain
5858792|NCT00010985|Alternative Medicine|alternative medicine
5858793|NCT00010985|Acupuncture|acupuncture
5858794|NCT00010985|Chiropractic|chiropractic
5858795|NCT00010985|Massage Therapy|massage therapy
5858796|NCT00010959|menopause|menopause
5858797|NCT00010959|hot flashes|hot flashes
5858798|NCT00010959|botanicals|botanicals
5858799|NCT00010946|acupuncture|acupuncture
5858800|NCT00010946|osteoarthritis|osteoarthritis
5858801|NCT00010946|elderly|elderly
5858802|NCT00010868|bipolar disorder|bipolar disorder
5858803|NCT00010868|omega-3 fatty acids|omega-3 fatty acids
5858804|NCT00010868|eicosapentaenoic acid|eicosapentaenoic acid
5858805|NCT00010868|docosahexaenoic acid|docosahexaenoic acid
5858806|NCT00010855|hypnosis|hypnosis
5858807|NCT00010855|relaxation|relaxation
5858808|NCT00010855|invasive medical procedures|invasive medical procedures
5858809|NCT00010855|interventional radiology|interventional radiology
5858810|NCT00010855|conscious sedation|conscious sedation
5858811|NCT00010855|anesthesia|anesthesia
5858812|NCT00010855|complications|complications
5858813|NCT00010855|cost analysis|cost analysis
5858814|NCT00010855|Interventional procedures, complications|interventional procedures, complications
5858815|NCT00010855|Angiography|angiography
5858816|NCT00010855|Nephrostomy|nephrostomy
5858817|NCT00010855|Hepatic chemoembolization|hepatic chemoembolization
5858818|NCT00010855|Fibroid Embolization|fibroid embolization
5858819|NCT00010829|Cardiovascular Diseases|cardiovascular diseases
5858820|NCT00010829|Osteoporosis|osteoporosis
5858821|NCT00010829|Breast Cancer|breast cancer
5858822|NCT00010829|Endometrial Cancer|endometrial cancer
5858824|NCT00010712|Menopause|menopause
5858825|NCT00010712|Hot Flashes|hot flashes
5858826|NCT00010712|Osteoporosis|osteoporosis
5858827|NCT00010712|Postmenopausal|postmenopausal
5858828|NCT00010699|cvd|cvd
5858829|NCT00010608|CVD|cvd
5858830|NCT00010530|CVD|cvd
5858831|NCT00010504|acupuncture|acupuncture
5858832|NCT00010504|fibromyalgia|fibromyalgia
5858833|NCT00010504|pain|pain
5858834|NCT00010504|analgesia|analgesia
5858835|NCT00010491|Diarrhea|diarrhea
5858836|NCT00010491|complementary therapies|complementary therapies
5858837|NCT00009685|Vaccine|vaccine
5858838|NCT00009685|HIV|hiv
5858839|NCT00009685|Codon-Optimized|codon-optimized
5858840|NCT00009685|HIV Vaccine|hiv vaccine
5858841|NCT00009685|Healthy Volunteer|healthy volunteer
5858842|NCT00009685|HIV-1 DNA Vaccine|hiv-1 dna vaccine
5858843|NCT00009685|HIV Seronegativity|hiv seronegativity
5858844|NCT00009685|HIV Preventive Vaccine|hiv preventive vaccine
5858845|NCT00009672|Low Back Pain|low back pain
5858846|NCT00009672|Opioid|opioid
5858847|NCT00009672|Antidepressant|antidepressant
5858848|NCT00009672|Randomized Controlled Trial|randomized controlled trial
5858849|NCT00009672|Analgesic|analgesic
5858850|NCT00009672|Sciatica|sciatica
5858851|NCT00009659|Endometrium|endometrium
5858852|NCT00009659|Estrogen|estrogen
5858860|NCT00009646|Indomethacin|indomethacin
5858861|NCT00009646|Infants, very low birth weight|infants, very low birth weight
5858862|NCT00009646|Intraventricular hemorrhage|intraventricular hemorrhage
5858863|NCT00009646|Necrotizing enterocolitis|necrotizing enterocolitis
5858864|NCT00009646|Patent ductus arteriosus|patent ductus arteriosus
5858865|NCT00009646|Pulmonary hemorrhage|pulmonary hemorrhage
5858866|NCT00009633|NICHD Neonatal Research Network|nichd neonatal research network
5858867|NCT00009633|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5858868|NCT00009633|Prematurity|prematurity
5858869|NCT00009633|Neurodevelopmental Outcome|neurodevelopmental outcome
5858870|NCT00009633|Follow up studies|follow up studies
5858871|NCT00009620|NICHD Neonatal Research Network|nichd neonatal research network
5858872|NCT00009620|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5858873|NCT00009620|Prematurity|prematurity
5858874|NCT00009620|Cerebral hemorrhage|cerebral hemorrhage
5858875|NCT00009620|Phenobarbital|phenobarbital
5858876|NCT00009620|Pregnancy|pregnancy
5858877|NCT00009620|Prenatal care|prenatal care
5858878|NCT00009620|Intraventricular hemorrhage|intraventricular hemorrhage
5858879|NCT00009620|Periventricular leukomalacia|periventricular leukomalacia
5858880|NCT00009620|Brain injury|brain injury
5858881|NCT00009620|Brain hemorrhage|brain hemorrhage
5858882|NCT00010452|cystic hygroma|cystic hygroma
5858883|NCT00010452|lymphangiomas|lymphangiomas
5858884|NCT00010452|lymphatic malformations|lymphatic malformations
5858885|NCT00010439|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858886|NCT00010439|idiopathic juvenile osteoporosis|idiopathic juvenile osteoporosis
5858887|NCT00010439|rare disease|rare disease
5858888|NCT00010426|cystinosis|cystinosis
5858889|NCT00010426|rare disease|rare disease
5858890|NCT00010426|renal and genitourinary disorders|renal and genitourinary disorders
5858891|NCT00010413|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5858892|NCT00010413|pemphigus|pemphigus
5858893|NCT00010413|rare disease|rare disease
5858894|NCT00010400|antiphospholipid antibody syndrome|antiphospholipid antibody syndrome
5858895|NCT00010400|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5858896|NCT00010400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5858897|NCT00010400|rare disease|rare disease
5858898|NCT00010400|systemic lupus erythematosus|systemic lupus erythematosus
5858899|NCT00010387|Felty syndrome|felty syndrome
5858900|NCT00010387|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5858901|NCT00010387|autoimmune neutropenia|autoimmune neutropenia
5858902|NCT00010387|hematologic disorders|hematologic disorders
5858903|NCT00010387|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5858904|NCT00010387|rare disease|rare disease
5858905|NCT00010374|Diaphragm for Ventilatory Assist|diaphragm for ventilatory assist
5858906|NCT00010374|environmental/toxic disorders|environmental/toxic disorders
5858907|NCT00010374|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5858908|NCT00010374|rare disease|rare disease
5858909|NCT00010374|spinal cord injury|spinal cord injury
5858910|NCT00010335|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5846471|NCT00044317|FEV|fev
5858911|NCT00010335|dermatomyositis|dermatomyositis
5858912|NCT00010335|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5858913|NCT00010335|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5858914|NCT00010335|rare disease|rare disease
5858915|NCT00010335|systemic lupus erythematosus|systemic lupus erythematosus
5858916|NCT00010335|systemic sclerosis|systemic sclerosis
5858917|NCT00009581|Endothelial Function|endothelial function
5858918|NCT00009581|Hydroxyurea|hydroxyurea
5858919|NCT00009581|Leukocyte Gene Expression|leukocyte gene expression
5858920|NCT00009581|Nitrosylated Hemoglobin|nitrosylated hemoglobin
5858921|NCT00009581|Sickle Cell Anemia|sickle cell anemia
5858922|NCT00009581|Nitric Oxide|nitric oxide
5858923|NCT00009568|Antidepressants|antidepressants
5858924|NCT00009568|Platelet Function|platelet function
5858925|NCT00009568|SSRI|ssri
5858926|NCT00009568|Depression|depression
5858927|NCT00009568|Bleeding Time|bleeding time
5858928|NCT00009256|Quasispecies Variation|quasispecies variation
5858929|NCT00009256|Genotyping|genotyping
5858930|NCT00009256|Phenotyping|phenotyping
5858931|NCT00009256|Antiretroviral Therapy|antiretroviral therapy
5858932|NCT00009256|Drug Naive Patients|drug naive patients
5858933|NCT00009256|HIV|hiv
5858934|NCT00009256|Treatment Naive|treatment naive
5858941|NCT00009230|Age associated memory impairment|age associated memory impairment
5858942|NCT00009230|Mild cognitive impairment|mild cognitive impairment
5858943|NCT00009217|Alzheimer's disease|alzheimer's disease
5858944|NCT00009217|psychosis|psychosis
5858945|NCT00009217|agitation|agitation
5858946|NCT00009217|haloperidol|haloperidol
5858947|NCT00009204|Behavioral problems|behavioral problems
5858948|NCT00009204|Agitation|agitation
5858949|NCT00009048|Dyskinesias|dyskinesias
5858950|NCT00009048|L-Dopa Infusion|l-dopa infusion
5858951|NCT00009048|Clinical Trial|clinical trial
5858952|NCT00009048|Motor Function|motor function
5858953|NCT00009048|Psychosis|psychosis
5858954|NCT00009048|Parkinson's Disease|parkinson's disease
5858955|NCT00009035|Brain|brain
5858956|NCT00009035|Tumor|tumor
5858957|NCT00009035|Chemotherapy|chemotherapy
5858958|NCT00009035|Antiangiogenesis|antiangiogenesis
5858962|NCT00009035|Medulloblastoma|medulloblastoma
5858963|NCT00009035|Astrocytoma|astrocytoma
5858964|NCT00009035|Glioblastoma|glioblastoma
5858965|NCT00009178|Primary Care|primary care
5858966|NCT00009178|Fluoxetine|fluoxetine
5858967|NCT00009009|Immune System|immune system
5858968|NCT00009009|Biopsy|biopsy
5858969|NCT00009009|AIDS|aids
5858970|NCT00009009|HIV|hiv
5858971|NCT00009009|End Stage Renal Disease|end stage renal disease
5858972|NCT00009009|Kidney Transplant|kidney transplant
5858973|NCT00008892|Magnetic Resonance Imaging|magnetic resonance imaging
5858974|NCT00008892|Diffusion Tensor Imaging|diffusion tensor imaging
5858975|NCT00008892|Twin Study|twin study
5858976|NCT00008892|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5858977|NCT00008892|Normal Volunteers|normal volunteers
5858978|NCT00008814|Cognition|cognition
5858979|NCT00008814|Infant Development|infant development
5858980|NCT00008814|MRI, Functional|mri, functional
5858981|NCT00008736|Feeding intolerance|feeding intolerance
5858982|NCT00008736|Infant, premature|infant, premature
5858983|NCT00008827|Obesity|obesity
5858984|NCT00008827|Behavioral weight control|behavioral weight control
5858985|NCT00008827|Internet|internet
5858986|NCT00008541|Keratitis|keratitis
5858987|NCT00008541|Conjunctivitis|conjunctivitis
5858988|NCT00008541|Meibomitis|meibomitis
5858989|NCT00008541|Corneal Infiltrates|corneal infiltrates
5858990|NCT00008541|Dacryocystitis|dacryocystitis
5858991|NCT00008541|Blepharitis|blepharitis
5858992|NCT00008541|Dacryoadenitis|dacryoadenitis
5858993|NCT00008541|Corneal Eye Disease|corneal eye disease
5858994|NCT00008515|Steroids|steroids
5858995|NCT00008515|Age-Related Macular Degeneration|age-related macular degeneration
5858996|NCT00008515|Implant|implant
5858997|NCT00008515|Choroidal Neovascularization|choroidal neovascularization
5858998|NCT00008515|Sustained Release Implant|sustained release implant
5858999|NCT00008502|Genetics|genetics
5859000|NCT00008502|African Americans|african americans
5859001|NCT00008502|Skin|skin
5859002|NCT00008502|Keloids|keloids
5859003|NCT00008476|Preemptive Analgesia|preemptive analgesia
5859004|NCT00008476|Vanilloid|vanilloid
5859005|NCT00008476|Vanilloid Receptor (VR)|vanilloid receptor (vr)
5859007|NCT00008476|Acute Pain|acute pain
5859008|NCT00008476|Orofacial|orofacial
5859009|NCT00008476|Visual Analog Scale (VAS)|visual analog scale (vas)
5859010|NCT00008476|Resiniferatoxin|resiniferatoxin
5859011|NCT00008476|Healthy Volunteer|healthy volunteer
5859012|NCT00008476|Wisdom Teeth|wisdom teeth
5859013|NCT00008476|Pain|pain
5859014|NCT00007800|obesity treatment|obesity treatment
5859015|NCT00007800|non insulin dependent diabetes|non insulin dependent diabetes
5859016|NCT00007800|type 2 diabetes|type 2 diabetes
5859017|NCT00007800|behavioral weight control|behavioral weight control
5859018|NCT00007800|motivational interviewing|motivational interviewing
5859019|NCT00007800|motivational enhancement|motivational enhancement
5855389|NCT00000945|HIV-1|hiv-1
5859020|NCT00007696|Diabetes Mellitus,DM,glycemic control|diabetes mellitus,dm,glycemic control
5859021|NCT00007670|gabapentin|gabapentin
5859022|NCT00007670|lamotrigine|lamotrigine
5859023|NCT00007670|seizures in the elderly|seizures in the elderly
5859024|NCT00007670|Carbamazepine|carbamazepine
5859025|NCT00007657|PCI plus intensive medical therapy|pci plus intensive medical therapy
5857485|NCT00023010|RCR|rcr
5859026|NCT00007774|Olanzapine, haloperidol, schizophrenia, schisoaffe|olanzapine, haloperidol, schizophrenia, schisoaffe
5859027|NCT00007761|Bipolar Disease Program intervention|bipolar disease program intervention
5859028|NCT00007748|aerobic exercise|aerobic exercise
5859029|NCT00007748|cognitive behavioral therapy|cognitive behavioral therapy
5859030|NCT00007748|CBT|cbt
5859031|NCT00007748|Gulf War Illnesses|gulf war illnesses
5859032|NCT00007748|GWI|gwi
5859033|NCT00007735|antibiotic treatment|antibiotic treatment
5859034|NCT00007735|mycoplasma species|mycoplasma species
5859035|NCT00007735|Gulf War Veterans' Illnesses (GWI)|gulf war veterans' illnesses (gwi)
5859036|NCT00007735|mycoplasma positive|mycoplasma positive
5859037|NCT00007735|Gulf War Syndrome|gulf war syndrome
5859038|NCT00007722|ALS|als
5859039|NCT00007722|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5859040|NCT00007722|Gulf War Veterans|gulf war veterans
5859041|NCT00007709|Hepatitis C|hepatitis c
5859042|NCT00007709|HIV|hiv
5859043|NCT00007709|severe mental illness (SMI)|severe mental illness (smi)
5859044|NCT00007683|aspirin|aspirin
5859045|NCT00007683|clopidogrel|clopidogrel
5859062|NCT00007618|colorectal cancer|colorectal cancer
5859063|NCT00007605|amiodarone|amiodarone
5859064|NCT00007605|atrial fibrillation converted to sinus rhythm|atrial fibrillation converted to sinus rhythm
5859065|NCT00007605|cardiac mortality|cardiac mortality
5859066|NCT00007605|major and minor bleeds|major and minor bleeds
5859067|NCT00007605|sinus rhythm|sinus rhythm
5859068|NCT00007605|sotalol|sotalol
5859069|NCT00007592|Hypertension|hypertension
5859070|NCT00007592|national data base on the treatment of hypertension|national data base on the treatment of hypertension
5859071|NCT00007592|cost of different antihypertensive regimens|cost of different antihypertensive regimens
5859072|NCT00007579|prostate cancer|prostate cancer
5859073|NCT00007540|Prostate cancer|prostate cancer
5859074|NCT00007540|CAG repeat sequence|cag repeat sequence
5859292|NCT00006445|Aneuploidy|aneuploidy
5859075|NCT00007527|buprenorphine and naloxone|buprenorphine and naloxone
5859076|NCT00007527|opiate dependence|opiate dependence
5859077|NCT00007527|narcotic treatment|narcotic treatment
5859078|NCT00007514|olfactory functioning|olfactory functioning
5859079|NCT00007514|neurotoxic exposure|neurotoxic exposure
5859080|NCT00007514|Gulf War-era veterans|gulf war-era veterans
5859081|NCT00007501|varicella-zoster vaccine|varicella-zoster vaccine
5859082|NCT00007475|Plasma Exchange|plasma exchange
5859083|NCT00007475|Cyclophosphamide|cyclophosphamide
5859084|NCT00007475|Proteinuria|proteinuria
5859085|NCT00007475|Hemodialysis|hemodialysis
5859086|NCT00007475|Expression Profiling|expression profiling
5859087|NCT00007358|Dexamethasone|dexamethasone
5859088|NCT00007358|Anti-SSA/Ro antibodies|anti-ssa/ro antibodies
5859089|NCT00007358|Anti-SSB/La antibodies|anti-ssb/la antibodies
5859090|NCT00007358|Ultrasound|ultrasound
5859091|NCT00007358|Atrioventricular (AV) nodal dysfunction|atrioventricular (av) nodal dysfunction
5859092|NCT00007358|Echocardiograms|echocardiograms
5859093|NCT00007358|Mothers|mothers
5859094|NCT00007345|Histone Acetylase|histone acetylase
5859095|NCT00007345|Differentiation|differentiation
5859096|NCT00007345|Sezary Syndrome|sezary syndrome
5859097|NCT00007345|Mycosis Fungoides|mycosis fungoides
5859098|NCT00007345|CD 30 Lymphoma|cd 30 lymphoma
5859099|NCT00007306|Parathyroid hormone|parathyroid hormone
5859100|NCT00007306|Psoriasis|psoriasis
5859101|NCT00007306|Lesions|lesions
5859102|NCT00007306|Topical medications|topical medications
5859103|NCT00007306|Ointment|ointment
5859104|NCT00007306|Calcium metabolism|calcium metabolism
5859105|NCT00007306|Skin biopsy|skin biopsy
5859106|NCT00007293|Phototherapy|phototherapy
5859107|NCT00007293|Psoriasis|psoriasis
5859108|NCT00007293|Scalp psoriasis|scalp psoriasis
5859109|NCT00007293|Fiber optic|fiber optic
5859110|NCT00007293|Light comb|light comb
5859111|NCT00007293|UV source|uv source
5859112|NCT00007280|Bioengineered skin|bioengineered skin
5859113|NCT00007280|Venous leg ulcer|venous leg ulcer
5859114|NCT00007267|Scleroderma|scleroderma
5859115|NCT00007267|Systemic sclerosis|systemic sclerosis
5859116|NCT00007267|Depression|depression
5859117|NCT00007267|Pain|pain
5859118|NCT00007267|Disfigurement|disfigurement
5859119|NCT00007267|Body image dissatisfaction|body image dissatisfaction
5859120|NCT00007267|Cognitive-behavioral therapy|cognitive-behavioral therapy
5859121|NCT00007267|Self-help|self-help
5859122|NCT00007267|Psychological intervention|psychological intervention
5859123|NCT00007254|Analgesia|analgesia
5859124|NCT00007254|Bedsore|bedsore
5859125|NCT00007254|Morphine gel|morphine gel
5859126|NCT00007254|Pressure ulcer|pressure ulcer
5859127|NCT00007254|Pain|pain
5859128|NCT00007254|Ulcer|ulcer
5859129|NCT00007241|Osteoarthritis|osteoarthritis
5859130|NCT00007241|Knee|knee
5859131|NCT00007241|OA|oa
5859132|NCT00007241|Isometric|isometric
5859133|NCT00007241|Exercise|exercise
5859134|NCT00007241|Strengthening|strengthening
5859135|NCT00007241|Joint-related pain|joint-related pain
5859136|NCT00007228|Chorea|chorea
5859137|NCT00007228|DCM|dcm
5859138|NCT00007228|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5859139|NCT00007228|Sudden Death|sudden death
5859140|NCT00007228|Neuroacanthocytosis|neuroacanthocytosis
5859141|NCT00007215|Cataract|cataract
5859142|NCT00007215|Early Lens Changes|early lens changes
5859143|NCT00007215|Protein Aggregation|protein aggregation
5859144|NCT00007215|Blindness|blindness
5859145|NCT00007215|Vision|vision
5859152|NCT00007189|Alzheimer disease|alzheimer disease
5859153|NCT00007189|Anti-inflammatory drugs|anti-inflammatory drugs
5859154|NCT00007163|Immunosuppression|immunosuppression
5859155|NCT00007163|Recombinant IgG1|recombinant igg1
5859156|NCT00007163|Apoptosis|apoptosis
5859157|NCT00007163|Interferon Gamma|interferon gamma
5859158|NCT00007163|Colonoscopy|colonoscopy
5859159|NCT00007163|Crohn's Disease|crohn's disease
5859160|NCT00007163|Immunotherapy|immunotherapy
5859171|NCT00007137|Volume|volume
5859172|NCT00007137|Healthy Volunteer|healthy volunteer
5859173|NCT00007137|Swallowing|swallowing
5859174|NCT00007137|Tongue Weakness|tongue weakness
5859175|NCT00007137|Tongue Movement Coordination Problem|tongue movement coordination problem
5859176|NCT00007124|Myoclonus|myoclonus
5859177|NCT00007124|Epilepsy|epilepsy
5859178|NCT00007124|Dementia|dementia
5859179|NCT00007124|Polyglucosan|polyglucosan
5859180|NCT00007124|Insulin|insulin
5859181|NCT00007124|Lafora Disease|lafora disease
5859182|NCT00007124|Restrictive Carbohydrate Diet|restrictive carbohydrate diet
5859183|NCT00007059|disease-related problem/condition|disease-related problem/condition
5859184|NCT00007059|graft versus host disease|graft versus host disease
5859185|NCT00007059|rare disease|rare disease
5859186|NCT00007046|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859187|NCT00007046|bone cancer|bone cancer
5859188|NCT00007046|diaphyseal medullary stenosis|diaphyseal medullary stenosis
5859294|NCT00006438|Rocker sole|rocker sole
5859189|NCT00007046|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859190|NCT00007046|malignant fibrous histiocytoma of bone|malignant fibrous histiocytoma of bone
5859191|NCT00007046|musculoskeletal/mesodermal cancer|musculoskeletal/mesodermal cancer
5859192|NCT00007046|oncologic disorders|oncologic disorders
5859193|NCT00007046|rare disease|rare disease
5859194|NCT00007033|Alagille syndrome|alagille syndrome
5859195|NCT00007033|biliary atresia|biliary atresia
5859196|NCT00007033|cholestasis|cholestasis
5859197|NCT00007033|gastrointestinal disorders|gastrointestinal disorders
5859198|NCT00007033|rare disease|rare disease
5859199|NCT00006565|asthma|asthma
5859200|NCT00006565|HEPA|hepa
5859201|NCT00006565|ETS|ets
5859202|NCT00006519|Pharmacokinetic|pharmacokinetic
5859203|NCT00006519|Pediatric AIDS|pediatric aids
5859204|NCT00006519|Resistance Testing|resistance testing
5859205|NCT00006519|Combination Therapy|combination therapy
5859206|NCT00006519|Viral Drug Dynamics|viral drug dynamics
5859207|NCT00006519|Treatment Experienced|treatment experienced
5859213|NCT00006517|Seasonal Affective Disorder (SAD)|seasonal affective disorder (sad)
5859214|NCT00006517|Winter Depression|winter depression
5859215|NCT00006517|Mood disorders|mood disorders
5859216|NCT00006517|Bipolar I and II disorders|bipolar i and ii disorders
5859217|NCT00006517|Major Depressive Disorder, Recurrent|major depressive disorder, recurrent
5859218|NCT00006517|Light therapy|light therapy
5859219|NCT00006517|Phototherapy|phototherapy
5859220|NCT00006517|Dawn Simulation therapy|dawn simulation therapy
5859221|NCT00006517|Negative air ionization therapy|negative air ionization therapy
5859222|NCT00006517|Chronobiology|chronobiology
5859223|NCT00006517|Biological rhythms|biological rhythms
5859224|NCT00006516|Neonatal brain injury|neonatal brain injury
5859225|NCT00006516|Brain Hypoxia|brain hypoxia
5859226|NCT00006516|Cerebral Hypoxia|cerebral hypoxia
5859227|NCT00006516|Brain Hypoxia-Ischemia|brain hypoxia-ischemia
5859228|NCT00006516|Brain Ischemia-Hypoxia|brain ischemia-hypoxia
5859229|NCT00006516|Cerebral Hypoxia-Ischemia|cerebral hypoxia-ischemia
5859230|NCT00006516|Cerebral Ischemia-Hypoxia|cerebral ischemia-hypoxia
5859231|NCT00006516|Environmental enrichment|environmental enrichment
5859232|NCT00006516|Cognitive/sensorimotor stimulation|cognitive/sensorimotor stimulation
5859233|NCT00006516|Parent-infant interactions|parent-infant interactions
5859234|NCT00006516|Prenatal hypoxia|prenatal hypoxia
5859235|NCT00006515|Pediatric|pediatric
5859236|NCT00006515|Sarcoma|sarcoma
5859237|NCT00006515|Effects|effects
5859238|NCT00006515|Survivors|survivors
5859239|NCT00006515|Pilot|pilot
5859242|NCT00006494|AIDS|aids
5859243|NCT00006494|Antiretroviral Therapy|antiretroviral therapy
5859244|NCT00006494|Drug Resistance|drug resistance
5859249|NCT00006493|HIV-associated hyperlipidemia|hiv-associated hyperlipidemia
5859250|NCT00006492|Celiac Disease|celiac disease
5859251|NCT00006492|Cerebellar Ataxia|cerebellar ataxia
5859252|NCT00006492|Gluten-Free Diet|gluten-free diet
5859253|NCT00006489|Alcoholism|alcoholism
5859254|NCT00006489|Alcohol Dependence|alcohol dependence
5859255|NCT00006489|Post-Traumatic Stress Disorder|post-traumatic stress disorder
5859256|NCT00006489|Naltrexone|naltrexone
5859257|NCT00006489|Cognitive Behavior Therapy|cognitive behavior therapy
5859258|NCT00006450|Children|children
5859259|NCT00006450|Brain|brain
5859260|NCT00006450|Maturation|maturation
5859261|NCT00006450|Phenylacetate|phenylacetate
5859262|NCT00006450|Differentiation|differentiation
5859263|NCT00006507|Sensory integration|sensory integration
5859264|NCT00006507|Occupational therapy|occupational therapy
5859265|NCT00006507|Sensory Modulation Dysfunction (SMD)|sensory modulation dysfunction (smd)
5859266|NCT00006448|Spinal cord injury|spinal cord injury
5859267|NCT00006448|Amputation|amputation
5859268|NCT00006448|Pain management|pain management
5859273|NCT00006447|Rehabilitation|rehabilitation
5859274|NCT00006447|Support, social|support, social
5859275|NCT00006447|Information System|information system
5859276|NCT00006447|Information Resources (PT)|information resources (pt)
5859277|NCT00006447|Disability, persons with|disability, persons with
5859278|NCT00006446|Behavioral disorders|behavioral disorders
5859279|NCT00006446|Parenting skills and communication|parenting skills and communication
5859280|NCT00006446|Parent-child interactions|parent-child interactions
5859281|NCT00006446|At-risk preschooler|at-risk preschooler
5859282|NCT00006446|Head Start|head start
5859283|NCT00006445|Pregnancy|pregnancy
5859284|NCT00006445|Ultrasound|ultrasound
5859285|NCT00006445|Serum screen|serum screen
5859286|NCT00006445|Pregnancy associated plasma protein-A (PAPP-A)|pregnancy associated plasma protein-a (papp-a)
5859287|NCT00006445|Free-beta human chorionic gonadotropin (FbhCG)|free-beta human chorionic gonadotropin (fbhcg)
5859288|NCT00006445|Alpha fetoprotein|alpha fetoprotein
5859289|NCT00006445|Unconjugated estriol|unconjugated estriol
5859290|NCT00006445|Inhibin-A|inhibin-a
5859291|NCT00006445|Down syndrome|down syndrome
5859295|NCT00006438|Plantar pressure|plantar pressure
5859296|NCT00006438|Diabetic feet|diabetic feet
5859297|NCT00006438|Insensate feet|insensate feet
5859298|NCT00006438|gait analysis|gait analysis
5859299|NCT00006438|Pedorthics|pedorthics
5859300|NCT00006438|Gait abnormalities|gait abnormalities
5859302|NCT00006437|Proteases|proteases
5859303|NCT00006437|Adhesion|adhesion
5859304|NCT00006437|Migration|migration
5859305|NCT00006437|Extracellular Matrix|extracellular matrix
5859306|NCT00006436|AIDS|aids
5859307|NCT00006436|Malignancy|malignancy
5859308|NCT00006436|Antiretroviral|antiretroviral
5859309|NCT00006436|Chemotherapy|chemotherapy
5859310|NCT00006436|Monoclonal|monoclonal
5859314|NCT00006434|Dendritic cells|dendritic cells
5859315|NCT00006429|Spinal Cord Injury|spinal cord injury
5859316|NCT00006429|Body Weight Supported Ambulation Training|body weight supported ambulation training
5859317|NCT00006429|Treadmill Training|treadmill training
5859318|NCT00006429|Physical therapy|physical therapy
5859319|NCT00006429|Gait|gait
5859320|NCT00006429|Assisted Ambulation|assisted ambulation
5859321|NCT00006428|Spinal Cord injury (SCI)|spinal cord injury (sci)
5859322|NCT00006428|Chronic Pain|chronic pain
5859323|NCT00006428|Amitriptyline|amitriptyline
5859324|NCT00006427|Amputation|amputation
5859325|NCT00006427|Chronic Pain|chronic pain
5859326|NCT00006427|Amitriptyline|amitriptyline
5859327|NCT00006426|Foot ulcers|foot ulcers
5859328|NCT00006426|Diabetes|diabetes
5859329|NCT00006426|Peripheral neuropathy|peripheral neuropathy
5859330|NCT00006426|Casting|casting
5859331|NCT00006426|Achilles Lengthening|achilles lengthening
5859332|NCT00006426|Ambulatory surgery|ambulatory surgery
5859333|NCT00006426|Foot deformity|foot deformity
5859338|NCT00006424|Plasticity|plasticity
5859339|NCT00006424|Motor|motor
5859340|NCT00006424|Stroke|stroke
5859341|NCT00006424|Amphetamine|amphetamine
5859342|NCT00006424|fMRI|fmri
5859343|NCT00006424|Cortical Reorganization|cortical reorganization
5859344|NCT00006424|Spectroscopy|spectroscopy
5859345|NCT00006422|Lazy Eye|lazy eye
5859346|NCT00006422|Amblyopia|amblyopia
5859347|NCT00006422|Nystagmus|nystagmus
5859361|NCT00006417|Engraftment|engraftment
5859362|NCT00006417|Graft-versus-host Disease|graft-versus-host disease
5859363|NCT00006417|Cyclophosphamide|cyclophosphamide
5859364|NCT00006417|Donor Apheresis|donor apheresis
5859365|NCT00006417|Peripheral Blood Stem Cells|peripheral blood stem cells
5859366|NCT00006417|Therapy|therapy
5859367|NCT00006414|Anesthesia|anesthesia
5859368|NCT00006414|Magnetic Stimulation|magnetic stimulation
5859369|NCT00006414|Motor|motor
5859370|NCT00006414|Neuroplasticity|neuroplasticity
5859371|NCT00006414|Practice|practice
5859372|NCT00006414|Rehabilitation|rehabilitation
5859373|NCT00006414|Stroke|stroke
5859374|NCT00006413|Peripheral Blood Stem Cells|peripheral blood stem cells
5859375|NCT00006413|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5859376|NCT00006413|Engraftment|engraftment
5859377|NCT00006413|Graft-versus-host Disease|graft-versus-host disease
5859378|NCT00006413|Graft-Versus-Leukemia|graft-versus-leukemia
5859379|NCT00006413|Graft-Versus-Mast Cell|graft-versus-mast cell
5859380|NCT00006413|Cyclophosphamide|cyclophosphamide
5859381|NCT00006413|Fludarabine|fludarabine
5859382|NCT00006413|Donor Apheresis|donor apheresis
5859383|NCT00006413|Mast Cells|mast cells
5859388|NCT00006400|Blood Diseases|blood diseases
5859389|NCT00006400|Sickle Cell Anemia|sickle cell anemia
5859390|NCT00006398|cirrhosis|cirrhosis
5859391|NCT00006398|esophageal varices|esophageal varices
5859392|NCT00006398|variceal hemorrhage|variceal hemorrhage
5859393|NCT00006398|beta-adrenergic blocker|beta-adrenergic blocker
5861965|NCT00001766|Drug Levels|drug levels
5859399|NCT00006394|rare disease|rare disease
5859400|NCT00006393|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859401|NCT00006393|rare disease|rare disease
5859402|NCT00006393|systemic sclerosis|systemic sclerosis
5859403|NCT00006337|Clinical Trial|clinical trial
5859404|NCT00006337|Dyskinesias|dyskinesias
5859405|NCT00006337|Levodopa Infusion|levodopa infusion
5859406|NCT00006336|Gap Detection Test|gap detection test
5859407|NCT00006336|Fahn-Scale|fahn-scale
5859408|NCT00006336|Visual Analog and Verbal Scale|visual analog and verbal scale
5859409|NCT00006336|Writing Standard Paragraph|writing standard paragraph
5859410|NCT00006336|Braille Reading Grade I|braille reading grade i
5859411|NCT00006335|Genetic|genetic
5859412|NCT00006335|Analysis|analysis
5859413|NCT00006335|Immune|immune
5859414|NCT00006335|Teenage|teenage
5859415|NCT00006335|Girls|girls
5859416|NCT00006335|Severe Combined Immune Deficiency (SCID)|severe combined immune deficiency (scid)
5859417|NCT00006335|XSCID|xscid
5859418|NCT00006335|Carrier Testing|carrier testing
5859419|NCT00006335|X-Linked Disease|x-linked disease
5859420|NCT00006335|Adolescent|adolescent
5859421|NCT00006334|Genes|genes
5859422|NCT00006334|X-Chromosome|x-chromosome
5859423|NCT00006334|Osteoporosis|osteoporosis
5859424|NCT00006334|Ovarian Failure|ovarian failure
5859425|NCT00006334|Imprinting|imprinting
5859426|NCT00006334|Turner's|turner's
5859427|NCT00006334|Turner|turner
5859429|NCT00006333|Pathogenesis|pathogenesis
5859430|NCT00006333|Rheumatoid Arthritis|rheumatoid arthritis
5859431|NCT00006333|Juvenile Rheumatoid Arthritis|juvenile rheumatoid arthritis
5859433|NCT00006332|Molybdenum|molybdenum
5859434|NCT00006331|Kidney transplantation|kidney transplantation
5859435|NCT00006331|Immunology|immunology
5859436|NCT00006330|Digoxin|digoxin
5859437|NCT00006330|Effect modifiers (Epidemiology)|effect modifiers (epidemiology)
5859438|NCT00006330|Rosales|rosales
5859439|NCT00006330|Drug Interaction|drug interaction
5859440|NCT00006329|Radionuclide imaging|radionuclide imaging
5859441|NCT00006329|Surgery|surgery
5859442|NCT00006328|Chronic Allograft Nephropathy (CAN)|chronic allograft nephropathy (can)
5859443|NCT00006328|Transplantation immunology|transplantation immunology
5859444|NCT00006328|Genetics|genetics
5859445|NCT00006328|Graft Rejection|graft rejection
5859446|NCT00006320|Reverse Transcriptase Inhibitor|reverse transcriptase inhibitor
5859447|NCT00006320|Protease Inhibitor|protease inhibitor
5861351|NCT00001951|POF|pof
5859453|NCT00006318|Cerebral Blood Flow|cerebral blood flow
5859454|NCT00006318|CO2 Inhalation|co2 inhalation
5859456|NCT00006318|MRI|mri
5859457|NCT00006318|Perfusion|perfusion
5859458|NCT00006318|Functional Activation|functional activation
5859459|NCT00006301|Hepatitis C|hepatitis c
5859460|NCT00006301|Viral Sequence|viral sequence
5859461|NCT00006301|PCR|pcr
5859462|NCT00006301|T Cell|t cell
5859463|NCT00006301|Seroconversion|seroconversion
5859464|NCT00006301|Cytokines|cytokines
5859465|NCT00006300|Immunosuppression|immunosuppression
5859466|NCT00006300|Treatment Recommendations|treatment recommendations
5859467|NCT00006300|Pancytopenia|pancytopenia
5859468|NCT00006300|Schizophrenia|schizophrenia
5859469|NCT00006300|Inpatient Population|inpatient population
5859470|NCT00006299|Celecoxib|celecoxib
5859471|NCT00006299|Thromboxane B2|thromboxane b2
5859472|NCT00006299|Prostaglandin E2|prostaglandin e2
5859473|NCT00006299|Microdialysis|microdialysis
5859474|NCT00006299|Ibuprofen|ibuprofen
5859475|NCT00006292|Biologic Therapy|biologic therapy
5859476|NCT00006292|Bone Erosion|bone erosion
5859478|NCT00006292|MRI|mri
5859479|NCT00006292|Rheumatoid Arthritis|rheumatoid arthritis
5859480|NCT00006292|RA|ra
5859481|NCT00006289|Analgesia|analgesia
5859482|NCT00006289|Causalgia|causalgia
5859483|NCT00006289|CRPS|crps
5859484|NCT00006289|Neuropathic Pain|neuropathic pain
5859485|NCT00006289|Oral Surgery|oral surgery
5859486|NCT00006289|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5859487|NCT00006289|Sympathetic Nervous System|sympathetic nervous system
5859488|NCT00006289|Chronic Regional Pain Syndrome|chronic regional pain syndrome
5859489|NCT00006285|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5859490|NCT00006285|Parietal Lobe|parietal lobe
5859491|NCT00006285|fMRI|fmri
5859492|NCT00006285|Cognition|cognition
5859493|NCT00006285|Perception|perception
5859494|NCT00006285|Cortical Stimulation|cortical stimulation
5859495|NCT00006285|Spatial Attention|spatial attention
5859496|NCT00006286|Depression|depression
5859497|NCT00006286|Major Depressive Disorder|major depressive disorder
5859498|NCT00006286|Fluoxetine|fluoxetine
5859500|NCT00006286|SSRI|ssri
5859501|NCT00006286|Psychotherapy|psychotherapy
5859502|NCT00006286|CBT|cbt
5859503|NCT00006286|Teenagers|teenagers
5859504|NCT00006286|Adolescents|adolescents
5859505|NCT00006286|Teens|teens
5855720|NCT00000894|Ganciclovir|ganciclovir
5859506|NCT00006278|Cushing's Syndrome|cushing's syndrome
5859507|NCT00006278|Adrenal Glands|adrenal glands
5859508|NCT00006278|Proteomics|proteomics
5859509|NCT00006278|Cortisol|cortisol
5859510|NCT00006276|Angiogenesis Inhibition|angiogenesis inhibition
5859511|NCT00006276|Skin Disease|skin disease
5859512|NCT00006276|Blood Vessels|blood vessels
5859513|NCT00006276|Cytokines|cytokines
5859514|NCT00006276|Autoimmune Disease|autoimmune disease
5859515|NCT00006280|Cystic Fibrosis|cystic fibrosis
5859516|NCT00006275|dermatologic disorders|dermatologic disorders
5859517|NCT00006275|psoriasis|psoriasis
5859518|NCT00006275|rare disease|rare disease
5859519|NCT00006274|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859520|NCT00006274|neonatal disorders|neonatal disorders
5859521|NCT00006274|rare disease|rare disease
5859522|NCT00006274|respiratory distress syndrome|respiratory distress syndrome
5859523|NCT00006273|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859524|NCT00006273|cystic fibrosis|cystic fibrosis
5859525|NCT00006273|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859526|NCT00006273|rare disease|rare disease
5859527|NCT00006272|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859528|NCT00006272|heart defects|heart defects
5859529|NCT00006272|rare disease|rare disease
5859530|NCT00006271|brain injury|brain injury
5859531|NCT00006271|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5859532|NCT00006271|rare disease|rare disease
5859533|NCT00006270|brain injury|brain injury
5859534|NCT00006270|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5859535|NCT00006270|rare disease|rare disease
5859536|NCT00006205|alcoholism|alcoholism
5859537|NCT00006205|alcohol addiction|alcohol addiction
5859538|NCT00006204|Alcoholism|alcoholism
5859539|NCT00006204|Alcohol Dependence|alcohol dependence
5859540|NCT00006204|Depression|depression
5859541|NCT00006204|Naltrexone|naltrexone
5859542|NCT00006204|Fluoxetine|fluoxetine
5859543|NCT00006202|Serum levels of Lutein|serum levels of lutein
5859544|NCT00006202|Age-Related Macular Degeneration|age-related macular degeneration
5859546|NCT00006202|Toxicity|toxicity
5859547|NCT00006199|solid tumor|solid tumor
5859548|NCT00006196|Vitamin D resistance|vitamin d resistance
5859549|NCT00006194|sarcopenia|sarcopenia
5859556|NCT00006188|Choroiditis|choroiditis
5859557|NCT00006188|Iridocyclitis|iridocyclitis
5859558|NCT00006188|Retinal Disease|retinal disease
5859559|NCT00006188|Cystoid Macular Edema|cystoid macular edema
5859560|NCT00006188|Uveitis|uveitis
5859561|NCT00006188|Intraocular Inflammation|intraocular inflammation
5859562|NCT00006188|Inflammatory Eye DIsease|inflammatory eye disease
5859563|NCT00006187|Investigational Drug|investigational drug
5859564|NCT00006186|dilutional coagulopathy|dilutional coagulopathy
5859565|NCT00006184|Immunoablative|immunoablative
5859566|NCT00006184|Mobilization|mobilization
5859567|NCT00006184|Apheresis|apheresis
5859568|NCT00006184|Multiple Myeloma|multiple myeloma
5859569|NCT00006184|IgG Multiple Myeloma|igg multiple myeloma
5859570|NCT00006184|IgA Multiple Myeloma|iga multiple myeloma
5859571|NCT00006185|peripheral fat wasting|peripheral fat wasting
5859572|NCT00006185|truncal adiposity|truncal adiposity
5859573|NCT00006185|fat biopsy|fat biopsy
5859574|NCT00006185|muscle biopsy|muscle biopsy
5859575|NCT00006185|intravenous lines|intravenous lines
5859576|NCT00006185|blood draws|blood draws
5859577|NCT00006185|insulin administration|insulin administration
5859578|NCT00006185|sugar water|sugar water
5859579|NCT00006185|screening|screening
5859580|NCT00006399|Alzheimer disease|alzheimer disease
5859581|NCT00006399|Estrogen therapy|estrogen therapy
5859582|NCT00006399|Post-menopausal women|post-menopausal women
5859583|NCT00006181|Health behavior change|health behavior change
5859584|NCT00006181|Motivational interviewing|motivational interviewing
5859585|NCT00006181|Motivational enhancement|motivational enhancement
5859586|NCT00006181|Health counseling|health counseling
5859587|NCT00006181|Team intervention|team intervention
5859588|NCT00006181|One-on-one intervention|one-on-one intervention
5859589|NCT00006181|Physical activity|physical activity
5859590|NCT00006181|Exercise|exercise
5859591|NCT00006181|Nutrition|nutrition
5859592|NCT00006181|Health assessments|health assessments
5859593|NCT00006181|Strength|strength
5859594|NCT00006181|Flexibility|flexibility
5859595|NCT00006181|Percent body fat|percent body fat
5859596|NCT00006181|Social-learning theory|social-learning theory
5859598|NCT00006181|Fire fighters|fire fighters
5859599|NCT00006181|Fire stations|fire stations
5859600|NCT00006181|Cancer|cancer
5859601|NCT00006181|Cardiovascular diseases|cardiovascular diseases
5859602|NCT00006180|Preventive Medicine|preventive medicine
5859603|NCT00006180|Women's Health|women's health
5859604|NCT00006180|Bone Formation|bone formation
5859605|NCT00006180|Mood Disorders|mood disorders
5859606|NCT00006180|Bone Resorption|bone resorption
5859607|NCT00006180|Major Depression|major depression
5859608|NCT00006180|Osteopenia|osteopenia
5859609|NCT00006180|Osteoporosis|osteoporosis
5859610|NCT00006180|Bone Fracture|bone fracture
5859611|NCT00006180|Bisphosphonate|bisphosphonate
5859612|NCT00006180|Depression|depression
5859613|NCT00006180|Bone Density|bone density
5859614|NCT00006180|Healthy Volunteer|healthy volunteer
5859615|NCT00006180|HV|hv
5859616|NCT00006180|Normal Control|normal control
5859617|NCT00006178|Renal Failure|renal failure
5859618|NCT00006178|Anti-rejection|anti-rejection
5859619|NCT00006178|Apoptosis|apoptosis
5859620|NCT00006178|Polyclonal Antibody|polyclonal antibody
5859621|NCT00006178|Kidney Transplant|kidney transplant
5859629|NCT00006176|FENIB|fenib
5859630|NCT00006176|Presenile Dementia|presenile dementia
5859631|NCT00006176|Progressive Myoclonic Epilepsy|progressive myoclonic epilepsy
5859632|NCT00006176|Dementia|dementia
5859633|NCT00006176|Early Onset Progressive Dementia|early onset progressive dementia
5859634|NCT00006176|Familial Presenile Dementia|familial presenile dementia
5859635|NCT00006176|FDNIB|fdnib
5859741|NCT00006158|androgen levels|androgen levels
5859636|NCT00006176|familial encephalopathy with neuroserpin inclusion bodies|familial encephalopathy with neuroserpin inclusion bodies
5859637|NCT00006176|Heredodegenerative Disorders, Nervous System|heredodegenerative disorders, nervous system
5859638|NCT00006175|Cyclooxygenase|cyclooxygenase
5859639|NCT00006175|COX-1|cox-1
5859640|NCT00006175|COX-2|cox-2
5859643|NCT00006175|Healthy Volunteer|healthy volunteer
5859644|NCT00006174|Precocious Puberty|precocious puberty
5859645|NCT00006174|Polyostotic|polyostotic
5859646|NCT00006174|Fibrous Dysplasia|fibrous dysplasia
5859647|NCT00006174|PFD|pfd
5859648|NCT00006174|McCune-Albright Syndrome (MAS)|mccune-albright syndrome (mas)
5859649|NCT00006173|Atherosclerosis|atherosclerosis
5859650|NCT00006173|Hypertension|hypertension
5859651|NCT00006173|Magnetic Resonance Angiography|magnetic resonance angiography
5859652|NCT00006172|Antidepressive Agents|antidepressive agents
5859653|NCT00006172|Chronobiology|chronobiology
5859654|NCT00006172|Chronotherapy|chronotherapy
5859655|NCT00006172|Circadian rhythms|circadian rhythms
5859656|NCT00006172|Depressive Disorder|depressive disorder
5859657|NCT00006172|Ions|ions
5859658|NCT00006172|Light|light
5859659|NCT00006172|Lighting|lighting
5859660|NCT00006172|Mood disorders|mood disorders
5859661|NCT00006172|Phototherapy.|phototherapy.
5859662|NCT00006171|HHV-8|hhv-8
5859663|NCT00006171|Pathophysiology|pathophysiology
5859664|NCT00006171|AIDS|aids
5859665|NCT00006171|Cancer|cancer
5859666|NCT00006171|Anti-Retroviral|anti-retroviral
5859667|NCT00006171|Kaposi's Sarcoma|kaposi's sarcoma
5859668|NCT00006171|HIV|hiv
5859669|NCT00006170|smoking cessation|smoking cessation
5859670|NCT00006170|Women|women
5859671|NCT00006170|bupropion|bupropion
5859672|NCT00006170|weight concerns|weight concerns
5859673|NCT00006170|weight|weight
5859674|NCT00006156|Ovarian Failure|ovarian failure
5859675|NCT00006156|Ovary|ovary
5859676|NCT00006156|Aging|aging
5859677|NCT00006156|Healthy Volunteer|healthy volunteer
5859678|NCT00006156|Primary Ovarian Insufficiency(POI)|primary ovarian insufficiency(poi)
5859679|NCT00006156|Premature Menopause|premature menopause
5859680|NCT00006156|Premature Ovarian Failure (POF)|premature ovarian failure (pof)
5859682|NCT00006169|Behavior Therapy|behavior therapy
5859683|NCT00006169|Cystic Fibrosis|cystic fibrosis
5859684|NCT00006168|primary biliary cirrhosis|primary biliary cirrhosis
5859685|NCT00006168|Ursodeoxycholic acid|ursodeoxycholic acid
5859686|NCT00006168|UDCA|udca
5859688|NCT00006168|Hepatology|hepatology
5859689|NCT00006168|methotrexate|methotrexate
5859690|NCT00006168|liver|liver
5859691|NCT00006167|oxandrolone|oxandrolone
5859692|NCT00006167|AIDS wasting|aids wasting
5859693|NCT00006167|strength training|strength training
5859694|NCT00006167|progressive resistance training|progressive resistance training
5859695|NCT00006167|exercise|exercise
5859696|NCT00006167|dietary intervention|dietary intervention
5859697|NCT00006166|refractory ascites|refractory ascites
5859698|NCT00006166|paracenteses|paracenteses
5859699|NCT00006165|Native Hawaiian|native hawaiian
5859700|NCT00006165|Diabetes Mellitus|diabetes mellitus
5859701|NCT00006165|Lifestyle Intervention|lifestyle intervention
5859702|NCT00006165|Family Support|family support
5859703|NCT00006165|Diabetes Mellitus, at-risk|diabetes mellitus, at-risk
5859704|NCT00006164|liver disease|liver disease
5859705|NCT00006164|hepatitis c virus|hepatitis c virus
5859706|NCT00006164|antiviral agent|antiviral agent
5859707|NCT00006164|cirrhosis|cirrhosis
5859708|NCT00006163|diabetes|diabetes
5859709|NCT00006163|self-management|self-management
5859710|NCT00006163|randomized trial|randomized trial
5859711|NCT00006163|RE-AIM evaluation|re-aim evaluation
5859712|NCT00006163|participation|participation
5859713|NCT00006163|maintenance|maintenance
5859714|NCT00006163|community resources|community resources
5859715|NCT00006163|dietary change|dietary change
5859716|NCT00006162|low fat diet|low fat diet
5859717|NCT00006162|aerobic exercise|aerobic exercise
5859718|NCT00006162|impaired glucose tolerance|impaired glucose tolerance
5859719|NCT00006162|Japanese Americans|japanese americans
5859720|NCT00006162|metabolic risk factors|metabolic risk factors
5859721|NCT00006161|TIPS|tips
5859722|NCT00006161|DSRS|dsrs
5859724|NCT00006161|Variceal bleeding|variceal bleeding
5859725|NCT00006161|Splenorenal Shunt|splenorenal shunt
5859726|NCT00006161|Transjugular Intrahepatic Portosystemic Shunt|transjugular intrahepatic portosystemic shunt
5859727|NCT00006161|Cirrhosis|cirrhosis
5859728|NCT00006161|Portal hypertension|portal hypertension
5859729|NCT00006161|Liver disease|liver disease
5859730|NCT00006159|diabetes|diabetes
5859731|NCT00006159|lifestyle intervention|lifestyle intervention
5859732|NCT00006159|Native American|native american
5859733|NCT00006159|community intervention|community intervention
5859734|NCT00006159|diet|diet
5859735|NCT00006159|exercise|exercise
5859736|NCT00006158|AIDS|aids
5859737|NCT00006158|HIV|hiv
5859738|NCT00006158|weight loss|weight loss
5859739|NCT00006158|Wasting Syndrome|wasting syndrome
5859740|NCT00006158|testosterone|testosterone
5859743|NCT00006157|Functional bowel disorder|functional bowel disorder
5859744|NCT00006157|Irritable bowel syndrome|irritable bowel syndrome
5859745|NCT00006157|Painful constipation|painful constipation
5859746|NCT00006157|Unspecified functional bowel disorder|unspecified functional bowel disorder
5859747|NCT00006157|Chronic functional abdominal pain|chronic functional abdominal pain
5859858|NCT00005934|Thalassemia Major|thalassemia major
5859748|NCT00006157|Cognitive-behavioral psychological treatment|cognitive-behavioral psychological treatment
5859749|NCT00006157|IBS|ibs
5859750|NCT00006157|CFAP|cfap
5859751|NCT00006151|nicotine fading|nicotine fading
5859752|NCT00006151|Accu Drop|accu drop
5859753|NCT00006151|cigarette tapering|cigarette tapering
5859754|NCT00006151|smoking cessation|smoking cessation
5859755|NCT00006151|motivational interviewing|motivational interviewing
5859767|NCT00006077|Levodopa Infusion|levodopa infusion
5859768|NCT00006077|Parkinson's Disease|parkinson's disease
5859769|NCT00006142|inborn errors of metabolism|inborn errors of metabolism
5859770|NCT00006142|phenylketonuria|phenylketonuria
5859771|NCT00006142|rare disease|rare disease
5859772|NCT00006138|disease-related problem/condition|disease-related problem/condition
5859773|NCT00006138|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859774|NCT00006138|hematologic disorders|hematologic disorders
5859775|NCT00006138|osteoporosis|osteoporosis
5859776|NCT00006138|rare disease|rare disease
5859777|NCT00006138|thalassemia major|thalassemia major
5859778|NCT00006137|IgA glomerulonephritis|iga glomerulonephritis
5859779|NCT00006137|rare disease|rare disease
5859780|NCT00006137|renal and genitourinary disorders|renal and genitourinary disorders
5859781|NCT00006136|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859782|NCT00006136|hematologic disorders|hematologic disorders
5859783|NCT00006136|rare disease|rare disease
5859784|NCT00006136|thalassemia intermedia|thalassemia intermedia
5859785|NCT00006135|herpes simplex virus infection|herpes simplex virus infection
5859786|NCT00006135|herpesvirus infection|herpesvirus infection
5859787|NCT00006135|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859788|NCT00006135|rare disease|rare disease
5859789|NCT00006135|viral infection|viral infection
5859790|NCT00006134|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859791|NCT00006134|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859792|NCT00006134|rare disease|rare disease
5859793|NCT00006134|systemic lupus erythematosus|systemic lupus erythematosus
5859794|NCT00006133|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859795|NCT00006133|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859796|NCT00006133|rare disease|rare disease
5859797|NCT00006133|systemic lupus erythematosus|systemic lupus erythematosus
5859798|NCT00006132|herpes simplex virus infection|herpes simplex virus infection
5859799|NCT00006132|herpes virus infection|herpes virus infection
5859800|NCT00006132|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859801|NCT00006132|rare disease|rare disease
5859802|NCT00006132|viral infection|viral infection
5859803|NCT00006130|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859804|NCT00006130|avascular necrosis|avascular necrosis
5859805|NCT00006130|disease-related problem/condition|disease-related problem/condition
5859806|NCT00006130|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859807|NCT00006130|hematologic disorders|hematologic disorders
5859808|NCT00006130|pain|pain
5859809|NCT00006130|rare disease|rare disease
5859810|NCT00006130|sickle cell anemia|sickle cell anemia
5859811|NCT00006129|burns|burns
5859812|NCT00006129|dermatologic disorders|dermatologic disorders
5859813|NCT00006129|rare disease|rare disease
5859814|NCT00006128|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5859815|NCT00006128|rare disease|rare disease
5859816|NCT00006127|Fanconi's anemia|fanconi's anemia
5859817|NCT00006127|aplastic anemia|aplastic anemia
5859818|NCT00006127|hematologic disorders|hematologic disorders
5859819|NCT00006127|rare disease|rare disease
5859820|NCT00006076|Hearing|hearing
5859821|NCT00006076|Auditory Processing|auditory processing
5859822|NCT00006076|Pitch Recognition|pitch recognition
5859823|NCT00006076|Tone Deafness|tone deafness
5859824|NCT00006076|Tune Deafness|tune deafness
5859825|NCT00006076|HV|hv
5859826|NCT00006076|Deafness|deafness
5859827|NCT00006076|Congenital Amusia|congenital amusia
5859828|NCT00006076|Healthy Volunteer|healthy volunteer
5859829|NCT00006070|Oral Surgery|oral surgery
5859830|NCT00006070|Swelling|swelling
5859831|NCT00006070|Pain|pain
5859832|NCT00006070|TNF|tnf
5859833|NCT00006070|Etanercept|etanercept
5859834|NCT00005937|MDS|mds
5859835|NCT00005937|Immunosuppression|immunosuppression
5859836|NCT00005937|ATG|atg
5859837|NCT00005937|Cyclosporine|cyclosporine
5859838|NCT00005937|Myelodysplastic Syndrome|myelodysplastic syndrome
5859839|NCT00005936|Fulminant Hepatitis|fulminant hepatitis
5859840|NCT00005936|Parvovirus|parvovirus
5859841|NCT00005936|Hepatitis|hepatitis
5859842|NCT00005936|Biopsy|biopsy
5859843|NCT00005936|Control|control
5859844|NCT00005936|Liver Biopsy|liver biopsy
5859845|NCT00005935|Immunosuppression|immunosuppression
5859847|NCT00005935|Autoimmunity|autoimmunity
5859848|NCT00005935|Bone Marrow Failure|bone marrow failure
5859849|NCT00005935|Hematopoiesis|hematopoiesis
5859850|NCT00005935|Relapsing Aplastic Anemia|relapsing aplastic anemia
5859851|NCT00005934|Fetal Hemoglobin|fetal hemoglobin
5859852|NCT00005934|5-Azacytidine|5-azacytidine
5859853|NCT00005934|Phenylbutyrate|phenylbutyrate
5859859|NCT00005934|Beta Thalassemia|beta thalassemia
5859860|NCT00006063|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859861|NCT00006063|cystic fibrosis|cystic fibrosis
5859862|NCT00006063|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859863|NCT00006063|rare disease|rare disease
5859864|NCT00006061|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859865|NCT00006061|inborn errors of metabolism|inborn errors of metabolism
5859866|NCT00006061|methionine adenosyltransferase deficiency|methionine adenosyltransferase deficiency
5859867|NCT00006061|rare disease|rare disease
5859868|NCT00006060|multiple sclerosis|multiple sclerosis
5859869|NCT00006060|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5859870|NCT00006060|rare disease|rare disease
5859871|NCT00006059|epilepsy|epilepsy
5859872|NCT00006059|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5859873|NCT00006059|rare disease|rare disease
5859874|NCT00006059|seizures|seizures
5859875|NCT00006058|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5859876|NCT00006058|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859877|NCT00006058|neonatal disorders|neonatal disorders
5859878|NCT00006058|rare disease|rare disease
5859879|NCT00006058|respiratory distress syndrome|respiratory distress syndrome
5859880|NCT00006056|Chediak-Higashi syndrome|chediak-higashi syndrome
5859881|NCT00006056|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
5859882|NCT00006056|disease-related problem/condition|disease-related problem/condition
5859883|NCT00006056|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
5859884|NCT00006056|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859885|NCT00006056|graft versus host disease|graft versus host disease
5859886|NCT00006056|hematologic disorders|hematologic disorders
5859887|NCT00006056|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5859888|NCT00006056|histiocytosis|histiocytosis
5859889|NCT00006056|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859890|NCT00006056|primary immunodeficiency disease|primary immunodeficiency disease
5859891|NCT00006056|rare disease|rare disease
5859892|NCT00006056|virus-associated hemophagocytic syndrome|virus-associated hemophagocytic syndrome
5859893|NCT00006055|Churg-Strauss syndrome|churg-strauss syndrome
5859894|NCT00006055|Schonlein-Henoch purpura|schonlein-henoch purpura
5859895|NCT00006055|Takayasu arteritis|takayasu arteritis
5859896|NCT00006055|Wegener's granulomatosis|wegener's granulomatosis
5859897|NCT00006055|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5859898|NCT00006055|autoimmune hemolytic anemia|autoimmune hemolytic anemia
5859899|NCT00006055|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5859900|NCT00006055|disease-related problem/condition|disease-related problem/condition
5859901|NCT00006055|giant cell arteritis|giant cell arteritis
5859902|NCT00006055|graft versus host disease|graft versus host disease
5859903|NCT00006055|hematologic disorders|hematologic disorders
5859904|NCT00006055|hypersensitivity vasculitis|hypersensitivity vasculitis
5859905|NCT00006055|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5859906|NCT00006055|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859907|NCT00006055|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5859908|NCT00006055|polyarteritis nodosa|polyarteritis nodosa
5859909|NCT00006055|pure red cell aplasia|pure red cell aplasia
5859910|NCT00006055|rare disease|rare disease
5859911|NCT00006055|rheumatoid arthritis|rheumatoid arthritis
5859912|NCT00006055|systemic lupus erythematosus|systemic lupus erythematosus
5859913|NCT00006055|vasculitis|vasculitis
5859914|NCT00006054|Chediak-Higashi syndrome|chediak-higashi syndrome
5859915|NCT00006054|Langerhans cell histiocytosis|langerhans cell histiocytosis
5859916|NCT00006054|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5859917|NCT00006054|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5859918|NCT00006054|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
5859919|NCT00006054|X-linked lymphoproliferative syndrome|x-linked lymphoproliferative syndrome
5859920|NCT00006054|chronic granulomatous disease|chronic granulomatous disease
5859921|NCT00006054|common variable immunodeficiency|common variable immunodeficiency
5859922|NCT00006054|complement deficiency|complement deficiency
5859923|NCT00006054|disease-related problem/condition|disease-related problem/condition
5859924|NCT00006054|familial erythrophagocytic lymphohistiocytosis|familial erythrophagocytic lymphohistiocytosis
5859925|NCT00006054|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5859926|NCT00006054|graft versus host disease|graft versus host disease
5859927|NCT00006054|hematologic disorders|hematologic disorders
5859928|NCT00006054|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis
5859929|NCT00006054|histiocytosis|histiocytosis
5859930|NCT00006054|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5859940|NCT00005933|Coping|coping
5859941|NCT00005933|Chronic Illness|chronic illness
5859942|NCT00005933|Learning|learning
5859943|NCT00005928|ACE Inhibitor|ace inhibitor
5859944|NCT00005928|Vascular Inflammation|vascular inflammation
5859945|NCT00005928|Vascular Compliance|vascular compliance
5859946|NCT00005928|Cell Adhesion Molecules|cell adhesion molecules
5859947|NCT00005928|Coronary Artery Disease|coronary artery disease
5859948|NCT00005927|Macronodular Adrenals|macronodular adrenals
5859949|NCT00005927|Cushing's Syndrome|cushing's syndrome
5859950|NCT00005927|Adrenal Gland|adrenal gland
5859951|NCT00005925|Video-EEG|video-eeg
5859952|NCT00005925|Muscimol|muscimol
5859953|NCT00005925|Depth Electrode|depth electrode
5859954|NCT00005925|Brain Catheter|brain catheter
5859955|NCT00005925|Pharmacology|pharmacology
5859956|NCT00005925|Epilepsy|epilepsy
5859957|NCT00005925|Infusion|infusion
5859958|NCT00005925|Magnetic Resonance Imaging|magnetic resonance imaging
5859959|NCT00005924|B Cell|b cell
5859960|NCT00005924|Epstein-Barr Virus|epstein-barr virus
5859961|NCT00005923|Joint Instability|joint instability
5859962|NCT00005922|Conditioning|conditioning
5859963|NCT00005922|Corticosteroid|corticosteroid
5859964|NCT00005922|Lesions|lesions
5859965|NCT00005922|Pharmacotherapy|pharmacotherapy
5859966|NCT00005922|Placebo effect|placebo effect
5859967|NCT00005922|Psoriasis|psoriasis
5859968|NCT00005922|Psychoneuroimmunology|psychoneuroimmunology
5859969|NCT00005919|Pigment Dispersion|pigment dispersion
5859970|NCT00005919|Ocular Hypertension|ocular hypertension
5859971|NCT00005919|Glaucoma|glaucoma
5859972|NCT00005919|Pupil Reaction|pupil reaction
5859973|NCT00005919|Natural History|natural history
5859974|NCT00005919|Pigment Dispersion Syndrome|pigment dispersion syndrome
5859975|NCT00005919|Gene Mutation|gene mutation
5859981|NCT00005916|Immunotherapy|immunotherapy
5859982|NCT00005916|Radiation|radiation
5859983|NCT00005916|Immunology|immunology
5859984|NCT00005916|Prostvac|prostvac
5859985|NCT00005916|Prostate Cancer|prostate cancer
5859986|NCT00005914|Depression|depression
5859987|NCT00005914|Depressive Disorder|depressive disorder
5859988|NCT00005914|Family|family
5859990|NCT00005914|Genetic Techniques|genetic techniques
5859991|NCT00005914|Genetics|genetics
5859992|NCT00005914|Linkage (Genetics)|linkage (genetics)
5859993|NCT00005914|Nuclear Family|nuclear family
5859994|NCT00005914|Recurrence|recurrence
5859995|NCT00005914|Severity of Illness Index|severity of illness index
5859996|NCT00005911|Magnetic Resonance Imaging|magnetic resonance imaging
5859997|NCT00005911|Human Eye|human eye
5859998|NCT00005911|Lens|lens
5859999|NCT00005911|Normal Volunteers|normal volunteers
5860000|NCT00005911|Cataract|cataract
5860001|NCT00005911|Human Lens|human lens
5860002|NCT00005911|Healthy Volunteer|healthy volunteer
5860003|NCT00005910|Islet Cell Tumors|islet cell tumors
5860004|NCT00005910|Surgery|surgery
5860005|NCT00005910|Ultrasound|ultrasound
5860006|NCT00005910|Insulin|insulin
5860007|NCT00005910|Rapid Assay|rapid assay
5860008|NCT00005910|Arteriogram|arteriogram
5860009|NCT00005910|Pancreas|pancreas
5860010|NCT00005910|Laparoscopy|laparoscopy
5860011|NCT00005910|Insulinoma|insulinoma
5860012|NCT00005910|Localization|localization
5860013|NCT00005910|Hypoglycemia|hypoglycemia
5860020|NCT00005908|cDNA Microarray|cdna microarray
5860021|NCT00005908|Stage II and Stage III Breast Cancer|stage ii and stage iii breast cancer
5860022|NCT00005908|Biological Response|biological response
5860023|NCT00005908|Molecular Profiling|molecular profiling
5860024|NCT00005908|Fine Needle Aspirate|fine needle aspirate
5860025|NCT00005908|Breast Cancer|breast cancer
5860026|NCT00005907|B Cell|b cell
5860027|NCT00005907|Reconstitution|reconstitution
5860028|NCT00005907|T Cell|t cell
5860029|NCT00005907|Transplant|transplant
5860030|NCT00005907|Vaccine|vaccine
5860031|NCT00005906|Chylous Ascites|chylous ascites
5860032|NCT00005906|Chylous Pleural Effusion|chylous pleural effusion
5860033|NCT00005906|Inhibitory Effects|inhibitory effects
5860034|NCT00005906|Lymphangioleiomyoma|lymphangioleiomyoma
5860038|NCT00005905|Insulin Resistance|insulin resistance
5860039|NCT00005905|Dyslipidemia|dyslipidemia
5860040|NCT00005905|Diabetes Mellitus|diabetes mellitus
5860041|NCT00005905|Non-Alcoholic Steatohepatitis|non-alcoholic steatohepatitis
5860042|NCT00005905|Leptin Replacement|leptin replacement
5860043|NCT00005903|Parkinsonism|parkinsonism
5860044|NCT00005903|Trophic Factor|trophic factor
5860045|NCT00005903|Neurodegenerative Disorder|neurodegenerative disorder
5860046|NCT00005903|Progressive Supranuclear Palsy|progressive supranuclear palsy
5860052|NCT00005901|Bisphosphonates|bisphosphonates
5860053|NCT00005901|Growth Hormone|growth hormone
5860054|NCT00005901|Bone Density|bone density
5860055|NCT00005901|Osteogenesis Imperfecta|osteogenesis imperfecta
5860056|NCT00005900|Gaucher's disease|gaucher's disease
5860057|NCT00005900|I cell disease|i cell disease
5860058|NCT00005900|Niemann-Pick disease|niemann-pick disease
5860059|NCT00005900|Wolman disease|wolman disease
5860060|NCT00005900|adrenoleukodystrophy|adrenoleukodystrophy
5860061|NCT00005900|disease-related problem/condition|disease-related problem/condition
5860063|NCT00005900|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860064|NCT00005900|globoid cell leukodystrophy|globoid cell leukodystrophy
5860065|NCT00005900|inborn errors of metabolism|inborn errors of metabolism
5860066|NCT00005900|mannosidosis|mannosidosis
5860067|NCT00005900|metachromatic leukodystrophy|metachromatic leukodystrophy
5860068|NCT00005900|mucopolysaccharidosis|mucopolysaccharidosis
5860069|NCT00005900|mucopolysaccharidosis I|mucopolysaccharidosis i
5860070|NCT00005900|mucopolysaccharidosis VI|mucopolysaccharidosis vi
5860071|NCT00005900|oncologic disorders|oncologic disorders
5860072|NCT00005900|pulmonary complications|pulmonary complications
5860073|NCT00005900|rare disease|rare disease
5860074|NCT00005900|sphingolipidoses|sphingolipidoses
5860075|NCT00005896|Fanconi's anemia|fanconi's anemia
5860076|NCT00005896|aplastic anemia|aplastic anemia
5860077|NCT00005896|hematologic disorders|hematologic disorders
5860078|NCT00005896|rare disease|rare disease
5860079|NCT00005893|chronic congenital neutropenia|chronic congenital neutropenia
5860080|NCT00005893|chronic neutropenia|chronic neutropenia
5860081|NCT00005893|congenital pure red cell aplasia|congenital pure red cell aplasia
5860082|NCT00005893|disease-related problem/condition|disease-related problem/condition
5860083|NCT00005893|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860084|NCT00005893|hematologic disorders|hematologic disorders
5860085|NCT00005893|neutropenia|neutropenia
5860086|NCT00005893|pure red cell aplasia|pure red cell aplasia
5860087|NCT00005893|rare disease|rare disease
5860088|NCT00005893|sickle cell anemia|sickle cell anemia
5860089|NCT00005893|thalassemia major|thalassemia major
5860090|NCT00005892|Fanconi's anemia|fanconi's anemia
5860091|NCT00005892|acute leukemia|acute leukemia
5860092|NCT00005892|acute lymphocytic leukemia|acute lymphocytic leukemia
5860093|NCT00005892|acute myeloid leukemia|acute myeloid leukemia
5860094|NCT00005892|acute undifferentiated leukemia|acute undifferentiated leukemia
5860095|NCT00005892|adult acute lymphoblastic leukemia|adult acute lymphoblastic leukemia
5860096|NCT00005892|adult acute lymphoblastic leukemia in remission|adult acute lymphoblastic leukemia in remission
5860097|NCT00005892|adult acute myeloid leukemia|adult acute myeloid leukemia
5860098|NCT00005892|adult acute myeloid leukemia in remission|adult acute myeloid leukemia in remission
5860099|NCT00005892|aplastic anemia|aplastic anemia
5860100|NCT00005892|childhood acute lymphoblastic leukemia|childhood acute lymphoblastic leukemia
5860101|NCT00005892|childhood acute lymphoblastic leukemia in remission|childhood acute lymphoblastic leukemia in remission
5860102|NCT00005892|childhood acute myeloid leukemia|childhood acute myeloid leukemia
5860103|NCT00005892|childhood acute myeloid leukemia in remission|childhood acute myeloid leukemia in remission
5860104|NCT00005892|de novo myelodysplastic syndrome|de novo myelodysplastic syndrome
5860105|NCT00005892|hematologic disorders|hematologic disorders
5860106|NCT00005892|hematopoietic/lymphoid cancer|hematopoietic/lymphoid cancer
5860108|NCT00005892|myelodysplastic syndrome|myelodysplastic syndrome
5860109|NCT00005892|oncologic disorders|oncologic disorders
5860110|NCT00005892|previously treated myelodysplastic syndrome|previously treated myelodysplastic syndrome
5860111|NCT00005892|rare disease|rare disease
5860112|NCT00005892|secondary myelodysplastic syndrome|secondary myelodysplastic syndrome
5860113|NCT00005891|Fanconi's Anemia|fanconi's anemia
5860114|NCT00005891|aplastic anemia|aplastic anemia
5860115|NCT00005891|hematologic disorders|hematologic disorders
5860116|NCT00005891|rare disease|rare disease
5860117|NCT00005890|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860118|NCT00005890|rare disease|rare disease
5860119|NCT00005890|sepsis|sepsis
5860120|NCT00005890|septic shock|septic shock
5860121|NCT00005889|endocrine disorders|endocrine disorders
5860122|NCT00005889|hyperglycemia|hyperglycemia
5860128|NCT00005888|low birth weight|low birth weight
5860129|NCT00005888|necrotizing enterocolitis|necrotizing enterocolitis
5860130|NCT00005888|neonatal disorders|neonatal disorders
5860131|NCT00005888|rare disease|rare disease
5860132|NCT00005888|sepsis|sepsis
5860133|NCT00005785|Peripheral Blood Stem Cells|peripheral blood stem cells
5860134|NCT00005785|Engraftment|engraftment
5860135|NCT00005785|Graft vs. Host Disease|graft vs. host disease
5856288|NCT00000808|Nevirapine|nevirapine
5860136|NCT00005785|Graft-Versus-Leukemia|graft-versus-leukemia
5860137|NCT00005785|Donor Apheresis|donor apheresis
5860138|NCT00005785|Cyclophosphamide|cyclophosphamide
5860139|NCT00005785|Fludarabine|fludarabine
5860140|NCT00005785|HIV|hiv
5860141|NCT00005785|AIDS|aids
5860142|NCT00005785|Gene Therapy|gene therapy
5860143|NCT00005785|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5860144|NCT00005785|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5860145|NCT00005785|Acute Myelogenous Leukemia|acute myelogenous leukemia
5860146|NCT00005785|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5860147|NCT00005784|Macular Degeneration|macular degeneration
5860148|NCT00005784|Diabetic Retinopathy|diabetic retinopathy
5860149|NCT00005784|Vascular Occlusive Disease|vascular occlusive disease
5860150|NCT00005784|Central Serous Retinopathy|central serous retinopathy
5860151|NCT00005784|Rare/Unknown Retinal Disease|rare/unknown retinal disease
5860152|NCT00005784|Retinal Disease|retinal disease
5861681|NCT00001872|Volunteer|volunteer
5860153|NCT00005784|Age-Related Macular Degeneration|age-related macular degeneration
5860154|NCT00005782|Donor Apheresis|donor apheresis
5860155|NCT00005782|Sickle Cell Trait|sickle cell trait
5860156|NCT00005782|Red Cell Alloimmunization|red cell alloimmunization
5860162|NCT00005778|Systemic Lupus Erythematosus (SLE)|systemic lupus erythematosus (sle)
5860163|NCT00005778|Cytoxan|cytoxan
5860164|NCT00005778|Cyclophosphamide|cyclophosphamide
5860165|NCT00005778|High-dose immunoablative therapy|high-dose immunoablative therapy
5860458|NCT00004992|glycemia|glycemia
5860166|NCT00005777|NICHD Neonatal Research Network|nichd neonatal research network
5860167|NCT00005777|Extremely Low Birth Weight (ELBW)|extremely low birth weight (elbw)
5860168|NCT00005777|Prematurity|prematurity
5860169|NCT00005777|Chronic Lung Disease (CLD)|chronic lung disease (cld)
5860170|NCT00005777|Dexamethasone|dexamethasone
5860171|NCT00005777|Glucocorticoids|glucocorticoids
5860172|NCT00005777|Respiration, Artificial|respiration, artificial
5860173|NCT00005777|Mechanical ventilation|mechanical ventilation
5860174|NCT00005777|Respiratory Insufficiency|respiratory insufficiency
5860175|NCT00005776|NICHD Neonatal Research Network|nichd neonatal research network
5860176|NCT00005776|Hypertension, pulmonary|hypertension, pulmonary
5860177|NCT00005776|Hypoxic respiratory failure|hypoxic respiratory failure
5860178|NCT00005776|Meconium aspiration|meconium aspiration
5860179|NCT00005776|Methemoglobinemia|methemoglobinemia
5860180|NCT00005776|Nitric oxide|nitric oxide
5860181|NCT00005776|Oxygen inhalation therapy|oxygen inhalation therapy
5860182|NCT00005776|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
5860183|NCT00005776|Pneumonia, aspiration|pneumonia, aspiration
5860184|NCT00005776|Respiratory distress syndrome|respiratory distress syndrome
5860185|NCT00005776|Respiratory insufficiency|respiratory insufficiency
5860186|NCT00005776|Severe respiratory failure|severe respiratory failure
5860187|NCT00005775|NICHD Neonatal Research Network|nichd neonatal research network
5860188|NCT00005775|Extremely Low Birth Weight (ELBW) infants|extremely low birth weight (elbw) infants
5860189|NCT00005775|Prematurity|prematurity
5860190|NCT00005775|Glutamine|glutamine
5860191|NCT00005775|Total parenteral nutrition|total parenteral nutrition
5860192|NCT00005775|Nutrition|nutrition
5860193|NCT00005775|Very low birth weight (VLBW) infants|very low birth weight (vlbw) infants
5860194|NCT00005774|NICHD Neonatal Research Network|nichd neonatal research network
5860195|NCT00005774|Pulmonary ventilation|pulmonary ventilation
5860196|NCT00005774|Respiratory distress syndrome|respiratory distress syndrome
5860197|NCT00005774|Respiratory insufficiency|respiratory insufficiency
5860198|NCT00005774|Surfactant, pulmonary|surfactant, pulmonary
5860199|NCT00005774|Mechanical Ventilation|mechanical ventilation
5860200|NCT00005774|Survanta|survanta
5860201|NCT00005773|NICHD Neonatal Research Network|nichd neonatal research network
5860202|NCT00005773|Hypertension, pulmonary|hypertension, pulmonary
5860203|NCT00005773|Hypoxic respiratory failure|hypoxic respiratory failure
5860204|NCT00005773|Meconium aspiration|meconium aspiration
5860205|NCT00005773|Methemoglobinemia|methemoglobinemia
5860206|NCT00005773|Nitric oxide|nitric oxide
5860207|NCT00005773|Oxygen inhalation therapy|oxygen inhalation therapy
5860208|NCT00005773|Persistent Fetal Circulation Syndrome|persistent fetal circulation syndrome
5860209|NCT00005773|Pneumonia, aspiration|pneumonia, aspiration
5861554|NCT00001911|Refractory|refractory
5860210|NCT00005773|Respiratory distress syndrome|respiratory distress syndrome
5860211|NCT00005773|Respiratory insufficiency|respiratory insufficiency
5860212|NCT00005773|Severe respiratory failure|severe respiratory failure
5860213|NCT00005772|NICHD Neonatal Research Network|nichd neonatal research network
5860214|NCT00005772|Hypoxic-ischemic encephalopathy (HIE)|hypoxic-ischemic encephalopathy (hie)
5860215|NCT00005772|Hypothermia|hypothermia
5860216|NCT00005772|Neonatal depression|neonatal depression
5860217|NCT00005772|Perinatal asphyxia|perinatal asphyxia
5860218|NCT00005771|Abdominal Hollowing Exercises|abdominal hollowing exercises
5860219|NCT00005770|elastic property of skin|elastic property of skin
5860220|NCT00005767|Amino Acid Metabolism|amino acid metabolism
5860222|NCT00005761|Types 1 & 2 Diabetes|types 1 & 2 diabetes
5860223|NCT00005761|Cell Adhesion Molecules|cell adhesion molecules
5860224|NCT00005761|Chemokines|chemokines
5860225|NCT00005761|Vascular Endothelial Growth Factor|vascular endothelial growth factor
5860226|NCT00005761|Cross-Sectional|cross-sectional
5860227|NCT00005761|Serum Levels|serum levels
5860228|NCT00005761|Diabetic Retinopathy|diabetic retinopathy
5860229|NCT00005760|Dyslipidemia|dyslipidemia
5860230|NCT00005760|Hypertension|hypertension
5860231|NCT00005760|Metabolic Syndrome X|metabolic syndrome x
5860232|NCT00005760|Obesity|obesity
5860233|NCT00005760|Subcutaneous Adipose Tissue|subcutaneous adipose tissue
5860234|NCT00005760|Visceral Abdominal Adipose Tissue|visceral abdominal adipose tissue
5860235|NCT00005675|Systemic Scleroderma (SSc)|systemic scleroderma (ssc)
5860236|NCT00005675|Bovine Type I Collagen (CI)|bovine type i collagen (ci)
5860237|NCT00005675|Multicenter|multicenter
5860238|NCT00005727|Nutrition|nutrition
5860239|NCT00005727|Education|education
5860240|NCT00005520|Hypertension|hypertension
5860241|NCT00005520|Pharmacogenetics|pharmacogenetics
5860242|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide
5860243|NCT00005520|Candesartan|candesartan
5860244|NCT00005487|Coronary Arteriosclerosis|coronary arteriosclerosis
5860245|NCT00005487|Cerebrovascular Accident|cerebrovascular accident
5860246|NCT00005487|Heart Failure, Congestive|heart failure, congestive
5860247|NCT00005487|Diabetes Mellitus, Non-Insulin Dependent|diabetes mellitus, non-insulin dependent
5860249|NCT00005673|Antiretroviral|antiretroviral
5860250|NCT00005673|NNRTI|nnrti
5860251|NCT00005671|Angina|angina
5860252|NCT00005671|Condition Specific|condition specific
5860253|NCT00005671|Heart Failure|heart failure
5860254|NCT00005671|Symptom Distress|symptom distress
5860255|NCT00005671|Revascularization|revascularization
5860256|NCT00005671|Coronary Artery Disease|coronary artery disease
5860257|NCT00005671|Ischemic Heart Disease|ischemic heart disease
5860258|NCT00005669|Child|child
5860259|NCT00005669|Body Fat|body fat
5860260|NCT00005669|Food Intake|food intake
5860261|NCT00005669|Diabetes Mellitus|diabetes mellitus
5860262|NCT00005669|Dyslipidemia|dyslipidemia
5860263|NCT00005669|Vitamin B12|vitamin b12
5860264|NCT00005669|Childhood Obesity|childhood obesity
5860265|NCT00005667|liver transplantation|liver transplantation
5860266|NCT00005667|vancomycin resistance|vancomycin resistance
5860267|NCT00005666|Diagnostic imaging|diagnostic imaging
5860268|NCT00005664|Healthy Volunteers|healthy volunteers
5860269|NCT00005664|Endocrine Related Conditions|endocrine related conditions
5860270|NCT00005664|Endocrine Dysfunction|endocrine dysfunction
5860271|NCT00005664|Early Pubertal Development|early pubertal development
5860272|NCT00005660|Hypertriglyceridemia|hypertriglyceridemia
5860273|NCT00005660|Teratogenicity|teratogenicity
5860274|NCT00005660|Ichthyosis|ichthyosis
5860275|NCT00005660|Darier's Disease|darier's disease
5860276|NCT00005660|Retinoids|retinoids
5860277|NCT00005660|Skin|skin
5860278|NCT00005660|Psoriasis|psoriasis
5860279|NCT00005660|Basal cell carcinoma|basal cell carcinoma
5860280|NCT00005660|Skin Cancer|skin cancer
5860281|NCT00005658|Biochemical|biochemical
5860282|NCT00005658|Schizophrenia|schizophrenia
5860283|NCT00005658|NMDA|nmda
5860284|NCT00005658|Adolescence|adolescence
5860285|NCT00005658|Psychosis|psychosis
5860286|NCT00005658|Child Psychosis|child psychosis
5860287|NCT00005658|Biochemical Correlates|biochemical correlates
5860288|NCT00005658|Brain Imaging|brain imaging
5860289|NCT00005658|Glycine|glycine
5860290|NCT00005658|Adjunctive Glycine Therapy|adjunctive glycine therapy
5860291|NCT00005657|Cytokines|cytokines
5860292|NCT00005657|Treatment|treatment
5860293|NCT00005657|Genetic Polymorphism|genetic polymorphism
5860294|NCT00005657|Chronic Hepatitis C|chronic hepatitis c
5860295|NCT00005657|Mononuclear Cells|mononuclear cells
5860296|NCT00005655|Gene Expression|gene expression
5860297|NCT00005655|Neovascularization|neovascularization
5860298|NCT00005655|antiangiogenic therapy|antiangiogenic therapy
5860299|NCT00005655|immunomodulatory therapy|immunomodulatory therapy
5860300|NCT00005655|Immunotherapy|immunotherapy
5860301|NCT00005655|Tumor|tumor
5860302|NCT00005654|endocrine disorders|endocrine disorders
5860303|NCT00005654|hyperinsulinism|hyperinsulinism
5860304|NCT00005654|polycystic ovarian syndrome|polycystic ovarian syndrome
5860305|NCT00005654|rare disease|rare disease
5860306|NCT00005652|hematologic disorders|hematologic disorders
5860307|NCT00005652|immune thrombocytopenic purpura|immune thrombocytopenic purpura
5860308|NCT00005652|rare disease|rare disease
5860309|NCT00005650|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860310|NCT00005650|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860311|NCT00005650|primary ciliary dyskinesia|primary ciliary dyskinesia
5860312|NCT00005650|rare disease|rare disease
5860313|NCT00005575|Imipramine|imipramine
5860314|NCT00005575|Cognitive-Behavioral Therapy|cognitive-behavioral therapy
5860315|NCT00005571|Skin|skin
5860316|NCT00005571|Humoral Immunity|humoral immunity
5860317|NCT00005571|Myositis|myositis
5860318|NCT00005571|Complement|complement
5860319|NCT00005571|Antibody|antibody
5860320|NCT00005571|Dermatomyositis|dermatomyositis
5860321|NCT00005569|Elastase|elastase
5860322|NCT00005569|Inflammation|inflammation
5860324|NCT00005569|Gender|gender
5860325|NCT00005569|Cytokine|cytokine
5863226|NCT00001353|HIV|hiv
5860326|NCT00005569|Healthy Volunteer|healthy volunteer
5860327|NCT00005566|Suicide|suicide
5860328|NCT00005119|Premenstrual Dysphoric Disorder|premenstrual dysphoric disorder
5860329|NCT00005119|Severe Premenstrual Syndrome|severe premenstrual syndrome
5860330|NCT00005119|Calcium metabolism|calcium metabolism
5860331|NCT00005119|Vitamin D|vitamin d
5860332|NCT00005119|Bone Markers|bone markers
5860333|NCT00005119|Premenopausal|premenopausal
5860334|NCT00005119|Menstrual Cycle|menstrual cycle
5860335|NCT00005117|endothelial dysfunction|endothelial dysfunction
5860336|NCT00005116|depression|depression
5860337|NCT00005108|Menopause|menopause
5860338|NCT00005108|Atherosclerosis|atherosclerosis
5860339|NCT00005108|Estrogen|estrogen
5860340|NCT00005108|MRI|mri
5860341|NCT00005108|Ultrasound|ultrasound
5860342|NCT00005105|endocrine disorders|endocrine disorders
5860343|NCT00005105|intrauterine growth retardation|intrauterine growth retardation
5860344|NCT00005105|rare disease|rare disease
5860345|NCT00005104|endocrine disorders|endocrine disorders
5860346|NCT00005104|hyperinsulinism|hyperinsulinism
5860347|NCT00005104|polycystic ovarian syndrome|polycystic ovarian syndrome
5860348|NCT00005104|rare disease|rare disease
5860349|NCT00005103|inborn errors of metabolism|inborn errors of metabolism
5860350|NCT00005103|porphyria|porphyria
5860351|NCT00005103|porphyria cutanea tarda|porphyria cutanea tarda
5860352|NCT00005103|rare disease|rare disease
5860353|NCT00005102|DiGeorge syndrome|digeorge syndrome
5860354|NCT00005102|Shprintzen syndrome|shprintzen syndrome
5860355|NCT00005102|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860586|NCT00004729|epilepsy|epilepsy
5860356|NCT00005102|conotruncal cardiac defects|conotruncal cardiac defects
5860357|NCT00005102|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860358|NCT00005102|rare disease|rare disease
5860359|NCT00005101|disease-related problem/condition|disease-related problem/condition
5860360|NCT00005101|osteoporosis|osteoporosis
5860361|NCT00005101|rare disease|rare disease
5860362|NCT00005100|acromegaly|acromegaly
5860363|NCT00005100|endocrine disorders|endocrine disorders
5860364|NCT00005100|rare disease|rare disease
5860365|NCT00005098|alpha 1-antitrypsin deficiency|alpha 1-antitrypsin deficiency
5860366|NCT00005098|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860367|NCT00005098|rare disease|rare disease
5860368|NCT00005015|Bipolar Disorder|bipolar disorder
5860369|NCT00005015|Depression|depression
5860370|NCT00005015|Fluoxetine|fluoxetine
5860371|NCT00005014|Autistic Disorder|autistic disorder
5860372|NCT00005014|Risperidone|risperidone
5860373|NCT00005013|Antidepressive Agents|antidepressive agents
5860374|NCT00005013|Depression|depression
5860375|NCT00005013|Depressive Disorder|depressive disorder
5860376|NCT00005013|Herbs|herbs
5860377|NCT00005013|Hypericum|hypericum
5860378|NCT00005013|Medicine, Herbal|medicine, herbal
5860379|NCT00005013|Plant Extracts|plant extracts
5860380|NCT00005013|Alternative Medicine|alternative medicine
5860381|NCT00005011|Depression|depression
5860382|NCT00005011|Menstrual Cycle|menstrual cycle
5860383|NCT00005011|Gonadal Steroids|gonadal steroids
5860384|NCT00005011|GnRH Agonist|gnrh agonist
5860385|NCT00005011|PMS|pms
5860386|NCT00005011|Estradiol|estradiol
5860387|NCT00005011|Progesterone|progesterone
5860388|NCT00005011|Mood|mood
5860389|NCT00005011|MRMD|mrmd
5860390|NCT00005011|PMDD|pmdd
5860391|NCT00005011|Menstrually Related Mood Disorders|menstrually related mood disorders
5860392|NCT00005007|Wegener's granulomatosis|wegener's granulomatosis
5860393|NCT00005007|Vasculitis|vasculitis
5860394|NCT00005007|Etanercept|etanercept
5860395|NCT00005007|Tumor necrosis factor|tumor necrosis factor
5860396|NCT00005006|Anabolic agent|anabolic agent
5860397|NCT00005006|hPTH|hpth
5860398|NCT00005006|PTH|pth
5860399|NCT00005006|Parathyroid hormone|parathyroid hormone
5860400|NCT00005006|Bone mass|bone mass
5860401|NCT00005006|Bone turnover|bone turnover
5860402|NCT00005006|Bone formation|bone formation
5860403|NCT00005006|Alendronate|alendronate
5860404|NCT00005006|Osteoporosis|osteoporosis
5860405|NCT00005006|Cyclical therapy|cyclical therapy
5860406|NCT00005005|PTH|pth
5860407|NCT00005005|Alendronate|alendronate
5860408|NCT00005005|Parathyroid hormone|parathyroid hormone
5860409|NCT00005005|Osteoporosis|osteoporosis
5860410|NCT00005005|Postmenopausal|postmenopausal
5860411|NCT00005004|Cognitive Processes|cognitive processes
5860412|NCT00005004|Inferential Ambiguities|inferential ambiguities
5860413|NCT00005004|Language Processes|language processes
5860414|NCT00005004|Lexical Ambiguities|lexical ambiguities
5860415|NCT00005004|Suppression Mechanism|suppression mechanism
5860416|NCT00005004|Discourse Processes|discourse processes
5860417|NCT00005004|Discourse Production Analysis|discourse production analysis
5860418|NCT00005004|Magnetic Resonance Imaging|magnetic resonance imaging
5860419|NCT00005004|Prefrontal Cortex Function|prefrontal cortex function
5860420|NCT00005004|Aging Effects|aging effects
5860421|NCT00005004|Garden Path Phenomena|garden path phenomena
5860422|NCT00005004|Text Integration|text integration
5860423|NCT00005003|Handedness|handedness
5860424|NCT00005003|Laterality|laterality
5860426|NCT00005003|VNTR/Dinucleotide|vntr/dinucleotide
5860427|NCT00005003|Dinucleotide|dinucleotide
5860428|NCT00005003|High-Frequency-Trait Analysis|high-frequency-trait analysis
5860429|NCT00004997|Hematopoietic|hematopoietic
5860430|NCT00004997|DHFR Enzyme|dhfr enzyme
5860431|NCT00004997|Anemia|anemia
5860432|NCT00004997|Folic Acid|folic acid
5860433|NCT00004997|MDS|mds
5860434|NCT00004997|Myelodysplasia|myelodysplasia
5860435|NCT00004997|Myelodysplastic|myelodysplastic
5860436|NCT00004996|Antigen Presentation|antigen presentation
5860437|NCT00004996|Cytokines|cytokines
5860438|NCT00004996|Helminth|helminth
5860439|NCT00004996|Healthy Volunteer|healthy volunteer
5860440|NCT00004996|Cross-Over Study|cross-over study
5860441|NCT00004996|Helminth Infection|helminth infection
5860442|NCT00004994|Allogeneic Transplant|allogeneic transplant
5860443|NCT00004994|Function|function
5860444|NCT00004994|Mini-Transplant|mini-transplant
5860445|NCT00004994|Physical Symptoms|physical symptoms
5860446|NCT00004994|Symptom Distress|symptom distress
5860447|NCT00004993|Parathyroid hormone (1-34)|parathyroid hormone (1-34)
5860448|NCT00004993|Glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis
5861821|NCT00001841|MRA|mra
5860449|NCT00004993|Postmenopausal women|postmenopausal women
5860450|NCT00004993|osteoporotic fractures|osteoporotic fractures
5860451|NCT00004992|clinical trial|clinical trial
5860452|NCT00004992|multi-center|multi-center
5860453|NCT00004992|NIDDM|niddm
5860454|NCT00004992|NIDDK|niddk
5860455|NCT00004992|Diabetes Prevention Program (DPP)|diabetes prevention program (dpp)
5860456|NCT00004992|diabetes risk factors|diabetes risk factors
5860457|NCT00004992|diabetes|diabetes
5860459|NCT00004992|cardiovascular risk factors|cardiovascular risk factors
5860460|NCT00004992|quality of life|quality of life
5860461|NCT00004992|physical activity and nutrition|physical activity and nutrition
5860462|NCT00004992|occurrence of adverse events|occurrence of adverse events
5860463|NCT00004992|insulin secretion and sensitivity|insulin secretion and sensitivity
5860464|NCT00004992|prevention|prevention
5860465|NCT00004992|abnormal glucose metabolism|abnormal glucose metabolism
5860466|NCT00004992|lifestyle intervention|lifestyle intervention
5860467|NCT00004992|drug intervention|drug intervention
5860468|NCT00004991|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5860469|NCT00004991|Stuttering|stuttering
5860470|NCT00004991|Speech Perception|speech perception
5860471|NCT00004991|Speech Production|speech production
5860472|NCT00004991|Phonology|phonology
5860473|NCT00004991|Development|development
5860474|NCT00004991|Motor Control|motor control
5860475|NCT00004991|Neural Networks|neural networks
5860476|NCT00004991|Phonological Disorders|phonological disorders
5860477|NCT00004990|Nephrotic Syndrome|nephrotic syndrome
5860478|NCT00004990|Steroids|steroids
5860479|NCT00004990|Osteoporosis|osteoporosis
5860480|NCT00004990|Adrenal Suppression|adrenal suppression
5860481|NCT00004990|Proteinuria|proteinuria
5860482|NCT00004990|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5860483|NCT00004988|Anti-Tumor Effects|anti-tumor effects
5860484|NCT00004988|Maximum Tolerated Dose (MTD)|maximum tolerated dose (mtd)
5860485|NCT00004988|Metastatic Cancer|metastatic cancer
5860486|NCT00004988|Pharmacokinetics|pharmacokinetics
5860487|NCT00004988|Solid Tumors|solid tumors
5860489|NCT00004984|diabetes|diabetes
5860490|NCT00004984|insulin|insulin
5860491|NCT00004984|prediction|prediction
5860492|NCT00004984|prevention|prevention
5860493|NCT00004984|C-peptide levels|c-peptide levels
5860494|NCT00004984|insulin autoantibodies|insulin autoantibodies
5860495|NCT00004984|pancreatic beta cell autoantibodies|pancreatic beta cell autoantibodies
5860496|NCT00004984|cellular immune responses|cellular immune responses
5860497|NCT00004984|prediction of type 1 diabetes|prediction of type 1 diabetes
5860498|NCT00004983|diabetes mellitus, type 2|diabetes mellitus, type 2
5860499|NCT00004983|diabetes self-management education|diabetes self-management education
5860500|NCT00004983|diabetes self-care|diabetes self-care
5860501|NCT00004983|blood glucose self-monitoring|blood glucose self-monitoring
5860502|NCT00004983|health education|health education
5860503|NCT00004983|patient education|patient education
5860504|NCT00004982|chelation therapy|chelation therapy
5860505|NCT00004982|combination chemotherapy|combination chemotherapy
5860518|NCT00004853|MPNST|mpnst
5860519|NCT00004853|Randomized|randomized
5860520|NCT00004853|Sarcoma|sarcoma
5860521|NCT00004853|Tumor|tumor
5860531|NCT00004846|Viral Gene Amplification|viral gene amplification
5860532|NCT00004846|Blood Transmitted Infections|blood transmitted infections
5860533|NCT00004846|Transfusion Risks|transfusion risks
5860534|NCT00004846|Transcription Mediated Analysis|transcription mediated analysis
5860535|NCT00004846|Viral Detection Assays|viral detection assays
5860536|NCT00004846|HIV Seronegativity|hiv seronegativity
5860537|NCT00004739|Pediatric HIV infection|pediatric hiv infection
5860538|NCT00004845|Anti-inflammatory|anti-inflammatory
5860544|NCT00004734|stroke|stroke
5860545|NCT00004734|cerebral infarction|cerebral infarction
5860546|NCT00004734|homocysteine|homocysteine
5860547|NCT00004734|vitamin|vitamin
5860549|NCT00004734|pyridoxine|pyridoxine
5860550|NCT00004734|vitamin B6|vitamin b6
5860551|NCT00004734|cyanocobalamin|cyanocobalamin
5860553|NCT00004734|multivitamin|multivitamin
5860554|NCT00004733|Parkinson's|parkinson's
5860555|NCT00004733|ELLDOPA|elldopa
5860556|NCT00004733|L-dopa|l-dopa
5860557|NCT00004733|levodopa|levodopa
5860558|NCT00004733|Sinemet|sinemet
5860559|NCT00004733|tremor|tremor
5860560|NCT00004732|angioplasty|angioplasty
5860561|NCT00004732|asymptomatic|asymptomatic
5860562|NCT00004732|atherosclerosis|atherosclerosis
5860563|NCT00004732|carotid endarterectomy|carotid endarterectomy
5860564|NCT00004732|carotid stenting|carotid stenting
5860565|NCT00004732|CREST|crest
5860566|NCT00004732|Cerebral Infarction|cerebral infarction
5860567|NCT00004732|device|device
5860568|NCT00004732|intervention|intervention
5860569|NCT00004732|restenosis|restenosis
5860570|NCT00004732|revascularization|revascularization
5860571|NCT00004732|stenosis|stenosis
5860572|NCT00004732|stent|stent
5860573|NCT00004732|stroke|stroke
5860574|NCT00004732|symptomatic|symptomatic
5860575|NCT00004732|surgery|surgery
5860576|NCT00004732|transient ischemic attack|transient ischemic attack
5860577|NCT00004731|Parkinson's disease|parkinson's disease
5860578|NCT00004731|coenzyme Q10|coenzyme q10
5860579|NCT00004730|head injury|head injury
5860580|NCT00004730|traumatic brain injury|traumatic brain injury
5860581|NCT00004730|concussion|concussion
5860582|NCT00004730|magnesium sulfate|magnesium sulfate
5860583|NCT00004730|neuroprotection|neuroprotection
5860584|NCT00004729|child|child
5860585|NCT00004729|children|children
5860590|NCT00004729|Lennox-Gastaut Syndrome|lennox-gastaut syndrome
5860591|NCT00004729|LGS|lgs
5860592|NCT00004728|stroke|stroke
5860593|NCT00004728|cerebral infarction|cerebral infarction
5860594|NCT00004728|warfarin|warfarin
5860595|NCT00004728|coumadin|coumadin
5860596|NCT00004728|aspirin|aspirin
5860597|NCT00004728|ASA|asa
5860598|NCT00004728|acetysalicylic acid|acetysalicylic acid
5860599|NCT00004728|atherosclerosis|atherosclerosis
5860600|NCT00004728|stenosis|stenosis
5860601|NCT00004728|intracranial|intracranial
5860602|NCT00004728|artery|artery
5860603|NCT00004728|arteries|arteries
5860604|NCT00004728|transient ischemic attack|transient ischemic attack
5860605|NCT00004728|TIA|tia
5860606|NCT00004728|minorities|minorities
5860607|NCT00004727|African American|african american
5860608|NCT00004727|antiplatelet|antiplatelet
5860609|NCT00004727|aspirin|aspirin
5860610|NCT00004727|ASA|asa
5860611|NCT00004727|acetylsalicylic acid|acetylsalicylic acid
5860612|NCT00004727|ticlopidine|ticlopidine
5860613|NCT00004727|prevention|prevention
5860614|NCT00004727|stroke|stroke
5860615|NCT00004727|cerebral infarction|cerebral infarction
5860616|NCT00004727|Chicago|chicago
5860617|NCT00004727|non-cardioembolic ischemic stroke|non-cardioembolic ischemic stroke
5860618|NCT00004941|Crohn's disease|crohn's disease
5860619|NCT00004941|gastrointestinal disorders|gastrointestinal disorders
5860620|NCT00004941|rare disease|rare disease
5860621|NCT00004940|erythropoietic protoporphyria|erythropoietic protoporphyria
5860622|NCT00004940|inborn errors of metabolism|inborn errors of metabolism
5860623|NCT00004940|porphyria|porphyria
5860624|NCT00004940|rare disease|rare disease
5860625|NCT00004939|demyelinating neuropathy|demyelinating neuropathy
5860626|NCT00004939|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860627|NCT00004939|rare disease|rare disease
5860628|NCT00004938|fungal infection|fungal infection
5860629|NCT00004938|rare disease|rare disease
5860630|NCT00004938|sporotrichosis|sporotrichosis
5860631|NCT00004844|Parkinson Disease|parkinson disease
5860632|NCT00004844|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860633|NCT00004844|rare disease|rare disease
5860634|NCT00004843|disease-related problem/condition|disease-related problem/condition
5860635|NCT00004843|endocrine disorders|endocrine disorders
5860636|NCT00004843|hyperparathyroidism|hyperparathyroidism
5860637|NCT00004843|quality of life|quality of life
5860638|NCT00004843|rare disease|rare disease
5860639|NCT00004842|cirrhosis|cirrhosis
5860640|NCT00004842|gastrointestinal disorders|gastrointestinal disorders
5860641|NCT00004842|primary biliary cirrhosis|primary biliary cirrhosis
5860642|NCT00004842|primary sclerosing cholangitis|primary sclerosing cholangitis
5860643|NCT00004842|rare disease|rare disease
5860644|NCT00004840|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860645|NCT00004840|neonatal disorders|neonatal disorders
5860646|NCT00004840|rare disease|rare disease
5860647|NCT00004840|respiratory distress syndrome|respiratory distress syndrome
5860648|NCT00004838|environmental/toxic disorders|environmental/toxic disorders
5860649|NCT00004838|lead poisoning|lead poisoning
5860650|NCT00004838|rare disease|rare disease
5860651|NCT00004834|anxiety disorder|anxiety disorder
5860652|NCT00004834|disease-related problem/condition|disease-related problem/condition
5860653|NCT00004834|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860654|NCT00004834|panic disorder|panic disorder
5860655|NCT00004834|rare disease|rare disease
5860656|NCT00004833|Guillain-Barre syndrome|guillain-barre syndrome
5860657|NCT00004833|demyelinating neuropathy|demyelinating neuropathy
5860658|NCT00004833|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860659|NCT00004833|rare disease|rare disease
5860660|NCT00004832|Lambert-Eaton myasthenic syndrome|lambert-eaton myasthenic syndrome
5860661|NCT00004832|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860662|NCT00004832|rare disease|rare disease
5860663|NCT00004831|erythropoietic protoporphyria|erythropoietic protoporphyria
5860664|NCT00004831|inborn errors of metabolism|inborn errors of metabolism
5860665|NCT00004831|porphyria|porphyria
5860666|NCT00004831|rare disease|rare disease
5860667|NCT00004829|bacterial infection|bacterial infection
5860668|NCT00004829|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860669|NCT00004829|cystic fibrosis|cystic fibrosis
5860670|NCT00004829|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860671|NCT00004829|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5862062|NCT00001729|Ribavirin|ribavirin
5860672|NCT00004829|rare disease|rare disease
5860673|NCT00004828|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860674|NCT00004828|heart defects|heart defects
5860675|NCT00004828|rare disease|rare disease
5860676|NCT00004827|ophthalmologic disorders|ophthalmologic disorders
5860677|NCT00004827|rare disease|rare disease
5860678|NCT00004827|retinitis pigmentosa|retinitis pigmentosa
5860679|NCT00004826|Parkinson disease|parkinson disease
5860680|NCT00004826|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860681|NCT00004826|rare disease|rare disease
5860682|NCT00004825|endocrine disorders|endocrine disorders
5860683|NCT00004825|hyperinsulinism|hyperinsulinism
5860684|NCT00004825|rare disease|rare disease
5860685|NCT00004817|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860686|NCT00004817|rare disease|rare disease
5860687|NCT00004817|seizures|seizures
5860688|NCT00004816|multiple sclerosis|multiple sclerosis
5860689|NCT00004816|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860690|NCT00004816|rare disease|rare disease
5860691|NCT00004815|Werner's syndrome|werner's syndrome
5860692|NCT00004815|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860693|NCT00004815|rare disease|rare disease
5860694|NCT00004814|multiple sclerosis|multiple sclerosis
5860695|NCT00004814|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860696|NCT00004814|rare disease|rare disease
5860697|NCT00004812|environmental/toxic disorders|environmental/toxic disorders
5860698|NCT00004812|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860699|NCT00004812|rare disease|rare disease
5860700|NCT00004812|spinal cord injury|spinal cord injury
5860701|NCT00004811|blastomycosis|blastomycosis
5860702|NCT00004811|fungal infection|fungal infection
5860703|NCT00004811|histoplasmosis|histoplasmosis
5860704|NCT00004811|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860705|NCT00004811|rare disease|rare disease
5860706|NCT00004811|sporotrichosis|sporotrichosis
5860707|NCT00004810|gastrointestinal disorders|gastrointestinal disorders
5860708|NCT00004810|rare disease|rare disease
5860709|NCT00004810|ulcerative colitis|ulcerative colitis
5860710|NCT00004809|familial hypercholesterolemia|familial hypercholesterolemia
5860711|NCT00004809|inborn errors of metabolism|inborn errors of metabolism
5860712|NCT00004809|rare disease|rare disease
5860713|NCT00004808|blastomycosis|blastomycosis
5860714|NCT00004808|fungal infection|fungal infection
5860715|NCT00004808|histoplasmosis|histoplasmosis
5860716|NCT00004808|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860717|NCT00004808|rare disease|rare disease
5860718|NCT00004808|sporotrichosis|sporotrichosis
5860719|NCT00004807|Rett syndrome|rett syndrome
5860720|NCT00004807|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860721|NCT00004807|rare disease|rare disease
5860722|NCT00004806|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860723|NCT00004806|cystic fibrosis|cystic fibrosis
5860724|NCT00004806|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860725|NCT00004806|rare disease|rare disease
5860726|NCT00004805|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5860727|NCT00004805|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860728|NCT00004805|disease-related problem/condition|disease-related problem/condition
5860729|NCT00004805|educational needs|educational needs
5860730|NCT00004805|hypertensive disorder|hypertensive disorder
5860731|NCT00004805|neonatal disorders|neonatal disorders
5860732|NCT00004805|primary pulmonary hypertension|primary pulmonary hypertension
5860733|NCT00004805|rare disease|rare disease
5860734|NCT00004805|respiratory distress syndrome|respiratory distress syndrome
5860736|NCT00004804|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860737|NCT00004804|rare disease|rare disease
5860738|NCT00004804|viral infection|viral infection
5860739|NCT00004802|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860740|NCT00004802|periodic paralysis|periodic paralysis
5848340|NCT00035113|cancer|cancer
5860741|NCT00004802|rare disease|rare disease
5860742|NCT00004801|hematologic disorders|hematologic disorders
5860743|NCT00004801|rare disease|rare disease
5860744|NCT00004800|bacterial infection|bacterial infection
5860745|NCT00004800|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860746|NCT00004800|pertussis|pertussis
5860747|NCT00004800|rare disease|rare disease
5860748|NCT00004799|bacterial infection|bacterial infection
5860749|NCT00004799|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860750|NCT00004799|pertussis|pertussis
5860751|NCT00004799|rare disease|rare disease
5860752|NCT00004797|disease-related problem/condition|disease-related problem/condition
5860753|NCT00004797|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860754|NCT00004797|hematologic disorders|hematologic disorders
5860755|NCT00004797|pain|pain
5860756|NCT00004797|rare disease|rare disease
5860757|NCT00004797|sickle cell anemia|sickle cell anemia
5860758|NCT00004796|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860759|NCT00004796|cirrhosis|cirrhosis
5860760|NCT00004796|gastrointestinal disorders|gastrointestinal disorders
5860761|NCT00004796|hypertensive disorder|hypertensive disorder
5860762|NCT00004796|portal hypertension|portal hypertension
5860763|NCT00004796|rare disease|rare disease
5860764|NCT00004795|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860765|NCT00004795|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860766|NCT00004795|rare disease|rare disease
5860767|NCT00004795|systemic lupus erythematosus|systemic lupus erythematosus
5860768|NCT00004794|cytomegalovirus retinitis|cytomegalovirus retinitis
5860769|NCT00004794|ophthalmologic disorders|ophthalmologic disorders
5860770|NCT00004794|rare disease|rare disease
5860771|NCT00004793|constitutional growth delay|constitutional growth delay
5860772|NCT00004793|endocrine disorders|endocrine disorders
5860773|NCT00004793|rare disease|rare disease
5860774|NCT00004791|dermatologic disorders|dermatologic disorders
5860775|NCT00004791|epidermolysis bullosa|epidermolysis bullosa
5860776|NCT00004791|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860777|NCT00004791|rare disease|rare disease
5860778|NCT00004789|inborn errors of metabolism|inborn errors of metabolism
5860779|NCT00004789|acute porphyria|acute porphyria
5860780|NCT00004789|rare disease|rare disease
5860781|NCT00004788|inborn errors of metabolism|inborn errors of metabolism
5860782|NCT00004788|porphyria|porphyria
5860783|NCT00004788|rare disease|rare disease
5860784|NCT00004787|Fanconi's anemia|fanconi's anemia
5860785|NCT00004787|Shwachman syndrome|shwachman syndrome
5860786|NCT00004787|aplastic anemia|aplastic anemia
5860787|NCT00004787|dermatologic disorders|dermatologic disorders
5860788|NCT00004787|dyskeratosis congenita|dyskeratosis congenita
5860789|NCT00004787|hematologic disorders|hematologic disorders
5860790|NCT00004787|rare disease|rare disease
5860791|NCT00004787|thrombocytopenia|thrombocytopenia
5860792|NCT00004786|Raynaud's syndrome|raynaud's syndrome
5860793|NCT00004786|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860794|NCT00004786|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860795|NCT00004786|rare disease|rare disease
5860796|NCT00004786|systemic sclerosis|systemic sclerosis
5860797|NCT00004785|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5860798|NCT00004785|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860799|NCT00004785|neonatal disorders|neonatal disorders
5860800|NCT00004785|rare disease|rare disease
5860801|NCT00004784|cirrhosis|cirrhosis
5860802|NCT00004784|gastrointestinal disorders|gastrointestinal disorders
5860803|NCT00004784|primary biliary cirrhosis|primary biliary cirrhosis
5860804|NCT00004784|rare disease|rare disease
5860805|NCT00004781|HIV-associated candidiasis|hiv-associated candidiasis
5860806|NCT00004781|candidiasis|candidiasis
5860807|NCT00004781|disease-related problem/condition|disease-related problem/condition
5860808|NCT00004781|fungal infection|fungal infection
5860809|NCT00004781|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860810|NCT00004781|infection|infection
5860811|NCT00004781|rare disease|rare disease
5860812|NCT00004779|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860813|NCT00004779|cystic fibrosis|cystic fibrosis
5860814|NCT00004779|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860815|NCT00004779|rare disease|rare disease
5860816|NCT00004778|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860817|NCT00004778|neonatal disorders|neonatal disorders
5860818|NCT00004778|rare disease|rare disease
5860819|NCT00004778|respiratory distress syndrome|respiratory distress syndrome
5860820|NCT00004776|Lennox-Gastaut syndrome|lennox-gastaut syndrome
5860821|NCT00004776|epilepsy|epilepsy
5860822|NCT00004776|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860823|NCT00004776|rare disease|rare disease
5860824|NCT00004776|seizures|seizures
5860825|NCT00004773|Rett syndrome|rett syndrome
5860826|NCT00004773|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860827|NCT00004773|rare disease|rare disease
5860828|NCT00004772|demyelinating neuropathy|demyelinating neuropathy
5860829|NCT00004772|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860830|NCT00004772|rare disease|rare disease
5860831|NCT00004771|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5860832|NCT00004771|motor neuron disease|motor neuron disease
5860833|NCT00004771|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860834|NCT00004771|rare disease|rare disease
5860835|NCT00004771|spinal and bulbar muscular atrophy|spinal and bulbar muscular atrophy
5860836|NCT00004771|spinal muscular atrophy|spinal muscular atrophy
5860837|NCT00004771|Kennedy's Syndrome|kennedy's syndrome
5860838|NCT00004770|inborn errors of metabolism|inborn errors of metabolism
5860839|NCT00004770|mitochondrial myopathy|mitochondrial myopathy
5860840|NCT00004770|rare disease|rare disease
5860841|NCT00004769|Genetic diseases|genetic diseases
5860842|NCT00004769|Myotonic muscular dystrophy|myotonic muscular dystrophy
5860843|NCT00004769|Facioscapulohumeral muscular dystrophy|facioscapulohumeral muscular dystrophy
5860844|NCT00004769|CMT|cmt
5860845|NCT00004769|Rare disease|rare disease
5860846|NCT00004767|inborn errors of metabolism|inborn errors of metabolism
5860847|NCT00004767|rare disease|rare disease
5860848|NCT00004767|urea cycle disorder|urea cycle disorder
5860849|NCT00004763|endocrine disorders|endocrine disorders
5860850|NCT00004763|hyperandrogenism|hyperandrogenism
5860851|NCT00004763|rare disease|rare disease
5860852|NCT00004762|gastrointestinal disorders|gastrointestinal disorders
5860853|NCT00004762|primary sclerosing cholangitis|primary sclerosing cholangitis
5860854|NCT00004762|rare disease|rare disease
5860855|NCT00004761|dermatologic disorders|dermatologic disorders
5860856|NCT00004761|epidermolysis bullosa|epidermolysis bullosa
5860857|NCT00004761|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860858|NCT00004761|rare disease|rare disease
5860859|NCT00004760|Parkinson disease|parkinson disease
5860860|NCT00004760|Neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860861|NCT00004760|Rare disease|rare disease
5860862|NCT00004759|environmental/toxic disorders|environmental/toxic disorders
5860863|NCT00004759|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860864|NCT00004759|rare disease|rare disease
5860865|NCT00004759|spinal cord injury|spinal cord injury
5860866|NCT00004758|infantile spasms|infantile spasms
5860867|NCT00004758|epilepsy|epilepsy
5860868|NCT00004758|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860869|NCT00004758|rare disease|rare disease
5860870|NCT00004758|seizures|seizures
5860871|NCT00004757|herpes simplex virus infection|herpes simplex virus infection
5860872|NCT00004757|herpesvirus infection|herpesvirus infection
5860873|NCT00004757|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860874|NCT00004757|rare disease|rare disease
5860875|NCT00004757|viral infection|viral infection
5860876|NCT00004756|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860877|NCT00004756|disease-related problem/condition|disease-related problem/condition
5860878|NCT00004756|educational needs|educational needs
5860879|NCT00004756|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860880|NCT00004756|rare disease|rare disease
5860881|NCT00004756|systemic lupus erythematosus|systemic lupus erythematosus
5860882|NCT00004755|dermatologic disorders|dermatologic disorders
5860883|NCT00004755|environmental/toxic disorders|environmental/toxic disorders
5860884|NCT00004755|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860885|NCT00004755|leishmaniasis|leishmaniasis
5860886|NCT00004755|rare disease|rare disease
5860887|NCT00004754|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860888|NCT00004754|hypertensive disorder|hypertensive disorder
5860889|NCT00004754|primary pulmonary hypertension|primary pulmonary hypertension
5860890|NCT00004754|rare disease|rare disease
5860891|NCT00004753|Huntington's disease|huntington's disease
5860892|NCT00004753|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860893|NCT00004753|rare disease|rare disease
5860894|NCT00004751|cerebral palsy|cerebral palsy
5860895|NCT00004751|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860896|NCT00004751|rare disease|rare disease
5860897|NCT00004751|spastic diplegia|spastic diplegia
5860898|NCT00004748|cirrhosis|cirrhosis
5860899|NCT00004748|gastrointestinal disorders|gastrointestinal disorders
5860900|NCT00004748|primary biliary cirrhosis|primary biliary cirrhosis
5860901|NCT00004748|rare disease|rare disease
5860902|NCT00004747|bacterial infections|bacterial infections
5860903|NCT00004747|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860904|NCT00004747|cystic fibrosis|cystic fibrosis
5860905|NCT00004747|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860906|NCT00004747|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860907|NCT00004747|rare disease|rare disease
5860908|NCT00004744|multiple sclerosis|multiple sclerosis
5860909|NCT00004744|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860910|NCT00004744|rare disease|rare disease
5857087|NCT00000676|Mycoses|mycoses
5860911|NCT00004740|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860912|NCT00004740|rare disease|rare disease
5860913|NCT00004740|tuberculosis|tuberculosis
5860914|NCT00004705|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860915|NCT00004705|cystic fibrosis|cystic fibrosis
5860916|NCT00004705|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860917|NCT00004705|rare disease|rare disease
5860918|NCT00004700|endocrine disorders|endocrine disorders
5860919|NCT00004700|hyperinsulinism|hyperinsulinism
5860920|NCT00004700|rare disease|rare disease
5860921|NCT00004699|endocrine disorders|endocrine disorders
5860922|NCT00004699|hyperinsulinism|hyperinsulinism
5860923|NCT00004699|rare disease|rare disease
5860924|NCT00004697|gastrointestinal disorders|gastrointestinal disorders
5860925|NCT00004697|hepatic steatosis|hepatic steatosis
5860926|NCT00004697|rare disease|rare disease
5860927|NCT00004696|disease-related problem/condition|disease-related problem/condition
5860929|NCT00004696|intraoperative/postoperative complications|intraoperative/postoperative complications
5860930|NCT00004696|rare disease|rare disease
5860931|NCT00004695|common variable immunodeficiency|common variable immunodeficiency
5860932|NCT00004695|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860933|NCT00004695|primary immunodeficiency disease|primary immunodeficiency disease
5860934|NCT00004695|rare disease|rare disease
5860935|NCT00004694|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860936|NCT00004694|hereditary angioedema|hereditary angioedema
5860937|NCT00004694|rare disease|rare disease
5860938|NCT00004690|dermatologic disorders|dermatologic disorders
5860939|NCT00004690|ichthyosis|ichthyosis
5860940|NCT00004690|rare disease|rare disease
5860941|NCT00004689|bacterial infection|bacterial infection
5860942|NCT00004689|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860943|NCT00004689|mycobacterium avium infection|mycobacterium avium infection
5860944|NCT00004689|mycobacterium infection|mycobacterium infection
5860946|NCT00004688|adult anaplastic astrocytoma|adult anaplastic astrocytoma
5860947|NCT00004688|adult anaplastic oligodendroglioma|adult anaplastic oligodendroglioma
5860948|NCT00004688|adult brain stem glioma|adult brain stem glioma
5860949|NCT00004688|adult brain tumor|adult brain tumor
5860950|NCT00004688|adult glioblastoma multiforme|adult glioblastoma multiforme
5860951|NCT00004688|adult infiltrating astrocytoma|adult infiltrating astrocytoma
5860952|NCT00004688|brain tumor|brain tumor
5860953|NCT00004688|genetic condition|genetic condition
5860954|NCT00004688|miscellaneous sites/terms|miscellaneous sites/terms
5860955|NCT00004688|mixed gliomas|mixed gliomas
5860956|NCT00004688|nervous tissue tumors|nervous tissue tumors
5860957|NCT00004688|oncologic disorders|oncologic disorders
5860958|NCT00004688|rare disease|rare disease
5860959|NCT00004688|recurrent adult brain tumor|recurrent adult brain tumor
5860960|NCT00004686|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860961|NCT00004686|giant cell arteritis|giant cell arteritis
5860962|NCT00004686|rare disease|rare disease
5861968|NCT00001765|Engraftment|engraftment
5860963|NCT00004685|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5860964|NCT00004685|muscular dystrophy|muscular dystrophy
5860965|NCT00004685|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860966|NCT00004685|rare disease|rare disease
5860967|NCT00004682|myasthenia gravis|myasthenia gravis
5860968|NCT00004682|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860969|NCT00004682|rare disease|rare disease
5860970|NCT00004670|Parkinson disease|parkinson disease
5860971|NCT00004670|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5860972|NCT00004670|rare disease|rare disease
5860973|NCT00004669|bronchopulmonary dysplasia|bronchopulmonary dysplasia
5860974|NCT00004669|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5860975|NCT00004669|neonatal disorders|neonatal disorders
5860976|NCT00004669|rare disease|rare disease
5860977|NCT00004667|hematologic disorders|hematologic disorders
5860978|NCT00004667|rare disease|rare disease
5860979|NCT00004667|von Willebrand's disease|von willebrand's disease
5860980|NCT00004665|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860981|NCT00004665|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860982|NCT00004665|rare disease|rare disease
5860983|NCT00004665|systemic lupus erythematosus|systemic lupus erythematosus
5860984|NCT00004664|disease-related problem/condition|disease-related problem/condition
5860985|NCT00004664|human immunodeficiency virus infection|human immunodeficiency virus infection
5860986|NCT00004664|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860987|NCT00004664|nutrition|nutrition
5860988|NCT00004664|rare disease|rare disease
5860989|NCT00004664|viral infection|viral infection
5860990|NCT00004663|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860991|NCT00004663|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860992|NCT00004663|rare disease|rare disease
5860993|NCT00004663|systemic lupus erythematosus|systemic lupus erythematosus
5860994|NCT00004662|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5860995|NCT00004662|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5860996|NCT00004662|rare disease|rare disease
5860997|NCT00004662|systemic lupus erythematosus|systemic lupus erythematosus
5860998|NCT00004661|endocrine disorders|endocrine disorders
5860999|NCT00004661|pseudohypoparathyroidism|pseudohypoparathyroidism
5861003|NCT00004660|endocrine disorders|endocrine disorders
5861004|NCT00004660|rare disease|rare disease
5861005|NCT00004659|adult brain tumor|adult brain tumor
5861006|NCT00004659|brain tumor|brain tumor
5861007|NCT00004659|childhood brain tumor|childhood brain tumor
5861008|NCT00004659|genetic condition|genetic condition
5861009|NCT00004659|nervous tissue tumors|nervous tissue tumors
5861010|NCT00004659|oncologic disorders|oncologic disorders
5861011|NCT00004659|rare disease|rare disease
5861012|NCT00004658|5'-nucleotidase syndrome|5'-nucleotidase syndrome
5861013|NCT00004658|inborn errors of metabolism|inborn errors of metabolism
5861014|NCT00004658|rare disease|rare disease
5861015|NCT00004656|Rett syndrome|rett syndrome
5861016|NCT00004656|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5861017|NCT00004656|rare disease|rare disease
5861018|NCT00004654|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5861019|NCT00004654|hematologic disorders|hematologic disorders
5861020|NCT00004654|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5861021|NCT00004654|rare disease|rare disease
5861022|NCT00004652|Tourette syndrome|tourette syndrome
5861023|NCT00004652|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5861024|NCT00004652|rare disease|rare disease
5861025|NCT00004650|disease-related problem/condition|disease-related problem/condition
5861026|NCT00004650|osteoporosis|osteoporosis
5861027|NCT00004650|rare disease|rare disease
5861028|NCT00004649|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5861029|NCT00004649|hematologic disorders|hematologic disorders
5861030|NCT00004649|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5861031|NCT00004649|rare disease|rare disease
5861032|NCT00004648|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5861033|NCT00004648|hematologic disorders|hematologic disorders
5861034|NCT00004648|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5861035|NCT00004648|rare disease|rare disease
5861036|NCT00004648|Osler-Rendu-Weber disease|osler-rendu-weber disease
5861037|NCT00004647|diabetic neuropathy|diabetic neuropathy
5861038|NCT00004647|disease-related problem/condition|disease-related problem/condition
5861039|NCT00004647|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5861041|NCT00004647|rare disease|rare disease
5861042|NCT00004646|Duchenne muscular dystrophy|duchenne muscular dystrophy
5861043|NCT00004646|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5861044|NCT00004646|muscular dystrophy|muscular dystrophy
5861045|NCT00004646|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5861053|NCT00004645|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5861055|NCT00004644|herpes simplex virus infection|herpes simplex virus infection
5861056|NCT00004644|herpesvirus infection|herpesvirus infection
5861057|NCT00004644|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5861058|NCT00004644|rare disease|rare disease
5861059|NCT00004644|viral infection|viral infection
5861060|NCT00004643|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5861061|NCT00004643|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5861062|NCT00004643|rare disease|rare disease
5861063|NCT00004643|systemic lupus erythematosus|systemic lupus erythematosus
5861064|NCT00004642|congenital cytomegalovirus infection|congenital cytomegalovirus infection
5861065|NCT00004642|cytomegalovirus infection|cytomegalovirus infection
5861066|NCT00004642|herpesvirus infection|herpesvirus infection
5861067|NCT00004642|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5861068|NCT00004642|neonatal disorders|neonatal disorders
5861069|NCT00004642|rare disease|rare disease
5861070|NCT00004642|viral infection|viral infection
5861071|NCT00004638|chronic sinusitis|chronic sinusitis
5861072|NCT00004635|Angiogenesis|angiogenesis
5861073|NCT00004635|Cancer|cancer
5861074|NCT00004635|Hormonal Therapy|hormonal therapy
5861075|NCT00004635|Prostate|prostate
5861076|NCT00004635|Thalidomide|thalidomide
5861077|NCT00004635|Prostate Cancer|prostate cancer
5861083|NCT00004573|cytomegalovirus viremia|cytomegalovirus viremia
5861084|NCT00004572|Type 2 Diabetes|type 2 diabetes
5861090|NCT00004570|Temporal Processing|temporal processing
5861091|NCT00004570|Language Impairment|language impairment
5861092|NCT00004570|Linkage Analysis|linkage analysis
5861093|NCT00004570|Inheritance|inheritance
5861094|NCT00004570|Language Delay|language delay
5861095|NCT00004570|Healthy|healthy
5861096|NCT00004570|Auditory Temporal Processing Disorder|auditory temporal processing disorder
5861097|NCT00004570|Speech Impediment|speech impediment
5861101|NCT00004567|Relapse|relapse
5861102|NCT00004567|Immunosuppressive|immunosuppressive
5861103|NCT00004567|Toxicity|toxicity
5861104|NCT00004567|Purineantimetabolite|purineantimetabolite
5861105|NCT00004567|Alternative Agents|alternative agents
5861106|NCT00004567|Wegener's Granulomatosis|wegener's granulomatosis
5861110|NCT00004566|3D Imaging|3d imaging
5861111|NCT00004566|Swallowing|swallowing
5861112|NCT00004566|Fetal Development|fetal development
5861113|NCT00004566|High-Risk Pregnancy|high-risk pregnancy
5861114|NCT00004566|Ultrasound|ultrasound
5861115|NCT00004565|Breast Cancer|breast cancer
5861116|NCT00004565|Genetics|genetics
5861117|NCT00004565|High Risk|high risk
5861118|NCT00004565|Polymorphisms|polymorphisms
5861119|NCT00004565|Susceptibility|susceptibility
5861120|NCT00004565|Biomarkers|biomarkers
5861121|NCT00004565|Estrogen|estrogen
5861122|NCT00004565|Genes|genes
5861123|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors
5861124|NCT00004564|Cerebrovascular accident|cerebrovascular accident
5861125|NCT00004563|Lung Diseases|lung diseases
5861126|NCT00004563|Pulmonary Fibrosis|pulmonary fibrosis
5861127|NCT00004563|Systemic Scleroderma|systemic scleroderma
5861128|NCT00004563|Scleroderma, systemic|scleroderma, systemic
5861129|NCT00004556|Stimulants|stimulants
5861130|NCT00004556|Affect|affect
5861131|NCT00004556|Cognition|cognition
5861132|NCT00004556|Brain Physiology|brain physiology
5861133|NCT00004556|Brain Metabolism|brain metabolism
5861134|NCT00004556|Catecholamines|catecholamines
5861135|NCT00004556|Brain Imaging|brain imaging
5861136|NCT00004556|Cognitive Efficiency|cognitive efficiency
5861137|NCT00004556|Dopamine Genes|dopamine genes
5861138|NCT00004553|Single Fiber EMG|single fiber emg
5861141|NCT00004553|Post-Polio Syndrome|post-polio syndrome
5861150|NCT00004550|Obsessive Compulsive Disorder|obsessive compulsive disorder
5861151|NCT00004550|Evaluation|evaluation
5861152|NCT00004550|Follow-Up|follow-up
5861153|NCT00004550|OC Spectrum Disorders|oc spectrum disorders
5861154|NCT00004550|OCD|ocd
5861155|NCT00004549|Atherosclerosis|atherosclerosis
5861156|NCT00004549|Endothelium|endothelium
5861157|NCT00004549|Peripheral Vascular Disease|peripheral vascular disease
5861158|NCT00004549|Markers of Inflammation|markers of inflammation
5861159|NCT00004549|Claudication|claudication
5861160|NCT00004547|Surgery|surgery
5861161|NCT00004547|Mesothelioma|mesothelioma
5861162|NCT00004547|Pseudomyxoma|pseudomyxoma
5861163|NCT00004547|Colon Cancer|colon cancer
5861164|NCT00004547|Chemotherapy|chemotherapy
5861165|NCT00004533|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5861166|NCT00004533|cystic fibrosis|cystic fibrosis
5861167|NCT00004533|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5861168|NCT00004533|rare disease|rare disease
5861172|NCT00000436|Hip fracture|hip fracture
5861173|NCT00000436|Self-efficacy|self-efficacy
5861174|NCT00000436|Strength training|strength training
5861175|NCT00000436|Rehabilitation|rehabilitation
5861176|NCT00000436|Postoperative|postoperative
5861177|NCT00001985|Diabetes|diabetes
5861178|NCT00001985|Gene|gene
5861179|NCT00001984|Immunosuppression|immunosuppression
5861180|NCT00001984|Tolerance|tolerance
5861181|NCT00001984|DSG|dsg
5861182|NCT00001984|Alemtuzumab|alemtuzumab
5861183|NCT00001983|Questionnaires|questionnaires
5861184|NCT00001983|Eligibility|eligibility
5861185|NCT00001983|History|history
5861186|NCT00001983|Physical Examination|physical examination
5861187|NCT00001983|Tests|tests
5861188|NCT00001983|Fibromyalgia|fibromyalgia
5861190|NCT00000435|RA|ra
5861191|NCT00000435|Immune Modulation|immune modulation
5861192|NCT00000435|Oral Tolerance|oral tolerance
5861193|NCT00000435|Peptide|peptide
5861194|NCT00000435|dnaJ|dnaj
5861195|NCT00000434|Osteoarthritis|osteoarthritis
5861196|NCT00000434|Health education|health education
5861197|NCT00000434|Aerobic exercise|aerobic exercise
5861198|NCT00000434|Self-efficacy|self-efficacy
5861199|NCT00000434|Muscle strength|muscle strength
5861200|NCT00000434|Outcomes research|outcomes research
5861201|NCT00000434|Longitudinal study|longitudinal study
5861208|NCT00001976|CMV|cmv
5861209|NCT00001976|Infection|infection
5861210|NCT00001976|Comparison|comparison
5861211|NCT00001976|Observational|observational
5861212|NCT00001976|Cytomegalovirus|cytomegalovirus
5861213|NCT00001976|RT-PCR|rt-pcr
5861214|NCT00001975|Skin Biopsy|skin biopsy
5861215|NCT00001975|Familial Tumor Syndrome|familial tumor syndrome
5861216|NCT00001975|Cell Growth|cell growth
5861217|NCT00001975|Loss of Heterozygosity|loss of heterozygosity
5861218|NCT00001975|Cytokines|cytokines
5861219|NCT00001975|Tuberous Sclerosis|tuberous sclerosis
5861220|NCT00001973|G Protein Mutation|g protein mutation
5861221|NCT00001973|McCune-Albright Syndrome|mccune-albright syndrome
5861222|NCT00001973|Fibrous Dysplasia|fibrous dysplasia
5861223|NCT00001973|Mutation|mutation
5861224|NCT00001973|Pathology|pathology
5861225|NCT00001973|Immunohistochemistry|immunohistochemistry
5861226|NCT00001973|PCR|pcr
5861227|NCT00001973|In Situ Hybridization|in situ hybridization
5861228|NCT00001973|Juvenile Dermatomyositis|juvenile dermatomyositis
5861257|NCT00001969|Insulin|insulin
5861258|NCT00001969|Cytokine|cytokine
5861259|NCT00001969|Depression|depression
5861261|NCT00001969|Healthy Volunteer|healthy volunteer
5861262|NCT00001967|HIV|hiv
5857344|NCT00000633|HIV-1|hiv-1
5861263|NCT00001967|HAART|haart
5861264|NCT00001967|Immunity|immunity
5861265|NCT00001967|Toxicity|toxicity
5861266|NCT00001967|Resistance|resistance
5861267|NCT00001967|Treatment Interruption|treatment interruption
5861271|NCT00001962|Immunosuppression|immunosuppression
5861272|NCT00001962|T-cells|t-cells
5861273|NCT00001962|Hematopoiesis|hematopoiesis
5861274|NCT00001962|Monoclonal Antibody Therapy|monoclonal antibody therapy
5861275|NCT00001962|Immunosuppressive Therapy|immunosuppressive therapy
5861276|NCT00001962|Aplastic Anemia|aplastic anemia
5861277|NCT00001961|Myocardial Infarction|myocardial infarction
5861278|NCT00001961|Coronary Artery Disease|coronary artery disease
5861279|NCT00001961|Adenosine|adenosine
5861280|NCT00001961|Stress Testing|stress testing
5861281|NCT00001961|Perfusion|perfusion
5861282|NCT00001960|HCM|hcm
5861283|NCT00001960|Pediatric|pediatric
5861284|NCT00001960|Pacemaker|pacemaker
5861285|NCT00001960|Treatment|treatment
5861286|NCT00001960|Symptoms|symptoms
5861287|NCT00001959|Fibrosis|fibrosis
5861288|NCT00001959|Nephrotic Syndrome|nephrotic syndrome
5861289|NCT00001959|Proteinuria|proteinuria
5861290|NCT00001959|Renal Failure|renal failure
5861291|NCT00001959|TGF-Beta|tgf-beta
5861292|NCT00001959|Focal Segmental Glomerulosclerosis|focal segmental glomerulosclerosis
5861293|NCT00001959|FSGS|fsgs
5861294|NCT00001958|Gamma Gene|gamma gene
5861295|NCT00001958|Hemoglobin Switching|hemoglobin switching
5861296|NCT00001958|Erythropoiesis|erythropoiesis
5861297|NCT00001958|HbE Hemoglobin Chain Synthesis Imbalance|hbe hemoglobin chain synthesis imbalance
5861298|NCT00001958|Cooley's Anemia|cooley's anemia
5861299|NCT00001958|Beta-Thalassemia Intermedia|beta-thalassemia intermedia
5861300|NCT00001957|Ostoacoustic Emission|ostoacoustic emission
5861301|NCT00001957|Central Auditory Processing|central auditory processing
5861302|NCT00001957|CAPD|capd
5861303|NCT00001957|Medial Olivocochlear Bundle|medial olivocochlear bundle
5861304|NCT00001957|Speech Impediment|speech impediment
5861305|NCT00001956|Genetic Markers|genetic markers
5861306|NCT00001956|Thermal Pain|thermal pain
5861307|NCT00001956|Hyperalgesia|hyperalgesia
5861308|NCT00001956|Oral Surgery|oral surgery
5861309|NCT00001956|Cold Pain|cold pain
5861310|NCT00001956|Peripheral Nerve|peripheral nerve
5861311|NCT00001956|Allodynia|allodynia
5861312|NCT00001956|Spinal Cord|spinal cord
5861313|NCT00001956|Personality Traits|personality traits
5861314|NCT00001956|Pain Ratings|pain ratings
5861315|NCT00001955|Clinical Trial|clinical trial
5861316|NCT00001955|Temporomandibular Joints|temporomandibular joints
5861317|NCT00001955|Celecoxib|celecoxib
5861318|NCT00001955|Etanercept|etanercept
5861319|NCT00001955|Tumor Necrosis Factor|tumor necrosis factor
5861320|NCT00001955|TMJ|tmj
5861321|NCT00001955|TMD|tmd
5861322|NCT00001954|Clinical Trial|clinical trial
5861323|NCT00001954|Autoimmune|autoimmune
5861324|NCT00001954|Disease Activity|disease activity
5861325|NCT00001954|Cytokine|cytokine
5861326|NCT00001954|Saliva|saliva
5861327|NCT00001954|Xerostomia|xerostomia
5861328|NCT00001954|Salivary Glands|salivary glands
5861329|NCT00001954|Sjogren's Syndrome|sjogren's syndrome
5861330|NCT00001953|Endocrine System|endocrine system
5861331|NCT00001953|Autoimmunity|autoimmunity
5861332|NCT00001953|Salivary Glands|salivary glands
5861334|NCT00001953|Growth Hormone|growth hormone
5861335|NCT00001953|Somatostatin|somatostatin
5861336|NCT00001953|Sjogren's Syndrome|sjogren's syndrome
5861337|NCT00001952|Fentanyl|fentanyl
5861338|NCT00001952|Intraosseous-Anesthesia|intraosseous-anesthesia
5861339|NCT00001952|Endodontics|endodontics
5861340|NCT00001952|Denti Patch|denti patch
5861341|NCT00001952|Pain|pain
5861342|NCT00001952|Chronic Inflammation|chronic inflammation
5861343|NCT00001951|Bone|bone
5861344|NCT00001951|Cognition|cognition
5861345|NCT00001951|Estrogen|estrogen
5861346|NCT00001951|Mood|mood
5861347|NCT00001951|Testosterone|testosterone
5861348|NCT00001951|Osteoporosis|osteoporosis
5861349|NCT00001951|Ovarian Failure|ovarian failure
5861350|NCT00001951|Hormone Replacement Therapy|hormone replacement therapy
5862187|NCT00001695|Herbal|herbal
5861352|NCT00001951|Premature Ovarian Failure|premature ovarian failure
5861353|NCT00001950|Cognition|cognition
5861354|NCT00001950|Infancy|infancy
5861355|NCT00001950|Perception|perception
5861356|NCT00001948|Human Immunodeficiency Virus|human immunodeficiency virus
5861357|NCT00001948|Symptom Distress|symptom distress
5861358|NCT00001948|Immune Function|immune function
5861359|NCT00001948|Medication Trial|medication trial
5861360|NCT00001948|Physical Symptoms|physical symptoms
5861361|NCT00001946|Magnetic Resonance Angiography|magnetic resonance angiography
5861362|NCT00001946|Gadolinium|gadolinium
5861363|NCT00001946|Suburban Hospital|suburban hospital
5861364|NCT00001946|Atherosclerosis|atherosclerosis
5861365|NCT00001941|Interleukin-2 Receptor alpha chain|interleukin-2 receptor alpha chain
5861366|NCT00001941|Interleukin-2|interleukin-2
5861367|NCT00001941|HTLV-I|htlv-i
5861368|NCT00001941|Adult T-Cell Leukemia (ATL)|adult t-cell leukemia (atl)
5861369|NCT00001941|Monoclonal Antibody (Daclizumab, Zenapax)|monoclonal antibody (daclizumab, zenapax)
5861370|NCT00001938|Ovarian Cancer|ovarian cancer
5861371|NCT00001938|Proteomics|proteomics
5861372|NCT00000433|Spondylitis|spondylitis
5861373|NCT00000433|Etanercept|etanercept
5861374|NCT00000433|ENBREL|enbrel
5861375|NCT00000433|Tumor necrosis factor-alpha|tumor necrosis factor-alpha
5861376|NCT00000432|Lyme disease|lyme disease
5861377|NCT00000432|Education evaluation|education evaluation
5861378|NCT00000432|Communicable disease control|communicable disease control
5861379|NCT00000432|Outcomes research|outcomes research
5861380|NCT00000432|Tick-transmitted diseases|tick-transmitted diseases
5861381|NCT00000431|Venous leg ulcer|venous leg ulcer
5861382|NCT00000431|Wound healing|wound healing
5861383|NCT00000431|Somatic gene therapy|somatic gene therapy
5861384|NCT00000431|PDGF-B|pdgf-b
5861385|NCT00000430|Osteoporosis|osteoporosis
5861386|NCT00000430|Osteopenia|osteopenia
5861387|NCT00000430|Postmenopausal women|postmenopausal women
5861388|NCT00000430|Hormone replacement therapy|hormone replacement therapy
5861389|NCT00000430|Alendronate|alendronate
5861390|NCT00000429|JRA|jra
5861391|NCT00000429|Osteopenia|osteopenia
5861392|NCT00000429|Dietary calcium|dietary calcium
5861393|NCT00000429|Diet therapy|diet therapy
5861394|NCT00000429|Bone density|bone density
5861395|NCT00000429|Ossification|ossification
5861396|NCT00000429|Biomarker|biomarker
5861398|NCT00000428|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
5861399|NCT00000428|Amitriptyline|amitriptyline
5861400|NCT00000428|Fluoxetine|fluoxetine
5861401|NCT00000427|Parathyroid Hormone (PTH)|parathyroid hormone (pth)
5861402|NCT00000427|Alendronate|alendronate
5861403|NCT00000427|Bone metabolism|bone metabolism
5861404|NCT00000427|Bone mineral density (BMD)|bone mineral density (bmd)
5861405|NCT00000427|Bone loss|bone loss
5861406|NCT00000427|Postmenopausal osteoporosis|postmenopausal osteoporosis
5861407|NCT00000427|Osteoporosis in men|osteoporosis in men
5861408|NCT00000111|mouth mucosa|mouth mucosa
5861409|NCT00000111|transplants|transplants
5861410|NCT00000110|exercise|exercise
5861411|NCT00000110|exertion|exertion
5861412|NCT00000110|physical fitness|physical fitness
5861413|NCT00000110|lipids|lipids
5861414|NCT00000110|nutrition|nutrition
5861415|NCT00000108|exercise|exercise
5861416|NCT00000107|Cyanotic Congenital Heart Disease|cyanotic congenital heart disease
5861417|NCT00000106|Rheumatoid Diseases|rheumatoid diseases
5861418|NCT00000393|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5861419|NCT00000392|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5861420|NCT00000392|AIDS-Related Complex|aids-related complex
5861421|NCT00000391|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5861422|NCT00000391|AIDS-Related Complex|aids-related complex
5861423|NCT00000390|Adult|adult
5861424|NCT00000390|Acquired Immunodeficiency Syndrome|acquired immunodeficiency syndrome
5861425|NCT00000390|Depression|depression
5861426|NCT00000390|Female|female
5861427|NCT00000390|Human|human
5861428|NCT00000390|Imipramine|imipramine
5861429|NCT00000390|Male|male
5861430|NCT00000390|Middle Age|middle age
5861431|NCT00000390|Acquired Immunodeficiency Syndrome -- *complications|acquired immunodeficiency syndrome -- *complications
5861432|NCT00000390|Depression -- *drug therapy|depression -- *drug therapy
5861433|NCT00000390|Depression -- etiology|depression -- etiology
5861434|NCT00000390|Imipramine -- *therapeutic use|imipramine -- *therapeutic use
5861435|NCT00001936|Neuromuscular Stimulation|neuromuscular stimulation
5861436|NCT00001936|Laryngeal Elevation|laryngeal elevation
5861437|NCT00001936|Dysphagia|dysphagia
5861438|NCT00001936|Stroke|stroke
5861439|NCT00001936|Neuroprosthesis|neuroprosthesis
5861440|NCT00001936|Dysphonia|dysphonia
5861441|NCT00001936|Aspiration|aspiration
5861442|NCT00001936|Motor Control|motor control
5861443|NCT00001936|Videofluoroscopy|videofluoroscopy
5861444|NCT00001936|Upper Esophageal Sphincter|upper esophageal sphincter
5861445|NCT00001936|Healthy Volunteer|healthy volunteer
5861446|NCT00001936|Swallowing Disorders|swallowing disorders
5861447|NCT00001934|Multiple Sclerosis|multiple sclerosis
5861448|NCT00001934|Immunotherapy|immunotherapy
5861449|NCT00001934|MRI|mri
5861450|NCT00001933|Acetylcholine|acetylcholine
5861451|NCT00001933|Clinical Trial|clinical trial
5861452|NCT00001933|GABA|gaba
5861453|NCT00001933|Cognition|cognition
5861454|NCT00001933|Nicotine|nicotine
5861455|NCT00001932|Epilepsy|epilepsy
5861456|NCT00001932|Temporal Lobe|temporal lobe
5861457|NCT00001932|Blood Flow|blood flow
5861458|NCT00001932|Metabolism|metabolism
5861459|NCT00001932|Localization|localization
5861460|NCT00001927|Factor V Leiden|factor v leiden
5861461|NCT00001927|Prothrombin Mutation|prothrombin mutation
5861462|NCT00001927|Antiphospholipids|antiphospholipids
5861463|NCT00001927|Cerebral Infarction|cerebral infarction
5861464|NCT00001927|Thrombophilia|thrombophilia
5861465|NCT00001927|Porencephaly|porencephaly
5861466|NCT00001927|Perinatal Stroke|perinatal stroke
5861467|NCT00001927|Healthy Mothers|healthy mothers
5861468|NCT00001927|Healthy Children|healthy children
5861469|NCT00001926|Plasticity|plasticity
5861470|NCT00001926|Magnetic Stimulation|magnetic stimulation
5861473|NCT00001926|Braille|braille
5861474|NCT00001926|Transcranial Magnetic Stimulation|transcranial magnetic stimulation
5861475|NCT00001925|Inferior Olives|inferior olives
5861476|NCT00001925|Calcium Channels|calcium channels
5861477|NCT00001925|Accelerometry|accelerometry
5861478|NCT00001925|Electromyography|electromyography
5861479|NCT00001925|Palatal Tremor|palatal tremor
5861480|NCT00001923|Pain|pain
5861481|NCT00001923|Amputee|amputee
5861482|NCT00001923|Phantom Limb|phantom limb
5861483|NCT00001923|Amputation|amputation
5861484|NCT00001923|Magnetic Stimulation|magnetic stimulation
5861485|NCT00001923|Phantom|phantom
5861486|NCT00001922|Evoked Response|evoked response
5861487|NCT00001922|Spasmodic Dysphonia|spasmodic dysphonia
5861488|NCT00001922|Aerodynamic|aerodynamic
5861489|NCT00001922|Vibration|vibration
5861490|NCT00001922|Laryngeal|laryngeal
5861491|NCT00001922|Voice Disorders|voice disorders
5861492|NCT00001922|Laryngeal Brainstem Evoked Responses|laryngeal brainstem evoked responses
5861493|NCT00001922|Long-latency Responses|long-latency responses
5861494|NCT00001922|Muscular Tension Dysphonia|muscular tension dysphonia
5861495|NCT00001921|Functional Connectivity|functional connectivity
5861496|NCT00001921|Frontotemporal Interaction|frontotemporal interaction
5861497|NCT00001921|Electrophysiology|electrophysiology
5861498|NCT00001921|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5861499|NCT00001921|Healthy Subjects|healthy subjects
5861501|NCT00001921|MEG|meg
5861502|NCT00001921|Neuroimaging|neuroimaging
5861503|NCT00001921|EEG|eeg
5861504|NCT00001921|MRI|mri
5861505|NCT00001920|Schizophrenia|schizophrenia
5861506|NCT00001920|Eyeblink|eyeblink
5861507|NCT00001920|Evoked Potentials|evoked potentials
5861508|NCT00001920|Learning|learning
5861509|NCT00001920|Normal Volunteer|normal volunteer
5861510|NCT00001920|Healthy Volunteer|healthy volunteer
5861511|NCT00001919|Mechanism of Action|mechanism of action
5861512|NCT00001919|BCIT-SPECT|bcit-spect
5861513|NCT00001919|St. John's Wort|st. john's wort
5861514|NCT00001919|Hypericum Perforatum|hypericum perforatum
5861515|NCT00001919|Depression|depression
5861516|NCT00001919|Serotonin|serotonin
5861517|NCT00001919|Dopamine Transporter|dopamine transporter
5861518|NCT00001919|SPECT|spect
5861519|NCT00001919|Brain Disorders|brain disorders
5861520|NCT00001917|Positron Emission Tomography|positron emission tomography
5861521|NCT00001917|Physostigmine|physostigmine
5861522|NCT00001917|Visual Stimulation|visual stimulation
5861523|NCT00001917|Cholinergic Stimulation|cholinergic stimulation
5861524|NCT00001917|[F-18] FP-TZIP|[f-18] fp-tzip
5861525|NCT00001917|Aging|aging
5861526|NCT00001917|Alzheimer's Disease|alzheimer's disease
5861527|NCT00001917|Visual Activation|visual activation
5861528|NCT00001915|Cortical Stimulation|cortical stimulation
5861529|NCT00001915|Motor Control|motor control
5861530|NCT00001915|Neuromotor Maturation|neuromotor maturation
5861531|NCT00001915|Magnetic Stimulation|magnetic stimulation
5861532|NCT00001915|Attention Deficit Hyperactivity Disorder|attention deficit hyperactivity disorder
5861533|NCT00001915|Hearing Loss|hearing loss
5861534|NCT00001915|Hearing Conservation|hearing conservation
5861535|NCT00001915|Hearing Protective Devices|hearing protective devices
5861536|NCT00001915|Safety Study|safety study
5861537|NCT00001915|Noise Induced Hearing Loss|noise induced hearing loss
5861538|NCT00001915|Normal Volunteer|normal volunteer
5861539|NCT00001913|Visual Processing|visual processing
5861540|NCT00001913|Functional Magnetic Resonance Imaging|functional magnetic resonance imaging
5861541|NCT00001913|Maternal Behavior|maternal behavior
5861543|NCT00001913|Bereavement|bereavement
5861544|NCT00001912|Cysticercosis|cysticercosis
5861545|NCT00001912|T. Solium|t. solium
5861546|NCT00001912|MRI|mri
5861547|NCT00001912|Seizures|seizures
5861548|NCT00001912|Calcified Cysts|calcified cysts
5861549|NCT00001912|Taenia|taenia
5861550|NCT00001911|Cytokine|cytokine
5861551|NCT00001911|Interferon Gamma|interferon gamma
5861552|NCT00001911|Pulmonary|pulmonary
5861553|NCT00001911|Disseminated|disseminated
5861682|NCT00001872|Leukocyte Donors|leukocyte donors
5861568|NCT00001905|Leukocyte Adhesion Deficiency Type I|leukocyte adhesion deficiency type i
5861569|NCT00001905|LAD I|lad i
5861570|NCT00001901|Vasculitis|vasculitis
5861571|NCT00001901|Prednisone-sparing|prednisone-sparing
5861572|NCT00001901|Methotrexate|methotrexate
5861573|NCT00001901|Tumor Necrosis Factor|tumor necrosis factor
5861574|NCT00001901|Remission|remission
5861575|NCT00001901|Wegener's Granulomatosis|wegener's granulomatosis
5861576|NCT00001899|Viral Suppression|viral suppression
5861577|NCT00001899|Latency|latency
5861578|NCT00001899|AIDS Therapy|aids therapy
5861579|NCT00001899|Viral Relapse|viral relapse
5861580|NCT00001899|Immunodeficiency|immunodeficiency
5861581|NCT00001899|HIV|hiv
5861582|NCT00001899|Treatment Interruption|treatment interruption
5861584|NCT00001898|Breast Cancer|breast cancer
5861585|NCT00001898|Gene Expression|gene expression
5861586|NCT00001898|DNA Chip Technology|dna chip technology
5861587|NCT00001898|Expressed Sequence Tags|expressed sequence tags
5857633|NCT00022750|Randomized trial|randomized trial
5861588|NCT00001895|Electromechanical Mapping|electromechanical mapping
5861589|NCT00001895|Myocardial Viability|myocardial viability
5861590|NCT00001895|Myocardial Ischemia|myocardial ischemia
5861591|NCT00001895|Positron Emission Tomography|positron emission tomography
5861592|NCT00001895|Magnetic Resonance Imaging|magnetic resonance imaging
5861593|NCT00001894|HCM|hcm
5861594|NCT00001894|Alcohol|alcohol
5861595|NCT00001894|Septal Ablation|septal ablation
5861596|NCT00001894|Pacemaker|pacemaker
5861597|NCT00001893|Bronchoprovocation|bronchoprovocation
5861598|NCT00001893|Airway Inflammation|airway inflammation
5861599|NCT00001893|Tumor Necrosis Factor|tumor necrosis factor
5861600|NCT00001893|Bronchoalveolar Lavage|bronchoalveolar lavage
5861601|NCT00001893|Pulmonary Function Test|pulmonary function test
5861602|NCT00001893|Asthma|asthma
5861608|NCT00001885|Interstitial Lung Disease|interstitial lung disease
5861609|NCT00001885|Inherited Disease|inherited disease
5861610|NCT00001885|Genetic Markers|genetic markers
5861611|NCT00001885|Alpha 1 Protease Inhibitor|alpha 1 protease inhibitor
5861612|NCT00001885|DNA Mutations|dna mutations
5861613|NCT00001885|Rheumatoid Arthritis|rheumatoid arthritis
5861614|NCT00001885|Pulmonary Fibrosis|pulmonary fibrosis
5861615|NCT00001885|Normal Volunteer|normal volunteer
5861616|NCT00001884|Bronchoscopy|bronchoscopy
5861617|NCT00001884|Idiopathic Pulmonary Fibrosis|idiopathic pulmonary fibrosis
5861618|NCT00001884|Proteases|proteases
5861619|NCT00001884|Fibroblast Proliferation|fibroblast proliferation
5861620|NCT00001884|Reactive Proteins|reactive proteins
5861621|NCT00001884|Rheumatoid Arthritis|rheumatoid arthritis
5861622|NCT00001884|Pulmonary Fibrosis|pulmonary fibrosis
5861623|NCT00001883|Treadmill|treadmill
5861624|NCT00001883|Bicycle|bicycle
5861625|NCT00001883|Lung Function|lung function
5861626|NCT00001883|Physiology|physiology
5861627|NCT00001883|Quality Control|quality control
5861628|NCT00001883|Normal Volunteers|normal volunteers
5861629|NCT00001880|Engraftment|engraftment
5861630|NCT00001880|Peripheral Blood Stem Cells|peripheral blood stem cells
5861631|NCT00001880|Non-Myeloablative Bone Marrow Transplantation|non-myeloablative bone marrow transplantation
5861632|NCT00001880|Metastatic Solid Tumors|metastatic solid tumors
5861633|NCT00001880|Graft-Versus-Host Disease|graft-versus-host disease
5861634|NCT00001880|Cancer|cancer
5861635|NCT00001880|Tumor|tumor
5861636|NCT00001878|Growth Hormone|growth hormone
5861637|NCT00001878|Cardiac Hypertrophy|cardiac hypertrophy
5861638|NCT00001878|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5861639|NCT00001878|Sarcomeric Gene Mutations|sarcomeric gene mutations
5861640|NCT00001877|Tumor Necrosis Factor|tumor necrosis factor
5861641|NCT00001877|Corticosteroids|corticosteroids
5861642|NCT00001877|Macrophages|macrophages
5861643|NCT00001877|Phosphodiesterase|phosphodiesterase
5861644|NCT00001877|Autoimmune|autoimmune
5861645|NCT00001877|Pulmonary Sarcoidosis|pulmonary sarcoidosis
5861656|NCT00001874|MRI|mri
5861657|NCT00001874|Cardiovascular|cardiovascular
5861658|NCT00001874|Technical Development|technical development
5861659|NCT00001874|Safety|safety
5861660|NCT00001874|Gadolinium|gadolinium
5861661|NCT00001874|Heart|heart
5861662|NCT00001874|Toxicity|toxicity
5861663|NCT00001874|Adverse Events|adverse events
5861664|NCT00001874|Normal Volunteer|normal volunteer
5861665|NCT00001873|Peripheral Blood Stem Cells|peripheral blood stem cells
5861666|NCT00001873|Cyclosporine|cyclosporine
5861667|NCT00001873|Cyclosphosphamide|cyclosphosphamide
5861668|NCT00001873|Whole Body Irradiation|whole body irradiation
5861669|NCT00001873|Donor Apheresis|donor apheresis
5861670|NCT00001873|Leukemic Relapse|leukemic relapse
5861671|NCT00001873|Graft vs. Host Disease|graft vs. host disease
5861672|NCT00001873|Graft-Versus-Leukemia|graft-versus-leukemia
5861673|NCT00001873|Graft-Versus-Myeloma|graft-versus-myeloma
5861674|NCT00001873|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5861675|NCT00001873|Acute Lymphoblastic Leukemia|acute lymphoblastic leukemia
5861676|NCT00001873|Acute Myelogenous Leukemia|acute myelogenous leukemia
5861677|NCT00001873|Myelodysplastic Syndromes|myelodysplastic syndromes
5861678|NCT00001873|Multiple Myeloma|multiple myeloma
5861679|NCT00001873|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5861680|NCT00001873|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5861683|NCT00001872|Family Members|family members
5861684|NCT00001872|Leukocyte Collection|leukocyte collection
5861685|NCT00001872|No Reimbursement|no reimbursement
5861686|NCT00001870|Insulin Resistance|insulin resistance
5861687|NCT00001870|Oxidative Stress|oxidative stress
5861688|NCT00001870|Antioxidant|antioxidant
5861689|NCT00001870|Endothelial Function|endothelial function
5861690|NCT00001870|Glucose Clamp|glucose clamp
5861691|NCT00001870|Type 2 Diabetes|type 2 diabetes
5861692|NCT00001870|Vitamin C Deficiency|vitamin c deficiency
5861693|NCT00001869|Progesterone|progesterone
5861694|NCT00001869|Pulmonary Function Tests|pulmonary function tests
5861695|NCT00001869|Pneumothorax|pneumothorax
5861696|NCT00001869|Oopherectomy|oopherectomy
5861697|NCT00001869|High Resolution CT|high resolution ct
5861698|NCT00001869|Tuberous Sclerosis Complex|tuberous sclerosis complex
5861699|NCT00001869|Lymphangioleiomyomatosis (LAM)|lymphangioleiomyomatosis (lam)
5861700|NCT00001865|Behcet's|behcet's
5861701|NCT00001865|Monoclonal Antibody|monoclonal antibody
5861703|NCT00001865|Interleukin 2|interleukin 2
5861704|NCT00001865|Retinal Vasculitis|retinal vasculitis
5861705|NCT00001865|Hyopyon|hyopyon
5861706|NCT00001865|Interleukin 2 Receptor|interleukin 2 receptor
5861707|NCT00001865|Bechet's Disease|bechet's disease
5861708|NCT00001865|Ocular Disease|ocular disease
5861709|NCT00001863|Immunosuppression|immunosuppression
5861710|NCT00001863|Inflammation|inflammation
5861711|NCT00001863|Eye|eye
5861712|NCT00001863|Vision|vision
5861713|NCT00001863|Medication|medication
5861714|NCT00001863|Uveitis|uveitis
5861715|NCT00001863|Leflunomide|leflunomide
5861716|NCT00001863|Vitritis|vitritis
5861717|NCT00001862|Ocular Inflammation|ocular inflammation
5861718|NCT00001862|Children|children
5861719|NCT00001862|Immunotherapy|immunotherapy
5861720|NCT00001862|Cytokine|cytokine
5861721|NCT00001862|Clinical Trial|clinical trial
5861722|NCT00001862|Uveitis|uveitis
5861723|NCT00001862|Immunosuppression|immunosuppression
5861724|NCT00001862|Joint|joint
5861725|NCT00001862|Inflammation|inflammation
5861726|NCT00001861|Eye Movements|eye movements
5861727|NCT00001861|Amblyopia|amblyopia
5861729|NCT00001861|Lazy Eye|lazy eye
5861730|NCT00001861|Eye Development|eye development
5861731|NCT00001861|Nystagmus|nystagmus
5861732|NCT00001861|Strabismus|strabismus
5861733|NCT00001861|Screening Protocol|screening protocol
5861734|NCT00001861|Eye Movement Disorders|eye movement disorders
5861735|NCT00001860|Growth Hormone|growth hormone
5861736|NCT00001860|Somatostatin|somatostatin
5861737|NCT00001860|Insulin-like Growth Factor-One|insulin-like growth factor-one
5861738|NCT00001860|Acromegaly|acromegaly
5861739|NCT00001860|Macroadenoma|macroadenoma
5861740|NCT00001859|Evaluation|evaluation
5861741|NCT00001859|Diabetes|diabetes
5861742|NCT00001859|Renal Failure|renal failure
5861743|NCT00001858|Biopsy|biopsy
5861744|NCT00001858|Immune System|immune system
5861745|NCT00001858|Renal|renal
5861746|NCT00001856|Living Donor|living donor
5861747|NCT00001856|Transplantation|transplantation
5861748|NCT00001856|Nephrectomy|nephrectomy
5861749|NCT00001854|Ribavirin|ribavirin
5861750|NCT00001854|Liver Disease|liver disease
5861751|NCT00001854|Antiviral Agent|antiviral agent
5861752|NCT00001854|Cirrhosis|cirrhosis
5861753|NCT00001854|Chronic Hepatitis|chronic hepatitis
5861754|NCT00001854|Iron|iron
5861755|NCT00001854|Viral Hepatitis|viral hepatitis
5861756|NCT00001854|Hepatitis C Virus|hepatitis c virus
5861781|NCT00001849|(18F)-DOPA|(18f)-dopa
5861782|NCT00001849|Pentetreotide|pentetreotide
5861783|NCT00001849|ACTH|acth
5861784|NCT00001849|Octreotide|octreotide
5861785|NCT00001849|Cushing's Syndrome|cushing's syndrome
5861786|NCT00001849|Ectopic Cushing Syndrome|ectopic cushing syndrome
5861787|NCT00001848|Estrogen Receptor|estrogen receptor
5861788|NCT00001848|Laparoscopy|laparoscopy
5861789|NCT00001848|Surgical Excision|surgical excision
5861790|NCT00001848|Raloxifene|raloxifene
5861791|NCT00001848|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator
5861792|NCT00001848|Estrogen|estrogen
5861793|NCT00001848|Endometriosis|endometriosis
5861794|NCT00001848|Pelvic Pain|pelvic pain
5861803|NCT00001845|Cerebral Blood Flow|cerebral blood flow
5861804|NCT00001845|CO2 Inhalation|co2 inhalation
5861805|NCT00001845|Acetazolamide|acetazolamide
5861806|NCT00001845|Perfusion|perfusion
5861807|NCT00001845|Healthy Volunteer|healthy volunteer
5861808|NCT00001844|MRI/MRS|mri/mrs
5861809|NCT00001844|Functional MRI|functional mri
5861810|NCT00001844|Metabolic Imaging|metabolic imaging
5861811|NCT00001844|Brain|brain
5861812|NCT00001844|Healthy Volunteer|healthy volunteer
5861813|NCT00001842|Granulocytes|granulocytes
5861814|NCT00001842|Granulocyte Colony Stimulating Factor|granulocyte colony stimulating factor
5861815|NCT00001842|Granulocyte Transfusion Factor|granulocyte transfusion factor
5861816|NCT00001842|Apheresis|apheresis
5861817|NCT00001842|Blood Donors|blood donors
5861818|NCT00001842|Healthy Volunteer|healthy volunteer
5861819|NCT00001841|Arteriosclerosis|arteriosclerosis
5861820|NCT00001841|Imaging|imaging
5861822|NCT00001841|Narrowing of Vessels|narrowing of vessels
5861823|NCT00001841|Hardening of Arteries|hardening of arteries
5861824|NCT00001837|Sonohysterography|sonohysterography
5861825|NCT00001837|Color Doppler Sonography|color doppler sonography
5861826|NCT00001837|Endometrium|endometrium
5861827|NCT00001837|Gynecologic|gynecologic
5861828|NCT00001837|Menstrual Cycle|menstrual cycle
5861829|NCT00001837|Premenopause|premenopause
5861830|NCT00001836|Coronary Artery Disease|coronary artery disease
5861831|NCT00001836|EBCT|ebct
5861832|NCT00001836|Volumetric Scan|volumetric scan
5861833|NCT00001836|Coronary Artery Calcium|coronary artery calcium
5861834|NCT00001836|Prospective Gating|prospective gating
5861835|NCT00001835|Renal Dysfunction|renal dysfunction
5861836|NCT00001835|Pharmacokinetics|pharmacokinetics
5861837|NCT00001835|Platinum Analogues|platinum analogues
5861838|NCT00001835|Renal Cancer|renal cancer
5861839|NCT00001835|Kidney Cancer|kidney cancer
5861840|NCT00001832|Immunotherapy|immunotherapy
5861841|NCT00001832|Adoptive Transfer|adoptive transfer
5861842|NCT00001832|IL-2|il-2
5861843|NCT00001832|Toxicity|toxicity
5861844|NCT00001832|Clinical Response|clinical response
5861845|NCT00001832|Breast Cancer|breast cancer
5861846|NCT00001830|Bone Marrow Transplantation|bone marrow transplantation
5861847|NCT00001830|Chronic Lymphocytic Leukemia|chronic lymphocytic leukemia
5861848|NCT00001830|Immunotherapy|immunotherapy
5861849|NCT00001830|Lymphoma|lymphoma
5861850|NCT00001830|Multiple Myeloma|multiple myeloma
5861851|NCT00001830|Graft vs. Host Disease|graft vs. host disease
5861852|NCT00001830|Lymphoid Malignancy|lymphoid malignancy
5861853|NCT00001830|Leukemia|leukemia
5861854|NCT00001827|Immunotherapy|immunotherapy
5861855|NCT00001827|Cancer|cancer
5861856|NCT00001827|Oncogenes|oncogenes
5861857|NCT00001827|T-cells|t-cells
5861858|NCT00001827|Vaccine Therapy|vaccine therapy
5861859|NCT00001827|p53 Peptide|p53 peptide
5861860|NCT00001827|Ovarian Cancer|ovarian cancer
5861880|NCT00001807|H-NMRS|h-nmrs
5861881|NCT00001807|MRI|mri
5861882|NCT00001806|Genetic Testing|genetic testing
5861883|NCT00001806|Genetic Counseling|genetic counseling
5861884|NCT00001806|BRCA1/BRCA2|brca1/brca2
5861885|NCT00001806|Genetic Education|genetic education
5861886|NCT00001806|Informed Consent|informed consent
5861887|NCT00001806|Breast Cancer|breast cancer
5861888|NCT00001806|Ovarian Cancer|ovarian cancer
5861889|NCT00001806|Known Family Mutation|known family mutation
5861890|NCT00001803|Gene-Environment Interaction|gene-environment interaction
5861891|NCT00001803|Kidney Cancer|kidney cancer
5861892|NCT00001803|VHL|vhl
5861893|NCT00001803|Genetic Epidemiology|genetic epidemiology
5861894|NCT00001788|Cytokine|cytokine
5861895|NCT00001788|Stat|stat
5861896|NCT00001788|Jak|jak
5861897|NCT00001788|IL-12|il-12
5861898|NCT00001788|Mutation|mutation
5861899|NCT00001788|Immunodeficiency|immunodeficiency
5861900|NCT00001785|HTLV-1-Associated Myelopathy|htlv-1-associated myelopathy
5861901|NCT00001785|Virus|virus
5861902|NCT00001785|Spontaneous Proliferation|spontaneous proliferation
5861903|NCT00001784|Blepharospasm|blepharospasm
5861904|NCT00001784|Writer's Cramp|writer's cramp
5861905|NCT00001784|Muscle Spindle Afferents|muscle spindle afferents
5861906|NCT00001784|Sodium Channels|sodium channels
5861907|NCT00001784|Sensorimotor Integration|sensorimotor integration
5861908|NCT00001784|Focal Dystonia|focal dystonia
5861909|NCT00001783|Rehabilitation|rehabilitation
5861910|NCT00001783|Plasticity|plasticity
5861911|NCT00001783|Stroke|stroke
5861912|NCT00001783|Amphetamine|amphetamine
5861913|NCT00001783|Motor|motor
5861914|NCT00001783|Hemiparetic|hemiparetic
5861915|NCT00001783|Thromboembolic Non-Hemorrhagic Infarction|thromboembolic non-hemorrhagic infarction
5861916|NCT00001781|Multiple Sclerosis|multiple sclerosis
5861917|NCT00001781|Immunology|immunology
5861918|NCT00001781|Treatment|treatment
5861919|NCT00001780|Myelopathy|myelopathy
5861920|NCT00001780|Demyelination|demyelination
5861921|NCT00001780|Leukodystrophy|leukodystrophy
5861922|NCT00001780|Motor Neuron Disease|motor neuron disease
5861923|NCT00001780|Movement Disorders|movement disorders
5861924|NCT00001780|Normal Volunteer|normal volunteer
5861925|NCT00001778|Immune Response|immune response
5861926|NCT00001778|Sero-Indeterminant|sero-indeterminant
5861927|NCT00001778|Transmission|transmission
5861928|NCT00001778|Tropical Spastic Paraparesis|tropical spastic paraparesis
5861930|NCT00001778|HTLV-I|htlv-i
5861931|NCT00001778|HAM/TSP|ham/tsp
5861932|NCT00001776|Magnetic Stimulation|magnetic stimulation
5861933|NCT00001776|Plasticity|plasticity
5861934|NCT00001776|SRTT|srtt
5861935|NCT00001776|Sequence|sequence
5861936|NCT00001776|Implicit Memory|implicit memory
5861937|NCT00001776|Explicit Memory|explicit memory
5861938|NCT00001776|Memory|memory
5861939|NCT00001776|Parkinson's Disease|parkinson's disease
5861940|NCT00001776|Cerebellar Deficit|cerebellar deficit
5861941|NCT00001776|Frontal Lobe Lesions|frontal lobe lesions
5861942|NCT00001776|Frontal Lobe Dementia|frontal lobe dementia
5861943|NCT00001776|Normal Volunteer|normal volunteer
5861944|NCT00001771|Receptors|receptors
5861945|NCT00001771|Re-Uptake|re-uptake
5861946|NCT00001771|Neurotransmitters|neurotransmitters
5861947|NCT00001771|Neuroimaging|neuroimaging
5861948|NCT00001771|Drug Abuse|drug abuse
5861949|NCT00001771|Serotonin|serotonin
5861950|NCT00001771|Brain Scan|brain scan
5861951|NCT00001771|Tourette's Syndrome|tourette's syndrome
5861952|NCT00001771|Obsessive Compulsive Disorder|obsessive compulsive disorder
5861953|NCT00001771|Schizophrenia|schizophrenia
5861954|NCT00001771|Normal Volunteer|normal volunteer
5861955|NCT00001770|Depression|depression
5861956|NCT00001770|Estrogen|estrogen
5861957|NCT00001770|Hormone Replacement Therapy|hormone replacement therapy
5861958|NCT00001770|Mood|mood
5861959|NCT00001770|Progestin|progestin
5861960|NCT00001770|Progesterone|progesterone
5861961|NCT00001770|Anxiety|anxiety
5861964|NCT00001766|Drug Interaction|drug interaction
5861966|NCT00001766|Anti-Viral|anti-viral
5861967|NCT00001766|HIV|hiv
5861974|NCT00001765|Anti-Thymocyte Globin|anti-thymocyte globin
5861975|NCT00001765|Cyclophosphamide|cyclophosphamide
5861976|NCT00001765|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
5861977|NCT00001765|Graft-versus-host Disease|graft-versus-host disease
5861978|NCT00001765|Chronic Granulomatous Disease|chronic granulomatous disease
5861979|NCT00001764|Alternative agent|alternative agent
5861980|NCT00001764|Purine Antimetabolite|purine antimetabolite
5861981|NCT00001764|Immunosuppressive|immunosuppressive
5861982|NCT00001764|Previous relapse|previous relapse
5861983|NCT00001764|Drug Intolerance|drug intolerance
5861984|NCT00001764|Wegener's Granulomatosis|wegener's granulomatosis
5861985|NCT00001762|Protease Inhibitor|protease inhibitor
5861986|NCT00001762|HIV Infection|hiv infection
5861987|NCT00001762|Appearance|appearance
5861988|NCT00001762|Subcutaneous Fat|subcutaneous fat
5861989|NCT00001762|Facial Wasting|facial wasting
5861990|NCT00001760|Stem Cell Factor|stem cell factor
5861991|NCT00001760|Cytokine|cytokine
5861992|NCT00001760|Chemokines|chemokines
5861993|NCT00001760|Chemotaxis|chemotaxis
5861994|NCT00001760|Mast Cells|mast cells
5861995|NCT00001760|Normal Volunteer|normal volunteer
5861996|NCT00001760|Systemic Mastocytosis|systemic mastocytosis
5861997|NCT00001760|Atopic Dermatitis|atopic dermatitis
5861998|NCT00001758|Antiretroviral|antiretroviral
5861999|NCT00001758|HIV-1|hiv-1
5862000|NCT00001758|1592U89|1592u89
5862001|NCT00001758|141W94|141w94
5862002|NCT00001758|DMP 266|dmp 266
5862008|NCT00001750|G-CSF|g-csf
5862009|NCT00001750|Cell-Cycle|cell-cycle
5862010|NCT00001750|Stem Cell|stem cell
5862011|NCT00001750|Apheresis|apheresis
5862012|NCT00001750|Melphalan|melphalan
5862013|NCT00001750|Gene Transfer|gene transfer
5862014|NCT00001750|Retroviral Receptor|retroviral receptor
5862015|NCT00001750|Stem Cell Expansion|stem cell expansion
5862016|NCT00001750|Multiple Myeloma|multiple myeloma
5862017|NCT00001749|Immune Suppression|immune suppression
5862018|NCT00001749|Erythroid Hypoplasia|erythroid hypoplasia
5862019|NCT00001749|Congenital Anemia|congenital anemia
5862020|NCT00001749|Reticulocytopenia|reticulocytopenia
5862021|NCT00001749|Diamond Blackfan Anemia|diamond blackfan anemia
5862022|NCT00001746|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5862024|NCT00001746|Evaluation for Research|evaluation for research
5862025|NCT00001746|Medical Advice|medical advice
5862026|NCT00001741|Angiotensin II Receptor|angiotensin ii receptor
5862027|NCT00001741|Polymorphism, Genetic|polymorphism, genetic
5862028|NCT00001741|Vascular Tone|vascular tone
5862029|NCT00001741|Angiotensin II|angiotensin ii
5862030|NCT00001741|Losartan|losartan
5862031|NCT00001737|Eye|eye
5862032|NCT00001737|Immunosuppression|immunosuppression
5862033|NCT00001737|Inflammation|inflammation
5862034|NCT00001737|Therapy|therapy
5862035|NCT00001737|Vitreous|vitreous
5862036|NCT00001737|Uveitis|uveitis
5862037|NCT00001734|Uveitis|uveitis
5862038|NCT00001734|Conjunctivitis|conjunctivitis
5862039|NCT00001734|Iritis|iritis
5862040|NCT00001734|Retinitis|retinitis
5862041|NCT00001734|Keratitis|keratitis
5862042|NCT00001734|Screening Protocol|screening protocol
5862043|NCT00001734|Ocular Immunology|ocular immunology
5862044|NCT00001734|Inflammation|inflammation
5862045|NCT00001734|Eye Inflammation|eye inflammation
5862046|NCT00001733|Diabetic Retinopathy|diabetic retinopathy
5862047|NCT00001733|Age-Related Macular Degeneration|age-related macular degeneration
5862048|NCT00001733|Neovascularization|neovascularization
5862049|NCT00001733|Macular Degeneration|macular degeneration
5862050|NCT00001733|Retinal Disease|retinal disease
5862051|NCT00001733|Diabetes|diabetes
5862052|NCT00001732|Genetics|genetics
5862053|NCT00001732|Diagnosis|diagnosis
5862054|NCT00001732|Screening Protocol|screening protocol
5862055|NCT00001732|Ophthalmic Genetic Diseases|ophthalmic genetic diseases
5862056|NCT00001732|Genetic Testing|genetic testing
5862057|NCT00001732|Family Studies|family studies
5862058|NCT00001729|Cirrhosis|cirrhosis
5862059|NCT00001729|Liver Disease|liver disease
5862060|NCT00001729|Hemolytic Anemia|hemolytic anemia
5862061|NCT00001729|Liver Biopsy|liver biopsy
5862063|NCT00001729|Alpha Interferon|alpha interferon
5862064|NCT00001729|Viral Hepatitis|viral hepatitis
5862065|NCT00001729|Hepatitis C Virus|hepatitis c virus
5862066|NCT00001729|Chronic Hepatitis|chronic hepatitis
5862067|NCT00001729|Antiviral Agents|antiviral agents
5862068|NCT00001728|Bone Marrow Stromal Cells|bone marrow stromal cells
5862069|NCT00001728|Bone Turnover|bone turnover
5862070|NCT00001728|Fibrous Dysplastic Lesion|fibrous dysplastic lesion
5862176|NCT00001701|Risk Factor|risk factor
5862080|NCT00001726|Adhesion|adhesion
5862081|NCT00001726|Dental Plaque Formation|dental plaque formation
5862082|NCT00001726|Dental Caries|dental caries
5862083|NCT00001725|Trigeminal Neuralgia|trigeminal neuralgia
5862084|NCT00001725|Dextromethorphan|dextromethorphan
5862085|NCT00001725|Topiramate|topiramate
5862086|NCT00001725|Orofacial Pain|orofacial pain
5862087|NCT00001725|Neuropathic Pain|neuropathic pain
5862088|NCT00001725|Facial Neuralgia|facial neuralgia
5862089|NCT00001724|Pain|pain
5862090|NCT00001724|Microencapsulated Drug|microencapsulated drug
5862091|NCT00001724|NSAID|nsaid
5862092|NCT00001724|Acute Inflammation|acute inflammation
5862093|NCT00001724|Peripheral Administration|peripheral administration
5862094|NCT00001724|Dose-Response|dose-response
5862095|NCT00001724|Relative Potency Assay|relative potency assay
5862096|NCT00001724|Pharmacokinetics|pharmacokinetics
5862097|NCT00001723|Dyslipidemia|dyslipidemia
5862098|NCT00001723|Race|race
5862099|NCT00001723|Body Fat|body fat
5862100|NCT00001723|Visceral Fat|visceral fat
5862101|NCT00001723|Sleep Apnea|sleep apnea
5862102|NCT00001723|Fat-Soluble Vitamins|fat-soluble vitamins
5862103|NCT00001723|Type 2 Diabetes|type 2 diabetes
5862104|NCT00001723|Obesity|obesity
5862105|NCT00001723|Childhood Obesity|childhood obesity
5862106|NCT00001722|Obesity|obesity
5862107|NCT00001722|Sympathetic Nervous System|sympathetic nervous system
5862108|NCT00001722|Fat Tissue|fat tissue
5862109|NCT00001722|Metabolism|metabolism
5862110|NCT00001722|Adipose Tissue|adipose tissue
5862111|NCT00001722|Microdialysis|microdialysis
5862112|NCT00001722|Leptin|leptin
5862113|NCT00001722|Lipolysis|lipolysis
5862114|NCT00001722|Normal Volunteer|normal volunteer
5862119|NCT00001720|Glucocorticoids|glucocorticoids
5862120|NCT00001720|Bone Mineral Density|bone mineral density
5862121|NCT00001720|Bisphosphonates|bisphosphonates
5862122|NCT00001720|Vertebral Fracture|vertebral fracture
5862123|NCT00001720|Childhood Osteoporosis|childhood osteoporosis
5862124|NCT00001719|Blood Flow|blood flow
5862125|NCT00001719|Hepatic Disease|hepatic disease
5862127|NCT00001719|Modeling|modeling
5862128|NCT00001719|Rheology|rheology
5862129|NCT00001719|Normal Volunteer|normal volunteer
5862130|NCT00001716|Hemoglobin|hemoglobin
5862132|NCT00001716|Microvascular|microvascular
5862133|NCT00001716|Perfusion|perfusion
5862134|NCT00001716|Magnetic Resonance Imaging|magnetic resonance imaging
5862135|NCT00001716|Sickle Cell Anemia|sickle cell anemia
5862136|NCT00001715|Consultation|consultation
5862137|NCT00001715|Training|training
5862138|NCT00001715|Referral|referral
5862139|NCT00001715|Fellowship Program|fellowship program
5862140|NCT00001715|Outpatient|outpatient
5862141|NCT00001715|Blood Disorder|blood disorder
5862142|NCT00001713|rtPA|rtpa
5862143|NCT00001713|Catheter Directed|catheter directed
5862144|NCT00001713|Thrombolysis|thrombolysis
5862145|NCT00001713|Anticoagulation|anticoagulation
5862146|NCT00001713|Emboli|emboli
5862147|NCT00001713|Acute Deep Venous Thrombosis|acute deep venous thrombosis
5862148|NCT00001713|TPA|tpa
5862149|NCT00001713|DVT|dvt
5862150|NCT00001712|Healthcare Worker|healthcare worker
5862151|NCT00001712|Bloodborne Diseases|bloodborne diseases
5862152|NCT00001712|Hepatitis B|hepatitis b
5862153|NCT00001712|Hepatitis C|hepatitis c
5862154|NCT00001712|Human Immunodeficiency Virus|human immunodeficiency virus
5862155|NCT00001712|Parenteral Exposure|parenteral exposure
5862156|NCT00001712|Non-Parenteral Exposure|non-parenteral exposure
5862157|NCT00001712|Blood and Body Substances|blood and body substances
5862158|NCT00001712|Universal Precautions|universal precautions
5862159|NCT00001712|HIV Seronegativity|hiv seronegativity
5862166|NCT00001703|Immunotherapy|immunotherapy
5862167|NCT00001703|Kidney|kidney
5862168|NCT00001703|Genes|genes
5862169|NCT00001703|Vaccine Therapy|vaccine therapy
5862170|NCT00001703|Renal Cell Carcinoma|renal cell carcinoma
5862171|NCT00001702|Genetic|genetic
5862173|NCT00001702|Risk Factor|risk factor
5862174|NCT00001702|Cancer|cancer
5862175|NCT00001702|Transplantation|transplantation
5862177|NCT00001701|Genetic|genetic
5862178|NCT00001701|Variant Alleles|variant alleles
5862179|NCT00001701|Cancer|cancer
5862180|NCT00001701|Transplantation|transplantation
5862181|NCT00001698|Chemoprevention|chemoprevention
5862182|NCT00001698|Direct Epithelial Delivery|direct epithelial delivery
5862183|NCT00001698|Tobacco-induced Cancer|tobacco-induced cancer
5862184|NCT00001698|Field Cancerization|field cancerization
5862185|NCT00001695|Complementary Medicine|complementary medicine
5862186|NCT00001695|Unproven Treatments|unproven treatments
5862188|NCT00001693|Chemoprevention|chemoprevention
5862189|NCT00001693|Biomarkers|biomarkers
5862190|NCT00001693|Endoscopy|endoscopy
5862191|NCT00001693|Colorectal|colorectal
5862192|NCT00001693|Celecoxib|celecoxib
5862193|NCT00001689|Neurotoxicity|neurotoxicity
5862194|NCT00001689|A.L.L.|a.l.l.
5862195|NCT00001689|Limited Sampling|limited sampling
5862196|NCT00001689|Dose Individualization|dose individualization
5862197|NCT00001689|Vinca Alkaloids|vinca alkaloids
5862198|NCT00001686|Leukemia|leukemia
5862199|NCT00001686|Ewing's Sarcoma|ewing's sarcoma
5862200|NCT00001686|Neuroectodermal Tumors|neuroectodermal tumors
5862201|NCT00001686|Lymphoma, Osteosarcoma|lymphoma, osteosarcoma
5862202|NCT00001686|Brain Tumors, Rhabdomyosarcoma|brain tumors, rhabdomyosarcoma
5862203|NCT00001686|Lymphoma|lymphoma
5862204|NCT00001686|Neoplasm|neoplasm
5862205|NCT00001686|Sarcoma|sarcoma
5862206|NCT00001683|Collagen Breakdown|collagen breakdown
5862207|NCT00001683|Pharmacokinetics|pharmacokinetics
5862208|NCT00001683|Rapid Escalation Phase I|rapid escalation phase i
5862209|NCT00001683|Angiogenesis|angiogenesis
5862210|NCT00001683|Tissue Inhibitors of Metalloproteinase|tissue inhibitors of metalloproteinase
5862211|NCT00001678|Autoimmunity|autoimmunity
5862212|NCT00001678|Sibling Pairs|sibling pairs
5862213|NCT00001678|Genes|genes
5862214|NCT00001678|Rheumatoid Arthritis|rheumatoid arthritis
5862215|NCT00001678|Bone Erosion|bone erosion
5862216|NCT00001676|Remission|remission
5862217|NCT00001676|Renal Function|renal function
5862218|NCT00001676|Infection|infection
5862219|NCT00001676|Germinal Center|germinal center
5862220|NCT00001676|Immunoglobulin|immunoglobulin
5862221|NCT00001676|Glomerulonephritis|glomerulonephritis
5862222|NCT00001676|Systemic Lupus Erythematosus|systemic lupus erythematosus
5862223|NCT00001676|Lupus Nephritis|lupus nephritis
5862224|NCT00001671|White Matter|white matter
5862225|NCT00001671|Myelin|myelin
5862226|NCT00001671|Degenerative Diseases|degenerative diseases
5862227|NCT00001671|Genetic|genetic
5862228|NCT00001671|Oligodendrocytes|oligodendrocytes
5862229|NCT00001671|Leukodystrophy|leukodystrophy
5862230|NCT00001666|Seizures|seizures
5862231|NCT00001666|Partial Epilepsy|partial epilepsy
5862232|NCT00001666|Intractable|intractable
5862234|NCT00001664|Narcolepsy|narcolepsy
5862235|NCT00001664|Polysomnography|polysomnography
5862236|NCT00001664|Multiple Sleep Latency Test|multiple sleep latency test
5862237|NCT00001664|Sleep Disorders|sleep disorders
5862238|NCT00001664|Hypersomnia|hypersomnia
5862239|NCT00001664|Periodic Leg Movements|periodic leg movements
5862240|NCT00001663|Neurological Disorders|neurological disorders
5862241|NCT00001663|Movement Disorders|movement disorders
5862242|NCT00001663|Physiology|physiology
5862243|NCT00001663|Noninvasive|noninvasive
5862244|NCT00001663|Brain Stimulation|brain stimulation
5862245|NCT00001663|Cortical Myoclonus|cortical myoclonus
5862246|NCT00001662|Dementia|dementia
5862247|NCT00001662|Glutamate|glutamate
5862248|NCT00001662|Clinical Trial|clinical trial
5862249|NCT00001662|Neurotransmitter|neurotransmitter
5862250|NCT00001662|Alzheimer's Disease|alzheimer's disease
5862251|NCT00001661|Plasticity|plasticity
5862253|NCT00001661|Stroke|stroke
5862254|NCT00001661|Spinal Cord Injury|spinal cord injury
5862255|NCT00001661|Amputation|amputation
5862256|NCT00001661|Intracortical Inhibition|intracortical inhibition
5862257|NCT00001659|Bereavement|bereavement
5862258|NCT00001659|Depression|depression
5862259|NCT00001659|Suicide|suicide
5862260|NCT00001659|Activity of Daily Living|activity of daily living
5862261|NCT00001659|Immune Function|immune function
5862262|NCT00001659|Occupational Performance|occupational performance
5862263|NCT00001659|Sleep Disorders|sleep disorders
5862264|NCT00001659|Mood Changes|mood changes
5862265|NCT00001656|Clozapine|clozapine
5862266|NCT00001656|Olanzapine|olanzapine
5862267|NCT00001656|Drug Response|drug response
5862268|NCT00001656|Safety|safety
5862269|NCT00001656|Childhood Onset Schizophrenia|childhood onset schizophrenia
5862270|NCT00001656|Schizoaffective Disorder|schizoaffective disorder
5862271|NCT00001656|Multidimensionally Impaired Syndrome|multidimensionally impaired syndrome
5862272|NCT00001656|Phenomenology|phenomenology
5862273|NCT00001656|Biochemical Correlates|biochemical correlates
5862274|NCT00001656|Brain Imaging|brain imaging
5862275|NCT00001656|Schizophrenia|schizophrenia
5862276|NCT00001656|Childhood Schizophrenia|childhood schizophrenia
5862277|NCT00001656|Psychosis|psychosis
5862278|NCT00001654|Adolescence|adolescence
5862279|NCT00001654|Comorbid Disorders|comorbid disorders
5862280|NCT00001654|Physiology|physiology
5862283|NCT00001654|Conduct Problems|conduct problems
5862284|NCT00001654|Anxiety|anxiety
5862285|NCT00001654|Sadness|sadness
5862286|NCT00001654|Emotion|emotion
5862287|NCT00001654|Psychophysiology|psychophysiology
5862288|NCT00001652|Life-Charting|life-charting
5862289|NCT00001652|Cerebrospinal Fluid|cerebrospinal fluid
5862290|NCT00001652|Diagnostic Tests|diagnostic tests
5862291|NCT00001652|Cognitive Testing|cognitive testing
5862292|NCT00001652|Course of Illness|course of illness
5862293|NCT00001652|Bipolar Disorder|bipolar disorder
5862300|NCT00001650|Immunodeficiency|immunodeficiency
5862301|NCT00001649|Clinical Trial|clinical trial
5862302|NCT00001649|Sexual Transmitted Disease|sexual transmitted disease
5862303|NCT00001649|Phase III|phase iii
5862304|NCT00001649|HSV|hsv
5862305|NCT00001649|Valtrex|valtrex
5862306|NCT00001649|Valaciclovir|valaciclovir
5862307|NCT00001649|HS2A/B3009|hs2a/b3009
5862308|NCT00001649|Herpes Simplex Virus Transmission|herpes simplex virus transmission
5862309|NCT00001649|Heterosexual Couples|heterosexual couples
5862310|NCT00001648|HVEM Gene|hvem gene
5862311|NCT00001648|HSV|hsv
5862312|NCT00001648|Herpes Simplex Virus|herpes simplex virus
5862313|NCT00001647|AIDS|aids
5862314|NCT00001647|Immunotherapy|immunotherapy
5862315|NCT00001647|Adoptive Cell Transfers|adoptive cell transfers
5862316|NCT00001647|T Cell Repertoire|t cell repertoire
5862317|NCT00001647|Identical Twins|identical twins
5862318|NCT00001645|Helminth Infection|helminth infection
5862320|NCT00001645|Known Parasitic Infection|known parasitic infection
5862321|NCT00001645|Suspected Parasitic Infection|suspected parasitic infection
5862322|NCT00001645|Parasitic Infection|parasitic infection
5862323|NCT00001644|Immunodeficiency|immunodeficiency
5862324|NCT00001644|Latency|latency
5862325|NCT00001644|T Cell Turnover|t cell turnover
5862326|NCT00001644|Infected Cell Turnover|infected cell turnover
5862327|NCT00001644|Follicular Dendritic Cells|follicular dendritic cells
5862328|NCT00001643|Lewy Body|lewy body
5862329|NCT00001643|Mutation|mutation
5862330|NCT00001643|Hereditary|hereditary
5862331|NCT00001643|Dominant|dominant
5862332|NCT00001643|Sporadic|sporadic
5862333|NCT00001643|Parkinson's Disease|parkinson's disease
5862334|NCT00001641|Fibrillin|fibrillin
5862335|NCT00001641|Collagen|collagen
5862336|NCT00001641|Marfan Syndrome|marfan syndrome
5862337|NCT00001641|Stickler Syndrome|stickler syndrome
5862338|NCT00001641|Aortic Dissection|aortic dissection
5862339|NCT00001641|Ehlers-Danlos|ehlers-danlos
5862340|NCT00001641|Connective Tissue Disorders|connective tissue disorders
5862341|NCT00001641|Ehlers-Danlos Syndrome|ehlers-danlos syndrome
5862342|NCT00001641|Nail-Patella Syndrome|nail-patella syndrome
5862343|NCT00001640|Parkinson's Disease|parkinson's disease
5862344|NCT00001638|Echocardiography|echocardiography
5862345|NCT00001638|Heart|heart
5862346|NCT00001638|Gadolinium|gadolinium
5862347|NCT00001638|Dobutamine|dobutamine
5862348|NCT00001638|Toxicity|toxicity
5862349|NCT00001638|Adverse Events|adverse events
5862350|NCT00001638|Myocardial Infarction|myocardial infarction
5862351|NCT00001638|Myocardial Viability|myocardial viability
5862352|NCT00001638|Myocardial Perfusion|myocardial perfusion
5862353|NCT00001638|Myocardial Function|myocardial function
5862354|NCT00001638|Cardiovascular Disease|cardiovascular disease
5862355|NCT00001637|Peripheral Blood Stem Cells|peripheral blood stem cells
5862356|NCT00001637|Engraftment|engraftment
5862357|NCT00001637|Fludarabine|fludarabine
5862358|NCT00001637|Nonmyeloablative|nonmyeloablative
5862359|NCT00001637|Graft-Versus-Leukemia|graft-versus-leukemia
5862360|NCT00001637|Graft vs. Host Disease|graft vs. host disease
5862361|NCT00001637|Cyclophosphamide|cyclophosphamide
5862362|NCT00001637|Donor Apheresis|donor apheresis
5862363|NCT00001637|Nonmyeloablative Bone Marrow Transplantation|nonmyeloablative bone marrow transplantation
5862364|NCT00001637|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5862365|NCT00001637|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5862366|NCT00001637|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5862367|NCT00001637|Myelodysplastic Syndromes|myelodysplastic syndromes
5862368|NCT00001637|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5862369|NCT00001637|Prolymphocytic Leukemia|prolymphocytic leukemia
5862370|NCT00001632|Hypertrophy|hypertrophy
5862371|NCT00001632|Integrated|integrated
5862372|NCT00001632|Backscatter|backscatter
5862373|NCT00001632|Cyclic|cyclic
5862374|NCT00001632|Echocardiography|echocardiography
5862375|NCT00001632|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5862376|NCT00001631|Gadolinium|gadolinium
5862377|NCT00001631|Ischemia|ischemia
5862378|NCT00001631|Coronary Artery Disease|coronary artery disease
5862379|NCT00001631|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5862380|NCT00001631|Dipyridamole|dipyridamole
5862381|NCT00001630|Immunosuppression|immunosuppression
5862398|NCT00001625|Mathematical Modeling|mathematical modeling
5862399|NCT00001625|Normal Volunteer|normal volunteer
5862400|NCT00001623|Peripheral Blood Stem Cells|peripheral blood stem cells
5862401|NCT00001623|Graft-Versus-Leukemia|graft-versus-leukemia
5862402|NCT00001623|Graft vs. Host Disease|graft vs. host disease
5862407|NCT00001623|Leukemic Relapse|leukemic relapse
5862408|NCT00001623|Multiple Myeloma|multiple myeloma
5862409|NCT00001623|Acute Myelogenous Leukemia (AML)|acute myelogenous leukemia (aml)
5862410|NCT00001623|Chronic Myelogenous Leukemia (CML)|chronic myelogenous leukemia (cml)
5862411|NCT00001623|Acute Lymphoblastic Leukemia (ALL)|acute lymphoblastic leukemia (all)
5862759|NCT00001524|Healing|healing
5862412|NCT00001623|Myelodysplastic Syndromes|myelodysplastic syndromes
5862413|NCT00001623|Chronic Lymphocytic Leukemia (CLL)|chronic lymphocytic leukemia (cll)
5862426|NCT00001619|Imaging|imaging
5862427|NCT00001619|Spectroscopy|spectroscopy
5862428|NCT00001619|MRI|mri
5862429|NCT00001619|Cardiovascular|cardiovascular
5862430|NCT00001619|Technical Development|technical development
5862431|NCT00001619|Heart|heart
5862432|NCT00001619|Safety|safety
5862433|NCT00001619|Toxicity|toxicity
5862434|NCT00001619|Gadolinium|gadolinium
5862435|NCT00001619|Adverse Events|adverse events
5862436|NCT00001619|Normal Volunteer|normal volunteer
5862437|NCT00001618|Cystic Fibrosis|cystic fibrosis
5862438|NCT00001618|Healthy Volunteers|healthy volunteers
5862439|NCT00001618|Asthma|asthma
5862440|NCT00001618|Normal Volunteer|normal volunteer
5862441|NCT00001618|Chronic Lung Disease|chronic lung disease
5862442|NCT00001613|Cataract Surgery|cataract surgery
5862443|NCT00001613|Human Lens|human lens
5862444|NCT00001613|Crystallins|crystallins
5862445|NCT00001613|Post-Translational|post-translational
5862446|NCT00001613|Protein Modification|protein modification
5862447|NCT00001613|Nuclear Cataract|nuclear cataract
5862448|NCT00001613|Cataract Extraction|cataract extraction
5862449|NCT00001611|AIDS|aids
5862450|NCT00001611|Eye|eye
5862451|NCT00001611|Treatment|treatment
5862452|NCT00001611|Opportunistic Infection|opportunistic infection
5862453|NCT00001611|Immunology|immunology
5862454|NCT00001611|Retinitis|retinitis
5862455|NCT00001610|Standing Potential|standing potential
5862456|NCT00001610|Fast Oscillation|fast oscillation
5862457|NCT00001610|Slow Oscillation|slow oscillation
5862458|NCT00001610|Retinal Pigment|retinal pigment
5862459|NCT00001610|Epithelium|epithelium
5862460|NCT00001610|Electro-oculogram|electro-oculogram
5862461|NCT00001610|Cellular Immune Response|cellular immune response
5862462|NCT00001610|Retinal Antigens|retinal antigens
5862463|NCT00001610|IRBP|irbp
5862464|NCT00001610|S-Antigen|s-antigen
5862465|NCT00001610|Normal Volunteer|normal volunteer
5862466|NCT00001609|Linkage|linkage
5862467|NCT00001609|Genetic Analysis|genetic analysis
5862468|NCT00001609|Lens|lens
5862469|NCT00001609|Opacity|opacity
5862470|NCT00001609|Inherited|inherited
5862471|NCT00001609|Linkage Analysis|linkage analysis
5862472|NCT00001609|Genomic DNA|genomic dna
5862473|NCT00001609|Risk Prediction|risk prediction
5862474|NCT00001609|Pedigree Analysis|pedigree analysis
5862475|NCT00001609|Congenital Cataracts|congenital cataracts
5862476|NCT00001609|Hereditary Cataracts|hereditary cataracts
5862477|NCT00001606|Linkage Analysis|linkage analysis
5862478|NCT00001606|Positional Cloning|positional cloning
5862479|NCT00001606|Mutation Screening|mutation screening
5862480|NCT00001606|Syndromic Hearing Impairment|syndromic hearing impairment
5862481|NCT00001606|Non-Syndromic Hearing Impairment|non-syndromic hearing impairment
5862491|NCT00001603|Communication|communication
5862493|NCT00001603|Head|head
5862494|NCT00001603|Neck|neck
5862495|NCT00001603|Head and Neck Cancer|head and neck cancer
5862496|NCT00001602|Dysfluency|dysfluency
5862497|NCT00001602|Polymorphism|polymorphism
5862498|NCT00001602|Stuttering|stuttering
5862499|NCT00001602|Dopamine|dopamine
5862500|NCT00001602|Family Studies|family studies
5862501|NCT00001602|Receptors|receptors
5862502|NCT00001602|Serotonin|serotonin
5862503|NCT00001602|Enzymes|enzymes
5862504|NCT00001602|Genetics|genetics
5862505|NCT00001602|Linkage Analysis|linkage analysis
5862506|NCT00001601|Oral Medicine|oral medicine
5862507|NCT00001601|Clinical Experience|clinical experience
5862508|NCT00001601|Therapy|therapy
5862509|NCT00001601|Educational Training|educational training
5862510|NCT00001601|Pathogenesis|pathogenesis
5862511|NCT00001601|Oral Lesions|oral lesions
5862512|NCT00001601|Aphthous Ulcers|aphthous ulcers
5862513|NCT00001601|Lichen Planus|lichen planus
5862514|NCT00001601|Burning Mouth|burning mouth
5862515|NCT00001601|Temporomandibular Dysfunction (TMD)|temporomandibular dysfunction (tmd)
5862516|NCT00001601|Oral Disease|oral disease
5862517|NCT00001601|Oral Manifestations|oral manifestations
5862518|NCT00001600|Screening Protocol|screening protocol
5862519|NCT00001600|Temporomandibular Disorders|temporomandibular disorders
5862520|NCT00001600|Oral Surgery|oral surgery
5862521|NCT00001600|Chronic Orofacial Pain|chronic orofacial pain
5862538|NCT00001597|Validation|validation
5862539|NCT00001597|Fentanyl|fentanyl
5862540|NCT00001597|Normal Volunteer|normal volunteer
5862541|NCT00001597|Pain|pain
5862542|NCT00001596|Albinism|albinism
5862543|NCT00001596|Platelet Storage Pool Deficiency|platelet storage pool deficiency
5862544|NCT00001596|Pulmonary Fibrosis|pulmonary fibrosis
5862545|NCT00001596|Hermansky-Pudlak Syndrome|hermansky-pudlak syndrome
5862551|NCT00001594|Natural History|natural history
5862552|NCT00001594|Brittle Bone|brittle bone
5862553|NCT00001594|Connective Tissue|connective tissue
5862554|NCT00001594|Osteogenesis Imperfecta|osteogenesis imperfecta
5862555|NCT00001591|Central Nervous System|central nervous system
5862556|NCT00001591|Technical Development|technical development
5862557|NCT00001591|Activation Studies|activation studies
5862558|NCT00001591|Pulse Sequences|pulse sequences
5862559|NCT00001591|Metabolites|metabolites
5862560|NCT00001591|Normal Volunteer|normal volunteer
5862561|NCT00001589|Ferritin|ferritin
5862562|NCT00001589|Atherosclerosis|atherosclerosis
5862563|NCT00001589|Myocardial Infarction|myocardial infarction
5862564|NCT00001589|Blood Donors|blood donors
5862565|NCT00001589|Low Density Lipoprotein|low density lipoprotein
5862566|NCT00001589|Asymptomatic Carotid Atherosclerosis|asymptomatic carotid atherosclerosis
5862567|NCT00001586|Genetics|genetics
5862568|NCT00001586|Bone Marrow Transplantation|bone marrow transplantation
5862569|NCT00001586|Immunosuppression|immunosuppression
5862570|NCT00001586|T Lymphocytes|t lymphocytes
5862571|NCT00001586|Marrow Purging|marrow purging
5862572|NCT00001582|Autoimmune Disorder|autoimmune disorder
5862573|NCT00001582|Immune System Evaluation|immune system evaluation
5862574|NCT00001582|Human Response Investigation|human response investigation
5862575|NCT00001582|Tissue Acquisition|tissue acquisition
5862576|NCT00001580|Molecular Diagnostics|molecular diagnostics
5862577|NCT00001580|Ovary|ovary
5862578|NCT00001580|Tissue Acquisition|tissue acquisition
5862579|NCT00001580|cDNA Library|cdna library
5862581|NCT00001576|Regional Therapy|regional therapy
5862582|NCT00001576|Organ Perfusion|organ perfusion
5862583|NCT00001576|Metastases|metastases
5862584|NCT00001576|Hyperthermia|hyperthermia
5862585|NCT00001575|Yttrium 90|yttrium 90
5862586|NCT00001575|Radiolabeled|radiolabeled
5858486|NCT00013546|Androgen|androgen
5862592|NCT00001572|B-Cell Lymphoma|b-cell lymphoma
5862593|NCT00001572|BCL- 2 Positive Tumor|bcl- 2 positive tumor
5862594|NCT00001572|Immunization|immunization
5862595|NCT00001572|Induction Chemotherapy|induction chemotherapy
5862596|NCT00001572|Lymphoma Vaccine|lymphoma vaccine
5862597|NCT00001572|Follicular Lymphoma|follicular lymphoma
5862598|NCT00001572|Tumor-Derived Immunoglobulin Idiotype|tumor-derived immunoglobulin idiotype
5862599|NCT00001569|Gastrointestinal|gastrointestinal
5862600|NCT00001569|Adenocarcinoma|adenocarcinoma
5862601|NCT00001569|Taxol|taxol
5862602|NCT00001568|Tumors|tumors
5862603|NCT00001568|Detection|detection
5862604|NCT00001568|Follow-Up|follow-up
5862605|NCT00001568|Markers|markers
5862606|NCT00001568|Radiolabeled|radiolabeled
5862607|NCT00001567|Follow-Up Study|follow-up study
5862608|NCT00001567|Relapse-Free Survival|relapse-free survival
5862609|NCT00001567|Serum Soluble IL-2 Receptor|serum soluble il-2 receptor
5862610|NCT00001567|Hematologic Malignancy|hematologic malignancy
5862611|NCT00001567|Chronic Therapy|chronic therapy
5862612|NCT00001566|Rhabdomyosarcoma|rhabdomyosarcoma
5863193|NCT00001359|Obsessive Compulsive Disorder|obsessive compulsive disorder
5863194|NCT00001359|PANDAS Associated with Streptococcal Infections|pandas associated with streptococcal infections
5863195|NCT00001359|Adolescents|adolescents
5863196|NCT00001359|Autoimmune Illness|autoimmune illness
5863225|NCT00001353|Ex Vivo Activation|ex vivo activation
5863227|NCT00001353|Gene Therapy|gene therapy
5863228|NCT00001353|Protease Inhibitor|protease inhibitor
5863229|NCT00001353|Interleukin-2|interleukin-2
5863230|NCT00001353|Indinavir|indinavir
5863245|NCT00001347|Linkage Analysis|linkage analysis
5863246|NCT00001347|Genomic DNA|genomic dna
5863247|NCT00001347|Pedigree Analysis|pedigree analysis
5863248|NCT00001347|Usher Syndrome|usher syndrome
5863249|NCT00001347|Usher Syndrome Type 1|usher syndrome type 1
5863250|NCT00001347|Usher Syndrome Type 2|usher syndrome type 2
5863251|NCT00001345|Hypercalcemia|hypercalcemia
5863252|NCT00001345|Multiple Endocrine Neoplasia (MEN)|multiple endocrine neoplasia (men)
5863253|NCT00001345|Familial Hypocalciuric Hypercalcemia|familial hypocalciuric hypercalcemia
5863254|NCT00001345|Hyperparathyroidism|hyperparathyroidism
5863255|NCT00001345|Linkage Analysis|linkage analysis
5863256|NCT00001343|Turner's Syndrome|turner's syndrome
5863257|NCT00001343|Short Stature|short stature
5863258|NCT00001343|Cognitive Function|cognitive function
5863259|NCT00001343|Sex Steroids|sex steroids
5863260|NCT00001343|Turner Syndrome|turner syndrome
5863262|NCT00001339|Multidrug Resistance|multidrug resistance
5863263|NCT00001339|Reversal of Drug Resistance|reversal of drug resistance
5863264|NCT00001339|P-Glycoprotein|p-glycoprotein
5863265|NCT00001339|MDR-1|mdr-1
5863271|NCT00001336|Transplantation|transplantation
5863272|NCT00001336|Cancer|cancer
5863273|NCT00001336|Cellular Immunity|cellular immunity
5863274|NCT00001336|Stem Cell Function|stem cell function
5863275|NCT00001336|Immunodeficiency|immunodeficiency
5863276|NCT00001335|Peripheral Stem Cell Transfusion|peripheral stem cell transfusion
5863277|NCT00001335|Up-Front Phase II Window|up-front phase ii window
5863278|NCT00001335|Dose-Intensive Vincristine|dose-intensive vincristine
5863279|NCT00001335|Dose-Intensive Doxorubicin|dose-intensive doxorubicin
5863280|NCT00001335|Dose-Intensive Cyclophosphamide|dose-intensive cyclophosphamide
5863281|NCT00001335|ADR-529 for Cardioprotection|adr-529 for cardioprotection
5863282|NCT00001335|BID Radiation Therapy for Local Control|bid radiation therapy for local control
5863283|NCT00001331|Myopathy|myopathy
5863284|NCT00001331|Phosphofructokinase|phosphofructokinase
5863285|NCT00001331|Acid Maltase|acid maltase
5863286|NCT00001331|Pompe|pompe
5863287|NCT00001331|Muscle Diseases|muscle diseases
5863288|NCT00001331|Genetic Muscle Diseases|genetic muscle diseases
5863289|NCT00001329|Yohimbine|yohimbine
5863290|NCT00001329|Catecholamines|catecholamines
5863291|NCT00001329|Sympathoadrenal Response|sympathoadrenal response
5863292|NCT00001329|Sympathetic Nervous System|sympathetic nervous system
5863293|NCT00001329|Stress|stress
5863294|NCT00001329|Hypertension|hypertension
5863295|NCT00001329|Autonomic Failure|autonomic failure
5863296|NCT00001328|Cancer|cancer
5863297|NCT00001328|Gene Transfer|gene transfer
5863315|NCT00001325|Positron|positron
5863316|NCT00001325|Tomography|tomography
5863317|NCT00001325|Seizures|seizures
5863318|NCT00001325|Epileptic Focus|epileptic focus
5863319|NCT00001325|Electroencephalography|electroencephalography
5863320|NCT00001325|Metabolism|metabolism
5863323|NCT00001325|Positron Emission Tomography|positron emission tomography
5863324|NCT00001325|Lennox Gastaut Syndrome|lennox gastaut syndrome
5863325|NCT00001323|Cognition|cognition
5863326|NCT00001323|Neuropsychology|neuropsychology
5863327|NCT00001323|Neuropsychological Tests|neuropsychological tests
5863328|NCT00001323|Neurological Exam|neurological exam
5863329|NCT00001323|Psychiatric|psychiatric
5863330|NCT00001323|Attention|attention
5863331|NCT00001323|Schizophrenic|schizophrenic
5863332|NCT00001323|Schizoaffective|schizoaffective
5863333|NCT00001323|Working Memory|working memory
5863334|NCT00001323|Memory|memory
5858584|NCT00011843|Mutation Screening|mutation screening
5863345|NCT00001320|Parkinson's Disease|parkinson's disease
5863346|NCT00001320|Schizophrenia|schizophrenia
5863347|NCT00001320|Dopamine D2/D3 receptors|dopamine d2/d3 receptors
5863348|NCT00001320|Brain Imaging|brain imaging
5863349|NCT00001320|SPECT|spect
5863350|NCT00001320|Equilibrium|equilibrium
5863351|NCT00001320|Brain Scan|brain scan
5863352|NCT00001320|Brain Research|brain research
5863353|NCT00001320|Brain Disorders|brain disorders
5863354|NCT00001320|Schizoaffective Disorder|schizoaffective disorder
5863355|NCT00001320|Normal Volunteer|normal volunteer
5863356|NCT00001319|HIV Negative|hiv negative
5863357|NCT00001319|CD4 Deficiency|cd4 deficiency
5863358|NCT00001319|Retrovirus|retrovirus
5863364|NCT00001313|Cardiac Diagnosis|cardiac diagnosis
5863365|NCT00001313|Chest Pain|chest pain
5863366|NCT00001313|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5863367|NCT00001313|Coronary Artery Disease|coronary artery disease
5863368|NCT00001313|Microvascular Angina|microvascular angina
5863369|NCT00001313|Cardiac Investigation|cardiac investigation
5863370|NCT00001313|Follow-up|follow-up
5863371|NCT00001313|Heart Disease|heart disease
5863372|NCT00001310|Retinal Disease|retinal disease
5863373|NCT00001310|Diabetic Retinopathy|diabetic retinopathy
5863375|NCT00001310|Age-Related Macular Degeneration|age-related macular degeneration
5863376|NCT00001310|Corneal Disease|corneal disease
5863377|NCT00001310|Ocular Disease|ocular disease
5863381|NCT00001308|Stuttering|stuttering
5863382|NCT00001308|Tourette's Syndrome|tourette's syndrome
5863383|NCT00001308|Spasmodic Dysphonia|spasmodic dysphonia
5863384|NCT00001308|Dysarthria|dysarthria
5863385|NCT00001308|Parkinson's Disease|parkinson's disease
5863386|NCT00001308|Verbal Dyspraxia|verbal dyspraxia
5863387|NCT00001308|Aphasia|aphasia
5863388|NCT00001308|Speech|speech
5863389|NCT00001308|Motor Control|motor control
5863392|NCT00001307|Positron Emission|positron emission
5863393|NCT00001307|Functional Brain Imaging|functional brain imaging
5863394|NCT00001307|Allodynia|allodynia
5863395|NCT00001307|Thalamus|thalamus
5863396|NCT00001307|Somatosensory Cortex|somatosensory cortex
5863397|NCT00001307|Reflex Sympathetic Dystrophy|reflex sympathetic dystrophy
5863398|NCT00001307|Normal Volunteer|normal volunteer
5863399|NCT00001307|Chronic Pain|chronic pain
5863400|NCT00001306|Infertility|infertility
5863415|NCT00001304|Calcium Metabolism|calcium metabolism
5863416|NCT00001304|PTH 1-34|pth 1-34
5863418|NCT00001303|Hemodynamics|hemodynamics
5863419|NCT00001303|Lung Permeability|lung permeability
5863420|NCT00001303|Endotoxin Tolerance|endotoxin tolerance
5863421|NCT00001303|Bronchoscopy|bronchoscopy
5863422|NCT00001303|Human Recombinant Interleukin-1 Receptor|human recombinant interleukin-1 receptor
5863423|NCT00001303|Normal Volunteer|normal volunteer
5863424|NCT00001302|Vinblastine|vinblastine
5863425|NCT00001302|Multidrug Resistance|multidrug resistance
5863426|NCT00001302|Resistance Reversal|resistance reversal
5863427|NCT00001302|Pgp Blocker|pgp blocker
5863428|NCT00001302|Pharmacokinetics|pharmacokinetics
5863429|NCT00001302|Cyclosporine|cyclosporine
5863430|NCT00001302|Drug Interactions|drug interactions
5863431|NCT00001295|Follow-Up|follow-up
5863432|NCT00001295|Treatment|treatment
5863433|NCT00001294|Genetic Linkage|genetic linkage
5863434|NCT00001294|Sex Behavior|sex behavior
5863435|NCT00001294|AIDS|aids
5863436|NCT00001294|Alcohol Dependence|alcohol dependence
5863437|NCT00001294|HLA System|hla system
5863438|NCT00001294|Cancer|cancer
5863439|NCT00001289|Enzyme Replacement|enzyme replacement
5863440|NCT00001289|Type 3 Gaucher's Disease|type 3 gaucher's disease
5863441|NCT00001289|Lysosomal Storage|lysosomal storage
5863442|NCT00001289|Supranuclear Gaze Palsy|supranuclear gaze palsy
5863443|NCT00001289|Seizures|seizures
5863444|NCT00001289|Mental Retardation|mental retardation
5863445|NCT00001289|Gaucher Disease|gaucher disease
5863446|NCT00001288|Positron Emission Tomography|positron emission tomography
5863447|NCT00001288|Epilepsy|epilepsy
5863448|NCT00001288|Stroke|stroke
5863449|NCT00001284|Cognition|cognition
5863450|NCT00001284|Schizophrenia|schizophrenia
5863451|NCT00001284|Magnetic Resonance Imaging|magnetic resonance imaging
5863452|NCT00001284|Magnetic Resonance Spectroscopy|magnetic resonance spectroscopy
5863453|NCT00001284|Dopaminergic Mechanisms|dopaminergic mechanisms
5863454|NCT00001282|HIV|hiv
5863455|NCT00001282|Immunomodulator|immunomodulator
5863456|NCT00001282|Anti-Viral|anti-viral
5863465|NCT00001275|Menopause|menopause
5863466|NCT00001275|Estrogen|estrogen
5863470|NCT00001275|Hypergonadotropic Hypogonadism|hypergonadotropic hypogonadism
5863471|NCT00001275|Young Women|young women
5863472|NCT00001275|Gonadal Steroid Deficiency|gonadal steroid deficiency
5863473|NCT00001275|Mineralocorticoid Deficiency|mineralocorticoid deficiency
5863474|NCT00001275|Premature Ovarian Failure|premature ovarian failure
5863475|NCT00001275|POF|pof
5863476|NCT00001266|Bayesian|bayesian
5863477|NCT00001266|Hydroxy-Flutamide|hydroxy-flutamide
5863478|NCT00001266|Combined Androgen Ablation|combined androgen ablation
5863479|NCT00001266|Prostate Specific Antigen|prostate specific antigen
5863486|NCT00001262|Menkes|menkes
5863487|NCT00001262|Copper|copper
5863488|NCT00001262|X-Linked|x-linked
5863489|NCT00001262|Neurodegeneration|neurodegeneration
5863490|NCT00001262|ATP7A|atp7a
5863491|NCT00001261|Polymyositis/Dermatomyositis|polymyositis/dermatomyositis
5863492|NCT00001261|Muscle Immunopathology|muscle immunopathology
5863493|NCT00001261|Intravenous High-Dose Immunoglobulin|intravenous high-dose immunoglobulin
5863494|NCT00001261|Inclusion Body Myositis|inclusion body myositis
5863495|NCT00001260|Schizophrenia|schizophrenia
5863496|NCT00001260|Neuropathology|neuropathology
5863497|NCT00001260|Neurochemistry|neurochemistry
5863498|NCT00001260|Substance Abuse|substance abuse
5863499|NCT00001260|Bipolar Disorder|bipolar disorder
5863500|NCT00001260|Aging|aging
5863501|NCT00001260|Normal Development|normal development
5863502|NCT00001260|Depression|depression
5863503|NCT00001260|Anxiety Disorders|anxiety disorders
5863552|NCT00001250|Neoadjuvant Chemotherapy|neoadjuvant chemotherapy
5863553|NCT00001250|Dose Intense Chemotherapy|dose intense chemotherapy
5863554|NCT00001250|Stage II Breast Cancer|stage ii breast cancer
5863555|NCT00001250|Early Stage Breast Cancer|early stage breast cancer
5863583|NCT00001245|Strongyloidiasis|strongyloidiasis
5863584|NCT00001245|Immediate Hypersensitivity Skin Test|immediate hypersensitivity skin test
5863585|NCT00001245|IgE|ige
5863650|NCT00001224|Ocular Inflammatory Disease|ocular inflammatory disease
5863651|NCT00001224|Cataracts|cataracts
5863652|NCT00001224|Vitrectomy|vitrectomy
5863653|NCT00001224|Extracapsular|extracapsular
5863654|NCT00001224|Cataract Surgery|cataract surgery
5863655|NCT00001224|Uveitis|uveitis
5863656|NCT00001224|Lenticular Opacity|lenticular opacity
5863657|NCT00001224|Vitreal Opacity|vitreal opacity
5863661|NCT00001221|Growth|growth
5863662|NCT00001221|Gonadal Dysgenesis|gonadal dysgenesis
5863663|NCT00001221|Estrogen|estrogen
5863664|NCT00001221|Somatotropin|somatotropin
5863665|NCT00001221|Turner's Syndrome|turner's syndrome
5863666|NCT00001221|Growth Hormone|growth hormone
5863668|NCT00001220|Neuromotor Dysfunction|neuromotor dysfunction
5863669|NCT00001220|Aspiration|aspiration
5863670|NCT00001220|Imaging|imaging
5863685|NCT00001213|Cysteamine Eye Drops|cysteamine eye drops
5863686|NCT00001213|Nephropathic Cystinosis|nephropathic cystinosis
5863687|NCT00001213|Corneal Crystals|corneal crystals
5863688|NCT00001213|Benzalkonium|benzalkonium
5863689|NCT00001213|Toxicity|toxicity
5863690|NCT00001213|Efficacy|efficacy
5863691|NCT00001213|Cystinosis|cystinosis
5863692|NCT00001212|Systemic Lupus Erythematosus|systemic lupus erythematosus
5863693|NCT00001212|Nephrotic Syndrome|nephrotic syndrome
5863694|NCT00001212|Immunosuppressive Drugs|immunosuppressive drugs
5863695|NCT00001212|Prednisone|prednisone
5863696|NCT00001212|Methylprednisolone|methylprednisolone
5863697|NCT00001212|Cyclophosphamide|cyclophosphamide
5863698|NCT00001212|Cyclosporine|cyclosporine
5863699|NCT00001212|Cyclosporin A|cyclosporin a
5863720|NCT00001205|Tapeworm|tapeworm
5863724|NCT00001203|Desferal|desferal
5863725|NCT00001203|Thalassemia|thalassemia
5863726|NCT00001203|Liver Iron Concentration|liver iron concentration
5863727|NCT00001203|Endocrine Evaluation|endocrine evaluation
5863728|NCT00001203|Diabetes Mellitus|diabetes mellitus
5863729|NCT00001203|Cardiac Disease|cardiac disease
5863730|NCT00001203|Acquired Anemia|acquired anemia
5863731|NCT00001202|Luteinizing Hormone|luteinizing hormone
5863732|NCT00001202|High Serum Testosterone Levels|high serum testosterone levels
5863733|NCT00001202|Low Baseline Gonadotropin|low baseline gonadotropin
5863735|NCT00001202|Precocious Puberty|precocious puberty
5863736|NCT00001202|Familial Isosexual Precocious Puberty|familial isosexual precocious puberty
5863737|NCT00001201|Nerve Conduction Studies|nerve conduction studies
5863739|NCT00001201|Normal Volunteer|normal volunteer
5863740|NCT00001201|Electrophysiology|electrophysiology
5863741|NCT00001201|Peripheral Neuropathies|peripheral neuropathies
5863742|NCT00001201|Myopathies|myopathies
5863743|NCT00001198|Schizophrenia|schizophrenia
5863744|NCT00001198|Observational|observational
5863745|NCT00001197|Gene Expression Therapy|gene expression therapy
5863746|NCT00001197|Gamma Globin Gene|gamma globin gene
5863747|NCT00001197|Hemoglobin Switching|hemoglobin switching
5863748|NCT00001197|Bone Marrow|bone marrow
5863749|NCT00001197|Sickle Cell Anemia|sickle cell anemia
5863750|NCT00001196|Salivary Function|salivary function
5863751|NCT00001196|Salivary Gland|salivary gland
5863752|NCT00001196|Sjogren's Syndrome|sjogren's syndrome
5863753|NCT00001196|Dry Mouth|dry mouth
5863754|NCT00001195|Development|development
5863758|NCT00001195|Eating Behavior|eating behavior
5863759|NCT00001195|Body Composition|body composition
5863760|NCT00001195|Normal Volunteer|normal volunteer
5863761|NCT00001192|Executive Functions|executive functions
5863762|NCT00001192|Language|language
5863763|NCT00001192|Attention|attention
5863764|NCT00001192|Visual-Spatial Ability|visual-spatial ability
5863765|NCT00001192|Memory|memory
5863766|NCT00001192|Motor Behavior|motor behavior
5863767|NCT00001192|Intelligence|intelligence
5863768|NCT00001192|Personality|personality
5863769|NCT00001192|Visual and Auditory Functioning|visual and auditory functioning
5863770|NCT00001192|Hand and Eye Dominance|hand and eye dominance
5863771|NCT00001192|Normal Volunteer|normal volunteer
5863772|NCT00001192|Neuropsychiatric Disorders|neuropsychiatric disorders
5863773|NCT00001191|Zollinger-Ellison Syndrome|zollinger-ellison syndrome
5863774|NCT00001191|Gastrinoma|gastrinoma
5863775|NCT00001191|Acid Hypersecretion|acid hypersecretion
5863776|NCT00001191|H+-K+ ATPase Inhibitor|h+-k+ atpase inhibitor
5863782|NCT00001185|Poliomyelitis|poliomyelitis
5863783|NCT00001185|Amyotrophic Lateral Sclerosis|amyotrophic lateral sclerosis
5858544|NCT00012558|Mania|mania
5863784|NCT00001185|Motor Neurons|motor neurons
5863785|NCT00001185|Late Viral Infection|late viral infection
5863786|NCT00001185|Motor Neuron Firing|motor neuron firing
5863787|NCT00001185|Immune Defects|immune defects
5863788|NCT00001185|Post-polio Syndrome|post-polio syndrome
5863789|NCT00001185|Post-polio Motor Neuron Disease|post-polio motor neuron disease
5863795|NCT00001183|Computed Tomography|computed tomography
5863798|NCT00001183|Cardiopulmonary Exercise Testing|cardiopulmonary exercise testing
5863799|NCT00001183|Allergen Skin Testing|allergen skin testing
5863800|NCT00001182|General Dental|general dental
5863801|NCT00001182|Diagnostic|diagnostic
5863802|NCT00001182|Therapeutic|therapeutic
5863803|NCT00001181|McCune-Albright Syndrome|mccune-albright syndrome
5863804|NCT00001181|Aromatase Inhibitor|aromatase inhibitor
5863805|NCT00001181|Teslac|teslac
5863806|NCT00001180|Corticotropin Releasing Hormone|corticotropin releasing hormone
5863823|NCT00001177|Depression|depression
5863824|NCT00001177|Cognition|cognition
5863825|NCT00001177|Menstrual|menstrual
5863826|NCT00001177|Neuroendocrine|neuroendocrine
5863827|NCT00001177|Genetics|genetics
5863828|NCT00001177|PMDD|pmdd
5863829|NCT00001177|PMS Premenstrual Syndrome|pms premenstrual syndrome
5863830|NCT00001177|MRMD Menstrually Related Mood Disorder|mrmd menstrually related mood disorder
5863831|NCT00001176|Adrenergic Nervous System|adrenergic nervous system
5863832|NCT00001176|Dopaminergic Nervous System|dopaminergic nervous system
5863833|NCT00001176|Salt-Sensitive Hypertension|salt-sensitive hypertension
5863834|NCT00001176|Hypertension|hypertension
5863835|NCT00001176|Primary Aldosteronism|primary aldosteronism
5863843|NCT00001172|Vision|vision
5863844|NCT00001172|Eye Movement|eye movement
5863845|NCT00001172|Perception|perception
5863846|NCT00001172|Healthy Volunteer|healthy volunteer
5863847|NCT00001171|Brain Tumors|brain tumors
5863848|NCT00001171|Glioma|glioma
5863849|NCT00001171|Glioblastoma Multiforme|glioblastoma multiforme
5863850|NCT00001171|Pituitary Adenoma|pituitary adenoma
5863851|NCT00001170|Parental Psychopathology|parental psychopathology
5863852|NCT00001170|Child Rearing|child rearing
5863853|NCT00001170|Depression|depression
5863854|NCT00001170|Bipolar Affective Disorders|bipolar affective disorders
5863855|NCT00001170|Manic-Depression|manic-depression
5863856|NCT00001170|Social-Emotional Development|social-emotional development
5863857|NCT00001170|Cognitive Development|cognitive development
5863858|NCT00001170|Child Psychopathology|child psychopathology
5863859|NCT00001170|Affective Disorder|affective disorder
5863860|NCT00001170|Children at Risk|children at risk
5863872|NCT00001167|Dysphagia|dysphagia
5863873|NCT00001167|Dysarthria|dysarthria
5863874|NCT00001167|Tongue Motion|tongue motion
5863875|NCT00001167|Xerostomia|xerostomia
5863876|NCT00001167|Swallowing|swallowing
5863877|NCT00001167|Speech|speech
5863878|NCT00001167|Polymyositis|polymyositis
5863879|NCT00001167|Speech Disorders|speech disorders
5863880|NCT00001167|Oral-Facial Paralysis|oral-facial paralysis
5863881|NCT00001167|Ultrasound|ultrasound
5863882|NCT00001166|Hyperornithinemia|hyperornithinemia
5863883|NCT00001166|Ornithine-Aminotransferase (OAT)|ornithine-aminotransferase (oat)
5863884|NCT00001166|Tissue Culture|tissue culture
5863885|NCT00001166|Pyridoxine Hydrochloride|pyridoxine hydrochloride
5863886|NCT00001166|Pyridoxal Phosphate|pyridoxal phosphate
5863887|NCT00001166|Arginine|arginine
5863888|NCT00001166|Skin Fibroblast|skin fibroblast
5863889|NCT00001166|Gyrate Atrophy|gyrate atrophy
5863890|NCT00001166|Autosomal Recessive Retinitis Pigmentosa|autosomal recessive retinitis pigmentosa
5863891|NCT00001166|Bietti's Crystalline Retinopathy|bietti's crystalline retinopathy
5863892|NCT00001166|Chorioretinal Degeneration|chorioretinal degeneration
5863893|NCT00001165|Gastrinoma|gastrinoma
5863894|NCT00001165|Acid Secretion|acid secretion
5863895|NCT00001165|Toxicity|toxicity
5863896|NCT00001163|Cancer|cancer
5863897|NCT00001163|Genes/Genetics|genes/genetics
5863898|NCT00001163|Hereditary Neoplasms|hereditary neoplasms
5863899|NCT00001163|Environment|environment
5863902|NCT00001162|Cryptosporidium|cryptosporidium
5863903|NCT00001162|Hookworms|hookworms
5863904|NCT00001162|Trichuris|trichuris
5863917|NCT00001162|Opisthorchis|opisthorchis
5863918|NCT00001162|Paragonimiasis|paragonimiasis
5863919|NCT00001162|Echinococcus|echinococcus
5863920|NCT00001161|Irido Corneal Angle|irido corneal angle
5863921|NCT00001161|Mesothelium|mesothelium
5863922|NCT00001161|Congenital Anomalies|congenital anomalies
5863923|NCT00001161|Neural Crest|neural crest
5863924|NCT00001161|Increased Intraocular Pressure|increased intraocular pressure
5863925|NCT00001161|Glaucoma|glaucoma
5863926|NCT00001161|Axenfeld's Syndrome|axenfeld's syndrome
5863927|NCT00001161|Rieger's Anomaly|rieger's anomaly
5863928|NCT00001161|Peter's Anomaly|peter's anomaly
5863929|NCT00001161|Iridocorneal Endothelial Syndrome|iridocorneal endothelial syndrome
5863930|NCT00001161|Aniridia|aniridia
5863931|NCT00001161|Pigment Dispersion Syndrome|pigment dispersion syndrome
5863932|NCT00001161|Megalocornea|megalocornea
5863940|NCT00001156|Immunogenetics|immunogenetics
5863941|NCT00001156|Tropical Spastic Paraplegia|tropical spastic paraplegia
5863942|NCT00001156|Twins|twins
5863943|NCT00001156|Epstein-Barr Virus|epstein-barr virus
5863944|NCT00001156|HTLV-I|htlv-i
5863945|NCT00001156|Vasculitis|vasculitis
5863946|NCT00001156|Cerebrospinal Fluid|cerebrospinal fluid
5863947|NCT00001156|Immunity to Viruses|immunity to viruses
5863948|NCT00001156|Multiple Sclerosis|multiple sclerosis
5863949|NCT00001156|Magnetic Resonance Imaging|magnetic resonance imaging
5863950|NCT00001155|Vasculitis|vasculitis
5863951|NCT00001155|Prednisone|prednisone
5863952|NCT00001155|Granuloma|granuloma
5863991|NCT00001146|Eicosapentaenoic Ethyl Ester|eicosapentaenoic ethyl ester
5863992|NCT00001146|Life Chart Methodology|life chart methodology
5863994|NCT00001146|Omega-3 Fatty Acid|omega-3 fatty acid
5863995|NCT00001146|Rapid Cycling|rapid cycling
5863996|NCT00001146|Treatment|treatment
5863997|NCT00001145|Primary Immunodeficiency|primary immunodeficiency
5863998|NCT00001145|Gamma Globulin (IgG) Immunization|gamma globulin (igg) immunization
5864000|NCT00001145|Phi-X 174|phi-x 174
5864001|NCT00001145|X-linked HyperIgM Syndrome|x-linked hyperigm syndrome
5864002|NCT00001144|Peripheral Blood Stem Cells|peripheral blood stem cells
5864004|NCT00001144|Graft vs. Host Disease|graft vs. host disease
5864005|NCT00001144|Graft-Versus-Leukemia|graft-versus-leukemia
5864006|NCT00001144|Graft-Versus-Tumor/Melanoma|graft-versus-tumor/melanoma
5864007|NCT00001144|Chronic Myelogenous Leukemia|chronic myelogenous leukemia
5864008|NCT00001143|Eye Movements|eye movements
5864009|NCT00001143|Strabismus|strabismus
5864010|NCT00001143|Infants|infants
5864011|NCT00001143|Development|development
5864012|NCT00001143|Ocular Motor System|ocular motor system
5864013|NCT00000426|Calcium deficiency|calcium deficiency
5864014|NCT00000426|Dietary calcium|dietary calcium
5864015|NCT00000426|Dietary protein|dietary protein
5864016|NCT00000426|Osteoporosis|osteoporosis
5864017|NCT00000426|Calcium supplement|calcium supplement
5864018|NCT00000426|Bone density|bone density
5864019|NCT00000426|Bone mass|bone mass
5864020|NCT00000426|Bone mass accumulation|bone mass accumulation
5864021|NCT00000425|Osteoarthritis|osteoarthritis
5864022|NCT00000425|Skeletal disorder|skeletal disorder
5864023|NCT00000425|Chemotherapy|chemotherapy
5864024|NCT00000425|Nonsteroidal anti-inflammatory drugs (NSAIDs)|nonsteroidal anti-inflammatory drugs (nsaids)
5864025|NCT00000425|Arthroplasty|arthroplasty
5864026|NCT00000425|Cartilage metabolism|cartilage metabolism
5864027|NCT00000425|Hip|hip
5864029|NCT00000425|Outcomes research|outcomes research
5864030|NCT00000424|Osteoarthritis (OA)|osteoarthritis (oa)
5864031|NCT00000424|Knee|knee
5864032|NCT00000424|Sham lavage|sham lavage
5864033|NCT00000424|Tidal lavage|tidal lavage
5864034|NCT00000424|Lavage therapy|lavage therapy
5864035|NCT00000424|Nonsteroidal anti-inflammatory drug (NSAID)|nonsteroidal anti-inflammatory drug (nsaid)
5864036|NCT00000424|Placebo|placebo
5864037|NCT00000424|Radiography|radiography
5864038|NCT00000424|Human therapy evaluation|human therapy evaluation
5864039|NCT00000424|WOMAC|womac
5864040|NCT00000423|Fibromyalgia|fibromyalgia
5864041|NCT00000423|Health education|health education
5864042|NCT00000423|Program evaluation|program evaluation
5864043|NCT00000423|Social support|social support
5864044|NCT00000423|Managed care|managed care
5864045|NCT00000423|Quality of well-being|quality of well-being
5864046|NCT00000422|Fibromyalgia Syndrome (FMS)|fibromyalgia syndrome (fms)
5864047|NCT00000422|Physical therapy|physical therapy
5864048|NCT00000422|Psychotherapy|psychotherapy
5864049|NCT00000422|Group counseling|group counseling
5864050|NCT00000422|Human therapy relations|human therapy relations
5864051|NCT00000422|Interpersonal relations|interpersonal relations
5864052|NCT00000422|Chronic pain|chronic pain
5864053|NCT00000422|Cognition|cognition
5864054|NCT00000422|Emotion|emotion
5864055|NCT00000422|Memory|memory
5864056|NCT00000422|Musculoskeletal disorder|musculoskeletal disorder
5864057|NCT00000422|Psychological stressor|psychological stressor
5864058|NCT00000422|Psychological adaptation|psychological adaptation
5864059|NCT00000422|Outcomes research|outcomes research
5864060|NCT00000421|SLE|sle
5864061|NCT00000421|Lupus|lupus
5864062|NCT00000421|Anti-double-stranded DNA antibody|anti-double-stranded dna antibody
5864063|NCT00000421|Corticosteroid treatment|corticosteroid treatment
5864064|NCT00000421|Hormone therapy|hormone therapy
5864065|NCT00000421|Complement|complement
5864066|NCT00000421|Hypertension|hypertension
5864067|NCT00000421|Estrogen|estrogen
5864068|NCT00000421|SELENA|selena
5864069|NCT00000420|SLE|sle
5864070|NCT00000420|SELENA|selena
5864071|NCT00000420|Oral contraceptives|oral contraceptives
5864072|NCT00000420|The pill|the pill
5864073|NCT00000420|Birth control|birth control
5864074|NCT00000420|Condom|condom
5864075|NCT00000420|Diaphragm|diaphragm
5864076|NCT00000420|Estrogen|estrogen
5864077|NCT00000420|Lupus|lupus
5864078|NCT00000420|Placebo|placebo
5864079|NCT00000419|SLE|sle
5864080|NCT00000419|SELENA|selena
5864081|NCT00000419|Estrogen Replacement Therapy (ERT)|estrogen replacement therapy (ert)
5858734|NCT00011336|SCI|sci
5864082|NCT00000419|Postmenopause|postmenopause
5864083|NCT00000419|Osteoporosis|osteoporosis
5864084|NCT00000419|Estrogens|estrogens
5864085|NCT00000419|Steroids|steroids
5864086|NCT00000419|Progestin|progestin
5864087|NCT00000419|Placebo|placebo
5864088|NCT00000418|OA|oa
5864089|NCT00000418|Patient education|patient education
5864090|NCT00000418|Acute low back pain (ALBP)|acute low back pain (albp)
5864091|NCT00000418|Social support systems|social support systems
5864092|NCT00000417|SLE|sle
5864093|NCT00000417|Lupus|lupus
5864094|NCT00000417|Educational intervention|educational intervention
5864095|NCT00000417|Health education|health education
5864102|NCT00000416|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
5864103|NCT00000416|Job retention services|job retention services
5864104|NCT00000416|Work limitations|work limitations
5864105|NCT00000416|Work instability|work instability
5864106|NCT00000415|Calcium|calcium
5864107|NCT00000415|Physical activity|physical activity
5864109|NCT00000415|Bone mass accretion|bone mass accretion
5864110|NCT00000415|Bone mineral density (BMD)|bone mineral density (bmd)
5864111|NCT00000415|Bone response to activity and calcium supplements|bone response to activity and calcium supplements
5864112|NCT00000415|Placebo|placebo
5864113|NCT00000415|Bone growth|bone growth
5864114|NCT00000414|Rheumatoid arthritis (RA)|rheumatoid arthritis (ra)
5864115|NCT00000414|Osteoarthritis (OA)|osteoarthritis (oa)
5864116|NCT00000414|Arthritis education|arthritis education
5864117|NCT00000414|Health care service evaluation|health care service evaluation
5864118|NCT00000414|Outcomes research|outcomes research
5864119|NCT00000414|Arthritis Self-Management Program (ASMP)|arthritis self-management program (asmp)
5864120|NCT00000414|Self-Managed Arthritis Relief Therapy (SMART) Program|self-managed arthritis relief therapy (smart) program
5864121|NCT00000413|Osteoporosis prevention|osteoporosis prevention
5864122|NCT00000413|Behavioral/educational intervention|behavioral/educational intervention
5864123|NCT00000413|Preadolescent|preadolescent
5864124|NCT00000413|Calcium|calcium
5864125|NCT00000413|Exercise|exercise
5864126|NCT00000413|Peak bone mass|peak bone mass
5864127|NCT00000413|Bone density|bone density
5864128|NCT00000412|Osteoporosis|osteoporosis
5864129|NCT00000412|Osteopenia|osteopenia
5864130|NCT00000412|Heart transplant|heart transplant
5864131|NCT00000412|Bone fracture|bone fracture
5864132|NCT00000412|Bone density|bone density
5864133|NCT00000412|Dual energy x-ray absorptiometry|dual energy x-ray absorptiometry
5864134|NCT00000411|Spinal stenosis (SpS)|spinal stenosis (sps)
5864135|NCT00000411|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5864136|NCT00000411|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
5864137|NCT00000411|Low back pain (LBP)|low back pain (lbp)
5864138|NCT00000411|Surgical therapy|surgical therapy
5864139|NCT00000411|Nonsurgical therapy|nonsurgical therapy
5864140|NCT00000411|Randomized study|randomized study
5864141|NCT00000411|Multicenter|multicenter
5864142|NCT00000411|MRI|mri
5864143|NCT00000410|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5864144|NCT00000410|Stenosis with degenerative spondylolisthesis (DS)|stenosis with degenerative spondylolisthesis (ds)
5864145|NCT00000410|Spinal stenosis (SpS)|spinal stenosis (sps)
5864146|NCT00000410|Low back pain (LBP)|low back pain (lbp)
5864147|NCT00000410|Leg pain|leg pain
5864148|NCT00000410|Surgical therapy|surgical therapy
5864149|NCT00000410|Non-surgical therapy|non-surgical therapy
5864150|NCT00000410|Randomized study|randomized study
5864151|NCT00000410|Multicenter|multicenter
5864152|NCT00000410|MRI|mri
5864153|NCT00000409|Intervertebral disc herniation (IDH)|intervertebral disc herniation (idh)
5864154|NCT00000409|Degenerative spondylolisthesis (DS)|degenerative spondylolisthesis (ds)
5864155|NCT00000409|Spinal stenosis (SpS)|spinal stenosis (sps)
5864156|NCT00000409|Low back pain (LBP)|low back pain (lbp)
5864157|NCT00000409|Leg pain|leg pain
5864158|NCT00000409|Surgical therapy|surgical therapy
5864159|NCT00000409|Randomized study|randomized study
5864160|NCT00000409|Multicenter|multicenter
5864161|NCT00000409|MRI|mri
5864162|NCT00000409|Nonsurgical therapy|nonsurgical therapy
5864163|NCT00000408|Health education|health education
5864164|NCT00000408|Back injury|back injury
5864165|NCT00000408|Chronic pain|chronic pain
5864166|NCT00000408|Education/evaluation planning|education/evaluation planning
5864167|NCT00000408|Outcomes research|outcomes research
5864168|NCT00000407|Arthritis and related musculoskeletal disorders (ARMD)|arthritis and related musculoskeletal disorders (armd)
5864169|NCT00000407|Vocational rehabilitation (VR)|vocational rehabilitation (vr)
5864170|NCT00000407|Agency enhancement intervention|agency enhancement intervention
5864171|NCT00000407|Health care service evaluation|health care service evaluation
5864172|NCT00000407|Musculoskeletal disability|musculoskeletal disability
5864173|NCT00000407|Return to work|return to work
5864174|NCT00000407|Outcomes research|outcomes research
5864175|NCT00000407|Unemployment|unemployment
5864176|NCT00000407|Work disability|work disability
5864177|NCT00000406|Osteoarthritis (OA)|osteoarthritis (oa)
5864178|NCT00000406|Knee|knee
5864179|NCT00000406|Radiographic OA|radiographic oa
5864180|NCT00000406|Strength training|strength training
5864181|NCT00000406|Physical therapy|physical therapy
5864182|NCT00000406|Exercise|exercise
5864183|NCT00000406|Body composition|body composition
5864184|NCT00000406|Striated muscle|striated muscle
5864185|NCT00000406|Depression|depression
5864186|NCT00000406|Radiographic OA with knee pain|radiographic oa with knee pain
5864187|NCT00000406|Radiographic OA without knee pain|radiographic oa without knee pain
5864188|NCT00000406|Knee pain without radiographic OA|knee pain without radiographic oa
5864189|NCT00000406|Normal elderly (no radiographic OA, no knee pain)|normal elderly (no radiographic oa, no knee pain)
5864190|NCT00000405|Osteoporosis|osteoporosis
5864191|NCT00000405|Bone fractures|bone fractures
5864192|NCT00000405|Bone mass|bone mass
5864193|NCT00000405|Bone mineral density (BMD)|bone mineral density (bmd)
5864196|NCT00000405|Exercise|exercise
5864198|NCT00000405|Spine|spine
5864199|NCT00000405|Middle childhood (6-11)|middle childhood (6-11)
5864200|NCT00000404|Osteoarthritis (OA)|osteoarthritis (oa)
5864203|NCT00000404|Comprehensive care|comprehensive care
5864204|NCT00000403|Osteoarthritis (OA)|osteoarthritis (oa)
5864205|NCT00000403|Knee|knee
5864206|NCT00000403|Doxycycline|doxycycline
5864207|NCT00000403|Skeletal disorder|skeletal disorder
5864208|NCT00000403|Placebo|placebo
5864209|NCT00000403|Urinalysis|urinalysis
5864210|NCT00000403|NSAIDs|nsaids
5864211|NCT00000403|Joint space narrowing (JSN)|joint space narrowing (jsn)
5864212|NCT00000403|WOMAC|womac
5864213|NCT00000402|Osteoporosis|osteoporosis
5864214|NCT00000402|Dietary calcium|dietary calcium
5864215|NCT00000402|Puberty|puberty
5864216|NCT00000402|Bone density|bone density
5864217|NCT00000402|Bone mass|bone mass
5864218|NCT00000402|Primary prevention of osteoporosis|primary prevention of osteoporosis
5864219|NCT00000401|NSAIDs|nsaids
5864220|NCT00000401|Oral Tolerance|oral tolerance
5864221|NCT00000401|Drug Interaction|drug interaction
5864222|NCT00000401|Oral Administration|oral administration
5864223|NCT00000401|Interleukin 10|interleukin 10
5864224|NCT00000401|Collagen|collagen
5864225|NCT00000401|Chemotherapy|chemotherapy
5864226|NCT00000401|Human Therapy Evaluation|human therapy evaluation
5864227|NCT00000401|DMARDs|dmards
5864228|NCT00000401|RA|ra
5864229|NCT00000401|IL-10|il-10
5864230|NCT00000400|Osteoporosis|osteoporosis
5864231|NCT00000400|Bone formation|bone formation
5864232|NCT00000400|Bone resorption|bone resorption
5864233|NCT00000400|Parathyroid hormone (PTH)|parathyroid hormone (pth)
5864234|NCT00000400|Postmenopause|postmenopause
5864235|NCT00000399|Estrogen|estrogen
5864236|NCT00000399|Hormone therapy|hormone therapy
5864237|NCT00000399|Strength training|strength training
5864238|NCT00000399|Exercise|exercise
5864239|NCT00000399|Postmenopause|postmenopause
5864240|NCT00000399|Disorder prevention|disorder prevention
5864241|NCT00000399|Osteoporosis|osteoporosis
5864242|NCT00000399|Bone mineral density|bone mineral density
5864243|NCT00000399|Bone mass|bone mass
5864244|NCT00000399|Cholesterol|cholesterol
5864245|NCT00000399|Body composition|body composition
5864246|NCT00000398|Fibromyalgia|fibromyalgia
5864247|NCT00000398|Pain|pain
5864248|NCT00000398|Coping skills training|coping skills training
5864249|NCT00000398|Physical exercise training|physical exercise training
5864250|NCT00000398|Combined coping skills training and exercise training|combined coping skills training and exercise training
5864251|NCT00000397|Fibromyalgia|fibromyalgia
5864252|NCT00000397|Insomnia|insomnia
5864253|NCT00000397|Cognitive-behavioral therapy (CBT)|cognitive-behavioral therapy (cbt)
5864254|NCT00000397|Behavioral insomnia therapy|behavioral insomnia therapy
5864255|NCT00000396|Arthritis|arthritis
5864256|NCT00000396|Arthritis education|arthritis education
5864257|NCT00000396|African Americans|african americans
5864258|NCT00000396|Self-help|self-help
5864259|NCT00000396|Self-management|self-management
5864260|NCT00000396|Cultural beliefs|cultural beliefs
5864261|NCT00000395|Rheumatoid arthritis|rheumatoid arthritis
5864262|NCT00000395|Lewis rat adjuvant arthritis|lewis rat adjuvant arthritis
5864263|NCT00000395|Antifolate efficacy|antifolate efficacy
5864264|NCT00000395|Autoimmunity|autoimmunity
5864265|NCT00000395|Adenosine metabolism|adenosine metabolism
5864266|NCT00000395|Methotrexate therapy|methotrexate therapy
5864267|NCT00000395|Skeletal disorder|skeletal disorder
5864268|NCT00000395|Dietary supplement|dietary supplement
5864269|NCT00000395|Antiarthritic agent|antiarthritic agent
5864270|NCT00000395|Folic acid|folic acid
5864271|NCT00000394|Carpal tunnel syndrome|carpal tunnel syndrome
5864272|NCT00000394|Acupuncture|acupuncture
5864273|NCT00000394|Median nerve|median nerve
5864274|NCT00000394|Single-blind mute methodology|single-blind mute methodology
5864275|NCT00000104|lead overburden|lead overburden
5864276|NCT00000456|Alcoholism|alcoholism
5864277|NCT00000456|Alcohol Dependence|alcohol dependence
5864278|NCT00000456|Naltrexone|naltrexone
5864279|NCT00000456|Cognitive Behavioral Therapy|cognitive behavioral therapy
5864280|NCT00000451|Alcoholism|alcoholism
5864281|NCT00000451|Alcohol Dependence|alcohol dependence
5864282|NCT00000389|Adolescence|adolescence
5864283|NCT00000389|Anxiety Disorders|anxiety disorders
5864284|NCT00000389|Child|child
5864285|NCT00000389|Female|female
5864286|NCT00000389|Fluvoxamine|fluvoxamine
5864287|NCT00000389|Human|human
5864288|NCT00000389|Male|male
5864289|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864290|NCT00000389|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
5864291|NCT00000389|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
5864535|NCT00000371|Quality of Life|quality of life
5864292|NCT00000389|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5864293|NCT00000388|Attention Deficit Disorder with Hyperactivity|attention deficit disorder with hyperactivity
5864294|NCT00000388|Adolescence|adolescence
5864295|NCT00000388|Child|child
5864296|NCT00000388|Cognition|cognition
5864297|NCT00000388|Combined Modality Therapy|combined modality therapy
5864298|NCT00000388|Female|female
5864299|NCT00000388|Human|human
5864300|NCT00000388|Male|male
5864301|NCT00000388|Peer Group|peer group
5864302|NCT00000388|Risk Factors|risk factors
5864303|NCT00000388|Treatment Outcome|treatment outcome
5864304|NCT00000388|Attention Deficit Disorder with Hyperactivity -- *therapy|attention deficit disorder with hyperactivity -- *therapy
5864305|NCT00000388|Attention Deficit Disorder with Hyperactivity -- drug therapy|attention deficit disorder with hyperactivity -- drug therapy
5864306|NCT00000388|Attention Deficit Disorder with Hyperactivity -- psychology|attention deficit disorder with hyperactivity -- psychology
5864307|NCT00000387|Adolescence|adolescence
5864308|NCT00000387|Family|family
5864309|NCT00000387|Female|female
5864310|NCT00000387|Human|human
5864311|NCT00000387|Male|male
5864312|NCT00000387|Schizophrenia|schizophrenia
5864313|NCT00000387|Self Care|self care
5864314|NCT00000387|Community Health Services|community health services
5864315|NCT00000386|Adolescence|adolescence
5864316|NCT00000386|Child|child
5864317|NCT00000386|Comparative Study|comparative study
5864318|NCT00000386|Family|family
5864319|NCT00000386|Female|female
5864320|NCT00000386|Human|human
5864321|NCT00000386|Male|male
5864322|NCT00000386|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5864323|NCT00000386|Relaxation Techniques|relaxation techniques
5864324|NCT00000386|Obsessive-Compulsive Disorder -- *therapy|obsessive-compulsive disorder -- *therapy
5864325|NCT00000385|Aggressive conduct disorder|aggressive conduct disorder
5864326|NCT00000385|Adolescence|adolescence
5864328|NCT00000385|Conduct Disorder|conduct disorder
5864329|NCT00000385|Female|female
5864330|NCT00000385|Lithium|lithium
5864331|NCT00000385|Male|male
5864332|NCT00000385|Placebos|placebos
5864333|NCT00000385|Conduct Disorder -- *drug therapy|conduct disorder -- *drug therapy
5864334|NCT00000385|Lithium -- *therapeutic use|lithium -- *therapeutic use
5864335|NCT00000384|Adolescence|adolescence
5864336|NCT00000384|Child|child
5864337|NCT00000384|Cognitive Therapy|cognitive therapy
5864338|NCT00000384|Combined Modality Therapy|combined modality therapy
5864339|NCT00000384|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5864340|NCT00000384|Placebos|placebos
5864341|NCT00000384|Sertraline|sertraline
5864342|NCT00000384|Patient Education|patient education
5864343|NCT00000384|Psychotherapy|psychotherapy
5864344|NCT00000383|Adolescence|adolescence
5864345|NCT00000383|Child|child
5864346|NCT00000383|Cognitive Therapy|cognitive therapy
5864347|NCT00000383|Comparative Study|comparative study
5864348|NCT00000383|Female|female
5864349|NCT00000383|Human|human
5864350|NCT00000383|Male|male
5864351|NCT00000383|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5864352|NCT00000383|Child Abuse, Sexual|child abuse, sexual
5864353|NCT00000383|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
5864354|NCT00000383|Child Abuse, Sexual -- *psychology|child abuse, sexual -- *psychology
5864355|NCT00000382|Child Abuse|child abuse
5864356|NCT00000382|Female|female
5864357|NCT00000382|Human|human
5864358|NCT00000382|Infant|infant
5864359|NCT00000382|Male|male
5864360|NCT00000382|Caregivers|caregivers
5864361|NCT00000382|Patient Education|patient education
5864362|NCT00000382|Psychotherapy|psychotherapy
5864363|NCT00000382|Child Abuse -- *prevention & control|child abuse -- *prevention & control
5864364|NCT00000381|Adolescence|adolescence
5864365|NCT00000381|Anxiety Disorders|anxiety disorders
5864366|NCT00000381|Child|child
5864367|NCT00000381|Female|female
5864368|NCT00000381|Fluoxetine|fluoxetine
5864369|NCT00000381|Male|male
5864370|NCT00000381|Placebos|placebos
5864371|NCT00000381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864372|NCT00000381|Anxiety Disorders -- *drug therapy|anxiety disorders -- *drug therapy
5864373|NCT00000381|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
5864374|NCT00000381|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5864375|NCT00000380|Adult|adult
5864376|NCT00000380|Estrogen Replacement Therapy|estrogen replacement therapy
5864377|NCT00000380|Female|female
5864378|NCT00000380|Hormone Replacement Therapy|hormone replacement therapy
5864379|NCT00000380|Human|human
5864380|NCT00000380|Insulin-Like Growth Factor I|insulin-like growth factor i
5864381|NCT00000380|Male|male
5859432|NCT00006333|JRA|jra
5864382|NCT00000380|Placebos|placebos
5864383|NCT00000380|Sleep Disorders|sleep disorders
5864384|NCT00000380|Somatotropin-Releasing Hormone|somatotropin-releasing hormone
5864385|NCT00000380|Somatotropin|somatotropin
5864386|NCT00000380|Insulin-Like Growth Factor I -- secretion|insulin-like growth factor i -- secretion
5864387|NCT00000380|Sleep Disorders -- *drug therapy|sleep disorders -- *drug therapy
5864388|NCT00000380|Somatotropin-Releasing Hormone -- *therapeutic use|somatotropin-releasing hormone -- *therapeutic use
5864389|NCT00000380|Somatotropin -- secretion|somatotropin -- secretion
5864390|NCT00000379|Adult|adult
5864391|NCT00000379|Comparative Study|comparative study
5864392|NCT00000379|Desensitization, Psychologic|desensitization, psychologic
5864393|NCT00000379|Eye Movements|eye movements
5864394|NCT00000379|Female|female
5864395|NCT00000379|Fluoxetine|fluoxetine
5864399|NCT00000379|Stress Disorders, Post-Traumatic|stress disorders, post-traumatic
5864400|NCT00000379|Treatment Outcome|treatment outcome
5864586|NCT00000363|Antibiotics|antibiotics
5864401|NCT00000379|Desensitization, Psychologic -- *methods|desensitization, psychologic -- *methods
5864402|NCT00000379|Fluoxetine -- *therapeutic use|fluoxetine -- *therapeutic use
5864403|NCT00000379|Stress Disorders, Post-Traumatic -- *therapy|stress disorders, post-traumatic -- *therapy
5864404|NCT00000379|Stress Disorders, Post-Traumatic -- drug therapy|stress disorders, post-traumatic -- drug therapy
5864405|NCT00000378|Aged|aged
5864406|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
5864407|NCT00000378|Depression|depression
5864408|NCT00000378|Female|female
5864409|NCT00000378|Human|human
5864410|NCT00000378|Male|male
5864411|NCT00000378|Middle Age|middle age
5864412|NCT00000378|Nortriptyline|nortriptyline
5864413|NCT00000378|Sertraline|sertraline
5864414|NCT00000378|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864659|NCT00004498|rare disease|rare disease
5864415|NCT00000378|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
5864416|NCT00000378|Antidepressive Agents, Tricyclic -- adverse effects|antidepressive agents, tricyclic -- adverse effects
5864417|NCT00000378|Depression -- *drug therapy|depression -- *drug therapy
5864418|NCT00000378|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5864419|NCT00000378|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
5864420|NCT00000378|Sertraline -- *therapeutic use|sertraline -- *therapeutic use
5864421|NCT00000378|Sertraline -- adverse effects|sertraline -- adverse effects
5864422|NCT00000378|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5864423|NCT00000378|Serotonin Uptake Inhibitors -- adverse effects|serotonin uptake inhibitors -- adverse effects
5864424|NCT00000377|Aged|aged
5864425|NCT00000377|Antidepressive Agents|antidepressive agents
5864426|NCT00000377|Depression|depression
5864427|NCT00000377|Dose-Response Relationship, Drug|dose-response relationship, drug
5864428|NCT00000377|Female|female
5864429|NCT00000377|Human|human
5864430|NCT00000377|Male|male
5864431|NCT00000377|Middle Age|middle age
5864432|NCT00000377|Nortriptyline|nortriptyline
5864433|NCT00000377|Placebos|placebos
5864434|NCT00000377|Recurrence|recurrence
5864435|NCT00000377|Aged, 80 and over|aged, 80 and over
5864436|NCT00000377|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5864437|NCT00000377|Antidepressive Agents -- administration & dosage|antidepressive agents -- administration & dosage
5864438|NCT00000377|Depression -- *drug therapy|depression -- *drug therapy
5864439|NCT00000377|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5864440|NCT00000377|Nortriptyline -- administration & dosage|nortriptyline -- administration & dosage
5864441|NCT00000376|Adult|adult
5864442|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic
5864443|NCT00000376|Anxiety Disorders|anxiety disorders
5864444|NCT00000376|Cognitive Therapy|cognitive therapy
5864445|NCT00000376|Combined Modality Therapy|combined modality therapy
5864447|NCT00000376|Desipramine|desipramine
5864448|NCT00000376|Female|female
5864449|NCT00000376|Human|human
5864450|NCT00000376|Male|male
5864451|NCT00000376|Personality Disorders|personality disorders
5864452|NCT00000376|Pilot Projects|pilot projects
5864453|NCT00000376|Patient Care Team|patient care team
5864454|NCT00000376|Antidepressive Agents, Tricyclic -- *therapeutic use|antidepressive agents, tricyclic -- *therapeutic use
5864455|NCT00000376|Depression -- *therapy|depression -- *therapy
5864456|NCT00000376|Depression -- drug therapy|depression -- drug therapy
5864457|NCT00000376|Desipramine -- *therapeutic use|desipramine -- *therapeutic use
5864458|NCT00000375|Adult|adult
5864459|NCT00000375|Antidepressive Agents|antidepressive agents
5864460|NCT00000375|Depressive Disorder|depressive disorder
5864461|NCT00000375|Electroconvulsive Therapy|electroconvulsive therapy
5864462|NCT00000375|Female|female
5864463|NCT00000375|Human|human
5864464|NCT00000375|Lithium|lithium
5864465|NCT00000375|Male|male
5864466|NCT00000375|Nortriptyline|nortriptyline
5864467|NCT00000375|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864468|NCT00000375|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5864469|NCT00000375|Antidepressive Agents -- adverse effects|antidepressive agents -- adverse effects
5859477|NCT00006292|CT|ct
5859161|NCT00007163|IL-12|il-12
5864470|NCT00000375|Lithium -- *therapeutic use|lithium -- *therapeutic use
5864471|NCT00000375|Lithium -- adverse effects|lithium -- adverse effects
5864472|NCT00000375|Nortriptyline -- *therapeutic use|nortriptyline -- *therapeutic use
5864473|NCT00000375|Nortriptyline -- adverse effects|nortriptyline -- adverse effects
5864474|NCT00000374|Adolescence|adolescence
5864475|NCT00000374|Adult|adult
5864476|NCT00000374|Antipsychotic Agents|antipsychotic agents
5864477|NCT00000374|Female|female
5864478|NCT00000374|Human|human
5864479|NCT00000374|Male|male
5864480|NCT00000374|olanzapine|olanzapine
5864481|NCT00000374|Risperidone|risperidone
5864482|NCT00000374|Schizophrenia|schizophrenia
5864483|NCT00000374|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
5864484|NCT00000374|olanzapine -- *therapeutic use|olanzapine -- *therapeutic use
5864485|NCT00000374|Risperidone -- *therapeutic use|risperidone -- *therapeutic use
5864486|NCT00000374|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
5864489|NCT00000373|Antipsychotic Agents|antipsychotic agents
5864490|NCT00000373|Dopamine Antagonists|dopamine antagonists
5864491|NCT00000373|Female|female
5864492|NCT00000373|Fluvoxamine|fluvoxamine
5864493|NCT00000373|Haloperidol|haloperidol
5864494|NCT00000373|Human|human
5864495|NCT00000373|Male|male
5864496|NCT00000373|Middle Age|middle age
5864497|NCT00000373|Obsessive-Compulsive Disorder|obsessive-compulsive disorder
5864498|NCT00000373|Placebos|placebos
5864499|NCT00000373|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864500|NCT00000373|Tourette Syndrome|tourette syndrome
5864501|NCT00000373|Tryptophan|tryptophan
5864502|NCT00000373|Drug Combinations|drug combinations
5864503|NCT00000373|Antipsychotic Agents -- *therapeutic use|antipsychotic agents -- *therapeutic use
5864504|NCT00000373|Fluvoxamine -- *therapeutic use|fluvoxamine -- *therapeutic use
5864505|NCT00000373|Haloperidol -- *therapeutic use|haloperidol -- *therapeutic use
5864506|NCT00000373|Obsessive-Compulsive Disorder -- *drug therapy|obsessive-compulsive disorder -- *drug therapy
5864507|NCT00000373|Obsessive-Compulsive Disorder -- physiopathology|obsessive-compulsive disorder -- physiopathology
5864508|NCT00000373|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5864509|NCT00000372|Adult|adult
5864510|NCT00000372|Amino Acids|amino acids
5864511|NCT00000372|Cycloserine|cycloserine
5864516|NCT00000372|N-Methylaspartate|n-methylaspartate
5864517|NCT00000372|Placebos|placebos
5864518|NCT00000372|Schizophrenia|schizophrenia
5864519|NCT00000372|Amino Acids -- blood|amino acids -- blood
5864520|NCT00000372|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
5864521|NCT00000372|Glycine -- *therapeutic use|glycine -- *therapeutic use
5864522|NCT00000372|Schizophrenia -- *drug therapy|schizophrenia -- *drug therapy
5864523|NCT00000372|Schizophrenia -- physiopathology|schizophrenia -- physiopathology
5864524|NCT00000371|Adult|adult
5864525|NCT00000371|Cognition|cognition
5864526|NCT00000371|Cycloserine|cycloserine
5864527|NCT00000371|Dopamine|dopamine
5864528|NCT00000371|Female|female
5864529|NCT00000371|Glutamic Acid|glutamic acid
5864530|NCT00000371|Human|human
5864531|NCT00000371|Male|male
5864532|NCT00000371|Receptors, N-Methyl-D-Aspartate|receptors, n-methyl-d-aspartate
5864533|NCT00000371|Schizophrenia|schizophrenia
5864534|NCT00000371|Serotonin|serotonin
5864536|NCT00000371|Cycloserine -- *therapeutic use|cycloserine -- *therapeutic use
5864537|NCT00000371|Dopamine -- blood|dopamine -- blood
5864538|NCT00000371|Dopamine -- cerebrospinal fluid|dopamine -- cerebrospinal fluid
5864539|NCT00000371|Glutamic Acid -- blood|glutamic acid -- blood
5864540|NCT00000371|Glutamic Acid -- cerebrospinal fluid|glutamic acid -- cerebrospinal fluid
5864541|NCT00000371|Serotonin -- blood|serotonin -- blood
5864542|NCT00000371|Serotonin -- cerebrospinal fluid|serotonin -- cerebrospinal fluid
5864543|NCT00000370|Cognitive Therapy|cognitive therapy
5864544|NCT00000370|Cost of Illness|cost of illness
5864545|NCT00000370|Female|female
5864546|NCT00000370|Human|human
5864547|NCT00000370|Male|male
5864548|NCT00000370|Phobic Disorders|phobic disorders
5864549|NCT00000370|Phobic Disorders -- *therapy|phobic disorders -- *therapy
5864550|NCT00000370|Phobic Disorders -- pathology|phobic disorders -- pathology
5864551|NCT00000369|Adult|adult
5864552|NCT00000369|Antidepressive Agents|antidepressive agents
5864553|NCT00000369|Bipolar Disorder|bipolar disorder
5864554|NCT00000369|Combined Modality Therapy|combined modality therapy
5864555|NCT00000369|Female|female
5864556|NCT00000369|Human|human
5864557|NCT00000369|Lithium Carbonate|lithium carbonate
5864558|NCT00000369|Male|male
5864559|NCT00000369|Psychotherapy|psychotherapy
5864560|NCT00000369|Antidepressive Agents -- *therapeutic use|antidepressive agents -- *therapeutic use
5864561|NCT00000369|Bipolar Disorder -- *therapy|bipolar disorder -- *therapy
5864562|NCT00000369|Bipolar Disorder -- drug therapy|bipolar disorder -- drug therapy
5864563|NCT00000369|Lithium Carbonate -- *therapeutic use|lithium carbonate -- *therapeutic use
5864564|NCT00000368|Adult|adult
5864565|NCT00000368|Cognitive Behavioral Therapy|cognitive behavioral therapy
5859270|NCT00006447|Trauma|trauma
5864566|NCT00000368|Pharmacotherapy|pharmacotherapy
5864567|NCT00000368|Long term treatment|long term treatment
5864568|NCT00000368|Remission and relapse|remission and relapse
5851219|NCT00006325|HIV-1|hiv-1
5859597|NCT00006181|PHLAME|phlame
5864569|NCT00000368|Male|male
5864570|NCT00000368|Panic Disorder|panic disorder
5864571|NCT00000368|Paroxetine|paroxetine
5864572|NCT00000368|Serotonin Uptake Inhibitors|serotonin uptake inhibitors
5864573|NCT00000368|Panic Disorder -- *therapy|panic disorder -- *therapy
5864574|NCT00000368|Panic Disorder -- drug therapy|panic disorder -- drug therapy
5864575|NCT00000368|Paroxetine -- *therapeutic use|paroxetine -- *therapeutic use
5864576|NCT00000368|Serotonin Uptake Inhibitors -- *therapeutic use|serotonin uptake inhibitors -- *therapeutic use
5864577|NCT00000367|Depression|depression
5864578|NCT00000367|Family|family
5864579|NCT00000367|Female|female
5864580|NCT00000367|Human|human
5864581|NCT00000367|Male|male
5864582|NCT00000367|Practice Guidelines|practice guidelines
5864583|NCT00000367|Education, Medical, Continuing|education, medical, continuing
5864584|NCT00000367|Patient Education|patient education
5864585|NCT00000367|Suicide|suicide
5864587|NCT00000363|Adrenal Cortex Hormones|adrenal cortex hormones
5864588|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists
5864589|NCT00000363|Infant|infant
5864591|NCT00000362|Deglutition Disorders|deglutition disorders
5864592|NCT00000362|Dementia|dementia
5864593|NCT00000362|Parkinson Disease|parkinson disease
5864594|NCT00000362|Pneumonia, Aspiration|pneumonia, aspiration
5864595|NCT00000361|Autoimmune Diseases|autoimmune diseases
5864596|NCT00000361|Cyclophosphamide|cyclophosphamide
5864597|NCT00000361|Hearing|hearing
5864598|NCT00000361|Labyrinth Diseases|labyrinth diseases
5864599|NCT00000361|Methotrexate|methotrexate
5864600|NCT00000361|Prednisone|prednisone
5864601|NCT00000359|Physical Therapy|physical therapy
5864602|NCT00000359|Vertigo|vertigo
5864603|NCT00000359|rehabilitation|rehabilitation
5864604|NCT00000359|occupational therapy|occupational therapy
5864605|NCT00000180|Memory|memory
5864606|NCT00000180|Mild cognitive impairment|mild cognitive impairment
5864607|NCT00000180|Nerve growth factors|nerve growth factors
5864608|NCT00000179|Alzheimer's disease|alzheimer's disease
5864609|NCT00000179|Psychomotor agitation|psychomotor agitation
5864610|NCT00000179|Behavioral symptoms|behavioral symptoms
5864611|NCT00000179|Haloperidol|haloperidol
5864612|NCT00000179|Trazodone|trazodone
5864613|NCT00000179|Anti-psychotic agents|anti-psychotic agents
5864614|NCT00000179|Anti-depressant agents|anti-depressant agents
5864616|NCT00000178|Prednisone|prednisone
5864617|NCT00000178|Anti-inflammatory agents|anti-inflammatory agents
5864618|NCT00000177|Alzheimer's disease|alzheimer's disease
5864619|NCT00000177|Estrogen|estrogen
5864620|NCT00000176|Alzheimer's disease|alzheimer's disease
5864621|NCT00000176|memory loss|memory loss
5864622|NCT00000176|Estrogen|estrogen
5864623|NCT00000175|Emotions|emotions
5864624|NCT00000175|Cognition|cognition
5864625|NCT00000175|Aging|aging
5864626|NCT00000175|Memory|memory
5864627|NCT00000174|Mild cognitive impairment|mild cognitive impairment
5864628|NCT00000174|Alzheimer's disease|alzheimer's disease
5864629|NCT00000174|Memory|memory
5864630|NCT00000174|Cholinergic agents|cholinergic agents
5864631|NCT00000174|Cholinesterase inhibitors|cholinesterase inhibitors
5864632|NCT00000173|Mild cognitive impairment|mild cognitive impairment
5864633|NCT00000173|Alzheimer's disease|alzheimer's disease
5864634|NCT00000173|Memory|memory
5864635|NCT00000173|Donepezil|donepezil
5864636|NCT00000173|Vitamin E|vitamin e
5864637|NCT00000173|Antioxidants|antioxidants
5864638|NCT00000173|Cholinergic agents|cholinergic agents
5864639|NCT00000173|Cholinesterase inhibitors|cholinesterase inhibitors
5864640|NCT00000172|Alzheimer's disease|alzheimer's disease
5864641|NCT00000172|Cholinergic agents|cholinergic agents
5864642|NCT00000172|Cholinergic agonists|cholinergic agonists
5864643|NCT00000172|Cholinesterase inhibitors|cholinesterase inhibitors
5864644|NCT00000171|Alzheimer's disease|alzheimer's disease
5864645|NCT00000171|Sleep disorders|sleep disorders
5864646|NCT00000171|Melatonin|melatonin
5864647|NCT00000623|chelator|chelator
5864648|NCT00000623|iron|iron
5864649|NCT00000623|transfusion|transfusion
5864650|NCT00000623|anemia|anemia
5864651|NCT00000623|thalassemia|thalassemia
5864652|NCT00000620|Diabetes Mellitus, Non-Insulin-Dependent|diabetes mellitus, non-insulin-dependent
5864653|NCT00004500|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864654|NCT00004500|meconium aspiration syndrome|meconium aspiration syndrome
5864655|NCT00004500|rare disease|rare disease
5864656|NCT00004498|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864657|NCT00004498|inborn errors of metabolism|inborn errors of metabolism
5864658|NCT00004498|ornithine transcarbamylase deficiency|ornithine transcarbamylase deficiency
5864660|NCT00004498|urea cycle disorder|urea cycle disorder
5864661|NCT00004497|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864662|NCT00004497|hypertensive disorder|hypertensive disorder
5864663|NCT00004497|primary pulmonary hypertension|primary pulmonary hypertension
5864664|NCT00004497|rare disease|rare disease
5864665|NCT00004496|acute renal failure|acute renal failure
5864666|NCT00004496|rare disease|rare disease
5859681|NCT00006169|Nutrition|nutrition
5864667|NCT00004496|renal and genitourinary disorders|renal and genitourinary disorders
5864668|NCT00004495|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864669|NCT00004495|end stage renal disease|end stage renal disease
5864670|NCT00004495|hyperhomocysteinemia|hyperhomocysteinemia
5864671|NCT00004495|rare disease|rare disease
5864672|NCT00004495|renal and genitourinary disorders|renal and genitourinary disorders
5864673|NCT00004494|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864674|NCT00004494|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864675|NCT00004494|neonatal disorders|neonatal disorders
5864676|NCT00004494|rare disease|rare disease
5864677|NCT00004494|respiratory distress syndrome|respiratory distress syndrome
5864678|NCT00004494|sepsis|sepsis
5864679|NCT00004493|inborn errors of metabolism|inborn errors of metabolism
5864680|NCT00004493|lactic acidosis|lactic acidosis
5864681|NCT00004493|rare disease|rare disease
5864682|NCT00004492|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864683|NCT00004492|hematologic disorders|hematologic disorders
5864684|NCT00004492|rare disease|rare disease
5864685|NCT00004492|sickle cell anemia|sickle cell anemia
5864686|NCT00004490|disease-related problem/condition|disease-related problem/condition
5864687|NCT00004490|inborn errors of metabolism|inborn errors of metabolism
5864688|NCT00004490|lactic acidosis|lactic acidosis
5864689|NCT00004490|quality of life|quality of life
5864690|NCT00004490|rare disease|rare disease
5864691|NCT00004489|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864692|NCT00004489|cystic fibrosis|cystic fibrosis
5864693|NCT00004489|disease-related problem/condition|disease-related problem/condition
5864694|NCT00004489|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864695|NCT00004489|osteoporosis|osteoporosis
5864696|NCT00004489|rare disease|rare disease
5864697|NCT00004488|Gaucher's disease|gaucher's disease
5864698|NCT00004488|inborn errors of metabolism|inborn errors of metabolism
5864699|NCT00004488|rare disease|rare disease
5864700|NCT00004488|sphingolipidoses|sphingolipidoses
5864701|NCT00004487|rare disease|rare disease
5864702|NCT00004487|renal and genitourinary disorders|renal and genitourinary disorders
5864703|NCT00004487|vesicoureteral reflux|vesicoureteral reflux
5864704|NCT00004486|autism|autism
5864705|NCT00004486|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864706|NCT00004486|rare disease|rare disease
5864707|NCT00004485|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864708|NCT00004485|hematologic disorders|hematologic disorders
5864709|NCT00004485|rare disease|rare disease
5864710|NCT00004485|sickle cell anemia|sickle cell anemia
5864711|NCT00004482|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864712|NCT00004482|giant cell myocarditis|giant cell myocarditis
5864713|NCT00004482|rare disease|rare disease
5864714|NCT00004481|endocrine disorders|endocrine disorders
5864715|NCT00004481|inborn errors of metabolism|inborn errors of metabolism
5864716|NCT00004481|rare disease|rare disease
5864717|NCT00004481|sitosterolemia|sitosterolemia
5864718|NCT00004480|dermatologic disorders|dermatologic disorders
5864719|NCT00004480|hyperhidrosis|hyperhidrosis
5864720|NCT00004480|rare disease|rare disease
5864721|NCT00004479|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864722|NCT00004479|rare disease|rare disease
5864723|NCT00004479|syncope|syncope
5864724|NCT00004478|Shy-Drager Syndrome|shy-drager syndrome
5864725|NCT00004478|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864726|NCT00004478|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864727|NCT00004478|orthostatic hypotension|orthostatic hypotension
5864728|NCT00004478|rare disease|rare disease
5864729|NCT00004474|Hematologic Disorders|hematologic disorders
5864730|NCT00004474|Rare Disease|rare disease
5864731|NCT00004471|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864732|NCT00004471|cystic fibrosis|cystic fibrosis
5864733|NCT00004471|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864734|NCT00004471|rare disease|rare disease
5864735|NCT00004468|dermatologic disorders|dermatologic disorders
5864736|NCT00004468|psoriasis|psoriasis
5864737|NCT00004468|rare disease|rare disease
5864738|NCT00004467|acute liver failure|acute liver failure
5864739|NCT00004467|gastrointestinal disorders|gastrointestinal disorders
5864740|NCT00004467|rare disease|rare disease
5864741|NCT00004466|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864742|NCT00004466|hyperlipidemia|hyperlipidemia
5864743|NCT00004466|nephrotic syndrome|nephrotic syndrome
5864744|NCT00004466|rare disease|rare disease
5864745|NCT00004466|renal and genitourinary disorders|renal and genitourinary disorders
5859499|NCT00006286|Prozac|prozac
5864746|NCT00004465|E. coli infection|e. coli infection
5864747|NCT00004465|bacterial infection|bacterial infection
5864748|NCT00004465|hemolytic uremic syndrome|hemolytic uremic syndrome
5864749|NCT00004465|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864750|NCT00004465|rare disease|rare disease
5864751|NCT00004465|renal and genitourinary disorders|renal and genitourinary disorders
5864752|NCT00004464|aplastic anemia|aplastic anemia
5864753|NCT00004464|hematologic disorders|hematologic disorders
5864754|NCT00004464|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria
5864755|NCT00004464|rare disease|rare disease
5864756|NCT00004458|autism|autism
5864757|NCT00004458|childhood disintegrative disorder|childhood disintegrative disorder
5864758|NCT00004458|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864759|NCT00004458|rare disease|rare disease
5864760|NCT00004457|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis
5864761|NCT00004457|motor neuron disease|motor neuron disease
5864762|NCT00004457|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864763|NCT00004457|rare disease|rare disease
5864764|NCT00004454|inborn errors of metabolism|inborn errors of metabolism
5864765|NCT00004454|mucopolysaccharidosis|mucopolysaccharidosis
5864766|NCT00004454|mucopolysaccharidosis II|mucopolysaccharidosis ii
5864767|NCT00004454|rare disease|rare disease
5864768|NCT00004451|Parkinson disease|parkinson disease
5864769|NCT00004451|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864770|NCT00004451|rare disease|rare disease
5864771|NCT00004450|adrenoleukodystrophy|adrenoleukodystrophy
5864772|NCT00004450|inborn errors of metabolism|inborn errors of metabolism
5864773|NCT00004450|rare disease|rare disease
5864774|NCT00004450|sphingolipidoses|sphingolipidoses
5864775|NCT00004449|autism|autism
5865007|NCT00004373|rare disease|rare disease
5864776|NCT00004449|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864777|NCT00004449|rare disease|rare disease
5864778|NCT00004448|IgA glomerulonephritis|iga glomerulonephritis
5864779|NCT00004448|rare disease|rare disease
5864780|NCT00004448|renal and genitourinary disorders|renal and genitourinary disorders
5864781|NCT00004446|depersonalization disorder|depersonalization disorder
5864782|NCT00004446|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864783|NCT00004446|rare disease|rare disease
5864784|NCT00004445|environmental/toxic disorders|environmental/toxic disorders
5864785|NCT00004445|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864786|NCT00004445|rare disease|rare disease
5864787|NCT00004445|spinal cord injury|spinal cord injury
5864788|NCT00004444|bacterial infection|bacterial infection
5864789|NCT00004444|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864790|NCT00004444|mycobacterium infection|mycobacterium infection
5864791|NCT00004444|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
5864792|NCT00004444|rare disease|rare disease
5864793|NCT00004443|inborn errors of metabolism|inborn errors of metabolism
5864794|NCT00004443|rare disease|rare disease
5864795|NCT00004443|tyrosinemia I|tyrosinemia i
5864796|NCT00004442|Zellweger syndrome|zellweger syndrome
5864797|NCT00004442|adrenoleukodystrophy|adrenoleukodystrophy
5864798|NCT00004442|bifunctional enzyme deficiency|bifunctional enzyme deficiency
5864799|NCT00004442|inborn errors of metabolism|inborn errors of metabolism
5864800|NCT00004442|infantile Refsum's disease|infantile refsum's disease
5864801|NCT00004442|peroxisomal disorders|peroxisomal disorders
5864802|NCT00004442|pseudo-Zellweger syndrome|pseudo-zellweger syndrome
5864803|NCT00004442|rare disease|rare disease
5864804|NCT00004442|sphingolipidoses|sphingolipidoses
5864805|NCT00004441|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864806|NCT00004441|cystic fibrosis|cystic fibrosis
5864807|NCT00004441|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864808|NCT00004441|rare disease|rare disease
5864809|NCT00004440|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864810|NCT00004440|cystic fibrosis|cystic fibrosis
5864811|NCT00004440|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864812|NCT00004440|rare disease|rare disease
5864813|NCT00004438|endocrine disorders|endocrine disorders
5864814|NCT00004438|hypogonadism|hypogonadism
5864815|NCT00004438|rare disease|rare disease
5864816|NCT00004437|acoustic neuroma|acoustic neuroma
5864817|NCT00004437|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864818|NCT00004437|hearing loss|hearing loss
5864819|NCT00004437|neurofibromatosis|neurofibromatosis
5864820|NCT00004437|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864821|NCT00004437|rare disease|rare disease
5864822|NCT00004436|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864823|NCT00004436|hemangioma|hemangioma
5864824|NCT00004436|rare disease|rare disease
5864825|NCT00004433|Tourette syndrome|tourette syndrome
5864826|NCT00004433|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864827|NCT00004433|rare disease|rare disease
5864828|NCT00004431|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864829|NCT00004431|rare disease|rare disease
5864830|NCT00004431|trigeminal neuralgia|trigeminal neuralgia
5864831|NCT00004430|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864832|NCT00004430|corneal neovascularization|corneal neovascularization
5864833|NCT00004430|rare disease|rare disease
5864834|NCT00004429|end stage renal disease|end stage renal disease
5864835|NCT00004429|rare disease|rare disease
5864836|NCT00004429|renal and genitourinary disorders|renal and genitourinary disorders
5864837|NCT00004428|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864838|NCT00004428|cystic fibrosis|cystic fibrosis
5864839|NCT00004428|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864840|NCT00004428|rare disease|rare disease
5864841|NCT00004426|endocrine disorders|endocrine disorders
5864842|NCT00004426|hypogonadism|hypogonadism
5864843|NCT00004426|rare disease|rare disease
5864844|NCT00004424|disease-related problem/condition|disease-related problem/condition
5864845|NCT00004424|oncologic disorders|oncologic disorders
5864846|NCT00004424|pulmonary complications|pulmonary complications
5864847|NCT00004424|rare disease|rare disease
5864848|NCT00004424|Respiration, Artificial|respiration, artificial
5864849|NCT00004423|Crohn's disease|crohn's disease
5864850|NCT00004423|gastrointestinal disorders|gastrointestinal disorders
5864851|NCT00004423|rare disease|rare disease
5864852|NCT00004422|bacterial infection|bacterial infection
5864853|NCT00004422|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864854|NCT00004422|pertussis|pertussis
5864855|NCT00004422|rare disease|rare disease
5864856|NCT00004421|dystonia|dystonia
5864857|NCT00004421|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864858|NCT00004421|rare disease|rare disease
5865035|NCT00004361|endocrine disorders|endocrine disorders
5864859|NCT00004420|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5864860|NCT00004420|juvenile rheumatoid arthritis|juvenile rheumatoid arthritis
5864861|NCT00004420|rare disease|rare disease
5864862|NCT00004419|endocrine disorders|endocrine disorders
5864863|NCT00004419|insulin resistance|insulin resistance
5864864|NCT00004419|rare disease|rare disease
5864865|NCT00004418|adrenoleukodystrophy|adrenoleukodystrophy
5864866|NCT00004418|inborn errors of metabolism|inborn errors of metabolism
5864867|NCT00004418|rare disease|rare disease
5864868|NCT00004418|sphingolipidoses|sphingolipidoses
5864869|NCT00004416|achalasia|achalasia
5864870|NCT00004416|gastrointestinal disorders|gastrointestinal disorders
5864871|NCT00004416|rare disease|rare disease
5864872|NCT00004415|environmental/toxic disorders|environmental/toxic disorders
5864873|NCT00004415|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864874|NCT00004415|rare disease|rare disease
5864875|NCT00004415|spinal cord injury|spinal cord injury
5864876|NCT00004414|cholestasis|cholestasis
5864877|NCT00004414|gastrointestinal disorders|gastrointestinal disorders
5864878|NCT00004414|rare disease|rare disease
5864879|NCT00004412|dermatologic disorders|dermatologic disorders
5864880|NCT00004412|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864881|NCT00004412|hematologic disorders|hematologic disorders
5864882|NCT00004412|rare disease|rare disease
5864883|NCT00004412|sickle cell anemia|sickle cell anemia
5864884|NCT00004412|skin ulcers|skin ulcers
5864885|NCT00004412|thalassemia major|thalassemia major
5864886|NCT00004410|cholestasis|cholestasis
5864887|NCT00004410|gastrointestinal disorders|gastrointestinal disorders
5864888|NCT00004410|rare disease|rare disease
5864889|NCT00004409|Dupuytren's disease|dupuytren's disease
5864890|NCT00004409|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5864891|NCT00004409|rare disease|rare disease
5864892|NCT00004408|disease-related problem/condition|disease-related problem/condition
5864893|NCT00004408|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864894|NCT00004408|hematologic disorders|hematologic disorders
5864895|NCT00004408|pain|pain
5864896|NCT00004408|rare disease|rare disease
5864897|NCT00004408|sickle cell anemia|sickle cell anemia
5864898|NCT00004407|diabetic amyotrophy|diabetic amyotrophy
5864899|NCT00004407|diabetic lumbosacral radiculoplexus neuropathy|diabetic lumbosacral radiculoplexus neuropathy
5864900|NCT00004407|diabetic neuropathy|diabetic neuropathy
5864901|NCT00004407|diabetic proximal neuropathy|diabetic proximal neuropathy
5864902|NCT00004407|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864903|NCT00004407|rare disease|rare disease
5864904|NCT00004406|disease-related problem/condition|disease-related problem/condition
5864905|NCT00004406|osteoporosis|osteoporosis
5864906|NCT00004406|rare disease|rare disease
5864907|NCT00004404|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864908|NCT00004404|hematologic disorders|hematologic disorders
5864909|NCT00004404|rare disease|rare disease
5864910|NCT00004404|sickle cell anemia|sickle cell anemia
5864911|NCT00004403|cysticercosis|cysticercosis
5864912|NCT00004403|epilepsy|epilepsy
5864913|NCT00004403|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864914|NCT00004403|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864915|NCT00004403|parasitic infection|parasitic infection
5864916|NCT00004403|rare disease|rare disease
5864917|NCT00004403|seizures|seizures
5864918|NCT00004402|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864919|NCT00004402|osteopetrosis|osteopetrosis
5864920|NCT00004402|rare disease|rare disease
5864921|NCT00004401|bacterial infection|bacterial infection
5864922|NCT00004401|clostridium infection|clostridium infection
5864923|NCT00004401|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864924|NCT00004401|infant botulism|infant botulism
5864925|NCT00004401|rare disease|rare disease
5864926|NCT00004400|cachexia|cachexia
5864927|NCT00004400|disease-related problem/condition|disease-related problem/condition
5864928|NCT00004400|human immunodeficiency virus infection|human immunodeficiency virus infection
5864929|NCT00004400|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864930|NCT00004400|nutrition|nutrition
5864931|NCT00004400|quality of life|quality of life
5864932|NCT00004400|rare disease|rare disease
5864933|NCT00004400|viral infection|viral infection
5864934|NCT00004399|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864935|NCT00004399|hypertensive disorder|hypertensive disorder
5864936|NCT00004399|pre-eclampsia|pre-eclampsia
5864937|NCT00004399|rare disease|rare disease
5864938|NCT00004398|inborn errors of metabolism|inborn errors of metabolism
5864939|NCT00004398|porphyria|porphyria
5864940|NCT00004398|rare disease|rare disease
5864941|NCT00004397|inborn errors of metabolism|inborn errors of metabolism
5864942|NCT00004397|porphyria|porphyria
5864943|NCT00004397|rare disease|rare disease
5864944|NCT00004396|inborn errors of metabolism|inborn errors of metabolism
5864945|NCT00004396|porphyria|porphyria
5864946|NCT00004396|rare disease|rare disease
5864947|NCT00004393|Tourette syndrome|tourette syndrome
5865301|NCT00000153|Optic Disk|optic disk
5864948|NCT00004393|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864949|NCT00004393|rare disease|rare disease
5864951|NCT00004392|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5864952|NCT00004392|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864953|NCT00004392|rare disease|rare disease
5864954|NCT00004392|sudden infant death syndrome|sudden infant death syndrome
5864955|NCT00004390|disease-related problem/condition|disease-related problem/condition
5864956|NCT00004390|herpes zoster infection|herpes zoster infection
5864957|NCT00004390|herpesvirus infection|herpesvirus infection
5864958|NCT00004390|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864959|NCT00004390|pain|pain
5864960|NCT00004390|rare disease|rare disease
5864961|NCT00004390|viral infection|viral infection
5864962|NCT00004387|Parkinson disease|parkinson disease
5864963|NCT00004387|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864964|NCT00004387|rare disease|rare disease
5864965|NCT00004386|inborn errors of metabolism|inborn errors of metabolism
5864966|NCT00004386|rare disease|rare disease
5864967|NCT00004386|urea cycle disorder|urea cycle disorder
5864968|NCT00004382|hematologic disorders|hematologic disorders
5864969|NCT00004382|hyperbilirubinemia|hyperbilirubinemia
5864970|NCT00004382|rare disease|rare disease
5864971|NCT00004381|glucose-6-phosphate dehydrogenase deficiency|glucose-6-phosphate dehydrogenase deficiency
5864972|NCT00004381|hematologic disorders|hematologic disorders
5864973|NCT00004381|hemolytic disease|hemolytic disease
5864974|NCT00004381|hyperbilirubinemia|hyperbilirubinemia
5864975|NCT00004381|neonatal disorders|neonatal disorders
5864976|NCT00004381|rare disease|rare disease
5864977|NCT00004380|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5864978|NCT00004380|rare disease|rare disease
5864979|NCT00004380|systemic sclerosis|systemic sclerosis
5864980|NCT00004378|Fanconi's anemia|fanconi's anemia
5864981|NCT00004378|amegakaryocytic thrombocytopenia|amegakaryocytic thrombocytopenia
5864982|NCT00004378|aplastic anemia|aplastic anemia
5864983|NCT00004378|congenital pure red cell aplasia|congenital pure red cell aplasia
5864984|NCT00004378|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5864985|NCT00004378|hematologic disorders|hematologic disorders
5864986|NCT00004378|inborn errors of metabolism|inborn errors of metabolism
5864987|NCT00004378|metachromatic leukodystrophy|metachromatic leukodystrophy
5864988|NCT00004378|pure red cell aplasia|pure red cell aplasia
5864989|NCT00004378|rare disease|rare disease
5864990|NCT00004378|sphingolipidoses|sphingolipidoses
5864991|NCT00004378|thalassemia major|thalassemia major
5864992|NCT00004376|Tourette syndrome|tourette syndrome
5864993|NCT00004376|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5864994|NCT00004376|rare disease|rare disease
5864995|NCT00004375|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5864996|NCT00004375|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5864997|NCT00004375|rare disease|rare disease
5864998|NCT00004375|systemic lupus erythematosus|systemic lupus erythematosus
5864999|NCT00004374|amyloidosis|amyloidosis
5865000|NCT00004374|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5865001|NCT00004374|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865002|NCT00004374|rare disease|rare disease
5865003|NCT00004373|anxiety disorder|anxiety disorder
5865004|NCT00004373|disease-related problem/condition|disease-related problem/condition
5865005|NCT00004373|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865006|NCT00004373|panic disorder|panic disorder
5865008|NCT00004368|hepatic cirrhosis|hepatic cirrhosis
5860107|NCT00005892|leukemia|leukemia
5865009|NCT00004368|gastrointestinal disorders|gastrointestinal disorders
5865010|NCT00004368|rare disease|rare disease
5865011|NCT00004367|anxiety disorder|anxiety disorder
5865012|NCT00004367|disease-related problem/condition|disease-related problem/condition
5865013|NCT00004367|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865014|NCT00004367|panic disorder|panic disorder
5865015|NCT00004367|rare disease|rare disease
5865016|NCT00004366|agoraphobia|agoraphobia
5865017|NCT00004366|anxiety disorder|anxiety disorder
5865018|NCT00004366|disease-related problem/condition|disease-related problem/condition
5865019|NCT00004366|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865020|NCT00004366|panic disorder|panic disorder
5865021|NCT00004366|rare disease|rare disease
5865022|NCT00004366|vestibular diseases|vestibular diseases
5865023|NCT00004365|endocrine disorders|endocrine disorders
5865024|NCT00004365|growth hormone deficiency|growth hormone deficiency
5865025|NCT00004365|rare disease|rare disease
5865026|NCT00004364|diabetes insipidus|diabetes insipidus
5865027|NCT00004364|endocrine disorders|endocrine disorders
5865028|NCT00004364|rare disease|rare disease
5865029|NCT00004363|diabetes insipidus|diabetes insipidus
5865030|NCT00004363|endocrine disorders|endocrine disorders
5865031|NCT00004363|rare disease|rare disease
5865032|NCT00004361|DiGeorge syndrome|digeorge syndrome
5865033|NCT00004361|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5865034|NCT00004361|conotruncal cardiac defects|conotruncal cardiac defects
5865036|NCT00004361|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865037|NCT00004361|hypoparathyroidism|hypoparathyroidism
5865038|NCT00004361|pulmonary valve stenosis|pulmonary valve stenosis
5865039|NCT00004361|rare disease|rare disease
5865040|NCT00004361|tetralogy of Fallot|tetralogy of fallot
5865041|NCT00004360|diabetes insipidus|diabetes insipidus
5865042|NCT00004360|endocrine disorders|endocrine disorders
5865043|NCT00004360|rare disease|rare disease
5865044|NCT00004359|dermatologic disorders|dermatologic disorders
5865045|NCT00004359|epidermolysis bullosa|epidermolysis bullosa
5865046|NCT00004359|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865047|NCT00004359|rare disease|rare disease
5865048|NCT00004358|arthritis & connective tissue diseases|arthritis & connective tissue diseases
5865049|NCT00004358|rare disease|rare disease
5865050|NCT00004358|tumoral calcinosis|tumoral calcinosis
5865051|NCT00004357|Cardiovascular Disease|cardiovascular disease
5865052|NCT00004357|Respiratory Disease|respiratory disease
5865053|NCT00004357|Rare Diseases|rare diseases
5865054|NCT00004357|Vasculitis|vasculitis
5865055|NCT00004356|homocystinuria|homocystinuria
5865056|NCT00004356|inborn errors of metabolism|inborn errors of metabolism
5865057|NCT00004356|rare disease|rare disease
5865058|NCT00004354|endocrine disorders|endocrine disorders
5865059|NCT00004354|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865060|NCT00004354|hyperaldosteronism|hyperaldosteronism
5865061|NCT00004354|rare disease|rare disease
5865062|NCT00004353|MELAS syndrome|melas syndrome
5865063|NCT00004353|inborn errors of metabolism|inborn errors of metabolism
5865064|NCT00004353|lactic acidosis|lactic acidosis
5865065|NCT00004353|mitochondrial myopathy|mitochondrial myopathy
5865066|NCT00004353|rare disease|rare disease
5865067|NCT00004351|Angelman syndrome|angelman syndrome
5865068|NCT00004351|DiGeorge syndrome|digeorge syndrome
5865069|NCT00004351|Prader-Willi syndrome|prader-willi syndrome
5865070|NCT00004351|Shprintzen syndrome|shprintzen syndrome
5865071|NCT00004351|Smith-Magenis syndrome|smith-magenis syndrome
5865072|NCT00004351|Williams syndrome|williams syndrome
5865073|NCT00004351|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865074|NCT00004351|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865075|NCT00004351|rare disease|rare disease
5865076|NCT00004350|Fanconi syndrome|fanconi syndrome
5865077|NCT00004350|cystinosis|cystinosis
5865078|NCT00004350|rare disease|rare disease
5865079|NCT00004350|renal and genitourinary disorders|renal and genitourinary disorders
5865080|NCT00004348|beta-oxidation disorder|beta-oxidation disorder
5865081|NCT00004348|inborn errors of metabolism|inborn errors of metabolism
5865082|NCT00004348|rare disease|rare disease
5865083|NCT00004347|Smith-Lemli-Opitz syndrome|smith-lemli-opitz syndrome
5865084|NCT00004347|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865085|NCT00004347|rare disease|rare disease
5865086|NCT00004346|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis
5865087|NCT00004346|inborn errors of metabolism|inborn errors of metabolism
5865088|NCT00004346|rare disease|rare disease
5865089|NCT00004345|Usher syndrome|usher syndrome
5865090|NCT00004345|ophthalmologic disorders|ophthalmologic disorders
5865091|NCT00004345|rare disease|rare disease
5865092|NCT00004345|retinitis pigmentosa|retinitis pigmentosa
5865093|NCT00004344|endocrine disorders|endocrine disorders
5865094|NCT00004344|precocious puberty|precocious puberty
5865095|NCT00004344|rare disease|rare disease
5865096|NCT00004343|Cushing's syndrome|cushing's syndrome
5865097|NCT00004343|endocrine disorders|endocrine disorders
5865098|NCT00004343|rare disease|rare disease
5865099|NCT00004342|chronic neutropenia|chronic neutropenia
5865100|NCT00004342|disease-related problem/condition|disease-related problem/condition
5865101|NCT00004342|hematologic disorders|hematologic disorders
5865103|NCT00004342|rare disease|rare disease
5865104|NCT00004342|severe chronic neutropenia|severe chronic neutropenia
5865105|NCT00004341|Wiskott-Aldrich syndrome|wiskott-aldrich syndrome
5865106|NCT00004341|X-linked agammaglobulinemia|x-linked agammaglobulinemia
5865107|NCT00004341|X-linked hyper IgM syndrome|x-linked hyper igm syndrome
5865108|NCT00004341|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865109|NCT00004341|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5865110|NCT00004341|leukocyte adhesion deficiency syndrome|leukocyte adhesion deficiency syndrome
5865111|NCT00004341|primary immunodeficiency disease|primary immunodeficiency disease
5865112|NCT00004341|rare disease|rare disease
5865113|NCT00004340|end stage renal disease|end stage renal disease
5865114|NCT00004340|rare disease|rare disease
5865115|NCT00004340|renal and genitourinary disorders|renal and genitourinary disorders
5865116|NCT00004340|renal osteodystrophy|renal osteodystrophy
5865117|NCT00004339|Wilson disease|wilson disease
5865118|NCT00004339|inborn errors of metabolism|inborn errors of metabolism
5865119|NCT00004339|rare disease|rare disease
5865120|NCT00004338|Wilson disease|wilson disease
5865121|NCT00004338|inborn errors of metabolism|inborn errors of metabolism
5865122|NCT00004338|rare disease|rare disease
5865123|NCT00004336|Mondini dysplasia|mondini dysplasia
5865124|NCT00004336|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865126|NCT00004335|endocrine disorders|endocrine disorders
5865127|NCT00004335|growth hormone deficiency|growth hormone deficiency
5865128|NCT00004335|hypogonadism|hypogonadism
5865129|NCT00004335|precocious puberty|precocious puberty
5865130|NCT00004335|rare disease|rare disease
5865131|NCT00004334|Cushing's syndrome|cushing's syndrome
5865132|NCT00004334|endocrine disorders|endocrine disorders
5865133|NCT00004334|rare disease|rare disease
5865134|NCT00004333|inborn errors of metabolism|inborn errors of metabolism
5865135|NCT00004333|rare disease|rare disease
5865136|NCT00004333|tyrosinemia I|tyrosinemia i
5865138|NCT00004332|endocrine disorders|endocrine disorders
5865139|NCT00004332|rare disease|rare disease
5865140|NCT00004331|inborn errors of metabolism|inborn errors of metabolism
5865141|NCT00004331|porphyria|porphyria
5865142|NCT00004331|rare disease|rare disease
5865143|NCT00004330|inborn errors of metabolism|inborn errors of metabolism
5865144|NCT00004330|porphyria|porphyria
5865145|NCT00004330|rare disease|rare disease
5865146|NCT00004329|endocrine disorders|endocrine disorders
5865147|NCT00004329|rare disease|rare disease
5865148|NCT00004328|endocrine disorders|endocrine disorders
5865149|NCT00004328|pseudohypoaldosteronism|pseudohypoaldosteronism
5865150|NCT00004328|rare disease|rare disease
5865151|NCT00004327|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865152|NCT00004327|hematologic disorders|hematologic disorders
5865153|NCT00004327|hereditary hemorrhagic telangiectasia|hereditary hemorrhagic telangiectasia
5865154|NCT00004327|rare disease|rare disease
5865155|NCT00004327|senile ectasia|senile ectasia
5865156|NCT00004326|Cushing's syndrome|cushing's syndrome
5865157|NCT00004326|endocrine disorders|endocrine disorders
5865158|NCT00004326|rare disease|rare disease
5865159|NCT00004325|Tourette syndrome|tourette syndrome
5865160|NCT00004325|anxiety disorder|anxiety disorder
5865161|NCT00004325|disease-related problem/condition|disease-related problem/condition
5865162|NCT00004325|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865163|NCT00004325|obsessive compulsive disorder|obsessive compulsive disorder
5865164|NCT00004325|oncologic disorders|oncologic disorders
5865165|NCT00004325|rare disease|rare disease
5865166|NCT00004324|Tourette syndrome|tourette syndrome
5865167|NCT00004324|anxiety disorder|anxiety disorder
5865168|NCT00004324|disease-related problem/condition|disease-related problem/condition
5865169|NCT00004324|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865170|NCT00004324|obsessive compulsive disorder|obsessive compulsive disorder
5865171|NCT00004324|oncologic disorders|oncologic disorders
5865172|NCT00004324|rare disease|rare disease
5865173|NCT00004323|aplastic anemia|aplastic anemia
5865174|NCT00004323|hematologic disorders|hematologic disorders
5865175|NCT00004323|rare disease|rare disease
5865176|NCT00004317|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5865177|NCT00004317|rare disease|rare disease
5865178|NCT00004317|toxoplasmosis|toxoplasmosis
5865179|NCT00004316|interstitial cystitis|interstitial cystitis
5865180|NCT00004316|rare disease|rare disease
5865181|NCT00004316|renal and genitourinary disorders|renal and genitourinary disorders
5865182|NCT00004316|vulvar vestibulitis|vulvar vestibulitis
5865183|NCT00004315|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5865184|NCT00004315|cholestasis|cholestasis
5865185|NCT00004315|cystic fibrosis|cystic fibrosis
5865186|NCT00004315|gastrointestinal disorders|gastrointestinal disorders
5865187|NCT00004315|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865188|NCT00004315|rare disease|rare disease
5865189|NCT00004314|Lesch-Nyhan syndrome|lesch-nyhan syndrome
5865190|NCT00004314|inborn errors of metabolism|inborn errors of metabolism
5865191|NCT00004314|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865192|NCT00004314|rare disease|rare disease
5865193|NCT00004313|Addison's disease|addison's disease
5865194|NCT00004313|endocrine disorders|endocrine disorders
5865195|NCT00004313|rare disease|rare disease
5865196|NCT00004313|primary adrenal insufficiency|primary adrenal insufficiency
5865197|NCT00004312|cystinosis|cystinosis
5865198|NCT00004312|rare disease|rare disease
5865199|NCT00004312|renal and genitourinary disorders|renal and genitourinary disorders
5865200|NCT00004311|acanthosis nigricans|acanthosis nigricans
5865201|NCT00004311|dermatologic disorders|dermatologic disorders
5865202|NCT00004311|endocrine disorders|endocrine disorders
5865203|NCT00004311|polycystic ovarian syndrome|polycystic ovarian syndrome
5865204|NCT00004311|rare disease|rare disease
5865205|NCT00004310|anxiety disorder|anxiety disorder
5865206|NCT00004310|disease-related problem/condition|disease-related problem/condition
5865207|NCT00004310|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865208|NCT00004310|obsessive compulsive disorder|obsessive compulsive disorder
5865209|NCT00004310|oncologic disorders|oncologic disorders
5865210|NCT00004310|rare disease|rare disease
5865211|NCT00004307|inborn errors of metabolism|inborn errors of metabolism
5865212|NCT00004307|rare disease|rare disease
5865213|NCT00004307|urea cycle disorder|urea cycle disorder
5865214|NCT00004306|hereditary ataxia|hereditary ataxia
5865215|NCT00004306|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865216|NCT00004306|rare disease|rare disease
5865217|NCT00004305|IgA glomerulonephritis|iga glomerulonephritis
5865218|NCT00004305|rare disease|rare disease
5865219|NCT00004305|renal and genitourinary disorders|renal and genitourinary disorders
5865220|NCT00004300|mental retardation|mental retardation
5865221|NCT00004300|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865222|NCT00004300|rare disease|rare disease
5865223|NCT00004300|stereotyped behavior|stereotyped behavior
5865224|NCT00004297|epilepsy|epilepsy
5865225|NCT00004297|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865226|NCT00004297|rare disease|rare disease
5865227|NCT00004297|seizures|seizures
5865228|NCT00004297|status epilepticus|status epilepticus
5865229|NCT00004296|atypical mycobacterium infection|atypical mycobacterium infection
5865230|NCT00004296|bacterial infection|bacterial infection
5865231|NCT00004296|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5865232|NCT00004296|cystic fibrosis|cystic fibrosis
5865233|NCT00004296|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865234|NCT00004296|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5865235|NCT00004296|mycobacterium infection|mycobacterium infection
5865236|NCT00004296|rare disease|rare disease
5865237|NCT00004294|Gaucher's disease|gaucher's disease
5865238|NCT00004294|inborn errors of metabolism|inborn errors of metabolism
5865239|NCT00004294|rare disease|rare disease
5865240|NCT00004294|sphingolipidoses|sphingolipidoses
5865241|NCT00004293|Gaucher's disease|gaucher's disease
5865242|NCT00004293|inborn errors of metabolism|inborn errors of metabolism
5865243|NCT00004293|rare disease|rare disease
5865244|NCT00004293|sphingolipidoses|sphingolipidoses
5865245|NCT00004288|ankylosing spondylitis|ankylosing spondylitis
5865246|NCT00004288|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865247|NCT00004288|rare disease|rare disease
5865248|NCT00004287|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5865249|NCT00004287|cystic fibrosis|cystic fibrosis
5865250|NCT00004287|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865251|NCT00004287|rare disease|rare disease
5865252|NCT00004286|demyelinating neuropathy|demyelinating neuropathy
5865253|NCT00004286|neurologic and psychiatric disorders|neurologic and psychiatric disorders
5865254|NCT00004286|rare disease|rare disease
5865255|NCT00004285|end stage renal disease|end stage renal disease
5865256|NCT00004285|rare disease|rare disease
5865257|NCT00004285|renal and genitourinary disorders|renal and genitourinary disorders
5865258|NCT00004284|hypercalciuria|hypercalciuria
5865259|NCT00004284|nephrolithiasis|nephrolithiasis
5865260|NCT00004284|rare disease|rare disease
5865261|NCT00004284|renal and genitourinary disorders|renal and genitourinary disorders
5865262|NCT00004278|congenital cytomegalovirus infection|congenital cytomegalovirus infection
5865263|NCT00004278|cytomegalovirus infection|cytomegalovirus infection
5865264|NCT00004278|herpesvirus infection|herpesvirus infection
5865265|NCT00004278|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5865266|NCT00004278|neonatal disorders|neonatal disorders
5865267|NCT00004278|rare disease|rare disease
5865268|NCT00004278|viral infection|viral infection
5865269|NCT00004276|bacterial infection|bacterial infection
5865270|NCT00004276|human immunodeficiency virus infection|human immunodeficiency virus infection
5865271|NCT00004276|immunologic disorders and infectious disorders|immunologic disorders and infectious disorders
5865272|NCT00004276|mycobacterium infection|mycobacterium infection
5865273|NCT00004276|mycobacterium tuberculosis infection|mycobacterium tuberculosis infection
5865274|NCT00004276|rare disease|rare disease
5865275|NCT00004276|viral infection|viral infection
5865276|NCT00004275|Turner's syndrome|turner's syndrome
5865277|NCT00004275|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865278|NCT00004275|rare disease|rare disease
5865279|NCT00004274|Turner's syndrome|turner's syndrome
5865280|NCT00004274|genetic diseases and dysmorphic syndromes|genetic diseases and dysmorphic syndromes
5865281|NCT00004274|rare disease|rare disease
5865282|NCT00004268|cardiovascular and respiratory diseases|cardiovascular and respiratory diseases
5865283|NCT00004268|disease-related problem/condition|disease-related problem/condition
5865284|NCT00004268|orthostatic hypotension|orthostatic hypotension
5865285|NCT00004268|quality of life|quality of life
5865286|NCT00004268|rare disease|rare disease
5865287|NCT00004266|diabetic nephropathy|diabetic nephropathy
5865288|NCT00004266|rare disease|rare disease
5865289|NCT00004266|renal and genitourinary disorders|renal and genitourinary disorders
5865291|NCT00000170|patching|patching
5865292|NCT00000170|atropine|atropine
5865293|NCT00000167|Age-Related Macular Degeneration|age-related macular degeneration
5865294|NCT00000163|Congenital Esotropia|congenital esotropia
5865295|NCT00000161|Age-Related Macular Degeneration|age-related macular degeneration
5865296|NCT00000160|Vision Loss|vision loss
5865297|NCT00000158|photocoagulation|photocoagulation
5865298|NCT00000158|argon blue-green laser|argon blue-green laser
5865299|NCT00000158|krypton red laser|krypton red laser
5865300|NCT00000153|Diabetic Disc Neovascularization|diabetic disc neovascularization
5865302|NCT00000152|Age-Related Macular Degeneration|age-related macular degeneration
5865303|NCT00000150|Ocular Histoplasmosis Syndrome|ocular histoplasmosis syndrome
5865304|NCT00000150|Idiopathic Choroidal Neovascularization|idiopathic choroidal neovascularization
5865305|NCT00000145|Age-Related Macular Degeneration|age-related macular degeneration
5865306|NCT00000139|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
5865307|NCT00000138|Herpes Simplex Stromal Keratitis|herpes simplex stromal keratitis
5865308|NCT00000131|Central Vein Occlusion|central vein occlusion
5865309|NCT00000131|Ischemic Retina|ischemic retina
5865310|NCT00000130|Bacterial Endophthalmitis|bacterial endophthalmitis
5865311|NCT00000128|Near-point Esophoria|near-point esophoria
5865312|NCT00000127|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
5865313|NCT00000126|Non-arteritic Ischemic Optic Neuropathy|non-arteritic ischemic optic neuropathy
5865314|NCT00000124|Choroidal Melanoma|choroidal melanoma
5865315|NCT00000124|Ocular Melanoma|ocular melanoma
5865317|NCT00000120|Neonatal Conjunctivitis|neonatal conjunctivitis
5865318|NCT00000114|retinitis pigmentosa|retinitis pigmentosa
5865319|NCT00000114|vitamin supplements|vitamin supplements
5865320|NCT00000113|myopia|myopia
5865321|NCT00000113|nearsightedness|nearsightedness
5865322|NCT00000357|opiate dependence|opiate dependence
5865323|NCT00000356|opiate dependence|opiate dependence
5865324|NCT00000355|opiate dependence|opiate dependence
5865325|NCT00000354|opiate dependence|opiate dependence
5865326|NCT00000353|opiate dependence|opiate dependence
5865327|NCT00000352|opiate dependence|opiate dependence
5865328|NCT00000350|amphetamine dependence|amphetamine dependence
5865329|NCT00000349|cocaine dependence|cocaine dependence
5865330|NCT00000348|cocaine dependence|cocaine dependence
5865331|NCT00000347|cocaine dependence|cocaine dependence
5865332|NCT00000346|amphetamine dependence|amphetamine dependence
5865333|NCT00000345|opioid dependence|opioid dependence
5865334|NCT00000344|opioid dependence|opioid dependence
5865335|NCT00000343|stimulant dependence|stimulant dependence
5865336|NCT00000342|cocaine dependence|cocaine dependence
5865337|NCT00000341|opioid dependence|opioid dependence
5865338|NCT00000340|cocaine dependence|cocaine dependence
5865339|NCT00000339|cocaine dependence|cocaine dependence
5865340|NCT00000338|cocaine dependence|cocaine dependence
5865341|NCT00000337|cocaine dependence|cocaine dependence
5865342|NCT00000336|cocaine dependence|cocaine dependence
5865343|NCT00000335|opioid dependence|opioid dependence
5865344|NCT00000331|Heroin Dependence|heroin dependence
5865345|NCT00000330|Heroin Dependence|heroin dependence
5865346|NCT00000329|drug dependence|drug dependence
5865347|NCT00000328|drug dependence|drug dependence
5865348|NCT00000327|drug dependence|drug dependence
5865349|NCT00000326|Heroin Dependence|heroin dependence
5865350|NCT00000325|cocaine dependence|cocaine dependence
5865351|NCT00000323|cocaine dependence|cocaine dependence
5865352|NCT00000322|amphetamine dependence|amphetamine dependence
5865353|NCT00000321|methamphetamine dependence|methamphetamine dependence
5865354|NCT00000320|opioid dependence|opioid dependence
5865355|NCT00000318|opioid dependence|opioid dependence
5865356|NCT00000317|Cocaine|cocaine
5865357|NCT00000317|METHADONE PATIENTS|methadone patients
5865358|NCT00000317|RISPERIDONE|risperidone
5865359|NCT00000316|cocaine dependence|cocaine dependence
5865360|NCT00000315|cocaine dependence|cocaine dependence
5865361|NCT00000314|cocaine dependence|cocaine dependence
5865362|NCT00000313|cocaine dependence|cocaine dependence
5865363|NCT00000311|Cocaine-Related Disorders|cocaine-related disorders
5865364|NCT00000311|Opioid-Related Disorders|opioid-related disorders
5865365|NCT00000311|Substance-Related Disorders|substance-related disorders
5865366|NCT00000310|cocaine dependence|cocaine dependence
5865367|NCT00000309|cocaine abuse, cocaine addiction|cocaine abuse, cocaine addiction
5865368|NCT00000308|cocaine dependence|cocaine dependence
5865369|NCT00000307|alcohol dependence|alcohol dependence
5865370|NCT00000306|cocaine dependence|cocaine dependence
5865371|NCT00000304|cocaine dependence|cocaine dependence
5865372|NCT00000303|Cocaine dependence|cocaine dependence
5865373|NCT00000301|Amantadine|amantadine
5865374|NCT00000301|Cocaine|cocaine
5865375|NCT00000301|Pharmacotherapy|pharmacotherapy
5865376|NCT00000301|Outpatient|outpatient
5865377|NCT00000300|opiate|opiate
5865378|NCT00000300|dependence|dependence
5865379|NCT00000299|Opioid-Related Disorders|opioid-related disorders
5865380|NCT00000296|nicotine dependence|nicotine dependence
5865381|NCT00000293|cocaine dependence|cocaine dependence
5865382|NCT00000291|cocaine dependence|cocaine dependence
5865383|NCT00000290|cocaine dependence|cocaine dependence
5865384|NCT00000288|nicotine dependence|nicotine dependence
5865385|NCT00000287|Cocaine-Related Disorders|cocaine-related disorders
5865386|NCT00000286|cocaine dependence|cocaine dependence
5865387|NCT00000285|cocaine dependence|cocaine dependence
5865388|NCT00000284|nicotine dependence|nicotine dependence
5865389|NCT00000282|pemoline|pemoline
5865390|NCT00000281|anti psychotic agents|anti psychotic agents
5865391|NCT00000280|cocaine|cocaine
5865392|NCT00000275|cocaine dependence|cocaine dependence
5865393|NCT00000274|cocaine dependence|cocaine dependence
5865394|NCT00000273|heroin, opioid disorders, substance related disorders|heroin, opioid disorders, substance related disorders
5865395|NCT00000271|Desipramine, cocaine, depression|desipramine, cocaine, depression
5865396|NCT00000270|cocaine|cocaine
5865397|NCT00000269|cocaine dependence|cocaine dependence
5865398|NCT00000268|cocaine dependence|cocaine dependence
5865399|NCT00000267|cocaine dependence|cocaine dependence
5865400|NCT00000266|cocaine dependence|cocaine dependence
5865401|NCT00000265|nitrous oxide|nitrous oxide
5865402|NCT00000265|anxiety|anxiety
5865403|NCT00000265|subjective effects|subjective effects
5865404|NCT00000265|dental|dental
5865405|NCT00000265|patients|patients
5865406|NCT00000264|nitrous oxide|nitrous oxide
5865407|NCT00000264|inhalant|inhalant
5865408|NCT00000264|ethanol|ethanol
5865409|NCT00000264|subjective effects|subjective effects
5865410|NCT00000264|psychomotor effects|psychomotor effects
5865411|NCT00000264|healthy volunteer|healthy volunteer
5865412|NCT00000263|nitrous oxide|nitrous oxide
5865413|NCT00000263|ethanol|ethanol
5865414|NCT00000263|drug interaction|drug interaction
5865415|NCT00000263|subjective effects|subjective effects
5865416|NCT00000263|healthy volunteer|healthy volunteer
5865417|NCT00000262|nitrous oxide|nitrous oxide
5865418|NCT00000262|sevoflurane|sevoflurane
5865419|NCT00000262|drug interaction|drug interaction
5865420|NCT00000262|subjective effects|subjective effects
5865421|NCT00000262|analgesia|analgesia
5865422|NCT00000262|healthy volunteers|healthy volunteers
5865423|NCT00000261|nitrous oxide|nitrous oxide
5865424|NCT00000261|sevoflurane|sevoflurane
5865425|NCT00000261|ethanol|ethanol
5865426|NCT00000261|subjective effects|subjective effects
5865427|NCT00000261|healthy volunteer|healthy volunteer
5865428|NCT00000260|nitrous oxide|nitrous oxide
5865429|NCT00000260|subjective effects|subjective effects
5865430|NCT00000260|reinforcer|reinforcer
5865431|NCT00000260|inhalant|inhalant
5865432|NCT00000260|healthy volunteer|healthy volunteer
5865433|NCT00000259|sevoflurane|sevoflurane
5865434|NCT00000259|nitrous oxide|nitrous oxide
5865435|NCT00000259|subjective effects|subjective effects
5865436|NCT00000259|healthy volunteer|healthy volunteer
5865437|NCT00000258|nitrous oxide|nitrous oxide
5865438|NCT00000258|instruction|instruction
5865439|NCT00000258|subjective effects|subjective effects
5865440|NCT00000258|reinforcer|reinforcer
5865441|NCT00000258|healthy volunteer|healthy volunteer
5865442|NCT00000257|nitrous oxide|nitrous oxide
5865443|NCT00000257|subjective effects|subjective effects
5865444|NCT00000257|ethanol|ethanol
5865445|NCT00000257|healthy volunteer|healthy volunteer
5865446|NCT00000256|nitrous oxide|nitrous oxide
5865447|NCT00000256|reinforcer|reinforcer
5865448|NCT00000256|subjective effects|subjective effects
5865449|NCT00000256|healthy volunteer|healthy volunteer
5865450|NCT00000255|nitrous oxide|nitrous oxide
5865451|NCT00000255|acute tolerance|acute tolerance
5865452|NCT00000255|subjective effects|subjective effects
5865453|NCT00000255|analgesia|analgesia
5865454|NCT00000255|psychomotor|psychomotor
5865455|NCT00000255|healthy volunteer|healthy volunteer
5865456|NCT00000254|isoflurane|isoflurane
5865457|NCT00000254|general anesthetic|general anesthetic
5865458|NCT00000254|inhalant|inhalant
5865459|NCT00000254|subjective effects|subjective effects
5865460|NCT00000254|healthy volunteer|healthy volunteer
5865461|NCT00000253|nitrous oxide|nitrous oxide
5865462|NCT00000253|inhalant|inhalant
5865463|NCT00000253|subjective effects|subjective effects
5865464|NCT00000253|healthy volunteer|healthy volunteer
5865465|NCT00000252|nitrous oxide|nitrous oxide
5865466|NCT00000252|acute tolerance|acute tolerance
5865467|NCT00000252|subjective effects|subjective effects
5865468|NCT00000252|psychomotor|psychomotor
5865469|NCT00000252|analgesia|analgesia
5865470|NCT00000252|healthy volunteer|healthy volunteer
5865471|NCT00000251|nitrous oxide|nitrous oxide
5865472|NCT00000251|isoflurane|isoflurane
5865473|NCT00000251|subjective effects|subjective effects
5865474|NCT00000251|psychomotor|psychomotor
5865475|NCT00000251|healthy volunteer|healthy volunteer
5865476|NCT00000251|drug interaction|drug interaction
5865477|NCT00000250|nitrous oxide|nitrous oxide
5865478|NCT00000250|choice|choice
5865479|NCT00000250|subjective effects|subjective effects
5865480|NCT00000250|pain|pain
5865481|NCT00000250|analgesia|analgesia
5865482|NCT00000250|reinforcer|reinforcer
5865483|NCT00000250|healthy volunteer|healthy volunteer
5865484|NCT00000249|nitrous oxide|nitrous oxide
5865485|NCT00000249|subjective effects|subjective effects
5865486|NCT00000249|healthy volunteer|healthy volunteer
5865487|NCT00000246|Substance-Related Disorders|substance-related disorders
5865488|NCT00000245|cocaine dependence|cocaine dependence
5865489|NCT00000244|addiction|addiction
5865490|NCT00000244|opiate|opiate
5865491|NCT00000244|heroin|heroin
5865492|NCT00000244|dynorphin|dynorphin
5865493|NCT00000243|opioid dependence|opioid dependence
5865494|NCT00000242|Cocaine|cocaine
5865495|NCT00000242|Substance Abuse|substance abuse
5865496|NCT00000241|methamphetamine dependence|methamphetamine dependence
5865497|NCT00000218|cocaine dependence|cocaine dependence
5865499|NCT00000215|cocaine dependence|cocaine dependence
5865500|NCT00000214|intravenous abuse|intravenous abuse
5865501|NCT00000213|intravenous abuse|intravenous abuse
5865503|NCT00000210|opioid addiction|opioid addiction
5865504|NCT00000210|cocaine addiction|cocaine addiction
5865505|NCT00000207|Buprenorphine|buprenorphine
5865506|NCT00000207|Opioid|opioid
5865507|NCT00000206|Opioid|opioid
5865508|NCT00000201|cocaine dependence|cocaine dependence
5865509|NCT00000200|self-administration|self-administration
5865510|NCT00000199|cocaine|cocaine
5865511|NCT00000198|cocaine|cocaine
5865512|NCT00000197|cocaine|cocaine
5865513|NCT00000195|opioid disorders|opioid disorders
5865514|NCT00000194|opioid disorders|opioid disorders
5865515|NCT00000193|Opioid disorders|opioid disorders
5865516|NCT00000192|opioid disorders|opioid disorders
5865517|NCT00000191|Cocaine Dependence|cocaine dependence
5865518|NCT00000191|Carbamazepine|carbamazepine
5865519|NCT00000190|Cocaine Detection|cocaine detection
5865520|NCT00000190|Parotid Saliva|parotid saliva
5865521|NCT00000189|Cocaine Dependence|cocaine dependence
5865522|NCT00000189|Gepirone|gepirone
5865523|NCT00000188|Cocaine Dependence|cocaine dependence
5865524|NCT00000188|Selegiline|selegiline
5865525|NCT00000187|Cocaine Dependence|cocaine dependence
5865526|NCT00000187|ritanserin|ritanserin
5865527|NCT00004640|Aging|aging
5865528|NCT00004640|Elderly|elderly
5865529|NCT00004640|Periodontal Disease|periodontal disease
5856626|NCT00000746|HIV-1|hiv-1
5860928|NCT00004696|pain|pain
5846410|NCT00044590|Genetic susceptibility|genetic susceptibility
5846411|NCT00044590|Polymorphisms|polymorphisms
5846412|NCT00044577|HIV-1 Abacavir Lamivudine Tenofovir|hiv-1 abacavir lamivudine tenofovir
5846413|NCT00044564|Taxane|taxane
5846414|NCT00044564|Renal Cell Carcinoma|renal cell carcinoma
5846415|NCT00044564|Advanced Renal Cell Carcinoma|advanced renal cell carcinoma
5846416|NCT00044551|Taxane|taxane
5846417|NCT00044551|Lymphoma|lymphoma
5846418|NCT00044551|Non-Hodgkin's Lymphoma|non-hodgkin's lymphoma
5846420|NCT00044538|Lung cancer, non-small cell|lung cancer, non-small cell
5846422|NCT00044525|Taxane|taxane
5846423|NCT00044525|Breast Cancer|breast cancer
5846424|NCT00044525|Metastasis|metastasis
5846425|NCT00044512|Cancer|cancer
5846426|NCT00044512|Liver Cancer|liver cancer
5846427|NCT00044512|Hepatocellular carcinoma (HCC)|hepatocellular carcinoma (hcc)
5846428|NCT00044486|Prophylaxis|prophylaxis
5846429|NCT00044486|neutropenia|neutropenia
5846430|NCT00044486|AML|aml
5846431|NCT00044486|MDS|mds
5846432|NCT00044486|fungal infections|fungal infections
5846433|NCT00044486|Acute Myelogenous Leukemia|acute myelogenous leukemia
5846434|NCT00044486|Anticipated prolonged profound neutropenia|anticipated prolonged profound neutropenia
5846435|NCT00044473|Otitis Media|otitis media
5846436|NCT00044473|Ear Diaeases|ear diaeases
5846437|NCT00044473|Levofloxacin|levofloxacin
5846438|NCT00044473|Quinolones|quinolones
5846439|NCT00044460|Type 2 diabetes drug-naive|type 2 diabetes drug-naive
5846440|NCT00044382|Revimid|revimid
5846441|NCT00044382|CC5013|cc5013
5846442|NCT00044382|CC-5013|cc-5013
5846443|NCT00044369|Varicocele|varicocele
5846444|NCT00044369|environmental toxins|environmental toxins
5846445|NCT00044369|male infertility|male infertility
5846446|NCT00044369|cadmium|cadmium
5846447|NCT00044356|Melanoma|melanoma
5846448|NCT00044356|Metastatic Melanoma|metastatic melanoma
5846449|NCT00044356|Malignant Melanoma|malignant melanoma
5846450|NCT00044356|Skin Cancer|skin cancer
5846451|NCT00044356|Tumor|tumor
5846452|NCT00044356|Experimental Treatment|experimental treatment
5846453|NCT00044356|Clinical Trial|clinical trial
5846454|NCT00044356|Gene Therapy|gene therapy
5846455|NCT00044356|Gene Delivery|gene delivery
5846456|NCT00044356|Gene Transfer|gene transfer
5846458|NCT00044356|Cancer|cancer
5847939|NCT00037544|A|a
5860735|NCT00004804|hepatitis C|hepatitis c
5849071|NCT00031343|HIV|hiv
5849848|NCT00027365|HIV-1|hiv-1
5850128|NCT00026598|PD|pd
5850620|NCT00017992|HIV-1|hiv-1
5851708|NCT00004581|ABT 378|abt 378
5851914|NCT00002423|VX 478|vx 478
5855770|NCT00000888|Fetal Blood|fetal blood
5856560|NCT00000757|HIV-1|hiv-1
5856791|NCT00000722|Lung|lung
5858492|NCT00013546|TS|ts
5858540|NCT00012558|Psychotic Disorders|psychotic disorders
5858758|NCT00011245|Trauma|trauma
5860488|NCT00004988|Tumor|tumor
5860945|NCT00004689|rare disease|rare disease
5864615|NCT00000178|Alzheimer's disease|alzheimer's disease
5865530|NCT00004640|Dental Caries|dental caries
5865531|NCT00004640|Fluoride|fluoride
5865532|NCT00004640|Antibacterial rinse|antibacterial rinse
5865533|NCT00004640|Chlorhexidine|chlorhexidine
5865534|NCT00004640|Tooth Mortality|tooth mortality
5865535|NCT00004639|cleft lip and palate|cleft lip and palate
5865536|NCT00004639|children|children
5865537|NCT00004639|speech|speech
5865538|NCT00004639|velopharyngeal function|velopharyngeal function
5865539|NCT00004639|congenital facial malformation|congenital facial malformation
5865540|NCT00004639|von Langenbeck procedure|von langenbeck procedure
5865541|NCT00004639|Furlow procedure|furlow procedure
5865542|NCT00004639|cleft lip and palate repair|cleft lip and palate repair
5865543|NCT00004639|Unilateral cleft lip and palate|unilateral cleft lip and palate
5861397|NCT00000429|Dietary supplement|dietary supplement
5862252|NCT00001661|Use|use
5862580|NCT00001580|CGAP|cgap
5863390|NCT00001307|Analgesia|analgesia
5854823|NCT00001031|HIV-1|hiv-1
5864446|NCT00000376|Depression|depression
5865102|NCT00004342|neutropenia|neutropenia
5838488|NCT00006471|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity|recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
5838490|NCT00006470|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5838491|NCT00006470|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5838492|NCT00006469|stage II non-small cell lung cancer|stage ii non-small cell lung cancer
5838493|NCT00006469|stage IIIA non-small cell lung cancer|stage iiia non-small cell lung cancer
5838494|NCT00006468|stage IV colon cancer|stage iv colon cancer
5838496|NCT00006468|recurrent colon cancer|recurrent colon cancer
5838497|NCT00006468|recurrent rectal cancer|recurrent rectal cancer
5838498|NCT00006468|adenocarcinoma of the colon|adenocarcinoma of the colon
5838499|NCT00006468|adenocarcinoma of the rectum|adenocarcinoma of the rectum
5838500|NCT00006465|unspecified adult solid tumor, protocol specific|unspecified adult solid tumor, protocol specific
5838501|NCT00006462|recurrent childhood acute lymphoblastic leukemia|recurrent childhood acute lymphoblastic leukemia
5838502|NCT00006462|recurrent childhood acute myeloid leukemia|recurrent childhood acute myeloid leukemia
5850505|NCT00023374|efficacy|efficacy
5839577|NCT00005859|adult glioblastoma|adult glioblastoma
5841764|NCT00003687|pain|pain
5851404|NCT00005918|Lamivudine|lamivudine
5858676|NCT00011531|SCI|sci
5841383|NCT00003910|LGL clone|lgl clone
5841434|NCT00003863|noncontiguous stage II mantle cell lymphoma|noncontiguous stage ii mantle cell lymphoma
5841435|NCT00003863|noncontiguous stage II adult diffuse mixed cell lymphoma|noncontiguous stage ii adult diffuse mixed cell lymphoma
5841436|NCT00003863|noncontiguous stage II adult immunoblastic large cell lymphoma|noncontiguous stage ii adult immunoblastic large cell lymphoma
5859046|NCT00007683|embolic events|embolic events
5859150|NCT00007215|Lens|lens
5841657|NCT00003739|neutropenia|neutropenia
5859360|NCT00006417|Oxidase|oxidase
5847582|NCT00038779|CLL|cll
5841877|NCT00003612|stage IV breast cancer|stage iv breast cancer
5849565|NCT00028405|Bulky Tumor|bulky tumor
5860062|NCT00005900|fucosidosis|fucosidosis
5862023|NCT00001746|HCM|hcm
5862078|NCT00001726|Mouth|mouth
5862384|NCT00001630|Evan's Syndrome|evan's syndrome
5843927|NCT00051701|Campath|campath
5843928|NCT00051701|alemtuzumab|alemtuzumab
5843929|NCT00051675|adenocarcinoma|adenocarcinoma
5843930|NCT00051675|monoclonal antibody|monoclonal antibody
5843931|NCT00051636|Bisphosphonate|bisphosphonate
5843932|NCT00051636|SAP|sap
5843933|NCT00051636|SAP excess|sap excess
5843934|NCT00051636|non-inferiority|non-inferiority
5843935|NCT00051636|therapeutic response|therapeutic response
5843936|NCT00051636|extended observation period|extended observation period
5843937|NCT00051623|Psoriatic arthritis|psoriatic arthritis
5843938|NCT00051623|Infliximab|infliximab
5843939|NCT00051623|Remicade|remicade
5843940|NCT00051571|Carcinoma, Non-Small-Cell Lung|carcinoma, non-small-cell lung
5843941|NCT00051428|Fibromyalgia, Reiki, Energy Medicine|fibromyalgia, reiki, energy medicine
5843942|NCT00051415|Flaxseed|flaxseed
5843943|NCT00051415|Cholesterol|cholesterol
5843944|NCT00051402|Postmenopausal|postmenopausal
5843945|NCT00051402|Memory Loss|memory loss
5843946|NCT00051402|Cognition|cognition
5843947|NCT00051402|Phytoestrogens|phytoestrogens
5843948|NCT00051545|liver|liver
5843949|NCT00051545|cancer|cancer
5843950|NCT00051545|hepatocellular|hepatocellular
5843951|NCT00051545|carcinoma|carcinoma
5843952|NCT00051532|hepatocellular|hepatocellular
5843953|NCT00051532|carcinoma|carcinoma
5843954|NCT00051532|liver|liver
5843955|NCT00051532|cancer|cancer
5843956|NCT00051493|Non-Small Cell Lung Cancer|non-small cell lung cancer
5843957|NCT00051493|Lung Cancer|lung cancer
5843958|NCT00051493|NSCLC|nsclc
5843959|NCT00051493|Advanced Non-Small Cell Lung Cancer|advanced non-small cell lung cancer
5843960|NCT00051519|HIV|hiv
5843961|NCT00051519|AIDS|aids
5843962|NCT00051519|Vaccine|vaccine
5843963|NCT00051519|HIV-positive|hiv-positive
5843964|NCT00051519|Therapy|therapy
5843965|NCT00051454|HIV Seronegativity|hiv seronegativity
5843966|NCT00051454|HIV Preventive Vaccine|hiv preventive vaccine
5843967|NCT00051441|stomatitis|stomatitis
5843968|NCT00051441|radiation effects|radiation effects
5843969|NCT00051363|Obstructive Sleep Apnea|obstructive sleep apnea
5843970|NCT00051337|Kinesiogenic|kinesiogenic
5843971|NCT00051337|Psychogenic|psychogenic
5843972|NCT00051337|Channelopathy|channelopathy
5843973|NCT00051337|Ictal|ictal
5849843|NCT00027378|Alcoholism|alcoholism
5863526|NCT00001257|LTB4|ltb4
5863527|NCT00001257|Inflammation|inflammation
5863528|NCT00001257|Normal Volunteer|normal volunteer
5863529|NCT00001257|Abnormal Phagocyte Function|abnormal phagocyte function
5863530|NCT00001256|Vasculitis|vasculitis
5844374|NCT00001968|HIV|hiv
5844863|NCT00001614|Iritis|iritis
5844967|NCT00001527|BQ-123|bq-123
5845173|NCT00001422|Psoriasis|psoriasis
5845670|NCT00050180|HV|hv
5845727|NCT00050011|Letrozole|letrozole
5846084|NCT00047593|POAG|poag
5846187|NCT00046410|Cognitive|cognitive
5846607|NCT00043888|fosamprenavir|fosamprenavir
5846608|NCT00043888|ritonavir|ritonavir
5846609|NCT00043888|COMBIVIR|combivir
5846610|NCT00043888|TRIZIVIR|trizivir
5846611|NCT00043888|abacavir|abacavir
5846612|NCT00043888|lamivudine|lamivudine
5846613|NCT00043888|zidovudine|zidovudine
5846614|NCT00043888|HIV|hiv
5846615|NCT00043888|protease inhibitors|protease inhibitors
5846616|NCT00043979|Ewing's Sarcoma|ewing's sarcoma
5846619|NCT00043979|Sarcoma|sarcoma
5846956|NCT00042185|Bulimia|bulimia
5847172|NCT00040651|Leukapheresis|leukapheresis
5847173|NCT00040651|Mesna|mesna
5847174|NCT00040651|Stem Cell|stem cell
5847175|NCT00040651|T-Cell|t-cell
5847176|NCT00040651|Thymoglobulin|thymoglobulin
5847177|NCT00040651|Scleroderma|scleroderma
5847178|NCT00040027|hepatitis C|hepatitis c
5847278|NCT00040248|Activated Lymphocyte|activated lymphocyte
5847279|NCT00040248|Wegener Granulomatosis|wegener granulomatosis
5847280|NCT00040248|Wegener's Granulomatosis|wegener's granulomatosis
5847281|NCT00040248|WG|wg
5847282|NCT00040235|Leukapheresis|leukapheresis
5847283|NCT00040235|Hypomagnesemia|hypomagnesemia
5847284|NCT00040235|Plateletpheresis|plateletpheresis
5847285|NCT00040235|Hypocalcemia|hypocalcemia
5847286|NCT00040235|Citrate|citrate
5847287|NCT00040235|Healthy Volunteer|healthy volunteer
5847540|NCT00038831|AML|aml
5848788|NCT00033787|Normal Control|normal control
5848797|NCT00033215|neovascularization|neovascularization
5848798|NCT00033215|matrix metalloproteinases|matrix metalloproteinases
5848799|NCT00033215|antiangiogenesis|antiangiogenesis
5848800|NCT00033215|type IV collagenases|type iv collagenases
5848801|NCT00033202|Solid Tumor|solid tumor
5848802|NCT00033202|Camptothecin|camptothecin
5848911|NCT00032721|Subtle energy therapy|subtle energy therapy
5849153|NCT00031083|Glioma|glioma
5849821|NCT00027469|ARAS|aras
5850351|NCT00025701|HV|hv
5850469|NCT00024479|Health Disparities|health disparities
5851582|NCT00004999|Anti-HIV Agents|anti-hiv agents
5852641|NCT00002285|Lymphocytes|lymphocytes
5852802|NCT00002250|IgG|igg
5852918|NCT00002230|Stavudine|stavudine
5853219|NCT00002183|VX 478|vx 478
5853415|NCT00002149|AIDS-Related Complex|aids-related complex
5854227|NCT00001131|Viremia|viremia
5854419|NCT00001094|Nelfinavir|nelfinavir
5854707|NCT00001048|Infusions, Intravenous|infusions, intravenous
5855938|NCT00000868|AIDS Vaccines|aids vaccines
5856032|NCT00000854|Anabolic Steroids|anabolic steroids
5856216|NCT00000822|Ritonavir|ritonavir
5856674|NCT00000737|Megestrol|megestrol
5857233|NCT00000647|IgG|igg
5857770|NCT00018850|ondansetron|ondansetron
5857874|NCT00018070|Choroid|choroid
5857875|NCT00018070|Blood Vessels|blood vessels
5857876|NCT00018070|Choroidal Neovascularization|choroidal neovascularization
5857877|NCT00018070|Laser|laser
5857878|NCT00018070|Macular Degeneration|macular degeneration
5857879|NCT00018070|AMD|amd
5857880|NCT00018057|fMRI|fmri
5857881|NCT00018057|Emotion|emotion
5857882|NCT00018057|Normal Volunteers|normal volunteers
5857883|NCT00018057|Magnetic Resonance Imaging|magnetic resonance imaging
5857884|NCT00018057|CBT|cbt
5857885|NCT00018057|Adolescent|adolescent
5857886|NCT00018057|Anxiety Disorder|anxiety disorder
5857887|NCT00018057|Mood Disorder|mood disorder
5857888|NCT00018057|Depression|depression
5858296|NCT00014807|Pesticide exposure|pesticide exposure
5858615|NCT00011765|Aggression|aggression
5858616|NCT00011765|Serotonin Reuptake Inhibitors (SSRI)|serotonin reuptake inhibitors (ssri)
5858617|NCT00011765|Rage|rage
5858618|NCT00011765|Fear|fear
5858619|NCT00011765|Violence|violence
5858626|NCT00011752|Alcoholism|alcoholism
5859167|NCT00007137|3D MRI|3d mri
5859168|NCT00007137|Diffusion Tensor|diffusion tensor
5859169|NCT00007137|Tongue|tongue
5859170|NCT00007137|Ultrasound|ultrasound
5859269|NCT00006447|Brain Injuries|brain injuries
5859271|NCT00006447|Caregivers|caregivers
5859272|NCT00006447|Burden and Dependency|burden and dependency
5859394|NCT00006394|disease-related problem/condition|disease-related problem/condition
5859395|NCT00006394|endocrine disorders|endocrine disorders
5859396|NCT00006394|growth hormone deficiency|growth hormone deficiency
5859397|NCT00006394|osteoporosis|osteoporosis
5859398|NCT00006394|quality of life|quality of life
5860323|NCT00005569|Age|age
5860552|NCT00004734|vitamin B12|vitamin b12
5861000|NCT00004661|rare disease|rare disease
5861001|NCT00004660|Graves' disease|graves' disease
5861002|NCT00004660|thyroid disease|thyroid disease
5861107|NCT00004567|Wegener's Disease|wegener's disease
5861108|NCT00004567|Blood Vessel Disorder|blood vessel disorder
5861109|NCT00004567|Systemic Vasculitis|systemic vasculitis
5861229|NCT00001973|Calcinosis|calcinosis
5861230|NCT00001972|Alzheimer's Disease|alzheimer's disease
5861231|NCT00001972|Positron Emission Tomography|positron emission tomography
5861232|NCT00001972|Brain Phospholipid|brain phospholipid
5861233|NCT00001972|Fatty Acids|fatty acids
5861234|NCT00001972|11C Arachidonate|11c arachidonate
5861235|NCT00001972|Signal Transduction|signal transduction
5861236|NCT00001972|Brain|brain
5861249|NCT00001969|Cardiovascular Disease|cardiovascular disease
5861250|NCT00001969|Glucose Clamp|glucose clamp
5861251|NCT00001969|Hypercortisolism|hypercortisolism
5861252|NCT00001969|Insulin Sensitivity|insulin sensitivity
5861253|NCT00001969|Major Depression Disorder|major depression disorder
5861254|NCT00001969|Inflammation|inflammation
5861255|NCT00001969|Coagulation|coagulation
5861256|NCT00001969|Metabolic|metabolic
5861333|NCT00001953|Glucose Tolerance Test|glucose tolerance test
5861542|NCT00001913|Attachment|attachment
5861702|NCT00001865|Uveitis|uveitis
5861929|NCT00001778|Viral Load|viral load
5862172|NCT00001702|Variant Alleles|variant alleles
5862403|NCT00001623|Whole Body Irradiation|whole body irradiation
5862404|NCT00001623|Donor Apheresis|donor apheresis
5862405|NCT00001623|Cyclophosphamide|cyclophosphamide
5862406|NCT00001623|Graft-Versus-Myeloma|graft-versus-myeloma
5862522|NCT00001599|Xerostomia|xerostomia
5862523|NCT00001599|Autoimmunity|autoimmunity
5862524|NCT00001599|Salivary Glands|salivary glands
5862525|NCT00001599|Lacrimal Function|lacrimal function
5862526|NCT00001599|Immunomodulator|immunomodulator
5862527|NCT00001599|Sjogren's Syndrome|sjogren's syndrome
5862528|NCT00001599|Dry Mouth|dry mouth
5862529|NCT00001598|Xerostomia|xerostomia
5862530|NCT00001598|Autoimmunity|autoimmunity
5862531|NCT00001598|Salivary Glands|salivary glands
5862532|NCT00001598|Androgen Therapy|androgen therapy
5862533|NCT00001598|Lacrimal Function|lacrimal function
5862534|NCT00001598|DHEA|dhea
5862535|NCT00001598|Sjogren's Syndrome|sjogren's syndrome
5862536|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone
5862537|NCT00001597|Psychophysics|psychophysics
5863391|NCT00001307|PET|pet
5863606|NCT00001241|Histamine H2-Receptor Antagonists|histamine h2-receptor antagonists
5863647|NCT00001225|Gene Mapping|gene mapping
5863648|NCT00001225|Linkage Analysis|linkage analysis
5863649|NCT00001225|Hypertrophic Cardiomyopathy|hypertrophic cardiomyopathy
5863993|NCT00001146|Mood Disorders|mood disorders
5864195|NCT00000405|Biomechanics|biomechanics
5864590|NCT00000363|Otitis Media|otitis media
5864950|NCT00004392|apnea|apnea
5865125|NCT00004336|rare disease|rare disease
5865316|NCT00000121|strabismus|strabismus
5865502|NCT00000212|crack cocaine|crack cocaine
5862131|NCT00001716|P50|p50
